id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
6281470|NCT00168805|7181545|FG000|STARTED|Overall Study||679
6281471|NCT00168805|7181546|FG001|STARTED|Overall Study||703
6281472|NCT00168805|7181547|FG002|STARTED|Overall Study||694
6281473|NCT00168805|7181545|FG000|COMPLETED|Overall Study||608
6281474|NCT00168805|7181546|FG001|COMPLETED|Overall Study||625
6281475|NCT00168805|7181547|FG002|COMPLETED|Overall Study||616
6281476|NCT00168805|7181545|FG000|NOT COMPLETED|Overall Study||71
6281477|NCT00168805|7181546|FG001|NOT COMPLETED|Overall Study||78
6281478|NCT00168805|7181547|FG002|NOT COMPLETED|Overall Study||78
6281479|NCT00168805|7181545|FG000|STARTED|Treatment||679
6281480|NCT00168805|7181546|FG001|STARTED|Treatment||703
6281481|NCT00168805|7181547|FG002|STARTED|Treatment||694
6281482|NCT00168805|7181545|FG000|COMPLETED|Treatment||630
6281483|NCT00168805|7181546|FG001|COMPLETED|Treatment||647
6281484|NCT00168805|7181547|FG002|COMPLETED|Treatment||632
6281485|NCT00168805|7181545|FG000|NOT COMPLETED|Treatment||49
6281486|NCT00168805|7181546|FG001|NOT COMPLETED|Treatment||56
6281487|NCT00168805|7181547|FG002|NOT COMPLETED|Treatment||62
6281488|NCT00168818|7181558|FG000|STARTED|Overall Study||1146
6281489|NCT00168818|7181559|FG001|STARTED|Overall Study||1163
6281490|NCT00168818|7181560|FG002|STARTED|Overall Study||1154
6281491|NCT00168818|7181558|FG000|COMPLETED|Overall Study||1029
6281492|NCT00168818|7181559|FG001|COMPLETED|Overall Study||1054
6281493|NCT00168818|7181560|FG002|COMPLETED|Overall Study||1030
6281494|NCT00168818|7181558|FG000|NOT COMPLETED|Overall Study||117
6281495|NCT00168818|7181559|FG001|NOT COMPLETED|Overall Study||109
6281496|NCT00168818|7181560|FG002|NOT COMPLETED|Overall Study||124
6281497|NCT00168818|7181558|FG000|STARTED|Treatment||1146
6281498|NCT00168818|7181559|FG001|STARTED|Treatment||1163
6281499|NCT00168818|7181560|FG002|STARTED|Treatment||1154
6281500|NCT00168818|7181558|FG000|COMPLETED|Treatment||1013
6281501|NCT00168818|7181559|FG001|COMPLETED|Treatment||1012
6281502|NCT00168818|7181560|FG002|COMPLETED|Treatment||1021
6281503|NCT00168818|7181558|FG000|NOT COMPLETED|Treatment||133
6281504|NCT00168818|7181559|FG001|NOT COMPLETED|Treatment||151
6281505|NCT00168818|7181560|FG002|NOT COMPLETED|Treatment||133
6281506|NCT00168831|7181571|FG000|STARTED|Overall Study||338
6281507|NCT00168831|7181572|FG001|STARTED|Overall Study||335
6281508|NCT00168831|7181573|FG002|STARTED|Overall Study||334
6281509|NCT00168831|7181571|FG000|COMPLETED|Overall Study||278
6281510|NCT00168831|7181572|FG001|COMPLETED|Overall Study||254
6281511|NCT00168831|7181573|FG002|COMPLETED|Overall Study||220
6281512|NCT00168831|7181571|FG000|NOT COMPLETED|Overall Study||60
6281513|NCT00168831|7181572|FG001|NOT COMPLETED|Overall Study||81
6281514|NCT00168831|7181573|FG002|NOT COMPLETED|Overall Study||114
6281515|NCT00168844|7181584|FG000|STARTED|Overall Study||332
6281516|NCT00168844|7181585|FG001|STARTED|Overall Study||332
6281517|NCT00168844|7181586|FG002|STARTED|Overall Study||319
6281518|NCT00168844|7181584|FG000|COMPLETED|Overall Study||277
6281519|NCT00168844|7181585|FG001|COMPLETED|Overall Study||277
6281520|NCT00168844|7181586|FG002|COMPLETED|Overall Study||228
6281521|NCT00168844|7181584|FG000|NOT COMPLETED|Overall Study||55
6281522|NCT00168844|7181585|FG001|NOT COMPLETED|Overall Study||55
6281523|NCT00168844|7181586|FG002|NOT COMPLETED|Overall Study||91
6281524|NCT00169104|7181596|FG000|STARTED|Overall Study||13
6281525|NCT00169104|7181597|FG001|STARTED|Overall Study||10
6281526|NCT00169104|7181596|FG000|COMPLETED|Overall Study||11
6281527|NCT00169104|7181597|FG001|COMPLETED|Overall Study||8
6281528|NCT00169104|7181596|FG000|NOT COMPLETED|Overall Study||2
6281529|NCT00169104|7181597|FG001|NOT COMPLETED|Overall Study||2
6281530|NCT00169442|7181610|FG000|STARTED|Overall Study||119
6281531|NCT00169442|7181611|FG001|STARTED|Overall Study||124
6281532|NCT00169442|7181612|FG002|STARTED|Overall Study||167
6281533|NCT00169442|7181613|FG003|STARTED|Overall Study||250
6281534|NCT00169442|7181614|FG004|STARTED|Overall Study||42
6281535|NCT00169442|7181615|FG005|STARTED|Overall Study||43
6281536|NCT00169442|7181610|FG000|COMPLETED|Overall Study||119
6281537|NCT00169442|7181611|FG001|COMPLETED|Overall Study||123
6281538|NCT00169442|7181612|FG002|COMPLETED|Overall Study||166
6281539|NCT00169442|7181613|FG003|COMPLETED|Overall Study||250
6281540|NCT00169442|7181614|FG004|COMPLETED|Overall Study||41
6281541|NCT00169442|7181615|FG005|COMPLETED|Overall Study||41
6281542|NCT00169442|7181610|FG000|NOT COMPLETED|Overall Study||0
6281543|NCT00169442|7181611|FG001|NOT COMPLETED|Overall Study||1
6281544|NCT00169442|7181612|FG002|NOT COMPLETED|Overall Study||1
6281545|NCT00169442|7181613|FG003|NOT COMPLETED|Overall Study||0
6281546|NCT00169442|7181614|FG004|NOT COMPLETED|Overall Study||1
6281547|NCT00169442|7181615|FG005|NOT COMPLETED|Overall Study||2
6281548|NCT00170157|7181631|FG000|STARTED|Treatment Period 1 Initial Randomization||54
6281549|NCT00170157|7181632|FG001|STARTED|Treatment Period 1 Initial Randomization||58
6395645|NCT00859833|7308256|FG000|STARTED|Overall Study||30
6281550|NCT00170157|7181631|FG000|COMPLETED|Treatment Period 1 Initial Randomization||54
6281551|NCT00170157|7181632|FG001|COMPLETED|Treatment Period 1 Initial Randomization||58
6281552|NCT00170157|7181631|FG000|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
6281553|NCT00170157|7181632|FG001|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
6281554|NCT00170157|7181631|FG000|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
6281555|NCT00170157|7181632|FG001|STARTED|Washout Period of 14 Days||58
6281556|NCT00170157|7181631|FG000|COMPLETED|Washout Period of 14 Days||0
6281557|NCT00170157|7181632|FG001|COMPLETED|Washout Period of 14 Days||41
6281558|NCT00170157|7181631|FG000|NOT COMPLETED|Washout Period of 14 Days||0
6281559|NCT00170157|7181632|FG001|NOT COMPLETED|Washout Period of 14 Days||17
6281560|NCT00170157|7181631|FG000|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
6281561|NCT00170157|7181632|FG001|STARTED|Treatment Period 2 Crossover||41
6281562|NCT00170157|7181631|FG000|COMPLETED|Treatment Period 2 Crossover||0
6281563|NCT00170157|7181632|FG001|COMPLETED|Treatment Period 2 Crossover||41
6281564|NCT00170157|7181631|FG000|NOT COMPLETED|Treatment Period 2 Crossover||0
6281565|NCT00170157|7181632|FG001|NOT COMPLETED|Treatment Period 2 Crossover||0
6281566|NCT00170625|7181638|FG000|STARTED|Overall Study||26
6281567|NCT00170625|7181638|FG000|COMPLETED|Overall Study||26
6281568|NCT00170625|7181638|FG000|NOT COMPLETED|Overall Study||0
6281569|NCT00170846|7181645|FG000|STARTED|Overall Study||123
6281570|NCT00170846|7181646|FG001|STARTED|Overall Study||127
6281571|NCT00170846|7181647|FG002|STARTED|Overall Study||144
6281572|NCT00170846|7181645|FG000|COMPLETED|Overall Study||112
6281573|NCT00170846|7181646|FG001|COMPLETED|Overall Study||108
6281574|NCT00170846|7181647|FG002|COMPLETED|Overall Study||131
6281575|NCT00170846|7181645|FG000|NOT COMPLETED|Overall Study||11
6281576|NCT00170846|7181646|FG001|NOT COMPLETED|Overall Study||19
6281577|NCT00170846|7181647|FG002|NOT COMPLETED|Overall Study||13
6281578|NCT00170950|7181657|FG000|STARTED|Overall Study||5744
6281579|NCT00170950|7181658|FG001|STARTED|Overall Study||5762
6281580|NCT00170950|7181657|FG000|COMPLETED|Overall Study||4859
6281581|NCT00170950|7181658|FG001|COMPLETED|Overall Study||4852
6281582|NCT00170950|7181657|FG000|NOT COMPLETED|Overall Study||885
6281583|NCT00170950|7181658|FG001|NOT COMPLETED|Overall Study||910
6281584|NCT00171054|7181666|FG000|STARTED|Overall Study||63
6281585|NCT00171054|7181667|FG001|STARTED|Overall Study||62
6281586|NCT00171054|7181666|FG000|COMPLETED|Overall Study||53
6281587|NCT00171054|7181667|FG001|COMPLETED|Overall Study||50
6281588|NCT00171054|7181666|FG000|NOT COMPLETED|Overall Study||10
6281589|NCT00171054|7181667|FG001|NOT COMPLETED|Overall Study||12
6281590|NCT00171158|7181673|FG000|STARTED|Core Study||260
6281591|NCT00171158|7181673|FG000|COMPLETED|Core Study||21
6281592|NCT00171158|7181673|FG000|NOT COMPLETED|Core Study||239
6281593|NCT00171158|7181673|FG000|STARTED|E2 Extension||8
6281594|NCT00171158|7181673|FG000|COMPLETED|E2 Extension||1
6281595|NCT00171158|7181673|FG000|NOT COMPLETED|E2 Extension||7
6373774|NCT00747474|7284559|FG006|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373775|NCT00747474|7284560|FG007|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373776|NCT00747474|7284561|FG008|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373777|NCT00747474|7284562|FG009|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373778|NCT00747474|7284563|FG010|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373779|NCT00747474|7284564|FG011|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373780|NCT00747474|7284553|FG000|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373781|NCT00747474|7284554|FG001|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373782|NCT00747474|7284555|FG002|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373783|NCT00747474|7284556|FG003|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373784|NCT00747474|7284557|FG004|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373785|NCT00747474|7284558|FG005|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
6373786|NCT00747474|7284559|FG006|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373787|NCT00747474|7284560|FG007|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373788|NCT00747474|7284561|FG008|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373789|NCT00747474|7284562|FG009|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373790|NCT00747474|7284563|FG010|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373791|NCT00747474|7284564|FG011|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373792|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373793|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373794|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373795|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373796|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373797|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373798|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373799|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373800|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6395646|NCT00859833|7308256|FG000|COMPLETED|Overall Study||30
6395647|NCT00859833|7308256|FG000|NOT COMPLETED|Overall Study||0
6625459|NCT02225353|7553125|FG000|STARTED|Overall Study||91
6625460|NCT02225353|7553126|FG001|STARTED|Overall Study||90
6625461|NCT02225353|7553127|FG002|STARTED|Overall Study||90
6625462|NCT02225353|7553125|FG000|COMPLETED|Overall Study||87
6625463|NCT02225353|7553126|FG001|COMPLETED|Overall Study||84
6395648|NCT00859898|7308264|FG000|STARTED|Overall Study||211
6395649|NCT00859898|7308265|FG001|STARTED|Overall Study||219
6395650|NCT00859898|7308266|FG002|STARTED|Overall Study||208
6395651|NCT00859898|7308264|FG000|COMPLETED|Overall Study||183
6395652|NCT00859898|7308265|FG001|COMPLETED|Overall Study||188
6395653|NCT00859898|7308266|FG002|COMPLETED|Overall Study||181
6395654|NCT00859898|7308264|FG000|NOT COMPLETED|Overall Study||28
6395655|NCT00859898|7308265|FG001|NOT COMPLETED|Overall Study||31
6395656|NCT00859898|7308266|FG002|NOT COMPLETED|Overall Study||27
6395657|NCT00859937|7308277|FG000|STARTED|Overall Study||41
6395658|NCT00859937|7308278|FG001|STARTED|Overall Study||14
6395659|NCT00859937|7308277|FG000|COMPLETED|Overall Study||40
6395660|NCT00859937|7308278|FG001|COMPLETED|Overall Study||14
6395661|NCT00859937|7308277|FG000|NOT COMPLETED|Overall Study||1
6395662|NCT00859937|7308278|FG001|NOT COMPLETED|Overall Study||0
6395663|NCT00859950|7308286|FG000|STARTED|Overall Study||49
6625464|NCT02225353|7553127|FG002|COMPLETED|Overall Study||75
6625465|NCT02225353|7553125|FG000|NOT COMPLETED|Overall Study||4
6281596|NCT00171210|7181679|FG000|STARTED|Overall Study||259
6281597|NCT00171210|7181680|FG001|STARTED|Overall Study||296
6281598|NCT00171210|7181679|FG000|STARTED EXTENSION STUDY|Overall Study||259
6281599|NCT00171210|7181680|FG001|STARTED EXTENSION STUDY|Overall Study||247
6281600|NCT00171210|7181679|FG000|COMPLETED|Overall Study||190
6281601|NCT00171210|7181680|FG001|COMPLETED|Overall Study||181
6281602|NCT00171210|7181679|FG000|NOT COMPLETED|Overall Study||69
6281603|NCT00171210|7181680|FG001|NOT COMPLETED|Overall Study||115
6281604|NCT00171223|7181689|FG000|STARTED|Overall Study||152
6281605|NCT00171223|7181690|FG001|STARTED|Overall Study||188
6281606|NCT00171223|7181691|FG002|STARTED|Overall Study||192
6281607|NCT00171223|7181689|FG000|COMPLETED|Overall Study||12
6281608|NCT00171223|7181690|FG001|COMPLETED|Overall Study||47
6281609|NCT00171223|7181691|FG002|COMPLETED|Overall Study||22
6281610|NCT00171223|7181689|FG000|NOT COMPLETED|Overall Study||140
6281611|NCT00171223|7181690|FG001|NOT COMPLETED|Overall Study||141
6281612|NCT00171223|7181691|FG002|NOT COMPLETED|Overall Study||170
6281613|NCT00171249|7181697|FG000|STARTED|Overall Study||77
6281614|NCT00171249|7181698|FG001|STARTED|Overall Study||5
6281615|NCT00171249|7181699|FG002|STARTED|Overall Study||5
6281616|NCT00171249|7181700|FG003|STARTED|Overall Study||158
6281617|NCT00171249|7181701|FG004|STARTED|Overall Study||3
6281618|NCT00171249|7181702|FG005|STARTED|Overall Study||43
6281619|NCT00171249|7181703|FG006|STARTED|Overall Study||2
6281620|NCT00171249|7181697|FG000|Completed Part 1|Overall Study||50
6281621|NCT00171249|7181698|FG001|Completed Part 1|Overall Study||0
6281622|NCT00171249|7181699|FG002|Completed Part 1|Overall Study||1
6281623|NCT00171249|7181700|FG003|Completed Part 1|Overall Study||125
6281624|NCT00171249|7181701|FG004|Completed Part 1|Overall Study||2
6281625|NCT00171249|7181702|FG005|Completed Part 1|Overall Study||6
6281626|NCT00171249|7181703|FG006|Completed Part 1|Overall Study||0
6281627|NCT00171249|7181697|FG000|COMPLETED|Overall Study||1
6281628|NCT00171249|7181698|FG001|COMPLETED|Overall Study||0
6281629|NCT00171249|7181699|FG002|COMPLETED|Overall Study||0
6281630|NCT00171249|7181700|FG003|COMPLETED|Overall Study||6
6281631|NCT00171249|7181701|FG004|COMPLETED|Overall Study||0
6281632|NCT00171249|7181702|FG005|COMPLETED|Overall Study||0
6281633|NCT00171249|7181703|FG006|COMPLETED|Overall Study||0
6281634|NCT00171249|7181697|FG000|NOT COMPLETED|Overall Study||76
6281635|NCT00171249|7181698|FG001|NOT COMPLETED|Overall Study||5
6281636|NCT00171249|7181699|FG002|NOT COMPLETED|Overall Study||5
6281637|NCT00171249|7181700|FG003|NOT COMPLETED|Overall Study||152
6281638|NCT00171249|7181701|FG004|NOT COMPLETED|Overall Study||3
6281639|NCT00171249|7181702|FG005|NOT COMPLETED|Overall Study||43
6281640|NCT00171249|7181703|FG006|NOT COMPLETED|Overall Study||2
6281641|NCT00171301|7181714|FG000|STARTED|Overall Study||162
6281642|NCT00171301|7181715|FG001|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
6281643|NCT00171301|7181714|FG000|Received Deferasirox|Overall Study||162
6281644|NCT00171301|7181715|FG001|Received Deferasirox|Overall Study||69
6281645|NCT00171301|7181714|FG000|COMPLETED|Overall Study||154
6281646|NCT00171301|7181715|FG001|COMPLETED|Overall Study||62
6281647|NCT00171301|7181714|FG000|NOT COMPLETED|Overall Study||8
6281648|NCT00171301|7181715|FG001|NOT COMPLETED|Overall Study||9
6281649|NCT00171314|7181724|FG000|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
6281650|NCT00171314|7181725|FG001|STARTED|Overall Study||264
6281651|NCT00171314|7181724|FG000|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
6281652|NCT00171314|7181725|FG001|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
6281653|NCT00171314|7181724|FG000|COMPLETED|Overall Study||172
6281654|NCT00171314|7181725|FG001|COMPLETED|Overall Study||186
6281655|NCT00171314|7181724|FG000|NOT COMPLETED|Overall Study||91
6281656|NCT00171314|7181725|FG001|NOT COMPLETED|Overall Study||78
6281657|NCT00171340|7181733|FG000|STARTED|Overall Study||532
6281658|NCT00171340|7181734|FG001|STARTED|Overall Study||533
6281659|NCT00171340|7181733|FG000|COMPLETED|Overall Study||408
6281660|NCT00171340|7181734|FG001|COMPLETED|Overall Study||398
6395664|NCT00859950|7308287|FG001|STARTED|Overall Study||21
6395665|NCT00859950|7308286|FG000|COMPLETED|Overall Study||49
6395666|NCT00859950|7308287|FG001|COMPLETED|Overall Study||21
6395667|NCT00859950|7308286|FG000|NOT COMPLETED|Overall Study||0
6395668|NCT00859950|7308287|FG001|NOT COMPLETED|Overall Study||0
6395669|NCT00859976|7308295|FG000|STARTED|Overall Study||82
6395670|NCT00859976|7308296|FG001|STARTED|Overall Study||85
6395671|NCT00859976|7308295|FG000|COMPLETED|Overall Study||66
6395672|NCT00859976|7308296|FG001|COMPLETED|Overall Study||67
6395673|NCT00859976|7308295|FG000|NOT COMPLETED|Overall Study||16
6395674|NCT00859976|7308296|FG001|NOT COMPLETED|Overall Study||18
6395675|NCT00860015|7308302|FG000|STARTED|Overall Study||12
6395676|NCT00860015|7308302|FG000|COMPLETED|Overall Study||12
6395677|NCT00860015|7308302|FG000|NOT COMPLETED|Overall Study||0
6395678|NCT00860028|7308308|FG000|STARTED|Placebo Controlled Pretreatment Period||15
6395679|NCT00860028|7308309|FG001|STARTED|Placebo Controlled Pretreatment Period||15
6395680|NCT00860028|7308308|FG000|COMPLETED|Placebo Controlled Pretreatment Period||13
6395681|NCT00860028|7308309|FG001|COMPLETED|Placebo Controlled Pretreatment Period||14
6281661|NCT00171340|7181733|FG000|NOT COMPLETED|Overall Study||124
6281662|NCT00171340|7181734|FG001|NOT COMPLETED|Overall Study||135
6281663|NCT00171704|7181744|FG000|STARTED|Overall Study||133
6395682|NCT00860028|7308308|FG000|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
6498576|NCT01410604|7417181|FG001|STARTED|Overall Study||16
6281664|NCT00171704|7181745|FG001|STARTED|Overall Study||130
6281665|NCT00171704|7181744|FG000|COMPLETED|Overall Study||89
6281666|NCT00171704|7181745|FG001|COMPLETED|Overall Study||81
6281667|NCT00171704|7181744|FG000|NOT COMPLETED|Overall Study||44
6281668|NCT00171704|7181745|FG001|NOT COMPLETED|Overall Study||49
6281669|NCT00171730|7181751|FG000|STARTED|Overall Study||30
6281670|NCT00171730|7181751|FG000|COMPLETED|Overall Study||15
6281671|NCT00171730|7181751|FG000|NOT COMPLETED|Overall Study||15
6281672|NCT00171834|7181768|FG000|STARTED|Overall Study||6
6281673|NCT00171834|7181769|FG001|STARTED|Overall Study||12
6281674|NCT00171834|7181770|FG002|STARTED|Overall Study||12
6281675|NCT00171834|7181771|FG003|STARTED|Overall Study||12
6281676|NCT00171834|7181772|FG004|STARTED|Overall Study||8
6281677|NCT00171834|7181773|FG005|STARTED|Overall Study||35
6281678|NCT00171834|7181774|FG006|STARTED|Overall Study||4
6281679|NCT00171834|7181768|FG000|Completed 6 Cycles of Treatment|Overall Study||0
6281680|NCT00171834|7181769|FG001|Completed 6 Cycles of Treatment|Overall Study||0
6281681|NCT00171834|7181770|FG002|Completed 6 Cycles of Treatment|Overall Study||1
6281682|NCT00171834|7181771|FG003|Completed 6 Cycles of Treatment|Overall Study||0
6281683|NCT00171834|7181772|FG004|Completed 6 Cycles of Treatment|Overall Study||2
6281684|NCT00171834|7181773|FG005|Completed 6 Cycles of Treatment|Overall Study||1
6281685|NCT00171834|7181774|FG006|Completed 6 Cycles of Treatment|Overall Study||0
6281686|NCT00171834|7181768|FG000|COMPLETED|Overall Study||0
6281687|NCT00171834|7181769|FG001|COMPLETED|Overall Study||0
6281688|NCT00171834|7181770|FG002|COMPLETED|Overall Study||0
6281689|NCT00171834|7181771|FG003|COMPLETED|Overall Study||0
6281690|NCT00171834|7181772|FG004|COMPLETED|Overall Study||0
6281691|NCT00171834|7181773|FG005|COMPLETED|Overall Study||0
6281692|NCT00171834|7181774|FG006|COMPLETED|Overall Study||0
6281693|NCT00171834|7181768|FG000|NOT COMPLETED|Overall Study||6
6281694|NCT00171834|7181769|FG001|NOT COMPLETED|Overall Study||12
6281695|NCT00171834|7181770|FG002|NOT COMPLETED|Overall Study||12
6281696|NCT00171834|7181771|FG003|NOT COMPLETED|Overall Study||12
6281697|NCT00171834|7181772|FG004|NOT COMPLETED|Overall Study||8
6281698|NCT00171834|7181773|FG005|NOT COMPLETED|Overall Study||35
6281699|NCT00171834|7181774|FG006|NOT COMPLETED|Overall Study||4
6281700|NCT00171873|7181806|FG000|STARTED|Overall Study||42
6281701|NCT00171873|7181807|FG001|STARTED|Overall Study||43
6281702|NCT00171873|7181806|FG000|COMPLETED|Overall Study||33
6281703|NCT00171873|7181807|FG001|COMPLETED|Overall Study||40
6281704|NCT00171873|7181806|FG000|NOT COMPLETED|Overall Study||9
6281705|NCT00171873|7181807|FG001|NOT COMPLETED|Overall Study||3
6281706|NCT00171925|7181815|FG000|STARTED|Overall Study||72
6281707|NCT00171925|7181816|FG001|STARTED|Overall Study||71
6281708|NCT00171925|7181815|FG000|COMPLETED|Overall Study||42
6281709|NCT00171925|7181816|FG001|COMPLETED|Overall Study||40
6281710|NCT00171925|7181815|FG000|NOT COMPLETED|Overall Study||30
6281711|NCT00171925|7181816|FG001|NOT COMPLETED|Overall Study||31
6281712|NCT00171951|7181822|FG000|STARTED|Overall Study||19
6281713|NCT00171951|7181822|FG000|COMPLETED|Overall Study||3
6281714|NCT00171951|7181822|FG000|NOT COMPLETED|Overall Study||16
6281715|NCT00172042|7181831|FG000|STARTED|Overall Study||226
6281716|NCT00172042|7181832|FG001|STARTED|Overall Study||211
6281717|NCT00172042|7181831|FG000|COMPLETED|Overall Study||68
6281718|NCT00172042|7181832|FG001|COMPLETED|Overall Study||86
6281719|NCT00172042|7181831|FG000|NOT COMPLETED|Overall Study||158
6281720|NCT00172042|7181832|FG001|NOT COMPLETED|Overall Study||125
6281721|NCT00172185|7181842|FG000|STARTED|Overall Study||6
6281722|NCT00172185|7181843|FG001|STARTED|Overall Study||7
6281723|NCT00172185|7181844|FG002|STARTED|Overall Study||25
6281724|NCT00172185|7181845|FG003|STARTED|Overall Study||27
6281725|NCT00172185|7181842|FG000|COMPLETED|Overall Study||6
6281726|NCT00172185|7181843|FG001|COMPLETED|Overall Study||5
6281727|NCT00172185|7181844|FG002|COMPLETED|Overall Study||20
6281728|NCT00172185|7181845|FG003|COMPLETED|Overall Study||23
6281729|NCT00172185|7181842|FG000|NOT COMPLETED|Overall Study||0
6281730|NCT00172185|7181843|FG001|NOT COMPLETED|Overall Study||2
6281731|NCT00172185|7181844|FG002|NOT COMPLETED|Overall Study||5
6281732|NCT00172185|7181845|FG003|NOT COMPLETED|Overall Study||4
6281733|NCT00174187|7181861|FG000|STARTED|Period 1 (up to 3 Years)||15
6281734|NCT00174187|7181862|FG001|STARTED|Period 1 (up to 3 Years)||15
6281735|NCT00174187|7181863|FG002|STARTED|Period 1 (up to 3 Years)||0
6281736|NCT00174187|7181861|FG000|COMPLETED|Period 1 (up to 3 Years)||15
6281737|NCT00174187|7181862|FG001|COMPLETED|Period 1 (up to 3 Years)||11
6281738|NCT00174187|7181863|FG002|COMPLETED|Period 1 (up to 3 Years)||0
6281739|NCT00174187|7181861|FG000|NOT COMPLETED|Period 1 (up to 3 Years)||0
6281740|NCT00174187|7181862|FG001|NOT COMPLETED|Period 1 (up to 3 Years)||4
6281741|NCT00174187|7181863|FG002|NOT COMPLETED|Period 1 (up to 3 Years)||0
6281742|NCT00174187|7181861|FG000|STARTED|Between Period 1 and Period 2||0
6281743|NCT00174187|7181862|FG001|STARTED|Between Period 1 and Period 2||0
6281744|NCT00174187|7181863|FG002|STARTED|Between Period 1 and Period 2||26
6281745|NCT00174187|7181861|FG000|Consented|Between Period 1 and Period 2||0
6281746|NCT00174187|7181862|FG001|Consented|Between Period 1 and Period 2||0
6281747|NCT00174187|7181863|FG002|Consented|Between Period 1 and Period 2||24
6281748|NCT00174187|7181861|FG000|COMPLETED|Between Period 1 and Period 2||0
6281749|NCT00174187|7181862|FG001|COMPLETED|Between Period 1 and Period 2||0
6281750|NCT00174187|7181863|FG002|COMPLETED|Between Period 1 and Period 2||21
6281751|NCT00174187|7181861|FG000|NOT COMPLETED|Between Period 1 and Period 2||0
6281752|NCT00174187|7181862|FG001|NOT COMPLETED|Between Period 1 and Period 2||0
6281753|NCT00174187|7181863|FG002|NOT COMPLETED|Between Period 1 and Period 2||5
6281754|NCT00174187|7181861|FG000|STARTED|Period 2 (After 3 Years)||0
6281755|NCT00174187|7181862|FG001|STARTED|Period 2 (After 3 Years)||0
6281756|NCT00174187|7181863|FG002|STARTED|Period 2 (After 3 Years)||21
6281757|NCT00174187|7181861|FG000|COMPLETED|Period 2 (After 3 Years)||0
6281758|NCT00174187|7181862|FG001|COMPLETED|Period 2 (After 3 Years)||0
6281759|NCT00174187|7181863|FG002|COMPLETED|Period 2 (After 3 Years)||13
6281760|NCT00174187|7181861|FG000|NOT COMPLETED|Period 2 (After 3 Years)||0
6281761|NCT00174187|7181862|FG001|NOT COMPLETED|Period 2 (After 3 Years)||0
6281762|NCT00174187|7181863|FG002|NOT COMPLETED|Period 2 (After 3 Years)||8
6281763|NCT00174252|7181871|FG000|STARTED|Overall Study||57
6281764|NCT00174252|7181871|FG000|COMPLETED|Overall Study||55
6281765|NCT00174252|7181871|FG000|NOT COMPLETED|Overall Study||2
6281766|NCT00174291|7181879|FG000|STARTED|Overall Study||11
6281767|NCT00174291|7181880|FG001|STARTED|Overall Study||10
6281768|NCT00174291|7181879|FG000|COMPLETED|Overall Study||6
6281769|NCT00174291|7181880|FG001|COMPLETED|Overall Study||4
6281770|NCT00174291|7181879|FG000|NOT COMPLETED|Overall Study||5
6281771|NCT00174291|7181880|FG001|NOT COMPLETED|Overall Study||6
6281772|NCT00174382|7181886|FG000|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
6281773|NCT00174382|7181886|FG000|COMPLETED|Overall Study||116
6281774|NCT00174382|7181886|FG000|NOT COMPLETED|Overall Study||33
6281775|NCT00174447|7181890|FG000|STARTED|Overall Study||43
6281776|NCT00174447|7181890|FG000|COMPLETED|Overall Study||5
6281777|NCT00174447|7181890|FG000|NOT COMPLETED|Overall Study||38
6281778|NCT00174460|7181896|FG000|STARTED|Overall Study||18
6281779|NCT00174460|7181897|FG001|STARTED|Overall Study||15
6281780|NCT00174460|7181896|FG000|Received Study Treatment|Overall Study||18
6281781|NCT00174460|7181897|FG001|Received Study Treatment|Overall Study||14
6281782|NCT00174460|7181896|FG000|COMPLETED|Overall Study||18
6281783|NCT00174460|7181897|FG001|COMPLETED|Overall Study||14
6281784|NCT00174460|7181896|FG000|NOT COMPLETED|Overall Study||0
6281785|NCT00174460|7181897|FG001|NOT COMPLETED|Overall Study||1
6281786|NCT00174785|7181906|FG000|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
6281787|NCT00174785|7181907|FG001|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
6281788|NCT00174785|7181906|FG000|COMPLETED|Overall Study|completed study drug|1605
6281789|NCT00174785|7181907|FG001|COMPLETED|Overall Study|completed study drug|1611
6281790|NCT00174785|7181906|FG000|NOT COMPLETED|Overall Study||696
6281791|NCT00174785|7181907|FG001|NOT COMPLETED|Overall Study||716
6281792|NCT00174915|7181918|FG000|STARTED|Overall Study||267
6281793|NCT00174915|7181919|FG001|STARTED|Overall Study||269
6281794|NCT00174915|7181920|FG002|STARTED|Overall Study||134
6281795|NCT00174915|7181921|FG003|STARTED|Overall Study||268
6281796|NCT00174915|7181922|FG004|STARTED|Overall Study||134
6281797|NCT00174915|7181918|FG000|COMPLETED|Overall Study||174
6281798|NCT00174915|7181919|FG001|COMPLETED|Overall Study||200
6281799|NCT00174915|7181920|FG002|COMPLETED|Overall Study||86
6281800|NCT00174915|7181921|FG003|COMPLETED|Overall Study||211
6281801|NCT00174915|7181922|FG004|COMPLETED|Overall Study||101
6281802|NCT00174915|7181918|FG000|NOT COMPLETED|Overall Study||93
6281803|NCT00174915|7181919|FG001|NOT COMPLETED|Overall Study||69
6281804|NCT00174915|7181920|FG002|NOT COMPLETED|Overall Study||48
6281805|NCT00174915|7181921|FG003|NOT COMPLETED|Overall Study||57
6281806|NCT00174915|7181922|FG004|NOT COMPLETED|Overall Study||33
6281807|NCT00174941|7181937|FG000|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
6281808|NCT00174941|7181938|FG001|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
6281809|NCT00174941|7181939|FG002|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
6281810|NCT00174941|7181940|FG003|STARTED|Overall Study||116
6281811|NCT00174941|7181937|FG000|COMPLETED|Overall Study||6
6281812|NCT00174941|7181938|FG001|COMPLETED|Overall Study||41
6281813|NCT00174941|7181939|FG002|COMPLETED|Overall Study||11
6281814|NCT00174941|7181940|FG003|COMPLETED|Overall Study||58
6281815|NCT00174941|7181937|FG000|NOT COMPLETED|Overall Study||2
6281816|NCT00174941|7181938|FG001|NOT COMPLETED|Overall Study||38
6281817|NCT00174941|7181939|FG002|NOT COMPLETED|Overall Study||18
6281818|NCT00174941|7181940|FG003|NOT COMPLETED|Overall Study||58
6281819|NCT00174954|7181950|FG000|STARTED|Overall Study||32
6281820|NCT00174954|7181950|FG000|COMPLETED|Overall Study||28
6281821|NCT00174954|7181950|FG000|NOT COMPLETED|Overall Study||4
6281822|NCT00174967|7181958|FG000|STARTED|Overall Study||37
6281823|NCT00174967|7181959|FG001|STARTED|Overall Study||40
6281824|NCT00174967|7181960|FG002|STARTED|Overall Study||38
6281825|NCT00174967|7181961|FG003|STARTED|Overall Study||38
6281826|NCT00174967|7181958|FG000|COMPLETED|Overall Study||36
6281827|NCT00174967|7181959|FG001|COMPLETED|Overall Study||37
6281828|NCT00174967|7181960|FG002|COMPLETED|Overall Study||36
6281829|NCT00174967|7181961|FG003|COMPLETED|Overall Study||36
6281830|NCT00174967|7181958|FG000|NOT COMPLETED|Overall Study||1
6281831|NCT00174967|7181959|FG001|NOT COMPLETED|Overall Study||3
6281832|NCT00174967|7181960|FG002|NOT COMPLETED|Overall Study||2
6281833|NCT00174967|7181961|FG003|NOT COMPLETED|Overall Study||2
6281834|NCT00175006|7181971|FG000|STARTED|Overall Study||13
6281835|NCT00175006|7181971|FG000|COMPLETED|Overall Study||13
6281836|NCT00175006|7181971|FG000|NOT COMPLETED|Overall Study||0
6281837|NCT00175019|7181978|FG000|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
6281838|NCT00175019|7181979|FG001|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
6281839|NCT00175019|7181980|FG002|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
6281840|NCT00175019|7181978|FG000|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
6281841|NCT00175019|7181979|FG001|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
6281842|NCT00175019|7181980|FG002|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
6281843|NCT00175019|7181978|FG000|NOT COMPLETED|Overall Study||194
6281844|NCT00175019|7181979|FG001|NOT COMPLETED|Overall Study||171
6281845|NCT00175019|7181980|FG002|NOT COMPLETED|Overall Study||57
6281846|NCT00175825|7181992|FG000|STARTED|Overall Study||54
6281847|NCT00175825|7181993|FG001|STARTED|Overall Study||50
6281848|NCT00175825|7181994|FG002|STARTED|Overall Study||52
6281849|NCT00175825|7181995|FG003|STARTED|Overall Study||52
6281850|NCT00175825|7181992|FG000|COMPLETED|Overall Study||49
6281851|NCT00175825|7181993|FG001|COMPLETED|Overall Study||46
6281852|NCT00175825|7181994|FG002|COMPLETED|Overall Study||51
6281853|NCT00175825|7181995|FG003|COMPLETED|Overall Study||51
6281854|NCT00175825|7181992|FG000|NOT COMPLETED|Overall Study||5
6281855|NCT00175825|7181993|FG001|NOT COMPLETED|Overall Study||4
6281856|NCT00175825|7181994|FG002|NOT COMPLETED|Overall Study||1
6281857|NCT00175825|7181995|FG003|NOT COMPLETED|Overall Study||1
6281858|NCT00175877|7182005|FG000|STARTED|Overall Study||846
6281859|NCT00175877|7182005|FG000|COMPLETED|Overall Study||497
6281860|NCT00175877|7182005|FG000|NOT COMPLETED|Overall Study||349
6281861|NCT00175916|7182009|FG000|STARTED|Overall Study||853
6281862|NCT00175916|7182009|FG000|COMPLETED|Overall Study||234
6281863|NCT00175916|7182009|FG000|NOT COMPLETED|Overall Study||619
6281864|NCT00176202|7182016|FG000|STARTED|Overall Study||32
6281865|NCT00176202|7182017|FG001|STARTED|Overall Study||33
6281866|NCT00176202|7182016|FG000|COMPLETED|Overall Study||27
6281867|NCT00176202|7182017|FG001|COMPLETED|Overall Study||17
6281868|NCT00176202|7182016|FG000|NOT COMPLETED|Overall Study||5
6281869|NCT00176202|7182017|FG001|NOT COMPLETED|Overall Study||16
6281870|NCT00176228|7182025|FG000|STARTED|Overall Study|When study began|48
6281871|NCT00176228|7182025|FG000|COMPLETED|Overall Study|Study ended|46
6281872|NCT00176228|7182025|FG000|NOT COMPLETED|Overall Study||2
6281873|NCT00176254|7182030|FG000|STARTED|Overall Study||40
6281874|NCT00176254|7182030|FG000|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
6281875|NCT00176254|7182030|FG000|NOT COMPLETED|Overall Study||1
6281876|NCT00176306|7182034|FG000|STARTED|Overall Study||15
6281877|NCT00176306|7182034|FG000|COMPLETED|Overall Study||15
6281878|NCT00176306|7182034|FG000|NOT COMPLETED|Overall Study||0
6281879|NCT00176423|7182040|FG000|STARTED|Overall Study||42
6281880|NCT00176423|7182041|FG001|STARTED|Overall Study||44
6281881|NCT00176423|7182040|FG000|COMPLETED|Overall Study||35
6281882|NCT00176423|7182041|FG001|COMPLETED|Overall Study||38
6281883|NCT00176423|7182040|FG000|NOT COMPLETED|Overall Study||7
6281884|NCT00176423|7182041|FG001|NOT COMPLETED|Overall Study||6
6281885|NCT00176462|7182049|FG000|STARTED|Induction (4 Weeks)||21
6281886|NCT00176462|7182050|FG001|STARTED|Induction (4 Weeks)||39
6281887|NCT00176462|7182049|FG000|COMPLETED|Induction (4 Weeks)||20
6281888|NCT00176462|7182050|FG001|COMPLETED|Induction (4 Weeks)||34
6281889|NCT00176462|7182049|FG000|NOT COMPLETED|Induction (4 Weeks)||1
6281890|NCT00176462|7182050|FG001|NOT COMPLETED|Induction (4 Weeks)||5
6281891|NCT00176462|7182049|FG000|STARTED|Consolidation (12 Weeks)||20
6281892|NCT00176462|7182050|FG001|STARTED|Consolidation (12 Weeks)||34
6281893|NCT00176462|7182049|FG000|COMPLETED|Consolidation (12 Weeks)||20
6281894|NCT00176462|7182050|FG001|COMPLETED|Consolidation (12 Weeks)||29
6281895|NCT00176462|7182049|FG000|NOT COMPLETED|Consolidation (12 Weeks)||0
6281896|NCT00176462|7182050|FG001|NOT COMPLETED|Consolidation (12 Weeks)||5
6281897|NCT00176462|7182049|FG000|STARTED|Delayed Intensification (8 Weeks)||20
6281898|NCT00176462|7182050|FG001|STARTED|Delayed Intensification (8 Weeks)||29
6281899|NCT00176462|7182049|FG000|COMPLETED|Delayed Intensification (8 Weeks)||20
6281900|NCT00176462|7182050|FG001|COMPLETED|Delayed Intensification (8 Weeks)||29
6281901|NCT00176462|7182049|FG000|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
6281902|NCT00176462|7182050|FG001|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
6281903|NCT00176462|7182049|FG000|STARTED|Intensive Continuation (8X8-week Cycles)||20
6281904|NCT00176462|7182050|FG001|STARTED|Intensive Continuation (8X8-week Cycles)||29
6281905|NCT00176462|7182049|FG000|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
6281906|NCT00176462|7182050|FG001|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
6281907|NCT00176462|7182049|FG000|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
6281908|NCT00176462|7182050|FG001|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
6281909|NCT00176462|7182049|FG000|STARTED|Continuation -up to 30mos Post Remission||19
6281910|NCT00176462|7182050|FG001|STARTED|Continuation -up to 30mos Post Remission||26
6281911|NCT00176462|7182049|FG000|COMPLETED|Continuation -up to 30mos Post Remission||19
6281912|NCT00176462|7182050|FG001|COMPLETED|Continuation -up to 30mos Post Remission||26
6281913|NCT00176462|7182049|FG000|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
6281914|NCT00176462|7182050|FG001|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
6281915|NCT00176592|7182059|FG000|STARTED|Overall Study||36
6281916|NCT00176592|7182060|FG001|STARTED|Overall Study||39
6281917|NCT00176592|7182059|FG000|Followed for 1 Year|Overall Study||35
6281918|NCT00176592|7182060|FG001|Followed for 1 Year|Overall Study||35
6281919|NCT00176592|7182059|FG000|Followed for 2 Years|Overall Study||29
6281920|NCT00176592|7182060|FG001|Followed for 2 Years|Overall Study||35
6281921|NCT00176592|7182059|FG000|COMPLETED|Overall Study||36
6281922|NCT00176592|7182060|FG001|COMPLETED|Overall Study||39
6281923|NCT00176592|7182059|FG000|NOT COMPLETED|Overall Study||0
6281924|NCT00176592|7182060|FG001|NOT COMPLETED|Overall Study||0
6281925|NCT00176605|7182066|FG000|STARTED|Overall Study||15
6281926|NCT00176605|7182066|FG000|COMPLETED|Overall Study||13
6281927|NCT00176605|7182066|FG000|NOT COMPLETED|Overall Study||2
6281928|NCT00176644|7182070|FG000|STARTED|Overall Study||23
6281929|NCT00176644|7182070|FG000|COMPLETED|Overall Study||22
6281930|NCT00176644|7182070|FG000|NOT COMPLETED|Overall Study||1
6281931|NCT00176800|7182074|FG000|STARTED|Overall Study||69
6281932|NCT00176800|7182074|FG000|COMPLETED|Overall Study||69
6281933|NCT00176800|7182074|FG000|NOT COMPLETED|Overall Study||0
6281934|NCT00176826|7182078|FG000|STARTED|Overall Study||22
6281935|NCT00176826|7182078|FG000|COMPLETED|Overall Study||22
6281936|NCT00176826|7182078|FG000|NOT COMPLETED|Overall Study||0
6281937|NCT00176839|7182082|FG000|STARTED|Overall Study||11
6281938|NCT00176839|7182082|FG000|COMPLETED|Overall Study||11
6281939|NCT00176839|7182082|FG000|NOT COMPLETED|Overall Study||0
6281940|NCT00176852|7182089|FG000|STARTED|Overall Study||3
6281941|NCT00176852|7182090|FG001|STARTED|Overall Study||5
6281942|NCT00176852|7182091|FG002|STARTED|Overall Study||14
6281943|NCT00176852|7182089|FG000|COMPLETED|Overall Study||3
6281944|NCT00176852|7182090|FG001|COMPLETED|Overall Study||5
6281945|NCT00176852|7182091|FG002|COMPLETED|Overall Study||14
6281946|NCT00176852|7182089|FG000|NOT COMPLETED|Overall Study||0
6281947|NCT00176852|7182090|FG001|NOT COMPLETED|Overall Study||0
6281948|NCT00176852|7182091|FG002|NOT COMPLETED|Overall Study||0
6281949|NCT00176865|7182102|FG000|STARTED|Overall Study||3
6281950|NCT00176865|7182103|FG001|STARTED|Overall Study||10
6281951|NCT00176865|7182104|FG002|STARTED|Overall Study||6
6281952|NCT00176865|7182102|FG000|COMPLETED|Overall Study||3
6281953|NCT00176865|7182103|FG001|COMPLETED|Overall Study||10
6281954|NCT00176865|7182104|FG002|COMPLETED|Overall Study||6
6281955|NCT00176865|7182102|FG000|NOT COMPLETED|Overall Study||0
6281956|NCT00176865|7182103|FG001|NOT COMPLETED|Overall Study||0
6281957|NCT00176865|7182104|FG002|NOT COMPLETED|Overall Study||0
6281958|NCT00176878|7182112|FG000|STARTED|Overall Study||10
6281959|NCT00176878|7182112|FG000|COMPLETED|Overall Study||10
6281960|NCT00176878|7182112|FG000|NOT COMPLETED|Overall Study||0
6281961|NCT00176891|7182116|FG000|STARTED|Overall Study||25
6281962|NCT00176891|7182116|FG000|COMPLETED|Overall Study||22
6281963|NCT00176891|7182116|FG000|NOT COMPLETED|Overall Study||3
6281964|NCT00176904|7182120|FG000|STARTED|Overall Study||135
6281965|NCT00176904|7182120|FG000|COMPLETED|Overall Study||135
6281966|NCT00176904|7182120|FG000|NOT COMPLETED|Overall Study||0
6281967|NCT00176917|7182124|FG000|STARTED|Overall Study||41
6281968|NCT00176917|7182124|FG000|COMPLETED|Overall Study||41
6395683|NCT00860028|7308309|FG001|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
6395684|NCT00860028|7308308|FG000|STARTED|Smoking Cessation Phase||13
6395685|NCT00860028|7308309|FG001|STARTED|Smoking Cessation Phase||14
6395686|NCT00860028|7308308|FG000|COMPLETED|Smoking Cessation Phase||13
6395687|NCT00860028|7308309|FG001|COMPLETED|Smoking Cessation Phase||12
6395688|NCT00860028|7308308|FG000|NOT COMPLETED|Smoking Cessation Phase||0
6625466|NCT02225353|7553126|FG001|NOT COMPLETED|Overall Study||6
6625467|NCT02225353|7553127|FG002|NOT COMPLETED|Overall Study||15
6625468|NCT02225587|7553140|FG000|STARTED|Overall Study||200
6625469|NCT02225587|7553141|FG001|STARTED|Overall Study||200
6625470|NCT02225587|7553140|FG000|Vaccination 2|Overall Study||188
6625471|NCT02225587|7553141|FG001|Vaccination 2|Overall Study||185
6625472|NCT02225587|7553140|FG000|Vaccination 3|Overall Study||172
6625473|NCT02225587|7553141|FG001|Vaccination 3|Overall Study||164
6625474|NCT02225587|7553140|FG000|COMPLETED|Overall Study||172
6625475|NCT02225587|7553141|FG001|COMPLETED|Overall Study||162
6625476|NCT02225587|7553140|FG000|NOT COMPLETED|Overall Study||28
6625477|NCT02225587|7553141|FG001|NOT COMPLETED|Overall Study||38
6625478|NCT02225665|7553149|FG000|STARTED|Overall Study||3
6625479|NCT02225665|7553150|FG001|STARTED|Overall Study||5
6625480|NCT02225665|7553149|FG000|COMPLETED|Overall Study||2
6625481|NCT02225665|7553150|FG001|COMPLETED|Overall Study||4
6625482|NCT02225665|7553149|FG000|NOT COMPLETED|Overall Study||1
6625483|NCT02225665|7553150|FG001|NOT COMPLETED|Overall Study||1
6625484|NCT02225743|7553156|FG000|STARTED|Overall Study||120
6625485|NCT02225743|7553156|FG000|COMPLETED|Overall Study|18 patients chose not to participate on the day of surgery.|102
6625486|NCT02225743|7553156|FG000|NOT COMPLETED|Overall Study||18
6625487|NCT02225860|7553162|FG000|STARTED|Overall Study||17
6625488|NCT02225860|7553163|FG001|STARTED|Overall Study||17
6625489|NCT02225860|7553162|FG000|COMPLETED|Overall Study||16
6625490|NCT02225860|7553163|FG001|COMPLETED|Overall Study||17
6625491|NCT02225860|7553162|FG000|NOT COMPLETED|Overall Study||1
6281969|NCT00176917|7182124|FG000|NOT COMPLETED|Overall Study||0
6281970|NCT00176930|7182136|FG000|STARTED|Overall Study||12
6395689|NCT00860028|7308309|FG001|NOT COMPLETED|Smoking Cessation Phase||2
6625492|NCT02225860|7553163|FG001|NOT COMPLETED|Overall Study||0
6281971|NCT00176930|7182137|FG001|STARTED|Overall Study||13
6281972|NCT00176930|7182138|FG002|STARTED|Overall Study||1
6395690|NCT00860067|7308320|FG000|STARTED|Overall Study||1200
6625493|NCT02225925|7553170|FG000|STARTED|Overall Study||45
6625494|NCT02225925|7553170|FG000|COMPLETED|Overall Study||45
6625495|NCT02225925|7553170|FG000|NOT COMPLETED|Overall Study||0
6625496|NCT02226003|7553177|FG000|STARTED|Overall Study||98
6625497|NCT02226003|7553178|FG001|STARTED|Overall Study||96
6625498|NCT02226003|7553179|FG002|STARTED|Overall Study||97
6625499|NCT02226003|7553177|FG000|COMPLETED|Overall Study||96
6625500|NCT02226003|7553178|FG001|COMPLETED|Overall Study||95
6625501|NCT02226003|7553179|FG002|COMPLETED|Overall Study||91
6625502|NCT02226003|7553177|FG000|NOT COMPLETED|Overall Study||2
6625503|NCT02226003|7553178|FG001|NOT COMPLETED|Overall Study||1
6625504|NCT02226003|7553179|FG002|NOT COMPLETED|Overall Study||6
6625505|NCT02226120|7553187|FG000|STARTED|Overall Study||1980
6625506|NCT02226120|7553187|FG000|COMPLETED|Overall Study||1660
6395691|NCT00860067|7308321|FG001|STARTED|Overall Study||299
6395692|NCT00860067|7308322|FG002|STARTED|Overall Study||301
6395693|NCT00860067|7308320|FG000|COMPLETED|Overall Study||1149
6395694|NCT00860067|7308321|FG001|COMPLETED|Overall Study||290
6395695|NCT00860067|7308322|FG002|COMPLETED|Overall Study||292
6395696|NCT00860067|7308320|FG000|NOT COMPLETED|Overall Study||51
6395697|NCT00860067|7308321|FG001|NOT COMPLETED|Overall Study||9
6395698|NCT00860067|7308322|FG002|NOT COMPLETED|Overall Study||9
6395699|NCT00860171|7308333|FG000|STARTED|Overall Study||16
6625507|NCT02226120|7553187|FG000|NOT COMPLETED|Overall Study||320
6625508|NCT02226159|7553193|FG000|STARTED|Overall Study||33
6625509|NCT02226159|7553194|FG001|STARTED|Overall Study||32
6625510|NCT02226159|7553193|FG000|COMPLETED|Overall Study||27
6625511|NCT02226159|7553194|FG001|COMPLETED|Overall Study||26
6625512|NCT02226159|7553193|FG000|NOT COMPLETED|Overall Study||6
6625513|NCT02226159|7553194|FG001|NOT COMPLETED|Overall Study||6
6625514|NCT02226172|7553200|FG000|STARTED|Overall Study||21
6625515|NCT02226172|7553200|FG000|COMPLETED|Overall Study||4
6625516|NCT02226172|7553200|FG000|NOT COMPLETED|Overall Study||17
6625517|NCT02226198|7553204|FG000|STARTED|Lead-in Phase||11
6625518|NCT02226198|7553205|FG001|STARTED|Lead-in Phase||0
6625519|NCT02226198|7553206|FG002|STARTED|Lead-in Phase||0
6625520|NCT02226198|7553204|FG000|COMPLETED|Lead-in Phase||10
6625521|NCT02226198|7553205|FG001|COMPLETED|Lead-in Phase||0
6625522|NCT02226198|7553206|FG002|COMPLETED|Lead-in Phase||0
6625523|NCT02226198|7553204|FG000|NOT COMPLETED|Lead-in Phase||1
6625524|NCT02226198|7553205|FG001|NOT COMPLETED|Lead-in Phase||0
6625525|NCT02226198|7553206|FG002|NOT COMPLETED|Lead-in Phase||0
6625526|NCT02226198|7553204|FG000|STARTED|Cross-Over: First Intervention (6 Weeks)||0
6625527|NCT02226198|7553205|FG001|STARTED|Cross-Over: First Intervention (6 Weeks)||7
6625528|NCT02226198|7553206|FG002|STARTED|Cross-Over: First Intervention (6 Weeks)||7
6625529|NCT02226198|7553204|FG000|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
6625530|NCT02226198|7553205|FG001|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
6625531|NCT02226198|7553206|FG002|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
6625532|NCT02226198|7553204|FG000|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
6625533|NCT02226198|7553205|FG001|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
6395700|NCT00860171|7308333|FG000|COMPLETED|Overall Study||16
6395701|NCT00860171|7308333|FG000|NOT COMPLETED|Overall Study||0
6395702|NCT00860262|7308340|FG000|STARTED|Overall Study||421
6395703|NCT00860262|7308341|FG001|STARTED|Overall Study||217
6395704|NCT00860262|7308342|FG002|STARTED|Overall Study||220
6395705|NCT00860262|7308340|FG000|COMPLETED|Overall Study||401
6395706|NCT00860262|7308341|FG001|COMPLETED|Overall Study||195
6395707|NCT00860262|7308342|FG002|COMPLETED|Overall Study||202
6395708|NCT00860262|7308340|FG000|NOT COMPLETED|Overall Study||20
6395709|NCT00860262|7308341|FG001|NOT COMPLETED|Overall Study||22
6395710|NCT00860262|7308342|FG002|NOT COMPLETED|Overall Study||18
6395711|NCT00860314|7308354|FG000|STARTED|Overall Study||48
6395712|NCT00860314|7308355|FG001|STARTED|Overall Study||48
6395713|NCT00860314|7308354|FG000|COMPLETED|Overall Study||48
6395714|NCT00860314|7308355|FG001|COMPLETED|Overall Study||48
6625534|NCT02226198|7553206|FG002|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
6625535|NCT02226198|7553204|FG000|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
6625536|NCT02226198|7553205|FG001|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
6625537|NCT02226198|7553206|FG002|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
6625538|NCT02226198|7553204|FG000|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
6625539|NCT02226198|7553205|FG001|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
6625540|NCT02226198|7553206|FG002|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
6625541|NCT02226198|7553204|FG000|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
6625542|NCT02226198|7553205|FG001|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
6625543|NCT02226198|7553206|FG002|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
6625544|NCT02226198|7553204|FG000|STARTED|Maintenance Phase (12 Weeks)||13
6625545|NCT02226198|7553205|FG001|STARTED|Maintenance Phase (12 Weeks)||0
6625546|NCT02226198|7553206|FG002|STARTED|Maintenance Phase (12 Weeks)||0
6625547|NCT02226198|7553204|FG000|COMPLETED|Maintenance Phase (12 Weeks)||13
6625548|NCT02226198|7553205|FG001|COMPLETED|Maintenance Phase (12 Weeks)||0
6395715|NCT00860314|7308354|FG000|NOT COMPLETED|Overall Study||0
6395716|NCT00860314|7308355|FG001|NOT COMPLETED|Overall Study||0
6395717|NCT00860379|7308364|FG000|STARTED|Overall Study||4
6395718|NCT00860379|7308365|FG001|STARTED|Overall Study||6
6395719|NCT00860379|7308366|FG002|STARTED|Overall Study||4
6395720|NCT00860379|7308364|FG000|COMPLETED|Overall Study||4
6395721|NCT00860379|7308365|FG001|COMPLETED|Overall Study||6
6395722|NCT00860379|7308366|FG002|COMPLETED|Overall Study||4
6395723|NCT00860379|7308364|FG000|NOT COMPLETED|Overall Study||0
6395724|NCT00860379|7308365|FG001|NOT COMPLETED|Overall Study||0
6395725|NCT00860379|7308366|FG002|NOT COMPLETED|Overall Study||0
6395726|NCT00860405|7308376|FG000|STARTED|Overall Study||31
6395727|NCT00860405|7308377|FG001|STARTED|Overall Study||30
6395728|NCT00860405|7308376|FG000|Completed Treatment|Overall Study||31
6395729|NCT00860405|7308377|FG001|Completed Treatment|Overall Study||29
6395730|NCT00860405|7308376|FG000|Day 28 Follow-up Performed|Overall Study||31
6395731|NCT00860405|7308377|FG001|Day 28 Follow-up Performed|Overall Study||29
6395732|NCT00860405|7308376|FG000|COMPLETED|Overall Study|completed overall study|26
6395733|NCT00860405|7308377|FG001|COMPLETED|Overall Study||26
6395734|NCT00860405|7308376|FG000|NOT COMPLETED|Overall Study||5
6395735|NCT00860405|7308377|FG001|NOT COMPLETED|Overall Study||4
6395736|NCT00860457|7308383|FG000|STARTED|Overall Study||22
6395737|NCT00860457|7308383|FG000|COMPLETED|Overall Study||11
6625549|NCT02226198|7553206|FG002|COMPLETED|Maintenance Phase (12 Weeks)||0
6625550|NCT02226198|7553204|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
6625551|NCT02226198|7553205|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
6625552|NCT02226198|7553206|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
6625553|NCT02226549|7553234|FG000|STARTED|Overall Study||23
6625554|NCT02226549|7553235|FG001|STARTED|Overall Study||24
6625555|NCT02226549|7553234|FG000|COMPLETED|Overall Study||22
6625556|NCT02226549|7553235|FG001|COMPLETED|Overall Study||23
6625557|NCT02226549|7553234|FG000|NOT COMPLETED|Overall Study||1
6625558|NCT02226549|7553235|FG001|NOT COMPLETED|Overall Study||1
6625559|NCT02226562|7553243|FG000|STARTED|Overall Study||95
6625560|NCT02226562|7553244|FG001|STARTED|Overall Study||96
6625561|NCT02226562|7553243|FG000|COMPLETED|Overall Study||95
6625562|NCT02226562|7553244|FG001|COMPLETED|Overall Study|Lost to follow up|95
6281973|NCT00176930|7182139|FG003|STARTED|Overall Study||1
6281974|NCT00176930|7182140|FG004|STARTED|Overall Study||213
6281975|NCT00176930|7182141|FG005|STARTED|Overall Study||85
6281976|NCT00176930|7182142|FG006|STARTED|Overall Study||2
6281977|NCT00176930|7182143|FG007|STARTED|Overall Study||2
6281978|NCT00176930|7182136|FG000|COMPLETED|Overall Study||12
6281979|NCT00176930|7182137|FG001|COMPLETED|Overall Study||13
6281980|NCT00176930|7182138|FG002|COMPLETED|Overall Study||1
6281981|NCT00176930|7182139|FG003|COMPLETED|Overall Study||1
6281982|NCT00176930|7182140|FG004|COMPLETED|Overall Study||213
6281983|NCT00176930|7182141|FG005|COMPLETED|Overall Study||85
6281984|NCT00176930|7182142|FG006|COMPLETED|Overall Study||2
6281985|NCT00176930|7182143|FG007|COMPLETED|Overall Study||2
6281986|NCT00176930|7182136|FG000|NOT COMPLETED|Overall Study||0
6281987|NCT00176930|7182137|FG001|NOT COMPLETED|Overall Study||0
6281988|NCT00176930|7182138|FG002|NOT COMPLETED|Overall Study||0
6281989|NCT00176930|7182139|FG003|NOT COMPLETED|Overall Study||0
6281990|NCT00176930|7182140|FG004|NOT COMPLETED|Overall Study||0
6281991|NCT00176930|7182141|FG005|NOT COMPLETED|Overall Study||0
6281992|NCT00176930|7182142|FG006|NOT COMPLETED|Overall Study||0
6281993|NCT00176930|7182143|FG007|NOT COMPLETED|Overall Study||0
6281994|NCT00177047|7182161|FG000|STARTED|Overall Study||363
6281995|NCT00177047|7182161|FG000|COMPLETED|Overall Study||363
6281996|NCT00177047|7182161|FG000|NOT COMPLETED|Overall Study||0
6281997|NCT00177164|7182167|FG000|STARTED|Overall Study||23
6281998|NCT00177164|7182168|FG001|STARTED|Overall Study||25
6281999|NCT00177164|7182167|FG000|COMPLETED|Overall Study||14
6282000|NCT00177164|7182168|FG001|COMPLETED|Overall Study||9
6282001|NCT00177164|7182167|FG000|NOT COMPLETED|Overall Study||9
6282002|NCT00177164|7182168|FG001|NOT COMPLETED|Overall Study||16
6282003|NCT00177216|7182177|FG000|STARTED|Overall Study||26
6282004|NCT00177216|7182178|FG001|STARTED|Overall Study||23
6282005|NCT00177216|7182179|FG002|STARTED|Overall Study||20
6282006|NCT00177216|7182177|FG000|COMPLETED|Overall Study||20
6282007|NCT00177216|7182178|FG001|COMPLETED|Overall Study||20
6282008|NCT00177216|7182179|FG002|COMPLETED|Overall Study||19
6282009|NCT00177216|7182177|FG000|NOT COMPLETED|Overall Study||6
6282010|NCT00177216|7182178|FG001|NOT COMPLETED|Overall Study||3
6282011|NCT00177216|7182179|FG002|NOT COMPLETED|Overall Study||1
6282012|NCT00177255|7182191|FG000|STARTED|Overall Study||39
6282013|NCT00177255|7182191|FG000|COMPLETED|Overall Study||39
6282014|NCT00177255|7182191|FG000|NOT COMPLETED|Overall Study||0
6282015|NCT00177294|7182197|FG000|STARTED|Overall Study||60
6282016|NCT00177294|7182198|FG001|STARTED|Overall Study||64
6282017|NCT00177294|7182197|FG000|COMPLETED|Overall Study||53
6282018|NCT00177294|7182198|FG001|COMPLETED|Overall Study||59
6282019|NCT00177294|7182197|FG000|NOT COMPLETED|Overall Study||7
6282020|NCT00177294|7182198|FG001|NOT COMPLETED|Overall Study||5
6282021|NCT00177307|7182204|FG000|STARTED|Overall Study||40
6282022|NCT00177307|7182204|FG000|COMPLETED|Overall Study||39
6282023|NCT00177307|7182204|FG000|NOT COMPLETED|Overall Study||1
6282024|NCT00177671|7182210|FG000|STARTED|Overall Study||67
6395738|NCT00860457|7308383|FG000|NOT COMPLETED|Overall Study||11
6395739|NCT00860470|7308389|FG000|STARTED|Overall Study||22162
6282025|NCT00177671|7182211|FG001|STARTED|Overall Study||63
6282026|NCT00177671|7182210|FG000|Month 12|Overall Study||45
6395740|NCT00860470|7308390|FG001|STARTED|Overall Study||22405
6625563|NCT02226562|7553243|FG000|NOT COMPLETED|Overall Study||0
6282027|NCT00177671|7182211|FG001|Month 12|Overall Study||57
6282028|NCT00177671|7182210|FG000|Month 24|Overall Study||42
6282029|NCT00177671|7182211|FG001|Month 24|Overall Study||49
6625564|NCT02226562|7553244|FG001|NOT COMPLETED|Overall Study||1
6625565|NCT02226653|7553252|FG000|STARTED|Treatment Period 1 Fasted State||24
6625566|NCT02226653|7553253|FG001|STARTED|Treatment Period 1 Fasted State||24
6625567|NCT02226653|7553252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
6625568|NCT02226653|7553253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 Fasted State||24
6625569|NCT02226653|7553252|FG000|COMPLETED|Treatment Period 1 Fasted State||24
6625570|NCT02226653|7553253|FG001|COMPLETED|Treatment Period 1 Fasted State||24
6625571|NCT02226653|7553252|FG000|NOT COMPLETED|Treatment Period 1 Fasted State||0
6625572|NCT02226653|7553253|FG001|NOT COMPLETED|Treatment Period 1 Fasted State||0
6625573|NCT02226653|7553252|FG000|STARTED|Washout Period 1 (at Least 21 Days)||24
6625574|NCT02226653|7553253|FG001|STARTED|Washout Period 1 (at Least 21 Days)||24
6625575|NCT02226653|7553252|FG000|COMPLETED|Washout Period 1 (at Least 21 Days)||24
6625576|NCT02226653|7553253|FG001|COMPLETED|Washout Period 1 (at Least 21 Days)||24
6625577|NCT02226653|7553252|FG000|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
6625578|NCT02226653|7553253|FG001|NOT COMPLETED|Washout Period 1 (at Least 21 Days)||0
6625579|NCT02226653|7553252|FG000|STARTED|Treatment Period 2 Fasted State||24
6625580|NCT02226653|7553253|FG001|STARTED|Treatment Period 2 Fasted State||24
6625581|NCT02226653|7553252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
6625582|NCT02226653|7553253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2 Fasted State||24
6625583|NCT02226653|7553252|FG000|COMPLETED|Treatment Period 2 Fasted State||23
6625584|NCT02226653|7553253|FG001|COMPLETED|Treatment Period 2 Fasted State||24
6625585|NCT02226653|7553252|FG000|NOT COMPLETED|Treatment Period 2 Fasted State||1
6625586|NCT02226653|7553253|FG001|NOT COMPLETED|Treatment Period 2 Fasted State||0
6625587|NCT02226653|7553252|FG000|STARTED|Washout Period 2 (at Least 21 Days)||23
6625588|NCT02226653|7553253|FG001|STARTED|Washout Period 2 (at Least 21 Days)||24
6282030|NCT00177671|7182210|FG000|COMPLETED|Overall Study||42
6282031|NCT00177671|7182211|FG001|COMPLETED|Overall Study||49
6282032|NCT00177671|7182210|FG000|NOT COMPLETED|Overall Study||25
6282033|NCT00177671|7182211|FG001|NOT COMPLETED|Overall Study||14
6282034|NCT00178126|7182219|FG000|STARTED|Overall Study||119
6282035|NCT00178126|7182220|FG001|STARTED|Overall Study||113
6282036|NCT00178126|7182219|FG000|COMPLETED|Overall Study||94
6282037|NCT00178126|7182220|FG001|COMPLETED|Overall Study||86
6282038|NCT00178126|7182219|FG000|NOT COMPLETED|Overall Study||25
6282039|NCT00178126|7182220|FG001|NOT COMPLETED|Overall Study||27
6282040|NCT00178178|7182230|FG000|STARTED|Overall Study||24
6282041|NCT00178178|7182231|FG001|STARTED|Overall Study||24
6282042|NCT00178178|7182232|FG002|STARTED|Overall Study||24
6282043|NCT00178178|7182233|FG003|STARTED|Overall Study||24
6282044|NCT00178178|7182230|FG000|COMPLETED|Overall Study||24
6282045|NCT00178178|7182231|FG001|COMPLETED|Overall Study||24
6282046|NCT00178178|7182232|FG002|COMPLETED|Overall Study||24
6282047|NCT00178178|7182233|FG003|COMPLETED|Overall Study||24
6282048|NCT00178178|7182230|FG000|NOT COMPLETED|Overall Study||0
6282049|NCT00178178|7182231|FG001|NOT COMPLETED|Overall Study||0
6282050|NCT00178178|7182232|FG002|NOT COMPLETED|Overall Study||0
6282051|NCT00178178|7182233|FG003|NOT COMPLETED|Overall Study||0
6282052|NCT00178191|7182246|FG000|STARTED|Overall Study||11
6282053|NCT00178191|7182247|FG001|STARTED|Overall Study||10
6282054|NCT00178191|7182248|FG002|STARTED|Overall Study||7
6282055|NCT00178191|7182246|FG000|COMPLETED|Overall Study||11
6282056|NCT00178191|7182247|FG001|COMPLETED|Overall Study||10
6282057|NCT00178191|7182248|FG002|COMPLETED|Overall Study||7
6282058|NCT00178191|7182246|FG000|NOT COMPLETED|Overall Study||0
6282059|NCT00178191|7182247|FG001|NOT COMPLETED|Overall Study||0
6282060|NCT00178191|7182248|FG002|NOT COMPLETED|Overall Study||0
6282061|NCT00178256|7182256|FG000|STARTED|Overall Study||10
6282062|NCT00178256|7182257|FG001|STARTED|Overall Study||7
6282063|NCT00178256|7182258|FG002|STARTED|Overall Study||6
6395741|NCT00860470|7308389|FG000|COMPLETED|Overall Study||22114
6395742|NCT00860470|7308390|FG001|COMPLETED|Overall Study||22346
6395743|NCT00860470|7308389|FG000|NOT COMPLETED|Overall Study||48
6395744|NCT00860470|7308390|FG001|NOT COMPLETED|Overall Study||59
6395745|NCT00860535|7308396|FG000|STARTED|Overall Study||9
6395746|NCT00860535|7308396|FG000|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
6395747|NCT00860535|7308396|FG000|COMPLETED|Overall Study||8
6282064|NCT00178256|7182259|FG003|STARTED|Overall Study||18
6282065|NCT00178256|7182256|FG000|COMPLETED|Overall Study||6
6282066|NCT00178256|7182257|FG001|COMPLETED|Overall Study||6
6282067|NCT00178256|7182258|FG002|COMPLETED|Overall Study||6
6282068|NCT00178256|7182259|FG003|COMPLETED|Overall Study||16
6282069|NCT00178256|7182256|FG000|NOT COMPLETED|Overall Study||4
6282070|NCT00178256|7182257|FG001|NOT COMPLETED|Overall Study||1
6282071|NCT00178256|7182258|FG002|NOT COMPLETED|Overall Study||0
6282072|NCT00178256|7182259|FG003|NOT COMPLETED|Overall Study||2
6282073|NCT00178399|7182266|FG000|STARTED|Overall Study||128
6282074|NCT00178399|7182266|FG000|COMPLETED|Overall Study||115
6282075|NCT00178399|7182266|FG000|NOT COMPLETED|Overall Study||13
6282076|NCT00178464|7182271|FG000|STARTED|Overall Study||11
6282077|NCT00178464|7182271|FG000|COMPLETED|Overall Study||9
6282078|NCT00178464|7182271|FG000|NOT COMPLETED|Overall Study||2
6282079|NCT00178503|7182275|FG000|STARTED|MPH Trial: Placebo||24
6282080|NCT00178503|7182275|FG000|COMPLETED|MPH Trial: Placebo||24
6282081|NCT00178503|7182275|FG000|NOT COMPLETED|MPH Trial: Placebo||0
6282082|NCT00178503|7182275|FG000|STARTED|MPH Trial: Low Dose||24
6282083|NCT00178503|7182275|FG000|COMPLETED|MPH Trial: Low Dose||24
6395748|NCT00860535|7308396|FG000|NOT COMPLETED|Overall Study||1
6395749|NCT00860574|7308400|FG000|STARTED|Overall Study||96
6395750|NCT00860574|7308400|FG000|COMPLETED|Overall Study||93
6395751|NCT00860574|7308400|FG000|NOT COMPLETED|Overall Study||3
6395752|NCT00860743|7308410|FG000|STARTED|Overall Study||40
6395753|NCT00860743|7308411|FG001|STARTED|Overall Study||23
6395754|NCT00860743|7308410|FG000|COMPLETED|Overall Study||37
6395755|NCT00860743|7308411|FG001|COMPLETED|Overall Study||23
6395756|NCT00860743|7308410|FG000|NOT COMPLETED|Overall Study||3
6395757|NCT00860743|7308411|FG001|NOT COMPLETED|Overall Study||0
6395758|NCT00860795|7308419|FG000|STARTED|Overall Study||10
6395759|NCT00860795|7308420|FG001|STARTED|Overall Study||10
6395760|NCT00860795|7308419|FG000|Number to Complete Study Medication|Overall Study||9
6395761|NCT00860795|7308420|FG001|Number to Complete Study Medication|Overall Study||10
6395762|NCT00860795|7308419|FG000|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
6395763|NCT00860795|7308420|FG001|COMPLETED|Overall Study||10
6395764|NCT00860795|7308419|FG000|NOT COMPLETED|Overall Study||0
6395765|NCT00860795|7308420|FG001|NOT COMPLETED|Overall Study||0
6395766|NCT00860847|7308428|FG000|STARTED|Overall Study||32
6395767|NCT00860847|7308429|FG001|STARTED|Overall Study||33
6395768|NCT00860847|7308428|FG000|COMPLETED|Overall Study||28
6395769|NCT00860847|7308429|FG001|COMPLETED|Overall Study||28
6395770|NCT00860847|7308428|FG000|NOT COMPLETED|Overall Study||4
6395771|NCT00860847|7308429|FG001|NOT COMPLETED|Overall Study||5
6395772|NCT00860938|7308437|FG000|STARTED|Overall Study||45
6395773|NCT00860938|7308438|FG001|STARTED|Overall Study||45
6395774|NCT00860938|7308437|FG000|COMPLETED|Overall Study||31
6395775|NCT00860938|7308438|FG001|COMPLETED|Overall Study||37
6395776|NCT00860938|7308437|FG000|NOT COMPLETED|Overall Study||14
6509980|NCT01478581|7429435|FG000|STARTED|Overall Study||13
6509981|NCT01478581|7429436|FG001|STARTED|Overall Study||18
6509982|NCT01478581|7429437|FG002|STARTED|Overall Study||18
6625589|NCT02226653|7553252|FG000|COMPLETED|Washout Period 2 (at Least 21 Days)||23
6625590|NCT02226653|7553253|FG001|COMPLETED|Washout Period 2 (at Least 21 Days)||24
6625591|NCT02226653|7553252|FG000|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
6625592|NCT02226653|7553253|FG001|NOT COMPLETED|Washout Period 2 (at Least 21 Days)||0
6625593|NCT02226653|7553252|FG000|STARTED|Treatment Period 3 Fasted State||23
6625594|NCT02226653|7553253|FG001|STARTED|Treatment Period 3 Fasted State||24
6625595|NCT02226653|7553252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||23
6625596|NCT02226653|7553253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3 Fasted State||24
6625597|NCT02226653|7553252|FG000|COMPLETED|Treatment Period 3 Fasted State||23
6625598|NCT02226653|7553253|FG001|COMPLETED|Treatment Period 3 Fasted State||24
6625599|NCT02226653|7553252|FG000|NOT COMPLETED|Treatment Period 3 Fasted State||0
6625600|NCT02226653|7553253|FG001|NOT COMPLETED|Treatment Period 3 Fasted State||0
6625601|NCT02226653|7553252|FG000|STARTED|Washout Period 3 (at Least 21 Days)||23
6625602|NCT02226653|7553253|FG001|STARTED|Washout Period 3 (at Least 21 Days)||24
6625603|NCT02226653|7553252|FG000|COMPLETED|Washout Period 3 (at Least 21 Days)||23
6625604|NCT02226653|7553253|FG001|COMPLETED|Washout Period 3 (at Least 21 Days)||24
6625605|NCT02226653|7553252|FG000|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
6625606|NCT02226653|7553253|FG001|NOT COMPLETED|Washout Period 3 (at Least 21 Days)||0
6625607|NCT02226653|7553252|FG000|STARTED|Treatment Period 4 Fasted State||23
6625608|NCT02226653|7553253|FG001|STARTED|Treatment Period 4 Fasted State||24
6625609|NCT02226653|7553252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||23
6625610|NCT02226653|7553253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 4 Fasted State||24
6625611|NCT02226653|7553252|FG000|COMPLETED|Treatment Period 4 Fasted State||23
6282084|NCT00178503|7182275|FG000|NOT COMPLETED|MPH Trial: Low Dose||0
6282085|NCT00178503|7182275|FG000|STARTED|MPH Trial: Med Dose||24
6282086|NCT00178503|7182275|FG000|COMPLETED|MPH Trial: Med Dose||24
6282087|NCT00178503|7182275|FG000|NOT COMPLETED|MPH Trial: Med Dose||0
6282088|NCT00178503|7182275|FG000|STARTED|MPH Trial: High Dose||24
6282089|NCT00178503|7182275|FG000|COMPLETED|MPH Trial: High Dose||24
6282090|NCT00178503|7182275|FG000|NOT COMPLETED|MPH Trial: High Dose||0
6282091|NCT00178633|7182290|FG000|STARTED|Overall Study||43
6282092|NCT00178633|7182290|FG000|COMPLETED|Overall Study||37
6282093|NCT00178633|7182290|FG000|NOT COMPLETED|Overall Study||6
6282094|NCT00178646|7182298|FG000|STARTED|Overall Study||12
6282095|NCT00178646|7182299|FG001|STARTED|Overall Study||9
6282096|NCT00178646|7182300|FG002|STARTED|Overall Study||11
6282097|NCT00178646|7182298|FG000|COMPLETED|Overall Study||12
6282098|NCT00178646|7182299|FG001|COMPLETED|Overall Study||8
6282099|NCT00178646|7182300|FG002|COMPLETED|Overall Study||10
6282100|NCT00178646|7182298|FG000|NOT COMPLETED|Overall Study||0
6282101|NCT00178646|7182299|FG001|NOT COMPLETED|Overall Study||1
6282102|NCT00178646|7182300|FG002|NOT COMPLETED|Overall Study||1
6282103|NCT00178685|7182314|FG000|STARTED|Overall Study||172
6282104|NCT00178685|7182315|FG001|STARTED|Overall Study||324
6282105|NCT00178685|7182316|FG002|STARTED|Overall Study||324
6395777|NCT00860938|7308438|FG001|NOT COMPLETED|Overall Study||8
6395778|NCT00860951|7308444|FG000|STARTED|Overall Study||29
6395779|NCT00860951|7308444|FG000|COMPLETED|Overall Study||22
6395780|NCT00860951|7308444|FG000|NOT COMPLETED|Overall Study||7
6625612|NCT02226653|7553253|FG001|COMPLETED|Treatment Period 4 Fasted State||24
6625613|NCT02226653|7553252|FG000|NOT COMPLETED|Treatment Period 4 Fasted State||0
6282106|NCT00178685|7182314|FG000|COMPLETED|Overall Study||61
6282107|NCT00178685|7182315|FG001|COMPLETED|Overall Study||120
6625614|NCT02226653|7553253|FG001|NOT COMPLETED|Treatment Period 4 Fasted State||0
6625615|NCT02226653|7553252|FG000|STARTED|Washout Period 4 (at Least 21 Days)||23
6625616|NCT02226653|7553253|FG001|STARTED|Washout Period 4 (at Least 21 Days)||24
6625617|NCT02226653|7553252|FG000|COMPLETED|Washout Period 4 (at Least 21 Days)||23
6625618|NCT02226653|7553253|FG001|COMPLETED|Washout Period 4 (at Least 21 Days)||24
6625619|NCT02226653|7553252|FG000|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
6625620|NCT02226653|7553253|FG001|NOT COMPLETED|Washout Period 4 (at Least 21 Days)||0
6625621|NCT02226653|7553252|FG000|STARTED|Treatment Period 5 Fed State||23
6625622|NCT02226653|7553253|FG001|STARTED|Treatment Period 5 Fed State||24
6625623|NCT02226653|7553252|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||23
6625624|NCT02226653|7553253|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 5 Fed State||24
6625625|NCT02226653|7553252|FG000|COMPLETED|Treatment Period 5 Fed State||23
6625626|NCT02226653|7553253|FG001|COMPLETED|Treatment Period 5 Fed State||23
6625627|NCT02226653|7553252|FG000|NOT COMPLETED|Treatment Period 5 Fed State||0
6625628|NCT02226653|7553253|FG001|NOT COMPLETED|Treatment Period 5 Fed State||1
6625629|NCT02226653|7553252|FG000|STARTED|Washout Period 5 (at Least 21 Days)||23
6625630|NCT02226653|7553253|FG001|STARTED|Washout Period 5 (at Least 21 Days)||23
6625631|NCT02226653|7553252|FG000|COMPLETED|Washout Period 5 (at Least 21 Days)||23
6625632|NCT02226653|7553253|FG001|COMPLETED|Washout Period 5 (at Least 21 Days)||23
6625633|NCT02226653|7553252|FG000|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
6625634|NCT02226653|7553253|FG001|NOT COMPLETED|Washout Period 5 (at Least 21 Days)||0
6625635|NCT02226796|7553266|FG000|STARTED|First Intervention Phase (Week 1)||2
6625636|NCT02226796|7553267|FG001|STARTED|First Intervention Phase (Week 1)||1
6625637|NCT02226796|7553266|FG000|Baseline Assessment|First Intervention Phase (Week 1)||2
6625638|NCT02226796|7553267|FG001|Baseline Assessment|First Intervention Phase (Week 1)||1
6625639|NCT02226796|7553266|FG000|Follow Up Assessment|First Intervention Phase (Week 1)||2
6625640|NCT02226796|7553267|FG001|Follow Up Assessment|First Intervention Phase (Week 1)||1
6625641|NCT02226796|7553266|FG000|COMPLETED|First Intervention Phase (Week 1)||2
6625642|NCT02226796|7553267|FG001|COMPLETED|First Intervention Phase (Week 1)||1
6625643|NCT02226796|7553266|FG000|NOT COMPLETED|First Intervention Phase (Week 1)||0
6625644|NCT02226796|7553267|FG001|NOT COMPLETED|First Intervention Phase (Week 1)||0
6625645|NCT02226796|7553266|FG000|STARTED|Washout (Weeks 2-5)||2
6625646|NCT02226796|7553267|FG001|STARTED|Washout (Weeks 2-5)||1
6625647|NCT02226796|7553266|FG000|COMPLETED|Washout (Weeks 2-5)||2
6625648|NCT02226796|7553267|FG001|COMPLETED|Washout (Weeks 2-5)||1
6625649|NCT02226796|7553266|FG000|NOT COMPLETED|Washout (Weeks 2-5)||0
6625650|NCT02226796|7553267|FG001|NOT COMPLETED|Washout (Weeks 2-5)||0
6625651|NCT02226796|7553266|FG000|STARTED|Second Intervention Phase (Week 6)||2
6625652|NCT02226796|7553267|FG001|STARTED|Second Intervention Phase (Week 6)||1
6625653|NCT02226796|7553266|FG000|Baseline Assessment|Second Intervention Phase (Week 6)||2
6625654|NCT02226796|7553267|FG001|Baseline Assessment|Second Intervention Phase (Week 6)||1
6625655|NCT02226796|7553266|FG000|Follow Up Assessment|Second Intervention Phase (Week 6)||2
6625656|NCT02226796|7553267|FG001|Follow Up Assessment|Second Intervention Phase (Week 6)||1
6625657|NCT02226796|7553266|FG000|COMPLETED|Second Intervention Phase (Week 6)||2
6625658|NCT02226796|7553267|FG001|COMPLETED|Second Intervention Phase (Week 6)||1
6625659|NCT02226796|7553266|FG000|NOT COMPLETED|Second Intervention Phase (Week 6)||0
6625660|NCT02226796|7553267|FG001|NOT COMPLETED|Second Intervention Phase (Week 6)||0
6625661|NCT02226965|7553273|FG000|STARTED|Overall Study||45
6625662|NCT02226965|7553273|FG000|COMPLETED|Overall Study||4
6625663|NCT02226965|7553273|FG000|NOT COMPLETED|Overall Study||41
6625664|NCT02227108|7553277|FG000|STARTED|Overall Study||32
6625665|NCT02227108|7553277|FG000|Treated|Overall Study||30
6625666|NCT02227108|7553277|FG000|COMPLETED|Overall Study||1
6625667|NCT02227108|7553277|FG000|NOT COMPLETED|Overall Study||31
6625668|NCT02227121|7553281|FG000|STARTED|Overall Study||16
6625669|NCT02227121|7553281|FG000|COMPLETED|Overall Study||16
6625670|NCT02227121|7553281|FG000|NOT COMPLETED|Overall Study||0
6625671|NCT02227316|7553289|FG000|STARTED|Overall Study||4
6625672|NCT02227316|7553290|FG001|STARTED|Overall Study||4
6625673|NCT02227316|7553291|FG002|STARTED|Overall Study||16
6625674|NCT02227316|7553292|FG003|STARTED|Overall Study||16
6625675|NCT02227316|7553289|FG000|COMPLETED|Overall Study||4
6625676|NCT02227316|7553290|FG001|COMPLETED|Overall Study||4
6625677|NCT02227316|7553291|FG002|COMPLETED|Overall Study||16
6625678|NCT02227316|7553292|FG003|COMPLETED|Overall Study||16
6625679|NCT02227316|7553289|FG000|NOT COMPLETED|Overall Study||0
6625680|NCT02227316|7553290|FG001|NOT COMPLETED|Overall Study||0
6625681|NCT02227316|7553291|FG002|NOT COMPLETED|Overall Study||0
6625682|NCT02227316|7553292|FG003|NOT COMPLETED|Overall Study||0
6625683|NCT02227329|7553304|FG000|STARTED|Overall Study||18
6625684|NCT02227329|7553305|FG001|STARTED|Overall Study||20
6625685|NCT02227329|7553304|FG000|COMPLETED|Overall Study||18
6625686|NCT02227329|7553305|FG001|COMPLETED|Overall Study||20
6625687|NCT02227329|7553304|FG000|NOT COMPLETED|Overall Study||0
6625688|NCT02227329|7553305|FG001|NOT COMPLETED|Overall Study||0
6625689|NCT02227368|7553313|FG000|STARTED|Overall Study||16
6625690|NCT02227368|7553314|FG001|STARTED|Overall Study||24
6625691|NCT02227368|7553313|FG000|Sujects Who Received Treatment|Overall Study||16
6625692|NCT02227368|7553314|FG001|Sujects Who Received Treatment|Overall Study||24
6625693|NCT02227368|7553313|FG000|Sujects Who Completed Treatment|Overall Study||10
6625694|NCT02227368|7553314|FG001|Sujects Who Completed Treatment|Overall Study||17
6625695|NCT02227368|7553313|FG000|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
6625696|NCT02227368|7553314|FG001|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
6625697|NCT02227368|7553313|FG000|NOT COMPLETED|Overall Study||2
6625698|NCT02227368|7553314|FG001|NOT COMPLETED|Overall Study||4
6625699|NCT02227446|7553322|FG000|STARTED|Overall Study||521
6625700|NCT02227446|7553323|FG001|STARTED|Overall Study||515
6625701|NCT02227446|7553322|FG000|COMPLETED|Overall Study||499
6625702|NCT02227446|7553323|FG001|COMPLETED|Overall Study||481
6625703|NCT02227446|7553322|FG000|NOT COMPLETED|Overall Study||22
6625704|NCT02227446|7553323|FG001|NOT COMPLETED|Overall Study||34
6625705|NCT02227485|7553331|FG000|STARTED|First Follow-up||40
6625706|NCT02227485|7553332|FG001|STARTED|First Follow-up||40
6625707|NCT02227485|7553331|FG000|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
6625708|NCT02227485|7553332|FG001|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
6625709|NCT02227485|7553331|FG000|NOT COMPLETED|First Follow-up||4
6625710|NCT02227485|7553332|FG001|NOT COMPLETED|First Follow-up||2
6625711|NCT02227485|7553331|FG000|STARTED|Second Follow-up||36
6625712|NCT02227485|7553332|FG001|STARTED|Second Follow-up||38
6625713|NCT02227485|7553331|FG000|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
6625714|NCT02227485|7553332|FG001|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
6625715|NCT02227485|7553331|FG000|NOT COMPLETED|Second Follow-up||2
6625716|NCT02227485|7553332|FG001|NOT COMPLETED|Second Follow-up||2
6625717|NCT02227667|7553339|FG000|STARTED|Overall Study||16
6625718|NCT02227667|7553339|FG000|COMPLETED|Overall Study||16
6625719|NCT02227667|7553339|FG000|NOT COMPLETED|Overall Study||0
6625720|NCT02227693|7553347|FG000|STARTED|Overall Study||11
6625721|NCT02227693|7553348|FG001|STARTED|Overall Study||7
6625722|NCT02227693|7553349|FG002|STARTED|Overall Study||11
6625723|NCT02227693|7553350|FG003|STARTED|Overall Study||10
6625724|NCT02227693|7553347|FG000|COMPLETED|Overall Study||11
6625725|NCT02227693|7553348|FG001|COMPLETED|Overall Study||7
6625726|NCT02227693|7553349|FG002|COMPLETED|Overall Study||11
6625727|NCT02227693|7553350|FG003|COMPLETED|Overall Study||10
6625728|NCT02227693|7553347|FG000|NOT COMPLETED|Overall Study||0
6625729|NCT02227693|7553348|FG001|NOT COMPLETED|Overall Study||0
6625730|NCT02227693|7553349|FG002|NOT COMPLETED|Overall Study||0
6625731|NCT02227693|7553350|FG003|NOT COMPLETED|Overall Study||0
6625732|NCT02227706|7553366|FG000|STARTED|Overall Study||20
6625733|NCT02227706|7553367|FG001|STARTED|Overall Study||20
6625734|NCT02227706|7553366|FG000|COMPLETED|Overall Study||20
6625735|NCT02227706|7553367|FG001|COMPLETED|Overall Study||20
6625736|NCT02227706|7553366|FG000|NOT COMPLETED|Overall Study||0
6625737|NCT02227706|7553367|FG001|NOT COMPLETED|Overall Study||0
6625738|NCT02227758|7553373|FG000|STARTED|Overall Study||112
6625739|NCT02227758|7553373|FG000|COMPLETED|Overall Study||45
6625740|NCT02227758|7553373|FG000|NOT COMPLETED|Overall Study||67
6625741|NCT02227784|7553383|FG000|STARTED|Double-Blind Phase||123
6625742|NCT02227784|7553384|FG001|STARTED|Double-Blind Phase||54
6625743|NCT02227784|7553385|FG002|STARTED|Double-Blind Phase||62
6625744|NCT02227784|7553386|FG003|STARTED|Double-Blind Phase||127
6625745|NCT02227784|7553387|FG004|STARTED|Double-Blind Phase||0
6625746|NCT02227784|7553383|FG000|COMPLETED|Double-Blind Phase||83
6625747|NCT02227784|7553384|FG001|COMPLETED|Double-Blind Phase||36
6625748|NCT02227784|7553385|FG002|COMPLETED|Double-Blind Phase||41
6625749|NCT02227784|7553386|FG003|COMPLETED|Double-Blind Phase||88
6625750|NCT02227784|7553387|FG004|COMPLETED|Double-Blind Phase||0
6625751|NCT02227784|7553383|FG000|NOT COMPLETED|Double-Blind Phase||40
6625752|NCT02227784|7553384|FG001|NOT COMPLETED|Double-Blind Phase||18
6625753|NCT02227784|7553385|FG002|NOT COMPLETED|Double-Blind Phase||21
6625754|NCT02227784|7553386|FG003|NOT COMPLETED|Double-Blind Phase||39
6625755|NCT02227784|7553387|FG004|NOT COMPLETED|Double-Blind Phase||0
6625756|NCT02227784|7553383|FG000|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
6625757|NCT02227784|7553384|FG001|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
6625758|NCT02227784|7553385|FG002|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
6625759|NCT02227784|7553386|FG003|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|0
6625760|NCT02227784|7553387|FG004|STARTED|Open-Label Extension Phase (OLE)|After the double-blind treatment phase, participants entered an OLE phase.|248
6625761|NCT02227784|7553383|FG000|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
6625762|NCT02227784|7553384|FG001|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
6625763|NCT02227784|7553385|FG002|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
6625764|NCT02227784|7553386|FG003|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||0
6625765|NCT02227784|7553387|FG004|Received at Least 1 Dose of Study Drug|Open-Label Extension Phase (OLE)||247
6625766|NCT02227784|7553383|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
6625767|NCT02227784|7553384|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
6625768|NCT02227784|7553385|FG002|COMPLETED|Open-Label Extension Phase (OLE)||0
6625769|NCT02227784|7553386|FG003|COMPLETED|Open-Label Extension Phase (OLE)||0
6625770|NCT02227784|7553387|FG004|COMPLETED|Open-Label Extension Phase (OLE)||0
6625771|NCT02227784|7553383|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6625772|NCT02227784|7553384|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6625773|NCT02227784|7553385|FG002|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6625774|NCT02227784|7553386|FG003|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6625775|NCT02227784|7553387|FG004|NOT COMPLETED|Open-Label Extension Phase (OLE)||248
6625776|NCT02227810|7553402|FG000|STARTED|Overall Study||19
6625777|NCT02227810|7553403|FG001|STARTED|Overall Study||34
6625778|NCT02227810|7553402|FG000|COMPLETED|Overall Study||17
6625779|NCT02227810|7553403|FG001|COMPLETED|Overall Study||29
6625780|NCT02227810|7553402|FG000|NOT COMPLETED|Overall Study||2
6625781|NCT02227810|7553403|FG001|NOT COMPLETED|Overall Study||5
6625782|NCT02227836|7553411|FG000|STARTED|Overall Study||8
6625783|NCT02227836|7553411|FG000|COMPLETED|Overall Study||8
6625784|NCT02227836|7553411|FG000|NOT COMPLETED|Overall Study||0
6625785|NCT02227849|7553415|FG000|STARTED|Overall Study||71
6625786|NCT02227849|7553415|FG000|COMPLETED|Overall Study||63
6625787|NCT02227849|7553415|FG000|NOT COMPLETED|Overall Study||8
6625788|NCT02228096|7553421|FG000|STARTED|Overall Study||75
6625789|NCT02228096|7553421|FG000|Enrolled Into Long-term f/u Protocol|Overall Study||31
6625790|NCT02228096|7553421|FG000|Enrolled But Not Infused|Overall Study||11
6625791|NCT02228096|7553421|FG000|Enrolled and Infused|Overall Study||64
6625792|NCT02228096|7553421|FG000|COMPLETED|Overall Study|Completed = study follow-up completed|4
6625793|NCT02228096|7553421|FG000|NOT COMPLETED|Overall Study||71
6625794|NCT02228174|7553439|FG000|STARTED|Overall Study||147
6625795|NCT02228174|7553439|FG000|Full Analysis Population|Overall Study|Subjects who didn't become pregnant or diagnosed with an interfering medical condition at 12-months|143
6625796|NCT02228174|7553439|FG000|COMPLETED|Overall Study||142
6625797|NCT02228174|7553439|FG000|NOT COMPLETED|Overall Study||5
6625798|NCT02228395|7553443|FG000|STARTED|First Intervention Period||3
6625799|NCT02228395|7553444|FG001|STARTED|First Intervention Period||3
6625800|NCT02228395|7553445|FG002|STARTED|First Intervention Period||3
6625801|NCT02228395|7553443|FG000|COMPLETED|First Intervention Period||2
6625802|NCT02228395|7553444|FG001|COMPLETED|First Intervention Period||2
6625803|NCT02228395|7553445|FG002|COMPLETED|First Intervention Period||2
6625804|NCT02228395|7553443|FG000|NOT COMPLETED|First Intervention Period||1
6625805|NCT02228395|7553444|FG001|NOT COMPLETED|First Intervention Period||1
6625806|NCT02228395|7553445|FG002|NOT COMPLETED|First Intervention Period||1
6625807|NCT02228395|7553443|FG000|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
6625808|NCT02228395|7553444|FG001|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
6625809|NCT02228395|7553445|FG002|STARTED|Washout Period (at Least 10 Days)|One participant discontinued in the First Intervention Period and was replaced.|3
6625810|NCT02228395|7553443|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
6625811|NCT02228395|7553444|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
6625812|NCT02228395|7553445|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
6625813|NCT02228395|7553443|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6625814|NCT02228395|7553444|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6625815|NCT02228395|7553445|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6625816|NCT02228395|7553443|FG000|STARTED|Second Intervention Period||3
6625817|NCT02228395|7553444|FG001|STARTED|Second Intervention Period||3
6625818|NCT02228395|7553445|FG002|STARTED|Second Intervention Period||3
6625819|NCT02228395|7553443|FG000|COMPLETED|Second Intervention Period||3
6625820|NCT02228395|7553444|FG001|COMPLETED|Second Intervention Period||3
6625821|NCT02228395|7553445|FG002|COMPLETED|Second Intervention Period||3
6625822|NCT02228395|7553443|FG000|NOT COMPLETED|Second Intervention Period||0
6625823|NCT02228395|7553444|FG001|NOT COMPLETED|Second Intervention Period||0
6625824|NCT02228395|7553445|FG002|NOT COMPLETED|Second Intervention Period||0
6625825|NCT02228395|7553443|FG000|STARTED|Washout Period (at Least 10 Days)||3
6625826|NCT02228395|7553444|FG001|STARTED|Washout Period (at Least 10 Days)||3
6625827|NCT02228395|7553445|FG002|STARTED|Washout Period (at Least 10 Days)||3
6625828|NCT02228395|7553443|FG000|COMPLETED|Washout Period (at Least 10 Days)||3
6625829|NCT02228395|7553444|FG001|COMPLETED|Washout Period (at Least 10 Days)||3
6625830|NCT02228395|7553445|FG002|COMPLETED|Washout Period (at Least 10 Days)||3
6625831|NCT02228395|7553443|FG000|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6625832|NCT02228395|7553444|FG001|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6625833|NCT02228395|7553445|FG002|NOT COMPLETED|Washout Period (at Least 10 Days)||0
6625834|NCT02228395|7553443|FG000|STARTED|Third Intervention Period||3
6625835|NCT02228395|7553444|FG001|STARTED|Third Intervention Period||3
6625836|NCT02228395|7553445|FG002|STARTED|Third Intervention Period||3
6625837|NCT02228395|7553443|FG000|COMPLETED|Third Intervention Period||3
6625838|NCT02228395|7553444|FG001|COMPLETED|Third Intervention Period||3
6625839|NCT02228395|7553445|FG002|COMPLETED|Third Intervention Period||3
6625840|NCT02228395|7553443|FG000|NOT COMPLETED|Third Intervention Period||0
6625841|NCT02228395|7553444|FG001|NOT COMPLETED|Third Intervention Period||0
6625842|NCT02228395|7553445|FG002|NOT COMPLETED|Third Intervention Period||0
6625843|NCT02228408|7553457|FG000|STARTED|Overall Study||7
6625844|NCT02228408|7553458|FG001|STARTED|Overall Study||10
6625845|NCT02228408|7553457|FG000|COMPLETED|Overall Study||7
6625846|NCT02228408|7553458|FG001|COMPLETED|Overall Study||10
6625847|NCT02228408|7553457|FG000|NOT COMPLETED|Overall Study||0
6625848|NCT02228408|7553458|FG001|NOT COMPLETED|Overall Study||0
6625849|NCT02228460|7553464|FG000|STARTED|Overall Study||11
6625850|NCT02228460|7553464|FG000|COMPLETED|Overall Study||9
6625851|NCT02228460|7553464|FG000|NOT COMPLETED|Overall Study||2
6625852|NCT02228499|7553471|FG000|STARTED|Overall Study||30
6625853|NCT02228499|7553472|FG001|STARTED|Overall Study||36
6625854|NCT02228499|7553471|FG000|COMPLETED|Overall Study||7
6625855|NCT02228499|7553472|FG001|COMPLETED|Overall Study||10
6625856|NCT02228499|7553471|FG000|NOT COMPLETED|Overall Study||23
6625857|NCT02228499|7553472|FG001|NOT COMPLETED|Overall Study||26
6625858|NCT02228564|7553478|FG000|STARTED|Overall Study||155
6625859|NCT02228564|7553478|FG000|COMPLETED|Overall Study||106
6625860|NCT02228564|7553478|FG000|NOT COMPLETED|Overall Study||49
6625861|NCT02228590|7553482|FG000|STARTED|Overall Study||20
6625862|NCT02228590|7553482|FG000|COMPLETED|Overall Study||19
6625863|NCT02228590|7553482|FG000|NOT COMPLETED|Overall Study||1
6625864|NCT02228681|7553489|FG000|STARTED|Overall Study||37
6625865|NCT02228681|7553490|FG001|STARTED|Overall Study||37
6625866|NCT02228681|7553489|FG000|COMPLETED|Overall Study||37
6625867|NCT02228681|7553490|FG001|COMPLETED|Overall Study||37
6625868|NCT02228681|7553489|FG000|NOT COMPLETED|Overall Study||0
6625869|NCT02228681|7553490|FG001|NOT COMPLETED|Overall Study||0
6625870|NCT02228720|7553496|FG000|STARTED|Open Label - Baseline||15
6625871|NCT02228720|7553496|FG000|COMPLETED|Open Label - Baseline||15
6625872|NCT02228720|7553496|FG000|NOT COMPLETED|Open Label - Baseline||0
6625873|NCT02228720|7553496|FG000|STARTED|Open Label - Day 30||15
6625874|NCT02228720|7553496|FG000|COMPLETED|Open Label - Day 30||14
6395781|NCT00861146|7308452|FG000|STARTED|Overall Study||105
6395782|NCT00861146|7308453|FG001|STARTED|Overall Study||46
6395783|NCT00861146|7308452|FG000|Week 2 Assessment|Overall Study||97
6395784|NCT00861146|7308453|FG001|Week 2 Assessment|Overall Study||45
6395785|NCT00861146|7308452|FG000|Week 13 Assessment|Overall Study||85
6395786|NCT00861146|7308453|FG001|Week 13 Assessment|Overall Study||38
6395787|NCT00861146|7308452|FG000|COMPLETED|Overall Study||85
6395788|NCT00861146|7308453|FG001|COMPLETED|Overall Study||38
6395789|NCT00861146|7308452|FG000|NOT COMPLETED|Overall Study||20
6395790|NCT00861146|7308453|FG001|NOT COMPLETED|Overall Study||8
6395791|NCT00861198|7308459|FG000|STARTED|Overall Study||75
6395792|NCT00861198|7308459|FG000|COMPLETED|Overall Study||70
6395793|NCT00861198|7308459|FG000|NOT COMPLETED|Overall Study||5
6395794|NCT00861263|7308463|FG000|STARTED|Overall Study||193
6395795|NCT00861263|7308463|FG000|COMPLETED|Overall Study||193
6395796|NCT00861263|7308463|FG000|NOT COMPLETED|Overall Study||0
6395797|NCT00861341|7308467|FG000|STARTED|Overall Study||40
6395798|NCT00861341|7308467|FG000|COMPLETED|Overall Study||38
6395799|NCT00861341|7308467|FG000|NOT COMPLETED|Overall Study||2
6395800|NCT00861380|7308478|FG000|STARTED|Overall Study||8427
6395801|NCT00861380|7308479|FG001|STARTED|Overall Study||9112
6395802|NCT00861380|7308480|FG002|STARTED|Overall Study||8872
6395803|NCT00861380|7308481|FG003|STARTED|Overall Study||3689
6395804|NCT00861380|7308482|FG004|STARTED|Overall Study||1812
6395805|NCT00861380|7308483|FG005|STARTED|Overall Study||6249
6395806|NCT00861380|7308484|FG006|STARTED|Overall Study||3020
6395807|NCT00861380|7308478|FG000|COMPLETED|Overall Study||0
6395808|NCT00861380|7308479|FG001|COMPLETED|Overall Study||0
6395809|NCT00861380|7308480|FG002|COMPLETED|Overall Study||0
6395810|NCT00861380|7308481|FG003|COMPLETED|Overall Study||0
6395811|NCT00861380|7308482|FG004|COMPLETED|Overall Study||0
6395812|NCT00861380|7308483|FG005|COMPLETED|Overall Study||0
6395813|NCT00861380|7308484|FG006|COMPLETED|Overall Study||0
6395814|NCT00861380|7308478|FG000|NOT COMPLETED|Overall Study||8427
6395815|NCT00861380|7308479|FG001|NOT COMPLETED|Overall Study||9112
6395816|NCT00861380|7308480|FG002|NOT COMPLETED|Overall Study||8872
6395817|NCT00861380|7308481|FG003|NOT COMPLETED|Overall Study||3689
6395818|NCT00861380|7308482|FG004|NOT COMPLETED|Overall Study||1812
6395819|NCT00861380|7308483|FG005|NOT COMPLETED|Overall Study||6249
6395820|NCT00861380|7308484|FG006|NOT COMPLETED|Overall Study||3020
6395821|NCT00861471|7308517|FG000|STARTED|Overall Study||12
6625875|NCT02228720|7553496|FG000|NOT COMPLETED|Open Label - Day 30||1
6625876|NCT02228720|7553496|FG000|STARTED|Open Label - Day 90||14
6625877|NCT02228720|7553496|FG000|COMPLETED|Open Label - Day 90||14
6625878|NCT02228720|7553496|FG000|NOT COMPLETED|Open Label - Day 90||0
6625879|NCT02228824|7553502|FG000|STARTED|Overall Study||118
6625880|NCT02228824|7553503|FG001|STARTED|Overall Study||120
6625881|NCT02228824|7553502|FG000|COMPLETED|Overall Study||89
6625882|NCT02228824|7553503|FG001|COMPLETED|Overall Study||98
6625883|NCT02228824|7553502|FG000|NOT COMPLETED|Overall Study||29
6625884|NCT02228824|7553503|FG001|NOT COMPLETED|Overall Study||22
6625885|NCT02228967|7553511|FG000|STARTED|Overall Study||403
6625886|NCT02228967|7553512|FG001|STARTED|Overall Study||388
6625887|NCT02228967|7553511|FG000|COMPLETED|Overall Study||244
6625888|NCT02228967|7553512|FG001|COMPLETED|Overall Study||228
6625889|NCT02228967|7553511|FG000|NOT COMPLETED|Overall Study||159
6625890|NCT02228967|7553512|FG001|NOT COMPLETED|Overall Study||160
6625891|NCT02228980|7553522|FG000|STARTED|Overall Study||150
6395822|NCT00861471|7308517|FG000|COMPLETED|Overall Study||3
6395823|NCT00861471|7308517|FG000|NOT COMPLETED|Overall Study||9
6395824|NCT00861601|7308524|FG000|STARTED|Overall Study||12
6395825|NCT00861601|7308525|FG001|STARTED|Overall Study||14
6395826|NCT00861601|7308526|FG002|STARTED|Overall Study||12
6395827|NCT00861601|7308524|FG000|COMPLETED|Overall Study||12
6395828|NCT00861601|7308525|FG001|COMPLETED|Overall Study||14
6395829|NCT00861601|7308526|FG002|COMPLETED|Overall Study||12
6395830|NCT00861601|7308524|FG000|NOT COMPLETED|Overall Study||0
6395831|NCT00861601|7308525|FG001|NOT COMPLETED|Overall Study||0
6395832|NCT00861601|7308526|FG002|NOT COMPLETED|Overall Study||0
6498577|NCT01410604|7417180|FG000|COMPLETED|Overall Study||12
6498578|NCT01410604|7417181|FG001|COMPLETED|Overall Study||14
6625892|NCT02228980|7553523|FG001|STARTED|Overall Study||150
6625893|NCT02228980|7553524|FG002|STARTED|Overall Study||151
6625894|NCT02228980|7553525|FG003|STARTED|Overall Study||151
6625895|NCT02228980|7553522|FG000|COMPLETED|Overall Study||126
6625896|NCT02228980|7553523|FG001|COMPLETED|Overall Study||147
6625897|NCT02228980|7553524|FG002|COMPLETED|Overall Study||149
6625898|NCT02228980|7553525|FG003|COMPLETED|Overall Study||148
6625899|NCT02228980|7553522|FG000|NOT COMPLETED|Overall Study||24
6625900|NCT02228980|7553523|FG001|NOT COMPLETED|Overall Study||3
6395833|NCT00861614|7308539|FG000|STARTED|Overall Study||393
6395834|NCT00861614|7308540|FG001|STARTED|Overall Study||396
6395835|NCT00861614|7308539|FG000|COMPLETED|Overall Study||22
6395836|NCT00861614|7308540|FG001|COMPLETED|Overall Study||28
6395837|NCT00861614|7308539|FG000|NOT COMPLETED|Overall Study||371
6395838|NCT00861614|7308540|FG001|NOT COMPLETED|Overall Study||368
6395839|NCT00861692|7308546|FG000|STARTED|Overall Study||20
6395840|NCT00861692|7308546|FG000|COMPLETED|Overall Study||14
6395841|NCT00861692|7308546|FG000|NOT COMPLETED|Overall Study||6
6395842|NCT00861744|7308554|FG000|STARTED|Overall Study||304
6395843|NCT00861744|7308555|FG001|STARTED|Overall Study||304
6395844|NCT00861744|7308556|FG002|STARTED|Overall Study||304
6395845|NCT00861744|7308557|FG003|STARTED|Overall Study||308
6395846|NCT00861744|7308554|FG000|COMPLETED|Overall Study||287
6395847|NCT00861744|7308555|FG001|COMPLETED|Overall Study||275
6395848|NCT00861744|7308556|FG002|COMPLETED|Overall Study||280
6395849|NCT00861744|7308557|FG003|COMPLETED|Overall Study||275
6395850|NCT00861744|7308554|FG000|NOT COMPLETED|Overall Study||17
6395851|NCT00861744|7308555|FG001|NOT COMPLETED|Overall Study||29
6395852|NCT00861744|7308556|FG002|NOT COMPLETED|Overall Study||24
6395853|NCT00861744|7308557|FG003|NOT COMPLETED|Overall Study||33
6395854|NCT00861757|7308571|FG000|STARTED|Overall Study||154
6395855|NCT00861757|7308572|FG001|STARTED|Overall Study||151
6395856|NCT00861757|7308573|FG002|STARTED|Overall Study||155
6395857|NCT00861757|7308574|FG003|STARTED|Overall Study||152
6395858|NCT00861757|7308571|FG000|COMPLETED|Overall Study||145
6395859|NCT00861757|7308572|FG001|COMPLETED|Overall Study||136
6395860|NCT00861757|7308573|FG002|COMPLETED|Overall Study||137
6395861|NCT00861757|7308574|FG003|COMPLETED|Overall Study||143
6395862|NCT00861757|7308571|FG000|NOT COMPLETED|Overall Study||9
6395863|NCT00861757|7308572|FG001|NOT COMPLETED|Overall Study||15
6395864|NCT00861757|7308573|FG002|NOT COMPLETED|Overall Study||18
6395865|NCT00861757|7308574|FG003|NOT COMPLETED|Overall Study||9
6395866|NCT00861913|7308588|FG000|STARTED|Overall Study||13
6395867|NCT00861913|7308588|FG000|COMPLETED|Overall Study||13
6395868|NCT00861913|7308588|FG000|NOT COMPLETED|Overall Study||0
6395869|NCT00862082|7308594|FG000|STARTED|Overall Study||8
6395870|NCT00862082|7308595|FG001|STARTED|Overall Study||6
6395871|NCT00862082|7308594|FG000|COMPLETED|Overall Study||3
6395872|NCT00862082|7308595|FG001|COMPLETED|Overall Study||5
6395873|NCT00862082|7308594|FG000|NOT COMPLETED|Overall Study||5
6395874|NCT00862082|7308595|FG001|NOT COMPLETED|Overall Study||1
6395875|NCT00862121|7308610|FG000|STARTED|Overall Study||8
6395876|NCT00862121|7308611|FG001|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
6395877|NCT00862121|7308610|FG000|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
6395878|NCT00862121|7308611|FG001|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
6395879|NCT00862121|7308610|FG000|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
6395880|NCT00862121|7308611|FG001|Safety Analysis Set|Overall Study||11
6395881|NCT00862121|7308610|FG000|COMPLETED|Overall Study||7
6395882|NCT00862121|7308611|FG001|COMPLETED|Overall Study||4
6395883|NCT00862121|7308610|FG000|NOT COMPLETED|Overall Study||1
6395884|NCT00862121|7308611|FG001|NOT COMPLETED|Overall Study||8
6395885|NCT00862134|7308619|FG000|STARTED|Overall Study||19
6395886|NCT00862134|7308620|FG001|STARTED|Overall Study||23
6395887|NCT00862134|7308619|FG000|COMPLETED|Overall Study||8
6395888|NCT00862134|7308620|FG001|COMPLETED|Overall Study||11
6395889|NCT00862134|7308619|FG000|NOT COMPLETED|Overall Study||11
6395890|NCT00862134|7308620|FG001|NOT COMPLETED|Overall Study||12
6395891|NCT00862186|7308626|FG000|STARTED|Overall Study||15
6395892|NCT00862186|7308626|FG000|COMPLETED|Overall Study||15
6395893|NCT00862186|7308626|FG000|NOT COMPLETED|Overall Study||0
6395894|NCT00862277|7308634|FG000|STARTED|Overall Study||561
6395895|NCT00862277|7308635|FG001|STARTED|Overall Study||96
6625901|NCT02228980|7553524|FG002|NOT COMPLETED|Overall Study||2
6395896|NCT00862277|7308636|FG002|STARTED|Overall Study||105
6395897|NCT00862277|7308634|FG000|COMPLETED|Overall Study||560
6395898|NCT00862277|7308635|FG001|COMPLETED|Overall Study||94
6395899|NCT00862277|7308636|FG002|COMPLETED|Overall Study||100
6395900|NCT00862277|7308634|FG000|NOT COMPLETED|Overall Study||1
6395901|NCT00862277|7308635|FG001|NOT COMPLETED|Overall Study||2
6395902|NCT00862277|7308636|FG002|NOT COMPLETED|Overall Study||5
6395903|NCT00862446|7308644|FG000|STARTED|Overall Study||48
6395904|NCT00862446|7308644|FG000|COMPLETED|Overall Study||48
6395905|NCT00862446|7308644|FG000|NOT COMPLETED|Overall Study||0
6395906|NCT00862459|7308651|FG000|STARTED|Overall Study||72
6395907|NCT00862459|7308652|FG001|STARTED|Overall Study||93
6395908|NCT00862459|7308653|FG002|STARTED|Overall Study||72
6395909|NCT00862459|7308651|FG000|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
6498579|NCT01410604|7417180|FG000|NOT COMPLETED|Overall Study||3
6625902|NCT02228980|7553525|FG003|NOT COMPLETED|Overall Study||3
6625903|NCT02229214|7553541|FG000|STARTED|Overall Study||41
6625904|NCT02229214|7553542|FG001|STARTED|Overall Study||10
6625905|NCT02229214|7553541|FG000|COMPLETED|Overall Study||35
6625906|NCT02229214|7553542|FG001|COMPLETED|Overall Study||10
6625907|NCT02229214|7553541|FG000|NOT COMPLETED|Overall Study||6
6625908|NCT02229214|7553542|FG001|NOT COMPLETED|Overall Study||0
6625909|NCT02229227|7553552|FG000|STARTED|Overall Study||402
6625910|NCT02229227|7553553|FG001|STARTED|Overall Study||412
6395910|NCT00862459|7308652|FG001|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
6395911|NCT00862459|7308653|FG002|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
6395912|NCT00862459|7308651|FG000|COMPLETED|Overall Study||66
6395913|NCT00862459|7308652|FG001|COMPLETED|Overall Study||85
6395914|NCT00862459|7308653|FG002|COMPLETED|Overall Study||66
6395915|NCT00862459|7308651|FG000|NOT COMPLETED|Overall Study||6
6395916|NCT00862459|7308652|FG001|NOT COMPLETED|Overall Study||8
6395917|NCT00862459|7308653|FG002|NOT COMPLETED|Overall Study||6
6395918|NCT00862537|7308662|FG000|STARTED|Overall Study||18
6395919|NCT00862537|7308662|FG000|COMPLETED|Overall Study||11
6395920|NCT00862537|7308662|FG000|NOT COMPLETED|Overall Study||7
6395921|NCT00862563|7308670|FG000|STARTED|Overall Study||19
6395922|NCT00862563|7308671|FG001|STARTED|Overall Study||21
6395923|NCT00862563|7308672|FG002|STARTED|Overall Study||21
6395924|NCT00862563|7308673|FG003|STARTED|Overall Study||24
6395925|NCT00862563|7308670|FG000|COMPLETED|Overall Study||15
6395926|NCT00862563|7308671|FG001|COMPLETED|Overall Study||17
6395927|NCT00862563|7308672|FG002|COMPLETED|Overall Study||15
6395928|NCT00862563|7308673|FG003|COMPLETED|Overall Study||19
6395929|NCT00862563|7308670|FG000|NOT COMPLETED|Overall Study||4
6395930|NCT00862563|7308671|FG001|NOT COMPLETED|Overall Study||4
6395931|NCT00862563|7308672|FG002|NOT COMPLETED|Overall Study||6
6395932|NCT00862563|7308673|FG003|NOT COMPLETED|Overall Study||5
6395933|NCT00862641|7308696|FG000|STARTED|Overall Study||177
6395934|NCT00862641|7308697|FG001|STARTED|Overall Study||360
6395935|NCT00862641|7308698|FG002|STARTED|Overall Study||152
6395936|NCT00862641|7308699|FG003|STARTED|Overall Study||320
6395937|NCT00862641|7308696|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
6395938|NCT00862641|7308697|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
6395939|NCT00862641|7308698|FG002|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
6395940|NCT00862641|7308699|FG003|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
6395941|NCT00862641|7308696|FG000|NOT COMPLETED|Overall Study||1
6395942|NCT00862641|7308697|FG001|NOT COMPLETED|Overall Study||4
6395943|NCT00862641|7308698|FG002|NOT COMPLETED|Overall Study||1
6395944|NCT00862641|7308699|FG003|NOT COMPLETED|Overall Study||4
6395945|NCT00862654|7308713|FG000|STARTED|Overall Study||82
6395946|NCT00862654|7308714|FG001|STARTED|Overall Study||82
6395947|NCT00862654|7308715|FG002|STARTED|Overall Study||82
6395948|NCT00862654|7308716|FG003|STARTED|Overall Study||80
6395949|NCT00862654|7308713|FG000|COMPLETED|Overall Study||76
6395950|NCT00862654|7308714|FG001|COMPLETED|Overall Study||74
6395951|NCT00862654|7308715|FG002|COMPLETED|Overall Study||76
6395952|NCT00862654|7308716|FG003|COMPLETED|Overall Study||74
6395953|NCT00862654|7308713|FG000|NOT COMPLETED|Overall Study||6
6395954|NCT00862654|7308714|FG001|NOT COMPLETED|Overall Study||8
6395955|NCT00862654|7308715|FG002|NOT COMPLETED|Overall Study||6
6395956|NCT00862654|7308716|FG003|NOT COMPLETED|Overall Study||6
6395957|NCT00862719|7308730|FG000|STARTED|Overall Study||17
6395958|NCT00862719|7308731|FG001|STARTED|Overall Study||7
6395959|NCT00862719|7308732|FG002|STARTED|Overall Study||4
6395960|NCT00862719|7308733|FG003|STARTED|Overall Study||1
6395961|NCT00862719|7308730|FG000|COMPLETED|Overall Study||7
6395962|NCT00862719|7308731|FG001|COMPLETED|Overall Study||1
6395963|NCT00862719|7308732|FG002|COMPLETED|Overall Study||0
6395964|NCT00862719|7308733|FG003|COMPLETED|Overall Study||0
6395965|NCT00862719|7308730|FG000|NOT COMPLETED|Overall Study||10
6395966|NCT00862719|7308731|FG001|NOT COMPLETED|Overall Study||6
6395967|NCT00862719|7308732|FG002|NOT COMPLETED|Overall Study||4
6395968|NCT00862719|7308733|FG003|NOT COMPLETED|Overall Study||1
6395969|NCT00862745|7308745|FG000|STARTED|Randomized Control Trial||322
6395970|NCT00862745|7308746|FG001|STARTED|Randomized Control Trial||323
6395971|NCT00862745|7308745|FG000|COMPLETED|Randomized Control Trial||284
6395972|NCT00862745|7308746|FG001|COMPLETED|Randomized Control Trial||284
6395973|NCT00862745|7308745|FG000|NOT COMPLETED|Randomized Control Trial||38
6395974|NCT00862745|7308746|FG001|NOT COMPLETED|Randomized Control Trial||39
6395975|NCT00862745|7308745|FG000|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
6395976|NCT00862745|7308746|FG001|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
6395977|NCT00862745|7308745|FG000|COMPLETED|Open-label Follow-up||229
6395978|NCT00862745|7308746|FG001|COMPLETED|Open-label Follow-up||225
6395979|NCT00862745|7308745|FG000|NOT COMPLETED|Open-label Follow-up||39
6625911|NCT02229227|7553552|FG000|COMPLETED|Overall Study||351
6625912|NCT02229227|7553553|FG001|COMPLETED|Overall Study||350
6625913|NCT02229227|7553552|FG000|NOT COMPLETED|Overall Study||51
6625914|NCT02229227|7553553|FG001|NOT COMPLETED|Overall Study||62
6625915|NCT02229318|7553559|FG000|STARTED|Overall Study|September 6th 2014 11 enrolled|11
6655293|NCT02452320|7585389|FG000|NOT COMPLETED|Overall Study||0
6625916|NCT02229318|7553559|FG000|COMPLETED|Overall Study|September 15th 2014 11 completed|11
6625917|NCT02229318|7553559|FG000|NOT COMPLETED|Overall Study||0
6625918|NCT02229383|7553566|FG000|STARTED|Overall Study||232
6625919|NCT02229383|7553567|FG001|STARTED|Overall Study||229
6625920|NCT02229383|7553566|FG000|Received Treatment|Overall Study||231
6625921|NCT02229383|7553567|FG001|Received Treatment|Overall Study||229
6625922|NCT02229383|7553566|FG000|Safety Analysis Set|Overall Study||231
6625923|NCT02229383|7553567|FG001|Safety Analysis Set|Overall Study||229
6625924|NCT02229383|7553566|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||230
6625925|NCT02229383|7553567|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||228
6625926|NCT02229383|7553566|FG000|COMPLETED|Overall Study||212
6625927|NCT02229383|7553567|FG001|COMPLETED|Overall Study||207
6625928|NCT02229383|7553566|FG000|NOT COMPLETED|Overall Study||20
6625929|NCT02229383|7553567|FG001|NOT COMPLETED|Overall Study||22
6625930|NCT02229396|7553576|FG000|STARTED|Overall Study||233
6625931|NCT02229396|7553577|FG001|STARTED|Overall Study||231
6625932|NCT02229396|7553578|FG002|STARTED|Overall Study||231
6625933|NCT02229396|7553576|FG000|Randomization Code Allocated|Overall Study||233
6625934|NCT02229396|7553577|FG001|Randomization Code Allocated|Overall Study||231
6625935|NCT02229396|7553578|FG002|Randomization Code Allocated|Overall Study||231
6625936|NCT02229396|7553576|FG000|Safety Analysis Set|Overall Study||233
6625937|NCT02229396|7553577|FG001|Safety Analysis Set|Overall Study||231
6625938|NCT02229396|7553578|FG002|Safety Analysis Set|Overall Study||230
6625939|NCT02229396|7553576|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||230
6625940|NCT02229396|7553577|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||228
6625941|NCT02229396|7553578|FG002|Intent-to-Treat (ITT) Analysis Set|Overall Study||227
6625942|NCT02229396|7553576|FG000|Completed 28-Week Study Period|Overall Study||208
6395980|NCT00862745|7308746|FG001|NOT COMPLETED|Open-label Follow-up||49
6395981|NCT00862784|7308752|FG000|STARTED|Overall Study||48
6395982|NCT00862784|7308752|FG000|Received Any Amount of Study Drug|Overall Study||48
6395983|NCT00862784|7308752|FG000|COMPLETED|Overall Study||48
6395984|NCT00862784|7308752|FG000|NOT COMPLETED|Overall Study||0
6395985|NCT00862810|7308758|FG000|STARTED|Overall Study||33
6395986|NCT00862810|7308759|FG001|STARTED|Overall Study||39
6395987|NCT00862810|7308758|FG000|COMPLETED|Overall Study||29
6395988|NCT00862810|7308759|FG001|COMPLETED|Overall Study||35
6395989|NCT00862810|7308758|FG000|NOT COMPLETED|Overall Study||4
6395990|NCT00862810|7308759|FG001|NOT COMPLETED|Overall Study||4
6395991|NCT00862823|7308765|FG000|STARTED|First Intervention||6
6395992|NCT00862823|7308766|FG001|STARTED|First Intervention||10
6395993|NCT00862823|7308765|FG000|COMPLETED|First Intervention||5
6395994|NCT00862823|7308766|FG001|COMPLETED|First Intervention||9
6395995|NCT00862823|7308765|FG000|NOT COMPLETED|First Intervention||1
6395996|NCT00862823|7308766|FG001|NOT COMPLETED|First Intervention||1
6395997|NCT00862823|7308765|FG000|STARTED|Washout Period of 2 Weeks||5
6395998|NCT00862823|7308766|FG001|STARTED|Washout Period of 2 Weeks||9
6395999|NCT00862823|7308765|FG000|COMPLETED|Washout Period of 2 Weeks||5
6396000|NCT00862823|7308766|FG001|COMPLETED|Washout Period of 2 Weeks||9
6396001|NCT00862823|7308765|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6396002|NCT00862823|7308766|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6396003|NCT00862823|7308765|FG000|STARTED|Second Intervention||5
6396004|NCT00862823|7308766|FG001|STARTED|Second Intervention||9
6396005|NCT00862823|7308765|FG000|COMPLETED|Second Intervention||5
6396006|NCT00862823|7308766|FG001|COMPLETED|Second Intervention||9
6396007|NCT00862823|7308765|FG000|NOT COMPLETED|Second Intervention||0
6625943|NCT02229396|7553577|FG001|Completed 28-Week Study Period|Overall Study||202
6625944|NCT02229396|7553578|FG002|Completed 28-Week Study Period|Overall Study||193
6625945|NCT02229396|7553576|FG000|Completed 52-Week Study Period|Overall Study||194
6396008|NCT00862823|7308766|FG001|NOT COMPLETED|Second Intervention||0
6396009|NCT00862836|7308771|FG000|STARTED|Overall Study||15
6396010|NCT00862836|7308771|FG000|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
6396011|NCT00862836|7308771|FG000|Evaluable for Activity (Tumour Response)|Overall Study||10
6396012|NCT00862836|7308771|FG000|COMPLETED|Overall Study||14
6396013|NCT00862836|7308771|FG000|NOT COMPLETED|Overall Study||1
6396014|NCT00862849|7308775|FG000|STARTED|Intervention 1||3
6396015|NCT00862849|7308776|FG001|STARTED|Intervention 1||5
6396016|NCT00862849|7308777|FG002|STARTED|Intervention 1||3
6396017|NCT00862849|7308778|FG003|STARTED|Intervention 1||4
6396018|NCT00862849|7308779|FG004|STARTED|Intervention 1||4
6396019|NCT00862849|7308780|FG005|STARTED|Intervention 1||3
6396020|NCT00862849|7308775|FG000|Received at Least One Dose of Study Drug|Intervention 1||3
6396021|NCT00862849|7308776|FG001|Received at Least One Dose of Study Drug|Intervention 1||5
6396022|NCT00862849|7308777|FG002|Received at Least One Dose of Study Drug|Intervention 1||3
6396023|NCT00862849|7308778|FG003|Received at Least One Dose of Study Drug|Intervention 1||4
6396024|NCT00862849|7308779|FG004|Received at Least One Dose of Study Drug|Intervention 1||4
6396025|NCT00862849|7308780|FG005|Received at Least One Dose of Study Drug|Intervention 1||3
6396026|NCT00862849|7308775|FG000|COMPLETED|Intervention 1||3
6396027|NCT00862849|7308776|FG001|COMPLETED|Intervention 1||5
6396028|NCT00862849|7308777|FG002|COMPLETED|Intervention 1||3
6396029|NCT00862849|7308778|FG003|COMPLETED|Intervention 1||4
6396030|NCT00862849|7308779|FG004|COMPLETED|Intervention 1||4
6396031|NCT00862849|7308780|FG005|COMPLETED|Intervention 1||3
6396032|NCT00862849|7308775|FG000|NOT COMPLETED|Intervention 1||0
6625946|NCT02229396|7553577|FG001|Completed 52-Week Study Period|Overall Study||193
6625947|NCT02229396|7553578|FG002|Completed 52-Week Study Period|Overall Study||177
6625948|NCT02229396|7553576|FG000|COMPLETED|Overall Study||155
6625949|NCT02229396|7553577|FG001|COMPLETED|Overall Study||154
6625950|NCT02229396|7553578|FG002|COMPLETED|Overall Study||136
6625951|NCT02229396|7553576|FG000|NOT COMPLETED|Overall Study||78
6625952|NCT02229396|7553577|FG001|NOT COMPLETED|Overall Study||77
6625953|NCT02229396|7553578|FG002|NOT COMPLETED|Overall Study||95
6625954|NCT02229461|7553593|FG000|STARTED|Overall Study|Randomized and received treatment|17
6625955|NCT02229461|7553594|FG001|STARTED|Overall Study|Randomized and received treatment|17
6625956|NCT02229461|7553595|FG002|STARTED|Overall Study|Randomized and received treatment|17
6625957|NCT02229461|7553596|FG003|STARTED|Overall Study|Randomized and received treatment|17
6625958|NCT02229461|7553597|FG004|STARTED|Overall Study|Randomized and received treatment|17
6625959|NCT02229461|7553598|FG005|STARTED|Overall Study|Randomized and received treatment|17
6625960|NCT02229461|7553593|FG000|COMPLETED|Overall Study||17
6625961|NCT02229461|7553594|FG001|COMPLETED|Overall Study||17
6625962|NCT02229461|7553595|FG002|COMPLETED|Overall Study||17
6625963|NCT02229461|7553596|FG003|COMPLETED|Overall Study||17
6625964|NCT02229461|7553597|FG004|COMPLETED|Overall Study||17
6625965|NCT02229461|7553598|FG005|COMPLETED|Overall Study||17
6625966|NCT02229461|7553593|FG000|NOT COMPLETED|Overall Study||0
6625967|NCT02229461|7553594|FG001|NOT COMPLETED|Overall Study||0
6625968|NCT02229461|7553595|FG002|NOT COMPLETED|Overall Study||0
6625969|NCT02229461|7553596|FG003|NOT COMPLETED|Overall Study||0
6625970|NCT02229461|7553597|FG004|NOT COMPLETED|Overall Study||0
6625971|NCT02229461|7553598|FG005|NOT COMPLETED|Overall Study||0
6625972|NCT02229474|7553615|FG000|STARTED|Overall Study||16
6625973|NCT02229474|7553616|FG001|STARTED|Overall Study||18
6625974|NCT02229474|7553615|FG000|COMPLETED|Overall Study||16
6625975|NCT02229474|7553616|FG001|COMPLETED|Overall Study||15
6625976|NCT02229474|7553615|FG000|NOT COMPLETED|Overall Study||0
6625977|NCT02229474|7553616|FG001|NOT COMPLETED|Overall Study||3
6625978|NCT02229487|7553625|FG000|STARTED|Overall Study||24
6625979|NCT02229487|7553626|FG001|STARTED|Overall Study||27
6625980|NCT02229487|7553625|FG000|COMPLETED|Overall Study||24
6625981|NCT02229487|7553626|FG001|COMPLETED|Overall Study||27
6625982|NCT02229487|7553625|FG000|NOT COMPLETED|Overall Study||0
6625983|NCT02229487|7553626|FG001|NOT COMPLETED|Overall Study||0
6625984|NCT02229513|7553634|FG000|STARTED|Overall Study||100
6625985|NCT02229513|7553635|FG001|STARTED|Overall Study||100
6625986|NCT02229513|7553634|FG000|COMPLETED|Overall Study||100
6625987|NCT02229513|7553635|FG001|COMPLETED|Overall Study||100
6625988|NCT02229513|7553634|FG000|NOT COMPLETED|Overall Study||0
6625989|NCT02229513|7553635|FG001|NOT COMPLETED|Overall Study||0
6625990|NCT02229539|7553644|FG000|STARTED|Cycle 1 (Treatment Per Protocol)||77
6625991|NCT02229539|7553645|FG001|STARTED|Cycle 1 (Treatment Per Protocol)||76
6625992|NCT02229539|7553646|FG002|STARTED|Cycle 1 (Treatment Per Protocol)||75
6625993|NCT02229539|7553644|FG000|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
6396033|NCT00862849|7308776|FG001|NOT COMPLETED|Intervention 1||0
6396034|NCT00862849|7308777|FG002|NOT COMPLETED|Intervention 1||0
6396035|NCT00862849|7308778|FG003|NOT COMPLETED|Intervention 1||0
6396036|NCT00862849|7308779|FG004|NOT COMPLETED|Intervention 1||0
6396037|NCT00862849|7308780|FG005|NOT COMPLETED|Intervention 1||0
6396038|NCT00862849|7308775|FG000|STARTED|Washout 1 (3 to 14 Days)||3
6396039|NCT00862849|7308776|FG001|STARTED|Washout 1 (3 to 14 Days)||5
6396040|NCT00862849|7308777|FG002|STARTED|Washout 1 (3 to 14 Days)||3
6396041|NCT00862849|7308778|FG003|STARTED|Washout 1 (3 to 14 Days)||4
6396042|NCT00862849|7308779|FG004|STARTED|Washout 1 (3 to 14 Days)||4
6396043|NCT00862849|7308780|FG005|STARTED|Washout 1 (3 to 14 Days)||3
6396044|NCT00862849|7308775|FG000|COMPLETED|Washout 1 (3 to 14 Days)||3
6396045|NCT00862849|7308776|FG001|COMPLETED|Washout 1 (3 to 14 Days)||4
6396046|NCT00862849|7308777|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
6396047|NCT00862849|7308778|FG003|COMPLETED|Washout 1 (3 to 14 Days)||4
6396048|NCT00862849|7308779|FG004|COMPLETED|Washout 1 (3 to 14 Days)||4
6396049|NCT00862849|7308780|FG005|COMPLETED|Washout 1 (3 to 14 Days)||3
6396050|NCT00862849|7308775|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6396051|NCT00862849|7308776|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
6396052|NCT00862849|7308777|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6396053|NCT00862849|7308778|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6396054|NCT00862849|7308779|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6396055|NCT00862849|7308780|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6396056|NCT00862849|7308775|FG000|STARTED|Intervention 2||3
6396057|NCT00862849|7308776|FG001|STARTED|Intervention 2||4
6396058|NCT00862849|7308777|FG002|STARTED|Intervention 2||3
6396059|NCT00862849|7308778|FG003|STARTED|Intervention 2||4
6396060|NCT00862849|7308779|FG004|STARTED|Intervention 2||4
6396061|NCT00862849|7308780|FG005|STARTED|Intervention 2||3
6396062|NCT00862849|7308775|FG000|COMPLETED|Intervention 2||3
6396063|NCT00862849|7308776|FG001|COMPLETED|Intervention 2||4
6396064|NCT00862849|7308777|FG002|COMPLETED|Intervention 2||3
6396065|NCT00862849|7308778|FG003|COMPLETED|Intervention 2||4
6396066|NCT00862849|7308779|FG004|COMPLETED|Intervention 2||4
6396067|NCT00862849|7308780|FG005|COMPLETED|Intervention 2||3
6396068|NCT00862849|7308775|FG000|NOT COMPLETED|Intervention 2||0
6625994|NCT02229539|7553645|FG001|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
6625995|NCT02229539|7553646|FG002|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
6625996|NCT02229539|7553644|FG000|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
6625997|NCT02229539|7553645|FG001|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
6625998|NCT02229539|7553646|FG002|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
6625999|NCT02229539|7553644|FG000|STARTED|Cycle 2 (Optional Continuation Phase)||35
6626000|NCT02229539|7553645|FG001|STARTED|Cycle 2 (Optional Continuation Phase)||36
6626001|NCT02229539|7553646|FG002|STARTED|Cycle 2 (Optional Continuation Phase)||32
6626002|NCT02229539|7553644|FG000|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
6626003|NCT02229539|7553645|FG001|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
6626004|NCT02229539|7553646|FG002|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
6626005|NCT02229539|7553644|FG000|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
6626006|NCT02229539|7553645|FG001|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
6626007|NCT02229539|7553646|FG002|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
6626008|NCT02229552|7553654|FG000|STARTED|Baseline||237
6626009|NCT02229552|7553654|FG000|COMPLETED|Baseline||231
6626010|NCT02229552|7553654|FG000|NOT COMPLETED|Baseline||6
6626011|NCT02229552|7553654|FG000|STARTED|1-year Follow up||231
6626012|NCT02229552|7553654|FG000|COMPLETED|1-year Follow up||206
6626013|NCT02229552|7553654|FG000|NOT COMPLETED|1-year Follow up||25
6626014|NCT02229552|7553654|FG000|STARTED|2-Year Follow up|All baseline participants were eligible for year 2 follow up, regardless of completion of year 1.|231
6626015|NCT02229552|7553654|FG000|COMPLETED|2-Year Follow up||205
6626016|NCT02229552|7553654|FG000|NOT COMPLETED|2-Year Follow up||26
6626017|NCT02229851|7553661|FG000|STARTED|Main Phase (Double-blind Phase)||61
6626018|NCT02229851|7553662|FG001|STARTED|Main Phase (Double-blind Phase)||119
6626019|NCT02229851|7553663|FG002|STARTED|Main Phase (Double-blind Phase)||120
6626020|NCT02229851|7553664|FG003|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
6626021|NCT02229851|7553665|FG004|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
6626022|NCT02229851|7553666|FG005|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
6626023|NCT02229851|7553667|FG006|STARTED|Main Phase (Double-blind Phase)|This arm is not applicable for the Main phase.|0
6626024|NCT02229851|7553661|FG000|Full Analysis Set|Main Phase (Double-blind Phase)||61
6626025|NCT02229851|7553662|FG001|Full Analysis Set|Main Phase (Double-blind Phase)||119
6626026|NCT02229851|7553663|FG002|Full Analysis Set|Main Phase (Double-blind Phase)||120
6626027|NCT02229851|7553664|FG003|Full Analysis Set|Main Phase (Double-blind Phase)||0
6626028|NCT02229851|7553665|FG004|Full Analysis Set|Main Phase (Double-blind Phase)||0
6626029|NCT02229851|7553666|FG005|Full Analysis Set|Main Phase (Double-blind Phase)||0
6626030|NCT02229851|7553667|FG006|Full Analysis Set|Main Phase (Double-blind Phase)||0
6626031|NCT02229851|7553661|FG000|Safety Analysis Set|Main Phase (Double-blind Phase)||61
6626032|NCT02229851|7553662|FG001|Safety Analysis Set|Main Phase (Double-blind Phase)||119
6626033|NCT02229851|7553663|FG002|Safety Analysis Set|Main Phase (Double-blind Phase)||120
6626034|NCT02229851|7553664|FG003|Safety Analysis Set|Main Phase (Double-blind Phase)||0
6626035|NCT02229851|7553665|FG004|Safety Analysis Set|Main Phase (Double-blind Phase)||0
6626036|NCT02229851|7553666|FG005|Safety Analysis Set|Main Phase (Double-blind Phase)||0
6626037|NCT02229851|7553667|FG006|Safety Analysis Set|Main Phase (Double-blind Phase)||0
6626038|NCT02229851|7553661|FG000|COMPLETED|Main Phase (Double-blind Phase)||55
6626039|NCT02229851|7553662|FG001|COMPLETED|Main Phase (Double-blind Phase)||103
6626040|NCT02229851|7553663|FG002|COMPLETED|Main Phase (Double-blind Phase)||114
6626041|NCT02229851|7553664|FG003|COMPLETED|Main Phase (Double-blind Phase)||0
6626042|NCT02229851|7553665|FG004|COMPLETED|Main Phase (Double-blind Phase)||0
6626043|NCT02229851|7553666|FG005|COMPLETED|Main Phase (Double-blind Phase)||0
6626044|NCT02229851|7553667|FG006|COMPLETED|Main Phase (Double-blind Phase)||0
6626045|NCT02229851|7553661|FG000|NOT COMPLETED|Main Phase (Double-blind Phase)||6
6626046|NCT02229851|7553662|FG001|NOT COMPLETED|Main Phase (Double-blind Phase)||16
6626047|NCT02229851|7553663|FG002|NOT COMPLETED|Main Phase (Double-blind Phase)||6
6626048|NCT02229851|7553664|FG003|NOT COMPLETED|Main Phase (Double-blind Phase)||0
6626049|NCT02229851|7553665|FG004|NOT COMPLETED|Main Phase (Double-blind Phase)||0
6626050|NCT02229851|7553666|FG005|NOT COMPLETED|Main Phase (Double-blind Phase)||0
6626051|NCT02229851|7553667|FG006|NOT COMPLETED|Main Phase (Double-blind Phase)||0
6626052|NCT02229851|7553661|FG000|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
6626053|NCT02229851|7553662|FG001|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
6626054|NCT02229851|7553663|FG002|STARTED|Extension Phase (Open-label Phase)|This arm is not applicable for the Extension phase.|0
6626055|NCT02229851|7553664|FG003|STARTED|Extension Phase (Open-label Phase)||55
6626056|NCT02229851|7553665|FG004|STARTED|Extension Phase (Open-label Phase)||114
6626057|NCT02229851|7553666|FG005|STARTED|Extension Phase (Open-label Phase)||52
6626058|NCT02229851|7553667|FG006|STARTED|Extension Phase (Open-label Phase)||51
6626059|NCT02229851|7553661|FG000|COMPLETED|Extension Phase (Open-label Phase)||0
6626060|NCT02229851|7553662|FG001|COMPLETED|Extension Phase (Open-label Phase)||0
6626061|NCT02229851|7553663|FG002|COMPLETED|Extension Phase (Open-label Phase)||0
6626062|NCT02229851|7553664|FG003|COMPLETED|Extension Phase (Open-label Phase)||53
6396069|NCT00862849|7308776|FG001|NOT COMPLETED|Intervention 2||0
6626063|NCT02229851|7553665|FG004|COMPLETED|Extension Phase (Open-label Phase)||109
6626064|NCT02229851|7553666|FG005|COMPLETED|Extension Phase (Open-label Phase)||47
6626065|NCT02229851|7553667|FG006|COMPLETED|Extension Phase (Open-label Phase)||48
6626066|NCT02229851|7553661|FG000|NOT COMPLETED|Extension Phase (Open-label Phase)||0
6626067|NCT02229851|7553662|FG001|NOT COMPLETED|Extension Phase (Open-label Phase)||0
6626068|NCT02229851|7553663|FG002|NOT COMPLETED|Extension Phase (Open-label Phase)||0
6626069|NCT02229851|7553664|FG003|NOT COMPLETED|Extension Phase (Open-label Phase)||2
6626070|NCT02229851|7553665|FG004|NOT COMPLETED|Extension Phase (Open-label Phase)||5
6626071|NCT02229851|7553666|FG005|NOT COMPLETED|Extension Phase (Open-label Phase)||5
6626072|NCT02229851|7553667|FG006|NOT COMPLETED|Extension Phase (Open-label Phase)||3
6626073|NCT02229864|7553682|FG000|STARTED|Overall Study||12
6626074|NCT02229864|7553682|FG000|COMPLETED|Overall Study||9
6626075|NCT02229864|7553682|FG000|NOT COMPLETED|Overall Study||3
6626076|NCT02230085|7553686|FG000|STARTED|Overall Study||110
6626077|NCT02230085|7553686|FG000|COMPLETED|Overall Study||106
6626078|NCT02230085|7553686|FG000|NOT COMPLETED|Overall Study||4
6626079|NCT02230306|7553690|FG000|STARTED|Overall Study||5
6626080|NCT02230306|7553690|FG000|COMPLETED|Overall Study||4
6626081|NCT02230306|7553690|FG000|NOT COMPLETED|Overall Study||1
6626082|NCT02230332|7553696|FG000|STARTED|Overall Study||38
6396070|NCT00862849|7308777|FG002|NOT COMPLETED|Intervention 2||0
6396071|NCT00862849|7308778|FG003|NOT COMPLETED|Intervention 2||0
6396072|NCT00862849|7308779|FG004|NOT COMPLETED|Intervention 2||0
6396073|NCT00862849|7308780|FG005|NOT COMPLETED|Intervention 2||0
6396074|NCT00862849|7308775|FG000|STARTED|Washout 2 (3 to 14 Days)||3
6396075|NCT00862849|7308776|FG001|STARTED|Washout 2 (3 to 14 Days)||4
6396076|NCT00862849|7308777|FG002|STARTED|Washout 2 (3 to 14 Days)||3
6396077|NCT00862849|7308778|FG003|STARTED|Washout 2 (3 to 14 Days)||4
6396078|NCT00862849|7308779|FG004|STARTED|Washout 2 (3 to 14 Days)||4
6396079|NCT00862849|7308780|FG005|STARTED|Washout 2 (3 to 14 Days)||3
6396080|NCT00862849|7308775|FG000|COMPLETED|Washout 2 (3 to 14 Days)||3
6396081|NCT00862849|7308776|FG001|COMPLETED|Washout 2 (3 to 14 Days)||3
6396082|NCT00862849|7308777|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
6396083|NCT00862849|7308778|FG003|COMPLETED|Washout 2 (3 to 14 Days)||4
6396084|NCT00862849|7308779|FG004|COMPLETED|Washout 2 (3 to 14 Days)||4
6396085|NCT00862849|7308780|FG005|COMPLETED|Washout 2 (3 to 14 Days)||3
6396086|NCT00862849|7308775|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6396087|NCT00862849|7308776|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
6396088|NCT00862849|7308777|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6396089|NCT00862849|7308778|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6396090|NCT00862849|7308779|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6396091|NCT00862849|7308780|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6396092|NCT00862849|7308775|FG000|STARTED|Intervention 3||3
6396093|NCT00862849|7308776|FG001|STARTED|Intervention 3||3
6396094|NCT00862849|7308777|FG002|STARTED|Intervention 3||3
6396095|NCT00862849|7308778|FG003|STARTED|Intervention 3||4
6396096|NCT00862849|7308779|FG004|STARTED|Intervention 3||4
6396097|NCT00862849|7308780|FG005|STARTED|Intervention 3||3
6396098|NCT00862849|7308775|FG000|COMPLETED|Intervention 3||3
6396099|NCT00862849|7308776|FG001|COMPLETED|Intervention 3||3
6396100|NCT00862849|7308777|FG002|COMPLETED|Intervention 3||3
6396101|NCT00862849|7308778|FG003|COMPLETED|Intervention 3||4
6396102|NCT00862849|7308779|FG004|COMPLETED|Intervention 3||4
6396103|NCT00862849|7308780|FG005|COMPLETED|Intervention 3||3
6396104|NCT00862849|7308775|FG000|NOT COMPLETED|Intervention 3||0
6396105|NCT00862849|7308776|FG001|NOT COMPLETED|Intervention 3||0
6396106|NCT00862849|7308777|FG002|NOT COMPLETED|Intervention 3||0
6396107|NCT00862849|7308778|FG003|NOT COMPLETED|Intervention 3||0
6396108|NCT00862849|7308779|FG004|NOT COMPLETED|Intervention 3||0
6396109|NCT00862849|7308780|FG005|NOT COMPLETED|Intervention 3||0
6396110|NCT00862849|7308775|FG000|STARTED|Washout 3 (3 to 14 Days)||3
6396111|NCT00862849|7308776|FG001|STARTED|Washout 3 (3 to 14 Days)||3
6396112|NCT00862849|7308777|FG002|STARTED|Washout 3 (3 to 14 Days)||3
6396113|NCT00862849|7308778|FG003|STARTED|Washout 3 (3 to 14 Days)||4
6396114|NCT00862849|7308779|FG004|STARTED|Washout 3 (3 to 14 Days)||4
6396115|NCT00862849|7308780|FG005|STARTED|Washout 3 (3 to 14 Days)||3
6396116|NCT00862849|7308775|FG000|COMPLETED|Washout 3 (3 to 14 Days)||3
6396117|NCT00862849|7308776|FG001|COMPLETED|Washout 3 (3 to 14 Days)||3
6396118|NCT00862849|7308777|FG002|COMPLETED|Washout 3 (3 to 14 Days)||3
6396119|NCT00862849|7308778|FG003|COMPLETED|Washout 3 (3 to 14 Days)||4
6396120|NCT00862849|7308779|FG004|COMPLETED|Washout 3 (3 to 14 Days)||4
6396121|NCT00862849|7308780|FG005|COMPLETED|Washout 3 (3 to 14 Days)||3
6396122|NCT00862849|7308775|FG000|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6396123|NCT00862849|7308776|FG001|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6626083|NCT02230332|7553697|FG001|STARTED|Overall Study||40
6396124|NCT00862849|7308777|FG002|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6396125|NCT00862849|7308778|FG003|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6396126|NCT00862849|7308779|FG004|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6396127|NCT00862849|7308780|FG005|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
6396128|NCT00862849|7308775|FG000|STARTED|Intervention 4||3
6396129|NCT00862849|7308776|FG001|STARTED|Intervention 4||3
6396130|NCT00862849|7308777|FG002|STARTED|Intervention 4||3
6396131|NCT00862849|7308778|FG003|STARTED|Intervention 4||4
6396132|NCT00862849|7308779|FG004|STARTED|Intervention 4||4
6396133|NCT00862849|7308780|FG005|STARTED|Intervention 4||3
6396134|NCT00862849|7308775|FG000|COMPLETED|Intervention 4||3
6396135|NCT00862849|7308776|FG001|COMPLETED|Intervention 4||3
6396136|NCT00862849|7308777|FG002|COMPLETED|Intervention 4||3
6396137|NCT00862849|7308778|FG003|COMPLETED|Intervention 4||4
6396138|NCT00862849|7308779|FG004|COMPLETED|Intervention 4||4
6396139|NCT00862849|7308780|FG005|COMPLETED|Intervention 4||3
6396140|NCT00862849|7308775|FG000|NOT COMPLETED|Intervention 4||0
6396141|NCT00862849|7308776|FG001|NOT COMPLETED|Intervention 4||0
6396142|NCT00862849|7308777|FG002|NOT COMPLETED|Intervention 4||0
6396143|NCT00862849|7308778|FG003|NOT COMPLETED|Intervention 4||0
6626084|NCT02230332|7553696|FG000|COMPLETED|Overall Study||34
6626085|NCT02230332|7553697|FG001|COMPLETED|Overall Study||39
6626086|NCT02230332|7553696|FG000|NOT COMPLETED|Overall Study||4
6626087|NCT02230332|7553697|FG001|NOT COMPLETED|Overall Study||1
6626088|NCT02230384|7553705|FG000|STARTED|Phase 1||30
6626089|NCT02230384|7553706|FG001|STARTED|Phase 1||32
6626090|NCT02230384|7553705|FG000|COMPLETED|Phase 1||29
6396144|NCT00862849|7308779|FG004|NOT COMPLETED|Intervention 4||0
6396145|NCT00862849|7308780|FG005|NOT COMPLETED|Intervention 4||0
6396146|NCT00862849|7308775|FG000|STARTED|Washout 4 (3 to 14 Days)||3
6396147|NCT00862849|7308776|FG001|STARTED|Washout 4 (3 to 14 Days)||3
6396148|NCT00862849|7308777|FG002|STARTED|Washout 4 (3 to 14 Days)||3
6396149|NCT00862849|7308778|FG003|STARTED|Washout 4 (3 to 14 Days)||4
6396150|NCT00862849|7308779|FG004|STARTED|Washout 4 (3 to 14 Days)||4
6396151|NCT00862849|7308780|FG005|STARTED|Washout 4 (3 to 14 Days)||3
6396152|NCT00862849|7308775|FG000|COMPLETED|Washout 4 (3 to 14 Days)||3
6396153|NCT00862849|7308776|FG001|COMPLETED|Washout 4 (3 to 14 Days)||3
6396154|NCT00862849|7308777|FG002|COMPLETED|Washout 4 (3 to 14 Days)||3
6396155|NCT00862849|7308778|FG003|COMPLETED|Washout 4 (3 to 14 Days)||4
6396156|NCT00862849|7308779|FG004|COMPLETED|Washout 4 (3 to 14 Days)||4
6396157|NCT00862849|7308780|FG005|COMPLETED|Washout 4 (3 to 14 Days)||3
6396158|NCT00862849|7308775|FG000|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6396159|NCT00862849|7308776|FG001|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6396160|NCT00862849|7308777|FG002|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6396161|NCT00862849|7308778|FG003|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6396162|NCT00862849|7308779|FG004|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6396163|NCT00862849|7308780|FG005|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
6396164|NCT00862849|7308775|FG000|STARTED|Intervention 5||3
6396165|NCT00862849|7308776|FG001|STARTED|Intervention 5||3
6396166|NCT00862849|7308777|FG002|STARTED|Intervention 5||3
6396167|NCT00862849|7308778|FG003|STARTED|Intervention 5||4
6396168|NCT00862849|7308779|FG004|STARTED|Intervention 5||4
6396169|NCT00862849|7308780|FG005|STARTED|Intervention 5||3
6396170|NCT00862849|7308775|FG000|COMPLETED|Intervention 5||3
6396171|NCT00862849|7308776|FG001|COMPLETED|Intervention 5||3
6396172|NCT00862849|7308777|FG002|COMPLETED|Intervention 5||3
6396173|NCT00862849|7308778|FG003|COMPLETED|Intervention 5||4
6396174|NCT00862849|7308779|FG004|COMPLETED|Intervention 5||4
6396175|NCT00862849|7308780|FG005|COMPLETED|Intervention 5||3
6396176|NCT00862849|7308775|FG000|NOT COMPLETED|Intervention 5||0
6396177|NCT00862849|7308776|FG001|NOT COMPLETED|Intervention 5||0
6396178|NCT00862849|7308777|FG002|NOT COMPLETED|Intervention 5||0
6396179|NCT00862849|7308778|FG003|NOT COMPLETED|Intervention 5||0
6396180|NCT00862849|7308779|FG004|NOT COMPLETED|Intervention 5||0
6396181|NCT00862849|7308780|FG005|NOT COMPLETED|Intervention 5||0
6396182|NCT00862849|7308775|FG000|STARTED|Washout 5 (3 to 14 Days)||3
6396183|NCT00862849|7308776|FG001|STARTED|Washout 5 (3 to 14 Days)||3
6396184|NCT00862849|7308777|FG002|STARTED|Washout 5 (3 to 14 Days)||3
6396185|NCT00862849|7308778|FG003|STARTED|Washout 5 (3 to 14 Days)||4
6396186|NCT00862849|7308779|FG004|STARTED|Washout 5 (3 to 14 Days)||4
6396187|NCT00862849|7308780|FG005|STARTED|Washout 5 (3 to 14 Days)||3
6396188|NCT00862849|7308775|FG000|COMPLETED|Washout 5 (3 to 14 Days)||3
6396189|NCT00862849|7308776|FG001|COMPLETED|Washout 5 (3 to 14 Days)||3
6396190|NCT00862849|7308777|FG002|COMPLETED|Washout 5 (3 to 14 Days)||3
6396191|NCT00862849|7308778|FG003|COMPLETED|Washout 5 (3 to 14 Days)||4
6396192|NCT00862849|7308779|FG004|COMPLETED|Washout 5 (3 to 14 Days)||4
6396193|NCT00862849|7308780|FG005|COMPLETED|Washout 5 (3 to 14 Days)||3
6396194|NCT00862849|7308775|FG000|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6396195|NCT00862849|7308776|FG001|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6396196|NCT00862849|7308777|FG002|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6396197|NCT00862849|7308778|FG003|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6396198|NCT00862849|7308779|FG004|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6396199|NCT00862849|7308780|FG005|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
6396200|NCT00862849|7308775|FG000|STARTED|Intervention 6||3
6396201|NCT00862849|7308776|FG001|STARTED|Intervention 6||3
6396202|NCT00862849|7308777|FG002|STARTED|Intervention 6||3
6396203|NCT00862849|7308778|FG003|STARTED|Intervention 6||4
6396204|NCT00862849|7308779|FG004|STARTED|Intervention 6||4
6396205|NCT00862849|7308780|FG005|STARTED|Intervention 6||3
6396206|NCT00862849|7308775|FG000|COMPLETED|Intervention 6||3
6396207|NCT00862849|7308776|FG001|COMPLETED|Intervention 6||3
6396208|NCT00862849|7308777|FG002|COMPLETED|Intervention 6||3
6396209|NCT00862849|7308778|FG003|COMPLETED|Intervention 6||4
6396210|NCT00862849|7308779|FG004|COMPLETED|Intervention 6||4
6396211|NCT00862849|7308780|FG005|COMPLETED|Intervention 6||3
6396212|NCT00862849|7308775|FG000|NOT COMPLETED|Intervention 6||0
6396213|NCT00862849|7308776|FG001|NOT COMPLETED|Intervention 6||0
6626091|NCT02230384|7553706|FG001|COMPLETED|Phase 1||31
6626092|NCT02230384|7553705|FG000|NOT COMPLETED|Phase 1||1
6396214|NCT00862849|7308777|FG002|NOT COMPLETED|Intervention 6||0
6626093|NCT02230384|7553706|FG001|NOT COMPLETED|Phase 1||1
6626094|NCT02230384|7553705|FG000|STARTED|Phase 1 Wash Out||29
6396215|NCT00862849|7308778|FG003|NOT COMPLETED|Intervention 6||0
6396216|NCT00862849|7308779|FG004|NOT COMPLETED|Intervention 6||0
6396217|NCT00862849|7308780|FG005|NOT COMPLETED|Intervention 6||0
6396218|NCT00862940|7308790|FG000|STARTED|Overall Study||133
6396219|NCT00862940|7308791|FG001|STARTED|Overall Study||144
6396220|NCT00862940|7308790|FG000|COMPLETED|Overall Study||103
6396221|NCT00862940|7308791|FG001|COMPLETED|Overall Study||114
6396222|NCT00862940|7308790|FG000|NOT COMPLETED|Overall Study||30
6396223|NCT00862940|7308791|FG001|NOT COMPLETED|Overall Study||30
6396224|NCT00862979|7308799|FG000|STARTED|Overall Study||84
6396225|NCT00862979|7308800|FG001|STARTED|Overall Study||78
6626095|NCT02230384|7553706|FG001|STARTED|Phase 1 Wash Out||31
6626096|NCT02230384|7553705|FG000|COMPLETED|Phase 1 Wash Out||29
6626097|NCT02230384|7553706|FG001|COMPLETED|Phase 1 Wash Out||31
6626098|NCT02230384|7553705|FG000|NOT COMPLETED|Phase 1 Wash Out||0
6626099|NCT02230384|7553706|FG001|NOT COMPLETED|Phase 1 Wash Out||0
6626100|NCT02230384|7553705|FG000|STARTED|Phase 2 - Switch||29
6626101|NCT02230384|7553706|FG001|STARTED|Phase 2 - Switch||31
6626102|NCT02230384|7553705|FG000|COMPLETED|Phase 2 - Switch||26
6626103|NCT02230384|7553706|FG001|COMPLETED|Phase 2 - Switch||30
6626104|NCT02230384|7553705|FG000|NOT COMPLETED|Phase 2 - Switch||3
6626105|NCT02230384|7553706|FG001|NOT COMPLETED|Phase 2 - Switch||1
6626106|NCT02230384|7553705|FG000|STARTED|Phase 2 Wash Out||26
6626107|NCT02230384|7553706|FG001|STARTED|Phase 2 Wash Out||30
6626108|NCT02230384|7553705|FG000|COMPLETED|Phase 2 Wash Out||26
6626109|NCT02230384|7553706|FG001|COMPLETED|Phase 2 Wash Out||30
6626110|NCT02230384|7553705|FG000|NOT COMPLETED|Phase 2 Wash Out||0
6626111|NCT02230384|7553706|FG001|NOT COMPLETED|Phase 2 Wash Out||0
6626112|NCT02230527|7553722|FG000|STARTED|Overall Study||23
6626113|NCT02230527|7553723|FG001|STARTED|Overall Study||23
6626114|NCT02230527|7553722|FG000|COMPLETED|Overall Study||18
6626115|NCT02230527|7553723|FG001|COMPLETED|Overall Study||21
6626116|NCT02230527|7553722|FG000|NOT COMPLETED|Overall Study||5
6626117|NCT02230527|7553723|FG001|NOT COMPLETED|Overall Study||2
6626118|NCT02230540|7553729|FG000|STARTED|Overall Study||8
6626119|NCT02230540|7553730|FG001|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
6626120|NCT02230540|7553729|FG000|COMPLETED|Overall Study||8
6626121|NCT02230540|7553730|FG001|COMPLETED|Overall Study||0
6626122|NCT02230540|7553729|FG000|NOT COMPLETED|Overall Study||0
6626123|NCT02230540|7553730|FG001|NOT COMPLETED|Overall Study||0
6626124|NCT02230566|7553738|FG000|STARTED|Overall Study||3
6626125|NCT02230566|7553739|FG001|STARTED|Overall Study||3
6626126|NCT02230566|7553740|FG002|STARTED|Overall Study||3
6626127|NCT02230566|7553741|FG003|STARTED|Overall Study||3
6626128|NCT02230566|7553738|FG000|COMPLETED|Overall Study||3
6626129|NCT02230566|7553739|FG001|COMPLETED|Overall Study||3
6626130|NCT02230566|7553740|FG002|COMPLETED|Overall Study||3
6626131|NCT02230566|7553741|FG003|COMPLETED|Overall Study||3
6626132|NCT02230566|7553738|FG000|NOT COMPLETED|Overall Study||0
6626133|NCT02230566|7553739|FG001|NOT COMPLETED|Overall Study||0
6626134|NCT02230566|7553740|FG002|NOT COMPLETED|Overall Study||0
6626135|NCT02230566|7553741|FG003|NOT COMPLETED|Overall Study||0
6626136|NCT02230579|7553753|FG000|STARTED|Overall Study||6
6626137|NCT02230579|7553754|FG001|STARTED|Overall Study||6
6626138|NCT02230579|7553755|FG002|STARTED|Overall Study||6
6626139|NCT02230579|7553756|FG003|STARTED|Overall Study||6
6626140|NCT02230579|7553757|FG004|STARTED|Overall Study||6
6626141|NCT02230579|7553758|FG005|STARTED|Overall Study||6
6626142|NCT02230579|7553759|FG006|STARTED|Overall Study||12
6626143|NCT02230579|7553753|FG000|COMPLETED|Overall Study||6
6626144|NCT02230579|7553754|FG001|COMPLETED|Overall Study||6
6396226|NCT00862979|7308799|FG000|Full Analysis Set (FAS)|Overall Study||74
6396227|NCT00862979|7308800|FG001|Full Analysis Set (FAS)|Overall Study||71
6396228|NCT00862979|7308799|FG000|COMPLETED|Overall Study||76
6396229|NCT00862979|7308800|FG001|COMPLETED|Overall Study||71
6396230|NCT00862979|7308799|FG000|NOT COMPLETED|Overall Study||8
6396231|NCT00862979|7308800|FG001|NOT COMPLETED|Overall Study||7
6396232|NCT00862992|7308809|FG000|STARTED|Overall Study||12
6396233|NCT00862992|7308810|FG001|STARTED|Overall Study||10
6396234|NCT00862992|7308811|FG002|STARTED|Overall Study||12
6396235|NCT00862992|7308809|FG000|COMPLETED|Overall Study||9
6396236|NCT00862992|7308810|FG001|COMPLETED|Overall Study||9
6396237|NCT00862992|7308811|FG002|COMPLETED|Overall Study||9
6396238|NCT00862992|7308809|FG000|NOT COMPLETED|Overall Study||3
6396239|NCT00862992|7308810|FG001|NOT COMPLETED|Overall Study||1
6396240|NCT00862992|7308811|FG002|NOT COMPLETED|Overall Study||3
6396241|NCT00863057|7308823|FG000|STARTED|Milestones Period 1 (Weeks 0-5)||4
6396242|NCT00863057|7308824|FG001|STARTED|Milestones Period 1 (Weeks 0-5)||4
6396243|NCT00863057|7308825|FG002|STARTED|Milestones Period 1 (Weeks 0-5)||3
6396244|NCT00863057|7308826|FG003|STARTED|Milestones Period 1 (Weeks 0-5)||4
6396245|NCT00863057|7308823|FG000|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
6396246|NCT00863057|7308824|FG001|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
6396247|NCT00863057|7308825|FG002|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
6396248|NCT00863057|7308826|FG003|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
6626145|NCT02230579|7553755|FG002|COMPLETED|Overall Study||6
6626146|NCT02230579|7553756|FG003|COMPLETED|Overall Study||6
6626147|NCT02230579|7553757|FG004|COMPLETED|Overall Study||6
6626148|NCT02230579|7553758|FG005|COMPLETED|Overall Study||6
6626149|NCT02230579|7553759|FG006|COMPLETED|Overall Study||12
6626150|NCT02230579|7553753|FG000|NOT COMPLETED|Overall Study||0
6626151|NCT02230579|7553754|FG001|NOT COMPLETED|Overall Study||0
6626152|NCT02230579|7553755|FG002|NOT COMPLETED|Overall Study||0
6626153|NCT02230579|7553756|FG003|NOT COMPLETED|Overall Study||0
6626154|NCT02230579|7553757|FG004|NOT COMPLETED|Overall Study||0
6626155|NCT02230579|7553758|FG005|NOT COMPLETED|Overall Study||0
6626156|NCT02230579|7553759|FG006|NOT COMPLETED|Overall Study||0
6626157|NCT02230670|7553777|FG000|STARTED|Overall Study||44
6655294|NCT02452320|7585390|FG001|NOT COMPLETED|Overall Study||1
6626158|NCT02230670|7553778|FG001|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
6626159|NCT02230670|7553777|FG000|COMPLETED|Overall Study||40
6626160|NCT02230670|7553778|FG001|COMPLETED|Overall Study||34
6626161|NCT02230670|7553777|FG000|NOT COMPLETED|Overall Study||4
6626162|NCT02230670|7553778|FG001|NOT COMPLETED|Overall Study||8
6626163|NCT02230683|7553784|FG000|STARTED|Overall Study||23
6626164|NCT02230683|7553784|FG000|COMPLETED|Overall Study||22
6626165|NCT02230683|7553784|FG000|NOT COMPLETED|Overall Study||1
6626166|NCT02230696|7553797|FG000|STARTED|Overall Study||381
6626167|NCT02230696|7553798|FG001|STARTED|Overall Study||376
6626168|NCT02230696|7553799|FG002|STARTED|Overall Study||194
6626169|NCT02230696|7553797|FG000|COMPLETED|Overall Study||366
6626170|NCT02230696|7553798|FG001|COMPLETED|Overall Study||365
6626171|NCT02230696|7553799|FG002|COMPLETED|Overall Study||190
6626172|NCT02230696|7553797|FG000|NOT COMPLETED|Overall Study||15
6626173|NCT02230696|7553798|FG001|NOT COMPLETED|Overall Study||11
6626174|NCT02230696|7553799|FG002|NOT COMPLETED|Overall Study||4
6626175|NCT02230761|7553809|FG000|STARTED|Overall Study||60
6626176|NCT02230761|7553810|FG001|STARTED|Overall Study||30
6626177|NCT02230761|7553809|FG000|COMPLETED|Overall Study||60
6626178|NCT02230761|7553810|FG001|COMPLETED|Overall Study||29
6626179|NCT02230761|7553809|FG000|NOT COMPLETED|Overall Study||0
6626180|NCT02230761|7553810|FG001|NOT COMPLETED|Overall Study||1
6626181|NCT02230904|7553818|FG000|STARTED|Overall Study||29
6626182|NCT02230904|7553819|FG001|STARTED|Overall Study||28
6626183|NCT02230904|7553818|FG000|COMPLETED|Overall Study||29
6626184|NCT02230904|7553819|FG001|COMPLETED|Overall Study||27
6626185|NCT02230904|7553818|FG000|NOT COMPLETED|Overall Study||0
6626186|NCT02230904|7553819|FG001|NOT COMPLETED|Overall Study||1
6626187|NCT02230956|7553830|FG000|STARTED|Overall Study||44
6626188|NCT02230956|7553831|FG001|STARTED|Overall Study||43
6626189|NCT02230956|7553832|FG002|STARTED|Overall Study||89
6626190|NCT02230956|7553830|FG000|COMPLETED|Overall Study||39
6626191|NCT02230956|7553831|FG001|COMPLETED|Overall Study||37
6626192|NCT02230956|7553832|FG002|COMPLETED|Overall Study||82
6626193|NCT02230956|7553830|FG000|NOT COMPLETED|Overall Study||5
6626194|NCT02230956|7553831|FG001|NOT COMPLETED|Overall Study||6
6626195|NCT02230956|7553832|FG002|NOT COMPLETED|Overall Study||7
6626196|NCT02230995|7553842|FG000|STARTED|Period 1 + Washout||15
6626197|NCT02230995|7553843|FG001|STARTED|Period 1 + Washout||15
6626198|NCT02230995|7553842|FG000|COMPLETED|Period 1 + Washout||15
6626199|NCT02230995|7553843|FG001|COMPLETED|Period 1 + Washout||15
6626200|NCT02230995|7553842|FG000|NOT COMPLETED|Period 1 + Washout||0
6626201|NCT02230995|7553843|FG001|NOT COMPLETED|Period 1 + Washout||0
6626202|NCT02230995|7553842|FG000|STARTED|Period 2 + Washout||15
6626203|NCT02230995|7553843|FG001|STARTED|Period 2 + Washout||15
6626204|NCT02230995|7553842|FG000|COMPLETED|Period 2 + Washout||15
6626205|NCT02230995|7553843|FG001|COMPLETED|Period 2 + Washout||15
6626206|NCT02230995|7553842|FG000|NOT COMPLETED|Period 2 + Washout||0
6626207|NCT02230995|7553843|FG001|NOT COMPLETED|Period 2 + Washout||0
6626208|NCT02231086|7553851|FG000|STARTED|Overall Study||102
6626209|NCT02231086|7553852|FG001|STARTED|Overall Study||102
6626210|NCT02231086|7553851|FG000|COMPLETED|Overall Study||63
6626211|NCT02231086|7553852|FG001|COMPLETED|Overall Study||65
6626212|NCT02231086|7553851|FG000|NOT COMPLETED|Overall Study||39
6626213|NCT02231086|7553852|FG001|NOT COMPLETED|Overall Study||37
6626214|NCT02231164|7553860|FG000|STARTED|Overall Study||6
6626215|NCT02231164|7553861|FG001|STARTED|Overall Study||6
6626216|NCT02231164|7553860|FG000|COMPLETED|Overall Study||0
6626217|NCT02231164|7553861|FG001|COMPLETED|Overall Study||0
6626218|NCT02231164|7553860|FG000|NOT COMPLETED|Overall Study||6
6626219|NCT02231164|7553861|FG001|NOT COMPLETED|Overall Study||6
6626220|NCT02231177|7553867|FG000|STARTED|Treatment Period 1 (21 Days)||8
6626221|NCT02231177|7553868|FG001|STARTED|Treatment Period 1 (21 Days)||7
6626222|NCT02231177|7553869|FG002|STARTED|Treatment Period 1 (21 Days)||8
6626223|NCT02231177|7553870|FG003|STARTED|Treatment Period 1 (21 Days)||7
6626224|NCT02231177|7553871|FG004|STARTED|Treatment Period 1 (21 Days)||8
6626225|NCT02231177|7553872|FG005|STARTED|Treatment Period 1 (21 Days)||9
6626226|NCT02231177|7553867|FG000|COMPLETED|Treatment Period 1 (21 Days)||8
6626227|NCT02231177|7553868|FG001|COMPLETED|Treatment Period 1 (21 Days)||7
6626228|NCT02231177|7553869|FG002|COMPLETED|Treatment Period 1 (21 Days)||8
6626229|NCT02231177|7553870|FG003|COMPLETED|Treatment Period 1 (21 Days)||7
6626230|NCT02231177|7553871|FG004|COMPLETED|Treatment Period 1 (21 Days)||8
6626231|NCT02231177|7553872|FG005|COMPLETED|Treatment Period 1 (21 Days)||9
6626232|NCT02231177|7553867|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6626233|NCT02231177|7553868|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6626234|NCT02231177|7553869|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6626235|NCT02231177|7553870|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6626236|NCT02231177|7553871|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6626237|NCT02231177|7553872|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6626238|NCT02231177|7553867|FG000|STARTED|Treatment Period 2 (21 Days)||8
6626239|NCT02231177|7553868|FG001|STARTED|Treatment Period 2 (21 Days)||7
6626240|NCT02231177|7553869|FG002|STARTED|Treatment Period 2 (21 Days)||8
6626241|NCT02231177|7553870|FG003|STARTED|Treatment Period 2 (21 Days)||7
6626242|NCT02231177|7553871|FG004|STARTED|Treatment Period 2 (21 Days)||8
6626243|NCT02231177|7553872|FG005|STARTED|Treatment Period 2 (21 Days)||9
6626244|NCT02231177|7553867|FG000|COMPLETED|Treatment Period 2 (21 Days)||8
6626245|NCT02231177|7553868|FG001|COMPLETED|Treatment Period 2 (21 Days)||7
6626246|NCT02231177|7553869|FG002|COMPLETED|Treatment Period 2 (21 Days)||8
6626247|NCT02231177|7553870|FG003|COMPLETED|Treatment Period 2 (21 Days)||7
6626248|NCT02231177|7553871|FG004|COMPLETED|Treatment Period 2 (21 Days)||8
6626249|NCT02231177|7553872|FG005|COMPLETED|Treatment Period 2 (21 Days)||9
6626250|NCT02231177|7553867|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6626251|NCT02231177|7553868|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6626252|NCT02231177|7553869|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6626253|NCT02231177|7553870|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6626254|NCT02231177|7553871|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6626255|NCT02231177|7553872|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6626256|NCT02231177|7553867|FG000|STARTED|Treatment Period 3 (21 Days)||8
6626257|NCT02231177|7553868|FG001|STARTED|Treatment Period 3 (21 Days)||7
6626258|NCT02231177|7553869|FG002|STARTED|Treatment Period 3 (21 Days)||8
6626259|NCT02231177|7553870|FG003|STARTED|Treatment Period 3 (21 Days)||7
6626260|NCT02231177|7553871|FG004|STARTED|Treatment Period 3 (21 Days)||8
6626261|NCT02231177|7553872|FG005|STARTED|Treatment Period 3 (21 Days)||9
6626262|NCT02231177|7553867|FG000|COMPLETED|Treatment Period 3 (21 Days)||8
6626263|NCT02231177|7553868|FG001|COMPLETED|Treatment Period 3 (21 Days)||7
6626264|NCT02231177|7553869|FG002|COMPLETED|Treatment Period 3 (21 Days)||8
6626265|NCT02231177|7553870|FG003|COMPLETED|Treatment Period 3 (21 Days)||7
6626266|NCT02231177|7553871|FG004|COMPLETED|Treatment Period 3 (21 Days)||8
6626267|NCT02231177|7553872|FG005|COMPLETED|Treatment Period 3 (21 Days)||9
6626268|NCT02231177|7553867|FG000|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6626269|NCT02231177|7553868|FG001|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6626270|NCT02231177|7553869|FG002|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6626271|NCT02231177|7553870|FG003|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6626272|NCT02231177|7553871|FG004|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6626273|NCT02231177|7553872|FG005|NOT COMPLETED|Treatment Period 3 (21 Days)||0
6626274|NCT02231580|7553883|FG000|STARTED|Overall Study||14
6626275|NCT02231580|7553884|FG001|STARTED|Overall Study||3
6626276|NCT02231580|7553883|FG000|Cohort 1|Overall Study||8
6626277|NCT02231580|7553884|FG001|Cohort 1|Overall Study||2
6626278|NCT02231580|7553883|FG000|Cohort 2|Overall Study||6
6626279|NCT02231580|7553884|FG001|Cohort 2|Overall Study||1
6626280|NCT02231580|7553883|FG000|COMPLETED|Overall Study||9
6626281|NCT02231580|7553884|FG001|COMPLETED|Overall Study||3
6626282|NCT02231580|7553883|FG000|NOT COMPLETED|Overall Study||5
6626283|NCT02231580|7553884|FG001|NOT COMPLETED|Overall Study||0
6626284|NCT02231749|7553894|FG000|STARTED|Overall Study||550
6626285|NCT02231749|7553895|FG001|STARTED|Overall Study||546
6626286|NCT02231749|7553894|FG000|Received Treatment|Overall Study||547
6626287|NCT02231749|7553895|FG001|Received Treatment|Overall Study||535
6626288|NCT02231749|7553894|FG000|COMPLETED|Overall Study||128
6626289|NCT02231749|7553895|FG001|COMPLETED|Overall Study||97
6626290|NCT02231749|7553894|FG000|NOT COMPLETED|Overall Study||422
6626291|NCT02231749|7553895|FG001|NOT COMPLETED|Overall Study||449
6626292|NCT02231918|7553904|FG000|STARTED|Overall Study||9
6626293|NCT02231918|7553905|FG001|STARTED|Overall Study||15
6626294|NCT02231918|7553906|FG002|STARTED|Overall Study||2
6626295|NCT02231918|7553904|FG000|COMPLETED|Overall Study||9
6626296|NCT02231918|7553905|FG001|COMPLETED|Overall Study||14
6626297|NCT02231918|7553906|FG002|COMPLETED|Overall Study||1
6626298|NCT02231918|7553904|FG000|NOT COMPLETED|Overall Study||0
6626299|NCT02231918|7553905|FG001|NOT COMPLETED|Overall Study||1
6626300|NCT02231918|7553906|FG002|NOT COMPLETED|Overall Study||1
6626301|NCT02232009|7553914|FG000|STARTED|Overall Study||9
6626302|NCT02232009|7553914|FG000|COMPLETED|Overall Study||9
6626303|NCT02232009|7553914|FG000|NOT COMPLETED|Overall Study||0
6626304|NCT02232022|7553918|FG000|STARTED|Overall Study||53
6626305|NCT02232022|7553918|FG000|COMPLETED|Overall Study||51
6626306|NCT02232022|7553918|FG000|NOT COMPLETED|Overall Study||2
6626307|NCT02232061|7553924|FG000|STARTED|Overall Study||6
6626308|NCT02232061|7553924|FG000|COMPLETED|Overall Study||4
6626309|NCT02232061|7553924|FG000|NOT COMPLETED|Overall Study||2
6626310|NCT02232074|7553930|FG000|STARTED|Overall Study||154
6626311|NCT02232074|7553931|FG001|STARTED|Overall Study||152
6626312|NCT02232074|7553930|FG000|COMPLETED|Overall Study||113
6626313|NCT02232074|7553931|FG001|COMPLETED|Overall Study||107
6626314|NCT02232074|7553930|FG000|NOT COMPLETED|Overall Study||41
6626315|NCT02232074|7553931|FG001|NOT COMPLETED|Overall Study||45
6626316|NCT02232087|7553943|FG000|STARTED|Overall Study||9
6626317|NCT02232087|7553944|FG001|STARTED|Overall Study||10
6626318|NCT02232087|7553945|FG002|STARTED|Overall Study||8
6626319|NCT02232087|7553946|FG003|STARTED|Overall Study||8
6626320|NCT02232087|7553947|FG004|STARTED|Overall Study||8
6626321|NCT02232087|7553948|FG005|STARTED|Overall Study||9
6626322|NCT02232087|7553943|FG000|COMPLETED|Overall Study||7
6626323|NCT02232087|7553944|FG001|COMPLETED|Overall Study||8
6626324|NCT02232087|7553945|FG002|COMPLETED|Overall Study||8
6626325|NCT02232087|7553946|FG003|COMPLETED|Overall Study||7
6626326|NCT02232087|7553947|FG004|COMPLETED|Overall Study||7
6626327|NCT02232087|7553948|FG005|COMPLETED|Overall Study||6
6626328|NCT02232087|7553943|FG000|NOT COMPLETED|Overall Study||2
6626329|NCT02232087|7553944|FG001|NOT COMPLETED|Overall Study||2
6626330|NCT02232087|7553945|FG002|NOT COMPLETED|Overall Study||0
6626331|NCT02232087|7553946|FG003|NOT COMPLETED|Overall Study||1
6626332|NCT02232087|7553947|FG004|NOT COMPLETED|Overall Study||1
6626333|NCT02232087|7553948|FG005|NOT COMPLETED|Overall Study||3
6626334|NCT02232126|7553969|FG000|STARTED|Overall Study||91
6626335|NCT02232126|7553970|FG001|STARTED|Overall Study||90
6626336|NCT02232126|7553969|FG000|COMPLETED|Overall Study||91
6626337|NCT02232126|7553970|FG001|COMPLETED|Overall Study||90
6626338|NCT02232126|7553969|FG000|NOT COMPLETED|Overall Study||0
6626339|NCT02232126|7553970|FG001|NOT COMPLETED|Overall Study||0
6626340|NCT02232178|7553981|FG000|STARTED|Overall Study||26
6626341|NCT02232178|7553982|FG001|STARTED|Overall Study||25
6626342|NCT02232178|7553983|FG002|STARTED|Overall Study||13
6626343|NCT02232178|7553981|FG000|Per Protocol PK Population|Overall Study||26
6626344|NCT02232178|7553982|FG001|Per Protocol PK Population|Overall Study||24
6626345|NCT02232178|7553983|FG002|Per Protocol PK Population|Overall Study||11
6626346|NCT02232178|7553981|FG000|Safety Population|Overall Study||26
6626347|NCT02232178|7553982|FG001|Safety Population|Overall Study||24
6626348|NCT02232178|7553983|FG002|Safety Population|Overall Study||12
6626349|NCT02232178|7553981|FG000|COMPLETED|Overall Study||25
6626350|NCT02232178|7553982|FG001|COMPLETED|Overall Study||24
6626351|NCT02232178|7553983|FG002|COMPLETED|Overall Study||12
6626352|NCT02232178|7553981|FG000|NOT COMPLETED|Overall Study||1
6626353|NCT02232178|7553982|FG001|NOT COMPLETED|Overall Study||1
6626354|NCT02232178|7553983|FG002|NOT COMPLETED|Overall Study||1
6626355|NCT02232243|7553994|FG000|STARTED|First Dose (200mg HCQ Twice Daily)||3
6396249|NCT00863057|7308823|FG000|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
6396250|NCT00863057|7308824|FG001|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
6396251|NCT00863057|7308825|FG002|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
6396252|NCT00863057|7308826|FG003|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
6396253|NCT00863057|7308823|FG000|STARTED|Period 2 (Weeks 6-10)||3
6396254|NCT00863057|7308824|FG001|STARTED|Period 2 (Weeks 6-10)||2
6396255|NCT00863057|7308825|FG002|STARTED|Period 2 (Weeks 6-10)||3
6396256|NCT00863057|7308826|FG003|STARTED|Period 2 (Weeks 6-10)||3
6396257|NCT00863057|7308823|FG000|COMPLETED|Period 2 (Weeks 6-10)||3
6396258|NCT00863057|7308824|FG001|COMPLETED|Period 2 (Weeks 6-10)||1
6396259|NCT00863057|7308825|FG002|COMPLETED|Period 2 (Weeks 6-10)||2
6396260|NCT00863057|7308826|FG003|COMPLETED|Period 2 (Weeks 6-10)||2
6396261|NCT00863057|7308823|FG000|NOT COMPLETED|Period 2 (Weeks 6-10)||0
6396262|NCT00863057|7308824|FG001|NOT COMPLETED|Period 2 (Weeks 6-10)||1
6396263|NCT00863057|7308825|FG002|NOT COMPLETED|Period 2 (Weeks 6-10)||1
6396264|NCT00863057|7308826|FG003|NOT COMPLETED|Period 2 (Weeks 6-10)||1
6396265|NCT00863057|7308823|FG000|STARTED|Period 3 (Weeks 11-15)||3
6396266|NCT00863057|7308824|FG001|STARTED|Period 3 (Weeks 11-15)||1
6396267|NCT00863057|7308825|FG002|STARTED|Period 3 (Weeks 11-15)||2
6396268|NCT00863057|7308826|FG003|STARTED|Period 3 (Weeks 11-15)||2
6396269|NCT00863057|7308823|FG000|COMPLETED|Period 3 (Weeks 11-15)||3
6396270|NCT00863057|7308824|FG001|COMPLETED|Period 3 (Weeks 11-15)||1
6396271|NCT00863057|7308825|FG002|COMPLETED|Period 3 (Weeks 11-15)||2
6396272|NCT00863057|7308826|FG003|COMPLETED|Period 3 (Weeks 11-15)||2
6396273|NCT00863057|7308823|FG000|NOT COMPLETED|Period 3 (Weeks 11-15)||0
6396274|NCT00863057|7308824|FG001|NOT COMPLETED|Period 3 (Weeks 11-15)||0
6396275|NCT00863057|7308825|FG002|NOT COMPLETED|Period 3 (Weeks 11-15)||0
6396276|NCT00863057|7308826|FG003|NOT COMPLETED|Period 3 (Weeks 11-15)||0
6396277|NCT00863057|7308823|FG000|STARTED|Period 4 (Weeks 16-20)||3
6396278|NCT00863057|7308824|FG001|STARTED|Period 4 (Weeks 16-20)||1
6396279|NCT00863057|7308825|FG002|STARTED|Period 4 (Weeks 16-20)||2
6396280|NCT00863057|7308826|FG003|STARTED|Period 4 (Weeks 16-20)||2
6396281|NCT00863057|7308823|FG000|COMPLETED|Period 4 (Weeks 16-20)||3
6396282|NCT00863057|7308824|FG001|COMPLETED|Period 4 (Weeks 16-20)||1
6396283|NCT00863057|7308825|FG002|COMPLETED|Period 4 (Weeks 16-20)||2
6396284|NCT00863057|7308826|FG003|COMPLETED|Period 4 (Weeks 16-20)||2
6396285|NCT00863057|7308823|FG000|NOT COMPLETED|Period 4 (Weeks 16-20)||0
6396286|NCT00863057|7308824|FG001|NOT COMPLETED|Period 4 (Weeks 16-20)||0
6396287|NCT00863057|7308825|FG002|NOT COMPLETED|Period 4 (Weeks 16-20)||0
6396288|NCT00863057|7308826|FG003|NOT COMPLETED|Period 4 (Weeks 16-20)||0
6396289|NCT00863109|7308842|FG000|STARTED|Treatment Period||130
6396290|NCT00863109|7308842|FG000|COMPLETED|Treatment Period||53
6396291|NCT00863109|7308842|FG000|NOT COMPLETED|Treatment Period||77
6396292|NCT00863109|7308842|FG000|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
6396293|NCT00863109|7308842|FG000|COMPLETED|Follow-up Period||48
6396294|NCT00863109|7308842|FG000|NOT COMPLETED|Follow-up Period||11
6396295|NCT00863122|7308850|FG000|STARTED|Overall Study||19
6396296|NCT00863122|7308851|FG001|STARTED|Overall Study||7
6396297|NCT00863122|7308850|FG000|COMPLETED|Overall Study||19
6396298|NCT00863122|7308851|FG001|COMPLETED|Overall Study||7
6396299|NCT00863122|7308850|FG000|NOT COMPLETED|Overall Study||0
6396300|NCT00863122|7308851|FG001|NOT COMPLETED|Overall Study||0
6626356|NCT02232243|7553995|FG001|STARTED|First Dose (200mg HCQ Twice Daily)||0
6626357|NCT02232243|7553996|FG002|STARTED|First Dose (200mg HCQ Twice Daily)||0
6626358|NCT02232243|7553994|FG000|COMPLETED|First Dose (200mg HCQ Twice Daily)||3
6626359|NCT02232243|7553995|FG001|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6626360|NCT02232243|7553996|FG002|COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6626361|NCT02232243|7553994|FG000|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6626362|NCT02232243|7553995|FG001|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6626363|NCT02232243|7553996|FG002|NOT COMPLETED|First Dose (200mg HCQ Twice Daily)||0
6626364|NCT02232243|7553994|FG000|STARTED|Second Dose (400mg HCQ Twice Daily)||0
6626365|NCT02232243|7553995|FG001|STARTED|Second Dose (400mg HCQ Twice Daily)||4
6626366|NCT02232243|7553996|FG002|STARTED|Second Dose (400mg HCQ Twice Daily)||0
6626367|NCT02232243|7553994|FG000|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
6626368|NCT02232243|7553995|FG001|COMPLETED|Second Dose (400mg HCQ Twice Daily)||3
6626369|NCT02232243|7553996|FG002|COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
6626370|NCT02232243|7553994|FG000|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
6626371|NCT02232243|7553995|FG001|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||1
6626372|NCT02232243|7553996|FG002|NOT COMPLETED|Second Dose (400mg HCQ Twice Daily)||0
6626373|NCT02232243|7553994|FG000|STARTED|Third Dose(200mg HCQ Twice Daily)||0
6626374|NCT02232243|7553995|FG001|STARTED|Third Dose(200mg HCQ Twice Daily)||0
6626375|NCT02232243|7553996|FG002|STARTED|Third Dose(200mg HCQ Twice Daily)||3
6626376|NCT02232243|7553994|FG000|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6626377|NCT02232243|7553995|FG001|COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6626378|NCT02232243|7553996|FG002|COMPLETED|Third Dose(200mg HCQ Twice Daily)||3
6396301|NCT00863265|7308861|FG000|STARTED|Overall Study||4
6396302|NCT00863265|7308862|FG001|STARTED|Overall Study||3
6396303|NCT00863265|7308863|FG002|STARTED|Overall Study||4
6396304|NCT00863265|7308864|FG003|STARTED|Overall Study||4
6396305|NCT00863265|7308865|FG004|STARTED|Overall Study||4
6396306|NCT00863265|7308866|FG005|STARTED|Overall Study||3
6396307|NCT00863265|7308861|FG000|COMPLETED|Overall Study||4
6396308|NCT00863265|7308862|FG001|COMPLETED|Overall Study||3
6396309|NCT00863265|7308863|FG002|COMPLETED|Overall Study||4
6396310|NCT00863265|7308864|FG003|COMPLETED|Overall Study||4
6396311|NCT00863265|7308865|FG004|COMPLETED|Overall Study||3
6396312|NCT00863265|7308866|FG005|COMPLETED|Overall Study||3
6396313|NCT00863265|7308861|FG000|NOT COMPLETED|Overall Study||0
6396314|NCT00863265|7308862|FG001|NOT COMPLETED|Overall Study||0
6396315|NCT00863265|7308863|FG002|NOT COMPLETED|Overall Study||0
6396316|NCT00863265|7308864|FG003|NOT COMPLETED|Overall Study||0
6396317|NCT00863265|7308865|FG004|NOT COMPLETED|Overall Study||1
6396318|NCT00863265|7308866|FG005|NOT COMPLETED|Overall Study||0
6396319|NCT00863304|7308884|FG000|STARTED|Overall Study||212
6396320|NCT00863304|7308885|FG001|STARTED|Overall Study||212
6396321|NCT00863304|7308886|FG002|STARTED|Overall Study||213
6396322|NCT00863304|7308887|FG003|STARTED|Overall Study||212
6396323|NCT00863304|7308884|FG000|Treated|Overall Study||209
6396324|NCT00863304|7308885|FG001|Treated|Overall Study||211
6396325|NCT00863304|7308886|FG002|Treated|Overall Study||209
6396326|NCT00863304|7308887|FG003|Treated|Overall Study||211
6396327|NCT00863304|7308884|FG000|COMPLETED|Overall Study||18
6396328|NCT00863304|7308885|FG001|COMPLETED|Overall Study||27
6396329|NCT00863304|7308886|FG002|COMPLETED|Overall Study||26
6396330|NCT00863304|7308887|FG003|COMPLETED|Overall Study||21
6396331|NCT00863304|7308884|FG000|NOT COMPLETED|Overall Study||194
6396332|NCT00863304|7308885|FG001|NOT COMPLETED|Overall Study||185
6396333|NCT00863304|7308886|FG002|NOT COMPLETED|Overall Study||187
6396334|NCT00863304|7308887|FG003|NOT COMPLETED|Overall Study||191
6396335|NCT00863317|7308901|FG000|STARTED|Overall Study||68
6396336|NCT00863317|7308902|FG001|STARTED|Overall Study||73
6396337|NCT00863317|7308901|FG000|COMPLETED|Overall Study||60
6396338|NCT00863317|7308902|FG001|COMPLETED|Overall Study||64
6396339|NCT00863317|7308901|FG000|NOT COMPLETED|Overall Study||8
6396340|NCT00863317|7308902|FG001|NOT COMPLETED|Overall Study||9
6396341|NCT00863343|7308910|FG000|STARTED|Overall Study||17
6396342|NCT00863343|7308911|FG001|STARTED|Overall Study||374
6396343|NCT00863343|7308910|FG000|COMPLETED|Overall Study||17
6396344|NCT00863343|7308911|FG001|COMPLETED|Overall Study||374
6396345|NCT00863343|7308910|FG000|NOT COMPLETED|Overall Study||0
6396346|NCT00863343|7308911|FG001|NOT COMPLETED|Overall Study||0
6396347|NCT00863356|7308919|FG000|STARTED|Overall Study||20
6396348|NCT00863356|7308919|FG000|COMPLETED|Overall Study||20
6396349|NCT00863356|7308919|FG000|NOT COMPLETED|Overall Study||0
6396350|NCT00863434|7308923|FG000|STARTED|Overall Study||2
6396351|NCT00863434|7308923|FG000|COMPLETED|Overall Study||2
6396352|NCT00863434|7308923|FG000|NOT COMPLETED|Overall Study||0
6396353|NCT00863551|7308927|FG000|STARTED|Overall Study||12
6396354|NCT00863551|7308927|FG000|COMPLETED|Overall Study||12
6396355|NCT00863551|7308927|FG000|NOT COMPLETED|Overall Study||0
6396356|NCT00863655|7308933|FG000|STARTED|Overall Study||485
6396357|NCT00863655|7308934|FG001|STARTED|Overall Study||239
6396358|NCT00863655|7308933|FG000|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
6396359|NCT00863655|7308934|FG001|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
6396360|NCT00863655|7308933|FG000|NOT COMPLETED|Overall Study||485
6396361|NCT00863655|7308934|FG001|NOT COMPLETED|Overall Study||239
6396362|NCT00863681|7308943|FG000|STARTED|Overall Study||231
6396363|NCT00863681|7308944|FG001|STARTED|Overall Study||109
6396364|NCT00863681|7308945|FG002|STARTED|Overall Study||56
6396365|NCT00863681|7308943|FG000|COMPLETED|Overall Study|Completed treatment|140
6396366|NCT00863681|7308944|FG001|COMPLETED|Overall Study|Completed treatment|66
6396367|NCT00863681|7308945|FG002|COMPLETED|Overall Study|Completed treatment|38
6396368|NCT00863681|7308943|FG000|NOT COMPLETED|Overall Study||91
6396369|NCT00863681|7308944|FG001|NOT COMPLETED|Overall Study||43
6396370|NCT00863681|7308945|FG002|NOT COMPLETED|Overall Study||18
6396371|NCT00863707|7308955|FG000|STARTED|Overall Study||174
6396372|NCT00863707|7308956|FG001|STARTED|Overall Study||337
6498580|NCT01410604|7417181|FG001|NOT COMPLETED|Overall Study||2
6626379|NCT02232243|7553994|FG000|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6626380|NCT02232243|7553995|FG001|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6626381|NCT02232243|7553996|FG002|NOT COMPLETED|Third Dose(200mg HCQ Twice Daily)||0
6626382|NCT02232425|7554007|FG000|STARTED|Overall Study||58
6626383|NCT02232425|7554008|FG001|STARTED|Overall Study||30
6626384|NCT02232425|7554007|FG000|COMPLETED|Overall Study||44
6626385|NCT02232425|7554008|FG001|COMPLETED|Overall Study||22
6626386|NCT02232425|7554007|FG000|NOT COMPLETED|Overall Study||14
6626387|NCT02232425|7554008|FG001|NOT COMPLETED|Overall Study||8
6626388|NCT02232698|7554016|FG000|STARTED|Overall Study||120
6626389|NCT02232698|7554017|FG001|STARTED|Overall Study||121
6626390|NCT02232698|7554016|FG000|COMPLETED|Overall Study||110
6396373|NCT00863707|7308955|FG000|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
6396374|NCT00863707|7308956|FG001|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
6396375|NCT00863707|7308955|FG000|NOT COMPLETED|Overall Study||4
6396376|NCT00863707|7308956|FG001|NOT COMPLETED|Overall Study||3
6396377|NCT00863746|7308964|FG000|STARTED|Treatment||350
6396378|NCT00863746|7308965|FG001|STARTED|Treatment||353
6396379|NCT00863746|7308964|FG000|Participants Received Treatment|Treatment|Safety population|346
6396380|NCT00863746|7308965|FG001|Participants Received Treatment|Treatment|Safety population|351
6396381|NCT00863746|7308964|FG000|COMPLETED|Treatment||279
6396382|NCT00863746|7308965|FG001|COMPLETED|Treatment||318
6396383|NCT00863746|7308964|FG000|NOT COMPLETED|Treatment||71
6396384|NCT00863746|7308965|FG001|NOT COMPLETED|Treatment||35
6396385|NCT00863746|7308964|FG000|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
6396386|NCT00863746|7308965|FG001|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
6396387|NCT00863746|7308964|FG000|COMPLETED|Survival Follow up||45
6396388|NCT00863746|7308965|FG001|COMPLETED|Survival Follow up||51
6396389|NCT00863746|7308964|FG000|NOT COMPLETED|Survival Follow up||253
6396390|NCT00863746|7308965|FG001|NOT COMPLETED|Survival Follow up||280
6396391|NCT00863772|7308974|FG000|STARTED|Overall Study||74
6396392|NCT00863772|7308975|FG001|STARTED|Overall Study||74
6396393|NCT00863772|7308976|FG002|STARTED|Overall Study||72
6396394|NCT00863772|7308974|FG000|Treated|Overall Study||73
6396395|NCT00863772|7308975|FG001|Treated|Overall Study||74
6396396|NCT00863772|7308976|FG002|Treated|Overall Study||72
6396397|NCT00863772|7308974|FG000|COMPLETED|Overall Study||6
6396398|NCT00863772|7308975|FG001|COMPLETED|Overall Study||9
6396399|NCT00863772|7308976|FG002|COMPLETED|Overall Study||11
6396400|NCT00863772|7308974|FG000|NOT COMPLETED|Overall Study||68
6396401|NCT00863772|7308975|FG001|NOT COMPLETED|Overall Study||65
6396402|NCT00863772|7308976|FG002|NOT COMPLETED|Overall Study||61
6396403|NCT00863798|7308987|FG000|STARTED|Overall Study||227
6396404|NCT00863798|7308988|FG001|STARTED|Overall Study||228
6396405|NCT00863798|7308989|FG002|STARTED|Overall Study||227
6396406|NCT00863798|7308987|FG000|Treated|Overall Study||223
6396407|NCT00863798|7308988|FG001|Treated|Overall Study||226
6396408|NCT00863798|7308989|FG002|Treated|Overall Study||224
6396409|NCT00863798|7308987|FG000|COMPLETED|Overall Study||195
6396410|NCT00863798|7308988|FG001|COMPLETED|Overall Study||198
6396411|NCT00863798|7308989|FG002|COMPLETED|Overall Study||202
6396412|NCT00863798|7308987|FG000|NOT COMPLETED|Overall Study||32
6396413|NCT00863798|7308988|FG001|NOT COMPLETED|Overall Study||30
6396414|NCT00863798|7308989|FG002|NOT COMPLETED|Overall Study||25
6396415|NCT00863928|7308999|FG000|STARTED|Overall Study||94
6396416|NCT00863928|7309000|FG001|STARTED|Overall Study||41
6396417|NCT00863928|7308999|FG000|COMPLETED|Overall Study||58
6396418|NCT00863928|7309000|FG001|COMPLETED|Overall Study||41
6396419|NCT00863928|7308999|FG000|NOT COMPLETED|Overall Study||36
6396420|NCT00863928|7309000|FG001|NOT COMPLETED|Overall Study||0
6396421|NCT00864032|7309006|FG000|STARTED|Overall Study||3
6396422|NCT00864032|7309007|FG001|STARTED|Overall Study||5
6396423|NCT00864032|7309008|FG002|STARTED|Overall Study||0
6396424|NCT00864032|7309006|FG000|COMPLETED|Overall Study||3
6396425|NCT00864032|7309007|FG001|COMPLETED|Overall Study||5
6396426|NCT00864032|7309008|FG002|COMPLETED|Overall Study||0
6396427|NCT00864032|7309006|FG000|NOT COMPLETED|Overall Study||0
6396428|NCT00864032|7309007|FG001|NOT COMPLETED|Overall Study||0
6396429|NCT00864032|7309008|FG002|NOT COMPLETED|Overall Study||0
6396430|NCT00864084|7309014|FG000|STARTED|Overall Study||14
6396431|NCT00864084|7309014|FG000|COMPLETED|Overall Study||11
6396432|NCT00864084|7309014|FG000|NOT COMPLETED|Overall Study||3
6396433|NCT00864097|7309027|FG000|STARTED|Overall Study||154
6396434|NCT00864097|7309028|FG001|STARTED|Overall Study||157
6396435|NCT00864097|7309029|FG002|STARTED|Overall Study||151
6396436|NCT00864097|7309030|FG003|STARTED|Overall Study||145
6396437|NCT00864097|7309027|FG000|Treated|Overall Study||152
6396438|NCT00864097|7309028|FG001|Treated|Overall Study||157
6396439|NCT00864097|7309029|FG002|Treated|Overall Study||150
6396440|NCT00864097|7309030|FG003|Treated|Overall Study||145
6396441|NCT00864097|7309027|FG000|COMPLETED|Overall Study||15
6396442|NCT00864097|7309028|FG001|COMPLETED|Overall Study||20
6396443|NCT00864097|7309029|FG002|COMPLETED|Overall Study||19
6396444|NCT00864097|7309030|FG003|COMPLETED|Overall Study||20
6626391|NCT02232698|7554017|FG001|COMPLETED|Overall Study||101
6626392|NCT02232698|7554016|FG000|NOT COMPLETED|Overall Study||10
6626393|NCT02232698|7554017|FG001|NOT COMPLETED|Overall Study||20
6626394|NCT02232802|7554025|FG000|STARTED|Period 1||24
6626395|NCT02232802|7554026|FG001|STARTED|Period 1||23
6626396|NCT02232802|7554025|FG000|COMPLETED|Period 1||22
6626397|NCT02232802|7554026|FG001|COMPLETED|Period 1||22
6626398|NCT02232802|7554025|FG000|NOT COMPLETED|Period 1||2
6626399|NCT02232802|7554026|FG001|NOT COMPLETED|Period 1||1
6626400|NCT02232802|7554025|FG000|STARTED|Washout||22
6626401|NCT02232802|7554026|FG001|STARTED|Washout||22
6396445|NCT00864097|7309027|FG000|NOT COMPLETED|Overall Study||139
6396446|NCT00864097|7309028|FG001|NOT COMPLETED|Overall Study||137
6396447|NCT00864097|7309029|FG002|NOT COMPLETED|Overall Study||132
6396448|NCT00864097|7309030|FG003|NOT COMPLETED|Overall Study||125
6396449|NCT00864123|7309042|FG000|STARTED|Overall Study||15
6396450|NCT00864123|7309043|FG001|STARTED|Overall Study||15
6396451|NCT00864123|7309042|FG000|COMPLETED|Overall Study||15
6396452|NCT00864123|7309043|FG001|COMPLETED|Overall Study||15
6396453|NCT00864123|7309042|FG000|NOT COMPLETED|Overall Study||0
6396454|NCT00864123|7309043|FG001|NOT COMPLETED|Overall Study||0
6396455|NCT00864253|7309051|FG000|STARTED|Overall Study||264
6396456|NCT00864253|7309052|FG001|STARTED|Overall Study||265
6396457|NCT00864253|7309051|FG000|Treated|Overall Study||257
6396458|NCT00864253|7309052|FG001|Treated|Overall Study||258
6396459|NCT00864253|7309051|FG000|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
6396460|NCT00864253|7309052|FG001|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
6396461|NCT00864253|7309051|FG000|NOT COMPLETED|Overall Study||99
6396462|NCT00864253|7309052|FG001|NOT COMPLETED|Overall Study||58
6396463|NCT00864383|7309063|FG000|STARTED|Per- Protocol||640
6396464|NCT00864383|7309064|FG001|STARTED|Per- Protocol||655
6396465|NCT00864383|7309065|FG002|STARTED|Per- Protocol||636
6396466|NCT00864383|7309063|FG000|COMPLETED|Per- Protocol||510
6396467|NCT00864383|7309064|FG001|COMPLETED|Per- Protocol||514
6396468|NCT00864383|7309065|FG002|COMPLETED|Per- Protocol||524
6396469|NCT00864383|7309063|FG000|NOT COMPLETED|Per- Protocol||130
6396470|NCT00864383|7309064|FG001|NOT COMPLETED|Per- Protocol||141
6396471|NCT00864383|7309065|FG002|NOT COMPLETED|Per- Protocol||112
6396472|NCT00864383|7309063|FG000|STARTED|Modified Intent to Treat||640
6396473|NCT00864383|7309064|FG001|STARTED|Modified Intent to Treat||655
6396474|NCT00864383|7309065|FG002|STARTED|Modified Intent to Treat||636
6396475|NCT00864383|7309063|FG000|COMPLETED|Modified Intent to Treat||555
6396476|NCT00864383|7309064|FG001|COMPLETED|Modified Intent to Treat||568
6396477|NCT00864383|7309065|FG002|COMPLETED|Modified Intent to Treat||551
6396478|NCT00864383|7309063|FG000|NOT COMPLETED|Modified Intent to Treat||85
6396479|NCT00864383|7309064|FG001|NOT COMPLETED|Modified Intent to Treat||87
6396480|NCT00864383|7309065|FG002|NOT COMPLETED|Modified Intent to Treat||85
6396481|NCT00864513|7309073|FG000|STARTED|Overall Study||15
6396482|NCT00864513|7309073|FG000|COMPLETED|Overall Study||12
6396483|NCT00864513|7309073|FG000|NOT COMPLETED|Overall Study||3
6396484|NCT00864539|7309083|FG000|STARTED|Overall Study||104
6396485|NCT00864539|7309084|FG001|STARTED|Overall Study||95
6396486|NCT00864539|7309085|FG002|STARTED|Overall Study||102
6396487|NCT00864539|7309086|FG003|STARTED|Overall Study||96
6396488|NCT00864539|7309087|FG004|STARTED|Overall Study||103
6396489|NCT00864539|7309088|FG005|STARTED|Overall Study||85
6396490|NCT00864539|7309083|FG000|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
6396491|NCT00864539|7309084|FG001|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
6396492|NCT00864539|7309085|FG002|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
6396493|NCT00864539|7309086|FG003|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
6396494|NCT00864539|7309087|FG004|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
6396495|NCT00864539|7309088|FG005|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
6396496|NCT00864539|7309083|FG000|NOT COMPLETED|Overall Study||9
6396497|NCT00864539|7309084|FG001|NOT COMPLETED|Overall Study||23
6396498|NCT00864539|7309085|FG002|NOT COMPLETED|Overall Study||10
6396499|NCT00864539|7309086|FG003|NOT COMPLETED|Overall Study||7
6396500|NCT00864539|7309087|FG004|NOT COMPLETED|Overall Study||22
6396501|NCT00864539|7309088|FG005|NOT COMPLETED|Overall Study||14
6396502|NCT00864682|7309105|FG000|STARTED|Overall Study||52
6396503|NCT00864682|7309106|FG001|STARTED|Overall Study||51
6396504|NCT00864682|7309107|FG002|STARTED|Overall Study||53
6396505|NCT00864682|7309105|FG000|COMPLETED|Overall Study||50
6396506|NCT00864682|7309106|FG001|COMPLETED|Overall Study||50
6396507|NCT00864682|7309107|FG002|COMPLETED|Overall Study||51
6396508|NCT00864682|7309105|FG000|NOT COMPLETED|Overall Study||2
6396509|NCT00864682|7309106|FG001|NOT COMPLETED|Overall Study||1
6396510|NCT00864682|7309107|FG002|NOT COMPLETED|Overall Study||2
6396511|NCT00864708|7309115|FG000|STARTED|Overall Study||1
6396512|NCT00864708|7309115|FG000|COMPLETED|Overall Study||1
6396513|NCT00864708|7309115|FG000|NOT COMPLETED|Overall Study||0
6396514|NCT00864721|7309121|FG000|STARTED|Overall Study||63
6396515|NCT00864721|7309121|FG000|COMPLETED|Overall Study||29
6396516|NCT00864721|7309121|FG000|NOT COMPLETED|Overall Study||34
6396517|NCT00864851|7309128|FG000|STARTED|Overall Study||20
6396518|NCT00864851|7309129|FG001|STARTED|Overall Study||19
6396519|NCT00864851|7309130|FG002|STARTED|Overall Study||5
6396520|NCT00864851|7309128|FG000|COMPLETED|Overall Study||17
6396521|NCT00864851|7309129|FG001|COMPLETED|Overall Study||18
6626402|NCT02232802|7554025|FG000|COMPLETED|Washout||22
6626403|NCT02232802|7554026|FG001|COMPLETED|Washout||22
6626404|NCT02232802|7554025|FG000|NOT COMPLETED|Washout||0
6626405|NCT02232802|7554026|FG001|NOT COMPLETED|Washout||0
6626406|NCT02232802|7554025|FG000|STARTED|Period 2||22
6626407|NCT02232802|7554026|FG001|STARTED|Period 2||22
6626408|NCT02232802|7554025|FG000|COMPLETED|Period 2||22
6740300|NCT03301779|7669119|FG000|STARTED|Overall Study||48
6282108|NCT00178685|7182316|FG002|COMPLETED|Overall Study||128
6282109|NCT00178685|7182314|FG000|NOT COMPLETED|Overall Study||111
6396522|NCT00864851|7309130|FG002|COMPLETED|Overall Study||5
6396523|NCT00864851|7309128|FG000|NOT COMPLETED|Overall Study||3
6396524|NCT00864851|7309129|FG001|NOT COMPLETED|Overall Study||1
6396525|NCT00864851|7309130|FG002|NOT COMPLETED|Overall Study||0
6396526|NCT00864916|7309142|FG000|STARTED|Overall Study||10
6396527|NCT00864916|7309143|FG001|STARTED|Overall Study||9
6396528|NCT00864916|7309142|FG000|COMPLETED|Overall Study||4
6396529|NCT00864916|7309143|FG001|COMPLETED|Overall Study||5
6396530|NCT00864916|7309142|FG000|NOT COMPLETED|Overall Study||6
6396531|NCT00864916|7309143|FG001|NOT COMPLETED|Overall Study||4
6396532|NCT00865020|7309151|FG000|STARTED|Overall Study||414
6396533|NCT00865020|7309152|FG001|STARTED|Overall Study||408
6396534|NCT00865020|7309151|FG000|COMPLETED|Overall Study||365
6396535|NCT00865020|7309152|FG001|COMPLETED|Overall Study||357
6626409|NCT02232802|7554026|FG001|COMPLETED|Period 2||22
6626410|NCT02232802|7554025|FG000|NOT COMPLETED|Period 2||0
6626411|NCT02232802|7554026|FG001|NOT COMPLETED|Period 2||0
6626412|NCT02232802|7554025|FG000|STARTED|Washout||22
6626413|NCT02232802|7554026|FG001|STARTED|Washout||22
6626414|NCT02232802|7554025|FG000|COMPLETED|Washout||22
6626415|NCT02232802|7554026|FG001|COMPLETED|Washout||22
6626416|NCT02232802|7554025|FG000|NOT COMPLETED|Washout||0
6626417|NCT02232802|7554026|FG001|NOT COMPLETED|Washout||0
6626418|NCT02232893|7554034|FG000|STARTED|Overall Study||35
6626419|NCT02232893|7554035|FG001|STARTED|Overall Study||34
6626420|NCT02232893|7554034|FG000|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|34
6626421|NCT02232893|7554035|FG001|Safety Population|Overall Study|Pts who rec'd at least 1 dose of study drug. All safety analyses performed using this population.|32
6626422|NCT02232893|7554034|FG000|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|24
6626423|NCT02232893|7554035|FG001|Primary Endpoint Population|Overall Study|Patients who provided GIQLI scores both at baseline and Visit 4 were analyzed for primary endpoint|19
6626424|NCT02232893|7554034|FG000|COMPLETED|Overall Study||31
6626425|NCT02232893|7554035|FG001|COMPLETED|Overall Study||27
6626426|NCT02232893|7554034|FG000|NOT COMPLETED|Overall Study||4
6626427|NCT02232893|7554035|FG001|NOT COMPLETED|Overall Study||7
6655295|NCT02452346|7585396|FG000|STARTED|Overall Study||12
6655296|NCT02452346|7585396|FG000|COMPLETED|Overall Study||3
6655297|NCT02452346|7585396|FG000|NOT COMPLETED|Overall Study||9
6655298|NCT02452424|7585411|FG000|STARTED|Overall Study||4
6655299|NCT02452424|7585412|FG001|STARTED|Overall Study||3
6655300|NCT02452424|7585413|FG002|STARTED|Overall Study||7
6655301|NCT02452424|7585414|FG003|STARTED|Overall Study||9
6655302|NCT02452424|7585415|FG004|STARTED|Overall Study||4
6655303|NCT02452424|7585416|FG005|STARTED|Overall Study||6
6655304|NCT02452424|7585417|FG006|STARTED|Overall Study||13
6655305|NCT02452424|7585418|FG007|STARTED|Overall Study||8
6655306|NCT02452424|7585419|FG008|STARTED|Overall Study||15
6655307|NCT02452424|7585420|FG009|STARTED|Overall Study||3
6655308|NCT02452424|7585421|FG010|STARTED|Overall Study||6
6655309|NCT02452424|7585411|FG000|COMPLETED|Overall Study||2
6655310|NCT02452424|7585412|FG001|COMPLETED|Overall Study||0
6655311|NCT02452424|7585413|FG002|COMPLETED|Overall Study||0
6655312|NCT02452424|7585414|FG003|COMPLETED|Overall Study||1
6655313|NCT02452424|7585415|FG004|COMPLETED|Overall Study||2
6655314|NCT02452424|7585416|FG005|COMPLETED|Overall Study||5
6655315|NCT02452424|7585417|FG006|COMPLETED|Overall Study||3
6655316|NCT02452424|7585418|FG007|COMPLETED|Overall Study||4
6655317|NCT02452424|7585419|FG008|COMPLETED|Overall Study||9
6655318|NCT02452424|7585420|FG009|COMPLETED|Overall Study||1
6655319|NCT02452424|7585421|FG010|COMPLETED|Overall Study||4
6655320|NCT02452424|7585411|FG000|NOT COMPLETED|Overall Study||2
6655321|NCT02452424|7585412|FG001|NOT COMPLETED|Overall Study||3
6655322|NCT02452424|7585413|FG002|NOT COMPLETED|Overall Study||7
6655323|NCT02452424|7585414|FG003|NOT COMPLETED|Overall Study||8
6655324|NCT02452424|7585415|FG004|NOT COMPLETED|Overall Study||2
6655325|NCT02452424|7585416|FG005|NOT COMPLETED|Overall Study||1
6655326|NCT02452424|7585417|FG006|NOT COMPLETED|Overall Study||10
6655327|NCT02452424|7585418|FG007|NOT COMPLETED|Overall Study||4
6655328|NCT02452424|7585419|FG008|NOT COMPLETED|Overall Study||6
6655329|NCT02452424|7585420|FG009|NOT COMPLETED|Overall Study||2
6655330|NCT02452424|7585421|FG010|NOT COMPLETED|Overall Study||2
6655331|NCT02452463|7585450|FG000|STARTED|Overall Study||5
6655332|NCT02452463|7585451|FG001|STARTED|Overall Study||3
6655333|NCT02452463|7585452|FG002|STARTED|Overall Study|"No participants were enrolled in the Arm III (Nintedanib, Durvalumab) Arm."|0
6655334|NCT02452463|7585450|FG000|COMPLETED|Overall Study||3
6655335|NCT02452463|7585451|FG001|COMPLETED|Overall Study||1
6655336|NCT02452463|7585452|FG002|COMPLETED|Overall Study||0
6655337|NCT02452463|7585450|FG000|NOT COMPLETED|Overall Study||2
6655338|NCT02452463|7585451|FG001|NOT COMPLETED|Overall Study||2
6655339|NCT02452463|7585452|FG002|NOT COMPLETED|Overall Study||0
6655340|NCT02452476|7585462|FG000|STARTED|Overall Study||64
6655341|NCT02452476|7585463|FG001|STARTED|Overall Study||59
6282110|NCT00178685|7182315|FG001|NOT COMPLETED|Overall Study||204
6396536|NCT00865020|7309151|FG000|NOT COMPLETED|Overall Study||49
6396537|NCT00865020|7309152|FG001|NOT COMPLETED|Overall Study||51
6396538|NCT00865046|7309161|FG000|STARTED|Overall Study||63
6626428|NCT02232984|7554041|FG000|STARTED|Overall Study|Enrolled subjects|749
6626429|NCT02232984|7554041|FG000|Successfully Implanted|Overall Study|Successfully implanted subjects|675
6626430|NCT02232984|7554041|FG000|COMPLETED|Overall Study|Total number of subjects who completed study|672
6626431|NCT02232984|7554041|FG000|NOT COMPLETED|Overall Study||77
6626432|NCT02233101|7554050|FG000|STARTED|Overall Study||86
6626433|NCT02233101|7554051|FG001|STARTED|Overall Study||81
6626434|NCT02233101|7554050|FG000|COMPLETED|Overall Study||74
6626435|NCT02233101|7554051|FG001|COMPLETED|Overall Study||80
6626436|NCT02233101|7554050|FG000|NOT COMPLETED|Overall Study||12
6626437|NCT02233101|7554051|FG001|NOT COMPLETED|Overall Study||1
6626438|NCT02233296|7554059|FG000|STARTED|Overall Study||16
6626439|NCT02233296|7554060|FG001|STARTED|Overall Study||14
6626440|NCT02233296|7554059|FG000|COMPLETED|Overall Study||16
6626441|NCT02233296|7554060|FG001|COMPLETED|Overall Study||14
6626442|NCT02233296|7554059|FG000|NOT COMPLETED|Overall Study||0
6626443|NCT02233296|7554060|FG001|NOT COMPLETED|Overall Study||0
6626444|NCT02233309|7554070|FG000|STARTED|Overall Study||36
6626445|NCT02233309|7554070|FG000|COMPLETED|Overall Study||31
6626446|NCT02233309|7554070|FG000|NOT COMPLETED|Overall Study||5
6626447|NCT02233413|7554076|FG000|STARTED|Overall Study||35
6626448|NCT02233413|7554077|FG001|STARTED|Overall Study||33
6626449|NCT02233413|7554076|FG000|COMPLETED|Overall Study||24
6626450|NCT02233413|7554077|FG001|COMPLETED|Overall Study||19
6626451|NCT02233413|7554076|FG000|NOT COMPLETED|Overall Study||11
6626452|NCT02233413|7554077|FG001|NOT COMPLETED|Overall Study||14
6626453|NCT02233478|7554083|FG000|STARTED|First Intervention (1 Day)||3
6626454|NCT02233478|7554084|FG001|STARTED|First Intervention (1 Day)||3
6626455|NCT02233478|7554085|FG002|STARTED|First Intervention (1 Day)||3
6626456|NCT02233478|7554086|FG003|STARTED|First Intervention (1 Day)||3
6626457|NCT02233478|7554087|FG004|STARTED|First Intervention (1 Day)||3
6626458|NCT02233478|7554088|FG005|STARTED|First Intervention (1 Day)||3
6626459|NCT02233478|7554083|FG000|COMPLETED|First Intervention (1 Day)||3
6626460|NCT02233478|7554084|FG001|COMPLETED|First Intervention (1 Day)||3
6626461|NCT02233478|7554085|FG002|COMPLETED|First Intervention (1 Day)||3
6626462|NCT02233478|7554086|FG003|COMPLETED|First Intervention (1 Day)||3
6626463|NCT02233478|7554087|FG004|COMPLETED|First Intervention (1 Day)||3
6626464|NCT02233478|7554088|FG005|COMPLETED|First Intervention (1 Day)||3
6626465|NCT02233478|7554083|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6626466|NCT02233478|7554084|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6626467|NCT02233478|7554085|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6626468|NCT02233478|7554086|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6626469|NCT02233478|7554087|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6626470|NCT02233478|7554088|FG005|NOT COMPLETED|First Intervention (1 Day)||0
6626471|NCT02233478|7554083|FG000|STARTED|Washout (7 Days)||3
6626472|NCT02233478|7554084|FG001|STARTED|Washout (7 Days)||3
6626473|NCT02233478|7554085|FG002|STARTED|Washout (7 Days)||3
6626474|NCT02233478|7554086|FG003|STARTED|Washout (7 Days)||3
6626475|NCT02233478|7554087|FG004|STARTED|Washout (7 Days)||3
6626476|NCT02233478|7554088|FG005|STARTED|Washout (7 Days)||3
6626477|NCT02233478|7554083|FG000|COMPLETED|Washout (7 Days)||3
6626478|NCT02233478|7554084|FG001|COMPLETED|Washout (7 Days)||3
6626479|NCT02233478|7554085|FG002|COMPLETED|Washout (7 Days)||3
6626480|NCT02233478|7554086|FG003|COMPLETED|Washout (7 Days)||3
6626481|NCT02233478|7554087|FG004|COMPLETED|Washout (7 Days)||3
6626482|NCT02233478|7554088|FG005|COMPLETED|Washout (7 Days)||3
6626483|NCT02233478|7554083|FG000|NOT COMPLETED|Washout (7 Days)||0
6626484|NCT02233478|7554084|FG001|NOT COMPLETED|Washout (7 Days)||0
6626485|NCT02233478|7554085|FG002|NOT COMPLETED|Washout (7 Days)||0
6626486|NCT02233478|7554086|FG003|NOT COMPLETED|Washout (7 Days)||0
6626487|NCT02233478|7554087|FG004|NOT COMPLETED|Washout (7 Days)||0
6626488|NCT02233478|7554088|FG005|NOT COMPLETED|Washout (7 Days)||0
6740301|NCT03301779|7669120|FG001|STARTED|Overall Study||52
6282111|NCT00178685|7182316|FG002|NOT COMPLETED|Overall Study||196
6282112|NCT00178711|7182326|FG000|STARTED|Overall Study||52
6282113|NCT00178711|7182327|FG001|STARTED|Overall Study||45
6626489|NCT02233478|7554083|FG000|STARTED|Second Intervention (1 Day)||3
6626490|NCT02233478|7554084|FG001|STARTED|Second Intervention (1 Day)||3
6626491|NCT02233478|7554085|FG002|STARTED|Second Intervention (1 Day)||3
6626492|NCT02233478|7554086|FG003|STARTED|Second Intervention (1 Day)||3
6626493|NCT02233478|7554087|FG004|STARTED|Second Intervention (1 Day)||3
6626494|NCT02233478|7554088|FG005|STARTED|Second Intervention (1 Day)||3
6626495|NCT02233478|7554083|FG000|COMPLETED|Second Intervention (1 Day)||3
6626496|NCT02233478|7554084|FG001|COMPLETED|Second Intervention (1 Day)||3
6626497|NCT02233478|7554085|FG002|COMPLETED|Second Intervention (1 Day)||3
6626498|NCT02233478|7554086|FG003|COMPLETED|Second Intervention (1 Day)||3
6626499|NCT02233478|7554087|FG004|COMPLETED|Second Intervention (1 Day)||3
6626500|NCT02233478|7554088|FG005|COMPLETED|Second Intervention (1 Day)||3
6626501|NCT02233478|7554083|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6626502|NCT02233478|7554084|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6626503|NCT02233478|7554085|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6626504|NCT02233478|7554086|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6626505|NCT02233478|7554087|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6282114|NCT00178711|7182326|FG000|COMPLETED|Overall Study||52
6282115|NCT00178711|7182327|FG001|COMPLETED|Overall Study||45
6282116|NCT00178711|7182326|FG000|NOT COMPLETED|Overall Study||0
6282117|NCT00178711|7182327|FG001|NOT COMPLETED|Overall Study||0
6626506|NCT02233478|7554088|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
6626507|NCT02233478|7554083|FG000|STARTED|Washout (7 Days)||3
6626508|NCT02233478|7554084|FG001|STARTED|Washout (7 Days)||3
6626509|NCT02233478|7554085|FG002|STARTED|Washout (7 Days)||3
6626510|NCT02233478|7554086|FG003|STARTED|Washout (7 Days)||3
6626511|NCT02233478|7554087|FG004|STARTED|Washout (7 Days)||3
6626512|NCT02233478|7554088|FG005|STARTED|Washout (7 Days)||3
6626513|NCT02233478|7554083|FG000|COMPLETED|Washout (7 Days)||3
6626514|NCT02233478|7554084|FG001|COMPLETED|Washout (7 Days)||3
6626515|NCT02233478|7554085|FG002|COMPLETED|Washout (7 Days)||3
6626516|NCT02233478|7554086|FG003|COMPLETED|Washout (7 Days)||3
6626517|NCT02233478|7554087|FG004|COMPLETED|Washout (7 Days)||3
6626518|NCT02233478|7554088|FG005|COMPLETED|Washout (7 Days)||3
6626519|NCT02233478|7554083|FG000|NOT COMPLETED|Washout (7 Days)||0
6626520|NCT02233478|7554084|FG001|NOT COMPLETED|Washout (7 Days)||0
6396539|NCT00865046|7309162|FG001|STARTED|Overall Study||64
6396540|NCT00865046|7309163|FG002|STARTED|Overall Study||63
6396541|NCT00865046|7309161|FG000|COMPLETED|Overall Study||57
6396542|NCT00865046|7309162|FG001|COMPLETED|Overall Study||59
6396543|NCT00865046|7309163|FG002|COMPLETED|Overall Study||62
6396544|NCT00865046|7309161|FG000|NOT COMPLETED|Overall Study||6
6396545|NCT00865046|7309162|FG001|NOT COMPLETED|Overall Study||5
6396546|NCT00865046|7309163|FG002|NOT COMPLETED|Overall Study||1
6396547|NCT00865098|7309171|FG000|STARTED|Overall Study||22
6396548|NCT00865098|7309171|FG000|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
6396549|NCT00865098|7309171|FG000|NOT COMPLETED|Overall Study||1
6396550|NCT00865124|7309178|FG000|STARTED|Overall Study||27
6396551|NCT00865124|7309179|FG001|STARTED|Overall Study||25
6396552|NCT00865124|7309180|FG002|STARTED|Overall Study||17
6396553|NCT00865124|7309178|FG000|COMPLETED|Overall Study||23
6396554|NCT00865124|7309179|FG001|COMPLETED|Overall Study||24
6396555|NCT00865124|7309180|FG002|COMPLETED|Overall Study||17
6396556|NCT00865124|7309178|FG000|NOT COMPLETED|Overall Study||4
6396557|NCT00865124|7309179|FG001|NOT COMPLETED|Overall Study||1
6396558|NCT00865124|7309180|FG002|NOT COMPLETED|Overall Study||0
6396559|NCT00865189|7309190|FG000|STARTED|Overall Study||46
6396560|NCT00865189|7309191|FG001|STARTED|Overall Study||45
6396561|NCT00865189|7309190|FG000|COMPLETED|Overall Study||34
6396562|NCT00865189|7309191|FG001|COMPLETED|Overall Study||26
6396563|NCT00865189|7309190|FG000|NOT COMPLETED|Overall Study||12
6396564|NCT00865189|7309191|FG001|NOT COMPLETED|Overall Study||19
6396565|NCT00865202|7309199|FG000|STARTED|Overall Study||152
6396566|NCT00865202|7309200|FG001|STARTED|Overall Study||149
6396567|NCT00865202|7309199|FG000|COMPLETED|Overall Study||152
6396568|NCT00865202|7309200|FG001|COMPLETED|Overall Study||149
6396569|NCT00865202|7309199|FG000|NOT COMPLETED|Overall Study||0
6396570|NCT00865202|7309200|FG001|NOT COMPLETED|Overall Study||0
6396571|NCT00865280|7309209|FG000|STARTED|Overall Study||70
6396572|NCT00865280|7309210|FG001|STARTED|Overall Study||73
6396573|NCT00865280|7309209|FG000|COMPLETED|Overall Study||64
6396574|NCT00865280|7309210|FG001|COMPLETED|Overall Study||70
6396575|NCT00865280|7309209|FG000|NOT COMPLETED|Overall Study||6
6396576|NCT00865280|7309210|FG001|NOT COMPLETED|Overall Study||3
6396577|NCT00865306|7309218|FG000|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
6396578|NCT00865306|7309219|FG001|STARTED|Controlled Trial||30
6396579|NCT00865306|7309218|FG000|COMPLETED|Controlled Trial||29
6396580|NCT00865306|7309219|FG001|COMPLETED|Controlled Trial||28
6396581|NCT00865306|7309218|FG000|NOT COMPLETED|Controlled Trial||5
6396582|NCT00865306|7309219|FG001|NOT COMPLETED|Controlled Trial||2
6396583|NCT00865306|7309218|FG000|STARTED|One-Year Follow-Up||29
6396584|NCT00865306|7309219|FG001|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
6396585|NCT00865306|7309218|FG000|COMPLETED|One-Year Follow-Up||29
6396586|NCT00865306|7309219|FG001|COMPLETED|One-Year Follow-Up||15
6396587|NCT00865306|7309218|FG000|NOT COMPLETED|One-Year Follow-Up||0
6396588|NCT00865306|7309219|FG001|NOT COMPLETED|One-Year Follow-Up||0
6396589|NCT00865345|7309225|FG000|STARTED|Overall Study||63
6396590|NCT00865345|7309225|FG000|COMPLETED|Overall Study||61
6396591|NCT00865345|7309225|FG000|NOT COMPLETED|Overall Study||2
6396592|NCT00865566|7309231|FG000|STARTED|Overall Study||1253
6396593|NCT00865566|7309232|FG001|STARTED|Overall Study||1251
6396594|NCT00865566|7309231|FG000|Modified Intent-to-Treat Population|Overall Study||1251
6396595|NCT00865566|7309232|FG001|Modified Intent-to-Treat Population|Overall Study||1245
6561190|NCT01791517|7484052|FG011|NOT COMPLETED|Phase I: Period 3||1
6626521|NCT02233478|7554085|FG002|NOT COMPLETED|Washout (7 Days)||0
6626522|NCT02233478|7554086|FG003|NOT COMPLETED|Washout (7 Days)||0
6626523|NCT02233478|7554087|FG004|NOT COMPLETED|Washout (7 Days)||0
6626524|NCT02233478|7554088|FG005|NOT COMPLETED|Washout (7 Days)||0
6626525|NCT02233478|7554083|FG000|STARTED|Third Intervention (1 Day)||3
6626526|NCT02233478|7554084|FG001|STARTED|Third Intervention (1 Day)||3
6626527|NCT02233478|7554085|FG002|STARTED|Third Intervention (1 Day)||3
6626528|NCT02233478|7554086|FG003|STARTED|Third Intervention (1 Day)||3
6626529|NCT02233478|7554087|FG004|STARTED|Third Intervention (1 Day)||3
6396596|NCT00865566|7309231|FG000|COMPLETED|Overall Study||629
6396597|NCT00865566|7309232|FG001|COMPLETED|Overall Study||564
6396598|NCT00865566|7309231|FG000|NOT COMPLETED|Overall Study||624
6396599|NCT00865566|7309232|FG001|NOT COMPLETED|Overall Study||687
6396600|NCT00865709|7309240|FG000|STARTED|Treatment||97
6396601|NCT00865709|7309241|FG001|STARTED|Treatment||101
6626530|NCT02233478|7554088|FG005|STARTED|Third Intervention (1 Day)||3
6626531|NCT02233478|7554083|FG000|COMPLETED|Third Intervention (1 Day)||3
6626532|NCT02233478|7554084|FG001|COMPLETED|Third Intervention (1 Day)||3
6626533|NCT02233478|7554085|FG002|COMPLETED|Third Intervention (1 Day)||3
6626534|NCT02233478|7554086|FG003|COMPLETED|Third Intervention (1 Day)||3
6626535|NCT02233478|7554087|FG004|COMPLETED|Third Intervention (1 Day)||3
6626536|NCT02233478|7554088|FG005|COMPLETED|Third Intervention (1 Day)||3
6626537|NCT02233478|7554083|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6626538|NCT02233478|7554084|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6626539|NCT02233478|7554085|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6626540|NCT02233478|7554086|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6626541|NCT02233478|7554087|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
6626542|NCT02233478|7554088|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
6626543|NCT02233517|7554098|FG000|STARTED|Overall Study||19
6626544|NCT02233517|7554099|FG001|STARTED|Overall Study||17
6626545|NCT02233517|7554098|FG000|COMPLETED|Overall Study||12
6626546|NCT02233517|7554099|FG001|COMPLETED|Overall Study||13
6626547|NCT02233517|7554098|FG000|NOT COMPLETED|Overall Study||7
6626548|NCT02233517|7554099|FG001|NOT COMPLETED|Overall Study||4
6626549|NCT02233530|7554105|FG000|STARTED|Overall Study||8
6626550|NCT02233530|7554105|FG000|COMPLETED|Overall Study||8
6626551|NCT02233530|7554105|FG000|NOT COMPLETED|Overall Study||0
6626552|NCT02233543|7554109|FG000|STARTED|Period 1||22
6626553|NCT02233543|7554110|FG001|STARTED|Period 1||16
6626554|NCT02233543|7554109|FG000|COMPLETED|Period 1||19
6626555|NCT02233543|7554110|FG001|COMPLETED|Period 1||13
6626556|NCT02233543|7554109|FG000|NOT COMPLETED|Period 1||3
6626557|NCT02233543|7554110|FG001|NOT COMPLETED|Period 1||3
6626558|NCT02233543|7554109|FG000|STARTED|Period 2||19
6626559|NCT02233543|7554110|FG001|STARTED|Period 2||13
6626560|NCT02233543|7554109|FG000|COMPLETED|Period 2|1 participant erroneously received QVA149 during both periods.|17
6626561|NCT02233543|7554110|FG001|COMPLETED|Period 2||12
6626562|NCT02233543|7554109|FG000|NOT COMPLETED|Period 2||2
6626563|NCT02233543|7554110|FG001|NOT COMPLETED|Period 2||1
6626564|NCT02233647|7554116|FG000|STARTED|Overall Study||11
6626565|NCT02233647|7554116|FG000|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
6626566|NCT02233647|7554116|FG000|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
6626567|NCT02233647|7554116|FG000|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
6626568|NCT02233647|7554116|FG000|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
6626569|NCT02233647|7554116|FG000|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
6626570|NCT02233647|7554116|FG000|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6626571|NCT02233647|7554116|FG000|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6626572|NCT02233647|7554116|FG000|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6626573|NCT02233647|7554116|FG000|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6626574|NCT02233647|7554116|FG000|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
6626575|NCT02233647|7554116|FG000|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
6626576|NCT02233647|7554116|FG000|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
6626577|NCT02233647|7554116|FG000|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
6626578|NCT02233647|7554116|FG000|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
6626579|NCT02233647|7554116|FG000|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
6626580|NCT02233647|7554116|FG000|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
6626581|NCT02233647|7554116|FG000|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
6626582|NCT02233647|7554116|FG000|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
6626583|NCT02233647|7554116|FG000|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
6626584|NCT02233647|7554116|FG000|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
6626585|NCT02233647|7554116|FG000|COMPLETED|Overall Study||10
6626586|NCT02233647|7554116|FG000|NOT COMPLETED|Overall Study||1
6626587|NCT02233738|7554122|FG000|STARTED|Overall Study||93
6626588|NCT02233738|7554123|FG001|STARTED|Overall Study||91
6626589|NCT02233738|7554122|FG000|1 Month Follow-Up|Overall Study||89
6626590|NCT02233738|7554123|FG001|1 Month Follow-Up|Overall Study||82
6626591|NCT02233738|7554122|FG000|3 Month Follow-Up|Overall Study||87
6626592|NCT02233738|7554123|FG001|3 Month Follow-Up|Overall Study||77
6626593|NCT02233738|7554122|FG000|6 Month Follow-Up|Overall Study||85
6626594|NCT02233738|7554123|FG001|6 Month Follow-Up|Overall Study||75
6626595|NCT02233738|7554122|FG000|COMPLETED|Overall Study||85
6626596|NCT02233738|7554123|FG001|COMPLETED|Overall Study||75
6626597|NCT02233738|7554122|FG000|NOT COMPLETED|Overall Study||8
6626598|NCT02233738|7554123|FG001|NOT COMPLETED|Overall Study||16
6626599|NCT02233751|7554293|FG000|STARTED|Overall Study||6
6626600|NCT02233751|7554294|FG001|STARTED|Overall Study||6
6626601|NCT02233751|7554293|FG000|COMPLETED|Overall Study||6
6626602|NCT02233751|7554294|FG001|COMPLETED|Overall Study||6
6626603|NCT02233751|7554293|FG000|NOT COMPLETED|Overall Study||0
6626604|NCT02233751|7554294|FG001|NOT COMPLETED|Overall Study||0
6626605|NCT02233803|7554300|FG000|STARTED|Treatment Period 1 (4-Wks)||100
6626606|NCT02233803|7554301|FG001|STARTED|Treatment Period 1 (4-Wks)||99
6626607|NCT02233803|7554300|FG000|COMPLETED|Treatment Period 1 (4-Wks)||97
6626608|NCT02233803|7554301|FG001|COMPLETED|Treatment Period 1 (4-Wks)||95
6626609|NCT02233803|7554300|FG000|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
6626610|NCT02233803|7554301|FG001|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
6626611|NCT02233803|7554300|FG000|STARTED|Washout Period (4-Wks)||97
6626612|NCT02233803|7554301|FG001|STARTED|Washout Period (4-Wks)||95
6626613|NCT02233803|7554300|FG000|COMPLETED|Washout Period (4-Wks)||95
6626614|NCT02233803|7554301|FG001|COMPLETED|Washout Period (4-Wks)||93
6626615|NCT02233803|7554300|FG000|NOT COMPLETED|Washout Period (4-Wks)||2
6626616|NCT02233803|7554301|FG001|NOT COMPLETED|Washout Period (4-Wks)||2
6626617|NCT02233803|7554300|FG000|STARTED|Treatment Period 2 (4-Wks)||95
6626618|NCT02233803|7554301|FG001|STARTED|Treatment Period 2 (4-Wks)||93
6626619|NCT02233803|7554300|FG000|COMPLETED|Treatment Period 2 (4-Wks)||93
6626620|NCT02233803|7554301|FG001|COMPLETED|Treatment Period 2 (4-Wks)||91
6626621|NCT02233803|7554300|FG000|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
6626622|NCT02233803|7554301|FG001|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
6626623|NCT02233842|7554309|FG000|STARTED|Questionnaire 1 Version 1||5
6626624|NCT02233842|7554309|FG000|COMPLETED|Questionnaire 1 Version 1||5
6626625|NCT02233842|7554309|FG000|NOT COMPLETED|Questionnaire 1 Version 1||0
6626626|NCT02233842|7554309|FG000|STARTED|Questionnaire 1 Version 2||5
6626627|NCT02233842|7554309|FG000|COMPLETED|Questionnaire 1 Version 2||5
6626628|NCT02233842|7554309|FG000|NOT COMPLETED|Questionnaire 1 Version 2||0
6626629|NCT02233842|7554309|FG000|STARTED|Questionnaire 2 Version 1||5
6626630|NCT02233842|7554309|FG000|COMPLETED|Questionnaire 2 Version 1||5
6626631|NCT02233842|7554309|FG000|NOT COMPLETED|Questionnaire 2 Version 1||0
6626632|NCT02233842|7554309|FG000|STARTED|Questionnaire 2 Version 2||5
6626633|NCT02233842|7554309|FG000|COMPLETED|Questionnaire 2 Version 2||5
6626634|NCT02233842|7554309|FG000|NOT COMPLETED|Questionnaire 2 Version 2||0
6626635|NCT02233842|7554309|FG000|STARTED|Questionnaire 3 Version 1||5
6626636|NCT02233842|7554309|FG000|COMPLETED|Questionnaire 3 Version 1||5
6740302|NCT03301779|7669119|FG000|COMPLETED|Overall Study||40
6740303|NCT03301779|7669120|FG001|COMPLETED|Overall Study||45
6740304|NCT03301779|7669119|FG000|NOT COMPLETED|Overall Study||8
6740305|NCT03301779|7669120|FG001|NOT COMPLETED|Overall Study||7
6740306|NCT03301831|7669128|FG000|STARTED|Overall Study||46
6740307|NCT03301831|7669129|FG001|STARTED|Overall Study||47
6740308|NCT03301831|7669128|FG000|COMPLETED|Overall Study||26
6740309|NCT03301831|7669129|FG001|COMPLETED|Overall Study||44
6740310|NCT03301831|7669128|FG000|NOT COMPLETED|Overall Study||20
6740311|NCT03301831|7669129|FG001|NOT COMPLETED|Overall Study||3
6740312|NCT03301844|7669137|FG000|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
6396602|NCT00865709|7309240|FG000|Received Treatment|Treatment|Safety population|97
6396603|NCT00865709|7309241|FG001|Received Treatment|Treatment|Safety population|101
6396604|NCT00865709|7309240|FG000|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
6396605|NCT00865709|7309241|FG001|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
6396606|NCT00865709|7309240|FG000|NOT COMPLETED|Treatment||30
6396607|NCT00865709|7309241|FG001|NOT COMPLETED|Treatment||18
6396608|NCT00865709|7309240|FG000|STARTED|Active Follow-up||25
6396609|NCT00865709|7309241|FG001|STARTED|Active Follow-up||16
6396610|NCT00865709|7309240|FG000|COMPLETED|Active Follow-up||17
6396611|NCT00865709|7309241|FG001|COMPLETED|Active Follow-up||15
6396612|NCT00865709|7309240|FG000|NOT COMPLETED|Active Follow-up||8
6396613|NCT00865709|7309241|FG001|NOT COMPLETED|Active Follow-up||1
6396614|NCT00865709|7309240|FG000|STARTED|Long Term Follow-up||70
6396615|NCT00865709|7309241|FG001|STARTED|Long Term Follow-up||82
6396616|NCT00865709|7309240|FG000|COMPLETED|Long Term Follow-up||24
6396617|NCT00865709|7309241|FG001|COMPLETED|Long Term Follow-up||33
6396618|NCT00865709|7309240|FG000|NOT COMPLETED|Long Term Follow-up||46
6396619|NCT00865709|7309241|FG001|NOT COMPLETED|Long Term Follow-up||49
6396620|NCT00865904|7309254|FG000|STARTED|Overall Study|Randomized.|19
6396621|NCT00865904|7309255|FG001|STARTED|Overall Study|Randomized.|18
6396622|NCT00865904|7309256|FG002|STARTED|Overall Study|Randomized.|18
6396623|NCT00865904|7309257|FG003|STARTED|Overall Study|Randomized.|18
6396624|NCT00865904|7309258|FG004|STARTED|Overall Study|Randomized.|20
6396625|NCT00865904|7309254|FG000|COMPLETED|Overall Study|Completed 14-day follow-up.|17
6396626|NCT00865904|7309255|FG001|COMPLETED|Overall Study|Completed 14-day follow-up.|18
6396627|NCT00865904|7309256|FG002|COMPLETED|Overall Study|Completed 14-day follow-up.|18
6396628|NCT00865904|7309257|FG003|COMPLETED|Overall Study|Completed 14-day follow-up.|17
6396629|NCT00865904|7309258|FG004|COMPLETED|Overall Study|Completed 14-day follow-up.|19
6396630|NCT00865904|7309254|FG000|NOT COMPLETED|Overall Study||2
6396631|NCT00865904|7309255|FG001|NOT COMPLETED|Overall Study||0
6396632|NCT00865904|7309256|FG002|NOT COMPLETED|Overall Study||0
6396633|NCT00865904|7309257|FG003|NOT COMPLETED|Overall Study||1
6396634|NCT00865904|7309258|FG004|NOT COMPLETED|Overall Study||1
6740313|NCT03301844|7669138|FG001|STARTED|Overall Study|Each patient apply the Blephapad Combo wipes to one eye and standard treatment to the other eye.|19
6740314|NCT03301844|7669137|FG000|COMPLETED|Overall Study||18
6740315|NCT03301844|7669138|FG001|COMPLETED|Overall Study||18
6740316|NCT03301844|7669137|FG000|NOT COMPLETED|Overall Study||1
6740317|NCT03301844|7669138|FG001|NOT COMPLETED|Overall Study||1
6740318|NCT03302091|7669146|FG000|STARTED|Overall Study||10
6740319|NCT03302091|7669147|FG001|STARTED|Overall Study||10
6740320|NCT03302091|7669146|FG000|COMPLETED|Overall Study||10
6740321|NCT03302091|7669147|FG001|COMPLETED|Overall Study||10
6740322|NCT03302091|7669146|FG000|NOT COMPLETED|Overall Study||0
6396635|NCT00865969|7309274|FG000|STARTED|Overall Study||129
6396636|NCT00865969|7309274|FG000|COMPLETED|Overall Study||129
6396637|NCT00865969|7309274|FG000|NOT COMPLETED|Overall Study||0
6396638|NCT00866034|7309280|FG000|STARTED|Overall Study||308
6740323|NCT03302091|7669147|FG001|NOT COMPLETED|Overall Study||0
6626637|NCT02233842|7554309|FG000|NOT COMPLETED|Questionnaire 3 Version 1||0
6626638|NCT02233842|7554309|FG000|STARTED|Questionnaire 3 Version 2||5
6626639|NCT02233842|7554309|FG000|COMPLETED|Questionnaire 3 Version 2||5
6626640|NCT02233842|7554309|FG000|NOT COMPLETED|Questionnaire 3 Version 2||0
6626641|NCT02233946|7554316|FG000|STARTED|Baseline|Allocated to and received the intervention|628
6626642|NCT02233946|7554317|FG001|STARTED|Baseline|Allocated to and received usual care|243
6626643|NCT02233946|7554316|FG000|COMPLETED|Baseline|Completed baseline assessment|626
6626644|NCT02233946|7554317|FG001|COMPLETED|Baseline|Completed baseline assessment|243
6626645|NCT02233946|7554316|FG000|NOT COMPLETED|Baseline||2
6626646|NCT02233946|7554317|FG001|NOT COMPLETED|Baseline||0
6626647|NCT02233946|7554316|FG000|STARTED|Immediate Post-visit Questionnaire||626
6626648|NCT02233946|7554317|FG001|STARTED|Immediate Post-visit Questionnaire||243
6626649|NCT02233946|7554316|FG000|COMPLETED|Immediate Post-visit Questionnaire||624
6626650|NCT02233946|7554317|FG001|COMPLETED|Immediate Post-visit Questionnaire||243
6626651|NCT02233946|7554316|FG000|NOT COMPLETED|Immediate Post-visit Questionnaire||2
6626652|NCT02233946|7554317|FG001|NOT COMPLETED|Immediate Post-visit Questionnaire||0
6626653|NCT02233946|7554316|FG000|STARTED|3-months Follow-up||624
6626654|NCT02233946|7554317|FG001|STARTED|3-months Follow-up||243
6626655|NCT02233946|7554316|FG000|COMPLETED|3-months Follow-up||571
6626656|NCT02233946|7554317|FG001|COMPLETED|3-months Follow-up||214
6626657|NCT02233946|7554316|FG000|NOT COMPLETED|3-months Follow-up||53
6626658|NCT02233946|7554317|FG001|NOT COMPLETED|3-months Follow-up||29
6626659|NCT02233946|7554316|FG000|STARTED|6-months Follow-up||571
6626660|NCT02233946|7554317|FG001|STARTED|6-months Follow-up||214
6626661|NCT02233946|7554316|FG000|COMPLETED|6-months Follow-up||550
6626662|NCT02233946|7554317|FG001|COMPLETED|6-months Follow-up||212
6626663|NCT02233946|7554316|FG000|NOT COMPLETED|6-months Follow-up||21
6626664|NCT02233946|7554317|FG001|NOT COMPLETED|6-months Follow-up||2
6626665|NCT02233946|7554316|FG000|STARTED|9-month Follow-up||550
6626666|NCT02233946|7554317|FG001|STARTED|9-month Follow-up||212
6626667|NCT02233946|7554316|FG000|COMPLETED|9-month Follow-up||530
6626668|NCT02233946|7554317|FG001|COMPLETED|9-month Follow-up||201
6626669|NCT02233946|7554316|FG000|NOT COMPLETED|9-month Follow-up||20
6626670|NCT02233946|7554317|FG001|NOT COMPLETED|9-month Follow-up||11
6626671|NCT02233946|7554316|FG000|STARTED|12-month Follow-up||530
6626672|NCT02233946|7554317|FG001|STARTED|12-month Follow-up||201
6626673|NCT02233946|7554316|FG000|COMPLETED|12-month Follow-up||502
6626674|NCT02233946|7554317|FG001|COMPLETED|12-month Follow-up||190
6626675|NCT02233946|7554316|FG000|NOT COMPLETED|12-month Follow-up||28
6626676|NCT02233946|7554317|FG001|NOT COMPLETED|12-month Follow-up||11
6626677|NCT02233985|7554325|FG000|STARTED|Overall Study||33
6626678|NCT02233985|7554326|FG001|STARTED|Overall Study||31
6626679|NCT02233985|7554325|FG000|COMPLETED|Overall Study||33
6626680|NCT02233985|7554326|FG001|COMPLETED|Overall Study||31
6626681|NCT02233985|7554325|FG000|NOT COMPLETED|Overall Study||0
6626682|NCT02233985|7554326|FG001|NOT COMPLETED|Overall Study||0
6626683|NCT02233998|7554337|FG000|STARTED|Overall Study||53
6626684|NCT02233998|7554338|FG001|STARTED|Overall Study||52
6626685|NCT02233998|7554339|FG002|STARTED|Overall Study||53
6626686|NCT02233998|7554337|FG000|COMPLETED|Overall Study||53
6626687|NCT02233998|7554338|FG001|COMPLETED|Overall Study||52
6626688|NCT02233998|7554339|FG002|COMPLETED|Overall Study||53
6626689|NCT02233998|7554337|FG000|NOT COMPLETED|Overall Study||0
6626690|NCT02233998|7554338|FG001|NOT COMPLETED|Overall Study||0
6626691|NCT02233998|7554339|FG002|NOT COMPLETED|Overall Study||0
6626692|NCT02234063|7554349|FG000|STARTED|Overall Study||1795
6626693|NCT02234063|7554350|FG001|STARTED|Overall Study||255
6626694|NCT02234063|7554349|FG000|COMPLETED|Overall Study||1540
6626695|NCT02234063|7554350|FG001|COMPLETED|Overall Study||212
6626696|NCT02234063|7554349|FG000|NOT COMPLETED|Overall Study||255
6626697|NCT02234063|7554350|FG001|NOT COMPLETED|Overall Study||43
6626698|NCT02234115|7554361|FG000|STARTED|Overall Study||137
6626699|NCT02234115|7554361|FG000|ITT|Overall Study||137
6626700|NCT02234115|7554361|FG000|PP|Overall Study||124
6396639|NCT00866034|7309281|FG001|STARTED|Overall Study||309
6396640|NCT00866034|7309280|FG000|COMPLETED|Overall Study||292
6396641|NCT00866034|7309281|FG001|COMPLETED|Overall Study||301
6396642|NCT00866034|7309280|FG000|NOT COMPLETED|Overall Study||16
6396643|NCT00866034|7309281|FG001|NOT COMPLETED|Overall Study||8
6626701|NCT02234115|7554361|FG000|PK Subgroup|Overall Study||31
6626702|NCT02234115|7554361|FG000|COMPLETED|Overall Study||122
6626703|NCT02234115|7554361|FG000|NOT COMPLETED|Overall Study||15
6626704|NCT02234128|7554368|FG000|STARTED|Overall Study||35
6626705|NCT02234128|7554369|FG001|STARTED|Overall Study||31
6626706|NCT02234128|7554370|FG002|STARTED|Overall Study||52
6626707|NCT02234128|7554368|FG000|COMPLETED|Overall Study||30
6626708|NCT02234128|7554369|FG001|COMPLETED|Overall Study||29
6626709|NCT02234128|7554370|FG002|COMPLETED|Overall Study||48
6626710|NCT02234128|7554368|FG000|NOT COMPLETED|Overall Study||5
6626711|NCT02234128|7554369|FG001|NOT COMPLETED|Overall Study||2
6626712|NCT02234128|7554370|FG002|NOT COMPLETED|Overall Study||4
6626713|NCT02234141|7554382|FG000|STARTED|Treatment Period (24 Weeks)||39
6626714|NCT02234141|7554383|FG001|STARTED|Treatment Period (24 Weeks)||38
6626715|NCT02234141|7554384|FG002|STARTED|Treatment Period (24 Weeks)||37
6626716|NCT02234141|7554385|FG003|STARTED|Treatment Period (24 Weeks)||37
6396644|NCT00866047|7309287|FG000|STARTED|Treatment Period||58
6498581|NCT01410773|7417187|FG000|STARTED|Overall Study||110
6626717|NCT02234141|7554386|FG004|STARTED|Treatment Period (24 Weeks)||0
6626718|NCT02234141|7554387|FG005|STARTED|Treatment Period (24 Weeks)||0
6626719|NCT02234141|7554388|FG006|STARTED|Treatment Period (24 Weeks)||0
6626720|NCT02234141|7554382|FG000|COMPLETED|Treatment Period (24 Weeks)||35
6626721|NCT02234141|7554383|FG001|COMPLETED|Treatment Period (24 Weeks)||32
6626722|NCT02234141|7554384|FG002|COMPLETED|Treatment Period (24 Weeks)||35
6626723|NCT02234141|7554385|FG003|COMPLETED|Treatment Period (24 Weeks)||32
6626724|NCT02234141|7554386|FG004|COMPLETED|Treatment Period (24 Weeks)||0
6626725|NCT02234141|7554387|FG005|COMPLETED|Treatment Period (24 Weeks)||0
6626726|NCT02234141|7554388|FG006|COMPLETED|Treatment Period (24 Weeks)||0
6626727|NCT02234141|7554382|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||4
6626728|NCT02234141|7554383|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||6
6626729|NCT02234141|7554384|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||2
6396645|NCT00866047|7309287|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
6396646|NCT00866047|7309287|FG000|NOT COMPLETED|Treatment Period||48
6396647|NCT00866047|7309287|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|58
6396648|NCT00866047|7309287|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
6396649|NCT00866047|7309287|FG000|NOT COMPLETED|Follow-up Period||5
6396650|NCT00866177|7309291|FG000|STARTED|Overall Study||167
6396651|NCT00866177|7309291|FG000|COMPLETED|Overall Study||15
6396652|NCT00866177|7309291|FG000|NOT COMPLETED|Overall Study||152
6396653|NCT00866281|7309297|FG000|STARTED|Overall Study||7
6396654|NCT00866281|7309298|FG001|STARTED|Overall Study||15
6396655|NCT00866281|7309297|FG000|COMPLETED|Overall Study||0
6396656|NCT00866281|7309298|FG001|COMPLETED|Overall Study||0
6396657|NCT00866281|7309297|FG000|NOT COMPLETED|Overall Study||7
6396658|NCT00866281|7309298|FG001|NOT COMPLETED|Overall Study||15
6396659|NCT00866294|7309310|FG000|STARTED|Overall Study||172
6396660|NCT00866294|7309311|FG001|STARTED|Overall Study||161
6396661|NCT00866294|7309312|FG002|STARTED|Overall Study||83
6396662|NCT00866294|7309310|FG000|COMPLETED|Overall Study||139
6396663|NCT00866294|7309311|FG001|COMPLETED|Overall Study||141
6396664|NCT00866294|7309312|FG002|COMPLETED|Overall Study||72
6396665|NCT00866294|7309310|FG000|NOT COMPLETED|Overall Study||33
6396666|NCT00866294|7309311|FG001|NOT COMPLETED|Overall Study||20
6396667|NCT00866294|7309312|FG002|NOT COMPLETED|Overall Study||11
6396668|NCT00866307|7309328|FG000|STARTED|Induction||104
6396669|NCT00866307|7309329|FG001|STARTED|Induction||0
6396670|NCT00866307|7309330|FG002|STARTED|Induction||0
6396671|NCT00866307|7309328|FG000|COMPLETED|Induction||84
6396672|NCT00866307|7309329|FG001|COMPLETED|Induction||0
6396673|NCT00866307|7309330|FG002|COMPLETED|Induction||0
6396674|NCT00866307|7309328|FG000|NOT COMPLETED|Induction||20
6396675|NCT00866307|7309329|FG001|NOT COMPLETED|Induction||0
6396676|NCT00866307|7309330|FG002|NOT COMPLETED|Induction||0
6396677|NCT00866307|7309328|FG000|STARTED|Consolidation/Maintenance||0
6396678|NCT00866307|7309329|FG001|STARTED|Consolidation/Maintenance||54
6396679|NCT00866307|7309330|FG002|STARTED|Consolidation/Maintenance||30
6396680|NCT00866307|7309328|FG000|COMPLETED|Consolidation/Maintenance||0
6396681|NCT00866307|7309329|FG001|COMPLETED|Consolidation/Maintenance||45
6396682|NCT00866307|7309330|FG002|COMPLETED|Consolidation/Maintenance||14
6396683|NCT00866307|7309328|FG000|NOT COMPLETED|Consolidation/Maintenance||0
6396684|NCT00866307|7309329|FG001|NOT COMPLETED|Consolidation/Maintenance||9
6396685|NCT00866307|7309330|FG002|NOT COMPLETED|Consolidation/Maintenance||16
6396686|NCT00866320|7309336|FG000|STARTED|Overall Study||49
6396687|NCT00866320|7309336|FG000|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
6396688|NCT00866320|7309336|FG000|NOT COMPLETED|Overall Study||6
6396689|NCT00866333|7309345|FG000|STARTED|Overall Study||16
6396690|NCT00866333|7309346|FG001|STARTED|Overall Study||17
6396691|NCT00866333|7309347|FG002|STARTED|Overall Study||16
6396692|NCT00866333|7309345|FG000|COMPLETED|Overall Study||11
6396693|NCT00866333|7309346|FG001|COMPLETED|Overall Study||10
6396694|NCT00866333|7309347|FG002|COMPLETED|Overall Study||4
6396695|NCT00866333|7309345|FG000|NOT COMPLETED|Overall Study||5
6396696|NCT00866333|7309346|FG001|NOT COMPLETED|Overall Study||7
6396697|NCT00866333|7309347|FG002|NOT COMPLETED|Overall Study||12
6396698|NCT00866359|7309357|FG000|STARTED|Treatment Phase (Days 1 to 85)||56
6396699|NCT00866359|7309358|FG001|STARTED|Treatment Phase (Days 1 to 85)||55
6396700|NCT00866359|7309359|FG002|STARTED|Treatment Phase (Days 1 to 85)||0
6396701|NCT00866359|7309360|FG003|STARTED|Treatment Phase (Days 1 to 85)||0
6396702|NCT00866359|7309357|FG000|COMPLETED|Treatment Phase (Days 1 to 85)||45
6626730|NCT02234141|7554385|FG003|NOT COMPLETED|Treatment Period (24 Weeks)||5
6626731|NCT02234141|7554386|FG004|NOT COMPLETED|Treatment Period (24 Weeks)||0
6396703|NCT00866359|7309358|FG001|COMPLETED|Treatment Phase (Days 1 to 85)||50
6396704|NCT00866359|7309359|FG002|COMPLETED|Treatment Phase (Days 1 to 85)||0
6396705|NCT00866359|7309360|FG003|COMPLETED|Treatment Phase (Days 1 to 85)||0
6396706|NCT00866359|7309357|FG000|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
6396707|NCT00866359|7309358|FG001|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
6396708|NCT00866359|7309359|FG002|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
6396709|NCT00866359|7309360|FG003|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
6396710|NCT00866359|7309357|FG000|STARTED|Extension Phase (Day 86 to 169)||0
6396711|NCT00866359|7309358|FG001|STARTED|Extension Phase (Day 86 to 169)||0
6396712|NCT00866359|7309359|FG002|STARTED|Extension Phase (Day 86 to 169)||45
6396713|NCT00866359|7309360|FG003|STARTED|Extension Phase (Day 86 to 169)||50
6396714|NCT00866359|7309357|FG000|COMPLETED|Extension Phase (Day 86 to 169)||0
6396715|NCT00866359|7309358|FG001|COMPLETED|Extension Phase (Day 86 to 169)||0
6626732|NCT02234141|7554387|FG005|NOT COMPLETED|Treatment Period (24 Weeks)||0
6626733|NCT02234141|7554388|FG006|NOT COMPLETED|Treatment Period (24 Weeks)||0
6626734|NCT02234141|7554382|FG000|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
6626735|NCT02234141|7554383|FG001|STARTED|Long-Term Treatment Period|1 participant who completed the Period 1 did not continue into the Long-Term Treatment Phase.|31
6626736|NCT02234141|7554384|FG002|STARTED|Long-Term Treatment Period|2 participants who completed Period 1 did not continue into the Long-Term Treatment Phase.|33
6626737|NCT02234141|7554385|FG003|STARTED|Long-Term Treatment Period|Participants were rerandomized to receive selonsertib during the Long-Term Treatment Phase.|0
6626738|NCT02234141|7554386|FG004|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
6626739|NCT02234141|7554387|FG005|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|12
6655342|NCT02452476|7585462|FG000|COMPLETED|Overall Study||53
6655343|NCT02452476|7585463|FG001|COMPLETED|Overall Study||49
6396716|NCT00866359|7309359|FG002|COMPLETED|Extension Phase (Day 86 to 169)||44
6396717|NCT00866359|7309360|FG003|COMPLETED|Extension Phase (Day 86 to 169)||47
6396718|NCT00866359|7309357|FG000|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
6396719|NCT00866359|7309358|FG001|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
6396720|NCT00866359|7309359|FG002|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
6396721|NCT00866359|7309360|FG003|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
6396722|NCT00866359|7309357|FG000|STARTED|Observational Follow-Up Phase||0
6396723|NCT00866359|7309358|FG001|STARTED|Observational Follow-Up Phase||0
6396724|NCT00866359|7309359|FG002|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
6396725|NCT00866359|7309360|FG003|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
6396726|NCT00866359|7309357|FG000|COMPLETED|Observational Follow-Up Phase||0
6396727|NCT00866359|7309358|FG001|COMPLETED|Observational Follow-Up Phase||0
6396728|NCT00866359|7309359|FG002|COMPLETED|Observational Follow-Up Phase||54
6396729|NCT00866359|7309360|FG003|COMPLETED|Observational Follow-Up Phase||54
6396730|NCT00866359|7309357|FG000|NOT COMPLETED|Observational Follow-Up Phase||0
6396731|NCT00866359|7309358|FG001|NOT COMPLETED|Observational Follow-Up Phase||0
6396732|NCT00866359|7309359|FG002|NOT COMPLETED|Observational Follow-Up Phase||0
6396733|NCT00866359|7309360|FG003|NOT COMPLETED|Observational Follow-Up Phase||0
6396734|NCT00866606|7309387|FG000|STARTED|Overall Study||35
6396735|NCT00866606|7309387|FG000|COMPLETED|Overall Study||31
6396736|NCT00866606|7309387|FG000|NOT COMPLETED|Overall Study||4
6396737|NCT00866619|7309395|FG000|STARTED|Overall Study||5948
6396738|NCT00866619|7309396|FG001|STARTED|Overall Study||4358
6396739|NCT00866619|7309397|FG002|STARTED|Overall Study||2974
6396740|NCT00866619|7309398|FG003|STARTED|Overall Study||2179
6396741|NCT00866619|7309395|FG000|COMPLETED|Overall Study||4102
6396742|NCT00866619|7309396|FG001|COMPLETED|Overall Study||3088
6396743|NCT00866619|7309397|FG002|COMPLETED|Overall Study||2085
6396744|NCT00866619|7309398|FG003|COMPLETED|Overall Study||1549
6396745|NCT00866619|7309395|FG000|NOT COMPLETED|Overall Study||1846
6396746|NCT00866619|7309396|FG001|NOT COMPLETED|Overall Study||1270
6396747|NCT00866619|7309397|FG002|NOT COMPLETED|Overall Study||889
6396748|NCT00866619|7309398|FG003|NOT COMPLETED|Overall Study||630
6396749|NCT00866658|7309435|FG000|STARTED|Overall Study|Randomized.|157
6396750|NCT00866658|7309436|FG001|STARTED|Overall Study||154
6396751|NCT00866658|7309435|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
6396752|NCT00866658|7309436|FG001|Safety Population|Overall Study||154
6396753|NCT00866658|7309435|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
6396754|NCT00866658|7309436|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||154
6396755|NCT00866658|7309435|FG000|COMPLETED|Overall Study||144
6396756|NCT00866658|7309436|FG001|COMPLETED|Overall Study||133
6396757|NCT00866658|7309435|FG000|NOT COMPLETED|Overall Study||13
6396758|NCT00866658|7309436|FG001|NOT COMPLETED|Overall Study||21
6396759|NCT00866697|7309444|FG000|STARTED|Overall Study||468
6396760|NCT00866697|7309445|FG001|STARTED|Overall Study||472
6396761|NCT00866697|7309444|FG000|COMPLETED|Overall Study||254
6396762|NCT00866697|7309445|FG001|COMPLETED|Overall Study||244
6396763|NCT00866697|7309444|FG000|NOT COMPLETED|Overall Study||214
6396764|NCT00866697|7309445|FG001|NOT COMPLETED|Overall Study||228
6396765|NCT00866723|7309451|FG000|STARTED|Overall Study||5
6396766|NCT00866723|7309451|FG000|COMPLETED|Overall Study||0
6396767|NCT00866723|7309451|FG000|NOT COMPLETED|Overall Study||5
6396768|NCT00866749|7309455|FG000|STARTED|Overall Study||120
6396769|NCT00866749|7309455|FG000|COMPLETED|Overall Study||120
6396770|NCT00866749|7309455|FG000|NOT COMPLETED|Overall Study||0
6396771|NCT00866775|7309461|FG000|STARTED|Overall Study||65
6396772|NCT00866775|7309462|FG001|STARTED|Overall Study||128
6396773|NCT00866775|7309461|FG000|COMPLETED|Overall Study||29
6396774|NCT00866775|7309462|FG001|COMPLETED|Overall Study||76
6396775|NCT00866775|7309461|FG000|NOT COMPLETED|Overall Study||36
6396776|NCT00866775|7309462|FG001|NOT COMPLETED|Overall Study||52
6396777|NCT00866788|7309474|FG000|STARTED|Overall Study||21
6396778|NCT00866788|7309475|FG001|STARTED|Overall Study||23
6396779|NCT00866788|7309476|FG002|STARTED|Overall Study||25
6396780|NCT00866788|7309477|FG003|STARTED|Overall Study||21
6396781|NCT00866788|7309474|FG000|COMPLETED|Overall Study||15
6396782|NCT00866788|7309475|FG001|COMPLETED|Overall Study||17
6626740|NCT02234141|7554388|FG006|STARTED|Long-Term Treatment Period|The Placebo group was rerandomized to receive selonsertib during the Long-Term Treatment Phase.|10
6626741|NCT02234141|7554382|FG000|COMPLETED|Long-Term Treatment Period||0
6626742|NCT02234141|7554383|FG001|COMPLETED|Long-Term Treatment Period||0
6626743|NCT02234141|7554384|FG002|COMPLETED|Long-Term Treatment Period||0
6626744|NCT02234141|7554385|FG003|COMPLETED|Long-Term Treatment Period||0
6626745|NCT02234141|7554386|FG004|COMPLETED|Long-Term Treatment Period||0
6626746|NCT02234141|7554387|FG005|COMPLETED|Long-Term Treatment Period||0
6626747|NCT02234141|7554388|FG006|COMPLETED|Long-Term Treatment Period||0
6396783|NCT00866788|7309476|FG002|COMPLETED|Overall Study||23
6396784|NCT00866788|7309477|FG003|COMPLETED|Overall Study||16
6396785|NCT00866788|7309474|FG000|NOT COMPLETED|Overall Study||6
6396786|NCT00866788|7309475|FG001|NOT COMPLETED|Overall Study||6
6396787|NCT00866788|7309476|FG002|NOT COMPLETED|Overall Study||2
6396788|NCT00866788|7309477|FG003|NOT COMPLETED|Overall Study||5
6396789|NCT00866814|7309490|FG000|STARTED|Overall Study||119
6396790|NCT00866814|7309490|FG000|COMPLETED|Overall Study||99
6396791|NCT00866814|7309490|FG000|NOT COMPLETED|Overall Study||20
6396792|NCT00866879|7309496|FG000|STARTED|Overall Study||90
6396793|NCT00866879|7309497|FG001|STARTED|Overall Study||185
6396794|NCT00866879|7309496|FG000|COMPLETED|Overall Study||90
6396795|NCT00866879|7309497|FG001|COMPLETED|Overall Study||185
6396796|NCT00866879|7309496|FG000|NOT COMPLETED|Overall Study||0
6396797|NCT00866879|7309497|FG001|NOT COMPLETED|Overall Study||0
6396798|NCT00866905|7309503|FG000|STARTED|Overall Study||168
6396799|NCT00866905|7309503|FG000|COMPLETED|Overall Study||135
6396800|NCT00866905|7309503|FG000|NOT COMPLETED|Overall Study||33
6396801|NCT00867009|7309509|FG000|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
6396802|NCT00867009|7309509|FG000|Received at Least 1 Dose of Study Drug|Induction Period||113
6396803|NCT00867009|7309509|FG000|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
6396804|NCT00867009|7309509|FG000|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
6396805|NCT00867009|7309509|FG000|NOT COMPLETED|Induction Period||62
6396806|NCT00867009|7309509|FG000|STARTED|Maintenance Period||51
6396807|NCT00867009|7309509|FG000|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
6396808|NCT00867009|7309509|FG000|NOT COMPLETED|Maintenance Period||4
6396809|NCT00867035|7309515|FG000|STARTED|Baseline to 1 Hour||13
6396810|NCT00867035|7309516|FG001|STARTED|Baseline to 1 Hour||9
6396811|NCT00867035|7309515|FG000|COMPLETED|Baseline to 1 Hour||12
6396812|NCT00867035|7309516|FG001|COMPLETED|Baseline to 1 Hour||8
6626748|NCT02234141|7554382|FG000|NOT COMPLETED|Long-Term Treatment Period||33
6626749|NCT02234141|7554383|FG001|NOT COMPLETED|Long-Term Treatment Period||31
6626750|NCT02234141|7554384|FG002|NOT COMPLETED|Long-Term Treatment Period||33
6626751|NCT02234141|7554385|FG003|NOT COMPLETED|Long-Term Treatment Period||0
6626752|NCT02234141|7554386|FG004|NOT COMPLETED|Long-Term Treatment Period||10
6626753|NCT02234141|7554387|FG005|NOT COMPLETED|Long-Term Treatment Period||12
6396813|NCT00867035|7309515|FG000|NOT COMPLETED|Baseline to 1 Hour||1
6396814|NCT00867035|7309516|FG001|NOT COMPLETED|Baseline to 1 Hour||1
6396815|NCT00867035|7309515|FG000|STARTED|Baseline to 2 Hours||12
6396816|NCT00867035|7309516|FG001|STARTED|Baseline to 2 Hours||8
6396817|NCT00867035|7309515|FG000|COMPLETED|Baseline to 2 Hours||12
6396818|NCT00867035|7309516|FG001|COMPLETED|Baseline to 2 Hours||8
6396819|NCT00867035|7309515|FG000|NOT COMPLETED|Baseline to 2 Hours||0
6396820|NCT00867035|7309516|FG001|NOT COMPLETED|Baseline to 2 Hours||0
6396821|NCT00867035|7309515|FG000|STARTED|Baseline to 4 Hours||12
6396822|NCT00867035|7309516|FG001|STARTED|Baseline to 4 Hours||8
6396823|NCT00867035|7309515|FG000|COMPLETED|Baseline to 4 Hours||12
6396824|NCT00867035|7309516|FG001|COMPLETED|Baseline to 4 Hours||8
6396825|NCT00867035|7309515|FG000|NOT COMPLETED|Baseline to 4 Hours||0
6396826|NCT00867035|7309516|FG001|NOT COMPLETED|Baseline to 4 Hours||0
6396827|NCT00867035|7309515|FG000|STARTED|Baseline to 1 Week||12
6396828|NCT00867035|7309516|FG001|STARTED|Baseline to 1 Week||8
6396829|NCT00867035|7309515|FG000|COMPLETED|Baseline to 1 Week||11
6396830|NCT00867035|7309516|FG001|COMPLETED|Baseline to 1 Week||8
6396831|NCT00867035|7309515|FG000|NOT COMPLETED|Baseline to 1 Week||1
6396832|NCT00867035|7309516|FG001|NOT COMPLETED|Baseline to 1 Week||0
6396833|NCT00867087|7309522|FG000|STARTED|Overall Study||63
6396834|NCT00867087|7309522|FG000|COMPLETED|Overall Study||21
6396835|NCT00867087|7309522|FG000|NOT COMPLETED|Overall Study||42
6396836|NCT00867100|7309539|FG000|STARTED|Overall Study||5
6396837|NCT00867100|7309540|FG001|STARTED|Overall Study||5
6396838|NCT00867100|7309541|FG002|STARTED|Overall Study||8
6396839|NCT00867100|7309542|FG003|STARTED|Overall Study||8
6396840|NCT00867100|7309543|FG004|STARTED|Overall Study||14
6396841|NCT00867100|7309544|FG005|STARTED|Overall Study||6
6396842|NCT00867100|7309545|FG006|STARTED|Overall Study||7
6396843|NCT00867100|7309546|FG007|STARTED|Overall Study||3
6396844|NCT00867100|7309547|FG008|STARTED|Overall Study||6
6396845|NCT00867100|7309548|FG009|STARTED|Overall Study||6
6396846|NCT00867100|7309549|FG010|STARTED|Overall Study||4
6396847|NCT00867100|7309550|FG011|STARTED|Overall Study||6
6396848|NCT00867100|7309551|FG012|STARTED|Overall Study||6
6396849|NCT00867100|7309539|FG000|COMPLETED|Overall Study||5
6396850|NCT00867100|7309540|FG001|COMPLETED|Overall Study||4
6396851|NCT00867100|7309541|FG002|COMPLETED|Overall Study||8
6396852|NCT00867100|7309542|FG003|COMPLETED|Overall Study||8
6626754|NCT02234141|7554388|FG006|NOT COMPLETED|Long-Term Treatment Period||10
6626755|NCT02234180|7554399|FG000|STARTED|Overall Study||2
6626756|NCT02234180|7554400|FG001|STARTED|Overall Study||1
6626757|NCT02234180|7554399|FG000|COMPLETED|Overall Study||2
6626758|NCT02234180|7554400|FG001|COMPLETED|Overall Study||1
6626759|NCT02234180|7554399|FG000|NOT COMPLETED|Overall Study||0
6626760|NCT02234180|7554400|FG001|NOT COMPLETED|Overall Study||0
6626761|NCT02234284|7554406|FG000|STARTED|Overall Study||100
6626762|NCT02234284|7554407|FG001|STARTED|Overall Study||92
6626763|NCT02234284|7554406|FG000|COMPLETED|Overall Study||75
6626764|NCT02234284|7554407|FG001|COMPLETED|Overall Study||83
6626765|NCT02234284|7554406|FG000|NOT COMPLETED|Overall Study||25
6626766|NCT02234284|7554407|FG001|NOT COMPLETED|Overall Study||9
6626767|NCT02234362|7554417|FG000|STARTED|Overall Study||47
6626768|NCT02234362|7554417|FG000|Received at Least One Dose of Medication|Overall Study||27
6626769|NCT02234362|7554417|FG000|COMPLETED|Overall Study||21
6740324|NCT03302416|7669153|FG000|STARTED|Overall Study||19
6740325|NCT03302416|7669153|FG000|COMPLETED|Overall Study||19
6740326|NCT03302416|7669153|FG000|NOT COMPLETED|Overall Study||0
6396853|NCT00867100|7309543|FG004|COMPLETED|Overall Study||14
6396854|NCT00867100|7309544|FG005|COMPLETED|Overall Study||6
6396855|NCT00867100|7309545|FG006|COMPLETED|Overall Study||6
6396856|NCT00867100|7309546|FG007|COMPLETED|Overall Study||3
6396857|NCT00867100|7309547|FG008|COMPLETED|Overall Study||6
6396858|NCT00867100|7309548|FG009|COMPLETED|Overall Study||6
6396859|NCT00867100|7309549|FG010|COMPLETED|Overall Study||3
6396860|NCT00867100|7309550|FG011|COMPLETED|Overall Study||6
6396861|NCT00867100|7309551|FG012|COMPLETED|Overall Study||6
6396862|NCT00867100|7309539|FG000|NOT COMPLETED|Overall Study||0
6396863|NCT00867100|7309540|FG001|NOT COMPLETED|Overall Study||1
6396864|NCT00867100|7309541|FG002|NOT COMPLETED|Overall Study||0
6396865|NCT00867100|7309542|FG003|NOT COMPLETED|Overall Study||0
6396866|NCT00867100|7309543|FG004|NOT COMPLETED|Overall Study||0
6396867|NCT00867100|7309544|FG005|NOT COMPLETED|Overall Study||0
6396868|NCT00867100|7309545|FG006|NOT COMPLETED|Overall Study||1
6396869|NCT00867100|7309546|FG007|NOT COMPLETED|Overall Study||0
6396870|NCT00867100|7309547|FG008|NOT COMPLETED|Overall Study||0
6396871|NCT00867100|7309548|FG009|NOT COMPLETED|Overall Study||0
6396872|NCT00867100|7309549|FG010|NOT COMPLETED|Overall Study||1
6396873|NCT00867100|7309550|FG011|NOT COMPLETED|Overall Study||0
6396874|NCT00867100|7309551|FG012|NOT COMPLETED|Overall Study||0
6396875|NCT00867113|7309583|FG000|STARTED|Treatment Period||91
6396876|NCT00867113|7309583|FG000|Safety Set|Treatment Period||91
6396877|NCT00867113|7309583|FG000|Full Analysis Set (FAS)|Treatment Period||91
6396878|NCT00867113|7309583|FG000|COMPLETED|Treatment Period||46
6396879|NCT00867113|7309583|FG000|NOT COMPLETED|Treatment Period||45
6396880|NCT00867113|7309583|FG000|STARTED|Post Treatment After Survival Follow-up||68
6396881|NCT00867113|7309583|FG000|COMPLETED|Post Treatment After Survival Follow-up||57
6396882|NCT00867113|7309583|FG000|NOT COMPLETED|Post Treatment After Survival Follow-up||11
6396883|NCT00867139|7309590|FG000|STARTED|Overall Study||2
6396884|NCT00867139|7309591|FG001|STARTED|Overall Study||1
6396885|NCT00867139|7309592|FG002|STARTED|Overall Study||4
6396886|NCT00867139|7309590|FG000|COMPLETED|Overall Study||2
6396887|NCT00867139|7309591|FG001|COMPLETED|Overall Study||1
6396888|NCT00867139|7309592|FG002|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
6396889|NCT00867139|7309590|FG000|NOT COMPLETED|Overall Study||0
6396890|NCT00867139|7309591|FG001|NOT COMPLETED|Overall Study||0
6396891|NCT00867139|7309592|FG002|NOT COMPLETED|Overall Study||1
6396892|NCT00867217|7309610|FG000|STARTED|Overall Study||80
6396893|NCT00867217|7309611|FG001|STARTED|Overall Study||80
6396894|NCT00867217|7309610|FG000|COMPLETED|Overall Study||77
6396895|NCT00867217|7309611|FG001|COMPLETED|Overall Study||70
6396896|NCT00867217|7309610|FG000|NOT COMPLETED|Overall Study||3
6396897|NCT00867217|7309611|FG001|NOT COMPLETED|Overall Study||10
6396898|NCT00867308|7309619|FG000|STARTED|Overall Study||9
6396899|NCT00867308|7309620|FG001|STARTED|Overall Study||18
6396900|NCT00867308|7309619|FG000|COMPLETED|Overall Study||0
6396901|NCT00867308|7309620|FG001|COMPLETED|Overall Study||0
6396902|NCT00867308|7309619|FG000|NOT COMPLETED|Overall Study||9
6396903|NCT00867308|7309620|FG001|NOT COMPLETED|Overall Study||18
6396904|NCT00867334|7309628|FG000|STARTED|Overall Study||6
6396905|NCT00867334|7309629|FG001|STARTED|Overall Study||1
6740327|NCT03302559|7669157|FG000|STARTED|Overall Study||29
6740328|NCT03302559|7669157|FG000|COMPLETED|Overall Study||23
6740329|NCT03302559|7669157|FG000|NOT COMPLETED|Overall Study||6
6740330|NCT03302741|7669163|FG000|STARTED|Overall Study||8
6740331|NCT03302741|7669164|FG001|STARTED|Overall Study||9
6740332|NCT03302741|7669163|FG000|COMPLETED|Overall Study||7
6740333|NCT03302741|7669164|FG001|COMPLETED|Overall Study||8
6740334|NCT03302741|7669163|FG000|NOT COMPLETED|Overall Study||1
6740335|NCT03302741|7669164|FG001|NOT COMPLETED|Overall Study||1
6396906|NCT00867334|7309628|FG000|COMPLETED|Overall Study||4
6396907|NCT00867334|7309629|FG001|COMPLETED|Overall Study||0
6396908|NCT00867334|7309628|FG000|NOT COMPLETED|Overall Study||2
6396909|NCT00867334|7309629|FG001|NOT COMPLETED|Overall Study||1
6396910|NCT00867360|7309637|FG000|STARTED|Overall Study||4
6396911|NCT00867360|7309638|FG001|STARTED|Overall Study||6
6396912|NCT00867360|7309637|FG000|COMPLETED|Overall Study||3
6626770|NCT02234362|7554417|FG000|NOT COMPLETED|Overall Study||26
6626771|NCT02234427|7554421|FG000|STARTED|Overall Study||34
6626772|NCT02234427|7554421|FG000|COMPLETED|Overall Study|One individual withdrew after first visit|33
6740336|NCT03302767|7669170|FG000|STARTED|Overall Study||29
6740337|NCT03302767|7669170|FG000|COMPLETED|Overall Study||29
6740338|NCT03302767|7669170|FG000|NOT COMPLETED|Overall Study||0
6740339|NCT03302780|7669174|FG000|STARTED|Overall Study||3
6740340|NCT03302780|7669175|FG001|STARTED|Overall Study||3
6740341|NCT03302780|7669174|FG000|COMPLETED|Overall Study||3
6740342|NCT03302780|7669175|FG001|COMPLETED|Overall Study||3
6740343|NCT03302780|7669174|FG000|NOT COMPLETED|Overall Study||0
6740344|NCT03302780|7669175|FG001|NOT COMPLETED|Overall Study||0
6740345|NCT03302793|7669181|FG000|STARTED|Overall Study||6
6740346|NCT03302793|7669182|FG001|STARTED|Overall Study||6
6740347|NCT03302793|7669181|FG000|COMPLETED|Overall Study||6
6740348|NCT03302793|7669182|FG001|COMPLETED|Overall Study||4
6740349|NCT03302793|7669181|FG000|NOT COMPLETED|Overall Study||0
6740350|NCT03302793|7669182|FG001|NOT COMPLETED|Overall Study||2
6740351|NCT03302936|7669190|FG000|STARTED|Overall Study||49
6740352|NCT03302936|7669191|FG001|STARTED|Overall Study||49
6740353|NCT03302936|7669190|FG000|COMPLETED|Overall Study||46
6740354|NCT03302936|7669191|FG001|COMPLETED|Overall Study||45
6740355|NCT03302936|7669190|FG000|NOT COMPLETED|Overall Study||3
6740356|NCT03302936|7669191|FG001|NOT COMPLETED|Overall Study||4
6740357|NCT03302975|7669201|FG000|STARTED|Overall Study||16
6740358|NCT03302975|7669201|FG000|COMPLETED|Overall Study||12
6740359|NCT03302975|7669201|FG000|NOT COMPLETED|Overall Study||4
6740360|NCT03303079|7669208|FG000|STARTED|Overall Study||189
6740361|NCT03303079|7669209|FG001|STARTED|Overall Study||191
6740362|NCT03303079|7669210|FG002|STARTED|Overall Study||191
6740363|NCT03303079|7669208|FG000|COMPLETED|Overall Study||182
6740364|NCT03303079|7669209|FG001|COMPLETED|Overall Study||180
6740365|NCT03303079|7669210|FG002|COMPLETED|Overall Study||179
6396913|NCT00867360|7309638|FG001|COMPLETED|Overall Study||5
6396914|NCT00867360|7309637|FG000|NOT COMPLETED|Overall Study||1
6396915|NCT00867360|7309638|FG001|NOT COMPLETED|Overall Study||1
6396916|NCT00867451|7309647|FG000|STARTED|Overall Study||4
6396917|NCT00867451|7309648|FG001|STARTED|Overall Study||4
6396918|NCT00867451|7309647|FG000|COMPLETED|Overall Study||4
6396919|NCT00867451|7309648|FG001|COMPLETED|Overall Study||4
6396920|NCT00867451|7309647|FG000|NOT COMPLETED|Overall Study||0
6396921|NCT00867451|7309648|FG001|NOT COMPLETED|Overall Study||0
6498582|NCT01410773|7417187|FG000|COMPLETED|Overall Study||110
6498583|NCT01410773|7417187|FG000|NOT COMPLETED|Overall Study||0
6498584|NCT01410812|7417194|FG000|STARTED|Overall Study||75
6498585|NCT01410812|7417195|FG001|STARTED|Overall Study||75
6498586|NCT01410812|7417196|FG002|STARTED|Overall Study||76
6498587|NCT01410812|7417194|FG000|COMPLETED|Overall Study||75
6498588|NCT01410812|7417195|FG001|COMPLETED|Overall Study||75
6498589|NCT01410812|7417196|FG002|COMPLETED|Overall Study||76
6498590|NCT01410812|7417194|FG000|NOT COMPLETED|Overall Study||0
6498591|NCT01410812|7417195|FG001|NOT COMPLETED|Overall Study||0
6498592|NCT01410812|7417196|FG002|NOT COMPLETED|Overall Study||0
6498593|NCT01411085|7417204|FG000|STARTED|Overall Study||10
6498594|NCT01411085|7417204|FG000|COMPLETED|Overall Study||7
6498595|NCT01411085|7417204|FG000|NOT COMPLETED|Overall Study||3
6498596|NCT01411137|7417208|FG000|STARTED|Part 1: Dose Conversion||43
6498597|NCT01411137|7417208|FG000|COMPLETED|Part 1: Dose Conversion||33
6498598|NCT01411137|7417208|FG000|NOT COMPLETED|Part 1: Dose Conversion||10
6498599|NCT01411137|7417208|FG000|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
6498600|NCT01411137|7417208|FG000|COMPLETED|Part 2: Open-Label Extension||25
6498601|NCT01411137|7417208|FG000|NOT COMPLETED|Part 2: Open-Label Extension||7
6498602|NCT01411137|7417208|FG000|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
6498603|NCT01411137|7417208|FG000|COMPLETED|Part 3: Open-Label Extension||12
6498604|NCT01411137|7417208|FG000|NOT COMPLETED|Part 3: Open-Label Extension||0
6498605|NCT01411215|7417225|FG000|STARTED|Overall Study||69
6498606|NCT01411215|7417226|FG001|STARTED|Overall Study||91
6498607|NCT01411215|7417225|FG000|Treated|Overall Study||69
6498608|NCT01411215|7417226|FG001|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
6498609|NCT01411215|7417225|FG000|COMPLETED|Overall Study||3
6498610|NCT01411215|7417226|FG001|COMPLETED|Overall Study||7
6498611|NCT01411215|7417225|FG000|NOT COMPLETED|Overall Study||66
6498612|NCT01411215|7417226|FG001|NOT COMPLETED|Overall Study||84
6498613|NCT01411228|7417235|FG000|STARTED|Overall Study||5
6498614|NCT01411228|7417236|FG001|STARTED|Overall Study||5
6498615|NCT01411228|7417237|FG002|STARTED|Overall Study||5
6498616|NCT01411228|7417235|FG000|COMPLETED|Overall Study||4
6498617|NCT01411228|7417236|FG001|COMPLETED|Overall Study||5
6498618|NCT01411228|7417237|FG002|COMPLETED|Overall Study||4
6498619|NCT01411228|7417235|FG000|NOT COMPLETED|Overall Study||1
6498620|NCT01411228|7417236|FG001|NOT COMPLETED|Overall Study||0
6498621|NCT01411228|7417237|FG002|NOT COMPLETED|Overall Study||1
6498622|NCT01411319|7417245|FG000|STARTED|Overall Study||25
6498623|NCT01411319|7417245|FG000|COMPLETED|Overall Study||24
6498624|NCT01411319|7417245|FG000|NOT COMPLETED|Overall Study||1
6498625|NCT01411488|7417251|FG000|STARTED|Overall Study||41
6498626|NCT01411488|7417252|FG001|STARTED|Overall Study||38
6498627|NCT01411488|7417251|FG000|COMPLETED|Overall Study||41
6498628|NCT01411488|7417252|FG001|COMPLETED|Overall Study||38
6498629|NCT01411488|7417251|FG000|NOT COMPLETED|Overall Study||0
6498630|NCT01411488|7417252|FG001|NOT COMPLETED|Overall Study||0
6740366|NCT03303079|7669208|FG000|NOT COMPLETED|Overall Study||7
6740367|NCT03303079|7669209|FG001|NOT COMPLETED|Overall Study||11
6740368|NCT03303079|7669210|FG002|NOT COMPLETED|Overall Study||12
6740369|NCT03303092|7669221|FG000|STARTED|Overall Study||121
6282118|NCT00178841|7182335|FG000|STARTED|Overall Study||4
6282119|NCT00178841|7182335|FG000|COMPLETED|Overall Study||4
6396922|NCT00867490|7309658|FG000|STARTED|Phase 1 - Candesartan+HCTZ||186
6396923|NCT00867490|7309658|FG000|COMPLETED|Phase 1 - Candesartan+HCTZ||176
6396924|NCT00867490|7309658|FG000|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
6396925|NCT00867490|7309658|FG000|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
6396926|NCT00867490|7309658|FG000|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
6396927|NCT00867490|7309658|FG000|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
6396928|NCT00867490|7309658|FG000|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
6396929|NCT00867490|7309658|FG000|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
6396930|NCT00867490|7309658|FG000|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
6396931|NCT00867503|7309665|FG000|STARTED|Overall Study||10
6396932|NCT00867503|7309665|FG000|COMPLETED|Overall Study||9
6396933|NCT00867503|7309665|FG000|NOT COMPLETED|Overall Study||1
6396934|NCT00867529|7309671|FG000|STARTED|Overall Study||63
6396935|NCT00867529|7309671|FG000|COMPLETED|Overall Study||63
6396936|NCT00867529|7309671|FG000|NOT COMPLETED|Overall Study||0
6396937|NCT00867659|7309675|FG000|STARTED|Overall Study|October 2009|20
6396938|NCT00867659|7309675|FG000|COMPLETED|Overall Study|January 2010|20
6396939|NCT00867659|7309675|FG000|NOT COMPLETED|Overall Study||0
6396940|NCT00867789|7309682|FG000|STARTED|Overall Study||70
6396941|NCT00867789|7309683|FG001|STARTED|Overall Study||70
6396942|NCT00867789|7309682|FG000|COMPLETED|Overall Study||68
6396943|NCT00867789|7309683|FG001|COMPLETED|Overall Study||70
6396944|NCT00867789|7309682|FG000|NOT COMPLETED|Overall Study||2
6396945|NCT00867789|7309683|FG001|NOT COMPLETED|Overall Study||0
6396946|NCT00867815|7309689|FG000|STARTED|Overall Study||10
6396947|NCT00867815|7309689|FG000|COMPLETED|Overall Study||9
6396948|NCT00867815|7309689|FG000|NOT COMPLETED|Overall Study||1
6396949|NCT00867932|7309693|FG000|STARTED|Overall Study||7
6396950|NCT00867932|7309693|FG000|Induction Phase|Overall Study||7
6396951|NCT00867932|7309693|FG000|Maintenance Phase|Overall Study||7
6396952|NCT00867932|7309693|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
6396953|NCT00867932|7309693|FG000|Intent-to-Treat (ITT) Population|Overall Study||7
6396954|NCT00867932|7309693|FG000|COMPLETED|Overall Study||7
6396955|NCT00867932|7309693|FG000|NOT COMPLETED|Overall Study||0
6396956|NCT00868101|7309699|FG000|STARTED|Overall Study||12
6396957|NCT00868101|7309700|FG001|STARTED|Overall Study||10
6396958|NCT00868101|7309699|FG000|COMPLETED|Overall Study||12
6396959|NCT00868101|7309700|FG001|COMPLETED|Overall Study||10
6396960|NCT00868101|7309699|FG000|NOT COMPLETED|Overall Study||0
6396961|NCT00868101|7309700|FG001|NOT COMPLETED|Overall Study||0
6396962|NCT00868140|7309710|FG000|STARTED|Overall Study||26
6396963|NCT00868140|7309711|FG001|STARTED|Overall Study||25
6396964|NCT00868140|7309710|FG000|COMPLETED|Overall Study||26
6396965|NCT00868140|7309711|FG001|COMPLETED|Overall Study||25
6396966|NCT00868140|7309710|FG000|NOT COMPLETED|Overall Study||0
6396967|NCT00868140|7309711|FG001|NOT COMPLETED|Overall Study||0
6396968|NCT00868166|7309721|FG000|STARTED|Overall Study||259
6396969|NCT00868166|7309722|FG001|STARTED|Overall Study||253
6396970|NCT00868166|7309721|FG000|COMPLETED|Overall Study||147
6396971|NCT00868166|7309722|FG001|COMPLETED|Overall Study||139
6396972|NCT00868166|7309721|FG000|NOT COMPLETED|Overall Study||112
6396973|NCT00868166|7309722|FG001|NOT COMPLETED|Overall Study||114
6396974|NCT00868192|7309728|FG000|STARTED|Overall Study||38
6396975|NCT00868192|7309728|FG000|COMPLETED|Overall Study||34
6396976|NCT00868192|7309728|FG000|NOT COMPLETED|Overall Study||4
6740370|NCT03303092|7669222|FG001|STARTED|Overall Study||119
6282120|NCT00178841|7182335|FG000|NOT COMPLETED|Overall Study||0
6282121|NCT00178919|7182342|FG000|STARTED|Overall Study||19
6282122|NCT00178919|7182343|FG001|STARTED|Overall Study||93
6282123|NCT00178919|7182342|FG000|COMPLETED|Overall Study||19
6282124|NCT00178919|7182343|FG001|COMPLETED|Overall Study||68
6282125|NCT00178919|7182342|FG000|NOT COMPLETED|Overall Study||0
6282126|NCT00178919|7182343|FG001|NOT COMPLETED|Overall Study||25
6282127|NCT00179010|7182351|FG000|STARTED|Overall Study||6
6282128|NCT00179010|7182352|FG001|STARTED|Overall Study||7
6282129|NCT00179010|7182351|FG000|COMPLETED|Overall Study||5
6282130|NCT00179010|7182352|FG001|COMPLETED|Overall Study||5
6282131|NCT00179010|7182351|FG000|NOT COMPLETED|Overall Study||1
6282132|NCT00179010|7182352|FG001|NOT COMPLETED|Overall Study||2
6282133|NCT00179309|7182361|FG000|STARTED|Treatment||25
6282134|NCT00179309|7182362|FG001|STARTED|Treatment||23
6282135|NCT00179309|7182361|FG000|COMPLETED|Treatment||21
6282136|NCT00179309|7182362|FG001|COMPLETED|Treatment||18
6282137|NCT00179309|7182361|FG000|NOT COMPLETED|Treatment||4
6282138|NCT00179309|7182362|FG001|NOT COMPLETED|Treatment||5
6282139|NCT00179309|7182361|FG000|STARTED|Crossover||0
6282140|NCT00179309|7182362|FG001|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
6282141|NCT00179309|7182361|FG000|COMPLETED|Crossover||0
6282142|NCT00179309|7182362|FG001|COMPLETED|Crossover||3
6282143|NCT00179309|7182361|FG000|NOT COMPLETED|Crossover||0
6282144|NCT00179309|7182362|FG001|NOT COMPLETED|Crossover||0
6282145|NCT00179413|7182370|FG000|STARTED|Overall Study||282
6282146|NCT00179413|7182371|FG001|STARTED|Overall Study||267
6396977|NCT00868218|7309736|FG000|STARTED|Overall Study||15
6396978|NCT00868218|7309737|FG001|STARTED|Overall Study||15
6396979|NCT00868218|7309738|FG002|STARTED|Overall Study||15
6740371|NCT03303092|7669223|FG002|STARTED|Overall Study||117
6740372|NCT03303092|7669221|FG000|COMPLETED|Overall Study||118
6740373|NCT03303092|7669222|FG001|COMPLETED|Overall Study||113
6740374|NCT03303092|7669223|FG002|COMPLETED|Overall Study||112
6740375|NCT03303092|7669221|FG000|NOT COMPLETED|Overall Study||3
6740376|NCT03303092|7669222|FG001|NOT COMPLETED|Overall Study||6
6740377|NCT03303092|7669223|FG002|NOT COMPLETED|Overall Study||5
6740378|NCT03303105|7669233|FG000|STARTED|Overall Study||25
6740379|NCT03303105|7669234|FG001|STARTED|Overall Study||25
6740380|NCT03303105|7669233|FG000|COMPLETED|Overall Study||23
6740381|NCT03303105|7669234|FG001|COMPLETED|Overall Study||21
6740382|NCT03303105|7669233|FG000|NOT COMPLETED|Overall Study||2
6740383|NCT03303105|7669234|FG001|NOT COMPLETED|Overall Study||4
6740384|NCT03303144|7669240|FG000|STARTED|Triferic Via Hemodialysate (Day 3)||26
6740385|NCT03303144|7669241|FG001|STARTED|Triferic Via Hemodialysate (Day 3)||0
6740386|NCT03303144|7669242|FG002|STARTED|Triferic Via Hemodialysate (Day 3)||0
6740387|NCT03303144|7669240|FG000|COMPLETED|Triferic Via Hemodialysate (Day 3)||26
6740388|NCT03303144|7669241|FG001|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
6740389|NCT03303144|7669242|FG002|COMPLETED|Triferic Via Hemodialysate (Day 3)||0
6740390|NCT03303144|7669240|FG000|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
6740391|NCT03303144|7669241|FG001|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
6740392|NCT03303144|7669242|FG002|NOT COMPLETED|Triferic Via Hemodialysate (Day 3)||0
6740393|NCT03303144|7669240|FG000|STARTED|Triferic Via IV Infusion (Day 8)||0
6740394|NCT03303144|7669241|FG001|STARTED|Triferic Via IV Infusion (Day 8)||26
6740395|NCT03303144|7669242|FG002|STARTED|Triferic Via IV Infusion (Day 8)||0
6740396|NCT03303144|7669240|FG000|COMPLETED|Triferic Via IV Infusion (Day 8)||0
6740397|NCT03303144|7669241|FG001|COMPLETED|Triferic Via IV Infusion (Day 8)||25
6740398|NCT03303144|7669242|FG002|COMPLETED|Triferic Via IV Infusion (Day 8)||0
6740399|NCT03303144|7669240|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
6740400|NCT03303144|7669241|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||1
6740401|NCT03303144|7669242|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 8)||0
6740402|NCT03303144|7669240|FG000|STARTED|Triferic Via IV Infusion (Day 10)||0
6740403|NCT03303144|7669241|FG001|STARTED|Triferic Via IV Infusion (Day 10)||0
6740404|NCT03303144|7669242|FG002|STARTED|Triferic Via IV Infusion (Day 10)||26
6740405|NCT03303144|7669240|FG000|COMPLETED|Triferic Via IV Infusion (Day 10)||0
6740406|NCT03303144|7669241|FG001|COMPLETED|Triferic Via IV Infusion (Day 10)||0
6740407|NCT03303144|7669242|FG002|COMPLETED|Triferic Via IV Infusion (Day 10)||25
6740408|NCT03303144|7669240|FG000|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
6740409|NCT03303144|7669241|FG001|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||0
6740410|NCT03303144|7669242|FG002|NOT COMPLETED|Triferic Via IV Infusion (Day 10)||1
6740411|NCT03303196|7669253|FG000|STARTED|Overall Study|Individuals who were assigned to BHBP admission then SC admission.|5
6740412|NCT03303196|7669254|FG001|STARTED|Overall Study|Individuals who were assigned to SC admission then BHBP admission.|5
6740413|NCT03303196|7669253|FG000|Washout|Overall Study||5
6740414|NCT03303196|7669254|FG001|Washout|Overall Study||5
6740415|NCT03303196|7669253|FG000|COMPLETED|Overall Study||5
6740416|NCT03303196|7669254|FG001|COMPLETED|Overall Study||5
6740417|NCT03303196|7669253|FG000|NOT COMPLETED|Overall Study||0
6740418|NCT03303196|7669254|FG001|NOT COMPLETED|Overall Study||0
6740419|NCT03303404|7669259|FG000|STARTED|Overall Study||22
6740420|NCT03303404|7669259|FG000|COMPLETED|Overall Study||22
6740421|NCT03303404|7669259|FG000|NOT COMPLETED|Overall Study||0
6740422|NCT03303417|7669263|FG000|STARTED|Overall Study||8
6396980|NCT00868218|7309739|FG003|STARTED|Overall Study||15
6396981|NCT00868218|7309736|FG000|COMPLETED|Overall Study||15
6396982|NCT00868218|7309737|FG001|COMPLETED|Overall Study||15
6396983|NCT00868218|7309738|FG002|COMPLETED|Overall Study||15
6396984|NCT00868218|7309739|FG003|COMPLETED|Overall Study||15
6396985|NCT00868218|7309736|FG000|NOT COMPLETED|Overall Study||0
6396986|NCT00868218|7309737|FG001|NOT COMPLETED|Overall Study||0
6396987|NCT00868218|7309738|FG002|NOT COMPLETED|Overall Study||0
6396988|NCT00868218|7309739|FG003|NOT COMPLETED|Overall Study||0
6396989|NCT00868231|7309753|FG000|STARTED|Treatment Period 1||5
6396990|NCT00868231|7309754|FG001|STARTED|Treatment Period 1||5
6396991|NCT00868231|7309755|FG002|STARTED|Treatment Period 1||5
6396992|NCT00868231|7309756|FG003|STARTED|Treatment Period 1||5
6396993|NCT00868231|7309757|FG004|STARTED|Treatment Period 1||5
6396994|NCT00868231|7309758|FG005|STARTED|Treatment Period 1||5
6396995|NCT00868231|7309753|FG000|COMPLETED|Treatment Period 1||5
6396996|NCT00868231|7309754|FG001|COMPLETED|Treatment Period 1||5
6396997|NCT00868231|7309755|FG002|COMPLETED|Treatment Period 1||5
6396998|NCT00868231|7309756|FG003|COMPLETED|Treatment Period 1||5
6396999|NCT00868231|7309757|FG004|COMPLETED|Treatment Period 1||4
6397000|NCT00868231|7309758|FG005|COMPLETED|Treatment Period 1||5
6397001|NCT00868231|7309753|FG000|NOT COMPLETED|Treatment Period 1||0
6740423|NCT03303417|7669264|FG001|STARTED|Overall Study||8
6740424|NCT03303417|7669263|FG000|COMPLETED|Overall Study||7
6740425|NCT03303417|7669264|FG001|COMPLETED|Overall Study||7
6740426|NCT03303417|7669263|FG000|NOT COMPLETED|Overall Study||1
6397002|NCT00868231|7309754|FG001|NOT COMPLETED|Treatment Period 1||0
6397003|NCT00868231|7309755|FG002|NOT COMPLETED|Treatment Period 1||0
6397004|NCT00868231|7309756|FG003|NOT COMPLETED|Treatment Period 1||0
6740427|NCT03303417|7669264|FG001|NOT COMPLETED|Overall Study||1
6740428|NCT03303521|7669272|FG000|STARTED|Overall Study||97
6740429|NCT03303521|7669273|FG001|STARTED|Overall Study||99
6740430|NCT03303521|7669272|FG000|COMPLETED|Overall Study||92
6740431|NCT03303521|7669273|FG001|COMPLETED|Overall Study||96
6740432|NCT03303521|7669272|FG000|NOT COMPLETED|Overall Study||5
6740433|NCT03303521|7669273|FG001|NOT COMPLETED|Overall Study||3
6397005|NCT00868231|7309757|FG004|NOT COMPLETED|Treatment Period 1||1
6397006|NCT00868231|7309758|FG005|NOT COMPLETED|Treatment Period 1||0
6397007|NCT00868231|7309753|FG000|STARTED|Treatment Period 2||5
6397008|NCT00868231|7309754|FG001|STARTED|Treatment Period 2||5
6397009|NCT00868231|7309755|FG002|STARTED|Treatment Period 2||5
6397010|NCT00868231|7309756|FG003|STARTED|Treatment Period 2||5
6397011|NCT00868231|7309757|FG004|STARTED|Treatment Period 2||4
6397012|NCT00868231|7309758|FG005|STARTED|Treatment Period 2||5
6397013|NCT00868231|7309753|FG000|COMPLETED|Treatment Period 2||4
6397014|NCT00868231|7309754|FG001|COMPLETED|Treatment Period 2||5
6397015|NCT00868231|7309755|FG002|COMPLETED|Treatment Period 2||5
6397016|NCT00868231|7309756|FG003|COMPLETED|Treatment Period 2||5
6397017|NCT00868231|7309757|FG004|COMPLETED|Treatment Period 2||4
6397018|NCT00868231|7309758|FG005|COMPLETED|Treatment Period 2||5
6397019|NCT00868231|7309753|FG000|NOT COMPLETED|Treatment Period 2||1
6397020|NCT00868231|7309754|FG001|NOT COMPLETED|Treatment Period 2||0
6397021|NCT00868231|7309755|FG002|NOT COMPLETED|Treatment Period 2||0
6397022|NCT00868231|7309756|FG003|NOT COMPLETED|Treatment Period 2||0
6397023|NCT00868231|7309757|FG004|NOT COMPLETED|Treatment Period 2||0
6397024|NCT00868231|7309758|FG005|NOT COMPLETED|Treatment Period 2||0
6397025|NCT00868231|7309753|FG000|STARTED|Treatment Period 3||4
6397026|NCT00868231|7309754|FG001|STARTED|Treatment Period 3||5
6397027|NCT00868231|7309755|FG002|STARTED|Treatment Period 3||5
6397028|NCT00868231|7309756|FG003|STARTED|Treatment Period 3||5
6397029|NCT00868231|7309757|FG004|STARTED|Treatment Period 3||4
6397030|NCT00868231|7309758|FG005|STARTED|Treatment Period 3||5
6397031|NCT00868231|7309753|FG000|COMPLETED|Treatment Period 3||4
6397032|NCT00868231|7309754|FG001|COMPLETED|Treatment Period 3||5
6397033|NCT00868231|7309755|FG002|COMPLETED|Treatment Period 3||4
6397034|NCT00868231|7309756|FG003|COMPLETED|Treatment Period 3||5
6397035|NCT00868231|7309757|FG004|COMPLETED|Treatment Period 3||4
6397036|NCT00868231|7309758|FG005|COMPLETED|Treatment Period 3||5
6397037|NCT00868231|7309753|FG000|NOT COMPLETED|Treatment Period 3||0
6397038|NCT00868231|7309754|FG001|NOT COMPLETED|Treatment Period 3||0
6397039|NCT00868231|7309755|FG002|NOT COMPLETED|Treatment Period 3||1
6397040|NCT00868231|7309756|FG003|NOT COMPLETED|Treatment Period 3||0
6397041|NCT00868231|7309757|FG004|NOT COMPLETED|Treatment Period 3||0
6397042|NCT00868231|7309758|FG005|NOT COMPLETED|Treatment Period 3||0
6397043|NCT00868296|7309768|FG000|STARTED|Overall Study||12
6397044|NCT00868296|7309769|FG001|STARTED|Overall Study||46
6397045|NCT00868296|7309768|FG000|COMPLETED|Overall Study||12
6397046|NCT00868296|7309769|FG001|COMPLETED|Overall Study||43
6397047|NCT00868296|7309768|FG000|NOT COMPLETED|Overall Study||0
6397048|NCT00868296|7309769|FG001|NOT COMPLETED|Overall Study||3
6397049|NCT00868309|7309777|FG000|STARTED|Overall Study||6
6397050|NCT00868309|7309778|FG001|STARTED|Overall Study||6
6397051|NCT00868309|7309777|FG000|COMPLETED|Overall Study||6
6397052|NCT00868309|7309778|FG001|COMPLETED|Overall Study||6
6397053|NCT00868309|7309777|FG000|NOT COMPLETED|Overall Study||0
6397054|NCT00868309|7309778|FG001|NOT COMPLETED|Overall Study||0
6397055|NCT00868348|7309786|FG000|STARTED|Overall Study||30
6397056|NCT00868348|7309787|FG001|STARTED|Overall Study||30
6397057|NCT00868348|7309786|FG000|COMPLETED|Overall Study||30
6397058|NCT00868348|7309787|FG001|COMPLETED|Overall Study||30
6397059|NCT00868348|7309786|FG000|NOT COMPLETED|Overall Study||0
6397060|NCT00868348|7309787|FG001|NOT COMPLETED|Overall Study||0
6397061|NCT00868374|7309795|FG000|STARTED|Overall Study||12
6397062|NCT00868374|7309796|FG001|STARTED|Overall Study||11
6397063|NCT00868374|7309795|FG000|COMPLETED|Overall Study||5
6397064|NCT00868374|7309796|FG001|COMPLETED|Overall Study||4
6397065|NCT00868374|7309795|FG000|NOT COMPLETED|Overall Study||7
6397066|NCT00868374|7309796|FG001|NOT COMPLETED|Overall Study||7
6397067|NCT00868439|7309804|FG000|STARTED|Overall Study||56
6397068|NCT00868439|7309805|FG001|STARTED|Overall Study||49
6397069|NCT00868439|7309804|FG000|COMPLETED|Overall Study||48
6397070|NCT00868439|7309805|FG001|COMPLETED|Overall Study||40
6397071|NCT00868439|7309804|FG000|NOT COMPLETED|Overall Study||8
6397072|NCT00868439|7309805|FG001|NOT COMPLETED|Overall Study||9
6397073|NCT00868452|7309813|FG000|STARTED|Overall Study||183
6397074|NCT00868452|7309814|FG001|STARTED|Overall Study||165
6397075|NCT00868452|7309813|FG000|COMPLETED|Overall Study||143
6397076|NCT00868452|7309814|FG001|COMPLETED|Overall Study||136
6397077|NCT00868452|7309813|FG000|NOT COMPLETED|Overall Study||40
6397078|NCT00868452|7309814|FG001|NOT COMPLETED|Overall Study||29
6740434|NCT03303794|7669281|FG000|STARTED|Overall Study||13
6397079|NCT00868517|7309824|FG000|STARTED|Overall Study||12
6397080|NCT00868517|7309825|FG001|STARTED|Overall Study||12
6397081|NCT00868517|7309826|FG002|STARTED|Overall Study||11
6397082|NCT00868517|7309824|FG000|COMPLETED|Overall Study||8
6397083|NCT00868517|7309825|FG001|COMPLETED|Overall Study||8
6397084|NCT00868517|7309826|FG002|COMPLETED|Overall Study||9
6397085|NCT00868517|7309824|FG000|NOT COMPLETED|Overall Study||4
6397086|NCT00868517|7309825|FG001|NOT COMPLETED|Overall Study||4
6397087|NCT00868517|7309826|FG002|NOT COMPLETED|Overall Study||2
6740435|NCT03303794|7669282|FG001|STARTED|Overall Study||12
6740436|NCT03303794|7669281|FG000|COMPLETED|Overall Study||13
6740437|NCT03303794|7669282|FG001|COMPLETED|Overall Study||12
6740438|NCT03303794|7669281|FG000|NOT COMPLETED|Overall Study||0
6740439|NCT03303794|7669282|FG001|NOT COMPLETED|Overall Study||0
6740440|NCT03303911|7669290|FG000|STARTED|Overall Study||13
6740441|NCT03303911|7669291|FG001|STARTED|Overall Study||13
6740442|NCT03303911|7669290|FG000|COMPLETED|Overall Study||13
6740443|NCT03303911|7669291|FG001|COMPLETED|Overall Study||13
6740444|NCT03303911|7669290|FG000|NOT COMPLETED|Overall Study||0
6740445|NCT03303911|7669291|FG001|NOT COMPLETED|Overall Study||0
6740446|NCT03303950|7669297|FG000|STARTED|Overall Study||6
6740447|NCT03303950|7669297|FG000|COMPLETED|Overall Study||6
6740448|NCT03303950|7669297|FG000|NOT COMPLETED|Overall Study||0
6740449|NCT03304054|7669305|FG000|STARTED|Overall Study||27
6740450|NCT03304054|7669306|FG001|STARTED|Overall Study||7
6740451|NCT03304054|7669307|FG002|STARTED|Overall Study||28
6740452|NCT03304054|7669308|FG003|STARTED|Overall Study||8
6740453|NCT03304054|7669309|FG004|STARTED|Overall Study||17
6740454|NCT03304054|7669310|FG005|STARTED|Overall Study||6
6740455|NCT03304054|7669305|FG000|COMPLETED|Overall Study||27
6740456|NCT03304054|7669306|FG001|COMPLETED|Overall Study||7
6740457|NCT03304054|7669307|FG002|COMPLETED|Overall Study||27
6740458|NCT03304054|7669308|FG003|COMPLETED|Overall Study||8
6740459|NCT03304054|7669309|FG004|COMPLETED|Overall Study||0
6740460|NCT03304054|7669310|FG005|COMPLETED|Overall Study||0
6740461|NCT03304054|7669305|FG000|NOT COMPLETED|Overall Study||0
6740462|NCT03304054|7669306|FG001|NOT COMPLETED|Overall Study||0
6740463|NCT03304054|7669307|FG002|NOT COMPLETED|Overall Study||1
6740464|NCT03304054|7669308|FG003|NOT COMPLETED|Overall Study||0
6740465|NCT03304054|7669309|FG004|NOT COMPLETED|Overall Study||17
6397088|NCT00868530|7309834|FG000|STARTED|Overall Study||53
6397089|NCT00868530|7309834|FG000|COMPLETED|Overall Study||49
6397090|NCT00868530|7309834|FG000|NOT COMPLETED|Overall Study||4
6397091|NCT00868608|7309841|FG000|STARTED|Overall Study||72
6740466|NCT03304054|7669310|FG005|NOT COMPLETED|Overall Study||6
6740467|NCT03304106|7669321|FG000|STARTED|Overall Study||44
6740468|NCT03304106|7669322|FG001|STARTED|Overall Study||58
6740469|NCT03304106|7669321|FG000|COMPLETED|Overall Study||31
6740470|NCT03304106|7669322|FG001|COMPLETED|Overall Study||56
6740471|NCT03304106|7669321|FG000|NOT COMPLETED|Overall Study||13
6740472|NCT03304106|7669322|FG001|NOT COMPLETED|Overall Study||2
6740473|NCT03304119|7669330|FG000|STARTED|Overall Study||37
6740474|NCT03304119|7669331|FG001|STARTED|Overall Study||55
6740475|NCT03304119|7669330|FG000|COMPLETED|Overall Study||37
6740476|NCT03304119|7669331|FG001|COMPLETED|Overall Study||55
6740477|NCT03304119|7669330|FG000|NOT COMPLETED|Overall Study||0
6740478|NCT03304119|7669331|FG001|NOT COMPLETED|Overall Study||0
6740479|NCT03304184|7669339|FG000|STARTED|Overall Study||15
6740480|NCT03304184|7669340|FG001|STARTED|Overall Study||9
6740481|NCT03304184|7669339|FG000|COMPLETED|Overall Study||14
6740482|NCT03304184|7669340|FG001|COMPLETED|Overall Study||7
6740483|NCT03304184|7669339|FG000|NOT COMPLETED|Overall Study||1
6740484|NCT03304184|7669340|FG001|NOT COMPLETED|Overall Study||2
6740485|NCT03304522|7669349|FG000|STARTED|Overall Study||46
6740486|NCT03304522|7669350|FG001|STARTED|Overall Study||43
6740487|NCT03304522|7669349|FG000|COMPLETED|Overall Study||45
6740488|NCT03304522|7669350|FG001|COMPLETED|Overall Study||35
6740489|NCT03304522|7669349|FG000|NOT COMPLETED|Overall Study||1
6740490|NCT03304522|7669350|FG001|NOT COMPLETED|Overall Study||8
6740491|NCT03304626|7669358|FG000|STARTED|Overall Study||20
6740492|NCT03304626|7669359|FG001|STARTED|Overall Study||20
6740493|NCT03304626|7669358|FG000|COMPLETED|Overall Study||18
6740494|NCT03304626|7669359|FG001|COMPLETED|Overall Study||19
6740495|NCT03304626|7669358|FG000|NOT COMPLETED|Overall Study||2
6740496|NCT03304626|7669359|FG001|NOT COMPLETED|Overall Study||1
6740497|NCT03304873|7669368|FG000|STARTED|Overall Study||23
6740498|NCT03304873|7669369|FG001|STARTED|Overall Study||24
6740499|NCT03304873|7669368|FG000|COMPLETED|Overall Study||22
6740500|NCT03304873|7669369|FG001|COMPLETED|Overall Study||16
6740501|NCT03304873|7669368|FG000|NOT COMPLETED|Overall Study||1
6740502|NCT03304873|7669369|FG001|NOT COMPLETED|Overall Study||8
6740503|NCT03305081|7669377|FG000|STARTED|Overall Study||25
6740504|NCT03305081|7669378|FG001|STARTED|Overall Study||20
6740505|NCT03305081|7669377|FG000|COMPLETED|Overall Study||15
6740506|NCT03305081|7669378|FG001|COMPLETED|Overall Study||5
6740507|NCT03305081|7669377|FG000|NOT COMPLETED|Overall Study||10
6740508|NCT03305081|7669378|FG001|NOT COMPLETED|Overall Study||15
6740509|NCT03305159|7669386|FG000|STARTED|Overall Study||66
6397092|NCT00868608|7309842|FG001|STARTED|Overall Study||4
6397093|NCT00868608|7309843|FG002|STARTED|Overall Study||5
6740510|NCT03305159|7669387|FG001|STARTED|Overall Study||68
6740511|NCT03305159|7669386|FG000|COMPLETED|Overall Study||63
6740512|NCT03305159|7669387|FG001|COMPLETED|Overall Study||60
6740513|NCT03305159|7669386|FG000|NOT COMPLETED|Overall Study||3
6397094|NCT00868608|7309841|FG000|COMPLETED|Overall Study||49
6740514|NCT03305159|7669387|FG001|NOT COMPLETED|Overall Study||8
6740515|NCT03305419|7669401|FG000|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6740516|NCT03305419|7669402|FG001|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6740517|NCT03305419|7669403|FG002|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6740518|NCT03305419|7669404|FG003|STARTED|Part A Period 1 (1Day) + Washout (7days)||3
6740519|NCT03305419|7669405|FG004|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6740520|NCT03305419|7669406|FG005|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6740521|NCT03305419|7669407|FG006|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6740522|NCT03305419|7669408|FG007|STARTED|Part A Period 1 (1Day) + Washout (7days)||0
6740523|NCT03305419|7669401|FG000|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6740524|NCT03305419|7669402|FG001|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||2
6740525|NCT03305419|7669403|FG002|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6740526|NCT03305419|7669404|FG003|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||3
6740527|NCT03305419|7669405|FG004|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740528|NCT03305419|7669406|FG005|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740529|NCT03305419|7669407|FG006|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740530|NCT03305419|7669408|FG007|COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740531|NCT03305419|7669401|FG000|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740532|NCT03305419|7669402|FG001|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||1
6740533|NCT03305419|7669403|FG002|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740534|NCT03305419|7669404|FG003|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740535|NCT03305419|7669405|FG004|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740536|NCT03305419|7669406|FG005|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740537|NCT03305419|7669407|FG006|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740538|NCT03305419|7669408|FG007|NOT COMPLETED|Part A Period 1 (1Day) + Washout (7days)||0
6740539|NCT03305419|7669401|FG000|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6740540|NCT03305419|7669402|FG001|STARTED|Part A Period 2 (1Day) + Washout (7days)|1 participant was added to GSK2982772 120 mg TID/240 mg TID/Placebo arm|3
6740541|NCT03305419|7669403|FG002|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6740542|NCT03305419|7669404|FG003|STARTED|Part A Period 2 (1Day) + Washout (7days)||3
6740543|NCT03305419|7669405|FG004|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6740544|NCT03305419|7669406|FG005|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6740545|NCT03305419|7669407|FG006|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6740546|NCT03305419|7669408|FG007|STARTED|Part A Period 2 (1Day) + Washout (7days)||0
6740547|NCT03305419|7669401|FG000|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||1
6740548|NCT03305419|7669402|FG001|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6740549|NCT03305419|7669403|FG002|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6740550|NCT03305419|7669404|FG003|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||3
6740551|NCT03305419|7669405|FG004|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740552|NCT03305419|7669406|FG005|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740553|NCT03305419|7669407|FG006|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740554|NCT03305419|7669408|FG007|COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740555|NCT03305419|7669401|FG000|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||2
6740556|NCT03305419|7669402|FG001|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740557|NCT03305419|7669403|FG002|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740558|NCT03305419|7669404|FG003|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740559|NCT03305419|7669405|FG004|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740560|NCT03305419|7669406|FG005|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740561|NCT03305419|7669407|FG006|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740562|NCT03305419|7669408|FG007|NOT COMPLETED|Part A Period 2 (1Day) + Washout (7days)||0
6740563|NCT03305419|7669401|FG000|STARTED|Part A Period 3 (1Day) + Washout (7days)|2 participants were added to GSK2982772 120 mg TID/240 mg TID/360 mg BID arm after Washout Period.|3
6740564|NCT03305419|7669402|FG001|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6740565|NCT03305419|7669403|FG002|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6740566|NCT03305419|7669404|FG003|STARTED|Part A Period 3 (1Day) + Washout (7days)||3
6397095|NCT00868608|7309842|FG001|COMPLETED|Overall Study||1
6397096|NCT00868608|7309843|FG002|COMPLETED|Overall Study||0
6397097|NCT00868608|7309841|FG000|NOT COMPLETED|Overall Study||23
6397098|NCT00868608|7309842|FG001|NOT COMPLETED|Overall Study||3
6397099|NCT00868608|7309843|FG002|NOT COMPLETED|Overall Study||5
6397100|NCT00868699|7309854|FG000|STARTED|Overall Study||170
6397101|NCT00868699|7309855|FG001|STARTED|Overall Study||169
6397102|NCT00868699|7309856|FG002|STARTED|Overall Study||166
6740567|NCT03305419|7669405|FG004|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6740568|NCT03305419|7669406|FG005|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6740569|NCT03305419|7669407|FG006|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6397103|NCT00868699|7309854|FG000|Intent-to-Treat Population|Overall Study||162
6740570|NCT03305419|7669408|FG007|STARTED|Part A Period 3 (1Day) + Washout (7days)||0
6740571|NCT03305419|7669401|FG000|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6740572|NCT03305419|7669402|FG001|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6740573|NCT03305419|7669403|FG002|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6740574|NCT03305419|7669404|FG003|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||3
6740575|NCT03305419|7669405|FG004|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740576|NCT03305419|7669406|FG005|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740577|NCT03305419|7669407|FG006|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740578|NCT03305419|7669408|FG007|COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740579|NCT03305419|7669401|FG000|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740580|NCT03305419|7669402|FG001|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6397104|NCT00868699|7309855|FG001|Intent-to-Treat Population|Overall Study||162
6397105|NCT00868699|7309856|FG002|Intent-to-Treat Population|Overall Study||161
6626773|NCT02234427|7554421|FG000|NOT COMPLETED|Overall Study||1
6626774|NCT02234479|7554427|FG000|STARTED|Overall Study||16
6626775|NCT02234479|7554428|FG001|STARTED|Overall Study||18
6626776|NCT02234479|7554427|FG000|COMPLETED|Overall Study||15
6626777|NCT02234479|7554428|FG001|COMPLETED|Overall Study||15
6626778|NCT02234479|7554427|FG000|NOT COMPLETED|Overall Study||1
6740581|NCT03305419|7669403|FG002|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740582|NCT03305419|7669404|FG003|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740583|NCT03305419|7669405|FG004|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740584|NCT03305419|7669406|FG005|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6397106|NCT00868699|7309854|FG000|Safety Population|Overall Study||168
6397107|NCT00868699|7309855|FG001|Safety Population|Overall Study||167
6397108|NCT00868699|7309856|FG002|Safety Population|Overall Study||164
6397109|NCT00868699|7309854|FG000|COMPLETED|Overall Study||127
6397110|NCT00868699|7309855|FG001|COMPLETED|Overall Study||124
6397111|NCT00868699|7309856|FG002|COMPLETED|Overall Study||123
6397112|NCT00868699|7309854|FG000|NOT COMPLETED|Overall Study||43
6397113|NCT00868699|7309855|FG001|NOT COMPLETED|Overall Study||45
6397114|NCT00868699|7309856|FG002|NOT COMPLETED|Overall Study||43
6397115|NCT00868712|7309867|FG000|STARTED|Overall Study||31
6397116|NCT00868712|7309868|FG001|STARTED|Overall Study||11
6397117|NCT00868712|7309869|FG002|STARTED|Overall Study||28
6397118|NCT00868712|7309867|FG000|COMPLETED|Overall Study||31
6397119|NCT00868712|7309868|FG001|COMPLETED|Overall Study||11
6397120|NCT00868712|7309869|FG002|COMPLETED|Overall Study||28
6397121|NCT00868712|7309867|FG000|NOT COMPLETED|Overall Study||0
6397122|NCT00868712|7309868|FG001|NOT COMPLETED|Overall Study||0
6397123|NCT00868712|7309869|FG002|NOT COMPLETED|Overall Study||0
6397124|NCT00868751|7309877|FG000|STARTED|Overall Study||1
6397125|NCT00868751|7309877|FG000|COMPLETED|Overall Study||0
6397126|NCT00868751|7309877|FG000|NOT COMPLETED|Overall Study||1
6397127|NCT00868790|7309881|FG000|STARTED|Period 1||11
6397128|NCT00868790|7309882|FG001|STARTED|Period 1||8
6397129|NCT00868790|7309883|FG002|STARTED|Period 1||4
6397130|NCT00868790|7309884|FG003|STARTED|Period 1||4
6397131|NCT00868790|7309885|FG004|STARTED|Period 1||19
6397132|NCT00868790|7309886|FG005|STARTED|Period 1||3
6397133|NCT00868790|7309887|FG006|STARTED|Period 1||4
6397134|NCT00868790|7309888|FG007|STARTED|Period 1||20
6397135|NCT00868790|7309889|FG008|STARTED|Period 1||11
6397136|NCT00868790|7309890|FG009|STARTED|Period 1||3
6397137|NCT00868790|7309891|FG010|STARTED|Period 1||9
6397138|NCT00868790|7309892|FG011|STARTED|Period 1||4
6397139|NCT00868790|7309893|FG012|STARTED|Period 1||7
6397140|NCT00868790|7309894|FG013|STARTED|Period 1||11
6397141|NCT00868790|7309881|FG000|COMPLETED|Period 1||9
6397142|NCT00868790|7309882|FG001|COMPLETED|Period 1||7
6397143|NCT00868790|7309883|FG002|COMPLETED|Period 1||4
6397144|NCT00868790|7309884|FG003|COMPLETED|Period 1||4
6397145|NCT00868790|7309885|FG004|COMPLETED|Period 1||18
6397146|NCT00868790|7309886|FG005|COMPLETED|Period 1||2
6397147|NCT00868790|7309887|FG006|COMPLETED|Period 1||4
6397148|NCT00868790|7309888|FG007|COMPLETED|Period 1||17
6397149|NCT00868790|7309889|FG008|COMPLETED|Period 1||10
6397150|NCT00868790|7309890|FG009|COMPLETED|Period 1||3
6397151|NCT00868790|7309891|FG010|COMPLETED|Period 1||9
6397152|NCT00868790|7309892|FG011|COMPLETED|Period 1||4
6397153|NCT00868790|7309893|FG012|COMPLETED|Period 1||7
6397154|NCT00868790|7309894|FG013|COMPLETED|Period 1||9
6397155|NCT00868790|7309881|FG000|NOT COMPLETED|Period 1||2
6397156|NCT00868790|7309882|FG001|NOT COMPLETED|Period 1||1
6397157|NCT00868790|7309883|FG002|NOT COMPLETED|Period 1||0
6397158|NCT00868790|7309884|FG003|NOT COMPLETED|Period 1||0
6397159|NCT00868790|7309885|FG004|NOT COMPLETED|Period 1||1
6397160|NCT00868790|7309886|FG005|NOT COMPLETED|Period 1||1
6397161|NCT00868790|7309887|FG006|NOT COMPLETED|Period 1||0
6397162|NCT00868790|7309888|FG007|NOT COMPLETED|Period 1||3
6397163|NCT00868790|7309889|FG008|NOT COMPLETED|Period 1||1
6397164|NCT00868790|7309890|FG009|NOT COMPLETED|Period 1||0
6397165|NCT00868790|7309891|FG010|NOT COMPLETED|Period 1||0
6397166|NCT00868790|7309892|FG011|NOT COMPLETED|Period 1||0
6397167|NCT00868790|7309893|FG012|NOT COMPLETED|Period 1||0
6397168|NCT00868790|7309894|FG013|NOT COMPLETED|Period 1||2
6397169|NCT00868790|7309881|FG000|STARTED|Period 2||9
6397170|NCT00868790|7309882|FG001|STARTED|Period 2||7
6397171|NCT00868790|7309883|FG002|STARTED|Period 2||4
6397172|NCT00868790|7309884|FG003|STARTED|Period 2||4
6397173|NCT00868790|7309885|FG004|STARTED|Period 2||18
6397174|NCT00868790|7309886|FG005|STARTED|Period 2||2
6397175|NCT00868790|7309887|FG006|STARTED|Period 2||4
6397176|NCT00868790|7309888|FG007|STARTED|Period 2||17
6397177|NCT00868790|7309889|FG008|STARTED|Period 2||10
6397178|NCT00868790|7309890|FG009|STARTED|Period 2||3
6397179|NCT00868790|7309891|FG010|STARTED|Period 2||9
6397180|NCT00868790|7309892|FG011|STARTED|Period 2||4
6397181|NCT00868790|7309893|FG012|STARTED|Period 2||7
6397182|NCT00868790|7309894|FG013|STARTED|Period 2||9
6397183|NCT00868790|7309881|FG000|COMPLETED|Period 2||9
6397184|NCT00868790|7309882|FG001|COMPLETED|Period 2||6
6397185|NCT00868790|7309883|FG002|COMPLETED|Period 2||4
6397186|NCT00868790|7309884|FG003|COMPLETED|Period 2||4
6397187|NCT00868790|7309885|FG004|COMPLETED|Period 2||18
6397188|NCT00868790|7309886|FG005|COMPLETED|Period 2||1
6397189|NCT00868790|7309887|FG006|COMPLETED|Period 2||4
6397190|NCT00868790|7309888|FG007|COMPLETED|Period 2||17
6397191|NCT00868790|7309889|FG008|COMPLETED|Period 2||8
6397192|NCT00868790|7309890|FG009|COMPLETED|Period 2||3
6740585|NCT03305419|7669407|FG006|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740586|NCT03305419|7669408|FG007|NOT COMPLETED|Part A Period 3 (1Day) + Washout (7days)||0
6740587|NCT03305419|7669401|FG000|STARTED|Part B (14 Days)||0
6282147|NCT00179413|7182370|FG000|COMPLETED|Overall Study||157
6397193|NCT00868790|7309891|FG010|COMPLETED|Period 2||9
6397194|NCT00868790|7309892|FG011|COMPLETED|Period 2||4
6397195|NCT00868790|7309893|FG012|COMPLETED|Period 2||7
6397196|NCT00868790|7309894|FG013|COMPLETED|Period 2||8
6397197|NCT00868790|7309881|FG000|NOT COMPLETED|Period 2||0
6397198|NCT00868790|7309882|FG001|NOT COMPLETED|Period 2||1
6397199|NCT00868790|7309883|FG002|NOT COMPLETED|Period 2||0
6397200|NCT00868790|7309884|FG003|NOT COMPLETED|Period 2||0
6397201|NCT00868790|7309885|FG004|NOT COMPLETED|Period 2||0
6397202|NCT00868790|7309886|FG005|NOT COMPLETED|Period 2||1
6397203|NCT00868790|7309887|FG006|NOT COMPLETED|Period 2||0
6397204|NCT00868790|7309888|FG007|NOT COMPLETED|Period 2||0
6397205|NCT00868790|7309889|FG008|NOT COMPLETED|Period 2||2
6397206|NCT00868790|7309890|FG009|NOT COMPLETED|Period 2||0
6397207|NCT00868790|7309891|FG010|NOT COMPLETED|Period 2||0
6397208|NCT00868790|7309892|FG011|NOT COMPLETED|Period 2||0
6397209|NCT00868790|7309893|FG012|NOT COMPLETED|Period 2||0
6397210|NCT00868790|7309894|FG013|NOT COMPLETED|Period 2||1
6397211|NCT00868790|7309881|FG000|STARTED|Period 3||9
6397212|NCT00868790|7309882|FG001|STARTED|Period 3||6
6397213|NCT00868790|7309883|FG002|STARTED|Period 3||4
6397214|NCT00868790|7309884|FG003|STARTED|Period 3||4
6397215|NCT00868790|7309885|FG004|STARTED|Period 3||18
6397216|NCT00868790|7309886|FG005|STARTED|Period 3||1
6397217|NCT00868790|7309887|FG006|STARTED|Period 3||4
6397218|NCT00868790|7309888|FG007|STARTED|Period 3||17
6397219|NCT00868790|7309889|FG008|STARTED|Period 3||8
6397220|NCT00868790|7309890|FG009|STARTED|Period 3||3
6397221|NCT00868790|7309891|FG010|STARTED|Period 3||9
6397222|NCT00868790|7309892|FG011|STARTED|Period 3||4
6397223|NCT00868790|7309893|FG012|STARTED|Period 3||7
6397224|NCT00868790|7309894|FG013|STARTED|Period 3||8
6397225|NCT00868790|7309881|FG000|COMPLETED|Period 3||9
6397226|NCT00868790|7309882|FG001|COMPLETED|Period 3||6
6397227|NCT00868790|7309883|FG002|COMPLETED|Period 3||4
6397228|NCT00868790|7309884|FG003|COMPLETED|Period 3||3
6397229|NCT00868790|7309885|FG004|COMPLETED|Period 3||18
6397230|NCT00868790|7309886|FG005|COMPLETED|Period 3||1
6397231|NCT00868790|7309887|FG006|COMPLETED|Period 3||4
6397232|NCT00868790|7309888|FG007|COMPLETED|Period 3||17
6397233|NCT00868790|7309889|FG008|COMPLETED|Period 3||8
6509983|NCT01478581|7429438|FG003|STARTED|Overall Study|Simon 2-stage design - cohort 4 expansion per stage 1 data (≥3 Clinical Benefit Responders observed|43
6509984|NCT01478581|7429435|FG000|COMPLETED|Overall Study||13
6509985|NCT01478581|7429436|FG001|COMPLETED|Overall Study||18
6509986|NCT01478581|7429437|FG002|COMPLETED|Overall Study||18
6509987|NCT01478581|7429438|FG003|COMPLETED|Overall Study||43
6509988|NCT01478581|7429435|FG000|NOT COMPLETED|Overall Study||0
6509989|NCT01478581|7429436|FG001|NOT COMPLETED|Overall Study||0
6509990|NCT01478581|7429437|FG002|NOT COMPLETED|Overall Study||0
6509991|NCT01478581|7429438|FG003|NOT COMPLETED|Overall Study||0
6509992|NCT01478594|7429454|FG000|STARTED|Overall Study||177
6509993|NCT01478594|7429455|FG001|STARTED|Overall Study||88
6509994|NCT01478594|7429454|FG000|Treated|Overall Study||177
6509995|NCT01478594|7429455|FG001|Treated|Overall Study||87
6509996|NCT01478594|7429454|FG000|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
6509997|NCT01478594|7429455|FG001|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
6509998|NCT01478594|7429454|FG000|NOT COMPLETED|Overall Study||65
6509999|NCT01478594|7429455|FG001|NOT COMPLETED|Overall Study||28
6510000|NCT01478620|7429514|FG000|STARTED|Overall Study||125
6510001|NCT01478620|7429514|FG000|COMPLETED|Overall Study||119
6510002|NCT01478620|7429514|FG000|NOT COMPLETED|Overall Study||6
6510003|NCT01478828|7429518|FG000|STARTED|Overall Study||2
6510004|NCT01478828|7429518|FG000|COMPLETED|Overall Study||1
6510005|NCT01478828|7429518|FG000|NOT COMPLETED|Overall Study||1
6740588|NCT03305419|7669402|FG001|STARTED|Part B (14 Days)||0
6282148|NCT00179413|7182371|FG001|COMPLETED|Overall Study||152
6282149|NCT00179413|7182370|FG000|NOT COMPLETED|Overall Study||125
6282150|NCT00179413|7182371|FG001|NOT COMPLETED|Overall Study||115
6282151|NCT00179478|7182379|FG000|STARTED|Overall Study||81
6282152|NCT00179478|7182380|FG001|STARTED|Overall Study||74
6282153|NCT00179478|7182379|FG000|COMPLETED|Overall Study||68
6282154|NCT00179478|7182380|FG001|COMPLETED|Overall Study||59
6282155|NCT00179478|7182379|FG000|NOT COMPLETED|Overall Study||13
6282156|NCT00179478|7182380|FG001|NOT COMPLETED|Overall Study||15
6282157|NCT00179517|7182387|FG000|STARTED|Overall Study||20
6282158|NCT00179517|7182388|FG001|STARTED|Overall Study||20
6282159|NCT00179517|7182387|FG000|COMPLETED|Overall Study||18
6282160|NCT00179517|7182388|FG001|COMPLETED|Overall Study||19
6282161|NCT00179517|7182387|FG000|NOT COMPLETED|Overall Study||2
6282162|NCT00179517|7182388|FG001|NOT COMPLETED|Overall Study||1
6282163|NCT00179621|7182397|FG000|STARTED|Double-Blind Period||67
6282164|NCT00179621|7182398|FG001|STARTED|Double-Blind Period||69
6397234|NCT00868790|7309890|FG009|COMPLETED|Period 3||2
6397235|NCT00868790|7309891|FG010|COMPLETED|Period 3||8
6397236|NCT00868790|7309892|FG011|COMPLETED|Period 3||4
6397237|NCT00868790|7309893|FG012|COMPLETED|Period 3||7
6397238|NCT00868790|7309894|FG013|COMPLETED|Period 3||8
6397239|NCT00868790|7309881|FG000|NOT COMPLETED|Period 3||0
6397240|NCT00868790|7309882|FG001|NOT COMPLETED|Period 3||0
6740589|NCT03305419|7669403|FG002|STARTED|Part B (14 Days)||0
6740590|NCT03305419|7669404|FG003|STARTED|Part B (14 Days)||0
6740591|NCT03305419|7669405|FG004|STARTED|Part B (14 Days)||14
6740592|NCT03305419|7669406|FG005|STARTED|Part B (14 Days)||20
6740593|NCT03305419|7669407|FG006|STARTED|Part B (14 Days)||13
6740594|NCT03305419|7669408|FG007|STARTED|Part B (14 Days)||0
6740595|NCT03305419|7669401|FG000|COMPLETED|Part B (14 Days)||0
6740596|NCT03305419|7669402|FG001|COMPLETED|Part B (14 Days)||0
6740597|NCT03305419|7669403|FG002|COMPLETED|Part B (14 Days)||0
6740598|NCT03305419|7669404|FG003|COMPLETED|Part B (14 Days)||0
6740599|NCT03305419|7669405|FG004|COMPLETED|Part B (14 Days)||11
6740600|NCT03305419|7669406|FG005|COMPLETED|Part B (14 Days)||10
6740601|NCT03305419|7669407|FG006|COMPLETED|Part B (14 Days)||8
6740602|NCT03305419|7669408|FG007|COMPLETED|Part B (14 Days)||0
6740603|NCT03305419|7669401|FG000|NOT COMPLETED|Part B (14 Days)||0
6740604|NCT03305419|7669402|FG001|NOT COMPLETED|Part B (14 Days)||0
6397241|NCT00868790|7309883|FG002|NOT COMPLETED|Period 3||0
6397242|NCT00868790|7309884|FG003|NOT COMPLETED|Period 3||1
6397243|NCT00868790|7309885|FG004|NOT COMPLETED|Period 3||0
6397244|NCT00868790|7309886|FG005|NOT COMPLETED|Period 3||0
6397245|NCT00868790|7309887|FG006|NOT COMPLETED|Period 3||0
6397246|NCT00868790|7309888|FG007|NOT COMPLETED|Period 3||0
6397247|NCT00868790|7309889|FG008|NOT COMPLETED|Period 3||0
6397248|NCT00868790|7309890|FG009|NOT COMPLETED|Period 3||1
6397249|NCT00868790|7309891|FG010|NOT COMPLETED|Period 3||1
6397250|NCT00868790|7309892|FG011|NOT COMPLETED|Period 3||0
6397251|NCT00868790|7309893|FG012|NOT COMPLETED|Period 3||0
6397252|NCT00868790|7309894|FG013|NOT COMPLETED|Period 3||0
6397253|NCT00868790|7309881|FG000|STARTED|Period 4||9
6397254|NCT00868790|7309882|FG001|STARTED|Period 4||6
6397255|NCT00868790|7309883|FG002|STARTED|Period 4||4
6397256|NCT00868790|7309884|FG003|STARTED|Period 4||3
6397257|NCT00868790|7309885|FG004|STARTED|Period 4||18
6397258|NCT00868790|7309886|FG005|STARTED|Period 4||1
6397259|NCT00868790|7309887|FG006|STARTED|Period 4||4
6397260|NCT00868790|7309888|FG007|STARTED|Period 4||17
6397261|NCT00868790|7309889|FG008|STARTED|Period 4||8
6397262|NCT00868790|7309890|FG009|STARTED|Period 4||2
6397263|NCT00868790|7309891|FG010|STARTED|Period 4||8
6397264|NCT00868790|7309892|FG011|STARTED|Period 4||4
6397265|NCT00868790|7309893|FG012|STARTED|Period 4||7
6397266|NCT00868790|7309894|FG013|STARTED|Period 4||8
6397267|NCT00868790|7309881|FG000|COMPLETED|Period 4||7
6397268|NCT00868790|7309882|FG001|COMPLETED|Period 4||6
6397269|NCT00868790|7309883|FG002|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
6397270|NCT00868790|7309884|FG003|COMPLETED|Period 4||3
6397271|NCT00868790|7309885|FG004|COMPLETED|Period 4||18
6397272|NCT00868790|7309886|FG005|COMPLETED|Period 4||1
6397273|NCT00868790|7309887|FG006|COMPLETED|Period 4||4
6397274|NCT00868790|7309888|FG007|COMPLETED|Period 4||14
6397275|NCT00868790|7309889|FG008|COMPLETED|Period 4||6
6397276|NCT00868790|7309890|FG009|COMPLETED|Period 4||2
6397277|NCT00868790|7309891|FG010|COMPLETED|Period 4||5
6397278|NCT00868790|7309892|FG011|COMPLETED|Period 4||3
6397279|NCT00868790|7309893|FG012|COMPLETED|Period 4||6
6397280|NCT00868790|7309894|FG013|COMPLETED|Period 4||7
6397281|NCT00868790|7309881|FG000|NOT COMPLETED|Period 4||2
6397282|NCT00868790|7309882|FG001|NOT COMPLETED|Period 4||0
6397283|NCT00868790|7309883|FG002|NOT COMPLETED|Period 4||1
6397284|NCT00868790|7309884|FG003|NOT COMPLETED|Period 4||0
6397285|NCT00868790|7309885|FG004|NOT COMPLETED|Period 4||0
6397286|NCT00868790|7309886|FG005|NOT COMPLETED|Period 4||0
6397287|NCT00868790|7309887|FG006|NOT COMPLETED|Period 4||0
6397288|NCT00868790|7309888|FG007|NOT COMPLETED|Period 4||3
6397289|NCT00868790|7309889|FG008|NOT COMPLETED|Period 4||2
6397290|NCT00868790|7309890|FG009|NOT COMPLETED|Period 4||0
6397291|NCT00868790|7309891|FG010|NOT COMPLETED|Period 4||3
6397292|NCT00868790|7309892|FG011|NOT COMPLETED|Period 4||1
6397293|NCT00868790|7309893|FG012|NOT COMPLETED|Period 4||1
6397294|NCT00868790|7309894|FG013|NOT COMPLETED|Period 4||1
6397295|NCT00868790|7309881|FG000|STARTED|Post-study||7
6397296|NCT00868790|7309882|FG001|STARTED|Post-study||6
6397297|NCT00868790|7309883|FG002|STARTED|Post-study||3
6397298|NCT00868790|7309884|FG003|STARTED|Post-study||3
6397299|NCT00868790|7309885|FG004|STARTED|Post-study||18
6397300|NCT00868790|7309886|FG005|STARTED|Post-study||1
6397301|NCT00868790|7309887|FG006|STARTED|Post-study||4
6397302|NCT00868790|7309888|FG007|STARTED|Post-study||14
6397303|NCT00868790|7309889|FG008|STARTED|Post-study||6
6397304|NCT00868790|7309890|FG009|STARTED|Post-study||2
6397305|NCT00868790|7309891|FG010|STARTED|Post-study||5
6740605|NCT03305419|7669403|FG002|NOT COMPLETED|Part B (14 Days)||0
6740606|NCT03305419|7669404|FG003|NOT COMPLETED|Part B (14 Days)||0
6740607|NCT03305419|7669405|FG004|NOT COMPLETED|Part B (14 Days)||3
6740608|NCT03305419|7669406|FG005|NOT COMPLETED|Part B (14 Days)||10
6397306|NCT00868790|7309892|FG011|STARTED|Post-study||3
6397307|NCT00868790|7309893|FG012|STARTED|Post-study||6
6397308|NCT00868790|7309894|FG013|STARTED|Post-study||7
6397309|NCT00868790|7309881|FG000|COMPLETED|Post-study||7
6397310|NCT00868790|7309882|FG001|COMPLETED|Post-study||6
6397311|NCT00868790|7309883|FG002|COMPLETED|Post-study||3
6397312|NCT00868790|7309884|FG003|COMPLETED|Post-study||3
6397313|NCT00868790|7309885|FG004|COMPLETED|Post-study||17
6397314|NCT00868790|7309886|FG005|COMPLETED|Post-study||1
6397315|NCT00868790|7309887|FG006|COMPLETED|Post-study||4
6397316|NCT00868790|7309888|FG007|COMPLETED|Post-study||12
6740609|NCT03305419|7669407|FG006|NOT COMPLETED|Part B (14 Days)||5
6740610|NCT03305419|7669408|FG007|NOT COMPLETED|Part B (14 Days)||0
6779577|NCT03728790|7707744|FG000|STARTED|Overall Study||112
6779578|NCT03728790|7707745|FG001|STARTED|Overall Study||101
6397317|NCT00868790|7309889|FG008|COMPLETED|Post-study||6
6397318|NCT00868790|7309890|FG009|COMPLETED|Post-study||1
6397319|NCT00868790|7309891|FG010|COMPLETED|Post-study||5
6397320|NCT00868790|7309892|FG011|COMPLETED|Post-study||3
6397321|NCT00868790|7309893|FG012|COMPLETED|Post-study||6
6397322|NCT00868790|7309894|FG013|COMPLETED|Post-study||7
6397323|NCT00868790|7309881|FG000|NOT COMPLETED|Post-study||0
6397324|NCT00868790|7309882|FG001|NOT COMPLETED|Post-study||0
6397325|NCT00868790|7309883|FG002|NOT COMPLETED|Post-study||0
6397326|NCT00868790|7309884|FG003|NOT COMPLETED|Post-study||0
6397327|NCT00868790|7309885|FG004|NOT COMPLETED|Post-study||1
6397328|NCT00868790|7309886|FG005|NOT COMPLETED|Post-study||0
6397329|NCT00868790|7309887|FG006|NOT COMPLETED|Post-study||0
6397330|NCT00868790|7309888|FG007|NOT COMPLETED|Post-study||2
6397331|NCT00868790|7309889|FG008|NOT COMPLETED|Post-study||0
6397332|NCT00868790|7309890|FG009|NOT COMPLETED|Post-study||1
6397333|NCT00868790|7309891|FG010|NOT COMPLETED|Post-study||0
6397334|NCT00868790|7309892|FG011|NOT COMPLETED|Post-study||0
6397335|NCT00868790|7309893|FG012|NOT COMPLETED|Post-study||0
6397336|NCT00868790|7309894|FG013|NOT COMPLETED|Post-study||0
6397337|NCT00868959|7309910|FG000|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
6397338|NCT00868959|7309910|FG000|COMPLETED|Overall Study||559
6397339|NCT00868959|7309910|FG000|NOT COMPLETED|Overall Study||258
6397340|NCT00869024|7309916|FG000|STARTED|Overall Study||16
6510006|NCT01478854|7429523|FG000|STARTED|Overall Study||30
6510007|NCT01478854|7429523|FG000|COMPLETED|Overall Study||30
6510008|NCT01478854|7429523|FG000|NOT COMPLETED|Overall Study||0
6510009|NCT01478958|7429530|FG000|STARTED|Overall Study||67
6510010|NCT01478958|7429531|FG001|STARTED|Overall Study||66
6510011|NCT01478958|7429532|FG002|STARTED|Overall Study||69
6510012|NCT01478958|7429530|FG000|COMPLETED|Overall Study||65
6510013|NCT01478958|7429531|FG001|COMPLETED|Overall Study||64
6510014|NCT01478958|7429532|FG002|COMPLETED|Overall Study||66
6510015|NCT01478958|7429530|FG000|NOT COMPLETED|Overall Study||2
6510016|NCT01478958|7429531|FG001|NOT COMPLETED|Overall Study||2
6510017|NCT01478958|7429532|FG002|NOT COMPLETED|Overall Study||3
6397341|NCT00869024|7309917|FG001|STARTED|Overall Study|One patient intent to treat, did not receive study product|9
6397342|NCT00869024|7309916|FG000|COMPLETED|Overall Study||14
6397343|NCT00869024|7309917|FG001|COMPLETED|Overall Study||4
6397344|NCT00869024|7309916|FG000|NOT COMPLETED|Overall Study||2
6397345|NCT00869024|7309917|FG001|NOT COMPLETED|Overall Study||5
6397346|NCT00869050|7309923|FG000|STARTED|Overall Study||41
6510018|NCT01478971|7429540|FG000|STARTED|Standard of Care Period||184
6510019|NCT01478971|7429540|FG000|Received Treatment|Standard of Care Period||178
6510020|NCT01478971|7429540|FG000|COMPLETED|Standard of Care Period||159
6510021|NCT01478971|7429540|FG000|NOT COMPLETED|Standard of Care Period||25
6510022|NCT01478971|7429540|FG000|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
6510023|NCT01478971|7429540|FG000|COMPLETED|Peginesatide Treatment Period||143
6510024|NCT01478971|7429540|FG000|NOT COMPLETED|Peginesatide Treatment Period||14
6510025|NCT01479127|7429548|FG000|STARTED|Overall Study|started oral study drug (full safety sample)|8
6510026|NCT01479127|7429548|FG000|Started LCIG|Overall Study||6
6510027|NCT01479127|7429548|FG000|COMPLETED|Overall Study||5
6510028|NCT01479127|7429548|FG000|NOT COMPLETED|Overall Study||3
6510029|NCT01479270|7429558|FG000|STARTED|Overall Study||28
6510030|NCT01479270|7429559|FG001|STARTED|Overall Study||28
6510031|NCT01479270|7429558|FG000|COMPLETED|Overall Study||28
6510032|NCT01479270|7429559|FG001|COMPLETED|Overall Study||28
6510033|NCT01479270|7429558|FG000|NOT COMPLETED|Overall Study||0
6510034|NCT01479270|7429559|FG001|NOT COMPLETED|Overall Study||0
6510035|NCT01479348|7429568|FG000|STARTED|Overall Study||5
6510036|NCT01479348|7429569|FG001|STARTED|Overall Study||0
6510037|NCT01479348|7429568|FG000|COMPLETED|Overall Study||5
6510038|NCT01479348|7429569|FG001|COMPLETED|Overall Study||0
6510039|NCT01479348|7429568|FG000|NOT COMPLETED|Overall Study||0
6510040|NCT01479348|7429569|FG001|NOT COMPLETED|Overall Study||0
6510041|NCT01479374|7429576|FG000|STARTED|Overall Study||66
6510042|NCT01479374|7429577|FG001|STARTED|Overall Study||68
6510043|NCT01479374|7429578|FG002|STARTED|Overall Study||68
6510044|NCT01479374|7429576|FG000|COMPLETED|Overall Study||63
6510045|NCT01479374|7429577|FG001|COMPLETED|Overall Study||60
6510046|NCT01479374|7429578|FG002|COMPLETED|Overall Study||63
6510047|NCT01479374|7429576|FG000|NOT COMPLETED|Overall Study||3
6510048|NCT01479374|7429577|FG001|NOT COMPLETED|Overall Study||8
6510049|NCT01479374|7429578|FG002|NOT COMPLETED|Overall Study||5
6510050|NCT01479426|7429588|FG000|STARTED|Overall Study||40
6510051|NCT01479426|7429589|FG001|STARTED|Overall Study||40
6510052|NCT01479426|7429588|FG000|COMPLETED|Overall Study||36
6510053|NCT01479426|7429589|FG001|COMPLETED|Overall Study||37
6779579|NCT03728790|7707744|FG000|COMPLETED|Overall Study||112
6779580|NCT03728790|7707745|FG001|COMPLETED|Overall Study||101
6510054|NCT01479426|7429588|FG000|NOT COMPLETED|Overall Study||4
6510055|NCT01479426|7429589|FG001|NOT COMPLETED|Overall Study||3
6510056|NCT01479439|7429598|FG000|STARTED|Overall Study||15
6510057|NCT01479439|7429599|FG001|STARTED|Overall Study||13
6510058|NCT01479439|7429600|FG002|STARTED|Overall Study||8
6510059|NCT01479439|7429598|FG000|COMPLETED|Overall Study||14
6740611|NCT03305575|7669433|FG000|STARTED|Overall Study||5
6740612|NCT03305575|7669434|FG001|STARTED|Overall Study||5
6740613|NCT03305575|7669433|FG000|COMPLETED|Overall Study||4
6740614|NCT03305575|7669434|FG001|COMPLETED|Overall Study||5
6740615|NCT03305575|7669433|FG000|NOT COMPLETED|Overall Study||1
6740616|NCT03305575|7669434|FG001|NOT COMPLETED|Overall Study||0
6740617|NCT03305653|7669440|FG000|STARTED|Overall Study||21
6740618|NCT03305653|7669440|FG000|COMPLETED|Overall Study||21
6740619|NCT03305653|7669440|FG000|NOT COMPLETED|Overall Study||0
6740620|NCT03305666|7669446|FG000|STARTED|Overall Study||18
6740621|NCT03305666|7669447|FG001|STARTED|Overall Study||18
6740622|NCT03305666|7669446|FG000|COMPLETED|Overall Study||16
6740623|NCT03305666|7669447|FG001|COMPLETED|Overall Study||18
6740624|NCT03305666|7669446|FG000|NOT COMPLETED|Overall Study||2
6740625|NCT03305666|7669447|FG001|NOT COMPLETED|Overall Study||0
6740626|NCT03305731|7669453|FG000|STARTED|Overall Study||21
6740627|NCT03305731|7669453|FG000|Week 6|Overall Study||20
6740628|NCT03305731|7669453|FG000|Week 11|Overall Study||20
6740629|NCT03305731|7669453|FG000|COMPLETED|Overall Study||20
6740630|NCT03305731|7669453|FG000|NOT COMPLETED|Overall Study||1
6740631|NCT03305770|7669459|FG000|STARTED|Overall Study||70
6740632|NCT03305770|7669460|FG001|STARTED|Overall Study||37
6740633|NCT03305770|7669459|FG000|Enrolled Dispensed Analysis Set|Overall Study||70
6740634|NCT03305770|7669460|FG001|Enrolled Dispensed Analysis Set|Overall Study||36
6740635|NCT03305770|7669459|FG000|Completed Analysis Set|Overall Study||69
6397347|NCT00869050|7309923|FG000|COMPLETED|Overall Study||38
6397348|NCT00869050|7309923|FG000|NOT COMPLETED|Overall Study||3
6397349|NCT00869089|7309927|FG000|STARTED|Overall Study||5
6397350|NCT00869089|7309927|FG000|COMPLETED|Overall Study||2
6397351|NCT00869089|7309927|FG000|NOT COMPLETED|Overall Study||3
6397352|NCT00869141|7309933|FG000|STARTED|Overall Study||26
6397353|NCT00869141|7309934|FG001|STARTED|Overall Study||26
6397354|NCT00869141|7309933|FG000|COMPLETED|Overall Study||26
6397355|NCT00869141|7309934|FG001|COMPLETED|Overall Study||26
6397356|NCT00869141|7309933|FG000|NOT COMPLETED|Overall Study||0
6397357|NCT00869141|7309934|FG001|NOT COMPLETED|Overall Study||0
6397358|NCT00869167|7309944|FG000|STARTED|Overall Study||2
6397359|NCT00869167|7309945|FG001|STARTED|Overall Study||1
6397360|NCT00869167|7309944|FG000|COMPLETED|Overall Study||2
6397361|NCT00869167|7309945|FG001|COMPLETED|Overall Study||0
6397362|NCT00869167|7309944|FG000|NOT COMPLETED|Overall Study||0
6397363|NCT00869167|7309945|FG001|NOT COMPLETED|Overall Study||1
6397364|NCT00869206|7309955|FG000|STARTED|Overall Study||911
6397365|NCT00869206|7309956|FG001|STARTED|Overall Study||911
6397366|NCT00869206|7309955|FG000|COMPLETED|Overall Study||882
6397367|NCT00869206|7309956|FG001|COMPLETED|Overall Study||884
6397368|NCT00869206|7309955|FG000|NOT COMPLETED|Overall Study||29
6397369|NCT00869206|7309956|FG001|NOT COMPLETED|Overall Study||27
6397370|NCT00869323|7309968|FG000|STARTED|Induction Therapy||3
6397371|NCT00869323|7309968|FG000|COMPLETED|Induction Therapy||3
6397372|NCT00869323|7309968|FG000|NOT COMPLETED|Induction Therapy||0
6397373|NCT00869323|7309968|FG000|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
6397374|NCT00869323|7309968|FG000|COMPLETED|Maintenance Therapy||1
6397375|NCT00869323|7309968|FG000|NOT COMPLETED|Maintenance Therapy||1
6397376|NCT00869349|7309974|FG000|STARTED|Overall Study||39
6397377|NCT00869349|7309975|FG001|STARTED|Overall Study||40
6397378|NCT00869349|7309974|FG000|COMPLETED|Overall Study||32
6397379|NCT00869349|7309975|FG001|COMPLETED|Overall Study||36
6397380|NCT00869349|7309974|FG000|NOT COMPLETED|Overall Study||7
6397381|NCT00869349|7309975|FG001|NOT COMPLETED|Overall Study||4
6397382|NCT00869362|7309983|FG000|STARTED|Overall Study||15
6397383|NCT00869362|7309984|FG001|STARTED|Overall Study||16
6397384|NCT00869362|7309983|FG000|COMPLETED|Overall Study||14
6397385|NCT00869362|7309984|FG001|COMPLETED|Overall Study||11
6397386|NCT00869362|7309983|FG000|NOT COMPLETED|Overall Study||1
6397387|NCT00869362|7309984|FG001|NOT COMPLETED|Overall Study||5
6397388|NCT00869375|7309993|FG000|STARTED|Overall Study||3
6397389|NCT00869375|7309994|FG001|STARTED|Overall Study||3
6397390|NCT00869375|7309993|FG000|COMPLETED|Overall Study||3
6397391|NCT00869375|7309994|FG001|COMPLETED|Overall Study||3
6397392|NCT00869375|7309993|FG000|NOT COMPLETED|Overall Study||0
6397393|NCT00869375|7309994|FG001|NOT COMPLETED|Overall Study||0
6397394|NCT00869401|7310005|FG000|STARTED|Overall Study||3
6397395|NCT00869401|7310006|FG001|STARTED|Overall Study||3
6397396|NCT00869401|7310007|FG002|STARTED|Overall Study||7
6397397|NCT00869401|7310008|FG003|STARTED|Overall Study||138
6397398|NCT00869401|7310009|FG004|STARTED|Overall Study||66
6397399|NCT00869401|7310005|FG000|COMPLETED|Overall Study||3
6397400|NCT00869401|7310006|FG001|COMPLETED|Overall Study||3
6397401|NCT00869401|7310007|FG002|COMPLETED|Overall Study||7
6397402|NCT00869401|7310008|FG003|COMPLETED|Overall Study||133
6397403|NCT00869401|7310009|FG004|COMPLETED|Overall Study||63
6397404|NCT00869401|7310005|FG000|NOT COMPLETED|Overall Study||0
6397405|NCT00869401|7310006|FG001|NOT COMPLETED|Overall Study||0
6740636|NCT03305770|7669460|FG001|Completed Analysis Set|Overall Study||36
6740637|NCT03305770|7669459|FG000|COMPLETED|Overall Study||69
6740638|NCT03305770|7669460|FG001|COMPLETED|Overall Study||36
6740639|NCT03305770|7669459|FG000|NOT COMPLETED|Overall Study||1
6740640|NCT03305770|7669460|FG001|NOT COMPLETED|Overall Study||1
6397406|NCT00869401|7310007|FG002|NOT COMPLETED|Overall Study||0
6397407|NCT00869401|7310008|FG003|NOT COMPLETED|Overall Study||5
6740641|NCT03305809|7669472|FG000|STARTED|Overall Study||86
6740642|NCT03305809|7669473|FG001|STARTED|Overall Study||86
6740643|NCT03305809|7669474|FG002|STARTED|Overall Study||85
6740644|NCT03305809|7669475|FG003|STARTED|Overall Study||87
6740645|NCT03305809|7669472|FG000|Received at Least One Dose of Study Drug|Overall Study||86
6397408|NCT00869401|7310009|FG004|NOT COMPLETED|Overall Study||3
6397409|NCT00869440|7310025|FG000|STARTED|Overall Study||25
6397410|NCT00869440|7310026|FG001|STARTED|Overall Study||25
6397411|NCT00869440|7310027|FG002|STARTED|Overall Study||25
6397412|NCT00869440|7310028|FG003|STARTED|Overall Study||25
6397413|NCT00869440|7310025|FG000|COMPLETED|Overall Study||23
6397414|NCT00869440|7310026|FG001|COMPLETED|Overall Study||24
6397415|NCT00869440|7310027|FG002|COMPLETED|Overall Study||25
6397416|NCT00869440|7310028|FG003|COMPLETED|Overall Study||25
6397417|NCT00869440|7310025|FG000|NOT COMPLETED|Overall Study||2
6397418|NCT00869440|7310026|FG001|NOT COMPLETED|Overall Study||1
6397419|NCT00869440|7310027|FG002|NOT COMPLETED|Overall Study||0
6397420|NCT00869440|7310028|FG003|NOT COMPLETED|Overall Study||0
6397421|NCT00869518|7310040|FG000|STARTED|Overall Study||6
6397422|NCT00869518|7310041|FG001|STARTED|Overall Study||6
6397423|NCT00869518|7310040|FG000|COMPLETED|Overall Study||5
6397424|NCT00869518|7310041|FG001|COMPLETED|Overall Study||5
6397425|NCT00869518|7310040|FG000|NOT COMPLETED|Overall Study||1
6397426|NCT00869518|7310041|FG001|NOT COMPLETED|Overall Study||1
6397427|NCT00869557|7310049|FG000|STARTED|Randomized Phase||48
6397428|NCT00869557|7310050|FG001|STARTED|Randomized Phase||23
6397429|NCT00869557|7310049|FG000|COMPLETED|Randomized Phase||45
6397430|NCT00869557|7310050|FG001|COMPLETED|Randomized Phase||21
6397431|NCT00869557|7310049|FG000|NOT COMPLETED|Randomized Phase||3
6397432|NCT00869557|7310050|FG001|NOT COMPLETED|Randomized Phase||2
6397433|NCT00869557|7310049|FG000|STARTED|Extension Phase||45
6397434|NCT00869557|7310050|FG001|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
6397435|NCT00869557|7310049|FG000|COMPLETED|Extension Phase||35
6397436|NCT00869557|7310050|FG001|COMPLETED|Extension Phase||11
6397437|NCT00869557|7310049|FG000|NOT COMPLETED|Extension Phase||10
6397438|NCT00869557|7310050|FG001|NOT COMPLETED|Extension Phase||3
6397439|NCT00869609|7310059|FG000|STARTED|Overall Study||31
6397440|NCT00869609|7310060|FG001|STARTED|Overall Study||29
6397441|NCT00869609|7310059|FG000|COMPLETED|Overall Study||25
6397442|NCT00869609|7310060|FG001|COMPLETED|Overall Study||26
6397443|NCT00869609|7310059|FG000|NOT COMPLETED|Overall Study||6
6397444|NCT00869609|7310060|FG001|NOT COMPLETED|Overall Study||3
6397445|NCT00869622|7310068|FG000|STARTED|Overall Study||40
6397446|NCT00869622|7310069|FG001|STARTED|Overall Study||40
6397447|NCT00869622|7310068|FG000|COMPLETED|Overall Study||27
6397448|NCT00869622|7310069|FG001|COMPLETED|Overall Study||26
6397449|NCT00869622|7310068|FG000|NOT COMPLETED|Overall Study||13
6397450|NCT00869622|7310069|FG001|NOT COMPLETED|Overall Study||14
6397451|NCT00869778|7310079|FG000|STARTED|Overall Study||120
6397452|NCT00869778|7310080|FG001|STARTED|Overall Study||120
6397453|NCT00869778|7310081|FG002|STARTED|Overall Study||120
6397454|NCT00869778|7310079|FG000|COMPLETED|Overall Study||108
6397455|NCT00869778|7310080|FG001|COMPLETED|Overall Study||113
6397456|NCT00869778|7310081|FG002|COMPLETED|Overall Study||110
6397457|NCT00869778|7310079|FG000|NOT COMPLETED|Overall Study||12
6397458|NCT00869778|7310080|FG001|NOT COMPLETED|Overall Study||7
6397459|NCT00869778|7310081|FG002|NOT COMPLETED|Overall Study||10
6397460|NCT00869791|7310092|FG000|STARTED|Period 1 Treatment for 7 Days||14
6397461|NCT00869791|7310093|FG001|STARTED|Period 1 Treatment for 7 Days||13
6397462|NCT00869791|7310092|FG000|COMPLETED|Period 1 Treatment for 7 Days||14
6397463|NCT00869791|7310093|FG001|COMPLETED|Period 1 Treatment for 7 Days||13
6397464|NCT00869791|7310092|FG000|NOT COMPLETED|Period 1 Treatment for 7 Days||0
6397465|NCT00869791|7310093|FG001|NOT COMPLETED|Period 1 Treatment for 7 Days||0
6397466|NCT00869791|7310092|FG000|STARTED|Period 2 Treatment for 7 Days||14
6397467|NCT00869791|7310093|FG001|STARTED|Period 2 Treatment for 7 Days||13
6397468|NCT00869791|7310092|FG000|COMPLETED|Period 2 Treatment for 7 Days||14
6397469|NCT00869791|7310093|FG001|COMPLETED|Period 2 Treatment for 7 Days||13
6397470|NCT00869791|7310092|FG000|NOT COMPLETED|Period 2 Treatment for 7 Days||0
6397471|NCT00869791|7310093|FG001|NOT COMPLETED|Period 2 Treatment for 7 Days||0
6397472|NCT00869947|7310101|FG000|STARTED|Overall Study||8
6397473|NCT00869947|7310102|FG001|STARTED|Overall Study||8
6397474|NCT00869947|7310101|FG000|COMPLETED|Overall Study||8
6397475|NCT00869947|7310102|FG001|COMPLETED|Overall Study||8
6397476|NCT00869947|7310101|FG000|NOT COMPLETED|Overall Study||0
6397477|NCT00869947|7310102|FG001|NOT COMPLETED|Overall Study||0
6740646|NCT03305809|7669473|FG001|Received at Least One Dose of Study Drug|Overall Study||86
6397478|NCT00869960|7310110|FG000|STARTED|Overall Study||24
6397479|NCT00869960|7310110|FG000|COMPLETED|Overall Study||22
6397480|NCT00869960|7310110|FG000|NOT COMPLETED|Overall Study||2
6397481|NCT00869999|7310114|FG000|STARTED|Overall Study||26
6397482|NCT00869999|7310114|FG000|COMPLETED|Overall Study||24
6397483|NCT00869999|7310114|FG000|NOT COMPLETED|Overall Study||2
6397484|NCT00870103|7310118|FG000|STARTED|Overall Study||64
6397485|NCT00870103|7310118|FG000|COMPLETED|Overall Study||60
6397486|NCT00870103|7310118|FG000|NOT COMPLETED|Overall Study||4
6397487|NCT00870194|7310124|FG000|STARTED|Overall Study||127
6397488|NCT00870194|7310125|FG001|STARTED|Overall Study||128
6397489|NCT00870194|7310124|FG000|Per Protocol Set|Overall Study||97
6397490|NCT00870194|7310125|FG001|Per Protocol Set|Overall Study||111
6397491|NCT00870194|7310124|FG000|COMPLETED|Overall Study||101
6740647|NCT03305809|7669474|FG002|Received at Least One Dose of Study Drug|Overall Study||85
6740648|NCT03305809|7669475|FG003|Received at Least One Dose of Study Drug|Overall Study||87
6740649|NCT03305809|7669472|FG000|COMPLETED|Overall Study||79
6740650|NCT03305809|7669473|FG001|COMPLETED|Overall Study||78
6740651|NCT03305809|7669474|FG002|COMPLETED|Overall Study||66
6740652|NCT03305809|7669475|FG003|COMPLETED|Overall Study||60
6740653|NCT03305809|7669472|FG000|NOT COMPLETED|Overall Study||7
6740654|NCT03305809|7669473|FG001|NOT COMPLETED|Overall Study||8
6740655|NCT03305809|7669474|FG002|NOT COMPLETED|Overall Study||19
6740656|NCT03305809|7669475|FG003|NOT COMPLETED|Overall Study||27
6397492|NCT00870194|7310125|FG001|COMPLETED|Overall Study||114
6397493|NCT00870194|7310124|FG000|NOT COMPLETED|Overall Study||26
6397494|NCT00870194|7310125|FG001|NOT COMPLETED|Overall Study||14
6397495|NCT00870233|7310131|FG000|STARTED|Overall Study||120
6397496|NCT00870233|7310131|FG000|COMPLETED|Overall Study||96
6397497|NCT00870233|7310131|FG000|NOT COMPLETED|Overall Study||24
6397498|NCT00870363|7310140|FG000|STARTED|Overall Study||10
6397499|NCT00870363|7310141|FG001|STARTED|Overall Study||11
6397500|NCT00870363|7310142|FG002|STARTED|Overall Study||11
6397501|NCT00870363|7310143|FG003|STARTED|Overall Study||12
6397502|NCT00870363|7310140|FG000|COMPLETED|Overall Study||10
6397503|NCT00870363|7310141|FG001|COMPLETED|Overall Study||8
6397504|NCT00870363|7310142|FG002|COMPLETED|Overall Study||8
6397505|NCT00870363|7310143|FG003|COMPLETED|Overall Study||12
6397506|NCT00870363|7310140|FG000|NOT COMPLETED|Overall Study||0
6397507|NCT00870363|7310141|FG001|NOT COMPLETED|Overall Study||3
6397508|NCT00870363|7310142|FG002|NOT COMPLETED|Overall Study||3
6397509|NCT00870363|7310143|FG003|NOT COMPLETED|Overall Study||0
6397510|NCT00870467|7310155|FG000|STARTED|Double-blind||171
6397511|NCT00870467|7310156|FG001|STARTED|Double-blind||163
6397512|NCT00870467|7310157|FG002|STARTED|Double-blind||0
6397513|NCT00870467|7310158|FG003|STARTED|Double-blind||0
6397514|NCT00870467|7310159|FG004|STARTED|Double-blind||0
6397515|NCT00870467|7310160|FG005|STARTED|Double-blind||0
6397516|NCT00870467|7310155|FG000|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
6397517|NCT00870467|7310156|FG001|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
6397518|NCT00870467|7310157|FG002|COMPLETED|Double-blind||0
6397519|NCT00870467|7310158|FG003|COMPLETED|Double-blind||0
6397520|NCT00870467|7310159|FG004|COMPLETED|Double-blind||0
6397521|NCT00870467|7310160|FG005|COMPLETED|Double-blind||0
6397522|NCT00870467|7310155|FG000|NOT COMPLETED|Double-blind||16
6397523|NCT00870467|7310156|FG001|NOT COMPLETED|Double-blind||12
6397524|NCT00870467|7310157|FG002|NOT COMPLETED|Double-blind||0
6397525|NCT00870467|7310158|FG003|NOT COMPLETED|Double-blind||0
6397526|NCT00870467|7310159|FG004|NOT COMPLETED|Double-blind||0
6397527|NCT00870467|7310160|FG005|NOT COMPLETED|Double-blind||0
6397528|NCT00870467|7310155|FG000|STARTED|Open-label||0
6397529|NCT00870467|7310156|FG001|STARTED|Open-label||0
6397530|NCT00870467|7310157|FG002|STARTED|Open-label||145
6397531|NCT00870467|7310158|FG003|STARTED|Open-label||127
6397532|NCT00870467|7310159|FG004|STARTED|Open-label||10
6397533|NCT00870467|7310160|FG005|STARTED|Open-label||24
6397534|NCT00870467|7310155|FG000|COMPLETED|Open-label||0
6397535|NCT00870467|7310156|FG001|COMPLETED|Open-label||0
6397536|NCT00870467|7310157|FG002|COMPLETED|Open-label||132
6397537|NCT00870467|7310158|FG003|COMPLETED|Open-label||120
6397538|NCT00870467|7310159|FG004|COMPLETED|Open-label||5
6397539|NCT00870467|7310160|FG005|COMPLETED|Open-label||21
6397540|NCT00870467|7310155|FG000|NOT COMPLETED|Open-label||0
6397541|NCT00870467|7310156|FG001|NOT COMPLETED|Open-label||0
6397542|NCT00870467|7310157|FG002|NOT COMPLETED|Open-label||13
6397543|NCT00870467|7310158|FG003|NOT COMPLETED|Open-label||7
6397544|NCT00870467|7310159|FG004|NOT COMPLETED|Open-label||5
6397545|NCT00870467|7310160|FG005|NOT COMPLETED|Open-label||3
6397546|NCT00870545|7310172|FG000|STARTED|Overall Study||86
6397547|NCT00870545|7310172|FG000|COMPLETED|Overall Study||69
6397548|NCT00870545|7310172|FG000|NOT COMPLETED|Overall Study||17
6397549|NCT00870584|7310178|FG000|STARTED|Overall Study||136
6397550|NCT00870584|7310179|FG001|STARTED|Overall Study||135
6397551|NCT00870584|7310178|FG000|COMPLETED|Overall Study||120
6397552|NCT00870584|7310179|FG001|COMPLETED|Overall Study||122
6397553|NCT00870584|7310178|FG000|NOT COMPLETED|Overall Study||16
6397554|NCT00870584|7310179|FG001|NOT COMPLETED|Overall Study||13
6397555|NCT00870727|7310187|FG000|STARTED|Overall Study||17
6397556|NCT00870727|7310188|FG001|STARTED|Overall Study||16
6397557|NCT00870727|7310187|FG000|COMPLETED|Overall Study||16
6397558|NCT00870727|7310188|FG001|COMPLETED|Overall Study||11
6397559|NCT00870727|7310187|FG000|NOT COMPLETED|Overall Study||1
6397560|NCT00870727|7310188|FG001|NOT COMPLETED|Overall Study||5
6397561|NCT00870740|7310200|FG000|STARTED|Overall Study|number randomized and dosed|86
6397562|NCT00870740|7310201|FG001|STARTED|Overall Study|number randomized and dosed|84
6397563|NCT00870740|7310202|FG002|STARTED|Overall Study|number randomized and dosed|86
6397564|NCT00870740|7310203|FG003|STARTED|Overall Study|number randomized and dosed|86
6397565|NCT00870740|7310204|FG004|STARTED|Overall Study|number randomized and dosed|88
6397566|NCT00870740|7310205|FG005|STARTED|Overall Study|number randomized and dosed|87
6397567|NCT00870740|7310200|FG000|COMPLETED|Overall Study||74
6397568|NCT00870740|7310201|FG001|COMPLETED|Overall Study||75
6740657|NCT03305822|7669488|FG000|STARTED|Period 1||20
6740658|NCT03305822|7669489|FG001|STARTED|Period 1||18
6740659|NCT03305822|7669488|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
6740660|NCT03305822|7669489|FG001|Received at Least 1 Dose of Study Drug|Period 1||18
6740661|NCT03305822|7669488|FG000|COMPLETED|Period 1||20
6740662|NCT03305822|7669489|FG001|COMPLETED|Period 1||18
6740663|NCT03305822|7669488|FG000|NOT COMPLETED|Period 1||0
6740664|NCT03305822|7669489|FG001|NOT COMPLETED|Period 1||0
6740665|NCT03305822|7669488|FG000|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|20
6740666|NCT03305822|7669489|FG001|STARTED|Washout|Cross-over study. All participants from Period 1 went on to Washout and Period 2.|18
6740667|NCT03305822|7669488|FG000|COMPLETED|Washout||20
6740668|NCT03305822|7669489|FG001|COMPLETED|Washout||18
6740669|NCT03305822|7669488|FG000|NOT COMPLETED|Washout||0
6740670|NCT03305822|7669489|FG001|NOT COMPLETED|Washout||0
6740671|NCT03305822|7669488|FG000|STARTED|Period 2||20
6740672|NCT03305822|7669489|FG001|STARTED|Period 2||18
6740673|NCT03305822|7669488|FG000|Received at Least 1 Dose of Study Drug|Period 2||20
6740674|NCT03305822|7669489|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
6740675|NCT03305822|7669488|FG000|COMPLETED|Period 2||20
6740676|NCT03305822|7669489|FG001|COMPLETED|Period 2||18
6740677|NCT03305822|7669488|FG000|NOT COMPLETED|Period 2||0
6740678|NCT03305822|7669489|FG001|NOT COMPLETED|Period 2||0
6740679|NCT03305887|7669497|FG000|STARTED|Overall Study||91
6740680|NCT03305887|7669498|FG001|STARTED|Overall Study||93
6740681|NCT03305887|7669497|FG000|COMPLETED|Overall Study||80
6740682|NCT03305887|7669498|FG001|COMPLETED|Overall Study||83
6740683|NCT03305887|7669497|FG000|NOT COMPLETED|Overall Study||11
6740684|NCT03305887|7669498|FG001|NOT COMPLETED|Overall Study||10
6740685|NCT03306043|7669504|FG000|STARTED|Overall Study||102
6740686|NCT03306043|7669504|FG000|COMPLETED|Overall Study||98
6740687|NCT03306043|7669504|FG000|NOT COMPLETED|Overall Study||4
6740688|NCT03306199|7669508|FG000|STARTED|Overall Study||82
6740689|NCT03306199|7669508|FG000|COMPLETED|Overall Study||67
6740690|NCT03306199|7669508|FG000|NOT COMPLETED|Overall Study||15
6740691|NCT03306277|7669512|FG000|STARTED|Overall Study||22
6740692|NCT03306277|7669512|FG000|COMPLETED|Overall Study||19
6740693|NCT03306277|7669512|FG000|NOT COMPLETED|Overall Study||3
6740694|NCT03306420|7669521|FG000|STARTED|Overall Study||3
6740695|NCT03306420|7669522|FG001|STARTED|Overall Study||3
6740696|NCT03306420|7669523|FG002|STARTED|Overall Study||3
6740697|NCT03306420|7669524|FG003|STARTED|Overall Study||3
6740698|NCT03306420|7669525|FG004|STARTED|Overall Study||3
6740699|NCT03306420|7669521|FG000|COMPLETED|Overall Study||3
6740700|NCT03306420|7669522|FG001|COMPLETED|Overall Study||3
6740701|NCT03306420|7669523|FG002|COMPLETED|Overall Study||3
6740702|NCT03306420|7669524|FG003|COMPLETED|Overall Study||3
6740703|NCT03306420|7669525|FG004|COMPLETED|Overall Study||3
6740704|NCT03306420|7669521|FG000|NOT COMPLETED|Overall Study||0
6397569|NCT00870740|7310202|FG002|COMPLETED|Overall Study||76
6397570|NCT00870740|7310203|FG003|COMPLETED|Overall Study||74
6397571|NCT00870740|7310204|FG004|COMPLETED|Overall Study||77
6397572|NCT00870740|7310205|FG005|COMPLETED|Overall Study||70
6397573|NCT00870740|7310200|FG000|NOT COMPLETED|Overall Study||12
6397574|NCT00870740|7310201|FG001|NOT COMPLETED|Overall Study||9
6397575|NCT00870740|7310202|FG002|NOT COMPLETED|Overall Study||10
6397576|NCT00870740|7310203|FG003|NOT COMPLETED|Overall Study||12
6397577|NCT00870740|7310204|FG004|NOT COMPLETED|Overall Study||11
6397578|NCT00870740|7310205|FG005|NOT COMPLETED|Overall Study||17
6397579|NCT00870870|7310234|FG000|STARTED|Overall Study||4
6397580|NCT00870870|7310235|FG001|STARTED|Overall Study||6
6397581|NCT00870870|7310236|FG002|STARTED|Overall Study||29
6397582|NCT00870870|7310237|FG003|STARTED|Overall Study||25
6397583|NCT00870870|7310234|FG000|COMPLETED|Overall Study||4
6397584|NCT00870870|7310235|FG001|COMPLETED|Overall Study||5
6397585|NCT00870870|7310236|FG002|COMPLETED|Overall Study||26
6397586|NCT00870870|7310237|FG003|COMPLETED|Overall Study||20
6397587|NCT00870870|7310234|FG000|NOT COMPLETED|Overall Study||0
6397588|NCT00870870|7310235|FG001|NOT COMPLETED|Overall Study||1
6397589|NCT00870870|7310236|FG002|NOT COMPLETED|Overall Study||3
6397590|NCT00870870|7310237|FG003|NOT COMPLETED|Overall Study||5
6397591|NCT00870896|7310252|FG000|STARTED|Overall Study||5
6397592|NCT00870896|7310252|FG000|COMPLETED|Overall Study||5
6397593|NCT00870896|7310252|FG000|NOT COMPLETED|Overall Study||0
6397594|NCT00871000|7310260|FG000|STARTED|Overall Study||151
6397595|NCT00871000|7310261|FG001|STARTED|Overall Study||152
6397596|NCT00871000|7310260|FG000|COMPLETED|Overall Study||150
6397597|NCT00871000|7310261|FG001|COMPLETED|Overall Study||152
6397598|NCT00871000|7310260|FG000|NOT COMPLETED|Overall Study||1
6397599|NCT00871000|7310261|FG001|NOT COMPLETED|Overall Study||0
6740705|NCT03306420|7669522|FG001|NOT COMPLETED|Overall Study||0
6740706|NCT03306420|7669523|FG002|NOT COMPLETED|Overall Study||0
6740707|NCT03306420|7669524|FG003|NOT COMPLETED|Overall Study||0
6740708|NCT03306420|7669525|FG004|NOT COMPLETED|Overall Study||0
6740709|NCT03306433|7669537|FG000|STARTED|Overall Study||16
6740710|NCT03306433|7669537|FG000|UDMA-K18|Overall Study||12
6397600|NCT00871117|7310269|FG000|STARTED|Overall Study||239
6397601|NCT00871117|7310270|FG001|STARTED|Overall Study||237
6510060|NCT01479439|7429599|FG001|COMPLETED|Overall Study||12
6740711|NCT03306433|7669537|FG000|Adhesive Control|Overall Study||12
6740712|NCT03306433|7669537|FG000|UDMA-control|Overall Study||9
6740713|NCT03306433|7669537|FG000|COMPLETED|Overall Study||9
6397602|NCT00871117|7310269|FG000|COMPLETED|Overall Study||234
6397603|NCT00871117|7310270|FG001|COMPLETED|Overall Study||227
6397604|NCT00871117|7310269|FG000|NOT COMPLETED|Overall Study||5
6510061|NCT01479439|7429600|FG002|COMPLETED|Overall Study||6
6397605|NCT00871117|7310270|FG001|NOT COMPLETED|Overall Study||10
6397606|NCT00871143|7310279|FG000|STARTED|Overall Study||21
6397607|NCT00871143|7310280|FG001|STARTED|Overall Study||25
6740714|NCT03306433|7669537|FG000|NOT COMPLETED|Overall Study||7
6740715|NCT03306589|7669551|FG000|STARTED|Part 1 (69 Days)||2
6740716|NCT03306589|7669552|FG001|STARTED|Part 1 (69 Days)||4
6740717|NCT03306589|7669553|FG002|STARTED|Part 1 (69 Days)||2
6740718|NCT03306589|7669554|FG003|STARTED|Part 1 (69 Days)||4
6740719|NCT03306589|7669555|FG004|STARTED|Part 1 (69 Days)||0
6740720|NCT03306589|7669556|FG005|STARTED|Part 1 (69 Days)||0
6740721|NCT03306589|7669551|FG000|COMPLETED|Part 1 (69 Days)||2
6740722|NCT03306589|7669552|FG001|COMPLETED|Part 1 (69 Days)||4
6740723|NCT03306589|7669553|FG002|COMPLETED|Part 1 (69 Days)||2
6740724|NCT03306589|7669554|FG003|COMPLETED|Part 1 (69 Days)||4
6740725|NCT03306589|7669555|FG004|COMPLETED|Part 1 (69 Days)||0
6740726|NCT03306589|7669556|FG005|COMPLETED|Part 1 (69 Days)||0
6740727|NCT03306589|7669551|FG000|NOT COMPLETED|Part 1 (69 Days)||0
6740728|NCT03306589|7669552|FG001|NOT COMPLETED|Part 1 (69 Days)||0
6740729|NCT03306589|7669553|FG002|NOT COMPLETED|Part 1 (69 Days)||0
6740730|NCT03306589|7669554|FG003|NOT COMPLETED|Part 1 (69 Days)||0
6740731|NCT03306589|7669555|FG004|NOT COMPLETED|Part 1 (69 Days)||0
6740732|NCT03306589|7669556|FG005|NOT COMPLETED|Part 1 (69 Days)||0
6740733|NCT03306589|7669551|FG000|STARTED|Part 2 (69 Days)||0
6740734|NCT03306589|7669552|FG001|STARTED|Part 2 (69 Days)||0
6740735|NCT03306589|7669553|FG002|STARTED|Part 2 (69 Days)||0
6740736|NCT03306589|7669554|FG003|STARTED|Part 2 (69 Days)||0
6740737|NCT03306589|7669555|FG004|STARTED|Part 2 (69 Days)||0
6740738|NCT03306589|7669556|FG005|STARTED|Part 2 (69 Days)||0
6740739|NCT03306589|7669551|FG000|COMPLETED|Part 2 (69 Days)||0
6740740|NCT03306589|7669552|FG001|COMPLETED|Part 2 (69 Days)||0
6740741|NCT03306589|7669553|FG002|COMPLETED|Part 2 (69 Days)||0
6740742|NCT03306589|7669554|FG003|COMPLETED|Part 2 (69 Days)||0
6740743|NCT03306589|7669555|FG004|COMPLETED|Part 2 (69 Days)||0
6740744|NCT03306589|7669556|FG005|COMPLETED|Part 2 (69 Days)||0
6740745|NCT03306589|7669551|FG000|NOT COMPLETED|Part 2 (69 Days)||0
6740746|NCT03306589|7669552|FG001|NOT COMPLETED|Part 2 (69 Days)||0
6740747|NCT03306589|7669553|FG002|NOT COMPLETED|Part 2 (69 Days)||0
6740748|NCT03306589|7669554|FG003|NOT COMPLETED|Part 2 (69 Days)||0
6740749|NCT03306589|7669555|FG004|NOT COMPLETED|Part 2 (69 Days)||0
6740750|NCT03306589|7669556|FG005|NOT COMPLETED|Part 2 (69 Days)||0
6740751|NCT03306641|7669572|FG000|STARTED|First Intervention||23
6740752|NCT03306641|7669573|FG001|STARTED|First Intervention||22
6740753|NCT03306641|7669572|FG000|COMPLETED|First Intervention||23
6740754|NCT03306641|7669573|FG001|COMPLETED|First Intervention||22
6740755|NCT03306641|7669572|FG000|NOT COMPLETED|First Intervention||0
6740756|NCT03306641|7669573|FG001|NOT COMPLETED|First Intervention||0
6740757|NCT03306641|7669572|FG000|STARTED|Second Intervention||23
6740758|NCT03306641|7669573|FG001|STARTED|Second Intervention||22
6740759|NCT03306641|7669572|FG000|COMPLETED|Second Intervention||23
6740760|NCT03306641|7669573|FG001|COMPLETED|Second Intervention||22
6740761|NCT03306641|7669572|FG000|NOT COMPLETED|Second Intervention||0
6740762|NCT03306641|7669573|FG001|NOT COMPLETED|Second Intervention||0
6740763|NCT03307005|7669581|FG000|STARTED|Overall Study||3
6740764|NCT03307005|7669582|FG001|STARTED|Overall Study||2
6740765|NCT03307005|7669581|FG000|COMPLETED|Overall Study||3
6740766|NCT03307005|7669582|FG001|COMPLETED|Overall Study||2
6740767|NCT03307005|7669581|FG000|NOT COMPLETED|Overall Study||0
6740768|NCT03307005|7669582|FG001|NOT COMPLETED|Overall Study||0
6740769|NCT03307174|7669592|FG000|STARTED|Overall Study||60
6740770|NCT03307174|7669593|FG001|STARTED|Overall Study||60
6740771|NCT03307174|7669592|FG000|COMPLETED|Overall Study||46
6740772|NCT03307174|7669593|FG001|COMPLETED|Overall Study||53
6740773|NCT03307174|7669592|FG000|NOT COMPLETED|Overall Study||14
6740774|NCT03307174|7669593|FG001|NOT COMPLETED|Overall Study||7
6740775|NCT03307252|7669610|FG000|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6740776|NCT03307252|7669611|FG001|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6740777|NCT03307252|7669612|FG002|STARTED|Part 1, Period 1|Participants randomised in Part 1|4
6740778|NCT03307252|7669613|FG003|STARTED|Part 1, Period 1||0
6740779|NCT03307252|7669614|FG004|STARTED|Part 1, Period 1||0
6740780|NCT03307252|7669615|FG005|STARTED|Part 1, Period 1||0
6740781|NCT03307252|7669616|FG006|STARTED|Part 1, Period 1||0
6740782|NCT03307252|7669617|FG007|STARTED|Part 1, Period 1||0
6740783|NCT03307252|7669618|FG008|STARTED|Part 1, Period 1||0
6740784|NCT03307252|7669619|FG009|STARTED|Part 1, Period 1||0
6740785|NCT03307252|7669620|FG010|STARTED|Part 1, Period 1||0
6740786|NCT03307252|7669610|FG000|COMPLETED|Part 1, Period 1||4
6740787|NCT03307252|7669611|FG001|COMPLETED|Part 1, Period 1||4
6740788|NCT03307252|7669612|FG002|COMPLETED|Part 1, Period 1||4
6740789|NCT03307252|7669613|FG003|COMPLETED|Part 1, Period 1||0
6740790|NCT03307252|7669614|FG004|COMPLETED|Part 1, Period 1||0
6740791|NCT03307252|7669615|FG005|COMPLETED|Part 1, Period 1||0
6397608|NCT00871143|7310279|FG000|COMPLETED|Overall Study||21
6397609|NCT00871143|7310280|FG001|COMPLETED|Overall Study||25
6740792|NCT03307252|7669616|FG006|COMPLETED|Part 1, Period 1||0
6740793|NCT03307252|7669617|FG007|COMPLETED|Part 1, Period 1||0
6740794|NCT03307252|7669618|FG008|COMPLETED|Part 1, Period 1||0
6740795|NCT03307252|7669619|FG009|COMPLETED|Part 1, Period 1||0
6740796|NCT03307252|7669620|FG010|COMPLETED|Part 1, Period 1||0
6740797|NCT03307252|7669610|FG000|NOT COMPLETED|Part 1, Period 1||0
6740798|NCT03307252|7669611|FG001|NOT COMPLETED|Part 1, Period 1||0
6740799|NCT03307252|7669612|FG002|NOT COMPLETED|Part 1, Period 1||0
6740800|NCT03307252|7669613|FG003|NOT COMPLETED|Part 1, Period 1||0
6740801|NCT03307252|7669614|FG004|NOT COMPLETED|Part 1, Period 1||0
6740802|NCT03307252|7669615|FG005|NOT COMPLETED|Part 1, Period 1||0
6740803|NCT03307252|7669616|FG006|NOT COMPLETED|Part 1, Period 1||0
6740804|NCT03307252|7669617|FG007|NOT COMPLETED|Part 1, Period 1||0
6740805|NCT03307252|7669618|FG008|NOT COMPLETED|Part 1, Period 1||0
6740806|NCT03307252|7669619|FG009|NOT COMPLETED|Part 1, Period 1||0
6740807|NCT03307252|7669620|FG010|NOT COMPLETED|Part 1, Period 1||0
6740808|NCT03307252|7669610|FG000|STARTED|Part 1, Washout Period 1 (13 Days)||4
6740809|NCT03307252|7669611|FG001|STARTED|Part 1, Washout Period 1 (13 Days)||4
6740810|NCT03307252|7669612|FG002|STARTED|Part 1, Washout Period 1 (13 Days)||4
6740811|NCT03307252|7669613|FG003|STARTED|Part 1, Washout Period 1 (13 Days)||0
6397610|NCT00871143|7310279|FG000|NOT COMPLETED|Overall Study||0
6397611|NCT00871143|7310280|FG001|NOT COMPLETED|Overall Study||0
6397612|NCT00871169|7310286|FG000|STARTED|Overall Study||61
6397613|NCT00871169|7310286|FG000|COMPLETED|Overall Study||58
6397614|NCT00871169|7310286|FG000|NOT COMPLETED|Overall Study||3
6397615|NCT00871234|7310290|FG000|STARTED|Overall Study||28
6397616|NCT00871234|7310290|FG000|COMPLETED|Overall Study||23
6397617|NCT00871234|7310290|FG000|NOT COMPLETED|Overall Study||5
6397618|NCT00871260|7310294|FG000|STARTED|Overall Study||20
6397619|NCT00871260|7310294|FG000|COMPLETED|Overall Study||20
6397620|NCT00871260|7310294|FG000|NOT COMPLETED|Overall Study||0
6397621|NCT00871286|7310300|FG000|STARTED|Overall Study||20
6397622|NCT00871286|7310301|FG001|STARTED|Overall Study||20
6397623|NCT00871286|7310300|FG000|COMPLETED|Overall Study||20
6397624|NCT00871286|7310301|FG001|COMPLETED|Overall Study||14
6397625|NCT00871286|7310300|FG000|NOT COMPLETED|Overall Study||0
6397626|NCT00871286|7310301|FG001|NOT COMPLETED|Overall Study||6
6397627|NCT00871338|7310309|FG000|STARTED|Prior to Booster||142
6397628|NCT00871338|7310310|FG001|STARTED|Prior to Booster||142
6397629|NCT00871338|7310309|FG000|COMPLETED|Prior to Booster||140
6397630|NCT00871338|7310310|FG001|COMPLETED|Prior to Booster||139
6397631|NCT00871338|7310309|FG000|NOT COMPLETED|Prior to Booster||2
6397632|NCT00871338|7310310|FG001|NOT COMPLETED|Prior to Booster||3
6397633|NCT00871338|7310309|FG000|STARTED|After Booster||139
6397634|NCT00871338|7310310|FG001|STARTED|After Booster||135
6397635|NCT00871338|7310309|FG000|COMPLETED|After Booster||139
6397636|NCT00871338|7310310|FG001|COMPLETED|After Booster||135
6397637|NCT00871338|7310309|FG000|NOT COMPLETED|After Booster||0
6397638|NCT00871338|7310310|FG001|NOT COMPLETED|After Booster||0
6397639|NCT00871377|7310316|FG000|STARTED|First Intervention (10 Weeks)||3
6397640|NCT00871377|7310317|FG001|STARTED|First Intervention (10 Weeks)||4
6397641|NCT00871377|7310318|FG002|STARTED|First Intervention (10 Weeks)||4
6397642|NCT00871377|7310319|FG003|STARTED|First Intervention (10 Weeks)||4
6397643|NCT00871377|7310320|FG004|STARTED|First Intervention (10 Weeks)||4
6397644|NCT00871377|7310321|FG005|STARTED|First Intervention (10 Weeks)||5
6397645|NCT00871377|7310316|FG000|COMPLETED|First Intervention (10 Weeks)||3
6397646|NCT00871377|7310317|FG001|COMPLETED|First Intervention (10 Weeks)||4
6397647|NCT00871377|7310318|FG002|COMPLETED|First Intervention (10 Weeks)||3
6397648|NCT00871377|7310319|FG003|COMPLETED|First Intervention (10 Weeks)||4
6397649|NCT00871377|7310320|FG004|COMPLETED|First Intervention (10 Weeks)||4
6397650|NCT00871377|7310321|FG005|COMPLETED|First Intervention (10 Weeks)||4
6397651|NCT00871377|7310316|FG000|NOT COMPLETED|First Intervention (10 Weeks)||0
6397652|NCT00871377|7310317|FG001|NOT COMPLETED|First Intervention (10 Weeks)||0
6397653|NCT00871377|7310318|FG002|NOT COMPLETED|First Intervention (10 Weeks)||1
6397654|NCT00871377|7310319|FG003|NOT COMPLETED|First Intervention (10 Weeks)||0
6397655|NCT00871377|7310320|FG004|NOT COMPLETED|First Intervention (10 Weeks)||0
6397656|NCT00871377|7310321|FG005|NOT COMPLETED|First Intervention (10 Weeks)||1
6397657|NCT00871377|7310316|FG000|STARTED|Washout (6 Weeks)||3
6397658|NCT00871377|7310317|FG001|STARTED|Washout (6 Weeks)||4
6397659|NCT00871377|7310318|FG002|STARTED|Washout (6 Weeks)||3
6397660|NCT00871377|7310319|FG003|STARTED|Washout (6 Weeks)||4
6397661|NCT00871377|7310320|FG004|STARTED|Washout (6 Weeks)||4
6397662|NCT00871377|7310321|FG005|STARTED|Washout (6 Weeks)||4
6397663|NCT00871377|7310316|FG000|COMPLETED|Washout (6 Weeks)||2
6397664|NCT00871377|7310317|FG001|COMPLETED|Washout (6 Weeks)||4
6397665|NCT00871377|7310318|FG002|COMPLETED|Washout (6 Weeks)||3
6397666|NCT00871377|7310319|FG003|COMPLETED|Washout (6 Weeks)||4
6397667|NCT00871377|7310320|FG004|COMPLETED|Washout (6 Weeks)||4
6397668|NCT00871377|7310321|FG005|COMPLETED|Washout (6 Weeks)||4
6397669|NCT00871377|7310316|FG000|NOT COMPLETED|Washout (6 Weeks)||1
6397670|NCT00871377|7310317|FG001|NOT COMPLETED|Washout (6 Weeks)||0
6740812|NCT03307252|7669614|FG004|STARTED|Part 1, Washout Period 1 (13 Days)||0
6397671|NCT00871377|7310318|FG002|NOT COMPLETED|Washout (6 Weeks)||0
6397672|NCT00871377|7310319|FG003|NOT COMPLETED|Washout (6 Weeks)||0
6397673|NCT00871377|7310320|FG004|NOT COMPLETED|Washout (6 Weeks)||0
6397674|NCT00871377|7310321|FG005|NOT COMPLETED|Washout (6 Weeks)||0
6397675|NCT00871377|7310316|FG000|STARTED|Second Intervention (10 Weeks)||2
6397676|NCT00871377|7310317|FG001|STARTED|Second Intervention (10 Weeks)||4
6397677|NCT00871377|7310318|FG002|STARTED|Second Intervention (10 Weeks)||3
6397678|NCT00871377|7310319|FG003|STARTED|Second Intervention (10 Weeks)||4
6397679|NCT00871377|7310320|FG004|STARTED|Second Intervention (10 Weeks)||4
6397680|NCT00871377|7310321|FG005|STARTED|Second Intervention (10 Weeks)||4
6740813|NCT03307252|7669615|FG005|STARTED|Part 1, Washout Period 1 (13 Days)||0
6740814|NCT03307252|7669616|FG006|STARTED|Part 1, Washout Period 1 (13 Days)||0
6740815|NCT03307252|7669617|FG007|STARTED|Part 1, Washout Period 1 (13 Days)||0
6740816|NCT03307252|7669618|FG008|STARTED|Part 1, Washout Period 1 (13 Days)||0
6740817|NCT03307252|7669619|FG009|STARTED|Part 1, Washout Period 1 (13 Days)||0
6740818|NCT03307252|7669620|FG010|STARTED|Part 1, Washout Period 1 (13 Days)||0
6740819|NCT03307252|7669610|FG000|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6740820|NCT03307252|7669611|FG001|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6740821|NCT03307252|7669612|FG002|COMPLETED|Part 1, Washout Period 1 (13 Days)||4
6740822|NCT03307252|7669613|FG003|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740823|NCT03307252|7669614|FG004|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740824|NCT03307252|7669615|FG005|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740825|NCT03307252|7669616|FG006|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6282165|NCT00179621|7182399|FG002|STARTED|Double-Blind Period||69
6282166|NCT00179621|7182400|FG003|STARTED|Double-Blind Period||0
6282167|NCT00179621|7182397|FG000|COMPLETED|Double-Blind Period||3
6282168|NCT00179621|7182398|FG001|COMPLETED|Double-Blind Period||23
6282169|NCT00179621|7182399|FG002|COMPLETED|Double-Blind Period||39
6282170|NCT00179621|7182400|FG003|COMPLETED|Double-Blind Period||0
6282171|NCT00179621|7182397|FG000|NOT COMPLETED|Double-Blind Period||64
6282172|NCT00179621|7182398|FG001|NOT COMPLETED|Double-Blind Period||46
6282173|NCT00179621|7182399|FG002|NOT COMPLETED|Double-Blind Period||30
6282174|NCT00179621|7182400|FG003|NOT COMPLETED|Double-Blind Period||0
6282175|NCT00179621|7182397|FG000|STARTED|Open-Label Period||0
6282176|NCT00179621|7182398|FG001|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
6282177|NCT00179621|7182399|FG002|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
6282178|NCT00179621|7182400|FG003|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
6282179|NCT00179621|7182397|FG000|COMPLETED|Open-Label Period||0
6282180|NCT00179621|7182398|FG001|COMPLETED|Open-Label Period||14
6282181|NCT00179621|7182399|FG002|COMPLETED|Open-Label Period||19
6282182|NCT00179621|7182400|FG003|COMPLETED|Open-Label Period||13
6282183|NCT00179621|7182397|FG000|NOT COMPLETED|Open-Label Period||0
6282184|NCT00179621|7182398|FG001|NOT COMPLETED|Open-Label Period||28
6282185|NCT00179621|7182399|FG002|NOT COMPLETED|Open-Label Period||28
6282186|NCT00179621|7182400|FG003|NOT COMPLETED|Open-Label Period||43
6282187|NCT00179647|7182409|FG000|STARTED|Overall Study||1913
6282188|NCT00179647|7182409|FG000|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
6282189|NCT00179647|7182409|FG000|NOT COMPLETED|Overall Study||1913
6282190|NCT00179660|7182413|FG000|STARTED|Overall Study||50
6282191|NCT00179660|7182413|FG000|Received Study Drug|Overall Study||49
6282192|NCT00179660|7182413|FG000|Completed 12 Cycles of Treatment|Overall Study||12
6282193|NCT00179660|7182413|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
6282194|NCT00179660|7182413|FG000|NOT COMPLETED|Overall Study||50
6282195|NCT00179673|7182417|FG000|STARTED|Overall Study||43
6282196|NCT00179673|7182417|FG000|Received Study Drug|Overall Study||43
6282197|NCT00179673|7182417|FG000|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
6282198|NCT00179673|7182417|FG000|NOT COMPLETED|Overall Study||43
6282199|NCT00179777|7182423|FG000|STARTED|Overall Study||2613
6282200|NCT00179777|7182424|FG001|STARTED|Overall Study||2543
6282201|NCT00179777|7182423|FG000|COMPLETED|Overall Study||1081
6282202|NCT00179777|7182424|FG001|COMPLETED|Overall Study||1078
6282203|NCT00179777|7182423|FG000|NOT COMPLETED|Overall Study||1532
6282204|NCT00179777|7182424|FG001|NOT COMPLETED|Overall Study||1465
6282205|NCT00179959|7182434|FG000|STARTED|Overall Study||15
6282206|NCT00179959|7182435|FG001|STARTED|Overall Study||16
6282207|NCT00179959|7182434|FG000|COMPLETED|Overall Study||9
6282208|NCT00179959|7182435|FG001|COMPLETED|Overall Study||13
6282209|NCT00179959|7182434|FG000|NOT COMPLETED|Overall Study||6
6282210|NCT00179959|7182435|FG001|NOT COMPLETED|Overall Study||3
6282211|NCT00179998|7182443|FG000|STARTED|Initial Period - 6 Months||12
6282212|NCT00179998|7182444|FG001|STARTED|Initial Period - 6 Months||12
6282213|NCT00179998|7182443|FG000|COMPLETED|Initial Period - 6 Months||12
6282214|NCT00179998|7182444|FG001|COMPLETED|Initial Period - 6 Months||12
6282215|NCT00179998|7182443|FG000|NOT COMPLETED|Initial Period - 6 Months||0
6282216|NCT00179998|7182444|FG001|NOT COMPLETED|Initial Period - 6 Months||0
6282217|NCT00179998|7182443|FG000|STARTED|Crossover Period - 6 Months||12
6282218|NCT00179998|7182444|FG001|STARTED|Crossover Period - 6 Months||12
6282219|NCT00179998|7182443|FG000|COMPLETED|Crossover Period - 6 Months||12
6282220|NCT00179998|7182444|FG001|COMPLETED|Crossover Period - 6 Months||10
6282221|NCT00179998|7182443|FG000|NOT COMPLETED|Crossover Period - 6 Months||0
6282222|NCT00179998|7182444|FG001|NOT COMPLETED|Crossover Period - 6 Months||2
6282223|NCT00180271|7182456|FG000|STARTED|Overall Study||1089
6282224|NCT00180271|7182457|FG001|STARTED|Overall Study||731
6282225|NCT00180271|7182456|FG000|COMPLETED|Overall Study||1089
6282226|NCT00180271|7182457|FG001|COMPLETED|Overall Study||731
6282227|NCT00180271|7182456|FG000|NOT COMPLETED|Overall Study||0
6282228|NCT00180271|7182457|FG001|NOT COMPLETED|Overall Study||0
6282229|NCT00180297|7182467|FG000|STARTED|Overall Study||107
6282230|NCT00180297|7182468|FG001|STARTED|Overall Study||108
6282231|NCT00180297|7182467|FG000|COMPLETED|Overall Study||61
6740826|NCT03307252|7669617|FG007|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740827|NCT03307252|7669618|FG008|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740828|NCT03307252|7669619|FG009|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740829|NCT03307252|7669620|FG010|COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740830|NCT03307252|7669610|FG000|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740831|NCT03307252|7669611|FG001|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740832|NCT03307252|7669612|FG002|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740833|NCT03307252|7669613|FG003|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740834|NCT03307252|7669614|FG004|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740835|NCT03307252|7669615|FG005|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740836|NCT03307252|7669616|FG006|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740837|NCT03307252|7669617|FG007|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740838|NCT03307252|7669618|FG008|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6397681|NCT00871377|7310316|FG000|COMPLETED|Second Intervention (10 Weeks)||2
6397682|NCT00871377|7310317|FG001|COMPLETED|Second Intervention (10 Weeks)||4
6397683|NCT00871377|7310318|FG002|COMPLETED|Second Intervention (10 Weeks)||3
6397684|NCT00871377|7310319|FG003|COMPLETED|Second Intervention (10 Weeks)||4
6397685|NCT00871377|7310320|FG004|COMPLETED|Second Intervention (10 Weeks)||4
6397686|NCT00871377|7310321|FG005|COMPLETED|Second Intervention (10 Weeks)||4
6397687|NCT00871377|7310316|FG000|NOT COMPLETED|Second Intervention (10 Weeks)||0
6397688|NCT00871377|7310317|FG001|NOT COMPLETED|Second Intervention (10 Weeks)||0
6397689|NCT00871377|7310318|FG002|NOT COMPLETED|Second Intervention (10 Weeks)||0
6397690|NCT00871377|7310319|FG003|NOT COMPLETED|Second Intervention (10 Weeks)||0
6397691|NCT00871377|7310320|FG004|NOT COMPLETED|Second Intervention (10 Weeks)||0
6397692|NCT00871377|7310321|FG005|NOT COMPLETED|Second Intervention (10 Weeks)||0
6397693|NCT00871377|7310316|FG000|STARTED|Washout (6 Weeks)||2
6397694|NCT00871377|7310317|FG001|STARTED|Washout (6 Weeks)||4
6397695|NCT00871377|7310318|FG002|STARTED|Washout (6 Weeks)||3
6397696|NCT00871377|7310319|FG003|STARTED|Washout (6 Weeks)||4
6397697|NCT00871377|7310320|FG004|STARTED|Washout (6 Weeks)||4
6397698|NCT00871377|7310321|FG005|STARTED|Washout (6 Weeks)||4
6397699|NCT00871377|7310316|FG000|COMPLETED|Washout (6 Weeks)||2
6397700|NCT00871377|7310317|FG001|COMPLETED|Washout (6 Weeks)||4
6397701|NCT00871377|7310318|FG002|COMPLETED|Washout (6 Weeks)||3
6397702|NCT00871377|7310319|FG003|COMPLETED|Washout (6 Weeks)||4
6397703|NCT00871377|7310320|FG004|COMPLETED|Washout (6 Weeks)||4
6397704|NCT00871377|7310321|FG005|COMPLETED|Washout (6 Weeks)||3
6397705|NCT00871377|7310316|FG000|NOT COMPLETED|Washout (6 Weeks)||0
6397706|NCT00871377|7310317|FG001|NOT COMPLETED|Washout (6 Weeks)||0
6397707|NCT00871377|7310318|FG002|NOT COMPLETED|Washout (6 Weeks)||0
6397708|NCT00871377|7310319|FG003|NOT COMPLETED|Washout (6 Weeks)||0
6397709|NCT00871377|7310320|FG004|NOT COMPLETED|Washout (6 Weeks)||0
6397710|NCT00871377|7310321|FG005|NOT COMPLETED|Washout (6 Weeks)||1
6397711|NCT00871377|7310316|FG000|STARTED|Third Intervention (10 Weeks)||2
6397712|NCT00871377|7310317|FG001|STARTED|Third Intervention (10 Weeks)||4
6397713|NCT00871377|7310318|FG002|STARTED|Third Intervention (10 Weeks)||3
6397714|NCT00871377|7310319|FG003|STARTED|Third Intervention (10 Weeks)||4
6397715|NCT00871377|7310320|FG004|STARTED|Third Intervention (10 Weeks)||4
6397716|NCT00871377|7310321|FG005|STARTED|Third Intervention (10 Weeks)||3
6397717|NCT00871377|7310316|FG000|COMPLETED|Third Intervention (10 Weeks)||2
6397718|NCT00871377|7310317|FG001|COMPLETED|Third Intervention (10 Weeks)||4
6397719|NCT00871377|7310318|FG002|COMPLETED|Third Intervention (10 Weeks)||3
6397720|NCT00871377|7310319|FG003|COMPLETED|Third Intervention (10 Weeks)||3
6397721|NCT00871377|7310320|FG004|COMPLETED|Third Intervention (10 Weeks)||4
6397722|NCT00871377|7310321|FG005|COMPLETED|Third Intervention (10 Weeks)||3
6397723|NCT00871377|7310316|FG000|NOT COMPLETED|Third Intervention (10 Weeks)||0
6397724|NCT00871377|7310317|FG001|NOT COMPLETED|Third Intervention (10 Weeks)||0
6397725|NCT00871377|7310318|FG002|NOT COMPLETED|Third Intervention (10 Weeks)||0
6397726|NCT00871377|7310319|FG003|NOT COMPLETED|Third Intervention (10 Weeks)||1
6397727|NCT00871377|7310320|FG004|NOT COMPLETED|Third Intervention (10 Weeks)||0
6397728|NCT00871377|7310321|FG005|NOT COMPLETED|Third Intervention (10 Weeks)||0
6397729|NCT00871403|7310332|FG000|STARTED|Combination Treatment Phase||9
6397730|NCT00871403|7310333|FG001|STARTED|Combination Treatment Phase||62
6397731|NCT00871403|7310334|FG002|STARTED|Combination Treatment Phase||35
6397732|NCT00871403|7310332|FG000|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
6397733|NCT00871403|7310333|FG001|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
6397734|NCT00871403|7310334|FG002|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
6397735|NCT00871403|7310332|FG000|NOT COMPLETED|Combination Treatment Phase||9
6397736|NCT00871403|7310333|FG001|NOT COMPLETED|Combination Treatment Phase||49
6397737|NCT00871403|7310334|FG002|NOT COMPLETED|Combination Treatment Phase||12
6397738|NCT00871403|7310332|FG000|STARTED|Monotherapy Treatment Phase||0
6397739|NCT00871403|7310333|FG001|STARTED|Monotherapy Treatment Phase||13
6397740|NCT00871403|7310334|FG002|STARTED|Monotherapy Treatment Phase||1
6397741|NCT00871403|7310332|FG000|COMPLETED|Monotherapy Treatment Phase||0
6397742|NCT00871403|7310333|FG001|COMPLETED|Monotherapy Treatment Phase||0
6397743|NCT00871403|7310334|FG002|COMPLETED|Monotherapy Treatment Phase||0
6397744|NCT00871403|7310332|FG000|NOT COMPLETED|Monotherapy Treatment Phase||0
6397745|NCT00871403|7310333|FG001|NOT COMPLETED|Monotherapy Treatment Phase||13
6397746|NCT00871403|7310334|FG002|NOT COMPLETED|Monotherapy Treatment Phase||1
6740839|NCT03307252|7669619|FG009|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740840|NCT03307252|7669620|FG010|NOT COMPLETED|Part 1, Washout Period 1 (13 Days)||0
6740841|NCT03307252|7669610|FG000|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6740842|NCT03307252|7669611|FG001|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6740843|NCT03307252|7669612|FG002|STARTED|Part 1, Period 2|Participants randomised in Part 1|4
6740844|NCT03307252|7669613|FG003|STARTED|Part 1, Period 2||0
6740845|NCT03307252|7669614|FG004|STARTED|Part 1, Period 2||0
6740846|NCT03307252|7669615|FG005|STARTED|Part 1, Period 2||0
6740847|NCT03307252|7669616|FG006|STARTED|Part 1, Period 2||0
6740848|NCT03307252|7669617|FG007|STARTED|Part 1, Period 2||0
6740849|NCT03307252|7669618|FG008|STARTED|Part 1, Period 2||0
6740850|NCT03307252|7669619|FG009|STARTED|Part 1, Period 2||0
6740851|NCT03307252|7669620|FG010|STARTED|Part 1, Period 2||0
6740852|NCT03307252|7669610|FG000|COMPLETED|Part 1, Period 2||4
6740853|NCT03307252|7669611|FG001|COMPLETED|Part 1, Period 2||4
6740854|NCT03307252|7669612|FG002|COMPLETED|Part 1, Period 2||4
6740855|NCT03307252|7669613|FG003|COMPLETED|Part 1, Period 2||0
6740856|NCT03307252|7669614|FG004|COMPLETED|Part 1, Period 2||0
6740857|NCT03307252|7669615|FG005|COMPLETED|Part 1, Period 2||0
6740858|NCT03307252|7669616|FG006|COMPLETED|Part 1, Period 2||0
6740859|NCT03307252|7669617|FG007|COMPLETED|Part 1, Period 2||0
6397747|NCT00871429|7310341|FG000|STARTED|Overall Study||99
6397748|NCT00871429|7310341|FG000|COMPLETED|Overall Study||75
6397749|NCT00871429|7310341|FG000|NOT COMPLETED|Overall Study||24
6397750|NCT00871494|7310349|FG000|STARTED|Overall Study||76
6397751|NCT00871494|7310349|FG000|COMPLETED|Overall Study||62
6397752|NCT00871494|7310349|FG000|NOT COMPLETED|Overall Study||14
6397753|NCT00871572|7310357|FG000|STARTED|Overall Study||10
6397754|NCT00871572|7310358|FG001|STARTED|Overall Study||17
6397755|NCT00871572|7310359|FG002|STARTED|Overall Study||34
6397756|NCT00871572|7310360|FG003|STARTED|Overall Study||26
6397757|NCT00871572|7310357|FG000|≥1 Post Baseline Value by Assigned Group|Overall Study||9
6397758|NCT00871572|7310358|FG001|≥1 Post Baseline Value by Assigned Group|Overall Study||17
6397759|NCT00871572|7310359|FG002|≥1 Post Baseline Value by Assigned Group|Overall Study||34
6397760|NCT00871572|7310360|FG003|≥1 Post Baseline Value by Assigned Group|Overall Study||25
6397761|NCT00871572|7310357|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
6397762|NCT00871572|7310358|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
6397763|NCT00871572|7310359|FG002|Received at Least 1 Dose of Study Drug|Overall Study||34
6397764|NCT00871572|7310360|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
6397765|NCT00871572|7310357|FG000|COMPLETED|Overall Study||8
6397766|NCT00871572|7310358|FG001|COMPLETED|Overall Study||11
6397767|NCT00871572|7310359|FG002|COMPLETED|Overall Study||30
6397768|NCT00871572|7310360|FG003|COMPLETED|Overall Study||19
6397769|NCT00871572|7310357|FG000|NOT COMPLETED|Overall Study||2
6397770|NCT00871572|7310358|FG001|NOT COMPLETED|Overall Study||6
6397771|NCT00871572|7310359|FG002|NOT COMPLETED|Overall Study||4
6397772|NCT00871572|7310360|FG003|NOT COMPLETED|Overall Study||7
6397773|NCT00871624|7310372|FG000|STARTED|Overall Study||18
6397774|NCT00871624|7310373|FG001|STARTED|Overall Study||18
6397775|NCT00871624|7310372|FG000|COMPLETED|Overall Study||16
6397776|NCT00871624|7310373|FG001|COMPLETED|Overall Study||17
6397777|NCT00871624|7310372|FG000|NOT COMPLETED|Overall Study||2
6397778|NCT00871624|7310373|FG001|NOT COMPLETED|Overall Study||1
6397779|NCT00871689|7310381|FG000|STARTED|Overall Study||2
6397780|NCT00871689|7310381|FG000|COMPLETED|Overall Study||2
6397781|NCT00871689|7310381|FG000|NOT COMPLETED|Overall Study||0
6397782|NCT00871715|7310388|FG000|STARTED|Overall Study||119
6397783|NCT00871715|7310389|FG001|STARTED|Overall Study||120
6397784|NCT00871715|7310390|FG002|STARTED|Overall Study||122
6397785|NCT00871715|7310388|FG000|Post-Intervention|Overall Study||112
6397786|NCT00871715|7310389|FG001|Post-Intervention|Overall Study||115
6397787|NCT00871715|7310390|FG002|Post-Intervention|Overall Study||115
6397788|NCT00871715|7310388|FG000|6-mo Follow-up|Overall Study||110
6397789|NCT00871715|7310389|FG001|6-mo Follow-up|Overall Study||113
6397790|NCT00871715|7310390|FG002|6-mo Follow-up|Overall Study||112
6397791|NCT00871715|7310388|FG000|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
6397792|NCT00871715|7310389|FG001|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
6397793|NCT00871715|7310390|FG002|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
6397794|NCT00871715|7310388|FG000|NOT COMPLETED|Overall Study||15
6397795|NCT00871715|7310389|FG001|NOT COMPLETED|Overall Study||16
6397796|NCT00871715|7310390|FG002|NOT COMPLETED|Overall Study||26
6397797|NCT00871728|7310399|FG000|STARTED|Overall Study||132
6397798|NCT00871728|7310399|FG000|Treated|Overall Study||130
6740860|NCT03307252|7669618|FG008|COMPLETED|Part 1, Period 2||0
6740861|NCT03307252|7669619|FG009|COMPLETED|Part 1, Period 2||0
6740862|NCT03307252|7669620|FG010|COMPLETED|Part 1, Period 2||0
6740863|NCT03307252|7669610|FG000|NOT COMPLETED|Part 1, Period 2||0
6397799|NCT00871728|7310399|FG000|COMPLETED|Overall Study||112
6397800|NCT00871728|7310399|FG000|NOT COMPLETED|Overall Study||20
6397801|NCT00871741|7310405|FG000|STARTED|Overall Study||9
6397802|NCT00871741|7310406|FG001|STARTED|Overall Study||7
6397803|NCT00871741|7310405|FG000|COMPLETED|Overall Study||0
6397804|NCT00871741|7310406|FG001|COMPLETED|Overall Study||0
6397805|NCT00871741|7310405|FG000|NOT COMPLETED|Overall Study||9
6740864|NCT03307252|7669611|FG001|NOT COMPLETED|Part 1, Period 2||0
6740865|NCT03307252|7669612|FG002|NOT COMPLETED|Part 1, Period 2||0
6740866|NCT03307252|7669613|FG003|NOT COMPLETED|Part 1, Period 2||0
6740867|NCT03307252|7669614|FG004|NOT COMPLETED|Part 1, Period 2||0
6740868|NCT03307252|7669615|FG005|NOT COMPLETED|Part 1, Period 2||0
6740869|NCT03307252|7669616|FG006|NOT COMPLETED|Part 1, Period 2||0
6740870|NCT03307252|7669617|FG007|NOT COMPLETED|Part 1, Period 2||0
6740871|NCT03307252|7669618|FG008|NOT COMPLETED|Part 1, Period 2||0
6740872|NCT03307252|7669619|FG009|NOT COMPLETED|Part 1, Period 2||0
6740873|NCT03307252|7669620|FG010|NOT COMPLETED|Part 1, Period 2||0
6740874|NCT03307252|7669610|FG000|STARTED|Part 1, Washout Period 2 (13 Days)||4
6740875|NCT03307252|7669611|FG001|STARTED|Part 1, Washout Period 2 (13 Days)||4
6740876|NCT03307252|7669612|FG002|STARTED|Part 1, Washout Period 2 (13 Days)||4
6740877|NCT03307252|7669613|FG003|STARTED|Part 1, Washout Period 2 (13 Days)||0
6740878|NCT03307252|7669614|FG004|STARTED|Part 1, Washout Period 2 (13 Days)||0
6740879|NCT03307252|7669615|FG005|STARTED|Part 1, Washout Period 2 (13 Days)||0
6740880|NCT03307252|7669616|FG006|STARTED|Part 1, Washout Period 2 (13 Days)||0
6740881|NCT03307252|7669617|FG007|STARTED|Part 1, Washout Period 2 (13 Days)||0
6740882|NCT03307252|7669618|FG008|STARTED|Part 1, Washout Period 2 (13 Days)||0
6740883|NCT03307252|7669619|FG009|STARTED|Part 1, Washout Period 2 (13 Days)||0
6740884|NCT03307252|7669620|FG010|STARTED|Part 1, Washout Period 2 (13 Days)||0
6740885|NCT03307252|7669610|FG000|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6740886|NCT03307252|7669611|FG001|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6740887|NCT03307252|7669612|FG002|COMPLETED|Part 1, Washout Period 2 (13 Days)||4
6740888|NCT03307252|7669613|FG003|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740889|NCT03307252|7669614|FG004|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740890|NCT03307252|7669615|FG005|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740891|NCT03307252|7669616|FG006|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740892|NCT03307252|7669617|FG007|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740893|NCT03307252|7669618|FG008|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740894|NCT03307252|7669619|FG009|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740895|NCT03307252|7669620|FG010|COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740896|NCT03307252|7669610|FG000|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740897|NCT03307252|7669611|FG001|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740898|NCT03307252|7669612|FG002|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740899|NCT03307252|7669613|FG003|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740900|NCT03307252|7669614|FG004|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740901|NCT03307252|7669615|FG005|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740902|NCT03307252|7669616|FG006|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740903|NCT03307252|7669617|FG007|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740904|NCT03307252|7669618|FG008|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740905|NCT03307252|7669619|FG009|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740906|NCT03307252|7669620|FG010|NOT COMPLETED|Part 1, Washout Period 2 (13 Days)||0
6740907|NCT03307252|7669610|FG000|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6740908|NCT03307252|7669611|FG001|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6740909|NCT03307252|7669612|FG002|STARTED|Part 1, Period 3|Participants randomised in Part 1|4
6740910|NCT03307252|7669613|FG003|STARTED|Part 1, Period 3||0
6740911|NCT03307252|7669614|FG004|STARTED|Part 1, Period 3||0
6740912|NCT03307252|7669615|FG005|STARTED|Part 1, Period 3||0
6740913|NCT03307252|7669616|FG006|STARTED|Part 1, Period 3||0
6740914|NCT03307252|7669617|FG007|STARTED|Part 1, Period 3||0
6740915|NCT03307252|7669618|FG008|STARTED|Part 1, Period 3||0
6740916|NCT03307252|7669619|FG009|STARTED|Part 1, Period 3||0
6740917|NCT03307252|7669620|FG010|STARTED|Part 1, Period 3||0
6740918|NCT03307252|7669610|FG000|COMPLETED|Part 1, Period 3||4
6740919|NCT03307252|7669611|FG001|COMPLETED|Part 1, Period 3||4
6740920|NCT03307252|7669612|FG002|COMPLETED|Part 1, Period 3||4
6740921|NCT03307252|7669613|FG003|COMPLETED|Part 1, Period 3||0
6740922|NCT03307252|7669614|FG004|COMPLETED|Part 1, Period 3||0
6740923|NCT03307252|7669615|FG005|COMPLETED|Part 1, Period 3||0
6740924|NCT03307252|7669616|FG006|COMPLETED|Part 1, Period 3||0
6740925|NCT03307252|7669617|FG007|COMPLETED|Part 1, Period 3||0
6740926|NCT03307252|7669618|FG008|COMPLETED|Part 1, Period 3||0
6740927|NCT03307252|7669619|FG009|COMPLETED|Part 1, Period 3||0
6740928|NCT03307252|7669620|FG010|COMPLETED|Part 1, Period 3||0
6740929|NCT03307252|7669610|FG000|NOT COMPLETED|Part 1, Period 3||0
6740930|NCT03307252|7669611|FG001|NOT COMPLETED|Part 1, Period 3||0
6740931|NCT03307252|7669612|FG002|NOT COMPLETED|Part 1, Period 3||0
6740932|NCT03307252|7669613|FG003|NOT COMPLETED|Part 1, Period 3||0
6740933|NCT03307252|7669614|FG004|NOT COMPLETED|Part 1, Period 3||0
6740934|NCT03307252|7669615|FG005|NOT COMPLETED|Part 1, Period 3||0
6740935|NCT03307252|7669616|FG006|NOT COMPLETED|Part 1, Period 3||0
6740936|NCT03307252|7669617|FG007|NOT COMPLETED|Part 1, Period 3||0
6740937|NCT03307252|7669618|FG008|NOT COMPLETED|Part 1, Period 3||0
6740938|NCT03307252|7669619|FG009|NOT COMPLETED|Part 1, Period 3||0
6740939|NCT03307252|7669620|FG010|NOT COMPLETED|Part 1, Period 3||0
6740940|NCT03307252|7669610|FG000|STARTED|Part 2, Period 1||0
6740941|NCT03307252|7669611|FG001|STARTED|Part 2, Period 1||0
6740942|NCT03307252|7669612|FG002|STARTED|Part 2, Period 1||0
6740943|NCT03307252|7669613|FG003|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6740944|NCT03307252|7669614|FG004|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6740945|NCT03307252|7669615|FG005|STARTED|Part 2, Period 1|Participants randomized in Part 2|4
6740946|NCT03307252|7669616|FG006|STARTED|Part 2, Period 1|Participants randomized in Part 2|5
6740947|NCT03307252|7669617|FG007|STARTED|Part 2, Period 1||0
6740948|NCT03307252|7669618|FG008|STARTED|Part 2, Period 1||0
6740949|NCT03307252|7669619|FG009|STARTED|Part 2, Period 1||0
6740950|NCT03307252|7669620|FG010|STARTED|Part 2, Period 1||0
6740951|NCT03307252|7669610|FG000|COMPLETED|Part 2, Period 1||0
6740952|NCT03307252|7669611|FG001|COMPLETED|Part 2, Period 1||0
6740953|NCT03307252|7669612|FG002|COMPLETED|Part 2, Period 1||0
6740954|NCT03307252|7669613|FG003|COMPLETED|Part 2, Period 1||4
6740955|NCT03307252|7669614|FG004|COMPLETED|Part 2, Period 1||4
6740956|NCT03307252|7669615|FG005|COMPLETED|Part 2, Period 1||3
6740957|NCT03307252|7669616|FG006|COMPLETED|Part 2, Period 1||5
6740958|NCT03307252|7669617|FG007|COMPLETED|Part 2, Period 1||0
6740959|NCT03307252|7669618|FG008|COMPLETED|Part 2, Period 1||0
6740960|NCT03307252|7669619|FG009|COMPLETED|Part 2, Period 1||0
6740961|NCT03307252|7669620|FG010|COMPLETED|Part 2, Period 1||0
6740962|NCT03307252|7669610|FG000|NOT COMPLETED|Part 2, Period 1||0
6740963|NCT03307252|7669611|FG001|NOT COMPLETED|Part 2, Period 1||0
6740964|NCT03307252|7669612|FG002|NOT COMPLETED|Part 2, Period 1||0
6740965|NCT03307252|7669613|FG003|NOT COMPLETED|Part 2, Period 1||0
6397806|NCT00871741|7310406|FG001|NOT COMPLETED|Overall Study||7
6397807|NCT00871780|7310412|FG000|STARTED|Overall Study|number enrolled|224
6397808|NCT00871780|7310412|FG000|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
6626779|NCT02234479|7554428|FG001|NOT COMPLETED|Overall Study||3
6626780|NCT02234570|7554442|FG000|STARTED|Overall Study||8
6397809|NCT00871780|7310412|FG000|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
6397810|NCT00871780|7310412|FG000|COMPLETED|Overall Study||197
6397811|NCT00871780|7310412|FG000|NOT COMPLETED|Overall Study||27
6397812|NCT00871819|7310419|FG000|STARTED|Overall Study||20
6397813|NCT00871819|7310419|FG000|COMPLETED|Overall Study||20
6397814|NCT00871819|7310419|FG000|NOT COMPLETED|Overall Study||0
6397815|NCT00871845|7310425|FG000|STARTED|Overall Study||11
6397816|NCT00871845|7310426|FG001|STARTED|Overall Study||25
6626781|NCT02234570|7554443|FG001|STARTED|Overall Study||8
6740966|NCT03307252|7669614|FG004|NOT COMPLETED|Part 2, Period 1||0
6740967|NCT03307252|7669615|FG005|NOT COMPLETED|Part 2, Period 1||1
6740968|NCT03307252|7669616|FG006|NOT COMPLETED|Part 2, Period 1||0
6740969|NCT03307252|7669617|FG007|NOT COMPLETED|Part 2, Period 1||0
6740970|NCT03307252|7669618|FG008|NOT COMPLETED|Part 2, Period 1||0
6397817|NCT00871845|7310425|FG000|COMPLETED|Overall Study||11
6397818|NCT00871845|7310426|FG001|COMPLETED|Overall Study||25
6397819|NCT00871845|7310425|FG000|NOT COMPLETED|Overall Study||0
6740971|NCT03307252|7669619|FG009|NOT COMPLETED|Part 2, Period 1||0
6740972|NCT03307252|7669620|FG010|NOT COMPLETED|Part 2, Period 1||0
6740973|NCT03307252|7669610|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
6740974|NCT03307252|7669611|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
6740975|NCT03307252|7669612|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
6740976|NCT03307252|7669613|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||4
6740977|NCT03307252|7669614|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||4
6740978|NCT03307252|7669615|FG005|STARTED|Part 2, Washout Period 1 (7 Days)||3
6740979|NCT03307252|7669616|FG006|STARTED|Part 2, Washout Period 1 (7 Days)||5
6740980|NCT03307252|7669617|FG007|STARTED|Part 2, Washout Period 1 (7 Days)||0
6740981|NCT03307252|7669618|FG008|STARTED|Part 2, Washout Period 1 (7 Days)||0
6740982|NCT03307252|7669619|FG009|STARTED|Part 2, Washout Period 1 (7 Days)||0
6740983|NCT03307252|7669620|FG010|STARTED|Part 2, Washout Period 1 (7 Days)||0
6740984|NCT03307252|7669610|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740985|NCT03307252|7669611|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740986|NCT03307252|7669612|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740987|NCT03307252|7669613|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
6740988|NCT03307252|7669614|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||4
6740989|NCT03307252|7669615|FG005|COMPLETED|Part 2, Washout Period 1 (7 Days)||3
6740990|NCT03307252|7669616|FG006|COMPLETED|Part 2, Washout Period 1 (7 Days)||5
6740991|NCT03307252|7669617|FG007|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740992|NCT03307252|7669618|FG008|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740993|NCT03307252|7669619|FG009|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740994|NCT03307252|7669620|FG010|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740995|NCT03307252|7669610|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740996|NCT03307252|7669611|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740997|NCT03307252|7669612|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740998|NCT03307252|7669613|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6740999|NCT03307252|7669614|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6741000|NCT03307252|7669615|FG005|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6741001|NCT03307252|7669616|FG006|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6741002|NCT03307252|7669617|FG007|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6741003|NCT03307252|7669618|FG008|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6741004|NCT03307252|7669619|FG009|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6741005|NCT03307252|7669620|FG010|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6741006|NCT03307252|7669610|FG000|STARTED|Part 2, Period 2||0
6741007|NCT03307252|7669611|FG001|STARTED|Part 2, Period 2||0
6741008|NCT03307252|7669612|FG002|STARTED|Part 2, Period 2||0
6741009|NCT03307252|7669613|FG003|STARTED|Part 2, Period 2||4
6741010|NCT03307252|7669614|FG004|STARTED|Part 2, Period 2||4
6741011|NCT03307252|7669615|FG005|STARTED|Part 2, Period 2||3
6741012|NCT03307252|7669616|FG006|STARTED|Part 2, Period 2||5
6397820|NCT00871845|7310426|FG001|NOT COMPLETED|Overall Study||0
6397821|NCT00871858|7310438|FG000|STARTED|Overall Study||61
6397822|NCT00871858|7310439|FG001|STARTED|Overall Study||59
6397823|NCT00871858|7310438|FG000|Evaluable for Safety|Overall Study|1 patient refused to continue study and therefore did not received treatment.|60
6397824|NCT00871858|7310439|FG001|Evaluable for Safety|Overall Study|1 patient refused to continue study after randomization and therefore did not received treatment.|58
6397825|NCT00871858|7310438|FG000|COMPLETED|Overall Study||56
6397826|NCT00871858|7310439|FG001|COMPLETED|Overall Study||52
6397827|NCT00871858|7310438|FG000|NOT COMPLETED|Overall Study||5
6397828|NCT00871858|7310439|FG001|NOT COMPLETED|Overall Study||7
6397829|NCT00871871|7310447|FG000|STARTED|Part I||18
6397830|NCT00871871|7310448|FG001|STARTED|Part I||18
6397831|NCT00871871|7310449|FG002|STARTED|Part I||0
6397832|NCT00871871|7310450|FG003|STARTED|Part I||0
6397833|NCT00871871|7310447|FG000|COMPLETED|Part I||15
6397834|NCT00871871|7310448|FG001|COMPLETED|Part I||15
6397835|NCT00871871|7310449|FG002|COMPLETED|Part I||0
6397836|NCT00871871|7310450|FG003|COMPLETED|Part I||0
6397837|NCT00871871|7310447|FG000|NOT COMPLETED|Part I||3
6397838|NCT00871871|7310448|FG001|NOT COMPLETED|Part I||3
6397839|NCT00871871|7310449|FG002|NOT COMPLETED|Part I||0
6397840|NCT00871871|7310450|FG003|NOT COMPLETED|Part I||0
6397841|NCT00871871|7310447|FG000|STARTED|Part II||0
6397842|NCT00871871|7310448|FG001|STARTED|Part II||0
6397843|NCT00871871|7310449|FG002|STARTED|Part II||13
6397844|NCT00871871|7310450|FG003|STARTED|Part II||15
6397845|NCT00871871|7310447|FG000|COMPLETED|Part II||0
6397846|NCT00871871|7310448|FG001|COMPLETED|Part II||0
6397847|NCT00871871|7310449|FG002|COMPLETED|Part II||9
6397848|NCT00871871|7310450|FG003|COMPLETED|Part II||11
6397849|NCT00871871|7310447|FG000|NOT COMPLETED|Part II||0
6397850|NCT00871871|7310448|FG001|NOT COMPLETED|Part II||0
6397851|NCT00871871|7310449|FG002|NOT COMPLETED|Part II||4
6397852|NCT00871871|7310450|FG003|NOT COMPLETED|Part II||4
6397853|NCT00871923|7310460|FG000|STARTED|Overall Study||44
6397854|NCT00871923|7310460|FG000|COMPLETED|Overall Study||42
6397855|NCT00871923|7310460|FG000|NOT COMPLETED|Overall Study||2
6741013|NCT03307252|7669617|FG007|STARTED|Part 2, Period 2||0
6741014|NCT03307252|7669618|FG008|STARTED|Part 2, Period 2||0
6741015|NCT03307252|7669619|FG009|STARTED|Part 2, Period 2||0
6741016|NCT03307252|7669620|FG010|STARTED|Part 2, Period 2||0
6741017|NCT03307252|7669610|FG000|COMPLETED|Part 2, Period 2||0
6741018|NCT03307252|7669611|FG001|COMPLETED|Part 2, Period 2||0
6741019|NCT03307252|7669612|FG002|COMPLETED|Part 2, Period 2||0
6741020|NCT03307252|7669613|FG003|COMPLETED|Part 2, Period 2||4
6741021|NCT03307252|7669614|FG004|COMPLETED|Part 2, Period 2||4
6741022|NCT03307252|7669615|FG005|COMPLETED|Part 2, Period 2||3
6741023|NCT03307252|7669616|FG006|COMPLETED|Part 2, Period 2||5
6741024|NCT03307252|7669617|FG007|COMPLETED|Part 2, Period 2||0
6397856|NCT00871975|7310464|FG000|STARTED|Overall Study||155
6397857|NCT00871975|7310464|FG000|COMPLETED|Overall Study||133
6397858|NCT00871975|7310464|FG000|NOT COMPLETED|Overall Study||22
6741025|NCT03307252|7669618|FG008|COMPLETED|Part 2, Period 2||0
6741026|NCT03307252|7669619|FG009|COMPLETED|Part 2, Period 2||0
6741027|NCT03307252|7669620|FG010|COMPLETED|Part 2, Period 2||0
6741028|NCT03307252|7669610|FG000|NOT COMPLETED|Part 2, Period 2||0
6741029|NCT03307252|7669611|FG001|NOT COMPLETED|Part 2, Period 2||0
6741030|NCT03307252|7669612|FG002|NOT COMPLETED|Part 2, Period 2||0
6741031|NCT03307252|7669613|FG003|NOT COMPLETED|Part 2, Period 2||0
6741032|NCT03307252|7669614|FG004|NOT COMPLETED|Part 2, Period 2||0
6741033|NCT03307252|7669615|FG005|NOT COMPLETED|Part 2, Period 2||0
6741034|NCT03307252|7669616|FG006|NOT COMPLETED|Part 2, Period 2||0
6741035|NCT03307252|7669617|FG007|NOT COMPLETED|Part 2, Period 2||0
6741036|NCT03307252|7669618|FG008|NOT COMPLETED|Part 2, Period 2||0
6741037|NCT03307252|7669619|FG009|NOT COMPLETED|Part 2, Period 2||0
6741038|NCT03307252|7669620|FG010|NOT COMPLETED|Part 2, Period 2||0
6741039|NCT03307252|7669610|FG000|STARTED|Part 2, Washout Period 2 (7 Days)||0
6741040|NCT03307252|7669611|FG001|STARTED|Part 2, Washout Period 2 (7 Days)||0
6741041|NCT03307252|7669612|FG002|STARTED|Part 2, Washout Period 2 (7 Days)||0
6741042|NCT03307252|7669613|FG003|STARTED|Part 2, Washout Period 2 (7 Days)||4
6741043|NCT03307252|7669614|FG004|STARTED|Part 2, Washout Period 2 (7 Days)||4
6741044|NCT03307252|7669615|FG005|STARTED|Part 2, Washout Period 2 (7 Days)||3
6741045|NCT03307252|7669616|FG006|STARTED|Part 2, Washout Period 2 (7 Days)||5
6741046|NCT03307252|7669617|FG007|STARTED|Part 2, Washout Period 2 (7 Days)||0
6741047|NCT03307252|7669618|FG008|STARTED|Part 2, Washout Period 2 (7 Days)||0
6741048|NCT03307252|7669619|FG009|STARTED|Part 2, Washout Period 2 (7 Days)||0
6741049|NCT03307252|7669620|FG010|STARTED|Part 2, Washout Period 2 (7 Days)||0
6741050|NCT03307252|7669610|FG000|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741051|NCT03307252|7669611|FG001|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741052|NCT03307252|7669612|FG002|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741053|NCT03307252|7669613|FG003|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
6741054|NCT03307252|7669614|FG004|COMPLETED|Part 2, Washout Period 2 (7 Days)||4
6741055|NCT03307252|7669615|FG005|COMPLETED|Part 2, Washout Period 2 (7 Days)||3
6741056|NCT03307252|7669616|FG006|COMPLETED|Part 2, Washout Period 2 (7 Days)||5
6741057|NCT03307252|7669617|FG007|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741058|NCT03307252|7669618|FG008|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741059|NCT03307252|7669619|FG009|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741060|NCT03307252|7669620|FG010|COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741061|NCT03307252|7669610|FG000|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741062|NCT03307252|7669611|FG001|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6397859|NCT00872001|7310470|FG000|STARTED|Overall Study||1536
6397860|NCT00872001|7310471|FG001|STARTED|Overall Study||1544
6397861|NCT00872001|7310470|FG000|COMPLETED|Overall Study||1400
6397862|NCT00872001|7310471|FG001|COMPLETED|Overall Study||1413
6397863|NCT00872001|7310470|FG000|NOT COMPLETED|Overall Study||136
6397864|NCT00872001|7310471|FG001|NOT COMPLETED|Overall Study||131
6397865|NCT00872027|7310481|FG000|STARTED|Overall Study||7
6397866|NCT00872027|7310482|FG001|STARTED|Overall Study||8
6397867|NCT00872027|7310481|FG000|COMPLETED|Overall Study||7
6397868|NCT00872027|7310482|FG001|COMPLETED|Overall Study||8
6397869|NCT00872027|7310481|FG000|NOT COMPLETED|Overall Study||0
6397870|NCT00872027|7310482|FG001|NOT COMPLETED|Overall Study||0
6397871|NCT00872079|7310488|FG000|STARTED|Overall Study||175
6397872|NCT00872079|7310488|FG000|COMPLETED|Overall Study||175
6397873|NCT00872079|7310488|FG000|NOT COMPLETED|Overall Study||0
6397874|NCT00872170|7310494|FG000|STARTED|Overall Study||14
6397875|NCT00872170|7310495|FG001|STARTED|Overall Study||13
6397876|NCT00872170|7310494|FG000|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
6397877|NCT00872170|7310495|FG001|COMPLETED|Overall Study||13
6741063|NCT03307252|7669612|FG002|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741064|NCT03307252|7669613|FG003|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6397878|NCT00872170|7310494|FG000|NOT COMPLETED|Overall Study||1
6397879|NCT00872170|7310495|FG001|NOT COMPLETED|Overall Study||0
6397880|NCT00872339|7310503|FG000|STARTED|Overall Study||201
6397881|NCT00872339|7310504|FG001|STARTED|Overall Study||14
6397882|NCT00872339|7310505|FG002|STARTED|Overall Study||37
6741065|NCT03307252|7669614|FG004|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741066|NCT03307252|7669615|FG005|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6397883|NCT00872339|7310503|FG000|COMPLETED|Overall Study||201
6397884|NCT00872339|7310504|FG001|COMPLETED|Overall Study||14
6397885|NCT00872339|7310505|FG002|COMPLETED|Overall Study||37
6397886|NCT00872339|7310503|FG000|NOT COMPLETED|Overall Study||0
6741067|NCT03307252|7669616|FG006|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741068|NCT03307252|7669617|FG007|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741069|NCT03307252|7669618|FG008|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6397887|NCT00872339|7310504|FG001|NOT COMPLETED|Overall Study||0
6397888|NCT00872339|7310505|FG002|NOT COMPLETED|Overall Study||0
6397889|NCT00872521|7310516|FG000|STARTED|Completed PAD Induction|Received allocated treatment|26
6397890|NCT00872521|7310517|FG001|STARTED|Completed PAD Induction|Received allocated treatment|72
6397891|NCT00872521|7310518|FG002|STARTED|Completed PAD Induction|Received allocated treatment|9
6397892|NCT00872521|7310516|FG000|COMPLETED|Completed PAD Induction|Completed PAD induction|21
6397893|NCT00872521|7310517|FG001|COMPLETED|Completed PAD Induction|Completed PAD induction|68
6397894|NCT00872521|7310518|FG002|COMPLETED|Completed PAD Induction|Completed PAD induction|9
6397895|NCT00872521|7310516|FG000|NOT COMPLETED|Completed PAD Induction||5
6397896|NCT00872521|7310517|FG001|NOT COMPLETED|Completed PAD Induction||4
6397897|NCT00872521|7310518|FG002|NOT COMPLETED|Completed PAD Induction||0
6397898|NCT00872521|7310516|FG000|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
6397899|NCT00872521|7310517|FG001|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
6397900|NCT00872521|7310518|FG002|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
6397901|NCT00872521|7310516|FG000|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
6397902|NCT00872521|7310517|FG001|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
6397903|NCT00872521|7310518|FG002|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
6397904|NCT00872521|7310516|FG000|NOT COMPLETED|Primary Endpoint Analysis||1
6397905|NCT00872521|7310517|FG001|NOT COMPLETED|Primary Endpoint Analysis||5
6397906|NCT00872521|7310518|FG002|NOT COMPLETED|Primary Endpoint Analysis||1
6397907|NCT00872521|7310516|FG000|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
6397908|NCT00872521|7310517|FG001|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
6397909|NCT00872521|7310518|FG002|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
6397910|NCT00872521|7310516|FG000|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
6397911|NCT00872521|7310517|FG001|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
6397912|NCT00872521|7310518|FG002|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
6397913|NCT00872521|7310516|FG000|NOT COMPLETED|Completed 3-month Follow up||0
6397914|NCT00872521|7310517|FG001|NOT COMPLETED|Completed 3-month Follow up||3
6397915|NCT00872521|7310518|FG002|NOT COMPLETED|Completed 3-month Follow up||0
6397916|NCT00872521|7310516|FG000|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
6397917|NCT00872521|7310517|FG001|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
6397918|NCT00872521|7310518|FG002|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
6397919|NCT00872521|7310516|FG000|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
6397920|NCT00872521|7310517|FG001|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
6397921|NCT00872521|7310518|FG002|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
6397922|NCT00872521|7310516|FG000|NOT COMPLETED|Secondary Endpoint Analysis||0
6397923|NCT00872521|7310517|FG001|NOT COMPLETED|Secondary Endpoint Analysis||2
6397924|NCT00872521|7310518|FG002|NOT COMPLETED|Secondary Endpoint Analysis||1
6397925|NCT00872534|7310539|FG000|STARTED|Overall Study||100
6397926|NCT00872534|7310540|FG001|STARTED|Overall Study||104
6397927|NCT00872534|7310539|FG000|COMPLETED|Overall Study||97
6397928|NCT00872534|7310540|FG001|COMPLETED|Overall Study||101
6397929|NCT00872534|7310539|FG000|NOT COMPLETED|Overall Study||3
6397930|NCT00872534|7310540|FG001|NOT COMPLETED|Overall Study||3
6397931|NCT00872599|7310546|FG000|STARTED|First Washout Period After Low Salt||16
6397932|NCT00872599|7310547|FG001|STARTED|First Washout Period After Low Salt||17
6397933|NCT00872599|7310546|FG000|COMPLETED|First Washout Period After Low Salt||16
6397934|NCT00872599|7310547|FG001|COMPLETED|First Washout Period After Low Salt||17
6397935|NCT00872599|7310546|FG000|NOT COMPLETED|First Washout Period After Low Salt||0
6397936|NCT00872599|7310547|FG001|NOT COMPLETED|First Washout Period After Low Salt||0
6397937|NCT00872599|7310546|FG000|STARTED|First Drug During High Salt Intake||16
6397938|NCT00872599|7310547|FG001|STARTED|First Drug During High Salt Intake||17
6397939|NCT00872599|7310546|FG000|COMPLETED|First Drug During High Salt Intake||16
6397940|NCT00872599|7310547|FG001|COMPLETED|First Drug During High Salt Intake||17
6397941|NCT00872599|7310546|FG000|NOT COMPLETED|First Drug During High Salt Intake||0
6397942|NCT00872599|7310547|FG001|NOT COMPLETED|First Drug During High Salt Intake||0
6397943|NCT00872599|7310546|FG000|STARTED|Second Washout Period||16
6397944|NCT00872599|7310547|FG001|STARTED|Second Washout Period||17
6397945|NCT00872599|7310546|FG000|COMPLETED|Second Washout Period||15
6397946|NCT00872599|7310547|FG001|COMPLETED|Second Washout Period||16
6397947|NCT00872599|7310546|FG000|NOT COMPLETED|Second Washout Period||1
6397948|NCT00872599|7310547|FG001|NOT COMPLETED|Second Washout Period||1
6397949|NCT00872599|7310546|FG000|STARTED|Second Drug During High Salt Intake||15
6397950|NCT00872599|7310547|FG001|STARTED|Second Drug During High Salt Intake||16
6397951|NCT00872599|7310546|FG000|COMPLETED|Second Drug During High Salt Intake||15
6397952|NCT00872599|7310547|FG001|COMPLETED|Second Drug During High Salt Intake||16
6397953|NCT00872599|7310546|FG000|NOT COMPLETED|Second Drug During High Salt Intake||0
6397954|NCT00872599|7310547|FG001|NOT COMPLETED|Second Drug During High Salt Intake||0
6397955|NCT00872729|7310553|FG000|STARTED|Overall Study||9
6397956|NCT00872729|7310553|FG000|COMPLETED|Overall Study||9
6397957|NCT00872729|7310553|FG000|NOT COMPLETED|Overall Study||0
6397958|NCT00872833|7310579|FG000|STARTED|Overall Study||15
6397959|NCT00872833|7310580|FG001|STARTED|Overall Study||17
6397960|NCT00872833|7310579|FG000|COMPLETED|Overall Study||15
6397961|NCT00872833|7310580|FG001|COMPLETED|Overall Study||17
6397962|NCT00872833|7310579|FG000|NOT COMPLETED|Overall Study||0
6741070|NCT03307252|7669619|FG009|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741071|NCT03307252|7669620|FG010|NOT COMPLETED|Part 2, Washout Period 2 (7 Days)||0
6741072|NCT03307252|7669610|FG000|STARTED|Part 2, Period 3||0
6741073|NCT03307252|7669611|FG001|STARTED|Part 2, Period 3||0
6741074|NCT03307252|7669612|FG002|STARTED|Part 2, Period 3||0
6741075|NCT03307252|7669613|FG003|STARTED|Part 2, Period 3||4
6741076|NCT03307252|7669614|FG004|STARTED|Part 2, Period 3||4
6741077|NCT03307252|7669615|FG005|STARTED|Part 2, Period 3||3
6741078|NCT03307252|7669616|FG006|STARTED|Part 2, Period 3||5
6741079|NCT03307252|7669617|FG007|STARTED|Part 2, Period 3||0
6741080|NCT03307252|7669618|FG008|STARTED|Part 2, Period 3||0
6741081|NCT03307252|7669619|FG009|STARTED|Part 2, Period 3||0
6741082|NCT03307252|7669620|FG010|STARTED|Part 2, Period 3||0
6741083|NCT03307252|7669610|FG000|COMPLETED|Part 2, Period 3||0
6741084|NCT03307252|7669611|FG001|COMPLETED|Part 2, Period 3||0
6741085|NCT03307252|7669612|FG002|COMPLETED|Part 2, Period 3||0
6741086|NCT03307252|7669613|FG003|COMPLETED|Part 2, Period 3||4
6741087|NCT03307252|7669614|FG004|COMPLETED|Part 2, Period 3||3
6741088|NCT03307252|7669615|FG005|COMPLETED|Part 2, Period 3||3
6741089|NCT03307252|7669616|FG006|COMPLETED|Part 2, Period 3||5
6741090|NCT03307252|7669617|FG007|COMPLETED|Part 2, Period 3||0
6741091|NCT03307252|7669618|FG008|COMPLETED|Part 2, Period 3||0
6741092|NCT03307252|7669619|FG009|COMPLETED|Part 2, Period 3||0
6741093|NCT03307252|7669620|FG010|COMPLETED|Part 2, Period 3||0
6741094|NCT03307252|7669610|FG000|NOT COMPLETED|Part 2, Period 3||0
6741095|NCT03307252|7669611|FG001|NOT COMPLETED|Part 2, Period 3||0
6741096|NCT03307252|7669612|FG002|NOT COMPLETED|Part 2, Period 3||0
6741097|NCT03307252|7669613|FG003|NOT COMPLETED|Part 2, Period 3||0
6741098|NCT03307252|7669614|FG004|NOT COMPLETED|Part 2, Period 3||1
6741099|NCT03307252|7669615|FG005|NOT COMPLETED|Part 2, Period 3||0
6741100|NCT03307252|7669616|FG006|NOT COMPLETED|Part 2, Period 3||0
6741101|NCT03307252|7669617|FG007|NOT COMPLETED|Part 2, Period 3||0
6741102|NCT03307252|7669618|FG008|NOT COMPLETED|Part 2, Period 3||0
6741103|NCT03307252|7669619|FG009|NOT COMPLETED|Part 2, Period 3||0
6741104|NCT03307252|7669620|FG010|NOT COMPLETED|Part 2, Period 3||0
6741105|NCT03307252|7669610|FG000|STARTED|Part 2, Washout Period 3 (7 Days)||0
6741106|NCT03307252|7669611|FG001|STARTED|Part 2, Washout Period 3 (7 Days)||0
6741107|NCT03307252|7669612|FG002|STARTED|Part 2, Washout Period 3 (7 Days)||0
6741108|NCT03307252|7669613|FG003|STARTED|Part 2, Washout Period 3 (7 Days)||4
6741109|NCT03307252|7669614|FG004|STARTED|Part 2, Washout Period 3 (7 Days)||3
6741110|NCT03307252|7669615|FG005|STARTED|Part 2, Washout Period 3 (7 Days)||3
6741111|NCT03307252|7669616|FG006|STARTED|Part 2, Washout Period 3 (7 Days)||5
6741112|NCT03307252|7669617|FG007|STARTED|Part 2, Washout Period 3 (7 Days)||0
6741113|NCT03307252|7669618|FG008|STARTED|Part 2, Washout Period 3 (7 Days)||0
6741114|NCT03307252|7669619|FG009|STARTED|Part 2, Washout Period 3 (7 Days)||0
6741115|NCT03307252|7669620|FG010|STARTED|Part 2, Washout Period 3 (7 Days)||0
6741116|NCT03307252|7669610|FG000|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741117|NCT03307252|7669611|FG001|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741118|NCT03307252|7669612|FG002|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741119|NCT03307252|7669613|FG003|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
6741120|NCT03307252|7669614|FG004|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
6741121|NCT03307252|7669615|FG005|COMPLETED|Part 2, Washout Period 3 (7 Days)||3
6741122|NCT03307252|7669616|FG006|COMPLETED|Part 2, Washout Period 3 (7 Days)||4
6741123|NCT03307252|7669617|FG007|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741124|NCT03307252|7669618|FG008|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741125|NCT03307252|7669619|FG009|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741126|NCT03307252|7669620|FG010|COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741127|NCT03307252|7669610|FG000|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741128|NCT03307252|7669611|FG001|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741129|NCT03307252|7669612|FG002|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741130|NCT03307252|7669613|FG003|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741131|NCT03307252|7669614|FG004|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741132|NCT03307252|7669615|FG005|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741133|NCT03307252|7669616|FG006|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||1
6741134|NCT03307252|7669617|FG007|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741135|NCT03307252|7669618|FG008|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741136|NCT03307252|7669619|FG009|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741137|NCT03307252|7669620|FG010|NOT COMPLETED|Part 2, Washout Period 3 (7 Days)||0
6741138|NCT03307252|7669610|FG000|STARTED|Part 2, Period 4||0
6741139|NCT03307252|7669611|FG001|STARTED|Part 2, Period 4||0
6741140|NCT03307252|7669612|FG002|STARTED|Part 2, Period 4||0
6741141|NCT03307252|7669613|FG003|STARTED|Part 2, Period 4||4
6741142|NCT03307252|7669614|FG004|STARTED|Part 2, Period 4||3
6741143|NCT03307252|7669615|FG005|STARTED|Part 2, Period 4||3
6741144|NCT03307252|7669616|FG006|STARTED|Part 2, Period 4||5
6397963|NCT00872833|7310580|FG001|NOT COMPLETED|Overall Study||0
6741145|NCT03307252|7669617|FG007|STARTED|Part 2, Period 4||0
6741146|NCT03307252|7669618|FG008|STARTED|Part 2, Period 4||0
6741147|NCT03307252|7669619|FG009|STARTED|Part 2, Period 4||0
6741148|NCT03307252|7669620|FG010|STARTED|Part 2, Period 4||0
6741149|NCT03307252|7669610|FG000|COMPLETED|Part 2, Period 4||0
6741150|NCT03307252|7669611|FG001|COMPLETED|Part 2, Period 4||0
6741151|NCT03307252|7669612|FG002|COMPLETED|Part 2, Period 4||0
6741152|NCT03307252|7669613|FG003|COMPLETED|Part 2, Period 4||4
6741153|NCT03307252|7669614|FG004|COMPLETED|Part 2, Period 4||3
6741154|NCT03307252|7669615|FG005|COMPLETED|Part 2, Period 4||3
6741155|NCT03307252|7669616|FG006|COMPLETED|Part 2, Period 4||4
6397964|NCT00872898|7310592|FG000|STARTED|Part One - Open Label, Pharmacokinetics||0
6397965|NCT00872898|7310593|FG001|STARTED|Part One - Open Label, Pharmacokinetics||4
6626782|NCT02234570|7554444|FG002|STARTED|Overall Study||8
6626783|NCT02234570|7554445|FG003|STARTED|Overall Study||8
6626784|NCT02234570|7554446|FG004|STARTED|Overall Study||8
6626785|NCT02234570|7554447|FG005|STARTED|Overall Study||8
6626786|NCT02234570|7554448|FG006|STARTED|Overall Study||8
6626787|NCT02234570|7554449|FG007|STARTED|Overall Study||14
6626788|NCT02234570|7554442|FG000|COMPLETED|Overall Study||8
6626789|NCT02234570|7554443|FG001|COMPLETED|Overall Study||8
6626790|NCT02234570|7554444|FG002|COMPLETED|Overall Study||8
6626791|NCT02234570|7554445|FG003|COMPLETED|Overall Study||8
6626792|NCT02234570|7554446|FG004|COMPLETED|Overall Study||8
6626793|NCT02234570|7554447|FG005|COMPLETED|Overall Study||8
6397966|NCT00872898|7310592|FG000|COMPLETED|Part One - Open Label, Pharmacokinetics||0
6397967|NCT00872898|7310593|FG001|COMPLETED|Part One - Open Label, Pharmacokinetics||4
6397968|NCT00872898|7310592|FG000|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
6397969|NCT00872898|7310593|FG001|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
6397970|NCT00872898|7310592|FG000|STARTED|Part Two - Double Blind||61
6397971|NCT00872898|7310593|FG001|STARTED|Part Two - Double Blind||60
6397972|NCT00872898|7310592|FG000|COMPLETED|Part Two - Double Blind||50
6397973|NCT00872898|7310593|FG001|COMPLETED|Part Two - Double Blind||54
6397974|NCT00872898|7310592|FG000|NOT COMPLETED|Part Two - Double Blind||11
6397975|NCT00872898|7310593|FG001|NOT COMPLETED|Part Two - Double Blind||6
6397976|NCT00872989|7310604|FG000|STARTED|Overall Study||66
6397977|NCT00872989|7310605|FG001|STARTED|Overall Study||63
6397978|NCT00872989|7310604|FG000|COMPLETED|Overall Study||1
6397979|NCT00872989|7310605|FG001|COMPLETED|Overall Study||0
6397980|NCT00872989|7310604|FG000|NOT COMPLETED|Overall Study||65
6397981|NCT00872989|7310605|FG001|NOT COMPLETED|Overall Study||63
6397982|NCT00873015|7310621|FG000|STARTED|Overall Study||9
6397983|NCT00873015|7310622|FG001|STARTED|Overall Study||4
6397984|NCT00873015|7310623|FG002|STARTED|Overall Study||3
6397985|NCT00873015|7310624|FG003|STARTED|Overall Study||3
6397986|NCT00873015|7310621|FG000|COMPLETED|Overall Study||9
6397987|NCT00873015|7310622|FG001|COMPLETED|Overall Study||3
6397988|NCT00873015|7310623|FG002|COMPLETED|Overall Study||3
6397989|NCT00873015|7310624|FG003|COMPLETED|Overall Study||3
6397990|NCT00873015|7310621|FG000|NOT COMPLETED|Overall Study||0
6397991|NCT00873015|7310622|FG001|NOT COMPLETED|Overall Study||1
6397992|NCT00873015|7310623|FG002|NOT COMPLETED|Overall Study||0
6397993|NCT00873015|7310624|FG003|NOT COMPLETED|Overall Study||0
6397994|NCT00873041|7310636|FG000|STARTED|Core Study||55
6397995|NCT00873041|7310637|FG001|STARTED|Core Study||55
6397996|NCT00873041|7310638|FG002|STARTED|Core Study||56
6397997|NCT00873041|7310636|FG000|COMPLETED|Core Study||48
6397998|NCT00873041|7310637|FG001|COMPLETED|Core Study||49
6397999|NCT00873041|7310638|FG002|COMPLETED|Core Study||51
6398000|NCT00873041|7310636|FG000|NOT COMPLETED|Core Study||7
6398001|NCT00873041|7310637|FG001|NOT COMPLETED|Core Study||6
6398002|NCT00873041|7310638|FG002|NOT COMPLETED|Core Study||5
6398003|NCT00873041|7310636|FG000|STARTED|Extension Study||41
6398004|NCT00873041|7310637|FG001|STARTED|Extension Study||44
6398005|NCT00873041|7310638|FG002|STARTED|Extension Study||48
6398006|NCT00873041|7310636|FG000|COMPLETED|Extension Study||40
6398007|NCT00873041|7310637|FG001|COMPLETED|Extension Study||44
6398008|NCT00873041|7310638|FG002|COMPLETED|Extension Study||46
6398009|NCT00873041|7310636|FG000|NOT COMPLETED|Extension Study||1
6398010|NCT00873041|7310637|FG001|NOT COMPLETED|Extension Study||0
6398011|NCT00873041|7310638|FG002|NOT COMPLETED|Extension Study||2
6398012|NCT00873093|7310658|FG000|STARTED|Overall Study||4
6398013|NCT00873093|7310659|FG001|STARTED|Overall Study||62
6398014|NCT00873093|7310660|FG002|STARTED|Overall Study||49
6398015|NCT00873093|7310661|FG003|STARTED|Overall Study||23
6398016|NCT00873093|7310662|FG004|STARTED|Overall Study||10
6398017|NCT00873093|7310658|FG000|COMPLETED|Overall Study||3
6398018|NCT00873093|7310659|FG001|COMPLETED|Overall Study||35
6398019|NCT00873093|7310660|FG002|COMPLETED|Overall Study||33
6398020|NCT00873093|7310661|FG003|COMPLETED|Overall Study||12
6398021|NCT00873093|7310662|FG004|COMPLETED|Overall Study||8
6398022|NCT00873093|7310658|FG000|NOT COMPLETED|Overall Study||1
6398023|NCT00873093|7310659|FG001|NOT COMPLETED|Overall Study||27
6398024|NCT00873093|7310660|FG002|NOT COMPLETED|Overall Study||16
6398025|NCT00873093|7310661|FG003|NOT COMPLETED|Overall Study||11
6398026|NCT00873093|7310662|FG004|NOT COMPLETED|Overall Study||2
6398027|NCT00873119|7310686|FG000|STARTED|Overall Study||44
6626794|NCT02234570|7554448|FG006|COMPLETED|Overall Study||8
6626795|NCT02234570|7554449|FG007|COMPLETED|Overall Study||14
6626796|NCT02234570|7554442|FG000|NOT COMPLETED|Overall Study||0
6398028|NCT00873119|7310687|FG001|STARTED|Overall Study||45
6398029|NCT00873119|7310686|FG000|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
6626797|NCT02234570|7554443|FG001|NOT COMPLETED|Overall Study||0
6398030|NCT00873119|7310687|FG001|COMPLETED|Overall Study||19
6626798|NCT02234570|7554444|FG002|NOT COMPLETED|Overall Study||0
6741156|NCT03307252|7669617|FG007|COMPLETED|Part 2, Period 4||0
6626799|NCT02234570|7554445|FG003|NOT COMPLETED|Overall Study||0
6626800|NCT02234570|7554446|FG004|NOT COMPLETED|Overall Study||0
6626801|NCT02234570|7554447|FG005|NOT COMPLETED|Overall Study||0
6626802|NCT02234570|7554448|FG006|NOT COMPLETED|Overall Study||0
6626803|NCT02234570|7554449|FG007|NOT COMPLETED|Overall Study||0
6398031|NCT00873119|7310686|FG000|NOT COMPLETED|Overall Study||44
6398032|NCT00873119|7310687|FG001|NOT COMPLETED|Overall Study||26
6498631|NCT01411501|7417262|FG000|STARTED|Overall Study||168
6498632|NCT01411501|7417263|FG001|STARTED|Overall Study||172
6498633|NCT01411501|7417264|FG002|STARTED|Overall Study||165
6498634|NCT01411501|7417265|FG003|STARTED|Overall Study||170
6498635|NCT01411501|7417262|FG000|COMPLETED|Overall Study||158
6498636|NCT01411501|7417263|FG001|COMPLETED|Overall Study||166
6498637|NCT01411501|7417264|FG002|COMPLETED|Overall Study||159
6498638|NCT01411501|7417265|FG003|COMPLETED|Overall Study||163
6498639|NCT01411501|7417262|FG000|NOT COMPLETED|Overall Study||10
6498640|NCT01411501|7417263|FG001|NOT COMPLETED|Overall Study||6
6498641|NCT01411501|7417264|FG002|NOT COMPLETED|Overall Study||6
6498642|NCT01411501|7417265|FG003|NOT COMPLETED|Overall Study||7
6498643|NCT01411527|7417277|FG000|STARTED|Overall Study||1864
6498644|NCT01411527|7417278|FG001|STARTED|Overall Study||93
6498645|NCT01411527|7417277|FG000|COMPLETED|Overall Study||1864
6498646|NCT01411527|7417278|FG001|COMPLETED|Overall Study||93
6498647|NCT01411527|7417277|FG000|NOT COMPLETED|Overall Study||0
6498648|NCT01411527|7417278|FG001|NOT COMPLETED|Overall Study||0
6498649|NCT01411592|7417285|FG000|STARTED|Overall Study||14
6498650|NCT01411592|7417286|FG001|STARTED|Overall Study||16
6498651|NCT01411592|7417285|FG000|5-Year Time Frame|Overall Study||14
6498652|NCT01411592|7417286|FG001|5-Year Time Frame|Overall Study||16
6498653|NCT01411592|7417285|FG000|COMPLETED|Overall Study||14
6498654|NCT01411592|7417286|FG001|COMPLETED|Overall Study||16
6498655|NCT01411592|7417285|FG000|NOT COMPLETED|Overall Study||0
6498656|NCT01411592|7417286|FG001|NOT COMPLETED|Overall Study||0
6501986|NCT01432236|7420656|FG001|STARTED|Overall Study||97
6501987|NCT01432236|7420655|FG000|COMPLETED|Overall Study||70
6501988|NCT01432236|7420656|FG001|COMPLETED|Overall Study||79
6501989|NCT01432236|7420655|FG000|NOT COMPLETED|Overall Study||26
6501990|NCT01432236|7420656|FG001|NOT COMPLETED|Overall Study||18
6501991|NCT01432262|7420671|FG000|STARTED|Overall Study||162
6501992|NCT01432262|7420672|FG001|STARTED|Overall Study||162
6501993|NCT01432262|7420671|FG000|Vaccinated|Overall Study||162
6501994|NCT01432262|7420672|FG001|Vaccinated|Overall Study||161
6501995|NCT01432262|7420671|FG000|COMPLETED|Overall Study||160
6501996|NCT01432262|7420672|FG001|COMPLETED|Overall Study||161
6501997|NCT01432262|7420671|FG000|NOT COMPLETED|Overall Study||2
6501998|NCT01432262|7420672|FG001|NOT COMPLETED|Overall Study||1
6501999|NCT01432275|7420678|FG000|STARTED|First BG Meter System (7 Days)||90
6502000|NCT01432275|7420679|FG001|STARTED|First BG Meter System (7 Days)||87
6502001|NCT01432275|7420678|FG000|COMPLETED|First BG Meter System (7 Days)||90
6502002|NCT01432275|7420679|FG001|COMPLETED|First BG Meter System (7 Days)||84
6502003|NCT01432275|7420678|FG000|NOT COMPLETED|First BG Meter System (7 Days)||0
6502004|NCT01432275|7420679|FG001|NOT COMPLETED|First BG Meter System (7 Days)||3
6502005|NCT01432275|7420678|FG000|STARTED|Second BG Meter System (7 Days)||90
6502006|NCT01432275|7420679|FG001|STARTED|Second BG Meter System (7 Days)||84
6502007|NCT01432275|7420678|FG000|COMPLETED|Second BG Meter System (7 Days)||88
6502008|NCT01432275|7420679|FG001|COMPLETED|Second BG Meter System (7 Days)||81
6502009|NCT01432275|7420678|FG000|NOT COMPLETED|Second BG Meter System (7 Days)||2
6502010|NCT01432275|7420679|FG001|NOT COMPLETED|Second BG Meter System (7 Days)||3
6502011|NCT01432275|7420678|FG000|STARTED|ADC With Calculator (10 Days)||88
6502012|NCT01432275|7420679|FG001|STARTED|ADC With Calculator (10 Days)||81
6502013|NCT01432275|7420678|FG000|COMPLETED|ADC With Calculator (10 Days)||85
6502014|NCT01432275|7420679|FG001|COMPLETED|ADC With Calculator (10 Days)||79
6502015|NCT01432275|7420678|FG000|NOT COMPLETED|ADC With Calculator (10 Days)||3
6502016|NCT01432275|7420679|FG001|NOT COMPLETED|ADC With Calculator (10 Days)||2
6502017|NCT01432327|7420689|FG000|STARTED|Baseline||56
6502018|NCT01432327|7420690|FG001|STARTED|Baseline||57
6502019|NCT01432327|7420691|FG002|STARTED|Baseline||57
6502020|NCT01432327|7420692|FG003|STARTED|Baseline||57
6502021|NCT01432327|7420689|FG000|COMPLETED|Baseline||56
6502022|NCT01432327|7420690|FG001|COMPLETED|Baseline||57
6502023|NCT01432327|7420691|FG002|COMPLETED|Baseline||57
6502024|NCT01432327|7420692|FG003|COMPLETED|Baseline||57
6502025|NCT01432327|7420689|FG000|NOT COMPLETED|Baseline||0
6502026|NCT01432327|7420690|FG001|NOT COMPLETED|Baseline||0
6502027|NCT01432327|7420691|FG002|NOT COMPLETED|Baseline||0
6502028|NCT01432327|7420692|FG003|NOT COMPLETED|Baseline||0
6502029|NCT01432327|7420689|FG000|STARTED|Posttest 3 Months||56
6502030|NCT01432327|7420690|FG001|STARTED|Posttest 3 Months||57
6502031|NCT01432327|7420691|FG002|STARTED|Posttest 3 Months||57
6502032|NCT01432327|7420692|FG003|STARTED|Posttest 3 Months||57
6502033|NCT01432327|7420689|FG000|COMPLETED|Posttest 3 Months||52
6502034|NCT01432327|7420690|FG001|COMPLETED|Posttest 3 Months||55
6502035|NCT01432327|7420691|FG002|COMPLETED|Posttest 3 Months||55
6502036|NCT01432327|7420692|FG003|COMPLETED|Posttest 3 Months||56
6502037|NCT01432327|7420689|FG000|NOT COMPLETED|Posttest 3 Months||4
6502038|NCT01432327|7420690|FG001|NOT COMPLETED|Posttest 3 Months||2
6502039|NCT01432327|7420691|FG002|NOT COMPLETED|Posttest 3 Months||2
6502040|NCT01432327|7420692|FG003|NOT COMPLETED|Posttest 3 Months||1
6502041|NCT01432327|7420689|FG000|STARTED|Posttest 6 Months||52
6502042|NCT01432327|7420690|FG001|STARTED|Posttest 6 Months||55
6626804|NCT02234583|7554469|FG000|STARTED|Overall Study||847
6626805|NCT02234583|7554470|FG001|STARTED|Overall Study||1241
6626806|NCT02234583|7554469|FG000|COMPLETED|Overall Study||434
6626807|NCT02234583|7554470|FG001|COMPLETED|Overall Study||685
6626808|NCT02234583|7554469|FG000|NOT COMPLETED|Overall Study||413
6626809|NCT02234583|7554470|FG001|NOT COMPLETED|Overall Study||556
6626810|NCT02234596|7554482|FG000|STARTED|Overall Study||34
6626811|NCT02234596|7554482|FG000|COMPLETED|Overall Study||32
6626812|NCT02234596|7554482|FG000|NOT COMPLETED|Overall Study||2
6626813|NCT02234622|7554488|FG000|STARTED|Overall Study||108
6626814|NCT02234622|7554489|FG001|STARTED|Overall Study||104
6626815|NCT02234622|7554488|FG000|COMPLETED|Overall Study||65
6626816|NCT02234622|7554489|FG001|COMPLETED|Overall Study||68
6626817|NCT02234622|7554488|FG000|NOT COMPLETED|Overall Study||43
6626818|NCT02234622|7554489|FG001|NOT COMPLETED|Overall Study||36
6626819|NCT02234713|7554499|FG000|STARTED|Overall Study||31
6398033|NCT00873327|7310693|FG000|STARTED|Overall Study||32
6398034|NCT00873327|7310693|FG000|COMPLETED|Overall Study||32
6398035|NCT00873327|7310693|FG000|NOT COMPLETED|Overall Study||0
6398036|NCT00873457|7310697|FG000|STARTED|Overall Study||16
6398037|NCT00873457|7310697|FG000|COMPLETED|Overall Study||16
6398038|NCT00873457|7310697|FG000|NOT COMPLETED|Overall Study||0
6398039|NCT00873730|7310703|FG000|STARTED|Overall Study||54
6398040|NCT00873730|7310704|FG001|STARTED|Overall Study||54
6398041|NCT00873730|7310703|FG000|COMPLETED|Overall Study||48
6398042|NCT00873730|7310704|FG001|COMPLETED|Overall Study||49
6398043|NCT00873730|7310703|FG000|NOT COMPLETED|Overall Study||6
6398044|NCT00873730|7310704|FG001|NOT COMPLETED|Overall Study||5
6398045|NCT00873782|7310710|FG000|STARTED|Overall Study||16
6398046|NCT00873782|7310710|FG000|COMPLETED|Overall Study||16
6398047|NCT00873782|7310710|FG000|NOT COMPLETED|Overall Study||0
6398048|NCT00873821|7310716|FG000|STARTED|Overall Study||22
6398049|NCT00873821|7310717|FG001|STARTED|Overall Study||22
6398050|NCT00873821|7310716|FG000|COMPLETED|Overall Study||22
6398051|NCT00873821|7310717|FG001|COMPLETED|Overall Study||22
6398052|NCT00873821|7310716|FG000|NOT COMPLETED|Overall Study||0
6398053|NCT00873821|7310717|FG001|NOT COMPLETED|Overall Study||0
6398054|NCT00873860|7310727|FG000|STARTED|Overall Study||48
6398055|NCT00873860|7310728|FG001|STARTED|Overall Study||47
6398056|NCT00873860|7310729|FG002|STARTED|Overall Study||51
6398057|NCT00873860|7310730|FG003|STARTED|Overall Study||48
6398058|NCT00873860|7310727|FG000|Treated|Overall Study||47
6398059|NCT00873860|7310728|FG001|Treated|Overall Study||47
6398060|NCT00873860|7310729|FG002|Treated|Overall Study||51
6398061|NCT00873860|7310730|FG003|Treated|Overall Study||48
6398062|NCT00873860|7310727|FG000|COMPLETED|Overall Study||44
6398063|NCT00873860|7310728|FG001|COMPLETED|Overall Study||47
6398064|NCT00873860|7310729|FG002|COMPLETED|Overall Study||48
6398065|NCT00873860|7310730|FG003|COMPLETED|Overall Study||47
6398066|NCT00873860|7310727|FG000|NOT COMPLETED|Overall Study||4
6398067|NCT00873860|7310728|FG001|NOT COMPLETED|Overall Study||0
6398068|NCT00873860|7310729|FG002|NOT COMPLETED|Overall Study||3
6398069|NCT00873860|7310730|FG003|NOT COMPLETED|Overall Study||1
6398070|NCT00873873|7310747|FG000|STARTED|Overall Study||20
6398071|NCT00873873|7310748|FG001|STARTED|Overall Study||8
6398072|NCT00873873|7310749|FG002|STARTED|Overall Study||9
6398073|NCT00873873|7310750|FG003|STARTED|Overall Study||18
6398074|NCT00873873|7310747|FG000|COMPLETED|Overall Study||20
6398075|NCT00873873|7310748|FG001|COMPLETED|Overall Study||8
6398076|NCT00873873|7310749|FG002|COMPLETED|Overall Study||9
6398077|NCT00873873|7310750|FG003|COMPLETED|Overall Study||18
6398078|NCT00873873|7310747|FG000|NOT COMPLETED|Overall Study||0
6398079|NCT00873873|7310748|FG001|NOT COMPLETED|Overall Study||0
6398080|NCT00873873|7310749|FG002|NOT COMPLETED|Overall Study||0
6398081|NCT00873873|7310750|FG003|NOT COMPLETED|Overall Study||0
6398082|NCT00873912|7310762|FG000|STARTED|Overall Study||240
6398083|NCT00873912|7310763|FG001|STARTED|Overall Study||60
6398084|NCT00873912|7310762|FG000|COMPLETED|Overall Study||237
6398085|NCT00873912|7310763|FG001|COMPLETED|Overall Study||60
6398086|NCT00873912|7310762|FG000|NOT COMPLETED|Overall Study||3
6398087|NCT00873912|7310763|FG001|NOT COMPLETED|Overall Study||0
6398088|NCT00874029|7310769|FG000|STARTED|Overall Study||137
6398089|NCT00874029|7310769|FG000|COMPLETED|Overall Study||116
6398090|NCT00874029|7310769|FG000|NOT COMPLETED|Overall Study||21
6398091|NCT00874094|7310783|FG000|STARTED|Overall Study||15
6398092|NCT00874094|7310783|FG000|COMPLETED|Overall Study||15
6398093|NCT00874094|7310783|FG000|NOT COMPLETED|Overall Study||0
6398094|NCT00874120|7310789|FG000|STARTED|First Intervention||58
6398095|NCT00874120|7310790|FG001|STARTED|First Intervention||58
6398096|NCT00874120|7310789|FG000|COMPLETED|First Intervention||52
6398097|NCT00874120|7310790|FG001|COMPLETED|First Intervention||56
6398098|NCT00874120|7310789|FG000|NOT COMPLETED|First Intervention||6
6398099|NCT00874120|7310790|FG001|NOT COMPLETED|First Intervention||2
6398100|NCT00874120|7310789|FG000|STARTED|Wash-out Period||52
6398101|NCT00874120|7310790|FG001|STARTED|Wash-out Period||56
6398102|NCT00874120|7310789|FG000|COMPLETED|Wash-out Period||52
6626820|NCT02234713|7554500|FG001|STARTED|Overall Study||32
6626821|NCT02234713|7554499|FG000|COMPLETED|Overall Study||25
6626822|NCT02234713|7554500|FG001|COMPLETED|Overall Study||27
6626823|NCT02234713|7554499|FG000|NOT COMPLETED|Overall Study||6
6626824|NCT02234713|7554500|FG001|NOT COMPLETED|Overall Study||5
6626825|NCT02234752|7554507|FG000|STARTED|Overall Study||3
6626826|NCT02234752|7554507|FG000|COMPLETED|Overall Study||2
6626827|NCT02234752|7554507|FG000|NOT COMPLETED|Overall Study||1
6626828|NCT02235064|7554514|FG000|STARTED|Overall Study||1
6282232|NCT00180297|7182468|FG001|COMPLETED|Overall Study||67
6282233|NCT00180297|7182467|FG000|NOT COMPLETED|Overall Study||46
6282234|NCT00180297|7182468|FG001|NOT COMPLETED|Overall Study||41
6282235|NCT00180323|7182474|FG000|STARTED|Overall Study||43
6282236|NCT00180323|7182474|FG000|COMPLETED|Overall Study||43
6398103|NCT00874120|7310790|FG001|COMPLETED|Wash-out Period||56
6398104|NCT00874120|7310789|FG000|NOT COMPLETED|Wash-out Period||0
6398105|NCT00874120|7310790|FG001|NOT COMPLETED|Wash-out Period||0
6398106|NCT00874120|7310789|FG000|STARTED|Second Intervention||52
6282237|NCT00180323|7182474|FG000|NOT COMPLETED|Overall Study||0
6282238|NCT00180479|7182482|FG000|STARTED|Overall Study||669
6282239|NCT00180479|7182483|FG001|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
6282240|NCT00180479|7182482|FG000|COMPLETED|Overall Study||653
6282241|NCT00180479|7182483|FG001|COMPLETED|Overall Study||320
6282242|NCT00180479|7182482|FG000|NOT COMPLETED|Overall Study||16
6282243|NCT00180479|7182483|FG001|NOT COMPLETED|Overall Study||13
6282244|NCT00180661|7182491|FG000|STARTED|Overall Study||19
6282245|NCT00180661|7182492|FG001|STARTED|Overall Study||20
6282246|NCT00180661|7182491|FG000|COMPLETED|Overall Study||19
6282247|NCT00180661|7182492|FG001|COMPLETED|Overall Study||20
6282248|NCT00180661|7182491|FG000|NOT COMPLETED|Overall Study||0
6282249|NCT00180661|7182492|FG001|NOT COMPLETED|Overall Study||0
6282250|NCT00180674|7182498|FG000|STARTED|Phase 1, Observation Period||14
6282251|NCT00180674|7182498|FG000|COMPLETED|Phase 1, Observation Period||10
6282252|NCT00180674|7182498|FG000|NOT COMPLETED|Phase 1, Observation Period||4
6282253|NCT00180674|7182498|FG000|STARTED|Phase 2, Warfarin Treatment Period||10
6282254|NCT00180674|7182498|FG000|COMPLETED|Phase 2, Warfarin Treatment Period||9
6282255|NCT00180674|7182498|FG000|NOT COMPLETED|Phase 2, Warfarin Treatment Period||1
6282256|NCT00180687|7182510|FG000|STARTED|Overall Study||20
6282257|NCT00180687|7182511|FG001|STARTED|Overall Study||20
6282258|NCT00180687|7182512|FG002|STARTED|Overall Study||20
6282259|NCT00180687|7182513|FG003|STARTED|Overall Study||20
6282260|NCT00180687|7182510|FG000|COMPLETED|Overall Study||20
6282261|NCT00180687|7182511|FG001|COMPLETED|Overall Study||20
6282262|NCT00180687|7182512|FG002|COMPLETED|Overall Study||20
6282263|NCT00180687|7182513|FG003|COMPLETED|Overall Study||20
6282264|NCT00180687|7182510|FG000|NOT COMPLETED|Overall Study||0
6282265|NCT00180687|7182511|FG001|NOT COMPLETED|Overall Study||0
6282266|NCT00180687|7182512|FG002|NOT COMPLETED|Overall Study||0
6282267|NCT00180687|7182513|FG003|NOT COMPLETED|Overall Study||0
6282268|NCT00180713|7182525|FG000|STARTED|Overall Study||23
6282269|NCT00180713|7182526|FG001|STARTED|Overall Study||19
6282270|NCT00180713|7182525|FG000|COMPLETED|Overall Study||18
6282271|NCT00180713|7182526|FG001|COMPLETED|Overall Study||16
6282272|NCT00180713|7182525|FG000|NOT COMPLETED|Overall Study||5
6282273|NCT00180713|7182526|FG001|NOT COMPLETED|Overall Study||3
6282274|NCT00181155|7182532|FG000|STARTED|Overall Study||15
6282275|NCT00181155|7182533|FG001|STARTED|Overall Study||3
6282276|NCT00181155|7182532|FG000|COMPLETED|Overall Study||13
6282277|NCT00181155|7182533|FG001|COMPLETED|Overall Study||3
6282278|NCT00181155|7182532|FG000|NOT COMPLETED|Overall Study||2
6282279|NCT00181155|7182533|FG001|NOT COMPLETED|Overall Study||0
6282280|NCT00181168|7182542|FG000|STARTED|Overall Study||30
6282281|NCT00181168|7182543|FG001|STARTED|Overall Study||33
6282282|NCT00181168|7182542|FG000|COMPLETED|Overall Study||30
6282283|NCT00181168|7182543|FG001|COMPLETED|Overall Study||33
6282284|NCT00181168|7182542|FG000|NOT COMPLETED|Overall Study||0
6282285|NCT00181168|7182543|FG001|NOT COMPLETED|Overall Study||0
6282286|NCT00181207|7182551|FG000|STARTED|Overall Study||24
6282287|NCT00181207|7182552|FG001|STARTED|Overall Study||26
6282288|NCT00181207|7182551|FG000|COMPLETED|Overall Study||24
6282289|NCT00181207|7182552|FG001|COMPLETED|Overall Study||26
6282290|NCT00181207|7182551|FG000|NOT COMPLETED|Overall Study||0
6282291|NCT00181207|7182552|FG001|NOT COMPLETED|Overall Study||0
6282292|NCT00181285|7182560|FG000|STARTED|Overall Study||27
6282293|NCT00181285|7182561|FG001|STARTED|Overall Study||25
6282294|NCT00181285|7182560|FG000|COMPLETED|Overall Study||27
6282295|NCT00181285|7182561|FG001|COMPLETED|Overall Study||25
6282296|NCT00181285|7182560|FG000|NOT COMPLETED|Overall Study||0
6282297|NCT00181285|7182561|FG001|NOT COMPLETED|Overall Study||0
6282298|NCT00181363|7182567|FG000|STARTED|Overall Study|10|10
6282299|NCT00181363|7182567|FG000|COMPLETED|Overall Study||10
6282300|NCT00181363|7182567|FG000|NOT COMPLETED|Overall Study||0
6282301|NCT00181610|7182577|FG000|STARTED|Overall Study||4
6282302|NCT00181610|7182578|FG001|STARTED|Overall Study||4
6282303|NCT00181610|7182579|FG002|STARTED|Overall Study||3
6282304|NCT00181610|7182577|FG000|COMPLETED|Overall Study||4
6282305|NCT00181610|7182578|FG001|COMPLETED|Overall Study||3
6282306|NCT00181610|7182579|FG002|COMPLETED|Overall Study||3
6282307|NCT00181610|7182577|FG000|NOT COMPLETED|Overall Study||0
6282308|NCT00181610|7182578|FG001|NOT COMPLETED|Overall Study||1
6282309|NCT00181610|7182579|FG002|NOT COMPLETED|Overall Study||0
6282310|NCT00181623|7182588|FG000|STARTED|Overall Study||6
6282311|NCT00181623|7182588|FG000|COMPLETED|Overall Study||5
6282312|NCT00181623|7182588|FG000|NOT COMPLETED|Overall Study||1
6282313|NCT00181714|7182593|FG000|STARTED|Signed Consent/Enrolled||203
6282314|NCT00181714|7182593|FG000|COMPLETED|Signed Consent/Enrolled||154
6282315|NCT00181714|7182593|FG000|NOT COMPLETED|Signed Consent/Enrolled||49
6398107|NCT00874120|7310790|FG001|STARTED|Second Intervention||56
6626829|NCT02235064|7554515|FG001|STARTED|Overall Study||1
6741157|NCT03307252|7669618|FG008|COMPLETED|Part 2, Period 4||0
6741158|NCT03307252|7669619|FG009|COMPLETED|Part 2, Period 4||0
6741159|NCT03307252|7669620|FG010|COMPLETED|Part 2, Period 4||0
6741160|NCT03307252|7669610|FG000|NOT COMPLETED|Part 2, Period 4||0
6741161|NCT03307252|7669611|FG001|NOT COMPLETED|Part 2, Period 4||0
6741162|NCT03307252|7669612|FG002|NOT COMPLETED|Part 2, Period 4||0
6741163|NCT03307252|7669613|FG003|NOT COMPLETED|Part 2, Period 4||0
6741164|NCT03307252|7669614|FG004|NOT COMPLETED|Part 2, Period 4||0
6741165|NCT03307252|7669615|FG005|NOT COMPLETED|Part 2, Period 4||0
6741166|NCT03307252|7669616|FG006|NOT COMPLETED|Part 2, Period 4||1
6741167|NCT03307252|7669617|FG007|NOT COMPLETED|Part 2, Period 4||0
6741168|NCT03307252|7669618|FG008|NOT COMPLETED|Part 2, Period 4||0
6741169|NCT03307252|7669619|FG009|NOT COMPLETED|Part 2, Period 4||0
6741170|NCT03307252|7669620|FG010|NOT COMPLETED|Part 2, Period 4||0
6741171|NCT03307252|7669610|FG000|STARTED|Part 3, Period 1||0
6741172|NCT03307252|7669611|FG001|STARTED|Part 3, Period 1||0
6741173|NCT03307252|7669612|FG002|STARTED|Part 3, Period 1||0
6741174|NCT03307252|7669613|FG003|STARTED|Part 3, Period 1||0
6741175|NCT03307252|7669614|FG004|STARTED|Part 3, Period 1||0
6741176|NCT03307252|7669615|FG005|STARTED|Part 3, Period 1||0
6741177|NCT03307252|7669616|FG006|STARTED|Part 3, Period 1||0
6741178|NCT03307252|7669617|FG007|STARTED|Part 3, Period 1||4
6741179|NCT03307252|7669618|FG008|STARTED|Part 3, Period 1||4
6741180|NCT03307252|7669619|FG009|STARTED|Part 3, Period 1||4
6741181|NCT03307252|7669620|FG010|STARTED|Part 3, Period 1||4
6741182|NCT03307252|7669610|FG000|COMPLETED|Part 3, Period 1||0
6741183|NCT03307252|7669611|FG001|COMPLETED|Part 3, Period 1||0
6741184|NCT03307252|7669612|FG002|COMPLETED|Part 3, Period 1||0
6741185|NCT03307252|7669613|FG003|COMPLETED|Part 3, Period 1||0
6741186|NCT03307252|7669614|FG004|COMPLETED|Part 3, Period 1||0
6398108|NCT00874120|7310789|FG000|COMPLETED|Second Intervention||50
6398109|NCT00874120|7310790|FG001|COMPLETED|Second Intervention||56
6398110|NCT00874120|7310789|FG000|NOT COMPLETED|Second Intervention||2
6398111|NCT00874120|7310790|FG001|NOT COMPLETED|Second Intervention||0
6398112|NCT00874237|7310796|FG000|STARTED|Overall Study||8
6398113|NCT00874237|7310797|FG001|STARTED|Overall Study||8
6398114|NCT00874237|7310798|FG002|STARTED|Overall Study||8
6398115|NCT00874237|7310799|FG003|STARTED|Overall Study||8
6398116|NCT00874237|7310800|FG004|STARTED|Overall Study||8
6398117|NCT00874237|7310801|FG005|STARTED|Overall Study||8
6398118|NCT00874237|7310796|FG000|COMPLETED|Overall Study||8
6398119|NCT00874237|7310797|FG001|COMPLETED|Overall Study||7
6398120|NCT00874237|7310798|FG002|COMPLETED|Overall Study||7
6398121|NCT00874237|7310799|FG003|COMPLETED|Overall Study||8
6398122|NCT00874237|7310800|FG004|COMPLETED|Overall Study||8
6398123|NCT00874237|7310801|FG005|COMPLETED|Overall Study||8
6398124|NCT00874237|7310796|FG000|NOT COMPLETED|Overall Study||0
6398125|NCT00874237|7310797|FG001|NOT COMPLETED|Overall Study||1
6398126|NCT00874237|7310798|FG002|NOT COMPLETED|Overall Study||1
6398127|NCT00874237|7310799|FG003|NOT COMPLETED|Overall Study||0
6398128|NCT00874237|7310800|FG004|NOT COMPLETED|Overall Study||0
6398129|NCT00874237|7310801|FG005|NOT COMPLETED|Overall Study||0
6398130|NCT00874250|7310811|FG000|STARTED|Overall Study||51
6398131|NCT00874250|7310811|FG000|COMPLETED|Overall Study||0
6398132|NCT00874250|7310811|FG000|NOT COMPLETED|Overall Study||51
6398133|NCT00874276|7310818|FG000|STARTED|Overall Study||6
6398134|NCT00874276|7310819|FG001|STARTED|Overall Study||8
6398135|NCT00874276|7310818|FG000|COMPLETED|Overall Study||5
6398136|NCT00874276|7310819|FG001|COMPLETED|Overall Study||7
6398137|NCT00874276|7310818|FG000|NOT COMPLETED|Overall Study||1
6398138|NCT00874276|7310819|FG001|NOT COMPLETED|Overall Study||1
6398139|NCT00874432|7310831|FG000|STARTED|Overall Study||8
6398140|NCT00874432|7310832|FG001|STARTED|Overall Study||4
6398141|NCT00874432|7310833|FG002|STARTED|Overall Study||17
6398142|NCT00874432|7310834|FG003|STARTED|Overall Study||14
6398143|NCT00874432|7310831|FG000|COMPLETED|Overall Study||5
6398144|NCT00874432|7310832|FG001|COMPLETED|Overall Study||2
6398145|NCT00874432|7310833|FG002|COMPLETED|Overall Study||9
6398146|NCT00874432|7310834|FG003|COMPLETED|Overall Study||11
6510062|NCT01479439|7429598|FG000|NOT COMPLETED|Overall Study||1
6510063|NCT01479439|7429599|FG001|NOT COMPLETED|Overall Study||1
6510064|NCT01479439|7429600|FG002|NOT COMPLETED|Overall Study||2
6510065|NCT01479465|7429615|FG000|STARTED|Overall Study||11
6510066|NCT01479465|7429616|FG001|STARTED|Overall Study||84
6398147|NCT00874432|7310831|FG000|NOT COMPLETED|Overall Study||3
6398148|NCT00874432|7310832|FG001|NOT COMPLETED|Overall Study||2
6398149|NCT00874432|7310833|FG002|NOT COMPLETED|Overall Study||8
6398150|NCT00874432|7310834|FG003|NOT COMPLETED|Overall Study||3
6398151|NCT00874497|7310848|FG000|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
6398152|NCT00874497|7310849|FG001|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
6398153|NCT00874497|7310848|FG000|COMPLETED|Overall Study||23
6398154|NCT00874497|7310849|FG001|COMPLETED|Overall Study||15
6741187|NCT03307252|7669615|FG005|COMPLETED|Part 3, Period 1||0
6741188|NCT03307252|7669616|FG006|COMPLETED|Part 3, Period 1||0
6741189|NCT03307252|7669617|FG007|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6741190|NCT03307252|7669618|FG008|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6741191|NCT03307252|7669619|FG009|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6741192|NCT03307252|7669620|FG010|COMPLETED|Part 3, Period 1|Participants randomized in Part 3|4
6741193|NCT03307252|7669610|FG000|NOT COMPLETED|Part 3, Period 1||0
6741194|NCT03307252|7669611|FG001|NOT COMPLETED|Part 3, Period 1||0
6741195|NCT03307252|7669612|FG002|NOT COMPLETED|Part 3, Period 1||0
6741196|NCT03307252|7669613|FG003|NOT COMPLETED|Part 3, Period 1||0
6741197|NCT03307252|7669614|FG004|NOT COMPLETED|Part 3, Period 1||0
6741198|NCT03307252|7669615|FG005|NOT COMPLETED|Part 3, Period 1||0
6741199|NCT03307252|7669616|FG006|NOT COMPLETED|Part 3, Period 1||0
6741200|NCT03307252|7669617|FG007|NOT COMPLETED|Part 3, Period 1||0
6741201|NCT03307252|7669618|FG008|NOT COMPLETED|Part 3, Period 1||0
6741202|NCT03307252|7669619|FG009|NOT COMPLETED|Part 3, Period 1||0
6741203|NCT03307252|7669620|FG010|NOT COMPLETED|Part 3, Period 1||0
6741204|NCT03307252|7669610|FG000|STARTED|Part 3, Washout Period 1 (7 Days)||0
6741205|NCT03307252|7669611|FG001|STARTED|Part 3, Washout Period 1 (7 Days)||0
6741206|NCT03307252|7669612|FG002|STARTED|Part 3, Washout Period 1 (7 Days)||0
6741207|NCT03307252|7669613|FG003|STARTED|Part 3, Washout Period 1 (7 Days)||0
6741208|NCT03307252|7669614|FG004|STARTED|Part 3, Washout Period 1 (7 Days)||0
6741209|NCT03307252|7669615|FG005|STARTED|Part 3, Washout Period 1 (7 Days)||0
6741210|NCT03307252|7669616|FG006|STARTED|Part 3, Washout Period 1 (7 Days)||0
6741211|NCT03307252|7669617|FG007|STARTED|Part 3, Washout Period 1 (7 Days)||4
6741212|NCT03307252|7669618|FG008|STARTED|Part 3, Washout Period 1 (7 Days)||4
6741213|NCT03307252|7669619|FG009|STARTED|Part 3, Washout Period 1 (7 Days)||4
6741214|NCT03307252|7669620|FG010|STARTED|Part 3, Washout Period 1 (7 Days)||4
6741215|NCT03307252|7669610|FG000|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741216|NCT03307252|7669611|FG001|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741217|NCT03307252|7669612|FG002|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741218|NCT03307252|7669613|FG003|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741219|NCT03307252|7669614|FG004|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6398155|NCT00874497|7310848|FG000|NOT COMPLETED|Overall Study||28
6398156|NCT00874497|7310849|FG001|NOT COMPLETED|Overall Study||18
6398157|NCT00874510|7310857|FG000|STARTED|Year 1||88
6398158|NCT00874510|7310858|FG001|STARTED|Year 1||85
6398159|NCT00874510|7310857|FG000|COMPLETED|Year 1||88
6398160|NCT00874510|7310858|FG001|COMPLETED|Year 1||85
6398161|NCT00874510|7310857|FG000|NOT COMPLETED|Year 1||0
6398162|NCT00874510|7310858|FG001|NOT COMPLETED|Year 1||0
6398163|NCT00874510|7310857|FG000|STARTED|Year 2||92
6398164|NCT00874510|7310858|FG001|STARTED|Year 2||87
6398165|NCT00874510|7310857|FG000|COMPLETED|Year 2||92
6398166|NCT00874510|7310858|FG001|COMPLETED|Year 2||87
6398167|NCT00874510|7310857|FG000|NOT COMPLETED|Year 2||0
6398168|NCT00874510|7310858|FG001|NOT COMPLETED|Year 2||0
6398169|NCT00874549|7310868|FG000|STARTED|Overall Study||51
6398170|NCT00874549|7310869|FG001|STARTED|Overall Study||56
6398171|NCT00874549|7310870|FG002|STARTED|Overall Study||51
6398172|NCT00874549|7310871|FG003|STARTED|Overall Study||58
6398173|NCT00874549|7310868|FG000|COMPLETED|Overall Study||50
6398174|NCT00874549|7310869|FG001|COMPLETED|Overall Study||55
6398175|NCT00874549|7310870|FG002|COMPLETED|Overall Study||47
6398176|NCT00874549|7310871|FG003|COMPLETED|Overall Study||56
6398177|NCT00874549|7310868|FG000|NOT COMPLETED|Overall Study||1
6398178|NCT00874549|7310869|FG001|NOT COMPLETED|Overall Study||1
6398179|NCT00874549|7310870|FG002|NOT COMPLETED|Overall Study||4
6398180|NCT00874549|7310871|FG003|NOT COMPLETED|Overall Study||2
6398181|NCT00874614|7310881|FG000|STARTED|Overall Study||74
6398182|NCT00874614|7310881|FG000|Received at Least One Therapeutic Dose|Overall Study||68
6398183|NCT00874614|7310881|FG000|Received Two Therapeutic Doses|Overall Study||50
6398184|NCT00874614|7310881|FG000|COMPLETED|Overall Study|As of December 2017|16
6398185|NCT00874614|7310881|FG000|NOT COMPLETED|Overall Study||58
6398186|NCT00874731|7310887|FG000|STARTED|Part 1, Day 1: Placebo||23
6398187|NCT00874731|7310888|FG001|STARTED|Part 1, Day 1: Placebo||0
6398188|NCT00874731|7310889|FG002|STARTED|Part 1, Day 1: Placebo||0
6398189|NCT00874731|7310887|FG000|COMPLETED|Part 1, Day 1: Placebo||22
6398190|NCT00874731|7310888|FG001|COMPLETED|Part 1, Day 1: Placebo||0
6398191|NCT00874731|7310889|FG002|COMPLETED|Part 1, Day 1: Placebo||0
6398192|NCT00874731|7310887|FG000|NOT COMPLETED|Part 1, Day 1: Placebo||1
6398193|NCT00874731|7310888|FG001|NOT COMPLETED|Part 1, Day 1: Placebo||0
6398194|NCT00874731|7310889|FG002|NOT COMPLETED|Part 1, Day 1: Placebo||0
6398195|NCT00874731|7310887|FG000|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, enter into the Pt 1, Day 2. Ridaforolimus 100 mg arm."|0
6398196|NCT00874731|7310888|FG001|STARTED|Part 1, Day 2: Ridaforolimus 100 mg|"Participants completing Pt 1, Day 1, started this period in Pt 1, Day 2. Ridaforolimus 100 mg arm."|22
6398197|NCT00874731|7310889|FG002|STARTED|Part 1, Day 2: Ridaforolimus 100 mg||0
6398198|NCT00874731|7310887|FG000|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6398199|NCT00874731|7310888|FG001|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||22
6398200|NCT00874731|7310889|FG002|COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6398201|NCT00874731|7310887|FG000|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6398202|NCT00874731|7310888|FG001|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6398203|NCT00874731|7310889|FG002|NOT COMPLETED|Part 1, Day 2: Ridaforolimus 100 mg||0
6398204|NCT00874731|7310887|FG000|STARTED|Washout Period||0
6398205|NCT00874731|7310888|FG001|STARTED|Washout Period||22
6398206|NCT00874731|7310889|FG002|STARTED|Washout Period||0
6398207|NCT00874731|7310887|FG000|COMPLETED|Washout Period||0
6398208|NCT00874731|7310888|FG001|COMPLETED|Washout Period||22
6398209|NCT00874731|7310889|FG002|COMPLETED|Washout Period||0
6398210|NCT00874731|7310887|FG000|NOT COMPLETED|Washout Period||0
6398211|NCT00874731|7310888|FG001|NOT COMPLETED|Washout Period||0
6510067|NCT01479465|7429617|FG002|STARTED|Overall Study||86
6741220|NCT03307252|7669615|FG005|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741221|NCT03307252|7669616|FG006|COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741222|NCT03307252|7669617|FG007|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6741223|NCT03307252|7669618|FG008|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6741224|NCT03307252|7669619|FG009|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6741225|NCT03307252|7669620|FG010|COMPLETED|Part 3, Washout Period 1 (7 Days)||4
6741226|NCT03307252|7669610|FG000|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741227|NCT03307252|7669611|FG001|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741228|NCT03307252|7669612|FG002|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741229|NCT03307252|7669613|FG003|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741230|NCT03307252|7669614|FG004|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741231|NCT03307252|7669615|FG005|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741232|NCT03307252|7669616|FG006|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6398212|NCT00874731|7310889|FG002|NOT COMPLETED|Washout Period||0
6398213|NCT00874731|7310887|FG000|STARTED|Part 2: Ridaforolimus 40 mg||0
6398214|NCT00874731|7310888|FG001|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, enter into the Pt 2. Ridaforolimus 40 mg arm."|0
6398215|NCT00874731|7310889|FG002|STARTED|Part 2: Ridaforolimus 40 mg|"Participants completing Pt 1 and washout, started this period in Pt 2. Ridaforolimus 40 mg arm."|22
6398216|NCT00874731|7310887|FG000|COMPLETED|Part 2: Ridaforolimus 40 mg||0
6398217|NCT00874731|7310888|FG001|COMPLETED|Part 2: Ridaforolimus 40 mg||0
6398218|NCT00874731|7310889|FG002|COMPLETED|Part 2: Ridaforolimus 40 mg||0
6398219|NCT00874731|7310887|FG000|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
6398220|NCT00874731|7310888|FG001|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||0
6398221|NCT00874731|7310889|FG002|NOT COMPLETED|Part 2: Ridaforolimus 40 mg||22
6398222|NCT00874770|7310901|FG000|STARTED|Overall Study||12
6398223|NCT00874770|7310902|FG001|STARTED|Overall Study||12
6398224|NCT00874770|7310903|FG002|STARTED|Overall Study||12
6398225|NCT00874770|7310904|FG003|STARTED|Overall Study||12
6398226|NCT00874770|7310901|FG000|COMPLETED|Overall Study||7
6398227|NCT00874770|7310902|FG001|COMPLETED|Overall Study||11
6398228|NCT00874770|7310903|FG002|COMPLETED|Overall Study||8
6398229|NCT00874770|7310904|FG003|COMPLETED|Overall Study||7
6398230|NCT00874770|7310901|FG000|NOT COMPLETED|Overall Study||5
6398231|NCT00874770|7310902|FG001|NOT COMPLETED|Overall Study||1
6398232|NCT00874770|7310903|FG002|NOT COMPLETED|Overall Study||4
6398233|NCT00874770|7310904|FG003|NOT COMPLETED|Overall Study||5
6398234|NCT00874822|7310924|FG000|STARTED|Overall Study||216
6398235|NCT00874822|7310924|FG000|COMPLETED|Overall Study||208
6398236|NCT00874822|7310924|FG000|NOT COMPLETED|Overall Study||8
6398237|NCT00874848|7310930|FG000|STARTED|Overall Study||59
6398238|NCT00874848|7310931|FG001|STARTED|Overall Study||29
6398239|NCT00874848|7310930|FG000|Discontinued|Overall Study||59
6398240|NCT00874848|7310931|FG001|Discontinued|Overall Study||28
6398241|NCT00874848|7310930|FG000|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
6398242|NCT00874848|7310931|FG001|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
6398243|NCT00874848|7310930|FG000|NOT COMPLETED|Overall Study||59
6398244|NCT00874848|7310931|FG001|NOT COMPLETED|Overall Study||28
6398245|NCT00874887|7310939|FG000|STARTED|Overall Study||32
6398246|NCT00874887|7310940|FG001|STARTED|Overall Study||34
6398247|NCT00874887|7310939|FG000|COMPLETED|Overall Study||32
6398248|NCT00874887|7310940|FG001|COMPLETED|Overall Study||34
6398249|NCT00874887|7310939|FG000|NOT COMPLETED|Overall Study||0
6398250|NCT00874887|7310940|FG001|NOT COMPLETED|Overall Study||0
6398251|NCT00875017|7310952|FG000|STARTED|First Intervention||5
6398252|NCT00875017|7310953|FG001|STARTED|First Intervention||5
6398253|NCT00875017|7310954|FG002|STARTED|First Intervention||5
6398254|NCT00875017|7310955|FG003|STARTED|First Intervention||6
6398255|NCT00875017|7310956|FG004|STARTED|First Intervention||5
6398256|NCT00875017|7310957|FG005|STARTED|First Intervention||5
6398257|NCT00875017|7310952|FG000|COMPLETED|First Intervention||3
6398258|NCT00875017|7310953|FG001|COMPLETED|First Intervention||5
6398259|NCT00875017|7310954|FG002|COMPLETED|First Intervention||4
6398260|NCT00875017|7310955|FG003|COMPLETED|First Intervention||5
6398261|NCT00875017|7310956|FG004|COMPLETED|First Intervention||4
6398262|NCT00875017|7310957|FG005|COMPLETED|First Intervention||5
6398263|NCT00875017|7310952|FG000|NOT COMPLETED|First Intervention||2
6398264|NCT00875017|7310953|FG001|NOT COMPLETED|First Intervention||0
6398265|NCT00875017|7310954|FG002|NOT COMPLETED|First Intervention||1
6398266|NCT00875017|7310955|FG003|NOT COMPLETED|First Intervention||1
6398267|NCT00875017|7310956|FG004|NOT COMPLETED|First Intervention||1
6398268|NCT00875017|7310957|FG005|NOT COMPLETED|First Intervention||0
6398269|NCT00875017|7310952|FG000|STARTED|Washout||3
6398270|NCT00875017|7310953|FG001|STARTED|Washout||5
6398271|NCT00875017|7310954|FG002|STARTED|Washout||4
6398272|NCT00875017|7310955|FG003|STARTED|Washout||5
6398273|NCT00875017|7310956|FG004|STARTED|Washout||4
6398274|NCT00875017|7310957|FG005|STARTED|Washout||5
6398275|NCT00875017|7310952|FG000|COMPLETED|Washout||3
6398276|NCT00875017|7310953|FG001|COMPLETED|Washout||5
6398277|NCT00875017|7310954|FG002|COMPLETED|Washout||3
6398278|NCT00875017|7310955|FG003|COMPLETED|Washout||5
6398279|NCT00875017|7310956|FG004|COMPLETED|Washout||4
6398280|NCT00875017|7310957|FG005|COMPLETED|Washout||5
6398281|NCT00875017|7310952|FG000|NOT COMPLETED|Washout||0
6741233|NCT03307252|7669617|FG007|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741234|NCT03307252|7669618|FG008|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741235|NCT03307252|7669619|FG009|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741236|NCT03307252|7669620|FG010|NOT COMPLETED|Part 3, Washout Period 1 (7 Days)||0
6741237|NCT03307252|7669610|FG000|STARTED|Part 3, Period 2||0
6741238|NCT03307252|7669611|FG001|STARTED|Part 3, Period 2||0
6741239|NCT03307252|7669612|FG002|STARTED|Part 3, Period 2||0
6741240|NCT03307252|7669613|FG003|STARTED|Part 3, Period 2||0
6741241|NCT03307252|7669614|FG004|STARTED|Part 3, Period 2||0
6741242|NCT03307252|7669615|FG005|STARTED|Part 3, Period 2||0
6741243|NCT03307252|7669616|FG006|STARTED|Part 3, Period 2||0
6741244|NCT03307252|7669617|FG007|STARTED|Part 3, Period 2||4
6741245|NCT03307252|7669618|FG008|STARTED|Part 3, Period 2||4
6741246|NCT03307252|7669619|FG009|STARTED|Part 3, Period 2||4
6741247|NCT03307252|7669620|FG010|STARTED|Part 3, Period 2||4
6741248|NCT03307252|7669610|FG000|COMPLETED|Part 3, Period 2||0
6741249|NCT03307252|7669611|FG001|COMPLETED|Part 3, Period 2||0
6741250|NCT03307252|7669612|FG002|COMPLETED|Part 3, Period 2||0
6741251|NCT03307252|7669613|FG003|COMPLETED|Part 3, Period 2||0
6741252|NCT03307252|7669614|FG004|COMPLETED|Part 3, Period 2||0
6741253|NCT03307252|7669615|FG005|COMPLETED|Part 3, Period 2||0
6741254|NCT03307252|7669616|FG006|COMPLETED|Part 3, Period 2||0
6741255|NCT03307252|7669617|FG007|COMPLETED|Part 3, Period 2||4
6741256|NCT03307252|7669618|FG008|COMPLETED|Part 3, Period 2||4
6741257|NCT03307252|7669619|FG009|COMPLETED|Part 3, Period 2||4
6741258|NCT03307252|7669620|FG010|COMPLETED|Part 3, Period 2||4
6741259|NCT03307252|7669610|FG000|NOT COMPLETED|Part 3, Period 2||0
6741260|NCT03307252|7669611|FG001|NOT COMPLETED|Part 3, Period 2||0
6741261|NCT03307252|7669612|FG002|NOT COMPLETED|Part 3, Period 2||0
6741262|NCT03307252|7669613|FG003|NOT COMPLETED|Part 3, Period 2||0
6741263|NCT03307252|7669614|FG004|NOT COMPLETED|Part 3, Period 2||0
6741264|NCT03307252|7669615|FG005|NOT COMPLETED|Part 3, Period 2||0
6741265|NCT03307252|7669616|FG006|NOT COMPLETED|Part 3, Period 2||0
6741266|NCT03307252|7669617|FG007|NOT COMPLETED|Part 3, Period 2||0
6741267|NCT03307252|7669618|FG008|NOT COMPLETED|Part 3, Period 2||0
6741268|NCT03307252|7669619|FG009|NOT COMPLETED|Part 3, Period 2||0
6741269|NCT03307252|7669620|FG010|NOT COMPLETED|Part 3, Period 2||0
6741270|NCT03307252|7669610|FG000|STARTED|Part 3, Washout Period 2 (7 Days)||0
6741271|NCT03307252|7669611|FG001|STARTED|Part 3, Washout Period 2 (7 Days)||0
6741272|NCT03307252|7669612|FG002|STARTED|Part 3, Washout Period 2 (7 Days)||0
6741273|NCT03307252|7669613|FG003|STARTED|Part 3, Washout Period 2 (7 Days)||0
6741274|NCT03307252|7669614|FG004|STARTED|Part 3, Washout Period 2 (7 Days)||0
6741275|NCT03307252|7669615|FG005|STARTED|Part 3, Washout Period 2 (7 Days)||0
6741276|NCT03307252|7669616|FG006|STARTED|Part 3, Washout Period 2 (7 Days)||0
6741277|NCT03307252|7669617|FG007|STARTED|Part 3, Washout Period 2 (7 Days)||4
6741278|NCT03307252|7669618|FG008|STARTED|Part 3, Washout Period 2 (7 Days)||4
6741279|NCT03307252|7669619|FG009|STARTED|Part 3, Washout Period 2 (7 Days)||4
6741280|NCT03307252|7669620|FG010|STARTED|Part 3, Washout Period 2 (7 Days)||4
6741281|NCT03307252|7669610|FG000|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741282|NCT03307252|7669611|FG001|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741283|NCT03307252|7669612|FG002|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741284|NCT03307252|7669613|FG003|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741285|NCT03307252|7669614|FG004|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741286|NCT03307252|7669615|FG005|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741287|NCT03307252|7669616|FG006|COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741288|NCT03307252|7669617|FG007|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6741289|NCT03307252|7669618|FG008|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6741290|NCT03307252|7669619|FG009|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6741291|NCT03307252|7669620|FG010|COMPLETED|Part 3, Washout Period 2 (7 Days)||4
6741292|NCT03307252|7669610|FG000|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741293|NCT03307252|7669611|FG001|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741294|NCT03307252|7669612|FG002|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741295|NCT03307252|7669613|FG003|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741296|NCT03307252|7669614|FG004|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741297|NCT03307252|7669615|FG005|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741298|NCT03307252|7669616|FG006|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741299|NCT03307252|7669617|FG007|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741300|NCT03307252|7669618|FG008|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741301|NCT03307252|7669619|FG009|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741302|NCT03307252|7669620|FG010|NOT COMPLETED|Part 3, Washout Period 2 (7 Days)||0
6741303|NCT03307252|7669610|FG000|STARTED|Part 3, Period 3||0
6741304|NCT03307252|7669611|FG001|STARTED|Part 3, Period 3||0
6741305|NCT03307252|7669612|FG002|STARTED|Part 3, Period 3||0
6741306|NCT03307252|7669613|FG003|STARTED|Part 3, Period 3||0
6741307|NCT03307252|7669614|FG004|STARTED|Part 3, Period 3||0
6741308|NCT03307252|7669615|FG005|STARTED|Part 3, Period 3||0
6741309|NCT03307252|7669616|FG006|STARTED|Part 3, Period 3||0
6741310|NCT03307252|7669617|FG007|STARTED|Part 3, Period 3||4
6741311|NCT03307252|7669618|FG008|STARTED|Part 3, Period 3||4
6741312|NCT03307252|7669619|FG009|STARTED|Part 3, Period 3||4
6741313|NCT03307252|7669620|FG010|STARTED|Part 3, Period 3||4
6741314|NCT03307252|7669610|FG000|COMPLETED|Part 3, Period 3||0
6741315|NCT03307252|7669611|FG001|COMPLETED|Part 3, Period 3||0
6282316|NCT00181714|7182593|FG000|STARTED|Began Treatment With OROS-MPH||154
6398282|NCT00875017|7310953|FG001|NOT COMPLETED|Washout||0
6398283|NCT00875017|7310954|FG002|NOT COMPLETED|Washout||1
6398284|NCT00875017|7310955|FG003|NOT COMPLETED|Washout||0
6398285|NCT00875017|7310956|FG004|NOT COMPLETED|Washout||0
6398286|NCT00875017|7310957|FG005|NOT COMPLETED|Washout||0
6398287|NCT00875017|7310952|FG000|STARTED|Second Intervention||3
6398288|NCT00875017|7310953|FG001|STARTED|Second Intervention||5
6398289|NCT00875017|7310954|FG002|STARTED|Second Intervention||3
6398290|NCT00875017|7310955|FG003|STARTED|Second Intervention||5
6398291|NCT00875017|7310956|FG004|STARTED|Second Intervention||4
6398292|NCT00875017|7310957|FG005|STARTED|Second Intervention||5
6398293|NCT00875017|7310952|FG000|COMPLETED|Second Intervention||3
6398294|NCT00875017|7310953|FG001|COMPLETED|Second Intervention||5
6398295|NCT00875017|7310954|FG002|COMPLETED|Second Intervention||3
6398296|NCT00875017|7310955|FG003|COMPLETED|Second Intervention||4
6398297|NCT00875017|7310956|FG004|COMPLETED|Second Intervention||4
6398298|NCT00875017|7310957|FG005|COMPLETED|Second Intervention||5
6398299|NCT00875017|7310952|FG000|NOT COMPLETED|Second Intervention||0
6398300|NCT00875017|7310953|FG001|NOT COMPLETED|Second Intervention||0
6398301|NCT00875017|7310954|FG002|NOT COMPLETED|Second Intervention||0
6398302|NCT00875017|7310955|FG003|NOT COMPLETED|Second Intervention||1
6398303|NCT00875017|7310956|FG004|NOT COMPLETED|Second Intervention||0
6398304|NCT00875017|7310957|FG005|NOT COMPLETED|Second Intervention||0
6398305|NCT00875017|7310952|FG000|STARTED|Washout||3
6398306|NCT00875017|7310953|FG001|STARTED|Washout||5
6398307|NCT00875017|7310954|FG002|STARTED|Washout||3
6398308|NCT00875017|7310955|FG003|STARTED|Washout||4
6398309|NCT00875017|7310956|FG004|STARTED|Washout||4
6398310|NCT00875017|7310957|FG005|STARTED|Washout||5
6398311|NCT00875017|7310952|FG000|COMPLETED|Washout||3
6398312|NCT00875017|7310953|FG001|COMPLETED|Washout||4
6398313|NCT00875017|7310954|FG002|COMPLETED|Washout||3
6398314|NCT00875017|7310955|FG003|COMPLETED|Washout||4
6282317|NCT00181714|7182593|FG000|COMPLETED|Began Treatment With OROS-MPH||30
6282318|NCT00181714|7182593|FG000|NOT COMPLETED|Began Treatment With OROS-MPH||124
6282319|NCT00181766|7182597|FG000|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
6282320|NCT00181766|7182597|FG000|COMPLETED|Overall Study|Completed the trial.|33
6282321|NCT00181766|7182597|FG000|NOT COMPLETED|Overall Study||12
6282322|NCT00181844|7182601|FG000|STARTED|Signed Consent||51
6282323|NCT00181844|7182601|FG000|COMPLETED|Signed Consent||39
6282324|NCT00181844|7182601|FG000|NOT COMPLETED|Signed Consent||12
6282325|NCT00181844|7182601|FG000|STARTED|Exposed to Study Medication||39
6282326|NCT00181844|7182601|FG000|COMPLETED|Exposed to Study Medication||22
6282327|NCT00181844|7182601|FG000|NOT COMPLETED|Exposed to Study Medication||17
6282328|NCT00181883|7182605|FG000|STARTED|Overall Study||30
6282329|NCT00181883|7182605|FG000|COMPLETED|Overall Study||20
6282330|NCT00181883|7182605|FG000|NOT COMPLETED|Overall Study||10
6373801|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373802|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373803|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
6373804|NCT00747474|7284553|FG000|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373805|NCT00747474|7284554|FG001|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373806|NCT00747474|7284555|FG002|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373807|NCT00747474|7284556|FG003|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373808|NCT00747474|7284557|FG004|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373809|NCT00747474|7284558|FG005|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373810|NCT00747474|7284559|FG006|STARTED|Cohort 7 (30 mg/m^2) Period||4
6373811|NCT00747474|7284560|FG007|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373812|NCT00747474|7284561|FG008|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373813|NCT00747474|7284562|FG009|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373814|NCT00747474|7284563|FG010|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373815|NCT00747474|7284564|FG011|STARTED|Cohort 7 (30 mg/m^2) Period||0
6373816|NCT00747474|7284553|FG000|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373817|NCT00747474|7284554|FG001|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373818|NCT00747474|7284555|FG002|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373819|NCT00747474|7284556|FG003|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373820|NCT00747474|7284557|FG004|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373821|NCT00747474|7284558|FG005|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373822|NCT00747474|7284559|FG006|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
6373823|NCT00747474|7284560|FG007|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373824|NCT00747474|7284561|FG008|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373825|NCT00747474|7284562|FG009|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373826|NCT00747474|7284563|FG010|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373827|NCT00747474|7284564|FG011|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373828|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373829|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373830|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6398315|NCT00875017|7310956|FG004|COMPLETED|Washout||4
6398316|NCT00875017|7310957|FG005|COMPLETED|Washout||5
6398317|NCT00875017|7310952|FG000|NOT COMPLETED|Washout||0
6398318|NCT00875017|7310953|FG001|NOT COMPLETED|Washout||1
6398319|NCT00875017|7310954|FG002|NOT COMPLETED|Washout||0
6398320|NCT00875017|7310955|FG003|NOT COMPLETED|Washout||0
6398321|NCT00875017|7310956|FG004|NOT COMPLETED|Washout||0
6398322|NCT00875017|7310957|FG005|NOT COMPLETED|Washout||0
6741316|NCT03307252|7669612|FG002|COMPLETED|Part 3, Period 3||0
6398323|NCT00875017|7310952|FG000|STARTED|Third Intervention||3
6398324|NCT00875017|7310953|FG001|STARTED|Third Intervention||4
6398325|NCT00875017|7310954|FG002|STARTED|Third Intervention||3
6398326|NCT00875017|7310955|FG003|STARTED|Third Intervention||4
6398327|NCT00875017|7310956|FG004|STARTED|Third Intervention||4
6398328|NCT00875017|7310957|FG005|STARTED|Third Intervention||5
6398329|NCT00875017|7310952|FG000|COMPLETED|Third Intervention||3
6398330|NCT00875017|7310953|FG001|COMPLETED|Third Intervention||3
6398331|NCT00875017|7310954|FG002|COMPLETED|Third Intervention||2
6398332|NCT00875017|7310955|FG003|COMPLETED|Third Intervention||4
6398333|NCT00875017|7310956|FG004|COMPLETED|Third Intervention||4
6398334|NCT00875017|7310957|FG005|COMPLETED|Third Intervention||5
6398335|NCT00875017|7310952|FG000|NOT COMPLETED|Third Intervention||0
6398336|NCT00875017|7310953|FG001|NOT COMPLETED|Third Intervention||1
6398337|NCT00875017|7310954|FG002|NOT COMPLETED|Third Intervention||1
6398338|NCT00875017|7310955|FG003|NOT COMPLETED|Third Intervention||0
6398339|NCT00875017|7310956|FG004|NOT COMPLETED|Third Intervention||0
6398340|NCT00875017|7310957|FG005|NOT COMPLETED|Third Intervention||0
6398341|NCT00875017|7310952|FG000|STARTED|Washout||3
6398342|NCT00875017|7310953|FG001|STARTED|Washout||3
6398343|NCT00875017|7310954|FG002|STARTED|Washout||2
6398344|NCT00875017|7310955|FG003|STARTED|Washout||4
6398345|NCT00875017|7310956|FG004|STARTED|Washout||4
6398346|NCT00875017|7310957|FG005|STARTED|Washout||5
6398347|NCT00875017|7310952|FG000|COMPLETED|Washout||3
6398348|NCT00875017|7310953|FG001|COMPLETED|Washout||3
6398349|NCT00875017|7310954|FG002|COMPLETED|Washout||2
6398350|NCT00875017|7310955|FG003|COMPLETED|Washout||4
6398351|NCT00875017|7310956|FG004|COMPLETED|Washout||3
6398352|NCT00875017|7310957|FG005|COMPLETED|Washout||5
6398353|NCT00875017|7310952|FG000|NOT COMPLETED|Washout||0
6398354|NCT00875017|7310953|FG001|NOT COMPLETED|Washout||0
6398355|NCT00875017|7310954|FG002|NOT COMPLETED|Washout||0
6398356|NCT00875017|7310955|FG003|NOT COMPLETED|Washout||0
6398357|NCT00875017|7310956|FG004|NOT COMPLETED|Washout||1
6398358|NCT00875017|7310957|FG005|NOT COMPLETED|Washout||0
6398359|NCT00875017|7310952|FG000|STARTED|Fourth Intervention||3
6398360|NCT00875017|7310953|FG001|STARTED|Fourth Intervention||3
6398361|NCT00875017|7310954|FG002|STARTED|Fourth Intervention||2
6398362|NCT00875017|7310955|FG003|STARTED|Fourth Intervention||4
6398363|NCT00875017|7310956|FG004|STARTED|Fourth Intervention||3
6398364|NCT00875017|7310957|FG005|STARTED|Fourth Intervention||5
6398365|NCT00875017|7310952|FG000|COMPLETED|Fourth Intervention||3
6398366|NCT00875017|7310953|FG001|COMPLETED|Fourth Intervention||3
6398367|NCT00875017|7310954|FG002|COMPLETED|Fourth Intervention||2
6398368|NCT00875017|7310955|FG003|COMPLETED|Fourth Intervention||4
6398369|NCT00875017|7310956|FG004|COMPLETED|Fourth Intervention||3
6398370|NCT00875017|7310957|FG005|COMPLETED|Fourth Intervention||4
6398371|NCT00875017|7310952|FG000|NOT COMPLETED|Fourth Intervention||0
6398372|NCT00875017|7310953|FG001|NOT COMPLETED|Fourth Intervention||0
6398373|NCT00875017|7310954|FG002|NOT COMPLETED|Fourth Intervention||0
6398374|NCT00875017|7310955|FG003|NOT COMPLETED|Fourth Intervention||0
6398375|NCT00875017|7310956|FG004|NOT COMPLETED|Fourth Intervention||0
6398376|NCT00875017|7310957|FG005|NOT COMPLETED|Fourth Intervention||1
6398377|NCT00875056|7310973|FG000|STARTED|Overall Study||39
6398378|NCT00875056|7310974|FG001|STARTED|Overall Study||11
6398379|NCT00875056|7310975|FG002|STARTED|Overall Study||6
6398380|NCT00875056|7310973|FG000|COMPLETED|Overall Study||16
6398381|NCT00875056|7310974|FG001|COMPLETED|Overall Study||2
6398382|NCT00875056|7310975|FG002|COMPLETED|Overall Study||0
6398383|NCT00875056|7310973|FG000|NOT COMPLETED|Overall Study||23
6398384|NCT00875056|7310974|FG001|NOT COMPLETED|Overall Study||9
6398385|NCT00875056|7310975|FG002|NOT COMPLETED|Overall Study||6
6398386|NCT00875212|7310983|FG000|STARTED|Placebo Dentifrice||12
6398387|NCT00875212|7310983|FG000|COMPLETED|Placebo Dentifrice|all participants completed this group|12
6398388|NCT00875212|7310983|FG000|NOT COMPLETED|Placebo Dentifrice||0
6398389|NCT00875212|7310983|FG000|STARTED|CaGP Only Dentifrice||12
6398390|NCT00875212|7310983|FG000|COMPLETED|CaGP Only Dentifrice||12
6398391|NCT00875212|7310983|FG000|NOT COMPLETED|CaGP Only Dentifrice||0
6398392|NCT00875212|7310983|FG000|STARTED|Fluoride Only Dentifrice||12
6398393|NCT00875212|7310983|FG000|COMPLETED|Fluoride Only Dentifrice||12
6398394|NCT00875212|7310983|FG000|NOT COMPLETED|Fluoride Only Dentifrice||0
6398395|NCT00875212|7310983|FG000|STARTED|CaGP and Fluoride Dentifrice||12
6398396|NCT00875212|7310983|FG000|COMPLETED|CaGP and Fluoride Dentifrice||12
6398397|NCT00875212|7310983|FG000|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
6398398|NCT00875277|7310994|FG000|STARTED|Overall Study||24
6398399|NCT00875277|7310994|FG000|COMPLETED|Overall Study||24
6398400|NCT00875277|7310994|FG000|NOT COMPLETED|Overall Study||0
6398401|NCT00875329|7311005|FG000|STARTED|Overall Study||97
6398402|NCT00875329|7311005|FG000|COMPLETED|Overall Study||97
6398403|NCT00875329|7311005|FG000|NOT COMPLETED|Overall Study||0
6398404|NCT00875342|7311011|FG000|STARTED|Overall Study||20
6398405|NCT00875342|7311012|FG001|STARTED|Overall Study||21
6398406|NCT00875342|7311011|FG000|COMPLETED|Overall Study||16
6398407|NCT00875342|7311012|FG001|COMPLETED|Overall Study||16
6398408|NCT00875342|7311011|FG000|NOT COMPLETED|Overall Study||4
6398409|NCT00875342|7311012|FG001|NOT COMPLETED|Overall Study||5
6398410|NCT00875420|7311023|FG000|STARTED|Overall Study||22
6398411|NCT00875420|7311024|FG001|STARTED|Overall Study||20
6741317|NCT03307252|7669613|FG003|COMPLETED|Part 3, Period 3||0
6741318|NCT03307252|7669614|FG004|COMPLETED|Part 3, Period 3||0
6741319|NCT03307252|7669615|FG005|COMPLETED|Part 3, Period 3||0
6741320|NCT03307252|7669616|FG006|COMPLETED|Part 3, Period 3||0
6741321|NCT03307252|7669617|FG007|COMPLETED|Part 3, Period 3||4
6741322|NCT03307252|7669618|FG008|COMPLETED|Part 3, Period 3||4
6741323|NCT03307252|7669619|FG009|COMPLETED|Part 3, Period 3||4
6741324|NCT03307252|7669620|FG010|COMPLETED|Part 3, Period 3||4
6741325|NCT03307252|7669610|FG000|NOT COMPLETED|Part 3, Period 3||0
6741326|NCT03307252|7669611|FG001|NOT COMPLETED|Part 3, Period 3||0
6741327|NCT03307252|7669612|FG002|NOT COMPLETED|Part 3, Period 3||0
6741328|NCT03307252|7669613|FG003|NOT COMPLETED|Part 3, Period 3||0
6741329|NCT03307252|7669614|FG004|NOT COMPLETED|Part 3, Period 3||0
6398412|NCT00875420|7311025|FG002|STARTED|Overall Study||21
6398413|NCT00875420|7311026|FG003|STARTED|Overall Study||18
6398414|NCT00875420|7311027|FG004|STARTED|Overall Study||19
6398415|NCT00875420|7311023|FG000|COMPLETED|Overall Study||20
6398416|NCT00875420|7311024|FG001|COMPLETED|Overall Study||18
6398417|NCT00875420|7311025|FG002|COMPLETED|Overall Study||18
6398418|NCT00875420|7311026|FG003|COMPLETED|Overall Study||16
6398419|NCT00875420|7311027|FG004|COMPLETED|Overall Study||17
6398420|NCT00875420|7311023|FG000|NOT COMPLETED|Overall Study||2
6398421|NCT00875420|7311024|FG001|NOT COMPLETED|Overall Study||2
6398422|NCT00875420|7311025|FG002|NOT COMPLETED|Overall Study||3
6398423|NCT00875420|7311026|FG003|NOT COMPLETED|Overall Study||2
6398424|NCT00875420|7311027|FG004|NOT COMPLETED|Overall Study||2
6398425|NCT00875433|7311039|FG000|STARTED|Overall Study|Treated|60
6398426|NCT00875433|7311039|FG000|COMPLETED|Overall Study||0
6398427|NCT00875433|7311039|FG000|NOT COMPLETED|Overall Study||60
6398428|NCT00875485|7311045|FG000|STARTED|Year 11||99
6398429|NCT00875485|7311046|FG001|STARTED|Year 11||111
6398430|NCT00875485|7311045|FG000|COMPLETED|Year 11||99
6398431|NCT00875485|7311046|FG001|COMPLETED|Year 11||111
6398432|NCT00875485|7311045|FG000|NOT COMPLETED|Year 11||0
6398433|NCT00875485|7311046|FG001|NOT COMPLETED|Year 11||0
6398434|NCT00875485|7311045|FG000|STARTED|Year 12||101
6398435|NCT00875485|7311046|FG001|STARTED|Year 12||109
6398436|NCT00875485|7311045|FG000|COMPLETED|Year 12||101
6398437|NCT00875485|7311046|FG001|COMPLETED|Year 12||109
6398438|NCT00875485|7311045|FG000|NOT COMPLETED|Year 12||0
6398439|NCT00875485|7311046|FG001|NOT COMPLETED|Year 12||0
6398440|NCT00875485|7311045|FG000|STARTED|Year 13||102
6398441|NCT00875485|7311046|FG001|STARTED|Year 13||113
6398442|NCT00875485|7311045|FG000|COMPLETED|Year 13||102
6398443|NCT00875485|7311046|FG001|COMPLETED|Year 13||113
6398444|NCT00875485|7311045|FG000|NOT COMPLETED|Year 13||0
6398445|NCT00875485|7311046|FG001|NOT COMPLETED|Year 13||0
6398446|NCT00875485|7311045|FG000|STARTED|Year 14||100
6398447|NCT00875485|7311046|FG001|STARTED|Year 14||113
6398448|NCT00875485|7311045|FG000|COMPLETED|Year 14||100
6398449|NCT00875485|7311046|FG001|COMPLETED|Year 14||113
6398450|NCT00875485|7311045|FG000|NOT COMPLETED|Year 14||0
6398451|NCT00875485|7311046|FG001|NOT COMPLETED|Year 14||0
6398452|NCT00875485|7311045|FG000|STARTED|Year 15||98
6398453|NCT00875485|7311046|FG001|STARTED|Year 15||111
6398454|NCT00875485|7311045|FG000|COMPLETED|Year 15||98
6398455|NCT00875485|7311046|FG001|COMPLETED|Year 15||111
6398456|NCT00875485|7311045|FG000|NOT COMPLETED|Year 15||0
6398457|NCT00875485|7311046|FG001|NOT COMPLETED|Year 15||0
6398458|NCT00875485|7311045|FG000|STARTED|Challenge Dose Epoch||8
6398459|NCT00875485|7311046|FG001|STARTED|Challenge Dose Epoch||11
6398460|NCT00875485|7311045|FG000|COMPLETED|Challenge Dose Epoch||7
6398461|NCT00875485|7311046|FG001|COMPLETED|Challenge Dose Epoch||11
6398462|NCT00875485|7311045|FG000|NOT COMPLETED|Challenge Dose Epoch||1
6398463|NCT00875485|7311046|FG001|NOT COMPLETED|Challenge Dose Epoch||0
6398464|NCT00875550|7311054|FG000|STARTED|Overall Study||89
6398465|NCT00875550|7311055|FG001|STARTED|Overall Study||86
6398466|NCT00875550|7311054|FG000|COMPLETED|Overall Study||77
6398467|NCT00875550|7311055|FG001|COMPLETED|Overall Study||76
6398468|NCT00875550|7311054|FG000|NOT COMPLETED|Overall Study||12
6398469|NCT00875550|7311055|FG001|NOT COMPLETED|Overall Study||10
6398470|NCT00875563|7311063|FG000|STARTED|Overall Study||42
6398471|NCT00875563|7311063|FG000|COMPLETED|Overall Study||18
6398472|NCT00875563|7311063|FG000|NOT COMPLETED|Overall Study||24
6398473|NCT00875589|7311069|FG000|STARTED|Overall Study||15
6398474|NCT00875589|7311070|FG001|STARTED|Overall Study||11
6398475|NCT00875589|7311069|FG000|COMPLETED|Overall Study||15
6398476|NCT00875589|7311070|FG001|COMPLETED|Overall Study||11
6398477|NCT00875589|7311069|FG000|NOT COMPLETED|Overall Study||0
6398478|NCT00875589|7311070|FG001|NOT COMPLETED|Overall Study||0
6398479|NCT00875615|7311076|FG000|STARTED|Overall Study||11
6398480|NCT00875615|7311076|FG000|COMPLETED|Overall Study||10
6398481|NCT00875615|7311076|FG000|NOT COMPLETED|Overall Study||1
6398482|NCT00875641|7311083|FG000|STARTED|Overall Study||57931
6398483|NCT00875641|7311084|FG001|STARTED|Overall Study||173384
6398484|NCT00875641|7311085|FG002|STARTED|Overall Study||159344
6398485|NCT00875641|7311083|FG000|COMPLETED|Overall Study||57931
6398486|NCT00875641|7311084|FG001|COMPLETED|Overall Study||173384
6398487|NCT00875641|7311085|FG002|COMPLETED|Overall Study||159344
6398488|NCT00875641|7311083|FG000|NOT COMPLETED|Overall Study||0
6398489|NCT00875641|7311084|FG001|NOT COMPLETED|Overall Study||0
6398490|NCT00875641|7311085|FG002|NOT COMPLETED|Overall Study||0
6741330|NCT03307252|7669615|FG005|NOT COMPLETED|Part 3, Period 3||0
6741331|NCT03307252|7669616|FG006|NOT COMPLETED|Part 3, Period 3||0
6741332|NCT03307252|7669617|FG007|NOT COMPLETED|Part 3, Period 3||0
6741333|NCT03307252|7669618|FG008|NOT COMPLETED|Part 3, Period 3||0
6741334|NCT03307252|7669619|FG009|NOT COMPLETED|Part 3, Period 3||0
6741335|NCT03307252|7669620|FG010|NOT COMPLETED|Part 3, Period 3||0
6741336|NCT03307252|7669610|FG000|STARTED|Part 3, Washout Period 3 (7 Days)||0
6741337|NCT03307252|7669611|FG001|STARTED|Part 3, Washout Period 3 (7 Days)||0
6741338|NCT03307252|7669612|FG002|STARTED|Part 3, Washout Period 3 (7 Days)||0
6741339|NCT03307252|7669613|FG003|STARTED|Part 3, Washout Period 3 (7 Days)||0
6741340|NCT03307252|7669614|FG004|STARTED|Part 3, Washout Period 3 (7 Days)||0
6741341|NCT03307252|7669615|FG005|STARTED|Part 3, Washout Period 3 (7 Days)||0
6741342|NCT03307252|7669616|FG006|STARTED|Part 3, Washout Period 3 (7 Days)||0
6741343|NCT03307252|7669617|FG007|STARTED|Part 3, Washout Period 3 (7 Days)||4
6398491|NCT00875667|7311095|FG000|STARTED|Overall Study||170
6398492|NCT00875667|7311096|FG001|STARTED|Overall Study||84
6398493|NCT00875667|7311095|FG000|Crossover From IC to Lenalidomide|Overall Study|NA = Participants in the IC arm were able to crossover to lenalidomide|0
6398494|NCT00875667|7311096|FG001|Crossover From IC to Lenalidomide|Overall Study|Upon disease progression, participants crossed over to lenalidomide|40
6398495|NCT00875667|7311095|FG000|Participants Treated|Overall Study||167
6398496|NCT00875667|7311096|FG001|Participants Treated|Overall Study||83
6398497|NCT00875667|7311095|FG000|COMPLETED|Overall Study||0
6398498|NCT00875667|7311096|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of IC single agent cytarabine, fludarabine, or gemcitabine.|11
6398499|NCT00875667|7311095|FG000|NOT COMPLETED|Overall Study||170
6398500|NCT00875667|7311096|FG001|NOT COMPLETED|Overall Study||73
6398501|NCT00875706|7311105|FG000|STARTED|Overall Study||8
6398502|NCT00875706|7311106|FG001|STARTED|Overall Study||24
6398503|NCT00875706|7311107|FG002|STARTED|Overall Study||13
6398504|NCT00875706|7311105|FG000|COMPLETED|Overall Study||7
6398505|NCT00875706|7311106|FG001|COMPLETED|Overall Study||24
6398506|NCT00875706|7311107|FG002|COMPLETED|Overall Study||13
6398507|NCT00875706|7311105|FG000|NOT COMPLETED|Overall Study||1
6398508|NCT00875706|7311106|FG001|NOT COMPLETED|Overall Study||0
6398509|NCT00875706|7311107|FG002|NOT COMPLETED|Overall Study||0
6398510|NCT00875797|7311117|FG000|STARTED|Overall Study||45
6398511|NCT00875797|7311118|FG001|STARTED|Overall Study||45
6398512|NCT00875797|7311117|FG000|COMPLETED|Overall Study||39
6398513|NCT00875797|7311118|FG001|COMPLETED|Overall Study||42
6398514|NCT00875797|7311117|FG000|NOT COMPLETED|Overall Study||6
6398515|NCT00875797|7311118|FG001|NOT COMPLETED|Overall Study||3
6398516|NCT00875810|7311127|FG000|STARTED|Overall Study||194
6398517|NCT00875810|7311127|FG000|Implanted|Overall Study||190
6398518|NCT00875810|7311127|FG000|Discharged|Overall Study||177
6626830|NCT02235064|7554514|FG000|COMPLETED|Overall Study||1
6626831|NCT02235064|7554515|FG001|COMPLETED|Overall Study||1
6626832|NCT02235064|7554514|FG000|NOT COMPLETED|Overall Study||0
6626833|NCT02235064|7554515|FG001|NOT COMPLETED|Overall Study||0
6626834|NCT02235077|7554525|FG000|STARTED|Overall Study||182
6398519|NCT00875810|7311127|FG000|3 Months Follow up|Overall Study||175
6398520|NCT00875810|7311127|FG000|6 Months Follow up|Overall Study||80
6398521|NCT00875810|7311127|FG000|12 Months Follow up|Overall Study||112
6398522|NCT00875810|7311127|FG000|24 Months Follow up|Overall Study||148
6398523|NCT00875810|7311127|FG000|COMPLETED|Overall Study||148
6398524|NCT00875810|7311127|FG000|NOT COMPLETED|Overall Study||46
6398525|NCT00875836|7311133|FG000|STARTED|Overall Study||88
6398526|NCT00875836|7311134|FG001|STARTED|Overall Study||87
6398527|NCT00875836|7311133|FG000|COMPLETED|Overall Study||45
6398528|NCT00875836|7311134|FG001|COMPLETED|Overall Study||47
6398529|NCT00875836|7311133|FG000|NOT COMPLETED|Overall Study||43
6398530|NCT00875836|7311134|FG001|NOT COMPLETED|Overall Study||40
6398531|NCT00875979|7311142|FG000|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
6398532|NCT00875979|7311143|FG001|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
6398533|NCT00875979|7311142|FG000|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
6398534|NCT00875979|7311143|FG001|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
6398535|NCT00875979|7311142|FG000|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
6398536|NCT00875979|7311143|FG001|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
6398537|NCT00875979|7311142|FG000|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
6398538|NCT00875979|7311143|FG001|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
6398539|NCT00875979|7311142|FG000|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
6398540|NCT00875979|7311143|FG001|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
6398541|NCT00875979|7311142|FG000|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
6398542|NCT00875979|7311143|FG001|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
6398543|NCT00875979|7311142|FG000|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
6398544|NCT00875979|7311143|FG001|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
6398545|NCT00875979|7311142|FG000|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
6398546|NCT00875979|7311143|FG001|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
6398547|NCT00875979|7311142|FG000|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
6398548|NCT00875979|7311143|FG001|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
6398549|NCT00876018|7311152|FG000|STARTED|Overall Study||100
6398550|NCT00876018|7311153|FG001|STARTED|Overall Study||100
6398551|NCT00876018|7311154|FG002|STARTED|Overall Study||100
6398552|NCT00876018|7311152|FG000|COMPLETED|Overall Study||95
6398553|NCT00876018|7311153|FG001|COMPLETED|Overall Study||95
6398554|NCT00876018|7311154|FG002|COMPLETED|Overall Study||97
6398555|NCT00876018|7311152|FG000|NOT COMPLETED|Overall Study||5
6626835|NCT02235077|7554526|FG001|STARTED|Overall Study||178
6626836|NCT02235077|7554525|FG000|COMPLETED|Overall Study||164
6741344|NCT03307252|7669618|FG008|STARTED|Part 3, Washout Period 3 (7 Days)||4
6741345|NCT03307252|7669619|FG009|STARTED|Part 3, Washout Period 3 (7 Days)||4
6741346|NCT03307252|7669620|FG010|STARTED|Part 3, Washout Period 3 (7 Days)||4
6741347|NCT03307252|7669610|FG000|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741348|NCT03307252|7669611|FG001|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741349|NCT03307252|7669612|FG002|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741350|NCT03307252|7669613|FG003|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741351|NCT03307252|7669614|FG004|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741352|NCT03307252|7669615|FG005|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741353|NCT03307252|7669616|FG006|COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741354|NCT03307252|7669617|FG007|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6741355|NCT03307252|7669618|FG008|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6741356|NCT03307252|7669619|FG009|COMPLETED|Part 3, Washout Period 3 (7 Days)||4
6741357|NCT03307252|7669620|FG010|COMPLETED|Part 3, Washout Period 3 (7 Days)||3
6741358|NCT03307252|7669610|FG000|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741359|NCT03307252|7669611|FG001|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741360|NCT03307252|7669612|FG002|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741361|NCT03307252|7669613|FG003|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741362|NCT03307252|7669614|FG004|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741363|NCT03307252|7669615|FG005|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741364|NCT03307252|7669616|FG006|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741365|NCT03307252|7669617|FG007|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741366|NCT03307252|7669618|FG008|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741367|NCT03307252|7669619|FG009|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||0
6741368|NCT03307252|7669620|FG010|NOT COMPLETED|Part 3, Washout Period 3 (7 Days)||1
6741369|NCT03307252|7669610|FG000|STARTED|Part 3, Period 4||0
6398556|NCT00876018|7311153|FG001|NOT COMPLETED|Overall Study||5
6398557|NCT00876018|7311154|FG002|NOT COMPLETED|Overall Study||3
6398558|NCT00876187|7311169|FG000|STARTED|Overall Study||233
6398559|NCT00876187|7311170|FG001|STARTED|Overall Study||233
6398560|NCT00876187|7311171|FG002|STARTED|Overall Study||298
6398561|NCT00876187|7311172|FG003|STARTED|Overall Study||297
6398562|NCT00876187|7311173|FG004|STARTED|Overall Study||298
6398563|NCT00876187|7311169|FG000|Treated|Overall Study||230
6398564|NCT00876187|7311170|FG001|Treated|Overall Study||232
6398565|NCT00876187|7311171|FG002|Treated|Overall Study||295
6398566|NCT00876187|7311172|FG003|Treated|Overall Study||295
6398567|NCT00876187|7311173|FG004|Treated|Overall Study||295
6398568|NCT00876187|7311169|FG000|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|128
6398569|NCT00876187|7311170|FG001|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|146
6398570|NCT00876187|7311171|FG002|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|193
6398571|NCT00876187|7311172|FG003|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|188
6398572|NCT00876187|7311173|FG004|Completed Treatment|Overall Study|Participants who completed treatment at Week 16 visit.|185
6398573|NCT00876187|7311169|FG000|COMPLETED|Overall Study||23
6398574|NCT00876187|7311170|FG001|COMPLETED|Overall Study||18
6398575|NCT00876187|7311171|FG002|COMPLETED|Overall Study||19
6398576|NCT00876187|7311172|FG003|COMPLETED|Overall Study||22
6398577|NCT00876187|7311173|FG004|COMPLETED|Overall Study||27
6398578|NCT00876187|7311169|FG000|NOT COMPLETED|Overall Study||210
6398579|NCT00876187|7311170|FG001|NOT COMPLETED|Overall Study||215
6398580|NCT00876187|7311171|FG002|NOT COMPLETED|Overall Study||279
6398581|NCT00876187|7311172|FG003|NOT COMPLETED|Overall Study||275
6398582|NCT00876187|7311173|FG004|NOT COMPLETED|Overall Study||271
6398583|NCT00876200|7311190|FG000|STARTED|Overall Study||9
6398584|NCT00876200|7311191|FG001|STARTED|Overall Study||12
6398585|NCT00876200|7311190|FG000|COMPLETED|Overall Study||8
6398586|NCT00876200|7311191|FG001|COMPLETED|Overall Study||9
6398587|NCT00876200|7311190|FG000|NOT COMPLETED|Overall Study||1
6398588|NCT00876200|7311191|FG001|NOT COMPLETED|Overall Study||3
6398589|NCT00876265|7311197|FG000|STARTED|Overall Study||118
6398590|NCT00876265|7311197|FG000|COMPLETED|Overall Study||106
6398591|NCT00876265|7311197|FG000|NOT COMPLETED|Overall Study||12
6398592|NCT00876343|7311206|FG000|STARTED|Overall Study||194
6398593|NCT00876343|7311207|FG001|STARTED|Overall Study||197
6398594|NCT00876343|7311208|FG002|STARTED|Overall Study||195
6398595|NCT00876343|7311206|FG000|COMPLETED|Overall Study||177
6398596|NCT00876343|7311207|FG001|COMPLETED|Overall Study||180
6398597|NCT00876343|7311208|FG002|COMPLETED|Overall Study||183
6398598|NCT00876343|7311206|FG000|NOT COMPLETED|Overall Study||17
6398599|NCT00876343|7311207|FG001|NOT COMPLETED|Overall Study||17
6398600|NCT00876343|7311208|FG002|NOT COMPLETED|Overall Study||12
6398601|NCT00876395|7311218|FG000|STARTED|Overall Study||480
6398602|NCT00876395|7311219|FG001|STARTED|Overall Study||239
6398603|NCT00876395|7311218|FG000|Untreated|Overall Study||8
6398604|NCT00876395|7311219|FG001|Untreated|Overall Study||1
6398605|NCT00876395|7311218|FG000|COMPLETED|Overall Study||0
6398606|NCT00876395|7311219|FG001|COMPLETED|Overall Study||0
6398607|NCT00876395|7311218|FG000|NOT COMPLETED|Overall Study||480
6398608|NCT00876395|7311219|FG001|NOT COMPLETED|Overall Study||239
6398609|NCT00876447|7311232|FG000|STARTED|Overall Study||185
6398610|NCT00876447|7311233|FG001|STARTED|Overall Study||203
6398611|NCT00876447|7311232|FG000|COMPLETED|Overall Study||105
6398612|NCT00876447|7311233|FG001|COMPLETED|Overall Study||122
6398613|NCT00876447|7311232|FG000|NOT COMPLETED|Overall Study||80
6398614|NCT00876447|7311233|FG001|NOT COMPLETED|Overall Study||81
6398615|NCT00876460|7311271|FG000|STARTED|Combination Therapy Phase||3
6741370|NCT03307252|7669611|FG001|STARTED|Part 3, Period 4||0
6741371|NCT03307252|7669612|FG002|STARTED|Part 3, Period 4||0
6741372|NCT03307252|7669613|FG003|STARTED|Part 3, Period 4||0
6741373|NCT03307252|7669614|FG004|STARTED|Part 3, Period 4||0
6741374|NCT03307252|7669615|FG005|STARTED|Part 3, Period 4||0
6741375|NCT03307252|7669616|FG006|STARTED|Part 3, Period 4||0
6741376|NCT03307252|7669617|FG007|STARTED|Part 3, Period 4||4
6741377|NCT03307252|7669618|FG008|STARTED|Part 3, Period 4||4
6741378|NCT03307252|7669619|FG009|STARTED|Part 3, Period 4||4
6741379|NCT03307252|7669620|FG010|STARTED|Part 3, Period 4||3
6741380|NCT03307252|7669610|FG000|COMPLETED|Part 3, Period 4||0
6741381|NCT03307252|7669611|FG001|COMPLETED|Part 3, Period 4||0
6741382|NCT03307252|7669612|FG002|COMPLETED|Part 3, Period 4||0
6741383|NCT03307252|7669613|FG003|COMPLETED|Part 3, Period 4||0
6741384|NCT03307252|7669614|FG004|COMPLETED|Part 3, Period 4||0
6741385|NCT03307252|7669615|FG005|COMPLETED|Part 3, Period 4||0
6741386|NCT03307252|7669616|FG006|COMPLETED|Part 3, Period 4||0
6741387|NCT03307252|7669617|FG007|COMPLETED|Part 3, Period 4||4
6741388|NCT03307252|7669618|FG008|COMPLETED|Part 3, Period 4||4
6741389|NCT03307252|7669619|FG009|COMPLETED|Part 3, Period 4||4
6741390|NCT03307252|7669620|FG010|COMPLETED|Part 3, Period 4||3
6741391|NCT03307252|7669610|FG000|NOT COMPLETED|Part 3, Period 4||0
6741392|NCT03307252|7669611|FG001|NOT COMPLETED|Part 3, Period 4||0
6741393|NCT03307252|7669612|FG002|NOT COMPLETED|Part 3, Period 4||0
6741394|NCT03307252|7669613|FG003|NOT COMPLETED|Part 3, Period 4||0
6741395|NCT03307252|7669614|FG004|NOT COMPLETED|Part 3, Period 4||0
6741396|NCT03307252|7669615|FG005|NOT COMPLETED|Part 3, Period 4||0
6741397|NCT03307252|7669616|FG006|NOT COMPLETED|Part 3, Period 4||0
6741398|NCT03307252|7669617|FG007|NOT COMPLETED|Part 3, Period 4||0
6741399|NCT03307252|7669618|FG008|NOT COMPLETED|Part 3, Period 4||0
6741400|NCT03307252|7669619|FG009|NOT COMPLETED|Part 3, Period 4||0
6741401|NCT03307252|7669620|FG010|NOT COMPLETED|Part 3, Period 4||0
6741402|NCT03307837|7669642|FG000|STARTED|Overall Study||6
6741403|NCT03307837|7669643|FG001|STARTED|Overall Study||6
6741404|NCT03307837|7669644|FG002|STARTED|Overall Study||6
6741405|NCT03307837|7669645|FG003|STARTED|Overall Study||6
6741406|NCT03307837|7669646|FG004|STARTED|Overall Study||6
6741407|NCT03307837|7669647|FG005|STARTED|Overall Study||10
6741408|NCT03307837|7669642|FG000|COMPLETED|Overall Study||5
6741409|NCT03307837|7669643|FG001|COMPLETED|Overall Study||5
6741410|NCT03307837|7669644|FG002|COMPLETED|Overall Study||5
6741411|NCT03307837|7669645|FG003|COMPLETED|Overall Study||6
6741412|NCT03307837|7669646|FG004|COMPLETED|Overall Study||6
6741413|NCT03307837|7669647|FG005|COMPLETED|Overall Study||8
6741414|NCT03307837|7669642|FG000|NOT COMPLETED|Overall Study||1
6741415|NCT03307837|7669643|FG001|NOT COMPLETED|Overall Study||1
6741416|NCT03307837|7669644|FG002|NOT COMPLETED|Overall Study||1
6741417|NCT03307837|7669645|FG003|NOT COMPLETED|Overall Study||0
6741418|NCT03307837|7669646|FG004|NOT COMPLETED|Overall Study||0
6741419|NCT03307837|7669647|FG005|NOT COMPLETED|Overall Study||2
6741420|NCT03308058|7669668|FG000|STARTED|Overall Study||23
6741421|NCT03308058|7669669|FG001|STARTED|Overall Study||23
6741422|NCT03308058|7669668|FG000|COMPLETED|Overall Study||23
6741423|NCT03308058|7669669|FG001|COMPLETED|Overall Study||23
6398616|NCT00876460|7311272|FG001|STARTED|Combination Therapy Phase||7
6398617|NCT00876460|7311273|FG002|STARTED|Combination Therapy Phase||3
6398618|NCT00876460|7311274|FG003|STARTED|Combination Therapy Phase||6
6398619|NCT00876460|7311275|FG004|STARTED|Combination Therapy Phase||7
6398620|NCT00876460|7311276|FG005|STARTED|Combination Therapy Phase||3
6398621|NCT00876460|7311277|FG006|STARTED|Combination Therapy Phase||8
6398622|NCT00876460|7311278|FG007|STARTED|Combination Therapy Phase||6
6398623|NCT00876460|7311271|FG000|COMPLETED|Combination Therapy Phase||0
6398624|NCT00876460|7311272|FG001|COMPLETED|Combination Therapy Phase||0
6398625|NCT00876460|7311273|FG002|COMPLETED|Combination Therapy Phase||0
6398626|NCT00876460|7311274|FG003|COMPLETED|Combination Therapy Phase||0
6398627|NCT00876460|7311275|FG004|COMPLETED|Combination Therapy Phase||0
6398628|NCT00876460|7311276|FG005|COMPLETED|Combination Therapy Phase||0
6398629|NCT00876460|7311277|FG006|COMPLETED|Combination Therapy Phase||0
6398630|NCT00876460|7311278|FG007|COMPLETED|Combination Therapy Phase||0
6398631|NCT00876460|7311271|FG000|NOT COMPLETED|Combination Therapy Phase||3
6398632|NCT00876460|7311272|FG001|NOT COMPLETED|Combination Therapy Phase||7
6398633|NCT00876460|7311273|FG002|NOT COMPLETED|Combination Therapy Phase||3
6398634|NCT00876460|7311274|FG003|NOT COMPLETED|Combination Therapy Phase||6
6398635|NCT00876460|7311275|FG004|NOT COMPLETED|Combination Therapy Phase||7
6398636|NCT00876460|7311276|FG005|NOT COMPLETED|Combination Therapy Phase||3
6741424|NCT03308058|7669668|FG000|NOT COMPLETED|Overall Study||0
6741425|NCT03308058|7669669|FG001|NOT COMPLETED|Overall Study||0
6741426|NCT03308097|7669677|FG000|STARTED|Overall Study||33
6741427|NCT03308097|7669678|FG001|STARTED|Overall Study||32
6741428|NCT03308097|7669677|FG000|COMPLETED|Overall Study||31
6741429|NCT03308097|7669678|FG001|COMPLETED|Overall Study||31
6741430|NCT03308097|7669677|FG000|NOT COMPLETED|Overall Study||2
6398637|NCT00876460|7311277|FG006|NOT COMPLETED|Combination Therapy Phase||8
6398638|NCT00876460|7311278|FG007|NOT COMPLETED|Combination Therapy Phase||6
6741431|NCT03308097|7669678|FG001|NOT COMPLETED|Overall Study||1
6741432|NCT03308669|7669686|FG000|STARTED|Overall Study||10
6741433|NCT03308669|7669687|FG001|STARTED|Overall Study||20
6741434|NCT03308669|7669686|FG000|Received at Least One Dose of Study Drug|Overall Study||10
6741435|NCT03308669|7669687|FG001|Received at Least One Dose of Study Drug|Overall Study||20
6741436|NCT03308669|7669686|FG000|COMPLETED|Overall Study||10
6741437|NCT03308669|7669687|FG001|COMPLETED|Overall Study||20
6741438|NCT03308669|7669686|FG000|NOT COMPLETED|Overall Study||0
6741439|NCT03308669|7669687|FG001|NOT COMPLETED|Overall Study||0
6741440|NCT03308799|7669708|FG000|STARTED|Overall Study||342
6741441|NCT03308799|7669709|FG001|STARTED|Overall Study||337
6741442|NCT03308799|7669710|FG002|STARTED|Overall Study||115
6741443|NCT03308799|7669708|FG000|COMPLETED|Overall Study||320
6741444|NCT03308799|7669709|FG001|COMPLETED|Overall Study||309
6741445|NCT03308799|7669710|FG002|COMPLETED|Overall Study||94
6741446|NCT03308799|7669708|FG000|NOT COMPLETED|Overall Study||22
6741447|NCT03308799|7669709|FG001|NOT COMPLETED|Overall Study||28
6741448|NCT03308799|7669710|FG002|NOT COMPLETED|Overall Study||21
6741449|NCT03308942|7669723|FG000|STARTED|Stage 1 (up to a Maximum of 29 Months)||17
6741450|NCT03308942|7669724|FG001|STARTED|Stage 1 (up to a Maximum of 29 Months)||21
6398639|NCT00876460|7311271|FG000|STARTED|Mono Therapy Phase||0
6398640|NCT00876460|7311272|FG001|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
6398641|NCT00876460|7311273|FG002|STARTED|Mono Therapy Phase||0
6398642|NCT00876460|7311274|FG003|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
6398643|NCT00876460|7311275|FG004|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
6398644|NCT00876460|7311276|FG005|STARTED|Mono Therapy Phase||0
6398645|NCT00876460|7311277|FG006|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
6398646|NCT00876460|7311278|FG007|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
6398647|NCT00876460|7311271|FG000|COMPLETED|Mono Therapy Phase||0
6398648|NCT00876460|7311272|FG001|COMPLETED|Mono Therapy Phase||0
6398649|NCT00876460|7311273|FG002|COMPLETED|Mono Therapy Phase||0
6398650|NCT00876460|7311274|FG003|COMPLETED|Mono Therapy Phase||0
6398651|NCT00876460|7311275|FG004|COMPLETED|Mono Therapy Phase||0
6398652|NCT00876460|7311276|FG005|COMPLETED|Mono Therapy Phase||0
6398653|NCT00876460|7311277|FG006|COMPLETED|Mono Therapy Phase||0
6398654|NCT00876460|7311278|FG007|COMPLETED|Mono Therapy Phase||0
6398655|NCT00876460|7311271|FG000|NOT COMPLETED|Mono Therapy Phase||0
6398656|NCT00876460|7311272|FG001|NOT COMPLETED|Mono Therapy Phase||1
6398657|NCT00876460|7311273|FG002|NOT COMPLETED|Mono Therapy Phase||0
6398658|NCT00876460|7311274|FG003|NOT COMPLETED|Mono Therapy Phase||1
6398659|NCT00876460|7311275|FG004|NOT COMPLETED|Mono Therapy Phase||2
6398660|NCT00876460|7311276|FG005|NOT COMPLETED|Mono Therapy Phase||0
6398661|NCT00876460|7311277|FG006|NOT COMPLETED|Mono Therapy Phase||1
6398662|NCT00876460|7311278|FG007|NOT COMPLETED|Mono Therapy Phase||3
6398663|NCT00876694|7311310|FG000|STARTED|Overall Study||125
6398664|NCT00876694|7311311|FG001|STARTED|Overall Study||61
6398665|NCT00876694|7311310|FG000|COMPLETED|Overall Study||104
6398666|NCT00876694|7311311|FG001|COMPLETED|Overall Study||49
6398667|NCT00876694|7311310|FG000|NOT COMPLETED|Overall Study||21
6398668|NCT00876694|7311311|FG001|NOT COMPLETED|Overall Study||12
6398669|NCT00876733|7311321|FG000|STARTED|Overall Study||288
6398670|NCT00876733|7311322|FG001|STARTED|Overall Study||203
6398671|NCT00876733|7311323|FG002|STARTED|Overall Study||93
6398672|NCT00876733|7311324|FG003|STARTED|Overall Study||21
6398673|NCT00876733|7311321|FG000|COMPLETED|Overall Study||197
6398674|NCT00876733|7311322|FG001|COMPLETED|Overall Study||161
6398675|NCT00876733|7311323|FG002|COMPLETED|Overall Study||63
6398676|NCT00876733|7311324|FG003|COMPLETED|Overall Study||14
6398677|NCT00876733|7311321|FG000|NOT COMPLETED|Overall Study||91
6398678|NCT00876733|7311322|FG001|NOT COMPLETED|Overall Study||42
6398679|NCT00876733|7311323|FG002|NOT COMPLETED|Overall Study||30
6398680|NCT00876733|7311324|FG003|NOT COMPLETED|Overall Study||7
6398681|NCT00876915|7311337|FG000|STARTED|Overall Study||50
6398682|NCT00876915|7311338|FG001|STARTED|Overall Study||48
6398683|NCT00876915|7311339|FG002|STARTED|Overall Study||101
6398684|NCT00876915|7311337|FG000|Week 4|Overall Study||38
6398685|NCT00876915|7311338|FG001|Week 4|Overall Study||45
6398686|NCT00876915|7311339|FG002|Week 4|Overall Study||0
6398687|NCT00876915|7311337|FG000|Week 8|Overall Study||33
6398688|NCT00876915|7311338|FG001|Week 8|Overall Study||36
6398689|NCT00876915|7311339|FG002|Week 8|Overall Study||0
6398690|NCT00876915|7311337|FG000|COMPLETED|Overall Study||31
6398691|NCT00876915|7311338|FG001|COMPLETED|Overall Study||34
6398692|NCT00876915|7311339|FG002|COMPLETED|Overall Study||101
6398693|NCT00876915|7311337|FG000|NOT COMPLETED|Overall Study||19
6741451|NCT03308942|7669725|FG002|STARTED|Stage 1 (up to a Maximum of 29 Months)||3
6741452|NCT03308942|7669726|FG003|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
6741453|NCT03308942|7669727|FG004|STARTED|Stage 1 (up to a Maximum of 29 Months)||0
6398694|NCT00876915|7311338|FG001|NOT COMPLETED|Overall Study||14
6398695|NCT00876915|7311339|FG002|NOT COMPLETED|Overall Study||0
6398696|NCT00876928|7311349|FG000|STARTED|Overall Study||56
6398697|NCT00876928|7311350|FG001|STARTED|Overall Study||61
6398698|NCT00876928|7311349|FG000|COMPLETED|Overall Study||53
6398699|NCT00876928|7311350|FG001|COMPLETED|Overall Study||56
6398700|NCT00876928|7311349|FG000|NOT COMPLETED|Overall Study||3
6398701|NCT00876928|7311350|FG001|NOT COMPLETED|Overall Study||5
6398702|NCT00876993|7311361|FG000|STARTED|Overall Study||5
6398703|NCT00876993|7311362|FG001|STARTED|Overall Study||6
6398704|NCT00876993|7311363|FG002|STARTED|Overall Study||5
6741454|NCT03308942|7669723|FG000|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
6741455|NCT03308942|7669724|FG001|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
6741456|NCT03308942|7669725|FG002|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
6398705|NCT00876993|7311364|FG003|STARTED|Overall Study||5
6398706|NCT00876993|7311365|FG004|STARTED|Overall Study||5
6398707|NCT00876993|7311361|FG000|COMPLETED|Overall Study||4
6398708|NCT00876993|7311362|FG001|COMPLETED|Overall Study||6
6398709|NCT00876993|7311363|FG002|COMPLETED|Overall Study||3
6398710|NCT00876993|7311364|FG003|COMPLETED|Overall Study||5
6398711|NCT00876993|7311365|FG004|COMPLETED|Overall Study||3
6398712|NCT00876993|7311361|FG000|NOT COMPLETED|Overall Study||1
6398713|NCT00876993|7311362|FG001|NOT COMPLETED|Overall Study||0
6398714|NCT00876993|7311363|FG002|NOT COMPLETED|Overall Study||2
6398715|NCT00876993|7311364|FG003|NOT COMPLETED|Overall Study||0
6398716|NCT00876993|7311365|FG004|NOT COMPLETED|Overall Study||2
6398717|NCT00877006|7311381|FG000|STARTED|Treatment Period||224
6398718|NCT00877006|7311382|FG001|STARTED|Treatment Period||223
6398719|NCT00877006|7311381|FG000|COMPLETED|Treatment Period||199
6398720|NCT00877006|7311382|FG001|COMPLETED|Treatment Period||196
6398721|NCT00877006|7311381|FG000|NOT COMPLETED|Treatment Period||25
6398722|NCT00877006|7311382|FG001|NOT COMPLETED|Treatment Period||27
6398723|NCT00877006|7311381|FG000|STARTED|Long-Term Follow-up Period||210
6398724|NCT00877006|7311382|FG001|STARTED|Long-Term Follow-up Period||209
6398725|NCT00877006|7311381|FG000|COMPLETED|Long-Term Follow-up Period||157
6398726|NCT00877006|7311382|FG001|COMPLETED|Long-Term Follow-up Period||154
6398727|NCT00877006|7311381|FG000|NOT COMPLETED|Long-Term Follow-up Period||53
6398728|NCT00877006|7311382|FG001|NOT COMPLETED|Long-Term Follow-up Period||55
6398729|NCT00877032|7311397|FG000|STARTED|Overall Study||6
6398730|NCT00877032|7311398|FG001|STARTED|Overall Study||6
6398731|NCT00877032|7311399|FG002|STARTED|Overall Study||6
6398732|NCT00877032|7311400|FG003|STARTED|Overall Study||7
6398733|NCT00877032|7311401|FG004|STARTED|Overall Study||6
6398734|NCT00877032|7311402|FG005|STARTED|Overall Study||6
6398735|NCT00877032|7311403|FG006|STARTED|Overall Study||20
6398736|NCT00877032|7311397|FG000|Treated|Overall Study||6
6398737|NCT00877032|7311398|FG001|Treated|Overall Study||6
6398738|NCT00877032|7311399|FG002|Treated|Overall Study||6
6398739|NCT00877032|7311400|FG003|Treated|Overall Study||6
6398740|NCT00877032|7311401|FG004|Treated|Overall Study||6
6398741|NCT00877032|7311402|FG005|Treated|Overall Study||6
6398742|NCT00877032|7311403|FG006|Treated|Overall Study||18
6398743|NCT00877032|7311397|FG000|COMPLETED|Overall Study||6
6398744|NCT00877032|7311398|FG001|COMPLETED|Overall Study||6
6398745|NCT00877032|7311399|FG002|COMPLETED|Overall Study||6
6398746|NCT00877032|7311400|FG003|COMPLETED|Overall Study||6
6398747|NCT00877032|7311401|FG004|COMPLETED|Overall Study||6
6398748|NCT00877032|7311402|FG005|COMPLETED|Overall Study||6
6398749|NCT00877032|7311403|FG006|COMPLETED|Overall Study||18
6398750|NCT00877032|7311397|FG000|NOT COMPLETED|Overall Study||0
6398751|NCT00877032|7311398|FG001|NOT COMPLETED|Overall Study||0
6398752|NCT00877032|7311399|FG002|NOT COMPLETED|Overall Study||0
6398753|NCT00877032|7311400|FG003|NOT COMPLETED|Overall Study||1
6398754|NCT00877032|7311401|FG004|NOT COMPLETED|Overall Study||0
6398755|NCT00877032|7311402|FG005|NOT COMPLETED|Overall Study||0
6398756|NCT00877032|7311403|FG006|NOT COMPLETED|Overall Study||2
6398757|NCT00877058|7311422|FG000|STARTED|Overall Study||174
6398758|NCT00877058|7311423|FG001|STARTED|Overall Study||171
6398759|NCT00877058|7311424|FG002|STARTED|Overall Study||114
6398760|NCT00877058|7311422|FG000|COMPLETED|Overall Study||137
6398761|NCT00877058|7311423|FG001|COMPLETED|Overall Study||131
6398762|NCT00877058|7311424|FG002|COMPLETED|Overall Study||75
6398763|NCT00877058|7311422|FG000|NOT COMPLETED|Overall Study||37
6398764|NCT00877058|7311423|FG001|NOT COMPLETED|Overall Study||40
6398765|NCT00877058|7311424|FG002|NOT COMPLETED|Overall Study||39
6398766|NCT00877370|7311432|FG000|STARTED|Overall Study||8
6398767|NCT00877370|7311432|FG000|COMPLETED|Overall Study||8
6398768|NCT00877370|7311432|FG000|NOT COMPLETED|Overall Study||0
6398769|NCT00877383|7311438|FG000|STARTED|Overall Study||572
6398770|NCT00877383|7311439|FG001|STARTED|Overall Study||570
6398771|NCT00877383|7311438|FG000|COMPLETED|Overall Study||543
6398772|NCT00877383|7311439|FG001|COMPLETED|Overall Study||533
6398773|NCT00877383|7311438|FG000|NOT COMPLETED|Overall Study||29
6398774|NCT00877383|7311439|FG001|NOT COMPLETED|Overall Study||37
6398775|NCT00877448|7311452|FG000|STARTED|Overall Study||10
6398776|NCT00877448|7311453|FG001|STARTED|Overall Study||10
6398777|NCT00877448|7311454|FG002|STARTED|Overall Study||10
6398778|NCT00877448|7311455|FG003|STARTED|Overall Study||10
6398779|NCT00877448|7311456|FG004|STARTED|Overall Study||10
6398780|NCT00877448|7311457|FG005|STARTED|Overall Study||10
6398781|NCT00877448|7311458|FG006|STARTED|Overall Study||3
6398782|NCT00877448|7311452|FG000|COMPLETED|Overall Study||10
6398783|NCT00877448|7311453|FG001|COMPLETED|Overall Study||9
6398784|NCT00877448|7311454|FG002|COMPLETED|Overall Study||10
6398785|NCT00877448|7311455|FG003|COMPLETED|Overall Study||9
6398786|NCT00877448|7311456|FG004|COMPLETED|Overall Study||10
6398787|NCT00877448|7311457|FG005|COMPLETED|Overall Study||9
6398788|NCT00877448|7311458|FG006|COMPLETED|Overall Study||3
6398789|NCT00877448|7311452|FG000|NOT COMPLETED|Overall Study||0
6398790|NCT00877448|7311453|FG001|NOT COMPLETED|Overall Study||1
6398791|NCT00877448|7311454|FG002|NOT COMPLETED|Overall Study||0
6398792|NCT00877448|7311455|FG003|NOT COMPLETED|Overall Study||1
6398793|NCT00877448|7311456|FG004|NOT COMPLETED|Overall Study||0
6398794|NCT00877448|7311457|FG005|NOT COMPLETED|Overall Study||1
6741457|NCT03308942|7669726|FG003|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
6741458|NCT03308942|7669727|FG004|COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
6741459|NCT03308942|7669723|FG000|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||17
6398795|NCT00877448|7311458|FG006|NOT COMPLETED|Overall Study||0
6398796|NCT00877487|7311474|FG000|STARTED|Open-label Treatment Phase||123
6398797|NCT00877487|7311475|FG001|STARTED|Open-label Treatment Phase||0
6398798|NCT00877487|7311474|FG000|COMPLETED|Open-label Treatment Phase||116
6398799|NCT00877487|7311475|FG001|COMPLETED|Open-label Treatment Phase||0
6398800|NCT00877487|7311474|FG000|NOT COMPLETED|Open-label Treatment Phase||7
6398801|NCT00877487|7311475|FG001|NOT COMPLETED|Open-label Treatment Phase||0
6398802|NCT00877487|7311474|FG000|STARTED|Double-blind Randomized Withdrawal Phase||56
6398803|NCT00877487|7311475|FG001|STARTED|Double-blind Randomized Withdrawal Phase||60
6398804|NCT00877487|7311474|FG000|COMPLETED|Double-blind Randomized Withdrawal Phase||50
6398805|NCT00877487|7311475|FG001|COMPLETED|Double-blind Randomized Withdrawal Phase||13
6398806|NCT00877487|7311474|FG000|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
6398807|NCT00877487|7311475|FG001|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
6398808|NCT00877604|7311483|FG000|STARTED|Overall Study||17
6398809|NCT00877604|7311484|FG001|STARTED|Overall Study||17
6398810|NCT00877604|7311483|FG000|COMPLETED|Overall Study||15
6398811|NCT00877604|7311484|FG001|COMPLETED|Overall Study||14
6398812|NCT00877604|7311483|FG000|NOT COMPLETED|Overall Study||2
6398813|NCT00877604|7311484|FG001|NOT COMPLETED|Overall Study||3
6398814|NCT00877773|7311490|FG000|STARTED|Overall Study||44
6398815|NCT00877773|7311490|FG000|COMPLETED|Overall Study|No participant reached to first restaging.|0
6398816|NCT00877773|7311490|FG000|NOT COMPLETED|Overall Study||44
6398817|NCT00877799|7311499|FG000|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
6398818|NCT00877799|7311500|FG001|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
6398819|NCT00877799|7311501|FG002|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
6398820|NCT00877799|7311502|FG003|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6398821|NCT00877799|7311503|FG004|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6398822|NCT00877799|7311499|FG000|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
6398823|NCT00877799|7311500|FG001|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
6398824|NCT00877799|7311501|FG002|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
6398825|NCT00877799|7311502|FG003|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6398826|NCT00877799|7311503|FG004|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6398827|NCT00877799|7311499|FG000|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
6398828|NCT00877799|7311500|FG001|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
6398829|NCT00877799|7311501|FG002|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
6398830|NCT00877799|7311502|FG003|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6398831|NCT00877799|7311503|FG004|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
6398832|NCT00877799|7311499|FG000|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
6398833|NCT00877799|7311500|FG001|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
6398834|NCT00877799|7311501|FG002|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
6398835|NCT00877799|7311502|FG003|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
6398836|NCT00877799|7311503|FG004|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
6398837|NCT00877799|7311499|FG000|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6398838|NCT00877799|7311500|FG001|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6398839|NCT00877799|7311501|FG002|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6398840|NCT00877799|7311502|FG003|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
6398841|NCT00877799|7311503|FG004|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
6398842|NCT00877799|7311499|FG000|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6398843|NCT00877799|7311500|FG001|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6398844|NCT00877799|7311501|FG002|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
6398845|NCT00877799|7311502|FG003|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
6398846|NCT00877799|7311503|FG004|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
6398847|NCT00877877|7311514|FG000|STARTED|Year 5||397
6398848|NCT00877877|7311514|FG000|COMPLETED|Year 5||397
6398849|NCT00877877|7311514|FG000|NOT COMPLETED|Year 5||0
6398850|NCT00877877|7311514|FG000|STARTED|Year 6||529
6398851|NCT00877877|7311514|FG000|COMPLETED|Year 6||529
6398852|NCT00877877|7311514|FG000|NOT COMPLETED|Year 6||0
6398853|NCT00877877|7311514|FG000|STARTED|Year 7||523
6398854|NCT00877877|7311514|FG000|COMPLETED|Year 7||523
6398855|NCT00877877|7311514|FG000|NOT COMPLETED|Year 7||0
6398856|NCT00877877|7311514|FG000|STARTED|Year 8||522
6398857|NCT00877877|7311514|FG000|COMPLETED|Year 8||522
6398858|NCT00877877|7311514|FG000|NOT COMPLETED|Year 8||0
6398859|NCT00877877|7311514|FG000|STARTED|Year 9||507
6398860|NCT00877877|7311514|FG000|COMPLETED|Year 9||507
6398861|NCT00877877|7311514|FG000|NOT COMPLETED|Year 9||0
6398862|NCT00877877|7311514|FG000|STARTED|Year 10||495
6398863|NCT00877877|7311514|FG000|COMPLETED|Year 10||495
6398864|NCT00877877|7311514|FG000|NOT COMPLETED|Year 10||0
6398865|NCT00877890|7311525|FG000|STARTED|Overall Study||129
6398866|NCT00877890|7311526|FG001|STARTED|Overall Study||125
6398867|NCT00877890|7311525|FG000|Intent to Treat (ITT)|Overall Study||129
6398868|NCT00877890|7311526|FG001|Intent to Treat (ITT)|Overall Study||123
6398869|NCT00877890|7311525|FG000|COMPLETED|Overall Study||109
6398870|NCT00877890|7311526|FG001|COMPLETED|Overall Study||95
6398871|NCT00877890|7311525|FG000|NOT COMPLETED|Overall Study||20
6398872|NCT00877890|7311526|FG001|NOT COMPLETED|Overall Study||30
6398873|NCT00877929|7311538|FG000|STARTED|Overall Study||352
6398874|NCT00877929|7311539|FG001|STARTED|Overall Study||354
6398875|NCT00877929|7311538|FG000|COMPLETED|Overall Study||332
6398876|NCT00877929|7311539|FG001|COMPLETED|Overall Study||319
6398877|NCT00877929|7311538|FG000|NOT COMPLETED|Overall Study||20
6398878|NCT00877929|7311539|FG001|NOT COMPLETED|Overall Study||35
6741460|NCT03308942|7669724|FG001|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||21
6741461|NCT03308942|7669725|FG002|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||3
6741462|NCT03308942|7669726|FG003|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
6741463|NCT03308942|7669727|FG004|NOT COMPLETED|Stage 1 (up to a Maximum of 29 Months)||0
6741464|NCT03308942|7669723|FG000|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
6741465|NCT03308942|7669724|FG001|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
6398879|NCT00878072|7311549|FG000|STARTED|Overall Study||53
6398880|NCT00878072|7311549|FG000|COMPLETED|Overall Study||51
6398881|NCT00878072|7311549|FG000|NOT COMPLETED|Overall Study||2
6741466|NCT03308942|7669725|FG002|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
6741467|NCT03308942|7669726|FG003|STARTED|Stage 2 (up to a Maximum of 17 Months)||12
6741468|NCT03308942|7669727|FG004|STARTED|Stage 2 (up to a Maximum of 17 Months)||0
6741469|NCT03308942|7669723|FG000|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741470|NCT03308942|7669724|FG001|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741471|NCT03308942|7669725|FG002|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741472|NCT03308942|7669726|FG003|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741473|NCT03308942|7669727|FG004|COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741474|NCT03308942|7669723|FG000|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741475|NCT03308942|7669724|FG001|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741476|NCT03308942|7669725|FG002|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741477|NCT03308942|7669726|FG003|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||12
6741478|NCT03308942|7669727|FG004|NOT COMPLETED|Stage 2 (up to a Maximum of 17 Months)||0
6741479|NCT03308968|7669743|FG000|STARTED|Double-Blind Period (12 Weeks)||279
6741480|NCT03308968|7669744|FG001|STARTED|Double-Blind Period (12 Weeks)||276
6741481|NCT03308968|7669745|FG002|STARTED|Double-Blind Period (12 Weeks)||283
6741482|NCT03308968|7669743|FG000|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|277
6741483|NCT03308968|7669744|FG001|DB Safety Analysis Set|Double-Blind Period (12 Weeks)||276
6741484|NCT03308968|7669745|FG002|DB Safety Analysis Set|Double-Blind Period (12 Weeks)|2 participants (1 with CM and 1 with EM) randomized to placebo but received Fremanezumab monthly.|285
6741485|NCT03308968|7669743|FG000|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||278
6741486|NCT03308968|7669744|FG001|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||276
6741487|NCT03308968|7669745|FG002|DB Modified ITT (mITT) Analysis Set|Double-Blind Period (12 Weeks)||283
6741488|NCT03308968|7669743|FG000|COMPLETED|Double-Blind Period (12 Weeks)||264
6741489|NCT03308968|7669744|FG001|COMPLETED|Double-Blind Period (12 Weeks)||271
6741490|NCT03308968|7669745|FG002|COMPLETED|Double-Blind Period (12 Weeks)||272
6741491|NCT03308968|7669743|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||15
6741492|NCT03308968|7669744|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||5
6741493|NCT03308968|7669745|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||11
6741494|NCT03308968|7669743|FG000|STARTED|Open-Label Period (12 Weeks)||264
6741495|NCT03308968|7669744|FG001|STARTED|Open-Label Period (12 Weeks)||271
6741496|NCT03308968|7669745|FG002|STARTED|Open-Label Period (12 Weeks)||272
6741497|NCT03308968|7669743|FG000|OL mITT Analysis Set|Open-Label Period (12 Weeks)||263
6741498|NCT03308968|7669744|FG001|OL mITT Analysis Set|Open-Label Period (12 Weeks)||271
6741499|NCT03308968|7669745|FG002|OL mITT Analysis Set|Open-Label Period (12 Weeks)||272
6741500|NCT03308968|7669743|FG000|COMPLETED|Open-Label Period (12 Weeks)||253
6741501|NCT03308968|7669744|FG001|COMPLETED|Open-Label Period (12 Weeks)||259
6741502|NCT03308968|7669745|FG002|COMPLETED|Open-Label Period (12 Weeks)||260
6741503|NCT03308968|7669743|FG000|NOT COMPLETED|Open-Label Period (12 Weeks)||11
6741504|NCT03308968|7669744|FG001|NOT COMPLETED|Open-Label Period (12 Weeks)||12
6398882|NCT00878189|7311560|FG000|STARTED|Overall Study||3
6398883|NCT00878189|7311561|FG001|STARTED|Overall Study||3
6398884|NCT00878189|7311562|FG002|STARTED|Overall Study||4
6398885|NCT00878189|7311563|FG003|STARTED|Overall Study||8
6398886|NCT00878189|7311564|FG004|STARTED|Overall Study||4
6398887|NCT00878189|7311565|FG005|STARTED|Overall Study||23
6741505|NCT03308968|7669745|FG002|NOT COMPLETED|Open-Label Period (12 Weeks)||12
6741506|NCT03309020|7669758|FG000|STARTED|Overall Study||12
6741507|NCT03309020|7669759|FG001|STARTED|Overall Study||25
6741508|NCT03309020|7669758|FG000|Underwent Cataract Surgery|Overall Study||10
6741509|NCT03309020|7669759|FG001|Underwent Cataract Surgery|Overall Study||24
6741510|NCT03309020|7669758|FG000|COMPLETED|Overall Study||9
6741511|NCT03309020|7669759|FG001|COMPLETED|Overall Study||24
6741512|NCT03309020|7669758|FG000|NOT COMPLETED|Overall Study||3
6741513|NCT03309020|7669759|FG001|NOT COMPLETED|Overall Study||1
6741514|NCT03309202|7669771|FG000|STARTED|Overall Study||6
6741515|NCT03309202|7669772|FG001|STARTED|Overall Study||6
6398888|NCT00878189|7311566|FG006|STARTED|Overall Study||16
6398889|NCT00878189|7311567|FG007|STARTED|Overall Study||3
6398890|NCT00878189|7311568|FG008|STARTED|Overall Study||8
6398891|NCT00878189|7311560|FG000|COMPLETED|Overall Study||0
6398892|NCT00878189|7311561|FG001|COMPLETED|Overall Study||0
6398893|NCT00878189|7311562|FG002|COMPLETED|Overall Study||0
6398894|NCT00878189|7311563|FG003|COMPLETED|Overall Study||0
6398895|NCT00878189|7311564|FG004|COMPLETED|Overall Study||0
6398896|NCT00878189|7311565|FG005|COMPLETED|Overall Study||0
6398897|NCT00878189|7311566|FG006|COMPLETED|Overall Study||0
6398898|NCT00878189|7311567|FG007|COMPLETED|Overall Study||0
6398899|NCT00878189|7311568|FG008|COMPLETED|Overall Study||0
6398900|NCT00878189|7311560|FG000|NOT COMPLETED|Overall Study||3
6398901|NCT00878189|7311561|FG001|NOT COMPLETED|Overall Study||3
6398902|NCT00878189|7311562|FG002|NOT COMPLETED|Overall Study||4
6398903|NCT00878189|7311563|FG003|NOT COMPLETED|Overall Study||8
6398904|NCT00878189|7311564|FG004|NOT COMPLETED|Overall Study||4
6398905|NCT00878189|7311565|FG005|NOT COMPLETED|Overall Study||23
6398906|NCT00878189|7311566|FG006|NOT COMPLETED|Overall Study||16
6398907|NCT00878189|7311567|FG007|NOT COMPLETED|Overall Study||3
6398908|NCT00878189|7311568|FG008|NOT COMPLETED|Overall Study||8
6398909|NCT00878215|7311606|FG000|STARTED|Overall Study||21
6398910|NCT00878215|7311607|FG001|STARTED|Overall Study||19
6398911|NCT00878215|7311608|FG002|STARTED|Overall Study|Phase 3 not performed because the liver imaging system became commercially available|0
6398912|NCT00878215|7311609|FG003|STARTED|Overall Study|Phase 4 not performed because the liver imaging system became commercially available|0
6398913|NCT00878215|7311606|FG000|COMPLETED|Overall Study||21
6398914|NCT00878215|7311607|FG001|COMPLETED|Overall Study||9
6398915|NCT00878215|7311608|FG002|COMPLETED|Overall Study||0
6398916|NCT00878215|7311609|FG003|COMPLETED|Overall Study||0
6398917|NCT00878215|7311606|FG000|NOT COMPLETED|Overall Study||0
6398918|NCT00878215|7311607|FG001|NOT COMPLETED|Overall Study||10
6398919|NCT00878215|7311608|FG002|NOT COMPLETED|Overall Study||0
6398920|NCT00878215|7311609|FG003|NOT COMPLETED|Overall Study||0
6398921|NCT00878228|7311621|FG000|STARTED|Overall Study||49
6398922|NCT00878228|7311622|FG001|STARTED|Overall Study||49
6398923|NCT00878228|7311621|FG000|COMPLETED|Overall Study||39
6398924|NCT00878228|7311622|FG001|COMPLETED|Overall Study||37
6398925|NCT00878228|7311621|FG000|NOT COMPLETED|Overall Study||10
6398926|NCT00878228|7311622|FG001|NOT COMPLETED|Overall Study||12
6398927|NCT00878436|7311630|FG000|STARTED|Overall Study||28
6741516|NCT03309202|7669773|FG002|STARTED|Overall Study||6
6741517|NCT03309202|7669774|FG003|STARTED|Overall Study||6
6741518|NCT03309202|7669771|FG000|COMPLETED|Overall Study||5
6741519|NCT03309202|7669772|FG001|COMPLETED|Overall Study||6
6741520|NCT03309202|7669773|FG002|COMPLETED|Overall Study||6
6741521|NCT03309202|7669774|FG003|COMPLETED|Overall Study||6
6741522|NCT03309202|7669771|FG000|NOT COMPLETED|Overall Study||1
6741523|NCT03309202|7669772|FG001|NOT COMPLETED|Overall Study||0
6741524|NCT03309202|7669773|FG002|NOT COMPLETED|Overall Study||0
6741525|NCT03309202|7669774|FG003|NOT COMPLETED|Overall Study||0
6741526|NCT03309449|7669787|FG000|STARTED|Overall Study||46
6741527|NCT03309449|7669788|FG001|STARTED|Overall Study||46
6741528|NCT03309449|7669789|FG002|STARTED|Overall Study||46
6741529|NCT03309449|7669787|FG000|COMPLETED|Overall Study||46
6741530|NCT03309449|7669788|FG001|COMPLETED|Overall Study||46
6741531|NCT03309449|7669789|FG002|COMPLETED|Overall Study||46
6741532|NCT03309449|7669787|FG000|NOT COMPLETED|Overall Study||0
6741533|NCT03309449|7669788|FG001|NOT COMPLETED|Overall Study||0
6741534|NCT03309449|7669789|FG002|NOT COMPLETED|Overall Study||0
6741535|NCT03309605|7669805|FG000|STARTED|Overall Study||6
6741536|NCT03309605|7669806|FG001|STARTED|Overall Study||5
6741537|NCT03309605|7669807|FG002|STARTED|Overall Study||6
6741538|NCT03309605|7669808|FG003|STARTED|Overall Study||6
6741539|NCT03309605|7669809|FG004|STARTED|Overall Study||6
6741540|NCT03309605|7669810|FG005|STARTED|Overall Study||6
6398928|NCT00878436|7311631|FG001|STARTED|Overall Study||24
6398929|NCT00878436|7311630|FG000|Completed 2 Cycles|Overall Study||21
6398930|NCT00878436|7311631|FG001|Completed 2 Cycles|Overall Study||20
6398931|NCT00878436|7311630|FG000|6 Months|Overall Study||8
6398932|NCT00878436|7311631|FG001|6 Months|Overall Study||0
6398933|NCT00878436|7311630|FG000|COMPLETED|Overall Study||5
6398934|NCT00878436|7311631|FG001|COMPLETED|Overall Study||0
6398935|NCT00878436|7311630|FG000|NOT COMPLETED|Overall Study||23
6398936|NCT00878436|7311631|FG001|NOT COMPLETED|Overall Study||24
6398937|NCT00878501|7311640|FG000|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
6398938|NCT00878501|7311641|FG001|STARTED|Overall Study||44
6398939|NCT00878501|7311642|FG002|STARTED|Overall Study||93
6398940|NCT00878501|7311640|FG000|Interim Analysis|Overall Study||83
6398941|NCT00878501|7311641|FG001|Interim Analysis|Overall Study||37
6398942|NCT00878501|7311642|FG002|Interim Analysis|Overall Study||81
6398943|NCT00878501|7311640|FG000|COMPLETED|Overall Study||87
6398944|NCT00878501|7311641|FG001|COMPLETED|Overall Study||37
6398945|NCT00878501|7311642|FG002|COMPLETED|Overall Study||85
6398946|NCT00878501|7311640|FG000|NOT COMPLETED|Overall Study||17
6398947|NCT00878501|7311641|FG001|NOT COMPLETED|Overall Study||7
6398948|NCT00878501|7311642|FG002|NOT COMPLETED|Overall Study||8
6398949|NCT00878553|7311654|FG000|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
6398950|NCT00878553|7311655|FG001|STARTED|Sleep Study||0
6398951|NCT00878553|7311656|FG002|STARTED|Sleep Study||0
6741541|NCT03309605|7669811|FG006|STARTED|Overall Study||6
6741542|NCT03309605|7669812|FG007|STARTED|Overall Study||21
6741543|NCT03309605|7669805|FG000|COMPLETED|Overall Study||6
6741544|NCT03309605|7669806|FG001|COMPLETED|Overall Study||5
6741545|NCT03309605|7669807|FG002|COMPLETED|Overall Study||6
6741546|NCT03309605|7669808|FG003|COMPLETED|Overall Study||5
6398952|NCT00878553|7311657|FG003|STARTED|Sleep Study||0
6398953|NCT00878553|7311658|FG004|STARTED|Sleep Study||0
6741547|NCT03309605|7669809|FG004|COMPLETED|Overall Study||5
6741548|NCT03309605|7669810|FG005|COMPLETED|Overall Study||6
6741549|NCT03309605|7669811|FG006|COMPLETED|Overall Study||3
6741550|NCT03309605|7669812|FG007|COMPLETED|Overall Study||19
6741551|NCT03309605|7669805|FG000|NOT COMPLETED|Overall Study||0
6741552|NCT03309605|7669806|FG001|NOT COMPLETED|Overall Study||0
6741553|NCT03309605|7669807|FG002|NOT COMPLETED|Overall Study||0
6741554|NCT03309605|7669808|FG003|NOT COMPLETED|Overall Study||1
6741555|NCT03309605|7669809|FG004|NOT COMPLETED|Overall Study||1
6741556|NCT03309605|7669810|FG005|NOT COMPLETED|Overall Study||0
6741557|NCT03309605|7669811|FG006|NOT COMPLETED|Overall Study||3
6741558|NCT03309605|7669812|FG007|NOT COMPLETED|Overall Study||2
6741559|NCT03309657|7669826|FG000|STARTED|Overall Study||10
6741560|NCT03309657|7669826|FG000|COMPLETED|Overall Study||10
6741561|NCT03309657|7669826|FG000|NOT COMPLETED|Overall Study||0
6741562|NCT03309696|7669832|FG000|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
6741563|NCT03309696|7669833|FG001|STARTED|Overall Study|All five subjects in this arm were randomize to all sham and active tDCS and rTMS interventions.|5
6741564|NCT03309696|7669834|FG002|STARTED|Overall Study||0
6741565|NCT03309696|7669835|FG003|STARTED|Overall Study||0
6741566|NCT03309696|7669832|FG000|COMPLETED|Overall Study||5
6741567|NCT03309696|7669833|FG001|COMPLETED|Overall Study||0
6741568|NCT03309696|7669834|FG002|COMPLETED|Overall Study||0
6741569|NCT03309696|7669835|FG003|COMPLETED|Overall Study||0
6741570|NCT03309696|7669832|FG000|NOT COMPLETED|Overall Study||0
6741571|NCT03309696|7669833|FG001|NOT COMPLETED|Overall Study||5
6741572|NCT03309696|7669834|FG002|NOT COMPLETED|Overall Study||0
6741573|NCT03309696|7669835|FG003|NOT COMPLETED|Overall Study||0
6741574|NCT03309787|7669846|FG000|STARTED|Overall Study||8
6741575|NCT03309787|7669847|FG001|STARTED|Overall Study||20
6741576|NCT03309787|7669848|FG002|STARTED|Overall Study||9
6741577|NCT03309787|7669846|FG000|COMPLETED|Overall Study||6
6741578|NCT03309787|7669847|FG001|COMPLETED|Overall Study||14
6741579|NCT03309787|7669848|FG002|COMPLETED|Overall Study||7
6741580|NCT03309787|7669846|FG000|NOT COMPLETED|Overall Study||2
6741581|NCT03309787|7669847|FG001|NOT COMPLETED|Overall Study||6
6741582|NCT03309787|7669848|FG002|NOT COMPLETED|Overall Study||2
6741583|NCT03309943|7669864|FG000|STARTED|Overall Study||22
6741584|NCT03309943|7669865|FG001|STARTED|Overall Study||22
6741585|NCT03309943|7669864|FG000|COMPLETED|Overall Study||22
6741586|NCT03309943|7669865|FG001|COMPLETED|Overall Study||20
6741587|NCT03309943|7669864|FG000|NOT COMPLETED|Overall Study||0
6741588|NCT03309943|7669865|FG001|NOT COMPLETED|Overall Study||2
6741589|NCT03310021|7669891|FG000|STARTED|Overall Study||6
6741590|NCT03310021|7669892|FG001|STARTED|Overall Study||3
6741591|NCT03310021|7669893|FG002|STARTED|Overall Study||6
6741592|NCT03310021|7669894|FG003|STARTED|Overall Study||3
6741593|NCT03310021|7669895|FG004|STARTED|Overall Study||8
6741594|NCT03310021|7669896|FG005|STARTED|Overall Study||4
6741595|NCT03310021|7669897|FG006|STARTED|Overall Study||8
6282331|NCT00181961|7182611|FG000|STARTED|Overall Study||7
6282332|NCT00181961|7182612|FG001|STARTED|Overall Study||9
6282333|NCT00181961|7182611|FG000|COMPLETED|Overall Study||6
6282334|NCT00181961|7182612|FG001|COMPLETED|Overall Study||4
6282335|NCT00181961|7182611|FG000|NOT COMPLETED|Overall Study||1
6282336|NCT00181961|7182612|FG001|NOT COMPLETED|Overall Study||5
6282337|NCT00182000|7182620|FG000|STARTED|Overall Study||14
6282338|NCT00182000|7182621|FG001|STARTED|Overall Study||15
6282339|NCT00182000|7182620|FG000|COMPLETED|Overall Study||9
6282340|NCT00182000|7182621|FG001|COMPLETED|Overall Study||13
6282341|NCT00182000|7182620|FG000|NOT COMPLETED|Overall Study||5
6282342|NCT00182000|7182621|FG001|NOT COMPLETED|Overall Study||2
6282343|NCT00182078|7182629|FG000|STARTED|Overall Study||9
6398954|NCT00878553|7311654|FG000|Number of Patients Receiving Placebo|Sleep Study||66
6398955|NCT00878553|7311655|FG001|Number of Patients Receiving Placebo|Sleep Study||0
6398956|NCT00878553|7311656|FG002|Number of Patients Receiving Placebo|Sleep Study||0
6398957|NCT00878553|7311657|FG003|Number of Patients Receiving Placebo|Sleep Study||0
6398958|NCT00878553|7311658|FG004|Number of Patients Receiving Placebo|Sleep Study||0
6398959|NCT00878553|7311654|FG000|Number of Patients Receiving 10mg|Sleep Study||65
6398960|NCT00878553|7311655|FG001|Number of Patients Receiving 10mg|Sleep Study||0
6398961|NCT00878553|7311656|FG002|Number of Patients Receiving 10mg|Sleep Study||0
6741596|NCT03310021|7669898|FG007|STARTED|Overall Study||4
6282344|NCT00182078|7182630|FG001|STARTED|Overall Study||17
6282345|NCT00182078|7182629|FG000|COMPLETED|Overall Study||8
6282346|NCT00182078|7182630|FG001|COMPLETED|Overall Study||17
6282347|NCT00182078|7182629|FG000|NOT COMPLETED|Overall Study||1
6282348|NCT00182078|7182630|FG001|NOT COMPLETED|Overall Study||0
6282349|NCT00182091|7182640|FG000|STARTED|Overall Study||15
6282350|NCT00182091|7182641|FG001|STARTED|Overall Study||15
6282351|NCT00182091|7182642|FG002|STARTED|Overall Study||25
6282352|NCT00182091|7182643|FG003|STARTED|Overall Study||20
6282353|NCT00182091|7182640|FG000|COMPLETED|Overall Study||14
6282354|NCT00182091|7182641|FG001|COMPLETED|Overall Study||15
6282355|NCT00182091|7182642|FG002|COMPLETED|Overall Study||25
6741597|NCT03310021|7669899|FG008|STARTED|Overall Study||6
6282356|NCT00182091|7182643|FG003|COMPLETED|Overall Study||20
6741598|NCT03310021|7669900|FG009|STARTED|Overall Study||3
6741599|NCT03310021|7669901|FG010|STARTED|Overall Study||6
6741600|NCT03310021|7669902|FG011|STARTED|Overall Study||3
6741601|NCT03310021|7669903|FG012|STARTED|Overall Study||8
6741602|NCT03310021|7669904|FG013|STARTED|Overall Study||4
6741603|NCT03310021|7669905|FG014|STARTED|Overall Study||6
6741604|NCT03310021|7669906|FG015|STARTED|Overall Study||3
6741605|NCT03310021|7669907|FG016|STARTED|Overall Study||10
6741606|NCT03310021|7669908|FG017|STARTED|Overall Study||5
6741607|NCT03310021|7669909|FG018|STARTED|Overall Study||8
6741608|NCT03310021|7669910|FG019|STARTED|Overall Study||3
6741609|NCT03310021|7669891|FG000|COMPLETED|Overall Study||6
6741610|NCT03310021|7669892|FG001|COMPLETED|Overall Study||3
6741611|NCT03310021|7669893|FG002|COMPLETED|Overall Study||6
6741612|NCT03310021|7669894|FG003|COMPLETED|Overall Study||3
6741613|NCT03310021|7669895|FG004|COMPLETED|Overall Study||8
6741614|NCT03310021|7669896|FG005|COMPLETED|Overall Study||4
6741615|NCT03310021|7669897|FG006|COMPLETED|Overall Study||7
6741616|NCT03310021|7669898|FG007|COMPLETED|Overall Study||4
6741617|NCT03310021|7669899|FG008|COMPLETED|Overall Study||6
6741618|NCT03310021|7669900|FG009|COMPLETED|Overall Study||3
6741619|NCT03310021|7669901|FG010|COMPLETED|Overall Study||5
6741620|NCT03310021|7669902|FG011|COMPLETED|Overall Study||3
6741621|NCT03310021|7669903|FG012|COMPLETED|Overall Study||8
6741622|NCT03310021|7669904|FG013|COMPLETED|Overall Study||4
6741623|NCT03310021|7669905|FG014|COMPLETED|Overall Study||6
6398962|NCT00878553|7311657|FG003|Number of Patients Receiving 10mg|Sleep Study||0
6398963|NCT00878553|7311658|FG004|Number of Patients Receiving 10mg|Sleep Study||0
6398964|NCT00878553|7311654|FG000|Number of Patients Receiving 15mg|Sleep Study||65
6741624|NCT03310021|7669906|FG015|COMPLETED|Overall Study||3
6741625|NCT03310021|7669907|FG016|COMPLETED|Overall Study||10
6741626|NCT03310021|7669908|FG017|COMPLETED|Overall Study||5
6741627|NCT03310021|7669909|FG018|COMPLETED|Overall Study||8
6741628|NCT03310021|7669910|FG019|COMPLETED|Overall Study||3
6741629|NCT03310021|7669891|FG000|NOT COMPLETED|Overall Study||0
6741630|NCT03310021|7669892|FG001|NOT COMPLETED|Overall Study||0
6741631|NCT03310021|7669893|FG002|NOT COMPLETED|Overall Study||0
6741632|NCT03310021|7669894|FG003|NOT COMPLETED|Overall Study||0
6741633|NCT03310021|7669895|FG004|NOT COMPLETED|Overall Study||0
6741634|NCT03310021|7669896|FG005|NOT COMPLETED|Overall Study||0
6741635|NCT03310021|7669897|FG006|NOT COMPLETED|Overall Study||1
6741636|NCT03310021|7669898|FG007|NOT COMPLETED|Overall Study||0
6741637|NCT03310021|7669899|FG008|NOT COMPLETED|Overall Study||0
6741638|NCT03310021|7669900|FG009|NOT COMPLETED|Overall Study||0
6741639|NCT03310021|7669901|FG010|NOT COMPLETED|Overall Study||1
6741640|NCT03310021|7669902|FG011|NOT COMPLETED|Overall Study||0
6741641|NCT03310021|7669903|FG012|NOT COMPLETED|Overall Study||0
6741642|NCT03310021|7669904|FG013|NOT COMPLETED|Overall Study||0
6741643|NCT03310021|7669905|FG014|NOT COMPLETED|Overall Study||0
6741644|NCT03310021|7669906|FG015|NOT COMPLETED|Overall Study||0
6741645|NCT03310021|7669907|FG016|NOT COMPLETED|Overall Study||0
6741646|NCT03310021|7669908|FG017|NOT COMPLETED|Overall Study||0
6741647|NCT03310021|7669909|FG018|NOT COMPLETED|Overall Study||0
6741648|NCT03310021|7669910|FG019|NOT COMPLETED|Overall Study||0
6741649|NCT03310268|7669955|FG000|STARTED|Overall Study||62
6741650|NCT03310268|7669956|FG001|STARTED|Overall Study||62
6741651|NCT03310268|7669957|FG002|STARTED|Overall Study||61
6741652|NCT03310268|7669955|FG000|COMPLETED|Overall Study||61
6741653|NCT03310268|7669956|FG001|COMPLETED|Overall Study||57
6741654|NCT03310268|7669957|FG002|COMPLETED|Overall Study||61
6741655|NCT03310268|7669955|FG000|NOT COMPLETED|Overall Study||1
6741656|NCT03310268|7669956|FG001|NOT COMPLETED|Overall Study||5
6741657|NCT03310268|7669957|FG002|NOT COMPLETED|Overall Study||0
6741658|NCT03310411|7669965|FG000|STARTED|Period 1||10
6741659|NCT03310411|7669966|FG001|STARTED|Period 1||10
6741660|NCT03310411|7669967|FG002|STARTED|Period 1||10
6741661|NCT03310411|7669968|FG003|STARTED|Period 1||10
6398965|NCT00878553|7311655|FG001|Number of Patients Receiving 15mg|Sleep Study||0
6398966|NCT00878553|7311656|FG002|Number of Patients Receiving 15mg|Sleep Study||0
6398967|NCT00878553|7311657|FG003|Number of Patients Receiving 15mg|Sleep Study||0
6398968|NCT00878553|7311658|FG004|Number of Patients Receiving 15mg|Sleep Study||0
6398969|NCT00878553|7311654|FG000|Number of Patients Receiving 20mg|Sleep Study||65
6398970|NCT00878553|7311655|FG001|Number of Patients Receiving 20mg|Sleep Study||0
6398971|NCT00878553|7311656|FG002|Number of Patients Receiving 20mg|Sleep Study||0
6398972|NCT00878553|7311657|FG003|Number of Patients Receiving 20mg|Sleep Study||0
6398973|NCT00878553|7311658|FG004|Number of Patients Receiving 20mg|Sleep Study||0
6398974|NCT00878553|7311654|FG000|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
6398975|NCT00878553|7311655|FG001|COMPLETED|Sleep Study||0
6398976|NCT00878553|7311656|FG002|COMPLETED|Sleep Study||0
6398977|NCT00878553|7311657|FG003|COMPLETED|Sleep Study||0
6398978|NCT00878553|7311658|FG004|COMPLETED|Sleep Study||0
6398979|NCT00878553|7311654|FG000|NOT COMPLETED|Sleep Study||5
6398980|NCT00878553|7311655|FG001|NOT COMPLETED|Sleep Study||0
6398981|NCT00878553|7311656|FG002|NOT COMPLETED|Sleep Study||0
6741662|NCT03310411|7669965|FG000|Received at Least 1 Dose of Study Drug|Period 1||10
6398982|NCT00878553|7311657|FG003|NOT COMPLETED|Sleep Study||0
6398983|NCT00878553|7311658|FG004|NOT COMPLETED|Sleep Study||0
6398984|NCT00878553|7311654|FG000|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
6741663|NCT03310411|7669966|FG001|Received at Least 1 Dose of Study Drug|Period 1||10
6741664|NCT03310411|7669967|FG002|Received at Least 1 Dose of Study Drug|Period 1||10
6741665|NCT03310411|7669968|FG003|Received at Least 1 Dose of Study Drug|Period 1||10
6741666|NCT03310411|7669965|FG000|COMPLETED|Period 1||10
6741667|NCT03310411|7669966|FG001|COMPLETED|Period 1||10
6741668|NCT03310411|7669967|FG002|COMPLETED|Period 1||10
6741669|NCT03310411|7669968|FG003|COMPLETED|Period 1||9
6741670|NCT03310411|7669965|FG000|NOT COMPLETED|Period 1||0
6741671|NCT03310411|7669966|FG001|NOT COMPLETED|Period 1||0
6741672|NCT03310411|7669967|FG002|NOT COMPLETED|Period 1||0
6741673|NCT03310411|7669968|FG003|NOT COMPLETED|Period 1||1
6741674|NCT03310411|7669965|FG000|STARTED|Period 2||10
6741675|NCT03310411|7669966|FG001|STARTED|Period 2||10
6741676|NCT03310411|7669967|FG002|STARTED|Period 2||10
6741677|NCT03310411|7669968|FG003|STARTED|Period 2||9
6741678|NCT03310411|7669965|FG000|COMPLETED|Period 2||10
6741679|NCT03310411|7669966|FG001|COMPLETED|Period 2||10
6741680|NCT03310411|7669967|FG002|COMPLETED|Period 2||10
6741681|NCT03310411|7669968|FG003|COMPLETED|Period 2||9
6398985|NCT00878553|7311655|FG001|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
6398986|NCT00878553|7311656|FG002|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
6626837|NCT02235077|7554526|FG001|COMPLETED|Overall Study||159
6626838|NCT02235077|7554525|FG000|NOT COMPLETED|Overall Study||18
6626839|NCT02235077|7554526|FG001|NOT COMPLETED|Overall Study||19
6626840|NCT02235285|7554532|FG000|STARTED|Overall Study||162
6626841|NCT02235285|7554532|FG000|COMPLETED|Overall Study||149
6626842|NCT02235285|7554532|FG000|NOT COMPLETED|Overall Study||13
6626843|NCT02235298|7554538|FG000|STARTED|Overall Study||50
6626844|NCT02235298|7554539|FG001|STARTED|Overall Study||50
6626845|NCT02235298|7554538|FG000|COMPLETED|Overall Study||42
6626846|NCT02235298|7554539|FG001|COMPLETED|Overall Study||42
6626847|NCT02235298|7554538|FG000|NOT COMPLETED|Overall Study||8
6626848|NCT02235298|7554539|FG001|NOT COMPLETED|Overall Study||8
6626849|NCT02235311|7554547|FG000|STARTED|Overall Study||1
6626850|NCT02235311|7554548|FG001|STARTED|Overall Study||2
6626851|NCT02235311|7554547|FG000|COMPLETED|Overall Study||1
6626852|NCT02235311|7554548|FG001|COMPLETED|Overall Study||0
6626853|NCT02235311|7554547|FG000|NOT COMPLETED|Overall Study||0
6626854|NCT02235311|7554548|FG001|NOT COMPLETED|Overall Study||2
6626855|NCT02235454|7554554|FG000|STARTED|Overall Study||57
6626856|NCT02235454|7554554|FG000|COMPLETED|Overall Study||55
6626857|NCT02235454|7554554|FG000|NOT COMPLETED|Overall Study||2
6626858|NCT02235493|7554558|FG000|STARTED|Overall Study||6
6626859|NCT02235493|7554558|FG000|COMPLETED|Overall Study||6
6626860|NCT02235493|7554558|FG000|NOT COMPLETED|Overall Study||0
6626861|NCT02235831|7554562|FG000|STARTED|Period 1, First 5 Days of Wear||4
6626862|NCT02235831|7554563|FG001|STARTED|Period 1, First 5 Days of Wear||4
6626863|NCT02235831|7554564|FG002|STARTED|Period 1, First 5 Days of Wear||4
6626864|NCT02235831|7554565|FG003|STARTED|Period 1, First 5 Days of Wear||4
6626865|NCT02235831|7554566|FG004|STARTED|Period 1, First 5 Days of Wear||4
6626866|NCT02235831|7554567|FG005|STARTED|Period 1, First 5 Days of Wear||4
6626867|NCT02235831|7554562|FG000|COMPLETED|Period 1, First 5 Days of Wear||4
6626868|NCT02235831|7554563|FG001|COMPLETED|Period 1, First 5 Days of Wear||4
6626869|NCT02235831|7554564|FG002|COMPLETED|Period 1, First 5 Days of Wear||4
6626870|NCT02235831|7554565|FG003|COMPLETED|Period 1, First 5 Days of Wear||4
6626871|NCT02235831|7554566|FG004|COMPLETED|Period 1, First 5 Days of Wear||4
6626872|NCT02235831|7554567|FG005|COMPLETED|Period 1, First 5 Days of Wear||4
6626873|NCT02235831|7554562|FG000|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6626874|NCT02235831|7554563|FG001|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6626875|NCT02235831|7554564|FG002|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6626876|NCT02235831|7554565|FG003|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6626877|NCT02235831|7554566|FG004|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6626878|NCT02235831|7554567|FG005|NOT COMPLETED|Period 1, First 5 Days of Wear||0
6626879|NCT02235831|7554562|FG000|STARTED|Period 2, Second 5 Days of Wear||4
6626880|NCT02235831|7554563|FG001|STARTED|Period 2, Second 5 Days of Wear||4
6626881|NCT02235831|7554564|FG002|STARTED|Period 2, Second 5 Days of Wear||4
6626882|NCT02235831|7554565|FG003|STARTED|Period 2, Second 5 Days of Wear||4
6741682|NCT03310411|7669965|FG000|NOT COMPLETED|Period 2||0
6741683|NCT03310411|7669966|FG001|NOT COMPLETED|Period 2||0
6741684|NCT03310411|7669967|FG002|NOT COMPLETED|Period 2||0
6398987|NCT00878553|7311657|FG003|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
6398988|NCT00878553|7311658|FG004|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
6398989|NCT00878553|7311654|FG000|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
6398990|NCT00878553|7311655|FG001|COMPLETED|PK Study||16
6398991|NCT00878553|7311656|FG002|COMPLETED|PK Study||17
6498657|NCT01411696|7417292|FG000|STARTED|Overall Study||289
6626883|NCT02235831|7554566|FG004|STARTED|Period 2, Second 5 Days of Wear||4
6626884|NCT02235831|7554567|FG005|STARTED|Period 2, Second 5 Days of Wear||4
6626885|NCT02235831|7554562|FG000|COMPLETED|Period 2, Second 5 Days of Wear||4
6626886|NCT02235831|7554563|FG001|COMPLETED|Period 2, Second 5 Days of Wear||4
6626887|NCT02235831|7554564|FG002|COMPLETED|Period 2, Second 5 Days of Wear||4
6626888|NCT02235831|7554565|FG003|COMPLETED|Period 2, Second 5 Days of Wear||4
6626889|NCT02235831|7554566|FG004|COMPLETED|Period 2, Second 5 Days of Wear||4
6626890|NCT02235831|7554567|FG005|COMPLETED|Period 2, Second 5 Days of Wear||4
6626891|NCT02235831|7554562|FG000|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6626892|NCT02235831|7554563|FG001|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6626893|NCT02235831|7554564|FG002|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6741685|NCT03310411|7669968|FG003|NOT COMPLETED|Period 2||0
6741686|NCT03310411|7669965|FG000|STARTED|Period 3||10
6741687|NCT03310411|7669966|FG001|STARTED|Period 3||10
6741688|NCT03310411|7669967|FG002|STARTED|Period 3||10
6741689|NCT03310411|7669968|FG003|STARTED|Period 3||9
6741690|NCT03310411|7669965|FG000|COMPLETED|Period 3||10
6741691|NCT03310411|7669966|FG001|COMPLETED|Period 3||10
6741692|NCT03310411|7669967|FG002|COMPLETED|Period 3||10
6741693|NCT03310411|7669968|FG003|COMPLETED|Period 3||9
6741694|NCT03310411|7669965|FG000|NOT COMPLETED|Period 3||0
6741695|NCT03310411|7669966|FG001|NOT COMPLETED|Period 3||0
6741696|NCT03310411|7669967|FG002|NOT COMPLETED|Period 3||0
6741697|NCT03310411|7669968|FG003|NOT COMPLETED|Period 3||0
6741698|NCT03310411|7669965|FG000|STARTED|Period Title: Period 4||10
6741699|NCT03310411|7669966|FG001|STARTED|Period Title: Period 4||10
6741700|NCT03310411|7669967|FG002|STARTED|Period Title: Period 4||10
6741701|NCT03310411|7669968|FG003|STARTED|Period Title: Period 4||9
6741702|NCT03310411|7669965|FG000|COMPLETED|Period Title: Period 4||10
6741703|NCT03310411|7669966|FG001|COMPLETED|Period Title: Period 4||10
6741704|NCT03310411|7669967|FG002|COMPLETED|Period Title: Period 4||10
6741705|NCT03310411|7669968|FG003|COMPLETED|Period Title: Period 4||9
6741706|NCT03310411|7669965|FG000|NOT COMPLETED|Period Title: Period 4||0
6741707|NCT03310411|7669966|FG001|NOT COMPLETED|Period Title: Period 4||0
6741708|NCT03310411|7669967|FG002|NOT COMPLETED|Period Title: Period 4||0
6741709|NCT03310411|7669968|FG003|NOT COMPLETED|Period Title: Period 4||0
6741710|NCT03310450|7669987|FG000|STARTED|Overall Study||32
6741711|NCT03310450|7669988|FG001|STARTED|Overall Study||34
6741712|NCT03310450|7669989|FG002|STARTED|Overall Study||28
6741713|NCT03310450|7669987|FG000|COMPLETED|Overall Study||30
6741714|NCT03310450|7669988|FG001|COMPLETED|Overall Study||30
6741715|NCT03310450|7669989|FG002|COMPLETED|Overall Study||28
6741716|NCT03310450|7669987|FG000|NOT COMPLETED|Overall Study||2
6741717|NCT03310450|7669988|FG001|NOT COMPLETED|Overall Study||4
6741718|NCT03310450|7669989|FG002|NOT COMPLETED|Overall Study||0
6741719|NCT03310580|7670003|FG000|STARTED|Overall Study||15
6741720|NCT03310580|7670004|FG001|STARTED|Overall Study||15
6741721|NCT03310580|7670005|FG002|STARTED|Overall Study||12
6741722|NCT03310580|7670003|FG000|COMPLETED|Overall Study||15
6741723|NCT03310580|7670004|FG001|COMPLETED|Overall Study||14
6741724|NCT03310580|7670005|FG002|COMPLETED|Overall Study||12
6741725|NCT03310580|7670003|FG000|NOT COMPLETED|Overall Study||0
6741726|NCT03310580|7670004|FG001|NOT COMPLETED|Overall Study||1
6741727|NCT03310580|7670005|FG002|NOT COMPLETED|Overall Study||0
6741728|NCT03310723|7670016|FG000|STARTED|Overall Study||20
6741729|NCT03310723|7670017|FG001|STARTED|Overall Study||20
6741730|NCT03310723|7670016|FG000|COMPLETED|Overall Study||20
6741731|NCT03310723|7670017|FG001|COMPLETED|Overall Study||17
6741732|NCT03310723|7670016|FG000|NOT COMPLETED|Overall Study||0
6741733|NCT03310723|7670017|FG001|NOT COMPLETED|Overall Study||3
6741734|NCT03310775|7670025|FG000|STARTED|Overall Study||19
6741735|NCT03310775|7670026|FG001|STARTED|Overall Study||18
6741736|NCT03310775|7670025|FG000|COMPLETED|Overall Study||17
6741737|NCT03310775|7670026|FG001|COMPLETED|Overall Study||14
6741738|NCT03310775|7670025|FG000|NOT COMPLETED|Overall Study||2
6626894|NCT02235831|7554565|FG003|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6626895|NCT02235831|7554566|FG004|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6626896|NCT02235831|7554567|FG005|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
6626897|NCT02235831|7554562|FG000|STARTED|Period 3, Third 5 Days of Wear||4
6626898|NCT02235831|7554563|FG001|STARTED|Period 3, Third 5 Days of Wear||4
6626899|NCT02235831|7554564|FG002|STARTED|Period 3, Third 5 Days of Wear||4
6626900|NCT02235831|7554565|FG003|STARTED|Period 3, Third 5 Days of Wear||4
6626901|NCT02235831|7554566|FG004|STARTED|Period 3, Third 5 Days of Wear||4
6626902|NCT02235831|7554567|FG005|STARTED|Period 3, Third 5 Days of Wear||4
6626903|NCT02235831|7554562|FG000|COMPLETED|Period 3, Third 5 Days of Wear||4
6626904|NCT02235831|7554563|FG001|COMPLETED|Period 3, Third 5 Days of Wear||4
6626905|NCT02235831|7554564|FG002|COMPLETED|Period 3, Third 5 Days of Wear||4
6626906|NCT02235831|7554565|FG003|COMPLETED|Period 3, Third 5 Days of Wear||4
6626907|NCT02235831|7554566|FG004|COMPLETED|Period 3, Third 5 Days of Wear||4
6626908|NCT02235831|7554567|FG005|COMPLETED|Period 3, Third 5 Days of Wear||4
6626909|NCT02235831|7554562|FG000|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6626910|NCT02235831|7554563|FG001|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6626911|NCT02235831|7554564|FG002|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6626912|NCT02235831|7554565|FG003|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6626913|NCT02235831|7554566|FG004|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6626914|NCT02235831|7554567|FG005|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
6741739|NCT03310775|7670026|FG001|NOT COMPLETED|Overall Study||4
6741740|NCT03310970|7670032|FG000|STARTED|Overall Study||11
6626915|NCT02235870|7554576|FG000|STARTED|Overall Study||198
6626916|NCT02235870|7554577|FG001|STARTED|Overall Study||189
6626917|NCT02235870|7554576|FG000|Completed Phase I (Week 24)|Overall Study||182
6626918|NCT02235870|7554577|FG001|Completed Phase I (Week 24)|Overall Study||179
6626919|NCT02235870|7554576|FG000|Crossover (Week 24)|Overall Study||170
6626920|NCT02235870|7554577|FG001|Crossover (Week 24)|Overall Study||138
6626921|NCT02235870|7554576|FG000|COMPLETED|Overall Study||160
6626922|NCT02235870|7554577|FG001|COMPLETED|Overall Study||128
6626923|NCT02235870|7554576|FG000|NOT COMPLETED|Overall Study||38
6741741|NCT03310970|7670033|FG001|STARTED|Overall Study||12
6741742|NCT03310970|7670032|FG000|COMPLETED|Overall Study||11
6741743|NCT03310970|7670033|FG001|COMPLETED|Overall Study||11
6741744|NCT03310970|7670032|FG000|NOT COMPLETED|Overall Study||0
6741745|NCT03310970|7670033|FG001|NOT COMPLETED|Overall Study||1
6741746|NCT03311230|7670044|FG000|STARTED|Overall Study||151
6741747|NCT03311230|7670045|FG001|STARTED|Overall Study||151
6741748|NCT03311230|7670046|FG002|STARTED|Overall Study||150
6741749|NCT03311230|7670047|FG003|STARTED|Overall Study||150
6741750|NCT03311230|7670044|FG000|COMPLETED|Overall Study||150
6626924|NCT02235870|7554577|FG001|NOT COMPLETED|Overall Study||61
6626925|NCT02235987|7554584|FG000|STARTED|Overall Study||20
6626926|NCT02235987|7554584|FG000|Received Octreotide|Overall Study||20
6741751|NCT03311230|7670045|FG001|COMPLETED|Overall Study||146
6741752|NCT03311230|7670046|FG002|COMPLETED|Overall Study||148
6741753|NCT03311230|7670047|FG003|COMPLETED|Overall Study||143
6741754|NCT03311230|7670044|FG000|NOT COMPLETED|Overall Study||1
6282357|NCT00182091|7182640|FG000|NOT COMPLETED|Overall Study||1
6282358|NCT00182091|7182641|FG001|NOT COMPLETED|Overall Study||0
6282359|NCT00182091|7182642|FG002|NOT COMPLETED|Overall Study||0
6282360|NCT00182091|7182643|FG003|NOT COMPLETED|Overall Study||0
6626927|NCT02235987|7554584|FG000|Received 100 µg DG3173|Overall Study||20
6626928|NCT02235987|7554584|FG000|Received 300 µg DG3173|Overall Study||20
6626929|NCT02235987|7554584|FG000|Received 900 µg DG3173|Overall Study||19
6626930|NCT02235987|7554584|FG000|Received 1800 µg DG3173|Overall Study||19
6282361|NCT00182325|7182653|FG000|STARTED|Overall Study||97
6626931|NCT02235987|7554584|FG000|COMPLETED|Overall Study||19
6626932|NCT02235987|7554584|FG000|NOT COMPLETED|Overall Study||1
6626933|NCT02236130|7554599|FG000|STARTED|Overall Study||22
6626934|NCT02236130|7554600|FG001|STARTED|Overall Study||27
6626935|NCT02236130|7554599|FG000|COMPLETED|Overall Study||15
6626936|NCT02236130|7554600|FG001|COMPLETED|Overall Study||15
6626937|NCT02236130|7554599|FG000|NOT COMPLETED|Overall Study||7
6626938|NCT02236130|7554600|FG001|NOT COMPLETED|Overall Study||12
6626939|NCT02236338|7554608|FG000|STARTED|Overall Study||100
6626940|NCT02236338|7554609|FG001|STARTED|Overall Study||100
6626941|NCT02236338|7554608|FG000|COMPLETED|Overall Study||100
6626942|NCT02236338|7554609|FG001|COMPLETED|Overall Study||100
6626943|NCT02236338|7554608|FG000|NOT COMPLETED|Overall Study||0
6626944|NCT02236338|7554609|FG001|NOT COMPLETED|Overall Study||0
6626945|NCT02236520|7554619|FG000|STARTED|Overall Study||16
6626946|NCT02236520|7554620|FG001|STARTED|Overall Study||13
6626947|NCT02236520|7554621|FG002|STARTED|Overall Study||15
6626948|NCT02236520|7554622|FG003|STARTED|Overall Study||15
6626949|NCT02236520|7554619|FG000|COMPLETED|Overall Study||14
6626950|NCT02236520|7554620|FG001|COMPLETED|Overall Study||8
6626951|NCT02236520|7554621|FG002|COMPLETED|Overall Study||15
6626952|NCT02236520|7554622|FG003|COMPLETED|Overall Study||14
6626953|NCT02236520|7554619|FG000|NOT COMPLETED|Overall Study||2
6626954|NCT02236520|7554620|FG001|NOT COMPLETED|Overall Study||5
6626955|NCT02236520|7554621|FG002|NOT COMPLETED|Overall Study||0
6626956|NCT02236520|7554622|FG003|NOT COMPLETED|Overall Study||1
6626957|NCT02236559|7554634|FG000|STARTED|Overall Study||112
6626958|NCT02236559|7554635|FG001|STARTED|Overall Study||116
6626959|NCT02236559|7554634|FG000|COMPLETED|Overall Study||100
6626960|NCT02236559|7554635|FG001|COMPLETED|Overall Study||104
6626961|NCT02236559|7554634|FG000|NOT COMPLETED|Overall Study||12
6626962|NCT02236559|7554635|FG001|NOT COMPLETED|Overall Study||12
6626963|NCT02236598|7554643|FG000|STARTED|Overall Study||15
6626964|NCT02236598|7554644|FG001|STARTED|Overall Study||14
6626965|NCT02236598|7554643|FG000|COMPLETED|Overall Study||15
6626966|NCT02236598|7554644|FG001|COMPLETED|Overall Study||12
6626967|NCT02236598|7554643|FG000|NOT COMPLETED|Overall Study||0
6626968|NCT02236598|7554644|FG001|NOT COMPLETED|Overall Study||2
6626969|NCT02236611|7554652|FG000|STARTED|Overall Study||516
6626970|NCT02236611|7554653|FG001|STARTED|Overall Study||518
6626971|NCT02236611|7554652|FG000|COMPLETED|Overall Study||490
6626972|NCT02236611|7554653|FG001|COMPLETED|Overall Study||484
6626973|NCT02236611|7554652|FG000|NOT COMPLETED|Overall Study||26
6626974|NCT02236611|7554653|FG001|NOT COMPLETED|Overall Study||34
6626975|NCT02236767|7554659|FG000|STARTED|Overall Study||1
6626976|NCT02236767|7554659|FG000|COMPLETED|Overall Study||1
6626977|NCT02236767|7554659|FG000|NOT COMPLETED|Overall Study||0
6626978|NCT02236988|7554667|FG000|STARTED|Overall Study||16
6626979|NCT02236988|7554668|FG001|STARTED|Overall Study||16
6626980|NCT02236988|7554669|FG002|STARTED|Overall Study||18
6626981|NCT02236988|7554670|FG003|STARTED|Overall Study||30
6626982|NCT02236988|7554667|FG000|COMPLETED|Overall Study||16
6626983|NCT02236988|7554668|FG001|COMPLETED|Overall Study||16
6626984|NCT02236988|7554669|FG002|COMPLETED|Overall Study||18
6626985|NCT02236988|7554670|FG003|COMPLETED|Overall Study||27
6626986|NCT02236988|7554667|FG000|NOT COMPLETED|Overall Study||0
6626987|NCT02236988|7554668|FG001|NOT COMPLETED|Overall Study||0
6626988|NCT02236988|7554669|FG002|NOT COMPLETED|Overall Study||0
6626989|NCT02236988|7554670|FG003|NOT COMPLETED|Overall Study||3
6626990|NCT02237001|7554721|FG000|STARTED|Overall Study||30
6626991|NCT02237001|7554721|FG000|6 Month Follow-up|Overall Study||27
6626992|NCT02237001|7554721|FG000|12 Month Follow-up|Overall Study||21
6626993|NCT02237001|7554721|FG000|24 Month Follow-up|Overall Study||19
6626994|NCT02237001|7554721|FG000|COMPLETED|Overall Study||19
6626995|NCT02237001|7554721|FG000|NOT COMPLETED|Overall Study||11
6626996|NCT02237092|7554725|FG000|STARTED|Overall Study||196
6741755|NCT03311230|7670045|FG001|NOT COMPLETED|Overall Study||5
6741756|NCT03311230|7670046|FG002|NOT COMPLETED|Overall Study||2
6741757|NCT03311230|7670047|FG003|NOT COMPLETED|Overall Study||7
6741758|NCT03311373|7670057|FG000|STARTED|Overall Study||56
6741759|NCT03311373|7670057|FG000|COMPLETED|Overall Study||47
6741760|NCT03311373|7670057|FG000|NOT COMPLETED|Overall Study||9
6741761|NCT03311646|7670067|FG000|STARTED|Overall Study|Number who were eligible and consented.|31
6741762|NCT03311646|7670067|FG000|COMPLETED|Overall Study|Completed VLNC Condition|16
6741763|NCT03311646|7670067|FG000|NOT COMPLETED|Overall Study||15
6741764|NCT03311659|7670072|FG000|STARTED|Overall Study||447
6741765|NCT03311659|7670072|FG000|COMPLETED|Overall Study||446
6741766|NCT03311659|7670072|FG000|NOT COMPLETED|Overall Study||1
6741767|NCT03311724|7670080|FG000|STARTED|Overall Study||26
6741768|NCT03311724|7670081|FG001|STARTED|Overall Study||29
6741769|NCT03311724|7670082|FG002|STARTED|Overall Study||28
6741770|NCT03311724|7670083|FG003|STARTED|Overall Study||28
6741771|NCT03311724|7670080|FG000|Received At Least One Dose of Study Drug|Overall Study||26
6741772|NCT03311724|7670081|FG001|Received At Least One Dose of Study Drug|Overall Study||29
6741773|NCT03311724|7670082|FG002|Received At Least One Dose of Study Drug|Overall Study||28
6741774|NCT03311724|7670083|FG003|Received At Least One Dose of Study Drug|Overall Study||28
6741775|NCT03311724|7670080|FG000|Completed Treatment|Overall Study||20
6741776|NCT03311724|7670081|FG001|Completed Treatment|Overall Study||27
6741777|NCT03311724|7670082|FG002|Completed Treatment|Overall Study||22
6741778|NCT03311724|7670083|FG003|Completed Treatment|Overall Study||26
6741779|NCT03311724|7670080|FG000|COMPLETED|Overall Study||23
6741780|NCT03311724|7670081|FG001|COMPLETED|Overall Study||28
6741781|NCT03311724|7670082|FG002|COMPLETED|Overall Study||26
6741782|NCT03311724|7670083|FG003|COMPLETED|Overall Study||27
6741783|NCT03311724|7670080|FG000|NOT COMPLETED|Overall Study||3
6741784|NCT03311724|7670081|FG001|NOT COMPLETED|Overall Study||1
6741785|NCT03311724|7670082|FG002|NOT COMPLETED|Overall Study||2
6741786|NCT03311724|7670083|FG003|NOT COMPLETED|Overall Study||1
6741787|NCT03311841|7670101|FG000|STARTED|Period 1||6
6741788|NCT03311841|7670102|FG001|STARTED|Period 1||7
6741789|NCT03311841|7670103|FG002|STARTED|Period 1||6
6741790|NCT03311841|7670104|FG003|STARTED|Period 1||7
6741791|NCT03311841|7670105|FG004|STARTED|Period 1||6
6741792|NCT03311841|7670101|FG000|COMPLETED|Period 1||6
6741793|NCT03311841|7670102|FG001|COMPLETED|Period 1||7
6741794|NCT03311841|7670103|FG002|COMPLETED|Period 1||6
6741795|NCT03311841|7670104|FG003|COMPLETED|Period 1||7
6626997|NCT02237092|7554725|FG000|COMPLETED|Overall Study||196
6626998|NCT02237092|7554725|FG000|NOT COMPLETED|Overall Study||0
6626999|NCT02237118|7554742|FG000|STARTED|Overall Study||60
6741796|NCT03311841|7670105|FG004|COMPLETED|Period 1||6
6741797|NCT03311841|7670101|FG000|NOT COMPLETED|Period 1||0
6741798|NCT03311841|7670102|FG001|NOT COMPLETED|Period 1||0
6741799|NCT03311841|7670103|FG002|NOT COMPLETED|Period 1||0
6741800|NCT03311841|7670104|FG003|NOT COMPLETED|Period 1||0
6741801|NCT03311841|7670105|FG004|NOT COMPLETED|Period 1||0
6741802|NCT03311841|7670101|FG000|STARTED|14-day Wash-out||6
6741803|NCT03311841|7670102|FG001|STARTED|14-day Wash-out||7
6627000|NCT02237118|7554743|FG001|STARTED|Overall Study||63
6627001|NCT02237118|7554742|FG000|COMPLETED|Overall Study||59
6627002|NCT02237118|7554743|FG001|COMPLETED|Overall Study||62
6627003|NCT02237118|7554742|FG000|NOT COMPLETED|Overall Study||1
6627004|NCT02237118|7554743|FG001|NOT COMPLETED|Overall Study||1
6627005|NCT02237157|7554757|FG000|STARTED|Gemcitabine, Local Delivery (Dose 1)||20
6627006|NCT02237157|7554758|FG001|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
6627007|NCT02237157|7554759|FG002|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
6627008|NCT02237157|7554760|FG003|STARTED|Gemcitabine, Local Delivery (Dose 1)||0
6627009|NCT02237157|7554757|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||16
6627010|NCT02237157|7554758|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
6627011|NCT02237157|7554759|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
6627012|NCT02237157|7554760|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
6627013|NCT02237157|7554757|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||4
6627014|NCT02237157|7554758|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
6627015|NCT02237157|7554759|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
6627016|NCT02237157|7554760|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 1)||0
6627017|NCT02237157|7554757|FG000|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
6627018|NCT02237157|7554758|FG001|STARTED|Gemcitabine, Local Delivery (Dose 2)||15
6627019|NCT02237157|7554759|FG002|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
6627020|NCT02237157|7554760|FG003|STARTED|Gemcitabine, Local Delivery (Dose 2)||0
6627021|NCT02237157|7554757|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
6627022|NCT02237157|7554758|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||15
6627023|NCT02237157|7554759|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
6627024|NCT02237157|7554760|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
6627025|NCT02237157|7554757|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
6627026|NCT02237157|7554758|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
6627027|NCT02237157|7554759|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
6627028|NCT02237157|7554760|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 2)||0
6627029|NCT02237157|7554757|FG000|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
6741804|NCT03311841|7670103|FG002|STARTED|14-day Wash-out||6
6741805|NCT03311841|7670104|FG003|STARTED|14-day Wash-out||7
6741806|NCT03311841|7670105|FG004|STARTED|14-day Wash-out||6
6741807|NCT03311841|7670101|FG000|COMPLETED|14-day Wash-out||6
6627030|NCT02237157|7554758|FG001|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
6741808|NCT03311841|7670102|FG001|COMPLETED|14-day Wash-out||6
6741809|NCT03311841|7670103|FG002|COMPLETED|14-day Wash-out||6
6741810|NCT03311841|7670104|FG003|COMPLETED|14-day Wash-out||6
6741811|NCT03311841|7670105|FG004|COMPLETED|14-day Wash-out||6
6741812|NCT03311841|7670101|FG000|NOT COMPLETED|14-day Wash-out||0
6741813|NCT03311841|7670102|FG001|NOT COMPLETED|14-day Wash-out||1
6741814|NCT03311841|7670103|FG002|NOT COMPLETED|14-day Wash-out||0
6741815|NCT03311841|7670104|FG003|NOT COMPLETED|14-day Wash-out||1
6741816|NCT03311841|7670105|FG004|NOT COMPLETED|14-day Wash-out||0
6741817|NCT03311841|7670101|FG000|STARTED|Period 2||6
6741818|NCT03311841|7670102|FG001|STARTED|Period 2||6
6741819|NCT03311841|7670103|FG002|STARTED|Period 2||6
6741820|NCT03311841|7670104|FG003|STARTED|Period 2||6
6741821|NCT03311841|7670105|FG004|STARTED|Period 2||6
6741822|NCT03311841|7670101|FG000|COMPLETED|Period 2||6
6741823|NCT03311841|7670102|FG001|COMPLETED|Period 2||6
6627031|NCT02237157|7554759|FG002|STARTED|Gemcitabine, Local Delivery (Dose 3)||11
6627032|NCT02237157|7554760|FG003|STARTED|Gemcitabine, Local Delivery (Dose 3)||0
6627033|NCT02237157|7554757|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
6741824|NCT03311841|7670103|FG002|COMPLETED|Period 2||6
6741825|NCT03311841|7670104|FG003|COMPLETED|Period 2||6
6741826|NCT03311841|7670105|FG004|COMPLETED|Period 2||6
6741827|NCT03311841|7670101|FG000|NOT COMPLETED|Period 2||0
6741828|NCT03311841|7670102|FG001|NOT COMPLETED|Period 2||0
6741829|NCT03311841|7670103|FG002|NOT COMPLETED|Period 2||0
6741830|NCT03311841|7670104|FG003|NOT COMPLETED|Period 2||0
6741831|NCT03311841|7670105|FG004|NOT COMPLETED|Period 2||0
6741832|NCT03312023|7670130|FG000|STARTED|Overall Study||8
6741833|NCT03312023|7670131|FG001|STARTED|Overall Study||5
6741834|NCT03312023|7670132|FG002|STARTED|Overall Study||4
6741835|NCT03312023|7670133|FG003|STARTED|Overall Study||4
6741836|NCT03312023|7670130|FG000|Completed Week 12|Overall Study||8
6741837|NCT03312023|7670131|FG001|Completed Week 12|Overall Study||5
6741838|NCT03312023|7670132|FG002|Completed Week 12|Overall Study||4
6741839|NCT03312023|7670133|FG003|Completed Week 12|Overall Study||4
6741840|NCT03312023|7670130|FG000|COMPLETED|Overall Study||8
6741841|NCT03312023|7670131|FG001|COMPLETED|Overall Study||5
6741842|NCT03312023|7670132|FG002|COMPLETED|Overall Study||4
6741843|NCT03312023|7670133|FG003|COMPLETED|Overall Study||4
6741844|NCT03312023|7670130|FG000|NOT COMPLETED|Overall Study||0
6741845|NCT03312023|7670131|FG001|NOT COMPLETED|Overall Study||0
6741846|NCT03312023|7670132|FG002|NOT COMPLETED|Overall Study||0
6741847|NCT03312023|7670133|FG003|NOT COMPLETED|Overall Study||0
6741848|NCT03312114|7670144|FG000|STARTED|Overall Study||5
6741849|NCT03312114|7670144|FG000|COMPLETED|Overall Study||0
6741850|NCT03312114|7670144|FG000|NOT COMPLETED|Overall Study||5
6741851|NCT03312218|7670151|FG000|STARTED|Overall Study||335
6741852|NCT03312218|7670152|FG001|STARTED|Overall Study||299
6741853|NCT03312218|7670151|FG000|COMPLETED|Overall Study||281
6741854|NCT03312218|7670152|FG001|COMPLETED|Overall Study||241
6741855|NCT03312218|7670151|FG000|NOT COMPLETED|Overall Study||54
6741856|NCT03312218|7670152|FG001|NOT COMPLETED|Overall Study||58
6741857|NCT03312231|7670163|FG000|STARTED|Overall Study||184
6741858|NCT03312231|7670164|FG001|STARTED|Overall Study||176
6741859|NCT03312231|7670165|FG002|STARTED|Overall Study||181
6741860|NCT03312231|7670166|FG003|STARTED|Overall Study||89
6741861|NCT03312231|7670167|FG004|STARTED|Overall Study||90
6741862|NCT03312231|7670163|FG000|COMPLETED|Overall Study||181
6741863|NCT03312231|7670164|FG001|COMPLETED|Overall Study||165
6741864|NCT03312231|7670165|FG002|COMPLETED|Overall Study||177
6741865|NCT03312231|7670166|FG003|COMPLETED|Overall Study||86
6741866|NCT03312231|7670167|FG004|COMPLETED|Overall Study||89
6741867|NCT03312231|7670163|FG000|NOT COMPLETED|Overall Study||3
6741868|NCT03312231|7670164|FG001|NOT COMPLETED|Overall Study||11
6741869|NCT03312231|7670165|FG002|NOT COMPLETED|Overall Study||4
6741870|NCT03312231|7670166|FG003|NOT COMPLETED|Overall Study||3
6741871|NCT03312231|7670167|FG004|NOT COMPLETED|Overall Study||1
6741872|NCT03312348|7670179|FG000|STARTED|Overall Study||30
6741873|NCT03312348|7670179|FG000|COMPLETED|Overall Study||30
6741874|NCT03312348|7670179|FG000|NOT COMPLETED|Overall Study||0
6741875|NCT03312517|7670183|FG000|STARTED|Overall Study||2
6741876|NCT03312517|7670184|FG001|STARTED|Overall Study||2
6741877|NCT03312517|7670185|FG002|STARTED|Overall Study||2
6741878|NCT03312517|7670186|FG003|STARTED|Overall Study||2
6741879|NCT03312517|7670187|FG004|STARTED|Overall Study||2
6741880|NCT03312517|7670188|FG005|STARTED|Overall Study||2
6741881|NCT03312517|7670183|FG000|COMPLETED|Overall Study||2
6741882|NCT03312517|7670184|FG001|COMPLETED|Overall Study||2
6741883|NCT03312517|7670185|FG002|COMPLETED|Overall Study||2
6741884|NCT03312517|7670186|FG003|COMPLETED|Overall Study||2
6741885|NCT03312517|7670187|FG004|COMPLETED|Overall Study||2
6741886|NCT03312517|7670188|FG005|COMPLETED|Overall Study||2
6741887|NCT03312517|7670183|FG000|NOT COMPLETED|Overall Study||0
6741888|NCT03312517|7670184|FG001|NOT COMPLETED|Overall Study||0
6741889|NCT03312517|7670185|FG002|NOT COMPLETED|Overall Study||0
6741890|NCT03312517|7670186|FG003|NOT COMPLETED|Overall Study||0
6741891|NCT03312517|7670187|FG004|NOT COMPLETED|Overall Study||0
6741892|NCT03312517|7670188|FG005|NOT COMPLETED|Overall Study||0
6741893|NCT03312543|7670198|FG000|STARTED|Before Treatment (Screening to Baseline)||61
6741894|NCT03312543|7670199|FG001|STARTED|Before Treatment (Screening to Baseline)||63
6741895|NCT03312543|7670198|FG000|COMPLETED|Before Treatment (Screening to Baseline)||60
6741896|NCT03312543|7670199|FG001|COMPLETED|Before Treatment (Screening to Baseline)||59
6741897|NCT03312543|7670198|FG000|NOT COMPLETED|Before Treatment (Screening to Baseline)||1
6741898|NCT03312543|7670199|FG001|NOT COMPLETED|Before Treatment (Screening to Baseline)||4
6741899|NCT03312543|7670198|FG000|STARTED|Treatment (Baseline to Week 12)||60
6741900|NCT03312543|7670199|FG001|STARTED|Treatment (Baseline to Week 12)||59
6741901|NCT03312543|7670198|FG000|COMPLETED|Treatment (Baseline to Week 12)||56
6741902|NCT03312543|7670199|FG001|COMPLETED|Treatment (Baseline to Week 12)||54
6627034|NCT02237157|7554758|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
6627035|NCT02237157|7554759|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||11
6627036|NCT02237157|7554760|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
6627037|NCT02237157|7554757|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
6627038|NCT02237157|7554758|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
6627039|NCT02237157|7554759|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
6627040|NCT02237157|7554760|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 3)||0
6627041|NCT02237157|7554757|FG000|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
6627042|NCT02237157|7554758|FG001|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
6627043|NCT02237157|7554759|FG002|STARTED|Gemcitabine, Local Delivery (Dose 4)||0
6627044|NCT02237157|7554760|FG003|STARTED|Gemcitabine, Local Delivery (Dose 4)||8
6627045|NCT02237157|7554757|FG000|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
6627046|NCT02237157|7554758|FG001|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
6627047|NCT02237157|7554759|FG002|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
6627048|NCT02237157|7554760|FG003|COMPLETED|Gemcitabine, Local Delivery (Dose 4)||8
6627049|NCT02237157|7554757|FG000|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
6627050|NCT02237157|7554758|FG001|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
6627051|NCT02237157|7554759|FG002|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
6627052|NCT02237157|7554760|FG003|NOT COMPLETED|Gemcitabine, Local Delivery (Dose 4)||0
6627053|NCT02237196|7554771|FG000|STARTED|Overall Study||32
6627054|NCT02237196|7554772|FG001|STARTED|Overall Study||31
6627055|NCT02237196|7554773|FG002|STARTED|Overall Study||30
6627056|NCT02237196|7554774|FG003|STARTED|Overall Study||28
6627057|NCT02237196|7554771|FG000|COMPLETED|Overall Study||24
6627058|NCT02237196|7554772|FG001|COMPLETED|Overall Study||25
6627059|NCT02237196|7554773|FG002|COMPLETED|Overall Study||20
6627060|NCT02237196|7554774|FG003|COMPLETED|Overall Study||17
6627061|NCT02237196|7554771|FG000|NOT COMPLETED|Overall Study||8
6627062|NCT02237196|7554772|FG001|NOT COMPLETED|Overall Study||6
6627063|NCT02237196|7554773|FG002|NOT COMPLETED|Overall Study||10
6627064|NCT02237196|7554774|FG003|NOT COMPLETED|Overall Study||11
6627065|NCT02237417|7554787|FG000|STARTED|Overall Study||16
6627066|NCT02237417|7554788|FG001|STARTED|Overall Study||15
6627067|NCT02237417|7554789|FG002|STARTED|Overall Study||16
6627068|NCT02237417|7554787|FG000|COMPLETED|Overall Study||16
6627069|NCT02237417|7554788|FG001|COMPLETED|Overall Study||9
6627070|NCT02237417|7554789|FG002|COMPLETED|Overall Study||7
6627071|NCT02237417|7554787|FG000|NOT COMPLETED|Overall Study||0
6627072|NCT02237417|7554788|FG001|NOT COMPLETED|Overall Study||6
6627073|NCT02237417|7554789|FG002|NOT COMPLETED|Overall Study||9
6627074|NCT02237898|7554799|FG000|STARTED|Overall Study||12
6627075|NCT02237898|7554800|FG001|STARTED|Overall Study||14
6627076|NCT02237898|7554799|FG000|Completed 12 Weeks of CM|Overall Study||7
6627077|NCT02237898|7554800|FG001|Completed 12 Weeks of CM|Overall Study||2
6627078|NCT02237898|7554799|FG000|Completed 3 Month Follow-up|Overall Study||6
6627079|NCT02237898|7554800|FG001|Completed 3 Month Follow-up|Overall Study||6
6627080|NCT02237898|7554799|FG000|Completed 9 Month Follow-up|Overall Study||6
6627081|NCT02237898|7554800|FG001|Completed 9 Month Follow-up|Overall Study||7
6627082|NCT02237898|7554799|FG000|Completed 15 Month Follow-up|Overall Study||8
6627083|NCT02237898|7554800|FG001|Completed 15 Month Follow-up|Overall Study||8
6627084|NCT02237898|7554799|FG000|COMPLETED|Overall Study||5
6627085|NCT02237898|7554800|FG001|COMPLETED|Overall Study||2
6627086|NCT02237898|7554799|FG000|NOT COMPLETED|Overall Study||7
6627087|NCT02237898|7554800|FG001|NOT COMPLETED|Overall Study||12
6627088|NCT02237911|7554811|FG000|STARTED|Overall Study||96
6627089|NCT02237911|7554812|FG001|STARTED|Overall Study||96
6627090|NCT02237911|7554813|FG002|STARTED|Overall Study||48
6627091|NCT02237911|7554811|FG000|3 Months|Overall Study||90
6627092|NCT02237911|7554812|FG001|3 Months|Overall Study||87
6627093|NCT02237911|7554813|FG002|3 Months|Overall Study||44
6627094|NCT02237911|7554811|FG000|6 Months|Overall Study||89
6627095|NCT02237911|7554812|FG001|6 Months|Overall Study||88
6627096|NCT02237911|7554813|FG002|6 Months|Overall Study||45
6627097|NCT02237911|7554811|FG000|COMPLETED|Overall Study||89
6627098|NCT02237911|7554812|FG001|COMPLETED|Overall Study||88
6627099|NCT02237911|7554813|FG002|COMPLETED|Overall Study||45
6627100|NCT02237911|7554811|FG000|NOT COMPLETED|Overall Study||7
6627101|NCT02237911|7554812|FG001|NOT COMPLETED|Overall Study||8
6627102|NCT02237911|7554813|FG002|NOT COMPLETED|Overall Study||3
6627103|NCT02237950|7554823|FG000|STARTED|Overall Study||295
6627104|NCT02237950|7554824|FG001|STARTED|Overall Study||291
6627105|NCT02237950|7554823|FG000|COMPLETED|Overall Study||247
6627106|NCT02237950|7554824|FG001|COMPLETED|Overall Study||243
6627107|NCT02237950|7554823|FG000|NOT COMPLETED|Overall Study||48
6627108|NCT02237950|7554824|FG001|NOT COMPLETED|Overall Study||48
6627109|NCT02237989|7554832|FG000|STARTED|Overall Study||19
6627110|NCT02237989|7554833|FG001|STARTED|Overall Study||20
6627111|NCT02237989|7554832|FG000|COMPLETED|Overall Study||19
6627112|NCT02237989|7554833|FG001|COMPLETED|Overall Study||20
6627113|NCT02237989|7554832|FG000|NOT COMPLETED|Overall Study||0
6741903|NCT03312543|7670198|FG000|NOT COMPLETED|Treatment (Baseline to Week 12)||4
6741904|NCT03312543|7670199|FG001|NOT COMPLETED|Treatment (Baseline to Week 12)||5
6627114|NCT02237989|7554833|FG001|NOT COMPLETED|Overall Study||0
6627115|NCT02238028|7554839|FG000|STARTED|Overall Study||14
6627116|NCT02238028|7554840|FG001|STARTED|Overall Study||14
6627117|NCT02238028|7554839|FG000|COMPLETED|Overall Study||12
6627118|NCT02238028|7554840|FG001|COMPLETED|Overall Study||12
6627119|NCT02238028|7554839|FG000|NOT COMPLETED|Overall Study||2
6627120|NCT02238028|7554840|FG001|NOT COMPLETED|Overall Study||2
6627121|NCT02238067|7554851|FG000|STARTED|Overall Study||196
6627122|NCT02238067|7554851|FG000|COMPLETED|Overall Study||151
6627123|NCT02238067|7554851|FG000|NOT COMPLETED|Overall Study||45
6627124|NCT02238080|7554855|FG000|STARTED|Overall Study||197
6627125|NCT02238080|7554855|FG000|COMPLETED|Overall Study||172
6627126|NCT02238080|7554855|FG000|NOT COMPLETED|Overall Study||25
6627127|NCT02238379|7554861|FG000|STARTED|Overall Study||12
6627128|NCT02238379|7554862|FG001|STARTED|Overall Study||14
6627129|NCT02238379|7554861|FG000|COMPLETED|Overall Study||11
6627130|NCT02238379|7554862|FG001|COMPLETED|Overall Study||14
6627131|NCT02238379|7554861|FG000|NOT COMPLETED|Overall Study||1
6627132|NCT02238379|7554862|FG001|NOT COMPLETED|Overall Study||0
6627133|NCT02238483|7554870|FG000|STARTED|Overall Study||108
6627134|NCT02238483|7554871|FG001|STARTED|Overall Study||105
6627135|NCT02238483|7554870|FG000|COMPLETED|Overall Study||93
6627136|NCT02238483|7554871|FG001|COMPLETED|Overall Study||91
6627137|NCT02238483|7554870|FG000|NOT COMPLETED|Overall Study||15
6627138|NCT02238483|7554871|FG001|NOT COMPLETED|Overall Study||14
6627139|NCT02238626|7554881|FG000|STARTED|Overall Study||17
6627140|NCT02238626|7554882|FG001|STARTED|Overall Study||34
6627141|NCT02238626|7554883|FG002|STARTED|Overall Study||8
6627142|NCT02238626|7554884|FG003|STARTED|Overall Study||11
6627143|NCT02238626|7554881|FG000|COMPLETED|Overall Study||12
6627144|NCT02238626|7554882|FG001|COMPLETED|Overall Study||20
6627145|NCT02238626|7554883|FG002|COMPLETED|Overall Study||5
6627146|NCT02238626|7554884|FG003|COMPLETED|Overall Study||4
6627147|NCT02238626|7554881|FG000|NOT COMPLETED|Overall Study||5
6627148|NCT02238626|7554882|FG001|NOT COMPLETED|Overall Study||14
6627149|NCT02238626|7554883|FG002|NOT COMPLETED|Overall Study||3
6627150|NCT02238626|7554884|FG003|NOT COMPLETED|Overall Study||7
6627151|NCT02238782|7554905|FG000|STARTED|Overall Study||12
6627152|NCT02238782|7554905|FG000|Subjects Treated|Overall Study||12
6627153|NCT02238782|7554905|FG000|COMPLETED|Overall Study||12
6627154|NCT02238782|7554905|FG000|NOT COMPLETED|Overall Study||0
6627155|NCT02238847|7554911|FG000|STARTED|Overall Study||59
6627156|NCT02238847|7554912|FG001|STARTED|Overall Study||60
6627157|NCT02238847|7554911|FG000|COMPLETED|Overall Study||37
6627158|NCT02238847|7554912|FG001|COMPLETED|Overall Study||36
6627159|NCT02238847|7554911|FG000|NOT COMPLETED|Overall Study||22
6627160|NCT02238847|7554912|FG001|NOT COMPLETED|Overall Study||24
6627161|NCT02238925|7554918|FG000|STARTED|Overall Study||26
6627162|NCT02238925|7554918|FG000|COMPLETED|Overall Study||1
6627163|NCT02238925|7554918|FG000|NOT COMPLETED|Overall Study||25
6627164|NCT02238977|7554924|FG000|STARTED|Overall Study||0
6627165|NCT02238977|7554925|FG001|STARTED|Overall Study||1
6627166|NCT02238977|7554924|FG000|COMPLETED|Overall Study||0
6627167|NCT02238977|7554925|FG001|COMPLETED|Overall Study||1
6627168|NCT02238977|7554924|FG000|NOT COMPLETED|Overall Study||0
6627169|NCT02238977|7554925|FG001|NOT COMPLETED|Overall Study||0
6627170|NCT02239094|7554931|FG000|STARTED|Overall Study||20
6627171|NCT02239094|7554931|FG000|COMPLETED|Overall Study||18
6627172|NCT02239094|7554931|FG000|NOT COMPLETED|Overall Study||2
6627173|NCT02239120|7554937|FG000|STARTED|Overall Study||2695
6627174|NCT02239120|7554938|FG001|STARTED|Overall Study||2695
6627175|NCT02239120|7554937|FG000|COMPLETED|Overall Study||2620
6627176|NCT02239120|7554938|FG001|COMPLETED|Overall Study||2623
6627177|NCT02239120|7554937|FG000|NOT COMPLETED|Overall Study||75
6627178|NCT02239120|7554938|FG001|NOT COMPLETED|Overall Study||72
6627179|NCT02239224|7554948|FG000|STARTED|Overall Study||3
6627180|NCT02239224|7554949|FG001|STARTED|Overall Study||6
6627181|NCT02239224|7554950|FG002|STARTED|Overall Study||6
6627182|NCT02239224|7554951|FG003|STARTED|Overall Study||5
6627183|NCT02239224|7554948|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6627184|NCT02239224|7554949|FG001|Received at Least One Dose of Study Drug|Overall Study||6
6627185|NCT02239224|7554950|FG002|Received at Least One Dose of Study Drug|Overall Study||6
6627186|NCT02239224|7554951|FG003|Received at Least One Dose of Study Drug|Overall Study||5
6741905|NCT03312543|7670198|FG000|STARTED|Regression (Week 12 to Week 24)||56
6627187|NCT02239224|7554948|FG000|COMPLETED|Overall Study||3
6627188|NCT02239224|7554949|FG001|COMPLETED|Overall Study||6
6627189|NCT02239224|7554950|FG002|COMPLETED|Overall Study||3
6627190|NCT02239224|7554951|FG003|COMPLETED|Overall Study||4
6627191|NCT02239224|7554948|FG000|NOT COMPLETED|Overall Study||0
6627192|NCT02239224|7554949|FG001|NOT COMPLETED|Overall Study||0
6627193|NCT02239224|7554950|FG002|NOT COMPLETED|Overall Study||3
6627194|NCT02239224|7554951|FG003|NOT COMPLETED|Overall Study||1
6627195|NCT02239263|7554961|FG000|STARTED|Overall Study||40
6627196|NCT02239263|7554961|FG000|COMPLETED|Overall Study||34
6627197|NCT02239263|7554961|FG000|NOT COMPLETED|Overall Study||6
6627198|NCT02239289|7554967|FG000|STARTED|Overall Study||21
6627199|NCT02239289|7554967|FG000|COMPLETED|Overall Study||21
6627200|NCT02239289|7554967|FG000|NOT COMPLETED|Overall Study||0
6627201|NCT02239328|7554971|FG000|STARTED|Overall Study||182
6627202|NCT02239328|7554971|FG000|COMPLETED|Overall Study||174
6627203|NCT02239328|7554971|FG000|NOT COMPLETED|Overall Study||8
6627204|NCT02239380|7554975|FG000|STARTED|Overall Study||26
6627205|NCT02239380|7554975|FG000|COMPLETED|Overall Study||26
6741906|NCT03312543|7670199|FG001|STARTED|Regression (Week 12 to Week 24)||54
6741907|NCT03312543|7670198|FG000|COMPLETED|Regression (Week 12 to Week 24)||55
6741908|NCT03312543|7670199|FG001|COMPLETED|Regression (Week 12 to Week 24)||52
6741909|NCT03312543|7670198|FG000|NOT COMPLETED|Regression (Week 12 to Week 24)||1
6741910|NCT03312543|7670199|FG001|NOT COMPLETED|Regression (Week 12 to Week 24)||2
6741911|NCT03312595|7670205|FG000|STARTED|Overall Study||30
6741912|NCT03312595|7670205|FG000|COMPLETED|Overall Study||24
6741913|NCT03312595|7670205|FG000|NOT COMPLETED|Overall Study||6
6741914|NCT03312933|7670209|FG000|STARTED|Overall Study||100
6627206|NCT02239380|7554975|FG000|NOT COMPLETED|Overall Study||0
6627207|NCT02239510|7554981|FG000|STARTED|Overall Study||5
6627208|NCT02239510|7554982|FG001|STARTED|Overall Study||4
6627209|NCT02239510|7554981|FG000|COMPLETED|Overall Study||3
6627210|NCT02239510|7554982|FG001|COMPLETED|Overall Study||3
6627211|NCT02239510|7554981|FG000|NOT COMPLETED|Overall Study||2
6627212|NCT02239510|7554982|FG001|NOT COMPLETED|Overall Study||1
6627213|NCT02239536|7554990|FG000|STARTED|Overall Study||190
6627214|NCT02239536|7554991|FG001|STARTED|Overall Study||172
6627215|NCT02239536|7554990|FG000|COMPLETED|Overall Study||167
6627216|NCT02239536|7554991|FG001|COMPLETED|Overall Study||155
6627217|NCT02239536|7554990|FG000|NOT COMPLETED|Overall Study||23
6627218|NCT02239536|7554991|FG001|NOT COMPLETED|Overall Study||17
6627219|NCT02239562|7555003|FG000|STARTED|Overall Study||6
6627220|NCT02239562|7555004|FG001|STARTED|Overall Study||6
6627221|NCT02239562|7555005|FG002|STARTED|Overall Study||6
6627222|NCT02239562|7555006|FG003|STARTED|Overall Study||6
6627223|NCT02239562|7555007|FG004|STARTED|Overall Study||6
6627224|NCT02239562|7555008|FG005|STARTED|Overall Study||6
6627225|NCT02239562|7555003|FG000|COMPLETED|Overall Study||6
6627226|NCT02239562|7555004|FG001|COMPLETED|Overall Study||6
6627227|NCT02239562|7555005|FG002|COMPLETED|Overall Study||6
6627228|NCT02239562|7555006|FG003|COMPLETED|Overall Study||6
6627229|NCT02239562|7555007|FG004|COMPLETED|Overall Study||6
6627230|NCT02239562|7555008|FG005|COMPLETED|Overall Study||6
6627231|NCT02239562|7555003|FG000|NOT COMPLETED|Overall Study||0
6627232|NCT02239562|7555004|FG001|NOT COMPLETED|Overall Study||0
6627233|NCT02239562|7555005|FG002|NOT COMPLETED|Overall Study||0
6627234|NCT02239562|7555006|FG003|NOT COMPLETED|Overall Study||0
6627235|NCT02239562|7555007|FG004|NOT COMPLETED|Overall Study||0
6627236|NCT02239562|7555008|FG005|NOT COMPLETED|Overall Study||0
6627237|NCT02239601|7555026|FG000|STARTED|Overall Study||29
6627238|NCT02239601|7555027|FG001|STARTED|Overall Study||32
6627239|NCT02239601|7555026|FG000|COMPLETED|Overall Study||22
6627240|NCT02239601|7555027|FG001|COMPLETED|Overall Study||26
6627241|NCT02239601|7555026|FG000|NOT COMPLETED|Overall Study||7
6627242|NCT02239601|7555027|FG001|NOT COMPLETED|Overall Study||6
6627243|NCT02239640|7555038|FG000|STARTED|Overall Study||984
6627244|NCT02239640|7555038|FG000|COMPLETED|Overall Study||767
6627245|NCT02239640|7555038|FG000|NOT COMPLETED|Overall Study||217
6627246|NCT02239679|7555051|FG000|STARTED|Overall Study||53
6627247|NCT02239679|7555052|FG001|STARTED|Overall Study||59
6627248|NCT02239679|7555053|FG002|STARTED|Overall Study||54
6627249|NCT02239679|7555051|FG000|COMPLETED|Overall Study||50
6627250|NCT02239679|7555052|FG001|COMPLETED|Overall Study||56
6627251|NCT02239679|7555053|FG002|COMPLETED|Overall Study||53
6627252|NCT02239679|7555051|FG000|NOT COMPLETED|Overall Study||3
6627253|NCT02239679|7555052|FG001|NOT COMPLETED|Overall Study||3
6627254|NCT02239679|7555053|FG002|NOT COMPLETED|Overall Study||1
6627255|NCT02239692|7555063|FG000|STARTED|Overall Study||73
6627256|NCT02239692|7555064|FG001|STARTED|Overall Study||131
6627257|NCT02239692|7555063|FG000|Intention-to-treat Analysis Set|Overall Study||73
6627258|NCT02239692|7555064|FG001|Intention-to-treat Analysis Set|Overall Study||131
6627259|NCT02239692|7555063|FG000|Per-protocol Analysis Set|Overall Study||66
6627260|NCT02239692|7555064|FG001|Per-protocol Analysis Set|Overall Study||120
6627261|NCT02239692|7555063|FG000|Safety Analysis Set|Overall Study||70
6627262|NCT02239692|7555064|FG001|Safety Analysis Set|Overall Study||125
6627263|NCT02239692|7555063|FG000|COMPLETED|Overall Study||67
6627264|NCT02239692|7555064|FG001|COMPLETED|Overall Study||118
6627265|NCT02239692|7555063|FG000|NOT COMPLETED|Overall Study||6
6627266|NCT02239692|7555064|FG001|NOT COMPLETED|Overall Study||13
6627267|NCT02239744|7555072|FG000|STARTED|Period 1||17
6627268|NCT02239744|7555073|FG001|STARTED|Period 1||18
6627269|NCT02239744|7555072|FG000|COMPLETED|Period 1||17
6627270|NCT02239744|7555073|FG001|COMPLETED|Period 1||18
6627271|NCT02239744|7555072|FG000|NOT COMPLETED|Period 1||0
6627272|NCT02239744|7555073|FG001|NOT COMPLETED|Period 1||0
6627273|NCT02239744|7555072|FG000|STARTED|Period 2||17
6627274|NCT02239744|7555073|FG001|STARTED|Period 2||18
6741915|NCT03312933|7670209|FG000|COMPLETED|Overall Study||46
6627275|NCT02239744|7555072|FG000|COMPLETED|Period 2||17
6627276|NCT02239744|7555073|FG001|COMPLETED|Period 2||18
6627277|NCT02239744|7555072|FG000|NOT COMPLETED|Period 2||0
6627278|NCT02239744|7555073|FG001|NOT COMPLETED|Period 2||0
6627279|NCT02239770|7555086|FG000|STARTED|Part 1||4
6627280|NCT02239770|7555087|FG001|STARTED|Part 1||4
6627281|NCT02239770|7555088|FG002|STARTED|Part 1||4
6627282|NCT02239770|7555089|FG003|STARTED|Part 1||0
6627283|NCT02239770|7555090|FG004|STARTED|Part 1||0
6627284|NCT02239770|7555091|FG005|STARTED|Part 1||0
6741916|NCT03312933|7670209|FG000|NOT COMPLETED|Overall Study||54
6741917|NCT03313037|7670215|FG000|STARTED|Overall Study||222
6741918|NCT03313037|7670216|FG001|STARTED|Overall Study||222
6741919|NCT03313037|7670215|FG000|Safety Population|Overall Study||221
6741920|NCT03313037|7670216|FG001|Safety Population|Overall Study||222
6741921|NCT03313037|7670215|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||210
6741922|NCT03313037|7670216|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||208
6741923|NCT03313037|7670215|FG000|COMPLETED|Overall Study||202
6741924|NCT03313037|7670216|FG001|COMPLETED|Overall Study||202
6741925|NCT03313037|7670215|FG000|NOT COMPLETED|Overall Study||20
6741926|NCT03313037|7670216|FG001|NOT COMPLETED|Overall Study||20
6741927|NCT03313050|7670226|FG000|STARTED|Stage 1: 6 Months||34
6741928|NCT03313050|7670227|FG001|STARTED|Stage 1: 6 Months||32
6741929|NCT03313050|7670228|FG002|STARTED|Stage 1: 6 Months||0
6741930|NCT03313050|7670229|FG003|STARTED|Stage 1: 6 Months||0
6741931|NCT03313050|7670226|FG000|Vaccinated|Stage 1: 6 Months||34
6741932|NCT03313050|7670227|FG001|Vaccinated|Stage 1: 6 Months||32
6741933|NCT03313050|7670228|FG002|Vaccinated|Stage 1: 6 Months||0
6741934|NCT03313050|7670229|FG003|Vaccinated|Stage 1: 6 Months||0
6741935|NCT03313050|7670226|FG000|COMPLETED|Stage 1: 6 Months||34
6741936|NCT03313050|7670227|FG001|COMPLETED|Stage 1: 6 Months||32
6741937|NCT03313050|7670228|FG002|COMPLETED|Stage 1: 6 Months||0
6741938|NCT03313050|7670229|FG003|COMPLETED|Stage 1: 6 Months||0
6741939|NCT03313050|7670226|FG000|NOT COMPLETED|Stage 1: 6 Months||0
6741940|NCT03313050|7670227|FG001|NOT COMPLETED|Stage 1: 6 Months||0
6741941|NCT03313050|7670228|FG002|NOT COMPLETED|Stage 1: 6 Months||0
6741942|NCT03313050|7670229|FG003|NOT COMPLETED|Stage 1: 6 Months||0
6741943|NCT03313050|7670226|FG000|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
6741944|NCT03313050|7670227|FG001|STARTED|Stage 2: 12 Months|Stage 1 participants did not continue in Stage 2.|0
6741945|NCT03313050|7670228|FG002|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|221
6741946|NCT03313050|7670229|FG003|STARTED|Stage 2: 12 Months|After Stage 1 safety was acceptable then Stage 2 followed with newer participants.|224
6741947|NCT03313050|7670226|FG000|Vaccinated|Stage 2: 12 Months||0
6741948|NCT03313050|7670227|FG001|Vaccinated|Stage 2: 12 Months||0
6741949|NCT03313050|7670228|FG002|Vaccinated|Stage 2: 12 Months||221
6741950|NCT03313050|7670229|FG003|Vaccinated|Stage 2: 12 Months||223
6741951|NCT03313050|7670226|FG000|COMPLETED|Stage 2: 12 Months||0
6741952|NCT03313050|7670227|FG001|COMPLETED|Stage 2: 12 Months||0
6741953|NCT03313050|7670228|FG002|COMPLETED|Stage 2: 12 Months||210
6741954|NCT03313050|7670229|FG003|COMPLETED|Stage 2: 12 Months||204
6741955|NCT03313050|7670226|FG000|NOT COMPLETED|Stage 2: 12 Months||0
6741956|NCT03313050|7670227|FG001|NOT COMPLETED|Stage 2: 12 Months||0
6741957|NCT03313050|7670228|FG002|NOT COMPLETED|Stage 2: 12 Months||11
6741958|NCT03313050|7670229|FG003|NOT COMPLETED|Stage 2: 12 Months||20
6741959|NCT03313076|7670243|FG000|STARTED|Overall Study||7
6741960|NCT03313076|7670244|FG001|STARTED|Overall Study||6
6741961|NCT03313076|7670245|FG002|STARTED|Overall Study||6
6741962|NCT03313076|7670246|FG003|STARTED|Overall Study||5
6741963|NCT03313076|7670243|FG000|COMPLETED|Overall Study||5
6741964|NCT03313076|7670244|FG001|COMPLETED|Overall Study||4
6741965|NCT03313076|7670245|FG002|COMPLETED|Overall Study||4
6741966|NCT03313076|7670246|FG003|COMPLETED|Overall Study||3
6741967|NCT03313076|7670243|FG000|NOT COMPLETED|Overall Study||2
6741968|NCT03313076|7670244|FG001|NOT COMPLETED|Overall Study||2
6741969|NCT03313076|7670245|FG002|NOT COMPLETED|Overall Study||2
6741970|NCT03313076|7670246|FG003|NOT COMPLETED|Overall Study||2
6741971|NCT03313310|7670264|FG000|STARTED|Phase 2||51
6741972|NCT03313310|7670265|FG001|STARTED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
6741973|NCT03313310|7670264|FG000|COMPLETED|Phase 2||47
6741974|NCT03313310|7670265|FG001|COMPLETED|Phase 2|Phase 2 participants did not participate in Phase 3.|0
6741975|NCT03313310|7670264|FG000|NOT COMPLETED|Phase 2||4
6741976|NCT03313310|7670265|FG001|NOT COMPLETED|Phase 2||0
6282362|NCT00182325|7182654|FG001|STARTED|Overall Study||96
6398992|NCT00878553|7311657|FG003|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
6398993|NCT00878553|7311658|FG004|COMPLETED|PK Study||15
6398994|NCT00878553|7311654|FG000|NOT COMPLETED|PK Study||0
6398995|NCT00878553|7311655|FG001|NOT COMPLETED|PK Study||0
6398996|NCT00878553|7311656|FG002|NOT COMPLETED|PK Study||0
6398997|NCT00878553|7311657|FG003|NOT COMPLETED|PK Study||1
6398998|NCT00878553|7311658|FG004|NOT COMPLETED|PK Study||0
6398999|NCT00878644|7311677|FG000|STARTED|Overall Study||155
6399000|NCT00878644|7311678|FG001|STARTED|Overall Study||140
6399001|NCT00878644|7311677|FG000|COMPLETED|Overall Study||151
6399002|NCT00878644|7311678|FG001|COMPLETED|Overall Study||136
6399003|NCT00878644|7311677|FG000|NOT COMPLETED|Overall Study||4
6399004|NCT00878644|7311678|FG001|NOT COMPLETED|Overall Study||4
6399005|NCT00878709|7311686|FG000|STARTED|Overall Study||1420
6399006|NCT00878709|7311687|FG001|STARTED|Overall Study||1420
6399007|NCT00878709|7311686|FG000|COMPLETED|Overall Study||1095
6399008|NCT00878709|7311687|FG001|COMPLETED|Overall Study||1183
6399009|NCT00878709|7311686|FG000|NOT COMPLETED|Overall Study||325
6399010|NCT00878709|7311687|FG001|NOT COMPLETED|Overall Study||237
6399011|NCT00878722|7311702|FG000|STARTED|Overall Study||3
6741977|NCT03313310|7670264|FG000|STARTED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
6741978|NCT03313310|7670265|FG001|STARTED|Phase 3||41
6779581|NCT03728790|7707744|FG000|NOT COMPLETED|Overall Study||0
6399012|NCT00878722|7311703|FG001|STARTED|Overall Study||3
6741979|NCT03313310|7670264|FG000|COMPLETED|Phase 3|Phase 3 participants did not participate in Phase 2.|0
6741980|NCT03313310|7670265|FG001|COMPLETED|Phase 3||40
6741981|NCT03313310|7670264|FG000|NOT COMPLETED|Phase 3||0
6741982|NCT03313310|7670265|FG001|NOT COMPLETED|Phase 3||1
6741983|NCT03314233|7670271|FG000|STARTED|Overall Study|21 mothers provided informed consent for participation in the trial.|21
6741984|NCT03314233|7670271|FG000|COMPLETED|Overall Study|20 mothers who had provided informed consent met eligibility criteria at time of delivery.|20
6741985|NCT03314233|7670271|FG000|NOT COMPLETED|Overall Study||1
6741986|NCT03314519|7670277|FG000|STARTED|Overall Study||100
6741987|NCT03314519|7670278|FG001|STARTED|Overall Study||100
6741988|NCT03314519|7670277|FG000|COMPLETED|Overall Study||97
6741989|NCT03314519|7670278|FG001|COMPLETED|Overall Study||98
6741990|NCT03314519|7670277|FG000|NOT COMPLETED|Overall Study||3
6741991|NCT03314519|7670278|FG001|NOT COMPLETED|Overall Study||2
6741992|NCT03314662|7670287|FG000|STARTED|Overall Study||889
6741993|NCT03314662|7670288|FG001|STARTED|Overall Study||445
6741994|NCT03314662|7670289|FG002|STARTED|Overall Study||444
6741995|NCT03314662|7670287|FG000|Treated|Overall Study||888
6741996|NCT03314662|7670288|FG001|Treated|Overall Study||444
6741997|NCT03314662|7670289|FG002|Treated|Overall Study||444
6741998|NCT03314662|7670287|FG000|COMPLETED|Overall Study||881
6741999|NCT03314662|7670288|FG001|COMPLETED|Overall Study||440
6742000|NCT03314662|7670289|FG002|COMPLETED|Overall Study||439
6742001|NCT03314662|7670287|FG000|NOT COMPLETED|Overall Study||8
6742002|NCT03314662|7670288|FG001|NOT COMPLETED|Overall Study||5
6742003|NCT03314662|7670289|FG002|NOT COMPLETED|Overall Study||5
6742004|NCT03314753|7670307|FG000|STARTED|Overall Study||53
6742005|NCT03314753|7670308|FG001|STARTED|Overall Study||36
6742006|NCT03314753|7670307|FG000|COMPLETED|Overall Study||53
6742007|NCT03314753|7670308|FG001|COMPLETED|Overall Study||36
6742008|NCT03314753|7670307|FG000|NOT COMPLETED|Overall Study||0
6742009|NCT03314753|7670308|FG001|NOT COMPLETED|Overall Study||0
6742010|NCT03314857|7670314|FG000|STARTED|Overall Study||67
6742011|NCT03314857|7670314|FG000|Analysis Population|Overall Study||61
6742012|NCT03314857|7670314|FG000|COMPLETED|Overall Study|62/67 patients completed the 30-day primary endpoint visit.|62
6742013|NCT03314857|7670314|FG000|NOT COMPLETED|Overall Study||5
6742014|NCT03315104|7670321|FG000|STARTED|Overall Study||21
6742015|NCT03315104|7670322|FG001|STARTED|Overall Study||20
6742016|NCT03315104|7670323|FG002|STARTED|Overall Study||24
6742017|NCT03315104|7670321|FG000|Dosed (Safety Population)|Overall Study||19
6742018|NCT03315104|7670322|FG001|Dosed (Safety Population)|Overall Study||19
6742019|NCT03315104|7670323|FG002|Dosed (Safety Population)|Overall Study||22
6742020|NCT03315104|7670321|FG000|COMPLETED|Overall Study||18
6742021|NCT03315104|7670322|FG001|COMPLETED|Overall Study||16
6742022|NCT03315104|7670323|FG002|COMPLETED|Overall Study||19
6742023|NCT03315104|7670321|FG000|NOT COMPLETED|Overall Study||3
6742024|NCT03315104|7670322|FG001|NOT COMPLETED|Overall Study||4
6742025|NCT03315104|7670323|FG002|NOT COMPLETED|Overall Study||5
6742026|NCT03315208|7670333|FG000|STARTED|Overall Study||29
6742027|NCT03315208|7670334|FG001|STARTED|Overall Study||18
6742028|NCT03315208|7670333|FG000|COMPLETED|Overall Study||16
6627285|NCT02239770|7555086|FG000|COMPLETED|Part 1||4
6627286|NCT02239770|7555087|FG001|COMPLETED|Part 1||4
6627287|NCT02239770|7555088|FG002|COMPLETED|Part 1||4
6627288|NCT02239770|7555089|FG003|COMPLETED|Part 1||0
6627289|NCT02239770|7555090|FG004|COMPLETED|Part 1||0
6627290|NCT02239770|7555091|FG005|COMPLETED|Part 1||0
6627291|NCT02239770|7555086|FG000|NOT COMPLETED|Part 1||0
6627292|NCT02239770|7555087|FG001|NOT COMPLETED|Part 1||0
6627293|NCT02239770|7555088|FG002|NOT COMPLETED|Part 1||0
6627294|NCT02239770|7555089|FG003|NOT COMPLETED|Part 1||0
6627295|NCT02239770|7555090|FG004|NOT COMPLETED|Part 1||0
6627296|NCT02239770|7555091|FG005|NOT COMPLETED|Part 1||0
6627297|NCT02239770|7555086|FG000|STARTED|Part 2||0
6627298|NCT02239770|7555087|FG001|STARTED|Part 2||0
6627299|NCT02239770|7555088|FG002|STARTED|Part 2||0
6627300|NCT02239770|7555089|FG003|STARTED|Part 2||4
6627301|NCT02239770|7555090|FG004|STARTED|Part 2||4
6627302|NCT02239770|7555091|FG005|STARTED|Part 2||4
6627303|NCT02239770|7555086|FG000|COMPLETED|Part 2||0
6627304|NCT02239770|7555087|FG001|COMPLETED|Part 2||0
6627305|NCT02239770|7555088|FG002|COMPLETED|Part 2||0
6627306|NCT02239770|7555089|FG003|COMPLETED|Part 2||4
6627307|NCT02239770|7555090|FG004|COMPLETED|Part 2||4
6627308|NCT02239770|7555091|FG005|COMPLETED|Part 2||4
6627309|NCT02239770|7555086|FG000|NOT COMPLETED|Part 2||0
6627310|NCT02239770|7555087|FG001|NOT COMPLETED|Part 2||0
6627311|NCT02239770|7555088|FG002|NOT COMPLETED|Part 2||0
6627312|NCT02239770|7555089|FG003|NOT COMPLETED|Part 2||0
6627313|NCT02239770|7555090|FG004|NOT COMPLETED|Part 2||0
6627314|NCT02239770|7555091|FG005|NOT COMPLETED|Part 2||0
6627315|NCT02239939|7555115|FG000|STARTED|Overall Study||20
6627316|NCT02239939|7555116|FG001|STARTED|Overall Study||17
6627317|NCT02239939|7555115|FG000|COMPLETED|Overall Study||18
6627318|NCT02239939|7555116|FG001|COMPLETED|Overall Study||15
6627319|NCT02239939|7555115|FG000|NOT COMPLETED|Overall Study||2
6627320|NCT02239939|7555116|FG001|NOT COMPLETED|Overall Study||2
6742029|NCT03315208|7670334|FG001|COMPLETED|Overall Study||12
6742030|NCT03315208|7670333|FG000|NOT COMPLETED|Overall Study||13
6742031|NCT03315208|7670334|FG001|NOT COMPLETED|Overall Study||6
6742032|NCT03315286|7670343|FG000|STARTED|Overall Study||50
6742033|NCT03315286|7670344|FG001|STARTED|Overall Study||47
6627321|NCT02239978|7555126|FG000|STARTED|Overall Study||30
6627322|NCT02239978|7555127|FG001|STARTED|Overall Study||12
6742034|NCT03315286|7670343|FG000|COMPLETED|Overall Study||49
6742035|NCT03315286|7670344|FG001|COMPLETED|Overall Study||43
6742036|NCT03315286|7670343|FG000|NOT COMPLETED|Overall Study||1
6742037|NCT03315286|7670344|FG001|NOT COMPLETED|Overall Study||4
6742038|NCT03315559|7670350|FG000|STARTED|Treatment Period 1 (8 Days)||6
6742039|NCT03315559|7670350|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
6742040|NCT03315559|7670350|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6742041|NCT03315559|7670350|FG000|STARTED|Washout Period (14 Days)||6
6742042|NCT03315559|7670350|FG000|COMPLETED|Washout Period (14 Days)||6
6742043|NCT03315559|7670350|FG000|NOT COMPLETED|Washout Period (14 Days)||0
6742044|NCT03315559|7670350|FG000|STARTED|Treatment Period 2 (15 Days)||6
6742045|NCT03315559|7670350|FG000|COMPLETED|Treatment Period 2 (15 Days)||6
6742046|NCT03315559|7670350|FG000|NOT COMPLETED|Treatment Period 2 (15 Days)||0
6742047|NCT03315572|7670359|FG000|STARTED|Overall Study||14
6742048|NCT03315572|7670360|FG001|STARTED|Overall Study||14
6742049|NCT03315572|7670359|FG000|COMPLETED|Overall Study||14
6742050|NCT03315572|7670360|FG001|COMPLETED|Overall Study||14
6742051|NCT03315572|7670359|FG000|NOT COMPLETED|Overall Study||0
6742052|NCT03315572|7670360|FG001|NOT COMPLETED|Overall Study||0
6742053|NCT03315689|7670369|FG000|STARTED|Double-blind Period = 28 Days||4
6742054|NCT03315689|7670370|FG001|STARTED|Double-blind Period = 28 Days||7
6742055|NCT03315689|7670369|FG000|COMPLETED|Double-blind Period = 28 Days||3
6742056|NCT03315689|7670370|FG001|COMPLETED|Double-blind Period = 28 Days||7
6742057|NCT03315689|7670369|FG000|NOT COMPLETED|Double-blind Period = 28 Days||1
6742058|NCT03315689|7670370|FG001|NOT COMPLETED|Double-blind Period = 28 Days||0
6742059|NCT03315689|7670369|FG000|STARTED|Open Label Extension = 52 Weeks||0
6742060|NCT03315689|7670370|FG001|STARTED|Open Label Extension = 52 Weeks||10
6742061|NCT03315689|7670369|FG000|COMPLETED|Open Label Extension = 52 Weeks||0
6742062|NCT03315689|7670370|FG001|COMPLETED|Open Label Extension = 52 Weeks||7
6742063|NCT03315689|7670369|FG000|NOT COMPLETED|Open Label Extension = 52 Weeks||0
6742064|NCT03315689|7670370|FG001|NOT COMPLETED|Open Label Extension = 52 Weeks||3
6742065|NCT03315702|7670378|FG000|STARTED|Overall Study||52
6742066|NCT03315702|7670378|FG000|COMPLETED|Overall Study||52
6742067|NCT03315702|7670378|FG000|NOT COMPLETED|Overall Study||0
6742068|NCT03315780|7670383|FG000|STARTED|Period 1||6
6742069|NCT03315780|7670384|FG001|STARTED|Period 1||6
6742070|NCT03315780|7670383|FG000|Received One Dose of Study Drug|Period 1||6
6742071|NCT03315780|7670384|FG001|Received One Dose of Study Drug|Period 1||6
6742072|NCT03315780|7670383|FG000|COMPLETED|Period 1||6
6742073|NCT03315780|7670384|FG001|COMPLETED|Period 1||6
6742074|NCT03315780|7670383|FG000|NOT COMPLETED|Period 1||0
6742075|NCT03315780|7670384|FG001|NOT COMPLETED|Period 1||0
6742076|NCT03315780|7670383|FG000|STARTED|Period 2||6
6742077|NCT03315780|7670384|FG001|STARTED|Period 2||6
6742078|NCT03315780|7670383|FG000|COMPLETED|Period 2||6
6742079|NCT03315780|7670384|FG001|COMPLETED|Period 2||6
6742080|NCT03315780|7670383|FG000|NOT COMPLETED|Period 2||0
6742081|NCT03315780|7670384|FG001|NOT COMPLETED|Period 2||0
6742082|NCT03315793|7670392|FG000|STARTED|Overall Study||75
6742083|NCT03315793|7670393|FG001|STARTED|Overall Study||74
6742084|NCT03315793|7670392|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
6742085|NCT03315793|7670393|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
6742086|NCT03315793|7670392|FG000|COMPLETED|Overall Study||70
6742087|NCT03315793|7670393|FG001|COMPLETED|Overall Study||71
6742088|NCT03315793|7670392|FG000|NOT COMPLETED|Overall Study||5
6742089|NCT03315793|7670393|FG001|NOT COMPLETED|Overall Study||3
6742090|NCT03315949|7670403|FG000|STARTED|Overall Study||176
6742091|NCT03315949|7670404|FG001|STARTED|Overall Study||176
6742092|NCT03315949|7670403|FG000|COMPLETED|Overall Study||171
6742093|NCT03315949|7670404|FG001|COMPLETED|Overall Study||166
6742094|NCT03315949|7670403|FG000|NOT COMPLETED|Overall Study||5
6742095|NCT03315949|7670404|FG001|NOT COMPLETED|Overall Study||10
6742096|NCT03316131|7670410|FG000|STARTED|Treatment Period 1||18
6742097|NCT03316131|7670411|FG001|STARTED|Treatment Period 1||18
6742098|NCT03316131|7670410|FG000|COMPLETED|Treatment Period 1||18
6742099|NCT03316131|7670411|FG001|COMPLETED|Treatment Period 1||18
6742100|NCT03316131|7670410|FG000|NOT COMPLETED|Treatment Period 1||0
6742101|NCT03316131|7670411|FG001|NOT COMPLETED|Treatment Period 1||0
6742102|NCT03316131|7670410|FG000|STARTED|Treatment Period 2||18
6742103|NCT03316131|7670411|FG001|STARTED|Treatment Period 2||18
6742104|NCT03316131|7670410|FG000|COMPLETED|Treatment Period 2||17
6742105|NCT03316131|7670411|FG001|COMPLETED|Treatment Period 2||18
6742106|NCT03316131|7670410|FG000|NOT COMPLETED|Treatment Period 2||1
6742107|NCT03316131|7670411|FG001|NOT COMPLETED|Treatment Period 2||0
6742108|NCT03316170|7670419|FG000|STARTED|Overall Study||24
6742109|NCT03316170|7670420|FG001|STARTED|Overall Study||25
6742110|NCT03316170|7670419|FG000|COMPLETED|Overall Study||17
6742111|NCT03316170|7670420|FG001|COMPLETED|Overall Study||18
6742112|NCT03316170|7670419|FG000|NOT COMPLETED|Overall Study||7
6742113|NCT03316170|7670420|FG001|NOT COMPLETED|Overall Study||7
6742114|NCT03316378|7670429|FG000|STARTED|Overall Study||23
6742115|NCT03316378|7670430|FG001|STARTED|Overall Study||23
6742116|NCT03316378|7670429|FG000|COMPLETED|Overall Study||23
6742117|NCT03316378|7670430|FG001|COMPLETED|Overall Study||23
6742118|NCT03316378|7670429|FG000|NOT COMPLETED|Overall Study||0
6742119|NCT03316378|7670430|FG001|NOT COMPLETED|Overall Study||0
6742120|NCT03316547|7670439|FG000|STARTED|Overall Study||39
6742121|NCT03316547|7670440|FG001|STARTED|Overall Study||31
6742122|NCT03316547|7670439|FG000|COMPLETED|Overall Study||21
6742123|NCT03316547|7670440|FG001|COMPLETED|Overall Study||18
6742124|NCT03316547|7670439|FG000|NOT COMPLETED|Overall Study||18
6742125|NCT03316547|7670440|FG001|NOT COMPLETED|Overall Study||13
6742126|NCT03316911|7670450|FG000|STARTED|Overall Study|2 did not complete baseline survey|122
6742127|NCT03316911|7670451|FG001|STARTED|Overall Study|3 did not complete baseline survey|139
6742128|NCT03316911|7670450|FG000|3-Month Follow-up Survey|Overall Study||93
6742129|NCT03316911|7670451|FG001|3-Month Follow-up Survey|Overall Study||112
6742130|NCT03316911|7670450|FG000|5-Month Follow-up Survey|Overall Study||89
6627323|NCT02239978|7555126|FG000|COMPLETED|Overall Study||28
6627324|NCT02239978|7555127|FG001|COMPLETED|Overall Study||12
6742131|NCT03316911|7670451|FG001|5-Month Follow-up Survey|Overall Study||110
6742132|NCT03316911|7670450|FG000|COMPLETED|Overall Study||89
6742133|NCT03316911|7670451|FG001|COMPLETED|Overall Study||110
6742134|NCT03316911|7670450|FG000|NOT COMPLETED|Overall Study||33
6742135|NCT03316911|7670451|FG001|NOT COMPLETED|Overall Study||29
6627325|NCT02239978|7555126|FG000|NOT COMPLETED|Overall Study||2
6627326|NCT02239978|7555127|FG001|NOT COMPLETED|Overall Study||0
6627327|NCT02240030|7555138|FG000|STARTED|Overall Study||113
6627328|NCT02240030|7555139|FG001|STARTED|Overall Study||114
6627329|NCT02240030|7555140|FG002|STARTED|Overall Study||112
6627330|NCT02240030|7555138|FG000|COMPLETED|Overall Study||96
6627331|NCT02240030|7555139|FG001|COMPLETED|Overall Study||97
6627332|NCT02240030|7555140|FG002|COMPLETED|Overall Study||97
6627333|NCT02240030|7555138|FG000|NOT COMPLETED|Overall Study||17
6627334|NCT02240030|7555139|FG001|NOT COMPLETED|Overall Study||17
6627335|NCT02240030|7555140|FG002|NOT COMPLETED|Overall Study||15
6627336|NCT02240108|7555152|FG000|STARTED|Overall Study||35
6627337|NCT02240108|7555153|FG001|STARTED|Overall Study||46
6627338|NCT02240108|7555152|FG000|Intent-to-treat (ITT) Population|Overall Study||35
6627339|NCT02240108|7555153|FG001|Intent-to-treat (ITT) Population|Overall Study||45
6627340|NCT02240108|7555152|FG000|COMPLETED|Overall Study||21
6627341|NCT02240108|7555153|FG001|COMPLETED|Overall Study||21
6627342|NCT02240108|7555152|FG000|NOT COMPLETED|Overall Study||14
6627343|NCT02240108|7555153|FG001|NOT COMPLETED|Overall Study||25
6627344|NCT02240121|7555161|FG000|STARTED|Overall Study||40
6627345|NCT02240121|7555162|FG001|STARTED|Overall Study||40
6627346|NCT02240121|7555161|FG000|COMPLETED|Overall Study||22
6627347|NCT02240121|7555162|FG001|COMPLETED|Overall Study||20
6627348|NCT02240121|7555161|FG000|NOT COMPLETED|Overall Study||18
6627349|NCT02240121|7555162|FG001|NOT COMPLETED|Overall Study||20
6627350|NCT02240186|7555168|FG000|STARTED|Overall Study||50
6627351|NCT02240186|7555168|FG000|COMPLETED|Overall Study||23
6627352|NCT02240186|7555168|FG000|NOT COMPLETED|Overall Study||27
6627353|NCT02240329|7555175|FG000|STARTED|Overall Study||4
6627354|NCT02240329|7555175|FG000|Determination of Urge to Cough|Overall Study||4
6627355|NCT02240329|7555175|FG000|COMPLETED|Overall Study||4
6627356|NCT02240329|7555175|FG000|NOT COMPLETED|Overall Study||0
6627357|NCT02240368|7555182|FG000|STARTED|Overall Study||9
6627358|NCT02240368|7555183|FG001|STARTED|Overall Study||22
6627359|NCT02240368|7555184|FG002|STARTED|Overall Study||19
6627360|NCT02240368|7555182|FG000|COMPLETED|Overall Study||8
6627361|NCT02240368|7555183|FG001|COMPLETED|Overall Study||22
6627362|NCT02240368|7555184|FG002|COMPLETED|Overall Study||18
6627363|NCT02240368|7555182|FG000|NOT COMPLETED|Overall Study||1
6627364|NCT02240368|7555183|FG001|NOT COMPLETED|Overall Study||0
6627365|NCT02240368|7555184|FG002|NOT COMPLETED|Overall Study||1
6627366|NCT02240589|7555194|FG000|STARTED|Overall Study||5
6627367|NCT02240589|7555195|FG001|STARTED|Overall Study||6
6627368|NCT02240589|7555194|FG000|COMPLETED|Overall Study||3
6627369|NCT02240589|7555195|FG001|COMPLETED|Overall Study||4
6627370|NCT02240589|7555194|FG000|NOT COMPLETED|Overall Study||2
6742136|NCT03316976|7670459|FG000|STARTED|Overall Study||20
6742137|NCT03316976|7670460|FG001|STARTED|Overall Study||20
6742138|NCT03316976|7670459|FG000|COMPLETED|Overall Study||20
6742139|NCT03316976|7670460|FG001|COMPLETED|Overall Study||20
6742140|NCT03316976|7670459|FG000|NOT COMPLETED|Overall Study||0
6742141|NCT03316976|7670460|FG001|NOT COMPLETED|Overall Study||0
6627371|NCT02240589|7555195|FG001|NOT COMPLETED|Overall Study||2
6627372|NCT02240628|7555203|FG000|STARTED|Overall Study||38
6627373|NCT02240628|7555204|FG001|STARTED|Overall Study||38
6627374|NCT02240628|7555203|FG000|COMPLETED|Overall Study||32
6627375|NCT02240628|7555204|FG001|COMPLETED|Overall Study||33
6627376|NCT02240628|7555203|FG000|NOT COMPLETED|Overall Study||6
6627377|NCT02240628|7555204|FG001|NOT COMPLETED|Overall Study||5
6627378|NCT02240654|7555215|FG000|STARTED|Overall Study||1706
6627379|NCT02240654|7555216|FG001|STARTED|Overall Study||2813
6627380|NCT02240654|7555217|FG002|STARTED|Overall Study||28619
6627381|NCT02240654|7555218|FG003|STARTED|Overall Study||2150
6742142|NCT03317002|7670469|FG000|STARTED|Overall Study||52
6742143|NCT03317002|7670470|FG001|STARTED|Overall Study||25
6627382|NCT02240654|7555219|FG004|STARTED|Overall Study||1285
6742144|NCT03317002|7670471|FG002|STARTED|Overall Study||52
6742145|NCT03317002|7670469|FG000|COMPLETED|Overall Study||50
6742146|NCT03317002|7670470|FG001|COMPLETED|Overall Study||24
6742147|NCT03317002|7670471|FG002|COMPLETED|Overall Study||51
6742148|NCT03317002|7670469|FG000|NOT COMPLETED|Overall Study||2
6742149|NCT03317002|7670470|FG001|NOT COMPLETED|Overall Study||1
6742150|NCT03317002|7670471|FG002|NOT COMPLETED|Overall Study||1
6742151|NCT03317288|7670479|FG000|STARTED|Overall Study||15
6742152|NCT03317288|7670479|FG000|COMPLETED|Overall Study||15
6742153|NCT03317288|7670479|FG000|NOT COMPLETED|Overall Study||0
6742154|NCT03317379|7670500|FG000|STARTED|Overall Study||20
6742155|NCT03317379|7670501|FG001|STARTED|Overall Study||18
6742156|NCT03317379|7670502|FG002|STARTED|Overall Study||22
6742157|NCT03317379|7670500|FG000|Completed Intervention|Overall Study||16
6742158|NCT03317379|7670501|FG001|Completed Intervention|Overall Study||6
6742159|NCT03317379|7670502|FG002|Completed Intervention|Overall Study||0
6742160|NCT03317379|7670500|FG000|COMPLETED|Overall Study||20
6742161|NCT03317379|7670501|FG001|COMPLETED|Overall Study||15
6742162|NCT03317379|7670502|FG002|COMPLETED|Overall Study||20
6742163|NCT03317379|7670500|FG000|NOT COMPLETED|Overall Study||0
6742164|NCT03317379|7670501|FG001|NOT COMPLETED|Overall Study||3
6742165|NCT03317379|7670502|FG002|NOT COMPLETED|Overall Study||2
6742166|NCT03317431|7670510|FG000|STARTED|Overall Study||46
6742167|NCT03317431|7670510|FG000|COMPLETED|Overall Study||46
6742168|NCT03317431|7670510|FG000|NOT COMPLETED|Overall Study||0
6742169|NCT03317444|7670516|FG000|STARTED|Overall Study||124
6742170|NCT03317444|7670517|FG001|STARTED|Overall Study||93
6742171|NCT03317444|7670516|FG000|COMPLETED|Overall Study||119
6742172|NCT03317444|7670517|FG001|COMPLETED|Overall Study||89
6742173|NCT03317444|7670516|FG000|NOT COMPLETED|Overall Study||5
6742174|NCT03317444|7670517|FG001|NOT COMPLETED|Overall Study||4
6742175|NCT03318315|7670526|FG000|STARTED|Overall Study||62
6742176|NCT03318315|7670527|FG001|STARTED|Overall Study||53
6742177|NCT03318315|7670528|FG002|STARTED|Overall Study||34
6742178|NCT03318315|7670526|FG000|Received First Vaccination|Overall Study||62
6742179|NCT03318315|7670527|FG001|Received First Vaccination|Overall Study||53
6742180|NCT03318315|7670528|FG002|Received First Vaccination|Overall Study||34
6742181|NCT03318315|7670526|FG000|Received Second Vaccination|Overall Study||59
6742182|NCT03318315|7670527|FG001|Received Second Vaccination|Overall Study||48
6627383|NCT02240654|7555215|FG000|COMPLETED|Overall Study||1706
6627384|NCT02240654|7555216|FG001|COMPLETED|Overall Study||2813
6627385|NCT02240654|7555217|FG002|COMPLETED|Overall Study||28619
6627386|NCT02240654|7555218|FG003|COMPLETED|Overall Study||2150
6627387|NCT02240654|7555219|FG004|COMPLETED|Overall Study||1285
6627388|NCT02240654|7555215|FG000|NOT COMPLETED|Overall Study||0
6627389|NCT02240654|7555216|FG001|NOT COMPLETED|Overall Study||0
6627390|NCT02240654|7555217|FG002|NOT COMPLETED|Overall Study||0
6627391|NCT02240654|7555218|FG003|NOT COMPLETED|Overall Study||0
6627392|NCT02240654|7555219|FG004|NOT COMPLETED|Overall Study||0
6627393|NCT02240667|7555233|FG000|STARTED|Overall Study||771
6627394|NCT02240667|7555234|FG001|STARTED|Overall Study||650
6627395|NCT02240667|7555233|FG000|COMPLETED|Overall Study||771
6627396|NCT02240667|7555234|FG001|COMPLETED|Overall Study||650
6627397|NCT02240667|7555233|FG000|NOT COMPLETED|Overall Study||0
6627398|NCT02240667|7555234|FG001|NOT COMPLETED|Overall Study||0
6627399|NCT02240680|7555242|FG000|STARTED|Overall Study (Up to 24 Weeks)||151
6627400|NCT02240680|7555243|FG001|STARTED|Overall Study (Up to 24 Weeks)||151
6627401|NCT02240680|7555244|FG002|STARTED|Overall Study (Up to 24 Weeks)||0
6627402|NCT02240680|7555245|FG003|STARTED|Overall Study (Up to 24 Weeks)||0
6627403|NCT02240680|7555242|FG000|COMPLETED|Overall Study (Up to 24 Weeks)||136
6627404|NCT02240680|7555243|FG001|COMPLETED|Overall Study (Up to 24 Weeks)||143
6627405|NCT02240680|7555244|FG002|COMPLETED|Overall Study (Up to 24 Weeks)||0
6627406|NCT02240680|7555245|FG003|COMPLETED|Overall Study (Up to 24 Weeks)||0
6627407|NCT02240680|7555242|FG000|NOT COMPLETED|Overall Study (Up to 24 Weeks)||15
6627408|NCT02240680|7555243|FG001|NOT COMPLETED|Overall Study (Up to 24 Weeks)||8
6627409|NCT02240680|7555244|FG002|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
6627410|NCT02240680|7555245|FG003|NOT COMPLETED|Overall Study (Up to 24 Weeks)||0
6627411|NCT02240680|7555242|FG000|STARTED|Japanese Patients (Up to 52 Weeks)||0
6627412|NCT02240680|7555243|FG001|STARTED|Japanese Patients (Up to 52 Weeks)||0
6627413|NCT02240680|7555244|FG002|STARTED|Japanese Patients (Up to 52 Weeks)||50
6627414|NCT02240680|7555245|FG003|STARTED|Japanese Patients (Up to 52 Weeks)||52
6627415|NCT02240680|7555242|FG000|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
6627416|NCT02240680|7555243|FG001|COMPLETED|Japanese Patients (Up to 52 Weeks)||0
6627417|NCT02240680|7555244|FG002|COMPLETED|Japanese Patients (Up to 52 Weeks)||42
6627418|NCT02240680|7555245|FG003|COMPLETED|Japanese Patients (Up to 52 Weeks)||45
6627419|NCT02240680|7555242|FG000|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
6627420|NCT02240680|7555243|FG001|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||0
6627421|NCT02240680|7555244|FG002|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||8
6627422|NCT02240680|7555245|FG003|NOT COMPLETED|Japanese Patients (Up to 52 Weeks)||7
6627423|NCT02240693|7555258|FG000|STARTED|Overall Study||22
6627424|NCT02240693|7555259|FG001|STARTED|Overall Study||21
6627425|NCT02240693|7555260|FG002|STARTED|Overall Study||21
6627426|NCT02240693|7555261|FG003|STARTED|Overall Study||21
6627427|NCT02240693|7555262|FG004|STARTED|Overall Study||43
6627428|NCT02240693|7555258|FG000|COMPLETED|Overall Study||22
6742183|NCT03318315|7670528|FG002|Received Second Vaccination|Overall Study||0
6742184|NCT03318315|7670526|FG000|Received Third Vaccination|Overall Study||0
6742185|NCT03318315|7670527|FG001|Received Third Vaccination|Overall Study||46
6742186|NCT03318315|7670528|FG002|Received Third Vaccination|Overall Study||0
6742187|NCT03318315|7670526|FG000|COMPLETED|Overall Study||58
6742188|NCT03318315|7670527|FG001|COMPLETED|Overall Study||50
6627429|NCT02240693|7555259|FG001|COMPLETED|Overall Study||21
6627430|NCT02240693|7555260|FG002|COMPLETED|Overall Study||17
6627431|NCT02240693|7555261|FG003|COMPLETED|Overall Study||20
6627432|NCT02240693|7555262|FG004|COMPLETED|Overall Study||42
6627433|NCT02240693|7555258|FG000|NOT COMPLETED|Overall Study||0
6627434|NCT02240693|7555259|FG001|NOT COMPLETED|Overall Study||0
6627435|NCT02240693|7555260|FG002|NOT COMPLETED|Overall Study||4
6627436|NCT02240693|7555261|FG003|NOT COMPLETED|Overall Study||1
6627437|NCT02240693|7555262|FG004|NOT COMPLETED|Overall Study||1
6655344|NCT02452476|7585462|FG000|NOT COMPLETED|Overall Study||11
6655345|NCT02452476|7585463|FG001|NOT COMPLETED|Overall Study||10
6655346|NCT02452528|7585471|FG000|STARTED|Overall Study||2
6655347|NCT02452528|7585472|FG001|STARTED|Overall Study||2
6655348|NCT02452528|7585471|FG000|COMPLETED|Overall Study||1
6655349|NCT02452528|7585472|FG001|COMPLETED|Overall Study||1
6655350|NCT02452528|7585471|FG000|NOT COMPLETED|Overall Study||1
6655351|NCT02452528|7585472|FG001|NOT COMPLETED|Overall Study||1
6655352|NCT02452762|7585480|FG000|STARTED|Overall Study||45
6655353|NCT02452762|7585481|FG001|STARTED|Overall Study||22
6655354|NCT02452762|7585480|FG000|COMPLETED|Overall Study||40
6655355|NCT02452762|7585481|FG001|COMPLETED|Overall Study||19
6655356|NCT02452762|7585480|FG000|NOT COMPLETED|Overall Study||5
6655357|NCT02452762|7585481|FG001|NOT COMPLETED|Overall Study||3
6655358|NCT02452866|7585488|FG000|STARTED|Overall Study||325
6655359|NCT02452866|7585488|FG000|COMPLETED|Overall Study||321
6655360|NCT02452866|7585488|FG000|NOT COMPLETED|Overall Study||4
6655361|NCT02452892|7585496|FG000|STARTED|Week 1 Initial Randommization||41
6655362|NCT02452892|7585497|FG001|STARTED|Week 1 Initial Randommization||40
6655363|NCT02452892|7585498|FG002|STARTED|Week 1 Initial Randommization||41
6655364|NCT02452892|7585499|FG003|STARTED|Week 1 Initial Randommization||0
6655365|NCT02452892|7585496|FG000|COMPLETED|Week 1 Initial Randommization||40
6655366|NCT02452892|7585497|FG001|COMPLETED|Week 1 Initial Randommization||40
6655367|NCT02452892|7585498|FG002|COMPLETED|Week 1 Initial Randommization||40
6655368|NCT02452892|7585499|FG003|COMPLETED|Week 1 Initial Randommization||0
6655369|NCT02452892|7585496|FG000|NOT COMPLETED|Week 1 Initial Randommization||1
6655370|NCT02452892|7585497|FG001|NOT COMPLETED|Week 1 Initial Randommization||0
6655371|NCT02452892|7585498|FG002|NOT COMPLETED|Week 1 Initial Randommization||1
6655372|NCT02452892|7585499|FG003|NOT COMPLETED|Week 1 Initial Randommization||0
6655373|NCT02452892|7585496|FG000|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that started LFMS sham (27), LFMS 20min (19), and LFMS 60min (19)|65
6655374|NCT02452892|7585497|FG001|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0), LFMS 20min (7), and LFMS 60min(0).|7
6655375|NCT02452892|7585498|FG002|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (0),LFMS 20min (0), LFMS 60min (7)|7
6655376|NCT02452892|7585499|FG003|STARTED|Week 2 Stratification & Re-Randomization|Week 1 Participants that Started LFMS Sham (13), LFMS 20min (14), and LFMS 60 min (14).|41
6655377|NCT02452892|7585496|FG000|Non-reponders|Week 2 Stratification & Re-Randomization||38
6655378|NCT02452892|7585497|FG001|Non-reponders|Week 2 Stratification & Re-Randomization||0
6655379|NCT02452892|7585498|FG002|Non-reponders|Week 2 Stratification & Re-Randomization||0
6655380|NCT02452892|7585499|FG003|Non-reponders|Week 2 Stratification & Re-Randomization||41
6655381|NCT02452892|7585496|FG000|Responders|Week 2 Stratification & Re-Randomization||27
6655382|NCT02452892|7585497|FG001|Responders|Week 2 Stratification & Re-Randomization||7
6655383|NCT02452892|7585498|FG002|Responders|Week 2 Stratification & Re-Randomization||7
6655384|NCT02452892|7585499|FG003|Responders|Week 2 Stratification & Re-Randomization||0
6655385|NCT02452892|7585496|FG000|COMPLETED|Week 2 Stratification & Re-Randomization||63
6655386|NCT02452892|7585497|FG001|COMPLETED|Week 2 Stratification & Re-Randomization||7
6655387|NCT02452892|7585498|FG002|COMPLETED|Week 2 Stratification & Re-Randomization||7
6655388|NCT02452892|7585499|FG003|COMPLETED|Week 2 Stratification & Re-Randomization||39
6655389|NCT02452892|7585496|FG000|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
6655390|NCT02452892|7585497|FG001|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
6655391|NCT02452892|7585498|FG002|NOT COMPLETED|Week 2 Stratification & Re-Randomization||0
6655392|NCT02452892|7585499|FG003|NOT COMPLETED|Week 2 Stratification & Re-Randomization||2
6655393|NCT02452892|7585496|FG000|STARTED|Follow-up||63
6655394|NCT02452892|7585497|FG001|STARTED|Follow-up||7
6655395|NCT02452892|7585498|FG002|STARTED|Follow-up||7
6655396|NCT02452892|7585499|FG003|STARTED|Follow-up||39
6655397|NCT02452892|7585496|FG000|COMPLETED|Follow-up||62
6655398|NCT02452892|7585497|FG001|COMPLETED|Follow-up||7
6655399|NCT02452892|7585498|FG002|COMPLETED|Follow-up||7
6655400|NCT02452892|7585499|FG003|COMPLETED|Follow-up||38
6655401|NCT02452892|7585496|FG000|NOT COMPLETED|Follow-up||1
6655402|NCT02452892|7585497|FG001|NOT COMPLETED|Follow-up||0
6655403|NCT02452892|7585498|FG002|NOT COMPLETED|Follow-up||0
6655404|NCT02452892|7585499|FG003|NOT COMPLETED|Follow-up||1
6655405|NCT02452931|7585512|FG000|STARTED|Overall Study||64
6655406|NCT02452931|7585512|FG000|COMPLETED|Overall Study||60
6655407|NCT02452931|7585512|FG000|NOT COMPLETED|Overall Study||4
6655408|NCT02452944|7585518|FG000|STARTED|Overall Study||31
6655409|NCT02452944|7585519|FG001|STARTED|Overall Study||31
6655410|NCT02452944|7585518|FG000|COMPLETED|Overall Study||31
6742189|NCT03318315|7670528|FG002|COMPLETED|Overall Study||30
6742190|NCT03318315|7670526|FG000|NOT COMPLETED|Overall Study||4
6742191|NCT03318315|7670527|FG001|NOT COMPLETED|Overall Study||3
6742192|NCT03318315|7670528|FG002|NOT COMPLETED|Overall Study||4
6742193|NCT03318341|7670539|FG000|STARTED|Month 1||13
6742194|NCT03318341|7670540|FG001|STARTED|Month 1||13
6742195|NCT03318341|7670539|FG000|COMPLETED|Month 1||13
6627438|NCT02240706|7555281|FG000|STARTED|Overall Study||3
6627439|NCT02240706|7555282|FG001|STARTED|Overall Study||3
6627440|NCT02240706|7555283|FG002|STARTED|Overall Study||6
6627441|NCT02240706|7555284|FG003|STARTED|Overall Study||4
6627442|NCT02240706|7555285|FG004|STARTED|Overall Study||11
6627443|NCT02240706|7555286|FG005|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
6627444|NCT02240706|7555287|FG006|STARTED|Overall Study|No patients were enrolled in the Phase II part due to strategic reasons.|0
6627445|NCT02240706|7555281|FG000|COMPLETED|Overall Study||0
6627446|NCT02240706|7555282|FG001|COMPLETED|Overall Study||0
6627447|NCT02240706|7555283|FG002|COMPLETED|Overall Study||0
6627448|NCT02240706|7555284|FG003|COMPLETED|Overall Study||0
6627449|NCT02240706|7555285|FG004|COMPLETED|Overall Study||0
6627450|NCT02240706|7555286|FG005|COMPLETED|Overall Study||0
6627451|NCT02240706|7555287|FG006|COMPLETED|Overall Study||0
6627452|NCT02240706|7555281|FG000|NOT COMPLETED|Overall Study||3
6627453|NCT02240706|7555282|FG001|NOT COMPLETED|Overall Study||3
6627454|NCT02240706|7555283|FG002|NOT COMPLETED|Overall Study||6
6627455|NCT02240706|7555284|FG003|NOT COMPLETED|Overall Study||4
6627456|NCT02240706|7555285|FG004|NOT COMPLETED|Overall Study||11
6627457|NCT02240706|7555286|FG005|NOT COMPLETED|Overall Study||0
6627458|NCT02240706|7555287|FG006|NOT COMPLETED|Overall Study||0
6627459|NCT02240810|7555304|FG000|STARTED|Overall Study||1501
6627460|NCT02240810|7555305|FG001|STARTED|Overall Study|correct typo|2681
6627461|NCT02240810|7555304|FG000|COMPLETED|Overall Study||1441
6627462|NCT02240810|7555305|FG001|COMPLETED|Overall Study||2621
6627463|NCT02240810|7555304|FG000|NOT COMPLETED|Overall Study||60
6627464|NCT02240810|7555305|FG001|NOT COMPLETED|Overall Study||60
6627465|NCT02241486|7555312|FG000|STARTED|Overall Study||2
6627466|NCT02241486|7555312|FG000|COMPLETED|Overall Study||2
6627467|NCT02241486|7555312|FG000|NOT COMPLETED|Overall Study||0
6627468|NCT02241512|7555318|FG000|STARTED|Overall Study||30
6627469|NCT02241512|7555319|FG001|STARTED|Overall Study||29
6627470|NCT02241512|7555318|FG000|COMPLETED|Overall Study||29
6627471|NCT02241512|7555319|FG001|COMPLETED|Overall Study||29
6627472|NCT02241512|7555318|FG000|NOT COMPLETED|Overall Study||1
6627473|NCT02241512|7555319|FG001|NOT COMPLETED|Overall Study||0
6627474|NCT02241655|7555327|FG000|STARTED|Overall Study||614
6627475|NCT02241655|7555328|FG001|STARTED|Overall Study||618
6627476|NCT02241655|7555327|FG000|COMPLETED|Overall Study||614
6627477|NCT02241655|7555328|FG001|COMPLETED|Overall Study||618
6627478|NCT02241655|7555327|FG000|NOT COMPLETED|Overall Study||0
6627479|NCT02241655|7555328|FG001|NOT COMPLETED|Overall Study||0
6627480|NCT02241720|7555339|FG000|STARTED|Overall Study||5
6627481|NCT02241720|7555339|FG000|COMPLETED|Overall Study||1
6627482|NCT02241720|7555339|FG000|NOT COMPLETED|Overall Study||4
6627483|NCT02241733|7555345|FG000|STARTED|Overall Study||40
6627484|NCT02241733|7555346|FG001|STARTED|Overall Study||40
6627485|NCT02241733|7555345|FG000|COMPLETED|Overall Study||25
6627486|NCT02241733|7555346|FG001|COMPLETED|Overall Study||30
6627487|NCT02241733|7555345|FG000|NOT COMPLETED|Overall Study||15
6627488|NCT02241733|7555346|FG001|NOT COMPLETED|Overall Study||10
6627489|NCT02241785|7555352|FG000|STARTED|Overall Study||47
6627490|NCT02241785|7555352|FG000|COMPLETED|Overall Study||0
6627491|NCT02241785|7555352|FG000|NOT COMPLETED|Overall Study||47
6627492|NCT02241889|7555356|FG000|STARTED|Overall Study||4
6627493|NCT02241889|7555357|FG001|STARTED|Overall Study||4
6627494|NCT02241889|7555358|FG002|STARTED|Overall Study||3
6627495|NCT02241889|7555359|FG003|STARTED|Overall Study||3
6627496|NCT02241889|7555360|FG004|STARTED|Overall Study||5
6627497|NCT02241889|7555361|FG005|STARTED|Overall Study||4
6627498|NCT02241889|7555356|FG000|COMPLETED|Overall Study||4
6627499|NCT02241889|7555357|FG001|COMPLETED|Overall Study||4
6627500|NCT02241889|7555358|FG002|COMPLETED|Overall Study||2
6627501|NCT02241889|7555359|FG003|COMPLETED|Overall Study||3
6627502|NCT02241889|7555360|FG004|COMPLETED|Overall Study||5
6627503|NCT02241889|7555361|FG005|COMPLETED|Overall Study||3
6627504|NCT02241889|7555356|FG000|NOT COMPLETED|Overall Study||0
6742196|NCT03318341|7670540|FG001|COMPLETED|Month 1||12
6742197|NCT03318341|7670539|FG000|NOT COMPLETED|Month 1||0
6742198|NCT03318341|7670540|FG001|NOT COMPLETED|Month 1||1
6627505|NCT02241889|7555357|FG001|NOT COMPLETED|Overall Study||0
6627506|NCT02241889|7555358|FG002|NOT COMPLETED|Overall Study||1
6627507|NCT02241889|7555359|FG003|NOT COMPLETED|Overall Study||0
6627508|NCT02241889|7555360|FG004|NOT COMPLETED|Overall Study||0
6627509|NCT02241889|7555361|FG005|NOT COMPLETED|Overall Study||1
6627510|NCT02241967|7555373|FG000|STARTED|Overall Study||30
6627511|NCT02241967|7555374|FG001|STARTED|Overall Study||30
6627512|NCT02241967|7555375|FG002|STARTED|Overall Study||30
6627513|NCT02241967|7555376|FG003|STARTED|Overall Study||29
6627514|NCT02241967|7555373|FG000|COMPLETED|Overall Study||30
6627515|NCT02241967|7555374|FG001|COMPLETED|Overall Study||30
6627516|NCT02241967|7555375|FG002|COMPLETED|Overall Study||30
6627517|NCT02241967|7555376|FG003|COMPLETED|Overall Study||29
6627518|NCT02241967|7555373|FG000|NOT COMPLETED|Overall Study||0
6627519|NCT02241967|7555374|FG001|NOT COMPLETED|Overall Study||0
6742199|NCT03318341|7670539|FG000|STARTED|Month 2||13
6742200|NCT03318341|7670540|FG001|STARTED|Month 2||12
6742201|NCT03318341|7670539|FG000|COMPLETED|Month 2||13
6742202|NCT03318341|7670540|FG001|COMPLETED|Month 2||12
6742203|NCT03318341|7670539|FG000|NOT COMPLETED|Month 2||0
6742204|NCT03318341|7670540|FG001|NOT COMPLETED|Month 2||0
6742205|NCT03318783|7670550|FG000|STARTED|Overall Study||10
6742206|NCT03318783|7670551|FG001|STARTED|Overall Study||10
6742207|NCT03318783|7670550|FG000|COMPLETED|Overall Study||10
6742208|NCT03318783|7670551|FG001|COMPLETED|Overall Study||8
6742209|NCT03318783|7670550|FG000|NOT COMPLETED|Overall Study||0
6742210|NCT03318783|7670551|FG001|NOT COMPLETED|Overall Study||2
6742211|NCT03318809|7670559|FG000|STARTED|Overall Study||6
6742212|NCT03318809|7670560|FG001|STARTED|Overall Study||6
6742213|NCT03318809|7670559|FG000|COMPLETED|Overall Study||6
6742214|NCT03318809|7670560|FG001|COMPLETED|Overall Study||6
6742215|NCT03318809|7670559|FG000|NOT COMPLETED|Overall Study||0
6742216|NCT03318809|7670560|FG001|NOT COMPLETED|Overall Study||0
6742217|NCT03319134|7670569|FG000|STARTED|Overall Study||15
6742218|NCT03319134|7670570|FG001|STARTED|Overall Study||15
6742219|NCT03319134|7670571|FG002|STARTED|Overall Study||15
6742220|NCT03319134|7670569|FG000|COMPLETED|Overall Study||15
6742221|NCT03319134|7670570|FG001|COMPLETED|Overall Study||15
6742222|NCT03319134|7670571|FG002|COMPLETED|Overall Study||15
6742223|NCT03319134|7670569|FG000|NOT COMPLETED|Overall Study||0
6742224|NCT03319134|7670570|FG001|NOT COMPLETED|Overall Study||0
6742225|NCT03319134|7670571|FG002|NOT COMPLETED|Overall Study||0
6742226|NCT03319173|7670581|FG000|STARTED|Overall Study||48
6742227|NCT03319173|7670582|FG001|STARTED|Overall Study||50
6742228|NCT03319173|7670581|FG000|COMPLETED|Overall Study||48
6742229|NCT03319173|7670582|FG001|COMPLETED|Overall Study||50
6742230|NCT03319173|7670581|FG000|NOT COMPLETED|Overall Study||0
6742231|NCT03319173|7670582|FG001|NOT COMPLETED|Overall Study||0
6742232|NCT03319212|7670594|FG000|STARTED|Overall Study||29
6742233|NCT03319212|7670595|FG001|STARTED|Overall Study||52
6742234|NCT03319212|7670594|FG000|COMPLETED|Overall Study||26
6742235|NCT03319212|7670595|FG001|COMPLETED|Overall Study||47
6742236|NCT03319212|7670594|FG000|NOT COMPLETED|Overall Study||3
6742237|NCT03319212|7670595|FG001|NOT COMPLETED|Overall Study||5
6742238|NCT03319277|7670602|FG000|STARTED|Overall Study||59
6742239|NCT03319277|7670603|FG001|STARTED|Overall Study||59
6742240|NCT03319277|7670602|FG000|COMPLETED|Overall Study||59
6742241|NCT03319277|7670603|FG001|COMPLETED|Overall Study||59
6742242|NCT03319277|7670602|FG000|NOT COMPLETED|Overall Study||0
6742243|NCT03319277|7670603|FG001|NOT COMPLETED|Overall Study||0
6742244|NCT03319719|7670609|FG000|STARTED|Overall Study||52
6742245|NCT03319719|7670609|FG000|COMPLETED|Overall Study||51
6742246|NCT03319719|7670609|FG000|NOT COMPLETED|Overall Study||1
6742247|NCT03319810|7670615|FG000|STARTED|Overall Study||5
6742248|NCT03319810|7670615|FG000|COMPLETED|Overall Study||5
6742249|NCT03319810|7670615|FG000|NOT COMPLETED|Overall Study||0
6742250|NCT03319953|7670623|FG000|STARTED|Period 1 (Day 1 to 14)||3
6742251|NCT03319953|7670624|FG001|STARTED|Period 1 (Day 1 to 14)||4
6742252|NCT03319953|7670625|FG002|STARTED|Period 1 (Day 1 to 14)||9
6627520|NCT02241967|7555375|FG002|NOT COMPLETED|Overall Study||0
6627521|NCT02241967|7555376|FG003|NOT COMPLETED|Overall Study||0
6627522|NCT02242019|7555386|FG000|STARTED|Overall Study||109
6742253|NCT03319953|7670626|FG003|STARTED|Period 1 (Day 1 to 14)||7
6742254|NCT03319953|7670623|FG000|COMPLETED|Period 1 (Day 1 to 14)||3
6742255|NCT03319953|7670624|FG001|COMPLETED|Period 1 (Day 1 to 14)||4
6627523|NCT02242019|7555386|FG000|COMPLETED|Overall Study||109
6627524|NCT02242019|7555386|FG000|NOT COMPLETED|Overall Study||0
6742256|NCT03319953|7670625|FG002|COMPLETED|Period 1 (Day 1 to 14)||9
6742257|NCT03319953|7670626|FG003|COMPLETED|Period 1 (Day 1 to 14)||7
6742258|NCT03319953|7670623|FG000|NOT COMPLETED|Period 1 (Day 1 to 14)||0
6742259|NCT03319953|7670624|FG001|NOT COMPLETED|Period 1 (Day 1 to 14)||0
6742260|NCT03319953|7670625|FG002|NOT COMPLETED|Period 1 (Day 1 to 14)||0
6742261|NCT03319953|7670626|FG003|NOT COMPLETED|Period 1 (Day 1 to 14)||0
6742262|NCT03319953|7670623|FG000|STARTED|Washout Period (Day 15 to 49)||3
6742263|NCT03319953|7670624|FG001|STARTED|Washout Period (Day 15 to 49)||4
6742264|NCT03319953|7670625|FG002|STARTED|Washout Period (Day 15 to 49)||9
6742265|NCT03319953|7670626|FG003|STARTED|Washout Period (Day 15 to 49)||7
6742266|NCT03319953|7670623|FG000|COMPLETED|Washout Period (Day 15 to 49)||3
6742267|NCT03319953|7670624|FG001|COMPLETED|Washout Period (Day 15 to 49)||4
6742268|NCT03319953|7670625|FG002|COMPLETED|Washout Period (Day 15 to 49)||9
6742269|NCT03319953|7670626|FG003|COMPLETED|Washout Period (Day 15 to 49)||7
6742270|NCT03319953|7670623|FG000|NOT COMPLETED|Washout Period (Day 15 to 49)||0
6742271|NCT03319953|7670624|FG001|NOT COMPLETED|Washout Period (Day 15 to 49)||0
6742272|NCT03319953|7670625|FG002|NOT COMPLETED|Washout Period (Day 15 to 49)||0
6742273|NCT03319953|7670626|FG003|NOT COMPLETED|Washout Period (Day 15 to 49)||0
6742274|NCT03319953|7670623|FG000|STARTED|Period 2 (Day 49 to 154)||3
6742275|NCT03319953|7670624|FG001|STARTED|Period 2 (Day 49 to 154)||4
6742276|NCT03319953|7670625|FG002|STARTED|Period 2 (Day 49 to 154)||9
6742277|NCT03319953|7670626|FG003|STARTED|Period 2 (Day 49 to 154)||7
6282363|NCT00182325|7182653|FG000|COMPLETED|Overall Study|63 completed survey, 85 included in intention-to-treat analysis|63
6627525|NCT02242045|7555390|FG000|STARTED|Overall Study||6
6742278|NCT03319953|7670623|FG000|Treated|Period 2 (Day 49 to 154)||2
6742279|NCT03319953|7670624|FG001|Treated|Period 2 (Day 49 to 154)||4
6742280|NCT03319953|7670625|FG002|Treated|Period 2 (Day 49 to 154)||8
6742281|NCT03319953|7670626|FG003|Treated|Period 2 (Day 49 to 154)||6
6742282|NCT03319953|7670623|FG000|COMPLETED|Period 2 (Day 49 to 154)||2
6742283|NCT03319953|7670624|FG001|COMPLETED|Period 2 (Day 49 to 154)||4
6742284|NCT03319953|7670625|FG002|COMPLETED|Period 2 (Day 49 to 154)||8
6742285|NCT03319953|7670626|FG003|COMPLETED|Period 2 (Day 49 to 154)||6
6742286|NCT03319953|7670623|FG000|NOT COMPLETED|Period 2 (Day 49 to 154)||1
6742287|NCT03319953|7670624|FG001|NOT COMPLETED|Period 2 (Day 49 to 154)||0
6742288|NCT03319953|7670625|FG002|NOT COMPLETED|Period 2 (Day 49 to 154)||1
6742289|NCT03319953|7670626|FG003|NOT COMPLETED|Period 2 (Day 49 to 154)||1
6742290|NCT03320057|7670634|FG000|STARTED|Overall Study||266
6742291|NCT03320057|7670635|FG001|STARTED|Overall Study|Includes pharmacists at study pharmacies that consented to training on mifepristone dispensing.|60
6742292|NCT03320057|7670634|FG000|Patient's Clinical Outcome Information Obtained|Overall Study||262
6742293|NCT03320057|7670635|FG001|Patient's Clinical Outcome Information Obtained|Overall Study|Clinical outcome data were not collected for pharmacists - this milestone does not apply|0
6742294|NCT03320057|7670634|FG000|Received Pharmacist Training|Overall Study||0
6742295|NCT03320057|7670635|FG001|Received Pharmacist Training|Overall Study||56
6742296|NCT03320057|7670634|FG000|Pharmacists Completed Baseline Survey|Overall Study||0
6742297|NCT03320057|7670635|FG001|Pharmacists Completed Baseline Survey|Overall Study||47
6742298|NCT03320057|7670634|FG000|COMPLETED|Overall Study||260
6742299|NCT03320057|7670635|FG001|COMPLETED|Overall Study|This includes pharmacists who completed the endline survey. Only trained pharmacists (n=56) were eligible.|43
6742300|NCT03320057|7670634|FG000|NOT COMPLETED|Overall Study||6
6742301|NCT03320057|7670635|FG001|NOT COMPLETED|Overall Study||17
6742302|NCT03320096|7670641|FG000|STARTED|Overall Study||20
6742303|NCT03320096|7670641|FG000|COMPLETED|Overall Study||20
6742304|NCT03320096|7670641|FG000|NOT COMPLETED|Overall Study||0
6742305|NCT03320369|7670645|FG000|STARTED|Overall Study||18
6742306|NCT03320369|7670645|FG000|COMPLETED|Overall Study||15
6742307|NCT03320369|7670645|FG000|NOT COMPLETED|Overall Study||3
6779582|NCT03728790|7707745|FG001|NOT COMPLETED|Overall Study||0
6779583|NCT03728348|7707751|FG000|STARTED|Overall Study||983
6779584|NCT03728348|7707751|FG000|Did Not Complete Study Procedures|Overall Study||107
6779585|NCT03728348|7707751|FG000|Multi-target DNA Test Excluded|Overall Study||15
6779586|NCT03728348|7707751|FG000|Colonoscopy Excluded|Overall Study||19
6779587|NCT03728348|7707751|FG000|COMPLETED|Overall Study||842
6779588|NCT03728348|7707751|FG000|NOT COMPLETED|Overall Study||141
6779589|NCT03728140|7707757|FG000|STARTED|Overall Study|embryo transfer with self-spent culture medium|160
6779590|NCT03728140|7707758|FG001|STARTED|Overall Study|embryo transfer with new culture medium|175
6779591|NCT03728140|7707757|FG000|COMPLETED|Overall Study||150
6779592|NCT03728140|7707758|FG001|COMPLETED|Overall Study||168
6779593|NCT03728140|7707757|FG000|NOT COMPLETED|Overall Study||10
6779594|NCT03728140|7707758|FG001|NOT COMPLETED|Overall Study||7
6779595|NCT03727854|7707766|FG000|STARTED|Overall Study||20
6779596|NCT03727854|7707767|FG001|STARTED|Overall Study||20
6779597|NCT03727854|7707766|FG000|COMPLETED|Overall Study||20
6779598|NCT03727854|7707767|FG001|COMPLETED|Overall Study||20
6779599|NCT03727854|7707766|FG000|NOT COMPLETED|Overall Study||0
6779600|NCT03727854|7707767|FG001|NOT COMPLETED|Overall Study||0
6627526|NCT02242045|7555390|FG000|COMPLETED|Overall Study||0
6627527|NCT02242045|7555390|FG000|NOT COMPLETED|Overall Study||6
6627528|NCT02242201|7555397|FG000|STARTED|Overall Study||55
6627529|NCT02242201|7555398|FG001|STARTED|Overall Study||55
6627530|NCT02242201|7555399|FG002|STARTED|Overall Study||55
6627531|NCT02242201|7555397|FG000|COMPLETED|Overall Study||51
6779601|NCT03727425|7707773|FG000|STARTED|Overall Study||55
6779602|NCT03727425|7707773|FG000|COMPLETED|Overall Study||55
6779603|NCT03727425|7707773|FG000|NOT COMPLETED|Overall Study||0
6779604|NCT03727347|7707777|FG000|STARTED|Overall Study||50
6779605|NCT03727347|7707777|FG000|2-week Evaluation|Overall Study||50
6779606|NCT03727347|7707777|FG000|4-week Evaluation|Overall Study||50
6779607|NCT03727347|7707777|FG000|12-week Primary Endpoint Evaluation|Overall Study||50
6779608|NCT03727347|7707777|FG000|26-week Evaluation|Overall Study||48
6779609|NCT03727347|7707777|FG000|52-week Evaluation|Overall Study||47
6779610|NCT03727347|7707777|FG000|COMPLETED|Overall Study||47
6779611|NCT03727347|7707777|FG000|NOT COMPLETED|Overall Study||3
6779612|NCT03726996|7707790|FG000|STARTED|Overall Study||4
6779613|NCT03726996|7707790|FG000|COMPLETED|Overall Study||0
6779614|NCT03726996|7707790|FG000|NOT COMPLETED|Overall Study||4
6779615|NCT03726164|7707796|FG000|STARTED|Overall Study||310
6779616|NCT03726164|7707797|FG001|STARTED|Overall Study||316
6779617|NCT03726164|7707796|FG000|COMPLETED|Overall Study||99
6779618|NCT03726164|7707797|FG001|COMPLETED|Overall Study||119
6779619|NCT03726164|7707796|FG000|NOT COMPLETED|Overall Study||211
6779620|NCT03726164|7707797|FG001|NOT COMPLETED|Overall Study||197
6779621|NCT03725852|7707805|FG000|STARTED|Overall Study||45
6779622|NCT03725852|7707806|FG001|STARTED|Overall Study||23
6627532|NCT02242201|7555398|FG001|COMPLETED|Overall Study||54
6779623|NCT03725852|7707805|FG000|COMPLETED|Overall Study||41
6779624|NCT03725852|7707806|FG001|COMPLETED|Overall Study||23
6779625|NCT03725852|7707805|FG000|NOT COMPLETED|Overall Study||4
6779626|NCT03725852|7707806|FG001|NOT COMPLETED|Overall Study||0
6779627|NCT03725722|7707817|FG000|STARTED|Overall Study||49
6779628|NCT03725722|7707818|FG001|STARTED|Overall Study||50
6779629|NCT03725722|7707819|FG002|STARTED|Overall Study||50
6779630|NCT03725722|7707820|FG003|STARTED|Overall Study||52
6779631|NCT03725722|7707821|FG004|STARTED|Overall Study||50
6779632|NCT03725722|7707817|FG000|COMPLETED|Overall Study||38
6779633|NCT03725722|7707818|FG001|COMPLETED|Overall Study||44
6779634|NCT03725722|7707819|FG002|COMPLETED|Overall Study||44
6779635|NCT03725722|7707820|FG003|COMPLETED|Overall Study||46
6627533|NCT02242201|7555399|FG002|COMPLETED|Overall Study||54
6627534|NCT02242201|7555397|FG000|NOT COMPLETED|Overall Study||4
6627535|NCT02242201|7555398|FG001|NOT COMPLETED|Overall Study||1
6627536|NCT02242201|7555399|FG002|NOT COMPLETED|Overall Study||1
6627537|NCT02242305|7555409|FG000|STARTED|Overall Study||151
6627538|NCT02242305|7555410|FG001|STARTED|Overall Study||151
6627539|NCT02242305|7555409|FG000|COMPLETED|Overall Study||145
6627540|NCT02242305|7555410|FG001|COMPLETED|Overall Study||141
6627541|NCT02242305|7555409|FG000|NOT COMPLETED|Overall Study||6
6627542|NCT02242305|7555410|FG001|NOT COMPLETED|Overall Study||10
6627543|NCT02242487|7555418|FG000|STARTED|Overall Study||161
6627544|NCT02242487|7555419|FG001|STARTED|Overall Study||164
6742308|NCT03320824|7670651|FG000|STARTED|Overall Study||184
6742309|NCT03320824|7670652|FG001|STARTED|Overall Study||89
6742310|NCT03320824|7670651|FG000|COMPLETED|Overall Study||166
6742311|NCT03320824|7670652|FG001|COMPLETED|Overall Study||85
6742312|NCT03320824|7670651|FG000|NOT COMPLETED|Overall Study||18
6742313|NCT03320824|7670652|FG001|NOT COMPLETED|Overall Study||4
6742314|NCT03320850|7670668|FG000|STARTED|Overall Study||18
6742315|NCT03320850|7670669|FG001|STARTED|Overall Study||12
6742316|NCT03320850|7670670|FG002|STARTED|Overall Study||18
6742317|NCT03320850|7670671|FG003|STARTED|Overall Study||22
6742318|NCT03320850|7670672|FG004|STARTED|Overall Study||19
6742319|NCT03320850|7670673|FG005|STARTED|Overall Study||58
6742320|NCT03320850|7670674|FG006|STARTED|Overall Study||57
6742321|NCT03320850|7670675|FG007|STARTED|Overall Study||60
6742322|NCT03320850|7670676|FG008|STARTED|Overall Study||60
6742323|NCT03320850|7670677|FG009|STARTED|Overall Study||59
6742324|NCT03320850|7670668|FG000|Safety Population|Overall Study||18
6742325|NCT03320850|7670669|FG001|Safety Population|Overall Study||12
6742326|NCT03320850|7670670|FG002|Safety Population|Overall Study||18
6742327|NCT03320850|7670671|FG003|Safety Population|Overall Study||22
6742328|NCT03320850|7670672|FG004|Safety Population|Overall Study||19
6742329|NCT03320850|7670673|FG005|Safety Population|Overall Study||57
6627545|NCT02242487|7555418|FG000|COMPLETED|Overall Study||99
6627546|NCT02242487|7555419|FG001|COMPLETED|Overall Study||117
6627547|NCT02242487|7555418|FG000|NOT COMPLETED|Overall Study||62
6627548|NCT02242487|7555419|FG001|NOT COMPLETED|Overall Study||47
6627549|NCT02242630|7555431|FG000|STARTED|Overall Study||15
6627550|NCT02242630|7555432|FG001|STARTED|Overall Study||15
6627551|NCT02242630|7555433|FG002|STARTED|Overall Study||15
6742330|NCT03320850|7670674|FG006|Safety Population|Overall Study||57
6742331|NCT03320850|7670675|FG007|Safety Population|Overall Study||60
6627552|NCT02242630|7555434|FG003|STARTED|Overall Study||16
6627553|NCT02242630|7555431|FG000|COMPLETED|Overall Study||15
6627554|NCT02242630|7555432|FG001|COMPLETED|Overall Study||15
6627555|NCT02242630|7555433|FG002|COMPLETED|Overall Study||15
6627556|NCT02242630|7555434|FG003|COMPLETED|Overall Study||16
6627557|NCT02242630|7555431|FG000|NOT COMPLETED|Overall Study||0
6627558|NCT02242630|7555432|FG001|NOT COMPLETED|Overall Study||0
6627559|NCT02242630|7555433|FG002|NOT COMPLETED|Overall Study||0
6627560|NCT02242630|7555434|FG003|NOT COMPLETED|Overall Study||0
6627561|NCT02242643|7555446|FG000|STARTED|Overall Study||1207
6627562|NCT02242643|7555447|FG001|STARTED|Overall Study||1217
6627563|NCT02242643|7555446|FG000|COMPLETED|Overall Study||1132
6627564|NCT02242643|7555447|FG001|COMPLETED|Overall Study||1139
6627565|NCT02242643|7555446|FG000|NOT COMPLETED|Overall Study||75
6627566|NCT02242643|7555447|FG001|NOT COMPLETED|Overall Study||78
6627567|NCT02242903|7555462|FG000|STARTED|Overall Study||12
6627568|NCT02242903|7555463|FG001|STARTED|Overall Study||6
6627569|NCT02242903|7555464|FG002|STARTED|Overall Study||6
6627570|NCT02242903|7555465|FG003|STARTED|Overall Study||6
6627571|NCT02242903|7555466|FG004|STARTED|Overall Study||6
6627572|NCT02242903|7555467|FG005|STARTED|Overall Study||6
6627573|NCT02242903|7555468|FG006|STARTED|Overall Study||6
6627574|NCT02242903|7555462|FG000|Received at Least One Dose of Study Drug|Overall Study||12
6627575|NCT02242903|7555463|FG001|Received at Least One Dose of Study Drug|Overall Study||6
6627576|NCT02242903|7555464|FG002|Received at Least One Dose of Study Drug|Overall Study||6
6627577|NCT02242903|7555465|FG003|Received at Least One Dose of Study Drug|Overall Study||6
6627578|NCT02242903|7555466|FG004|Received at Least One Dose of Study Drug|Overall Study||6
6627579|NCT02242903|7555467|FG005|Received at Least One Dose of Study Drug|Overall Study||6
6627580|NCT02242903|7555468|FG006|Received at Least One Dose of Study Drug|Overall Study||6
6627581|NCT02242903|7555462|FG000|COMPLETED|Overall Study||11
6627582|NCT02242903|7555463|FG001|COMPLETED|Overall Study||6
6627583|NCT02242903|7555464|FG002|COMPLETED|Overall Study||6
6627584|NCT02242903|7555465|FG003|COMPLETED|Overall Study||6
6627585|NCT02242903|7555466|FG004|COMPLETED|Overall Study||6
6627586|NCT02242903|7555467|FG005|COMPLETED|Overall Study||6
6627587|NCT02242903|7555468|FG006|COMPLETED|Overall Study||6
6627588|NCT02242903|7555462|FG000|NOT COMPLETED|Overall Study||1
6627589|NCT02242903|7555463|FG001|NOT COMPLETED|Overall Study||0
6627590|NCT02242903|7555464|FG002|NOT COMPLETED|Overall Study||0
6627591|NCT02242903|7555465|FG003|NOT COMPLETED|Overall Study||0
6627592|NCT02242903|7555466|FG004|NOT COMPLETED|Overall Study||0
6627593|NCT02242903|7555467|FG005|NOT COMPLETED|Overall Study||0
6627594|NCT02242903|7555468|FG006|NOT COMPLETED|Overall Study||0
6627595|NCT02242981|7555490|FG000|STARTED|Overall Study||6
6627596|NCT02242981|7555490|FG000|Received Study Drug|Overall Study||6
6627597|NCT02242981|7555490|FG000|COMPLETED|Overall Study||5
6627598|NCT02242981|7555490|FG000|NOT COMPLETED|Overall Study||1
6627599|NCT02242994|7555494|FG000|STARTED|Overall Study||5
6627600|NCT02242994|7555494|FG000|COMPLETED|Overall Study||5
6627601|NCT02242994|7555494|FG000|NOT COMPLETED|Overall Study||0
6627602|NCT02243007|7555500|FG000|STARTED|Overall Study||4
6627603|NCT02243007|7555501|FG001|STARTED|Overall Study||3
6627604|NCT02243007|7555500|FG000|COMPLETED|Overall Study||4
6627605|NCT02243007|7555501|FG001|COMPLETED|Overall Study||3
6627606|NCT02243007|7555500|FG000|NOT COMPLETED|Overall Study||0
6627607|NCT02243007|7555501|FG001|NOT COMPLETED|Overall Study||0
6627608|NCT02243046|7555510|FG000|STARTED|Overall Study||55
6627609|NCT02243046|7555511|FG001|STARTED|Overall Study||54
6627610|NCT02243046|7555512|FG002|STARTED|Overall Study||53
6627611|NCT02243046|7555510|FG000|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
6627612|NCT02243046|7555511|FG001|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
6627613|NCT02243046|7555512|FG002|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
6627614|NCT02243046|7555510|FG000|6 Month|Overall Study||54
6627615|NCT02243046|7555511|FG001|6 Month|Overall Study||53
6627616|NCT02243046|7555512|FG002|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
6627617|NCT02243046|7555510|FG000|COMPLETED|Overall Study||54
6627618|NCT02243046|7555511|FG001|COMPLETED|Overall Study||53
6627619|NCT02243046|7555512|FG002|COMPLETED|Overall Study||49
6627620|NCT02243046|7555510|FG000|NOT COMPLETED|Overall Study||1
6627621|NCT02243046|7555511|FG001|NOT COMPLETED|Overall Study||1
6627622|NCT02243046|7555512|FG002|NOT COMPLETED|Overall Study||4
6627623|NCT02243176|7555522|FG000|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
6627624|NCT02243176|7555523|FG001|STARTED|Overall Study||244
6627625|NCT02243176|7555522|FG000|COMPLETED|Overall Study||230
6627626|NCT02243176|7555523|FG001|COMPLETED|Overall Study||229
6627627|NCT02243176|7555522|FG000|NOT COMPLETED|Overall Study||14
6627628|NCT02243176|7555523|FG001|NOT COMPLETED|Overall Study||15
6627629|NCT02243202|7555533|FG000|STARTED|Overall Study||82
6627630|NCT02243202|7555534|FG001|STARTED|Overall Study||85
6627631|NCT02243202|7555535|FG002|STARTED|Overall Study||84
6627632|NCT02243202|7555536|FG003|STARTED|Overall Study||84
6627633|NCT02243202|7555533|FG000|Treated|Overall Study||82
6627634|NCT02243202|7555534|FG001|Treated|Overall Study||85
6627635|NCT02243202|7555535|FG002|Treated|Overall Study||84
6627636|NCT02243202|7555536|FG003|Treated|Overall Study||83
6627637|NCT02243202|7555533|FG000|COMPLETED|Overall Study||57
6627638|NCT02243202|7555534|FG001|COMPLETED|Overall Study||60
6627639|NCT02243202|7555535|FG002|COMPLETED|Overall Study||53
6627640|NCT02243202|7555536|FG003|COMPLETED|Overall Study||61
6627641|NCT02243202|7555533|FG000|NOT COMPLETED|Overall Study||25
6627642|NCT02243202|7555534|FG001|NOT COMPLETED|Overall Study||25
6627643|NCT02243202|7555535|FG002|NOT COMPLETED|Overall Study||31
6627644|NCT02243202|7555536|FG003|NOT COMPLETED|Overall Study||23
6627645|NCT02243280|7555557|FG000|STARTED|Enrolled||40
6627646|NCT02243280|7555558|FG001|STARTED|Enrolled||39
6627647|NCT02243280|7555559|FG002|STARTED|Enrolled||0
6627648|NCT02243280|7555560|FG003|STARTED|Enrolled||0
6627649|NCT02243280|7555561|FG004|STARTED|Enrolled||0
6627650|NCT02243280|7555562|FG005|STARTED|Enrolled||27
6627651|NCT02243280|7555563|FG006|STARTED|Enrolled||0
6627652|NCT02243280|7555564|FG007|STARTED|Enrolled||0
6627653|NCT02243280|7555565|FG008|STARTED|Enrolled||34
6627654|NCT02243280|7555566|FG009|STARTED|Enrolled||0
6627655|NCT02243280|7555567|FG010|STARTED|Enrolled||34
6627656|NCT02243280|7555557|FG000|COMPLETED|Enrolled||40
6627657|NCT02243280|7555558|FG001|COMPLETED|Enrolled||39
6627658|NCT02243280|7555559|FG002|COMPLETED|Enrolled||0
6627659|NCT02243280|7555560|FG003|COMPLETED|Enrolled||0
6627660|NCT02243280|7555561|FG004|COMPLETED|Enrolled||0
6627661|NCT02243280|7555562|FG005|COMPLETED|Enrolled||27
6627662|NCT02243280|7555563|FG006|COMPLETED|Enrolled||0
6627663|NCT02243280|7555564|FG007|COMPLETED|Enrolled||0
6627664|NCT02243280|7555565|FG008|COMPLETED|Enrolled||34
6627665|NCT02243280|7555566|FG009|COMPLETED|Enrolled||0
6627666|NCT02243280|7555567|FG010|COMPLETED|Enrolled||34
6627667|NCT02243280|7555557|FG000|NOT COMPLETED|Enrolled||0
6627668|NCT02243280|7555558|FG001|NOT COMPLETED|Enrolled||0
6627669|NCT02243280|7555559|FG002|NOT COMPLETED|Enrolled||0
6627670|NCT02243280|7555560|FG003|NOT COMPLETED|Enrolled||0
6627671|NCT02243280|7555561|FG004|NOT COMPLETED|Enrolled||0
6627672|NCT02243280|7555562|FG005|NOT COMPLETED|Enrolled||0
6627673|NCT02243280|7555563|FG006|NOT COMPLETED|Enrolled||0
6627674|NCT02243280|7555564|FG007|NOT COMPLETED|Enrolled||0
6627675|NCT02243280|7555565|FG008|NOT COMPLETED|Enrolled||0
6627676|NCT02243280|7555566|FG009|NOT COMPLETED|Enrolled||0
6627677|NCT02243280|7555567|FG010|NOT COMPLETED|Enrolled||0
6627678|NCT02243280|7555557|FG000|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
6627679|NCT02243280|7555558|FG001|STARTED|Treated||39
6627680|NCT02243280|7555559|FG002|STARTED|Treated||0
6627681|NCT02243280|7555560|FG003|STARTED|Treated||0
6627682|NCT02243280|7555561|FG004|STARTED|Treated||0
6627683|NCT02243280|7555562|FG005|STARTED|Treated||27
6627684|NCT02243280|7555563|FG006|STARTED|Treated||0
6627685|NCT02243280|7555564|FG007|STARTED|Treated||0
6627686|NCT02243280|7555565|FG008|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
6627687|NCT02243280|7555566|FG009|STARTED|Treated||0
6627688|NCT02243280|7555567|FG010|STARTED|Treated||34
6627689|NCT02243280|7555557|FG000|Completed Treatment|Treated||42
6627690|NCT02243280|7555558|FG001|Completed Treatment|Treated||38
6627691|NCT02243280|7555559|FG002|Completed Treatment|Treated||0
6627692|NCT02243280|7555560|FG003|Completed Treatment|Treated||0
6627693|NCT02243280|7555561|FG004|Completed Treatment|Treated||0
6627694|NCT02243280|7555562|FG005|Completed Treatment|Treated||27
6627695|NCT02243280|7555563|FG006|Completed Treatment|Treated||0
6627696|NCT02243280|7555564|FG007|Completed Treatment|Treated||0
6627697|NCT02243280|7555565|FG008|Completed Treatment|Treated||32
6627698|NCT02243280|7555566|FG009|Completed Treatment|Treated||0
6627699|NCT02243280|7555567|FG010|Completed Treatment|Treated||33
6627700|NCT02243280|7555557|FG000|COMPLETED|Treated||41
6627701|NCT02243280|7555558|FG001|COMPLETED|Treated||39
6627702|NCT02243280|7555559|FG002|COMPLETED|Treated||0
6627703|NCT02243280|7555560|FG003|COMPLETED|Treated||0
6627704|NCT02243280|7555561|FG004|COMPLETED|Treated||0
6627705|NCT02243280|7555562|FG005|COMPLETED|Treated||27
6627706|NCT02243280|7555563|FG006|COMPLETED|Treated||0
6627707|NCT02243280|7555564|FG007|COMPLETED|Treated||0
6627708|NCT02243280|7555565|FG008|COMPLETED|Treated||31
6627709|NCT02243280|7555566|FG009|COMPLETED|Treated||0
6627710|NCT02243280|7555567|FG010|COMPLETED|Treated||31
6627711|NCT02243280|7555557|FG000|NOT COMPLETED|Treated||1
6627712|NCT02243280|7555558|FG001|NOT COMPLETED|Treated||0
6627713|NCT02243280|7555559|FG002|NOT COMPLETED|Treated||0
6627714|NCT02243280|7555560|FG003|NOT COMPLETED|Treated||0
6627715|NCT02243280|7555561|FG004|NOT COMPLETED|Treated||0
6627716|NCT02243280|7555562|FG005|NOT COMPLETED|Treated||0
6627717|NCT02243280|7555563|FG006|NOT COMPLETED|Treated||0
6627718|NCT02243280|7555564|FG007|NOT COMPLETED|Treated||0
6627719|NCT02243280|7555565|FG008|NOT COMPLETED|Treated||1
6627720|NCT02243280|7555566|FG009|NOT COMPLETED|Treated||0
6627721|NCT02243280|7555567|FG010|NOT COMPLETED|Treated||3
6627722|NCT02243293|7555602|FG000|STARTED|Overall Study||25
6627723|NCT02243293|7555603|FG001|STARTED|Overall Study||24
6627724|NCT02243293|7555604|FG002|STARTED|Overall Study||25
6627725|NCT02243293|7555605|FG003|STARTED|Overall Study||30
6627726|NCT02243293|7555606|FG004|STARTED|Overall Study||31
6627727|NCT02243293|7555607|FG005|STARTED|Overall Study||31
6627728|NCT02243293|7555608|FG006|STARTED|Overall Study||30
6627729|NCT02243293|7555609|FG007|STARTED|Overall Study||0
6627730|NCT02243293|7555610|FG008|STARTED|Overall Study||0
6627731|NCT02243293|7555611|FG009|STARTED|Overall Study||55
6627732|NCT02243293|7555612|FG010|STARTED|Overall Study||0
6627733|NCT02243293|7555613|FG011|STARTED|Overall Study||53
6627734|NCT02243293|7555614|FG012|STARTED|Overall Study||0
6627735|NCT02243293|7555615|FG013|STARTED|Overall Study||0
6627736|NCT02243293|7555616|FG014|STARTED|Overall Study||28
6627737|NCT02243293|7555617|FG015|STARTED|Overall Study||27
6627738|NCT02243293|7555618|FG016|STARTED|Overall Study||40
6627739|NCT02243293|7555619|FG017|STARTED|Overall Study||22
6627740|NCT02243293|7555620|FG018|STARTED|Overall Study||22
6627741|NCT02243293|7555621|FG019|STARTED|Overall Study||48
6627742|NCT02243293|7555622|FG020|STARTED|Overall Study||145
6627743|NCT02243293|7555623|FG021|STARTED|Overall Study||58
6627744|NCT02243293|7555602|FG000|COMPLETED|Overall Study||23
6627745|NCT02243293|7555603|FG001|COMPLETED|Overall Study||23
6627746|NCT02243293|7555604|FG002|COMPLETED|Overall Study||24
6627747|NCT02243293|7555605|FG003|COMPLETED|Overall Study||29
6627748|NCT02243293|7555606|FG004|COMPLETED|Overall Study||30
6627749|NCT02243293|7555607|FG005|COMPLETED|Overall Study||31
6627750|NCT02243293|7555608|FG006|COMPLETED|Overall Study||27
6627751|NCT02243293|7555609|FG007|COMPLETED|Overall Study||0
6627752|NCT02243293|7555610|FG008|COMPLETED|Overall Study||0
6627753|NCT02243293|7555611|FG009|COMPLETED|Overall Study||53
6627754|NCT02243293|7555612|FG010|COMPLETED|Overall Study||0
6627755|NCT02243293|7555613|FG011|COMPLETED|Overall Study||50
6627756|NCT02243293|7555614|FG012|COMPLETED|Overall Study||0
6627757|NCT02243293|7555615|FG013|COMPLETED|Overall Study||0
6627758|NCT02243293|7555616|FG014|COMPLETED|Overall Study||27
6627759|NCT02243293|7555617|FG015|COMPLETED|Overall Study||26
6627760|NCT02243293|7555618|FG016|COMPLETED|Overall Study||37
6627761|NCT02243293|7555619|FG017|COMPLETED|Overall Study||21
6627762|NCT02243293|7555620|FG018|COMPLETED|Overall Study||22
6627763|NCT02243293|7555621|FG019|COMPLETED|Overall Study||47
6627764|NCT02243293|7555622|FG020|COMPLETED|Overall Study||143
6627765|NCT02243293|7555623|FG021|COMPLETED|Overall Study||55
6627766|NCT02243293|7555602|FG000|NOT COMPLETED|Overall Study||2
6627767|NCT02243293|7555603|FG001|NOT COMPLETED|Overall Study||1
6627768|NCT02243293|7555604|FG002|NOT COMPLETED|Overall Study||1
6627769|NCT02243293|7555605|FG003|NOT COMPLETED|Overall Study||1
6627770|NCT02243293|7555606|FG004|NOT COMPLETED|Overall Study||1
6627771|NCT02243293|7555607|FG005|NOT COMPLETED|Overall Study||0
6627772|NCT02243293|7555608|FG006|NOT COMPLETED|Overall Study||3
6627773|NCT02243293|7555609|FG007|NOT COMPLETED|Overall Study||0
6627774|NCT02243293|7555610|FG008|NOT COMPLETED|Overall Study||0
6627775|NCT02243293|7555611|FG009|NOT COMPLETED|Overall Study||2
6627776|NCT02243293|7555612|FG010|NOT COMPLETED|Overall Study||0
6627777|NCT02243293|7555613|FG011|NOT COMPLETED|Overall Study||3
6627778|NCT02243293|7555614|FG012|NOT COMPLETED|Overall Study||0
6627779|NCT02243293|7555615|FG013|NOT COMPLETED|Overall Study||0
6627780|NCT02243293|7555616|FG014|NOT COMPLETED|Overall Study||1
6627781|NCT02243293|7555617|FG015|NOT COMPLETED|Overall Study||1
6627782|NCT02243293|7555618|FG016|NOT COMPLETED|Overall Study||3
6627783|NCT02243293|7555619|FG017|NOT COMPLETED|Overall Study||1
6627784|NCT02243293|7555620|FG018|NOT COMPLETED|Overall Study||0
6627785|NCT02243293|7555621|FG019|NOT COMPLETED|Overall Study||1
6627786|NCT02243293|7555622|FG020|NOT COMPLETED|Overall Study||2
6627787|NCT02243293|7555623|FG021|NOT COMPLETED|Overall Study||3
6627788|NCT02243371|7555662|FG000|STARTED|Overall Study||51
6627789|NCT02243371|7555663|FG001|STARTED|Overall Study||42
6627790|NCT02243371|7555662|FG000|COMPLETED|Overall Study||14
6627791|NCT02243371|7555663|FG001|COMPLETED|Overall Study||10
6627792|NCT02243371|7555662|FG000|NOT COMPLETED|Overall Study||37
6627793|NCT02243371|7555663|FG001|NOT COMPLETED|Overall Study||32
6627794|NCT02243527|7555671|FG000|STARTED|Overall Study||12
6627795|NCT02243527|7555672|FG001|STARTED|Overall Study||13
6627796|NCT02243527|7555671|FG000|COMPLETED|Overall Study||12
6627797|NCT02243527|7555672|FG001|COMPLETED|Overall Study||13
6627798|NCT02243527|7555671|FG000|NOT COMPLETED|Overall Study||0
6627799|NCT02243527|7555672|FG001|NOT COMPLETED|Overall Study||0
6627800|NCT02243579|7555678|FG000|STARTED|Overall Study||24
6627801|NCT02243579|7555678|FG000|COMPLETED|Overall Study||4
6627802|NCT02243579|7555678|FG000|NOT COMPLETED|Overall Study||20
6627803|NCT02243605|7555684|FG000|STARTED|Stage 1 - Interim Analysis Population||23
6627804|NCT02243605|7555685|FG001|STARTED|Stage 1 - Interim Analysis Population||22
6627805|NCT02243605|7555684|FG000|COMPLETED|Stage 1 - Interim Analysis Population||21
6627806|NCT02243605|7555685|FG001|COMPLETED|Stage 1 - Interim Analysis Population||21
6627807|NCT02243605|7555684|FG000|NOT COMPLETED|Stage 1 - Interim Analysis Population||2
6627808|NCT02243605|7555685|FG001|NOT COMPLETED|Stage 1 - Interim Analysis Population||1
6627809|NCT02243605|7555684|FG000|STARTED|Stage 2 - Final Analysis Population||45
6627810|NCT02243605|7555685|FG001|STARTED|Stage 2 - Final Analysis Population||45
6627811|NCT02243605|7555684|FG000|COMPLETED|Stage 2 - Final Analysis Population||39
6627812|NCT02243605|7555685|FG001|COMPLETED|Stage 2 - Final Analysis Population||42
6627813|NCT02243605|7555684|FG000|NOT COMPLETED|Stage 2 - Final Analysis Population||6
6627814|NCT02243605|7555685|FG001|NOT COMPLETED|Stage 2 - Final Analysis Population||3
6627815|NCT02243696|7555691|FG000|STARTED|Overall Study||1694
6627816|NCT02243696|7555691|FG000|COMPLETED|Overall Study||0
6627817|NCT02243696|7555691|FG000|NOT COMPLETED|Overall Study||1694
6627818|NCT02243865|7555697|FG000|STARTED|Overall Study||44
6627819|NCT02243865|7555698|FG001|STARTED|Overall Study||43
6627820|NCT02243865|7555697|FG000|COMPLETED|Overall Study||40
6627821|NCT02243865|7555698|FG001|COMPLETED|Overall Study||38
6627822|NCT02243865|7555697|FG000|NOT COMPLETED|Overall Study||4
6627823|NCT02243865|7555698|FG001|NOT COMPLETED|Overall Study||5
6627824|NCT02243943|7555708|FG000|STARTED|Overall Study||50
6627825|NCT02243943|7555709|FG001|STARTED|Overall Study||50
6627826|NCT02243943|7555708|FG000|COMPLETED|Overall Study||50
6627827|NCT02243943|7555709|FG001|COMPLETED|Overall Study||50
6627828|NCT02243943|7555708|FG000|NOT COMPLETED|Overall Study||0
6627829|NCT02243943|7555709|FG001|NOT COMPLETED|Overall Study||0
6627830|NCT02244424|7555717|FG000|STARTED|Overall Study|Teens were the participants who received the intervention. Data were collected on the infants.|102
6627831|NCT02244424|7555718|FG001|STARTED|Overall Study|Teen participants received the MIHP standard care. Data were collected on infants.|62
6627832|NCT02244424|7555717|FG000|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|51
6627833|NCT02244424|7555718|FG001|Infants|Overall Study|Infants of participants included in the study for collection of demographic and weight data.|31
6627834|NCT02244424|7555717|FG000|Mothers|Overall Study||51
6627835|NCT02244424|7555718|FG001|Mothers|Overall Study||31
6627836|NCT02244424|7555717|FG000|COMPLETED|Overall Study|Data were collected on all of the infants of the teen moms (n = 41).|82
6627837|NCT02244424|7555718|FG001|COMPLETED|Overall Study|Data were collected on all of the infants of teen moms (n = 26).|52
6627838|NCT02244424|7555717|FG000|NOT COMPLETED|Overall Study||20
6627839|NCT02244424|7555718|FG001|NOT COMPLETED|Overall Study||10
6627840|NCT02244580|7555724|FG000|STARTED|Overall Study||1010
6627841|NCT02244580|7555724|FG000|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
6627842|NCT02244580|7555724|FG000|NOT COMPLETED|Overall Study||241
6627843|NCT02244619|7555734|FG000|STARTED|Overall Study||249
6627844|NCT02244619|7555735|FG001|STARTED|Overall Study||266
6627845|NCT02244619|7555734|FG000|COMPLETED|Overall Study||241
6627846|NCT02244619|7555735|FG001|COMPLETED|Overall Study||245
6627847|NCT02244619|7555734|FG000|NOT COMPLETED|Overall Study||8
6627848|NCT02244619|7555735|FG001|NOT COMPLETED|Overall Study||21
6627849|NCT02244840|7555741|FG000|STARTED|Overall Study||40
6627850|NCT02244840|7555741|FG000|COMPLETED|Overall Study||40
6627851|NCT02244840|7555741|FG000|NOT COMPLETED|Overall Study||0
6627852|NCT02244918|7555747|FG000|STARTED|Overall Study||185
6627853|NCT02244918|7555748|FG001|STARTED|Overall Study||93
6627854|NCT02244918|7555747|FG000|Week 12|Overall Study||160
6627855|NCT02244918|7555748|FG001|Week 12|Overall Study||83
6627856|NCT02244918|7555747|FG000|COMPLETED|Overall Study||185
6627857|NCT02244918|7555748|FG001|COMPLETED|Overall Study||93
6627858|NCT02244918|7555747|FG000|NOT COMPLETED|Overall Study||0
6627859|NCT02244918|7555748|FG001|NOT COMPLETED|Overall Study||0
6627860|NCT02244957|7555757|FG000|STARTED|Overall Study||7
6627861|NCT02244957|7555758|FG001|STARTED|Overall Study||16
6627862|NCT02244957|7555757|FG000|COMPLETED|Overall Study||6
6627863|NCT02244957|7555758|FG001|COMPLETED|Overall Study||16
6282364|NCT00182325|7182654|FG001|COMPLETED|Overall Study|43 completed survey, 89 included in intention-to-treat analysis|43
6282365|NCT00182325|7182653|FG000|NOT COMPLETED|Overall Study||34
6282366|NCT00182325|7182654|FG001|NOT COMPLETED|Overall Study||53
6282367|NCT00182689|7182662|FG000|STARTED|Overall Study||40
6282368|NCT00182689|7182663|FG001|STARTED|Overall Study||49
6282369|NCT00182689|7182662|FG000|Eligible|Overall Study||39
6282370|NCT00182689|7182663|FG001|Eligible|Overall Study||45
6282371|NCT00182689|7182662|FG000|Eligible and Began Protocol Therapy|Overall Study||38
6282372|NCT00182689|7182663|FG001|Eligible and Began Protocol Therapy|Overall Study||45
6282373|NCT00182689|7182662|FG000|COMPLETED|Overall Study||0
6282374|NCT00182689|7182663|FG001|COMPLETED|Overall Study||0
6282375|NCT00182689|7182662|FG000|NOT COMPLETED|Overall Study||40
6282376|NCT00182689|7182663|FG001|NOT COMPLETED|Overall Study||49
6282377|NCT00182754|7182675|FG000|STARTED|Overall Study||16
6282378|NCT00182754|7182676|FG001|STARTED|Overall Study||17
6282379|NCT00182754|7182675|FG000|COMPLETED|Overall Study||16
6282380|NCT00182754|7182676|FG001|COMPLETED|Overall Study||17
6282381|NCT00182754|7182675|FG000|NOT COMPLETED|Overall Study||0
6282382|NCT00182754|7182676|FG001|NOT COMPLETED|Overall Study||0
6282383|NCT00182767|7182682|FG000|STARTED|Overall Study||6
6282384|NCT00182767|7182683|FG001|STARTED|Overall Study||6
6282385|NCT00182767|7182684|FG002|STARTED|Overall Study||6
6282386|NCT00182767|7182685|FG003|STARTED|Overall Study||3
6627864|NCT02244957|7555757|FG000|NOT COMPLETED|Overall Study||1
6627865|NCT02244957|7555758|FG001|NOT COMPLETED|Overall Study||0
6282387|NCT00182767|7182686|FG004|STARTED|Overall Study||24
6282388|NCT00182767|7182682|FG000|COMPLETED|Overall Study||6
6282389|NCT00182767|7182683|FG001|COMPLETED|Overall Study||6
6282390|NCT00182767|7182684|FG002|COMPLETED|Overall Study||6
6282391|NCT00182767|7182685|FG003|COMPLETED|Overall Study||3
6282392|NCT00182767|7182686|FG004|COMPLETED|Overall Study||24
6282393|NCT00182767|7182682|FG000|NOT COMPLETED|Overall Study||0
6282394|NCT00182767|7182683|FG001|NOT COMPLETED|Overall Study||0
6282395|NCT00182767|7182684|FG002|NOT COMPLETED|Overall Study||0
6282396|NCT00182767|7182685|FG003|NOT COMPLETED|Overall Study||0
6282397|NCT00182767|7182686|FG004|NOT COMPLETED|Overall Study||0
6282398|NCT00182793|7182700|FG000|STARTED|Overall Study||32
6282399|NCT00182793|7182700|FG000|COMPLETED|Overall Study||32
6282400|NCT00182793|7182700|FG000|NOT COMPLETED|Overall Study||0
6282401|NCT00183092|7182706|FG000|STARTED|Double-blind (Baseline - Month 2)||23
6282402|NCT00183092|7182707|FG001|STARTED|Double-blind (Baseline - Month 2)||28
6282403|NCT00183092|7182708|FG002|STARTED|Double-blind (Baseline - Month 2)||0
6627866|NCT02244996|7555768|FG000|STARTED|Overall Study||25
6627867|NCT02244996|7555769|FG001|STARTED|Overall Study||25
6627868|NCT02244996|7555768|FG000|COMPLETED|Overall Study||23
6627869|NCT02244996|7555769|FG001|COMPLETED|Overall Study||19
6627870|NCT02244996|7555768|FG000|NOT COMPLETED|Overall Study||2
6627871|NCT02244996|7555769|FG001|NOT COMPLETED|Overall Study||6
6627872|NCT02245217|7555775|FG000|STARTED|Overall Study||9
6627873|NCT02245217|7555775|FG000|COMPLETED|Overall Study||7
6627874|NCT02245217|7555775|FG000|NOT COMPLETED|Overall Study||2
6627875|NCT02245360|7555781|FG000|STARTED|Overall Study||53
6627876|NCT02245360|7555782|FG001|STARTED|Overall Study||54
6627877|NCT02245360|7555781|FG000|COMPLETED|Overall Study||48
6627878|NCT02245360|7555782|FG001|COMPLETED|Overall Study||52
6627879|NCT02245360|7555781|FG000|NOT COMPLETED|Overall Study||5
6627880|NCT02245360|7555782|FG001|NOT COMPLETED|Overall Study||2
6627881|NCT02245412|7555791|FG000|STARTED|Treatment Period||17
6627882|NCT02245412|7555792|FG001|STARTED|Treatment Period||6
6627883|NCT02245412|7555793|FG002|STARTED|Treatment Period||2
6627884|NCT02245412|7555791|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||17
6627885|NCT02245412|7555792|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
6627886|NCT02245412|7555793|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||2
6627887|NCT02245412|7555791|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||16
6627888|NCT02245412|7555792|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||6
6627889|NCT02245412|7555793|FG002|Modified Full Analysis Set (mFAS)|Treatment Period||2
6627890|NCT02245412|7555791|FG000|COMPLETED|Treatment Period||12
6627891|NCT02245412|7555792|FG001|COMPLETED|Treatment Period||3
6627892|NCT02245412|7555793|FG002|COMPLETED|Treatment Period||2
6627893|NCT02245412|7555791|FG000|NOT COMPLETED|Treatment Period||5
6627894|NCT02245412|7555792|FG001|NOT COMPLETED|Treatment Period||3
6627895|NCT02245412|7555793|FG002|NOT COMPLETED|Treatment Period||0
6627896|NCT02245412|7555791|FG000|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|13
6627897|NCT02245412|7555792|FG001|STARTED|Follow-Up Period|One participant who discontinued Study Drug in Treatment Period continued to Follow-Up Period.|4
6627898|NCT02245412|7555793|FG002|STARTED|Follow-Up Period||2
6627899|NCT02245412|7555791|FG000|COMPLETED|Follow-Up Period||8
6627900|NCT02245412|7555792|FG001|COMPLETED|Follow-Up Period||2
6627901|NCT02245412|7555793|FG002|COMPLETED|Follow-Up Period||0
6627902|NCT02245412|7555791|FG000|NOT COMPLETED|Follow-Up Period||5
6627903|NCT02245412|7555792|FG001|NOT COMPLETED|Follow-Up Period||2
6627904|NCT02245412|7555793|FG002|NOT COMPLETED|Follow-Up Period||2
6627905|NCT02245516|7555803|FG000|STARTED|Overall Study||9
6627906|NCT02245516|7555804|FG001|STARTED|Overall Study||7
6627907|NCT02245516|7555803|FG000|COMPLETED|Overall Study||9
6627908|NCT02245516|7555804|FG001|COMPLETED|Overall Study||4
6627909|NCT02245516|7555803|FG000|NOT COMPLETED|Overall Study||0
6627910|NCT02245516|7555804|FG001|NOT COMPLETED|Overall Study||3
6627911|NCT02245568|7555810|FG000|STARTED|Overall Study||913
6627912|NCT02245568|7555810|FG000|COMPLETED|Overall Study||60
6627913|NCT02245568|7555810|FG000|NOT COMPLETED|Overall Study||853
6627914|NCT02245620|7555816|FG000|STARTED|Overall Study||20
6627915|NCT02245620|7555817|FG001|STARTED|Overall Study||21
6627916|NCT02245620|7555816|FG000|COMPLETED|Overall Study||19
6627917|NCT02245620|7555817|FG001|COMPLETED|Overall Study||20
6627918|NCT02245620|7555816|FG000|NOT COMPLETED|Overall Study||1
6627919|NCT02245620|7555817|FG001|NOT COMPLETED|Overall Study||1
6627920|NCT02245737|7555826|FG000|STARTED|Overall Study||740
6627921|NCT02245737|7555827|FG001|STARTED|Overall Study||739
6627922|NCT02245737|7555828|FG002|STARTED|Overall Study||739
6627923|NCT02245737|7555826|FG000|Received at Least 1 Dose of Study Drug|Overall Study||738
6627924|NCT02245737|7555827|FG001|Received at Least 1 Dose of Study Drug|Overall Study||736
6627925|NCT02245737|7555828|FG002|Received at Least 1 Dose of Study Drug|Overall Study||735
6627926|NCT02245737|7555826|FG000|COMPLETED|Overall Study||187
6627927|NCT02245737|7555827|FG001|COMPLETED|Overall Study||184
6627928|NCT02245737|7555828|FG002|COMPLETED|Overall Study||168
6627929|NCT02245737|7555826|FG000|NOT COMPLETED|Overall Study||553
6627930|NCT02245737|7555827|FG001|NOT COMPLETED|Overall Study||555
6627931|NCT02245737|7555828|FG002|NOT COMPLETED|Overall Study||571
6627932|NCT02245815|7555840|FG000|STARTED|Overall Study||45
6627933|NCT02245815|7555841|FG001|STARTED|Overall Study||45
6627934|NCT02245815|7555840|FG000|COMPLETED|Overall Study||45
6627935|NCT02245815|7555841|FG001|COMPLETED|Overall Study||45
6627936|NCT02245815|7555840|FG000|NOT COMPLETED|Overall Study||0
6627937|NCT02245815|7555841|FG001|NOT COMPLETED|Overall Study||0
6627938|NCT02246010|7555851|FG000|STARTED|Overall Study||4
6627939|NCT02246010|7555852|FG001|STARTED|Overall Study||2
6627940|NCT02246010|7555851|FG000|COMPLETED|Overall Study||4
6627941|NCT02246010|7555852|FG001|COMPLETED|Overall Study||2
6627942|NCT02246010|7555851|FG000|NOT COMPLETED|Overall Study||0
6627943|NCT02246010|7555852|FG001|NOT COMPLETED|Overall Study||0
6627944|NCT02246062|7555862|FG000|STARTED|Overall Study||21
6627945|NCT02246062|7555863|FG001|STARTED|Overall Study||21
6627946|NCT02246062|7555864|FG002|STARTED|Overall Study||21
6627947|NCT02246062|7555865|FG003|STARTED|Overall Study||21
6627948|NCT02246062|7555862|FG000|COMPLETED|Overall Study||21
6627949|NCT02246062|7555863|FG001|COMPLETED|Overall Study||21
6627950|NCT02246062|7555864|FG002|COMPLETED|Overall Study||21
6627951|NCT02246062|7555865|FG003|COMPLETED|Overall Study||21
6627952|NCT02246062|7555862|FG000|NOT COMPLETED|Overall Study||0
6627953|NCT02246062|7555863|FG001|NOT COMPLETED|Overall Study||0
6627954|NCT02246062|7555864|FG002|NOT COMPLETED|Overall Study||0
6627955|NCT02246062|7555865|FG003|NOT COMPLETED|Overall Study||0
6627956|NCT02246166|7555877|FG000|STARTED|Overall Study||26
6627957|NCT02246166|7555878|FG001|STARTED|Overall Study||27
6627958|NCT02246166|7555877|FG000|COMPLETED|Overall Study||25
6627959|NCT02246166|7555878|FG001|COMPLETED|Overall Study||27
6627960|NCT02246166|7555877|FG000|NOT COMPLETED|Overall Study||1
6627961|NCT02246166|7555878|FG001|NOT COMPLETED|Overall Study||0
6627962|NCT02246218|7555886|FG000|STARTED|Overall Study||10
6627963|NCT02246218|7555887|FG001|STARTED|Overall Study||16
6627964|NCT02246218|7555886|FG000|COMPLETED|Overall Study||6
6627965|NCT02246218|7555887|FG001|COMPLETED|Overall Study||10
6627966|NCT02246218|7555886|FG000|NOT COMPLETED|Overall Study||4
6627967|NCT02246218|7555887|FG001|NOT COMPLETED|Overall Study||6
6627968|NCT02246309|7555895|FG000|STARTED|Overall Study|16 patients going through Time Lapse System and 15 through Standard Embryo Culture.|16
6627969|NCT02246309|7555896|FG001|STARTED|Overall Study||15
6627970|NCT02246309|7555895|FG000|COMPLETED|Overall Study||16
6627971|NCT02246309|7555896|FG001|COMPLETED|Overall Study||15
6627972|NCT02246309|7555895|FG000|NOT COMPLETED|Overall Study||0
6627973|NCT02246309|7555896|FG001|NOT COMPLETED|Overall Study||0
6627974|NCT02246413|7555904|FG000|STARTED|12-months (Primary Outcome)||204
6627975|NCT02246413|7555905|FG001|STARTED|12-months (Primary Outcome)||205
6627976|NCT02246413|7555904|FG000|COMPLETED|12-months (Primary Outcome)||169
6627977|NCT02246413|7555905|FG001|COMPLETED|12-months (Primary Outcome)||175
6627978|NCT02246413|7555904|FG000|NOT COMPLETED|12-months (Primary Outcome)||35
6627979|NCT02246413|7555905|FG001|NOT COMPLETED|12-months (Primary Outcome)||30
6627980|NCT02246413|7555904|FG000|STARTED|24-months (Secondary Outcome)||204
6627981|NCT02246413|7555905|FG001|STARTED|24-months (Secondary Outcome)||205
6627982|NCT02246413|7555904|FG000|COMPLETED|24-months (Secondary Outcome)||153
6627983|NCT02246413|7555905|FG001|COMPLETED|24-months (Secondary Outcome)||173
6627984|NCT02246413|7555904|FG000|NOT COMPLETED|24-months (Secondary Outcome)||51
6627985|NCT02246413|7555905|FG001|NOT COMPLETED|24-months (Secondary Outcome)||32
6627986|NCT02246439|7555913|FG000|STARTED|Overall Study|6 participants that enrolled in the study did not receive allocated intervention.|192
6627987|NCT02246439|7555914|FG001|STARTED|Overall Study|3 participants that enrolled in the study did not receive allocated intervention.|129
6627988|NCT02246439|7555913|FG000|Randomized|Overall Study||198
6627989|NCT02246439|7555914|FG001|Randomized|Overall Study||132
6627990|NCT02246439|7555913|FG000|COMPLETED|Overall Study||180
6627991|NCT02246439|7555914|FG001|COMPLETED|Overall Study||118
6627992|NCT02246439|7555913|FG000|NOT COMPLETED|Overall Study||12
6627993|NCT02246439|7555914|FG001|NOT COMPLETED|Overall Study||11
6627994|NCT02246478|7555924|FG000|STARTED|Single-dose Phase||6
6627995|NCT02246478|7555925|FG001|STARTED|Single-dose Phase||5
6627996|NCT02246478|7555926|FG002|STARTED|Single-dose Phase||5
6627997|NCT02246478|7555927|FG003|STARTED|Single-dose Phase||5
6627998|NCT02246478|7555924|FG000|COMPLETED|Single-dose Phase||6
6627999|NCT02246478|7555925|FG001|COMPLETED|Single-dose Phase||5
6628000|NCT02246478|7555926|FG002|COMPLETED|Single-dose Phase||5
6628001|NCT02246478|7555927|FG003|COMPLETED|Single-dose Phase||5
6628002|NCT02246478|7555924|FG000|NOT COMPLETED|Single-dose Phase||0
6628003|NCT02246478|7555925|FG001|NOT COMPLETED|Single-dose Phase||0
6628004|NCT02246478|7555926|FG002|NOT COMPLETED|Single-dose Phase||0
6628005|NCT02246478|7555927|FG003|NOT COMPLETED|Single-dose Phase||0
6628006|NCT02246478|7555924|FG000|STARTED|Multiple-dose Phase||6
6628007|NCT02246478|7555925|FG001|STARTED|Multiple-dose Phase||5
6628008|NCT02246478|7555926|FG002|STARTED|Multiple-dose Phase||5
6628009|NCT02246478|7555927|FG003|STARTED|Multiple-dose Phase||5
6628010|NCT02246478|7555924|FG000|COMPLETED|Multiple-dose Phase||5
6628011|NCT02246478|7555925|FG001|COMPLETED|Multiple-dose Phase||5
6628012|NCT02246478|7555926|FG002|COMPLETED|Multiple-dose Phase||5
6628013|NCT02246478|7555927|FG003|COMPLETED|Multiple-dose Phase||4
6628014|NCT02246478|7555924|FG000|NOT COMPLETED|Multiple-dose Phase||1
6628015|NCT02246478|7555925|FG001|NOT COMPLETED|Multiple-dose Phase||0
6628016|NCT02246478|7555926|FG002|NOT COMPLETED|Multiple-dose Phase||0
6628017|NCT02246478|7555927|FG003|NOT COMPLETED|Multiple-dose Phase||1
6628018|NCT02246582|7555944|FG000|STARTED|Overall Study||44
6628019|NCT02246582|7555945|FG001|STARTED|Overall Study||45
6628020|NCT02246582|7555944|FG000|COMPLETED|Overall Study||41
6628021|NCT02246582|7555945|FG001|COMPLETED|Overall Study||41
6628022|NCT02246582|7555944|FG000|NOT COMPLETED|Overall Study||3
6628023|NCT02246582|7555945|FG001|NOT COMPLETED|Overall Study||4
6628024|NCT02246608|7555951|FG000|STARTED|Overall Study||22
6628025|NCT02246608|7555952|FG001|STARTED|Overall Study||21
6628026|NCT02246608|7555951|FG000|COMPLETED|Overall Study||10
6628027|NCT02246608|7555952|FG001|COMPLETED|Overall Study||11
6628028|NCT02246608|7555951|FG000|NOT COMPLETED|Overall Study||12
6628029|NCT02246608|7555952|FG001|NOT COMPLETED|Overall Study||10
6628030|NCT02246647|7555960|FG000|STARTED|Overall Study||19
6628031|NCT02246647|7555961|FG001|STARTED|Overall Study||20
6628032|NCT02246647|7555960|FG000|COMPLETED|Overall Study||18
6628033|NCT02246647|7555961|FG001|COMPLETED|Overall Study||19
6628034|NCT02246647|7555960|FG000|NOT COMPLETED|Overall Study||1
6628035|NCT02246647|7555961|FG001|NOT COMPLETED|Overall Study||1
6628036|NCT02246660|7555984|FG000|STARTED|Overall Study||23
6628037|NCT02246660|7555985|FG001|STARTED|Overall Study||21
6628038|NCT02246660|7555986|FG002|STARTED|Overall Study||22
6628039|NCT02246660|7555984|FG000|COMPLETED|Overall Study||23
6628040|NCT02246660|7555985|FG001|COMPLETED|Overall Study||20
6628041|NCT02246660|7555986|FG002|COMPLETED|Overall Study||21
6628042|NCT02246660|7555984|FG000|NOT COMPLETED|Overall Study||0
6628043|NCT02246660|7555985|FG001|NOT COMPLETED|Overall Study||1
6628044|NCT02246660|7555986|FG002|NOT COMPLETED|Overall Study||1
6628045|NCT02246673|7555999|FG000|STARTED|Overall Study||14
6628046|NCT02246673|7556000|FG001|STARTED|Overall Study||12
6628047|NCT02246673|7556001|FG002|STARTED|Overall Study||12
6628048|NCT02246673|7556002|FG003|STARTED|Overall Study||14
6628049|NCT02246673|7556003|FG004|STARTED|Overall Study||12
6628050|NCT02246673|7555999|FG000|COMPLETED|Overall Study||13
6628051|NCT02246673|7556000|FG001|COMPLETED|Overall Study||12
6628052|NCT02246673|7556001|FG002|COMPLETED|Overall Study||12
6628053|NCT02246673|7556002|FG003|COMPLETED|Overall Study||12
6628054|NCT02246673|7556003|FG004|COMPLETED|Overall Study||11
6628055|NCT02246673|7555999|FG000|NOT COMPLETED|Overall Study||1
6628056|NCT02246673|7556000|FG001|NOT COMPLETED|Overall Study||0
6628057|NCT02246673|7556001|FG002|NOT COMPLETED|Overall Study||0
6628058|NCT02246673|7556002|FG003|NOT COMPLETED|Overall Study||2
6628059|NCT02246673|7556003|FG004|NOT COMPLETED|Overall Study||1
6628060|NCT02246764|7556048|FG000|STARTED|Overall Study||34
6628061|NCT02246764|7556049|FG001|STARTED|Overall Study||36
6628062|NCT02246764|7556050|FG002|STARTED|Overall Study||23
6628063|NCT02246764|7556048|FG000|COMPLETED|Overall Study||16
6628064|NCT02246764|7556049|FG001|COMPLETED|Overall Study||4
6628065|NCT02246764|7556050|FG002|COMPLETED|Overall Study||19
6628066|NCT02246764|7556048|FG000|NOT COMPLETED|Overall Study||18
6628067|NCT02246764|7556049|FG001|NOT COMPLETED|Overall Study||32
6628068|NCT02246764|7556050|FG002|NOT COMPLETED|Overall Study||4
6628069|NCT02246777|7556058|FG000|STARTED|Overall Study||32
6628070|NCT02246777|7556058|FG000|COMPLETED|Overall Study||29
6628071|NCT02246777|7556058|FG000|NOT COMPLETED|Overall Study||3
6628072|NCT02246998|7556071|FG000|STARTED|Overall Study||18
6628073|NCT02246998|7556072|FG001|STARTED|Overall Study||18
6628074|NCT02246998|7556073|FG002|STARTED|Overall Study||18
6628075|NCT02246998|7556074|FG003|STARTED|Overall Study||18
6628076|NCT02246998|7556071|FG000|COMPLETED|Overall Study||16
6628077|NCT02246998|7556072|FG001|COMPLETED|Overall Study||15
6628078|NCT02246998|7556073|FG002|COMPLETED|Overall Study||15
6628079|NCT02246998|7556074|FG003|COMPLETED|Overall Study||16
6628080|NCT02246998|7556071|FG000|NOT COMPLETED|Overall Study||2
6628081|NCT02246998|7556072|FG001|NOT COMPLETED|Overall Study||3
6628082|NCT02246998|7556073|FG002|NOT COMPLETED|Overall Study||3
6628083|NCT02246998|7556074|FG003|NOT COMPLETED|Overall Study||2
6628084|NCT02247011|7556089|FG000|STARTED|Overall Study||1100
6628085|NCT02247011|7556089|FG000|COMPLETED|Overall Study||975
6628086|NCT02247011|7556089|FG000|NOT COMPLETED|Overall Study||125
6628087|NCT02247063|7556098|FG000|STARTED|Overall Study||12
6628088|NCT02247063|7556099|FG001|STARTED|Overall Study||12
6628089|NCT02247063|7556098|FG000|COMPLETED|Overall Study||12
6628090|NCT02247063|7556099|FG001|COMPLETED|Overall Study||12
6628091|NCT02247063|7556098|FG000|NOT COMPLETED|Overall Study||0
6628092|NCT02247063|7556099|FG001|NOT COMPLETED|Overall Study||0
6628093|NCT02247193|7556107|FG000|STARTED|Overall Study||15
6282404|NCT00183092|7182709|FG003|STARTED|Double-blind (Baseline - Month 2)||0
6282405|NCT00183092|7182706|FG000|Alive at Month 2|Double-blind (Baseline - Month 2)||13
6282406|NCT00183092|7182707|FG001|Alive at Month 2|Double-blind (Baseline - Month 2)||19
6282407|NCT00183092|7182708|FG002|Alive at Month 2|Double-blind (Baseline - Month 2)||0
6282408|NCT00183092|7182709|FG003|Alive at Month 2|Double-blind (Baseline - Month 2)||0
6282409|NCT00183092|7182706|FG000|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
6282410|NCT00183092|7182707|FG001|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
6282411|NCT00183092|7182708|FG002|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
6282412|NCT00183092|7182709|FG003|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
6282413|NCT00183092|7182706|FG000|COMPLETED|Double-blind (Baseline - Month 2)||11
6282414|NCT00183092|7182707|FG001|COMPLETED|Double-blind (Baseline - Month 2)||16
6282415|NCT00183092|7182708|FG002|COMPLETED|Double-blind (Baseline - Month 2)||0
6282416|NCT00183092|7182709|FG003|COMPLETED|Double-blind (Baseline - Month 2)||0
6282417|NCT00183092|7182706|FG000|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
6282418|NCT00183092|7182707|FG001|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
6282419|NCT00183092|7182708|FG002|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
6282420|NCT00183092|7182709|FG003|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
6282421|NCT00183092|7182706|FG000|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
6282422|NCT00183092|7182707|FG001|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
6282423|NCT00183092|7182708|FG002|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
6282424|NCT00183092|7182709|FG003|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
6282425|NCT00183092|7182706|FG000|COMPLETED|Open-label Period (Month 2 Until Death)||0
6282426|NCT00183092|7182707|FG001|COMPLETED|Open-label Period (Month 2 Until Death)||0
6282427|NCT00183092|7182708|FG002|COMPLETED|Open-label Period (Month 2 Until Death)||0
6282428|NCT00183092|7182709|FG003|COMPLETED|Open-label Period (Month 2 Until Death)||0
6282429|NCT00183092|7182706|FG000|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
6282430|NCT00183092|7182707|FG001|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
6282431|NCT00183092|7182708|FG002|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
6282432|NCT00183092|7182709|FG003|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
6282433|NCT00183170|7182718|FG000|STARTED|First Intervention||103
6282434|NCT00183170|7182719|FG001|STARTED|First Intervention||109
6282435|NCT00183170|7182718|FG000|COMPLETED|First Intervention||101
6282436|NCT00183170|7182719|FG001|COMPLETED|First Intervention||109
6282437|NCT00183170|7182718|FG000|NOT COMPLETED|First Intervention||2
6282438|NCT00183170|7182719|FG001|NOT COMPLETED|First Intervention||0
6282439|NCT00183170|7182718|FG000|STARTED|Washout 1 Week||101
6282440|NCT00183170|7182719|FG001|STARTED|Washout 1 Week||109
6282441|NCT00183170|7182718|FG000|COMPLETED|Washout 1 Week||95
6282442|NCT00183170|7182719|FG001|COMPLETED|Washout 1 Week||101
6282443|NCT00183170|7182718|FG000|NOT COMPLETED|Washout 1 Week||6
6282444|NCT00183170|7182719|FG001|NOT COMPLETED|Washout 1 Week||8
6282445|NCT00183170|7182718|FG000|STARTED|Second Intervention||95
6282446|NCT00183170|7182719|FG001|STARTED|Second Intervention||101
6282447|NCT00183170|7182718|FG000|COMPLETED|Second Intervention||94
6282448|NCT00183170|7182719|FG001|COMPLETED|Second Intervention||99
6282449|NCT00183170|7182718|FG000|NOT COMPLETED|Second Intervention||1
6282450|NCT00183170|7182719|FG001|NOT COMPLETED|Second Intervention||2
6282451|NCT00183196|7182728|FG000|STARTED|Overall Study|2 subjects had no post-randomization data|50
6282452|NCT00183196|7182729|FG001|STARTED|Overall Study|1 subject had no post-randomization data|50
6282453|NCT00183196|7182730|FG002|STARTED|Overall Study|1 subject had no post-randomization data|50
6282454|NCT00183196|7182728|FG000|COMPLETED|Overall Study||30
6282455|NCT00183196|7182729|FG001|COMPLETED|Overall Study||35
6282456|NCT00183196|7182730|FG002|COMPLETED|Overall Study||32
6282457|NCT00183196|7182728|FG000|NOT COMPLETED|Overall Study||20
6282458|NCT00183196|7182729|FG001|NOT COMPLETED|Overall Study||15
6282459|NCT00183196|7182730|FG002|NOT COMPLETED|Overall Study||18
6282460|NCT00183248|7182740|FG000|STARTED|Overall Study||4
6282461|NCT00183248|7182741|FG001|STARTED|Overall Study||5
6282462|NCT00183248|7182740|FG000|COMPLETED|Overall Study||3
6282463|NCT00183248|7182741|FG001|COMPLETED|Overall Study||4
6282464|NCT00183248|7182740|FG000|NOT COMPLETED|Overall Study||1
6282465|NCT00183248|7182741|FG001|NOT COMPLETED|Overall Study||1
6282466|NCT00183274|7182747|FG000|STARTED|Phase 1: Open-Label||268
6282467|NCT00183274|7182748|FG001|STARTED|Phase 1: Open-Label||0
6282468|NCT00183274|7182749|FG002|STARTED|Phase 1: Open-Label||0
6282469|NCT00183274|7182750|FG003|STARTED|Phase 1: Open-Label||0
6282470|NCT00183274|7182751|FG004|STARTED|Phase 1: Open-Label||0
6282471|NCT00183274|7182752|FG005|STARTED|Phase 1: Open-Label||0
6282472|NCT00183274|7182747|FG000|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
6282473|NCT00183274|7182748|FG001|COMPLETED|Phase 1: Open-Label||0
6282474|NCT00183274|7182749|FG002|COMPLETED|Phase 1: Open-Label||0
6282475|NCT00183274|7182750|FG003|COMPLETED|Phase 1: Open-Label||0
6282476|NCT00183274|7182751|FG004|COMPLETED|Phase 1: Open-Label||0
6282477|NCT00183274|7182752|FG005|COMPLETED|Phase 1: Open-Label||0
6282478|NCT00183274|7182747|FG000|NOT COMPLETED|Phase 1: Open-Label||110
6282479|NCT00183274|7182748|FG001|NOT COMPLETED|Phase 1: Open-Label||0
6282480|NCT00183274|7182749|FG002|NOT COMPLETED|Phase 1: Open-Label||0
6282481|NCT00183274|7182750|FG003|NOT COMPLETED|Phase 1: Open-Label||0
6282482|NCT00183274|7182751|FG004|NOT COMPLETED|Phase 1: Open-Label||0
6282483|NCT00183274|7182752|FG005|NOT COMPLETED|Phase 1: Open-Label||0
6282484|NCT00183274|7182747|FG000|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
6282485|NCT00183274|7182748|FG001|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
6282486|NCT00183274|7182749|FG002|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
6628094|NCT02247193|7556108|FG001|STARTED|Overall Study||15
6628095|NCT02247193|7556107|FG000|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
6628096|NCT02247193|7556108|FG001|Number Who Underwent Cleft Lip Repair Surgery|Overall Study||15
6628097|NCT02247193|7556107|FG000|Number Who Received Botox or Placebo|Overall Study||15
6628098|NCT02247193|7556108|FG001|Number Who Received Botox or Placebo|Overall Study||15
6628099|NCT02247193|7556107|FG000|Number Who Completed the 6-month Follow up|Overall Study||15
6628100|NCT02247193|7556108|FG001|Number Who Completed the 6-month Follow up|Overall Study||15
6628101|NCT02247193|7556107|FG000|Number Who Completed the 12-month Follow up|Overall Study||15
6628102|NCT02247193|7556108|FG001|Number Who Completed the 12-month Follow up|Overall Study||15
6628103|NCT02247193|7556107|FG000|COMPLETED|Overall Study||15
6628104|NCT02247193|7556108|FG001|COMPLETED|Overall Study||15
6628105|NCT02247193|7556107|FG000|NOT COMPLETED|Overall Study||0
6628106|NCT02247193|7556108|FG001|NOT COMPLETED|Overall Study||0
6628107|NCT02247245|7556118|FG000|STARTED|Overall Study||13
6628108|NCT02247245|7556119|FG001|STARTED|Overall Study||13
6628109|NCT02247245|7556120|FG002|STARTED|Overall Study||7
6628110|NCT02247245|7556121|FG003|STARTED|Overall Study||7
6628111|NCT02247245|7556118|FG000|COMPLETED|Overall Study||13
6628112|NCT02247245|7556119|FG001|COMPLETED|Overall Study||13
6628113|NCT02247245|7556120|FG002|COMPLETED|Overall Study||7
6628114|NCT02247245|7556121|FG003|COMPLETED|Overall Study||7
6628115|NCT02247245|7556118|FG000|NOT COMPLETED|Overall Study||0
6628116|NCT02247245|7556119|FG001|NOT COMPLETED|Overall Study||0
6628117|NCT02247245|7556120|FG002|NOT COMPLETED|Overall Study||0
6628118|NCT02247245|7556121|FG003|NOT COMPLETED|Overall Study||0
6628119|NCT02247336|7556133|FG000|STARTED|Overall Study||252
6628120|NCT02247336|7556134|FG001|STARTED|Overall Study||253
6628121|NCT02247336|7556133|FG000|COMPLETED|Overall Study||252
6628122|NCT02247336|7556134|FG001|COMPLETED|Overall Study||253
6628123|NCT02247336|7556133|FG000|NOT COMPLETED|Overall Study||0
6628124|NCT02247336|7556134|FG001|NOT COMPLETED|Overall Study||0
6628125|NCT02247401|7556143|FG000|STARTED|Overall Study||100
6628126|NCT02247401|7556144|FG001|STARTED|Overall Study||31
6628127|NCT02247401|7556145|FG002|STARTED|Overall Study||29
6628128|NCT02247401|7556143|FG000|COMPLETED|Overall Study||94
6628129|NCT02247401|7556144|FG001|COMPLETED|Overall Study||29
6628130|NCT02247401|7556145|FG002|COMPLETED|Overall Study||27
6628131|NCT02247401|7556143|FG000|NOT COMPLETED|Overall Study||6
6628132|NCT02247401|7556144|FG001|NOT COMPLETED|Overall Study||2
6628133|NCT02247401|7556145|FG002|NOT COMPLETED|Overall Study||2
6628134|NCT02247440|7556154|FG000|STARTED|Overall Study||18
6628135|NCT02247440|7556154|FG000|COMPLETED|Overall Study||14
6628136|NCT02247440|7556154|FG000|NOT COMPLETED|Overall Study||4
6628137|NCT02247466|7556160|FG000|STARTED|Overall Study||19
6628138|NCT02247466|7556161|FG001|STARTED|Overall Study||18
6628139|NCT02247466|7556160|FG000|COMPLETED|Overall Study||19
6628140|NCT02247466|7556161|FG001|COMPLETED|Overall Study||15
6628141|NCT02247466|7556160|FG000|NOT COMPLETED|Overall Study||0
6628142|NCT02247466|7556161|FG001|NOT COMPLETED|Overall Study||3
6628143|NCT02247479|7556170|FG000|STARTED|Overall Study||305
6628144|NCT02247479|7556171|FG001|STARTED|Overall Study||298
6628145|NCT02247479|7556172|FG002|STARTED|Overall Study||303
6628146|NCT02247479|7556170|FG000|COMPLETED|Overall Study||163
6628147|NCT02247479|7556171|FG001|COMPLETED|Overall Study||160
6628148|NCT02247479|7556172|FG002|COMPLETED|Overall Study||165
6628149|NCT02247479|7556170|FG000|NOT COMPLETED|Overall Study||142
6628150|NCT02247479|7556171|FG001|NOT COMPLETED|Overall Study||138
6628151|NCT02247479|7556172|FG002|NOT COMPLETED|Overall Study||138
6628152|NCT02247531|7556183|FG000|STARTED|Overall Study||321
6628153|NCT02247531|7556184|FG001|STARTED|Overall Study||330
6628154|NCT02247531|7556185|FG002|STARTED|Overall Study||324
6628155|NCT02247531|7556183|FG000|COMPLETED|Overall Study||215
6628156|NCT02247531|7556184|FG001|COMPLETED|Overall Study||205
6628157|NCT02247531|7556185|FG002|COMPLETED|Overall Study||214
6628158|NCT02247531|7556183|FG000|NOT COMPLETED|Overall Study||106
6628159|NCT02247531|7556184|FG001|NOT COMPLETED|Overall Study||125
6628160|NCT02247531|7556185|FG002|NOT COMPLETED|Overall Study||110
6628161|NCT02247739|7556193|FG000|STARTED|Overall Study||5
6628162|NCT02247739|7556194|FG001|STARTED|Overall Study||6
6628163|NCT02247739|7556195|FG002|STARTED|Overall Study||5
6628164|NCT02247739|7556196|FG003|STARTED|Overall Study||5
6628165|NCT02247739|7556197|FG004|STARTED|Overall Study||6
6628166|NCT02247739|7556198|FG005|STARTED|Overall Study||5
6628167|NCT02247739|7556193|FG000|COMPLETED|Overall Study||5
6628168|NCT02247739|7556194|FG001|COMPLETED|Overall Study||3
6628169|NCT02247739|7556195|FG002|COMPLETED|Overall Study||4
6628170|NCT02247739|7556196|FG003|COMPLETED|Overall Study||5
6628171|NCT02247739|7556197|FG004|COMPLETED|Overall Study||5
6628172|NCT02247739|7556198|FG005|COMPLETED|Overall Study||4
6628173|NCT02247739|7556193|FG000|NOT COMPLETED|Overall Study||0
6628174|NCT02247739|7556194|FG001|NOT COMPLETED|Overall Study||3
6628175|NCT02247739|7556195|FG002|NOT COMPLETED|Overall Study||1
6628176|NCT02247739|7556196|FG003|NOT COMPLETED|Overall Study||0
6628177|NCT02247739|7556197|FG004|NOT COMPLETED|Overall Study||1
6628178|NCT02247739|7556198|FG005|NOT COMPLETED|Overall Study||1
6628179|NCT02247765|7556208|FG000|STARTED|Overall Study||18
6628180|NCT02247765|7556208|FG000|COMPLETED|Overall Study||18
6628181|NCT02247765|7556208|FG000|NOT COMPLETED|Overall Study||0
6628182|NCT02247804|7556215|FG000|STARTED|Treatment Period 1||198
6628183|NCT02247804|7556216|FG001|STARTED|Treatment Period 1||198
6628184|NCT02247804|7556217|FG002|STARTED|Treatment Period 1||198
6628185|NCT02247804|7556215|FG000|Received (Sham or Bimatoprost SR)|Treatment Period 1||193
6628186|NCT02247804|7556216|FG001|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
6628187|NCT02247804|7556217|FG002|Received (Sham or Bimatoprost SR)|Treatment Period 1||197
6628188|NCT02247804|7556215|FG000|COMPLETED|Treatment Period 1||176
6628189|NCT02247804|7556216|FG001|COMPLETED|Treatment Period 1||194
6628190|NCT02247804|7556217|FG002|COMPLETED|Treatment Period 1||190
6628191|NCT02247804|7556215|FG000|NOT COMPLETED|Treatment Period 1||22
6628192|NCT02247804|7556216|FG001|NOT COMPLETED|Treatment Period 1||4
6628193|NCT02247804|7556217|FG002|NOT COMPLETED|Treatment Period 1||8
6628194|NCT02247804|7556215|FG000|STARTED|Treatment Period 2||172
6628195|NCT02247804|7556216|FG001|STARTED|Treatment Period 2||191
6628196|NCT02247804|7556217|FG002|STARTED|Treatment Period 2||187
6628197|NCT02247804|7556215|FG000|COMPLETED|Treatment Period 2||164
6628198|NCT02247804|7556216|FG001|COMPLETED|Treatment Period 2||186
6628199|NCT02247804|7556217|FG002|COMPLETED|Treatment Period 2||179
6628200|NCT02247804|7556215|FG000|NOT COMPLETED|Treatment Period 2||8
6628201|NCT02247804|7556216|FG001|NOT COMPLETED|Treatment Period 2||5
6628202|NCT02247804|7556217|FG002|NOT COMPLETED|Treatment Period 2||8
6628203|NCT02247804|7556215|FG000|STARTED|Treatment Period 3||158
6628204|NCT02247804|7556216|FG001|STARTED|Treatment Period 3||183
6628205|NCT02247804|7556217|FG002|STARTED|Treatment Period 3||177
6628206|NCT02247804|7556215|FG000|COMPLETED|Treatment Period 3||147
6628207|NCT02247804|7556216|FG001|COMPLETED|Treatment Period 3||173
6628208|NCT02247804|7556217|FG002|COMPLETED|Treatment Period 3||167
6628209|NCT02247804|7556215|FG000|NOT COMPLETED|Treatment Period 3||11
6628210|NCT02247804|7556216|FG001|NOT COMPLETED|Treatment Period 3||10
6628211|NCT02247804|7556217|FG002|NOT COMPLETED|Treatment Period 3||10
6628212|NCT02247960|7556227|FG000|STARTED|Patient Consent and Randomization||85
6628213|NCT02247960|7556228|FG001|STARTED|Patient Consent and Randomization||90
6628214|NCT02247960|7556227|FG000|COMPLETED|Patient Consent and Randomization||83
6628215|NCT02247960|7556228|FG001|COMPLETED|Patient Consent and Randomization||84
6628216|NCT02247960|7556227|FG000|NOT COMPLETED|Patient Consent and Randomization||2
6628217|NCT02247960|7556228|FG001|NOT COMPLETED|Patient Consent and Randomization||6
6628218|NCT02247960|7556227|FG000|STARTED|Catheter Removed||83
6628219|NCT02247960|7556228|FG001|STARTED|Catheter Removed||84
6628220|NCT02247960|7556227|FG000|COMPLETED|Catheter Removed||76
6628221|NCT02247960|7556228|FG001|COMPLETED|Catheter Removed||74
6628222|NCT02247960|7556227|FG000|NOT COMPLETED|Catheter Removed||7
6628223|NCT02247960|7556228|FG001|NOT COMPLETED|Catheter Removed||10
6628224|NCT02248103|7556236|FG000|STARTED|Overall Study||10
6628225|NCT02248103|7556237|FG001|STARTED|Overall Study||10
6628226|NCT02248103|7556236|FG000|COMPLETED|Overall Study||10
6628227|NCT02248103|7556237|FG001|COMPLETED|Overall Study||10
6628228|NCT02248103|7556236|FG000|NOT COMPLETED|Overall Study||0
6628229|NCT02248103|7556237|FG001|NOT COMPLETED|Overall Study||0
6628230|NCT02248246|7556243|FG000|STARTED|Overall Study||40
6628231|NCT02248246|7556243|FG000|COMPLETED|Overall Study||40
6628232|NCT02248246|7556243|FG000|NOT COMPLETED|Overall Study||0
6628233|NCT02248285|7556249|FG000|STARTED|Overall Study||687
6628234|NCT02248285|7556250|FG001|STARTED|Overall Study||858
6628235|NCT02248285|7556249|FG000|COMPLETED|Overall Study||586
6628236|NCT02248285|7556250|FG001|COMPLETED|Overall Study||571
6628237|NCT02248285|7556249|FG000|NOT COMPLETED|Overall Study||101
6628238|NCT02248285|7556250|FG001|NOT COMPLETED|Overall Study||287
6628239|NCT02248480|7556258|FG000|STARTED|Overall Study||178
6628240|NCT02248480|7556259|FG001|STARTED|Overall Study||176
6628241|NCT02248480|7556258|FG000|Efficacy Population|Overall Study||177
6628242|NCT02248480|7556259|FG001|Efficacy Population|Overall Study||176
6628243|NCT02248480|7556258|FG000|COMPLETED|Overall Study||161
6628244|NCT02248480|7556259|FG001|COMPLETED|Overall Study||162
6628245|NCT02248480|7556258|FG000|NOT COMPLETED|Overall Study||17
6628246|NCT02248480|7556259|FG001|NOT COMPLETED|Overall Study||14
6628247|NCT02248558|7556268|FG000|STARTED|Overall Study||369
6628248|NCT02248558|7556269|FG001|STARTED|Overall Study||352
6628249|NCT02248558|7556268|FG000|COMPLETED|Overall Study||317
6742332|NCT03320850|7670676|FG008|Safety Population|Overall Study||60
6742333|NCT03320850|7670677|FG009|Safety Population|Overall Study||58
6742334|NCT03320850|7670668|FG000|COMPLETED|Overall Study||18
6742335|NCT03320850|7670669|FG001|COMPLETED|Overall Study||12
6742336|NCT03320850|7670670|FG002|COMPLETED|Overall Study||18
6742337|NCT03320850|7670671|FG003|COMPLETED|Overall Study||21
6742338|NCT03320850|7670672|FG004|COMPLETED|Overall Study||17
6742339|NCT03320850|7670673|FG005|COMPLETED|Overall Study||49
6742340|NCT03320850|7670674|FG006|COMPLETED|Overall Study||50
6742341|NCT03320850|7670675|FG007|COMPLETED|Overall Study||53
6628250|NCT02248558|7556269|FG001|COMPLETED|Overall Study||307
6628251|NCT02248558|7556268|FG000|NOT COMPLETED|Overall Study||52
6628252|NCT02248558|7556269|FG001|NOT COMPLETED|Overall Study||45
6628253|NCT02248636|7556279|FG000|STARTED|Overall Study||26
6742342|NCT03320850|7670676|FG008|COMPLETED|Overall Study||50
6628254|NCT02248636|7556280|FG001|STARTED|Overall Study||35
6628255|NCT02248636|7556279|FG000|COMPLETED|Overall Study||20
6628256|NCT02248636|7556280|FG001|COMPLETED|Overall Study||32
6628257|NCT02248636|7556279|FG000|NOT COMPLETED|Overall Study||6
6628258|NCT02248636|7556280|FG001|NOT COMPLETED|Overall Study||3
6628259|NCT02248649|7556288|FG000|STARTED|Overall Study||80
6628260|NCT02248649|7556289|FG001|STARTED|Overall Study||80
6628261|NCT02248649|7556288|FG000|COMPLETED|Overall Study||59
6628262|NCT02248649|7556289|FG001|COMPLETED|Overall Study||59
6628263|NCT02248649|7556288|FG000|NOT COMPLETED|Overall Study||21
6628264|NCT02248649|7556289|FG001|NOT COMPLETED|Overall Study||21
6628265|NCT02248662|7556297|FG000|STARTED|Overall Study||5320
6628266|NCT02248662|7556298|FG001|STARTED|Overall Study||33194
6628267|NCT02248662|7556297|FG000|COMPLETED|Overall Study||757
6628268|NCT02248662|7556298|FG001|COMPLETED|Overall Study||2679
6628269|NCT02248662|7556297|FG000|NOT COMPLETED|Overall Study||4563
6628270|NCT02248662|7556298|FG001|NOT COMPLETED|Overall Study||30515
6628271|NCT02248675|7556310|FG000|STARTED|Overall Study||26
6742343|NCT03320850|7670677|FG009|COMPLETED|Overall Study||50
6628272|NCT02248675|7556311|FG001|STARTED|Overall Study||28
6628273|NCT02248675|7556310|FG000|COMPLETED|Overall Study||23
6628274|NCT02248675|7556311|FG001|COMPLETED|Overall Study||27
6628275|NCT02248675|7556310|FG000|NOT COMPLETED|Overall Study||3
6628276|NCT02248675|7556311|FG001|NOT COMPLETED|Overall Study||1
6628277|NCT02248714|7556319|FG000|STARTED|Overall Study||66
6628278|NCT02248714|7556320|FG001|STARTED|Overall Study||65
6628279|NCT02248714|7556319|FG000|COMPLETED|Overall Study||62
6628280|NCT02248714|7556320|FG001|COMPLETED|Overall Study||61
6282487|NCT00183274|7182750|FG003|STARTED|Phase 2: Double-Blind||0
6282488|NCT00183274|7182751|FG004|STARTED|Phase 2: Double-Blind||0
6282489|NCT00183274|7182752|FG005|STARTED|Phase 2: Double-Blind||0
6282490|NCT00183274|7182747|FG000|COMPLETED|Phase 2: Double-Blind||0
6282491|NCT00183274|7182748|FG001|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
6628281|NCT02248714|7556319|FG000|NOT COMPLETED|Overall Study||4
6628282|NCT02248714|7556320|FG001|NOT COMPLETED|Overall Study||4
6628283|NCT02248727|7556326|FG000|STARTED|Overall Study||30
6628284|NCT02248727|7556326|FG000|COMPLETED|Overall Study||30
6628285|NCT02248727|7556326|FG000|NOT COMPLETED|Overall Study||0
6628286|NCT02248766|7556333|FG000|STARTED|Overall Study||30
6628287|NCT02248766|7556333|FG000|COMPLETED|Overall Study||30
6628288|NCT02248766|7556333|FG000|NOT COMPLETED|Overall Study||0
6628289|NCT02248818|7556349|FG000|STARTED|Screening||0
6628290|NCT02248818|7556350|FG001|STARTED|Screening||0
6628291|NCT02248818|7556351|FG002|STARTED|Screening||0
6742344|NCT03320850|7670668|FG000|NOT COMPLETED|Overall Study||0
6628292|NCT02248818|7556352|FG003|STARTED|Screening||0
6628293|NCT02248818|7556353|FG004|STARTED|Screening||0
6628294|NCT02248818|7556354|FG005|STARTED|Screening||0
6628295|NCT02248818|7556355|FG006|STARTED|Screening||0
6628296|NCT02248818|7556356|FG007|STARTED|Screening||0
6628297|NCT02248818|7556357|FG008|STARTED|Screening||155
6628298|NCT02248818|7556349|FG000|COMPLETED|Screening||0
6628299|NCT02248818|7556350|FG001|COMPLETED|Screening||0
6628300|NCT02248818|7556351|FG002|COMPLETED|Screening||0
6628301|NCT02248818|7556352|FG003|COMPLETED|Screening||0
6628302|NCT02248818|7556353|FG004|COMPLETED|Screening||0
6628303|NCT02248818|7556354|FG005|COMPLETED|Screening||0
6742345|NCT03320850|7670669|FG001|NOT COMPLETED|Overall Study||0
6282492|NCT00183274|7182749|FG002|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
6282493|NCT00183274|7182750|FG003|COMPLETED|Phase 2: Double-Blind||0
6282494|NCT00183274|7182751|FG004|COMPLETED|Phase 2: Double-Blind||0
6282495|NCT00183274|7182752|FG005|COMPLETED|Phase 2: Double-Blind||0
6282496|NCT00183274|7182747|FG000|NOT COMPLETED|Phase 2: Double-Blind||0
6282497|NCT00183274|7182748|FG001|NOT COMPLETED|Phase 2: Double-Blind||26
6282498|NCT00183274|7182749|FG002|NOT COMPLETED|Phase 2: Double-Blind||43
6282499|NCT00183274|7182750|FG003|NOT COMPLETED|Phase 2: Double-Blind||0
6282500|NCT00183274|7182751|FG004|NOT COMPLETED|Phase 2: Double-Blind||0
6282501|NCT00183274|7182752|FG005|NOT COMPLETED|Phase 2: Double-Blind||0
6282502|NCT00183274|7182747|FG000|STARTED|Phase 3: Double-Blind||0
6282503|NCT00183274|7182748|FG001|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
6282504|NCT00183274|7182749|FG002|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
6282505|NCT00183274|7182750|FG003|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
6282506|NCT00183274|7182751|FG004|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
6282507|NCT00183274|7182752|FG005|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
6282508|NCT00183274|7182747|FG000|COMPLETED|Phase 3: Double-Blind||0
6282509|NCT00183274|7182748|FG001|COMPLETED|Phase 3: Double-Blind||0
6282510|NCT00183274|7182749|FG002|COMPLETED|Phase 3: Double-Blind||0
6282511|NCT00183274|7182750|FG003|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
6282512|NCT00183274|7182751|FG004|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
6282513|NCT00183274|7182752|FG005|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
6282514|NCT00183274|7182747|FG000|NOT COMPLETED|Phase 3: Double-Blind||0
6282515|NCT00183274|7182748|FG001|NOT COMPLETED|Phase 3: Double-Blind||0
6282516|NCT00183274|7182749|FG002|NOT COMPLETED|Phase 3: Double-Blind||0
6282517|NCT00183274|7182750|FG003|NOT COMPLETED|Phase 3: Double-Blind||2
6282518|NCT00183274|7182751|FG004|NOT COMPLETED|Phase 3: Double-Blind||20
6282519|NCT00183274|7182752|FG005|NOT COMPLETED|Phase 3: Double-Blind||4
6282520|NCT00183339|7182769|FG000|STARTED|Overall Study||10
6282521|NCT00183339|7182770|FG001|STARTED|Overall Study||8
6282522|NCT00183339|7182769|FG000|COMPLETED|Overall Study||4
6282523|NCT00183339|7182770|FG001|COMPLETED|Overall Study||4
6282524|NCT00183339|7182769|FG000|NOT COMPLETED|Overall Study||6
6282525|NCT00183339|7182770|FG001|NOT COMPLETED|Overall Study||4
6282526|NCT00183391|7182781|FG000|STARTED|Block 1 - 5 Weeks||108
6282527|NCT00183391|7182782|FG001|STARTED|Block 1 - 5 Weeks||124
6282528|NCT00183391|7182781|FG000|COMPLETED|Block 1 - 5 Weeks||95
6628304|NCT02248818|7556355|FG006|COMPLETED|Screening||0
6282529|NCT00183391|7182782|FG001|COMPLETED|Block 1 - 5 Weeks||110
6282530|NCT00183391|7182781|FG000|NOT COMPLETED|Block 1 - 5 Weeks||13
6282531|NCT00183391|7182782|FG001|NOT COMPLETED|Block 1 - 5 Weeks||14
6628305|NCT02248818|7556356|FG007|COMPLETED|Screening||0
6628306|NCT02248818|7556357|FG008|COMPLETED|Screening||48
6628307|NCT02248818|7556349|FG000|NOT COMPLETED|Screening||0
6628308|NCT02248818|7556350|FG001|NOT COMPLETED|Screening||0
6628309|NCT02248818|7556351|FG002|NOT COMPLETED|Screening||0
6628310|NCT02248818|7556352|FG003|NOT COMPLETED|Screening||0
6628311|NCT02248818|7556353|FG004|NOT COMPLETED|Screening||0
6628312|NCT02248818|7556354|FG005|NOT COMPLETED|Screening||0
6628313|NCT02248818|7556355|FG006|NOT COMPLETED|Screening||0
6628314|NCT02248818|7556356|FG007|NOT COMPLETED|Screening||0
6628315|NCT02248818|7556357|FG008|NOT COMPLETED|Screening||107
6628316|NCT02248818|7556349|FG000|STARTED|Randomised Study||6
6628317|NCT02248818|7556350|FG001|STARTED|Randomised Study||6
6628318|NCT02248818|7556351|FG002|STARTED|Randomised Study||6
6628319|NCT02248818|7556352|FG003|STARTED|Randomised Study||6
6628320|NCT02248818|7556353|FG004|STARTED|Randomised Study||6
6628321|NCT02248818|7556354|FG005|STARTED|Randomised Study||8
6628322|NCT02248818|7556355|FG006|STARTED|Randomised Study||6
6628323|NCT02248818|7556356|FG007|STARTED|Randomised Study||4
6628324|NCT02248818|7556357|FG008|STARTED|Randomised Study||0
6628325|NCT02248818|7556349|FG000|COMPLETED|Randomised Study||6
6628326|NCT02248818|7556350|FG001|COMPLETED|Randomised Study||6
6628327|NCT02248818|7556351|FG002|COMPLETED|Randomised Study||6
6628328|NCT02248818|7556352|FG003|COMPLETED|Randomised Study||6
6628329|NCT02248818|7556353|FG004|COMPLETED|Randomised Study||6
6628330|NCT02248818|7556354|FG005|COMPLETED|Randomised Study||0
6628331|NCT02248818|7556355|FG006|COMPLETED|Randomised Study||6
6628332|NCT02248818|7556356|FG007|COMPLETED|Randomised Study||4
6628333|NCT02248818|7556357|FG008|COMPLETED|Randomised Study||0
6628334|NCT02248818|7556349|FG000|NOT COMPLETED|Randomised Study||0
6742346|NCT03320850|7670670|FG002|NOT COMPLETED|Overall Study||0
6742347|NCT03320850|7670671|FG003|NOT COMPLETED|Overall Study||1
6742348|NCT03320850|7670672|FG004|NOT COMPLETED|Overall Study||2
6742349|NCT03320850|7670673|FG005|NOT COMPLETED|Overall Study||9
6742350|NCT03320850|7670674|FG006|NOT COMPLETED|Overall Study||7
6742351|NCT03320850|7670675|FG007|NOT COMPLETED|Overall Study||7
6742352|NCT03320850|7670676|FG008|NOT COMPLETED|Overall Study||10
6742353|NCT03320850|7670677|FG009|NOT COMPLETED|Overall Study||9
6742354|NCT03320941|7670709|FG000|STARTED|Overall Study||19
6742355|NCT03320941|7670710|FG001|STARTED|Overall Study||19
6742356|NCT03320941|7670711|FG002|STARTED|Overall Study||28
6742357|NCT03320941|7670712|FG003|STARTED|Overall Study||31
6742358|NCT03320941|7670713|FG004|STARTED|Overall Study||29
6742359|NCT03320941|7670709|FG000|COMPLETED|Overall Study||19
6742360|NCT03320941|7670710|FG001|COMPLETED|Overall Study||19
6742361|NCT03320941|7670711|FG002|COMPLETED|Overall Study||28
6742362|NCT03320941|7670712|FG003|COMPLETED|Overall Study||30
6742363|NCT03320941|7670713|FG004|COMPLETED|Overall Study||29
6742364|NCT03320941|7670709|FG000|NOT COMPLETED|Overall Study||0
6742365|NCT03320941|7670710|FG001|NOT COMPLETED|Overall Study||0
6742366|NCT03320941|7670711|FG002|NOT COMPLETED|Overall Study||0
6742367|NCT03320941|7670712|FG003|NOT COMPLETED|Overall Study||1
6742368|NCT03320941|7670713|FG004|NOT COMPLETED|Overall Study||0
6742369|NCT03321006|7670727|FG000|STARTED|Overall Study||14
6742370|NCT03321006|7670728|FG001|STARTED|Overall Study||11
6742371|NCT03321006|7670727|FG000|COMPLETED|Overall Study||12
6742372|NCT03321006|7670728|FG001|COMPLETED|Overall Study||11
6742373|NCT03321006|7670727|FG000|NOT COMPLETED|Overall Study||2
6742374|NCT03321006|7670728|FG001|NOT COMPLETED|Overall Study||0
6742375|NCT03321097|7670736|FG000|STARTED|Overall Study||18
6742376|NCT03321097|7670737|FG001|STARTED|Overall Study||18
6742377|NCT03321097|7670736|FG000|COMPLETED|Overall Study||18
6742378|NCT03321097|7670737|FG001|COMPLETED|Overall Study||18
6742379|NCT03321097|7670736|FG000|NOT COMPLETED|Overall Study||0
6628335|NCT02248818|7556350|FG001|NOT COMPLETED|Randomised Study||0
6628336|NCT02248818|7556351|FG002|NOT COMPLETED|Randomised Study||0
6628337|NCT02248818|7556352|FG003|NOT COMPLETED|Randomised Study||0
6628338|NCT02248818|7556353|FG004|NOT COMPLETED|Randomised Study||0
6628339|NCT02248818|7556354|FG005|NOT COMPLETED|Randomised Study||8
6742380|NCT03321097|7670737|FG001|NOT COMPLETED|Overall Study||0
6628340|NCT02248818|7556355|FG006|NOT COMPLETED|Randomised Study||0
6628341|NCT02248818|7556356|FG007|NOT COMPLETED|Randomised Study||0
6628342|NCT02248818|7556357|FG008|NOT COMPLETED|Randomised Study||0
6628343|NCT02248857|7556378|FG000|STARTED|Baseline||157
6628344|NCT02248857|7556379|FG001|STARTED|Baseline||168
6628345|NCT02248857|7556380|FG002|STARTED|Baseline||127
6628346|NCT02248857|7556378|FG000|COMPLETED|Baseline||157
6628347|NCT02248857|7556379|FG001|COMPLETED|Baseline||168
6628348|NCT02248857|7556380|FG002|COMPLETED|Baseline||127
6628349|NCT02248857|7556378|FG000|NOT COMPLETED|Baseline||0
6628350|NCT02248857|7556379|FG001|NOT COMPLETED|Baseline||0
6628351|NCT02248857|7556380|FG002|NOT COMPLETED|Baseline||0
6628352|NCT02248857|7556378|FG000|STARTED|3 Month||157
6628353|NCT02248857|7556379|FG001|STARTED|3 Month||168
6628354|NCT02248857|7556380|FG002|STARTED|3 Month||127
6628355|NCT02248857|7556378|FG000|COMPLETED|3 Month||111
6628356|NCT02248857|7556379|FG001|COMPLETED|3 Month||134
6628357|NCT02248857|7556380|FG002|COMPLETED|3 Month||96
6628358|NCT02248857|7556378|FG000|NOT COMPLETED|3 Month||46
6628359|NCT02248857|7556379|FG001|NOT COMPLETED|3 Month||34
6628360|NCT02248857|7556380|FG002|NOT COMPLETED|3 Month||31
6628361|NCT02248857|7556378|FG000|STARTED|6 Month|157 baseline - 9 who withdrew = 148|148
6628362|NCT02248857|7556379|FG001|STARTED|6 Month|168 baseline - 3 who withdrew = 165|165
6628363|NCT02248857|7556380|FG002|STARTED|6 Month|127 baseline - 4 who withdrew = 123|123
6628364|NCT02248857|7556378|FG000|COMPLETED|6 Month||120
6628365|NCT02248857|7556379|FG001|COMPLETED|6 Month||136
6628366|NCT02248857|7556380|FG002|COMPLETED|6 Month||106
6628367|NCT02248857|7556378|FG000|NOT COMPLETED|6 Month||28
6628368|NCT02248857|7556379|FG001|NOT COMPLETED|6 Month||29
6628369|NCT02248857|7556380|FG002|NOT COMPLETED|6 Month||17
6742381|NCT03321253|7670743|FG000|STARTED|Overall Study||38
6742382|NCT03321253|7670743|FG000|COMPLETED|Overall Study||38
6742383|NCT03321253|7670743|FG000|NOT COMPLETED|Overall Study||0
6742384|NCT03321396|7670747|FG000|STARTED|Overall Study||13
6742385|NCT03321396|7670747|FG000|COMPLETED|Overall Study||12
6742386|NCT03321396|7670747|FG000|NOT COMPLETED|Overall Study||1
6742387|NCT03321721|7670754|FG000|STARTED|Overall Study||4
6742388|NCT03321721|7670755|FG001|STARTED|Overall Study||10
6742389|NCT03321721|7670756|FG002|STARTED|Overall Study||12
6742390|NCT03321721|7670754|FG000|COMPLETED|Overall Study||0
6628370|NCT02248922|7556390|FG000|STARTED|Overall Study||5
6628371|NCT02248922|7556391|FG001|STARTED|Overall Study||12
6628372|NCT02248922|7556390|FG000|COMPLETED|Overall Study||5
6628373|NCT02248922|7556391|FG001|COMPLETED|Overall Study||12
6628374|NCT02248922|7556390|FG000|NOT COMPLETED|Overall Study||0
6628375|NCT02248922|7556391|FG001|NOT COMPLETED|Overall Study||0
6628376|NCT02248961|7556398|FG000|STARTED|Overall Study||89
6628377|NCT02248961|7556399|FG001|STARTED|Overall Study||90
6628378|NCT02248961|7556398|FG000|COMPLETED|Overall Study||86
6628379|NCT02248961|7556399|FG001|COMPLETED|Overall Study||88
6742391|NCT03321721|7670755|FG001|COMPLETED|Overall Study||2
6742392|NCT03321721|7670756|FG002|COMPLETED|Overall Study||1
6742393|NCT03321721|7670754|FG000|NOT COMPLETED|Overall Study||4
6628380|NCT02248961|7556398|FG000|NOT COMPLETED|Overall Study||3
6628381|NCT02248961|7556399|FG001|NOT COMPLETED|Overall Study||2
6628382|NCT02248974|7556407|FG000|STARTED|Baseline||47
6628383|NCT02248974|7556408|FG001|STARTED|Baseline||51
6742394|NCT03321721|7670755|FG001|NOT COMPLETED|Overall Study||8
6742395|NCT03321721|7670756|FG002|NOT COMPLETED|Overall Study||11
6742396|NCT03322423|7670765|FG000|STARTED|Period 1||38
6742397|NCT03322423|7670766|FG001|STARTED|Period 1||40
6742398|NCT03322423|7670765|FG000|COMPLETED|Period 1||36
6742399|NCT03322423|7670766|FG001|COMPLETED|Period 1||38
6742400|NCT03322423|7670765|FG000|NOT COMPLETED|Period 1||2
6742401|NCT03322423|7670766|FG001|NOT COMPLETED|Period 1||2
6742402|NCT03322423|7670765|FG000|STARTED|Period 2||36
6742403|NCT03322423|7670766|FG001|STARTED|Period 2||38
6742404|NCT03322423|7670765|FG000|COMPLETED|Period 2||35
6742405|NCT03322423|7670766|FG001|COMPLETED|Period 2||36
6742406|NCT03322423|7670765|FG000|NOT COMPLETED|Period 2||1
6742407|NCT03322423|7670766|FG001|NOT COMPLETED|Period 2||2
6742408|NCT03322462|7670772|FG000|STARTED|Overall Study||155
6742409|NCT03322462|7670772|FG000|Flortaucipir PET Scan|Overall Study||155
6742410|NCT03322462|7670772|FG000|COMPLETED|Overall Study||152
6742411|NCT03322462|7670772|FG000|NOT COMPLETED|Overall Study||3
6742412|NCT03322514|7670780|FG000|STARTED|Overall Study||6
6742413|NCT03322514|7670781|FG001|STARTED|Overall Study||6
6742414|NCT03322514|7670780|FG000|COMPLETED|Overall Study||5
6742415|NCT03322514|7670781|FG001|COMPLETED|Overall Study||5
6742416|NCT03322514|7670780|FG000|NOT COMPLETED|Overall Study||1
6742417|NCT03322514|7670781|FG001|NOT COMPLETED|Overall Study||1
6742418|NCT03322657|7670789|FG000|STARTED|Overall Study||34
6742419|NCT03322657|7670790|FG001|STARTED|Overall Study||35
6742420|NCT03322657|7670789|FG000|COMPLETED|Overall Study||33
6742421|NCT03322657|7670790|FG001|COMPLETED|Overall Study||35
6742422|NCT03322657|7670789|FG000|NOT COMPLETED|Overall Study||1
6742423|NCT03322657|7670790|FG001|NOT COMPLETED|Overall Study||0
6742424|NCT03322930|7670798|FG000|STARTED|Overall Study|recruitment of 20 patients with retinitis pigmentosa|20
6742425|NCT03322930|7670799|FG001|STARTED|Overall Study|recruitment of 20 patients with macular degeneration|20
6742426|NCT03322930|7670798|FG000|COMPLETED|Overall Study||20
6742427|NCT03322930|7670799|FG001|COMPLETED|Overall Study||20
6742428|NCT03322930|7670798|FG000|NOT COMPLETED|Overall Study||0
6742429|NCT03322930|7670799|FG001|NOT COMPLETED|Overall Study||0
6742430|NCT03323086|7670807|FG000|STARTED|Overall Study||26
6742431|NCT03323086|7670808|FG001|STARTED|Overall Study||22
6742432|NCT03323086|7670807|FG000|COMPLETED|Overall Study||23
6742433|NCT03323086|7670808|FG001|COMPLETED|Overall Study||20
6742434|NCT03323086|7670807|FG000|NOT COMPLETED|Overall Study||3
6742435|NCT03323086|7670808|FG001|NOT COMPLETED|Overall Study||2
6742436|NCT03323164|7670816|FG000|STARTED|Overall Study||18
6742437|NCT03323164|7670817|FG001|STARTED|Overall Study||17
6742438|NCT03323164|7670816|FG000|COMPLETED|Overall Study||16
6742439|NCT03323164|7670817|FG001|COMPLETED|Overall Study||15
6742440|NCT03323164|7670816|FG000|NOT COMPLETED|Overall Study||2
6742441|NCT03323164|7670817|FG001|NOT COMPLETED|Overall Study||2
6742442|NCT03323307|7670827|FG000|STARTED|Overall Study||70
6742443|NCT03323307|7670827|FG000|COMPLETED|Overall Study||70
6742444|NCT03323307|7670827|FG000|NOT COMPLETED|Overall Study||0
6742445|NCT03323723|7670831|FG000|STARTED|Screening||73
6742446|NCT03323723|7670831|FG000|COMPLETED|Screening||64
6742447|NCT03323723|7670831|FG000|NOT COMPLETED|Screening||9
6742448|NCT03323723|7670831|FG000|STARTED|Baseline Phase||64
6742449|NCT03323723|7670831|FG000|COMPLETED|Baseline Phase||60
6742450|NCT03323723|7670831|FG000|NOT COMPLETED|Baseline Phase||4
6742451|NCT03323723|7670831|FG000|STARTED|Treatment Phase||60
6742452|NCT03323723|7670831|FG000|COMPLETED|Treatment Phase||51
6742453|NCT03323723|7670831|FG000|NOT COMPLETED|Treatment Phase||9
6742454|NCT03323736|7670839|FG000|STARTED|Overall Study||241
6742455|NCT03323736|7670840|FG001|STARTED|Overall Study||59
6742456|NCT03323736|7670841|FG002|STARTED|Overall Study||70
6742457|NCT03323736|7670839|FG000|Treated|Overall Study||222
6742458|NCT03323736|7670840|FG001|Treated|Overall Study||47
6742459|NCT03323736|7670841|FG002|Treated|Overall Study||68
6742460|NCT03323736|7670839|FG000|COMPLETED|Overall Study||222
6742461|NCT03323736|7670840|FG001|COMPLETED|Overall Study||47
6628384|NCT02248974|7556407|FG000|COMPLETED|Baseline||47
6628385|NCT02248974|7556408|FG001|COMPLETED|Baseline||51
6628386|NCT02248974|7556407|FG000|NOT COMPLETED|Baseline||0
6628387|NCT02248974|7556408|FG001|NOT COMPLETED|Baseline||0
6628388|NCT02248974|7556407|FG000|STARTED|1-Day Follow-Up||47
6628389|NCT02248974|7556408|FG001|STARTED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
6628390|NCT02248974|7556407|FG000|COMPLETED|1-Day Follow-Up||37
6628391|NCT02248974|7556408|FG001|COMPLETED|1-Day Follow-Up|"No DA group did not receive 1-Day Follow-up survey."|0
6742462|NCT03323736|7670841|FG002|COMPLETED|Overall Study||68
6628392|NCT02248974|7556407|FG000|NOT COMPLETED|1-Day Follow-Up||10
6628393|NCT02248974|7556408|FG001|NOT COMPLETED|1-Day Follow-Up||0
6628394|NCT02248974|7556407|FG000|STARTED|1-Week Follow-Up||37
6628395|NCT02248974|7556408|FG001|STARTED|1-Week Follow-Up||51
6628396|NCT02248974|7556407|FG000|COMPLETED|1-Week Follow-Up||29
6628397|NCT02248974|7556408|FG001|COMPLETED|1-Week Follow-Up||34
6628398|NCT02248974|7556407|FG000|NOT COMPLETED|1-Week Follow-Up||8
6628399|NCT02248974|7556408|FG001|NOT COMPLETED|1-Week Follow-Up||17
6628400|NCT02248974|7556407|FG000|STARTED|1-Month Follow-Up||29
6628401|NCT02248974|7556408|FG001|STARTED|1-Month Follow-Up||34
6628402|NCT02248974|7556407|FG000|COMPLETED|1-Month Follow-Up||27
6742463|NCT03323736|7670839|FG000|NOT COMPLETED|Overall Study||19
6742464|NCT03323736|7670840|FG001|NOT COMPLETED|Overall Study||12
6742465|NCT03323736|7670841|FG002|NOT COMPLETED|Overall Study||2
6742466|NCT03323801|7670851|FG000|STARTED|Overall Study||10
6742467|NCT03323801|7670851|FG000|COMPLETED|Overall Study||10
6742468|NCT03323801|7670851|FG000|NOT COMPLETED|Overall Study||0
6742469|NCT03323853|7670858|FG000|STARTED|Overall Study||213
6742470|NCT03323853|7670859|FG001|STARTED|Overall Study||238
6742471|NCT03323853|7670858|FG000|COMPLETED|Overall Study||213
6742472|NCT03323853|7670859|FG001|COMPLETED|Overall Study||238
6742473|NCT03323853|7670858|FG000|NOT COMPLETED|Overall Study||0
6742474|NCT03323853|7670859|FG001|NOT COMPLETED|Overall Study||0
6742475|NCT03324451|7670867|FG000|STARTED|Overall Study||97
6742476|NCT03324451|7670868|FG001|STARTED|Overall Study||54
6742477|NCT03324451|7670867|FG000|COMPLETED|Overall Study||65
6742478|NCT03324451|7670868|FG001|COMPLETED|Overall Study||41
6742479|NCT03324451|7670867|FG000|NOT COMPLETED|Overall Study||32
6742480|NCT03324451|7670868|FG001|NOT COMPLETED|Overall Study||13
6742481|NCT03324581|7670877|FG000|STARTED|Overall Study||77
6742482|NCT03324581|7670878|FG001|STARTED|Overall Study||80
6742483|NCT03324581|7670879|FG002|STARTED|Overall Study||82
6742484|NCT03324581|7670877|FG000|COMPLETED|Overall Study||38
6742485|NCT03324581|7670878|FG001|COMPLETED|Overall Study||44
6742486|NCT03324581|7670879|FG002|COMPLETED|Overall Study||57
6742487|NCT03324581|7670877|FG000|NOT COMPLETED|Overall Study||39
6742488|NCT03324581|7670878|FG001|NOT COMPLETED|Overall Study||36
6742489|NCT03324581|7670879|FG002|NOT COMPLETED|Overall Study||25
6742490|NCT03324607|7670887|FG000|STARTED|Overall Study||20
6742491|NCT03324607|7670887|FG000|COMPLETED|Overall Study||20
6742492|NCT03324607|7670887|FG000|NOT COMPLETED|Overall Study||0
6742493|NCT03325010|7670896|FG000|STARTED|Overall Study||64
6742494|NCT03325010|7670897|FG001|STARTED|Overall Study||63
6742495|NCT03325010|7670896|FG000|Safety Analysis Set|Overall Study||62
6742496|NCT03325010|7670897|FG001|Safety Analysis Set|Overall Study||59
6742497|NCT03325010|7670896|FG000|Full Analysis Set|Overall Study||61
6742498|NCT03325010|7670897|FG001|Full Analysis Set|Overall Study||58
6742499|NCT03325010|7670896|FG000|COMPLETED|Overall Study||55
6742500|NCT03325010|7670897|FG001|COMPLETED|Overall Study||43
6742501|NCT03325010|7670896|FG000|NOT COMPLETED|Overall Study||9
6742502|NCT03325010|7670897|FG001|NOT COMPLETED|Overall Study||20
6742503|NCT03325556|7670903|FG000|STARTED|Open-label Period||392
6742504|NCT03325556|7670904|FG001|STARTED|Open-label Period||0
6742505|NCT03325556|7670905|FG002|STARTED|Open-label Period||0
6742506|NCT03325556|7670903|FG000|COMPLETED|Open-label Period||217
6742507|NCT03325556|7670904|FG001|COMPLETED|Open-label Period||0
6742508|NCT03325556|7670905|FG002|COMPLETED|Open-label Period||0
6742509|NCT03325556|7670903|FG000|NOT COMPLETED|Open-label Period||175
6742510|NCT03325556|7670904|FG001|NOT COMPLETED|Open-label Period||0
6742511|NCT03325556|7670905|FG002|NOT COMPLETED|Open-label Period||0
6742512|NCT03325556|7670903|FG000|STARTED|Double-blind Period||0
6742513|NCT03325556|7670904|FG001|STARTED|Double-blind Period||105
6742514|NCT03325556|7670905|FG002|STARTED|Double-blind Period||112
6742515|NCT03325556|7670903|FG000|COMPLETED|Double-blind Period||0
6742516|NCT03325556|7670904|FG001|COMPLETED|Double-blind Period||44
6742517|NCT03325556|7670905|FG002|COMPLETED|Double-blind Period||35
6742518|NCT03325556|7670903|FG000|NOT COMPLETED|Double-blind Period||0
6742519|NCT03325556|7670904|FG001|NOT COMPLETED|Double-blind Period||61
6742520|NCT03325556|7670905|FG002|NOT COMPLETED|Double-blind Period||77
6742521|NCT03325673|7670914|FG000|STARTED|Overall Study||42
6742522|NCT03325673|7670915|FG001|STARTED|Overall Study||42
6742523|NCT03325673|7670914|FG000|COMPLETED|Overall Study||38
6742524|NCT03325673|7670915|FG001|COMPLETED|Overall Study||42
6742525|NCT03325673|7670914|FG000|NOT COMPLETED|Overall Study||4
6742526|NCT03325673|7670915|FG001|NOT COMPLETED|Overall Study||0
6742527|NCT03325816|7670923|FG000|STARTED|Overall Study||3
6742528|NCT03325816|7670924|FG001|STARTED|Overall Study||6
6742529|NCT03325816|7670923|FG000|COMPLETED|Overall Study||3
6628403|NCT02248974|7556408|FG001|COMPLETED|1-Month Follow-Up||31
6628404|NCT02248974|7556407|FG000|NOT COMPLETED|1-Month Follow-Up||2
6628405|NCT02248974|7556408|FG001|NOT COMPLETED|1-Month Follow-Up||3
6628406|NCT02249052|7556414|FG000|STARTED|Overall Study||19
6628407|NCT02249052|7556414|FG000|COMPLETED|Overall Study||19
6742530|NCT03325816|7670924|FG001|COMPLETED|Overall Study||6
6742531|NCT03325816|7670923|FG000|NOT COMPLETED|Overall Study||0
6742532|NCT03325816|7670924|FG001|NOT COMPLETED|Overall Study||0
6742533|NCT03325881|7670934|FG000|STARTED|Overall Study||44
6742534|NCT03325881|7670935|FG001|STARTED|Overall Study||45
6742535|NCT03325881|7670934|FG000|Treated|Overall Study||43
6742536|NCT03325881|7670935|FG001|Treated|Overall Study||45
6742537|NCT03325881|7670934|FG000|COMPLETED|Overall Study||41
6742538|NCT03325881|7670935|FG001|COMPLETED|Overall Study||42
6628408|NCT02249052|7556414|FG000|NOT COMPLETED|Overall Study||0
6628409|NCT02249065|7556422|FG000|STARTED|Overall Study||205
6742539|NCT03325881|7670934|FG000|NOT COMPLETED|Overall Study||3
6282532|NCT00183391|7182781|FG000|STARTED|Crossover Placebo - 2 Weeks||95
6282533|NCT00183391|7182782|FG001|STARTED|Crossover Placebo - 2 Weeks||110
6399013|NCT00878722|7311704|FG002|STARTED|Overall Study||3
6399014|NCT00878722|7311705|FG003|STARTED|Overall Study||9
6742540|NCT03325881|7670935|FG001|NOT COMPLETED|Overall Study||3
6742541|NCT03325894|7670945|FG000|STARTED|Overall Study||64
6742542|NCT03325894|7670946|FG001|STARTED|Overall Study||77
6742543|NCT03325894|7670945|FG000|COMPLETED|Overall Study||0
6742544|NCT03325894|7670946|FG001|COMPLETED|Overall Study||0
6742545|NCT03325894|7670945|FG000|NOT COMPLETED|Overall Study||64
6742546|NCT03325894|7670946|FG001|NOT COMPLETED|Overall Study||77
6742547|NCT03326323|7670955|FG000|STARTED|Overall Study||43
6742548|NCT03326323|7670955|FG000|COMPLETED|Overall Study||40
6742549|NCT03326323|7670955|FG000|NOT COMPLETED|Overall Study||3
6742550|NCT03326518|7670962|FG000|STARTED|Overall Study||19
6742551|NCT03326518|7670963|FG001|STARTED|Overall Study||12
6742552|NCT03326518|7670964|FG002|STARTED|Overall Study||14
6742553|NCT03326518|7670962|FG000|COMPLETED|Overall Study||16
6742554|NCT03326518|7670963|FG001|COMPLETED|Overall Study||12
6742555|NCT03326518|7670964|FG002|COMPLETED|Overall Study||13
6742556|NCT03326518|7670962|FG000|NOT COMPLETED|Overall Study||3
6742557|NCT03326518|7670963|FG001|NOT COMPLETED|Overall Study||0
6742558|NCT03326518|7670964|FG002|NOT COMPLETED|Overall Study||1
6742559|NCT03326843|7670972|FG000|STARTED|Overall Study||4
6742560|NCT03326843|7670972|FG000|COMPLETED|Overall Study||4
6742561|NCT03326843|7670972|FG000|NOT COMPLETED|Overall Study||0
6742562|NCT03326895|7670976|FG000|STARTED|Overall Study||168
6742563|NCT03326895|7670976|FG000|COMPLETED|Overall Study||168
6742564|NCT03326895|7670976|FG000|NOT COMPLETED|Overall Study||0
6742565|NCT03326986|7670983|FG000|STARTED|Overall Study||8
6742566|NCT03326986|7670984|FG001|STARTED|Overall Study||8
6742567|NCT03326986|7670985|FG002|STARTED|Overall Study||8
6742568|NCT03326986|7670983|FG000|COMPLETED|Overall Study||8
6742569|NCT03326986|7670984|FG001|COMPLETED|Overall Study||8
6742570|NCT03326986|7670985|FG002|COMPLETED|Overall Study||8
6742571|NCT03326986|7670983|FG000|NOT COMPLETED|Overall Study||0
6742572|NCT03326986|7670984|FG001|NOT COMPLETED|Overall Study||0
6742573|NCT03326986|7670985|FG002|NOT COMPLETED|Overall Study||0
6742574|NCT03326999|7671028|FG000|STARTED|Overall Study||30
6742575|NCT03326999|7671029|FG001|STARTED|Overall Study||30
6742576|NCT03326999|7671028|FG000|COMPLETED|Overall Study||30
6742577|NCT03326999|7671029|FG001|COMPLETED|Overall Study||30
6742578|NCT03326999|7671028|FG000|NOT COMPLETED|Overall Study||0
6742579|NCT03326999|7671029|FG001|NOT COMPLETED|Overall Study||0
6742580|NCT03327051|7671037|FG000|STARTED|Overall Study||19
6742581|NCT03327051|7671038|FG001|STARTED|Overall Study||20
6742582|NCT03327051|7671037|FG000|Received Treatment|Overall Study||16
6742583|NCT03327051|7671038|FG001|Received Treatment|Overall Study||16
6742584|NCT03327051|7671037|FG000|Attended Visit 2 (Week 0)|Overall Study||15
6742585|NCT03327051|7671038|FG001|Attended Visit 2 (Week 0)|Overall Study||15
6742586|NCT03327051|7671037|FG000|COMPLETED|Overall Study||14
6742587|NCT03327051|7671038|FG001|COMPLETED|Overall Study||15
6742588|NCT03327051|7671037|FG000|NOT COMPLETED|Overall Study||5
6282534|NCT00183391|7182781|FG000|COMPLETED|Crossover Placebo - 2 Weeks||95
6282535|NCT00183391|7182782|FG001|COMPLETED|Crossover Placebo - 2 Weeks||110
6742589|NCT03327051|7671038|FG001|NOT COMPLETED|Overall Study||5
6742590|NCT03327220|7671047|FG000|STARTED|Overall Study||62
6742591|NCT03327220|7671048|FG001|STARTED|Overall Study||62
6742592|NCT03327220|7671047|FG000|Safety Population: Received Study Treatment|Overall Study||59
6742593|NCT03327220|7671048|FG001|Safety Population: Received Study Treatment|Overall Study||60
6628410|NCT02249065|7556422|FG000|Treated|Overall Study||181
6628411|NCT02249065|7556422|FG000|COMPLETED|Overall Study||176
6628412|NCT02249065|7556422|FG000|NOT COMPLETED|Overall Study||29
6628413|NCT02249091|7556428|FG000|STARTED|Overall Study||27
6628414|NCT02249091|7556429|FG001|STARTED|Overall Study||15
6628415|NCT02249091|7556428|FG000|COMPLETED|Overall Study||7
6628416|NCT02249091|7556429|FG001|COMPLETED|Overall Study||2
6628417|NCT02249091|7556428|FG000|NOT COMPLETED|Overall Study||20
6628418|NCT02249091|7556429|FG001|NOT COMPLETED|Overall Study||13
6628419|NCT02249104|7556435|FG000|STARTED|Overall Study||28
6628420|NCT02249104|7556435|FG000|COMPLETED|Overall Study||25
6628421|NCT02249104|7556435|FG000|NOT COMPLETED|Overall Study||3
6628422|NCT02249143|7556441|FG000|STARTED|Overall Study||24
6628423|NCT02249143|7556442|FG001|STARTED|Overall Study|randomized|26
6628424|NCT02249143|7556441|FG000|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
6628425|NCT02249143|7556442|FG001|COMPLETED|Overall Study|with technically acceptable pulmonary function tests in the neonatal intensive care unit|22
6628426|NCT02249143|7556441|FG000|NOT COMPLETED|Overall Study||2
6628427|NCT02249143|7556442|FG001|NOT COMPLETED|Overall Study||4
6655411|NCT02452944|7585519|FG001|COMPLETED|Overall Study||31
6655412|NCT02452944|7585518|FG000|NOT COMPLETED|Overall Study||0
6655413|NCT02452944|7585519|FG001|NOT COMPLETED|Overall Study||0
6655414|NCT02453048|7585532|FG000|STARTED|Overall Study||12
6655415|NCT02453048|7585533|FG001|STARTED|Overall Study||12
6655416|NCT02453048|7585534|FG002|STARTED|Overall Study||12
6655417|NCT02453048|7585535|FG003|STARTED|Overall Study||12
6655418|NCT02453048|7585536|FG004|STARTED|Overall Study||6
6655419|NCT02453048|7585532|FG000|6-month Follow-up|Overall Study||12
6655420|NCT02453048|7585533|FG001|6-month Follow-up|Overall Study||12
6655421|NCT02453048|7585534|FG002|6-month Follow-up|Overall Study||12
6655422|NCT02453048|7585535|FG003|6-month Follow-up|Overall Study||12
6655423|NCT02453048|7585536|FG004|6-month Follow-up|Overall Study||6
6655424|NCT02453048|7585532|FG000|COMPLETED|Overall Study||12
6655425|NCT02453048|7585533|FG001|COMPLETED|Overall Study||11
6655426|NCT02453048|7585534|FG002|COMPLETED|Overall Study||10
6655427|NCT02453048|7585535|FG003|COMPLETED|Overall Study||12
6655428|NCT02453048|7585536|FG004|COMPLETED|Overall Study||0
6655429|NCT02453048|7585532|FG000|NOT COMPLETED|Overall Study||0
6655430|NCT02453048|7585533|FG001|NOT COMPLETED|Overall Study||1
6655431|NCT02453048|7585534|FG002|NOT COMPLETED|Overall Study||2
6655432|NCT02453048|7585535|FG003|NOT COMPLETED|Overall Study||0
6655433|NCT02453048|7585536|FG004|NOT COMPLETED|Overall Study||6
6655434|NCT02453113|7585548|FG000|STARTED|Overall Study||10
6655435|NCT02453113|7585548|FG000|COMPLETED|Overall Study||10
6655436|NCT02453113|7585548|FG000|NOT COMPLETED|Overall Study||0
6655437|NCT02453191|7585552|FG000|STARTED|Overall Study||30
6655438|NCT02453191|7585552|FG000|COMPLETED|Overall Study||29
6655439|NCT02453191|7585552|FG000|NOT COMPLETED|Overall Study||1
6655440|NCT02453256|7585558|FG000|STARTED|Double Blind Period||106
6655441|NCT02453256|7585559|FG001|STARTED|Double Blind Period||104
6655442|NCT02453256|7585558|FG000|COMPLETED|Double Blind Period||93
6655443|NCT02453256|7585559|FG001|COMPLETED|Double Blind Period||95
6655444|NCT02453256|7585558|FG000|NOT COMPLETED|Double Blind Period||13
6655445|NCT02453256|7585559|FG001|NOT COMPLETED|Double Blind Period||9
6655446|NCT02453256|7585558|FG000|STARTED|Open Label Period||89
6655447|NCT02453256|7585559|FG001|STARTED|Open Label Period||92
6742594|NCT03327220|7671047|FG000|COMPLETED|Overall Study||57
6742595|NCT03327220|7671048|FG001|COMPLETED|Overall Study||58
6742596|NCT03327220|7671047|FG000|NOT COMPLETED|Overall Study||5
6742597|NCT03327220|7671048|FG001|NOT COMPLETED|Overall Study||4
6742598|NCT03327402|7671054|FG000|STARTED|Overall Study||24
6742599|NCT03327402|7671054|FG000|Rich PK Sampling Group|Overall Study||12
6742600|NCT03327402|7671054|FG000|Sparse PK Sampling Group|Overall Study||12
6655448|NCT02453256|7585558|FG000|COMPLETED|Open Label Period||82
6655449|NCT02453256|7585559|FG001|COMPLETED|Open Label Period||85
6655450|NCT02453256|7585558|FG000|NOT COMPLETED|Open Label Period||7
6655451|NCT02453256|7585559|FG001|NOT COMPLETED|Open Label Period||7
6655452|NCT02453282|7585575|FG000|STARTED|Overall Study||374
6655453|NCT02453282|7585576|FG001|STARTED|Overall Study||372
6655454|NCT02453282|7585577|FG002|STARTED|Overall Study||372
6655455|NCT02453282|7585575|FG000|Received Treatment|Overall Study||369
6655456|NCT02453282|7585576|FG001|Received Treatment|Overall Study||371
6655457|NCT02453282|7585577|FG002|Received Treatment|Overall Study||352
6655458|NCT02453282|7585575|FG000|COMPLETED|Overall Study||0
6655459|NCT02453282|7585576|FG001|COMPLETED|Overall Study||0
6655460|NCT02453282|7585577|FG002|COMPLETED|Overall Study||0
6655461|NCT02453282|7585575|FG000|NOT COMPLETED|Overall Study||374
6655462|NCT02453282|7585576|FG001|NOT COMPLETED|Overall Study||372
6655463|NCT02453282|7585577|FG002|NOT COMPLETED|Overall Study||372
6655464|NCT02453321|7585590|FG000|STARTED|Overall Study||20
6655465|NCT02453321|7585591|FG001|STARTED|Overall Study||21
6655466|NCT02453321|7585592|FG002|STARTED|Overall Study||21
6655467|NCT02453321|7585590|FG000|COMPLETED|Overall Study||19
6655468|NCT02453321|7585591|FG001|COMPLETED|Overall Study||19
6655469|NCT02453321|7585592|FG002|COMPLETED|Overall Study||19
6742601|NCT03327402|7671054|FG000|COMPLETED|Overall Study||22
6742602|NCT03327402|7671054|FG000|NOT COMPLETED|Overall Study||2
6628428|NCT02249182|7556453|FG000|STARTED|PK Lead-In Phase||10
6628429|NCT02249182|7556454|FG001|STARTED|PK Lead-In Phase||12
6628430|NCT02249182|7556455|FG002|STARTED|PK Lead-In Phase||0
6628431|NCT02249182|7556456|FG003|STARTED|PK Lead-In Phase||0
6628432|NCT02249182|7556457|FG004|STARTED|PK Lead-In Phase||17
6628433|NCT02249182|7556453|FG000|COMPLETED|PK Lead-In Phase||10
6628434|NCT02249182|7556454|FG001|COMPLETED|PK Lead-In Phase||12
6628435|NCT02249182|7556455|FG002|COMPLETED|PK Lead-In Phase||0
6628436|NCT02249182|7556456|FG003|COMPLETED|PK Lead-In Phase||0
6628437|NCT02249182|7556457|FG004|COMPLETED|PK Lead-In Phase||17
6628438|NCT02249182|7556453|FG000|NOT COMPLETED|PK Lead-In Phase||0
6628439|NCT02249182|7556454|FG001|NOT COMPLETED|PK Lead-In Phase||0
6628440|NCT02249182|7556455|FG002|NOT COMPLETED|PK Lead-In Phase||0
6628441|NCT02249182|7556456|FG003|NOT COMPLETED|PK Lead-In Phase||0
6628442|NCT02249182|7556457|FG004|NOT COMPLETED|PK Lead-In Phase||0
6628443|NCT02249182|7556453|FG000|STARTED|Treatment Phase|90 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|100
6628444|NCT02249182|7556454|FG001|STARTED|Treatment Phase|77 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|89
6628445|NCT02249182|7556455|FG002|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|1
6628446|NCT02249182|7556456|FG003|STARTED|Treatment Phase|2 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|2
6628447|NCT02249182|7556457|FG004|STARTED|Treatment Phase|17 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|34
6628448|NCT02249182|7556453|FG000|COMPLETED|Treatment Phase||96
6628449|NCT02249182|7556454|FG001|COMPLETED|Treatment Phase||89
6628450|NCT02249182|7556455|FG002|COMPLETED|Treatment Phase||1
6628451|NCT02249182|7556456|FG003|COMPLETED|Treatment Phase||2
6628452|NCT02249182|7556457|FG004|COMPLETED|Treatment Phase||34
6628453|NCT02249182|7556453|FG000|NOT COMPLETED|Treatment Phase||4
6628454|NCT02249182|7556454|FG001|NOT COMPLETED|Treatment Phase||0
6628455|NCT02249182|7556455|FG002|NOT COMPLETED|Treatment Phase||0
6628456|NCT02249182|7556456|FG003|NOT COMPLETED|Treatment Phase||0
6628457|NCT02249182|7556457|FG004|NOT COMPLETED|Treatment Phase||0
6628458|NCT02249585|7556485|FG000|STARTED|Overall Study||43
6628459|NCT02249585|7556486|FG001|STARTED|Overall Study||44
6628460|NCT02249585|7556487|FG002|STARTED|Overall Study||44
6628461|NCT02249585|7556485|FG000|COMPLETED|Overall Study||43
6628462|NCT02249585|7556486|FG001|COMPLETED|Overall Study||44
6628463|NCT02249585|7556487|FG002|COMPLETED|Overall Study||44
6628464|NCT02249585|7556485|FG000|NOT COMPLETED|Overall Study||0
6628465|NCT02249585|7556486|FG001|NOT COMPLETED|Overall Study||0
6628466|NCT02249585|7556487|FG002|NOT COMPLETED|Overall Study||0
6628467|NCT02249728|7556495|FG000|STARTED|Part One (4 Days)||6
6628468|NCT02249728|7556495|FG000|COMPLETED|Part One (4 Days)||6
6628469|NCT02249728|7556495|FG000|NOT COMPLETED|Part One (4 Days)||0
6628470|NCT02249728|7556495|FG000|STARTED|Part Two (up to 6 Days)||6
6628471|NCT02249728|7556495|FG000|COMPLETED|Part Two (up to 6 Days)||6
6628472|NCT02249728|7556495|FG000|NOT COMPLETED|Part Two (up to 6 Days)||0
6628473|NCT02249767|7556505|FG000|STARTED|Overall Study||230
6628474|NCT02249767|7556506|FG001|STARTED|Overall Study||229
6628475|NCT02249767|7556507|FG002|STARTED|Overall Study||115
6628476|NCT02249767|7556505|FG000|COMPLETED|Overall Study||222
6628477|NCT02249767|7556506|FG001|COMPLETED|Overall Study||220
6628478|NCT02249767|7556507|FG002|COMPLETED|Overall Study||107
6628479|NCT02249767|7556505|FG000|NOT COMPLETED|Overall Study||8
6628480|NCT02249767|7556506|FG001|NOT COMPLETED|Overall Study||9
6628481|NCT02249767|7556507|FG002|NOT COMPLETED|Overall Study||8
6628482|NCT02249793|7556515|FG000|STARTED|Session 1, 48-hours Healthy Volunteers||6
6628483|NCT02249793|7556515|FG000|COMPLETED|Session 1, 48-hours Healthy Volunteers||6
6628484|NCT02249793|7556515|FG000|NOT COMPLETED|Session 1, 48-hours Healthy Volunteers||0
6628485|NCT02249793|7556515|FG000|STARTED|Session 2, 48-Hours Healthy Volunteers||6
6628486|NCT02249793|7556515|FG000|COMPLETED|Session 2, 48-Hours Healthy Volunteers||6
6628487|NCT02249793|7556515|FG000|NOT COMPLETED|Session 2, 48-Hours Healthy Volunteers||0
6628488|NCT02249819|7556520|FG000|STARTED|Overall Study||8
6628489|NCT02249819|7556521|FG001|STARTED|Overall Study||7
6628490|NCT02249819|7556520|FG000|COMPLETED|Overall Study||8
6628491|NCT02249819|7556521|FG001|COMPLETED|Overall Study||7
6628492|NCT02249819|7556520|FG000|NOT COMPLETED|Overall Study||0
6628493|NCT02249819|7556521|FG001|NOT COMPLETED|Overall Study||0
6628494|NCT02249832|7556527|FG000|STARTED|Overall Study||55
6628495|NCT02249832|7556527|FG000|COMPLETED|Overall Study||42
6628496|NCT02249832|7556527|FG000|NOT COMPLETED|Overall Study||13
6628497|NCT02249949|7556536|FG000|STARTED|Overall Study||13
6628498|NCT02249949|7556536|FG000|COMPLETED|Overall Study||11
6742603|NCT03327571|7671060|FG000|STARTED|Group 1: cHL||1598
6742604|NCT03327571|7671061|FG001|STARTED|Group 1: cHL||0
6742605|NCT03327571|7671060|FG000|COMPLETED|Group 1: cHL||1598
6742606|NCT03327571|7671061|FG001|COMPLETED|Group 1: cHL||0
6742607|NCT03327571|7671060|FG000|NOT COMPLETED|Group 1: cHL||0
6742608|NCT03327571|7671061|FG001|NOT COMPLETED|Group 1: cHL||0
6742609|NCT03327571|7671060|FG000|STARTED|Group 2: RRHL||0
6628499|NCT02249949|7556536|FG000|NOT COMPLETED|Overall Study||2
6628500|NCT02250092|7556542|FG000|STARTED|Overall Study||10
6628501|NCT02250092|7556543|FG001|STARTED|Overall Study||10
6628502|NCT02250092|7556542|FG000|COMPLETED|Overall Study||10
6779636|NCT03725722|7707821|FG004|COMPLETED|Overall Study||36
6282536|NCT00183391|7182781|FG000|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
6628503|NCT02250092|7556543|FG001|COMPLETED|Overall Study||10
6628504|NCT02250092|7556542|FG000|NOT COMPLETED|Overall Study||0
6628505|NCT02250092|7556543|FG001|NOT COMPLETED|Overall Study||0
6628506|NCT02250183|7556549|FG000|STARTED|Overall Study||21
6628507|NCT02250183|7556549|FG000|COMPLETED|Overall Study||13
6628508|NCT02250183|7556549|FG000|NOT COMPLETED|Overall Study||8
6628509|NCT02250274|7556558|FG000|STARTED|Overall Study||85
6628510|NCT02250274|7556559|FG001|STARTED|Overall Study||46
6628511|NCT02250274|7556558|FG000|COMPLETED|Overall Study||78
6628512|NCT02250274|7556559|FG001|COMPLETED|Overall Study||40
6628513|NCT02250274|7556558|FG000|NOT COMPLETED|Overall Study||7
6628514|NCT02250274|7556559|FG001|NOT COMPLETED|Overall Study||6
6628515|NCT02250417|7556571|FG000|STARTED|First Intervention (1 Night)||6
6628516|NCT02250417|7556572|FG001|STARTED|First Intervention (1 Night)||6
6628517|NCT02250417|7556571|FG000|COMPLETED|First Intervention (1 Night)||6
6628518|NCT02250417|7556572|FG001|COMPLETED|First Intervention (1 Night)||6
6628519|NCT02250417|7556571|FG000|NOT COMPLETED|First Intervention (1 Night)||0
6628520|NCT02250417|7556572|FG001|NOT COMPLETED|First Intervention (1 Night)||0
6628521|NCT02250417|7556571|FG000|STARTED|Second Intervention (1 Night)||6
6628522|NCT02250417|7556572|FG001|STARTED|Second Intervention (1 Night)||6
6628523|NCT02250417|7556571|FG000|COMPLETED|Second Intervention (1 Night)||6
6628524|NCT02250417|7556572|FG001|COMPLETED|Second Intervention (1 Night)||6
6628525|NCT02250417|7556571|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
6628526|NCT02250417|7556572|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
6628527|NCT02250443|7556581|FG000|STARTED|Overall Study||10
6628528|NCT02250443|7556581|FG000|COMPLETED|Overall Study||0
6628529|NCT02250443|7556581|FG000|NOT COMPLETED|Overall Study||10
6628530|NCT02250521|7556585|FG000|STARTED|Overall Study||100
6628531|NCT02250521|7556585|FG000|COMPLETED|Overall Study||99
6628532|NCT02250521|7556585|FG000|NOT COMPLETED|Overall Study||1
6628533|NCT02250612|7556594|FG000|STARTED|Overall Study||37
6628534|NCT02250612|7556595|FG001|STARTED|Overall Study||40
6628535|NCT02250612|7556596|FG002|STARTED|Overall Study||37
6628536|NCT02250612|7556597|FG003|STARTED|Overall Study||33
6628537|NCT02250612|7556598|FG004|STARTED|Overall Study||37
6628538|NCT02250612|7556594|FG000|COMPLETED|Overall Study||36
6628539|NCT02250612|7556595|FG001|COMPLETED|Overall Study||38
6628540|NCT02250612|7556596|FG002|COMPLETED|Overall Study||35
6628541|NCT02250612|7556597|FG003|COMPLETED|Overall Study||33
6628542|NCT02250612|7556598|FG004|COMPLETED|Overall Study||36
6628543|NCT02250612|7556594|FG000|NOT COMPLETED|Overall Study||1
6628544|NCT02250612|7556595|FG001|NOT COMPLETED|Overall Study||2
6628545|NCT02250612|7556596|FG002|NOT COMPLETED|Overall Study||2
6628546|NCT02250612|7556597|FG003|NOT COMPLETED|Overall Study||0
6628547|NCT02250612|7556598|FG004|NOT COMPLETED|Overall Study||1
6628548|NCT02250651|7556620|FG000|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
6628549|NCT02250651|7556621|FG001|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
6628550|NCT02250651|7556622|FG002|STARTED|Treatment Period 1 (Day 1 to Week 15)||176
6628551|NCT02250651|7556620|FG000|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||176
6628552|NCT02250651|7556621|FG001|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||175
6628553|NCT02250651|7556622|FG002|Received Sham or Bimatoprost SR|Treatment Period 1 (Day 1 to Week 15)||173
6399015|NCT00878722|7311706|FG004|STARTED|Overall Study||7
6628554|NCT02250651|7556620|FG000|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||172
6628555|NCT02250651|7556621|FG001|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||170
6742610|NCT03327571|7671061|FG001|STARTED|Group 2: RRHL|105 RRHL only participants and 321 common participants who had CHL, and subsequently RRHL between 2010-2013.|426
6742611|NCT03327571|7671060|FG000|Participants Were Counted in Both Groups|Group 2: RRHL||0
6742612|NCT03327571|7671061|FG001|Participants Were Counted in Both Groups|Group 2: RRHL|Participants who were diagnosed with CHL, and subsequently RRHL between 2010 and 2013.|321
6742613|NCT03327571|7671060|FG000|COMPLETED|Group 2: RRHL||0
6742614|NCT03327571|7671061|FG001|COMPLETED|Group 2: RRHL||426
6742615|NCT03327571|7671060|FG000|NOT COMPLETED|Group 2: RRHL||0
6742616|NCT03327571|7671061|FG001|NOT COMPLETED|Group 2: RRHL||0
6742617|NCT03328182|7671068|FG000|STARTED|Overall Study||34
6742618|NCT03328182|7671068|FG000|COMPLETED|Overall Study||30
6742619|NCT03328182|7671068|FG000|NOT COMPLETED|Overall Study||4
6742620|NCT03328208|7671074|FG000|STARTED|Overall Study||37
6742621|NCT03328208|7671075|FG001|STARTED|Overall Study||35
6742622|NCT03328208|7671074|FG000|COMPLETED|Overall Study||37
6742623|NCT03328208|7671075|FG001|COMPLETED|Overall Study||35
6742624|NCT03328208|7671074|FG000|NOT COMPLETED|Overall Study||0
6742625|NCT03328208|7671075|FG001|NOT COMPLETED|Overall Study||0
6742626|NCT03328325|7671081|FG000|STARTED|Overall Study||152
6742627|NCT03328325|7671081|FG000|COMPLETED|Overall Study||141
6742628|NCT03328325|7671081|FG000|NOT COMPLETED|Overall Study||11
6742629|NCT03328624|7671085|FG000|STARTED|Overall Study||36
6742630|NCT03328624|7671085|FG000|COMPLETED|Overall Study||36
6742631|NCT03328624|7671085|FG000|NOT COMPLETED|Overall Study||0
6742632|NCT03328832|7671091|FG000|STARTED|Overall Study||35
6282537|NCT00183391|7182782|FG001|NOT COMPLETED|Crossover Placebo - 2 Weeks||0
6282538|NCT00183391|7182781|FG000|STARTED|Block 2 - 5 Weeks||95
6282539|NCT00183391|7182782|FG001|STARTED|Block 2 - 5 Weeks||110
6628556|NCT02250651|7556622|FG002|COMPLETED|Treatment Period 1 (Day 1 to Week 15)||165
6628557|NCT02250651|7556620|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||4
6628558|NCT02250651|7556621|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||6
6628559|NCT02250651|7556622|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to Week 15)||11
6628560|NCT02250651|7556620|FG000|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
6628561|NCT02250651|7556621|FG001|STARTED|Treatment Period 2 (Week 16 to Week 31)||168
6628562|NCT02250651|7556622|FG002|STARTED|Treatment Period 2 (Week 16 to Week 31)||165
6628563|NCT02250651|7556620|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||159
6628564|NCT02250651|7556621|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||162
6628565|NCT02250651|7556622|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 31)||160
6628566|NCT02250651|7556620|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
6628567|NCT02250651|7556621|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||6
6628568|NCT02250651|7556622|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 31)||5
6628569|NCT02250651|7556620|FG000|STARTED|Treatment Period 3 (Week 32 to Week 52)||147
6628570|NCT02250651|7556621|FG001|STARTED|Treatment Period 3 (Week 32 to Week 52)||156
6628571|NCT02250651|7556622|FG002|STARTED|Treatment Period 3 (Week 32 to Week 52)||159
6628572|NCT02250651|7556620|FG000|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||138
6628573|NCT02250651|7556621|FG001|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||152
6628574|NCT02250651|7556622|FG002|COMPLETED|Treatment Period 3 (Week 32 to Week 52)||154
6628575|NCT02250651|7556620|FG000|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||9
6628576|NCT02250651|7556621|FG001|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||4
6628577|NCT02250651|7556622|FG002|NOT COMPLETED|Treatment Period 3 (Week 32 to Week 52)||5
6628578|NCT02250703|7556632|FG000|STARTED|Overall Study||38
6628579|NCT02250703|7556633|FG001|STARTED|Overall Study||37
6628580|NCT02250703|7556632|FG000|COMPLETED|Overall Study||37
6628581|NCT02250703|7556633|FG001|COMPLETED|Overall Study||36
6628582|NCT02250703|7556632|FG000|NOT COMPLETED|Overall Study||1
6628583|NCT02250703|7556633|FG001|NOT COMPLETED|Overall Study||1
6628584|NCT02250807|7556639|FG000|STARTED|Overall Study||40
6628585|NCT02250807|7556639|FG000|COMPLETED|Overall Study||40
6628586|NCT02250807|7556639|FG000|NOT COMPLETED|Overall Study||0
6628587|NCT02251236|7556646|FG000|STARTED|Overall Study||9
6628588|NCT02251236|7556647|FG001|STARTED|Overall Study||5
6628589|NCT02251236|7556648|FG002|STARTED|Overall Study||0
6628590|NCT02251236|7556646|FG000|COMPLETED|Overall Study||9
6628591|NCT02251236|7556647|FG001|COMPLETED|Overall Study||5
6628592|NCT02251236|7556648|FG002|COMPLETED|Overall Study||0
6628593|NCT02251236|7556646|FG000|NOT COMPLETED|Overall Study||0
6628594|NCT02251236|7556647|FG001|NOT COMPLETED|Overall Study||0
6628595|NCT02251236|7556648|FG002|NOT COMPLETED|Overall Study||0
6628596|NCT02251275|7556661|FG000|STARTED|Overall Study||506
6628597|NCT02251275|7556662|FG001|STARTED|Overall Study||570
6628598|NCT02251275|7556663|FG002|STARTED|Overall Study||718
6628599|NCT02251275|7556664|FG003|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|6
6628600|NCT02251275|7556665|FG004|STARTED|Overall Study|From trials 156-04-251 and 156-09-290|3
6628601|NCT02251275|7556661|FG000|Received at Least 1 Dose of Study Drug|Overall Study||505
6628602|NCT02251275|7556662|FG001|Received at Least 1 Dose of Study Drug|Overall Study||569
6628603|NCT02251275|7556663|FG002|Received at Least 1 Dose of Study Drug|Overall Study||717
6628604|NCT02251275|7556664|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6628605|NCT02251275|7556665|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
6628606|NCT02251275|7556661|FG000|COMPLETED|Overall Study||434
6628607|NCT02251275|7556662|FG001|COMPLETED|Overall Study||423
6628608|NCT02251275|7556663|FG002|COMPLETED|Overall Study||624
6628609|NCT02251275|7556664|FG003|COMPLETED|Overall Study||5
6628610|NCT02251275|7556665|FG004|COMPLETED|Overall Study||2
6628611|NCT02251275|7556661|FG000|NOT COMPLETED|Overall Study||72
6628612|NCT02251275|7556662|FG001|NOT COMPLETED|Overall Study||147
6628613|NCT02251275|7556663|FG002|NOT COMPLETED|Overall Study||94
6628614|NCT02251275|7556664|FG003|NOT COMPLETED|Overall Study||1
6628615|NCT02251275|7556665|FG004|NOT COMPLETED|Overall Study||1
6628616|NCT02251379|7556679|FG000|STARTED|Overall Study||77
6628617|NCT02251379|7556680|FG001|STARTED|Overall Study||78
6628618|NCT02251379|7556679|FG000|COMPLETED|Overall Study||57
6628619|NCT02251379|7556680|FG001|COMPLETED|Overall Study||58
6628620|NCT02251379|7556679|FG000|NOT COMPLETED|Overall Study||20
6628621|NCT02251379|7556680|FG001|NOT COMPLETED|Overall Study||20
6628622|NCT02251496|7556688|FG000|STARTED|Overall Study||19
6628623|NCT02251496|7556689|FG001|STARTED|Overall Study||15
6628624|NCT02251496|7556688|FG000|COMPLETED|Overall Study||14
6628625|NCT02251496|7556689|FG001|COMPLETED|Overall Study||11
6628626|NCT02251496|7556688|FG000|NOT COMPLETED|Overall Study||5
6628627|NCT02251496|7556689|FG001|NOT COMPLETED|Overall Study||4
6628628|NCT02251561|7556695|FG000|STARTED|Overall Study||28
6628629|NCT02251561|7556695|FG000|COMPLETED|Overall Study||28
6628630|NCT02251561|7556695|FG000|NOT COMPLETED|Overall Study||0
6628631|NCT02251613|7556701|FG000|STARTED|Overall Study||50
6628632|NCT02251613|7556701|FG000|COMPLETED|Overall Study||50
6628633|NCT02251613|7556701|FG000|NOT COMPLETED|Overall Study||0
6628634|NCT02251652|7556707|FG000|STARTED|Overall Study||17
6628635|NCT02251652|7556707|FG000|COMPLETED|Overall Study||16
6628636|NCT02251652|7556707|FG000|NOT COMPLETED|Overall Study||1
6628637|NCT02251717|7556715|FG000|STARTED|Overall Study||57
6628638|NCT02251717|7556716|FG001|STARTED|Overall Study||57
6628639|NCT02251717|7556715|FG000|COMPLETED|Overall Study||56
6628640|NCT02251717|7556716|FG001|COMPLETED|Overall Study||56
6742633|NCT03328832|7671092|FG001|STARTED|Overall Study||35
6742634|NCT03328832|7671091|FG000|COMPLETED|Overall Study||35
6742635|NCT03328832|7671092|FG001|COMPLETED|Overall Study||34
6742636|NCT03328832|7671091|FG000|NOT COMPLETED|Overall Study||0
6742637|NCT03328832|7671092|FG001|NOT COMPLETED|Overall Study||1
6742638|NCT03328897|7671101|FG000|STARTED|Randomized-treatment Epoch||168
6742639|NCT03328897|7671102|FG001|STARTED|Randomized-treatment Epoch||167
6742640|NCT03328897|7671103|FG002|STARTED|Randomized-treatment Epoch||83
6742641|NCT03328897|7671101|FG000|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
6742642|NCT03328897|7671102|FG001|Full Analysis Set (FAS)|Randomized-treatment Epoch||167
6742643|NCT03328897|7671103|FG002|Full Analysis Set (FAS)|Randomized-treatment Epoch||83
6742644|NCT03328897|7671101|FG000|COMPLETED|Randomized-treatment Epoch||152
6742645|NCT03328897|7671102|FG001|COMPLETED|Randomized-treatment Epoch||162
6742646|NCT03328897|7671103|FG002|COMPLETED|Randomized-treatment Epoch||81
6742647|NCT03328897|7671101|FG000|NOT COMPLETED|Randomized-treatment Epoch||16
6742648|NCT03328897|7671102|FG001|NOT COMPLETED|Randomized-treatment Epoch||5
6742649|NCT03328897|7671103|FG002|NOT COMPLETED|Randomized-treatment Epoch||2
6742650|NCT03328897|7671101|FG000|STARTED|Follow-up Epoch||161
6742651|NCT03328897|7671102|FG001|STARTED|Follow-up Epoch||163
6628641|NCT02251717|7556715|FG000|NOT COMPLETED|Overall Study||1
6742652|NCT03328897|7671103|FG002|STARTED|Follow-up Epoch||81
6628642|NCT02251717|7556716|FG001|NOT COMPLETED|Overall Study||1
6628643|NCT02251743|7556724|FG000|STARTED|Overall Study||85
6628644|NCT02251743|7556725|FG001|STARTED|Overall Study||59
6742653|NCT03328897|7671101|FG000|COMPLETED|Follow-up Epoch||153
6742654|NCT03328897|7671102|FG001|COMPLETED|Follow-up Epoch||160
6742655|NCT03328897|7671103|FG002|COMPLETED|Follow-up Epoch||79
6742656|NCT03328897|7671101|FG000|NOT COMPLETED|Follow-up Epoch||8
6742657|NCT03328897|7671102|FG001|NOT COMPLETED|Follow-up Epoch||3
6628645|NCT02251743|7556724|FG000|COMPLETED|Overall Study||84
6628646|NCT02251743|7556725|FG001|COMPLETED|Overall Study||58
6628647|NCT02251743|7556724|FG000|NOT COMPLETED|Overall Study||1
6628648|NCT02251743|7556725|FG001|NOT COMPLETED|Overall Study||1
6628649|NCT02251886|7556735|FG000|STARTED|Overall Study||48
6628650|NCT02251886|7556736|FG001|STARTED|Overall Study||54
6628651|NCT02251886|7556737|FG002|STARTED|Overall Study||44
6628652|NCT02251886|7556738|FG003|STARTED|Overall Study||54
6628653|NCT02251886|7556735|FG000|COMPLETED|Overall Study||48
6742658|NCT03328897|7671103|FG002|NOT COMPLETED|Follow-up Epoch||2
6742659|NCT03328949|7671111|FG000|STARTED|Overall Study||120
6742660|NCT03328949|7671111|FG000|COMPLETED|Overall Study||120
6742661|NCT03328949|7671111|FG000|NOT COMPLETED|Overall Study||0
6742662|NCT03329196|7671118|FG000|STARTED|Overall Study||151
6742663|NCT03329196|7671119|FG001|STARTED|Overall Study||153
6742664|NCT03329196|7671118|FG000|COMPLETED|Overall Study||111
6742665|NCT03329196|7671119|FG001|COMPLETED|Overall Study||123
6742666|NCT03329196|7671118|FG000|NOT COMPLETED|Overall Study||40
6742667|NCT03329196|7671119|FG001|NOT COMPLETED|Overall Study||30
6742668|NCT03329209|7671125|FG000|STARTED|Overall Study||16
6742669|NCT03329209|7671125|FG000|COMPLETED|Overall Study||16
6742670|NCT03329209|7671125|FG000|NOT COMPLETED|Overall Study||0
6628654|NCT02251886|7556736|FG001|COMPLETED|Overall Study||54
6628655|NCT02251886|7556737|FG002|COMPLETED|Overall Study||44
6628656|NCT02251886|7556738|FG003|COMPLETED|Overall Study||54
6742671|NCT03329352|7671129|FG000|STARTED|F&P Toffee Full Face Mask Validation||44
6742672|NCT03329352|7671129|FG000|COMPLETED|F&P Toffee Full Face Mask Validation||42
6282540|NCT00183391|7182781|FG000|COMPLETED|Block 2 - 5 Weeks||91
6628657|NCT02251886|7556735|FG000|NOT COMPLETED|Overall Study||0
6628658|NCT02251886|7556736|FG001|NOT COMPLETED|Overall Study||0
6742673|NCT03329352|7671129|FG000|NOT COMPLETED|F&P Toffee Full Face Mask Validation||2
6742674|NCT03329352|7671129|FG000|STARTED|Extension||29
6742675|NCT03329352|7671129|FG000|COMPLETED|Extension||22
6742676|NCT03329352|7671129|FG000|NOT COMPLETED|Extension||7
6282541|NCT00183391|7182782|FG001|COMPLETED|Block 2 - 5 Weeks||108
6282542|NCT00183391|7182781|FG000|NOT COMPLETED|Block 2 - 5 Weeks||4
6282543|NCT00183391|7182782|FG001|NOT COMPLETED|Block 2 - 5 Weeks||2
6282544|NCT00183430|7182792|FG000|STARTED|Overall Study||9
6282545|NCT00183430|7182793|FG001|STARTED|Overall Study||11
6282546|NCT00183430|7182792|FG000|COMPLETED|Overall Study||3
6282547|NCT00183430|7182793|FG001|COMPLETED|Overall Study||11
6282548|NCT00183430|7182792|FG000|NOT COMPLETED|Overall Study||6
6282549|NCT00183430|7182793|FG001|NOT COMPLETED|Overall Study||0
6282550|NCT00183443|7182802|FG000|STARTED|Overall Study||24
6282551|NCT00183443|7182803|FG001|STARTED|Overall Study||26
6628659|NCT02251886|7556737|FG002|NOT COMPLETED|Overall Study||0
6628660|NCT02251886|7556738|FG003|NOT COMPLETED|Overall Study||0
6628661|NCT02251912|7556750|FG000|STARTED|Overall Study||12
6628662|NCT02251912|7556751|FG001|STARTED|Overall Study||10
6628663|NCT02251912|7556750|FG000|COMPLETED|Overall Study||10
6628664|NCT02251912|7556751|FG001|COMPLETED|Overall Study||5
6628665|NCT02251912|7556750|FG000|NOT COMPLETED|Overall Study||2
6628666|NCT02251912|7556751|FG001|NOT COMPLETED|Overall Study||5
6628667|NCT02251938|7556757|FG000|STARTED|Overall Study||60
6628668|NCT02251938|7556757|FG000|COMPLETED|Overall Study||43
6628669|NCT02251938|7556757|FG000|NOT COMPLETED|Overall Study||17
6628670|NCT02251990|7556763|FG000|STARTED|Period 1 (Double-blind [DB])||366
6628671|NCT02251990|7556764|FG001|STARTED|Period 1 (Double-blind [DB])||123
6628672|NCT02251990|7556763|FG000|Treated|Period 1 (Double-blind [DB])|Started Grazoprevir/Elbasvir|365
6628673|NCT02251990|7556764|FG001|Treated|Period 1 (Double-blind [DB])|Started Placebo|123
6628674|NCT02251990|7556763|FG000|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Grazoprevir/Elbasvir|358
6628675|NCT02251990|7556764|FG001|COMPLETED|Period 1 (Double-blind [DB])|Completed 12 weeks of Placebo|122
6628676|NCT02251990|7556763|FG000|NOT COMPLETED|Period 1 (Double-blind [DB])||8
6628677|NCT02251990|7556764|FG001|NOT COMPLETED|Period 1 (Double-blind [DB])||1
6628678|NCT02251990|7556763|FG000|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|2 participants that did not complete Period 1 treatment were included in Follow-up.|360
6628679|NCT02251990|7556764|FG001|STARTED|Period 2 (ITG Follow-up/DTG Open Label)|1 participant completing Period 1 was not eligible for Period 2 and was not treated.|121
6628680|NCT02251990|7556763|FG000|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 24 weeks of follow-up|360
6628681|NCT02251990|7556764|FG001|COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)|Completed 12 weeks of Grazoprevir/Elbasvir|118
6628682|NCT02251990|7556763|FG000|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||0
6628683|NCT02251990|7556764|FG001|NOT COMPLETED|Period 2 (ITG Follow-up/DTG Open Label)||3
6628684|NCT02251990|7556763|FG000|STARTED|Period 3 (DTG Follow-up)|The ITG completed the study with Period 2|0
6628685|NCT02251990|7556764|FG001|STARTED|Period 3 (DTG Follow-up)|3 participants that discontinued treatment in Period 2 were included in Follow-up.|121
6628686|NCT02251990|7556763|FG000|COMPLETED|Period 3 (DTG Follow-up)||0
6628687|NCT02251990|7556764|FG001|COMPLETED|Period 3 (DTG Follow-up)|Completed 24 weeks of follow-up|121
6628688|NCT02251990|7556763|FG000|NOT COMPLETED|Period 3 (DTG Follow-up)||0
6282552|NCT00183443|7182804|FG002|STARTED|Overall Study||25
6373831|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373832|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6742677|NCT03329573|7671139|FG000|STARTED|Treatment Period 1 (Up to 5 Days)||23
6742678|NCT03329573|7671140|FG001|STARTED|Treatment Period 1 (Up to 5 Days)||24
6742679|NCT03329573|7671141|FG002|STARTED|Treatment Period 1 (Up to 5 Days)||19
6742680|NCT03329573|7671142|FG003|STARTED|Treatment Period 1 (Up to 5 Days)||19
6742681|NCT03329573|7671139|FG000|COMPLETED|Treatment Period 1 (Up to 5 Days)||22
6742682|NCT03329573|7671140|FG001|COMPLETED|Treatment Period 1 (Up to 5 Days)||21
6742683|NCT03329573|7671141|FG002|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
6742684|NCT03329573|7671142|FG003|COMPLETED|Treatment Period 1 (Up to 5 Days)||19
6742685|NCT03329573|7671139|FG000|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||1
6742686|NCT03329573|7671140|FG001|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||3
6742687|NCT03329573|7671141|FG002|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
6742688|NCT03329573|7671142|FG003|NOT COMPLETED|Treatment Period 1 (Up to 5 Days)||0
6742689|NCT03329573|7671139|FG000|STARTED|Washout Period (Day 6 to Day 11)||22
6742690|NCT03329573|7671140|FG001|STARTED|Washout Period (Day 6 to Day 11)||21
6742691|NCT03329573|7671141|FG002|STARTED|Washout Period (Day 6 to Day 11)||19
6742692|NCT03329573|7671142|FG003|STARTED|Washout Period (Day 6 to Day 11)||19
6742693|NCT03329573|7671139|FG000|COMPLETED|Washout Period (Day 6 to Day 11)||22
6742694|NCT03329573|7671140|FG001|COMPLETED|Washout Period (Day 6 to Day 11)||21
6742695|NCT03329573|7671141|FG002|COMPLETED|Washout Period (Day 6 to Day 11)||19
6742696|NCT03329573|7671142|FG003|COMPLETED|Washout Period (Day 6 to Day 11)||19
6742697|NCT03329573|7671139|FG000|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
6742698|NCT03329573|7671140|FG001|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
6742699|NCT03329573|7671141|FG002|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
6742700|NCT03329573|7671142|FG003|NOT COMPLETED|Washout Period (Day 6 to Day 11)||0
6742701|NCT03329573|7671139|FG000|STARTED|Treatment Period 2 (Day 12 to Day 26)||22
6742702|NCT03329573|7671140|FG001|STARTED|Treatment Period 2 (Day 12 to Day 26)||21
6742703|NCT03329573|7671141|FG002|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
6742704|NCT03329573|7671142|FG003|STARTED|Treatment Period 2 (Day 12 to Day 26)||19
6742705|NCT03329573|7671139|FG000|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||21
6742706|NCT03329573|7671140|FG001|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||20
6742707|NCT03329573|7671141|FG002|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
6742708|NCT03329573|7671142|FG003|COMPLETED|Treatment Period 2 (Day 12 to Day 26)||19
6742709|NCT03329573|7671139|FG000|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
6742710|NCT03329573|7671140|FG001|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||1
6742711|NCT03329573|7671141|FG002|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
6742712|NCT03329573|7671142|FG003|NOT COMPLETED|Treatment Period 2 (Day 12 to Day 26)||0
6742713|NCT03329846|7671154|FG000|STARTED|Overall Study||10
6742714|NCT03329846|7671155|FG001|STARTED|Overall Study||10
6742715|NCT03329846|7671154|FG000|COMPLETED|Overall Study||2
6742716|NCT03329846|7671155|FG001|COMPLETED|Overall Study||1
6742717|NCT03329846|7671154|FG000|NOT COMPLETED|Overall Study||8
6742718|NCT03329846|7671155|FG001|NOT COMPLETED|Overall Study||9
6742719|NCT03329885|7671167|FG000|STARTED|Overall Study||9
6742720|NCT03329885|7671168|FG001|STARTED|Overall Study||6
6742721|NCT03329885|7671169|FG002|STARTED|Overall Study||6
6742722|NCT03329885|7671170|FG003|STARTED|Overall Study||6
6742723|NCT03329885|7671171|FG004|STARTED|Overall Study||6
6742724|NCT03329885|7671172|FG005|STARTED|Overall Study||3
6628689|NCT02251990|7556764|FG001|NOT COMPLETED|Period 3 (DTG Follow-up)||0
6628690|NCT02252016|7556773|FG000|STARTED|Overall Study||107
6628691|NCT02252016|7556774|FG001|STARTED|Overall Study||52
6628692|NCT02252016|7556773|FG000|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
6628693|NCT02252016|7556774|FG001|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
6628694|NCT02252016|7556773|FG000|NOT COMPLETED|Overall Study||3
6628695|NCT02252016|7556774|FG001|NOT COMPLETED|Overall Study||3
6628696|NCT02252042|7556782|FG000|STARTED|Overall Study||247
6628697|NCT02252042|7556783|FG001|STARTED|Overall Study||248
6628698|NCT02252042|7556782|FG000|Treated|Overall Study|1 participant was randomized but did not receive study treatment.|246
6628699|NCT02252042|7556783|FG001|Treated|Overall Study|14 participants were randomized but did not receive study treatment.|234
6628700|NCT02252042|7556782|FG000|COMPLETED|Overall Study||0
6628701|NCT02252042|7556783|FG001|COMPLETED|Overall Study||0
6628702|NCT02252042|7556782|FG000|NOT COMPLETED|Overall Study||247
6628703|NCT02252042|7556783|FG001|NOT COMPLETED|Overall Study||248
6628704|NCT02252068|7556792|FG000|STARTED|Overall Study||5
6628705|NCT02252068|7556793|FG001|STARTED|Overall Study||13
6628706|NCT02252068|7556794|FG002|STARTED|Overall Study||13
6628707|NCT02252068|7556792|FG000|COMPLETED|Overall Study||3
6628708|NCT02252068|7556793|FG001|COMPLETED|Overall Study||13
6628709|NCT02252068|7556794|FG002|COMPLETED|Overall Study||13
6628710|NCT02252068|7556792|FG000|NOT COMPLETED|Overall Study||2
6628711|NCT02252068|7556793|FG001|NOT COMPLETED|Overall Study||0
6628712|NCT02252068|7556794|FG002|NOT COMPLETED|Overall Study||0
6628713|NCT02252081|7556804|FG000|STARTED|Overall Study||30
6628714|NCT02252081|7556805|FG001|STARTED|Overall Study||30
6628715|NCT02252081|7556804|FG000|COMPLETED|Overall Study||24
6628716|NCT02252081|7556805|FG001|COMPLETED|Overall Study||26
6628717|NCT02252081|7556804|FG000|NOT COMPLETED|Overall Study||6
6628718|NCT02252081|7556805|FG001|NOT COMPLETED|Overall Study||4
6628719|NCT02252133|7556816|FG000|STARTED|Period 1||23
6628720|NCT02252133|7556817|FG001|STARTED|Period 1||24
6628721|NCT02252133|7556816|FG000|COMPLETED|Period 1||23
6628722|NCT02252133|7556817|FG001|COMPLETED|Period 1||24
6628723|NCT02252133|7556816|FG000|NOT COMPLETED|Period 1||0
6628724|NCT02252133|7556817|FG001|NOT COMPLETED|Period 1||0
6628725|NCT02252133|7556816|FG000|STARTED|Period 2||23
6628726|NCT02252133|7556817|FG001|STARTED|Period 2||24
6628727|NCT02252133|7556816|FG000|COMPLETED|Period 2||23
6628728|NCT02252133|7556817|FG001|COMPLETED|Period 2||24
6628729|NCT02252133|7556816|FG000|NOT COMPLETED|Period 2||0
6628730|NCT02252133|7556817|FG001|NOT COMPLETED|Period 2||0
6628731|NCT02252146|7556823|FG000|STARTED|Overall Study||6
6628732|NCT02252146|7556823|FG000|COMPLETED|Overall Study||0
6628733|NCT02252146|7556823|FG000|NOT COMPLETED|Overall Study||6
6628734|NCT02252211|7556829|FG000|STARTED|Overall Study||5
6628735|NCT02252211|7556830|FG001|STARTED|Overall Study||3
6628736|NCT02252211|7556831|FG002|STARTED|Overall Study||1
6742725|NCT03329885|7671173|FG006|STARTED|Overall Study||1
6742726|NCT03329885|7671174|FG007|STARTED|Overall Study||1
6742727|NCT03329885|7671175|FG008|STARTED|Overall Study|Due to early termination of study, Part C was cancelled and no patients were dosed|0
6742728|NCT03329885|7671167|FG000|COMPLETED|Overall Study||9
6742729|NCT03329885|7671168|FG001|COMPLETED|Overall Study||6
6742730|NCT03329885|7671169|FG002|COMPLETED|Overall Study||6
6742731|NCT03329885|7671170|FG003|COMPLETED|Overall Study||6
6742732|NCT03329885|7671171|FG004|COMPLETED|Overall Study||6
6742733|NCT03329885|7671172|FG005|COMPLETED|Overall Study||3
6742734|NCT03329885|7671173|FG006|COMPLETED|Overall Study||0
6742735|NCT03329885|7671174|FG007|COMPLETED|Overall Study||0
6742736|NCT03329885|7671175|FG008|COMPLETED|Overall Study||0
6742737|NCT03329885|7671167|FG000|NOT COMPLETED|Overall Study||0
6742738|NCT03329885|7671168|FG001|NOT COMPLETED|Overall Study||0
6742739|NCT03329885|7671169|FG002|NOT COMPLETED|Overall Study||0
6742740|NCT03329885|7671170|FG003|NOT COMPLETED|Overall Study||0
6742741|NCT03329885|7671171|FG004|NOT COMPLETED|Overall Study||0
6742742|NCT03329885|7671172|FG005|NOT COMPLETED|Overall Study||0
6742743|NCT03329885|7671173|FG006|NOT COMPLETED|Overall Study||1
6742744|NCT03329885|7671174|FG007|NOT COMPLETED|Overall Study||1
6742745|NCT03329885|7671175|FG008|NOT COMPLETED|Overall Study||0
6742746|NCT03329911|7671197|FG000|STARTED|Overall Study||326
6742747|NCT03329911|7671198|FG001|STARTED|Overall Study||325
6742748|NCT03329911|7671197|FG000|COMPLETED|Overall Study||209
6742749|NCT03329911|7671198|FG001|COMPLETED|Overall Study||222
6742750|NCT03329911|7671197|FG000|NOT COMPLETED|Overall Study||117
6742751|NCT03329911|7671198|FG001|NOT COMPLETED|Overall Study||103
6742752|NCT03329937|7671204|FG000|STARTED|Overall Study||21
6742753|NCT03329937|7671204|FG000|COMPLETED|Overall Study||21
6742754|NCT03329937|7671204|FG000|NOT COMPLETED|Overall Study||0
6742755|NCT03329989|7671208|FG000|STARTED|Overall Study||158
6742756|NCT03329989|7671208|FG000|COMPLETED|Overall Study||135
6742757|NCT03329989|7671208|FG000|NOT COMPLETED|Overall Study||23
6742758|NCT03330002|7671212|FG000|STARTED|Overall Study|Subjects that received the MANTA VCD|500
6742759|NCT03330002|7671212|FG000|COMPLETED|Overall Study|Subjects that received the MANTA VCD and completed 30 day follow-up visit|478
6742760|NCT03330002|7671212|FG000|NOT COMPLETED|Overall Study||22
6628737|NCT02252211|7556829|FG000|Received Dose 1 (Day 1)|Overall Study||4
6628738|NCT02252211|7556830|FG001|Received Dose 1 (Day 1)|Overall Study||3
6742761|NCT03330041|7671216|FG000|STARTED|Overall Study||50
6742762|NCT03330041|7671216|FG000|COMPLETED|Overall Study||48
6742763|NCT03330041|7671216|FG000|NOT COMPLETED|Overall Study||2
6742764|NCT03330119|7671224|FG000|STARTED|Overall Study||641
6742765|NCT03330119|7671225|FG001|STARTED|Overall Study||853
6742766|NCT03330119|7671224|FG000|COMPLETED|Overall Study||475
6742767|NCT03330119|7671225|FG001|COMPLETED|Overall Study||571
6628739|NCT02252211|7556831|FG002|Received Dose 1 (Day 1)|Overall Study||0
6628740|NCT02252211|7556829|FG000|Received Dose 2 (Day 8)|Overall Study||4
6628741|NCT02252211|7556830|FG001|Received Dose 2 (Day 8)|Overall Study||3
6628742|NCT02252211|7556831|FG002|Received Dose 2 (Day 8)|Overall Study||0
6628743|NCT02252211|7556829|FG000|Received Dose 3 (Day 22)|Overall Study||3
6628744|NCT02252211|7556830|FG001|Received Dose 3 (Day 22)|Overall Study||3
6628745|NCT02252211|7556831|FG002|Received Dose 3 (Day 22)|Overall Study||0
6628746|NCT02252211|7556829|FG000|Received Dose 4 (Day 36)|Overall Study||1
6628747|NCT02252211|7556830|FG001|Received Dose 4 (Day 36)|Overall Study||1
6628748|NCT02252211|7556831|FG002|Received Dose 4 (Day 36)|Overall Study||0
6628749|NCT02252211|7556829|FG000|Received Further Doses (Through Dose 24)|Overall Study||1
6628750|NCT02252211|7556830|FG001|Received Further Doses (Through Dose 24)|Overall Study||0
6628751|NCT02252211|7556831|FG002|Received Further Doses (Through Dose 24)|Overall Study||0
6628752|NCT02252211|7556829|FG000|COMPLETED|Overall Study||0
6628753|NCT02252211|7556830|FG001|COMPLETED|Overall Study||0
6628754|NCT02252211|7556831|FG002|COMPLETED|Overall Study||0
6628755|NCT02252211|7556829|FG000|NOT COMPLETED|Overall Study||5
6628756|NCT02252211|7556830|FG001|NOT COMPLETED|Overall Study||3
6628757|NCT02252211|7556831|FG002|NOT COMPLETED|Overall Study||1
6628758|NCT02252354|7556840|FG000|STARTED|Overall Study||6
6628759|NCT02252354|7556841|FG001|STARTED|Overall Study||6
6628760|NCT02252354|7556840|FG000|COMPLETED|Overall Study||6
6628761|NCT02252354|7556841|FG001|COMPLETED|Overall Study||6
6628762|NCT02252354|7556840|FG000|NOT COMPLETED|Overall Study||0
6628763|NCT02252354|7556841|FG001|NOT COMPLETED|Overall Study||0
6628764|NCT02252406|7556849|FG000|STARTED|Starting Dose Ranolazine 500 mg BID||16
6628765|NCT02252406|7556850|FG001|STARTED|Starting Dose Ranolazine 500 mg BID||17
6628766|NCT02252406|7556849|FG000|COMPLETED|Starting Dose Ranolazine 500 mg BID||12
6628767|NCT02252406|7556850|FG001|COMPLETED|Starting Dose Ranolazine 500 mg BID||14
6628768|NCT02252406|7556849|FG000|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||4
6628769|NCT02252406|7556850|FG001|NOT COMPLETED|Starting Dose Ranolazine 500 mg BID||3
6628770|NCT02252406|7556849|FG000|STARTED|Titrated to Ranolazine 1000mg BID||12
6628771|NCT02252406|7556850|FG001|STARTED|Titrated to Ranolazine 1000mg BID||14
6628772|NCT02252406|7556849|FG000|COMPLETED|Titrated to Ranolazine 1000mg BID||9
6628773|NCT02252406|7556850|FG001|COMPLETED|Titrated to Ranolazine 1000mg BID||13
6628774|NCT02252406|7556849|FG000|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||3
6628775|NCT02252406|7556850|FG001|NOT COMPLETED|Titrated to Ranolazine 1000mg BID||1
6628776|NCT02252445|7556858|FG000|STARTED|Overall Study||41
6628777|NCT02252445|7556859|FG001|STARTED|Overall Study||41
6628778|NCT02252445|7556858|FG000|COMPLETED|Overall Study||41
6628779|NCT02252445|7556859|FG001|COMPLETED|Overall Study||41
6628780|NCT02252445|7556858|FG000|NOT COMPLETED|Overall Study||0
6628781|NCT02252445|7556859|FG001|NOT COMPLETED|Overall Study||0
6628782|NCT02252536|7556867|FG000|STARTED|Overall Study||173
6628783|NCT02252536|7556868|FG001|STARTED|Overall Study||173
6628784|NCT02252536|7556867|FG000|COMPLETED|Overall Study||168
6628785|NCT02252536|7556868|FG001|COMPLETED|Overall Study||170
6628786|NCT02252536|7556867|FG000|NOT COMPLETED|Overall Study||5
6628787|NCT02252536|7556868|FG001|NOT COMPLETED|Overall Study||3
6628788|NCT02252562|7556876|FG000|STARTED|Overall Study||1620
6628789|NCT02252562|7556877|FG001|STARTED|Overall Study||1636
6628790|NCT02252562|7556876|FG000|COMPLETED|Overall Study||1620
6628791|NCT02252562|7556877|FG001|COMPLETED|Overall Study||1636
6628792|NCT02252562|7556876|FG000|NOT COMPLETED|Overall Study||0
6628793|NCT02252562|7556877|FG001|NOT COMPLETED|Overall Study||0
6628794|NCT02252588|7556886|FG000|STARTED|Overall Study||24
6628795|NCT02252588|7556887|FG001|STARTED|Overall Study||20
6628796|NCT02252588|7556886|FG000|COMPLETED|Overall Study||20
6628797|NCT02252588|7556887|FG001|COMPLETED|Overall Study||20
6628798|NCT02252588|7556886|FG000|NOT COMPLETED|Overall Study||4
6628799|NCT02252588|7556887|FG001|NOT COMPLETED|Overall Study||0
6628800|NCT02252666|7556893|FG000|STARTED|Overall Study||6
6628801|NCT02252666|7556893|FG000|COMPLETED|Overall Study||6
6628802|NCT02252666|7556893|FG000|NOT COMPLETED|Overall Study||0
6628803|NCT02252718|7556897|FG000|STARTED|Overall Study||100
6628804|NCT02252718|7556897|FG000|COMPLETED|Overall Study||100
6628805|NCT02252718|7556897|FG000|NOT COMPLETED|Overall Study||0
6628806|NCT02252744|7556901|FG000|STARTED|Overall Study||286
6628807|NCT02252744|7556901|FG000|COMPLETED|Overall Study||286
6628808|NCT02252744|7556901|FG000|NOT COMPLETED|Overall Study||0
6628809|NCT02252939|7556905|FG000|STARTED|Overall Study||62
6628810|NCT02252939|7556905|FG000|COMPLETED|Overall Study||59
6628811|NCT02252939|7556905|FG000|NOT COMPLETED|Overall Study||3
6628812|NCT02252965|7556916|FG000|STARTED|Overall Study||267
6742768|NCT03330119|7671224|FG000|NOT COMPLETED|Overall Study||166
6628813|NCT02252965|7556917|FG001|STARTED|Overall Study||265
6628814|NCT02252965|7556916|FG000|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
6628815|NCT02252965|7556917|FG001|Safety Population|Overall Study||264
6628816|NCT02252965|7556916|FG000|COMPLETED|Overall Study||227
6628817|NCT02252965|7556917|FG001|COMPLETED|Overall Study||222
6628818|NCT02252965|7556916|FG000|NOT COMPLETED|Overall Study||40
6628819|NCT02252965|7556917|FG001|NOT COMPLETED|Overall Study||43
6742769|NCT03330119|7671225|FG001|NOT COMPLETED|Overall Study||282
6742770|NCT03330236|7671233|FG000|STARTED|Overall Study||779
6742771|NCT03330236|7671234|FG001|STARTED|Overall Study||781
6742772|NCT03330236|7671233|FG000|Received Surgery|Overall Study||779
6742773|NCT03330236|7671234|FG001|Received Surgery|Overall Study||781
6742774|NCT03330236|7671233|FG000|Modified ITT|Overall Study||773
6742775|NCT03330236|7671234|FG001|Modified ITT|Overall Study||774
6742776|NCT03330236|7671233|FG000|COMPLETED|Overall Study||679
6742777|NCT03330236|7671234|FG001|COMPLETED|Overall Study||697
6742778|NCT03330236|7671233|FG000|NOT COMPLETED|Overall Study||100
6742779|NCT03330236|7671234|FG001|NOT COMPLETED|Overall Study||84
6742780|NCT03330262|7671242|FG000|STARTED|First Six Weeks||7
6742781|NCT03330262|7671243|FG001|STARTED|First Six Weeks||6
6742782|NCT03330262|7671242|FG000|COMPLETED|First Six Weeks||7
6742783|NCT03330262|7671243|FG001|COMPLETED|First Six Weeks||6
6742784|NCT03330262|7671242|FG000|NOT COMPLETED|First Six Weeks||0
6742785|NCT03330262|7671243|FG001|NOT COMPLETED|First Six Weeks||0
6742786|NCT03330262|7671242|FG000|STARTED|Second Six Weeks||7
6628820|NCT02253147|7556925|FG000|STARTED|Overall Study||118
6628821|NCT02253147|7556925|FG000|N Patients at W24 (Primary Outcome)|Overall Study||88
6628822|NCT02253147|7556925|FG000|N Patients at W36|Overall Study||86
6628823|NCT02253147|7556925|FG000|N Patients at W52|Overall Study||84
6628824|NCT02253147|7556925|FG000|COMPLETED|Overall Study||71
6628825|NCT02253147|7556925|FG000|NOT COMPLETED|Overall Study||47
6628826|NCT02253160|7556934|FG000|STARTED|Overall Study||1
6628827|NCT02253160|7556935|FG001|STARTED|Overall Study||12
6628828|NCT02253160|7556936|FG002|STARTED|Overall Study||10
6628829|NCT02253160|7556934|FG000|COMPLETED|Overall Study||1
6628830|NCT02253160|7556935|FG001|COMPLETED|Overall Study||12
6628831|NCT02253160|7556936|FG002|COMPLETED|Overall Study||10
6628832|NCT02253160|7556934|FG000|NOT COMPLETED|Overall Study||0
6628833|NCT02253160|7556935|FG001|NOT COMPLETED|Overall Study||0
6628834|NCT02253160|7556936|FG002|NOT COMPLETED|Overall Study||0
6628835|NCT02253173|7556950|FG000|STARTED|Overall Study||191
6628836|NCT02253173|7556951|FG001|STARTED|Overall Study||191
6628837|NCT02253173|7556952|FG002|STARTED|Overall Study||190
6628838|NCT02253173|7556953|FG003|STARTED|Overall Study||192
6628839|NCT02253173|7556950|FG000|COMPLETED|Overall Study||175
6628840|NCT02253173|7556951|FG001|COMPLETED|Overall Study||174
6628841|NCT02253173|7556952|FG002|COMPLETED|Overall Study||177
6628842|NCT02253173|7556953|FG003|COMPLETED|Overall Study||178
6628843|NCT02253173|7556950|FG000|NOT COMPLETED|Overall Study||16
6628844|NCT02253173|7556951|FG001|NOT COMPLETED|Overall Study||17
6628845|NCT02253173|7556952|FG002|NOT COMPLETED|Overall Study||13
6628846|NCT02253173|7556953|FG003|NOT COMPLETED|Overall Study||14
6628847|NCT02253433|7556969|FG000|STARTED|Overall Study||130
6628848|NCT02253433|7556970|FG001|STARTED|Overall Study||134
6628849|NCT02253433|7556969|FG000|COMPLETED|Overall Study||114
6628850|NCT02253433|7556970|FG001|COMPLETED|Overall Study||79
6628851|NCT02253433|7556969|FG000|NOT COMPLETED|Overall Study||16
6628852|NCT02253433|7556970|FG001|NOT COMPLETED|Overall Study||55
6628853|NCT02253537|7556977|FG000|STARTED|Overall Study||15
6628854|NCT02253537|7556977|FG000|COMPLETED|Overall Study||15
6628855|NCT02253537|7556977|FG000|NOT COMPLETED|Overall Study||0
6628856|NCT02253654|7556983|FG000|STARTED|Overall Study||108
6628857|NCT02253654|7556984|FG001|STARTED|Overall Study||108
6628858|NCT02253654|7556983|FG000|Received Treatment|Overall Study||104
6628859|NCT02253654|7556984|FG001|Received Treatment|Overall Study||107
6628860|NCT02253654|7556983|FG000|COMPLETED|Overall Study||85
6628861|NCT02253654|7556984|FG001|COMPLETED|Overall Study||90
6628862|NCT02253654|7556983|FG000|NOT COMPLETED|Overall Study||23
6628863|NCT02253654|7556984|FG001|NOT COMPLETED|Overall Study||18
6628864|NCT02253992|7556993|FG000|STARTED|Overall Study||6
6628865|NCT02253992|7556994|FG001|STARTED|Overall Study||4
6628866|NCT02253992|7556995|FG002|STARTED|Overall Study||150
6628867|NCT02253992|7556993|FG000|COMPLETED|Overall Study||0
6628868|NCT02253992|7556994|FG001|COMPLETED|Overall Study||0
6628869|NCT02253992|7556995|FG002|COMPLETED|Overall Study||6
6628870|NCT02253992|7556993|FG000|NOT COMPLETED|Overall Study||6
6628871|NCT02253992|7556994|FG001|NOT COMPLETED|Overall Study||4
6628872|NCT02253992|7556995|FG002|NOT COMPLETED|Overall Study||144
6628873|NCT02254252|7557019|FG000|STARTED|Overall Study||27
6628874|NCT02254252|7557020|FG001|STARTED|Overall Study||27
6628875|NCT02254252|7557019|FG000|COMPLETED|Overall Study||24
6628876|NCT02254252|7557020|FG001|COMPLETED|Overall Study||25
6628877|NCT02254252|7557019|FG000|NOT COMPLETED|Overall Study||3
6628878|NCT02254252|7557020|FG001|NOT COMPLETED|Overall Study||2
6628879|NCT02254265|7557029|FG000|STARTED|Overall Study||151
6628880|NCT02254265|7557030|FG001|STARTED|Overall Study||152
6628881|NCT02254265|7557031|FG002|STARTED|Overall Study||152
6742787|NCT03330262|7671243|FG001|STARTED|Second Six Weeks||6
6742788|NCT03330262|7671242|FG000|COMPLETED|Second Six Weeks||5
6742789|NCT03330262|7671243|FG001|COMPLETED|Second Six Weeks||5
6742790|NCT03330262|7671242|FG000|NOT COMPLETED|Second Six Weeks||2
6742791|NCT03330262|7671243|FG001|NOT COMPLETED|Second Six Weeks||1
6628882|NCT02254265|7557029|FG000|COMPLETED|Overall Study||142
6628883|NCT02254265|7557030|FG001|COMPLETED|Overall Study||140
6628884|NCT02254265|7557031|FG002|COMPLETED|Overall Study||144
6628885|NCT02254265|7557029|FG000|NOT COMPLETED|Overall Study||9
6628886|NCT02254265|7557030|FG001|NOT COMPLETED|Overall Study||12
6628887|NCT02254265|7557031|FG002|NOT COMPLETED|Overall Study||8
6742792|NCT03330275|7671252|FG000|STARTED|Visit 1 - Period 1||6
6742793|NCT03330275|7671253|FG001|STARTED|Visit 1 - Period 1||6
6742794|NCT03330275|7671254|FG002|STARTED|Visit 1 - Period 1||6
6742795|NCT03330275|7671255|FG003|STARTED|Visit 1 - Period 1||6
6742796|NCT03330275|7671256|FG004|STARTED|Visit 1 - Period 1||0
6742797|NCT03330275|7671257|FG005|STARTED|Visit 1 - Period 1||0
6742798|NCT03330275|7671258|FG006|STARTED|Visit 1 - Period 1||0
6742799|NCT03330275|7671259|FG007|STARTED|Visit 1 - Period 1||0
6742800|NCT03330275|7671260|FG008|STARTED|Visit 1 - Period 1||0
6742801|NCT03330275|7671261|FG009|STARTED|Visit 1 - Period 1||0
6742802|NCT03330275|7671252|FG000|COMPLETED|Visit 1 - Period 1||6
6742803|NCT03330275|7671253|FG001|COMPLETED|Visit 1 - Period 1||6
6742804|NCT03330275|7671254|FG002|COMPLETED|Visit 1 - Period 1||6
6742805|NCT03330275|7671255|FG003|COMPLETED|Visit 1 - Period 1||6
6742806|NCT03330275|7671256|FG004|COMPLETED|Visit 1 - Period 1||0
6742807|NCT03330275|7671257|FG005|COMPLETED|Visit 1 - Period 1||0
6742808|NCT03330275|7671258|FG006|COMPLETED|Visit 1 - Period 1||0
6742809|NCT03330275|7671259|FG007|COMPLETED|Visit 1 - Period 1||0
6742810|NCT03330275|7671260|FG008|COMPLETED|Visit 1 - Period 1||0
6742811|NCT03330275|7671261|FG009|COMPLETED|Visit 1 - Period 1||0
6742812|NCT03330275|7671252|FG000|NOT COMPLETED|Visit 1 - Period 1||0
6742813|NCT03330275|7671253|FG001|NOT COMPLETED|Visit 1 - Period 1||0
6742814|NCT03330275|7671254|FG002|NOT COMPLETED|Visit 1 - Period 1||0
6742815|NCT03330275|7671255|FG003|NOT COMPLETED|Visit 1 - Period 1||0
6742816|NCT03330275|7671256|FG004|NOT COMPLETED|Visit 1 - Period 1||0
6742817|NCT03330275|7671257|FG005|NOT COMPLETED|Visit 1 - Period 1||0
6742818|NCT03330275|7671258|FG006|NOT COMPLETED|Visit 1 - Period 1||0
6742819|NCT03330275|7671259|FG007|NOT COMPLETED|Visit 1 - Period 1||0
6742820|NCT03330275|7671260|FG008|NOT COMPLETED|Visit 1 - Period 1||0
6628888|NCT02254291|7557042|FG000|STARTED|Overall Study||103
6628889|NCT02254291|7557043|FG001|STARTED|Overall Study||102
6628890|NCT02254291|7557044|FG002|STARTED|Overall Study||103
6628891|NCT02254291|7557042|FG000|Exposed|Overall Study||103
6628892|NCT02254291|7557043|FG001|Exposed|Overall Study||102
6628893|NCT02254291|7557044|FG002|Exposed|Overall Study||103
6628894|NCT02254291|7557042|FG000|COMPLETED|Overall Study||103
6628895|NCT02254291|7557043|FG001|COMPLETED|Overall Study||99
6628896|NCT02254291|7557044|FG002|COMPLETED|Overall Study||101
6628897|NCT02254291|7557042|FG000|NOT COMPLETED|Overall Study||0
6628898|NCT02254291|7557043|FG001|NOT COMPLETED|Overall Study||3
6628899|NCT02254291|7557044|FG002|NOT COMPLETED|Overall Study||2
6628900|NCT02254304|7557054|FG000|STARTED|Overall Study||89
6628901|NCT02254304|7557055|FG001|STARTED|Overall Study||17
6628902|NCT02254304|7557054|FG000|COMPLETED|Overall Study||75
6628903|NCT02254304|7557055|FG001|COMPLETED|Overall Study||13
6628904|NCT02254304|7557054|FG000|NOT COMPLETED|Overall Study||14
6628905|NCT02254304|7557055|FG001|NOT COMPLETED|Overall Study||4
6628906|NCT02254408|7557065|FG000|STARTED|Overall Study||96
6628907|NCT02254408|7557066|FG001|STARTED|Overall Study||93
6628908|NCT02254408|7557065|FG000|COMPLETED|Overall Study||88
6628909|NCT02254408|7557066|FG001|COMPLETED|Overall Study||83
6628910|NCT02254408|7557065|FG000|NOT COMPLETED|Overall Study||8
6628911|NCT02254408|7557066|FG001|NOT COMPLETED|Overall Study||10
6628912|NCT02254421|7557074|FG000|STARTED|Overall Study||31
6628913|NCT02254421|7557075|FG001|STARTED|Overall Study||29
6628914|NCT02254421|7557074|FG000|COMPLETED|Overall Study||29
6628915|NCT02254421|7557075|FG001|COMPLETED|Overall Study||26
6628916|NCT02254421|7557074|FG000|NOT COMPLETED|Overall Study||2
6628917|NCT02254421|7557075|FG001|NOT COMPLETED|Overall Study||3
6628918|NCT02254460|7557081|FG000|STARTED|Overall Study||13
6628919|NCT02254460|7557082|FG001|STARTED|Overall Study||12
6628920|NCT02254460|7557081|FG000|COMPLETED|Overall Study||12
6628921|NCT02254460|7557082|FG001|COMPLETED|Overall Study||12
6628922|NCT02254460|7557081|FG000|NOT COMPLETED|Overall Study||1
6628923|NCT02254460|7557082|FG001|NOT COMPLETED|Overall Study||0
6628924|NCT02254473|7557090|FG000|STARTED|Overall Study||9
6628925|NCT02254473|7557091|FG001|STARTED|Overall Study||3
6628926|NCT02254473|7557090|FG000|COMPLETED|Overall Study||7
6628927|NCT02254473|7557091|FG001|COMPLETED|Overall Study||2
6628928|NCT02254473|7557090|FG000|NOT COMPLETED|Overall Study||2
6628929|NCT02254473|7557091|FG001|NOT COMPLETED|Overall Study||1
6628930|NCT02254486|7557099|FG000|STARTED|Overall Study||311
6628931|NCT02254486|7557100|FG001|STARTED|Overall Study||310
6628932|NCT02254486|7557099|FG000|COMPLETED|Overall Study||261
6628933|NCT02254486|7557100|FG001|COMPLETED|Overall Study||255
6628934|NCT02254486|7557099|FG000|NOT COMPLETED|Overall Study||50
6628935|NCT02254486|7557100|FG001|NOT COMPLETED|Overall Study||55
6628936|NCT02254551|7557106|FG000|STARTED|Dose Escalation||7
6628937|NCT02254551|7557106|FG000|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
6628938|NCT02254551|7557106|FG000|Cohort 2: LDE225 600mg|Dose Escalation||0
6742821|NCT03330275|7671261|FG009|NOT COMPLETED|Visit 1 - Period 1||0
6742822|NCT03330275|7671252|FG000|STARTED|Visit 1 - Period 2||6
6742823|NCT03330275|7671253|FG001|STARTED|Visit 1 - Period 2||6
6742824|NCT03330275|7671254|FG002|STARTED|Visit 1 - Period 2||6
6742825|NCT03330275|7671255|FG003|STARTED|Visit 1 - Period 2||6
6742826|NCT03330275|7671256|FG004|STARTED|Visit 1 - Period 2||0
6742827|NCT03330275|7671257|FG005|STARTED|Visit 1 - Period 2||0
6742828|NCT03330275|7671258|FG006|STARTED|Visit 1 - Period 2||0
6742829|NCT03330275|7671259|FG007|STARTED|Visit 1 - Period 2||0
6742830|NCT03330275|7671260|FG008|STARTED|Visit 1 - Period 2||0
6742831|NCT03330275|7671261|FG009|STARTED|Visit 1 - Period 2||0
6742832|NCT03330275|7671252|FG000|COMPLETED|Visit 1 - Period 2||6
6742833|NCT03330275|7671253|FG001|COMPLETED|Visit 1 - Period 2||6
6742834|NCT03330275|7671254|FG002|COMPLETED|Visit 1 - Period 2||6
6742835|NCT03330275|7671255|FG003|COMPLETED|Visit 1 - Period 2||6
6742836|NCT03330275|7671256|FG004|COMPLETED|Visit 1 - Period 2||0
6742837|NCT03330275|7671257|FG005|COMPLETED|Visit 1 - Period 2||0
6742838|NCT03330275|7671258|FG006|COMPLETED|Visit 1 - Period 2||0
6742839|NCT03330275|7671259|FG007|COMPLETED|Visit 1 - Period 2||0
6628939|NCT02254551|7557106|FG000|Cohort 3: LDE225 800mg|Dose Escalation||0
6628940|NCT02254551|7557106|FG000|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
6628941|NCT02254551|7557106|FG000|NOT COMPLETED|Dose Escalation||3
6628942|NCT02254551|7557106|FG000|STARTED|Expansion||0
6628943|NCT02254551|7557106|FG000|COMPLETED|Expansion||0
6628944|NCT02254551|7557106|FG000|NOT COMPLETED|Expansion||0
6628945|NCT02254551|7557106|FG000|STARTED|Maintenance||0
6628946|NCT02254551|7557106|FG000|COMPLETED|Maintenance||0
6628947|NCT02254551|7557106|FG000|NOT COMPLETED|Maintenance||0
6628948|NCT02254681|7557113|FG000|STARTED|Overall Study||6
6628949|NCT02254681|7557113|FG000|COMPLETED|Overall Study||0
6628950|NCT02254681|7557113|FG000|NOT COMPLETED|Overall Study||6
6628951|NCT02254772|7557118|FG000|STARTED|Overall Study||9
6628952|NCT02254772|7557118|FG000|COMPLETED|Overall Study||7
6628953|NCT02254772|7557118|FG000|NOT COMPLETED|Overall Study||2
6628954|NCT02255032|7557124|FG000|STARTED|Overall Study||17
6628955|NCT02255032|7557125|FG001|STARTED|Overall Study||5
6628956|NCT02255032|7557124|FG000|COMPLETED|Overall Study||17
6628957|NCT02255032|7557125|FG001|COMPLETED|Overall Study||5
6628958|NCT02255032|7557124|FG000|NOT COMPLETED|Overall Study||0
6628959|NCT02255032|7557125|FG001|NOT COMPLETED|Overall Study||0
6628960|NCT02255097|7557131|FG000|STARTED|Overall Study||172
6628961|NCT02255097|7557131|FG000|Treated|Overall Study||171
6628962|NCT02255097|7557131|FG000|COMPLETED|Overall Study||0
6628963|NCT02255097|7557131|FG000|NOT COMPLETED|Overall Study||172
6628964|NCT02255110|7557135|FG000|STARTED|Overall Study||6
6628965|NCT02255110|7557135|FG000|COMPLETED|Overall Study||6
6628966|NCT02255110|7557135|FG000|NOT COMPLETED|Overall Study||0
6628967|NCT02255149|7557139|FG000|STARTED|Overall Study||10
6628968|NCT02255149|7557139|FG000|COMPLETED|Overall Study||5
6628969|NCT02255149|7557139|FG000|NOT COMPLETED|Overall Study||5
6628970|NCT02255175|7557145|FG000|STARTED|Overall Study||33
6628971|NCT02255175|7557146|FG001|STARTED|Overall Study||31
6628972|NCT02255175|7557145|FG000|COMPLETED|Overall Study||16
6628973|NCT02255175|7557146|FG001|COMPLETED|Overall Study||19
6628974|NCT02255175|7557145|FG000|NOT COMPLETED|Overall Study||17
6628975|NCT02255175|7557146|FG001|NOT COMPLETED|Overall Study||12
6628976|NCT02255279|7557158|FG000|STARTED|Overall Study||144
6628977|NCT02255279|7557159|FG001|STARTED|Overall Study||143
6628978|NCT02255279|7557158|FG000|COMPLETED|Overall Study||139
6628979|NCT02255279|7557159|FG001|COMPLETED|Overall Study||134
6628980|NCT02255279|7557158|FG000|NOT COMPLETED|Overall Study||5
6628981|NCT02255279|7557159|FG001|NOT COMPLETED|Overall Study||9
6628982|NCT02255357|7557181|FG000|STARTED|Overall Study||11
6628983|NCT02255357|7557182|FG001|STARTED|Overall Study||15
6628984|NCT02255357|7557181|FG000|COMPLETED|Overall Study||4
6628985|NCT02255357|7557182|FG001|COMPLETED|Overall Study||5
6628986|NCT02255357|7557181|FG000|NOT COMPLETED|Overall Study||7
6628987|NCT02255357|7557182|FG001|NOT COMPLETED|Overall Study||10
6628988|NCT02255422|7557195|FG000|STARTED|Overall Study||13
6628989|NCT02255422|7557196|FG001|STARTED|Overall Study||6
6628990|NCT02255422|7557197|FG002|STARTED|Overall Study||6
6628991|NCT02255422|7557198|FG003|STARTED|Overall Study||6
6628992|NCT02255422|7557199|FG004|STARTED|Overall Study||6
6628993|NCT02255422|7557200|FG005|STARTED|Overall Study||6
6628994|NCT02255422|7557201|FG006|STARTED|Overall Study||10
6628995|NCT02255422|7557195|FG000|COMPLETED|Overall Study||13
6628996|NCT02255422|7557196|FG001|COMPLETED|Overall Study||6
6628997|NCT02255422|7557197|FG002|COMPLETED|Overall Study||5
6628998|NCT02255422|7557198|FG003|COMPLETED|Overall Study||6
6628999|NCT02255422|7557199|FG004|COMPLETED|Overall Study||6
6629000|NCT02255422|7557200|FG005|COMPLETED|Overall Study||6
6629001|NCT02255422|7557201|FG006|COMPLETED|Overall Study||8
6629002|NCT02255422|7557195|FG000|NOT COMPLETED|Overall Study||0
6629003|NCT02255422|7557196|FG001|NOT COMPLETED|Overall Study||0
6629004|NCT02255422|7557197|FG002|NOT COMPLETED|Overall Study||1
6629005|NCT02255422|7557198|FG003|NOT COMPLETED|Overall Study||0
6629006|NCT02255422|7557199|FG004|NOT COMPLETED|Overall Study||0
6629007|NCT02255422|7557200|FG005|NOT COMPLETED|Overall Study||0
6629008|NCT02255422|7557201|FG006|NOT COMPLETED|Overall Study||2
6629009|NCT02255461|7557222|FG000|STARTED|Overall Study||3
6629010|NCT02255461|7557223|FG001|STARTED|Overall Study||12
6629011|NCT02255461|7557224|FG002|STARTED|Overall Study||6
6629012|NCT02255461|7557225|FG003|STARTED|Overall Study||4
6629013|NCT02255461|7557226|FG004|STARTED|Overall Study||10
6629014|NCT02255461|7557222|FG000|COMPLETED|Overall Study||3
6629015|NCT02255461|7557223|FG001|COMPLETED|Overall Study||10
6629016|NCT02255461|7557224|FG002|COMPLETED|Overall Study||5
6629017|NCT02255461|7557225|FG003|COMPLETED|Overall Study||4
6629018|NCT02255461|7557226|FG004|COMPLETED|Overall Study||8
6629019|NCT02255461|7557222|FG000|NOT COMPLETED|Overall Study||0
6629020|NCT02255461|7557223|FG001|NOT COMPLETED|Overall Study||2
6629021|NCT02255461|7557224|FG002|NOT COMPLETED|Overall Study||1
6629022|NCT02255461|7557225|FG003|NOT COMPLETED|Overall Study||0
6629023|NCT02255461|7557226|FG004|NOT COMPLETED|Overall Study||2
6742840|NCT03330275|7671260|FG008|COMPLETED|Visit 1 - Period 2||0
6742841|NCT03330275|7671261|FG009|COMPLETED|Visit 1 - Period 2||0
6742842|NCT03330275|7671252|FG000|NOT COMPLETED|Visit 1 - Period 2||0
6742843|NCT03330275|7671253|FG001|NOT COMPLETED|Visit 1 - Period 2||0
6742844|NCT03330275|7671254|FG002|NOT COMPLETED|Visit 1 - Period 2||0
6742845|NCT03330275|7671255|FG003|NOT COMPLETED|Visit 1 - Period 2||0
6742846|NCT03330275|7671256|FG004|NOT COMPLETED|Visit 1 - Period 2||0
6742847|NCT03330275|7671257|FG005|NOT COMPLETED|Visit 1 - Period 2||0
6742848|NCT03330275|7671258|FG006|NOT COMPLETED|Visit 1 - Period 2||0
6629024|NCT02255474|7557246|FG000|STARTED|Overall Study||98
6629025|NCT02255474|7557247|FG001|STARTED|Overall Study||98
6629026|NCT02255474|7557248|FG002|STARTED|Overall Study||98
6742849|NCT03330275|7671259|FG007|NOT COMPLETED|Visit 1 - Period 2||0
6742850|NCT03330275|7671260|FG008|NOT COMPLETED|Visit 1 - Period 2||0
6742851|NCT03330275|7671261|FG009|NOT COMPLETED|Visit 1 - Period 2||0
6742852|NCT03330275|7671252|FG000|STARTED|Visits 2, 3 and 4 - Period 1||0
6742853|NCT03330275|7671253|FG001|STARTED|Visits 2, 3 and 4 - Period 1||0
6742854|NCT03330275|7671254|FG002|STARTED|Visits 2, 3 and 4 - Period 1||0
6742855|NCT03330275|7671255|FG003|STARTED|Visits 2, 3 and 4 - Period 1||0
6742856|NCT03330275|7671256|FG004|STARTED|Visits 2, 3 and 4 - Period 1||4
6742857|NCT03330275|7671257|FG005|STARTED|Visits 2, 3 and 4 - Period 1||4
6629027|NCT02255474|7557246|FG000|COMPLETED|Overall Study||96
6629028|NCT02255474|7557247|FG001|COMPLETED|Overall Study||96
6629029|NCT02255474|7557248|FG002|COMPLETED|Overall Study||95
6629030|NCT02255474|7557246|FG000|NOT COMPLETED|Overall Study||2
6629031|NCT02255474|7557247|FG001|NOT COMPLETED|Overall Study||2
6629032|NCT02255474|7557248|FG002|NOT COMPLETED|Overall Study||3
6629033|NCT02255500|7557259|FG000|STARTED|Overall Study||16
6629034|NCT02255500|7557260|FG001|STARTED|Overall Study||7
6629035|NCT02255500|7557259|FG000|COMPLETED|Overall Study||15
6629036|NCT02255500|7557260|FG001|COMPLETED|Overall Study||7
6629037|NCT02255500|7557259|FG000|NOT COMPLETED|Overall Study||1
6629038|NCT02255500|7557260|FG001|NOT COMPLETED|Overall Study||0
6629039|NCT02255513|7557268|FG000|STARTED|Open-label, Treatment Optimization||43
6629040|NCT02255513|7557269|FG001|STARTED|Open-label, Treatment Optimization||0
6629041|NCT02255513|7557268|FG000|COMPLETED|Open-label, Treatment Optimization||43
6629042|NCT02255513|7557269|FG001|COMPLETED|Open-label, Treatment Optimization||0
6629043|NCT02255513|7557268|FG000|NOT COMPLETED|Open-label, Treatment Optimization||0
6629044|NCT02255513|7557269|FG001|NOT COMPLETED|Open-label, Treatment Optimization||0
6629045|NCT02255513|7557268|FG000|STARTED|Double Blind, Placebo-controlled||22
6629046|NCT02255513|7557269|FG001|STARTED|Double Blind, Placebo-controlled||21
6629047|NCT02255513|7557268|FG000|COMPLETED|Double Blind, Placebo-controlled||22
6629048|NCT02255513|7557269|FG001|COMPLETED|Double Blind, Placebo-controlled||21
6629049|NCT02255513|7557268|FG000|NOT COMPLETED|Double Blind, Placebo-controlled||0
6629050|NCT02255513|7557269|FG001|NOT COMPLETED|Double Blind, Placebo-controlled||0
6629051|NCT02255552|7557277|FG000|STARTED|Overall Study||79
6629052|NCT02255552|7557278|FG001|STARTED|Overall Study||30
6629053|NCT02255552|7557277|FG000|COMPLETED|Overall Study||78
6629054|NCT02255552|7557278|FG001|COMPLETED|Overall Study||15
6629055|NCT02255552|7557277|FG000|NOT COMPLETED|Overall Study||1
6629056|NCT02255552|7557278|FG001|NOT COMPLETED|Overall Study||15
6629057|NCT02255565|7557287|FG000|STARTED|Overall Study||9
6629058|NCT02255565|7557288|FG001|STARTED|Overall Study||9
6629059|NCT02255565|7557289|FG002|STARTED|Overall Study||9
6629060|NCT02255565|7557287|FG000|COMPLETED|Overall Study||9
6629061|NCT02255565|7557288|FG001|COMPLETED|Overall Study||8
6629062|NCT02255565|7557289|FG002|COMPLETED|Overall Study||9
6629063|NCT02255565|7557287|FG000|NOT COMPLETED|Overall Study||0
6629064|NCT02255565|7557288|FG001|NOT COMPLETED|Overall Study||1
6629065|NCT02255565|7557289|FG002|NOT COMPLETED|Overall Study||0
6629066|NCT02255604|7557333|FG000|STARTED|Overall Study||12
6629067|NCT02255604|7557334|FG001|STARTED|Overall Study||12
6629068|NCT02255604|7557335|FG002|STARTED|Overall Study||12
6629069|NCT02255604|7557333|FG000|COMPLETED|Overall Study||10
6629070|NCT02255604|7557334|FG001|COMPLETED|Overall Study||11
6629071|NCT02255604|7557335|FG002|COMPLETED|Overall Study||9
6629072|NCT02255604|7557333|FG000|NOT COMPLETED|Overall Study||2
6629073|NCT02255604|7557334|FG001|NOT COMPLETED|Overall Study||1
6629074|NCT02255604|7557335|FG002|NOT COMPLETED|Overall Study||3
6629075|NCT02255760|7557348|FG000|STARTED|Overall Study||14
6629076|NCT02255760|7557349|FG001|STARTED|Overall Study||3
6629077|NCT02255760|7557350|FG002|STARTED|Overall Study||15
6629078|NCT02255760|7557351|FG003|STARTED|Overall Study||15
6629079|NCT02255760|7557352|FG004|STARTED|Overall Study||9
6629080|NCT02255760|7557348|FG000|COMPLETED|Overall Study||14
6629081|NCT02255760|7557349|FG001|COMPLETED|Overall Study||2
6629082|NCT02255760|7557350|FG002|COMPLETED|Overall Study||15
6629083|NCT02255760|7557351|FG003|COMPLETED|Overall Study||15
6629084|NCT02255760|7557352|FG004|COMPLETED|Overall Study||9
6629085|NCT02255760|7557348|FG000|NOT COMPLETED|Overall Study||0
6742858|NCT03330275|7671258|FG006|STARTED|Visits 2, 3 and 4 - Period 1||4
6742859|NCT03330275|7671259|FG007|STARTED|Visits 2, 3 and 4 - Period 1||4
6629086|NCT02255760|7557349|FG001|NOT COMPLETED|Overall Study||1
6629087|NCT02255760|7557350|FG002|NOT COMPLETED|Overall Study||0
6629088|NCT02255760|7557351|FG003|NOT COMPLETED|Overall Study||0
6629089|NCT02255760|7557352|FG004|NOT COMPLETED|Overall Study||0
6655470|NCT02453321|7585590|FG000|NOT COMPLETED|Overall Study||1
6742860|NCT03330275|7671260|FG008|STARTED|Visits 2, 3 and 4 - Period 1||4
6742861|NCT03330275|7671261|FG009|STARTED|Visits 2, 3 and 4 - Period 1||4
6742862|NCT03330275|7671252|FG000|COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742863|NCT03330275|7671253|FG001|COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742864|NCT03330275|7671254|FG002|COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742865|NCT03330275|7671255|FG003|COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742866|NCT03330275|7671256|FG004|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6742867|NCT03330275|7671257|FG005|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6742868|NCT03330275|7671258|FG006|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6742869|NCT03330275|7671259|FG007|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6742870|NCT03330275|7671260|FG008|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6742871|NCT03330275|7671261|FG009|COMPLETED|Visits 2, 3 and 4 - Period 1||4
6742872|NCT03330275|7671252|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742873|NCT03330275|7671253|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6629090|NCT02255981|7557368|FG000|STARTED|Overall Study|Both eyes of each patient were included except 2 that not were treatable|33
6629091|NCT02255981|7557368|FG000|COMPLETED|Overall Study|2 eyes of the final 29 subjects were excluded.|29
6629092|NCT02255981|7557368|FG000|NOT COMPLETED|Overall Study||4
6629093|NCT02256072|7557380|FG000|STARTED|Overall Study||194
6629094|NCT02256072|7557381|FG001|STARTED|Overall Study||191
6629095|NCT02256072|7557380|FG000|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
6629096|NCT02256072|7557381|FG001|Completed 1 Month Follow-Up|Overall Study||179
6629097|NCT02256072|7557380|FG000|COMPLETED|Overall Study|Completed the 3-month follow-up|152
6629098|NCT02256072|7557381|FG001|COMPLETED|Overall Study||162
6629099|NCT02256072|7557380|FG000|NOT COMPLETED|Overall Study||42
6629100|NCT02256072|7557381|FG001|NOT COMPLETED|Overall Study||29
6629101|NCT02256111|7557390|FG000|STARTED|Overall Study||13
6629102|NCT02256111|7557391|FG001|STARTED|Overall Study||13
6629103|NCT02256111|7557390|FG000|COMPLETED|Overall Study||13
6629104|NCT02256111|7557391|FG001|COMPLETED|Overall Study||13
6629105|NCT02256111|7557390|FG000|NOT COMPLETED|Overall Study||0
6629106|NCT02256111|7557391|FG001|NOT COMPLETED|Overall Study||0
6629107|NCT02256189|7557400|FG000|STARTED|Overall Study||15
6629108|NCT02256189|7557401|FG001|STARTED|Overall Study||13
6629109|NCT02256189|7557400|FG000|COMPLETED|Overall Study||15
6629110|NCT02256189|7557401|FG001|COMPLETED|Overall Study||13
6629111|NCT02256189|7557400|FG000|NOT COMPLETED|Overall Study||0
6629112|NCT02256189|7557401|FG001|NOT COMPLETED|Overall Study||0
6629113|NCT02256267|7557409|FG000|STARTED|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
6629114|NCT02256267|7557409|FG000|Received at Least 1 Dose of LY2835219|Period 1 (Day 1; Day 2 to Day 9 Washout)||24
6629115|NCT02256267|7557409|FG000|COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||23
6629116|NCT02256267|7557409|FG000|NOT COMPLETED|Period 1 (Day 1; Day 2 to Day 9 Washout)||1
6629117|NCT02256267|7557409|FG000|STARTED|Period 2 (Day 1 to Day 6)||23
6629118|NCT02256267|7557409|FG000|Received at Least 1 Dose of Rifampin|Period 2 (Day 1 to Day 6)||23
6629119|NCT02256267|7557409|FG000|COMPLETED|Period 2 (Day 1 to Day 6)||23
6629120|NCT02256267|7557409|FG000|NOT COMPLETED|Period 2 (Day 1 to Day 6)||0
6629121|NCT02256267|7557409|FG000|STARTED|Period 2 (Day 7 to Day 14)||23
6629122|NCT02256267|7557409|FG000|Received LY2835219 + Rifampin|Period 2 (Day 7 to Day 14)||23
6629123|NCT02256267|7557409|FG000|COMPLETED|Period 2 (Day 7 to Day 14)||22
6629124|NCT02256267|7557409|FG000|NOT COMPLETED|Period 2 (Day 7 to Day 14)||1
6742874|NCT03330275|7671254|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742875|NCT03330275|7671255|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6629125|NCT02256345|7557418|FG000|STARTED|Overall Study||9
6629126|NCT02256345|7557419|FG001|STARTED|Overall Study||3
6629127|NCT02256345|7557418|FG000|COMPLETED|Overall Study||9
6629128|NCT02256345|7557419|FG001|COMPLETED|Overall Study||3
6629129|NCT02256345|7557418|FG000|NOT COMPLETED|Overall Study||0
6629130|NCT02256345|7557419|FG001|NOT COMPLETED|Overall Study||0
6629131|NCT02256358|7557427|FG000|STARTED|Overall Study||34
6629132|NCT02256358|7557428|FG001|STARTED|Overall Study||34
6629133|NCT02256358|7557427|FG000|COMPLETED|Overall Study||34
6629134|NCT02256358|7557428|FG001|COMPLETED|Overall Study||33
6629135|NCT02256358|7557427|FG000|NOT COMPLETED|Overall Study||0
6629136|NCT02256358|7557428|FG001|NOT COMPLETED|Overall Study||1
6629137|NCT02256384|7557434|FG000|STARTED|Overall Study||76
6629138|NCT02256384|7557434|FG000|COMPLETED|Overall Study||62
6629139|NCT02256384|7557434|FG000|NOT COMPLETED|Overall Study||14
6629140|NCT02256436|7557444|FG000|STARTED|Overall Study||272
6629141|NCT02256436|7557445|FG001|STARTED|Overall Study||270
6629142|NCT02256436|7557444|FG000|Treated|Overall Study||255
6629143|NCT02256436|7557445|FG001|Treated|Overall Study||266
6629144|NCT02256436|7557444|FG000|Switched Over to Pembrolizumab|Overall Study||13
6629145|NCT02256436|7557445|FG001|Switched Over to Pembrolizumab|Overall Study||0
6629146|NCT02256436|7557444|FG000|COMPLETED|Overall Study||0
6629147|NCT02256436|7557445|FG001|COMPLETED|Overall Study||0
6629148|NCT02256436|7557444|FG000|NOT COMPLETED|Overall Study||272
6629149|NCT02256436|7557445|FG001|NOT COMPLETED|Overall Study||270
6629150|NCT02256488|7557456|FG000|STARTED|Overall Study||387
6629151|NCT02256488|7557457|FG001|STARTED|Overall Study||392
6629152|NCT02256488|7557458|FG002|STARTED|Overall Study||392
6629153|NCT02256488|7557459|FG003|STARTED|Overall Study||390
6629154|NCT02256488|7557456|FG000|COMPLETED|Overall Study||379
6629155|NCT02256488|7557457|FG001|COMPLETED|Overall Study||386
6629156|NCT02256488|7557458|FG002|COMPLETED|Overall Study||382
6629157|NCT02256488|7557459|FG003|COMPLETED|Overall Study||384
6629158|NCT02256488|7557456|FG000|NOT COMPLETED|Overall Study||8
6629159|NCT02256488|7557457|FG001|NOT COMPLETED|Overall Study||6
6629160|NCT02256488|7557458|FG002|NOT COMPLETED|Overall Study||10
6629161|NCT02256488|7557459|FG003|NOT COMPLETED|Overall Study||6
6629162|NCT02256540|7557470|FG000|STARTED|Overall Study||6
6629163|NCT02256540|7557471|FG001|STARTED|Overall Study||6
6629164|NCT02256540|7557472|FG002|STARTED|Overall Study||6
6629165|NCT02256540|7557470|FG000|COMPLETED|Overall Study||6
6629166|NCT02256540|7557471|FG001|COMPLETED|Overall Study||5
6629167|NCT02256540|7557472|FG002|COMPLETED|Overall Study||4
6629168|NCT02256540|7557470|FG000|NOT COMPLETED|Overall Study||0
6629169|NCT02256540|7557471|FG001|NOT COMPLETED|Overall Study||1
6629170|NCT02256540|7557472|FG002|NOT COMPLETED|Overall Study||2
6629171|NCT02256553|7557480|FG000|STARTED|Period I||102
6629172|NCT02256553|7557480|FG000|COMPLETED|Period I||96
6629173|NCT02256553|7557480|FG000|NOT COMPLETED|Period I||6
6629174|NCT02256553|7557480|FG000|STARTED|Period II||96
6629175|NCT02256553|7557480|FG000|COMPLETED|Period II||94
6629176|NCT02256553|7557480|FG000|NOT COMPLETED|Period II||2
6629177|NCT02256553|7557480|FG000|STARTED|Period III||94
6629178|NCT02256553|7557480|FG000|COMPLETED|Period III||91
6629179|NCT02256553|7557480|FG000|NOT COMPLETED|Period III||3
6629180|NCT02256839|7557488|FG000|STARTED|Overall Study||53
6629181|NCT02256839|7557489|FG001|STARTED|Overall Study||215
6629182|NCT02256839|7557488|FG000|COMPLETED|Overall Study||51
6629183|NCT02256839|7557489|FG001|COMPLETED|Overall Study||212
6629184|NCT02256839|7557488|FG000|NOT COMPLETED|Overall Study||2
6629185|NCT02256839|7557489|FG001|NOT COMPLETED|Overall Study||3
6629186|NCT02256891|7557497|FG000|STARTED|Overall Study||55
6629187|NCT02256891|7557498|FG001|STARTED|Overall Study||42
6629188|NCT02256891|7557497|FG000|COMPLETED|Overall Study||43
6629189|NCT02256891|7557498|FG001|COMPLETED|Overall Study||29
6629190|NCT02256891|7557497|FG000|NOT COMPLETED|Overall Study||12
6629191|NCT02256891|7557498|FG001|NOT COMPLETED|Overall Study||13
6629192|NCT02256917|7557506|FG000|STARTED|Pharmacokinetic (PK) Evaluation Phase||58
6629193|NCT02256917|7557506|FG000|COMPLETED|Pharmacokinetic (PK) Evaluation Phase||58
6629194|NCT02256917|7557506|FG000|NOT COMPLETED|Pharmacokinetic (PK) Evaluation Phase||0
6629195|NCT02256917|7557506|FG000|STARTED|Prophylactic Treatment Phase I||57
6629196|NCT02256917|7557506|FG000|COMPLETED|Prophylactic Treatment Phase I||56
6629197|NCT02256917|7557506|FG000|NOT COMPLETED|Prophylactic Treatment Phase I||1
6629198|NCT02256917|7557506|FG000|STARTED|Prophylactic Treatment Phase II||56
6629199|NCT02256917|7557506|FG000|COMPLETED|Prophylactic Treatment Phase II||52
6629200|NCT02256917|7557506|FG000|NOT COMPLETED|Prophylactic Treatment Phase II||4
6629201|NCT02256969|7557520|FG000|STARTED|Overall Study||15
6629202|NCT02256969|7557521|FG001|STARTED|Overall Study||15
6629203|NCT02256969|7557522|FG002|STARTED|Overall Study||15
6629204|NCT02256969|7557520|FG000|COMPLETED|Overall Study||13
6629205|NCT02256969|7557521|FG001|COMPLETED|Overall Study||14
6629206|NCT02256969|7557522|FG002|COMPLETED|Overall Study||14
6629207|NCT02256969|7557520|FG000|NOT COMPLETED|Overall Study||2
6629208|NCT02256969|7557521|FG001|NOT COMPLETED|Overall Study||1
6629209|NCT02256969|7557522|FG002|NOT COMPLETED|Overall Study||1
6655471|NCT02453321|7585591|FG001|NOT COMPLETED|Overall Study||2
6655472|NCT02453321|7585592|FG002|NOT COMPLETED|Overall Study||2
6655473|NCT02453334|7585605|FG000|STARTED|Overall Study||122
6655474|NCT02453334|7585606|FG001|STARTED|Overall Study||122
6655475|NCT02453334|7585605|FG000|COMPLETED|Overall Study||81
6655476|NCT02453334|7585606|FG001|COMPLETED|Overall Study||82
6655477|NCT02453334|7585605|FG000|NOT COMPLETED|Overall Study||41
6655478|NCT02453334|7585606|FG001|NOT COMPLETED|Overall Study||40
6655479|NCT02453347|7585612|FG000|STARTED|Overall Study||6
6655480|NCT02453347|7585612|FG000|COMPLETED|Overall Study||6
6655481|NCT02453347|7585612|FG000|NOT COMPLETED|Overall Study||0
6655482|NCT02453360|7585619|FG000|STARTED|Overall Study||20
6655483|NCT02453360|7585620|FG001|STARTED|Overall Study||20
6655484|NCT02453360|7585621|FG002|STARTED|Overall Study||20
6655485|NCT02453360|7585619|FG000|COMPLETED|Overall Study||20
6655486|NCT02453360|7585620|FG001|COMPLETED|Overall Study||20
6655487|NCT02453360|7585621|FG002|COMPLETED|Overall Study||20
6655488|NCT02453360|7585619|FG000|NOT COMPLETED|Overall Study||0
6655489|NCT02453360|7585620|FG001|NOT COMPLETED|Overall Study||0
6655490|NCT02453360|7585621|FG002|NOT COMPLETED|Overall Study||0
6655491|NCT02453386|7585632|FG000|STARTED|Overall Study||151
6655492|NCT02453386|7585633|FG001|STARTED|Overall Study||149
6655493|NCT02453386|7585634|FG002|STARTED|Overall Study||149
6655494|NCT02453386|7585632|FG000|COMPLETED|Overall Study||102
6655495|NCT02453386|7585633|FG001|COMPLETED|Overall Study||100
6655496|NCT02453386|7585634|FG002|COMPLETED|Overall Study||108
6655497|NCT02453386|7585632|FG000|NOT COMPLETED|Overall Study||49
6655498|NCT02453386|7585633|FG001|NOT COMPLETED|Overall Study||49
6655499|NCT02453386|7585634|FG002|NOT COMPLETED|Overall Study||41
6655500|NCT02453555|7585651|FG000|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|182
6655501|NCT02453555|7585652|FG001|STARTED|24-week Double-blind Treatment Period|Started are treated subjects.|93
6655502|NCT02453555|7585653|FG002|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
6655503|NCT02453555|7585654|FG003|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
6655504|NCT02453555|7585655|FG004|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
6655505|NCT02453555|7585656|FG005|STARTED|24-week Double-blind Treatment Period|This reporting group is not applicable in this period.|0
6655506|NCT02453555|7585651|FG000|COMPLETED|24-week Double-blind Treatment Period||177
6655507|NCT02453555|7585652|FG001|COMPLETED|24-week Double-blind Treatment Period||86
6655508|NCT02453555|7585653|FG002|COMPLETED|24-week Double-blind Treatment Period||0
6282553|NCT00183443|7182802|FG000|COMPLETED|Overall Study|13 eligible participants were offered enrollment in the continuation phase|24
6282554|NCT00183443|7182803|FG001|COMPLETED|Overall Study|8 eligible participants were offered enrollment in the continuation phase|26
6282555|NCT00183443|7182804|FG002|COMPLETED|Overall Study|4 eligible participants were offered enrollment in the continuation phase|25
6282556|NCT00183443|7182802|FG000|NOT COMPLETED|Overall Study||0
6282557|NCT00183443|7182803|FG001|NOT COMPLETED|Overall Study||0
6282558|NCT00183443|7182804|FG002|NOT COMPLETED|Overall Study||0
6282559|NCT00183456|7182816|FG000|STARTED|Overall Study||85
6282560|NCT00183456|7182817|FG001|STARTED|Overall Study||84
6282561|NCT00183456|7182818|FG002|STARTED|Overall Study||329
6282562|NCT00183456|7182819|FG003|STARTED|Overall Study||248
6282563|NCT00183456|7182816|FG000|6 Month Follow-up|Overall Study||74
6655509|NCT02453555|7585654|FG003|COMPLETED|24-week Double-blind Treatment Period||0
6655510|NCT02453555|7585655|FG004|COMPLETED|24-week Double-blind Treatment Period||0
6655511|NCT02453555|7585656|FG005|COMPLETED|24-week Double-blind Treatment Period||0
6629210|NCT02256982|7557532|FG000|STARTED|Overall Study||1
6629211|NCT02256982|7557533|FG001|STARTED|Overall Study||2
6629212|NCT02256982|7557532|FG000|COMPLETED|Overall Study||1
6629213|NCT02256982|7557533|FG001|COMPLETED|Overall Study||1
6629214|NCT02256982|7557532|FG000|NOT COMPLETED|Overall Study||0
6629215|NCT02256982|7557533|FG001|NOT COMPLETED|Overall Study||1
6629216|NCT02257099|7557539|FG000|STARTED|Overall Study||20
6629217|NCT02257099|7557539|FG000|COMPLETED|Overall Study||20
6629218|NCT02257099|7557539|FG000|NOT COMPLETED|Overall Study||0
6629219|NCT02257177|7557556|FG000|STARTED|Overall Study||4
6629220|NCT02257177|7557557|FG001|STARTED|Overall Study||4
6629221|NCT02257177|7557558|FG002|STARTED|Overall Study||4
6629222|NCT02257177|7557559|FG003|STARTED|Overall Study||4
6629223|NCT02257177|7557560|FG004|STARTED|Overall Study||4
6629224|NCT02257177|7557561|FG005|STARTED|Overall Study||4
6629225|NCT02257177|7557562|FG006|STARTED|Overall Study||12
6629226|NCT02257177|7557563|FG007|STARTED|Overall Study||5
6629227|NCT02257177|7557564|FG008|STARTED|Overall Study||5
6629228|NCT02257177|7557565|FG009|STARTED|Overall Study||5
6629229|NCT02257177|7557566|FG010|STARTED|Overall Study||9
6629230|NCT02257177|7557556|FG000|COMPLETED|Overall Study||4
6629231|NCT02257177|7557557|FG001|COMPLETED|Overall Study||4
6629232|NCT02257177|7557558|FG002|COMPLETED|Overall Study||4
6629233|NCT02257177|7557559|FG003|COMPLETED|Overall Study||4
6629234|NCT02257177|7557560|FG004|COMPLETED|Overall Study||4
6629235|NCT02257177|7557561|FG005|COMPLETED|Overall Study||4
6629236|NCT02257177|7557562|FG006|COMPLETED|Overall Study||12
6629237|NCT02257177|7557563|FG007|COMPLETED|Overall Study||5
6629238|NCT02257177|7557564|FG008|COMPLETED|Overall Study||5
6629239|NCT02257177|7557565|FG009|COMPLETED|Overall Study||4
6629240|NCT02257177|7557566|FG010|COMPLETED|Overall Study||9
6629241|NCT02257177|7557556|FG000|NOT COMPLETED|Overall Study||0
6629242|NCT02257177|7557557|FG001|NOT COMPLETED|Overall Study||0
6629243|NCT02257177|7557558|FG002|NOT COMPLETED|Overall Study||0
6629244|NCT02257177|7557559|FG003|NOT COMPLETED|Overall Study||0
6629245|NCT02257177|7557560|FG004|NOT COMPLETED|Overall Study||0
6629246|NCT02257177|7557561|FG005|NOT COMPLETED|Overall Study||0
6629247|NCT02257177|7557562|FG006|NOT COMPLETED|Overall Study||0
6629248|NCT02257177|7557563|FG007|NOT COMPLETED|Overall Study||0
6629249|NCT02257177|7557564|FG008|NOT COMPLETED|Overall Study||0
6629250|NCT02257177|7557565|FG009|NOT COMPLETED|Overall Study||1
6629251|NCT02257177|7557566|FG010|NOT COMPLETED|Overall Study||0
6629252|NCT02257372|7557592|FG000|STARTED|Overall Study||117
6629253|NCT02257372|7557593|FG001|STARTED|Overall Study||119
6629254|NCT02257372|7557592|FG000|COMPLETED|Overall Study||110
6629255|NCT02257372|7557593|FG001|COMPLETED|Overall Study||109
6629256|NCT02257372|7557592|FG000|NOT COMPLETED|Overall Study||7
6629257|NCT02257372|7557593|FG001|NOT COMPLETED|Overall Study||10
6629258|NCT02257385|7557601|FG000|STARTED|Overall Study||482
6629259|NCT02257385|7557602|FG001|STARTED|Overall Study||479
6629260|NCT02257385|7557601|FG000|COMPLETED|Overall Study||460
6629261|NCT02257385|7557602|FG001|COMPLETED|Overall Study||457
6629262|NCT02257385|7557601|FG000|NOT COMPLETED|Overall Study||22
6629263|NCT02257385|7557602|FG001|NOT COMPLETED|Overall Study||22
6629264|NCT02257489|7557617|FG000|STARTED|Overall Study||6
6629265|NCT02257489|7557618|FG001|STARTED|Overall Study||6
6629266|NCT02257489|7557619|FG002|STARTED|Overall Study||6
6629267|NCT02257489|7557620|FG003|STARTED|Overall Study||6
6629268|NCT02257489|7557621|FG004|STARTED|Overall Study||6
6629269|NCT02257489|7557622|FG005|STARTED|Overall Study||6
6629270|NCT02257489|7557623|FG006|STARTED|Overall Study||6
6629271|NCT02257489|7557624|FG007|STARTED|Overall Study||10
6629272|NCT02257489|7557625|FG008|STARTED|Overall Study||6
6629273|NCT02257489|7557617|FG000|COMPLETED|Overall Study||6
6629274|NCT02257489|7557618|FG001|COMPLETED|Overall Study||6
6629275|NCT02257489|7557619|FG002|COMPLETED|Overall Study||6
6629276|NCT02257489|7557620|FG003|COMPLETED|Overall Study||5
6629277|NCT02257489|7557621|FG004|COMPLETED|Overall Study||6
6629278|NCT02257489|7557622|FG005|COMPLETED|Overall Study||6
6629279|NCT02257489|7557623|FG006|COMPLETED|Overall Study||6
6629280|NCT02257489|7557624|FG007|COMPLETED|Overall Study||10
6629281|NCT02257489|7557625|FG008|COMPLETED|Overall Study||6
6629282|NCT02257489|7557617|FG000|NOT COMPLETED|Overall Study||0
6629283|NCT02257489|7557618|FG001|NOT COMPLETED|Overall Study||0
6629284|NCT02257489|7557619|FG002|NOT COMPLETED|Overall Study||0
6629285|NCT02257489|7557620|FG003|NOT COMPLETED|Overall Study||1
6629286|NCT02257489|7557621|FG004|NOT COMPLETED|Overall Study||0
6629287|NCT02257489|7557622|FG005|NOT COMPLETED|Overall Study||0
6629288|NCT02257489|7557623|FG006|NOT COMPLETED|Overall Study||0
6629289|NCT02257489|7557624|FG007|NOT COMPLETED|Overall Study||0
6629290|NCT02257489|7557625|FG008|NOT COMPLETED|Overall Study||0
6629291|NCT02257541|7557650|FG000|STARTED|Overall Study||3
6629292|NCT02257541|7557651|FG001|STARTED|Overall Study||8
6629293|NCT02257541|7557652|FG002|STARTED|Overall Study||1
6629294|NCT02257541|7557653|FG003|STARTED|Overall Study||3
6629295|NCT02257541|7557654|FG004|STARTED|Overall Study||1
6629296|NCT02257541|7557650|FG000|COMPLETED|Overall Study||3
6629297|NCT02257541|7557651|FG001|COMPLETED|Overall Study||8
6629298|NCT02257541|7557652|FG002|COMPLETED|Overall Study||1
6629299|NCT02257541|7557653|FG003|COMPLETED|Overall Study||3
6629300|NCT02257541|7557654|FG004|COMPLETED|Overall Study||1
6629301|NCT02257541|7557650|FG000|NOT COMPLETED|Overall Study||0
6629302|NCT02257541|7557651|FG001|NOT COMPLETED|Overall Study||0
6629303|NCT02257541|7557652|FG002|NOT COMPLETED|Overall Study||0
6629304|NCT02257541|7557653|FG003|NOT COMPLETED|Overall Study||0
6629305|NCT02257541|7557654|FG004|NOT COMPLETED|Overall Study||0
6629306|NCT02257632|7557667|FG000|STARTED|Overall Study||19
6629307|NCT02257632|7557668|FG001|STARTED|Overall Study||22
6629308|NCT02257632|7557667|FG000|Full Analysis Set (FAS)|Overall Study||19
6629309|NCT02257632|7557668|FG001|Full Analysis Set (FAS)|Overall Study||21
6629310|NCT02257632|7557667|FG000|Safety Set (SAF)|Overall Study||19
6629311|NCT02257632|7557668|FG001|Safety Set (SAF)|Overall Study||21
6629312|NCT02257632|7557667|FG000|Per-Protocol Set (PPS)|Overall Study||17
6629313|NCT02257632|7557668|FG001|Per-Protocol Set (PPS)|Overall Study||20
6629314|NCT02257632|7557667|FG000|COMPLETED|Overall Study||18
6629315|NCT02257632|7557668|FG001|COMPLETED|Overall Study||19
6629316|NCT02257632|7557667|FG000|NOT COMPLETED|Overall Study||1
6629317|NCT02257632|7557668|FG001|NOT COMPLETED|Overall Study||3
6629318|NCT02257684|7557676|FG000|STARTED|Overall Study||4
6629319|NCT02257684|7557676|FG000|COMPLETED|Overall Study||0
6629320|NCT02257684|7557676|FG000|NOT COMPLETED|Overall Study||4
6629321|NCT02257957|7557682|FG000|STARTED|Overall Study||15
6629322|NCT02257957|7557683|FG001|STARTED|Overall Study||15
6629323|NCT02257957|7557682|FG000|COMPLETED|Overall Study||15
6629324|NCT02257957|7557683|FG001|COMPLETED|Overall Study||15
6629325|NCT02257957|7557682|FG000|NOT COMPLETED|Overall Study||0
6629326|NCT02257957|7557683|FG001|NOT COMPLETED|Overall Study||0
6629327|NCT02257970|7557693|FG000|STARTED|Part 1||50
6629328|NCT02257970|7557694|FG001|STARTED|Part 1||0
6629329|NCT02257970|7557695|FG002|STARTED|Part 1||0
6629330|NCT02257970|7557696|FG003|STARTED|Part 1||0
6629331|NCT02257970|7557693|FG000|COMPLETED|Part 1||50
6629332|NCT02257970|7557694|FG001|COMPLETED|Part 1||0
6629333|NCT02257970|7557695|FG002|COMPLETED|Part 1||0
6629334|NCT02257970|7557696|FG003|COMPLETED|Part 1||0
6629335|NCT02257970|7557693|FG000|NOT COMPLETED|Part 1||0
6629336|NCT02257970|7557694|FG001|NOT COMPLETED|Part 1||0
6629337|NCT02257970|7557695|FG002|NOT COMPLETED|Part 1||0
6629338|NCT02257970|7557696|FG003|NOT COMPLETED|Part 1||0
6629339|NCT02257970|7557693|FG000|STARTED|Part 2||0
6629340|NCT02257970|7557694|FG001|STARTED|Part 2||23
6629341|NCT02257970|7557695|FG002|STARTED|Part 2||0
6629342|NCT02257970|7557696|FG003|STARTED|Part 2||0
6629343|NCT02257970|7557693|FG000|COMPLETED|Part 2||0
6629344|NCT02257970|7557694|FG001|COMPLETED|Part 2||16
6629345|NCT02257970|7557695|FG002|COMPLETED|Part 2||0
6629346|NCT02257970|7557696|FG003|COMPLETED|Part 2||0
6629347|NCT02257970|7557693|FG000|NOT COMPLETED|Part 2||0
6629348|NCT02257970|7557694|FG001|NOT COMPLETED|Part 2||7
6629349|NCT02257970|7557695|FG002|NOT COMPLETED|Part 2||0
6629350|NCT02257970|7557696|FG003|NOT COMPLETED|Part 2||0
6629351|NCT02257970|7557693|FG000|STARTED|Part 3||0
6629352|NCT02257970|7557694|FG001|STARTED|Part 3||0
6629353|NCT02257970|7557695|FG002|STARTED|Part 3||23
6629354|NCT02257970|7557696|FG003|STARTED|Part 3||21
6629355|NCT02257970|7557693|FG000|COMPLETED|Part 3||0
6629356|NCT02257970|7557694|FG001|COMPLETED|Part 3||0
6629357|NCT02257970|7557695|FG002|COMPLETED|Part 3||16
6629358|NCT02257970|7557696|FG003|COMPLETED|Part 3||14
6629359|NCT02257970|7557693|FG000|NOT COMPLETED|Part 3||0
6629360|NCT02257970|7557694|FG001|NOT COMPLETED|Part 3||0
6629361|NCT02257970|7557695|FG002|NOT COMPLETED|Part 3||7
6629362|NCT02257970|7557696|FG003|NOT COMPLETED|Part 3||7
6629363|NCT02258074|7557719|FG000|STARTED|Overall Study||53
6629364|NCT02258074|7557720|FG001|STARTED|Overall Study||50
6629365|NCT02258074|7557721|FG002|STARTED|Overall Study||51
6629366|NCT02258074|7557722|FG003|STARTED|Overall Study||51
6629367|NCT02258074|7557719|FG000|COMPLETED|Overall Study||52
6629368|NCT02258074|7557720|FG001|COMPLETED|Overall Study||50
6629369|NCT02258074|7557721|FG002|COMPLETED|Overall Study||51
6629370|NCT02258074|7557722|FG003|COMPLETED|Overall Study||51
6629371|NCT02258074|7557719|FG000|NOT COMPLETED|Overall Study||1
6629372|NCT02258074|7557720|FG001|NOT COMPLETED|Overall Study||0
6629373|NCT02258074|7557721|FG002|NOT COMPLETED|Overall Study||0
6629374|NCT02258074|7557722|FG003|NOT COMPLETED|Overall Study||0
6629375|NCT02258139|7557732|FG000|STARTED|Overall Study||38
6629376|NCT02258139|7557732|FG000|COMPLETED|Overall Study||30
6629377|NCT02258139|7557732|FG000|NOT COMPLETED|Overall Study||8
6629378|NCT02258152|7557740|FG000|STARTED|Overall Study||44
6629379|NCT02258152|7557741|FG001|STARTED|Overall Study||38
6629380|NCT02258152|7557740|FG000|COMPLETED|Overall Study||38
6629381|NCT02258152|7557741|FG001|COMPLETED|Overall Study||34
6629382|NCT02258152|7557740|FG000|NOT COMPLETED|Overall Study||6
6629383|NCT02258152|7557741|FG001|NOT COMPLETED|Overall Study||4
6629384|NCT02258217|7557747|FG000|STARTED|Overall Study||30
6629385|NCT02258217|7557747|FG000|COMPLETED|Overall Study||30
6629386|NCT02258217|7557747|FG000|NOT COMPLETED|Overall Study||0
6629387|NCT02258256|7557751|FG000|STARTED|Overall Study||11
6629388|NCT02258256|7557751|FG000|COMPLETED|Overall Study||11
6629389|NCT02258256|7557751|FG000|NOT COMPLETED|Overall Study||0
6629390|NCT02258334|7557759|FG000|STARTED|Overall Study||50
6629391|NCT02258334|7557760|FG001|STARTED|Overall Study||54
6629392|NCT02258334|7557761|FG002|STARTED|Overall Study||52
6629393|NCT02258334|7557762|FG003|STARTED|Overall Study||52
6629394|NCT02258334|7557759|FG000|COMPLETED|Overall Study||49
6629395|NCT02258334|7557760|FG001|COMPLETED|Overall Study||54
6629396|NCT02258334|7557761|FG002|COMPLETED|Overall Study||52
6629397|NCT02258334|7557762|FG003|COMPLETED|Overall Study||52
6629398|NCT02258334|7557759|FG000|NOT COMPLETED|Overall Study||1
6629399|NCT02258334|7557760|FG001|NOT COMPLETED|Overall Study||0
6629400|NCT02258334|7557761|FG002|NOT COMPLETED|Overall Study||0
6629401|NCT02258334|7557762|FG003|NOT COMPLETED|Overall Study||0
6629402|NCT02258373|7557776|FG000|STARTED|Overall Study||149
6629403|NCT02258373|7557777|FG001|STARTED|Overall Study||77
6629404|NCT02258373|7557776|FG000|COMPLETED|Overall Study||142
6629405|NCT02258373|7557777|FG001|COMPLETED|Overall Study||75
6629406|NCT02258373|7557776|FG000|NOT COMPLETED|Overall Study||7
6629407|NCT02258373|7557777|FG001|NOT COMPLETED|Overall Study||2
6629408|NCT02258412|7557786|FG000|STARTED|Overall Study||26
6629409|NCT02258412|7557787|FG001|STARTED|Overall Study||25
6629410|NCT02258412|7557788|FG002|STARTED|Overall Study||61
6629411|NCT02258412|7557786|FG000|COMPLETED|Overall Study||26
6629412|NCT02258412|7557787|FG001|COMPLETED|Overall Study||25
6629413|NCT02258412|7557788|FG002|COMPLETED|Overall Study||61
6629414|NCT02258412|7557786|FG000|NOT COMPLETED|Overall Study||0
6629415|NCT02258412|7557787|FG001|NOT COMPLETED|Overall Study||0
6629416|NCT02258412|7557788|FG002|NOT COMPLETED|Overall Study||0
6629417|NCT02258464|7557797|FG000|STARTED|Overall Study||49
6629418|NCT02258464|7557798|FG001|STARTED|Overall Study||50
6629419|NCT02258464|7557797|FG000|COMPLETED|Overall Study||32
6629420|NCT02258464|7557798|FG001|COMPLETED|Overall Study||25
6629421|NCT02258464|7557797|FG000|NOT COMPLETED|Overall Study||17
6629422|NCT02258464|7557798|FG001|NOT COMPLETED|Overall Study||25
6629423|NCT02258477|7557804|FG000|STARTED|First Intervention (1 Week)||10
6629424|NCT02258477|7557805|FG001|STARTED|First Intervention (1 Week)||9
6629425|NCT02258477|7557806|FG002|STARTED|First Intervention (1 Week)||9
6629426|NCT02258477|7557807|FG003|STARTED|First Intervention (1 Week)||9
6629427|NCT02258477|7557804|FG000|COMPLETED|First Intervention (1 Week)||9
6629428|NCT02258477|7557805|FG001|COMPLETED|First Intervention (1 Week)||8
6629429|NCT02258477|7557806|FG002|COMPLETED|First Intervention (1 Week)||9
6629430|NCT02258477|7557807|FG003|COMPLETED|First Intervention (1 Week)||9
6629431|NCT02258477|7557804|FG000|NOT COMPLETED|First Intervention (1 Week)||1
6629432|NCT02258477|7557805|FG001|NOT COMPLETED|First Intervention (1 Week)||1
6629433|NCT02258477|7557806|FG002|NOT COMPLETED|First Intervention (1 Week)||0
6629434|NCT02258477|7557807|FG003|NOT COMPLETED|First Intervention (1 Week)||0
6629435|NCT02258477|7557804|FG000|STARTED|Second Intervention (1 Week)||9
6629436|NCT02258477|7557805|FG001|STARTED|Second Intervention (1 Week)||8
6629437|NCT02258477|7557806|FG002|STARTED|Second Intervention (1 Week)||9
6629438|NCT02258477|7557807|FG003|STARTED|Second Intervention (1 Week)||9
6629439|NCT02258477|7557804|FG000|COMPLETED|Second Intervention (1 Week)||9
6629440|NCT02258477|7557805|FG001|COMPLETED|Second Intervention (1 Week)||8
6629441|NCT02258477|7557806|FG002|COMPLETED|Second Intervention (1 Week)||8
6629442|NCT02258477|7557807|FG003|COMPLETED|Second Intervention (1 Week)||8
6629443|NCT02258477|7557804|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6629444|NCT02258477|7557805|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6629445|NCT02258477|7557806|FG002|NOT COMPLETED|Second Intervention (1 Week)||1
6629446|NCT02258477|7557807|FG003|NOT COMPLETED|Second Intervention (1 Week)||1
6629447|NCT02258477|7557804|FG000|STARTED|Third Intervention (1 Week)||9
6742876|NCT03330275|7671256|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742877|NCT03330275|7671257|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742878|NCT03330275|7671258|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742879|NCT03330275|7671259|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742880|NCT03330275|7671260|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742881|NCT03330275|7671261|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 1||0
6742882|NCT03330275|7671252|FG000|STARTED|Visits 2, 3 and 4 - Period 2||0
6742883|NCT03330275|7671253|FG001|STARTED|Visits 2, 3 and 4 - Period 2||0
6742884|NCT03330275|7671254|FG002|STARTED|Visits 2, 3 and 4 - Period 2||0
6742885|NCT03330275|7671255|FG003|STARTED|Visits 2, 3 and 4 - Period 2||0
6629448|NCT02258477|7557805|FG001|STARTED|Third Intervention (1 Week)||8
6629449|NCT02258477|7557806|FG002|STARTED|Third Intervention (1 Week)||8
6629450|NCT02258477|7557807|FG003|STARTED|Third Intervention (1 Week)||8
6629451|NCT02258477|7557804|FG000|COMPLETED|Third Intervention (1 Week)||9
6629452|NCT02258477|7557805|FG001|COMPLETED|Third Intervention (1 Week)||8
6629453|NCT02258477|7557806|FG002|COMPLETED|Third Intervention (1 Week)||8
6742886|NCT03330275|7671256|FG004|STARTED|Visits 2, 3 and 4 - Period 2||4
6742887|NCT03330275|7671257|FG005|STARTED|Visits 2, 3 and 4 - Period 2||4
6629454|NCT02258477|7557807|FG003|COMPLETED|Third Intervention (1 Week)||8
6629455|NCT02258477|7557804|FG000|NOT COMPLETED|Third Intervention (1 Week)||0
6629456|NCT02258477|7557805|FG001|NOT COMPLETED|Third Intervention (1 Week)||0
6629457|NCT02258477|7557806|FG002|NOT COMPLETED|Third Intervention (1 Week)||0
6629458|NCT02258477|7557807|FG003|NOT COMPLETED|Third Intervention (1 Week)||0
6629459|NCT02258477|7557804|FG000|STARTED|Fourth Intervention (1 Week)||9
6629460|NCT02258477|7557805|FG001|STARTED|Fourth Intervention (1 Week)||8
6629461|NCT02258477|7557806|FG002|STARTED|Fourth Intervention (1 Week)||8
6282564|NCT00183456|7182817|FG001|6 Month Follow-up|Overall Study||77
6282565|NCT00183456|7182818|FG002|6 Month Follow-up|Overall Study||278
6282566|NCT00183456|7182819|FG003|6 Month Follow-up|Overall Study||175
6282567|NCT00183456|7182816|FG000|12 Month Follow-up|Overall Study||76
6282568|NCT00183456|7182817|FG001|12 Month Follow-up|Overall Study||74
6282569|NCT00183456|7182818|FG002|12 Month Follow-up|Overall Study||267
6282570|NCT00183456|7182819|FG003|12 Month Follow-up|Overall Study||186
6282571|NCT00183456|7182816|FG000|18 Month Follow-up|Overall Study||80
6282572|NCT00183456|7182817|FG001|18 Month Follow-up|Overall Study||81
6282573|NCT00183456|7182818|FG002|18 Month Follow-up|Overall Study||303
6282574|NCT00183456|7182819|FG003|18 Month Follow-up|Overall Study||207
6282575|NCT00183456|7182816|FG000|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
6282576|NCT00183456|7182817|FG001|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
6282577|NCT00183456|7182818|FG002|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
6282578|NCT00183456|7182819|FG003|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
6282579|NCT00183456|7182816|FG000|NOT COMPLETED|Overall Study||3
6282580|NCT00183456|7182817|FG001|NOT COMPLETED|Overall Study||1
6282581|NCT00183456|7182818|FG002|NOT COMPLETED|Overall Study||16
6282582|NCT00183456|7182819|FG003|NOT COMPLETED|Overall Study||28
6282583|NCT00183469|7182831|FG000|STARTED|Overall Study||41
6282584|NCT00183469|7182832|FG001|STARTED|Overall Study||45
6282585|NCT00183469|7182831|FG000|COMPLETED|Overall Study||13
6282586|NCT00183469|7182832|FG001|COMPLETED|Overall Study||16
6282587|NCT00183469|7182831|FG000|NOT COMPLETED|Overall Study||28
6282588|NCT00183469|7182832|FG001|NOT COMPLETED|Overall Study||29
6282589|NCT00183625|7182840|FG000|STARTED|Overall Study||27
6282590|NCT00183625|7182841|FG001|STARTED|Overall Study||28
6282591|NCT00183625|7182842|FG002|STARTED|Overall Study||28
6282592|NCT00183625|7182843|FG003|STARTED|Overall Study||24
6282593|NCT00183625|7182840|FG000|Obtained Employment|Overall Study||21
6282594|NCT00183625|7182841|FG001|Obtained Employment|Overall Study||18
6282595|NCT00183625|7182842|FG002|Obtained Employment|Overall Study||14
6282596|NCT00183625|7182843|FG003|Obtained Employment|Overall Study||14
6282597|NCT00183625|7182840|FG000|COMPLETED|Overall Study||9
6282598|NCT00183625|7182841|FG001|COMPLETED|Overall Study||10
6282599|NCT00183625|7182842|FG002|COMPLETED|Overall Study||9
6282600|NCT00183625|7182843|FG003|COMPLETED|Overall Study||10
6282601|NCT00183625|7182840|FG000|NOT COMPLETED|Overall Study||18
6282602|NCT00183625|7182841|FG001|NOT COMPLETED|Overall Study||18
6282603|NCT00183625|7182842|FG002|NOT COMPLETED|Overall Study||19
6282604|NCT00183625|7182843|FG003|NOT COMPLETED|Overall Study||14
6282605|NCT00183677|7182851|FG000|STARTED|Overall Study||97
6282606|NCT00183677|7182851|FG000|COMPLETED|Overall Study||53
6282607|NCT00183677|7182851|FG000|NOT COMPLETED|Overall Study||44
6282608|NCT00183729|7182857|FG000|STARTED|Overall Study||17
6282609|NCT00183729|7182858|FG001|STARTED|Overall Study||18
6282610|NCT00183729|7182857|FG000|COMPLETED|Overall Study||14
6282611|NCT00183729|7182858|FG001|COMPLETED|Overall Study||13
6282612|NCT00183729|7182857|FG000|NOT COMPLETED|Overall Study||3
6282613|NCT00183729|7182858|FG001|NOT COMPLETED|Overall Study||5
6282614|NCT00183794|7182864|FG000|STARTED|Overall Study||20
6282615|NCT00183794|7182864|FG000|COMPLETED|Overall Study||20
6282616|NCT00183794|7182864|FG000|NOT COMPLETED|Overall Study||0
6282617|NCT00183872|7182868|FG000|STARTED|Overall Study||40
6282618|NCT00183872|7182868|FG000|COMPLETED|Overall Study||24
6282619|NCT00183872|7182868|FG000|NOT COMPLETED|Overall Study||16
6282620|NCT00184002|7182872|FG000|STARTED|Overall Study||68
6282621|NCT00184002|7182872|FG000|COMPLETED|Overall Study||51
6282622|NCT00184002|7182872|FG000|NOT COMPLETED|Overall Study||17
6282623|NCT00184028|7182876|FG000|STARTED|Overall Study||12
6282624|NCT00184028|7182876|FG000|COMPLETED|Overall Study||2
6282625|NCT00184028|7182876|FG000|NOT COMPLETED|Overall Study||10
6282626|NCT00184054|7182881|FG000|STARTED|Overall Study||11
6282627|NCT00184054|7182881|FG000|COMPLETED|Overall Study||10
6282628|NCT00184054|7182881|FG000|NOT COMPLETED|Overall Study||1
6282629|NCT00184093|7182885|FG000|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
6282630|NCT00184093|7182885|FG000|COMPLETED|Overall Study||26
6282631|NCT00184093|7182885|FG000|NOT COMPLETED|Overall Study||9
6282632|NCT00184548|7182893|FG000|STARTED|Overall Study||226
6282633|NCT00184548|7182894|FG001|STARTED|Overall Study||255
6282634|NCT00184548|7182895|FG002|STARTED|Overall Study||47
6282635|NCT00184548|7182896|FG003|STARTED|Overall Study||45
6282636|NCT00184548|7182893|FG000|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
6282637|NCT00184548|7182894|FG001|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
6282638|NCT00184548|7182895|FG002|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
6282639|NCT00184548|7182896|FG003|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
6282640|NCT00184548|7182893|FG000|COMPLETED|Overall Study||218
6282641|NCT00184548|7182894|FG001|COMPLETED|Overall Study||242
6282642|NCT00184548|7182895|FG002|COMPLETED|Overall Study||44
6282643|NCT00184548|7182896|FG003|COMPLETED|Overall Study||38
6282644|NCT00184548|7182893|FG000|NOT COMPLETED|Overall Study||8
6282645|NCT00184548|7182894|FG001|NOT COMPLETED|Overall Study||13
6282646|NCT00184548|7182895|FG002|NOT COMPLETED|Overall Study||3
6282647|NCT00184548|7182896|FG003|NOT COMPLETED|Overall Study||7
6282648|NCT00184600|7182909|FG000|STARTED|Overall Study||234
6282649|NCT00184600|7182910|FG001|STARTED|Overall Study||239
6282650|NCT00184600|7182911|FG002|STARTED|Overall Study||235
6282651|NCT00184600|7182909|FG000|COMPLETED|Overall Study||189
6629462|NCT02258477|7557807|FG003|STARTED|Fourth Intervention (1 Week)||8
6629463|NCT02258477|7557804|FG000|COMPLETED|Fourth Intervention (1 Week)||9
6629464|NCT02258477|7557805|FG001|COMPLETED|Fourth Intervention (1 Week)||8
6629465|NCT02258477|7557806|FG002|COMPLETED|Fourth Intervention (1 Week)||8
6629466|NCT02258477|7557807|FG003|COMPLETED|Fourth Intervention (1 Week)||8
6629467|NCT02258477|7557804|FG000|NOT COMPLETED|Fourth Intervention (1 Week)||0
6629468|NCT02258477|7557805|FG001|NOT COMPLETED|Fourth Intervention (1 Week)||0
6629469|NCT02258477|7557806|FG002|NOT COMPLETED|Fourth Intervention (1 Week)||0
6629470|NCT02258477|7557807|FG003|NOT COMPLETED|Fourth Intervention (1 Week)||0
6629471|NCT02258529|7557816|FG000|STARTED|Overall Study||10
6629472|NCT02258529|7557816|FG000|COMPLETED|Overall Study||0
6629473|NCT02258529|7557816|FG000|NOT COMPLETED|Overall Study||10
6629474|NCT02259010|7557820|FG000|STARTED|Overall Study||24
6629475|NCT02259010|7557820|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|19
6629476|NCT02259010|7557820|FG000|NOT COMPLETED|Overall Study||5
6629477|NCT02259088|7557828|FG000|STARTED|Overall Study||307
6282652|NCT00184600|7182910|FG001|COMPLETED|Overall Study||188
6282653|NCT00184600|7182911|FG002|COMPLETED|Overall Study||201
6629478|NCT02259088|7557829|FG001|STARTED|Overall Study||77
6629479|NCT02259088|7557828|FG000|Full Analysis Set|Overall Study||307
6629480|NCT02259088|7557829|FG001|Full Analysis Set|Overall Study||77
6629481|NCT02259088|7557828|FG000|Treated (Safety Analysis Set)|Overall Study||307
6629482|NCT02259088|7557829|FG001|Treated (Safety Analysis Set)|Overall Study||75
6629483|NCT02259088|7557828|FG000|COMPLETED|Overall Study||279
6629484|NCT02259088|7557829|FG001|COMPLETED|Overall Study||63
6629485|NCT02259088|7557828|FG000|NOT COMPLETED|Overall Study||28
6629486|NCT02259088|7557829|FG001|NOT COMPLETED|Overall Study||14
6629487|NCT02259114|7557840|FG000|STARTED|Overall Study||21
6629488|NCT02259114|7557841|FG001|STARTED|Overall Study||4
6629489|NCT02259114|7557842|FG002|STARTED|Overall Study||13
6629490|NCT02259114|7557843|FG003|STARTED|Overall Study||3
6629491|NCT02259114|7557844|FG004|STARTED|Overall Study||6
6629492|NCT02259114|7557840|FG000|Treated|Overall Study|One participant was randomized but did not receive treatment due to a protocol violation.|20
6629493|NCT02259114|7557841|FG001|Treated|Overall Study||4
6629494|NCT02259114|7557842|FG002|Treated|Overall Study||13
6629495|NCT02259114|7557843|FG003|Treated|Overall Study||3
6629496|NCT02259114|7557844|FG004|Treated|Overall Study||6
6629497|NCT02259114|7557840|FG000|COMPLETED|Overall Study||0
6629498|NCT02259114|7557841|FG001|COMPLETED|Overall Study||0
6629499|NCT02259114|7557842|FG002|COMPLETED|Overall Study||0
6629500|NCT02259114|7557843|FG003|COMPLETED|Overall Study||0
6629501|NCT02259114|7557844|FG004|COMPLETED|Overall Study||0
6629502|NCT02259114|7557840|FG000|NOT COMPLETED|Overall Study||21
6629503|NCT02259114|7557841|FG001|NOT COMPLETED|Overall Study||4
6629504|NCT02259114|7557842|FG002|NOT COMPLETED|Overall Study||13
6629505|NCT02259114|7557843|FG003|NOT COMPLETED|Overall Study||3
6629506|NCT02259114|7557844|FG004|NOT COMPLETED|Overall Study||6
6629507|NCT02259231|7557863|FG000|STARTED|Overall Study||6
6629508|NCT02259231|7557864|FG001|STARTED|Overall Study||6
6629509|NCT02259231|7557865|FG002|STARTED|Overall Study||6
6629510|NCT02259231|7557866|FG003|STARTED|Overall Study||6
6629511|NCT02259231|7557867|FG004|STARTED|Overall Study||6
6629512|NCT02259231|7557868|FG005|STARTED|Overall Study||6
6629513|NCT02259231|7557869|FG006|STARTED|Overall Study||5
6629514|NCT02259231|7557863|FG000|COMPLETED|Overall Study||0
6629515|NCT02259231|7557864|FG001|COMPLETED|Overall Study||0
6629516|NCT02259231|7557865|FG002|COMPLETED|Overall Study||0
6629517|NCT02259231|7557866|FG003|COMPLETED|Overall Study||0
6629518|NCT02259231|7557867|FG004|COMPLETED|Overall Study||0
6629519|NCT02259231|7557868|FG005|COMPLETED|Overall Study||0
6629520|NCT02259231|7557869|FG006|COMPLETED|Overall Study||0
6629521|NCT02259231|7557863|FG000|NOT COMPLETED|Overall Study||6
6629522|NCT02259231|7557864|FG001|NOT COMPLETED|Overall Study||6
6629523|NCT02259231|7557865|FG002|NOT COMPLETED|Overall Study||6
6629524|NCT02259231|7557866|FG003|NOT COMPLETED|Overall Study||6
6629525|NCT02259231|7557867|FG004|NOT COMPLETED|Overall Study||6
6629526|NCT02259231|7557868|FG005|NOT COMPLETED|Overall Study||6
6629527|NCT02259231|7557869|FG006|NOT COMPLETED|Overall Study||5
6629528|NCT02259348|7557885|FG000|STARTED|Overall Study||12
6629529|NCT02259348|7557885|FG000|One Year Post-transplant|Overall Study||2
6629530|NCT02259348|7557885|FG000|COMPLETED|Overall Study||2
6629531|NCT02259348|7557885|FG000|NOT COMPLETED|Overall Study||10
6629532|NCT02259400|7557891|FG000|STARTED|Overall Study||62
6629533|NCT02259400|7557892|FG001|STARTED|Overall Study||62
6629534|NCT02259400|7557891|FG000|COMPLETED|Overall Study||62
6629535|NCT02259400|7557892|FG001|COMPLETED|Overall Study||60
6629536|NCT02259400|7557891|FG000|NOT COMPLETED|Overall Study||0
6629537|NCT02259400|7557892|FG001|NOT COMPLETED|Overall Study||2
6629538|NCT02259582|7557901|FG000|STARTED|Overall Study||25
6629539|NCT02259582|7557902|FG001|STARTED|Overall Study||28
6629540|NCT02259582|7557903|FG002|STARTED|Overall Study||29
6629541|NCT02259582|7557901|FG000|COMPLETED|Overall Study||9
6629542|NCT02259582|7557902|FG001|COMPLETED|Overall Study||11
6629543|NCT02259582|7557903|FG002|COMPLETED|Overall Study||8
6629544|NCT02259582|7557901|FG000|NOT COMPLETED|Overall Study||16
6629545|NCT02259582|7557902|FG001|NOT COMPLETED|Overall Study||17
6629546|NCT02259582|7557903|FG002|NOT COMPLETED|Overall Study||21
6629547|NCT02259608|7557911|FG000|STARTED|Overall Study||15
6629548|NCT02259608|7557911|FG000|COMPLETED|Overall Study||15
6629549|NCT02259608|7557911|FG000|NOT COMPLETED|Overall Study||0
6629550|NCT02259699|7557917|FG000|STARTED|Overall Study||64
6629551|NCT02259699|7557918|FG001|STARTED|Overall Study||60
6629552|NCT02259699|7557917|FG000|COMPLETED|Overall Study||37
6629553|NCT02259699|7557918|FG001|COMPLETED|Overall Study||40
6629554|NCT02259699|7557917|FG000|NOT COMPLETED|Overall Study||27
6629555|NCT02259699|7557918|FG001|NOT COMPLETED|Overall Study||20
6629556|NCT02260154|7557924|FG000|STARTED|Overall Study||220
6629557|NCT02260154|7557924|FG000|COMPLETED|Overall Study||218
6629558|NCT02260154|7557924|FG000|NOT COMPLETED|Overall Study||2
6629559|NCT02260180|7557932|FG000|STARTED|Overall Study||39
6629560|NCT02260180|7557933|FG001|STARTED|Overall Study||39
6629561|NCT02260180|7557934|FG002|STARTED|Overall Study||41
6629562|NCT02260180|7557932|FG000|COMPLETED|Overall Study||37
6629563|NCT02260180|7557933|FG001|COMPLETED|Overall Study||39
6629564|NCT02260180|7557934|FG002|COMPLETED|Overall Study||40
6629565|NCT02260180|7557932|FG000|NOT COMPLETED|Overall Study||2
6629566|NCT02260180|7557933|FG001|NOT COMPLETED|Overall Study||0
6629567|NCT02260180|7557934|FG002|NOT COMPLETED|Overall Study||1
6629568|NCT02260258|7557944|FG000|STARTED|Overall Study||39
6629569|NCT02260258|7557945|FG001|STARTED|Overall Study||44
6629570|NCT02260258|7557944|FG000|COMPLETED|Overall Study||37
6629571|NCT02260258|7557945|FG001|COMPLETED|Overall Study||43
6629572|NCT02260258|7557944|FG000|NOT COMPLETED|Overall Study||2
6629573|NCT02260258|7557945|FG001|NOT COMPLETED|Overall Study||1
6629574|NCT02260388|7557956|FG000|STARTED|Overall Study||134
6629575|NCT02260388|7557957|FG001|STARTED|Overall Study||126
6629576|NCT02260388|7557958|FG002|STARTED|Overall Study||73
6629577|NCT02260388|7557959|FG003|STARTED|Overall Study||69
6629578|NCT02260388|7557956|FG000|COMPLETED|Overall Study||132
6629579|NCT02260388|7557957|FG001|COMPLETED|Overall Study||118
6629580|NCT02260388|7557958|FG002|COMPLETED|Overall Study||70
6629581|NCT02260388|7557959|FG003|COMPLETED|Overall Study||65
6629582|NCT02260388|7557956|FG000|NOT COMPLETED|Overall Study||2
6629583|NCT02260388|7557957|FG001|NOT COMPLETED|Overall Study||8
6629584|NCT02260388|7557958|FG002|NOT COMPLETED|Overall Study||3
6629585|NCT02260388|7557959|FG003|NOT COMPLETED|Overall Study||4
6629586|NCT02260401|7557971|FG000|STARTED|Overall Study||80
6629587|NCT02260401|7557972|FG001|STARTED|Overall Study||85
6629588|NCT02260401|7557971|FG000|COMPLETED|Overall Study||75
6629589|NCT02260401|7557972|FG001|COMPLETED|Overall Study||73
6629590|NCT02260401|7557971|FG000|NOT COMPLETED|Overall Study||5
6629591|NCT02260401|7557972|FG001|NOT COMPLETED|Overall Study||12
6629592|NCT02260440|7557978|FG000|STARTED|Overall Study||31
6629593|NCT02260440|7557978|FG000|COMPLETED|Overall Study||31
6629594|NCT02260440|7557978|FG000|NOT COMPLETED|Overall Study||0
6629595|NCT02260492|7557985|FG000|STARTED|Overall Study||418
6629596|NCT02260492|7557986|FG001|STARTED|Overall Study||419
6629597|NCT02260492|7557987|FG002|STARTED|Overall Study||42
6629598|NCT02260492|7557985|FG000|Completed Day 1|Overall Study||418
6629599|NCT02260492|7557986|FG001|Completed Day 1|Overall Study||419
6629600|NCT02260492|7557987|FG002|Completed Day 1|Overall Study||42
6629601|NCT02260492|7557985|FG000|COMPLETED|Overall Study||395
6629602|NCT02260492|7557986|FG001|COMPLETED|Overall Study||406
6629603|NCT02260492|7557987|FG002|COMPLETED|Overall Study||37
6629604|NCT02260492|7557985|FG000|NOT COMPLETED|Overall Study||23
6629605|NCT02260492|7557986|FG001|NOT COMPLETED|Overall Study||13
6629606|NCT02260492|7557987|FG002|NOT COMPLETED|Overall Study||5
6629607|NCT02260531|7557998|FG000|STARTED|Overall Study||21
6629608|NCT02260531|7557999|FG001|STARTED|Overall Study||7
6629609|NCT02260531|7558000|FG002|STARTED|Overall Study||8
6629610|NCT02260531|7557998|FG000|COMPLETED|Overall Study||21
6629611|NCT02260531|7557999|FG001|COMPLETED|Overall Study||7
6629612|NCT02260531|7558000|FG002|COMPLETED|Overall Study||8
6629613|NCT02260531|7557998|FG000|NOT COMPLETED|Overall Study||0
6629614|NCT02260531|7557999|FG001|NOT COMPLETED|Overall Study||0
6629615|NCT02260531|7558000|FG002|NOT COMPLETED|Overall Study||0
6629616|NCT02260622|7558017|FG000|STARTED|Overall Study||11
6629617|NCT02260622|7558018|FG001|STARTED|Overall Study||9
6629618|NCT02260622|7558017|FG000|COMPLETED|Overall Study||11
6742888|NCT03330275|7671258|FG006|STARTED|Visits 2, 3 and 4 - Period 2||4
6742889|NCT03330275|7671259|FG007|STARTED|Visits 2, 3 and 4 - Period 2||4
6742890|NCT03330275|7671260|FG008|STARTED|Visits 2, 3 and 4 - Period 2||4
6742891|NCT03330275|7671261|FG009|STARTED|Visits 2, 3 and 4 - Period 2||4
6629619|NCT02260622|7558018|FG001|COMPLETED|Overall Study||9
6629620|NCT02260622|7558017|FG000|NOT COMPLETED|Overall Study||0
6629621|NCT02260622|7558018|FG001|NOT COMPLETED|Overall Study||0
6629622|NCT02260635|7558026|FG000|STARTED|Double-Blind Treatment Period||27
6629623|NCT02260635|7558027|FG001|STARTED|Double-Blind Treatment Period||27
6629624|NCT02260635|7558026|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||27
6629625|NCT02260635|7558027|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||26
6629626|NCT02260635|7558026|FG000|COMPLETED|Double-Blind Treatment Period||26
6629627|NCT02260635|7558027|FG001|COMPLETED|Double-Blind Treatment Period||25
6629628|NCT02260635|7558026|FG000|NOT COMPLETED|Double-Blind Treatment Period||1
6629629|NCT02260635|7558027|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
6629630|NCT02260635|7558026|FG000|STARTED|Open-Label Extension||26
6629631|NCT02260635|7558027|FG001|STARTED|Open-Label Extension||25
6629632|NCT02260635|7558026|FG000|Received at Least One Dose of Study Drug|Open-Label Extension||26
6629633|NCT02260635|7558027|FG001|Received at Least One Dose of Study Drug|Open-Label Extension||25
6629634|NCT02260635|7558026|FG000|COMPLETED|Open-Label Extension||0
6629635|NCT02260635|7558027|FG001|COMPLETED|Open-Label Extension||0
6629636|NCT02260635|7558026|FG000|NOT COMPLETED|Open-Label Extension||26
6629637|NCT02260635|7558027|FG001|NOT COMPLETED|Open-Label Extension||25
6629638|NCT02260648|7558038|FG000|STARTED|Overall Study||53
6629639|NCT02260648|7558039|FG001|STARTED|Overall Study||46
6629640|NCT02260648|7558040|FG002|STARTED|Overall Study||50
6629641|NCT02260648|7558038|FG000|Received at Least One Dose of Study Drug|Overall Study||53
6629642|NCT02260648|7558039|FG001|Received at Least One Dose of Study Drug|Overall Study||46
6629643|NCT02260648|7558040|FG002|Received at Least One Dose of Study Drug|Overall Study||50
6742892|NCT03330275|7671252|FG000|COMPLETED|Visits 2, 3 and 4 - Period 2||0
6629644|NCT02260648|7558038|FG000|COMPLETED|Overall Study||35
6629645|NCT02260648|7558039|FG001|COMPLETED|Overall Study||33
6629646|NCT02260648|7558040|FG002|COMPLETED|Overall Study||42
6629647|NCT02260648|7558038|FG000|NOT COMPLETED|Overall Study||18
6629648|NCT02260648|7558039|FG001|NOT COMPLETED|Overall Study||13
6629649|NCT02260648|7558040|FG002|NOT COMPLETED|Overall Study||8
6629650|NCT02260791|7558050|FG000|STARTED|Overall Study||366
6629651|NCT02260791|7558051|FG001|STARTED|Overall Study||362
6629652|NCT02260791|7558050|FG000|COMPLETED|Overall Study||333
6629653|NCT02260791|7558051|FG001|COMPLETED|Overall Study||328
6629654|NCT02260791|7558050|FG000|NOT COMPLETED|Overall Study||33
6629655|NCT02260791|7558051|FG001|NOT COMPLETED|Overall Study||34
6629656|NCT02260804|7558059|FG000|STARTED|Induction Study Period||130
6629657|NCT02260804|7558060|FG001|STARTED|Induction Study Period||128
6629658|NCT02260804|7558059|FG000|COMPLETED|Induction Study Period||128
6629659|NCT02260804|7558060|FG001|COMPLETED|Induction Study Period||128
6629660|NCT02260804|7558059|FG000|NOT COMPLETED|Induction Study Period||2
6629661|NCT02260804|7558060|FG001|NOT COMPLETED|Induction Study Period||0
6629662|NCT02260804|7558059|FG000|STARTED|1st Year of the Maintenance Period (MP1)|Five subjects completed the induction period but did not initiate this period in the CT-P10 group.|123
6629663|NCT02260804|7558060|FG001|STARTED|1st Year of the Maintenance Period (MP1)|Eight subjects completed the induction period but did not initiate this period in the Rituxan group.|120
6629664|NCT02260804|7558059|FG000|COMPLETED|1st Year of the Maintenance Period (MP1)||111
6629665|NCT02260804|7558060|FG001|COMPLETED|1st Year of the Maintenance Period (MP1)||105
6629666|NCT02260804|7558059|FG000|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||12
6629667|NCT02260804|7558060|FG001|NOT COMPLETED|1st Year of the Maintenance Period (MP1)||15
6629668|NCT02260804|7558059|FG000|STARTED|2nd Year of the Maintenance Period (MP2)|One subject completed the MP1 but did not initiate this period in the CT-P10 group.|110
6629669|NCT02260804|7558060|FG001|STARTED|2nd Year of the Maintenance Period (MP2)|Two subjects completed the MP1 but did not initiate this period in the Rituxan group.|103
6629670|NCT02260804|7558059|FG000|COMPLETED|2nd Year of the Maintenance Period (MP2)||101
6629671|NCT02260804|7558060|FG001|COMPLETED|2nd Year of the Maintenance Period (MP2)||97
6629672|NCT02260804|7558059|FG000|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||9
6629673|NCT02260804|7558060|FG001|NOT COMPLETED|2nd Year of the Maintenance Period (MP2)||6
6629674|NCT02260817|7558068|FG000|STARTED|Overall Study||14
6629675|NCT02260817|7558069|FG001|STARTED|Overall Study||95
6629676|NCT02260817|7558068|FG000|COMPLETED|Overall Study||14
6629677|NCT02260817|7558069|FG001|COMPLETED|Overall Study||58
6629678|NCT02260817|7558068|FG000|NOT COMPLETED|Overall Study||0
6629679|NCT02260817|7558069|FG001|NOT COMPLETED|Overall Study||37
6629680|NCT02260882|7558077|FG000|STARTED|Overall Study||161
6629681|NCT02260882|7558078|FG001|STARTED|Overall Study||82
6629682|NCT02260882|7558077|FG000|COMPLETED|Overall Study||161
6629683|NCT02260882|7558078|FG001|COMPLETED|Overall Study||81
6629684|NCT02260882|7558077|FG000|NOT COMPLETED|Overall Study||0
6629685|NCT02260882|7558078|FG001|NOT COMPLETED|Overall Study||1
6629686|NCT02260921|7558087|FG000|STARTED|Overall Study||121
6629687|NCT02260921|7558088|FG001|STARTED|Overall Study||59
6629688|NCT02260921|7558087|FG000|Per-Protocol Population|Overall Study||112
6629689|NCT02260921|7558088|FG001|Per-Protocol Population|Overall Study||56
6629690|NCT02260921|7558087|FG000|COMPLETED|Overall Study||107
6629691|NCT02260921|7558088|FG001|COMPLETED|Overall Study||55
6629692|NCT02260921|7558087|FG000|NOT COMPLETED|Overall Study||14
6629693|NCT02260921|7558088|FG001|NOT COMPLETED|Overall Study||4
6629694|NCT02260934|7558096|FG000|STARTED|Overall Study||22
6629695|NCT02260934|7558097|FG001|STARTED|Overall Study||21
6629696|NCT02260934|7558096|FG000|COMPLETED|Overall Study|At primary outcome timepoint: Ten participants engaged in ongoing scheduled study visits.|19
6629697|NCT02260934|7558097|FG001|COMPLETED|Overall Study|At primary outcome timepoint: Eleven participants engaged in ongoing scheduled study visits.|17
6629698|NCT02260934|7558096|FG000|NOT COMPLETED|Overall Study||3
6629699|NCT02260934|7558097|FG001|NOT COMPLETED|Overall Study||4
6629700|NCT02260986|7558113|FG000|STARTED|Overall Study||315
6629701|NCT02260986|7558114|FG001|STARTED|Overall Study||106
6629702|NCT02260986|7558115|FG002|STARTED|Overall Study||319
6629703|NCT02260986|7558113|FG000|Safety Population|Overall Study||315
6629704|NCT02260986|7558114|FG001|Safety Population|Overall Study|4 participants from Dupilumab 300 mg qw arm analyzed in Dupilumab 300 mg q2w arm|110
6655512|NCT02453555|7585651|FG000|NOT COMPLETED|24-week Double-blind Treatment Period||5
6629705|NCT02260986|7558115|FG002|Safety Population|Overall Study|4 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|315
6629706|NCT02260986|7558113|FG000|COMPLETED|Overall Study||225
6629707|NCT02260986|7558114|FG001|COMPLETED|Overall Study||93
6629708|NCT02260986|7558115|FG002|COMPLETED|Overall Study||278
6629709|NCT02260986|7558113|FG000|NOT COMPLETED|Overall Study||90
6629710|NCT02260986|7558114|FG001|NOT COMPLETED|Overall Study||13
6629711|NCT02260986|7558115|FG002|NOT COMPLETED|Overall Study||41
6629712|NCT02261428|7558130|FG000|STARTED|Overall Study|Washout (30 minutes)|10
6629713|NCT02261428|7558131|FG001|STARTED|Overall Study|Washout (30 minutes)|10
6629714|NCT02261428|7558130|FG000|COMPLETED|Overall Study||10
6629715|NCT02261428|7558131|FG001|COMPLETED|Overall Study||10
6629716|NCT02261428|7558130|FG000|NOT COMPLETED|Overall Study||0
6629717|NCT02261428|7558131|FG001|NOT COMPLETED|Overall Study||0
6629718|NCT02261467|7558151|FG000|STARTED|Overall Study||101
6629719|NCT02261467|7558152|FG001|STARTED|Overall Study||290
6629720|NCT02261467|7558151|FG000|COMPLETED|Overall Study||80
6629721|NCT02261467|7558152|FG001|COMPLETED|Overall Study||253
6629722|NCT02261467|7558151|FG000|NOT COMPLETED|Overall Study||21
6629723|NCT02261467|7558152|FG001|NOT COMPLETED|Overall Study||37
6629724|NCT02261493|7558161|FG000|STARTED|Overall Study||156
6629725|NCT02261493|7558162|FG001|STARTED|Overall Study||318
6629726|NCT02261493|7558163|FG002|STARTED|Overall Study||313
6629727|NCT02261493|7558161|FG000|COMPLETED|Overall Study||126
6629728|NCT02261493|7558162|FG001|COMPLETED|Overall Study||271
6629729|NCT02261493|7558163|FG002|COMPLETED|Overall Study||287
6629730|NCT02261493|7558161|FG000|NOT COMPLETED|Overall Study||30
6629731|NCT02261493|7558162|FG001|NOT COMPLETED|Overall Study||47
6629732|NCT02261493|7558163|FG002|NOT COMPLETED|Overall Study||26
6629733|NCT02261597|7558173|FG000|STARTED|Overall Study||22
6629734|NCT02261597|7558174|FG001|STARTED|Overall Study||22
6629735|NCT02261597|7558173|FG000|COMPLETED|Overall Study||22
6629736|NCT02261597|7558174|FG001|COMPLETED|Overall Study||22
6629737|NCT02261597|7558173|FG000|NOT COMPLETED|Overall Study||0
6629738|NCT02261597|7558174|FG001|NOT COMPLETED|Overall Study||0
6629739|NCT02261714|7558180|FG000|STARTED|Overall Study||32
6629740|NCT02261714|7558180|FG000|COMPLETED|Overall Study||4
6629741|NCT02261714|7558180|FG000|NOT COMPLETED|Overall Study||28
6629742|NCT02261727|7558188|FG000|STARTED|Overall Study||568
6629743|NCT02261727|7558189|FG001|STARTED|Overall Study||554
6629744|NCT02261727|7558190|FG002|STARTED|Overall Study||548
6629745|NCT02261727|7558188|FG000|COMPLETED|Overall Study||411
6629746|NCT02261727|7558189|FG001|COMPLETED|Overall Study||408
6629747|NCT02261727|7558190|FG002|COMPLETED|Overall Study||423
6629748|NCT02261727|7558188|FG000|NOT COMPLETED|Overall Study||157
6629749|NCT02261727|7558189|FG001|NOT COMPLETED|Overall Study||146
6629750|NCT02261727|7558190|FG002|NOT COMPLETED|Overall Study||125
6629751|NCT02261805|7558198|FG000|STARTED|Overall Study||3
6629752|NCT02261805|7558199|FG001|STARTED|Overall Study||6
6629753|NCT02261805|7558200|FG002|STARTED|Overall Study||2
6629754|NCT02261805|7558198|FG000|COMPLETED|Overall Study||3
6629755|NCT02261805|7558199|FG001|COMPLETED|Overall Study||6
6629756|NCT02261805|7558200|FG002|COMPLETED|Overall Study||2
6629757|NCT02261805|7558198|FG000|NOT COMPLETED|Overall Study||0
6629758|NCT02261805|7558199|FG001|NOT COMPLETED|Overall Study||0
6629759|NCT02261805|7558200|FG002|NOT COMPLETED|Overall Study||0
6629760|NCT02261818|7558206|FG000|STARTED|Overall Study||30
6629761|NCT02261818|7558206|FG000|COMPLETED|Overall Study||27
6629762|NCT02261818|7558206|FG000|NOT COMPLETED|Overall Study||3
6629763|NCT02261948|7558212|FG000|STARTED|Overall Study||23
6629764|NCT02261948|7558213|FG001|STARTED|Overall Study||19
6629765|NCT02261948|7558212|FG000|COMPLETED|Overall Study||23
6629766|NCT02261948|7558213|FG001|COMPLETED|Overall Study||19
6629767|NCT02261948|7558212|FG000|NOT COMPLETED|Overall Study||0
6629768|NCT02261948|7558213|FG001|NOT COMPLETED|Overall Study||0
6629769|NCT02261961|7558221|FG000|STARTED|Overall Study||22
6629770|NCT02261961|7558222|FG001|STARTED|Overall Study||22
6629771|NCT02261961|7558221|FG000|COMPLETED|Overall Study||13
6629772|NCT02261961|7558222|FG001|COMPLETED|Overall Study|One subject listed as completed who withdrew but finished training phase and has usable data.|20
6629773|NCT02261961|7558221|FG000|NOT COMPLETED|Overall Study||9
6629774|NCT02261961|7558222|FG001|NOT COMPLETED|Overall Study||2
6629775|NCT02261974|7558241|FG000|STARTED|Overall Study||123
6629776|NCT02261974|7558242|FG001|STARTED|Overall Study||63
6629777|NCT02261974|7558241|FG000|Treated|Overall Study||117
6629778|NCT02261974|7558242|FG001|Treated|Overall Study||57
6629779|NCT02261974|7558241|FG000|COMPLETED|Overall Study||108
6629780|NCT02261974|7558242|FG001|COMPLETED|Overall Study||56
6629781|NCT02261974|7558241|FG000|NOT COMPLETED|Overall Study||15
6629782|NCT02261974|7558242|FG001|NOT COMPLETED|Overall Study||7
6629783|NCT02262039|7558250|FG000|STARTED|Overall Study||14
6629784|NCT02262039|7558251|FG001|STARTED|Overall Study||27
6629785|NCT02262039|7558250|FG000|COMPLETED|Overall Study||14
6629786|NCT02262039|7558251|FG001|COMPLETED|Overall Study||27
6629787|NCT02262039|7558250|FG000|NOT COMPLETED|Overall Study||0
6629788|NCT02262039|7558251|FG001|NOT COMPLETED|Overall Study||0
6629789|NCT02262078|7558259|FG000|STARTED|Overall Study||13
6629790|NCT02262078|7558260|FG001|STARTED|Overall Study||13
6629791|NCT02262078|7558259|FG000|COMPLETED|Overall Study||13
6629792|NCT02262078|7558260|FG001|COMPLETED|Overall Study||13
6629793|NCT02262078|7558259|FG000|NOT COMPLETED|Overall Study||0
6629794|NCT02262078|7558260|FG001|NOT COMPLETED|Overall Study||0
6629795|NCT02262130|7558266|FG000|STARTED|Overall Study||10
6629796|NCT02262130|7558266|FG000|COMPLETED|Overall Study||10
6629797|NCT02262130|7558266|FG000|NOT COMPLETED|Overall Study||0
6629798|NCT02262260|7558272|FG000|STARTED|Overall Study||45
6629799|NCT02262260|7558273|FG001|STARTED|Overall Study||42
6629800|NCT02262260|7558272|FG000|COMPLETED|Overall Study||34
6629801|NCT02262260|7558273|FG001|COMPLETED|Overall Study||32
6629802|NCT02262260|7558272|FG000|NOT COMPLETED|Overall Study||11
6629803|NCT02262260|7558273|FG001|NOT COMPLETED|Overall Study||10
6629804|NCT02262364|7558279|FG000|STARTED|Study Enrollment||11
6629805|NCT02262364|7558279|FG000|COMPLETED|Study Enrollment||11
6629806|NCT02262364|7558279|FG000|NOT COMPLETED|Study Enrollment||0
6629807|NCT02262364|7558279|FG000|STARTED|Blood Draw for Device Processing||11
6629808|NCT02262364|7558279|FG000|COMPLETED|Blood Draw for Device Processing||10
6629809|NCT02262364|7558279|FG000|NOT COMPLETED|Blood Draw for Device Processing||1
6629810|NCT02262364|7558279|FG000|STARTED|Injection With APS||10
6629811|NCT02262364|7558279|FG000|COMPLETED|Injection With APS||10
6629812|NCT02262364|7558279|FG000|NOT COMPLETED|Injection With APS||0
6629813|NCT02262364|7558279|FG000|STARTED|Follow-Up Through 12 Months||10
6629814|NCT02262364|7558279|FG000|COMPLETED|Follow-Up Through 12 Months||10
6629815|NCT02262364|7558279|FG000|NOT COMPLETED|Follow-Up Through 12 Months||0
6629816|NCT02262377|7558285|FG000|STARTED|Overall Study||80
6629817|NCT02262377|7558286|FG001|STARTED|Overall Study||79
6629818|NCT02262377|7558285|FG000|COMPLETED|Overall Study||68
6629819|NCT02262377|7558286|FG001|COMPLETED|Overall Study||73
6629820|NCT02262377|7558285|FG000|NOT COMPLETED|Overall Study||12
6629821|NCT02262377|7558286|FG001|NOT COMPLETED|Overall Study||6
6629822|NCT02262507|7558293|FG000|STARTED|Overall Study||410
6629823|NCT02262507|7558293|FG000|COMPLETED|Overall Study||410
6629824|NCT02262507|7558293|FG000|NOT COMPLETED|Overall Study||0
6629825|NCT02262728|7558300|FG000|STARTED|Treatment Period (12 Weeks)||19
6629826|NCT02262728|7558301|FG001|STARTED|Treatment Period (12 Weeks)||21
6629827|NCT02262728|7558300|FG000|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|19
6629828|NCT02262728|7558301|FG001|COMPLETED|Treatment Period (12 Weeks)|Participants who completed continued follow-up phase.|21
6629829|NCT02262728|7558300|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||0
6629830|NCT02262728|7558301|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
6629831|NCT02262728|7558300|FG000|STARTED|Follow-up Phase (3 Years)||19
6629832|NCT02262728|7558301|FG001|STARTED|Follow-up Phase (3 Years)||21
6629833|NCT02262728|7558300|FG000|COMPLETED|Follow-up Phase (3 Years)||15
6629834|NCT02262728|7558301|FG001|COMPLETED|Follow-up Phase (3 Years)||18
6629835|NCT02262728|7558300|FG000|NOT COMPLETED|Follow-up Phase (3 Years)||4
6629836|NCT02262728|7558301|FG001|NOT COMPLETED|Follow-up Phase (3 Years)||3
6629837|NCT02262754|7558310|FG000|STARTED|Overall Study||74
6629838|NCT02262754|7558311|FG001|STARTED|Overall Study||74
6629839|NCT02262754|7558312|FG002|STARTED|Overall Study||74
6629840|NCT02262754|7558310|FG000|COMPLETED|Overall Study||58
6629841|NCT02262754|7558311|FG001|COMPLETED|Overall Study||65
6629842|NCT02262754|7558312|FG002|COMPLETED|Overall Study||65
6629843|NCT02262754|7558310|FG000|NOT COMPLETED|Overall Study||16
6629844|NCT02262754|7558311|FG001|NOT COMPLETED|Overall Study||9
6629845|NCT02262754|7558312|FG002|NOT COMPLETED|Overall Study||9
6629846|NCT02263014|7558324|FG000|STARTED|Overall Study||44
6629847|NCT02263014|7558325|FG001|STARTED|Overall Study||208
6629848|NCT02263014|7558324|FG000|COMPLETED|Overall Study||44
6629849|NCT02263014|7558325|FG001|COMPLETED|Overall Study||208
6629850|NCT02263014|7558324|FG000|NOT COMPLETED|Overall Study||0
6629851|NCT02263014|7558325|FG001|NOT COMPLETED|Overall Study||0
6629852|NCT02263040|7558335|FG000|STARTED|Overall Study||87
6629853|NCT02263040|7558336|FG001|STARTED|Overall Study||83
6629854|NCT02263040|7558335|FG000|COMPLETED|Overall Study||87
6629855|NCT02263040|7558336|FG001|COMPLETED|Overall Study||83
6629856|NCT02263040|7558335|FG000|NOT COMPLETED|Overall Study||0
6629857|NCT02263040|7558336|FG001|NOT COMPLETED|Overall Study||0
6629858|NCT02263079|7558349|FG000|STARTED|Overall Study||26
6629859|NCT02263079|7558350|FG001|STARTED|Overall Study||33
6629860|NCT02263079|7558351|FG002|STARTED|Overall Study||3
6629861|NCT02263079|7558349|FG000|COMPLETED|Overall Study||23
6629862|NCT02263079|7558350|FG001|COMPLETED|Overall Study||25
6629863|NCT02263079|7558351|FG002|COMPLETED|Overall Study|Completed study but not included in the analysis|3
6629864|NCT02263079|7558349|FG000|NOT COMPLETED|Overall Study||3
6629865|NCT02263079|7558350|FG001|NOT COMPLETED|Overall Study||8
6629866|NCT02263079|7558351|FG002|NOT COMPLETED|Overall Study||0
6629867|NCT02263118|7558363|FG000|STARTED|Overall Study||24
6629868|NCT02263118|7558364|FG001|STARTED|Overall Study||32
6629869|NCT02263118|7558365|FG002|STARTED|Overall Study||30
6629870|NCT02263118|7558366|FG003|STARTED|Overall Study||14
6629871|NCT02263118|7558363|FG000|COMPLETED|Overall Study||20
6629872|NCT02263118|7558364|FG001|COMPLETED|Overall Study||24
6629873|NCT02263118|7558365|FG002|COMPLETED|Overall Study||22
6629874|NCT02263118|7558366|FG003|COMPLETED|Overall Study||12
6629875|NCT02263118|7558363|FG000|NOT COMPLETED|Overall Study||4
6629876|NCT02263118|7558364|FG001|NOT COMPLETED|Overall Study||8
6629877|NCT02263118|7558365|FG002|NOT COMPLETED|Overall Study||8
6629878|NCT02263118|7558366|FG003|NOT COMPLETED|Overall Study||2
6629879|NCT02263131|7558380|FG000|STARTED|Overall Study||347
6629880|NCT02263131|7558381|FG001|STARTED|Overall Study||69
6629881|NCT02263131|7558380|FG000|COMPLETED|Overall Study||337
6629882|NCT02263131|7558381|FG001|COMPLETED|Overall Study||68
6629883|NCT02263131|7558380|FG000|NOT COMPLETED|Overall Study||10
6629884|NCT02263131|7558381|FG001|NOT COMPLETED|Overall Study||1
6629885|NCT02263326|7558389|FG000|STARTED|Overall Study||44
6629886|NCT02263326|7558390|FG001|STARTED|Overall Study||45
6629887|NCT02263326|7558389|FG000|COMPLETED|Overall Study||43
6629888|NCT02263326|7558390|FG001|COMPLETED|Overall Study||44
6629889|NCT02263326|7558389|FG000|NOT COMPLETED|Overall Study||1
6629890|NCT02263326|7558390|FG001|NOT COMPLETED|Overall Study||1
6629891|NCT02263547|7558396|FG000|STARTED|Overall Study||14
6629892|NCT02263547|7558396|FG000|COMPLETED|Overall Study||11
6629893|NCT02263547|7558396|FG000|NOT COMPLETED|Overall Study||3
6629894|NCT02263833|7558400|FG000|STARTED|Overall Study||742
6629895|NCT02263833|7558400|FG000|COMPLETED|Overall Study||742
6629896|NCT02263833|7558400|FG000|NOT COMPLETED|Overall Study||0
6629897|NCT02263911|7558404|FG000|STARTED|Period 1||4
6629898|NCT02263911|7558405|FG001|STARTED|Period 1||4
6629899|NCT02263911|7558406|FG002|STARTED|Period 1||4
6629900|NCT02263911|7558407|FG003|STARTED|Period 1||4
6629901|NCT02263911|7558404|FG000|COMPLETED|Period 1||4
6629902|NCT02263911|7558405|FG001|COMPLETED|Period 1||4
6629903|NCT02263911|7558406|FG002|COMPLETED|Period 1||4
6629904|NCT02263911|7558407|FG003|COMPLETED|Period 1||4
6629905|NCT02263911|7558404|FG000|NOT COMPLETED|Period 1||0
6629906|NCT02263911|7558405|FG001|NOT COMPLETED|Period 1||0
6629907|NCT02263911|7558406|FG002|NOT COMPLETED|Period 1||0
6629908|NCT02263911|7558407|FG003|NOT COMPLETED|Period 1||0
6629909|NCT02263911|7558404|FG000|STARTED|Period 1 Washout||4
6629910|NCT02263911|7558405|FG001|STARTED|Period 1 Washout||4
6629911|NCT02263911|7558406|FG002|STARTED|Period 1 Washout||4
6629912|NCT02263911|7558407|FG003|STARTED|Period 1 Washout||4
6629913|NCT02263911|7558404|FG000|COMPLETED|Period 1 Washout||4
6629914|NCT02263911|7558405|FG001|COMPLETED|Period 1 Washout||4
6629915|NCT02263911|7558406|FG002|COMPLETED|Period 1 Washout||4
6629916|NCT02263911|7558407|FG003|COMPLETED|Period 1 Washout||4
6629917|NCT02263911|7558404|FG000|NOT COMPLETED|Period 1 Washout||0
6629918|NCT02263911|7558405|FG001|NOT COMPLETED|Period 1 Washout||0
6629919|NCT02263911|7558406|FG002|NOT COMPLETED|Period 1 Washout||0
6629920|NCT02263911|7558407|FG003|NOT COMPLETED|Period 1 Washout||0
6629921|NCT02263911|7558404|FG000|STARTED|Period 2||4
6629922|NCT02263911|7558405|FG001|STARTED|Period 2||4
6629923|NCT02263911|7558406|FG002|STARTED|Period 2||4
6629924|NCT02263911|7558407|FG003|STARTED|Period 2||4
6629925|NCT02263911|7558404|FG000|COMPLETED|Period 2||4
6629926|NCT02263911|7558405|FG001|COMPLETED|Period 2||4
6629927|NCT02263911|7558406|FG002|COMPLETED|Period 2||4
6629928|NCT02263911|7558407|FG003|COMPLETED|Period 2||4
6629929|NCT02263911|7558404|FG000|NOT COMPLETED|Period 2||0
6629930|NCT02263911|7558405|FG001|NOT COMPLETED|Period 2||0
6629931|NCT02263911|7558406|FG002|NOT COMPLETED|Period 2||0
6629932|NCT02263911|7558407|FG003|NOT COMPLETED|Period 2||0
6629933|NCT02263911|7558404|FG000|STARTED|Period 2 Washout||4
6629934|NCT02263911|7558405|FG001|STARTED|Period 2 Washout||4
6629935|NCT02263911|7558406|FG002|STARTED|Period 2 Washout||4
6629936|NCT02263911|7558407|FG003|STARTED|Period 2 Washout||4
6629937|NCT02263911|7558404|FG000|COMPLETED|Period 2 Washout||4
6629938|NCT02263911|7558405|FG001|COMPLETED|Period 2 Washout||4
6629939|NCT02263911|7558406|FG002|COMPLETED|Period 2 Washout||4
6629940|NCT02263911|7558407|FG003|COMPLETED|Period 2 Washout||4
6629941|NCT02263911|7558404|FG000|NOT COMPLETED|Period 2 Washout||0
6629942|NCT02263911|7558405|FG001|NOT COMPLETED|Period 2 Washout||0
6629943|NCT02263911|7558406|FG002|NOT COMPLETED|Period 2 Washout||0
6629944|NCT02263911|7558407|FG003|NOT COMPLETED|Period 2 Washout||0
6629945|NCT02263911|7558404|FG000|STARTED|Period 3||4
6629946|NCT02263911|7558405|FG001|STARTED|Period 3||4
6629947|NCT02263911|7558406|FG002|STARTED|Period 3||4
6629948|NCT02263911|7558407|FG003|STARTED|Period 3||4
6629949|NCT02263911|7558404|FG000|COMPLETED|Period 3||4
6629950|NCT02263911|7558405|FG001|COMPLETED|Period 3||4
6629951|NCT02263911|7558406|FG002|COMPLETED|Period 3||4
6629952|NCT02263911|7558407|FG003|COMPLETED|Period 3||4
6629953|NCT02263911|7558404|FG000|NOT COMPLETED|Period 3||0
6629954|NCT02263911|7558405|FG001|NOT COMPLETED|Period 3||0
6629955|NCT02263911|7558406|FG002|NOT COMPLETED|Period 3||0
6629956|NCT02263911|7558407|FG003|NOT COMPLETED|Period 3||0
6629957|NCT02263911|7558404|FG000|STARTED|Period 3 Washout||4
6629958|NCT02263911|7558405|FG001|STARTED|Period 3 Washout||4
6629959|NCT02263911|7558406|FG002|STARTED|Period 3 Washout||4
6629960|NCT02263911|7558407|FG003|STARTED|Period 3 Washout||4
6629961|NCT02263911|7558404|FG000|COMPLETED|Period 3 Washout||4
6629962|NCT02263911|7558405|FG001|COMPLETED|Period 3 Washout||4
6629963|NCT02263911|7558406|FG002|COMPLETED|Period 3 Washout||4
6629964|NCT02263911|7558407|FG003|COMPLETED|Period 3 Washout||4
6629965|NCT02263911|7558404|FG000|NOT COMPLETED|Period 3 Washout||0
6629966|NCT02263911|7558405|FG001|NOT COMPLETED|Period 3 Washout||0
6629967|NCT02263911|7558406|FG002|NOT COMPLETED|Period 3 Washout||0
6629968|NCT02263911|7558407|FG003|NOT COMPLETED|Period 3 Washout||0
6629969|NCT02263911|7558404|FG000|STARTED|Period 4||4
6629970|NCT02263911|7558405|FG001|STARTED|Period 4||4
6629971|NCT02263911|7558406|FG002|STARTED|Period 4||4
6629972|NCT02263911|7558407|FG003|STARTED|Period 4||4
6629973|NCT02263911|7558404|FG000|COMPLETED|Period 4||4
6629974|NCT02263911|7558405|FG001|COMPLETED|Period 4||4
6629975|NCT02263911|7558406|FG002|COMPLETED|Period 4||4
6629976|NCT02263911|7558407|FG003|COMPLETED|Period 4||4
6629977|NCT02263911|7558404|FG000|NOT COMPLETED|Period 4||0
6629978|NCT02263911|7558405|FG001|NOT COMPLETED|Period 4||0
6629979|NCT02263911|7558406|FG002|NOT COMPLETED|Period 4||0
6629980|NCT02263911|7558407|FG003|NOT COMPLETED|Period 4||0
6629981|NCT02263911|7558404|FG000|STARTED|Period 4 Washout||4
6629982|NCT02263911|7558405|FG001|STARTED|Period 4 Washout||4
6629983|NCT02263911|7558406|FG002|STARTED|Period 4 Washout||4
6629984|NCT02263911|7558407|FG003|STARTED|Period 4 Washout||4
6629985|NCT02263911|7558404|FG000|COMPLETED|Period 4 Washout||4
6629986|NCT02263911|7558405|FG001|COMPLETED|Period 4 Washout||4
6629987|NCT02263911|7558406|FG002|COMPLETED|Period 4 Washout||4
6629988|NCT02263911|7558407|FG003|COMPLETED|Period 4 Washout||4
6629989|NCT02263911|7558404|FG000|NOT COMPLETED|Period 4 Washout||0
6629990|NCT02263911|7558405|FG001|NOT COMPLETED|Period 4 Washout||0
6629991|NCT02263911|7558406|FG002|NOT COMPLETED|Period 4 Washout||0
6629992|NCT02263911|7558407|FG003|NOT COMPLETED|Period 4 Washout||0
6629993|NCT02263911|7558404|FG000|STARTED|Period 5||4
6629994|NCT02263911|7558405|FG001|STARTED|Period 5||4
6629995|NCT02263911|7558406|FG002|STARTED|Period 5||4
6629996|NCT02263911|7558407|FG003|STARTED|Period 5||4
6629997|NCT02263911|7558404|FG000|COMPLETED|Period 5||4
6629998|NCT02263911|7558405|FG001|COMPLETED|Period 5||4
6629999|NCT02263911|7558406|FG002|COMPLETED|Period 5||4
6630000|NCT02263911|7558407|FG003|COMPLETED|Period 5||4
6630001|NCT02263911|7558404|FG000|NOT COMPLETED|Period 5||0
6630002|NCT02263911|7558405|FG001|NOT COMPLETED|Period 5||0
6630003|NCT02263911|7558406|FG002|NOT COMPLETED|Period 5||0
6630004|NCT02263911|7558407|FG003|NOT COMPLETED|Period 5||0
6630005|NCT02264249|7558424|FG000|STARTED|Overall Study||21
6630006|NCT02264249|7558425|FG001|STARTED|Overall Study||187
6630007|NCT02264249|7558426|FG002|STARTED|Overall Study||241
6630008|NCT02264249|7558424|FG000|COMPLETED|Overall Study||21
6630009|NCT02264249|7558425|FG001|COMPLETED|Overall Study||187
6630010|NCT02264249|7558426|FG002|COMPLETED|Overall Study||241
6630011|NCT02264249|7558424|FG000|NOT COMPLETED|Overall Study||0
6630012|NCT02264249|7558425|FG001|NOT COMPLETED|Overall Study||0
6630013|NCT02264249|7558426|FG002|NOT COMPLETED|Overall Study||0
6630014|NCT02264353|7558434|FG000|STARTED|Overall Study||20
6630015|NCT02264353|7558435|FG001|STARTED|Overall Study||24
6630016|NCT02264353|7558434|FG000|COMPLETED|Overall Study||17
6630017|NCT02264353|7558435|FG001|COMPLETED|Overall Study||24
6630018|NCT02264353|7558434|FG000|NOT COMPLETED|Overall Study||3
6630019|NCT02264353|7558435|FG001|NOT COMPLETED|Overall Study||0
6742893|NCT03330275|7671253|FG001|COMPLETED|Visits 2, 3 and 4 - Period 2||0
6630020|NCT02264574|7558443|FG000|STARTED|Overall Study||113
6630021|NCT02264574|7558444|FG001|STARTED|Overall Study||116
6630022|NCT02264574|7558443|FG000|COMPLETED|Overall Study||84
6630023|NCT02264574|7558444|FG001|COMPLETED|Overall Study||86
6630024|NCT02264574|7558443|FG000|NOT COMPLETED|Overall Study||29
6630025|NCT02264574|7558444|FG001|NOT COMPLETED|Overall Study||30
6630026|NCT02264639|7558455|FG000|STARTED|Overall Study|Subjects in this arm participated in Cohort 1 only.|2
6630027|NCT02264639|7558456|FG001|STARTED|Overall Study|Subject in this arm participated in Cohort 2 only.|1
6630028|NCT02264639|7558457|FG002|STARTED|Overall Study|Subject in this arm participated in Cohorts 2, 3 and 4.|1
6655513|NCT02453555|7585652|FG001|NOT COMPLETED|24-week Double-blind Treatment Period||7
6630029|NCT02264639|7558458|FG003|STARTED|Overall Study|Subject in this arm participated in Cohorts 3 and 4; single-dose phase was not applicable.|1
6630030|NCT02264639|7558459|FG004|STARTED|Overall Study|Subjects in this arm participated in Cohort 4 only; single-dose phase was not applicable.|4
6630031|NCT02264639|7558455|FG000|COMPLETED|Overall Study||0
6282654|NCT00184600|7182909|FG000|NOT COMPLETED|Overall Study||45
6282655|NCT00184600|7182910|FG001|NOT COMPLETED|Overall Study||51
6282656|NCT00184600|7182911|FG002|NOT COMPLETED|Overall Study||34
6630032|NCT02264639|7558456|FG001|COMPLETED|Overall Study||1
6630033|NCT02264639|7558457|FG002|COMPLETED|Overall Study||0
6630034|NCT02264639|7558458|FG003|COMPLETED|Overall Study||1
6630035|NCT02264639|7558459|FG004|COMPLETED|Overall Study||3
6630036|NCT02264639|7558455|FG000|NOT COMPLETED|Overall Study||2
6630037|NCT02264639|7558456|FG001|NOT COMPLETED|Overall Study||0
6630038|NCT02264639|7558457|FG002|NOT COMPLETED|Overall Study||1
6630039|NCT02264639|7558458|FG003|NOT COMPLETED|Overall Study||0
6630040|NCT02264639|7558459|FG004|NOT COMPLETED|Overall Study||1
6630041|NCT02264821|7558477|FG000|STARTED|Overall Study|Double Blind|64
6630042|NCT02264821|7558478|FG001|STARTED|Overall Study|Double Blind|64
6282657|NCT00184717|7182922|FG000|STARTED|Main Period (GHLIQUID-1516)||39
6282658|NCT00184717|7182923|FG001|STARTED|Main Period (GHLIQUID-1516)||38
6282659|NCT00184717|7182924|FG002|STARTED|Main Period (GHLIQUID-1516)||21
6282660|NCT00184717|7182925|FG003|STARTED|Main Period (GHLIQUID-1516)||0
6282661|NCT00184717|7182926|FG004|STARTED|Main Period (GHLIQUID-1516)||0
6282662|NCT00184717|7182922|FG000|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
6282663|NCT00184717|7182923|FG001|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
6282664|NCT00184717|7182924|FG002|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
6282665|NCT00184717|7182925|FG003|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
6282666|NCT00184717|7182926|FG004|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
6282667|NCT00184717|7182922|FG000|COMPLETED|Main Period (GHLIQUID-1516)||36
6282668|NCT00184717|7182923|FG001|COMPLETED|Main Period (GHLIQUID-1516)||36
6282669|NCT00184717|7182924|FG002|COMPLETED|Main Period (GHLIQUID-1516)||20
6282670|NCT00184717|7182925|FG003|COMPLETED|Main Period (GHLIQUID-1516)||0
6282671|NCT00184717|7182926|FG004|COMPLETED|Main Period (GHLIQUID-1516)||0
6282672|NCT00184717|7182922|FG000|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
6282673|NCT00184717|7182923|FG001|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
6282674|NCT00184717|7182924|FG002|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
6630043|NCT02264821|7558479|FG002|STARTED|Overall Study|Double Blind|64
6630044|NCT02264821|7558477|FG000|COMPLETED|Overall Study||63
6630045|NCT02264821|7558478|FG001|COMPLETED|Overall Study||61
6630046|NCT02264821|7558479|FG002|COMPLETED|Overall Study||58
6630047|NCT02264821|7558477|FG000|NOT COMPLETED|Overall Study||1
6630048|NCT02264821|7558478|FG001|NOT COMPLETED|Overall Study||3
6630049|NCT02264821|7558479|FG002|NOT COMPLETED|Overall Study||6
6630050|NCT02264990|7558489|FG000|STARTED|Overall Study||297
6630051|NCT02264990|7558490|FG001|STARTED|Overall Study||298
6630052|NCT02264990|7558489|FG000|Received Treatment|Overall Study||288
6630053|NCT02264990|7558490|FG001|Received Treatment|Overall Study||293
6630054|NCT02264990|7558489|FG000|Received Maintenance Therapy|Overall Study||148
6630055|NCT02264990|7558490|FG001|Received Maintenance Therapy|Overall Study||123
6630056|NCT02264990|7558489|FG000|COMPLETED|Overall Study||37
6630057|NCT02264990|7558490|FG001|COMPLETED|Overall Study||39
6630058|NCT02264990|7558489|FG000|NOT COMPLETED|Overall Study||260
6630059|NCT02264990|7558490|FG001|NOT COMPLETED|Overall Study||259
6630060|NCT02265224|7558497|FG000|STARTED|Overall Study||48
6630061|NCT02265224|7558497|FG000|COMPLETED|Overall Study||48
6630062|NCT02265224|7558497|FG000|NOT COMPLETED|Overall Study||0
6630063|NCT02265237|7558508|FG000|STARTED|As Enrolled (Overall Study)||59
6630064|NCT02265237|7558509|FG001|STARTED|As Enrolled (Overall Study)||61
6630065|NCT02265237|7558510|FG002|STARTED|As Enrolled (Overall Study)||61
6630066|NCT02265237|7558511|FG003|STARTED|As Enrolled (Overall Study)||3
6630067|NCT02265237|7558508|FG000|COMPLETED|As Enrolled (Overall Study)||54
6630068|NCT02265237|7558509|FG001|COMPLETED|As Enrolled (Overall Study)||58
6630069|NCT02265237|7558510|FG002|COMPLETED|As Enrolled (Overall Study)||51
6630070|NCT02265237|7558511|FG003|COMPLETED|As Enrolled (Overall Study)||2
6630071|NCT02265237|7558508|FG000|NOT COMPLETED|As Enrolled (Overall Study)||5
6630072|NCT02265237|7558509|FG001|NOT COMPLETED|As Enrolled (Overall Study)||3
6630073|NCT02265237|7558510|FG002|NOT COMPLETED|As Enrolled (Overall Study)||10
6630074|NCT02265237|7558511|FG003|NOT COMPLETED|As Enrolled (Overall Study)||1
6630075|NCT02265237|7558508|FG000|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
6630076|NCT02265237|7558509|FG001|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
6630077|NCT02265237|7558510|FG002|STARTED|As Treated (Overall Study)||61
6630078|NCT02265237|7558511|FG003|STARTED|As Treated (Overall Study)||3
6630079|NCT02265237|7558508|FG000|COMPLETED|As Treated (Overall Study)||55
6630080|NCT02265237|7558509|FG001|COMPLETED|As Treated (Overall Study)||57
6630081|NCT02265237|7558510|FG002|COMPLETED|As Treated (Overall Study)||51
6630082|NCT02265237|7558511|FG003|COMPLETED|As Treated (Overall Study)||2
6630083|NCT02265237|7558508|FG000|NOT COMPLETED|As Treated (Overall Study)||5
6630084|NCT02265237|7558509|FG001|NOT COMPLETED|As Treated (Overall Study)||3
6630085|NCT02265237|7558510|FG002|NOT COMPLETED|As Treated (Overall Study)||10
6630086|NCT02265237|7558511|FG003|NOT COMPLETED|As Treated (Overall Study)||1
6630087|NCT02265341|7558522|FG000|STARTED|Overall Study||12
6630088|NCT02265341|7558522|FG000|COMPLETED|Overall Study||12
6630089|NCT02265341|7558522|FG000|NOT COMPLETED|Overall Study||0
6630090|NCT02265510|7558540|FG000|STARTED|Overall Study||3
6630091|NCT02265510|7558541|FG001|STARTED|Overall Study||3
6630092|NCT02265510|7558542|FG002|STARTED|Overall Study||6
6630093|NCT02265510|7558543|FG003|STARTED|Overall Study||4
6630094|NCT02265510|7558544|FG004|STARTED|Overall Study||3
6630095|NCT02265510|7558545|FG005|STARTED|Overall Study||6
6630096|NCT02265510|7558546|FG006|STARTED|Overall Study||3
6630097|NCT02265510|7558547|FG007|STARTED|Overall Study||4
6630098|NCT02265510|7558548|FG008|STARTED|Overall Study||4
6630099|NCT02265510|7558549|FG009|STARTED|Overall Study||7
6630100|NCT02265510|7558550|FG010|STARTED|Overall Study||5
6630101|NCT02265510|7558551|FG011|STARTED|Overall Study||16
6630102|NCT02265510|7558552|FG012|STARTED|Overall Study||9
6630103|NCT02265510|7558553|FG013|STARTED|Overall Study||10
6630104|NCT02265510|7558540|FG000|COMPLETED|Overall Study||0
6630105|NCT02265510|7558541|FG001|COMPLETED|Overall Study||0
6630106|NCT02265510|7558542|FG002|COMPLETED|Overall Study||0
6630107|NCT02265510|7558543|FG003|COMPLETED|Overall Study||0
6630108|NCT02265510|7558544|FG004|COMPLETED|Overall Study||0
6630109|NCT02265510|7558545|FG005|COMPLETED|Overall Study||0
6630110|NCT02265510|7558546|FG006|COMPLETED|Overall Study||0
6630111|NCT02265510|7558547|FG007|COMPLETED|Overall Study||0
6630112|NCT02265510|7558548|FG008|COMPLETED|Overall Study||0
6630113|NCT02265510|7558549|FG009|COMPLETED|Overall Study||0
6630114|NCT02265510|7558550|FG010|COMPLETED|Overall Study||0
6630115|NCT02265510|7558551|FG011|COMPLETED|Overall Study||0
6630116|NCT02265510|7558552|FG012|COMPLETED|Overall Study||0
6630117|NCT02265510|7558553|FG013|COMPLETED|Overall Study||0
6630118|NCT02265510|7558540|FG000|NOT COMPLETED|Overall Study||3
6630119|NCT02265510|7558541|FG001|NOT COMPLETED|Overall Study||3
6630120|NCT02265510|7558542|FG002|NOT COMPLETED|Overall Study||6
6630121|NCT02265510|7558543|FG003|NOT COMPLETED|Overall Study||4
6630122|NCT02265510|7558544|FG004|NOT COMPLETED|Overall Study||3
6630123|NCT02265510|7558545|FG005|NOT COMPLETED|Overall Study||6
6630124|NCT02265510|7558546|FG006|NOT COMPLETED|Overall Study||3
6630125|NCT02265510|7558547|FG007|NOT COMPLETED|Overall Study||4
6630126|NCT02265510|7558548|FG008|NOT COMPLETED|Overall Study||4
6630127|NCT02265510|7558549|FG009|NOT COMPLETED|Overall Study||7
6630128|NCT02265510|7558550|FG010|NOT COMPLETED|Overall Study||5
6630129|NCT02265510|7558551|FG011|NOT COMPLETED|Overall Study||16
6630130|NCT02265510|7558552|FG012|NOT COMPLETED|Overall Study||9
6630131|NCT02265510|7558553|FG013|NOT COMPLETED|Overall Study||10
6630132|NCT02265705|7558611|FG000|STARTED|Treatment Period Week 0-24||145
6630133|NCT02265705|7558612|FG001|STARTED|Treatment Period Week 0-24||145
6630134|NCT02265705|7558613|FG002|STARTED|Treatment Period Week 0-24||0
6630135|NCT02265705|7558614|FG003|STARTED|Treatment Period Week 0-24||0
6630136|NCT02265705|7558615|FG004|STARTED|Treatment Period Week 0-24||0
6630137|NCT02265705|7558616|FG005|STARTED|Treatment Period Week 0-24||0
6630138|NCT02265705|7558617|FG006|STARTED|Treatment Period Week 0-24||0
6630139|NCT02265705|7558611|FG000|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
6630140|NCT02265705|7558612|FG001|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||145
6630141|NCT02265705|7558613|FG002|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6630142|NCT02265705|7558614|FG003|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6630143|NCT02265705|7558615|FG004|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6630144|NCT02265705|7558616|FG005|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6630145|NCT02265705|7558617|FG006|Received at Least One Dose of Study Drug|Treatment Period Week 0-24||0
6282675|NCT00184717|7182925|FG003|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
6630146|NCT02265705|7558611|FG000|Rescued|Treatment Period Week 0-24||59
6630147|NCT02265705|7558612|FG001|Rescued|Treatment Period Week 0-24||17
6630148|NCT02265705|7558613|FG002|Rescued|Treatment Period Week 0-24||0
6630149|NCT02265705|7558614|FG003|Rescued|Treatment Period Week 0-24||0
6630150|NCT02265705|7558615|FG004|Rescued|Treatment Period Week 0-24||0
6630151|NCT02265705|7558616|FG005|Rescued|Treatment Period Week 0-24||0
6630152|NCT02265705|7558617|FG006|Rescued|Treatment Period Week 0-24||0
6630153|NCT02265705|7558611|FG000|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|133
6630154|NCT02265705|7558612|FG001|COMPLETED|Treatment Period Week 0-24|"Completers include rescued participants."|136
6630155|NCT02265705|7558613|FG002|COMPLETED|Treatment Period Week 0-24||0
6630156|NCT02265705|7558614|FG003|COMPLETED|Treatment Period Week 0-24||0
6630157|NCT02265705|7558615|FG004|COMPLETED|Treatment Period Week 0-24||0
6630158|NCT02265705|7558616|FG005|COMPLETED|Treatment Period Week 0-24||0
6630159|NCT02265705|7558617|FG006|COMPLETED|Treatment Period Week 0-24||0
6630160|NCT02265705|7558611|FG000|NOT COMPLETED|Treatment Period Week 0-24||12
6630161|NCT02265705|7558612|FG001|NOT COMPLETED|Treatment Period Week 0-24||9
6630162|NCT02265705|7558613|FG002|NOT COMPLETED|Treatment Period Week 0-24||0
6630163|NCT02265705|7558614|FG003|NOT COMPLETED|Treatment Period Week 0-24||0
6630164|NCT02265705|7558615|FG004|NOT COMPLETED|Treatment Period Week 0-24||0
6630165|NCT02265705|7558616|FG005|NOT COMPLETED|Treatment Period Week 0-24||0
6630166|NCT02265705|7558617|FG006|NOT COMPLETED|Treatment Period Week 0-24||0
6630167|NCT02265705|7558611|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6630168|NCT02265705|7558612|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6630169|NCT02265705|7558613|FG002|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|77
6630170|NCT02265705|7558614|FG003|STARTED|Rescue Period||0
6630171|NCT02265705|7558615|FG004|STARTED|Rescue Period||0
6630172|NCT02265705|7558616|FG005|STARTED|Rescue Period||0
6630173|NCT02265705|7558617|FG006|STARTED|Rescue Period||0
6630174|NCT02265705|7558611|FG000|COMPLETED|Rescue Period||0
6630175|NCT02265705|7558612|FG001|COMPLETED|Rescue Period||0
6630176|NCT02265705|7558613|FG002|COMPLETED|Rescue Period||74
6630177|NCT02265705|7558614|FG003|COMPLETED|Rescue Period||0
6630178|NCT02265705|7558615|FG004|COMPLETED|Rescue Period||0
6630179|NCT02265705|7558616|FG005|COMPLETED|Rescue Period||0
6630180|NCT02265705|7558617|FG006|COMPLETED|Rescue Period||0
6630181|NCT02265705|7558611|FG000|NOT COMPLETED|Rescue Period||0
6630182|NCT02265705|7558612|FG001|NOT COMPLETED|Rescue Period||0
6630183|NCT02265705|7558613|FG002|NOT COMPLETED|Rescue Period||3
6630184|NCT02265705|7558614|FG003|NOT COMPLETED|Rescue Period||0
6630185|NCT02265705|7558615|FG004|NOT COMPLETED|Rescue Period||0
6630186|NCT02265705|7558616|FG005|NOT COMPLETED|Rescue Period||0
6630187|NCT02265705|7558617|FG006|NOT COMPLETED|Rescue Period||0
6630188|NCT02265705|7558611|FG000|STARTED|Open Label Period||0
6630189|NCT02265705|7558612|FG001|STARTED|Open Label Period||0
6630190|NCT02265705|7558613|FG002|STARTED|Open Label Period||0
6630191|NCT02265705|7558614|FG003|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|74
6630192|NCT02265705|7558615|FG004|STARTED|Open Label Period|Completed Wk 24 w/o rescue Tx, switched to or remained on active Tx, and entered Open Label Period.|120
6630193|NCT02265705|7558616|FG005|STARTED|Open Label Period||0
6630194|NCT02265705|7558617|FG006|STARTED|Open Label Period||0
6630195|NCT02265705|7558611|FG000|COMPLETED|Open Label Period||0
6630196|NCT02265705|7558612|FG001|COMPLETED|Open Label Period||0
6630197|NCT02265705|7558613|FG002|COMPLETED|Open Label Period||0
6630198|NCT02265705|7558614|FG003|COMPLETED|Open Label Period||72
6630199|NCT02265705|7558615|FG004|COMPLETED|Open Label Period||115
6630200|NCT02265705|7558616|FG005|COMPLETED|Open Label Period||0
6630201|NCT02265705|7558617|FG006|COMPLETED|Open Label Period||0
6630202|NCT02265705|7558611|FG000|NOT COMPLETED|Open Label Period||0
6630203|NCT02265705|7558612|FG001|NOT COMPLETED|Open Label Period||0
6630204|NCT02265705|7558613|FG002|NOT COMPLETED|Open Label Period||0
6630205|NCT02265705|7558614|FG003|NOT COMPLETED|Open Label Period||2
6630206|NCT02265705|7558615|FG004|NOT COMPLETED|Open Label Period||5
6630207|NCT02265705|7558616|FG005|NOT COMPLETED|Open Label Period||0
6630208|NCT02265705|7558617|FG006|NOT COMPLETED|Open Label Period||0
6630209|NCT02265705|7558611|FG000|STARTED|Follow-up Period||0
6630210|NCT02265705|7558612|FG001|STARTED|Follow-up Period||0
6630211|NCT02265705|7558613|FG002|STARTED|Follow-up Period||0
6630212|NCT02265705|7558614|FG003|STARTED|Follow-up Period||0
6630213|NCT02265705|7558615|FG004|STARTED|Follow-up Period||0
6630214|NCT02265705|7558616|FG005|STARTED|Follow-up Period|Participants from placebo who never rescued or switched and entered post-treatment follow-up period.|2
6630215|NCT02265705|7558617|FG006|STARTED|Follow-up Period|Participants who ever took baricitinib and entered the post-treatment follow-up period.|58
6630216|NCT02265705|7558611|FG000|COMPLETED|Follow-up Period||0
6630217|NCT02265705|7558612|FG001|COMPLETED|Follow-up Period||0
6630218|NCT02265705|7558613|FG002|COMPLETED|Follow-up Period||0
6630219|NCT02265705|7558614|FG003|COMPLETED|Follow-up Period||0
6630220|NCT02265705|7558615|FG004|COMPLETED|Follow-up Period||0
6630221|NCT02265705|7558616|FG005|COMPLETED|Follow-up Period||1
6630222|NCT02265705|7558617|FG006|COMPLETED|Follow-up Period||47
6630223|NCT02265705|7558611|FG000|NOT COMPLETED|Follow-up Period||0
6630224|NCT02265705|7558612|FG001|NOT COMPLETED|Follow-up Period||0
6630225|NCT02265705|7558613|FG002|NOT COMPLETED|Follow-up Period||0
6630226|NCT02265705|7558614|FG003|NOT COMPLETED|Follow-up Period||0
6630227|NCT02265705|7558615|FG004|NOT COMPLETED|Follow-up Period||0
6630228|NCT02265705|7558616|FG005|NOT COMPLETED|Follow-up Period||1
6630229|NCT02265705|7558617|FG006|NOT COMPLETED|Follow-up Period||11
6630230|NCT02265744|7558633|FG000|STARTED|Overall Study||69
6630231|NCT02265744|7558634|FG001|STARTED|Overall Study||68
6630232|NCT02265744|7558635|FG002|STARTED|Overall Study||68
6630233|NCT02265744|7558636|FG003|STARTED|Overall Study||70
6630234|NCT02265744|7558637|FG004|STARTED|Overall Study||71
6630235|NCT02265744|7558633|FG000|COMPLETED|Overall Study||49
6630236|NCT02265744|7558634|FG001|COMPLETED|Overall Study||53
6630237|NCT02265744|7558635|FG002|COMPLETED|Overall Study||51
6630238|NCT02265744|7558636|FG003|COMPLETED|Overall Study||47
6630239|NCT02265744|7558637|FG004|COMPLETED|Overall Study||58
6630240|NCT02265744|7558633|FG000|NOT COMPLETED|Overall Study||20
6630241|NCT02265744|7558634|FG001|NOT COMPLETED|Overall Study||15
6630242|NCT02265744|7558635|FG002|NOT COMPLETED|Overall Study||17
6630243|NCT02265744|7558636|FG003|NOT COMPLETED|Overall Study||23
6630244|NCT02265744|7558637|FG004|NOT COMPLETED|Overall Study||13
6630245|NCT02265783|7558649|FG000|STARTED|Overall Study||20
6630246|NCT02265783|7558649|FG000|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
6630247|NCT02265783|7558649|FG000|NOT COMPLETED|Overall Study||0
6630248|NCT02265796|7558655|FG000|STARTED|Overall Study||25
6630249|NCT02265796|7558656|FG001|STARTED|Overall Study||25
6630250|NCT02265796|7558655|FG000|COMPLETED|Overall Study||22
6630251|NCT02265796|7558656|FG001|COMPLETED|Overall Study||24
6630252|NCT02265796|7558655|FG000|NOT COMPLETED|Overall Study||3
6630253|NCT02265796|7558656|FG001|NOT COMPLETED|Overall Study||1
6630254|NCT02265848|7558664|FG000|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
6630255|NCT02265848|7558665|FG001|STARTED|Overall Study||11
6630256|NCT02265848|7558664|FG000|COMPLETED|Overall Study||11
6630257|NCT02265848|7558665|FG001|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
6630258|NCT02265848|7558664|FG000|NOT COMPLETED|Overall Study||0
6630259|NCT02265848|7558665|FG001|NOT COMPLETED|Overall Study||0
6630260|NCT02265913|7558674|FG000|STARTED|Overall Study||1357
6630261|NCT02265913|7558675|FG001|STARTED|Overall Study||1361
6630262|NCT02265913|7558676|FG002|STARTED|Overall Study||1358
6630263|NCT02265913|7558674|FG000|COMPLETED|Overall Study||793
6630264|NCT02265913|7558675|FG001|COMPLETED|Overall Study||810
6630265|NCT02265913|7558676|FG002|COMPLETED|Overall Study||813
6630266|NCT02265913|7558674|FG000|NOT COMPLETED|Overall Study||564
6630267|NCT02265913|7558675|FG001|NOT COMPLETED|Overall Study||551
6630268|NCT02265913|7558676|FG002|NOT COMPLETED|Overall Study||545
6630269|NCT02265952|7558684|FG000|STARTED|Main Study Period||9
6630270|NCT02265952|7558685|FG001|STARTED|Main Study Period||0
6630271|NCT02265952|7558684|FG000|COMPLETED|Main Study Period||9
6630272|NCT02265952|7558685|FG001|COMPLETED|Main Study Period||0
6630273|NCT02265952|7558684|FG000|NOT COMPLETED|Main Study Period||0
6630274|NCT02265952|7558685|FG001|NOT COMPLETED|Main Study Period||0
6630275|NCT02265952|7558684|FG000|STARTED|Open Label Extension (OLE) Period||0
6630276|NCT02265952|7558685|FG001|STARTED|Open Label Extension (OLE) Period||8
6630277|NCT02265952|7558684|FG000|COMPLETED|Open Label Extension (OLE) Period||0
6630278|NCT02265952|7558685|FG001|COMPLETED|Open Label Extension (OLE) Period||0
6630279|NCT02265952|7558684|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
6630280|NCT02265952|7558685|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||8
6630281|NCT02265965|7558693|FG000|STARTED|Overall Study||7
6630282|NCT02265965|7558694|FG001|STARTED|Overall Study||11
6630283|NCT02265965|7558693|FG000|COMPLETED|Overall Study||7
6630284|NCT02265965|7558694|FG001|COMPLETED|Overall Study||11
6630285|NCT02265965|7558693|FG000|NOT COMPLETED|Overall Study||0
6630286|NCT02265965|7558694|FG001|NOT COMPLETED|Overall Study||0
6630287|NCT02266004|7558700|FG000|STARTED|Overall Study||9
6630288|NCT02266004|7558700|FG000|COMPLETED|Overall Study||7
6630289|NCT02266004|7558700|FG000|NOT COMPLETED|Overall Study||2
6630290|NCT02266108|7558706|FG000|STARTED|Overall Study||80
6630291|NCT02266108|7558707|FG001|STARTED|Overall Study||71
6630292|NCT02266108|7558706|FG000|COMPLETED|Overall Study||80
6630293|NCT02266108|7558707|FG001|COMPLETED|Overall Study||71
6630294|NCT02266108|7558706|FG000|NOT COMPLETED|Overall Study||0
6630295|NCT02266108|7558707|FG001|NOT COMPLETED|Overall Study||0
6630296|NCT02266147|7558717|FG000|STARTED|PART 1: Dose Escalation||3
6630297|NCT02266147|7558718|FG001|STARTED|PART 1: Dose Escalation||3
6630298|NCT02266147|7558719|FG002|STARTED|PART 1: Dose Escalation||3
6630299|NCT02266147|7558720|FG003|STARTED|PART 1: Dose Escalation||4
6630300|NCT02266147|7558717|FG000|COMPLETED|PART 1: Dose Escalation||2
6630301|NCT02266147|7558718|FG001|COMPLETED|PART 1: Dose Escalation||0
6630302|NCT02266147|7558719|FG002|COMPLETED|PART 1: Dose Escalation||0
6630303|NCT02266147|7558720|FG003|COMPLETED|PART 1: Dose Escalation||0
6630304|NCT02266147|7558717|FG000|NOT COMPLETED|PART 1: Dose Escalation||1
6630305|NCT02266147|7558718|FG001|NOT COMPLETED|PART 1: Dose Escalation||3
6630306|NCT02266147|7558719|FG002|NOT COMPLETED|PART 1: Dose Escalation||3
6630307|NCT02266147|7558720|FG003|NOT COMPLETED|PART 1: Dose Escalation||4
6630308|NCT02266147|7558717|FG000|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|7
6630309|NCT02266147|7558718|FG001|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
6630310|NCT02266147|7558719|FG002|STARTED|PART 2: Dose Expansion|No new participants were enrolled and sponsor terminated the trial early during Part 2.|0
6630311|NCT02266147|7558720|FG003|STARTED|PART 2: Dose Expansion|Participants were enrolled separately from Part 1; sponsor terminated the trial early during Part 2.|9
6630312|NCT02266147|7558717|FG000|COMPLETED|PART 2: Dose Expansion||0
6630313|NCT02266147|7558718|FG001|COMPLETED|PART 2: Dose Expansion||0
6630314|NCT02266147|7558719|FG002|COMPLETED|PART 2: Dose Expansion||0
6630315|NCT02266147|7558720|FG003|COMPLETED|PART 2: Dose Expansion||0
6630316|NCT02266147|7558717|FG000|NOT COMPLETED|PART 2: Dose Expansion||7
6630317|NCT02266147|7558718|FG001|NOT COMPLETED|PART 2: Dose Expansion||0
6630318|NCT02266147|7558719|FG002|NOT COMPLETED|PART 2: Dose Expansion||0
6630319|NCT02266147|7558720|FG003|NOT COMPLETED|PART 2: Dose Expansion||9
6630320|NCT02266225|7558732|FG000|STARTED|Overall Study||48
6630321|NCT02266225|7558732|FG000|Enrolled in Intervention|Overall Study||44
6630322|NCT02266225|7558732|FG000|COMPLETED|Overall Study||32
6630323|NCT02266225|7558732|FG000|NOT COMPLETED|Overall Study||16
6655514|NCT02453555|7585653|FG002|NOT COMPLETED|24-week Double-blind Treatment Period||0
6655515|NCT02453555|7585654|FG003|NOT COMPLETED|24-week Double-blind Treatment Period||0
6655516|NCT02453555|7585655|FG004|NOT COMPLETED|24-week Double-blind Treatment Period||0
6655517|NCT02453555|7585656|FG005|NOT COMPLETED|24-week Double-blind Treatment Period||0
6655518|NCT02453555|7585651|FG000|STARTED|Extension Period|This reporting group is not applicable in this period.|0
6655519|NCT02453555|7585652|FG001|STARTED|Extension Period|This reporting group is not applicable in this period.|0
6655520|NCT02453555|7585653|FG002|STARTED|Extension Period||126
6655521|NCT02453555|7585654|FG003|STARTED|Extension Period||51
6655522|NCT02453555|7585655|FG004|STARTED|Extension Period||80
6655523|NCT02453555|7585656|FG005|STARTED|Extension Period||6
6655524|NCT02453555|7585651|FG000|COMPLETED|Extension Period||0
6655525|NCT02453555|7585652|FG001|COMPLETED|Extension Period||0
6655526|NCT02453555|7585653|FG002|COMPLETED|Extension Period||123
6655527|NCT02453555|7585654|FG003|COMPLETED|Extension Period||49
6655528|NCT02453555|7585655|FG004|COMPLETED|Extension Period||79
6655529|NCT02453555|7585656|FG005|COMPLETED|Extension Period||5
6655530|NCT02453555|7585651|FG000|NOT COMPLETED|Extension Period||0
6655531|NCT02453555|7585652|FG001|NOT COMPLETED|Extension Period||0
6655532|NCT02453555|7585653|FG002|NOT COMPLETED|Extension Period||3
6655533|NCT02453555|7585654|FG003|NOT COMPLETED|Extension Period||2
6655534|NCT02453555|7585655|FG004|NOT COMPLETED|Extension Period||1
6655535|NCT02453555|7585656|FG005|NOT COMPLETED|Extension Period||1
6655536|NCT02453581|7585666|FG000|STARTED|Overall Study||8
6655537|NCT02453581|7585667|FG001|STARTED|Overall Study||8
6655538|NCT02453581|7585668|FG002|STARTED|Overall Study||8
6655539|NCT02453581|7585666|FG000|COMPLETED|Overall Study||8
6655540|NCT02453581|7585667|FG001|COMPLETED|Overall Study||8
6655541|NCT02453581|7585668|FG002|COMPLETED|Overall Study||8
6655542|NCT02453581|7585666|FG000|NOT COMPLETED|Overall Study||0
6655543|NCT02453581|7585667|FG001|NOT COMPLETED|Overall Study||0
6655544|NCT02453581|7585668|FG002|NOT COMPLETED|Overall Study||0
6655545|NCT02453672|7585688|FG000|STARTED|Overall Study||40
6655546|NCT02453672|7585689|FG001|STARTED|Overall Study||40
6655547|NCT02453672|7585690|FG002|STARTED|Overall Study||39
6655548|NCT02453672|7585688|FG000|COMPLETED|Overall Study||37
6655549|NCT02453672|7585689|FG001|COMPLETED|Overall Study||38
6655550|NCT02453672|7585690|FG002|COMPLETED|Overall Study||38
6655551|NCT02453672|7585688|FG000|NOT COMPLETED|Overall Study||3
6655552|NCT02453672|7585689|FG001|NOT COMPLETED|Overall Study||2
6655553|NCT02453672|7585690|FG002|NOT COMPLETED|Overall Study||1
6655554|NCT02453685|7585700|FG000|STARTED|Overall Study||168
6655555|NCT02453685|7585701|FG001|STARTED|Overall Study||167
6655556|NCT02453685|7585700|FG000|Exposed|Overall Study||166
6655557|NCT02453685|7585701|FG001|Exposed|Overall Study||166
6655558|NCT02453685|7585700|FG000|COMPLETED|Overall Study||149
6655559|NCT02453685|7585701|FG001|COMPLETED|Overall Study||155
6655560|NCT02453685|7585700|FG000|NOT COMPLETED|Overall Study||19
6655561|NCT02453685|7585701|FG001|NOT COMPLETED|Overall Study||12
6655562|NCT02453711|7585716|FG000|STARTED|Overall Study||103
6655563|NCT02453711|7585717|FG001|STARTED|Overall Study||102
6655564|NCT02453711|7585718|FG002|STARTED|Overall Study||103
6655565|NCT02453711|7585719|FG003|STARTED|Overall Study||103
6655566|NCT02453711|7585720|FG004|STARTED|Overall Study||102
6282676|NCT00184717|7182926|FG004|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
6630324|NCT02266277|7558743|FG000|STARTED|Overall Study||5000
6630325|NCT02266277|7558744|FG001|STARTED|Overall Study||5000
6630326|NCT02266277|7558745|FG002|STARTED|Overall Study||5000
6630327|NCT02266277|7558746|FG003|STARTED|Overall Study||5000
6630328|NCT02266277|7558747|FG004|STARTED|Overall Study||5000
6630329|NCT02266277|7558748|FG005|STARTED|Overall Study||5000
6630330|NCT02266277|7558743|FG000|COMPLETED|Overall Study||5000
6630331|NCT02266277|7558744|FG001|COMPLETED|Overall Study||5000
6630332|NCT02266277|7558745|FG002|COMPLETED|Overall Study||5000
6630333|NCT02266277|7558746|FG003|COMPLETED|Overall Study||5000
6630334|NCT02266277|7558747|FG004|COMPLETED|Overall Study||5000
6630335|NCT02266277|7558748|FG005|COMPLETED|Overall Study||5000
6630336|NCT02266277|7558743|FG000|NOT COMPLETED|Overall Study||0
6630337|NCT02266277|7558744|FG001|NOT COMPLETED|Overall Study||0
6630338|NCT02266277|7558745|FG002|NOT COMPLETED|Overall Study||0
6630339|NCT02266277|7558746|FG003|NOT COMPLETED|Overall Study||0
6630340|NCT02266277|7558747|FG004|NOT COMPLETED|Overall Study||0
6630341|NCT02266277|7558748|FG005|NOT COMPLETED|Overall Study||0
6630342|NCT02266381|7558767|FG000|STARTED|Overall Study||150
6630343|NCT02266381|7558768|FG001|STARTED|Overall Study||150
6630344|NCT02266381|7558769|FG002|STARTED|Overall Study||150
6630345|NCT02266381|7558767|FG000|COMPLETED|Overall Study||147
6630346|NCT02266381|7558768|FG001|COMPLETED|Overall Study||145
6630347|NCT02266381|7558769|FG002|COMPLETED|Overall Study||146
6630348|NCT02266381|7558767|FG000|NOT COMPLETED|Overall Study||3
6630349|NCT02266381|7558768|FG001|NOT COMPLETED|Overall Study||5
6630350|NCT02266381|7558769|FG002|NOT COMPLETED|Overall Study||4
6630351|NCT02266433|7558781|FG000|STARTED|Overall Study||127
6630352|NCT02266433|7558782|FG001|STARTED|Overall Study||118
6630353|NCT02266433|7558781|FG000|COMPLETED|Overall Study||68
6630354|NCT02266433|7558782|FG001|COMPLETED|Overall Study||65
6630355|NCT02266433|7558781|FG000|NOT COMPLETED|Overall Study||59
6630356|NCT02266433|7558782|FG001|NOT COMPLETED|Overall Study||53
6630357|NCT02266472|7558791|FG000|STARTED|Period 1+ Washout||15
6630358|NCT02266472|7558792|FG001|STARTED|Period 1+ Washout||15
6630359|NCT02266472|7558791|FG000|COMPLETED|Period 1+ Washout||15
6630360|NCT02266472|7558792|FG001|COMPLETED|Period 1+ Washout||15
6630361|NCT02266472|7558791|FG000|NOT COMPLETED|Period 1+ Washout||0
6630362|NCT02266472|7558792|FG001|NOT COMPLETED|Period 1+ Washout||0
6630363|NCT02266472|7558791|FG000|STARTED|Period 2+ Washout||15
6630364|NCT02266472|7558792|FG001|STARTED|Period 2+ Washout||15
6630365|NCT02266472|7558791|FG000|COMPLETED|Period 2+ Washout||15
6630366|NCT02266472|7558792|FG001|COMPLETED|Period 2+ Washout||15
6630367|NCT02266472|7558791|FG000|NOT COMPLETED|Period 2+ Washout||0
6630368|NCT02266472|7558792|FG001|NOT COMPLETED|Period 2+ Washout||0
6630369|NCT02266576|7558800|FG000|STARTED|Overall Study||102
6630370|NCT02266576|7558801|FG001|STARTED|Overall Study||105
6630371|NCT02266576|7558800|FG000|COMPLETED|Overall Study||85
6630372|NCT02266576|7558801|FG001|COMPLETED|Overall Study||90
6630373|NCT02266576|7558800|FG000|NOT COMPLETED|Overall Study||17
6630374|NCT02266576|7558801|FG001|NOT COMPLETED|Overall Study||15
6630375|NCT02266706|7558816|FG000|STARTED|Overall Study||6
6630376|NCT02266706|7558817|FG001|STARTED|Overall Study||7
6630377|NCT02266706|7558818|FG002|STARTED|Overall Study||4
6630378|NCT02266706|7558819|FG003|STARTED|Overall Study||4
6630379|NCT02266706|7558820|FG004|STARTED|Overall Study||1
6630380|NCT02266706|7558821|FG005|STARTED|Overall Study||7
6630381|NCT02266706|7558822|FG006|STARTED|Overall Study||8
6630382|NCT02266706|7558823|FG007|STARTED|Overall Study||2
6630383|NCT02266706|7558824|FG008|STARTED|Overall Study||4
6630384|NCT02266706|7558816|FG000|Treated|Overall Study||6
6630385|NCT02266706|7558817|FG001|Treated|Overall Study||6
6630386|NCT02266706|7558818|FG002|Treated|Overall Study||3
6630387|NCT02266706|7558819|FG003|Treated|Overall Study||3
6630388|NCT02266706|7558820|FG004|Treated|Overall Study||1
6630389|NCT02266706|7558821|FG005|Treated|Overall Study||5
6630390|NCT02266706|7558822|FG006|Treated|Overall Study||7
6630391|NCT02266706|7558823|FG007|Treated|Overall Study||2
6630392|NCT02266706|7558824|FG008|Treated|Overall Study||4
6630393|NCT02266706|7558816|FG000|COMPLETED|Overall Study||6
6630394|NCT02266706|7558817|FG001|COMPLETED|Overall Study||6
6630395|NCT02266706|7558818|FG002|COMPLETED|Overall Study||3
6630396|NCT02266706|7558819|FG003|COMPLETED|Overall Study||3
6630397|NCT02266706|7558820|FG004|COMPLETED|Overall Study||1
6630398|NCT02266706|7558821|FG005|COMPLETED|Overall Study||5
6630399|NCT02266706|7558822|FG006|COMPLETED|Overall Study||7
6630400|NCT02266706|7558823|FG007|COMPLETED|Overall Study||2
6630401|NCT02266706|7558824|FG008|COMPLETED|Overall Study||4
6630402|NCT02266706|7558816|FG000|NOT COMPLETED|Overall Study||0
6630403|NCT02266706|7558817|FG001|NOT COMPLETED|Overall Study||1
6630404|NCT02266706|7558818|FG002|NOT COMPLETED|Overall Study||1
6630405|NCT02266706|7558819|FG003|NOT COMPLETED|Overall Study||1
6630406|NCT02266706|7558820|FG004|NOT COMPLETED|Overall Study||0
6630407|NCT02266706|7558821|FG005|NOT COMPLETED|Overall Study||2
6630408|NCT02266706|7558822|FG006|NOT COMPLETED|Overall Study||1
6630409|NCT02266706|7558823|FG007|NOT COMPLETED|Overall Study||0
6630410|NCT02266706|7558824|FG008|NOT COMPLETED|Overall Study||0
6630411|NCT02266810|7558846|FG000|STARTED|Overall Study|sinus sides|80
6630412|NCT02266810|7558847|FG001|STARTED|Overall Study|sinus sides|80
6630413|NCT02266810|7558846|FG000|COMPLETED|Overall Study|sinus sides|79
6630414|NCT02266810|7558847|FG001|COMPLETED|Overall Study|sinus sides|79
6630415|NCT02266810|7558846|FG000|NOT COMPLETED|Overall Study||1
6630416|NCT02266810|7558847|FG001|NOT COMPLETED|Overall Study||1
6630417|NCT02266875|7558864|FG000|STARTED|Overall Study||40
6630418|NCT02266875|7558865|FG001|STARTED|Overall Study||30
6630419|NCT02266875|7558864|FG000|COMPLETED|Overall Study||29
6630420|NCT02266875|7558865|FG001|COMPLETED|Overall Study||30
6630421|NCT02266875|7558864|FG000|NOT COMPLETED|Overall Study||11
6630422|NCT02266875|7558865|FG001|NOT COMPLETED|Overall Study||0
6630423|NCT02266888|7558873|FG000|STARTED|Overall Study||15
6630424|NCT02266888|7558874|FG001|STARTED|Overall Study||12
6630425|NCT02266888|7558875|FG002|STARTED|Overall Study||11
6630426|NCT02266888|7558876|FG003|STARTED|Overall Study||7
6630427|NCT02266888|7558873|FG000|COMPLETED|Overall Study||8
6630428|NCT02266888|7558874|FG001|COMPLETED|Overall Study||8
6630429|NCT02266888|7558875|FG002|COMPLETED|Overall Study||0
6630430|NCT02266888|7558876|FG003|COMPLETED|Overall Study||0
6630431|NCT02266888|7558873|FG000|NOT COMPLETED|Overall Study||7
6630432|NCT02266888|7558874|FG001|NOT COMPLETED|Overall Study||4
6630433|NCT02266888|7558875|FG002|NOT COMPLETED|Overall Study||11
6630434|NCT02266888|7558876|FG003|NOT COMPLETED|Overall Study||7
6630435|NCT02267083|7558884|FG000|STARTED|Overall Study||22
6630436|NCT02267083|7558884|FG000|COMPLETED|Overall Study||3
6630437|NCT02267083|7558884|FG000|NOT COMPLETED|Overall Study||19
6630438|NCT02267135|7558890|FG000|STARTED|Period 1 (Randomized Set)||51
6630439|NCT02267135|7558891|FG001|STARTED|Period 1 (Randomized Set)||51
6630440|NCT02267135|7558890|FG000|COMPLETED|Period 1 (Randomized Set)||50
6630441|NCT02267135|7558891|FG001|COMPLETED|Period 1 (Randomized Set)||47
6630442|NCT02267135|7558890|FG000|NOT COMPLETED|Period 1 (Randomized Set)||1
6630443|NCT02267135|7558891|FG001|NOT COMPLETED|Period 1 (Randomized Set)||4
6630444|NCT02267135|7558890|FG000|STARTED|Period 2 (Randomized Set)||50
6630445|NCT02267135|7558891|FG001|STARTED|Period 2 (Randomized Set)||47
6630446|NCT02267135|7558890|FG000|COMPLETED|Period 2 (Randomized Set)||46
6630447|NCT02267135|7558891|FG001|COMPLETED|Period 2 (Randomized Set)||46
6630448|NCT02267135|7558890|FG000|NOT COMPLETED|Period 2 (Randomized Set)||4
6630449|NCT02267135|7558891|FG001|NOT COMPLETED|Period 2 (Randomized Set)||1
6630450|NCT02267187|7558900|FG000|STARTED|Overall Study||15
6630451|NCT02267187|7558900|FG000|COMPLETED|Overall Study||10
6630452|NCT02267187|7558900|FG000|NOT COMPLETED|Overall Study||5
6630453|NCT02267226|7558904|FG000|STARTED|Overall Study||25
6630454|NCT02267226|7558904|FG000|SAFETY Population|Overall Study||25
6630455|NCT02267226|7558904|FG000|FAS-Bleeding Population|Overall Study||24
6630456|NCT02267226|7558904|FG000|Surgical Prophylaxis Population|Overall Study||9
6630457|NCT02267226|7558904|FG000|COMPLETED|Overall Study||18
6630458|NCT02267226|7558904|FG000|NOT COMPLETED|Overall Study||7
6630459|NCT02267278|7558923|FG000|STARTED|Overall Study||25
6630460|NCT02267278|7558923|FG000|COMPLETED|Overall Study||20
6630461|NCT02267278|7558923|FG000|NOT COMPLETED|Overall Study||5
6630462|NCT02267317|7558930|FG000|STARTED|Infusion1||8
6630463|NCT02267317|7558931|FG001|STARTED|Infusion1||3
6630464|NCT02267317|7558932|FG002|STARTED|Infusion1||1
6630465|NCT02267317|7558933|FG003|STARTED|Infusion1||2
6630466|NCT02267317|7558934|FG004|STARTED|Infusion1||0
6630467|NCT02267317|7558935|FG005|STARTED|Infusion1||1
6630468|NCT02267317|7558930|FG000|COMPLETED|Infusion1||8
6630469|NCT02267317|7558931|FG001|COMPLETED|Infusion1||3
6630470|NCT02267317|7558932|FG002|COMPLETED|Infusion1||1
6630471|NCT02267317|7558933|FG003|COMPLETED|Infusion1||2
6630472|NCT02267317|7558934|FG004|COMPLETED|Infusion1||0
6630473|NCT02267317|7558935|FG005|COMPLETED|Infusion1||1
6630474|NCT02267317|7558930|FG000|NOT COMPLETED|Infusion1||0
6630475|NCT02267317|7558931|FG001|NOT COMPLETED|Infusion1||0
6630476|NCT02267317|7558932|FG002|NOT COMPLETED|Infusion1||0
6630477|NCT02267317|7558933|FG003|NOT COMPLETED|Infusion1||0
6630478|NCT02267317|7558934|FG004|NOT COMPLETED|Infusion1||0
6630479|NCT02267317|7558935|FG005|NOT COMPLETED|Infusion1||0
6630480|NCT02267317|7558930|FG000|STARTED|Washout (3-4weeks Between Infusions)||8
6630481|NCT02267317|7558931|FG001|STARTED|Washout (3-4weeks Between Infusions)||3
6630482|NCT02267317|7558932|FG002|STARTED|Washout (3-4weeks Between Infusions)||1
6630483|NCT02267317|7558933|FG003|STARTED|Washout (3-4weeks Between Infusions)||2
6630484|NCT02267317|7558934|FG004|STARTED|Washout (3-4weeks Between Infusions)||0
6630485|NCT02267317|7558935|FG005|STARTED|Washout (3-4weeks Between Infusions)||1
6630486|NCT02267317|7558930|FG000|COMPLETED|Washout (3-4weeks Between Infusions)||6
6630487|NCT02267317|7558931|FG001|COMPLETED|Washout (3-4weeks Between Infusions)||3
6630488|NCT02267317|7558932|FG002|COMPLETED|Washout (3-4weeks Between Infusions)||1
6630489|NCT02267317|7558933|FG003|COMPLETED|Washout (3-4weeks Between Infusions)||2
6630490|NCT02267317|7558934|FG004|COMPLETED|Washout (3-4weeks Between Infusions)||0
6630491|NCT02267317|7558935|FG005|COMPLETED|Washout (3-4weeks Between Infusions)||1
6630492|NCT02267317|7558930|FG000|NOT COMPLETED|Washout (3-4weeks Between Infusions)||2
6630493|NCT02267317|7558931|FG001|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6630494|NCT02267317|7558932|FG002|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6630495|NCT02267317|7558933|FG003|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6630496|NCT02267317|7558934|FG004|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6630497|NCT02267317|7558935|FG005|NOT COMPLETED|Washout (3-4weeks Between Infusions)||0
6630498|NCT02267317|7558930|FG000|STARTED|Infusion2||6
6630499|NCT02267317|7558931|FG001|STARTED|Infusion2||3
6630500|NCT02267317|7558932|FG002|STARTED|Infusion2||1
6630501|NCT02267317|7558933|FG003|STARTED|Infusion2||2
6630502|NCT02267317|7558934|FG004|STARTED|Infusion2||0
6630503|NCT02267317|7558935|FG005|STARTED|Infusion2||1
6630504|NCT02267317|7558930|FG000|COMPLETED|Infusion2||6
6630505|NCT02267317|7558931|FG001|COMPLETED|Infusion2||3
6630506|NCT02267317|7558932|FG002|COMPLETED|Infusion2||1
6630507|NCT02267317|7558933|FG003|COMPLETED|Infusion2||2
6630508|NCT02267317|7558934|FG004|COMPLETED|Infusion2||0
6630509|NCT02267317|7558935|FG005|COMPLETED|Infusion2||1
6630510|NCT02267317|7558930|FG000|NOT COMPLETED|Infusion2||0
6630511|NCT02267317|7558931|FG001|NOT COMPLETED|Infusion2||0
6630512|NCT02267317|7558932|FG002|NOT COMPLETED|Infusion2||0
6630513|NCT02267317|7558933|FG003|NOT COMPLETED|Infusion2||0
6630514|NCT02267317|7558934|FG004|NOT COMPLETED|Infusion2||0
6630515|NCT02267317|7558935|FG005|NOT COMPLETED|Infusion2||0
6630516|NCT02267356|7558954|FG000|STARTED|Initial Study||53
6630517|NCT02267356|7558955|FG001|STARTED|Initial Study||53
6630518|NCT02267356|7558956|FG002|STARTED|Initial Study||52
6630519|NCT02267356|7558957|FG003|STARTED|Initial Study||54
6630520|NCT02267356|7558958|FG004|STARTED|Initial Study||47
6630521|NCT02267356|7558954|FG000|COMPLETED|Initial Study||47
6630522|NCT02267356|7558955|FG001|COMPLETED|Initial Study||48
6630523|NCT02267356|7558956|FG002|COMPLETED|Initial Study||42
6630524|NCT02267356|7558957|FG003|COMPLETED|Initial Study||43
6630525|NCT02267356|7558958|FG004|COMPLETED|Initial Study||42
6630526|NCT02267356|7558954|FG000|NOT COMPLETED|Initial Study||6
6630527|NCT02267356|7558955|FG001|NOT COMPLETED|Initial Study||5
6630528|NCT02267356|7558956|FG002|NOT COMPLETED|Initial Study||10
6630529|NCT02267356|7558957|FG003|NOT COMPLETED|Initial Study||11
6630530|NCT02267356|7558958|FG004|NOT COMPLETED|Initial Study||5
6630531|NCT02267356|7558954|FG000|STARTED|Study Extension||33
6630532|NCT02267356|7558955|FG001|STARTED|Study Extension||37
6630533|NCT02267356|7558956|FG002|STARTED|Study Extension||30
6630534|NCT02267356|7558957|FG003|STARTED|Study Extension||32
6630535|NCT02267356|7558958|FG004|STARTED|Study Extension||26
6630536|NCT02267356|7558954|FG000|COMPLETED|Study Extension||32
6630537|NCT02267356|7558955|FG001|COMPLETED|Study Extension||37
6630538|NCT02267356|7558956|FG002|COMPLETED|Study Extension||29
6630539|NCT02267356|7558957|FG003|COMPLETED|Study Extension||30
6630540|NCT02267356|7558958|FG004|COMPLETED|Study Extension||26
6630541|NCT02267356|7558954|FG000|NOT COMPLETED|Study Extension||1
6630542|NCT02267356|7558955|FG001|NOT COMPLETED|Study Extension||0
6630543|NCT02267356|7558956|FG002|NOT COMPLETED|Study Extension||1
6630544|NCT02267356|7558957|FG003|NOT COMPLETED|Study Extension||2
6630545|NCT02267356|7558958|FG004|NOT COMPLETED|Study Extension||0
6630546|NCT02267382|7558975|FG000|STARTED|Overall Study||42
6630547|NCT02267382|7558976|FG001|STARTED|Overall Study||43
6630548|NCT02267382|7558977|FG002|STARTED|Overall Study||43
6630549|NCT02267382|7558978|FG003|STARTED|Overall Study||41
6630550|NCT02267382|7558979|FG004|STARTED|Overall Study||46
6630551|NCT02267382|7558975|FG000|COMPLETED|Overall Study||35
6630552|NCT02267382|7558976|FG001|COMPLETED|Overall Study||33
6630553|NCT02267382|7558977|FG002|COMPLETED|Overall Study||34
6630554|NCT02267382|7558978|FG003|COMPLETED|Overall Study||35
6630555|NCT02267382|7558979|FG004|COMPLETED|Overall Study||39
6630556|NCT02267382|7558975|FG000|NOT COMPLETED|Overall Study||7
6630557|NCT02267382|7558976|FG001|NOT COMPLETED|Overall Study||10
6630558|NCT02267382|7558977|FG002|NOT COMPLETED|Overall Study||9
6630559|NCT02267382|7558978|FG003|NOT COMPLETED|Overall Study||6
6630560|NCT02267382|7558979|FG004|NOT COMPLETED|Overall Study||7
6630561|NCT02267447|7558993|FG000|STARTED|Overall Study||77251
6630562|NCT02267447|7558994|FG001|STARTED|Overall Study||26968
6630563|NCT02267447|7558993|FG000|COMPLETED|Overall Study||77251
6630564|NCT02267447|7558994|FG001|COMPLETED|Overall Study||26968
6630565|NCT02267447|7558993|FG000|NOT COMPLETED|Overall Study||0
6630566|NCT02267447|7558994|FG001|NOT COMPLETED|Overall Study||0
6630567|NCT02267538|7559003|FG000|STARTED|Overall Study||142
6630568|NCT02267538|7559004|FG001|STARTED|Overall Study||143
6630569|NCT02267538|7559003|FG000|COMPLETED|Overall Study||142
6630570|NCT02267538|7559004|FG001|COMPLETED|Overall Study||143
6630571|NCT02267538|7559003|FG000|NOT COMPLETED|Overall Study||0
6630572|NCT02267538|7559004|FG001|NOT COMPLETED|Overall Study||0
6630573|NCT02267577|7559010|FG000|STARTED|Overall Study||85
6630574|NCT02267577|7559010|FG000|COMPLETED|Overall Study||81
6630575|NCT02267577|7559010|FG000|NOT COMPLETED|Overall Study||4
6630576|NCT02267629|7559015|FG000|STARTED|Overall Study||7
6630577|NCT02267629|7559015|FG000|COMPLETED|Overall Study||7
6630578|NCT02267629|7559015|FG000|NOT COMPLETED|Overall Study||0
6630579|NCT02267746|7559022|FG000|STARTED|Overall Study||298
6630580|NCT02267746|7559023|FG001|STARTED|Overall Study||296
6630581|NCT02267746|7559024|FG002|STARTED|Overall Study||299
6630582|NCT02267746|7559022|FG000|COMPLETED|Overall Study||277
6630583|NCT02267746|7559023|FG001|COMPLETED|Overall Study||274
6630584|NCT02267746|7559024|FG002|COMPLETED|Overall Study||278
6630585|NCT02267746|7559022|FG000|NOT COMPLETED|Overall Study||21
6630586|NCT02267746|7559023|FG001|NOT COMPLETED|Overall Study||22
6630587|NCT02267746|7559024|FG002|NOT COMPLETED|Overall Study||21
6630588|NCT02267772|7559036|FG000|STARTED|Overall Study||50
6630589|NCT02267772|7559037|FG001|STARTED|Overall Study||52
6630590|NCT02267772|7559036|FG000|Randomized|Overall Study||50
6630591|NCT02267772|7559037|FG001|Randomized|Overall Study||52
6630592|NCT02267772|7559036|FG000|Received Study Drug|Overall Study||48
6630593|NCT02267772|7559037|FG001|Received Study Drug|Overall Study||52
6630594|NCT02267772|7559036|FG000|COMPLETED|Overall Study||48
6630595|NCT02267772|7559037|FG001|COMPLETED|Overall Study||52
6630596|NCT02267772|7559036|FG000|NOT COMPLETED|Overall Study||2
6630597|NCT02267772|7559037|FG001|NOT COMPLETED|Overall Study||0
6630598|NCT02267811|7559045|FG000|STARTED|Overall Study||16
6630599|NCT02267811|7559046|FG001|STARTED|Overall Study||17
6630600|NCT02267811|7559045|FG000|COMPLETED|Overall Study||15
6630601|NCT02267811|7559046|FG001|COMPLETED|Overall Study||15
6630602|NCT02267811|7559045|FG000|NOT COMPLETED|Overall Study||1
6630603|NCT02267811|7559046|FG001|NOT COMPLETED|Overall Study||2
6630604|NCT02267824|7559056|FG000|STARTED|Overall Study||83
6630605|NCT02267824|7559057|FG001|STARTED|Overall Study||18
6630606|NCT02267824|7559056|FG000|COMPLETED|Overall Study||73
6630607|NCT02267824|7559057|FG001|COMPLETED|Overall Study||17
6630608|NCT02267824|7559056|FG000|NOT COMPLETED|Overall Study||10
6630609|NCT02267824|7559057|FG001|NOT COMPLETED|Overall Study||1
6630610|NCT02267837|7559065|FG000|STARTED|Overall Study||11
6630611|NCT02267837|7559066|FG001|STARTED|Overall Study||9
6630612|NCT02267837|7559065|FG000|COMPLETED|Overall Study||11
6630613|NCT02267837|7559066|FG001|COMPLETED|Overall Study||9
6630614|NCT02267837|7559065|FG000|NOT COMPLETED|Overall Study||0
6630615|NCT02267837|7559066|FG001|NOT COMPLETED|Overall Study||0
6630616|NCT02267850|7559074|FG000|STARTED|Overall Study||15
6630617|NCT02267850|7559075|FG001|STARTED|Overall Study||14
6630618|NCT02267850|7559074|FG000|COMPLETED|Overall Study||14
6630619|NCT02267850|7559075|FG001|COMPLETED|Overall Study||12
6630620|NCT02267850|7559074|FG000|NOT COMPLETED|Overall Study||1
6630621|NCT02267850|7559075|FG001|NOT COMPLETED|Overall Study||2
6630622|NCT02268045|7559083|FG000|STARTED|Overall Study||136
6630623|NCT02268045|7559084|FG001|STARTED|Overall Study||136
6630624|NCT02268045|7559083|FG000|COMPLETED|Overall Study||120
6630625|NCT02268045|7559084|FG001|COMPLETED|Overall Study||116
6630626|NCT02268045|7559083|FG000|NOT COMPLETED|Overall Study||16
6630627|NCT02268045|7559084|FG001|NOT COMPLETED|Overall Study||20
6630628|NCT02268058|7559096|FG000|STARTED|Overall Study||20
6630629|NCT02268058|7559097|FG001|STARTED|Overall Study||20
6630630|NCT02268058|7559098|FG002|STARTED|Overall Study||20
6630631|NCT02268058|7559099|FG003|STARTED|Overall Study||20
6630632|NCT02268058|7559096|FG000|COMPLETED|Overall Study||19
6630633|NCT02268058|7559097|FG001|COMPLETED|Overall Study||20
6630634|NCT02268058|7559098|FG002|COMPLETED|Overall Study||20
6630635|NCT02268058|7559099|FG003|COMPLETED|Overall Study||20
6630636|NCT02268058|7559096|FG000|NOT COMPLETED|Overall Study||1
6630637|NCT02268058|7559097|FG001|NOT COMPLETED|Overall Study||0
6630638|NCT02268058|7559098|FG002|NOT COMPLETED|Overall Study||0
6630639|NCT02268058|7559099|FG003|NOT COMPLETED|Overall Study||0
6630640|NCT02268084|7559111|FG000|STARTED|Overall Study||49
6630641|NCT02268084|7559112|FG001|STARTED|Overall Study||47
6630642|NCT02268084|7559111|FG000|COMPLETED|Overall Study||40
6630643|NCT02268084|7559112|FG001|COMPLETED|Overall Study||40
6630644|NCT02268084|7559111|FG000|NOT COMPLETED|Overall Study||9
6630645|NCT02268084|7559112|FG001|NOT COMPLETED|Overall Study||7
6282677|NCT00184717|7182922|FG000|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
6282678|NCT00184717|7182923|FG001|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
6282679|NCT00184717|7182924|FG002|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
6630646|NCT02268214|7559127|FG000|STARTED|Overall Study||277
6630647|NCT02268214|7559128|FG001|STARTED|Overall Study||296
6630648|NCT02268214|7559129|FG002|STARTED|Overall Study||260
6630649|NCT02268214|7559127|FG000|COMPLETED 24 WEEK PERIOD|Overall Study||252
6630650|NCT02268214|7559128|FG001|COMPLETED 24 WEEK PERIOD|Overall Study||273
6630651|NCT02268214|7559129|FG002|COMPLETED 24 WEEK PERIOD|Overall Study||232
6630652|NCT02268214|7559127|FG000|COMPLETED|Overall Study||235
6630653|NCT02268214|7559128|FG001|COMPLETED|Overall Study||255
6630654|NCT02268214|7559129|FG002|COMPLETED|Overall Study||218
6630655|NCT02268214|7559127|FG000|NOT COMPLETED|Overall Study||42
6630656|NCT02268214|7559128|FG001|NOT COMPLETED|Overall Study||41
6630657|NCT02268214|7559129|FG002|NOT COMPLETED|Overall Study||42
6630658|NCT02268396|7559137|FG000|STARTED|Overall Study||138
6630659|NCT02268396|7559137|FG000|COMPLETED|Overall Study||126
6630660|NCT02268396|7559137|FG000|NOT COMPLETED|Overall Study||12
6630661|NCT02268500|7559143|FG000|STARTED|Overall Study||24
6630662|NCT02268500|7559144|FG001|STARTED|Overall Study||24
6630663|NCT02268500|7559143|FG000|COMPLETED|Overall Study||24
6630664|NCT02268500|7559144|FG001|COMPLETED|Overall Study||24
6630665|NCT02268500|7559143|FG000|NOT COMPLETED|Overall Study||0
6630666|NCT02268500|7559144|FG001|NOT COMPLETED|Overall Study||0
6630667|NCT02268526|7559153|FG000|STARTED|Overall Study||6
6630668|NCT02268526|7559154|FG001|STARTED|Overall Study||59
6630669|NCT02268526|7559155|FG002|STARTED|Overall Study||21
6630670|NCT02268526|7559153|FG000|PD Analysis Set (Cohort 2)|Overall Study||0
6630671|NCT02268526|7559154|FG001|PD Analysis Set (Cohort 2)|Overall Study||42
6630672|NCT02268526|7559155|FG002|PD Analysis Set (Cohort 2)|Overall Study||17
6630673|NCT02268526|7559153|FG000|COMPLETED|Overall Study||5
6630674|NCT02268526|7559154|FG001|COMPLETED|Overall Study||38
6630675|NCT02268526|7559155|FG002|COMPLETED|Overall Study||16
6630676|NCT02268526|7559153|FG000|NOT COMPLETED|Overall Study||1
6630677|NCT02268526|7559154|FG001|NOT COMPLETED|Overall Study||21
6630678|NCT02268526|7559155|FG002|NOT COMPLETED|Overall Study||5
6630679|NCT02268786|7559167|FG000|STARTED|Overall Study||330
6630680|NCT02268786|7559168|FG001|STARTED|Overall Study||331
6282680|NCT00184717|7182925|FG003|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
6282681|NCT00184717|7182926|FG004|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
6282682|NCT00184717|7182922|FG000|COMPLETED|Extension Period (GHLIQUID-1517)||23
6282683|NCT00184717|7182923|FG001|COMPLETED|Extension Period (GHLIQUID-1517)||27
6282684|NCT00184717|7182924|FG002|COMPLETED|Extension Period (GHLIQUID-1517)||0
6282685|NCT00184717|7182925|FG003|COMPLETED|Extension Period (GHLIQUID-1517)||7
6282686|NCT00184717|7182926|FG004|COMPLETED|Extension Period (GHLIQUID-1517)||5
6282687|NCT00184717|7182922|FG000|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
6282688|NCT00184717|7182923|FG001|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
6282689|NCT00184717|7182924|FG002|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
6282690|NCT00184717|7182925|FG003|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
6282691|NCT00184717|7182926|FG004|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
6282692|NCT00185211|7182938|FG000|STARTED|Placebo-controlled Study (92012)||292
6282693|NCT00185211|7182939|FG001|STARTED|Placebo-controlled Study (92012)||176
6282694|NCT00185211|7182938|FG000|COMPLETED|Placebo-controlled Study (92012)||271
6282695|NCT00185211|7182939|FG001|COMPLETED|Placebo-controlled Study (92012)||166
6282696|NCT00185211|7182938|FG000|NOT COMPLETED|Placebo-controlled Study (92012)||21
6282697|NCT00185211|7182939|FG001|NOT COMPLETED|Placebo-controlled Study (92012)||10
6282698|NCT00185211|7182938|FG000|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
6282699|NCT00185211|7182939|FG001|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
6282700|NCT00185211|7182938|FG000|COMPLETED|Follow-up Study (91031 - This Study)||235
6282701|NCT00185211|7182939|FG001|COMPLETED|Follow-up Study (91031 - This Study)||123
6282702|NCT00185211|7182938|FG000|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
6282703|NCT00185211|7182939|FG001|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
6282704|NCT00185380|7182949|FG000|STARTED|Overall Study||240
6282705|NCT00185380|7182950|FG001|STARTED|Overall Study||246
6282706|NCT00185380|7182951|FG002|STARTED|Overall Study||256
6282707|NCT00185380|7182949|FG000|Subjects Received Treatment|Overall Study||239
6282708|NCT00185380|7182950|FG001|Subjects Received Treatment|Overall Study||245
6282709|NCT00185380|7182951|FG002|Subjects Received Treatment|Overall Study||254
6282710|NCT00185380|7182949|FG000|COMPLETED|Overall Study||174
6282711|NCT00185380|7182950|FG001|COMPLETED|Overall Study||174
6282712|NCT00185380|7182951|FG002|COMPLETED|Overall Study||182
6282713|NCT00185380|7182949|FG000|NOT COMPLETED|Overall Study||66
6282714|NCT00185380|7182950|FG001|NOT COMPLETED|Overall Study||72
6282715|NCT00185380|7182951|FG002|NOT COMPLETED|Overall Study||74
6282716|NCT00185458|7182959|FG000|STARTED|Contraception Phase||394
6282717|NCT00185458|7182959|FG000|COMPLETED|Contraception Phase||336
6282718|NCT00185458|7182959|FG000|NOT COMPLETED|Contraception Phase||58
6282719|NCT00185458|7182959|FG000|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
6282720|NCT00185458|7182959|FG000|COMPLETED|HRT Phase||141
6282721|NCT00185458|7182959|FG000|NOT COMPLETED|HRT Phase||27
6282722|NCT00185588|7182975|FG000|STARTED|Overall Study||6
6282723|NCT00185588|7182976|FG001|STARTED|Overall Study||4
6282724|NCT00185588|7182977|FG002|STARTED|Overall Study||6
6282725|NCT00185588|7182978|FG003|STARTED|Overall Study||17
6282726|NCT00185588|7182975|FG000|COMPLETED|Overall Study||3
6282727|NCT00185588|7182976|FG001|COMPLETED|Overall Study||2
6282728|NCT00185588|7182977|FG002|COMPLETED|Overall Study||0
6282729|NCT00185588|7182978|FG003|COMPLETED|Overall Study||13
6282730|NCT00185588|7182975|FG000|NOT COMPLETED|Overall Study||3
6282731|NCT00185588|7182976|FG001|NOT COMPLETED|Overall Study||2
6282732|NCT00185588|7182977|FG002|NOT COMPLETED|Overall Study||6
6282733|NCT00185588|7182978|FG003|NOT COMPLETED|Overall Study||4
6282734|NCT00185614|7182988|FG000|STARTED|Autologous HCT (Auto-HCT)||63
6282735|NCT00185614|7182988|FG000|COMPLETED|Autologous HCT (Auto-HCT)||63
6282736|NCT00185614|7182988|FG000|NOT COMPLETED|Autologous HCT (Auto-HCT)||0
6282737|NCT00185614|7182988|FG000|STARTED|Inter-treatment Period|Not all participants who received autologous transplant continued to receive allogeneic transplant.|63
6282738|NCT00185614|7182988|FG000|COMPLETED|Inter-treatment Period||59
6630681|NCT02268786|7559167|FG000|COMPLETED|Overall Study||274
6630682|NCT02268786|7559168|FG001|COMPLETED|Overall Study||313
6630683|NCT02268786|7559167|FG000|NOT COMPLETED|Overall Study||56
6630684|NCT02268786|7559168|FG001|NOT COMPLETED|Overall Study||18
6630685|NCT02268812|7559178|FG000|STARTED|Overall Study||77
6630686|NCT02268812|7559179|FG001|STARTED|Overall Study||72
6630687|NCT02268812|7559180|FG002|STARTED|Overall Study||30
6630688|NCT02268812|7559181|FG003|STARTED|Overall Study||40
6282739|NCT00185614|7182988|FG000|NOT COMPLETED|Inter-treatment Period||4
6282740|NCT00185614|7182988|FG000|STARTED|Allogenic HCT (Allo-HCT)||59
6282741|NCT00185614|7182988|FG000|COMPLETED|Allogenic HCT (Allo-HCT)||59
6282742|NCT00185614|7182988|FG000|NOT COMPLETED|Allogenic HCT (Allo-HCT)||0
6282743|NCT00185640|7182992|FG000|STARTED|Overall Study||303
6282744|NCT00185640|7182992|FG000|Transplanted|Overall Study||296
6282745|NCT00185640|7182992|FG000|90 Days Post-transplant|Overall Study||161
6282746|NCT00185640|7182992|FG000|COMPLETED|Overall Study||158
6282747|NCT00185640|7182992|FG000|NOT COMPLETED|Overall Study||145
6282748|NCT00185679|7182996|FG000|STARTED|Overall Study||13
6282749|NCT00185679|7182996|FG000|COMPLETED|Overall Study||13
6282750|NCT00185679|7182996|FG000|NOT COMPLETED|Overall Study||0
6282751|NCT00185692|7183000|FG000|STARTED|Overall Study||16
6630689|NCT02268812|7559178|FG000|COMPLETED|Overall Study||61
6630690|NCT02268812|7559179|FG001|COMPLETED|Overall Study||40
6630691|NCT02268812|7559180|FG002|COMPLETED|Overall Study||21
6630692|NCT02268812|7559181|FG003|COMPLETED|Overall Study||26
6630693|NCT02268812|7559178|FG000|NOT COMPLETED|Overall Study||16
6630694|NCT02268812|7559179|FG001|NOT COMPLETED|Overall Study||32
6630695|NCT02268812|7559180|FG002|NOT COMPLETED|Overall Study||9
6630696|NCT02268812|7559181|FG003|NOT COMPLETED|Overall Study||14
6630697|NCT02268851|7559197|FG000|STARTED|Overall Study||3
6630698|NCT02268851|7559198|FG001|STARTED|Overall Study||3
6630699|NCT02268851|7559199|FG002|STARTED|Overall Study||4
6630700|NCT02268851|7559200|FG003|STARTED|Overall Study||3
6630701|NCT02268851|7559201|FG004|STARTED|Overall Study||15
6630702|NCT02268851|7559202|FG005|STARTED|Overall Study||15
6630703|NCT02268851|7559197|FG000|COMPLETED|Overall Study||2
6630704|NCT02268851|7559198|FG001|COMPLETED|Overall Study||0
6630705|NCT02268851|7559199|FG002|COMPLETED|Overall Study||3
6630706|NCT02268851|7559200|FG003|COMPLETED|Overall Study||0
6630707|NCT02268851|7559201|FG004|COMPLETED|Overall Study||8
6630708|NCT02268851|7559202|FG005|COMPLETED|Overall Study||4
6630709|NCT02268851|7559197|FG000|NOT COMPLETED|Overall Study||1
6630710|NCT02268851|7559198|FG001|NOT COMPLETED|Overall Study||3
6630711|NCT02268851|7559199|FG002|NOT COMPLETED|Overall Study||1
6630712|NCT02268851|7559200|FG003|NOT COMPLETED|Overall Study||3
6630713|NCT02268851|7559201|FG004|NOT COMPLETED|Overall Study||7
6630714|NCT02268851|7559202|FG005|NOT COMPLETED|Overall Study||11
6630715|NCT02268864|7559219|FG000|STARTED|Overall Study||17
6630716|NCT02268864|7559220|FG001|STARTED|Overall Study||25
6630717|NCT02268864|7559221|FG002|STARTED|Overall Study||64
6630718|NCT02268864|7559219|FG000|COMPLETED|Overall Study||15
6630719|NCT02268864|7559220|FG001|COMPLETED|Overall Study||24
6630720|NCT02268864|7559221|FG002|COMPLETED|Overall Study||64
6630721|NCT02268864|7559219|FG000|NOT COMPLETED|Overall Study||2
6630722|NCT02268864|7559220|FG001|NOT COMPLETED|Overall Study||1
6630723|NCT02268864|7559221|FG002|NOT COMPLETED|Overall Study||0
6630724|NCT02268877|7559233|FG000|STARTED|Overall Study||122
6630725|NCT02268877|7559234|FG001|STARTED|Overall Study|111 patients were randomized to this arm.|111
6630726|NCT02268877|7559233|FG000|COMPLETED|Overall Study||118
6630727|NCT02268877|7559234|FG001|COMPLETED|Overall Study|106 patients received the intervention.|106
6630728|NCT02268877|7559233|FG000|NOT COMPLETED|Overall Study||4
6630729|NCT02268877|7559234|FG001|NOT COMPLETED|Overall Study||5
6630730|NCT02268942|7559240|FG000|STARTED|Overall Study||144
6630731|NCT02268942|7559240|FG000|COMPLETED|Overall Study||144
6630732|NCT02268942|7559240|FG000|NOT COMPLETED|Overall Study||0
6630733|NCT02268955|7559246|FG000|STARTED|Overall Study||11
6630734|NCT02268955|7559247|FG001|STARTED|Overall Study||11
6630735|NCT02268955|7559246|FG000|COMPLETED|Overall Study||9
6630736|NCT02268955|7559247|FG001|COMPLETED|Overall Study||9
6630737|NCT02268955|7559246|FG000|NOT COMPLETED|Overall Study||2
6630738|NCT02268955|7559247|FG001|NOT COMPLETED|Overall Study||2
6630739|NCT02268994|7559255|FG000|STARTED|Overall Study||117
6630740|NCT02268994|7559256|FG001|STARTED|Overall Study||116
6630741|NCT02268994|7559255|FG000|COMPLETED|Overall Study||86
6630742|NCT02268994|7559256|FG001|COMPLETED|Overall Study||81
6630743|NCT02268994|7559255|FG000|NOT COMPLETED|Overall Study||31
6630744|NCT02268994|7559256|FG001|NOT COMPLETED|Overall Study||35
6630745|NCT02269098|7559267|FG000|STARTED|Overall Study||51
6630746|NCT02269098|7559268|FG001|STARTED|Overall Study||50
6630747|NCT02269098|7559267|FG000|COMPLETED|Overall Study||37
6630748|NCT02269098|7559268|FG001|COMPLETED|Overall Study||41
6630749|NCT02269098|7559267|FG000|NOT COMPLETED|Overall Study||14
6630750|NCT02269098|7559268|FG001|NOT COMPLETED|Overall Study||9
6630751|NCT02269124|7559277|FG000|STARTED|Overall Study||21
6630752|NCT02269124|7559278|FG001|STARTED|Overall Study||16
6630753|NCT02269124|7559277|FG000|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||20
6630754|NCT02269124|7559278|FG001|Completed Survey Round 1 (Arm 1, 0 Weeks)|Overall Study||14
6630755|NCT02269124|7559277|FG000|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||17
6630756|NCT02269124|7559278|FG001|Completed Survey Round 2 (Arm 1, 6 Weeks)|Overall Study||13
6630757|NCT02269124|7559277|FG000|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||17
6630758|NCT02269124|7559278|FG001|Completed Survey Round 3 (Arm 1, 12 Weeks)|Overall Study||11
6630759|NCT02269124|7559277|FG000|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||11
6630760|NCT02269124|7559278|FG001|Completed Survey Round 4 (Arm 2, 12 Weeks)|Overall Study||8
6630761|NCT02269124|7559277|FG000|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||16
6630762|NCT02269124|7559278|FG001|Completed Survey Round 5 (Arm 2, 18 Weeks)|Overall Study||10
6630763|NCT02269124|7559277|FG000|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||14
6630764|NCT02269124|7559278|FG001|Completed Survey Round 6 (Arm 2, 24 Weeks)|Overall Study||10
6630765|NCT02269124|7559277|FG000|COMPLETED|Overall Study|One participant from the Conventional Measures Only First arm did not return any surveys, nor did their parent/guardian or teacher, and were deemed lost to follow-up.|20
6630766|NCT02269124|7559278|FG001|COMPLETED|Overall Study|Two participants from the Conventional measures + Hearing Aid First arm withdrew from the study prior to the second arm because they did not wish to stop using the hearing aid.|14
6630767|NCT02269124|7559277|FG000|NOT COMPLETED|Overall Study||1
6630768|NCT02269124|7559278|FG001|NOT COMPLETED|Overall Study||2
6630769|NCT02269163|7559287|FG000|STARTED|Overall Study||50
6630770|NCT02269163|7559288|FG001|STARTED|Overall Study||25
6630771|NCT02269163|7559287|FG000|COMPLETED|Overall Study||47
6630772|NCT02269163|7559288|FG001|COMPLETED|Overall Study||18
6630773|NCT02269163|7559287|FG000|NOT COMPLETED|Overall Study||3
6630774|NCT02269163|7559288|FG001|NOT COMPLETED|Overall Study||7
6630775|NCT02269241|7559296|FG000|STARTED|Overall Study||1552
6630776|NCT02269241|7559296|FG000|COMPLETED|Overall Study||352
6630777|NCT02269241|7559296|FG000|NOT COMPLETED|Overall Study||1200
6630778|NCT02269423|7559305|FG000|STARTED|Overall Study||10
6630779|NCT02269423|7559306|FG001|STARTED|Overall Study||10
6630780|NCT02269423|7559307|FG002|STARTED|Overall Study||10
6630781|NCT02269423|7559308|FG003|STARTED|Overall Study||9
6630782|NCT02269423|7559305|FG000|COMPLETED|Overall Study||10
6630783|NCT02269423|7559306|FG001|COMPLETED|Overall Study||9
6630784|NCT02269423|7559307|FG002|COMPLETED|Overall Study||10
6630785|NCT02269423|7559308|FG003|COMPLETED|Overall Study||8
6630786|NCT02269423|7559305|FG000|NOT COMPLETED|Overall Study||0
6630787|NCT02269423|7559306|FG001|NOT COMPLETED|Overall Study||1
6630788|NCT02269423|7559307|FG002|NOT COMPLETED|Overall Study||0
6630789|NCT02269423|7559308|FG003|NOT COMPLETED|Overall Study||1
6630790|NCT02269475|7559320|FG000|STARTED|Overall Study||868
6282752|NCT00185692|7183000|FG000|COMPLETED|Overall Study||0
6282753|NCT00185692|7183000|FG000|NOT COMPLETED|Overall Study||16
6282754|NCT00185731|7183004|FG000|STARTED|Overall Study||25
6282755|NCT00185731|7183004|FG000|COMPLETED|Overall Study||23
6282756|NCT00185731|7183004|FG000|NOT COMPLETED|Overall Study||2
6282757|NCT00185900|7183012|FG000|STARTED|Overall Study||92
6282758|NCT00185900|7183013|FG001|STARTED|Overall Study||100
6282759|NCT00185900|7183012|FG000|COMPLETED|Overall Study||92
6282760|NCT00185900|7183013|FG001|COMPLETED|Overall Study||100
6282761|NCT00185900|7183012|FG000|NOT COMPLETED|Overall Study||0
6282762|NCT00185900|7183013|FG001|NOT COMPLETED|Overall Study||0
6282763|NCT00185965|7183021|FG000|STARTED|Overall Study||15
6630791|NCT02269475|7559321|FG001|STARTED|Overall Study||433
6282764|NCT00185965|7183022|FG001|STARTED|Overall Study||15
6399016|NCT00878722|7311707|FG005|STARTED|Overall Study||3
6399017|NCT00878722|7311708|FG006|STARTED|Overall Study||6
6399018|NCT00878722|7311709|FG007|STARTED|Overall Study||7
6399019|NCT00878722|7311702|FG000|COMPLETED|Overall Study||0
6399020|NCT00878722|7311703|FG001|COMPLETED|Overall Study||0
6399021|NCT00878722|7311704|FG002|COMPLETED|Overall Study||0
6399022|NCT00878722|7311705|FG003|COMPLETED|Overall Study||0
6399023|NCT00878722|7311706|FG004|COMPLETED|Overall Study||0
6399024|NCT00878722|7311707|FG005|COMPLETED|Overall Study||1
6399025|NCT00878722|7311708|FG006|COMPLETED|Overall Study||0
6399026|NCT00878722|7311709|FG007|COMPLETED|Overall Study||0
6399027|NCT00878722|7311702|FG000|NOT COMPLETED|Overall Study||3
6399028|NCT00878722|7311703|FG001|NOT COMPLETED|Overall Study||3
6399029|NCT00878722|7311704|FG002|NOT COMPLETED|Overall Study||3
6630792|NCT02269475|7559320|FG000|Received IP (Safety Population)|Overall Study||868
6630793|NCT02269475|7559321|FG001|Received IP (Safety Population)|Overall Study||433
6630794|NCT02269475|7559320|FG000|Per Protocol Population|Overall Study||849
6630795|NCT02269475|7559321|FG001|Per Protocol Population|Overall Study||430
6630796|NCT02269475|7559320|FG000|COMPLETED|Overall Study||865
6630797|NCT02269475|7559321|FG001|COMPLETED|Overall Study||432
6630798|NCT02269475|7559320|FG000|NOT COMPLETED|Overall Study||3
6630799|NCT02269475|7559321|FG001|NOT COMPLETED|Overall Study||1
6630800|NCT02269488|7559328|FG000|STARTED|Overall Study||100
6630801|NCT02269488|7559328|FG000|COMPLETED|Overall Study||100
6282765|NCT00185965|7183021|FG000|COMPLETED|Overall Study||15
6399030|NCT00878722|7311705|FG003|NOT COMPLETED|Overall Study||9
6399031|NCT00878722|7311706|FG004|NOT COMPLETED|Overall Study||7
6630802|NCT02269488|7559328|FG000|NOT COMPLETED|Overall Study||0
6630803|NCT02269631|7559334|FG000|STARTED|Overall Study||7
6630804|NCT02269631|7559335|FG001|STARTED|Overall Study||5
6630805|NCT02269631|7559334|FG000|COMPLETED|Overall Study||7
6630806|NCT02269631|7559335|FG001|COMPLETED|Overall Study||5
6630807|NCT02269631|7559334|FG000|NOT COMPLETED|Overall Study||0
6630808|NCT02269631|7559335|FG001|NOT COMPLETED|Overall Study||0
6630809|NCT02269657|7559341|FG000|STARTED|Overall Study||40
6630810|NCT02269657|7559341|FG000|COMPLETED|Overall Study||37
6630811|NCT02269657|7559341|FG000|NOT COMPLETED|Overall Study||3
6630812|NCT02269709|7559347|FG000|STARTED|Time of Enrollment||21
6630813|NCT02269709|7559347|FG000|COMPLETED|Time of Enrollment||18
6630814|NCT02269709|7559347|FG000|NOT COMPLETED|Time of Enrollment||3
6630815|NCT02269709|7559347|FG000|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
6630816|NCT02269709|7559347|FG000|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
6630817|NCT02269709|7559347|FG000|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
6630818|NCT02269709|7559347|FG000|STARTED|Prior to Hospital Discharge||17
6630819|NCT02269709|7559347|FG000|COMPLETED|Prior to Hospital Discharge||17
6630820|NCT02269709|7559347|FG000|NOT COMPLETED|Prior to Hospital Discharge||0
6630821|NCT02269709|7559347|FG000|STARTED|Six Month Follow-up||17
6630822|NCT02269709|7559347|FG000|COMPLETED|Six Month Follow-up||5
6630823|NCT02269709|7559347|FG000|NOT COMPLETED|Six Month Follow-up||12
6630824|NCT02269787|7559354|FG000|STARTED|Overall Study||148
6630825|NCT02269787|7559355|FG001|STARTED|Overall Study||150
6630826|NCT02269787|7559354|FG000|COMPLETED|Overall Study||126
6630827|NCT02269787|7559355|FG001|COMPLETED|Overall Study||140
6630828|NCT02269787|7559354|FG000|NOT COMPLETED|Overall Study||22
6630829|NCT02269787|7559355|FG001|NOT COMPLETED|Overall Study||10
6630830|NCT02269943|7559363|FG000|STARTED|Treatment Period||6
6630831|NCT02269943|7559364|FG001|STARTED|Treatment Period||30
6630832|NCT02269943|7559363|FG000|Investigational Product (IP) Stopped|Treatment Period||6
6630833|NCT02269943|7559364|FG001|Investigational Product (IP) Stopped|Treatment Period||30
6630834|NCT02269943|7559363|FG000|COMPLETED|Treatment Period|Not applicable according to the study design|0
6630835|NCT02269943|7559364|FG001|COMPLETED|Treatment Period|Not applicable according to the study design|0
6630836|NCT02269943|7559363|FG000|NOT COMPLETED|Treatment Period||6
6630837|NCT02269943|7559364|FG001|NOT COMPLETED|Treatment Period||30
6630838|NCT02269943|7559363|FG000|STARTED|Follow-Up Survival Period||5
6630839|NCT02269943|7559364|FG001|STARTED|Follow-Up Survival Period||26
6630840|NCT02269943|7559363|FG000|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
6630841|NCT02269943|7559364|FG001|COMPLETED|Follow-Up Survival Period|Not applicable according to the study design.|0
6630842|NCT02269943|7559363|FG000|NOT COMPLETED|Follow-Up Survival Period||5
6630843|NCT02269943|7559364|FG001|NOT COMPLETED|Follow-Up Survival Period||26
6630844|NCT02270060|7559373|FG000|STARTED|Overall Study||20
6742894|NCT03330275|7671254|FG002|COMPLETED|Visits 2, 3 and 4 - Period 2||0
6630845|NCT02270060|7559374|FG001|STARTED|Overall Study||20
6630846|NCT02270060|7559375|FG002|STARTED|Overall Study||20
6630847|NCT02270060|7559373|FG000|COMPLETED|Overall Study||20
6630848|NCT02270060|7559374|FG001|COMPLETED|Overall Study||20
6630849|NCT02270060|7559375|FG002|COMPLETED|Overall Study||20
6742895|NCT03330275|7671255|FG003|COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742896|NCT03330275|7671256|FG004|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6742897|NCT03330275|7671257|FG005|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6742898|NCT03330275|7671258|FG006|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6742899|NCT03330275|7671259|FG007|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6742900|NCT03330275|7671260|FG008|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6742901|NCT03330275|7671261|FG009|COMPLETED|Visits 2, 3 and 4 - Period 2||4
6742902|NCT03330275|7671252|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742903|NCT03330275|7671253|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742904|NCT03330275|7671254|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742905|NCT03330275|7671255|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742906|NCT03330275|7671256|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742907|NCT03330275|7671257|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742908|NCT03330275|7671258|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742909|NCT03330275|7671259|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742910|NCT03330275|7671260|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742911|NCT03330275|7671261|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 2||0
6742912|NCT03330275|7671252|FG000|STARTED|Visits 2, 3 and 4 - Period 3||0
6742913|NCT03330275|7671253|FG001|STARTED|Visits 2, 3 and 4 - Period 3||0
6742914|NCT03330275|7671254|FG002|STARTED|Visits 2, 3 and 4 - Period 3||0
6742915|NCT03330275|7671255|FG003|STARTED|Visits 2, 3 and 4 - Period 3||0
6742916|NCT03330275|7671256|FG004|STARTED|Visits 2, 3 and 4 - Period 3||4
6742917|NCT03330275|7671257|FG005|STARTED|Visits 2, 3 and 4 - Period 3||4
6742918|NCT03330275|7671258|FG006|STARTED|Visits 2, 3 and 4 - Period 3||4
6742919|NCT03330275|7671259|FG007|STARTED|Visits 2, 3 and 4 - Period 3||4
6282766|NCT00185965|7183022|FG001|COMPLETED|Overall Study||14
6282767|NCT00185965|7183021|FG000|NOT COMPLETED|Overall Study||0
6282768|NCT00185965|7183022|FG001|NOT COMPLETED|Overall Study||1
6282769|NCT00186017|7183030|FG000|STARTED|Overall Study||25
6282770|NCT00186017|7183031|FG001|STARTED|Overall Study||25
6630850|NCT02270060|7559373|FG000|NOT COMPLETED|Overall Study||0
6630851|NCT02270060|7559374|FG001|NOT COMPLETED|Overall Study||0
6630852|NCT02270060|7559375|FG002|NOT COMPLETED|Overall Study||0
6630853|NCT02270242|7559385|FG000|STARTED|Overall Study||3555
6630854|NCT02270242|7559386|FG001|STARTED|Overall Study||3564
6630855|NCT02270242|7559385|FG000|COMPLETED|Overall Study||3496
6630856|NCT02270242|7559386|FG001|COMPLETED|Overall Study||3511
6630857|NCT02270242|7559385|FG000|NOT COMPLETED|Overall Study||59
6630858|NCT02270242|7559386|FG001|NOT COMPLETED|Overall Study||53
6630859|NCT02270255|7559394|FG000|STARTED|Overall Study||22
6630860|NCT02270255|7559395|FG001|STARTED|Overall Study||22
6630861|NCT02270255|7559394|FG000|Complete Data at Discharge PACU|Overall Study||22
6630862|NCT02270255|7559395|FG001|Complete Data at Discharge PACU|Overall Study||22
6630863|NCT02270255|7559394|FG000|Complete Data From Home Survey|Overall Study||21
6630864|NCT02270255|7559395|FG001|Complete Data From Home Survey|Overall Study||22
6630865|NCT02270255|7559394|FG000|COMPLETED|Overall Study||21
6630866|NCT02270255|7559395|FG001|COMPLETED|Overall Study||22
6630867|NCT02270255|7559394|FG000|NOT COMPLETED|Overall Study||1
6630868|NCT02270255|7559395|FG001|NOT COMPLETED|Overall Study||0
6630869|NCT02270515|7559401|FG000|STARTED|Intervention Period 1: 0-6 Months||175
6630870|NCT02270515|7559401|FG000|COMPLETED|Intervention Period 1: 0-6 Months||159
6630871|NCT02270515|7559401|FG000|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
6282771|NCT00186017|7183030|FG000|COMPLETED|Overall Study||23
6630872|NCT02270515|7559401|FG000|STARTED|Intervention Period 2: 6-12 Months||159
6630873|NCT02270515|7559401|FG000|COMPLETED|Intervention Period 2: 6-12 Months||127
6630874|NCT02270515|7559401|FG000|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
6630875|NCT02270515|7559401|FG000|STARTED|Intervention Period 3: 12-18 Months||127
6630876|NCT02270515|7559401|FG000|COMPLETED|Intervention Period 3: 12-18 Months||103
6630877|NCT02270515|7559401|FG000|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
6630878|NCT02270645|7559414|FG000|STARTED|Overall Study||8
6630879|NCT02270645|7559415|FG001|STARTED|Overall Study||4
6630880|NCT02270645|7559414|FG000|COMPLETED|Overall Study||6
6630881|NCT02270645|7559415|FG001|COMPLETED|Overall Study||4
6630882|NCT02270645|7559414|FG000|NOT COMPLETED|Overall Study||2
6630883|NCT02270645|7559415|FG001|NOT COMPLETED|Overall Study||0
6630884|NCT02270671|7559423|FG000|STARTED|Overall Study||64
6630885|NCT02270671|7559424|FG001|STARTED|Overall Study||66
6630886|NCT02270671|7559423|FG000|COMPLETED|Overall Study||59
6630887|NCT02270671|7559424|FG001|COMPLETED|Overall Study||61
6630888|NCT02270671|7559423|FG000|NOT COMPLETED|Overall Study||5
6630889|NCT02270671|7559424|FG001|NOT COMPLETED|Overall Study||5
6630890|NCT02270736|7559433|FG000|STARTED|Main Period (MP) (up to 16 Weeks)||72
6630891|NCT02270736|7559434|FG001|STARTED|Main Period (MP) (up to 16 Weeks)||148
6630892|NCT02270736|7559435|FG002|STARTED|Main Period (MP) (up to 16 Weeks)||36
6630893|NCT02270736|7559436|FG003|STARTED|Main Period (MP) (up to 16 Weeks)||0
6630894|NCT02270736|7559437|FG004|STARTED|Main Period (MP) (up to 16 Weeks)||0
6630895|NCT02270736|7559433|FG000|Treated|Main Period (MP) (up to 16 Weeks)||72
6630896|NCT02270736|7559434|FG001|Treated|Main Period (MP) (up to 16 Weeks)||148
6630897|NCT02270736|7559435|FG002|Treated|Main Period (MP) (up to 16 Weeks)||35
6630898|NCT02270736|7559436|FG003|Treated|Main Period (MP) (up to 16 Weeks)||0
6630899|NCT02270736|7559437|FG004|Treated|Main Period (MP) (up to 16 Weeks)||0
6630900|NCT02270736|7559433|FG000|COMPLETED|Main Period (MP) (up to 16 Weeks)||70
6630901|NCT02270736|7559434|FG001|COMPLETED|Main Period (MP) (up to 16 Weeks)||146
6630902|NCT02270736|7559435|FG002|COMPLETED|Main Period (MP) (up to 16 Weeks)||34
6630903|NCT02270736|7559436|FG003|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
6630904|NCT02270736|7559437|FG004|COMPLETED|Main Period (MP) (up to 16 Weeks)||0
6630905|NCT02270736|7559433|FG000|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
6630906|NCT02270736|7559434|FG001|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
6630907|NCT02270736|7559435|FG002|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||2
6630908|NCT02270736|7559436|FG003|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
6630909|NCT02270736|7559437|FG004|NOT COMPLETED|Main Period (MP) (up to 16 Weeks)||0
6630910|NCT02270736|7559433|FG000|STARTED|OLEX Period (up to 48 Weeks)||0
6630911|NCT02270736|7559434|FG001|STARTED|OLEX Period (up to 48 Weeks)||0
6630912|NCT02270736|7559435|FG002|STARTED|OLEX Period (up to 48 Weeks)||0
6630913|NCT02270736|7559436|FG003|STARTED|OLEX Period (up to 48 Weeks)|2 participants from MP did not enter OLEX due to withdrawal of consent.|214
6630914|NCT02270736|7559437|FG004|STARTED|OLEX Period (up to 48 Weeks)|1 participant from MP did not enter OLEX due to adverse event.|33
6282772|NCT00186017|7183031|FG001|COMPLETED|Overall Study||22
6630915|NCT02270736|7559433|FG000|COMPLETED|OLEX Period (up to 48 Weeks)||0
6630916|NCT02270736|7559434|FG001|COMPLETED|OLEX Period (up to 48 Weeks)||0
6630917|NCT02270736|7559435|FG002|COMPLETED|OLEX Period (up to 48 Weeks)||0
6630918|NCT02270736|7559436|FG003|COMPLETED|OLEX Period (up to 48 Weeks)||189
6282773|NCT00186017|7183030|FG000|NOT COMPLETED|Overall Study||2
6282774|NCT00186017|7183031|FG001|NOT COMPLETED|Overall Study||3
6282775|NCT00186043|7183040|FG000|STARTED|Overall Study||30
6282776|NCT00186043|7183041|FG001|STARTED|Overall Study||25
6282777|NCT00186043|7183040|FG000|COMPLETED|Overall Study||15
6282778|NCT00186043|7183041|FG001|COMPLETED|Overall Study||12
6282779|NCT00186043|7183040|FG000|NOT COMPLETED|Overall Study||15
6282780|NCT00186043|7183041|FG001|NOT COMPLETED|Overall Study||13
6282781|NCT00186056|7183049|FG000|STARTED|Overall Study||14
6282782|NCT00186056|7183050|FG001|STARTED|Overall Study||17
6282783|NCT00186056|7183049|FG000|COMPLETED|Overall Study||12
6282784|NCT00186056|7183050|FG001|COMPLETED|Overall Study||16
6282785|NCT00186056|7183049|FG000|NOT COMPLETED|Overall Study||2
6282786|NCT00186056|7183050|FG001|NOT COMPLETED|Overall Study||1
6282787|NCT00186069|7183058|FG000|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
6282788|NCT00186069|7183059|FG001|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
6282789|NCT00186069|7183058|FG000|COMPLETED|Overall Study||15
6282790|NCT00186069|7183059|FG001|COMPLETED|Overall Study||15
6282791|NCT00186069|7183058|FG000|NOT COMPLETED|Overall Study||0
6282792|NCT00186069|7183059|FG001|NOT COMPLETED|Overall Study||0
6282793|NCT00186121|7183065|FG000|STARTED|Overall Study||35
6282794|NCT00186121|7183065|FG000|COMPLETED|Overall Study||32
6282795|NCT00186121|7183065|FG000|NOT COMPLETED|Overall Study||3
6630919|NCT02270736|7559437|FG004|COMPLETED|OLEX Period (up to 48 Weeks)||33
6282796|NCT00186186|7183069|FG000|STARTED|Overall Study||28
6282797|NCT00186186|7183069|FG000|COMPLETED|Overall Study||20
6282798|NCT00186186|7183069|FG000|NOT COMPLETED|Overall Study||8
6630920|NCT02270736|7559433|FG000|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
6630921|NCT02270736|7559434|FG001|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
6630922|NCT02270736|7559435|FG002|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
6630923|NCT02270736|7559436|FG003|NOT COMPLETED|OLEX Period (up to 48 Weeks)||25
6630924|NCT02270736|7559437|FG004|NOT COMPLETED|OLEX Period (up to 48 Weeks)||0
6282799|NCT00186446|7183074|FG000|STARTED|Overall Study||20
6282800|NCT00186446|7183074|FG000|COMPLETED|Overall Study||11
6282801|NCT00186446|7183074|FG000|NOT COMPLETED|Overall Study||9
6282802|NCT00186485|7183080|FG000|STARTED|Overall Study||28
6282803|NCT00186485|7183080|FG000|COMPLETED|Overall Study||25
6282804|NCT00186485|7183080|FG000|NOT COMPLETED|Overall Study||3
6282805|NCT00186498|7183086|FG000|STARTED|Overall Study||6
6282806|NCT00186498|7183087|FG001|STARTED|Overall Study||5
6282807|NCT00186498|7183086|FG000|COMPLETED|Overall Study||4
6282808|NCT00186498|7183087|FG001|COMPLETED|Overall Study||3
6282809|NCT00186498|7183086|FG000|NOT COMPLETED|Overall Study||2
6282810|NCT00186498|7183087|FG001|NOT COMPLETED|Overall Study||2
6282811|NCT00186537|7183096|FG000|STARTED|Overall Study||19
6282812|NCT00186537|7183097|FG001|STARTED|Overall Study||12
6282813|NCT00186537|7183098|FG002|STARTED|Overall Study||16
6282814|NCT00186537|7183096|FG000|COMPLETED|Overall Study||12
6282815|NCT00186537|7183097|FG001|COMPLETED|Overall Study||12
6282816|NCT00186537|7183098|FG002|COMPLETED|Overall Study||13
6282817|NCT00186537|7183096|FG000|NOT COMPLETED|Overall Study||7
6282818|NCT00186537|7183097|FG001|NOT COMPLETED|Overall Study||0
6282819|NCT00186537|7183098|FG002|NOT COMPLETED|Overall Study||3
6282820|NCT00186628|7183106|FG000|STARTED|Overall Study||36
6630925|NCT02270944|7559452|FG000|STARTED|Overall Study||529
6630926|NCT02270944|7559453|FG001|STARTED|Overall Study||521
6630927|NCT02270944|7559452|FG000|COMPLETED|Overall Study||518
6630928|NCT02270944|7559453|FG001|COMPLETED|Overall Study||516
6630929|NCT02270944|7559452|FG000|NOT COMPLETED|Overall Study||11
6630930|NCT02270944|7559453|FG001|NOT COMPLETED|Overall Study||5
6630931|NCT02270983|7559463|FG000|STARTED|Overall Study||79
6630932|NCT02270983|7559464|FG001|STARTED|Overall Study||87
6630933|NCT02270983|7559465|FG002|STARTED|Overall Study||88
6630934|NCT02270983|7559463|FG000|COMPLETED|Overall Study||70
6630935|NCT02270983|7559464|FG001|COMPLETED|Overall Study||80
6630936|NCT02270983|7559465|FG002|COMPLETED|Overall Study||76
6630937|NCT02270983|7559463|FG000|NOT COMPLETED|Overall Study||9
6630938|NCT02270983|7559464|FG001|NOT COMPLETED|Overall Study||7
6630939|NCT02270983|7559465|FG002|NOT COMPLETED|Overall Study||12
6630940|NCT02271217|7559476|FG000|STARTED|Overall Study||126
6630941|NCT02271217|7559477|FG001|STARTED|Overall Study||126
6630942|NCT02271217|7559478|FG002|STARTED|Overall Study||125
6630943|NCT02271217|7559476|FG000|COMPLETED|Overall Study||115
6630944|NCT02271217|7559477|FG001|COMPLETED|Overall Study||113
6630945|NCT02271217|7559478|FG002|COMPLETED|Overall Study||113
6630946|NCT02271217|7559476|FG000|NOT COMPLETED|Overall Study||11
6630947|NCT02271217|7559477|FG001|NOT COMPLETED|Overall Study||13
6630948|NCT02271217|7559478|FG002|NOT COMPLETED|Overall Study||12
6630949|NCT02271386|7559490|FG000|STARTED|Baseline Period- 8 Months||53
6630950|NCT02271386|7559491|FG001|STARTED|Baseline Period- 8 Months||52
6630951|NCT02271386|7559492|FG002|STARTED|Baseline Period- 8 Months||200
6630952|NCT02271386|7559493|FG003|STARTED|Baseline Period- 8 Months||191
6630953|NCT02271386|7559490|FG000|COMPLETED|Baseline Period- 8 Months||53
6630954|NCT02271386|7559491|FG001|COMPLETED|Baseline Period- 8 Months||52
6630955|NCT02271386|7559492|FG002|COMPLETED|Baseline Period- 8 Months||200
6630956|NCT02271386|7559493|FG003|COMPLETED|Baseline Period- 8 Months||191
6630957|NCT02271386|7559490|FG000|NOT COMPLETED|Baseline Period- 8 Months||0
6630958|NCT02271386|7559491|FG001|NOT COMPLETED|Baseline Period- 8 Months||0
6630959|NCT02271386|7559492|FG002|NOT COMPLETED|Baseline Period- 8 Months||0
6630960|NCT02271386|7559493|FG003|NOT COMPLETED|Baseline Period- 8 Months||0
6630961|NCT02271386|7559490|FG000|STARTED|Intervention Period- 8 Months||53
6630962|NCT02271386|7559491|FG001|STARTED|Intervention Period- 8 Months||52
6630963|NCT02271386|7559492|FG002|STARTED|Intervention Period- 8 Months||202
6630964|NCT02271386|7559493|FG003|STARTED|Intervention Period- 8 Months||197
6282821|NCT00186628|7183106|FG000|COMPLETED|Overall Study||33
6282822|NCT00186628|7183106|FG000|NOT COMPLETED|Overall Study||3
6282823|NCT00186875|7183114|FG000|STARTED|Overall Study||26
6282824|NCT00186875|7183115|FG001|STARTED|Overall Study||14
6282825|NCT00186875|7183114|FG000|COMPLETED|Overall Study||26
6282826|NCT00186875|7183115|FG001|COMPLETED|Overall Study||14
6282827|NCT00186875|7183114|FG000|NOT COMPLETED|Overall Study||0
6282828|NCT00186875|7183115|FG001|NOT COMPLETED|Overall Study||0
6282829|NCT00186901|7183125|FG000|STARTED|Overall Study||134
6282830|NCT00186901|7183126|FG001|STARTED|Overall Study||141
6282831|NCT00186901|7183127|FG002|STARTED|Overall Study||149
6630965|NCT02271386|7559490|FG000|COMPLETED|Intervention Period- 8 Months||53
6630966|NCT02271386|7559491|FG001|COMPLETED|Intervention Period- 8 Months||52
6630967|NCT02271386|7559492|FG002|COMPLETED|Intervention Period- 8 Months||202
6630968|NCT02271386|7559493|FG003|COMPLETED|Intervention Period- 8 Months||197
6282832|NCT00186901|7183125|FG000|Baseline|Overall Study||134
6282833|NCT00186901|7183126|FG001|Baseline|Overall Study||141
6282834|NCT00186901|7183127|FG002|Baseline|Overall Study||0
6282835|NCT00186901|7183125|FG000|12 Month Follow-up|Overall Study||117
6282836|NCT00186901|7183126|FG001|12 Month Follow-up|Overall Study||122
6282837|NCT00186901|7183127|FG002|12 Month Follow-up|Overall Study||0
6282838|NCT00186901|7183125|FG000|24 Month Follow-up|Overall Study||106
6282839|NCT00186901|7183126|FG001|24 Month Follow-up|Overall Study||107
6282840|NCT00186901|7183127|FG002|24 Month Follow-up|Overall Study||0
6282841|NCT00186901|7183125|FG000|COMPLETED|Overall Study||85
6282842|NCT00186901|7183126|FG001|COMPLETED|Overall Study||96
6282843|NCT00186901|7183127|FG002|COMPLETED|Overall Study||0
6282844|NCT00186901|7183125|FG000|NOT COMPLETED|Overall Study||49
6282845|NCT00186901|7183126|FG001|NOT COMPLETED|Overall Study||45
6282846|NCT00186901|7183127|FG002|NOT COMPLETED|Overall Study||149
6282847|NCT00187096|7183167|FG000|STARTED|Overall Study||10
6282848|NCT00187096|7183168|FG001|STARTED|Overall Study||3
6282849|NCT00187096|7183169|FG002|STARTED|Overall Study||12
6282850|NCT00187096|7183167|FG000|COMPLETED|Overall Study||10
6282851|NCT00187096|7183168|FG001|COMPLETED|Overall Study||3
6282852|NCT00187096|7183169|FG002|COMPLETED|Overall Study||11
6282853|NCT00187096|7183167|FG000|NOT COMPLETED|Overall Study||0
6282854|NCT00187096|7183168|FG001|NOT COMPLETED|Overall Study||0
6282855|NCT00187096|7183169|FG002|NOT COMPLETED|Overall Study||1
6282856|NCT00187135|7183183|FG000|STARTED|Visit One||30
6282857|NCT00187135|7183184|FG001|STARTED|Visit One||28
6282858|NCT00187135|7183185|FG002|STARTED|Visit One||25
6282859|NCT00187135|7183186|FG003|STARTED|Visit One||26
6282860|NCT00187135|7183187|FG004|STARTED|Visit One||25
6282861|NCT00187135|7183188|FG005|STARTED|Visit One||28
6282862|NCT00187135|7183183|FG000|COMPLETED|Visit One||26
6282863|NCT00187135|7183184|FG001|COMPLETED|Visit One||27
6282864|NCT00187135|7183185|FG002|COMPLETED|Visit One||25
6282865|NCT00187135|7183186|FG003|COMPLETED|Visit One||26
6282866|NCT00187135|7183187|FG004|COMPLETED|Visit One||25
6282867|NCT00187135|7183188|FG005|COMPLETED|Visit One||26
6282868|NCT00187135|7183183|FG000|NOT COMPLETED|Visit One||4
6282869|NCT00187135|7183184|FG001|NOT COMPLETED|Visit One||1
6282870|NCT00187135|7183185|FG002|NOT COMPLETED|Visit One||0
6282871|NCT00187135|7183186|FG003|NOT COMPLETED|Visit One||0
6282872|NCT00187135|7183187|FG004|NOT COMPLETED|Visit One||0
6282873|NCT00187135|7183188|FG005|NOT COMPLETED|Visit One||2
6282874|NCT00187135|7183183|FG000|STARTED|Visit Two||26
6282875|NCT00187135|7183184|FG001|STARTED|Visit Two||27
6282876|NCT00187135|7183185|FG002|STARTED|Visit Two||25
6282877|NCT00187135|7183186|FG003|STARTED|Visit Two||26
6282878|NCT00187135|7183187|FG004|STARTED|Visit Two||25
6282879|NCT00187135|7183188|FG005|STARTED|Visit Two||26
6282880|NCT00187135|7183183|FG000|COMPLETED|Visit Two||21
6282881|NCT00187135|7183184|FG001|COMPLETED|Visit Two||24
6282882|NCT00187135|7183185|FG002|COMPLETED|Visit Two||23
6282883|NCT00187135|7183186|FG003|COMPLETED|Visit Two||18
6282884|NCT00187135|7183187|FG004|COMPLETED|Visit Two||19
6282885|NCT00187135|7183188|FG005|COMPLETED|Visit Two||18
6282886|NCT00187135|7183183|FG000|NOT COMPLETED|Visit Two||5
6282887|NCT00187135|7183184|FG001|NOT COMPLETED|Visit Two||3
6282888|NCT00187135|7183185|FG002|NOT COMPLETED|Visit Two||2
6282889|NCT00187135|7183186|FG003|NOT COMPLETED|Visit Two||8
6282890|NCT00187135|7183187|FG004|NOT COMPLETED|Visit Two||6
6282891|NCT00187135|7183188|FG005|NOT COMPLETED|Visit Two||8
6282892|NCT00187135|7183183|FG000|STARTED|Visit Three||21
6282893|NCT00187135|7183184|FG001|STARTED|Visit Three||24
6282894|NCT00187135|7183185|FG002|STARTED|Visit Three||23
6282895|NCT00187135|7183186|FG003|STARTED|Visit Three||18
6282896|NCT00187135|7183187|FG004|STARTED|Visit Three||19
6282897|NCT00187135|7183188|FG005|STARTED|Visit Three||18
6282898|NCT00187135|7183183|FG000|COMPLETED|Visit Three||14
6282899|NCT00187135|7183184|FG001|COMPLETED|Visit Three||17
6282900|NCT00187135|7183185|FG002|COMPLETED|Visit Three||14
6282901|NCT00187135|7183186|FG003|COMPLETED|Visit Three||9
6282902|NCT00187135|7183187|FG004|COMPLETED|Visit Three||11
6282903|NCT00187135|7183188|FG005|COMPLETED|Visit Three||12
6282904|NCT00187135|7183183|FG000|NOT COMPLETED|Visit Three||7
6282905|NCT00187135|7183184|FG001|NOT COMPLETED|Visit Three||7
6282906|NCT00187135|7183185|FG002|NOT COMPLETED|Visit Three||9
6282907|NCT00187135|7183186|FG003|NOT COMPLETED|Visit Three||9
6282908|NCT00187135|7183187|FG004|NOT COMPLETED|Visit Three||8
6282909|NCT00187135|7183188|FG005|NOT COMPLETED|Visit Three||6
6282910|NCT00187200|7183202|FG000|STARTED|Overall Study||49
6282911|NCT00187200|7183203|FG001|STARTED|Overall Study||44
6282912|NCT00187200|7183202|FG000|COMPLETED|Overall Study||31
6282913|NCT00187200|7183203|FG001|COMPLETED|Overall Study||26
6282914|NCT00187200|7183202|FG000|NOT COMPLETED|Overall Study||18
6282915|NCT00187200|7183203|FG001|NOT COMPLETED|Overall Study||18
6282916|NCT00187226|7183217|FG000|STARTED|Overall Study||88
6282917|NCT00187226|7183218|FG001|STARTED|Overall Study||49
6282918|NCT00187226|7183219|FG002|STARTED|Overall Study||28
6282919|NCT00187226|7183220|FG003|STARTED|Overall Study||2
6282920|NCT00187226|7183221|FG004|STARTED|Overall Study||34
6282921|NCT00187226|7183222|FG005|STARTED|Overall Study||1
6282922|NCT00187226|7183217|FG000|COMPLETED|Overall Study||88
6282923|NCT00187226|7183218|FG001|COMPLETED|Overall Study||49
6282924|NCT00187226|7183219|FG002|COMPLETED|Overall Study||28
6282925|NCT00187226|7183220|FG003|COMPLETED|Overall Study||2
6282926|NCT00187226|7183221|FG004|COMPLETED|Overall Study||34
6282927|NCT00187226|7183222|FG005|COMPLETED|Overall Study||1
6282928|NCT00187226|7183217|FG000|NOT COMPLETED|Overall Study||0
6282929|NCT00187226|7183218|FG001|NOT COMPLETED|Overall Study||0
6282930|NCT00187226|7183219|FG002|NOT COMPLETED|Overall Study||0
6282931|NCT00187226|7183220|FG003|NOT COMPLETED|Overall Study||0
6282932|NCT00187226|7183221|FG004|NOT COMPLETED|Overall Study||0
6282933|NCT00187226|7183222|FG005|NOT COMPLETED|Overall Study||0
6282934|NCT00187278|7183238|FG000|STARTED|Overall Study||918
6282935|NCT00187278|7183239|FG001|STARTED|Overall Study||915
6282936|NCT00187278|7183238|FG000|COMPLETED|Overall Study||908
6282937|NCT00187278|7183239|FG001|COMPLETED|Overall Study||902
6282938|NCT00187278|7183238|FG000|NOT COMPLETED|Overall Study||10
6282939|NCT00187278|7183239|FG001|NOT COMPLETED|Overall Study||13
6282940|NCT00187369|7183249|FG000|STARTED|Mothers||1398
6282941|NCT00187369|7183250|FG001|STARTED|Mothers||1406
6282942|NCT00187369|7183249|FG000|Included in the Study|Mothers||1393
6282943|NCT00187369|7183250|FG001|Included in the Study|Mothers||1393
6282944|NCT00187369|7183249|FG000|COMPLETED|Mothers||1392
6282945|NCT00187369|7183250|FG001|COMPLETED|Mothers||1392
6282946|NCT00187369|7183249|FG000|NOT COMPLETED|Mothers||6
6282947|NCT00187369|7183250|FG001|NOT COMPLETED|Mothers||14
6399032|NCT00878722|7311707|FG005|NOT COMPLETED|Overall Study||2
6399033|NCT00878722|7311708|FG006|NOT COMPLETED|Overall Study||6
6630969|NCT02271386|7559490|FG000|NOT COMPLETED|Intervention Period- 8 Months||0
6630970|NCT02271386|7559491|FG001|NOT COMPLETED|Intervention Period- 8 Months||0
6630971|NCT02271386|7559492|FG002|NOT COMPLETED|Intervention Period- 8 Months||0
6630972|NCT02271386|7559493|FG003|NOT COMPLETED|Intervention Period- 8 Months||0
6630973|NCT02271425|7559507|FG000|STARTED|Overall Study||8
6630974|NCT02271425|7559507|FG000|COMPLETED|Overall Study||8
6630975|NCT02271425|7559507|FG000|NOT COMPLETED|Overall Study||0
6630976|NCT02271451|7559514|FG000|STARTED|Overall Study||7
6630977|NCT02271451|7559515|FG001|STARTED|Overall Study||8
6399034|NCT00878722|7311709|FG007|NOT COMPLETED|Overall Study||7
6399035|NCT00878800|7311735|FG000|STARTED|Overall Study||3
6399036|NCT00878800|7311736|FG001|STARTED|Overall Study||7
6399037|NCT00878800|7311737|FG002|STARTED|Overall Study||9
6399038|NCT00878800|7311738|FG003|STARTED|Overall Study||6
6399039|NCT00878800|7311739|FG004|STARTED|Overall Study||16
6399040|NCT00878800|7311735|FG000|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
6399041|NCT00878800|7311736|FG001|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
6399042|NCT00878800|7311737|FG002|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
6399043|NCT00878800|7311738|FG003|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
6399044|NCT00878800|7311739|FG004|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
6399045|NCT00878800|7311735|FG000|NOT COMPLETED|Overall Study||3
6399046|NCT00878800|7311736|FG001|NOT COMPLETED|Overall Study||7
6399047|NCT00878800|7311737|FG002|NOT COMPLETED|Overall Study||9
6399048|NCT00878800|7311738|FG003|NOT COMPLETED|Overall Study||6
6399049|NCT00878800|7311739|FG004|NOT COMPLETED|Overall Study||16
6399050|NCT00878826|7311753|FG000|STARTED|Overall Study||3
6399051|NCT00878826|7311754|FG001|STARTED|Overall Study||6
6399052|NCT00878826|7311755|FG002|STARTED|Overall Study||2
6399053|NCT00878826|7311753|FG000|COMPLETED|Overall Study||3
6399054|NCT00878826|7311754|FG001|COMPLETED|Overall Study||6
6399055|NCT00878826|7311755|FG002|COMPLETED|Overall Study||2
6399056|NCT00878826|7311753|FG000|NOT COMPLETED|Overall Study||0
6399057|NCT00878826|7311754|FG001|NOT COMPLETED|Overall Study||0
6399058|NCT00878826|7311755|FG002|NOT COMPLETED|Overall Study||0
6399059|NCT00878878|7311765|FG000|STARTED|Overall Study||15
6399060|NCT00878878|7311766|FG001|STARTED|Overall Study||15
6399061|NCT00878878|7311765|FG000|COMPLETED|Overall Study||15
6399062|NCT00878878|7311766|FG001|COMPLETED|Overall Study||15
6399063|NCT00878878|7311765|FG000|NOT COMPLETED|Overall Study||0
6630978|NCT02271451|7559514|FG000|COMPLETED|Overall Study||7
6630979|NCT02271451|7559515|FG001|COMPLETED|Overall Study|one subject does not have MRI data due to braces|7
6630980|NCT02271451|7559514|FG000|NOT COMPLETED|Overall Study||0
6630981|NCT02271451|7559515|FG001|NOT COMPLETED|Overall Study||1
6630982|NCT02271477|7559523|FG000|STARTED|Overall Study||80
6630983|NCT02271477|7559524|FG001|STARTED|Overall Study||80
6630984|NCT02271477|7559523|FG000|COMPLETED|Overall Study||80
6630985|NCT02271477|7559524|FG001|COMPLETED|Overall Study||80
6630986|NCT02271477|7559523|FG000|NOT COMPLETED|Overall Study||0
6630987|NCT02271477|7559524|FG001|NOT COMPLETED|Overall Study||0
6630988|NCT02271529|7559531|FG000|STARTED|Overall Study||40
6630989|NCT02271529|7559531|FG000|COMPLETED|Overall Study||39
6630990|NCT02271529|7559531|FG000|NOT COMPLETED|Overall Study||1
6630991|NCT02271698|7559539|FG000|STARTED|Overall Study||11
6630992|NCT02271698|7559540|FG001|STARTED|Overall Study||10
6630993|NCT02271698|7559541|FG002|STARTED|Overall Study||10
6630994|NCT02271698|7559542|FG003|STARTED|Overall Study||11
6630995|NCT02271698|7559539|FG000|COMPLETED|Overall Study||11
6630996|NCT02271698|7559540|FG001|COMPLETED|Overall Study||10
6630997|NCT02271698|7559541|FG002|COMPLETED|Overall Study||10
6630998|NCT02271698|7559542|FG003|COMPLETED|Overall Study||11
6630999|NCT02271698|7559539|FG000|NOT COMPLETED|Overall Study||0
6631000|NCT02271698|7559540|FG001|NOT COMPLETED|Overall Study||0
6631001|NCT02271698|7559541|FG002|NOT COMPLETED|Overall Study||0
6631002|NCT02271698|7559542|FG003|NOT COMPLETED|Overall Study||0
6631003|NCT02271854|7559552|FG000|STARTED|Overall Study||102
6399064|NCT00878878|7311766|FG001|NOT COMPLETED|Overall Study||0
6631004|NCT02271854|7559552|FG000|COMPLETED|Overall Study||98
6282948|NCT00187369|7183249|FG000|STARTED|Fetuses or Infants||2795
6282949|NCT00187369|7183250|FG001|STARTED|Fetuses or Infants||2812
6282950|NCT00187369|7183249|FG000|Included in the Study|Fetuses or Infants||2785
6399065|NCT00878995|7311776|FG000|STARTED|Baseline Study - Midpoint Study||12
6399066|NCT00878995|7311777|FG001|STARTED|Baseline Study - Midpoint Study||12
6282951|NCT00187369|7183250|FG001|Included in the Study|Fetuses or Infants||2786
6282952|NCT00187369|7183249|FG000|COMPLETED|Fetuses or Infants||2783
6282953|NCT00187369|7183250|FG001|COMPLETED|Fetuses or Infants||2782
6282954|NCT00187369|7183249|FG000|NOT COMPLETED|Fetuses or Infants||12
6282955|NCT00187369|7183250|FG001|NOT COMPLETED|Fetuses or Infants||30
6282956|NCT00187486|7183262|FG000|STARTED|Overall Study||66
6282957|NCT00187486|7183262|FG000|COMPLETED|Overall Study||65
6282958|NCT00187486|7183262|FG000|NOT COMPLETED|Overall Study||1
6282959|NCT00187655|7183266|FG000|STARTED|Overall Study||24
6282960|NCT00187655|7183266|FG000|COMPLETED|Overall Study||24
6282961|NCT00187655|7183266|FG000|NOT COMPLETED|Overall Study||0
6282962|NCT00187681|7183273|FG000|STARTED|Overall Study||12
6282963|NCT00187681|7183274|FG001|STARTED|Overall Study||8
6282964|NCT00187681|7183273|FG000|COMPLETED|Overall Study||12
6282965|NCT00187681|7183274|FG001|COMPLETED|Overall Study||8
6631005|NCT02271854|7559552|FG000|NOT COMPLETED|Overall Study||4
6631006|NCT02271880|7559559|FG000|STARTED|Overall Study||3
6631007|NCT02271880|7559560|FG001|STARTED|Overall Study||4
6282966|NCT00187681|7183273|FG000|NOT COMPLETED|Overall Study||0
6282967|NCT00187681|7183274|FG001|NOT COMPLETED|Overall Study||0
6282968|NCT00187720|7183284|FG000|STARTED|Overall Study||9
6282969|NCT00187720|7183285|FG001|STARTED|Overall Study||14
6282970|NCT00187720|7183284|FG000|COMPLETED|Overall Study||9
6282971|NCT00187720|7183285|FG001|COMPLETED|Overall Study||14
6282972|NCT00187720|7183284|FG000|NOT COMPLETED|Overall Study||0
6282973|NCT00187720|7183285|FG001|NOT COMPLETED|Overall Study||0
6282974|NCT00187876|7183293|FG000|STARTED|Overall Study||24
6282975|NCT00187876|7183294|FG001|STARTED|Overall Study||43
6282976|NCT00187876|7183293|FG000|COMPLETED|Overall Study||24
6282977|NCT00187876|7183294|FG001|COMPLETED|Overall Study||43
6282978|NCT00187876|7183293|FG000|NOT COMPLETED|Overall Study||0
6282979|NCT00187876|7183294|FG001|NOT COMPLETED|Overall Study||0
6282980|NCT00187889|7183302|FG000|STARTED|Overall Study||25
6282981|NCT00187889|7183303|FG001|STARTED|Overall Study||26
6282982|NCT00187889|7183302|FG000|COMPLETED|Overall Study||19
6282983|NCT00187889|7183303|FG001|COMPLETED|Overall Study||22
6282984|NCT00187889|7183302|FG000|NOT COMPLETED|Overall Study||6
6282985|NCT00187889|7183303|FG001|NOT COMPLETED|Overall Study||4
6282986|NCT00189098|7183312|FG000|STARTED|Overall Study||51
6282987|NCT00189098|7183313|FG001|STARTED|Overall Study||50
6282988|NCT00189098|7183312|FG000|COMPLETED|Overall Study||46
6282989|NCT00189098|7183313|FG001|COMPLETED|Overall Study||44
6282990|NCT00189098|7183312|FG000|NOT COMPLETED|Overall Study||5
6282991|NCT00189098|7183313|FG001|NOT COMPLETED|Overall Study||6
6282992|NCT00189137|7183323|FG000|STARTED|Overall Study||37
6282993|NCT00189137|7183324|FG001|STARTED|Overall Study||43
6282994|NCT00189137|7183323|FG000|COMPLETED|Overall Study||37
6282995|NCT00189137|7183324|FG001|COMPLETED|Overall Study||43
6282996|NCT00189137|7183323|FG000|NOT COMPLETED|Overall Study||0
6282997|NCT00189137|7183324|FG001|NOT COMPLETED|Overall Study||0
6282998|NCT00189202|7183330|FG000|STARTED|Overall Study||49
6631008|NCT02271880|7559559|FG000|COMPLETED|Overall Study||0
6631009|NCT02271880|7559560|FG001|COMPLETED|Overall Study||0
6631010|NCT02271880|7559559|FG000|NOT COMPLETED|Overall Study||3
6631011|NCT02271880|7559560|FG001|NOT COMPLETED|Overall Study||4
6631012|NCT02271906|7559568|FG000|STARTED|Overall Study||2
6631013|NCT02271906|7559568|FG000|COMPLETED|Overall Study||2
6631014|NCT02271906|7559568|FG000|NOT COMPLETED|Overall Study||0
6631015|NCT02271945|7559574|FG000|STARTED|Overall Study||5
6631016|NCT02271945|7559575|FG001|STARTED|Overall Study||5
6282999|NCT00189202|7183330|FG000|COMPLETED|Overall Study||44
6283000|NCT00189202|7183330|FG000|NOT COMPLETED|Overall Study||5
6283001|NCT00189228|7183334|FG000|STARTED|Overall Study||18
6283002|NCT00189228|7183334|FG000|COMPLETED|Overall Study||18
6283003|NCT00189228|7183334|FG000|NOT COMPLETED|Overall Study||0
6283004|NCT00189306|7183338|FG000|STARTED|Treatment Period||169
6283005|NCT00189306|7183338|FG000|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
6283006|NCT00189306|7183338|FG000|NOT COMPLETED|Treatment Period||5
6283007|NCT00189306|7183338|FG000|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
6631017|NCT02271945|7559574|FG000|COMPLETED|Overall Study||0
6631018|NCT02271945|7559575|FG001|COMPLETED|Overall Study||0
6631019|NCT02271945|7559574|FG000|NOT COMPLETED|Overall Study||5
6631020|NCT02271945|7559575|FG001|NOT COMPLETED|Overall Study||5
6631021|NCT02271984|7559581|FG000|STARTED|First Intervention Period (1 Day)||3
6631022|NCT02271984|7559582|FG001|STARTED|First Intervention Period (1 Day)||3
6631023|NCT02271984|7559583|FG002|STARTED|First Intervention Period (1 Day)||3
6631024|NCT02271984|7559584|FG003|STARTED|First Intervention Period (1 Day)||3
6631025|NCT02271984|7559585|FG004|STARTED|First Intervention Period (1 Day)||3
6631026|NCT02271984|7559586|FG005|STARTED|First Intervention Period (1 Day)||3
6631027|NCT02271984|7559587|FG006|STARTED|First Intervention Period (1 Day)||3
6283008|NCT00189306|7183338|FG000|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
6283009|NCT00189306|7183338|FG000|NOT COMPLETED|Posttreatment Period||12
6283010|NCT00189306|7183338|FG000|STARTED|Long-Term Follow-up||157
6283011|NCT00189306|7183338|FG000|COMPLETED|Long-Term Follow-up||119
6283012|NCT00189306|7183338|FG000|NOT COMPLETED|Long-Term Follow-up||38
6283013|NCT00189423|7183344|FG000|STARTED|Overall Study||813
6631028|NCT02271984|7559588|FG007|STARTED|First Intervention Period (1 Day)||3
6631029|NCT02271984|7559589|FG008|STARTED|First Intervention Period (1 Day)||3
6283014|NCT00189423|7183345|FG001|STARTED|Overall Study||840
6283015|NCT00189423|7183344|FG000|COMPLETED|Overall Study||48
6283016|NCT00189423|7183345|FG001|COMPLETED|Overall Study||74
6283017|NCT00189423|7183344|FG000|NOT COMPLETED|Overall Study||765
6283018|NCT00189423|7183345|FG001|NOT COMPLETED|Overall Study||766
6283019|NCT00189436|7183353|FG000|STARTED|Overall Study||31
6283020|NCT00189436|7183354|FG001|STARTED|Overall Study||30
6283021|NCT00189436|7183353|FG000|COMPLETED|Overall Study||23
6283022|NCT00189436|7183354|FG001|COMPLETED|Overall Study||25
6283023|NCT00189436|7183353|FG000|NOT COMPLETED|Overall Study||8
6283024|NCT00189436|7183354|FG001|NOT COMPLETED|Overall Study||5
6283025|NCT00189462|7183362|FG000|STARTED|Overall Study||50
6283026|NCT00189462|7183363|FG001|STARTED|Overall Study||49
6283027|NCT00189462|7183362|FG000|COMPLETED|Overall Study||27
6283028|NCT00189462|7183363|FG001|COMPLETED|Overall Study||28
6283029|NCT00189462|7183362|FG000|NOT COMPLETED|Overall Study||23
6283030|NCT00189462|7183363|FG001|NOT COMPLETED|Overall Study||21
6283031|NCT00189475|7183371|FG000|STARTED|Overall Study||42
6283032|NCT00189475|7183372|FG001|STARTED|Overall Study||42
6283033|NCT00189475|7183371|FG000|COMPLETED|Overall Study||42
6631030|NCT02271984|7559590|FG009|STARTED|First Intervention Period (1 Day)||3
6631031|NCT02271984|7559591|FG010|STARTED|First Intervention Period (1 Day)||3
6631032|NCT02271984|7559592|FG011|STARTED|First Intervention Period (1 Day)||3
6631033|NCT02271984|7559581|FG000|COMPLETED|First Intervention Period (1 Day)||3
6631034|NCT02271984|7559582|FG001|COMPLETED|First Intervention Period (1 Day)||3
6631035|NCT02271984|7559583|FG002|COMPLETED|First Intervention Period (1 Day)||3
6631036|NCT02271984|7559584|FG003|COMPLETED|First Intervention Period (1 Day)||3
6631037|NCT02271984|7559585|FG004|COMPLETED|First Intervention Period (1 Day)||3
6631038|NCT02271984|7559586|FG005|COMPLETED|First Intervention Period (1 Day)||3
6631039|NCT02271984|7559587|FG006|COMPLETED|First Intervention Period (1 Day)||3
6631040|NCT02271984|7559588|FG007|COMPLETED|First Intervention Period (1 Day)||3
6631041|NCT02271984|7559589|FG008|COMPLETED|First Intervention Period (1 Day)||3
6631042|NCT02271984|7559590|FG009|COMPLETED|First Intervention Period (1 Day)||3
6631043|NCT02271984|7559591|FG010|COMPLETED|First Intervention Period (1 Day)||3
6631044|NCT02271984|7559592|FG011|COMPLETED|First Intervention Period (1 Day)||3
6631045|NCT02271984|7559581|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
6631046|NCT02271984|7559582|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
6631047|NCT02271984|7559583|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
6631048|NCT02271984|7559584|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
6631049|NCT02271984|7559585|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
6631050|NCT02271984|7559586|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
6631051|NCT02271984|7559587|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
6631052|NCT02271984|7559588|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
6631053|NCT02271984|7559589|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
6742920|NCT03330275|7671260|FG008|STARTED|Visits 2, 3 and 4 - Period 3||4
6742921|NCT03330275|7671261|FG009|STARTED|Visits 2, 3 and 4 - Period 3||4
6742922|NCT03330275|7671252|FG000|COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742923|NCT03330275|7671253|FG001|COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742924|NCT03330275|7671254|FG002|COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742925|NCT03330275|7671255|FG003|COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742926|NCT03330275|7671256|FG004|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6742927|NCT03330275|7671257|FG005|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6742928|NCT03330275|7671258|FG006|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6742929|NCT03330275|7671259|FG007|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6742930|NCT03330275|7671260|FG008|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6742931|NCT03330275|7671261|FG009|COMPLETED|Visits 2, 3 and 4 - Period 3||4
6742932|NCT03330275|7671252|FG000|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742933|NCT03330275|7671253|FG001|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742934|NCT03330275|7671254|FG002|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742935|NCT03330275|7671255|FG003|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742936|NCT03330275|7671256|FG004|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742937|NCT03330275|7671257|FG005|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742938|NCT03330275|7671258|FG006|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742939|NCT03330275|7671259|FG007|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742940|NCT03330275|7671260|FG008|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742941|NCT03330275|7671261|FG009|NOT COMPLETED|Visits 2, 3 and 4 - Period 3||0
6742942|NCT03330288|7671271|FG000|STARTED|Overall Study|Enrolled|824
6742943|NCT03330288|7671272|FG001|STARTED|Overall Study|Enrolled|278
6742944|NCT03330288|7671271|FG000|COMPLETED|Overall Study||794
6742945|NCT03330288|7671272|FG001|COMPLETED|Overall Study||270
6742946|NCT03330288|7671271|FG000|NOT COMPLETED|Overall Study||30
6742947|NCT03330288|7671272|FG001|NOT COMPLETED|Overall Study||8
6742948|NCT03330457|7671282|FG000|STARTED|Overall Study||6
6742949|NCT03330457|7671283|FG001|STARTED|Overall Study||3
6742950|NCT03330457|7671284|FG002|STARTED|Overall Study||6
6742951|NCT03330457|7671285|FG003|STARTED|Overall Study||3
6742952|NCT03330457|7671282|FG000|COMPLETED|Overall Study||6
6283034|NCT00189475|7183372|FG001|COMPLETED|Overall Study||42
6283035|NCT00189475|7183371|FG000|NOT COMPLETED|Overall Study||0
6283036|NCT00189475|7183372|FG001|NOT COMPLETED|Overall Study||0
6631054|NCT02271984|7559590|FG009|NOT COMPLETED|First Intervention Period (1 Day)||0
6631055|NCT02271984|7559591|FG010|NOT COMPLETED|First Intervention Period (1 Day)||0
6283037|NCT00189488|7183380|FG000|STARTED|Overall Study||78
6283038|NCT00189488|7183381|FG001|STARTED|Overall Study||77
6283039|NCT00189488|7183380|FG000|Received Palifermin/Placebo|Overall Study||75
6283040|NCT00189488|7183381|FG001|Received Palifermin/Placebo|Overall Study||76
6283041|NCT00189488|7183380|FG000|COMPLETED|Overall Study||63
6283042|NCT00189488|7183381|FG001|COMPLETED|Overall Study||55
6283043|NCT00189488|7183380|FG000|NOT COMPLETED|Overall Study||15
6283044|NCT00189488|7183381|FG001|NOT COMPLETED|Overall Study||22
6283045|NCT00189540|7183390|FG000|STARTED|Overall Study||21
6283046|NCT00189540|7183391|FG001|STARTED|Overall Study||6
6631056|NCT02271984|7559592|FG011|NOT COMPLETED|First Intervention Period (1 Day)||0
6631057|NCT02271984|7559581|FG000|STARTED|Washout Period 1 (7 Days)||3
6631058|NCT02271984|7559582|FG001|STARTED|Washout Period 1 (7 Days)||3
6631059|NCT02271984|7559583|FG002|STARTED|Washout Period 1 (7 Days)||3
6631060|NCT02271984|7559584|FG003|STARTED|Washout Period 1 (7 Days)||3
6631061|NCT02271984|7559585|FG004|STARTED|Washout Period 1 (7 Days)||3
6631062|NCT02271984|7559586|FG005|STARTED|Washout Period 1 (7 Days)||3
6631063|NCT02271984|7559587|FG006|STARTED|Washout Period 1 (7 Days)||3
6631064|NCT02271984|7559588|FG007|STARTED|Washout Period 1 (7 Days)||3
6631065|NCT02271984|7559589|FG008|STARTED|Washout Period 1 (7 Days)||3
6631066|NCT02271984|7559590|FG009|STARTED|Washout Period 1 (7 Days)||3
6631067|NCT02271984|7559591|FG010|STARTED|Washout Period 1 (7 Days)||3
6631068|NCT02271984|7559592|FG011|STARTED|Washout Period 1 (7 Days)||3
6631069|NCT02271984|7559581|FG000|COMPLETED|Washout Period 1 (7 Days)||3
6631070|NCT02271984|7559582|FG001|COMPLETED|Washout Period 1 (7 Days)||3
6631071|NCT02271984|7559583|FG002|COMPLETED|Washout Period 1 (7 Days)||3
6631072|NCT02271984|7559584|FG003|COMPLETED|Washout Period 1 (7 Days)||3
6631073|NCT02271984|7559585|FG004|COMPLETED|Washout Period 1 (7 Days)||3
6631074|NCT02271984|7559586|FG005|COMPLETED|Washout Period 1 (7 Days)||3
6631075|NCT02271984|7559587|FG006|COMPLETED|Washout Period 1 (7 Days)||3
6631076|NCT02271984|7559588|FG007|COMPLETED|Washout Period 1 (7 Days)||3
6631077|NCT02271984|7559589|FG008|COMPLETED|Washout Period 1 (7 Days)||3
6631078|NCT02271984|7559590|FG009|COMPLETED|Washout Period 1 (7 Days)||3
6631079|NCT02271984|7559591|FG010|COMPLETED|Washout Period 1 (7 Days)||3
6631080|NCT02271984|7559592|FG011|COMPLETED|Washout Period 1 (7 Days)||3
6631081|NCT02271984|7559581|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631082|NCT02271984|7559582|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631083|NCT02271984|7559583|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631084|NCT02271984|7559584|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631085|NCT02271984|7559585|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631086|NCT02271984|7559586|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631087|NCT02271984|7559587|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631088|NCT02271984|7559588|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631089|NCT02271984|7559589|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631090|NCT02271984|7559590|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631091|NCT02271984|7559591|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631092|NCT02271984|7559592|FG011|NOT COMPLETED|Washout Period 1 (7 Days)||0
6631093|NCT02271984|7559581|FG000|STARTED|Second Intervention Period (1 Day)||3
6631094|NCT02271984|7559582|FG001|STARTED|Second Intervention Period (1 Day)||3
6631095|NCT02271984|7559583|FG002|STARTED|Second Intervention Period (1 Day)||3
6631096|NCT02271984|7559584|FG003|STARTED|Second Intervention Period (1 Day)||3
6631097|NCT02271984|7559585|FG004|STARTED|Second Intervention Period (1 Day)||3
6631098|NCT02271984|7559586|FG005|STARTED|Second Intervention Period (1 Day)||3
6631099|NCT02271984|7559587|FG006|STARTED|Second Intervention Period (1 Day)||3
6631100|NCT02271984|7559588|FG007|STARTED|Second Intervention Period (1 Day)||3
6631101|NCT02271984|7559589|FG008|STARTED|Second Intervention Period (1 Day)||3
6631102|NCT02271984|7559590|FG009|STARTED|Second Intervention Period (1 Day)||3
6631103|NCT02271984|7559591|FG010|STARTED|Second Intervention Period (1 Day)||3
6631104|NCT02271984|7559592|FG011|STARTED|Second Intervention Period (1 Day)||3
6631105|NCT02271984|7559581|FG000|COMPLETED|Second Intervention Period (1 Day)||3
6631106|NCT02271984|7559582|FG001|COMPLETED|Second Intervention Period (1 Day)||3
6631107|NCT02271984|7559583|FG002|COMPLETED|Second Intervention Period (1 Day)||3
6631108|NCT02271984|7559584|FG003|COMPLETED|Second Intervention Period (1 Day)||3
6631109|NCT02271984|7559585|FG004|COMPLETED|Second Intervention Period (1 Day)||3
6631110|NCT02271984|7559586|FG005|COMPLETED|Second Intervention Period (1 Day)||3
6631111|NCT02271984|7559587|FG006|COMPLETED|Second Intervention Period (1 Day)||3
6631112|NCT02271984|7559588|FG007|COMPLETED|Second Intervention Period (1 Day)||3
6631113|NCT02271984|7559589|FG008|COMPLETED|Second Intervention Period (1 Day)||3
6631114|NCT02271984|7559590|FG009|COMPLETED|Second Intervention Period (1 Day)||3
6631115|NCT02271984|7559591|FG010|COMPLETED|Second Intervention Period (1 Day)||3
6631116|NCT02271984|7559592|FG011|COMPLETED|Second Intervention Period (1 Day)||3
6631117|NCT02271984|7559581|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631118|NCT02271984|7559582|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631119|NCT02271984|7559583|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631120|NCT02271984|7559584|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631121|NCT02271984|7559585|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631122|NCT02271984|7559586|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
6283047|NCT00189540|7183390|FG000|COMPLETED|Overall Study||14
6631123|NCT02271984|7559587|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631124|NCT02271984|7559588|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631125|NCT02271984|7559589|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
6283048|NCT00189540|7183391|FG001|COMPLETED|Overall Study||5
6283049|NCT00189540|7183390|FG000|NOT COMPLETED|Overall Study||7
6283050|NCT00189540|7183391|FG001|NOT COMPLETED|Overall Study||1
6283051|NCT00190671|7183399|FG000|STARTED|Overall Study||42
6283052|NCT00190671|7183400|FG001|STARTED|Overall Study||61
6283053|NCT00190671|7183399|FG000|COMPLETED|Overall Study||15
6283054|NCT00190671|7183400|FG001|COMPLETED|Overall Study||19
6283055|NCT00190671|7183399|FG000|NOT COMPLETED|Overall Study||27
6283056|NCT00190671|7183400|FG001|NOT COMPLETED|Overall Study||42
6283057|NCT00190684|7183407|FG000|STARTED|Overall Study||1553
6283058|NCT00190684|7183407|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
6283059|NCT00190684|7183407|FG000|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
6283060|NCT00190684|7183407|FG000|NOT COMPLETED|Overall Study||1489
6283061|NCT00190749|7183413|FG000|STARTED|Overall Study||68
6283062|NCT00190749|7183414|FG001|STARTED|Overall Study||62
6283063|NCT00190749|7183413|FG000|COMPLETED|Overall Study||42
6283064|NCT00190749|7183414|FG001|COMPLETED|Overall Study||31
6283065|NCT00190749|7183413|FG000|NOT COMPLETED|Overall Study||26
6283066|NCT00190749|7183414|FG001|NOT COMPLETED|Overall Study||31
6283067|NCT00190775|7183422|FG000|STARTED|Overall Study||268
6283068|NCT00190775|7183423|FG001|STARTED|Overall Study||234
6283069|NCT00190775|7183422|FG000|Received Study Drug|Overall Study||266
6283070|NCT00190775|7183423|FG001|Received Study Drug|Overall Study||234
6283071|NCT00190775|7183422|FG000|COMPLETED|Overall Study||119
6283072|NCT00190775|7183423|FG001|COMPLETED|Overall Study||134
6283073|NCT00190775|7183422|FG000|NOT COMPLETED|Overall Study||149
6283074|NCT00190775|7183423|FG001|NOT COMPLETED|Overall Study||100
6283075|NCT00190983|7183436|FG000|STARTED|Overall Study||29
6283076|NCT00190983|7183436|FG000|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
6283077|NCT00190983|7183436|FG000|NOT COMPLETED|Overall Study||2
6283078|NCT00191100|7183442|FG000|STARTED|Overall Study||259
6283079|NCT00191100|7183443|FG001|STARTED|Overall Study||256
6283080|NCT00191100|7183442|FG000|COMPLETED|Overall Study||217
6283081|NCT00191100|7183443|FG001|COMPLETED|Overall Study||244
6283082|NCT00191100|7183442|FG000|NOT COMPLETED|Overall Study||42
6283083|NCT00191100|7183443|FG001|NOT COMPLETED|Overall Study||12
6283084|NCT00191113|7183451|FG000|STARTED|Core Study||78
6631126|NCT02271984|7559590|FG009|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631127|NCT02271984|7559591|FG010|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631128|NCT02271984|7559592|FG011|NOT COMPLETED|Second Intervention Period (1 Day)||0
6631129|NCT02271984|7559581|FG000|STARTED|Washout Period 2 (7 Days)||3
6631130|NCT02271984|7559582|FG001|STARTED|Washout Period 2 (7 Days)||3
6631131|NCT02271984|7559583|FG002|STARTED|Washout Period 2 (7 Days)||3
6631132|NCT02271984|7559584|FG003|STARTED|Washout Period 2 (7 Days)||3
6631133|NCT02271984|7559585|FG004|STARTED|Washout Period 2 (7 Days)||3
6631134|NCT02271984|7559586|FG005|STARTED|Washout Period 2 (7 Days)||3
6631135|NCT02271984|7559587|FG006|STARTED|Washout Period 2 (7 Days)||3
6631136|NCT02271984|7559588|FG007|STARTED|Washout Period 2 (7 Days)||3
6631137|NCT02271984|7559589|FG008|STARTED|Washout Period 2 (7 Days)||3
6631138|NCT02271984|7559590|FG009|STARTED|Washout Period 2 (7 Days)||3
6631139|NCT02271984|7559591|FG010|STARTED|Washout Period 2 (7 Days)||3
6631140|NCT02271984|7559592|FG011|STARTED|Washout Period 2 (7 Days)||3
6631141|NCT02271984|7559581|FG000|COMPLETED|Washout Period 2 (7 Days)||3
6631142|NCT02271984|7559582|FG001|COMPLETED|Washout Period 2 (7 Days)||3
6631143|NCT02271984|7559583|FG002|COMPLETED|Washout Period 2 (7 Days)||3
6631144|NCT02271984|7559584|FG003|COMPLETED|Washout Period 2 (7 Days)||3
6631145|NCT02271984|7559585|FG004|COMPLETED|Washout Period 2 (7 Days)||3
6631146|NCT02271984|7559586|FG005|COMPLETED|Washout Period 2 (7 Days)||3
6631147|NCT02271984|7559587|FG006|COMPLETED|Washout Period 2 (7 Days)||3
6631148|NCT02271984|7559588|FG007|COMPLETED|Washout Period 2 (7 Days)||3
6631149|NCT02271984|7559589|FG008|COMPLETED|Washout Period 2 (7 Days)||3
6631150|NCT02271984|7559590|FG009|COMPLETED|Washout Period 2 (7 Days)||3
6631151|NCT02271984|7559591|FG010|COMPLETED|Washout Period 2 (7 Days)||3
6631152|NCT02271984|7559592|FG011|COMPLETED|Washout Period 2 (7 Days)||3
6631153|NCT02271984|7559581|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631154|NCT02271984|7559582|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631155|NCT02271984|7559583|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631156|NCT02271984|7559584|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631157|NCT02271984|7559585|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631158|NCT02271984|7559586|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631159|NCT02271984|7559587|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631160|NCT02271984|7559588|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631161|NCT02271984|7559589|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631162|NCT02271984|7559590|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
6283085|NCT00191113|7183452|FG001|STARTED|Core Study||76
6283086|NCT00191113|7183451|FG000|COMPLETED|Core Study||43
6283087|NCT00191113|7183452|FG001|COMPLETED|Core Study||61
6283088|NCT00191113|7183451|FG000|NOT COMPLETED|Core Study||35
6283089|NCT00191113|7183452|FG001|NOT COMPLETED|Core Study||15
6283090|NCT00191113|7183451|FG000|STARTED|Addendum 1||2
6283091|NCT00191113|7183452|FG001|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
6283092|NCT00191113|7183451|FG000|COMPLETED|Addendum 1||2
6283093|NCT00191113|7183452|FG001|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
6283094|NCT00191113|7183451|FG000|NOT COMPLETED|Addendum 1||0
6283095|NCT00191113|7183452|FG001|NOT COMPLETED|Addendum 1||0
6283096|NCT00191113|7183451|FG000|STARTED|Addendum 2||28
6283097|NCT00191113|7183452|FG001|STARTED|Addendum 2||48
6283098|NCT00191113|7183451|FG000|COMPLETED|Addendum 2||18
6283099|NCT00191113|7183452|FG001|COMPLETED|Addendum 2||31
6283100|NCT00191113|7183451|FG000|NOT COMPLETED|Addendum 2||10
6283101|NCT00191113|7183452|FG001|NOT COMPLETED|Addendum 2||17
6283102|NCT00191113|7183451|FG000|STARTED|Addendum 3||20
6283103|NCT00191113|7183452|FG001|STARTED|Addendum 3||37
6283104|NCT00191113|7183451|FG000|COMPLETED|Addendum 3||20
6283105|NCT00191113|7183452|FG001|COMPLETED|Addendum 3||37
6283106|NCT00191113|7183451|FG000|NOT COMPLETED|Addendum 3||0
6283107|NCT00191113|7183452|FG001|NOT COMPLETED|Addendum 3||0
6283108|NCT00191139|7183466|FG000|STARTED|Overall Study||32
6283109|NCT00191139|7183467|FG001|STARTED|Overall Study||32
6283110|NCT00191139|7183466|FG000|COMPLETED|Overall Study||27
6631163|NCT02271984|7559591|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631164|NCT02271984|7559592|FG011|NOT COMPLETED|Washout Period 2 (7 Days)||0
6631165|NCT02271984|7559581|FG000|STARTED|Third Intervention Period (1 Day)||3
6631166|NCT02271984|7559582|FG001|STARTED|Third Intervention Period (1 Day)||3
6631167|NCT02271984|7559583|FG002|STARTED|Third Intervention Period (1 Day)||3
6631168|NCT02271984|7559584|FG003|STARTED|Third Intervention Period (1 Day)||3
6631169|NCT02271984|7559585|FG004|STARTED|Third Intervention Period (1 Day)||3
6631170|NCT02271984|7559586|FG005|STARTED|Third Intervention Period (1 Day)||3
6631171|NCT02271984|7559587|FG006|STARTED|Third Intervention Period (1 Day)||3
6631172|NCT02271984|7559588|FG007|STARTED|Third Intervention Period (1 Day)||3
6631173|NCT02271984|7559589|FG008|STARTED|Third Intervention Period (1 Day)||3
6631174|NCT02271984|7559590|FG009|STARTED|Third Intervention Period (1 Day)||3
6631175|NCT02271984|7559591|FG010|STARTED|Third Intervention Period (1 Day)||3
6631176|NCT02271984|7559592|FG011|STARTED|Third Intervention Period (1 Day)||3
6631177|NCT02271984|7559581|FG000|COMPLETED|Third Intervention Period (1 Day)||3
6631178|NCT02271984|7559582|FG001|COMPLETED|Third Intervention Period (1 Day)||3
6631179|NCT02271984|7559583|FG002|COMPLETED|Third Intervention Period (1 Day)||3
6631180|NCT02271984|7559584|FG003|COMPLETED|Third Intervention Period (1 Day)||3
6631181|NCT02271984|7559585|FG004|COMPLETED|Third Intervention Period (1 Day)||3
6631182|NCT02271984|7559586|FG005|COMPLETED|Third Intervention Period (1 Day)||3
6631183|NCT02271984|7559587|FG006|COMPLETED|Third Intervention Period (1 Day)||3
6631184|NCT02271984|7559588|FG007|COMPLETED|Third Intervention Period (1 Day)||3
6631185|NCT02271984|7559589|FG008|COMPLETED|Third Intervention Period (1 Day)||3
6631186|NCT02271984|7559590|FG009|COMPLETED|Third Intervention Period (1 Day)||3
6631187|NCT02271984|7559591|FG010|COMPLETED|Third Intervention Period (1 Day)||3
6631188|NCT02271984|7559592|FG011|COMPLETED|Third Intervention Period (1 Day)||3
6631189|NCT02271984|7559581|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631190|NCT02271984|7559582|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631191|NCT02271984|7559583|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631192|NCT02271984|7559584|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631193|NCT02271984|7559585|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631194|NCT02271984|7559586|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631195|NCT02271984|7559587|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631196|NCT02271984|7559588|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631197|NCT02271984|7559589|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631198|NCT02271984|7559590|FG009|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631199|NCT02271984|7559591|FG010|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631200|NCT02271984|7559592|FG011|NOT COMPLETED|Third Intervention Period (1 Day)||0
6631201|NCT02271984|7559581|FG000|STARTED|Washout Period 3 (7 Days)||3
6631202|NCT02271984|7559582|FG001|STARTED|Washout Period 3 (7 Days)||3
6631203|NCT02271984|7559583|FG002|STARTED|Washout Period 3 (7 Days)||3
6631204|NCT02271984|7559584|FG003|STARTED|Washout Period 3 (7 Days)||3
6631205|NCT02271984|7559585|FG004|STARTED|Washout Period 3 (7 Days)||3
6631206|NCT02271984|7559586|FG005|STARTED|Washout Period 3 (7 Days)||3
6631207|NCT02271984|7559587|FG006|STARTED|Washout Period 3 (7 Days)||3
6631208|NCT02271984|7559588|FG007|STARTED|Washout Period 3 (7 Days)||3
6631209|NCT02271984|7559589|FG008|STARTED|Washout Period 3 (7 Days)||3
6631210|NCT02271984|7559590|FG009|STARTED|Washout Period 3 (7 Days)||3
6631211|NCT02271984|7559591|FG010|STARTED|Washout Period 3 (7 Days)||3
6631212|NCT02271984|7559592|FG011|STARTED|Washout Period 3 (7 Days)||3
6631213|NCT02271984|7559581|FG000|COMPLETED|Washout Period 3 (7 Days)||3
6631214|NCT02271984|7559582|FG001|COMPLETED|Washout Period 3 (7 Days)||3
6631215|NCT02271984|7559583|FG002|COMPLETED|Washout Period 3 (7 Days)||3
6631216|NCT02271984|7559584|FG003|COMPLETED|Washout Period 3 (7 Days)||3
6631217|NCT02271984|7559585|FG004|COMPLETED|Washout Period 3 (7 Days)||3
6631218|NCT02271984|7559586|FG005|COMPLETED|Washout Period 3 (7 Days)||3
6631219|NCT02271984|7559587|FG006|COMPLETED|Washout Period 3 (7 Days)||3
6631220|NCT02271984|7559588|FG007|COMPLETED|Washout Period 3 (7 Days)||3
6631221|NCT02271984|7559589|FG008|COMPLETED|Washout Period 3 (7 Days)||3
6631222|NCT02271984|7559590|FG009|COMPLETED|Washout Period 3 (7 Days)||3
6631223|NCT02271984|7559591|FG010|COMPLETED|Washout Period 3 (7 Days)||3
6283111|NCT00191139|7183467|FG001|COMPLETED|Overall Study||20
6283112|NCT00191139|7183466|FG000|NOT COMPLETED|Overall Study||5
6283113|NCT00191139|7183467|FG001|NOT COMPLETED|Overall Study||12
6283114|NCT00191152|7183475|FG000|STARTED|Initial Treatment||239
6283115|NCT00191152|7183476|FG001|STARTED|Initial Treatment||236
6283116|NCT00191152|7183475|FG000|Received Initial Treatment|Initial Treatment||236
6283117|NCT00191152|7183476|FG001|Received Initial Treatment|Initial Treatment||227
6283118|NCT00191152|7183475|FG000|COMPLETED|Initial Treatment||98
6283119|NCT00191152|7183476|FG001|COMPLETED|Initial Treatment||83
6283120|NCT00191152|7183475|FG000|NOT COMPLETED|Initial Treatment||141
6283121|NCT00191152|7183476|FG001|NOT COMPLETED|Initial Treatment||153
6283122|NCT00191152|7183475|FG000|STARTED|Crossover Treatment||77
6283123|NCT00191152|7183476|FG001|STARTED|Crossover Treatment||81
6283124|NCT00191152|7183475|FG000|Received Treatment|Crossover Treatment||76
6283125|NCT00191152|7183476|FG001|Received Treatment|Crossover Treatment||80
6283126|NCT00191152|7183475|FG000|COMPLETED|Crossover Treatment||50
6283127|NCT00191152|7183476|FG001|COMPLETED|Crossover Treatment||53
6283128|NCT00191152|7183475|FG000|NOT COMPLETED|Crossover Treatment||27
6283129|NCT00191152|7183476|FG001|NOT COMPLETED|Crossover Treatment||28
6631224|NCT02271984|7559592|FG011|COMPLETED|Washout Period 3 (7 Days)||3
6631225|NCT02271984|7559581|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631226|NCT02271984|7559582|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631227|NCT02271984|7559583|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631228|NCT02271984|7559584|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631229|NCT02271984|7559585|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631230|NCT02271984|7559586|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631231|NCT02271984|7559587|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631232|NCT02271984|7559588|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631233|NCT02271984|7559589|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631234|NCT02271984|7559590|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631235|NCT02271984|7559591|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631236|NCT02271984|7559592|FG011|NOT COMPLETED|Washout Period 3 (7 Days)||0
6631237|NCT02271984|7559581|FG000|STARTED|Fourth Intervention Period (Day 1)||3
6631238|NCT02271984|7559582|FG001|STARTED|Fourth Intervention Period (Day 1)||3
6631239|NCT02271984|7559583|FG002|STARTED|Fourth Intervention Period (Day 1)||3
6631240|NCT02271984|7559584|FG003|STARTED|Fourth Intervention Period (Day 1)||3
6631241|NCT02271984|7559585|FG004|STARTED|Fourth Intervention Period (Day 1)||3
6631242|NCT02271984|7559586|FG005|STARTED|Fourth Intervention Period (Day 1)||3
6631243|NCT02271984|7559587|FG006|STARTED|Fourth Intervention Period (Day 1)||3
6631244|NCT02271984|7559588|FG007|STARTED|Fourth Intervention Period (Day 1)||3
6631245|NCT02271984|7559589|FG008|STARTED|Fourth Intervention Period (Day 1)||3
6631246|NCT02271984|7559590|FG009|STARTED|Fourth Intervention Period (Day 1)||3
6631247|NCT02271984|7559591|FG010|STARTED|Fourth Intervention Period (Day 1)||3
6631248|NCT02271984|7559592|FG011|STARTED|Fourth Intervention Period (Day 1)||3
6631249|NCT02271984|7559581|FG000|COMPLETED|Fourth Intervention Period (Day 1)||3
6631250|NCT02271984|7559582|FG001|COMPLETED|Fourth Intervention Period (Day 1)||3
6631251|NCT02271984|7559583|FG002|COMPLETED|Fourth Intervention Period (Day 1)||3
6631252|NCT02271984|7559584|FG003|COMPLETED|Fourth Intervention Period (Day 1)||3
6631253|NCT02271984|7559585|FG004|COMPLETED|Fourth Intervention Period (Day 1)||3
6631254|NCT02271984|7559586|FG005|COMPLETED|Fourth Intervention Period (Day 1)||3
6631255|NCT02271984|7559587|FG006|COMPLETED|Fourth Intervention Period (Day 1)||3
6631256|NCT02271984|7559588|FG007|COMPLETED|Fourth Intervention Period (Day 1)||3
6631257|NCT02271984|7559589|FG008|COMPLETED|Fourth Intervention Period (Day 1)||3
6631258|NCT02271984|7559590|FG009|COMPLETED|Fourth Intervention Period (Day 1)||3
6631259|NCT02271984|7559591|FG010|COMPLETED|Fourth Intervention Period (Day 1)||3
6631260|NCT02271984|7559592|FG011|COMPLETED|Fourth Intervention Period (Day 1)||3
6631261|NCT02271984|7559581|FG000|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631262|NCT02271984|7559582|FG001|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631263|NCT02271984|7559583|FG002|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631264|NCT02271984|7559584|FG003|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631265|NCT02271984|7559585|FG004|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631266|NCT02271984|7559586|FG005|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631267|NCT02271984|7559587|FG006|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631268|NCT02271984|7559588|FG007|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631269|NCT02271984|7559589|FG008|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631270|NCT02271984|7559590|FG009|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631271|NCT02271984|7559591|FG010|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631272|NCT02271984|7559592|FG011|NOT COMPLETED|Fourth Intervention Period (Day 1)||0
6631273|NCT02271984|7559581|FG000|STARTED|Washout Period 4 (7 Days)||3
6631274|NCT02271984|7559582|FG001|STARTED|Washout Period 4 (7 Days)||3
6631275|NCT02271984|7559583|FG002|STARTED|Washout Period 4 (7 Days)||3
6631276|NCT02271984|7559584|FG003|STARTED|Washout Period 4 (7 Days)||3
6631277|NCT02271984|7559585|FG004|STARTED|Washout Period 4 (7 Days)||3
6631278|NCT02271984|7559586|FG005|STARTED|Washout Period 4 (7 Days)||3
6631279|NCT02271984|7559587|FG006|STARTED|Washout Period 4 (7 Days)||3
6631280|NCT02271984|7559588|FG007|STARTED|Washout Period 4 (7 Days)||3
6631281|NCT02271984|7559589|FG008|STARTED|Washout Period 4 (7 Days)||3
6631282|NCT02271984|7559590|FG009|STARTED|Washout Period 4 (7 Days)||3
6631283|NCT02271984|7559591|FG010|STARTED|Washout Period 4 (7 Days)||3
6631284|NCT02271984|7559592|FG011|STARTED|Washout Period 4 (7 Days)||3
6631285|NCT02271984|7559581|FG000|COMPLETED|Washout Period 4 (7 Days)||3
6631286|NCT02271984|7559582|FG001|COMPLETED|Washout Period 4 (7 Days)||3
6283130|NCT00191165|7183496|FG000|STARTED|Overall Study||14
6283131|NCT00191165|7183497|FG001|STARTED|Overall Study||13
6283132|NCT00191165|7183496|FG000|COMPLETED|Overall Study||12
6283133|NCT00191165|7183497|FG001|COMPLETED|Overall Study||11
6283134|NCT00191165|7183496|FG000|NOT COMPLETED|Overall Study||2
6631287|NCT02271984|7559583|FG002|COMPLETED|Washout Period 4 (7 Days)||3
6631288|NCT02271984|7559584|FG003|COMPLETED|Washout Period 4 (7 Days)||3
6631289|NCT02271984|7559585|FG004|COMPLETED|Washout Period 4 (7 Days)||3
6631290|NCT02271984|7559586|FG005|COMPLETED|Washout Period 4 (7 Days)||2
6631291|NCT02271984|7559587|FG006|COMPLETED|Washout Period 4 (7 Days)||3
6631292|NCT02271984|7559588|FG007|COMPLETED|Washout Period 4 (7 Days)||2
6631293|NCT02271984|7559589|FG008|COMPLETED|Washout Period 4 (7 Days)||3
6631294|NCT02271984|7559590|FG009|COMPLETED|Washout Period 4 (7 Days)||3
6631295|NCT02271984|7559591|FG010|COMPLETED|Washout Period 4 (7 Days)||3
6631296|NCT02271984|7559592|FG011|COMPLETED|Washout Period 4 (7 Days)||3
6631297|NCT02271984|7559581|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631298|NCT02271984|7559582|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631299|NCT02271984|7559583|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631300|NCT02271984|7559584|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631301|NCT02271984|7559585|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631302|NCT02271984|7559586|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||1
6631303|NCT02271984|7559587|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631304|NCT02271984|7559588|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||1
6631305|NCT02271984|7559589|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631306|NCT02271984|7559590|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631307|NCT02271984|7559591|FG010|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631308|NCT02271984|7559592|FG011|NOT COMPLETED|Washout Period 4 (7 Days)||0
6631309|NCT02271984|7559581|FG000|STARTED|Fifth Intervention Period (1 Day)||3
6631310|NCT02271984|7559582|FG001|STARTED|Fifth Intervention Period (1 Day)||3
6631311|NCT02271984|7559583|FG002|STARTED|Fifth Intervention Period (1 Day)||3
6631312|NCT02271984|7559584|FG003|STARTED|Fifth Intervention Period (1 Day)||3
6631313|NCT02271984|7559585|FG004|STARTED|Fifth Intervention Period (1 Day)||3
6631314|NCT02271984|7559586|FG005|STARTED|Fifth Intervention Period (1 Day)||2
6631315|NCT02271984|7559587|FG006|STARTED|Fifth Intervention Period (1 Day)||3
6631316|NCT02271984|7559588|FG007|STARTED|Fifth Intervention Period (1 Day)||2
6631317|NCT02271984|7559589|FG008|STARTED|Fifth Intervention Period (1 Day)||3
6631318|NCT02271984|7559590|FG009|STARTED|Fifth Intervention Period (1 Day)||3
6631319|NCT02271984|7559591|FG010|STARTED|Fifth Intervention Period (1 Day)||3
6631320|NCT02271984|7559592|FG011|STARTED|Fifth Intervention Period (1 Day)||3
6631321|NCT02271984|7559581|FG000|COMPLETED|Fifth Intervention Period (1 Day)||3
6631322|NCT02271984|7559582|FG001|COMPLETED|Fifth Intervention Period (1 Day)||3
6742953|NCT03330457|7671283|FG001|COMPLETED|Overall Study||3
6742954|NCT03330457|7671284|FG002|COMPLETED|Overall Study||6
6742955|NCT03330457|7671285|FG003|COMPLETED|Overall Study||3
6742956|NCT03330457|7671282|FG000|NOT COMPLETED|Overall Study||0
6742957|NCT03330457|7671283|FG001|NOT COMPLETED|Overall Study||0
6742958|NCT03330457|7671284|FG002|NOT COMPLETED|Overall Study||0
6742959|NCT03330457|7671285|FG003|NOT COMPLETED|Overall Study||0
6742960|NCT03330834|7671295|FG000|STARTED|Overall Study||1
6742961|NCT03330834|7671295|FG000|COMPLETED|Overall Study||1
6742962|NCT03330834|7671295|FG000|NOT COMPLETED|Overall Study||0
6742963|NCT03331042|7671303|FG000|STARTED|Overall Study||22
6742964|NCT03331042|7671304|FG001|STARTED|Overall Study||21
6742965|NCT03331042|7671305|FG002|STARTED|Overall Study||21
6742966|NCT03331042|7671306|FG003|STARTED|Overall Study||21
6742967|NCT03331042|7671303|FG000|COMPLETED|Overall Study||21
6742968|NCT03331042|7671304|FG001|COMPLETED|Overall Study||21
6742969|NCT03331042|7671305|FG002|COMPLETED|Overall Study||20
6742970|NCT03331042|7671306|FG003|COMPLETED|Overall Study||20
6742971|NCT03331042|7671303|FG000|NOT COMPLETED|Overall Study||1
6742972|NCT03331042|7671304|FG001|NOT COMPLETED|Overall Study||0
6742973|NCT03331042|7671305|FG002|NOT COMPLETED|Overall Study||1
6742974|NCT03331042|7671306|FG003|NOT COMPLETED|Overall Study||1
6742975|NCT03331185|7671324|FG000|STARTED|Overall Study||14
6742976|NCT03331185|7671325|FG001|STARTED|Overall Study||12
6742977|NCT03331185|7671324|FG000|COMPLETED|Overall Study||14
6742978|NCT03331185|7671325|FG001|COMPLETED|Overall Study||12
6742979|NCT03331185|7671324|FG000|NOT COMPLETED|Overall Study||0
6742980|NCT03331185|7671325|FG001|NOT COMPLETED|Overall Study||0
6742981|NCT03331315|7671333|FG000|STARTED|Overall Study||88
6742982|NCT03331315|7671334|FG001|STARTED|Overall Study||82
6742983|NCT03331315|7671333|FG000|COMPLETED|Overall Study||70
6742984|NCT03331315|7671334|FG001|COMPLETED|Overall Study||68
6742985|NCT03331315|7671333|FG000|NOT COMPLETED|Overall Study||18
6742986|NCT03331315|7671334|FG001|NOT COMPLETED|Overall Study||14
6742987|NCT03331666|7671344|FG000|STARTED|Overall Study||2
6742988|NCT03331666|7671345|FG001|STARTED|Overall Study||2
6742989|NCT03331666|7671344|FG000|COMPLETED|Overall Study||0
6742990|NCT03331666|7671345|FG001|COMPLETED|Overall Study||0
6742991|NCT03331666|7671344|FG000|NOT COMPLETED|Overall Study||2
6742992|NCT03331666|7671345|FG001|NOT COMPLETED|Overall Study||2
6742993|NCT03331835|7671353|FG000|STARTED|Overall Study||105
6742994|NCT03331835|7671354|FG001|STARTED|Overall Study||105
6742995|NCT03331835|7671353|FG000|COMPLETED|Overall Study||91
6742996|NCT03331835|7671354|FG001|COMPLETED|Overall Study||58
6742997|NCT03331835|7671353|FG000|NOT COMPLETED|Overall Study||14
6742998|NCT03331835|7671354|FG001|NOT COMPLETED|Overall Study||47
6742999|NCT03331965|7671362|FG000|STARTED|Overall Study||55
6631323|NCT02271984|7559583|FG002|COMPLETED|Fifth Intervention Period (1 Day)||3
6743000|NCT03331965|7671363|FG001|STARTED|Overall Study||55
6743001|NCT03331965|7671362|FG000|COMPLETED|Overall Study||45
6283135|NCT00191165|7183497|FG001|NOT COMPLETED|Overall Study||2
6283136|NCT00191191|7183505|FG000|STARTED|Overall Study||114
6283137|NCT00191191|7183506|FG001|STARTED|Overall Study||112
6283138|NCT00191191|7183505|FG000|Safety Analysis Population|Overall Study||114
6283139|NCT00191191|7183506|FG001|Safety Analysis Population|Overall Study||111
6283140|NCT00191191|7183505|FG000|Full Analysis Set Population|Overall Study||108
6283141|NCT00191191|7183506|FG001|Full Analysis Set Population|Overall Study||108
6283142|NCT00191191|7183505|FG000|COMPLETED|Overall Study||0
6283143|NCT00191191|7183506|FG001|COMPLETED|Overall Study||0
6283144|NCT00191191|7183505|FG000|NOT COMPLETED|Overall Study||114
6283145|NCT00191191|7183506|FG001|NOT COMPLETED|Overall Study||112
6283146|NCT00191269|7183514|FG000|STARTED|Overall Study||6
6283147|NCT00191269|7183515|FG001|STARTED|Overall Study||62
6283148|NCT00191269|7183514|FG000|COMPLETED|Overall Study||0
6283149|NCT00191269|7183515|FG001|COMPLETED|Overall Study||4
6631324|NCT02271984|7559584|FG003|COMPLETED|Fifth Intervention Period (1 Day)||3
6631325|NCT02271984|7559585|FG004|COMPLETED|Fifth Intervention Period (1 Day)||3
6631326|NCT02271984|7559586|FG005|COMPLETED|Fifth Intervention Period (1 Day)||2
6631327|NCT02271984|7559587|FG006|COMPLETED|Fifth Intervention Period (1 Day)||3
6631328|NCT02271984|7559588|FG007|COMPLETED|Fifth Intervention Period (1 Day)||2
6631329|NCT02271984|7559589|FG008|COMPLETED|Fifth Intervention Period (1 Day)||3
6631330|NCT02271984|7559590|FG009|COMPLETED|Fifth Intervention Period (1 Day)||3
6631331|NCT02271984|7559591|FG010|COMPLETED|Fifth Intervention Period (1 Day)||3
6631332|NCT02271984|7559592|FG011|COMPLETED|Fifth Intervention Period (1 Day)||3
6631333|NCT02271984|7559581|FG000|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631334|NCT02271984|7559582|FG001|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631335|NCT02271984|7559583|FG002|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631336|NCT02271984|7559584|FG003|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631337|NCT02271984|7559585|FG004|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631338|NCT02271984|7559586|FG005|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631339|NCT02271984|7559587|FG006|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631340|NCT02271984|7559588|FG007|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631341|NCT02271984|7559589|FG008|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631342|NCT02271984|7559590|FG009|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631343|NCT02271984|7559591|FG010|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631344|NCT02271984|7559592|FG011|NOT COMPLETED|Fifth Intervention Period (1 Day)||0
6631345|NCT02272244|7559609|FG000|STARTED|Overall Study||203
6631346|NCT02272244|7559610|FG001|STARTED|Overall Study||197
6631347|NCT02272244|7559609|FG000|COMPLETED|Overall Study||203
6631348|NCT02272244|7559610|FG001|COMPLETED|Overall Study||197
6631349|NCT02272244|7559609|FG000|NOT COMPLETED|Overall Study||0
6631350|NCT02272244|7559610|FG001|NOT COMPLETED|Overall Study||0
6631351|NCT02272413|7559618|FG000|STARTED|Randomized Through Treatment Start|Started for this period|338
6631352|NCT02272413|7559619|FG001|STARTED|Randomized Through Treatment Start|Started for this period|333
6631353|NCT02272413|7559618|FG000|Treated|Randomized Through Treatment Start||335
6631354|NCT02272413|7559619|FG001|Treated|Randomized Through Treatment Start||328
6631355|NCT02272413|7559618|FG000|COMPLETED|Randomized Through Treatment Start||335
6631356|NCT02272413|7559619|FG001|COMPLETED|Randomized Through Treatment Start||328
6631357|NCT02272413|7559618|FG000|NOT COMPLETED|Randomized Through Treatment Start||3
6631358|NCT02272413|7559619|FG001|NOT COMPLETED|Randomized Through Treatment Start||5
6631359|NCT02272413|7559618|FG000|STARTED|Pre-switch Period|Started for this period|335
6631360|NCT02272413|7559619|FG001|STARTED|Pre-switch Period|Started for this period|328
6631361|NCT02272413|7559618|FG000|COMPLETED|Pre-switch Period||42
6631362|NCT02272413|7559619|FG001|COMPLETED|Pre-switch Period||46
6631363|NCT02272413|7559618|FG000|NOT COMPLETED|Pre-switch Period||293
6631364|NCT02272413|7559619|FG001|NOT COMPLETED|Pre-switch Period||282
6631365|NCT02272413|7559618|FG000|STARTED|Post-switch Period|Started for this period|42
6631366|NCT02272413|7559619|FG001|STARTED|Post-switch Period|Started for this period|46
6631367|NCT02272413|7559618|FG000|COMPLETED|Post-switch Period||0
6631368|NCT02272413|7559619|FG001|COMPLETED|Post-switch Period||0
6631369|NCT02272413|7559618|FG000|NOT COMPLETED|Post-switch Period||42
6631370|NCT02272413|7559619|FG001|NOT COMPLETED|Post-switch Period||46
6631371|NCT02272634|7559630|FG000|STARTED|Overall Study||20
6631372|NCT02272634|7559631|FG001|STARTED|Overall Study||21
6631373|NCT02272634|7559632|FG002|STARTED|Overall Study||20
6631374|NCT02272634|7559630|FG000|COMPLETED|Overall Study||19
6631375|NCT02272634|7559631|FG001|COMPLETED|Overall Study||20
6631376|NCT02272634|7559632|FG002|COMPLETED|Overall Study||19
6631377|NCT02272634|7559630|FG000|NOT COMPLETED|Overall Study||1
6631378|NCT02272634|7559631|FG001|NOT COMPLETED|Overall Study||1
6631379|NCT02272634|7559632|FG002|NOT COMPLETED|Overall Study||1
6631380|NCT02272686|7559643|FG000|STARTED|Overall Study||1
6631381|NCT02272686|7559643|FG000|COMPLETED|Overall Study||1
6631382|NCT02272686|7559643|FG000|NOT COMPLETED|Overall Study||0
6631383|NCT02272725|7559649|FG000|STARTED|Overall Study||49
6631384|NCT02272725|7559650|FG001|STARTED|Overall Study||42
6283150|NCT00191269|7183514|FG000|NOT COMPLETED|Overall Study||6
6283151|NCT00191269|7183515|FG001|NOT COMPLETED|Overall Study||58
6283152|NCT00191282|7183524|FG000|STARTED|Overall Study||558
6283153|NCT00191282|7183525|FG001|STARTED|Overall Study||558
6283154|NCT00191282|7183524|FG000|COMPLETED|Overall Study||338
6283155|NCT00191282|7183525|FG001|COMPLETED|Overall Study||346
6283156|NCT00191282|7183524|FG000|NOT COMPLETED|Overall Study||220
6283157|NCT00191282|7183525|FG001|NOT COMPLETED|Overall Study||212
6283158|NCT00191308|7183531|FG000|STARTED|Overall Study||30
6283159|NCT00191308|7183531|FG000|COMPLETED|Overall Study||29
6283160|NCT00191308|7183531|FG000|NOT COMPLETED|Overall Study||1
6283161|NCT00191334|7183535|FG000|STARTED|Overall Study||50
6283162|NCT00191334|7183535|FG000|COMPLETED|Overall Study||33
6283163|NCT00191334|7183535|FG000|NOT COMPLETED|Overall Study||17
6283164|NCT00191386|7183539|FG000|STARTED|Overall Study||228
6283165|NCT00191386|7183539|FG000|6 Months|Overall Study||183
6283166|NCT00191386|7183539|FG000|12 Months|Overall Study||149
6283167|NCT00191386|7183539|FG000|2 Years|Overall Study||105
6283168|NCT00191386|7183539|FG000|3 Years|Overall Study||65
6283169|NCT00191386|7183539|FG000|COMPLETED|Overall Study||68
6283170|NCT00191386|7183539|FG000|NOT COMPLETED|Overall Study||160
6283171|NCT00191451|7183546|FG000|STARTED|Overall Study||50
6283172|NCT00191451|7183547|FG001|STARTED|Overall Study||51
6283173|NCT00191451|7183548|FG002|STARTED|Overall Study||49
6283174|NCT00191451|7183546|FG000|Received at Least One Dose of Study Drug|Overall Study||50
6283175|NCT00191451|7183547|FG001|Received at Least One Dose of Study Drug|Overall Study||48
6283176|NCT00191451|7183548|FG002|Received at Least One Dose of Study Drug|Overall Study||47
6283177|NCT00191451|7183546|FG000|COMPLETED|Overall Study||43
6283178|NCT00191451|7183547|FG001|COMPLETED|Overall Study||37
6283179|NCT00191451|7183548|FG002|COMPLETED|Overall Study||35
6283180|NCT00191451|7183546|FG000|NOT COMPLETED|Overall Study||7
6283181|NCT00191451|7183547|FG001|NOT COMPLETED|Overall Study||14
6283182|NCT00191451|7183548|FG002|NOT COMPLETED|Overall Study||14
6283183|NCT00191477|7183558|FG000|STARTED|Overall Study||179
6283184|NCT00191477|7183559|FG001|STARTED|Overall Study||176
6283185|NCT00191477|7183558|FG000|Received Study Drug|Overall Study||166
6283186|NCT00191477|7183559|FG001|Received Study Drug|Overall Study||162
6283187|NCT00191477|7183558|FG000|COMPLETED|Overall Study||41
6283188|NCT00191477|7183559|FG001|COMPLETED|Overall Study||47
6283189|NCT00191477|7183558|FG000|NOT COMPLETED|Overall Study||138
6283190|NCT00191477|7183559|FG001|NOT COMPLETED|Overall Study||129
6283191|NCT00191646|7183567|FG000|STARTED|Overall Study||417
6283192|NCT00191646|7183568|FG001|STARTED|Overall Study||414
6283193|NCT00191646|7183567|FG000|Received Induction Therapy|Overall Study||411
6283194|NCT00191646|7183568|FG001|Received Induction Therapy|Overall Study||409
6283195|NCT00191646|7183567|FG000|Received Consolidation Therapy|Overall Study||169
6283196|NCT00191646|7183568|FG001|Received Consolidation Therapy|Overall Study||183
6283197|NCT00191646|7183567|FG000|Received Crossover Therapy|Overall Study||77
6283198|NCT00191646|7183568|FG001|Received Crossover Therapy|Overall Study||78
6283199|NCT00191646|7183567|FG000|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
6631385|NCT02272725|7559649|FG000|COMPLETED|Overall Study||47
6631386|NCT02272725|7559650|FG001|COMPLETED|Overall Study||42
6631387|NCT02272725|7559649|FG000|NOT COMPLETED|Overall Study||2
6631388|NCT02272725|7559650|FG001|NOT COMPLETED|Overall Study||0
6631389|NCT02272777|7559658|FG000|STARTED|Overall Study||112
6631390|NCT02272777|7559659|FG001|STARTED|Overall Study||113
6631391|NCT02272777|7559658|FG000|COMPLETED|Overall Study||108
6631392|NCT02272777|7559659|FG001|COMPLETED|Overall Study||109
6631393|NCT02272777|7559658|FG000|NOT COMPLETED|Overall Study||4
6631394|NCT02272777|7559659|FG001|NOT COMPLETED|Overall Study||4
6631395|NCT02272816|7559665|FG000|STARTED|Overall Study||48
6631396|NCT02272816|7559665|FG000|COMPLETED|Overall Study||47
6631397|NCT02272816|7559665|FG000|NOT COMPLETED|Overall Study||1
6631398|NCT02272842|7559671|FG000|STARTED|Overall Study||300
6631399|NCT02272842|7559672|FG001|STARTED|Overall Study||300
6631400|NCT02272842|7559671|FG000|COMPLETED|Overall Study||284
6631401|NCT02272842|7559672|FG001|COMPLETED|Overall Study||290
6631402|NCT02272842|7559671|FG000|NOT COMPLETED|Overall Study||16
6631403|NCT02272842|7559672|FG001|NOT COMPLETED|Overall Study||10
6631404|NCT02272985|7559679|FG000|STARTED|Overall Study||15
6631405|NCT02272985|7559679|FG000|COMPLETED|Overall Study||12
6631406|NCT02272985|7559679|FG000|NOT COMPLETED|Overall Study||3
6631407|NCT02273037|7559686|FG000|STARTED|Overall Study||987
6631408|NCT02273037|7559687|FG001|STARTED|Overall Study||1000
6631409|NCT02273037|7559686|FG000|COMPLETED|Overall Study||979
6631410|NCT02273037|7559687|FG001|COMPLETED|Overall Study||992
6631411|NCT02273037|7559686|FG000|NOT COMPLETED|Overall Study||8
6631412|NCT02273037|7559687|FG001|NOT COMPLETED|Overall Study||8
6631413|NCT02273050|7559698|FG000|STARTED|Overall Study||210
6631414|NCT02273050|7559699|FG001|STARTED|Overall Study||216
6631415|NCT02273050|7559700|FG002|STARTED|Overall Study||214
6631416|NCT02273050|7559698|FG000|COMPLETED|Overall Study||186
6631417|NCT02273050|7559699|FG001|COMPLETED|Overall Study||194
6631418|NCT02273050|7559700|FG002|COMPLETED|Overall Study||185
6631419|NCT02273050|7559698|FG000|NOT COMPLETED|Overall Study||24
6631420|NCT02273050|7559699|FG001|NOT COMPLETED|Overall Study||22
6631421|NCT02273050|7559700|FG002|NOT COMPLETED|Overall Study||29
6631422|NCT02273063|7559708|FG000|STARTED|Overall Study||40
6631423|NCT02273063|7559708|FG000|COMPLETED|Overall Study||35
6631424|NCT02273063|7559708|FG000|NOT COMPLETED|Overall Study||5
6631425|NCT02273115|7559717|FG000|STARTED|Overall Study||94
6631426|NCT02273115|7559718|FG001|STARTED|Overall Study||90
6631427|NCT02273115|7559719|FG002|STARTED|Overall Study||67
6631428|NCT02273115|7559720|FG003|STARTED|Overall Study||72
6631429|NCT02273115|7559717|FG000|COMPLETED|Overall Study||94
6631430|NCT02273115|7559718|FG001|COMPLETED|Overall Study||90
6631431|NCT02273115|7559719|FG002|COMPLETED|Overall Study||67
6631432|NCT02273115|7559720|FG003|COMPLETED|Overall Study||71
6373833|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6631433|NCT02273115|7559717|FG000|NOT COMPLETED|Overall Study||0
6631434|NCT02273115|7559718|FG001|NOT COMPLETED|Overall Study||0
6631435|NCT02273115|7559719|FG002|NOT COMPLETED|Overall Study||0
6631436|NCT02273115|7559720|FG003|NOT COMPLETED|Overall Study||1
6631437|NCT02273141|7559732|FG000|STARTED|Overall Study||257
6631438|NCT02273141|7559733|FG001|STARTED|Overall Study||258
6631439|NCT02273141|7559732|FG000|COMPLETED|Overall Study||240
6631440|NCT02273141|7559733|FG001|COMPLETED|Overall Study||233
6631441|NCT02273141|7559732|FG000|NOT COMPLETED|Overall Study||17
6631442|NCT02273141|7559733|FG001|NOT COMPLETED|Overall Study||25
6631443|NCT02273167|7559742|FG000|STARTED|Overall Study||283
6631444|NCT02273167|7559743|FG001|STARTED|Overall Study||283
6631445|NCT02273167|7559744|FG002|STARTED|Overall Study||283
6631446|NCT02273167|7559742|FG000|COMPLETED|Overall Study||259
6631447|NCT02273167|7559743|FG001|COMPLETED|Overall Study||260
6631448|NCT02273167|7559744|FG002|COMPLETED|Overall Study||262
6631449|NCT02273167|7559742|FG000|NOT COMPLETED|Overall Study||24
6631450|NCT02273167|7559743|FG001|NOT COMPLETED|Overall Study||23
6631451|NCT02273167|7559744|FG002|NOT COMPLETED|Overall Study||21
6631452|NCT02273180|7559755|FG000|STARTED|Overall Study||253
6631453|NCT02273180|7559756|FG001|STARTED|Overall Study||254
6631454|NCT02273180|7559755|FG000|Treated|Overall Study||252
6631455|NCT02273180|7559756|FG001|Treated|Overall Study||254
6631456|NCT02273180|7559755|FG000|COMPLETED|Overall Study||226
6631457|NCT02273180|7559756|FG001|COMPLETED|Overall Study||235
6631458|NCT02273180|7559755|FG000|NOT COMPLETED|Overall Study||27
6631459|NCT02273180|7559756|FG001|NOT COMPLETED|Overall Study||19
6631460|NCT02273206|7559764|FG000|STARTED|Overall Study||378
6631461|NCT02273206|7559765|FG001|STARTED|Overall Study||379
6631462|NCT02273206|7559764|FG000|COMPLETED|Overall Study||353
6631463|NCT02273206|7559765|FG001|COMPLETED|Overall Study||337
6631464|NCT02273206|7559764|FG000|NOT COMPLETED|Overall Study||25
6631465|NCT02273206|7559765|FG001|NOT COMPLETED|Overall Study||42
6631466|NCT02273310|7559773|FG000|STARTED|Overall Study||42
6631467|NCT02273310|7559774|FG001|STARTED|Overall Study||41
6631468|NCT02273310|7559773|FG000|COMPLETED|Overall Study||24
6631469|NCT02273310|7559774|FG001|COMPLETED|Overall Study||38
6631470|NCT02273310|7559773|FG000|NOT COMPLETED|Overall Study||18
6631471|NCT02273310|7559774|FG001|NOT COMPLETED|Overall Study||3
6631472|NCT02273323|7559781|FG000|STARTED|Overall Study||15
6631473|NCT02273323|7559782|FG001|STARTED|Overall Study||15
6631474|NCT02273323|7559781|FG000|COMPLETED|Overall Study||15
6631475|NCT02273323|7559782|FG001|COMPLETED|Overall Study||15
6631476|NCT02273323|7559781|FG000|NOT COMPLETED|Overall Study||0
6631477|NCT02273323|7559782|FG001|NOT COMPLETED|Overall Study||0
6631478|NCT02273596|7559788|FG000|STARTED|24-Week Treatment Period||29
6631479|NCT02273596|7559788|FG000|Received at Least 1 Dose of Study Drug|24-Week Treatment Period||28
6631480|NCT02273596|7559788|FG000|COMPLETED|24-Week Treatment Period||22
6631481|NCT02273596|7559788|FG000|NOT COMPLETED|24-Week Treatment Period||7
6631482|NCT02273596|7559788|FG000|STARTED|Extension Period||22
6631483|NCT02273596|7559788|FG000|Received at Least 1 Dose of Study Drug|Extension Period||22
6631484|NCT02273596|7559788|FG000|COMPLETED|Extension Period||0
6631485|NCT02273596|7559788|FG000|NOT COMPLETED|Extension Period||22
6631486|NCT02273726|7559800|FG000|STARTED|Overall Study||370
6631487|NCT02273726|7559801|FG001|STARTED|Overall Study||371
6631488|NCT02273726|7559800|FG000|Received at Least 1 Dose of Study Drug|Overall Study||370
6631489|NCT02273726|7559801|FG001|Received at Least 1 Dose of Study Drug|Overall Study||370
6631490|NCT02273726|7559800|FG000|COMPLETED|Overall Study||127
6631491|NCT02273726|7559801|FG001|COMPLETED|Overall Study||183
6631492|NCT02273726|7559800|FG000|NOT COMPLETED|Overall Study||243
6631493|NCT02273726|7559801|FG001|NOT COMPLETED|Overall Study||188
6631494|NCT02273739|7559811|FG000|STARTED|Overall Study||3
6631495|NCT02273739|7559812|FG001|STARTED|Overall Study||4
6631496|NCT02273739|7559813|FG002|STARTED|Overall Study||7
6631497|NCT02273739|7559814|FG003|STARTED|Overall Study||7
6631498|NCT02273739|7559811|FG000|COMPLETED|Overall Study||0
6631499|NCT02273739|7559812|FG001|COMPLETED|Overall Study||0
6631500|NCT02273739|7559813|FG002|COMPLETED|Overall Study||0
6631501|NCT02273739|7559814|FG003|COMPLETED|Overall Study||0
6631502|NCT02273739|7559811|FG000|NOT COMPLETED|Overall Study||3
6631503|NCT02273739|7559812|FG001|NOT COMPLETED|Overall Study||4
6631504|NCT02273739|7559813|FG002|NOT COMPLETED|Overall Study||7
6631505|NCT02273739|7559814|FG003|NOT COMPLETED|Overall Study||7
6631506|NCT02273908|7559831|FG000|STARTED|Overall Study||157
6631507|NCT02273908|7559832|FG001|STARTED|Overall Study||174
6631508|NCT02273908|7559831|FG000|COMPLETED|Overall Study||124
6631509|NCT02273908|7559832|FG001|COMPLETED|Overall Study||169
6631510|NCT02273908|7559831|FG000|NOT COMPLETED|Overall Study||33
6631511|NCT02273908|7559832|FG001|NOT COMPLETED|Overall Study||5
6631512|NCT02273960|7559846|FG000|STARTED|Short Term Period||5
6631513|NCT02273960|7559847|FG001|STARTED|Short Term Period||6
6631514|NCT02273960|7559848|FG002|STARTED|Short Term Period||5
6631515|NCT02273960|7559849|FG003|STARTED|Short Term Period||10
6631516|NCT02273960|7559846|FG000|COMPLETED|Short Term Period||0
6631517|NCT02273960|7559847|FG001|COMPLETED|Short Term Period||0
6631518|NCT02273960|7559848|FG002|COMPLETED|Short Term Period||1
6631519|NCT02273960|7559849|FG003|COMPLETED|Short Term Period||4
6631520|NCT02273960|7559846|FG000|NOT COMPLETED|Short Term Period||5
6631521|NCT02273960|7559847|FG001|NOT COMPLETED|Short Term Period||6
6631522|NCT02273960|7559848|FG002|NOT COMPLETED|Short Term Period||4
6283200|NCT00191646|7183568|FG001|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
6283201|NCT00191646|7183567|FG000|NOT COMPLETED|Overall Study||171
6283202|NCT00191646|7183568|FG001|NOT COMPLETED|Overall Study||153
6283203|NCT00191724|7183587|FG000|STARTED|Overall Study||6
6283204|NCT00191724|7183588|FG001|STARTED|Overall Study||9
6631523|NCT02273960|7559849|FG003|NOT COMPLETED|Short Term Period||6
6631524|NCT02273960|7559846|FG000|STARTED|Long Term Extension||0
6631525|NCT02273960|7559847|FG001|STARTED|Long Term Extension||0
6631526|NCT02273960|7559848|FG002|STARTED|Long Term Extension||1
6631527|NCT02273960|7559849|FG003|STARTED|Long Term Extension||4
6631528|NCT02273960|7559846|FG000|COMPLETED|Long Term Extension||0
6631529|NCT02273960|7559847|FG001|COMPLETED|Long Term Extension||0
6631530|NCT02273960|7559848|FG002|COMPLETED|Long Term Extension||1
6631531|NCT02273960|7559849|FG003|COMPLETED|Long Term Extension||3
6631532|NCT02273960|7559846|FG000|NOT COMPLETED|Long Term Extension||0
6631533|NCT02273960|7559847|FG001|NOT COMPLETED|Long Term Extension||0
6631534|NCT02273960|7559848|FG002|NOT COMPLETED|Long Term Extension||0
6631535|NCT02273960|7559849|FG003|NOT COMPLETED|Long Term Extension||1
6631536|NCT02273973|7559861|FG000|STARTED|Overall Study||166
6631537|NCT02273973|7559862|FG001|STARTED|Overall Study||168
6631538|NCT02273973|7559861|FG000|COMPLETED|Overall Study||157
6631539|NCT02273973|7559862|FG001|COMPLETED|Overall Study||160
6631540|NCT02273973|7559861|FG000|NOT COMPLETED|Overall Study||9
6631541|NCT02273973|7559862|FG001|NOT COMPLETED|Overall Study||8
6655567|NCT02453711|7585721|FG005|STARTED|Overall Study||102
6655568|NCT02453711|7585722|FG006|STARTED|Overall Study||103
6655569|NCT02453711|7585723|FG007|STARTED|Overall Study||103
6655570|NCT02453711|7585724|FG008|STARTED|Overall Study||136
6655571|NCT02453711|7585716|FG000|Full Analysis Set|Overall Study||103
6655572|NCT02453711|7585717|FG001|Full Analysis Set|Overall Study||102
6655573|NCT02453711|7585718|FG002|Full Analysis Set|Overall Study||103
6655574|NCT02453711|7585719|FG003|Full Analysis Set|Overall Study||103
6655575|NCT02453711|7585720|FG004|Full Analysis Set|Overall Study||102
6655576|NCT02453711|7585721|FG005|Full Analysis Set|Overall Study||102
6655577|NCT02453711|7585722|FG006|Full Analysis Set|Overall Study||103
6655578|NCT02453711|7585723|FG007|Full Analysis Set|Overall Study||103
6655579|NCT02453711|7585724|FG008|Full Analysis Set|Overall Study||136
6655580|NCT02453711|7585716|FG000|Safety Analysis Set|Overall Study||103
6655581|NCT02453711|7585717|FG001|Safety Analysis Set|Overall Study||102
6655582|NCT02453711|7585718|FG002|Safety Analysis Set|Overall Study||103
6655583|NCT02453711|7585719|FG003|Safety Analysis Set|Overall Study||103
6655584|NCT02453711|7585720|FG004|Safety Analysis Set|Overall Study||102
6655585|NCT02453711|7585721|FG005|Safety Analysis Set|Overall Study||102
6655586|NCT02453711|7585722|FG006|Safety Analysis Set|Overall Study||103
6655587|NCT02453711|7585723|FG007|Safety Analysis Set|Overall Study||103
6655588|NCT02453711|7585724|FG008|Safety Analysis Set|Overall Study||136
6655589|NCT02453711|7585716|FG000|COMPLETED|Overall Study||92
6655590|NCT02453711|7585717|FG001|COMPLETED|Overall Study||95
6655591|NCT02453711|7585718|FG002|COMPLETED|Overall Study||94
6655592|NCT02453711|7585719|FG003|COMPLETED|Overall Study||96
6655593|NCT02453711|7585720|FG004|COMPLETED|Overall Study||100
6743002|NCT03331965|7671363|FG001|COMPLETED|Overall Study||51
6743003|NCT03331965|7671362|FG000|NOT COMPLETED|Overall Study||10
6743004|NCT03331965|7671363|FG001|NOT COMPLETED|Overall Study||4
6743005|NCT03332160|7671371|FG000|STARTED|Overall Study||25
6743006|NCT03332160|7671372|FG001|STARTED|Overall Study||24
6743007|NCT03332160|7671371|FG000|COMPLETED|Overall Study||24
6743008|NCT03332160|7671372|FG001|COMPLETED|Overall Study||19
6743009|NCT03332160|7671371|FG000|NOT COMPLETED|Overall Study||1
6743010|NCT03332160|7671372|FG001|NOT COMPLETED|Overall Study||5
6283205|NCT00191724|7183589|FG002|STARTED|Overall Study||9
6743011|NCT03332212|7671383|FG000|STARTED|Overall Study||19
6743012|NCT03332212|7671384|FG001|STARTED|Overall Study||18
6743013|NCT03332212|7671385|FG002|STARTED|Overall Study||17
6743014|NCT03332212|7671386|FG003|STARTED|Overall Study||18
6743015|NCT03332212|7671383|FG000|Treated|Overall Study||19
6743016|NCT03332212|7671384|FG001|Treated|Overall Study||17
6743017|NCT03332212|7671385|FG002|Treated|Overall Study||17
6743018|NCT03332212|7671386|FG003|Treated|Overall Study||18
6743019|NCT03332212|7671383|FG000|COMPLETED|Overall Study||18
6743020|NCT03332212|7671384|FG001|COMPLETED|Overall Study||16
6743021|NCT03332212|7671385|FG002|COMPLETED|Overall Study||17
6743022|NCT03332212|7671386|FG003|COMPLETED|Overall Study||17
6743023|NCT03332212|7671383|FG000|NOT COMPLETED|Overall Study||1
6743024|NCT03332212|7671384|FG001|NOT COMPLETED|Overall Study||2
6743025|NCT03332212|7671385|FG002|NOT COMPLETED|Overall Study||0
6743026|NCT03332212|7671386|FG003|NOT COMPLETED|Overall Study||1
6743027|NCT03332459|7671397|FG000|STARTED|Overall Study||3
6743028|NCT03332459|7671398|FG001|STARTED|Overall Study||1
6743029|NCT03332459|7671399|FG002|STARTED|Overall Study||3
6655594|NCT02453711|7585721|FG005|COMPLETED|Overall Study||96
6655595|NCT02453711|7585722|FG006|COMPLETED|Overall Study||100
6655596|NCT02453711|7585723|FG007|COMPLETED|Overall Study||96
6743030|NCT03332459|7671397|FG000|COMPLETED|Overall Study||3
6743031|NCT03332459|7671398|FG001|COMPLETED|Overall Study||1
6743032|NCT03332459|7671399|FG002|COMPLETED|Overall Study||3
6743033|NCT03332459|7671397|FG000|NOT COMPLETED|Overall Study||0
6655597|NCT02453711|7585724|FG008|COMPLETED|Overall Study||123
6655598|NCT02453711|7585716|FG000|NOT COMPLETED|Overall Study||11
6655599|NCT02453711|7585717|FG001|NOT COMPLETED|Overall Study||7
6743034|NCT03332459|7671398|FG001|NOT COMPLETED|Overall Study||0
6283206|NCT00191724|7183590|FG003|STARTED|Overall Study||8
6283207|NCT00191724|7183591|FG004|STARTED|Overall Study||15
6283208|NCT00191724|7183587|FG000|COMPLETED|Overall Study||5
6283209|NCT00191724|7183588|FG001|COMPLETED|Overall Study||8
6283210|NCT00191724|7183589|FG002|COMPLETED|Overall Study||8
6283211|NCT00191724|7183590|FG003|COMPLETED|Overall Study||5
6283212|NCT00191724|7183591|FG004|COMPLETED|Overall Study||12
6283213|NCT00191724|7183587|FG000|NOT COMPLETED|Overall Study||1
6631542|NCT02274038|7559868|FG000|STARTED|Overall Study||3
6631543|NCT02274038|7559868|FG000|COMPLETED|Overall Study||2
6631544|NCT02274038|7559868|FG000|NOT COMPLETED|Overall Study||1
6631545|NCT02274311|7559874|FG000|STARTED|Three Months of Clomiphene Treatment||16
6631546|NCT02274311|7559874|FG000|COMPLETED|Three Months of Clomiphene Treatment||16
6631547|NCT02274311|7559874|FG000|NOT COMPLETED|Three Months of Clomiphene Treatment||0
6631548|NCT02274311|7559874|FG000|STARTED|Three Months of Clomiphene Wash-out||16
6631549|NCT02274311|7559874|FG000|COMPLETED|Three Months of Clomiphene Wash-out||15
6631550|NCT02274311|7559874|FG000|NOT COMPLETED|Three Months of Clomiphene Wash-out||1
6631551|NCT02274493|7559880|FG000|STARTED|Overall Study||15
6631552|NCT02274493|7559880|FG000|COMPLETED|Overall Study||14
6631553|NCT02274493|7559880|FG000|NOT COMPLETED|Overall Study||1
6631554|NCT02274558|7559887|FG000|STARTED|Overall Study||78
6631555|NCT02274558|7559888|FG001|STARTED|Overall Study||76
6631556|NCT02274558|7559889|FG002|STARTED|Overall Study||80
6631557|NCT02274558|7559887|FG000|Included in the Safety Analysis Set|Overall Study||76
6631558|NCT02274558|7559888|FG001|Included in the Safety Analysis Set|Overall Study||72
6631559|NCT02274558|7559889|FG002|Included in the Safety Analysis Set|Overall Study||79
6631560|NCT02274558|7559887|FG000|COMPLETED|Overall Study||71
6631561|NCT02274558|7559888|FG001|COMPLETED|Overall Study||63
6631562|NCT02274558|7559889|FG002|COMPLETED|Overall Study||71
6631563|NCT02274558|7559887|FG000|NOT COMPLETED|Overall Study||7
6631564|NCT02274558|7559888|FG001|NOT COMPLETED|Overall Study||13
6631565|NCT02274558|7559889|FG002|NOT COMPLETED|Overall Study||9
6631566|NCT02274649|7559901|FG000|STARTED|Overall Study||101
6631567|NCT02274649|7559902|FG001|STARTED|Overall Study||93
6631568|NCT02274649|7559901|FG000|COMPLETED|Overall Study||77
6631569|NCT02274649|7559902|FG001|COMPLETED|Overall Study||81
6631570|NCT02274649|7559901|FG000|NOT COMPLETED|Overall Study||24
6631571|NCT02274649|7559902|FG001|NOT COMPLETED|Overall Study||12
6631572|NCT02274675|7559908|FG000|STARTED|Overall Study||7
6631573|NCT02274675|7559908|FG000|COMPLETED|Overall Study||7
6631574|NCT02274675|7559908|FG000|NOT COMPLETED|Overall Study||0
6631575|NCT02274688|7559914|FG000|STARTED|Overall Study||86
6631576|NCT02274688|7559915|FG001|STARTED|Overall Study||85
6631577|NCT02274688|7559914|FG000|COMPLETED|Overall Study||72
6631578|NCT02274688|7559915|FG001|COMPLETED|Overall Study||72
6631579|NCT02274688|7559914|FG000|NOT COMPLETED|Overall Study||14
6631580|NCT02274688|7559915|FG001|NOT COMPLETED|Overall Study||13
6631581|NCT02274766|7559924|FG000|STARTED|Overall Study||39
6631582|NCT02274766|7559925|FG001|STARTED|Overall Study||38
6631583|NCT02274766|7559924|FG000|Received Study Drug|Overall Study||38
6631584|NCT02274766|7559925|FG001|Received Study Drug|Overall Study||37
6631585|NCT02274766|7559924|FG000|COMPLETED|Overall Study||35
6631586|NCT02274766|7559925|FG001|COMPLETED|Overall Study||29
6631587|NCT02274766|7559924|FG000|NOT COMPLETED|Overall Study||4
6631588|NCT02274766|7559925|FG001|NOT COMPLETED|Overall Study||9
6631589|NCT02274792|7559931|FG000|STARTED|Overall Study||132
6631590|NCT02274792|7559931|FG000|Received Treatment|Overall Study||131
6631591|NCT02274792|7559931|FG000|COMPLETED|Overall Study||107
6631592|NCT02274792|7559931|FG000|NOT COMPLETED|Overall Study||25
6631593|NCT02274844|7559937|FG000|STARTED|Overall Study||203
6631594|NCT02274844|7559938|FG001|STARTED|Overall Study||270
6631595|NCT02274844|7559937|FG000|COMPLETED|Overall Study||165
6631596|NCT02274844|7559938|FG001|COMPLETED|Overall Study||238
6631597|NCT02274844|7559937|FG000|NOT COMPLETED|Overall Study||38
6631598|NCT02274844|7559938|FG001|NOT COMPLETED|Overall Study||32
6631599|NCT02274857|7559946|FG000|STARTED|Overall Study||179
6631600|NCT02274857|7559947|FG001|STARTED|Overall Study||171
6631601|NCT02274857|7559946|FG000|Completed Per Protocol|Overall Study||102
6631602|NCT02274857|7559947|FG001|Completed Per Protocol|Overall Study||114
6631603|NCT02274857|7559946|FG000|COMPLETED|Overall Study||159
6631604|NCT02274857|7559947|FG001|COMPLETED|Overall Study||165
6631605|NCT02274857|7559946|FG000|NOT COMPLETED|Overall Study||20
6631606|NCT02274857|7559947|FG001|NOT COMPLETED|Overall Study||6
6631607|NCT02274870|7559956|FG000|STARTED|Overall Study||32
6631608|NCT02274870|7559957|FG001|STARTED|Overall Study||33
6631609|NCT02274870|7559956|FG000|COMPLETED|Overall Study||32
6631610|NCT02274870|7559957|FG001|COMPLETED|Overall Study||33
6283214|NCT00191724|7183588|FG001|NOT COMPLETED|Overall Study||1
6631611|NCT02274870|7559956|FG000|NOT COMPLETED|Overall Study||0
6631612|NCT02274870|7559957|FG001|NOT COMPLETED|Overall Study||0
6631613|NCT02274948|7559968|FG000|STARTED|Overall Study||166
6283215|NCT00191724|7183589|FG002|NOT COMPLETED|Overall Study||1
6631614|NCT02274948|7559969|FG001|STARTED|Overall Study||173
6631615|NCT02274948|7559968|FG000|COMPLETED|Overall Study||68
6631616|NCT02274948|7559969|FG001|COMPLETED|Overall Study||82
6631617|NCT02274948|7559968|FG000|NOT COMPLETED|Overall Study||98
6631618|NCT02274948|7559969|FG001|NOT COMPLETED|Overall Study||91
6631619|NCT02275026|7559976|FG000|STARTED|Overall Study||104
6631620|NCT02275026|7559976|FG000|COMPLETED|Overall Study||71
6631621|NCT02275026|7559976|FG000|NOT COMPLETED|Overall Study||33
6631622|NCT02275052|7559983|FG000|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
6283216|NCT00191724|7183590|FG003|NOT COMPLETED|Overall Study||3
6283217|NCT00191724|7183591|FG004|NOT COMPLETED|Overall Study||3
6283218|NCT00191789|7183603|FG000|STARTED|Overall Study||65
6283219|NCT00191789|7183603|FG000|COMPLETED|Overall Study||40
6283220|NCT00191789|7183603|FG000|NOT COMPLETED|Overall Study||25
6373834|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373835|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373836|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373837|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373838|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373839|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
6373840|NCT00747474|7284553|FG000|STARTED|Cohort 8 (40 mg/m^2) Period||0
6373841|NCT00747474|7284554|FG001|STARTED|Cohort 8 (40 mg/m^2) Period||0
6631623|NCT02275052|7559984|FG001|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
6631624|NCT02275052|7559985|FG002|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
6631625|NCT02275052|7559986|FG003|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
6631626|NCT02275052|7559983|FG000|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
6631627|NCT02275052|7559984|FG001|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
6631628|NCT02275052|7559985|FG002|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
6631629|NCT02275052|7559986|FG003|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
6631630|NCT02275052|7559983|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
6631631|NCT02275052|7559984|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
6631632|NCT02275052|7559985|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
6631633|NCT02275052|7559986|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
6631634|NCT02275052|7559983|FG000|STARTED|Washout Period (12-17 Days)||90
6631635|NCT02275052|7559984|FG001|STARTED|Washout Period (12-17 Days)||93
6631636|NCT02275052|7559985|FG002|STARTED|Washout Period (12-17 Days)||0
6631637|NCT02275052|7559986|FG003|STARTED|Washout Period (12-17 Days)||0
6631638|NCT02275052|7559983|FG000|COMPLETED|Washout Period (12-17 Days)||86
6631639|NCT02275052|7559984|FG001|COMPLETED|Washout Period (12-17 Days)||93
6631640|NCT02275052|7559985|FG002|COMPLETED|Washout Period (12-17 Days)||0
6631641|NCT02275052|7559986|FG003|COMPLETED|Washout Period (12-17 Days)||0
6631642|NCT02275052|7559983|FG000|NOT COMPLETED|Washout Period (12-17 Days)||4
6631643|NCT02275052|7559984|FG001|NOT COMPLETED|Washout Period (12-17 Days)||0
6631644|NCT02275052|7559985|FG002|NOT COMPLETED|Washout Period (12-17 Days)||0
6631645|NCT02275052|7559986|FG003|NOT COMPLETED|Washout Period (12-17 Days)||0
6631646|NCT02275052|7559983|FG000|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
6631647|NCT02275052|7559984|FG001|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
6631648|NCT02275052|7559985|FG002|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
6631649|NCT02275052|7559986|FG003|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
6631650|NCT02275052|7559983|FG000|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
6631651|NCT02275052|7559984|FG001|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
6631652|NCT02275052|7559985|FG002|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
6631653|NCT02275052|7559986|FG003|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
6631654|NCT02275052|7559983|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
6631655|NCT02275052|7559984|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
6631656|NCT02275052|7559985|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
6631657|NCT02275052|7559986|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
6631658|NCT02275065|7559997|FG000|STARTED|Overall Study||5
6631659|NCT02275065|7559998|FG001|STARTED|Overall Study||4
6631660|NCT02275065|7559999|FG002|STARTED|Overall Study||5
6631661|NCT02275065|7560000|FG003|STARTED|Overall Study||5
6631662|NCT02275065|7560001|FG004|STARTED|Overall Study||4
6631663|NCT02275065|7559997|FG000|COMPLETED|Overall Study||4
6631664|NCT02275065|7559998|FG001|COMPLETED|Overall Study||4
6631665|NCT02275065|7559999|FG002|COMPLETED|Overall Study||4
6631666|NCT02275065|7560000|FG003|COMPLETED|Overall Study||4
6631667|NCT02275065|7560001|FG004|COMPLETED|Overall Study||4
6631668|NCT02275065|7559997|FG000|NOT COMPLETED|Overall Study||1
6631669|NCT02275065|7559998|FG001|NOT COMPLETED|Overall Study||0
6631670|NCT02275065|7559999|FG002|NOT COMPLETED|Overall Study||1
6631671|NCT02275065|7560000|FG003|NOT COMPLETED|Overall Study||1
6631672|NCT02275065|7560001|FG004|NOT COMPLETED|Overall Study||0
6631673|NCT02275117|7560018|FG000|STARTED|Overall Study||131
6631674|NCT02275117|7560019|FG001|STARTED|Overall Study||133
6631675|NCT02275117|7560020|FG002|STARTED|Overall Study||134
6631676|NCT02275117|7560021|FG003|STARTED|Overall Study||133
6631677|NCT02275117|7560022|FG004|STARTED|Overall Study||134
6743035|NCT03332459|7671399|FG002|NOT COMPLETED|Overall Study||0
6743036|NCT03332628|7671407|FG000|STARTED|Overall Study||113
6743037|NCT03332628|7671407|FG000|COMPLETED|Overall Study||111
6743038|NCT03332628|7671407|FG000|NOT COMPLETED|Overall Study||2
6743039|NCT03332771|7671416|FG000|STARTED|Overall Study||159
6743040|NCT03332771|7671417|FG001|STARTED|Overall Study||317
6743041|NCT03332771|7671418|FG002|STARTED|Overall Study||160
6743042|NCT03332771|7671419|FG003|STARTED|Overall Study||318
6743043|NCT03332771|7671416|FG000|COMPLETED|Overall Study||125
6743044|NCT03332771|7671417|FG001|COMPLETED|Overall Study||266
6743045|NCT03332771|7671418|FG002|COMPLETED|Overall Study||128
6743046|NCT03332771|7671419|FG003|COMPLETED|Overall Study||270
6743047|NCT03332771|7671416|FG000|NOT COMPLETED|Overall Study||34
6743048|NCT03332771|7671417|FG001|NOT COMPLETED|Overall Study||51
6373842|NCT00747474|7284555|FG002|STARTED|Cohort 8 (40 mg/m^2) Period||0
6743049|NCT03332771|7671418|FG002|NOT COMPLETED|Overall Study||32
6283221|NCT00191815|7183607|FG000|STARTED|Overall Study||70
6283222|NCT00191815|7183607|FG000|Treated|Overall Study||67
6283223|NCT00191815|7183607|FG000|COMPLETED|Overall Study||30
6283224|NCT00191815|7183607|FG000|NOT COMPLETED|Overall Study||40
6283225|NCT00191854|7183614|FG000|STARTED|Overall Study||49
6283226|NCT00191854|7183615|FG001|STARTED|Overall Study||47
6283227|NCT00191854|7183616|FG002|STARTED|Overall Study||51
6283228|NCT00191854|7183614|FG000|Received at Least One Dose of Study Drug|Overall Study||49
6283229|NCT00191854|7183615|FG001|Received at Least One Dose of Study Drug|Overall Study||47
6283230|NCT00191854|7183616|FG002|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
6283231|NCT00191854|7183614|FG000|COMPLETED|Overall Study||12
6283232|NCT00191854|7183615|FG001|COMPLETED|Overall Study||17
6283233|NCT00191854|7183616|FG002|COMPLETED|Overall Study||12
6283234|NCT00191854|7183614|FG000|NOT COMPLETED|Overall Study||37
6283235|NCT00191854|7183615|FG001|NOT COMPLETED|Overall Study||30
6283236|NCT00191854|7183616|FG002|NOT COMPLETED|Overall Study||39
6283237|NCT00191906|7183628|FG000|STARTED|Study Period II||39
6283238|NCT00191906|7183629|FG001|STARTED|Study Period II||37
6283239|NCT00191906|7183630|FG002|STARTED|Study Period II||27
6283240|NCT00191906|7183631|FG003|STARTED|Study Period II||18
6283241|NCT00191906|7183628|FG000|COMPLETED|Study Period II||39
6283242|NCT00191906|7183629|FG001|COMPLETED|Study Period II||32
6283243|NCT00191906|7183630|FG002|COMPLETED|Study Period II||26
6283244|NCT00191906|7183631|FG003|COMPLETED|Study Period II||18
6283245|NCT00191906|7183628|FG000|NOT COMPLETED|Study Period II||0
6283246|NCT00191906|7183629|FG001|NOT COMPLETED|Study Period II||5
6283247|NCT00191906|7183630|FG002|NOT COMPLETED|Study Period II||1
6283248|NCT00191906|7183631|FG003|NOT COMPLETED|Study Period II||0
6283249|NCT00191906|7183628|FG000|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
6283250|NCT00191906|7183629|FG001|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
6283251|NCT00191906|7183630|FG002|STARTED|Study Period III||0
6283252|NCT00191906|7183631|FG003|STARTED|Study Period III||0
6283253|NCT00191906|7183628|FG000|COMPLETED|Study Period III||9
6283254|NCT00191906|7183629|FG001|COMPLETED|Study Period III||7
6283255|NCT00191906|7183630|FG002|COMPLETED|Study Period III||0
6283256|NCT00191906|7183631|FG003|COMPLETED|Study Period III||0
6283257|NCT00191906|7183628|FG000|NOT COMPLETED|Study Period III||5
6283258|NCT00191906|7183629|FG001|NOT COMPLETED|Study Period III||4
6283259|NCT00191906|7183630|FG002|NOT COMPLETED|Study Period III||0
6283260|NCT00191906|7183631|FG003|NOT COMPLETED|Study Period III||0
6283261|NCT00191945|7183649|FG000|STARTED|Double-Blind Acute Treatment||100
6283262|NCT00191945|7183650|FG001|STARTED|Double-Blind Acute Treatment||51
6283263|NCT00191945|7183649|FG000|COMPLETED|Double-Blind Acute Treatment||94
6283264|NCT00191945|7183650|FG001|COMPLETED|Double-Blind Acute Treatment||48
6283265|NCT00191945|7183649|FG000|NOT COMPLETED|Double-Blind Acute Treatment||6
6283266|NCT00191945|7183650|FG001|NOT COMPLETED|Double-Blind Acute Treatment||3
6283267|NCT00191945|7183649|FG000|STARTED|Open-Label Treatment Extension||94
6283268|NCT00191945|7183650|FG001|STARTED|Open-Label Treatment Extension||48
6283269|NCT00191945|7183649|FG000|COMPLETED|Open-Label Treatment Extension||94
6283270|NCT00191945|7183650|FG001|COMPLETED|Open-Label Treatment Extension||48
6283271|NCT00191945|7183649|FG000|NOT COMPLETED|Open-Label Treatment Extension||0
6283272|NCT00191945|7183650|FG001|NOT COMPLETED|Open-Label Treatment Extension||0
6283273|NCT00191984|7183657|FG000|STARTED|Overall Study||46
6283274|NCT00191984|7183657|FG000|COMPLETED|Overall Study||7
6283275|NCT00191984|7183657|FG000|NOT COMPLETED|Overall Study||39
6283276|NCT00192023|7183663|FG000|STARTED|Period III - Double-Blind||107
6283277|NCT00192023|7183664|FG001|STARTED|Period III - Double-Blind||32
6283278|NCT00192023|7183663|FG000|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
6283279|NCT00192023|7183664|FG001|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
6283280|NCT00192023|7183663|FG000|NOT COMPLETED|Period III - Double-Blind||7
6283281|NCT00192023|7183664|FG001|NOT COMPLETED|Period III - Double-Blind||0
6283282|NCT00192023|7183663|FG000|STARTED|Period IV - Optional Open-Label||124
6283283|NCT00192023|7183664|FG001|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
6283284|NCT00192023|7183663|FG000|COMPLETED|Period IV - Optional Open-Label||49
6283285|NCT00192023|7183664|FG001|COMPLETED|Period IV - Optional Open-Label||0
6283286|NCT00192023|7183663|FG000|NOT COMPLETED|Period IV - Optional Open-Label||75
6283287|NCT00192023|7183664|FG001|NOT COMPLETED|Period IV - Optional Open-Label||0
6283288|NCT00192036|7183670|FG000|STARTED|Overall Study||49
6283289|NCT00192036|7183670|FG000|COMPLETED|Overall Study||28
6283290|NCT00192036|7183670|FG000|NOT COMPLETED|Overall Study||21
6283291|NCT00192075|7183676|FG000|STARTED|Overall Study||42
6283292|NCT00192075|7183677|FG001|STARTED|Overall Study||42
6283293|NCT00192075|7183676|FG000|COMPLETED|Overall Study||3
6283294|NCT00192075|7183677|FG001|COMPLETED|Overall Study||23
6283295|NCT00192075|7183676|FG000|NOT COMPLETED|Overall Study||39
6283296|NCT00192075|7183677|FG001|NOT COMPLETED|Overall Study||19
6283297|NCT00192114|7183688|FG000|STARTED|Overall Study||28
6283298|NCT00192114|7183688|FG000|Received at Least 1 Dose of Study Drug|Overall Study||28
6283299|NCT00192114|7183688|FG000|COMPLETED|Overall Study||4
6283300|NCT00192114|7183688|FG000|NOT COMPLETED|Overall Study||24
6399067|NCT00878995|7311776|FG000|Baseline Study|Baseline Study - Midpoint Study||12
6283301|NCT00192296|7183696|FG000|STARTED|Overall Study||6
6283302|NCT00192296|7183697|FG001|STARTED|Overall Study||6
6283303|NCT00192296|7183698|FG002|STARTED|Overall Study||6
6283304|NCT00192296|7183699|FG003|STARTED|Overall Study||6
6283305|NCT00192296|7183696|FG000|COMPLETED|Overall Study||6
6283306|NCT00192296|7183697|FG001|COMPLETED|Overall Study||5
6283307|NCT00192296|7183698|FG002|COMPLETED|Overall Study||6
6283308|NCT00192296|7183699|FG003|COMPLETED|Overall Study||6
6283309|NCT00192296|7183696|FG000|NOT COMPLETED|Overall Study||0
6283310|NCT00192296|7183697|FG001|NOT COMPLETED|Overall Study||1
6283311|NCT00192296|7183698|FG002|NOT COMPLETED|Overall Study||0
6283312|NCT00192296|7183699|FG003|NOT COMPLETED|Overall Study||0
6283313|NCT00192504|7183713|FG000|STARTED|Overall Study||5
6283314|NCT00192504|7183714|FG001|STARTED|Overall Study||5
6283315|NCT00192504|7183715|FG002|STARTED|Overall Study|Baseline demographics are not available on one patient who did not receive study drug.|6
6283316|NCT00192504|7183716|FG003|STARTED|Overall Study||15
6283317|NCT00192504|7183713|FG000|COMPLETED|Overall Study||4
6283318|NCT00192504|7183714|FG001|COMPLETED|Overall Study||5
6283319|NCT00192504|7183715|FG002|COMPLETED|Overall Study||5
6283320|NCT00192504|7183716|FG003|COMPLETED|Overall Study||15
6283321|NCT00192504|7183713|FG000|NOT COMPLETED|Overall Study||1
6283322|NCT00192504|7183714|FG001|NOT COMPLETED|Overall Study||0
6283323|NCT00192504|7183715|FG002|NOT COMPLETED|Overall Study||1
6283324|NCT00192504|7183716|FG003|NOT COMPLETED|Overall Study||0
6283325|NCT00192647|7183728|FG000|STARTED|Overall Study||448
6283326|NCT00192647|7183729|FG001|STARTED|Overall Study||448
6283327|NCT00192647|7183728|FG000|Treated|Overall Study||433
6283328|NCT00192647|7183729|FG001|Treated|Overall Study||438
6283329|NCT00192647|7183728|FG000|COMPLETED|Overall Study||320
6283330|NCT00192647|7183729|FG001|COMPLETED|Overall Study||302
6631678|NCT02275117|7560018|FG000|Randomized and Treated|Overall Study||120
6631679|NCT02275117|7560019|FG001|Randomized and Treated|Overall Study||123
6631680|NCT02275117|7560020|FG002|Randomized and Treated|Overall Study||122
6631681|NCT02275117|7560021|FG003|Randomized and Treated|Overall Study||130
6631682|NCT02275117|7560022|FG004|Randomized and Treated|Overall Study||121
6631683|NCT02275117|7560018|FG000|COMPLETED|Overall Study||97
6631684|NCT02275117|7560019|FG001|COMPLETED|Overall Study||96
6631685|NCT02275117|7560020|FG002|COMPLETED|Overall Study||92
6631686|NCT02275117|7560021|FG003|COMPLETED|Overall Study||100
6631687|NCT02275117|7560022|FG004|COMPLETED|Overall Study||98
6631688|NCT02275117|7560018|FG000|NOT COMPLETED|Overall Study||34
6631689|NCT02275117|7560019|FG001|NOT COMPLETED|Overall Study||37
6631690|NCT02275117|7560020|FG002|NOT COMPLETED|Overall Study||42
6631691|NCT02275117|7560021|FG003|NOT COMPLETED|Overall Study||33
6631692|NCT02275117|7560022|FG004|NOT COMPLETED|Overall Study||36
6631693|NCT02275156|7560037|FG000|STARTED|Overall Study||6
6631694|NCT02275156|7560038|FG001|STARTED|Overall Study||6
6631695|NCT02275156|7560039|FG002|STARTED|Overall Study||6
6631696|NCT02275156|7560037|FG000|COMPLETED|Overall Study||6
6631697|NCT02275156|7560038|FG001|COMPLETED|Overall Study||6
6631698|NCT02275156|7560039|FG002|COMPLETED|Overall Study||6
6631699|NCT02275156|7560037|FG000|NOT COMPLETED|Overall Study||0
6631700|NCT02275156|7560038|FG001|NOT COMPLETED|Overall Study||0
6631701|NCT02275156|7560039|FG002|NOT COMPLETED|Overall Study||0
6631702|NCT02275338|7560048|FG000|STARTED|Overall Study||52
6631703|NCT02275338|7560048|FG000|Completed Phase 1|Overall Study||25
6631704|NCT02275338|7560048|FG000|Started Phase 2|Overall Study||21
6631705|NCT02275338|7560048|FG000|COMPLETED|Overall Study||19
6631706|NCT02275338|7560048|FG000|NOT COMPLETED|Overall Study||33
6631707|NCT02275364|7560053|FG000|STARTED|Period 1||14
6631708|NCT02275364|7560054|FG001|STARTED|Period 1||14
6631709|NCT02275364|7560053|FG000|COMPLETED|Period 1||12
6631710|NCT02275364|7560054|FG001|COMPLETED|Period 1||14
6631711|NCT02275364|7560053|FG000|NOT COMPLETED|Period 1||2
6631712|NCT02275364|7560054|FG001|NOT COMPLETED|Period 1||0
6631713|NCT02275364|7560053|FG000|STARTED|Washout Period 1||12
6631714|NCT02275364|7560054|FG001|STARTED|Washout Period 1||14
6631715|NCT02275364|7560053|FG000|COMPLETED|Washout Period 1||12
6631716|NCT02275364|7560054|FG001|COMPLETED|Washout Period 1||14
6631717|NCT02275364|7560053|FG000|NOT COMPLETED|Washout Period 1||0
6631718|NCT02275364|7560054|FG001|NOT COMPLETED|Washout Period 1||0
6631719|NCT02275364|7560053|FG000|STARTED|Period 2||12
6631720|NCT02275364|7560054|FG001|STARTED|Period 2||14
6631721|NCT02275364|7560053|FG000|COMPLETED|Period 2||12
6631722|NCT02275364|7560054|FG001|COMPLETED|Period 2||14
6631723|NCT02275364|7560053|FG000|NOT COMPLETED|Period 2||0
6631724|NCT02275364|7560054|FG001|NOT COMPLETED|Period 2||0
6631725|NCT02275364|7560053|FG000|STARTED|Washout Period 2||12
6283331|NCT00192647|7183728|FG000|NOT COMPLETED|Overall Study||128
6283332|NCT00192647|7183729|FG001|NOT COMPLETED|Overall Study||146
6283333|NCT00193037|7183737|FG000|STARTED|Randomized Treatment||50
6283334|NCT00193037|7183738|FG001|STARTED|Randomized Treatment||52
6283335|NCT00193037|7183737|FG000|COMPLETED|Randomized Treatment||32
6631726|NCT02275364|7560054|FG001|STARTED|Washout Period 2||14
6631727|NCT02275364|7560053|FG000|COMPLETED|Washout Period 2||12
6631728|NCT02275364|7560054|FG001|COMPLETED|Washout Period 2||14
6631729|NCT02275364|7560053|FG000|NOT COMPLETED|Washout Period 2||0
6631730|NCT02275364|7560054|FG001|NOT COMPLETED|Washout Period 2||0
6631731|NCT02275364|7560053|FG000|STARTED|Period 3||12
6631732|NCT02275364|7560054|FG001|STARTED|Period 3||14
6631733|NCT02275364|7560053|FG000|COMPLETED|Period 3||12
6631734|NCT02275364|7560054|FG001|COMPLETED|Period 3||14
6283336|NCT00193037|7183738|FG001|COMPLETED|Randomized Treatment||24
6283337|NCT00193037|7183737|FG000|NOT COMPLETED|Randomized Treatment||18
6283338|NCT00193037|7183738|FG001|NOT COMPLETED|Randomized Treatment||28
6283339|NCT00193037|7183737|FG000|STARTED|Crossover Treatment||32
6283340|NCT00193037|7183738|FG001|STARTED|Crossover Treatment||24
6283341|NCT00193037|7183737|FG000|COMPLETED|Crossover Treatment||32
6283342|NCT00193037|7183738|FG001|COMPLETED|Crossover Treatment||24
6283343|NCT00193037|7183737|FG000|NOT COMPLETED|Crossover Treatment||0
6283344|NCT00193037|7183738|FG001|NOT COMPLETED|Crossover Treatment||0
6283345|NCT00193050|7183744|FG000|STARTED|Neoadjuvant Treatment||110
6283346|NCT00193050|7183744|FG000|COMPLETED|Neoadjuvant Treatment||101
6283347|NCT00193050|7183744|FG000|NOT COMPLETED|Neoadjuvant Treatment||9
6283348|NCT00193050|7183744|FG000|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
6283349|NCT00193050|7183744|FG000|COMPLETED|Surgery||103
6283350|NCT00193050|7183744|FG000|NOT COMPLETED|Surgery||0
6283351|NCT00193050|7183744|FG000|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
6283352|NCT00193050|7183744|FG000|COMPLETED|Adjuvant||77
6283353|NCT00193050|7183744|FG000|NOT COMPLETED|Adjuvant||10
6283354|NCT00193063|7183749|FG000|STARTED|Overall Study||41
6283355|NCT00193063|7183749|FG000|COMPLETED|Overall Study||37
6283356|NCT00193063|7183749|FG000|NOT COMPLETED|Overall Study||4
6283357|NCT00193128|7183755|FG000|STARTED|Overall Study||10
6283358|NCT00193128|7183756|FG001|STARTED|Overall Study||49
6283359|NCT00193128|7183755|FG000|COMPLETED|Overall Study||10
6283360|NCT00193128|7183756|FG001|COMPLETED|Overall Study||39
6283361|NCT00193128|7183755|FG000|NOT COMPLETED|Overall Study||0
6283362|NCT00193128|7183756|FG001|NOT COMPLETED|Overall Study||10
6283363|NCT00193180|7183764|FG000|STARTED|Overall Study||37
6283364|NCT00193180|7183764|FG000|COMPLETED|Overall Study||27
6283365|NCT00193180|7183764|FG000|NOT COMPLETED|Overall Study||10
6283366|NCT00193206|7183769|FG000|STARTED|Preoperative Therapy||123
6283367|NCT00193206|7183769|FG000|COMPLETED|Preoperative Therapy||116
6283368|NCT00193206|7183769|FG000|NOT COMPLETED|Preoperative Therapy||7
6283369|NCT00193206|7183769|FG000|STARTED|Surgery||116
6283370|NCT00193206|7183769|FG000|COMPLETED|Surgery||116
6283371|NCT00193206|7183769|FG000|NOT COMPLETED|Surgery||0
6283372|NCT00193206|7183769|FG000|STARTED|Postoperative Therapy||116
6283373|NCT00193206|7183769|FG000|COMPLETED|Postoperative Therapy||102
6283374|NCT00193206|7183769|FG000|NOT COMPLETED|Postoperative Therapy||14
6283375|NCT00193258|7183773|FG000|STARTED|Overall Study||94
6283376|NCT00193258|7183773|FG000|COMPLETED|Overall Study||94
6283377|NCT00193258|7183773|FG000|NOT COMPLETED|Overall Study||0
6283378|NCT00193375|7183777|FG000|STARTED|Overall Study||60
6283379|NCT00193375|7183777|FG000|COMPLETED|Overall Study||41
6283380|NCT00193375|7183777|FG000|NOT COMPLETED|Overall Study||19
6283381|NCT00193453|7183781|FG000|STARTED|Overall Study||69
6283382|NCT00193453|7183781|FG000|COMPLETED|Overall Study||21
6283383|NCT00193453|7183781|FG000|NOT COMPLETED|Overall Study||48
6283384|NCT00193492|7183787|FG000|STARTED|Overall Study||31
6283385|NCT00193492|7183788|FG001|STARTED|Overall Study||29
6283386|NCT00193492|7183787|FG000|COMPLETED|Overall Study||14
6283387|NCT00193492|7183788|FG001|COMPLETED|Overall Study||14
6283388|NCT00193492|7183787|FG000|NOT COMPLETED|Overall Study||17
6283389|NCT00193492|7183788|FG001|NOT COMPLETED|Overall Study||15
6283390|NCT00193596|7183796|FG000|STARTED|Overall Study||93
6283391|NCT00193596|7183797|FG001|STARTED|Overall Study||105
6283392|NCT00193596|7183796|FG000|COMPLETED|Overall Study||37
6283393|NCT00193596|7183797|FG001|COMPLETED|Overall Study||39
6283394|NCT00193596|7183796|FG000|NOT COMPLETED|Overall Study||56
6283395|NCT00193596|7183797|FG001|NOT COMPLETED|Overall Study||66
6283396|NCT00193609|7183803|FG000|STARTED|Overall Study||48
6283397|NCT00193609|7183803|FG000|COMPLETED|Overall Study||44
6283398|NCT00193609|7183803|FG000|NOT COMPLETED|Overall Study||4
6283399|NCT00194012|7183809|FG000|STARTED|Randomized Phase||31
6283400|NCT00194012|7183810|FG001|STARTED|Randomized Phase||31
6283401|NCT00194012|7183809|FG000|Received More Than One Dose|Randomized Phase||30
6283402|NCT00194012|7183810|FG001|Received More Than One Dose|Randomized Phase||29
6283403|NCT00194012|7183809|FG000|COMPLETED|Randomized Phase||15
6283404|NCT00194012|7183810|FG001|COMPLETED|Randomized Phase||6
6283405|NCT00194012|7183809|FG000|NOT COMPLETED|Randomized Phase||16
6283406|NCT00194012|7183810|FG001|NOT COMPLETED|Randomized Phase||25
6283407|NCT00194012|7183809|FG000|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
6283408|NCT00194012|7183810|FG001|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
6283409|NCT00194012|7183809|FG000|COMPLETED|Open Label Extension (OLE)||17
6283410|NCT00194012|7183810|FG001|COMPLETED|Open Label Extension (OLE)||15
6631735|NCT02275364|7560053|FG000|NOT COMPLETED|Period 3||0
6631736|NCT02275364|7560054|FG001|NOT COMPLETED|Period 3||0
6283411|NCT00194012|7183809|FG000|NOT COMPLETED|Open Label Extension (OLE)||5
6283412|NCT00194012|7183810|FG001|NOT COMPLETED|Open Label Extension (OLE)||6
6283413|NCT00194025|7183822|FG000|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
6283414|NCT00194025|7183822|FG000|COMPLETED|Overall Study|5 participants withdrew prematurely|15
6283415|NCT00194025|7183822|FG000|NOT COMPLETED|Overall Study||5
6283416|NCT00194077|7183828|FG000|STARTED|Overall Study||30
6283417|NCT00194077|7183829|FG001|STARTED|Overall Study||30
6631737|NCT02275364|7560053|FG000|STARTED|Period 4||12
6631738|NCT02275364|7560054|FG001|STARTED|Period 4||14
6283418|NCT00194077|7183828|FG000|COMPLETED|Overall Study|"Lack of efficacy:~Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
6283419|NCT00194077|7183829|FG001|COMPLETED|Overall Study|"Lack of efficacy:~hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
6283420|NCT00194077|7183828|FG000|NOT COMPLETED|Overall Study||24
6283421|NCT00194077|7183829|FG001|NOT COMPLETED|Overall Study||30
6283422|NCT00194116|7183837|FG000|STARTED|Overall Study||26
6283423|NCT00194116|7183838|FG001|STARTED|Overall Study||28
6283424|NCT00194116|7183837|FG000|COMPLETED|Overall Study||13
6283425|NCT00194116|7183838|FG001|COMPLETED|Overall Study||13
6283426|NCT00194116|7183837|FG000|NOT COMPLETED|Overall Study||13
6283427|NCT00194116|7183838|FG001|NOT COMPLETED|Overall Study||15
6283428|NCT00194129|7183846|FG000|STARTED|Overall Study||15
6283429|NCT00194129|7183847|FG001|STARTED|Overall Study||16
6283430|NCT00194129|7183846|FG000|COMPLETED|Overall Study||5
6283431|NCT00194129|7183847|FG001|COMPLETED|Overall Study||3
6283432|NCT00194129|7183846|FG000|NOT COMPLETED|Overall Study||10
6283433|NCT00194129|7183847|FG001|NOT COMPLETED|Overall Study||13
6283434|NCT00194532|7183862|FG000|STARTED|Overall Study||150
6283435|NCT00194532|7183863|FG001|STARTED|Overall Study||150
6283436|NCT00194532|7183862|FG000|COMPLETED|Overall Study||150
6283437|NCT00194532|7183863|FG001|COMPLETED|Overall Study||150
6283438|NCT00194532|7183862|FG000|NOT COMPLETED|Overall Study||0
6283439|NCT00194532|7183863|FG001|NOT COMPLETED|Overall Study||0
6283440|NCT00194610|7183871|FG000|STARTED|Overall Study||11
6283441|NCT00194610|7183872|FG001|STARTED|Overall Study||9
6283442|NCT00194610|7183871|FG000|COMPLETED|Overall Study||11
6283443|NCT00194610|7183872|FG001|COMPLETED|Overall Study||9
6283444|NCT00194610|7183871|FG000|NOT COMPLETED|Overall Study||0
6283445|NCT00194610|7183872|FG001|NOT COMPLETED|Overall Study||0
6283446|NCT00194675|7183880|FG000|STARTED|Overall Study||27
6283447|NCT00194675|7183881|FG001|STARTED|Overall Study||26
6283448|NCT00194675|7183880|FG000|COMPLETED|Overall Study||22
6283449|NCT00194675|7183881|FG001|COMPLETED|Overall Study||24
6283450|NCT00194675|7183880|FG000|NOT COMPLETED|Overall Study||5
6283451|NCT00194675|7183881|FG001|NOT COMPLETED|Overall Study||2
6283452|NCT00194779|7183889|FG000|STARTED|Overall Study||50
6283453|NCT00194779|7183889|FG000|COMPLETED|Overall Study||50
6283454|NCT00194779|7183889|FG000|NOT COMPLETED|Overall Study||0
6283455|NCT00194792|7183893|FG000|STARTED|Overall Study||28
6283456|NCT00194792|7183893|FG000|COMPLETED|Overall Study||27
6283457|NCT00194792|7183893|FG000|NOT COMPLETED|Overall Study||1
6283458|NCT00194896|7183901|FG000|STARTED|Overall Study||15
6283459|NCT00194896|7183902|FG001|STARTED|Overall Study||15
6283460|NCT00194896|7183903|FG002|STARTED|Overall Study||13
6283461|NCT00194896|7183904|FG003|STARTED|Overall Study||21
6283462|NCT00194896|7183901|FG000|COMPLETED|Overall Study||4
6283463|NCT00194896|7183902|FG001|COMPLETED|Overall Study||10
6283464|NCT00194896|7183903|FG002|COMPLETED|Overall Study||7
6283465|NCT00194896|7183904|FG003|COMPLETED|Overall Study||9
6283466|NCT00194896|7183901|FG000|NOT COMPLETED|Overall Study||11
6283467|NCT00194896|7183902|FG001|NOT COMPLETED|Overall Study||5
6283468|NCT00194896|7183903|FG002|NOT COMPLETED|Overall Study||6
6283469|NCT00194896|7183904|FG003|NOT COMPLETED|Overall Study||12
6283470|NCT00194987|7183916|FG000|STARTED|Overall Study||51
6283471|NCT00194987|7183917|FG001|STARTED|Overall Study||51
6283472|NCT00194987|7183916|FG000|COMPLETED|Overall Study||51
6283473|NCT00194987|7183917|FG001|COMPLETED|Overall Study|"3 women chose to withdraw because they felt the study was too inconvenient."|48
6283474|NCT00194987|7183916|FG000|NOT COMPLETED|Overall Study||0
6283475|NCT00194987|7183917|FG001|NOT COMPLETED|Overall Study||3
6283476|NCT00195013|7183927|FG000|STARTED|Overall Study||14
6283477|NCT00195013|7183928|FG001|STARTED|Overall Study||16
6283478|NCT00195013|7183927|FG000|COMPLETED|Overall Study||12
6283479|NCT00195013|7183928|FG001|COMPLETED|Overall Study||15
6283480|NCT00195013|7183927|FG000|NOT COMPLETED|Overall Study||2
6283481|NCT00195013|7183928|FG001|NOT COMPLETED|Overall Study||1
6283482|NCT00195039|7183934|FG000|STARTED|Overall Study||47
6283483|NCT00195039|7183934|FG000|COMPLETED|Overall Study||47
6283484|NCT00195039|7183934|FG000|NOT COMPLETED|Overall Study||0
6283485|NCT00195260|7183940|FG000|STARTED|Part 1: Dose Escalation||4
6283486|NCT00195260|7183941|FG001|STARTED|Part 1: Dose Escalation||4
6283487|NCT00195260|7183942|FG002|STARTED|Part 1: Dose Escalation||6
6283488|NCT00195260|7183943|FG003|STARTED|Part 1: Dose Escalation||7
6283489|NCT00195260|7183944|FG004|STARTED|Part 1: Dose Escalation||7
6283490|NCT00195260|7183945|FG005|STARTED|Part 1: Dose Escalation||7
6283491|NCT00195260|7183946|FG006|STARTED|Part 1: Dose Escalation||10
6283492|NCT00195260|7183947|FG007|STARTED|Part 1: Dose Escalation||6
6283493|NCT00195260|7183948|FG008|STARTED|Part 1: Dose Escalation||0
6283494|NCT00195260|7183949|FG009|STARTED|Part 1: Dose Escalation||0
6283495|NCT00195260|7183950|FG010|STARTED|Part 1: Dose Escalation||0
6283496|NCT00195260|7183940|FG000|COMPLETED|Part 1: Dose Escalation||0
6283497|NCT00195260|7183941|FG001|COMPLETED|Part 1: Dose Escalation||0
6283498|NCT00195260|7183942|FG002|COMPLETED|Part 1: Dose Escalation||0
6283499|NCT00195260|7183943|FG003|COMPLETED|Part 1: Dose Escalation||0
6283500|NCT00195260|7183944|FG004|COMPLETED|Part 1: Dose Escalation||0
6283501|NCT00195260|7183945|FG005|COMPLETED|Part 1: Dose Escalation||0
6283502|NCT00195260|7183946|FG006|COMPLETED|Part 1: Dose Escalation||0
6283503|NCT00195260|7183947|FG007|COMPLETED|Part 1: Dose Escalation||0
6283504|NCT00195260|7183948|FG008|COMPLETED|Part 1: Dose Escalation||0
6283505|NCT00195260|7183949|FG009|COMPLETED|Part 1: Dose Escalation||0
6283506|NCT00195260|7183950|FG010|COMPLETED|Part 1: Dose Escalation||0
6283507|NCT00195260|7183940|FG000|NOT COMPLETED|Part 1: Dose Escalation||4
6283508|NCT00195260|7183941|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
6283509|NCT00195260|7183942|FG002|NOT COMPLETED|Part 1: Dose Escalation||6
6283510|NCT00195260|7183943|FG003|NOT COMPLETED|Part 1: Dose Escalation||7
6283511|NCT00195260|7183944|FG004|NOT COMPLETED|Part 1: Dose Escalation||7
6283512|NCT00195260|7183945|FG005|NOT COMPLETED|Part 1: Dose Escalation||7
6283513|NCT00195260|7183946|FG006|NOT COMPLETED|Part 1: Dose Escalation||10
6283514|NCT00195260|7183947|FG007|NOT COMPLETED|Part 1: Dose Escalation||6
6283515|NCT00195260|7183948|FG008|NOT COMPLETED|Part 1: Dose Escalation||0
6283516|NCT00195260|7183949|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
6283517|NCT00195260|7183950|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
6283518|NCT00195260|7183940|FG000|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283519|NCT00195260|7183941|FG001|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283520|NCT00195260|7183942|FG002|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283521|NCT00195260|7183943|FG003|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283522|NCT00195260|7183944|FG004|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283523|NCT00195260|7183945|FG005|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283524|NCT00195260|7183946|FG006|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6631739|NCT02275364|7560053|FG000|COMPLETED|Period 4||12
6631740|NCT02275364|7560054|FG001|COMPLETED|Period 4||14
6631741|NCT02275364|7560053|FG000|NOT COMPLETED|Period 4||0
6631742|NCT02275364|7560054|FG001|NOT COMPLETED|Period 4||0
6631743|NCT02275611|7560075|FG000|STARTED|Inpatient Withdrawal||5
6631744|NCT02275611|7560076|FG001|STARTED|Inpatient Withdrawal||4
6631745|NCT02275611|7560077|FG002|STARTED|Inpatient Withdrawal||0
6631746|NCT02275611|7560078|FG003|STARTED|Inpatient Withdrawal||0
6631747|NCT02275611|7560075|FG000|COMPLETED|Inpatient Withdrawal||4
6631748|NCT02275611|7560076|FG001|COMPLETED|Inpatient Withdrawal||4
6631749|NCT02275611|7560077|FG002|COMPLETED|Inpatient Withdrawal||0
6631750|NCT02275611|7560078|FG003|COMPLETED|Inpatient Withdrawal||0
6631751|NCT02275611|7560075|FG000|NOT COMPLETED|Inpatient Withdrawal||1
6631752|NCT02275611|7560076|FG001|NOT COMPLETED|Inpatient Withdrawal||0
6631753|NCT02275611|7560077|FG002|NOT COMPLETED|Inpatient Withdrawal||0
6631754|NCT02275611|7560078|FG003|NOT COMPLETED|Inpatient Withdrawal||0
6631755|NCT02275611|7560075|FG000|STARTED|Outpatient Drinking||0
6631756|NCT02275611|7560076|FG001|STARTED|Outpatient Drinking||0
6631757|NCT02275611|7560077|FG002|STARTED|Outpatient Drinking||6
6631758|NCT02275611|7560078|FG003|STARTED|Outpatient Drinking||3
6631759|NCT02275611|7560075|FG000|COMPLETED|Outpatient Drinking||0
6631760|NCT02275611|7560076|FG001|COMPLETED|Outpatient Drinking||0
6631761|NCT02275611|7560077|FG002|COMPLETED|Outpatient Drinking||6
6631762|NCT02275611|7560078|FG003|COMPLETED|Outpatient Drinking||3
6631763|NCT02275611|7560075|FG000|NOT COMPLETED|Outpatient Drinking||0
6631764|NCT02275611|7560076|FG001|NOT COMPLETED|Outpatient Drinking||0
6631765|NCT02275611|7560077|FG002|NOT COMPLETED|Outpatient Drinking||0
6631766|NCT02275611|7560078|FG003|NOT COMPLETED|Outpatient Drinking||0
6631767|NCT02275767|7560093|FG000|STARTED|Overall Study||22
6631768|NCT02275767|7560094|FG001|STARTED|Overall Study||22
6631769|NCT02275767|7560095|FG002|STARTED|Overall Study||22
6631770|NCT02275767|7560093|FG000|COMPLETED|Overall Study||20
6631771|NCT02275767|7560094|FG001|COMPLETED|Overall Study||18
6631772|NCT02275767|7560095|FG002|COMPLETED|Overall Study||19
6631773|NCT02275767|7560093|FG000|NOT COMPLETED|Overall Study||2
6631774|NCT02275767|7560094|FG001|NOT COMPLETED|Overall Study||4
6631775|NCT02275767|7560095|FG002|NOT COMPLETED|Overall Study||3
6631776|NCT02275780|7560105|FG000|STARTED|Base Study: 96 Weeks||385
6631777|NCT02275780|7560106|FG001|STARTED|Base Study: 96 Weeks||384
6631778|NCT02275780|7560105|FG000|Treated|Base Study: 96 Weeks||383
6631779|NCT02275780|7560106|FG001|Treated|Base Study: 96 Weeks||383
6631780|NCT02275780|7560105|FG000|COMPLETED|Base Study: 96 Weeks||292
6631781|NCT02275780|7560106|FG001|COMPLETED|Base Study: 96 Weeks||273
6631782|NCT02275780|7560105|FG000|NOT COMPLETED|Base Study: 96 Weeks||93
6631783|NCT02275780|7560106|FG001|NOT COMPLETED|Base Study: 96 Weeks||111
6631784|NCT02275780|7560105|FG000|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|260
6631785|NCT02275780|7560106|FG001|STARTED|Extension Study: up to 192 Weeks|The extension study is optional; not all eligible participants enrolled|233
6631786|NCT02275780|7560105|FG000|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
6631787|NCT02275780|7560106|FG001|COMPLETED|Extension Study: up to 192 Weeks|The extension study is ongoing|0
6631788|NCT02275780|7560105|FG000|NOT COMPLETED|Extension Study: up to 192 Weeks||260
6631789|NCT02275780|7560106|FG001|NOT COMPLETED|Extension Study: up to 192 Weeks||233
6631790|NCT02275819|7560114|FG000|STARTED|Overall Study||5
6631791|NCT02275819|7560115|FG001|STARTED|Overall Study||6
6631792|NCT02275819|7560114|FG000|COMPLETED|Overall Study||5
6283525|NCT00195260|7183947|FG007|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283526|NCT00195260|7183948|FG008|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
6283527|NCT00195260|7183949|FG009|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
6283528|NCT00195260|7183950|FG010|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
6283529|NCT00195260|7183940|FG000|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6631793|NCT02275819|7560115|FG001|COMPLETED|Overall Study||5
6631794|NCT02275819|7560114|FG000|NOT COMPLETED|Overall Study||0
6631795|NCT02275819|7560115|FG001|NOT COMPLETED|Overall Study||1
6631796|NCT02275923|7560121|FG000|STARTED|Overall Study||9
6631797|NCT02275923|7560121|FG000|COMPLETED|Overall Study||7
6631798|NCT02275923|7560121|FG000|NOT COMPLETED|Overall Study||2
6283530|NCT00195260|7183941|FG001|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283531|NCT00195260|7183942|FG002|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283532|NCT00195260|7183943|FG003|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283533|NCT00195260|7183944|FG004|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283534|NCT00195260|7183945|FG005|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283535|NCT00195260|7183946|FG006|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283536|NCT00195260|7183947|FG007|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283537|NCT00195260|7183948|FG008|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
6283538|NCT00195260|7183949|FG009|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283539|NCT00195260|7183950|FG010|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
6283540|NCT00195260|7183940|FG000|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283541|NCT00195260|7183941|FG001|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283542|NCT00195260|7183942|FG002|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283543|NCT00195260|7183943|FG003|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283544|NCT00195260|7183944|FG004|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283545|NCT00195260|7183945|FG005|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283546|NCT00195260|7183946|FG006|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283547|NCT00195260|7183947|FG007|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
6283548|NCT00195260|7183948|FG008|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
6283549|NCT00195260|7183949|FG009|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
6283550|NCT00195260|7183950|FG010|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
6631799|NCT02276027|7560129|FG000|STARTED|Overall Study||2
6631800|NCT02276027|7560130|FG001|STARTED|Overall Study||16
6631801|NCT02276027|7560131|FG002|STARTED|Overall Study||26
6631802|NCT02276027|7560132|FG003|STARTED|Overall Study||22
6631803|NCT02276027|7560129|FG000|COMPLETED|Overall Study||0
6631804|NCT02276027|7560130|FG001|COMPLETED|Overall Study||0
6631805|NCT02276027|7560131|FG002|COMPLETED|Overall Study||6
6631806|NCT02276027|7560132|FG003|COMPLETED|Overall Study||0
6631807|NCT02276027|7560129|FG000|NOT COMPLETED|Overall Study||2
6631808|NCT02276027|7560130|FG001|NOT COMPLETED|Overall Study||16
6631809|NCT02276027|7560131|FG002|NOT COMPLETED|Overall Study||20
6631810|NCT02276027|7560132|FG003|NOT COMPLETED|Overall Study||22
6631811|NCT02276040|7560142|FG000|STARTED|Overall Study||26
6631812|NCT02276040|7560142|FG000|COMPLETED|Overall Study||11
6631813|NCT02276040|7560142|FG000|NOT COMPLETED|Overall Study||15
6631814|NCT02276053|7560146|FG000|STARTED|Overall Study||93
6631815|NCT02276053|7560146|FG000|COMPLETED|Overall Study||79
6631816|NCT02276053|7560146|FG000|NOT COMPLETED|Overall Study||14
6631817|NCT02276222|7560153|FG000|STARTED|Overall Study||621
6631818|NCT02276222|7560154|FG001|STARTED|Overall Study||466
6631819|NCT02276222|7560153|FG000|COMPLETED|Overall Study|one subject withdrew at randomization due to a pre-treatment event prior to being dosed|436
6631820|NCT02276222|7560154|FG001|COMPLETED|Overall Study||402
6631821|NCT02276222|7560153|FG000|NOT COMPLETED|Overall Study||185
6631822|NCT02276222|7560154|FG001|NOT COMPLETED|Overall Study||64
6631823|NCT02276274|7560162|FG000|STARTED|First Intervention Period||6
6631824|NCT02276274|7560163|FG001|STARTED|First Intervention Period||6
6631825|NCT02276274|7560162|FG000|COMPLETED|First Intervention Period||6
6631826|NCT02276274|7560163|FG001|COMPLETED|First Intervention Period||6
6631827|NCT02276274|7560162|FG000|NOT COMPLETED|First Intervention Period||0
6631828|NCT02276274|7560163|FG001|NOT COMPLETED|First Intervention Period||0
6631829|NCT02276274|7560162|FG000|STARTED|Washout Period (at Least 15 Days)||6
6631830|NCT02276274|7560163|FG001|STARTED|Washout Period (at Least 15 Days)||6
6631831|NCT02276274|7560162|FG000|COMPLETED|Washout Period (at Least 15 Days)||6
6631832|NCT02276274|7560163|FG001|COMPLETED|Washout Period (at Least 15 Days)||6
6631833|NCT02276274|7560162|FG000|NOT COMPLETED|Washout Period (at Least 15 Days)||0
6631834|NCT02276274|7560163|FG001|NOT COMPLETED|Washout Period (at Least 15 Days)||0
6631835|NCT02276274|7560162|FG000|STARTED|Second Intervention Period||6
6631836|NCT02276274|7560163|FG001|STARTED|Second Intervention Period||6
6631837|NCT02276274|7560162|FG000|COMPLETED|Second Intervention Period||6
6631838|NCT02276274|7560163|FG001|COMPLETED|Second Intervention Period||6
6631839|NCT02276274|7560162|FG000|NOT COMPLETED|Second Intervention Period||0
6631840|NCT02276274|7560163|FG001|NOT COMPLETED|Second Intervention Period||0
6631841|NCT02276482|7560171|FG000|STARTED|Overall Study||91
6631842|NCT02276482|7560172|FG001|STARTED|Overall Study||29
6631843|NCT02276482|7560171|FG000|COMPLETED|Overall Study||88
6631844|NCT02276482|7560172|FG001|COMPLETED|Overall Study||28
6631845|NCT02276482|7560171|FG000|NOT COMPLETED|Overall Study||3
6631846|NCT02276482|7560172|FG001|NOT COMPLETED|Overall Study||1
6631847|NCT02276612|7560180|FG000|STARTED|Overall Study||50
6631848|NCT02276612|7560181|FG001|STARTED|Overall Study||10
6631849|NCT02276612|7560180|FG000|COMPLETED|Overall Study||46
6631850|NCT02276612|7560181|FG001|COMPLETED|Overall Study||10
6283551|NCT00195273|7183980|FG000|STARTED|Overall Study||31
6283552|NCT00195273|7183981|FG001|STARTED|Overall Study||30
6399068|NCT00878995|7311777|FG001|Baseline Study|Baseline Study - Midpoint Study||12
6631851|NCT02276612|7560180|FG000|NOT COMPLETED|Overall Study||4
6631852|NCT02276612|7560181|FG001|NOT COMPLETED|Overall Study||0
6631853|NCT02276638|7560190|FG000|STARTED|Overall Study||28
6631854|NCT02276638|7560191|FG001|STARTED|Overall Study||28
6631855|NCT02276638|7560192|FG002|STARTED|Overall Study||23
6631856|NCT02276638|7560190|FG000|COMPLETED|Overall Study||28
6631857|NCT02276638|7560191|FG001|COMPLETED|Overall Study||28
6631858|NCT02276638|7560192|FG002|COMPLETED|Overall Study||23
6631859|NCT02276638|7560190|FG000|NOT COMPLETED|Overall Study||0
6631860|NCT02276638|7560191|FG001|NOT COMPLETED|Overall Study||0
6631861|NCT02276638|7560192|FG002|NOT COMPLETED|Overall Study||0
6631862|NCT02276807|7560202|FG000|STARTED|Overall Study||68
6631863|NCT02276807|7560203|FG001|STARTED|Overall Study||72
6283553|NCT00195273|7183980|FG000|COMPLETED|Overall Study||10
6283554|NCT00195273|7183981|FG001|COMPLETED|Overall Study||16
6283555|NCT00195273|7183980|FG000|NOT COMPLETED|Overall Study||21
6283556|NCT00195273|7183981|FG001|NOT COMPLETED|Overall Study||14
6283557|NCT00195338|7183987|FG000|STARTED|Overall Study||25
6283558|NCT00195338|7183987|FG000|COMPLETED|Overall Study||13
6283559|NCT00195338|7183987|FG000|NOT COMPLETED|Overall Study||12
6283560|NCT00195351|7183993|FG000|STARTED|Overall Study||236
6283561|NCT00195351|7183994|FG001|STARTED|Overall Study||231
6283562|NCT00195351|7183993|FG000|COMPLETED|Overall Study||215
6283563|NCT00195351|7183994|FG001|COMPLETED|Overall Study||215
6283564|NCT00195351|7183993|FG000|NOT COMPLETED|Overall Study||21
6283565|NCT00195351|7183994|FG001|NOT COMPLETED|Overall Study||16
6283566|NCT00195403|7184000|FG000|STARTED|Overall Study||1014
6283567|NCT00195403|7184000|FG000|COMPLETED|Overall Study||1014
6283568|NCT00195403|7184000|FG000|NOT COMPLETED|Overall Study||0
6283569|NCT00195429|7184006|FG000|STARTED|Overall Study||24
6283570|NCT00195429|7184007|FG001|STARTED|Overall Study||23
6283571|NCT00195429|7184006|FG000|COMPLETED|Overall Study||19
6283572|NCT00195429|7184007|FG001|COMPLETED|Overall Study||18
6283573|NCT00195429|7184006|FG000|NOT COMPLETED|Overall Study||5
6283574|NCT00195429|7184007|FG001|NOT COMPLETED|Overall Study||5
6283575|NCT00195442|7184013|FG000|STARTED|Overall Study||288
6283576|NCT00195442|7184013|FG000|COMPLETED|Overall Study||152
6283577|NCT00195442|7184013|FG000|NOT COMPLETED|Overall Study||136
6283578|NCT00195494|7184019|FG000|STARTED|Year 1||0
6283579|NCT00195494|7184020|FG001|STARTED|Year 1||0
6283580|NCT00195494|7184021|FG002|STARTED|Year 1||0
6283581|NCT00195494|7184022|FG003|STARTED|Year 1||0
6283582|NCT00195494|7184023|FG004|STARTED|Year 1||268
6283583|NCT00195494|7184024|FG005|STARTED|Year 1||274
6283584|NCT00195494|7184019|FG000|COMPLETED|Year 1||0
6283585|NCT00195494|7184020|FG001|COMPLETED|Year 1||0
6283586|NCT00195494|7184021|FG002|COMPLETED|Year 1||0
6283587|NCT00195494|7184022|FG003|COMPLETED|Year 1||0
6283588|NCT00195494|7184023|FG004|COMPLETED|Year 1||189
6283589|NCT00195494|7184024|FG005|COMPLETED|Year 1||221
6283590|NCT00195494|7184019|FG000|NOT COMPLETED|Year 1||0
6283591|NCT00195494|7184020|FG001|NOT COMPLETED|Year 1||0
6283592|NCT00195494|7184021|FG002|NOT COMPLETED|Year 1||0
6283593|NCT00195494|7184022|FG003|NOT COMPLETED|Year 1||0
6283594|NCT00195494|7184023|FG004|NOT COMPLETED|Year 1||79
6283595|NCT00195494|7184024|FG005|NOT COMPLETED|Year 1||53
6283596|NCT00195494|7184019|FG000|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
6283597|NCT00195494|7184020|FG001|STARTED|Year 2||90
6283598|NCT00195494|7184021|FG002|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
6283599|NCT00195494|7184022|FG003|STARTED|Year 2||99
6283600|NCT00195494|7184023|FG004|STARTED|Year 2||0
6283601|NCT00195494|7184024|FG005|STARTED|Year 2||0
6283602|NCT00195494|7184019|FG000|COMPLETED|Year 2||104
6283603|NCT00195494|7184020|FG001|COMPLETED|Year 2||74
6283604|NCT00195494|7184021|FG002|COMPLETED|Year 2||93
6283605|NCT00195494|7184022|FG003|COMPLETED|Year 2||76
6283606|NCT00195494|7184023|FG004|COMPLETED|Year 2||0
6283607|NCT00195494|7184024|FG005|COMPLETED|Year 2||0
6283608|NCT00195494|7184019|FG000|NOT COMPLETED|Year 2||7
6283609|NCT00195494|7184020|FG001|NOT COMPLETED|Year 2||16
6283610|NCT00195494|7184021|FG002|NOT COMPLETED|Year 2||18
6283611|NCT00195494|7184022|FG003|NOT COMPLETED|Year 2||23
6283612|NCT00195494|7184023|FG004|NOT COMPLETED|Year 2||0
6283613|NCT00195494|7184024|FG005|NOT COMPLETED|Year 2||0
6283614|NCT00195507|7184042|FG000|STARTED|Overall Study||357
6283615|NCT00195507|7184043|FG001|STARTED|Overall Study||363
6283616|NCT00195507|7184042|FG000|COMPLETED|Overall Study||258
6283617|NCT00195507|7184043|FG001|COMPLETED|Overall Study||245
6283618|NCT00195507|7184042|FG000|NOT COMPLETED|Overall Study||99
6283619|NCT00195507|7184043|FG001|NOT COMPLETED|Overall Study||118
6283620|NCT00195624|7184051|FG000|STARTED|Overall Study||5
6283621|NCT00195624|7184052|FG001|STARTED|Overall Study||42
6283622|NCT00195624|7184051|FG000|COMPLETED|Overall Study||5
6283623|NCT00195624|7184052|FG001|COMPLETED|Overall Study||42
6283624|NCT00195624|7184051|FG000|NOT COMPLETED|Overall Study||0
6283625|NCT00195624|7184052|FG001|NOT COMPLETED|Overall Study||0
6283626|NCT00195650|7184058|FG000|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
6283627|NCT00195650|7184058|FG000|COMPLETED|Overall Study||321
6283628|NCT00195650|7184058|FG000|NOT COMPLETED|Overall Study||525
6283629|NCT00195663|7184065|FG000|STARTED|2-year Double-blind Treatment Period||257
6631864|NCT02276807|7560202|FG000|12-week Assessment|Overall Study||57
6631865|NCT02276807|7560203|FG001|12-week Assessment|Overall Study||63
6283630|NCT00195663|7184066|FG001|STARTED|2-year Double-blind Treatment Period||274
6283631|NCT00195663|7184067|FG002|STARTED|2-year Double-blind Treatment Period||268
6283632|NCT00195663|7184065|FG000|COMPLETED|2-year Double-blind Treatment Period||164
6283633|NCT00195663|7184066|FG001|COMPLETED|2-year Double-blind Treatment Period||166
6283634|NCT00195663|7184067|FG002|COMPLETED|2-year Double-blind Treatment Period||196
6283635|NCT00195663|7184065|FG000|NOT COMPLETED|2-year Double-blind Treatment Period||93
6283636|NCT00195663|7184066|FG001|NOT COMPLETED|2-year Double-blind Treatment Period||108
6283637|NCT00195663|7184067|FG002|NOT COMPLETED|2-year Double-blind Treatment Period||72
6283638|NCT00195663|7184065|FG000|STARTED|Open-Label Extension Period||155
6283639|NCT00195663|7184066|FG001|STARTED|Open-Label Extension Period||159
6283640|NCT00195663|7184067|FG002|STARTED|Open-Label Extension Period||183
6283641|NCT00195663|7184065|FG000|COMPLETED|Open-Label Extension Period||79
6283642|NCT00195663|7184066|FG001|COMPLETED|Open-Label Extension Period||85
6283643|NCT00195663|7184067|FG002|COMPLETED|Open-Label Extension Period||86
6283644|NCT00195663|7184065|FG000|NOT COMPLETED|Open-Label Extension Period||76
6283645|NCT00195663|7184066|FG001|NOT COMPLETED|Open-Label Extension Period||74
6283646|NCT00195663|7184067|FG002|NOT COMPLETED|Open-Label Extension Period||97
6283647|NCT00195676|7184085|FG000|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
6283648|NCT00195676|7184085|FG000|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
6283649|NCT00195676|7184085|FG000|NOT COMPLETED|Period O - Open-label Treatment||606
6283650|NCT00195676|7184085|FG000|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
6283651|NCT00195676|7184085|FG000|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
6283652|NCT00195676|7184085|FG000|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
6399069|NCT00878995|7311776|FG000|COMPLETED|Baseline Study - Midpoint Study||12
6399070|NCT00878995|7311777|FG001|COMPLETED|Baseline Study - Midpoint Study|2 subjects dropped after the baseline study. They decided to seek treatment closer to home.|10
6399071|NCT00878995|7311776|FG000|NOT COMPLETED|Baseline Study - Midpoint Study||0
6399072|NCT00878995|7311777|FG001|NOT COMPLETED|Baseline Study - Midpoint Study||2
6399073|NCT00878995|7311776|FG000|STARTED|Midpoint Study - Post Study||12
6399074|NCT00878995|7311777|FG001|STARTED|Midpoint Study - Post Study||10
6399075|NCT00878995|7311776|FG000|COMPLETED|Midpoint Study - Post Study||12
6399076|NCT00878995|7311777|FG001|COMPLETED|Midpoint Study - Post Study||10
6399077|NCT00878995|7311776|FG000|NOT COMPLETED|Midpoint Study - Post Study||0
6399078|NCT00878995|7311777|FG001|NOT COMPLETED|Midpoint Study - Post Study||0
6399079|NCT00879034|7311783|FG000|STARTED|Overall Study||5
6399080|NCT00879034|7311783|FG000|Received Treatment|Overall Study||4
6399081|NCT00879034|7311783|FG000|COMPLETED|Overall Study||5
6631866|NCT02276807|7560202|FG000|COMPLETED|Overall Study||50
6631867|NCT02276807|7560203|FG001|COMPLETED|Overall Study||55
6631868|NCT02276807|7560202|FG000|NOT COMPLETED|Overall Study||18
6631869|NCT02276807|7560203|FG001|NOT COMPLETED|Overall Study||17
6631870|NCT02276872|7560212|FG000|STARTED|Overall Study||10
6631871|NCT02276872|7560213|FG001|STARTED|Overall Study||10
6631872|NCT02276872|7560214|FG002|STARTED|Overall Study||12
6631873|NCT02276872|7560212|FG000|COMPLETED|Overall Study||9
6631874|NCT02276872|7560213|FG001|COMPLETED|Overall Study||10
6631875|NCT02276872|7560214|FG002|COMPLETED|Overall Study||12
6631876|NCT02276872|7560212|FG000|NOT COMPLETED|Overall Study||1
6631877|NCT02276872|7560213|FG001|NOT COMPLETED|Overall Study||0
6631878|NCT02276872|7560214|FG002|NOT COMPLETED|Overall Study||0
6631879|NCT02276963|7560227|FG000|STARTED|Overall Study||6
6631880|NCT02276963|7560227|FG000|COMPLETED|Overall Study||3
6631881|NCT02276963|7560227|FG000|NOT COMPLETED|Overall Study||3
6631882|NCT02277054|7560231|FG000|STARTED|Overall Study||5
6631883|NCT02277054|7560231|FG000|COMPLETED|Overall Study||5
6631884|NCT02277054|7560231|FG000|NOT COMPLETED|Overall Study||0
6631885|NCT02277093|7560236|FG000|STARTED|Overall Study||11
6631886|NCT02277093|7560236|FG000|COMPLETED|Overall Study||11
6631887|NCT02277093|7560236|FG000|NOT COMPLETED|Overall Study||0
6631888|NCT02277249|7560242|FG000|STARTED|Overall Study||30
6631889|NCT02277249|7560243|FG001|STARTED|Overall Study||30
6631890|NCT02277249|7560242|FG000|COMPLETED|Overall Study||30
6631891|NCT02277249|7560243|FG001|COMPLETED|Overall Study||30
6631892|NCT02277249|7560242|FG000|NOT COMPLETED|Overall Study||0
6631893|NCT02277249|7560243|FG001|NOT COMPLETED|Overall Study||0
6631894|NCT02277548|7560251|FG000|STARTED|Overall Study||9
6631895|NCT02277548|7560252|FG001|STARTED|Overall Study||11
6631896|NCT02277548|7560251|FG000|COMPLETED|Overall Study||9
6631897|NCT02277548|7560252|FG001|COMPLETED|Overall Study||9
6631898|NCT02277548|7560251|FG000|NOT COMPLETED|Overall Study||0
6631899|NCT02277548|7560252|FG001|NOT COMPLETED|Overall Study||2
6631900|NCT02277626|7560258|FG000|STARTED|Overall Study||6
6631901|NCT02277626|7560259|FG001|STARTED|Overall Study||9
6631902|NCT02277626|7560258|FG000|COMPLETED|Overall Study||6
6631903|NCT02277626|7560259|FG001|COMPLETED|Overall Study||9
6631904|NCT02277626|7560258|FG000|NOT COMPLETED|Overall Study||0
6631905|NCT02277626|7560259|FG001|NOT COMPLETED|Overall Study||0
6399082|NCT00879034|7311783|FG000|NOT COMPLETED|Overall Study||0
6399083|NCT00879060|7311789|FG000|STARTED|Overall Study||26
6399084|NCT00879060|7311790|FG001|STARTED|Overall Study||27
6399085|NCT00879060|7311789|FG000|COMPLETED|Overall Study||26
6399086|NCT00879060|7311790|FG001|COMPLETED|Overall Study||27
6399087|NCT00879060|7311789|FG000|NOT COMPLETED|Overall Study||0
6399088|NCT00879060|7311790|FG001|NOT COMPLETED|Overall Study||0
6631906|NCT02277639|7560272|FG000|STARTED|Overall Study||0
6631907|NCT02277639|7560273|FG001|STARTED|Overall Study||2
6631908|NCT02277639|7560272|FG000|COMPLETED|Overall Study||0
6631909|NCT02277639|7560273|FG001|COMPLETED|Overall Study||2
6631910|NCT02277639|7560272|FG000|NOT COMPLETED|Overall Study||0
6283653|NCT00195676|7184085|FG000|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
6283654|NCT00195676|7184085|FG000|COMPLETED|Period R - Retreatment 16 Weeks||490
6283655|NCT00195676|7184085|FG000|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
6283656|NCT00195702|7184096|FG000|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
6283657|NCT00195702|7184097|FG001|STARTED|Double-blind Phase||207
6283658|NCT00195702|7184098|FG002|STARTED|Double-blind Phase||200
6283659|NCT00195702|7184099|FG003|STARTED|Double-blind Phase||0
6283660|NCT00195702|7184100|FG004|STARTED|Double-blind Phase||0
6283661|NCT00195702|7184101|FG005|STARTED|Double-blind Phase||0
6283662|NCT00195702|7184096|FG000|COMPLETED|Double-blind Phase||168
6283663|NCT00195702|7184097|FG001|COMPLETED|Double-blind Phase||159
6283664|NCT00195702|7184098|FG002|COMPLETED|Double-blind Phase||140
6283665|NCT00195702|7184099|FG003|COMPLETED|Double-blind Phase||0
6283666|NCT00195702|7184100|FG004|COMPLETED|Double-blind Phase||0
6283667|NCT00195702|7184101|FG005|COMPLETED|Double-blind Phase||0
6283668|NCT00195702|7184096|FG000|NOT COMPLETED|Double-blind Phase||44
6283669|NCT00195702|7184097|FG001|NOT COMPLETED|Double-blind Phase||48
6283670|NCT00195702|7184098|FG002|NOT COMPLETED|Double-blind Phase||60
6283671|NCT00195702|7184099|FG003|NOT COMPLETED|Double-blind Phase||0
6283672|NCT00195702|7184100|FG004|NOT COMPLETED|Double-blind Phase||0
6283673|NCT00195702|7184101|FG005|NOT COMPLETED|Double-blind Phase||0
6283674|NCT00195702|7184096|FG000|STARTED|Open-label Extension Phase||0
6283675|NCT00195702|7184097|FG001|STARTED|Open-label Extension Phase||0
6283676|NCT00195702|7184098|FG002|STARTED|Open-label Extension Phase||0
6283677|NCT00195702|7184099|FG003|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
6283678|NCT00195702|7184100|FG004|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
6283679|NCT00195702|7184101|FG005|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
6283680|NCT00195702|7184096|FG000|COMPLETED|Open-label Extension Phase||0
6283681|NCT00195702|7184097|FG001|COMPLETED|Open-label Extension Phase||0
6283682|NCT00195702|7184098|FG002|COMPLETED|Open-label Extension Phase||0
6283683|NCT00195702|7184099|FG003|COMPLETED|Open-label Extension Phase||66
6283684|NCT00195702|7184100|FG004|COMPLETED|Open-label Extension Phase||80
6283685|NCT00195702|7184101|FG005|COMPLETED|Open-label Extension Phase||56
6283686|NCT00195702|7184096|FG000|NOT COMPLETED|Open-label Extension Phase||0
6283687|NCT00195702|7184097|FG001|NOT COMPLETED|Open-label Extension Phase||0
6283688|NCT00195702|7184098|FG002|NOT COMPLETED|Open-label Extension Phase||0
6283689|NCT00195702|7184099|FG003|NOT COMPLETED|Open-label Extension Phase||99
6283690|NCT00195702|7184100|FG004|NOT COMPLETED|Open-label Extension Phase||78
6283691|NCT00195702|7184101|FG005|NOT COMPLETED|Open-label Extension Phase||78
6283692|NCT00195715|7184114|FG000|STARTED|Overall Study||777
6283693|NCT00195715|7184114|FG000|COMPLETED|Overall Study||400
6631911|NCT02277639|7560273|FG001|NOT COMPLETED|Overall Study||0
6631912|NCT02277665|7560281|FG000|STARTED|Overall Study||33
6631913|NCT02277665|7560282|FG001|STARTED|Overall Study||34
6631914|NCT02277665|7560281|FG000|COMPLETED|Overall Study||33
6631915|NCT02277665|7560282|FG001|COMPLETED|Overall Study||34
6631916|NCT02277665|7560281|FG000|NOT COMPLETED|Overall Study||0
6631917|NCT02277665|7560282|FG001|NOT COMPLETED|Overall Study||0
6631918|NCT02277691|7560290|FG000|STARTED|Overall Study||341
6631919|NCT02277691|7560290|FG000|COMPLETED|Overall Study||295
6631920|NCT02277691|7560290|FG000|NOT COMPLETED|Overall Study||46
6631921|NCT02277743|7560297|FG000|STARTED|Overall Study||224
6631922|NCT02277743|7560298|FG001|STARTED|Overall Study||224
6631923|NCT02277743|7560299|FG002|STARTED|Overall Study||223
6631924|NCT02277743|7560297|FG000|Treated|Overall Study||223
6631925|NCT02277743|7560298|FG001|Treated|Overall Study||223
6631926|NCT02277743|7560299|FG002|Treated|Overall Study||223
6631927|NCT02277743|7560297|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|222
6631928|NCT02277743|7560298|FG001|Safety Population|Overall Study|6 participants (1 [placebo] + 5 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|229
6631929|NCT02277743|7560299|FG002|Safety Population|Overall Study|5 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|218
6631930|NCT02277743|7560297|FG000|COMPLETED|Overall Study||184
6631931|NCT02277743|7560298|FG001|COMPLETED|Overall Study||208
6631932|NCT02277743|7560299|FG002|COMPLETED|Overall Study||197
6631933|NCT02277743|7560297|FG000|NOT COMPLETED|Overall Study||40
6631934|NCT02277743|7560298|FG001|NOT COMPLETED|Overall Study||16
6631935|NCT02277743|7560299|FG002|NOT COMPLETED|Overall Study||26
6631936|NCT02277769|7560310|FG000|STARTED|Overall Study||236
6631937|NCT02277769|7560311|FG001|STARTED|Overall Study||233
6631938|NCT02277769|7560312|FG002|STARTED|Overall Study||239
6631939|NCT02277769|7560310|FG000|Treated|Overall Study||235
6631940|NCT02277769|7560311|FG001|Treated|Overall Study||233
6631941|NCT02277769|7560312|FG002|Treated|Overall Study||239
6631942|NCT02277769|7560310|FG000|Safety Population|Overall Study|1 participant received at least 1 injection of Dupilumab 300mg(analyzed in Dupilumab 300 mg q2w arm)|234
6631943|NCT02277769|7560311|FG001|Safety Population|Overall Study|3 participants (1 [placebo] + 2 [Dupilumab 300 mg qw arm]) analyzed in Dupilumab 300 mg q2w arm|236
6631944|NCT02277769|7560312|FG002|Safety Population|Overall Study|2 participants received fewer injections of Dupilumab 300 mg (analyzed in Dupilumab 300 mg q2w arm)|237
6283694|NCT00195715|7184114|FG000|NOT COMPLETED|Overall Study||377
6283695|NCT00195819|7184118|FG000|STARTED|Double-Blind||44
6283696|NCT00195819|7184119|FG001|STARTED|Double-Blind||38
6283697|NCT00195819|7184118|FG000|COMPLETED|Double-Blind||42
6283698|NCT00195819|7184119|FG001|COMPLETED|Double-Blind||38
6283699|NCT00195819|7184118|FG000|NOT COMPLETED|Double-Blind||2
6283700|NCT00195819|7184119|FG001|NOT COMPLETED|Double-Blind||0
6283701|NCT00195819|7184118|FG000|STARTED|Open-label||0
6283702|NCT00195819|7184119|FG001|STARTED|Open-label||82
6283703|NCT00195819|7184118|FG000|COMPLETED|Open-label||0
6283704|NCT00195819|7184119|FG001|COMPLETED|Open-label||62
6283705|NCT00195819|7184118|FG000|NOT COMPLETED|Open-label||0
6283706|NCT00195819|7184119|FG001|NOT COMPLETED|Open-label||20
6283707|NCT00196105|7184134|FG000|STARTED|Overall Study||64
6283708|NCT00196105|7184135|FG001|STARTED|Overall Study||88
6283709|NCT00196105|7184136|FG002|STARTED|Overall Study||89
6283710|NCT00196105|7184134|FG000|COMPLETED|Overall Study||60
6283711|NCT00196105|7184135|FG001|COMPLETED|Overall Study||83
6283712|NCT00196105|7184136|FG002|COMPLETED|Overall Study||82
6283713|NCT00196105|7184134|FG000|NOT COMPLETED|Overall Study||4
6283714|NCT00196105|7184135|FG001|NOT COMPLETED|Overall Study||5
6283715|NCT00196105|7184136|FG002|NOT COMPLETED|Overall Study||7
6283716|NCT00196196|7184144|FG000|STARTED|Overall Study||274
6283717|NCT00196196|7184144|FG000|COMPLETED|Overall Study||267
6283718|NCT00196196|7184144|FG000|NOT COMPLETED|Overall Study||7
6283719|NCT00196313|7184150|FG000|STARTED|Overall Study||47
6283720|NCT00196313|7184151|FG001|STARTED|Overall Study||48
6283721|NCT00196313|7184150|FG000|COMPLETED|Overall Study||36
6283722|NCT00196313|7184151|FG001|COMPLETED|Overall Study||40
6283723|NCT00196313|7184150|FG000|NOT COMPLETED|Overall Study||11
6283724|NCT00196313|7184151|FG001|NOT COMPLETED|Overall Study||8
6283725|NCT00196326|7184158|FG000|STARTED|Overall Study|Took at least one dose of study medication|2235
6283726|NCT00196326|7184158|FG000|Safety Population|Overall Study|Treated participants|2185
6283727|NCT00196326|7184158|FG000|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
6283728|NCT00196326|7184158|FG000|COMPLETED|Overall Study||1249
6283729|NCT00196326|7184158|FG000|NOT COMPLETED|Overall Study||986
6283730|NCT00196716|7184162|FG000|STARTED|1.0 mg/kg Period||21
6283731|NCT00196716|7184162|FG000|COMPLETED|1.0 mg/kg Period||21
6283732|NCT00196716|7184162|FG000|NOT COMPLETED|1.0 mg/kg Period||0
6283733|NCT00196716|7184162|FG000|STARTED|0.3 mg/kg Period||21
6283734|NCT00196716|7184162|FG000|COMPLETED|0.3 mg/kg Period||21
6283735|NCT00196716|7184162|FG000|NOT COMPLETED|0.3 mg/kg Period||0
6631945|NCT02277769|7560310|FG000|COMPLETED|Overall Study||190
6631946|NCT02277769|7560311|FG001|COMPLETED|Overall Study||220
6631947|NCT02277769|7560312|FG002|COMPLETED|Overall Study||221
6631948|NCT02277769|7560310|FG000|NOT COMPLETED|Overall Study||46
6631949|NCT02277769|7560311|FG001|NOT COMPLETED|Overall Study||13
6631950|NCT02277769|7560312|FG002|NOT COMPLETED|Overall Study||18
6631951|NCT02277925|7560322|FG000|STARTED|Overall Study||102
6631952|NCT02277925|7560323|FG001|STARTED|Overall Study||102
6631953|NCT02277925|7560322|FG000|Surgery|Overall Study||99
6631954|NCT02277925|7560323|FG001|Surgery|Overall Study||101
6631955|NCT02277925|7560322|FG000|COMPLETED|Overall Study||95
6631956|NCT02277925|7560323|FG001|COMPLETED|Overall Study||87
6631957|NCT02277925|7560322|FG000|NOT COMPLETED|Overall Study||7
6631958|NCT02277925|7560323|FG001|NOT COMPLETED|Overall Study||15
6631959|NCT02277990|7560333|FG000|STARTED|Overall Study||3495
6631960|NCT02277990|7560334|FG001|STARTED|Overall Study||3488
6631961|NCT02277990|7560333|FG000|COMPLETED|Overall Study||3129
6631962|NCT02277990|7560334|FG001|COMPLETED|Overall Study||3112
6631963|NCT02277990|7560333|FG000|NOT COMPLETED|Overall Study||366
6631964|NCT02277990|7560334|FG001|NOT COMPLETED|Overall Study||376
6631965|NCT02278003|7560342|FG000|STARTED|Overall Study||49
6631966|NCT02278003|7560343|FG001|STARTED|Overall Study||20
6631967|NCT02278003|7560342|FG000|COMPLETED|Overall Study||30
6631968|NCT02278003|7560343|FG001|COMPLETED|Overall Study||20
6631969|NCT02278003|7560342|FG000|NOT COMPLETED|Overall Study||19
6631970|NCT02278003|7560343|FG001|NOT COMPLETED|Overall Study||0
6631971|NCT02278146|7560351|FG000|STARTED|Overall Study||6
6631972|NCT02278146|7560352|FG001|STARTED|Overall Study||10
6631973|NCT02278146|7560351|FG000|COMPLETED|Overall Study||6
6631974|NCT02278146|7560352|FG001|COMPLETED|Overall Study||8
6283736|NCT00196937|7184171|FG000|STARTED|Overall Study||229
6283737|NCT00196937|7184172|FG001|STARTED|Overall Study||226
6283738|NCT00196937|7184173|FG002|STARTED|Overall Study||211
6283739|NCT00196937|7184171|FG000|COMPLETED|Overall Study||220
6283740|NCT00196937|7184172|FG001|COMPLETED|Overall Study||221
6283741|NCT00196937|7184173|FG002|COMPLETED|Overall Study||204
6283742|NCT00196937|7184171|FG000|NOT COMPLETED|Overall Study||9
6283743|NCT00196937|7184172|FG001|NOT COMPLETED|Overall Study||5
6283744|NCT00196937|7184173|FG002|NOT COMPLETED|Overall Study||7
6283745|NCT00196976|7184196|FG000|STARTED|Primary Study||39
6283746|NCT00196976|7184197|FG001|STARTED|Primary Study||41
6283747|NCT00196976|7184198|FG002|STARTED|Primary Study||41
6283748|NCT00196976|7184199|FG003|STARTED|Primary Study||40
6283749|NCT00196976|7184200|FG004|STARTED|Primary Study||40
6283750|NCT00196976|7184201|FG005|STARTED|Primary Study||54
6283751|NCT00196976|7184202|FG006|STARTED|Primary Study||50
6283752|NCT00196976|7184203|FG007|STARTED|Primary Study||52
6631975|NCT02278146|7560351|FG000|NOT COMPLETED|Overall Study||0
6631976|NCT02278146|7560352|FG001|NOT COMPLETED|Overall Study||2
6631977|NCT02278237|7560358|FG000|STARTED|Overall Study||90
6631978|NCT02278237|7560358|FG000|COMPLETED|Overall Study||83
6631979|NCT02278237|7560358|FG000|NOT COMPLETED|Overall Study||7
6631980|NCT02278263|7560365|FG000|STARTED|Overall Study||30
6631981|NCT02278263|7560366|FG001|STARTED|Overall Study||60
6631982|NCT02278263|7560367|FG002|STARTED|Overall Study||60
6631983|NCT02278263|7560365|FG000|COMPLETED|Overall Study||23
6631984|NCT02278263|7560366|FG001|COMPLETED|Overall Study|Correction|60
6283753|NCT00196976|7184204|FG008|STARTED|Primary Study||52
6283754|NCT00196976|7184205|FG009|STARTED|Primary Study||52
6283755|NCT00196976|7184206|FG010|STARTED|Primary Study||0
6283756|NCT00196976|7184207|FG011|STARTED|Primary Study||0
6283757|NCT00196976|7184208|FG012|STARTED|Primary Study||0
6283758|NCT00196976|7184209|FG013|STARTED|Primary Study||0
6283759|NCT00196976|7184196|FG000|COMPLETED|Primary Study||38
6283760|NCT00196976|7184197|FG001|COMPLETED|Primary Study||40
6283761|NCT00196976|7184198|FG002|COMPLETED|Primary Study||37
6283762|NCT00196976|7184199|FG003|COMPLETED|Primary Study||39
6283763|NCT00196976|7184200|FG004|COMPLETED|Primary Study||37
6283764|NCT00196976|7184201|FG005|COMPLETED|Primary Study||52
6283765|NCT00196976|7184202|FG006|COMPLETED|Primary Study||50
6283766|NCT00196976|7184203|FG007|COMPLETED|Primary Study||49
6283767|NCT00196976|7184204|FG008|COMPLETED|Primary Study||52
6283768|NCT00196976|7184205|FG009|COMPLETED|Primary Study||51
6283769|NCT00196976|7184206|FG010|COMPLETED|Primary Study||0
6283770|NCT00196976|7184207|FG011|COMPLETED|Primary Study||0
6283771|NCT00196976|7184208|FG012|COMPLETED|Primary Study||0
6283772|NCT00196976|7184209|FG013|COMPLETED|Primary Study||0
6283773|NCT00196976|7184196|FG000|NOT COMPLETED|Primary Study||1
6283774|NCT00196976|7184197|FG001|NOT COMPLETED|Primary Study||1
6283775|NCT00196976|7184198|FG002|NOT COMPLETED|Primary Study||4
6283776|NCT00196976|7184199|FG003|NOT COMPLETED|Primary Study||1
6283777|NCT00196976|7184200|FG004|NOT COMPLETED|Primary Study||3
6283778|NCT00196976|7184201|FG005|NOT COMPLETED|Primary Study||2
6283779|NCT00196976|7184202|FG006|NOT COMPLETED|Primary Study||0
6631985|NCT02278263|7560367|FG002|COMPLETED|Overall Study||51
6631986|NCT02278263|7560365|FG000|NOT COMPLETED|Overall Study||7
6631987|NCT02278263|7560366|FG001|NOT COMPLETED|Overall Study||0
6631988|NCT02278263|7560367|FG002|NOT COMPLETED|Overall Study||9
6631989|NCT02278289|7560380|FG000|STARTED|Overall Study||30
6631990|NCT02278289|7560381|FG001|STARTED|Overall Study||30
6631991|NCT02278289|7560380|FG000|COMPLETED|Overall Study||24
6631992|NCT02278289|7560381|FG001|COMPLETED|Overall Study||23
6631993|NCT02278289|7560380|FG000|NOT COMPLETED|Overall Study||6
6631994|NCT02278289|7560381|FG001|NOT COMPLETED|Overall Study||7
6631995|NCT02278328|7560387|FG000|STARTED|Neuropsych Screening||10
6631996|NCT02278328|7560388|FG001|STARTED|Neuropsych Screening||7
6631997|NCT02278328|7560389|FG002|STARTED|Neuropsych Screening||8
6631998|NCT02278328|7560387|FG000|COMPLETED|Neuropsych Screening||9
6631999|NCT02278328|7560388|FG001|COMPLETED|Neuropsych Screening||6
6632000|NCT02278328|7560389|FG002|COMPLETED|Neuropsych Screening||6
6632001|NCT02278328|7560387|FG000|NOT COMPLETED|Neuropsych Screening||1
6632002|NCT02278328|7560388|FG001|NOT COMPLETED|Neuropsych Screening||1
6632003|NCT02278328|7560389|FG002|NOT COMPLETED|Neuropsych Screening||2
6632004|NCT02278328|7560387|FG000|STARTED|First Intervention (1 Day)||9
6632005|NCT02278328|7560388|FG001|STARTED|First Intervention (1 Day)||6
6632006|NCT02278328|7560389|FG002|STARTED|First Intervention (1 Day)||6
6632007|NCT02278328|7560387|FG000|COMPLETED|First Intervention (1 Day)||9
6632008|NCT02278328|7560388|FG001|COMPLETED|First Intervention (1 Day)||6
6632009|NCT02278328|7560389|FG002|COMPLETED|First Intervention (1 Day)||6
6632010|NCT02278328|7560387|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6632011|NCT02278328|7560388|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6632012|NCT02278328|7560389|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6632013|NCT02278328|7560387|FG000|STARTED|Washout (1 Week)||9
6632014|NCT02278328|7560388|FG001|STARTED|Washout (1 Week)||6
6632015|NCT02278328|7560389|FG002|STARTED|Washout (1 Week)||6
6632016|NCT02278328|7560387|FG000|COMPLETED|Washout (1 Week)||9
6632017|NCT02278328|7560388|FG001|COMPLETED|Washout (1 Week)||6
6632018|NCT02278328|7560389|FG002|COMPLETED|Washout (1 Week)||6
6632019|NCT02278328|7560387|FG000|NOT COMPLETED|Washout (1 Week)||0
6632020|NCT02278328|7560388|FG001|NOT COMPLETED|Washout (1 Week)||0
6632021|NCT02278328|7560389|FG002|NOT COMPLETED|Washout (1 Week)||0
6632022|NCT02278328|7560387|FG000|STARTED|Second Intervention (1 Day)||9
6632023|NCT02278328|7560388|FG001|STARTED|Second Intervention (1 Day)||6
6632024|NCT02278328|7560389|FG002|STARTED|Second Intervention (1 Day)||6
6632025|NCT02278328|7560387|FG000|COMPLETED|Second Intervention (1 Day)||9
6283780|NCT00196976|7184203|FG007|NOT COMPLETED|Primary Study||3
6283781|NCT00196976|7184204|FG008|NOT COMPLETED|Primary Study||0
6283782|NCT00196976|7184205|FG009|NOT COMPLETED|Primary Study||1
6283783|NCT00196976|7184206|FG010|NOT COMPLETED|Primary Study||0
6283784|NCT00196976|7184207|FG011|NOT COMPLETED|Primary Study||0
6283785|NCT00196976|7184208|FG012|NOT COMPLETED|Primary Study||0
6283786|NCT00196976|7184209|FG013|NOT COMPLETED|Primary Study||0
6283787|NCT00196976|7184196|FG000|STARTED|Booster Study||0
6283788|NCT00196976|7184197|FG001|STARTED|Booster Study||0
6283789|NCT00196976|7184198|FG002|STARTED|Booster Study||0
6283790|NCT00196976|7184199|FG003|STARTED|Booster Study||0
6283791|NCT00196976|7184200|FG004|STARTED|Booster Study||0
6632026|NCT02278328|7560388|FG001|COMPLETED|Second Intervention (1 Day)||6
6632027|NCT02278328|7560389|FG002|COMPLETED|Second Intervention (1 Day)||6
6632028|NCT02278328|7560387|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6283792|NCT00196976|7184201|FG005|STARTED|Booster Study||0
6283793|NCT00196976|7184202|FG006|STARTED|Booster Study||0
6283794|NCT00196976|7184203|FG007|STARTED|Booster Study||0
6283795|NCT00196976|7184204|FG008|STARTED|Booster Study||0
6283796|NCT00196976|7184205|FG009|STARTED|Booster Study||0
6283797|NCT00196976|7184206|FG010|STARTED|Booster Study||33
6283798|NCT00196976|7184207|FG011|STARTED|Booster Study||32
6283799|NCT00196976|7184208|FG012|STARTED|Booster Study||45
6283800|NCT00196976|7184209|FG013|STARTED|Booster Study||43
6283801|NCT00196976|7184196|FG000|COMPLETED|Booster Study||0
6283802|NCT00196976|7184197|FG001|COMPLETED|Booster Study||0
6283803|NCT00196976|7184198|FG002|COMPLETED|Booster Study||0
6283804|NCT00196976|7184199|FG003|COMPLETED|Booster Study||0
6283805|NCT00196976|7184200|FG004|COMPLETED|Booster Study||0
6283806|NCT00196976|7184201|FG005|COMPLETED|Booster Study||0
6283807|NCT00196976|7184202|FG006|COMPLETED|Booster Study||0
6283808|NCT00196976|7184203|FG007|COMPLETED|Booster Study||0
6283809|NCT00196976|7184204|FG008|COMPLETED|Booster Study||0
6283810|NCT00196976|7184205|FG009|COMPLETED|Booster Study||0
6283811|NCT00196976|7184206|FG010|COMPLETED|Booster Study||31
6283812|NCT00196976|7184207|FG011|COMPLETED|Booster Study||30
6283813|NCT00196976|7184208|FG012|COMPLETED|Booster Study||45
6283814|NCT00196976|7184209|FG013|COMPLETED|Booster Study||43
6283815|NCT00196976|7184196|FG000|NOT COMPLETED|Booster Study||0
6283816|NCT00196976|7184197|FG001|NOT COMPLETED|Booster Study||0
6283817|NCT00196976|7184198|FG002|NOT COMPLETED|Booster Study||0
6283818|NCT00196976|7184199|FG003|NOT COMPLETED|Booster Study||0
6283819|NCT00196976|7184200|FG004|NOT COMPLETED|Booster Study||0
6283820|NCT00196976|7184201|FG005|NOT COMPLETED|Booster Study||0
6283821|NCT00196976|7184202|FG006|NOT COMPLETED|Booster Study||0
6632029|NCT02278328|7560388|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6632030|NCT02278328|7560389|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6632031|NCT02278328|7560387|FG000|STARTED|Second Washout (1 Week)||9
6283822|NCT00196976|7184203|FG007|NOT COMPLETED|Booster Study||0
6283823|NCT00196976|7184204|FG008|NOT COMPLETED|Booster Study||0
6632032|NCT02278328|7560388|FG001|STARTED|Second Washout (1 Week)||6
6632033|NCT02278328|7560389|FG002|STARTED|Second Washout (1 Week)||6
6632034|NCT02278328|7560387|FG000|COMPLETED|Second Washout (1 Week)||9
6632035|NCT02278328|7560388|FG001|COMPLETED|Second Washout (1 Week)||6
6632036|NCT02278328|7560389|FG002|COMPLETED|Second Washout (1 Week)||6
6632037|NCT02278328|7560387|FG000|NOT COMPLETED|Second Washout (1 Week)||0
6632038|NCT02278328|7560388|FG001|NOT COMPLETED|Second Washout (1 Week)||0
6632039|NCT02278328|7560389|FG002|NOT COMPLETED|Second Washout (1 Week)||0
6632040|NCT02278328|7560387|FG000|STARTED|Third Intervention (1 Day)||9
6632041|NCT02278328|7560388|FG001|STARTED|Third Intervention (1 Day)||6
6632042|NCT02278328|7560389|FG002|STARTED|Third Intervention (1 Day)||6
6632043|NCT02278328|7560387|FG000|COMPLETED|Third Intervention (1 Day)||9
6632044|NCT02278328|7560388|FG001|COMPLETED|Third Intervention (1 Day)||6
6632045|NCT02278328|7560389|FG002|COMPLETED|Third Intervention (1 Day)||6
6632046|NCT02278328|7560387|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6632047|NCT02278328|7560388|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6632048|NCT02278328|7560389|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6632049|NCT02278328|7560387|FG000|STARTED|Third Washout (1 Week)||9
6632050|NCT02278328|7560388|FG001|STARTED|Third Washout (1 Week)||6
6632051|NCT02278328|7560389|FG002|STARTED|Third Washout (1 Week)||6
6632052|NCT02278328|7560387|FG000|COMPLETED|Third Washout (1 Week)||9
6632053|NCT02278328|7560388|FG001|COMPLETED|Third Washout (1 Week)||6
6632054|NCT02278328|7560389|FG002|COMPLETED|Third Washout (1 Week)||6
6632055|NCT02278328|7560387|FG000|NOT COMPLETED|Third Washout (1 Week)||0
6632056|NCT02278328|7560388|FG001|NOT COMPLETED|Third Washout (1 Week)||0
6632057|NCT02278328|7560389|FG002|NOT COMPLETED|Third Washout (1 Week)||0
6632058|NCT02278341|7560397|FG000|STARTED|Overall Study||415
6632059|NCT02278341|7560398|FG001|STARTED|Overall Study||421
6632060|NCT02278341|7560397|FG000|Received Treatment|Overall Study||414
6632061|NCT02278341|7560398|FG001|Received Treatment|Overall Study||420
6632062|NCT02278341|7560397|FG000|COMPLETED|Overall Study||297
6632063|NCT02278341|7560398|FG001|COMPLETED|Overall Study||329
6632064|NCT02278341|7560397|FG000|NOT COMPLETED|Overall Study||118
6632065|NCT02278341|7560398|FG001|NOT COMPLETED|Overall Study||92
6632066|NCT02278354|7560407|FG000|STARTED|Overall Study||12
6283824|NCT00196976|7184205|FG009|NOT COMPLETED|Booster Study||0
6283825|NCT00196976|7184206|FG010|NOT COMPLETED|Booster Study||2
6283826|NCT00196976|7184207|FG011|NOT COMPLETED|Booster Study||2
6283827|NCT00196976|7184208|FG012|NOT COMPLETED|Booster Study||0
6283828|NCT00196976|7184209|FG013|NOT COMPLETED|Booster Study||0
6283829|NCT00197002|7184252|FG000|STARTED|Overall Study||147
6283830|NCT00197002|7184253|FG001|STARTED|Overall Study||137
6283831|NCT00197002|7184254|FG002|STARTED|Overall Study||149
6283832|NCT00197002|7184252|FG000|COMPLETED|Overall Study||125
6283833|NCT00197002|7184253|FG001|COMPLETED|Overall Study||119
6283834|NCT00197002|7184254|FG002|COMPLETED|Overall Study||132
6283835|NCT00197002|7184252|FG000|NOT COMPLETED|Overall Study||22
6283836|NCT00197002|7184253|FG001|NOT COMPLETED|Overall Study||18
6283837|NCT00197002|7184254|FG002|NOT COMPLETED|Overall Study||17
6632067|NCT02278354|7560408|FG001|STARTED|Overall Study||23
6632068|NCT02278354|7560407|FG000|Flortaucipir PET Scan|Overall Study||10
6632069|NCT02278354|7560408|FG001|Flortaucipir PET Scan|Overall Study||20
6632070|NCT02278354|7560407|FG000|COMPLETED|Overall Study||8
6632071|NCT02278354|7560408|FG001|COMPLETED|Overall Study||20
6632072|NCT02278354|7560407|FG000|NOT COMPLETED|Overall Study||4
6283838|NCT00197015|7184268|FG000|STARTED|Overall Study||324
6283839|NCT00197015|7184269|FG001|STARTED|Overall Study||455
6632073|NCT02278354|7560408|FG001|NOT COMPLETED|Overall Study||3
6632074|NCT02278367|7560418|FG000|STARTED|Overall Study||69
6632075|NCT02278367|7560419|FG001|STARTED|Overall Study||110
6632076|NCT02278367|7560418|FG000|COMPLETED|Overall Study||59
6632077|NCT02278367|7560419|FG001|COMPLETED|Overall Study||110
6632078|NCT02278367|7560418|FG000|NOT COMPLETED|Overall Study||10
6632079|NCT02278367|7560419|FG001|NOT COMPLETED|Overall Study||0
6632080|NCT02278471|7560427|FG000|STARTED|Overall Study||155
6632081|NCT02278471|7560428|FG001|STARTED|Overall Study||148
6632082|NCT02278471|7560427|FG000|COMPLETED|Overall Study||147
6632083|NCT02278471|7560428|FG001|COMPLETED|Overall Study||128
6632084|NCT02278471|7560427|FG000|NOT COMPLETED|Overall Study||8
6632085|NCT02278471|7560428|FG001|NOT COMPLETED|Overall Study||20
6632086|NCT02278484|7560435|FG000|STARTED|Overall Study||50
6632087|NCT02278484|7560435|FG000|COMPLETED|Overall Study||50
6632088|NCT02278484|7560435|FG000|NOT COMPLETED|Overall Study||0
6632089|NCT02278562|7560443|FG000|STARTED|Overall Study||9
6632090|NCT02278562|7560444|FG001|STARTED|Overall Study||7
6632091|NCT02278562|7560445|FG002|STARTED|Overall Study||8
6632092|NCT02278562|7560443|FG000|COMPLETED|Overall Study||9
6632093|NCT02278562|7560444|FG001|COMPLETED|Overall Study||7
6632094|NCT02278562|7560445|FG002|COMPLETED|Overall Study||8
6632095|NCT02278562|7560443|FG000|NOT COMPLETED|Overall Study||0
6632096|NCT02278562|7560444|FG001|NOT COMPLETED|Overall Study||0
6632097|NCT02278562|7560445|FG002|NOT COMPLETED|Overall Study||0
6632098|NCT02278614|7560455|FG000|STARTED|Overall Study||127
6632099|NCT02278614|7560456|FG001|STARTED|Overall Study||115
6632100|NCT02278614|7560455|FG000|COMPLETED|Overall Study||122
6632101|NCT02278614|7560456|FG001|COMPLETED|Overall Study||110
6632102|NCT02278614|7560455|FG000|NOT COMPLETED|Overall Study||5
6632103|NCT02278614|7560456|FG001|NOT COMPLETED|Overall Study||5
6632104|NCT02278640|7560462|FG000|STARTED|Overall Study||40
6632105|NCT02278640|7560462|FG000|COMPLETED|Overall Study||40
6632106|NCT02278640|7560462|FG000|NOT COMPLETED|Overall Study||0
6632107|NCT02278783|7560466|FG000|STARTED|Overall Study||1
6632108|NCT02278783|7560466|FG000|COMPLETED|Overall Study||1
6632109|NCT02278783|7560466|FG000|NOT COMPLETED|Overall Study||0
6632110|NCT02278939|7560472|FG000|STARTED|Overall Study||33
6632111|NCT02278939|7560473|FG001|STARTED|Overall Study||34
6632112|NCT02278939|7560472|FG000|COMPLETED|Overall Study||28
6632113|NCT02278939|7560473|FG001|COMPLETED|Overall Study||33
6632114|NCT02278939|7560472|FG000|NOT COMPLETED|Overall Study||5
6632115|NCT02278939|7560473|FG001|NOT COMPLETED|Overall Study||1
6632116|NCT02278952|7560479|FG000|STARTED|Overall Study|The number of biopsy procedures performed during the time the patient was enrolled in the study.|50
6632117|NCT02278952|7560479|FG000|COMPLETED|Overall Study|The number of biopsy samples assayed during the time the patient was enrolled in the study.|44
6632118|NCT02278952|7560479|FG000|NOT COMPLETED|Overall Study||6
6743050|NCT03332771|7671419|FG003|NOT COMPLETED|Overall Study||48
6743051|NCT03332784|7671449|FG000|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743052|NCT03332784|7671450|FG001|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743053|NCT03332784|7671451|FG002|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743054|NCT03332784|7671452|FG003|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743055|NCT03332784|7671453|FG004|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743056|NCT03332784|7671454|FG005|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743057|NCT03332784|7671455|FG006|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743058|NCT03332784|7671456|FG007|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743059|NCT03332784|7671457|FG008|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
6743060|NCT03332784|7671458|FG009|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
6743061|NCT03332784|7671459|FG010|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
6743062|NCT03332784|7671460|FG011|STARTED|Parts 1 and 2 - Period 1 (1 Day)||2
6743063|NCT03332784|7671461|FG012|STARTED|Parts 1 and 2 - Period 1 (1 Day)||6
6743064|NCT03332784|7671462|FG013|STARTED|Parts 1 and 2 - Period 1 (1 Day)||4
6743065|NCT03332784|7671463|FG014|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
6743066|NCT03332784|7671464|FG015|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
6743067|NCT03332784|7671465|FG016|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
6743068|NCT03332784|7671466|FG017|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|2
6743069|NCT03332784|7671467|FG018|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
6743070|NCT03332784|7671468|FG019|STARTED|Parts 1 and 2 - Period 1 (1 Day)|A washout period of 7 days was required before the dosing on Day 1 for prior medications.|3
6743071|NCT03332784|7671449|FG000|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743072|NCT03332784|7671450|FG001|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
6743073|NCT03332784|7671451|FG002|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743074|NCT03332784|7671452|FG003|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743075|NCT03332784|7671453|FG004|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743076|NCT03332784|7671454|FG005|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743077|NCT03332784|7671455|FG006|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6632119|NCT02279043|7560492|FG000|STARTED|Overall Study||175
6283840|NCT00197015|7184270|FG002|STARTED|Overall Study||462
6632120|NCT02279043|7560493|FG001|STARTED|Overall Study||315
6632121|NCT02279043|7560494|FG002|STARTED|Overall Study||140
6283841|NCT00197015|7184268|FG000|COMPLETED|Overall Study||274
6283842|NCT00197015|7184269|FG001|COMPLETED|Overall Study||366
6283843|NCT00197015|7184270|FG002|COMPLETED|Overall Study||385
6283844|NCT00197015|7184268|FG000|NOT COMPLETED|Overall Study||50
6283845|NCT00197015|7184269|FG001|NOT COMPLETED|Overall Study||89
6283846|NCT00197015|7184270|FG002|NOT COMPLETED|Overall Study||77
6283847|NCT00197028|7184280|FG000|STARTED|Overall Study||107
6283848|NCT00197028|7184281|FG001|STARTED|Overall Study||107
6283849|NCT00197028|7184280|FG000|COMPLETED|Overall Study||91
6283850|NCT00197028|7184281|FG001|COMPLETED|Overall Study||86
6283851|NCT00197028|7184280|FG000|NOT COMPLETED|Overall Study||16
6283852|NCT00197028|7184281|FG001|NOT COMPLETED|Overall Study||21
6283853|NCT00197054|7184290|FG000|STARTED|Overall Study||85
6283854|NCT00197054|7184291|FG001|STARTED|Overall Study||85
6283855|NCT00197054|7184292|FG002|STARTED|Overall Study||85
6283856|NCT00197054|7184290|FG000|COMPLETED|Overall Study||68
6283857|NCT00197054|7184291|FG001|COMPLETED|Overall Study||64
6283858|NCT00197054|7184292|FG002|COMPLETED|Overall Study||73
6283859|NCT00197054|7184290|FG000|NOT COMPLETED|Overall Study||17
6283860|NCT00197054|7184291|FG001|NOT COMPLETED|Overall Study||21
6283861|NCT00197054|7184292|FG002|NOT COMPLETED|Overall Study||12
6283862|NCT00197106|7184312|FG000|STARTED|4-Week Run-In Period||257
6283863|NCT00197106|7184313|FG001|STARTED|4-Week Run-In Period||0
6283864|NCT00197106|7184314|FG002|STARTED|4-Week Run-In Period||0
6283865|NCT00197106|7184312|FG000|COMPLETED|4-Week Run-In Period||158
6283866|NCT00197106|7184313|FG001|COMPLETED|4-Week Run-In Period||0
6283867|NCT00197106|7184314|FG002|COMPLETED|4-Week Run-In Period||0
6283868|NCT00197106|7184312|FG000|NOT COMPLETED|4-Week Run-In Period||99
6283869|NCT00197106|7184313|FG001|NOT COMPLETED|4-Week Run-In Period||0
6283870|NCT00197106|7184314|FG002|NOT COMPLETED|4-Week Run-In Period||0
6283871|NCT00197106|7184312|FG000|STARTED|Overall Treatment Period||0
6283872|NCT00197106|7184313|FG001|STARTED|Overall Treatment Period||78
6283873|NCT00197106|7184314|FG002|STARTED|Overall Treatment Period||80
6283874|NCT00197106|7184312|FG000|COMPLETED|Overall Treatment Period||0
6283875|NCT00197106|7184313|FG001|COMPLETED|Overall Treatment Period||77
6283876|NCT00197106|7184314|FG002|COMPLETED|Overall Treatment Period||74
6283877|NCT00197106|7184312|FG000|NOT COMPLETED|Overall Treatment Period||0
6283878|NCT00197106|7184313|FG001|NOT COMPLETED|Overall Treatment Period||1
6632122|NCT02279043|7560492|FG000|COMPLETED|Overall Study||128
6632123|NCT02279043|7560493|FG001|COMPLETED|Overall Study||226
6632124|NCT02279043|7560494|FG002|COMPLETED|Overall Study||140
6632125|NCT02279043|7560492|FG000|NOT COMPLETED|Overall Study||47
6632126|NCT02279043|7560493|FG001|NOT COMPLETED|Overall Study||89
6632127|NCT02279043|7560494|FG002|NOT COMPLETED|Overall Study||0
6632128|NCT02279082|7560500|FG000|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
6632129|NCT02279082|7560500|FG000|COMPLETED|Overall Study||134
6632130|NCT02279082|7560500|FG000|NOT COMPLETED|Overall Study||33
6632131|NCT02279108|7560506|FG000|STARTED|Overall Study||50
6632132|NCT02279108|7560507|FG001|STARTED|Overall Study||50
6632133|NCT02279108|7560506|FG000|COMPLETED|Overall Study||50
6632134|NCT02279108|7560507|FG001|COMPLETED|Overall Study||49
6632135|NCT02279108|7560506|FG000|NOT COMPLETED|Overall Study||0
6632136|NCT02279108|7560507|FG001|NOT COMPLETED|Overall Study||1
6632137|NCT02279160|7560515|FG000|STARTED|Overall Study||40
6632138|NCT02279160|7560516|FG001|STARTED|Overall Study||21
6632139|NCT02279160|7560515|FG000|COMPLETED|Overall Study||34
6632140|NCT02279160|7560516|FG001|COMPLETED|Overall Study||19
6632141|NCT02279160|7560515|FG000|NOT COMPLETED|Overall Study||6
6632142|NCT02279160|7560516|FG001|NOT COMPLETED|Overall Study||2
6632143|NCT02279173|7560522|FG000|STARTED|Overall Study||203
6632144|NCT02279173|7560522|FG000|Received Treatment|Overall Study||203
6632145|NCT02279173|7560522|FG000|Enrolled Under Protocol Supplement|Overall Study||79
6632146|NCT02279173|7560522|FG000|COMPLETED|Overall Study||109
6632147|NCT02279173|7560522|FG000|NOT COMPLETED|Overall Study||94
6632148|NCT02279407|7560532|FG000|STARTED|Overall Study||22
6632149|NCT02279407|7560533|FG001|STARTED|Overall Study||21
6632150|NCT02279407|7560534|FG002|STARTED|Overall Study||20
6632151|NCT02279407|7560535|FG003|STARTED|Overall Study||21
6632152|NCT02279407|7560532|FG000|COMPLETED|Overall Study||20
6632153|NCT02279407|7560533|FG001|COMPLETED|Overall Study||20
6632154|NCT02279407|7560534|FG002|COMPLETED|Overall Study||15
6632155|NCT02279407|7560535|FG003|COMPLETED|Overall Study||20
6632156|NCT02279407|7560532|FG000|NOT COMPLETED|Overall Study||2
6632157|NCT02279407|7560533|FG001|NOT COMPLETED|Overall Study||1
6632158|NCT02279407|7560534|FG002|NOT COMPLETED|Overall Study||5
6632159|NCT02279407|7560535|FG003|NOT COMPLETED|Overall Study||1
6632160|NCT02279420|7560545|FG000|STARTED|Overall Study||73
6283879|NCT00197106|7184314|FG002|NOT COMPLETED|Overall Treatment Period||6
6283880|NCT00197119|7184322|FG000|STARTED|Year 6||126
6283881|NCT00197119|7184323|FG001|STARTED|Year 6||118
6283882|NCT00197119|7184322|FG000|COMPLETED|Year 6||126
6283883|NCT00197119|7184323|FG001|COMPLETED|Year 6||118
6283884|NCT00197119|7184322|FG000|NOT COMPLETED|Year 6||0
6632161|NCT02279420|7560545|FG000|COMPLETED|Overall Study||50
6632162|NCT02279420|7560545|FG000|NOT COMPLETED|Overall Study||23
6632163|NCT02279498|7560551|FG000|STARTED|Overall Study||65
6632164|NCT02279498|7560552|FG001|STARTED|Overall Study||63
6632165|NCT02279498|7560551|FG000|COMPLETED|Overall Study||47
6283885|NCT00197119|7184323|FG001|NOT COMPLETED|Year 6||0
6373843|NCT00747474|7284556|FG003|STARTED|Cohort 8 (40 mg/m^2) Period||0
6632166|NCT02279498|7560552|FG001|COMPLETED|Overall Study||59
6283886|NCT00197119|7184322|FG000|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
6283887|NCT00197119|7184323|FG001|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
6283888|NCT00197119|7184322|FG000|COMPLETED|Year 7||122
6283889|NCT00197119|7184323|FG001|COMPLETED|Year 7||114
6283890|NCT00197119|7184322|FG000|NOT COMPLETED|Year 7||0
6283891|NCT00197119|7184323|FG001|NOT COMPLETED|Year 7||0
6283892|NCT00197119|7184322|FG000|STARTED|Year 8||122
6399089|NCT00879190|7311801|FG000|STARTED|Overall Study||43
6632167|NCT02279498|7560551|FG000|NOT COMPLETED|Overall Study||18
6632168|NCT02279498|7560552|FG001|NOT COMPLETED|Overall Study||4
6632169|NCT02279524|7560562|FG000|STARTED|Overall Study||98
6632170|NCT02279524|7560563|FG001|STARTED|Overall Study||101
6632171|NCT02279524|7560564|FG002|STARTED|Overall Study||48
6632172|NCT02279524|7560562|FG000|COMPLETED|Overall Study||88
6632173|NCT02279524|7560563|FG001|COMPLETED|Overall Study||90
6632174|NCT02279524|7560564|FG002|COMPLETED|Overall Study||41
6743078|NCT03332784|7671456|FG007|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743079|NCT03332784|7671457|FG008|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
6743080|NCT03332784|7671458|FG009|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
6743081|NCT03332784|7671459|FG010|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
6743082|NCT03332784|7671460|FG011|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743083|NCT03332784|7671461|FG012|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||6
6743084|NCT03332784|7671462|FG013|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||4
6743085|NCT03332784|7671463|FG014|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
6743086|NCT03332784|7671464|FG015|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743087|NCT03332784|7671465|FG016|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743088|NCT03332784|7671466|FG017|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||2
6743089|NCT03332784|7671467|FG018|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
6743090|NCT03332784|7671468|FG019|COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||3
6743091|NCT03332784|7671449|FG000|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743092|NCT03332784|7671450|FG001|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
6743093|NCT03332784|7671451|FG002|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743094|NCT03332784|7671452|FG003|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743095|NCT03332784|7671453|FG004|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743096|NCT03332784|7671454|FG005|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743097|NCT03332784|7671455|FG006|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743098|NCT03332784|7671456|FG007|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743099|NCT03332784|7671457|FG008|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743100|NCT03332784|7671458|FG009|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743101|NCT03332784|7671459|FG010|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743102|NCT03332784|7671460|FG011|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743103|NCT03332784|7671461|FG012|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743104|NCT03332784|7671462|FG013|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743105|NCT03332784|7671463|FG014|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||1
6743106|NCT03332784|7671464|FG015|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743107|NCT03332784|7671465|FG016|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743108|NCT03332784|7671466|FG017|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743109|NCT03332784|7671467|FG018|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743110|NCT03332784|7671468|FG019|NOT COMPLETED|Parts 1 and 2 - Period 1 (1 Day)||0
6743111|NCT03332784|7671449|FG000|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743112|NCT03332784|7671450|FG001|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
6743113|NCT03332784|7671451|FG002|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743114|NCT03332784|7671452|FG003|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743115|NCT03332784|7671453|FG004|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743116|NCT03332784|7671454|FG005|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6283893|NCT00197119|7184323|FG001|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
6743117|NCT03332784|7671455|FG006|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743118|NCT03332784|7671456|FG007|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743119|NCT03332784|7671457|FG008|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743120|NCT03332784|7671458|FG009|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743121|NCT03332784|7671459|FG010|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743122|NCT03332784|7671460|FG011|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743123|NCT03332784|7671461|FG012|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6779637|NCT03725722|7707817|FG000|NOT COMPLETED|Overall Study||11
6283894|NCT00197119|7184322|FG000|COMPLETED|Year 8||122
6632175|NCT02279524|7560562|FG000|NOT COMPLETED|Overall Study||10
6632176|NCT02279524|7560563|FG001|NOT COMPLETED|Overall Study||11
6632177|NCT02279524|7560564|FG002|NOT COMPLETED|Overall Study||7
6632178|NCT02279641|7560574|FG000|STARTED|Overall Study||6
6632179|NCT02279641|7560575|FG001|STARTED|Overall Study||6
6632180|NCT02279641|7560574|FG000|COMPLETED|Overall Study||6
6632181|NCT02279641|7560575|FG001|COMPLETED|Overall Study||6
6632182|NCT02279641|7560574|FG000|NOT COMPLETED|Overall Study||0
6632183|NCT02279641|7560575|FG001|NOT COMPLETED|Overall Study||0
6632184|NCT02279667|7560594|FG000|STARTED|Overall Study||6
6283895|NCT00197119|7184323|FG001|COMPLETED|Year 8||115
6283896|NCT00197119|7184322|FG000|NOT COMPLETED|Year 8||0
6283897|NCT00197119|7184323|FG001|NOT COMPLETED|Year 8||0
6283898|NCT00197119|7184322|FG000|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
6283899|NCT00197119|7184323|FG001|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
6283900|NCT00197119|7184322|FG000|COMPLETED|Year 9||121
6283901|NCT00197119|7184323|FG001|COMPLETED|Year 9||114
6283902|NCT00197119|7184322|FG000|NOT COMPLETED|Year 9||0
6283903|NCT00197119|7184323|FG001|NOT COMPLETED|Year 9||0
6283904|NCT00197119|7184322|FG000|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
6283905|NCT00197119|7184323|FG001|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
6283906|NCT00197119|7184322|FG000|COMPLETED|Year 10||120
6283907|NCT00197119|7184323|FG001|COMPLETED|Year 10||108
6283908|NCT00197119|7184322|FG000|NOT COMPLETED|Year 10||0
6283909|NCT00197119|7184323|FG001|NOT COMPLETED|Year 10||0
6283910|NCT00197145|7184331|FG000|STARTED|Period 1: Randomized Treatment Phase||13
6632185|NCT02279667|7560595|FG001|STARTED|Overall Study||6
6632186|NCT02279667|7560596|FG002|STARTED|Overall Study||6
6632187|NCT02279667|7560594|FG000|COMPLETED|Overall Study||6
6632188|NCT02279667|7560595|FG001|COMPLETED|Overall Study||6
6632189|NCT02279667|7560596|FG002|COMPLETED|Overall Study||6
6632190|NCT02279667|7560594|FG000|NOT COMPLETED|Overall Study||0
6632191|NCT02279667|7560595|FG001|NOT COMPLETED|Overall Study||0
6632192|NCT02279667|7560596|FG002|NOT COMPLETED|Overall Study||0
6632193|NCT02279732|7560607|FG000|STARTED|Overall Study||98
6632194|NCT02279732|7560608|FG001|STARTED|Overall Study||106
6743124|NCT03332784|7671462|FG013|STARTED|Parts 1 and 2- Period 2 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743125|NCT03332784|7671463|FG014|STARTED|Parts 1 and 2- Period 2 (1 Day)||1
6743126|NCT03332784|7671464|FG015|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743127|NCT03332784|7671465|FG016|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743128|NCT03332784|7671466|FG017|STARTED|Parts 1 and 2- Period 2 (1 Day)||2
6743129|NCT03332784|7671467|FG018|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
6743130|NCT03332784|7671468|FG019|STARTED|Parts 1 and 2- Period 2 (1 Day)||3
6743131|NCT03332784|7671449|FG000|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743132|NCT03332784|7671450|FG001|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
6743133|NCT03332784|7671451|FG002|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743134|NCT03332784|7671452|FG003|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743135|NCT03332784|7671453|FG004|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743136|NCT03332784|7671454|FG005|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743137|NCT03332784|7671455|FG006|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743138|NCT03332784|7671456|FG007|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743139|NCT03332784|7671457|FG008|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743140|NCT03332784|7671458|FG009|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743141|NCT03332784|7671459|FG010|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743142|NCT03332784|7671460|FG011|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743143|NCT03332784|7671461|FG012|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743144|NCT03332784|7671462|FG013|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743145|NCT03332784|7671463|FG014|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||1
6743146|NCT03332784|7671464|FG015|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743147|NCT03332784|7671465|FG016|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743148|NCT03332784|7671466|FG017|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||2
6743149|NCT03332784|7671467|FG018|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
6743150|NCT03332784|7671468|FG019|COMPLETED|Parts 1 and 2- Period 2 (1 Day)||3
6743151|NCT03332784|7671449|FG000|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743152|NCT03332784|7671450|FG001|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743153|NCT03332784|7671451|FG002|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743154|NCT03332784|7671452|FG003|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743155|NCT03332784|7671453|FG004|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743156|NCT03332784|7671454|FG005|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743157|NCT03332784|7671455|FG006|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743158|NCT03332784|7671456|FG007|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743159|NCT03332784|7671457|FG008|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743160|NCT03332784|7671458|FG009|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743161|NCT03332784|7671459|FG010|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743162|NCT03332784|7671460|FG011|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743163|NCT03332784|7671461|FG012|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743164|NCT03332784|7671462|FG013|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743165|NCT03332784|7671463|FG014|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743166|NCT03332784|7671464|FG015|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743167|NCT03332784|7671465|FG016|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743168|NCT03332784|7671466|FG017|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743169|NCT03332784|7671467|FG018|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743170|NCT03332784|7671468|FG019|NOT COMPLETED|Parts 1 and 2- Period 2 (1 Day)||0
6743171|NCT03332784|7671449|FG000|STARTED|Part 1- Period 3 (1 Day)||2
6743172|NCT03332784|7671450|FG001|STARTED|Part 1- Period 3 (1 Day)||1
6743173|NCT03332784|7671451|FG002|STARTED|Part 1- Period 3 (1 Day)||2
6743174|NCT03332784|7671452|FG003|STARTED|Part 1- Period 3 (1 Day)||2
6632195|NCT02279732|7560607|FG000|COMPLETED|Overall Study||0
6632196|NCT02279732|7560608|FG001|COMPLETED|Overall Study||0
6283911|NCT00197145|7184332|FG001|STARTED|Period 1: Randomized Treatment Phase||11
6283912|NCT00197145|7184331|FG000|COMPLETED|Period 1: Randomized Treatment Phase||0
6283913|NCT00197145|7184332|FG001|COMPLETED|Period 1: Randomized Treatment Phase||0
6283914|NCT00197145|7184331|FG000|NOT COMPLETED|Period 1: Randomized Treatment Phase||13
6283915|NCT00197145|7184332|FG001|NOT COMPLETED|Period 1: Randomized Treatment Phase||11
6283916|NCT00197145|7184331|FG000|STARTED|Period 2 : Open Label Phase||10
6283917|NCT00197145|7184332|FG001|STARTED|Period 2 : Open Label Phase||0
6283918|NCT00197145|7184331|FG000|COMPLETED|Period 2 : Open Label Phase||0
6283919|NCT00197145|7184332|FG001|COMPLETED|Period 2 : Open Label Phase||0
6283920|NCT00197145|7184331|FG000|NOT COMPLETED|Period 2 : Open Label Phase||10
6283921|NCT00197145|7184332|FG001|NOT COMPLETED|Period 2 : Open Label Phase||0
6283922|NCT00197184|7184341|FG000|STARTED|Overall Study||139
6283923|NCT00197184|7184342|FG001|STARTED|Overall Study||137
6283924|NCT00197184|7184341|FG000|COMPLETED|Overall Study||139
6283925|NCT00197184|7184342|FG001|COMPLETED|Overall Study||137
6283926|NCT00197184|7184341|FG000|NOT COMPLETED|Overall Study||0
6283927|NCT00197184|7184342|FG001|NOT COMPLETED|Overall Study||0
6283928|NCT00197236|7184351|FG000|STARTED|Overall Study||135
6283929|NCT00197236|7184352|FG001|STARTED|Overall Study||127
6283930|NCT00197236|7184353|FG002|STARTED|Overall Study||132
6283931|NCT00197236|7184351|FG000|COMPLETED|Overall Study||121
6283932|NCT00197236|7184352|FG001|COMPLETED|Overall Study||110
6283933|NCT00197236|7184353|FG002|COMPLETED|Overall Study||109
6283934|NCT00197236|7184351|FG000|NOT COMPLETED|Overall Study||14
6283935|NCT00197236|7184352|FG001|NOT COMPLETED|Overall Study||17
6283936|NCT00197236|7184353|FG002|NOT COMPLETED|Overall Study||23
6283937|NCT00197392|7184366|FG000|STARTED|Overall Study||214
6283938|NCT00197392|7184367|FG001|STARTED|Overall Study||220
6283939|NCT00197392|7184366|FG000|Safety Population|Overall Study||214
6283940|NCT00197392|7184367|FG001|Safety Population|Overall Study||220
6283941|NCT00197392|7184366|FG000|Modified Intent to Treat|Overall Study||209
6283942|NCT00197392|7184367|FG001|Modified Intent to Treat|Overall Study||210
6283943|NCT00197392|7184366|FG000|Evaluable|Overall Study||176
6283944|NCT00197392|7184367|FG001|Evaluable|Overall Study||181
6283945|NCT00197392|7184366|FG000|Per Protocol|Overall Study||126
6283946|NCT00197392|7184367|FG001|Per Protocol|Overall Study||134
6283947|NCT00197392|7184366|FG000|COMPLETED|Overall Study||126
6283948|NCT00197392|7184367|FG001|COMPLETED|Overall Study||134
6283949|NCT00197392|7184366|FG000|NOT COMPLETED|Overall Study||88
6283950|NCT00197392|7184367|FG001|NOT COMPLETED|Overall Study||86
6283951|NCT00197496|7184391|FG000|STARTED|Baseline to Discharge||14
6283952|NCT00197496|7184392|FG001|STARTED|Baseline to Discharge||7
6283953|NCT00197496|7184391|FG000|COMPLETED|Baseline to Discharge||12
6283954|NCT00197496|7184392|FG001|COMPLETED|Baseline to Discharge||5
6283955|NCT00197496|7184391|FG000|NOT COMPLETED|Baseline to Discharge||2
6283956|NCT00197496|7184392|FG001|NOT COMPLETED|Baseline to Discharge||2
6283957|NCT00197496|7184391|FG000|STARTED|Follow-up||12
6283958|NCT00197496|7184392|FG001|STARTED|Follow-up||5
6632197|NCT02279732|7560607|FG000|NOT COMPLETED|Overall Study||98
6632198|NCT02279732|7560608|FG001|NOT COMPLETED|Overall Study||106
6632199|NCT02279862|7560616|FG000|STARTED|Overall Study||26
6632200|NCT02279862|7560617|FG001|STARTED|Overall Study||27
6632201|NCT02279862|7560616|FG000|Treated|Overall Study||25
6632202|NCT02279862|7560617|FG001|Treated|Overall Study||26
6632203|NCT02279862|7560616|FG000|COMPLETED|Overall Study|Completed treatment in induction period|0
6632204|NCT02279862|7560617|FG001|COMPLETED|Overall Study|Completed treatment in induction period|2
6632205|NCT02279862|7560616|FG000|NOT COMPLETED|Overall Study||26
6632206|NCT02279862|7560617|FG001|NOT COMPLETED|Overall Study||25
6632207|NCT02280044|7560625|FG000|STARTED|Overall Study||15
6632208|NCT02280044|7560626|FG001|STARTED|Overall Study||15
6632209|NCT02280044|7560625|FG000|COMPLETED|Overall Study||15
6632210|NCT02280044|7560626|FG001|COMPLETED|Overall Study||13
6632211|NCT02280044|7560625|FG000|NOT COMPLETED|Overall Study||0
6632212|NCT02280044|7560626|FG001|NOT COMPLETED|Overall Study||2
6632213|NCT02280096|7560634|FG000|STARTED|Overall Study||13
6632214|NCT02280096|7560635|FG001|STARTED|Overall Study||11
6632215|NCT02280096|7560634|FG000|COMPLETED|Overall Study||11
6632216|NCT02280096|7560635|FG001|COMPLETED|Overall Study||10
6632217|NCT02280096|7560634|FG000|NOT COMPLETED|Overall Study||2
6632218|NCT02280096|7560635|FG001|NOT COMPLETED|Overall Study||1
6632219|NCT02280122|7560652|FG000|STARTED|Overall Study||15
6632220|NCT02280122|7560653|FG001|STARTED|Overall Study||15
6632221|NCT02280122|7560654|FG002|STARTED|Overall Study||30
6632222|NCT02280122|7560652|FG000|COMPLETED|Overall Study||15
6632223|NCT02280122|7560653|FG001|COMPLETED|Overall Study||15
6632224|NCT02280122|7560654|FG002|COMPLETED|Overall Study||30
6632225|NCT02280122|7560652|FG000|NOT COMPLETED|Overall Study||0
6632226|NCT02280122|7560653|FG001|NOT COMPLETED|Overall Study||0
6632227|NCT02280122|7560654|FG002|NOT COMPLETED|Overall Study||0
6632228|NCT02280187|7560660|FG000|STARTED|Overall Study||400
6632229|NCT02280187|7560660|FG000|COMPLETED|Overall Study||182
6632230|NCT02280187|7560660|FG000|NOT COMPLETED|Overall Study||218
6632231|NCT02280200|7560666|FG000|STARTED|Overall Study||15
6632232|NCT02280200|7560667|FG001|STARTED|Overall Study||13
6632233|NCT02280200|7560666|FG000|COMPLETED|Overall Study||12
6283959|NCT00197496|7184391|FG000|COMPLETED|Follow-up||10
6283960|NCT00197496|7184392|FG001|COMPLETED|Follow-up||4
6632234|NCT02280200|7560667|FG001|COMPLETED|Overall Study||10
6632235|NCT02280200|7560666|FG000|NOT COMPLETED|Overall Study||3
6283961|NCT00197496|7184391|FG000|NOT COMPLETED|Follow-up||2
6283962|NCT00197496|7184392|FG001|NOT COMPLETED|Follow-up||1
6283963|NCT00198029|7184398|FG000|STARTED|Overall Study||32
6283964|NCT00198029|7184398|FG000|COMPLETED|Overall Study||28
6632236|NCT02280200|7560667|FG001|NOT COMPLETED|Overall Study||3
6632237|NCT02280226|7560673|FG000|STARTED|Overall Study||17
6632238|NCT02280226|7560673|FG000|COMPLETED|Overall Study||17
6632239|NCT02280226|7560673|FG000|NOT COMPLETED|Overall Study||0
6632240|NCT02280291|7560681|FG000|STARTED|Overall Study||25
6632241|NCT02280291|7560682|FG001|STARTED|Overall Study||25
6632242|NCT02280291|7560683|FG002|STARTED|Overall Study||24
6632243|NCT02280291|7560684|FG003|STARTED|Overall Study||26
6632244|NCT02280291|7560681|FG000|COMPLETED|Overall Study||21
6632245|NCT02280291|7560682|FG001|COMPLETED|Overall Study||23
6632246|NCT02280291|7560683|FG002|COMPLETED|Overall Study||21
6632247|NCT02280291|7560684|FG003|COMPLETED|Overall Study||18
6632248|NCT02280291|7560681|FG000|NOT COMPLETED|Overall Study||4
6632249|NCT02280291|7560682|FG001|NOT COMPLETED|Overall Study||2
6632250|NCT02280291|7560683|FG002|NOT COMPLETED|Overall Study||3
6632251|NCT02280291|7560684|FG003|NOT COMPLETED|Overall Study||8
6632252|NCT02280304|7560698|FG000|STARTED|Overall Study||19
6632253|NCT02280304|7560699|FG001|STARTED|Overall Study||18
6632254|NCT02280304|7560698|FG000|COMPLETED|Overall Study||12
6632255|NCT02280304|7560699|FG001|COMPLETED|Overall Study|A non completer received the allocated intervention before being lost to follow-up.|10
6632256|NCT02280304|7560698|FG000|NOT COMPLETED|Overall Study||7
6632257|NCT02280304|7560699|FG001|NOT COMPLETED|Overall Study||8
6632258|NCT02280317|7560717|FG000|STARTED|Overall Study|Patients receiving at least one dose.|1
6632259|NCT02280317|7560718|FG001|STARTED|Overall Study|Patients receiving at least one dose.|1
6632260|NCT02280317|7560719|FG002|STARTED|Overall Study|Patients receiving at least one dose.|3
6632261|NCT02280317|7560720|FG003|STARTED|Overall Study|Patients receiving at least one dose.|5
6632262|NCT02280317|7560721|FG004|STARTED|Overall Study|Patients receiving at least one dose.|2
6632263|NCT02280317|7560717|FG000|COMPLETED|Overall Study|Patients completing six cycles.|1
6632264|NCT02280317|7560718|FG001|COMPLETED|Overall Study|Patients completing six cycles.|1
6632265|NCT02280317|7560719|FG002|COMPLETED|Overall Study|Patients completing six cycles.|0
6632266|NCT02280317|7560720|FG003|COMPLETED|Overall Study|Patients completing six cycles.|2
6632267|NCT02280317|7560721|FG004|COMPLETED|Overall Study|Patients completing six cycles.|0
6632268|NCT02280317|7560717|FG000|NOT COMPLETED|Overall Study||0
6632269|NCT02280317|7560718|FG001|NOT COMPLETED|Overall Study||0
6632270|NCT02280317|7560719|FG002|NOT COMPLETED|Overall Study||3
6632271|NCT02280317|7560720|FG003|NOT COMPLETED|Overall Study||3
6632272|NCT02280317|7560721|FG004|NOT COMPLETED|Overall Study||2
6632273|NCT02280408|7560748|FG000|STARTED|Overall Study||10
6632274|NCT02280408|7560749|FG001|STARTED|Overall Study||10
6632275|NCT02280408|7560750|FG002|STARTED|Overall Study||10
6632276|NCT02280408|7560751|FG003|STARTED|Overall Study||9
6632277|NCT02280408|7560748|FG000|Vaccination 1|Overall Study||10
6632278|NCT02280408|7560749|FG001|Vaccination 1|Overall Study||10
6632279|NCT02280408|7560750|FG002|Vaccination 1|Overall Study||10
6632280|NCT02280408|7560751|FG003|Vaccination 1|Overall Study||9
6632281|NCT02280408|7560748|FG000|Vaccination 2|Overall Study||10
6632282|NCT02280408|7560749|FG001|Vaccination 2|Overall Study||10
6632283|NCT02280408|7560750|FG002|Vaccination 2|Overall Study||10
6743175|NCT03332784|7671453|FG004|STARTED|Part 1- Period 3 (1 Day)||2
6743176|NCT03332784|7671454|FG005|STARTED|Part 1- Period 3 (1 Day)||2
6743177|NCT03332784|7671455|FG006|STARTED|Part 1- Period 3 (1 Day)||2
6743178|NCT03332784|7671456|FG007|STARTED|Part 1- Period 3 (1 Day)||2
6743179|NCT03332784|7671457|FG008|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743180|NCT03332784|7671458|FG009|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743181|NCT03332784|7671459|FG010|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743182|NCT03332784|7671460|FG011|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743183|NCT03332784|7671461|FG012|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743184|NCT03332784|7671462|FG013|STARTED|Part 1- Period 3 (1 Day)|Part 1 Cohorts S1-2, 3, and 4 participants did not continue in subsequent periods after Period 1.|0
6743185|NCT03332784|7671463|FG014|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
6743186|NCT03332784|7671464|FG015|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
6743187|NCT03332784|7671465|FG016|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
6743188|NCT03332784|7671466|FG017|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
6743189|NCT03332784|7671467|FG018|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
6743190|NCT03332784|7671468|FG019|STARTED|Part 1- Period 3 (1 Day)|Part 2 participants did not continue in subsequent periods after Period 2.|0
6743191|NCT03332784|7671449|FG000|COMPLETED|Part 1- Period 3 (1 Day)||2
6743192|NCT03332784|7671450|FG001|COMPLETED|Part 1- Period 3 (1 Day)||1
6743193|NCT03332784|7671451|FG002|COMPLETED|Part 1- Period 3 (1 Day)||2
6743194|NCT03332784|7671452|FG003|COMPLETED|Part 1- Period 3 (1 Day)||2
6743195|NCT03332784|7671453|FG004|COMPLETED|Part 1- Period 3 (1 Day)||2
6283965|NCT00198029|7184398|FG000|NOT COMPLETED|Overall Study||4
6283966|NCT00198042|7184402|FG000|STARTED|Overall Study||18
6283967|NCT00198042|7184402|FG000|COMPLETED|Overall Study||18
6283968|NCT00198042|7184402|FG000|NOT COMPLETED|Overall Study||0
6283969|NCT00198081|7184408|FG000|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
6283970|NCT00198081|7184409|FG001|STARTED|Overall Study|No enrollment on this arm.|0
6283971|NCT00198081|7184408|FG000|COMPLETED|Overall Study||4
6283972|NCT00198081|7184409|FG001|COMPLETED|Overall Study|No enrollment on this arm.|0
6283973|NCT00198081|7184408|FG000|NOT COMPLETED|Overall Study||1
6283974|NCT00198081|7184409|FG001|NOT COMPLETED|Overall Study||0
6283975|NCT00198107|7184422|FG000|STARTED|Double-Blind Period||41
6283976|NCT00198107|7184423|FG001|STARTED|Double-Blind Period||40
6283977|NCT00198107|7184424|FG002|STARTED|Double-Blind Period||0
6632284|NCT02280408|7560751|FG003|Vaccination 2|Overall Study||9
6632285|NCT02280408|7560748|FG000|COMPLETED|Overall Study||10
6632286|NCT02280408|7560749|FG001|COMPLETED|Overall Study||8
6632287|NCT02280408|7560750|FG002|COMPLETED|Overall Study||10
6632288|NCT02280408|7560751|FG003|COMPLETED|Overall Study||9
6632289|NCT02280408|7560748|FG000|NOT COMPLETED|Overall Study||0
6632290|NCT02280408|7560749|FG001|NOT COMPLETED|Overall Study||2
6632291|NCT02280408|7560750|FG002|NOT COMPLETED|Overall Study||0
6632292|NCT02280408|7560751|FG003|NOT COMPLETED|Overall Study||0
6632293|NCT02280421|7560763|FG000|STARTED|First Intervention(2 Weeks)||12
6632294|NCT02280421|7560764|FG001|STARTED|First Intervention(2 Weeks)||12
6632295|NCT02280421|7560763|FG000|Received Intervention|First Intervention(2 Weeks)||12
6632296|NCT02280421|7560764|FG001|Received Intervention|First Intervention(2 Weeks)||12
6632297|NCT02280421|7560763|FG000|COMPLETED|First Intervention(2 Weeks)||12
6632298|NCT02280421|7560764|FG001|COMPLETED|First Intervention(2 Weeks)||12
6632299|NCT02280421|7560763|FG000|NOT COMPLETED|First Intervention(2 Weeks)||0
6632300|NCT02280421|7560764|FG001|NOT COMPLETED|First Intervention(2 Weeks)||0
6632301|NCT02280421|7560763|FG000|STARTED|Washout (2 Weeks)||12
6632302|NCT02280421|7560764|FG001|STARTED|Washout (2 Weeks)||12
6632303|NCT02280421|7560763|FG000|COMPLETED|Washout (2 Weeks)||11
6632304|NCT02280421|7560764|FG001|COMPLETED|Washout (2 Weeks)||11
6632305|NCT02280421|7560763|FG000|NOT COMPLETED|Washout (2 Weeks)||1
6632306|NCT02280421|7560764|FG001|NOT COMPLETED|Washout (2 Weeks)||1
6632307|NCT02280421|7560763|FG000|STARTED|Second Intervention(2 Weeks)||12
6632308|NCT02280421|7560764|FG001|STARTED|Second Intervention(2 Weeks)||12
6632309|NCT02280421|7560763|FG000|Received Intervention|Second Intervention(2 Weeks)||12
6632310|NCT02280421|7560764|FG001|Received Intervention|Second Intervention(2 Weeks)||12
6632311|NCT02280421|7560763|FG000|COMPLETED|Second Intervention(2 Weeks)||12
6632312|NCT02280421|7560764|FG001|COMPLETED|Second Intervention(2 Weeks)||12
6632313|NCT02280421|7560763|FG000|NOT COMPLETED|Second Intervention(2 Weeks)||0
6632314|NCT02280421|7560764|FG001|NOT COMPLETED|Second Intervention(2 Weeks)||0
6632315|NCT02280473|7560784|FG000|STARTED|Overall Study||94
6632316|NCT02280473|7560785|FG001|STARTED|Overall Study||94
6632317|NCT02280473|7560784|FG000|COMPLETED|Overall Study||93
6632318|NCT02280473|7560785|FG001|COMPLETED|Overall Study||91
6632319|NCT02280473|7560784|FG000|NOT COMPLETED|Overall Study||1
6632320|NCT02280473|7560785|FG001|NOT COMPLETED|Overall Study||3
6632321|NCT02280499|7560791|FG000|STARTED|Overall Study||87
6632322|NCT02280499|7560791|FG000|COMPLETED|Overall Study||26
6632323|NCT02280499|7560791|FG000|NOT COMPLETED|Overall Study||61
6632324|NCT02280655|7560797|FG000|STARTED|Overall Study||25
6632325|NCT02280655|7560798|FG001|STARTED|Overall Study||18
6632326|NCT02280655|7560797|FG000|COMPLETED|Overall Study||25
6632327|NCT02280655|7560798|FG001|COMPLETED|Overall Study||18
6632328|NCT02280655|7560797|FG000|NOT COMPLETED|Overall Study||0
6632329|NCT02280655|7560798|FG001|NOT COMPLETED|Overall Study||0
6632330|NCT02280811|7560809|FG000|STARTED|Drug Administration||1
6632331|NCT02280811|7560810|FG001|STARTED|Drug Administration||2
6632332|NCT02280811|7560811|FG002|STARTED|Drug Administration||1
6632333|NCT02280811|7560812|FG003|STARTED|Drug Administration||6
6632334|NCT02280811|7560813|FG004|STARTED|Drug Administration||2
6632335|NCT02280811|7560809|FG000|COMPLETED|Drug Administration||1
6632336|NCT02280811|7560810|FG001|COMPLETED|Drug Administration||2
6632337|NCT02280811|7560811|FG002|COMPLETED|Drug Administration||1
6632338|NCT02280811|7560812|FG003|COMPLETED|Drug Administration||6
6632339|NCT02280811|7560813|FG004|COMPLETED|Drug Administration||2
6632340|NCT02280811|7560809|FG000|NOT COMPLETED|Drug Administration||0
6632341|NCT02280811|7560810|FG001|NOT COMPLETED|Drug Administration||0
6632342|NCT02280811|7560811|FG002|NOT COMPLETED|Drug Administration||0
6632343|NCT02280811|7560812|FG003|NOT COMPLETED|Drug Administration||0
6632344|NCT02280811|7560813|FG004|NOT COMPLETED|Drug Administration||0
6632345|NCT02280811|7560809|FG000|STARTED|Retreated at the MTD||0
6632346|NCT02280811|7560810|FG001|STARTED|Retreated at the MTD||0
6632347|NCT02280811|7560811|FG002|STARTED|Retreated at the MTD||0
6632348|NCT02280811|7560812|FG003|STARTED|Retreated at the MTD||0
6632349|NCT02280811|7560813|FG004|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
6632350|NCT02280811|7560809|FG000|COMPLETED|Retreated at the MTD||0
6632351|NCT02280811|7560810|FG001|COMPLETED|Retreated at the MTD||0
6632352|NCT02280811|7560811|FG002|COMPLETED|Retreated at the MTD||0
6632353|NCT02280811|7560812|FG003|COMPLETED|Retreated at the MTD||0
6632354|NCT02280811|7560813|FG004|COMPLETED|Retreated at the MTD||1
6632355|NCT02280811|7560809|FG000|NOT COMPLETED|Retreated at the MTD||0
6283978|NCT00198107|7184422|FG000|1 or More Follow-up Visits|Double-Blind Period||40
6283979|NCT00198107|7184423|FG001|1 or More Follow-up Visits|Double-Blind Period||38
6283980|NCT00198107|7184424|FG002|1 or More Follow-up Visits|Double-Blind Period||0
6283981|NCT00198107|7184422|FG000|COMPLETED|Double-Blind Period||35
6283982|NCT00198107|7184423|FG001|COMPLETED|Double-Blind Period||37
6283983|NCT00198107|7184424|FG002|COMPLETED|Double-Blind Period||0
6632356|NCT02280811|7560810|FG001|NOT COMPLETED|Retreated at the MTD||0
6632357|NCT02280811|7560811|FG002|NOT COMPLETED|Retreated at the MTD||0
6632358|NCT02280811|7560812|FG003|NOT COMPLETED|Retreated at the MTD||0
6632359|NCT02280811|7560813|FG004|NOT COMPLETED|Retreated at the MTD||0
6632360|NCT02280863|7560829|FG000|STARTED|Android Platform||8
6632361|NCT02280863|7560830|FG001|STARTED|Android Platform||0
6632362|NCT02280863|7560829|FG000|COMPLETED|Android Platform||8
6632363|NCT02280863|7560830|FG001|COMPLETED|Android Platform||0
6632364|NCT02280863|7560829|FG000|NOT COMPLETED|Android Platform||0
6632365|NCT02280863|7560830|FG001|NOT COMPLETED|Android Platform||0
6632366|NCT02280863|7560829|FG000|STARTED|Integrated Platform|One additional participant was enrolled for part 2.|9
6632367|NCT02280863|7560830|FG001|STARTED|Integrated Platform||15
6632368|NCT02280863|7560829|FG000|COMPLETED|Integrated Platform||9
6632369|NCT02280863|7560830|FG001|COMPLETED|Integrated Platform||14
6632370|NCT02280863|7560829|FG000|NOT COMPLETED|Integrated Platform||0
6632371|NCT02280863|7560830|FG001|NOT COMPLETED|Integrated Platform||1
6632372|NCT02281136|7560840|FG000|STARTED|Overall Study||29
6632373|NCT02281136|7560840|FG000|COMPLETED|Overall Study||29
6632374|NCT02281136|7560840|FG000|NOT COMPLETED|Overall Study||0
6632375|NCT02281318|7560846|FG000|STARTED|Overall Study||277
6632376|NCT02281318|7560847|FG001|STARTED|Overall Study||274
6632377|NCT02281318|7560846|FG000|COMPLETED|Overall Study||263
6632378|NCT02281318|7560847|FG001|COMPLETED|Overall Study||269
6632379|NCT02281318|7560846|FG000|NOT COMPLETED|Overall Study||14
6632380|NCT02281318|7560847|FG001|NOT COMPLETED|Overall Study||5
6632381|NCT02281344|7560853|FG000|STARTED|Overall Study||6
6632382|NCT02281344|7560853|FG000|COMPLETED|Overall Study||6
6632383|NCT02281344|7560853|FG000|NOT COMPLETED|Overall Study||0
6632384|NCT02281357|7560859|FG000|STARTED|Overall Study||70
6632385|NCT02281357|7560860|FG001|STARTED|Overall Study||70
6632386|NCT02281357|7560859|FG000|COMPLETED|Overall Study||63
6632387|NCT02281357|7560860|FG001|COMPLETED|Overall Study||66
6632388|NCT02281357|7560859|FG000|NOT COMPLETED|Overall Study||7
6632389|NCT02281357|7560860|FG001|NOT COMPLETED|Overall Study||4
6632390|NCT02281409|7560870|FG000|STARTED|Overall Study||3
6632391|NCT02281409|7560871|FG001|STARTED|Overall Study||3
6632392|NCT02281409|7560872|FG002|STARTED|Overall Study||5
6632393|NCT02281409|7560873|FG003|STARTED|Overall Study||6
6632394|NCT02281409|7560870|FG000|COMPLETED|Overall Study||3
6632395|NCT02281409|7560871|FG001|COMPLETED|Overall Study||3
6632396|NCT02281409|7560872|FG002|COMPLETED|Overall Study||5
6632397|NCT02281409|7560873|FG003|COMPLETED|Overall Study||6
6632398|NCT02281409|7560870|FG000|NOT COMPLETED|Overall Study||0
6632399|NCT02281409|7560871|FG001|NOT COMPLETED|Overall Study||0
6632400|NCT02281409|7560872|FG002|NOT COMPLETED|Overall Study||0
6632401|NCT02281409|7560873|FG003|NOT COMPLETED|Overall Study||0
6632402|NCT02281422|7560889|FG000|STARTED|Overall Study||8
6632403|NCT02281422|7560890|FG001|STARTED|Overall Study||8
6632404|NCT02281422|7560891|FG002|STARTED|Overall Study||8
6632405|NCT02281422|7560892|FG003|STARTED|Overall Study||8
6632406|NCT02281422|7560893|FG004|STARTED|Overall Study||8
6632407|NCT02281422|7560889|FG000|COMPLETED|Overall Study||8
6632408|NCT02281422|7560890|FG001|COMPLETED|Overall Study||8
6632409|NCT02281422|7560891|FG002|COMPLETED|Overall Study||8
6632410|NCT02281422|7560892|FG003|COMPLETED|Overall Study||8
6632411|NCT02281422|7560893|FG004|COMPLETED|Overall Study||8
6632412|NCT02281422|7560889|FG000|NOT COMPLETED|Overall Study||0
6632413|NCT02281422|7560890|FG001|NOT COMPLETED|Overall Study||0
6632414|NCT02281422|7560891|FG002|NOT COMPLETED|Overall Study||0
6632415|NCT02281422|7560892|FG003|NOT COMPLETED|Overall Study||0
6632416|NCT02281422|7560893|FG004|NOT COMPLETED|Overall Study||0
6655600|NCT02453711|7585718|FG002|NOT COMPLETED|Overall Study||9
6655601|NCT02453711|7585719|FG003|NOT COMPLETED|Overall Study||7
6655602|NCT02453711|7585720|FG004|NOT COMPLETED|Overall Study||2
6655603|NCT02453711|7585721|FG005|NOT COMPLETED|Overall Study||6
6655604|NCT02453711|7585722|FG006|NOT COMPLETED|Overall Study||3
6283984|NCT00198107|7184422|FG000|NOT COMPLETED|Double-Blind Period||6
6655605|NCT02453711|7585723|FG007|NOT COMPLETED|Overall Study||7
6655606|NCT02453711|7585724|FG008|NOT COMPLETED|Overall Study||13
6655607|NCT02453750|7585744|FG000|STARTED|Overall Study||21
6655608|NCT02453750|7585744|FG000|COMPLETED|Overall Study||21
6655609|NCT02453750|7585744|FG000|NOT COMPLETED|Overall Study||0
6655610|NCT02453841|7585751|FG000|STARTED|Overall Study||30
6655611|NCT02453841|7585751|FG000|COMPLETED|Overall Study||27
6655612|NCT02453841|7585751|FG000|NOT COMPLETED|Overall Study||3
6655613|NCT02454075|7585755|FG000|STARTED|Overall Study||3
6655614|NCT02454075|7585755|FG000|COMPLETED|Overall Study||3
6655615|NCT02454075|7585755|FG000|NOT COMPLETED|Overall Study||0
6655616|NCT02454101|7585763|FG000|STARTED|Overall Study||150
6655617|NCT02454101|7585764|FG001|STARTED|Overall Study||150
6655618|NCT02454101|7585763|FG000|COMPLETED|Overall Study||145
6655619|NCT02454101|7585764|FG001|COMPLETED|Overall Study||143
6655620|NCT02454101|7585763|FG000|NOT COMPLETED|Overall Study||5
6655621|NCT02454101|7585764|FG001|NOT COMPLETED|Overall Study||7
6283985|NCT00198107|7184423|FG001|NOT COMPLETED|Double-Blind Period||3
6283986|NCT00198107|7184424|FG002|NOT COMPLETED|Double-Blind Period||0
6283987|NCT00198107|7184422|FG000|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
6283988|NCT00198107|7184423|FG001|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||0
6283989|NCT00198107|7184424|FG002|STARTED|Pilot Add-On Aripiprazole +D-cycloserine||10
6283990|NCT00198107|7184422|FG000|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
6283991|NCT00198107|7184423|FG001|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
6283992|NCT00198107|7184424|FG002|COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||8
6283993|NCT00198107|7184422|FG000|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
6283994|NCT00198107|7184423|FG001|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||0
6283995|NCT00198107|7184424|FG002|NOT COMPLETED|Pilot Add-On Aripiprazole +D-cycloserine||2
6283996|NCT00198133|7184434|FG000|STARTED|Overall Study||16
6283997|NCT00198133|7184435|FG001|STARTED|Overall Study||11
6283998|NCT00198133|7184434|FG000|COMPLETED|Overall Study||11
6283999|NCT00198133|7184435|FG001|COMPLETED|Overall Study||3
6284000|NCT00198133|7184434|FG000|NOT COMPLETED|Overall Study||5
6284001|NCT00198133|7184435|FG001|NOT COMPLETED|Overall Study||8
6284002|NCT00198822|7184444|FG000|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
6284003|NCT00198822|7184445|FG001|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
6284004|NCT00198822|7184446|FG002|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
6284005|NCT00198822|7184444|FG000|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
6284006|NCT00198822|7184445|FG001|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
6284007|NCT00198822|7184446|FG002|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
6284008|NCT00198822|7184444|FG000|NOT COMPLETED|Overall Study||14
6284009|NCT00198822|7184445|FG001|NOT COMPLETED|Overall Study||20
6284010|NCT00198822|7184446|FG002|NOT COMPLETED|Overall Study||21
6284011|NCT00199381|7184454|FG000|STARTED|Overall Study||504
6284012|NCT00199381|7184454|FG000|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
6632417|NCT02281448|7560907|FG000|STARTED|Overall Study||10
6632418|NCT02281448|7560908|FG001|STARTED|Overall Study||10
6632419|NCT02281448|7560907|FG000|COMPLETED|Overall Study||8
6632420|NCT02281448|7560908|FG001|COMPLETED|Overall Study||9
6632421|NCT02281448|7560907|FG000|NOT COMPLETED|Overall Study||2
6632422|NCT02281448|7560908|FG001|NOT COMPLETED|Overall Study||1
6632423|NCT02281526|7560916|FG000|STARTED|Overall Study||9
6632424|NCT02281526|7560917|FG001|STARTED|Overall Study||8
6632425|NCT02281526|7560916|FG000|COMPLETED|Overall Study||8
6632426|NCT02281526|7560917|FG001|COMPLETED|Overall Study||8
6632427|NCT02281526|7560916|FG000|NOT COMPLETED|Overall Study||1
6632428|NCT02281526|7560917|FG001|NOT COMPLETED|Overall Study||0
6632429|NCT02281552|7560925|FG000|STARTED|Overall Study||104
6632430|NCT02281552|7560926|FG001|STARTED|Overall Study||105
6632431|NCT02281552|7560925|FG000|COMPLETED|Overall Study||100
6632432|NCT02281552|7560926|FG001|COMPLETED|Overall Study||95
6632433|NCT02281552|7560925|FG000|NOT COMPLETED|Overall Study||4
6632434|NCT02281552|7560926|FG001|NOT COMPLETED|Overall Study||10
6632435|NCT02281591|7560936|FG000|STARTED|Overall Study||8
6632436|NCT02281591|7560937|FG001|STARTED|Overall Study||8
6632437|NCT02281591|7560938|FG002|STARTED|Overall Study||8
6632438|NCT02281591|7560939|FG003|STARTED|Overall Study||8
6632439|NCT02281591|7560936|FG000|COMPLETED|Overall Study||8
6632440|NCT02281591|7560937|FG001|COMPLETED|Overall Study||8
6632441|NCT02281591|7560938|FG002|COMPLETED|Overall Study||8
6632442|NCT02281591|7560939|FG003|COMPLETED|Overall Study||8
6632443|NCT02281591|7560936|FG000|NOT COMPLETED|Overall Study||0
6632444|NCT02281591|7560937|FG001|NOT COMPLETED|Overall Study||0
6632445|NCT02281591|7560938|FG002|NOT COMPLETED|Overall Study||0
6632446|NCT02281591|7560939|FG003|NOT COMPLETED|Overall Study||0
6632447|NCT02281760|7560949|FG000|STARTED|Overall Study||6
6632448|NCT02281760|7560949|FG000|COMPLETED|Overall Study||5
6632449|NCT02281760|7560949|FG000|NOT COMPLETED|Overall Study||1
6632450|NCT02281773|7560958|FG000|STARTED|Overall Study||87
6632451|NCT02281773|7560959|FG001|STARTED|Overall Study|Started are the treated patients|85
6632452|NCT02281773|7560960|FG002|STARTED|Overall Study||85
6632453|NCT02281773|7560961|FG003|STARTED|Overall Study||86
6632454|NCT02281773|7560962|FG004|STARTED|Overall Study|Started are the treated patients|173
6632455|NCT02281773|7560958|FG000|COMPLETED|Overall Study||76
6632456|NCT02281773|7560959|FG001|COMPLETED|Overall Study||70
6632457|NCT02281773|7560960|FG002|COMPLETED|Overall Study||67
6632458|NCT02281773|7560961|FG003|COMPLETED|Overall Study||65
6632459|NCT02281773|7560962|FG004|COMPLETED|Overall Study||143
6632460|NCT02281773|7560958|FG000|NOT COMPLETED|Overall Study||11
6632461|NCT02281773|7560959|FG001|NOT COMPLETED|Overall Study||15
6632462|NCT02281773|7560960|FG002|NOT COMPLETED|Overall Study||18
6632463|NCT02281773|7560961|FG003|NOT COMPLETED|Overall Study||21
6632464|NCT02281773|7560962|FG004|NOT COMPLETED|Overall Study||30
6632465|NCT02281851|7560976|FG000|STARTED|Overall Study||4
6632466|NCT02281851|7560977|FG001|STARTED|Overall Study||10
6632467|NCT02281851|7560976|FG000|COMPLETED|Overall Study||4
6632468|NCT02281851|7560977|FG001|COMPLETED|Overall Study||10
6632469|NCT02281851|7560976|FG000|NOT COMPLETED|Overall Study||0
6632470|NCT02281851|7560977|FG001|NOT COMPLETED|Overall Study||0
6632471|NCT02282111|7560985|FG000|STARTED|Overall Study||26
6284013|NCT00199381|7184454|FG000|NOT COMPLETED|Overall Study||504
6284014|NCT00199797|7184458|FG000|STARTED|Overall Study||20
6284015|NCT00199797|7184458|FG000|COMPLETED|Overall Study||17
6284016|NCT00199797|7184458|FG000|NOT COMPLETED|Overall Study||3
6284017|NCT00199836|7184463|FG000|STARTED|Overall Study||14
6632472|NCT02282111|7560986|FG001|STARTED|Overall Study||30
6632473|NCT02282111|7560985|FG000|COMPLETED|Overall Study||19
6632474|NCT02282111|7560986|FG001|COMPLETED|Overall Study||22
6632475|NCT02282111|7560985|FG000|NOT COMPLETED|Overall Study||7
6632476|NCT02282111|7560986|FG001|NOT COMPLETED|Overall Study||8
6632477|NCT02282163|7560992|FG000|STARTED|Overall Study||13
6632478|NCT02282163|7560992|FG000|COMPLETED|Overall Study||12
6632479|NCT02282163|7560992|FG000|NOT COMPLETED|Overall Study||1
6632480|NCT02282293|7561007|FG000|STARTED|Overall Study||100
6632481|NCT02282293|7561008|FG001|STARTED|Overall Study||100
6632482|NCT02282293|7561007|FG000|COMPLETED|Overall Study||97
6632483|NCT02282293|7561008|FG001|COMPLETED|Overall Study||97
6632484|NCT02282293|7561007|FG000|NOT COMPLETED|Overall Study||3
6632485|NCT02282293|7561008|FG001|NOT COMPLETED|Overall Study||3
6632486|NCT02282514|7561014|FG000|STARTED|Overall Study||23
6632487|NCT02282514|7561014|FG000|COMPLETED|Overall Study||23
6632488|NCT02282514|7561014|FG000|NOT COMPLETED|Overall Study||0
6632489|NCT02282527|7561020|FG000|STARTED|Overall Study||16
6632490|NCT02282527|7561021|FG001|STARTED|Overall Study||16
6632491|NCT02282527|7561020|FG000|COMPLETED|Overall Study||15
6632492|NCT02282527|7561021|FG001|COMPLETED|Overall Study||15
6632493|NCT02282527|7561020|FG000|NOT COMPLETED|Overall Study||1
6632494|NCT02282527|7561021|FG001|NOT COMPLETED|Overall Study||1
6743196|NCT03332784|7671454|FG005|COMPLETED|Part 1- Period 3 (1 Day)||2
6743197|NCT03332784|7671455|FG006|COMPLETED|Part 1- Period 3 (1 Day)||2
6743198|NCT03332784|7671456|FG007|COMPLETED|Part 1- Period 3 (1 Day)||2
6743199|NCT03332784|7671457|FG008|COMPLETED|Part 1- Period 3 (1 Day)||0
6743200|NCT03332784|7671458|FG009|COMPLETED|Part 1- Period 3 (1 Day)||0
6743201|NCT03332784|7671459|FG010|COMPLETED|Part 1- Period 3 (1 Day)||0
6743202|NCT03332784|7671460|FG011|COMPLETED|Part 1- Period 3 (1 Day)||0
6743203|NCT03332784|7671461|FG012|COMPLETED|Part 1- Period 3 (1 Day)||0
6743204|NCT03332784|7671462|FG013|COMPLETED|Part 1- Period 3 (1 Day)||0
6743205|NCT03332784|7671463|FG014|COMPLETED|Part 1- Period 3 (1 Day)||0
6743206|NCT03332784|7671464|FG015|COMPLETED|Part 1- Period 3 (1 Day)||0
6743207|NCT03332784|7671465|FG016|COMPLETED|Part 1- Period 3 (1 Day)||0
6743208|NCT03332784|7671466|FG017|COMPLETED|Part 1- Period 3 (1 Day)||0
6743209|NCT03332784|7671467|FG018|COMPLETED|Part 1- Period 3 (1 Day)||0
6743210|NCT03332784|7671468|FG019|COMPLETED|Part 1- Period 3 (1 Day)||0
6743211|NCT03332784|7671449|FG000|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743212|NCT03332784|7671450|FG001|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743213|NCT03332784|7671451|FG002|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743214|NCT03332784|7671452|FG003|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743215|NCT03332784|7671453|FG004|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743216|NCT03332784|7671454|FG005|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743217|NCT03332784|7671455|FG006|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743218|NCT03332784|7671456|FG007|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743219|NCT03332784|7671457|FG008|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743220|NCT03332784|7671458|FG009|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743221|NCT03332784|7671459|FG010|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743222|NCT03332784|7671460|FG011|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743223|NCT03332784|7671461|FG012|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743224|NCT03332784|7671462|FG013|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743225|NCT03332784|7671463|FG014|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743226|NCT03332784|7671464|FG015|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743227|NCT03332784|7671465|FG016|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743228|NCT03332784|7671466|FG017|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743229|NCT03332784|7671467|FG018|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743230|NCT03332784|7671468|FG019|NOT COMPLETED|Part 1- Period 3 (1 Day)||0
6743231|NCT03332979|7671522|FG000|STARTED|Overall Study||150
6743232|NCT03332979|7671522|FG000|COMPLETED|Overall Study||150
6743233|NCT03332979|7671522|FG000|NOT COMPLETED|Overall Study||0
6743234|NCT03333109|7671529|FG000|STARTED|Double-blind Treatment Period (DBTP)||338
6743235|NCT03333109|7671530|FG001|STARTED|Double-blind Treatment Period (DBTP)||224
6743236|NCT03333109|7671531|FG002|STARTED|Double-blind Treatment Period (DBTP)||338
6743237|NCT03333109|7671529|FG000|Full Analysis Set|Double-blind Treatment Period (DBTP)||329
6743238|NCT03333109|7671530|FG001|Full Analysis Set|Double-blind Treatment Period (DBTP)||219
6743239|NCT03333109|7671531|FG002|Full Analysis Set|Double-blind Treatment Period (DBTP)||330
6743240|NCT03333109|7671529|FG000|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
6743241|NCT03333109|7671530|FG001|Safety Analysis Set|Double-blind Treatment Period (DBTP)||224
6743242|NCT03333109|7671531|FG002|Safety Analysis Set|Double-blind Treatment Period (DBTP)||335
6743243|NCT03333109|7671529|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||321
6743244|NCT03333109|7671530|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||218
6743245|NCT03333109|7671531|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||326
6743246|NCT03333109|7671529|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||17
6743247|NCT03333109|7671530|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||6
6284018|NCT00199836|7184463|FG000|COMPLETED|Overall Study||8
6632495|NCT02282605|7561033|FG000|STARTED|Overall Study||27
6632496|NCT02282605|7561034|FG001|STARTED|Overall Study||12
6284019|NCT00199836|7184463|FG000|NOT COMPLETED|Overall Study||6
6284020|NCT00199849|7184471|FG000|STARTED|Overall Study||3
6284021|NCT00199849|7184472|FG001|STARTED|Overall Study||7
6284022|NCT00199849|7184473|FG002|STARTED|Overall Study||8
6284023|NCT00199849|7184471|FG000|COMPLETED|Overall Study||3
6284024|NCT00199849|7184472|FG001|COMPLETED|Overall Study||6
6284025|NCT00199849|7184473|FG002|COMPLETED|Overall Study||6
6284026|NCT00199849|7184471|FG000|NOT COMPLETED|Overall Study||0
6284027|NCT00199849|7184472|FG001|NOT COMPLETED|Overall Study||1
6284028|NCT00199849|7184473|FG002|NOT COMPLETED|Overall Study||2
6284029|NCT00199875|7184486|FG000|STARTED|Overall Study||3
6284030|NCT00199875|7184487|FG001|STARTED|Overall Study||3
6284031|NCT00199875|7184488|FG002|STARTED|Overall Study||6
6284032|NCT00199875|7184489|FG003|STARTED|Overall Study||3
6632497|NCT02282605|7561035|FG002|STARTED|Overall Study||24
6632498|NCT02282605|7561033|FG000|COMPLETED|Overall Study||24
6632499|NCT02282605|7561034|FG001|COMPLETED|Overall Study||12
6632500|NCT02282605|7561035|FG002|COMPLETED|Overall Study||24
6632501|NCT02282605|7561033|FG000|NOT COMPLETED|Overall Study||3
6632502|NCT02282605|7561034|FG001|NOT COMPLETED|Overall Study||0
6632503|NCT02282605|7561035|FG002|NOT COMPLETED|Overall Study||0
6632504|NCT02282631|7561045|FG000|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
6632505|NCT02282631|7561046|FG001|STARTED|Overall Study||15
6632506|NCT02282631|7561045|FG000|COMPLETED|Overall Study||12
6632507|NCT02282631|7561046|FG001|COMPLETED|Overall Study||15
6632508|NCT02282631|7561045|FG000|NOT COMPLETED|Overall Study||2
6632509|NCT02282631|7561046|FG001|NOT COMPLETED|Overall Study||0
6632510|NCT02282722|7561060|FG000|STARTED|Overall Study||94
6632511|NCT02282722|7561061|FG001|STARTED|Overall Study||92
6632512|NCT02282722|7561060|FG000|2-week Assessment|Overall Study||79
6632513|NCT02282722|7561061|FG001|2-week Assessment|Overall Study||75
6632514|NCT02282722|7561060|FG000|3-month Assessment|Overall Study||71
6632515|NCT02282722|7561061|FG001|3-month Assessment|Overall Study||73
6632516|NCT02282722|7561060|FG000|COMPLETED|Overall Study||71
6632517|NCT02282722|7561061|FG001|COMPLETED|Overall Study||73
6632518|NCT02282722|7561060|FG000|NOT COMPLETED|Overall Study||23
6632519|NCT02282722|7561061|FG001|NOT COMPLETED|Overall Study||19
6632520|NCT02282813|7561070|FG000|STARTED|Overall Study|ITT Population|103
6632521|NCT02282813|7561071|FG001|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
6632522|NCT02282813|7561072|FG002|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
6632523|NCT02282813|7561070|FG000|COMPLETED|Overall Study||91
6632524|NCT02282813|7561071|FG001|COMPLETED|Overall Study||130
6632525|NCT02282813|7561072|FG002|COMPLETED|Overall Study||39
6632526|NCT02282813|7561070|FG000|NOT COMPLETED|Overall Study||12
6632527|NCT02282813|7561071|FG001|NOT COMPLETED|Overall Study||23
6632528|NCT02282813|7561072|FG002|NOT COMPLETED|Overall Study||3
6632529|NCT02282904|7561082|FG000|STARTED|Overall Study||7
6632530|NCT02282904|7561082|FG000|COMPLETED|Overall Study|Patient accrual was stopped early, and the protocol closed after completing followup|7
6632531|NCT02282904|7561082|FG000|NOT COMPLETED|Overall Study||0
6632532|NCT02282930|7561086|FG000|STARTED|Overall Study||20
6632533|NCT02282930|7561086|FG000|COMPLETED|Overall Study||19
6632534|NCT02282930|7561086|FG000|NOT COMPLETED|Overall Study||1
6632535|NCT02282982|7561090|FG000|STARTED|Overall Study||359
6632536|NCT02282982|7561090|FG000|Attended Visit 1|Overall Study||359
6632537|NCT02282982|7561090|FG000|Attended Visit 2|Overall Study||341
6632538|NCT02282982|7561090|FG000|Attended Visit 3|Overall Study||298
6632539|NCT02282982|7561090|FG000|Attended Visit 4|Overall Study||194
6632540|NCT02282982|7561090|FG000|Attended Visit 5|Overall Study||83
6632541|NCT02282982|7561090|FG000|Attended Follow-up Visit|Overall Study||349
6632542|NCT02282982|7561090|FG000|COMPLETED|Overall Study||153
6632543|NCT02282982|7561090|FG000|NOT COMPLETED|Overall Study||206
6632544|NCT02283268|7561094|FG000|STARTED|Overall Study||15
6632545|NCT02283268|7561094|FG000|COMPLETED|Overall Study||14
6632546|NCT02283268|7561094|FG000|NOT COMPLETED|Overall Study||1
6632547|NCT02283294|7561108|FG000|STARTED|Overall Study||41
6632548|NCT02283294|7561109|FG001|STARTED|Overall Study||47
6632549|NCT02283294|7561108|FG000|Received Allocated Treatment Intervention|Overall Study||38
6632550|NCT02283294|7561109|FG001|Received Allocated Treatment Intervention|Overall Study||31
6632551|NCT02283294|7561108|FG000|COMPLETED|Overall Study||38
6632552|NCT02283294|7561109|FG001|COMPLETED|Overall Study||39
6632553|NCT02283294|7561108|FG000|NOT COMPLETED|Overall Study||3
6632554|NCT02283294|7561109|FG001|NOT COMPLETED|Overall Study||8
6632555|NCT02283333|7561118|FG000|STARTED|Overall Study||77
6284033|NCT00199875|7184490|FG004|STARTED|Overall Study||3
6284034|NCT00199875|7184486|FG000|COMPLETED|Overall Study||3
6284035|NCT00199875|7184487|FG001|COMPLETED|Overall Study||3
6284036|NCT00199875|7184488|FG002|COMPLETED|Overall Study||6
6284037|NCT00199875|7184489|FG003|COMPLETED|Overall Study||3
6632556|NCT02283333|7561119|FG001|STARTED|Overall Study||78
6632557|NCT02283333|7561118|FG000|COMPLETED|Overall Study||63
6632558|NCT02283333|7561119|FG001|COMPLETED|Overall Study||64
6632559|NCT02283333|7561118|FG000|NOT COMPLETED|Overall Study||14
6632560|NCT02283333|7561119|FG001|NOT COMPLETED|Overall Study||14
6632561|NCT02283411|7561125|FG000|STARTED|Overall Study||156
6632562|NCT02283411|7561125|FG000|COMPLETED|Overall Study||125
6632563|NCT02283411|7561125|FG000|NOT COMPLETED|Overall Study||31
6632564|NCT02283528|7561131|FG000|STARTED|Overall Study||26
6632565|NCT02283528|7561132|FG001|STARTED|Overall Study||24
6632566|NCT02283528|7561131|FG000|COMPLETED|Overall Study||26
6284038|NCT00199875|7184490|FG004|COMPLETED|Overall Study||2
6284039|NCT00199875|7184486|FG000|NOT COMPLETED|Overall Study||0
6284040|NCT00199875|7184487|FG001|NOT COMPLETED|Overall Study||0
6284041|NCT00199875|7184488|FG002|NOT COMPLETED|Overall Study||0
6284042|NCT00199875|7184489|FG003|NOT COMPLETED|Overall Study||0
6284043|NCT00199875|7184490|FG004|NOT COMPLETED|Overall Study||1
6284044|NCT00199888|7184502|FG000|STARTED|Overall Study||26
6284045|NCT00199888|7184502|FG000|COMPLETED|Overall Study||25
6632567|NCT02283528|7561132|FG001|COMPLETED|Overall Study||24
6632568|NCT02283528|7561131|FG000|NOT COMPLETED|Overall Study||0
6632569|NCT02283528|7561132|FG001|NOT COMPLETED|Overall Study||0
6632570|NCT02283658|7561138|FG000|STARTED|Overall Study||20
6632571|NCT02283658|7561138|FG000|COMPLETED|Overall Study||19
6632572|NCT02283658|7561138|FG000|NOT COMPLETED|Overall Study||1
6632573|NCT02283749|7561142|FG000|STARTED|Overall Study||5
6632574|NCT02283749|7561142|FG000|COMPLETED|Overall Study||5
6632575|NCT02283749|7561142|FG000|NOT COMPLETED|Overall Study||0
6632576|NCT02283762|7561148|FG000|STARTED|Main Treatment Phase (MT)||60
6632577|NCT02283762|7561149|FG001|STARTED|Main Treatment Phase (MT)||61
6632578|NCT02283762|7561148|FG000|COMPLETED|Main Treatment Phase (MT)||42
6632579|NCT02283762|7561149|FG001|COMPLETED|Main Treatment Phase (MT)||46
6632580|NCT02283762|7561148|FG000|NOT COMPLETED|Main Treatment Phase (MT)||18
6632581|NCT02283762|7561149|FG001|NOT COMPLETED|Main Treatment Phase (MT)||15
6632582|NCT02283762|7561148|FG000|STARTED|Long-term Extension Phase (LTE)||42
6632583|NCT02283762|7561149|FG001|STARTED|Long-term Extension Phase (LTE)|Of the 46 patients who completed the main treatment phase, 1 patient did not enter the LTE phase|45
6632584|NCT02283762|7561148|FG000|COMPLETED|Long-term Extension Phase (LTE)||32
6632585|NCT02283762|7561149|FG001|COMPLETED|Long-term Extension Phase (LTE)||31
6632586|NCT02283762|7561148|FG000|NOT COMPLETED|Long-term Extension Phase (LTE)||10
6632587|NCT02283762|7561149|FG001|NOT COMPLETED|Long-term Extension Phase (LTE)||14
6632588|NCT02283788|7561161|FG000|STARTED|Overall Study||17
6632589|NCT02283788|7561162|FG001|STARTED|Overall Study||17
6632590|NCT02283788|7561163|FG002|STARTED|Overall Study||17
6632591|NCT02283788|7561164|FG003|STARTED|Overall Study||16
6632592|NCT02283788|7561161|FG000|COMPLETED|Overall Study||16
6632593|NCT02283788|7561162|FG001|COMPLETED|Overall Study||13
6632594|NCT02283788|7561163|FG002|COMPLETED|Overall Study||12
6632595|NCT02283788|7561164|FG003|COMPLETED|Overall Study||14
6632596|NCT02283788|7561161|FG000|NOT COMPLETED|Overall Study||1
6632597|NCT02283788|7561162|FG001|NOT COMPLETED|Overall Study||4
6632598|NCT02283788|7561163|FG002|NOT COMPLETED|Overall Study||5
6632599|NCT02283788|7561164|FG003|NOT COMPLETED|Overall Study||2
6632600|NCT02283814|7561176|FG000|STARTED|Overall Study||16
6632601|NCT02283814|7561177|FG001|STARTED|Overall Study||16
6632602|NCT02283814|7561176|FG000|COMPLETED|Overall Study||13
6632603|NCT02283814|7561177|FG001|COMPLETED|Overall Study||14
6632604|NCT02283814|7561176|FG000|NOT COMPLETED|Overall Study||3
6632605|NCT02283814|7561177|FG001|NOT COMPLETED|Overall Study||2
6632606|NCT02283827|7561185|FG000|STARTED|Overall Study||16
6632607|NCT02283827|7561186|FG001|STARTED|Overall Study||16
6632608|NCT02283827|7561185|FG000|COMPLETED|Overall Study||15
6632609|NCT02283827|7561186|FG001|COMPLETED|Overall Study||13
6632610|NCT02283827|7561185|FG000|NOT COMPLETED|Overall Study||1
6632611|NCT02283827|7561186|FG001|NOT COMPLETED|Overall Study||3
6632612|NCT02283840|7561201|FG000|STARTED|Overall Study||20
6632613|NCT02283840|7561202|FG001|STARTED|Overall Study||20
6632614|NCT02283840|7561203|FG002|STARTED|Overall Study||20
6632615|NCT02283840|7561201|FG000|COMPLETED|Overall Study||20
6632616|NCT02283840|7561202|FG001|COMPLETED|Overall Study||19
6632617|NCT02283840|7561203|FG002|COMPLETED|Overall Study||20
6632618|NCT02283840|7561201|FG000|NOT COMPLETED|Overall Study||0
6632619|NCT02283840|7561202|FG001|NOT COMPLETED|Overall Study||1
6632620|NCT02283840|7561203|FG002|NOT COMPLETED|Overall Study||0
6632621|NCT02284009|7561216|FG000|STARTED|Overall Study||17
6632622|NCT02284009|7561217|FG001|STARTED|Overall Study||50
6632623|NCT02284009|7561216|FG000|COMPLETED|Overall Study||11
6632624|NCT02284009|7561217|FG001|COMPLETED|Overall Study||40
6632625|NCT02284009|7561216|FG000|NOT COMPLETED|Overall Study||6
6632626|NCT02284009|7561217|FG001|NOT COMPLETED|Overall Study||10
6632627|NCT02284126|7561227|FG000|STARTED|Overall Study||552
6632628|NCT02284126|7561228|FG001|STARTED|Overall Study||551
6632629|NCT02284126|7561227|FG000|COMPLETED|Overall Study||484
6632630|NCT02284126|7561228|FG001|COMPLETED|Overall Study||489
6632631|NCT02284126|7561227|FG000|NOT COMPLETED|Overall Study||68
6632632|NCT02284126|7561228|FG001|NOT COMPLETED|Overall Study||62
6632633|NCT02284165|7561237|FG000|STARTED|Overall Study||36448
6632634|NCT02284165|7561238|FG001|STARTED|Overall Study||40272
6632635|NCT02284165|7561239|FG002|STARTED|Overall Study||70996
6632636|NCT02284165|7561237|FG000|COMPLETED|Overall Study||36448
6632637|NCT02284165|7561238|FG001|COMPLETED|Overall Study||40272
6632638|NCT02284165|7561239|FG002|COMPLETED|Overall Study||70996
6632639|NCT02284165|7561237|FG000|NOT COMPLETED|Overall Study||0
6632640|NCT02284165|7561238|FG001|NOT COMPLETED|Overall Study||0
6632641|NCT02284165|7561239|FG002|NOT COMPLETED|Overall Study||0
6284046|NCT00199888|7184502|FG000|NOT COMPLETED|Overall Study||1
6284047|NCT00199901|7184508|FG000|STARTED|Overall Study||56
6632642|NCT02284178|7561247|FG000|STARTED|Overall Study||255
6632643|NCT02284178|7561248|FG001|STARTED|Overall Study||258
6632644|NCT02284178|7561247|FG000|COMPLETED|Overall Study||206
6632645|NCT02284178|7561248|FG001|COMPLETED|Overall Study||204
6632646|NCT02284178|7561247|FG000|NOT COMPLETED|Overall Study||49
6284048|NCT00199901|7184509|FG001|STARTED|Overall Study||54
6284049|NCT00199901|7184508|FG000|COMPLETED|Overall Study||29
6284050|NCT00199901|7184509|FG001|COMPLETED|Overall Study||30
6284051|NCT00199901|7184508|FG000|NOT COMPLETED|Overall Study||27
6284052|NCT00199901|7184509|FG001|NOT COMPLETED|Overall Study||24
6284053|NCT00199914|7184519|FG000|STARTED|Overall Study||53
6284054|NCT00199914|7184520|FG001|STARTED|Overall Study||60
6284055|NCT00199914|7184519|FG000|COMPLETED|Overall Study||50
6284056|NCT00199914|7184520|FG001|COMPLETED|Overall Study||54
6284057|NCT00199914|7184519|FG000|NOT COMPLETED|Overall Study||3
6284058|NCT00199914|7184520|FG001|NOT COMPLETED|Overall Study||6
6284059|NCT00200057|7184526|FG000|STARTED|Overall Study||120
6284060|NCT00200057|7184526|FG000|1 Month Follow-up|Overall Study||117
6284061|NCT00200057|7184526|FG000|3 Month Follow-up|Overall Study||116
6284062|NCT00200057|7184526|FG000|6 Month Follow-up|Overall Study||114
6284063|NCT00200057|7184526|FG000|12 Month Follow-up|Overall Study||111
6284064|NCT00200057|7184526|FG000|COMPLETED|Overall Study||111
6284065|NCT00200057|7184526|FG000|NOT COMPLETED|Overall Study||9
6284066|NCT00200161|7184532|FG000|STARTED|Overall Study||43
6284067|NCT00200161|7184533|FG001|STARTED|Overall Study||42
6284068|NCT00200161|7184532|FG000|COMPLETED|Overall Study||43
6284069|NCT00200161|7184533|FG001|COMPLETED|Overall Study||42
6284070|NCT00200161|7184532|FG000|NOT COMPLETED|Overall Study||0
6284071|NCT00200161|7184533|FG001|NOT COMPLETED|Overall Study||0
6284072|NCT00200343|7184542|FG000|STARTED|Overall Study||199
6284073|NCT00200343|7184543|FG001|STARTED|Overall Study||200
6284074|NCT00200343|7184544|FG002|STARTED|Overall Study||197
6284075|NCT00200343|7184542|FG000|COMPLETED|Overall Study||183
6284076|NCT00200343|7184543|FG001|COMPLETED|Overall Study||192
6284077|NCT00200343|7184544|FG002|COMPLETED|Overall Study||184
6284078|NCT00200343|7184542|FG000|NOT COMPLETED|Overall Study||16
6284079|NCT00200343|7184543|FG001|NOT COMPLETED|Overall Study||8
6284080|NCT00200343|7184544|FG002|NOT COMPLETED|Overall Study||13
6284081|NCT00200356|7184554|FG000|STARTED|Overall Study||199
6284082|NCT00200356|7184555|FG001|STARTED|Overall Study||202
6284083|NCT00200356|7184554|FG000|Safety Analysis Set|Overall Study||194
6284084|NCT00200356|7184555|FG001|Safety Analysis Set|Overall Study||198
6284085|NCT00200356|7184554|FG000|COMPLETED|Overall Study||191
6284086|NCT00200356|7184555|FG001|COMPLETED|Overall Study||195
6284087|NCT00200356|7184554|FG000|NOT COMPLETED|Overall Study||8
6284088|NCT00200356|7184555|FG001|NOT COMPLETED|Overall Study||7
6284089|NCT00200785|7184563|FG000|STARTED|First Intervention||9
6284090|NCT00200785|7184564|FG001|STARTED|First Intervention||6
6284091|NCT00200785|7184563|FG000|COMPLETED|First Intervention||9
6284092|NCT00200785|7184564|FG001|COMPLETED|First Intervention||6
6284093|NCT00200785|7184563|FG000|NOT COMPLETED|First Intervention||0
6284094|NCT00200785|7184564|FG001|NOT COMPLETED|First Intervention||0
6284095|NCT00200785|7184563|FG000|STARTED|Washout Period of 1 Week||9
6284096|NCT00200785|7184564|FG001|STARTED|Washout Period of 1 Week||6
6284097|NCT00200785|7184563|FG000|COMPLETED|Washout Period of 1 Week||9
6284098|NCT00200785|7184564|FG001|COMPLETED|Washout Period of 1 Week||6
6284099|NCT00200785|7184563|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6284100|NCT00200785|7184564|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6284101|NCT00200785|7184563|FG000|STARTED|Second Intervention||9
6284102|NCT00200785|7184564|FG001|STARTED|Second Intervention||6
6284103|NCT00200785|7184563|FG000|COMPLETED|Second Intervention||9
6284104|NCT00200785|7184564|FG001|COMPLETED|Second Intervention||6
6284105|NCT00200785|7184563|FG000|NOT COMPLETED|Second Intervention||0
6284106|NCT00200785|7184564|FG001|NOT COMPLETED|Second Intervention||0
6284107|NCT00200850|7184573|FG000|STARTED|Overall Study||10
6284108|NCT00200850|7184574|FG001|STARTED|Overall Study||10
6284109|NCT00200850|7184575|FG002|STARTED|Overall Study||11
6284110|NCT00200850|7184573|FG000|COMPLETED|Overall Study||7
6284111|NCT00200850|7184574|FG001|COMPLETED|Overall Study||9
6284112|NCT00200850|7184575|FG002|COMPLETED|Overall Study||5
6284113|NCT00200850|7184573|FG000|NOT COMPLETED|Overall Study||3
6284114|NCT00200850|7184574|FG001|NOT COMPLETED|Overall Study||1
6284115|NCT00200850|7184575|FG002|NOT COMPLETED|Overall Study||6
6284116|NCT00200902|7184586|FG000|STARTED|Overall Study||39
6284117|NCT00200902|7184587|FG001|STARTED|Overall Study||29
6284118|NCT00200902|7184588|FG002|STARTED|Overall Study||20
6284119|NCT00200902|7184586|FG000|COMPLETED|Overall Study||29
6284120|NCT00200902|7184587|FG001|COMPLETED|Overall Study||26
6284121|NCT00200902|7184588|FG002|COMPLETED|Overall Study||12
6284122|NCT00200902|7184586|FG000|NOT COMPLETED|Overall Study||10
6284123|NCT00200902|7184587|FG001|NOT COMPLETED|Overall Study||3
6284124|NCT00200902|7184588|FG002|NOT COMPLETED|Overall Study||8
6284125|NCT00200967|7184604|FG000|STARTED|First Treatment Period||42
6284126|NCT00200967|7184605|FG001|STARTED|First Treatment Period||45
6284127|NCT00200967|7184604|FG000|First Treatment Period|First Treatment Period||42
6284128|NCT00200967|7184605|FG001|First Treatment Period|First Treatment Period||45
6284129|NCT00200967|7184604|FG000|COMPLETED|First Treatment Period||36
6284130|NCT00200967|7184605|FG001|COMPLETED|First Treatment Period||44
6284131|NCT00200967|7184604|FG000|NOT COMPLETED|First Treatment Period||6
6284132|NCT00200967|7184605|FG001|NOT COMPLETED|First Treatment Period||1
6284133|NCT00200967|7184604|FG000|STARTED|Wash-out Period||36
6284134|NCT00200967|7184605|FG001|STARTED|Wash-out Period||44
6284135|NCT00200967|7184604|FG000|COMPLETED|Wash-out Period||36
6284136|NCT00200967|7184605|FG001|COMPLETED|Wash-out Period||43
6284137|NCT00200967|7184604|FG000|NOT COMPLETED|Wash-out Period||0
6284138|NCT00200967|7184605|FG001|NOT COMPLETED|Wash-out Period||1
6284139|NCT00200967|7184604|FG000|STARTED|Second Treatment Period||36
6284140|NCT00200967|7184605|FG001|STARTED|Second Treatment Period||43
6284141|NCT00200967|7184604|FG000|COMPLETED|Second Treatment Period||35
6284142|NCT00200967|7184605|FG001|COMPLETED|Second Treatment Period||41
6284143|NCT00200967|7184604|FG000|NOT COMPLETED|Second Treatment Period||1
6284144|NCT00200967|7184605|FG001|NOT COMPLETED|Second Treatment Period||2
6284145|NCT00200967|7184604|FG000|STARTED|Run-out Period||35
6284146|NCT00200967|7184605|FG001|STARTED|Run-out Period||41
6284147|NCT00200967|7184604|FG000|COMPLETED|Run-out Period||34
6284148|NCT00200967|7184605|FG001|COMPLETED|Run-out Period||41
6284149|NCT00200967|7184604|FG000|NOT COMPLETED|Run-out Period||1
6284150|NCT00200967|7184605|FG001|NOT COMPLETED|Run-out Period||0
6284151|NCT00201006|7184614|FG000|STARTED|Overall Study||83
6284152|NCT00201006|7184615|FG001|STARTED|Overall Study||72
6284153|NCT00201006|7184616|FG002|STARTED|Overall Study||79
6284154|NCT00201006|7184614|FG000|COMPLETED|Overall Study||75
6284155|NCT00201006|7184615|FG001|COMPLETED|Overall Study||70
6284156|NCT00201006|7184616|FG002|COMPLETED|Overall Study||75
6284157|NCT00201006|7184614|FG000|NOT COMPLETED|Overall Study||8
6284158|NCT00201006|7184615|FG001|NOT COMPLETED|Overall Study||2
6284159|NCT00201006|7184616|FG002|NOT COMPLETED|Overall Study||4
6284160|NCT00201123|7184627|FG000|STARTED|Overall Study||32
6284161|NCT00201123|7184628|FG001|STARTED|Overall Study||32
6284162|NCT00201123|7184629|FG002|STARTED|Overall Study||32
6284163|NCT00201123|7184627|FG000|Did Not Meet Continuation Criteria|Overall Study||2
6284164|NCT00201123|7184628|FG001|Did Not Meet Continuation Criteria|Overall Study||0
6284165|NCT00201123|7184629|FG002|Did Not Meet Continuation Criteria|Overall Study||5
6284166|NCT00201123|7184627|FG000|COMPLETED|Overall Study||26
6284167|NCT00201123|7184628|FG001|COMPLETED|Overall Study||28
6284168|NCT00201123|7184629|FG002|COMPLETED|Overall Study||23
6399090|NCT00879190|7311802|FG001|STARTED|Overall Study||49
6399091|NCT00879190|7311801|FG000|COMPLETED|Overall Study||43
6399092|NCT00879190|7311802|FG001|COMPLETED|Overall Study||49
6399093|NCT00879190|7311801|FG000|NOT COMPLETED|Overall Study||0
6399094|NCT00879190|7311802|FG001|NOT COMPLETED|Overall Study||0
6399095|NCT00879229|7311810|FG000|STARTED|Overall Study||25
6399096|NCT00879229|7311811|FG001|STARTED|Overall Study||15
6399097|NCT00879229|7311810|FG000|COMPLETED|Overall Study||3
6399098|NCT00879229|7311811|FG001|COMPLETED|Overall Study||1
6399099|NCT00879229|7311810|FG000|NOT COMPLETED|Overall Study||22
6399100|NCT00879229|7311811|FG001|NOT COMPLETED|Overall Study||14
6399101|NCT00879255|7311819|FG000|STARTED|Overall Study||61
6399102|NCT00879255|7311820|FG001|STARTED|Overall Study||64
6399103|NCT00879255|7311819|FG000|Received Allocated Intervention:|Overall Study||51
6399104|NCT00879255|7311820|FG001|Received Allocated Intervention:|Overall Study||56
6399105|NCT00879255|7311819|FG000|Completed Posttreatment Follow-up|Overall Study||50
6399106|NCT00879255|7311820|FG001|Completed Posttreatment Follow-up|Overall Study||55
6399107|NCT00879255|7311819|FG000|Completed 3-mo Follow-up|Overall Study||48
6399108|NCT00879255|7311820|FG001|Completed 3-mo Follow-up|Overall Study||49
6399109|NCT00879255|7311819|FG000|COMPLETED|Overall Study|Completed 6-mo follow-up|45
6399110|NCT00879255|7311820|FG001|COMPLETED|Overall Study|Completed 6-mo follow-up|45
6399111|NCT00879255|7311819|FG000|NOT COMPLETED|Overall Study||16
6399112|NCT00879255|7311820|FG001|NOT COMPLETED|Overall Study||19
6399113|NCT00879333|7311828|FG000|STARTED|Overall Study||439
6399114|NCT00879333|7311829|FG001|STARTED|Overall Study||217
6510068|NCT01479465|7429618|FG003|STARTED|Overall Study||85
6510069|NCT01479465|7429615|FG000|COMPLETED|Overall Study||0
6510070|NCT01479465|7429616|FG001|COMPLETED|Overall Study||0
6510071|NCT01479465|7429617|FG002|COMPLETED|Overall Study||0
6510072|NCT01479465|7429618|FG003|COMPLETED|Overall Study||0
6510073|NCT01479465|7429615|FG000|NOT COMPLETED|Overall Study||11
6510074|NCT01479465|7429616|FG001|NOT COMPLETED|Overall Study||84
6510075|NCT01479465|7429617|FG002|NOT COMPLETED|Overall Study||86
6510076|NCT01479465|7429618|FG003|NOT COMPLETED|Overall Study||85
6510077|NCT01479478|7429630|FG000|STARTED|Overall Study||125
6510078|NCT01479478|7429631|FG001|STARTED|Overall Study||126
6510079|NCT01479478|7429630|FG000|COMPLETED|Overall Study||125
6510080|NCT01479478|7429631|FG001|COMPLETED|Overall Study||126
6510081|NCT01479478|7429630|FG000|NOT COMPLETED|Overall Study||0
6510082|NCT01479478|7429631|FG001|NOT COMPLETED|Overall Study||0
6510083|NCT01479517|7429640|FG000|STARTED|Overall Study||10
6510084|NCT01479517|7429641|FG001|STARTED|Overall Study||10
6510085|NCT01479517|7429642|FG002|STARTED|Overall Study||10
6632647|NCT02284178|7561248|FG001|NOT COMPLETED|Overall Study||54
6632648|NCT02284243|7561256|FG000|STARTED|Overall Study||84
6632649|NCT02284243|7561257|FG001|STARTED|Overall Study||84
6632650|NCT02284243|7561256|FG000|COMPLETED|Overall Study||80
6632651|NCT02284243|7561257|FG001|COMPLETED|Overall Study||81
6632652|NCT02284243|7561256|FG000|NOT COMPLETED|Overall Study||4
6632653|NCT02284243|7561257|FG001|NOT COMPLETED|Overall Study||3
6632654|NCT02284347|7561263|FG000|STARTED|Overall Study||51
6632655|NCT02284347|7561263|FG000|COMPLETED|Overall Study||48
6284169|NCT00201123|7184627|FG000|NOT COMPLETED|Overall Study||6
6284170|NCT00201123|7184628|FG001|NOT COMPLETED|Overall Study||4
6284171|NCT00201123|7184629|FG002|NOT COMPLETED|Overall Study||9
6284172|NCT00201201|7184643|FG000|STARTED|Overall Study||87
6284173|NCT00201201|7184644|FG001|STARTED|Overall Study||73
6284174|NCT00201201|7184643|FG000|COMPLETED|Overall Study||82
6284175|NCT00201201|7184644|FG001|COMPLETED|Overall Study||66
6284176|NCT00201201|7184643|FG000|NOT COMPLETED|Overall Study||5
6284177|NCT00201201|7184644|FG001|NOT COMPLETED|Overall Study||7
6284178|NCT00201240|7184650|FG000|STARTED|Overall Study||47
6284179|NCT00201240|7184650|FG000|COMPLETED|Overall Study||44
6284180|NCT00201240|7184650|FG000|NOT COMPLETED|Overall Study||3
6284181|NCT00201409|7184657|FG000|STARTED|Overall Study||65
6284182|NCT00201409|7184658|FG001|STARTED|Overall Study||67
6284183|NCT00201409|7184657|FG000|COMPLETED|Overall Study||64
6284184|NCT00201409|7184658|FG001|COMPLETED|Overall Study||66
6632656|NCT02284347|7561263|FG000|NOT COMPLETED|Overall Study||3
6632657|NCT02284386|7561267|FG000|STARTED|Overall Study||15
6632658|NCT02284386|7561267|FG000|COMPLETED|Overall Study||15
6284185|NCT00201409|7184657|FG000|NOT COMPLETED|Overall Study||1
6284186|NCT00201409|7184658|FG001|NOT COMPLETED|Overall Study||1
6284187|NCT00201448|7184666|FG000|STARTED|Overall Study||42
6284188|NCT00201448|7184667|FG001|STARTED|Overall Study||40
6284189|NCT00201448|7184666|FG000|COMPLETED|Overall Study||42
6284190|NCT00201448|7184667|FG001|COMPLETED|Overall Study||40
6284191|NCT00201448|7184666|FG000|NOT COMPLETED|Overall Study||0
6284192|NCT00201448|7184667|FG001|NOT COMPLETED|Overall Study||0
6373844|NCT00747474|7284557|FG004|STARTED|Cohort 8 (40 mg/m^2) Period||0
6373845|NCT00747474|7284558|FG005|STARTED|Cohort 8 (40 mg/m^2) Period||0
6373846|NCT00747474|7284559|FG006|STARTED|Cohort 8 (40 mg/m^2) Period||0
6373847|NCT00747474|7284560|FG007|STARTED|Cohort 8 (40 mg/m^2) Period||6
6373848|NCT00747474|7284561|FG008|STARTED|Cohort 8 (40 mg/m^2) Period||0
6373849|NCT00747474|7284562|FG009|STARTED|Cohort 8 (40 mg/m^2) Period||0
6373850|NCT00747474|7284563|FG010|STARTED|Cohort 8 (40 mg/m^2) Period||0
6373851|NCT00747474|7284564|FG011|STARTED|Cohort 8 (40 mg/m^2) Period||0
6373852|NCT00747474|7284553|FG000|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373853|NCT00747474|7284554|FG001|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373854|NCT00747474|7284555|FG002|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373855|NCT00747474|7284556|FG003|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373856|NCT00747474|7284557|FG004|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373857|NCT00747474|7284558|FG005|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373858|NCT00747474|7284559|FG006|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373859|NCT00747474|7284560|FG007|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
6373860|NCT00747474|7284561|FG008|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373861|NCT00747474|7284562|FG009|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373862|NCT00747474|7284563|FG010|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373863|NCT00747474|7284564|FG011|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6632659|NCT02284386|7561267|FG000|NOT COMPLETED|Overall Study||0
6632660|NCT02284399|7561273|FG000|STARTED|Overall Study||1414
6632661|NCT02284399|7561274|FG001|STARTED|Overall Study||3074
6632662|NCT02284399|7561273|FG000|COMPLETED|Overall Study||1414
6632663|NCT02284399|7561274|FG001|COMPLETED|Overall Study||3074
6632664|NCT02284399|7561273|FG000|NOT COMPLETED|Overall Study||0
6632665|NCT02284399|7561274|FG001|NOT COMPLETED|Overall Study||0
6632666|NCT02284464|7561284|FG000|STARTED|Overall Study||52
6632667|NCT02284464|7561285|FG001|STARTED|Overall Study||53
6632668|NCT02284464|7561284|FG000|COMPLETED|Overall Study||39
6632669|NCT02284464|7561285|FG001|COMPLETED|Overall Study||36
6632670|NCT02284464|7561284|FG000|NOT COMPLETED|Overall Study||13
6632671|NCT02284464|7561285|FG001|NOT COMPLETED|Overall Study||17
6632672|NCT02284516|7561293|FG000|STARTED|Overall Study||356
6743248|NCT03333109|7671531|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||12
6743249|NCT03333109|7671529|FG000|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|324
6743250|NCT03333109|7671530|FG001|STARTED|Safety Follow-up Period||218
6743251|NCT03333109|7671531|FG002|STARTED|Safety Follow-up Period|Subjects discontinued from DBTP and still entered the safety follow-up.|328
6743252|NCT03333109|7671529|FG000|COMPLETED|Safety Follow-up Period||311
6743253|NCT03333109|7671530|FG001|COMPLETED|Safety Follow-up Period||214
6743254|NCT03333109|7671531|FG002|COMPLETED|Safety Follow-up Period||315
6743255|NCT03333109|7671529|FG000|NOT COMPLETED|Safety Follow-up Period||13
6743256|NCT03333109|7671530|FG001|NOT COMPLETED|Safety Follow-up Period||4
6743257|NCT03333109|7671531|FG002|NOT COMPLETED|Safety Follow-up Period||13
6743258|NCT03333317|7671542|FG000|STARTED|Overall Study||3
6743259|NCT03333317|7671543|FG001|STARTED|Overall Study||1
6743260|NCT03333317|7671544|FG002|STARTED|Overall Study||3
6743261|NCT03333317|7671542|FG000|COMPLETED|Overall Study||3
6743262|NCT03333317|7671543|FG001|COMPLETED|Overall Study||1
6743263|NCT03333317|7671544|FG002|COMPLETED|Overall Study||3
6743264|NCT03333317|7671542|FG000|NOT COMPLETED|Overall Study||0
6743265|NCT03333317|7671543|FG001|NOT COMPLETED|Overall Study||0
6743266|NCT03333317|7671544|FG002|NOT COMPLETED|Overall Study||0
6743267|NCT03333577|7671554|FG000|STARTED|Overall Study||32
6743268|NCT03333577|7671554|FG000|COMPLETED|Overall Study||25
6743269|NCT03333577|7671554|FG000|NOT COMPLETED|Overall Study||7
6743270|NCT03333876|7671560|FG000|STARTED|Screening Period||58
6743271|NCT03333876|7671560|FG000|COMPLETED|Screening Period||54
6743272|NCT03333876|7671560|FG000|NOT COMPLETED|Screening Period||4
6743273|NCT03333876|7671560|FG000|STARTED|Nasal Dilator||54
6743274|NCT03333876|7671560|FG000|COMPLETED|Nasal Dilator||48
6743275|NCT03333876|7671560|FG000|NOT COMPLETED|Nasal Dilator||6
6743276|NCT03333876|7671560|FG000|STARTED|Mandibular Advancement||54
6373864|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6632673|NCT02284516|7561294|FG001|STARTED|Overall Study||355
6743277|NCT03333876|7671560|FG000|COMPLETED|Mandibular Advancement||50
6743278|NCT03333876|7671560|FG000|NOT COMPLETED|Mandibular Advancement||4
6743279|NCT03333876|7671560|FG000|STARTED|Positional Therapy||54
6284193|NCT00201643|7184677|FG000|STARTED|Overall Study||223
6284194|NCT00201643|7184678|FG001|STARTED|Overall Study||214
6284195|NCT00201643|7184677|FG000|COMPLETED|Overall Study||218
6284196|NCT00201643|7184678|FG001|COMPLETED|Overall Study||210
6284197|NCT00201643|7184677|FG000|NOT COMPLETED|Overall Study||5
6284198|NCT00201643|7184678|FG001|NOT COMPLETED|Overall Study||4
6284199|NCT00201734|7184686|FG000|STARTED|Overall Study||32
6284200|NCT00201734|7184687|FG001|STARTED|Overall Study||25
6284201|NCT00201734|7184686|FG000|Patients Not Evaluable|Overall Study||3
6284202|NCT00201734|7184687|FG001|Patients Not Evaluable|Overall Study||0
6284203|NCT00201734|7184686|FG000|COMPLETED|Overall Study||29
6284204|NCT00201734|7184687|FG001|COMPLETED|Overall Study||25
6284205|NCT00201734|7184686|FG000|NOT COMPLETED|Overall Study||3
6284206|NCT00201734|7184687|FG001|NOT COMPLETED|Overall Study||0
6284207|NCT00201760|7184696|FG000|STARTED|Overall Study||5
6284208|NCT00201760|7184697|FG001|STARTED|Overall Study||5
6284209|NCT00201760|7184696|FG000|COMPLETED|Overall Study||5
6284210|NCT00201760|7184697|FG001|COMPLETED|Overall Study||5
6284211|NCT00201760|7184696|FG000|NOT COMPLETED|Overall Study||0
6284212|NCT00201760|7184697|FG001|NOT COMPLETED|Overall Study||0
6284213|NCT00201773|7184703|FG000|STARTED|Overall Study||22
6284214|NCT00201773|7184703|FG000|Completed 8 Weeks of Planned Therapy|Overall Study||16
6284215|NCT00201773|7184703|FG000|Received All Exemestane Therapy|Overall Study||5
6284216|NCT00201773|7184703|FG000|Stopped Exemestane After 4 Weeks|Overall Study||1
6284217|NCT00201773|7184703|FG000|COMPLETED|Overall Study||16
6284218|NCT00201773|7184703|FG000|NOT COMPLETED|Overall Study||6
6284219|NCT00201825|7184710|FG000|STARTED|Overall Study||29
6284220|NCT00201825|7184710|FG000|COMPLETED|Overall Study||29
6284221|NCT00201825|7184710|FG000|NOT COMPLETED|Overall Study||0
6284222|NCT00201838|7184716|FG000|STARTED|Overall Study||30
6284223|NCT00201838|7184717|FG001|STARTED|Overall Study||8
6284224|NCT00201838|7184716|FG000|Treatment Cohort|Overall Study||30
6284225|NCT00201838|7184717|FG001|Treatment Cohort|Overall Study||8
6284226|NCT00201838|7184716|FG000|COMPLETED|Overall Study||30
6284227|NCT00201838|7184717|FG001|COMPLETED|Overall Study||8
6284228|NCT00201838|7184716|FG000|NOT COMPLETED|Overall Study||0
6284229|NCT00201838|7184717|FG001|NOT COMPLETED|Overall Study||0
6284230|NCT00201851|7184732|FG000|STARTED|Overall Study||252
6284231|NCT00201851|7184733|FG001|STARTED|Overall Study||257
6284232|NCT00201851|7184734|FG002|STARTED|Overall Study||231
6284233|NCT00201851|7184732|FG000|COMPLETED|Overall Study||244
6284234|NCT00201851|7184733|FG001|COMPLETED|Overall Study||255
6284235|NCT00201851|7184734|FG002|COMPLETED|Overall Study||230
6284236|NCT00201851|7184732|FG000|NOT COMPLETED|Overall Study||8
6284237|NCT00201851|7184733|FG001|NOT COMPLETED|Overall Study||2
6284238|NCT00201851|7184734|FG002|NOT COMPLETED|Overall Study||1
6284239|NCT00201864|7184742|FG000|STARTED|Overall Study||40
6284240|NCT00201864|7184742|FG000|COMPLETED|Overall Study||40
6284241|NCT00201864|7184742|FG000|NOT COMPLETED|Overall Study||0
6284242|NCT00201877|7184748|FG000|STARTED|Overall Study||25
6284243|NCT00201877|7184748|FG000|COMPLETED|Overall Study||25
6284244|NCT00201877|7184748|FG000|NOT COMPLETED|Overall Study||0
6284245|NCT00202449|7184756|FG000|STARTED|Overall Study||18
6284246|NCT00202449|7184757|FG001|STARTED|Overall Study||20
6284247|NCT00202449|7184758|FG002|STARTED|Overall Study||21
6284248|NCT00202449|7184756|FG000|COMPLETED|Overall Study||7
6284249|NCT00202449|7184757|FG001|COMPLETED|Overall Study||9
6284250|NCT00202449|7184758|FG002|COMPLETED|Overall Study||9
6284251|NCT00202449|7184756|FG000|NOT COMPLETED|Overall Study||11
6284252|NCT00202449|7184757|FG001|NOT COMPLETED|Overall Study||11
6284253|NCT00202449|7184758|FG002|NOT COMPLETED|Overall Study||12
6284254|NCT00202644|7184768|FG000|STARTED|Overall Study|One participant not randomized but treated.|76
6284255|NCT00202644|7184769|FG001|STARTED|Overall Study||70
6284256|NCT00202644|7184768|FG000|COMPLETED|Overall Study||41
6284257|NCT00202644|7184769|FG001|COMPLETED|Overall Study||43
6284258|NCT00202644|7184768|FG000|NOT COMPLETED|Overall Study||35
6284259|NCT00202644|7184769|FG001|NOT COMPLETED|Overall Study||27
6284260|NCT00202722|7184775|FG000|STARTED|Overall Study||41
6284261|NCT00202722|7184775|FG000|COMPLETED|Overall Study||41
6284262|NCT00202722|7184775|FG000|NOT COMPLETED|Overall Study||0
6284263|NCT00202839|7184782|FG000|STARTED|Overall Study||78
6284264|NCT00202839|7184783|FG001|STARTED|Overall Study||82
6284265|NCT00202839|7184782|FG000|COMPLETED|Overall Study||54
6284266|NCT00202839|7184783|FG001|COMPLETED|Overall Study||72
6284267|NCT00202839|7184782|FG000|NOT COMPLETED|Overall Study||24
6284268|NCT00202839|7184783|FG001|NOT COMPLETED|Overall Study||10
6284269|NCT00202930|7184789|FG000|STARTED|Overall Study||4
6284270|NCT00202930|7184789|FG000|COMPLETED|Overall Study||4
6284271|NCT00202930|7184789|FG000|NOT COMPLETED|Overall Study||0
6284272|NCT00203021|7184795|FG000|STARTED|Overall Study||107
6284273|NCT00203021|7184796|FG001|STARTED|Overall Study||101
6284274|NCT00203021|7184795|FG000|Received at Least 1 Dose of Study Drug|Overall Study||107
6284275|NCT00203021|7184796|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
6284276|NCT00203021|7184795|FG000|COMPLETED|Overall Study||28
6284277|NCT00203021|7184796|FG001|COMPLETED|Overall Study||24
6284278|NCT00203021|7184795|FG000|NOT COMPLETED|Overall Study||79
6284279|NCT00203021|7184796|FG001|NOT COMPLETED|Overall Study||77
6284280|NCT00203047|7184804|FG000|STARTED|Overall Study||204
6284281|NCT00203047|7184805|FG001|STARTED|Overall Study||210
6284282|NCT00203047|7184804|FG000|In Database as of January 29, 2009|Overall Study||199
6284283|NCT00203047|7184805|FG001|In Database as of January 29, 2009|Overall Study||209
6284284|NCT00203047|7184804|FG000|COMPLETED|Overall Study||13
6284285|NCT00203047|7184805|FG001|COMPLETED|Overall Study||7
6284286|NCT00203047|7184804|FG000|NOT COMPLETED|Overall Study||191
6284287|NCT00203047|7184805|FG001|NOT COMPLETED|Overall Study||203
6284288|NCT00203203|7184813|FG000|STARTED|Overall Study||10
6284289|NCT00203203|7184814|FG001|STARTED|Overall Study||20
6284290|NCT00203203|7184813|FG000|COMPLETED|Overall Study||9
6284291|NCT00203203|7184814|FG001|COMPLETED|Overall Study||20
6284292|NCT00203203|7184813|FG000|NOT COMPLETED|Overall Study||1
6284293|NCT00203203|7184814|FG001|NOT COMPLETED|Overall Study||0
6284294|NCT00203216|7184820|FG000|STARTED|Overall Study||31
6284295|NCT00203216|7184820|FG000|COMPLETED|Overall Study||27
6284296|NCT00203216|7184820|FG000|NOT COMPLETED|Overall Study||4
6284297|NCT00203229|7184826|FG000|STARTED|Overall Study||10
6284298|NCT00203229|7184827|FG001|STARTED|Overall Study||10
6284299|NCT00203229|7184826|FG000|COMPLETED|Overall Study||7
6284300|NCT00203229|7184827|FG001|COMPLETED|Overall Study||7
6284301|NCT00203229|7184826|FG000|NOT COMPLETED|Overall Study||3
6284302|NCT00203229|7184827|FG001|NOT COMPLETED|Overall Study||3
6284303|NCT00203242|7184833|FG000|STARTED|Overall Study||15
6284304|NCT00203242|7184833|FG000|COMPLETED|Overall Study||14
6284305|NCT00203242|7184833|FG000|NOT COMPLETED|Overall Study||1
6284306|NCT00203268|7184837|FG000|STARTED|Early Treatment||13
6284307|NCT00203268|7184837|FG000|COMPLETED|Early Treatment||9
6284308|NCT00203268|7184837|FG000|NOT COMPLETED|Early Treatment||4
6284309|NCT00203268|7184837|FG000|STARTED|Late Treatment||9
6284310|NCT00203268|7184837|FG000|COMPLETED|Late Treatment||9
6284311|NCT00203268|7184837|FG000|NOT COMPLETED|Late Treatment||0
6284312|NCT00203294|7184845|FG000|STARTED|Overall Study||22
6284313|NCT00203294|7184846|FG001|STARTED|Overall Study||23
6284314|NCT00203294|7184845|FG000|COMPLETED|Overall Study||14
6284315|NCT00203294|7184846|FG001|COMPLETED|Overall Study||10
6284316|NCT00203294|7184845|FG000|NOT COMPLETED|Overall Study||8
6284317|NCT00203294|7184846|FG001|NOT COMPLETED|Overall Study||13
6284318|NCT00203307|7184854|FG000|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
6284319|NCT00203307|7184855|FG001|STARTED|First Intervention||0
6284320|NCT00203307|7184854|FG000|COMPLETED|First Intervention||1
6284321|NCT00203307|7184855|FG001|COMPLETED|First Intervention||0
6284322|NCT00203307|7184854|FG000|NOT COMPLETED|First Intervention||2
6632674|NCT02284516|7561293|FG000|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
6632675|NCT02284516|7561294|FG001|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
6632676|NCT02284516|7561293|FG000|COMPLETED|Overall Study||318
6632677|NCT02284516|7561294|FG001|COMPLETED|Overall Study||319
6632678|NCT02284516|7561293|FG000|NOT COMPLETED|Overall Study||38
6632679|NCT02284516|7561294|FG001|NOT COMPLETED|Overall Study||36
6632680|NCT02284555|7561300|FG000|STARTED|Overall Study||12
6632681|NCT02284555|7561300|FG000|COMPLETED|Overall Study||12
6632682|NCT02284555|7561300|FG000|NOT COMPLETED|Overall Study||0
6632683|NCT02284828|7561304|FG000|STARTED|Overall Study||26
6632684|NCT02284828|7561304|FG000|COMPLETED|Overall Study||22
6632685|NCT02284828|7561304|FG000|NOT COMPLETED|Overall Study||4
6632686|NCT02284854|7561313|FG000|STARTED|Overall Study||23
6632687|NCT02284854|7561314|FG001|STARTED|Overall Study||20
6632688|NCT02284854|7561313|FG000|COMPLETED|Overall Study||18
6632689|NCT02284854|7561314|FG001|COMPLETED|Overall Study||20
6632690|NCT02284854|7561313|FG000|NOT COMPLETED|Overall Study||5
6632691|NCT02284854|7561314|FG001|NOT COMPLETED|Overall Study||0
6284323|NCT00203307|7184855|FG001|NOT COMPLETED|First Intervention||0
6284324|NCT00203307|7184854|FG000|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
6284325|NCT00203307|7184855|FG001|STARTED|Second Intervention||0
6284326|NCT00203307|7184854|FG000|COMPLETED|Second Intervention||1
6284327|NCT00203307|7184855|FG001|COMPLETED|Second Intervention||0
6284328|NCT00203307|7184854|FG000|NOT COMPLETED|Second Intervention||0
6284329|NCT00203307|7184855|FG001|NOT COMPLETED|Second Intervention||0
6284330|NCT00203411|7184861|FG000|STARTED|Treatment Period||45
6632692|NCT02284867|7561329|FG000|STARTED|Overall Study||30
6632693|NCT02284867|7561330|FG001|STARTED|Overall Study||30
6632694|NCT02284867|7561329|FG000|COMPLETED|Overall Study||30
6632695|NCT02284867|7561330|FG001|COMPLETED|Overall Study||30
6632696|NCT02284867|7561329|FG000|NOT COMPLETED|Overall Study||0
6632697|NCT02284867|7561330|FG001|NOT COMPLETED|Overall Study||0
6632698|NCT02284880|7561338|FG000|STARTED|Overall Study||11
6632699|NCT02284880|7561339|FG001|STARTED|Overall Study||9
6632700|NCT02284880|7561340|FG002|STARTED|Overall Study||10
6632701|NCT02284880|7561341|FG003|STARTED|Overall Study||10
6632702|NCT02284880|7561338|FG000|First Period (4 Days)|Overall Study||11
6632703|NCT02284880|7561339|FG001|First Period (4 Days)|Overall Study||9
6632704|NCT02284880|7561340|FG002|First Period (4 Days)|Overall Study||10
6632705|NCT02284880|7561341|FG003|First Period (4 Days)|Overall Study||10
6632706|NCT02284880|7561338|FG000|Wash-out Period (7 Days)|Overall Study||11
6284331|NCT00203411|7184861|FG000|COMPLETED|Treatment Period||45
6284332|NCT00203411|7184861|FG000|NOT COMPLETED|Treatment Period||0
6284333|NCT00203411|7184861|FG000|STARTED|Follow-up||45
6284334|NCT00203411|7184861|FG000|COMPLETED|Follow-up||41
6284335|NCT00203411|7184861|FG000|NOT COMPLETED|Follow-up||4
6284336|NCT00203424|7184866|FG000|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
6373865|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6284337|NCT00203424|7184866|FG000|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
6284338|NCT00203424|7184866|FG000|NOT COMPLETED|Treatment Period||11
6284339|NCT00203424|7184866|FG000|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
6284340|NCT00203424|7184866|FG000|COMPLETED|Follow-up Period||10
6284341|NCT00203424|7184866|FG000|NOT COMPLETED|Follow-up Period||6
6284342|NCT00203476|7184873|FG000|STARTED|Overall Study||10
6284343|NCT00203476|7184874|FG001|STARTED|Overall Study||10
6284344|NCT00203476|7184875|FG002|STARTED|Overall Study||10
6284345|NCT00203476|7184873|FG000|COMPLETED|Overall Study||9
6284346|NCT00203476|7184874|FG001|COMPLETED|Overall Study||9
6284347|NCT00203476|7184875|FG002|COMPLETED|Overall Study||10
6284348|NCT00203476|7184873|FG000|NOT COMPLETED|Overall Study||1
6284349|NCT00203476|7184874|FG001|NOT COMPLETED|Overall Study||1
6284350|NCT00203476|7184875|FG002|NOT COMPLETED|Overall Study||0
6284351|NCT00203502|7184883|FG000|STARTED|Overall Study||40
6284352|NCT00203502|7184883|FG000|COMPLETED|Overall Study||39
6284353|NCT00203502|7184883|FG000|NOT COMPLETED|Overall Study||1
6284354|NCT00203892|7184890|FG000|STARTED|Overall Study||7
6284355|NCT00203892|7184891|FG001|STARTED|Overall Study||10
6284356|NCT00203892|7184892|FG002|STARTED|Overall Study||6
6284357|NCT00203892|7184890|FG000|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
6284358|NCT00203892|7184891|FG001|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
6284359|NCT00203892|7184892|FG002|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
6284360|NCT00203892|7184890|FG000|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
6284361|NCT00203892|7184891|FG001|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
6284362|NCT00203892|7184892|FG002|COMPLETED|Overall Study||6
6284363|NCT00203892|7184890|FG000|NOT COMPLETED|Overall Study||2
6284364|NCT00203892|7184891|FG001|NOT COMPLETED|Overall Study||2
6284365|NCT00203892|7184892|FG002|NOT COMPLETED|Overall Study||0
6284366|NCT00203931|7184902|FG000|STARTED|Overall Study||27
6284367|NCT00203931|7184903|FG001|STARTED|Overall Study||28
6284368|NCT00203931|7184902|FG000|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
6284369|NCT00203931|7184903|FG001|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
6632707|NCT02284880|7561339|FG001|Wash-out Period (7 Days)|Overall Study||9
6632708|NCT02284880|7561340|FG002|Wash-out Period (7 Days)|Overall Study||10
6632709|NCT02284880|7561341|FG003|Wash-out Period (7 Days)|Overall Study||10
6284370|NCT00203931|7184902|FG000|NOT COMPLETED|Overall Study||7
6284371|NCT00203931|7184903|FG001|NOT COMPLETED|Overall Study||5
6284372|NCT00203996|7184919|FG000|STARTED|Overall Study||0
6284373|NCT00203996|7184920|FG001|STARTED|Overall Study||0
6284374|NCT00203996|7184921|FG002|STARTED|Overall Study||0
6284375|NCT00203996|7184922|FG003|STARTED|Overall Study||19
6284376|NCT00203996|7184923|FG004|STARTED|Overall Study||4
6284377|NCT00203996|7184924|FG005|STARTED|Overall Study||3
6284378|NCT00203996|7184925|FG006|STARTED|Overall Study||2
6284379|NCT00203996|7184926|FG007|STARTED|Overall Study||4
6284380|NCT00203996|7184927|FG008|STARTED|Overall Study||2
6284381|NCT00203996|7184928|FG009|STARTED|Overall Study||3
6284382|NCT00203996|7184919|FG000|Aim 3 Only: First Intervention|Overall Study||0
6284383|NCT00203996|7184920|FG001|Aim 3 Only: First Intervention|Overall Study||0
6284384|NCT00203996|7184921|FG002|Aim 3 Only: First Intervention|Overall Study||0
6284385|NCT00203996|7184922|FG003|Aim 3 Only: First Intervention|Overall Study||0
6284386|NCT00203996|7184923|FG004|Aim 3 Only: First Intervention|Overall Study||0
6284387|NCT00203996|7184924|FG005|Aim 3 Only: First Intervention|Overall Study||3
6284388|NCT00203996|7184925|FG006|Aim 3 Only: First Intervention|Overall Study||2
6284389|NCT00203996|7184926|FG007|Aim 3 Only: First Intervention|Overall Study||4
6284390|NCT00203996|7184927|FG008|Aim 3 Only: First Intervention|Overall Study||2
6284391|NCT00203996|7184928|FG009|Aim 3 Only: First Intervention|Overall Study||3
6284392|NCT00203996|7184919|FG000|Aim 3 Only: Washout|Overall Study||0
6284393|NCT00203996|7184920|FG001|Aim 3 Only: Washout|Overall Study||0
6284394|NCT00203996|7184921|FG002|Aim 3 Only: Washout|Overall Study||0
6284395|NCT00203996|7184922|FG003|Aim 3 Only: Washout|Overall Study||0
6284396|NCT00203996|7184923|FG004|Aim 3 Only: Washout|Overall Study||0
6284397|NCT00203996|7184924|FG005|Aim 3 Only: Washout|Overall Study||3
6284398|NCT00203996|7184925|FG006|Aim 3 Only: Washout|Overall Study||2
6284399|NCT00203996|7184926|FG007|Aim 3 Only: Washout|Overall Study||2
6284400|NCT00203996|7184927|FG008|Aim 3 Only: Washout|Overall Study||2
6284401|NCT00203996|7184928|FG009|Aim 3 Only: Washout|Overall Study||2
6284402|NCT00203996|7184919|FG000|Aim 3 Only: Second Intervention|Overall Study||0
6284403|NCT00203996|7184920|FG001|Aim 3 Only: Second Intervention|Overall Study||0
6284404|NCT00203996|7184921|FG002|Aim 3 Only: Second Intervention|Overall Study||0
6284405|NCT00203996|7184922|FG003|Aim 3 Only: Second Intervention|Overall Study||0
6284406|NCT00203996|7184923|FG004|Aim 3 Only: Second Intervention|Overall Study||0
6284407|NCT00203996|7184924|FG005|Aim 3 Only: Second Intervention|Overall Study||3
6284408|NCT00203996|7184925|FG006|Aim 3 Only: Second Intervention|Overall Study||2
6284409|NCT00203996|7184926|FG007|Aim 3 Only: Second Intervention|Overall Study||2
6284410|NCT00203996|7184927|FG008|Aim 3 Only: Second Intervention|Overall Study||2
6284411|NCT00203996|7184928|FG009|Aim 3 Only: Second Intervention|Overall Study||2
6284412|NCT00203996|7184919|FG000|Aim 3 Only: Second Washout|Overall Study||0
6284413|NCT00203996|7184920|FG001|Aim 3 Only: Second Washout|Overall Study||0
6284414|NCT00203996|7184921|FG002|Aim 3 Only: Second Washout|Overall Study||0
6284415|NCT00203996|7184922|FG003|Aim 3 Only: Second Washout|Overall Study||0
6284416|NCT00203996|7184923|FG004|Aim 3 Only: Second Washout|Overall Study||0
6284417|NCT00203996|7184924|FG005|Aim 3 Only: Second Washout|Overall Study||3
6284418|NCT00203996|7184925|FG006|Aim 3 Only: Second Washout|Overall Study||2
6284419|NCT00203996|7184926|FG007|Aim 3 Only: Second Washout|Overall Study||2
6284420|NCT00203996|7184927|FG008|Aim 3 Only: Second Washout|Overall Study||2
6284421|NCT00203996|7184928|FG009|Aim 3 Only: Second Washout|Overall Study||2
6284422|NCT00203996|7184919|FG000|Aim 3 Only: Third Intervention|Overall Study||0
6284423|NCT00203996|7184920|FG001|Aim 3 Only: Third Intervention|Overall Study||0
6284424|NCT00203996|7184921|FG002|Aim 3 Only: Third Intervention|Overall Study||0
6284425|NCT00203996|7184922|FG003|Aim 3 Only: Third Intervention|Overall Study||0
6284426|NCT00203996|7184923|FG004|Aim 3 Only: Third Intervention|Overall Study||0
6284427|NCT00203996|7184924|FG005|Aim 3 Only: Third Intervention|Overall Study||3
6284428|NCT00203996|7184925|FG006|Aim 3 Only: Third Intervention|Overall Study||2
6284429|NCT00203996|7184926|FG007|Aim 3 Only: Third Intervention|Overall Study||2
6284430|NCT00203996|7184927|FG008|Aim 3 Only: Third Intervention|Overall Study||2
6284431|NCT00203996|7184928|FG009|Aim 3 Only: Third Intervention|Overall Study||2
6284432|NCT00203996|7184919|FG000|COMPLETED|Overall Study||0
6284433|NCT00203996|7184920|FG001|COMPLETED|Overall Study||0
6284434|NCT00203996|7184921|FG002|COMPLETED|Overall Study||0
6284435|NCT00203996|7184922|FG003|COMPLETED|Overall Study||9
6284436|NCT00203996|7184923|FG004|COMPLETED|Overall Study||3
6284437|NCT00203996|7184924|FG005|COMPLETED|Overall Study||3
6284438|NCT00203996|7184925|FG006|COMPLETED|Overall Study||2
6284439|NCT00203996|7184926|FG007|COMPLETED|Overall Study||2
6284440|NCT00203996|7184927|FG008|COMPLETED|Overall Study||2
6284441|NCT00203996|7184928|FG009|COMPLETED|Overall Study||2
6284442|NCT00203996|7184919|FG000|NOT COMPLETED|Overall Study||0
6284443|NCT00203996|7184920|FG001|NOT COMPLETED|Overall Study||0
6284444|NCT00203996|7184921|FG002|NOT COMPLETED|Overall Study||0
6284445|NCT00203996|7184922|FG003|NOT COMPLETED|Overall Study||10
6284446|NCT00203996|7184923|FG004|NOT COMPLETED|Overall Study||1
6284447|NCT00203996|7184924|FG005|NOT COMPLETED|Overall Study||0
6284448|NCT00203996|7184925|FG006|NOT COMPLETED|Overall Study||0
6284449|NCT00203996|7184926|FG007|NOT COMPLETED|Overall Study||2
6284450|NCT00203996|7184927|FG008|NOT COMPLETED|Overall Study||0
6284451|NCT00203996|7184928|FG009|NOT COMPLETED|Overall Study||1
6284452|NCT00204373|7184944|FG000|STARTED|Overall Study||72
6284453|NCT00204373|7184944|FG000|COMPLETED|Overall Study||72
6284454|NCT00204373|7184944|FG000|NOT COMPLETED|Overall Study||0
6284455|NCT00204932|7184950|FG000|STARTED|Overall Study||24
6284456|NCT00204932|7184951|FG001|STARTED|Overall Study||24
6284457|NCT00204932|7184950|FG000|COMPLETED|Overall Study||22
6284458|NCT00204932|7184951|FG001|COMPLETED|Overall Study||18
6284459|NCT00204932|7184950|FG000|NOT COMPLETED|Overall Study||2
6284460|NCT00204932|7184951|FG001|NOT COMPLETED|Overall Study||6
6284461|NCT00205179|7184959|FG000|STARTED|Overall Study||32
6284462|NCT00205179|7184960|FG001|STARTED|Overall Study||33
6284463|NCT00205179|7184959|FG000|COMPLETED|Overall Study||30
6284464|NCT00205179|7184960|FG001|COMPLETED|Overall Study||29
6284465|NCT00205179|7184959|FG000|NOT COMPLETED|Overall Study||2
6284466|NCT00205179|7184960|FG001|NOT COMPLETED|Overall Study||4
6284467|NCT00205348|7184967|FG000|STARTED|Overall Study||146
6284468|NCT00205348|7184967|FG000|COMPLETED|Overall Study||116
6284469|NCT00205348|7184967|FG000|NOT COMPLETED|Overall Study||30
6284470|NCT00205374|7184973|FG000|STARTED|Overall Study||10
6284471|NCT00205374|7184974|FG001|STARTED|Overall Study||9
6284472|NCT00205374|7184973|FG000|COMPLETED|Overall Study||10
6284473|NCT00205374|7184974|FG001|COMPLETED|Overall Study||9
6632710|NCT02284880|7561338|FG000|Second Period (4 Days)|Overall Study||11
6632711|NCT02284880|7561339|FG001|Second Period (4 Days)|Overall Study||9
6632712|NCT02284880|7561340|FG002|Second Period (4 Days)|Overall Study||8
6632713|NCT02284880|7561341|FG003|Second Period (4 Days)|Overall Study||10
6632714|NCT02284880|7561338|FG000|COMPLETED|Overall Study||11
6632715|NCT02284880|7561339|FG001|COMPLETED|Overall Study||9
6632716|NCT02284880|7561340|FG002|COMPLETED|Overall Study||8
6632717|NCT02284880|7561341|FG003|COMPLETED|Overall Study||10
6632718|NCT02284880|7561338|FG000|NOT COMPLETED|Overall Study||0
6632719|NCT02284880|7561339|FG001|NOT COMPLETED|Overall Study||0
6632720|NCT02284880|7561340|FG002|NOT COMPLETED|Overall Study||2
6632721|NCT02284880|7561341|FG003|NOT COMPLETED|Overall Study||0
6632722|NCT02284893|7561353|FG000|STARTED|26 Week (Short Term)||232
6284474|NCT00205374|7184973|FG000|NOT COMPLETED|Overall Study||0
6284475|NCT00205374|7184974|FG001|NOT COMPLETED|Overall Study||0
6284476|NCT00205504|7184982|FG000|STARTED|Overall Study||21
6284477|NCT00205504|7184983|FG001|STARTED|Overall Study||15
6284478|NCT00205504|7184982|FG000|COMPLETED|Overall Study||14
6284479|NCT00205504|7184983|FG001|COMPLETED|Overall Study||15
6284480|NCT00205504|7184982|FG000|NOT COMPLETED|Overall Study||7
6284481|NCT00205504|7184983|FG001|NOT COMPLETED|Overall Study||0
6632723|NCT02284893|7561354|FG001|STARTED|26 Week (Short Term)||229
6632724|NCT02284893|7561353|FG000|COMPLETED|26 Week (Short Term)||213
6632725|NCT02284893|7561354|FG001|COMPLETED|26 Week (Short Term)||198
6632726|NCT02284893|7561353|FG000|NOT COMPLETED|26 Week (Short Term)||19
6632727|NCT02284893|7561354|FG001|NOT COMPLETED|26 Week (Short Term)||31
6284482|NCT00205660|7184995|FG000|STARTED|Overall Study||14
6284483|NCT00205660|7184996|FG001|STARTED|Overall Study||37
6284484|NCT00205660|7184995|FG000|COMPLETED|Overall Study||12
6284485|NCT00205660|7184996|FG001|COMPLETED|Overall Study||35
6284486|NCT00205660|7184995|FG000|NOT COMPLETED|Overall Study||2
6284487|NCT00205660|7184996|FG001|NOT COMPLETED|Overall Study||2
6284488|NCT00205699|7185006|FG000|STARTED|Overall Study||49
6284489|NCT00205699|7185007|FG001|STARTED|Overall Study||46
6284490|NCT00205699|7185008|FG002|STARTED|Overall Study||49
6284491|NCT00205699|7185006|FG000|COMPLETED|Overall Study||46
6284492|NCT00205699|7185007|FG001|COMPLETED|Overall Study||40
6284493|NCT00205699|7185008|FG002|COMPLETED|Overall Study||43
6284494|NCT00205699|7185006|FG000|NOT COMPLETED|Overall Study||3
6284495|NCT00205699|7185007|FG001|NOT COMPLETED|Overall Study||6
6284496|NCT00205699|7185008|FG002|NOT COMPLETED|Overall Study||6
6284497|NCT00205712|7185021|FG000|STARTED|Overall Study||20
6284498|NCT00205712|7185022|FG001|STARTED|Overall Study||20
6284499|NCT00205712|7185021|FG000|COMPLETED|Overall Study||20
6284500|NCT00205712|7185022|FG001|COMPLETED|Overall Study||19
6284501|NCT00205712|7185021|FG000|NOT COMPLETED|Overall Study||0
6284502|NCT00205712|7185022|FG001|NOT COMPLETED|Overall Study||1
6284503|NCT00205777|7185034|FG000|STARTED|Core Study (Up to 3 Years)||1907
6284504|NCT00205777|7185035|FG001|STARTED|Core Study (Up to 3 Years)||1904
6284505|NCT00205777|7185036|FG002|STARTED|Core Study (Up to 3 Years)||1884
6284506|NCT00205777|7185037|FG003|STARTED|Core Study (Up to 3 Years)||1914
6284507|NCT00205777|7185038|FG004|STARTED|Core Study (Up to 3 Years)||0
6284508|NCT00205777|7185039|FG005|STARTED|Core Study (Up to 3 Years)||0
6284509|NCT00205777|7185034|FG000|TREATED|Core Study (Up to 3 Years)||1886
6284510|NCT00205777|7185035|FG001|TREATED|Core Study (Up to 3 Years)||1872
6284511|NCT00205777|7185036|FG002|TREATED|Core Study (Up to 3 Years)||1849
6284512|NCT00205777|7185037|FG003|TREATED|Core Study (Up to 3 Years)||1885
6284513|NCT00205777|7185038|FG004|TREATED|Core Study (Up to 3 Years)||0
6284514|NCT00205777|7185039|FG005|TREATED|Core Study (Up to 3 Years)||0
6284515|NCT00205777|7185034|FG000|COMPLETED|Core Study (Up to 3 Years)||1279
6284516|NCT00205777|7185035|FG001|COMPLETED|Core Study (Up to 3 Years)||1245
6284517|NCT00205777|7185036|FG002|COMPLETED|Core Study (Up to 3 Years)||1277
6284518|NCT00205777|7185037|FG003|COMPLETED|Core Study (Up to 3 Years)||1282
6284519|NCT00205777|7185038|FG004|COMPLETED|Core Study (Up to 3 Years)||0
6284520|NCT00205777|7185039|FG005|COMPLETED|Core Study (Up to 3 Years)||0
6284521|NCT00205777|7185034|FG000|NOT COMPLETED|Core Study (Up to 3 Years)||628
6284522|NCT00205777|7185035|FG001|NOT COMPLETED|Core Study (Up to 3 Years)||659
6284523|NCT00205777|7185036|FG002|NOT COMPLETED|Core Study (Up to 3 Years)||607
6284524|NCT00205777|7185037|FG003|NOT COMPLETED|Core Study (Up to 3 Years)||632
6284525|NCT00205777|7185038|FG004|NOT COMPLETED|Core Study (Up to 3 Years)||0
6284526|NCT00205777|7185039|FG005|NOT COMPLETED|Core Study (Up to 3 Years)||0
6284527|NCT00205777|7185034|FG000|STARTED|Completed Core Study, Entered SE I||1279
6284528|NCT00205777|7185035|FG001|STARTED|Completed Core Study, Entered SE I||1245
6284529|NCT00205777|7185036|FG002|STARTED|Completed Core Study, Entered SE I||1277
6284530|NCT00205777|7185037|FG003|STARTED|Completed Core Study, Entered SE I||1282
6284531|NCT00205777|7185038|FG004|STARTED|Completed Core Study, Entered SE I||0
6284532|NCT00205777|7185039|FG005|STARTED|Completed Core Study, Entered SE I||0
6284533|NCT00205777|7185034|FG000|COMPLETED|Completed Core Study, Entered SE I||1047
6284534|NCT00205777|7185035|FG001|COMPLETED|Completed Core Study, Entered SE I||1041
6284535|NCT00205777|7185036|FG002|COMPLETED|Completed Core Study, Entered SE I||1070
6284536|NCT00205777|7185037|FG003|COMPLETED|Completed Core Study, Entered SE I||1058
6284537|NCT00205777|7185038|FG004|COMPLETED|Completed Core Study, Entered SE I||0
6284538|NCT00205777|7185039|FG005|COMPLETED|Completed Core Study, Entered SE I||0
6284539|NCT00205777|7185034|FG000|NOT COMPLETED|Completed Core Study, Entered SE I||232
6284540|NCT00205777|7185035|FG001|NOT COMPLETED|Completed Core Study, Entered SE I||204
6284541|NCT00205777|7185036|FG002|NOT COMPLETED|Completed Core Study, Entered SE I||207
6284542|NCT00205777|7185037|FG003|NOT COMPLETED|Completed Core Study, Entered SE I||224
6284543|NCT00205777|7185038|FG004|NOT COMPLETED|Completed Core Study, Entered SE I||0
6284544|NCT00205777|7185039|FG005|NOT COMPLETED|Completed Core Study, Entered SE I||0
6284545|NCT00205777|7185034|FG000|STARTED|Study Extension I||1047
6284546|NCT00205777|7185035|FG001|STARTED|Study Extension I||0
6284547|NCT00205777|7185036|FG002|STARTED|Study Extension I||1070
6284548|NCT00205777|7185037|FG003|STARTED|Study Extension I||1058
6284549|NCT00205777|7185038|FG004|STARTED|Study Extension I||1041
6284550|NCT00205777|7185039|FG005|STARTED|Study Extension I||0
6284551|NCT00205777|7185034|FG000|COMPLETED|Study Extension I||833
6284552|NCT00205777|7185035|FG001|COMPLETED|Study Extension I||0
6284553|NCT00205777|7185036|FG002|COMPLETED|Study Extension I||0
6284554|NCT00205777|7185037|FG003|COMPLETED|Study Extension I||830
6284555|NCT00205777|7185038|FG004|COMPLETED|Study Extension I||840
6284556|NCT00205777|7185039|FG005|COMPLETED|Study Extension I||0
6284557|NCT00205777|7185034|FG000|NOT COMPLETED|Study Extension I||214
6284558|NCT00205777|7185035|FG001|NOT COMPLETED|Study Extension I||0
6284559|NCT00205777|7185036|FG002|NOT COMPLETED|Study Extension I||1070
6399115|NCT00879333|7311828|FG000|Discontinued Study Treatment|Overall Study||428
6284560|NCT00205777|7185037|FG003|NOT COMPLETED|Study Extension I||228
6284561|NCT00205777|7185038|FG004|NOT COMPLETED|Study Extension I||201
6284562|NCT00205777|7185039|FG005|NOT COMPLETED|Study Extension I||0
6284563|NCT00205777|7185034|FG000|STARTED|Completed SE I, Entered Extension SE II||833
6284564|NCT00205777|7185035|FG001|STARTED|Completed SE I, Entered Extension SE II||0
6284565|NCT00205777|7185036|FG002|STARTED|Completed SE I, Entered Extension SE II||0
6284566|NCT00205777|7185037|FG003|STARTED|Completed SE I, Entered Extension SE II||830
6284567|NCT00205777|7185038|FG004|STARTED|Completed SE I, Entered Extension SE II||840
6284568|NCT00205777|7185039|FG005|STARTED|Completed SE I, Entered Extension SE II||0
6284569|NCT00205777|7185034|FG000|COMPLETED|Completed SE I, Entered Extension SE II||560
6284570|NCT00205777|7185035|FG001|COMPLETED|Completed SE I, Entered Extension SE II||0
6284571|NCT00205777|7185036|FG002|COMPLETED|Completed SE I, Entered Extension SE II||0
6284572|NCT00205777|7185037|FG003|COMPLETED|Completed SE I, Entered Extension SE II||590
6284573|NCT00205777|7185038|FG004|COMPLETED|Completed SE I, Entered Extension SE II||582
6284574|NCT00205777|7185039|FG005|COMPLETED|Completed SE I, Entered Extension SE II||0
6399116|NCT00879333|7311829|FG001|Discontinued Study Treatment|Overall Study||217
6399117|NCT00879333|7311828|FG000|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
6399118|NCT00879333|7311829|FG001|COMPLETED|Overall Study||0
6399119|NCT00879333|7311828|FG000|NOT COMPLETED|Overall Study||428
6399120|NCT00879333|7311829|FG001|NOT COMPLETED|Overall Study||217
6399121|NCT00879359|7311837|FG000|STARTED|Overall Study||15
6399122|NCT00879359|7311837|FG000|COMPLETED|Overall Study||15
6399123|NCT00879359|7311837|FG000|NOT COMPLETED|Overall Study||0
6399124|NCT00879398|7311842|FG000|STARTED|Overall Study||3109
6399125|NCT00879398|7311842|FG000|COMPLETED|Overall Study||2434
6399126|NCT00879398|7311842|FG000|NOT COMPLETED|Overall Study||675
6399127|NCT00879411|7311846|FG000|STARTED|Overall Study||701
6399128|NCT00879411|7311846|FG000|COMPLETED|Overall Study||539
6399129|NCT00879411|7311846|FG000|NOT COMPLETED|Overall Study||162
6399130|NCT00879437|7311850|FG000|STARTED|Overall Study||20
6399131|NCT00879437|7311851|FG001|STARTED|Overall Study||18
6399132|NCT00879437|7311850|FG000|COMPLETED|Overall Study||19
6399133|NCT00879437|7311851|FG001|COMPLETED|Overall Study||17
6399134|NCT00879437|7311850|FG000|NOT COMPLETED|Overall Study||1
6399135|NCT00879437|7311851|FG001|NOT COMPLETED|Overall Study||1
6399136|NCT00879645|7311863|FG000|STARTED|Overall Study||9
6399137|NCT00879645|7311864|FG001|STARTED|Overall Study||6
6399138|NCT00879645|7311865|FG002|STARTED|Overall Study||6
6399139|NCT00879645|7311866|FG003|STARTED|Overall Study||7
6399140|NCT00879645|7311863|FG000|COMPLETED|Overall Study||8
6399141|NCT00879645|7311864|FG001|COMPLETED|Overall Study||6
6399142|NCT00879645|7311865|FG002|COMPLETED|Overall Study||6
6399143|NCT00879645|7311866|FG003|COMPLETED|Overall Study||7
6399144|NCT00879645|7311863|FG000|NOT COMPLETED|Overall Study||1
6399145|NCT00879645|7311864|FG001|NOT COMPLETED|Overall Study||0
6399146|NCT00879645|7311865|FG002|NOT COMPLETED|Overall Study||0
6399147|NCT00879645|7311866|FG003|NOT COMPLETED|Overall Study||0
6399148|NCT00879658|7311883|FG000|STARTED|Overall Study||50
6399149|NCT00879658|7311884|FG001|STARTED|Overall Study||49
6399150|NCT00879658|7311885|FG002|STARTED|Overall Study||43
6399151|NCT00879658|7311886|FG003|STARTED|Overall Study||46
6399152|NCT00879658|7311887|FG004|STARTED|Overall Study||42
6399153|NCT00879658|7311888|FG005|STARTED|Overall Study||51
6399154|NCT00879658|7311889|FG006|STARTED|Overall Study||16
6399155|NCT00879658|7311883|FG000|COMPLETED|Overall Study||35
6399156|NCT00879658|7311884|FG001|COMPLETED|Overall Study||44
6399157|NCT00879658|7311885|FG002|COMPLETED|Overall Study||36
6399158|NCT00879658|7311886|FG003|COMPLETED|Overall Study||42
6399159|NCT00879658|7311887|FG004|COMPLETED|Overall Study||40
6399160|NCT00879658|7311888|FG005|COMPLETED|Overall Study||50
6399161|NCT00879658|7311889|FG006|COMPLETED|Overall Study||16
6399162|NCT00879658|7311883|FG000|NOT COMPLETED|Overall Study||15
6399163|NCT00879658|7311884|FG001|NOT COMPLETED|Overall Study||5
6399164|NCT00879658|7311885|FG002|NOT COMPLETED|Overall Study||7
6399165|NCT00879658|7311886|FG003|NOT COMPLETED|Overall Study||4
6399166|NCT00879658|7311887|FG004|NOT COMPLETED|Overall Study||2
6399167|NCT00879658|7311888|FG005|NOT COMPLETED|Overall Study||1
6399168|NCT00879658|7311889|FG006|NOT COMPLETED|Overall Study||0
6399169|NCT00879684|7311911|FG000|STARTED|Stage 1: Dose Escalation||3
6399170|NCT00879684|7311912|FG001|STARTED|Stage 1: Dose Escalation||3
6399171|NCT00879684|7311913|FG002|STARTED|Stage 1: Dose Escalation||3
6399172|NCT00879684|7311914|FG003|STARTED|Stage 1: Dose Escalation||6
6399173|NCT00879684|7311915|FG004|STARTED|Stage 1: Dose Escalation||3
6399174|NCT00879684|7311916|FG005|STARTED|Stage 1: Dose Escalation||3
6399175|NCT00879684|7311917|FG006|STARTED|Stage 1: Dose Escalation||0
6399176|NCT00879684|7311911|FG000|COMPLETED|Stage 1: Dose Escalation||0
6399177|NCT00879684|7311912|FG001|COMPLETED|Stage 1: Dose Escalation||0
6399178|NCT00879684|7311913|FG002|COMPLETED|Stage 1: Dose Escalation||0
6399179|NCT00879684|7311914|FG003|COMPLETED|Stage 1: Dose Escalation||0
6399180|NCT00879684|7311915|FG004|COMPLETED|Stage 1: Dose Escalation||0
6399181|NCT00879684|7311916|FG005|COMPLETED|Stage 1: Dose Escalation||0
6399182|NCT00879684|7311917|FG006|COMPLETED|Stage 1: Dose Escalation||0
6399183|NCT00879684|7311911|FG000|NOT COMPLETED|Stage 1: Dose Escalation||3
6399184|NCT00879684|7311912|FG001|NOT COMPLETED|Stage 1: Dose Escalation||3
6399185|NCT00879684|7311913|FG002|NOT COMPLETED|Stage 1: Dose Escalation||3
6399186|NCT00879684|7311914|FG003|NOT COMPLETED|Stage 1: Dose Escalation||6
6399187|NCT00879684|7311915|FG004|NOT COMPLETED|Stage 1: Dose Escalation||3
6399188|NCT00879684|7311916|FG005|NOT COMPLETED|Stage 1: Dose Escalation||3
6399189|NCT00879684|7311917|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
6399190|NCT00879684|7311911|FG000|STARTED|Stage 2: Expanded Cohort||0
6399191|NCT00879684|7311912|FG001|STARTED|Stage 2: Expanded Cohort||0
6399192|NCT00879684|7311913|FG002|STARTED|Stage 2: Expanded Cohort||0
6284575|NCT00205777|7185034|FG000|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
6284576|NCT00205777|7185035|FG001|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
6284577|NCT00205777|7185036|FG002|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
6284578|NCT00205777|7185037|FG003|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
6284579|NCT00205777|7185038|FG004|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
6284580|NCT00205777|7185039|FG005|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
6284581|NCT00205777|7185034|FG000|STARTED|Study Extension II||0
6284582|NCT00205777|7185035|FG001|STARTED|Study Extension II||0
6284583|NCT00205777|7185036|FG002|STARTED|Study Extension II||0
6284584|NCT00205777|7185037|FG003|STARTED|Study Extension II||590
6284585|NCT00205777|7185038|FG004|STARTED|Study Extension II||0
6284586|NCT00205777|7185039|FG005|STARTED|Study Extension II||1142
6284587|NCT00205777|7185034|FG000|TREATED|Study Extension II||0
6284588|NCT00205777|7185035|FG001|TREATED|Study Extension II||0
6284589|NCT00205777|7185036|FG002|TREATED|Study Extension II||0
6284590|NCT00205777|7185037|FG003|TREATED|Study Extension II||519
6284591|NCT00205777|7185038|FG004|TREATED|Study Extension II||0
6284592|NCT00205777|7185039|FG005|TREATED|Study Extension II||1011
6284593|NCT00205777|7185034|FG000|COMPLETED|Study Extension II||0
6284594|NCT00205777|7185035|FG001|COMPLETED|Study Extension II||0
6284595|NCT00205777|7185036|FG002|COMPLETED|Study Extension II||0
6284596|NCT00205777|7185037|FG003|COMPLETED|Study Extension II||441
6284597|NCT00205777|7185038|FG004|COMPLETED|Study Extension II||0
6284598|NCT00205777|7185039|FG005|COMPLETED|Study Extension II||860
6284599|NCT00205777|7185034|FG000|NOT COMPLETED|Study Extension II||0
6284600|NCT00205777|7185035|FG001|NOT COMPLETED|Study Extension II||0
6284601|NCT00205777|7185036|FG002|NOT COMPLETED|Study Extension II||0
6284602|NCT00205777|7185037|FG003|NOT COMPLETED|Study Extension II||149
6284603|NCT00205777|7185038|FG004|NOT COMPLETED|Study Extension II||0
6284604|NCT00205777|7185039|FG005|NOT COMPLETED|Study Extension II||282
6284605|NCT00205803|7185056|FG000|STARTED|Infant Series||122
6284606|NCT00205803|7185057|FG001|STARTED|Infant Series||127
6284607|NCT00205803|7185056|FG000|Vaccinated Dose 1|Infant Series||121
6284608|NCT00205803|7185057|FG001|Vaccinated Dose 1|Infant Series||126
6284609|NCT00205803|7185056|FG000|Vaccinated Dose 2|Infant Series||115
6399193|NCT00879684|7311914|FG003|STARTED|Stage 2: Expanded Cohort||0
6399194|NCT00879684|7311915|FG004|STARTED|Stage 2: Expanded Cohort||0
6399195|NCT00879684|7311916|FG005|STARTED|Stage 2: Expanded Cohort||0
6632728|NCT02284893|7561353|FG000|STARTED|52 Week (Long Term)||209
6284610|NCT00205803|7185057|FG001|Vaccinated Dose 2|Infant Series||122
6284611|NCT00205803|7185056|FG000|Vaccinated Dose 3|Infant Series||110
6284612|NCT00205803|7185057|FG001|Vaccinated Dose 3|Infant Series||118
6284613|NCT00205803|7185056|FG000|COMPLETED|Infant Series||104
6284614|NCT00205803|7185057|FG001|COMPLETED|Infant Series||116
6284615|NCT00205803|7185056|FG000|NOT COMPLETED|Infant Series||18
6284616|NCT00205803|7185057|FG001|NOT COMPLETED|Infant Series||11
6284617|NCT00205803|7185056|FG000|STARTED|After Infant Series||104
6284618|NCT00205803|7185057|FG001|STARTED|After Infant Series||116
6284619|NCT00205803|7185056|FG000|COMPLETED|After Infant Series||86
6284620|NCT00205803|7185057|FG001|COMPLETED|After Infant Series||103
6284621|NCT00205803|7185056|FG000|NOT COMPLETED|After Infant Series||18
6284622|NCT00205803|7185057|FG001|NOT COMPLETED|After Infant Series||13
6284623|NCT00205803|7185056|FG000|STARTED|Toddler Dose||86
6284624|NCT00205803|7185057|FG001|STARTED|Toddler Dose||103
6284625|NCT00205803|7185056|FG000|COMPLETED|Toddler Dose||84
6284626|NCT00205803|7185057|FG001|COMPLETED|Toddler Dose||100
6284627|NCT00205803|7185056|FG000|NOT COMPLETED|Toddler Dose||2
6284628|NCT00205803|7185057|FG001|NOT COMPLETED|Toddler Dose||3
6284629|NCT00205855|7185081|FG000|STARTED|Overall Study||65
6284630|NCT00205855|7185081|FG000|COMPLETED|Overall Study||44
6284631|NCT00205855|7185081|FG000|NOT COMPLETED|Overall Study||21
6284632|NCT00205881|7185085|FG000|STARTED|Overall Study||32
6284633|NCT00205881|7185085|FG000|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
6284634|NCT00205881|7185085|FG000|NOT COMPLETED|Overall Study||16
6284635|NCT00206076|7185092|FG000|STARTED|Overall Study||9
6284636|NCT00206076|7185093|FG001|STARTED|Overall Study||10
6284637|NCT00206076|7185092|FG000|COMPLETED|Overall Study||6
6284638|NCT00206076|7185093|FG001|COMPLETED|Overall Study||9
6284639|NCT00206076|7185092|FG000|NOT COMPLETED|Overall Study||3
6399196|NCT00879684|7311917|FG006|STARTED|Stage 2: Expanded Cohort||13
6399197|NCT00879684|7311911|FG000|COMPLETED|Stage 2: Expanded Cohort||0
6399198|NCT00879684|7311912|FG001|COMPLETED|Stage 2: Expanded Cohort||0
6399199|NCT00879684|7311913|FG002|COMPLETED|Stage 2: Expanded Cohort||0
6399200|NCT00879684|7311914|FG003|COMPLETED|Stage 2: Expanded Cohort||0
6399201|NCT00879684|7311915|FG004|COMPLETED|Stage 2: Expanded Cohort||0
6399202|NCT00879684|7311916|FG005|COMPLETED|Stage 2: Expanded Cohort||0
6399203|NCT00879684|7311917|FG006|COMPLETED|Stage 2: Expanded Cohort||0
6632729|NCT02284893|7561354|FG001|STARTED|52 Week (Long Term)||193
6284640|NCT00206076|7185093|FG001|NOT COMPLETED|Overall Study||1
6284641|NCT00206102|7185103|FG000|STARTED|Overall Study||596
6284642|NCT00206102|7185104|FG001|STARTED|Overall Study||502
6284643|NCT00206102|7185103|FG000|COMPLETED|Overall Study||188
6399204|NCT00879684|7311911|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
6399205|NCT00879684|7311912|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
6399206|NCT00879684|7311913|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
6399207|NCT00879684|7311914|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||0
6284644|NCT00206102|7185104|FG001|COMPLETED|Overall Study||187
6284645|NCT00206102|7185103|FG000|NOT COMPLETED|Overall Study||408
6284646|NCT00206102|7185104|FG001|NOT COMPLETED|Overall Study||315
6284647|NCT00206323|7185112|FG000|STARTED|Overall Study||14
6284648|NCT00206323|7185113|FG001|STARTED|Overall Study||15
6284649|NCT00206323|7185112|FG000|COMPLETED|Overall Study||8
6284650|NCT00206323|7185113|FG001|COMPLETED|Overall Study||12
6284651|NCT00206323|7185112|FG000|NOT COMPLETED|Overall Study||6
6284652|NCT00206323|7185113|FG001|NOT COMPLETED|Overall Study||3
6284653|NCT00206336|7185119|FG000|STARTED|Overall Study||20
6284654|NCT00206336|7185119|FG000|COMPLETED|Overall Study||20
6284655|NCT00206336|7185119|FG000|NOT COMPLETED|Overall Study||0
6284656|NCT00206427|7185123|FG000|STARTED|Overall Study|Received First Dose|49
6284657|NCT00206427|7185123|FG000|COMPLETED|Overall Study|Complete 6-week therapy|47
6284658|NCT00206427|7185123|FG000|NOT COMPLETED|Overall Study||2
6284659|NCT00206440|7185129|FG000|STARTED|Overall Study||21
6284660|NCT00206440|7185130|FG001|STARTED|Overall Study||22
6284661|NCT00206440|7185129|FG000|COMPLETED|Overall Study||16
6284662|NCT00206440|7185130|FG001|COMPLETED|Overall Study||18
6284663|NCT00206440|7185129|FG000|NOT COMPLETED|Overall Study||5
6284664|NCT00206440|7185130|FG001|NOT COMPLETED|Overall Study||4
6284665|NCT00206518|7185138|FG000|STARTED|Overall Study||83
6284666|NCT00206518|7185139|FG001|STARTED|Overall Study||84
6284667|NCT00206518|7185138|FG000|COMPLETED|Overall Study||73
6284668|NCT00206518|7185139|FG001|COMPLETED|Overall Study||78
6284669|NCT00206518|7185138|FG000|NOT COMPLETED|Overall Study||10
6284670|NCT00206518|7185139|FG001|NOT COMPLETED|Overall Study||6
6632730|NCT02284893|7561353|FG000|COMPLETED|52 Week (Long Term)||198
6632731|NCT02284893|7561354|FG001|COMPLETED|52 Week (Long Term)||180
6632732|NCT02284893|7561353|FG000|NOT COMPLETED|52 Week (Long Term)||11
6632733|NCT02284893|7561354|FG001|NOT COMPLETED|52 Week (Long Term)||13
6632734|NCT02285010|7561362|FG000|STARTED|Overall Study||63
6632735|NCT02285010|7561363|FG001|STARTED|Overall Study||62
6632736|NCT02285010|7561362|FG000|COMPLETED|Overall Study||58
6632737|NCT02285010|7561363|FG001|COMPLETED|Overall Study||61
6632738|NCT02285010|7561362|FG000|NOT COMPLETED|Overall Study||5
6632739|NCT02285010|7561363|FG001|NOT COMPLETED|Overall Study||1
6632740|NCT02285023|7561369|FG000|STARTED|Overall Study||166
6632741|NCT02285023|7561369|FG000|COMPLETED|Overall Study||166
6632742|NCT02285023|7561369|FG000|NOT COMPLETED|Overall Study||0
6632743|NCT02285114|7561382|FG000|STARTED|Overall Study||29
6632744|NCT02285114|7561383|FG001|STARTED|Overall Study||9
6632745|NCT02285114|7561384|FG002|STARTED|Overall Study||3
6632746|NCT02285114|7561382|FG000|COMPLETED|Overall Study||7
6632747|NCT02285114|7561383|FG001|COMPLETED|Overall Study||2
6632748|NCT02285114|7561384|FG002|COMPLETED|Overall Study||0
6632749|NCT02285114|7561382|FG000|NOT COMPLETED|Overall Study||22
6632750|NCT02285114|7561383|FG001|NOT COMPLETED|Overall Study||7
6632751|NCT02285114|7561384|FG002|NOT COMPLETED|Overall Study||3
6632752|NCT02285153|7561400|FG000|STARTED|Overall Study||7
6632753|NCT02285153|7561401|FG001|STARTED|Overall Study||8
6632754|NCT02285153|7561400|FG000|COMPLETED|Overall Study||6
6632755|NCT02285153|7561401|FG001|COMPLETED|Overall Study||8
6632756|NCT02285153|7561400|FG000|NOT COMPLETED|Overall Study||1
6632757|NCT02285153|7561401|FG001|NOT COMPLETED|Overall Study||0
6632758|NCT02285283|7561409|FG000|STARTED|Overall Study||29
6632759|NCT02285283|7561410|FG001|STARTED|Overall Study||29
6632760|NCT02285283|7561409|FG000|COMPLETED|Overall Study||25
6632761|NCT02285283|7561410|FG001|COMPLETED|Overall Study||20
6632762|NCT02285283|7561409|FG000|NOT COMPLETED|Overall Study||4
6632763|NCT02285283|7561410|FG001|NOT COMPLETED|Overall Study||9
6632764|NCT02285361|7561416|FG000|STARTED|Overall Study||1272
6632765|NCT02285361|7561416|FG000|COMPLETED|Overall Study||1221
6632766|NCT02285361|7561416|FG000|NOT COMPLETED|Overall Study||51
6632767|NCT02285634|7561424|FG000|STARTED|Overall Study||15
6632768|NCT02285634|7561425|FG001|STARTED|Overall Study||20
6632769|NCT02285634|7561426|FG002|STARTED|Overall Study||15
6632770|NCT02285634|7561427|FG003|STARTED|Overall Study||18
6632771|NCT02285634|7561424|FG000|COMPLETED|Overall Study||15
6632772|NCT02285634|7561425|FG001|COMPLETED|Overall Study||20
6632773|NCT02285634|7561426|FG002|COMPLETED|Overall Study||11
6632774|NCT02285634|7561427|FG003|COMPLETED|Overall Study||17
6632775|NCT02285634|7561424|FG000|NOT COMPLETED|Overall Study||0
6632776|NCT02285634|7561425|FG001|NOT COMPLETED|Overall Study||0
6632777|NCT02285634|7561426|FG002|NOT COMPLETED|Overall Study||4
6284671|NCT00206726|7185145|FG000|STARTED|Overall Study||60
6284672|NCT00206726|7185145|FG000|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
6284673|NCT00206726|7185145|FG000|4 Cycles Completed|Overall Study|per protocol population|41
6632778|NCT02285634|7561427|FG003|NOT COMPLETED|Overall Study||1
6632779|NCT02285777|7561440|FG000|STARTED|Overall Study||95
6632780|NCT02285777|7561441|FG001|STARTED|Overall Study||94
6632781|NCT02285777|7561440|FG000|COMPLETED|Overall Study||90
6632782|NCT02285777|7561441|FG001|COMPLETED|Overall Study||91
6632783|NCT02285777|7561440|FG000|NOT COMPLETED|Overall Study||5
6632784|NCT02285777|7561441|FG001|NOT COMPLETED|Overall Study||3
6632785|NCT02285855|7561449|FG000|STARTED|Overall Study||16
6632786|NCT02285855|7561450|FG001|STARTED|Overall Study||2
6632787|NCT02285855|7561449|FG000|Randomized|Overall Study||16
6632788|NCT02285855|7561450|FG001|Randomized|Overall Study||2
6632789|NCT02285855|7561449|FG000|COMPLETED|Overall Study||14
6632790|NCT02285855|7561450|FG001|COMPLETED|Overall Study||1
6632791|NCT02285855|7561449|FG000|NOT COMPLETED|Overall Study||2
6284674|NCT00206726|7185145|FG000|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
6284675|NCT00206726|7185145|FG000|NOT COMPLETED|Overall Study||51
6284676|NCT00207090|7185149|FG000|STARTED|Overall Study|Number of participants treated|15
6284677|NCT00207090|7185149|FG000|COMPLETED|Overall Study||8
6284678|NCT00207090|7185149|FG000|NOT COMPLETED|Overall Study||7
6284679|NCT00207142|7185161|FG000|STARTED|Induction Phase||252
6284680|NCT00207142|7185162|FG001|STARTED|Induction Phase||0
6284681|NCT00207142|7185163|FG002|STARTED|Induction Phase||0
6284682|NCT00207142|7185164|FG003|STARTED|Induction Phase||0
6284683|NCT00207142|7185161|FG000|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
6284684|NCT00207142|7185162|FG001|COMPLETED|Induction Phase||0
6284685|NCT00207142|7185163|FG002|COMPLETED|Induction Phase||0
6284686|NCT00207142|7185164|FG003|COMPLETED|Induction Phase||0
6284687|NCT00207142|7185161|FG000|NOT COMPLETED|Induction Phase||30
6284688|NCT00207142|7185162|FG001|NOT COMPLETED|Induction Phase||0
6284689|NCT00207142|7185163|FG002|NOT COMPLETED|Induction Phase||0
6284690|NCT00207142|7185164|FG003|NOT COMPLETED|Induction Phase||0
6284691|NCT00207142|7185161|FG000|STARTED|Maintenance Phase/Rescue Phase||0
6284692|NCT00207142|7185162|FG001|STARTED|Maintenance Phase/Rescue Phase||87
6284693|NCT00207142|7185163|FG002|STARTED|Maintenance Phase/Rescue Phase||85
6284694|NCT00207142|7185164|FG003|STARTED|Maintenance Phase/Rescue Phase||50
6284695|NCT00207142|7185161|FG000|COMPLETED|Maintenance Phase/Rescue Phase||0
6284696|NCT00207142|7185162|FG001|COMPLETED|Maintenance Phase/Rescue Phase||78
6284697|NCT00207142|7185163|FG002|COMPLETED|Maintenance Phase/Rescue Phase||72
6284698|NCT00207142|7185164|FG003|COMPLETED|Maintenance Phase/Rescue Phase||41
6284699|NCT00207142|7185161|FG000|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
6284700|NCT00207142|7185162|FG001|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
6284701|NCT00207142|7185163|FG002|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
6284702|NCT00207142|7185164|FG003|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
6284703|NCT00207714|7185184|FG000|STARTED|Overall Study||35
6284704|NCT00207714|7185185|FG001|STARTED|Overall Study||35
6284705|NCT00207714|7185186|FG002|STARTED|Overall Study||34
6284706|NCT00207714|7185187|FG003|STARTED|Overall Study||34
6284707|NCT00207714|7185188|FG004|STARTED|Overall Study||34
6284708|NCT00207714|7185184|FG000|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
6284709|NCT00207714|7185185|FG001|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
6284710|NCT00207714|7185186|FG002|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
6284711|NCT00207714|7185187|FG003|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
6284712|NCT00207714|7185188|FG004|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
6284713|NCT00207714|7185184|FG000|NOT COMPLETED|Overall Study||14
6284714|NCT00207714|7185185|FG001|NOT COMPLETED|Overall Study||7
6284715|NCT00207714|7185186|FG002|NOT COMPLETED|Overall Study||10
6284716|NCT00207714|7185187|FG003|NOT COMPLETED|Overall Study||8
6284717|NCT00207714|7185188|FG004|NOT COMPLETED|Overall Study||5
6284718|NCT00207727|7185212|FG000|STARTED|Overall Study||49
6284719|NCT00207727|7185213|FG001|STARTED|Overall Study||50
6284720|NCT00207727|7185214|FG002|STARTED|Overall Study||50
6284721|NCT00207727|7185215|FG003|STARTED|Overall Study||50
6284722|NCT00207727|7185216|FG004|STARTED|Overall Study||50
6284723|NCT00207727|7185212|FG000|COMPLETED|Overall Study||11
6284724|NCT00207727|7185213|FG001|COMPLETED|Overall Study||8
6284725|NCT00207727|7185214|FG002|COMPLETED|Overall Study||9
6284726|NCT00207727|7185215|FG003|COMPLETED|Overall Study||13
6284727|NCT00207727|7185216|FG004|COMPLETED|Overall Study||16
6284728|NCT00207727|7185212|FG000|NOT COMPLETED|Overall Study||38
6284729|NCT00207727|7185213|FG001|NOT COMPLETED|Overall Study||42
6284730|NCT00207727|7185214|FG002|NOT COMPLETED|Overall Study||41
6284731|NCT00207727|7185215|FG003|NOT COMPLETED|Overall Study||37
6284732|NCT00207727|7185216|FG004|NOT COMPLETED|Overall Study||34
6632792|NCT02285855|7561450|FG001|NOT COMPLETED|Overall Study||1
6632793|NCT02285907|7561456|FG000|STARTED|Overall Study||21
6632794|NCT02285907|7561456|FG000|Began 1st Intervention|Overall Study||21
6632795|NCT02285907|7561456|FG000|Began 2nd Intervention|Overall Study||21
6632796|NCT02285907|7561456|FG000|Began 3rd Intervention|Overall Study||21
6632797|NCT02285907|7561456|FG000|Began 4th Intervention|Overall Study||21
6632798|NCT02285907|7561456|FG000|COMPLETED|Overall Study||21
6632799|NCT02285907|7561456|FG000|NOT COMPLETED|Overall Study||0
6632800|NCT02285920|7561473|FG000|STARTED|Overall Study||51
6632801|NCT02285920|7561474|FG001|STARTED|Overall Study||27
6284733|NCT00207740|7185232|FG000|STARTED|Overall Study||78
6284734|NCT00207740|7185233|FG001|STARTED|Overall Study||77
6284735|NCT00207740|7185234|FG002|STARTED|Overall Study||76
6284736|NCT00207740|7185235|FG003|STARTED|Overall Study||78
6284737|NCT00207740|7185232|FG000|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
6284738|NCT00207740|7185233|FG001|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
6284739|NCT00207740|7185234|FG002|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
6284740|NCT00207740|7185235|FG003|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
6284741|NCT00207740|7185232|FG000|NOT COMPLETED|Overall Study||29
6632802|NCT02285920|7561475|FG002|STARTED|Overall Study||26
6632803|NCT02285920|7561476|FG003|STARTED|Overall Study||25
6284742|NCT00207740|7185233|FG001|NOT COMPLETED|Overall Study||41
6284743|NCT00207740|7185234|FG002|NOT COMPLETED|Overall Study||40
6284744|NCT00207740|7185235|FG003|NOT COMPLETED|Overall Study||43
6284745|NCT00207883|7185251|FG000|STARTED|Overall Study||93
6284746|NCT00207883|7185252|FG001|STARTED|Overall Study||119
6284747|NCT00207883|7185251|FG000|COMPLETED|Overall Study||93
6284748|NCT00207883|7185252|FG001|COMPLETED|Overall Study||119
6284749|NCT00207883|7185251|FG000|NOT COMPLETED|Overall Study||0
6284750|NCT00207883|7185252|FG001|NOT COMPLETED|Overall Study||0
6284751|NCT00208026|7185258|FG000|STARTED|Overall Study||3
6284752|NCT00208026|7185258|FG000|COMPLETED|Overall Study||3
6284753|NCT00208026|7185258|FG000|NOT COMPLETED|Overall Study||0
6284754|NCT00208091|7185264|FG000|STARTED|Overall Study||16
6284755|NCT00208091|7185264|FG000|COMPLETED|Overall Study||16
6284756|NCT00208091|7185264|FG000|NOT COMPLETED|Overall Study||0
6284757|NCT00208325|7185276|FG000|STARTED|Overall Study||193
6284758|NCT00208325|7185277|FG001|STARTED|Overall Study||196
6284759|NCT00208325|7185278|FG002|STARTED|Overall Study||170
6284760|NCT00208325|7185279|FG003|STARTED|Overall Study||161
6284761|NCT00208325|7185276|FG000|COMPLETED|Overall Study||142
6284762|NCT00208325|7185277|FG001|COMPLETED|Overall Study||142
6284763|NCT00208325|7185278|FG002|COMPLETED|Overall Study||156
6284764|NCT00208325|7185279|FG003|COMPLETED|Overall Study||147
6284765|NCT00208325|7185276|FG000|NOT COMPLETED|Overall Study||51
6284766|NCT00208325|7185277|FG001|NOT COMPLETED|Overall Study||54
6284767|NCT00208325|7185278|FG002|NOT COMPLETED|Overall Study||14
6284768|NCT00208325|7185279|FG003|NOT COMPLETED|Overall Study||14
6284769|NCT00208494|7185291|FG000|STARTED|Overall Study||194
6284770|NCT00208494|7185292|FG001|STARTED|Overall Study||196
6284771|NCT00208494|7185291|FG000|COMPLETED|Overall Study||164
6284772|NCT00208494|7185292|FG001|COMPLETED|Overall Study||162
6284773|NCT00208494|7185291|FG000|NOT COMPLETED|Overall Study||30
6284774|NCT00208494|7185292|FG001|NOT COMPLETED|Overall Study||34
6284775|NCT00208507|7185300|FG000|STARTED|Overall Study||177
6284776|NCT00208507|7185301|FG001|STARTED|Overall Study||87
6284777|NCT00208507|7185300|FG000|COMPLETED|Overall Study||163
6284778|NCT00208507|7185301|FG001|COMPLETED|Overall Study||79
6284779|NCT00208507|7185300|FG000|NOT COMPLETED|Overall Study||14
6284780|NCT00208507|7185301|FG001|NOT COMPLETED|Overall Study||8
6284781|NCT00208767|7185309|FG000|STARTED|Overall Study||80
6284782|NCT00208767|7185310|FG001|STARTED|Overall Study||40
6284783|NCT00208767|7185309|FG000|COMPLETED|Overall Study||53
6284784|NCT00208767|7185310|FG001|COMPLETED|Overall Study||33
6284785|NCT00208767|7185309|FG000|NOT COMPLETED|Overall Study||27
6284786|NCT00208767|7185310|FG001|NOT COMPLETED|Overall Study||7
6284787|NCT00208949|7185318|FG000|STARTED|Overall Study||25
6284788|NCT00208949|7185319|FG001|STARTED|Overall Study||25
6284789|NCT00208949|7185318|FG000|COMPLETED|Overall Study||25
6284790|NCT00208949|7185319|FG001|COMPLETED|Overall Study||25
6284791|NCT00208949|7185318|FG000|NOT COMPLETED|Overall Study||0
6284792|NCT00208949|7185319|FG001|NOT COMPLETED|Overall Study||0
6284793|NCT00208975|7185325|FG000|STARTED|Overall Study||15
6284794|NCT00208975|7185325|FG000|COMPLETED|Overall Study||15
6284795|NCT00208975|7185325|FG000|NOT COMPLETED|Overall Study||0
6284796|NCT00209092|7185332|FG000|STARTED|Overall Study||25
6284797|NCT00209092|7185333|FG001|STARTED|Overall Study||26
6284798|NCT00209092|7185332|FG000|COMPLETED|Overall Study||17
6284799|NCT00209092|7185333|FG001|COMPLETED|Overall Study||24
6284800|NCT00209092|7185332|FG000|NOT COMPLETED|Overall Study||8
6284801|NCT00209092|7185333|FG001|NOT COMPLETED|Overall Study||2
6284802|NCT00209170|7185341|FG000|STARTED|Overall Study||7
6284803|NCT00209170|7185342|FG001|STARTED|Overall Study||7
6284804|NCT00209170|7185341|FG000|COMPLETED|Overall Study||5
6284805|NCT00209170|7185342|FG001|COMPLETED|Overall Study||4
6284806|NCT00209170|7185341|FG000|NOT COMPLETED|Overall Study||2
6284807|NCT00209170|7185342|FG001|NOT COMPLETED|Overall Study||3
6284808|NCT00209274|7185350|FG000|STARTED|Overall Study||184
6284809|NCT00209274|7185351|FG001|STARTED|Overall Study||95
6284810|NCT00209274|7185350|FG000|COMPLETED|Overall Study||113
6284811|NCT00209274|7185351|FG001|COMPLETED|Overall Study||48
6284812|NCT00209274|7185350|FG000|NOT COMPLETED|Overall Study||71
6284813|NCT00209274|7185351|FG001|NOT COMPLETED|Overall Study||47
6284814|NCT00209339|7185357|FG000|STARTED|At 12 Months Follow-up||55
6284815|NCT00209339|7185357|FG000|COMPLETED|At 12 Months Follow-up||40
6284816|NCT00209339|7185357|FG000|NOT COMPLETED|At 12 Months Follow-up||15
6284817|NCT00209339|7185357|FG000|STARTED|At 24 Months Follow-up||40
6284818|NCT00209339|7185357|FG000|COMPLETED|At 24 Months Follow-up||29
6284819|NCT00209339|7185357|FG000|NOT COMPLETED|At 24 Months Follow-up||11
6284820|NCT00209339|7185357|FG000|STARTED|At 3 Years Follow-up||29
6284821|NCT00209339|7185357|FG000|COMPLETED|At 3 Years Follow-up||28
6284822|NCT00209339|7185357|FG000|NOT COMPLETED|At 3 Years Follow-up||1
6284823|NCT00209339|7185357|FG000|STARTED|At 4 Years Follow-up||28
6284824|NCT00209339|7185357|FG000|COMPLETED|At 4 Years Follow-up||23
6284825|NCT00209339|7185357|FG000|NOT COMPLETED|At 4 Years Follow-up||5
6284826|NCT00209339|7185357|FG000|STARTED|At 5 Years Follow-up||23
6284827|NCT00209339|7185357|FG000|COMPLETED|At 5 Years Follow-up||15
6284828|NCT00209339|7185357|FG000|NOT COMPLETED|At 5 Years Follow-up||8
6284829|NCT00209417|7185363|FG000|STARTED|Overall Study||321
6284830|NCT00209417|7185364|FG001|STARTED|Overall Study||327
6284831|NCT00209417|7185363|FG000|COMPLETED|Overall Study||321
6284832|NCT00209417|7185364|FG001|COMPLETED|Overall Study||327
6284833|NCT00209417|7185363|FG000|NOT COMPLETED|Overall Study||0
6284834|NCT00209417|7185364|FG001|NOT COMPLETED|Overall Study||0
6284835|NCT00209560|7185372|FG000|STARTED|Overall Study||121
6284836|NCT00209560|7185373|FG001|STARTED|Overall Study||42
6284837|NCT00209560|7185372|FG000|COMPLETED|Overall Study||120
6284838|NCT00209560|7185373|FG001|COMPLETED|Overall Study||42
6284839|NCT00209560|7185372|FG000|NOT COMPLETED|Overall Study||1
6284840|NCT00209560|7185373|FG001|NOT COMPLETED|Overall Study||0
6284841|NCT00210106|7185379|FG000|STARTED|Overall Study||52
6284842|NCT00210106|7185379|FG000|Safety Population|Overall Study||49
6284843|NCT00210106|7185379|FG000|COMPLETED|Overall Study||38
6284844|NCT00210106|7185379|FG000|NOT COMPLETED|Overall Study||14
6284845|NCT00210119|7185384|FG000|STARTED|Overall Study||19
6284846|NCT00210119|7185384|FG000|COMPLETED|Overall Study||17
6284847|NCT00210119|7185384|FG000|NOT COMPLETED|Overall Study||2
6632804|NCT02285920|7561473|FG000|COMPLETED|Overall Study||47
6632805|NCT02285920|7561474|FG001|COMPLETED|Overall Study||23
6632806|NCT02285920|7561475|FG002|COMPLETED|Overall Study||21
6632807|NCT02285920|7561476|FG003|COMPLETED|Overall Study||24
6632808|NCT02285920|7561473|FG000|NOT COMPLETED|Overall Study||4
6632809|NCT02285920|7561474|FG001|NOT COMPLETED|Overall Study||4
6632810|NCT02285920|7561475|FG002|NOT COMPLETED|Overall Study||5
6632811|NCT02285920|7561476|FG003|NOT COMPLETED|Overall Study||1
6632812|NCT02285998|7561488|FG000|STARTED|Overall Study||4474
6632813|NCT02285998|7561489|FG001|STARTED|Overall Study||4489
6632814|NCT02285998|7561488|FG000|COMPLETED|Overall Study||4228
6632815|NCT02285998|7561489|FG001|COMPLETED|Overall Study||4236
6632816|NCT02285998|7561488|FG000|NOT COMPLETED|Overall Study||246
6632817|NCT02285998|7561489|FG001|NOT COMPLETED|Overall Study||253
6632818|NCT02286102|7561497|FG000|STARTED|Overall Study||36
6632819|NCT02286102|7561498|FG001|STARTED|Overall Study||34
6632820|NCT02286102|7561497|FG000|COMPLETED|Overall Study||35
6632821|NCT02286102|7561498|FG001|COMPLETED|Overall Study||33
6632822|NCT02286102|7561497|FG000|NOT COMPLETED|Overall Study||1
6632823|NCT02286102|7561498|FG001|NOT COMPLETED|Overall Study||1
6632824|NCT02286193|7561504|FG000|STARTED|Overall Study||622
6632825|NCT02286193|7561504|FG000|COMPLETED|Overall Study||418
6632826|NCT02286193|7561504|FG000|NOT COMPLETED|Overall Study||204
6632827|NCT02286466|7561511|FG000|STARTED|Overall Study||72
6632828|NCT02286466|7561512|FG001|STARTED|Overall Study||73
6632829|NCT02286466|7561511|FG000|Baseline Clinician Assessment|Overall Study||72
6632830|NCT02286466|7561512|FG001|Baseline Clinician Assessment|Overall Study||72
6632831|NCT02286466|7561511|FG000|Post Self-report|Overall Study||67
6632832|NCT02286466|7561512|FG001|Post Self-report|Overall Study||68
6632833|NCT02286466|7561511|FG000|COMPLETED|Overall Study||65
6632834|NCT02286466|7561512|FG001|COMPLETED|Overall Study||63
6632835|NCT02286466|7561511|FG000|NOT COMPLETED|Overall Study||7
6632836|NCT02286466|7561512|FG001|NOT COMPLETED|Overall Study||10
6632837|NCT02286518|7561532|FG000|STARTED|All Parts (16 Days)||6
6632838|NCT02286518|7561533|FG001|STARTED|All Parts (16 Days)||6
6632839|NCT02286518|7561534|FG002|STARTED|All Parts (16 Days)||6
6632840|NCT02286518|7561535|FG003|STARTED|All Parts (16 Days)||6
6632841|NCT02286518|7561536|FG004|STARTED|All Parts (16 Days)||6
6632842|NCT02286518|7561537|FG005|STARTED|All Parts (16 Days)||6
6632843|NCT02286518|7561538|FG006|STARTED|All Parts (16 Days)||6
6632844|NCT02286518|7561539|FG007|STARTED|All Parts (16 Days)||6
6632845|NCT02286518|7561540|FG008|STARTED|All Parts (16 Days)||6
6632846|NCT02286518|7561541|FG009|STARTED|All Parts (16 Days)||4
6632847|NCT02286518|7561542|FG010|STARTED|All Parts (16 Days)||6
6632848|NCT02286518|7561543|FG011|STARTED|All Parts (16 Days)||6
6632849|NCT02286518|7561544|FG012|STARTED|All Parts (16 Days)||6
6632850|NCT02286518|7561545|FG013|STARTED|All Parts (16 Days)||6
6632851|NCT02286518|7561532|FG000|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632852|NCT02286518|7561533|FG001|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632853|NCT02286518|7561534|FG002|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632854|NCT02286518|7561535|FG003|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632855|NCT02286518|7561536|FG004|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632856|NCT02286518|7561537|FG005|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632857|NCT02286518|7561538|FG006|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632858|NCT02286518|7561539|FG007|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
6632859|NCT02286518|7561540|FG008|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
6632860|NCT02286518|7561541|FG009|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
6632861|NCT02286518|7561542|FG010|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632862|NCT02286518|7561543|FG011|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6284848|NCT00210184|7185388|FG000|STARTED|Overall Study||42
6284849|NCT00210184|7185388|FG000|COMPLETED|Overall Study||40
6284850|NCT00210184|7185388|FG000|NOT COMPLETED|Overall Study||2
6284851|NCT00210353|7185395|FG000|STARTED|Overall Study||151
6284852|NCT00210353|7185396|FG001|STARTED|Overall Study||152
6284853|NCT00210353|7185397|FG002|STARTED|Overall Study||151
6284854|NCT00210353|7185395|FG000|COMPLETED|Overall Study||113
6284855|NCT00210353|7185396|FG001|COMPLETED|Overall Study||107
6284856|NCT00210353|7185397|FG002|COMPLETED|Overall Study||125
6284857|NCT00210353|7185395|FG000|NOT COMPLETED|Overall Study||38
6284858|NCT00210353|7185396|FG001|NOT COMPLETED|Overall Study||45
6284859|NCT00210353|7185397|FG002|NOT COMPLETED|Overall Study||26
6284860|NCT00210470|7185410|FG000|STARTED|Overall Study||27
6284861|NCT00210470|7185410|FG000|COMPLETED|Overall Study||27
6284862|NCT00210470|7185410|FG000|NOT COMPLETED|Overall Study||0
6284863|NCT00210626|7185419|FG000|STARTED|Overall Study||97
6284864|NCT00210626|7185420|FG001|STARTED|Overall Study||95
6632863|NCT02286518|7561544|FG012|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632864|NCT02286518|7561545|FG013|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
6632865|NCT02286518|7561532|FG000|NOT COMPLETED|All Parts (16 Days)||0
6632866|NCT02286518|7561533|FG001|NOT COMPLETED|All Parts (16 Days)||0
6632867|NCT02286518|7561534|FG002|NOT COMPLETED|All Parts (16 Days)||0
6632868|NCT02286518|7561535|FG003|NOT COMPLETED|All Parts (16 Days)||0
6632869|NCT02286518|7561536|FG004|NOT COMPLETED|All Parts (16 Days)||0
6632870|NCT02286518|7561537|FG005|NOT COMPLETED|All Parts (16 Days)||0
6632871|NCT02286518|7561538|FG006|NOT COMPLETED|All Parts (16 Days)||0
6632872|NCT02286518|7561539|FG007|NOT COMPLETED|All Parts (16 Days)||0
6632873|NCT02286518|7561540|FG008|NOT COMPLETED|All Parts (16 Days)||0
6632874|NCT02286518|7561541|FG009|NOT COMPLETED|All Parts (16 Days)||0
6632875|NCT02286518|7561542|FG010|NOT COMPLETED|All Parts (16 Days)||0
6632876|NCT02286518|7561543|FG011|NOT COMPLETED|All Parts (16 Days)||0
6632877|NCT02286518|7561544|FG012|NOT COMPLETED|All Parts (16 Days)||0
6632878|NCT02286518|7561545|FG013|NOT COMPLETED|All Parts (16 Days)||0
6632879|NCT02286518|7561532|FG000|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632880|NCT02286518|7561533|FG001|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632881|NCT02286518|7561534|FG002|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632882|NCT02286518|7561535|FG003|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632883|NCT02286518|7561536|FG004|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632884|NCT02286518|7561537|FG005|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632885|NCT02286518|7561538|FG006|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632886|NCT02286518|7561539|FG007|STARTED|Washout Crossover Period(Part 2:14 Days)||6
6632887|NCT02286518|7561540|FG008|STARTED|Washout Crossover Period(Part 2:14 Days)||6
6632888|NCT02286518|7561541|FG009|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632889|NCT02286518|7561542|FG010|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632890|NCT02286518|7561543|FG011|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632891|NCT02286518|7561544|FG012|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632892|NCT02286518|7561545|FG013|STARTED|Washout Crossover Period(Part 2:14 Days)||0
6632893|NCT02286518|7561532|FG000|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632894|NCT02286518|7561533|FG001|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632895|NCT02286518|7561534|FG002|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632896|NCT02286518|7561535|FG003|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632897|NCT02286518|7561536|FG004|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632898|NCT02286518|7561537|FG005|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632899|NCT02286518|7561538|FG006|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632900|NCT02286518|7561539|FG007|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
6632901|NCT02286518|7561540|FG008|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
6632902|NCT02286518|7561541|FG009|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632903|NCT02286518|7561542|FG010|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632904|NCT02286518|7561543|FG011|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632905|NCT02286518|7561544|FG012|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632906|NCT02286518|7561545|FG013|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632907|NCT02286518|7561532|FG000|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632908|NCT02286518|7561533|FG001|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632909|NCT02286518|7561534|FG002|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632910|NCT02286518|7561535|FG003|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632911|NCT02286518|7561536|FG004|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632912|NCT02286518|7561537|FG005|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632913|NCT02286518|7561538|FG006|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632914|NCT02286518|7561539|FG007|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632915|NCT02286518|7561540|FG008|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632916|NCT02286518|7561541|FG009|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632917|NCT02286518|7561542|FG010|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632918|NCT02286518|7561543|FG011|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632919|NCT02286518|7561544|FG012|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632920|NCT02286518|7561545|FG013|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
6632921|NCT02286518|7561532|FG000|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632922|NCT02286518|7561533|FG001|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6284865|NCT00210626|7185419|FG000|COMPLETED|Overall Study||49
6284866|NCT00210626|7185420|FG001|COMPLETED|Overall Study||50
6284867|NCT00210626|7185419|FG000|NOT COMPLETED|Overall Study||48
6284868|NCT00210626|7185420|FG001|NOT COMPLETED|Overall Study||45
6284869|NCT00210639|7185428|FG000|STARTED|Overall Study||124
6284870|NCT00210639|7185429|FG001|STARTED|Overall Study||83
6284871|NCT00210639|7185428|FG000|COMPLETED|Overall Study||61
6284872|NCT00210639|7185429|FG001|COMPLETED|Overall Study||41
6284873|NCT00210639|7185428|FG000|NOT COMPLETED|Overall Study||63
6284874|NCT00210639|7185429|FG001|NOT COMPLETED|Overall Study||42
6284875|NCT00211081|7185435|FG000|STARTED|Overall Study||12
6284876|NCT00211081|7185435|FG000|COMPLETED|Overall Study||10
6284877|NCT00211081|7185435|FG000|NOT COMPLETED|Overall Study||2
6284878|NCT00211172|7185441|FG000|STARTED|Overall Study||449
6284879|NCT00211172|7185442|FG001|STARTED|Overall Study||458
6284880|NCT00211172|7185441|FG000|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
6284881|NCT00211172|7185442|FG001|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
6284882|NCT00211172|7185441|FG000|NOT COMPLETED|Overall Study||39
6284883|NCT00211172|7185442|FG001|NOT COMPLETED|Overall Study||32
6284884|NCT00211185|7185448|FG000|STARTED|Overall Study||49
6399208|NCT00879684|7311915|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||0
6399209|NCT00879684|7311916|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||0
6399210|NCT00879684|7311917|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||13
6399211|NCT00879697|7311938|FG000|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
6399212|NCT00879697|7311939|FG001|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
6399213|NCT00879697|7311938|FG000|COMPLETED|Overall Study|Two patients did not finish the trial|15
6399214|NCT00879697|7311939|FG001|COMPLETED|Overall Study|Two patients did not finish the trial|15
6399215|NCT00879697|7311938|FG000|NOT COMPLETED|Overall Study||2
6399216|NCT00879697|7311939|FG001|NOT COMPLETED|Overall Study||2
6399217|NCT00879710|7311947|FG000|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
6399218|NCT00879710|7311948|FG001|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
6399219|NCT00879710|7311949|FG002|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
6399220|NCT00879710|7311950|FG003|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
6399221|NCT00879710|7311947|FG000|COMPLETED|Phase 1 - 6 Weeks||10
6399222|NCT00879710|7311948|FG001|COMPLETED|Phase 1 - 6 Weeks||14
6399223|NCT00879710|7311949|FG002|COMPLETED|Phase 1 - 6 Weeks||9
6399224|NCT00879710|7311950|FG003|COMPLETED|Phase 1 - 6 Weeks||13
6399225|NCT00879710|7311947|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||2
6399226|NCT00879710|7311948|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||3
6399227|NCT00879710|7311949|FG002|NOT COMPLETED|Phase 1 - 6 Weeks||2
6399228|NCT00879710|7311950|FG003|NOT COMPLETED|Phase 1 - 6 Weeks||4
6399229|NCT00879710|7311947|FG000|STARTED|Wash Out Period of 4 Weeks||10
6399230|NCT00879710|7311948|FG001|STARTED|Wash Out Period of 4 Weeks||14
6399231|NCT00879710|7311949|FG002|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
6399232|NCT00879710|7311950|FG003|STARTED|Wash Out Period of 4 Weeks||13
6399233|NCT00879710|7311947|FG000|COMPLETED|Wash Out Period of 4 Weeks||10
6399234|NCT00879710|7311948|FG001|COMPLETED|Wash Out Period of 4 Weeks||14
6399235|NCT00879710|7311949|FG002|COMPLETED|Wash Out Period of 4 Weeks||10
6399236|NCT00879710|7311950|FG003|COMPLETED|Wash Out Period of 4 Weeks||13
6399237|NCT00879710|7311947|FG000|NOT COMPLETED|Wash Out Period of 4 Weeks||0
6399238|NCT00879710|7311948|FG001|NOT COMPLETED|Wash Out Period of 4 Weeks||0
6399239|NCT00879710|7311949|FG002|NOT COMPLETED|Wash Out Period of 4 Weeks||0
6399240|NCT00879710|7311950|FG003|NOT COMPLETED|Wash Out Period of 4 Weeks||0
6399241|NCT00879710|7311947|FG000|STARTED|Phase 2 6 Weeks||10
6399242|NCT00879710|7311948|FG001|STARTED|Phase 2 6 Weeks||14
6399243|NCT00879710|7311949|FG002|STARTED|Phase 2 6 Weeks||10
6399244|NCT00879710|7311950|FG003|STARTED|Phase 2 6 Weeks||13
6399245|NCT00879710|7311947|FG000|COMPLETED|Phase 2 6 Weeks||10
6399246|NCT00879710|7311948|FG001|COMPLETED|Phase 2 6 Weeks||14
6399247|NCT00879710|7311949|FG002|COMPLETED|Phase 2 6 Weeks||10
6399248|NCT00879710|7311950|FG003|COMPLETED|Phase 2 6 Weeks||13
6399249|NCT00879710|7311947|FG000|NOT COMPLETED|Phase 2 6 Weeks||0
6399250|NCT00879710|7311948|FG001|NOT COMPLETED|Phase 2 6 Weeks||0
6399251|NCT00879710|7311949|FG002|NOT COMPLETED|Phase 2 6 Weeks||0
6399252|NCT00879710|7311950|FG003|NOT COMPLETED|Phase 2 6 Weeks||0
6399253|NCT00879775|7311960|FG000|STARTED|Overall Study||20
6399254|NCT00879775|7311961|FG001|STARTED|Overall Study||21
6399255|NCT00879775|7311960|FG000|COMPLETED|Overall Study||18
6399256|NCT00879775|7311961|FG001|COMPLETED|Overall Study||20
6399257|NCT00879775|7311960|FG000|NOT COMPLETED|Overall Study||2
6399258|NCT00879775|7311961|FG001|NOT COMPLETED|Overall Study||1
6498658|NCT01411696|7417292|FG000|COMPLETED|Overall Study||289
6498659|NCT01411696|7417292|FG000|NOT COMPLETED|Overall Study||0
6498660|NCT01411774|7417298|FG000|STARTED|Overall Study||72
6498661|NCT01411774|7417299|FG001|STARTED|Overall Study||70
6498662|NCT01411774|7417298|FG000|COMPLETED|Overall Study||72
6498663|NCT01411774|7417299|FG001|COMPLETED|Overall Study||67
6498664|NCT01411774|7417298|FG000|NOT COMPLETED|Overall Study||0
6498665|NCT01411774|7417299|FG001|NOT COMPLETED|Overall Study||3
6498666|NCT01411839|7417307|FG000|STARTED|Overall Study||20
6498667|NCT01411839|7417308|FG001|STARTED|Overall Study||20
6498668|NCT01411839|7417307|FG000|COMPLETED|Overall Study||16
6498669|NCT01411839|7417308|FG001|COMPLETED|Overall Study||17
6498670|NCT01411839|7417307|FG000|NOT COMPLETED|Overall Study||4
6498671|NCT01411839|7417308|FG001|NOT COMPLETED|Overall Study||3
6502043|NCT01432327|7420691|FG002|STARTED|Posttest 6 Months||55
6502044|NCT01432327|7420692|FG003|STARTED|Posttest 6 Months||56
6284885|NCT00211185|7185448|FG000|COMPLETED|Overall Study||29
6284886|NCT00211185|7185448|FG000|NOT COMPLETED|Overall Study||20
6284887|NCT00211237|7185454|FG000|STARTED|Baseline||70
6284888|NCT00211237|7185455|FG001|STARTED|Baseline||64
6284889|NCT00211237|7185456|FG002|STARTED|Baseline||0
6284890|NCT00211237|7185454|FG000|COMPLETED|Baseline||68
6284891|NCT00211237|7185455|FG001|COMPLETED|Baseline||61
6284892|NCT00211237|7185456|FG002|COMPLETED|Baseline||0
6284893|NCT00211237|7185454|FG000|NOT COMPLETED|Baseline||2
6284894|NCT00211237|7185455|FG001|NOT COMPLETED|Baseline||3
6284895|NCT00211237|7185456|FG002|NOT COMPLETED|Baseline||0
6284896|NCT00211237|7185454|FG000|STARTED|1 Month||68
6632923|NCT02286518|7561534|FG002|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632924|NCT02286518|7561535|FG003|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632925|NCT02286518|7561536|FG004|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632926|NCT02286518|7561537|FG005|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632927|NCT02286518|7561538|FG006|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632928|NCT02286518|7561539|FG007|STARTED|Crossover Treatment (Part 2: 3 Days)||6
6284897|NCT00211237|7185455|FG001|STARTED|1 Month||61
6284898|NCT00211237|7185456|FG002|STARTED|1 Month||0
6284899|NCT00211237|7185454|FG000|COMPLETED|1 Month||65
6284900|NCT00211237|7185455|FG001|COMPLETED|1 Month||52
6284901|NCT00211237|7185456|FG002|COMPLETED|1 Month||0
6284902|NCT00211237|7185454|FG000|NOT COMPLETED|1 Month||3
6284903|NCT00211237|7185455|FG001|NOT COMPLETED|1 Month||9
6632929|NCT02286518|7561540|FG008|STARTED|Crossover Treatment (Part 2: 3 Days)||6
6632930|NCT02286518|7561541|FG009|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632931|NCT02286518|7561542|FG010|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632932|NCT02286518|7561543|FG011|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632933|NCT02286518|7561544|FG012|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632934|NCT02286518|7561545|FG013|STARTED|Crossover Treatment (Part 2: 3 Days)||0
6632935|NCT02286518|7561532|FG000|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632936|NCT02286518|7561533|FG001|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632937|NCT02286518|7561534|FG002|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632938|NCT02286518|7561535|FG003|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632939|NCT02286518|7561536|FG004|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632940|NCT02286518|7561537|FG005|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632941|NCT02286518|7561538|FG006|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632942|NCT02286518|7561539|FG007|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
6632943|NCT02286518|7561540|FG008|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
6632944|NCT02286518|7561541|FG009|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632945|NCT02286518|7561542|FG010|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632946|NCT02286518|7561543|FG011|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632947|NCT02286518|7561544|FG012|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632948|NCT02286518|7561545|FG013|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632949|NCT02286518|7561532|FG000|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632950|NCT02286518|7561533|FG001|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632951|NCT02286518|7561534|FG002|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632952|NCT02286518|7561535|FG003|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632953|NCT02286518|7561536|FG004|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632954|NCT02286518|7561537|FG005|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632955|NCT02286518|7561538|FG006|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632956|NCT02286518|7561539|FG007|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632957|NCT02286518|7561540|FG008|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632958|NCT02286518|7561541|FG009|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632959|NCT02286518|7561542|FG010|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632960|NCT02286518|7561543|FG011|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632961|NCT02286518|7561544|FG012|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632962|NCT02286518|7561545|FG013|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
6632963|NCT02286713|7561593|FG000|STARTED|One Week Follow-Up||259
6632964|NCT02286713|7561594|FG001|STARTED|One Week Follow-Up||257
6632965|NCT02286713|7561593|FG000|COMPLETED|One Week Follow-Up||235
6632966|NCT02286713|7561594|FG001|COMPLETED|One Week Follow-Up||233
6632967|NCT02286713|7561593|FG000|NOT COMPLETED|One Week Follow-Up||24
6632968|NCT02286713|7561594|FG001|NOT COMPLETED|One Week Follow-Up||24
6632969|NCT02286713|7561593|FG000|STARTED|Three Month Follow-Up||252
6632970|NCT02286713|7561594|FG001|STARTED|Three Month Follow-Up||254
6632971|NCT02286713|7561593|FG000|COMPLETED|Three Month Follow-Up||224
6632972|NCT02286713|7561594|FG001|COMPLETED|Three Month Follow-Up||228
6632973|NCT02286713|7561593|FG000|NOT COMPLETED|Three Month Follow-Up||28
6632974|NCT02286713|7561594|FG001|NOT COMPLETED|Three Month Follow-Up||26
6632975|NCT02286713|7561593|FG000|STARTED|Six Month Follow-Up||250
6632976|NCT02286713|7561594|FG001|STARTED|Six Month Follow-Up||252
6632977|NCT02286713|7561593|FG000|COMPLETED|Six Month Follow-Up||218
6632978|NCT02286713|7561594|FG001|COMPLETED|Six Month Follow-Up||225
6632979|NCT02286713|7561593|FG000|NOT COMPLETED|Six Month Follow-Up||32
6284904|NCT00211237|7185456|FG002|NOT COMPLETED|1 Month||0
6284905|NCT00211237|7185454|FG000|STARTED|3 Months||65
6284906|NCT00211237|7185455|FG001|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
6284907|NCT00211237|7185456|FG002|STARTED|3 Months||34
6284908|NCT00211237|7185454|FG000|COMPLETED|3 Months||57
6284909|NCT00211237|7185455|FG001|COMPLETED|3 Months||14
6284910|NCT00211237|7185456|FG002|COMPLETED|3 Months||33
6284911|NCT00211237|7185454|FG000|NOT COMPLETED|3 Months||8
6284912|NCT00211237|7185455|FG001|NOT COMPLETED|3 Months||4
6284913|NCT00211237|7185456|FG002|NOT COMPLETED|3 Months||1
6632980|NCT02286713|7561594|FG001|NOT COMPLETED|Six Month Follow-Up||27
6632981|NCT02286726|7561603|FG000|STARTED|Overall Study||16
6632982|NCT02286726|7561604|FG001|STARTED|Overall Study||24
6632983|NCT02286726|7561605|FG002|STARTED|Overall Study||16
6632984|NCT02286726|7561603|FG000|COMPLETED|Overall Study||16
6632985|NCT02286726|7561604|FG001|COMPLETED|Overall Study||24
6632986|NCT02286726|7561605|FG002|COMPLETED|Overall Study||16
6632987|NCT02286726|7561603|FG000|NOT COMPLETED|Overall Study||0
6632988|NCT02286726|7561604|FG001|NOT COMPLETED|Overall Study||0
6632989|NCT02286726|7561605|FG002|NOT COMPLETED|Overall Study||0
6632990|NCT02286843|7561613|FG000|STARTED|Overall Study||49
6632991|NCT02286843|7561613|FG000|COMPLETED|Overall Study||43
6632992|NCT02286843|7561613|FG000|NOT COMPLETED|Overall Study||6
6632993|NCT02286895|7561619|FG000|STARTED|Randomized and Vaccinated||300
6632994|NCT02286895|7561620|FG001|STARTED|Randomized and Vaccinated||300
6632995|NCT02286895|7561619|FG000|COMPLETED|Randomized and Vaccinated||300
6632996|NCT02286895|7561620|FG001|COMPLETED|Randomized and Vaccinated||300
6632997|NCT02286895|7561619|FG000|NOT COMPLETED|Randomized and Vaccinated||0
6632998|NCT02286895|7561620|FG001|NOT COMPLETED|Randomized and Vaccinated||0
6632999|NCT02286895|7561619|FG000|STARTED|Assessed for Measles Seroconversion||300
6633000|NCT02286895|7561620|FG001|STARTED|Assessed for Measles Seroconversion||300
6633001|NCT02286895|7561619|FG000|COMPLETED|Assessed for Measles Seroconversion||252
6633002|NCT02286895|7561620|FG001|COMPLETED|Assessed for Measles Seroconversion||261
6633003|NCT02286895|7561619|FG000|NOT COMPLETED|Assessed for Measles Seroconversion||48
6633004|NCT02286895|7561620|FG001|NOT COMPLETED|Assessed for Measles Seroconversion||39
6633005|NCT02286921|7561628|FG000|STARTED|Overall Study||94
6633006|NCT02286921|7561629|FG001|STARTED|Overall Study||101
6633007|NCT02286921|7561628|FG000|COMPLETED|Overall Study||94
6633008|NCT02286921|7561629|FG001|COMPLETED|Overall Study||101
6633009|NCT02286921|7561628|FG000|NOT COMPLETED|Overall Study||0
6633010|NCT02286921|7561629|FG001|NOT COMPLETED|Overall Study||0
6633011|NCT02286947|7561635|FG000|STARTED|Overall Study||24
6633012|NCT02286947|7561635|FG000|COMPLETED|Overall Study||22
6633013|NCT02286947|7561635|FG000|NOT COMPLETED|Overall Study||2
6633014|NCT02286960|7561643|FG000|STARTED|Overall Study||19
6633015|NCT02286960|7561644|FG001|STARTED|Overall Study||17
6633016|NCT02286960|7561643|FG000|COMPLETED|Overall Study||16
6633017|NCT02286960|7561644|FG001|COMPLETED|Overall Study||14
6633018|NCT02286960|7561643|FG000|NOT COMPLETED|Overall Study||3
6633019|NCT02286960|7561644|FG001|NOT COMPLETED|Overall Study||3
6633020|NCT02287038|7561652|FG000|STARTED|Overall Study||23
6633021|NCT02287038|7561653|FG001|STARTED|Overall Study||21
6633022|NCT02287038|7561652|FG000|COMPLETED|Overall Study||18
6633023|NCT02287038|7561653|FG001|COMPLETED|Overall Study||18
6633024|NCT02287038|7561652|FG000|NOT COMPLETED|Overall Study||5
6633025|NCT02287038|7561653|FG001|NOT COMPLETED|Overall Study||3
6633026|NCT02287350|7561661|FG000|STARTED|Overall Study||51
6633027|NCT02287350|7561661|FG000|COMPLETED|Overall Study||48
6633028|NCT02287350|7561661|FG000|NOT COMPLETED|Overall Study||3
6633029|NCT02287376|7561665|FG000|STARTED|Overall Study||25
6633030|NCT02287376|7561665|FG000|COMPLETED|Overall Study||25
6633031|NCT02287376|7561665|FG000|NOT COMPLETED|Overall Study||0
6633032|NCT02287402|7561669|FG000|STARTED|Treatment Period||197
6633033|NCT02287402|7561669|FG000|COMPLETED|Treatment Period||170
6633034|NCT02287402|7561669|FG000|NOT COMPLETED|Treatment Period||27
6633035|NCT02287402|7561669|FG000|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
6633036|NCT02287402|7561669|FG000|COMPLETED|Follow-up||103
6633037|NCT02287402|7561669|FG000|NOT COMPLETED|Follow-up||3
6633038|NCT02287415|7561673|FG000|STARTED|Overall Study||13
6633039|NCT02287415|7561673|FG000|COMPLETED|Overall Study||13
6633040|NCT02287415|7561673|FG000|NOT COMPLETED|Overall Study||0
6633041|NCT02287467|7561679|FG000|STARTED|Overall Study||168
6633042|NCT02287467|7561680|FG001|STARTED|Overall Study||161
6633043|NCT02287467|7561679|FG000|COMPLETED|Overall Study||156
6633044|NCT02287467|7561680|FG001|COMPLETED|Overall Study||152
6633045|NCT02287467|7561679|FG000|NOT COMPLETED|Overall Study||12
6633046|NCT02287467|7561680|FG001|NOT COMPLETED|Overall Study||9
6633047|NCT02287610|7561689|FG000|STARTED|Overall Study||64
6633048|NCT02287610|7561689|FG000|Per Protocol Follow-Up|Overall Study||56
6633049|NCT02287610|7561689|FG000|COMPLETED|Overall Study||48
6633050|NCT02287610|7561689|FG000|NOT COMPLETED|Overall Study||16
6633051|NCT02287623|7561695|FG000|STARTED|Overall Study||30
6633052|NCT02287623|7561696|FG001|STARTED|Overall Study||30
6633053|NCT02287623|7561695|FG000|COMPLETED|Overall Study||30
6633054|NCT02287623|7561696|FG001|COMPLETED|Overall Study||29
6633055|NCT02287623|7561695|FG000|NOT COMPLETED|Overall Study||0
6633056|NCT02287623|7561696|FG001|NOT COMPLETED|Overall Study||1
6633057|NCT02287675|7561704|FG000|STARTED|Overall Study||22
6633058|NCT02287675|7561705|FG001|STARTED|Overall Study||18
6633059|NCT02287675|7561704|FG000|COMPLETED|Overall Study||22
6633060|NCT02287675|7561705|FG001|COMPLETED|Overall Study||18
6633061|NCT02287675|7561704|FG000|NOT COMPLETED|Overall Study||0
6633062|NCT02287675|7561705|FG001|NOT COMPLETED|Overall Study||0
6633063|NCT02287688|7561711|FG000|STARTED|Overall Study||138
6633064|NCT02287688|7561711|FG000|COMPLETED|Overall Study||138
6633065|NCT02287688|7561711|FG000|NOT COMPLETED|Overall Study||0
6284914|NCT00211237|7185454|FG000|STARTED|6 Months||57
6284915|NCT00211237|7185455|FG001|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
6284916|NCT00211237|7185456|FG002|STARTED|6 Months||36
6284917|NCT00211237|7185454|FG000|COMPLETED|6 Months||49
6284918|NCT00211237|7185455|FG001|COMPLETED|6 Months||9
6284919|NCT00211237|7185456|FG002|COMPLETED|6 Months||33
6284920|NCT00211237|7185454|FG000|NOT COMPLETED|6 Months||8
6284921|NCT00211237|7185455|FG001|NOT COMPLETED|6 Months||2
6284922|NCT00211237|7185456|FG002|NOT COMPLETED|6 Months||3
6284923|NCT00211237|7185454|FG000|STARTED|12 Months||49
6284924|NCT00211237|7185455|FG001|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
6284925|NCT00211237|7185456|FG002|STARTED|12 Months||34
6284926|NCT00211237|7185454|FG000|COMPLETED|12 Months||40
6284927|NCT00211237|7185455|FG001|COMPLETED|12 Months||6
6284928|NCT00211237|7185456|FG002|COMPLETED|12 Months||28
6284929|NCT00211237|7185454|FG000|NOT COMPLETED|12 Months||9
6284930|NCT00211237|7185455|FG001|NOT COMPLETED|12 Months||2
6284931|NCT00211237|7185456|FG002|NOT COMPLETED|12 Months||6
6284932|NCT00211510|7185475|FG000|STARTED|Overall Study||72
6284933|NCT00211510|7185476|FG001|STARTED|Overall Study||74
6284934|NCT00211510|7185475|FG000|COMPLETED|Overall Study||66
6284935|NCT00211510|7185476|FG001|COMPLETED|Overall Study||72
6284936|NCT00211510|7185475|FG000|NOT COMPLETED|Overall Study||6
6284937|NCT00211510|7185476|FG001|NOT COMPLETED|Overall Study||2
6284938|NCT00211536|7185487|FG000|STARTED|Overall Study||53
6284939|NCT00211536|7185488|FG001|STARTED|Overall Study||54
6284940|NCT00211536|7185487|FG000|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
6284941|NCT00211536|7185488|FG001|As Treated Data Analysis Set|Overall Study||48
6284942|NCT00211536|7185487|FG000|COMPLETED|Overall Study||49
6284943|NCT00211536|7185488|FG001|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
6284944|NCT00211536|7185487|FG000|NOT COMPLETED|Overall Study||4
6284945|NCT00211536|7185488|FG001|NOT COMPLETED|Overall Study||7
6284946|NCT00211692|7185496|FG000|STARTED|Overall Study||33
6284947|NCT00211692|7185497|FG001|STARTED|Overall Study||31
6284948|NCT00211692|7185496|FG000|COMPLETED|Overall Study||33
6284949|NCT00211692|7185497|FG001|COMPLETED|Overall Study||31
6284950|NCT00211692|7185496|FG000|NOT COMPLETED|Overall Study||0
6284951|NCT00211692|7185497|FG001|NOT COMPLETED|Overall Study||0
6284952|NCT00211757|7185505|FG000|STARTED|Overall Study||11
6284953|NCT00211757|7185506|FG001|STARTED|Overall Study||16
6284954|NCT00211757|7185505|FG000|COMPLETED|Overall Study||10
6284955|NCT00211757|7185506|FG001|COMPLETED|Overall Study||14
6284956|NCT00211757|7185505|FG000|NOT COMPLETED|Overall Study||1
6284957|NCT00211757|7185506|FG001|NOT COMPLETED|Overall Study||2
6284958|NCT00211809|7185514|FG000|STARTED|Overall Study||17
6284959|NCT00211809|7185514|FG000|COMPLETED|Overall Study||11
6284960|NCT00211809|7185514|FG000|NOT COMPLETED|Overall Study||6
6284961|NCT00211887|7185523|FG000|STARTED|Overall Study||499
6284962|NCT00211887|7185524|FG001|STARTED|Overall Study||250
6633066|NCT02287779|7561723|FG000|STARTED|Overall Study||21
6633067|NCT02287779|7561724|FG001|STARTED|Overall Study||9
6633068|NCT02287779|7561725|FG002|STARTED|Overall Study||9
6633069|NCT02287779|7561726|FG003|STARTED|Overall Study||9
6633070|NCT02287779|7561727|FG004|STARTED|Overall Study||9
6633071|NCT02287779|7561728|FG005|STARTED|Overall Study||9
6633072|NCT02287779|7561729|FG006|STARTED|Overall Study||9
6633073|NCT02287779|7561730|FG007|STARTED|Overall Study||9
6633074|NCT02287779|7561723|FG000|COMPLETED|Overall Study||21
6633075|NCT02287779|7561724|FG001|COMPLETED|Overall Study||9
6633076|NCT02287779|7561725|FG002|COMPLETED|Overall Study||9
6633077|NCT02287779|7561726|FG003|COMPLETED|Overall Study||9
6633078|NCT02287779|7561727|FG004|COMPLETED|Overall Study||9
6633079|NCT02287779|7561728|FG005|COMPLETED|Overall Study||9
6633080|NCT02287779|7561729|FG006|COMPLETED|Overall Study||9
6633081|NCT02287779|7561730|FG007|COMPLETED|Overall Study||9
6633082|NCT02287779|7561723|FG000|NOT COMPLETED|Overall Study||0
6633083|NCT02287779|7561724|FG001|NOT COMPLETED|Overall Study||0
6633084|NCT02287779|7561725|FG002|NOT COMPLETED|Overall Study||0
6633085|NCT02287779|7561726|FG003|NOT COMPLETED|Overall Study||0
6633086|NCT02287779|7561727|FG004|NOT COMPLETED|Overall Study||0
6633087|NCT02287779|7561728|FG005|NOT COMPLETED|Overall Study||0
6633088|NCT02287779|7561729|FG006|NOT COMPLETED|Overall Study||0
6633089|NCT02287779|7561730|FG007|NOT COMPLETED|Overall Study||0
6633090|NCT02287818|7561754|FG000|STARTED|Overall Study||60
6633091|NCT02287818|7561755|FG001|STARTED|Overall Study||67
6633092|NCT02287818|7561754|FG000|COMPLETED|Overall Study||53
6633093|NCT02287818|7561755|FG001|COMPLETED|Overall Study||54
6633094|NCT02287818|7561754|FG000|NOT COMPLETED|Overall Study||7
6633095|NCT02287818|7561755|FG001|NOT COMPLETED|Overall Study||13
6633096|NCT02287883|7561763|FG000|STARTED|Overall Study||1081
6633097|NCT02287883|7561764|FG001|STARTED|Overall Study||1095
6633098|NCT02287883|7561763|FG000|One-year Follow-up Survey|Overall Study||622
6633099|NCT02287883|7561764|FG001|One-year Follow-up Survey|Overall Study||669
6633100|NCT02287883|7561763|FG000|COMPLETED|Overall Study||622
6633101|NCT02287883|7561764|FG001|COMPLETED|Overall Study||669
6633102|NCT02287883|7561763|FG000|NOT COMPLETED|Overall Study||459
6284963|NCT00211887|7185525|FG002|STARTED|Overall Study||259
6284964|NCT00211887|7185523|FG000|COMPLETED|Overall Study||397
6284965|NCT00211887|7185524|FG001|COMPLETED|Overall Study||194
6633103|NCT02287883|7561764|FG001|NOT COMPLETED|Overall Study||426
6633104|NCT02287896|7561772|FG000|STARTED|Screening Visit V1||36
6284966|NCT00211887|7185525|FG002|COMPLETED|Overall Study||223
6284967|NCT00211887|7185523|FG000|NOT COMPLETED|Overall Study||102
6284968|NCT00211887|7185524|FG001|NOT COMPLETED|Overall Study||56
6284969|NCT00211887|7185525|FG002|NOT COMPLETED|Overall Study||36
6284970|NCT00212134|7185535|FG000|STARTED|Phase 1 (to Age 1 Year)||57
6284971|NCT00212134|7185536|FG001|STARTED|Phase 1 (to Age 1 Year)||57
6284972|NCT00212134|7185535|FG000|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
6284973|NCT00212134|7185536|FG001|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
6284974|NCT00212134|7185535|FG000|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
6284975|NCT00212134|7185536|FG001|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
6284976|NCT00212134|7185535|FG000|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
6284977|NCT00212134|7185536|FG001|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
6284978|NCT00212134|7185535|FG000|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
6284979|NCT00212134|7185536|FG001|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
6284980|NCT00212134|7185535|FG000|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
6284981|NCT00212134|7185536|FG001|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
6284982|NCT00212134|7185535|FG000|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
6284983|NCT00212134|7185536|FG001|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
6284984|NCT00212134|7185535|FG000|STARTED|Phase 3 (Age 10 Years)||57
6284985|NCT00212134|7185536|FG001|STARTED|Phase 3 (Age 10 Years)||56
6284986|NCT00212134|7185535|FG000|COMPLETED|Phase 3 (Age 10 Years)||55
6284987|NCT00212134|7185536|FG001|COMPLETED|Phase 3 (Age 10 Years)||55
6284988|NCT00212134|7185535|FG000|NOT COMPLETED|Phase 3 (Age 10 Years)||2
6284989|NCT00212134|7185536|FG001|NOT COMPLETED|Phase 3 (Age 10 Years)||1
6284990|NCT00212264|7185549|FG000|STARTED|Overall Study||70
6284991|NCT00212264|7185550|FG001|STARTED|Overall Study||70
6284992|NCT00212264|7185551|FG002|STARTED|Overall Study||68
6284993|NCT00212264|7185549|FG000|COMPLETED|Overall Study||58
6284994|NCT00212264|7185550|FG001|COMPLETED|Overall Study||54
6284995|NCT00212264|7185551|FG002|COMPLETED|Overall Study||64
6284996|NCT00212264|7185549|FG000|NOT COMPLETED|Overall Study||12
6284997|NCT00212264|7185550|FG001|NOT COMPLETED|Overall Study||16
6284998|NCT00212264|7185551|FG002|NOT COMPLETED|Overall Study||4
6284999|NCT00212355|7185559|FG000|STARTED|Overall Study||37
6285000|NCT00212355|7185559|FG000|COMPLETED|Overall Study||34
6285001|NCT00212355|7185559|FG000|NOT COMPLETED|Overall Study||3
6285002|NCT00212446|7185563|FG000|STARTED|Overall Study||8
6285003|NCT00212446|7185563|FG000|COMPLETED|Overall Study||8
6285004|NCT00212446|7185563|FG000|NOT COMPLETED|Overall Study||0
6285005|NCT00212758|7185567|FG000|STARTED|First Intervention (7 Days)||8
6285006|NCT00212758|7185568|FG001|STARTED|First Intervention (7 Days)||9
6285007|NCT00212758|7185567|FG000|COMPLETED|First Intervention (7 Days)||8
6285008|NCT00212758|7185568|FG001|COMPLETED|First Intervention (7 Days)||9
6285009|NCT00212758|7185567|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6285010|NCT00212758|7185568|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6285011|NCT00212758|7185567|FG000|STARTED|Wash Out Period (2 Weeks)||8
6285012|NCT00212758|7185568|FG001|STARTED|Wash Out Period (2 Weeks)||9
6285013|NCT00212758|7185567|FG000|COMPLETED|Wash Out Period (2 Weeks)||8
6285014|NCT00212758|7185568|FG001|COMPLETED|Wash Out Period (2 Weeks)||9
6285015|NCT00212758|7185567|FG000|NOT COMPLETED|Wash Out Period (2 Weeks)||0
6285016|NCT00212758|7185568|FG001|NOT COMPLETED|Wash Out Period (2 Weeks)||0
6285017|NCT00212758|7185567|FG000|STARTED|Second Intervention (7 Days)||8
6285018|NCT00212758|7185568|FG001|STARTED|Second Intervention (7 Days)||9
6285019|NCT00212758|7185567|FG000|COMPLETED|Second Intervention (7 Days)||8
6285020|NCT00212758|7185568|FG001|COMPLETED|Second Intervention (7 Days)||9
6285021|NCT00212758|7185567|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6285022|NCT00212758|7185568|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6285023|NCT00212758|7185567|FG000|STARTED|Standard Therapy of GH (12 Months)||8
6285024|NCT00212758|7185568|FG001|STARTED|Standard Therapy of GH (12 Months)||9
6285025|NCT00212758|7185567|FG000|COMPLETED|Standard Therapy of GH (12 Months)||6
6285026|NCT00212758|7185568|FG001|COMPLETED|Standard Therapy of GH (12 Months)||8
6285027|NCT00212758|7185567|FG000|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
6285028|NCT00212758|7185568|FG001|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
6285029|NCT00212888|7185577|FG000|STARTED|Overall Study||19
6285030|NCT00212888|7185578|FG001|STARTED|Overall Study||18
6285031|NCT00212888|7185579|FG002|STARTED|Overall Study||15
6285032|NCT00212888|7185577|FG000|COMPLETED|Overall Study||16
6285033|NCT00212888|7185578|FG001|COMPLETED|Overall Study||18
6285034|NCT00212888|7185579|FG002|COMPLETED|Overall Study||14
6285035|NCT00212888|7185577|FG000|NOT COMPLETED|Overall Study||3
6285036|NCT00212888|7185578|FG001|NOT COMPLETED|Overall Study||0
6285037|NCT00212888|7185579|FG002|NOT COMPLETED|Overall Study||1
6285038|NCT00213135|7185592|FG000|STARTED|Overall Study||456
6285039|NCT00213135|7185593|FG001|STARTED|Overall Study||433
6285040|NCT00213135|7185594|FG002|STARTED|Overall Study||437
6285041|NCT00213135|7185592|FG000|COMPLETED|Overall Study||406
6285042|NCT00213135|7185593|FG001|COMPLETED|Overall Study||398
6285043|NCT00213135|7185594|FG002|COMPLETED|Overall Study||380
6285044|NCT00213135|7185592|FG000|NOT COMPLETED|Overall Study||50
6285045|NCT00213135|7185593|FG001|NOT COMPLETED|Overall Study||35
6285046|NCT00213135|7185594|FG002|NOT COMPLETED|Overall Study||57
6285047|NCT00213148|7185606|FG000|STARTED|Cycle 1 (1 Month)||77
6285048|NCT00213148|7185607|FG001|STARTED|Cycle 1 (1 Month)||0
6285049|NCT00213148|7185608|FG002|STARTED|Cycle 1 (1 Month)||79
6633105|NCT02287896|7561773|FG001|STARTED|Screening Visit V1||26
6633106|NCT02287896|7561772|FG000|COMPLETED|Screening Visit V1||36
6633107|NCT02287896|7561773|FG001|COMPLETED|Screening Visit V1||26
6633108|NCT02287896|7561772|FG000|NOT COMPLETED|Screening Visit V1||0
6633109|NCT02287896|7561773|FG001|NOT COMPLETED|Screening Visit V1||0
6633110|NCT02287896|7561772|FG000|STARTED|First Injection Visit||36
6633111|NCT02287896|7561773|FG001|STARTED|First Injection Visit||26
6633112|NCT02287896|7561772|FG000|COMPLETED|First Injection Visit||36
6633113|NCT02287896|7561773|FG001|COMPLETED|First Injection Visit||26
6633114|NCT02287896|7561772|FG000|NOT COMPLETED|First Injection Visit||0
6633115|NCT02287896|7561773|FG001|NOT COMPLETED|First Injection Visit||0
6633116|NCT02287896|7561772|FG000|STARTED|Second Injection Visit||36
6633117|NCT02287896|7561773|FG001|STARTED|Second Injection Visit||26
6633118|NCT02287896|7561772|FG000|COMPLETED|Second Injection Visit||36
6633119|NCT02287896|7561773|FG001|COMPLETED|Second Injection Visit||25
6633120|NCT02287896|7561772|FG000|NOT COMPLETED|Second Injection Visit||0
6633121|NCT02287896|7561773|FG001|NOT COMPLETED|Second Injection Visit||1
6633122|NCT02287909|7561789|FG000|STARTED|Overall Study||20
6633123|NCT02287909|7561790|FG001|STARTED|Overall Study||20
6633124|NCT02287909|7561791|FG002|STARTED|Overall Study||20
6633125|NCT02287909|7561792|FG003|STARTED|Overall Study||20
6633126|NCT02287909|7561789|FG000|COMPLETED|Overall Study||18
6633127|NCT02287909|7561790|FG001|COMPLETED|Overall Study||19
6633128|NCT02287909|7561791|FG002|COMPLETED|Overall Study||20
6633129|NCT02287909|7561792|FG003|COMPLETED|Overall Study||19
6633130|NCT02287909|7561789|FG000|NOT COMPLETED|Overall Study||2
6633131|NCT02287909|7561790|FG001|NOT COMPLETED|Overall Study||1
6633132|NCT02287909|7561791|FG002|NOT COMPLETED|Overall Study||0
6633133|NCT02287909|7561792|FG003|NOT COMPLETED|Overall Study||1
6633134|NCT02287922|7561806|FG000|STARTED|Overall Study||62
6633135|NCT02287922|7561807|FG001|STARTED|Overall Study||62
6633136|NCT02287922|7561808|FG002|STARTED|Overall Study||63
6633137|NCT02287922|7561809|FG003|STARTED|Overall Study||64
6633138|NCT02287922|7561806|FG000|COMPLETED|Overall Study||59
6633139|NCT02287922|7561807|FG001|COMPLETED|Overall Study||60
6633140|NCT02287922|7561808|FG002|COMPLETED|Overall Study||56
6633141|NCT02287922|7561809|FG003|COMPLETED|Overall Study||57
6633142|NCT02287922|7561806|FG000|NOT COMPLETED|Overall Study||3
6633143|NCT02287922|7561807|FG001|NOT COMPLETED|Overall Study||2
6633144|NCT02287922|7561808|FG002|NOT COMPLETED|Overall Study||7
6633145|NCT02287922|7561809|FG003|NOT COMPLETED|Overall Study||7
6633146|NCT02288091|7561820|FG000|STARTED|Overall Study||32
6633147|NCT02288091|7561820|FG000|Randomized/Treated|Overall Study||25
6633148|NCT02288091|7561820|FG000|COMPLETED|Overall Study||24
6633149|NCT02288091|7561820|FG000|NOT COMPLETED|Overall Study||8
6633150|NCT02288156|7561828|FG000|STARTED|Overall Study||20
6633151|NCT02288156|7561829|FG001|STARTED|Overall Study||20
6633152|NCT02288156|7561830|FG002|STARTED|Overall Study||20
6633153|NCT02288156|7561831|FG003|STARTED|Overall Study||20
6633154|NCT02288156|7561828|FG000|COMPLETED|Overall Study||16
6633155|NCT02288156|7561829|FG001|COMPLETED|Overall Study||16
6633156|NCT02288156|7561830|FG002|COMPLETED|Overall Study||18
6633157|NCT02288156|7561831|FG003|COMPLETED|Overall Study||18
6633158|NCT02288156|7561828|FG000|NOT COMPLETED|Overall Study||4
6633159|NCT02288156|7561829|FG001|NOT COMPLETED|Overall Study||4
6633160|NCT02288156|7561830|FG002|NOT COMPLETED|Overall Study||2
6633161|NCT02288156|7561831|FG003|NOT COMPLETED|Overall Study||2
6633162|NCT02288182|7561845|FG000|STARTED|Overall Study||25
6633163|NCT02288182|7561846|FG001|STARTED|Overall Study||27
6633164|NCT02288182|7561845|FG000|COMPLETED|Overall Study||25
6633165|NCT02288182|7561846|FG001|COMPLETED|Overall Study||25
6633166|NCT02288182|7561845|FG000|NOT COMPLETED|Overall Study||0
6633167|NCT02288182|7561846|FG001|NOT COMPLETED|Overall Study||2
6633168|NCT02288273|7561856|FG000|STARTED|Overall Study||61
6633169|NCT02288273|7561857|FG001|STARTED|Overall Study||56
6633170|NCT02288273|7561856|FG000|COMPLETED|Overall Study||53
6633171|NCT02288273|7561857|FG001|COMPLETED|Overall Study||48
6633172|NCT02288273|7561856|FG000|NOT COMPLETED|Overall Study||8
6633173|NCT02288273|7561857|FG001|NOT COMPLETED|Overall Study||8
6633174|NCT02288312|7561866|FG000|STARTED|Overall Study||6
6633175|NCT02288312|7561867|FG001|STARTED|Overall Study||6
6633176|NCT02288312|7561868|FG002|STARTED|Overall Study||6
6633177|NCT02288312|7561866|FG000|COMPLETED|Overall Study||5
6633178|NCT02288312|7561867|FG001|COMPLETED|Overall Study||6
6633179|NCT02288312|7561868|FG002|COMPLETED|Overall Study||6
6633180|NCT02288312|7561866|FG000|NOT COMPLETED|Overall Study||1
6633181|NCT02288312|7561867|FG001|NOT COMPLETED|Overall Study||0
6633182|NCT02288312|7561868|FG002|NOT COMPLETED|Overall Study||0
6633183|NCT02288325|7561876|FG000|STARTED|Run-in Period||644
6633184|NCT02288325|7561877|FG001|STARTED|Run-in Period||0
6633185|NCT02288325|7561878|FG002|STARTED|Run-in Period||0
6633186|NCT02288325|7561876|FG000|COMPLETED|Run-in Period||499
6633187|NCT02288325|7561877|FG001|COMPLETED|Run-in Period||0
6633188|NCT02288325|7561878|FG002|COMPLETED|Run-in Period||0
6633189|NCT02288325|7561876|FG000|NOT COMPLETED|Run-in Period||145
6633190|NCT02288325|7561877|FG001|NOT COMPLETED|Run-in Period||0
6633191|NCT02288325|7561878|FG002|NOT COMPLETED|Run-in Period||0
6633192|NCT02288325|7561876|FG000|STARTED|Stabilization Period|70 participants did not enter Stabilization Period (69 did not meet entry criteria; 1 other reason)|429
6633193|NCT02288325|7561877|FG001|STARTED|Stabilization Period||0
6285050|NCT00213148|7185609|FG003|STARTED|Cycle 1 (1 Month)||76
6285051|NCT00213148|7185610|FG004|STARTED|Cycle 1 (1 Month)||39
6285052|NCT00213148|7185606|FG000|COMPLETED|Cycle 1 (1 Month)||53
6285053|NCT00213148|7185607|FG001|COMPLETED|Cycle 1 (1 Month)||0
6285054|NCT00213148|7185608|FG002|COMPLETED|Cycle 1 (1 Month)||60
6285055|NCT00213148|7185609|FG003|COMPLETED|Cycle 1 (1 Month)||58
6285056|NCT00213148|7185610|FG004|COMPLETED|Cycle 1 (1 Month)||17
6285057|NCT00213148|7185606|FG000|NOT COMPLETED|Cycle 1 (1 Month)||24
6633194|NCT02288325|7561878|FG002|STARTED|Stabilization Period||0
6633195|NCT02288325|7561876|FG000|COMPLETED|Stabilization Period||331
6633196|NCT02288325|7561877|FG001|COMPLETED|Stabilization Period||0
6633197|NCT02288325|7561878|FG002|COMPLETED|Stabilization Period||0
6633198|NCT02288325|7561876|FG000|NOT COMPLETED|Stabilization Period||98
6633199|NCT02288325|7561877|FG001|NOT COMPLETED|Stabilization Period||0
6633200|NCT02288325|7561878|FG002|NOT COMPLETED|Stabilization Period||0
6633201|NCT02288325|7561876|FG000|STARTED|Double-blind Treatment Period||0
6633202|NCT02288325|7561877|FG001|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|159
6633203|NCT02288325|7561878|FG002|STARTED|Double-blind Treatment Period|7 participants did not enter Double-Blind Period (2 did not meet entry criteria; 5 other reasons)|165
6633204|NCT02288325|7561876|FG000|COMPLETED|Double-blind Treatment Period||0
6633205|NCT02288325|7561877|FG001|COMPLETED|Double-blind Treatment Period||135
6633206|NCT02288325|7561878|FG002|COMPLETED|Double-blind Treatment Period||139
6633207|NCT02288325|7561876|FG000|NOT COMPLETED|Double-blind Treatment Period||0
6633208|NCT02288325|7561877|FG001|NOT COMPLETED|Double-blind Treatment Period||24
6633209|NCT02288325|7561878|FG002|NOT COMPLETED|Double-blind Treatment Period||26
6633210|NCT02288364|7561887|FG000|STARTED|Overall Study||42
6633211|NCT02288364|7561888|FG001|STARTED|Overall Study||44
6633212|NCT02288364|7561887|FG000|COMPLETED|Overall Study||42
6633213|NCT02288364|7561888|FG001|COMPLETED|Overall Study||44
6633214|NCT02288364|7561887|FG000|NOT COMPLETED|Overall Study||0
6633215|NCT02288364|7561888|FG001|NOT COMPLETED|Overall Study||0
6633216|NCT02288377|7561896|FG000|STARTED|Overall Study||26
6633217|NCT02288377|7561897|FG001|STARTED|Overall Study||27
6633218|NCT02288377|7561896|FG000|COMPLETED|Overall Study||25
6633219|NCT02288377|7561897|FG001|COMPLETED|Overall Study||27
6633220|NCT02288377|7561896|FG000|NOT COMPLETED|Overall Study||1
6633221|NCT02288377|7561897|FG001|NOT COMPLETED|Overall Study||0
6633222|NCT02288559|7561907|FG000|STARTED|Overall Study||10
6633223|NCT02288559|7561908|FG001|STARTED|Overall Study||11
6633224|NCT02288559|7561909|FG002|STARTED|Overall Study||46
6633225|NCT02288559|7561910|FG003|STARTED|Overall Study||22
6633226|NCT02288559|7561907|FG000|COMPLETED|Overall Study||9
6633227|NCT02288559|7561908|FG001|COMPLETED|Overall Study||10
6633228|NCT02288559|7561909|FG002|COMPLETED|Overall Study||35
6633229|NCT02288559|7561910|FG003|COMPLETED|Overall Study||20
6633230|NCT02288559|7561907|FG000|NOT COMPLETED|Overall Study||1
6633231|NCT02288559|7561908|FG001|NOT COMPLETED|Overall Study||1
6633232|NCT02288559|7561909|FG002|NOT COMPLETED|Overall Study||11
6633233|NCT02288559|7561910|FG003|NOT COMPLETED|Overall Study||2
6633234|NCT02288819|7561922|FG000|STARTED|Overall Study||50
6633235|NCT02288819|7561922|FG000|COMPLETED|Overall Study||50
6633236|NCT02288819|7561922|FG000|NOT COMPLETED|Overall Study||0
6633237|NCT02289079|7561928|FG000|STARTED|Overall Study||30
6633238|NCT02289079|7561929|FG001|STARTED|Overall Study||30
6633239|NCT02289079|7561928|FG000|COMPLETED|Overall Study||28
6633240|NCT02289079|7561929|FG001|COMPLETED|Overall Study||29
6633241|NCT02289079|7561928|FG000|NOT COMPLETED|Overall Study||2
6633242|NCT02289079|7561929|FG001|NOT COMPLETED|Overall Study||1
6633243|NCT02289105|7561937|FG000|STARTED|Overall Study||642
6633244|NCT02289105|7561938|FG001|STARTED|Overall Study||637
6633245|NCT02289105|7561937|FG000|COMPLETED|Overall Study||642
6633246|NCT02289105|7561938|FG001|COMPLETED|Overall Study||637
6633247|NCT02289105|7561937|FG000|NOT COMPLETED|Overall Study||0
6633248|NCT02289105|7561938|FG001|NOT COMPLETED|Overall Study||0
6633249|NCT02289157|7561946|FG000|STARTED|Overall Study||222
6633250|NCT02289157|7561947|FG001|STARTED|Overall Study||219
6633251|NCT02289157|7561946|FG000|No Post op Check or Follow up Phone Call|Overall Study||2
6633252|NCT02289157|7561947|FG001|No Post op Check or Follow up Phone Call|Overall Study||4
6633253|NCT02289157|7561946|FG000|COMPLETED|Overall Study||222
6633254|NCT02289157|7561947|FG001|COMPLETED|Overall Study||219
6633255|NCT02289157|7561946|FG000|NOT COMPLETED|Overall Study||0
6633256|NCT02289157|7561947|FG001|NOT COMPLETED|Overall Study||0
6633257|NCT02289222|7561953|FG000|STARTED|Overall Study||48
6633258|NCT02289222|7561953|FG000|COMPLETED|Overall Study||48
6633259|NCT02289222|7561953|FG000|NOT COMPLETED|Overall Study||0
6655622|NCT02454127|7585774|FG000|STARTED|Overall Study||40
6655623|NCT02454127|7585775|FG001|STARTED|Overall Study||40
6655624|NCT02454127|7585776|FG002|STARTED|Overall Study||40
6655625|NCT02454127|7585777|FG003|STARTED|Overall Study||40
6655626|NCT02454127|7585774|FG000|COMPLETED|Overall Study||21
6655627|NCT02454127|7585775|FG001|COMPLETED|Overall Study||26
6655628|NCT02454127|7585776|FG002|COMPLETED|Overall Study||26
6655629|NCT02454127|7585777|FG003|COMPLETED|Overall Study||20
6655630|NCT02454127|7585774|FG000|NOT COMPLETED|Overall Study||19
6655631|NCT02454127|7585775|FG001|NOT COMPLETED|Overall Study||14
6655632|NCT02454127|7585776|FG002|NOT COMPLETED|Overall Study||14
6655633|NCT02454127|7585777|FG003|NOT COMPLETED|Overall Study||20
6285058|NCT00213148|7185607|FG001|NOT COMPLETED|Cycle 1 (1 Month)||0
6285059|NCT00213148|7185608|FG002|NOT COMPLETED|Cycle 1 (1 Month)||19
6633260|NCT02289352|7561960|FG000|STARTED|Overall Study||199
6633261|NCT02289352|7561961|FG001|STARTED|Overall Study||199
6633262|NCT02289352|7561962|FG002|STARTED|Overall Study||64
6633263|NCT02289352|7561960|FG000|Safety Population|Overall Study||199
6633264|NCT02289352|7561961|FG001|Safety Population|Overall Study||199
6633265|NCT02289352|7561962|FG002|Safety Population|Overall Study||64
6633266|NCT02289352|7561960|FG000|mITT Population|Overall Study||191
6633267|NCT02289352|7561961|FG001|mITT Population|Overall Study||193
6633268|NCT02289352|7561962|FG002|mITT Population|Overall Study||58
6633269|NCT02289352|7561960|FG000|PP Population|Overall Study||173
6633270|NCT02289352|7561961|FG001|PP Population|Overall Study||173
6633271|NCT02289352|7561962|FG002|PP Population|Overall Study||54
6633272|NCT02289352|7561960|FG000|COMPLETED|Overall Study||198
6633273|NCT02289352|7561961|FG001|COMPLETED|Overall Study||198
6633274|NCT02289352|7561962|FG002|COMPLETED|Overall Study||64
6633275|NCT02289352|7561960|FG000|NOT COMPLETED|Overall Study||1
6633276|NCT02289352|7561961|FG001|NOT COMPLETED|Overall Study||1
6633277|NCT02289352|7561962|FG002|NOT COMPLETED|Overall Study||0
6633278|NCT02289417|7561974|FG000|STARTED|Placebo-Controlled Phase Weeks 0-12||58
6633279|NCT02289417|7561975|FG001|STARTED|Placebo-Controlled Phase Weeks 0-12||57
6633280|NCT02289417|7561976|FG002|STARTED|Placebo-Controlled Phase Weeks 0-12||55
6633281|NCT02289417|7561977|FG003|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6633282|NCT02289417|7561978|FG004|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6633283|NCT02289417|7561979|FG005|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6633284|NCT02289417|7561980|FG006|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6633285|NCT02289417|7561981|FG007|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6633286|NCT02289417|7561982|FG008|STARTED|Placebo-Controlled Phase Weeks 0-12||0
6633287|NCT02289417|7561974|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-12||51
6633288|NCT02289417|7561975|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-12||53
6633289|NCT02289417|7561976|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-12||52
6633290|NCT02289417|7561977|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633291|NCT02289417|7561978|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633292|NCT02289417|7561979|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633293|NCT02289417|7561980|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633294|NCT02289417|7561981|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633295|NCT02289417|7561982|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633296|NCT02289417|7561974|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||7
6633297|NCT02289417|7561975|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||4
6633298|NCT02289417|7561976|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||3
6633299|NCT02289417|7561977|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633300|NCT02289417|7561978|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633301|NCT02289417|7561979|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633302|NCT02289417|7561980|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633303|NCT02289417|7561981|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633304|NCT02289417|7561982|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-12||0
6633305|NCT02289417|7561974|FG000|STARTED|Active Treatment Phase Weeks 12-52||0
6633306|NCT02289417|7561975|FG001|STARTED|Active Treatment Phase Weeks 12-52||41
6633307|NCT02289417|7561976|FG002|STARTED|Active Treatment Phase Weeks 12-52||42
6633308|NCT02289417|7561977|FG003|STARTED|Active Treatment Phase Weeks 12-52||26
6633309|NCT02289417|7561978|FG004|STARTED|Active Treatment Phase Weeks 12-52||25
6633310|NCT02289417|7561979|FG005|STARTED|Active Treatment Phase Weeks 12-52|1 participant went only to Week 20|12
6633311|NCT02289417|7561980|FG006|STARTED|Active Treatment Phase Weeks 12-52|Week 12 TMS were missing for 3 participants|7
6633312|NCT02289417|7561981|FG007|STARTED|Active Treatment Phase Weeks 12-52||0
6633313|NCT02289417|7561982|FG008|STARTED|Active Treatment Phase Weeks 12-52||0
6633314|NCT02289417|7561974|FG000|COMPLETED|Active Treatment Phase Weeks 12-52||0
6633315|NCT02289417|7561975|FG001|COMPLETED|Active Treatment Phase Weeks 12-52||39
6633316|NCT02289417|7561976|FG002|COMPLETED|Active Treatment Phase Weeks 12-52||32
6633317|NCT02289417|7561977|FG003|COMPLETED|Active Treatment Phase Weeks 12-52||17
6633318|NCT02289417|7561978|FG004|COMPLETED|Active Treatment Phase Weeks 12-52||20
6633319|NCT02289417|7561979|FG005|COMPLETED|Active Treatment Phase Weeks 12-52||7
6633320|NCT02289417|7561980|FG006|COMPLETED|Active Treatment Phase Weeks 12-52||5
6633321|NCT02289417|7561981|FG007|COMPLETED|Active Treatment Phase Weeks 12-52||0
6633322|NCT02289417|7561982|FG008|COMPLETED|Active Treatment Phase Weeks 12-52||0
6633323|NCT02289417|7561974|FG000|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
6633324|NCT02289417|7561975|FG001|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
6633325|NCT02289417|7561976|FG002|NOT COMPLETED|Active Treatment Phase Weeks 12-52||10
6633326|NCT02289417|7561977|FG003|NOT COMPLETED|Active Treatment Phase Weeks 12-52||9
6633327|NCT02289417|7561978|FG004|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
6633328|NCT02289417|7561979|FG005|NOT COMPLETED|Active Treatment Phase Weeks 12-52||5
6633329|NCT02289417|7561980|FG006|NOT COMPLETED|Active Treatment Phase Weeks 12-52||2
6633330|NCT02289417|7561981|FG007|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
6633331|NCT02289417|7561982|FG008|NOT COMPLETED|Active Treatment Phase Weeks 12-52||0
6633332|NCT02289417|7561974|FG000|STARTED|Extension Phase Weeks 52-104||0
6633333|NCT02289417|7561975|FG001|STARTED|Extension Phase Weeks 52-104||0
6633334|NCT02289417|7561976|FG002|STARTED|Extension Phase Weeks 52-104||0
6633335|NCT02289417|7561977|FG003|STARTED|Extension Phase Weeks 52-104||0
6633336|NCT02289417|7561978|FG004|STARTED|Extension Phase Weeks 52-104||0
6285060|NCT00213148|7185609|FG003|NOT COMPLETED|Cycle 1 (1 Month)||18
6285061|NCT00213148|7185610|FG004|NOT COMPLETED|Cycle 1 (1 Month)||22
6285062|NCT00213148|7185606|FG000|STARTED|Cycle 2 (1 Month)||43
6285063|NCT00213148|7185607|FG001|STARTED|Cycle 2 (1 Month)||10
6285064|NCT00213148|7185608|FG002|STARTED|Cycle 2 (1 Month)||42
6285065|NCT00213148|7185609|FG003|STARTED|Cycle 2 (1 Month)||52
6285066|NCT00213148|7185610|FG004|STARTED|Cycle 2 (1 Month)||41
6285067|NCT00213148|7185606|FG000|COMPLETED|Cycle 2 (1 Month)||29
6285068|NCT00213148|7185607|FG001|COMPLETED|Cycle 2 (1 Month)||4
6285069|NCT00213148|7185608|FG002|COMPLETED|Cycle 2 (1 Month)||28
6285070|NCT00213148|7185609|FG003|COMPLETED|Cycle 2 (1 Month)||33
6285071|NCT00213148|7185610|FG004|COMPLETED|Cycle 2 (1 Month)||11
6285072|NCT00213148|7185606|FG000|NOT COMPLETED|Cycle 2 (1 Month)||14
6285073|NCT00213148|7185607|FG001|NOT COMPLETED|Cycle 2 (1 Month)||6
6285074|NCT00213148|7185608|FG002|NOT COMPLETED|Cycle 2 (1 Month)||14
6285075|NCT00213148|7185609|FG003|NOT COMPLETED|Cycle 2 (1 Month)||19
6285076|NCT00213148|7185610|FG004|NOT COMPLETED|Cycle 2 (1 Month)||30
6285077|NCT00213148|7185606|FG000|STARTED|Cycle 3 (1 Month)||23
6285078|NCT00213148|7185607|FG001|STARTED|Cycle 3 (1 Month)||10
6285079|NCT00213148|7185608|FG002|STARTED|Cycle 3 (1 Month)||26
6285080|NCT00213148|7185609|FG003|STARTED|Cycle 3 (1 Month)||24
6285081|NCT00213148|7185610|FG004|STARTED|Cycle 3 (1 Month)||22
6285082|NCT00213148|7185606|FG000|COMPLETED|Cycle 3 (1 Month)||23
6285083|NCT00213148|7185607|FG001|COMPLETED|Cycle 3 (1 Month)||8
6285084|NCT00213148|7185608|FG002|COMPLETED|Cycle 3 (1 Month)||25
6285085|NCT00213148|7185609|FG003|COMPLETED|Cycle 3 (1 Month)||23
6285086|NCT00213148|7185610|FG004|COMPLETED|Cycle 3 (1 Month)||21
6285087|NCT00213148|7185606|FG000|NOT COMPLETED|Cycle 3 (1 Month)||0
6285088|NCT00213148|7185607|FG001|NOT COMPLETED|Cycle 3 (1 Month)||2
6285089|NCT00213148|7185608|FG002|NOT COMPLETED|Cycle 3 (1 Month)||1
6285090|NCT00213148|7185609|FG003|NOT COMPLETED|Cycle 3 (1 Month)||1
6285091|NCT00213148|7185610|FG004|NOT COMPLETED|Cycle 3 (1 Month)||1
6285092|NCT00213239|7185632|FG000|STARTED|Overall Study||32
6285093|NCT00213239|7185633|FG001|STARTED|Overall Study||32
6285094|NCT00213239|7185632|FG000|COMPLETED|Overall Study||32
6285095|NCT00213239|7185633|FG001|COMPLETED|Overall Study||32
6285096|NCT00213239|7185632|FG000|NOT COMPLETED|Overall Study||0
6285097|NCT00213239|7185633|FG001|NOT COMPLETED|Overall Study||0
6285098|NCT00213980|7185641|FG000|STARTED|Overall Study||32
6285099|NCT00213980|7185642|FG001|STARTED|Overall Study||36
6285100|NCT00213980|7185641|FG000|COMPLETED|Overall Study||26
6285101|NCT00213980|7185642|FG001|COMPLETED|Overall Study||29
6633337|NCT02289417|7561979|FG005|STARTED|Extension Phase Weeks 52-104||0
6633338|NCT02289417|7561980|FG006|STARTED|Extension Phase Weeks 52-104||0
6285102|NCT00213980|7185641|FG000|NOT COMPLETED|Overall Study||6
6285103|NCT00213980|7185642|FG001|NOT COMPLETED|Overall Study||7
6285104|NCT00214019|7185648|FG000|STARTED|Overall Study||36
6285105|NCT00214019|7185648|FG000|Placebo/Placebo Arm|Overall Study||6
6285106|NCT00214019|7185648|FG000|Placebo/Salmeterol Arm|Overall Study||6
6285107|NCT00214019|7185648|FG000|Fluticasone/Placebo Arm|Overall Study||6
6285108|NCT00214019|7185648|FG000|Fluticason/Salmeterol Arm|Overall Study||6
6285109|NCT00214019|7185648|FG000|COMPLETED|Overall Study||6
6285110|NCT00214019|7185648|FG000|NOT COMPLETED|Overall Study||30
6285111|NCT00214045|7185657|FG000|STARTED|Overall Study||18
6285112|NCT00214045|7185658|FG001|STARTED|Overall Study||18
6285113|NCT00214045|7185657|FG000|COMPLETED|Overall Study||18
6285114|NCT00214045|7185658|FG001|COMPLETED|Overall Study||18
6285115|NCT00214045|7185657|FG000|NOT COMPLETED|Overall Study||0
6285116|NCT00214045|7185658|FG001|NOT COMPLETED|Overall Study||0
6373866|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373867|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373868|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373869|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373870|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373871|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
6373872|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373873|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373874|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373875|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
6373876|NCT00747474|7284553|FG000|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373877|NCT00747474|7284554|FG001|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373878|NCT00747474|7284555|FG002|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373879|NCT00747474|7284556|FG003|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373880|NCT00747474|7284557|FG004|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373881|NCT00747474|7284558|FG005|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373882|NCT00747474|7284559|FG006|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373883|NCT00747474|7284560|FG007|STARTED|Cohort 9 (35 mg/m^2) Period||0
6399259|NCT00879814|7311971|FG000|STARTED|Overall Study||12
6373884|NCT00747474|7284561|FG008|STARTED|Cohort 9 (35 mg/m^2) Period||4
6373885|NCT00747474|7284562|FG009|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373886|NCT00747474|7284563|FG010|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373887|NCT00747474|7284564|FG011|STARTED|Cohort 9 (35 mg/m^2) Period||0
6373888|NCT00747474|7284553|FG000|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373889|NCT00747474|7284554|FG001|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373890|NCT00747474|7284555|FG002|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373891|NCT00747474|7284556|FG003|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373892|NCT00747474|7284557|FG004|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6285117|NCT00214097|7185667|FG000|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|101
6285118|NCT00214097|7185668|FG001|STARTED|Overall Study|Escalation to the next higher level will occur when > 20 pt yrs of F/U and > 5 pts followed >1 yr|111
6285119|NCT00214097|7185669|FG002|STARTED|Overall Study||135
6285120|NCT00214097|7185667|FG000|COMPLETED|Overall Study||101
6285121|NCT00214097|7185668|FG001|COMPLETED|Overall Study||111
6285122|NCT00214097|7185669|FG002|COMPLETED|Overall Study||135
6285123|NCT00214097|7185667|FG000|NOT COMPLETED|Overall Study||0
6285124|NCT00214097|7185668|FG001|NOT COMPLETED|Overall Study||0
6285125|NCT00214097|7185669|FG002|NOT COMPLETED|Overall Study||0
6285126|NCT00214136|7185683|FG000|STARTED|Overall Study||30
6285127|NCT00214136|7185683|FG000|COMPLETED|Overall Study||25
6285128|NCT00214136|7185683|FG000|NOT COMPLETED|Overall Study||5
6285129|NCT00214201|7185689|FG000|STARTED|Overall Study||20
6285130|NCT00214201|7185690|FG001|STARTED|Overall Study||20
6285131|NCT00214201|7185689|FG000|COMPLETED|Overall Study||18
6285132|NCT00214201|7185690|FG001|COMPLETED|Overall Study||18
6285133|NCT00214201|7185689|FG000|NOT COMPLETED|Overall Study||2
6285134|NCT00214201|7185690|FG001|NOT COMPLETED|Overall Study||2
6285135|NCT00214383|7185699|FG000|STARTED|Overall Study||148
6285136|NCT00214383|7185700|FG001|STARTED|Overall Study||153
6633339|NCT02289417|7561981|FG007|STARTED|Extension Phase Weeks 52-104||45
6633340|NCT02289417|7561982|FG008|STARTED|Extension Phase Weeks 52-104||54
6633341|NCT02289417|7561974|FG000|COMPLETED|Extension Phase Weeks 52-104||0
6633342|NCT02289417|7561975|FG001|COMPLETED|Extension Phase Weeks 52-104||0
6633343|NCT02289417|7561976|FG002|COMPLETED|Extension Phase Weeks 52-104||0
6633344|NCT02289417|7561977|FG003|COMPLETED|Extension Phase Weeks 52-104||0
6633345|NCT02289417|7561978|FG004|COMPLETED|Extension Phase Weeks 52-104||0
6633346|NCT02289417|7561979|FG005|COMPLETED|Extension Phase Weeks 52-104||0
6633347|NCT02289417|7561980|FG006|COMPLETED|Extension Phase Weeks 52-104||0
6633348|NCT02289417|7561981|FG007|COMPLETED|Extension Phase Weeks 52-104||38
6633349|NCT02289417|7561982|FG008|COMPLETED|Extension Phase Weeks 52-104||48
6633350|NCT02289417|7561974|FG000|NOT COMPLETED|Extension Phase Weeks 52-104||0
6633351|NCT02289417|7561975|FG001|NOT COMPLETED|Extension Phase Weeks 52-104||0
6633352|NCT02289417|7561976|FG002|NOT COMPLETED|Extension Phase Weeks 52-104||0
6633353|NCT02289417|7561977|FG003|NOT COMPLETED|Extension Phase Weeks 52-104||0
6633354|NCT02289417|7561978|FG004|NOT COMPLETED|Extension Phase Weeks 52-104||0
6633355|NCT02289417|7561979|FG005|NOT COMPLETED|Extension Phase Weeks 52-104||0
6633356|NCT02289417|7561980|FG006|NOT COMPLETED|Extension Phase Weeks 52-104||0
6633357|NCT02289417|7561981|FG007|NOT COMPLETED|Extension Phase Weeks 52-104||7
6633358|NCT02289417|7561982|FG008|NOT COMPLETED|Extension Phase Weeks 52-104||6
6633359|NCT02289456|7561998|FG000|STARTED|Induction Period||40
6633360|NCT02289456|7561998|FG000|Treated Population|Induction Period||40
6633361|NCT02289456|7561998|FG000|COMPLETED|Induction Period||16
6633362|NCT02289456|7561998|FG000|NOT COMPLETED|Induction Period||24
6633363|NCT02289456|7561998|FG000|STARTED|Monotherapy Period||16
6633364|NCT02289456|7561998|FG000|COMPLETED|Monotherapy Period||0
6633365|NCT02289456|7561998|FG000|NOT COMPLETED|Monotherapy Period||16
6633366|NCT02289469|7562009|FG000|STARTED|Overall Study||250
6633367|NCT02289469|7562010|FG001|STARTED|Overall Study||244
6633368|NCT02289469|7562009|FG000|COMPLETED|Overall Study||244
6633369|NCT02289469|7562010|FG001|COMPLETED|Overall Study||244
6633370|NCT02289469|7562009|FG000|NOT COMPLETED|Overall Study||6
6633371|NCT02289469|7562010|FG001|NOT COMPLETED|Overall Study||0
6633372|NCT02289690|7562026|FG000|STARTED|Overall Study||4
6633373|NCT02289690|7562027|FG001|STARTED|Overall Study||3
6633374|NCT02289690|7562028|FG002|STARTED|Overall Study||4
6633375|NCT02289690|7562029|FG003|STARTED|Overall Study||3
6285137|NCT00214383|7185699|FG000|COMPLETED|Overall Study||132
6285138|NCT00214383|7185700|FG001|COMPLETED|Overall Study||127
6285139|NCT00214383|7185699|FG000|NOT COMPLETED|Overall Study||16
6285140|NCT00214383|7185700|FG001|NOT COMPLETED|Overall Study||26
6285141|NCT00214422|7185709|FG000|STARTED|Overall Study||12
6285142|NCT00214422|7185710|FG001|STARTED|Overall Study||3
6285143|NCT00214422|7185711|FG002|STARTED|Overall Study||4
6285144|NCT00214422|7185709|FG000|COMPLETED|Overall Study||7
6285145|NCT00214422|7185710|FG001|COMPLETED|Overall Study||2
6285146|NCT00214422|7185711|FG002|COMPLETED|Overall Study||3
6285147|NCT00214422|7185709|FG000|NOT COMPLETED|Overall Study||5
6285148|NCT00214422|7185710|FG001|NOT COMPLETED|Overall Study||1
6285149|NCT00214422|7185711|FG002|NOT COMPLETED|Overall Study||1
6285150|NCT00214461|7185727|FG000|STARTED|Overall Study||12
6285151|NCT00214461|7185728|FG001|STARTED|Overall Study||12
6285152|NCT00214461|7185729|FG002|STARTED|Overall Study||12
6285153|NCT00214461|7185730|FG003|STARTED|Overall Study||12
6285154|NCT00214461|7185727|FG000|COMPLETED|Overall Study||12
6285155|NCT00214461|7185728|FG001|COMPLETED|Overall Study||12
6285156|NCT00214461|7185729|FG002|COMPLETED|Overall Study||10
6285157|NCT00214461|7185730|FG003|COMPLETED|Overall Study||11
6285158|NCT00214461|7185727|FG000|NOT COMPLETED|Overall Study||0
6285159|NCT00214461|7185728|FG001|NOT COMPLETED|Overall Study||0
6633376|NCT02289690|7562030|FG004|STARTED|Overall Study||8
6633377|NCT02289690|7562031|FG005|STARTED|Overall Study||14
6633378|NCT02289690|7562032|FG006|STARTED|Overall Study||4
6633379|NCT02289690|7562033|FG007|STARTED|Overall Study||61
6633380|NCT02289690|7562034|FG008|STARTED|Overall Study||59
6633381|NCT02289690|7562035|FG009|STARTED|Overall Study||61
6633382|NCT02289690|7562026|FG000|Received Study Drug|Overall Study||4
6285160|NCT00214461|7185729|FG002|NOT COMPLETED|Overall Study||2
6285161|NCT00214461|7185730|FG003|NOT COMPLETED|Overall Study||1
6285162|NCT00214487|7185742|FG000|STARTED|Overall Study||43
6285163|NCT00214487|7185743|FG001|STARTED|Overall Study||43
6285164|NCT00214487|7185742|FG000|COMPLETED|Overall Study||38
6285165|NCT00214487|7185743|FG001|COMPLETED|Overall Study||40
6285166|NCT00214487|7185742|FG000|NOT COMPLETED|Overall Study||5
6285167|NCT00214487|7185743|FG001|NOT COMPLETED|Overall Study||3
6285168|NCT00214526|7185751|FG000|STARTED|Randomized||56
6285169|NCT00214526|7185752|FG001|STARTED|Randomized||56
6285170|NCT00214526|7185751|FG000|COMPLETED|Randomized||55
6285171|NCT00214526|7185752|FG001|COMPLETED|Randomized||54
6285172|NCT00214526|7185751|FG000|NOT COMPLETED|Randomized||1
6285173|NCT00214526|7185752|FG001|NOT COMPLETED|Randomized||2
6285174|NCT00214526|7185751|FG000|STARTED|Treatment Period||55
6285175|NCT00214526|7185752|FG001|STARTED|Treatment Period||54
6285176|NCT00214526|7185751|FG000|COMPLETED|Treatment Period||53
6285177|NCT00214526|7185752|FG001|COMPLETED|Treatment Period||49
6285178|NCT00214526|7185751|FG000|NOT COMPLETED|Treatment Period||2
6285179|NCT00214526|7185752|FG001|NOT COMPLETED|Treatment Period||5
6285180|NCT00214526|7185751|FG000|STARTED|Post-Treatment Period||53
6285181|NCT00214526|7185752|FG001|STARTED|Post-Treatment Period||49
6285182|NCT00214526|7185751|FG000|COMPLETED|Post-Treatment Period||52
6285183|NCT00214526|7185752|FG001|COMPLETED|Post-Treatment Period||49
6633383|NCT02289690|7562027|FG001|Received Study Drug|Overall Study||3
6633384|NCT02289690|7562028|FG002|Received Study Drug|Overall Study||4
6285184|NCT00214526|7185751|FG000|NOT COMPLETED|Post-Treatment Period||1
6285185|NCT00214526|7185752|FG001|NOT COMPLETED|Post-Treatment Period||0
6285186|NCT00214539|7185762|FG000|STARTED|Randomized||17
6285187|NCT00214539|7185763|FG001|STARTED|Randomized||17
6285188|NCT00214539|7185762|FG000|COMPLETED|Randomized||15
6285189|NCT00214539|7185763|FG001|COMPLETED|Randomized||17
6285190|NCT00214539|7185762|FG000|NOT COMPLETED|Randomized||2
6285191|NCT00214539|7185763|FG001|NOT COMPLETED|Randomized||0
6285192|NCT00214539|7185762|FG000|STARTED|Treatment Period||15
6285193|NCT00214539|7185763|FG001|STARTED|Treatment Period||17
6285194|NCT00214539|7185762|FG000|COMPLETED|Treatment Period||15
6285195|NCT00214539|7185763|FG001|COMPLETED|Treatment Period||17
6285196|NCT00214539|7185762|FG000|NOT COMPLETED|Treatment Period||0
6285197|NCT00214539|7185763|FG001|NOT COMPLETED|Treatment Period||0
6285198|NCT00214539|7185762|FG000|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
6285199|NCT00214539|7185763|FG001|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
6285200|NCT00214539|7185762|FG000|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
6285201|NCT00214539|7185763|FG001|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
6285202|NCT00214539|7185762|FG000|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
6285203|NCT00214539|7185763|FG001|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
6285204|NCT00214539|7185762|FG000|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
6285205|NCT00214539|7185763|FG001|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
6285206|NCT00214539|7185762|FG000|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
6285207|NCT00214539|7185763|FG001|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
6285208|NCT00214539|7185762|FG000|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
6285209|NCT00214539|7185763|FG001|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
6285210|NCT00214786|7185773|FG000|STARTED|Overall Study||4
6285211|NCT00214786|7185773|FG000|COMPLETED|Overall Study||1
6285212|NCT00214786|7185773|FG000|NOT COMPLETED|Overall Study||3
6285213|NCT00214890|7185779|FG000|STARTED|Overall Study||10
6285214|NCT00214890|7185780|FG001|STARTED|Overall Study||11
6285215|NCT00214890|7185779|FG000|COMPLETED|Overall Study||10
6285216|NCT00214890|7185780|FG001|COMPLETED|Overall Study||11
6285217|NCT00214890|7185779|FG000|NOT COMPLETED|Overall Study||0
6285218|NCT00214890|7185780|FG001|NOT COMPLETED|Overall Study||0
6285219|NCT00214903|7185790|FG000|STARTED|Overall Study||10043
6285220|NCT00214903|7185791|FG001|STARTED|Overall Study||13384
6285221|NCT00214903|7185792|FG002|STARTED|Overall Study||4113
6285222|NCT00214903|7185793|FG003|STARTED|Overall Study||3057
6285223|NCT00214903|7185790|FG000|COMPLETED|Overall Study||10043
6285224|NCT00214903|7185791|FG001|COMPLETED|Overall Study||13384
6285225|NCT00214903|7185792|FG002|COMPLETED|Overall Study||4113
6285226|NCT00214903|7185793|FG003|COMPLETED|Overall Study||3057
6285227|NCT00214903|7185790|FG000|NOT COMPLETED|Overall Study||0
6285228|NCT00214903|7185791|FG001|NOT COMPLETED|Overall Study||0
6285229|NCT00214903|7185792|FG002|NOT COMPLETED|Overall Study||0
6285230|NCT00214903|7185793|FG003|NOT COMPLETED|Overall Study||0
6285231|NCT00215137|7185803|FG000|STARTED|Open Label Escitalopram||14
6285232|NCT00215137|7185804|FG001|STARTED|Open Label Escitalopram||0
6285233|NCT00215137|7185805|FG002|STARTED|Open Label Escitalopram||0
6285234|NCT00215137|7185803|FG000|COMPLETED|Open Label Escitalopram||13
6285235|NCT00215137|7185804|FG001|COMPLETED|Open Label Escitalopram||0
6285236|NCT00215137|7185805|FG002|COMPLETED|Open Label Escitalopram||0
6285237|NCT00215137|7185803|FG000|NOT COMPLETED|Open Label Escitalopram||1
6285238|NCT00215137|7185804|FG001|NOT COMPLETED|Open Label Escitalopram||0
6285239|NCT00215137|7185805|FG002|NOT COMPLETED|Open Label Escitalopram||0
6285240|NCT00215137|7185803|FG000|STARTED|Randomization Period||0
6285241|NCT00215137|7185804|FG001|STARTED|Randomization Period||7
6285242|NCT00215137|7185805|FG002|STARTED|Randomization Period||5
6285243|NCT00215137|7185803|FG000|COMPLETED|Randomization Period||0
6285244|NCT00215137|7185804|FG001|COMPLETED|Randomization Period||5
6633385|NCT02289690|7562029|FG003|Received Study Drug|Overall Study||3
6285245|NCT00215137|7185805|FG002|COMPLETED|Randomization Period||5
6285246|NCT00215137|7185803|FG000|NOT COMPLETED|Randomization Period||0
6285247|NCT00215137|7185804|FG001|NOT COMPLETED|Randomization Period||2
6285248|NCT00215137|7185805|FG002|NOT COMPLETED|Randomization Period||0
6285249|NCT00215150|7185813|FG000|STARTED|Open Label Phase|Number of subjects consented|51
6633386|NCT02289690|7562030|FG004|Received Study Drug|Overall Study||8
6633387|NCT02289690|7562031|FG005|Received Study Drug|Overall Study||14
6633388|NCT02289690|7562032|FG006|Received Study Drug|Overall Study||4
6633389|NCT02289690|7562033|FG007|Received Study Drug|Overall Study||60
6633390|NCT02289690|7562034|FG008|Received Study Drug|Overall Study||58
6633391|NCT02289690|7562035|FG009|Received Study Drug|Overall Study||60
6633392|NCT02289690|7562026|FG000|COMPLETED|Overall Study||0
6633393|NCT02289690|7562027|FG001|COMPLETED|Overall Study||0
6633394|NCT02289690|7562028|FG002|COMPLETED|Overall Study||0
6633395|NCT02289690|7562029|FG003|COMPLETED|Overall Study||0
6633396|NCT02289690|7562030|FG004|COMPLETED|Overall Study||0
6633397|NCT02289690|7562031|FG005|COMPLETED|Overall Study||0
6633398|NCT02289690|7562032|FG006|COMPLETED|Overall Study||0
6633399|NCT02289690|7562033|FG007|COMPLETED|Overall Study||0
6633400|NCT02289690|7562034|FG008|COMPLETED|Overall Study||0
6633401|NCT02289690|7562035|FG009|COMPLETED|Overall Study||0
6633402|NCT02289690|7562026|FG000|NOT COMPLETED|Overall Study||4
6633403|NCT02289690|7562027|FG001|NOT COMPLETED|Overall Study||3
6633404|NCT02289690|7562028|FG002|NOT COMPLETED|Overall Study||4
6633405|NCT02289690|7562029|FG003|NOT COMPLETED|Overall Study||3
6633406|NCT02289690|7562030|FG004|NOT COMPLETED|Overall Study||8
6633407|NCT02289690|7562031|FG005|NOT COMPLETED|Overall Study||14
6633408|NCT02289690|7562032|FG006|NOT COMPLETED|Overall Study||4
6633409|NCT02289690|7562033|FG007|NOT COMPLETED|Overall Study||61
6633410|NCT02289690|7562034|FG008|NOT COMPLETED|Overall Study||59
6633411|NCT02289690|7562035|FG009|NOT COMPLETED|Overall Study||61
6743280|NCT03333876|7671560|FG000|COMPLETED|Positional Therapy||54
6743281|NCT03333876|7671560|FG000|NOT COMPLETED|Positional Therapy||0
6743282|NCT03333941|7671573|FG000|STARTED|Overall Study||76
6743283|NCT03333941|7671573|FG000|COMPLETED|Overall Study||63
6743284|NCT03333941|7671573|FG000|NOT COMPLETED|Overall Study||13
6743285|NCT03334175|7671579|FG000|STARTED|Overall Study||8
6743286|NCT03334175|7671580|FG001|STARTED|Overall Study||10
6743287|NCT03334175|7671579|FG000|COMPLETED|Overall Study||8
6743288|NCT03334175|7671580|FG001|COMPLETED|Overall Study||9
6743289|NCT03334175|7671579|FG000|NOT COMPLETED|Overall Study||0
6743290|NCT03334175|7671580|FG001|NOT COMPLETED|Overall Study||1
6743291|NCT03334188|7671588|FG000|STARTED|Overall Study||153
6743292|NCT03334188|7671589|FG001|STARTED|Overall Study||153
6743293|NCT03334188|7671588|FG000|COMPLETED|Overall Study||145
6743294|NCT03334188|7671589|FG001|COMPLETED|Overall Study||145
6743295|NCT03334188|7671588|FG000|NOT COMPLETED|Overall Study||8
6743296|NCT03334188|7671589|FG001|NOT COMPLETED|Overall Study||8
6743297|NCT03334214|7671598|FG000|STARTED|Overall Study||15
6743298|NCT03334214|7671599|FG001|STARTED|Overall Study||29
6743299|NCT03334214|7671598|FG000|COMPLETED|Overall Study||14
6743300|NCT03334214|7671599|FG001|COMPLETED|Overall Study||27
6743301|NCT03334214|7671598|FG000|NOT COMPLETED|Overall Study||1
6743302|NCT03334214|7671599|FG001|NOT COMPLETED|Overall Study||2
6743303|NCT03334396|7671614|FG000|STARTED|Overall Study||249
6743304|NCT03334396|7671615|FG001|STARTED|Overall Study||127
6743305|NCT03334396|7671616|FG002|STARTED|Overall Study||123
6743306|NCT03334396|7671617|FG003|STARTED|Overall Study||125
6743307|NCT03334396|7671618|FG004|STARTED|Overall Study||15
6743308|NCT03334396|7671619|FG005|STARTED|Overall Study||5
6743309|NCT03334396|7671620|FG006|STARTED|Overall Study||8
6743310|NCT03334396|7671621|FG007|STARTED|Overall Study||8
6743311|NCT03334396|7671614|FG000|Received at Least One Dose of Study Drug|Overall Study||249
6743312|NCT03334396|7671615|FG001|Received at Least One Dose of Study Drug|Overall Study||127
6743313|NCT03334396|7671616|FG002|Received at Least One Dose of Study Drug|Overall Study||123
6743314|NCT03334396|7671617|FG003|Received at Least One Dose of Study Drug|Overall Study||125
6743315|NCT03334396|7671618|FG004|Received at Least One Dose of Study Drug|Overall Study||15
6743316|NCT03334396|7671619|FG005|Received at Least One Dose of Study Drug|Overall Study||5
6743317|NCT03334396|7671620|FG006|Received at Least One Dose of Study Drug|Overall Study||8
6743318|NCT03334396|7671621|FG007|Received at Least One Dose of Study Drug|Overall Study||8
6743319|NCT03334396|7671614|FG000|COMPLETED|Overall Study||226
6743320|NCT03334396|7671615|FG001|COMPLETED|Overall Study||116
6743321|NCT03334396|7671616|FG002|COMPLETED|Overall Study||113
6743322|NCT03334396|7671617|FG003|COMPLETED|Overall Study||120
6743323|NCT03334396|7671618|FG004|COMPLETED|Overall Study||12
6743324|NCT03334396|7671619|FG005|COMPLETED|Overall Study||4
6743325|NCT03334396|7671620|FG006|COMPLETED|Overall Study||5
6743326|NCT03334396|7671621|FG007|COMPLETED|Overall Study||7
6285250|NCT00215150|7185813|FG000|COMPLETED|Open Label Phase||21
6285251|NCT00215150|7185813|FG000|NOT COMPLETED|Open Label Phase||30
6285252|NCT00215150|7185813|FG000|STARTED|Randomization Phase Ziprasidone||10
6633412|NCT02289729|7562071|FG000|STARTED|Overall Study||59
6743327|NCT03334396|7671614|FG000|NOT COMPLETED|Overall Study||23
6743328|NCT03334396|7671615|FG001|NOT COMPLETED|Overall Study||11
6743329|NCT03334396|7671616|FG002|NOT COMPLETED|Overall Study||10
6743330|NCT03334396|7671617|FG003|NOT COMPLETED|Overall Study||5
6743331|NCT03334396|7671618|FG004|NOT COMPLETED|Overall Study||3
6743332|NCT03334396|7671619|FG005|NOT COMPLETED|Overall Study||1
6743333|NCT03334396|7671620|FG006|NOT COMPLETED|Overall Study||3
6285253|NCT00215150|7185813|FG000|COMPLETED|Randomization Phase Ziprasidone||7
6285254|NCT00215150|7185813|FG000|NOT COMPLETED|Randomization Phase Ziprasidone||3
6285255|NCT00215150|7185813|FG000|STARTED|Randomization Phase Placebo||11
6285256|NCT00215150|7185813|FG000|COMPLETED|Randomization Phase Placebo||10
6285257|NCT00215150|7185813|FG000|NOT COMPLETED|Randomization Phase Placebo||1
6285258|NCT00215540|7185824|FG000|STARTED|Overall Study||45
6285259|NCT00215540|7185825|FG001|STARTED|Overall Study||47
6285260|NCT00215540|7185826|FG002|STARTED|Overall Study||44
6285261|NCT00215540|7185824|FG000|COMPLETED|Overall Study||44
6285262|NCT00215540|7185825|FG001|COMPLETED|Overall Study||47
6285263|NCT00215540|7185826|FG002|COMPLETED|Overall Study||44
6285264|NCT00215540|7185824|FG000|NOT COMPLETED|Overall Study||1
6285265|NCT00215540|7185825|FG001|NOT COMPLETED|Overall Study||0
6285266|NCT00215540|7185826|FG002|NOT COMPLETED|Overall Study||0
6285267|NCT00215553|7185841|FG000|STARTED|Overall Study||5
6285268|NCT00215553|7185842|FG001|STARTED|Overall Study||6
6285269|NCT00215553|7185843|FG002|STARTED|Overall Study||6
6285270|NCT00215553|7185844|FG003|STARTED|Overall Study||5
6285271|NCT00215553|7185845|FG004|STARTED|Overall Study||28
6285272|NCT00215553|7185846|FG005|STARTED|Overall Study||38
6285273|NCT00215553|7185847|FG006|STARTED|Overall Study||36
6285274|NCT00215553|7185841|FG000|COMPLETED|Overall Study||5
6285275|NCT00215553|7185842|FG001|COMPLETED|Overall Study||5
6285276|NCT00215553|7185843|FG002|COMPLETED|Overall Study||4
6285277|NCT00215553|7185844|FG003|COMPLETED|Overall Study||4
6285278|NCT00215553|7185845|FG004|COMPLETED|Overall Study||26
6285279|NCT00215553|7185846|FG005|COMPLETED|Overall Study||32
6285280|NCT00215553|7185847|FG006|COMPLETED|Overall Study||36
6285281|NCT00215553|7185841|FG000|NOT COMPLETED|Overall Study||0
6285282|NCT00215553|7185842|FG001|NOT COMPLETED|Overall Study||1
6285283|NCT00215553|7185843|FG002|NOT COMPLETED|Overall Study||2
6285284|NCT00215553|7185844|FG003|NOT COMPLETED|Overall Study||1
6285285|NCT00215553|7185845|FG004|NOT COMPLETED|Overall Study||2
6285286|NCT00215553|7185846|FG005|NOT COMPLETED|Overall Study||6
6285287|NCT00215553|7185847|FG006|NOT COMPLETED|Overall Study||0
6285288|NCT00215644|7185865|FG000|STARTED|Overall Study||36
6285289|NCT00215644|7185866|FG001|STARTED|Overall Study||36
6285290|NCT00215644|7185865|FG000|Treated|Overall Study||35
6285291|NCT00215644|7185866|FG001|Treated|Overall Study||36
6285292|NCT00215644|7185865|FG000|COMPLETED|Overall Study||0
6285293|NCT00215644|7185866|FG001|COMPLETED|Overall Study||0
6285294|NCT00215644|7185865|FG000|NOT COMPLETED|Overall Study||36
6285295|NCT00215644|7185866|FG001|NOT COMPLETED|Overall Study||36
6285296|NCT00215657|7185880|FG000|STARTED|Overall Study||26
6285297|NCT00215657|7185881|FG001|STARTED|Overall Study||12
6285298|NCT00215657|7185882|FG002|STARTED|Overall Study||13
6285299|NCT00215657|7185883|FG003|STARTED|Overall Study||24
6285300|NCT00215657|7185884|FG004|STARTED|Overall Study||27
6285301|NCT00215657|7185885|FG005|STARTED|Overall Study||24
6285302|NCT00215657|7185886|FG006|STARTED|Overall Study||27
6285303|NCT00215657|7185887|FG007|STARTED|Overall Study||27
6285304|NCT00215657|7185880|FG000|Intention-to-treat Population|Overall Study||25
6285305|NCT00215657|7185881|FG001|Intention-to-treat Population|Overall Study||12
6285306|NCT00215657|7185882|FG002|Intention-to-treat Population|Overall Study||12
6285307|NCT00215657|7185883|FG003|Intention-to-treat Population|Overall Study||24
6285308|NCT00215657|7185884|FG004|Intention-to-treat Population|Overall Study||24
6285309|NCT00215657|7185885|FG005|Intention-to-treat Population|Overall Study||24
6285310|NCT00215657|7185886|FG006|Intention-to-treat Population|Overall Study||24
6285311|NCT00215657|7185887|FG007|Intention-to-treat Population|Overall Study||27
6285312|NCT00215657|7185880|FG000|Started FE200486 CS07A|Overall Study||20
6285313|NCT00215657|7185881|FG001|Started FE200486 CS07A|Overall Study||6
6285314|NCT00215657|7185882|FG002|Started FE200486 CS07A|Overall Study||7
6285315|NCT00215657|7185883|FG003|Started FE200486 CS07A|Overall Study||24
6285316|NCT00215657|7185884|FG004|Started FE200486 CS07A|Overall Study||17
6285317|NCT00215657|7185885|FG005|Started FE200486 CS07A|Overall Study||20
6399260|NCT00879814|7311972|FG001|STARTED|Overall Study||12
6285318|NCT00215657|7185886|FG006|Started FE200486 CS07A|Overall Study||14
6285319|NCT00215657|7185887|FG007|Started FE200486 CS07A|Overall Study||23
6285320|NCT00215657|7185880|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
6285321|NCT00215657|7185881|FG001|COMPLETED|Overall Study||1
6285322|NCT00215657|7185882|FG002|COMPLETED|Overall Study||2
6285323|NCT00215657|7185883|FG003|COMPLETED|Overall Study||6
6285324|NCT00215657|7185884|FG004|COMPLETED|Overall Study||4
6285325|NCT00215657|7185885|FG005|COMPLETED|Overall Study||4
6285326|NCT00215657|7185886|FG006|COMPLETED|Overall Study||4
6285327|NCT00215657|7185887|FG007|COMPLETED|Overall Study||11
6285328|NCT00215657|7185880|FG000|NOT COMPLETED|Overall Study||22
6285329|NCT00215657|7185881|FG001|NOT COMPLETED|Overall Study||11
6285330|NCT00215657|7185882|FG002|NOT COMPLETED|Overall Study||11
6285331|NCT00215657|7185883|FG003|NOT COMPLETED|Overall Study||18
6285332|NCT00215657|7185884|FG004|NOT COMPLETED|Overall Study||23
6285333|NCT00215657|7185885|FG005|NOT COMPLETED|Overall Study||20
6285334|NCT00215657|7185886|FG006|NOT COMPLETED|Overall Study||23
6285335|NCT00215657|7185887|FG007|NOT COMPLETED|Overall Study||16
6285336|NCT00215683|7185908|FG000|STARTED|Overall Study|Safety analysis set|45
6285337|NCT00215683|7185909|FG001|STARTED|Overall Study||48
6285338|NCT00215683|7185910|FG002|STARTED|Overall Study||44
6373893|NCT00747474|7284558|FG005|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6285339|NCT00215683|7185908|FG000|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
6285340|NCT00215683|7185909|FG001|Switched to 160 mg|Overall Study||41
6285341|NCT00215683|7185910|FG002|Switched to 160 mg|Overall Study||36
6285342|NCT00215683|7185908|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
6285343|NCT00215683|7185909|FG001|COMPLETED|Overall Study||22
6285344|NCT00215683|7185910|FG002|COMPLETED|Overall Study||12
6285345|NCT00215683|7185908|FG000|NOT COMPLETED|Overall Study||29
6285346|NCT00215683|7185909|FG001|NOT COMPLETED|Overall Study||26
6285347|NCT00215683|7185910|FG002|NOT COMPLETED|Overall Study||32
6285348|NCT00215787|7185918|FG000|STARTED|Overall Study||20
6285349|NCT00215787|7185918|FG000|COMPLETED|Overall Study||20
6285350|NCT00215787|7185918|FG000|NOT COMPLETED|Overall Study||0
6285351|NCT00215930|7185922|FG000|STARTED|Overall Study||53
6285352|NCT00215930|7185922|FG000|COMPLETED|Overall Study||53
6285353|NCT00215930|7185922|FG000|NOT COMPLETED|Overall Study||0
6285354|NCT00215943|7185929|FG000|STARTED|Overall Study||36
6285355|NCT00215943|7185930|FG001|STARTED|Overall Study||37
6285356|NCT00215943|7185929|FG000|COMPLETED|Overall Study||27
6285357|NCT00215943|7185930|FG001|COMPLETED|Overall Study||23
6285358|NCT00215943|7185929|FG000|NOT COMPLETED|Overall Study||9
6285359|NCT00215943|7185930|FG001|NOT COMPLETED|Overall Study||14
6285360|NCT00216060|7185938|FG000|STARTED|Overall Study||32
6285361|NCT00216060|7185939|FG001|STARTED|Overall Study||31
6285362|NCT00216060|7185938|FG000|COMPLETED|Overall Study||32
6285363|NCT00216060|7185939|FG001|COMPLETED|Overall Study||31
6285364|NCT00216060|7185938|FG000|NOT COMPLETED|Overall Study||0
6285365|NCT00216060|7185939|FG001|NOT COMPLETED|Overall Study||0
6285366|NCT00216086|7185947|FG000|STARTED|Overall Study||22
6285367|NCT00216086|7185947|FG000|COMPLETED|Overall Study||18
6285368|NCT00216086|7185947|FG000|NOT COMPLETED|Overall Study||4
6285369|NCT00216099|7185951|FG000|STARTED|Overall Study||49
6285370|NCT00216099|7185951|FG000|Toxicity Analysis|Overall Study||49
6285371|NCT00216099|7185951|FG000|Response Analysis|Overall Study||48
6285372|NCT00216099|7185951|FG000|COMPLETED|Overall Study||48
6285373|NCT00216099|7185951|FG000|NOT COMPLETED|Overall Study||1
6285374|NCT00216125|7185955|FG000|STARTED|Pre-Randomization Phase||243
6285375|NCT00216125|7185956|FG001|STARTED|Pre-Randomization Phase||0
6285376|NCT00216125|7185957|FG002|STARTED|Pre-Randomization Phase||0
6285377|NCT00216125|7185955|FG000|DSMB Cohort for Futility|Pre-Randomization Phase||203
6285378|NCT00216125|7185956|FG001|DSMB Cohort for Futility|Pre-Randomization Phase||0
6285379|NCT00216125|7185957|FG002|DSMB Cohort for Futility|Pre-Randomization Phase||0
6285380|NCT00216125|7185955|FG000|COMPLETED|Pre-Randomization Phase||166
6285381|NCT00216125|7185956|FG001|COMPLETED|Pre-Randomization Phase||0
6285382|NCT00216125|7185957|FG002|COMPLETED|Pre-Randomization Phase||0
6285383|NCT00216125|7185955|FG000|NOT COMPLETED|Pre-Randomization Phase||77
6285384|NCT00216125|7185956|FG001|NOT COMPLETED|Pre-Randomization Phase||0
6285385|NCT00216125|7185957|FG002|NOT COMPLETED|Pre-Randomization Phase||0
6285386|NCT00216125|7185955|FG000|STARTED|Randomization Phase||0
6285387|NCT00216125|7185956|FG001|STARTED|Randomization Phase||84
6285388|NCT00216125|7185957|FG002|STARTED|Randomization Phase||82
6285389|NCT00216125|7185955|FG000|DSMB Cohort for Futility|Randomization Phase||0
6285390|NCT00216125|7185956|FG001|DSMB Cohort for Futility|Randomization Phase||73
6285391|NCT00216125|7185957|FG002|DSMB Cohort for Futility|Randomization Phase||74
6285392|NCT00216125|7185955|FG000|COMPLETED|Randomization Phase||0
6285393|NCT00216125|7185956|FG001|COMPLETED|Randomization Phase||73
6285394|NCT00216125|7185957|FG002|COMPLETED|Randomization Phase||74
6285395|NCT00216125|7185955|FG000|NOT COMPLETED|Randomization Phase||0
6285396|NCT00216125|7185956|FG001|NOT COMPLETED|Randomization Phase||11
6285397|NCT00216125|7185957|FG002|NOT COMPLETED|Randomization Phase||8
6285398|NCT00216203|7185964|FG000|STARTED|Overall Study||36
6285399|NCT00216203|7185964|FG000|COMPLETED|Overall Study||34
6285400|NCT00216203|7185964|FG000|NOT COMPLETED|Overall Study||2
6285401|NCT00216320|7185972|FG000|STARTED|Phase 1 (Weeks 0 - 6)||43
6285402|NCT00216320|7185973|FG001|STARTED|Phase 1 (Weeks 0 - 6)||39
6285403|NCT00216320|7185974|FG002|STARTED|Phase 1 (Weeks 0 - 6)||30
6285404|NCT00216320|7185972|FG000|COMPLETED|Phase 1 (Weeks 0 - 6)||43
6285405|NCT00216320|7185973|FG001|COMPLETED|Phase 1 (Weeks 0 - 6)||35
6285406|NCT00216320|7185974|FG002|COMPLETED|Phase 1 (Weeks 0 - 6)||25
6285407|NCT00216320|7185972|FG000|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
6285408|NCT00216320|7185973|FG001|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
6285409|NCT00216320|7185974|FG002|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
6285410|NCT00216320|7185972|FG000|STARTED|Phase 2 (Weeks 6 -12)||43
6285411|NCT00216320|7185973|FG001|STARTED|Phase 2 (Weeks 6 -12)||35
6285412|NCT00216320|7185974|FG002|STARTED|Phase 2 (Weeks 6 -12)||25
6285413|NCT00216320|7185972|FG000|COMPLETED|Phase 2 (Weeks 6 -12)||38
6285414|NCT00216320|7185973|FG001|COMPLETED|Phase 2 (Weeks 6 -12)||31
6285415|NCT00216320|7185974|FG002|COMPLETED|Phase 2 (Weeks 6 -12)||24
6285416|NCT00216320|7185972|FG000|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
6285417|NCT00216320|7185973|FG001|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
6285418|NCT00216320|7185974|FG002|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
6285419|NCT00216476|7185985|FG000|STARTED|Overall Study||329
6285420|NCT00216476|7185986|FG001|STARTED|Overall Study||337
6285421|NCT00216476|7185987|FG002|STARTED|Overall Study||45
6285422|NCT00216476|7185985|FG000|COMPLETED|Overall Study||224
6285423|NCT00216476|7185986|FG001|COMPLETED|Overall Study||230
6285424|NCT00216476|7185987|FG002|COMPLETED|Overall Study||28
6285425|NCT00216476|7185985|FG000|NOT COMPLETED|Overall Study||105
6285426|NCT00216476|7185986|FG001|NOT COMPLETED|Overall Study||107
6285427|NCT00216476|7185987|FG002|NOT COMPLETED|Overall Study||17
6285428|NCT00216671|7186000|FG000|STARTED|Overall Study||110
6285429|NCT00216671|7186001|FG001|STARTED|Overall Study||110
6285430|NCT00216671|7186000|FG000|COMPLETED|Overall Study||75
6285431|NCT00216671|7186001|FG001|COMPLETED|Overall Study||60
6285432|NCT00216671|7186000|FG000|NOT COMPLETED|Overall Study||35
6285433|NCT00216671|7186001|FG001|NOT COMPLETED|Overall Study||50
6285434|NCT00216736|7186009|FG000|STARTED|Overall Study||32
6285435|NCT00216736|7186010|FG001|STARTED|Overall Study||31
6285436|NCT00216736|7186009|FG000|COMPLETED|Overall Study||31
6285437|NCT00216736|7186010|FG001|COMPLETED|Overall Study||30
6285438|NCT00216736|7186009|FG000|NOT COMPLETED|Overall Study||1
6285439|NCT00216736|7186010|FG001|NOT COMPLETED|Overall Study||1
6285440|NCT00217022|7186018|FG000|STARTED|Overall Study||12
6285441|NCT00217022|7186019|FG001|STARTED|Overall Study||4
6285442|NCT00217022|7186018|FG000|COMPLETED|Overall Study||11
6285443|NCT00217022|7186019|FG001|COMPLETED|Overall Study||3
6285444|NCT00217022|7186018|FG000|NOT COMPLETED|Overall Study||1
6285445|NCT00217022|7186019|FG001|NOT COMPLETED|Overall Study||1
6285446|NCT00217087|7186027|FG000|STARTED|Overall Study||36
6285447|NCT00217087|7186028|FG001|STARTED|Overall Study||37
6285448|NCT00217087|7186027|FG000|COMPLETED|Overall Study||25
6285449|NCT00217087|7186028|FG001|COMPLETED|Overall Study||17
6285450|NCT00217087|7186027|FG000|NOT COMPLETED|Overall Study||11
6285451|NCT00217087|7186028|FG001|NOT COMPLETED|Overall Study||20
6285452|NCT00217399|7186040|FG000|STARTED|Overall Study||35
6633413|NCT02289729|7562071|FG000|COMPLETED|Overall Study||53
6633414|NCT02289729|7562071|FG000|NOT COMPLETED|Overall Study||6
6633415|NCT02289742|7562077|FG000|STARTED|First Wear Period||11
6633416|NCT02289742|7562078|FG001|STARTED|First Wear Period||12
6633417|NCT02289742|7562079|FG002|STARTED|First Wear Period||12
6633418|NCT02289742|7562080|FG003|STARTED|First Wear Period||10
6633419|NCT02289742|7562077|FG000|Treated|First Wear Period||11
6633420|NCT02289742|7562078|FG001|Treated|First Wear Period||11
6285453|NCT00217399|7186040|FG000|COMPLETED|Overall Study||35
6285454|NCT00217399|7186040|FG000|NOT COMPLETED|Overall Study||0
6285455|NCT00217425|7186046|FG000|STARTED|Overall Study||46
6285456|NCT00217425|7186046|FG000|Treated|Overall Study||44
6285457|NCT00217425|7186046|FG000|Eligible and Treated|Overall Study||39
6285458|NCT00217425|7186046|FG000|COMPLETED|Overall Study||9
6285459|NCT00217425|7186046|FG000|NOT COMPLETED|Overall Study||37
6285460|NCT00217438|7186052|FG000|STARTED|Overall Study||66
6285461|NCT00217438|7186053|FG001|STARTED|Overall Study||64
6285462|NCT00217438|7186052|FG000|COMPLETED|Overall Study||66
6285463|NCT00217438|7186053|FG001|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
6285464|NCT00217438|7186052|FG000|NOT COMPLETED|Overall Study||0
6285465|NCT00217438|7186053|FG001|NOT COMPLETED|Overall Study||1
6285466|NCT00217464|7186059|FG000|STARTED|Overall Study||17
6285467|NCT00217464|7186059|FG000|COMPLETED|Overall Study||0
6285468|NCT00217464|7186059|FG000|NOT COMPLETED|Overall Study||17
6285469|NCT00217490|7186067|FG000|STARTED|Overall Study||154
6285470|NCT00217490|7186068|FG001|STARTED|Overall Study||153
6285471|NCT00217490|7186069|FG002|STARTED|Overall Study||155
6285472|NCT00217490|7186070|FG003|STARTED|Overall Study||153
6285473|NCT00217490|7186067|FG000|COMPLETED|Overall Study||137
6285474|NCT00217490|7186068|FG001|COMPLETED|Overall Study||128
6285475|NCT00217490|7186069|FG002|COMPLETED|Overall Study||131
6285476|NCT00217490|7186070|FG003|COMPLETED|Overall Study||130
6285477|NCT00217490|7186067|FG000|NOT COMPLETED|Overall Study||17
6285478|NCT00217490|7186068|FG001|NOT COMPLETED|Overall Study||25
6285479|NCT00217490|7186069|FG002|NOT COMPLETED|Overall Study||24
6285480|NCT00217490|7186070|FG003|NOT COMPLETED|Overall Study||23
6285481|NCT00217581|7186084|FG000|STARTED|Overall Study||39
6285482|NCT00217581|7186084|FG000|COMPLETED|Overall Study||38
6285483|NCT00217581|7186084|FG000|NOT COMPLETED|Overall Study||1
6285484|NCT00217594|7186089|FG000|STARTED|Overall Study||31
6285485|NCT00217594|7186089|FG000|COMPLETED|Overall Study||31
6633421|NCT02289742|7562079|FG002|Treated|First Wear Period||12
6285486|NCT00217594|7186089|FG000|NOT COMPLETED|Overall Study||0
6285487|NCT00217620|7186093|FG000|STARTED|Overall Study||51
6285488|NCT00217620|7186093|FG000|Eligible|Overall Study||38
6285489|NCT00217620|7186093|FG000|Eligible and Began Protocol Therapy|Overall Study||37
6285490|NCT00217620|7186093|FG000|COMPLETED|Overall Study||0
6285491|NCT00217620|7186093|FG000|NOT COMPLETED|Overall Study||51
6285492|NCT00217672|7186101|FG000|STARTED|Allocation||69
6285493|NCT00217672|7186102|FG001|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
6285494|NCT00217672|7186101|FG000|COMPLETED|Allocation||67
6285495|NCT00217672|7186102|FG001|COMPLETED|Allocation||7
6285496|NCT00217672|7186101|FG000|NOT COMPLETED|Allocation||2
6285497|NCT00217672|7186102|FG001|NOT COMPLETED|Allocation||0
6285498|NCT00217672|7186101|FG000|STARTED|Treatment||67
6285499|NCT00217672|7186102|FG001|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
6285500|NCT00217672|7186101|FG000|COMPLETED|Treatment||0
6285501|NCT00217672|7186102|FG001|COMPLETED|Treatment||0
6285502|NCT00217672|7186101|FG000|NOT COMPLETED|Treatment||67
6285503|NCT00217672|7186102|FG001|NOT COMPLETED|Treatment||7
6285504|NCT00217672|7186101|FG000|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
6633422|NCT02289742|7562080|FG003|Treated|First Wear Period||9
6633423|NCT02289742|7562077|FG000|COMPLETED|First Wear Period||11
6633424|NCT02289742|7562078|FG001|COMPLETED|First Wear Period||11
6285505|NCT00217672|7186102|FG001|STARTED|Follow-up||0
6285506|NCT00217672|7186101|FG000|COMPLETED|Follow-up||69
6285507|NCT00217672|7186102|FG001|COMPLETED|Follow-up||0
6285508|NCT00217672|7186101|FG000|NOT COMPLETED|Follow-up||5
6285509|NCT00217672|7186102|FG001|NOT COMPLETED|Follow-up||0
6285510|NCT00217724|7186106|FG000|STARTED|Course 1, (Glutamine/Placebo Arms)||8
6285511|NCT00217724|7186107|FG001|STARTED|Course 1, (Glutamine/Placebo Arms)||10
6285512|NCT00217724|7186106|FG000|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
6285513|NCT00217724|7186107|FG001|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
6285514|NCT00217724|7186106|FG000|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
6285515|NCT00217724|7186107|FG001|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
6285516|NCT00217724|7186106|FG000|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
6285517|NCT00217724|7186107|FG001|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
6285518|NCT00217724|7186106|FG000|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
6285519|NCT00217724|7186107|FG001|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
6285520|NCT00217724|7186106|FG000|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
6285521|NCT00217724|7186107|FG001|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
6285522|NCT00217971|7186115|FG000|STARTED|Overall Study||79
6285523|NCT00217971|7186116|FG001|STARTED|Overall Study||77
6285524|NCT00217971|7186115|FG000|COMPLETED|Overall Study||55
6285525|NCT00217971|7186116|FG001|COMPLETED|Overall Study||44
6285526|NCT00217971|7186115|FG000|NOT COMPLETED|Overall Study||24
6285527|NCT00217971|7186116|FG001|NOT COMPLETED|Overall Study||33
6285528|NCT00218023|7186126|FG000|STARTED|Overall Study||22
6285529|NCT00218023|7186127|FG001|STARTED|Overall Study||25
6285530|NCT00218023|7186128|FG002|STARTED|Overall Study||16
6285531|NCT00218023|7186129|FG003|STARTED|Overall Study||18
6285532|NCT00218023|7186126|FG000|Received Drug or Placebo in Phase II|Overall Study||18
6285533|NCT00218023|7186127|FG001|Received Drug or Placebo in Phase II|Overall Study||24
6285534|NCT00218023|7186128|FG002|Received Drug or Placebo in Phase II|Overall Study||15
6285535|NCT00218023|7186129|FG003|Received Drug or Placebo in Phase II|Overall Study||18
6285536|NCT00218023|7186126|FG000|COMPLETED|Overall Study||9
6285537|NCT00218023|7186127|FG001|COMPLETED|Overall Study||10
6285538|NCT00218023|7186128|FG002|COMPLETED|Overall Study||6
6285539|NCT00218023|7186129|FG003|COMPLETED|Overall Study||11
6285540|NCT00218023|7186126|FG000|NOT COMPLETED|Overall Study||13
6285541|NCT00218023|7186127|FG001|NOT COMPLETED|Overall Study||15
6285542|NCT00218023|7186128|FG002|NOT COMPLETED|Overall Study||10
6285543|NCT00218023|7186129|FG003|NOT COMPLETED|Overall Study||7
6633425|NCT02289742|7562079|FG002|COMPLETED|First Wear Period||11
6633426|NCT02289742|7562080|FG003|COMPLETED|First Wear Period||9
6633427|NCT02289742|7562077|FG000|NOT COMPLETED|First Wear Period||0
6633428|NCT02289742|7562078|FG001|NOT COMPLETED|First Wear Period||1
6633429|NCT02289742|7562079|FG002|NOT COMPLETED|First Wear Period||1
6633430|NCT02289742|7562080|FG003|NOT COMPLETED|First Wear Period||1
6633431|NCT02289742|7562077|FG000|STARTED|Second Wear Period||11
6633432|NCT02289742|7562078|FG001|STARTED|Second Wear Period||11
6633433|NCT02289742|7562079|FG002|STARTED|Second Wear Period||11
6633434|NCT02289742|7562080|FG003|STARTED|Second Wear Period||9
6633435|NCT02289742|7562077|FG000|COMPLETED|Second Wear Period||11
6633436|NCT02289742|7562078|FG001|COMPLETED|Second Wear Period||11
6633437|NCT02289742|7562079|FG002|COMPLETED|Second Wear Period||11
6633438|NCT02289742|7562080|FG003|COMPLETED|Second Wear Period||9
6633439|NCT02289742|7562077|FG000|NOT COMPLETED|Second Wear Period||0
6633440|NCT02289742|7562078|FG001|NOT COMPLETED|Second Wear Period||0
6633441|NCT02289742|7562079|FG002|NOT COMPLETED|Second Wear Period||0
6633442|NCT02289742|7562080|FG003|NOT COMPLETED|Second Wear Period||0
6633443|NCT02289742|7562077|FG000|STARTED|Third Wear Period||11
6633444|NCT02289742|7562078|FG001|STARTED|Third Wear Period||11
6633445|NCT02289742|7562079|FG002|STARTED|Third Wear Period||11
6633446|NCT02289742|7562080|FG003|STARTED|Third Wear Period||9
6633447|NCT02289742|7562077|FG000|COMPLETED|Third Wear Period||11
6633448|NCT02289742|7562078|FG001|COMPLETED|Third Wear Period||10
6633449|NCT02289742|7562079|FG002|COMPLETED|Third Wear Period||11
6633450|NCT02289742|7562080|FG003|COMPLETED|Third Wear Period||8
6633451|NCT02289742|7562077|FG000|NOT COMPLETED|Third Wear Period||0
6633452|NCT02289742|7562078|FG001|NOT COMPLETED|Third Wear Period||1
6633453|NCT02289742|7562079|FG002|NOT COMPLETED|Third Wear Period||0
6633454|NCT02289742|7562080|FG003|NOT COMPLETED|Third Wear Period||1
6633455|NCT02289755|7562094|FG000|STARTED|Baseline Period [No Treatment, 3 Days]||16
6633456|NCT02289755|7562094|FG000|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
6633457|NCT02289755|7562094|FG000|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
6633458|NCT02289755|7562094|FG000|STARTED|ALLN-177 Treatment Period [4 Days]||16
6633459|NCT02289755|7562094|FG000|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
6633460|NCT02289755|7562094|FG000|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
6633461|NCT02289755|7562094|FG000|STARTED|Follow up Period [4 Days]||16
6633462|NCT02289755|7562094|FG000|COMPLETED|Follow up Period [4 Days]||16
6633463|NCT02289755|7562094|FG000|NOT COMPLETED|Follow up Period [4 Days]||0
6633464|NCT02289820|7562105|FG000|STARTED|Overall Study||39
6285544|NCT00218062|7186143|FG000|STARTED|Overall Study||22
6285545|NCT00218062|7186144|FG001|STARTED|Overall Study||20
6633465|NCT02289820|7562106|FG001|STARTED|Overall Study||20
6633466|NCT02289820|7562107|FG002|STARTED|Overall Study||44
6285546|NCT00218062|7186145|FG002|STARTED|Overall Study||15
6285547|NCT00218062|7186146|FG003|STARTED|Overall Study||16
6285548|NCT00218062|7186143|FG000|Received First Dose of Study Medication|Overall Study||16
6285549|NCT00218062|7186144|FG001|Received First Dose of Study Medication|Overall Study||11
6285550|NCT00218062|7186145|FG002|Received First Dose of Study Medication|Overall Study||10
6285551|NCT00218062|7186146|FG003|Received First Dose of Study Medication|Overall Study||12
6285552|NCT00218062|7186143|FG000|COMPLETED|Overall Study||7
6285553|NCT00218062|7186144|FG001|COMPLETED|Overall Study||4
6285554|NCT00218062|7186145|FG002|COMPLETED|Overall Study||3
6285555|NCT00218062|7186146|FG003|COMPLETED|Overall Study||3
6285556|NCT00218062|7186143|FG000|NOT COMPLETED|Overall Study||15
6285557|NCT00218062|7186144|FG001|NOT COMPLETED|Overall Study||16
6285558|NCT00218062|7186145|FG002|NOT COMPLETED|Overall Study||12
6285559|NCT00218062|7186146|FG003|NOT COMPLETED|Overall Study||13
6285560|NCT00218257|7186156|FG000|STARTED|Intervention 1||23
6285561|NCT00218257|7186157|FG001|STARTED|Intervention 1||22
6285562|NCT00218257|7186156|FG000|COMPLETED|Intervention 1||23
6285563|NCT00218257|7186157|FG001|COMPLETED|Intervention 1||22
6285564|NCT00218257|7186156|FG000|NOT COMPLETED|Intervention 1||0
6285565|NCT00218257|7186157|FG001|NOT COMPLETED|Intervention 1||0
6285566|NCT00218257|7186156|FG000|STARTED|Period Between Visit 1 and 2||23
6285567|NCT00218257|7186157|FG001|STARTED|Period Between Visit 1 and 2||22
6285568|NCT00218257|7186156|FG000|COMPLETED|Period Between Visit 1 and 2||19
6285569|NCT00218257|7186157|FG001|COMPLETED|Period Between Visit 1 and 2||19
6285570|NCT00218257|7186156|FG000|NOT COMPLETED|Period Between Visit 1 and 2||4
6285571|NCT00218257|7186157|FG001|NOT COMPLETED|Period Between Visit 1 and 2||3
6285572|NCT00218257|7186156|FG000|STARTED|Intervention 2||19
6285573|NCT00218257|7186157|FG001|STARTED|Intervention 2||19
6285574|NCT00218257|7186156|FG000|COMPLETED|Intervention 2||19
6285575|NCT00218257|7186157|FG001|COMPLETED|Intervention 2||19
6285576|NCT00218257|7186156|FG000|NOT COMPLETED|Intervention 2||0
6285577|NCT00218257|7186157|FG001|NOT COMPLETED|Intervention 2||0
6285578|NCT00218296|7186168|FG000|STARTED|Overall Study||163
6285579|NCT00218296|7186169|FG001|STARTED|Overall Study||169
6285580|NCT00218296|7186168|FG000|Attended Visti|Overall Study||97
6285581|NCT00218296|7186169|FG001|Attended Visti|Overall Study||102
6285582|NCT00218296|7186168|FG000|COMPLETED|Overall Study||52
6285583|NCT00218296|7186169|FG001|COMPLETED|Overall Study||48
6285584|NCT00218296|7186168|FG000|NOT COMPLETED|Overall Study||111
6285585|NCT00218296|7186169|FG001|NOT COMPLETED|Overall Study||121
6285586|NCT00218335|7186181|FG000|STARTED|Overall Study||114
6285587|NCT00218335|7186182|FG001|STARTED|Overall Study||113
6285588|NCT00218335|7186183|FG002|STARTED|Overall Study||373
6285589|NCT00218335|7186184|FG003|STARTED|Overall Study||424
6285590|NCT00218335|7186181|FG000|6 Month Follow-up|Overall Study||103
6285591|NCT00218335|7186182|FG001|6 Month Follow-up|Overall Study||99
6285592|NCT00218335|7186183|FG002|6 Month Follow-up|Overall Study||219
6285593|NCT00218335|7186184|FG003|6 Month Follow-up|Overall Study||301
6285594|NCT00218335|7186181|FG000|12 Month Follow-up|Overall Study||95
6285595|NCT00218335|7186182|FG001|12 Month Follow-up|Overall Study||102
6285596|NCT00218335|7186183|FG002|12 Month Follow-up|Overall Study||244
6285597|NCT00218335|7186184|FG003|12 Month Follow-up|Overall Study||303
6285598|NCT00218335|7186181|FG000|18 Month Follow-up|Overall Study||101
6285599|NCT00218335|7186182|FG001|18 Month Follow-up|Overall Study||108
6285600|NCT00218335|7186183|FG002|18 Month Follow-up|Overall Study||296
6285601|NCT00218335|7186184|FG003|18 Month Follow-up|Overall Study||368
6285602|NCT00218335|7186181|FG000|COMPLETED|Overall Study||108
6285603|NCT00218335|7186182|FG001|COMPLETED|Overall Study||110
6285604|NCT00218335|7186183|FG002|COMPLETED|Overall Study||319
6285605|NCT00218335|7186184|FG003|COMPLETED|Overall Study||388
6285606|NCT00218335|7186181|FG000|NOT COMPLETED|Overall Study||6
6285607|NCT00218335|7186182|FG001|NOT COMPLETED|Overall Study||3
6285608|NCT00218335|7186183|FG002|NOT COMPLETED|Overall Study||54
6285609|NCT00218335|7186184|FG003|NOT COMPLETED|Overall Study||36
6633467|NCT02289820|7562108|FG003|STARTED|Overall Study||39
6633468|NCT02289820|7562109|FG004|STARTED|Overall Study||40
6633469|NCT02289820|7562110|FG005|STARTED|Overall Study||40
6633470|NCT02289820|7562111|FG006|STARTED|Overall Study||39
6633471|NCT02289820|7562105|FG000|COMPLETED|Overall Study||37
6633472|NCT02289820|7562106|FG001|COMPLETED|Overall Study||18
6633473|NCT02289820|7562107|FG002|COMPLETED|Overall Study||38
6633474|NCT02289820|7562108|FG003|COMPLETED|Overall Study||37
6633475|NCT02289820|7562109|FG004|COMPLETED|Overall Study||40
6633476|NCT02289820|7562110|FG005|COMPLETED|Overall Study||39
6633477|NCT02289820|7562111|FG006|COMPLETED|Overall Study||37
6633478|NCT02289820|7562105|FG000|NOT COMPLETED|Overall Study||2
6633479|NCT02289820|7562106|FG001|NOT COMPLETED|Overall Study||2
6633480|NCT02289820|7562107|FG002|NOT COMPLETED|Overall Study||6
6633481|NCT02289820|7562108|FG003|NOT COMPLETED|Overall Study||2
6633482|NCT02289820|7562109|FG004|NOT COMPLETED|Overall Study||0
6633483|NCT02289820|7562110|FG005|NOT COMPLETED|Overall Study||1
6633484|NCT02289820|7562111|FG006|NOT COMPLETED|Overall Study||2
6285610|NCT00218387|7186199|FG000|STARTED|Overall Study||40
6285611|NCT00218387|7186200|FG001|STARTED|Overall Study||43
6285612|NCT00218387|7186201|FG002|STARTED|Overall Study||40
6285613|NCT00218387|7186199|FG000|COMPLETED|Overall Study||25
6285614|NCT00218387|7186200|FG001|COMPLETED|Overall Study||25
6285615|NCT00218387|7186201|FG002|COMPLETED|Overall Study||17
6285616|NCT00218387|7186199|FG000|NOT COMPLETED|Overall Study||15
6285617|NCT00218387|7186200|FG001|NOT COMPLETED|Overall Study||18
6285618|NCT00218387|7186201|FG002|NOT COMPLETED|Overall Study||23
6285619|NCT00218426|7186212|FG000|STARTED|Overall Study||102
6285620|NCT00218426|7186213|FG001|STARTED|Overall Study||102
6285621|NCT00218426|7186214|FG002|STARTED|Overall Study||102
6285622|NCT00218426|7186212|FG000|COMPLETED|Overall Study||54
6285623|NCT00218426|7186213|FG001|COMPLETED|Overall Study||16
6285624|NCT00218426|7186214|FG002|COMPLETED|Overall Study||11
6285625|NCT00218426|7186212|FG000|NOT COMPLETED|Overall Study||48
6285626|NCT00218426|7186213|FG001|NOT COMPLETED|Overall Study||86
6285627|NCT00218426|7186214|FG002|NOT COMPLETED|Overall Study||91
6285628|NCT00218439|7186227|FG000|STARTED|First Intervention (4 Weeks)||58
6285629|NCT00218439|7186228|FG001|STARTED|First Intervention (4 Weeks)||47
6285630|NCT00218439|7186227|FG000|COMPLETED|First Intervention (4 Weeks)||40
6285631|NCT00218439|7186228|FG001|COMPLETED|First Intervention (4 Weeks)||35
6285632|NCT00218439|7186227|FG000|NOT COMPLETED|First Intervention (4 Weeks)||18
6285633|NCT00218439|7186228|FG001|NOT COMPLETED|First Intervention (4 Weeks)||12
6285634|NCT00218439|7186227|FG000|STARTED|Second Intervention (4 Weeks)||40
6285635|NCT00218439|7186228|FG001|STARTED|Second Intervention (4 Weeks)||35
6285636|NCT00218439|7186227|FG000|COMPLETED|Second Intervention (4 Weeks)||33
6285637|NCT00218439|7186228|FG001|COMPLETED|Second Intervention (4 Weeks)||30
6285638|NCT00218439|7186227|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||7
6285639|NCT00218439|7186228|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||5
6285640|NCT00218465|7186244|FG000|STARTED|Overall Study||50
6285641|NCT00218465|7186245|FG001|STARTED|Overall Study||48
6285642|NCT00218465|7186244|FG000|COMPLETED|Overall Study||33
6285643|NCT00218465|7186245|FG001|COMPLETED|Overall Study||30
6285644|NCT00218465|7186244|FG000|NOT COMPLETED|Overall Study||17
6285645|NCT00218465|7186245|FG001|NOT COMPLETED|Overall Study||18
6285646|NCT00218491|7186254|FG000|STARTED|Overall Study||40
6285647|NCT00218491|7186255|FG001|STARTED|Overall Study||33
6285648|NCT00218491|7186256|FG002|STARTED|Overall Study||38
6285649|NCT00218491|7186254|FG000|COMPLETED|Overall Study||40
6285650|NCT00218491|7186255|FG001|COMPLETED|Overall Study||33
6285651|NCT00218491|7186256|FG002|COMPLETED|Overall Study||38
6285652|NCT00218491|7186254|FG000|NOT COMPLETED|Overall Study||0
6285653|NCT00218491|7186255|FG001|NOT COMPLETED|Overall Study||0
6633485|NCT02289833|7562133|FG000|STARTED|Overall Study||29
6633486|NCT02289833|7562134|FG001|STARTED|Overall Study||20
6633487|NCT02289833|7562133|FG000|COMPLETED|Overall Study||2
6633488|NCT02289833|7562134|FG001|COMPLETED|Overall Study||3
6633489|NCT02289833|7562133|FG000|NOT COMPLETED|Overall Study||27
6633490|NCT02289833|7562134|FG001|NOT COMPLETED|Overall Study||17
6633491|NCT02289898|7562145|FG000|STARTED|Overall Study||68
6633492|NCT02289898|7562146|FG001|STARTED|Overall Study||71
6633493|NCT02289898|7562147|FG002|STARTED|Overall Study||65
6633494|NCT02289898|7562145|FG000|COMPLETED|Overall Study||16
6633495|NCT02289898|7562146|FG001|COMPLETED|Overall Study||18
6633496|NCT02289898|7562147|FG002|COMPLETED|Overall Study||9
6633497|NCT02289898|7562145|FG000|NOT COMPLETED|Overall Study||52
6633498|NCT02289898|7562146|FG001|NOT COMPLETED|Overall Study||53
6633499|NCT02289898|7562147|FG002|NOT COMPLETED|Overall Study||56
6633500|NCT02289950|7562156|FG000|STARTED|Overall Study||142
6633501|NCT02289950|7562157|FG001|STARTED|Overall Study||72
6633502|NCT02289950|7562156|FG000|Treated|Overall Study|1 participant randomized to placebo group but was treated with farletuzumab, and was analyzed in the farletuzumab group in safety analysis set.|140
6633503|NCT02289950|7562157|FG001|Treated|Overall Study||71
6633504|NCT02289950|7562156|FG000|COMPLETED|Overall Study||0
6633505|NCT02289950|7562157|FG001|COMPLETED|Overall Study||0
6633506|NCT02289950|7562156|FG000|NOT COMPLETED|Overall Study||142
6633507|NCT02289950|7562157|FG001|NOT COMPLETED|Overall Study||72
6633508|NCT02289963|7562165|FG000|STARTED|Overall Study|Randomized|102
6633509|NCT02289963|7562166|FG001|STARTED|Overall Study|Randomized|97
6633510|NCT02289963|7562165|FG000|Treated|Overall Study||102
6633511|NCT02289963|7562166|FG001|Treated|Overall Study||97
6633512|NCT02289963|7562165|FG000|COMPLETED|Overall Study||97
6633513|NCT02289963|7562166|FG001|COMPLETED|Overall Study||87
6633514|NCT02289963|7562165|FG000|NOT COMPLETED|Overall Study||5
6633515|NCT02289963|7562166|FG001|NOT COMPLETED|Overall Study||10
6633516|NCT02289989|7562174|FG000|STARTED|Overall Study||0
6633517|NCT02289989|7562175|FG001|STARTED|Overall Study||1
6633518|NCT02289989|7562174|FG000|COMPLETED|Overall Study||0
6633519|NCT02289989|7562175|FG001|COMPLETED|Overall Study||1
6633520|NCT02289989|7562174|FG000|NOT COMPLETED|Overall Study||0
6633521|NCT02289989|7562175|FG001|NOT COMPLETED|Overall Study||0
6633522|NCT02290028|7562181|FG000|STARTED|Overall Study||2226
6633523|NCT02290028|7562181|FG000|COMPLETED|Overall Study||0
6633524|NCT02290028|7562181|FG000|NOT COMPLETED|Overall Study||2226
6285654|NCT00218491|7186256|FG002|NOT COMPLETED|Overall Study||0
6285655|NCT00218543|7186264|FG000|STARTED|Overall Study||20
6285656|NCT00218543|7186264|FG000|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
6285657|NCT00218543|7186264|FG000|NOT COMPLETED|Overall Study||15
6285658|NCT00218634|7186270|FG000|STARTED|Overall Study||44
6633525|NCT02290106|7562190|FG000|STARTED|Overall Study||25
6633526|NCT02290106|7562191|FG001|STARTED|Overall Study||25
6633527|NCT02290106|7562190|FG000|COMPLETED|Overall Study||24
6633528|NCT02290106|7562191|FG001|COMPLETED|Overall Study||23
6633529|NCT02290106|7562190|FG000|NOT COMPLETED|Overall Study||1
6285659|NCT00218634|7186271|FG001|STARTED|Overall Study||45
6633530|NCT02290106|7562191|FG001|NOT COMPLETED|Overall Study||2
6285660|NCT00218634|7186270|FG000|COMPLETED|Overall Study||36
6285661|NCT00218634|7186271|FG001|COMPLETED|Overall Study||30
6285662|NCT00218634|7186270|FG000|NOT COMPLETED|Overall Study||8
6285663|NCT00218634|7186271|FG001|NOT COMPLETED|Overall Study||15
6285664|NCT00219141|7186283|FG000|STARTED|Overall Study||154
6285665|NCT00219141|7186284|FG001|STARTED|Overall Study||152
6285666|NCT00219141|7186285|FG002|STARTED|Overall Study||154
6285667|NCT00219141|7186283|FG000|COMPLETED|Overall Study||140
6285668|NCT00219141|7186284|FG001|COMPLETED|Overall Study||131
6285669|NCT00219141|7186285|FG002|COMPLETED|Overall Study||142
6285670|NCT00219141|7186283|FG000|NOT COMPLETED|Overall Study||14
6285671|NCT00219141|7186284|FG001|NOT COMPLETED|Overall Study||21
6285672|NCT00219141|7186285|FG002|NOT COMPLETED|Overall Study||12
6285673|NCT00219284|7186295|FG000|STARTED|Treatment Phase - 16 Weeks||180
6285674|NCT00219284|7186296|FG001|STARTED|Treatment Phase - 16 Weeks||179
6285675|NCT00219284|7186295|FG000|COMPLETED|Treatment Phase - 16 Weeks||136
6285676|NCT00219284|7186296|FG001|COMPLETED|Treatment Phase - 16 Weeks||128
6285677|NCT00219284|7186295|FG000|NOT COMPLETED|Treatment Phase - 16 Weeks||44
6285678|NCT00219284|7186296|FG001|NOT COMPLETED|Treatment Phase - 16 Weeks||51
6285679|NCT00219284|7186295|FG000|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
6285680|NCT00219284|7186296|FG001|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
6285681|NCT00219284|7186295|FG000|COMPLETED|Extension Phase - 8 Weeks||112
6285682|NCT00219284|7186296|FG001|COMPLETED|Extension Phase - 8 Weeks||99
6285683|NCT00219284|7186295|FG000|NOT COMPLETED|Extension Phase - 8 Weeks||2
6285684|NCT00219284|7186296|FG001|NOT COMPLETED|Extension Phase - 8 Weeks||7
6285685|NCT00219349|7186302|FG000|STARTED|Cognitive Behavioral Therapy Phase||25
6285686|NCT00219349|7186302|FG000|COMPLETED|Cognitive Behavioral Therapy Phase||15
6633531|NCT02290184|7562199|FG000|STARTED|Overall Study||22
6633532|NCT02290184|7562200|FG001|STARTED|Overall Study||23
6633533|NCT02290184|7562199|FG000|3-month Follow-up|Overall Study|Completed initial 3-month intervention and now transition to a 3-month maintenance phase|22
6633534|NCT02290184|7562200|FG001|3-month Follow-up|Overall Study|Completed initial 3-month control period and transition to receive the 3-month intervention|23
6633535|NCT02290184|7562199|FG000|COMPLETED|Overall Study|6-month follow-up visit - completed the 3-month maintenance phase and completed study|22
6633536|NCT02290184|7562200|FG001|COMPLETED|Overall Study|6-month follow up visit - completed 3-month intervention and competed study|23
6633537|NCT02290184|7562199|FG000|NOT COMPLETED|Overall Study||0
6633538|NCT02290184|7562200|FG001|NOT COMPLETED|Overall Study||0
6633539|NCT02290223|7562214|FG000|STARTED|Baseline||189
6633540|NCT02290223|7562215|FG001|STARTED|Baseline||187
6633541|NCT02290223|7562214|FG000|COMPLETED|Baseline||189
6633542|NCT02290223|7562215|FG001|COMPLETED|Baseline||187
6633543|NCT02290223|7562214|FG000|NOT COMPLETED|Baseline||0
6633544|NCT02290223|7562215|FG001|NOT COMPLETED|Baseline||0
6633545|NCT02290223|7562214|FG000|STARTED|6 Months||189
6633546|NCT02290223|7562215|FG001|STARTED|6 Months||187
6633547|NCT02290223|7562214|FG000|COMPLETED|6 Months||173
6633548|NCT02290223|7562215|FG001|COMPLETED|6 Months||181
6633549|NCT02290223|7562214|FG000|NOT COMPLETED|6 Months||16
6633550|NCT02290223|7562215|FG001|NOT COMPLETED|6 Months||6
6633551|NCT02290223|7562214|FG000|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=7).|182
6633552|NCT02290223|7562215|FG001|STARTED|12 Months|All participants were contacted at 12 mo, unless deceased or withdrawn (n=0).|187
6633553|NCT02290223|7562214|FG000|COMPLETED|12 Months||166
6633554|NCT02290223|7562215|FG001|COMPLETED|12 Months||176
6633555|NCT02290223|7562214|FG000|NOT COMPLETED|12 Months||16
6633556|NCT02290223|7562215|FG001|NOT COMPLETED|12 Months||11
6633557|NCT02290340|7562225|FG000|STARTED|Overall Study||18
6633558|NCT02290340|7562226|FG001|STARTED|Overall Study||8
6633559|NCT02290340|7562227|FG002|STARTED|Overall Study||31
6633560|NCT02290340|7562228|FG003|STARTED|Overall Study||32
6633561|NCT02290340|7562225|FG000|COMPLETED|Overall Study||16
6633562|NCT02290340|7562226|FG001|COMPLETED|Overall Study||8
6633563|NCT02290340|7562227|FG002|COMPLETED|Overall Study||31
6633564|NCT02290340|7562228|FG003|COMPLETED|Overall Study||30
6633565|NCT02290340|7562225|FG000|NOT COMPLETED|Overall Study||2
6633566|NCT02290340|7562226|FG001|NOT COMPLETED|Overall Study||0
6633567|NCT02290340|7562227|FG002|NOT COMPLETED|Overall Study||0
6633568|NCT02290340|7562228|FG003|NOT COMPLETED|Overall Study||2
6633569|NCT02290405|7562243|FG000|STARTED|Overall Study||36
6633570|NCT02290405|7562244|FG001|STARTED|Overall Study||53
6633571|NCT02290405|7562243|FG000|COMPLETED|Overall Study||35
6633572|NCT02290405|7562244|FG001|COMPLETED|Overall Study||53
6633573|NCT02290405|7562243|FG000|NOT COMPLETED|Overall Study||1
6633574|NCT02290405|7562244|FG001|NOT COMPLETED|Overall Study||0
6633575|NCT02290444|7562252|FG000|STARTED|Overall Study||30
6633576|NCT02290444|7562253|FG001|STARTED|Overall Study||34
6633577|NCT02290444|7562252|FG000|COMPLETED|Overall Study||29
6633578|NCT02290444|7562253|FG001|COMPLETED|Overall Study||32
6633579|NCT02290444|7562252|FG000|NOT COMPLETED|Overall Study||1
6633580|NCT02290444|7562253|FG001|NOT COMPLETED|Overall Study||2
6633581|NCT02290509|7562261|FG000|STARTED|Overall Study||1011
6633582|NCT02290509|7562262|FG001|STARTED|Overall Study||339
6633583|NCT02290509|7562261|FG000|COMPLETED|Overall Study||962
6743334|NCT03334396|7671621|FG007|NOT COMPLETED|Overall Study||1
6633584|NCT02290509|7562262|FG001|COMPLETED|Overall Study||325
6633585|NCT02290509|7562261|FG000|NOT COMPLETED|Overall Study||49
6633586|NCT02290509|7562262|FG001|NOT COMPLETED|Overall Study||14
6285687|NCT00219349|7186302|FG000|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
6285688|NCT00219349|7186302|FG000|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|7
6285689|NCT00219349|7186302|FG000|COMPLETED|Escitalopram Phase||4
6285690|NCT00219349|7186302|FG000|NOT COMPLETED|Escitalopram Phase||3
6285691|NCT00219544|7186306|FG000|STARTED|Single Blind Treatment Period||256
6285692|NCT00219544|7186307|FG001|STARTED|Single Blind Treatment Period||0
6285693|NCT00219544|7186306|FG000|COMPLETED|Single Blind Treatment Period||234
6285694|NCT00219544|7186307|FG001|COMPLETED|Single Blind Treatment Period||0
6285695|NCT00219544|7186306|FG000|NOT COMPLETED|Single Blind Treatment Period||22
6285696|NCT00219544|7186307|FG001|NOT COMPLETED|Single Blind Treatment Period||0
6285697|NCT00219544|7186306|FG000|STARTED|Double Blind Treatment Period||80
6285698|NCT00219544|7186307|FG001|STARTED|Double Blind Treatment Period||77
6285699|NCT00219544|7186306|FG000|COMPLETED|Double Blind Treatment Period||80
6285700|NCT00219544|7186307|FG001|COMPLETED|Double Blind Treatment Period||77
6285701|NCT00219544|7186306|FG000|NOT COMPLETED|Double Blind Treatment Period||0
6285702|NCT00219544|7186307|FG001|NOT COMPLETED|Double Blind Treatment Period||0
6285703|NCT00219557|7186318|FG000|STARTED|Phase 1||8
6285704|NCT00219557|7186319|FG001|STARTED|Phase 1||0
6285705|NCT00219557|7186320|FG002|STARTED|Phase 1||0
6285706|NCT00219557|7186318|FG000|COMPLETED|Phase 1||1
6285707|NCT00219557|7186319|FG001|COMPLETED|Phase 1||0
6285708|NCT00219557|7186320|FG002|COMPLETED|Phase 1||0
6285709|NCT00219557|7186318|FG000|NOT COMPLETED|Phase 1||7
6285710|NCT00219557|7186319|FG001|NOT COMPLETED|Phase 1||0
6285711|NCT00219557|7186320|FG002|NOT COMPLETED|Phase 1||0
6285712|NCT00219557|7186318|FG000|STARTED|Phase 2||0
6285713|NCT00219557|7186319|FG001|STARTED|Phase 2||69
6285714|NCT00219557|7186320|FG002|STARTED|Phase 2||34
6285715|NCT00219557|7186318|FG000|Treated|Phase 2||0
6285716|NCT00219557|7186319|FG001|Treated|Phase 2||68
6285717|NCT00219557|7186320|FG002|Treated|Phase 2||31
6633587|NCT02290574|7562268|FG000|STARTED|Overall Study||14
6633588|NCT02290574|7562268|FG000|COMPLETED|Overall Study||13
6633589|NCT02290574|7562268|FG000|NOT COMPLETED|Overall Study||1
6633590|NCT02290613|7562275|FG000|STARTED|Overall Study||19
6633591|NCT02290613|7562276|FG001|STARTED|Overall Study||19
6633592|NCT02290613|7562275|FG000|COMPLETED|Overall Study||17
6633593|NCT02290613|7562276|FG001|COMPLETED|Overall Study||15
6633594|NCT02290613|7562275|FG000|NOT COMPLETED|Overall Study||2
6633595|NCT02290613|7562276|FG001|NOT COMPLETED|Overall Study||4
6633596|NCT02290691|7562284|FG000|STARTED|Overall Study||496
6633597|NCT02290691|7562285|FG001|STARTED|Overall Study||488
6633598|NCT02290691|7562284|FG000|COMPLETED|Overall Study||488
6633599|NCT02290691|7562285|FG001|COMPLETED|Overall Study||479
6633600|NCT02290691|7562284|FG000|NOT COMPLETED|Overall Study||8
6633601|NCT02290691|7562285|FG001|NOT COMPLETED|Overall Study||9
6633602|NCT02290821|7562293|FG000|STARTED|Overall Study||109
6633603|NCT02290821|7562294|FG001|STARTED|Overall Study||106
6633604|NCT02290821|7562293|FG000|COMPLETED|Overall Study||103
6633605|NCT02290821|7562294|FG001|COMPLETED|Overall Study||103
6633606|NCT02290821|7562293|FG000|NOT COMPLETED|Overall Study||6
6633607|NCT02290821|7562294|FG001|NOT COMPLETED|Overall Study||3
6633608|NCT02290873|7562303|FG000|STARTED|Overall Study||298
6633609|NCT02290873|7562304|FG001|STARTED|Overall Study||60
6633610|NCT02290873|7562305|FG002|STARTED|Overall Study||103
6633611|NCT02290873|7562303|FG000|Modified Intention to Treat (mITT)|Overall Study||296
6633612|NCT02290873|7562304|FG001|Modified Intention to Treat (mITT)|Overall Study||60
6633613|NCT02290873|7562305|FG002|Modified Intention to Treat (mITT)|Overall Study||102
6633614|NCT02290873|7562303|FG000|Safety Population|Overall Study||296
6633615|NCT02290873|7562304|FG001|Safety Population|Overall Study||60
6633616|NCT02290873|7562305|FG002|Safety Population|Overall Study||102
6633617|NCT02290873|7562303|FG000|COMPLETED|Overall Study||296
6633618|NCT02290873|7562304|FG001|COMPLETED|Overall Study||59
6633619|NCT02290873|7562305|FG002|COMPLETED|Overall Study||101
6633620|NCT02290873|7562303|FG000|NOT COMPLETED|Overall Study||2
6633621|NCT02290873|7562304|FG001|NOT COMPLETED|Overall Study||1
6633622|NCT02290873|7562305|FG002|NOT COMPLETED|Overall Study||2
6633623|NCT02290925|7562316|FG000|STARTED|First Period of Three Months||62
6633624|NCT02290925|7562317|FG001|STARTED|First Period of Three Months||71
6633625|NCT02290925|7562316|FG000|COMPLETED|First Period of Three Months||58
6633626|NCT02290925|7562317|FG001|COMPLETED|First Period of Three Months||69
6633627|NCT02290925|7562316|FG000|NOT COMPLETED|First Period of Three Months||4
6285718|NCT00219557|7186318|FG000|COMPLETED|Phase 2||0
6285719|NCT00219557|7186319|FG001|COMPLETED|Phase 2||0
6285720|NCT00219557|7186320|FG002|COMPLETED|Phase 2||1
6285721|NCT00219557|7186318|FG000|NOT COMPLETED|Phase 2||0
6285722|NCT00219557|7186319|FG001|NOT COMPLETED|Phase 2||69
6285723|NCT00219557|7186320|FG002|NOT COMPLETED|Phase 2||33
6285724|NCT00220636|7186329|FG000|STARTED|Overall Study||15
6285725|NCT00220636|7186329|FG000|COMPLETED|Overall Study||11
6633628|NCT02290925|7562317|FG001|NOT COMPLETED|First Period of Three Months||2
6633629|NCT02290925|7562316|FG000|STARTED|Second Period of 3 Months||58
6633630|NCT02290925|7562317|FG001|STARTED|Second Period of 3 Months||69
6633631|NCT02290925|7562316|FG000|COMPLETED|Second Period of 3 Months||57
6633632|NCT02290925|7562317|FG001|COMPLETED|Second Period of 3 Months||65
6633633|NCT02290925|7562316|FG000|NOT COMPLETED|Second Period of 3 Months||1
6633634|NCT02290925|7562317|FG001|NOT COMPLETED|Second Period of 3 Months||4
6633635|NCT02291016|7562327|FG000|STARTED|Visit 1||2
6633636|NCT02291016|7562328|FG001|STARTED|Visit 1||5
6285726|NCT00220636|7186329|FG000|NOT COMPLETED|Overall Study||4
6285727|NCT00220701|7186336|FG000|STARTED|Overall Study||17
6285728|NCT00220701|7186337|FG001|STARTED|Overall Study||17
6285729|NCT00220701|7186336|FG000|COMPLETED|Overall Study||12
6285730|NCT00220701|7186337|FG001|COMPLETED|Overall Study||13
6285731|NCT00220701|7186336|FG000|NOT COMPLETED|Overall Study||5
6285732|NCT00220701|7186337|FG001|NOT COMPLETED|Overall Study||4
6285733|NCT00220727|7186345|FG000|STARTED|First Infusion (Week 0)||4
6285734|NCT00220727|7186346|FG001|STARTED|First Infusion (Week 0)||4
6285735|NCT00220727|7186345|FG000|COMPLETED|First Infusion (Week 0)||4
6285736|NCT00220727|7186346|FG001|COMPLETED|First Infusion (Week 0)||4
6285737|NCT00220727|7186345|FG000|NOT COMPLETED|First Infusion (Week 0)||0
6285738|NCT00220727|7186346|FG001|NOT COMPLETED|First Infusion (Week 0)||0
6285739|NCT00220727|7186345|FG000|STARTED|Second Infusion (Week <6)||4
6285740|NCT00220727|7186346|FG001|STARTED|Second Infusion (Week <6)||4
6285741|NCT00220727|7186345|FG000|COMPLETED|Second Infusion (Week <6)||3
6285742|NCT00220727|7186346|FG001|COMPLETED|Second Infusion (Week <6)||4
6285743|NCT00220727|7186345|FG000|NOT COMPLETED|Second Infusion (Week <6)||1
6285744|NCT00220727|7186346|FG001|NOT COMPLETED|Second Infusion (Week <6)||0
6285745|NCT00220740|7186356|FG000|STARTED|Efficacy Period||59
6285746|NCT00220740|7186357|FG001|STARTED|Efficacy Period||58
6285747|NCT00220740|7186356|FG000|COMPLETED|Efficacy Period||33
6633637|NCT02291016|7562327|FG000|COMPLETED|Visit 1||2
6633638|NCT02291016|7562328|FG001|COMPLETED|Visit 1||5
6633639|NCT02291016|7562327|FG000|NOT COMPLETED|Visit 1||0
6633640|NCT02291016|7562328|FG001|NOT COMPLETED|Visit 1||0
6633641|NCT02291016|7562327|FG000|STARTED|Visit 2||2
6633642|NCT02291016|7562328|FG001|STARTED|Visit 2||5
6633643|NCT02291016|7562327|FG000|COMPLETED|Visit 2|Patients did not meet visit 2 FEV1 criteria ( 15% or closer to value at visit 1)|1
6633644|NCT02291016|7562328|FG001|COMPLETED|Visit 2||5
6633645|NCT02291016|7562327|FG000|NOT COMPLETED|Visit 2||1
6633646|NCT02291016|7562328|FG001|NOT COMPLETED|Visit 2||0
6633647|NCT02291029|7562341|FG000|STARTED|Overall Study||8
6633648|NCT02291029|7562342|FG001|STARTED|Overall Study||4
6633649|NCT02291029|7562343|FG002|STARTED|Overall Study||21
6633650|NCT02291029|7562344|FG003|STARTED|Overall Study||11
6633651|NCT02291029|7562345|FG004|STARTED|Overall Study||13
6633652|NCT02291029|7562346|FG005|STARTED|Overall Study||12
6633653|NCT02291029|7562341|FG000|COMPLETED|Overall Study||8
6633654|NCT02291029|7562342|FG001|COMPLETED|Overall Study||3
6633655|NCT02291029|7562343|FG002|COMPLETED|Overall Study||20
6633656|NCT02291029|7562344|FG003|COMPLETED|Overall Study||11
6633657|NCT02291029|7562345|FG004|COMPLETED|Overall Study||13
6633658|NCT02291029|7562346|FG005|COMPLETED|Overall Study||12
6633659|NCT02291029|7562341|FG000|NOT COMPLETED|Overall Study||0
6633660|NCT02291029|7562342|FG001|NOT COMPLETED|Overall Study||1
6633661|NCT02291029|7562343|FG002|NOT COMPLETED|Overall Study||1
6633662|NCT02291029|7562344|FG003|NOT COMPLETED|Overall Study||0
6633663|NCT02291029|7562345|FG004|NOT COMPLETED|Overall Study||0
6633664|NCT02291029|7562346|FG005|NOT COMPLETED|Overall Study||0
6633665|NCT02291133|7562360|FG000|STARTED|Overall Study||25
6633666|NCT02291133|7562360|FG000|COMPLETED|Overall Study||24
6633667|NCT02291133|7562360|FG000|NOT COMPLETED|Overall Study||1
6633668|NCT02291237|7562366|FG000|STARTED|Overall Study||86
6633669|NCT02291237|7562367|FG001|STARTED|Overall Study||86
6633670|NCT02291237|7562366|FG000|COMPLETED|Overall Study||0
6633671|NCT02291237|7562367|FG001|COMPLETED|Overall Study||0
6633672|NCT02291237|7562366|FG000|NOT COMPLETED|Overall Study||86
6633673|NCT02291237|7562367|FG001|NOT COMPLETED|Overall Study||86
6633674|NCT02291289|7562377|FG000|STARTED|Induction Treatment||60
6633675|NCT02291289|7562378|FG001|STARTED|Induction Treatment||0
6633676|NCT02291289|7562379|FG002|STARTED|Induction Treatment||0
6633677|NCT02291289|7562380|FG003|STARTED|Induction Treatment||445
6633678|NCT02291289|7562381|FG004|STARTED|Induction Treatment||0
6633679|NCT02291289|7562382|FG005|STARTED|Induction Treatment||0
6633680|NCT02291289|7562383|FG006|STARTED|Induction Treatment||5
6633681|NCT02291289|7562384|FG007|STARTED|Induction Treatment||0
6633682|NCT02291289|7562385|FG008|STARTED|Induction Treatment||0
6633683|NCT02291289|7562386|FG009|STARTED|Induction Treatment||99
6633684|NCT02291289|7562387|FG010|STARTED|Induction Treatment||0
6633685|NCT02291289|7562388|FG011|STARTED|Induction Treatment||0
6633686|NCT02291289|7562377|FG000|COMPLETED|Induction Treatment||58
6633687|NCT02291289|7562378|FG001|COMPLETED|Induction Treatment||0
6633688|NCT02291289|7562379|FG002|COMPLETED|Induction Treatment||0
6633689|NCT02291289|7562380|FG003|COMPLETED|Induction Treatment||436
6633690|NCT02291289|7562381|FG004|COMPLETED|Induction Treatment||0
6633691|NCT02291289|7562382|FG005|COMPLETED|Induction Treatment||0
6633692|NCT02291289|7562383|FG006|COMPLETED|Induction Treatment||5
6285748|NCT00220740|7186357|FG001|COMPLETED|Efficacy Period||12
6285749|NCT00220740|7186356|FG000|NOT COMPLETED|Efficacy Period||26
6285750|NCT00220740|7186357|FG001|NOT COMPLETED|Efficacy Period||46
6633693|NCT02291289|7562384|FG007|COMPLETED|Induction Treatment||0
6633694|NCT02291289|7562385|FG008|COMPLETED|Induction Treatment||0
6633695|NCT02291289|7562386|FG009|COMPLETED|Induction Treatment||98
6633696|NCT02291289|7562387|FG010|COMPLETED|Induction Treatment||0
6633697|NCT02291289|7562388|FG011|COMPLETED|Induction Treatment||0
6633698|NCT02291289|7562377|FG000|NOT COMPLETED|Induction Treatment||2
6633699|NCT02291289|7562378|FG001|NOT COMPLETED|Induction Treatment||0
6633700|NCT02291289|7562379|FG002|NOT COMPLETED|Induction Treatment||0
6633701|NCT02291289|7562380|FG003|NOT COMPLETED|Induction Treatment||9
6285751|NCT00220740|7186356|FG000|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
6285752|NCT00220740|7186357|FG001|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
6285753|NCT00220740|7186356|FG000|COMPLETED|Rescue Treatment||26
6285754|NCT00220740|7186357|FG001|COMPLETED|Rescue Treatment||5
6285755|NCT00220740|7186356|FG000|NOT COMPLETED|Rescue Treatment||19
6285756|NCT00220740|7186357|FG001|NOT COMPLETED|Rescue Treatment||18
6285757|NCT00220740|7186356|FG000|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
6285758|NCT00220740|7186357|FG001|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
6285759|NCT00220740|7186356|FG000|COMPLETED|Withdrawal Period||37
6285760|NCT00220740|7186357|FG001|COMPLETED|Withdrawal Period||16
6285761|NCT00220740|7186356|FG000|NOT COMPLETED|Withdrawal Period||6
6285762|NCT00220740|7186357|FG001|NOT COMPLETED|Withdrawal Period||15
6285763|NCT00220779|7186368|FG000|STARTED|Overall Study||45
6285764|NCT00220779|7186369|FG001|STARTED|Overall Study||42
6285765|NCT00220779|7186370|FG002|STARTED|Overall Study||41
6285766|NCT00220779|7186368|FG000|COMPLETED|Overall Study||38
6285767|NCT00220779|7186369|FG001|COMPLETED|Overall Study||38
6285768|NCT00220779|7186370|FG002|COMPLETED|Overall Study||37
6285769|NCT00220779|7186368|FG000|NOT COMPLETED|Overall Study||7
6285770|NCT00220779|7186369|FG001|NOT COMPLETED|Overall Study||4
6285771|NCT00220779|7186370|FG002|NOT COMPLETED|Overall Study||4
6285772|NCT00220805|7186380|FG000|STARTED|Overall Study||30
6285773|NCT00220805|7186381|FG001|STARTED|Overall Study||27
6285774|NCT00220805|7186380|FG000|COMPLETED|Overall Study||22
6285775|NCT00220805|7186381|FG001|COMPLETED|Overall Study||16
6285776|NCT00220805|7186380|FG000|NOT COMPLETED|Overall Study||8
6285777|NCT00220805|7186381|FG001|NOT COMPLETED|Overall Study||11
6285778|NCT00220961|7186389|FG000|STARTED|Overall Study||299
6285779|NCT00220961|7186390|FG001|STARTED|Overall Study||303
6285780|NCT00220961|7186389|FG000|COMPLETED|Overall Study||228
6285781|NCT00220961|7186390|FG001|COMPLETED|Overall Study||213
6285782|NCT00220961|7186389|FG000|NOT COMPLETED|Overall Study||71
6285783|NCT00220961|7186390|FG001|NOT COMPLETED|Overall Study||90
6285784|NCT00221104|7186398|FG000|STARTED|Overall Study||793
6285785|NCT00221104|7186399|FG001|STARTED|Overall Study||785
6285786|NCT00221104|7186398|FG000|COMPLETED|Overall Study||710
6285787|NCT00221104|7186399|FG001|COMPLETED|Overall Study||709
6285788|NCT00221104|7186398|FG000|NOT COMPLETED|Overall Study||83
6285789|NCT00221104|7186399|FG001|NOT COMPLETED|Overall Study||76
6285790|NCT00221117|7186409|FG000|STARTED|Overall Study||12
6285791|NCT00221117|7186410|FG001|STARTED|Overall Study|One participant dropped out of the study after signing consent but prior to baseline assessments.|9
6285792|NCT00221117|7186409|FG000|COMPLETED|Overall Study||12
6633702|NCT02291289|7562381|FG004|NOT COMPLETED|Induction Treatment||0
6633703|NCT02291289|7562382|FG005|NOT COMPLETED|Induction Treatment||0
6633704|NCT02291289|7562383|FG006|NOT COMPLETED|Induction Treatment||0
6633705|NCT02291289|7562384|FG007|NOT COMPLETED|Induction Treatment||0
6633706|NCT02291289|7562385|FG008|NOT COMPLETED|Induction Treatment||0
6633707|NCT02291289|7562386|FG009|NOT COMPLETED|Induction Treatment||1
6633708|NCT02291289|7562387|FG010|NOT COMPLETED|Induction Treatment||0
6633709|NCT02291289|7562388|FG011|NOT COMPLETED|Induction Treatment||0
6633710|NCT02291289|7562377|FG000|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
6633711|NCT02291289|7562378|FG001|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|40
6633712|NCT02291289|7562379|FG002|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|20
6633713|NCT02291289|7562380|FG003|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
6633714|NCT02291289|7562381|FG004|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|297
6633715|NCT02291289|7562382|FG005|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|148
6633716|NCT02291289|7562383|FG006|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
6633717|NCT02291289|7562384|FG007|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|3
6633718|NCT02291289|7562385|FG008|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|2
6633719|NCT02291289|7562386|FG009|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|0
6633720|NCT02291289|7562387|FG010|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|65
6633721|NCT02291289|7562388|FG011|STARTED|Maintenance Treatment Phase|Participants from IP Cohorts were randomized to the MP Cohorts based on bio-marker assessments.|34
6633722|NCT02291289|7562377|FG000|Dosed|Maintenance Treatment Phase||0
6633723|NCT02291289|7562378|FG001|Dosed|Maintenance Treatment Phase||40
6285793|NCT00221117|7186410|FG001|COMPLETED|Overall Study||9
6285794|NCT00221117|7186409|FG000|NOT COMPLETED|Overall Study||0
6285795|NCT00221117|7186410|FG001|NOT COMPLETED|Overall Study||0
6285796|NCT00221195|7186420|FG000|STARTED|Therapy 1 (Months 1-6)||17
6285797|NCT00221195|7186421|FG001|STARTED|Therapy 1 (Months 1-6)||17
6285798|NCT00221195|7186420|FG000|COMPLETED|Therapy 1 (Months 1-6)||14
6285799|NCT00221195|7186421|FG001|COMPLETED|Therapy 1 (Months 1-6)||15
6285800|NCT00221195|7186420|FG000|NOT COMPLETED|Therapy 1 (Months 1-6)||3
6285801|NCT00221195|7186421|FG001|NOT COMPLETED|Therapy 1 (Months 1-6)||2
6285802|NCT00221195|7186420|FG000|STARTED|Washout Period (Months 7-9)||14
6285803|NCT00221195|7186421|FG001|STARTED|Washout Period (Months 7-9)||15
6285804|NCT00221195|7186420|FG000|COMPLETED|Washout Period (Months 7-9)||14
6285805|NCT00221195|7186421|FG001|COMPLETED|Washout Period (Months 7-9)||14
6285806|NCT00221195|7186420|FG000|NOT COMPLETED|Washout Period (Months 7-9)||0
6285807|NCT00221195|7186421|FG001|NOT COMPLETED|Washout Period (Months 7-9)||1
6285808|NCT00221195|7186420|FG000|STARTED|Therapy 2 (Months 10-15)||14
6285809|NCT00221195|7186421|FG001|STARTED|Therapy 2 (Months 10-15)||14
6285810|NCT00221195|7186420|FG000|COMPLETED|Therapy 2 (Months 10-15)||12
6285811|NCT00221195|7186421|FG001|COMPLETED|Therapy 2 (Months 10-15)||14
6285812|NCT00221195|7186420|FG000|NOT COMPLETED|Therapy 2 (Months 10-15)||2
6285813|NCT00221195|7186421|FG001|NOT COMPLETED|Therapy 2 (Months 10-15)||0
6285814|NCT00221299|7186431|FG000|STARTED|Overall Study||11
6633724|NCT02291289|7562379|FG002|Dosed|Maintenance Treatment Phase||18
6633725|NCT02291289|7562380|FG003|Dosed|Maintenance Treatment Phase||0
6633726|NCT02291289|7562381|FG004|Dosed|Maintenance Treatment Phase||293
6633727|NCT02291289|7562382|FG005|Dosed|Maintenance Treatment Phase||143
6633728|NCT02291289|7562383|FG006|Dosed|Maintenance Treatment Phase||0
6633729|NCT02291289|7562384|FG007|Dosed|Maintenance Treatment Phase||3
6633730|NCT02291289|7562385|FG008|Dosed|Maintenance Treatment Phase||2
6633731|NCT02291289|7562386|FG009|Dosed|Maintenance Treatment Phase||0
6633732|NCT02291289|7562387|FG010|Dosed|Maintenance Treatment Phase||64
6633733|NCT02291289|7562388|FG011|Dosed|Maintenance Treatment Phase||34
6633734|NCT02291289|7562377|FG000|COMPLETED|Maintenance Treatment Phase||0
6633735|NCT02291289|7562378|FG001|COMPLETED|Maintenance Treatment Phase||16
6633736|NCT02291289|7562379|FG002|COMPLETED|Maintenance Treatment Phase||4
6633737|NCT02291289|7562380|FG003|COMPLETED|Maintenance Treatment Phase||0
6633738|NCT02291289|7562381|FG004|COMPLETED|Maintenance Treatment Phase||45
6633739|NCT02291289|7562382|FG005|COMPLETED|Maintenance Treatment Phase||19
6633740|NCT02291289|7562383|FG006|COMPLETED|Maintenance Treatment Phase||0
6633741|NCT02291289|7562384|FG007|COMPLETED|Maintenance Treatment Phase||1
6633742|NCT02291289|7562385|FG008|COMPLETED|Maintenance Treatment Phase||0
6633743|NCT02291289|7562386|FG009|COMPLETED|Maintenance Treatment Phase||0
6633744|NCT02291289|7562387|FG010|COMPLETED|Maintenance Treatment Phase||34
6633745|NCT02291289|7562388|FG011|COMPLETED|Maintenance Treatment Phase||18
6633746|NCT02291289|7562377|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
6633747|NCT02291289|7562378|FG001|NOT COMPLETED|Maintenance Treatment Phase||24
6633748|NCT02291289|7562379|FG002|NOT COMPLETED|Maintenance Treatment Phase||16
6633749|NCT02291289|7562380|FG003|NOT COMPLETED|Maintenance Treatment Phase||0
6633750|NCT02291289|7562381|FG004|NOT COMPLETED|Maintenance Treatment Phase||252
6633751|NCT02291289|7562382|FG005|NOT COMPLETED|Maintenance Treatment Phase||129
6633752|NCT02291289|7562383|FG006|NOT COMPLETED|Maintenance Treatment Phase||0
6633753|NCT02291289|7562384|FG007|NOT COMPLETED|Maintenance Treatment Phase||2
6633754|NCT02291289|7562385|FG008|NOT COMPLETED|Maintenance Treatment Phase||2
6633755|NCT02291289|7562386|FG009|NOT COMPLETED|Maintenance Treatment Phase||0
6633756|NCT02291289|7562387|FG010|NOT COMPLETED|Maintenance Treatment Phase||31
6633757|NCT02291289|7562388|FG011|NOT COMPLETED|Maintenance Treatment Phase||16
6633758|NCT02291302|7562417|FG000|STARTED|Overall Study||59
6633759|NCT02291302|7562418|FG001|STARTED|Overall Study||59
6633760|NCT02291302|7562419|FG002|STARTED|Overall Study||59
6633761|NCT02291302|7562420|FG003|STARTED|Overall Study||59
6633762|NCT02291302|7562417|FG000|COMPLETED|Overall Study||59
6633763|NCT02291302|7562418|FG001|COMPLETED|Overall Study||59
6633764|NCT02291302|7562419|FG002|COMPLETED|Overall Study||59
6633765|NCT02291302|7562420|FG003|COMPLETED|Overall Study||59
6633766|NCT02291302|7562417|FG000|NOT COMPLETED|Overall Study||0
6633767|NCT02291302|7562418|FG001|NOT COMPLETED|Overall Study||0
6633768|NCT02291302|7562419|FG002|NOT COMPLETED|Overall Study||0
6633769|NCT02291302|7562420|FG003|NOT COMPLETED|Overall Study||0
6633770|NCT02291419|7562432|FG000|STARTED|Overall Study||1
6633771|NCT02291419|7562433|FG001|STARTED|Overall Study||5
6633772|NCT02291419|7562432|FG000|COMPLETED|Overall Study||0
6633773|NCT02291419|7562433|FG001|COMPLETED|Overall Study||0
6633774|NCT02291419|7562432|FG000|NOT COMPLETED|Overall Study||1
6633775|NCT02291419|7562433|FG001|NOT COMPLETED|Overall Study||5
6633776|NCT02291432|7562439|FG000|STARTED|Overall Study||25
6633777|NCT02291432|7562439|FG000|Muscle Biopsy|Overall Study||25
6633778|NCT02291432|7562439|FG000|AMDC Injection|Overall Study||23
6285815|NCT00221299|7186432|FG001|STARTED|Overall Study||13
6285816|NCT00221299|7186433|FG002|STARTED|Overall Study||14
6633779|NCT02291432|7562439|FG000|1-Month Follow Up|Overall Study||23
6633780|NCT02291432|7562439|FG000|3-Month Follow Up|Overall Study||23
6633781|NCT02291432|7562439|FG000|6-Month Follow Up|Overall Study||23
6633782|NCT02291432|7562439|FG000|12-Month Follow Up|Overall Study||23
6633783|NCT02291432|7562439|FG000|COMPLETED|Overall Study||23
6633784|NCT02291432|7562439|FG000|NOT COMPLETED|Overall Study||2
6633785|NCT02291510|7562447|FG000|STARTED|Overall Study||5
6633786|NCT02291510|7562448|FG001|STARTED|Overall Study||5
6633787|NCT02291510|7562449|FG002|STARTED|Overall Study||5
6633788|NCT02291510|7562450|FG003|STARTED|Overall Study||5
6633789|NCT02291510|7562447|FG000|Completed Treatment A|Overall Study||5
6285817|NCT00221299|7186434|FG003|STARTED|Overall Study||11
6285818|NCT00221299|7186431|FG000|COMPLETED|Overall Study||10
6285819|NCT00221299|7186432|FG001|COMPLETED|Overall Study||11
6285820|NCT00221299|7186433|FG002|COMPLETED|Overall Study||14
6285821|NCT00221299|7186434|FG003|COMPLETED|Overall Study||10
6285822|NCT00221299|7186431|FG000|NOT COMPLETED|Overall Study||1
6285823|NCT00221299|7186432|FG001|NOT COMPLETED|Overall Study||2
6285824|NCT00221299|7186433|FG002|NOT COMPLETED|Overall Study||0
6285825|NCT00221299|7186434|FG003|NOT COMPLETED|Overall Study||1
6285826|NCT00221338|7186444|FG000|STARTED|Overall Study||374
6285827|NCT00221338|7186445|FG001|STARTED|Overall Study||376
6285828|NCT00221338|7186444|FG000|COMPLETED|Overall Study||350
6285829|NCT00221338|7186445|FG001|COMPLETED|Overall Study||347
6633790|NCT02291510|7562448|FG001|Completed Treatment A|Overall Study||5
6633791|NCT02291510|7562449|FG002|Completed Treatment A|Overall Study||5
6633792|NCT02291510|7562450|FG003|Completed Treatment A|Overall Study||5
6633793|NCT02291510|7562447|FG000|Completed Treatment B|Overall Study||5
6633794|NCT02291510|7562448|FG001|Completed Treatment B|Overall Study||5
6633795|NCT02291510|7562449|FG002|Completed Treatment B|Overall Study||5
6285830|NCT00221338|7186444|FG000|NOT COMPLETED|Overall Study||24
6285831|NCT00221338|7186445|FG001|NOT COMPLETED|Overall Study||29
6285832|NCT00221403|7186454|FG000|STARTED|Overall Study||18
6285833|NCT00221403|7186455|FG001|STARTED|Overall Study||21
6285834|NCT00221403|7186456|FG002|STARTED|Overall Study||7
6285835|NCT00221403|7186454|FG000|COMPLETED|Overall Study||16
6633796|NCT02291510|7562450|FG003|Completed Treatment B|Overall Study||4
6633797|NCT02291510|7562447|FG000|Completed Treatment C|Overall Study||5
6633798|NCT02291510|7562448|FG001|Completed Treatment C|Overall Study||5
6633799|NCT02291510|7562449|FG002|Completed Treatment C|Overall Study||5
6633800|NCT02291510|7562450|FG003|Completed Treatment C|Overall Study||4
6633801|NCT02291510|7562447|FG000|Completed Treatment D|Overall Study||5
6633802|NCT02291510|7562448|FG001|Completed Treatment D|Overall Study||5
6633803|NCT02291510|7562449|FG002|Completed Treatment D|Overall Study||5
6633804|NCT02291510|7562450|FG003|Completed Treatment D|Overall Study||5
6633805|NCT02291510|7562447|FG000|COMPLETED|Overall Study||5
6633806|NCT02291510|7562448|FG001|COMPLETED|Overall Study||5
6633807|NCT02291510|7562449|FG002|COMPLETED|Overall Study||5
6633808|NCT02291510|7562450|FG003|COMPLETED|Overall Study||4
6633809|NCT02291510|7562447|FG000|NOT COMPLETED|Overall Study||0
6633810|NCT02291510|7562448|FG001|NOT COMPLETED|Overall Study||0
6633811|NCT02291510|7562449|FG002|NOT COMPLETED|Overall Study||0
6633812|NCT02291510|7562450|FG003|NOT COMPLETED|Overall Study||1
6633813|NCT02291549|7562462|FG000|STARTED|Overall Study||201
6633814|NCT02291549|7562463|FG001|STARTED|Overall Study||99
6633815|NCT02291549|7562462|FG000|COMPLETED|Overall Study||200
6633816|NCT02291549|7562463|FG001|COMPLETED|Overall Study||98
6633817|NCT02291549|7562462|FG000|NOT COMPLETED|Overall Study||1
6633818|NCT02291549|7562463|FG001|NOT COMPLETED|Overall Study||1
6633819|NCT02291601|7562471|FG000|STARTED|Abdomen||638
6633820|NCT02291601|7562472|FG001|STARTED|Abdomen||108
6633821|NCT02291601|7562473|FG002|STARTED|Abdomen||642
6633822|NCT02291601|7562471|FG000|COMPLETED|Abdomen|638 participants received CHG cloth|305
6633823|NCT02291601|7562472|FG001|COMPLETED|Abdomen|108 participants received vehicle|54
6633824|NCT02291601|7562473|FG002|COMPLETED|Abdomen|642 participants received comparator CHG|303
6633825|NCT02291601|7562471|FG000|NOT COMPLETED|Abdomen||333
6633826|NCT02291601|7562472|FG001|NOT COMPLETED|Abdomen||54
6633827|NCT02291601|7562473|FG002|NOT COMPLETED|Abdomen||339
6633828|NCT02291601|7562471|FG000|STARTED|Groin||520
6633829|NCT02291601|7562472|FG001|STARTED|Groin||93
6633830|NCT02291601|7562473|FG002|STARTED|Groin||515
6633831|NCT02291601|7562471|FG000|COMPLETED|Groin|520 participants received CHG cloth|337
6633832|NCT02291601|7562472|FG001|COMPLETED|Groin|93 participants received vehicle|63
6633833|NCT02291601|7562473|FG002|COMPLETED|Groin|515 participants received Comparator CHG|338
6633834|NCT02291601|7562471|FG000|NOT COMPLETED|Groin||183
6633835|NCT02291601|7562472|FG001|NOT COMPLETED|Groin||30
6633836|NCT02291601|7562473|FG002|NOT COMPLETED|Groin||177
6633837|NCT02291614|7562495|FG000|STARTED|Overall Study||3
6633838|NCT02291614|7562496|FG001|STARTED|Overall Study||3
6633839|NCT02291614|7562497|FG002|STARTED|Overall Study||3
6633840|NCT02291614|7562498|FG003|STARTED|Overall Study||5
6633841|NCT02291614|7562499|FG004|STARTED|Overall Study||3
6633842|NCT02291614|7562500|FG005|STARTED|Overall Study||3
6633843|NCT02291614|7562501|FG006|STARTED|Overall Study||6
6633844|NCT02291614|7562502|FG007|STARTED|Overall Study||3
6285836|NCT00221403|7186455|FG001|COMPLETED|Overall Study||16
6285837|NCT00221403|7186456|FG002|COMPLETED|Overall Study||7
6285838|NCT00221403|7186454|FG000|NOT COMPLETED|Overall Study||2
6285839|NCT00221403|7186455|FG001|NOT COMPLETED|Overall Study||5
6285840|NCT00221403|7186456|FG002|NOT COMPLETED|Overall Study||0
6285841|NCT00222105|7186464|FG000|STARTED|Overall Study||25
6633845|NCT02291614|7562503|FG008|STARTED|Overall Study||3
6633846|NCT02291614|7562504|FG009|STARTED|Overall Study||11
6633847|NCT02291614|7562505|FG010|STARTED|Overall Study||2
6633848|NCT02291614|7562495|FG000|Received AMG 211|Overall Study||3
6633849|NCT02291614|7562496|FG001|Received AMG 211|Overall Study||3
6633850|NCT02291614|7562497|FG002|Received AMG 211|Overall Study||3
6633851|NCT02291614|7562498|FG003|Received AMG 211|Overall Study||5
6633852|NCT02291614|7562499|FG004|Received AMG 211|Overall Study||3
6633853|NCT02291614|7562500|FG005|Received AMG 211|Overall Study||3
6633854|NCT02291614|7562501|FG006|Received AMG 211|Overall Study||6
6633855|NCT02291614|7562502|FG007|Received AMG 211|Overall Study||3
6633856|NCT02291614|7562503|FG008|Received AMG 211|Overall Study||3
6285842|NCT00222105|7186464|FG000|COMPLETED|Overall Study||11
6285843|NCT00222105|7186464|FG000|NOT COMPLETED|Overall Study||14
6285844|NCT00222131|7186470|FG000|STARTED|Overall Study||38
6285845|NCT00222131|7186471|FG001|STARTED|Overall Study||35
6285846|NCT00222131|7186470|FG000|COMPLETED|Overall Study||38
6285847|NCT00222131|7186471|FG001|COMPLETED|Overall Study||35
6285848|NCT00222131|7186470|FG000|NOT COMPLETED|Overall Study||0
6285849|NCT00222131|7186471|FG001|NOT COMPLETED|Overall Study||0
6285850|NCT00222729|7186477|FG000|STARTED|Overall Study||40
6285851|NCT00222729|7186477|FG000|COMPLETED|Overall Study||37
6285852|NCT00222729|7186477|FG000|NOT COMPLETED|Overall Study||3
6285853|NCT00223080|7186483|FG000|STARTED|Overall Study||8197
6285854|NCT00223080|7186484|FG001|STARTED|Overall Study||8198
6285855|NCT00223080|7186483|FG000|COMPLETED|Overall Study||7401
6285856|NCT00223080|7186484|FG001|COMPLETED|Overall Study||7401
6285857|NCT00223080|7186483|FG000|NOT COMPLETED|Overall Study||796
6285858|NCT00223080|7186484|FG001|NOT COMPLETED|Overall Study||797
6285859|NCT00223236|7186492|FG000|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
6285860|NCT00223236|7186493|FG001|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
6285861|NCT00223236|7186492|FG000|COMPLETED|Overall Study|9 completed 12 week trial.|9
6285862|NCT00223236|7186493|FG001|COMPLETED|Overall Study|4 completed 12 week trial.|4
6285863|NCT00223236|7186492|FG000|NOT COMPLETED|Overall Study||7
6285864|NCT00223236|7186493|FG001|NOT COMPLETED|Overall Study||14
6285865|NCT00223262|7186501|FG000|STARTED|Overall Study||16
6285866|NCT00223262|7186502|FG001|STARTED|Overall Study||12
6285867|NCT00223262|7186501|FG000|COMPLETED|Overall Study||8
6285868|NCT00223262|7186502|FG001|COMPLETED|Overall Study||11
6285869|NCT00223262|7186501|FG000|NOT COMPLETED|Overall Study||8
6285870|NCT00223262|7186502|FG001|NOT COMPLETED|Overall Study||1
6285871|NCT00223496|7186508|FG000|STARTED|Overall Study|32 people consented, 19 were baselined|32
6285872|NCT00223496|7186508|FG000|COMPLETED|Overall Study||10
6285873|NCT00223496|7186508|FG000|NOT COMPLETED|Overall Study||22
6285874|NCT00223652|7186514|FG000|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
6285875|NCT00223652|7186515|FG001|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
6285876|NCT00223652|7186514|FG000|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
6285877|NCT00223652|7186515|FG001|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
6285878|NCT00223652|7186514|FG000|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
6285879|NCT00223652|7186515|FG001|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
6285880|NCT00223652|7186514|FG000|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
6285881|NCT00223652|7186515|FG001|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
6285882|NCT00223652|7186514|FG000|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
6285883|NCT00223652|7186515|FG001|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
6285884|NCT00223652|7186514|FG000|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
6285885|NCT00223652|7186515|FG001|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
6285886|NCT00223652|7186514|FG000|STARTED|T-CBT and TAU 6 Month Follow-up||40
6285887|NCT00223652|7186515|FG001|STARTED|T-CBT and TAU 6 Month Follow-up||41
6285888|NCT00223652|7186514|FG000|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
6285889|NCT00223652|7186515|FG001|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
6285890|NCT00223652|7186514|FG000|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
6285891|NCT00223652|7186515|FG001|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
6285892|NCT00223665|7186522|FG000|STARTED|Overall Study||102
6285893|NCT00223665|7186522|FG000|COMPLETED|Overall Study||102
6285894|NCT00223665|7186522|FG000|NOT COMPLETED|Overall Study||0
6285895|NCT00223678|7186529|FG000|STARTED|Overall Study||13
6285896|NCT00223678|7186530|FG001|STARTED|Overall Study||7
6285897|NCT00223678|7186529|FG000|COMPLETED|Overall Study||13
6285898|NCT00223678|7186530|FG001|COMPLETED|Overall Study||7
6285899|NCT00223678|7186529|FG000|NOT COMPLETED|Overall Study||0
6285900|NCT00223678|7186530|FG001|NOT COMPLETED|Overall Study||0
6285901|NCT00223704|7186539|FG000|STARTED|Overall Study||38
6285902|NCT00223704|7186540|FG001|STARTED|Overall Study||37
6285903|NCT00223704|7186541|FG002|STARTED|Overall Study||40
6285904|NCT00223704|7186539|FG000|COMPLETED|Overall Study||38
6285905|NCT00223704|7186540|FG001|COMPLETED|Overall Study||37
6285906|NCT00223704|7186541|FG002|COMPLETED|Overall Study||40
6285907|NCT00223704|7186539|FG000|NOT COMPLETED|Overall Study||0
6285908|NCT00223704|7186540|FG001|NOT COMPLETED|Overall Study||0
6285909|NCT00223704|7186541|FG002|NOT COMPLETED|Overall Study||0
6285910|NCT00223795|7186549|FG000|STARTED|First Intervention - Eight Weeks||26
6285911|NCT00223795|7186550|FG001|STARTED|First Intervention - Eight Weeks||27
6285912|NCT00223795|7186549|FG000|COMPLETED|First Intervention - Eight Weeks||19
6285913|NCT00223795|7186550|FG001|COMPLETED|First Intervention - Eight Weeks||18
6285914|NCT00223795|7186549|FG000|NOT COMPLETED|First Intervention - Eight Weeks||7
6285915|NCT00223795|7186550|FG001|NOT COMPLETED|First Intervention - Eight Weeks||9
6285916|NCT00223795|7186549|FG000|STARTED|Second Intervention - All Use Canes 4 mo||19
6285917|NCT00223795|7186550|FG001|STARTED|Second Intervention - All Use Canes 4 mo||18
6285918|NCT00223795|7186549|FG000|COMPLETED|Second Intervention - All Use Canes 4 mo||18
6285919|NCT00223795|7186550|FG001|COMPLETED|Second Intervention - All Use Canes 4 mo||17
6285920|NCT00223795|7186549|FG000|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
6285921|NCT00223795|7186550|FG001|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
6285922|NCT00223808|7186560|FG000|STARTED|Overall Study||22
6285923|NCT00223808|7186561|FG001|STARTED|Overall Study||22
6285924|NCT00223808|7186562|FG002|STARTED|Overall Study||23
6285925|NCT00223808|7186560|FG000|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
6373894|NCT00747474|7284559|FG006|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6633857|NCT02291614|7562504|FG009|Received AMG 211|Overall Study||10
6743335|NCT03334422|7671642|FG000|STARTED|Overall Study||244
6285926|NCT00223808|7186561|FG001|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
6285927|NCT00223808|7186562|FG002|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
6285928|NCT00223808|7186560|FG000|NOT COMPLETED|Overall Study||3
6285929|NCT00223808|7186561|FG001|NOT COMPLETED|Overall Study||5
6285930|NCT00223808|7186562|FG002|NOT COMPLETED|Overall Study||5
6285931|NCT00223821|7186572|FG000|STARTED|Overall Study||32
6285932|NCT00223821|7186573|FG001|STARTED|Overall Study||32
6285933|NCT00223821|7186572|FG000|Completed Therapy|Overall Study||31
6285934|NCT00223821|7186573|FG001|Completed Therapy|Overall Study||28
6285935|NCT00223821|7186572|FG000|Completed Post-treatment Assessment|Overall Study||31
6285936|NCT00223821|7186573|FG001|Completed Post-treatment Assessment|Overall Study||27
6285937|NCT00223821|7186572|FG000|Completed 6-month Follow-up|Overall Study||28
6285938|NCT00223821|7186573|FG001|Completed 6-month Follow-up|Overall Study||25
6285939|NCT00223821|7186572|FG000|COMPLETED|Overall Study||28
6285940|NCT00223821|7186573|FG001|COMPLETED|Overall Study||22
6285941|NCT00223821|7186572|FG000|NOT COMPLETED|Overall Study||4
6285942|NCT00223821|7186573|FG001|NOT COMPLETED|Overall Study||10
6285943|NCT00223977|7186582|FG000|STARTED|Overall Study||46
6285944|NCT00223977|7186583|FG001|STARTED|Overall Study||58
6285945|NCT00223977|7186584|FG002|STARTED|Overall Study||42
6285946|NCT00223977|7186582|FG000|COMPLETED|Overall Study||37
6285947|NCT00223977|7186583|FG001|COMPLETED|Overall Study||47
6285948|NCT00223977|7186584|FG002|COMPLETED|Overall Study||39
6285949|NCT00223977|7186582|FG000|NOT COMPLETED|Overall Study||9
6285950|NCT00223977|7186583|FG001|NOT COMPLETED|Overall Study||11
6285951|NCT00223977|7186584|FG002|NOT COMPLETED|Overall Study||3
6285952|NCT00223990|7186594|FG000|STARTED|Overall Study||200
6285953|NCT00223990|7186595|FG001|STARTED|Overall Study||200
6285954|NCT00223990|7186594|FG000|COMPLETED|Overall Study||193
6285955|NCT00223990|7186595|FG001|COMPLETED|Overall Study||191
6285956|NCT00223990|7186594|FG000|NOT COMPLETED|Overall Study||7
6285957|NCT00223990|7186595|FG001|NOT COMPLETED|Overall Study||9
6285958|NCT00224016|7186603|FG000|STARTED|Titration Period||39
6285959|NCT00224016|7186604|FG001|STARTED|Titration Period||16
6285960|NCT00224016|7186603|FG000|COMPLETED|Titration Period||38
6285961|NCT00224016|7186604|FG001|COMPLETED|Titration Period||15
6285962|NCT00224016|7186603|FG000|NOT COMPLETED|Titration Period||1
6285963|NCT00224016|7186604|FG001|NOT COMPLETED|Titration Period||1
6285964|NCT00224016|7186603|FG000|STARTED|Maintenance Period||38
6285965|NCT00224016|7186604|FG001|STARTED|Maintenance Period||15
6285966|NCT00224016|7186603|FG000|COMPLETED|Maintenance Period||36
6285967|NCT00224016|7186604|FG001|COMPLETED|Maintenance Period||14
6285968|NCT00224016|7186603|FG000|NOT COMPLETED|Maintenance Period||2
6285969|NCT00224016|7186604|FG001|NOT COMPLETED|Maintenance Period||1
6285970|NCT00224016|7186603|FG000|STARTED|Follow-Up Period||35
6285971|NCT00224016|7186604|FG001|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
6285972|NCT00224016|7186603|FG000|COMPLETED|Follow-Up Period||35
6285973|NCT00224016|7186604|FG001|COMPLETED|Follow-Up Period||0
6285974|NCT00224016|7186603|FG000|NOT COMPLETED|Follow-Up Period||0
6285975|NCT00224016|7186604|FG001|NOT COMPLETED|Follow-Up Period||0
6285976|NCT00224029|7186610|FG000|STARTED|Overall Study||24
6285977|NCT00224029|7186610|FG000|COMPLETED|Overall Study||18
6285978|NCT00224029|7186610|FG000|NOT COMPLETED|Overall Study||6
6285979|NCT00224042|7186616|FG000|STARTED|Overall Study||26
6285980|NCT00224042|7186617|FG001|STARTED|Overall Study||26
6285981|NCT00224042|7186616|FG000|COMPLETED|Overall Study||20
6285982|NCT00224042|7186617|FG001|COMPLETED|Overall Study||20
6285983|NCT00224042|7186616|FG000|NOT COMPLETED|Overall Study||6
6285984|NCT00224042|7186617|FG001|NOT COMPLETED|Overall Study||6
6285985|NCT00224055|7186625|FG000|STARTED|Overall Study||44
6285986|NCT00224055|7186626|FG001|STARTED|Overall Study||45
6285987|NCT00224055|7186625|FG000|COMPLETED|Overall Study||29
6285988|NCT00224055|7186626|FG001|COMPLETED|Overall Study||31
6285989|NCT00224055|7186625|FG000|NOT COMPLETED|Overall Study||15
6285990|NCT00224055|7186626|FG001|NOT COMPLETED|Overall Study||14
6285991|NCT00224107|7186634|FG000|STARTED|Overall Study||233
6285992|NCT00224107|7186635|FG001|STARTED|Overall Study||228
6285993|NCT00224107|7186634|FG000|COMPLETED|Overall Study||202
6285994|NCT00224107|7186635|FG001|COMPLETED|Overall Study||214
6285995|NCT00224107|7186634|FG000|NOT COMPLETED|Overall Study||31
6399261|NCT00879814|7311973|FG002|STARTED|Overall Study||12
6399262|NCT00879814|7311974|FG003|STARTED|Overall Study||12
6399263|NCT00879814|7311971|FG000|COMPLETED|Overall Study||8
6399264|NCT00879814|7311972|FG001|COMPLETED|Overall Study||10
6399265|NCT00879814|7311973|FG002|COMPLETED|Overall Study||9
6399266|NCT00879814|7311974|FG003|COMPLETED|Overall Study||7
6399267|NCT00879814|7311971|FG000|NOT COMPLETED|Overall Study||4
6399268|NCT00879814|7311972|FG001|NOT COMPLETED|Overall Study||2
6399269|NCT00879814|7311973|FG002|NOT COMPLETED|Overall Study||3
6399270|NCT00879814|7311974|FG003|NOT COMPLETED|Overall Study||5
6285996|NCT00224107|7186635|FG001|NOT COMPLETED|Overall Study||14
6285997|NCT00224120|7186643|FG000|STARTED|Overall Study||233
6285998|NCT00224120|7186644|FG001|STARTED|Overall Study||229
6285999|NCT00224120|7186643|FG000|COMPLETED|Overall Study||211
6286000|NCT00224120|7186644|FG001|COMPLETED|Overall Study||205
6286001|NCT00224120|7186643|FG000|NOT COMPLETED|Overall Study||22
6286002|NCT00224120|7186644|FG001|NOT COMPLETED|Overall Study||24
6286003|NCT00224133|7186650|FG000|STARTED|Overall Study||661
6286004|NCT00224133|7186650|FG000|COMPLETED|Overall Study||435
6286005|NCT00224133|7186650|FG000|NOT COMPLETED|Overall Study||226
6286006|NCT00224289|7186654|FG000|STARTED|Overall Study||17
6286007|NCT00224289|7186654|FG000|COMPLETED|Overall Study||17
6286008|NCT00224289|7186654|FG000|NOT COMPLETED|Overall Study||0
6633858|NCT02291614|7562505|FG010|Received AMG 211|Overall Study||2
6633859|NCT02291614|7562495|FG000|COMPLETED|Overall Study||3
6633860|NCT02291614|7562496|FG001|COMPLETED|Overall Study||2
6633861|NCT02291614|7562497|FG002|COMPLETED|Overall Study||2
6633862|NCT02291614|7562498|FG003|COMPLETED|Overall Study||4
6633863|NCT02291614|7562499|FG004|COMPLETED|Overall Study||2
6633864|NCT02291614|7562500|FG005|COMPLETED|Overall Study||2
6633865|NCT02291614|7562501|FG006|COMPLETED|Overall Study||5
6633866|NCT02291614|7562502|FG007|COMPLETED|Overall Study||2
6633867|NCT02291614|7562503|FG008|COMPLETED|Overall Study||3
6633868|NCT02291614|7562504|FG009|COMPLETED|Overall Study||9
6633869|NCT02291614|7562505|FG010|COMPLETED|Overall Study||0
6633870|NCT02291614|7562495|FG000|NOT COMPLETED|Overall Study||0
6633871|NCT02291614|7562496|FG001|NOT COMPLETED|Overall Study||1
6633872|NCT02291614|7562497|FG002|NOT COMPLETED|Overall Study||1
6633873|NCT02291614|7562498|FG003|NOT COMPLETED|Overall Study||1
6633874|NCT02291614|7562499|FG004|NOT COMPLETED|Overall Study||1
6633875|NCT02291614|7562500|FG005|NOT COMPLETED|Overall Study||1
6633876|NCT02291614|7562501|FG006|NOT COMPLETED|Overall Study||1
6633877|NCT02291614|7562502|FG007|NOT COMPLETED|Overall Study||1
6633878|NCT02291614|7562503|FG008|NOT COMPLETED|Overall Study||0
6633879|NCT02291614|7562504|FG009|NOT COMPLETED|Overall Study||2
6633880|NCT02291614|7562505|FG010|NOT COMPLETED|Overall Study||2
6633881|NCT02291679|7562538|FG000|STARTED|Overall Study||401
6633882|NCT02291679|7562539|FG001|STARTED|Overall Study||411
6633883|NCT02291679|7562540|FG002|STARTED|Overall Study||411
6633884|NCT02291679|7562538|FG000|COMPLETED|Overall Study||357
6633885|NCT02291679|7562539|FG001|COMPLETED|Overall Study||369
6633886|NCT02291679|7562540|FG002|COMPLETED|Overall Study||352
6633887|NCT02291679|7562538|FG000|NOT COMPLETED|Overall Study||44
6633888|NCT02291679|7562539|FG001|NOT COMPLETED|Overall Study||42
6633889|NCT02291679|7562540|FG002|NOT COMPLETED|Overall Study||59
6633890|NCT02291718|7562550|FG000|STARTED|Overall Study||50
6633891|NCT02291718|7562551|FG001|STARTED|Overall Study||50
6633892|NCT02291718|7562552|FG002|STARTED|Overall Study||50
6633893|NCT02291718|7562550|FG000|COMPLETED|Overall Study||50
6633894|NCT02291718|7562551|FG001|COMPLETED|Overall Study||50
6633895|NCT02291718|7562552|FG002|COMPLETED|Overall Study||50
6633896|NCT02291718|7562550|FG000|NOT COMPLETED|Overall Study||0
6633897|NCT02291718|7562551|FG001|NOT COMPLETED|Overall Study||0
6633898|NCT02291718|7562552|FG002|NOT COMPLETED|Overall Study||0
6633899|NCT02291861|7562564|FG000|STARTED|Overall Study||74
6633900|NCT02291861|7562565|FG001|STARTED|Overall Study||75
6633901|NCT02291861|7562566|FG002|STARTED|Overall Study||74
6633902|NCT02291861|7562567|FG003|STARTED|Overall Study||75
6633903|NCT02291861|7562564|FG000|Safety Population|Overall Study||72
6633904|NCT02291861|7562565|FG001|Safety Population|Overall Study||74
6633905|NCT02291861|7562566|FG002|Safety Population|Overall Study||73
6633906|NCT02291861|7562567|FG003|Safety Population|Overall Study||74
6633907|NCT02291861|7562564|FG000|Modified Intent to Treat Pop (mITT)|Overall Study||58
6633908|NCT02291861|7562565|FG001|Modified Intent to Treat Pop (mITT)|Overall Study||60
6633909|NCT02291861|7562566|FG002|Modified Intent to Treat Pop (mITT)|Overall Study||49
6633910|NCT02291861|7562567|FG003|Modified Intent to Treat Pop (mITT)|Overall Study||55
6633911|NCT02291861|7562564|FG000|COMPLETED|Overall Study||67
6633912|NCT02291861|7562565|FG001|COMPLETED|Overall Study||67
6633913|NCT02291861|7562566|FG002|COMPLETED|Overall Study||65
6633914|NCT02291861|7562567|FG003|COMPLETED|Overall Study||65
6633915|NCT02291861|7562564|FG000|NOT COMPLETED|Overall Study||7
6633916|NCT02291861|7562565|FG001|NOT COMPLETED|Overall Study||8
6633917|NCT02291861|7562566|FG002|NOT COMPLETED|Overall Study||9
6633918|NCT02291861|7562567|FG003|NOT COMPLETED|Overall Study||10
6633919|NCT02291913|7562577|FG000|STARTED|Overall Study||48
6633920|NCT02291913|7562577|FG000|COMPLETED|Overall Study||0
6633921|NCT02291913|7562577|FG000|NOT COMPLETED|Overall Study||48
6286009|NCT00224484|7186661|FG000|STARTED|Overall Study||2977
6286010|NCT00224484|7186662|FG001|STARTED|Overall Study||1491
6286011|NCT00224484|7186663|FG002|STARTED|Overall Study||1487
6633922|NCT02292082|7562583|FG000|STARTED|Overall Study||56
6633923|NCT02292082|7562584|FG001|STARTED|Overall Study||55
6633924|NCT02292082|7562583|FG000|COMPLETED|Overall Study||56
6633925|NCT02292082|7562584|FG001|COMPLETED|Overall Study||55
6633926|NCT02292082|7562583|FG000|NOT COMPLETED|Overall Study||0
6633927|NCT02292082|7562584|FG001|NOT COMPLETED|Overall Study||0
6633928|NCT02292186|7562590|FG000|STARTED|Overall Study||25
6633929|NCT02292186|7562590|FG000|COMPLETED|Overall Study||7
6633930|NCT02292186|7562590|FG000|NOT COMPLETED|Overall Study||18
6633931|NCT02292212|7562594|FG000|STARTED|Pre-ViE Phase||17
6633932|NCT02292212|7562594|FG000|COMPLETED|Pre-ViE Phase||17
6633933|NCT02292212|7562594|FG000|NOT COMPLETED|Pre-ViE Phase||0
6633934|NCT02292212|7562594|FG000|STARTED|ViE Phase||17
6633935|NCT02292212|7562594|FG000|COMPLETED|ViE Phase||14
6633936|NCT02292212|7562594|FG000|NOT COMPLETED|ViE Phase||3
6633937|NCT02292212|7562594|FG000|STARTED|Post-ViE Phase||14
6286012|NCT00224484|7186661|FG000|COMPLETED|Overall Study||2831
6633938|NCT02292212|7562594|FG000|COMPLETED|Post-ViE Phase||14
6286013|NCT00224484|7186662|FG001|COMPLETED|Overall Study||1426
6286014|NCT00224484|7186663|FG002|COMPLETED|Overall Study||1425
6286015|NCT00224484|7186661|FG000|NOT COMPLETED|Overall Study||146
6286016|NCT00224484|7186662|FG001|NOT COMPLETED|Overall Study||65
6286017|NCT00224484|7186663|FG002|NOT COMPLETED|Overall Study||62
6286018|NCT00224770|7186677|FG000|STARTED|Overall Study||42
6286019|NCT00224770|7186678|FG001|STARTED|Overall Study||54
6286020|NCT00224770|7186679|FG002|STARTED|Overall Study||14
6286021|NCT00224770|7186677|FG000|COMPLETED|Overall Study||38
6286022|NCT00224770|7186678|FG001|COMPLETED|Overall Study||52
6286023|NCT00224770|7186679|FG002|COMPLETED|Overall Study||14
6286024|NCT00224770|7186677|FG000|NOT COMPLETED|Overall Study||4
6286025|NCT00224770|7186678|FG001|NOT COMPLETED|Overall Study||2
6286026|NCT00224770|7186679|FG002|NOT COMPLETED|Overall Study||0
6373895|NCT00747474|7284560|FG007|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373896|NCT00747474|7284561|FG008|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
6373897|NCT00747474|7284562|FG009|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373898|NCT00747474|7284563|FG010|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373899|NCT00747474|7284564|FG011|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373900|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373901|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373902|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373903|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373904|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373905|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373906|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373907|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373908|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373909|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373910|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373911|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
6373912|NCT00747474|7284553|FG000|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373913|NCT00747474|7284554|FG001|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373914|NCT00747474|7284555|FG002|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373915|NCT00747474|7284556|FG003|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373916|NCT00747474|7284557|FG004|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373917|NCT00747474|7284558|FG005|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373918|NCT00747474|7284559|FG006|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373919|NCT00747474|7284560|FG007|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373920|NCT00747474|7284561|FG008|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373921|NCT00747474|7284562|FG009|STARTED|Cohort 10 (40 mg/m^2) Period||7
6373922|NCT00747474|7284563|FG010|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373923|NCT00747474|7284564|FG011|STARTED|Cohort 10 (40 mg/m^2) Period||0
6373924|NCT00747474|7284553|FG000|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373925|NCT00747474|7284554|FG001|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373926|NCT00747474|7284555|FG002|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373927|NCT00747474|7284556|FG003|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373928|NCT00747474|7284557|FG004|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373929|NCT00747474|7284558|FG005|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6633939|NCT02292212|7562594|FG000|NOT COMPLETED|Post-ViE Phase||0
6633940|NCT02292433|7562608|FG000|STARTED|First Intervention Period (7 Days)||4
6633941|NCT02292433|7562609|FG001|STARTED|First Intervention Period (7 Days)||4
6633942|NCT02292433|7562610|FG002|STARTED|First Intervention Period (7 Days)||4
6633943|NCT02292433|7562608|FG000|COMPLETED|First Intervention Period (7 Days)||4
6633944|NCT02292433|7562609|FG001|COMPLETED|First Intervention Period (7 Days)||4
6633945|NCT02292433|7562610|FG002|COMPLETED|First Intervention Period (7 Days)||4
6633946|NCT02292433|7562608|FG000|NOT COMPLETED|First Intervention Period (7 Days)||0
6633947|NCT02292433|7562609|FG001|NOT COMPLETED|First Intervention Period (7 Days)||0
6633948|NCT02292433|7562610|FG002|NOT COMPLETED|First Intervention Period (7 Days)||0
6633949|NCT02292433|7562608|FG000|STARTED|First Washout Period (7 to 14 Days)||4
6633950|NCT02292433|7562609|FG001|STARTED|First Washout Period (7 to 14 Days)||4
6633951|NCT02292433|7562610|FG002|STARTED|First Washout Period (7 to 14 Days)||4
6633952|NCT02292433|7562608|FG000|COMPLETED|First Washout Period (7 to 14 Days)||4
6633953|NCT02292433|7562609|FG001|COMPLETED|First Washout Period (7 to 14 Days)||4
6633954|NCT02292433|7562610|FG002|COMPLETED|First Washout Period (7 to 14 Days)||4
6633955|NCT02292433|7562608|FG000|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
6633956|NCT02292433|7562609|FG001|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
6633957|NCT02292433|7562610|FG002|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
6633958|NCT02292433|7562608|FG000|STARTED|Second Intervention Period (7 Days)||4
6633959|NCT02292433|7562609|FG001|STARTED|Second Intervention Period (7 Days)||4
6633960|NCT02292433|7562610|FG002|STARTED|Second Intervention Period (7 Days)||4
6633961|NCT02292433|7562608|FG000|COMPLETED|Second Intervention Period (7 Days)||4
6633962|NCT02292433|7562609|FG001|COMPLETED|Second Intervention Period (7 Days)||4
6633963|NCT02292433|7562610|FG002|COMPLETED|Second Intervention Period (7 Days)||4
6373930|NCT00747474|7284559|FG006|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373931|NCT00747474|7284560|FG007|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373932|NCT00747474|7284561|FG008|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373933|NCT00747474|7284562|FG009|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
6373934|NCT00747474|7284563|FG010|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373935|NCT00747474|7284564|FG011|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6655634|NCT02454153|7585789|FG000|STARTED|Overall Study||92
6286027|NCT00224874|7186692|FG000|STARTED|Overall Study||46
6286028|NCT00224874|7186693|FG001|STARTED|Overall Study||45
6286029|NCT00224874|7186694|FG002|STARTED|Overall Study||47
6633964|NCT02292433|7562608|FG000|NOT COMPLETED|Second Intervention Period (7 Days)||0
6633965|NCT02292433|7562609|FG001|NOT COMPLETED|Second Intervention Period (7 Days)||0
6633966|NCT02292433|7562610|FG002|NOT COMPLETED|Second Intervention Period (7 Days)||0
6633967|NCT02292433|7562608|FG000|STARTED|Second Washout Period (7 to 14 Days)||4
6633968|NCT02292433|7562609|FG001|STARTED|Second Washout Period (7 to 14 Days)||4
6633969|NCT02292433|7562610|FG002|STARTED|Second Washout Period (7 to 14 Days)||4
6633970|NCT02292433|7562608|FG000|COMPLETED|Second Washout Period (7 to 14 Days)||4
6633971|NCT02292433|7562609|FG001|COMPLETED|Second Washout Period (7 to 14 Days)||4
6633972|NCT02292433|7562610|FG002|COMPLETED|Second Washout Period (7 to 14 Days)||4
6633973|NCT02292433|7562608|FG000|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
6633974|NCT02292433|7562609|FG001|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
6633975|NCT02292433|7562610|FG002|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
6633976|NCT02292433|7562608|FG000|STARTED|Third Intervention Period (7 Days)||4
6633977|NCT02292433|7562609|FG001|STARTED|Third Intervention Period (7 Days)||4
6633978|NCT02292433|7562610|FG002|STARTED|Third Intervention Period (7 Days)||4
6633979|NCT02292433|7562608|FG000|COMPLETED|Third Intervention Period (7 Days)||4
6633980|NCT02292433|7562609|FG001|COMPLETED|Third Intervention Period (7 Days)||4
6633981|NCT02292433|7562610|FG002|COMPLETED|Third Intervention Period (7 Days)||4
6633982|NCT02292433|7562608|FG000|NOT COMPLETED|Third Intervention Period (7 Days)||0
6633983|NCT02292433|7562609|FG001|NOT COMPLETED|Third Intervention Period (7 Days)||0
6633984|NCT02292433|7562610|FG002|NOT COMPLETED|Third Intervention Period (7 Days)||0
6633985|NCT02292446|7562618|FG000|STARTED|Overall Study||161
6633986|NCT02292446|7562618|FG000|COMPLETED|Overall Study||141
6633987|NCT02292446|7562618|FG000|NOT COMPLETED|Overall Study||20
6633988|NCT02292537|7562627|FG000|STARTED|Overall Study||42
6633989|NCT02292537|7562628|FG001|STARTED|Overall Study||84
6633990|NCT02292537|7562627|FG000|Completed Treatment|Overall Study||42
6633991|NCT02292537|7562628|FG001|Completed Treatment|Overall Study|1 participant completed the study but did not complete treatments due to early study closure|83
6633992|NCT02292537|7562627|FG000|COMPLETED|Overall Study||42
6633993|NCT02292537|7562628|FG001|COMPLETED|Overall Study||84
6633994|NCT02292537|7562627|FG000|NOT COMPLETED|Overall Study||0
6633995|NCT02292537|7562628|FG001|NOT COMPLETED|Overall Study||0
6633996|NCT02292719|7562640|FG000|STARTED|Overall Study||9
6633997|NCT02292719|7562641|FG001|STARTED|Overall Study||11
6633998|NCT02292719|7562642|FG002|STARTED|Overall Study||10
6633999|NCT02292719|7562643|FG003|STARTED|Overall Study||9
6634000|NCT02292719|7562644|FG004|STARTED|Overall Study||21
6634001|NCT02292719|7562645|FG005|STARTED|Overall Study||10
6634002|NCT02292719|7562640|FG000|COMPLETED|Overall Study||9
6634003|NCT02292719|7562641|FG001|COMPLETED|Overall Study||11
6634004|NCT02292719|7562642|FG002|COMPLETED|Overall Study||9
6634005|NCT02292719|7562643|FG003|COMPLETED|Overall Study||8
6634006|NCT02292719|7562644|FG004|COMPLETED|Overall Study||20
6634007|NCT02292719|7562645|FG005|COMPLETED|Overall Study||10
6634008|NCT02292719|7562640|FG000|NOT COMPLETED|Overall Study||0
6634009|NCT02292719|7562641|FG001|NOT COMPLETED|Overall Study||0
6634010|NCT02292719|7562642|FG002|NOT COMPLETED|Overall Study||1
6634011|NCT02292719|7562643|FG003|NOT COMPLETED|Overall Study||1
6634012|NCT02292719|7562644|FG004|NOT COMPLETED|Overall Study||1
6634013|NCT02292719|7562645|FG005|NOT COMPLETED|Overall Study||0
6634014|NCT02292771|7562661|FG000|STARTED|Overall Study||47
6634015|NCT02292771|7562662|FG001|STARTED|Overall Study||50
6634016|NCT02292771|7562661|FG000|COMPLETED|Overall Study||43
6634017|NCT02292771|7562662|FG001|COMPLETED|Overall Study||48
6634018|NCT02292771|7562661|FG000|NOT COMPLETED|Overall Study||4
6634019|NCT02292771|7562662|FG001|NOT COMPLETED|Overall Study||2
6634020|NCT02292784|7562675|FG000|STARTED|Overall Study||5
6634021|NCT02292784|7562676|FG001|STARTED|Overall Study||44
6634022|NCT02292784|7562677|FG002|STARTED|Overall Study||49
6634023|NCT02292784|7562675|FG000|COMPLETED|Overall Study||4
6634024|NCT02292784|7562676|FG001|COMPLETED|Overall Study||24
6634025|NCT02292784|7562677|FG002|COMPLETED|Overall Study||28
6634026|NCT02292784|7562675|FG000|NOT COMPLETED|Overall Study||1
6634027|NCT02292784|7562676|FG001|NOT COMPLETED|Overall Study||20
6634028|NCT02292784|7562677|FG002|NOT COMPLETED|Overall Study||21
6634029|NCT02292849|7562688|FG000|STARTED|Overall Study||11
6634030|NCT02292849|7562689|FG001|STARTED|Overall Study||8
6634031|NCT02292849|7562690|FG002|STARTED|Overall Study||10
6634032|NCT02292849|7562688|FG000|COMPLETED|Overall Study||7
6634033|NCT02292849|7562689|FG001|COMPLETED|Overall Study||6
6634034|NCT02292849|7562690|FG002|COMPLETED|Overall Study||8
6634035|NCT02292849|7562688|FG000|NOT COMPLETED|Overall Study||4
6634036|NCT02292849|7562689|FG001|NOT COMPLETED|Overall Study||2
6286030|NCT00224874|7186695|FG003|STARTED|Overall Study||42
6286031|NCT00224874|7186692|FG000|COMPLETED|Overall Study||46
6286032|NCT00224874|7186693|FG001|COMPLETED|Overall Study||45
6634037|NCT02292849|7562690|FG002|NOT COMPLETED|Overall Study||2
6634038|NCT02292927|7562700|FG000|STARTED|Overall Study||13
6634039|NCT02292927|7562701|FG001|STARTED|Overall Study||12
6634040|NCT02292927|7562700|FG000|COMPLETED|Overall Study||0
6634041|NCT02292927|7562701|FG001|COMPLETED|Overall Study||5
6634042|NCT02292927|7562700|FG000|NOT COMPLETED|Overall Study||13
6286033|NCT00224874|7186694|FG002|COMPLETED|Overall Study||46
6286034|NCT00224874|7186695|FG003|COMPLETED|Overall Study||42
6286035|NCT00224874|7186692|FG000|NOT COMPLETED|Overall Study||0
6286036|NCT00224874|7186693|FG001|NOT COMPLETED|Overall Study||0
6286037|NCT00224874|7186694|FG002|NOT COMPLETED|Overall Study||1
6286038|NCT00224874|7186695|FG003|NOT COMPLETED|Overall Study||0
6634043|NCT02292927|7562701|FG001|NOT COMPLETED|Overall Study||7
6634044|NCT02292940|7562712|FG000|STARTED|Overall Study||165477
6634045|NCT02292940|7562713|FG001|STARTED|Overall Study||3000
6634046|NCT02292940|7562712|FG000|COMPLETED|Overall Study||165477
6634047|NCT02292940|7562713|FG001|COMPLETED|Overall Study||1824
6634048|NCT02292940|7562712|FG000|NOT COMPLETED|Overall Study||0
6634049|NCT02292940|7562713|FG001|NOT COMPLETED|Overall Study||1176
6634050|NCT02293044|7562720|FG000|STARTED|Overall Study||15
6634051|NCT02293044|7562720|FG000|COMPLETED|Overall Study||15
6634052|NCT02293044|7562720|FG000|NOT COMPLETED|Overall Study||0
6634053|NCT02293096|7562724|FG000|STARTED|Overall Study||140
6634054|NCT02293096|7562724|FG000|COMPLETED|Overall Study||140
6634055|NCT02293096|7562724|FG000|NOT COMPLETED|Overall Study||0
6634056|NCT02293395|7562730|FG000|STARTED|Overall Study||1519
6634057|NCT02293395|7562731|FG001|STARTED|Overall Study||1518
6634058|NCT02293395|7562730|FG000|Treated|Overall Study||1510
6634059|NCT02293395|7562731|FG001|Treated|Overall Study||1506
6634060|NCT02293395|7562730|FG000|COMPLETED|Overall Study||1510
6634061|NCT02293395|7562731|FG001|COMPLETED|Overall Study||1511
6634062|NCT02293395|7562730|FG000|NOT COMPLETED|Overall Study||9
6634063|NCT02293395|7562731|FG001|NOT COMPLETED|Overall Study||7
6634064|NCT02293460|7562737|FG000|STARTED|Overall Study||43
6634065|NCT02293460|7562737|FG000|COMPLETED|Overall Study||37
6634066|NCT02293460|7562737|FG000|NOT COMPLETED|Overall Study||6
6634067|NCT02293499|7562744|FG000|STARTED|Baseline - Enrollment||152
6634068|NCT02293499|7562745|FG001|STARTED|Baseline - Enrollment||168
6634069|NCT02293499|7562746|FG002|STARTED|Baseline - Enrollment||51
6634070|NCT02293499|7562744|FG000|COMPLETED|Baseline - Enrollment||152
6634071|NCT02293499|7562745|FG001|COMPLETED|Baseline - Enrollment||168
6634072|NCT02293499|7562746|FG002|COMPLETED|Baseline - Enrollment||51
6634073|NCT02293499|7562744|FG000|NOT COMPLETED|Baseline - Enrollment||0
6634074|NCT02293499|7562745|FG001|NOT COMPLETED|Baseline - Enrollment||0
6634075|NCT02293499|7562746|FG002|NOT COMPLETED|Baseline - Enrollment||0
6634076|NCT02293499|7562744|FG000|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
6634077|NCT02293499|7562745|FG001|STARTED|Training - Peer Leaders Only|Participant number carried over from previous time point.|0
6634078|NCT02293499|7562746|FG002|STARTED|Training - Peer Leaders Only||51
6634079|NCT02293499|7562744|FG000|COMPLETED|Training - Peer Leaders Only||0
6634080|NCT02293499|7562745|FG001|COMPLETED|Training - Peer Leaders Only||0
6634081|NCT02293499|7562746|FG002|COMPLETED|Training - Peer Leaders Only||41
6634082|NCT02293499|7562744|FG000|NOT COMPLETED|Training - Peer Leaders Only||0
6634083|NCT02293499|7562745|FG001|NOT COMPLETED|Training - Peer Leaders Only||0
6634084|NCT02293499|7562746|FG002|NOT COMPLETED|Training - Peer Leaders Only||10
6634085|NCT02293499|7562744|FG000|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|152
6634086|NCT02293499|7562745|FG001|STARTED|Intervention - Camp|By design, they did not participate in the previous period.|168
6634087|NCT02293499|7562746|FG002|STARTED|Intervention - Camp||41
6634088|NCT02293499|7562744|FG000|COMPLETED|Intervention - Camp||125
6634089|NCT02293499|7562745|FG001|COMPLETED|Intervention - Camp||134
6634090|NCT02293499|7562746|FG002|COMPLETED|Intervention - Camp||35
6634091|NCT02293499|7562744|FG000|NOT COMPLETED|Intervention - Camp||27
6634092|NCT02293499|7562745|FG001|NOT COMPLETED|Intervention - Camp||34
6634093|NCT02293499|7562746|FG002|NOT COMPLETED|Intervention - Camp||6
6634094|NCT02293499|7562744|FG000|STARTED|3 Month Follow Up||149
6634095|NCT02293499|7562745|FG001|STARTED|3 Month Follow Up||162
6634096|NCT02293499|7562746|FG002|STARTED|3 Month Follow Up||39
6634097|NCT02293499|7562744|FG000|COMPLETED|3 Month Follow Up||134
6634098|NCT02293499|7562745|FG001|COMPLETED|3 Month Follow Up||147
6634099|NCT02293499|7562746|FG002|COMPLETED|3 Month Follow Up||29
6634100|NCT02293499|7562744|FG000|NOT COMPLETED|3 Month Follow Up||15
6634101|NCT02293499|7562745|FG001|NOT COMPLETED|3 Month Follow Up||15
6634102|NCT02293499|7562746|FG002|NOT COMPLETED|3 Month Follow Up||10
6634103|NCT02293499|7562744|FG000|STARTED|6 Month Follow Up||148
6634104|NCT02293499|7562745|FG001|STARTED|6 Month Follow Up||162
6634105|NCT02293499|7562746|FG002|STARTED|6 Month Follow Up||35
6286039|NCT00224887|7186707|FG000|STARTED|Overall Study||154
6286040|NCT00224887|7186708|FG001|STARTED|Overall Study||153
6634106|NCT02293499|7562744|FG000|COMPLETED|6 Month Follow Up||131
6634107|NCT02293499|7562745|FG001|COMPLETED|6 Month Follow Up||135
6634108|NCT02293499|7562746|FG002|COMPLETED|6 Month Follow Up||28
6634109|NCT02293499|7562744|FG000|NOT COMPLETED|6 Month Follow Up||17
6634110|NCT02293499|7562745|FG001|NOT COMPLETED|6 Month Follow Up||27
6634111|NCT02293499|7562746|FG002|NOT COMPLETED|6 Month Follow Up||7
6634112|NCT02293499|7562744|FG000|STARTED|9 Month Follow Up||148
6634113|NCT02293499|7562745|FG001|STARTED|9 Month Follow Up||162
6634114|NCT02293499|7562746|FG002|STARTED|9 Month Follow Up||34
6634115|NCT02293499|7562744|FG000|COMPLETED|9 Month Follow Up||122
6634116|NCT02293499|7562745|FG001|COMPLETED|9 Month Follow Up||134
6634117|NCT02293499|7562746|FG002|COMPLETED|9 Month Follow Up||30
6634118|NCT02293499|7562744|FG000|NOT COMPLETED|9 Month Follow Up||26
6634119|NCT02293499|7562745|FG001|NOT COMPLETED|9 Month Follow Up||28
6634120|NCT02293499|7562746|FG002|NOT COMPLETED|9 Month Follow Up||4
6634121|NCT02293499|7562744|FG000|STARTED|12 Month Follow Up||146
6634122|NCT02293499|7562745|FG001|STARTED|12 Month Follow Up||162
6286041|NCT00224887|7186707|FG000|COMPLETED|Overall Study||148
6286042|NCT00224887|7186708|FG001|COMPLETED|Overall Study||147
6286043|NCT00224887|7186707|FG000|NOT COMPLETED|Overall Study||6
6286044|NCT00224887|7186708|FG001|NOT COMPLETED|Overall Study||6
6286045|NCT00224952|7186717|FG000|STARTED|Overall Study||53
6286046|NCT00224952|7186718|FG001|STARTED|Overall Study||87
6286047|NCT00224952|7186719|FG002|STARTED|Overall Study||134
6286048|NCT00224952|7186717|FG000|COMPLETED|Overall Study||53
6286049|NCT00224952|7186718|FG001|COMPLETED|Overall Study||87
6286050|NCT00224952|7186719|FG002|COMPLETED|Overall Study||134
6286051|NCT00224952|7186717|FG000|NOT COMPLETED|Overall Study||0
6286052|NCT00224952|7186718|FG001|NOT COMPLETED|Overall Study||0
6286053|NCT00224952|7186719|FG002|NOT COMPLETED|Overall Study||0
6286054|NCT00225017|7186730|FG000|STARTED|Overall Study||26
6286055|NCT00225017|7186731|FG001|STARTED|Overall Study||24
6286056|NCT00225017|7186730|FG000|COMPLETED|Overall Study||26
6286057|NCT00225017|7186731|FG001|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
6286058|NCT00225017|7186730|FG000|NOT COMPLETED|Overall Study||0
6286059|NCT00225017|7186731|FG001|NOT COMPLETED|Overall Study||1
6286060|NCT00225147|7186741|FG000|STARTED|Double-blind Phase||13
6286061|NCT00225147|7186742|FG001|STARTED|Double-blind Phase||12
6286062|NCT00225147|7186743|FG002|STARTED|Double-blind Phase||13
6286063|NCT00225147|7186744|FG003|STARTED|Double-blind Phase||0
6286064|NCT00225147|7186741|FG000|COMPLETED|Double-blind Phase||13
6286065|NCT00225147|7186742|FG001|COMPLETED|Double-blind Phase||12
6286066|NCT00225147|7186743|FG002|COMPLETED|Double-blind Phase||13
6286067|NCT00225147|7186744|FG003|COMPLETED|Double-blind Phase||0
6286068|NCT00225147|7186741|FG000|NOT COMPLETED|Double-blind Phase||0
6286069|NCT00225147|7186742|FG001|NOT COMPLETED|Double-blind Phase||0
6286070|NCT00225147|7186743|FG002|NOT COMPLETED|Double-blind Phase||0
6286071|NCT00225147|7186744|FG003|NOT COMPLETED|Double-blind Phase||0
6286072|NCT00225147|7186741|FG000|STARTED|Open-label Phase||0
6286073|NCT00225147|7186742|FG001|STARTED|Open-label Phase||0
6286074|NCT00225147|7186743|FG002|STARTED|Open-label Phase||0
6286075|NCT00225147|7186744|FG003|STARTED|Open-label Phase||62
6286076|NCT00225147|7186741|FG000|COMPLETED|Open-label Phase||0
6286077|NCT00225147|7186742|FG001|COMPLETED|Open-label Phase||0
6286078|NCT00225147|7186743|FG002|COMPLETED|Open-label Phase||0
6286079|NCT00225147|7186744|FG003|COMPLETED|Open-label Phase||52
6286080|NCT00225147|7186741|FG000|NOT COMPLETED|Open-label Phase||0
6286081|NCT00225147|7186742|FG001|NOT COMPLETED|Open-label Phase||0
6286082|NCT00225147|7186743|FG002|NOT COMPLETED|Open-label Phase||0
6286083|NCT00225147|7186744|FG003|NOT COMPLETED|Open-label Phase||10
6286084|NCT00225212|7186756|FG000|STARTED|Overall Study||35
6286085|NCT00225212|7186756|FG000|COMPLETED|Overall Study||29
6286086|NCT00225212|7186756|FG000|NOT COMPLETED|Overall Study||6
6634123|NCT02293499|7562746|FG002|STARTED|12 Month Follow Up||34
6634124|NCT02293499|7562744|FG000|COMPLETED|12 Month Follow Up||120
6634125|NCT02293499|7562745|FG001|COMPLETED|12 Month Follow Up||136
6634126|NCT02293499|7562746|FG002|COMPLETED|12 Month Follow Up||28
6634127|NCT02293499|7562744|FG000|NOT COMPLETED|12 Month Follow Up||26
6634128|NCT02293499|7562745|FG001|NOT COMPLETED|12 Month Follow Up||26
6634129|NCT02293499|7562746|FG002|NOT COMPLETED|12 Month Follow Up||6
6634130|NCT02293499|7562744|FG000|STARTED|15 Month Follow Up||146
6634131|NCT02293499|7562745|FG001|STARTED|15 Month Follow Up||161
6634132|NCT02293499|7562746|FG002|STARTED|15 Month Follow Up||34
6634133|NCT02293499|7562744|FG000|COMPLETED|15 Month Follow Up||124
6634134|NCT02293499|7562745|FG001|COMPLETED|15 Month Follow Up||139
6634135|NCT02293499|7562746|FG002|COMPLETED|15 Month Follow Up||27
6634136|NCT02293499|7562744|FG000|NOT COMPLETED|15 Month Follow Up||22
6634137|NCT02293499|7562745|FG001|NOT COMPLETED|15 Month Follow Up||22
6634138|NCT02293499|7562746|FG002|NOT COMPLETED|15 Month Follow Up||7
6634139|NCT02293512|7562759|FG000|STARTED|Overall Study||10
6634140|NCT02293512|7562760|FG001|STARTED|Overall Study||10
6634141|NCT02293512|7562761|FG002|STARTED|Overall Study||10
6634142|NCT02293512|7562762|FG003|STARTED|Overall Study||10
6634143|NCT02293512|7562759|FG000|COMPLETED|Overall Study||6
6634144|NCT02293512|7562760|FG001|COMPLETED|Overall Study||4
6634145|NCT02293512|7562761|FG002|COMPLETED|Overall Study||7
6634146|NCT02293512|7562762|FG003|COMPLETED|Overall Study||8
6634147|NCT02293512|7562759|FG000|NOT COMPLETED|Overall Study||4
6634148|NCT02293512|7562760|FG001|NOT COMPLETED|Overall Study||6
6634149|NCT02293512|7562761|FG002|NOT COMPLETED|Overall Study||3
6634150|NCT02293512|7562762|FG003|NOT COMPLETED|Overall Study||2
6634151|NCT02293538|7562774|FG000|STARTED|Overall Study||73
6634152|NCT02293538|7562775|FG001|STARTED|Overall Study||71
6634153|NCT02293538|7562774|FG000|COMPLETED|Overall Study||72
6634154|NCT02293538|7562775|FG001|COMPLETED|Overall Study||69
6634155|NCT02293538|7562774|FG000|NOT COMPLETED|Overall Study||1
6286087|NCT00225251|7186762|FG000|STARTED|Overall Study||11
6286088|NCT00225251|7186763|FG001|STARTED|Overall Study||7
6286089|NCT00225251|7186762|FG000|COMPLETED|Overall Study||10
6286090|NCT00225251|7186763|FG001|COMPLETED|Overall Study||6
6286091|NCT00225251|7186762|FG000|NOT COMPLETED|Overall Study||1
6634156|NCT02293538|7562775|FG001|NOT COMPLETED|Overall Study||2
6634157|NCT02293798|7562782|FG000|STARTED|Overall Study|2 units of SERI Mesh placed in each patient|13
6634158|NCT02293798|7562782|FG000|COMPLETED|Overall Study|2 units of SERI Mesh placed in each patient|13
6634159|NCT02293798|7562782|FG000|NOT COMPLETED|Overall Study||0
6634160|NCT02293837|7562790|FG000|STARTED|Overall Study||54
6634161|NCT02293837|7562791|FG001|STARTED|Overall Study||27
6634162|NCT02293837|7562792|FG002|STARTED|Overall Study|1 randomized adult was never treated|35
6286092|NCT00225251|7186763|FG001|NOT COMPLETED|Overall Study||1
6286093|NCT00225277|7186771|FG000|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
6286094|NCT00225277|7186772|FG001|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
6286095|NCT00225277|7186771|FG000|COMPLETED|Overall Study||177
6286096|NCT00225277|7186772|FG001|COMPLETED|Overall Study||178
6286097|NCT00225277|7186771|FG000|NOT COMPLETED|Overall Study||97
6286098|NCT00225277|7186772|FG001|NOT COMPLETED|Overall Study||95
6286099|NCT00225420|7186778|FG000|STARTED|Overall Study||9
6286100|NCT00225420|7186779|FG001|STARTED|Overall Study||6
6634163|NCT02293837|7562793|FG003|STARTED|Overall Study||20
6634164|NCT02293837|7562790|FG000|COMPLETED|Overall Study||51
6634165|NCT02293837|7562791|FG001|COMPLETED|Overall Study||23
6634166|NCT02293837|7562792|FG002|COMPLETED|Overall Study||31
6634167|NCT02293837|7562793|FG003|COMPLETED|Overall Study||19
6634168|NCT02293837|7562790|FG000|NOT COMPLETED|Overall Study||3
6634169|NCT02293837|7562791|FG001|NOT COMPLETED|Overall Study||4
6634170|NCT02293837|7562792|FG002|NOT COMPLETED|Overall Study||4
6634171|NCT02293837|7562793|FG003|NOT COMPLETED|Overall Study||1
6634172|NCT02293863|7562810|FG000|STARTED|Overall Study||56
6634173|NCT02293863|7562811|FG001|STARTED|Overall Study||55
6634174|NCT02293863|7562812|FG002|STARTED|Overall Study||47
6634175|NCT02293863|7562810|FG000|COMPLETED|Overall Study||47
6634176|NCT02293863|7562811|FG001|COMPLETED|Overall Study||42
6634177|NCT02293863|7562812|FG002|COMPLETED|Overall Study||38
6634178|NCT02293863|7562810|FG000|NOT COMPLETED|Overall Study||9
6634179|NCT02293863|7562811|FG001|NOT COMPLETED|Overall Study||13
6634180|NCT02293863|7562812|FG002|NOT COMPLETED|Overall Study||9
6634181|NCT02293902|7562825|FG000|STARTED|Double-Blind Period (Up to Week 24)||82
6634182|NCT02293902|7562826|FG001|STARTED|Double-Blind Period (Up to Week 24)||81
6634183|NCT02293902|7562827|FG002|STARTED|Double-Blind Period (Up to Week 24)||80
6634184|NCT02293902|7562828|FG003|STARTED|Double-Blind Period (Up to Week 24)||0
6634185|NCT02293902|7562829|FG004|STARTED|Double-Blind Period (Up to Week 24)||0
6634186|NCT02293902|7562825|FG000|Treated|Double-Blind Period (Up to Week 24)||81
6634187|NCT02293902|7562826|FG001|Treated|Double-Blind Period (Up to Week 24)||81
6634188|NCT02293902|7562827|FG002|Treated|Double-Blind Period (Up to Week 24)||80
6634189|NCT02293902|7562828|FG003|Treated|Double-Blind Period (Up to Week 24)||0
6634190|NCT02293902|7562829|FG004|Treated|Double-Blind Period (Up to Week 24)||0
6634191|NCT02293902|7562825|FG000|Rescued|Double-Blind Period (Up to Week 24)||44
6634192|NCT02293902|7562826|FG001|Rescued|Double-Blind Period (Up to Week 24)||6
6634193|NCT02293902|7562827|FG002|Rescued|Double-Blind Period (Up to Week 24)||8
6634194|NCT02293902|7562828|FG003|Rescued|Double-Blind Period (Up to Week 24)||0
6634195|NCT02293902|7562829|FG004|Rescued|Double-Blind Period (Up to Week 24)||0
6634196|NCT02293902|7562825|FG000|COMPLETED|Double-Blind Period (Up to Week 24)|42 rescued and 29 not rescued completed.|71
6634197|NCT02293902|7562826|FG001|COMPLETED|Double-Blind Period (Up to Week 24)|6 rescued and 68 not rescued completed.|74
6634198|NCT02293902|7562827|FG002|COMPLETED|Double-Blind Period (Up to Week 24)|8 rescued and 62 not rescued completed.|70
6634199|NCT02293902|7562828|FG003|COMPLETED|Double-Blind Period (Up to Week 24)||0
6634200|NCT02293902|7562829|FG004|COMPLETED|Double-Blind Period (Up to Week 24)||0
6634201|NCT02293902|7562825|FG000|NOT COMPLETED|Double-Blind Period (Up to Week 24)||11
6634202|NCT02293902|7562826|FG001|NOT COMPLETED|Double-Blind Period (Up to Week 24)||7
6634203|NCT02293902|7562827|FG002|NOT COMPLETED|Double-Blind Period (Up to Week 24)||10
6634204|NCT02293902|7562828|FG003|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
6634205|NCT02293902|7562829|FG004|NOT COMPLETED|Double-Blind Period (Up to Week 24)||0
6634206|NCT02293902|7562825|FG000|STARTED|Single-Blind Period (Week 25 to Week 52)||0
6634207|NCT02293902|7562826|FG001|STARTED|Single-Blind Period (Week 25 to Week 52)|68 participants not rescued continued same treatment and 6 rescued continued open label treatment.|74
6634208|NCT02293902|7562827|FG002|STARTED|Single-Blind Period (Week 25 to Week 52)|62 participants not rescued continued same treatment and 8 rescued continued open label treatment.|70
6634209|NCT02293902|7562828|FG003|STARTED|Single-Blind Period (Week 25 to Week 52)|14 participants not rescued were switched and 20 rescued continued open label treatment.|34
6634210|NCT02293902|7562829|FG004|STARTED|Single-Blind Period (Week 25 to Week 52)|15 participants not rescued were switched and 22 rescued continued open label treatment.|37
6634211|NCT02293902|7562825|FG000|COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
6634212|NCT02293902|7562826|FG001|COMPLETED|Single-Blind Period (Week 25 to Week 52)|5 rescued and 61 not rescued completed.|66
6634213|NCT02293902|7562827|FG002|COMPLETED|Single-Blind Period (Week 25 to Week 52)|8 rescued and 60 not rescued completed.|68
6634214|NCT02293902|7562828|FG003|COMPLETED|Single-Blind Period (Week 25 to Week 52)|20 rescued and 13 not rescued completed.|33
6634215|NCT02293902|7562829|FG004|COMPLETED|Single-Blind Period (Week 25 to Week 52)|18 rescued and 13 not rescued completed.|31
6634216|NCT02293902|7562825|FG000|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||0
6634217|NCT02293902|7562826|FG001|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||8
6634218|NCT02293902|7562827|FG002|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||2
6634219|NCT02293902|7562828|FG003|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||1
6634220|NCT02293902|7562829|FG004|NOT COMPLETED|Single-Blind Period (Week 25 to Week 52)||6
6634221|NCT02293993|7562851|FG000|STARTED|Course 1 (DLT Evaluation Period)||4
6634222|NCT02293993|7562852|FG001|STARTED|Course 1 (DLT Evaluation Period)||6
6634223|NCT02293993|7562853|FG002|STARTED|Course 1 (DLT Evaluation Period)||7
6634224|NCT02293993|7562854|FG003|STARTED|Course 1 (DLT Evaluation Period)||4
6286101|NCT00225420|7186780|FG002|STARTED|Overall Study||3
6286102|NCT00225420|7186778|FG000|COMPLETED|Overall Study||9
6286103|NCT00225420|7186779|FG001|COMPLETED|Overall Study||6
6286104|NCT00225420|7186780|FG002|COMPLETED|Overall Study||3
6286105|NCT00225420|7186778|FG000|NOT COMPLETED|Overall Study||0
6286106|NCT00225420|7186779|FG001|NOT COMPLETED|Overall Study||0
6286107|NCT00225420|7186780|FG002|NOT COMPLETED|Overall Study||0
6634225|NCT02293993|7562851|FG000|COMPLETED|Course 1 (DLT Evaluation Period)||3
6634226|NCT02293993|7562852|FG001|COMPLETED|Course 1 (DLT Evaluation Period)||6
6634227|NCT02293993|7562853|FG002|COMPLETED|Course 1 (DLT Evaluation Period)||7
6634228|NCT02293993|7562854|FG003|COMPLETED|Course 1 (DLT Evaluation Period)||3
6634229|NCT02293993|7562851|FG000|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
6634230|NCT02293993|7562852|FG001|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
6634231|NCT02293993|7562853|FG002|NOT COMPLETED|Course 1 (DLT Evaluation Period)||0
6634232|NCT02293993|7562854|FG003|NOT COMPLETED|Course 1 (DLT Evaluation Period)||1
6634233|NCT02293993|7562851|FG000|STARTED|Course ≥2 (Extended Treatment Period)||2
6634234|NCT02293993|7562852|FG001|STARTED|Course ≥2 (Extended Treatment Period)||5
6634235|NCT02293993|7562853|FG002|STARTED|Course ≥2 (Extended Treatment Period)||6
6634236|NCT02293993|7562854|FG003|STARTED|Course ≥2 (Extended Treatment Period)||3
6634237|NCT02293993|7562851|FG000|COMPLETED|Course ≥2 (Extended Treatment Period)||0
6634238|NCT02293993|7562852|FG001|COMPLETED|Course ≥2 (Extended Treatment Period)||0
6634239|NCT02293993|7562853|FG002|COMPLETED|Course ≥2 (Extended Treatment Period)||1
6634240|NCT02293993|7562854|FG003|COMPLETED|Course ≥2 (Extended Treatment Period)||2
6634241|NCT02293993|7562851|FG000|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||2
6634242|NCT02293993|7562852|FG001|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
6634243|NCT02293993|7562853|FG002|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||5
6634244|NCT02293993|7562854|FG003|NOT COMPLETED|Course ≥2 (Extended Treatment Period)||1
6634245|NCT02294019|7562872|FG000|STARTED|Overall Study||738
6634246|NCT02294019|7562872|FG000|COMPLETED|Overall Study||635
6634247|NCT02294019|7562872|FG000|NOT COMPLETED|Overall Study||103
6634248|NCT02294058|7562879|FG000|STARTED|Overall Study||448
6634249|NCT02294058|7562880|FG001|STARTED|Overall Study||451
6634250|NCT02294058|7562881|FG002|STARTED|Overall Study||447
6634251|NCT02294058|7562879|FG000|Safety Population|Overall Study||445
6634252|NCT02294058|7562880|FG001|Safety Population|Overall Study||453
6634253|NCT02294058|7562881|FG002|Safety Population|Overall Study||448
6634254|NCT02294058|7562879|FG000|COMPLETED|Overall Study||412
6634255|NCT02294058|7562880|FG001|COMPLETED|Overall Study||425
6634256|NCT02294058|7562881|FG002|COMPLETED|Overall Study||418
6634257|NCT02294058|7562879|FG000|NOT COMPLETED|Overall Study||36
6634258|NCT02294058|7562880|FG001|NOT COMPLETED|Overall Study||26
6634259|NCT02294058|7562881|FG002|NOT COMPLETED|Overall Study||29
6634260|NCT02294175|7562892|FG000|STARTED|Overall Study||23
6634261|NCT02294175|7562893|FG001|STARTED|Overall Study||22
6634262|NCT02294175|7562892|FG000|COMPLETED|Overall Study||18
6634263|NCT02294175|7562893|FG001|COMPLETED|Overall Study||16
6634264|NCT02294175|7562892|FG000|NOT COMPLETED|Overall Study||5
6634265|NCT02294175|7562893|FG001|NOT COMPLETED|Overall Study||6
6634266|NCT02294227|7562902|FG000|STARTED|Overall Study||114
6634267|NCT02294227|7562903|FG001|STARTED|Overall Study||113
6634268|NCT02294227|7562904|FG002|STARTED|Overall Study||114
6634269|NCT02294227|7562902|FG000|COMPLETED|Overall Study||89
6634270|NCT02294227|7562903|FG001|COMPLETED|Overall Study||88
6634271|NCT02294227|7562904|FG002|COMPLETED|Overall Study||95
6634272|NCT02294227|7562902|FG000|NOT COMPLETED|Overall Study||25
6634273|NCT02294227|7562903|FG001|NOT COMPLETED|Overall Study||25
6634274|NCT02294227|7562904|FG002|NOT COMPLETED|Overall Study||19
6634275|NCT02294253|7562914|FG000|STARTED|Overall Study||30
6634276|NCT02294253|7562914|FG000|COMPLETED|Overall Study||15
6634277|NCT02294253|7562914|FG000|NOT COMPLETED|Overall Study||15
6634278|NCT02294318|7562920|FG000|STARTED|Overall Study||24
6634279|NCT02294318|7562921|FG001|STARTED|Overall Study||23
6634280|NCT02294318|7562920|FG000|COMPLETED|Overall Study||21
6634281|NCT02294318|7562921|FG001|COMPLETED|Overall Study||21
6634282|NCT02294318|7562920|FG000|NOT COMPLETED|Overall Study||3
6634283|NCT02294318|7562921|FG001|NOT COMPLETED|Overall Study||2
6634284|NCT02294396|7562931|FG000|STARTED|Overall Study||167
6634285|NCT02294396|7562932|FG001|STARTED|Overall Study||161
6634286|NCT02294396|7562933|FG002|STARTED|Overall Study||161
6634287|NCT02294396|7562934|FG003|STARTED|Overall Study||160
6634288|NCT02294396|7562931|FG000|COMPLETED|Overall Study||127
6634289|NCT02294396|7562932|FG001|COMPLETED|Overall Study||128
6634290|NCT02294396|7562933|FG002|COMPLETED|Overall Study||126
6634291|NCT02294396|7562934|FG003|COMPLETED|Overall Study||123
6634292|NCT02294396|7562931|FG000|NOT COMPLETED|Overall Study||40
6634293|NCT02294396|7562932|FG001|NOT COMPLETED|Overall Study||33
6634294|NCT02294396|7562933|FG002|NOT COMPLETED|Overall Study||35
6634295|NCT02294396|7562934|FG003|NOT COMPLETED|Overall Study||37
6286108|NCT00225498|7186787|FG000|STARTED|Overall Study||10
6634296|NCT02294474|7562946|FG000|STARTED|Overall Study||253
6634297|NCT02294474|7562947|FG001|STARTED|Overall Study||252
6373936|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6634298|NCT02294474|7562946|FG000|COMPLETED|Overall Study||228
6634299|NCT02294474|7562947|FG001|COMPLETED|Overall Study||230
6634300|NCT02294474|7562946|FG000|NOT COMPLETED|Overall Study||25
6634301|NCT02294474|7562947|FG001|NOT COMPLETED|Overall Study||22
6634302|NCT02294604|7562957|FG000|STARTED|Overall Study||80
6634303|NCT02294604|7562958|FG001|STARTED|Overall Study||80
6634304|NCT02294604|7562959|FG002|STARTED|Overall Study||80
6286109|NCT00225498|7186787|FG000|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
6286110|NCT00225498|7186787|FG000|NOT COMPLETED|Overall Study||0
6634305|NCT02294604|7562957|FG000|COMPLETED|Overall Study||79
6634306|NCT02294604|7562958|FG001|COMPLETED|Overall Study||77
6634307|NCT02294604|7562959|FG002|COMPLETED|Overall Study||80
6634308|NCT02294604|7562957|FG000|NOT COMPLETED|Overall Study||1
6634309|NCT02294604|7562958|FG001|NOT COMPLETED|Overall Study||3
6634310|NCT02294604|7562959|FG002|NOT COMPLETED|Overall Study||0
6634311|NCT02294630|7562971|FG000|STARTED|Overall Study||37
6634312|NCT02294630|7562972|FG001|STARTED|Overall Study||38
6634313|NCT02294630|7562973|FG002|STARTED|Overall Study||35
6634314|NCT02294630|7562974|FG003|STARTED|Overall Study||39
6634315|NCT02294630|7562971|FG000|COMPLETED|Overall Study||37
6634316|NCT02294630|7562972|FG001|COMPLETED|Overall Study||38
6634317|NCT02294630|7562973|FG002|COMPLETED|Overall Study||35
6634318|NCT02294630|7562974|FG003|COMPLETED|Overall Study||39
6634319|NCT02294630|7562971|FG000|NOT COMPLETED|Overall Study||0
6634320|NCT02294630|7562972|FG001|NOT COMPLETED|Overall Study||0
6634321|NCT02294630|7562973|FG002|NOT COMPLETED|Overall Study||0
6634322|NCT02294630|7562974|FG003|NOT COMPLETED|Overall Study||0
6634323|NCT02294682|7562986|FG000|STARTED|Overall Study||53
6634324|NCT02294682|7562987|FG001|STARTED|Overall Study||53
6634325|NCT02294682|7562986|FG000|COMPLETED|Overall Study||52
6634326|NCT02294682|7562987|FG001|COMPLETED|Overall Study||53
6634327|NCT02294682|7562986|FG000|NOT COMPLETED|Overall Study||1
6634328|NCT02294682|7562987|FG001|NOT COMPLETED|Overall Study||0
6634329|NCT02294734|7562995|FG000|STARTED|Overall Study||63
6634330|NCT02294734|7562996|FG001|STARTED|Overall Study||63
6634331|NCT02294734|7562995|FG000|COMPLETED|Overall Study||49
6634332|NCT02294734|7562996|FG001|COMPLETED|Overall Study||55
6634333|NCT02294734|7562995|FG000|NOT COMPLETED|Overall Study||14
6634334|NCT02294734|7562996|FG001|NOT COMPLETED|Overall Study||8
6634335|NCT02294773|7563006|FG000|STARTED|Overall Study||7
6634336|NCT02294773|7563007|FG001|STARTED|Overall Study||6
6634337|NCT02294773|7563006|FG000|COMPLETED|Overall Study||7
6634338|NCT02294773|7563007|FG001|COMPLETED|Overall Study||4
6634339|NCT02294773|7563006|FG000|NOT COMPLETED|Overall Study||0
6634340|NCT02294773|7563007|FG001|NOT COMPLETED|Overall Study||2
6634341|NCT02294786|7563015|FG000|STARTED|Overall Study||30
6634342|NCT02294786|7563016|FG001|STARTED|Overall Study||32
6634343|NCT02294786|7563015|FG000|Safety Population|Overall Study|One subject randomized to Octreotide received only 0.1 mg dose.|29
6634344|NCT02294786|7563016|FG001|Safety Population|Overall Study|The subject was included in the No-Octreotide arm.|33
6634345|NCT02294786|7563015|FG000|ITT Population|Overall Study||30
6634346|NCT02294786|7563016|FG001|ITT Population|Overall Study||32
6634347|NCT02294786|7563015|FG000|COMPLETED|Overall Study||19
6634348|NCT02294786|7563016|FG001|COMPLETED|Overall Study||18
6634349|NCT02294786|7563015|FG000|NOT COMPLETED|Overall Study||11
6634350|NCT02294786|7563016|FG001|NOT COMPLETED|Overall Study||14
6634351|NCT02295020|7563025|FG000|STARTED|Overall Study||20
6634352|NCT02295020|7563026|FG001|STARTED|Overall Study||20
6634353|NCT02295020|7563025|FG000|COMPLETED|Overall Study||17
6634354|NCT02295020|7563026|FG001|COMPLETED|Overall Study||17
6634355|NCT02295020|7563025|FG000|NOT COMPLETED|Overall Study||3
6634356|NCT02295020|7563026|FG001|NOT COMPLETED|Overall Study||3
6634357|NCT02295280|7563040|FG000|STARTED|Overall Study||35
6634358|NCT02295280|7563041|FG001|STARTED|Overall Study||35
6634359|NCT02295280|7563040|FG000|COMPLETED|Overall Study||35
6634360|NCT02295280|7563041|FG001|COMPLETED|Overall Study||34
6634361|NCT02295280|7563040|FG000|NOT COMPLETED|Overall Study||0
6634362|NCT02295280|7563041|FG001|NOT COMPLETED|Overall Study||1
6634363|NCT02295553|7563051|FG000|STARTED|Overall Study||14
6634364|NCT02295553|7563052|FG001|STARTED|Overall Study||14
6634365|NCT02295553|7563053|FG002|STARTED|Overall Study||14
6634366|NCT02295553|7563054|FG003|STARTED|Overall Study||14
6634367|NCT02295553|7563051|FG000|COMPLETED|Overall Study||14
6634368|NCT02295553|7563052|FG001|COMPLETED|Overall Study||14
6634369|NCT02295553|7563053|FG002|COMPLETED|Overall Study||13
6634370|NCT02295553|7563054|FG003|COMPLETED|Overall Study||13
6634371|NCT02295553|7563051|FG000|NOT COMPLETED|Overall Study||0
6634372|NCT02295553|7563052|FG001|NOT COMPLETED|Overall Study||0
6634373|NCT02295553|7563053|FG002|NOT COMPLETED|Overall Study||1
6634374|NCT02295553|7563054|FG003|NOT COMPLETED|Overall Study||1
6634375|NCT02295644|7563068|FG000|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
6634376|NCT02295644|7563069|FG001|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
6634377|NCT02295644|7563070|FG002|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
6634378|NCT02295644|7563071|FG003|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
6634379|NCT02295644|7563068|FG000|COMPLETED|Overall Study||7
6634380|NCT02295644|7563069|FG001|COMPLETED|Overall Study||7
6634381|NCT02295644|7563070|FG002|COMPLETED|Overall Study||6
6634382|NCT02295644|7563071|FG003|COMPLETED|Overall Study||5
6634383|NCT02295644|7563068|FG000|NOT COMPLETED|Overall Study||0
6634384|NCT02295644|7563069|FG001|NOT COMPLETED|Overall Study||0
6634385|NCT02295644|7563070|FG002|NOT COMPLETED|Overall Study||1
6634386|NCT02295644|7563071|FG003|NOT COMPLETED|Overall Study||2
6634387|NCT02295735|7563083|FG000|STARTED|Overall Study||238
6634388|NCT02295735|7563084|FG001|STARTED|Overall Study||237
6634389|NCT02295735|7563083|FG000|COMPLETED|Overall Study||212
6286111|NCT00225732|7186793|FG000|STARTED|Overall Study||153
6286112|NCT00225732|7186794|FG001|STARTED|Overall Study||166
6286113|NCT00225732|7186793|FG000|COMPLETED|Overall Study||153
6286114|NCT00225732|7186794|FG001|COMPLETED|Overall Study||166
6286115|NCT00225732|7186793|FG000|NOT COMPLETED|Overall Study||0
6286116|NCT00225732|7186794|FG001|NOT COMPLETED|Overall Study||0
6286117|NCT00225758|7186800|FG000|STARTED|Overall Study||27
6286118|NCT00225758|7186800|FG000|COMPLETED|Overall Study||23
6286119|NCT00225758|7186800|FG000|NOT COMPLETED|Overall Study||4
6286120|NCT00225784|7186806|FG000|STARTED|Overall Study||37
6286121|NCT00225784|7186806|FG000|COMPLETED|Overall Study||33
6286122|NCT00225784|7186806|FG000|NOT COMPLETED|Overall Study||4
6286123|NCT00226239|7186813|FG000|STARTED|TPE, Induction Therapy||39
6286124|NCT00226239|7186813|FG000|COMPLETED|TPE, Induction Therapy||37
6286125|NCT00226239|7186813|FG000|NOT COMPLETED|TPE, Induction Therapy||2
6286126|NCT00226239|7186813|FG000|STARTED|XPE, Definitive Therapy||37
6286127|NCT00226239|7186813|FG000|COMPLETED|XPE, Definitive Therapy||33
6286128|NCT00226239|7186813|FG000|NOT COMPLETED|XPE, Definitive Therapy||4
6286129|NCT00226239|7186813|FG000|STARTED|Maintenance Cetuximab||31
6286130|NCT00226239|7186813|FG000|COMPLETED|Maintenance Cetuximab||17
6286131|NCT00226239|7186813|FG000|NOT COMPLETED|Maintenance Cetuximab||14
6286132|NCT00226499|7186821|FG000|STARTED|Overall Study||2489
6286133|NCT00226499|7186822|FG001|STARTED|Overall Study||2487
6286134|NCT00226499|7186823|FG002|STARTED|Overall Study||827
6286135|NCT00226499|7186821|FG000|COMPLETED|Overall Study||1415
6286136|NCT00226499|7186822|FG001|COMPLETED|Overall Study||1415
6286137|NCT00226499|7186823|FG002|COMPLETED|Overall Study||468
6286138|NCT00226499|7186821|FG000|NOT COMPLETED|Overall Study||1074
6286139|NCT00226499|7186822|FG001|NOT COMPLETED|Overall Study||1072
6286140|NCT00226499|7186823|FG002|NOT COMPLETED|Overall Study||359
6286141|NCT00226577|7186833|FG000|STARTED|Overall Study||52
6286142|NCT00226577|7186833|FG000|COMPLETED|Overall Study||52
6286143|NCT00226577|7186833|FG000|NOT COMPLETED|Overall Study||0
6286144|NCT00226590|7186837|FG000|STARTED|Overall Study||39
6286145|NCT00226590|7186837|FG000|COMPLETED|Overall Study||39
6286146|NCT00226590|7186837|FG000|NOT COMPLETED|Overall Study||0
6286147|NCT00226655|7186842|FG000|STARTED|Overall Study||112
6286148|NCT00226655|7186842|FG000|COMPLETED|Overall Study||33
6286149|NCT00226655|7186842|FG000|NOT COMPLETED|Overall Study||79
6286150|NCT00226811|7186846|FG000|STARTED|Overall Study||78
6286151|NCT00226811|7186846|FG000|COMPLETED|Overall Study||2
6286152|NCT00226811|7186846|FG000|NOT COMPLETED|Overall Study||76
6286153|NCT00226941|7186854|FG000|STARTED|Overall Study||6
6286154|NCT00226941|7186855|FG001|STARTED|Overall Study||6
6286155|NCT00226941|7186856|FG002|STARTED|Overall Study||4
6286156|NCT00226941|7186857|FG003|STARTED|Overall Study||7
6286157|NCT00226941|7186854|FG000|COMPLETED|Overall Study||6
6286158|NCT00226941|7186855|FG001|COMPLETED|Overall Study||6
6286159|NCT00226941|7186856|FG002|COMPLETED|Overall Study||4
6286160|NCT00226941|7186857|FG003|COMPLETED|Overall Study||5
6286161|NCT00226941|7186854|FG000|NOT COMPLETED|Overall Study||0
6286162|NCT00226941|7186855|FG001|NOT COMPLETED|Overall Study||0
6286163|NCT00226941|7186856|FG002|NOT COMPLETED|Overall Study||0
6286164|NCT00226941|7186857|FG003|NOT COMPLETED|Overall Study||2
6286165|NCT00227019|7186873|FG000|STARTED|Overall Study||16
6286166|NCT00227019|7186873|FG000|COMPLETED|Overall Study||16
6286167|NCT00227019|7186873|FG000|NOT COMPLETED|Overall Study||0
6286168|NCT00227266|7186881|FG000|STARTED|Overall Study||31
6286169|NCT00227266|7186882|FG001|STARTED|Overall Study||30
6286170|NCT00227266|7186883|FG002|STARTED|Overall Study||33
6286171|NCT00227266|7186881|FG000|COMPLETED|Overall Study||30
6286172|NCT00227266|7186882|FG001|COMPLETED|Overall Study||30
6286173|NCT00227266|7186883|FG002|COMPLETED|Overall Study||29
6286174|NCT00227266|7186881|FG000|NOT COMPLETED|Overall Study||1
6286175|NCT00227266|7186882|FG001|NOT COMPLETED|Overall Study||0
6286176|NCT00227266|7186883|FG002|NOT COMPLETED|Overall Study||4
6286177|NCT00227305|7186894|FG000|STARTED|Overall Study|enrolled|381
6286178|NCT00227305|7186894|FG000|Drug Received|Overall Study|safety population|380
6286179|NCT00227305|7186894|FG000|COMPLETED|Overall Study|Completed 26 weeks|237
6286180|NCT00227305|7186894|FG000|NOT COMPLETED|Overall Study||144
6286181|NCT00227344|7186900|FG000|STARTED|Overall Study||87
6286182|NCT00227344|7186901|FG001|STARTED|Overall Study||42
6286183|NCT00227344|7186900|FG000|COMPLETED|Overall Study||75
6286184|NCT00227344|7186901|FG001|COMPLETED|Overall Study||37
6286185|NCT00227344|7186900|FG000|NOT COMPLETED|Overall Study||12
6286186|NCT00227344|7186901|FG001|NOT COMPLETED|Overall Study||5
6286187|NCT00227370|7186909|FG000|STARTED|Overall Study|Placebo Group|66
6286188|NCT00227370|7186910|FG001|STARTED|Overall Study|Treatment Group|70
6286189|NCT00227370|7186909|FG000|COMPLETED|Overall Study||45
6286190|NCT00227370|7186910|FG001|COMPLETED|Overall Study||46
6286191|NCT00227370|7186909|FG000|NOT COMPLETED|Overall Study||21
6286192|NCT00227370|7186910|FG001|NOT COMPLETED|Overall Study||24
6286193|NCT00227539|7186916|FG000|STARTED|Overall Study||25
6286194|NCT00227539|7186916|FG000|COMPLETED|Overall Study||24
6286195|NCT00227539|7186916|FG000|NOT COMPLETED|Overall Study||1
6286196|NCT00227591|7186920|FG000|STARTED|Overall Study|48 pts registered to the study|48
6286197|NCT00227591|7186920|FG000|Began Treatment|Overall Study||47
6286198|NCT00227591|7186920|FG000|COMPLETED|Overall Study||47
6286199|NCT00227591|7186920|FG000|NOT COMPLETED|Overall Study||1
6286200|NCT00227617|7186924|FG000|STARTED|Stage 1||22
6286201|NCT00227617|7186925|FG001|STARTED|Stage 1||12
6286202|NCT00227617|7186926|FG002|STARTED|Stage 1||2
6286203|NCT00227617|7186924|FG000|COMPLETED|Stage 1||22
6286204|NCT00227617|7186925|FG001|COMPLETED|Stage 1||12
6286205|NCT00227617|7186926|FG002|COMPLETED|Stage 1||2
6286206|NCT00227617|7186924|FG000|NOT COMPLETED|Stage 1||0
6286207|NCT00227617|7186925|FG001|NOT COMPLETED|Stage 1||0
6286208|NCT00227617|7186926|FG002|NOT COMPLETED|Stage 1||0
6286209|NCT00227617|7186924|FG000|STARTED|Stage 2||0
6286210|NCT00227617|7186925|FG001|STARTED|Stage 2||0
6286211|NCT00227617|7186926|FG002|STARTED|Stage 2||0
6286212|NCT00227617|7186924|FG000|COMPLETED|Stage 2||0
6286213|NCT00227617|7186925|FG001|COMPLETED|Stage 2||0
6286214|NCT00227617|7186926|FG002|COMPLETED|Stage 2||0
6286215|NCT00227617|7186924|FG000|NOT COMPLETED|Stage 2||0
6286216|NCT00227617|7186925|FG001|NOT COMPLETED|Stage 2||0
6286217|NCT00227617|7186926|FG002|NOT COMPLETED|Stage 2||0
6286218|NCT00227721|7186938|FG000|STARTED|Overall Study||30
6286219|NCT00227721|7186938|FG000|COMPLETED|Overall Study||29
6286220|NCT00227721|7186938|FG000|NOT COMPLETED|Overall Study||1
6286221|NCT00227760|7186942|FG000|STARTED|Overall Study||44
6286222|NCT00227760|7186942|FG000|COMPLETED|Overall Study||44
6286223|NCT00227760|7186942|FG000|NOT COMPLETED|Overall Study||0
6286224|NCT00227877|7186950|FG000|STARTED|Pre-visit Assessment||1075
6286225|NCT00227877|7186951|FG001|STARTED|Pre-visit Assessment||1031
6286226|NCT00227877|7186952|FG002|STARTED|Pre-visit Assessment||297
6286227|NCT00227877|7186953|FG003|STARTED|Pre-visit Assessment||292
6286228|NCT00227877|7186950|FG000|COMPLETED|Pre-visit Assessment|Final analysis sample|1068
6286229|NCT00227877|7186951|FG001|COMPLETED|Pre-visit Assessment|Final analysis sample|1028
6286230|NCT00227877|7186952|FG002|COMPLETED|Pre-visit Assessment|Final analysis sample|297
6286231|NCT00227877|7186953|FG003|COMPLETED|Pre-visit Assessment|Final analysis sample|292
6286232|NCT00227877|7186950|FG000|NOT COMPLETED|Pre-visit Assessment||7
6286233|NCT00227877|7186951|FG001|NOT COMPLETED|Pre-visit Assessment||3
6286234|NCT00227877|7186952|FG002|NOT COMPLETED|Pre-visit Assessment||0
6286235|NCT00227877|7186953|FG003|NOT COMPLETED|Pre-visit Assessment||0
6286236|NCT00227877|7186950|FG000|STARTED|Post-visit Checklist||1068
6286237|NCT00227877|7186951|FG001|STARTED|Post-visit Checklist||1028
6286238|NCT00227877|7186952|FG002|STARTED|Post-visit Checklist||297
6286239|NCT00227877|7186953|FG003|STARTED|Post-visit Checklist||292
6286240|NCT00227877|7186950|FG000|COMPLETED|Post-visit Checklist||1044
6286241|NCT00227877|7186951|FG001|COMPLETED|Post-visit Checklist||1015
6286242|NCT00227877|7186952|FG002|COMPLETED|Post-visit Checklist||296
6286243|NCT00227877|7186953|FG003|COMPLETED|Post-visit Checklist||292
6286244|NCT00227877|7186950|FG000|NOT COMPLETED|Post-visit Checklist||24
6286245|NCT00227877|7186951|FG001|NOT COMPLETED|Post-visit Checklist||13
6286246|NCT00227877|7186952|FG002|NOT COMPLETED|Post-visit Checklist||1
6286247|NCT00227877|7186953|FG003|NOT COMPLETED|Post-visit Checklist||0
6286248|NCT00227877|7186950|FG000|STARTED|3-months Follow-up||1068
6286249|NCT00227877|7186951|FG001|STARTED|3-months Follow-up||1028
6286250|NCT00227877|7186952|FG002|STARTED|3-months Follow-up||297
6286251|NCT00227877|7186953|FG003|STARTED|3-months Follow-up||292
6286252|NCT00227877|7186950|FG000|COMPLETED|3-months Follow-up||755
6286253|NCT00227877|7186951|FG001|COMPLETED|3-months Follow-up||761
6286254|NCT00227877|7186952|FG002|COMPLETED|3-months Follow-up||245
6286255|NCT00227877|7186953|FG003|COMPLETED|3-months Follow-up||271
6286256|NCT00227877|7186950|FG000|NOT COMPLETED|3-months Follow-up||313
6286257|NCT00227877|7186951|FG001|NOT COMPLETED|3-months Follow-up||267
6286258|NCT00227877|7186952|FG002|NOT COMPLETED|3-months Follow-up||52
6286259|NCT00227877|7186953|FG003|NOT COMPLETED|3-months Follow-up||21
6634390|NCT02295735|7563084|FG001|COMPLETED|Overall Study||210
6634391|NCT02295735|7563083|FG000|NOT COMPLETED|Overall Study||26
6634392|NCT02295735|7563084|FG001|NOT COMPLETED|Overall Study||27
6634393|NCT02295774|7563090|FG000|STARTED|Overall Study||13
6634394|NCT02295774|7563090|FG000|COMPLETED|Overall Study||10
6634395|NCT02295774|7563090|FG000|NOT COMPLETED|Overall Study||3
6634396|NCT02295995|7563097|FG000|STARTED|Overall Study||36
6634397|NCT02295995|7563098|FG001|STARTED|Overall Study||18
6634398|NCT02295995|7563097|FG000|COMPLETED|Overall Study||31
6634399|NCT02295995|7563098|FG001|COMPLETED|Overall Study||17
6634400|NCT02295995|7563097|FG000|NOT COMPLETED|Overall Study||5
6634401|NCT02295995|7563098|FG001|NOT COMPLETED|Overall Study||1
6634402|NCT02296099|7563107|FG000|STARTED|Overall Study||57
6634403|NCT02296099|7563108|FG001|STARTED|Overall Study||57
6634404|NCT02296099|7563107|FG000|COMPLETED|Overall Study||54
6634405|NCT02296099|7563108|FG001|COMPLETED|Overall Study||55
6634406|NCT02296099|7563107|FG000|NOT COMPLETED|Overall Study||3
6634407|NCT02296099|7563108|FG001|NOT COMPLETED|Overall Study||2
6634408|NCT02296112|7563114|FG000|STARTED|Overall Study||9
6286260|NCT00227877|7186950|FG000|STARTED|12-months Follow-up||1068
6286261|NCT00227877|7186951|FG001|STARTED|12-months Follow-up||1028
6286262|NCT00227877|7186952|FG002|STARTED|12-months Follow-up||297
6286263|NCT00227877|7186953|FG003|STARTED|12-months Follow-up||292
6286264|NCT00227877|7186950|FG000|COMPLETED|12-months Follow-up||758
6286265|NCT00227877|7186951|FG001|COMPLETED|12-months Follow-up||765
6286266|NCT00227877|7186952|FG002|COMPLETED|12-months Follow-up||266
6286267|NCT00227877|7186953|FG003|COMPLETED|12-months Follow-up||266
6634409|NCT02296112|7563114|FG000|COMPLETED|Overall Study||0
6634410|NCT02296112|7563114|FG000|NOT COMPLETED|Overall Study||9
6634411|NCT02296138|7563125|FG000|STARTED|Overall Study||3952
6634412|NCT02296138|7563126|FG001|STARTED|Overall Study||3951
6634413|NCT02296138|7563125|FG000|Treated|Overall Study||3941
6634414|NCT02296138|7563126|FG001|Treated|Overall Study||3939
6634415|NCT02296138|7563125|FG000|COMPLETED|Overall Study||3291
6634416|NCT02296138|7563126|FG001|COMPLETED|Overall Study||3451
6634417|NCT02296138|7563125|FG000|NOT COMPLETED|Overall Study||661
6634418|NCT02296138|7563126|FG001|NOT COMPLETED|Overall Study||500
6634419|NCT02296164|7563132|FG000|STARTED|Overall Study|2 patients not eligible as were not on Valchlor at time of study start|298
6634420|NCT02296164|7563132|FG000|COMPLETED|Overall Study||188
6634421|NCT02296164|7563132|FG000|NOT COMPLETED|Overall Study||110
6634422|NCT02296190|7563142|FG000|STARTED|Overall Study||35
6286268|NCT00227877|7186950|FG000|NOT COMPLETED|12-months Follow-up||310
6286269|NCT00227877|7186951|FG001|NOT COMPLETED|12-months Follow-up||263
6286270|NCT00227877|7186952|FG002|NOT COMPLETED|12-months Follow-up||31
6286271|NCT00227877|7186953|FG003|NOT COMPLETED|12-months Follow-up||26
6286272|NCT00227903|7186967|FG000|STARTED|Overall Study||91
6286273|NCT00227903|7186968|FG001|STARTED|Overall Study||92
6286274|NCT00227903|7186967|FG000|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
6286275|NCT00227903|7186968|FG001|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
6286276|NCT00227903|7186967|FG000|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
6286277|NCT00227903|7186968|FG001|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
6286278|NCT00227903|7186967|FG000|NOT COMPLETED|Overall Study||5
6286279|NCT00227903|7186968|FG001|NOT COMPLETED|Overall Study||10
6286280|NCT00227994|7186976|FG000|STARTED|Overall Study||20
6286281|NCT00227994|7186977|FG001|STARTED|Overall Study||20
6286282|NCT00227994|7186976|FG000|COMPLETED|Overall Study||13
6286283|NCT00227994|7186977|FG001|COMPLETED|Overall Study||13
6286284|NCT00227994|7186976|FG000|NOT COMPLETED|Overall Study||7
6286285|NCT00227994|7186977|FG001|NOT COMPLETED|Overall Study||7
6286286|NCT00228384|7186985|FG000|STARTED|Overall Study||72
6286287|NCT00228384|7186986|FG001|STARTED|Overall Study||76
6286288|NCT00228384|7186985|FG000|Baseline|Overall Study||72
6286289|NCT00228384|7186986|FG001|Baseline|Overall Study||76
6286290|NCT00228384|7186985|FG000|30-Day Follow-up (Safety Outcome)|Overall Study||69
6286291|NCT00228384|7186986|FG001|30-Day Follow-up (Safety Outcome)|Overall Study||72
6286292|NCT00228384|7186985|FG000|Three Year Follow-up (Final)|Overall Study||43
6286293|NCT00228384|7186986|FG001|Three Year Follow-up (Final)|Overall Study||47
6286294|NCT00228384|7186985|FG000|COMPLETED|Overall Study||43
6286295|NCT00228384|7186986|FG001|COMPLETED|Overall Study||47
6286296|NCT00228384|7186985|FG000|NOT COMPLETED|Overall Study||29
6286297|NCT00228384|7186986|FG001|NOT COMPLETED|Overall Study||29
6286298|NCT00228423|7186994|FG000|STARTED|Overall Study||56
6286299|NCT00228423|7186995|FG001|STARTED|Overall Study||57
6286300|NCT00228423|7186994|FG000|COMPLETED|Overall Study||46
6286301|NCT00228423|7186995|FG001|COMPLETED|Overall Study||45
6286302|NCT00228423|7186994|FG000|NOT COMPLETED|Overall Study||10
6286303|NCT00228423|7186995|FG001|NOT COMPLETED|Overall Study||12
6286304|NCT00228553|7187001|FG000|STARTED|Overall Study||743
6286305|NCT00228553|7187001|FG000|COMPLETED|Overall Study||313
6286306|NCT00228553|7187001|FG000|NOT COMPLETED|Overall Study||430
6286307|NCT00228566|7187005|FG000|STARTED|Overall Study||247
6286308|NCT00228566|7187005|FG000|COMPLETED|Overall Study||176
6286309|NCT00228566|7187005|FG000|NOT COMPLETED|Overall Study||71
6286310|NCT00228813|7187009|FG000|STARTED|Overall Study||8
6286311|NCT00228813|7187009|FG000|COMPLETED|Overall Study||4
6286312|NCT00228813|7187009|FG000|NOT COMPLETED|Overall Study||4
6286313|NCT00228917|7187021|FG000|STARTED|Overall Study||193
6286314|NCT00228917|7187022|FG001|STARTED|Overall Study||96
6286315|NCT00228917|7187023|FG002|STARTED|Overall Study||65
6286316|NCT00228917|7187024|FG003|STARTED|Overall Study||33
6286317|NCT00228917|7187025|FG004|STARTED|Overall Study||205
6286318|NCT00228917|7187026|FG005|STARTED|Overall Study||104
6286319|NCT00228917|7187027|FG006|STARTED|Overall Study||69
6286320|NCT00228917|7187028|FG007|STARTED|Overall Study||33
6286321|NCT00228917|7187021|FG000|COMPLETED|Overall Study||193
6286322|NCT00228917|7187022|FG001|COMPLETED|Overall Study||96
6286323|NCT00228917|7187023|FG002|COMPLETED|Overall Study||65
6286324|NCT00228917|7187024|FG003|COMPLETED|Overall Study||33
6286325|NCT00228917|7187025|FG004|COMPLETED|Overall Study||205
6286326|NCT00228917|7187026|FG005|COMPLETED|Overall Study||102
6286327|NCT00228917|7187027|FG006|COMPLETED|Overall Study||69
6286328|NCT00228917|7187028|FG007|COMPLETED|Overall Study||33
6286329|NCT00228917|7187021|FG000|NOT COMPLETED|Overall Study||0
6286330|NCT00228917|7187022|FG001|NOT COMPLETED|Overall Study||0
6286331|NCT00228917|7187023|FG002|NOT COMPLETED|Overall Study||0
6286332|NCT00228917|7187024|FG003|NOT COMPLETED|Overall Study||0
6286333|NCT00228917|7187025|FG004|NOT COMPLETED|Overall Study||0
6286334|NCT00228917|7187026|FG005|NOT COMPLETED|Overall Study||2
6286335|NCT00228917|7187027|FG006|NOT COMPLETED|Overall Study||0
6286336|NCT00228917|7187028|FG007|NOT COMPLETED|Overall Study||0
6286337|NCT00228943|7187042|FG000|STARTED|Week 1||28
6286338|NCT00228943|7187042|FG000|COMPLETED|Week 1||28
6286339|NCT00228943|7187042|FG000|NOT COMPLETED|Week 1||0
6286340|NCT00228943|7187042|FG000|STARTED|Week 2||28
6286341|NCT00228943|7187042|FG000|COMPLETED|Week 2||27
6286342|NCT00228943|7187042|FG000|NOT COMPLETED|Week 2||1
6286343|NCT00229203|7187050|FG000|STARTED|Overall Study||32
6286344|NCT00229203|7187051|FG001|STARTED|Overall Study||19
6286345|NCT00229203|7187050|FG000|COMPLETED|Overall Study||0
6286346|NCT00229203|7187051|FG001|COMPLETED|Overall Study||0
6634423|NCT02296190|7563143|FG001|STARTED|Overall Study||41
6634424|NCT02296190|7563144|FG002|STARTED|Overall Study||35
6286347|NCT00229203|7187050|FG000|NOT COMPLETED|Overall Study||32
6286348|NCT00229203|7187051|FG001|NOT COMPLETED|Overall Study||19
6286349|NCT00229619|7187057|FG000|STARTED|Overall Study||11
6286350|NCT00229619|7187057|FG000|COMPLETED|Overall Study||11
6286351|NCT00229619|7187057|FG000|NOT COMPLETED|Overall Study||0
6286352|NCT00229658|7187065|FG000|STARTED|Overall Study||766
6286353|NCT00229658|7187066|FG001|STARTED|Overall Study||531
6286354|NCT00229658|7187065|FG000|COMPLETED|Overall Study||541
6286355|NCT00229658|7187066|FG001|COMPLETED|Overall Study||364
6286356|NCT00229658|7187065|FG000|NOT COMPLETED|Overall Study||225
6286357|NCT00229658|7187066|FG001|NOT COMPLETED|Overall Study||167
6286358|NCT00229723|7187079|FG000|STARTED|Concomitant Phase|Received randomized treatment|60
6286359|NCT00229723|7187080|FG001|STARTED|Concomitant Phase|Received randomized treatment|24
6286360|NCT00229723|7187081|FG002|STARTED|Concomitant Phase|Received randomized treatment|31
6286361|NCT00229723|7187082|FG003|STARTED|Concomitant Phase|Received randomized treatment|31
6286362|NCT00229723|7187083|FG004|STARTED|Concomitant Phase|Received randomized treatment|24
6286363|NCT00229723|7187084|FG005|STARTED|Concomitant Phase|Received randomized treatment|34
6286364|NCT00229723|7187085|FG006|STARTED|Concomitant Phase|Received randomized treatment|22
6286365|NCT00229723|7187079|FG000|COMPLETED|Concomitant Phase||50
6286366|NCT00229723|7187080|FG001|COMPLETED|Concomitant Phase||19
6286367|NCT00229723|7187081|FG002|COMPLETED|Concomitant Phase||25
6286368|NCT00229723|7187082|FG003|COMPLETED|Concomitant Phase||26
6286369|NCT00229723|7187083|FG004|COMPLETED|Concomitant Phase||22
6286370|NCT00229723|7187084|FG005|COMPLETED|Concomitant Phase||31
6286371|NCT00229723|7187085|FG006|COMPLETED|Concomitant Phase||19
6286372|NCT00229723|7187079|FG000|NOT COMPLETED|Concomitant Phase||10
6286373|NCT00229723|7187080|FG001|NOT COMPLETED|Concomitant Phase||5
6286374|NCT00229723|7187081|FG002|NOT COMPLETED|Concomitant Phase||6
6286375|NCT00229723|7187082|FG003|NOT COMPLETED|Concomitant Phase||5
6286376|NCT00229723|7187083|FG004|NOT COMPLETED|Concomitant Phase||2
6286377|NCT00229723|7187084|FG005|NOT COMPLETED|Concomitant Phase||3
6286378|NCT00229723|7187085|FG006|NOT COMPLETED|Concomitant Phase||3
6286379|NCT00229723|7187079|FG000|STARTED|Maintenance Phase||50
6286380|NCT00229723|7187080|FG001|STARTED|Maintenance Phase||19
6286381|NCT00229723|7187081|FG002|STARTED|Maintenance Phase||25
6286382|NCT00229723|7187082|FG003|STARTED|Maintenance Phase||26
6286383|NCT00229723|7187083|FG004|STARTED|Maintenance Phase||22
6286384|NCT00229723|7187084|FG005|STARTED|Maintenance Phase||31
6286385|NCT00229723|7187085|FG006|STARTED|Maintenance Phase||19
6286386|NCT00229723|7187079|FG000|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
6286387|NCT00229723|7187080|FG001|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
6286388|NCT00229723|7187081|FG002|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
6286389|NCT00229723|7187082|FG003|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
6286390|NCT00229723|7187083|FG004|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
6286391|NCT00229723|7187084|FG005|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
6286392|NCT00229723|7187085|FG006|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
6286393|NCT00229723|7187079|FG000|NOT COMPLETED|Maintenance Phase||25
6286394|NCT00229723|7187080|FG001|NOT COMPLETED|Maintenance Phase||14
6286395|NCT00229723|7187081|FG002|NOT COMPLETED|Maintenance Phase||9
6286396|NCT00229723|7187082|FG003|NOT COMPLETED|Maintenance Phase||17
6286397|NCT00229723|7187083|FG004|NOT COMPLETED|Maintenance Phase||15
6286398|NCT00229723|7187084|FG005|NOT COMPLETED|Maintenance Phase||19
6286399|NCT00229723|7187085|FG006|NOT COMPLETED|Maintenance Phase||10
6286400|NCT00229957|7187103|FG000|STARTED|Overall Study||152
6286401|NCT00229957|7187104|FG001|STARTED|Overall Study||151
6286402|NCT00229957|7187103|FG000|COMPLETED|Overall Study||132
6286403|NCT00229957|7187104|FG001|COMPLETED|Overall Study||139
6286404|NCT00229957|7187103|FG000|NOT COMPLETED|Overall Study||20
6286405|NCT00229957|7187104|FG001|NOT COMPLETED|Overall Study||12
6286406|NCT00230009|7187112|FG000|STARTED|Single Session Intervention/Control||50
6286407|NCT00230009|7187113|FG001|STARTED|Single Session Intervention/Control||50
6286408|NCT00230009|7187112|FG000|COMPLETED|Single Session Intervention/Control||50
6286409|NCT00230009|7187113|FG001|COMPLETED|Single Session Intervention/Control||50
6286410|NCT00230009|7187112|FG000|NOT COMPLETED|Single Session Intervention/Control||0
6286411|NCT00230009|7187113|FG001|NOT COMPLETED|Single Session Intervention/Control||0
6286412|NCT00230009|7187112|FG000|STARTED|Follow-up||50
6286413|NCT00230009|7187113|FG001|STARTED|Follow-up||50
6286414|NCT00230009|7187112|FG000|COMPLETED|Follow-up||19
6286415|NCT00230009|7187113|FG001|COMPLETED|Follow-up||24
6286416|NCT00230009|7187112|FG000|NOT COMPLETED|Follow-up||31
6286417|NCT00230009|7187113|FG001|NOT COMPLETED|Follow-up||26
6286418|NCT00230022|7187121|FG000|STARTED|Overall Study||15
6286419|NCT00230022|7187122|FG001|STARTED|Overall Study||15
6286420|NCT00230022|7187121|FG000|COMPLETED|Overall Study||15
6286421|NCT00230022|7187122|FG001|COMPLETED|Overall Study||15
6286422|NCT00230022|7187121|FG000|NOT COMPLETED|Overall Study||0
6286423|NCT00230022|7187122|FG001|NOT COMPLETED|Overall Study||0
6286424|NCT00230048|7187130|FG000|STARTED|Overall Study||52
6286425|NCT00230048|7187131|FG001|STARTED|Overall Study||55
6286426|NCT00230048|7187130|FG000|Completed Intervention/Control Session|Overall Study||52
6286427|NCT00230048|7187131|FG001|Completed Intervention/Control Session|Overall Study||55
6286428|NCT00230048|7187130|FG000|COMPLETED|Overall Study||39
6286429|NCT00230048|7187131|FG001|COMPLETED|Overall Study||37
6286430|NCT00230048|7187130|FG000|NOT COMPLETED|Overall Study||13
6286431|NCT00230048|7187131|FG001|NOT COMPLETED|Overall Study||18
6286432|NCT00230100|7187141|FG000|STARTED|Overall Study||29
6286433|NCT00230100|7187142|FG001|STARTED|Overall Study||17
6286434|NCT00230100|7187141|FG000|COMPLETED|Overall Study||29
6286435|NCT00230100|7187142|FG001|COMPLETED|Overall Study||17
6286436|NCT00230100|7187141|FG000|NOT COMPLETED|Overall Study||0
6286437|NCT00230100|7187142|FG001|NOT COMPLETED|Overall Study||0
6286438|NCT00230126|7187150|FG000|STARTED|Overall Study||30
6286439|NCT00230126|7187151|FG001|STARTED|Overall Study||28
6286440|NCT00230126|7187150|FG000|COMPLETED|Overall Study||28
6286441|NCT00230126|7187151|FG001|COMPLETED|Overall Study||27
6286442|NCT00230126|7187150|FG000|NOT COMPLETED|Overall Study||2
6286443|NCT00230126|7187151|FG001|NOT COMPLETED|Overall Study||1
6286444|NCT00230178|7187162|FG000|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
6634425|NCT02296190|7563145|FG003|STARTED|Overall Study||43
6634426|NCT02296190|7563146|FG004|STARTED|Overall Study||36
6634427|NCT02296190|7563147|FG005|STARTED|Overall Study||9
6634428|NCT02296190|7563142|FG000|COMPLETED|Overall Study||21
6634429|NCT02296190|7563143|FG001|COMPLETED|Overall Study||20
6634430|NCT02296190|7563144|FG002|COMPLETED|Overall Study||23
6634431|NCT02296190|7563145|FG003|COMPLETED|Overall Study||20
6634432|NCT02296190|7563146|FG004|COMPLETED|Overall Study||20
6634433|NCT02296190|7563147|FG005|COMPLETED|Overall Study||9
6634434|NCT02296190|7563142|FG000|NOT COMPLETED|Overall Study||14
6634435|NCT02296190|7563143|FG001|NOT COMPLETED|Overall Study||21
6634436|NCT02296190|7563144|FG002|NOT COMPLETED|Overall Study||12
6634437|NCT02296190|7563145|FG003|NOT COMPLETED|Overall Study||23
6634438|NCT02296190|7563146|FG004|NOT COMPLETED|Overall Study||16
6634439|NCT02296190|7563147|FG005|NOT COMPLETED|Overall Study||0
6634440|NCT02296242|7563165|FG000|STARTED|Overall Study||5
6634441|NCT02296242|7563166|FG001|STARTED|Overall Study||6
6634442|NCT02296242|7563167|FG002|STARTED|Overall Study||7
6634443|NCT02296242|7563168|FG003|STARTED|Overall Study||14
6634444|NCT02296242|7563169|FG004|STARTED|Overall Study||21
6634445|NCT02296242|7563165|FG000|COMPLETED|Overall Study||0
6634446|NCT02296242|7563166|FG001|COMPLETED|Overall Study||0
6634447|NCT02296242|7563167|FG002|COMPLETED|Overall Study||0
6634448|NCT02296242|7563168|FG003|COMPLETED|Overall Study||0
6634449|NCT02296242|7563169|FG004|COMPLETED|Overall Study||0
6634450|NCT02296242|7563165|FG000|NOT COMPLETED|Overall Study||5
6634451|NCT02296242|7563166|FG001|NOT COMPLETED|Overall Study||6
6634452|NCT02296242|7563167|FG002|NOT COMPLETED|Overall Study||7
6634453|NCT02296242|7563168|FG003|NOT COMPLETED|Overall Study||14
6634454|NCT02296242|7563169|FG004|NOT COMPLETED|Overall Study||21
6634455|NCT02296320|7563192|FG000|STARTED|Overall Study||102
6634456|NCT02296320|7563193|FG001|STARTED|Overall Study||15
6634457|NCT02296320|7563194|FG002|STARTED|Overall Study||96
6634458|NCT02296320|7563192|FG000|Treated|Overall Study||100
6634459|NCT02296320|7563193|FG001|Treated|Overall Study||15
6634460|NCT02296320|7563194|FG002|Treated|Overall Study||96
6634461|NCT02296320|7563192|FG000|COMPLETED|Overall Study||67
6634462|NCT02296320|7563193|FG001|COMPLETED|Overall Study||10
6634463|NCT02296320|7563194|FG002|COMPLETED|Overall Study||59
6634464|NCT02296320|7563192|FG000|NOT COMPLETED|Overall Study||35
6634465|NCT02296320|7563193|FG001|NOT COMPLETED|Overall Study||5
6634466|NCT02296320|7563194|FG002|NOT COMPLETED|Overall Study||37
6634467|NCT02296346|7563206|FG000|STARTED|Overall Study||7
6634468|NCT02296346|7563207|FG001|STARTED|Overall Study||6
6634469|NCT02296346|7563206|FG000|COMPLETED|Overall Study||2
6634470|NCT02296346|7563207|FG001|COMPLETED|Overall Study||0
6286445|NCT00230178|7187163|FG001|STARTED|Overall Study||93
6286446|NCT00230178|7187164|FG002|STARTED|Overall Study||93
6286447|NCT00230178|7187162|FG000|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
6286448|NCT00230178|7187163|FG001|Treated|Overall Study||92
6286449|NCT00230178|7187164|FG002|Treated|Overall Study||91
6286450|NCT00230178|7187162|FG000|COMPLETED|Overall Study||90
6286451|NCT00230178|7187163|FG001|COMPLETED|Overall Study||86
6286452|NCT00230178|7187164|FG002|COMPLETED|Overall Study||86
6286453|NCT00230178|7187162|FG000|NOT COMPLETED|Overall Study||4
6286454|NCT00230178|7187163|FG001|NOT COMPLETED|Overall Study||7
6286455|NCT00230178|7187164|FG002|NOT COMPLETED|Overall Study||7
6286456|NCT00230282|7187172|FG000|STARTED|Fludarabine + Cyclophosphamide||25
6286457|NCT00230282|7187172|FG000|COMPLETED|Fludarabine + Cyclophosphamide||17
6286458|NCT00230282|7187172|FG000|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
6286459|NCT00230282|7187172|FG000|STARTED|Maintanence Therapy With Alemtuzumab||17
6286460|NCT00230282|7187172|FG000|COMPLETED|Maintanence Therapy With Alemtuzumab||17
6286461|NCT00230282|7187172|FG000|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
6286462|NCT00230737|7187179|FG000|STARTED|Overall Study||9
6634471|NCT02296346|7563206|FG000|NOT COMPLETED|Overall Study||5
6634472|NCT02296346|7563207|FG001|NOT COMPLETED|Overall Study||6
6634473|NCT02296424|7563217|FG000|STARTED|Part 1|16 patients immediately went into Part II|84
6634474|NCT02296424|7563218|FG001|STARTED|Part 1||98
6634475|NCT02296424|7563219|FG002|STARTED|Part 1||0
6634476|NCT02296424|7563220|FG003|STARTED|Part 1||0
6634477|NCT02296424|7563217|FG000|COMPLETED|Part 1||61
6634478|NCT02296424|7563218|FG001|COMPLETED|Part 1||65
6634479|NCT02296424|7563219|FG002|COMPLETED|Part 1||0
6634480|NCT02296424|7563220|FG003|COMPLETED|Part 1||0
6634481|NCT02296424|7563217|FG000|NOT COMPLETED|Part 1||23
6634482|NCT02296424|7563218|FG001|NOT COMPLETED|Part 1||33
6634483|NCT02296424|7563219|FG002|NOT COMPLETED|Part 1||0
6634484|NCT02296424|7563220|FG003|NOT COMPLETED|Part 1||0
6286463|NCT00230737|7187180|FG001|STARTED|Overall Study||10
6286464|NCT00230737|7187181|FG002|STARTED|Overall Study||8
6286465|NCT00230737|7187179|FG000|COMPLETED|Overall Study||9
6286466|NCT00230737|7187180|FG001|COMPLETED|Overall Study||10
6286467|NCT00230737|7187181|FG002|COMPLETED|Overall Study||8
6286468|NCT00230737|7187179|FG000|NOT COMPLETED|Overall Study||0
6286469|NCT00230737|7187180|FG001|NOT COMPLETED|Overall Study||0
6286470|NCT00230737|7187181|FG002|NOT COMPLETED|Overall Study||0
6286471|NCT00230802|7187191|FG000|STARTED|Overall Study||25
6286472|NCT00230802|7187192|FG001|STARTED|Overall Study||23
6286473|NCT00230802|7187191|FG000|COMPLETED|Overall Study||25
6286474|NCT00230802|7187192|FG001|COMPLETED|Overall Study||23
6286475|NCT00230802|7187191|FG000|NOT COMPLETED|Overall Study||0
6286476|NCT00230802|7187192|FG001|NOT COMPLETED|Overall Study||0
6286477|NCT00230971|7187202|FG000|STARTED|Randomization||235
6286478|NCT00230971|7187203|FG001|STARTED|Randomization||238
6286479|NCT00230971|7187202|FG000|COMPLETED|Randomization||232
6286480|NCT00230971|7187203|FG001|COMPLETED|Randomization||235
6286481|NCT00230971|7187202|FG000|NOT COMPLETED|Randomization||3
6286482|NCT00230971|7187203|FG001|NOT COMPLETED|Randomization||3
6286483|NCT00230971|7187202|FG000|STARTED|Baseline Participants||232
6286484|NCT00230971|7187203|FG001|STARTED|Baseline Participants||235
6286485|NCT00230971|7187202|FG000|COMPLETED|Baseline Participants||210
6286486|NCT00230971|7187203|FG001|COMPLETED|Baseline Participants||216
6286487|NCT00230971|7187202|FG000|NOT COMPLETED|Baseline Participants||22
6286488|NCT00230971|7187203|FG001|NOT COMPLETED|Baseline Participants||19
6286489|NCT00231062|7187209|FG000|STARTED|Overall Study||115
6286490|NCT00231062|7187209|FG000|COMPLETED|Overall Study||109
6286491|NCT00231062|7187209|FG000|NOT COMPLETED|Overall Study||6
6286492|NCT00231114|7187215|FG000|STARTED|Randomized||196
6286493|NCT00231114|7187216|FG001|STARTED|Randomized||101
6286494|NCT00231114|7187215|FG000|COMPLETED|Randomized||190
6286495|NCT00231114|7187216|FG001|COMPLETED|Randomized||98
6286496|NCT00231114|7187215|FG000|NOT COMPLETED|Randomized||6
6286497|NCT00231114|7187216|FG001|NOT COMPLETED|Randomized||3
6286498|NCT00231114|7187215|FG000|STARTED|Treatment Period||190
6286499|NCT00231114|7187216|FG001|STARTED|Treatment Period||98
6286500|NCT00231114|7187215|FG000|COMPLETED|Treatment Period||189
6286501|NCT00231114|7187216|FG001|COMPLETED|Treatment Period||98
6286502|NCT00231114|7187215|FG000|NOT COMPLETED|Treatment Period||1
6286503|NCT00231114|7187216|FG001|NOT COMPLETED|Treatment Period||0
6286504|NCT00231114|7187215|FG000|STARTED|Post-Treatment Period||189
6286505|NCT00231114|7187216|FG001|STARTED|Post-Treatment Period||98
6286506|NCT00231114|7187215|FG000|COMPLETED|Post-Treatment Period||181
6286507|NCT00231114|7187216|FG001|COMPLETED|Post-Treatment Period||97
6286508|NCT00231114|7187215|FG000|NOT COMPLETED|Post-Treatment Period||8
6286509|NCT00231114|7187216|FG001|NOT COMPLETED|Post-Treatment Period||1
6286510|NCT00231179|7187226|FG000|STARTED|Overall Study||152
6286511|NCT00231179|7187227|FG001|STARTED|Overall Study||150
6286512|NCT00231179|7187226|FG000|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
6286513|NCT00231179|7187227|FG001|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
6286514|NCT00231179|7187226|FG000|NOT COMPLETED|Overall Study||24
6286515|NCT00231179|7187227|FG001|NOT COMPLETED|Overall Study||24
6286516|NCT00231283|7187233|FG000|STARTED|Overall Study||100
6286517|NCT00231283|7187233|FG000|COMPLETED|Overall Study||95
6286518|NCT00231283|7187233|FG000|NOT COMPLETED|Overall Study||5
6286519|NCT00231309|7187237|FG000|STARTED|Overall Study||10
6286520|NCT00231309|7187237|FG000|COMPLETED|Overall Study||10
6286521|NCT00231309|7187237|FG000|NOT COMPLETED|Overall Study||0
6634485|NCT02296424|7563217|FG000|STARTED|Part 2||0
6634486|NCT02296424|7563218|FG001|STARTED|Part 2||0
6743336|NCT03334422|7671643|FG001|STARTED|Overall Study||125
6286522|NCT00231413|7187249|FG000|STARTED|Overall Study||88
6399271|NCT00879879|7311984|FG000|STARTED|Overall Study||20
6399272|NCT00879879|7311984|FG000|COMPLETED|Overall Study||17
6399273|NCT00879879|7311984|FG000|NOT COMPLETED|Overall Study||3
6399274|NCT00879970|7311993|FG000|STARTED|Period 1 TZD Randomization||541
6399275|NCT00879970|7311994|FG001|STARTED|Period 1 TZD Randomization||392
6399276|NCT00879970|7311995|FG002|STARTED|Period 1 TZD Randomization||399
6399277|NCT00879970|7311996|FG003|STARTED|Period 1 TZD Randomization||0
6399278|NCT00879970|7311997|FG004|STARTED|Period 1 TZD Randomization||0
6399279|NCT00879970|7311993|FG000|COMPLETED|Period 1 TZD Randomization||533
6399280|NCT00879970|7311994|FG001|COMPLETED|Period 1 TZD Randomization||388
6399281|NCT00879970|7311995|FG002|COMPLETED|Period 1 TZD Randomization||393
6399282|NCT00879970|7311996|FG003|COMPLETED|Period 1 TZD Randomization||0
6399283|NCT00879970|7311997|FG004|COMPLETED|Period 1 TZD Randomization||0
6399284|NCT00879970|7311993|FG000|NOT COMPLETED|Period 1 TZD Randomization||8
6399285|NCT00879970|7311994|FG001|NOT COMPLETED|Period 1 TZD Randomization||4
6399286|NCT00879970|7311995|FG002|NOT COMPLETED|Period 1 TZD Randomization||6
6399287|NCT00879970|7311996|FG003|NOT COMPLETED|Period 1 TZD Randomization||0
6399288|NCT00879970|7311997|FG004|NOT COMPLETED|Period 1 TZD Randomization||0
6399289|NCT00879970|7311993|FG000|STARTED|Period 2 Vitamin D Randomization||0
6399290|NCT00879970|7311994|FG001|STARTED|Period 2 Vitamin D Randomization||0
6634487|NCT02296424|7563219|FG002|STARTED|Part 2||38
6634488|NCT02296424|7563220|FG003|STARTED|Part 2||37
6634489|NCT02296424|7563217|FG000|COMPLETED|Part 2||0
6286523|NCT00231413|7187250|FG001|STARTED|Overall Study||50
6286524|NCT00231413|7187251|FG002|STARTED|Overall Study||49
6286525|NCT00231413|7187252|FG003|STARTED|Overall Study||48
6286526|NCT00231413|7187253|FG004|STARTED|Overall Study||48
6286527|NCT00231413|7187254|FG005|STARTED|Overall Study||50
6286528|NCT00231413|7187255|FG006|STARTED|Overall Study||50
6286529|NCT00231413|7187249|FG000|COMPLETED|Overall Study||80
6286530|NCT00231413|7187250|FG001|COMPLETED|Overall Study||45
6286531|NCT00231413|7187251|FG002|COMPLETED|Overall Study||42
6286532|NCT00231413|7187252|FG003|COMPLETED|Overall Study||45
6286533|NCT00231413|7187253|FG004|COMPLETED|Overall Study||45
6286534|NCT00231413|7187254|FG005|COMPLETED|Overall Study||45
6286535|NCT00231413|7187255|FG006|COMPLETED|Overall Study||46
6286536|NCT00231413|7187249|FG000|NOT COMPLETED|Overall Study||8
6286537|NCT00231413|7187250|FG001|NOT COMPLETED|Overall Study||5
6286538|NCT00231413|7187251|FG002|NOT COMPLETED|Overall Study||7
6286539|NCT00231413|7187252|FG003|NOT COMPLETED|Overall Study||3
6286540|NCT00231413|7187253|FG004|NOT COMPLETED|Overall Study||3
6286541|NCT00231413|7187254|FG005|NOT COMPLETED|Overall Study||5
6286542|NCT00231413|7187255|FG006|NOT COMPLETED|Overall Study||4
6286543|NCT00231465|7187271|FG000|STARTED|Overall Study||44
6286544|NCT00231465|7187271|FG000|COMPLETED|Overall Study||42
6286545|NCT00231465|7187271|FG000|NOT COMPLETED|Overall Study||2
6286546|NCT00231478|7187277|FG000|STARTED|Overall Study||87
6286547|NCT00231478|7187278|FG001|STARTED|Overall Study||84
6286548|NCT00231478|7187277|FG000|COMPLETED|Overall Study||79
6286549|NCT00231478|7187278|FG001|COMPLETED|Overall Study||78
6286550|NCT00231478|7187277|FG000|NOT COMPLETED|Overall Study||8
6286551|NCT00231478|7187278|FG001|NOT COMPLETED|Overall Study||6
6286552|NCT00231777|7187286|FG000|STARTED|Overall Study||170
6286553|NCT00231777|7187287|FG001|STARTED|Overall Study||46
6286554|NCT00231777|7187286|FG000|COMPLETED|Overall Study||164
6286555|NCT00231777|7187287|FG001|COMPLETED|Overall Study||44
6286556|NCT00231777|7187286|FG000|NOT COMPLETED|Overall Study||6
6286557|NCT00231777|7187287|FG001|NOT COMPLETED|Overall Study||2
6286558|NCT00231816|7187295|FG000|STARTED|Overall Study||382
6286559|NCT00231816|7187296|FG001|STARTED|Overall Study||381
6286560|NCT00231816|7187295|FG000|Vaccinated at Visit 1|Overall Study||382
6286561|NCT00231816|7187296|FG001|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
6286562|NCT00231816|7187295|FG000|Vaccinated at Visit 2|Overall Study||369
6286563|NCT00231816|7187296|FG001|Vaccinated at Visit 2|Overall Study||371
6286564|NCT00231816|7187295|FG000|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
6286565|NCT00231816|7187296|FG001|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
6286566|NCT00231816|7187295|FG000|NOT COMPLETED|Overall Study||16
6286567|NCT00231816|7187296|FG001|NOT COMPLETED|Overall Study||12
6286568|NCT00231842|7187303|FG000|STARTED|Overall Study||30
6286569|NCT00231842|7187303|FG000|Initiated Therapy|Overall Study||27
6286570|NCT00231842|7187303|FG000|Completed First 3 Cycles|Overall Study||27
6286571|NCT00231842|7187303|FG000|Completed Prescribed RT|Overall Study||27
6286572|NCT00231842|7187303|FG000|Completed Full Prescribed Therapy|Overall Study||19
6286573|NCT00231842|7187303|FG000|COMPLETED|Overall Study||19
6286574|NCT00231842|7187303|FG000|NOT COMPLETED|Overall Study||11
6286575|NCT00231868|7187308|FG000|STARTED|Overall Study||81
6286576|NCT00231868|7187308|FG000|COMPLETED|Overall Study||65
6286577|NCT00231868|7187308|FG000|NOT COMPLETED|Overall Study||16
6286578|NCT00231894|7187314|FG000|STARTED|Overall Study||31
6286579|NCT00231894|7187315|FG001|STARTED|Overall Study||25
6286580|NCT00231894|7187314|FG000|COMPLETED|Overall Study||30
6286581|NCT00231894|7187315|FG001|COMPLETED|Overall Study||24
6634490|NCT02296424|7563218|FG001|COMPLETED|Part 2||0
6634491|NCT02296424|7563219|FG002|COMPLETED|Part 2||35
6634492|NCT02296424|7563220|FG003|COMPLETED|Part 2||37
6634493|NCT02296424|7563217|FG000|NOT COMPLETED|Part 2||0
6634494|NCT02296424|7563218|FG001|NOT COMPLETED|Part 2||0
6634495|NCT02296424|7563219|FG002|NOT COMPLETED|Part 2||3
6286582|NCT00231894|7187314|FG000|NOT COMPLETED|Overall Study||1
6286583|NCT00231894|7187315|FG001|NOT COMPLETED|Overall Study||1
6286584|NCT00232180|7187329|FG000|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
6286585|NCT00232180|7187330|FG001|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
6286586|NCT00232180|7187331|FG002|STARTED|Double-blind (DB) Phase||0
6634496|NCT02296424|7563220|FG003|NOT COMPLETED|Part 2||0
6634497|NCT02296476|7563231|FG000|STARTED|Overall Study||6
6634498|NCT02296476|7563232|FG001|STARTED|Overall Study||4
6634499|NCT02296476|7563233|FG002|STARTED|Overall Study||2
6634500|NCT02296476|7563231|FG000|COMPLETED|Overall Study||0
6634501|NCT02296476|7563232|FG001|COMPLETED|Overall Study||0
6634502|NCT02296476|7563233|FG002|COMPLETED|Overall Study||0
6634503|NCT02296476|7563231|FG000|NOT COMPLETED|Overall Study||6
6634504|NCT02296476|7563232|FG001|NOT COMPLETED|Overall Study||4
6634505|NCT02296476|7563233|FG002|NOT COMPLETED|Overall Study||2
6634506|NCT02296502|7563245|FG000|STARTED|Overall Study||248
6634507|NCT02296502|7563246|FG001|STARTED|Overall Study||1
6634508|NCT02296502|7563247|FG002|STARTED|Overall Study||30
6286587|NCT00232180|7187329|FG000|Treated|Double-blind (DB) Phase||1364
6286588|NCT00232180|7187330|FG001|Treated|Double-blind (DB) Phase||1372
6286589|NCT00232180|7187331|FG002|Treated|Double-blind (DB) Phase||0
6634509|NCT02296502|7563248|FG003|STARTED|Overall Study||160
6634510|NCT02296502|7563245|FG000|COMPLETED|Overall Study||248
6634511|NCT02296502|7563246|FG001|COMPLETED|Overall Study||1
6634512|NCT02296502|7563247|FG002|COMPLETED|Overall Study||30
6634513|NCT02296502|7563248|FG003|COMPLETED|Overall Study||160
6286590|NCT00232180|7187329|FG000|COMPLETED|Double-blind (DB) Phase||826
6286591|NCT00232180|7187330|FG001|COMPLETED|Double-blind (DB) Phase||771
6286592|NCT00232180|7187331|FG002|COMPLETED|Double-blind (DB) Phase||0
6286593|NCT00232180|7187329|FG000|NOT COMPLETED|Double-blind (DB) Phase||541
6286594|NCT00232180|7187330|FG001|NOT COMPLETED|Double-blind (DB) Phase||605
6286595|NCT00232180|7187331|FG002|NOT COMPLETED|Double-blind (DB) Phase||0
6286596|NCT00232180|7187329|FG000|STARTED|Open Label Phase||0
6286597|NCT00232180|7187330|FG001|STARTED|Open Label Phase||0
6286598|NCT00232180|7187331|FG002|STARTED|Open Label Phase||1246
6286599|NCT00232180|7187329|FG000|Treated|Open Label Phase||0
6286600|NCT00232180|7187330|FG001|Treated|Open Label Phase||0
6286601|NCT00232180|7187331|FG002|Treated|Open Label Phase||1245
6286602|NCT00232180|7187329|FG000|COMPLETED|Open Label Phase||0
6286603|NCT00232180|7187330|FG001|COMPLETED|Open Label Phase||0
6286604|NCT00232180|7187331|FG002|COMPLETED|Open Label Phase||1098
6286605|NCT00232180|7187329|FG000|NOT COMPLETED|Open Label Phase||0
6286606|NCT00232180|7187330|FG001|NOT COMPLETED|Open Label Phase||0
6286607|NCT00232180|7187331|FG002|NOT COMPLETED|Open Label Phase||148
6286608|NCT00232479|7187340|FG000|STARTED|Overall Study||44
6286609|NCT00232479|7187340|FG000|COMPLETED|Overall Study||44
6286610|NCT00232479|7187340|FG000|NOT COMPLETED|Overall Study||0
6286611|NCT00232505|7187347|FG000|STARTED|Overall Study||31
6286612|NCT00232505|7187348|FG001|STARTED|Overall Study||71
6286613|NCT00232505|7187347|FG000|Not Evaluable|Overall Study||0
6286614|NCT00232505|7187348|FG001|Not Evaluable|Overall Study||6
6286615|NCT00232505|7187347|FG000|Early Progressors|Overall Study||2
6286616|NCT00232505|7187348|FG001|Early Progressors|Overall Study||5
6286617|NCT00232505|7187347|FG000|Off Protocol|Overall Study||5
6286618|NCT00232505|7187348|FG001|Off Protocol|Overall Study||0
6286619|NCT00232505|7187347|FG000|COMPLETED|Overall Study||26
6286620|NCT00232505|7187348|FG001|COMPLETED|Overall Study||60
6286621|NCT00232505|7187347|FG000|NOT COMPLETED|Overall Study||5
6286622|NCT00232505|7187348|FG001|NOT COMPLETED|Overall Study||11
6286623|NCT00232544|7187360|FG000|STARTED|Overall Study||124
6286624|NCT00232544|7187361|FG001|STARTED|Overall Study||126
6286625|NCT00232544|7187360|FG000|COMPLETED|Overall Study||104
6286626|NCT00232544|7187361|FG001|COMPLETED|Overall Study||111
6286627|NCT00232544|7187360|FG000|NOT COMPLETED|Overall Study||20
6286628|NCT00232544|7187361|FG001|NOT COMPLETED|Overall Study||15
6286629|NCT00232557|7187369|FG000|STARTED|Overall Study||71
6286630|NCT00232557|7187370|FG001|STARTED|Overall Study||65
6286631|NCT00232557|7187369|FG000|COMPLETED|Overall Study||68
6286632|NCT00232557|7187370|FG001|COMPLETED|Overall Study||60
6286633|NCT00232557|7187369|FG000|NOT COMPLETED|Overall Study||3
6286634|NCT00232557|7187370|FG001|NOT COMPLETED|Overall Study||5
6286635|NCT00232583|7187378|FG000|STARTED|Overall Study||29
6286636|NCT00232583|7187379|FG001|STARTED|Overall Study||29
6286637|NCT00232583|7187378|FG000|COMPLETED|Overall Study||19
6286638|NCT00232583|7187379|FG001|COMPLETED|Overall Study||16
6286639|NCT00232583|7187378|FG000|NOT COMPLETED|Overall Study||10
6286640|NCT00232583|7187379|FG001|NOT COMPLETED|Overall Study||13
6286641|NCT00232596|7187391|FG000|STARTED|6-Week Titration Phase||152
6286642|NCT00232596|7187392|FG001|STARTED|6-Week Titration Phase||154
6286643|NCT00232596|7187391|FG000|COMPLETED|6-Week Titration Phase||138
6286644|NCT00232596|7187392|FG001|COMPLETED|6-Week Titration Phase||125
6286645|NCT00232596|7187391|FG000|NOT COMPLETED|6-Week Titration Phase||14
6286646|NCT00232596|7187392|FG001|NOT COMPLETED|6-Week Titration Phase||29
6286647|NCT00232596|7187391|FG000|STARTED|12-Week Maintenance Phase||138
6286648|NCT00232596|7187392|FG001|STARTED|12-Week Maintenance Phase||125
6286649|NCT00232596|7187391|FG000|COMPLETED|12-Week Maintenance Phase|"One participant withdrew after being considered a completer and is listed as an early withdraw."|126
6286650|NCT00232596|7187392|FG001|COMPLETED|12-Week Maintenance Phase||97
6286651|NCT00232596|7187391|FG000|NOT COMPLETED|12-Week Maintenance Phase||12
6286652|NCT00232596|7187392|FG001|NOT COMPLETED|12-Week Maintenance Phase||28
6286653|NCT00232739|7187410|FG000|STARTED|Overall Study||100
6286654|NCT00232739|7187410|FG000|COMPLETED|Overall Study||91
6286655|NCT00232739|7187410|FG000|NOT COMPLETED|Overall Study||9
6286656|NCT00233064|7187416|FG000|STARTED|Overall Study||211
6286657|NCT00233064|7187417|FG001|STARTED|Overall Study||202
6286658|NCT00233064|7187416|FG000|COMPLETED|Overall Study||197
6286659|NCT00233064|7187417|FG001|COMPLETED|Overall Study||190
6286660|NCT00233064|7187416|FG000|NOT COMPLETED|Overall Study||14
6286661|NCT00233064|7187417|FG001|NOT COMPLETED|Overall Study||12
6286662|NCT00233103|7187426|FG000|STARTED|Overall Study||27
6286663|NCT00233103|7187427|FG001|STARTED|Overall Study||25
6286664|NCT00233103|7187426|FG000|COMPLETED|Overall Study||22
6286665|NCT00233103|7187427|FG001|COMPLETED|Overall Study||19
6286666|NCT00233103|7187426|FG000|NOT COMPLETED|Overall Study||5
6286667|NCT00233103|7187427|FG001|NOT COMPLETED|Overall Study||6
6286668|NCT00233324|7187437|FG000|STARTED|Main Study||318
6286669|NCT00233324|7187438|FG001|STARTED|Main Study||335
6286670|NCT00233324|7187439|FG002|STARTED|Main Study||336
6286671|NCT00233324|7187440|FG003|STARTED|Main Study||327
6286672|NCT00233324|7187437|FG000|COMPLETED|Main Study||250
6286673|NCT00233324|7187438|FG001|COMPLETED|Main Study||275
6286674|NCT00233324|7187439|FG002|COMPLETED|Main Study||274
6286675|NCT00233324|7187440|FG003|COMPLETED|Main Study||280
6286676|NCT00233324|7187437|FG000|NOT COMPLETED|Main Study||68
6286677|NCT00233324|7187438|FG001|NOT COMPLETED|Main Study||60
6286678|NCT00233324|7187439|FG002|NOT COMPLETED|Main Study||62
6286679|NCT00233324|7187440|FG003|NOT COMPLETED|Main Study||47
6286680|NCT00233324|7187437|FG000|STARTED|Follow up at 18-22 Months Corrected Age||250
6286681|NCT00233324|7187438|FG001|STARTED|Follow up at 18-22 Months Corrected Age||275
6286682|NCT00233324|7187439|FG002|STARTED|Follow up at 18-22 Months Corrected Age||274
6286683|NCT00233324|7187440|FG003|STARTED|Follow up at 18-22 Months Corrected Age||280
6286684|NCT00233324|7187437|FG000|COMPLETED|Follow up at 18-22 Months Corrected Age||237
6286685|NCT00233324|7187438|FG001|COMPLETED|Follow up at 18-22 Months Corrected Age||261
6286686|NCT00233324|7187439|FG002|COMPLETED|Follow up at 18-22 Months Corrected Age||256
6286687|NCT00233324|7187440|FG003|COMPLETED|Follow up at 18-22 Months Corrected Age||269
6286688|NCT00233324|7187437|FG000|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
6286689|NCT00233324|7187438|FG001|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
6286690|NCT00233324|7187439|FG002|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
6286691|NCT00233324|7187440|FG003|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
6286692|NCT00233363|7187459|FG000|STARTED|Overall Study||53
6286693|NCT00233363|7187460|FG001|STARTED|Overall Study||51
6286694|NCT00233363|7187459|FG000|COMPLETED|Overall Study||50
6286695|NCT00233363|7187460|FG001|COMPLETED|Overall Study||46
6286696|NCT00233363|7187459|FG000|NOT COMPLETED|Overall Study||3
6286697|NCT00233363|7187460|FG001|NOT COMPLETED|Overall Study||5
6286698|NCT00233389|7187468|FG000|STARTED|Overall Study||154
6286699|NCT00233389|7187469|FG001|STARTED|Overall Study||147
6286700|NCT00233389|7187468|FG000|COMPLETED|Overall Study||136
6286701|NCT00233389|7187469|FG001|COMPLETED|Overall Study||131
6286702|NCT00233389|7187468|FG000|NOT COMPLETED|Overall Study||18
6286703|NCT00233389|7187469|FG001|NOT COMPLETED|Overall Study||16
6286704|NCT00233402|7187477|FG000|STARTED|Overall Study||384
6286705|NCT00233402|7187478|FG001|STARTED|Overall Study||395
6286706|NCT00233402|7187477|FG000|COMPLETED|Overall Study||280
6286707|NCT00233402|7187478|FG001|COMPLETED|Overall Study||271
6286708|NCT00233402|7187477|FG000|NOT COMPLETED|Overall Study||104
6286709|NCT00233402|7187478|FG001|NOT COMPLETED|Overall Study||124
6286710|NCT00233454|7187486|FG000|STARTED|Overall Study||26
6286711|NCT00233454|7187486|FG000|2 Months (for Response Rate)|Overall Study||26
6286712|NCT00233454|7187486|FG000|COMPLETED|Overall Study||20
6286713|NCT00233454|7187486|FG000|NOT COMPLETED|Overall Study||6
6286714|NCT00233480|7187492|FG000|STARTED|Overall Study||14
6286715|NCT00233480|7187493|FG001|STARTED|Overall Study||13
6286716|NCT00233480|7187492|FG000|COMPLETED|Overall Study||14
6286717|NCT00233480|7187493|FG001|COMPLETED|Overall Study||12
6286718|NCT00233480|7187492|FG000|NOT COMPLETED|Overall Study||0
6286719|NCT00233480|7187493|FG001|NOT COMPLETED|Overall Study||1
6286720|NCT00233519|7187503|FG000|STARTED|Overall Study||7
6286721|NCT00233519|7187504|FG001|STARTED|Overall Study||10
6286722|NCT00233519|7187503|FG000|COMPLETED|Overall Study||6
6286723|NCT00233519|7187504|FG001|COMPLETED|Overall Study||9
6286724|NCT00233519|7187503|FG000|NOT COMPLETED|Overall Study||1
6286725|NCT00233519|7187504|FG001|NOT COMPLETED|Overall Study||1
6286726|NCT00233948|7187512|FG000|STARTED|Overall Study||4
6286727|NCT00233948|7187513|FG001|STARTED|Overall Study||3
6286728|NCT00233948|7187514|FG002|STARTED|Overall Study||3
6286729|NCT00233948|7187515|FG003|STARTED|Overall Study||3
6286730|NCT00233948|7187516|FG004|STARTED|Overall Study||4
6286731|NCT00233948|7187517|FG005|STARTED|Overall Study||12
6286732|NCT00233948|7187512|FG000|COMPLETED|Overall Study||3
6286733|NCT00233948|7187513|FG001|COMPLETED|Overall Study||3
6286734|NCT00233948|7187514|FG002|COMPLETED|Overall Study||3
6286735|NCT00233948|7187515|FG003|COMPLETED|Overall Study||3
6286736|NCT00233948|7187516|FG004|COMPLETED|Overall Study||4
6286737|NCT00233948|7187517|FG005|COMPLETED|Overall Study||12
6286738|NCT00233948|7187512|FG000|NOT COMPLETED|Overall Study||1
6286739|NCT00233948|7187513|FG001|NOT COMPLETED|Overall Study||0
6286740|NCT00233948|7187514|FG002|NOT COMPLETED|Overall Study||0
6286741|NCT00233948|7187515|FG003|NOT COMPLETED|Overall Study||0
6286742|NCT00233948|7187516|FG004|NOT COMPLETED|Overall Study||0
6286743|NCT00233948|7187517|FG005|NOT COMPLETED|Overall Study||0
6286744|NCT00233987|7187532|FG000|STARTED|Overall Study||98
6286745|NCT00233987|7187532|FG000|Eligible|Overall Study||94
6286746|NCT00233987|7187532|FG000|Eligible and Treated|Overall Study||92
6286747|NCT00233987|7187532|FG000|COMPLETED|Overall Study||83
6286748|NCT00233987|7187532|FG000|NOT COMPLETED|Overall Study||15
6286749|NCT00234039|7187536|FG000|STARTED|Overall Study||58
6286750|NCT00234039|7187536|FG000|Eligible|Overall Study||49
6286751|NCT00234039|7187536|FG000|Eligible and Began Protocol Therapy|Overall Study||47
6286752|NCT00234039|7187536|FG000|COMPLETED|Overall Study||8
6286753|NCT00234039|7187536|FG000|NOT COMPLETED|Overall Study||50
6286754|NCT00234052|7187540|FG000|STARTED|Treatment||51
6286755|NCT00234052|7187540|FG000|Started Treatment|Treatment||50
6286756|NCT00234052|7187540|FG000|Completed 6 Cycles|Treatment||33
6286757|NCT00234052|7187540|FG000|Went Into Maintenance Phase|Treatment||30
6286758|NCT00234052|7187540|FG000|COMPLETED|Treatment||30
6286759|NCT00234052|7187540|FG000|NOT COMPLETED|Treatment||21
6286760|NCT00234052|7187540|FG000|STARTED|Follow-up for 5 Years|All patients that are treated on study go into the follow up period.|50
6286761|NCT00234052|7187540|FG000|COMPLETED|Follow-up for 5 Years||1
6286762|NCT00234052|7187540|FG000|NOT COMPLETED|Follow-up for 5 Years||49
6286763|NCT00234065|7187546|FG000|STARTED|Overall Study||1356
6286764|NCT00234065|7187547|FG001|STARTED|Overall Study||1360
6286765|NCT00234065|7187546|FG000|COMPLETED|Overall Study||881
6286766|NCT00234065|7187547|FG001|COMPLETED|Overall Study||1004
6286767|NCT00234065|7187546|FG000|NOT COMPLETED|Overall Study||475
6286768|NCT00234065|7187547|FG001|NOT COMPLETED|Overall Study||356
6286769|NCT00234078|7187557|FG000|STARTED|Overall Study||72
6634514|NCT02296502|7563245|FG000|NOT COMPLETED|Overall Study||0
6286770|NCT00234078|7187558|FG001|STARTED|Overall Study||72
6286771|NCT00234078|7187559|FG002|STARTED|Overall Study||74
6286772|NCT00234078|7187560|FG003|STARTED|Overall Study||72
6286773|NCT00234078|7187557|FG000|COMPLETED|Overall Study||66
6286774|NCT00234078|7187558|FG001|COMPLETED|Overall Study||63
6286775|NCT00234078|7187559|FG002|COMPLETED|Overall Study||64
6286776|NCT00234078|7187560|FG003|COMPLETED|Overall Study||68
6286777|NCT00234078|7187557|FG000|NOT COMPLETED|Overall Study||6
6286778|NCT00234078|7187558|FG001|NOT COMPLETED|Overall Study||9
6286779|NCT00234078|7187559|FG002|NOT COMPLETED|Overall Study||10
6286780|NCT00234078|7187560|FG003|NOT COMPLETED|Overall Study||4
6286781|NCT00234104|7187574|FG000|STARTED|Overall Study||30
6286782|NCT00234104|7187575|FG001|STARTED|Overall Study||29
6286783|NCT00234104|7187576|FG002|STARTED|Overall Study||34
6286784|NCT00234104|7187577|FG003|STARTED|Overall Study||29
6286785|NCT00234104|7187574|FG000|COMPLETED|Overall Study||26
6286786|NCT00234104|7187575|FG001|COMPLETED|Overall Study||28
6286787|NCT00234104|7187576|FG002|COMPLETED|Overall Study||29
6286788|NCT00234104|7187577|FG003|COMPLETED|Overall Study||21
6286789|NCT00234104|7187574|FG000|NOT COMPLETED|Overall Study||4
6286790|NCT00234104|7187575|FG001|NOT COMPLETED|Overall Study||1
6286791|NCT00234104|7187576|FG002|NOT COMPLETED|Overall Study||5
6286792|NCT00234104|7187577|FG003|NOT COMPLETED|Overall Study||8
6286793|NCT00234286|7187587|FG000|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
6634515|NCT02296502|7563246|FG001|NOT COMPLETED|Overall Study||0
6286794|NCT00234286|7187587|FG000|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
6286795|NCT00234286|7187587|FG000|NOT COMPLETED|Overall Study||0
6286796|NCT00234494|7187620|FG000|STARTED|Overall Study||45
6286797|NCT00234494|7187620|FG000|COMPLETED|Overall Study||43
6286798|NCT00234494|7187620|FG000|NOT COMPLETED|Overall Study||2
6286799|NCT00234533|7187624|FG000|STARTED|Overall Study||251
6286800|NCT00234533|7187624|FG000|COMPLETED|Overall Study||240
6286801|NCT00234533|7187624|FG000|NOT COMPLETED|Overall Study||11
6286802|NCT00234832|7187631|FG000|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
6286803|NCT00234832|7187632|FG001|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
6286804|NCT00234832|7187631|FG000|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
6286805|NCT00234832|7187632|FG001|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
6286806|NCT00234832|7187631|FG000|NOT COMPLETED|Overall Study||1016
6286807|NCT00234832|7187632|FG001|NOT COMPLETED|Overall Study||996
6286808|NCT00234884|7187645|FG000|STARTED|Overall Study||3435
6286809|NCT00234884|7187645|FG000|COMPLETED|Overall Study||1805
6286810|NCT00234884|7187645|FG000|NOT COMPLETED|Overall Study||1630
6286811|NCT00235391|7187655|FG000|STARTED|Overall Study||97
6286812|NCT00235391|7187656|FG001|STARTED|Overall Study||200
6286813|NCT00235391|7187657|FG002|STARTED|Overall Study||172
6286814|NCT00235391|7187658|FG003|STARTED|Overall Study||1164
6286815|NCT00235391|7187659|FG004|STARTED|Overall Study||43
6286816|NCT00235391|7187660|FG005|STARTED|Overall Study||7
6286817|NCT00235391|7187655|FG000|Deferasirox Treatment|Overall Study||97
6286818|NCT00235391|7187656|FG001|Deferasirox Treatment|Overall Study||200
6286819|NCT00235391|7187657|FG002|Deferasirox Treatment|Overall Study||172
6286820|NCT00235391|7187658|FG003|Deferasirox Treatment|Overall Study||1164
6286821|NCT00235391|7187659|FG004|Deferasirox Treatment|Overall Study||43
6286822|NCT00235391|7187660|FG005|Deferasirox Treatment|Overall Study||7
6286823|NCT00235391|7187655|FG000|COMPLETED|Overall Study||85
6286824|NCT00235391|7187656|FG001|COMPLETED|Overall Study||182
6286825|NCT00235391|7187657|FG002|COMPLETED|Overall Study||148
6286826|NCT00235391|7187658|FG003|COMPLETED|Overall Study||944
6286827|NCT00235391|7187659|FG004|COMPLETED|Overall Study||31
6286828|NCT00235391|7187660|FG005|COMPLETED|Overall Study||3
6286829|NCT00235391|7187655|FG000|NOT COMPLETED|Overall Study||12
6286830|NCT00235391|7187656|FG001|NOT COMPLETED|Overall Study||18
6286831|NCT00235391|7187657|FG002|NOT COMPLETED|Overall Study||24
6286832|NCT00235391|7187658|FG003|NOT COMPLETED|Overall Study||220
6286833|NCT00235391|7187659|FG004|NOT COMPLETED|Overall Study||12
6286834|NCT00235391|7187660|FG005|NOT COMPLETED|Overall Study||4
6286835|NCT00235443|7187675|FG000|STARTED|Overall Study||11
6286836|NCT00235443|7187676|FG001|STARTED|Overall Study||57
6286837|NCT00235443|7187677|FG002|STARTED|Overall Study||85
6286838|NCT00235443|7187678|FG003|STARTED|Overall Study||205
6286839|NCT00235443|7187679|FG004|STARTED|Overall Study||39
6286840|NCT00235443|7187680|FG005|STARTED|Overall Study||54
6286841|NCT00235443|7187675|FG000|COMPLETED|Overall Study||3
6286842|NCT00235443|7187676|FG001|COMPLETED|Overall Study||19
6634516|NCT02296502|7563247|FG002|NOT COMPLETED|Overall Study||0
6634517|NCT02296502|7563248|FG003|NOT COMPLETED|Overall Study||0
6286843|NCT00235443|7187677|FG002|COMPLETED|Overall Study||23
6286844|NCT00235443|7187678|FG003|COMPLETED|Overall Study||108
6286845|NCT00235443|7187679|FG004|COMPLETED|Overall Study||9
6286846|NCT00235443|7187680|FG005|COMPLETED|Overall Study||9
6286847|NCT00235443|7187675|FG000|NOT COMPLETED|Overall Study||8
6286848|NCT00235443|7187676|FG001|NOT COMPLETED|Overall Study||38
6286849|NCT00235443|7187677|FG002|NOT COMPLETED|Overall Study||62
6286850|NCT00235443|7187678|FG003|NOT COMPLETED|Overall Study||97
6286851|NCT00235443|7187679|FG004|NOT COMPLETED|Overall Study||30
6286852|NCT00235443|7187680|FG005|NOT COMPLETED|Overall Study||45
6286853|NCT00235456|7187698|FG000|STARTED|Overall Study||150
6286854|NCT00235456|7187699|FG001|STARTED|Overall Study||150
6286855|NCT00235456|7187698|FG000|COMPLETED|Overall Study||148
6286856|NCT00235456|7187699|FG001|COMPLETED|Overall Study||143
6286857|NCT00235456|7187698|FG000|NOT COMPLETED|Overall Study||2
6286858|NCT00235456|7187699|FG001|NOT COMPLETED|Overall Study||7
6373937|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373938|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373939|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373940|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373941|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373942|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373943|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373944|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373945|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373946|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373947|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
6373948|NCT00747474|7284553|FG000|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373949|NCT00747474|7284554|FG001|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373950|NCT00747474|7284555|FG002|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373951|NCT00747474|7284556|FG003|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373952|NCT00747474|7284557|FG004|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373953|NCT00747474|7284558|FG005|STARTED|Cohort 11 (50 mg/m^2) Period||0
6634518|NCT02296606|7563261|FG000|STARTED|Overall Study||127
6634519|NCT02296606|7563261|FG000|COMPLETED|Overall Study||127
6634520|NCT02296606|7563261|FG000|NOT COMPLETED|Overall Study||0
6373954|NCT00747474|7284559|FG006|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373955|NCT00747474|7284560|FG007|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373956|NCT00747474|7284561|FG008|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373957|NCT00747474|7284562|FG009|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373958|NCT00747474|7284563|FG010|STARTED|Cohort 11 (50 mg/m^2) Period||5
6373959|NCT00747474|7284564|FG011|STARTED|Cohort 11 (50 mg/m^2) Period||0
6373960|NCT00747474|7284553|FG000|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6634521|NCT02296775|7563268|FG000|STARTED|Treatment and Evaluation||91
6634522|NCT02296775|7563269|FG001|STARTED|Treatment and Evaluation||92
6634523|NCT02296775|7563270|FG002|STARTED|Treatment and Evaluation||93
6634524|NCT02296775|7563268|FG000|COMPLETED|Treatment and Evaluation||87
6634525|NCT02296775|7563269|FG001|COMPLETED|Treatment and Evaluation||84
6634526|NCT02296775|7563270|FG002|COMPLETED|Treatment and Evaluation||83
6634527|NCT02296775|7563268|FG000|NOT COMPLETED|Treatment and Evaluation||4
6634528|NCT02296775|7563269|FG001|NOT COMPLETED|Treatment and Evaluation||8
6634529|NCT02296775|7563270|FG002|NOT COMPLETED|Treatment and Evaluation||10
6634530|NCT02296775|7563268|FG000|STARTED|Recovery and Follow-up||87
6634531|NCT02296775|7563269|FG001|STARTED|Recovery and Follow-up||84
6634532|NCT02296775|7563270|FG002|STARTED|Recovery and Follow-up||83
6634533|NCT02296775|7563268|FG000|COMPLETED|Recovery and Follow-up||82
6634534|NCT02296775|7563269|FG001|COMPLETED|Recovery and Follow-up||79
6634535|NCT02296775|7563270|FG002|COMPLETED|Recovery and Follow-up||79
6634536|NCT02296775|7563268|FG000|NOT COMPLETED|Recovery and Follow-up||5
6634537|NCT02296775|7563269|FG001|NOT COMPLETED|Recovery and Follow-up||5
6634538|NCT02296775|7563270|FG002|NOT COMPLETED|Recovery and Follow-up||4
6634539|NCT02296840|7563280|FG000|STARTED|Overall Study||18
6634540|NCT02296840|7563281|FG001|STARTED|Overall Study||27
6634541|NCT02296840|7563280|FG000|COMPLETED|Overall Study||9
6634542|NCT02296840|7563281|FG001|COMPLETED|Overall Study||8
6634543|NCT02296840|7563280|FG000|NOT COMPLETED|Overall Study||9
6634544|NCT02296840|7563281|FG001|NOT COMPLETED|Overall Study||19
6634545|NCT02296853|7563289|FG000|STARTED|Overall Study||10
6634546|NCT02296853|7563290|FG001|STARTED|Overall Study||10
6634547|NCT02296853|7563289|FG000|COMPLETED|Overall Study||10
6634548|NCT02296853|7563290|FG001|COMPLETED|Overall Study||10
6634549|NCT02296853|7563289|FG000|NOT COMPLETED|Overall Study||0
6634550|NCT02296853|7563290|FG001|NOT COMPLETED|Overall Study||0
6634551|NCT02296892|7563299|FG000|STARTED|Overall Study||310
6373961|NCT00747474|7284554|FG001|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373962|NCT00747474|7284555|FG002|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373963|NCT00747474|7284556|FG003|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373964|NCT00747474|7284557|FG004|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373965|NCT00747474|7284558|FG005|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373966|NCT00747474|7284559|FG006|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373967|NCT00747474|7284560|FG007|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6399291|NCT00879970|7311995|FG002|STARTED|Period 2 Vitamin D Randomization||0
6634552|NCT02296892|7563300|FG001|STARTED|Overall Study||63
6634553|NCT02296892|7563301|FG002|STARTED|Overall Study||73
6373968|NCT00747474|7284561|FG008|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373969|NCT00747474|7284562|FG009|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373970|NCT00747474|7284563|FG010|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
6373971|NCT00747474|7284564|FG011|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373972|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373973|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6377830|NCT00765336|7288490|FG000|STARTED|Overall Study||91
6634554|NCT02296892|7563299|FG000|Safety Population|Overall Study||303
6286859|NCT00235495|7187707|FG000|STARTED|Overall Study||422
6286860|NCT00235495|7187708|FG001|STARTED|Overall Study||419
6286861|NCT00235495|7187707|FG000|COMPLETED|Overall Study||354
6286862|NCT00235495|7187708|FG001|COMPLETED|Overall Study||351
6286863|NCT00235495|7187707|FG000|NOT COMPLETED|Overall Study||68
6286864|NCT00235495|7187708|FG001|NOT COMPLETED|Overall Study||68
6286865|NCT00235547|7187716|FG000|STARTED|2 Month Follow-up Survey||154
6286866|NCT00235547|7187717|FG001|STARTED|2 Month Follow-up Survey||144
6286867|NCT00235547|7187716|FG000|COMPLETED|2 Month Follow-up Survey||108
6286868|NCT00235547|7187717|FG001|COMPLETED|2 Month Follow-up Survey||104
6286869|NCT00235547|7187716|FG000|NOT COMPLETED|2 Month Follow-up Survey||46
6286870|NCT00235547|7187717|FG001|NOT COMPLETED|2 Month Follow-up Survey||40
6286871|NCT00235547|7187716|FG000|STARTED|6 Month Follow-up Survey||154
6286872|NCT00235547|7187717|FG001|STARTED|6 Month Follow-up Survey||144
6286873|NCT00235547|7187716|FG000|COMPLETED|6 Month Follow-up Survey||83
6286874|NCT00235547|7187717|FG001|COMPLETED|6 Month Follow-up Survey||76
6286875|NCT00235547|7187716|FG000|NOT COMPLETED|6 Month Follow-up Survey||71
6286876|NCT00235547|7187717|FG001|NOT COMPLETED|6 Month Follow-up Survey||68
6286877|NCT00235573|7187723|FG000|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
6286878|NCT00235573|7187723|FG000|COMPLETED|Overall Study||21
6286879|NCT00235573|7187723|FG000|NOT COMPLETED|Overall Study||0
6286880|NCT00235716|7187731|FG000|STARTED|Overall Study||152
6286881|NCT00235716|7187732|FG001|STARTED|Overall Study||155
6286882|NCT00235716|7187733|FG002|STARTED|Overall Study||154
6286883|NCT00235716|7187734|FG003|STARTED|Overall Study||152
6286884|NCT00235716|7187731|FG000|COMPLETED|Overall Study||90
6286885|NCT00235716|7187732|FG001|COMPLETED|Overall Study||88
6286886|NCT00235716|7187733|FG002|COMPLETED|Overall Study||89
6286887|NCT00235716|7187734|FG003|COMPLETED|Overall Study||90
6286888|NCT00235716|7187731|FG000|NOT COMPLETED|Overall Study||62
6286889|NCT00235716|7187732|FG001|NOT COMPLETED|Overall Study||67
6286890|NCT00235716|7187733|FG002|NOT COMPLETED|Overall Study||65
6286891|NCT00235716|7187734|FG003|NOT COMPLETED|Overall Study||62
6286892|NCT00235755|7187747|FG000|STARTED|4-Week Titration Phase||179
6286893|NCT00235755|7187748|FG001|STARTED|4-Week Titration Phase||181
6286894|NCT00235755|7187749|FG002|STARTED|4-Week Titration Phase||179
6286895|NCT00235755|7187747|FG000|COMPLETED|4-Week Titration Phase||168
6286896|NCT00235755|7187748|FG001|COMPLETED|4-Week Titration Phase||162
6286897|NCT00235755|7187749|FG002|COMPLETED|4-Week Titration Phase||153
6286898|NCT00235755|7187747|FG000|NOT COMPLETED|4-Week Titration Phase||11
6286899|NCT00235755|7187748|FG001|NOT COMPLETED|4-Week Titration Phase||19
6286900|NCT00235755|7187749|FG002|NOT COMPLETED|4-Week Titration Phase||26
6286901|NCT00235755|7187747|FG000|STARTED|12-Week Maintenance Phase||168
6286902|NCT00235755|7187748|FG001|STARTED|12-Week Maintenance Phase||162
6286903|NCT00235755|7187749|FG002|STARTED|12-Week Maintenance Phase||153
6286904|NCT00235755|7187747|FG000|COMPLETED|12-Week Maintenance Phase||152
6286905|NCT00235755|7187748|FG001|COMPLETED|12-Week Maintenance Phase||135
6286906|NCT00235755|7187749|FG002|COMPLETED|12-Week Maintenance Phase||122
6286907|NCT00235755|7187747|FG000|NOT COMPLETED|12-Week Maintenance Phase||16
6286908|NCT00235755|7187748|FG001|NOT COMPLETED|12-Week Maintenance Phase||27
6286909|NCT00235755|7187749|FG002|NOT COMPLETED|12-Week Maintenance Phase||31
6286910|NCT00235833|7187772|FG000|STARTED|Overall Study||25
6286911|NCT00235833|7187772|FG000|COMPLETED|Overall Study||9
6286912|NCT00235833|7187772|FG000|NOT COMPLETED|Overall Study||16
6286913|NCT00235872|7187776|FG000|STARTED|Overall Study||309
6286914|NCT00235872|7187776|FG000|COMPLETED|Overall Study||162
6286915|NCT00235872|7187776|FG000|NOT COMPLETED|Overall Study||147
6286916|NCT00235989|7187784|FG000|STARTED|Core Treatment Period (CT)||0
6286917|NCT00235989|7187785|FG001|STARTED|Core Treatment Period (CT)||0
6286918|NCT00235989|7187786|FG002|STARTED|Core Treatment Period (CT)||0
6286919|NCT00235989|7187787|FG003|STARTED|Core Treatment Period (CT)||0
6286920|NCT00235989|7187788|FG004|STARTED|Core Treatment Period (CT)||36
6286921|NCT00235989|7187789|FG005|STARTED|Core Treatment Period (CT)||27
6286922|NCT00235989|7187784|FG000|COMPLETED|Core Treatment Period (CT)||0
6286923|NCT00235989|7187785|FG001|COMPLETED|Core Treatment Period (CT)||0
6286924|NCT00235989|7187786|FG002|COMPLETED|Core Treatment Period (CT)||0
6286925|NCT00235989|7187787|FG003|COMPLETED|Core Treatment Period (CT)||0
6286926|NCT00235989|7187788|FG004|COMPLETED|Core Treatment Period (CT)||36
6286927|NCT00235989|7187789|FG005|COMPLETED|Core Treatment Period (CT)||25
6286928|NCT00235989|7187784|FG000|NOT COMPLETED|Core Treatment Period (CT)||0
6286929|NCT00235989|7187785|FG001|NOT COMPLETED|Core Treatment Period (CT)||0
6286930|NCT00235989|7187786|FG002|NOT COMPLETED|Core Treatment Period (CT)||0
6286931|NCT00235989|7187787|FG003|NOT COMPLETED|Core Treatment Period (CT)||0
6286932|NCT00235989|7187788|FG004|NOT COMPLETED|Core Treatment Period (CT)||0
6286933|NCT00235989|7187789|FG005|NOT COMPLETED|Core Treatment Period (CT)||2
6286934|NCT00235989|7187784|FG000|STARTED|Extension Treatment Period (ET)||16
6286935|NCT00235989|7187785|FG001|STARTED|Extension Treatment Period (ET)||6
6286936|NCT00235989|7187786|FG002|STARTED|Extension Treatment Period (ET)||19
6286937|NCT00235989|7187787|FG003|STARTED|Extension Treatment Period (ET)||20
6286938|NCT00235989|7187788|FG004|STARTED|Extension Treatment Period (ET)||0
6286939|NCT00235989|7187789|FG005|STARTED|Extension Treatment Period (ET)||0
6286940|NCT00235989|7187784|FG000|COMPLETED|Extension Treatment Period (ET)||8
6286941|NCT00235989|7187785|FG001|COMPLETED|Extension Treatment Period (ET)||2
6286942|NCT00235989|7187786|FG002|COMPLETED|Extension Treatment Period (ET)||14
6286943|NCT00235989|7187787|FG003|COMPLETED|Extension Treatment Period (ET)||14
6286944|NCT00235989|7187788|FG004|COMPLETED|Extension Treatment Period (ET)||0
6286945|NCT00235989|7187789|FG005|COMPLETED|Extension Treatment Period (ET)||0
6286946|NCT00235989|7187784|FG000|NOT COMPLETED|Extension Treatment Period (ET)||8
6286947|NCT00235989|7187785|FG001|NOT COMPLETED|Extension Treatment Period (ET)||4
6286948|NCT00235989|7187786|FG002|NOT COMPLETED|Extension Treatment Period (ET)||5
6286949|NCT00235989|7187787|FG003|NOT COMPLETED|Extension Treatment Period (ET)||6
6286950|NCT00235989|7187788|FG004|NOT COMPLETED|Extension Treatment Period (ET)||0
6286951|NCT00235989|7187789|FG005|NOT COMPLETED|Extension Treatment Period (ET)||0
6286952|NCT00236080|7187804|FG000|STARTED|Overall Study||29
6286953|NCT00236080|7187805|FG001|STARTED|Overall Study||28
6286954|NCT00236080|7187806|FG002|STARTED|Overall Study||27
6286955|NCT00236080|7187807|FG003|STARTED|Overall Study||25
6286956|NCT00236080|7187808|FG004|STARTED|Overall Study||27
6286957|NCT00236080|7187804|FG000|COMPLETED|Overall Study||27
6286958|NCT00236080|7187805|FG001|COMPLETED|Overall Study||27
6286959|NCT00236080|7187806|FG002|COMPLETED|Overall Study||22
6286960|NCT00236080|7187807|FG003|COMPLETED|Overall Study||23
6286961|NCT00236080|7187808|FG004|COMPLETED|Overall Study||26
6286962|NCT00236080|7187804|FG000|NOT COMPLETED|Overall Study||2
6286963|NCT00236080|7187805|FG001|NOT COMPLETED|Overall Study||1
6286964|NCT00236080|7187806|FG002|NOT COMPLETED|Overall Study||5
6286965|NCT00236080|7187807|FG003|NOT COMPLETED|Overall Study||2
6286966|NCT00236080|7187808|FG004|NOT COMPLETED|Overall Study||1
6286967|NCT00236184|7187822|FG000|STARTED|Overall Study||310
6286968|NCT00236184|7187823|FG001|STARTED|Overall Study||319
6286969|NCT00236184|7187822|FG000|COMPLETED|Overall Study||292
6286970|NCT00236184|7187823|FG001|COMPLETED|Overall Study||308
6286971|NCT00236184|7187822|FG000|NOT COMPLETED|Overall Study||18
6286972|NCT00236184|7187823|FG001|NOT COMPLETED|Overall Study||11
6286973|NCT00236197|7187831|FG000|STARTED|Overall Study||312
6286974|NCT00236197|7187832|FG001|STARTED|Overall Study||307
6286975|NCT00236197|7187831|FG000|COMPLETED|Overall Study||307
6286976|NCT00236197|7187832|FG001|COMPLETED|Overall Study||293
6286977|NCT00236197|7187831|FG000|NOT COMPLETED|Overall Study||5
6286978|NCT00236197|7187832|FG001|NOT COMPLETED|Overall Study||14
6286979|NCT00236899|7187842|FG000|STARTED|Overall Study||60
6286980|NCT00236899|7187843|FG001|STARTED|Overall Study||64
6286981|NCT00236899|7187844|FG002|STARTED|Overall Study||58
6286982|NCT00236899|7187845|FG003|STARTED|Overall Study||59
6286983|NCT00236899|7187842|FG000|COMPLETED|Overall Study||18
6286984|NCT00236899|7187843|FG001|COMPLETED|Overall Study||24
6286985|NCT00236899|7187844|FG002|COMPLETED|Overall Study||14
6286986|NCT00236899|7187845|FG003|COMPLETED|Overall Study||19
6286987|NCT00236899|7187842|FG000|NOT COMPLETED|Overall Study||42
6286988|NCT00236899|7187843|FG001|NOT COMPLETED|Overall Study||40
6286989|NCT00236899|7187844|FG002|NOT COMPLETED|Overall Study||44
6286990|NCT00236899|7187845|FG003|NOT COMPLETED|Overall Study||40
6286991|NCT00236938|7187864|FG000|STARTED|Overall Study||75
6286992|NCT00236938|7187865|FG001|STARTED|Overall Study||46
6286993|NCT00236938|7187864|FG000|COMPLETED|Overall Study||62
6286994|NCT00236938|7187865|FG001|COMPLETED|Overall Study||26
6286995|NCT00236938|7187864|FG000|NOT COMPLETED|Overall Study||13
6286996|NCT00236938|7187865|FG001|NOT COMPLETED|Overall Study||20
6286997|NCT00236951|7187875|FG000|STARTED|Overall Study||59
6286998|NCT00236951|7187876|FG001|STARTED|Overall Study||77
6286999|NCT00236951|7187877|FG002|STARTED|Overall Study||40
6287000|NCT00236951|7187878|FG003|STARTED|Overall Study||48
6287001|NCT00236951|7187875|FG000|COMPLETED|Overall Study||33
6287002|NCT00236951|7187876|FG001|COMPLETED|Overall Study||46
6287003|NCT00236951|7187877|FG002|COMPLETED|Overall Study||21
6287004|NCT00236951|7187878|FG003|COMPLETED|Overall Study||17
6287005|NCT00236951|7187875|FG000|NOT COMPLETED|Overall Study||26
6287006|NCT00236951|7187876|FG001|NOT COMPLETED|Overall Study||31
6287007|NCT00236951|7187877|FG002|NOT COMPLETED|Overall Study||19
6287008|NCT00236951|7187878|FG003|NOT COMPLETED|Overall Study||31
6287009|NCT00236977|7187890|FG000|STARTED|Overall Study||91
6287010|NCT00236977|7187891|FG001|STARTED|Overall Study||91
6287011|NCT00236977|7187890|FG000|COMPLETED|Overall Study||70
6634555|NCT02296892|7563300|FG001|Safety Population|Overall Study||59
6287012|NCT00236977|7187891|FG001|COMPLETED|Overall Study||72
6287013|NCT00236977|7187890|FG000|NOT COMPLETED|Overall Study||21
6287014|NCT00236977|7187891|FG001|NOT COMPLETED|Overall Study||19
6287015|NCT00237042|7187900|FG000|STARTED|Treatment||60
6287016|NCT00237042|7187901|FG001|STARTED|Treatment||57
6287017|NCT00237042|7187902|FG002|STARTED|Treatment||74
6287018|NCT00237042|7187900|FG000|COMPLETED|Treatment||54
6287019|NCT00237042|7187901|FG001|COMPLETED|Treatment||50
6287020|NCT00237042|7187902|FG002|COMPLETED|Treatment||36
6287021|NCT00237042|7187900|FG000|NOT COMPLETED|Treatment||6
6287022|NCT00237042|7187901|FG001|NOT COMPLETED|Treatment||7
6287023|NCT00237042|7187902|FG002|NOT COMPLETED|Treatment||38
6287024|NCT00237042|7187900|FG000|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
6287025|NCT00237042|7187901|FG001|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
6287026|NCT00237042|7187902|FG002|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
6287027|NCT00237042|7187900|FG000|COMPLETED|Short Term (6 Month) Follow up||50
6287028|NCT00237042|7187901|FG001|COMPLETED|Short Term (6 Month) Follow up||47
6287029|NCT00237042|7187902|FG002|COMPLETED|Short Term (6 Month) Follow up||46
6287030|NCT00237042|7187900|FG000|NOT COMPLETED|Short Term (6 Month) Follow up||9
6287031|NCT00237042|7187901|FG001|NOT COMPLETED|Short Term (6 Month) Follow up||8
6287032|NCT00237042|7187902|FG002|NOT COMPLETED|Short Term (6 Month) Follow up||11
6287033|NCT00237042|7187900|FG000|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
6287034|NCT00237042|7187901|FG001|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
6287035|NCT00237042|7187902|FG002|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
6287036|NCT00237042|7187900|FG000|COMPLETED|Long Term (12 Month) Follow up||48
6287037|NCT00237042|7187901|FG001|COMPLETED|Long Term (12 Month) Follow up||46
6287038|NCT00237042|7187902|FG002|COMPLETED|Long Term (12 Month) Follow up||48
6287039|NCT00237042|7187900|FG000|NOT COMPLETED|Long Term (12 Month) Follow up||11
6287040|NCT00237042|7187901|FG001|NOT COMPLETED|Long Term (12 Month) Follow up||9
6287041|NCT00237042|7187902|FG002|NOT COMPLETED|Long Term (12 Month) Follow up||9
6287042|NCT00237185|7187912|FG000|STARTED|Core||74
6287043|NCT00237185|7187913|FG001|STARTED|Core||74
6634556|NCT02296892|7563301|FG002|Safety Population|Overall Study||69
6634557|NCT02296892|7563299|FG000|Complete Trial Treatment Period|Overall Study||303
6634558|NCT02296892|7563300|FG001|Complete Trial Treatment Period|Overall Study||59
6634559|NCT02296892|7563301|FG002|Complete Trial Treatment Period|Overall Study||69
6634560|NCT02296892|7563299|FG000|COMPLETED|Overall Study||298
6634561|NCT02296892|7563300|FG001|COMPLETED|Overall Study||59
6634562|NCT02296892|7563301|FG002|COMPLETED|Overall Study||68
6634563|NCT02296892|7563299|FG000|NOT COMPLETED|Overall Study||12
6634564|NCT02296892|7563300|FG001|NOT COMPLETED|Overall Study||4
6634565|NCT02296892|7563301|FG002|NOT COMPLETED|Overall Study||5
6634566|NCT02296931|7563311|FG000|STARTED|Overall Study||10
6287044|NCT00237185|7187912|FG000|Treated Participants|Core||73
6287045|NCT00237185|7187913|FG001|Treated Participants|Core||74
6287046|NCT00237185|7187912|FG000|COMPLETED|Core||30
6287047|NCT00237185|7187913|FG001|COMPLETED|Core||37
6287048|NCT00237185|7187912|FG000|NOT COMPLETED|Core||44
6287049|NCT00237185|7187913|FG001|NOT COMPLETED|Core||37
6287050|NCT00237185|7187912|FG000|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
6399292|NCT00879970|7311996|FG003|STARTED|Period 2 Vitamin D Randomization||614
6399293|NCT00879970|7311997|FG004|STARTED|Period 2 Vitamin D Randomization||607
6399294|NCT00879970|7311993|FG000|COMPLETED|Period 2 Vitamin D Randomization||0
6399295|NCT00879970|7311994|FG001|COMPLETED|Period 2 Vitamin D Randomization||0
6399296|NCT00879970|7311995|FG002|COMPLETED|Period 2 Vitamin D Randomization||0
6399297|NCT00879970|7311996|FG003|COMPLETED|Period 2 Vitamin D Randomization||610
6399298|NCT00879970|7311997|FG004|COMPLETED|Period 2 Vitamin D Randomization||600
6399299|NCT00879970|7311993|FG000|NOT COMPLETED|Period 2 Vitamin D Randomization||0
6399300|NCT00879970|7311994|FG001|NOT COMPLETED|Period 2 Vitamin D Randomization||0
6399301|NCT00879970|7311995|FG002|NOT COMPLETED|Period 2 Vitamin D Randomization||0
6399302|NCT00879970|7311996|FG003|NOT COMPLETED|Period 2 Vitamin D Randomization||4
6399303|NCT00879970|7311997|FG004|NOT COMPLETED|Period 2 Vitamin D Randomization||7
6399304|NCT00879996|7312017|FG000|STARTED|Overall Study||28
6399305|NCT00879996|7312018|FG001|STARTED|Overall Study||26
6399306|NCT00879996|7312017|FG000|COMPLETED|Overall Study||13
6399307|NCT00879996|7312018|FG001|COMPLETED|Overall Study||13
6399308|NCT00879996|7312017|FG000|NOT COMPLETED|Overall Study||15
6399309|NCT00879996|7312018|FG001|NOT COMPLETED|Overall Study||13
6399310|NCT00880009|7312026|FG000|STARTED|Overall Study||16
6399311|NCT00880009|7312026|FG000|COMPLETED|Overall Study||0
6399312|NCT00880009|7312026|FG000|NOT COMPLETED|Overall Study||16
6399313|NCT00880022|7312035|FG000|STARTED|Overall Study||23
6399314|NCT00880022|7312036|FG001|STARTED|Overall Study||24
6399315|NCT00880022|7312035|FG000|COMPLETED|Overall Study||21
6399316|NCT00880022|7312036|FG001|COMPLETED|Overall Study||21
6399317|NCT00880022|7312035|FG000|NOT COMPLETED|Overall Study||2
6399318|NCT00880022|7312036|FG001|NOT COMPLETED|Overall Study||3
6399319|NCT00880048|7312047|FG000|STARTED|Overall Study||116
6399320|NCT00880048|7312048|FG001|STARTED|Overall Study||115
6399321|NCT00880048|7312049|FG002|STARTED|Overall Study||112
6399322|NCT00880048|7312047|FG000|COMPLETED|Overall Study||88
6399323|NCT00880048|7312048|FG001|COMPLETED|Overall Study||82
6399324|NCT00880048|7312049|FG002|COMPLETED|Overall Study||77
6399325|NCT00880048|7312047|FG000|NOT COMPLETED|Overall Study||28
6399326|NCT00880048|7312048|FG001|NOT COMPLETED|Overall Study||33
6399327|NCT00880048|7312049|FG002|NOT COMPLETED|Overall Study||35
6399328|NCT00880087|7312059|FG000|STARTED|Overall Study|Among the 166 Started, 161 received Therapeutic Hypothermia and 5 received no treatment.|166
6399329|NCT00880087|7312060|FG001|STARTED|Overall Study|Among the 163 Started, 160 received Therapeutic Normothermia and 3 received no treatment.|163
6399330|NCT00880087|7312059|FG000|COMPLETED|Overall Study|1-year vital status available for all 166 Started patients.|166
6399331|NCT00880087|7312060|FG001|COMPLETED|Overall Study|Of 161 with 1-year vital status, 158 had received Therapeutic Normothermia, 3 received no treatment.|161
6399332|NCT00880087|7312059|FG000|NOT COMPLETED|Overall Study||0
6399333|NCT00880087|7312060|FG001|NOT COMPLETED|Overall Study||2
6399334|NCT00880100|7312066|FG000|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
6399335|NCT00880100|7312066|FG000|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
6399336|NCT00880100|7312066|FG000|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
6634567|NCT02296931|7563312|FG001|STARTED|Overall Study||24
6634568|NCT02296931|7563311|FG000|COMPLETED|Overall Study||10
6634569|NCT02296931|7563312|FG001|COMPLETED|Overall Study||22
6634570|NCT02296931|7563311|FG000|NOT COMPLETED|Overall Study||0
6287051|NCT00237185|7187913|FG001|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
6287052|NCT00237185|7187912|FG000|COMPLETED|Extension||8
6287053|NCT00237185|7187913|FG001|COMPLETED|Extension||13
6287054|NCT00237185|7187912|FG000|NOT COMPLETED|Extension||16
6287055|NCT00237185|7187913|FG001|NOT COMPLETED|Extension||19
6287056|NCT00237458|7187919|FG000|STARTED|Overall Study||7
6287057|NCT00237458|7187919|FG000|COMPLETED|Overall Study||4
6287058|NCT00237458|7187919|FG000|NOT COMPLETED|Overall Study||3
6287059|NCT00237666|7187923|FG000|STARTED|Overall Study||30
6287060|NCT00237666|7187923|FG000|COMPLETED|Overall Study||24
6287061|NCT00237666|7187923|FG000|NOT COMPLETED|Overall Study||6
6634571|NCT02296931|7563312|FG001|NOT COMPLETED|Overall Study||2
6634572|NCT02297100|7563320|FG000|STARTED|Overall Study||13
6634573|NCT02297100|7563321|FG001|STARTED|Overall Study||14
6634574|NCT02297100|7563320|FG000|COMPLETED|Overall Study||13
6634575|NCT02297100|7563321|FG001|COMPLETED|Overall Study||14
6634576|NCT02297100|7563320|FG000|NOT COMPLETED|Overall Study||0
6634577|NCT02297100|7563321|FG001|NOT COMPLETED|Overall Study||0
6634578|NCT02297308|7563327|FG000|STARTED|Overall Study||90
6634579|NCT02297308|7563327|FG000|COMPLETED|Overall Study||90
6634580|NCT02297308|7563327|FG000|NOT COMPLETED|Overall Study||0
6634581|NCT02297503|7563334|FG000|STARTED|Overall Study||30
6287062|NCT00237692|7187931|FG000|STARTED|Overall Study||147
6287063|NCT00237692|7187932|FG001|STARTED|Overall Study||148
6287064|NCT00237692|7187933|FG002|STARTED|Overall Study||149
6287065|NCT00237692|7187934|FG003|STARTED|Overall Study||147
6287066|NCT00237692|7187931|FG000|6 Month f/u|Overall Study||132
6287067|NCT00237692|7187932|FG001|6 Month f/u|Overall Study||134
6287068|NCT00237692|7187933|FG002|6 Month f/u|Overall Study||135
6287069|NCT00237692|7187934|FG003|6 Month f/u|Overall Study||134
6287070|NCT00237692|7187931|FG000|12 Month f/u|Overall Study||137
6287071|NCT00237692|7187932|FG001|12 Month f/u|Overall Study||127
6287072|NCT00237692|7187933|FG002|12 Month f/u|Overall Study||132
6287073|NCT00237692|7187934|FG003|12 Month f/u|Overall Study||127
6634582|NCT02297503|7563335|FG001|STARTED|Overall Study||31
6634583|NCT02297503|7563334|FG000|Initial Single Treatment|Overall Study||29
6287074|NCT00237692|7187931|FG000|18 Month f/u|Overall Study||124
6287075|NCT00237692|7187932|FG001|18 Month f/u|Overall Study||131
6287076|NCT00237692|7187933|FG002|18 Month f/u|Overall Study||126
6287077|NCT00237692|7187934|FG003|18 Month f/u|Overall Study||122
6287078|NCT00237692|7187931|FG000|COMPLETED|Overall Study||129
6287079|NCT00237692|7187932|FG001|COMPLETED|Overall Study||134
6287080|NCT00237692|7187933|FG002|COMPLETED|Overall Study||127
6287081|NCT00237692|7187934|FG003|COMPLETED|Overall Study||128
6287082|NCT00237692|7187931|FG000|NOT COMPLETED|Overall Study||18
6287083|NCT00237692|7187932|FG001|NOT COMPLETED|Overall Study||14
6287084|NCT00237692|7187933|FG002|NOT COMPLETED|Overall Study||22
6287085|NCT00237692|7187934|FG003|NOT COMPLETED|Overall Study||19
6287086|NCT00237718|7187946|FG000|STARTED|Overall Study||160
6287087|NCT00237718|7187947|FG001|STARTED|Overall Study||165
6287088|NCT00237718|7187946|FG000|COMPLETED|Overall Study||114
6287089|NCT00237718|7187947|FG001|COMPLETED|Overall Study||124
6287090|NCT00237718|7187946|FG000|NOT COMPLETED|Overall Study||46
6287091|NCT00237718|7187947|FG001|NOT COMPLETED|Overall Study||41
6287092|NCT00237744|7187956|FG000|STARTED|Overall Study||11
6287093|NCT00237744|7187957|FG001|STARTED|Overall Study||11
6287094|NCT00237744|7187958|FG002|STARTED|Overall Study||18
6287095|NCT00237744|7187956|FG000|COMPLETED|Overall Study||8
6287096|NCT00237744|7187957|FG001|COMPLETED|Overall Study||10
6287097|NCT00237744|7187958|FG002|COMPLETED|Overall Study||18
6287098|NCT00237744|7187956|FG000|NOT COMPLETED|Overall Study||3
6287099|NCT00237744|7187957|FG001|NOT COMPLETED|Overall Study||1
6287100|NCT00237744|7187958|FG002|NOT COMPLETED|Overall Study||0
6287101|NCT00237770|7187971|FG000|STARTED|Overall Study||9
6287102|NCT00237770|7187972|FG001|STARTED|Overall Study||7
6287103|NCT00237770|7187971|FG000|COMPLETED|Overall Study||9
6287104|NCT00237770|7187972|FG001|COMPLETED|Overall Study||7
6287105|NCT00237770|7187971|FG000|NOT COMPLETED|Overall Study||0
6287106|NCT00237770|7187972|FG001|NOT COMPLETED|Overall Study||0
6287107|NCT00237796|7187984|FG000|STARTED|Overall Study||41
6287108|NCT00237796|7187985|FG001|STARTED|Overall Study||38
6287109|NCT00237796|7187984|FG000|COMPLETED|Overall Study||31
6287110|NCT00237796|7187985|FG001|COMPLETED|Overall Study||33
6287111|NCT00237796|7187984|FG000|NOT COMPLETED|Overall Study||10
6287112|NCT00237796|7187985|FG001|NOT COMPLETED|Overall Study||5
6287113|NCT00237809|7187996|FG000|STARTED|Overall Study||27
6287114|NCT00237809|7187997|FG001|STARTED|Overall Study||27
6287115|NCT00237809|7187998|FG002|STARTED|Overall Study||24
6287116|NCT00237809|7187999|FG003|STARTED|Overall Study||26
6287117|NCT00237809|7187996|FG000|COMPLETED|Overall Study||16
6287118|NCT00237809|7187997|FG001|COMPLETED|Overall Study||17
6287119|NCT00237809|7187998|FG002|COMPLETED|Overall Study||15
6287120|NCT00237809|7187999|FG003|COMPLETED|Overall Study||17
6287121|NCT00237809|7187996|FG000|NOT COMPLETED|Overall Study||11
6287122|NCT00237809|7187997|FG001|NOT COMPLETED|Overall Study||10
6287123|NCT00237809|7187998|FG002|NOT COMPLETED|Overall Study||9
6287124|NCT00237809|7187999|FG003|NOT COMPLETED|Overall Study||9
6287125|NCT00238108|7188011|FG000|STARTED|Overall Study||8
6634584|NCT02297503|7563335|FG001|Initial Single Treatment|Overall Study||31
6634585|NCT02297503|7563334|FG000|First Combined Treatment|Overall Study||28
6634586|NCT02297503|7563335|FG001|First Combined Treatment|Overall Study||28
6634587|NCT02297503|7563334|FG000|Second Combined Treatment|Overall Study||28
6287126|NCT00238108|7188012|FG001|STARTED|Overall Study||8
6287127|NCT00238108|7188011|FG000|COMPLETED|Overall Study||8
6287128|NCT00238108|7188012|FG001|COMPLETED|Overall Study||8
6287129|NCT00238108|7188011|FG000|NOT COMPLETED|Overall Study||0
6287130|NCT00238108|7188012|FG001|NOT COMPLETED|Overall Study||0
6287131|NCT00238121|7188020|FG000|STARTED|Overall Study||40
6287132|NCT00238121|7188021|FG001|STARTED|Overall Study||16
6287133|NCT00238121|7188020|FG000|COMPLETED|Overall Study||37
6287134|NCT00238121|7188021|FG001|COMPLETED|Overall Study||14
6287135|NCT00238121|7188020|FG000|NOT COMPLETED|Overall Study||3
6287136|NCT00238121|7188021|FG001|NOT COMPLETED|Overall Study||2
6287137|NCT00238238|7188029|FG000|STARTED|Overall Study||3
6287138|NCT00238238|7188030|FG001|STARTED|Overall Study||48
6287139|NCT00238238|7188031|FG002|STARTED|Overall Study||46
6287140|NCT00238238|7188029|FG000|COMPLETED|Overall Study||3
6287141|NCT00238238|7188030|FG001|COMPLETED|Overall Study||45
6287142|NCT00238238|7188031|FG002|COMPLETED|Overall Study||46
6287143|NCT00238238|7188029|FG000|NOT COMPLETED|Overall Study||0
6287144|NCT00238238|7188030|FG001|NOT COMPLETED|Overall Study||3
6287145|NCT00238238|7188031|FG002|NOT COMPLETED|Overall Study||0
6287146|NCT00238264|7188039|FG000|STARTED|Overall Study||92
6287147|NCT00238264|7188039|FG000|COMPLETED|Overall Study||56
6287148|NCT00238264|7188039|FG000|NOT COMPLETED|Overall Study||36
6287149|NCT00238303|7188046|FG000|STARTED|Overall Study||68
6287150|NCT00238303|7188047|FG001|STARTED|Overall Study||15
6287151|NCT00238303|7188048|FG002|STARTED|Overall Study||20
6287152|NCT00238303|7188046|FG000|COMPLETED|Overall Study||53
6287153|NCT00238303|7188047|FG001|COMPLETED|Overall Study||13
6287154|NCT00238303|7188048|FG002|COMPLETED|Overall Study||11
6287155|NCT00238303|7188046|FG000|NOT COMPLETED|Overall Study||15
6287156|NCT00238303|7188047|FG001|NOT COMPLETED|Overall Study||2
6287157|NCT00238303|7188048|FG002|NOT COMPLETED|Overall Study||9
6287158|NCT00238355|7188057|FG000|STARTED|Overall Study||13
6287159|NCT00238355|7188057|FG000|COMPLETED|Overall Study||10
6287160|NCT00238355|7188057|FG000|NOT COMPLETED|Overall Study||3
6287161|NCT00238433|7188061|FG000|STARTED|Overall Study||37
6287162|NCT00238433|7188061|FG000|COMPLETED|Overall Study||34
6287163|NCT00238433|7188061|FG000|NOT COMPLETED|Overall Study||3
6287164|NCT00238615|7188066|FG000|STARTED|Overall Study||13
6287165|NCT00238615|7188066|FG000|COMPLETED|Overall Study||13
6287166|NCT00238615|7188066|FG000|NOT COMPLETED|Overall Study||0
6287167|NCT00239005|7188074|FG000|STARTED|Overall Study||69
6287168|NCT00239005|7188075|FG001|STARTED|Overall Study||65
6287169|NCT00239005|7188074|FG000|Intention-to-treat Population (ITT)|Overall Study||68
6287170|NCT00239005|7188075|FG001|Intention-to-treat Population (ITT)|Overall Study||61
6287171|NCT00239005|7188074|FG000|COMPLETED|Overall Study||57
6287172|NCT00239005|7188075|FG001|COMPLETED|Overall Study||53
6287173|NCT00239005|7188074|FG000|NOT COMPLETED|Overall Study||12
6287174|NCT00239005|7188075|FG001|NOT COMPLETED|Overall Study||12
6287175|NCT00239226|7188085|FG000|STARTED|Overall Study||30
6287176|NCT00239226|7188086|FG001|STARTED|Overall Study||18
6287177|NCT00239226|7188087|FG002|STARTED|Overall Study||37
6287178|NCT00239226|7188088|FG003|STARTED|Overall Study||17
6287179|NCT00239226|7188085|FG000|COMPLETED|Overall Study||29
6287180|NCT00239226|7188086|FG001|COMPLETED|Overall Study||18
6287181|NCT00239226|7188087|FG002|COMPLETED|Overall Study||36
6287182|NCT00239226|7188088|FG003|COMPLETED|Overall Study||14
6287183|NCT00239226|7188085|FG000|NOT COMPLETED|Overall Study||1
6287184|NCT00239226|7188086|FG001|NOT COMPLETED|Overall Study||0
6287185|NCT00239226|7188087|FG002|NOT COMPLETED|Overall Study||1
6287186|NCT00239226|7188088|FG003|NOT COMPLETED|Overall Study||3
6287187|NCT00239356|7188100|FG000|STARTED|Overall Study||97
6287188|NCT00239356|7188101|FG001|STARTED|Overall Study||20
6287189|NCT00239356|7188100|FG000|COMPLETED|Overall Study||58
6287190|NCT00239356|7188101|FG001|COMPLETED|Overall Study||11
6287191|NCT00239356|7188100|FG000|NOT COMPLETED|Overall Study||39
6287192|NCT00239356|7188101|FG001|NOT COMPLETED|Overall Study||9
6287193|NCT00239577|7188111|FG000|STARTED|Primary Phase||22
6287194|NCT00239577|7188112|FG001|STARTED|Primary Phase||22
6287195|NCT00239577|7188113|FG002|STARTED|Primary Phase||21
6287196|NCT00239577|7188114|FG003|STARTED|Primary Phase||21
6287197|NCT00239577|7188111|FG000|COMPLETED|Primary Phase||17
6287198|NCT00239577|7188112|FG001|COMPLETED|Primary Phase||19
6287199|NCT00239577|7188113|FG002|COMPLETED|Primary Phase||18
6287200|NCT00239577|7188114|FG003|COMPLETED|Primary Phase||21
6287201|NCT00239577|7188111|FG000|NOT COMPLETED|Primary Phase||5
6287202|NCT00239577|7188112|FG001|NOT COMPLETED|Primary Phase||3
6287203|NCT00239577|7188113|FG002|NOT COMPLETED|Primary Phase||3
6287204|NCT00239577|7188114|FG003|NOT COMPLETED|Primary Phase||0
6287205|NCT00239577|7188111|FG000|STARTED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
6287206|NCT00239577|7188112|FG001|STARTED|Booster Phase||9
6287207|NCT00239577|7188113|FG002|STARTED|Booster Phase||12
6287208|NCT00239577|7188114|FG003|STARTED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
6287209|NCT00239577|7188111|FG000|COMPLETED|Booster Phase|The subjects belonging to this group did not receive a booster dose of Dengue vaccine.|0
6287210|NCT00239577|7188112|FG001|COMPLETED|Booster Phase||9
6287211|NCT00239577|7188113|FG002|COMPLETED|Booster Phase||12
6287212|NCT00239577|7188114|FG003|COMPLETED|Booster Phase|The subjects belonging to this group did not receive an additional dose of Placebo.|0
6287213|NCT00239577|7188111|FG000|NOT COMPLETED|Booster Phase||0
6287214|NCT00239577|7188112|FG001|NOT COMPLETED|Booster Phase||0
6287215|NCT00239577|7188113|FG002|NOT COMPLETED|Booster Phase||0
6287216|NCT00239577|7188114|FG003|NOT COMPLETED|Booster Phase||0
6287217|NCT00239590|7188126|FG000|STARTED|Randomized||14
6287218|NCT00239590|7188127|FG001|STARTED|Randomized||14
6287219|NCT00239590|7188126|FG000|COMPLETED|Randomized||14
6287220|NCT00239590|7188127|FG001|COMPLETED|Randomized||12
6287221|NCT00239590|7188126|FG000|NOT COMPLETED|Randomized||0
6287222|NCT00239590|7188127|FG001|NOT COMPLETED|Randomized||2
6287223|NCT00239590|7188126|FG000|STARTED|Started Intervention After Randomization||14
6287224|NCT00239590|7188127|FG001|STARTED|Started Intervention After Randomization||12
6287225|NCT00239590|7188126|FG000|COMPLETED|Started Intervention After Randomization||14
6287226|NCT00239590|7188127|FG001|COMPLETED|Started Intervention After Randomization||12
6287227|NCT00239590|7188126|FG000|NOT COMPLETED|Started Intervention After Randomization||0
6287228|NCT00239590|7188127|FG001|NOT COMPLETED|Started Intervention After Randomization||0
6287229|NCT00239590|7188126|FG000|STARTED|Completed Study Protocol||14
6287230|NCT00239590|7188127|FG001|STARTED|Completed Study Protocol||12
6287231|NCT00239590|7188126|FG000|COMPLETED|Completed Study Protocol||13
6287232|NCT00239590|7188127|FG001|COMPLETED|Completed Study Protocol||10
6287233|NCT00239590|7188126|FG000|NOT COMPLETED|Completed Study Protocol||1
6287234|NCT00239590|7188127|FG001|NOT COMPLETED|Completed Study Protocol||2
6287235|NCT00239642|7188138|FG000|STARTED|Overall Study||49
6287236|NCT00239642|7188139|FG001|STARTED|Overall Study||47
6287237|NCT00239642|7188140|FG002|STARTED|Overall Study||49
6287238|NCT00239642|7188138|FG000|COMPLETED|Overall Study||47
6287239|NCT00239642|7188139|FG001|COMPLETED|Overall Study||47
6287240|NCT00239642|7188140|FG002|COMPLETED|Overall Study||47
6287241|NCT00239642|7188138|FG000|NOT COMPLETED|Overall Study||2
6287242|NCT00239642|7188139|FG001|NOT COMPLETED|Overall Study||0
6287243|NCT00239642|7188140|FG002|NOT COMPLETED|Overall Study||2
6287244|NCT00239681|7188150|FG000|STARTED|Overall Study||8901
6287245|NCT00239681|7188151|FG001|STARTED|Overall Study||8901
6287246|NCT00239681|7188150|FG000|Randomized and Treated (Safety Pop)|Overall Study||8869
6287247|NCT00239681|7188151|FG001|Randomized and Treated (Safety Pop)|Overall Study||8864
6287248|NCT00239681|7188150|FG000|COMPLETED|Overall Study||8208
6287249|NCT00239681|7188151|FG001|COMPLETED|Overall Study||8186
6287250|NCT00239681|7188150|FG000|NOT COMPLETED|Overall Study||693
6287251|NCT00239681|7188151|FG001|NOT COMPLETED|Overall Study||715
6287252|NCT00239733|7188157|FG000|STARTED|Overall Study||6
6287253|NCT00239733|7188157|FG000|COMPLETED|Overall Study||6
6287254|NCT00239733|7188157|FG000|NOT COMPLETED|Overall Study||0
6287255|NCT00239837|7188163|FG000|STARTED|Overall Study||48
6287256|NCT00239837|7188164|FG001|STARTED|Overall Study||52
6287257|NCT00239837|7188163|FG000|6 Months|Overall Study||48
6287258|NCT00239837|7188164|FG001|6 Months|Overall Study||50
6287259|NCT00239837|7188163|FG000|COMPLETED|Overall Study|3-year follow-up|45
6287260|NCT00239837|7188164|FG001|COMPLETED|Overall Study|3-year follow-up|45
6287261|NCT00239837|7188163|FG000|NOT COMPLETED|Overall Study||3
6287262|NCT00239837|7188164|FG001|NOT COMPLETED|Overall Study||7
6287263|NCT00239928|7188172|FG000|STARTED|Overall Study||61
6287264|NCT00239928|7188172|FG000|COMPLETED|Overall Study||51
6287265|NCT00239928|7188172|FG000|NOT COMPLETED|Overall Study||10
6287266|NCT00240071|7188176|FG000|STARTED|Overall Study||30
6399337|NCT00880100|7312066|FG000|STARTED|Treatment Phase With Ultrase® MT12||48
6399338|NCT00880100|7312066|FG000|COMPLETED|Treatment Phase With Ultrase® MT12||45
6399339|NCT00880100|7312066|FG000|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
6399340|NCT00880165|7312072|FG000|STARTED|Overall Study||148
6399341|NCT00880165|7312073|FG001|STARTED|Overall Study||148
6399342|NCT00880165|7312072|FG000|COMPLETED|Overall Study||86
6399343|NCT00880165|7312073|FG001|COMPLETED|Overall Study||98
6399344|NCT00880165|7312072|FG000|NOT COMPLETED|Overall Study||62
6399345|NCT00880165|7312073|FG001|NOT COMPLETED|Overall Study||50
6399346|NCT00880191|7312081|FG000|STARTED|Overall Study||207
6399347|NCT00880191|7312082|FG001|STARTED|Overall Study||206
6399348|NCT00880191|7312081|FG000|Available for Primary Endpoint Analysis|Overall Study||207
6399349|NCT00880191|7312082|FG001|Available for Primary Endpoint Analysis|Overall Study||206
6399350|NCT00880191|7312081|FG000|COMPLETED|Overall Study||194
6399351|NCT00880191|7312082|FG001|COMPLETED|Overall Study||198
6287267|NCT00240071|7188176|FG000|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
6287268|NCT00240071|7188176|FG000|NOT COMPLETED|Overall Study||3
6287269|NCT00240097|7188181|FG000|STARTED|Part I||30
6287270|NCT00240097|7188181|FG000|COMPLETED|Part I||26
6287271|NCT00240097|7188181|FG000|NOT COMPLETED|Part I||4
6287272|NCT00240097|7188181|FG000|STARTED|Part II||26
6287273|NCT00240097|7188181|FG000|COMPLETED|Part II||3
6287274|NCT00240097|7188181|FG000|NOT COMPLETED|Part II||23
6287275|NCT00240110|7188191|FG000|STARTED|Overall Study||13
6287276|NCT00240110|7188192|FG001|STARTED|Overall Study||13
6287277|NCT00240110|7188191|FG000|COMPLETED|Overall Study||7
6287278|NCT00240110|7188192|FG001|COMPLETED|Overall Study||6
6287279|NCT00240110|7188191|FG000|NOT COMPLETED|Overall Study||6
6287280|NCT00240110|7188192|FG001|NOT COMPLETED|Overall Study||7
6287281|NCT00240162|7188200|FG000|STARTED|Overall Study||21
6287282|NCT00240162|7188200|FG000|COMPLETED|Overall Study||21
6287283|NCT00240162|7188200|FG000|NOT COMPLETED|Overall Study||0
6287284|NCT00240331|7188206|FG000|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
6287285|NCT00240331|7188207|FG001|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
6287286|NCT00240331|7188206|FG000|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
6287287|NCT00240331|7188207|FG001|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
6287288|NCT00240331|7188206|FG000|NOT COMPLETED|Overall Study||126
6287289|NCT00240331|7188207|FG001|NOT COMPLETED|Overall Study||134
6287290|NCT00240487|7188215|FG000|STARTED|Overall Study||24
6287291|NCT00240487|7188216|FG001|STARTED|Overall Study||28
6287292|NCT00240487|7188215|FG000|COMPLETED|Overall Study||24
6287293|NCT00240487|7188216|FG001|COMPLETED|Overall Study||28
6287294|NCT00240487|7188215|FG000|NOT COMPLETED|Overall Study||0
6287295|NCT00240487|7188216|FG001|NOT COMPLETED|Overall Study||0
6287296|NCT00240526|7188226|FG000|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
6287297|NCT00240526|7188227|FG001|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
6287298|NCT00240526|7188228|FG002|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
6287299|NCT00240526|7188229|FG003|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
6287300|NCT00240526|7188226|FG000|COMPLETED|Year 15||19
6287301|NCT00240526|7188227|FG001|COMPLETED|Year 15||19
6287302|NCT00240526|7188228|FG002|COMPLETED|Year 15||14
6287303|NCT00240526|7188229|FG003|COMPLETED|Year 15||21
6287304|NCT00240526|7188226|FG000|NOT COMPLETED|Year 15||0
6287305|NCT00240526|7188227|FG001|NOT COMPLETED|Year 15||0
6287306|NCT00240526|7188228|FG002|NOT COMPLETED|Year 15||0
6287307|NCT00240526|7188229|FG003|NOT COMPLETED|Year 15||0
6287308|NCT00240526|7188226|FG000|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
6287309|NCT00240526|7188227|FG001|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
6287310|NCT00240526|7188228|FG002|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
6287311|NCT00240526|7188229|FG003|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
6287312|NCT00240526|7188226|FG000|COMPLETED|Year 16||17
6287313|NCT00240526|7188227|FG001|COMPLETED|Year 16||19
6287314|NCT00240526|7188228|FG002|COMPLETED|Year 16||16
6287315|NCT00240526|7188229|FG003|COMPLETED|Year 16||22
6287316|NCT00240526|7188226|FG000|NOT COMPLETED|Year 16||0
6287317|NCT00240526|7188227|FG001|NOT COMPLETED|Year 16||0
6287318|NCT00240526|7188228|FG002|NOT COMPLETED|Year 16||0
6287319|NCT00240526|7188229|FG003|NOT COMPLETED|Year 16||0
6287320|NCT00240526|7188226|FG000|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
6287321|NCT00240526|7188227|FG001|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
6287322|NCT00240526|7188228|FG002|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
6287323|NCT00240526|7188229|FG003|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
6287324|NCT00240526|7188226|FG000|COMPLETED|Year 17||19
6287325|NCT00240526|7188227|FG001|COMPLETED|Year 17||17
6287326|NCT00240526|7188228|FG002|COMPLETED|Year 17||13
6287327|NCT00240526|7188229|FG003|COMPLETED|Year 17||20
6287328|NCT00240526|7188226|FG000|NOT COMPLETED|Year 17||0
6287329|NCT00240526|7188227|FG001|NOT COMPLETED|Year 17||0
6287330|NCT00240526|7188228|FG002|NOT COMPLETED|Year 17||0
6287331|NCT00240526|7188229|FG003|NOT COMPLETED|Year 17||0
6287332|NCT00240526|7188226|FG000|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
6287333|NCT00240526|7188227|FG001|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
6287334|NCT00240526|7188228|FG002|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
6287335|NCT00240526|7188229|FG003|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
6287336|NCT00240526|7188226|FG000|COMPLETED|Year 18||16
6287337|NCT00240526|7188227|FG001|COMPLETED|Year 18||17
6287338|NCT00240526|7188228|FG002|COMPLETED|Year 18||14
6287339|NCT00240526|7188229|FG003|COMPLETED|Year 18||20
6287340|NCT00240526|7188226|FG000|NOT COMPLETED|Year 18||0
6287341|NCT00240526|7188227|FG001|NOT COMPLETED|Year 18||0
6287342|NCT00240526|7188228|FG002|NOT COMPLETED|Year 18||0
6287343|NCT00240526|7188229|FG003|NOT COMPLETED|Year 18||0
6287344|NCT00240526|7188226|FG000|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
6287345|NCT00240526|7188227|FG001|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
6287346|NCT00240526|7188228|FG002|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
6287347|NCT00240526|7188229|FG003|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
6287348|NCT00240526|7188226|FG000|COMPLETED|Year 19||17
6287349|NCT00240526|7188227|FG001|COMPLETED|Year 19||16
6287350|NCT00240526|7188228|FG002|COMPLETED|Year 19||12
6287351|NCT00240526|7188229|FG003|COMPLETED|Year 19||18
6287352|NCT00240526|7188226|FG000|NOT COMPLETED|Year 19||0
6287353|NCT00240526|7188227|FG001|NOT COMPLETED|Year 19||0
6287354|NCT00240526|7188228|FG002|NOT COMPLETED|Year 19||0
6287355|NCT00240526|7188229|FG003|NOT COMPLETED|Year 19||0
6287356|NCT00240526|7188226|FG000|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
6287357|NCT00240526|7188227|FG001|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
6287358|NCT00240526|7188228|FG002|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
6287359|NCT00240526|7188229|FG003|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
6287360|NCT00240526|7188226|FG000|COMPLETED|Year 20||19
6287361|NCT00240526|7188227|FG001|COMPLETED|Year 20||17
6287362|NCT00240526|7188228|FG002|COMPLETED|Year 20||13
6287363|NCT00240526|7188229|FG003|COMPLETED|Year 20||20
6287364|NCT00240526|7188226|FG000|NOT COMPLETED|Year 20||0
6287365|NCT00240526|7188227|FG001|NOT COMPLETED|Year 20||0
6287366|NCT00240526|7188228|FG002|NOT COMPLETED|Year 20||0
6287367|NCT00240526|7188229|FG003|NOT COMPLETED|Year 20||0
6287368|NCT00240539|7188247|FG000|STARTED|Overall Study||2
6287369|NCT00240539|7188248|FG001|STARTED|Overall Study||2
6287370|NCT00240539|7188249|FG002|STARTED|Overall Study||31
6287371|NCT00240539|7188250|FG003|STARTED|Overall Study||1
6287372|NCT00240539|7188247|FG000|COMPLETED|Overall Study||2
6287373|NCT00240539|7188248|FG001|COMPLETED|Overall Study||2
6287374|NCT00240539|7188249|FG002|COMPLETED|Overall Study||31
6287375|NCT00240539|7188250|FG003|COMPLETED|Overall Study||1
6287376|NCT00240539|7188247|FG000|NOT COMPLETED|Overall Study||0
6287377|NCT00240539|7188248|FG001|NOT COMPLETED|Overall Study||0
6287378|NCT00240539|7188249|FG002|NOT COMPLETED|Overall Study||0
6287379|NCT00240539|7188250|FG003|NOT COMPLETED|Overall Study||0
6287380|NCT00240981|7188262|FG000|STARTED|Overall Study||106
6287381|NCT00240981|7188263|FG001|STARTED|Overall Study||103
6287382|NCT00240981|7188262|FG000|Intent to Treat Sample|Overall Study||82
6287383|NCT00240981|7188263|FG001|Intent to Treat Sample|Overall Study||83
6287384|NCT00240981|7188262|FG000|COMPLETED|Overall Study||68
6287385|NCT00240981|7188263|FG001|COMPLETED|Overall Study||70
6287386|NCT00240981|7188262|FG000|NOT COMPLETED|Overall Study||38
6287387|NCT00240981|7188263|FG001|NOT COMPLETED|Overall Study||33
6287388|NCT00240994|7188270|FG000|STARTED|Overall Study||35
6287389|NCT00240994|7188270|FG000|COMPLETED|Overall Study||32
6287390|NCT00240994|7188270|FG000|NOT COMPLETED|Overall Study||3
6287391|NCT00241176|7188274|FG000|STARTED|Overall Study||11
6287392|NCT00241176|7188274|FG000|COMPLETED|Overall Study||11
6287393|NCT00241176|7188274|FG000|NOT COMPLETED|Overall Study||0
6287394|NCT00241280|7188281|FG000|STARTED|Overall Study||247
6287395|NCT00241280|7188282|FG001|STARTED|Overall Study||254
6287396|NCT00241280|7188281|FG000|COMPLETED|Overall Study||199
6287397|NCT00241280|7188282|FG001|COMPLETED|Overall Study||186
6287398|NCT00241280|7188281|FG000|NOT COMPLETED|Overall Study||48
6287399|NCT00241280|7188282|FG001|NOT COMPLETED|Overall Study||68
6634588|NCT02297503|7563335|FG001|Second Combined Treatment|Overall Study||28
6634589|NCT02297503|7563334|FG000|COMPLETED|Overall Study||28
6634590|NCT02297503|7563335|FG001|COMPLETED|Overall Study||27
6287400|NCT00241358|7188292|FG000|STARTED|Overall Study||25
6287401|NCT00241358|7188293|FG001|STARTED|Overall Study||46
6287402|NCT00241358|7188294|FG002|STARTED|Overall Study||21
6287403|NCT00241358|7188292|FG000|COMPLETED|Overall Study||25
6287404|NCT00241358|7188293|FG001|COMPLETED|Overall Study||45
6287405|NCT00241358|7188294|FG002|COMPLETED|Overall Study||20
6287406|NCT00241358|7188292|FG000|NOT COMPLETED|Overall Study||0
6287407|NCT00241358|7188293|FG001|NOT COMPLETED|Overall Study||1
6287408|NCT00241358|7188294|FG002|NOT COMPLETED|Overall Study||1
6287409|NCT00241631|7188303|FG000|STARTED|Run in (2 Weeks)||25
6287410|NCT00241631|7188304|FG001|STARTED|Run in (2 Weeks)||24
6287411|NCT00241631|7188303|FG000|COMPLETED|Run in (2 Weeks)||22
6287412|NCT00241631|7188304|FG001|COMPLETED|Run in (2 Weeks)||21
6287413|NCT00241631|7188303|FG000|NOT COMPLETED|Run in (2 Weeks)||3
6287414|NCT00241631|7188304|FG001|NOT COMPLETED|Run in (2 Weeks)||3
6287415|NCT00241631|7188303|FG000|STARTED|Phase 1 (4 Weeks)||22
6287416|NCT00241631|7188304|FG001|STARTED|Phase 1 (4 Weeks)||21
6287417|NCT00241631|7188303|FG000|COMPLETED|Phase 1 (4 Weeks)||14
6287418|NCT00241631|7188304|FG001|COMPLETED|Phase 1 (4 Weeks)||16
6287419|NCT00241631|7188303|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||8
6287420|NCT00241631|7188304|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
6287421|NCT00241631|7188303|FG000|STARTED|Wash Out (2 Weeks)||14
6287422|NCT00241631|7188304|FG001|STARTED|Wash Out (2 Weeks)||16
6287423|NCT00241631|7188303|FG000|COMPLETED|Wash Out (2 Weeks)||14
6287424|NCT00241631|7188304|FG001|COMPLETED|Wash Out (2 Weeks)||16
6287425|NCT00241631|7188303|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
6287426|NCT00241631|7188304|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
6287427|NCT00241631|7188303|FG000|STARTED|Phase 2 (4 Weeks)||14
6287428|NCT00241631|7188304|FG001|STARTED|Phase 2 (4 Weeks)||16
6287429|NCT00241631|7188303|FG000|COMPLETED|Phase 2 (4 Weeks)||14
6287430|NCT00241631|7188304|FG001|COMPLETED|Phase 2 (4 Weeks)||16
6287431|NCT00241631|7188303|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||0
6287432|NCT00241631|7188304|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||0
6287433|NCT00241644|7188314|FG000|STARTED|First Efficacy Period (Year 1)||1647
6287434|NCT00241644|7188315|FG001|STARTED|First Efficacy Period (Year 1)||1651
6287435|NCT00241644|7188316|FG002|STARTED|First Efficacy Period (Year 1)||1641
6287436|NCT00241644|7188317|FG003|STARTED|First Efficacy Period (Year 1)||3298
6287437|NCT00241644|7188314|FG000|COMPLETED|First Efficacy Period (Year 1)||1420
6287438|NCT00241644|7188315|FG001|COMPLETED|First Efficacy Period (Year 1)||1383
6287439|NCT00241644|7188316|FG002|COMPLETED|First Efficacy Period (Year 1)||1392
6287440|NCT00241644|7188317|FG003|COMPLETED|First Efficacy Period (Year 1)||2803
6287441|NCT00241644|7188314|FG000|NOT COMPLETED|First Efficacy Period (Year 1)||227
6287442|NCT00241644|7188315|FG001|NOT COMPLETED|First Efficacy Period (Year 1)||268
6287443|NCT00241644|7188316|FG002|NOT COMPLETED|First Efficacy Period (Year 1)||249
6287444|NCT00241644|7188317|FG003|NOT COMPLETED|First Efficacy Period (Year 1)||495
6287445|NCT00241644|7188314|FG000|STARTED|Second Efficacy Period (Year 2)||771
6287446|NCT00241644|7188315|FG001|STARTED|Second Efficacy Period (Year 2)||754
6287447|NCT00241644|7188316|FG002|STARTED|Second Efficacy Period (Year 2)||746
6634591|NCT02297503|7563334|FG000|NOT COMPLETED|Overall Study||2
6634592|NCT02297503|7563335|FG001|NOT COMPLETED|Overall Study||4
6287448|NCT00241644|7188317|FG003|STARTED|Second Efficacy Period (Year 2)||1525
6287449|NCT00241644|7188314|FG000|COMPLETED|Second Efficacy Period (Year 2)||710
6287450|NCT00241644|7188315|FG001|COMPLETED|Second Efficacy Period (Year 2)||697
6287451|NCT00241644|7188316|FG002|COMPLETED|Second Efficacy Period (Year 2)||682
6287452|NCT00241644|7188317|FG003|COMPLETED|Second Efficacy Period (Year 2)||1407
6287453|NCT00241644|7188314|FG000|NOT COMPLETED|Second Efficacy Period (Year 2)||61
6287454|NCT00241644|7188315|FG001|NOT COMPLETED|Second Efficacy Period (Year 2)||57
6287455|NCT00241644|7188316|FG002|NOT COMPLETED|Second Efficacy Period (Year 2)||64
6287456|NCT00241644|7188317|FG003|NOT COMPLETED|Second Efficacy Period (Year 2)||118
6287457|NCT00241839|7188329|FG000|STARTED|Overall Study||71
6287458|NCT00241839|7188330|FG001|STARTED|Overall Study||71
6287459|NCT00241839|7188329|FG000|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
6287460|NCT00241839|7188330|FG001|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
6287461|NCT00241839|7188329|FG000|NOT COMPLETED|Overall Study||19
6287462|NCT00241839|7188330|FG001|NOT COMPLETED|Overall Study||18
6287463|NCT00241904|7188338|FG000|STARTED|Overall Study||261
6287464|NCT00241904|7188339|FG001|STARTED|Overall Study||264
6287465|NCT00241904|7188338|FG000|COMPLETED|Overall Study||227
6287466|NCT00241904|7188339|FG001|COMPLETED|Overall Study||240
6287467|NCT00241904|7188338|FG000|NOT COMPLETED|Overall Study||34
6287468|NCT00241904|7188339|FG001|NOT COMPLETED|Overall Study||24
6287469|NCT00241969|7188348|FG000|STARTED|Overall Study||36
6287470|NCT00241969|7188349|FG001|STARTED|Overall Study||42
6287471|NCT00241969|7188348|FG000|COMPLETED|Overall Study||36
6287472|NCT00241969|7188349|FG001|COMPLETED|Overall Study||42
6287473|NCT00241969|7188348|FG000|NOT COMPLETED|Overall Study||0
6287474|NCT00241969|7188349|FG001|NOT COMPLETED|Overall Study||0
6287475|NCT00242216|7188357|FG000|STARTED|Overall Study||39
6287476|NCT00242216|7188358|FG001|STARTED|Overall Study||37
6287477|NCT00242216|7188357|FG000|COMPLETED|Overall Study||21
6287478|NCT00242216|7188358|FG001|COMPLETED|Overall Study||15
6287479|NCT00242216|7188357|FG000|NOT COMPLETED|Overall Study||18
6287480|NCT00242216|7188358|FG001|NOT COMPLETED|Overall Study||22
6287481|NCT00242385|7188364|FG000|STARTED|Period 1||14
6287482|NCT00242385|7188365|FG001|STARTED|Period 1||11
6287483|NCT00242385|7188364|FG000|COMPLETED|Period 1||14
6287484|NCT00242385|7188365|FG001|COMPLETED|Period 1||11
6287485|NCT00242385|7188364|FG000|NOT COMPLETED|Period 1||0
6287486|NCT00242385|7188365|FG001|NOT COMPLETED|Period 1||0
6287487|NCT00242385|7188364|FG000|STARTED|Period 2||14
6287488|NCT00242385|7188365|FG001|STARTED|Period 2||11
6287489|NCT00242385|7188364|FG000|COMPLETED|Period 2||14
6287490|NCT00242385|7188365|FG001|COMPLETED|Period 2||11
6287491|NCT00242385|7188364|FG000|NOT COMPLETED|Period 2||0
6287492|NCT00242385|7188365|FG001|NOT COMPLETED|Period 2||0
6287493|NCT00242502|7188371|FG000|STARTED|Overall Study||59
6287494|NCT00242502|7188371|FG000|COMPLETED|Overall Study||59
6287495|NCT00242502|7188371|FG000|NOT COMPLETED|Overall Study||0
6287496|NCT00242567|7188377|FG000|STARTED|Overall Study||259
6287497|NCT00242567|7188378|FG001|STARTED|Overall Study||263
6287498|NCT00242567|7188377|FG000|Received at Least 1 Dose of Study Drug|Overall Study||259
6287499|NCT00242567|7188378|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
6287500|NCT00242567|7188377|FG000|Never Received Study Drug|Overall Study||0
6287501|NCT00242567|7188378|FG001|Never Received Study Drug|Overall Study||191
6287502|NCT00242567|7188377|FG000|COMPLETED|Overall Study||93
6287503|NCT00242567|7188378|FG001|COMPLETED|Overall Study||123
6287504|NCT00242567|7188377|FG000|NOT COMPLETED|Overall Study||166
6287505|NCT00242567|7188378|FG001|NOT COMPLETED|Overall Study||140
6287506|NCT00242580|7188389|FG000|STARTED|Overall Study||32
6287507|NCT00242580|7188390|FG001|STARTED|Overall Study||41
6287508|NCT00242580|7188391|FG002|STARTED|Overall Study||38
6287509|NCT00242580|7188389|FG000|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
6287510|NCT00242580|7188390|FG001|COMPLETED|Overall Study||29
6287511|NCT00242580|7188391|FG002|COMPLETED|Overall Study||24
6287512|NCT00242580|7188389|FG000|NOT COMPLETED|Overall Study||10
6287513|NCT00242580|7188390|FG001|NOT COMPLETED|Overall Study||12
6287514|NCT00242580|7188391|FG002|NOT COMPLETED|Overall Study||14
6287515|NCT00242619|7188401|FG000|STARTED|Overall Study||8
6287516|NCT00242619|7188402|FG001|STARTED|Overall Study||4
6287517|NCT00242619|7188401|FG000|COMPLETED|Overall Study||8
6287518|NCT00242619|7188402|FG001|COMPLETED|Overall Study||4
6287519|NCT00242619|7188401|FG000|NOT COMPLETED|Overall Study||0
6287520|NCT00242619|7188402|FG001|NOT COMPLETED|Overall Study||0
6287521|NCT00242632|7188412|FG000|STARTED|Overall Study||11
6287522|NCT00242632|7188413|FG001|STARTED|Overall Study||11
6287523|NCT00242632|7188412|FG000|COMPLETED|Overall Study||11
6287524|NCT00242632|7188413|FG001|COMPLETED|Overall Study||11
6287525|NCT00242632|7188412|FG000|NOT COMPLETED|Overall Study||0
6287526|NCT00242632|7188413|FG001|NOT COMPLETED|Overall Study||0
6287527|NCT00242658|7188420|FG000|STARTED|Overall Study||187
6287528|NCT00242658|7188421|FG001|STARTED|Overall Study||207
6287529|NCT00242658|7188420|FG000|COMPLETED|Overall Study||165
6287530|NCT00242658|7188421|FG001|COMPLETED|Overall Study||188
6287531|NCT00242658|7188420|FG000|NOT COMPLETED|Overall Study||22
6287532|NCT00242658|7188421|FG001|NOT COMPLETED|Overall Study||19
6287533|NCT00242684|7188427|FG000|STARTED|Overall Study||446
6287534|NCT00242684|7188427|FG000|COMPLETED|Overall Study||446
6287535|NCT00242684|7188427|FG000|NOT COMPLETED|Overall Study||0
6287536|NCT00242710|7188435|FG000|STARTED|Core Study (up to Year 1)||373
6287537|NCT00242710|7188436|FG001|STARTED|Core Study (up to Year 1)||353
6287538|NCT00242710|7188437|FG002|STARTED|Core Study (up to Year 1)||183
6287539|NCT00242710|7188438|FG003|STARTED|Core Study (up to Year 1)||174
6287540|NCT00242710|7188435|FG000|Treated|Core Study (up to Year 1)||361
6287541|NCT00242710|7188436|FG001|Treated|Core Study (up to Year 1)||349
6287542|NCT00242710|7188437|FG002|Treated|Core Study (up to Year 1)||179
6287543|NCT00242710|7188438|FG003|Treated|Core Study (up to Year 1)||172
6287544|NCT00242710|7188435|FG000|COMPLETED|Core Study (up to Year 1)||287
6287545|NCT00242710|7188436|FG001|COMPLETED|Core Study (up to Year 1)||289
6287546|NCT00242710|7188437|FG002|COMPLETED|Core Study (up to Year 1)||132
6287547|NCT00242710|7188438|FG003|COMPLETED|Core Study (up to Year 1)||143
6287548|NCT00242710|7188435|FG000|NOT COMPLETED|Core Study (up to Year 1)||86
6287549|NCT00242710|7188436|FG001|NOT COMPLETED|Core Study (up to Year 1)||64
6287550|NCT00242710|7188437|FG002|NOT COMPLETED|Core Study (up to Year 1)||51
6287551|NCT00242710|7188438|FG003|NOT COMPLETED|Core Study (up to Year 1)||31
6287552|NCT00242710|7188435|FG000|STARTED|Period Between Core Study and Extension||287
6287553|NCT00242710|7188436|FG001|STARTED|Period Between Core Study and Extension||289
6287554|NCT00242710|7188437|FG002|STARTED|Period Between Core Study and Extension||132
6287555|NCT00242710|7188438|FG003|STARTED|Period Between Core Study and Extension||143
6287556|NCT00242710|7188435|FG000|COMPLETED|Period Between Core Study and Extension||168
6287557|NCT00242710|7188436|FG001|COMPLETED|Period Between Core Study and Extension||177
6287558|NCT00242710|7188437|FG002|COMPLETED|Period Between Core Study and Extension||84
6287559|NCT00242710|7188438|FG003|COMPLETED|Period Between Core Study and Extension||94
6287560|NCT00242710|7188435|FG000|NOT COMPLETED|Period Between Core Study and Extension||119
6287561|NCT00242710|7188436|FG001|NOT COMPLETED|Period Between Core Study and Extension||112
6287562|NCT00242710|7188437|FG002|NOT COMPLETED|Period Between Core Study and Extension||48
6287563|NCT00242710|7188438|FG003|NOT COMPLETED|Period Between Core Study and Extension||49
6287564|NCT00242710|7188435|FG000|STARTED|Study Extension (up to Year 2)||168
6287565|NCT00242710|7188436|FG001|STARTED|Study Extension (up to Year 2)||177
6287566|NCT00242710|7188437|FG002|STARTED|Study Extension (up to Year 2)||84
6287567|NCT00242710|7188438|FG003|STARTED|Study Extension (up to Year 2)||94
6287568|NCT00242710|7188435|FG000|COMPLETED|Study Extension (up to Year 2)||141
6287569|NCT00242710|7188436|FG001|COMPLETED|Study Extension (up to Year 2)||148
6287570|NCT00242710|7188437|FG002|COMPLETED|Study Extension (up to Year 2)||69
6287571|NCT00242710|7188438|FG003|COMPLETED|Study Extension (up to Year 2)||84
6287572|NCT00242710|7188435|FG000|NOT COMPLETED|Study Extension (up to Year 2)||27
6287573|NCT00242710|7188436|FG001|NOT COMPLETED|Study Extension (up to Year 2)||29
6287574|NCT00242710|7188437|FG002|NOT COMPLETED|Study Extension (up to Year 2)||15
6287575|NCT00242710|7188438|FG003|NOT COMPLETED|Study Extension (up to Year 2)||10
6287576|NCT00243022|7188450|FG000|STARTED|Overall Study||7
6287577|NCT00243022|7188451|FG001|STARTED|Overall Study||5
6287578|NCT00243022|7188450|FG000|COMPLETED|Overall Study||5
6287579|NCT00243022|7188451|FG001|COMPLETED|Overall Study||4
6287580|NCT00243022|7188450|FG000|NOT COMPLETED|Overall Study||2
6287581|NCT00243022|7188451|FG001|NOT COMPLETED|Overall Study||1
6287582|NCT00243061|7188458|FG000|STARTED|Overall Study||24
6287583|NCT00243061|7188458|FG000|COMPLETED|Overall Study||24
6634593|NCT02297516|7563352|FG000|STARTED|Single Treatment Phase (6 Months)||32
6634594|NCT02297516|7563353|FG001|STARTED|Single Treatment Phase (6 Months)||33
6287584|NCT00243061|7188458|FG000|NOT COMPLETED|Overall Study||0
6287585|NCT00243074|7188463|FG000|STARTED|Overall Study||54
6287586|NCT00243074|7188463|FG000|COMPLETED|Overall Study||0
6287587|NCT00243074|7188463|FG000|NOT COMPLETED|Overall Study||54
6287588|NCT00243152|7188468|FG000|STARTED|Overall Study||3
6287589|NCT00243152|7188469|FG001|STARTED|Overall Study||3
6634595|NCT02297516|7563352|FG000|COMPLETED|Single Treatment Phase (6 Months)||31
6634596|NCT02297516|7563353|FG001|COMPLETED|Single Treatment Phase (6 Months)||31
6655635|NCT02454153|7585790|FG001|STARTED|Overall Study||92
6287590|NCT00243152|7188468|FG000|Scan 1: Drug or Placebo|Overall Study||3
6287591|NCT00243152|7188469|FG001|Scan 1: Drug or Placebo|Overall Study||3
6287592|NCT00243152|7188468|FG000|Scan 2: Placebo or Drug|Overall Study||3
6287593|NCT00243152|7188469|FG001|Scan 2: Placebo or Drug|Overall Study||3
6287594|NCT00243152|7188468|FG000|COMPLETED|Overall Study||3
6287595|NCT00243152|7188469|FG001|COMPLETED|Overall Study||3
6287596|NCT00243152|7188468|FG000|NOT COMPLETED|Overall Study||0
6287597|NCT00243152|7188469|FG001|NOT COMPLETED|Overall Study||0
6287598|NCT00243191|7188476|FG000|STARTED|Overall Study||18
6287599|NCT00243191|7188476|FG000|COMPLETED|Overall Study||18
6287600|NCT00243191|7188476|FG000|NOT COMPLETED|Overall Study||0
6287601|NCT00243230|7188483|FG000|STARTED|Double-Blind Period||39
6287602|NCT00243230|7188484|FG001|STARTED|Double-Blind Period||40
6287603|NCT00243230|7188485|FG002|STARTED|Double-Blind Period||37
6287604|NCT00243230|7188486|FG003|STARTED|Double-Blind Period||0
6287605|NCT00243230|7188483|FG000|Treated|Double-Blind Period||39
6287606|NCT00243230|7188484|FG001|Treated|Double-Blind Period||40
6287607|NCT00243230|7188485|FG002|Treated|Double-Blind Period||35
6287608|NCT00243230|7188486|FG003|Treated|Double-Blind Period||0
6287609|NCT00243230|7188483|FG000|COMPLETED|Double-Blind Period||33
6287610|NCT00243230|7188484|FG001|COMPLETED|Double-Blind Period||35
6287611|NCT00243230|7188485|FG002|COMPLETED|Double-Blind Period||18
6287612|NCT00243230|7188486|FG003|COMPLETED|Double-Blind Period||0
6287613|NCT00243230|7188483|FG000|NOT COMPLETED|Double-Blind Period||6
6287614|NCT00243230|7188484|FG001|NOT COMPLETED|Double-Blind Period||5
6287615|NCT00243230|7188485|FG002|NOT COMPLETED|Double-Blind Period||19
6287616|NCT00243230|7188486|FG003|NOT COMPLETED|Double-Blind Period||0
6287617|NCT00243230|7188483|FG000|STARTED|Open Label Period||0
6287618|NCT00243230|7188484|FG001|STARTED|Open Label Period||0
6287619|NCT00243230|7188485|FG002|STARTED|Open Label Period||0
6287620|NCT00243230|7188486|FG003|STARTED|Open Label Period||85
6287621|NCT00243230|7188483|FG000|COMPLETED|Open Label Period||0
6287622|NCT00243230|7188484|FG001|COMPLETED|Open Label Period||0
6287623|NCT00243230|7188485|FG002|COMPLETED|Open Label Period||0
6287624|NCT00243230|7188486|FG003|COMPLETED|Open Label Period||0
6287625|NCT00243230|7188483|FG000|NOT COMPLETED|Open Label Period||0
6287626|NCT00243230|7188484|FG001|NOT COMPLETED|Open Label Period||0
6287627|NCT00243230|7188485|FG002|NOT COMPLETED|Open Label Period||0
6287628|NCT00243230|7188486|FG003|NOT COMPLETED|Open Label Period||85
6287629|NCT00243243|7188498|FG000|STARTED|Overall Study||10
6287630|NCT00243243|7188499|FG001|STARTED|Overall Study||10
6287631|NCT00243243|7188498|FG000|COMPLETED|Overall Study||10
6287632|NCT00243243|7188499|FG001|COMPLETED|Overall Study||10
6287633|NCT00243243|7188498|FG000|NOT COMPLETED|Overall Study||0
6287634|NCT00243243|7188499|FG001|NOT COMPLETED|Overall Study||0
6287635|NCT00243269|7188509|FG000|STARTED|Overall Study||31
6287636|NCT00243269|7188510|FG001|STARTED|Overall Study||11
6287637|NCT00243269|7188511|FG002|STARTED|Overall Study||12
6287638|NCT00243269|7188512|FG003|STARTED|Overall Study||29
6287639|NCT00243269|7188509|FG000|COMPLETED|Overall Study||28
6287640|NCT00243269|7188510|FG001|COMPLETED|Overall Study||10
6287641|NCT00243269|7188511|FG002|COMPLETED|Overall Study||11
6287642|NCT00243269|7188512|FG003|COMPLETED|Overall Study||25
6287643|NCT00243269|7188509|FG000|NOT COMPLETED|Overall Study||3
6287644|NCT00243269|7188510|FG001|NOT COMPLETED|Overall Study||1
6287645|NCT00243269|7188511|FG002|NOT COMPLETED|Overall Study||1
6287646|NCT00243269|7188512|FG003|NOT COMPLETED|Overall Study||4
6287647|NCT00243347|7188522|FG000|STARTED|Overall Study|Treated|19
6287648|NCT00243347|7188522|FG000|COMPLETED|Overall Study|Completed study|0
6287649|NCT00243347|7188522|FG000|NOT COMPLETED|Overall Study||19
6287650|NCT00243386|7188526|FG000|STARTED|On-Demand Regimen (Study Part 1)||73
6287651|NCT00243386|7188527|FG001|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6287652|NCT00243386|7188528|FG002|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6287653|NCT00243386|7188526|FG000|COMPLETED|On-Demand Regimen (Study Part 1)||69
6287654|NCT00243386|7188527|FG001|COMPLETED|On-Demand Regimen (Study Part 1)||0
6287655|NCT00243386|7188528|FG002|COMPLETED|On-Demand Regimen (Study Part 1)||0
6287656|NCT00243386|7188526|FG000|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
6287657|NCT00243386|7188527|FG001|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
6287658|NCT00243386|7188528|FG002|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
6287659|NCT00243386|7188526|FG000|STARTED|End of Part 1, But Prior to Prophylaxis||69
6287660|NCT00243386|7188527|FG001|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6287661|NCT00243386|7188528|FG002|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6634597|NCT02297516|7563352|FG000|NOT COMPLETED|Single Treatment Phase (6 Months)||1
6634598|NCT02297516|7563353|FG001|NOT COMPLETED|Single Treatment Phase (6 Months)||2
6634599|NCT02297516|7563352|FG000|STARTED|Combination Treatment Phase (up to 18 m)||31
6634600|NCT02297516|7563353|FG001|STARTED|Combination Treatment Phase (up to 18 m)||31
6287662|NCT00243386|7188526|FG000|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
6287663|NCT00243386|7188527|FG001|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
6287664|NCT00243386|7188528|FG002|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
6287665|NCT00243386|7188526|FG000|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
6287666|NCT00243386|7188527|FG001|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
6287667|NCT00243386|7188528|FG002|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
6287668|NCT00243386|7188526|FG000|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
6287669|NCT00243386|7188527|FG001|STARTED|PK-Driven or Standard Prophylaxis||34
6287670|NCT00243386|7188528|FG002|STARTED|PK-Driven or Standard Prophylaxis||32
6287671|NCT00243386|7188526|FG000|COMPLETED|PK-Driven or Standard Prophylaxis||0
6287672|NCT00243386|7188527|FG001|COMPLETED|PK-Driven or Standard Prophylaxis||31
6287673|NCT00243386|7188528|FG002|COMPLETED|PK-Driven or Standard Prophylaxis||32
6287674|NCT00243386|7188526|FG000|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
6287675|NCT00243386|7188527|FG001|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
6287676|NCT00243386|7188528|FG002|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
6287677|NCT00243412|7188566|FG000|STARTED|Overall Study|Intent to treat|21
6287678|NCT00243412|7188567|FG001|STARTED|Overall Study|Intent to treat|21
6287679|NCT00243412|7188566|FG000|Safety Evaluable|Overall Study||21
6287680|NCT00243412|7188567|FG001|Safety Evaluable|Overall Study||20
6287681|NCT00243412|7188566|FG000|COMPLETED|Overall Study|Completed Week 104|11
6287682|NCT00243412|7188567|FG001|COMPLETED|Overall Study|Completed Week 104|10
6634601|NCT02297516|7563352|FG000|COMPLETED|Combination Treatment Phase (up to 18 m)||31
6655636|NCT02454153|7585789|FG000|COMPLETED|Overall Study||92
6287683|NCT00243412|7188566|FG000|NOT COMPLETED|Overall Study||10
6287684|NCT00243412|7188567|FG001|NOT COMPLETED|Overall Study||11
6287685|NCT00243503|7188573|FG000|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
6287686|NCT00243503|7188573|FG000|COMPLETED|Overall Study||2
6287687|NCT00243503|7188573|FG000|NOT COMPLETED|Overall Study||58
6287688|NCT00243659|7188580|FG000|STARTED|Overall Study||22
6287689|NCT00243659|7188581|FG001|STARTED|Overall Study||8
6287690|NCT00243659|7188580|FG000|COMPLETED|Overall Study||20
6287691|NCT00243659|7188581|FG001|COMPLETED|Overall Study||5
6287692|NCT00243659|7188580|FG000|NOT COMPLETED|Overall Study||2
6287693|NCT00243659|7188581|FG001|NOT COMPLETED|Overall Study||3
6287694|NCT00243841|7188590|FG000|STARTED|Overall Study||3
6287695|NCT00243841|7188591|FG001|STARTED|Overall Study||6
6287696|NCT00243841|7188592|FG002|STARTED|Overall Study||5
6287697|NCT00243841|7188593|FG003|STARTED|Overall Study||3
6287698|NCT00243841|7188594|FG004|STARTED|Overall Study||39
6287699|NCT00243841|7188595|FG005|STARTED|Overall Study||21
6287700|NCT00243841|7188590|FG000|COMPLETED|Overall Study||3
6287701|NCT00243841|7188591|FG001|COMPLETED|Overall Study||6
6287702|NCT00243841|7188592|FG002|COMPLETED|Overall Study||4
6287703|NCT00243841|7188593|FG003|COMPLETED|Overall Study||3
6287704|NCT00243841|7188594|FG004|COMPLETED|Overall Study||39
6287705|NCT00243841|7188595|FG005|COMPLETED|Overall Study||19
6287706|NCT00243841|7188590|FG000|NOT COMPLETED|Overall Study||0
6287707|NCT00243841|7188591|FG001|NOT COMPLETED|Overall Study||0
6287708|NCT00243841|7188592|FG002|NOT COMPLETED|Overall Study||1
6287709|NCT00243841|7188593|FG003|NOT COMPLETED|Overall Study||0
6287710|NCT00243841|7188594|FG004|NOT COMPLETED|Overall Study||0
6287711|NCT00243841|7188595|FG005|NOT COMPLETED|Overall Study||2
6287712|NCT00243919|7188614|FG000|STARTED|Overall Study||139
6287713|NCT00243919|7188615|FG001|STARTED|Overall Study||143
6287714|NCT00243919|7188616|FG002|STARTED|Overall Study||126
6287715|NCT00243919|7188614|FG000|COMPLETED|Overall Study||122
6287716|NCT00243919|7188615|FG001|COMPLETED|Overall Study||125
6287717|NCT00243919|7188616|FG002|COMPLETED|Overall Study||115
6287718|NCT00243919|7188614|FG000|NOT COMPLETED|Overall Study||17
6287719|NCT00243919|7188615|FG001|NOT COMPLETED|Overall Study||18
6287720|NCT00243919|7188616|FG002|NOT COMPLETED|Overall Study||11
6287721|NCT00243932|7188627|FG000|STARTED|Stage 1: Dose Selection||35
6287722|NCT00243932|7188628|FG001|STARTED|Stage 1: Dose Selection||35
6287723|NCT00243932|7188629|FG002|STARTED|Stage 1: Dose Selection||35
6287724|NCT00243932|7188627|FG000|COMPLETED|Stage 1: Dose Selection||33
6287725|NCT00243932|7188628|FG001|COMPLETED|Stage 1: Dose Selection||35
6287726|NCT00243932|7188629|FG002|COMPLETED|Stage 1: Dose Selection||35
6287727|NCT00243932|7188627|FG000|NOT COMPLETED|Stage 1: Dose Selection||2
6287728|NCT00243932|7188628|FG001|NOT COMPLETED|Stage 1: Dose Selection||0
6287729|NCT00243932|7188629|FG002|NOT COMPLETED|Stage 1: Dose Selection||0
6287730|NCT00243932|7188627|FG000|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
6287731|NCT00243932|7188628|FG001|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
6287732|NCT00243932|7188629|FG002|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
6287733|NCT00243932|7188627|FG000|COMPLETED|Stage 2: Efficacy||40
6287734|NCT00243932|7188628|FG001|COMPLETED|Stage 2: Efficacy||40
6287735|NCT00243932|7188629|FG002|COMPLETED|Stage 2: Efficacy||0
6287736|NCT00243932|7188627|FG000|NOT COMPLETED|Stage 2: Efficacy||0
6287737|NCT00243932|7188628|FG001|NOT COMPLETED|Stage 2: Efficacy||0
6287738|NCT00243932|7188629|FG002|NOT COMPLETED|Stage 2: Efficacy||0
6287739|NCT00244101|7188640|FG000|STARTED|Overall Study||209
6287740|NCT00244101|7188641|FG001|STARTED|Overall Study||223
6287741|NCT00244101|7188642|FG002|STARTED|Overall Study||216
6287742|NCT00244101|7188640|FG000|COMPLETED|Overall Study||209
6287743|NCT00244101|7188641|FG001|COMPLETED|Overall Study||223
6287744|NCT00244101|7188642|FG002|COMPLETED|Overall Study||216
6287745|NCT00244101|7188640|FG000|NOT COMPLETED|Overall Study||0
6287746|NCT00244101|7188641|FG001|NOT COMPLETED|Overall Study||0
6287747|NCT00244101|7188642|FG002|NOT COMPLETED|Overall Study||0
6287748|NCT00244140|7188652|FG000|STARTED|Overall Study||412
6287749|NCT00244140|7188653|FG001|STARTED|Overall Study||22
6287750|NCT00244140|7188652|FG000|COMPLETED|Overall Study||412
6287751|NCT00244140|7188653|FG001|COMPLETED|Overall Study||22
6287752|NCT00244140|7188652|FG000|NOT COMPLETED|Overall Study||0
6287753|NCT00244140|7188653|FG001|NOT COMPLETED|Overall Study||0
6287754|NCT00244374|7188659|FG000|STARTED|Pre-Randomization Cross-sectional Study||546
6287755|NCT00244374|7188660|FG001|STARTED|Pre-Randomization Cross-sectional Study||0
6287756|NCT00244374|7188661|FG002|STARTED|Pre-Randomization Cross-sectional Study||0
6287757|NCT00244374|7188662|FG003|STARTED|Pre-Randomization Cross-sectional Study||0
6287758|NCT00244374|7188663|FG004|STARTED|Pre-Randomization Cross-sectional Study||0
6287759|NCT00244374|7188659|FG000|COMPLETED|Pre-Randomization Cross-sectional Study||409
6287760|NCT00244374|7188660|FG001|COMPLETED|Pre-Randomization Cross-sectional Study||0
6287761|NCT00244374|7188661|FG002|COMPLETED|Pre-Randomization Cross-sectional Study||0
6287762|NCT00244374|7188662|FG003|COMPLETED|Pre-Randomization Cross-sectional Study||0
6287763|NCT00244374|7188663|FG004|COMPLETED|Pre-Randomization Cross-sectional Study||0
6287764|NCT00244374|7188659|FG000|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
6287765|NCT00244374|7188660|FG001|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
6287766|NCT00244374|7188661|FG002|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
6287767|NCT00244374|7188662|FG003|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
6287768|NCT00244374|7188663|FG004|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
6287769|NCT00244374|7188659|FG000|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
6287770|NCT00244374|7188660|FG001|STARTED|Evaluation for Vaccine Adherence Cohort||0
6287771|NCT00244374|7188661|FG002|STARTED|Evaluation for Vaccine Adherence Cohort||0
6399352|NCT00880191|7312081|FG000|NOT COMPLETED|Overall Study||13
6399353|NCT00880191|7312082|FG001|NOT COMPLETED|Overall Study||8
6399354|NCT00880230|7312088|FG000|STARTED|Overall Study||141
6287772|NCT00244374|7188662|FG003|STARTED|Evaluation for Vaccine Adherence Cohort||0
6287773|NCT00244374|7188663|FG004|STARTED|Evaluation for Vaccine Adherence Cohort||0
6287774|NCT00244374|7188659|FG000|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
6287775|NCT00244374|7188660|FG001|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
6287776|NCT00244374|7188661|FG002|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
6287777|NCT00244374|7188662|FG003|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
6287778|NCT00244374|7188663|FG004|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
6287779|NCT00244374|7188659|FG000|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
6287780|NCT00244374|7188660|FG001|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6287781|NCT00244374|7188661|FG002|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6287782|NCT00244374|7188662|FG003|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6287783|NCT00244374|7188663|FG004|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6287784|NCT00244374|7188659|FG000|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
6287785|NCT00244374|7188660|FG001|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6287786|NCT00244374|7188661|FG002|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6287787|NCT00244374|7188662|FG003|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6287788|NCT00244374|7188663|FG004|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
6287789|NCT00244374|7188659|FG000|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
6287790|NCT00244374|7188660|FG001|STARTED|Vaccine Adherence Cohort||47
6287791|NCT00244374|7188661|FG002|STARTED|Vaccine Adherence Cohort||43
6287792|NCT00244374|7188662|FG003|STARTED|Vaccine Adherence Cohort||36
6287793|NCT00244374|7188663|FG004|STARTED|Vaccine Adherence Cohort||41
6287794|NCT00244374|7188659|FG000|COMPLETED|Vaccine Adherence Cohort||0
6287795|NCT00244374|7188660|FG001|COMPLETED|Vaccine Adherence Cohort||47
6287796|NCT00244374|7188661|FG002|COMPLETED|Vaccine Adherence Cohort||43
6287797|NCT00244374|7188662|FG003|COMPLETED|Vaccine Adherence Cohort||36
6287798|NCT00244374|7188663|FG004|COMPLETED|Vaccine Adherence Cohort||41
6287799|NCT00244374|7188659|FG000|NOT COMPLETED|Vaccine Adherence Cohort||0
6287800|NCT00244374|7188660|FG001|NOT COMPLETED|Vaccine Adherence Cohort||0
6287801|NCT00244374|7188661|FG002|NOT COMPLETED|Vaccine Adherence Cohort||0
6287802|NCT00244374|7188662|FG003|NOT COMPLETED|Vaccine Adherence Cohort||0
6287803|NCT00244374|7188663|FG004|NOT COMPLETED|Vaccine Adherence Cohort||0
6287804|NCT00244621|7188682|FG000|STARTED|Double-blind Treatment Period||29
6287805|NCT00244621|7188683|FG001|STARTED|Double-blind Treatment Period||32
6287806|NCT00244621|7188684|FG002|STARTED|Double-blind Treatment Period||32
6287807|NCT00244621|7188682|FG000|COMPLETED|Double-blind Treatment Period||27
6287808|NCT00244621|7188683|FG001|COMPLETED|Double-blind Treatment Period||29
6287809|NCT00244621|7188684|FG002|COMPLETED|Double-blind Treatment Period||30
6287810|NCT00244621|7188682|FG000|NOT COMPLETED|Double-blind Treatment Period||2
6287811|NCT00244621|7188683|FG001|NOT COMPLETED|Double-blind Treatment Period||3
6287812|NCT00244621|7188684|FG002|NOT COMPLETED|Double-blind Treatment Period||2
6287813|NCT00244621|7188682|FG000|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
6287814|NCT00244621|7188683|FG001|STARTED|Open-label Treatment Period||29
6287815|NCT00244621|7188684|FG002|STARTED|Open-label Treatment Period||30
6287816|NCT00244621|7188682|FG000|COMPLETED|Open-label Treatment Period||25
6287817|NCT00244621|7188683|FG001|COMPLETED|Open-label Treatment Period||28
6287818|NCT00244621|7188684|FG002|COMPLETED|Open-label Treatment Period||28
6287819|NCT00244621|7188682|FG000|NOT COMPLETED|Open-label Treatment Period||1
6287820|NCT00244621|7188683|FG001|NOT COMPLETED|Open-label Treatment Period||1
6287821|NCT00244621|7188684|FG002|NOT COMPLETED|Open-label Treatment Period||2
6287822|NCT00244712|7188694|FG000|STARTED|Overall Study||343
6287823|NCT00244712|7188695|FG001|STARTED|Overall Study||345
6287824|NCT00244712|7188694|FG000|COMPLETED|Overall Study||234
6287825|NCT00244712|7188695|FG001|COMPLETED|Overall Study||221
6287826|NCT00244712|7188694|FG000|NOT COMPLETED|Overall Study||109
6287827|NCT00244712|7188695|FG001|NOT COMPLETED|Overall Study||124
6287828|NCT00244725|7188705|FG000|STARTED|Overall Study||237
6287829|NCT00244725|7188706|FG001|STARTED|Overall Study||245
6287830|NCT00244725|7188707|FG002|STARTED|Overall Study||239
6287831|NCT00244725|7188708|FG003|STARTED|Overall Study||237
6287832|NCT00244725|7188705|FG000|COMPLETED|Overall Study||214
6287833|NCT00244725|7188706|FG001|COMPLETED|Overall Study||226
6287834|NCT00244725|7188707|FG002|COMPLETED|Overall Study||215
6287835|NCT00244725|7188708|FG003|COMPLETED|Overall Study||216
6287836|NCT00244725|7188705|FG000|NOT COMPLETED|Overall Study||23
6287837|NCT00244725|7188706|FG001|NOT COMPLETED|Overall Study||19
6287838|NCT00244725|7188707|FG002|NOT COMPLETED|Overall Study||24
6287839|NCT00244725|7188708|FG003|NOT COMPLETED|Overall Study||21
6287840|NCT00244751|7188721|FG000|STARTED|Overall Study||88
6287841|NCT00244751|7188722|FG001|STARTED|Overall Study||89
6287842|NCT00244751|7188723|FG002|STARTED|Overall Study||88
6287843|NCT00244751|7188721|FG000|COMPLETED|Overall Study||72
6287844|NCT00244751|7188722|FG001|COMPLETED|Overall Study||74
6287845|NCT00244751|7188723|FG002|COMPLETED|Overall Study||78
6287846|NCT00244751|7188721|FG000|NOT COMPLETED|Overall Study||16
6287847|NCT00244751|7188722|FG001|NOT COMPLETED|Overall Study||15
6287848|NCT00244751|7188723|FG002|NOT COMPLETED|Overall Study||10
6287849|NCT00244764|7188740|FG000|STARTED|Overall Study||225
6287850|NCT00244764|7188740|FG000|COMPLETED|Overall Study||129
6287851|NCT00244764|7188740|FG000|NOT COMPLETED|Overall Study||96
6287852|NCT00244855|7188747|FG000|STARTED|Overall Study||7
6287853|NCT00244855|7188748|FG001|STARTED|Overall Study||25
6287854|NCT00244855|7188747|FG000|COMPLETED|Overall Study||7
6287855|NCT00244855|7188748|FG001|COMPLETED|Overall Study||24
6287856|NCT00244855|7188747|FG000|NOT COMPLETED|Overall Study||0
6287857|NCT00244855|7188748|FG001|NOT COMPLETED|Overall Study||1
6287858|NCT00244881|7188756|FG000|STARTED|Overall Study||26
6287859|NCT00244881|7188756|FG000|COMPLETED|Overall Study||23
6287860|NCT00244881|7188756|FG000|NOT COMPLETED|Overall Study||3
6287861|NCT00244933|7188760|FG000|STARTED|Overall Study||19
6287862|NCT00244933|7188760|FG000|COMPLETED|Overall Study||17
6287863|NCT00244933|7188760|FG000|NOT COMPLETED|Overall Study||2
6287864|NCT00244985|7188764|FG000|STARTED|Overall Study||42
6287865|NCT00244985|7188764|FG000|COMPLETED|Overall Study||42
6287866|NCT00244985|7188764|FG000|NOT COMPLETED|Overall Study||0
6287867|NCT00245011|7188768|FG000|STARTED|Overall Study||11
6287868|NCT00245011|7188768|FG000|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
6287869|NCT00245011|7188768|FG000|NOT COMPLETED|Overall Study||1
6373974|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373975|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373976|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373977|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373978|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373979|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373980|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373981|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373982|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373983|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
6373984|NCT00747474|7284553|FG000|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373985|NCT00747474|7284554|FG001|STARTED|Cohort 12 (60 mg/m^2) Period||0
6510086|NCT01479517|7429640|FG000|COMPLETED|Overall Study||10
6510087|NCT01479517|7429641|FG001|COMPLETED|Overall Study||10
6510088|NCT01479517|7429642|FG002|COMPLETED|Overall Study||10
6510089|NCT01479517|7429640|FG000|NOT COMPLETED|Overall Study||0
6510090|NCT01479517|7429641|FG001|NOT COMPLETED|Overall Study||0
6510091|NCT01479517|7429642|FG002|NOT COMPLETED|Overall Study||0
6634602|NCT02297516|7563353|FG001|COMPLETED|Combination Treatment Phase (up to 18 m)||30
6510092|NCT01479530|7429652|FG000|STARTED|Overall Study||158
6510093|NCT01479530|7429653|FG001|STARTED|Overall Study||163
6510094|NCT01479530|7429652|FG000|COMPLETED|Overall Study||148
6510095|NCT01479530|7429653|FG001|COMPLETED|Overall Study||151
6510096|NCT01479530|7429652|FG000|NOT COMPLETED|Overall Study||10
6510097|NCT01479530|7429653|FG001|NOT COMPLETED|Overall Study||12
6510098|NCT01479543|7429664|FG000|STARTED|Overall Study||21
6510099|NCT01479543|7429665|FG001|STARTED|Overall Study||20
6510100|NCT01479543|7429666|FG002|STARTED|Overall Study||21
6510101|NCT01479543|7429667|FG003|STARTED|Overall Study||20
6510102|NCT01479543|7429668|FG004|STARTED|Overall Study||21
6510103|NCT01479543|7429664|FG000|COMPLETED|Overall Study||20
6510104|NCT01479543|7429665|FG001|COMPLETED|Overall Study||20
6510105|NCT01479543|7429666|FG002|COMPLETED|Overall Study||20
6510106|NCT01479543|7429667|FG003|COMPLETED|Overall Study||20
6373986|NCT00747474|7284555|FG002|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373987|NCT00747474|7284556|FG003|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373988|NCT00747474|7284557|FG004|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373989|NCT00747474|7284558|FG005|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373990|NCT00747474|7284559|FG006|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373991|NCT00747474|7284560|FG007|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373992|NCT00747474|7284561|FG008|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373993|NCT00747474|7284562|FG009|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373994|NCT00747474|7284563|FG010|STARTED|Cohort 12 (60 mg/m^2) Period||0
6373995|NCT00747474|7284564|FG011|STARTED|Cohort 12 (60 mg/m^2) Period||6
6373996|NCT00747474|7284553|FG000|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6373997|NCT00747474|7284554|FG001|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6373998|NCT00747474|7284555|FG002|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6373999|NCT00747474|7284556|FG003|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374000|NCT00747474|7284557|FG004|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374001|NCT00747474|7284558|FG005|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374002|NCT00747474|7284559|FG006|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374003|NCT00747474|7284560|FG007|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374004|NCT00747474|7284561|FG008|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374005|NCT00747474|7284562|FG009|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374006|NCT00747474|7284563|FG010|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374007|NCT00747474|7284564|FG011|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
6374008|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374009|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374010|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374011|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6510107|NCT01479543|7429668|FG004|COMPLETED|Overall Study||20
6287870|NCT00245037|7188772|FG000|STARTED|Overall Study||147
6287871|NCT00245037|7188772|FG000|COMPLETED|Overall Study|17 participants died from infectious complications.|130
6287872|NCT00245037|7188772|FG000|NOT COMPLETED|Overall Study||17
6287873|NCT00245050|7188778|FG000|STARTED|Overall Study||18
6287874|NCT00245050|7188779|FG001|STARTED|Overall Study||16
6287875|NCT00245050|7188778|FG000|COMPLETED|Overall Study||15
6287876|NCT00245050|7188779|FG001|COMPLETED|Overall Study||14
6287877|NCT00245050|7188778|FG000|NOT COMPLETED|Overall Study||3
6287878|NCT00245050|7188779|FG001|NOT COMPLETED|Overall Study||2
6287879|NCT00245063|7188787|FG000|STARTED|Overall Study||12
6287880|NCT00245063|7188788|FG001|STARTED|Overall Study||13
6287881|NCT00245063|7188787|FG000|COMPLETED|Overall Study||5
6287882|NCT00245063|7188788|FG001|COMPLETED|Overall Study||8
6287883|NCT00245063|7188787|FG000|NOT COMPLETED|Overall Study||7
6287884|NCT00245063|7188788|FG001|NOT COMPLETED|Overall Study||5
6287885|NCT00245102|7188800|FG000|STARTED|Overall Study||44
6287886|NCT00245102|7188801|FG001|STARTED|Overall Study||16
6287887|NCT00245102|7188802|FG002|STARTED|Overall Study||46
6287888|NCT00245102|7188803|FG003|STARTED|Overall Study||13
6634603|NCT02297516|7563352|FG000|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||0
6634604|NCT02297516|7563353|FG001|NOT COMPLETED|Combination Treatment Phase (up to 18 m)||1
6634605|NCT02297815|7563368|FG000|STARTED|Overall Study||1604
6634606|NCT02297815|7563369|FG001|STARTED|Overall Study||868
6634607|NCT02297815|7563368|FG000|5-10 Day Interview|Overall Study||1604
6634608|NCT02297815|7563369|FG001|5-10 Day Interview|Overall Study||868
6287889|NCT00245102|7188804|FG004|STARTED|Overall Study||5
6287890|NCT00245102|7188805|FG005|STARTED|Overall Study||23
6287891|NCT00245102|7188800|FG000|COMPLETED|Overall Study||37
6287892|NCT00245102|7188801|FG001|COMPLETED|Overall Study||12
6287893|NCT00245102|7188802|FG002|COMPLETED|Overall Study||39
6287894|NCT00245102|7188803|FG003|COMPLETED|Overall Study||10
6634609|NCT02297815|7563368|FG000|14-20 Day Interview|Overall Study||1368
6634610|NCT02297815|7563369|FG001|14-20 Day Interview|Overall Study||728
6634611|NCT02297815|7563368|FG000|COMPLETED|Overall Study||1368
6634612|NCT02297815|7563369|FG001|COMPLETED|Overall Study||728
6634613|NCT02297815|7563368|FG000|NOT COMPLETED|Overall Study||236
6634614|NCT02297815|7563369|FG001|NOT COMPLETED|Overall Study||140
6634615|NCT02297841|7563377|FG000|STARTED|Overall Study||209
6634616|NCT02297841|7563377|FG000|Induction Phase|Overall Study||209
6634617|NCT02297841|7563377|FG000|Challenge Phase|Overall Study||201
6634618|NCT02297841|7563377|FG000|COMPLETED|Overall Study||201
6634619|NCT02297841|7563377|FG000|NOT COMPLETED|Overall Study||8
6287895|NCT00245102|7188804|FG004|COMPLETED|Overall Study||5
6287896|NCT00245102|7188805|FG005|COMPLETED|Overall Study||19
6287897|NCT00245102|7188800|FG000|NOT COMPLETED|Overall Study||7
6287898|NCT00245102|7188801|FG001|NOT COMPLETED|Overall Study||4
6287899|NCT00245102|7188802|FG002|NOT COMPLETED|Overall Study||7
6287900|NCT00245102|7188803|FG003|NOT COMPLETED|Overall Study||3
6287901|NCT00245102|7188804|FG004|NOT COMPLETED|Overall Study||0
6287902|NCT00245102|7188805|FG005|NOT COMPLETED|Overall Study||4
6287903|NCT00245219|7188822|FG000|STARTED|Overall Study||91
6287904|NCT00245219|7188823|FG001|STARTED|Overall Study||94
6287905|NCT00245219|7188824|FG002|STARTED|Overall Study||60
6287906|NCT00245219|7188822|FG000|COMPLETED|Overall Study||85
6287907|NCT00245219|7188823|FG001|COMPLETED|Overall Study||88
6287908|NCT00245219|7188824|FG002|COMPLETED|Overall Study||58
6287909|NCT00245219|7188822|FG000|NOT COMPLETED|Overall Study||6
6287910|NCT00245219|7188823|FG001|NOT COMPLETED|Overall Study||6
6287911|NCT00245219|7188824|FG002|NOT COMPLETED|Overall Study||2
6287912|NCT00245466|7188835|FG000|STARTED|Overall Study||43
6287913|NCT00245466|7188836|FG001|STARTED|Overall Study||46
6287914|NCT00245466|7188837|FG002|STARTED|Overall Study||40
6287915|NCT00245466|7188835|FG000|Started FE200486 CS02A|Overall Study||32
6287916|NCT00245466|7188836|FG001|Started FE200486 CS02A|Overall Study||30
6287917|NCT00245466|7188837|FG002|Started FE200486 CS02A|Overall Study||26
6287918|NCT00245466|7188835|FG000|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
6287919|NCT00245466|7188836|FG001|COMPLETED|Overall Study||2
6287920|NCT00245466|7188837|FG002|COMPLETED|Overall Study||3
6287921|NCT00245466|7188835|FG000|NOT COMPLETED|Overall Study||36
6287922|NCT00245466|7188836|FG001|NOT COMPLETED|Overall Study||44
6287923|NCT00245466|7188837|FG002|NOT COMPLETED|Overall Study||37
6287924|NCT00245518|7188847|FG000|STARTED|Overall Study||17
6287925|NCT00245518|7188848|FG001|STARTED|Overall Study||16
6287926|NCT00245518|7188847|FG000|COMPLETED|Overall Study||17
6287927|NCT00245518|7188848|FG001|COMPLETED|Overall Study||16
6287928|NCT00245518|7188847|FG000|NOT COMPLETED|Overall Study||0
6634620|NCT02298023|7563384|FG000|STARTED|Overall Study||8
6634621|NCT02298023|7563385|FG001|STARTED|Overall Study||8
6287929|NCT00245518|7188848|FG001|NOT COMPLETED|Overall Study||0
6287930|NCT00245557|7188856|FG000|STARTED|Overall Study||17
6287931|NCT00245557|7188857|FG001|STARTED|Overall Study||26
6287932|NCT00245557|7188856|FG000|COMPLETED|Overall Study||11
6287933|NCT00245557|7188857|FG001|COMPLETED|Overall Study||10
6287934|NCT00245557|7188856|FG000|NOT COMPLETED|Overall Study||6
6287935|NCT00245557|7188857|FG001|NOT COMPLETED|Overall Study||16
6287936|NCT00245583|7188866|FG000|STARTED|Overall Study||20
6287937|NCT00245583|7188867|FG001|STARTED|Overall Study||22
6287938|NCT00245583|7188866|FG000|COMPLETED|Overall Study||14
6287939|NCT00245583|7188867|FG001|COMPLETED|Overall Study||13
6287940|NCT00245583|7188866|FG000|NOT COMPLETED|Overall Study||6
6287941|NCT00245583|7188867|FG001|NOT COMPLETED|Overall Study||9
6287942|NCT00245635|7188875|FG000|STARTED|Overall Study||25
6287943|NCT00245635|7188876|FG001|STARTED|Overall Study||18
6287944|NCT00245635|7188875|FG000|COMPLETED|Overall Study||25
6287945|NCT00245635|7188876|FG001|COMPLETED|Overall Study||18
6287946|NCT00245635|7188875|FG000|NOT COMPLETED|Overall Study||0
6287947|NCT00245635|7188876|FG001|NOT COMPLETED|Overall Study||0
6287948|NCT00245765|7188885|FG000|STARTED|Overall Study||59
6287949|NCT00245765|7188886|FG001|STARTED|Overall Study||59
6287950|NCT00245765|7188887|FG002|STARTED|Overall Study||58
6287951|NCT00245765|7188885|FG000|Safety Population|Overall Study|One subject in the Placebo (PBO) group received one injection of CDP870 200 mg on one occasion.|58
6287952|NCT00245765|7188886|FG001|Safety Population|Overall Study|For safety analysis, the PBO group subj. who received CDP870 was considered to be in the 200mg group|60
6287953|NCT00245765|7188887|FG002|Safety Population|Overall Study|One subject in the 400 mg group was randomized by mistake but did not receive study medication.|57
6287954|NCT00245765|7188885|FG000|COMPLETED|Overall Study||27
6287955|NCT00245765|7188886|FG001|COMPLETED|Overall Study||45
6287956|NCT00245765|7188887|FG002|COMPLETED|Overall Study||50
6287957|NCT00245765|7188885|FG000|NOT COMPLETED|Overall Study||32
6287958|NCT00245765|7188886|FG001|NOT COMPLETED|Overall Study||14
6287959|NCT00245765|7188887|FG002|NOT COMPLETED|Overall Study||8
6287960|NCT00245856|7188895|FG000|STARTED|Period One||28
6287961|NCT00245856|7188896|FG001|STARTED|Period One||0
6287962|NCT00245856|7188895|FG000|COMPLETED|Period One||28
6287963|NCT00245856|7188896|FG001|COMPLETED|Period One||0
6287964|NCT00245856|7188895|FG000|NOT COMPLETED|Period One||0
6287965|NCT00245856|7188896|FG001|NOT COMPLETED|Period One||0
6399355|NCT00880230|7312088|FG000|COMPLETED|Overall Study||134
6399356|NCT00880230|7312088|FG000|NOT COMPLETED|Overall Study||7
6399357|NCT00880256|7312092|FG000|STARTED|Overall Study||93
6399358|NCT00880256|7312092|FG000|COMPLETED|Overall Study||65
6399359|NCT00880256|7312092|FG000|NOT COMPLETED|Overall Study||28
6399360|NCT00880269|7312098|FG000|STARTED|Overall Study||32
6399361|NCT00880269|7312099|FG001|STARTED|Overall Study||27
6399362|NCT00880269|7312098|FG000|Discontinued Treatment|Overall Study||32
6399363|NCT00880269|7312099|FG001|Discontinued Treatment|Overall Study||27
6399364|NCT00880269|7312098|FG000|COMPLETED|Overall Study||0
6399365|NCT00880269|7312099|FG001|COMPLETED|Overall Study||0
6399366|NCT00880269|7312098|FG000|NOT COMPLETED|Overall Study||32
6399367|NCT00880269|7312099|FG001|NOT COMPLETED|Overall Study||27
6399368|NCT00880334|7312107|FG000|STARTED|Randomized Phase||74
6399369|NCT00880334|7312108|FG001|STARTED|Randomized Phase||75
6399370|NCT00880334|7312107|FG000|Eligible & Treated|Randomized Phase||70
6399371|NCT00880334|7312108|FG001|Eligible & Treated|Randomized Phase||72
6399372|NCT00880334|7312107|FG000|COMPLETED|Randomized Phase||70
6399373|NCT00880334|7312108|FG001|COMPLETED|Randomized Phase||35
6399374|NCT00880334|7312107|FG000|NOT COMPLETED|Randomized Phase||4
6399375|NCT00880334|7312108|FG001|NOT COMPLETED|Randomized Phase||40
6399376|NCT00880334|7312107|FG000|STARTED|Crossover Phase||0
6399377|NCT00880334|7312108|FG001|STARTED|Crossover Phase|Only participants randomized to placebo and docetaxel potentially received crossover treatment.|37
6399378|NCT00880334|7312107|FG000|COMPLETED|Crossover Phase||0
6399379|NCT00880334|7312108|FG001|COMPLETED|Crossover Phase||37
6399380|NCT00880334|7312107|FG000|NOT COMPLETED|Crossover Phase||0
6399381|NCT00880334|7312108|FG001|NOT COMPLETED|Crossover Phase||0
6399382|NCT00880360|7312118|FG000|STARTED|Overall Study||19
6399383|NCT00880360|7312118|FG000|COMPLETED|Overall Study||19
6399384|NCT00880360|7312118|FG000|NOT COMPLETED|Overall Study||0
6399385|NCT00880399|7312126|FG000|STARTED|Overall Study||108
6399386|NCT00880399|7312127|FG001|STARTED|Overall Study||113
6399387|NCT00880399|7312128|FG002|STARTED|Overall Study||107
6399388|NCT00880399|7312126|FG000|COMPLETED|Overall Study||77
6399389|NCT00880399|7312127|FG001|COMPLETED|Overall Study||84
6399390|NCT00880399|7312128|FG002|COMPLETED|Overall Study||81
6399391|NCT00880399|7312126|FG000|NOT COMPLETED|Overall Study||31
6399392|NCT00880399|7312127|FG001|NOT COMPLETED|Overall Study||29
6399393|NCT00880399|7312128|FG002|NOT COMPLETED|Overall Study||26
6399394|NCT00880425|7312136|FG000|STARTED|Overall Study||18
6399395|NCT00880425|7312137|FG001|STARTED|Overall Study||27
6399396|NCT00880425|7312136|FG000|COMPLETED|Overall Study||18
6399397|NCT00880425|7312137|FG001|COMPLETED|Overall Study||27
6399398|NCT00880425|7312136|FG000|NOT COMPLETED|Overall Study||0
6399399|NCT00880425|7312137|FG001|NOT COMPLETED|Overall Study||0
6399400|NCT00880464|7312143|FG000|STARTED|Overall Study||7
6399401|NCT00880464|7312143|FG000|COMPLETED|Overall Study||7
6287966|NCT00245856|7188895|FG000|STARTED|Period Two||0
6287967|NCT00245856|7188896|FG001|STARTED|Period Two||39
6287968|NCT00245856|7188895|FG000|COMPLETED|Period Two||0
6287969|NCT00245856|7188896|FG001|COMPLETED|Period Two||38
6287970|NCT00245856|7188895|FG000|NOT COMPLETED|Period Two||0
6287971|NCT00245856|7188896|FG001|NOT COMPLETED|Period Two||1
6287972|NCT00246012|7188912|FG000|STARTED|Overall Study||3
6287973|NCT00246012|7188913|FG001|STARTED|Overall Study||3
6287974|NCT00246012|7188914|FG002|STARTED|Overall Study||3
6287975|NCT00246012|7188915|FG003|STARTED|Overall Study||3
6287976|NCT00246012|7188916|FG004|STARTED|Overall Study||3
6287977|NCT00246012|7188917|FG005|STARTED|Overall Study||32
6287978|NCT00246012|7188918|FG006|STARTED|Overall Study||32
6287979|NCT00246012|7188919|FG007|STARTED|Overall Study||33
6287980|NCT00246012|7188920|FG008|STARTED|Overall Study||32
6287981|NCT00246012|7188912|FG000|Treated|Overall Study||3
6287982|NCT00246012|7188913|FG001|Treated|Overall Study||3
6287983|NCT00246012|7188914|FG002|Treated|Overall Study||3
6287984|NCT00246012|7188915|FG003|Treated|Overall Study||3
6287985|NCT00246012|7188916|FG004|Treated|Overall Study||3
6287986|NCT00246012|7188917|FG005|Treated|Overall Study||31
6287987|NCT00246012|7188918|FG006|Treated|Overall Study||31
6287988|NCT00246012|7188919|FG007|Treated|Overall Study||33
6287989|NCT00246012|7188920|FG008|Treated|Overall Study||32
6287990|NCT00246012|7188912|FG000|COMPLETED|Overall Study||0
6287991|NCT00246012|7188913|FG001|COMPLETED|Overall Study||2
6287992|NCT00246012|7188914|FG002|COMPLETED|Overall Study||1
6287993|NCT00246012|7188915|FG003|COMPLETED|Overall Study||0
6287994|NCT00246012|7188916|FG004|COMPLETED|Overall Study||0
6287995|NCT00246012|7188917|FG005|COMPLETED|Overall Study||4
6287996|NCT00246012|7188918|FG006|COMPLETED|Overall Study||1
6287997|NCT00246012|7188919|FG007|COMPLETED|Overall Study||5
6287998|NCT00246012|7188920|FG008|COMPLETED|Overall Study||4
6287999|NCT00246012|7188912|FG000|NOT COMPLETED|Overall Study||3
6288000|NCT00246012|7188913|FG001|NOT COMPLETED|Overall Study||1
6288001|NCT00246012|7188914|FG002|NOT COMPLETED|Overall Study||2
6288002|NCT00246012|7188915|FG003|NOT COMPLETED|Overall Study||3
6288003|NCT00246012|7188916|FG004|NOT COMPLETED|Overall Study||3
6288004|NCT00246012|7188917|FG005|NOT COMPLETED|Overall Study||28
6288005|NCT00246012|7188918|FG006|NOT COMPLETED|Overall Study||31
6288006|NCT00246012|7188919|FG007|NOT COMPLETED|Overall Study||28
6288007|NCT00246012|7188920|FG008|NOT COMPLETED|Overall Study||28
6288008|NCT00246025|7188946|FG000|STARTED|Overall Study||124
6288009|NCT00246025|7188947|FG001|STARTED|Overall Study||133
6288010|NCT00246025|7188948|FG002|STARTED|Overall Study||126
6288011|NCT00246025|7188949|FG003|STARTED|Overall Study||129
6288012|NCT00246025|7188946|FG000|COMPLETED|Overall Study||114
6288013|NCT00246025|7188947|FG001|COMPLETED|Overall Study||124
6288014|NCT00246025|7188948|FG002|COMPLETED|Overall Study||116
6288015|NCT00246025|7188949|FG003|COMPLETED|Overall Study||116
6288016|NCT00246025|7188946|FG000|NOT COMPLETED|Overall Study||10
6288017|NCT00246025|7188947|FG001|NOT COMPLETED|Overall Study||9
6288018|NCT00246025|7188948|FG002|NOT COMPLETED|Overall Study||10
6288019|NCT00246025|7188949|FG003|NOT COMPLETED|Overall Study||13
6288020|NCT00246090|7188959|FG000|STARTED|Overall Study||298
6288021|NCT00246090|7188959|FG000|COMPLETED|Overall Study||3
6288022|NCT00246090|7188959|FG000|NOT COMPLETED|Overall Study||295
6288023|NCT00246129|7188965|FG000|STARTED|Overall Study||82
6288024|NCT00246129|7188966|FG001|STARTED|Overall Study||41
6288025|NCT00246129|7188965|FG000|COMPLETED|Overall Study||75
6288026|NCT00246129|7188966|FG001|COMPLETED|Overall Study||39
6288027|NCT00246129|7188965|FG000|NOT COMPLETED|Overall Study||7
6288028|NCT00246129|7188966|FG001|NOT COMPLETED|Overall Study||2
6288029|NCT00246259|7188977|FG000|STARTED|Overall Study||44
6288030|NCT00246259|7188978|FG001|STARTED|Overall Study||41
6288031|NCT00246259|7188977|FG000|Eligible for Intent-to-treat (ITT)|Overall Study||42
6288032|NCT00246259|7188978|FG001|Eligible for Intent-to-treat (ITT)|Overall Study||35
6288033|NCT00246259|7188977|FG000|COMPLETED|Overall Study||16
6288034|NCT00246259|7188978|FG001|COMPLETED|Overall Study||15
6288035|NCT00246259|7188977|FG000|NOT COMPLETED|Overall Study||28
6288036|NCT00246259|7188978|FG001|NOT COMPLETED|Overall Study||26
6288037|NCT00246324|7188984|FG000|STARTED|Overall Study||16
6288038|NCT00246324|7188984|FG000|COMPLETED|Overall Study||15
6288039|NCT00246324|7188984|FG000|NOT COMPLETED|Overall Study||1
6288040|NCT00246337|7188997|FG000|STARTED|Overall Study||147
6288041|NCT00246337|7188998|FG001|STARTED|Overall Study||16
6288042|NCT00246337|7188999|FG002|STARTED|Overall Study||18
6288043|NCT00246337|7189000|FG003|STARTED|Overall Study||17
6288044|NCT00246337|7189001|FG004|STARTED|Overall Study||16
6288045|NCT00246337|7189002|FG005|STARTED|Overall Study||54
6288046|NCT00246337|7189003|FG006|STARTED|Overall Study||54
6288047|NCT00246337|7189004|FG007|STARTED|Overall Study||53
6288048|NCT00246337|7189005|FG008|STARTED|Overall Study||45
6288049|NCT00246337|7188997|FG000|Completed Period (Initial Dose)|Overall Study||46
6288050|NCT00246337|7188998|FG001|Completed Period (Initial Dose)|Overall Study||4
6288051|NCT00246337|7188999|FG002|Completed Period (Initial Dose)|Overall Study||9
6288052|NCT00246337|7189000|FG003|Completed Period (Initial Dose)|Overall Study||5
6288053|NCT00246337|7189001|FG004|Completed Period (Initial Dose)|Overall Study||8
6288054|NCT00246337|7189002|FG005|Completed Period (Initial Dose)|Overall Study||29
6288055|NCT00246337|7189003|FG006|Completed Period (Initial Dose)|Overall Study||29
6288056|NCT00246337|7189004|FG007|Completed Period (Initial Dose)|Overall Study||27
6288057|NCT00246337|7189005|FG008|Completed Period (Initial Dose)|Overall Study||19
6288058|NCT00246337|7188997|FG000|Completed Period (Both Doses)|Overall Study||69
6288059|NCT00246337|7188998|FG001|Completed Period (Both Doses)|Overall Study||10
6288060|NCT00246337|7188999|FG002|Completed Period (Both Doses)|Overall Study||6
6634622|NCT02298023|7563386|FG002|STARTED|Overall Study||8
6634623|NCT02298023|7563384|FG000|Intervention|Overall Study|Withdrawal by participant before intervention.|7
6288061|NCT00246337|7189000|FG003|Completed Period (Both Doses)|Overall Study||11
6288062|NCT00246337|7189001|FG004|Completed Period (Both Doses)|Overall Study||4
6288063|NCT00246337|7189002|FG005|Completed Period (Both Doses)|Overall Study||10
6288064|NCT00246337|7189003|FG006|Completed Period (Both Doses)|Overall Study||16
6288065|NCT00246337|7189004|FG007|Completed Period (Both Doses)|Overall Study||13
6288066|NCT00246337|7189005|FG008|Completed Period (Both Doses)|Overall Study||15
6288067|NCT00246337|7188997|FG000|COMPLETED|Overall Study||115
6288068|NCT00246337|7188998|FG001|COMPLETED|Overall Study||14
6288069|NCT00246337|7188999|FG002|COMPLETED|Overall Study||15
6288070|NCT00246337|7189000|FG003|COMPLETED|Overall Study||16
6288071|NCT00246337|7189001|FG004|COMPLETED|Overall Study||12
6288072|NCT00246337|7189002|FG005|COMPLETED|Overall Study||39
6288073|NCT00246337|7189003|FG006|COMPLETED|Overall Study||45
6288074|NCT00246337|7189004|FG007|COMPLETED|Overall Study||40
6288075|NCT00246337|7189005|FG008|COMPLETED|Overall Study||34
6288076|NCT00246337|7188997|FG000|NOT COMPLETED|Overall Study||32
6288077|NCT00246337|7188998|FG001|NOT COMPLETED|Overall Study||2
6288078|NCT00246337|7188999|FG002|NOT COMPLETED|Overall Study||3
6288079|NCT00246337|7189000|FG003|NOT COMPLETED|Overall Study||1
6288080|NCT00246337|7189001|FG004|NOT COMPLETED|Overall Study||4
6288081|NCT00246337|7189002|FG005|NOT COMPLETED|Overall Study||15
6288082|NCT00246337|7189003|FG006|NOT COMPLETED|Overall Study||9
6288083|NCT00246337|7189004|FG007|NOT COMPLETED|Overall Study||13
6288084|NCT00246337|7189005|FG008|NOT COMPLETED|Overall Study||11
6288085|NCT00246376|7189030|FG000|STARTED|Overall Study||41
6288086|NCT00246376|7189031|FG001|STARTED|Overall Study||43
6288087|NCT00246376|7189032|FG002|STARTED|Overall Study||45
6288088|NCT00246376|7189033|FG003|STARTED|Overall Study||47
6288089|NCT00246376|7189034|FG004|STARTED|Overall Study||45
6288090|NCT00246376|7189030|FG000|After Dietary run-in at Two Weeks|Overall Study||30
6288091|NCT00246376|7189031|FG001|After Dietary run-in at Two Weeks|Overall Study||38
6288092|NCT00246376|7189032|FG002|After Dietary run-in at Two Weeks|Overall Study||41
6288093|NCT00246376|7189033|FG003|After Dietary run-in at Two Weeks|Overall Study||40
6288094|NCT00246376|7189034|FG004|After Dietary run-in at Two Weeks|Overall Study||42
6288095|NCT00246376|7189030|FG000|COMPLETED|Overall Study||26
6288096|NCT00246376|7189031|FG001|COMPLETED|Overall Study||24
6288097|NCT00246376|7189032|FG002|COMPLETED|Overall Study||29
6288098|NCT00246376|7189033|FG003|COMPLETED|Overall Study||21
6288099|NCT00246376|7189034|FG004|COMPLETED|Overall Study||28
6288100|NCT00246376|7189030|FG000|NOT COMPLETED|Overall Study||15
6288101|NCT00246376|7189031|FG001|NOT COMPLETED|Overall Study||19
6288102|NCT00246376|7189032|FG002|NOT COMPLETED|Overall Study||16
6288103|NCT00246376|7189033|FG003|NOT COMPLETED|Overall Study||26
6288104|NCT00246376|7189034|FG004|NOT COMPLETED|Overall Study||17
6288105|NCT00246441|7189054|FG000|STARTED|Overall Study||20
6288106|NCT00246441|7189055|FG001|STARTED|Overall Study||22
6288107|NCT00246441|7189054|FG000|COMPLETED|Overall Study||19
6288108|NCT00246441|7189055|FG001|COMPLETED|Overall Study||22
6288109|NCT00246441|7189054|FG000|NOT COMPLETED|Overall Study||1
6288110|NCT00246441|7189055|FG001|NOT COMPLETED|Overall Study||0
6288111|NCT00246519|7189063|FG000|STARTED|Overall Study||442
6288112|NCT00246519|7189064|FG001|STARTED|Overall Study||446
6288113|NCT00246519|7189063|FG000|COMPLETED|Overall Study||386
6288114|NCT00246519|7189064|FG001|COMPLETED|Overall Study||382
6288115|NCT00246519|7189063|FG000|NOT COMPLETED|Overall Study||56
6288116|NCT00246519|7189064|FG001|NOT COMPLETED|Overall Study||64
6288117|NCT00246571|7189072|FG000|STARTED|Overall Study||113
6288118|NCT00246571|7189073|FG001|STARTED|Overall Study||104
6288119|NCT00246571|7189072|FG000|Randomized But Not Treated|Overall Study||3
6288120|NCT00246571|7189073|FG001|Randomized But Not Treated|Overall Study||1
6288121|NCT00246571|7189072|FG000|COMPLETED|Overall Study||0
6288122|NCT00246571|7189073|FG001|COMPLETED|Overall Study||0
6288123|NCT00246571|7189072|FG000|NOT COMPLETED|Overall Study||113
6288124|NCT00246571|7189073|FG001|NOT COMPLETED|Overall Study||104
6288125|NCT00246740|7189081|FG000|STARTED|Initial Enrollment||28
6288126|NCT00246740|7189082|FG001|STARTED|Initial Enrollment||28
6288127|NCT00246740|7189081|FG000|COMPLETED|Initial Enrollment||22
6288128|NCT00246740|7189082|FG001|COMPLETED|Initial Enrollment||20
6288129|NCT00246740|7189081|FG000|NOT COMPLETED|Initial Enrollment||6
6288130|NCT00246740|7189082|FG001|NOT COMPLETED|Initial Enrollment||8
6288131|NCT00246740|7189081|FG000|STARTED|Experimental Phase||22
6288132|NCT00246740|7189082|FG001|STARTED|Experimental Phase||20
6288133|NCT00246740|7189081|FG000|COMPLETED|Experimental Phase||22
6288134|NCT00246740|7189082|FG001|COMPLETED|Experimental Phase||20
6288135|NCT00246740|7189081|FG000|NOT COMPLETED|Experimental Phase||0
6634624|NCT02298023|7563385|FG001|Intervention|Overall Study||8
6634625|NCT02298023|7563386|FG002|Intervention|Overall Study||8
6288136|NCT00246740|7189082|FG001|NOT COMPLETED|Experimental Phase||0
6288137|NCT00246753|7189088|FG000|STARTED|Overall Study||29
6288138|NCT00246753|7189088|FG000|COMPLETED|Overall Study||21
6288139|NCT00246753|7189088|FG000|NOT COMPLETED|Overall Study||8
6288140|NCT00246805|7189094|FG000|STARTED|Phase 1||34
6288141|NCT00246805|7189095|FG001|STARTED|Phase 1||33
6288142|NCT00246805|7189094|FG000|COMPLETED|Phase 1||33
6288143|NCT00246805|7189095|FG001|COMPLETED|Phase 1||33
6288144|NCT00246805|7189094|FG000|NOT COMPLETED|Phase 1||1
6288145|NCT00246805|7189095|FG001|NOT COMPLETED|Phase 1||0
6288146|NCT00246805|7189094|FG000|STARTED|Phase 2||33
6288147|NCT00246805|7189095|FG001|STARTED|Phase 2||33
6288148|NCT00246805|7189094|FG000|COMPLETED|Phase 2||33
6288149|NCT00246805|7189095|FG001|COMPLETED|Phase 2||33
6288150|NCT00246805|7189094|FG000|NOT COMPLETED|Phase 2||0
6288151|NCT00246805|7189095|FG001|NOT COMPLETED|Phase 2||0
6288152|NCT00247273|7189103|FG000|STARTED|Overall Study||644
6288153|NCT00247273|7189104|FG001|STARTED|Overall Study||650
6288154|NCT00247273|7189103|FG000|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
6288155|NCT00247273|7189104|FG001|Intent to Treat Population|Overall Study||650
6288156|NCT00247273|7189103|FG000|COMPLETED|Overall Study||498
6288157|NCT00247273|7189104|FG001|COMPLETED|Overall Study||513
6288158|NCT00247273|7189103|FG000|NOT COMPLETED|Overall Study||146
6288159|NCT00247273|7189104|FG001|NOT COMPLETED|Overall Study||137
6288160|NCT00247377|7189112|FG000|STARTED|Overall Study||111
6288161|NCT00247377|7189113|FG001|STARTED|Overall Study||86
6288162|NCT00247377|7189112|FG000|COMPLETED|Overall Study||111
6288163|NCT00247377|7189113|FG001|COMPLETED|Overall Study||86
6288164|NCT00247377|7189112|FG000|NOT COMPLETED|Overall Study||0
6288165|NCT00247377|7189113|FG001|NOT COMPLETED|Overall Study||0
6288166|NCT00247416|7189121|FG000|STARTED|Overall Study||26
6288167|NCT00247416|7189122|FG001|STARTED|Overall Study||33
6288168|NCT00247416|7189121|FG000|COMPLETED|Overall Study||25
6288169|NCT00247416|7189122|FG001|COMPLETED|Overall Study||31
6288170|NCT00247416|7189121|FG000|NOT COMPLETED|Overall Study||1
6288171|NCT00247416|7189122|FG001|NOT COMPLETED|Overall Study||2
6288172|NCT00247611|7189132|FG000|STARTED|Baselined|Participants randomized|304
6288173|NCT00247611|7189133|FG001|STARTED|Baselined|Participants randomized|290
6288174|NCT00247611|7189132|FG000|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
6288175|NCT00247611|7189133|FG001|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
6288176|NCT00247611|7189132|FG000|NOT COMPLETED|Baselined||17
6288177|NCT00247611|7189133|FG001|NOT COMPLETED|Baselined||13
6288178|NCT00247611|7189132|FG000|STARTED|Intention to Treat Sample|Participants randomized|304
6288179|NCT00247611|7189133|FG001|STARTED|Intention to Treat Sample|Participants randomized|290
6288180|NCT00247611|7189132|FG000|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
6288181|NCT00247611|7189133|FG001|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
6288182|NCT00247611|7189132|FG000|NOT COMPLETED|Intention to Treat Sample||17
6288183|NCT00247611|7189133|FG001|NOT COMPLETED|Intention to Treat Sample||13
6288184|NCT00247611|7189132|FG000|STARTED|On Protocol Sample|ITT sample participants|287
6288185|NCT00247611|7189133|FG001|STARTED|On Protocol Sample|ITT sample participants|277
6288186|NCT00247611|7189132|FG000|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
6288187|NCT00247611|7189133|FG001|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
6288188|NCT00247611|7189132|FG000|NOT COMPLETED|On Protocol Sample||111
6288189|NCT00247611|7189133|FG001|NOT COMPLETED|On Protocol Sample||125
6288190|NCT00247624|7189147|FG000|STARTED|Overall Study||30
6288191|NCT00247624|7189148|FG001|STARTED|Overall Study||30
6288192|NCT00247624|7189147|FG000|COMPLETED|Overall Study||25
6288193|NCT00247624|7189148|FG001|COMPLETED|Overall Study||26
6288194|NCT00247624|7189147|FG000|NOT COMPLETED|Overall Study||5
6288195|NCT00247624|7189148|FG001|NOT COMPLETED|Overall Study||4
6288196|NCT00247676|7189154|FG000|STARTED|Overall Study||37
6288197|NCT00247676|7189154|FG000|COMPLETED|Overall Study||1
6288198|NCT00247676|7189154|FG000|NOT COMPLETED|Overall Study||36
6288199|NCT00247728|7189161|FG000|STARTED|Overall Study||58
6288200|NCT00247728|7189162|FG001|STARTED|Overall Study||57
6288201|NCT00247728|7189163|FG002|STARTED|Overall Study||57
6288202|NCT00247728|7189161|FG000|COMPLETED|Overall Study||55
6288203|NCT00247728|7189162|FG001|COMPLETED|Overall Study||51
6288204|NCT00247728|7189163|FG002|COMPLETED|Overall Study||43
6288205|NCT00247728|7189161|FG000|NOT COMPLETED|Overall Study||3
6288206|NCT00247728|7189162|FG001|NOT COMPLETED|Overall Study||6
6288207|NCT00247728|7189163|FG002|NOT COMPLETED|Overall Study||14
6288208|NCT00247962|7189175|FG000|STARTED|Overall Study||379
6288209|NCT00247962|7189176|FG001|STARTED|Overall Study||187
6288210|NCT00247962|7189175|FG000|COMPLETED|Overall Study||353
6288211|NCT00247962|7189176|FG001|COMPLETED|Overall Study||168
6288212|NCT00247962|7189175|FG000|NOT COMPLETED|Overall Study||26
6288213|NCT00247962|7189176|FG001|NOT COMPLETED|Overall Study||19
6288214|NCT00248040|7189185|FG000|STARTED|Overall Study||25
6288215|NCT00248040|7189186|FG001|STARTED|Overall Study||23
6288216|NCT00248040|7189187|FG002|STARTED|Overall Study||26
6288217|NCT00248040|7189185|FG000|COMPLETED|Overall Study||22
6288218|NCT00248040|7189186|FG001|COMPLETED|Overall Study||22
6288219|NCT00248040|7189187|FG002|COMPLETED|Overall Study||22
6288220|NCT00248040|7189185|FG000|NOT COMPLETED|Overall Study||3
6288221|NCT00248040|7189186|FG001|NOT COMPLETED|Overall Study||1
6288222|NCT00248040|7189187|FG002|NOT COMPLETED|Overall Study||4
6288223|NCT00248170|7189198|FG000|STARTED|Overall Study||2078
6288224|NCT00248170|7189199|FG001|STARTED|Overall Study||2094
6288225|NCT00248170|7189198|FG000|Intent-to-treat (ITT)|Overall Study||2061
6288226|NCT00248170|7189199|FG001|Intent-to-treat (ITT)|Overall Study||2075
6288227|NCT00248170|7189198|FG000|Safety Set|Overall Study||2049
6288228|NCT00248170|7189199|FG001|Safety Set|Overall Study||2062
6288229|NCT00248170|7189198|FG000|COMPLETED|Overall Study||1317
6288230|NCT00248170|7189199|FG001|COMPLETED|Overall Study||1286
6288231|NCT00248170|7189198|FG000|NOT COMPLETED|Overall Study||761
6288232|NCT00248170|7189199|FG001|NOT COMPLETED|Overall Study||808
6288233|NCT00248495|7189205|FG000|STARTED|Overall Study||38
6288234|NCT00248495|7189205|FG000|COMPLETED|Overall Study||37
6288235|NCT00248495|7189205|FG000|NOT COMPLETED|Overall Study||1
6288236|NCT00248534|7189209|FG000|STARTED|Overall Study||16
6288237|NCT00248534|7189209|FG000|COMPLETED|Overall Study||16
6288238|NCT00248534|7189209|FG000|NOT COMPLETED|Overall Study||0
6288239|NCT00248547|7189215|FG000|STARTED|Overall Study||20
6288240|NCT00248547|7189216|FG001|STARTED|Overall Study||20
6288241|NCT00248547|7189215|FG000|COMPLETED|Overall Study||20
6288242|NCT00248547|7189216|FG001|COMPLETED|Overall Study||20
6288243|NCT00248547|7189215|FG000|NOT COMPLETED|Overall Study||0
6288244|NCT00248547|7189216|FG001|NOT COMPLETED|Overall Study||0
6288245|NCT00248560|7189222|FG000|STARTED|Overall Study||36
6288246|NCT00248560|7189222|FG000|COMPLETED|Overall Study||36
6288247|NCT00248560|7189222|FG000|NOT COMPLETED|Overall Study||0
6288248|NCT00248612|7189231|FG000|STARTED|Overall Study||24
6288249|NCT00248612|7189232|FG001|STARTED|Overall Study||21
6288250|NCT00248612|7189233|FG002|STARTED|Overall Study||14
6288251|NCT00248612|7189234|FG003|STARTED|Overall Study||22
6288252|NCT00248612|7189231|FG000|COMPLETED|Overall Study||24
6288253|NCT00248612|7189232|FG001|COMPLETED|Overall Study||21
6288254|NCT00248612|7189233|FG002|COMPLETED|Overall Study||14
6288255|NCT00248612|7189234|FG003|COMPLETED|Overall Study||22
6288256|NCT00248612|7189231|FG000|NOT COMPLETED|Overall Study||0
6288257|NCT00248612|7189232|FG001|NOT COMPLETED|Overall Study||0
6288258|NCT00248612|7189233|FG002|NOT COMPLETED|Overall Study||0
6288259|NCT00248612|7189234|FG003|NOT COMPLETED|Overall Study||0
6288260|NCT00248625|7189248|FG000|STARTED|Overall Study||92
6288261|NCT00248625|7189249|FG001|STARTED|Overall Study||92
6288262|NCT00248625|7189248|FG000|COMPLETED|Overall Study||92
6288263|NCT00248625|7189249|FG001|COMPLETED|Overall Study||90
6288264|NCT00248625|7189248|FG000|NOT COMPLETED|Overall Study||0
6288265|NCT00248625|7189249|FG001|NOT COMPLETED|Overall Study||2
6288266|NCT00248638|7189257|FG000|STARTED|Overall Study||75
6288267|NCT00248638|7189258|FG001|STARTED|Overall Study||75
6288268|NCT00248638|7189257|FG000|COMPLETED|Overall Study||75
6288269|NCT00248638|7189258|FG001|COMPLETED|Overall Study||75
6288270|NCT00248638|7189257|FG000|NOT COMPLETED|Overall Study||0
6288271|NCT00248638|7189258|FG001|NOT COMPLETED|Overall Study||0
6288272|NCT00248651|7189269|FG000|STARTED|Overall Study||97
6288273|NCT00248651|7189270|FG001|STARTED|Overall Study||98
6288274|NCT00248651|7189271|FG002|STARTED|Overall Study||97
6288275|NCT00248651|7189269|FG000|Completed 12 Weeks of Treatment|Overall Study||78
6288276|NCT00248651|7189270|FG001|Completed 12 Weeks of Treatment|Overall Study||66
6288277|NCT00248651|7189271|FG002|Completed 12 Weeks of Treatment|Overall Study||75
6288278|NCT00248651|7189269|FG000|COMPLETED|Overall Study||69
6399402|NCT00880464|7312143|FG000|NOT COMPLETED|Overall Study||0
6399403|NCT00880555|7312150|FG000|STARTED|Overall Study||23
6399404|NCT00880555|7312151|FG001|STARTED|Overall Study||40
6399405|NCT00880555|7312152|FG002|STARTED|Overall Study||11
6399406|NCT00880555|7312153|FG003|STARTED|Overall Study||2
6399407|NCT00880555|7312154|FG004|STARTED|Overall Study||1
6399408|NCT00880555|7312155|FG005|STARTED|Overall Study||1
6399409|NCT00880555|7312150|FG000|COMPLETED|Overall Study||13
6399410|NCT00880555|7312151|FG001|COMPLETED|Overall Study||23
6399411|NCT00880555|7312152|FG002|COMPLETED|Overall Study||6
6399412|NCT00880555|7312153|FG003|COMPLETED|Overall Study||0
6399413|NCT00880555|7312154|FG004|COMPLETED|Overall Study||0
6399414|NCT00880555|7312155|FG005|COMPLETED|Overall Study||0
6399415|NCT00880555|7312150|FG000|NOT COMPLETED|Overall Study||10
6399416|NCT00880555|7312151|FG001|NOT COMPLETED|Overall Study||17
6399417|NCT00880555|7312152|FG002|NOT COMPLETED|Overall Study||5
6399418|NCT00880555|7312153|FG003|NOT COMPLETED|Overall Study||2
6399419|NCT00880555|7312154|FG004|NOT COMPLETED|Overall Study||1
6399420|NCT00880555|7312155|FG005|NOT COMPLETED|Overall Study||1
6399421|NCT00880568|7312175|FG000|STARTED|Overall Study||3
6399422|NCT00880568|7312176|FG001|STARTED|Overall Study||3
6399423|NCT00880568|7312177|FG002|STARTED|Overall Study||3
6399424|NCT00880568|7312178|FG003|STARTED|Overall Study||1
6399425|NCT00880568|7312179|FG004|STARTED|Overall Study||3
6399426|NCT00880568|7312180|FG005|STARTED|Overall Study||3
6399427|NCT00880568|7312181|FG006|STARTED|Overall Study||6
6399428|NCT00880568|7312182|FG007|STARTED|Overall Study||2
6399429|NCT00880568|7312183|FG008|STARTED|Overall Study||3
6399430|NCT00880568|7312175|FG000|COMPLETED|Overall Study||0
6399431|NCT00880568|7312176|FG001|COMPLETED|Overall Study||0
6399432|NCT00880568|7312177|FG002|COMPLETED|Overall Study||0
6288279|NCT00248651|7189270|FG001|COMPLETED|Overall Study||58
6288280|NCT00248651|7189271|FG002|COMPLETED|Overall Study||65
6288281|NCT00248651|7189269|FG000|NOT COMPLETED|Overall Study||28
6399433|NCT00880568|7312178|FG003|COMPLETED|Overall Study||0
6399434|NCT00880568|7312179|FG004|COMPLETED|Overall Study||0
6399435|NCT00880568|7312180|FG005|COMPLETED|Overall Study||0
6399436|NCT00880568|7312181|FG006|COMPLETED|Overall Study||0
6399437|NCT00880568|7312182|FG007|COMPLETED|Overall Study||0
6399438|NCT00880568|7312183|FG008|COMPLETED|Overall Study||0
6288282|NCT00248651|7189270|FG001|NOT COMPLETED|Overall Study||40
6288283|NCT00248651|7189271|FG002|NOT COMPLETED|Overall Study||32
6288284|NCT00248781|7189281|FG000|STARTED|Overall Study||52
6288285|NCT00248781|7189282|FG001|STARTED|Overall Study||51
6288286|NCT00248781|7189281|FG000|COMPLETED|Overall Study||42
6288287|NCT00248781|7189282|FG001|COMPLETED|Overall Study||47
6288288|NCT00248781|7189281|FG000|NOT COMPLETED|Overall Study||10
6288289|NCT00248781|7189282|FG001|NOT COMPLETED|Overall Study||4
6288290|NCT00248794|7189291|FG000|STARTED|Overall Study||25
6288291|NCT00248794|7189292|FG001|STARTED|Overall Study||24
6288292|NCT00248794|7189293|FG002|STARTED|Overall Study||10
6288293|NCT00248794|7189291|FG000|COMPLETED|Overall Study||19
6288294|NCT00248794|7189292|FG001|COMPLETED|Overall Study||16
6288295|NCT00248794|7189293|FG002|COMPLETED|Overall Study||7
6288296|NCT00248794|7189291|FG000|NOT COMPLETED|Overall Study||6
6288297|NCT00248794|7189292|FG001|NOT COMPLETED|Overall Study||8
6288298|NCT00248794|7189293|FG002|NOT COMPLETED|Overall Study||3
6288299|NCT00248807|7189309|FG000|STARTED|Overall Study||19
6288300|NCT00248807|7189310|FG001|STARTED|Overall Study||11
6288301|NCT00248807|7189309|FG000|COMPLETED|Overall Study||19
6288302|NCT00248807|7189310|FG001|COMPLETED|Overall Study||11
6288303|NCT00248807|7189309|FG000|NOT COMPLETED|Overall Study||0
6288304|NCT00248807|7189310|FG001|NOT COMPLETED|Overall Study||0
6288305|NCT00248833|7189325|FG000|STARTED|Overall Study||12
6288306|NCT00248833|7189326|FG001|STARTED|Overall Study||11
6288307|NCT00248833|7189327|FG002|STARTED|Overall Study||11
6288308|NCT00248833|7189325|FG000|COMPLETED|Overall Study||9
6288309|NCT00248833|7189326|FG001|COMPLETED|Overall Study||8
6288310|NCT00248833|7189327|FG002|COMPLETED|Overall Study||9
6288311|NCT00248833|7189325|FG000|NOT COMPLETED|Overall Study||3
6288312|NCT00248833|7189326|FG001|NOT COMPLETED|Overall Study||3
6288313|NCT00248833|7189327|FG002|NOT COMPLETED|Overall Study||2
6288314|NCT00249002|7189337|FG000|STARTED|Overall Study||9
6288315|NCT00249002|7189337|FG000|COMPLETED|Overall Study||2
6288316|NCT00249002|7189337|FG000|NOT COMPLETED|Overall Study||7
6288317|NCT00249249|7189345|FG000|STARTED|Overall Study||321
6288318|NCT00249249|7189346|FG001|STARTED|Overall Study||103
6288319|NCT00249249|7189347|FG002|STARTED|Overall Study||303
6288320|NCT00249249|7189348|FG003|STARTED|Overall Study||103
6288321|NCT00249249|7189345|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
6288322|NCT00249249|7189346|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
6288323|NCT00249249|7189347|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
6288324|NCT00249249|7189348|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
6288325|NCT00249249|7189345|FG000|COMPLETED|Overall Study||301
6288326|NCT00249249|7189346|FG001|COMPLETED|Overall Study||98
6288327|NCT00249249|7189347|FG002|COMPLETED|Overall Study||288
6288328|NCT00249249|7189348|FG003|COMPLETED|Overall Study||100
6288329|NCT00249249|7189345|FG000|NOT COMPLETED|Overall Study||20
6288330|NCT00249249|7189346|FG001|NOT COMPLETED|Overall Study||5
6288331|NCT00249249|7189347|FG002|NOT COMPLETED|Overall Study||15
6288332|NCT00249249|7189348|FG003|NOT COMPLETED|Overall Study||3
6288333|NCT00249288|7189360|FG000|STARTED|Overall Study||19
6288334|NCT00249288|7189361|FG001|STARTED|Overall Study||19
6288335|NCT00249288|7189360|FG000|Initiated Treatment|Overall Study||17
6288336|NCT00249288|7189361|FG001|Initiated Treatment|Overall Study||15
6288337|NCT00249288|7189360|FG000|COMPLETED|Overall Study||14
6288338|NCT00249288|7189361|FG001|COMPLETED|Overall Study||14
6288339|NCT00249288|7189360|FG000|NOT COMPLETED|Overall Study||5
6288340|NCT00249288|7189361|FG001|NOT COMPLETED|Overall Study||5
6288341|NCT00249379|7189377|FG000|STARTED|Overall Study||14
6288342|NCT00249379|7189378|FG001|STARTED|Overall Study||12
6288343|NCT00249379|7189377|FG000|COMPLETED|Overall Study||6
6288344|NCT00249379|7189378|FG001|COMPLETED|Overall Study||4
6288345|NCT00249379|7189377|FG000|NOT COMPLETED|Overall Study||8
6288346|NCT00249379|7189378|FG001|NOT COMPLETED|Overall Study||8
6288347|NCT00249444|7189386|FG000|STARTED|Overall Study||42
6288348|NCT00249444|7189387|FG001|STARTED|Overall Study||44
6288349|NCT00249444|7189386|FG000|COMPLETED|Overall Study||30
6288350|NCT00249444|7189387|FG001|COMPLETED|Overall Study||29
6288351|NCT00249444|7189386|FG000|NOT COMPLETED|Overall Study||12
6288352|NCT00249444|7189387|FG001|NOT COMPLETED|Overall Study||15
6634626|NCT02298023|7563384|FG000|COMPLETED|Overall Study||7
6634627|NCT02298023|7563385|FG001|COMPLETED|Overall Study||8
6634628|NCT02298023|7563386|FG002|COMPLETED|Overall Study||8
6634629|NCT02298023|7563384|FG000|NOT COMPLETED|Overall Study||1
6634630|NCT02298023|7563385|FG001|NOT COMPLETED|Overall Study||0
6288353|NCT00249470|7189395|FG000|STARTED|Overall Study||28
6288354|NCT00249470|7189396|FG001|STARTED|Overall Study||28
6288355|NCT00249470|7189395|FG000|COMPLETED|Overall Study||28
6288356|NCT00249470|7189396|FG001|COMPLETED|Overall Study||28
6288357|NCT00249470|7189395|FG000|NOT COMPLETED|Overall Study||0
6634631|NCT02298023|7563386|FG002|NOT COMPLETED|Overall Study||0
6288358|NCT00249470|7189396|FG001|NOT COMPLETED|Overall Study||0
6288359|NCT00249496|7189404|FG000|STARTED|Overall Study||24
6288360|NCT00249496|7189405|FG001|STARTED|Overall Study||27
6288361|NCT00249496|7189404|FG000|COMPLETED|Overall Study||24
6288362|NCT00249496|7189405|FG001|COMPLETED|Overall Study||26
6288363|NCT00249496|7189404|FG000|NOT COMPLETED|Overall Study||0
6634632|NCT02298179|7563409|FG000|STARTED|Overall Study||24
6634633|NCT02298179|7563410|FG001|STARTED|Overall Study||24
6288364|NCT00249496|7189405|FG001|NOT COMPLETED|Overall Study||1
6634634|NCT02298179|7563411|FG002|STARTED|Overall Study||24
6634635|NCT02298179|7563412|FG003|STARTED|Overall Study||24
6634636|NCT02298179|7563413|FG004|STARTED|Overall Study||24
6634637|NCT02298179|7563414|FG005|STARTED|Overall Study||24
6634638|NCT02298179|7563415|FG006|STARTED|Overall Study||24
6634639|NCT02298179|7563416|FG007|STARTED|Overall Study||24
6634640|NCT02298179|7563417|FG008|STARTED|Overall Study||24
6634641|NCT02298179|7563418|FG009|STARTED|Overall Study||24
6634642|NCT02298179|7563419|FG010|STARTED|Overall Study||24
6743337|NCT03334422|7671644|FG002|STARTED|Overall Study||123
6743338|NCT03334422|7671645|FG003|STARTED|Overall Study||123
6743339|NCT03334422|7671642|FG000|Received at Least One Dose of Study Drug|Overall Study||244
6743340|NCT03334422|7671643|FG001|Received at Least One Dose of Study Drug|Overall Study||124
6743341|NCT03334422|7671644|FG002|Received at Least One Dose of Study Drug|Overall Study||123
6743342|NCT03334422|7671645|FG003|Received at Least One Dose of Study Drug|Overall Study||123
6288365|NCT00249613|7189415|FG000|STARTED|Baseline||152
6288366|NCT00249613|7189416|FG001|STARTED|Baseline||139
6288367|NCT00249613|7189415|FG000|COMPLETED|Baseline||152
6288368|NCT00249613|7189416|FG001|COMPLETED|Baseline||139
6288369|NCT00249613|7189415|FG000|NOT COMPLETED|Baseline||0
6288370|NCT00249613|7189416|FG001|NOT COMPLETED|Baseline||0
6288371|NCT00249613|7189415|FG000|STARTED|12 Month Follow-up||152
6288372|NCT00249613|7189416|FG001|STARTED|12 Month Follow-up||139
6288373|NCT00249613|7189415|FG000|COMPLETED|12 Month Follow-up||135
6288374|NCT00249613|7189416|FG001|COMPLETED|12 Month Follow-up||124
6288375|NCT00249613|7189415|FG000|NOT COMPLETED|12 Month Follow-up||17
6288376|NCT00249613|7189416|FG001|NOT COMPLETED|12 Month Follow-up||15
6288377|NCT00249769|7189428|FG000|STARTED|Overall Study||100
6288378|NCT00249769|7189429|FG001|STARTED|Overall Study||250
6288379|NCT00249769|7189430|FG002|STARTED|Overall Study||250
6288380|NCT00249769|7189428|FG000|Received LJEV|Overall Study||100
6288381|NCT00249769|7189429|FG001|Received LJEV|Overall Study||236
6288382|NCT00249769|7189430|FG002|Received LJEV|Overall Study||224
6288383|NCT00249769|7189428|FG000|Received Measles Vaccine|Overall Study||97
6288384|NCT00249769|7189429|FG001|Received Measles Vaccine|Overall Study||236
6288385|NCT00249769|7189430|FG002|Received Measles Vaccine|Overall Study||235
6288386|NCT00249769|7189428|FG000|COMPLETED|Overall Study||98
6288387|NCT00249769|7189429|FG001|COMPLETED|Overall Study||235
6288388|NCT00249769|7189430|FG002|COMPLETED|Overall Study||222
6288389|NCT00249769|7189428|FG000|NOT COMPLETED|Overall Study||2
6288390|NCT00249769|7189429|FG001|NOT COMPLETED|Overall Study||15
6288391|NCT00249769|7189430|FG002|NOT COMPLETED|Overall Study||28
6288392|NCT00249795|7189440|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
6288393|NCT00249795|7189441|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
6288394|NCT00249795|7189440|FG000|COMPLETED|Overall Study|started and completed study drug|3124
6288395|NCT00249795|7189441|FG001|COMPLETED|Overall Study|started and completed study drug|3108
6288396|NCT00249795|7189440|FG000|NOT COMPLETED|Overall Study||1394
6288397|NCT00249795|7189441|FG001|NOT COMPLETED|Overall Study||1390
6288398|NCT00249808|7189447|FG000|STARTED|Overall Study||1266
6288399|NCT00249808|7189447|FG000|COMPLETED|Overall Study||1084
6288400|NCT00249808|7189447|FG000|NOT COMPLETED|Overall Study||182
6288401|NCT00249821|7189453|FG000|STARTED|Overall Study||10
6288402|NCT00249821|7189454|FG001|STARTED|Overall Study||12
6288403|NCT00249821|7189453|FG000|COMPLETED|Overall Study||10
6288404|NCT00249821|7189454|FG001|COMPLETED|Overall Study||11
6288405|NCT00249821|7189453|FG000|NOT COMPLETED|Overall Study||0
6288406|NCT00249821|7189454|FG001|NOT COMPLETED|Overall Study||1
6288407|NCT00249834|7189468|FG000|STARTED|Overall Study||1
6288408|NCT00249834|7189469|FG001|STARTED|Overall Study||48
6288409|NCT00249834|7189470|FG002|STARTED|Overall Study||45
6288410|NCT00249834|7189471|FG003|STARTED|Overall Study||34
6288411|NCT00249834|7189472|FG004|STARTED|Overall Study||24
6288412|NCT00249834|7189473|FG005|STARTED|Overall Study||10
6288413|NCT00249834|7189474|FG006|STARTED|Overall Study||2
6288414|NCT00249834|7189475|FG007|STARTED|Overall Study||2
6288415|NCT00249834|7189468|FG000|COMPLETED|Overall Study||0
6288416|NCT00249834|7189469|FG001|COMPLETED|Overall Study||29
6288417|NCT00249834|7189470|FG002|COMPLETED|Overall Study||31
6288418|NCT00249834|7189471|FG003|COMPLETED|Overall Study||26
6288419|NCT00249834|7189472|FG004|COMPLETED|Overall Study||19
6288420|NCT00249834|7189473|FG005|COMPLETED|Overall Study||8
6288421|NCT00249834|7189474|FG006|COMPLETED|Overall Study||1
6288422|NCT00249834|7189475|FG007|COMPLETED|Overall Study||2
6288423|NCT00249834|7189468|FG000|NOT COMPLETED|Overall Study||1
6288424|NCT00249834|7189469|FG001|NOT COMPLETED|Overall Study||19
6288425|NCT00249834|7189470|FG002|NOT COMPLETED|Overall Study||14
6288426|NCT00249834|7189471|FG003|NOT COMPLETED|Overall Study||8
6288427|NCT00249834|7189472|FG004|NOT COMPLETED|Overall Study||5
6288428|NCT00249834|7189473|FG005|NOT COMPLETED|Overall Study||2
6288429|NCT00249834|7189474|FG006|NOT COMPLETED|Overall Study||1
6288430|NCT00249834|7189475|FG007|NOT COMPLETED|Overall Study||0
6288431|NCT00249873|7189489|FG000|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
6374012|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6634643|NCT02298179|7563420|FG011|STARTED|Overall Study||24
6634644|NCT02298179|7563409|FG000|COMPLETED|Overall Study||24
6634645|NCT02298179|7563410|FG001|COMPLETED|Overall Study||24
6743343|NCT03334422|7671642|FG000|COMPLETED|Overall Study||225
6288432|NCT00249873|7189490|FG001|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
6288433|NCT00249873|7189489|FG000|COMPLETED|Overall Study|started and completed study drug|2442
6288434|NCT00249873|7189490|FG001|COMPLETED|Overall Study|started and completed study drug|2528
6288435|NCT00249873|7189489|FG000|NOT COMPLETED|Overall Study||1330
6288436|NCT00249873|7189490|FG001|NOT COMPLETED|Overall Study||1254
6288437|NCT00250276|7189500|FG000|STARTED|Overall Study||199
6288438|NCT00250276|7189501|FG001|STARTED|Overall Study||198
6288439|NCT00250276|7189502|FG002|STARTED|Overall Study||201
6288440|NCT00250276|7189503|FG003|STARTED|Overall Study||200
6288441|NCT00250276|7189500|FG000|COMPLETED|Overall Study||182
6288442|NCT00250276|7189501|FG001|COMPLETED|Overall Study||177
6288443|NCT00250276|7189502|FG002|COMPLETED|Overall Study||182
6288444|NCT00250276|7189503|FG003|COMPLETED|Overall Study||181
6288445|NCT00250276|7189500|FG000|NOT COMPLETED|Overall Study||17
6288446|NCT00250276|7189501|FG001|NOT COMPLETED|Overall Study||21
6288447|NCT00250276|7189502|FG002|NOT COMPLETED|Overall Study||19
6288448|NCT00250276|7189503|FG003|NOT COMPLETED|Overall Study||19
6288449|NCT00250432|7189520|FG000|STARTED|Overall Study||104
6288450|NCT00250432|7189521|FG001|STARTED|Overall Study||100
6288451|NCT00250432|7189520|FG000|COMPLETED|Overall Study||59
6288452|NCT00250432|7189521|FG001|COMPLETED|Overall Study||53
6288453|NCT00250432|7189520|FG000|NOT COMPLETED|Overall Study||45
6288454|NCT00250432|7189521|FG001|NOT COMPLETED|Overall Study||47
6288455|NCT00250484|7189529|FG000|STARTED|Overall Study||9
6288456|NCT00250484|7189530|FG001|STARTED|Overall Study||8
6288457|NCT00250484|7189529|FG000|COMPLETED|Overall Study||9
6288458|NCT00250484|7189530|FG001|COMPLETED|Overall Study||8
6288459|NCT00250484|7189529|FG000|NOT COMPLETED|Overall Study||0
6288460|NCT00250484|7189530|FG001|NOT COMPLETED|Overall Study||0
6288461|NCT00250497|7189538|FG000|STARTED|Overall Study||182
6288462|NCT00250497|7189539|FG001|STARTED|Overall Study||174
6288463|NCT00250497|7189538|FG000|COMPLETED|Overall Study||177
6288464|NCT00250497|7189539|FG001|COMPLETED|Overall Study||159
6288465|NCT00250497|7189538|FG000|NOT COMPLETED|Overall Study||5
6288466|NCT00250497|7189539|FG001|NOT COMPLETED|Overall Study||15
6288467|NCT00250588|7189548|FG000|STARTED|Overall Study||81
6288468|NCT00250588|7189549|FG001|STARTED|Overall Study||84
6288469|NCT00250588|7189550|FG002|STARTED|Overall Study||87
6288470|NCT00250588|7189548|FG000|COMPLETED|Overall Study||72
6288471|NCT00250588|7189549|FG001|COMPLETED|Overall Study||65
6288472|NCT00250588|7189550|FG002|COMPLETED|Overall Study||74
6288473|NCT00250588|7189548|FG000|NOT COMPLETED|Overall Study||9
6288474|NCT00250588|7189549|FG001|NOT COMPLETED|Overall Study||19
6288475|NCT00250588|7189550|FG002|NOT COMPLETED|Overall Study||13
6288476|NCT00250679|7189561|FG000|STARTED|Overall Study||147
6288477|NCT00250679|7189562|FG001|STARTED|Overall Study||149
6288478|NCT00250679|7189563|FG002|STARTED|Overall Study||147
6288479|NCT00250679|7189561|FG000|COMPLETED|Overall Study||108
6288480|NCT00250679|7189562|FG001|COMPLETED|Overall Study||100
6288481|NCT00250679|7189563|FG002|COMPLETED|Overall Study||103
6288482|NCT00250679|7189561|FG000|NOT COMPLETED|Overall Study||39
6288483|NCT00250679|7189562|FG001|NOT COMPLETED|Overall Study||49
6288484|NCT00250679|7189563|FG002|NOT COMPLETED|Overall Study||44
6288485|NCT00250705|7189571|FG000|STARTED|Overall Study||12
6288486|NCT00250705|7189571|FG000|COMPLETED|Overall Study||10
6288487|NCT00250705|7189571|FG000|NOT COMPLETED|Overall Study||2
6288488|NCT00250835|7189577|FG000|STARTED|Overall Study||38
6288489|NCT00250835|7189577|FG000|COMPLETED|Overall Study||37
6288490|NCT00250835|7189577|FG000|NOT COMPLETED|Overall Study||1
6288491|NCT00250926|7189581|FG000|STARTED|Overall Study||23
6288492|NCT00250926|7189581|FG000|COMPLETED|Overall Study||23
6288493|NCT00250926|7189581|FG000|NOT COMPLETED|Overall Study||0
6288494|NCT00251004|7189589|FG000|STARTED|Overall Study||277
6288495|NCT00251004|7189590|FG001|STARTED|Overall Study||279
6288496|NCT00251004|7189591|FG002|STARTED|Overall Study||277
6288497|NCT00251004|7189589|FG000|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
6288498|NCT00251004|7189590|FG001|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
6288499|NCT00251004|7189591|FG002|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
6288500|NCT00251004|7189589|FG000|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
6288501|NCT00251004|7189590|FG001|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
6288502|NCT00251004|7189591|FG002|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
6288503|NCT00251004|7189589|FG000|COMPLETED|Overall Study||232
6288504|NCT00251004|7189590|FG001|COMPLETED|Overall Study||238
6634646|NCT02298179|7563411|FG002|COMPLETED|Overall Study||23
6634647|NCT02298179|7563412|FG003|COMPLETED|Overall Study||24
6288505|NCT00251004|7189591|FG002|COMPLETED|Overall Study||246
6288506|NCT00251004|7189589|FG000|NOT COMPLETED|Overall Study||45
6288507|NCT00251004|7189590|FG001|NOT COMPLETED|Overall Study||41
6288508|NCT00251004|7189591|FG002|NOT COMPLETED|Overall Study||31
6288509|NCT00251225|7189599|FG000|STARTED|Overall Study||49
6288510|NCT00251225|7189599|FG000|COMPLETED|Overall Study||49
6288511|NCT00251225|7189599|FG000|NOT COMPLETED|Overall Study||0
6288512|NCT00251238|7189605|FG000|STARTED|Overall Study||21
6288513|NCT00251238|7189606|FG001|STARTED|Overall Study||20
6634648|NCT02298179|7563413|FG004|COMPLETED|Overall Study||24
6634649|NCT02298179|7563414|FG005|COMPLETED|Overall Study||24
6288514|NCT00251238|7189605|FG000|COMPLETED|Overall Study||21
6288515|NCT00251238|7189606|FG001|COMPLETED|Overall Study||20
6288516|NCT00251238|7189605|FG000|NOT COMPLETED|Overall Study||0
6288517|NCT00251238|7189606|FG001|NOT COMPLETED|Overall Study||0
6288518|NCT00251303|7189614|FG000|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
6288519|NCT00251303|7189615|FG001|STARTED|Overall Study||30
6288520|NCT00251303|7189614|FG000|COMPLETED|Overall Study||22
6288521|NCT00251303|7189615|FG001|COMPLETED|Overall Study||29
6288522|NCT00251303|7189614|FG000|NOT COMPLETED|Overall Study||8
6288523|NCT00251303|7189615|FG001|NOT COMPLETED|Overall Study||1
6288524|NCT00251316|7189625|FG000|STARTED|Overall Study||17
6288525|NCT00251316|7189626|FG001|STARTED|Overall Study||17
6288526|NCT00251316|7189625|FG000|COMPLETED|Overall Study||15
6288527|NCT00251316|7189626|FG001|COMPLETED|Overall Study||14
6288528|NCT00251316|7189625|FG000|NOT COMPLETED|Overall Study||2
6288529|NCT00251316|7189626|FG001|NOT COMPLETED|Overall Study||3
6288530|NCT00251589|7189636|FG000|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
6288531|NCT00251589|7189637|FG001|STARTED|Overall Study||3
6288532|NCT00251589|7189638|FG002|STARTED|Overall Study||2
6288533|NCT00251589|7189639|FG003|STARTED|Overall Study||2
6288534|NCT00251589|7189636|FG000|COMPLETED|Overall Study||1
6288535|NCT00251589|7189637|FG001|COMPLETED|Overall Study||0
6288536|NCT00251589|7189638|FG002|COMPLETED|Overall Study||0
6288537|NCT00251589|7189639|FG003|COMPLETED|Overall Study||0
6288538|NCT00251589|7189636|FG000|NOT COMPLETED|Overall Study||15
6288539|NCT00251589|7189637|FG001|NOT COMPLETED|Overall Study||3
6288540|NCT00251589|7189638|FG002|NOT COMPLETED|Overall Study||2
6288541|NCT00251589|7189639|FG003|NOT COMPLETED|Overall Study||2
6288542|NCT00251641|7189651|FG000|STARTED|Overall Study||653
6288543|NCT00251641|7189652|FG001|STARTED|Overall Study||215
6288544|NCT00251641|7189651|FG000|COMPLETED|Overall Study||541
6288545|NCT00251641|7189652|FG001|COMPLETED|Overall Study||127
6288546|NCT00251641|7189651|FG000|NOT COMPLETED|Overall Study||112
6288547|NCT00251641|7189652|FG001|NOT COMPLETED|Overall Study||88
6288548|NCT00251693|7189663|FG000|STARTED|Overall Study||680
6288549|NCT00251693|7189664|FG001|STARTED|Overall Study||668
6288550|NCT00251693|7189665|FG002|STARTED|Overall Study||690
6288551|NCT00251693|7189663|FG000|COMPLETED|Overall Study||629
6288552|NCT00251693|7189664|FG001|COMPLETED|Overall Study||624
6288553|NCT00251693|7189665|FG002|COMPLETED|Overall Study||644
6288554|NCT00251693|7189663|FG000|NOT COMPLETED|Overall Study||51
6288555|NCT00251693|7189664|FG001|NOT COMPLETED|Overall Study||44
6288556|NCT00251693|7189665|FG002|NOT COMPLETED|Overall Study||46
6288557|NCT00251719|7189676|FG000|STARTED|Overall Study||694
6288558|NCT00251719|7189677|FG001|STARTED|Overall Study||687
6288559|NCT00251719|7189678|FG002|STARTED|Overall Study||673
6288560|NCT00251719|7189676|FG000|COMPLETED|Overall Study||641
6288561|NCT00251719|7189677|FG001|COMPLETED|Overall Study||642
6288562|NCT00251719|7189678|FG002|COMPLETED|Overall Study||643
6288563|NCT00251719|7189676|FG000|NOT COMPLETED|Overall Study||53
6288564|NCT00251719|7189677|FG001|NOT COMPLETED|Overall Study||45
6288565|NCT00251719|7189678|FG002|NOT COMPLETED|Overall Study||30
6288566|NCT00251745|7189689|FG000|STARTED|Overall Study||292
6288567|NCT00251745|7189690|FG001|STARTED|Overall Study||312
6288568|NCT00251745|7189691|FG002|STARTED|Overall Study||304
6288569|NCT00251745|7189689|FG000|COMPLETED|Overall Study||264
6288570|NCT00251745|7189690|FG001|COMPLETED|Overall Study||285
6288571|NCT00251745|7189691|FG002|COMPLETED|Overall Study||277
6288572|NCT00251745|7189689|FG000|NOT COMPLETED|Overall Study||28
6288573|NCT00251745|7189690|FG001|NOT COMPLETED|Overall Study||27
6288574|NCT00251745|7189691|FG002|NOT COMPLETED|Overall Study||27
6288575|NCT00251758|7189702|FG000|STARTED|Overall Study||292
6743344|NCT03334422|7671643|FG001|COMPLETED|Overall Study||115
6743345|NCT03334422|7671644|FG002|COMPLETED|Overall Study||113
6743346|NCT03334422|7671645|FG003|COMPLETED|Overall Study||117
6743347|NCT03334422|7671642|FG000|NOT COMPLETED|Overall Study||19
6743348|NCT03334422|7671643|FG001|NOT COMPLETED|Overall Study||10
6288576|NCT00251758|7189703|FG001|STARTED|Overall Study||312
6288577|NCT00251758|7189704|FG002|STARTED|Overall Study||304
6288578|NCT00251758|7189702|FG000|COMPLETED|Overall Study||264
6288579|NCT00251758|7189703|FG001|COMPLETED|Overall Study||285
6288580|NCT00251758|7189704|FG002|COMPLETED|Overall Study||277
6288581|NCT00251758|7189702|FG000|NOT COMPLETED|Overall Study||28
6288582|NCT00251758|7189703|FG001|NOT COMPLETED|Overall Study||27
6288583|NCT00251758|7189704|FG002|NOT COMPLETED|Overall Study||27
6288584|NCT00251862|7189715|FG000|STARTED|Overall Study||280
6288585|NCT00251862|7189716|FG001|STARTED|Overall Study||269
6288586|NCT00251862|7189717|FG002|STARTED|Overall Study||276
6288587|NCT00251862|7189715|FG000|COMPLETED|Overall Study||280
6288588|NCT00251862|7189716|FG001|COMPLETED|Overall Study||269
6288589|NCT00251862|7189717|FG002|COMPLETED|Overall Study||276
6288590|NCT00251862|7189715|FG000|NOT COMPLETED|Overall Study||0
6288591|NCT00251862|7189716|FG001|NOT COMPLETED|Overall Study||0
6288592|NCT00251862|7189717|FG002|NOT COMPLETED|Overall Study||0
6288593|NCT00251927|7189727|FG000|STARTED|Overall Study|Randomised|288
6288594|NCT00251927|7189728|FG001|STARTED|Overall Study|Randomised|266
6288595|NCT00251927|7189727|FG000|COMPLETED|Overall Study|Completed 5 year visit|180
6288596|NCT00251927|7189728|FG001|COMPLETED|Overall Study|Completed 5 year visit|192
6288597|NCT00251927|7189727|FG000|NOT COMPLETED|Overall Study||108
6288598|NCT00251927|7189728|FG001|NOT COMPLETED|Overall Study||74
6743349|NCT03334422|7671644|FG002|NOT COMPLETED|Overall Study||10
6288599|NCT00251979|7189737|FG000|STARTED|Overall Study|ITT population|375
6288600|NCT00251979|7189738|FG001|STARTED|Overall Study|ITT population|389
6288601|NCT00251979|7189737|FG000|COMPLETED|Overall Study||337
6288602|NCT00251979|7189738|FG001|COMPLETED|Overall Study||349
6288603|NCT00251979|7189737|FG000|NOT COMPLETED|Overall Study||38
6288604|NCT00251979|7189738|FG001|NOT COMPLETED|Overall Study||40
6288605|NCT00252057|7189746|FG000|STARTED|Overall Study||373
6288606|NCT00252057|7189747|FG001|STARTED|Overall Study||376
6288607|NCT00252057|7189746|FG000|COMPLETED|Overall Study||370
6288608|NCT00252057|7189747|FG001|COMPLETED|Overall Study||368
6288609|NCT00252057|7189746|FG000|NOT COMPLETED|Overall Study||3
6288610|NCT00252057|7189747|FG001|NOT COMPLETED|Overall Study||8
6288611|NCT00252187|7189755|FG000|STARTED|Overall Study||24
6288612|NCT00252187|7189756|FG001|STARTED|Overall Study||21
6288613|NCT00252187|7189755|FG000|COMPLETED|Overall Study||20
6288614|NCT00252187|7189756|FG001|COMPLETED|Overall Study||20
6288615|NCT00252187|7189755|FG000|NOT COMPLETED|Overall Study||4
6288616|NCT00252187|7189756|FG001|NOT COMPLETED|Overall Study||1
6288617|NCT00252239|7189766|FG000|STARTED|Overall Study||31
6288618|NCT00252239|7189767|FG001|STARTED|Overall Study||31
6288619|NCT00252239|7189768|FG002|STARTED|Overall Study||19
6288620|NCT00252239|7189769|FG003|STARTED|Overall Study||31
6288621|NCT00252239|7189766|FG000|COMPLETED|Overall Study||30
6288622|NCT00252239|7189767|FG001|COMPLETED|Overall Study||31
6288623|NCT00252239|7189768|FG002|COMPLETED|Overall Study||17
6288624|NCT00252239|7189769|FG003|COMPLETED|Overall Study||30
6288625|NCT00252239|7189766|FG000|NOT COMPLETED|Overall Study||1
6288626|NCT00252239|7189767|FG001|NOT COMPLETED|Overall Study||0
6288627|NCT00252239|7189768|FG002|NOT COMPLETED|Overall Study||2
6288628|NCT00252239|7189769|FG003|NOT COMPLETED|Overall Study||1
6288629|NCT00252382|7189779|FG000|STARTED|Overall Study||31
6288630|NCT00252382|7189779|FG000|COMPLETED|Overall Study||5
6288631|NCT00252382|7189779|FG000|NOT COMPLETED|Overall Study||26
6288632|NCT00252499|7189786|FG000|STARTED|Overall Study||5
6288633|NCT00252499|7189787|FG001|STARTED|Overall Study||2
6288634|NCT00252499|7189788|FG002|STARTED|Overall Study||6
6288635|NCT00252499|7189786|FG000|COMPLETED|Overall Study||4
6288636|NCT00252499|7189787|FG001|COMPLETED|Overall Study||2
6288637|NCT00252499|7189788|FG002|COMPLETED|Overall Study||6
6288638|NCT00252499|7189786|FG000|NOT COMPLETED|Overall Study||1
6288639|NCT00252499|7189787|FG001|NOT COMPLETED|Overall Study||0
6288640|NCT00252499|7189788|FG002|NOT COMPLETED|Overall Study||0
6288641|NCT00252512|7189798|FG000|STARTED|Intervention||165
6288642|NCT00252512|7189799|FG001|STARTED|Intervention||165
6288643|NCT00252512|7189798|FG000|COMPLETED|Intervention||136
6288644|NCT00252512|7189799|FG001|COMPLETED|Intervention||134
6288645|NCT00252512|7189798|FG000|NOT COMPLETED|Intervention||29
6288646|NCT00252512|7189799|FG001|NOT COMPLETED|Intervention||31
6288647|NCT00252512|7189798|FG000|STARTED|Six Month Follow up||136
6288648|NCT00252512|7189799|FG001|STARTED|Six Month Follow up||134
6288649|NCT00252512|7189798|FG000|COMPLETED|Six Month Follow up||132
6288650|NCT00252512|7189799|FG001|COMPLETED|Six Month Follow up||122
6288651|NCT00252512|7189798|FG000|NOT COMPLETED|Six Month Follow up||4
6288652|NCT00252512|7189799|FG001|NOT COMPLETED|Six Month Follow up||12
6288653|NCT00252512|7189798|FG000|STARTED|12 Month Follow up||132
6288654|NCT00252512|7189799|FG001|STARTED|12 Month Follow up||122
6288655|NCT00252512|7189798|FG000|COMPLETED|12 Month Follow up||123
6288656|NCT00252512|7189799|FG001|COMPLETED|12 Month Follow up||121
6288657|NCT00252512|7189798|FG000|NOT COMPLETED|12 Month Follow up||9
6288658|NCT00252512|7189799|FG001|NOT COMPLETED|12 Month Follow up||1
6288659|NCT00252538|7189805|FG000|STARTED|Overall Study||19
6288660|NCT00252538|7189806|FG001|STARTED|Overall Study||114
6288661|NCT00252538|7189805|FG000|COMPLETED|Overall Study||19
6288662|NCT00252538|7189806|FG001|COMPLETED|Overall Study||114
6288663|NCT00252538|7189805|FG000|NOT COMPLETED|Overall Study||0
6288664|NCT00252538|7189806|FG001|NOT COMPLETED|Overall Study||0
6288665|NCT00252564|7189813|FG000|STARTED|Overall Study|From randomization|124
6288666|NCT00252564|7189814|FG001|STARTED|Overall Study|From randomization|123
6288667|NCT00252564|7189813|FG000|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
6288668|NCT00252564|7189814|FG001|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
6288669|NCT00252564|7189813|FG000|NOT COMPLETED|Overall Study||39
6288670|NCT00252564|7189814|FG001|NOT COMPLETED|Overall Study||44
6288671|NCT00252577|7189820|FG000|STARTED|Overall Study||130
6288672|NCT00252577|7189820|FG000|COMPLETED|Overall Study||110
6288673|NCT00252577|7189820|FG000|NOT COMPLETED|Overall Study||20
6288674|NCT00252590|7189827|FG000|STARTED|Overall Study||35
6288675|NCT00252590|7189828|FG001|STARTED|Overall Study||30
6288676|NCT00252590|7189829|FG002|STARTED|Overall Study||34
6288677|NCT00252590|7189827|FG000|COMPLETED|Overall Study||33
6288678|NCT00252590|7189828|FG001|COMPLETED|Overall Study||28
6288679|NCT00252590|7189829|FG002|COMPLETED|Overall Study||31
6288680|NCT00252590|7189827|FG000|NOT COMPLETED|Overall Study||2
6288681|NCT00252590|7189828|FG001|NOT COMPLETED|Overall Study||2
6288682|NCT00252590|7189829|FG002|NOT COMPLETED|Overall Study||3
6288683|NCT00252629|7189840|FG000|STARTED|Overall Study||9
6288684|NCT00252629|7189841|FG001|STARTED|Overall Study||9
6288685|NCT00252629|7189842|FG002|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
6288686|NCT00252629|7189840|FG000|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
6288687|NCT00252629|7189841|FG001|COMPLETED|Overall Study||9
6288688|NCT00252629|7189842|FG002|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
6288689|NCT00252629|7189840|FG000|NOT COMPLETED|Overall Study||1
6288690|NCT00252629|7189841|FG001|NOT COMPLETED|Overall Study||0
6288691|NCT00252629|7189842|FG002|NOT COMPLETED|Overall Study||0
6288692|NCT00252694|7189857|FG000|STARTED|Overall Study||951
6288693|NCT00252694|7189858|FG001|STARTED|Overall Study||954
6288694|NCT00252694|7189857|FG000|COMPLETED|Overall Study||807
6288695|NCT00252694|7189858|FG001|COMPLETED|Overall Study||800
6288696|NCT00252694|7189857|FG000|NOT COMPLETED|Overall Study||144
6288697|NCT00252694|7189858|FG001|NOT COMPLETED|Overall Study||154
6288698|NCT00252720|7189866|FG000|STARTED|Overall Study||951
6288699|NCT00252720|7189867|FG001|STARTED|Overall Study||954
6288700|NCT00252720|7189866|FG000|COMPLETED|Overall Study||819
6288701|NCT00252720|7189867|FG001|COMPLETED|Overall Study||789
6288702|NCT00252720|7189866|FG000|NOT COMPLETED|Overall Study||132
6288703|NCT00252720|7189867|FG001|NOT COMPLETED|Overall Study||165
6288704|NCT00252733|7189875|FG000|STARTED|Overall Study||711
6288705|NCT00252733|7189876|FG001|STARTED|Overall Study||710
6288706|NCT00252733|7189875|FG000|COMPLETED|Overall Study||605
6288707|NCT00252733|7189876|FG001|COMPLETED|Overall Study||618
6288708|NCT00252733|7189875|FG000|NOT COMPLETED|Overall Study||106
6288709|NCT00252733|7189876|FG001|NOT COMPLETED|Overall Study||92
6288710|NCT00252967|7189884|FG000|STARTED|Overall Study||31
6288711|NCT00252967|7189885|FG001|STARTED|Overall Study||33
6288712|NCT00252967|7189884|FG000|COMPLETED|Overall Study||31
6288713|NCT00252967|7189885|FG001|COMPLETED|Overall Study||33
6288714|NCT00252967|7189884|FG000|NOT COMPLETED|Overall Study||0
6288715|NCT00252967|7189885|FG001|NOT COMPLETED|Overall Study||0
6374013|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374014|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374015|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374016|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374017|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374018|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374019|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
6374020|NCT00747552|7284569|FG000|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
6374021|NCT00747552|7284569|FG000|COMPLETED|Overall Study||30
6374022|NCT00747552|7284569|FG000|NOT COMPLETED|Overall Study||0
6374023|NCT00747565|7284575|FG000|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
6374024|NCT00747565|7284576|FG001|STARTED|Overall Study||123
6374025|NCT00747565|7284575|FG000|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
6374026|NCT00747565|7284576|FG001|COMPLETED|Overall Study||116
6374027|NCT00747565|7284575|FG000|NOT COMPLETED|Overall Study||14
6374028|NCT00747565|7284576|FG001|NOT COMPLETED|Overall Study||7
6374029|NCT00747617|7284584|FG000|STARTED|Overall Study||13
6374030|NCT00747617|7284585|FG001|STARTED|Overall Study||12
6374031|NCT00747617|7284584|FG000|COMPLETED|Overall Study||10
6374032|NCT00747617|7284585|FG001|COMPLETED|Overall Study||11
6374033|NCT00747617|7284584|FG000|NOT COMPLETED|Overall Study||3
6374034|NCT00747617|7284585|FG001|NOT COMPLETED|Overall Study||1
6374035|NCT00747643|7284593|FG000|STARTED|Overall Study||82
6374036|NCT00747643|7284594|FG001|STARTED|Overall Study||81
6374037|NCT00747643|7284593|FG000|COMPLETED|Overall Study||46
6374038|NCT00747643|7284594|FG001|COMPLETED|Overall Study||54
6374039|NCT00747643|7284593|FG000|NOT COMPLETED|Overall Study||36
6374040|NCT00747643|7284594|FG001|NOT COMPLETED|Overall Study||27
6374041|NCT00747747|7284603|FG000|STARTED|Overall Study||14
6374042|NCT00747747|7284604|FG001|STARTED|Overall Study||14
6374043|NCT00747747|7284605|FG002|STARTED|Overall Study||21
6374044|NCT00747747|7284603|FG000|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
6374045|NCT00747747|7284604|FG001|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
6374046|NCT00747747|7284605|FG002|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
6374047|NCT00747747|7284603|FG000|NOT COMPLETED|Overall Study||0
6374048|NCT00747747|7284604|FG001|NOT COMPLETED|Overall Study||0
6374049|NCT00747747|7284605|FG002|NOT COMPLETED|Overall Study||0
6374050|NCT00747812|7284615|FG000|STARTED|Overall Study||5
6374051|NCT00747812|7284616|FG001|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
6374052|NCT00747812|7284615|FG000|COMPLETED|Overall Study||0
6374053|NCT00747812|7284616|FG001|COMPLETED|Overall Study||0
6374054|NCT00747812|7284615|FG000|NOT COMPLETED|Overall Study||5
6374055|NCT00747812|7284616|FG001|NOT COMPLETED|Overall Study||3
6374056|NCT00748033|7284624|FG000|STARTED|Overall Study||12
6374057|NCT00748033|7284625|FG001|STARTED|Overall Study||13
6374058|NCT00748033|7284624|FG000|COMPLETED|Overall Study||12
6374059|NCT00748033|7284625|FG001|COMPLETED|Overall Study|One subject participated only in 2 arms due to an adverse event.|12
6374060|NCT00748033|7284624|FG000|NOT COMPLETED|Overall Study||0
6374061|NCT00748033|7284625|FG001|NOT COMPLETED|Overall Study||1
6374062|NCT00748072|7284641|FG000|STARTED|Overall Study||82
6374063|NCT00748072|7284642|FG001|STARTED|Overall Study||80
6374064|NCT00748072|7284641|FG000|COMPLETED|Overall Study||82
6374065|NCT00748072|7284642|FG001|COMPLETED|Overall Study||80
6374066|NCT00748072|7284641|FG000|NOT COMPLETED|Overall Study||0
6374067|NCT00748072|7284642|FG001|NOT COMPLETED|Overall Study||0
6288716|NCT00253019|7189894|FG000|STARTED|Overall Study||111
6288717|NCT00253019|7189895|FG001|STARTED|Overall Study||109
6288718|NCT00253019|7189896|FG002|STARTED|Overall Study||101
6288719|NCT00253019|7189894|FG000|COMPLETED|Overall Study||82
6288720|NCT00253019|7189895|FG001|COMPLETED|Overall Study||78
6288721|NCT00253019|7189896|FG002|COMPLETED|Overall Study||83
6288722|NCT00253019|7189894|FG000|NOT COMPLETED|Overall Study||29
6288723|NCT00253019|7189895|FG001|NOT COMPLETED|Overall Study||31
6288724|NCT00253019|7189896|FG002|NOT COMPLETED|Overall Study||18
6288725|NCT00253370|7189904|FG000|STARTED|Overall Study||44
6288726|NCT00253370|7189904|FG000|COMPLETED|Overall Study||1
6288727|NCT00253370|7189904|FG000|NOT COMPLETED|Overall Study||43
6288728|NCT00253435|7189911|FG000|STARTED|Overall Study|Total number is 42|42
6288729|NCT00253435|7189912|FG001|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
6288730|NCT00253435|7189911|FG000|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
6288731|NCT00253435|7189912|FG001|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
6288732|NCT00253435|7189911|FG000|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
6288733|NCT00253435|7189912|FG001|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
6288734|NCT00253435|7189911|FG000|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
6288735|NCT00253435|7189912|FG001|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
6288736|NCT00253435|7189911|FG000|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
6288737|NCT00253435|7189912|FG001|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
6288738|NCT00253435|7189911|FG000|NOT COMPLETED|Overall Study||0
6288739|NCT00253435|7189912|FG001|NOT COMPLETED|Overall Study||0
6288740|NCT00253448|7189918|FG000|STARTED|Overall Study||35
6288741|NCT00253448|7189918|FG000|COMPLETED|Overall Study||34
6288742|NCT00253448|7189918|FG000|NOT COMPLETED|Overall Study||1
6288743|NCT00253513|7189922|FG000|STARTED|Overall Study||60
6288744|NCT00253513|7189922|FG000|COMPLETED|Overall Study||60
6288745|NCT00253513|7189922|FG000|NOT COMPLETED|Overall Study||0
6288746|NCT00253630|7189926|FG000|STARTED|Overall Study||37
6288747|NCT00253630|7189926|FG000|COMPLETED|Overall Study||35
6288748|NCT00253630|7189926|FG000|NOT COMPLETED|Overall Study||2
6288749|NCT00253643|7189934|FG000|STARTED|Overall Study||14
6288750|NCT00253643|7189935|FG001|STARTED|Overall Study||15
6288751|NCT00253643|7189936|FG002|STARTED|Overall Study||29
6288752|NCT00253643|7189937|FG003|STARTED|Overall Study||31
6288753|NCT00253643|7189934|FG000|COMPLETED|Overall Study||14
6288754|NCT00253643|7189935|FG001|COMPLETED|Overall Study||15
6288755|NCT00253643|7189936|FG002|COMPLETED|Overall Study||28
6288756|NCT00253643|7189937|FG003|COMPLETED|Overall Study||28
6288757|NCT00253643|7189934|FG000|NOT COMPLETED|Overall Study||0
6288758|NCT00253643|7189935|FG001|NOT COMPLETED|Overall Study||0
6288759|NCT00253643|7189936|FG002|NOT COMPLETED|Overall Study||1
6288760|NCT00253643|7189937|FG003|NOT COMPLETED|Overall Study||3
6288761|NCT00253708|7189950|FG000|STARTED|Overall Study||20
6288762|NCT00253708|7189951|FG001|STARTED|Overall Study||10
6288763|NCT00253708|7189952|FG002|STARTED|Overall Study||9
6288764|NCT00253708|7189950|FG000|COMPLETED|Overall Study||20
6288765|NCT00253708|7189951|FG001|COMPLETED|Overall Study||10
6288766|NCT00253708|7189952|FG002|COMPLETED|Overall Study||8
6288767|NCT00253708|7189950|FG000|NOT COMPLETED|Overall Study||0
6288768|NCT00253708|7189951|FG001|NOT COMPLETED|Overall Study||0
6288769|NCT00253708|7189952|FG002|NOT COMPLETED|Overall Study||1
6399439|NCT00880568|7312175|FG000|NOT COMPLETED|Overall Study||3
6399440|NCT00880568|7312176|FG001|NOT COMPLETED|Overall Study||3
6399441|NCT00880568|7312177|FG002|NOT COMPLETED|Overall Study||3
6399442|NCT00880568|7312178|FG003|NOT COMPLETED|Overall Study||1
6399443|NCT00880568|7312179|FG004|NOT COMPLETED|Overall Study||3
6399444|NCT00880568|7312180|FG005|NOT COMPLETED|Overall Study||3
6399445|NCT00880568|7312181|FG006|NOT COMPLETED|Overall Study||6
6399446|NCT00880568|7312182|FG007|NOT COMPLETED|Overall Study||2
6399447|NCT00880568|7312183|FG008|NOT COMPLETED|Overall Study||3
6399448|NCT00880581|7312208|FG000|STARTED|Cycle 1||30
6399449|NCT00880581|7312208|FG000|COMPLETED|Cycle 1||30
6399450|NCT00880581|7312208|FG000|NOT COMPLETED|Cycle 1||0
6399451|NCT00880581|7312208|FG000|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
6399452|NCT00880581|7312208|FG000|COMPLETED|Cycle 2 Re-treatment||24
6399453|NCT00880581|7312208|FG000|NOT COMPLETED|Cycle 2 Re-treatment||0
6399454|NCT00880607|7312214|FG000|STARTED|Overall Study||44
6399455|NCT00880607|7312215|FG001|STARTED|Overall Study||37
6399456|NCT00880607|7312214|FG000|Observation After Receiving Medication|Overall Study||42
6399457|NCT00880607|7312215|FG001|Observation After Receiving Medication|Overall Study||35
6634650|NCT02298179|7563415|FG006|COMPLETED|Overall Study||24
6634651|NCT02298179|7563416|FG007|COMPLETED|Overall Study||23
6634652|NCT02298179|7563417|FG008|COMPLETED|Overall Study||24
6634653|NCT02298179|7563418|FG009|COMPLETED|Overall Study||24
6634654|NCT02298179|7563419|FG010|COMPLETED|Overall Study||24
6634655|NCT02298179|7563420|FG011|COMPLETED|Overall Study||24
6634656|NCT02298179|7563409|FG000|NOT COMPLETED|Overall Study||0
6634657|NCT02298179|7563410|FG001|NOT COMPLETED|Overall Study||0
6634658|NCT02298179|7563411|FG002|NOT COMPLETED|Overall Study||1
6634659|NCT02298179|7563412|FG003|NOT COMPLETED|Overall Study||0
6288770|NCT00253747|7189962|FG000|STARTED|Overall Study||127
6288771|NCT00253747|7189963|FG001|STARTED|Overall Study||128
6288772|NCT00253747|7189962|FG000|COMPLETED|Overall Study||103
6288773|NCT00253747|7189963|FG001|COMPLETED|Overall Study||101
6288774|NCT00253747|7189962|FG000|NOT COMPLETED|Overall Study||24
6288775|NCT00253747|7189963|FG001|NOT COMPLETED|Overall Study||27
6288776|NCT00253890|7189981|FG000|STARTED|Overall Study||69
6288777|NCT00253890|7189982|FG001|STARTED|Overall Study||68
6288778|NCT00253890|7189981|FG000|COMPLETED|Overall Study||62
6288779|NCT00253890|7189982|FG001|COMPLETED|Overall Study||61
6288780|NCT00253890|7189981|FG000|NOT COMPLETED|Overall Study||7
6288781|NCT00253890|7189982|FG001|NOT COMPLETED|Overall Study||7
6288782|NCT00254072|7189990|FG000|STARTED|Overall Study||180
6288783|NCT00254072|7189991|FG001|STARTED|Overall Study||175
6288784|NCT00254072|7189990|FG000|COMPLETED|Overall Study||180
6288785|NCT00254072|7189991|FG001|COMPLETED|Overall Study||175
6288786|NCT00254072|7189990|FG000|NOT COMPLETED|Overall Study||0
6288787|NCT00254072|7189991|FG001|NOT COMPLETED|Overall Study||0
6288788|NCT00254163|7189999|FG000|STARTED|Overall Study||92
6288789|NCT00254163|7190000|FG001|STARTED|Overall Study||92
6288790|NCT00254163|7189999|FG000|COMPLETED|Overall Study||47
6288791|NCT00254163|7190000|FG001|COMPLETED|Overall Study||46
6288792|NCT00254163|7189999|FG000|NOT COMPLETED|Overall Study||45
6288793|NCT00254163|7190000|FG001|NOT COMPLETED|Overall Study||46
6288794|NCT00254293|7190012|FG000|STARTED|Short Term (12 Week) Randomized Dosing||7
6288795|NCT00254293|7190013|FG001|STARTED|Short Term (12 Week) Randomized Dosing||4
6288796|NCT00254293|7190014|FG002|STARTED|Short Term (12 Week) Randomized Dosing||29
6288797|NCT00254293|7190015|FG003|STARTED|Short Term (12 Week) Randomized Dosing||6
6288798|NCT00254293|7190016|FG004|STARTED|Short Term (12 Week) Randomized Dosing||5
6288799|NCT00254293|7190017|FG005|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
6288800|NCT00254293|7190018|FG006|STARTED|Short Term (12 Week) Randomized Dosing||0
6288801|NCT00254293|7190012|FG000|COMPLETED|Short Term (12 Week) Randomized Dosing||7
6288802|NCT00254293|7190013|FG001|COMPLETED|Short Term (12 Week) Randomized Dosing||3
6288803|NCT00254293|7190014|FG002|COMPLETED|Short Term (12 Week) Randomized Dosing||26
6288804|NCT00254293|7190015|FG003|COMPLETED|Short Term (12 Week) Randomized Dosing||5
6288805|NCT00254293|7190016|FG004|COMPLETED|Short Term (12 Week) Randomized Dosing||5
6288806|NCT00254293|7190017|FG005|COMPLETED|Short Term (12 Week) Randomized Dosing||17
6288807|NCT00254293|7190018|FG006|COMPLETED|Short Term (12 Week) Randomized Dosing||0
6288808|NCT00254293|7190012|FG000|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
6288809|NCT00254293|7190013|FG001|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
6288810|NCT00254293|7190014|FG002|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
6288811|NCT00254293|7190015|FG003|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
6288812|NCT00254293|7190016|FG004|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
6288813|NCT00254293|7190017|FG005|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
6288814|NCT00254293|7190018|FG006|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
6288815|NCT00254293|7190012|FG000|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
6288816|NCT00254293|7190013|FG001|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
6288817|NCT00254293|7190014|FG002|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
6288818|NCT00254293|7190015|FG003|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
6288819|NCT00254293|7190016|FG004|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
6288820|NCT00254293|7190017|FG005|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
6288821|NCT00254293|7190018|FG006|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
6288822|NCT00254293|7190012|FG000|COMPLETED|LTE Open Label Variable SC Dosing||8
6288823|NCT00254293|7190013|FG001|COMPLETED|LTE Open Label Variable SC Dosing||0
6288824|NCT00254293|7190014|FG002|COMPLETED|LTE Open Label Variable SC Dosing||32
6288825|NCT00254293|7190015|FG003|COMPLETED|LTE Open Label Variable SC Dosing||0
6288826|NCT00254293|7190016|FG004|COMPLETED|LTE Open Label Variable SC Dosing||8
6288827|NCT00254293|7190017|FG005|COMPLETED|LTE Open Label Variable SC Dosing||0
6288828|NCT00254293|7190018|FG006|COMPLETED|LTE Open Label Variable SC Dosing||0
6288829|NCT00254293|7190012|FG000|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
6288830|NCT00254293|7190013|FG001|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
6288831|NCT00254293|7190014|FG002|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
6288832|NCT00254293|7190015|FG003|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
6288833|NCT00254293|7190016|FG004|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
6288834|NCT00254293|7190017|FG005|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
6288835|NCT00254293|7190018|FG006|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
6288836|NCT00254293|7190012|FG000|STARTED|LTE Open Label Fixed Dosing||0
6288837|NCT00254293|7190013|FG001|STARTED|LTE Open Label Fixed Dosing||0
6288838|NCT00254293|7190014|FG002|STARTED|LTE Open Label Fixed Dosing||0
6288839|NCT00254293|7190015|FG003|STARTED|LTE Open Label Fixed Dosing||0
6288840|NCT00254293|7190016|FG004|STARTED|LTE Open Label Fixed Dosing||0
6288841|NCT00254293|7190017|FG005|STARTED|LTE Open Label Fixed Dosing||0
6288842|NCT00254293|7190018|FG006|STARTED|LTE Open Label Fixed Dosing||48
6288843|NCT00254293|7190012|FG000|COMPLETED|LTE Open Label Fixed Dosing||0
6288844|NCT00254293|7190013|FG001|COMPLETED|LTE Open Label Fixed Dosing||0
6288845|NCT00254293|7190014|FG002|COMPLETED|LTE Open Label Fixed Dosing||0
6288846|NCT00254293|7190015|FG003|COMPLETED|LTE Open Label Fixed Dosing||0
6288847|NCT00254293|7190016|FG004|COMPLETED|LTE Open Label Fixed Dosing||0
6288848|NCT00254293|7190017|FG005|COMPLETED|LTE Open Label Fixed Dosing||0
6288849|NCT00254293|7190018|FG006|COMPLETED|LTE Open Label Fixed Dosing||35
6288850|NCT00254293|7190012|FG000|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6288851|NCT00254293|7190013|FG001|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6288852|NCT00254293|7190014|FG002|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6288853|NCT00254293|7190015|FG003|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6288854|NCT00254293|7190016|FG004|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6288855|NCT00254293|7190017|FG005|NOT COMPLETED|LTE Open Label Fixed Dosing||0
6288856|NCT00254293|7190018|FG006|NOT COMPLETED|LTE Open Label Fixed Dosing||13
6288857|NCT00254397|7190065|FG000|STARTED|Overall Study||10
6288858|NCT00254397|7190066|FG001|STARTED|Overall Study||6
6288859|NCT00254397|7190067|FG002|STARTED|Overall Study||37
6288860|NCT00254397|7190068|FG003|STARTED|Overall Study||45
6288861|NCT00254397|7190065|FG000|COMPLETED|Overall Study||4
6288862|NCT00254397|7190066|FG001|COMPLETED|Overall Study||5
6288863|NCT00254397|7190067|FG002|COMPLETED|Overall Study||18
6288864|NCT00254397|7190068|FG003|COMPLETED|Overall Study||20
6288865|NCT00254397|7190065|FG000|NOT COMPLETED|Overall Study||6
6288866|NCT00254397|7190066|FG001|NOT COMPLETED|Overall Study||1
6288867|NCT00254397|7190067|FG002|NOT COMPLETED|Overall Study||19
6288868|NCT00254397|7190068|FG003|NOT COMPLETED|Overall Study||25
6288869|NCT00254410|7190077|FG000|STARTED|Overall Study||30
6288870|NCT00254410|7190077|FG000|COMPLETED|Overall Study||30
6288871|NCT00254410|7190077|FG000|NOT COMPLETED|Overall Study||0
6288872|NCT00254462|7190083|FG000|STARTED|Overall Study||44
6288873|NCT00254462|7190084|FG001|STARTED|Overall Study||49
6288874|NCT00254462|7190083|FG000|COMPLETED|Overall Study||36
6288875|NCT00254462|7190084|FG001|COMPLETED|Overall Study||39
6288876|NCT00254462|7190083|FG000|NOT COMPLETED|Overall Study||8
6288877|NCT00254462|7190084|FG001|NOT COMPLETED|Overall Study||10
6288878|NCT00254488|7190094|FG000|STARTED|Overall Study||112
6288879|NCT00254488|7190095|FG001|STARTED|Overall Study||112
6288880|NCT00254488|7190094|FG000|COMPLETED|Overall Study||55
6288881|NCT00254488|7190095|FG001|COMPLETED|Overall Study||63
6288882|NCT00254488|7190094|FG000|NOT COMPLETED|Overall Study||57
6288883|NCT00254488|7190095|FG001|NOT COMPLETED|Overall Study||49
6288884|NCT00254501|7190103|FG000|STARTED|Overall Study||32
6634660|NCT02298179|7563413|FG004|NOT COMPLETED|Overall Study||0
6634661|NCT02298179|7563414|FG005|NOT COMPLETED|Overall Study||0
6634662|NCT02298179|7563415|FG006|NOT COMPLETED|Overall Study||0
6634663|NCT02298179|7563416|FG007|NOT COMPLETED|Overall Study||1
6634664|NCT02298179|7563417|FG008|NOT COMPLETED|Overall Study||0
6634665|NCT02298179|7563418|FG009|NOT COMPLETED|Overall Study||0
6634666|NCT02298179|7563419|FG010|NOT COMPLETED|Overall Study||0
6634667|NCT02298179|7563420|FG011|NOT COMPLETED|Overall Study||0
6288885|NCT00254501|7190104|FG001|STARTED|Overall Study||37
6288886|NCT00254501|7190103|FG000|COMPLETED|Overall Study||31
6288887|NCT00254501|7190104|FG001|COMPLETED|Overall Study||36
6288888|NCT00254501|7190103|FG000|NOT COMPLETED|Overall Study||1
6288889|NCT00254501|7190104|FG001|NOT COMPLETED|Overall Study||1
6288890|NCT00254540|7190114|FG000|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
6288891|NCT00254540|7190115|FG001|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
6288892|NCT00254540|7190114|FG000|COMPLETED|Overall Study||6
6288893|NCT00254540|7190115|FG001|COMPLETED|Overall Study||4
6288894|NCT00254540|7190114|FG000|NOT COMPLETED|Overall Study||19
6288895|NCT00254540|7190115|FG001|NOT COMPLETED|Overall Study||22
6288896|NCT00254566|7190124|FG000|STARTED|Overall Study||198
6288897|NCT00254566|7190125|FG001|STARTED|Overall Study||198
6288898|NCT00254566|7190124|FG000|COMPLETED|Overall Study||167
6288899|NCT00254566|7190125|FG001|COMPLETED|Overall Study||172
6288900|NCT00254566|7190124|FG000|NOT COMPLETED|Overall Study||31
6288901|NCT00254566|7190125|FG001|NOT COMPLETED|Overall Study||26
6288902|NCT00254592|7190131|FG000|STARTED|Overall Study||43
6288903|NCT00254592|7190131|FG000|COMPLETED|Overall Study||41
6288904|NCT00254592|7190131|FG000|NOT COMPLETED|Overall Study||2
6288905|NCT00254982|7190137|FG000|STARTED|Overall Study||297
6288906|NCT00254982|7190138|FG001|STARTED|Overall Study||296
6288907|NCT00254982|7190137|FG000|COMPLETED|Overall Study||261
6288908|NCT00254982|7190138|FG001|COMPLETED|Overall Study||265
6288909|NCT00254982|7190137|FG000|NOT COMPLETED|Overall Study||36
6288910|NCT00254982|7190138|FG001|NOT COMPLETED|Overall Study||31
6288911|NCT00254995|7190146|FG000|STARTED|Overall Study||31561
6288912|NCT00254995|7190147|FG001|STARTED|Overall Study||31065
6288913|NCT00254995|7190146|FG000|COMPLETED|Overall Study||31561
6288914|NCT00254995|7190147|FG001|COMPLETED|Overall Study||31065
6288915|NCT00254995|7190146|FG000|NOT COMPLETED|Overall Study||0
6634668|NCT02298192|7563448|FG000|STARTED|Overall Study||210
6634669|NCT02298192|7563449|FG001|STARTED|Overall Study||210
6288916|NCT00254995|7190147|FG001|NOT COMPLETED|Overall Study||0
6288917|NCT00255008|7190159|FG000|STARTED|Overall Study||45
6288918|NCT00255008|7190160|FG001|STARTED|Overall Study||9
6288919|NCT00255008|7190161|FG002|STARTED|Overall Study||33
6288920|NCT00255008|7190162|FG003|STARTED|Overall Study||34
6288921|NCT00255008|7190159|FG000|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
6288922|NCT00255008|7190160|FG001|COMPLETED|Overall Study||0
6288923|NCT00255008|7190161|FG002|COMPLETED|Overall Study||17
6288924|NCT00255008|7190162|FG003|COMPLETED|Overall Study||12
6288925|NCT00255008|7190159|FG000|NOT COMPLETED|Overall Study||32
6288926|NCT00255008|7190160|FG001|NOT COMPLETED|Overall Study||9
6288927|NCT00255008|7190161|FG002|NOT COMPLETED|Overall Study||16
6288928|NCT00255008|7190162|FG003|NOT COMPLETED|Overall Study||22
6288929|NCT00255034|7190174|FG000|STARTED|Overall Study||79
6288930|NCT00255034|7190175|FG001|STARTED|Overall Study||64
6288931|NCT00255034|7190174|FG000|COMPLETED|Overall Study||64
6288932|NCT00255034|7190175|FG001|COMPLETED|Overall Study||26
6288933|NCT00255034|7190174|FG000|NOT COMPLETED|Overall Study||15
6288934|NCT00255034|7190175|FG001|NOT COMPLETED|Overall Study||38
6288935|NCT00255047|7190185|FG000|STARTED|Overall Study||538
6288936|NCT00255047|7190186|FG001|STARTED|Overall Study||535
6288937|NCT00255047|7190187|FG002|STARTED|Overall Study||546
6288938|NCT00255047|7190188|FG003|STARTED|Overall Study||548
6288939|NCT00255047|7190185|FG000|COMPLETED|Overall Study||490
6288940|NCT00255047|7190186|FG001|COMPLETED|Overall Study||487
6288941|NCT00255047|7190187|FG002|COMPLETED|Overall Study||496
6288942|NCT00255047|7190188|FG003|COMPLETED|Overall Study||502
6288943|NCT00255047|7190185|FG000|NOT COMPLETED|Overall Study||48
6288944|NCT00255047|7190186|FG001|NOT COMPLETED|Overall Study||48
6288945|NCT00255047|7190187|FG002|NOT COMPLETED|Overall Study||50
6288946|NCT00255047|7190188|FG003|NOT COMPLETED|Overall Study||46
6288947|NCT00255086|7190200|FG000|STARTED|Overall Study||9
6288948|NCT00255086|7190201|FG001|STARTED|Overall Study||8
6288949|NCT00255086|7190200|FG000|COMPLETED|Overall Study||7
6288950|NCT00255086|7190201|FG001|COMPLETED|Overall Study||6
6288951|NCT00255086|7190200|FG000|NOT COMPLETED|Overall Study||2
6288952|NCT00255086|7190201|FG001|NOT COMPLETED|Overall Study||2
6288953|NCT00255125|7190210|FG000|STARTED|Overall Study||42
6288954|NCT00255125|7190211|FG001|STARTED|Overall Study||44
6288955|NCT00255125|7190210|FG000|COMPLETED|Overall Study||42
6288956|NCT00255125|7190211|FG001|COMPLETED|Overall Study||44
6288957|NCT00255125|7190210|FG000|NOT COMPLETED|Overall Study||0
6288958|NCT00255125|7190211|FG001|NOT COMPLETED|Overall Study||0
6288959|NCT00255151|7190222|FG000|STARTED|Overall Study||140
6288960|NCT00255151|7190223|FG001|STARTED|Overall Study||159
6288961|NCT00255151|7190224|FG002|STARTED|Overall Study||152
6288962|NCT00255151|7190222|FG000|COMPLETED|Overall Study||17
6288963|NCT00255151|7190223|FG001|COMPLETED|Overall Study||110
6288964|NCT00255151|7190224|FG002|COMPLETED|Overall Study||103
6288965|NCT00255151|7190222|FG000|NOT COMPLETED|Overall Study||123
6288966|NCT00255151|7190223|FG001|NOT COMPLETED|Overall Study||49
6288967|NCT00255151|7190224|FG002|NOT COMPLETED|Overall Study||49
6288968|NCT00255164|7190235|FG000|STARTED|Overall Study||140
6288969|NCT00255164|7190236|FG001|STARTED|Overall Study||159
6288970|NCT00255164|7190237|FG002|STARTED|Overall Study||152
6288971|NCT00255164|7190235|FG000|COMPLETED|Overall Study||17
6288972|NCT00255164|7190236|FG001|COMPLETED|Overall Study||110
6288973|NCT00255164|7190237|FG002|COMPLETED|Overall Study||103
6288974|NCT00255164|7190235|FG000|NOT COMPLETED|Overall Study||123
6288975|NCT00255164|7190236|FG001|NOT COMPLETED|Overall Study||49
6288976|NCT00255164|7190237|FG002|NOT COMPLETED|Overall Study||49
6288977|NCT00255177|7190249|FG000|STARTED|Overall Study||11
6288978|NCT00255177|7190250|FG001|STARTED|Overall Study||14
6288979|NCT00255177|7190251|FG002|STARTED|Overall Study||13
6288980|NCT00255177|7190252|FG003|STARTED|Overall Study||6
6288981|NCT00255177|7190249|FG000|COMPLETED|Overall Study||9
6288982|NCT00255177|7190250|FG001|COMPLETED|Overall Study||13
6288983|NCT00255177|7190251|FG002|COMPLETED|Overall Study||12
6288984|NCT00255177|7190252|FG003|COMPLETED|Overall Study||4
6288985|NCT00255177|7190249|FG000|NOT COMPLETED|Overall Study||2
6288986|NCT00255177|7190250|FG001|NOT COMPLETED|Overall Study||1
6288987|NCT00255177|7190251|FG002|NOT COMPLETED|Overall Study||1
6288988|NCT00255177|7190252|FG003|NOT COMPLETED|Overall Study||2
6288989|NCT00255190|7190264|FG000|STARTED|Overall Study||153
6288990|NCT00255190|7190265|FG001|STARTED|Overall Study||438
6288991|NCT00255190|7190264|FG000|COMPLETED|Overall Study||103
6288992|NCT00255190|7190265|FG001|COMPLETED|Overall Study||281
6288993|NCT00255190|7190264|FG000|NOT COMPLETED|Overall Study||50
6288994|NCT00255190|7190265|FG001|NOT COMPLETED|Overall Study||157
6288995|NCT00255346|7190276|FG000|STARTED|Overall Study||10
6288996|NCT00255346|7190277|FG001|STARTED|Overall Study||6
6288997|NCT00255346|7190278|FG002|STARTED|Overall Study||8
6288998|NCT00255346|7190279|FG003|STARTED|Overall Study||11
6288999|NCT00255346|7190280|FG004|STARTED|Overall Study||33
6289000|NCT00255346|7190276|FG000|COMPLETED|Overall Study||9
6289001|NCT00255346|7190277|FG001|COMPLETED|Overall Study||6
6289002|NCT00255346|7190278|FG002|COMPLETED|Overall Study||8
6289003|NCT00255346|7190279|FG003|COMPLETED|Overall Study||11
6289004|NCT00255346|7190280|FG004|COMPLETED|Overall Study||33
6289005|NCT00255346|7190276|FG000|NOT COMPLETED|Overall Study||1
6289006|NCT00255346|7190277|FG001|NOT COMPLETED|Overall Study||0
6289007|NCT00255346|7190278|FG002|NOT COMPLETED|Overall Study||0
6289008|NCT00255346|7190279|FG003|NOT COMPLETED|Overall Study||0
6289009|NCT00255346|7190280|FG004|NOT COMPLETED|Overall Study||0
6289010|NCT00255684|7190288|FG000|STARTED|Overall Study||16
6289011|NCT00255684|7190288|FG000|COMPLETED|Overall Study||16
6289012|NCT00255684|7190288|FG000|NOT COMPLETED|Overall Study||0
6289013|NCT00255723|7190294|FG000|STARTED|Overall Study||56
6289014|NCT00255723|7190295|FG001|STARTED|Overall Study||41
6289015|NCT00255723|7190294|FG000|COMPLETED|Overall Study||54
6289016|NCT00255723|7190295|FG001|COMPLETED|Overall Study||39
6289017|NCT00255723|7190294|FG000|NOT COMPLETED|Overall Study||2
6289018|NCT00255723|7190295|FG001|NOT COMPLETED|Overall Study||2
6289019|NCT00255801|7190301|FG000|STARTED|Overall Study||37
6634670|NCT02298192|7563448|FG000|COMPLETED|Overall Study||191
6289020|NCT00255801|7190301|FG000|COMPLETED|Overall Study||37
6289021|NCT00255801|7190301|FG000|NOT COMPLETED|Overall Study||0
6289022|NCT00255840|7190307|FG000|STARTED|Overall Study||408
6289023|NCT00255840|7190308|FG001|STARTED|Overall Study||404
6289024|NCT00255840|7190307|FG000|COMPLETED|Overall Study||345
6289025|NCT00255840|7190308|FG001|COMPLETED|Overall Study||334
6289026|NCT00255840|7190307|FG000|NOT COMPLETED|Overall Study||63
6289027|NCT00255840|7190308|FG001|NOT COMPLETED|Overall Study||70
6289028|NCT00255944|7190316|FG000|STARTED|Overall Study||1311
6289029|NCT00255944|7190317|FG001|STARTED|Overall Study||1311
6289030|NCT00255944|7190316|FG000|COMPLETED|Overall Study||514
6289031|NCT00255944|7190317|FG001|COMPLETED|Overall Study||477
6289032|NCT00255944|7190316|FG000|NOT COMPLETED|Overall Study||797
6289033|NCT00255944|7190317|FG001|NOT COMPLETED|Overall Study||834
6289034|NCT00255970|7190325|FG000|STARTED|Overall Study||21
6289035|NCT00255970|7190326|FG001|STARTED|Overall Study||19
6289036|NCT00255970|7190325|FG000|Screening Visit|Overall Study||21
6289037|NCT00255970|7190326|FG001|Screening Visit|Overall Study||19
6289038|NCT00255970|7190325|FG000|Final Visit Week 24|Overall Study||21
6289039|NCT00255970|7190326|FG001|Final Visit Week 24|Overall Study||19
6289040|NCT00255970|7190325|FG000|COMPLETED|Overall Study||21
6289041|NCT00255970|7190326|FG001|COMPLETED|Overall Study||19
6289042|NCT00255970|7190325|FG000|NOT COMPLETED|Overall Study||0
6289043|NCT00255970|7190326|FG001|NOT COMPLETED|Overall Study||0
6289044|NCT00256126|7190334|FG000|STARTED|Overall Study||149
6289045|NCT00256126|7190335|FG001|STARTED|Overall Study||169
6289046|NCT00256126|7190334|FG000|COMPLETED|Overall Study||147
6289047|NCT00256126|7190335|FG001|COMPLETED|Overall Study||167
6289048|NCT00256126|7190334|FG000|NOT COMPLETED|Overall Study||2
6289049|NCT00256126|7190335|FG001|NOT COMPLETED|Overall Study||2
6289050|NCT00256204|7190345|FG000|STARTED|Overall Study||298
6634671|NCT02298192|7563449|FG001|COMPLETED|Overall Study||204
6634672|NCT02298192|7563448|FG000|NOT COMPLETED|Overall Study||19
6634673|NCT02298192|7563449|FG001|NOT COMPLETED|Overall Study||6
6289051|NCT00256204|7190346|FG001|STARTED|Overall Study||288
6289052|NCT00256204|7190347|FG002|STARTED|Overall Study||295
6289053|NCT00256204|7190348|FG003|STARTED|Overall Study||293
6289054|NCT00256204|7190345|FG000|COMPLETED|Overall Study||231
6289055|NCT00256204|7190346|FG001|COMPLETED|Overall Study||238
6289056|NCT00256204|7190347|FG002|COMPLETED|Overall Study||241
6289057|NCT00256204|7190348|FG003|COMPLETED|Overall Study||244
6289058|NCT00256204|7190345|FG000|NOT COMPLETED|Overall Study||67
6289059|NCT00256204|7190346|FG001|NOT COMPLETED|Overall Study||50
6289060|NCT00256204|7190347|FG002|NOT COMPLETED|Overall Study||54
6289061|NCT00256204|7190348|FG003|NOT COMPLETED|Overall Study||49
6289062|NCT00256217|7190361|FG000|STARTED|Overall Study||42
6289063|NCT00256217|7190361|FG000|COMPLETED|Overall Study||34
6289064|NCT00256217|7190361|FG000|NOT COMPLETED|Overall Study||8
6289065|NCT00256243|7190365|FG000|STARTED|Overall Study||48
6289066|NCT00256243|7190365|FG000|COMPLETED|Overall Study||38
6289067|NCT00256243|7190365|FG000|NOT COMPLETED|Overall Study||10
6289068|NCT00256282|7190370|FG000|STARTED|Overall Study||52
6289069|NCT00256282|7190370|FG000|COMPLETED|Overall Study||36
6289070|NCT00256282|7190370|FG000|NOT COMPLETED|Overall Study||16
6289071|NCT00256308|7190374|FG000|STARTED|Overall Study||6
6289072|NCT00256308|7190374|FG000|COMPLETED|Overall Study||4
6289073|NCT00256308|7190374|FG000|NOT COMPLETED|Overall Study||2
6289074|NCT00256451|7190378|FG000|STARTED|Session1||10
6289075|NCT00256451|7190379|FG001|STARTED|Session1||11
6289076|NCT00256451|7190380|FG002|STARTED|Session1||11
6289077|NCT00256451|7190381|FG003|STARTED|Session1||11
6289078|NCT00256451|7190378|FG000|COMPLETED|Session1||10
6289079|NCT00256451|7190379|FG001|COMPLETED|Session1||11
6289080|NCT00256451|7190380|FG002|COMPLETED|Session1||11
6289081|NCT00256451|7190381|FG003|COMPLETED|Session1||11
6289082|NCT00256451|7190378|FG000|NOT COMPLETED|Session1||0
6289083|NCT00256451|7190379|FG001|NOT COMPLETED|Session1||0
6289084|NCT00256451|7190380|FG002|NOT COMPLETED|Session1||0
6289085|NCT00256451|7190381|FG003|NOT COMPLETED|Session1||0
6289086|NCT00256451|7190378|FG000|STARTED|Session2||9
6289087|NCT00256451|7190379|FG001|STARTED|Session2||11
6289088|NCT00256451|7190380|FG002|STARTED|Session2||10
6289089|NCT00256451|7190381|FG003|STARTED|Session2||10
6289090|NCT00256451|7190378|FG000|COMPLETED|Session2||9
6289091|NCT00256451|7190379|FG001|COMPLETED|Session2||11
6634674|NCT02298322|7563455|FG000|STARTED|Overall Study||60
6634675|NCT02298322|7563455|FG000|COMPLETED|Overall Study||60
6289092|NCT00256451|7190380|FG002|COMPLETED|Session2||10
6289093|NCT00256451|7190381|FG003|COMPLETED|Session2||10
6289094|NCT00256451|7190378|FG000|NOT COMPLETED|Session2||0
6289095|NCT00256451|7190379|FG001|NOT COMPLETED|Session2||0
6289096|NCT00256451|7190380|FG002|NOT COMPLETED|Session2||0
6289097|NCT00256451|7190381|FG003|NOT COMPLETED|Session2||0
6289098|NCT00256451|7190378|FG000|STARTED|Session3||9
6289099|NCT00256451|7190379|FG001|STARTED|Session3||9
6289100|NCT00256451|7190380|FG002|STARTED|Session3||10
6289101|NCT00256451|7190381|FG003|STARTED|Session3||9
6289102|NCT00256451|7190378|FG000|COMPLETED|Session3||9
6289103|NCT00256451|7190379|FG001|COMPLETED|Session3||9
6289104|NCT00256451|7190380|FG002|COMPLETED|Session3||10
6289105|NCT00256451|7190381|FG003|COMPLETED|Session3||9
6289106|NCT00256451|7190378|FG000|NOT COMPLETED|Session3||0
6289107|NCT00256451|7190379|FG001|NOT COMPLETED|Session3||0
6289108|NCT00256451|7190380|FG002|NOT COMPLETED|Session3||0
6289109|NCT00256451|7190381|FG003|NOT COMPLETED|Session3||0
6289110|NCT00256451|7190378|FG000|STARTED|Session4||9
6289111|NCT00256451|7190379|FG001|STARTED|Session4||8
6289112|NCT00256451|7190380|FG002|STARTED|Session4||10
6289113|NCT00256451|7190381|FG003|STARTED|Session4||8
6289114|NCT00256451|7190378|FG000|COMPLETED|Session4||9
6289115|NCT00256451|7190379|FG001|COMPLETED|Session4||8
6289116|NCT00256451|7190380|FG002|COMPLETED|Session4||10
6289117|NCT00256451|7190381|FG003|COMPLETED|Session4||8
6289118|NCT00256451|7190378|FG000|NOT COMPLETED|Session4||0
6289119|NCT00256451|7190379|FG001|NOT COMPLETED|Session4||0
6289120|NCT00256451|7190380|FG002|NOT COMPLETED|Session4||0
6289121|NCT00256451|7190381|FG003|NOT COMPLETED|Session4||0
6289122|NCT00256698|7190393|FG000|STARTED|Overall Study||258
6289123|NCT00256698|7190394|FG001|STARTED|Overall Study||256
6289124|NCT00256698|7190393|FG000|COMPLETED|Overall Study||91
6289125|NCT00256698|7190394|FG001|COMPLETED|Overall Study||84
6289126|NCT00256698|7190393|FG000|NOT COMPLETED|Overall Study||167
6289127|NCT00256698|7190394|FG001|NOT COMPLETED|Overall Study||172
6289128|NCT00256724|7190402|FG000|STARTED|Overall Study||23
6289129|NCT00256724|7190403|FG001|STARTED|Overall Study||24
6289130|NCT00256724|7190402|FG000|COMPLETED|Overall Study||18
6289131|NCT00256724|7190403|FG001|COMPLETED|Overall Study||16
6289132|NCT00256724|7190402|FG000|NOT COMPLETED|Overall Study||5
6289133|NCT00256724|7190403|FG001|NOT COMPLETED|Overall Study||8
6289134|NCT00256750|7190412|FG000|STARTED|Transplanted Pre-Treatment||221
6289135|NCT00256750|7190413|FG001|STARTED|Transplanted Pre-Treatment||226
6289136|NCT00256750|7190414|FG002|STARTED|Transplanted Pre-Treatment||219
6289137|NCT00256750|7190412|FG000|COMPLETED|Transplanted Pre-Treatment||215
6289138|NCT00256750|7190413|FG001|COMPLETED|Transplanted Pre-Treatment||226
6289139|NCT00256750|7190414|FG002|COMPLETED|Transplanted Pre-Treatment||219
6289140|NCT00256750|7190412|FG000|NOT COMPLETED|Transplanted Pre-Treatment||6
6289141|NCT00256750|7190413|FG001|NOT COMPLETED|Transplanted Pre-Treatment||0
6289142|NCT00256750|7190414|FG002|NOT COMPLETED|Transplanted Pre-Treatment||0
6289143|NCT00256750|7190412|FG000|STARTED|Post-Transplant Treated (12 Months)||215
6289144|NCT00256750|7190413|FG001|STARTED|Post-Transplant Treated (12 Months)||226
6289145|NCT00256750|7190414|FG002|STARTED|Post-Transplant Treated (12 Months)||219
6289146|NCT00256750|7190412|FG000|COMPLETED|Post-Transplant Treated (12 Months)||174
6289147|NCT00256750|7190413|FG001|COMPLETED|Post-Transplant Treated (12 Months)||183
6289148|NCT00256750|7190414|FG002|COMPLETED|Post-Transplant Treated (12 Months)||173
6289149|NCT00256750|7190412|FG000|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
6289150|NCT00256750|7190413|FG001|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
6289151|NCT00256750|7190414|FG002|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
6289152|NCT00256750|7190412|FG000|STARTED|Post-Transplant Treated (24 Months)||174
6289153|NCT00256750|7190413|FG001|STARTED|Post-Transplant Treated (24 Months)||183
6289154|NCT00256750|7190414|FG002|STARTED|Post-Transplant Treated (24 Months)||173
6289155|NCT00256750|7190412|FG000|COMPLETED|Post-Transplant Treated (24 Months)||153
6289156|NCT00256750|7190413|FG001|COMPLETED|Post-Transplant Treated (24 Months)||176
6289157|NCT00256750|7190414|FG002|COMPLETED|Post-Transplant Treated (24 Months)||164
6289158|NCT00256750|7190412|FG000|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
6289159|NCT00256750|7190413|FG001|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
6289160|NCT00256750|7190414|FG002|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
6289161|NCT00256750|7190412|FG000|STARTED|Post-Transplant Treated (36 Months)||153
6289162|NCT00256750|7190413|FG001|STARTED|Post-Transplant Treated (36 Months)||176
6289163|NCT00256750|7190414|FG002|STARTED|Post-Transplant Treated (36 Months)||164
6289164|NCT00256750|7190412|FG000|COMPLETED|Post-Transplant Treated (36 Months)||143
6289165|NCT00256750|7190413|FG001|COMPLETED|Post-Transplant Treated (36 Months)||170
6289166|NCT00256750|7190414|FG002|COMPLETED|Post-Transplant Treated (36 Months)||158
6289167|NCT00256750|7190412|FG000|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
6289168|NCT00256750|7190413|FG001|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
6289169|NCT00256750|7190414|FG002|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
6289170|NCT00256750|7190412|FG000|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
6289171|NCT00256750|7190413|FG001|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
6289172|NCT00256750|7190414|FG002|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
6289173|NCT00256750|7190412|FG000|COMPLETED|Long Term Extension (LTE; 84 Months)||89
6289174|NCT00256750|7190413|FG001|COMPLETED|Long Term Extension (LTE; 84 Months)||136
6289175|NCT00256750|7190414|FG002|COMPLETED|Long Term Extension (LTE; 84 Months)||127
6289176|NCT00256750|7190412|FG000|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
6289177|NCT00256750|7190413|FG001|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
6289178|NCT00256750|7190414|FG002|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
6289179|NCT00256776|7190425|FG000|STARTED|Overall Study||135
6289180|NCT00256776|7190426|FG001|STARTED|Overall Study||134
6289181|NCT00256776|7190425|FG000|COMPLETED|Overall Study||52
6289182|NCT00256776|7190426|FG001|COMPLETED|Overall Study||54
6289183|NCT00256776|7190425|FG000|NOT COMPLETED|Overall Study||83
6289184|NCT00256776|7190426|FG001|NOT COMPLETED|Overall Study||80
6289185|NCT00256854|7190440|FG000|STARTED|Overall Study||26
6289186|NCT00256854|7190441|FG001|STARTED|Overall Study||26
6289187|NCT00256854|7190442|FG002|STARTED|Overall Study||26
6289188|NCT00256854|7190443|FG003|STARTED|Overall Study||27
6289189|NCT00256854|7190444|FG004|STARTED|Overall Study||16
6289190|NCT00256854|7190445|FG005|STARTED|Overall Study||14
6289191|NCT00256854|7190440|FG000|COMPLETED|Overall Study||23
6289192|NCT00256854|7190441|FG001|COMPLETED|Overall Study||22
6289193|NCT00256854|7190442|FG002|COMPLETED|Overall Study||23
6289194|NCT00256854|7190443|FG003|COMPLETED|Overall Study||24
6289195|NCT00256854|7190444|FG004|COMPLETED|Overall Study||15
6289196|NCT00256854|7190445|FG005|COMPLETED|Overall Study||13
6289197|NCT00256854|7190440|FG000|NOT COMPLETED|Overall Study||3
6289198|NCT00256854|7190441|FG001|NOT COMPLETED|Overall Study||4
6289199|NCT00256854|7190442|FG002|NOT COMPLETED|Overall Study||3
6289200|NCT00256854|7190443|FG003|NOT COMPLETED|Overall Study||3
6289201|NCT00256854|7190444|FG004|NOT COMPLETED|Overall Study||1
6289202|NCT00256854|7190445|FG005|NOT COMPLETED|Overall Study||1
6289203|NCT00256867|7190468|FG000|STARTED|Overall Study||47
6289204|NCT00256867|7190469|FG001|STARTED|Overall Study||44
6289205|NCT00256867|7190470|FG002|STARTED|Overall Study||45
6289206|NCT00256867|7190471|FG003|STARTED|Overall Study||46
6289207|NCT00256867|7190472|FG004|STARTED|Overall Study||48
6289208|NCT00256867|7190473|FG005|STARTED|Overall Study||46
6289209|NCT00256867|7190474|FG006|STARTED|Overall Study||46
6289210|NCT00256867|7190475|FG007|STARTED|Overall Study||47
6289211|NCT00256867|7190468|FG000|COMPLETED|Overall Study||45
6289212|NCT00256867|7190469|FG001|COMPLETED|Overall Study||39
6289213|NCT00256867|7190470|FG002|COMPLETED|Overall Study||40
6289214|NCT00256867|7190471|FG003|COMPLETED|Overall Study||40
6289215|NCT00256867|7190472|FG004|COMPLETED|Overall Study||41
6289216|NCT00256867|7190473|FG005|COMPLETED|Overall Study||40
6289217|NCT00256867|7190474|FG006|COMPLETED|Overall Study||41
6289218|NCT00256867|7190475|FG007|COMPLETED|Overall Study||36
6289219|NCT00256867|7190468|FG000|NOT COMPLETED|Overall Study||2
6289220|NCT00256867|7190469|FG001|NOT COMPLETED|Overall Study||5
6289221|NCT00256867|7190470|FG002|NOT COMPLETED|Overall Study||5
6289222|NCT00256867|7190471|FG003|NOT COMPLETED|Overall Study||6
6289223|NCT00256867|7190472|FG004|NOT COMPLETED|Overall Study||7
6289224|NCT00256867|7190473|FG005|NOT COMPLETED|Overall Study||6
6289225|NCT00256867|7190474|FG006|NOT COMPLETED|Overall Study||5
6289226|NCT00256867|7190475|FG007|NOT COMPLETED|Overall Study||11
6289227|NCT00256984|7190498|FG000|STARTED|Overall Study||75
6289228|NCT00256984|7190498|FG000|COMPLETED|Overall Study||59
6289229|NCT00256984|7190498|FG000|NOT COMPLETED|Overall Study||16
6289230|NCT00256997|7190504|FG000|STARTED|Overall Study||81
6289231|NCT00256997|7190505|FG001|STARTED|Overall Study||86
6289232|NCT00256997|7190504|FG000|Treated|Overall Study||79
6289233|NCT00256997|7190505|FG001|Treated|Overall Study||86
6289234|NCT00256997|7190504|FG000|COMPLETED|Overall Study||33
6289235|NCT00256997|7190505|FG001|COMPLETED|Overall Study||31
6289236|NCT00256997|7190504|FG000|NOT COMPLETED|Overall Study||48
6289237|NCT00256997|7190505|FG001|NOT COMPLETED|Overall Study||55
6289238|NCT00257010|7190512|FG000|STARTED|Overall Study||447
6289239|NCT00257010|7190512|FG000|COMPLETED|Overall Study||319
6289240|NCT00257010|7190512|FG000|NOT COMPLETED|Overall Study||128
6289241|NCT00257166|7190518|FG000|STARTED|Overall Study||150
6634676|NCT02298322|7563455|FG000|NOT COMPLETED|Overall Study||0
6634677|NCT02298361|7563465|FG000|STARTED|Overall Study||2240
6634678|NCT02298361|7563466|FG001|STARTED|Overall Study||12784
6289242|NCT00257166|7190519|FG001|STARTED|Overall Study||88
6289243|NCT00257166|7190518|FG000|Treated|Overall Study||149
6289244|NCT00257166|7190519|FG001|Treated|Overall Study||88
6289245|NCT00257166|7190518|FG000|COMPLETED|Overall Study||97
6289246|NCT00257166|7190519|FG001|COMPLETED|Overall Study||51
6289247|NCT00257166|7190518|FG000|NOT COMPLETED|Overall Study||53
6289248|NCT00257166|7190519|FG001|NOT COMPLETED|Overall Study||37
6289249|NCT00257192|7190527|FG000|STARTED|Overall Study||193
6289250|NCT00257192|7190528|FG001|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
6289251|NCT00257192|7190527|FG000|Received Study Treatment|Overall Study||193
6289252|NCT00257192|7190528|FG001|Received Study Treatment|Overall Study||90
6289253|NCT00257192|7190527|FG000|COMPLETED|Overall Study||135
6289254|NCT00257192|7190528|FG001|COMPLETED|Overall Study||52
6289255|NCT00257192|7190527|FG000|NOT COMPLETED|Overall Study||58
6289256|NCT00257192|7190528|FG001|NOT COMPLETED|Overall Study||39
6289257|NCT00257309|7190536|FG000|STARTED|Overall Study||134
6289258|NCT00257309|7190537|FG001|STARTED|Overall Study||132
6289259|NCT00257309|7190536|FG000|COMPLETED|Overall Study||132
6289260|NCT00257309|7190537|FG001|COMPLETED|Overall Study||130
6289261|NCT00257309|7190536|FG000|NOT COMPLETED|Overall Study||2
6289262|NCT00257309|7190537|FG001|NOT COMPLETED|Overall Study||2
6289263|NCT00257322|7190543|FG000|STARTED|Overall Study|20 subjects accrued.|20
6289264|NCT00257322|7190543|FG000|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
6289265|NCT00257322|7190543|FG000|NOT COMPLETED|Overall Study||4
6289266|NCT00257556|7190549|FG000|STARTED|Overall Study||38
6289267|NCT00257556|7190550|FG001|STARTED|Overall Study||42
6374068|NCT00748098|7284648|FG000|STARTED|First Treatment Intervention Period||69
6634679|NCT02298361|7563467|FG002|STARTED|Overall Study||12227
6634680|NCT02298361|7563465|FG000|COMPLETED|Overall Study||2240
6634681|NCT02298361|7563466|FG001|COMPLETED|Overall Study||12784
6634682|NCT02298361|7563467|FG002|COMPLETED|Overall Study||12227
6634683|NCT02298361|7563465|FG000|NOT COMPLETED|Overall Study||0
6289268|NCT00257556|7190549|FG000|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
6289269|NCT00257556|7190550|FG001|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
6289270|NCT00257556|7190549|FG000|COMPLETED|Overall Study||24
6289271|NCT00257556|7190550|FG001|COMPLETED|Overall Study||32
6289272|NCT00257556|7190549|FG000|NOT COMPLETED|Overall Study||14
6289273|NCT00257556|7190550|FG001|NOT COMPLETED|Overall Study||10
6289274|NCT00257608|7190558|FG000|STARTED|Chemotherapy Phase||1145
6289275|NCT00257608|7190559|FG001|STARTED|Chemotherapy Phase||0
6289276|NCT00257608|7190560|FG002|STARTED|Chemotherapy Phase||0
6289277|NCT00257608|7190558|FG000|COMPLETED|Chemotherapy Phase||769
6289278|NCT00257608|7190559|FG001|COMPLETED|Chemotherapy Phase||0
6289279|NCT00257608|7190560|FG002|COMPLETED|Chemotherapy Phase||0
6634684|NCT02298361|7563466|FG001|NOT COMPLETED|Overall Study||0
6634685|NCT02298361|7563467|FG002|NOT COMPLETED|Overall Study||0
6634686|NCT02298491|7563475|FG000|STARTED|Overall Study||4
6634687|NCT02298491|7563475|FG000|COMPLETED|Overall Study||3
6289280|NCT00257608|7190558|FG000|NOT COMPLETED|Chemotherapy Phase||376
6289281|NCT00257608|7190559|FG001|NOT COMPLETED|Chemotherapy Phase||0
6289282|NCT00257608|7190560|FG002|NOT COMPLETED|Chemotherapy Phase||0
6289283|NCT00257608|7190558|FG000|STARTED|Post Chemotherapy Phase||0
6289284|NCT00257608|7190559|FG001|STARTED|Post Chemotherapy Phase||373
6289285|NCT00257608|7190560|FG002|STARTED|Post Chemotherapy Phase||370
6289286|NCT00257608|7190558|FG000|COMPLETED|Post Chemotherapy Phase||0
6289287|NCT00257608|7190559|FG001|COMPLETED|Post Chemotherapy Phase||109
6289288|NCT00257608|7190560|FG002|COMPLETED|Post Chemotherapy Phase||126
6289289|NCT00257608|7190558|FG000|NOT COMPLETED|Post Chemotherapy Phase||0
6289290|NCT00257608|7190559|FG001|NOT COMPLETED|Post Chemotherapy Phase||264
6289291|NCT00257608|7190560|FG002|NOT COMPLETED|Post Chemotherapy Phase||244
6289292|NCT00257660|7190575|FG000|STARTED|Overall Study||55
6289293|NCT00257660|7190576|FG001|STARTED|Overall Study||61
6289294|NCT00257660|7190575|FG000|COMPLETED|Overall Study||45
6289295|NCT00257660|7190576|FG001|COMPLETED|Overall Study||38
6289296|NCT00257660|7190575|FG000|NOT COMPLETED|Overall Study||10
6289297|NCT00257660|7190576|FG001|NOT COMPLETED|Overall Study||23
6289298|NCT00257686|7190588|FG000|STARTED|Overall Study||209
6289299|NCT00257686|7190589|FG001|STARTED|Overall Study||108
6289300|NCT00257686|7190590|FG002|STARTED|Overall Study||226
6289301|NCT00257686|7190591|FG003|STARTED|Overall Study||99
6289302|NCT00257686|7190592|FG004|STARTED|Overall Study||216
6289303|NCT00257686|7190593|FG005|STARTED|Overall Study||104
6289304|NCT00257686|7190588|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
6289305|NCT00257686|7190589|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
6289306|NCT00257686|7190590|FG002|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
6289307|NCT00257686|7190591|FG003|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
6289308|NCT00257686|7190592|FG004|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
6634688|NCT02298491|7563475|FG000|NOT COMPLETED|Overall Study||1
6289309|NCT00257686|7190593|FG005|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
6289310|NCT00257686|7190588|FG000|COMPLETED|Overall Study||188
6289311|NCT00257686|7190589|FG001|COMPLETED|Overall Study||89
6289312|NCT00257686|7190590|FG002|COMPLETED|Overall Study||208
6289313|NCT00257686|7190591|FG003|COMPLETED|Overall Study||88
6289314|NCT00257686|7190592|FG004|COMPLETED|Overall Study||194
6289315|NCT00257686|7190593|FG005|COMPLETED|Overall Study||95
6289316|NCT00257686|7190588|FG000|NOT COMPLETED|Overall Study||21
6289317|NCT00257686|7190589|FG001|NOT COMPLETED|Overall Study||19
6289318|NCT00257686|7190590|FG002|NOT COMPLETED|Overall Study||18
6289319|NCT00257686|7190591|FG003|NOT COMPLETED|Overall Study||11
6289320|NCT00257686|7190592|FG004|NOT COMPLETED|Overall Study||22
6289321|NCT00257686|7190593|FG005|NOT COMPLETED|Overall Study||9
6289322|NCT00257725|7190607|FG000|STARTED|Overall Study||11
6289323|NCT00257725|7190607|FG000|COMPLETED|Overall Study||8
6289324|NCT00257725|7190607|FG000|NOT COMPLETED|Overall Study||3
6289325|NCT00257894|7190614|FG000|STARTED|Overall Study||21
6289326|NCT00257894|7190615|FG001|STARTED|Overall Study||20
6289327|NCT00257894|7190614|FG000|COMPLETED|Overall Study||17
6289328|NCT00257894|7190615|FG001|COMPLETED|Overall Study||15
6289329|NCT00257894|7190614|FG000|NOT COMPLETED|Overall Study||4
6289330|NCT00257894|7190615|FG001|NOT COMPLETED|Overall Study||5
6289331|NCT00257920|7190623|FG000|STARTED|Period: First Intervention||21
6289332|NCT00257920|7190624|FG001|STARTED|Period: First Intervention||20
6289333|NCT00257920|7190623|FG000|COMPLETED|Period: First Intervention||21
6289334|NCT00257920|7190624|FG001|COMPLETED|Period: First Intervention||20
6289335|NCT00257920|7190623|FG000|NOT COMPLETED|Period: First Intervention||0
6289336|NCT00257920|7190624|FG001|NOT COMPLETED|Period: First Intervention||0
6289337|NCT00257920|7190623|FG000|STARTED|Period: Washout Period of Two Weeks||21
6289338|NCT00257920|7190624|FG001|STARTED|Period: Washout Period of Two Weeks||20
6634689|NCT02298803|7563481|FG000|STARTED|Overall Study||30
6289339|NCT00257920|7190623|FG000|COMPLETED|Period: Washout Period of Two Weeks||21
6289340|NCT00257920|7190624|FG001|COMPLETED|Period: Washout Period of Two Weeks||19
6289341|NCT00257920|7190623|FG000|NOT COMPLETED|Period: Washout Period of Two Weeks||0
6634690|NCT02298803|7563481|FG000|COMPLETED|Overall Study||30
6289342|NCT00257920|7190624|FG001|NOT COMPLETED|Period: Washout Period of Two Weeks||1
6289343|NCT00257920|7190623|FG000|STARTED|Period: Second Intervention||21
6289344|NCT00257920|7190624|FG001|STARTED|Period: Second Intervention||19
6289345|NCT00257920|7190623|FG000|COMPLETED|Period: Second Intervention||19
6289346|NCT00257920|7190624|FG001|COMPLETED|Period: Second Intervention||18
6289347|NCT00257920|7190623|FG000|NOT COMPLETED|Period: Second Intervention||2
6289348|NCT00257920|7190624|FG001|NOT COMPLETED|Period: Second Intervention||1
6289349|NCT00257933|7190633|FG000|STARTED|Overall Study||74
6289350|NCT00257933|7190634|FG001|STARTED|Overall Study||78
6289351|NCT00257933|7190633|FG000|COMPLETED|Overall Study||74
6289352|NCT00257933|7190634|FG001|COMPLETED|Overall Study||78
6289353|NCT00257933|7190633|FG000|NOT COMPLETED|Overall Study||0
6289354|NCT00257933|7190634|FG001|NOT COMPLETED|Overall Study||0
6289355|NCT00258011|7190640|FG000|STARTED|Overall Study||3
6289356|NCT00258011|7190640|FG000|COMPLETED|Overall Study||3
6289357|NCT00258011|7190640|FG000|NOT COMPLETED|Overall Study||0
6289358|NCT00258128|7190646|FG000|STARTED|Overall Study||8
6289359|NCT00258128|7190647|FG001|STARTED|Overall Study||9
6289360|NCT00258128|7190646|FG000|COMPLETED|Overall Study||8
6289361|NCT00258128|7190647|FG001|COMPLETED|Overall Study||9
6289362|NCT00258128|7190646|FG000|NOT COMPLETED|Overall Study||0
6289363|NCT00258128|7190647|FG001|NOT COMPLETED|Overall Study||0
6289364|NCT00258154|7190657|FG000|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
6289365|NCT00258154|7190658|FG001|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
6289366|NCT00258154|7190657|FG000|Vaccinated at Visit 1|Overall Study||201
6289367|NCT00258154|7190658|FG001|Vaccinated at Visit 1|Overall Study||202
6289368|NCT00258154|7190657|FG000|Vaccinated at Visit 2|Overall Study||198
6289369|NCT00258154|7190658|FG001|Vaccinated at Visit 2|Overall Study||198
6289370|NCT00258154|7190657|FG000|Vaccinated at Visit 3|Overall Study||195
6289371|NCT00258154|7190658|FG001|Vaccinated at Visit 3|Overall Study||197
6289372|NCT00258154|7190657|FG000|COMPLETED|Overall Study|Subjects who completed the study.|192
6289373|NCT00258154|7190658|FG001|COMPLETED|Overall Study|Subjects who completed the study.|195
6289374|NCT00258154|7190657|FG000|NOT COMPLETED|Overall Study||9
6289375|NCT00258154|7190658|FG001|NOT COMPLETED|Overall Study||7
6289376|NCT00258180|7190664|FG000|STARTED|Overall Study||2
6289377|NCT00258180|7190664|FG000|COMPLETED|Overall Study||2
6289378|NCT00258180|7190664|FG000|NOT COMPLETED|Overall Study||0
6289379|NCT00258206|7190669|FG000|STARTED|Overall Study||21
6289380|NCT00258206|7190669|FG000|COMPLETED|Overall Study||21
6289381|NCT00258206|7190669|FG000|NOT COMPLETED|Overall Study||0
6289382|NCT00258310|7190673|FG000|STARTED|Overall Study||35
6289383|NCT00258310|7190673|FG000|COMPLETED|Overall Study||35
6289384|NCT00258310|7190673|FG000|NOT COMPLETED|Overall Study||0
6289385|NCT00258349|7190677|FG000|STARTED|Overall Study||16
6289386|NCT00258349|7190677|FG000|HER2-positive by Central Review|Overall Study||10
6289387|NCT00258349|7190677|FG000|COMPLETED|Overall Study||16
6289388|NCT00258349|7190677|FG000|NOT COMPLETED|Overall Study||0
6289389|NCT00258362|7190683|FG000|STARTED|Overall Study||41
6289390|NCT00258362|7190683|FG000|COMPLETED|Overall Study||41
6289391|NCT00258362|7190683|FG000|NOT COMPLETED|Overall Study||0
6289392|NCT00258440|7190691|FG000|STARTED|Overall Study||1
6289393|NCT00258440|7190692|FG001|STARTED|Overall Study||0
6289394|NCT00258440|7190693|FG002|STARTED|Overall Study||6
6289395|NCT00258440|7190691|FG000|COMPLETED|Overall Study||1
6289396|NCT00258440|7190692|FG001|COMPLETED|Overall Study||0
6289397|NCT00258440|7190693|FG002|COMPLETED|Overall Study||5
6289398|NCT00258440|7190691|FG000|NOT COMPLETED|Overall Study||0
6289399|NCT00258440|7190692|FG001|NOT COMPLETED|Overall Study||0
6289400|NCT00258440|7190693|FG002|NOT COMPLETED|Overall Study||1
6289401|NCT00258674|7190704|FG000|STARTED|Overall Study||597
6289402|NCT00258674|7190705|FG001|STARTED|Overall Study||811
6289403|NCT00258674|7190706|FG002|STARTED|Overall Study||602
6289404|NCT00258674|7190704|FG000|COMPLETED|Overall Study||565
6289405|NCT00258674|7190705|FG001|COMPLETED|Overall Study||758
6289406|NCT00258674|7190706|FG002|COMPLETED|Overall Study||568
6289407|NCT00258674|7190704|FG000|NOT COMPLETED|Overall Study||32
6289408|NCT00258674|7190705|FG001|NOT COMPLETED|Overall Study||53
6289409|NCT00258674|7190706|FG002|NOT COMPLETED|Overall Study||34
6289410|NCT00258817|7190716|FG000|STARTED|Overall Study||15
6289411|NCT00258817|7190717|FG001|STARTED|Overall Study||15
6289412|NCT00258817|7190716|FG000|COMPLETED|Overall Study||15
6289413|NCT00258817|7190717|FG001|COMPLETED|Overall Study||15
6289414|NCT00258817|7190716|FG000|NOT COMPLETED|Overall Study||0
6289415|NCT00258817|7190717|FG001|NOT COMPLETED|Overall Study||0
6289416|NCT00258830|7190725|FG000|STARTED|Overall Study||60
6289417|NCT00258830|7190726|FG001|STARTED|Overall Study||60
6289418|NCT00258830|7190725|FG000|COMPLETED|Overall Study||60
6289419|NCT00258830|7190726|FG001|COMPLETED|Overall Study||60
6289420|NCT00258830|7190725|FG000|NOT COMPLETED|Overall Study||0
6289421|NCT00258830|7190726|FG001|NOT COMPLETED|Overall Study||0
6289422|NCT00258856|7190736|FG000|STARTED|Overall Study||59
6289423|NCT00258856|7190737|FG001|STARTED|Overall Study||58
6289424|NCT00258856|7190738|FG002|STARTED|Overall Study||58
6289425|NCT00258856|7190739|FG003|STARTED|Overall Study||59
6289426|NCT00258856|7190736|FG000|COMPLETED|Overall Study||56
6289427|NCT00258856|7190737|FG001|COMPLETED|Overall Study||58
6289428|NCT00258856|7190738|FG002|COMPLETED|Overall Study||56
6289429|NCT00258856|7190739|FG003|COMPLETED|Overall Study||58
6289430|NCT00258856|7190736|FG000|NOT COMPLETED|Overall Study||3
6289431|NCT00258856|7190737|FG001|NOT COMPLETED|Overall Study||0
6289432|NCT00258856|7190738|FG002|NOT COMPLETED|Overall Study||2
6289433|NCT00258856|7190739|FG003|NOT COMPLETED|Overall Study||1
6289434|NCT00258882|7190751|FG000|STARTED|Adacel Recipients Historic Cohort Method||124139
6289435|NCT00258882|7190752|FG001|STARTED|Adacel Recipients Historic Cohort Method||203154
6289436|NCT00258882|7190751|FG000|COMPLETED|Adacel Recipients Historic Cohort Method||124139
6289437|NCT00258882|7190752|FG001|COMPLETED|Adacel Recipients Historic Cohort Method||203154
6289438|NCT00258882|7190751|FG000|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
6289439|NCT00258882|7190752|FG001|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
6289440|NCT00258882|7190751|FG000|STARTED|Adacel Recipients-Risk Interval Method||124139
6289441|NCT00258882|7190752|FG001|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
6289442|NCT00258882|7190751|FG000|COMPLETED|Adacel Recipients-Risk Interval Method||124139
6289443|NCT00258882|7190752|FG001|COMPLETED|Adacel Recipients-Risk Interval Method||0
6289444|NCT00258882|7190751|FG000|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
6289445|NCT00258882|7190752|FG001|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
6289446|NCT00258882|7190751|FG000|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
6289447|NCT00258882|7190752|FG001|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
6289448|NCT00258882|7190751|FG000|COMPLETED|Pregnancy Surveillance||225
6289449|NCT00258882|7190752|FG001|COMPLETED|Pregnancy Surveillance||675
6289450|NCT00258882|7190751|FG000|NOT COMPLETED|Pregnancy Surveillance||0
6289451|NCT00258882|7190752|FG001|NOT COMPLETED|Pregnancy Surveillance||0
6289452|NCT00258895|7190762|FG000|STARTED|Overall Study||487
6289453|NCT00258895|7190763|FG001|STARTED|Overall Study||162
6289454|NCT00258895|7190762|FG000|COMPLETED|Overall Study||477
6289455|NCT00258895|7190763|FG001|COMPLETED|Overall Study||159
6289456|NCT00258895|7190762|FG000|NOT COMPLETED|Overall Study||10
6289457|NCT00258895|7190763|FG001|NOT COMPLETED|Overall Study||3
6289458|NCT00258908|7190769|FG000|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
6289459|NCT00258908|7190769|FG000|COMPLETED|Overall Study||112
6289460|NCT00258908|7190769|FG000|NOT COMPLETED|Overall Study||0
6289461|NCT00258960|7190773|FG000|STARTED|Overall Study|49 patients included but 1 is not considered due to not receive any treatment and died before start|49
6289462|NCT00258960|7190773|FG000|COMPLETED|Overall Study||32
6289463|NCT00258960|7190773|FG000|NOT COMPLETED|Overall Study||17
6289464|NCT00259012|7190779|FG000|STARTED|Overall Study||33
6289465|NCT00259012|7190780|FG001|STARTED|Overall Study||34
6289466|NCT00259012|7190779|FG000|COMPLETED|Overall Study||31
6289467|NCT00259012|7190780|FG001|COMPLETED|Overall Study||30
6289468|NCT00259012|7190779|FG000|NOT COMPLETED|Overall Study||2
6289469|NCT00259012|7190780|FG001|NOT COMPLETED|Overall Study||4
6289470|NCT00259090|7190789|FG000|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
6289471|NCT00259090|7190790|FG001|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
6289472|NCT00259090|7190791|FG002|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
6289473|NCT00259090|7190789|FG000|COMPLETED|Overall Study||35
6289474|NCT00259090|7190790|FG001|COMPLETED|Overall Study||31
6289475|NCT00259090|7190791|FG002|COMPLETED|Overall Study||37
6289476|NCT00259090|7190789|FG000|NOT COMPLETED|Overall Study||0
6289477|NCT00259090|7190790|FG001|NOT COMPLETED|Overall Study||0
6289478|NCT00259090|7190791|FG002|NOT COMPLETED|Overall Study||0
6289479|NCT00259272|7190803|FG000|STARTED|Overall Study||36
6289480|NCT00259272|7190804|FG001|STARTED|Overall Study||31
6289481|NCT00259272|7190805|FG002|STARTED|Overall Study||26
6289482|NCT00259272|7190806|FG003|STARTED|Overall Study||48
6289483|NCT00259272|7190803|FG000|COMPLETED|Overall Study||21
6289484|NCT00259272|7190804|FG001|COMPLETED|Overall Study||24
6289485|NCT00259272|7190805|FG002|COMPLETED|Overall Study||21
6289486|NCT00259272|7190806|FG003|COMPLETED|Overall Study||27
6289487|NCT00259272|7190803|FG000|NOT COMPLETED|Overall Study||15
6289488|NCT00259272|7190804|FG001|NOT COMPLETED|Overall Study||7
6289489|NCT00259272|7190805|FG002|NOT COMPLETED|Overall Study||5
6289490|NCT00259272|7190806|FG003|NOT COMPLETED|Overall Study||21
6289491|NCT00259285|7190821|FG000|STARTED|Overall Study||10
6289492|NCT00259285|7190821|FG000|COMPLETED|Overall Study||10
6289493|NCT00259285|7190821|FG000|NOT COMPLETED|Overall Study||0
6289494|NCT00259298|7190825|FG000|STARTED|Overall Study||12
6289495|NCT00259298|7190825|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
6289496|NCT00259298|7190825|FG000|COMPLETED|Overall Study||9
6289497|NCT00259298|7190825|FG000|NOT COMPLETED|Overall Study||3
6399458|NCT00880607|7312214|FG000|COMPLETED|Overall Study||37
6399459|NCT00880607|7312215|FG001|COMPLETED|Overall Study||34
6399460|NCT00880607|7312214|FG000|NOT COMPLETED|Overall Study||7
6399461|NCT00880607|7312215|FG001|NOT COMPLETED|Overall Study||3
6399462|NCT00880620|7312227|FG000|STARTED|Overall Study||92
6399463|NCT00880620|7312228|FG001|STARTED|Overall Study||87
6399464|NCT00880620|7312229|FG002|STARTED|Overall Study||104
6399465|NCT00880620|7312230|FG003|STARTED|Overall Study||98
6399466|NCT00880620|7312227|FG000|Week 4|Overall Study||88
6399467|NCT00880620|7312228|FG001|Week 4|Overall Study||79
6399468|NCT00880620|7312229|FG002|Week 4|Overall Study||94
6399469|NCT00880620|7312230|FG003|Week 4|Overall Study||86
6289498|NCT00259610|7190833|FG000|STARTED|Overall Study||244
6289499|NCT00259610|7190834|FG001|STARTED|Overall Study||132
6289500|NCT00259610|7190835|FG002|STARTED|Overall Study||255
6289501|NCT00259610|7190836|FG003|STARTED|Overall Study||124
6289502|NCT00259610|7190833|FG000|COMPLETED|Overall Study||168
6289503|NCT00259610|7190834|FG001|COMPLETED|Overall Study||86
6289504|NCT00259610|7190835|FG002|COMPLETED|Overall Study||182
6289505|NCT00259610|7190836|FG003|COMPLETED|Overall Study||81
6289506|NCT00259610|7190833|FG000|NOT COMPLETED|Overall Study||76
6289507|NCT00259610|7190834|FG001|NOT COMPLETED|Overall Study||46
6289508|NCT00259610|7190835|FG002|NOT COMPLETED|Overall Study||73
6289509|NCT00259610|7190836|FG003|NOT COMPLETED|Overall Study||43
6289510|NCT00259649|7190846|FG000|STARTED|Overall Study||71
6289511|NCT00259649|7190846|FG000|COMPLETED|Overall Study||61
6289512|NCT00259649|7190846|FG000|NOT COMPLETED|Overall Study||10
6289513|NCT00259740|7190852|FG000|STARTED|Overall Study||43
6289514|NCT00259740|7190853|FG001|STARTED|Overall Study||53
6289515|NCT00259740|7190852|FG000|Received Study Medication|Overall Study||42
6289516|NCT00259740|7190853|FG001|Received Study Medication|Overall Study||53
6289517|NCT00259740|7190852|FG000|COMPLETED|Overall Study||0
6289518|NCT00259740|7190853|FG001|COMPLETED|Overall Study||0
6289519|NCT00259740|7190852|FG000|NOT COMPLETED|Overall Study||43
6289520|NCT00259740|7190853|FG001|NOT COMPLETED|Overall Study||53
6289521|NCT00259857|7190861|FG000|STARTED|12 Months Treatment||11
6289522|NCT00259857|7190862|FG001|STARTED|12 Months Treatment||11
6289523|NCT00259857|7190861|FG000|COMPLETED|12 Months Treatment||10
6289524|NCT00259857|7190862|FG001|COMPLETED|12 Months Treatment||9
6289525|NCT00259857|7190861|FG000|NOT COMPLETED|12 Months Treatment||1
6289526|NCT00259857|7190862|FG001|NOT COMPLETED|12 Months Treatment||2
6289527|NCT00259857|7190861|FG000|STARTED|24 Months Treatment||10
6289528|NCT00259857|7190862|FG001|STARTED|24 Months Treatment||9
6289529|NCT00259857|7190861|FG000|COMPLETED|24 Months Treatment||10
6289530|NCT00259857|7190862|FG001|COMPLETED|24 Months Treatment||6
6289531|NCT00259857|7190861|FG000|NOT COMPLETED|24 Months Treatment||0
6289532|NCT00259857|7190862|FG001|NOT COMPLETED|24 Months Treatment||3
6289533|NCT00260065|7190868|FG000|STARTED|Overall Study||99
6289534|NCT00260065|7190868|FG000|COMPLETED|Overall Study||6
6289535|NCT00260065|7190868|FG000|NOT COMPLETED|Overall Study||93
6289536|NCT00260195|7190874|FG000|STARTED|Overall Study||39
6289537|NCT00260195|7190875|FG001|STARTED|Overall Study||37
6289538|NCT00260195|7190874|FG000|COMPLETED|Overall Study||39
6289539|NCT00260195|7190875|FG001|COMPLETED|Overall Study||37
6289540|NCT00260195|7190874|FG000|NOT COMPLETED|Overall Study||0
6289541|NCT00260195|7190875|FG001|NOT COMPLETED|Overall Study||0
6289542|NCT00260208|7190884|FG000|STARTED|Overall Study|"Started indicates safety population."|184
6289543|NCT00260208|7190885|FG001|STARTED|Overall Study||172
6289544|NCT00260208|7190884|FG000|Intent to Treat (ITT) Population|Overall Study||182
6289545|NCT00260208|7190885|FG001|Intent to Treat (ITT) Population|Overall Study||169
6289546|NCT00260208|7190884|FG000|Modified ITT|Overall Study||101
6289547|NCT00260208|7190885|FG001|Modified ITT|Overall Study||96
6289548|NCT00260208|7190884|FG000|COMPLETED|Overall Study||137
6289549|NCT00260208|7190885|FG001|COMPLETED|Overall Study||138
6289550|NCT00260208|7190884|FG000|NOT COMPLETED|Overall Study||47
6289551|NCT00260208|7190885|FG001|NOT COMPLETED|Overall Study||34
6289552|NCT00260429|7190893|FG000|STARTED|Overall Study||23
6289553|NCT00260429|7190894|FG001|STARTED|Overall Study||12
6289554|NCT00260429|7190893|FG000|COMPLETED|Overall Study||21
6289555|NCT00260429|7190894|FG001|COMPLETED|Overall Study||12
6289556|NCT00260429|7190893|FG000|NOT COMPLETED|Overall Study||2
6289557|NCT00260429|7190894|FG001|NOT COMPLETED|Overall Study||0
6289558|NCT00260533|7190902|FG000|STARTED|Overall Study||14
6289559|NCT00260533|7190903|FG001|STARTED|Overall Study||13
6289560|NCT00260533|7190902|FG000|COMPLETED|Overall Study||11
6289561|NCT00260533|7190903|FG001|COMPLETED|Overall Study||10
6289562|NCT00260533|7190902|FG000|NOT COMPLETED|Overall Study||3
6289563|NCT00260533|7190903|FG001|NOT COMPLETED|Overall Study||3
6289564|NCT00260689|7190912|FG000|STARTED|Overall Study||60
6289565|NCT00260689|7190913|FG001|STARTED|Overall Study||60
6289566|NCT00260689|7190914|FG002|STARTED|Overall Study||16
6289567|NCT00260689|7190912|FG000|COMPLETED|Overall Study||19
6289568|NCT00260689|7190913|FG001|COMPLETED|Overall Study||11
6289569|NCT00260689|7190914|FG002|COMPLETED|Overall Study||1
6289570|NCT00260689|7190912|FG000|NOT COMPLETED|Overall Study||41
6289571|NCT00260689|7190913|FG001|NOT COMPLETED|Overall Study||49
6289572|NCT00260689|7190914|FG002|NOT COMPLETED|Overall Study||15
6289573|NCT00260832|7190924|FG000|STARTED|Overall Study||243
6289574|NCT00260832|7190925|FG001|STARTED|Overall Study||242
6634691|NCT02298803|7563481|FG000|NOT COMPLETED|Overall Study||0
6289575|NCT00260832|7190924|FG000|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
6289576|NCT00260832|7190925|FG001|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
6289577|NCT00260832|7190924|FG000|NOT COMPLETED|Overall Study||228
6289578|NCT00260832|7190925|FG001|NOT COMPLETED|Overall Study||211
6374069|NCT00748098|7284649|FG001|STARTED|First Treatment Intervention Period||67
6374070|NCT00748098|7284648|FG000|COMPLETED|First Treatment Intervention Period||64
6374071|NCT00748098|7284649|FG001|COMPLETED|First Treatment Intervention Period||66
6374072|NCT00748098|7284648|FG000|NOT COMPLETED|First Treatment Intervention Period||5
6374073|NCT00748098|7284649|FG001|NOT COMPLETED|First Treatment Intervention Period||1
6374074|NCT00748098|7284648|FG000|STARTED|First Taper Period||64
6289579|NCT00260962|7190933|FG000|STARTED|Overall Study||18
6289580|NCT00260962|7190934|FG001|STARTED|Overall Study||16
6289581|NCT00260962|7190933|FG000|COMPLETED|Overall Study||14
6289582|NCT00260962|7190934|FG001|COMPLETED|Overall Study||14
6289583|NCT00260962|7190933|FG000|NOT COMPLETED|Overall Study||4
6289584|NCT00260962|7190934|FG001|NOT COMPLETED|Overall Study||2
6289585|NCT00261040|7190942|FG000|STARTED|Overall Study||20
6289586|NCT00261040|7190943|FG001|STARTED|Overall Study||20
6289587|NCT00261040|7190942|FG000|COMPLETED|Overall Study||19
6289588|NCT00261040|7190943|FG001|COMPLETED|Overall Study||20
6289589|NCT00261040|7190942|FG000|NOT COMPLETED|Overall Study||1
6289590|NCT00261040|7190943|FG001|NOT COMPLETED|Overall Study||0
6289591|NCT00261443|7190951|FG000|STARTED|1: Confirmation of Partial Nonresponse||1270
6289592|NCT00261443|7190952|FG001|STARTED|1: Confirmation of Partial Nonresponse||0
6289593|NCT00261443|7190953|FG002|STARTED|1: Confirmation of Partial Nonresponse||0
6289594|NCT00261443|7190951|FG000|COMPLETED|1: Confirmation of Partial Nonresponse||686
6289595|NCT00261443|7190952|FG001|COMPLETED|1: Confirmation of Partial Nonresponse||0
6289596|NCT00261443|7190953|FG002|COMPLETED|1: Confirmation of Partial Nonresponse||0
6289597|NCT00261443|7190951|FG000|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
6289598|NCT00261443|7190952|FG001|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
6289599|NCT00261443|7190953|FG002|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
6289600|NCT00261443|7190951|FG000|STARTED|2: Stability & Maintenance of Stability||686
6289601|NCT00261443|7190952|FG001|STARTED|2: Stability & Maintenance of Stability||0
6289602|NCT00261443|7190953|FG002|STARTED|2: Stability & Maintenance of Stability||0
6289603|NCT00261443|7190951|FG000|COMPLETED|2: Stability & Maintenance of Stability||346
6289604|NCT00261443|7190952|FG001|COMPLETED|2: Stability & Maintenance of Stability||0
6289605|NCT00261443|7190953|FG002|COMPLETED|2: Stability & Maintenance of Stability||0
6289606|NCT00261443|7190951|FG000|NOT COMPLETED|2: Stability & Maintenance of Stability||340
6289607|NCT00261443|7190952|FG001|NOT COMPLETED|2: Stability & Maintenance of Stability||0
6289608|NCT00261443|7190953|FG002|NOT COMPLETED|2: Stability & Maintenance of Stability||0
6289609|NCT00261443|7190951|FG000|STARTED|3: Assessment of Relapse||0
6289610|NCT00261443|7190952|FG001|STARTED|3: Assessment of Relapse||169
6289611|NCT00261443|7190953|FG002|STARTED|3: Assessment of Relapse||168
6289612|NCT00261443|7190951|FG000|COMPLETED|3: Assessment of Relapse||0
6289613|NCT00261443|7190952|FG001|COMPLETED|3: Assessment of Relapse||89
6289614|NCT00261443|7190953|FG002|COMPLETED|3: Assessment of Relapse||103
6289615|NCT00261443|7190951|FG000|NOT COMPLETED|3: Assessment of Relapse||0
6289616|NCT00261443|7190952|FG001|NOT COMPLETED|3: Assessment of Relapse||80
6289617|NCT00261443|7190953|FG002|NOT COMPLETED|3: Assessment of Relapse||65
6289618|NCT00261443|7190951|FG000|STARTED|4: Extension Phase||0
6289619|NCT00261443|7190952|FG001|STARTED|4: Extension Phase||19
6289620|NCT00261443|7190953|FG002|STARTED|4: Extension Phase||23
6289621|NCT00261443|7190951|FG000|COMPLETED|4: Extension Phase||0
6289622|NCT00261443|7190952|FG001|COMPLETED|4: Extension Phase||16
6289623|NCT00261443|7190953|FG002|COMPLETED|4: Extension Phase||21
6289624|NCT00261443|7190951|FG000|NOT COMPLETED|4: Extension Phase||0
6289625|NCT00261443|7190952|FG001|NOT COMPLETED|4: Extension Phase||3
6289626|NCT00261443|7190953|FG002|NOT COMPLETED|4: Extension Phase||2
6289627|NCT00261495|7190966|FG000|STARTED|Titration Phase (Weeks 0 to 4)||254
6289628|NCT00261495|7190967|FG001|STARTED|Titration Phase (Weeks 0 to 4)||250
6289629|NCT00261495|7190966|FG000|COMPLETED|Titration Phase (Weeks 0 to 4)||206
6289630|NCT00261495|7190967|FG001|COMPLETED|Titration Phase (Weeks 0 to 4)||185
6289631|NCT00261495|7190966|FG000|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
6289632|NCT00261495|7190967|FG001|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
6289633|NCT00261495|7190966|FG000|STARTED|Maintenance Phase (Weeks 4 to 24)||206
6289634|NCT00261495|7190967|FG001|STARTED|Maintenance Phase (Weeks 4 to 24)||185
6289635|NCT00261495|7190966|FG000|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
6289636|NCT00261495|7190967|FG001|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
6289637|NCT00261495|7190966|FG000|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
6289638|NCT00261495|7190967|FG001|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
6289639|NCT00261495|7190966|FG000|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
6289640|NCT00261495|7190967|FG001|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
6289641|NCT00261495|7190966|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||50
6289642|NCT00261495|7190967|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||47
6289643|NCT00261495|7190966|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
6289644|NCT00261495|7190967|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
6289645|NCT00261716|7190975|FG000|STARTED|Overall Study||17
6289646|NCT00261716|7190976|FG001|STARTED|Overall Study||21
6289647|NCT00261716|7190975|FG000|COMPLETED|Overall Study||11
6289648|NCT00261716|7190976|FG001|COMPLETED|Overall Study||11
6289649|NCT00261716|7190975|FG000|NOT COMPLETED|Overall Study||6
6289650|NCT00261716|7190976|FG001|NOT COMPLETED|Overall Study||10
6289651|NCT00261833|7190988|FG000|STARTED|Overall Study||93
6289652|NCT00261833|7190989|FG001|STARTED|Overall Study||87
6289653|NCT00261833|7190988|FG000|COMPLETED|Overall Study||84
6289654|NCT00261833|7190989|FG001|COMPLETED|Overall Study||69
6289655|NCT00261833|7190988|FG000|NOT COMPLETED|Overall Study||9
6289656|NCT00261833|7190989|FG001|NOT COMPLETED|Overall Study||18
6289657|NCT00261846|7191005|FG000|STARTED|Period 1: Part 1 (Dose Escalation)||3
6289658|NCT00261846|7191006|FG001|STARTED|Period 1: Part 1 (Dose Escalation)||3
6289659|NCT00261846|7191007|FG002|STARTED|Period 1: Part 1 (Dose Escalation)||12
6289660|NCT00261846|7191008|FG003|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289661|NCT00261846|7191009|FG004|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289662|NCT00261846|7191010|FG005|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289663|NCT00261846|7191011|FG006|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289664|NCT00261846|7191012|FG007|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289665|NCT00261846|7191013|FG008|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289666|NCT00261846|7191014|FG009|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289667|NCT00261846|7191015|FG010|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289668|NCT00261846|7191016|FG011|STARTED|Period 1: Part 1 (Dose Escalation)||0
6289669|NCT00261846|7191005|FG000|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289670|NCT00261846|7191006|FG001|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289671|NCT00261846|7191007|FG002|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289672|NCT00261846|7191008|FG003|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289673|NCT00261846|7191009|FG004|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289674|NCT00261846|7191010|FG005|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289675|NCT00261846|7191011|FG006|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289676|NCT00261846|7191012|FG007|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289677|NCT00261846|7191013|FG008|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289678|NCT00261846|7191014|FG009|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289679|NCT00261846|7191015|FG010|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289680|NCT00261846|7191016|FG011|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289681|NCT00261846|7191005|FG000|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
6289682|NCT00261846|7191006|FG001|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
6289683|NCT00261846|7191007|FG002|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
6289684|NCT00261846|7191008|FG003|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289685|NCT00261846|7191009|FG004|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289686|NCT00261846|7191010|FG005|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289687|NCT00261846|7191011|FG006|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289688|NCT00261846|7191012|FG007|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289689|NCT00261846|7191013|FG008|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289690|NCT00261846|7191014|FG009|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289691|NCT00261846|7191015|FG010|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289692|NCT00261846|7191016|FG011|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
6289693|NCT00261846|7191005|FG000|STARTED|Period 2: Part 2 (Efficacy)||0
6289694|NCT00261846|7191006|FG001|STARTED|Period 2: Part 2 (Efficacy)||0
6289695|NCT00261846|7191007|FG002|STARTED|Period 2: Part 2 (Efficacy)||0
6289696|NCT00261846|7191008|FG003|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
6289697|NCT00261846|7191009|FG004|STARTED|Period 2: Part 2 (Efficacy)||89
6289698|NCT00261846|7191010|FG005|STARTED|Period 2: Part 2 (Efficacy)||5
6289699|NCT00261846|7191011|FG006|STARTED|Period 2: Part 2 (Efficacy)||38
6289700|NCT00261846|7191012|FG007|STARTED|Period 2: Part 2 (Efficacy)||50
6399470|NCT00880620|7312227|FG000|Week 9|Overall Study||80
6399471|NCT00880620|7312228|FG001|Week 9|Overall Study||73
6399472|NCT00880620|7312229|FG002|Week 9|Overall Study||88
6399473|NCT00880620|7312230|FG003|Week 9|Overall Study||78
6399474|NCT00880620|7312227|FG000|Week 16|Overall Study||74
6399475|NCT00880620|7312228|FG001|Week 16|Overall Study||73
6399476|NCT00880620|7312229|FG002|Week 16|Overall Study||87
6399477|NCT00880620|7312230|FG003|Week 16|Overall Study||74
6399478|NCT00880620|7312227|FG000|Week 23|Overall Study||71
6399479|NCT00880620|7312228|FG001|Week 23|Overall Study||72
6399480|NCT00880620|7312229|FG002|Week 23|Overall Study||85
6399481|NCT00880620|7312230|FG003|Week 23|Overall Study||74
6399482|NCT00880620|7312227|FG000|COMPLETED|Overall Study||71
6399483|NCT00880620|7312228|FG001|COMPLETED|Overall Study||72
6399484|NCT00880620|7312229|FG002|COMPLETED|Overall Study||83
6399485|NCT00880620|7312230|FG003|COMPLETED|Overall Study||74
6399486|NCT00880620|7312227|FG000|NOT COMPLETED|Overall Study||21
6399487|NCT00880620|7312228|FG001|NOT COMPLETED|Overall Study||15
6399488|NCT00880620|7312229|FG002|NOT COMPLETED|Overall Study||21
6399489|NCT00880620|7312230|FG003|NOT COMPLETED|Overall Study||24
6399490|NCT00880685|7312244|FG000|STARTED|Memantine 10mg||12
6399491|NCT00880685|7312244|FG000|COMPLETED|Memantine 10mg||10
6399492|NCT00880685|7312244|FG000|NOT COMPLETED|Memantine 10mg||2
6399493|NCT00880685|7312244|FG000|STARTED|Memantine 20mg||10
6399494|NCT00880685|7312244|FG000|COMPLETED|Memantine 20mg||9
6399495|NCT00880685|7312244|FG000|NOT COMPLETED|Memantine 20mg||1
6399496|NCT00880685|7312244|FG000|STARTED|Memantine 30mg||9
6399497|NCT00880685|7312244|FG000|COMPLETED|Memantine 30mg||9
6399498|NCT00880685|7312244|FG000|NOT COMPLETED|Memantine 30mg||0
6399499|NCT00880698|7312255|FG000|STARTED|Overall Study||62
6399500|NCT00880698|7312256|FG001|STARTED|Overall Study||64
6399501|NCT00880698|7312257|FG002|STARTED|Overall Study||37
6399502|NCT00880698|7312258|FG003|STARTED|Overall Study||39
6634692|NCT02298842|7563492|FG000|STARTED|First Platelet Donation (Day 0)||44
6634693|NCT02298842|7563493|FG001|STARTED|First Platelet Donation (Day 0)||41
6399503|NCT00880698|7312255|FG000|COMPLETED|Overall Study||61
6399504|NCT00880698|7312256|FG001|COMPLETED|Overall Study||61
6399505|NCT00880698|7312257|FG002|COMPLETED|Overall Study||36
6399506|NCT00880698|7312258|FG003|COMPLETED|Overall Study||36
6634694|NCT02298842|7563492|FG000|COMPLETED|First Platelet Donation (Day 0)||38
6289701|NCT00261846|7191013|FG008|STARTED|Period 2: Part 2 (Efficacy)||26
6289702|NCT00261846|7191014|FG009|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
6289703|NCT00261846|7191015|FG010|STARTED|Period 2: Part 2 (Efficacy)||64
6289704|NCT00261846|7191016|FG011|STARTED|Period 2: Part 2 (Efficacy)||24
6289705|NCT00261846|7191005|FG000|COMPLETED|Period 2: Part 2 (Efficacy)||0
6289706|NCT00261846|7191006|FG001|COMPLETED|Period 2: Part 2 (Efficacy)||0
6289707|NCT00261846|7191007|FG002|COMPLETED|Period 2: Part 2 (Efficacy)||0
6289708|NCT00261846|7191008|FG003|COMPLETED|Period 2: Part 2 (Efficacy)||60
6289709|NCT00261846|7191009|FG004|COMPLETED|Period 2: Part 2 (Efficacy)||39
6289710|NCT00261846|7191010|FG005|COMPLETED|Period 2: Part 2 (Efficacy)||3
6289711|NCT00261846|7191011|FG006|COMPLETED|Period 2: Part 2 (Efficacy)||16
6289712|NCT00261846|7191012|FG007|COMPLETED|Period 2: Part 2 (Efficacy)||21
6289713|NCT00261846|7191013|FG008|COMPLETED|Period 2: Part 2 (Efficacy)||12
6289714|NCT00261846|7191014|FG009|COMPLETED|Period 2: Part 2 (Efficacy)||30
6289715|NCT00261846|7191015|FG010|COMPLETED|Period 2: Part 2 (Efficacy)||15
6289716|NCT00261846|7191016|FG011|COMPLETED|Period 2: Part 2 (Efficacy)||1
6289717|NCT00261846|7191005|FG000|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
6289718|NCT00261846|7191006|FG001|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
6289719|NCT00261846|7191007|FG002|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
6289720|NCT00261846|7191008|FG003|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
6289721|NCT00261846|7191009|FG004|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
6289722|NCT00261846|7191010|FG005|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
6289723|NCT00261846|7191011|FG006|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
6289724|NCT00261846|7191012|FG007|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
6289725|NCT00261846|7191013|FG008|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
6289726|NCT00261846|7191014|FG009|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
6289727|NCT00261846|7191015|FG010|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
6289728|NCT00261846|7191016|FG011|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
6289729|NCT00261950|7191055|FG000|STARTED|Overall Study||110
6289730|NCT00261950|7191055|FG000|COMPLETED|Overall Study||84
6289731|NCT00261950|7191055|FG000|NOT COMPLETED|Overall Study||26
6289732|NCT00262002|7191066|FG000|STARTED|Overall Study||90
6289733|NCT00262002|7191067|FG001|STARTED|Overall Study||90
6289734|NCT00262002|7191068|FG002|STARTED|Overall Study||45
6289735|NCT00262002|7191069|FG003|STARTED|Overall Study||98
6289736|NCT00262002|7191070|FG004|STARTED|Overall Study||98
6289737|NCT00262002|7191071|FG005|STARTED|Overall Study||90
6289738|NCT00262002|7191072|FG006|STARTED|Overall Study||90
6289739|NCT00262002|7191066|FG000|COMPLETED|Overall Study||79
6289740|NCT00262002|7191067|FG001|COMPLETED|Overall Study||84
6289741|NCT00262002|7191068|FG002|COMPLETED|Overall Study||45
6289742|NCT00262002|7191069|FG003|COMPLETED|Overall Study||93
6289743|NCT00262002|7191070|FG004|COMPLETED|Overall Study||91
6289744|NCT00262002|7191071|FG005|COMPLETED|Overall Study||83
6289745|NCT00262002|7191072|FG006|COMPLETED|Overall Study||84
6289746|NCT00262002|7191066|FG000|NOT COMPLETED|Overall Study||11
6289747|NCT00262002|7191067|FG001|NOT COMPLETED|Overall Study||6
6289748|NCT00262002|7191068|FG002|NOT COMPLETED|Overall Study||0
6289749|NCT00262002|7191069|FG003|NOT COMPLETED|Overall Study||5
6289750|NCT00262002|7191070|FG004|NOT COMPLETED|Overall Study||7
6289751|NCT00262002|7191071|FG005|NOT COMPLETED|Overall Study||7
6289752|NCT00262002|7191072|FG006|NOT COMPLETED|Overall Study||6
6289753|NCT00262028|7191146|FG000|STARTED|Overall Study||152
6289754|NCT00262028|7191147|FG001|STARTED|Overall Study||153
6289755|NCT00262028|7191148|FG002|STARTED|Overall Study||157
6289756|NCT00262028|7191149|FG003|STARTED|Overall Study||157
6289757|NCT00262028|7191150|FG004|STARTED|Overall Study||74
6289758|NCT00262028|7191151|FG005|STARTED|Overall Study||73
6289759|NCT00262028|7191152|FG006|STARTED|Overall Study||71
6289760|NCT00262028|7191153|FG007|STARTED|Overall Study||73
6289761|NCT00262028|7191154|FG008|STARTED|Overall Study||100
6289762|NCT00262028|7191146|FG000|COMPLETED|Overall Study||128
6289763|NCT00262028|7191147|FG001|COMPLETED|Overall Study||126
6289764|NCT00262028|7191148|FG002|COMPLETED|Overall Study||137
6289765|NCT00262028|7191149|FG003|COMPLETED|Overall Study||134
6289766|NCT00262028|7191150|FG004|COMPLETED|Overall Study||62
6289767|NCT00262028|7191151|FG005|COMPLETED|Overall Study||60
6289768|NCT00262028|7191152|FG006|COMPLETED|Overall Study||59
6289769|NCT00262028|7191153|FG007|COMPLETED|Overall Study||55
6289770|NCT00262028|7191154|FG008|COMPLETED|Overall Study||81
6289771|NCT00262028|7191146|FG000|NOT COMPLETED|Overall Study||24
6289772|NCT00262028|7191147|FG001|NOT COMPLETED|Overall Study||27
6289773|NCT00262028|7191148|FG002|NOT COMPLETED|Overall Study||20
6289774|NCT00262028|7191149|FG003|NOT COMPLETED|Overall Study||23
6289775|NCT00262028|7191150|FG004|NOT COMPLETED|Overall Study||12
6289776|NCT00262028|7191151|FG005|NOT COMPLETED|Overall Study||13
6289777|NCT00262028|7191152|FG006|NOT COMPLETED|Overall Study||12
6289778|NCT00262028|7191153|FG007|NOT COMPLETED|Overall Study||18
6289779|NCT00262028|7191154|FG008|NOT COMPLETED|Overall Study||19
6289780|NCT00262041|7191200|FG000|STARTED|Overall Study||164
6289781|NCT00262041|7191201|FG001|STARTED|Overall Study||151
6289782|NCT00262041|7191202|FG002|STARTED|Overall Study||209
6289783|NCT00262041|7191200|FG000|COMPLETED|Overall Study||162
6289784|NCT00262041|7191201|FG001|COMPLETED|Overall Study||147
6289785|NCT00262041|7191202|FG002|COMPLETED|Overall Study||203
6289786|NCT00262041|7191200|FG000|NOT COMPLETED|Overall Study||2
6289787|NCT00262041|7191201|FG001|NOT COMPLETED|Overall Study||4
6289788|NCT00262041|7191202|FG002|NOT COMPLETED|Overall Study||6
6289789|NCT00262067|7191220|FG000|STARTED|Overall Study||415
6289790|NCT00262067|7191221|FG001|STARTED|Overall Study||207
6289791|NCT00262067|7191222|FG002|STARTED|Overall Study||409
6289792|NCT00262067|7191223|FG003|STARTED|Overall Study||206
6289793|NCT00262067|7191220|FG000|COMPLETED|Overall Study||196
6289794|NCT00262067|7191221|FG001|COMPLETED|Overall Study||107
6289795|NCT00262067|7191222|FG002|COMPLETED|Overall Study||193
6289796|NCT00262067|7191223|FG003|COMPLETED|Overall Study||93
6289797|NCT00262067|7191220|FG000|NOT COMPLETED|Overall Study||219
6289798|NCT00262067|7191221|FG001|NOT COMPLETED|Overall Study||100
6289799|NCT00262067|7191222|FG002|NOT COMPLETED|Overall Study||216
6289800|NCT00262067|7191223|FG003|NOT COMPLETED|Overall Study||113
6289801|NCT00262080|7191236|FG000|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
6289802|NCT00262080|7191237|FG001|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
6289803|NCT00262080|7191238|FG002|STARTED|Double Blind Treatment Period||0
6289804|NCT00262080|7191236|FG000|COMPLETED|Double Blind Treatment Period||35
6289805|NCT00262080|7191237|FG001|COMPLETED|Double Blind Treatment Period||36
6289806|NCT00262080|7191238|FG002|COMPLETED|Double Blind Treatment Period||0
6289807|NCT00262080|7191236|FG000|NOT COMPLETED|Double Blind Treatment Period||1
6289808|NCT00262080|7191237|FG001|NOT COMPLETED|Double Blind Treatment Period||0
6289809|NCT00262080|7191238|FG002|NOT COMPLETED|Double Blind Treatment Period||0
6289810|NCT00262080|7191236|FG000|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
6289811|NCT00262080|7191237|FG001|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
6289812|NCT00262080|7191238|FG002|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
6289813|NCT00262080|7191236|FG000|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
6289814|NCT00262080|7191237|FG001|COMPLETED|Repeat Dose Treatment Period||25
6289815|NCT00262080|7191238|FG002|COMPLETED|Repeat Dose Treatment Period||14
6289816|NCT00262080|7191236|FG000|NOT COMPLETED|Repeat Dose Treatment Period||4
6289817|NCT00262080|7191237|FG001|NOT COMPLETED|Repeat Dose Treatment Period||1
6289818|NCT00262080|7191238|FG002|NOT COMPLETED|Repeat Dose Treatment Period||5
6289819|NCT00262119|7191249|FG000|STARTED|Overall Study||385
6289820|NCT00262119|7191250|FG001|STARTED|Overall Study||398
6289821|NCT00262119|7191251|FG002|STARTED|Overall Study||383
6289822|NCT00262119|7191249|FG000|COMPLETED|Overall Study||327
6289823|NCT00262119|7191250|FG001|COMPLETED|Overall Study||328
6289824|NCT00262119|7191251|FG002|COMPLETED|Overall Study||325
6289825|NCT00262119|7191249|FG000|NOT COMPLETED|Overall Study||58
6289826|NCT00262119|7191250|FG001|NOT COMPLETED|Overall Study||70
6289827|NCT00262119|7191251|FG002|NOT COMPLETED|Overall Study||58
6289828|NCT00262223|7191261|FG000|STARTED|Treatment Phase||32
6289829|NCT00262223|7191262|FG001|STARTED|Treatment Phase||37
6289830|NCT00262223|7191261|FG000|COMPLETED|Treatment Phase||28
6289831|NCT00262223|7191262|FG001|COMPLETED|Treatment Phase||29
6289832|NCT00262223|7191261|FG000|NOT COMPLETED|Treatment Phase||4
6289833|NCT00262223|7191262|FG001|NOT COMPLETED|Treatment Phase||8
6289834|NCT00262223|7191261|FG000|STARTED|1-week Post-treatment Follow-up||28
6289835|NCT00262223|7191262|FG001|STARTED|1-week Post-treatment Follow-up||29
6289836|NCT00262223|7191261|FG000|COMPLETED|1-week Post-treatment Follow-up||24
6289837|NCT00262223|7191262|FG001|COMPLETED|1-week Post-treatment Follow-up||25
6289838|NCT00262223|7191261|FG000|NOT COMPLETED|1-week Post-treatment Follow-up||4
6289839|NCT00262223|7191262|FG001|NOT COMPLETED|1-week Post-treatment Follow-up||4
6289840|NCT00262223|7191261|FG000|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
6289841|NCT00262223|7191262|FG001|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
6289842|NCT00262223|7191261|FG000|COMPLETED|6-month Post-treatment Follow-up||22
6289843|NCT00262223|7191262|FG001|COMPLETED|6-month Post-treatment Follow-up||28
6289844|NCT00262223|7191261|FG000|NOT COMPLETED|6-month Post-treatment Follow-up||6
6289845|NCT00262223|7191262|FG001|NOT COMPLETED|6-month Post-treatment Follow-up||1
6289846|NCT00262223|7191261|FG000|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
6289847|NCT00262223|7191262|FG001|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
6289848|NCT00262223|7191261|FG000|COMPLETED|12-month Post-treatment Follow-up||21
6289849|NCT00262223|7191262|FG001|COMPLETED|12-month Post-treatment Follow-up||22
6289850|NCT00262223|7191261|FG000|NOT COMPLETED|12-month Post-treatment Follow-up||7
6289851|NCT00262223|7191262|FG001|NOT COMPLETED|12-month Post-treatment Follow-up||7
6289852|NCT00262301|7191272|FG000|STARTED|Double-blind Phase||16
6289853|NCT00262301|7191273|FG001|STARTED|Double-blind Phase||16
6289854|NCT00262301|7191274|FG002|STARTED|Double-blind Phase||0
6289855|NCT00262301|7191272|FG000|COMPLETED|Double-blind Phase||15
6289856|NCT00262301|7191273|FG001|COMPLETED|Double-blind Phase||15
6289857|NCT00262301|7191274|FG002|COMPLETED|Double-blind Phase||0
6289858|NCT00262301|7191272|FG000|NOT COMPLETED|Double-blind Phase||1
6289859|NCT00262301|7191273|FG001|NOT COMPLETED|Double-blind Phase||1
6289860|NCT00262301|7191274|FG002|NOT COMPLETED|Double-blind Phase||0
6289861|NCT00262301|7191272|FG000|STARTED|Open-label Phase||0
6289862|NCT00262301|7191273|FG001|STARTED|Open-label Phase||0
6374075|NCT00748098|7284649|FG001|STARTED|First Taper Period||66
6289863|NCT00262301|7191274|FG002|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
6289864|NCT00262301|7191272|FG000|COMPLETED|Open-label Phase||0
6289865|NCT00262301|7191273|FG001|COMPLETED|Open-label Phase||0
6289866|NCT00262301|7191274|FG002|COMPLETED|Open-label Phase||57
6289867|NCT00262301|7191272|FG000|NOT COMPLETED|Open-label Phase||0
6289868|NCT00262301|7191273|FG001|NOT COMPLETED|Open-label Phase||0
6289869|NCT00262301|7191274|FG002|NOT COMPLETED|Open-label Phase||0
6289870|NCT00262314|7191282|FG000|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
6289871|NCT00262314|7191282|FG000|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
6289872|NCT00262314|7191282|FG000|NOT COMPLETED|Overall Study||337
6289873|NCT00262509|7191288|FG000|STARTED|Overall Study||8
6289874|NCT00262509|7191289|FG001|STARTED|Overall Study||9
6289875|NCT00262509|7191288|FG000|COMPLETED|Overall Study||8
6289876|NCT00262509|7191289|FG001|COMPLETED|Overall Study||9
6289877|NCT00262509|7191288|FG000|NOT COMPLETED|Overall Study||0
6289878|NCT00262509|7191289|FG001|NOT COMPLETED|Overall Study||0
6289879|NCT00262522|7191299|FG000|STARTED|Study Start Through 8 Weeks||167
6289880|NCT00262522|7191300|FG001|STARTED|Study Start Through 8 Weeks||166
6289881|NCT00262522|7191301|FG002|STARTED|Study Start Through 8 Weeks||166
6289882|NCT00262522|7191302|FG003|STARTED|Study Start Through 8 Weeks||165
6289883|NCT00262522|7191299|FG000|COMPLETED|Study Start Through 8 Weeks||163
6289884|NCT00262522|7191300|FG001|COMPLETED|Study Start Through 8 Weeks||161
6289885|NCT00262522|7191301|FG002|COMPLETED|Study Start Through 8 Weeks||155
6289886|NCT00262522|7191302|FG003|COMPLETED|Study Start Through 8 Weeks||160
6289887|NCT00262522|7191299|FG000|NOT COMPLETED|Study Start Through 8 Weeks||4
6289888|NCT00262522|7191300|FG001|NOT COMPLETED|Study Start Through 8 Weeks||5
6289889|NCT00262522|7191301|FG002|NOT COMPLETED|Study Start Through 8 Weeks||11
6289890|NCT00262522|7191302|FG003|NOT COMPLETED|Study Start Through 8 Weeks||5
6289891|NCT00262522|7191299|FG000|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
6289892|NCT00262522|7191300|FG001|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
6289893|NCT00262522|7191301|FG002|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
6289894|NCT00262522|7191302|FG003|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
6289895|NCT00262522|7191299|FG000|COMPLETED|Study Start Through 48 Weeks||284
6289896|NCT00262522|7191300|FG001|COMPLETED|Study Start Through 48 Weeks||0
6289897|NCT00262522|7191301|FG002|COMPLETED|Study Start Through 48 Weeks||276
6289898|NCT00262522|7191302|FG003|COMPLETED|Study Start Through 48 Weeks||0
6289899|NCT00262522|7191299|FG000|NOT COMPLETED|Study Start Through 48 Weeks||49
6289900|NCT00262522|7191300|FG001|NOT COMPLETED|Study Start Through 48 Weeks||0
6289901|NCT00262522|7191301|FG002|NOT COMPLETED|Study Start Through 48 Weeks||55
6399507|NCT00880698|7312255|FG000|NOT COMPLETED|Overall Study||1
6399508|NCT00880698|7312256|FG001|NOT COMPLETED|Overall Study||3
6399509|NCT00880698|7312257|FG002|NOT COMPLETED|Overall Study||1
6289902|NCT00262522|7191302|FG003|NOT COMPLETED|Study Start Through 48 Weeks||0
6289903|NCT00262522|7191299|FG000|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
6289904|NCT00262522|7191300|FG001|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
6289905|NCT00262522|7191301|FG002|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
6289906|NCT00262522|7191302|FG003|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
6289907|NCT00262522|7191299|FG000|COMPLETED|Study Start Through 96 Weeks||256
6289908|NCT00262522|7191300|FG001|COMPLETED|Study Start Through 96 Weeks||0
6289909|NCT00262522|7191301|FG002|COMPLETED|Study Start Through 96 Weeks||254
6289910|NCT00262522|7191302|FG003|COMPLETED|Study Start Through 96 Weeks||0
6289911|NCT00262522|7191299|FG000|NOT COMPLETED|Study Start Through 96 Weeks||77
6289912|NCT00262522|7191300|FG001|NOT COMPLETED|Study Start Through 96 Weeks||0
6289913|NCT00262522|7191301|FG002|NOT COMPLETED|Study Start Through 96 Weeks||77
6289914|NCT00262522|7191302|FG003|NOT COMPLETED|Study Start Through 96 Weeks||0
6289915|NCT00262600|7191313|FG000|STARTED|Overall Study||6015
6289916|NCT00262600|7191314|FG001|STARTED|Overall Study||6076
6289917|NCT00262600|7191315|FG002|STARTED|Overall Study||6022
6289918|NCT00262600|7191313|FG000|COMPLETED|Overall Study||5780
6289919|NCT00262600|7191314|FG001|COMPLETED|Overall Study||5824
6289920|NCT00262600|7191315|FG002|COMPLETED|Overall Study||5756
6289921|NCT00262600|7191313|FG000|NOT COMPLETED|Overall Study||235
6289922|NCT00262600|7191314|FG001|NOT COMPLETED|Overall Study||252
6289923|NCT00262600|7191315|FG002|NOT COMPLETED|Overall Study||266
6289924|NCT00262639|7191327|FG000|STARTED|Overall Study||18
6289925|NCT00262639|7191328|FG001|STARTED|Overall Study||26
6289926|NCT00262639|7191329|FG002|STARTED|Overall Study||9
6289927|NCT00262639|7191330|FG003|STARTED|Overall Study||7
6289928|NCT00262639|7191327|FG000|COMPLETED|Overall Study||18
6289929|NCT00262639|7191328|FG001|COMPLETED|Overall Study||26
6289930|NCT00262639|7191329|FG002|COMPLETED|Overall Study||9
6289931|NCT00262639|7191330|FG003|COMPLETED|Overall Study||7
6289932|NCT00262639|7191327|FG000|NOT COMPLETED|Overall Study||0
6289933|NCT00262639|7191328|FG001|NOT COMPLETED|Overall Study||0
6289934|NCT00262639|7191329|FG002|NOT COMPLETED|Overall Study||0
6289935|NCT00262639|7191330|FG003|NOT COMPLETED|Overall Study||0
6289936|NCT00262730|7191340|FG000|STARTED|Overall Study||97
6289937|NCT00262730|7191340|FG000|COMPLETED|Overall Study||97
6289938|NCT00262730|7191340|FG000|NOT COMPLETED|Overall Study||0
6289939|NCT00262743|7191346|FG000|STARTED|Overall Study||27
6289940|NCT00262743|7191347|FG001|STARTED|Overall Study||42
6289941|NCT00262743|7191346|FG000|COMPLETED|Overall Study||27
6289942|NCT00262743|7191347|FG001|COMPLETED|Overall Study||30
6289943|NCT00262743|7191346|FG000|NOT COMPLETED|Overall Study||0
6289944|NCT00262743|7191347|FG001|NOT COMPLETED|Overall Study||12
6289945|NCT00262821|7191353|FG000|STARTED|Overall Study||198
6289946|NCT00262821|7191354|FG001|STARTED|Overall Study||204
6289947|NCT00262821|7191353|FG000|COMPLETED|Overall Study||194
6289948|NCT00262821|7191354|FG001|COMPLETED|Overall Study||185
6289949|NCT00262821|7191353|FG000|NOT COMPLETED|Overall Study||4
6289950|NCT00262821|7191354|FG001|NOT COMPLETED|Overall Study||19
6289951|NCT00262834|7191362|FG000|STARTED|Overall Study||25
6289952|NCT00262834|7191363|FG001|STARTED|Overall Study||29
6289953|NCT00262834|7191362|FG000|COMPLETED|Overall Study||24
6289954|NCT00262834|7191363|FG001|COMPLETED|Overall Study||25
6289955|NCT00262834|7191362|FG000|NOT COMPLETED|Overall Study||1
6289956|NCT00262834|7191363|FG001|NOT COMPLETED|Overall Study||4
6289957|NCT00262847|7191372|FG000|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
6289958|NCT00262847|7191373|FG001|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
6289959|NCT00262847|7191374|FG002|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
6289960|NCT00262847|7191372|FG000|COMPLETED|Overall Study||107
6289961|NCT00262847|7191373|FG001|COMPLETED|Overall Study||112
6289962|NCT00262847|7191374|FG002|COMPLETED|Overall Study||227
6289963|NCT00262847|7191372|FG000|NOT COMPLETED|Overall Study||518
6289964|NCT00262847|7191373|FG001|NOT COMPLETED|Overall Study||513
6289965|NCT00262847|7191374|FG002|NOT COMPLETED|Overall Study||396
6289966|NCT00262860|7191385|FG000|STARTED|Overall Study||18
6289967|NCT00262860|7191385|FG000|COMPLETED|Overall Study||16
6289968|NCT00262860|7191385|FG000|NOT COMPLETED|Overall Study||2
6289969|NCT00262873|7191389|FG000|STARTED|Overall Study||8
6289970|NCT00262873|7191389|FG000|COMPLETED|Overall Study||0
6289971|NCT00262873|7191389|FG000|NOT COMPLETED|Overall Study||8
6289972|NCT00262925|7191393|FG000|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
6289973|NCT00262925|7191393|FG000|COMPLETED|Overall Study||1
6289974|NCT00262925|7191393|FG000|NOT COMPLETED|Overall Study||11
6289975|NCT00262951|7191399|FG000|STARTED|Overall Study||23
6289976|NCT00262951|7191399|FG000|COMPLETED|Overall Study||7
6289977|NCT00262951|7191399|FG000|NOT COMPLETED|Overall Study||16
6289978|NCT00262964|7191405|FG000|STARTED|Overall Study||11
6289979|NCT00262964|7191406|FG001|STARTED|Overall Study||11
6289980|NCT00262964|7191407|FG002|STARTED|Overall Study||17
6289981|NCT00262964|7191408|FG003|STARTED|Overall Study||12
6289982|NCT00262964|7191405|FG000|COMPLETED|Overall Study||11
6289983|NCT00262964|7191406|FG001|COMPLETED|Overall Study||11
6289984|NCT00262964|7191407|FG002|COMPLETED|Overall Study||17
6289985|NCT00262964|7191408|FG003|COMPLETED|Overall Study||12
6289986|NCT00262964|7191405|FG000|NOT COMPLETED|Overall Study||0
6289987|NCT00262964|7191406|FG001|NOT COMPLETED|Overall Study||0
6289988|NCT00262964|7191407|FG002|NOT COMPLETED|Overall Study||0
6289989|NCT00262964|7191408|FG003|NOT COMPLETED|Overall Study||0
6289990|NCT00263211|7191432|FG000|STARTED|Overall Study||24
6289991|NCT00263211|7191433|FG001|STARTED|Overall Study||24
6289992|NCT00263211|7191432|FG000|COMPLETED|Overall Study||19
6289993|NCT00263211|7191433|FG001|COMPLETED|Overall Study||23
6289994|NCT00263211|7191432|FG000|NOT COMPLETED|Overall Study||5
6289995|NCT00263211|7191433|FG001|NOT COMPLETED|Overall Study||1
6289996|NCT00263328|7191445|FG000|STARTED|Overall Study||18
6289997|NCT00263328|7191446|FG001|STARTED|Overall Study||14
6289998|NCT00263328|7191447|FG002|STARTED|Overall Study||13
6289999|NCT00263328|7191445|FG000|COMPLETED|Overall Study||10
6290000|NCT00263328|7191446|FG001|COMPLETED|Overall Study||12
6290001|NCT00263328|7191447|FG002|COMPLETED|Overall Study||6
6290002|NCT00263328|7191445|FG000|NOT COMPLETED|Overall Study||8
6290003|NCT00263328|7191446|FG001|NOT COMPLETED|Overall Study||2
6290004|NCT00263328|7191447|FG002|NOT COMPLETED|Overall Study||7
6290005|NCT00263562|7191459|FG000|STARTED|Overall Study||9
6290006|NCT00263562|7191460|FG001|STARTED|Overall Study||9
6290007|NCT00263562|7191459|FG000|COMPLETED|Overall Study||6
6290008|NCT00263562|7191460|FG001|COMPLETED|Overall Study||9
6290009|NCT00263562|7191459|FG000|NOT COMPLETED|Overall Study||3
6290010|NCT00263562|7191460|FG001|NOT COMPLETED|Overall Study||0
6290011|NCT00263575|7191468|FG000|STARTED|Titration Period||139
6290012|NCT00263575|7191468|FG000|COMPLETED|Titration Period||96
6290013|NCT00263575|7191468|FG000|NOT COMPLETED|Titration Period||43
6290014|NCT00263575|7191468|FG000|STARTED|Maintence Period||96
6290015|NCT00263575|7191468|FG000|COMPLETED|Maintence Period||19
6290016|NCT00263575|7191468|FG000|NOT COMPLETED|Maintence Period||77
6290017|NCT00263588|7191476|FG000|STARTED|Overall Study||95
6290018|NCT00263588|7191477|FG001|STARTED|Overall Study||147
6290019|NCT00263588|7191476|FG000|COMPLETED|Overall Study||14
6290020|NCT00263588|7191477|FG001|COMPLETED|Overall Study||15
6290021|NCT00263588|7191476|FG000|NOT COMPLETED|Overall Study||81
6290022|NCT00263588|7191477|FG001|NOT COMPLETED|Overall Study||132
6290023|NCT00263666|7191486|FG000|STARTED|Overall Study||50
6290024|NCT00263666|7191487|FG001|STARTED|Overall Study||50
6290025|NCT00263666|7191486|FG000|COMPLETED|Overall Study||43
6290026|NCT00263666|7191487|FG001|COMPLETED|Overall Study||39
6290027|NCT00263666|7191486|FG000|NOT COMPLETED|Overall Study||7
6290028|NCT00263666|7191487|FG001|NOT COMPLETED|Overall Study||11
6290029|NCT00263757|7191495|FG000|STARTED|Overall Study||12
6290030|NCT00263757|7191496|FG001|STARTED|Overall Study||13
6290031|NCT00263757|7191495|FG000|COMPLETED|Overall Study||4
6290032|NCT00263757|7191496|FG001|COMPLETED|Overall Study||5
6290033|NCT00263757|7191495|FG000|NOT COMPLETED|Overall Study||8
6290034|NCT00263757|7191496|FG001|NOT COMPLETED|Overall Study||8
6290035|NCT00263887|7191504|FG000|STARTED|Overall Study||38
6290036|NCT00263887|7191505|FG001|STARTED|Overall Study||39
6290037|NCT00263887|7191504|FG000|COMPLETED|Overall Study||35
6290038|NCT00263887|7191505|FG001|COMPLETED|Overall Study||32
6290039|NCT00263887|7191504|FG000|NOT COMPLETED|Overall Study||3
6290040|NCT00263887|7191505|FG001|NOT COMPLETED|Overall Study||7
6290041|NCT00264004|7191515|FG000|STARTED|Overall Study|Randomised|30
6290042|NCT00264004|7191516|FG001|STARTED|Overall Study|Randomised|32
6290043|NCT00264004|7191517|FG002|STARTED|Overall Study|Randomised|30
6290044|NCT00264004|7191518|FG003|STARTED|Overall Study|Randomised|34
6290045|NCT00264004|7191515|FG000|COMPLETED|Overall Study|Completed 12 weeks treatment|13
6290046|NCT00264004|7191516|FG001|COMPLETED|Overall Study|Completed 12 weeks treatment|21
6290047|NCT00264004|7191517|FG002|COMPLETED|Overall Study|Completed 12 weeks treatment|16
6290048|NCT00264004|7191518|FG003|COMPLETED|Overall Study|Completed 12 weeks treatment|19
6290049|NCT00264004|7191515|FG000|NOT COMPLETED|Overall Study||17
6290050|NCT00264004|7191516|FG001|NOT COMPLETED|Overall Study||11
6290051|NCT00264004|7191517|FG002|NOT COMPLETED|Overall Study||14
6290052|NCT00264004|7191518|FG003|NOT COMPLETED|Overall Study||15
6290053|NCT00264238|7191528|FG000|STARTED|Overall Study||15
6290054|NCT00264238|7191528|FG000|COMPLETED|Overall Study||14
6290055|NCT00264238|7191528|FG000|NOT COMPLETED|Overall Study||1
6290056|NCT00264290|7191536|FG000|STARTED|Intervention (8 Weeks)||16
6290057|NCT00264290|7191537|FG001|STARTED|Intervention (8 Weeks)||14
6290058|NCT00264290|7191536|FG000|COMPLETED|Intervention (8 Weeks)||15
6290059|NCT00264290|7191537|FG001|COMPLETED|Intervention (8 Weeks)||14
6290060|NCT00264290|7191536|FG000|NOT COMPLETED|Intervention (8 Weeks)||1
6290061|NCT00264290|7191537|FG001|NOT COMPLETED|Intervention (8 Weeks)||0
6290062|NCT00264290|7191536|FG000|STARTED|Observation (4 Weeks)||15
6290063|NCT00264290|7191537|FG001|STARTED|Observation (4 Weeks)||14
6290064|NCT00264290|7191536|FG000|COMPLETED|Observation (4 Weeks)||15
6290065|NCT00264290|7191537|FG001|COMPLETED|Observation (4 Weeks)||14
6290066|NCT00264290|7191536|FG000|NOT COMPLETED|Observation (4 Weeks)||0
6290067|NCT00264290|7191537|FG001|NOT COMPLETED|Observation (4 Weeks)||0
6290068|NCT00264303|7191549|FG000|STARTED|Overall Study||438
6290069|NCT00264303|7191550|FG001|STARTED|Overall Study||448
6290070|NCT00264303|7191549|FG000|COMPLETED|Overall Study||413
6290071|NCT00264303|7191550|FG001|COMPLETED|Overall Study||419
6290072|NCT00264303|7191549|FG000|NOT COMPLETED|Overall Study||25
6290073|NCT00264303|7191550|FG001|NOT COMPLETED|Overall Study||29
6290074|NCT00264381|7191558|FG000|STARTED|Overall Study||35
6290075|NCT00264381|7191559|FG001|STARTED|Overall Study||37
6290076|NCT00264381|7191558|FG000|COMPLETED|Overall Study||35
6290077|NCT00264381|7191559|FG001|COMPLETED|Overall Study||37
6290078|NCT00264381|7191558|FG000|NOT COMPLETED|Overall Study||0
6290079|NCT00264381|7191559|FG001|NOT COMPLETED|Overall Study||0
6290080|NCT00264498|7191567|FG000|STARTED|Randomized Treatment||17
6290081|NCT00264498|7191568|FG001|STARTED|Randomized Treatment||18
6290082|NCT00264498|7191567|FG000|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6290083|NCT00264498|7191568|FG001|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6290084|NCT00264498|7191567|FG000|NOT COMPLETED|Randomized Treatment||17
6290085|NCT00264498|7191568|FG001|NOT COMPLETED|Randomized Treatment||18
6290086|NCT00264498|7191567|FG000|STARTED|Crossover Treatment||6
6290087|NCT00264498|7191568|FG001|STARTED|Crossover Treatment||9
6290088|NCT00264498|7191567|FG000|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6290089|NCT00264498|7191568|FG001|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6290090|NCT00264498|7191567|FG000|NOT COMPLETED|Crossover Treatment||6
6290091|NCT00264498|7191568|FG001|NOT COMPLETED|Crossover Treatment||9
6290092|NCT00264537|7191578|FG000|STARTED|Overall Study||160
6290093|NCT00264537|7191579|FG001|STARTED|Overall Study||159
6290094|NCT00264537|7191580|FG002|STARTED|Overall Study||159
6290095|NCT00264537|7191581|FG003|STARTED|Overall Study||159
6290096|NCT00264537|7191578|FG000|COMPLETED|Overall Study||110
6290097|NCT00264537|7191579|FG001|COMPLETED|Overall Study||101
6290098|NCT00264537|7191580|FG002|COMPLETED|Overall Study||109
6290099|NCT00264537|7191581|FG003|COMPLETED|Overall Study||99
6290100|NCT00264537|7191578|FG000|NOT COMPLETED|Overall Study||50
6290101|NCT00264537|7191579|FG001|NOT COMPLETED|Overall Study||58
6290102|NCT00264537|7191580|FG002|NOT COMPLETED|Overall Study||50
6290103|NCT00264537|7191581|FG003|NOT COMPLETED|Overall Study||60
6290104|NCT00264550|7191597|FG000|STARTED|Overall Study||133
6290105|NCT00264550|7191598|FG001|STARTED|Overall Study||133
6290106|NCT00264550|7191599|FG002|STARTED|Overall Study||89
6290107|NCT00264550|7191600|FG003|STARTED|Overall Study||89
6290108|NCT00264550|7191597|FG000|COMPLETED|Overall Study||90
6290109|NCT00264550|7191598|FG001|COMPLETED|Overall Study||92
6290110|NCT00264550|7191599|FG002|COMPLETED|Overall Study||72
6290111|NCT00264550|7191600|FG003|COMPLETED|Overall Study||59
6290112|NCT00264550|7191597|FG000|NOT COMPLETED|Overall Study||43
6290113|NCT00264550|7191598|FG001|NOT COMPLETED|Overall Study||41
6290114|NCT00264550|7191599|FG002|NOT COMPLETED|Overall Study||17
6290115|NCT00264550|7191600|FG003|NOT COMPLETED|Overall Study||30
6290116|NCT00264576|7191612|FG000|STARTED|Overall Study||308
6290117|NCT00264576|7191613|FG001|STARTED|Overall Study||305
6290118|NCT00264576|7191612|FG000|COMPLETED|Overall Study||307
6290119|NCT00264576|7191613|FG001|COMPLETED|Overall Study||304
6290120|NCT00264576|7191612|FG000|NOT COMPLETED|Overall Study||1
6290121|NCT00264576|7191613|FG001|NOT COMPLETED|Overall Study||1
6290122|NCT00264641|7191622|FG000|STARTED|Overall Study||10
6290123|NCT00264641|7191623|FG001|STARTED|Overall Study||10
6290124|NCT00264641|7191622|FG000|Initiation of the Study|Overall Study||10
6290125|NCT00264641|7191623|FG001|Initiation of the Study|Overall Study||10
6290126|NCT00264641|7191622|FG000|COMPLETED|Overall Study||10
6290127|NCT00264641|7191623|FG001|COMPLETED|Overall Study||10
6290128|NCT00264641|7191622|FG000|NOT COMPLETED|Overall Study||0
6290129|NCT00264641|7191623|FG001|NOT COMPLETED|Overall Study||0
6290130|NCT00264797|7191630|FG000|STARTED|Overall Study||151
6290131|NCT00264797|7191631|FG001|STARTED|Overall Study||152
6290132|NCT00264797|7191630|FG000|COMPLETED|Overall Study||118
6290133|NCT00264797|7191631|FG001|COMPLETED|Overall Study||109
6290134|NCT00264797|7191630|FG000|NOT COMPLETED|Overall Study||33
6290135|NCT00264797|7191631|FG001|NOT COMPLETED|Overall Study||43
6290136|NCT00264810|7191639|FG000|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
6290137|NCT00264810|7191640|FG001|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
6290138|NCT00264810|7191639|FG000|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
6290139|NCT00264810|7191640|FG001|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
6290140|NCT00264810|7191639|FG000|NOT COMPLETED|Baseline||23
6290141|NCT00264810|7191640|FG001|NOT COMPLETED|Baseline||26
6290142|NCT00264810|7191639|FG000|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
6290143|NCT00264810|7191640|FG001|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
6290144|NCT00264810|7191639|FG000|COMPLETED|Post-Operative Stabilization Period||97
6290145|NCT00264810|7191640|FG001|COMPLETED|Post-Operative Stabilization Period||94
6290146|NCT00264810|7191639|FG000|NOT COMPLETED|Post-Operative Stabilization Period||0
6290147|NCT00264810|7191640|FG001|NOT COMPLETED|Post-Operative Stabilization Period||0
6290148|NCT00264810|7191639|FG000|STARTED|Stimulation Optimization Period||97
6290149|NCT00264810|7191640|FG001|STARTED|Stimulation Optimization Period||94
6290150|NCT00264810|7191639|FG000|COMPLETED|Stimulation Optimization Period||96
6290151|NCT00264810|7191640|FG001|COMPLETED|Stimulation Optimization Period||93
6290152|NCT00264810|7191639|FG000|NOT COMPLETED|Stimulation Optimization Period||1
6290153|NCT00264810|7191640|FG001|NOT COMPLETED|Stimulation Optimization Period||1
6290154|NCT00264810|7191639|FG000|STARTED|Blinded Evaluation Period||96
6290155|NCT00264810|7191640|FG001|STARTED|Blinded Evaluation Period||93
6290156|NCT00264810|7191639|FG000|COMPLETED|Blinded Evaluation Period||95
6290157|NCT00264810|7191640|FG001|COMPLETED|Blinded Evaluation Period||92
6290158|NCT00264810|7191639|FG000|NOT COMPLETED|Blinded Evaluation Period||1
6290159|NCT00264810|7191640|FG001|NOT COMPLETED|Blinded Evaluation Period||1
6290160|NCT00264810|7191639|FG000|STARTED|Open Label Evaluation Period||95
6290161|NCT00264810|7191640|FG001|STARTED|Open Label Evaluation Period||92
6290162|NCT00264810|7191639|FG000|1-year Post-implant|Open Label Evaluation Period||92
6290163|NCT00264810|7191640|FG001|1-year Post-implant|Open Label Evaluation Period||90
6290164|NCT00264810|7191639|FG000|COMPLETED|Open Label Evaluation Period||89
6290165|NCT00264810|7191640|FG001|COMPLETED|Open Label Evaluation Period||86
6290166|NCT00264810|7191639|FG000|NOT COMPLETED|Open Label Evaluation Period||6
6290167|NCT00264810|7191640|FG001|NOT COMPLETED|Open Label Evaluation Period||6
6290168|NCT00264849|7191650|FG000|STARTED|Overall Study||275
6290169|NCT00264849|7191651|FG001|STARTED|Overall Study||131
6290170|NCT00264849|7191650|FG000|COMPLETED|Overall Study||253
6290171|NCT00264849|7191651|FG001|COMPLETED|Overall Study||106
6290172|NCT00264849|7191650|FG000|NOT COMPLETED|Overall Study||22
6290173|NCT00264849|7191651|FG001|NOT COMPLETED|Overall Study||25
6290174|NCT00264875|7191657|FG000|STARTED|Overall Study||220
6290175|NCT00264875|7191657|FG000|COMPLETED|Overall Study||190
6290176|NCT00264875|7191657|FG000|NOT COMPLETED|Overall Study||30
6290177|NCT00265083|7191664|FG000|STARTED|Overall Study||78
6290178|NCT00265083|7191665|FG001|STARTED|Overall Study|One patient did not receive study agent.|138
6290179|NCT00265083|7191666|FG002|STARTED|Overall Study||140
6290180|NCT00265083|7191664|FG000|COMPLETED|Overall Study||61
6290181|NCT00265083|7191665|FG001|COMPLETED|Overall Study|One patient did not receive study agent.|96
6290182|NCT00265083|7191666|FG002|COMPLETED|Overall Study||98
6290183|NCT00265083|7191664|FG000|NOT COMPLETED|Overall Study||17
6290184|NCT00265083|7191665|FG001|NOT COMPLETED|Overall Study||42
6290185|NCT00265083|7191666|FG002|NOT COMPLETED|Overall Study||42
6290186|NCT00265096|7191678|FG000|STARTED|Overall Study||113
6290187|NCT00265096|7191679|FG001|STARTED|Overall Study||146
6290188|NCT00265096|7191680|FG002|STARTED|Overall Study||146
6290189|NCT00265096|7191678|FG000|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
6374076|NCT00748098|7284648|FG000|COMPLETED|First Taper Period||61
6290190|NCT00265096|7191679|FG001|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
6290191|NCT00265096|7191680|FG002|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
6290192|NCT00265096|7191678|FG000|NOT COMPLETED|Overall Study||36
6290193|NCT00265096|7191679|FG001|NOT COMPLETED|Overall Study||51
6290194|NCT00265096|7191680|FG002|NOT COMPLETED|Overall Study||39
6290195|NCT00265109|7191690|FG000|STARTED|Overall Study||17
6290196|NCT00265109|7191690|FG000|COMPLETED|Overall Study||11
6290197|NCT00265109|7191690|FG000|NOT COMPLETED|Overall Study||6
6290198|NCT00265122|7191701|FG000|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
6290199|NCT00265122|7191702|FG001|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
6290200|NCT00265122|7191703|FG002|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
6290201|NCT00265122|7191704|FG003|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
6290202|NCT00265122|7191705|FG004|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
6290203|NCT00265122|7191706|FG005|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
6290204|NCT00265122|7191701|FG000|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
6290205|NCT00265122|7191702|FG001|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
6290206|NCT00265122|7191703|FG002|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
6290207|NCT00265122|7191704|FG003|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
6290208|NCT00265122|7191705|FG004|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
6290209|NCT00265122|7191706|FG005|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
6290210|NCT00265122|7191701|FG000|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
6290211|NCT00265122|7191702|FG001|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
6290212|NCT00265122|7191703|FG002|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
6290213|NCT00265122|7191704|FG003|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
6290214|NCT00265122|7191705|FG004|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
6290215|NCT00265122|7191706|FG005|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
6290216|NCT00265122|7191701|FG000|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
6290217|NCT00265122|7191702|FG001|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
6290218|NCT00265122|7191703|FG002|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
6290219|NCT00265122|7191704|FG003|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
6290220|NCT00265122|7191705|FG004|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
6290221|NCT00265122|7191706|FG005|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
6290222|NCT00265122|7191701|FG000|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
6290223|NCT00265122|7191702|FG001|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
6290224|NCT00265122|7191703|FG002|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
6290225|NCT00265122|7191704|FG003|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
6290226|NCT00265122|7191705|FG004|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
6290227|NCT00265122|7191706|FG005|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
6290228|NCT00265122|7191701|FG000|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
6290229|NCT00265122|7191702|FG001|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
6290230|NCT00265122|7191703|FG002|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
6290231|NCT00265122|7191704|FG003|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
6290232|NCT00265122|7191705|FG004|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
6290233|NCT00265122|7191706|FG005|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
6290234|NCT00265148|7191727|FG000|STARTED|Overall Study||40
6290235|NCT00265148|7191728|FG001|STARTED|Overall Study||40
6290236|NCT00265148|7191727|FG000|COMPLETED|Overall Study||31
6290237|NCT00265148|7191728|FG001|COMPLETED|Overall Study||31
6290238|NCT00265148|7191727|FG000|NOT COMPLETED|Overall Study||9
6290239|NCT00265148|7191728|FG001|NOT COMPLETED|Overall Study||9
6290240|NCT00265200|7191735|FG000|STARTED|Overall Study||28
6290241|NCT00265200|7191735|FG000|COMPLETED|Overall Study||24
6290242|NCT00265200|7191735|FG000|NOT COMPLETED|Overall Study||4
6290243|NCT00265239|7191741|FG000|STARTED|Overall Study||52
6290244|NCT00265239|7191742|FG001|STARTED|Overall Study||52
6290245|NCT00265239|7191741|FG000|COMPLETED|Overall Study||50
6290246|NCT00265239|7191742|FG001|COMPLETED|Overall Study||51
6290247|NCT00265239|7191741|FG000|NOT COMPLETED|Overall Study||2
6290248|NCT00265239|7191742|FG001|NOT COMPLETED|Overall Study||1
6290249|NCT00265317|7191752|FG000|STARTED|Lead-In||13
6290250|NCT00265317|7191753|FG001|STARTED|Lead-In||17
6290251|NCT00265317|7191754|FG002|STARTED|Lead-In||0
6290252|NCT00265317|7191755|FG003|STARTED|Lead-In||0
6290253|NCT00265317|7191752|FG000|COMPLETED|Lead-In||1
6290254|NCT00265317|7191753|FG001|COMPLETED|Lead-In||0
6290255|NCT00265317|7191754|FG002|COMPLETED|Lead-In||0
6290256|NCT00265317|7191755|FG003|COMPLETED|Lead-In||0
6290257|NCT00265317|7191752|FG000|NOT COMPLETED|Lead-In||12
6290258|NCT00265317|7191753|FG001|NOT COMPLETED|Lead-In||17
6290259|NCT00265317|7191754|FG002|NOT COMPLETED|Lead-In||0
6290260|NCT00265317|7191755|FG003|NOT COMPLETED|Lead-In||0
6290261|NCT00265317|7191752|FG000|STARTED|Phase 2||0
6290262|NCT00265317|7191753|FG001|STARTED|Phase 2||0
6290263|NCT00265317|7191754|FG002|STARTED|Phase 2||65
6290264|NCT00265317|7191755|FG003|STARTED|Phase 2||67
6290265|NCT00265317|7191752|FG000|COMPLETED|Phase 2||0
6290266|NCT00265317|7191753|FG001|COMPLETED|Phase 2||0
6290267|NCT00265317|7191754|FG002|COMPLETED|Phase 2||1
6290268|NCT00265317|7191755|FG003|COMPLETED|Phase 2||2
6290269|NCT00265317|7191752|FG000|NOT COMPLETED|Phase 2||0
6290270|NCT00265317|7191753|FG001|NOT COMPLETED|Phase 2||0
6290271|NCT00265317|7191754|FG002|NOT COMPLETED|Phase 2||64
6290272|NCT00265317|7191755|FG003|NOT COMPLETED|Phase 2||65
6290273|NCT00265330|7191774|FG000|STARTED|Overall Study||162
6290274|NCT00265330|7191774|FG000|COMPLETED|Overall Study||67
6290275|NCT00265330|7191774|FG000|NOT COMPLETED|Overall Study||95
6290276|NCT00265382|7191778|FG000|STARTED|Overall Study||221
6290277|NCT00265382|7191778|FG000|COMPLETED|Overall Study||76
6290278|NCT00265382|7191778|FG000|NOT COMPLETED|Overall Study||145
6290279|NCT00265395|7191784|FG000|STARTED|Overall Study||86
6290280|NCT00265395|7191785|FG001|STARTED|Overall Study||73
6290281|NCT00265395|7191784|FG000|COMPLETED|Overall Study||78
6290282|NCT00265395|7191785|FG001|COMPLETED|Overall Study||56
6290283|NCT00265395|7191784|FG000|NOT COMPLETED|Overall Study||8
6290284|NCT00265395|7191785|FG001|NOT COMPLETED|Overall Study||17
6290285|NCT00265473|7191790|FG000|STARTED|Overall Study||5
6290286|NCT00265473|7191790|FG000|COMPLETED|Overall Study||5
6290287|NCT00265473|7191790|FG000|NOT COMPLETED|Overall Study||0
6290288|NCT00265512|7191797|FG000|STARTED|Overall Study||213
6290289|NCT00265512|7191798|FG001|STARTED|Overall Study||454
6290290|NCT00265512|7191797|FG000|COMPLETED|Overall Study||168
6290291|NCT00265512|7191798|FG001|COMPLETED|Overall Study||359
6290292|NCT00265512|7191797|FG000|NOT COMPLETED|Overall Study||45
6290293|NCT00265512|7191798|FG001|NOT COMPLETED|Overall Study||95
6290294|NCT00265538|7191806|FG000|STARTED|Overall Study||196
6290295|NCT00265538|7191807|FG001|STARTED|Overall Study||170
6290296|NCT00265538|7191808|FG002|STARTED|Overall Study||182
6290297|NCT00265538|7191809|FG003|STARTED|Overall Study||286
6290298|NCT00265538|7191806|FG000|COMPLETED|Overall Study||186
6290299|NCT00265538|7191807|FG001|COMPLETED|Overall Study||161
6290300|NCT00265538|7191808|FG002|COMPLETED|Overall Study||171
6290301|NCT00265538|7191809|FG003|COMPLETED|Overall Study||267
6290302|NCT00265538|7191806|FG000|NOT COMPLETED|Overall Study||10
6290303|NCT00265538|7191807|FG001|NOT COMPLETED|Overall Study||9
6290304|NCT00265538|7191808|FG002|NOT COMPLETED|Overall Study||11
6290305|NCT00265538|7191809|FG003|NOT COMPLETED|Overall Study||19
6290306|NCT00265564|7191823|FG000|STARTED|Overall Study||59
6290307|NCT00265564|7191824|FG001|STARTED|Overall Study||58
6290308|NCT00265564|7191823|FG000|COMPLETED|Overall Study||49
6290309|NCT00265564|7191824|FG001|COMPLETED|Overall Study||49
6290310|NCT00265564|7191823|FG000|NOT COMPLETED|Overall Study||10
6290311|NCT00265564|7191824|FG001|NOT COMPLETED|Overall Study||9
6290312|NCT00265616|7191832|FG000|STARTED|Overall Study||14
6290313|NCT00265616|7191833|FG001|STARTED|Overall Study||9
6290314|NCT00265616|7191832|FG000|COMPLETED|Overall Study||14
6290315|NCT00265616|7191833|FG001|COMPLETED|Overall Study||9
6290316|NCT00265616|7191832|FG000|NOT COMPLETED|Overall Study||0
6290317|NCT00265616|7191833|FG001|NOT COMPLETED|Overall Study||0
6290318|NCT00265759|7191845|FG000|STARTED|Overall Study||124
6290319|NCT00265759|7191846|FG001|STARTED|Overall Study||128
6290320|NCT00265759|7191847|FG002|STARTED|Overall Study||125
6290321|NCT00265759|7191848|FG003|STARTED|Overall Study||245
6290322|NCT00265759|7191845|FG000|COMPLETED|Overall Study||124
6290323|NCT00265759|7191846|FG001|COMPLETED|Overall Study||127
6290324|NCT00265759|7191847|FG002|COMPLETED|Overall Study||123
6290325|NCT00265759|7191848|FG003|COMPLETED|Overall Study||236
6290326|NCT00265759|7191845|FG000|NOT COMPLETED|Overall Study||0
6290327|NCT00265759|7191846|FG001|NOT COMPLETED|Overall Study||1
6290328|NCT00265759|7191847|FG002|NOT COMPLETED|Overall Study||2
6290329|NCT00265759|7191848|FG003|NOT COMPLETED|Overall Study||9
6290330|NCT00265785|7191859|FG000|STARTED|Overall Study||27
6290331|NCT00265785|7191859|FG000|Eligible|Overall Study||26
6290332|NCT00265785|7191859|FG000|Eligible and Began Protocol Treatment|Overall Study||24
6290333|NCT00265785|7191859|FG000|COMPLETED|Overall Study||0
6290334|NCT00265785|7191859|FG000|NOT COMPLETED|Overall Study||27
6290335|NCT00265850|7191866|FG000|STARTED|Overall Study||899
6290336|NCT00265850|7191867|FG001|STARTED|Overall Study||902
6290337|NCT00265850|7191868|FG002|STARTED|Overall Study||533
6290338|NCT00265850|7191866|FG000|COMPLETED|Overall Study||899
6290339|NCT00265850|7191867|FG001|COMPLETED|Overall Study||902
6290340|NCT00265850|7191868|FG002|COMPLETED|Overall Study||533
6290341|NCT00265850|7191866|FG000|NOT COMPLETED|Overall Study||0
6290342|NCT00265850|7191867|FG001|NOT COMPLETED|Overall Study||0
6290343|NCT00265850|7191868|FG002|NOT COMPLETED|Overall Study||0
6290344|NCT00265889|7191875|FG000|STARTED|Overall Study||42
6290345|NCT00265889|7191875|FG000|Cycle 1: 1st Regimen/Transplant|Overall Study||37
6290346|NCT00265889|7191875|FG000|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
6290347|NCT00265889|7191875|FG000|COMPLETED|Overall Study||37
6290348|NCT00265889|7191875|FG000|NOT COMPLETED|Overall Study||5
6290349|NCT00265941|7191881|FG000|STARTED|Overall Study||470
6290350|NCT00265941|7191882|FG001|STARTED|Overall Study||470
6290351|NCT00265941|7191881|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|447
6290352|NCT00265941|7191882|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|444
6290353|NCT00265941|7191881|FG000|NOT COMPLETED|Overall Study||23
6290354|NCT00265941|7191882|FG001|NOT COMPLETED|Overall Study||26
6290355|NCT00265980|7191896|FG000|STARTED|Overall Study||22
6290356|NCT00265980|7191896|FG000|Weight Initial|Overall Study||22
6290357|NCT00265980|7191896|FG000|Weight -10% Placebo|Overall Study||22
6290358|NCT00265980|7191896|FG000|Weight -10% Leptin|Overall Study||22
6290359|NCT00265980|7191896|FG000|COMPLETED|Overall Study||22
6290360|NCT00265980|7191896|FG000|NOT COMPLETED|Overall Study||0
6290361|NCT00266032|7191903|FG000|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
6290362|NCT00266032|7191904|FG001|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
6290363|NCT00266032|7191905|FG002|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
6290364|NCT00266032|7191903|FG000|Patients Treated|Treatment||684
6290365|NCT00266032|7191904|FG001|Patients Treated|Treatment||221
6290366|NCT00266032|7191905|FG002|Patients Treated|Treatment||229
6290367|NCT00266032|7191903|FG000|Patients Treated and in FAS|Treatment|FAS|642
6290368|NCT00266032|7191904|FG001|Patients Treated and in FAS|Treatment|FAS|209
6290369|NCT00266032|7191905|FG002|Patients Treated and in FAS|Treatment|FAS|216
6290370|NCT00266032|7191903|FG000|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
6290371|NCT00266032|7191904|FG001|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
6290372|NCT00266032|7191905|FG002|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
6290373|NCT00266032|7191903|FG000|NOT COMPLETED|Treatment||111
6290374|NCT00266032|7191904|FG001|NOT COMPLETED|Treatment||64
6290375|NCT00266032|7191905|FG002|NOT COMPLETED|Treatment||47
6290376|NCT00266032|7191903|FG000|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
6290377|NCT00266032|7191904|FG001|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
6290378|NCT00266032|7191905|FG002|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
6290379|NCT00266032|7191903|FG000|COMPLETED|Open-label Safety Extension||448
6290380|NCT00266032|7191904|FG001|COMPLETED|Open-label Safety Extension||115
6290381|NCT00266032|7191905|FG002|COMPLETED|Open-label Safety Extension||140
6290382|NCT00266032|7191903|FG000|NOT COMPLETED|Open-label Safety Extension||41
6290383|NCT00266032|7191904|FG001|NOT COMPLETED|Open-label Safety Extension||14
6290384|NCT00266032|7191905|FG002|NOT COMPLETED|Open-label Safety Extension||25
6290385|NCT00266110|7191913|FG000|STARTED|Overall Study||17
6290386|NCT00266110|7191913|FG000|COMPLETED|Overall Study||10
6290387|NCT00266110|7191913|FG000|NOT COMPLETED|Overall Study||7
6290388|NCT00266227|7191920|FG000|STARTED|Initial Treatment||0
6290389|NCT00266227|7191921|FG001|STARTED|Initial Treatment||0
6290390|NCT00266227|7191922|FG002|STARTED|Initial Treatment||559
6290391|NCT00266227|7191920|FG000|COMPLETED|Initial Treatment||0
6290392|NCT00266227|7191921|FG001|COMPLETED|Initial Treatment||0
6290393|NCT00266227|7191922|FG002|COMPLETED|Initial Treatment||482
6290394|NCT00266227|7191920|FG000|NOT COMPLETED|Initial Treatment||0
6290395|NCT00266227|7191921|FG001|NOT COMPLETED|Initial Treatment||0
6290396|NCT00266227|7191922|FG002|NOT COMPLETED|Initial Treatment||77
6290397|NCT00266227|7191920|FG000|STARTED|Retreatment: Up to Week 48||318
6290398|NCT00266227|7191921|FG001|STARTED|Retreatment: Up to Week 48||157
6290399|NCT00266227|7191922|FG002|STARTED|Retreatment: Up to Week 48||0
6290400|NCT00266227|7191920|FG000|COMPLETED|Retreatment: Up to Week 48||291
6290401|NCT00266227|7191921|FG001|COMPLETED|Retreatment: Up to Week 48||134
6290402|NCT00266227|7191922|FG002|COMPLETED|Retreatment: Up to Week 48||0
6290403|NCT00266227|7191920|FG000|NOT COMPLETED|Retreatment: Up to Week 48||27
6290404|NCT00266227|7191921|FG001|NOT COMPLETED|Retreatment: Up to Week 48||23
6290405|NCT00266227|7191922|FG002|NOT COMPLETED|Retreatment: Up to Week 48||0
6290406|NCT00266227|7191920|FG000|STARTED|Retreatment: Week 48 to Week 72||291
6290407|NCT00266227|7191921|FG001|STARTED|Retreatment: Week 48 to Week 72||134
6290408|NCT00266227|7191922|FG002|STARTED|Retreatment: Week 48 to Week 72||0
6290409|NCT00266227|7191920|FG000|COMPLETED|Retreatment: Week 48 to Week 72||227
6290410|NCT00266227|7191921|FG001|COMPLETED|Retreatment: Week 48 to Week 72||92
6290411|NCT00266227|7191922|FG002|COMPLETED|Retreatment: Week 48 to Week 72||0
6290412|NCT00266227|7191920|FG000|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
6290413|NCT00266227|7191921|FG001|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
6290414|NCT00266227|7191922|FG002|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
6290415|NCT00266279|7191931|FG000|STARTED|Overall Study||17
6290416|NCT00266279|7191931|FG000|COMPLETED|Overall Study||15
6290417|NCT00266279|7191931|FG000|NOT COMPLETED|Overall Study||2
6290418|NCT00266409|7191940|FG000|STARTED|Overall Study||137
6290419|NCT00266409|7191941|FG001|STARTED|Overall Study||138
6290420|NCT00266409|7191942|FG002|STARTED|Overall Study||72
6290421|NCT00266409|7191943|FG003|STARTED|Overall Study||71
6290422|NCT00266409|7191940|FG000|COMPLETED|Overall Study||92
6290423|NCT00266409|7191941|FG001|COMPLETED|Overall Study||92
6290424|NCT00266409|7191942|FG002|COMPLETED|Overall Study||55
6290425|NCT00266409|7191943|FG003|COMPLETED|Overall Study||49
6290426|NCT00266409|7191940|FG000|NOT COMPLETED|Overall Study||45
6399510|NCT00880698|7312258|FG003|NOT COMPLETED|Overall Study||3
6399511|NCT00880750|7312272|FG000|STARTED|First Intervention||39
6399512|NCT00880750|7312273|FG001|STARTED|First Intervention||33
6399513|NCT00880750|7312272|FG000|COMPLETED|First Intervention||30
6399514|NCT00880750|7312273|FG001|COMPLETED|First Intervention||32
6399515|NCT00880750|7312272|FG000|NOT COMPLETED|First Intervention||9
6399516|NCT00880750|7312273|FG001|NOT COMPLETED|First Intervention||1
6399517|NCT00880750|7312272|FG000|STARTED|Washout Period||30
6399518|NCT00880750|7312273|FG001|STARTED|Washout Period||32
6399519|NCT00880750|7312272|FG000|COMPLETED|Washout Period||30
6399520|NCT00880750|7312273|FG001|COMPLETED|Washout Period||32
6399521|NCT00880750|7312272|FG000|NOT COMPLETED|Washout Period||0
6399522|NCT00880750|7312273|FG001|NOT COMPLETED|Washout Period||0
6399523|NCT00880750|7312272|FG000|STARTED|Second Intervention||30
6399524|NCT00880750|7312273|FG001|STARTED|Second Intervention||32
6399525|NCT00880750|7312272|FG000|COMPLETED|Second Intervention||26
6399526|NCT00880750|7312273|FG001|COMPLETED|Second Intervention||30
6290427|NCT00266409|7191941|FG001|NOT COMPLETED|Overall Study||46
6290428|NCT00266409|7191942|FG002|NOT COMPLETED|Overall Study||17
6290429|NCT00266409|7191943|FG003|NOT COMPLETED|Overall Study||22
6290430|NCT00266630|7191955|FG000|STARTED|Overall Study||100
6290431|NCT00266630|7191956|FG001|STARTED|Overall Study||39
6290432|NCT00266630|7191955|FG000|COMPLETED|Overall Study||58
6290433|NCT00266630|7191956|FG001|COMPLETED|Overall Study||11
6290434|NCT00266630|7191955|FG000|NOT COMPLETED|Overall Study||42
6290435|NCT00266630|7191956|FG001|NOT COMPLETED|Overall Study||28
6290436|NCT00266656|7191966|FG000|STARTED|Overall Study||36
6290437|NCT00266656|7191967|FG001|STARTED|Overall Study||33
6290438|NCT00266656|7191966|FG000|COMPLETED|Overall Study||22
6290439|NCT00266656|7191967|FG001|COMPLETED|Overall Study||20
6290440|NCT00266656|7191966|FG000|NOT COMPLETED|Overall Study||14
6290441|NCT00266656|7191967|FG001|NOT COMPLETED|Overall Study||13
6290442|NCT00266695|7191973|FG000|STARTED|Overall Study||203
6290443|NCT00266695|7191973|FG000|COMPLETED|Overall Study||174
6290444|NCT00266695|7191973|FG000|NOT COMPLETED|Overall Study||29
6290445|NCT00266708|7191979|FG000|STARTED|Overall Study||20
6290446|NCT00266708|7191980|FG001|STARTED|Overall Study||22
6290447|NCT00266708|7191979|FG000|COMPLETED|Overall Study||16
6290448|NCT00266708|7191980|FG001|COMPLETED|Overall Study||13
6290449|NCT00266708|7191979|FG000|NOT COMPLETED|Overall Study||4
6290450|NCT00266708|7191980|FG001|NOT COMPLETED|Overall Study||9
6290451|NCT00266799|7191988|FG000|STARTED|Overall Study||98
6290452|NCT00266799|7191989|FG001|STARTED|Overall Study||102
6290453|NCT00266799|7191988|FG000|COMPLETED|Overall Study||62
6290454|NCT00266799|7191989|FG001|COMPLETED|Overall Study||68
6290455|NCT00266799|7191988|FG000|NOT COMPLETED|Overall Study||36
6290456|NCT00266799|7191989|FG001|NOT COMPLETED|Overall Study||34
6290457|NCT00266812|7191997|FG000|STARTED|Overall Study||22
6290458|NCT00266812|7191998|FG001|STARTED|Overall Study||13
6290459|NCT00266812|7191997|FG000|COMPLETED|Overall Study||1
6290460|NCT00266812|7191998|FG001|COMPLETED|Overall Study||2
6290461|NCT00266812|7191997|FG000|NOT COMPLETED|Overall Study||21
6290462|NCT00266812|7191998|FG001|NOT COMPLETED|Overall Study||11
6290463|NCT00266825|7192006|FG000|STARTED|Enrolled and Allocated Intervention||172
6290464|NCT00266825|7192007|FG001|STARTED|Enrolled and Allocated Intervention||178
6290465|NCT00266825|7192006|FG000|COMPLETED|Enrolled and Allocated Intervention||172
6290466|NCT00266825|7192007|FG001|COMPLETED|Enrolled and Allocated Intervention||178
6290467|NCT00266825|7192006|FG000|NOT COMPLETED|Enrolled and Allocated Intervention||0
6290468|NCT00266825|7192007|FG001|NOT COMPLETED|Enrolled and Allocated Intervention||0
6290469|NCT00266825|7192006|FG000|STARTED|Completed Follow-Up||172
6290470|NCT00266825|7192007|FG001|STARTED|Completed Follow-Up||178
6290471|NCT00266825|7192006|FG000|COMPLETED|Completed Follow-Up||147
6290472|NCT00266825|7192007|FG001|COMPLETED|Completed Follow-Up||154
6290473|NCT00266825|7192006|FG000|NOT COMPLETED|Completed Follow-Up||25
6290474|NCT00266825|7192007|FG001|NOT COMPLETED|Completed Follow-Up||24
6290475|NCT00266851|7192018|FG000|STARTED|Overall Study||37
6634695|NCT02298842|7563493|FG001|COMPLETED|First Platelet Donation (Day 0)||36
6634696|NCT02298842|7563492|FG000|NOT COMPLETED|First Platelet Donation (Day 0)||6
6290476|NCT00266851|7192019|FG001|STARTED|Overall Study||38
6290477|NCT00266851|7192020|FG002|STARTED|Overall Study||22
6290478|NCT00266851|7192018|FG000|Completed 3 Month Follow up|Overall Study||26
6290479|NCT00266851|7192019|FG001|Completed 3 Month Follow up|Overall Study||22
6290480|NCT00266851|7192020|FG002|Completed 3 Month Follow up|Overall Study||15
6290481|NCT00266851|7192018|FG000|Completed 6 Month Follow up|Overall Study||27
6290482|NCT00266851|7192019|FG001|Completed 6 Month Follow up|Overall Study||22
6290483|NCT00266851|7192020|FG002|Completed 6 Month Follow up|Overall Study||17
6290484|NCT00266851|7192018|FG000|Completed 9 Month Follow up|Overall Study||22
6290485|NCT00266851|7192019|FG001|Completed 9 Month Follow up|Overall Study||23
6290486|NCT00266851|7192020|FG002|Completed 9 Month Follow up|Overall Study||15
6290487|NCT00266851|7192018|FG000|Completed 12 Month Follow up|Overall Study||25
6290488|NCT00266851|7192019|FG001|Completed 12 Month Follow up|Overall Study||19
6290489|NCT00266851|7192020|FG002|Completed 12 Month Follow up|Overall Study||13
6290490|NCT00266851|7192018|FG000|COMPLETED|Overall Study||37
6290491|NCT00266851|7192019|FG001|COMPLETED|Overall Study||38
6290492|NCT00266851|7192020|FG002|COMPLETED|Overall Study||22
6290493|NCT00266851|7192018|FG000|NOT COMPLETED|Overall Study||0
6290494|NCT00266851|7192019|FG001|NOT COMPLETED|Overall Study||0
6290495|NCT00266851|7192020|FG002|NOT COMPLETED|Overall Study||0
6290496|NCT00266864|7192034|FG000|STARTED|Overall Study||18
6290497|NCT00266864|7192035|FG001|STARTED|Overall Study||13
6290498|NCT00266864|7192034|FG000|COMPLETED|Overall Study||13
6290499|NCT00266864|7192035|FG001|COMPLETED|Overall Study||11
6290500|NCT00266864|7192034|FG000|NOT COMPLETED|Overall Study||5
6290501|NCT00266864|7192035|FG001|NOT COMPLETED|Overall Study||2
6290502|NCT00266877|7192044|FG000|STARTED|Overall Study||91
6290503|NCT00266877|7192045|FG001|STARTED|Overall Study||48
6290504|NCT00266877|7192046|FG002|STARTED|Overall Study||28
6290505|NCT00266877|7192044|FG000|COMPLETED|Overall Study||0
6290506|NCT00266877|7192045|FG001|COMPLETED|Overall Study||0
6290507|NCT00266877|7192046|FG002|COMPLETED|Overall Study||0
6290508|NCT00266877|7192044|FG000|NOT COMPLETED|Overall Study||91
6290509|NCT00266877|7192045|FG001|NOT COMPLETED|Overall Study||48
6290510|NCT00266877|7192046|FG002|NOT COMPLETED|Overall Study||28
6290511|NCT00267007|7192056|FG000|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
6290512|NCT00267007|7192057|FG001|STARTED|Overall Study||11
6290513|NCT00267007|7192056|FG000|COMPLETED|Overall Study||11
6290514|NCT00267007|7192057|FG001|COMPLETED|Overall Study||10
6290515|NCT00267007|7192056|FG000|NOT COMPLETED|Overall Study||8
6290516|NCT00267007|7192057|FG001|NOT COMPLETED|Overall Study||1
6290517|NCT00267020|7192065|FG000|STARTED|Overall Study||86
6290518|NCT00267020|7192066|FG001|STARTED|Overall Study||44
6290519|NCT00267020|7192065|FG000|Received at Least 1 Dose|Overall Study||82
6290520|NCT00267020|7192066|FG001|Received at Least 1 Dose|Overall Study||39
6290521|NCT00267020|7192065|FG000|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|81
6290522|NCT00267020|7192066|FG001|Per-Protocol Population|Overall Study|With: cancer of the pancreas;no other chemotherapy;disease at baseline;received 1 dose of study drug|38
6290523|NCT00267020|7192065|FG000|COMPLETED|Overall Study||0
6290524|NCT00267020|7192066|FG001|COMPLETED|Overall Study||1
6290525|NCT00267020|7192065|FG000|NOT COMPLETED|Overall Study||86
6290526|NCT00267020|7192066|FG001|NOT COMPLETED|Overall Study||43
6290527|NCT00267046|7192074|FG000|STARTED|Overall Study||32
6290528|NCT00267046|7192075|FG001|STARTED|Overall Study||16
6290529|NCT00267046|7192074|FG000|COMPLETED|Overall Study||20
6290530|NCT00267046|7192075|FG001|COMPLETED|Overall Study||5
6290531|NCT00267046|7192074|FG000|NOT COMPLETED|Overall Study||12
6290532|NCT00267046|7192075|FG001|NOT COMPLETED|Overall Study||11
6290533|NCT00267059|7192081|FG000|STARTED|Overall Study||44
6290534|NCT00267059|7192081|FG000|COMPLETED|Overall Study||44
6290535|NCT00267059|7192081|FG000|NOT COMPLETED|Overall Study||0
6290536|NCT00267085|7192085|FG000|STARTED|Overall Study||10
6290537|NCT00267085|7192085|FG000|COMPLETED|Overall Study||10
6290538|NCT00267085|7192085|FG000|NOT COMPLETED|Overall Study||0
6290539|NCT00267098|7192097|FG000|STARTED|Overall Study||109
6290540|NCT00267098|7192098|FG001|STARTED|Overall Study||51
6290541|NCT00267098|7192099|FG002|STARTED|Overall Study||243
6290542|NCT00267098|7192100|FG003|STARTED|Overall Study||241
6290543|NCT00267098|7192101|FG004|STARTED|Overall Study||47
6290544|NCT00267098|7192102|FG005|STARTED|Overall Study||106
6290545|NCT00267098|7192103|FG006|STARTED|Overall Study||101
6290546|NCT00267098|7192104|FG007|STARTED|Overall Study||20
6290547|NCT00267098|7192097|FG000|COMPLETED|Overall Study||0
6290548|NCT00267098|7192098|FG001|COMPLETED|Overall Study||0
6290549|NCT00267098|7192099|FG002|COMPLETED|Overall Study||149
6290550|NCT00267098|7192100|FG003|COMPLETED|Overall Study||135
6290551|NCT00267098|7192101|FG004|COMPLETED|Overall Study||10
6290552|NCT00267098|7192102|FG005|COMPLETED|Overall Study||66
6290553|NCT00267098|7192103|FG006|COMPLETED|Overall Study||55
6290554|NCT00267098|7192104|FG007|COMPLETED|Overall Study||5
6290555|NCT00267098|7192097|FG000|NOT COMPLETED|Overall Study||109
6290556|NCT00267098|7192098|FG001|NOT COMPLETED|Overall Study||51
6290557|NCT00267098|7192099|FG002|NOT COMPLETED|Overall Study||94
6290558|NCT00267098|7192100|FG003|NOT COMPLETED|Overall Study||106
6290559|NCT00267098|7192101|FG004|NOT COMPLETED|Overall Study||37
6290560|NCT00267098|7192102|FG005|NOT COMPLETED|Overall Study||40
6290561|NCT00267098|7192103|FG006|NOT COMPLETED|Overall Study||46
6290562|NCT00267098|7192104|FG007|NOT COMPLETED|Overall Study||15
6290563|NCT00267111|7192129|FG000|STARTED|Overall Study||55
6290564|NCT00267111|7192130|FG001|STARTED|Overall Study||55
6290565|NCT00267111|7192129|FG000|COMPLETED|Overall Study||55
6290566|NCT00267111|7192130|FG001|COMPLETED|Overall Study||55
6290567|NCT00267111|7192129|FG000|NOT COMPLETED|Overall Study||0
6290568|NCT00267111|7192130|FG001|NOT COMPLETED|Overall Study||0
6290569|NCT00267150|7192137|FG000|STARTED|Overall Study||31
6290570|NCT00267150|7192137|FG000|COMPLETED|Overall Study||30
6290571|NCT00267150|7192137|FG000|NOT COMPLETED|Overall Study||1
6290572|NCT00267189|7192143|FG000|STARTED|Overall Study|Intention to treat (ITT) population.|72
6290573|NCT00267189|7192144|FG001|STARTED|Overall Study||73
6290574|NCT00267189|7192143|FG000|Completed Study Medication|Overall Study||54
6290575|NCT00267189|7192144|FG001|Completed Study Medication|Overall Study||72
6290576|NCT00267189|7192143|FG000|COMPLETED|Overall Study|"Completed indicates completed study."|67
6290577|NCT00267189|7192144|FG001|COMPLETED|Overall Study||72
6290578|NCT00267189|7192143|FG000|NOT COMPLETED|Overall Study||5
6290579|NCT00267189|7192144|FG001|NOT COMPLETED|Overall Study||1
6290580|NCT00267202|7192152|FG000|STARTED|Overall Study||136
6290581|NCT00267202|7192153|FG001|STARTED|Overall Study||139
6290582|NCT00267202|7192152|FG000|COMPLETED|Overall Study||83
6290583|NCT00267202|7192153|FG001|COMPLETED|Overall Study||105
6290584|NCT00267202|7192152|FG000|NOT COMPLETED|Overall Study||53
6290585|NCT00267202|7192153|FG001|NOT COMPLETED|Overall Study||34
6374077|NCT00748098|7284649|FG001|COMPLETED|First Taper Period||65
6374078|NCT00748098|7284648|FG000|NOT COMPLETED|First Taper Period||3
6374079|NCT00748098|7284649|FG001|NOT COMPLETED|First Taper Period||1
6374080|NCT00748098|7284648|FG000|STARTED|1-Week Washout Period||61
6374081|NCT00748098|7284649|FG001|STARTED|1-Week Washout Period||65
6374082|NCT00748098|7284648|FG000|COMPLETED|1-Week Washout Period||59
6374083|NCT00748098|7284649|FG001|COMPLETED|1-Week Washout Period||64
6374084|NCT00748098|7284648|FG000|NOT COMPLETED|1-Week Washout Period||2
6374085|NCT00748098|7284649|FG001|NOT COMPLETED|1-Week Washout Period||1
6374086|NCT00748098|7284648|FG000|STARTED|Second Treatment Intervention Period||59
6374087|NCT00748098|7284649|FG001|STARTED|Second Treatment Intervention Period||64
6374088|NCT00748098|7284648|FG000|COMPLETED|Second Treatment Intervention Period||53
6374089|NCT00748098|7284649|FG001|COMPLETED|Second Treatment Intervention Period||61
6374090|NCT00748098|7284648|FG000|NOT COMPLETED|Second Treatment Intervention Period||6
6377831|NCT00765336|7288491|FG001|STARTED|Overall Study||89
6290586|NCT00267293|7192163|FG000|STARTED|Overall Study||20
6290587|NCT00267293|7192164|FG001|STARTED|Overall Study||20
6290588|NCT00267293|7192165|FG002|STARTED|Overall Study||20
6290589|NCT00267293|7192163|FG000|COMPLETED|Overall Study||20
6290590|NCT00267293|7192164|FG001|COMPLETED|Overall Study||20
6290591|NCT00267293|7192165|FG002|COMPLETED|Overall Study||20
6290592|NCT00267293|7192163|FG000|NOT COMPLETED|Overall Study||0
6290593|NCT00267293|7192164|FG001|NOT COMPLETED|Overall Study||0
6290594|NCT00267293|7192165|FG002|NOT COMPLETED|Overall Study||0
6290595|NCT00267488|7192173|FG000|STARTED|Overall Study||37
6290596|NCT00267488|7192173|FG000|COMPLETED|Overall Study||26
6290597|NCT00267488|7192173|FG000|NOT COMPLETED|Overall Study||11
6290598|NCT00267631|7192179|FG000|STARTED|Overall Study||2361
6290599|NCT00267631|7192180|FG001|STARTED|Overall Study||3031
6290600|NCT00267631|7192179|FG000|COMPLETED|Overall Study||2361
6290601|NCT00267631|7192180|FG001|COMPLETED|Overall Study||3031
6290602|NCT00267631|7192179|FG000|NOT COMPLETED|Overall Study||0
6290603|NCT00267631|7192180|FG001|NOT COMPLETED|Overall Study||0
6290604|NCT00267644|7192188|FG000|STARTED|Overall Study||13
6290605|NCT00267644|7192189|FG001|STARTED|Overall Study||63
6290606|NCT00267644|7192188|FG000|COMPLETED|Overall Study||13
6290607|NCT00267644|7192189|FG001|COMPLETED|Overall Study||63
6290608|NCT00267644|7192188|FG000|NOT COMPLETED|Overall Study||0
6290609|NCT00267644|7192189|FG001|NOT COMPLETED|Overall Study||0
6290610|NCT00267670|7192199|FG000|STARTED|Overall Study||19
6290611|NCT00267670|7192200|FG001|STARTED|Overall Study||7
6290612|NCT00267670|7192199|FG000|COMPLETED|Overall Study||15
6290613|NCT00267670|7192200|FG001|COMPLETED|Overall Study||7
6290614|NCT00267670|7192199|FG000|NOT COMPLETED|Overall Study||4
6290615|NCT00267670|7192200|FG001|NOT COMPLETED|Overall Study||0
6290616|NCT00267696|7192207|FG000|STARTED|Overall Study||45
6290617|NCT00267696|7192207|FG000|COMPLETED|Overall Study||45
6290618|NCT00267696|7192207|FG000|NOT COMPLETED|Overall Study||0
6290619|NCT00267748|7192214|FG000|STARTED|Non-randomized Period||25
6290620|NCT00267748|7192215|FG001|STARTED|Non-randomized Period||0
6290621|NCT00267748|7192216|FG002|STARTED|Non-randomized Period||0
6290622|NCT00267748|7192214|FG000|COMPLETED|Non-randomized Period||2
6290623|NCT00267748|7192215|FG001|COMPLETED|Non-randomized Period||0
6290624|NCT00267748|7192216|FG002|COMPLETED|Non-randomized Period||0
6290625|NCT00267748|7192214|FG000|NOT COMPLETED|Non-randomized Period||23
6290626|NCT00267748|7192215|FG001|NOT COMPLETED|Non-randomized Period||0
6290627|NCT00267748|7192216|FG002|NOT COMPLETED|Non-randomized Period||0
6290628|NCT00267748|7192214|FG000|STARTED|Randomized Period||0
6290629|NCT00267748|7192215|FG001|STARTED|Randomized Period||146
6290630|NCT00267748|7192216|FG002|STARTED|Randomized Period||146
6290631|NCT00267748|7192214|FG000|Treated|Randomized Period||0
6290632|NCT00267748|7192215|FG001|Treated|Randomized Period||146
6290633|NCT00267748|7192216|FG002|Treated|Randomized Period||143
6290634|NCT00267748|7192214|FG000|COMPLETED|Randomized Period||0
6290635|NCT00267748|7192215|FG001|COMPLETED|Randomized Period||19
6290636|NCT00267748|7192216|FG002|COMPLETED|Randomized Period||14
6290637|NCT00267748|7192214|FG000|NOT COMPLETED|Randomized Period||0
6290638|NCT00267748|7192215|FG001|NOT COMPLETED|Randomized Period||127
6290639|NCT00267748|7192216|FG002|NOT COMPLETED|Randomized Period||132
6290640|NCT00267774|7192225|FG000|STARTED|Overall Study||509
6290641|NCT00267774|7192226|FG001|STARTED|Overall Study||496
6290642|NCT00267774|7192225|FG000|COMPLETED|Overall Study||509
6290643|NCT00267774|7192226|FG001|COMPLETED|Overall Study||496
6290644|NCT00267774|7192225|FG000|NOT COMPLETED|Overall Study||0
6290645|NCT00267774|7192226|FG001|NOT COMPLETED|Overall Study||0
6290646|NCT00267865|7192232|FG000|STARTED|Induction Treatment||12
6290647|NCT00267865|7192232|FG000|COMPLETED|Induction Treatment||9
6290648|NCT00267865|7192232|FG000|NOT COMPLETED|Induction Treatment||3
6290649|NCT00267865|7192232|FG000|STARTED|Consolidation Treatment||5
6290650|NCT00267865|7192232|FG000|COMPLETED|Consolidation Treatment||5
6290651|NCT00267865|7192232|FG000|NOT COMPLETED|Consolidation Treatment||0
6290652|NCT00267956|7192238|FG000|STARTED|Controlled Period||70
6290653|NCT00267956|7192239|FG001|STARTED|Controlled Period||76
6290654|NCT00267956|7192240|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6290655|NCT00267956|7192241|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6290656|NCT00267956|7192238|FG000|COMPLETED|Controlled Period||57
6290657|NCT00267956|7192239|FG001|COMPLETED|Controlled Period||72
6290658|NCT00267956|7192240|FG002|COMPLETED|Controlled Period||0
6290659|NCT00267956|7192241|FG003|COMPLETED|Controlled Period||0
6290660|NCT00267956|7192238|FG000|NOT COMPLETED|Controlled Period||13
6290661|NCT00267956|7192239|FG001|NOT COMPLETED|Controlled Period||4
6290662|NCT00267956|7192240|FG002|NOT COMPLETED|Controlled Period||0
6290663|NCT00267956|7192241|FG003|NOT COMPLETED|Controlled Period||0
6290664|NCT00267956|7192238|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6290665|NCT00267956|7192239|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6290666|NCT00267956|7192240|FG002|STARTED|After Controlled Period||57
6290667|NCT00267956|7192241|FG003|STARTED|After Controlled Period||72
6290668|NCT00267956|7192238|FG000|COMPLETED|After Controlled Period||0
6290669|NCT00267956|7192239|FG001|COMPLETED|After Controlled Period||0
6290670|NCT00267956|7192240|FG002|COMPLETED|After Controlled Period||52
6290671|NCT00267956|7192241|FG003|COMPLETED|After Controlled Period||70
6290672|NCT00267956|7192238|FG000|NOT COMPLETED|After Controlled Period||0
6290673|NCT00267956|7192239|FG001|NOT COMPLETED|After Controlled Period||0
6290674|NCT00267956|7192240|FG002|NOT COMPLETED|After Controlled Period||5
6290675|NCT00267956|7192241|FG003|NOT COMPLETED|After Controlled Period||2
6290676|NCT00267969|7192252|FG000|STARTED|Controlled Period|Number of patients randomized|255
6290677|NCT00267969|7192253|FG001|STARTED|Controlled Period|Number of patients randomized|255
6290678|NCT00267969|7192254|FG002|STARTED|Controlled Period|Number of patients randomized|256
6290679|NCT00267969|7192255|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6374091|NCT00748098|7284649|FG001|NOT COMPLETED|Second Treatment Intervention Period||3
6399527|NCT00880750|7312272|FG000|NOT COMPLETED|Second Intervention||4
6399528|NCT00880750|7312273|FG001|NOT COMPLETED|Second Intervention||2
6399529|NCT00880763|7312283|FG000|STARTED|Initial Treatment Period (Part 1)||23
6399530|NCT00880763|7312284|FG001|STARTED|Initial Treatment Period (Part 1)||22
6399531|NCT00880763|7312285|FG002|STARTED|Initial Treatment Period (Part 1)||23
6399532|NCT00880763|7312286|FG003|STARTED|Initial Treatment Period (Part 1)||22
6399533|NCT00880763|7312283|FG000|COMPLETED|Initial Treatment Period (Part 1)||23
6399534|NCT00880763|7312284|FG001|COMPLETED|Initial Treatment Period (Part 1)||22
6399535|NCT00880763|7312285|FG002|COMPLETED|Initial Treatment Period (Part 1)||23
6399536|NCT00880763|7312286|FG003|COMPLETED|Initial Treatment Period (Part 1)||22
6399537|NCT00880763|7312283|FG000|NOT COMPLETED|Initial Treatment Period (Part 1)||0
6399538|NCT00880763|7312284|FG001|NOT COMPLETED|Initial Treatment Period (Part 1)||0
6399539|NCT00880763|7312285|FG002|NOT COMPLETED|Initial Treatment Period (Part 1)||0
6399540|NCT00880763|7312286|FG003|NOT COMPLETED|Initial Treatment Period (Part 1)||0
6399541|NCT00880763|7312283|FG000|STARTED|Extension Period (Part 2)||23
6399542|NCT00880763|7312284|FG001|STARTED|Extension Period (Part 2)||22
6399543|NCT00880763|7312285|FG002|STARTED|Extension Period (Part 2)||23
6399544|NCT00880763|7312286|FG003|STARTED|Extension Period (Part 2)||22
6399545|NCT00880763|7312283|FG000|COMPLETED|Extension Period (Part 2)||23
6399546|NCT00880763|7312284|FG001|COMPLETED|Extension Period (Part 2)||19
6399547|NCT00880763|7312285|FG002|COMPLETED|Extension Period (Part 2)||20
6399548|NCT00880763|7312286|FG003|COMPLETED|Extension Period (Part 2)||19
6399549|NCT00880763|7312283|FG000|NOT COMPLETED|Extension Period (Part 2)||0
6399550|NCT00880763|7312284|FG001|NOT COMPLETED|Extension Period (Part 2)||3
6399551|NCT00880763|7312285|FG002|NOT COMPLETED|Extension Period (Part 2)||3
6399552|NCT00880763|7312286|FG003|NOT COMPLETED|Extension Period (Part 2)||3
6399553|NCT00880906|7312298|FG000|STARTED|Overall Study||29
6399554|NCT00880906|7312299|FG001|STARTED|Overall Study||21
6399555|NCT00880906|7312298|FG000|COMPLETED|Overall Study||17
6399556|NCT00880906|7312299|FG001|COMPLETED|Overall Study||14
6399557|NCT00880906|7312298|FG000|NOT COMPLETED|Overall Study||12
6399558|NCT00880906|7312299|FG001|NOT COMPLETED|Overall Study||7
6399559|NCT00880919|7312308|FG000|STARTED|Overall Study||33
6399560|NCT00880919|7312309|FG001|STARTED|Overall Study||33
6399561|NCT00880919|7312310|FG002|STARTED|Overall Study||29
6399562|NCT00880919|7312308|FG000|COMPLETED|Overall Study||18
6399563|NCT00880919|7312309|FG001|COMPLETED|Overall Study||19
6399564|NCT00880919|7312310|FG002|COMPLETED|Overall Study||23
6399565|NCT00880919|7312308|FG000|NOT COMPLETED|Overall Study||15
6399566|NCT00880919|7312309|FG001|NOT COMPLETED|Overall Study||14
6399567|NCT00880919|7312310|FG002|NOT COMPLETED|Overall Study||6
6399568|NCT00880997|7312324|FG000|STARTED|Overall Study||9
6399569|NCT00880997|7312325|FG001|STARTED|Overall Study||8
6399570|NCT00880997|7312326|FG002|STARTED|Overall Study||13
6399571|NCT00880997|7312324|FG000|COMPLETED|Overall Study||6
6399572|NCT00880997|7312325|FG001|COMPLETED|Overall Study||6
6399573|NCT00880997|7312326|FG002|COMPLETED|Overall Study||5
6399574|NCT00880997|7312324|FG000|NOT COMPLETED|Overall Study||3
6399575|NCT00880997|7312325|FG001|NOT COMPLETED|Overall Study||2
6399576|NCT00880997|7312326|FG002|NOT COMPLETED|Overall Study||8
6399577|NCT00881335|7312336|FG000|STARTED|Overall Study||30
6399578|NCT00881335|7312337|FG001|STARTED|Overall Study||30
6399579|NCT00881335|7312336|FG000|COMPLETED|Overall Study|3 participants did not complete the period|27
6399580|NCT00881335|7312337|FG001|COMPLETED|Overall Study|2 participants did not complete the period|28
6399581|NCT00881335|7312336|FG000|NOT COMPLETED|Overall Study||3
6399582|NCT00881335|7312337|FG001|NOT COMPLETED|Overall Study||2
6399583|NCT00881361|7312345|FG000|STARTED|Overall Study||707
6399584|NCT00881361|7312346|FG001|STARTED|Overall Study||47
6399585|NCT00881361|7312347|FG002|STARTED|Overall Study||2
6399586|NCT00881361|7312345|FG000|COMPLETED|Overall Study||663
6399587|NCT00881361|7312346|FG001|COMPLETED|Overall Study||38
6399588|NCT00881361|7312347|FG002|COMPLETED|Overall Study||0
6399589|NCT00881361|7312345|FG000|NOT COMPLETED|Overall Study||44
6399590|NCT00881361|7312346|FG001|NOT COMPLETED|Overall Study||9
6399591|NCT00881361|7312347|FG002|NOT COMPLETED|Overall Study||2
6399592|NCT00881465|7312358|FG000|STARTED|Overall Study||16
6399593|NCT00881465|7312359|FG001|STARTED|Overall Study||15
6399594|NCT00881465|7312358|FG000|COMPLETED|Overall Study||14
6399595|NCT00881465|7312359|FG001|COMPLETED|Overall Study||15
6399596|NCT00881465|7312358|FG000|NOT COMPLETED|Overall Study||2
6399597|NCT00881465|7312359|FG001|NOT COMPLETED|Overall Study||0
6399598|NCT00881504|7312365|FG000|STARTED|Overall Study||9
6399599|NCT00881504|7312365|FG000|COMPLETED|Overall Study||8
6399600|NCT00881504|7312365|FG000|NOT COMPLETED|Overall Study||1
6399601|NCT00881530|7312375|FG000|STARTED|Overall Study||106
6399602|NCT00881530|7312376|FG001|STARTED|Overall Study||109
6399603|NCT00881530|7312377|FG002|STARTED|Overall Study||56
6290680|NCT00267969|7192256|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6290681|NCT00267969|7192257|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6290682|NCT00267969|7192258|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6290683|NCT00267969|7192252|FG000|COMPLETED|Controlled Period||243
6290684|NCT00267969|7192253|FG001|COMPLETED|Controlled Period||254
6290685|NCT00267969|7192254|FG002|COMPLETED|Controlled Period||245
6290686|NCT00267969|7192255|FG003|COMPLETED|Controlled Period||0
6290687|NCT00267969|7192256|FG004|COMPLETED|Controlled Period||0
6290688|NCT00267969|7192257|FG005|COMPLETED|Controlled Period||0
6290689|NCT00267969|7192258|FG006|COMPLETED|Controlled Period||0
6290690|NCT00267969|7192252|FG000|NOT COMPLETED|Controlled Period||12
6290691|NCT00267969|7192253|FG001|NOT COMPLETED|Controlled Period||1
6290692|NCT00267969|7192254|FG002|NOT COMPLETED|Controlled Period||11
6290693|NCT00267969|7192255|FG003|NOT COMPLETED|Controlled Period||0
6290694|NCT00267969|7192256|FG004|NOT COMPLETED|Controlled Period||0
6290695|NCT00267969|7192257|FG005|NOT COMPLETED|Controlled Period||0
6290696|NCT00267969|7192258|FG006|NOT COMPLETED|Controlled Period||0
6290697|NCT00267969|7192252|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6290698|NCT00267969|7192253|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6290699|NCT00267969|7192254|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6290700|NCT00267969|7192255|FG003|STARTED|After Controlled Period||123
6290701|NCT00267969|7192256|FG004|STARTED|After Controlled Period||120
6290702|NCT00267969|7192257|FG005|STARTED|After Controlled Period||254
6290703|NCT00267969|7192258|FG006|STARTED|After Controlled Period||245
6290704|NCT00267969|7192252|FG000|COMPLETED|After Controlled Period||0
6290705|NCT00267969|7192253|FG001|COMPLETED|After Controlled Period||0
6290706|NCT00267969|7192254|FG002|COMPLETED|After Controlled Period||0
6290707|NCT00267969|7192255|FG003|COMPLETED|After Controlled Period||87
6290708|NCT00267969|7192256|FG004|COMPLETED|After Controlled Period||85
6290709|NCT00267969|7192257|FG005|COMPLETED|After Controlled Period||172
6290710|NCT00267969|7192258|FG006|COMPLETED|After Controlled Period||173
6290711|NCT00267969|7192252|FG000|NOT COMPLETED|After Controlled Period||0
6290712|NCT00267969|7192253|FG001|NOT COMPLETED|After Controlled Period||0
6290713|NCT00267969|7192254|FG002|NOT COMPLETED|After Controlled Period||0
6290714|NCT00267969|7192255|FG003|NOT COMPLETED|After Controlled Period||36
6290715|NCT00267969|7192256|FG004|NOT COMPLETED|After Controlled Period||35
6290716|NCT00267969|7192257|FG005|NOT COMPLETED|After Controlled Period||82
6290717|NCT00267969|7192258|FG006|NOT COMPLETED|After Controlled Period||72
6290718|NCT00268203|7192276|FG000|STARTED|Overall Study||765
6290719|NCT00268203|7192276|FG000|Completed 2 Years of Follow-up|Overall Study||62
6290720|NCT00268203|7192276|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
6290721|NCT00268203|7192276|FG000|NOT COMPLETED|Overall Study||647
6290722|NCT00268242|7192280|FG000|STARTED|Overall Study||24
6290723|NCT00268242|7192280|FG000|COMPLETED|Overall Study||23
6399604|NCT00881530|7312378|FG003|STARTED|Overall Study||166
6399605|NCT00881530|7312379|FG004|STARTED|Overall Study||166
6399606|NCT00881530|7312380|FG005|STARTED|Overall Study||56
6399607|NCT00881530|7312375|FG000|COMPLETED|Overall Study||92
6399608|NCT00881530|7312376|FG001|COMPLETED|Overall Study||104
6399609|NCT00881530|7312377|FG002|COMPLETED|Overall Study||51
6399610|NCT00881530|7312378|FG003|COMPLETED|Overall Study||157
6399611|NCT00881530|7312379|FG004|COMPLETED|Overall Study||152
6399612|NCT00881530|7312380|FG005|COMPLETED|Overall Study||51
6399613|NCT00881530|7312375|FG000|NOT COMPLETED|Overall Study||14
6399614|NCT00881530|7312376|FG001|NOT COMPLETED|Overall Study||5
6399615|NCT00881530|7312377|FG002|NOT COMPLETED|Overall Study||5
6399616|NCT00881530|7312378|FG003|NOT COMPLETED|Overall Study||9
6399617|NCT00881530|7312379|FG004|NOT COMPLETED|Overall Study||14
6399618|NCT00881530|7312380|FG005|NOT COMPLETED|Overall Study||5
6399619|NCT00881569|7312396|FG000|STARTED|Overall Study||1
6399620|NCT00881569|7312397|FG001|STARTED|Overall Study||1
6399621|NCT00881569|7312396|FG000|COMPLETED|Overall Study||0
6399622|NCT00881569|7312397|FG001|COMPLETED|Overall Study||0
6399623|NCT00881569|7312396|FG000|NOT COMPLETED|Overall Study||1
6399624|NCT00881569|7312397|FG001|NOT COMPLETED|Overall Study||1
6399625|NCT00881621|7312403|FG000|STARTED|Overall Study||51
6399626|NCT00881621|7312403|FG000|COMPLETED|Overall Study||17
6399627|NCT00881621|7312403|FG000|NOT COMPLETED|Overall Study||34
6399628|NCT00881647|7312409|FG000|STARTED|Overall Study||29
6399629|NCT00881647|7312410|FG001|STARTED|Overall Study||16
6399630|NCT00881647|7312409|FG000|COMPLETED|Overall Study||27
6399631|NCT00881647|7312410|FG001|COMPLETED|Overall Study||15
6399632|NCT00881647|7312409|FG000|NOT COMPLETED|Overall Study||2
6399633|NCT00881647|7312410|FG001|NOT COMPLETED|Overall Study||1
6399634|NCT00881712|7312419|FG000|STARTED|Overall Study||15
6399635|NCT00881712|7312420|FG001|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
6399636|NCT00881712|7312421|FG002|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
6399637|NCT00881712|7312419|FG000|COMPLETED|Overall Study||13
6399638|NCT00881712|7312420|FG001|COMPLETED|Overall Study||0
6743350|NCT03334422|7671645|FG003|NOT COMPLETED|Overall Study||6
6743351|NCT03334448|7671660|FG000|STARTED|Period 1||12
6743352|NCT03334448|7671661|FG001|STARTED|Period 1||12
6743353|NCT03334448|7671662|FG002|STARTED|Period 1||13
6743354|NCT03334448|7671663|FG003|STARTED|Period 1||12
6743355|NCT03334448|7671660|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
6399639|NCT00881712|7312421|FG002|COMPLETED|Overall Study||0
6399640|NCT00881712|7312419|FG000|NOT COMPLETED|Overall Study||2
6399641|NCT00881712|7312420|FG001|NOT COMPLETED|Overall Study||0
6399642|NCT00881712|7312421|FG002|NOT COMPLETED|Overall Study||0
6399643|NCT00881751|7312431|FG000|STARTED|Overall Study||47
6399644|NCT00881751|7312432|FG001|STARTED|Overall Study||48
6399645|NCT00881751|7312431|FG000|COMPLETED|Overall Study||47
6399646|NCT00881751|7312432|FG001|COMPLETED|Overall Study||43
6399647|NCT00881751|7312431|FG000|NOT COMPLETED|Overall Study||0
6399648|NCT00881751|7312432|FG001|NOT COMPLETED|Overall Study||5
6399649|NCT00881868|7312440|FG000|STARTED|Overall Study||41
6399650|NCT00881868|7312441|FG001|STARTED|Overall Study||40
6399651|NCT00881868|7312440|FG000|COMPLETED|Overall Study||33
6399652|NCT00881868|7312441|FG001|COMPLETED|Overall Study||38
6399653|NCT00881868|7312440|FG000|NOT COMPLETED|Overall Study||8
6399654|NCT00881868|7312441|FG001|NOT COMPLETED|Overall Study||2
6399655|NCT00881894|7312449|FG000|STARTED|Overall Study||26
6399656|NCT00881894|7312450|FG001|STARTED|Overall Study||26
6399657|NCT00881894|7312449|FG000|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
6399658|NCT00881894|7312450|FG001|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
6399659|NCT00881894|7312449|FG000|COMPLETED|Overall Study||25
6399660|NCT00881894|7312450|FG001|COMPLETED|Overall Study||23
6399661|NCT00881894|7312449|FG000|NOT COMPLETED|Overall Study||1
6399662|NCT00881894|7312450|FG001|NOT COMPLETED|Overall Study||3
6399663|NCT00881959|7312458|FG000|STARTED|Overall Study||38
6399664|NCT00881959|7312459|FG001|STARTED|Overall Study||42
6399665|NCT00881959|7312458|FG000|COMPLETED|Overall Study||36
6399666|NCT00881959|7312459|FG001|COMPLETED|Overall Study||38
6399667|NCT00881959|7312458|FG000|NOT COMPLETED|Overall Study||2
6399668|NCT00881959|7312459|FG001|NOT COMPLETED|Overall Study||4
6399669|NCT00882102|7312465|FG000|STARTED|Overall Study||40
6399670|NCT00882102|7312465|FG000|COMPLETED|Overall Study||40
6399671|NCT00882102|7312465|FG000|NOT COMPLETED|Overall Study||0
6399672|NCT00882115|7312469|FG000|STARTED|Overall Study||38
6399673|NCT00882115|7312469|FG000|COMPLETED|Overall Study||29
6399674|NCT00882115|7312469|FG000|NOT COMPLETED|Overall Study||9
6399675|NCT00882206|7312473|FG000|STARTED|Overall Study||13
6399676|NCT00882206|7312473|FG000|COMPLETED|Overall Study||13
6399677|NCT00882206|7312473|FG000|NOT COMPLETED|Overall Study||0
6399678|NCT00882362|7312480|FG000|STARTED|Overall Study||122
6399679|NCT00882362|7312481|FG001|STARTED|Overall Study||33
6399680|NCT00882362|7312480|FG000|COMPLETED|Overall Study||73
6399681|NCT00882362|7312481|FG001|COMPLETED|Overall Study||10
6399682|NCT00882362|7312480|FG000|NOT COMPLETED|Overall Study||49
6399683|NCT00882362|7312481|FG001|NOT COMPLETED|Overall Study||23
6399684|NCT00882518|7312489|FG000|STARTED|Overall Study||196
6399685|NCT00882518|7312490|FG001|STARTED|Overall Study||192
6399686|NCT00882518|7312489|FG000|COMPLETED|Overall Study||158
6399687|NCT00882518|7312490|FG001|COMPLETED|Overall Study||148
6399688|NCT00882518|7312489|FG000|NOT COMPLETED|Overall Study||38
6399689|NCT00882518|7312490|FG001|NOT COMPLETED|Overall Study||44
6399690|NCT00882557|7312498|FG000|STARTED|Overall Study||8
6399691|NCT00882557|7312499|FG001|STARTED|Overall Study||8
6399692|NCT00882557|7312498|FG000|Completed Dose 1|Overall Study||8
6399693|NCT00882557|7312499|FG001|Completed Dose 1|Overall Study||7
6399694|NCT00882557|7312498|FG000|Completed Dose 2|Overall Study||6
6399695|NCT00882557|7312499|FG001|Completed Dose 2|Overall Study||7
6399696|NCT00882557|7312498|FG000|COMPLETED|Overall Study||6
6399697|NCT00882557|7312499|FG001|COMPLETED|Overall Study||7
6399698|NCT00882557|7312498|FG000|NOT COMPLETED|Overall Study||2
6399699|NCT00882557|7312499|FG001|NOT COMPLETED|Overall Study||1
6399700|NCT00882583|7312507|FG000|STARTED|Overall Study||7
6399701|NCT00882583|7312508|FG001|STARTED|Overall Study||12
6399702|NCT00882583|7312507|FG000|COMPLETED|Overall Study||6
6399703|NCT00882583|7312508|FG001|COMPLETED|Overall Study||11
6399704|NCT00882583|7312507|FG000|NOT COMPLETED|Overall Study||1
6399705|NCT00882583|7312508|FG001|NOT COMPLETED|Overall Study||1
6399706|NCT00882661|7312517|FG000|STARTED|Investigational Training||89
6399707|NCT00882661|7312518|FG001|STARTED|Investigational Training||0
6399708|NCT00882661|7312517|FG000|COMPLETED|Investigational Training||79
6399709|NCT00882661|7312518|FG001|COMPLETED|Investigational Training||0
6399710|NCT00882661|7312517|FG000|NOT COMPLETED|Investigational Training||10
6399711|NCT00882661|7312518|FG001|NOT COMPLETED|Investigational Training||0
6399712|NCT00882661|7312517|FG000|STARTED|Treatment||151
6399713|NCT00882661|7312518|FG001|STARTED|Treatment||140
6399714|NCT00882661|7312517|FG000|COMPLETED|Treatment||141
6399715|NCT00882661|7312518|FG001|COMPLETED|Treatment||114
6399716|NCT00882661|7312517|FG000|NOT COMPLETED|Treatment||10
6399717|NCT00882661|7312518|FG001|NOT COMPLETED|Treatment||26
6743356|NCT03334448|7671661|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
6743357|NCT03334448|7671662|FG002|Received at Least 1 Dose of Study Drug|Period 1||13
6399718|NCT00882687|7312530|FG000|STARTED|Overall Study||15
6399719|NCT00882687|7312531|FG001|STARTED|Overall Study||15
6399720|NCT00882687|7312532|FG002|STARTED|Overall Study||15
6399721|NCT00882687|7312533|FG003|STARTED|Overall Study||15
6399722|NCT00882687|7312530|FG000|COMPLETED|Overall Study||13
6399723|NCT00882687|7312531|FG001|COMPLETED|Overall Study||13
6399724|NCT00882687|7312532|FG002|COMPLETED|Overall Study||12
6399725|NCT00882687|7312533|FG003|COMPLETED|Overall Study||13
6399726|NCT00882687|7312530|FG000|NOT COMPLETED|Overall Study||2
6399727|NCT00882687|7312531|FG001|NOT COMPLETED|Overall Study||2
6399728|NCT00882687|7312532|FG002|NOT COMPLETED|Overall Study||3
6399729|NCT00882687|7312533|FG003|NOT COMPLETED|Overall Study||2
6399730|NCT00882713|7312543|FG000|STARTED|Overall Study||194
6399731|NCT00882713|7312543|FG000|COMPLETED|Overall Study||172
6399732|NCT00882713|7312543|FG000|NOT COMPLETED|Overall Study||22
6399733|NCT00882778|7312548|FG000|STARTED|Overall Study||86
6399734|NCT00882778|7312548|FG000|COMPLETED|Overall Study||86
6399735|NCT00882778|7312548|FG000|NOT COMPLETED|Overall Study||0
6399736|NCT00882908|7312557|FG000|STARTED|Overall Study||78
6399737|NCT00882908|7312558|FG001|STARTED|Overall Study||75
6399738|NCT00882908|7312559|FG002|STARTED|Overall Study||77
6399739|NCT00882908|7312560|FG003|STARTED|Overall Study||79
6399740|NCT00882908|7312561|FG004|STARTED|Overall Study||77
6399741|NCT00882908|7312557|FG000|COMPLETED|Overall Study||75
6399742|NCT00882908|7312558|FG001|COMPLETED|Overall Study||69
6399743|NCT00882908|7312559|FG002|COMPLETED|Overall Study||70
6399744|NCT00882908|7312560|FG003|COMPLETED|Overall Study||72
6399745|NCT00882908|7312561|FG004|COMPLETED|Overall Study||71
6399746|NCT00882908|7312557|FG000|NOT COMPLETED|Overall Study||3
6399747|NCT00882908|7312558|FG001|NOT COMPLETED|Overall Study||6
6399748|NCT00882908|7312559|FG002|NOT COMPLETED|Overall Study||7
6399749|NCT00882908|7312560|FG003|NOT COMPLETED|Overall Study||7
6399750|NCT00882908|7312561|FG004|NOT COMPLETED|Overall Study||6
6399751|NCT00882921|7312574|FG000|STARTED|Overall Study||26
6399752|NCT00882921|7312574|FG000|COMPLETED|Overall Study||15
6399753|NCT00882921|7312574|FG000|NOT COMPLETED|Overall Study||11
6399754|NCT00882999|7312586|FG000|STARTED|Overall Study||35
6399755|NCT00882999|7312587|FG001|STARTED|Overall Study||34
6399756|NCT00882999|7312588|FG002|STARTED|Overall Study||34
6399757|NCT00882999|7312589|FG003|STARTED|Overall Study||36
6399758|NCT00882999|7312590|FG004|STARTED|Overall Study||36
6399759|NCT00882999|7312591|FG005|STARTED|Overall Study||35
6399760|NCT00882999|7312592|FG006|STARTED|Overall Study||35
6399761|NCT00882999|7312586|FG000|Received Any Amount of Study Drug|Overall Study||35
6399762|NCT00882999|7312587|FG001|Received Any Amount of Study Drug|Overall Study||34
6399763|NCT00882999|7312588|FG002|Received Any Amount of Study Drug|Overall Study||34
6399764|NCT00882999|7312589|FG003|Received Any Amount of Study Drug|Overall Study||36
6399765|NCT00882999|7312590|FG004|Received Any Amount of Study Drug|Overall Study||36
6399766|NCT00882999|7312591|FG005|Received Any Amount of Study Drug|Overall Study||35
6399767|NCT00882999|7312592|FG006|Received Any Amount of Study Drug|Overall Study||35
6399768|NCT00882999|7312586|FG000|Completed Study Treatment|Overall Study||29
6399769|NCT00882999|7312587|FG001|Completed Study Treatment|Overall Study||29
6399770|NCT00882999|7312588|FG002|Completed Study Treatment|Overall Study||31
6399771|NCT00882999|7312589|FG003|Completed Study Treatment|Overall Study||33
6399772|NCT00882999|7312590|FG004|Completed Study Treatment|Overall Study||29
6399773|NCT00882999|7312591|FG005|Completed Study Treatment|Overall Study||30
6399774|NCT00882999|7312592|FG006|Completed Study Treatment|Overall Study||31
6399775|NCT00882999|7312586|FG000|COMPLETED|Overall Study||27
6399776|NCT00882999|7312587|FG001|COMPLETED|Overall Study||26
6399777|NCT00882999|7312588|FG002|COMPLETED|Overall Study||30
6399778|NCT00882999|7312589|FG003|COMPLETED|Overall Study||31
6399779|NCT00882999|7312590|FG004|COMPLETED|Overall Study||28
6399780|NCT00882999|7312591|FG005|COMPLETED|Overall Study||28
6399781|NCT00882999|7312592|FG006|COMPLETED|Overall Study||27
6399782|NCT00882999|7312586|FG000|NOT COMPLETED|Overall Study||8
6399783|NCT00882999|7312587|FG001|NOT COMPLETED|Overall Study||8
6399784|NCT00882999|7312588|FG002|NOT COMPLETED|Overall Study||4
6399785|NCT00882999|7312589|FG003|NOT COMPLETED|Overall Study||5
6399786|NCT00882999|7312590|FG004|NOT COMPLETED|Overall Study||8
6399787|NCT00882999|7312591|FG005|NOT COMPLETED|Overall Study||7
6399788|NCT00882999|7312592|FG006|NOT COMPLETED|Overall Study||8
6399789|NCT00883051|7312620|FG000|STARTED|Overall Study||106
6399790|NCT00883051|7312621|FG001|STARTED|Overall Study||104
6399791|NCT00883051|7312622|FG002|STARTED|Overall Study||100
6399792|NCT00883051|7312623|FG003|STARTED|Overall Study||99
6399793|NCT00883051|7312624|FG004|STARTED|Overall Study||103
6399794|NCT00883051|7312620|FG000|No Study Medication Used|Overall Study||24
6399795|NCT00883051|7312621|FG001|No Study Medication Used|Overall Study||22
6399796|NCT00883051|7312622|FG002|No Study Medication Used|Overall Study||29
6399797|NCT00883051|7312623|FG003|No Study Medication Used|Overall Study||29
6399798|NCT00883051|7312624|FG004|No Study Medication Used|Overall Study||17
6399799|NCT00883051|7312620|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
6399800|NCT00883051|7312621|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
6399801|NCT00883051|7312622|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
6399802|NCT00883051|7312623|FG003|Received at Least 1 Dose of Study Drug|Overall Study||70
6399803|NCT00883051|7312624|FG004|Received at Least 1 Dose of Study Drug|Overall Study||86
6399804|NCT00883051|7312620|FG000|COMPLETED|Overall Study||82
6399805|NCT00883051|7312621|FG001|COMPLETED|Overall Study||82
6399806|NCT00883051|7312622|FG002|COMPLETED|Overall Study||71
6399807|NCT00883051|7312623|FG003|COMPLETED|Overall Study||70
6399808|NCT00883051|7312624|FG004|COMPLETED|Overall Study|One participant was lost to follow up and did not provide adverse event data.|85
6399809|NCT00883051|7312620|FG000|NOT COMPLETED|Overall Study||24
6399810|NCT00883051|7312621|FG001|NOT COMPLETED|Overall Study||22
6399811|NCT00883051|7312622|FG002|NOT COMPLETED|Overall Study||29
6399812|NCT00883051|7312623|FG003|NOT COMPLETED|Overall Study||29
6399813|NCT00883051|7312624|FG004|NOT COMPLETED|Overall Study||18
6399814|NCT00883090|7312636|FG000|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
6399815|NCT00883090|7312636|FG000|COMPLETED|Overall Study||13
6399816|NCT00883090|7312636|FG000|NOT COMPLETED|Overall Study||2
6399817|NCT00883103|7312642|FG000|STARTED|Overall Study||69
6399818|NCT00883103|7312643|FG001|STARTED|Overall Study||68
6399819|NCT00883103|7312642|FG000|COMPLETED|Overall Study||69
6399820|NCT00883103|7312643|FG001|COMPLETED|Overall Study||68
6399821|NCT00883103|7312642|FG000|NOT COMPLETED|Overall Study||0
6399822|NCT00883103|7312643|FG001|NOT COMPLETED|Overall Study||0
6290724|NCT00268242|7192280|FG000|NOT COMPLETED|Overall Study||1
6290725|NCT00268346|7192286|FG000|STARTED|Overall Study||18
6290726|NCT00268346|7192287|FG001|STARTED|Overall Study||40
6290727|NCT00268346|7192286|FG000|Started Treatment|Overall Study||18
6290728|NCT00268346|7192287|FG001|Started Treatment|Overall Study||40
6290729|NCT00268346|7192286|FG000|COMPLETED|Overall Study||18
6290730|NCT00268346|7192287|FG001|COMPLETED|Overall Study||37
6290731|NCT00268346|7192286|FG000|NOT COMPLETED|Overall Study||0
6290732|NCT00268346|7192287|FG001|NOT COMPLETED|Overall Study||3
6290733|NCT00268437|7192293|FG000|STARTED|Overall Study||27
6290734|NCT00268437|7192293|FG000|COMPLETED|Overall Study||26
6290735|NCT00268437|7192293|FG000|NOT COMPLETED|Overall Study||1
6290736|NCT00268762|7192298|FG000|STARTED|Overall Study||65
6290737|NCT00268762|7192298|FG000|COMPLETED|Overall Study||65
6290738|NCT00268762|7192298|FG000|NOT COMPLETED|Overall Study||0
6399823|NCT00883116|7312651|FG000|STARTED|Overall Study||248
6399824|NCT00883116|7312652|FG001|STARTED|Overall Study||248
6399825|NCT00883116|7312651|FG000|Received Treatment|Overall Study||248
6399826|NCT00883116|7312652|FG001|Received Treatment|Overall Study||239
6399827|NCT00883116|7312651|FG000|COMPLETED|Overall Study||39
6399828|NCT00883116|7312652|FG001|COMPLETED|Overall Study||29
6399829|NCT00883116|7312651|FG000|NOT COMPLETED|Overall Study||209
6399830|NCT00883116|7312652|FG001|NOT COMPLETED|Overall Study||219
6399831|NCT00883129|7312662|FG000|STARTED|Overall Study||69
6399832|NCT00883129|7312663|FG001|STARTED|Overall Study||73
6399833|NCT00883129|7312662|FG000|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
6399834|NCT00883129|7312663|FG001|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
6399835|NCT00883129|7312662|FG000|NOT COMPLETED|Overall Study||20
6399836|NCT00883129|7312663|FG001|NOT COMPLETED|Overall Study||36
6399837|NCT00883168|7312673|FG000|STARTED|Overall Study||448
6399838|NCT00883168|7312674|FG001|STARTED|Overall Study||445
6399839|NCT00883168|7312675|FG002|STARTED|Overall Study||450
6399840|NCT00883168|7312676|FG003|STARTED|Overall Study||448
6399841|NCT00883168|7312673|FG000|COMPLETED|Overall Study||434
6399842|NCT00883168|7312674|FG001|COMPLETED|Overall Study||430
6399843|NCT00883168|7312675|FG002|COMPLETED|Overall Study||431
6399844|NCT00883168|7312676|FG003|COMPLETED|Overall Study||433
6399845|NCT00883168|7312673|FG000|NOT COMPLETED|Overall Study||14
6399846|NCT00883168|7312674|FG001|NOT COMPLETED|Overall Study||15
6399847|NCT00883168|7312675|FG002|NOT COMPLETED|Overall Study||19
6399848|NCT00883168|7312676|FG003|NOT COMPLETED|Overall Study||15
6399849|NCT00883181|7312686|FG000|STARTED|Overall Study|Full analysis set|1347
6399850|NCT00883181|7312686|FG000|COMPLETED|Overall Study|Completed planned chemotherapy|1069
6399851|NCT00883181|7312686|FG000|NOT COMPLETED|Overall Study||278
6399852|NCT00883233|7312707|FG000|STARTED|Overall Study||32
6399853|NCT00883233|7312708|FG001|STARTED|Overall Study||32
6399854|NCT00883233|7312709|FG002|STARTED|Overall Study||29
6399855|NCT00883233|7312710|FG003|STARTED|Overall Study||30
6399856|NCT00883233|7312707|FG000|COMPLETED|Overall Study||27
6399857|NCT00883233|7312708|FG001|COMPLETED|Overall Study||28
6399858|NCT00883233|7312709|FG002|COMPLETED|Overall Study||25
6399859|NCT00883233|7312710|FG003|COMPLETED|Overall Study||25
6399860|NCT00883233|7312707|FG000|NOT COMPLETED|Overall Study||5
6399861|NCT00883233|7312708|FG001|NOT COMPLETED|Overall Study||4
6399862|NCT00883233|7312709|FG002|NOT COMPLETED|Overall Study||4
6399863|NCT00883233|7312710|FG003|NOT COMPLETED|Overall Study||5
6399864|NCT00883246|7312720|FG000|STARTED|Overall Study||799
6399865|NCT00883246|7312720|FG000|COMPLETED|Overall Study||626
6399866|NCT00883246|7312720|FG000|NOT COMPLETED|Overall Study||173
6399867|NCT00883337|7312733|FG000|STARTED|Core Treatment Period||109
6399868|NCT00883337|7312734|FG001|STARTED|Core Treatment Period||111
6399869|NCT00883337|7312735|FG002|STARTED|Core Treatment Period||104
6399870|NCT00883337|7312733|FG000|Treated|Core Treatment Period||109
6399871|NCT00883337|7312734|FG001|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
6399872|NCT00883337|7312735|FG002|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
6399873|NCT00883337|7312733|FG000|COMPLETED|Core Treatment Period||89
6399874|NCT00883337|7312734|FG001|COMPLETED|Core Treatment Period||89
6399875|NCT00883337|7312735|FG002|COMPLETED|Core Treatment Period||71
6399876|NCT00883337|7312733|FG000|NOT COMPLETED|Core Treatment Period||20
6399877|NCT00883337|7312734|FG001|NOT COMPLETED|Core Treatment Period||22
6290739|NCT00268892|7192305|FG000|STARTED|Overall Study||90
6290740|NCT00268892|7192306|FG001|STARTED|Overall Study||95
6290741|NCT00268892|7192307|FG002|STARTED|Overall Study||93
6290742|NCT00268892|7192305|FG000|Switched to Higher Dose|Overall Study||59
6290743|NCT00268892|7192306|FG001|Switched to Higher Dose|Overall Study||68
6290744|NCT00268892|7192307|FG002|Switched to Higher Dose|Overall Study||76
6290745|NCT00268892|7192305|FG000|COMPLETED|Overall Study||51
6290746|NCT00268892|7192306|FG001|COMPLETED|Overall Study||53
6290747|NCT00268892|7192307|FG002|COMPLETED|Overall Study||54
6290748|NCT00268892|7192305|FG000|NOT COMPLETED|Overall Study||39
6290749|NCT00268892|7192306|FG001|NOT COMPLETED|Overall Study||42
6290750|NCT00268892|7192307|FG002|NOT COMPLETED|Overall Study||39
6290751|NCT00268905|7192318|FG000|STARTED|Overall Study||43
6290752|NCT00268905|7192319|FG001|STARTED|Overall Study||9
6290753|NCT00268905|7192320|FG002|STARTED|Overall Study||12
6290754|NCT00268905|7192318|FG000|COMPLETED|Overall Study||0
6290755|NCT00268905|7192319|FG001|COMPLETED|Overall Study||0
6290756|NCT00268905|7192320|FG002|COMPLETED|Overall Study||0
6290757|NCT00268905|7192318|FG000|NOT COMPLETED|Overall Study||43
6290758|NCT00268905|7192319|FG001|NOT COMPLETED|Overall Study||9
6290759|NCT00268905|7192320|FG002|NOT COMPLETED|Overall Study||12
6290760|NCT00268983|7192330|FG000|STARTED|Overall Study||6
6290761|NCT00268983|7192331|FG001|STARTED|Overall Study||8
6290762|NCT00268983|7192330|FG000|COMPLETED|Overall Study||3
6290763|NCT00268983|7192331|FG001|COMPLETED|Overall Study||8
6290764|NCT00268983|7192330|FG000|NOT COMPLETED|Overall Study||3
6290765|NCT00268983|7192331|FG001|NOT COMPLETED|Overall Study||0
6290766|NCT00268996|7192339|FG000|STARTED|Overall Study||151
6290767|NCT00268996|7192340|FG001|STARTED|Overall Study||172
6290768|NCT00268996|7192339|FG000|COMPLETED|Overall Study||130
6290769|NCT00268996|7192340|FG001|COMPLETED|Overall Study||152
6290770|NCT00268996|7192339|FG000|NOT COMPLETED|Overall Study||21
6290771|NCT00268996|7192340|FG001|NOT COMPLETED|Overall Study||20
6290772|NCT00269087|7192348|FG000|STARTED|Overall Study||122
6290773|NCT00269087|7192348|FG000|COMPLETED|Overall Study||88
6290774|NCT00269087|7192348|FG000|NOT COMPLETED|Overall Study||34
6290775|NCT00269113|7192354|FG000|STARTED|Overall Study||177
6290776|NCT00269113|7192355|FG001|STARTED|Overall Study||183
6290777|NCT00269113|7192354|FG000|COMPLETED|Overall Study||103
6290778|NCT00269113|7192355|FG001|COMPLETED|Overall Study||146
6290779|NCT00269113|7192354|FG000|NOT COMPLETED|Overall Study||74
6290780|NCT00269113|7192355|FG001|NOT COMPLETED|Overall Study||37
6290781|NCT00269152|7192363|FG000|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
6290782|NCT00269152|7192364|FG001|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
6290783|NCT00269152|7192363|FG000|COMPLETED|Overall Study||45
6290784|NCT00269152|7192364|FG001|COMPLETED|Overall Study||49
6290785|NCT00269152|7192363|FG000|NOT COMPLETED|Overall Study||18
6290786|NCT00269152|7192364|FG001|NOT COMPLETED|Overall Study||10
6290787|NCT00269399|7192372|FG000|STARTED|Overall Study||119
6290788|NCT00269399|7192373|FG001|STARTED|Overall Study||118
6290789|NCT00269399|7192372|FG000|COMPLETED|Overall Study||78
6290790|NCT00269399|7192373|FG001|COMPLETED|Overall Study||91
6290791|NCT00269399|7192372|FG000|NOT COMPLETED|Overall Study||41
6290792|NCT00269399|7192373|FG001|NOT COMPLETED|Overall Study||27
6290793|NCT00269477|7192383|FG000|STARTED|Overall Study||9
6290794|NCT00269477|7192384|FG001|STARTED|Overall Study||18
6290795|NCT00269477|7192385|FG002|STARTED|Overall Study||58
6290796|NCT00269477|7192386|FG003|STARTED|Overall Study||60
6290797|NCT00269477|7192383|FG000|COMPLETED|Overall Study||4
6290798|NCT00269477|7192384|FG001|COMPLETED|Overall Study||12
6290799|NCT00269477|7192385|FG002|COMPLETED|Overall Study||57
6290800|NCT00269477|7192386|FG003|COMPLETED|Overall Study||60
6290801|NCT00269477|7192383|FG000|NOT COMPLETED|Overall Study||5
6290802|NCT00269477|7192384|FG001|NOT COMPLETED|Overall Study||6
6290803|NCT00269477|7192385|FG002|NOT COMPLETED|Overall Study||1
6290804|NCT00269477|7192386|FG003|NOT COMPLETED|Overall Study||0
6290805|NCT00269633|7192398|FG000|STARTED|Overall Study||4
6290806|NCT00269633|7192399|FG001|STARTED|Overall Study||5
6290807|NCT00269633|7192398|FG000|COMPLETED|Overall Study||3
6290808|NCT00269633|7192399|FG001|COMPLETED|Overall Study||5
6290809|NCT00269633|7192398|FG000|NOT COMPLETED|Overall Study||1
6290810|NCT00269633|7192399|FG001|NOT COMPLETED|Overall Study||0
6290811|NCT00269919|7192405|FG000|STARTED|Overall Study||40
6290812|NCT00269919|7192405|FG000|Treated|Overall Study||39
6290813|NCT00269919|7192405|FG000|COMPLETED|Overall Study||13
6290814|NCT00269919|7192405|FG000|NOT COMPLETED|Overall Study||27
6290815|NCT00270205|7192414|FG000|STARTED|Overall Study||6
6290816|NCT00270205|7192415|FG001|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
6290817|NCT00270205|7192416|FG002|STARTED|Overall Study||6
6290818|NCT00270205|7192417|FG003|STARTED|Overall Study||7
6290819|NCT00270205|7192414|FG000|COMPLETED|Overall Study||5
6290820|NCT00270205|7192415|FG001|COMPLETED|Overall Study||6
6290821|NCT00270205|7192416|FG002|COMPLETED|Overall Study||6
6290822|NCT00270205|7192417|FG003|COMPLETED|Overall Study||6
6290823|NCT00270205|7192414|FG000|NOT COMPLETED|Overall Study||1
6290824|NCT00270205|7192415|FG001|NOT COMPLETED|Overall Study||0
6290825|NCT00270205|7192416|FG002|NOT COMPLETED|Overall Study||0
6290826|NCT00270205|7192417|FG003|NOT COMPLETED|Overall Study||1
6290827|NCT00270231|7192427|FG000|STARTED|First Intervention||32
6290828|NCT00270231|7192428|FG001|STARTED|First Intervention||32
6290829|NCT00270231|7192427|FG000|COMPLETED|First Intervention||31
6290830|NCT00270231|7192428|FG001|COMPLETED|First Intervention||31
6290831|NCT00270231|7192427|FG000|NOT COMPLETED|First Intervention||1
6290832|NCT00270231|7192428|FG001|NOT COMPLETED|First Intervention||1
6399878|NCT00883337|7312735|FG002|NOT COMPLETED|Core Treatment Period||33
6399879|NCT00883337|7312733|FG000|STARTED|Extension Treatment Period||89
6399880|NCT00883337|7312734|FG001|STARTED|Extension Treatment Period||89
6399881|NCT00883337|7312735|FG002|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
6290833|NCT00270231|7192427|FG000|STARTED|Washout Period||31
6290834|NCT00270231|7192428|FG001|STARTED|Washout Period||31
6290835|NCT00270231|7192427|FG000|COMPLETED|Washout Period||30
6290836|NCT00270231|7192428|FG001|COMPLETED|Washout Period||31
6290837|NCT00270231|7192427|FG000|NOT COMPLETED|Washout Period||1
6290838|NCT00270231|7192428|FG001|NOT COMPLETED|Washout Period||0
6290839|NCT00270231|7192427|FG000|STARTED|Second Intervention||30
6290840|NCT00270231|7192428|FG001|STARTED|Second Intervention||31
6290841|NCT00270231|7192427|FG000|COMPLETED|Second Intervention||30
6290842|NCT00270231|7192428|FG001|COMPLETED|Second Intervention||30
6290843|NCT00270231|7192427|FG000|NOT COMPLETED|Second Intervention||0
6290844|NCT00270231|7192428|FG001|NOT COMPLETED|Second Intervention||1
6290845|NCT00270257|7192436|FG000|STARTED|Overall Study||623
6290846|NCT00270257|7192437|FG001|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
6399882|NCT00883337|7312733|FG000|COMPLETED|Extension Treatment Period||61
6399883|NCT00883337|7312734|FG001|COMPLETED|Extension Treatment Period||66
6399884|NCT00883337|7312735|FG002|COMPLETED|Extension Treatment Period||40
6399885|NCT00883337|7312733|FG000|NOT COMPLETED|Extension Treatment Period||28
6399886|NCT00883337|7312734|FG001|NOT COMPLETED|Extension Treatment Period||23
6399887|NCT00883337|7312735|FG002|NOT COMPLETED|Extension Treatment Period||19
6399888|NCT00883389|7312749|FG000|STARTED|Overall Study||26
6399889|NCT00883389|7312749|FG000|COMPLETED|Overall Study||26
6399890|NCT00883389|7312749|FG000|NOT COMPLETED|Overall Study||0
6399891|NCT00883415|7312753|FG000|STARTED|Overall Study||20
6399892|NCT00883415|7312753|FG000|COMPLETED|Overall Study||18
6399893|NCT00883415|7312753|FG000|NOT COMPLETED|Overall Study||2
6399894|NCT00883493|7312759|FG000|STARTED|Overall Study||212
6399895|NCT00883493|7312760|FG001|STARTED|Overall Study||209
6399896|NCT00883493|7312759|FG000|Intention To Treat Analysis Population|Overall Study||204
6399897|NCT00883493|7312760|FG001|Intention To Treat Analysis Population|Overall Study||195
6399898|NCT00883493|7312759|FG000|Per Protocol Analysis Population|Overall Study||162
6399899|NCT00883493|7312760|FG001|Per Protocol Analysis Population|Overall Study||155
6399900|NCT00883493|7312759|FG000|COMPLETED|Overall Study||166
6399901|NCT00883493|7312760|FG001|COMPLETED|Overall Study||159
6634697|NCT02298842|7563493|FG001|NOT COMPLETED|First Platelet Donation (Day 0)||5
6634698|NCT02298842|7563492|FG000|STARTED|Second Platelet Donation (Day 6-8)||38
6290847|NCT00270257|7192436|FG000|Week 8|Overall Study||510
6290848|NCT00270257|7192437|FG001|Week 8|Overall Study||443
6290849|NCT00270257|7192436|FG000|Week 26|Overall Study||460
6290850|NCT00270257|7192437|FG001|Week 26|Overall Study||440
6290851|NCT00270257|7192436|FG000|Week 52|Overall Study||362
6290852|NCT00270257|7192437|FG001|Week 52|Overall Study||340
6290853|NCT00270257|7192436|FG000|Week 78|Overall Study||283
6290854|NCT00270257|7192437|FG001|Week 78|Overall Study||285
6290855|NCT00270257|7192436|FG000|Visit 104|Overall Study||211
6290856|NCT00270257|7192437|FG001|Visit 104|Overall Study||204
6290857|NCT00270257|7192436|FG000|COMPLETED|Overall Study||211
6290858|NCT00270257|7192437|FG001|COMPLETED|Overall Study||204
6290859|NCT00270257|7192436|FG000|NOT COMPLETED|Overall Study||412
6290860|NCT00270257|7192437|FG001|NOT COMPLETED|Overall Study||424
6290861|NCT00270296|7192448|FG000|STARTED|Overall Study||285
6290862|NCT00270296|7192449|FG001|STARTED|Overall Study||275
6634699|NCT02298842|7563493|FG001|STARTED|Second Platelet Donation (Day 6-8)||36
6634700|NCT02298842|7563492|FG000|COMPLETED|Second Platelet Donation (Day 6-8)||30
6634701|NCT02298842|7563493|FG001|COMPLETED|Second Platelet Donation (Day 6-8)||30
6634702|NCT02298842|7563492|FG000|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
6290863|NCT00270296|7192450|FG002|STARTED|Overall Study||170
6290864|NCT00270296|7192448|FG000|COMPLETED|Overall Study||186
6290865|NCT00270296|7192449|FG001|COMPLETED|Overall Study||185
6290866|NCT00270296|7192450|FG002|COMPLETED|Overall Study||109
6290867|NCT00270296|7192448|FG000|NOT COMPLETED|Overall Study||99
6290868|NCT00270296|7192449|FG001|NOT COMPLETED|Overall Study||90
6290869|NCT00270296|7192450|FG002|NOT COMPLETED|Overall Study||61
6290870|NCT00270634|7192462|FG000|STARTED|Overall Study||87
6290871|NCT00270634|7192463|FG001|STARTED|Overall Study||77
6290872|NCT00270634|7192464|FG002|STARTED|Overall Study||84
6290873|NCT00270634|7192465|FG003|STARTED|Overall Study||86
6290874|NCT00270634|7192462|FG000|COMPLETED|Overall Study||70
6290875|NCT00270634|7192463|FG001|COMPLETED|Overall Study||64
6290876|NCT00270634|7192464|FG002|COMPLETED|Overall Study||62
6290877|NCT00270634|7192465|FG003|COMPLETED|Overall Study||81
6290878|NCT00270634|7192462|FG000|NOT COMPLETED|Overall Study||17
6399902|NCT00883493|7312759|FG000|NOT COMPLETED|Overall Study||46
6399903|NCT00883493|7312760|FG001|NOT COMPLETED|Overall Study||50
6399904|NCT00883558|7312766|FG000|STARTED|Titration Period (Weeks 0 to 4)||48
6399905|NCT00883558|7312767|FG001|STARTED|Titration Period (Weeks 0 to 4)||0
6634703|NCT02298842|7563493|FG001|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
6634704|NCT02298868|7563501|FG000|STARTED|Overall Study||10
6290879|NCT00270634|7192463|FG001|NOT COMPLETED|Overall Study||13
6290880|NCT00270634|7192464|FG002|NOT COMPLETED|Overall Study||22
6290881|NCT00270634|7192465|FG003|NOT COMPLETED|Overall Study||5
6290882|NCT00270790|7192479|FG000|STARTED|Overall Study||21
6399906|NCT00883558|7312768|FG002|STARTED|Titration Period (Weeks 0 to 4)||0
6399907|NCT00883558|7312766|FG000|COMPLETED|Titration Period (Weeks 0 to 4)||46
6399908|NCT00883558|7312767|FG001|COMPLETED|Titration Period (Weeks 0 to 4)||0
6634705|NCT02298868|7563501|FG000|COMPLETED|Overall Study||7
6634706|NCT02298868|7563501|FG000|NOT COMPLETED|Overall Study||3
6634707|NCT02298933|7563505|FG000|STARTED|Overall Study||10
6634708|NCT02298933|7563505|FG000|COMPLETED|Overall Study||10
6290883|NCT00270790|7192479|FG000|COMPLETED|Overall Study||16
6290884|NCT00270790|7192479|FG000|NOT COMPLETED|Overall Study||5
6290885|NCT00270842|7192486|FG000|STARTED|Overall Study||33
6290886|NCT00270842|7192487|FG001|STARTED|Overall Study||34
6290887|NCT00270842|7192488|FG002|STARTED|Overall Study||34
6290888|NCT00270842|7192486|FG000|COMPLETED|Overall Study||18
6290889|NCT00270842|7192487|FG001|COMPLETED|Overall Study||18
6290890|NCT00270842|7192488|FG002|COMPLETED|Overall Study||18
6290891|NCT00270842|7192486|FG000|NOT COMPLETED|Overall Study||15
6290892|NCT00270842|7192487|FG001|NOT COMPLETED|Overall Study||16
6290893|NCT00270842|7192488|FG002|NOT COMPLETED|Overall Study||16
6290894|NCT00270855|7192498|FG000|STARTED|Overall Study||15
6290895|NCT00270855|7192499|FG001|STARTED|Overall Study||14
6290896|NCT00270855|7192498|FG000|COMPLETED|Overall Study||7
6290897|NCT00270855|7192499|FG001|COMPLETED|Overall Study||6
6290898|NCT00270855|7192498|FG000|NOT COMPLETED|Overall Study||8
6290899|NCT00270855|7192499|FG001|NOT COMPLETED|Overall Study||8
6290900|NCT00270894|7192507|FG000|STARTED|Overall Study||30
6290901|NCT00270894|7192507|FG000|COMPLETED|Overall Study||28
6290902|NCT00270894|7192507|FG000|NOT COMPLETED|Overall Study||2
6290903|NCT00270998|7192514|FG000|STARTED|3 Month Follow-up||149
6290904|NCT00270998|7192515|FG001|STARTED|3 Month Follow-up||146
6290905|NCT00270998|7192516|FG002|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
6290906|NCT00270998|7192514|FG000|COMPLETED|3 Month Follow-up||110
6290907|NCT00270998|7192515|FG001|COMPLETED|3 Month Follow-up||124
6290908|NCT00270998|7192516|FG002|COMPLETED|3 Month Follow-up||132
6290909|NCT00270998|7192514|FG000|NOT COMPLETED|3 Month Follow-up||39
6290910|NCT00270998|7192515|FG001|NOT COMPLETED|3 Month Follow-up||22
6290911|NCT00270998|7192516|FG002|NOT COMPLETED|3 Month Follow-up||18
6290912|NCT00270998|7192514|FG000|STARTED|12 Month Follow-up||110
6290913|NCT00270998|7192515|FG001|STARTED|12 Month Follow-up||124
6290914|NCT00270998|7192516|FG002|STARTED|12 Month Follow-up||132
6290915|NCT00270998|7192514|FG000|COMPLETED|12 Month Follow-up||96
6290916|NCT00270998|7192515|FG001|COMPLETED|12 Month Follow-up||99
6290917|NCT00270998|7192516|FG002|COMPLETED|12 Month Follow-up||111
6290918|NCT00270998|7192514|FG000|NOT COMPLETED|12 Month Follow-up||14
6290919|NCT00270998|7192515|FG001|NOT COMPLETED|12 Month Follow-up||25
6290920|NCT00270998|7192516|FG002|NOT COMPLETED|12 Month Follow-up||21
6290921|NCT00271024|7192530|FG000|STARTED|Overall Study||80
6290922|NCT00271024|7192531|FG001|STARTED|Overall Study||77
6290923|NCT00271024|7192532|FG002|STARTED|Overall Study||88
6290924|NCT00271024|7192533|FG003|STARTED|Overall Study||88
6290925|NCT00271024|7192530|FG000|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
6290926|NCT00271024|7192531|FG001|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
6290927|NCT00271024|7192532|FG002|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
6290928|NCT00271024|7192533|FG003|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
6290929|NCT00271024|7192530|FG000|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
6290930|NCT00271024|7192531|FG001|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
6290931|NCT00271024|7192532|FG002|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
6290932|NCT00271024|7192533|FG003|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
6290933|NCT00271024|7192530|FG000|NOT COMPLETED|Overall Study||22
6290934|NCT00271024|7192531|FG001|NOT COMPLETED|Overall Study||26
6290935|NCT00271024|7192532|FG002|NOT COMPLETED|Overall Study||23
6290936|NCT00271024|7192533|FG003|NOT COMPLETED|Overall Study||24
6290937|NCT00271154|7192545|FG000|STARTED|Overall Study||191
6290938|NCT00271154|7192546|FG001|STARTED|Overall Study||419
6290939|NCT00271154|7192545|FG000|COMPLETED|Overall Study||191
6290940|NCT00271154|7192546|FG001|COMPLETED|Overall Study||419
6290941|NCT00271154|7192545|FG000|NOT COMPLETED|Overall Study||0
6290942|NCT00271154|7192546|FG001|NOT COMPLETED|Overall Study||0
6290943|NCT00271219|7192555|FG000|STARTED|Overall Study||89
6290944|NCT00271219|7192556|FG001|STARTED|Overall Study||86
6290945|NCT00271219|7192555|FG000|COMPLETED|Overall Study||73
6290946|NCT00271219|7192556|FG001|COMPLETED|Overall Study||58
6290947|NCT00271219|7192555|FG000|NOT COMPLETED|Overall Study||16
6290948|NCT00271219|7192556|FG001|NOT COMPLETED|Overall Study||28
6290949|NCT00271375|7192569|FG000|STARTED|Overall Study||114
6290950|NCT00271375|7192570|FG001|STARTED|Overall Study||83
6634709|NCT02298933|7563505|FG000|NOT COMPLETED|Overall Study||0
6634710|NCT02298946|7563511|FG000|STARTED|Overall Study||8
6634711|NCT02298946|7563512|FG001|STARTED|Overall Study||9
6290951|NCT00271375|7192571|FG002|STARTED|Overall Study||57
6290952|NCT00271375|7192569|FG000|COMPLETED|Overall Study||114
6290953|NCT00271375|7192570|FG001|COMPLETED|Overall Study||83
6290954|NCT00271375|7192571|FG002|COMPLETED|Overall Study||57
6399909|NCT00883558|7312768|FG002|COMPLETED|Titration Period (Weeks 0 to 4)||0
6290955|NCT00271375|7192569|FG000|NOT COMPLETED|Overall Study||0
6290956|NCT00271375|7192570|FG001|NOT COMPLETED|Overall Study||0
6290957|NCT00271375|7192571|FG002|NOT COMPLETED|Overall Study||0
6290958|NCT00271505|7192580|FG000|STARTED|Overall Study||43
6290959|NCT00271505|7192580|FG000|COMPLETED|Overall Study||38
6290960|NCT00271505|7192580|FG000|NOT COMPLETED|Overall Study||5
6290961|NCT00271570|7192587|FG000|STARTED|Overall Study||12
6290962|NCT00271570|7192588|FG001|STARTED|Overall Study||12
6290963|NCT00271570|7192587|FG000|COMPLETED|Overall Study||12
6290964|NCT00271570|7192588|FG001|COMPLETED|Overall Study||12
6290965|NCT00271570|7192587|FG000|NOT COMPLETED|Overall Study||0
6634712|NCT02298946|7563511|FG000|COMPLETED|Overall Study||4
6634713|NCT02298946|7563512|FG001|COMPLETED|Overall Study||8
6634714|NCT02298946|7563511|FG000|NOT COMPLETED|Overall Study||4
6634715|NCT02298946|7563512|FG001|NOT COMPLETED|Overall Study||1
6634716|NCT02299050|7563519|FG000|STARTED|Overall Study||23
6634717|NCT02299050|7563519|FG000|COMPLETED|Overall Study||15
6290966|NCT00271570|7192588|FG001|NOT COMPLETED|Overall Study||0
6290967|NCT00271596|7192596|FG000|STARTED|Overall Study||17
6290968|NCT00271596|7192597|FG001|STARTED|Overall Study||16
6290969|NCT00271596|7192596|FG000|COMPLETED|Overall Study||16
6290970|NCT00271596|7192597|FG001|COMPLETED|Overall Study||15
6290971|NCT00271596|7192596|FG000|NOT COMPLETED|Overall Study||1
6290972|NCT00271596|7192597|FG001|NOT COMPLETED|Overall Study||1
6290973|NCT00271609|7192605|FG000|STARTED|Overall Study||56
6290974|NCT00271609|7192606|FG001|STARTED|Overall Study||32
6290975|NCT00271609|7192605|FG000|COMPLETED|Overall Study||43
6290976|NCT00271609|7192606|FG001|COMPLETED|Overall Study||29
6290977|NCT00271609|7192605|FG000|NOT COMPLETED|Overall Study||13
6290978|NCT00271609|7192606|FG001|NOT COMPLETED|Overall Study||3
6290979|NCT00271739|7192614|FG000|STARTED|Overall Study||844
6290980|NCT00271739|7192615|FG001|STARTED|Overall Study||821
6290981|NCT00271739|7192614|FG000|COMPLETED|Overall Study||729
6290982|NCT00271739|7192615|FG001|COMPLETED|Overall Study||716
6290983|NCT00271739|7192614|FG000|NOT COMPLETED|Overall Study||115
6290984|NCT00271739|7192615|FG001|NOT COMPLETED|Overall Study||105
6290985|NCT00271856|7192623|FG000|STARTED|Overall Study||89
6290986|NCT00271856|7192624|FG001|STARTED|Overall Study||88
6290987|NCT00271856|7192623|FG000|COMPLETED|Overall Study||78
6290988|NCT00271856|7192624|FG001|COMPLETED|Overall Study||70
6290989|NCT00271856|7192623|FG000|NOT COMPLETED|Overall Study||11
6290990|NCT00271856|7192624|FG001|NOT COMPLETED|Overall Study||18
6290991|NCT00272038|7192630|FG000|STARTED|Overall Study||29
6290992|NCT00272038|7192630|FG000|COMPLETED|Overall Study||22
6290993|NCT00272038|7192630|FG000|NOT COMPLETED|Overall Study||7
6634718|NCT02299050|7563519|FG000|NOT COMPLETED|Overall Study||8
6634719|NCT02299076|7563525|FG000|STARTED|Overall Study||230
6634720|NCT02299076|7563526|FG001|STARTED|Overall Study||226
6634721|NCT02299076|7563525|FG000|COMPLETED|Overall Study||210
6634722|NCT02299076|7563526|FG001|COMPLETED|Overall Study||212
6634723|NCT02299076|7563525|FG000|NOT COMPLETED|Overall Study||20
6634724|NCT02299076|7563526|FG001|NOT COMPLETED|Overall Study||14
6634725|NCT02299089|7563536|FG000|STARTED|Overall Study||3
6634726|NCT02299089|7563537|FG001|STARTED|Overall Study||4
6634727|NCT02299089|7563538|FG002|STARTED|Overall Study||1
6634728|NCT02299089|7563539|FG003|STARTED|Overall Study||4
6634729|NCT02299089|7563536|FG000|COMPLETED|Overall Study||3
6634730|NCT02299089|7563537|FG001|COMPLETED|Overall Study||4
6634731|NCT02299089|7563538|FG002|COMPLETED|Overall Study||1
6634732|NCT02299089|7563539|FG003|COMPLETED|Overall Study||4
6634733|NCT02299089|7563536|FG000|NOT COMPLETED|Overall Study||0
6634734|NCT02299089|7563537|FG001|NOT COMPLETED|Overall Study||0
6634735|NCT02299089|7563538|FG002|NOT COMPLETED|Overall Study||0
6634736|NCT02299089|7563539|FG003|NOT COMPLETED|Overall Study||0
6290994|NCT00272168|7192637|FG000|STARTED|Overall Study||47
6290995|NCT00272168|7192638|FG001|STARTED|Overall Study||41
6290996|NCT00272168|7192637|FG000|COMPLETED|Overall Study||37
6634737|NCT02299141|7563559|FG000|STARTED|Overall Study||20
6634738|NCT02299141|7563559|FG000|COMPLETED|Overall Study||20
6634739|NCT02299141|7563559|FG000|NOT COMPLETED|Overall Study||0
6634740|NCT02299167|7563570|FG000|STARTED|Overall Study||35
6634741|NCT02299167|7563570|FG000|Dural Puncture|Overall Study||24
6634742|NCT02299167|7563570|FG000|Success Rate|Overall Study||24
6290997|NCT00272168|7192638|FG001|COMPLETED|Overall Study||31
6290998|NCT00272168|7192637|FG000|NOT COMPLETED|Overall Study||10
6290999|NCT00272168|7192638|FG001|NOT COMPLETED|Overall Study||10
6291000|NCT00272311|7192649|FG000|STARTED|Overall Study||14
6291001|NCT00272311|7192650|FG001|STARTED|Overall Study||14
6291002|NCT00272311|7192651|FG002|STARTED|Overall Study||14
6291003|NCT00272311|7192652|FG003|STARTED|Overall Study||14
6291004|NCT00272311|7192653|FG004|STARTED|Overall Study||14
6291005|NCT00272311|7192649|FG000|COMPLETED|Overall Study||14
6291006|NCT00272311|7192650|FG001|COMPLETED|Overall Study||14
6291007|NCT00272311|7192651|FG002|COMPLETED|Overall Study||14
6291008|NCT00272311|7192652|FG003|COMPLETED|Overall Study||14
6634743|NCT02299167|7563570|FG000|Adverse Effects|Overall Study||24
6634744|NCT02299167|7563570|FG000|COMPLETED|Overall Study||24
6634745|NCT02299167|7563570|FG000|NOT COMPLETED|Overall Study||11
6634746|NCT02299258|7563576|FG000|STARTED|Overall Study||32
6634747|NCT02299258|7563577|FG001|STARTED|Overall Study||31
6634748|NCT02299258|7563576|FG000|COMPLETED|Overall Study||31
6634749|NCT02299258|7563577|FG001|COMPLETED|Overall Study||30
6634750|NCT02299258|7563576|FG000|NOT COMPLETED|Overall Study||1
6634751|NCT02299258|7563577|FG001|NOT COMPLETED|Overall Study||1
6291009|NCT00272311|7192653|FG004|COMPLETED|Overall Study||14
6291010|NCT00272311|7192649|FG000|NOT COMPLETED|Overall Study||0
6291011|NCT00272311|7192650|FG001|NOT COMPLETED|Overall Study||0
6291012|NCT00272311|7192651|FG002|NOT COMPLETED|Overall Study||0
6291013|NCT00272311|7192652|FG003|NOT COMPLETED|Overall Study||0
6291014|NCT00272311|7192653|FG004|NOT COMPLETED|Overall Study||0
6291015|NCT00272337|7192670|FG000|STARTED|Overall Study||8
6291016|NCT00272337|7192671|FG001|STARTED|Overall Study||7
6291017|NCT00272337|7192672|FG002|STARTED|Overall Study||7
6291018|NCT00272337|7192673|FG003|STARTED|Overall Study||7
6291019|NCT00272337|7192674|FG004|STARTED|Overall Study||8
6291020|NCT00272337|7192670|FG000|COMPLETED|Overall Study||8
6291021|NCT00272337|7192671|FG001|COMPLETED|Overall Study||7
6291022|NCT00272337|7192672|FG002|COMPLETED|Overall Study||7
6291023|NCT00272337|7192673|FG003|COMPLETED|Overall Study||7
6291024|NCT00272337|7192674|FG004|COMPLETED|Overall Study||8
6291025|NCT00272337|7192670|FG000|NOT COMPLETED|Overall Study||0
6291026|NCT00272337|7192671|FG001|NOT COMPLETED|Overall Study||0
6291027|NCT00272337|7192672|FG002|NOT COMPLETED|Overall Study||0
6291028|NCT00272337|7192673|FG003|NOT COMPLETED|Overall Study||0
6291029|NCT00272337|7192674|FG004|NOT COMPLETED|Overall Study||0
6291030|NCT00272779|7192688|FG000|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
6291031|NCT00272779|7192689|FG001|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
6291032|NCT00272779|7192688|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
6291033|NCT00272779|7192689|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
6291034|NCT00272779|7192688|FG000|TREATED AS RANDOMIZED|Baseline Through Week 48||438
6291035|NCT00272779|7192689|FG001|TREATED AS RANDOMIZED|Baseline Through Week 48||440
6291036|NCT00272779|7192688|FG000|Discontinued Before Week 48|Baseline Through Week 48||39
6291037|NCT00272779|7192689|FG001|Discontinued Before Week 48|Baseline Through Week 48||58
6291038|NCT00272779|7192688|FG000|Discontinued on or After Week 48|Baseline Through Week 48||14
6291039|NCT00272779|7192689|FG001|Discontinued on or After Week 48|Baseline Through Week 48||14
6291040|NCT00272779|7192688|FG000|STILL ON TREATMENT|Baseline Through Week 48||385
6291041|NCT00272779|7192689|FG001|STILL ON TREATMENT|Baseline Through Week 48||368
6291042|NCT00272779|7192688|FG000|COMPLETED|Baseline Through Week 48||0
6291043|NCT00272779|7192689|FG001|COMPLETED|Baseline Through Week 48||0
6291044|NCT00272779|7192688|FG000|NOT COMPLETED|Baseline Through Week 48||440
6291045|NCT00272779|7192689|FG001|NOT COMPLETED|Baseline Through Week 48||443
6291046|NCT00272779|7192688|FG000|STARTED|Baseline Through Week 96|Number randomized to ATV|440
6291047|NCT00272779|7192689|FG001|STARTED|Baseline Through Week 96|Number randomized to LPV|443
6291048|NCT00272779|7192688|FG000|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
6291049|NCT00272779|7192689|FG001|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
6291050|NCT00272779|7192688|FG000|COMPLETED|Baseline Through Week 96||301
6291051|NCT00272779|7192689|FG001|COMPLETED|Baseline Through Week 96||307
6291052|NCT00272779|7192688|FG000|NOT COMPLETED|Baseline Through Week 96||139
6291053|NCT00272779|7192689|FG001|NOT COMPLETED|Baseline Through Week 96||136
6291054|NCT00272792|7192698|FG000|STARTED|Part 1: Responsiveness||90
6291055|NCT00272792|7192699|FG001|STARTED|Part 1: Responsiveness||0
6291056|NCT00272792|7192698|FG000|COMPLETED|Part 1: Responsiveness||89
6291057|NCT00272792|7192699|FG001|COMPLETED|Part 1: Responsiveness||0
6291058|NCT00272792|7192698|FG000|NOT COMPLETED|Part 1: Responsiveness||1
6291059|NCT00272792|7192699|FG001|NOT COMPLETED|Part 1: Responsiveness||0
6291060|NCT00272792|7192698|FG000|STARTED|Part 2: Blinded, Placebo Control Period||33
6291061|NCT00272792|7192699|FG001|STARTED|Part 2: Blinded, Placebo Control Period||12
6291062|NCT00272792|7192698|FG000|COMPLETED|Part 2: Blinded, Placebo Control Period||32
6291063|NCT00272792|7192699|FG001|COMPLETED|Part 2: Blinded, Placebo Control Period||9
6291064|NCT00272792|7192698|FG000|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
6291065|NCT00272792|7192699|FG001|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
6291066|NCT00272844|7192705|FG000|STARTED|Overall Study||23
6291067|NCT00272844|7192705|FG000|COMPLETED|Overall Study||18
6291068|NCT00272844|7192705|FG000|NOT COMPLETED|Overall Study||5
6291069|NCT00272961|7192714|FG000|STARTED|Placebo Run-in Phase: Up to Week 2||60
6291070|NCT00272961|7192715|FG001|STARTED|Placebo Run-in Phase: Up to Week 2||0
6291071|NCT00272961|7192716|FG002|STARTED|Placebo Run-in Phase: Up to Week 2||0
6291072|NCT00272961|7192717|FG003|STARTED|Placebo Run-in Phase: Up to Week 2||0
6291073|NCT00272961|7192718|FG004|STARTED|Placebo Run-in Phase: Up to Week 2||0
6291074|NCT00272961|7192714|FG000|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
6291075|NCT00272961|7192715|FG001|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6291076|NCT00272961|7192716|FG002|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6291077|NCT00272961|7192717|FG003|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6291078|NCT00272961|7192718|FG004|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6291079|NCT00272961|7192714|FG000|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
6291080|NCT00272961|7192715|FG001|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6291081|NCT00272961|7192716|FG002|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6291082|NCT00272961|7192717|FG003|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6291083|NCT00272961|7192718|FG004|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
6291084|NCT00272961|7192714|FG000|STARTED|Treatment Phase: Week 3 Up to Week 12||10
6291085|NCT00272961|7192715|FG001|STARTED|Treatment Phase: Week 3 Up to Week 12||8
6291086|NCT00272961|7192716|FG002|STARTED|Treatment Phase: Week 3 Up to Week 12||11
6291087|NCT00272961|7192717|FG003|STARTED|Treatment Phase: Week 3 Up to Week 12||10
6291088|NCT00272961|7192718|FG004|STARTED|Treatment Phase: Week 3 Up to Week 12||10
6291089|NCT00272961|7192714|FG000|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
6291090|NCT00272961|7192715|FG001|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
6291091|NCT00272961|7192716|FG002|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
6291092|NCT00272961|7192717|FG003|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
6291093|NCT00272961|7192718|FG004|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
6291094|NCT00272961|7192714|FG000|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
6291095|NCT00272961|7192715|FG001|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
6291096|NCT00272961|7192716|FG002|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
6399910|NCT00883558|7312766|FG000|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
6291097|NCT00272961|7192717|FG003|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
6291098|NCT00272961|7192718|FG004|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
6291099|NCT00272987|7192733|FG000|STARTED|Overall Study||29
6291100|NCT00272987|7192734|FG001|STARTED|Overall Study||14
6291101|NCT00272987|7192735|FG002|STARTED|Overall Study||20
6291102|NCT00272987|7192733|FG000|COMPLETED|Overall Study||20
6291103|NCT00272987|7192734|FG001|COMPLETED|Overall Study||10
6291104|NCT00272987|7192735|FG002|COMPLETED|Overall Study||9
6291105|NCT00272987|7192733|FG000|NOT COMPLETED|Overall Study||9
6291106|NCT00272987|7192734|FG001|NOT COMPLETED|Overall Study||4
6291107|NCT00272987|7192735|FG002|NOT COMPLETED|Overall Study||11
6291108|NCT00273052|7192745|FG000|STARTED|Overall Study||290
6291109|NCT00273052|7192746|FG001|STARTED|Overall Study||278
6291110|NCT00273052|7192745|FG000|COMPLETED|Overall Study||221
6291111|NCT00273052|7192746|FG001|COMPLETED|Overall Study||190
6291112|NCT00273052|7192745|FG000|NOT COMPLETED|Overall Study||69
6291113|NCT00273052|7192746|FG001|NOT COMPLETED|Overall Study||88
6291114|NCT00273182|7192752|FG000|STARTED|Overall Study||1999
6291115|NCT00273182|7192752|FG000|COMPLETED|Overall Study||1014
6291116|NCT00273182|7192752|FG000|NOT COMPLETED|Overall Study||985
6291117|NCT00273364|7192759|FG000|STARTED|Overall Study||55
6291118|NCT00273364|7192760|FG001|STARTED|Overall Study||55
6291119|NCT00273364|7192759|FG000|COMPLETED|Overall Study||55
6291120|NCT00273364|7192760|FG001|COMPLETED|Overall Study||55
6291121|NCT00273364|7192759|FG000|NOT COMPLETED|Overall Study||0
6291122|NCT00273364|7192760|FG001|NOT COMPLETED|Overall Study||0
6291123|NCT00273754|7192768|FG000|STARTED|Overall Study||36
6291124|NCT00273754|7192769|FG001|STARTED|Overall Study||36
6291125|NCT00273754|7192768|FG000|COMPLETED|Overall Study||36
6291126|NCT00273754|7192769|FG001|COMPLETED|Overall Study||36
6291127|NCT00273754|7192768|FG000|NOT COMPLETED|Overall Study||0
6291128|NCT00273754|7192769|FG001|NOT COMPLETED|Overall Study||0
6291129|NCT00273793|7192781|FG000|STARTED|Overall Study||36
6291130|NCT00273793|7192782|FG001|STARTED|Overall Study||38
6291131|NCT00273793|7192783|FG002|STARTED|Overall Study||18
6291132|NCT00273793|7192784|FG003|STARTED|Overall Study||60
6291133|NCT00273793|7192785|FG004|STARTED|Overall Study||58
6291134|NCT00273793|7192786|FG005|STARTED|Overall Study||29
6291135|NCT00273793|7192781|FG000|COMPLETED|Overall Study||36
6291136|NCT00273793|7192782|FG001|COMPLETED|Overall Study||38
6291137|NCT00273793|7192783|FG002|COMPLETED|Overall Study||18
6291138|NCT00273793|7192784|FG003|COMPLETED|Overall Study||60
6291139|NCT00273793|7192785|FG004|COMPLETED|Overall Study||58
6291140|NCT00273793|7192786|FG005|COMPLETED|Overall Study||29
6291141|NCT00273793|7192781|FG000|NOT COMPLETED|Overall Study||0
6291142|NCT00273793|7192782|FG001|NOT COMPLETED|Overall Study||0
6291143|NCT00273793|7192783|FG002|NOT COMPLETED|Overall Study||0
6291144|NCT00273793|7192784|FG003|NOT COMPLETED|Overall Study||0
6291145|NCT00273793|7192785|FG004|NOT COMPLETED|Overall Study||0
6291146|NCT00273793|7192786|FG005|NOT COMPLETED|Overall Study||0
6291147|NCT00273858|7192800|FG000|STARTED|Overall Study||880
6291148|NCT00273858|7192800|FG000|COMPLETED|Overall Study||343
6291149|NCT00273858|7192800|FG000|NOT COMPLETED|Overall Study||537
6291150|NCT00273910|7192810|FG000|STARTED|Overall Study||19
6291151|NCT00273910|7192811|FG001|STARTED|Overall Study||19
6291152|NCT00273910|7192812|FG002|STARTED|Overall Study||18
6291153|NCT00273910|7192813|FG003|STARTED|Overall Study||19
6291154|NCT00273910|7192814|FG004|STARTED|Overall Study||15
6291155|NCT00273910|7192815|FG005|STARTED|Overall Study||14
6291156|NCT00273910|7192810|FG000|COMPLETED|Overall Study||19
6291157|NCT00273910|7192811|FG001|COMPLETED|Overall Study||19
6291158|NCT00273910|7192812|FG002|COMPLETED|Overall Study||18
6291159|NCT00273910|7192813|FG003|COMPLETED|Overall Study||19
6291160|NCT00273910|7192814|FG004|COMPLETED|Overall Study||15
6291161|NCT00273910|7192815|FG005|COMPLETED|Overall Study||14
6291162|NCT00273910|7192810|FG000|NOT COMPLETED|Overall Study||0
6291163|NCT00273910|7192811|FG001|NOT COMPLETED|Overall Study||0
6291164|NCT00273910|7192812|FG002|NOT COMPLETED|Overall Study||0
6291165|NCT00273910|7192813|FG003|NOT COMPLETED|Overall Study||0
6291166|NCT00273910|7192814|FG004|NOT COMPLETED|Overall Study||0
6291167|NCT00273910|7192815|FG005|NOT COMPLETED|Overall Study||0
6291168|NCT00274261|7192831|FG000|STARTED|Overall Study||932
6291169|NCT00274261|7192832|FG001|STARTED|Overall Study||633
6291170|NCT00274261|7192831|FG000|COMPLETED|Overall Study||443
6291171|NCT00274261|7192832|FG001|COMPLETED|Overall Study||296
6291172|NCT00274261|7192831|FG000|NOT COMPLETED|Overall Study||489
6291173|NCT00274261|7192832|FG001|NOT COMPLETED|Overall Study||337
6291174|NCT00274287|7192840|FG000|STARTED|Overall Study||15
6291175|NCT00274287|7192840|FG000|COMPLETED|Overall Study||13
6291176|NCT00274287|7192840|FG000|NOT COMPLETED|Overall Study||2
6291177|NCT00274456|7192849|FG000|STARTED|Overall Study||76
6291178|NCT00274456|7192850|FG001|STARTED|Overall Study||76
6291179|NCT00274456|7192851|FG002|STARTED|Overall Study||74
6291180|NCT00274456|7192852|FG003|STARTED|Overall Study||74
6291181|NCT00274456|7192849|FG000|At Least One Response Assessment|Overall Study||73
6291182|NCT00274456|7192850|FG001|At Least One Response Assessment|Overall Study||76
6291183|NCT00274456|7192851|FG002|At Least One Response Assessment|Overall Study||73
6291184|NCT00274456|7192852|FG003|At Least One Response Assessment|Overall Study||70
6291185|NCT00274456|7192849|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
6291186|NCT00274456|7192850|FG001|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
6291187|NCT00274456|7192851|FG002|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
6399911|NCT00883558|7312767|FG001|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
6399912|NCT00883558|7312768|FG002|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
6399913|NCT00883558|7312766|FG000|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
6291188|NCT00274456|7192852|FG003|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
6291189|NCT00274456|7192849|FG000|NOT COMPLETED|Overall Study||37
6291190|NCT00274456|7192850|FG001|NOT COMPLETED|Overall Study||27
6291191|NCT00274456|7192851|FG002|NOT COMPLETED|Overall Study||35
6291192|NCT00274456|7192852|FG003|NOT COMPLETED|Overall Study||45
6291193|NCT00274469|7192864|FG000|STARTED|Overall Study|Number of patients randomized|102
6291194|NCT00274469|7192865|FG001|STARTED|Overall Study|Number of patients randomized|103
6291195|NCT00274469|7192864|FG000|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|23
6291196|NCT00274469|7192865|FG001|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|10
6291197|NCT00274469|7192864|FG000|NOT COMPLETED|Overall Study||79
6291198|NCT00274469|7192865|FG001|NOT COMPLETED|Overall Study||93
6291199|NCT00274625|7192873|FG000|STARTED|Overall Study||199
6291200|NCT00274625|7192874|FG001|STARTED|Overall Study||203
6291201|NCT00274625|7192873|FG000|COMPLETED|Overall Study||139
6291202|NCT00274625|7192874|FG001|COMPLETED|Overall Study||141
6291203|NCT00274625|7192873|FG000|NOT COMPLETED|Overall Study||60
6291204|NCT00274625|7192874|FG001|NOT COMPLETED|Overall Study||62
6291205|NCT00274651|7192882|FG000|STARTED|Overall Study||29
6291206|NCT00274651|7192883|FG001|STARTED|Overall Study||24
6291207|NCT00274651|7192882|FG000|COMPLETED|Overall Study||1
6291208|NCT00274651|7192883|FG001|COMPLETED|Overall Study||4
6291209|NCT00274651|7192882|FG000|NOT COMPLETED|Overall Study||28
6291210|NCT00274651|7192883|FG001|NOT COMPLETED|Overall Study||20
6291211|NCT00274716|7192896|FG000|STARTED|Phase A||54
6291212|NCT00274716|7192897|FG001|STARTED|Phase A||54
6291213|NCT00274716|7192898|FG002|STARTED|Phase A||52
6291214|NCT00274716|7192899|FG003|STARTED|Phase A||51
6291215|NCT00274716|7192900|FG004|STARTED|Phase A||19
6291216|NCT00274716|7192901|FG005|STARTED|Phase A||19
6291217|NCT00274716|7192896|FG000|COMPLETED|Phase A||43
6291218|NCT00274716|7192897|FG001|COMPLETED|Phase A||44
6291219|NCT00274716|7192898|FG002|COMPLETED|Phase A||44
6291220|NCT00274716|7192899|FG003|COMPLETED|Phase A||42
6291221|NCT00274716|7192900|FG004|COMPLETED|Phase A||16
6291222|NCT00274716|7192901|FG005|COMPLETED|Phase A||15
6291223|NCT00274716|7192896|FG000|NOT COMPLETED|Phase A||11
6291224|NCT00274716|7192897|FG001|NOT COMPLETED|Phase A||10
6291225|NCT00274716|7192898|FG002|NOT COMPLETED|Phase A||8
6291226|NCT00274716|7192899|FG003|NOT COMPLETED|Phase A||9
6291227|NCT00274716|7192900|FG004|NOT COMPLETED|Phase A||3
6291228|NCT00274716|7192901|FG005|NOT COMPLETED|Phase A||4
6291229|NCT00274716|7192896|FG000|STARTED|Phase B||43
6291230|NCT00274716|7192897|FG001|STARTED|Phase B||44
6291231|NCT00274716|7192898|FG002|STARTED|Phase B||44
6291232|NCT00274716|7192899|FG003|STARTED|Phase B||42
6291233|NCT00274716|7192900|FG004|STARTED|Phase B||16
6399914|NCT00883558|7312767|FG001|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
6399915|NCT00883558|7312768|FG002|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
6399916|NCT00883558|7312766|FG000|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
6399917|NCT00883558|7312767|FG001|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
6399918|NCT00883558|7312768|FG002|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
6399919|NCT00883558|7312766|FG000|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
6399920|NCT00883558|7312767|FG001|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
6399921|NCT00883558|7312768|FG002|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
6291234|NCT00274716|7192901|FG005|STARTED|Phase B||15
6291235|NCT00274716|7192896|FG000|COMPLETED|Phase B||42
6291236|NCT00274716|7192897|FG001|COMPLETED|Phase B||40
6291237|NCT00274716|7192898|FG002|COMPLETED|Phase B||41
6291238|NCT00274716|7192899|FG003|COMPLETED|Phase B||41
6291239|NCT00274716|7192900|FG004|COMPLETED|Phase B||16
6291240|NCT00274716|7192901|FG005|COMPLETED|Phase B||14
6291241|NCT00274716|7192896|FG000|NOT COMPLETED|Phase B||1
6291242|NCT00274716|7192897|FG001|NOT COMPLETED|Phase B||4
6291243|NCT00274716|7192898|FG002|NOT COMPLETED|Phase B||3
6291244|NCT00274716|7192899|FG003|NOT COMPLETED|Phase B||1
6291245|NCT00274716|7192900|FG004|NOT COMPLETED|Phase B||0
6291246|NCT00274716|7192901|FG005|NOT COMPLETED|Phase B||1
6291247|NCT00274742|7192925|FG000|STARTED|Overall Study||12
6291248|NCT00274742|7192926|FG001|STARTED|Overall Study||13
6291249|NCT00274742|7192927|FG002|STARTED|Overall Study||6
6291250|NCT00274742|7192928|FG003|STARTED|Overall Study||9
6291251|NCT00274742|7192929|FG004|STARTED|Overall Study||32
6291252|NCT00274742|7192930|FG005|STARTED|Overall Study||4
6291253|NCT00274742|7192925|FG000|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
6291254|NCT00274742|7192926|FG001|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
6291255|NCT00274742|7192927|FG002|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
6291256|NCT00274742|7192928|FG003|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
6291257|NCT00274742|7192929|FG004|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
6291258|NCT00274742|7192930|FG005|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
6291259|NCT00274742|7192925|FG000|NOT COMPLETED|Overall Study||0
6291260|NCT00274742|7192926|FG001|NOT COMPLETED|Overall Study||8
6291261|NCT00274742|7192927|FG002|NOT COMPLETED|Overall Study||2
6291262|NCT00274742|7192928|FG003|NOT COMPLETED|Overall Study||5
6291263|NCT00274742|7192929|FG004|NOT COMPLETED|Overall Study||16
6291264|NCT00274742|7192930|FG005|NOT COMPLETED|Overall Study||3
6291265|NCT00274768|7192950|FG000|STARTED|Overall Study||26
6291266|NCT00274768|7192950|FG000|COMPLETED|Overall Study||26
6634752|NCT02299297|7563583|FG000|STARTED|Overall Study||12
6634753|NCT02299297|7563583|FG000|COMPLETED|Overall Study||11
6634754|NCT02299297|7563583|FG000|NOT COMPLETED|Overall Study||1
6634755|NCT02299336|7563587|FG000|STARTED|Overall Study||60
6634756|NCT02299336|7563587|FG000|COMPLETED|Overall Study||46
6634757|NCT02299336|7563587|FG000|NOT COMPLETED|Overall Study||14
6634758|NCT02299349|7563593|FG000|STARTED|Overall Study||35
6291267|NCT00274768|7192950|FG000|NOT COMPLETED|Overall Study||0
6291268|NCT00274781|7192954|FG000|STARTED|Overall Study||30
6291269|NCT00274781|7192954|FG000|COMPLETED|Overall Study||30
6291270|NCT00274781|7192954|FG000|NOT COMPLETED|Overall Study||0
6291271|NCT00274846|7192959|FG000|STARTED|Overall Study||21
6291272|NCT00274846|7192959|FG000|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
6291273|NCT00274846|7192959|FG000|NOT COMPLETED|Overall Study||1
6291274|NCT00274924|7192967|FG000|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
6291275|NCT00274924|7192968|FG001|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
6291276|NCT00274924|7192969|FG002|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
6291277|NCT00274924|7192967|FG000|Treated|Step 1 (R-CHOP X 3 Cycles)||17
6291278|NCT00274924|7192968|FG001|Treated|Step 1 (R-CHOP X 3 Cycles)||77
6291279|NCT00274924|7192969|FG002|Treated|Step 1 (R-CHOP X 3 Cycles)||5
6291280|NCT00274924|7192967|FG000|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
6291281|NCT00274924|7192968|FG001|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
6291282|NCT00274924|7192969|FG002|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
6291283|NCT00274924|7192967|FG000|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
6291284|NCT00274924|7192968|FG001|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
6291285|NCT00274924|7192969|FG002|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
6291286|NCT00274924|7192967|FG000|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
6291287|NCT00274924|7192968|FG001|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
6291288|NCT00274924|7192969|FG002|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
6291289|NCT00274924|7192967|FG000|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
6291290|NCT00274924|7192968|FG001|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
6291291|NCT00274924|7192969|FG002|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
6291292|NCT00274924|7192967|FG000|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
6291293|NCT00274924|7192968|FG001|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
6291294|NCT00274924|7192969|FG002|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
6291295|NCT00274924|7192967|FG000|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
6291296|NCT00274924|7192968|FG001|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
6291297|NCT00274924|7192969|FG002|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
6291298|NCT00274924|7192967|FG000|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
6291299|NCT00274924|7192968|FG001|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
6291300|NCT00274924|7192969|FG002|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
6291301|NCT00274937|7192976|FG000|STARTED|Overall Study||111
6291302|NCT00274937|7192976|FG000|COMPLETED|Overall Study||91
6291303|NCT00274937|7192976|FG000|NOT COMPLETED|Overall Study||20
6291304|NCT00275002|7192982|FG000|STARTED|Overall Study||25
6291305|NCT00275002|7192983|FG001|STARTED|Overall Study||16
6291306|NCT00275002|7192982|FG000|COMPLETED|Overall Study||3
6291307|NCT00275002|7192983|FG001|COMPLETED|Overall Study||0
6291308|NCT00275002|7192982|FG000|NOT COMPLETED|Overall Study||22
6291309|NCT00275002|7192983|FG001|NOT COMPLETED|Overall Study||16
6291310|NCT00275028|7192989|FG000|STARTED|Overall Study||47
6291311|NCT00275028|7192989|FG000|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
6291312|NCT00275028|7192989|FG000|NOT COMPLETED|Overall Study||47
6291313|NCT00275262|7192995|FG000|STARTED|Overall Study||12
6634759|NCT02299349|7563594|FG001|STARTED|Overall Study||35
6291314|NCT00275262|7192996|FG001|STARTED|Overall Study||13
6291315|NCT00275262|7192995|FG000|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
6291316|NCT00275262|7192996|FG001|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
6291317|NCT00275262|7192995|FG000|NOT COMPLETED|Overall Study||6
6291318|NCT00275262|7192996|FG001|NOT COMPLETED|Overall Study||9
6291319|NCT00275275|7193005|FG000|STARTED|Overall Study||20
6291320|NCT00275275|7193006|FG001|STARTED|Overall Study||20
6291321|NCT00275275|7193007|FG002|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
6291322|NCT00275275|7193005|FG000|COMPLETED|Overall Study||14
6291323|NCT00275275|7193006|FG001|COMPLETED|Overall Study||18
6291324|NCT00275275|7193007|FG002|COMPLETED|Overall Study||15
6291325|NCT00275275|7193005|FG000|NOT COMPLETED|Overall Study||6
6291326|NCT00275275|7193006|FG001|NOT COMPLETED|Overall Study||2
6291327|NCT00275275|7193007|FG002|NOT COMPLETED|Overall Study||6
6291328|NCT00275301|7193015|FG000|STARTED|Overall Study||19
6291329|NCT00275301|7193015|FG000|COMPLETED|Overall Study||14
6291330|NCT00275301|7193015|FG000|NOT COMPLETED|Overall Study||5
6291331|NCT00275392|7193021|FG000|STARTED|Overall Study||20
6291332|NCT00275392|7193022|FG001|STARTED|Overall Study||19
6291333|NCT00275392|7193021|FG000|COMPLETED|Overall Study||20
6291334|NCT00275392|7193022|FG001|COMPLETED|Overall Study||17
6291335|NCT00275392|7193021|FG000|NOT COMPLETED|Overall Study||0
6291336|NCT00275392|7193022|FG001|NOT COMPLETED|Overall Study||2
6291337|NCT00275509|7193030|FG000|STARTED|Overall Study||30
6291338|NCT00275509|7193031|FG001|STARTED|Overall Study||26
6291339|NCT00275509|7193030|FG000|COMPLETED|Overall Study||30
6291340|NCT00275509|7193031|FG001|COMPLETED|Overall Study||25
6291341|NCT00275509|7193030|FG000|NOT COMPLETED|Overall Study||0
6291342|NCT00275509|7193031|FG001|NOT COMPLETED|Overall Study||1
6291343|NCT00275561|7193039|FG000|STARTED|Overall Study||21
6291344|NCT00275561|7193040|FG001|STARTED|Overall Study||21
6291345|NCT00275561|7193039|FG000|COMPLETED|Overall Study||19
6291346|NCT00275561|7193040|FG001|COMPLETED|Overall Study||15
6291347|NCT00275561|7193039|FG000|NOT COMPLETED|Overall Study||2
6291348|NCT00275561|7193040|FG001|NOT COMPLETED|Overall Study||6
6291349|NCT00275821|7193049|FG000|STARTED|Overall Study||120
6291350|NCT00275821|7193050|FG001|STARTED|Overall Study||118
6291351|NCT00275821|7193051|FG002|STARTED|Overall Study||115
6291352|NCT00275821|7193049|FG000|COMPLETED|Overall Study||106
6291353|NCT00275821|7193050|FG001|COMPLETED|Overall Study||95
6291354|NCT00275821|7193051|FG002|COMPLETED|Overall Study||103
6291355|NCT00275821|7193049|FG000|NOT COMPLETED|Overall Study||14
6291356|NCT00275821|7193050|FG001|NOT COMPLETED|Overall Study||23
6291357|NCT00275821|7193051|FG002|NOT COMPLETED|Overall Study||12
6291358|NCT00275834|7193062|FG000|STARTED|Overall Study||74
6291359|NCT00275834|7193063|FG001|STARTED|Overall Study||76
6291360|NCT00275834|7193064|FG002|STARTED|Overall Study||75
6291361|NCT00275834|7193062|FG000|Completed Study While on Study Drug|Overall Study||54
6291362|NCT00275834|7193063|FG001|Completed Study While on Study Drug|Overall Study||51
6291363|NCT00275834|7193064|FG002|Completed Study While on Study Drug|Overall Study||62
6291364|NCT00275834|7193062|FG000|COMPLETED|Overall Study||71
6291365|NCT00275834|7193063|FG001|COMPLETED|Overall Study||73
6291366|NCT00275834|7193064|FG002|COMPLETED|Overall Study||74
6291367|NCT00275834|7193062|FG000|NOT COMPLETED|Overall Study||3
6291368|NCT00275834|7193063|FG001|NOT COMPLETED|Overall Study||3
6291369|NCT00275834|7193064|FG002|NOT COMPLETED|Overall Study||1
6291370|NCT00276094|7193077|FG000|STARTED|Overall Study||282
6291371|NCT00276094|7193078|FG001|STARTED|Overall Study||276
6291372|NCT00276094|7193079|FG002|STARTED|Overall Study||268
6291373|NCT00276094|7193077|FG000|COMPLETED|Overall Study||225
6291374|NCT00276094|7193078|FG001|COMPLETED|Overall Study||234
6291375|NCT00276094|7193079|FG002|COMPLETED|Overall Study||230
6291376|NCT00276094|7193077|FG000|NOT COMPLETED|Overall Study||57
6291377|NCT00276094|7193078|FG001|NOT COMPLETED|Overall Study||42
6291378|NCT00276094|7193079|FG002|NOT COMPLETED|Overall Study||38
6399922|NCT00883558|7312766|FG000|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
6399923|NCT00883558|7312767|FG001|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
6291379|NCT00276159|7193087|FG000|STARTED|Overall Study||6
6291380|NCT00276159|7193087|FG000|COMPLETED|Overall Study||0
6291381|NCT00276159|7193087|FG000|NOT COMPLETED|Overall Study||6
6291382|NCT00276250|7193094|FG000|STARTED|Overall Study||4
6291383|NCT00276250|7193095|FG001|STARTED|Overall Study||1
6291384|NCT00276250|7193096|FG002|STARTED|Overall Study||0
6291385|NCT00276250|7193094|FG000|COMPLETED|Overall Study||4
6291386|NCT00276250|7193095|FG001|COMPLETED|Overall Study||1
6291387|NCT00276250|7193096|FG002|COMPLETED|Overall Study||0
6291388|NCT00276250|7193094|FG000|NOT COMPLETED|Overall Study||0
6291389|NCT00276250|7193095|FG001|NOT COMPLETED|Overall Study||0
6291390|NCT00276250|7193096|FG002|NOT COMPLETED|Overall Study||0
6291391|NCT00276380|7193106|FG000|STARTED|Overall Study||102
6291392|NCT00276380|7193107|FG001|STARTED|Overall Study||102
6291393|NCT00276380|7193106|FG000|COMPLETED|Overall Study||88
6291394|NCT00276380|7193107|FG001|COMPLETED|Overall Study||88
6291395|NCT00276380|7193106|FG000|NOT COMPLETED|Overall Study||14
6291396|NCT00276380|7193107|FG001|NOT COMPLETED|Overall Study||14
6291397|NCT00276406|7193116|FG000|STARTED|Overall Study||16
6291398|NCT00276406|7193117|FG001|STARTED|Overall Study||14
6291399|NCT00276406|7193116|FG000|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
6291400|NCT00276406|7193117|FG001|COMPLETED|Overall Study||14
6291401|NCT00276406|7193116|FG000|NOT COMPLETED|Overall Study||0
6291402|NCT00276406|7193117|FG001|NOT COMPLETED|Overall Study||0
6291403|NCT00276549|7193123|FG000|STARTED|Overall Study||35
6291404|NCT00276549|7193123|FG000|COMPLETED|Overall Study||35
6291405|NCT00276549|7193123|FG000|NOT COMPLETED|Overall Study||0
6291406|NCT00276614|7193127|FG000|STARTED|Overall Study||4
6291407|NCT00276614|7193127|FG000|COMPLETED|Overall Study||1
6291408|NCT00276614|7193127|FG000|NOT COMPLETED|Overall Study||3
6291409|NCT00276744|7193131|FG000|STARTED|PART A||240
6291410|NCT00276744|7193131|FG000|COMPLETED|PART A||142
6291411|NCT00276744|7193131|FG000|NOT COMPLETED|PART A||98
6291412|NCT00276744|7193131|FG000|STARTED|PART B|This study was terminated before participants could reach this stage of the study.|0
6291413|NCT00276744|7193131|FG000|COMPLETED|PART B||0
6291414|NCT00276744|7193131|FG000|NOT COMPLETED|PART B||0
6291415|NCT00276861|7193135|FG000|STARTED|Overall Study||10
6291416|NCT00276861|7193135|FG000|COMPLETED|Overall Study||10
6291417|NCT00276861|7193135|FG000|NOT COMPLETED|Overall Study||0
6291418|NCT00277095|7193140|FG000|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
6291419|NCT00277095|7193140|FG000|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
6291420|NCT00277095|7193140|FG000|NOT COMPLETED|Overall Study||21
6291421|NCT00277212|7193144|FG000|STARTED|Phase 1 - Single-Blind Treatment||787
6291422|NCT00277212|7193145|FG001|STARTED|Phase 1 - Single-Blind Treatment||0
6291423|NCT00277212|7193146|FG002|STARTED|Phase 1 - Single-Blind Treatment||0
6291424|NCT00277212|7193144|FG000|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
6291425|NCT00277212|7193145|FG001|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
6291426|NCT00277212|7193146|FG002|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
6291427|NCT00277212|7193144|FG000|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
6291428|NCT00277212|7193145|FG001|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
6291429|NCT00277212|7193146|FG002|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
6291430|NCT00277212|7193144|FG000|COMPLETED|Phase 1 - Single-Blind Treatment||352
6291431|NCT00277212|7193145|FG001|COMPLETED|Phase 1 - Single-Blind Treatment||0
6291432|NCT00277212|7193146|FG002|COMPLETED|Phase 1 - Single-Blind Treatment||0
6291433|NCT00277212|7193144|FG000|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
6291434|NCT00277212|7193145|FG001|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
6291435|NCT00277212|7193146|FG002|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
6291436|NCT00277212|7193144|FG000|STARTED|Phase 2 - Double-Blind Treatment||0
6291437|NCT00277212|7193145|FG001|STARTED|Phase 2 - Double-Blind Treatment||173
6291438|NCT00277212|7193146|FG002|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
6291439|NCT00277212|7193144|FG000|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
6291440|NCT00277212|7193145|FG001|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
6291441|NCT00277212|7193146|FG002|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
6291442|NCT00277212|7193144|FG000|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
6291443|NCT00277212|7193145|FG001|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
6291444|NCT00277212|7193146|FG002|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
6291445|NCT00277212|7193144|FG000|COMPLETED|Phase 2 - Double-Blind Treatment||0
6291446|NCT00277212|7193145|FG001|COMPLETED|Phase 2 - Double-Blind Treatment||53
6291447|NCT00277212|7193146|FG002|COMPLETED|Phase 2 - Double-Blind Treatment||65
6291448|NCT00277212|7193144|FG000|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
6291449|NCT00277212|7193145|FG001|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
6291450|NCT00277212|7193146|FG002|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
6291451|NCT00277355|7193156|FG000|STARTED|Overall Study||87
6291452|NCT00277355|7193157|FG001|STARTED|Overall Study||27
6291453|NCT00277355|7193156|FG000|COMPLETED|Overall Study||73
6291454|NCT00277355|7193157|FG001|COMPLETED|Overall Study||22
6291455|NCT00277355|7193156|FG000|NOT COMPLETED|Overall Study||14
6291456|NCT00277355|7193157|FG001|NOT COMPLETED|Overall Study||5
6291457|NCT00277394|7193166|FG000|STARTED|Overall Study||269
6291458|NCT00277394|7193167|FG001|STARTED|Overall Study||270
6399924|NCT00883558|7312768|FG002|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
6399925|NCT00883558|7312766|FG000|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
6399926|NCT00883558|7312767|FG001|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
6399927|NCT00883558|7312768|FG002|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
6399928|NCT00883558|7312766|FG000|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
6399929|NCT00883558|7312767|FG001|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
6399930|NCT00883558|7312768|FG002|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
6399931|NCT00883558|7312766|FG000|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
6399932|NCT00883558|7312767|FG001|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
6399933|NCT00883558|7312768|FG002|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
6399934|NCT00883558|7312766|FG000|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
6399935|NCT00883558|7312767|FG001|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
6399936|NCT00883558|7312768|FG002|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
6399937|NCT00883675|7312774|FG000|STARTED|Overall Study||133
6399938|NCT00883675|7312774|FG000|COMPLETED|Overall Study||133
6399939|NCT00883675|7312774|FG000|NOT COMPLETED|Overall Study||0
6399940|NCT00883688|7312778|FG000|STARTED|Overall Study||24
6399941|NCT00883688|7312778|FG000|COMPLETED|Overall Study||22
6399942|NCT00883688|7312778|FG000|NOT COMPLETED|Overall Study||2
6399943|NCT00883740|7312782|FG000|STARTED|First Intervention||60
6399944|NCT00883740|7312783|FG001|STARTED|First Intervention||59
6399945|NCT00883740|7312782|FG000|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
6291459|NCT00277394|7193166|FG000|COMPLETED|Overall Study||232
6291460|NCT00277394|7193167|FG001|COMPLETED|Overall Study||246
6291461|NCT00277394|7193166|FG000|NOT COMPLETED|Overall Study||37
6291462|NCT00277394|7193167|FG001|NOT COMPLETED|Overall Study||24
6291463|NCT00277446|7193173|FG000|STARTED|Overall Study||13
6291464|NCT00277446|7193173|FG000|COMPLETED|Overall Study||13
6291465|NCT00277446|7193173|FG000|NOT COMPLETED|Overall Study||0
6374092|NCT00748098|7284648|FG000|STARTED|Second Taper Period||53
6374093|NCT00748098|7284649|FG001|STARTED|Second Taper Period||61
6374094|NCT00748098|7284648|FG000|COMPLETED|Second Taper Period||53
6374095|NCT00748098|7284649|FG001|COMPLETED|Second Taper Period||61
6374096|NCT00748098|7284648|FG000|NOT COMPLETED|Second Taper Period||0
6374097|NCT00748098|7284649|FG001|NOT COMPLETED|Second Taper Period||0
6374098|NCT00748189|7284658|FG000|STARTED|Overall Study||226
6374099|NCT00748189|7284659|FG001|STARTED|Overall Study||221
6374100|NCT00748189|7284658|FG000|COMPLETED|Overall Study||10
6374101|NCT00748189|7284659|FG001|COMPLETED|Overall Study||9
6374102|NCT00748189|7284658|FG000|NOT COMPLETED|Overall Study||216
6374103|NCT00748189|7284659|FG001|NOT COMPLETED|Overall Study||212
6374104|NCT00748215|7284672|FG000|STARTED|Overall Study||50
6374105|NCT00748215|7284673|FG001|STARTED|Overall Study||50
6374106|NCT00748215|7284672|FG000|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||22
6374107|NCT00748215|7284673|FG001|Open Label CASAD After Initial 6 Weeks Intervention|Overall Study||17
6374108|NCT00748215|7284672|FG000|COMPLETED|Overall Study||41
6374109|NCT00748215|7284673|FG001|COMPLETED|Overall Study||32
6374110|NCT00748215|7284672|FG000|NOT COMPLETED|Overall Study||9
6374111|NCT00748215|7284673|FG001|NOT COMPLETED|Overall Study||18
6374112|NCT00748241|7284679|FG000|STARTED|Overall Study||19
6374113|NCT00748241|7284679|FG000|COMPLETED|Overall Study||11
6374114|NCT00748241|7284679|FG000|NOT COMPLETED|Overall Study||8
6374115|NCT00748410|7284685|FG000|STARTED|Overall Study||1
6374116|NCT00748410|7284686|FG001|STARTED|Overall Study||2
6374117|NCT00748410|7284685|FG000|COMPLETED|Overall Study||1
6374118|NCT00748410|7284686|FG001|COMPLETED|Overall Study||2
6374119|NCT00748410|7284685|FG000|NOT COMPLETED|Overall Study||0
6374120|NCT00748410|7284686|FG001|NOT COMPLETED|Overall Study||0
6374121|NCT00748540|7284692|FG000|STARTED|Overall Study||50
6374122|NCT00748540|7284692|FG000|COMPLETED|Overall Study||49
6374123|NCT00748540|7284692|FG000|NOT COMPLETED|Overall Study||1
6374124|NCT00748553|7284698|FG000|STARTED|Overall Study||16
6374125|NCT00748553|7284699|FG001|STARTED|Overall Study||14
6374126|NCT00748553|7284698|FG000|COMPLETED|Overall Study||13
6374127|NCT00748553|7284699|FG001|COMPLETED|Overall Study||13
6374128|NCT00748553|7284698|FG000|NOT COMPLETED|Overall Study||3
6374129|NCT00748553|7284699|FG001|NOT COMPLETED|Overall Study||1
6374130|NCT00748566|7284704|FG000|STARTED|Overall Study||172
6374131|NCT00748566|7284704|FG000|COMPLETED|Overall Study||60
6374132|NCT00748566|7284704|FG000|NOT COMPLETED|Overall Study||112
6374133|NCT00748657|7284708|FG000|STARTED|Overall Study||36
6374134|NCT00748657|7284708|FG000|COMPLETED|Overall Study||36
6374135|NCT00748657|7284708|FG000|NOT COMPLETED|Overall Study||0
6374136|NCT00748709|7284718|FG000|STARTED|Overall Study|Treated|20
6374137|NCT00748709|7284718|FG000|COMPLETED|Overall Study||0
6374138|NCT00748709|7284718|FG000|NOT COMPLETED|Overall Study||20
6374139|NCT00748826|7284722|FG000|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
6374140|NCT00748826|7284722|FG000|COMPLETED|Overall Study||207
6374141|NCT00748826|7284722|FG000|NOT COMPLETED|Overall Study||301
6374142|NCT00748865|7284726|FG000|STARTED|Overall Study||10
6374143|NCT00748865|7284727|FG001|STARTED|Overall Study||10
6374144|NCT00748865|7284726|FG000|COMPLETED|Overall Study||10
6374145|NCT00748865|7284727|FG001|COMPLETED|Overall Study||10
6374146|NCT00748865|7284726|FG000|NOT COMPLETED|Overall Study||0
6374147|NCT00748865|7284727|FG001|NOT COMPLETED|Overall Study||0
6374148|NCT00748956|7284736|FG000|STARTED|Overall Study||0
6374149|NCT00748956|7284737|FG001|STARTED|Overall Study||5
6374150|NCT00748956|7284738|FG002|STARTED|Overall Study||5
6374151|NCT00748956|7284736|FG000|COMPLETED|Overall Study||0
6374152|NCT00748956|7284737|FG001|COMPLETED|Overall Study||5
6374153|NCT00748956|7284738|FG002|COMPLETED|Overall Study||5
6374154|NCT00748956|7284736|FG000|NOT COMPLETED|Overall Study||0
6374155|NCT00748956|7284737|FG001|NOT COMPLETED|Overall Study||0
6374156|NCT00748956|7284738|FG002|NOT COMPLETED|Overall Study||0
6374157|NCT00748969|7284748|FG000|STARTED|Overall Study|Subject withdrew from study due to worsening sleep apnea|1
6374158|NCT00748969|7284749|FG001|STARTED|Overall Study|Subject withdrew from study due to randomization to no treatment|1
6374159|NCT00748969|7284748|FG000|COMPLETED|Overall Study||0
6374160|NCT00748969|7284749|FG001|COMPLETED|Overall Study||0
6374161|NCT00748969|7284748|FG000|NOT COMPLETED|Overall Study||1
6374162|NCT00748969|7284749|FG001|NOT COMPLETED|Overall Study||1
6374163|NCT00748982|7284757|FG000|STARTED|Overall Study||12
6374164|NCT00748982|7284758|FG001|STARTED|Overall Study||4
6374165|NCT00748982|7284757|FG000|COMPLETED|Overall Study||12
6374166|NCT00748982|7284758|FG001|COMPLETED|Overall Study||4
6374167|NCT00748982|7284757|FG000|NOT COMPLETED|Overall Study||0
6374168|NCT00748982|7284758|FG001|NOT COMPLETED|Overall Study||0
6374169|NCT00749073|7284764|FG000|STARTED|Overall Study||10
6374170|NCT00749073|7284764|FG000|COMPLETED|Overall Study||10
6374171|NCT00749073|7284764|FG000|NOT COMPLETED|Overall Study||0
6374172|NCT00749125|7284771|FG000|STARTED|Overall Study||47
6374173|NCT00749125|7284772|FG001|STARTED|Overall Study||52
6374174|NCT00749125|7284771|FG000|COMPLETED|Overall Study||36
6374175|NCT00749125|7284772|FG001|COMPLETED|Overall Study||34
6291466|NCT00277524|7193177|FG000|STARTED|Overall Study||621
6291467|NCT00277524|7193178|FG001|STARTED|Overall Study||324
6291468|NCT00277524|7193179|FG002|STARTED|Overall Study||1088
6291469|NCT00277524|7193180|FG003|STARTED|Overall Study||850
6291470|NCT00277524|7193177|FG000|COMPLETED|Overall Study||621
6291471|NCT00277524|7193178|FG001|COMPLETED|Overall Study||324
6291472|NCT00277524|7193179|FG002|COMPLETED|Overall Study||1088
6291473|NCT00277524|7193180|FG003|COMPLETED|Overall Study||850
6291474|NCT00277524|7193177|FG000|NOT COMPLETED|Overall Study||0
6291475|NCT00277524|7193178|FG001|NOT COMPLETED|Overall Study||0
6291476|NCT00277524|7193179|FG002|NOT COMPLETED|Overall Study||0
6291477|NCT00277524|7193180|FG003|NOT COMPLETED|Overall Study||0
6291478|NCT00278109|7193198|FG000|STARTED|Overall Study||25
6291479|NCT00278109|7193198|FG000|Completed 3 Cycles of Chemotherapy|Overall Study||25
6291480|NCT00278109|7193198|FG000|COMPLETED|Overall Study||21
6291481|NCT00278109|7193198|FG000|NOT COMPLETED|Overall Study||4
6291482|NCT00278148|7193202|FG000|STARTED|Phase I - Dose Escalation||4
6291483|NCT00278148|7193203|FG001|STARTED|Phase I - Dose Escalation||2
6291484|NCT00278148|7193204|FG002|STARTED|Phase I - Dose Escalation||3
6291485|NCT00278148|7193202|FG000|COMPLETED|Phase I - Dose Escalation||4
6291486|NCT00278148|7193203|FG001|COMPLETED|Phase I - Dose Escalation||2
6291487|NCT00278148|7193204|FG002|COMPLETED|Phase I - Dose Escalation||3
6291488|NCT00278148|7193202|FG000|NOT COMPLETED|Phase I - Dose Escalation||0
6291489|NCT00278148|7193203|FG001|NOT COMPLETED|Phase I - Dose Escalation||0
6291490|NCT00278148|7193204|FG002|NOT COMPLETED|Phase I - Dose Escalation||0
6291491|NCT00278148|7193202|FG000|STARTED|Phase II - Expansion Phase||0
6291492|NCT00278148|7193203|FG001|STARTED|Phase II - Expansion Phase||0
6291493|NCT00278148|7193204|FG002|STARTED|Phase II - Expansion Phase|Includes the 3 participants from phase I|26
6291494|NCT00278148|7193202|FG000|COMPLETED|Phase II - Expansion Phase||0
6291495|NCT00278148|7193203|FG001|COMPLETED|Phase II - Expansion Phase||0
6291496|NCT00278148|7193204|FG002|COMPLETED|Phase II - Expansion Phase||20
6291497|NCT00278148|7193202|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
6291498|NCT00278148|7193203|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
6291499|NCT00278148|7193204|FG002|NOT COMPLETED|Phase II - Expansion Phase||6
6291500|NCT00278161|7193211|FG000|STARTED|Overall Study||81
6291501|NCT00278161|7193211|FG000|COMPLETED|Overall Study||70
6291502|NCT00278161|7193211|FG000|NOT COMPLETED|Overall Study||11
6291503|NCT00278200|7193217|FG000|STARTED|Overall Study||2
6291504|NCT00278200|7193218|FG001|STARTED|Overall Study||12
6291505|NCT00278200|7193217|FG000|COMPLETED|Overall Study||1
6291506|NCT00278200|7193218|FG001|COMPLETED|Overall Study||8
6291507|NCT00278200|7193217|FG000|NOT COMPLETED|Overall Study||1
6291508|NCT00278200|7193218|FG001|NOT COMPLETED|Overall Study||4
6291509|NCT00278395|7193224|FG000|STARTED|Overall Study||14
6291510|NCT00278395|7193224|FG000|COMPLETED|Overall Study||11
6291511|NCT00278395|7193224|FG000|NOT COMPLETED|Overall Study||3
6291512|NCT00278473|7193233|FG000|STARTED|Overall Study||45
6291513|NCT00278473|7193234|FG001|STARTED|Overall Study||43
6291514|NCT00278473|7193233|FG000|COMPLETED|Overall Study||41
6291515|NCT00278473|7193234|FG001|COMPLETED|Overall Study||40
6291516|NCT00278473|7193233|FG000|NOT COMPLETED|Overall Study||4
6291517|NCT00278473|7193234|FG001|NOT COMPLETED|Overall Study||3
6291518|NCT00278512|7193242|FG000|STARTED|Overall Study||7
6291519|NCT00278512|7193243|FG001|STARTED|Overall Study||0
6291520|NCT00278512|7193242|FG000|COMPLETED|Overall Study||6
6291521|NCT00278512|7193243|FG001|COMPLETED|Overall Study||0
6291522|NCT00278512|7193242|FG000|NOT COMPLETED|Overall Study||1
6291523|NCT00278512|7193243|FG001|NOT COMPLETED|Overall Study||0
6634760|NCT02299349|7563593|FG000|COMPLETED|Overall Study||35
6634761|NCT02299349|7563594|FG001|COMPLETED|Overall Study||35
6634762|NCT02299349|7563593|FG000|NOT COMPLETED|Overall Study||0
6634763|NCT02299349|7563594|FG001|NOT COMPLETED|Overall Study||0
6634764|NCT02299375|7563602|FG000|STARTED|Overall Study||94
6634765|NCT02299375|7563603|FG001|STARTED|Overall Study||90
6634766|NCT02299375|7563602|FG000|COMPLETED|Overall Study||14
6634767|NCT02299375|7563603|FG001|COMPLETED|Overall Study||10
6634768|NCT02299375|7563602|FG000|NOT COMPLETED|Overall Study||80
6634769|NCT02299375|7563603|FG001|NOT COMPLETED|Overall Study||80
6291524|NCT00278525|7193251|FG000|STARTED|Overall Study||9
6291525|NCT00278525|7193252|FG001|STARTED|Overall Study||10
6291526|NCT00278525|7193251|FG000|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
6634770|NCT02299388|7563612|FG000|STARTED|Overall Study||6
6634771|NCT02299388|7563613|FG001|STARTED|Overall Study||5
6291527|NCT00278525|7193252|FG001|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
6291528|NCT00278525|7193251|FG000|NOT COMPLETED|Overall Study||0
6291529|NCT00278525|7193252|FG001|NOT COMPLETED|Overall Study||0
6291530|NCT00278538|7193258|FG000|STARTED|Overall Study||32
6291531|NCT00278538|7193258|FG000|COMPLETED|Overall Study||30
6291532|NCT00278538|7193258|FG000|NOT COMPLETED|Overall Study||2
6291533|NCT00278564|7193262|FG000|STARTED|Overall Study||7
6291534|NCT00278564|7193262|FG000|COMPLETED|Overall Study||3
6291535|NCT00278564|7193262|FG000|NOT COMPLETED|Overall Study||4
6291536|NCT00278629|7193266|FG000|STARTED|Overall Study||80
6291537|NCT00278629|7193266|FG000|COMPLETED|Overall Study||66
6634772|NCT02299388|7563612|FG000|COMPLETED|Overall Study||6
6634773|NCT02299388|7563613|FG001|COMPLETED|Overall Study||4
6634774|NCT02299388|7563612|FG000|NOT COMPLETED|Overall Study||0
6634775|NCT02299388|7563613|FG001|NOT COMPLETED|Overall Study||1
6291538|NCT00278629|7193266|FG000|NOT COMPLETED|Overall Study||14
6291539|NCT00278655|7193271|FG000|STARTED|Overall Study||21
6291540|NCT00278655|7193271|FG000|COMPLETED|Overall Study||21
6291541|NCT00278655|7193271|FG000|NOT COMPLETED|Overall Study||0
6291542|NCT00278863|7193278|FG000|STARTED|Overall Study||49
6291543|NCT00278863|7193279|FG001|STARTED|Overall Study||47
6291544|NCT00278863|7193278|FG000|COMPLETED|Overall Study||44
6291545|NCT00278863|7193279|FG001|COMPLETED|Overall Study||45
6291546|NCT00278863|7193278|FG000|NOT COMPLETED|Overall Study||5
6291547|NCT00278863|7193279|FG001|NOT COMPLETED|Overall Study||2
6291548|NCT00278876|7193285|FG000|STARTED|Overall Study||47
6291549|NCT00278876|7193285|FG000|COMPLETED|Overall Study||38
6291550|NCT00278876|7193285|FG000|NOT COMPLETED|Overall Study||9
6291551|NCT00278889|7193292|FG000|STARTED|Overall Study|Randomised|73
6291552|NCT00278889|7193293|FG001|STARTED|Overall Study|Randomised|74
6291553|NCT00278889|7193294|FG002|STARTED|Overall Study|Randomised|68
6291554|NCT00278889|7193292|FG000|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
6291555|NCT00278889|7193293|FG001|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
6291556|NCT00278889|7193294|FG002|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
6291557|NCT00278889|7193292|FG000|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
6291558|NCT00278889|7193293|FG001|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
6291559|NCT00278889|7193294|FG002|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
6291560|NCT00278889|7193292|FG000|NOT COMPLETED|Overall Study||25
6291561|NCT00278889|7193293|FG001|NOT COMPLETED|Overall Study||27
6291562|NCT00278889|7193294|FG002|NOT COMPLETED|Overall Study||20
6291563|NCT00278954|7193302|FG000|STARTED|Overall Study||50
6291564|NCT00278954|7193302|FG000|COMPLETED|Overall Study||45
6291565|NCT00278954|7193302|FG000|NOT COMPLETED|Overall Study||5
6291566|NCT00278993|7193306|FG000|STARTED|Overall Study||108
6291567|NCT00278993|7193306|FG000|COMPLETED|Overall Study||1
6291568|NCT00278993|7193306|FG000|NOT COMPLETED|Overall Study||107
6291569|NCT00279201|7193312|FG000|STARTED|Initiation||1046
6291570|NCT00279201|7193313|FG001|STARTED|Initiation||1045
6291571|NCT00279201|7193314|FG002|STARTED|Initiation||0
6291572|NCT00279201|7193315|FG003|STARTED|Initiation||0
6291573|NCT00279201|7193316|FG004|STARTED|Initiation||0
6291574|NCT00279201|7193317|FG005|STARTED|Initiation||0
6291575|NCT00279201|7193312|FG000|COMPLETED|Initiation||918
6291576|NCT00279201|7193313|FG001|COMPLETED|Initiation||900
6291577|NCT00279201|7193314|FG002|COMPLETED|Initiation||0
6399946|NCT00883740|7312783|FG001|COMPLETED|First Intervention||51
6399947|NCT00883740|7312782|FG000|NOT COMPLETED|First Intervention||7
6399948|NCT00883740|7312783|FG001|NOT COMPLETED|First Intervention||8
6399949|NCT00883740|7312782|FG000|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
6291578|NCT00279201|7193315|FG003|COMPLETED|Initiation||0
6291579|NCT00279201|7193316|FG004|COMPLETED|Initiation||0
6291580|NCT00279201|7193317|FG005|COMPLETED|Initiation||0
6291581|NCT00279201|7193312|FG000|NOT COMPLETED|Initiation||128
6291582|NCT00279201|7193313|FG001|NOT COMPLETED|Initiation||145
6291583|NCT00279201|7193314|FG002|NOT COMPLETED|Initiation||0
6291584|NCT00279201|7193315|FG003|NOT COMPLETED|Initiation||0
6291585|NCT00279201|7193316|FG004|NOT COMPLETED|Initiation||0
6291586|NCT00279201|7193317|FG005|NOT COMPLETED|Initiation||0
6291587|NCT00279201|7193312|FG000|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
6291588|NCT00279201|7193313|FG001|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
6291589|NCT00279201|7193314|FG002|STARTED|Maintenance||0
6291590|NCT00279201|7193315|FG003|STARTED|Maintenance||0
6291591|NCT00279201|7193316|FG004|STARTED|Maintenance||0
6291592|NCT00279201|7193317|FG005|STARTED|Maintenance||0
6291593|NCT00279201|7193312|FG000|COMPLETED|Maintenance||188
6291594|NCT00279201|7193313|FG001|COMPLETED|Maintenance||239
6291595|NCT00279201|7193314|FG002|COMPLETED|Maintenance||0
6291596|NCT00279201|7193315|FG003|COMPLETED|Maintenance||0
6291597|NCT00279201|7193316|FG004|COMPLETED|Maintenance||0
6291598|NCT00279201|7193317|FG005|COMPLETED|Maintenance||0
6291599|NCT00279201|7193312|FG000|NOT COMPLETED|Maintenance||231
6291600|NCT00279201|7193313|FG001|NOT COMPLETED|Maintenance||234
6291601|NCT00279201|7193314|FG002|NOT COMPLETED|Maintenance||0
6291602|NCT00279201|7193315|FG003|NOT COMPLETED|Maintenance||0
6291603|NCT00279201|7193316|FG004|NOT COMPLETED|Maintenance||0
6291604|NCT00279201|7193317|FG005|NOT COMPLETED|Maintenance||0
6291605|NCT00279201|7193312|FG000|STARTED|Intensification Addendum||0
6291606|NCT00279201|7193313|FG001|STARTED|Intensification Addendum||0
6291607|NCT00279201|7193314|FG002|STARTED|Intensification Addendum||174
6291608|NCT00279201|7193315|FG003|STARTED|Intensification Addendum||200
6291609|NCT00279201|7193316|FG004|STARTED|Intensification Addendum||171
6291610|NCT00279201|7193317|FG005|STARTED|Intensification Addendum||199
6291611|NCT00279201|7193312|FG000|COMPLETED|Intensification Addendum||0
6291612|NCT00279201|7193313|FG001|COMPLETED|Intensification Addendum||0
6291613|NCT00279201|7193314|FG002|COMPLETED|Intensification Addendum||151
6291614|NCT00279201|7193315|FG003|COMPLETED|Intensification Addendum||172
6291615|NCT00279201|7193316|FG004|COMPLETED|Intensification Addendum||142
6291616|NCT00279201|7193317|FG005|COMPLETED|Intensification Addendum||162
6291617|NCT00279201|7193312|FG000|NOT COMPLETED|Intensification Addendum||0
6291618|NCT00279201|7193313|FG001|NOT COMPLETED|Intensification Addendum||0
6291619|NCT00279201|7193314|FG002|NOT COMPLETED|Intensification Addendum||23
6291620|NCT00279201|7193315|FG003|NOT COMPLETED|Intensification Addendum||28
6291621|NCT00279201|7193316|FG004|NOT COMPLETED|Intensification Addendum||29
6291622|NCT00279201|7193317|FG005|NOT COMPLETED|Intensification Addendum||37
6291623|NCT00279214|7193352|FG000|STARTED|Overall Study||22
6291624|NCT00279214|7193353|FG001|STARTED|Overall Study||21
6291625|NCT00279214|7193352|FG000|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
6634776|NCT02299427|7563621|FG000|STARTED|Overall Study||35
6291626|NCT00279214|7193353|FG001|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
6291627|NCT00279214|7193352|FG000|NOT COMPLETED|Overall Study||3
6291628|NCT00279214|7193353|FG001|NOT COMPLETED|Overall Study||2
6291629|NCT00279305|7193361|FG000|STARTED|Overall Study||57
6291630|NCT00279305|7193362|FG001|STARTED|Overall Study||30
6291631|NCT00279305|7193361|FG000|COMPLETED|Overall Study||49
6291632|NCT00279305|7193362|FG001|COMPLETED|Overall Study||29
6291633|NCT00279305|7193361|FG000|NOT COMPLETED|Overall Study||8
6291634|NCT00279305|7193362|FG001|NOT COMPLETED|Overall Study||1
6291635|NCT00279500|7193368|FG000|STARTED|Overall Study|6 patients treated|6
6291636|NCT00279500|7193368|FG000|COMPLETED|Overall Study|6 patients treated|6
6291637|NCT00279500|7193368|FG000|NOT COMPLETED|Overall Study||0
6291638|NCT00279591|7193374|FG000|STARTED|Overall Study||48
6291639|NCT00279591|7193375|FG001|STARTED|Overall Study||46
6291640|NCT00279591|7193374|FG000|COMPLETED|Overall Study||48
6291641|NCT00279591|7193375|FG001|COMPLETED|Overall Study||46
6291642|NCT00279591|7193374|FG000|NOT COMPLETED|Overall Study||0
6291643|NCT00279591|7193375|FG001|NOT COMPLETED|Overall Study||0
6291644|NCT00279708|7193385|FG000|STARTED|Overall Study|"Started meaning randomized"|27
6291645|NCT00279708|7193386|FG001|STARTED|Overall Study||28
6291646|NCT00279708|7193385|FG000|COMPLETED|Overall Study||24
6291647|NCT00279708|7193386|FG001|COMPLETED|Overall Study||24
6291648|NCT00279708|7193385|FG000|NOT COMPLETED|Overall Study||3
6291649|NCT00279708|7193386|FG001|NOT COMPLETED|Overall Study||4
6291650|NCT00279812|7193398|FG000|STARTED|Overall Study||21
6291651|NCT00279812|7193399|FG001|STARTED|Overall Study||26
6291652|NCT00279812|7193400|FG002|STARTED|Overall Study||24
6291653|NCT00279812|7193401|FG003|STARTED|Overall Study||23
6291654|NCT00279812|7193402|FG004|STARTED|Overall Study||20
6291655|NCT00279812|7193403|FG005|STARTED|Overall Study||19
6399950|NCT00883740|7312783|FG001|STARTED|Taper and Washout Period (2 Weeks)||51
6399951|NCT00883740|7312782|FG000|COMPLETED|Taper and Washout Period (2 Weeks)||54
6399952|NCT00883740|7312783|FG001|COMPLETED|Taper and Washout Period (2 Weeks)||51
6399953|NCT00883740|7312782|FG000|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
6399954|NCT00883740|7312783|FG001|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
6399955|NCT00883740|7312782|FG000|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
6399956|NCT00883740|7312783|FG001|STARTED|Second Intervention||51
6399957|NCT00883740|7312782|FG000|COMPLETED|Second Intervention||52
6399958|NCT00883740|7312783|FG001|COMPLETED|Second Intervention||50
6399959|NCT00883740|7312782|FG000|NOT COMPLETED|Second Intervention||1
6399960|NCT00883740|7312783|FG001|NOT COMPLETED|Second Intervention||1
6291656|NCT00279812|7193398|FG000|COMPLETED|Overall Study||20
6291657|NCT00279812|7193399|FG001|COMPLETED|Overall Study||20
6291658|NCT00279812|7193400|FG002|COMPLETED|Overall Study||21
6291659|NCT00279812|7193401|FG003|COMPLETED|Overall Study||23
6291660|NCT00279812|7193402|FG004|COMPLETED|Overall Study||17
6291661|NCT00279812|7193403|FG005|COMPLETED|Overall Study||18
6291662|NCT00279812|7193398|FG000|NOT COMPLETED|Overall Study||1
6291663|NCT00279812|7193399|FG001|NOT COMPLETED|Overall Study||6
6291664|NCT00279812|7193400|FG002|NOT COMPLETED|Overall Study||3
6291665|NCT00279812|7193401|FG003|NOT COMPLETED|Overall Study||0
6291666|NCT00279812|7193402|FG004|NOT COMPLETED|Overall Study||3
6291667|NCT00279812|7193403|FG005|NOT COMPLETED|Overall Study||1
6291668|NCT00279916|7193419|FG000|STARTED|Overall Study||45
6291669|NCT00279916|7193420|FG001|STARTED|Overall Study||46
6291670|NCT00279916|7193419|FG000|COMPLETED|Overall Study||38
6291671|NCT00279916|7193420|FG001|COMPLETED|Overall Study||41
6291672|NCT00279916|7193419|FG000|NOT COMPLETED|Overall Study||7
6291673|NCT00279916|7193420|FG001|NOT COMPLETED|Overall Study||5
6291674|NCT00279955|7193429|FG000|STARTED|Overall Study||157
6291675|NCT00279955|7193430|FG001|STARTED|Overall Study||486
6291676|NCT00279955|7193431|FG002|STARTED|Overall Study||358
6399961|NCT00883753|7312789|FG000|STARTED|Overall Study||934
6399962|NCT00883753|7312789|FG000|COMPLETED|Overall Study||827
6399963|NCT00883753|7312789|FG000|NOT COMPLETED|Overall Study||107
6291677|NCT00279955|7193429|FG000|COMPLETED|Overall Study||157
6291678|NCT00279955|7193430|FG001|COMPLETED|Overall Study||486
6291679|NCT00279955|7193431|FG002|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
6291680|NCT00279955|7193429|FG000|NOT COMPLETED|Overall Study||0
6291681|NCT00279955|7193430|FG001|NOT COMPLETED|Overall Study||0
6291682|NCT00279955|7193431|FG002|NOT COMPLETED|Overall Study||0
6291683|NCT00280059|7193440|FG000|STARTED|Efficacy Assessment Phase||330
6291684|NCT00280059|7193441|FG001|STARTED|Efficacy Assessment Phase||330
6291685|NCT00280059|7193440|FG000|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
6291686|NCT00280059|7193441|FG001|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
6291687|NCT00280059|7193440|FG000|NOT COMPLETED|Efficacy Assessment Phase||94
6291688|NCT00280059|7193441|FG001|NOT COMPLETED|Efficacy Assessment Phase||80
6291689|NCT00280059|7193440|FG000|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
6291690|NCT00280059|7193441|FG001|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
6291691|NCT00280059|7193440|FG000|COMPLETED|Extension Phase||145
6291692|NCT00280059|7193441|FG001|COMPLETED|Extension Phase||177
6291693|NCT00280059|7193440|FG000|NOT COMPLETED|Extension Phase||49
6291694|NCT00280059|7193441|FG001|NOT COMPLETED|Extension Phase||38
6291695|NCT00280150|7193459|FG000|STARTED|Overall Study||5
6291696|NCT00280150|7193460|FG001|STARTED|Overall Study||5
6291697|NCT00280150|7193461|FG002|STARTED|Overall Study||6
6291698|NCT00280150|7193462|FG003|STARTED|Overall Study||30
6291699|NCT00280150|7193459|FG000|Cohort Induction|Overall Study||5
6291700|NCT00280150|7193460|FG001|Cohort Induction|Overall Study||5
6291701|NCT00280150|7193461|FG002|Cohort Induction|Overall Study||6
6291702|NCT00280150|7193462|FG003|Cohort Induction|Overall Study||30
6291703|NCT00280150|7193459|FG000|Consolidation Therapy|Overall Study||2
6291704|NCT00280150|7193460|FG001|Consolidation Therapy|Overall Study||5
6291705|NCT00280150|7193461|FG002|Consolidation Therapy|Overall Study||3
6291706|NCT00280150|7193462|FG003|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
6291707|NCT00280150|7193459|FG000|COMPLETED|Overall Study||2
6291708|NCT00280150|7193460|FG001|COMPLETED|Overall Study||4
6291709|NCT00280150|7193461|FG002|COMPLETED|Overall Study||1
6291710|NCT00280150|7193462|FG003|COMPLETED|Overall Study||20
6291711|NCT00280150|7193459|FG000|NOT COMPLETED|Overall Study||3
6291712|NCT00280150|7193460|FG001|NOT COMPLETED|Overall Study||1
6291713|NCT00280150|7193461|FG002|NOT COMPLETED|Overall Study||5
6291714|NCT00280150|7193462|FG003|NOT COMPLETED|Overall Study||10
6291715|NCT00280241|7193473|FG000|STARTED|Overall Study||65
6291716|NCT00280241|7193473|FG000|COMPLETED|Overall Study||55
6291717|NCT00280241|7193473|FG000|NOT COMPLETED|Overall Study||10
6291718|NCT00280293|7193479|FG000|STARTED|Overall Study||55
6291719|NCT00280293|7193480|FG001|STARTED|Overall Study||57
6291720|NCT00280293|7193479|FG000|COMPLETED|Overall Study||29
6291721|NCT00280293|7193480|FG001|COMPLETED|Overall Study||34
6291722|NCT00280293|7193479|FG000|NOT COMPLETED|Overall Study||26
6291723|NCT00280293|7193480|FG001|NOT COMPLETED|Overall Study||23
6291724|NCT00280384|7193494|FG000|STARTED|Overall Study||6
6291725|NCT00280384|7193495|FG001|STARTED|Overall Study||6
6291726|NCT00280384|7193496|FG002|STARTED|Overall Study||6
6291727|NCT00280384|7193497|FG003|STARTED|Overall Study||6
6291728|NCT00280384|7193498|FG004|STARTED|Overall Study||6
6291729|NCT00280384|7193499|FG005|STARTED|Overall Study||6
6291730|NCT00280384|7193500|FG006|STARTED|Overall Study||6
6291731|NCT00280384|7193501|FG007|STARTED|Overall Study||6
6291732|NCT00280384|7193494|FG000|COMPLETED|Overall Study||6
6291733|NCT00280384|7193495|FG001|COMPLETED|Overall Study||6
6291734|NCT00280384|7193496|FG002|COMPLETED|Overall Study||6
6291735|NCT00280384|7193497|FG003|COMPLETED|Overall Study||6
6291736|NCT00280384|7193498|FG004|COMPLETED|Overall Study||6
6291737|NCT00280384|7193499|FG005|COMPLETED|Overall Study||6
6291738|NCT00280384|7193500|FG006|COMPLETED|Overall Study||6
6291739|NCT00280384|7193501|FG007|COMPLETED|Overall Study||6
6291740|NCT00280384|7193494|FG000|NOT COMPLETED|Overall Study||0
6291741|NCT00280384|7193495|FG001|NOT COMPLETED|Overall Study||0
6291742|NCT00280384|7193496|FG002|NOT COMPLETED|Overall Study||0
6291743|NCT00280384|7193497|FG003|NOT COMPLETED|Overall Study||0
6291744|NCT00280384|7193498|FG004|NOT COMPLETED|Overall Study||0
6291745|NCT00280384|7193499|FG005|NOT COMPLETED|Overall Study||0
6291746|NCT00280384|7193500|FG006|NOT COMPLETED|Overall Study||0
6291747|NCT00280384|7193501|FG007|NOT COMPLETED|Overall Study||0
6291748|NCT00280397|7193519|FG000|STARTED|Overall Study||27
6291749|NCT00280397|7193519|FG000|COMPLETED|Overall Study||26
6291750|NCT00280397|7193519|FG000|NOT COMPLETED|Overall Study||1
6291751|NCT00280566|7193527|FG000|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
6291752|NCT00280566|7193528|FG001|STARTED|Period 1 Open Label Ziprasidone||0
6291753|NCT00280566|7193529|FG002|STARTED|Period 1 Open Label Ziprasidone||0
6291754|NCT00280566|7193527|FG000|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
6291755|NCT00280566|7193528|FG001|COMPLETED|Period 1 Open Label Ziprasidone||0
6291756|NCT00280566|7193529|FG002|COMPLETED|Period 1 Open Label Ziprasidone||0
6291757|NCT00280566|7193527|FG000|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
6291758|NCT00280566|7193528|FG001|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
6291759|NCT00280566|7193529|FG002|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
6291760|NCT00280566|7193527|FG000|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
6291761|NCT00280566|7193528|FG001|STARTED|Period 2 Double Blind||127
6291762|NCT00280566|7193529|FG002|STARTED|Period 2 Double Blind||111
6291763|NCT00280566|7193527|FG000|COMPLETED|Period 2 Double Blind||0
6291764|NCT00280566|7193528|FG001|COMPLETED|Period 2 Double Blind||84
6291765|NCT00280566|7193529|FG002|COMPLETED|Period 2 Double Blind||54
6291766|NCT00280566|7193527|FG000|NOT COMPLETED|Period 2 Double Blind||0
6291767|NCT00280566|7193528|FG001|NOT COMPLETED|Period 2 Double Blind||43
6291768|NCT00280566|7193529|FG002|NOT COMPLETED|Period 2 Double Blind||57
6291769|NCT00280683|7193538|FG000|STARTED|Overall Study||10
6291770|NCT00280683|7193539|FG001|STARTED|Overall Study||10
6291771|NCT00280683|7193538|FG000|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
6291772|NCT00280683|7193539|FG001|COMPLETED|Overall Study||7
6291773|NCT00280683|7193538|FG000|NOT COMPLETED|Overall Study||2
6291774|NCT00280683|7193539|FG001|NOT COMPLETED|Overall Study||3
6291775|NCT00280735|7193547|FG000|STARTED|Overall Study||75
6291776|NCT00280735|7193547|FG000|Received Treatment|Overall Study||72
6291777|NCT00280735|7193547|FG000|Received Adequate Exposure|Overall Study||57
6291778|NCT00280735|7193547|FG000|COMPLETED|Overall Study||57
6291779|NCT00280735|7193547|FG000|NOT COMPLETED|Overall Study||18
6291780|NCT00280748|7193555|FG000|STARTED|Overall Study||10
6291781|NCT00280748|7193555|FG000|COMPLETED|Overall Study||6
6291782|NCT00280748|7193555|FG000|NOT COMPLETED|Overall Study||4
6291783|NCT00280826|7193559|FG000|STARTED|Overall Study||6
6291784|NCT00280826|7193559|FG000|COMPLETED|Overall Study||6
6291785|NCT00280826|7193559|FG000|NOT COMPLETED|Overall Study||0
6291786|NCT00280904|7193563|FG000|STARTED|Overall Study||433
6291787|NCT00280904|7193563|FG000|COMPLETED|Overall Study||433
6399964|NCT00883779|7312798|FG000|STARTED|Primary Study Treatment Phase||225
6399965|NCT00883779|7312799|FG001|STARTED|Primary Study Treatment Phase||226
6399966|NCT00883779|7312798|FG000|COMPLETED|Primary Study Treatment Phase||120
6399967|NCT00883779|7312799|FG001|COMPLETED|Primary Study Treatment Phase||140
6291788|NCT00280904|7193563|FG000|NOT COMPLETED|Overall Study||0
6291789|NCT00280917|7193572|FG000|STARTED|Overall Study||65
6291790|NCT00280917|7193573|FG001|STARTED|Overall Study||63
6291791|NCT00280917|7193574|FG002|STARTED|Overall Study||63
6291792|NCT00280917|7193575|FG003|STARTED|Overall Study||63
6291793|NCT00280917|7193572|FG000|COMPLETED|Overall Study||63
6291794|NCT00280917|7193573|FG001|COMPLETED|Overall Study||57
6291795|NCT00280917|7193574|FG002|COMPLETED|Overall Study||57
6291796|NCT00280917|7193575|FG003|COMPLETED|Overall Study||61
6291797|NCT00280917|7193572|FG000|NOT COMPLETED|Overall Study||2
6291798|NCT00280917|7193573|FG001|NOT COMPLETED|Overall Study||6
6291799|NCT00280917|7193574|FG002|NOT COMPLETED|Overall Study||6
6291800|NCT00280917|7193575|FG003|NOT COMPLETED|Overall Study||2
6399968|NCT00883779|7312798|FG000|NOT COMPLETED|Primary Study Treatment Phase||105
6399969|NCT00883779|7312799|FG001|NOT COMPLETED|Primary Study Treatment Phase||86
6399970|NCT00883779|7312798|FG000|STARTED|Post-Study Treatment Phase||112
6399971|NCT00883779|7312799|FG001|STARTED|Post-Study Treatment Phase||135
6399972|NCT00883779|7312798|FG000|COMPLETED|Post-Study Treatment Phase||0
6399973|NCT00883779|7312799|FG001|COMPLETED|Post-Study Treatment Phase||0
6399974|NCT00883779|7312798|FG000|NOT COMPLETED|Post-Study Treatment Phase||112
6399975|NCT00883779|7312799|FG001|NOT COMPLETED|Post-Study Treatment Phase||135
6399976|NCT00883779|7312798|FG000|STARTED|Off-study Phase||209
6399977|NCT00883779|7312799|FG001|STARTED|Off-study Phase||202
6399978|NCT00883779|7312798|FG000|COMPLETED|Off-study Phase||0
6399979|NCT00883779|7312799|FG001|COMPLETED|Off-study Phase||0
6399980|NCT00883779|7312798|FG000|NOT COMPLETED|Off-study Phase||209
6399981|NCT00883779|7312799|FG001|NOT COMPLETED|Off-study Phase||202
6399982|NCT00884039|7312807|FG000|STARTED|Overall Study||5
6399983|NCT00884039|7312808|FG001|STARTED|Overall Study||2
6399984|NCT00884039|7312807|FG000|COMPLETED|Overall Study||3
6399985|NCT00884039|7312808|FG001|COMPLETED|Overall Study||1
6399986|NCT00884039|7312807|FG000|NOT COMPLETED|Overall Study||2
6399987|NCT00884039|7312808|FG001|NOT COMPLETED|Overall Study||1
6399988|NCT00884052|7312814|FG000|STARTED|Overall Study||6
6399989|NCT00884052|7312815|FG001|STARTED|Overall Study||12
6399990|NCT00884052|7312814|FG000|COMPLETED|Overall Study||6
6399991|NCT00884052|7312815|FG001|COMPLETED|Overall Study||12
6399992|NCT00884052|7312814|FG000|NOT COMPLETED|Overall Study||0
6399993|NCT00884052|7312815|FG001|NOT COMPLETED|Overall Study||0
6399994|NCT00884065|7312823|FG000|STARTED|Overall Study||25
6399995|NCT00884065|7312824|FG001|STARTED|Overall Study||25
6399996|NCT00884065|7312823|FG000|COMPLETED|Overall Study||25
6399997|NCT00884065|7312824|FG001|COMPLETED|Overall Study||25
6399998|NCT00884065|7312823|FG000|NOT COMPLETED|Overall Study||0
6399999|NCT00884065|7312824|FG001|NOT COMPLETED|Overall Study||0
6400000|NCT00884117|7312830|FG000|STARTED|Overall Study||4561
6400001|NCT00884117|7312830|FG000|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
6400002|NCT00884117|7312830|FG000|NOT COMPLETED|Overall Study||249
6400003|NCT00884221|7312849|FG000|STARTED|Overall Study||374
6400004|NCT00884221|7312850|FG001|STARTED|Overall Study||375
6400005|NCT00884221|7312849|FG000|COMPLETED|Overall Study||340
6400006|NCT00884221|7312850|FG001|COMPLETED|Overall Study||343
6400007|NCT00884221|7312849|FG000|NOT COMPLETED|Overall Study||34
6400008|NCT00884221|7312850|FG001|NOT COMPLETED|Overall Study||32
6400009|NCT00884273|7312860|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
6400010|NCT00884273|7312861|FG001|STARTED|Overall Study|ITT population.|98
6400011|NCT00884273|7312860|FG000|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
6400012|NCT00884273|7312861|FG001|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
6400013|NCT00884273|7312860|FG000|Per Protocol (PP) Analysis Set|Overall Study||81
6291801|NCT00281021|7193585|FG000|STARTED|Overall Study||26
6291802|NCT00281021|7193585|FG000|COMPLETED|Overall Study||24
6291803|NCT00281021|7193585|FG000|NOT COMPLETED|Overall Study||2
6291804|NCT00281099|7193591|FG000|STARTED|Overall Study||513
6291805|NCT00281099|7193592|FG001|STARTED|Overall Study||518
6291806|NCT00281099|7193591|FG000|COMPLETED|Overall Study||308
6291807|NCT00281099|7193592|FG001|COMPLETED|Overall Study||296
6291808|NCT00281099|7193591|FG000|NOT COMPLETED|Overall Study||205
6291809|NCT00281099|7193592|FG001|NOT COMPLETED|Overall Study||222
6291810|NCT00281463|7193599|FG000|STARTED|Overall Study||45
6291811|NCT00281463|7193599|FG000|COMPLETED|Overall Study||45
6291812|NCT00281463|7193599|FG000|NOT COMPLETED|Overall Study||0
6291813|NCT00281528|7193606|FG000|STARTED|Overall Study||75
6291814|NCT00281528|7193607|FG001|STARTED|Overall Study||54
6291815|NCT00281528|7193608|FG002|STARTED|Overall Study||79
6291816|NCT00281528|7193606|FG000|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
6291817|NCT00281528|7193607|FG001|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
6291818|NCT00281528|7193608|FG002|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
6291819|NCT00281528|7193606|FG000|NOT COMPLETED|Overall Study||75
6291820|NCT00281528|7193607|FG001|NOT COMPLETED|Overall Study||54
6291821|NCT00281528|7193608|FG002|NOT COMPLETED|Overall Study||79
6291822|NCT00281580|7193632|FG000|STARTED|Overall Study||46
6291823|NCT00281580|7193633|FG001|STARTED|Overall Study||42
6291824|NCT00281580|7193634|FG002|STARTED|Overall Study||130
6291825|NCT00281580|7193635|FG003|STARTED|Overall Study||135
6291826|NCT00281580|7193636|FG004|STARTED|Overall Study||44
6291827|NCT00281580|7193637|FG005|STARTED|Overall Study||46
6291828|NCT00281580|7193638|FG006|STARTED|Overall Study||44
6291829|NCT00281580|7193639|FG007|STARTED|Overall Study||47
6291830|NCT00281580|7193640|FG008|STARTED|Overall Study||143
6291831|NCT00281580|7193641|FG009|STARTED|Overall Study||129
6291832|NCT00281580|7193642|FG010|STARTED|Overall Study||48
6291833|NCT00281580|7193643|FG011|STARTED|Overall Study||146
6291834|NCT00281580|7193644|FG012|STARTED|Overall Study||142
6291835|NCT00281580|7193645|FG013|STARTED|Overall Study||50
6291836|NCT00281580|7193646|FG014|STARTED|Overall Study||140
6291837|NCT00281580|7193647|FG015|STARTED|Overall Study||129
6291838|NCT00281580|7193632|FG000|COMPLETED|Overall Study||39
6291839|NCT00281580|7193633|FG001|COMPLETED|Overall Study||41
6291840|NCT00281580|7193634|FG002|COMPLETED|Overall Study||125
6291841|NCT00281580|7193635|FG003|COMPLETED|Overall Study||118
6291842|NCT00281580|7193636|FG004|COMPLETED|Overall Study||40
6291843|NCT00281580|7193637|FG005|COMPLETED|Overall Study||43
6291844|NCT00281580|7193638|FG006|COMPLETED|Overall Study||39
6291845|NCT00281580|7193639|FG007|COMPLETED|Overall Study||46
6291846|NCT00281580|7193640|FG008|COMPLETED|Overall Study||135
6291847|NCT00281580|7193641|FG009|COMPLETED|Overall Study||117
6291848|NCT00281580|7193642|FG010|COMPLETED|Overall Study||44
6291849|NCT00281580|7193643|FG011|COMPLETED|Overall Study||136
6291850|NCT00281580|7193644|FG012|COMPLETED|Overall Study||129
6291851|NCT00281580|7193645|FG013|COMPLETED|Overall Study||43
6291852|NCT00281580|7193646|FG014|COMPLETED|Overall Study||133
6291853|NCT00281580|7193647|FG015|COMPLETED|Overall Study||116
6291854|NCT00281580|7193632|FG000|NOT COMPLETED|Overall Study||7
6291855|NCT00281580|7193633|FG001|NOT COMPLETED|Overall Study||1
6291856|NCT00281580|7193634|FG002|NOT COMPLETED|Overall Study||5
6291857|NCT00281580|7193635|FG003|NOT COMPLETED|Overall Study||17
6291858|NCT00281580|7193636|FG004|NOT COMPLETED|Overall Study||4
6291859|NCT00281580|7193637|FG005|NOT COMPLETED|Overall Study||3
6291860|NCT00281580|7193638|FG006|NOT COMPLETED|Overall Study||5
6291861|NCT00281580|7193639|FG007|NOT COMPLETED|Overall Study||1
6291862|NCT00281580|7193640|FG008|NOT COMPLETED|Overall Study||8
6291863|NCT00281580|7193641|FG009|NOT COMPLETED|Overall Study||12
6291864|NCT00281580|7193642|FG010|NOT COMPLETED|Overall Study||4
6291865|NCT00281580|7193643|FG011|NOT COMPLETED|Overall Study||10
6291866|NCT00281580|7193644|FG012|NOT COMPLETED|Overall Study||13
6291867|NCT00281580|7193645|FG013|NOT COMPLETED|Overall Study||7
6291868|NCT00281580|7193646|FG014|NOT COMPLETED|Overall Study||7
6291869|NCT00281580|7193647|FG015|NOT COMPLETED|Overall Study||13
6291870|NCT00281632|7193716|FG000|STARTED|Overall Study||36
6291871|NCT00281632|7193716|FG000|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
6291872|NCT00281632|7193716|FG000|NOT COMPLETED|Overall Study||36
6291873|NCT00281671|7193728|FG000|STARTED|Overall Study||5
6291874|NCT00281671|7193729|FG001|STARTED|Overall Study||4
6291875|NCT00281671|7193728|FG000|COMPLETED|Overall Study||5
6291876|NCT00281671|7193729|FG001|COMPLETED|Overall Study||4
6291877|NCT00281671|7193728|FG000|NOT COMPLETED|Overall Study||0
6291878|NCT00281671|7193729|FG001|NOT COMPLETED|Overall Study||0
6291879|NCT00281684|7193742|FG000|STARTED|Overall Study||37
6291880|NCT00281684|7193743|FG001|STARTED|Overall Study||36
6291881|NCT00281684|7193744|FG002|STARTED|Overall Study||34
6291882|NCT00281684|7193745|FG003|STARTED|Overall Study||38
6291883|NCT00281684|7193742|FG000|COMPLETED|Overall Study||36
6291884|NCT00281684|7193743|FG001|COMPLETED|Overall Study||36
6291885|NCT00281684|7193744|FG002|COMPLETED|Overall Study||33
6291886|NCT00281684|7193745|FG003|COMPLETED|Overall Study||38
6291887|NCT00281684|7193742|FG000|NOT COMPLETED|Overall Study||1
6291888|NCT00281684|7193743|FG001|NOT COMPLETED|Overall Study||0
6291889|NCT00281684|7193744|FG002|NOT COMPLETED|Overall Study||1
6291890|NCT00281684|7193745|FG003|NOT COMPLETED|Overall Study||0
6291891|NCT00281697|7193759|FG000|STARTED|Overall Study||459
6291892|NCT00281697|7193760|FG001|STARTED|Overall Study||225
6291893|NCT00281697|7193759|FG000|COMPLETED|Overall Study||58
6291894|NCT00281697|7193760|FG001|COMPLETED|Overall Study||28
6291895|NCT00281697|7193759|FG000|NOT COMPLETED|Overall Study||401
6291896|NCT00281697|7193760|FG001|NOT COMPLETED|Overall Study||197
6291897|NCT00281827|7193766|FG000|STARTED|Overall Study||22
6291898|NCT00281827|7193766|FG000|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
6291899|NCT00281827|7193766|FG000|NOT COMPLETED|Overall Study||0
6291900|NCT00281840|7193772|FG000|STARTED|Overall Study||30
6291901|NCT00281840|7193772|FG000|COMPLETED|Overall Study||5
6291902|NCT00281840|7193772|FG000|NOT COMPLETED|Overall Study||25
6291903|NCT00281918|7193779|FG000|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
6291904|NCT00281918|7193780|FG001|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
6291905|NCT00281918|7193779|FG000|Safety Population; Received Study Drug|Overall Study||398
6291906|NCT00281918|7193780|FG001|Safety Population; Received Study Drug|Overall Study||402
6291907|NCT00281918|7193779|FG000|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
6291908|NCT00281918|7193780|FG001|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
6291909|NCT00281918|7193779|FG000|NOT COMPLETED|Overall Study||142
6291910|NCT00281918|7193780|FG001|NOT COMPLETED|Overall Study||108
6291911|NCT00281957|7193788|FG000|STARTED|Overall Study||67
6291912|NCT00281957|7193789|FG001|STARTED|Overall Study||42
6291913|NCT00281957|7193788|FG000|Eligible|Overall Study||66
6291914|NCT00281957|7193789|FG001|Eligible|Overall Study||40
6291915|NCT00281957|7193788|FG000|Eligible and Received Treatment|Overall Study||63
6291916|NCT00281957|7193789|FG001|Eligible and Received Treatment|Overall Study||39
6291917|NCT00281957|7193788|FG000|COMPLETED|Overall Study||0
6291918|NCT00281957|7193789|FG001|COMPLETED|Overall Study||0
6291919|NCT00281957|7193788|FG000|NOT COMPLETED|Overall Study||67
6291920|NCT00281957|7193789|FG001|NOT COMPLETED|Overall Study||42
6291921|NCT00282048|7193797|FG000|STARTED|Overall Study||62
6291922|NCT00282048|7193797|FG000|COMPLETED|Overall Study||0
6291923|NCT00282048|7193797|FG000|NOT COMPLETED|Overall Study||62
6291924|NCT00282087|7193801|FG000|STARTED|Overall Study||47
6291925|NCT00282087|7193801|FG000|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
6291926|NCT00282087|7193801|FG000|NOT COMPLETED|Overall Study||1
6291927|NCT00282113|7193809|FG000|STARTED|Overall Study||31
6291928|NCT00282113|7193810|FG001|STARTED|Overall Study||30
6291929|NCT00282113|7193811|FG002|STARTED|Overall Study||29
6291930|NCT00282113|7193809|FG000|COMPLETED|Overall Study||30
6291931|NCT00282113|7193810|FG001|COMPLETED|Overall Study||30
6291932|NCT00282113|7193811|FG002|COMPLETED|Overall Study||29
6291933|NCT00282113|7193809|FG000|NOT COMPLETED|Overall Study||1
6291934|NCT00282113|7193810|FG001|NOT COMPLETED|Overall Study||0
6291935|NCT00282113|7193811|FG002|NOT COMPLETED|Overall Study||0
6291936|NCT00282152|7193821|FG000|STARTED|Overall Study||15
6291937|NCT00282152|7193822|FG001|STARTED|Overall Study||15
6291938|NCT00282152|7193821|FG000|COMPLETED|Overall Study||14
6291939|NCT00282152|7193822|FG001|COMPLETED|Overall Study||15
6291940|NCT00282152|7193821|FG000|NOT COMPLETED|Overall Study||1
6291941|NCT00282152|7193822|FG001|NOT COMPLETED|Overall Study||0
6291942|NCT00282243|7193829|FG000|STARTED|Pharmacokinetic Treatment Period||70
6291943|NCT00282243|7193829|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||70
6291944|NCT00282243|7193829|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
6291945|NCT00282243|7193829|FG000|COMPLETED|Pharmacokinetic Treatment Period||65
6291946|NCT00282243|7193829|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||5
6291947|NCT00282243|7193829|FG000|STARTED|Extension Treatment Period||65
6291948|NCT00282243|7193829|FG000|COMPLETED|Extension Treatment Period||43
6291949|NCT00282243|7193829|FG000|NOT COMPLETED|Extension Treatment Period||22
6291950|NCT00282256|7193833|FG000|STARTED|Pharmacokinetic Treatment Period||19
6291951|NCT00282256|7193833|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||19
6291952|NCT00282256|7193833|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
6291953|NCT00282256|7193833|FG000|COMPLETED|Pharmacokinetic Treatment Period||18
6291954|NCT00282256|7193833|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||1
6291955|NCT00282256|7193833|FG000|STARTED|Extension Treatment Period||18
6291956|NCT00282256|7193833|FG000|COMPLETED|Extension Treatment Period||16
6291957|NCT00282256|7193833|FG000|NOT COMPLETED|Extension Treatment Period||2
6291958|NCT00282282|7193837|FG000|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
6400014|NCT00884273|7312861|FG001|Per Protocol (PP) Analysis Set|Overall Study||92
6400015|NCT00884273|7312860|FG000|Safety Analysis Set|Overall Study||84
6400016|NCT00884273|7312861|FG001|Safety Analysis Set|Overall Study||98
6400017|NCT00884273|7312860|FG000|COMPLETED|Overall Study||82
6400018|NCT00884273|7312861|FG001|COMPLETED|Overall Study||93
6400019|NCT00884273|7312860|FG000|NOT COMPLETED|Overall Study||2
6400020|NCT00884273|7312861|FG001|NOT COMPLETED|Overall Study||5
6400021|NCT00884286|7312869|FG000|STARTED|Overall Study||34
6400022|NCT00884286|7312870|FG001|STARTED|Overall Study||33
6400023|NCT00884286|7312869|FG000|COMPLETED|Overall Study||2
6400024|NCT00884286|7312870|FG001|COMPLETED|Overall Study||0
6400025|NCT00884286|7312869|FG000|NOT COMPLETED|Overall Study||32
6400026|NCT00884286|7312870|FG001|NOT COMPLETED|Overall Study||33
6291959|NCT00282282|7193837|FG000|COMPLETED|Overall Study||29
6291960|NCT00282282|7193837|FG000|NOT COMPLETED|Overall Study||0
6291961|NCT00282295|7193845|FG000|STARTED|Overall Study||446
6291962|NCT00282295|7193846|FG001|STARTED|Overall Study||446
6291963|NCT00282295|7193847|FG002|STARTED|Overall Study||449
6291964|NCT00282295|7193845|FG000|COMPLETED|Overall Study||443
6400027|NCT00884312|7312879|FG000|STARTED|Overall Study||9
6400028|NCT00884312|7312880|FG001|STARTED|Overall Study||92
6400029|NCT00884312|7312879|FG000|Received Treatment|Overall Study||9
6400030|NCT00884312|7312880|FG001|Received Treatment|Overall Study||91
6400031|NCT00884312|7312879|FG000|COMPLETED|Overall Study||7
6291965|NCT00282295|7193846|FG001|COMPLETED|Overall Study||429
6291966|NCT00282295|7193847|FG002|COMPLETED|Overall Study||441
6291967|NCT00282295|7193845|FG000|NOT COMPLETED|Overall Study||3
6291968|NCT00282295|7193846|FG001|NOT COMPLETED|Overall Study||17
6291969|NCT00282295|7193847|FG002|NOT COMPLETED|Overall Study||8
6291970|NCT00282308|7193862|FG000|STARTED|Treatment Period||69
6291971|NCT00282308|7193863|FG001|STARTED|Treatment Period||34
6291972|NCT00282308|7193864|FG002|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
6291973|NCT00282308|7193862|FG000|COMPLETED|Treatment Period||65
6291974|NCT00282308|7193863|FG001|COMPLETED|Treatment Period||28
6291975|NCT00282308|7193864|FG002|COMPLETED|Treatment Period||0
6291976|NCT00282308|7193862|FG000|NOT COMPLETED|Treatment Period||4
6291977|NCT00282308|7193863|FG001|NOT COMPLETED|Treatment Period||6
6291978|NCT00282308|7193864|FG002|NOT COMPLETED|Treatment Period||0
6291979|NCT00282308|7193862|FG000|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
6291980|NCT00282308|7193863|FG001|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
6291981|NCT00282308|7193864|FG002|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
6291982|NCT00282308|7193862|FG000|COMPLETED|Optional Extension Re-treatment Period||0
6400032|NCT00884312|7312880|FG001|COMPLETED|Overall Study||67
6400033|NCT00884312|7312879|FG000|NOT COMPLETED|Overall Study||2
6400034|NCT00884312|7312880|FG001|NOT COMPLETED|Overall Study||25
6400035|NCT00884325|7312888|FG000|STARTED|Overall Study||20
6400036|NCT00884325|7312889|FG001|STARTED|Overall Study||20
6400037|NCT00884325|7312888|FG000|COMPLETED|Overall Study||17
6291983|NCT00282308|7193863|FG001|COMPLETED|Optional Extension Re-treatment Period||0
6291984|NCT00282308|7193864|FG002|COMPLETED|Optional Extension Re-treatment Period||72
6291985|NCT00282308|7193862|FG000|NOT COMPLETED|Optional Extension Re-treatment Period||0
6291986|NCT00282308|7193863|FG001|NOT COMPLETED|Optional Extension Re-treatment Period||0
6291987|NCT00282308|7193864|FG002|NOT COMPLETED|Optional Extension Re-treatment Period||6
6291988|NCT00282308|7193862|FG000|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
6291989|NCT00282308|7193863|FG001|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
6291990|NCT00282308|7193864|FG002|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
6291991|NCT00282308|7193862|FG000|COMPLETED|Safety Follow-up Period||0
6291992|NCT00282308|7193863|FG001|COMPLETED|Safety Follow-up Period||0
6291993|NCT00282308|7193864|FG002|COMPLETED|Safety Follow-up Period||81
6291994|NCT00282308|7193862|FG000|NOT COMPLETED|Safety Follow-up Period||0
6291995|NCT00282308|7193863|FG001|NOT COMPLETED|Safety Follow-up Period||0
6291996|NCT00282308|7193864|FG002|NOT COMPLETED|Safety Follow-up Period||19
6291997|NCT00282334|7193876|FG000|STARTED|Overall Study||113
6291998|NCT00282334|7193877|FG001|STARTED|Overall Study||123
6291999|NCT00282334|7193876|FG000|COMPLETED|Overall Study||105
6292000|NCT00282334|7193877|FG001|COMPLETED|Overall Study||118
6292001|NCT00282334|7193876|FG000|NOT COMPLETED|Overall Study||8
6292002|NCT00282334|7193877|FG001|NOT COMPLETED|Overall Study||5
6292003|NCT00282347|7193885|FG000|STARTED|Treatment Period||72
6292004|NCT00282347|7193886|FG001|STARTED|Treatment Period||72
6292005|NCT00282347|7193885|FG000|COMPLETED|Treatment Period||67
6400038|NCT00884325|7312889|FG001|COMPLETED|Overall Study||16
6400039|NCT00884325|7312888|FG000|NOT COMPLETED|Overall Study||3
6400040|NCT00884325|7312889|FG001|NOT COMPLETED|Overall Study||4
6400041|NCT00884377|7312897|FG000|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
6400042|NCT00884377|7312898|FG001|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
6400043|NCT00884377|7312897|FG000|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
6400044|NCT00884377|7312898|FG001|COMPLETED|Overall Study||27
6400045|NCT00884377|7312897|FG000|NOT COMPLETED|Overall Study||2
6400046|NCT00884377|7312898|FG001|NOT COMPLETED|Overall Study||1
6400047|NCT00884390|7312912|FG000|STARTED|Overall Study||146
6400048|NCT00884390|7312913|FG001|STARTED|Overall Study||62
6400049|NCT00884390|7312912|FG000|COMPLETED|Overall Study||123
6400050|NCT00884390|7312913|FG001|COMPLETED|Overall Study||54
6400051|NCT00884390|7312912|FG000|NOT COMPLETED|Overall Study||23
6400052|NCT00884390|7312913|FG001|NOT COMPLETED|Overall Study||8
6400053|NCT00884585|7312929|FG000|STARTED|Double-Masked Phase (Day 1-Month 3)||89
6400054|NCT00884585|7312930|FG001|STARTED|Double-Masked Phase (Day 1-Month 3)||87
6400055|NCT00884585|7312929|FG000|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
6400056|NCT00884585|7312930|FG001|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
6400057|NCT00884585|7312929|FG000|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
6634777|NCT02299427|7563622|FG001|STARTED|Overall Study||34
6634778|NCT02299427|7563621|FG000|COMPLETED|Overall Study||12
6634779|NCT02299427|7563622|FG001|COMPLETED|Overall Study||31
6634780|NCT02299427|7563621|FG000|NOT COMPLETED|Overall Study||23
6400058|NCT00884585|7312930|FG001|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
6400059|NCT00884585|7312929|FG000|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
6400060|NCT00884585|7312930|FG001|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
6400061|NCT00884585|7312929|FG000|COMPLETED|Open-Label Phase (Months 3-9)||147
6400062|NCT00884585|7312930|FG001|COMPLETED|Open-Label Phase (Months 3-9)||0
6400063|NCT00884585|7312929|FG000|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
6400064|NCT00884585|7312930|FG001|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
6400065|NCT00884585|7312929|FG000|STARTED|Open-Label Maintenance (Months 9-12)||147
6400066|NCT00884585|7312930|FG001|STARTED|Open-Label Maintenance (Months 9-12)||0
6400067|NCT00884585|7312929|FG000|COMPLETED|Open-Label Maintenance (Months 9-12)||144
6400068|NCT00884585|7312930|FG001|COMPLETED|Open-Label Maintenance (Months 9-12)||0
6400069|NCT00884585|7312929|FG000|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
6400070|NCT00884585|7312930|FG001|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
6400071|NCT00884611|7312936|FG000|STARTED|Overall Study||20
6400072|NCT00884611|7312936|FG000|Enrolled, Not Treated|Overall Study||1
6400073|NCT00884611|7312936|FG000|COMPLETED|Overall Study||19
6400074|NCT00884611|7312936|FG000|NOT COMPLETED|Overall Study||1
6400075|NCT00884650|7312948|FG000|STARTED|Overall Study||25
6400076|NCT00884650|7312949|FG001|STARTED|Overall Study||29
6400077|NCT00884650|7312948|FG000|COMPLETED|Overall Study||16
6400078|NCT00884650|7312949|FG001|COMPLETED|Overall Study||21
6400079|NCT00884650|7312948|FG000|NOT COMPLETED|Overall Study||9
6400080|NCT00884650|7312949|FG001|NOT COMPLETED|Overall Study||8
6400081|NCT00884741|7312959|FG000|STARTED|Step 1 Registration: Tissue Screening||978
6400082|NCT00884741|7312960|FG001|STARTED|Step 1 Registration: Tissue Screening||0
6400083|NCT00884741|7312961|FG002|STARTED|Step 1 Registration: Tissue Screening||0
6400084|NCT00884741|7312962|FG003|STARTED|Step 1 Registration: Tissue Screening||0
6400085|NCT00884741|7312959|FG000|COMPLETED|Step 1 Registration: Tissue Screening||666
6400086|NCT00884741|7312960|FG001|COMPLETED|Step 1 Registration: Tissue Screening||0
6400087|NCT00884741|7312961|FG002|COMPLETED|Step 1 Registration: Tissue Screening||0
6400088|NCT00884741|7312962|FG003|COMPLETED|Step 1 Registration: Tissue Screening||0
6400089|NCT00884741|7312959|FG000|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
6400090|NCT00884741|7312960|FG001|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
6400091|NCT00884741|7312961|FG002|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
6400092|NCT00884741|7312962|FG003|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
6400093|NCT00884741|7312959|FG000|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
6400094|NCT00884741|7312960|FG001|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
6400095|NCT00884741|7312961|FG002|STARTED|Step 2 Registration: Tissue Analysis||0
6400096|NCT00884741|7312962|FG003|STARTED|Step 2 Registration: Tissue Analysis||0
6400097|NCT00884741|7312959|FG000|COMPLETED|Step 2 Registration: Tissue Analysis||0
6400098|NCT00884741|7312960|FG001|COMPLETED|Step 2 Registration: Tissue Analysis||637
6400099|NCT00884741|7312961|FG002|COMPLETED|Step 2 Registration: Tissue Analysis||0
6400100|NCT00884741|7312962|FG003|COMPLETED|Step 2 Registration: Tissue Analysis||0
6400101|NCT00884741|7312959|FG000|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
6400102|NCT00884741|7312960|FG001|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
6400103|NCT00884741|7312961|FG002|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
6400104|NCT00884741|7312962|FG003|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
6400105|NCT00884741|7312959|FG000|STARTED|Randomization||0
6400106|NCT00884741|7312960|FG001|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
6400107|NCT00884741|7312961|FG002|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
6400108|NCT00884741|7312962|FG003|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
6400109|NCT00884741|7312959|FG000|COMPLETED|Randomization||0
6400110|NCT00884741|7312960|FG001|COMPLETED|Randomization||0
6400111|NCT00884741|7312961|FG002|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
6400112|NCT00884741|7312962|FG003|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
6400113|NCT00884741|7312959|FG000|NOT COMPLETED|Randomization||0
6400114|NCT00884741|7312960|FG001|NOT COMPLETED|Randomization||0
6400115|NCT00884741|7312961|FG002|NOT COMPLETED|Randomization||8
6400116|NCT00884741|7312962|FG003|NOT COMPLETED|Randomization||8
6400117|NCT00884754|7312971|FG000|STARTED|Overall Study||30
6400118|NCT00884754|7312972|FG001|STARTED|Overall Study||30
6400119|NCT00884754|7312971|FG000|COMPLETED|Overall Study||30
6400120|NCT00884754|7312972|FG001|COMPLETED|Overall Study||30
6400121|NCT00884754|7312971|FG000|NOT COMPLETED|Overall Study||0
6400122|NCT00884754|7312972|FG001|NOT COMPLETED|Overall Study||0
6400123|NCT00884793|7312978|FG000|STARTED|Overall Study||8
6400124|NCT00884793|7312978|FG000|COMPLETED|Overall Study||7
6400125|NCT00884793|7312978|FG000|NOT COMPLETED|Overall Study||1
6400126|NCT00884806|7312982|FG000|STARTED|Overall Study||110
6400127|NCT00884806|7312982|FG000|COMPLETED|Overall Study||110
6400128|NCT00884806|7312982|FG000|NOT COMPLETED|Overall Study||0
6400129|NCT00884832|7312988|FG000|STARTED|Overall Study||22
6400130|NCT00884832|7312989|FG001|STARTED|Overall Study||22
6400131|NCT00884832|7312988|FG000|COMPLETED|Overall Study||22
6400132|NCT00884832|7312989|FG001|COMPLETED|Overall Study||21
6292006|NCT00282347|7193886|FG001|COMPLETED|Treatment Period||63
6292007|NCT00282347|7193885|FG000|NOT COMPLETED|Treatment Period||5
6292008|NCT00282347|7193886|FG001|NOT COMPLETED|Treatment Period||9
6292009|NCT00282347|7193885|FG000|STARTED|Safety Follow-up Period||67
6292010|NCT00282347|7193886|FG001|STARTED|Safety Follow-up Period||63
6292011|NCT00282347|7193885|FG000|COMPLETED|Safety Follow-up Period||64
6292012|NCT00282347|7193886|FG001|COMPLETED|Safety Follow-up Period||57
6292013|NCT00282347|7193885|FG000|NOT COMPLETED|Safety Follow-up Period||3
6292014|NCT00282347|7193886|FG001|NOT COMPLETED|Safety Follow-up Period||6
6400133|NCT00884832|7312988|FG000|NOT COMPLETED|Overall Study||0
6400134|NCT00884832|7312989|FG001|NOT COMPLETED|Overall Study||1
6400135|NCT00884897|7312997|FG000|STARTED|Overall Study||13
6400136|NCT00884897|7312998|FG001|STARTED|Overall Study||15
6400137|NCT00884897|7312997|FG000|COMPLETED|Overall Study||13
6400138|NCT00884897|7312998|FG001|COMPLETED|Overall Study||15
6400139|NCT00884897|7312997|FG000|NOT COMPLETED|Overall Study||0
6400140|NCT00884897|7312998|FG001|NOT COMPLETED|Overall Study||0
6400141|NCT00884910|7313004|FG000|STARTED|Overall Study||33
6400142|NCT00884910|7313004|FG000|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
6400143|NCT00884910|7313004|FG000|NOT COMPLETED|Overall Study||1
6400144|NCT00884949|7313008|FG000|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
6400145|NCT00884949|7313008|FG000|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
6400146|NCT00884949|7313008|FG000|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
6400147|NCT00884949|7313008|FG000|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
6400148|NCT00884949|7313008|FG000|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
6400149|NCT00884949|7313008|FG000|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
6400150|NCT00884949|7313008|FG000|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
6510108|NCT01479543|7429664|FG000|NOT COMPLETED|Overall Study||1
6292015|NCT00282347|7193885|FG000|STARTED|B Cell Follow-up Period||20
6292016|NCT00282347|7193886|FG001|STARTED|B Cell Follow-up Period||4
6292017|NCT00282347|7193885|FG000|COMPLETED|B Cell Follow-up Period||15
6292018|NCT00282347|7193886|FG001|COMPLETED|B Cell Follow-up Period||4
6292019|NCT00282347|7193885|FG000|NOT COMPLETED|B Cell Follow-up Period||5
6292020|NCT00282347|7193886|FG001|NOT COMPLETED|B Cell Follow-up Period||0
6292021|NCT00282412|7193894|FG000|STARTED|Overall Study||4
6292022|NCT00282412|7193894|FG000|COMPLETED|Overall Study|Two late deaths non-treatment related. One from pulmonary embolism and one from late leukemia.|2
6292023|NCT00282412|7193894|FG000|NOT COMPLETED|Overall Study||2
6292024|NCT00282438|7193900|FG000|STARTED|Overall Study||1
6292025|NCT00282438|7193901|FG001|STARTED|Overall Study||1
6292026|NCT00282438|7193900|FG000|COMPLETED|Overall Study||0
6292027|NCT00282438|7193901|FG001|COMPLETED|Overall Study||0
6292028|NCT00282438|7193900|FG000|NOT COMPLETED|Overall Study||1
6292029|NCT00282438|7193901|FG001|NOT COMPLETED|Overall Study||1
6292030|NCT00282464|7193909|FG000|STARTED|Overall Study||185
6292031|NCT00282464|7193910|FG001|STARTED|Overall Study||196
6292032|NCT00282464|7193909|FG000|COMPLETED|Overall Study||112
6292033|NCT00282464|7193910|FG001|COMPLETED|Overall Study||134
6292034|NCT00282464|7193909|FG000|NOT COMPLETED|Overall Study||73
6292035|NCT00282464|7193910|FG001|NOT COMPLETED|Overall Study||62
6292036|NCT00282568|7193916|FG000|STARTED|Pharmacokinetic Treatment Period||70
6292037|NCT00282568|7193916|FG000|Received Tacrolimus|Pharmacokinetic Treatment Period||68
6292038|NCT00282568|7193916|FG000|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
6292039|NCT00282568|7193916|FG000|COMPLETED|Pharmacokinetic Treatment Period||67
6292040|NCT00282568|7193916|FG000|NOT COMPLETED|Pharmacokinetic Treatment Period||3
6292041|NCT00282568|7193916|FG000|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
6292042|NCT00282568|7193916|FG000|COMPLETED|Extended Treatment Period||42
6292043|NCT00282568|7193916|FG000|NOT COMPLETED|Extended Treatment Period||24
6292044|NCT00282672|7193924|FG000|STARTED|1 Year||22
6292045|NCT00282672|7193925|FG001|STARTED|1 Year||42
6292046|NCT00282672|7193926|FG002|STARTED|1 Year||21
6292047|NCT00282672|7193927|FG003|STARTED|1 Year||42
6292048|NCT00282672|7193924|FG000|COMPLETED|1 Year||19
6292049|NCT00282672|7193925|FG001|COMPLETED|1 Year||40
6292050|NCT00282672|7193926|FG002|COMPLETED|1 Year||20
6292051|NCT00282672|7193927|FG003|COMPLETED|1 Year||38
6292052|NCT00282672|7193924|FG000|NOT COMPLETED|1 Year||3
6292053|NCT00282672|7193925|FG001|NOT COMPLETED|1 Year||2
6292054|NCT00282672|7193926|FG002|NOT COMPLETED|1 Year||1
6292055|NCT00282672|7193927|FG003|NOT COMPLETED|1 Year||4
6292056|NCT00282672|7193924|FG000|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
6292057|NCT00282672|7193925|FG001|STARTED|2 Year: Sham Crossed Over to RFA||40
6292058|NCT00282672|7193926|FG002|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
6292059|NCT00282672|7193927|FG003|STARTED|2 Year: Sham Crossed Over to RFA||38
6292060|NCT00282672|7193924|FG000|COMPLETED|2 Year: Sham Crossed Over to RFA||16
6292061|NCT00282672|7193925|FG001|COMPLETED|2 Year: Sham Crossed Over to RFA||39
6292062|NCT00282672|7193926|FG002|COMPLETED|2 Year: Sham Crossed Over to RFA||15
6292063|NCT00282672|7193927|FG003|COMPLETED|2 Year: Sham Crossed Over to RFA||36
6292064|NCT00282672|7193924|FG000|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
6292065|NCT00282672|7193925|FG001|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
6292066|NCT00282672|7193926|FG002|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
6400151|NCT00884949|7313008|FG000|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
6400152|NCT00884949|7313008|FG000|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
6400153|NCT00884949|7313008|FG000|STARTED|Continuation Period||18
6510109|NCT01479543|7429665|FG001|NOT COMPLETED|Overall Study||0
6292067|NCT00282672|7193927|FG003|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
6292068|NCT00282672|7193924|FG000|STARTED|5 Year: Follow up|1 withdrew|15
6292069|NCT00282672|7193925|FG001|STARTED|5 Year: Follow up|7 withdrew|32
6292070|NCT00282672|7193926|FG002|STARTED|5 Year: Follow up|3 withdrew|12
6292071|NCT00282672|7193927|FG003|STARTED|5 Year: Follow up|11 withdrew|25
6292072|NCT00282672|7193924|FG000|COMPLETED|5 Year: Follow up||14
6292073|NCT00282672|7193925|FG001|COMPLETED|5 Year: Follow up||27
6292074|NCT00282672|7193926|FG002|COMPLETED|5 Year: Follow up||12
6292075|NCT00282672|7193927|FG003|COMPLETED|5 Year: Follow up||20
6292076|NCT00282672|7193924|FG000|NOT COMPLETED|5 Year: Follow up||1
6292077|NCT00282672|7193925|FG001|NOT COMPLETED|5 Year: Follow up||5
6292078|NCT00282672|7193926|FG002|NOT COMPLETED|5 Year: Follow up||0
6292079|NCT00282672|7193927|FG003|NOT COMPLETED|5 Year: Follow up||5
6292080|NCT00282815|7193963|FG000|STARTED|Overall Study||15
6292081|NCT00282815|7193964|FG001|STARTED|Overall Study||17
6292082|NCT00282815|7193963|FG000|COMPLETED|Overall Study||8
6292083|NCT00282815|7193964|FG001|COMPLETED|Overall Study||11
6292084|NCT00282815|7193963|FG000|NOT COMPLETED|Overall Study||7
6400154|NCT00884949|7313008|FG000|COMPLETED|Continuation Period||18
6400155|NCT00884949|7313008|FG000|NOT COMPLETED|Continuation Period||0
6400156|NCT00885079|7313023|FG000|STARTED|Overall Study||93
6400157|NCT00885079|7313024|FG001|STARTED|Overall Study||95
6400158|NCT00885079|7313023|FG000|COMPLETED|Overall Study||91
6400159|NCT00885079|7313024|FG001|COMPLETED|Overall Study||91
6400160|NCT00885079|7313023|FG000|NOT COMPLETED|Overall Study||2
6400161|NCT00885079|7313024|FG001|NOT COMPLETED|Overall Study||4
6498672|NCT01411852|7417316|FG000|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
6498673|NCT01411852|7417317|FG001|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
6498674|NCT01411852|7417316|FG000|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
6502045|NCT01432327|7420689|FG000|COMPLETED|Posttest 6 Months||52
6292085|NCT00282815|7193964|FG001|NOT COMPLETED|Overall Study||6
6292086|NCT00282828|7193976|FG000|STARTED|Overall Study||63
6292087|NCT00282828|7193977|FG001|STARTED|Overall Study||59
6292088|NCT00282828|7193978|FG002|STARTED|Overall Study||59
6292089|NCT00282828|7193976|FG000|COMPLETED|Overall Study||57
6292090|NCT00282828|7193977|FG001|COMPLETED|Overall Study||47
6292091|NCT00282828|7193978|FG002|COMPLETED|Overall Study||50
6292092|NCT00282828|7193976|FG000|NOT COMPLETED|Overall Study||6
6292093|NCT00282828|7193977|FG001|NOT COMPLETED|Overall Study||12
6292094|NCT00282828|7193978|FG002|NOT COMPLETED|Overall Study||9
6292095|NCT00282841|7193986|FG000|STARTED|Overall Study|Anticipated recruitment 400; stopped due to funding and poor recruitment.|61
6292096|NCT00282841|7193986|FG000|COMPLETED|Overall Study||61
6292097|NCT00282841|7193986|FG000|NOT COMPLETED|Overall Study||0
6292098|NCT00282919|7193991|FG000|STARTED|Overall Study||110
6634781|NCT02299427|7563622|FG001|NOT COMPLETED|Overall Study||3
6634782|NCT02299479|7563628|FG000|STARTED|Overall Study||20
6634783|NCT02299479|7563628|FG000|COMPLETED|Overall Study||18
6634784|NCT02299479|7563628|FG000|NOT COMPLETED|Overall Study||2
6634785|NCT02299570|7563635|FG000|STARTED|Overall Study||45
6634786|NCT02299570|7563636|FG001|STARTED|Overall Study||44
6634787|NCT02299570|7563637|FG002|STARTED|Overall Study||44
6634788|NCT02299570|7563635|FG000|COMPLETED|Overall Study||31
6634789|NCT02299570|7563636|FG001|COMPLETED|Overall Study||35
6634790|NCT02299570|7563637|FG002|COMPLETED|Overall Study||25
6292099|NCT00282919|7193991|FG000|COMPLETED|Overall Study||103
6292100|NCT00282919|7193991|FG000|NOT COMPLETED|Overall Study||7
6292101|NCT00282971|7193997|FG000|STARTED|Overall Study||180
6292102|NCT00282971|7193998|FG001|STARTED|Overall Study||171
6292103|NCT00282971|7193997|FG000|COMPLETED|Overall Study||146
6292104|NCT00282971|7193998|FG001|COMPLETED|Overall Study||149
6292105|NCT00282971|7193997|FG000|NOT COMPLETED|Overall Study||34
6292106|NCT00282971|7193998|FG001|NOT COMPLETED|Overall Study||22
6292107|NCT00282984|7194006|FG000|STARTED|Overall Study||353
6292108|NCT00282984|7194007|FG001|STARTED|Overall Study||350
6292109|NCT00282984|7194006|FG000|COMPLETED|Overall Study||302
6292110|NCT00282984|7194007|FG001|COMPLETED|Overall Study||289
6292111|NCT00282984|7194006|FG000|NOT COMPLETED|Overall Study||51
6292112|NCT00282984|7194007|FG001|NOT COMPLETED|Overall Study||61
6292113|NCT00283049|7194016|FG000|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
6292114|NCT00283049|7194017|FG001|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
6292115|NCT00283049|7194018|FG002|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
6292116|NCT00283049|7194016|FG000|COMPLETED|Overall Study||70
6292117|NCT00283049|7194017|FG001|COMPLETED|Overall Study||83
6292118|NCT00283049|7194018|FG002|COMPLETED|Overall Study||76
6292119|NCT00283049|7194016|FG000|NOT COMPLETED|Overall Study||58
6292120|NCT00283049|7194017|FG001|NOT COMPLETED|Overall Study||45
6634791|NCT02299570|7563635|FG000|NOT COMPLETED|Overall Study||14
6634792|NCT02299570|7563636|FG001|NOT COMPLETED|Overall Study||9
6292121|NCT00283049|7194018|FG002|NOT COMPLETED|Overall Study||54
6292122|NCT00283062|7194030|FG000|STARTED|Overall Study||55
6292123|NCT00283062|7194031|FG001|STARTED|Overall Study||55
6634793|NCT02299570|7563637|FG002|NOT COMPLETED|Overall Study||19
6634794|NCT02299635|7563650|FG000|STARTED|Overall Study||19
6634795|NCT02299635|7563650|FG000|COMPLETED|Overall Study||0
6292124|NCT00283062|7194032|FG002|STARTED|Overall Study||56
6292125|NCT00283062|7194033|FG003|STARTED|Overall Study||62
6292126|NCT00283062|7194030|FG000|ADMINISTERED STUDY TREATMENT|Overall Study||50
6400162|NCT00885092|7313032|FG000|STARTED|Period 1, 7 Days||20
6400163|NCT00885092|7313033|FG001|STARTED|Period 1, 7 Days||20
6400164|NCT00885092|7313032|FG000|COMPLETED|Period 1, 7 Days||20
6400165|NCT00885092|7313033|FG001|COMPLETED|Period 1, 7 Days||20
6634796|NCT02299635|7563650|FG000|NOT COMPLETED|Overall Study||19
6634797|NCT02299791|7563656|FG000|STARTED|Overall Study||2053
6292127|NCT00283062|7194031|FG001|ADMINISTERED STUDY TREATMENT|Overall Study||51
6292128|NCT00283062|7194032|FG002|ADMINISTERED STUDY TREATMENT|Overall Study||20
6292129|NCT00283062|7194033|FG003|ADMINISTERED STUDY TREATMENT|Overall Study||17
6292130|NCT00283062|7194030|FG000|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
6292131|NCT00283062|7194031|FG001|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
6292132|NCT00283062|7194032|FG002|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
6292133|NCT00283062|7194033|FG003|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
6292134|NCT00283062|7194030|FG000|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
6292135|NCT00283062|7194031|FG001|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
6292136|NCT00283062|7194032|FG002|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
6292137|NCT00283062|7194033|FG003|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
6292138|NCT00283062|7194030|FG000|COMPLETED|Overall Study||43
6292139|NCT00283062|7194031|FG001|COMPLETED|Overall Study||48
6292140|NCT00283062|7194032|FG002|COMPLETED|Overall Study||15
6292141|NCT00283062|7194033|FG003|COMPLETED|Overall Study||13
6292142|NCT00283062|7194030|FG000|NOT COMPLETED|Overall Study||12
6292143|NCT00283062|7194031|FG001|NOT COMPLETED|Overall Study||7
6292144|NCT00283062|7194032|FG002|NOT COMPLETED|Overall Study||41
6292145|NCT00283062|7194033|FG003|NOT COMPLETED|Overall Study||49
6292146|NCT00283075|7194043|FG000|STARTED|Overall Study||25
6292147|NCT00283075|7194044|FG001|STARTED|Overall Study||6
6292148|NCT00283075|7194043|FG000|COMPLETED|Overall Study||25
6292149|NCT00283075|7194044|FG001|COMPLETED|Overall Study||6
6292150|NCT00283075|7194043|FG000|NOT COMPLETED|Overall Study||0
6292151|NCT00283075|7194044|FG001|NOT COMPLETED|Overall Study||0
6292152|NCT00283244|7194058|FG000|STARTED|Overall Study||44
6292153|NCT00283244|7194059|FG001|STARTED|Overall Study||51
6292154|NCT00283244|7194060|FG002|STARTED|Overall Study||51
6292155|NCT00283244|7194058|FG000|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
6292156|NCT00283244|7194059|FG001|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
6292157|NCT00283244|7194060|FG002|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
6292158|NCT00283244|7194058|FG000|NOT COMPLETED|Overall Study||18
6292159|NCT00283244|7194059|FG001|NOT COMPLETED|Overall Study||51
6292160|NCT00283244|7194060|FG002|NOT COMPLETED|Overall Study||51
6292161|NCT00283283|7194073|FG000|STARTED|Overall Study||274
6292162|NCT00283283|7194074|FG001|STARTED|Overall Study||284
6292163|NCT00283283|7194075|FG002|STARTED|Overall Study||280
6292164|NCT00283283|7194076|FG003|STARTED|Overall Study||276
6292165|NCT00283283|7194073|FG000|COMPLETED|Overall Study||274
6292166|NCT00283283|7194074|FG001|COMPLETED|Overall Study||284
6292167|NCT00283283|7194075|FG002|COMPLETED|Overall Study||280
6292168|NCT00283283|7194076|FG003|COMPLETED|Overall Study||276
6292169|NCT00283283|7194073|FG000|NOT COMPLETED|Overall Study||0
6292170|NCT00283283|7194074|FG001|NOT COMPLETED|Overall Study||0
6292171|NCT00283283|7194075|FG002|NOT COMPLETED|Overall Study||0
6292172|NCT00283283|7194076|FG003|NOT COMPLETED|Overall Study||0
6292173|NCT00283296|7194091|FG000|STARTED|Overall Study||14
6292174|NCT00283296|7194091|FG000|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
6292175|NCT00283296|7194091|FG000|NOT COMPLETED|Overall Study||5
6292176|NCT00283387|7194096|FG000|STARTED|First Intervention||6
6292177|NCT00283387|7194097|FG001|STARTED|First Intervention||7
6292178|NCT00283387|7194096|FG000|COMPLETED|First Intervention||5
6292179|NCT00283387|7194097|FG001|COMPLETED|First Intervention||5
6292180|NCT00283387|7194096|FG000|NOT COMPLETED|First Intervention||1
6292181|NCT00283387|7194097|FG001|NOT COMPLETED|First Intervention||2
6292182|NCT00283387|7194096|FG000|STARTED|Washout Period of 2 Months||5
6292183|NCT00283387|7194097|FG001|STARTED|Washout Period of 2 Months||5
6292184|NCT00283387|7194096|FG000|COMPLETED|Washout Period of 2 Months||5
6292185|NCT00283387|7194097|FG001|COMPLETED|Washout Period of 2 Months||5
6292186|NCT00283387|7194096|FG000|NOT COMPLETED|Washout Period of 2 Months||0
6292187|NCT00283387|7194097|FG001|NOT COMPLETED|Washout Period of 2 Months||0
6292188|NCT00283387|7194096|FG000|STARTED|Second Intervention||5
6292189|NCT00283387|7194097|FG001|STARTED|Second Intervention||5
6292190|NCT00283387|7194096|FG000|COMPLETED|Second Intervention||5
6292191|NCT00283387|7194097|FG001|COMPLETED|Second Intervention||5
6292192|NCT00283387|7194096|FG000|NOT COMPLETED|Second Intervention||0
6292193|NCT00283387|7194097|FG001|NOT COMPLETED|Second Intervention||0
6292194|NCT00283400|7194107|FG000|STARTED|Overall Study||20
6292195|NCT00283400|7194108|FG001|STARTED|Overall Study||20
6292196|NCT00283400|7194109|FG002|STARTED|Overall Study||7
6292197|NCT00283400|7194110|FG003|STARTED|Overall Study||0
6400166|NCT00885092|7313032|FG000|NOT COMPLETED|Period 1, 7 Days||0
6634798|NCT02299791|7563657|FG001|STARTED|Overall Study||2803
6634799|NCT02299791|7563656|FG000|COMPLETED|Overall Study||2053
6292198|NCT00283400|7194107|FG000|COMPLETED|Overall Study||18
6292199|NCT00283400|7194108|FG001|COMPLETED|Overall Study||19
6292200|NCT00283400|7194109|FG002|COMPLETED|Overall Study||6
6292201|NCT00283400|7194110|FG003|COMPLETED|Overall Study||0
6292202|NCT00283400|7194107|FG000|NOT COMPLETED|Overall Study||2
6292203|NCT00283400|7194108|FG001|NOT COMPLETED|Overall Study||1
6292204|NCT00283400|7194109|FG002|NOT COMPLETED|Overall Study||1
6400167|NCT00885092|7313033|FG001|NOT COMPLETED|Period 1, 7 Days||0
6400168|NCT00885092|7313032|FG000|STARTED|Period 2, 7 Days||20
6400169|NCT00885092|7313033|FG001|STARTED|Period 2, 7 Days||20
6292205|NCT00283400|7194110|FG003|NOT COMPLETED|Overall Study||0
6292206|NCT00283439|7194124|FG000|STARTED|Overall Study||8
6292207|NCT00283439|7194125|FG001|STARTED|Overall Study||11
6292208|NCT00283439|7194126|FG002|STARTED|Overall Study||11
6292209|NCT00283439|7194127|FG003|STARTED|Overall Study||9
6292210|NCT00283439|7194124|FG000|COMPLETED|Overall Study||0
6292211|NCT00283439|7194125|FG001|COMPLETED|Overall Study||0
6292212|NCT00283439|7194126|FG002|COMPLETED|Overall Study||0
6292213|NCT00283439|7194127|FG003|COMPLETED|Overall Study||0
6292214|NCT00283439|7194124|FG000|NOT COMPLETED|Overall Study||8
6292215|NCT00283439|7194125|FG001|NOT COMPLETED|Overall Study||11
6292216|NCT00283439|7194126|FG002|NOT COMPLETED|Overall Study||11
6292217|NCT00283439|7194127|FG003|NOT COMPLETED|Overall Study||9
6292218|NCT00283504|7194139|FG000|STARTED|Overall Study||7
6292219|NCT00283504|7194140|FG001|STARTED|Overall Study||6
6292220|NCT00283504|7194139|FG000|COMPLETED|Overall Study||7
6292221|NCT00283504|7194140|FG001|COMPLETED|Overall Study||6
6292222|NCT00283504|7194139|FG000|NOT COMPLETED|Overall Study||0
6292223|NCT00283504|7194140|FG001|NOT COMPLETED|Overall Study||0
6292224|NCT00283595|7194150|FG000|STARTED|Overall Study||10
6292225|NCT00283595|7194151|FG001|STARTED|Overall Study||11
6292226|NCT00283595|7194150|FG000|COMPLETED|Overall Study||9
6292227|NCT00283595|7194151|FG001|COMPLETED|Overall Study||9
6292228|NCT00283595|7194150|FG000|NOT COMPLETED|Overall Study||1
6292229|NCT00283595|7194151|FG001|NOT COMPLETED|Overall Study||2
6292230|NCT00283686|7194161|FG000|STARTED|Overall Study||140
6292231|NCT00283686|7194162|FG001|STARTED|Overall Study||133
6292232|NCT00283686|7194163|FG002|STARTED|Overall Study||144
6292233|NCT00283686|7194164|FG003|STARTED|Overall Study||141
6292234|NCT00283686|7194161|FG000|COMPLETED|Overall Study||111
6292235|NCT00283686|7194162|FG001|COMPLETED|Overall Study||92
6292236|NCT00283686|7194163|FG002|COMPLETED|Overall Study||111
6292237|NCT00283686|7194164|FG003|COMPLETED|Overall Study||109
6292238|NCT00283686|7194161|FG000|NOT COMPLETED|Overall Study||29
6292239|NCT00283686|7194162|FG001|NOT COMPLETED|Overall Study||41
6292240|NCT00283686|7194163|FG002|NOT COMPLETED|Overall Study||33
6292241|NCT00283686|7194164|FG003|NOT COMPLETED|Overall Study||32
6292242|NCT00283712|7194176|FG000|STARTED|Overall Study||10
6292243|NCT00283712|7194177|FG001|STARTED|Overall Study||10
6292244|NCT00283712|7194176|FG000|Intent-to-treat Sample|Overall Study||10
6292245|NCT00283712|7194177|FG001|Intent-to-treat Sample|Overall Study||10
6292246|NCT00283712|7194176|FG000|Safety Sample|Overall Study||10
6292247|NCT00283712|7194177|FG001|Safety Sample|Overall Study||10
6292248|NCT00283712|7194176|FG000|Per-Protocol Sample|Overall Study||6
6292249|NCT00283712|7194177|FG001|Per-Protocol Sample|Overall Study||7
6292250|NCT00283712|7194176|FG000|COMPLETED|Overall Study||10
6292251|NCT00283712|7194177|FG001|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
6292252|NCT00283712|7194176|FG000|NOT COMPLETED|Overall Study||0
6292253|NCT00283712|7194177|FG001|NOT COMPLETED|Overall Study||1
6292254|NCT00283803|7194183|FG000|STARTED|Overall Study||32
6634800|NCT02299791|7563657|FG001|COMPLETED|Overall Study||2803
6634801|NCT02299791|7563656|FG000|NOT COMPLETED|Overall Study||0
6634802|NCT02299791|7563657|FG001|NOT COMPLETED|Overall Study||0
6634803|NCT02299869|7563667|FG000|STARTED|Overall Study||10
6634804|NCT02299869|7563668|FG001|STARTED|Overall Study||10
6634805|NCT02299869|7563669|FG002|STARTED|Overall Study||10
6634806|NCT02299869|7563670|FG003|STARTED|Overall Study||10
6634807|NCT02299869|7563667|FG000|COMPLETED|Overall Study||10
6634808|NCT02299869|7563668|FG001|COMPLETED|Overall Study||10
6634809|NCT02299869|7563669|FG002|COMPLETED|Overall Study||10
6634810|NCT02299869|7563670|FG003|COMPLETED|Overall Study||10
6634811|NCT02299869|7563667|FG000|NOT COMPLETED|Overall Study||0
6634812|NCT02299869|7563668|FG001|NOT COMPLETED|Overall Study||0
6634813|NCT02299869|7563669|FG002|NOT COMPLETED|Overall Study||0
6634814|NCT02299869|7563670|FG003|NOT COMPLETED|Overall Study||0
6634815|NCT02300025|7563681|FG000|STARTED|Overall Study||10
6292255|NCT00283803|7194183|FG000|COMPLETED|Overall Study||19
6292256|NCT00283803|7194183|FG000|NOT COMPLETED|Overall Study||13
6292257|NCT00283816|7194189|FG000|STARTED|Overall Study||18
6292258|NCT00283816|7194190|FG001|STARTED|Overall Study||18
6292259|NCT00283816|7194189|FG000|COMPLETED|Overall Study||16
6292260|NCT00283816|7194190|FG001|COMPLETED|Overall Study||16
6292261|NCT00283816|7194189|FG000|NOT COMPLETED|Overall Study||2
6292262|NCT00283816|7194190|FG001|NOT COMPLETED|Overall Study||2
6292263|NCT00283842|7194203|FG000|STARTED|Overall Study||63
6292264|NCT00283842|7194204|FG001|STARTED|Overall Study||87
6400170|NCT00885092|7313032|FG000|COMPLETED|Period 2, 7 Days||20
6634816|NCT02300025|7563682|FG001|STARTED|Overall Study||6
6634817|NCT02300025|7563683|FG002|STARTED|Overall Study||6
6634818|NCT02300025|7563684|FG003|STARTED|Overall Study||6
6634819|NCT02300025|7563681|FG000|COMPLETED|Overall Study||10
6634820|NCT02300025|7563682|FG001|COMPLETED|Overall Study||6
6634821|NCT02300025|7563683|FG002|COMPLETED|Overall Study||6
6634822|NCT02300025|7563684|FG003|COMPLETED|Overall Study||6
6634823|NCT02300025|7563681|FG000|NOT COMPLETED|Overall Study||0
6634824|NCT02300025|7563682|FG001|NOT COMPLETED|Overall Study||0
6634825|NCT02300025|7563683|FG002|NOT COMPLETED|Overall Study||0
6634826|NCT02300025|7563684|FG003|NOT COMPLETED|Overall Study||0
6634827|NCT02300077|7563698|FG000|STARTED|Overall Study||21
6634828|NCT02300077|7563699|FG001|STARTED|Overall Study||18
6634829|NCT02300077|7563700|FG002|STARTED|Overall Study||21
6634830|NCT02300077|7563698|FG000|COMPLETED|Overall Study||21
6634831|NCT02300077|7563699|FG001|COMPLETED|Overall Study||18
6634832|NCT02300077|7563700|FG002|COMPLETED|Overall Study||21
6292265|NCT00283842|7194205|FG002|STARTED|Overall Study||99
6292266|NCT00283842|7194206|FG003|STARTED|Overall Study||69
6292267|NCT00283842|7194207|FG004|STARTED|Overall Study||90
6292268|NCT00283842|7194203|FG000|COMPLETED|Overall Study||51
6292269|NCT00283842|7194204|FG001|COMPLETED|Overall Study||69
6292270|NCT00283842|7194205|FG002|COMPLETED|Overall Study||68
6292271|NCT00283842|7194206|FG003|COMPLETED|Overall Study||42
6292272|NCT00283842|7194207|FG004|COMPLETED|Overall Study||75
6292273|NCT00283842|7194203|FG000|NOT COMPLETED|Overall Study||12
6292274|NCT00283842|7194204|FG001|NOT COMPLETED|Overall Study||18
6292275|NCT00283842|7194205|FG002|NOT COMPLETED|Overall Study||31
6292276|NCT00283842|7194206|FG003|NOT COMPLETED|Overall Study||27
6292277|NCT00283842|7194207|FG004|NOT COMPLETED|Overall Study||15
6292278|NCT00283933|7194219|FG000|STARTED|Treatment Period||5
6292279|NCT00283933|7194219|FG000|Safety Population|Treatment Period||5
6292280|NCT00283933|7194219|FG000|Pharmacodynamic (PD) Population|Treatment Period||5
6292281|NCT00283933|7194219|FG000|COMPLETED|Treatment Period||5
6292282|NCT00283933|7194219|FG000|NOT COMPLETED|Treatment Period||0
6292283|NCT00283933|7194219|FG000|STARTED|Extension Period||5
6292284|NCT00283933|7194219|FG000|COMPLETED|Extension Period||5
6292285|NCT00283933|7194219|FG000|NOT COMPLETED|Extension Period||0
6292286|NCT00284050|7194226|FG000|STARTED|Overall Study||51
6292287|NCT00284050|7194227|FG001|STARTED|Overall Study||51
6292288|NCT00284050|7194228|FG002|STARTED|Overall Study||49
6292289|NCT00284050|7194226|FG000|COMPLETED|Overall Study||46
6292290|NCT00284050|7194227|FG001|COMPLETED|Overall Study||46
6292291|NCT00284050|7194228|FG002|COMPLETED|Overall Study||40
6292292|NCT00284050|7194226|FG000|NOT COMPLETED|Overall Study||5
6292293|NCT00284050|7194227|FG001|NOT COMPLETED|Overall Study||5
6292294|NCT00284050|7194228|FG002|NOT COMPLETED|Overall Study||9
6292295|NCT00284089|7194240|FG000|STARTED|Single Dose Phase||6
6292296|NCT00284089|7194241|FG001|STARTED|Single Dose Phase||6
6292297|NCT00284089|7194242|FG002|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
6292298|NCT00284089|7194243|FG003|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
6292299|NCT00284089|7194240|FG000|COMPLETED|Single Dose Phase||6
6292300|NCT00284089|7194241|FG001|COMPLETED|Single Dose Phase||6
6292301|NCT00284089|7194242|FG002|COMPLETED|Single Dose Phase||0
6292302|NCT00284089|7194243|FG003|COMPLETED|Single Dose Phase||0
6292303|NCT00284089|7194240|FG000|NOT COMPLETED|Single Dose Phase||0
6292304|NCT00284089|7194241|FG001|NOT COMPLETED|Single Dose Phase||0
6292305|NCT00284089|7194242|FG002|NOT COMPLETED|Single Dose Phase||0
6292306|NCT00284089|7194243|FG003|NOT COMPLETED|Single Dose Phase||0
6292307|NCT00284089|7194240|FG000|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
6292308|NCT00284089|7194241|FG001|STARTED|Multiple Dose Phase||6
6292309|NCT00284089|7194242|FG002|STARTED|Multiple Dose Phase||35
6292310|NCT00284089|7194243|FG003|STARTED|Multiple Dose Phase||41
6292311|NCT00284089|7194240|FG000|COMPLETED|Multiple Dose Phase||4
6292312|NCT00284089|7194241|FG001|COMPLETED|Multiple Dose Phase||6
6292313|NCT00284089|7194242|FG002|COMPLETED|Multiple Dose Phase||31
6292314|NCT00284089|7194243|FG003|COMPLETED|Multiple Dose Phase||37
6292315|NCT00284089|7194240|FG000|NOT COMPLETED|Multiple Dose Phase||1
6292316|NCT00284089|7194241|FG001|NOT COMPLETED|Multiple Dose Phase||0
6292317|NCT00284089|7194242|FG002|NOT COMPLETED|Multiple Dose Phase||4
6292318|NCT00284089|7194243|FG003|NOT COMPLETED|Multiple Dose Phase||4
6292319|NCT00284089|7194240|FG000|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
6292320|NCT00284089|7194241|FG001|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
6292321|NCT00284089|7194242|FG002|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
6292322|NCT00284089|7194243|FG003|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
6292323|NCT00284089|7194240|FG000|COMPLETED|Extension Phase||1
6292324|NCT00284089|7194241|FG001|COMPLETED|Extension Phase||6
6292325|NCT00284089|7194242|FG002|COMPLETED|Extension Phase||22
6292326|NCT00284089|7194243|FG003|COMPLETED|Extension Phase||21
6292327|NCT00284089|7194240|FG000|NOT COMPLETED|Extension Phase||2
6292328|NCT00284089|7194241|FG001|NOT COMPLETED|Extension Phase||0
6292329|NCT00284089|7194242|FG002|NOT COMPLETED|Extension Phase||6
6292330|NCT00284089|7194243|FG003|NOT COMPLETED|Extension Phase||12
6292331|NCT00284141|7194253|FG000|STARTED|Overall Study||98
6634833|NCT02300077|7563698|FG000|NOT COMPLETED|Overall Study||0
6634834|NCT02300077|7563699|FG001|NOT COMPLETED|Overall Study||0
6634835|NCT02300077|7563700|FG002|NOT COMPLETED|Overall Study||0
6634836|NCT02300103|7563708|FG000|STARTED|Overall Study||69
6634837|NCT02300103|7563708|FG000|COMPLETED|Overall Study||63
6292332|NCT00284141|7194253|FG000|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
6292333|NCT00284141|7194253|FG000|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
6292334|NCT00284141|7194253|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
6292335|NCT00284141|7194253|FG000|NOT COMPLETED|Overall Study||98
6292336|NCT00284154|7194259|FG000|STARTED|Overall Study||51
6292337|NCT00284154|7194259|FG000|COMPLETED|Overall Study||9
6292338|NCT00284154|7194259|FG000|NOT COMPLETED|Overall Study||42
6292339|NCT00284180|7194265|FG000|STARTED|Overall Study||11
6292340|NCT00284180|7194266|FG001|STARTED|Overall Study||21
6400171|NCT00885092|7313033|FG001|COMPLETED|Period 2, 7 Days||20
6400172|NCT00885092|7313032|FG000|NOT COMPLETED|Period 2, 7 Days||0
6400173|NCT00885092|7313033|FG001|NOT COMPLETED|Period 2, 7 Days||0
6400174|NCT00885105|7313041|FG000|STARTED|Overall Study||112
6400175|NCT00885105|7313042|FG001|STARTED|Overall Study||130
6400176|NCT00885105|7313041|FG000|COMPLETED|Overall Study||111
6400177|NCT00885105|7313042|FG001|COMPLETED|Overall Study||120
6400178|NCT00885105|7313041|FG000|NOT COMPLETED|Overall Study||1
6400179|NCT00885105|7313042|FG001|NOT COMPLETED|Overall Study||10
6400180|NCT00885118|7313053|FG000|STARTED|Overall Study||21
6400181|NCT00885118|7313054|FG001|STARTED|Overall Study||19
6400182|NCT00885118|7313055|FG002|STARTED|Overall Study||21
6400183|NCT00885118|7313056|FG003|STARTED|Overall Study||20
6400184|NCT00885118|7313057|FG004|STARTED|Overall Study||19
6400185|NCT00885118|7313053|FG000|COMPLETED|Overall Study||20
6400186|NCT00885118|7313054|FG001|COMPLETED|Overall Study||19
6400187|NCT00885118|7313055|FG002|COMPLETED|Overall Study||20
6400188|NCT00885118|7313056|FG003|COMPLETED|Overall Study||20
6400189|NCT00885118|7313057|FG004|COMPLETED|Overall Study||18
6400190|NCT00885118|7313053|FG000|NOT COMPLETED|Overall Study||1
6400191|NCT00885118|7313054|FG001|NOT COMPLETED|Overall Study||0
6400192|NCT00885118|7313055|FG002|NOT COMPLETED|Overall Study||1
6400193|NCT00885118|7313056|FG003|NOT COMPLETED|Overall Study||0
6400194|NCT00885118|7313057|FG004|NOT COMPLETED|Overall Study||1
6400195|NCT00885170|7313075|FG000|STARTED|Overall Study||124
6400196|NCT00885170|7313076|FG001|STARTED|Overall Study||122
6400197|NCT00885170|7313075|FG000|Treated|Overall Study||122
6400198|NCT00885170|7313076|FG001|Treated|Overall Study||121
6400199|NCT00885170|7313075|FG000|COMPLETED|Overall Study||86
6400200|NCT00885170|7313076|FG001|COMPLETED|Overall Study||99
6400201|NCT00885170|7313075|FG000|NOT COMPLETED|Overall Study||38
6400202|NCT00885170|7313076|FG001|NOT COMPLETED|Overall Study||23
6400203|NCT00885352|7313084|FG000|STARTED|Overall Study||157
6400204|NCT00885352|7313085|FG001|STARTED|Overall Study||156
6400205|NCT00885352|7313084|FG000|COMPLETED|Overall Study||149
6400206|NCT00885352|7313085|FG001|COMPLETED|Overall Study||136
6400207|NCT00885352|7313084|FG000|NOT COMPLETED|Overall Study||8
6400208|NCT00885352|7313085|FG001|NOT COMPLETED|Overall Study||20
6400209|NCT00885365|7313093|FG000|STARTED|4 Weeks ON Treatment||159
6400210|NCT00885365|7313094|FG001|STARTED|4 Weeks ON Treatment||165
6400211|NCT00885365|7313093|FG000|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
6400212|NCT00885365|7313094|FG001|Intent-to-Treat Population|4 Weeks ON Treatment||163
6400213|NCT00885365|7313093|FG000|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
6400214|NCT00885365|7313094|FG001|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
6400215|NCT00885365|7313093|FG000|COMPLETED|4 Weeks ON Treatment||155
6400216|NCT00885365|7313094|FG001|COMPLETED|4 Weeks ON Treatment||159
6400217|NCT00885365|7313093|FG000|NOT COMPLETED|4 Weeks ON Treatment||4
6400218|NCT00885365|7313094|FG001|NOT COMPLETED|4 Weeks ON Treatment||6
6400219|NCT00885365|7313093|FG000|STARTED|4 Weeks OFF Treatment||155
6400220|NCT00885365|7313094|FG001|STARTED|4 Weeks OFF Treatment||159
6400221|NCT00885365|7313093|FG000|COMPLETED|4 Weeks OFF Treatment||155
6400222|NCT00885365|7313094|FG001|COMPLETED|4 Weeks OFF Treatment||159
6400223|NCT00885365|7313093|FG000|NOT COMPLETED|4 Weeks OFF Treatment||0
6400224|NCT00885365|7313094|FG001|NOT COMPLETED|4 Weeks OFF Treatment||0
6400225|NCT00885378|7313102|FG000|STARTED|Overall Study|Number randomized.|74
6400226|NCT00885378|7313103|FG001|STARTED|Overall Study|Number randomized.|86
6400227|NCT00885378|7313102|FG000|COMPLETED|Overall Study||66
6400228|NCT00885378|7313103|FG001|COMPLETED|Overall Study||78
6400229|NCT00885378|7313102|FG000|NOT COMPLETED|Overall Study||8
6400230|NCT00885378|7313103|FG001|NOT COMPLETED|Overall Study||8
6400231|NCT00885482|7313109|FG000|STARTED|Overall Study||40
6400232|NCT00885482|7313109|FG000|COMPLETED|Overall Study||36
6400233|NCT00885482|7313109|FG000|NOT COMPLETED|Overall Study||4
6400234|NCT00885534|7313113|FG000|STARTED|Overall Study||7
6400235|NCT00885534|7313113|FG000|COMPLETED|Overall Study||6
6400236|NCT00885534|7313113|FG000|NOT COMPLETED|Overall Study||1
6400237|NCT00885638|7313117|FG000|STARTED|Overall Study||6
6400238|NCT00885638|7313118|FG001|STARTED|Overall Study||6
6400239|NCT00885638|7313117|FG000|COMPLETED|Overall Study||6
6400240|NCT00885638|7313118|FG001|COMPLETED|Overall Study||6
6400241|NCT00885638|7313117|FG000|NOT COMPLETED|Overall Study||0
6400242|NCT00885638|7313118|FG001|NOT COMPLETED|Overall Study||0
6400243|NCT00885677|7313127|FG000|STARTED|Overall Study||462
6400244|NCT00885677|7313128|FG001|STARTED|Overall Study||455
6400245|NCT00885677|7313127|FG000|Intention To Treat|Overall Study||437
6400246|NCT00885677|7313128|FG001|Intention To Treat|Overall Study||428
6400247|NCT00885677|7313127|FG000|COMPLETED|Overall Study||279
6400248|NCT00885677|7313128|FG001|COMPLETED|Overall Study||277
6400249|NCT00885677|7313127|FG000|NOT COMPLETED|Overall Study||183
6400250|NCT00885677|7313128|FG001|NOT COMPLETED|Overall Study||178
6400251|NCT00885703|7313141|FG000|STARTED|Overall Study||22
6400252|NCT00885703|7313142|FG001|STARTED|Overall Study||26
6400253|NCT00885703|7313143|FG002|STARTED|Overall Study||24
6400254|NCT00885703|7313144|FG003|STARTED|Overall Study||24
6400255|NCT00885703|7313145|FG004|STARTED|Overall Study||24
6400256|NCT00885703|7313146|FG005|STARTED|Overall Study||24
6400257|NCT00885703|7313147|FG006|STARTED|Overall Study||24
6400258|NCT00885703|7313141|FG000|COMPLETED|Overall Study||12
6400259|NCT00885703|7313142|FG001|COMPLETED|Overall Study||16
6634838|NCT02300103|7563708|FG000|NOT COMPLETED|Overall Study||6
6634839|NCT02300129|7563712|FG000|STARTED|Period 1 Session 1 (Day 1)||11
6634840|NCT02300129|7563713|FG001|STARTED|Period 1 Session 1 (Day 1)||5
6634841|NCT02300129|7563714|FG002|STARTED|Period 1 Session 1 (Day 1)||7
6634842|NCT02300129|7563715|FG003|STARTED|Period 1 Session 1 (Day 1)||11
6634843|NCT02300129|7563712|FG000|COMPLETED|Period 1 Session 1 (Day 1)||11
6292341|NCT00284180|7194265|FG000|COMPLETED|Overall Study||11
6292342|NCT00284180|7194266|FG001|COMPLETED|Overall Study||17
6292343|NCT00284180|7194265|FG000|NOT COMPLETED|Overall Study||0
6292344|NCT00284180|7194266|FG001|NOT COMPLETED|Overall Study||4
6292345|NCT00284518|7194276|FG000|STARTED|Overall Study||97
6292346|NCT00284518|7194277|FG001|STARTED|Overall Study||94
6292347|NCT00284518|7194278|FG002|STARTED|Overall Study||95
6292348|NCT00284518|7194279|FG003|STARTED|Overall Study||94
6292349|NCT00284518|7194276|FG000|COMPLETED|Overall Study||71
6292350|NCT00284518|7194277|FG001|COMPLETED|Overall Study||66
6292351|NCT00284518|7194278|FG002|COMPLETED|Overall Study||67
6292352|NCT00284518|7194279|FG003|COMPLETED|Overall Study||61
6292353|NCT00284518|7194276|FG000|NOT COMPLETED|Overall Study||26
6292354|NCT00284518|7194277|FG001|NOT COMPLETED|Overall Study||28
6292355|NCT00284518|7194278|FG002|NOT COMPLETED|Overall Study||28
6292356|NCT00284518|7194279|FG003|NOT COMPLETED|Overall Study||33
6292357|NCT00284557|7194291|FG000|STARTED|Overall Study||67
6292358|NCT00284557|7194292|FG001|STARTED|Overall Study||63
6292359|NCT00284557|7194291|FG000|COMPLETED|Overall Study||58
6292360|NCT00284557|7194292|FG001|COMPLETED|Overall Study||50
6292361|NCT00284557|7194291|FG000|NOT COMPLETED|Overall Study||9
6292362|NCT00284557|7194292|FG001|NOT COMPLETED|Overall Study||13
6292363|NCT00284739|7194300|FG000|STARTED|Overall Study||11
6292364|NCT00284739|7194301|FG001|STARTED|Overall Study||9
6292365|NCT00284739|7194300|FG000|COMPLETED|Overall Study||11
6292366|NCT00284739|7194301|FG001|COMPLETED|Overall Study||9
6292367|NCT00284739|7194300|FG000|NOT COMPLETED|Overall Study||0
6292368|NCT00284739|7194301|FG001|NOT COMPLETED|Overall Study||0
6374176|NCT00749125|7284771|FG000|NOT COMPLETED|Overall Study||11
6374177|NCT00749125|7284772|FG001|NOT COMPLETED|Overall Study||18
6374178|NCT00749190|7284785|FG000|STARTED|Overall Study||71
6374179|NCT00749190|7284786|FG001|STARTED|Overall Study||71
6374180|NCT00749190|7284787|FG002|STARTED|Overall Study||71
6374181|NCT00749190|7284788|FG003|STARTED|Overall Study||71
6374182|NCT00749190|7284789|FG004|STARTED|Overall Study||70
6374183|NCT00749190|7284790|FG005|STARTED|Overall Study||70
6374184|NCT00749190|7284791|FG006|STARTED|Overall Study||71
6374185|NCT00749190|7284785|FG000|COMPLETED|Overall Study||66
6374186|NCT00749190|7284786|FG001|COMPLETED|Overall Study||66
6374187|NCT00749190|7284787|FG002|COMPLETED|Overall Study||70
6374188|NCT00749190|7284788|FG003|COMPLETED|Overall Study||66
6374189|NCT00749190|7284789|FG004|COMPLETED|Overall Study||70
6374190|NCT00749190|7284790|FG005|COMPLETED|Overall Study||65
6374191|NCT00749190|7284791|FG006|COMPLETED|Overall Study||70
6374192|NCT00749190|7284785|FG000|NOT COMPLETED|Overall Study||5
6374193|NCT00749190|7284786|FG001|NOT COMPLETED|Overall Study||5
6374194|NCT00749190|7284787|FG002|NOT COMPLETED|Overall Study||1
6374195|NCT00749190|7284788|FG003|NOT COMPLETED|Overall Study||5
6374196|NCT00749190|7284789|FG004|NOT COMPLETED|Overall Study||0
6374197|NCT00749190|7284790|FG005|NOT COMPLETED|Overall Study||5
6374198|NCT00749190|7284791|FG006|NOT COMPLETED|Overall Study||1
6374199|NCT00749203|7284814|FG000|STARTED|First Infusion Day 1||22
6374200|NCT00749203|7284815|FG001|STARTED|First Infusion Day 1||19
6374201|NCT00749203|7284814|FG000|COMPLETED|First Infusion Day 1||22
6374202|NCT00749203|7284815|FG001|COMPLETED|First Infusion Day 1||19
6374203|NCT00749203|7284814|FG000|NOT COMPLETED|First Infusion Day 1||0
6374204|NCT00749203|7284815|FG001|NOT COMPLETED|First Infusion Day 1||0
6374205|NCT00749203|7284814|FG000|STARTED|no Infusion at Week 1||22
6374206|NCT00749203|7284815|FG001|STARTED|no Infusion at Week 1||19
6374207|NCT00749203|7284814|FG000|COMPLETED|no Infusion at Week 1||22
6374208|NCT00749203|7284815|FG001|COMPLETED|no Infusion at Week 1||15
6374209|NCT00749203|7284814|FG000|NOT COMPLETED|no Infusion at Week 1||0
6374210|NCT00749203|7284815|FG001|NOT COMPLETED|no Infusion at Week 1||4
6374211|NCT00749203|7284814|FG000|STARTED|Second Infusion at 2 Weeks|N=6 completed the study at 2 wks due to CAPS scores < 50, precluding 2nd infusion.|16
6400260|NCT00885703|7313143|FG002|COMPLETED|Overall Study||13
6634844|NCT02300129|7563713|FG001|COMPLETED|Period 1 Session 1 (Day 1)||5
6374212|NCT00749203|7284815|FG001|STARTED|Second Infusion at 2 Weeks||15
6400261|NCT00885703|7313144|FG003|COMPLETED|Overall Study||15
6400262|NCT00885703|7313145|FG004|COMPLETED|Overall Study||12
6400263|NCT00885703|7313146|FG005|COMPLETED|Overall Study||11
6400264|NCT00885703|7313147|FG006|COMPLETED|Overall Study||18
6292369|NCT00284934|7194309|FG000|STARTED|Overall Study||48
6292370|NCT00284934|7194310|FG001|STARTED|Overall Study||46
6292371|NCT00284934|7194309|FG000|Intent-to-treat Population (ITT)|Overall Study||47
6292372|NCT00284934|7194310|FG001|Intent-to-treat Population (ITT)|Overall Study||45
6292373|NCT00284934|7194309|FG000|COMPLETED|Overall Study||44
6292374|NCT00284934|7194310|FG001|COMPLETED|Overall Study||43
6292375|NCT00284934|7194309|FG000|NOT COMPLETED|Overall Study||4
6292376|NCT00284934|7194310|FG001|NOT COMPLETED|Overall Study||3
6292377|NCT00285012|7194318|FG000|STARTED|Assigned to Study Treatment (Tx)||250
6292378|NCT00285012|7194319|FG001|STARTED|Assigned to Study Treatment (Tx)||254
6292379|NCT00285012|7194318|FG000|COMPLETED|Assigned to Study Treatment (Tx)||248
6292380|NCT00285012|7194319|FG001|COMPLETED|Assigned to Study Treatment (Tx)||251
6292381|NCT00285012|7194318|FG000|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
6292382|NCT00285012|7194319|FG001|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
6292383|NCT00285012|7194318|FG000|STARTED|Received Study Tx||248
6292384|NCT00285012|7194319|FG001|STARTED|Received Study Tx||251
6292385|NCT00285012|7194318|FG000|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
6292386|NCT00285012|7194319|FG001|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
6292387|NCT00285012|7194318|FG000|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
6292388|NCT00285012|7194319|FG001|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
6292389|NCT00285012|7194318|FG000|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
6292390|NCT00285012|7194319|FG001|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
6292391|NCT00285012|7194318|FG000|NOT COMPLETED|Received Study Tx||72
6292392|NCT00285012|7194319|FG001|NOT COMPLETED|Received Study Tx||94
6292393|NCT00285207|7194327|FG000|STARTED|Overall Study||70
6292394|NCT00285207|7194328|FG001|STARTED|Overall Study||77
6292395|NCT00285207|7194327|FG000|Treated|Overall Study||63
6292396|NCT00285207|7194328|FG001|Treated|Overall Study||75
6292397|NCT00285207|7194327|FG000|COMPLETED|Overall Study||61
6292398|NCT00285207|7194328|FG001|COMPLETED|Overall Study||71
6292399|NCT00285207|7194327|FG000|NOT COMPLETED|Overall Study||9
6292400|NCT00285207|7194328|FG001|NOT COMPLETED|Overall Study||6
6292401|NCT00285246|7194334|FG000|STARTED|Overall Study||838
6292402|NCT00285246|7194334|FG000|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
6292403|NCT00285246|7194334|FG000|NOT COMPLETED|Overall Study||48
6292404|NCT00285467|7194340|FG000|STARTED|Overall Study||25
6292405|NCT00285467|7194341|FG001|STARTED|Overall Study||22
6292406|NCT00285467|7194340|FG000|COMPLETED|Overall Study||25
6292407|NCT00285467|7194341|FG001|COMPLETED|Overall Study||22
6292408|NCT00285467|7194340|FG000|NOT COMPLETED|Overall Study||0
6292409|NCT00285467|7194341|FG001|NOT COMPLETED|Overall Study||0
6292410|NCT00285584|7194349|FG000|STARTED|Enrollment (Month 0)||20
6292411|NCT00285584|7194350|FG001|STARTED|Enrollment (Month 0)||21
6292412|NCT00285584|7194349|FG000|COMPLETED|Enrollment (Month 0)||20
6292413|NCT00285584|7194350|FG001|COMPLETED|Enrollment (Month 0)||21
6292414|NCT00285584|7194349|FG000|NOT COMPLETED|Enrollment (Month 0)||0
6400265|NCT00885703|7313141|FG000|NOT COMPLETED|Overall Study||10
6400266|NCT00885703|7313142|FG001|NOT COMPLETED|Overall Study||10
6400267|NCT00885703|7313143|FG002|NOT COMPLETED|Overall Study||11
6400268|NCT00885703|7313144|FG003|NOT COMPLETED|Overall Study||9
6400269|NCT00885703|7313145|FG004|NOT COMPLETED|Overall Study||12
6400270|NCT00885703|7313146|FG005|NOT COMPLETED|Overall Study||13
6292415|NCT00285584|7194350|FG001|NOT COMPLETED|Enrollment (Month 0)||0
6292416|NCT00285584|7194349|FG000|STARTED|Month 3||20
6292417|NCT00285584|7194350|FG001|STARTED|Month 3||21
6292418|NCT00285584|7194349|FG000|COMPLETED|Month 3||16
6292419|NCT00285584|7194350|FG001|COMPLETED|Month 3||18
6292420|NCT00285584|7194349|FG000|NOT COMPLETED|Month 3||4
6292421|NCT00285584|7194350|FG001|NOT COMPLETED|Month 3||3
6292422|NCT00285584|7194349|FG000|STARTED|Month 6||16
6292423|NCT00285584|7194350|FG001|STARTED|Month 6||18
6292424|NCT00285584|7194349|FG000|COMPLETED|Month 6||16
6292425|NCT00285584|7194350|FG001|COMPLETED|Month 6||17
6292426|NCT00285584|7194349|FG000|NOT COMPLETED|Month 6||0
6292427|NCT00285584|7194350|FG001|NOT COMPLETED|Month 6||1
6292428|NCT00285584|7194349|FG000|STARTED|Month 9||16
6292429|NCT00285584|7194350|FG001|STARTED|Month 9||17
6292430|NCT00285584|7194349|FG000|COMPLETED|Month 9||15
6292431|NCT00285584|7194350|FG001|COMPLETED|Month 9||14
6292432|NCT00285584|7194349|FG000|NOT COMPLETED|Month 9||1
6292433|NCT00285584|7194350|FG001|NOT COMPLETED|Month 9||3
6292434|NCT00285649|7194363|FG000|STARTED|Overall Study||72
6292435|NCT00285649|7194364|FG001|STARTED|Overall Study||72
6292436|NCT00285649|7194365|FG002|STARTED|Overall Study||48
6292437|NCT00285649|7194363|FG000|COMPLETED|Overall Study||63
6292438|NCT00285649|7194364|FG001|COMPLETED|Overall Study||66
6292439|NCT00285649|7194365|FG002|COMPLETED|Overall Study||42
6292440|NCT00285649|7194363|FG000|NOT COMPLETED|Overall Study||9
6292441|NCT00285649|7194364|FG001|NOT COMPLETED|Overall Study||6
6292442|NCT00285649|7194365|FG002|NOT COMPLETED|Overall Study||6
6400271|NCT00885703|7313147|FG006|NOT COMPLETED|Overall Study||6
6400272|NCT00885742|7313167|FG000|STARTED|Overall Study||41
6400273|NCT00885742|7313167|FG000|COMPLETED|Overall Study||41
6292443|NCT00285779|7194375|FG000|STARTED|Placebo-controlled Period (wk 1-12)||14
6292444|NCT00285779|7194376|FG001|STARTED|Placebo-controlled Period (wk 1-12)||13
6292445|NCT00285779|7194375|FG000|COMPLETED|Placebo-controlled Period (wk 1-12)||11
6292446|NCT00285779|7194376|FG001|COMPLETED|Placebo-controlled Period (wk 1-12)||12
6292447|NCT00285779|7194375|FG000|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
6292448|NCT00285779|7194376|FG001|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
6292449|NCT00285779|7194375|FG000|STARTED|Open Label Period (wk 12-24)||11
6292450|NCT00285779|7194376|FG001|STARTED|Open Label Period (wk 12-24)||12
6292451|NCT00285779|7194375|FG000|COMPLETED|Open Label Period (wk 12-24)||9
6292452|NCT00285779|7194376|FG001|COMPLETED|Open Label Period (wk 12-24)||10
6292453|NCT00285779|7194375|FG000|NOT COMPLETED|Open Label Period (wk 12-24)||2
6292454|NCT00285779|7194376|FG001|NOT COMPLETED|Open Label Period (wk 12-24)||2
6292455|NCT00285779|7194375|FG000|STARTED|Follow-up Period (wk 24-32)||9
6292456|NCT00285779|7194376|FG001|STARTED|Follow-up Period (wk 24-32)||10
6292457|NCT00285779|7194375|FG000|COMPLETED|Follow-up Period (wk 24-32)||8
6292458|NCT00285779|7194376|FG001|COMPLETED|Follow-up Period (wk 24-32)||10
6292459|NCT00285779|7194375|FG000|NOT COMPLETED|Follow-up Period (wk 24-32)||1
6292460|NCT00285779|7194376|FG001|NOT COMPLETED|Follow-up Period (wk 24-32)||0
6292461|NCT00285818|7194384|FG000|STARTED|Overall Study||6
6292462|NCT00285818|7194385|FG001|STARTED|Overall Study||5
6292463|NCT00285818|7194384|FG000|COMPLETED|Overall Study||2
6292464|NCT00285818|7194385|FG001|COMPLETED|Overall Study||3
6292465|NCT00285818|7194384|FG000|NOT COMPLETED|Overall Study||4
6292466|NCT00285818|7194385|FG001|NOT COMPLETED|Overall Study||2
6292467|NCT00285857|7194391|FG000|STARTED|Overall Study||30
6292468|NCT00285857|7194391|FG000|COMPLETED|Overall Study||26
6292469|NCT00285857|7194391|FG000|NOT COMPLETED|Overall Study||4
6292470|NCT00286078|7194402|FG000|STARTED|Overall Study||72
6292471|NCT00286078|7194403|FG001|STARTED|Overall Study||68
6292472|NCT00286078|7194402|FG000|12 Weeks|Overall Study||63
6292473|NCT00286078|7194403|FG001|12 Weeks|Overall Study||62
6292474|NCT00286078|7194402|FG000|COMPLETED|Overall Study||40
6292475|NCT00286078|7194403|FG001|COMPLETED|Overall Study||34
6292476|NCT00286078|7194402|FG000|NOT COMPLETED|Overall Study||32
6292477|NCT00286078|7194403|FG001|NOT COMPLETED|Overall Study||34
6292478|NCT00286091|7194411|FG000|STARTED|Double-blind Treatment Phase||716
6292479|NCT00286091|7194412|FG001|STARTED|Double-blind Treatment Phase||716
6292480|NCT00286091|7194411|FG000|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
6292481|NCT00286091|7194412|FG001|Received Treatment|Double-blind Treatment Phase||716
6292482|NCT00286091|7194411|FG000|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
6292483|NCT00286091|7194412|FG001|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
6292484|NCT00286091|7194411|FG000|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
6292485|NCT00286091|7194412|FG001|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
6292486|NCT00286091|7194411|FG000|NOT COMPLETED|Double-blind Treatment Phase||584
6292487|NCT00286091|7194412|FG001|NOT COMPLETED|Double-blind Treatment Phase||593
6292488|NCT00286091|7194411|FG000|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
6292489|NCT00286091|7194412|FG001|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
6292490|NCT00286091|7194411|FG000|Received Treatment|Open-label Treatment Phase||109
6292491|NCT00286091|7194412|FG001|Received Treatment|Open-label Treatment Phase||101
6292492|NCT00286091|7194411|FG000|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
6292493|NCT00286091|7194412|FG001|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
6292494|NCT00286091|7194411|FG000|NOT COMPLETED|Open-label Treatment Phase||77
6292495|NCT00286091|7194412|FG001|NOT COMPLETED|Open-label Treatment Phase||71
6292496|NCT00286156|7194423|FG000|STARTED|Overall Study||10
6292497|NCT00286156|7194424|FG001|STARTED|Overall Study||10
6292498|NCT00286156|7194425|FG002|STARTED|Overall Study||10
6292499|NCT00286156|7194423|FG000|COMPLETED|Overall Study||8
6292500|NCT00286156|7194424|FG001|COMPLETED|Overall Study||9
6292501|NCT00286156|7194425|FG002|COMPLETED|Overall Study||9
6292502|NCT00286156|7194423|FG000|NOT COMPLETED|Overall Study||2
6292503|NCT00286156|7194424|FG001|NOT COMPLETED|Overall Study||1
6292504|NCT00286156|7194425|FG002|NOT COMPLETED|Overall Study||1
6292505|NCT00286182|7194435|FG000|STARTED|Overall Study||28
6292506|NCT00286182|7194436|FG001|STARTED|Overall Study||28
6292507|NCT00286182|7194435|FG000|COMPLETED|Overall Study||23
6292508|NCT00286182|7194436|FG001|COMPLETED|Overall Study||25
6292509|NCT00286182|7194435|FG000|NOT COMPLETED|Overall Study||5
6292510|NCT00286182|7194436|FG001|NOT COMPLETED|Overall Study||3
6292511|NCT00286221|7194446|FG000|STARTED|Overall Study||39
6292512|NCT00286221|7194447|FG001|STARTED|Overall Study||40
6292513|NCT00286221|7194448|FG002|STARTED|Overall Study||40
6292514|NCT00286221|7194449|FG003|STARTED|Overall Study||40
6292515|NCT00286221|7194446|FG000|COMPLETED|Overall Study||29
6292516|NCT00286221|7194447|FG001|COMPLETED|Overall Study||35
6292517|NCT00286221|7194448|FG002|COMPLETED|Overall Study||31
6292518|NCT00286221|7194449|FG003|COMPLETED|Overall Study||34
6292519|NCT00286221|7194446|FG000|NOT COMPLETED|Overall Study||10
6292520|NCT00286221|7194447|FG001|NOT COMPLETED|Overall Study||5
6292521|NCT00286221|7194448|FG002|NOT COMPLETED|Overall Study||9
6292522|NCT00286221|7194449|FG003|NOT COMPLETED|Overall Study||6
6292523|NCT00286234|7194463|FG000|STARTED|Overall Study||17
6292524|NCT00286234|7194464|FG001|STARTED|Overall Study||17
6292525|NCT00286234|7194465|FG002|STARTED|Overall Study||17
6292526|NCT00286234|7194466|FG003|STARTED|Overall Study||17
6292527|NCT00286234|7194463|FG000|COMPLETED|Overall Study||15
6292528|NCT00286234|7194464|FG001|COMPLETED|Overall Study||15
6292529|NCT00286234|7194465|FG002|COMPLETED|Overall Study||17
6292530|NCT00286234|7194466|FG003|COMPLETED|Overall Study||13
6292531|NCT00286234|7194463|FG000|NOT COMPLETED|Overall Study||2
6292532|NCT00286234|7194464|FG001|NOT COMPLETED|Overall Study||2
6292533|NCT00286234|7194465|FG002|NOT COMPLETED|Overall Study||0
6292534|NCT00286234|7194466|FG003|NOT COMPLETED|Overall Study||4
6292535|NCT00286325|7194476|FG000|STARTED|Overall Study||8
6292536|NCT00286325|7194476|FG000|COMPLETED|Overall Study||8
6292537|NCT00286325|7194476|FG000|NOT COMPLETED|Overall Study||0
6400274|NCT00885742|7313167|FG000|NOT COMPLETED|Overall Study||0
6400275|NCT00885755|7313174|FG000|STARTED|Part I: Trastuzumab+Taxane||31
6400276|NCT00885755|7313175|FG001|STARTED|Part I: Trastuzumab+Taxane||1
6292538|NCT00286429|7194483|FG000|STARTED|Overall Study||130
6292539|NCT00286429|7194484|FG001|STARTED|Overall Study||131
6292540|NCT00286429|7194485|FG002|STARTED|Overall Study||129
6292541|NCT00286429|7194483|FG000|COMPLETED|Overall Study||55
6292542|NCT00286429|7194484|FG001|COMPLETED|Overall Study||83
6292543|NCT00286429|7194485|FG002|COMPLETED|Overall Study||77
6292544|NCT00286429|7194483|FG000|NOT COMPLETED|Overall Study||75
6292545|NCT00286429|7194484|FG001|NOT COMPLETED|Overall Study||48
6292546|NCT00286429|7194485|FG002|NOT COMPLETED|Overall Study||52
6292547|NCT00286442|7194496|FG000|STARTED|Overall Study||213
6292548|NCT00286442|7194497|FG001|STARTED|Overall Study||210
6292549|NCT00286442|7194498|FG002|STARTED|Overall Study||104
6292550|NCT00286442|7194496|FG000|COMPLETED|Overall Study||176
6292551|NCT00286442|7194497|FG001|COMPLETED|Overall Study||165
6292552|NCT00286442|7194498|FG002|COMPLETED|Overall Study||72
6292553|NCT00286442|7194496|FG000|NOT COMPLETED|Overall Study||37
6292554|NCT00286442|7194497|FG001|NOT COMPLETED|Overall Study||45
6292555|NCT00286442|7194498|FG002|NOT COMPLETED|Overall Study||32
6292556|NCT00286455|7194509|FG000|STARTED|Overall Study||65
6292557|NCT00286455|7194510|FG001|STARTED|Overall Study||133
6292558|NCT00286455|7194511|FG002|STARTED|Overall Study||131
6292559|NCT00286455|7194509|FG000|COMPLETED|Overall Study||40
6292560|NCT00286455|7194510|FG001|COMPLETED|Overall Study||105
6292561|NCT00286455|7194511|FG002|COMPLETED|Overall Study||107
6292562|NCT00286455|7194509|FG000|NOT COMPLETED|Overall Study||25
6292563|NCT00286455|7194510|FG001|NOT COMPLETED|Overall Study||28
6292564|NCT00286455|7194511|FG002|NOT COMPLETED|Overall Study||24
6292565|NCT00286468|7194522|FG000|STARTED|Overall Study||99
6292566|NCT00286468|7194523|FG001|STARTED|Overall Study||203
6292567|NCT00286468|7194524|FG002|STARTED|Overall Study||198
6292568|NCT00286468|7194522|FG000|COMPLETED|Overall Study||62
6292569|NCT00286468|7194523|FG001|COMPLETED|Overall Study||153
6292570|NCT00286468|7194524|FG002|COMPLETED|Overall Study||148
6292571|NCT00286468|7194522|FG000|NOT COMPLETED|Overall Study||37
6292572|NCT00286468|7194523|FG001|NOT COMPLETED|Overall Study||50
6292573|NCT00286468|7194524|FG002|NOT COMPLETED|Overall Study||50
6292574|NCT00286494|7194535|FG000|STARTED|Overall Study||97
6292575|NCT00286494|7194536|FG001|STARTED|Overall Study||197
6292576|NCT00286494|7194537|FG002|STARTED|Overall Study||199
6292577|NCT00286494|7194535|FG000|COMPLETED|Overall Study||71
6292578|NCT00286494|7194536|FG001|COMPLETED|Overall Study||153
6292579|NCT00286494|7194537|FG002|COMPLETED|Overall Study||160
6292580|NCT00286494|7194535|FG000|NOT COMPLETED|Overall Study||26
6292581|NCT00286494|7194536|FG001|NOT COMPLETED|Overall Study||44
6292582|NCT00286494|7194537|FG002|NOT COMPLETED|Overall Study||39
6292583|NCT00286728|7194547|FG000|STARTED|Overall Study||142
6292584|NCT00286728|7194548|FG001|STARTED|Overall Study||145
6292585|NCT00286728|7194547|FG000|COMPLETED|Overall Study||106
6292586|NCT00286728|7194548|FG001|COMPLETED|Overall Study||116
6292587|NCT00286728|7194547|FG000|NOT COMPLETED|Overall Study||36
6292588|NCT00286728|7194548|FG001|NOT COMPLETED|Overall Study||29
6292589|NCT00286741|7194556|FG000|STARTED|Overall Study||133
6292590|NCT00286741|7194557|FG001|STARTED|Overall Study||106
6292591|NCT00286741|7194556|FG000|COMPLETED|Overall Study||122
6400277|NCT00885755|7313176|FG002|STARTED|Part I: Trastuzumab+Taxane||1
6400278|NCT00885755|7313174|FG000|COMPLETED|Part I: Trastuzumab+Taxane||13
6400279|NCT00885755|7313175|FG001|COMPLETED|Part I: Trastuzumab+Taxane||1
6400280|NCT00885755|7313176|FG002|COMPLETED|Part I: Trastuzumab+Taxane||0
6400281|NCT00885755|7313174|FG000|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
6400282|NCT00885755|7313175|FG001|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
6400283|NCT00885755|7313176|FG002|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
6400284|NCT00885755|7313174|FG000|STARTED|Part II: Trastuzumab + Capecitabine.||13
6400285|NCT00885755|7313175|FG001|STARTED|Part II: Trastuzumab + Capecitabine.||1
6400286|NCT00885755|7313176|FG002|STARTED|Part II: Trastuzumab + Capecitabine.||0
6292592|NCT00286741|7194557|FG001|COMPLETED|Overall Study||89
6292593|NCT00286741|7194556|FG000|NOT COMPLETED|Overall Study||11
6292594|NCT00286741|7194557|FG001|NOT COMPLETED|Overall Study||17
6292595|NCT00286754|7194569|FG000|STARTED|Overall Study||176
6292596|NCT00286754|7194570|FG001|STARTED|Overall Study||177
6292597|NCT00286754|7194571|FG002|STARTED|Overall Study||180
6292598|NCT00286754|7194569|FG000|COMPLETED|Overall Study||156
6292599|NCT00286754|7194570|FG001|COMPLETED|Overall Study||159
6292600|NCT00286754|7194571|FG002|COMPLETED|Overall Study||170
6292601|NCT00286754|7194569|FG000|NOT COMPLETED|Overall Study||20
6292602|NCT00286754|7194570|FG001|NOT COMPLETED|Overall Study||18
6292603|NCT00286754|7194571|FG002|NOT COMPLETED|Overall Study||10
6292604|NCT00286949|7194585|FG000|STARTED|Overall Study||12
6292605|NCT00286949|7194585|FG000|COMPLETED|Overall Study||12
6292606|NCT00286949|7194585|FG000|NOT COMPLETED|Overall Study||0
6292607|NCT00287053|7194593|FG000|STARTED|Overall Study||30
6292608|NCT00287053|7194594|FG001|STARTED|Overall Study||27
6292609|NCT00287053|7194593|FG000|COMPLETED|Overall Study||26
6292610|NCT00287053|7194594|FG001|COMPLETED|Overall Study||26
6292611|NCT00287053|7194593|FG000|NOT COMPLETED|Overall Study||4
6292612|NCT00287053|7194594|FG001|NOT COMPLETED|Overall Study||1
6292613|NCT00287079|7194602|FG000|STARTED|Overall Study||32
6292614|NCT00287079|7194603|FG001|STARTED|Overall Study||3
6292615|NCT00287079|7194602|FG000|COMPLETED|Overall Study||10
6292616|NCT00287079|7194603|FG001|COMPLETED|Overall Study||2
6292617|NCT00287079|7194602|FG000|NOT COMPLETED|Overall Study||22
6292618|NCT00287079|7194603|FG001|NOT COMPLETED|Overall Study||1
6292619|NCT00287118|7194609|FG000|STARTED|Overall Study||189
6292620|NCT00287118|7194609|FG000|COMPLETED|Overall Study||137
6292621|NCT00287118|7194609|FG000|NOT COMPLETED|Overall Study||52
6292622|NCT00287222|7194613|FG000|STARTED|Overall Study||21
6292623|NCT00287222|7194613|FG000|COMPLETED|Overall Study||21
6292624|NCT00287222|7194613|FG000|NOT COMPLETED|Overall Study||0
6292625|NCT00287287|7194617|FG000|STARTED|Overall Study||25
6292626|NCT00287287|7194617|FG000|COMPLETED|Overall Study||25
6292627|NCT00287287|7194617|FG000|NOT COMPLETED|Overall Study||0
6292628|NCT00287339|7194623|FG000|STARTED|Overall Study||22
6292629|NCT00287339|7194624|FG001|STARTED|Overall Study||18
6292630|NCT00287339|7194623|FG000|COMPLETED|Overall Study||22
6292631|NCT00287339|7194624|FG001|COMPLETED|Overall Study||18
6292632|NCT00287339|7194623|FG000|NOT COMPLETED|Overall Study||0
6292633|NCT00287339|7194624|FG001|NOT COMPLETED|Overall Study||0
6292634|NCT00287365|7194630|FG000|STARTED|Overall Study||25
6292635|NCT00287365|7194630|FG000|COMPLETED|Overall Study||12
6292636|NCT00287365|7194630|FG000|NOT COMPLETED|Overall Study||13
6292637|NCT00287469|7194637|FG000|STARTED|Overall Study||1000
6292638|NCT00287469|7194638|FG001|STARTED|Overall Study||1000
6292639|NCT00287469|7194637|FG000|COMPLETED|Overall Study||780
6292640|NCT00287469|7194638|FG001|COMPLETED|Overall Study||786
6292641|NCT00287469|7194637|FG000|NOT COMPLETED|Overall Study||220
6292642|NCT00287469|7194638|FG001|NOT COMPLETED|Overall Study||214
6292643|NCT00287586|7194648|FG000|STARTED|Overall Study||156
6292644|NCT00287586|7194649|FG001|STARTED|Overall Study||152
6292645|NCT00287586|7194648|FG000|Intent-to-treat: Received Study Drug|Overall Study||155
6292646|NCT00287586|7194649|FG001|Intent-to-treat: Received Study Drug|Overall Study||151
6292647|NCT00287586|7194648|FG000|COMPLETED|Overall Study||111
6292648|NCT00287586|7194649|FG001|COMPLETED|Overall Study||100
6292649|NCT00287586|7194648|FG000|NOT COMPLETED|Overall Study||45
6292650|NCT00287586|7194649|FG001|NOT COMPLETED|Overall Study||52
6292651|NCT00287690|7194657|FG000|STARTED|Overall Study||33
6292652|NCT00287690|7194658|FG001|STARTED|Overall Study||38
6292653|NCT00287690|7194657|FG000|COMPLETED|Overall Study||13
6292654|NCT00287690|7194658|FG001|COMPLETED|Overall Study||12
6292655|NCT00287690|7194657|FG000|NOT COMPLETED|Overall Study||20
6292656|NCT00287690|7194658|FG001|NOT COMPLETED|Overall Study||26
6292657|NCT00287716|7194667|FG000|STARTED|Overall Study||174
6292658|NCT00287716|7194668|FG001|STARTED|Overall Study||87
6292659|NCT00287716|7194669|FG002|STARTED|Overall Study||174
6400287|NCT00885755|7313174|FG000|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
6400288|NCT00885755|7313175|FG001|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
6400289|NCT00885755|7313176|FG002|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
6400290|NCT00885755|7313174|FG000|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
6400291|NCT00885755|7313175|FG001|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
6400292|NCT00885755|7313176|FG002|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
6400293|NCT00885768|7313184|FG000|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
6400294|NCT00885768|7313184|FG000|COMPLETED|Overall Study|all patients with including criteria completed the study|146
6292660|NCT00287716|7194667|FG000|COMPLETED|Overall Study||136
6292661|NCT00287716|7194668|FG001|COMPLETED|Overall Study||70
6292662|NCT00287716|7194669|FG002|COMPLETED|Overall Study||143
6400295|NCT00885768|7313184|FG000|NOT COMPLETED|Overall Study||0
6400296|NCT00885846|7313191|FG000|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
6292663|NCT00287716|7194667|FG000|NOT COMPLETED|Overall Study||38
6292664|NCT00287716|7194668|FG001|NOT COMPLETED|Overall Study||17
6292665|NCT00287716|7194669|FG002|NOT COMPLETED|Overall Study||31
6292666|NCT00287729|7194679|FG000|STARTED|Overall Study||171
6292667|NCT00287729|7194680|FG001|STARTED|Overall Study||173
6292668|NCT00287729|7194679|FG000|COMPLETED|Overall Study||137
6292669|NCT00287729|7194680|FG001|COMPLETED|Overall Study||142
6292670|NCT00287729|7194679|FG000|NOT COMPLETED|Overall Study||34
6292671|NCT00287729|7194680|FG001|NOT COMPLETED|Overall Study||31
6292672|NCT00287872|7194686|FG000|STARTED|Overall Study||30
6292673|NCT00287872|7194686|FG000|COMPLETED|Overall Study||30
6292674|NCT00287872|7194686|FG000|NOT COMPLETED|Overall Study||0
6292675|NCT00287989|7194694|FG000|STARTED|Overall Study||28
6292676|NCT00287989|7194695|FG001|STARTED|Overall Study||29
6400297|NCT00885846|7313192|FG001|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
6400298|NCT00885846|7313193|FG002|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
6292677|NCT00287989|7194696|FG002|STARTED|Overall Study||29
6292678|NCT00287989|7194694|FG000|COMPLETED|Overall Study||28
6292679|NCT00287989|7194695|FG001|COMPLETED|Overall Study||29
6292680|NCT00287989|7194696|FG002|COMPLETED|Overall Study||29
6292681|NCT00287989|7194694|FG000|NOT COMPLETED|Overall Study||0
6292682|NCT00287989|7194695|FG001|NOT COMPLETED|Overall Study||0
6292683|NCT00287989|7194696|FG002|NOT COMPLETED|Overall Study||0
6292684|NCT00288015|7194704|FG000|STARTED|Registered to Study||32
6292685|NCT00288015|7194704|FG000|COMPLETED|Registered to Study||32
6292686|NCT00288015|7194704|FG000|NOT COMPLETED|Registered to Study||0
6292687|NCT00288015|7194704|FG000|STARTED|Bevacizumab Treatment Cycles 1-2||32
6292688|NCT00288015|7194704|FG000|COMPLETED|Bevacizumab Treatment Cycles 1-2||30
6292689|NCT00288015|7194704|FG000|NOT COMPLETED|Bevacizumab Treatment Cycles 1-2||2
6292690|NCT00288015|7194704|FG000|STARTED|First Response Assessment||30
6292691|NCT00288015|7194704|FG000|COMPLETED|First Response Assessment||26
6292692|NCT00288015|7194704|FG000|NOT COMPLETED|First Response Assessment||4
6292693|NCT00288015|7194704|FG000|STARTED|Continued Bevacizumab Cycle 3+||26
6292694|NCT00288015|7194704|FG000|COMPLETED|Continued Bevacizumab Cycle 3+||19
6292695|NCT00288015|7194704|FG000|NOT COMPLETED|Continued Bevacizumab Cycle 3+||7
6292696|NCT00288015|7194704|FG000|STARTED|Follow up for Survival x 2 Years||29
6292697|NCT00288015|7194704|FG000|COMPLETED|Follow up for Survival x 2 Years||3
6292698|NCT00288015|7194704|FG000|NOT COMPLETED|Follow up for Survival x 2 Years||26
6292699|NCT00288054|7194708|FG000|STARTED|Overall Study||24
6292700|NCT00288054|7194708|FG000|COMPLETED|Overall Study||0
6292701|NCT00288054|7194708|FG000|NOT COMPLETED|Overall Study||24
6292702|NCT00288067|7194714|FG000|STARTED|Overall Study||32
6292703|NCT00288067|7194714|FG000|COMPLETED|Overall Study||32
6292704|NCT00288067|7194714|FG000|NOT COMPLETED|Overall Study||0
6510110|NCT01479543|7429666|FG002|NOT COMPLETED|Overall Study||1
6510111|NCT01479543|7429667|FG003|NOT COMPLETED|Overall Study||0
6510112|NCT01479543|7429668|FG004|NOT COMPLETED|Overall Study||1
6510113|NCT01479595|7429682|FG000|STARTED|Overall Study||44
6510114|NCT01479595|7429683|FG001|STARTED|Overall Study||21
6510115|NCT01479595|7429682|FG000|PK Analysis Set|Overall Study||42
6510116|NCT01479595|7429683|FG001|PK Analysis Set|Overall Study||0
6510117|NCT01479595|7429682|FG000|Per Protocol Analysis Set|Overall Study||41
6510118|NCT01479595|7429683|FG001|Per Protocol Analysis Set|Overall Study||20
6510119|NCT01479595|7429682|FG000|COMPLETED|Overall Study||42
6510120|NCT01479595|7429683|FG001|COMPLETED|Overall Study||19
6510121|NCT01479595|7429682|FG000|NOT COMPLETED|Overall Study||2
6510122|NCT01479595|7429683|FG001|NOT COMPLETED|Overall Study||2
6510123|NCT01479621|7429695|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||909
6510124|NCT01479621|7429696|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6510125|NCT01479621|7429697|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6292705|NCT00288366|7194722|FG000|STARTED|Overall Study||23
6292706|NCT00288366|7194723|FG001|STARTED|Overall Study||26
6292707|NCT00288366|7194722|FG000|COMPLETED|Overall Study||23
6292708|NCT00288366|7194723|FG001|COMPLETED|Overall Study||26
6292709|NCT00288366|7194722|FG000|NOT COMPLETED|Overall Study||0
6292710|NCT00288366|7194723|FG001|NOT COMPLETED|Overall Study||0
6292711|NCT00288509|7194729|FG000|STARTED|Treatment Cycle 1||108
6292712|NCT00288509|7194729|FG000|COMPLETED|Treatment Cycle 1||102
6292713|NCT00288509|7194729|FG000|NOT COMPLETED|Treatment Cycle 1||6
6292714|NCT00288509|7194729|FG000|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
6292715|NCT00288509|7194729|FG000|COMPLETED|Treatment Cycle 2||97
6292716|NCT00288509|7194729|FG000|NOT COMPLETED|Treatment Cycle 2||3
6292717|NCT00288509|7194729|FG000|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
6292718|NCT00288509|7194729|FG000|COMPLETED|Treatment Cycle 3||91
6292719|NCT00288509|7194729|FG000|NOT COMPLETED|Treatment Cycle 3||5
6292720|NCT00288509|7194729|FG000|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
6292721|NCT00288509|7194729|FG000|COMPLETED|Treatment Cycle 4||80
6292722|NCT00288509|7194729|FG000|NOT COMPLETED|Treatment Cycle 4||8
6292723|NCT00288574|7194735|FG000|STARTED|Overall Study||49
6292724|NCT00288574|7194736|FG001|STARTED|Overall Study||44
6292725|NCT00288574|7194735|FG000|COMPLETED|Overall Study||49
6292726|NCT00288574|7194736|FG001|COMPLETED|Overall Study||44
6292727|NCT00288574|7194735|FG000|NOT COMPLETED|Overall Study||0
6292728|NCT00288574|7194736|FG001|NOT COMPLETED|Overall Study||0
6292729|NCT00288587|7194747|FG000|STARTED|Overall Study||19
6292730|NCT00288587|7194748|FG001|STARTED|Overall Study||17
6292731|NCT00288587|7194747|FG000|COMPLETED|Overall Study||14
6292732|NCT00288587|7194748|FG001|COMPLETED|Overall Study||7
6292733|NCT00288587|7194747|FG000|NOT COMPLETED|Overall Study||5
6292734|NCT00288587|7194748|FG001|NOT COMPLETED|Overall Study||10
6292735|NCT00288600|7194756|FG000|STARTED|Overall Study||46
6292736|NCT00288600|7194757|FG001|STARTED|Overall Study||46
6292737|NCT00288600|7194756|FG000|COMPLETED|Overall Study||46
6292738|NCT00288600|7194757|FG001|COMPLETED|Overall Study||46
6292739|NCT00288600|7194756|FG000|NOT COMPLETED|Overall Study||0
6292740|NCT00288600|7194757|FG001|NOT COMPLETED|Overall Study||0
6292741|NCT00288626|7194763|FG000|STARTED|Overall Study||24
6292742|NCT00288626|7194763|FG000|COMPLETED|Overall Study||17
6510126|NCT01479621|7429698|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6510127|NCT01479621|7429699|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6510128|NCT01479621|7429700|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6292743|NCT00288626|7194763|FG000|NOT COMPLETED|Overall Study||7
6292744|NCT00288639|7194769|FG000|STARTED|Overall Study||98
6292745|NCT00288639|7194769|FG000|COMPLETED|Overall Study||86
6292746|NCT00288639|7194769|FG000|NOT COMPLETED|Overall Study||12
6292747|NCT00288704|7194776|FG000|STARTED|Part A, Double Blind, Weeks 1-6||24
6292748|NCT00288704|7194777|FG001|STARTED|Part A, Double Blind, Weeks 1-6||23
6292749|NCT00288704|7194778|FG002|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
6292750|NCT00288704|7194776|FG000|COMPLETED|Part A, Double Blind, Weeks 1-6||24
6292751|NCT00288704|7194777|FG001|COMPLETED|Part A, Double Blind, Weeks 1-6||22
6292752|NCT00288704|7194778|FG002|COMPLETED|Part A, Double Blind, Weeks 1-6||0
6292753|NCT00288704|7194776|FG000|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
6292754|NCT00288704|7194777|FG001|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
6292755|NCT00288704|7194778|FG002|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
6292756|NCT00288704|7194776|FG000|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
6292757|NCT00288704|7194777|FG001|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
6292758|NCT00288704|7194778|FG002|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
6292759|NCT00288704|7194776|FG000|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
6292760|NCT00288704|7194777|FG001|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
6292761|NCT00288704|7194778|FG002|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
6292762|NCT00288704|7194776|FG000|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
6292763|NCT00288704|7194777|FG001|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
6292764|NCT00288704|7194778|FG002|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
6292765|NCT00288704|7194776|FG000|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
6292766|NCT00288704|7194777|FG001|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
6292767|NCT00288704|7194778|FG002|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
6292768|NCT00288704|7194776|FG000|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
6292769|NCT00288704|7194777|FG001|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
6292770|NCT00288704|7194778|FG002|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
6292771|NCT00288704|7194776|FG000|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
6292772|NCT00288704|7194777|FG001|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
6292773|NCT00288704|7194778|FG002|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
6292774|NCT00288860|7194787|FG000|STARTED|Overall Study||412
6292775|NCT00288860|7194788|FG001|STARTED|Overall Study||425
6292776|NCT00288860|7194787|FG000|Completed Intake Survey|Overall Study||408
6292777|NCT00288860|7194788|FG001|Completed Intake Survey|Overall Study||417
6292778|NCT00288860|7194787|FG000|Completed 4 Month fu Survey|Overall Study||275
6292779|NCT00288860|7194788|FG001|Completed 4 Month fu Survey|Overall Study||299
6292780|NCT00288860|7194787|FG000|Completed 12 Month fu Survey|Overall Study||257
6292781|NCT00288860|7194788|FG001|Completed 12 Month fu Survey|Overall Study||281
6292782|NCT00288860|7194787|FG000|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
6292783|NCT00288860|7194788|FG001|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
6292784|NCT00288860|7194787|FG000|NOT COMPLETED|Overall Study||102
6292785|NCT00288860|7194788|FG001|NOT COMPLETED|Overall Study||97
6292786|NCT00288886|7194799|FG000|STARTED|Overall Study||91
6634845|NCT02300129|7563714|FG002|COMPLETED|Period 1 Session 1 (Day 1)||7
6634846|NCT02300129|7563715|FG003|COMPLETED|Period 1 Session 1 (Day 1)||11
6634847|NCT02300129|7563712|FG000|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
6634848|NCT02300129|7563713|FG001|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
6634849|NCT02300129|7563714|FG002|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
6634850|NCT02300129|7563715|FG003|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
6634851|NCT02300129|7563712|FG000|STARTED|Period 1 Session 2 (Day 3)||11
6634852|NCT02300129|7563713|FG001|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
6634853|NCT02300129|7563714|FG002|STARTED|Period 1 Session 2 (Day 3)||7
6634854|NCT02300129|7563715|FG003|STARTED|Period 1 Session 2 (Day 3)||11
6634855|NCT02300129|7563712|FG000|COMPLETED|Period 1 Session 2 (Day 3)||11
6292787|NCT00288886|7194800|FG001|STARTED|Overall Study||92
6292788|NCT00288886|7194799|FG000|3-month Follow Up|Overall Study||82
6292789|NCT00288886|7194800|FG001|3-month Follow Up|Overall Study||85
6292790|NCT00288886|7194799|FG000|6-month Follow Up|Overall Study||85
6292791|NCT00288886|7194800|FG001|6-month Follow Up|Overall Study||84
6292792|NCT00288886|7194799|FG000|12-month Follow Up|Overall Study||80
6292793|NCT00288886|7194800|FG001|12-month Follow Up|Overall Study||81
6292794|NCT00288886|7194799|FG000|COMPLETED|Overall Study||80
6292795|NCT00288886|7194800|FG001|COMPLETED|Overall Study||81
6292796|NCT00288886|7194799|FG000|NOT COMPLETED|Overall Study||11
6292797|NCT00288886|7194800|FG001|NOT COMPLETED|Overall Study||11
6292798|NCT00288912|7194809|FG000|STARTED|Overall Study||175
6292799|NCT00288912|7194810|FG001|STARTED|Overall Study||174
6292800|NCT00288912|7194811|FG002|STARTED|Overall Study||174
6292801|NCT00288912|7194809|FG000|COMPLETED|Overall Study||158
6292802|NCT00288912|7194810|FG001|COMPLETED|Overall Study||157
6292803|NCT00288912|7194811|FG002|COMPLETED|Overall Study||146
6634856|NCT02300129|7563713|FG001|COMPLETED|Period 1 Session 2 (Day 3)||4
6634857|NCT02300129|7563714|FG002|COMPLETED|Period 1 Session 2 (Day 3)||7
6634858|NCT02300129|7563715|FG003|COMPLETED|Period 1 Session 2 (Day 3)||11
6634859|NCT02300129|7563712|FG000|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
6292804|NCT00288912|7194809|FG000|NOT COMPLETED|Overall Study||17
6292805|NCT00288912|7194810|FG001|NOT COMPLETED|Overall Study||17
6292806|NCT00288912|7194811|FG002|NOT COMPLETED|Overall Study||28
6292807|NCT00289016|7194819|FG000|STARTED|Overall Study||50
6292808|NCT00289016|7194819|FG000|COMPLETED|Overall Study||13
6292809|NCT00289016|7194819|FG000|NOT COMPLETED|Overall Study||37
6292810|NCT00289094|7194825|FG000|STARTED|Overall Study||50
6292811|NCT00289094|7194826|FG001|STARTED|Overall Study||49
6292812|NCT00289094|7194825|FG000|COMPLETED|Overall Study||3
6292813|NCT00289094|7194826|FG001|COMPLETED|Overall Study||2
6292814|NCT00289094|7194825|FG000|NOT COMPLETED|Overall Study||47
6292815|NCT00289094|7194826|FG001|NOT COMPLETED|Overall Study||47
6292816|NCT00289107|7194834|FG000|STARTED|Overall Study||77
6292817|NCT00289107|7194835|FG001|STARTED|Overall Study||72
6292818|NCT00289107|7194834|FG000|COMPLETED|Overall Study||24
6292819|NCT00289107|7194835|FG001|COMPLETED|Overall Study||28
6292820|NCT00289107|7194834|FG000|NOT COMPLETED|Overall Study||53
6292821|NCT00289107|7194835|FG001|NOT COMPLETED|Overall Study||44
6292822|NCT00289120|7194841|FG000|STARTED|Overall Study||13
6292823|NCT00289120|7194841|FG000|COMPLETED|Overall Study||13
6292824|NCT00289120|7194841|FG000|NOT COMPLETED|Overall Study||0
6292825|NCT00289133|7194851|FG000|STARTED|Overall Study||461
6292826|NCT00289133|7194852|FG001|STARTED|Overall Study||477
6292827|NCT00289133|7194851|FG000|COMPLETED|Overall Study||189
6292828|NCT00289133|7194852|FG001|COMPLETED|Overall Study||179
6292829|NCT00289133|7194851|FG000|NOT COMPLETED|Overall Study||272
6292830|NCT00289133|7194852|FG001|NOT COMPLETED|Overall Study||298
6292831|NCT00289185|7194864|FG000|STARTED|Overall Study||170
6292832|NCT00289185|7194865|FG001|STARTED|Overall Study||170
6292833|NCT00289185|7194864|FG000|COMPLETED|Overall Study||142
6292834|NCT00289185|7194865|FG001|COMPLETED|Overall Study||144
6292835|NCT00289185|7194864|FG000|NOT COMPLETED|Overall Study||28
6292836|NCT00289185|7194865|FG001|NOT COMPLETED|Overall Study||26
6292837|NCT00289198|7194874|FG000|STARTED|Overall Study||151
6292838|NCT00289198|7194875|FG001|STARTED|Overall Study||151
6292839|NCT00289198|7194874|FG000|COMPLETED|Overall Study||120
6292840|NCT00289198|7194875|FG001|COMPLETED|Overall Study||121
6292841|NCT00289198|7194874|FG000|NOT COMPLETED|Overall Study||31
6292842|NCT00289198|7194875|FG001|NOT COMPLETED|Overall Study||30
6292843|NCT00289211|7194885|FG000|STARTED|Overall Study||36
6292844|NCT00289211|7194886|FG001|STARTED|Overall Study||35
6292845|NCT00289211|7194887|FG002|STARTED|Overall Study||12
6292846|NCT00289211|7194885|FG000|COMPLETED|Overall Study||36
6292847|NCT00289211|7194886|FG001|COMPLETED|Overall Study||34
6292848|NCT00289211|7194887|FG002|COMPLETED|Overall Study||2
6292849|NCT00289211|7194885|FG000|NOT COMPLETED|Overall Study||0
6292850|NCT00289211|7194886|FG001|NOT COMPLETED|Overall Study||1
6292851|NCT00289211|7194887|FG002|NOT COMPLETED|Overall Study||10
6292852|NCT00289276|7194895|FG000|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
6292853|NCT00289276|7194896|FG001|STARTED|First Part of FAST Study (Pivotal)||0
6292854|NCT00289276|7194895|FG000|COMPLETED|First Part of FAST Study (Pivotal)||47
6292855|NCT00289276|7194896|FG001|COMPLETED|First Part of FAST Study (Pivotal)||0
6292856|NCT00289276|7194895|FG000|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
6292857|NCT00289276|7194896|FG001|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
6292858|NCT00289276|7194895|FG000|STARTED|Second Part of FAST Study (Expansion)||0
6292859|NCT00289276|7194896|FG001|STARTED|Second Part of FAST Study (Expansion)||109
6292860|NCT00289276|7194895|FG000|COMPLETED|Second Part of FAST Study (Expansion)||0
6292861|NCT00289276|7194896|FG001|COMPLETED|Second Part of FAST Study (Expansion)||106
6292862|NCT00289276|7194895|FG000|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
6292863|NCT00289276|7194896|FG001|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
6292864|NCT00289289|7194905|FG000|STARTED|Overall Study||132
6292865|NCT00289289|7194906|FG001|STARTED|Overall Study||124
6292866|NCT00289289|7194907|FG002|STARTED|Overall Study||144
6292867|NCT00289289|7194905|FG000|COMPLETED|Overall Study||113
6292868|NCT00289289|7194906|FG001|COMPLETED|Overall Study||114
6292869|NCT00289289|7194907|FG002|COMPLETED|Overall Study||95
6292870|NCT00289289|7194905|FG000|NOT COMPLETED|Overall Study||19
6292871|NCT00289289|7194906|FG001|NOT COMPLETED|Overall Study||10
6292872|NCT00289289|7194907|FG002|NOT COMPLETED|Overall Study||49
6292873|NCT00289315|7194917|FG000|STARTED|Overall Study||713
6292874|NCT00289315|7194918|FG001|STARTED|Overall Study||760
6292875|NCT00289315|7194919|FG002|STARTED|Overall Study||587
6292876|NCT00289315|7194917|FG000|COMPLETED|Overall Study||612
6292877|NCT00289315|7194918|FG001|COMPLETED|Overall Study||638
6292878|NCT00289315|7194919|FG002|COMPLETED|Overall Study||447
6292879|NCT00289315|7194917|FG000|NOT COMPLETED|Overall Study||101
6292880|NCT00289315|7194918|FG001|NOT COMPLETED|Overall Study||122
6292881|NCT00289315|7194919|FG002|NOT COMPLETED|Overall Study||140
6292882|NCT00289341|7194929|FG000|STARTED|Overall Study||12
6292883|NCT00289341|7194930|FG001|STARTED|Overall Study||12
6292884|NCT00289341|7194929|FG000|COMPLETED|Overall Study||12
6292885|NCT00289341|7194930|FG001|COMPLETED|Overall Study||12
6292886|NCT00289341|7194929|FG000|NOT COMPLETED|Overall Study||0
6292887|NCT00289341|7194930|FG001|NOT COMPLETED|Overall Study||0
6292888|NCT00289458|7194943|FG000|STARTED|Overall Study||25
6292889|NCT00289458|7194944|FG001|STARTED|Overall Study||26
6292890|NCT00289458|7194945|FG002|STARTED|Overall Study||28
6292891|NCT00289458|7194943|FG000|COMPLETED|Overall Study||19
6292892|NCT00289458|7194944|FG001|COMPLETED|Overall Study||20
6292893|NCT00289458|7194945|FG002|COMPLETED|Overall Study||22
6292894|NCT00289458|7194943|FG000|NOT COMPLETED|Overall Study||6
6292895|NCT00289458|7194944|FG001|NOT COMPLETED|Overall Study||6
6292896|NCT00289458|7194945|FG002|NOT COMPLETED|Overall Study||6
6292897|NCT00289471|7194953|FG000|STARTED|Overall Study||630
6292898|NCT00289471|7194953|FG000|COMPLETED|Overall Study||630
6292899|NCT00289471|7194953|FG000|NOT COMPLETED|Overall Study||0
6292900|NCT00289536|7194957|FG000|STARTED|Period 1||9
6292901|NCT00289536|7194958|FG001|STARTED|Period 1||8
6292902|NCT00289536|7194959|FG002|STARTED|Period 1||9
6292903|NCT00289536|7194957|FG000|COMPLETED|Period 1||9
6292904|NCT00289536|7194958|FG001|COMPLETED|Period 1||8
6634860|NCT02300129|7563713|FG001|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
6634861|NCT02300129|7563714|FG002|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
6634862|NCT02300129|7563715|FG003|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
6634863|NCT02300129|7563712|FG000|STARTED|Period 1 Session 3 (Day 5)||11
6634864|NCT02300129|7563713|FG001|STARTED|Period 1 Session 3 (Day 5)||4
6634865|NCT02300129|7563714|FG002|STARTED|Period 1 Session 3 (Day 5)||7
6292905|NCT00289536|7194959|FG002|COMPLETED|Period 1||9
6292906|NCT00289536|7194957|FG000|NOT COMPLETED|Period 1||0
6292907|NCT00289536|7194958|FG001|NOT COMPLETED|Period 1||0
6292908|NCT00289536|7194959|FG002|NOT COMPLETED|Period 1||0
6292909|NCT00289536|7194957|FG000|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
6292910|NCT00289536|7194958|FG001|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
6292911|NCT00289536|7194959|FG002|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
6292912|NCT00289536|7194957|FG000|COMPLETED|Period 2||10
6292913|NCT00289536|7194958|FG001|COMPLETED|Period 2||9
6292914|NCT00289536|7194959|FG002|COMPLETED|Period 2||7
6292915|NCT00289536|7194957|FG000|NOT COMPLETED|Period 2||0
6292916|NCT00289536|7194958|FG001|NOT COMPLETED|Period 2||0
6292917|NCT00289536|7194959|FG002|NOT COMPLETED|Period 2||0
6292918|NCT00289536|7194957|FG000|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
6292919|NCT00289536|7194958|FG001|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
6292920|NCT00289536|7194959|FG002|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
6292921|NCT00289536|7194957|FG000|COMPLETED|Period 3||7
6292922|NCT00289536|7194958|FG001|COMPLETED|Period 3||9
6292923|NCT00289536|7194959|FG002|COMPLETED|Period 3||9
6292924|NCT00289536|7194957|FG000|NOT COMPLETED|Period 3||0
6292925|NCT00289536|7194958|FG001|NOT COMPLETED|Period 3||0
6292926|NCT00289536|7194959|FG002|NOT COMPLETED|Period 3||1
6292927|NCT00289653|7194965|FG000|STARTED|Overall Study||23
6292928|NCT00289653|7194965|FG000|COMPLETED|Overall Study||12
6292929|NCT00289653|7194965|FG000|NOT COMPLETED|Overall Study||11
6292930|NCT00289718|7194970|FG000|STARTED|Overall Study||51
6292931|NCT00289718|7194970|FG000|COMPLETED|Overall Study||51
6292932|NCT00289718|7194970|FG000|NOT COMPLETED|Overall Study||0
6292933|NCT00289731|7194982|FG000|STARTED|Overall Study||199
6292934|NCT00289731|7194983|FG001|STARTED|Overall Study||200
6292935|NCT00289731|7194984|FG002|STARTED|Overall Study||197
6292936|NCT00289731|7194982|FG000|COMPLETED|Overall Study||197
6292937|NCT00289731|7194983|FG001|COMPLETED|Overall Study||198
6292938|NCT00289731|7194984|FG002|COMPLETED|Overall Study||195
6292939|NCT00289731|7194982|FG000|NOT COMPLETED|Overall Study||2
6292940|NCT00289731|7194983|FG001|NOT COMPLETED|Overall Study||2
6292941|NCT00289731|7194984|FG002|NOT COMPLETED|Overall Study||2
6292942|NCT00289744|7194994|FG000|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
6292943|NCT00289744|7194995|FG001|STARTED|Year 6 Long-term Follow-up||0
6292944|NCT00289744|7194996|FG002|STARTED|Year 6 Long-term Follow-up||0
6292945|NCT00289744|7194994|FG000|COMPLETED|Year 6 Long-term Follow-up||178
6292946|NCT00289744|7194995|FG001|COMPLETED|Year 6 Long-term Follow-up||0
6292947|NCT00289744|7194996|FG002|COMPLETED|Year 6 Long-term Follow-up||0
6292948|NCT00289744|7194994|FG000|NOT COMPLETED|Year 6 Long-term Follow-up||0
6292949|NCT00289744|7194995|FG001|NOT COMPLETED|Year 6 Long-term Follow-up||0
6292950|NCT00289744|7194996|FG002|NOT COMPLETED|Year 6 Long-term Follow-up||0
6292951|NCT00289744|7194994|FG000|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
6292952|NCT00289744|7194995|FG001|STARTED|Year 7 Long-term Follow-up||0
6292953|NCT00289744|7194996|FG002|STARTED|Year 7 Long-term Follow-up||0
6292954|NCT00289744|7194994|FG000|COMPLETED|Year 7 Long-term Follow-up||175
6292955|NCT00289744|7194995|FG001|COMPLETED|Year 7 Long-term Follow-up||0
6292956|NCT00289744|7194996|FG002|COMPLETED|Year 7 Long-term Follow-up||0
6292957|NCT00289744|7194994|FG000|NOT COMPLETED|Year 7 Long-term Follow-up||0
6292958|NCT00289744|7194995|FG001|NOT COMPLETED|Year 7 Long-term Follow-up||0
6292959|NCT00289744|7194996|FG002|NOT COMPLETED|Year 7 Long-term Follow-up||0
6292960|NCT00289744|7194994|FG000|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
6292961|NCT00289744|7194995|FG001|STARTED|Year 8 Long-term Follow-up||0
6292962|NCT00289744|7194996|FG002|STARTED|Year 8 Long-term Follow-up||0
6292963|NCT00289744|7194994|FG000|COMPLETED|Year 8 Long-term Follow-up||174
6292964|NCT00289744|7194995|FG001|COMPLETED|Year 8 Long-term Follow-up||0
6292965|NCT00289744|7194996|FG002|COMPLETED|Year 8 Long-term Follow-up||0
6292966|NCT00289744|7194994|FG000|NOT COMPLETED|Year 8 Long-term Follow-up||0
6292967|NCT00289744|7194995|FG001|NOT COMPLETED|Year 8 Long-term Follow-up||0
6292968|NCT00289744|7194996|FG002|NOT COMPLETED|Year 8 Long-term Follow-up||0
6292969|NCT00289744|7194994|FG000|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
6292970|NCT00289744|7194995|FG001|STARTED|Year 9 Long-term Follow-up||0
6292971|NCT00289744|7194996|FG002|STARTED|Year 9 Long-term Follow-up||0
6292972|NCT00289744|7194994|FG000|COMPLETED|Year 9 Long-term Follow-up||173
6292973|NCT00289744|7194995|FG001|COMPLETED|Year 9 Long-term Follow-up||0
6292974|NCT00289744|7194996|FG002|COMPLETED|Year 9 Long-term Follow-up||0
6292975|NCT00289744|7194994|FG000|NOT COMPLETED|Year 9 Long-term Follow-up||0
6292976|NCT00289744|7194995|FG001|NOT COMPLETED|Year 9 Long-term Follow-up||0
6292977|NCT00289744|7194996|FG002|NOT COMPLETED|Year 9 Long-term Follow-up||0
6292978|NCT00289744|7194994|FG000|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
6292979|NCT00289744|7194995|FG001|STARTED|Year 10 Long-term Follow-up||0
6292980|NCT00289744|7194996|FG002|STARTED|Year 10 Long-term Follow-up||0
6292981|NCT00289744|7194994|FG000|COMPLETED|Year 10 Long-term Follow-up||171
6292982|NCT00289744|7194995|FG001|COMPLETED|Year 10 Long-term Follow-up||0
6292983|NCT00289744|7194996|FG002|COMPLETED|Year 10 Long-term Follow-up||0
6292984|NCT00289744|7194994|FG000|NOT COMPLETED|Year 10 Long-term Follow-up||0
6292985|NCT00289744|7194995|FG001|NOT COMPLETED|Year 10 Long-term Follow-up||0
6292986|NCT00289744|7194996|FG002|NOT COMPLETED|Year 10 Long-term Follow-up||0
6292987|NCT00289744|7194994|FG000|STARTED|Additional Dose Phase||0
6292988|NCT00289744|7194995|FG001|STARTED|Additional Dose Phase||19
6292989|NCT00289744|7194996|FG002|STARTED|Additional Dose Phase||6
6292990|NCT00289744|7194994|FG000|COMPLETED|Additional Dose Phase||0
6292991|NCT00289744|7194995|FG001|COMPLETED|Additional Dose Phase||19
6292992|NCT00289744|7194996|FG002|COMPLETED|Additional Dose Phase||6
6292993|NCT00289744|7194994|FG000|NOT COMPLETED|Additional Dose Phase||0
6292994|NCT00289744|7194995|FG001|NOT COMPLETED|Additional Dose Phase||0
6292995|NCT00289744|7194996|FG002|NOT COMPLETED|Additional Dose Phase||0
6292996|NCT00289757|7195004|FG000|STARTED|Overall Study||78
6292997|NCT00289757|7195004|FG000|COMPLETED|Overall Study||78
6292998|NCT00289757|7195004|FG000|NOT COMPLETED|Overall Study||0
6292999|NCT00289770|7195008|FG000|STARTED|Year 11||37
6293000|NCT00289770|7195008|FG000|COMPLETED|Year 11||37
6293001|NCT00289770|7195008|FG000|NOT COMPLETED|Year 11||0
6293002|NCT00289770|7195008|FG000|STARTED|Year 12||40
6293003|NCT00289770|7195008|FG000|COMPLETED|Year 12||40
6293004|NCT00289770|7195008|FG000|NOT COMPLETED|Year 12||0
6293005|NCT00289770|7195008|FG000|STARTED|Year 13||37
6293006|NCT00289770|7195008|FG000|COMPLETED|Year 13||37
6293007|NCT00289770|7195008|FG000|NOT COMPLETED|Year 13||0
6293008|NCT00289770|7195008|FG000|STARTED|Year 14||43
6293009|NCT00289770|7195008|FG000|COMPLETED|Year 14||43
6293010|NCT00289770|7195008|FG000|NOT COMPLETED|Year 14||0
6293011|NCT00289770|7195008|FG000|STARTED|Year 15||50
6293012|NCT00289770|7195008|FG000|COMPLETED|Year 15||49
6293013|NCT00289770|7195008|FG000|NOT COMPLETED|Year 15||1
6293014|NCT00289783|7195014|FG000|STARTED|Primary Phase||3136
6293015|NCT00289783|7195015|FG001|STARTED|Primary Phase||1044
6293016|NCT00289783|7195014|FG000|COMPLETED|Primary Phase||2888
6293017|NCT00289783|7195015|FG001|COMPLETED|Primary Phase||961
6293018|NCT00289783|7195014|FG000|NOT COMPLETED|Primary Phase||248
6293019|NCT00289783|7195015|FG001|NOT COMPLETED|Primary Phase||83
6293020|NCT00289783|7195014|FG000|STARTED|Fourth Dose Phase||2769
6293021|NCT00289783|7195015|FG001|STARTED|Fourth Dose Phase||923
6293022|NCT00289783|7195014|FG000|COMPLETED|Fourth Dose Phase||2682
6293023|NCT00289783|7195015|FG001|COMPLETED|Fourth Dose Phase||899
6293024|NCT00289783|7195014|FG000|NOT COMPLETED|Fourth Dose Phase||87
6293025|NCT00289783|7195015|FG001|NOT COMPLETED|Fourth Dose Phase||24
6293026|NCT00289848|7195031|FG000|STARTED|Overall Study||352
6293027|NCT00289848|7195032|FG001|STARTED|Overall Study||178
6293028|NCT00289848|7195031|FG000|COMPLETED|Overall Study||306
6293029|NCT00289848|7195032|FG001|COMPLETED|Overall Study||133
6293030|NCT00289848|7195031|FG000|NOT COMPLETED|Overall Study||46
6293031|NCT00289848|7195032|FG001|NOT COMPLETED|Overall Study||45
6293032|NCT00289900|7195044|FG000|STARTED|Overall Study||297
6293033|NCT00289900|7195045|FG001|STARTED|Overall Study||436
6293034|NCT00289900|7195046|FG002|STARTED|Overall Study||298
6293035|NCT00289900|7195047|FG003|STARTED|Overall Study||439
6293036|NCT00289900|7195048|FG004|STARTED|Overall Study||437
6293037|NCT00289900|7195049|FG005|STARTED|Overall Study||433
6293038|NCT00289900|7195044|FG000|Treated|Overall Study||297
6293039|NCT00289900|7195045|FG001|Treated|Overall Study||435
6293040|NCT00289900|7195046|FG002|Treated|Overall Study||298
6293041|NCT00289900|7195047|FG003|Treated|Overall Study||439
6293042|NCT00289900|7195048|FG004|Treated|Overall Study||437
6293043|NCT00289900|7195049|FG005|Treated|Overall Study||433
6293044|NCT00289900|7195044|FG000|COMPLETED|Overall Study||229
6293045|NCT00289900|7195045|FG001|COMPLETED|Overall Study||316
6293046|NCT00289900|7195046|FG002|COMPLETED|Overall Study||265
6293047|NCT00289900|7195047|FG003|COMPLETED|Overall Study||380
6293048|NCT00289900|7195048|FG004|COMPLETED|Overall Study||392
6293049|NCT00289900|7195049|FG005|COMPLETED|Overall Study||372
6293050|NCT00289900|7195044|FG000|NOT COMPLETED|Overall Study||68
6293051|NCT00289900|7195045|FG001|NOT COMPLETED|Overall Study||120
6293052|NCT00289900|7195046|FG002|NOT COMPLETED|Overall Study||33
6293053|NCT00289900|7195047|FG003|NOT COMPLETED|Overall Study||59
6293054|NCT00289900|7195048|FG004|NOT COMPLETED|Overall Study||45
6293055|NCT00289900|7195049|FG005|NOT COMPLETED|Overall Study||61
6293056|NCT00289913|7195071|FG000|STARTED|Visit 1 (Stage I and Stage II)||155
6293057|NCT00289913|7195072|FG001|STARTED|Visit 1 (Stage I and Stage II)||151
6293058|NCT00289913|7195073|FG002|STARTED|Visit 1 (Stage I and Stage II)||159
6293059|NCT00289913|7195074|FG003|STARTED|Visit 1 (Stage I and Stage II)||152
6293060|NCT00289913|7195075|FG004|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
6293061|NCT00289913|7195071|FG000|COMPLETED|Visit 1 (Stage I and Stage II)||146
6293062|NCT00289913|7195072|FG001|COMPLETED|Visit 1 (Stage I and Stage II)||135
6293063|NCT00289913|7195073|FG002|COMPLETED|Visit 1 (Stage I and Stage II)||150
6293064|NCT00289913|7195074|FG003|COMPLETED|Visit 1 (Stage I and Stage II)||141
6293065|NCT00289913|7195075|FG004|COMPLETED|Visit 1 (Stage I and Stage II)||645
6293066|NCT00289913|7195071|FG000|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
6293067|NCT00289913|7195072|FG001|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
6293068|NCT00289913|7195073|FG002|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
6293069|NCT00289913|7195074|FG003|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
6293070|NCT00289913|7195075|FG004|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
6293071|NCT00289913|7195071|FG000|STARTED|Visit 2 (Stage I and Stage II)||146
6293072|NCT00289913|7195072|FG001|STARTED|Visit 2 (Stage I and Stage II)||135
6293073|NCT00289913|7195073|FG002|STARTED|Visit 2 (Stage I and Stage II)||150
6293074|NCT00289913|7195074|FG003|STARTED|Visit 2 (Stage I and Stage II)||141
6293075|NCT00289913|7195075|FG004|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
6293076|NCT00289913|7195071|FG000|COMPLETED|Visit 2 (Stage I and Stage II)||131
6293077|NCT00289913|7195072|FG001|COMPLETED|Visit 2 (Stage I and Stage II)||114
6293078|NCT00289913|7195073|FG002|COMPLETED|Visit 2 (Stage I and Stage II)||140
6293079|NCT00289913|7195074|FG003|COMPLETED|Visit 2 (Stage I and Stage II)||135
6293080|NCT00289913|7195075|FG004|COMPLETED|Visit 2 (Stage I and Stage II)||605
6293081|NCT00289913|7195071|FG000|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
6293082|NCT00289913|7195072|FG001|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
6293083|NCT00289913|7195073|FG002|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
6400299|NCT00885846|7313191|FG000|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
6293084|NCT00289913|7195074|FG003|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
6293085|NCT00289913|7195075|FG004|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
6293086|NCT00289913|7195071|FG000|STARTED|Visit 3 (Stage I and Stage II)||131
6293087|NCT00289913|7195072|FG001|STARTED|Visit 3 (Stage I and Stage II)||114
6293088|NCT00289913|7195073|FG002|STARTED|Visit 3 (Stage I and Stage II)||140
6293089|NCT00289913|7195074|FG003|STARTED|Visit 3 (Stage I and Stage II)||135
6293090|NCT00289913|7195075|FG004|STARTED|Visit 3 (Stage I and Stage II)||605
6293091|NCT00289913|7195071|FG000|COMPLETED|Visit 3 (Stage I and Stage II)||122
6293092|NCT00289913|7195072|FG001|COMPLETED|Visit 3 (Stage I and Stage II)||106
6293093|NCT00289913|7195073|FG002|COMPLETED|Visit 3 (Stage I and Stage II)||138
6293094|NCT00289913|7195074|FG003|COMPLETED|Visit 3 (Stage I and Stage II)||131
6293095|NCT00289913|7195075|FG004|COMPLETED|Visit 3 (Stage I and Stage II)||597
6293096|NCT00289913|7195071|FG000|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
6293097|NCT00289913|7195072|FG001|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
6293098|NCT00289913|7195073|FG002|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
6293099|NCT00289913|7195074|FG003|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
6293100|NCT00289913|7195075|FG004|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
6293101|NCT00289913|7195071|FG000|STARTED|Visit 4 (Stage I and Stage II)||122
6293102|NCT00289913|7195072|FG001|STARTED|Visit 4 (Stage I and Stage II)||106
6293103|NCT00289913|7195073|FG002|STARTED|Visit 4 (Stage I and Stage II)||138
6293104|NCT00289913|7195074|FG003|STARTED|Visit 4 (Stage I and Stage II)||131
6293105|NCT00289913|7195075|FG004|STARTED|Visit 4 (Stage I and Stage II)||597
6293106|NCT00289913|7195071|FG000|COMPLETED|Visit 4 (Stage I and Stage II)||122
6293107|NCT00289913|7195072|FG001|COMPLETED|Visit 4 (Stage I and Stage II)||106
6293108|NCT00289913|7195073|FG002|COMPLETED|Visit 4 (Stage I and Stage II)||138
6293109|NCT00289913|7195074|FG003|COMPLETED|Visit 4 (Stage I and Stage II)||131
6293110|NCT00289913|7195075|FG004|COMPLETED|Visit 4 (Stage I and Stage II)||597
6293111|NCT00289913|7195071|FG000|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6293112|NCT00289913|7195072|FG001|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6293113|NCT00289913|7195073|FG002|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6293114|NCT00289913|7195074|FG003|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6293115|NCT00289913|7195075|FG004|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
6293116|NCT00289978|7195093|FG000|STARTED|Overall Study||429
6293117|NCT00289978|7195094|FG001|STARTED|Overall Study||425
6293118|NCT00289978|7195095|FG002|STARTED|Overall Study||418
6293119|NCT00289978|7195093|FG000|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
6293120|NCT00289978|7195094|FG001|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
6293121|NCT00289978|7195095|FG002|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
6293122|NCT00289978|7195093|FG000|NOT COMPLETED|Overall Study||97
6293123|NCT00289978|7195094|FG001|NOT COMPLETED|Overall Study||56
6293124|NCT00289978|7195095|FG002|NOT COMPLETED|Overall Study||86
6293125|NCT00289991|7195105|FG000|STARTED|Overall Study||234
6293126|NCT00289991|7195106|FG001|STARTED|Overall Study||255
6293127|NCT00289991|7195105|FG000|COMPLETED|Overall Study||176
6293128|NCT00289991|7195106|FG001|COMPLETED|Overall Study||175
6293129|NCT00289991|7195105|FG000|NOT COMPLETED|Overall Study||58
6293130|NCT00289991|7195106|FG001|NOT COMPLETED|Overall Study||80
6293131|NCT00290147|7195114|FG000|STARTED|Overall Study||10
6293132|NCT00290147|7195115|FG001|STARTED|Overall Study||12
6293133|NCT00290147|7195114|FG000|COMPLETED|Overall Study||10
6293134|NCT00290147|7195115|FG001|COMPLETED|Overall Study||12
6293135|NCT00290147|7195114|FG000|NOT COMPLETED|Overall Study||0
6293136|NCT00290147|7195115|FG001|NOT COMPLETED|Overall Study||0
6293137|NCT00290186|7195123|FG000|STARTED|Overall Study||25
6293138|NCT00290186|7195124|FG001|STARTED|Overall Study||24
6293139|NCT00290186|7195123|FG000|Completed Baseline Assessments|Overall Study||25
6293140|NCT00290186|7195124|FG001|Completed Baseline Assessments|Overall Study||24
6293141|NCT00290186|7195123|FG000|Completed 8 Weeks of Treatment|Overall Study||24
6293142|NCT00290186|7195124|FG001|Completed 8 Weeks of Treatment|Overall Study||22
6293143|NCT00290186|7195123|FG000|Completed Post-treatment Assessments|Overall Study||24
6293144|NCT00290186|7195124|FG001|Completed Post-treatment Assessments|Overall Study||22
6293145|NCT00290186|7195123|FG000|Completed 3-month Followup Assessments|Overall Study||20
6293146|NCT00290186|7195124|FG001|Completed 3-month Followup Assessments|Overall Study||21
6293147|NCT00290186|7195123|FG000|Completed 6-month Followup Assessments|Overall Study||20
6293148|NCT00290186|7195124|FG001|Completed 6-month Followup Assessments|Overall Study||19
6293149|NCT00290186|7195123|FG000|COMPLETED|Overall Study||20
6293150|NCT00290186|7195124|FG001|COMPLETED|Overall Study||19
6293151|NCT00290186|7195123|FG000|NOT COMPLETED|Overall Study||5
6293152|NCT00290186|7195124|FG001|NOT COMPLETED|Overall Study||5
6293153|NCT00290199|7195134|FG000|STARTED|Overall Study||87
6293154|NCT00290199|7195135|FG001|STARTED|Overall Study||82
6293155|NCT00290199|7195134|FG000|COMPLETED|Overall Study||87
6293156|NCT00290199|7195135|FG001|COMPLETED|Overall Study||82
6293157|NCT00290199|7195134|FG000|NOT COMPLETED|Overall Study||0
6293158|NCT00290199|7195135|FG001|NOT COMPLETED|Overall Study||0
6293159|NCT00290238|7195145|FG000|STARTED|Overall Study||57
6293160|NCT00290238|7195146|FG001|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
6293161|NCT00290238|7195145|FG000|COMPLETED|Overall Study||15
6293162|NCT00290238|7195146|FG001|COMPLETED|Overall Study||24
6293163|NCT00290238|7195145|FG000|NOT COMPLETED|Overall Study||42
6293164|NCT00290238|7195146|FG001|NOT COMPLETED|Overall Study||41
6293165|NCT00290290|7195154|FG000|STARTED|Overall Study||440
6293166|NCT00290290|7195155|FG001|STARTED|Overall Study||409
6293167|NCT00290290|7195154|FG000|COMPLETED|Overall Study||422
6293168|NCT00290290|7195155|FG001|COMPLETED|Overall Study||391
6293169|NCT00290290|7195154|FG000|NOT COMPLETED|Overall Study||18
6293170|NCT00290290|7195155|FG001|NOT COMPLETED|Overall Study||18
6400300|NCT00885846|7313192|FG001|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
6400301|NCT00885846|7313193|FG002|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
6400302|NCT00885846|7313191|FG000|NOT COMPLETED|Overall Study||2
6400303|NCT00885846|7313192|FG001|NOT COMPLETED|Overall Study||5
6293171|NCT00290329|7195164|FG000|STARTED|Overall Study||102
6293172|NCT00290329|7195165|FG001|STARTED|Overall Study||86
6293173|NCT00290329|7195166|FG002|STARTED|Overall Study||61
6293174|NCT00290329|7195164|FG000|COMPLETED|Overall Study||102
6293175|NCT00290329|7195165|FG001|COMPLETED|Overall Study||86
6293176|NCT00290329|7195166|FG002|COMPLETED|Overall Study||61
6293177|NCT00290329|7195164|FG000|NOT COMPLETED|Overall Study||0
6293178|NCT00290329|7195165|FG001|NOT COMPLETED|Overall Study||0
6293179|NCT00290329|7195166|FG002|NOT COMPLETED|Overall Study||0
6293180|NCT00290342|7195178|FG000|STARTED|Overall Study||224
6293181|NCT00290342|7195179|FG001|STARTED|Overall Study||228
6293182|NCT00290342|7195178|FG000|COMPLETED|Overall Study||217
6293183|NCT00290342|7195179|FG001|COMPLETED|Overall Study||223
6293184|NCT00290342|7195178|FG000|NOT COMPLETED|Overall Study||7
6293185|NCT00290342|7195179|FG001|NOT COMPLETED|Overall Study||5
6293186|NCT00290355|7195187|FG000|STARTED|Overall Study||122
6400304|NCT00885846|7313193|FG002|NOT COMPLETED|Overall Study||2
6400305|NCT00886015|7313203|FG000|STARTED|Overall Study|1674 eyes; 960 participants|1674
6400306|NCT00886015|7313204|FG001|STARTED|Overall Study|1671 eyes; 957 participants|1671
6400307|NCT00886015|7313203|FG000|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
6400308|NCT00886015|7313204|FG001|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
6400309|NCT00886015|7313203|FG000|NOT COMPLETED|Overall Study||0
6400310|NCT00886015|7313204|FG001|NOT COMPLETED|Overall Study||2
6400311|NCT00886119|7313210|FG000|STARTED|Period 1||24
6400312|NCT00886119|7313211|FG001|STARTED|Period 1||22
6400313|NCT00886119|7313210|FG000|COMPLETED|Period 1||23
6400314|NCT00886119|7313211|FG001|COMPLETED|Period 1||22
6400315|NCT00886119|7313210|FG000|NOT COMPLETED|Period 1||1
6400316|NCT00886119|7313211|FG001|NOT COMPLETED|Period 1||0
6400317|NCT00886119|7313210|FG000|STARTED|Period 2||23
6400318|NCT00886119|7313211|FG001|STARTED|Period 2||22
6400319|NCT00886119|7313210|FG000|COMPLETED|Period 2||23
6400320|NCT00886119|7313211|FG001|COMPLETED|Period 2||22
6400321|NCT00886119|7313210|FG000|NOT COMPLETED|Period 2||0
6400322|NCT00886119|7313211|FG001|NOT COMPLETED|Period 2||0
6400323|NCT00886145|7313217|FG000|STARTED|Overall Study||1
6400324|NCT00886145|7313217|FG000|COMPLETED|Overall Study||1
6400325|NCT00886145|7313217|FG000|NOT COMPLETED|Overall Study||0
6400326|NCT00886236|7313226|FG000|STARTED|Overall Study||20
6400327|NCT00886236|7313227|FG001|STARTED|Overall Study||21
6400328|NCT00886236|7313228|FG002|STARTED|Overall Study||21
6400329|NCT00886236|7313226|FG000|COMPLETED|Overall Study||18
6400330|NCT00886236|7313227|FG001|COMPLETED|Overall Study||17
6293187|NCT00290355|7195188|FG001|STARTED|Overall Study||60
6293188|NCT00290355|7195187|FG000|COMPLETED|Overall Study||105
6293189|NCT00290355|7195188|FG001|COMPLETED|Overall Study||55
6293190|NCT00290355|7195187|FG000|NOT COMPLETED|Overall Study||17
6293191|NCT00290355|7195188|FG001|NOT COMPLETED|Overall Study||5
6293192|NCT00290433|7195194|FG000|STARTED|Overall Study||53
6293193|NCT00290433|7195194|FG000|COMPLETED|Overall Study||17
6293194|NCT00290433|7195194|FG000|NOT COMPLETED|Overall Study||36
6293195|NCT00290472|7195201|FG000|STARTED|Overall Study||32
6293196|NCT00290472|7195202|FG001|STARTED|Overall Study||39
6293197|NCT00290472|7195203|FG002|STARTED|Overall Study||18
6293198|NCT00290472|7195201|FG000|COMPLETED|Overall Study||32
6293199|NCT00290472|7195202|FG001|COMPLETED|Overall Study||39
6293200|NCT00290472|7195203|FG002|COMPLETED|Overall Study||18
6293201|NCT00290472|7195201|FG000|NOT COMPLETED|Overall Study||0
6293202|NCT00290472|7195202|FG001|NOT COMPLETED|Overall Study||0
6293203|NCT00290472|7195203|FG002|NOT COMPLETED|Overall Study||0
6293204|NCT00290498|7195211|FG000|STARTED|Overall Study||49
6293205|NCT00290498|7195212|FG001|STARTED|Overall Study||10
6293206|NCT00290498|7195211|FG000|COMPLETED|Overall Study||41
6293207|NCT00290498|7195212|FG001|COMPLETED|Overall Study||10
6293208|NCT00290498|7195211|FG000|NOT COMPLETED|Overall Study||8
6293209|NCT00290498|7195212|FG001|NOT COMPLETED|Overall Study||0
6293210|NCT00290537|7195219|FG000|STARTED|Overall Study||4
6293211|NCT00290537|7195220|FG001|STARTED|Overall Study||0
6293212|NCT00290537|7195219|FG000|COMPLETED|Overall Study||4
6293213|NCT00290537|7195220|FG001|COMPLETED|Overall Study||0
6293214|NCT00290537|7195219|FG000|NOT COMPLETED|Overall Study||0
6293215|NCT00290537|7195220|FG001|NOT COMPLETED|Overall Study||0
6293216|NCT00290589|7195227|FG000|STARTED|Overall Study||39
6293217|NCT00290589|7195228|FG001|STARTED|Overall Study||43
6293218|NCT00290589|7195227|FG000|COMPLETED|Overall Study||37
6293219|NCT00290589|7195228|FG001|COMPLETED|Overall Study||41
6293220|NCT00290589|7195227|FG000|NOT COMPLETED|Overall Study||2
6293221|NCT00290589|7195228|FG001|NOT COMPLETED|Overall Study||2
6293222|NCT00290615|7195234|FG000|STARTED|Overall Study||30
6293223|NCT00290615|7195234|FG000|COMPLETED|Overall Study||30
6293224|NCT00290615|7195234|FG000|NOT COMPLETED|Overall Study||0
6293225|NCT00290654|7195238|FG000|STARTED|Overall Study||41
6293226|NCT00290654|7195238|FG000|COMPLETED|Overall Study||41
6293227|NCT00290654|7195238|FG000|NOT COMPLETED|Overall Study||0
6293228|NCT00290693|7195242|FG000|STARTED|Overall Study||45
6293229|NCT00290693|7195242|FG000|COMPLETED|Overall Study||43
6293230|NCT00290693|7195242|FG000|NOT COMPLETED|Overall Study||2
6293231|NCT00290706|7195251|FG000|STARTED|Overall Study||5
6293232|NCT00290706|7195252|FG001|STARTED|Overall Study||6
6293233|NCT00290706|7195253|FG002|STARTED|Overall Study||7
6293234|NCT00290706|7195254|FG003|STARTED|Overall Study||14
6293235|NCT00290706|7195251|FG000|Attempted1st Cycle|Overall Study||5
6293236|NCT00290706|7195252|FG001|Attempted1st Cycle|Overall Study||6
6293237|NCT00290706|7195253|FG002|Attempted1st Cycle|Overall Study||7
6293238|NCT00290706|7195254|FG003|Attempted1st Cycle|Overall Study||14
6293239|NCT00290706|7195251|FG000|Reached 1st Response/Cycle 3|Overall Study||0
6293240|NCT00290706|7195252|FG001|Reached 1st Response/Cycle 3|Overall Study||0
6293241|NCT00290706|7195253|FG002|Reached 1st Response/Cycle 3|Overall Study||1
6293242|NCT00290706|7195254|FG003|Reached 1st Response/Cycle 3|Overall Study||2
6293243|NCT00290706|7195251|FG000|COMPLETED|Overall Study||0
6293244|NCT00290706|7195252|FG001|COMPLETED|Overall Study||0
6293245|NCT00290706|7195253|FG002|COMPLETED|Overall Study||1
6293246|NCT00290706|7195254|FG003|COMPLETED|Overall Study||2
6293247|NCT00290706|7195251|FG000|NOT COMPLETED|Overall Study||5
6293248|NCT00290706|7195252|FG001|NOT COMPLETED|Overall Study||6
6293249|NCT00290706|7195253|FG002|NOT COMPLETED|Overall Study||6
6293250|NCT00290706|7195254|FG003|NOT COMPLETED|Overall Study||12
6293251|NCT00290732|7195267|FG000|STARTED|Overall Study||3
6293252|NCT00290732|7195268|FG001|STARTED|Overall Study||4
6293253|NCT00290732|7195269|FG002|STARTED|Overall Study||4
6293254|NCT00290732|7195270|FG003|STARTED|Overall Study||6
6293255|NCT00290732|7195271|FG004|STARTED|Overall Study||3
6293256|NCT00290732|7195267|FG000|COMPLETED|Overall Study||3
6293257|NCT00290732|7195268|FG001|COMPLETED|Overall Study||3
6293258|NCT00290732|7195269|FG002|COMPLETED|Overall Study||3
6293259|NCT00290732|7195270|FG003|COMPLETED|Overall Study||6
6293260|NCT00290732|7195271|FG004|COMPLETED|Overall Study||3
6293261|NCT00290732|7195267|FG000|NOT COMPLETED|Overall Study||0
6400331|NCT00886236|7313228|FG002|COMPLETED|Overall Study||17
6400332|NCT00886236|7313226|FG000|NOT COMPLETED|Overall Study||2
6400333|NCT00886236|7313227|FG001|NOT COMPLETED|Overall Study||4
6400334|NCT00886236|7313228|FG002|NOT COMPLETED|Overall Study||4
6400335|NCT00886262|7313238|FG000|STARTED|Overall Study||8
6400336|NCT00886262|7313239|FG001|STARTED|Overall Study||10
6400337|NCT00886262|7313238|FG000|COMPLETED|Overall Study||8
6400338|NCT00886262|7313239|FG001|COMPLETED|Overall Study||7
6293262|NCT00290732|7195268|FG001|NOT COMPLETED|Overall Study||1
6293263|NCT00290732|7195269|FG002|NOT COMPLETED|Overall Study||1
6293264|NCT00290732|7195270|FG003|NOT COMPLETED|Overall Study||0
6293265|NCT00290732|7195271|FG004|NOT COMPLETED|Overall Study||0
6400339|NCT00886262|7313238|FG000|NOT COMPLETED|Overall Study||0
6400340|NCT00886262|7313239|FG001|NOT COMPLETED|Overall Study||3
6293266|NCT00290745|7195284|FG000|STARTED|Overall Study||79
6293267|NCT00290745|7195284|FG000|COMPLETED|Overall Study||67
6293268|NCT00290745|7195284|FG000|NOT COMPLETED|Overall Study||12
6374213|NCT00749203|7284814|FG000|COMPLETED|Second Infusion at 2 Weeks||16
6374214|NCT00749203|7284815|FG001|COMPLETED|Second Infusion at 2 Weeks||13
6374215|NCT00749203|7284814|FG000|NOT COMPLETED|Second Infusion at 2 Weeks||0
6400341|NCT00886288|7313247|FG000|STARTED|Overall Study|Baseline Population|2027
6293269|NCT00290771|7195290|FG000|STARTED|Overall Study||131
6293270|NCT00290771|7195291|FG001|STARTED|Overall Study||100
6293271|NCT00290771|7195290|FG000|COMPLETED|Overall Study||4
6293272|NCT00290771|7195291|FG001|COMPLETED|Overall Study||3
6293273|NCT00290771|7195290|FG000|NOT COMPLETED|Overall Study||127
6293274|NCT00290771|7195291|FG001|NOT COMPLETED|Overall Study||97
6293275|NCT00290810|7195298|FG000|STARTED|Overall Study||12
6293276|NCT00290810|7195298|FG000|COMPLETED|Overall Study||12
6293277|NCT00290810|7195298|FG000|NOT COMPLETED|Overall Study||0
6293278|NCT00290888|7195304|FG000|STARTED|Overall Study||41
6293279|NCT00290888|7195305|FG001|STARTED|Overall Study||45
6293280|NCT00290888|7195304|FG000|COMPLETED|Overall Study||38
6293281|NCT00290888|7195305|FG001|COMPLETED|Overall Study||44
6293282|NCT00290888|7195304|FG000|NOT COMPLETED|Overall Study||3
6293283|NCT00290888|7195305|FG001|NOT COMPLETED|Overall Study||1
6293284|NCT00291018|7195315|FG000|STARTED|Overall Study|Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated.|103
6293285|NCT00291018|7195316|FG001|STARTED|Overall Study|Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated.|106
6293286|NCT00291018|7195317|FG002|STARTED|Overall Study|Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated.|136
6293287|NCT00291018|7195315|FG000|Evaluated at 24 Months|Overall Study||99
6293288|NCT00291018|7195316|FG001|Evaluated at 24 Months|Overall Study||92
6293289|NCT00291018|7195317|FG002|Evaluated at 24 Months|Overall Study||105
6293290|NCT00291018|7195315|FG000|COMPLETED|Overall Study|Evaluated at 84 Months|78
6293291|NCT00291018|7195316|FG001|COMPLETED|Overall Study|Evaluated at 84 Months|64
6293292|NCT00291018|7195317|FG002|COMPLETED|Overall Study|Evaluated at 84 Months|93
6293293|NCT00291018|7195315|FG000|NOT COMPLETED|Overall Study||25
6293294|NCT00291018|7195316|FG001|NOT COMPLETED|Overall Study||42
6293295|NCT00291018|7195317|FG002|NOT COMPLETED|Overall Study||43
6293296|NCT00291135|7195328|FG000|STARTED|Overall Study||42
6293297|NCT00291135|7195328|FG000|COMPLETED|Overall Study||42
6293298|NCT00291135|7195328|FG000|NOT COMPLETED|Overall Study||0
6293299|NCT00291161|7195336|FG000|STARTED|Overall Study||316
6293300|NCT00291161|7195337|FG001|STARTED|Overall Study||192
6293301|NCT00291161|7195338|FG002|STARTED|Overall Study||299
6293302|NCT00291161|7195339|FG003|STARTED|Overall Study||187
6293303|NCT00291161|7195336|FG000|COMPLETED|Overall Study||235
6293304|NCT00291161|7195337|FG001|COMPLETED|Overall Study||134
6293305|NCT00291161|7195338|FG002|COMPLETED|Overall Study||206
6293306|NCT00291161|7195339|FG003|COMPLETED|Overall Study||122
6293307|NCT00291161|7195336|FG000|NOT COMPLETED|Overall Study||81
6293308|NCT00291161|7195337|FG001|NOT COMPLETED|Overall Study||58
6293309|NCT00291161|7195338|FG002|NOT COMPLETED|Overall Study||93
6293310|NCT00291161|7195339|FG003|NOT COMPLETED|Overall Study||65
6293311|NCT00291187|7195351|FG000|STARTED|Overall Study||103
6293312|NCT00291187|7195352|FG001|STARTED|Overall Study||100
6293313|NCT00291187|7195353|FG002|STARTED|Overall Study||103
6293314|NCT00291187|7195354|FG003|STARTED|Overall Study||106
6293315|NCT00291187|7195351|FG000|COMPLETED|Overall Study||103
6293316|NCT00291187|7195352|FG001|COMPLETED|Overall Study||100
6634866|NCT02300129|7563715|FG003|STARTED|Period 1 Session 3 (Day 5)||11
6634867|NCT02300129|7563712|FG000|COMPLETED|Period 1 Session 3 (Day 5)||11
6634868|NCT02300129|7563713|FG001|COMPLETED|Period 1 Session 3 (Day 5)||4
6293317|NCT00291187|7195353|FG002|COMPLETED|Overall Study||102
6293318|NCT00291187|7195354|FG003|COMPLETED|Overall Study||106
6293319|NCT00291187|7195351|FG000|NOT COMPLETED|Overall Study||0
6293320|NCT00291187|7195352|FG001|NOT COMPLETED|Overall Study||0
6293321|NCT00291187|7195353|FG002|NOT COMPLETED|Overall Study||1
6293322|NCT00291187|7195354|FG003|NOT COMPLETED|Overall Study||0
6293323|NCT00291226|7195370|FG000|STARTED|Overall Study||4
6293324|NCT00291226|7195371|FG001|STARTED|Overall Study||4
6293325|NCT00291226|7195370|FG000|COMPLETED|Overall Study||3
6293326|NCT00291226|7195371|FG001|COMPLETED|Overall Study||3
6293327|NCT00291226|7195370|FG000|NOT COMPLETED|Overall Study||1
6293328|NCT00291226|7195371|FG001|NOT COMPLETED|Overall Study||1
6293329|NCT00291317|7195377|FG000|STARTED|Overall Study||6
6293330|NCT00291317|7195377|FG000|COMPLETED|Overall Study||6
6293331|NCT00291317|7195377|FG000|NOT COMPLETED|Overall Study||0
6293332|NCT00291330|7195384|FG000|STARTED|Overall Study|Started Treatment|1273
6293333|NCT00291330|7195385|FG001|STARTED|Overall Study|Started Treatment|1266
6293334|NCT00291330|7195384|FG000|COMPLETED|Overall Study|Completed planned observation time|1172
6293335|NCT00291330|7195385|FG001|COMPLETED|Overall Study|Completed planned observation time|1169
6293336|NCT00291330|7195384|FG000|NOT COMPLETED|Overall Study||101
6293337|NCT00291330|7195385|FG001|NOT COMPLETED|Overall Study||97
6293338|NCT00291343|7195393|FG000|STARTED|Overall Study||203
6293339|NCT00291343|7195394|FG001|STARTED|Overall Study||93
6293340|NCT00291343|7195393|FG000|COMPLETED|Overall Study||203
6293341|NCT00291343|7195394|FG001|COMPLETED|Overall Study||93
6293342|NCT00291343|7195393|FG000|NOT COMPLETED|Overall Study||0
6293343|NCT00291343|7195394|FG001|NOT COMPLETED|Overall Study||0
6293344|NCT00291447|7195404|FG000|STARTED|Overall Study||2
6293345|NCT00291447|7195405|FG001|STARTED|Overall Study||2
6293346|NCT00291447|7195406|FG002|STARTED|Overall Study||2
6634869|NCT02300129|7563714|FG002|COMPLETED|Period 1 Session 3 (Day 5)||7
6293347|NCT00291447|7195407|FG003|STARTED|Overall Study||2
6293348|NCT00291447|7195404|FG000|COMPLETED|Overall Study||2
6293349|NCT00291447|7195405|FG001|COMPLETED|Overall Study||2
6293350|NCT00291447|7195406|FG002|COMPLETED|Overall Study||2
6293351|NCT00291447|7195407|FG003|COMPLETED|Overall Study||2
6293352|NCT00291447|7195404|FG000|NOT COMPLETED|Overall Study||0
6293353|NCT00291447|7195405|FG001|NOT COMPLETED|Overall Study||0
6293354|NCT00291447|7195406|FG002|NOT COMPLETED|Overall Study||0
6293355|NCT00291447|7195407|FG003|NOT COMPLETED|Overall Study||0
6293356|NCT00291499|7195420|FG000|STARTED|Overall Study||81
6293357|NCT00291499|7195421|FG001|STARTED|Overall Study||82
6293358|NCT00291499|7195420|FG000|Intention to Treat (ITT)|Overall Study||80
6400342|NCT00886288|7313248|FG001|STARTED|Overall Study|Baseline Population|684
6400343|NCT00886288|7313247|FG000|COMPLETED|Overall Study||1284
6400344|NCT00886288|7313248|FG001|COMPLETED|Overall Study||457
6400345|NCT00886288|7313247|FG000|NOT COMPLETED|Overall Study||743
6400346|NCT00886288|7313248|FG001|NOT COMPLETED|Overall Study||227
6400347|NCT00886340|7313258|FG000|STARTED|Overall Study||27
6293359|NCT00291499|7195421|FG001|Intention to Treat (ITT)|Overall Study||82
6293360|NCT00291499|7195420|FG000|Per Protocol (PP)|Overall Study||72
6293361|NCT00291499|7195421|FG001|Per Protocol (PP)|Overall Study||67
6293362|NCT00291499|7195420|FG000|Safety Population|Overall Study||81
6293363|NCT00291499|7195421|FG001|Safety Population|Overall Study||82
6293364|NCT00291499|7195420|FG000|COMPLETED|Overall Study||72
6293365|NCT00291499|7195421|FG001|COMPLETED|Overall Study||67
6293366|NCT00291499|7195420|FG000|NOT COMPLETED|Overall Study||9
6293367|NCT00291499|7195421|FG001|NOT COMPLETED|Overall Study||15
6293368|NCT00291551|7195427|FG000|STARTED|Overall Study||39
6293369|NCT00291551|7195427|FG000|COMPLETED|Overall Study||26
6293370|NCT00291551|7195427|FG000|NOT COMPLETED|Overall Study||13
6400348|NCT00886340|7313259|FG001|STARTED|Overall Study||31
6400349|NCT00886340|7313258|FG000|COMPLETED|Overall Study||27
6400350|NCT00886340|7313259|FG001|COMPLETED|Overall Study||24
6293371|NCT00291577|7195432|FG000|STARTED|Overall Study||22
6293372|NCT00291577|7195432|FG000|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
6293373|NCT00291577|7195432|FG000|NOT COMPLETED|Overall Study||21
6293374|NCT00291642|7195441|FG000|STARTED|Overall Study||78
6293375|NCT00291642|7195442|FG001|STARTED|Overall Study||116
6293376|NCT00291642|7195443|FG002|STARTED|Overall Study||119
6293377|NCT00291642|7195444|FG003|STARTED|Overall Study||119
6293378|NCT00291642|7195445|FG004|STARTED|Overall Study||119
6293379|NCT00291642|7195441|FG000|COMPLETED|Overall Study||76
6293380|NCT00291642|7195442|FG001|COMPLETED|Overall Study||116
6293381|NCT00291642|7195443|FG002|COMPLETED|Overall Study||117
6293382|NCT00291642|7195444|FG003|COMPLETED|Overall Study||119
6293383|NCT00291642|7195445|FG004|COMPLETED|Overall Study||118
6293384|NCT00291642|7195441|FG000|NOT COMPLETED|Overall Study||2
6293385|NCT00291642|7195442|FG001|NOT COMPLETED|Overall Study||0
6400351|NCT00886340|7313258|FG000|NOT COMPLETED|Overall Study||0
6400352|NCT00886340|7313259|FG001|NOT COMPLETED|Overall Study||7
6400353|NCT00886379|7313270|FG000|STARTED|Overall Study||104
6400354|NCT00886379|7313271|FG001|STARTED|Overall Study||143
6400355|NCT00886379|7313272|FG002|STARTED|Overall Study||143
6400356|NCT00886379|7313273|FG003|STARTED|Overall Study||112
6400357|NCT00886379|7313274|FG004|STARTED|Overall Study||95
6400358|NCT00886379|7313270|FG000|COMPLETED|Overall Study||101
6293386|NCT00291642|7195443|FG002|NOT COMPLETED|Overall Study||2
6293387|NCT00291642|7195444|FG003|NOT COMPLETED|Overall Study||0
6293388|NCT00291642|7195445|FG004|NOT COMPLETED|Overall Study||1
6293389|NCT00291655|7195457|FG000|STARTED|Overall Study||130
6293390|NCT00291655|7195457|FG000|COMPLETED|Overall Study||115
6293391|NCT00291655|7195457|FG000|NOT COMPLETED|Overall Study||15
6293392|NCT00291668|7195464|FG000|STARTED|Overall Study||32
6293393|NCT00291668|7195465|FG001|STARTED|Overall Study||30
6293394|NCT00291668|7195466|FG002|STARTED|Overall Study||32
6293395|NCT00291668|7195464|FG000|COMPLETED|Overall Study||28
6293396|NCT00291668|7195465|FG001|COMPLETED|Overall Study||29
6293397|NCT00291668|7195466|FG002|COMPLETED|Overall Study||31
6293398|NCT00291668|7195464|FG000|NOT COMPLETED|Overall Study||4
6293399|NCT00291668|7195465|FG001|NOT COMPLETED|Overall Study||1
6293400|NCT00291668|7195466|FG002|NOT COMPLETED|Overall Study||1
6293401|NCT00291694|7195476|FG000|STARTED|Overall Study||24
6293402|NCT00291694|7195477|FG001|STARTED|Overall Study||48
6293403|NCT00291694|7195476|FG000|COMPLETED|Overall Study||21
6293404|NCT00291694|7195477|FG001|COMPLETED|Overall Study||43
6293405|NCT00291694|7195476|FG000|NOT COMPLETED|Overall Study||3
6293406|NCT00291694|7195477|FG001|NOT COMPLETED|Overall Study||5
6293407|NCT00291876|7195485|FG000|STARTED|Month 138||107
6293408|NCT00291876|7195485|FG000|COMPLETED|Month 138||107
6293409|NCT00291876|7195485|FG000|NOT COMPLETED|Month 138||0
6293410|NCT00291876|7195485|FG000|STARTED|Month 150||117
6293411|NCT00291876|7195485|FG000|COMPLETED|Month 150||117
6293412|NCT00291876|7195485|FG000|NOT COMPLETED|Month 150||0
6293413|NCT00291876|7195485|FG000|STARTED|Month 162||127
6293414|NCT00291876|7195485|FG000|COMPLETED|Month 162||127
6293415|NCT00291876|7195485|FG000|NOT COMPLETED|Month 162||0
6293416|NCT00291876|7195485|FG000|STARTED|Month 174||127
6293417|NCT00291876|7195485|FG000|COMPLETED|Month 174||127
6293418|NCT00291876|7195485|FG000|NOT COMPLETED|Month 174||0
6400359|NCT00886379|7313271|FG001|COMPLETED|Overall Study||140
6400360|NCT00886379|7313272|FG002|COMPLETED|Overall Study||137
6400361|NCT00886379|7313273|FG003|COMPLETED|Overall Study||109
6400362|NCT00886379|7313274|FG004|COMPLETED|Overall Study||92
6400363|NCT00886379|7313270|FG000|NOT COMPLETED|Overall Study||3
6293419|NCT00291876|7195485|FG000|STARTED|Month 186||129
6293420|NCT00291876|7195485|FG000|COMPLETED|Month 186||129
6293421|NCT00291876|7195485|FG000|NOT COMPLETED|Month 186||0
6293422|NCT00291876|7195485|FG000|STARTED|Month 198||135
6293423|NCT00291876|7195485|FG000|COMPLETED|Month 198||135
6293424|NCT00291876|7195485|FG000|NOT COMPLETED|Month 198||0
6293425|NCT00291876|7195485|FG000|STARTED|Month 210||124
6293426|NCT00291876|7195485|FG000|COMPLETED|Month 210||124
6293427|NCT00291876|7195485|FG000|NOT COMPLETED|Month 210||0
6293428|NCT00291876|7195485|FG000|STARTED|Month 222||114
6293429|NCT00291876|7195485|FG000|COMPLETED|Month 222||114
6293430|NCT00291876|7195485|FG000|NOT COMPLETED|Month 222||0
6293431|NCT00291876|7195485|FG000|STARTED|Month 234||110
6293432|NCT00291876|7195485|FG000|COMPLETED|Month 234||110
6293433|NCT00291876|7195485|FG000|NOT COMPLETED|Month 234||0
6293434|NCT00291876|7195485|FG000|STARTED|Month 246||116
6293435|NCT00291876|7195485|FG000|COMPLETED|Month 246||116
6293436|NCT00291876|7195485|FG000|NOT COMPLETED|Month 246||0
6293437|NCT00292045|7195489|FG000|STARTED|Core Study (Through Week 13)||15
6293438|NCT00292045|7195489|FG000|COMPLETED|Core Study (Through Week 13)||13
6293439|NCT00292045|7195489|FG000|NOT COMPLETED|Core Study (Through Week 13)||2
6293440|NCT00292045|7195489|FG000|STARTED|Extended Treatment Beyond Week 13||10
6293441|NCT00292045|7195489|FG000|COMPLETED|Extended Treatment Beyond Week 13||10
6293442|NCT00292045|7195489|FG000|NOT COMPLETED|Extended Treatment Beyond Week 13||0
6293443|NCT00292162|7195495|FG000|STARTED|Overall Study||19
6293444|NCT00292162|7195496|FG001|STARTED|Overall Study||22
6293445|NCT00292162|7195495|FG000|COMPLETED|Overall Study||18
6293446|NCT00292162|7195496|FG001|COMPLETED|Overall Study||20
6293447|NCT00292162|7195495|FG000|NOT COMPLETED|Overall Study||1
6293448|NCT00292162|7195496|FG001|NOT COMPLETED|Overall Study||2
6293449|NCT00292188|7195504|FG000|STARTED|Single-Blind||368
6293450|NCT00292188|7195505|FG001|STARTED|Single-Blind||0
6293451|NCT00292188|7195506|FG002|STARTED|Single-Blind||0
6293452|NCT00292188|7195504|FG000|Received Treatment|Single-Blind||367
6293453|NCT00292188|7195505|FG001|Received Treatment|Single-Blind||0
6293454|NCT00292188|7195506|FG002|Received Treatment|Single-Blind||0
6293455|NCT00292188|7195504|FG000|COMPLETED|Single-Blind||254
6293456|NCT00292188|7195505|FG001|COMPLETED|Single-Blind||0
6293457|NCT00292188|7195506|FG002|COMPLETED|Single-Blind||0
6293458|NCT00292188|7195504|FG000|NOT COMPLETED|Single-Blind||114
6293459|NCT00292188|7195505|FG001|NOT COMPLETED|Single-Blind||0
6293460|NCT00292188|7195506|FG002|NOT COMPLETED|Single-Blind||0
6293461|NCT00292188|7195504|FG000|STARTED|Double-Blind||0
6293462|NCT00292188|7195505|FG001|STARTED|Double-Blind||127
6293463|NCT00292188|7195506|FG002|STARTED|Double-Blind||127
6293464|NCT00292188|7195504|FG000|COMPLETED|Double-Blind||0
6293465|NCT00292188|7195505|FG001|COMPLETED|Double-Blind||96
6293466|NCT00292188|7195506|FG002|COMPLETED|Double-Blind||98
6293467|NCT00292188|7195504|FG000|NOT COMPLETED|Double-Blind||0
6293468|NCT00292188|7195505|FG001|NOT COMPLETED|Double-Blind||31
6293469|NCT00292188|7195506|FG002|NOT COMPLETED|Double-Blind||29
6293470|NCT00292227|7195515|FG000|STARTED|Patch Period||66
6293471|NCT00292227|7195516|FG001|STARTED|Patch Period||31
6400364|NCT00886379|7313271|FG001|NOT COMPLETED|Overall Study||3
6400365|NCT00886379|7313272|FG002|NOT COMPLETED|Overall Study||6
6400366|NCT00886379|7313273|FG003|NOT COMPLETED|Overall Study||3
6400367|NCT00886379|7313274|FG004|NOT COMPLETED|Overall Study||3
6400368|NCT00886483|7313288|FG000|STARTED|Overall Study||26
6293472|NCT00292227|7195517|FG002|STARTED|Patch Period||33
6293473|NCT00292227|7195515|FG000|COMPLETED|Patch Period||65
6293474|NCT00292227|7195516|FG001|COMPLETED|Patch Period||31
6293475|NCT00292227|7195517|FG002|COMPLETED|Patch Period||30
6293476|NCT00292227|7195515|FG000|NOT COMPLETED|Patch Period||1
6293477|NCT00292227|7195516|FG001|NOT COMPLETED|Patch Period||0
6293478|NCT00292227|7195517|FG002|NOT COMPLETED|Patch Period||3
6293479|NCT00292227|7195515|FG000|STARTED|Cross-over Period 1 (Day 32)||65
6293480|NCT00292227|7195516|FG001|STARTED|Cross-over Period 1 (Day 32)||31
6293481|NCT00292227|7195517|FG002|STARTED|Cross-over Period 1 (Day 32)||30
6293482|NCT00292227|7195515|FG000|COMPLETED|Cross-over Period 1 (Day 32)||65
6293483|NCT00292227|7195516|FG001|COMPLETED|Cross-over Period 1 (Day 32)||31
6293484|NCT00292227|7195517|FG002|COMPLETED|Cross-over Period 1 (Day 32)||30
6293485|NCT00292227|7195515|FG000|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
6293486|NCT00292227|7195516|FG001|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
6293487|NCT00292227|7195517|FG002|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
6293488|NCT00292227|7195515|FG000|STARTED|Cross-over Period 2 (Day 39)||65
6293489|NCT00292227|7195516|FG001|STARTED|Cross-over Period 2 (Day 39)||31
6293490|NCT00292227|7195517|FG002|STARTED|Cross-over Period 2 (Day 39)||30
6293491|NCT00292227|7195515|FG000|COMPLETED|Cross-over Period 2 (Day 39)||65
6293492|NCT00292227|7195516|FG001|COMPLETED|Cross-over Period 2 (Day 39)||31
6293493|NCT00292227|7195517|FG002|COMPLETED|Cross-over Period 2 (Day 39)||30
6293494|NCT00292227|7195515|FG000|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
6293495|NCT00292227|7195516|FG001|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
6293496|NCT00292227|7195517|FG002|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
6293497|NCT00292318|7195527|FG000|STARTED|Overall Study||4
6293498|NCT00292318|7195528|FG001|STARTED|Overall Study||3
6293499|NCT00292318|7195527|FG000|COMPLETED|Overall Study||2
6293500|NCT00292318|7195528|FG001|COMPLETED|Overall Study||2
6293501|NCT00292318|7195527|FG000|NOT COMPLETED|Overall Study||2
6293502|NCT00292318|7195528|FG001|NOT COMPLETED|Overall Study||1
6400369|NCT00886483|7313289|FG001|STARTED|Overall Study||13
6293503|NCT00292370|7195537|FG000|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
6293504|NCT00292370|7195538|FG001|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
6400370|NCT00886483|7313288|FG000|Completed 20 Treatments|Overall Study||25
6293505|NCT00292370|7195539|FG002|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
6293506|NCT00292370|7195537|FG000|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
6293507|NCT00292370|7195538|FG001|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
6293508|NCT00292370|7195539|FG002|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
6293509|NCT00292370|7195537|FG000|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
6293510|NCT00292370|7195538|FG001|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
6293511|NCT00292370|7195539|FG002|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
6293512|NCT00292370|7195537|FG000|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I~28 Excluded Ph II:~20 responded~7 declined~1 medical~50 to Arm 2 & 3"|0
6293513|NCT00292370|7195538|FG001|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
6293514|NCT00292370|7195539|FG002|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
6293515|NCT00292370|7195537|FG000|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
6293516|NCT00292370|7195538|FG001|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
6293517|NCT00292370|7195539|FG002|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
6293518|NCT00292370|7195537|FG000|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
6293519|NCT00292370|7195538|FG001|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
6293520|NCT00292370|7195539|FG002|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
6293521|NCT00292461|7195548|FG000|STARTED|Overall Study||34
6293522|NCT00292461|7195549|FG001|STARTED|Overall Study||30
6293523|NCT00292461|7195548|FG000|COMPLETED|Overall Study||24
6293524|NCT00292461|7195549|FG001|COMPLETED|Overall Study||24
6634870|NCT02300129|7563715|FG003|COMPLETED|Period 1 Session 3 (Day 5)||11
6634871|NCT02300129|7563712|FG000|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
6634872|NCT02300129|7563713|FG001|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
6634873|NCT02300129|7563714|FG002|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
6293525|NCT00292461|7195548|FG000|NOT COMPLETED|Overall Study||10
6293526|NCT00292461|7195549|FG001|NOT COMPLETED|Overall Study||6
6293527|NCT00292591|7195558|FG000|STARTED|Overall Study||166
6293528|NCT00292591|7195559|FG001|STARTED|Overall Study||167
6293529|NCT00292591|7195560|FG002|STARTED|Overall Study||168
6293530|NCT00292591|7195558|FG000|COMPLETED|Overall Study||102
6293531|NCT00292591|7195559|FG001|COMPLETED|Overall Study||111
6293532|NCT00292591|7195560|FG002|COMPLETED|Overall Study||110
6293533|NCT00292591|7195558|FG000|NOT COMPLETED|Overall Study||64
6293534|NCT00292591|7195559|FG001|NOT COMPLETED|Overall Study||56
6293535|NCT00292591|7195560|FG002|NOT COMPLETED|Overall Study||58
6293536|NCT00292942|7195572|FG000|STARTED|Overall Study||6
6293537|NCT00292942|7195573|FG001|STARTED|Overall Study||6
6293538|NCT00292942|7195574|FG002|STARTED|Overall Study||7
6293539|NCT00292942|7195575|FG003|STARTED|Overall Study||7
6293540|NCT00292942|7195572|FG000|COMPLETED|Overall Study||6
6293541|NCT00292942|7195573|FG001|COMPLETED|Overall Study||6
6293542|NCT00292942|7195574|FG002|COMPLETED|Overall Study||6
6293543|NCT00292942|7195575|FG003|COMPLETED|Overall Study||6
6293544|NCT00292942|7195572|FG000|NOT COMPLETED|Overall Study||0
6293545|NCT00292942|7195573|FG001|NOT COMPLETED|Overall Study||0
6293546|NCT00292942|7195574|FG002|NOT COMPLETED|Overall Study||1
6293547|NCT00292942|7195575|FG003|NOT COMPLETED|Overall Study||1
6293548|NCT00292981|7195588|FG000|STARTED|Overall Study||57
6293549|NCT00292981|7195588|FG000|COMPLETED|Overall Study||18
6293550|NCT00292981|7195588|FG000|NOT COMPLETED|Overall Study||39
6293551|NCT00293020|7195592|FG000|STARTED|Overall Study||244
6293552|NCT00293020|7195592|FG000|COMPLETED|Overall Study||82
6293553|NCT00293020|7195592|FG000|NOT COMPLETED|Overall Study||162
6293554|NCT00293033|7195596|FG000|STARTED|Open-label Titration Period|152 subjects enrolled; 151 subjects received at least one dose of study drug|151
6293555|NCT00293033|7195596|FG000|COMPLETED|Open-label Titration Period||82
6293556|NCT00293033|7195596|FG000|NOT COMPLETED|Open-label Titration Period||69
6293557|NCT00293033|7195596|FG000|STARTED|Double-blind Treatment Period|82 randomized; 1 didn't take double-blind drug; 1 didn't report a pain assessment within 30 minutes|82
6400371|NCT00886483|7313289|FG001|Completed 20 Treatments|Overall Study||11
6400372|NCT00886483|7313288|FG000|COMPLETED|Overall Study||24
6400373|NCT00886483|7313289|FG001|COMPLETED|Overall Study||10
6400374|NCT00886483|7313288|FG000|NOT COMPLETED|Overall Study||2
6400375|NCT00886483|7313289|FG001|NOT COMPLETED|Overall Study||3
6400376|NCT00886587|7313305|FG000|STARTED|Overall Study||41
6400377|NCT00886587|7313306|FG001|STARTED|Overall Study||41
6400378|NCT00886587|7313305|FG000|COMPLETED|Overall Study||37
6400379|NCT00886587|7313306|FG001|COMPLETED|Overall Study||39
6400380|NCT00886587|7313305|FG000|NOT COMPLETED|Overall Study||4
6400381|NCT00886587|7313306|FG001|NOT COMPLETED|Overall Study||2
6400382|NCT00886613|7313315|FG000|STARTED|Overall Study||41
6400383|NCT00886613|7313316|FG001|STARTED|Overall Study||39
6400384|NCT00886613|7313317|FG002|STARTED|Overall Study||40
6400385|NCT00886613|7313315|FG000|COMPLETED|Overall Study||39
6400386|NCT00886613|7313316|FG001|COMPLETED|Overall Study||39
6400387|NCT00886613|7313317|FG002|COMPLETED|Overall Study||37
6400388|NCT00886613|7313315|FG000|NOT COMPLETED|Overall Study||2
6634874|NCT02300129|7563715|FG003|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
6634875|NCT02300129|7563712|FG000|STARTED|Period 2 Treatment 1 (2 Weeks)||11
6634876|NCT02300129|7563713|FG001|STARTED|Period 2 Treatment 1 (2 Weeks)||4
6634877|NCT02300129|7563714|FG002|STARTED|Period 2 Treatment 1 (2 Weeks)||7
6634878|NCT02300129|7563715|FG003|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
6634879|NCT02300129|7563712|FG000|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
6293558|NCT00293033|7195596|FG000|COMPLETED|Double-blind Treatment Period||70
6293559|NCT00293033|7195596|FG000|NOT COMPLETED|Double-blind Treatment Period||12
6293560|NCT00293059|7195606|FG000|STARTED|Overall Study||120
6293561|NCT00293059|7195607|FG001|STARTED|Overall Study||70
6293562|NCT00293059|7195606|FG000|Subjects Received Treatment|Overall Study||119
6293563|NCT00293059|7195607|FG001|Subjects Received Treatment|Overall Study||66
6293564|NCT00293059|7195606|FG000|Cycle 1/Treatment Day 28|Overall Study||115
6293565|NCT00293059|7195607|FG001|Cycle 1/Treatment Day 28|Overall Study||64
6293566|NCT00293059|7195606|FG000|Cycle 3/Treatment Day 84|Overall Study||100
6293567|NCT00293059|7195607|FG001|Cycle 3/Treatment Day 84|Overall Study||55
6293568|NCT00293059|7195606|FG000|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
6293569|NCT00293059|7195607|FG001|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
6293570|NCT00293059|7195606|FG000|COMPLETED|Overall Study||85
6293571|NCT00293059|7195607|FG001|COMPLETED|Overall Study||51
6293572|NCT00293059|7195606|FG000|NOT COMPLETED|Overall Study||35
6293573|NCT00293059|7195607|FG001|NOT COMPLETED|Overall Study||19
6293574|NCT00293202|7195615|FG000|STARTED|Overall Study||5
6293575|NCT00293202|7195616|FG001|STARTED|Overall Study||5
6293576|NCT00293202|7195615|FG000|COMPLETED|Overall Study||2
6293577|NCT00293202|7195616|FG001|COMPLETED|Overall Study||3
6293578|NCT00293202|7195615|FG000|NOT COMPLETED|Overall Study||3
6293579|NCT00293202|7195616|FG001|NOT COMPLETED|Overall Study||2
6293580|NCT00293215|7195628|FG000|STARTED|Overall Study||6
6293581|NCT00293215|7195629|FG001|STARTED|Overall Study||3
6293582|NCT00293215|7195628|FG000|COMPLETED|Overall Study||1
6293583|NCT00293215|7195629|FG001|COMPLETED|Overall Study||0
6293584|NCT00293215|7195628|FG000|NOT COMPLETED|Overall Study||5
6293585|NCT00293215|7195629|FG001|NOT COMPLETED|Overall Study||3
6293586|NCT00293241|7195637|FG000|STARTED|Overall Study||299
6293587|NCT00293241|7195638|FG001|STARTED|Overall Study||306
6293588|NCT00293241|7195637|FG000|COMPLETED|Overall Study||263
6293589|NCT00293241|7195638|FG001|COMPLETED|Overall Study||265
6293590|NCT00293241|7195637|FG000|NOT COMPLETED|Overall Study||36
6293591|NCT00293241|7195638|FG001|NOT COMPLETED|Overall Study||41
6293592|NCT00293254|7195649|FG000|STARTED|Primary Study - Double-Blind Week 0-48||232
6293593|NCT00293254|7195650|FG001|STARTED|Primary Study - Double-Blind Week 0-48||119
6293594|NCT00293254|7195649|FG000|Treated|Primary Study - Double-Blind Week 0-48||230
6293595|NCT00293254|7195650|FG001|Treated|Primary Study - Double-Blind Week 0-48||119
6293596|NCT00293254|7195649|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
6293597|NCT00293254|7195650|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
6293598|NCT00293254|7195649|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||177
6293599|NCT00293254|7195650|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||55
6293600|NCT00293254|7195649|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
6293601|NCT00293254|7195650|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
6293602|NCT00293254|7195649|FG000|STARTED|Extension - Double-Blind Week 49-156||177
6293603|NCT00293254|7195650|FG001|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
6293604|NCT00293254|7195649|FG000|COMPLETED|Extension - Double-Blind Week 49-156||120
6293605|NCT00293254|7195650|FG001|COMPLETED|Extension - Double-Blind Week 49-156||25
6293606|NCT00293254|7195649|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
6293607|NCT00293254|7195650|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
6293608|NCT00293254|7195649|FG000|STARTED|Extension - Open-Label Week 157-240||120
6293609|NCT00293254|7195650|FG001|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
6293610|NCT00293254|7195649|FG000|COMPLETED|Extension - Open-Label Week 157-240||110
6293611|NCT00293254|7195650|FG001|COMPLETED|Extension - Open-Label Week 157-240||18
6293612|NCT00293254|7195649|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||10
6293613|NCT00293254|7195650|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||1
6293614|NCT00293254|7195649|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
6293615|NCT00293254|7195650|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
6293616|NCT00293254|7195649|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||19
6293617|NCT00293254|7195650|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||37
6293618|NCT00293254|7195649|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
6293619|NCT00293254|7195650|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
6293620|NCT00293267|7195660|FG000|STARTED|Primary Study - Double-Blind Week 0-48||234
6293621|NCT00293267|7195661|FG001|STARTED|Primary Study - Double-Blind Week 0-48||118
6293622|NCT00293267|7195660|FG000|Treated|Primary Study - Double-Blind Week 0-48||232
6293623|NCT00293267|7195661|FG001|Treated|Primary Study - Double-Blind Week 0-48||118
6293624|NCT00293267|7195660|FG000|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
6293625|NCT00293267|7195661|FG001|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
6293626|NCT00293267|7195660|FG000|COMPLETED|Primary Study - Double-Blind Week 0-48||193
6293627|NCT00293267|7195661|FG001|COMPLETED|Primary Study - Double-Blind Week 0-48||50
6293628|NCT00293267|7195660|FG000|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
6293629|NCT00293267|7195661|FG001|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
6293630|NCT00293267|7195660|FG000|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
6293631|NCT00293267|7195661|FG001|STARTED|Extension - Double-Blind Week 49-156||50
6400389|NCT00886613|7313316|FG001|NOT COMPLETED|Overall Study||0
6400390|NCT00886613|7313317|FG002|NOT COMPLETED|Overall Study||3
6400391|NCT00886626|7313328|FG000|STARTED|Period 1 (90 Days)||6
6400392|NCT00886626|7313329|FG001|STARTED|Period 1 (90 Days)||6
6400393|NCT00886626|7313328|FG000|COMPLETED|Period 1 (90 Days)||5
6400394|NCT00886626|7313329|FG001|COMPLETED|Period 1 (90 Days)||6
6293632|NCT00293267|7195660|FG000|COMPLETED|Extension - Double-Blind Week 49-156||139
6293633|NCT00293267|7195661|FG001|COMPLETED|Extension - Double-Blind Week 49-156||35
6293634|NCT00293267|7195660|FG000|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
6293635|NCT00293267|7195661|FG001|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
6293636|NCT00293267|7195660|FG000|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
6293637|NCT00293267|7195661|FG001|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
6293638|NCT00293267|7195660|FG000|COMPLETED|Extension - Open-Label Week 157-240||111
6293639|NCT00293267|7195661|FG001|COMPLETED|Extension - Open-Label Week 157-240||26
6293640|NCT00293267|7195660|FG000|NOT COMPLETED|Extension - Open-Label Week 157-240||20
6293641|NCT00293267|7195661|FG001|NOT COMPLETED|Extension - Open-Label Week 157-240||2
6293642|NCT00293267|7195660|FG000|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
6293643|NCT00293267|7195661|FG001|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
6293644|NCT00293267|7195660|FG000|COMPLETED|Open-Label Post Virologic Failure Phase||15
6293645|NCT00293267|7195661|FG001|COMPLETED|Open-Label Post Virologic Failure Phase||29
6293646|NCT00293267|7195660|FG000|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
6293647|NCT00293267|7195661|FG001|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
6293648|NCT00293293|7195671|FG000|STARTED|Overall Study||20
6293649|NCT00293293|7195672|FG001|STARTED|Overall Study||23
6400395|NCT00886626|7313328|FG000|NOT COMPLETED|Period 1 (90 Days)||1
6400396|NCT00886626|7313329|FG001|NOT COMPLETED|Period 1 (90 Days)||0
6400397|NCT00886626|7313328|FG000|STARTED|Period 2 (90 Days)||5
6634880|NCT02300129|7563713|FG001|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
6293650|NCT00293293|7195671|FG000|COMPLETED|Overall Study||18
6293651|NCT00293293|7195672|FG001|COMPLETED|Overall Study||21
6293652|NCT00293293|7195671|FG000|NOT COMPLETED|Overall Study||2
6293653|NCT00293293|7195672|FG001|NOT COMPLETED|Overall Study||2
6293654|NCT00293384|7195679|FG000|STARTED|Overall Study||40
6293655|NCT00293384|7195679|FG000|COMPLETED|Overall Study||35
6293656|NCT00293384|7195679|FG000|NOT COMPLETED|Overall Study||5
6293657|NCT00293397|7195683|FG000|STARTED|Overall Study||20
6293658|NCT00293397|7195683|FG000|Received First DEB-TACE|Overall Study|1 patient death after baseline inclusion screening and before first treatment|19
6293659|NCT00293397|7195683|FG000|COMPLETED|Overall Study|1 patient death within 30 days post-TACE - not attributed to TACE procedure|18
6293660|NCT00293397|7195683|FG000|NOT COMPLETED|Overall Study||2
6293661|NCT00293423|7195690|FG000|STARTED|Surgical Resection||28
6293662|NCT00293423|7195691|FG001|STARTED|Surgical Resection||68
6293663|NCT00293423|7195690|FG000|COMPLETED|Surgical Resection||12
6293664|NCT00293423|7195691|FG001|COMPLETED|Surgical Resection||41
6293665|NCT00293423|7195690|FG000|NOT COMPLETED|Surgical Resection||16
6293666|NCT00293423|7195691|FG001|NOT COMPLETED|Surgical Resection||27
6293667|NCT00293423|7195690|FG000|STARTED|Vaccination Treatment Period||12
6293668|NCT00293423|7195691|FG001|STARTED|Vaccination Treatment Period||41
6293669|NCT00293423|7195690|FG000|COMPLETED|Vaccination Treatment Period||12
6293670|NCT00293423|7195691|FG001|COMPLETED|Vaccination Treatment Period||38
6293671|NCT00293423|7195690|FG000|NOT COMPLETED|Vaccination Treatment Period||0
6293672|NCT00293423|7195691|FG001|NOT COMPLETED|Vaccination Treatment Period||3
6293673|NCT00293462|7195700|FG000|STARTED|Overall Study||31
6293674|NCT00293462|7195701|FG001|STARTED|Overall Study||29
6293675|NCT00293462|7195702|FG002|STARTED|Overall Study||31
6293676|NCT00293462|7195700|FG000|COMPLETED|Overall Study||24
6293677|NCT00293462|7195701|FG001|COMPLETED|Overall Study||21
6293678|NCT00293462|7195702|FG002|COMPLETED|Overall Study||19
6293679|NCT00293462|7195700|FG000|NOT COMPLETED|Overall Study||7
6293680|NCT00293462|7195701|FG001|NOT COMPLETED|Overall Study||8
6293681|NCT00293462|7195702|FG002|NOT COMPLETED|Overall Study||12
6293682|NCT00293540|7195712|FG000|STARTED|Overall Study||122
6293683|NCT00293540|7195713|FG001|STARTED|Overall Study||127
6293684|NCT00293540|7195712|FG000|COMPLETED|Overall Study||115
6293685|NCT00293540|7195713|FG001|COMPLETED|Overall Study||119
6293686|NCT00293540|7195712|FG000|NOT COMPLETED|Overall Study||7
6293687|NCT00293540|7195713|FG001|NOT COMPLETED|Overall Study||8
6293688|NCT00293579|7195719|FG000|STARTED|Overall Study||5
6400398|NCT00886626|7313329|FG001|STARTED|Period 2 (90 Days)||6
6400399|NCT00886626|7313328|FG000|COMPLETED|Period 2 (90 Days)||5
6400400|NCT00886626|7313329|FG001|COMPLETED|Period 2 (90 Days)||6
6400401|NCT00886626|7313328|FG000|NOT COMPLETED|Period 2 (90 Days)||0
6400402|NCT00886626|7313329|FG001|NOT COMPLETED|Period 2 (90 Days)||0
6400403|NCT00886639|7313335|FG000|STARTED|Overall Study||127
6400404|NCT00886639|7313335|FG000|COMPLETED|Overall Study||111
6400405|NCT00886639|7313335|FG000|NOT COMPLETED|Overall Study||16
6293689|NCT00293579|7195719|FG000|COMPLETED|Overall Study||4
6293690|NCT00293579|7195719|FG000|NOT COMPLETED|Overall Study||1
6293691|NCT00293709|7195724|FG000|STARTED|Overall Study||149
6293692|NCT00293709|7195724|FG000|COMPLETED|Overall Study||102
6293693|NCT00293709|7195724|FG000|NOT COMPLETED|Overall Study||47
6293694|NCT00293722|7195728|FG000|STARTED|Overall Study||1291
6293695|NCT00293722|7195728|FG000|COMPLETED|Overall Study||864
6293696|NCT00293722|7195728|FG000|NOT COMPLETED|Overall Study||427
6293697|NCT00293813|7195735|FG000|STARTED|Overall Study||82
6293698|NCT00293813|7195736|FG001|STARTED|Overall Study||83
6293699|NCT00293813|7195737|FG002|STARTED|Overall Study||82
6293700|NCT00293813|7195735|FG000|COMPLETED|Overall Study||69
6293701|NCT00293813|7195736|FG001|COMPLETED|Overall Study||74
6293702|NCT00293813|7195737|FG002|COMPLETED|Overall Study||74
6293703|NCT00293813|7195735|FG000|NOT COMPLETED|Overall Study||13
6293704|NCT00293813|7195736|FG001|NOT COMPLETED|Overall Study||9
6293705|NCT00293813|7195737|FG002|NOT COMPLETED|Overall Study||8
6293706|NCT00294047|7195747|FG000|STARTED|Month 48||2881
6293707|NCT00294047|7195748|FG001|STARTED|Month 48||2871
6293708|NCT00294047|7195747|FG000|Participated up to Month 48|Month 48||2305
6293709|NCT00294047|7195748|FG001|Participated up to Month 48|Month 48||2281
6293710|NCT00294047|7195747|FG000|COMPLETED|Month 48||2456
6293711|NCT00294047|7195748|FG001|COMPLETED|Month 48||2438
6293712|NCT00294047|7195747|FG000|NOT COMPLETED|Month 48||425
6293713|NCT00294047|7195748|FG001|NOT COMPLETED|Month 48||433
6293714|NCT00294047|7195747|FG000|STARTED|Month 84||2877
6293715|NCT00294047|7195748|FG001|STARTED|Month 84||2870
6293716|NCT00294047|7195747|FG000|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
6293717|NCT00294047|7195748|FG001|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
6293718|NCT00294047|7195747|FG000|NOT COMPLETED|Month 84||973
6293719|NCT00294047|7195748|FG001|NOT COMPLETED|Month 84||989
6293720|NCT00294060|7195755|FG000|STARTED|Overall Study||2013
6293721|NCT00294060|7195755|FG000|COMPLETED|Overall Study||840
6293722|NCT00294060|7195755|FG000|NOT COMPLETED|Overall Study||1173
6293723|NCT00294398|7195761|FG000|STARTED|Overall Study||78
6293724|NCT00294398|7195762|FG001|STARTED|Overall Study||74
6293725|NCT00294398|7195761|FG000|COMPLETED|Overall Study||57
6293726|NCT00294398|7195762|FG001|COMPLETED|Overall Study||48
6293727|NCT00294398|7195761|FG000|NOT COMPLETED|Overall Study||21
6293728|NCT00294398|7195762|FG001|NOT COMPLETED|Overall Study||26
6293729|NCT00294515|7195770|FG000|STARTED|Overall Study|Randomized|166
6293730|NCT00294515|7195771|FG001|STARTED|Overall Study|Randomized|160
6293731|NCT00294515|7195770|FG000|COMPLETED|Overall Study||132
6293732|NCT00294515|7195771|FG001|COMPLETED|Overall Study||132
6293733|NCT00294515|7195770|FG000|NOT COMPLETED|Overall Study||34
6293734|NCT00294515|7195771|FG001|NOT COMPLETED|Overall Study||28
6634881|NCT02300129|7563714|FG002|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
6634882|NCT02300129|7563715|FG003|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
6634883|NCT02300129|7563712|FG000|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
6634884|NCT02300129|7563713|FG001|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
6634885|NCT02300129|7563714|FG002|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
6634886|NCT02300129|7563715|FG003|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
6293735|NCT00294554|7195779|FG000|STARTED|Overall Study||10
6293736|NCT00294554|7195780|FG001|STARTED|Overall Study||10
6293737|NCT00294554|7195779|FG000|COMPLETED|Overall Study||10
6293738|NCT00294554|7195780|FG001|COMPLETED|Overall Study|"1 S withdrew @ 20 wks for lack perceived benefit~1 S withdrawn @ 13 wks b/o extreme agitation"|8
6293739|NCT00294554|7195779|FG000|NOT COMPLETED|Overall Study||0
6293740|NCT00294554|7195780|FG001|NOT COMPLETED|Overall Study||2
6634887|NCT02300129|7563712|FG000|STARTED|Period 2 Treatment 2 (2 Weeks)||10
6634888|NCT02300129|7563713|FG001|STARTED|Period 2 Treatment 2 (2 Weeks)||4
6634889|NCT02300129|7563714|FG002|STARTED|Period 2 Treatment 2 (2 Weeks)||7
6634890|NCT02300129|7563715|FG003|STARTED|Period 2 Treatment 2 (2 Weeks)||10
6634891|NCT02300129|7563712|FG000|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
6634892|NCT02300129|7563713|FG001|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
6634893|NCT02300129|7563714|FG002|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
6634894|NCT02300129|7563715|FG003|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
6634895|NCT02300129|7563712|FG000|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
6634896|NCT02300129|7563713|FG001|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
6293741|NCT00294632|7195788|FG000|STARTED|Phase I Dose Escalation Period||14
6293742|NCT00294632|7195789|FG001|STARTED|Phase I Dose Escalation Period||0
6293743|NCT00294632|7195788|FG000|Cohort 1: 10 mg|Phase I Dose Escalation Period||3
6293744|NCT00294632|7195789|FG001|Cohort 1: 10 mg|Phase I Dose Escalation Period||0
6400406|NCT00886704|7313341|FG000|STARTED|Overall Study||40
6400407|NCT00886704|7313342|FG001|STARTED|Overall Study||10
6400408|NCT00886704|7313341|FG000|COMPLETED|Overall Study||40
6400409|NCT00886704|7313342|FG001|COMPLETED|Overall Study||10
6634897|NCT02300129|7563714|FG002|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
6293745|NCT00294632|7195788|FG000|Cohort 2: 15 mg|Phase I Dose Escalation Period||3
6293746|NCT00294632|7195789|FG001|Cohort 2: 15 mg|Phase I Dose Escalation Period||0
6293747|NCT00294632|7195788|FG000|Cohort 3: 20 mg|Phase I Dose Escalation Period||6
6293748|NCT00294632|7195789|FG001|Cohort 3: 20 mg|Phase I Dose Escalation Period||0
6293749|NCT00294632|7195788|FG000|Cohort 4: 25 mg|Phase I Dose Escalation Period||2
6293750|NCT00294632|7195789|FG001|Cohort 4: 25 mg|Phase I Dose Escalation Period||0
6293751|NCT00294632|7195788|FG000|COMPLETED|Phase I Dose Escalation Period||14
6293752|NCT00294632|7195789|FG001|COMPLETED|Phase I Dose Escalation Period||0
6293753|NCT00294632|7195788|FG000|NOT COMPLETED|Phase I Dose Escalation Period||0
6293754|NCT00294632|7195789|FG001|NOT COMPLETED|Phase I Dose Escalation Period||0
6293755|NCT00294632|7195788|FG000|STARTED|Phase II: 20 mg Lenalidomide||6
6293756|NCT00294632|7195789|FG001|STARTED|Phase II: 20 mg Lenalidomide||38
6293757|NCT00294632|7195788|FG000|COMPLETED|Phase II: 20 mg Lenalidomide||6
6293758|NCT00294632|7195789|FG001|COMPLETED|Phase II: 20 mg Lenalidomide||38
6293759|NCT00294632|7195788|FG000|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
6293760|NCT00294632|7195789|FG001|NOT COMPLETED|Phase II: 20 mg Lenalidomide||0
6293761|NCT00294645|7195798|FG000|STARTED|Overall Study||295
6293762|NCT00294645|7195799|FG001|STARTED|Overall Study||602
6293763|NCT00294645|7195798|FG000|COMPLETED|Overall Study||247
6293764|NCT00294645|7195799|FG001|COMPLETED|Overall Study||510
6293765|NCT00294645|7195798|FG000|NOT COMPLETED|Overall Study||48
6293766|NCT00294645|7195799|FG001|NOT COMPLETED|Overall Study||92
6293767|NCT00294658|7195807|FG000|STARTED|Overall Study||66
6293768|NCT00294658|7195808|FG001|STARTED|Overall Study||60
6293769|NCT00294658|7195807|FG000|COMPLETED|Overall Study||60
6293770|NCT00294658|7195808|FG001|COMPLETED|Overall Study||51
6293771|NCT00294658|7195807|FG000|NOT COMPLETED|Overall Study||6
6293772|NCT00294658|7195808|FG001|NOT COMPLETED|Overall Study||9
6293773|NCT00294671|7195816|FG000|STARTED|Overall Study||64
6293774|NCT00294671|7195817|FG001|STARTED|Overall Study||66
6293775|NCT00294671|7195816|FG000|COMPLETED|Overall Study||37
6293776|NCT00294671|7195817|FG001|COMPLETED|Overall Study||26
6293777|NCT00294671|7195816|FG000|NOT COMPLETED|Overall Study||27
6293778|NCT00294671|7195817|FG001|NOT COMPLETED|Overall Study||40
6293779|NCT00294684|7195825|FG000|STARTED|Overall Study||70
6293780|NCT00294684|7195826|FG001|STARTED|Overall Study||70
6293781|NCT00294684|7195825|FG000|COMPLETED|Overall Study||65
6293782|NCT00294684|7195826|FG001|COMPLETED|Overall Study||62
6293783|NCT00294684|7195825|FG000|NOT COMPLETED|Overall Study||5
6293784|NCT00294684|7195826|FG001|NOT COMPLETED|Overall Study||8
6293785|NCT00294723|7195835|FG000|STARTED|Double-Blind Period 52 Weeks|Randomised|247
6293786|NCT00294723|7195836|FG001|STARTED|Double-Blind Period 52 Weeks|Randomised|251
6293787|NCT00294723|7195837|FG002|STARTED|Double-Blind Period 52 Weeks|Randomised|248
6293788|NCT00294723|7195835|FG000|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
6293789|NCT00294723|7195836|FG001|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
6293790|NCT00294723|7195837|FG002|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
6293791|NCT00294723|7195835|FG000|COMPLETED|Double-Blind Period 52 Weeks||173
6293792|NCT00294723|7195836|FG001|COMPLETED|Double-Blind Period 52 Weeks||162
6293793|NCT00294723|7195837|FG002|COMPLETED|Double-Blind Period 52 Weeks||152
6293794|NCT00294723|7195835|FG000|NOT COMPLETED|Double-Blind Period 52 Weeks||74
6293795|NCT00294723|7195836|FG001|NOT COMPLETED|Double-Blind Period 52 Weeks||89
6293796|NCT00294723|7195837|FG002|NOT COMPLETED|Double-Blind Period 52 Weeks||96
6293797|NCT00294723|7195835|FG000|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
6293798|NCT00294723|7195836|FG001|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
6293799|NCT00294723|7195837|FG002|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
6293800|NCT00294723|7195835|FG000|COMPLETED|Open-Label Extension 52 Weeks||114
6293801|NCT00294723|7195836|FG001|COMPLETED|Open-Label Extension 52 Weeks||110
6293802|NCT00294723|7195837|FG002|COMPLETED|Open-Label Extension 52 Weeks||97
6293803|NCT00294723|7195835|FG000|NOT COMPLETED|Open-Label Extension 52 Weeks||40
6293804|NCT00294723|7195836|FG001|NOT COMPLETED|Open-Label Extension 52 Weeks||39
6293805|NCT00294723|7195837|FG002|NOT COMPLETED|Open-Label Extension 52 Weeks||40
6293806|NCT00294723|7195835|FG000|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
6293807|NCT00294723|7195836|FG001|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
6293808|NCT00294723|7195837|FG002|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
6293809|NCT00294723|7195835|FG000|COMPLETED|Additional Open-Label Extension 91 Weeks||34
6293810|NCT00294723|7195836|FG001|COMPLETED|Additional Open-Label Extension 91 Weeks||32
6293811|NCT00294723|7195837|FG002|COMPLETED|Additional Open-Label Extension 91 Weeks||8
6293812|NCT00294723|7195835|FG000|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
6293813|NCT00294723|7195836|FG001|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
6293814|NCT00294723|7195837|FG002|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
6293815|NCT00294762|7195850|FG000|STARTED|Overall Study||72
6293816|NCT00294762|7195851|FG001|STARTED|Overall Study||71
6293817|NCT00294762|7195850|FG000|COMPLETED|Overall Study||69
6293818|NCT00294762|7195851|FG001|COMPLETED|Overall Study||68
6293819|NCT00294762|7195850|FG000|NOT COMPLETED|Overall Study||3
6293820|NCT00294762|7195851|FG001|NOT COMPLETED|Overall Study||3
6293821|NCT00295009|7195863|FG000|STARTED|Overall Study||93
6293822|NCT00295009|7195864|FG001|STARTED|Overall Study||183
6293823|NCT00295009|7195865|FG002|STARTED|Overall Study||51
6293824|NCT00295009|7195866|FG003|STARTED|Overall Study||82
6293825|NCT00295009|7195867|FG004|STARTED|Overall Study||174
6293826|NCT00295009|7195868|FG005|STARTED|Overall Study||269
6293827|NCT00295009|7195863|FG000|Treated|Overall Study||80
6293828|NCT00295009|7195864|FG001|Treated|Overall Study||162
6293829|NCT00295009|7195865|FG002|Treated|Overall Study||50
6293830|NCT00295009|7195866|FG003|Treated|Overall Study||72
6293831|NCT00295009|7195867|FG004|Treated|Overall Study||165
6293832|NCT00295009|7195868|FG005|Treated|Overall Study||259
6293833|NCT00295009|7195863|FG000|Completed 24 Month Analysis|Overall Study||71
6293834|NCT00295009|7195864|FG001|Completed 24 Month Analysis|Overall Study||148
6293835|NCT00295009|7195865|FG002|Completed 24 Month Analysis|Overall Study||45
6293836|NCT00295009|7195866|FG003|Completed 24 Month Analysis|Overall Study||60
6293837|NCT00295009|7195867|FG004|Completed 24 Month Analysis|Overall Study||133
6293838|NCT00295009|7195868|FG005|Completed 24 Month Analysis|Overall Study||198
6293839|NCT00295009|7195863|FG000|COMPLETED|Overall Study|Completed 60 month visit|52
6293840|NCT00295009|7195864|FG001|COMPLETED|Overall Study|Completed 60 month visit|134
6293841|NCT00295009|7195865|FG002|COMPLETED|Overall Study|Completed 60 month visit|39
6293842|NCT00295009|7195866|FG003|COMPLETED|Overall Study|Completed 60 month visit|57
6293843|NCT00295009|7195867|FG004|COMPLETED|Overall Study|Completed 60 month visit|116
6293844|NCT00295009|7195868|FG005|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
6293845|NCT00295009|7195863|FG000|NOT COMPLETED|Overall Study||41
6293846|NCT00295009|7195864|FG001|NOT COMPLETED|Overall Study||49
6293847|NCT00295009|7195865|FG002|NOT COMPLETED|Overall Study||12
6293848|NCT00295009|7195866|FG003|NOT COMPLETED|Overall Study||25
6293849|NCT00295009|7195867|FG004|NOT COMPLETED|Overall Study||58
6293850|NCT00295009|7195868|FG005|NOT COMPLETED|Overall Study||269
6293851|NCT00295022|7195885|FG000|STARTED|Overall Study||105
6293852|NCT00295022|7195886|FG001|STARTED|Overall Study||157
6293853|NCT00295022|7195887|FG002|STARTED|Overall Study||156
6293854|NCT00295022|7195885|FG000|COMPLETED|Overall Study||104
6293855|NCT00295022|7195886|FG001|COMPLETED|Overall Study||156
6293856|NCT00295022|7195887|FG002|COMPLETED|Overall Study||151
6293857|NCT00295022|7195885|FG000|NOT COMPLETED|Overall Study||1
6293858|NCT00295022|7195886|FG001|NOT COMPLETED|Overall Study||1
6293859|NCT00295022|7195887|FG002|NOT COMPLETED|Overall Study||5
6293860|NCT00295061|7195899|FG000|STARTED|Overall Study||12
6293861|NCT00295061|7195900|FG001|STARTED|Overall Study||12
6293862|NCT00295061|7195899|FG000|COMPLETED|Overall Study||12
6293863|NCT00295061|7195900|FG001|COMPLETED|Overall Study||12
6293864|NCT00295061|7195899|FG000|NOT COMPLETED|Overall Study||0
6293865|NCT00295061|7195900|FG001|NOT COMPLETED|Overall Study||0
6293866|NCT00295503|7195906|FG000|STARTED|Overall Study||53
6293867|NCT00295503|7195906|FG000|COMPLETED|Overall Study||53
6293868|NCT00295503|7195906|FG000|NOT COMPLETED|Overall Study||0
6400410|NCT00886704|7313341|FG000|NOT COMPLETED|Overall Study||0
6400411|NCT00886704|7313342|FG001|NOT COMPLETED|Overall Study||0
6400412|NCT00886743|7313350|FG000|STARTED|Overall Study|Received treatment|19
6400413|NCT00886743|7313350|FG000|COMPLETED|Overall Study||15
6400414|NCT00886743|7313350|FG000|NOT COMPLETED|Overall Study||4
6400415|NCT00886769|7313356|FG000|STARTED|Overall Study||43
6400416|NCT00886769|7313357|FG001|STARTED|Overall Study||41
6400417|NCT00886769|7313356|FG000|COMPLETED|Overall Study||37
6400418|NCT00886769|7313357|FG001|COMPLETED|Overall Study||4
6400419|NCT00886769|7313356|FG000|NOT COMPLETED|Overall Study||6
6400420|NCT00886769|7313357|FG001|NOT COMPLETED|Overall Study||37
6400421|NCT00886795|7313363|FG000|STARTED|Overall Study||4
6400422|NCT00886795|7313363|FG000|COMPLETED|Overall Study||3
6400423|NCT00886795|7313363|FG000|NOT COMPLETED|Overall Study||1
6400424|NCT00886821|7313382|FG000|STARTED|Stage 1||7
6400425|NCT00886821|7313383|FG001|STARTED|Stage 1||6
6400426|NCT00886821|7313384|FG002|STARTED|Stage 1||6
6400427|NCT00886821|7313385|FG003|STARTED|Stage 1||7
6400428|NCT00886821|7313386|FG004|STARTED|Stage 1||6
6400429|NCT00886821|7313387|FG005|STARTED|Stage 1||6
6400430|NCT00886821|7313388|FG006|STARTED|Stage 1||6
6400431|NCT00886821|7313389|FG007|STARTED|Stage 1||6
6400432|NCT00886821|7313390|FG008|STARTED|Stage 1||6
6400433|NCT00886821|7313391|FG009|STARTED|Stage 1||18
6400434|NCT00886821|7313392|FG010|STARTED|Stage 1||0
6400435|NCT00886821|7313393|FG011|STARTED|Stage 1||0
6400436|NCT00886821|7313394|FG012|STARTED|Stage 1||0
6400437|NCT00886821|7313395|FG013|STARTED|Stage 1||0
6400438|NCT00886821|7313382|FG000|COMPLETED|Stage 1||7
6400439|NCT00886821|7313383|FG001|COMPLETED|Stage 1||6
6400440|NCT00886821|7313384|FG002|COMPLETED|Stage 1||6
6400441|NCT00886821|7313385|FG003|COMPLETED|Stage 1||7
6400442|NCT00886821|7313386|FG004|COMPLETED|Stage 1||6
6400443|NCT00886821|7313387|FG005|COMPLETED|Stage 1||6
6634898|NCT02300129|7563715|FG003|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
6634899|NCT02300220|7563727|FG000|STARTED|Overall Study||72
6634900|NCT02300220|7563728|FG001|STARTED|Overall Study||72
6634901|NCT02300220|7563727|FG000|COMPLETED|Overall Study||68
6634902|NCT02300220|7563728|FG001|COMPLETED|Overall Study||65
6634903|NCT02300220|7563727|FG000|NOT COMPLETED|Overall Study||4
6634904|NCT02300220|7563728|FG001|NOT COMPLETED|Overall Study||7
6634905|NCT02300259|7563737|FG000|STARTED|Period 1||16
6634906|NCT02300259|7563738|FG001|STARTED|Period 1||16
6293869|NCT00295620|7195913|FG000|STARTED|Overall Study||1732
6293870|NCT00295620|7195914|FG001|STARTED|Overall Study||1738
6293871|NCT00295620|7195913|FG000|Safety Analysis Set|Overall Study||1705
6293872|NCT00295620|7195914|FG001|Safety Analysis Set|Overall Study||1710
6400444|NCT00886821|7313388|FG006|COMPLETED|Stage 1||6
6400445|NCT00886821|7313389|FG007|COMPLETED|Stage 1||6
6400446|NCT00886821|7313390|FG008|COMPLETED|Stage 1||6
6400447|NCT00886821|7313391|FG009|COMPLETED|Stage 1||18
6400448|NCT00886821|7313392|FG010|COMPLETED|Stage 1||0
6400449|NCT00886821|7313393|FG011|COMPLETED|Stage 1||0
6400450|NCT00886821|7313394|FG012|COMPLETED|Stage 1||0
6400451|NCT00886821|7313395|FG013|COMPLETED|Stage 1||0
6400452|NCT00886821|7313382|FG000|NOT COMPLETED|Stage 1||0
6400453|NCT00886821|7313383|FG001|NOT COMPLETED|Stage 1||0
6400454|NCT00886821|7313384|FG002|NOT COMPLETED|Stage 1||0
6400455|NCT00886821|7313385|FG003|NOT COMPLETED|Stage 1||0
6400456|NCT00886821|7313386|FG004|NOT COMPLETED|Stage 1||0
6400457|NCT00886821|7313387|FG005|NOT COMPLETED|Stage 1||0
6400458|NCT00886821|7313388|FG006|NOT COMPLETED|Stage 1||0
6400459|NCT00886821|7313389|FG007|NOT COMPLETED|Stage 1||0
6293873|NCT00295620|7195913|FG000|COMPLETED|Overall Study||860
6293874|NCT00295620|7195914|FG001|COMPLETED|Overall Study||842
6293875|NCT00295620|7195913|FG000|NOT COMPLETED|Overall Study||872
6293876|NCT00295620|7195914|FG001|NOT COMPLETED|Overall Study||896
6293877|NCT00295633|7195923|FG000|STARTED|Overall Study||195
6293878|NCT00295633|7195924|FG001|STARTED|Overall Study||186
6293879|NCT00295633|7195925|FG002|STARTED|Overall Study||184
6293880|NCT00295633|7195923|FG000|Completed Study Without Being Rescued|Overall Study||88
6293881|NCT00295633|7195924|FG001|Completed Study Without Being Rescued|Overall Study||82
6293882|NCT00295633|7195925|FG002|Completed Study Without Being Rescued|Overall Study||51
6293883|NCT00295633|7195923|FG000|COMPLETED|Overall Study||133
6293884|NCT00295633|7195924|FG001|COMPLETED|Overall Study||119
6293885|NCT00295633|7195925|FG002|COMPLETED|Overall Study||108
6293886|NCT00295633|7195923|FG000|NOT COMPLETED|Overall Study||62
6293887|NCT00295633|7195924|FG001|NOT COMPLETED|Overall Study||67
6293888|NCT00295633|7195925|FG002|NOT COMPLETED|Overall Study||76
6293889|NCT00295750|7195936|FG000|STARTED|Overall Study|randomized|206
6293890|NCT00295750|7195937|FG001|STARTED|Overall Study|randomized|210
6293891|NCT00295750|7195938|FG002|STARTED|Overall Study|randomized|204
6293892|NCT00295750|7195936|FG000|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
6293893|NCT00295750|7195937|FG001|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
6293894|NCT00295750|7195938|FG002|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
6293895|NCT00295750|7195936|FG000|COMPLETED|Overall Study||163
6293896|NCT00295750|7195937|FG001|COMPLETED|Overall Study||169
6293897|NCT00295750|7195938|FG002|COMPLETED|Overall Study||172
6293898|NCT00295750|7195936|FG000|NOT COMPLETED|Overall Study||43
6293899|NCT00295750|7195937|FG001|NOT COMPLETED|Overall Study||41
6400460|NCT00886821|7313390|FG008|NOT COMPLETED|Stage 1||0
6400461|NCT00886821|7313391|FG009|NOT COMPLETED|Stage 1||0
6400462|NCT00886821|7313392|FG010|NOT COMPLETED|Stage 1||0
6400463|NCT00886821|7313393|FG011|NOT COMPLETED|Stage 1||0
6400464|NCT00886821|7313394|FG012|NOT COMPLETED|Stage 1||0
6400465|NCT00886821|7313395|FG013|NOT COMPLETED|Stage 1||0
6400466|NCT00886821|7313382|FG000|STARTED|Stage 2||0
6400467|NCT00886821|7313383|FG001|STARTED|Stage 2||0
6293900|NCT00295750|7195938|FG002|NOT COMPLETED|Overall Study||32
6293901|NCT00295854|7195949|FG000|STARTED|Overall Study||95
6293902|NCT00295854|7195950|FG001|STARTED|Overall Study||108
6293903|NCT00295854|7195951|FG002|STARTED|Overall Study||102
6293904|NCT00295854|7195949|FG000|Safety Population (N=304)|Overall Study||95
6293905|NCT00295854|7195950|FG001|Safety Population (N=304)|Overall Study||108
6293906|NCT00295854|7195951|FG002|Safety Population (N=304)|Overall Study||101
6293907|NCT00295854|7195949|FG000|ITT Population (N=296)|Overall Study||92
6293908|NCT00295854|7195950|FG001|ITT Population (N=296)|Overall Study||105
6293909|NCT00295854|7195951|FG002|ITT Population (N=296)|Overall Study||99
6293910|NCT00295854|7195949|FG000|COMPLETED|Overall Study||77
6293911|NCT00295854|7195950|FG001|COMPLETED|Overall Study||87
6293912|NCT00295854|7195951|FG002|COMPLETED|Overall Study||87
6293913|NCT00295854|7195949|FG000|NOT COMPLETED|Overall Study||18
6293914|NCT00295854|7195950|FG001|NOT COMPLETED|Overall Study||21
6293915|NCT00295854|7195951|FG002|NOT COMPLETED|Overall Study||15
6293916|NCT00295867|7195959|FG000|STARTED|Overall Study||45
6293917|NCT00295867|7195959|FG000|COMPLETED|Overall Study||34
6293918|NCT00295867|7195959|FG000|NOT COMPLETED|Overall Study||11
6293919|NCT00295880|7195963|FG000|STARTED|Overall Study||12
6293920|NCT00295880|7195963|FG000|COMPLETED|Overall Study||10
6293921|NCT00295880|7195963|FG000|NOT COMPLETED|Overall Study||2
6293922|NCT00295932|7195978|FG000|STARTED|Overall Study||4
6293923|NCT00295932|7195979|FG001|STARTED|Overall Study||6
6293924|NCT00295932|7195980|FG002|STARTED|Overall Study||3
6293925|NCT00295932|7195981|FG003|STARTED|Overall Study||4
6293926|NCT00295932|7195982|FG004|STARTED|Overall Study||2
6293927|NCT00295932|7195983|FG005|STARTED|Overall Study||18
6293928|NCT00295932|7195984|FG006|STARTED|Overall Study||3
6293929|NCT00295932|7195985|FG007|STARTED|Overall Study||4
6293930|NCT00295932|7195986|FG008|STARTED|Overall Study||10
6293931|NCT00295932|7195987|FG009|STARTED|Overall Study||12
6293932|NCT00295932|7195988|FG010|STARTED|Overall Study||13
6293933|NCT00295932|7195978|FG000|COMPLETED|Overall Study||4
6293934|NCT00295932|7195979|FG001|COMPLETED|Overall Study||6
6400468|NCT00886821|7313384|FG002|STARTED|Stage 2||0
6400469|NCT00886821|7313385|FG003|STARTED|Stage 2||0
6293935|NCT00295932|7195980|FG002|COMPLETED|Overall Study||3
6293936|NCT00295932|7195981|FG003|COMPLETED|Overall Study||4
6293937|NCT00295932|7195982|FG004|COMPLETED|Overall Study||2
6293938|NCT00295932|7195983|FG005|COMPLETED|Overall Study||18
6293939|NCT00295932|7195984|FG006|COMPLETED|Overall Study||3
6293940|NCT00295932|7195985|FG007|COMPLETED|Overall Study||4
6293941|NCT00295932|7195986|FG008|COMPLETED|Overall Study||10
6293942|NCT00295932|7195987|FG009|COMPLETED|Overall Study||12
6400470|NCT00886821|7313386|FG004|STARTED|Stage 2||0
6400471|NCT00886821|7313387|FG005|STARTED|Stage 2||0
6293943|NCT00295932|7195988|FG010|COMPLETED|Overall Study||12
6293944|NCT00295932|7195978|FG000|NOT COMPLETED|Overall Study||0
6400472|NCT00886821|7313388|FG006|STARTED|Stage 2||0
6400473|NCT00886821|7313389|FG007|STARTED|Stage 2||0
6293945|NCT00295932|7195979|FG001|NOT COMPLETED|Overall Study||0
6293946|NCT00295932|7195980|FG002|NOT COMPLETED|Overall Study||0
6293947|NCT00295932|7195981|FG003|NOT COMPLETED|Overall Study||0
6293948|NCT00295932|7195982|FG004|NOT COMPLETED|Overall Study||0
6293949|NCT00295932|7195983|FG005|NOT COMPLETED|Overall Study||0
6293950|NCT00295932|7195984|FG006|NOT COMPLETED|Overall Study||0
6293951|NCT00295932|7195985|FG007|NOT COMPLETED|Overall Study||0
6293952|NCT00295932|7195986|FG008|NOT COMPLETED|Overall Study||0
6293953|NCT00295932|7195987|FG009|NOT COMPLETED|Overall Study||0
6293954|NCT00295932|7195988|FG010|NOT COMPLETED|Overall Study||1
6293955|NCT00296036|7196016|FG000|STARTED|Overall Study||19
6293956|NCT00296036|7196017|FG001|STARTED|Overall Study||18
6293957|NCT00296036|7196018|FG002|STARTED|Overall Study||18
6293958|NCT00296036|7196019|FG003|STARTED|Overall Study||17
6293959|NCT00296036|7196020|FG004|STARTED|Overall Study||33
6293960|NCT00296036|7196021|FG005|STARTED|Overall Study||32
6293961|NCT00296036|7196016|FG000|COMPLETED|Overall Study||18
6293962|NCT00296036|7196017|FG001|COMPLETED|Overall Study||18
6293963|NCT00296036|7196018|FG002|COMPLETED|Overall Study||16
6293964|NCT00296036|7196019|FG003|COMPLETED|Overall Study||16
6293965|NCT00296036|7196020|FG004|COMPLETED|Overall Study||31
6293966|NCT00296036|7196021|FG005|COMPLETED|Overall Study||28
6293967|NCT00296036|7196016|FG000|NOT COMPLETED|Overall Study||1
6293968|NCT00296036|7196017|FG001|NOT COMPLETED|Overall Study||0
6293969|NCT00296036|7196018|FG002|NOT COMPLETED|Overall Study||2
6293970|NCT00296036|7196019|FG003|NOT COMPLETED|Overall Study||1
6293971|NCT00296036|7196020|FG004|NOT COMPLETED|Overall Study||2
6293972|NCT00296036|7196021|FG005|NOT COMPLETED|Overall Study||4
6293973|NCT00296140|7196040|FG000|STARTED|Overall Study||33
6293974|NCT00296140|7196041|FG001|STARTED|Overall Study||33
6400474|NCT00886821|7313390|FG008|STARTED|Stage 2||0
6400475|NCT00886821|7313391|FG009|STARTED|Stage 2||0
6400476|NCT00886821|7313392|FG010|STARTED|Stage 2||9
6400477|NCT00886821|7313393|FG011|STARTED|Stage 2||9
6400478|NCT00886821|7313394|FG012|STARTED|Stage 2||13
6400479|NCT00886821|7313395|FG013|STARTED|Stage 2||9
6400480|NCT00886821|7313382|FG000|COMPLETED|Stage 2||0
6400481|NCT00886821|7313383|FG001|COMPLETED|Stage 2||0
6400482|NCT00886821|7313384|FG002|COMPLETED|Stage 2||0
6400483|NCT00886821|7313385|FG003|COMPLETED|Stage 2||0
6293975|NCT00296140|7196040|FG000|COMPLETED|Overall Study||30
6293976|NCT00296140|7196041|FG001|COMPLETED|Overall Study||33
6293977|NCT00296140|7196040|FG000|NOT COMPLETED|Overall Study||3
6293978|NCT00296140|7196041|FG001|NOT COMPLETED|Overall Study||0
6293979|NCT00296192|7196052|FG000|STARTED|Overall Study||17
6293980|NCT00296192|7196053|FG001|STARTED|Overall Study||16
6293981|NCT00296192|7196054|FG002|STARTED|Overall Study||16
6293982|NCT00296192|7196055|FG003|STARTED|Overall Study||17
6293983|NCT00296192|7196056|FG004|STARTED|Overall Study||16
6293984|NCT00296192|7196052|FG000|COMPLETED|Overall Study||17
6293985|NCT00296192|7196053|FG001|COMPLETED|Overall Study||16
6293986|NCT00296192|7196054|FG002|COMPLETED|Overall Study||16
6293987|NCT00296192|7196055|FG003|COMPLETED|Overall Study||17
6293988|NCT00296192|7196056|FG004|COMPLETED|Overall Study||16
6293989|NCT00296192|7196052|FG000|NOT COMPLETED|Overall Study||0
6293990|NCT00296192|7196053|FG001|NOT COMPLETED|Overall Study||0
6293991|NCT00296192|7196054|FG002|NOT COMPLETED|Overall Study||0
6293992|NCT00296192|7196055|FG003|NOT COMPLETED|Overall Study||0
6293993|NCT00296192|7196056|FG004|NOT COMPLETED|Overall Study||0
6293994|NCT00296231|7196068|FG000|STARTED|Overall Study||14
6293995|NCT00296231|7196068|FG000|COMPLETED|Overall Study||14
6293996|NCT00296231|7196068|FG000|NOT COMPLETED|Overall Study||0
6293997|NCT00296244|7196074|FG000|STARTED|Overall Study||20
6293998|NCT00296244|7196075|FG001|STARTED|Overall Study||20
6293999|NCT00296244|7196074|FG000|COMPLETED|Overall Study||20
6294000|NCT00296244|7196075|FG001|COMPLETED|Overall Study||19
6294001|NCT00296244|7196074|FG000|NOT COMPLETED|Overall Study||0
6294002|NCT00296244|7196075|FG001|NOT COMPLETED|Overall Study||1
6294003|NCT00296296|7196088|FG000|STARTED|Overall Study||11
6294004|NCT00296296|7196089|FG001|STARTED|Overall Study||18
6294005|NCT00296296|7196088|FG000|COMPLETED|Overall Study||9
6294006|NCT00296296|7196089|FG001|COMPLETED|Overall Study||5
6294007|NCT00296296|7196088|FG000|NOT COMPLETED|Overall Study||2
6294008|NCT00296296|7196089|FG001|NOT COMPLETED|Overall Study||13
6294009|NCT00296322|7196097|FG000|STARTED|Overall Study||258
6294010|NCT00296322|7196098|FG001|STARTED|Overall Study||263
6294011|NCT00296322|7196097|FG000|COMPLETED|Overall Study||237
6294012|NCT00296322|7196098|FG001|COMPLETED|Overall Study||184
6294013|NCT00296322|7196097|FG000|NOT COMPLETED|Overall Study||21
6294014|NCT00296322|7196098|FG001|NOT COMPLETED|Overall Study||79
6400484|NCT00886821|7313386|FG004|COMPLETED|Stage 2||0
6400485|NCT00886821|7313387|FG005|COMPLETED|Stage 2||0
6400486|NCT00886821|7313388|FG006|COMPLETED|Stage 2||0
6400487|NCT00886821|7313389|FG007|COMPLETED|Stage 2||0
6400488|NCT00886821|7313390|FG008|COMPLETED|Stage 2||0
6400489|NCT00886821|7313391|FG009|COMPLETED|Stage 2||0
6400490|NCT00886821|7313392|FG010|COMPLETED|Stage 2||9
6400491|NCT00886821|7313393|FG011|COMPLETED|Stage 2||8
6400492|NCT00886821|7313394|FG012|COMPLETED|Stage 2||8
6400493|NCT00886821|7313395|FG013|COMPLETED|Stage 2||8
6400494|NCT00886821|7313382|FG000|NOT COMPLETED|Stage 2||0
6294015|NCT00296335|7196106|FG000|STARTED|Overall Study||424
6294016|NCT00296335|7196107|FG001|STARTED|Overall Study||431
6400495|NCT00886821|7313383|FG001|NOT COMPLETED|Stage 2||0
6400496|NCT00886821|7313384|FG002|NOT COMPLETED|Stage 2||0
6400497|NCT00886821|7313385|FG003|NOT COMPLETED|Stage 2||0
6294017|NCT00296335|7196106|FG000|COMPLETED|Overall Study||394
6294018|NCT00296335|7196107|FG001|COMPLETED|Overall Study||309
6294019|NCT00296335|7196106|FG000|NOT COMPLETED|Overall Study||30
6294020|NCT00296335|7196107|FG001|NOT COMPLETED|Overall Study||122
6294021|NCT00296374|7196118|FG000|STARTED|Overall Study||118
6294022|NCT00296374|7196119|FG001|STARTED|Overall Study||124
6294023|NCT00296374|7196120|FG002|STARTED|Overall Study||111
6294024|NCT00296374|7196118|FG000|COMPLETED|Overall Study||93
6294025|NCT00296374|7196119|FG001|COMPLETED|Overall Study||101
6294026|NCT00296374|7196120|FG002|COMPLETED|Overall Study||82
6294027|NCT00296374|7196118|FG000|NOT COMPLETED|Overall Study||25
6294028|NCT00296374|7196119|FG001|NOT COMPLETED|Overall Study||23
6294029|NCT00296374|7196120|FG002|NOT COMPLETED|Overall Study||29
6294030|NCT00296400|7196137|FG000|STARTED|Overall Study||70
6294031|NCT00296400|7196138|FG001|STARTED|Overall Study||87
6294032|NCT00296400|7196139|FG002|STARTED|Overall Study||80
6294033|NCT00296400|7196137|FG000|COMPLETED|Overall Study||53
6294034|NCT00296400|7196138|FG001|COMPLETED|Overall Study||69
6294035|NCT00296400|7196139|FG002|COMPLETED|Overall Study||67
6294036|NCT00296400|7196137|FG000|NOT COMPLETED|Overall Study||17
6294037|NCT00296400|7196138|FG001|NOT COMPLETED|Overall Study||18
6294038|NCT00296400|7196139|FG002|NOT COMPLETED|Overall Study||13
6294039|NCT00296491|7196154|FG000|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
6294040|NCT00296491|7196155|FG001|STARTED|Overall Study||182
6294041|NCT00296491|7196156|FG002|STARTED|Overall Study||180
6294042|NCT00296491|7196157|FG003|STARTED|Overall Study||181
6294043|NCT00296491|7196154|FG000|COMPLETED|Overall Study||140
6294044|NCT00296491|7196155|FG001|COMPLETED|Overall Study||129
6294045|NCT00296491|7196156|FG002|COMPLETED|Overall Study||137
6294046|NCT00296491|7196157|FG003|COMPLETED|Overall Study||138
6294047|NCT00296491|7196154|FG000|NOT COMPLETED|Overall Study||42
6294048|NCT00296491|7196155|FG001|NOT COMPLETED|Overall Study||53
6294049|NCT00296491|7196156|FG002|NOT COMPLETED|Overall Study||43
6294050|NCT00296491|7196157|FG003|NOT COMPLETED|Overall Study||43
6294051|NCT00296504|7196182|FG000|STARTED|Interim Analysis||119
6294052|NCT00296504|7196183|FG001|STARTED|Interim Analysis||18
6294053|NCT00296504|7196184|FG002|STARTED|Interim Analysis||221
6294054|NCT00296504|7196185|FG003|STARTED|Interim Analysis||54
6294055|NCT00296504|7196186|FG004|STARTED|Interim Analysis||73
6294056|NCT00296504|7196187|FG005|STARTED|Interim Analysis||78
6294057|NCT00296504|7196188|FG006|STARTED|Interim Analysis||104
6294058|NCT00296504|7196189|FG007|STARTED|Interim Analysis||86
6294059|NCT00296504|7196190|FG008|STARTED|Interim Analysis||0
6294060|NCT00296504|7196182|FG000|Ongoing|Interim Analysis||32
6294061|NCT00296504|7196183|FG001|Ongoing|Interim Analysis||12
6294062|NCT00296504|7196184|FG002|Ongoing|Interim Analysis||16
6294063|NCT00296504|7196185|FG003|Ongoing|Interim Analysis||22
6294064|NCT00296504|7196186|FG004|Ongoing|Interim Analysis||0
6294065|NCT00296504|7196187|FG005|Ongoing|Interim Analysis||0
6294066|NCT00296504|7196188|FG006|Ongoing|Interim Analysis||30
6294067|NCT00296504|7196189|FG007|Ongoing|Interim Analysis||1
6294068|NCT00296504|7196190|FG008|Ongoing|Interim Analysis||0
6294069|NCT00296504|7196182|FG000|COMPLETED|Interim Analysis||43
6294070|NCT00296504|7196183|FG001|COMPLETED|Interim Analysis||0
6294071|NCT00296504|7196184|FG002|COMPLETED|Interim Analysis||116
6294072|NCT00296504|7196185|FG003|COMPLETED|Interim Analysis||11
6294073|NCT00296504|7196186|FG004|COMPLETED|Interim Analysis||36
6294074|NCT00296504|7196187|FG005|COMPLETED|Interim Analysis||41
6294075|NCT00296504|7196188|FG006|COMPLETED|Interim Analysis||30
6400498|NCT00886821|7313386|FG004|NOT COMPLETED|Stage 2||0
6400499|NCT00886821|7313387|FG005|NOT COMPLETED|Stage 2||0
6400500|NCT00886821|7313388|FG006|NOT COMPLETED|Stage 2||0
6400501|NCT00886821|7313389|FG007|NOT COMPLETED|Stage 2||0
6400502|NCT00886821|7313390|FG008|NOT COMPLETED|Stage 2||0
6400503|NCT00886821|7313391|FG009|NOT COMPLETED|Stage 2||0
6400504|NCT00886821|7313392|FG010|NOT COMPLETED|Stage 2||0
6400505|NCT00886821|7313393|FG011|NOT COMPLETED|Stage 2||1
6400506|NCT00886821|7313394|FG012|NOT COMPLETED|Stage 2||5
6400507|NCT00886821|7313395|FG013|NOT COMPLETED|Stage 2||1
6400508|NCT00886834|7313441|FG000|STARTED|Overall Study||54
6400509|NCT00886834|7313442|FG001|STARTED|Overall Study||54
6400510|NCT00886834|7313441|FG000|COMPLETED|Overall Study||54
6400511|NCT00886834|7313442|FG001|COMPLETED|Overall Study||51
6294076|NCT00296504|7196189|FG007|COMPLETED|Interim Analysis||37
6294077|NCT00296504|7196190|FG008|COMPLETED|Interim Analysis||0
6294078|NCT00296504|7196182|FG000|NOT COMPLETED|Interim Analysis||76
6294079|NCT00296504|7196183|FG001|NOT COMPLETED|Interim Analysis||18
6294080|NCT00296504|7196184|FG002|NOT COMPLETED|Interim Analysis||105
6294081|NCT00296504|7196185|FG003|NOT COMPLETED|Interim Analysis||43
6400512|NCT00886834|7313441|FG000|NOT COMPLETED|Overall Study||0
6400513|NCT00886834|7313442|FG001|NOT COMPLETED|Overall Study||3
6400514|NCT00886899|7313448|FG000|STARTED|Overall Study||147
6294082|NCT00296504|7196186|FG004|NOT COMPLETED|Interim Analysis||37
6294083|NCT00296504|7196187|FG005|NOT COMPLETED|Interim Analysis||37
6400515|NCT00886899|7313448|FG000|COMPLETED|Overall Study||147
6400516|NCT00886899|7313448|FG000|NOT COMPLETED|Overall Study||0
6294084|NCT00296504|7196188|FG006|NOT COMPLETED|Interim Analysis||74
6294085|NCT00296504|7196189|FG007|NOT COMPLETED|Interim Analysis||49
6294086|NCT00296504|7196190|FG008|NOT COMPLETED|Interim Analysis||0
6294087|NCT00296504|7196182|FG000|STARTED|Final Analysis||0
6294088|NCT00296504|7196183|FG001|STARTED|Final Analysis||0
6294089|NCT00296504|7196184|FG002|STARTED|Final Analysis||0
6294090|NCT00296504|7196185|FG003|STARTED|Final Analysis||0
6294091|NCT00296504|7196186|FG004|STARTED|Final Analysis||0
6400517|NCT00886938|7313452|FG000|STARTED|Overall Study||12
6400518|NCT00886938|7313452|FG000|COMPLETED|Overall Study||10
6400519|NCT00886938|7313452|FG000|NOT COMPLETED|Overall Study||2
6400520|NCT00887068|7313458|FG000|STARTED|Overall Study||93
6400521|NCT00887068|7313459|FG001|STARTED|Overall Study||94
6400522|NCT00887068|7313458|FG000|COMPLETED|Overall Study||87
6400523|NCT00887068|7313459|FG001|COMPLETED|Overall Study||94
6400524|NCT00887068|7313458|FG000|NOT COMPLETED|Overall Study||6
6400525|NCT00887068|7313459|FG001|NOT COMPLETED|Overall Study||0
6400526|NCT00887159|7313468|FG000|STARTED|Overall Study||56
6400527|NCT00887159|7313469|FG001|STARTED|Overall Study||56
6400528|NCT00887159|7313470|FG002|STARTED|Overall Study||56
6400529|NCT00887159|7313468|FG000|Patients Who Started Assigned Treatment|Overall Study||53
6634907|NCT02300259|7563739|FG002|STARTED|Period 1||16
6634908|NCT02300259|7563737|FG000|Received at Least One Dose of Study Drug|Period 1||16
6634909|NCT02300259|7563738|FG001|Received at Least One Dose of Study Drug|Period 1||16
6294092|NCT00296504|7196187|FG005|STARTED|Final Analysis||0
6294093|NCT00296504|7196188|FG006|STARTED|Final Analysis||0
6294094|NCT00296504|7196189|FG007|STARTED|Final Analysis||0
6294095|NCT00296504|7196190|FG008|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
6294096|NCT00296504|7196182|FG000|COMPLETED|Final Analysis||0
6294097|NCT00296504|7196183|FG001|COMPLETED|Final Analysis||0
6294098|NCT00296504|7196184|FG002|COMPLETED|Final Analysis||0
6294099|NCT00296504|7196185|FG003|COMPLETED|Final Analysis||0
6294100|NCT00296504|7196186|FG004|COMPLETED|Final Analysis||0
6294101|NCT00296504|7196187|FG005|COMPLETED|Final Analysis||0
6294102|NCT00296504|7196188|FG006|COMPLETED|Final Analysis||0
6294103|NCT00296504|7196189|FG007|COMPLETED|Final Analysis||0
6294104|NCT00296504|7196190|FG008|COMPLETED|Final Analysis||90
6294105|NCT00296504|7196182|FG000|NOT COMPLETED|Final Analysis||0
6294106|NCT00296504|7196183|FG001|NOT COMPLETED|Final Analysis||0
6294107|NCT00296504|7196184|FG002|NOT COMPLETED|Final Analysis||0
6294108|NCT00296504|7196185|FG003|NOT COMPLETED|Final Analysis||0
6294109|NCT00296504|7196186|FG004|NOT COMPLETED|Final Analysis||0
6294110|NCT00296504|7196187|FG005|NOT COMPLETED|Final Analysis||0
6294111|NCT00296504|7196188|FG006|NOT COMPLETED|Final Analysis||0
6294112|NCT00296504|7196189|FG007|NOT COMPLETED|Final Analysis||0
6294113|NCT00296504|7196190|FG008|NOT COMPLETED|Final Analysis||21
6294114|NCT00296517|7196217|FG000|STARTED|Dose Level 1 - Week 1||159
6294115|NCT00296517|7196218|FG001|STARTED|Dose Level 1 - Week 1||166
6294116|NCT00296517|7196217|FG000|COMPLETED|Dose Level 1 - Week 1||159
6294117|NCT00296517|7196218|FG001|COMPLETED|Dose Level 1 - Week 1||166
6294118|NCT00296517|7196217|FG000|NOT COMPLETED|Dose Level 1 - Week 1||0
6294119|NCT00296517|7196218|FG001|NOT COMPLETED|Dose Level 1 - Week 1||0
6294120|NCT00296517|7196217|FG000|STARTED|Dose Level 2 - Week 2||159
6294121|NCT00296517|7196218|FG001|STARTED|Dose Level 2 - Week 2||166
6294122|NCT00296517|7196217|FG000|COMPLETED|Dose Level 2 - Week 2||157
6294123|NCT00296517|7196218|FG001|COMPLETED|Dose Level 2 - Week 2||161
6294124|NCT00296517|7196217|FG000|NOT COMPLETED|Dose Level 2 - Week 2||2
6294125|NCT00296517|7196218|FG001|NOT COMPLETED|Dose Level 2 - Week 2||5
6294126|NCT00296517|7196217|FG000|STARTED|Dose Level 3 - Weeks 3-12||157
6294127|NCT00296517|7196218|FG001|STARTED|Dose Level 3 - Weeks 3-12||161
6294128|NCT00296517|7196217|FG000|COMPLETED|Dose Level 3 - Weeks 3-12||112
6294129|NCT00296517|7196218|FG001|COMPLETED|Dose Level 3 - Weeks 3-12||99
6294130|NCT00296517|7196217|FG000|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
6294131|NCT00296517|7196218|FG001|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
6294132|NCT00296647|7196229|FG000|STARTED|Overall Study||282
6294133|NCT00296647|7196230|FG001|STARTED|Overall Study||261
6294134|NCT00296647|7196231|FG002|STARTED|Overall Study||256
6294135|NCT00296647|7196232|FG003|STARTED|Overall Study||279
6294136|NCT00296647|7196233|FG004|STARTED|Overall Study||268
6294137|NCT00296647|7196229|FG000|COMPLETED|Overall Study||250
6294138|NCT00296647|7196230|FG001|COMPLETED|Overall Study||233
6294139|NCT00296647|7196231|FG002|COMPLETED|Overall Study||222
6294140|NCT00296647|7196232|FG003|COMPLETED|Overall Study||262
6294141|NCT00296647|7196233|FG004|COMPLETED|Overall Study||248
6294142|NCT00296647|7196229|FG000|NOT COMPLETED|Overall Study||32
6294143|NCT00296647|7196230|FG001|NOT COMPLETED|Overall Study||28
6294144|NCT00296647|7196231|FG002|NOT COMPLETED|Overall Study||34
6294145|NCT00296647|7196232|FG003|NOT COMPLETED|Overall Study||17
6294146|NCT00296647|7196233|FG004|NOT COMPLETED|Overall Study||20
6294147|NCT00296725|7196245|FG000|STARTED|Phase 1: Fluoxetine (1-12 Weeks)||17
6294148|NCT00296725|7196245|FG000|COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||12
6634910|NCT02300259|7563739|FG002|Received at Least One Dose of Study Drug|Period 1||16
6634911|NCT02300259|7563737|FG000|COMPLETED|Period 1||16
6634912|NCT02300259|7563738|FG001|COMPLETED|Period 1||16
6634913|NCT02300259|7563739|FG002|COMPLETED|Period 1||14
6634914|NCT02300259|7563737|FG000|NOT COMPLETED|Period 1||0
6294149|NCT00296725|7196245|FG000|NOT COMPLETED|Phase 1: Fluoxetine (1-12 Weeks)||5
6400530|NCT00887159|7313469|FG001|Patients Who Started Assigned Treatment|Overall Study||53
6634915|NCT02300259|7563738|FG001|NOT COMPLETED|Period 1||0
6294150|NCT00296725|7196245|FG000|STARTED|Phase 2: Imipramine (1-6 Weeks)||8
6294151|NCT00296725|7196245|FG000|COMPLETED|Phase 2: Imipramine (1-6 Weeks)||7
6634916|NCT02300259|7563739|FG002|NOT COMPLETED|Period 1||2
6400531|NCT00887159|7313470|FG002|Patients Who Started Assigned Treatment|Overall Study||52
6400532|NCT00887159|7313468|FG000|Eligible and Treated Patients|Overall Study||48
6400533|NCT00887159|7313469|FG001|Eligible and Treated Patients|Overall Study||52
6400534|NCT00887159|7313470|FG002|Eligible and Treated Patients|Overall Study||52
6400535|NCT00887159|7313468|FG000|Eligible/Treated Pts With CTCs Results|Overall Study||40
6400536|NCT00887159|7313469|FG001|Eligible/Treated Pts With CTCs Results|Overall Study||42
6400537|NCT00887159|7313470|FG002|Eligible/Treated Pts With CTCs Results|Overall Study||38
6400538|NCT00887159|7313468|FG000|COMPLETED|Overall Study||27
6400539|NCT00887159|7313469|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
6400540|NCT00887159|7313470|FG002|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
6400541|NCT00887159|7313468|FG000|NOT COMPLETED|Overall Study||29
6400542|NCT00887159|7313469|FG001|NOT COMPLETED|Overall Study||56
6400543|NCT00887159|7313470|FG002|NOT COMPLETED|Overall Study||56
6400544|NCT00887198|7313482|FG000|STARTED|Randomized Period||546
6400545|NCT00887198|7313483|FG001|STARTED|Randomized Period||542
6400546|NCT00887198|7313484|FG002|STARTED|Randomized Period||0
6400547|NCT00887198|7313482|FG000|Treated|Randomized Period||542
6400548|NCT00887198|7313483|FG001|Treated|Randomized Period||540
6400549|NCT00887198|7313484|FG002|Treated|Randomized Period||0
6400550|NCT00887198|7313482|FG000|COMPLETED|Randomized Period||0
6294152|NCT00296725|7196245|FG000|NOT COMPLETED|Phase 2: Imipramine (1-6 Weeks)||1
6294153|NCT00296816|7196253|FG000|STARTED|Overall Study||132
6294154|NCT00296816|7196253|FG000|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
6294155|NCT00296816|7196253|FG000|NOT COMPLETED|Overall Study||74
6294156|NCT00297037|7196259|FG000|STARTED|Overall Study||10
6294157|NCT00297037|7196260|FG001|STARTED|Overall Study||11
6294158|NCT00297037|7196259|FG000|COMPLETED|Overall Study||8
6294159|NCT00297037|7196260|FG001|COMPLETED|Overall Study||11
6294160|NCT00297037|7196259|FG000|NOT COMPLETED|Overall Study||2
6294161|NCT00297037|7196260|FG001|NOT COMPLETED|Overall Study||0
6294162|NCT00297102|7196270|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
6294163|NCT00297102|7196271|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
6294164|NCT00297102|7196270|FG000|COMPLETED|Overall Study||502
6294165|NCT00297102|7196271|FG001|COMPLETED|Overall Study||525
6294166|NCT00297102|7196270|FG000|NOT COMPLETED|Overall Study||263
6294167|NCT00297102|7196271|FG001|NOT COMPLETED|Overall Study||233
6294168|NCT00297115|7196279|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
6294169|NCT00297115|7196280|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
6294170|NCT00297115|7196279|FG000|COMPLETED|Overall Study||527
6294171|NCT00297115|7196280|FG001|COMPLETED|Overall Study||550
6294172|NCT00297115|7196279|FG000|NOT COMPLETED|Overall Study||245
6294173|NCT00297115|7196280|FG001|NOT COMPLETED|Overall Study||246
6294174|NCT00297167|7196286|FG000|STARTED|First Double-blind Intervention Period||17
6294175|NCT00297167|7196287|FG001|STARTED|First Double-blind Intervention Period||16
6294176|NCT00297167|7196288|FG002|STARTED|First Double-blind Intervention Period||0
6294177|NCT00297167|7196286|FG000|COMPLETED|First Double-blind Intervention Period||17
6294178|NCT00297167|7196287|FG001|COMPLETED|First Double-blind Intervention Period||16
6294179|NCT00297167|7196288|FG002|COMPLETED|First Double-blind Intervention Period||0
6294180|NCT00297167|7196286|FG000|NOT COMPLETED|First Double-blind Intervention Period||0
6294181|NCT00297167|7196287|FG001|NOT COMPLETED|First Double-blind Intervention Period||0
6294182|NCT00297167|7196288|FG002|NOT COMPLETED|First Double-blind Intervention Period||0
6294183|NCT00297167|7196286|FG000|STARTED|Open-label Dose Normalization Period 1||0
6294184|NCT00297167|7196287|FG001|STARTED|Open-label Dose Normalization Period 1||0
6294185|NCT00297167|7196288|FG002|STARTED|Open-label Dose Normalization Period 1||33
6294186|NCT00297167|7196286|FG000|COMPLETED|Open-label Dose Normalization Period 1||0
6294187|NCT00297167|7196287|FG001|COMPLETED|Open-label Dose Normalization Period 1||0
6294188|NCT00297167|7196288|FG002|COMPLETED|Open-label Dose Normalization Period 1||32
6294189|NCT00297167|7196286|FG000|NOT COMPLETED|Open-label Dose Normalization Period 1||0
6294190|NCT00297167|7196287|FG001|NOT COMPLETED|Open-label Dose Normalization Period 1||0
6294191|NCT00297167|7196288|FG002|NOT COMPLETED|Open-label Dose Normalization Period 1||1
6294192|NCT00297167|7196286|FG000|STARTED|Second Double-blind Intervention Period||17
6294193|NCT00297167|7196287|FG001|STARTED|Second Double-blind Intervention Period||15
6294194|NCT00297167|7196288|FG002|STARTED|Second Double-blind Intervention Period||0
6294195|NCT00297167|7196286|FG000|COMPLETED|Second Double-blind Intervention Period||16
6294196|NCT00297167|7196287|FG001|COMPLETED|Second Double-blind Intervention Period||15
6294197|NCT00297167|7196288|FG002|COMPLETED|Second Double-blind Intervention Period||0
6294198|NCT00297167|7196286|FG000|NOT COMPLETED|Second Double-blind Intervention Period||1
6294199|NCT00297167|7196287|FG001|NOT COMPLETED|Second Double-blind Intervention Period||0
6400551|NCT00887198|7313483|FG001|COMPLETED|Randomized Period||0
6400552|NCT00887198|7313484|FG002|COMPLETED|Randomized Period||0
6400553|NCT00887198|7313482|FG000|NOT COMPLETED|Randomized Period||546
6400554|NCT00887198|7313483|FG001|NOT COMPLETED|Randomized Period||542
6400555|NCT00887198|7313484|FG002|NOT COMPLETED|Randomized Period||0
6634917|NCT02300259|7563737|FG000|STARTED|Period 2||16
6294200|NCT00297167|7196288|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
6294201|NCT00297167|7196286|FG000|STARTED|Open-label Dose Normalization Period 2||0
6294202|NCT00297167|7196287|FG001|STARTED|Open-label Dose Normalization Period 2||0
6294203|NCT00297167|7196288|FG002|STARTED|Open-label Dose Normalization Period 2||31
6294204|NCT00297167|7196286|FG000|COMPLETED|Open-label Dose Normalization Period 2||0
6294205|NCT00297167|7196287|FG001|COMPLETED|Open-label Dose Normalization Period 2||0
6294206|NCT00297167|7196288|FG002|COMPLETED|Open-label Dose Normalization Period 2||31
6294207|NCT00297167|7196286|FG000|NOT COMPLETED|Open-label Dose Normalization Period 2||0
6294208|NCT00297167|7196287|FG001|NOT COMPLETED|Open-label Dose Normalization Period 2||0
6294209|NCT00297167|7196288|FG002|NOT COMPLETED|Open-label Dose Normalization Period 2||0
6294210|NCT00297232|7196295|FG000|STARTED|Overall Study||1094
6294211|NCT00297232|7196295|FG000|COMPLETED|Overall Study||489
6294212|NCT00297232|7196295|FG000|NOT COMPLETED|Overall Study||605
6294213|NCT00297258|7196299|FG000|STARTED|Overall Study||142
6294214|NCT00297258|7196299|FG000|COMPLETED|Overall Study||0
6294215|NCT00297258|7196299|FG000|NOT COMPLETED|Overall Study||142
6400556|NCT00887198|7313482|FG000|STARTED|Cross Over (Placebo to AA)||0
6400557|NCT00887198|7313483|FG001|STARTED|Cross Over (Placebo to AA)||0
6400558|NCT00887198|7313484|FG002|STARTED|Cross Over (Placebo to AA)|93= 51 participants(crossed over under amendment 3)+42 participants (crossed over under amendment 4)|93
6400559|NCT00887198|7313482|FG000|COMPLETED|Cross Over (Placebo to AA)||0
6400560|NCT00887198|7313483|FG001|COMPLETED|Cross Over (Placebo to AA)||0
6400561|NCT00887198|7313484|FG002|COMPLETED|Cross Over (Placebo to AA)||0
6400562|NCT00887198|7313482|FG000|NOT COMPLETED|Cross Over (Placebo to AA)||0
6400563|NCT00887198|7313483|FG001|NOT COMPLETED|Cross Over (Placebo to AA)||0
6400564|NCT00887198|7313484|FG002|NOT COMPLETED|Cross Over (Placebo to AA)||93
6400565|NCT00887224|7313495|FG000|STARTED|Open-label Response (OLR) Phase||874
6400566|NCT00887224|7313496|FG001|STARTED|Open-label Response (OLR) Phase||0
6400567|NCT00887224|7313497|FG002|STARTED|Open-label Response (OLR) Phase||0
6400568|NCT00887224|7313495|FG000|COMPLETED|Open-label Response (OLR) Phase||752
6400569|NCT00887224|7313496|FG001|COMPLETED|Open-label Response (OLR) Phase||0
6400570|NCT00887224|7313497|FG002|COMPLETED|Open-label Response (OLR) Phase||0
6400571|NCT00887224|7313495|FG000|NOT COMPLETED|Open-label Response (OLR) Phase||122
6400572|NCT00887224|7313496|FG001|NOT COMPLETED|Open-label Response (OLR) Phase||0
6400573|NCT00887224|7313497|FG002|NOT COMPLETED|Open-label Response (OLR) Phase||0
6294216|NCT00297427|7196308|FG000|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
6294217|NCT00297427|7196309|FG001|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
6294218|NCT00297427|7196308|FG000|COMPLETED|Phase 1: Initial Intervention||56
6294219|NCT00297427|7196309|FG001|COMPLETED|Phase 1: Initial Intervention||54
6294220|NCT00297427|7196308|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
6294221|NCT00297427|7196309|FG001|NOT COMPLETED|Phase 1: Initial Intervention||9
6294222|NCT00297427|7196308|FG000|STARTED|Phase 2: Optional Crossover for Sham||54
6294223|NCT00297427|7196309|FG001|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
6294224|NCT00297427|7196308|FG000|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
6294225|NCT00297427|7196309|FG001|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
6294226|NCT00297427|7196308|FG000|COMPLETED|Phase 2: Optional Crossover for Sham||38
6294227|NCT00297427|7196309|FG001|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
6294228|NCT00297427|7196308|FG000|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
6294229|NCT00297427|7196309|FG001|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
6294230|NCT00297427|7196308|FG000|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
6294231|NCT00297427|7196309|FG001|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
6294232|NCT00297427|7196308|FG000|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
6294233|NCT00297427|7196309|FG001|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
6294234|NCT00297427|7196308|FG000|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
6294235|NCT00297427|7196309|FG001|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
6294236|NCT00297479|7196326|FG000|STARTED|Overall Study||103
6294237|NCT00297479|7196327|FG001|STARTED|Overall Study||155
6294238|NCT00297479|7196328|FG002|STARTED|Overall Study||154
6294239|NCT00297479|7196326|FG000|4-Week Follow Up|Overall Study||78
6294240|NCT00297479|7196327|FG001|4-Week Follow Up|Overall Study||132
6294241|NCT00297479|7196328|FG002|4-Week Follow Up|Overall Study||128
6294242|NCT00297479|7196326|FG000|26- Week Follow Up|Overall Study||66
6294243|NCT00297479|7196327|FG001|26- Week Follow Up|Overall Study||101
6294244|NCT00297479|7196328|FG002|26- Week Follow Up|Overall Study||103
6294245|NCT00297479|7196326|FG000|COMPLETED|Overall Study||66
6294246|NCT00297479|7196327|FG001|COMPLETED|Overall Study||101
6294247|NCT00297479|7196328|FG002|COMPLETED|Overall Study||103
6294248|NCT00297479|7196326|FG000|NOT COMPLETED|Overall Study||37
6294249|NCT00297479|7196327|FG001|NOT COMPLETED|Overall Study||54
6400574|NCT00887224|7313495|FG000|STARTED|Between OLR and OLS Phases||752
6400575|NCT00887224|7313496|FG001|STARTED|Between OLR and OLS Phases||0
6294250|NCT00297479|7196328|FG002|NOT COMPLETED|Overall Study||51
6294251|NCT00297492|7196339|FG000|STARTED|Set Quit Date||297
6294252|NCT00297492|7196340|FG001|STARTED|Set Quit Date||299
6294253|NCT00297492|7196341|FG002|STARTED|Set Quit Date||150
6294254|NCT00297492|7196339|FG000|COMPLETED|Set Quit Date||290
6294255|NCT00297492|7196340|FG001|COMPLETED|Set Quit Date||286
6294256|NCT00297492|7196341|FG002|COMPLETED|Set Quit Date||145
6294257|NCT00297492|7196339|FG000|NOT COMPLETED|Set Quit Date||7
6294258|NCT00297492|7196340|FG001|NOT COMPLETED|Set Quit Date||13
6294259|NCT00297492|7196341|FG002|NOT COMPLETED|Set Quit Date||5
6294260|NCT00297492|7196339|FG000|STARTED|6 Month Follow-up||290
6294261|NCT00297492|7196340|FG001|STARTED|6 Month Follow-up||286
6294262|NCT00297492|7196341|FG002|STARTED|6 Month Follow-up||145
6294263|NCT00297492|7196339|FG000|COMPLETED|6 Month Follow-up||227
6294264|NCT00297492|7196340|FG001|COMPLETED|6 Month Follow-up||237
6294265|NCT00297492|7196341|FG002|COMPLETED|6 Month Follow-up||118
6294266|NCT00297492|7196339|FG000|NOT COMPLETED|6 Month Follow-up||63
6294267|NCT00297492|7196340|FG001|NOT COMPLETED|6 Month Follow-up||49
6294268|NCT00297492|7196341|FG002|NOT COMPLETED|6 Month Follow-up||27
6294269|NCT00297596|7196349|FG000|STARTED|Overall Study||25
6294270|NCT00297596|7196349|FG000|COMPLETED|Overall Study||25
6294271|NCT00297596|7196349|FG000|NOT COMPLETED|Overall Study||0
6294272|NCT00297648|7196353|FG000|STARTED|Overall Study||89
6294273|NCT00297648|7196353|FG000|COMPLETED|Overall Study||53
6294274|NCT00297648|7196353|FG000|NOT COMPLETED|Overall Study||36
6294275|NCT00297778|7196359|FG000|STARTED|Overall Study||152
6294276|NCT00297778|7196360|FG001|STARTED|Overall Study||144
6294277|NCT00297778|7196359|FG000|COMPLETED|Overall Study||133
6294278|NCT00297778|7196360|FG001|COMPLETED|Overall Study||124
6294279|NCT00297778|7196359|FG000|NOT COMPLETED|Overall Study||19
6294280|NCT00297778|7196360|FG001|NOT COMPLETED|Overall Study||20
6294281|NCT00297830|7196369|FG000|STARTED|Baseline||41
6294282|NCT00297830|7196370|FG001|STARTED|Baseline||43
6294283|NCT00297830|7196371|FG002|STARTED|Baseline||27
6400576|NCT00887224|7313497|FG002|STARTED|Between OLR and OLS Phases||0
6400577|NCT00887224|7313495|FG000|COMPLETED|Between OLR and OLS Phases||659
6400578|NCT00887224|7313496|FG001|COMPLETED|Between OLR and OLS Phases||0
6400579|NCT00887224|7313497|FG002|COMPLETED|Between OLR and OLS Phases||0
6400580|NCT00887224|7313495|FG000|NOT COMPLETED|Between OLR and OLS Phases||93
6634918|NCT02300259|7563738|FG001|STARTED|Period 2|There was no period 2 for Group 2.|0
6294284|NCT00297830|7196369|FG000|COMPLETED|Baseline||41
6294285|NCT00297830|7196370|FG001|COMPLETED|Baseline||43
6294286|NCT00297830|7196371|FG002|COMPLETED|Baseline||27
6294287|NCT00297830|7196369|FG000|NOT COMPLETED|Baseline||0
6294288|NCT00297830|7196370|FG001|NOT COMPLETED|Baseline||0
6294289|NCT00297830|7196371|FG002|NOT COMPLETED|Baseline||0
6294290|NCT00297830|7196369|FG000|STARTED|6 Month Visit||41
6294291|NCT00297830|7196370|FG001|STARTED|6 Month Visit||43
6294292|NCT00297830|7196371|FG002|STARTED|6 Month Visit||27
6294293|NCT00297830|7196369|FG000|COMPLETED|6 Month Visit||38
6294294|NCT00297830|7196370|FG001|COMPLETED|6 Month Visit||41
6294295|NCT00297830|7196371|FG002|COMPLETED|6 Month Visit||24
6294296|NCT00297830|7196369|FG000|NOT COMPLETED|6 Month Visit||3
6294297|NCT00297830|7196370|FG001|NOT COMPLETED|6 Month Visit||2
6634919|NCT02300259|7563739|FG002|STARTED|Period 2||14
6634920|NCT02300259|7563737|FG000|COMPLETED|Period 2||15
6634921|NCT02300259|7563738|FG001|COMPLETED|Period 2||0
6634922|NCT02300259|7563739|FG002|COMPLETED|Period 2||13
6634923|NCT02300259|7563737|FG000|NOT COMPLETED|Period 2||1
6634924|NCT02300259|7563738|FG001|NOT COMPLETED|Period 2||0
6294298|NCT00297830|7196371|FG002|NOT COMPLETED|6 Month Visit||3
6294299|NCT00297830|7196369|FG000|STARTED|12 Month Visit||38
6294300|NCT00297830|7196370|FG001|STARTED|12 Month Visit||41
6294301|NCT00297830|7196371|FG002|STARTED|12 Month Visit||24
6294302|NCT00297830|7196369|FG000|COMPLETED|12 Month Visit||37
6294303|NCT00297830|7196370|FG001|COMPLETED|12 Month Visit||35
6294304|NCT00297830|7196371|FG002|COMPLETED|12 Month Visit||24
6294305|NCT00297830|7196369|FG000|NOT COMPLETED|12 Month Visit||1
6294306|NCT00297830|7196370|FG001|NOT COMPLETED|12 Month Visit||6
6294307|NCT00297830|7196371|FG002|NOT COMPLETED|12 Month Visit||0
6374216|NCT00749203|7284815|FG001|NOT COMPLETED|Second Infusion at 2 Weeks||2
6374217|NCT00749268|7284825|FG000|STARTED|Overall Study||106
6374218|NCT00749268|7284826|FG001|STARTED|Overall Study||110
6374219|NCT00749268|7284825|FG000|COMPLETED|Overall Study||72
6374220|NCT00749268|7284826|FG001|COMPLETED|Overall Study||74
6374221|NCT00749268|7284825|FG000|NOT COMPLETED|Overall Study||34
6374222|NCT00749268|7284826|FG001|NOT COMPLETED|Overall Study||36
6400581|NCT00887224|7313496|FG001|NOT COMPLETED|Between OLR and OLS Phases||0
6400582|NCT00887224|7313497|FG002|NOT COMPLETED|Between OLR and OLS Phases||0
6400583|NCT00887224|7313495|FG000|STARTED|Open-label Stability (OLS) Phase||659
6400584|NCT00887224|7313496|FG001|STARTED|Open-label Stability (OLS) Phase||0
6374223|NCT00749398|7284836|FG000|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
6374224|NCT00749398|7284836|FG000|COMPLETED|Overall Study||71
6374225|NCT00749398|7284836|FG000|NOT COMPLETED|Overall Study||53
6374226|NCT00749411|7284842|FG000|STARTED|Overall Study||21
6374227|NCT00749411|7284843|FG001|STARTED|Overall Study||40
6374228|NCT00749411|7284842|FG000|COMPLETED|Overall Study||20
6374229|NCT00749411|7284843|FG001|COMPLETED|Overall Study||35
6374230|NCT00749411|7284842|FG000|NOT COMPLETED|Overall Study||1
6374231|NCT00749411|7284843|FG001|NOT COMPLETED|Overall Study||5
6374232|NCT00749463|7284852|FG000|STARTED|Overall Study||86
6400585|NCT00887224|7313497|FG002|STARTED|Open-label Stability (OLS) Phase||0
6400586|NCT00887224|7313495|FG000|COMPLETED|Open-label Stability (OLS) Phase||576
6400587|NCT00887224|7313496|FG001|COMPLETED|Open-label Stability (OLS) Phase||0
6400588|NCT00887224|7313497|FG002|COMPLETED|Open-label Stability (OLS) Phase||0
6400589|NCT00887224|7313495|FG000|NOT COMPLETED|Open-label Stability (OLS) Phase||83
6400590|NCT00887224|7313496|FG001|NOT COMPLETED|Open-label Stability (OLS) Phase||0
6400591|NCT00887224|7313497|FG002|NOT COMPLETED|Open-label Stability (OLS) Phase||0
6400592|NCT00887224|7313495|FG000|STARTED|Between OLS and DB Phases||576
6400593|NCT00887224|7313496|FG001|STARTED|Between OLS and DB Phases||0
6634925|NCT02300259|7563739|FG002|NOT COMPLETED|Period 2||1
6294308|NCT00297882|7196381|FG000|STARTED|Day 14||204
6294309|NCT00297882|7196382|FG001|STARTED|Day 14||612
6294310|NCT00297882|7196381|FG000|COMPLETED|Day 14||192
6294311|NCT00297882|7196382|FG001|COMPLETED|Day 14||563
6294312|NCT00297882|7196381|FG000|NOT COMPLETED|Day 14||12
6294313|NCT00297882|7196382|FG001|NOT COMPLETED|Day 14||49
6294314|NCT00297882|7196381|FG000|STARTED|Day 28||192
6294315|NCT00297882|7196382|FG001|STARTED|Day 28||563
6294316|NCT00297882|7196381|FG000|COMPLETED|Day 28||176
6294317|NCT00297882|7196382|FG001|COMPLETED|Day 28||540
6294318|NCT00297882|7196381|FG000|NOT COMPLETED|Day 28||16
6294319|NCT00297882|7196382|FG001|NOT COMPLETED|Day 28||23
6294320|NCT00298038|7196392|FG000|STARTED|Overall Study||140
6294321|NCT00298038|7196393|FG001|STARTED|Overall Study||159
6294322|NCT00298038|7196392|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||140
6294323|NCT00298038|7196393|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||159
6294324|NCT00298038|7196392|FG000|COMPLETED|Overall Study||88
6294325|NCT00298038|7196393|FG001|COMPLETED|Overall Study||66
6294326|NCT00298038|7196392|FG000|NOT COMPLETED|Overall Study||52
6294327|NCT00298038|7196393|FG001|NOT COMPLETED|Overall Study||93
6294328|NCT00298090|7196399|FG000|STARTED|Overall Study||47
6294329|NCT00298090|7196399|FG000|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
6294330|NCT00298090|7196399|FG000|NOT COMPLETED|Overall Study||18
6294331|NCT00298155|7196406|FG000|STARTED|Overall Study||12
6294332|NCT00298155|7196407|FG001|STARTED|Overall Study||10
6294333|NCT00298155|7196408|FG002|STARTED|Overall Study||13
6294334|NCT00298155|7196406|FG000|COMPLETED|Overall Study||12
6294335|NCT00298155|7196407|FG001|COMPLETED|Overall Study||10
6294336|NCT00298155|7196408|FG002|COMPLETED|Overall Study||13
6294337|NCT00298155|7196406|FG000|NOT COMPLETED|Overall Study||0
6294338|NCT00298155|7196407|FG001|NOT COMPLETED|Overall Study||0
6294339|NCT00298155|7196408|FG002|NOT COMPLETED|Overall Study||0
6294340|NCT00298233|7196418|FG000|STARTED|Overall Study||39
6294341|NCT00298233|7196419|FG001|STARTED|Overall Study||41
6294342|NCT00298233|7196420|FG002|STARTED|Overall Study||122
6294343|NCT00298233|7196421|FG003|STARTED|Overall Study||124
6294344|NCT00298233|7196418|FG000|COMPLETED|Overall Study||39
6294345|NCT00298233|7196419|FG001|COMPLETED|Overall Study||41
6294346|NCT00298233|7196420|FG002|COMPLETED|Overall Study||122
6294347|NCT00298233|7196421|FG003|COMPLETED|Overall Study||124
6294348|NCT00298233|7196418|FG000|NOT COMPLETED|Overall Study||0
6294349|NCT00298233|7196419|FG001|NOT COMPLETED|Overall Study||0
6294350|NCT00298233|7196420|FG002|NOT COMPLETED|Overall Study||0
6294351|NCT00298233|7196421|FG003|NOT COMPLETED|Overall Study||0
6294352|NCT00298272|7196429|FG000|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
6294353|NCT00298272|7196430|FG001|STARTED|Double-blind Phase||18
6294354|NCT00298272|7196429|FG000|Safety Population|Double-blind Phase|received treatment|33
6294355|NCT00298272|7196430|FG001|Safety Population|Double-blind Phase||18
6294356|NCT00298272|7196429|FG000|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
6294357|NCT00298272|7196430|FG001|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
6294358|NCT00298272|7196429|FG000|Completed to Week 56|Double-blind Phase||8
6294359|NCT00298272|7196430|FG001|Completed to Week 56|Double-blind Phase||3
6294360|NCT00298272|7196429|FG000|COMPLETED|Double-blind Phase||28
6294361|NCT00298272|7196430|FG001|COMPLETED|Double-blind Phase||18
6294362|NCT00298272|7196429|FG000|NOT COMPLETED|Double-blind Phase||8
6294363|NCT00298272|7196430|FG001|NOT COMPLETED|Double-blind Phase||0
6294364|NCT00298272|7196429|FG000|STARTED|Open Label Retreatment Phase||22
6294365|NCT00298272|7196430|FG001|STARTED|Open Label Retreatment Phase||16
6400594|NCT00887224|7313497|FG002|STARTED|Between OLS and DB Phases||0
6400595|NCT00887224|7313495|FG000|COMPLETED|Between OLS and DB Phases||548
6400596|NCT00887224|7313496|FG001|COMPLETED|Between OLS and DB Phases||0
6400597|NCT00887224|7313497|FG002|COMPLETED|Between OLS and DB Phases||0
6400598|NCT00887224|7313495|FG000|NOT COMPLETED|Between OLS and DB Phases||28
6400599|NCT00887224|7313496|FG001|NOT COMPLETED|Between OLS and DB Phases||0
6400600|NCT00887224|7313497|FG002|NOT COMPLETED|Between OLS and DB Phases||0
6400601|NCT00887224|7313495|FG000|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
6400602|NCT00887224|7313496|FG001|STARTED|OL Taper Phase / OL Follow Up||0
6400603|NCT00887224|7313497|FG002|STARTED|OL Taper Phase / OL Follow Up||0
6502046|NCT01432327|7420690|FG001|COMPLETED|Posttest 6 Months||55
6294366|NCT00298272|7196429|FG000|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
6294367|NCT00298272|7196430|FG001|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
6294368|NCT00298272|7196429|FG000|Completed to Week 56|Open Label Retreatment Phase||13
6294369|NCT00298272|7196430|FG001|Completed to Week 56|Open Label Retreatment Phase||12
6294370|NCT00298272|7196429|FG000|COMPLETED|Open Label Retreatment Phase||13
6294371|NCT00298272|7196430|FG001|COMPLETED|Open Label Retreatment Phase||12
6294372|NCT00298272|7196429|FG000|NOT COMPLETED|Open Label Retreatment Phase||9
6294373|NCT00298272|7196430|FG001|NOT COMPLETED|Open Label Retreatment Phase||4
6294374|NCT00298272|7196429|FG000|STARTED|Safety Follow-up Phase||22
6294375|NCT00298272|7196430|FG001|STARTED|Safety Follow-up Phase||17
6294376|NCT00298272|7196429|FG000|COMPLETED|Safety Follow-up Phase||18
6294377|NCT00298272|7196430|FG001|COMPLETED|Safety Follow-up Phase||13
6294378|NCT00298272|7196429|FG000|NOT COMPLETED|Safety Follow-up Phase||4
6294379|NCT00298272|7196430|FG001|NOT COMPLETED|Safety Follow-up Phase||4
6294380|NCT00298363|7196442|FG000|STARTED|Overall Study||45
6294381|NCT00298363|7196443|FG001|STARTED|Overall Study||45
6294382|NCT00298363|7196444|FG002|STARTED|Overall Study||22
6294383|NCT00298363|7196442|FG000|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
6294384|NCT00298363|7196443|FG001|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
6294385|NCT00298363|7196444|FG002|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
6294386|NCT00298363|7196442|FG000|NOT COMPLETED|Overall Study||17
6294387|NCT00298363|7196443|FG001|NOT COMPLETED|Overall Study||8
6294388|NCT00298363|7196444|FG002|NOT COMPLETED|Overall Study||6
6294389|NCT00298389|7196461|FG000|STARTED|Overall Study||20
6294390|NCT00298389|7196462|FG001|STARTED|Overall Study||17
6294391|NCT00298389|7196463|FG002|STARTED|Overall Study||19
6294392|NCT00298389|7196461|FG000|COMPLETED|Overall Study||20
6294393|NCT00298389|7196462|FG001|COMPLETED|Overall Study||17
6294394|NCT00298389|7196463|FG002|COMPLETED|Overall Study||19
6294395|NCT00298389|7196461|FG000|NOT COMPLETED|Overall Study||0
6294396|NCT00298389|7196462|FG001|NOT COMPLETED|Overall Study||0
6294397|NCT00298389|7196463|FG002|NOT COMPLETED|Overall Study||0
6294398|NCT00298558|7196475|FG000|STARTED|Baseline||711
6294399|NCT00298558|7196476|FG001|STARTED|Baseline||705
6294400|NCT00298558|7196477|FG002|STARTED|Baseline||712
6294401|NCT00298558|7196478|FG003|STARTED|Baseline||704
6294402|NCT00298558|7196475|FG000|COMPLETED|Baseline||711
6294403|NCT00298558|7196476|FG001|COMPLETED|Baseline||705
6294404|NCT00298558|7196477|FG002|COMPLETED|Baseline||712
6294405|NCT00298558|7196478|FG003|COMPLETED|Baseline||704
6294406|NCT00298558|7196475|FG000|NOT COMPLETED|Baseline||0
6294407|NCT00298558|7196476|FG001|NOT COMPLETED|Baseline||0
6294408|NCT00298558|7196477|FG002|NOT COMPLETED|Baseline||0
6294409|NCT00298558|7196478|FG003|NOT COMPLETED|Baseline||0
6294410|NCT00298558|7196475|FG000|STARTED|Intervention||711
6294411|NCT00298558|7196476|FG001|STARTED|Intervention||705
6294412|NCT00298558|7196477|FG002|STARTED|Intervention||712
6294413|NCT00298558|7196478|FG003|STARTED|Intervention||704
6294414|NCT00298558|7196475|FG000|COMPLETED|Intervention||620
6294415|NCT00298558|7196476|FG001|COMPLETED|Intervention||627
6294416|NCT00298558|7196477|FG002|COMPLETED|Intervention||637
6294417|NCT00298558|7196478|FG003|COMPLETED|Intervention||285
6294418|NCT00298558|7196475|FG000|NOT COMPLETED|Intervention||91
6294419|NCT00298558|7196476|FG001|NOT COMPLETED|Intervention||78
6294420|NCT00298558|7196477|FG002|NOT COMPLETED|Intervention||75
6294421|NCT00298558|7196478|FG003|NOT COMPLETED|Intervention||419
6294422|NCT00298558|7196475|FG000|STARTED|Immediate Post Test||711
6294423|NCT00298558|7196476|FG001|STARTED|Immediate Post Test||705
6294424|NCT00298558|7196477|FG002|STARTED|Immediate Post Test||712
6294425|NCT00298558|7196478|FG003|STARTED|Immediate Post Test||704
6294426|NCT00298558|7196475|FG000|COMPLETED|Immediate Post Test||640
6294427|NCT00298558|7196476|FG001|COMPLETED|Immediate Post Test||629
6294428|NCT00298558|7196477|FG002|COMPLETED|Immediate Post Test||653
6294429|NCT00298558|7196478|FG003|COMPLETED|Immediate Post Test||639
6294430|NCT00298558|7196475|FG000|NOT COMPLETED|Immediate Post Test||71
6294431|NCT00298558|7196476|FG001|NOT COMPLETED|Immediate Post Test||76
6294432|NCT00298558|7196477|FG002|NOT COMPLETED|Immediate Post Test||59
6294433|NCT00298558|7196478|FG003|NOT COMPLETED|Immediate Post Test||65
6294434|NCT00298558|7196475|FG000|STARTED|Booster||372
6294435|NCT00298558|7196476|FG001|STARTED|Booster||371
6294436|NCT00298558|7196477|FG002|STARTED|Booster||370
6294437|NCT00298558|7196478|FG003|STARTED|Booster||0
6294438|NCT00298558|7196475|FG000|COMPLETED|Booster||283
6294439|NCT00298558|7196476|FG001|COMPLETED|Booster||301
6294440|NCT00298558|7196477|FG002|COMPLETED|Booster||295
6294441|NCT00298558|7196478|FG003|COMPLETED|Booster||0
6294442|NCT00298558|7196475|FG000|NOT COMPLETED|Booster||89
6294443|NCT00298558|7196476|FG001|NOT COMPLETED|Booster||70
6294444|NCT00298558|7196477|FG002|NOT COMPLETED|Booster||75
6294445|NCT00298558|7196478|FG003|NOT COMPLETED|Booster||0
6294446|NCT00298558|7196475|FG000|STARTED|1st Annual (A1)||640
6294447|NCT00298558|7196476|FG001|STARTED|1st Annual (A1)||629
6294448|NCT00298558|7196477|FG002|STARTED|1st Annual (A1)||653
6502047|NCT01432327|7420691|FG002|COMPLETED|Posttest 6 Months||50
6294449|NCT00298558|7196478|FG003|STARTED|1st Annual (A1)||639
6294450|NCT00298558|7196475|FG000|COMPLETED|1st Annual (A1)||585
6294451|NCT00298558|7196476|FG001|COMPLETED|1st Annual (A1)||566
6294452|NCT00298558|7196477|FG002|COMPLETED|1st Annual (A1)||601
6294453|NCT00298558|7196478|FG003|COMPLETED|1st Annual (A1)||584
6294454|NCT00298558|7196475|FG000|NOT COMPLETED|1st Annual (A1)||55
6294455|NCT00298558|7196476|FG001|NOT COMPLETED|1st Annual (A1)||63
6294456|NCT00298558|7196477|FG002|NOT COMPLETED|1st Annual (A1)||52
6294457|NCT00298558|7196478|FG003|NOT COMPLETED|1st Annual (A1)||55
6294458|NCT00298558|7196475|FG000|STARTED|2nd Annual (A2)||585
6294459|NCT00298558|7196476|FG001|STARTED|2nd Annual (A2)||566
6294460|NCT00298558|7196477|FG002|STARTED|2nd Annual (A2)||601
6294461|NCT00298558|7196478|FG003|STARTED|2nd Annual (A2)||584
6294462|NCT00298558|7196475|FG000|COMPLETED|2nd Annual (A2)||563
6294463|NCT00298558|7196476|FG001|COMPLETED|2nd Annual (A2)||555
6294464|NCT00298558|7196477|FG002|COMPLETED|2nd Annual (A2)||574
6294465|NCT00298558|7196478|FG003|COMPLETED|2nd Annual (A2)||552
6294466|NCT00298558|7196475|FG000|NOT COMPLETED|2nd Annual (A2)||22
6294467|NCT00298558|7196476|FG001|NOT COMPLETED|2nd Annual (A2)||11
6294468|NCT00298558|7196477|FG002|NOT COMPLETED|2nd Annual (A2)||27
6294469|NCT00298558|7196478|FG003|NOT COMPLETED|2nd Annual (A2)||32
6294470|NCT00298558|7196475|FG000|STARTED|3rd Annual Booster||372
6634926|NCT02300285|7563760|FG000|STARTED|Overall Study||3
6634927|NCT02300285|7563761|FG001|STARTED|Overall Study||3
6634928|NCT02300285|7563760|FG000|COMPLETED|Overall Study||3
6634929|NCT02300285|7563761|FG001|COMPLETED|Overall Study||3
6634930|NCT02300285|7563760|FG000|NOT COMPLETED|Overall Study||0
6634931|NCT02300285|7563761|FG001|NOT COMPLETED|Overall Study||0
6634932|NCT02300298|7563767|FG000|STARTED|Disposition for Nintedanib||10
6634933|NCT02300298|7563768|FG001|STARTED|Disposition for Nintedanib||0
6634934|NCT02300298|7563767|FG000|COMPLETED|Disposition for Nintedanib||0
6634935|NCT02300298|7563768|FG001|COMPLETED|Disposition for Nintedanib||0
6634936|NCT02300298|7563767|FG000|NOT COMPLETED|Disposition for Nintedanib||10
6634937|NCT02300298|7563768|FG001|NOT COMPLETED|Disposition for Nintedanib||0
6294471|NCT00298558|7196476|FG001|STARTED|3rd Annual Booster||371
6294472|NCT00298558|7196477|FG002|STARTED|3rd Annual Booster||370
6294473|NCT00298558|7196478|FG003|STARTED|3rd Annual Booster||0
6294474|NCT00298558|7196475|FG000|COMPLETED|3rd Annual Booster||250
6294475|NCT00298558|7196476|FG001|COMPLETED|3rd Annual Booster||243
6294476|NCT00298558|7196477|FG002|COMPLETED|3rd Annual Booster||230
6294477|NCT00298558|7196478|FG003|COMPLETED|3rd Annual Booster||0
6294478|NCT00298558|7196475|FG000|NOT COMPLETED|3rd Annual Booster||122
6294479|NCT00298558|7196476|FG001|NOT COMPLETED|3rd Annual Booster||128
6294480|NCT00298558|7196477|FG002|NOT COMPLETED|3rd Annual Booster||140
6294481|NCT00298558|7196478|FG003|NOT COMPLETED|3rd Annual Booster||0
6294482|NCT00298558|7196475|FG000|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
6294483|NCT00298558|7196476|FG001|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
6294484|NCT00298558|7196477|FG002|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
6294485|NCT00298558|7196478|FG003|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
6294486|NCT00298558|7196475|FG000|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
6294487|NCT00298558|7196476|FG001|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
6294488|NCT00298558|7196477|FG002|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
6294489|NCT00298558|7196478|FG003|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
6294490|NCT00298558|7196475|FG000|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
6294491|NCT00298558|7196476|FG001|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
6294492|NCT00298558|7196477|FG002|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
6294493|NCT00298558|7196478|FG003|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
6294494|NCT00298558|7196475|FG000|STARTED|10th Annual (A10)||472
6294495|NCT00298558|7196476|FG001|STARTED|10th Annual (A10)||469
6294496|NCT00298558|7196477|FG002|STARTED|10th Annual (A10)||490
6294497|NCT00298558|7196478|FG003|STARTED|10th Annual (A10)||448
6294498|NCT00298558|7196475|FG000|COMPLETED|10th Annual (A10)||300
6294499|NCT00298558|7196476|FG001|COMPLETED|10th Annual (A10)||316
6294500|NCT00298558|7196477|FG002|COMPLETED|10th Annual (A10)||319
6294501|NCT00298558|7196478|FG003|COMPLETED|10th Annual (A10)||285
6294502|NCT00298558|7196475|FG000|NOT COMPLETED|10th Annual (A10)||172
6294503|NCT00298558|7196476|FG001|NOT COMPLETED|10th Annual (A10)||153
6294504|NCT00298558|7196477|FG002|NOT COMPLETED|10th Annual (A10)||171
6294505|NCT00298558|7196478|FG003|NOT COMPLETED|10th Annual (A10)||163
6294506|NCT00298610|7196488|FG000|STARTED|Overall Study||30
6294507|NCT00298610|7196488|FG000|COMPLETED|Overall Study||30
6294508|NCT00298610|7196488|FG000|NOT COMPLETED|Overall Study||0
6294509|NCT00298766|7196492|FG000|STARTED|Overall Study||70
6294510|NCT00298766|7196492|FG000|COMPLETED|Overall Study||24
6294511|NCT00298766|7196492|FG000|NOT COMPLETED|Overall Study||46
6294512|NCT00298831|7196496|FG000|STARTED|Overall Study||224
6294513|NCT00298831|7196496|FG000|Treated|Overall Study||197
6294514|NCT00298831|7196496|FG000|COMPLETED|Overall Study||192
6294515|NCT00298831|7196496|FG000|NOT COMPLETED|Overall Study||32
6294516|NCT00298896|7196500|FG000|STARTED|Overall Study||55
6294517|NCT00298896|7196500|FG000|COMPLETED|Overall Study||5
6634938|NCT02300298|7563767|FG000|STARTED|Disposition for Docetaxel||0
6294518|NCT00298896|7196500|FG000|NOT COMPLETED|Overall Study||50
6294519|NCT00299000|7196506|FG000|STARTED|Overall Study||2
6294520|NCT00299000|7196507|FG001|STARTED|Overall Study||2
6294521|NCT00299000|7196506|FG000|COMPLETED|Overall Study||2
6294522|NCT00299000|7196507|FG001|COMPLETED|Overall Study||2
6294523|NCT00299000|7196506|FG000|NOT COMPLETED|Overall Study||0
6294524|NCT00299000|7196507|FG001|NOT COMPLETED|Overall Study||0
6294525|NCT00299104|7196516|FG000|STARTED|Treatment Period||251
6294526|NCT00299104|7196517|FG001|STARTED|Treatment Period||252
6294527|NCT00299104|7196518|FG002|STARTED|Treatment Period||252
6294528|NCT00299104|7196516|FG000|Safety/ITT: Received Study Drug|Treatment Period||249
6294529|NCT00299104|7196517|FG001|Safety/ITT: Received Study Drug|Treatment Period||249
6294530|NCT00299104|7196518|FG002|Safety/ITT: Received Study Drug|Treatment Period||250
6294531|NCT00299104|7196516|FG000|Completed Week 24|Treatment Period||227
6294532|NCT00299104|7196517|FG001|Completed Week 24|Treatment Period||240
6294533|NCT00299104|7196518|FG002|Completed Week 24|Treatment Period||241
6294534|NCT00299104|7196516|FG000|Completed Week 52|Treatment Period||213
6294535|NCT00299104|7196517|FG001|Completed Week 52|Treatment Period||227
6294536|NCT00299104|7196518|FG002|Completed Week 52|Treatment Period||232
6294537|NCT00299104|7196516|FG000|Completed Week 104|Treatment Period||178
6294538|NCT00299104|7196517|FG001|Completed Week 104|Treatment Period||213
6294539|NCT00299104|7196518|FG002|Completed Week 104|Treatment Period||216
6294540|NCT00299104|7196516|FG000|COMPLETED|Treatment Period|Completed Week 152|62
6294541|NCT00299104|7196517|FG001|COMPLETED|Treatment Period||77
6294542|NCT00299104|7196518|FG002|COMPLETED|Treatment Period||80
6294543|NCT00299104|7196516|FG000|NOT COMPLETED|Treatment Period||189
6294544|NCT00299104|7196517|FG001|NOT COMPLETED|Treatment Period||175
6294545|NCT00299104|7196518|FG002|NOT COMPLETED|Treatment Period||172
6294546|NCT00299104|7196516|FG000|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
6294547|NCT00299104|7196517|FG001|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
6294548|NCT00299104|7196518|FG002|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
6294549|NCT00299104|7196516|FG000|COMPLETED|Safety Follow-Up (SFU) Period||129
6294550|NCT00299104|7196517|FG001|COMPLETED|Safety Follow-Up (SFU) Period||171
6294551|NCT00299104|7196518|FG002|COMPLETED|Safety Follow-Up (SFU) Period||176
6294552|NCT00299104|7196516|FG000|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
6294553|NCT00299104|7196517|FG001|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
6294554|NCT00299104|7196518|FG002|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
6294555|NCT00299104|7196516|FG000|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
6294556|NCT00299104|7196517|FG001|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
6294557|NCT00299104|7196518|FG002|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
6294558|NCT00299104|7196516|FG000|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
6294559|NCT00299104|7196517|FG001|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
6294560|NCT00299104|7196518|FG002|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
6294561|NCT00299104|7196516|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
6294562|NCT00299104|7196517|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
6294563|NCT00299104|7196518|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
6294564|NCT00299130|7196529|FG000|STARTED|Treatment Period (up to 5 Years)||172
6294565|NCT00299130|7196530|FG001|STARTED|Treatment Period (up to 5 Years)||168
6294566|NCT00299130|7196531|FG002|STARTED|Treatment Period (up to 5 Years)||171
6294567|NCT00299130|7196529|FG000|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
6294568|NCT00299130|7196530|FG001|Treated|Treatment Period (up to 5 Years)||167
6294569|NCT00299130|7196531|FG002|Treated|Treatment Period (up to 5 Years)||170
6294570|NCT00299130|7196529|FG000|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
6294571|NCT00299130|7196530|FG001|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
6294572|NCT00299130|7196531|FG002|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
6294573|NCT00299130|7196529|FG000|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
6294574|NCT00299130|7196530|FG001|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
6294575|NCT00299130|7196531|FG002|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
6294576|NCT00299130|7196529|FG000|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
6294577|NCT00299130|7196530|FG001|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
6294578|NCT00299130|7196531|FG002|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
6294579|NCT00299130|7196529|FG000|COMPLETED|Treatment Period (up to 5 Years)||119
6294580|NCT00299130|7196530|FG001|COMPLETED|Treatment Period (up to 5 Years)||125
6294581|NCT00299130|7196531|FG002|COMPLETED|Treatment Period (up to 5 Years)||121
6294582|NCT00299130|7196529|FG000|NOT COMPLETED|Treatment Period (up to 5 Years)||53
6294583|NCT00299130|7196530|FG001|NOT COMPLETED|Treatment Period (up to 5 Years)||43
6294584|NCT00299130|7196531|FG002|NOT COMPLETED|Treatment Period (up to 5 Years)||50
6294585|NCT00299130|7196529|FG000|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
6294586|NCT00299130|7196530|FG001|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
6400604|NCT00887224|7313495|FG000|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
6400605|NCT00887224|7313496|FG001|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
6400606|NCT00887224|7313497|FG002|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
6400607|NCT00887224|7313495|FG000|COMPLETED|OL Taper Phase / OL Follow Up||163
6400608|NCT00887224|7313496|FG001|COMPLETED|OL Taper Phase / OL Follow Up||0
6400609|NCT00887224|7313497|FG002|COMPLETED|OL Taper Phase / OL Follow Up||0
6400610|NCT00887224|7313495|FG000|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
6400611|NCT00887224|7313496|FG001|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
6400612|NCT00887224|7313497|FG002|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
6400613|NCT00887224|7313495|FG000|STARTED|Double-blind (DB) Phase||0
6400614|NCT00887224|7313496|FG001|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
6400615|NCT00887224|7313497|FG002|STARTED|Double-blind (DB) Phase||272
6400616|NCT00887224|7313495|FG000|COMPLETED|Double-blind (DB) Phase||0
6400617|NCT00887224|7313496|FG001|COMPLETED|Double-blind (DB) Phase||176
6400618|NCT00887224|7313497|FG002|COMPLETED|Double-blind (DB) Phase||210
6400619|NCT00887224|7313495|FG000|NOT COMPLETED|Double-blind (DB) Phase||0
6400620|NCT00887224|7313496|FG001|NOT COMPLETED|Double-blind (DB) Phase||100
6400621|NCT00887224|7313497|FG002|NOT COMPLETED|Double-blind (DB) Phase||62
6400622|NCT00887224|7313495|FG000|STARTED|DB Taper Phase / Post Study Follow Up||0
6400623|NCT00887224|7313496|FG001|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
6400624|NCT00887224|7313497|FG002|STARTED|DB Taper Phase / Post Study Follow Up||265
6400625|NCT00887224|7313495|FG000|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
6400626|NCT00887224|7313496|FG001|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
6400627|NCT00887224|7313497|FG002|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
6294587|NCT00299130|7196531|FG002|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
6294588|NCT00299130|7196529|FG000|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
6294589|NCT00299130|7196530|FG001|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
6294590|NCT00299130|7196531|FG002|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
6294591|NCT00299130|7196529|FG000|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
6294592|NCT00299130|7196530|FG001|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
6294593|NCT00299130|7196531|FG002|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
6294594|NCT00299130|7196529|FG000|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
6294595|NCT00299130|7196530|FG001|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
6294596|NCT00299130|7196531|FG002|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
6294597|NCT00299130|7196529|FG000|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
6294598|NCT00299130|7196530|FG001|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
6294599|NCT00299130|7196531|FG002|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
6294600|NCT00299130|7196529|FG000|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
6294601|NCT00299130|7196530|FG001|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
6294602|NCT00299130|7196531|FG002|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
6294603|NCT00299156|7196549|FG000|STARTED|Period 1 (Non-Randomized)||32
6294604|NCT00299156|7196550|FG001|STARTED|Period 1 (Non-Randomized)||0
6294605|NCT00299156|7196551|FG002|STARTED|Period 1 (Non-Randomized)||0
6294606|NCT00299156|7196549|FG000|COMPLETED|Period 1 (Non-Randomized)||32
6294607|NCT00299156|7196550|FG001|COMPLETED|Period 1 (Non-Randomized)||0
6294608|NCT00299156|7196551|FG002|COMPLETED|Period 1 (Non-Randomized)||0
6294609|NCT00299156|7196549|FG000|NOT COMPLETED|Period 1 (Non-Randomized)||0
6294610|NCT00299156|7196550|FG001|NOT COMPLETED|Period 1 (Non-Randomized)||0
6294611|NCT00299156|7196551|FG002|NOT COMPLETED|Period 1 (Non-Randomized)||0
6294612|NCT00299156|7196549|FG000|STARTED|Period 2 (Randomized)||0
6294613|NCT00299156|7196550|FG001|STARTED|Period 2 (Randomized)||17
6294614|NCT00299156|7196551|FG002|STARTED|Period 2 (Randomized)||16
6294615|NCT00299156|7196549|FG000|COMPLETED|Period 2 (Randomized)||0
6294616|NCT00299156|7196550|FG001|COMPLETED|Period 2 (Randomized)||16
6294617|NCT00299156|7196551|FG002|COMPLETED|Period 2 (Randomized)||16
6294618|NCT00299156|7196549|FG000|NOT COMPLETED|Period 2 (Randomized)||0
6294619|NCT00299156|7196550|FG001|NOT COMPLETED|Period 2 (Randomized)||1
6294620|NCT00299156|7196551|FG002|NOT COMPLETED|Period 2 (Randomized)||0
6294621|NCT00299182|7196566|FG000|STARTED|Overall Study||6
6294622|NCT00299182|7196567|FG001|STARTED|Overall Study||4
6294623|NCT00299182|7196568|FG002|STARTED|Overall Study||6
6294624|NCT00299182|7196569|FG003|STARTED|Overall Study||14
6294625|NCT00299182|7196570|FG004|STARTED|Overall Study||8
6294626|NCT00299182|7196571|FG005|STARTED|Overall Study||7
6294627|NCT00299182|7196572|FG006|STARTED|Overall Study||5
6294628|NCT00299182|7196566|FG000|COMPLETED|Overall Study||6
6294629|NCT00299182|7196567|FG001|COMPLETED|Overall Study||4
6294630|NCT00299182|7196568|FG002|COMPLETED|Overall Study||4
6294631|NCT00299182|7196569|FG003|COMPLETED|Overall Study||14
6294632|NCT00299182|7196570|FG004|COMPLETED|Overall Study||5
6294633|NCT00299182|7196571|FG005|COMPLETED|Overall Study||4
6294634|NCT00299182|7196572|FG006|COMPLETED|Overall Study||4
6294635|NCT00299182|7196566|FG000|NOT COMPLETED|Overall Study||0
6294636|NCT00299182|7196567|FG001|NOT COMPLETED|Overall Study||0
6294637|NCT00299182|7196568|FG002|NOT COMPLETED|Overall Study||2
6294638|NCT00299182|7196569|FG003|NOT COMPLETED|Overall Study||0
6294639|NCT00299182|7196570|FG004|NOT COMPLETED|Overall Study||3
6294640|NCT00299182|7196571|FG005|NOT COMPLETED|Overall Study||3
6294641|NCT00299182|7196572|FG006|NOT COMPLETED|Overall Study||1
6294642|NCT00299221|7196592|FG000|STARTED|Overall Study||79
6294643|NCT00299221|7196593|FG001|STARTED|Overall Study||71
6294644|NCT00299221|7196592|FG000|COMPLETED|Overall Study||79
6294645|NCT00299221|7196593|FG001|COMPLETED|Overall Study||71
6294646|NCT00299221|7196592|FG000|NOT COMPLETED|Overall Study||0
6294647|NCT00299221|7196593|FG001|NOT COMPLETED|Overall Study||0
6294648|NCT00299416|7196599|FG000|STARTED|Overall Study||30
6294649|NCT00299416|7196599|FG000|COMPLETED|Overall Study||30
6294650|NCT00299416|7196599|FG000|NOT COMPLETED|Overall Study||0
6294651|NCT00299494|7196609|FG000|STARTED|Overall Study||5
6294652|NCT00299494|7196610|FG001|STARTED|Overall Study||3
6294653|NCT00299494|7196611|FG002|STARTED|Overall Study||7
6294654|NCT00299494|7196612|FG003|STARTED|Overall Study||34
6294655|NCT00299494|7196613|FG004|STARTED|Overall Study|1 participant received rituximab only, and did not receive inotuzumab ozogamicin|40
6294656|NCT00299494|7196614|FG005|STARTED|Overall Study||30
6294657|NCT00299494|7196609|FG000|COMPLETED|Overall Study||2
6502048|NCT01432327|7420692|FG003|COMPLETED|Posttest 6 Months||54
6294658|NCT00299494|7196610|FG001|COMPLETED|Overall Study||2
6294659|NCT00299494|7196611|FG002|COMPLETED|Overall Study||3
6294660|NCT00299494|7196612|FG003|COMPLETED|Overall Study||24
6294661|NCT00299494|7196613|FG004|COMPLETED|Overall Study||13
6400628|NCT00887224|7313495|FG000|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
6400629|NCT00887224|7313496|FG001|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
6400630|NCT00887224|7313497|FG002|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
6400631|NCT00887224|7313495|FG000|COMPLETED|DB Taper Phase / Post Study Follow Up||0
6400632|NCT00887224|7313496|FG001|COMPLETED|DB Taper Phase / Post Study Follow Up||226
6400633|NCT00887224|7313497|FG002|COMPLETED|DB Taper Phase / Post Study Follow Up||235
6294662|NCT00299494|7196614|FG005|COMPLETED|Overall Study||4
6294663|NCT00299494|7196609|FG000|NOT COMPLETED|Overall Study||3
6294664|NCT00299494|7196610|FG001|NOT COMPLETED|Overall Study||1
6294665|NCT00299494|7196611|FG002|NOT COMPLETED|Overall Study||4
6294666|NCT00299494|7196612|FG003|NOT COMPLETED|Overall Study||10
6294667|NCT00299494|7196613|FG004|NOT COMPLETED|Overall Study||27
6294668|NCT00299494|7196614|FG005|NOT COMPLETED|Overall Study||26
6294669|NCT00299546|7196642|FG000|STARTED|Overall Study||155
6294670|NCT00299546|7196643|FG001|STARTED|Overall Study||153
6294671|NCT00299546|7196644|FG002|STARTED|Overall Study||153
6294672|NCT00299546|7196642|FG000|COMPLETED|Overall Study||55
6294673|NCT00299546|7196643|FG001|COMPLETED|Overall Study||61
6294674|NCT00299546|7196644|FG002|COMPLETED|Overall Study||67
6294675|NCT00299546|7196642|FG000|NOT COMPLETED|Overall Study||100
6294676|NCT00299546|7196643|FG001|NOT COMPLETED|Overall Study||92
6294677|NCT00299546|7196644|FG002|NOT COMPLETED|Overall Study||86
6294678|NCT00299689|7196653|FG000|STARTED|Overall Study||69
6294679|NCT00299689|7196653|FG000|COMPLETED|Overall Study||69
6294680|NCT00299689|7196653|FG000|NOT COMPLETED|Overall Study||0
6294681|NCT00299702|7196659|FG000|STARTED|Overall Study||179
6294682|NCT00299702|7196660|FG001|STARTED|Overall Study||176
6294683|NCT00299702|7196659|FG000|COMPLETED|Overall Study||126
6294684|NCT00299702|7196660|FG001|COMPLETED|Overall Study||126
6294685|NCT00299702|7196659|FG000|NOT COMPLETED|Overall Study||53
6294686|NCT00299702|7196660|FG001|NOT COMPLETED|Overall Study||50
6294687|NCT00299741|7196666|FG000|STARTED|Overall Study||36
6294688|NCT00299741|7196666|FG000|COMPLETED|Overall Study||36
6294689|NCT00299741|7196666|FG000|NOT COMPLETED|Overall Study||0
6294690|NCT00299975|7196673|FG000|STARTED|Overall Study||32
6294691|NCT00299975|7196674|FG001|STARTED|Overall Study||32
6294692|NCT00299975|7196675|FG002|STARTED|Overall Study||33
6294693|NCT00299975|7196673|FG000|Received Allocated Intervention|Overall Study||32
6294694|NCT00299975|7196674|FG001|Received Allocated Intervention|Overall Study||32
6294695|NCT00299975|7196675|FG002|Received Allocated Intervention|Overall Study||32
6294696|NCT00299975|7196673|FG000|COMPLETED|Overall Study||29
6294697|NCT00299975|7196674|FG001|COMPLETED|Overall Study||31
6294698|NCT00299975|7196675|FG002|COMPLETED|Overall Study||25
6294699|NCT00299975|7196673|FG000|NOT COMPLETED|Overall Study||3
6294700|NCT00299975|7196674|FG001|NOT COMPLETED|Overall Study||1
6294701|NCT00299975|7196675|FG002|NOT COMPLETED|Overall Study||8
6294702|NCT00299988|7196685|FG000|STARTED|Overall Study||16
6294703|NCT00299988|7196686|FG001|STARTED|Overall Study||8
6294704|NCT00299988|7196685|FG000|COMPLETED|Overall Study||16
6294705|NCT00299988|7196686|FG001|COMPLETED|Overall Study||8
6294706|NCT00299988|7196685|FG000|NOT COMPLETED|Overall Study||0
6294707|NCT00299988|7196686|FG001|NOT COMPLETED|Overall Study||0
6294708|NCT00300053|7196696|FG000|STARTED|Overall Study|started = randomized and treated/injected|55
6294709|NCT00300053|7196697|FG001|STARTED|Overall Study|started = randomized and treated/injected|56
6294710|NCT00300053|7196698|FG002|STARTED|Overall Study|started = randomized and treated/injected|56
6294711|NCT00300053|7196696|FG000|3-Month Evaluation|Overall Study||55
6294712|NCT00300053|7196697|FG001|3-Month Evaluation|Overall Study||56
6294713|NCT00300053|7196698|FG002|3-Month Evaluation|Overall Study||54
6294714|NCT00300053|7196696|FG000|6-Month Evaluation|Overall Study||54
6294715|NCT00300053|7196697|FG001|6-Month Evaluation|Overall Study||55
6294716|NCT00300053|7196698|FG002|6-Month Evaluation|Overall Study||53
6294717|NCT00300053|7196696|FG000|COMPLETED|Overall Study||53
6294718|NCT00300053|7196697|FG001|COMPLETED|Overall Study||53
6294719|NCT00300053|7196698|FG002|COMPLETED|Overall Study||50
6294720|NCT00300053|7196696|FG000|NOT COMPLETED|Overall Study||2
6294721|NCT00300053|7196697|FG001|NOT COMPLETED|Overall Study||3
6294722|NCT00300053|7196698|FG002|NOT COMPLETED|Overall Study||6
6294723|NCT00300235|7196712|FG000|STARTED|Overall Study||208
6294724|NCT00300235|7196713|FG001|STARTED|Overall Study||240
6294725|NCT00300235|7196714|FG002|STARTED|Overall Study||398
6294726|NCT00300235|7196715|FG003|STARTED|Overall Study||362
6294727|NCT00300235|7196716|FG004|STARTED|Overall Study||251
6294728|NCT00300235|7196712|FG000|COMPLETED|Overall Study||208
6294729|NCT00300235|7196713|FG001|COMPLETED|Overall Study||240
6294730|NCT00300235|7196714|FG002|COMPLETED|Overall Study||398
6294731|NCT00300235|7196715|FG003|COMPLETED|Overall Study||362
6294732|NCT00300235|7196716|FG004|COMPLETED|Overall Study||251
6294733|NCT00300235|7196712|FG000|NOT COMPLETED|Overall Study||0
6294734|NCT00300235|7196713|FG001|NOT COMPLETED|Overall Study||0
6294735|NCT00300235|7196714|FG002|NOT COMPLETED|Overall Study||0
6294736|NCT00300235|7196715|FG003|NOT COMPLETED|Overall Study||0
6294737|NCT00300235|7196716|FG004|NOT COMPLETED|Overall Study||0
6294738|NCT00300274|7196731|FG000|STARTED|Overall Study||282
6294739|NCT00300274|7196732|FG001|STARTED|Overall Study||168
6294740|NCT00300274|7196733|FG002|STARTED|Overall Study||271
6294741|NCT00300274|7196731|FG000|Completed 12 Month|Overall Study||250
6294742|NCT00300274|7196732|FG001|Completed 12 Month|Overall Study||149
6294743|NCT00300274|7196733|FG002|Completed 12 Month|Overall Study||248
6294744|NCT00300274|7196731|FG000|COMPLETED|Overall Study||236
6294745|NCT00300274|7196732|FG001|COMPLETED|Overall Study||141
6294746|NCT00300274|7196733|FG002|COMPLETED|Overall Study||226
6294747|NCT00300274|7196731|FG000|NOT COMPLETED|Overall Study||46
6294748|NCT00300274|7196732|FG001|NOT COMPLETED|Overall Study||27
6400634|NCT00887224|7313495|FG000|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
6400635|NCT00887224|7313496|FG001|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
6400636|NCT00887224|7313497|FG002|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
6294749|NCT00300274|7196733|FG002|NOT COMPLETED|Overall Study||45
6294750|NCT00300365|7196743|FG000|STARTED|Overall Study||38
6294751|NCT00300365|7196744|FG001|STARTED|Overall Study||40
6294752|NCT00300365|7196743|FG000|COMPLETED|Overall Study||34
6294753|NCT00300365|7196744|FG001|COMPLETED|Overall Study||38
6294754|NCT00300365|7196743|FG000|NOT COMPLETED|Overall Study||4
6294755|NCT00300365|7196744|FG001|NOT COMPLETED|Overall Study||2
6294756|NCT00300391|7196752|FG000|STARTED|Overall Study||16
6294757|NCT00300391|7196753|FG001|STARTED|Overall Study||14
6294758|NCT00300391|7196752|FG000|COMPLETED|Overall Study||16
6294759|NCT00300391|7196753|FG001|COMPLETED|Overall Study||14
6294760|NCT00300391|7196752|FG000|NOT COMPLETED|Overall Study||0
6400637|NCT00887289|7313509|FG000|STARTED|Overall Study||1504
6400638|NCT00887289|7313509|FG000|COMPLETED|Overall Study||1409
6400639|NCT00887289|7313509|FG000|NOT COMPLETED|Overall Study||95
6400640|NCT00887341|7313515|FG000|STARTED|Overall Study||37
6400641|NCT00887341|7313516|FG001|STARTED|Overall Study||39
6400642|NCT00887341|7313515|FG000|COMPLETED|Overall Study||35
6400643|NCT00887341|7313516|FG001|COMPLETED|Overall Study||36
6400644|NCT00887341|7313515|FG000|NOT COMPLETED|Overall Study||2
6400645|NCT00887341|7313516|FG001|NOT COMPLETED|Overall Study||3
6400646|NCT00887354|7313524|FG000|STARTED|Treatment Phase (Week 0 to Week 26)||111
6400647|NCT00887354|7313525|FG001|STARTED|Treatment Phase (Week 0 to Week 26)||113
6400648|NCT00887354|7313524|FG000|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
6294761|NCT00300391|7196753|FG001|NOT COMPLETED|Overall Study||0
6294762|NCT00300430|7196763|FG000|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
6294763|NCT00300430|7196764|FG001|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
6294764|NCT00300430|7196765|FG002|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
6294765|NCT00300430|7196763|FG000|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
6294766|NCT00300430|7196764|FG001|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
6294767|NCT00300430|7196765|FG002|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
6294768|NCT00300430|7196763|FG000|NOT COMPLETED|Overall Study||367
6294769|NCT00300430|7196764|FG001|NOT COMPLETED|Overall Study||169
6294770|NCT00300430|7196765|FG002|NOT COMPLETED|Overall Study||151
6294771|NCT00300456|7196779|FG000|STARTED|Overall Study|"For all arms, started means treated."|119
6294772|NCT00300456|7196780|FG001|STARTED|Overall Study||118
6294773|NCT00300456|7196781|FG002|STARTED|Overall Study||119
6294774|NCT00300456|7196782|FG003|STARTED|Overall Study||119
6294775|NCT00300456|7196783|FG004|STARTED|Overall Study||116
6294776|NCT00300456|7196784|FG005|STARTED|Overall Study||59
6294777|NCT00300456|7196779|FG000|COMPLETED|Overall Study||103
6294778|NCT00300456|7196780|FG001|COMPLETED|Overall Study||102
6294779|NCT00300456|7196781|FG002|COMPLETED|Overall Study||98
6294780|NCT00300456|7196782|FG003|COMPLETED|Overall Study||105
6400649|NCT00887354|7313525|FG001|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
6400650|NCT00887354|7313524|FG000|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
6400651|NCT00887354|7313525|FG001|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
6400652|NCT00887354|7313524|FG000|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
6400653|NCT00887354|7313525|FG001|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
6400654|NCT00887354|7313524|FG000|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
6400655|NCT00887354|7313525|FG001|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
6400656|NCT00887354|7313524|FG000|STARTED|Open Label Phase (Week 26 to Week 78)||60
6400657|NCT00887354|7313525|FG001|STARTED|Open Label Phase (Week 26 to Week 78)||65
6400658|NCT00887354|7313524|FG000|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
6400659|NCT00887354|7313525|FG001|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
6400660|NCT00887354|7313524|FG000|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
6400661|NCT00887354|7313525|FG001|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
6400662|NCT00887432|7313534|FG000|STARTED|Overall Study||58
6294781|NCT00300456|7196783|FG004|COMPLETED|Overall Study||99
6294782|NCT00300456|7196784|FG005|COMPLETED|Overall Study||48
6294783|NCT00300456|7196779|FG000|NOT COMPLETED|Overall Study||16
6294784|NCT00300456|7196780|FG001|NOT COMPLETED|Overall Study||16
6294785|NCT00300456|7196781|FG002|NOT COMPLETED|Overall Study||21
6294786|NCT00300456|7196782|FG003|NOT COMPLETED|Overall Study||14
6294787|NCT00300456|7196783|FG004|NOT COMPLETED|Overall Study||17
6294788|NCT00300456|7196784|FG005|NOT COMPLETED|Overall Study||11
6294789|NCT00300469|7196804|FG000|STARTED|Overall Study|"For all arms, started means treated."|110
6294790|NCT00300469|7196805|FG001|STARTED|Overall Study||110
6294791|NCT00300469|7196806|FG002|STARTED|Overall Study||112
6294792|NCT00300469|7196807|FG003|STARTED|Overall Study||113
6400663|NCT00887432|7313535|FG001|STARTED|Overall Study||74
6400664|NCT00887432|7313534|FG000|COMPLETED|Overall Study||43
6400665|NCT00887432|7313535|FG001|COMPLETED|Overall Study||60
6400666|NCT00887432|7313534|FG000|NOT COMPLETED|Overall Study||15
6400667|NCT00887432|7313535|FG001|NOT COMPLETED|Overall Study||14
6400668|NCT00887458|7313543|FG000|STARTED|Overall Study||17
6400669|NCT00887458|7313544|FG001|STARTED|Overall Study||29
6400670|NCT00887458|7313543|FG000|COMPLETED|Overall Study||17
6400671|NCT00887458|7313544|FG001|COMPLETED|Overall Study||25
6400672|NCT00887458|7313543|FG000|NOT COMPLETED|Overall Study||0
6400673|NCT00887458|7313544|FG001|NOT COMPLETED|Overall Study||4
6400674|NCT00887471|7313554|FG000|STARTED|Overall Study||15
6400675|NCT00887471|7313555|FG001|STARTED|Overall Study||15
6294793|NCT00300469|7196808|FG004|STARTED|Overall Study||109
6294794|NCT00300469|7196809|FG005|STARTED|Overall Study||55
6294795|NCT00300469|7196804|FG000|COMPLETED|Overall Study||89
6294796|NCT00300469|7196805|FG001|COMPLETED|Overall Study||89
6294797|NCT00300469|7196806|FG002|COMPLETED|Overall Study||95
6294798|NCT00300469|7196807|FG003|COMPLETED|Overall Study||104
6294799|NCT00300469|7196808|FG004|COMPLETED|Overall Study||95
6294800|NCT00300469|7196809|FG005|COMPLETED|Overall Study||46
6294801|NCT00300469|7196804|FG000|NOT COMPLETED|Overall Study||21
6294802|NCT00300469|7196805|FG001|NOT COMPLETED|Overall Study||21
6294803|NCT00300469|7196806|FG002|NOT COMPLETED|Overall Study||17
6294804|NCT00300469|7196807|FG003|NOT COMPLETED|Overall Study||9
6294805|NCT00300469|7196808|FG004|NOT COMPLETED|Overall Study||14
6294806|NCT00300469|7196809|FG005|NOT COMPLETED|Overall Study||9
6294807|NCT00300482|7196829|FG000|STARTED|Overall Study|"For all arms, started means treated."|261
6294808|NCT00300482|7196830|FG001|STARTED|Overall Study||261
6294809|NCT00300482|7196831|FG002|STARTED|Overall Study||259
6294810|NCT00300482|7196832|FG003|STARTED|Overall Study||261
6294811|NCT00300482|7196833|FG004|STARTED|Overall Study||266
6294812|NCT00300482|7196834|FG005|STARTED|Overall Study||131
6294813|NCT00300482|7196829|FG000|COMPLETED|Overall Study||220
6294814|NCT00300482|7196830|FG001|COMPLETED|Overall Study||220
6294815|NCT00300482|7196831|FG002|COMPLETED|Overall Study||208
6294816|NCT00300482|7196832|FG003|COMPLETED|Overall Study||237
6294817|NCT00300482|7196833|FG004|COMPLETED|Overall Study||243
6294818|NCT00300482|7196834|FG005|COMPLETED|Overall Study||115
6294819|NCT00300482|7196829|FG000|NOT COMPLETED|Overall Study||41
6294820|NCT00300482|7196830|FG001|NOT COMPLETED|Overall Study||41
6294821|NCT00300482|7196831|FG002|NOT COMPLETED|Overall Study||51
6294822|NCT00300482|7196832|FG003|NOT COMPLETED|Overall Study||24
6294823|NCT00300482|7196833|FG004|NOT COMPLETED|Overall Study||23
6294824|NCT00300482|7196834|FG005|NOT COMPLETED|Overall Study||16
6294825|NCT00300495|7196850|FG000|STARTED|Overall Study||10
6294826|NCT00300495|7196851|FG001|STARTED|Overall Study||9
6294827|NCT00300495|7196850|FG000|COMPLETED|Overall Study||6
6294828|NCT00300495|7196851|FG001|COMPLETED|Overall Study||8
6294829|NCT00300495|7196850|FG000|NOT COMPLETED|Overall Study||4
6294830|NCT00300495|7196851|FG001|NOT COMPLETED|Overall Study||1
6294831|NCT00300677|7196857|FG000|STARTED|Overall Study||12
6294832|NCT00300677|7196857|FG000|COMPLETED|Overall Study||12
6294833|NCT00300677|7196857|FG000|NOT COMPLETED|Overall Study||0
6400676|NCT00887471|7313554|FG000|COMPLETED|Overall Study||15
6400677|NCT00887471|7313555|FG001|COMPLETED|Overall Study||15
6400678|NCT00887471|7313554|FG000|NOT COMPLETED|Overall Study||0
6294834|NCT00300742|7196861|FG000|STARTED|Overall Study||5
6294835|NCT00300742|7196861|FG000|COMPLETED|Overall Study||3
6294836|NCT00300742|7196861|FG000|NOT COMPLETED|Overall Study||2
6294837|NCT00300755|7196869|FG000|STARTED|Overall Study||18
6294838|NCT00300755|7196870|FG001|STARTED|Overall Study||21
6294839|NCT00300755|7196871|FG002|STARTED|Overall Study||21
6294840|NCT00300755|7196869|FG000|COMPLETED|Overall Study||17
6294841|NCT00300755|7196870|FG001|COMPLETED|Overall Study||17
6294842|NCT00300755|7196871|FG002|COMPLETED|Overall Study||19
6400679|NCT00887471|7313555|FG001|NOT COMPLETED|Overall Study||0
6400680|NCT00887484|7313561|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||48
6400681|NCT00887484|7313561|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
6400682|NCT00887484|7313561|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
6400683|NCT00887484|7313561|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||48
6400684|NCT00887484|7313561|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
6294843|NCT00300755|7196869|FG000|NOT COMPLETED|Overall Study||1
6294844|NCT00300755|7196870|FG001|NOT COMPLETED|Overall Study||4
6294845|NCT00300755|7196871|FG002|NOT COMPLETED|Overall Study||2
6294846|NCT00300781|7196881|FG000|STARTED|Overall Study||66
6294847|NCT00300781|7196882|FG001|STARTED|Overall Study||70
6294848|NCT00300781|7196881|FG000|COMPLETED|Overall Study||3
6294849|NCT00300781|7196882|FG001|COMPLETED|Overall Study||8
6294850|NCT00300781|7196881|FG000|NOT COMPLETED|Overall Study||63
6294851|NCT00300781|7196882|FG001|NOT COMPLETED|Overall Study||62
6294852|NCT00300885|7196890|FG000|STARTED|Treatment||464
6294853|NCT00300885|7196891|FG001|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
6294854|NCT00300885|7196890|FG000|Received Treatment|Treatment||463
6294855|NCT00300885|7196891|FG001|Received Treatment|Treatment||459
6294856|NCT00300885|7196890|FG000|COMPLETED|Treatment||91
6294857|NCT00300885|7196891|FG001|COMPLETED|Treatment||88
6294858|NCT00300885|7196890|FG000|NOT COMPLETED|Treatment||373
6294859|NCT00300885|7196891|FG001|NOT COMPLETED|Treatment||374
6294860|NCT00300885|7196890|FG000|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
6294861|NCT00300885|7196891|FG001|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
6294862|NCT00300885|7196890|FG000|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
6294863|NCT00300885|7196891|FG001|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
6294864|NCT00300885|7196890|FG000|NOT COMPLETED|Follow-up||178
6294865|NCT00300885|7196891|FG001|NOT COMPLETED|Follow-up||195
6294866|NCT00301028|7196897|FG000|STARTED|Overall Study||47
6294867|NCT00301028|7196897|FG000|COMPLETED|Overall Study||47
6294868|NCT00301028|7196897|FG000|NOT COMPLETED|Overall Study||0
6294869|NCT00301067|7196901|FG000|STARTED|Completed DLT Period/1st Cycle||4
6294870|NCT00301067|7196902|FG001|STARTED|Completed DLT Period/1st Cycle||3
6294871|NCT00301067|7196903|FG002|STARTED|Completed DLT Period/1st Cycle||3
6294872|NCT00301067|7196904|FG003|STARTED|Completed DLT Period/1st Cycle|Patients did not participate in the DLT portion of the trial, they completed 1st cycle of treatment.|10
6294873|NCT00301067|7196901|FG000|COMPLETED|Completed DLT Period/1st Cycle||3
6294874|NCT00301067|7196902|FG001|COMPLETED|Completed DLT Period/1st Cycle||3
6294875|NCT00301067|7196903|FG002|COMPLETED|Completed DLT Period/1st Cycle||3
6294876|NCT00301067|7196904|FG003|COMPLETED|Completed DLT Period/1st Cycle||9
6294877|NCT00301067|7196901|FG000|NOT COMPLETED|Completed DLT Period/1st Cycle||1
6294878|NCT00301067|7196902|FG001|NOT COMPLETED|Completed DLT Period/1st Cycle||0
6294879|NCT00301067|7196903|FG002|NOT COMPLETED|Completed DLT Period/1st Cycle||0
6294880|NCT00301067|7196904|FG003|NOT COMPLETED|Completed DLT Period/1st Cycle||1
6294881|NCT00301067|7196901|FG000|STARTED|Reached 1st Response/2 Cycles||3
6294882|NCT00301067|7196902|FG001|STARTED|Reached 1st Response/2 Cycles||3
6294883|NCT00301067|7196903|FG002|STARTED|Reached 1st Response/2 Cycles||3
6294884|NCT00301067|7196904|FG003|STARTED|Reached 1st Response/2 Cycles||9
6294885|NCT00301067|7196901|FG000|COMPLETED|Reached 1st Response/2 Cycles||1
6294886|NCT00301067|7196902|FG001|COMPLETED|Reached 1st Response/2 Cycles||2
6294887|NCT00301067|7196903|FG002|COMPLETED|Reached 1st Response/2 Cycles||2
6294888|NCT00301067|7196904|FG003|COMPLETED|Reached 1st Response/2 Cycles||7
6294889|NCT00301067|7196901|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
6294890|NCT00301067|7196902|FG001|NOT COMPLETED|Reached 1st Response/2 Cycles||1
6294891|NCT00301067|7196903|FG002|NOT COMPLETED|Reached 1st Response/2 Cycles||1
6294892|NCT00301067|7196904|FG003|NOT COMPLETED|Reached 1st Response/2 Cycles||2
6294893|NCT00301067|7196901|FG000|STARTED|Completed 4 Cycles of Treatment||1
6294894|NCT00301067|7196902|FG001|STARTED|Completed 4 Cycles of Treatment||2
6294895|NCT00301067|7196903|FG002|STARTED|Completed 4 Cycles of Treatment||2
6294896|NCT00301067|7196904|FG003|STARTED|Completed 4 Cycles of Treatment||7
6294897|NCT00301067|7196901|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
6294898|NCT00301067|7196902|FG001|COMPLETED|Completed 4 Cycles of Treatment||1
6294899|NCT00301067|7196903|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
6294900|NCT00301067|7196904|FG003|COMPLETED|Completed 4 Cycles of Treatment||2
6294901|NCT00301067|7196901|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||1
6294902|NCT00301067|7196902|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||1
6294903|NCT00301067|7196903|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||2
6294904|NCT00301067|7196904|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||5
6294905|NCT00301067|7196901|FG000|STARTED|Completed 12 Cycles of Treatment||0
6294906|NCT00301067|7196902|FG001|STARTED|Completed 12 Cycles of Treatment||1
6294907|NCT00301067|7196903|FG002|STARTED|Completed 12 Cycles of Treatment||0
6294908|NCT00301067|7196904|FG003|STARTED|Completed 12 Cycles of Treatment||2
6294909|NCT00301067|7196901|FG000|COMPLETED|Completed 12 Cycles of Treatment||0
6400685|NCT00887484|7313561|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
6400686|NCT00887510|7313572|FG000|STARTED|Overall Study||12
6400687|NCT00887510|7313573|FG001|STARTED|Overall Study||12
6400688|NCT00887510|7313572|FG000|COMPLETED|Overall Study||12
6400689|NCT00887510|7313573|FG001|COMPLETED|Overall Study||12
6400690|NCT00887510|7313572|FG000|NOT COMPLETED|Overall Study||0
6400691|NCT00887510|7313573|FG001|NOT COMPLETED|Overall Study||0
6400692|NCT00887549|7313579|FG000|STARTED|Induction Therapy||70
6400693|NCT00887549|7313579|FG000|COMPLETED|Induction Therapy||43
6400694|NCT00887549|7313579|FG000|NOT COMPLETED|Induction Therapy||27
6400695|NCT00887549|7313579|FG000|STARTED|Maintenance Therapy||43
6400696|NCT00887549|7313579|FG000|COMPLETED|Maintenance Therapy||0
6294910|NCT00301067|7196902|FG001|COMPLETED|Completed 12 Cycles of Treatment||0
6294911|NCT00301067|7196903|FG002|COMPLETED|Completed 12 Cycles of Treatment||0
6294912|NCT00301067|7196904|FG003|COMPLETED|Completed 12 Cycles of Treatment||0
6294913|NCT00301067|7196901|FG000|NOT COMPLETED|Completed 12 Cycles of Treatment||0
6294914|NCT00301067|7196902|FG001|NOT COMPLETED|Completed 12 Cycles of Treatment||1
6294915|NCT00301067|7196903|FG002|NOT COMPLETED|Completed 12 Cycles of Treatment||0
6294916|NCT00301067|7196904|FG003|NOT COMPLETED|Completed 12 Cycles of Treatment||2
6294917|NCT00301067|7196901|FG000|STARTED|Follow up Until Death||4
6294918|NCT00301067|7196902|FG001|STARTED|Follow up Until Death||3
6294919|NCT00301067|7196903|FG002|STARTED|Follow up Until Death||3
6294920|NCT00301067|7196904|FG003|STARTED|Follow up Until Death||3
6294921|NCT00301067|7196901|FG000|COMPLETED|Follow up Until Death||3
6294922|NCT00301067|7196902|FG001|COMPLETED|Follow up Until Death||3
6294923|NCT00301067|7196903|FG002|COMPLETED|Follow up Until Death||3
6294924|NCT00301067|7196904|FG003|COMPLETED|Follow up Until Death||2
6294925|NCT00301067|7196901|FG000|NOT COMPLETED|Follow up Until Death||1
6294926|NCT00301067|7196902|FG001|NOT COMPLETED|Follow up Until Death||0
6400697|NCT00887549|7313579|FG000|NOT COMPLETED|Maintenance Therapy||43
6294927|NCT00301067|7196903|FG002|NOT COMPLETED|Follow up Until Death||0
6294928|NCT00301067|7196904|FG003|NOT COMPLETED|Follow up Until Death||1
6294929|NCT00301366|7196915|FG000|STARTED|Overall Study||38
6294930|NCT00301366|7196915|FG000|COMPLETED|Overall Study||37
6294931|NCT00301366|7196915|FG000|NOT COMPLETED|Overall Study||1
6294932|NCT00301418|7196919|FG000|STARTED|Overall Study||11
6294933|NCT00301418|7196919|FG000|COMPLETED|Overall Study||11
6294934|NCT00301418|7196919|FG000|NOT COMPLETED|Overall Study||0
6294935|NCT00301756|7196923|FG000|STARTED|Overall Study||32
6294936|NCT00301756|7196923|FG000|COMPLETED|Overall Study||32
6294937|NCT00301756|7196923|FG000|NOT COMPLETED|Overall Study||0
6294938|NCT00301808|7196929|FG000|STARTED|Overall Study||29
6294939|NCT00301808|7196929|FG000|COMPLETED|Overall Study||17
6294940|NCT00301808|7196929|FG000|NOT COMPLETED|Overall Study||12
6294941|NCT00301821|7196933|FG000|STARTED|Overall Study||107
6294942|NCT00301821|7196933|FG000|COMPLETED|Overall Study||81
6294943|NCT00301821|7196933|FG000|NOT COMPLETED|Overall Study||26
6294944|NCT00301834|7196937|FG000|STARTED|Overall Study||35
6294945|NCT00301834|7196937|FG000|COMPLETED|Overall Study||34
6294946|NCT00301834|7196937|FG000|NOT COMPLETED|Overall Study||1
6294947|NCT00301873|7196944|FG000|STARTED|Overall Study||59
6294948|NCT00301873|7196944|FG000|COMPLETED|Overall Study||59
6294949|NCT00301873|7196944|FG000|NOT COMPLETED|Overall Study||0
6294950|NCT00301964|7196948|FG000|STARTED|Overall Study||56
6294951|NCT00301964|7196948|FG000|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
6294952|NCT00301964|7196948|FG000|NOT COMPLETED|Overall Study||4
6294953|NCT00302003|7196958|FG000|STARTED|Overall Study||287
6294954|NCT00302003|7196958|FG000|COMPLETED|Overall Study||207
6294955|NCT00302003|7196958|FG000|NOT COMPLETED|Overall Study||80
6294956|NCT00302042|7196964|FG000|STARTED|Overall Study||46
6294957|NCT00302042|7196965|FG001|STARTED|Overall Study||46
6294958|NCT00302042|7196964|FG000|COMPLETED|Overall Study||39
6294959|NCT00302042|7196965|FG001|COMPLETED|Overall Study||38
6294960|NCT00302042|7196964|FG000|NOT COMPLETED|Overall Study||7
6294961|NCT00302042|7196965|FG001|NOT COMPLETED|Overall Study||8
6294962|NCT00302055|7196973|FG000|STARTED|Overall Study||23
6294963|NCT00302055|7196974|FG001|STARTED|Overall Study||49
6294964|NCT00302055|7196973|FG000|COMPLETED|Overall Study||14
6294965|NCT00302055|7196974|FG001|COMPLETED|Overall Study||36
6294966|NCT00302055|7196973|FG000|NOT COMPLETED|Overall Study||9
6294967|NCT00302055|7196974|FG001|NOT COMPLETED|Overall Study||13
6400698|NCT00887562|7313586|FG000|STARTED|Overall Study||10
6400699|NCT00887562|7313587|FG001|STARTED|Overall Study||9
6294968|NCT00302068|7196983|FG000|STARTED|Overall Study||37
6294969|NCT00302068|7196984|FG001|STARTED|Overall Study||40
6294970|NCT00302068|7196985|FG002|STARTED|Overall Study||24
6294971|NCT00302068|7196983|FG000|COMPLETED|Overall Study||36
6294972|NCT00302068|7196984|FG001|COMPLETED|Overall Study||36
6294973|NCT00302068|7196985|FG002|COMPLETED|Overall Study||23
6294974|NCT00302068|7196983|FG000|NOT COMPLETED|Overall Study||1
6294975|NCT00302068|7196984|FG001|NOT COMPLETED|Overall Study||4
6294976|NCT00302068|7196985|FG002|NOT COMPLETED|Overall Study||1
6294977|NCT00302081|7196997|FG000|STARTED|Overall Study||237
6294978|NCT00302081|7196998|FG001|STARTED|Overall Study||229
6294979|NCT00302081|7196999|FG002|STARTED|Overall Study||230
6294980|NCT00302081|7196997|FG000|COMPLETED|Overall Study||181
6294981|NCT00302081|7196998|FG001|COMPLETED|Overall Study||186
6294982|NCT00302081|7196999|FG002|COMPLETED|Overall Study||178
6294983|NCT00302081|7196997|FG000|NOT COMPLETED|Overall Study||56
6294984|NCT00302081|7196998|FG001|NOT COMPLETED|Overall Study||43
6294985|NCT00302081|7196999|FG002|NOT COMPLETED|Overall Study||52
6294986|NCT00302107|7197009|FG000|STARTED|Overall Study||39
6294987|NCT00302107|7197010|FG001|STARTED|Overall Study||39
6294988|NCT00302107|7197009|FG000|COMPLETED|Overall Study||31
6294989|NCT00302107|7197010|FG001|COMPLETED|Overall Study||30
6294990|NCT00302107|7197009|FG000|NOT COMPLETED|Overall Study||8
6294991|NCT00302107|7197010|FG001|NOT COMPLETED|Overall Study||9
6294992|NCT00302133|7197018|FG000|STARTED|Overall Study||9
6294993|NCT00302133|7197019|FG001|STARTED|Overall Study||9
6294994|NCT00302133|7197018|FG000|COMPLETED|Overall Study||5
6294995|NCT00302133|7197019|FG001|COMPLETED|Overall Study||5
6294996|NCT00302133|7197018|FG000|NOT COMPLETED|Overall Study||4
6294997|NCT00302133|7197019|FG001|NOT COMPLETED|Overall Study||4
6294998|NCT00302159|7197025|FG000|STARTED|Overall Study||43
6294999|NCT00302159|7197025|FG000|COMPLETED|Overall Study||41
6295000|NCT00302159|7197025|FG000|NOT COMPLETED|Overall Study||2
6295001|NCT00302211|7197033|FG000|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|26
6295002|NCT00302211|7197034|FG001|STARTED|Double Blind Period (New Patients)|These subjects had the option to continue with the same dose of iloprost during the OL period|27
6295003|NCT00302211|7197035|FG002|STARTED|Double Blind Period (New Patients)|These subjects could receive either iloprost 4x/day or 6x/day in the OL period|14
6295004|NCT00302211|7197036|FG003|STARTED|Double Blind Period (New Patients)||0
6295005|NCT00302211|7197037|FG004|STARTED|Double Blind Period (New Patients)||0
6295006|NCT00302211|7197033|FG000|COMPLETED|Double Blind Period (New Patients)||23
6295007|NCT00302211|7197034|FG001|COMPLETED|Double Blind Period (New Patients)||25
6295008|NCT00302211|7197035|FG002|COMPLETED|Double Blind Period (New Patients)||10
6295009|NCT00302211|7197036|FG003|COMPLETED|Double Blind Period (New Patients)||0
6295010|NCT00302211|7197037|FG004|COMPLETED|Double Blind Period (New Patients)||0
6295011|NCT00302211|7197033|FG000|NOT COMPLETED|Double Blind Period (New Patients)||3
6295012|NCT00302211|7197034|FG001|NOT COMPLETED|Double Blind Period (New Patients)||2
6295013|NCT00302211|7197035|FG002|NOT COMPLETED|Double Blind Period (New Patients)||4
6295014|NCT00302211|7197036|FG003|NOT COMPLETED|Double Blind Period (New Patients)||0
6295015|NCT00302211|7197037|FG004|NOT COMPLETED|Double Blind Period (New Patients)||0
6295016|NCT00302211|7197033|FG000|STARTED|Open Label-Patients From Double-Blind||0
6295017|NCT00302211|7197034|FG001|STARTED|Open Label-Patients From Double-Blind||0
6295018|NCT00302211|7197035|FG002|STARTED|Open Label-Patients From Double-Blind||0
6295019|NCT00302211|7197036|FG003|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
6295020|NCT00302211|7197037|FG004|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
6295021|NCT00302211|7197033|FG000|COMPLETED|Open Label-Patients From Double-Blind||0
6295022|NCT00302211|7197034|FG001|COMPLETED|Open Label-Patients From Double-Blind||0
6295023|NCT00302211|7197035|FG002|COMPLETED|Open Label-Patients From Double-Blind||0
6295024|NCT00302211|7197036|FG003|COMPLETED|Open Label-Patients From Double-Blind||18
6295025|NCT00302211|7197037|FG004|COMPLETED|Open Label-Patients From Double-Blind||24
6295026|NCT00302211|7197033|FG000|NOT COMPLETED|Open Label-Patients From Double-Blind||0
6295027|NCT00302211|7197034|FG001|NOT COMPLETED|Open Label-Patients From Double-Blind||0
6295028|NCT00302211|7197035|FG002|NOT COMPLETED|Open Label-Patients From Double-Blind||0
6295029|NCT00302211|7197036|FG003|NOT COMPLETED|Open Label-Patients From Double-Blind||8
6295030|NCT00302211|7197037|FG004|NOT COMPLETED|Open Label-Patients From Double-Blind||8
6295031|NCT00302328|7197052|FG000|STARTED|Overall Study||25
6295032|NCT00302328|7197053|FG001|STARTED|Overall Study||35
6295033|NCT00302328|7197054|FG002|STARTED|Overall Study||18
6295034|NCT00302328|7197052|FG000|COMPLETED|Overall Study||25
6295035|NCT00302328|7197053|FG001|COMPLETED|Overall Study|developed cancer during the study|34
6295036|NCT00302328|7197054|FG002|COMPLETED|Overall Study||18
6295037|NCT00302328|7197052|FG000|NOT COMPLETED|Overall Study||0
6295038|NCT00302328|7197053|FG001|NOT COMPLETED|Overall Study||1
6295039|NCT00302328|7197054|FG002|NOT COMPLETED|Overall Study||0
6295040|NCT00302458|7197065|FG000|STARTED|Overall Study||29
6295041|NCT00302458|7197065|FG000|COMPLETED|Overall Study||26
6295042|NCT00302458|7197065|FG000|NOT COMPLETED|Overall Study||3
6295043|NCT00302718|7197077|FG000|STARTED|Overall Study||20
6295044|NCT00302718|7197078|FG001|STARTED|Overall Study||21
6295045|NCT00302718|7197079|FG002|STARTED|Overall Study||21
6295046|NCT00302718|7197080|FG003|STARTED|Overall Study||21
6295047|NCT00302718|7197077|FG000|COMPLETED|Overall Study||19
6295048|NCT00302718|7197078|FG001|COMPLETED|Overall Study||20
6295049|NCT00302718|7197079|FG002|COMPLETED|Overall Study||19
6295050|NCT00302718|7197080|FG003|COMPLETED|Overall Study||19
6295051|NCT00302718|7197077|FG000|NOT COMPLETED|Overall Study||1
6295052|NCT00302718|7197078|FG001|NOT COMPLETED|Overall Study||1
6295053|NCT00302718|7197079|FG002|NOT COMPLETED|Overall Study||2
6295054|NCT00302718|7197080|FG003|NOT COMPLETED|Overall Study||2
6295055|NCT00302731|7197099|FG000|STARTED|Overall Study||6
6295056|NCT00302731|7197100|FG001|STARTED|Overall Study||6
6295057|NCT00302731|7197101|FG002|STARTED|Overall Study||5
6295058|NCT00302731|7197102|FG003|STARTED|Overall Study||4
6295059|NCT00302731|7197099|FG000|COMPLETED|Overall Study||2
6295060|NCT00302731|7197100|FG001|COMPLETED|Overall Study||1
6295061|NCT00302731|7197101|FG002|COMPLETED|Overall Study||2
6295062|NCT00302731|7197102|FG003|COMPLETED|Overall Study||4
6295063|NCT00302731|7197099|FG000|NOT COMPLETED|Overall Study||4
6295064|NCT00302731|7197100|FG001|NOT COMPLETED|Overall Study||5
6295065|NCT00302731|7197101|FG002|NOT COMPLETED|Overall Study||3
6295066|NCT00302731|7197102|FG003|NOT COMPLETED|Overall Study||0
6295067|NCT00302848|7197115|FG000|STARTED|Overall Study||16534
6295068|NCT00302848|7197116|FG001|STARTED|Overall Study||15428
6295069|NCT00302848|7197117|FG002|STARTED|Overall Study||26341
6295070|NCT00302848|7197115|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
6295071|NCT00302848|7197116|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
6295072|NCT00302848|7197117|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
6295073|NCT00302848|7197115|FG000|NOT COMPLETED|Overall Study||401
6295074|NCT00302848|7197116|FG001|NOT COMPLETED|Overall Study||419
6295075|NCT00302848|7197117|FG002|NOT COMPLETED|Overall Study||579
6295076|NCT00302952|7197126|FG000|STARTED|Overall Study||34
6295077|NCT00302952|7197127|FG001|STARTED|Overall Study||30
6295078|NCT00302952|7197126|FG000|Started Intent-to-Treat (ITT)|Overall Study||34
6295079|NCT00302952|7197127|FG001|Started Intent-to-Treat (ITT)|Overall Study||30
6295080|NCT00302952|7197126|FG000|Completed Intent-to-Treat (ITT)|Overall Study||34
6295081|NCT00302952|7197127|FG001|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
6295082|NCT00302952|7197126|FG000|COMPLETED|Overall Study||31
6295083|NCT00302952|7197127|FG001|COMPLETED|Overall Study||25
6295084|NCT00302952|7197126|FG000|NOT COMPLETED|Overall Study||3
6295085|NCT00302952|7197127|FG001|NOT COMPLETED|Overall Study||5
6295086|NCT00303069|7197137|FG000|STARTED|Overall Study||31
6295087|NCT00303069|7197138|FG001|STARTED|Overall Study||28
6295088|NCT00303069|7197139|FG002|STARTED|Overall Study||34
6295089|NCT00303069|7197140|FG003|STARTED|Overall Study||31
6295090|NCT00303069|7197137|FG000|COMPLETED|Overall Study||29
6295091|NCT00303069|7197138|FG001|COMPLETED|Overall Study||28
6295092|NCT00303069|7197139|FG002|COMPLETED|Overall Study||33
6295093|NCT00303069|7197140|FG003|COMPLETED|Overall Study||29
6295094|NCT00303069|7197137|FG000|NOT COMPLETED|Overall Study||2
6295095|NCT00303069|7197138|FG001|NOT COMPLETED|Overall Study||0
6295096|NCT00303069|7197139|FG002|NOT COMPLETED|Overall Study||1
6295097|NCT00303069|7197140|FG003|NOT COMPLETED|Overall Study||2
6295098|NCT00303108|7197153|FG000|STARTED|Overall Study||43
6295099|NCT00303108|7197154|FG001|STARTED|Overall Study||46
6295100|NCT00303108|7197155|FG002|STARTED|Overall Study||47
6295101|NCT00303108|7197153|FG000|COMPLETED|Overall Study||31
6295102|NCT00303108|7197154|FG001|COMPLETED|Overall Study||37
6295103|NCT00303108|7197155|FG002|COMPLETED|Overall Study||31
6295104|NCT00303108|7197153|FG000|NOT COMPLETED|Overall Study||12
6295105|NCT00303108|7197154|FG001|NOT COMPLETED|Overall Study||9
6295106|NCT00303108|7197155|FG002|NOT COMPLETED|Overall Study||16
6295107|NCT00303186|7197162|FG000|STARTED|Overall Study||107
6295108|NCT00303186|7197162|FG000|COMPLETED|Overall Study||55
6295109|NCT00303186|7197162|FG000|NOT COMPLETED|Overall Study||52
6295110|NCT00303316|7197168|FG000|STARTED|Overall Study||232
6295111|NCT00303316|7197169|FG001|STARTED|Overall Study||226
6295112|NCT00303316|7197168|FG000|COMPLETED|Overall Study||230
6295113|NCT00303316|7197169|FG001|COMPLETED|Overall Study||223
6295114|NCT00303316|7197168|FG000|NOT COMPLETED|Overall Study||2
6295115|NCT00303316|7197169|FG001|NOT COMPLETED|Overall Study||3
6295116|NCT00303329|7197177|FG000|STARTED|Overall Study||85
6295117|NCT00303329|7197178|FG001|STARTED|Overall Study||99
6295118|NCT00303329|7197177|FG000|COMPLETED|Overall Study||50
6295119|NCT00303329|7197178|FG001|COMPLETED|Overall Study||37
6295120|NCT00303329|7197177|FG000|NOT COMPLETED|Overall Study||35
6295121|NCT00303329|7197178|FG001|NOT COMPLETED|Overall Study||62
6295122|NCT00303446|7197186|FG000|STARTED|Overall Study||25
6295123|NCT00303446|7197187|FG001|STARTED|Overall Study||25
6295124|NCT00303446|7197186|FG000|COMPLETED|Overall Study||23
6295125|NCT00303446|7197187|FG001|COMPLETED|Overall Study||21
6295126|NCT00303446|7197186|FG000|NOT COMPLETED|Overall Study||2
6295127|NCT00303446|7197187|FG001|NOT COMPLETED|Overall Study||4
6295128|NCT00303459|7197195|FG000|STARTED|Overall Study||159
6295129|NCT00303459|7197196|FG001|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
6295130|NCT00303459|7197195|FG000|COMPLETED|Overall Study||76
6295131|NCT00303459|7197196|FG001|COMPLETED|Overall Study||86
6295132|NCT00303459|7197195|FG000|NOT COMPLETED|Overall Study||83
6295133|NCT00303459|7197196|FG001|NOT COMPLETED|Overall Study||89
6295134|NCT00303472|7197210|FG000|STARTED|Treatment Period||6
6295135|NCT00303472|7197211|FG001|STARTED|Treatment Period||11
6295136|NCT00303472|7197212|FG002|STARTED|Treatment Period||11
6295137|NCT00303472|7197213|FG003|STARTED|Treatment Period||16
6295138|NCT00303472|7197214|FG004|STARTED|Treatment Period||11
6295139|NCT00303472|7197215|FG005|STARTED|Treatment Period||12
6295140|NCT00303472|7197216|FG006|STARTED|Treatment Period||5
6295141|NCT00303472|7197210|FG000|COMPLETED|Treatment Period||6
6295142|NCT00303472|7197211|FG001|COMPLETED|Treatment Period||11
6295143|NCT00303472|7197212|FG002|COMPLETED|Treatment Period||11
6295144|NCT00303472|7197213|FG003|COMPLETED|Treatment Period||14
6295145|NCT00303472|7197214|FG004|COMPLETED|Treatment Period||8
6295146|NCT00303472|7197215|FG005|COMPLETED|Treatment Period||11
6295147|NCT00303472|7197216|FG006|COMPLETED|Treatment Period||3
6295148|NCT00303472|7197210|FG000|NOT COMPLETED|Treatment Period||0
6295149|NCT00303472|7197211|FG001|NOT COMPLETED|Treatment Period||0
6295150|NCT00303472|7197212|FG002|NOT COMPLETED|Treatment Period||0
6295151|NCT00303472|7197213|FG003|NOT COMPLETED|Treatment Period||2
6295152|NCT00303472|7197214|FG004|NOT COMPLETED|Treatment Period||3
6295153|NCT00303472|7197215|FG005|NOT COMPLETED|Treatment Period||1
6295154|NCT00303472|7197216|FG006|NOT COMPLETED|Treatment Period||2
6295155|NCT00303472|7197210|FG000|STARTED|Treatment Extension (Optional)||6
6295156|NCT00303472|7197211|FG001|STARTED|Treatment Extension (Optional)||11
6295157|NCT00303472|7197212|FG002|STARTED|Treatment Extension (Optional)||11
6295158|NCT00303472|7197213|FG003|STARTED|Treatment Extension (Optional)||13
6295159|NCT00303472|7197214|FG004|STARTED|Treatment Extension (Optional)||5
6295160|NCT00303472|7197215|FG005|STARTED|Treatment Extension (Optional)||5
6295161|NCT00303472|7197216|FG006|STARTED|Treatment Extension (Optional)||1
6295162|NCT00303472|7197210|FG000|COMPLETED|Treatment Extension (Optional)||1
6295163|NCT00303472|7197211|FG001|COMPLETED|Treatment Extension (Optional)||5
6295164|NCT00303472|7197212|FG002|COMPLETED|Treatment Extension (Optional)||2
6295165|NCT00303472|7197213|FG003|COMPLETED|Treatment Extension (Optional)||5
6295166|NCT00303472|7197214|FG004|COMPLETED|Treatment Extension (Optional)||1
6295167|NCT00303472|7197215|FG005|COMPLETED|Treatment Extension (Optional)||4
6295168|NCT00303472|7197216|FG006|COMPLETED|Treatment Extension (Optional)||1
6295169|NCT00303472|7197210|FG000|NOT COMPLETED|Treatment Extension (Optional)||5
6295170|NCT00303472|7197211|FG001|NOT COMPLETED|Treatment Extension (Optional)||6
6295171|NCT00303472|7197212|FG002|NOT COMPLETED|Treatment Extension (Optional)||9
6295172|NCT00303472|7197213|FG003|NOT COMPLETED|Treatment Extension (Optional)||8
6295173|NCT00303472|7197214|FG004|NOT COMPLETED|Treatment Extension (Optional)||4
6295174|NCT00303472|7197215|FG005|NOT COMPLETED|Treatment Extension (Optional)||1
6295175|NCT00303472|7197216|FG006|NOT COMPLETED|Treatment Extension (Optional)||0
6295176|NCT00303485|7197234|FG000|STARTED|Overall Study||49
6295177|NCT00303485|7197235|FG001|STARTED|Overall Study||17
6295178|NCT00303485|7197234|FG000|COMPLETED|Overall Study||48
6295179|NCT00303485|7197235|FG001|COMPLETED|Overall Study||15
6400700|NCT00887562|7313588|FG002|STARTED|Overall Study||8
6400701|NCT00887562|7313586|FG000|COMPLETED|Overall Study||7
6400702|NCT00887562|7313587|FG001|COMPLETED|Overall Study||7
6400703|NCT00887562|7313588|FG002|COMPLETED|Overall Study||7
6400704|NCT00887562|7313586|FG000|NOT COMPLETED|Overall Study||3
6400705|NCT00887562|7313587|FG001|NOT COMPLETED|Overall Study||2
6295180|NCT00303485|7197234|FG000|NOT COMPLETED|Overall Study||1
6295181|NCT00303485|7197235|FG001|NOT COMPLETED|Overall Study||2
6295182|NCT00303511|7197241|FG000|STARTED|Overall Study||10
6295183|NCT00303511|7197241|FG000|COMPLETED|Overall Study||10
6295184|NCT00303511|7197241|FG000|NOT COMPLETED|Overall Study||0
6295185|NCT00303602|7197247|FG000|STARTED|Overall Study||84
6295186|NCT00303602|7197248|FG001|STARTED|Overall Study||65
6295187|NCT00303602|7197247|FG000|COMPLETED|Overall Study||65
6295188|NCT00303602|7197248|FG001|COMPLETED|Overall Study||50
6295189|NCT00303602|7197247|FG000|NOT COMPLETED|Overall Study||19
6295190|NCT00303602|7197248|FG001|NOT COMPLETED|Overall Study||15
6295191|NCT00303628|7197256|FG000|STARTED|Overall Study||176
6295192|NCT00303628|7197257|FG001|STARTED|Overall Study||179
6295193|NCT00303628|7197256|FG000|Eligible|Overall Study||171
6295194|NCT00303628|7197257|FG001|Eligible|Overall Study||177
6295195|NCT00303628|7197256|FG000|Treated|Overall Study||173
6634939|NCT02300298|7563768|FG001|STARTED|Disposition for Docetaxel||10
6634940|NCT02300298|7563767|FG000|COMPLETED|Disposition for Docetaxel||0
6634941|NCT02300298|7563768|FG001|COMPLETED|Disposition for Docetaxel||0
6634942|NCT02300298|7563767|FG000|NOT COMPLETED|Disposition for Docetaxel||0
6634943|NCT02300298|7563768|FG001|NOT COMPLETED|Disposition for Docetaxel||10
6634944|NCT02300311|7563774|FG000|STARTED|Overall Study||69
6634945|NCT02300311|7563775|FG001|STARTED|Overall Study||69
6634946|NCT02300311|7563774|FG000|COMPLETED|Overall Study||50
6634947|NCT02300311|7563775|FG001|COMPLETED|Overall Study||69
6634948|NCT02300311|7563774|FG000|NOT COMPLETED|Overall Study||19
6634949|NCT02300311|7563775|FG001|NOT COMPLETED|Overall Study||0
6634950|NCT02300545|7563781|FG000|STARTED|Overall Study||56
6634951|NCT02300545|7563781|FG000|COMPLETED|Overall Study||56
6634952|NCT02300545|7563781|FG000|NOT COMPLETED|Overall Study||0
6634953|NCT02300558|7563785|FG000|STARTED|Single Blind Phase (24 Weeks)||41
6634954|NCT02300558|7563785|FG000|COMPLETED|Single Blind Phase (24 Weeks)||35
6634955|NCT02300558|7563785|FG000|NOT COMPLETED|Single Blind Phase (24 Weeks)||6
6634956|NCT02300558|7563785|FG000|STARTED|Open-Label (OL) Extension Phase||32
6634957|NCT02300558|7563785|FG000|COMPLETED|Open-Label (OL) Extension Phase||0
6634958|NCT02300558|7563785|FG000|NOT COMPLETED|Open-Label (OL) Extension Phase||32
6634959|NCT02300610|7563796|FG000|STARTED|Overall Study||3
6634960|NCT02300610|7563797|FG001|STARTED|Overall Study||3
6295196|NCT00303628|7197257|FG001|Treated|Overall Study||174
6295197|NCT00303628|7197256|FG000|COMPLETED|Overall Study||126
6295198|NCT00303628|7197257|FG001|COMPLETED|Overall Study||106
6295199|NCT00303628|7197256|FG000|NOT COMPLETED|Overall Study||50
6295200|NCT00303628|7197257|FG001|NOT COMPLETED|Overall Study||73
6295201|NCT00303667|7197265|FG000|STARTED|Overall Study||8
6295202|NCT00303667|7197266|FG001|STARTED|Overall Study||39
6295203|NCT00303667|7197265|FG000|COMPLETED|Overall Study||8
6295204|NCT00303667|7197266|FG001|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
6295205|NCT00303667|7197265|FG000|NOT COMPLETED|Overall Study||0
6295206|NCT00303667|7197266|FG001|NOT COMPLETED|Overall Study||4
6295207|NCT00303719|7197274|FG000|STARTED|Overall Study||13
6295208|NCT00303719|7197275|FG001|STARTED|Overall Study||329
6295209|NCT00303719|7197274|FG000|COMPLETED|Overall Study||13
6295210|NCT00303719|7197275|FG001|COMPLETED|Overall Study||292
6295211|NCT00303719|7197274|FG000|NOT COMPLETED|Overall Study||0
6295212|NCT00303719|7197275|FG001|NOT COMPLETED|Overall Study||37
6295213|NCT00303823|7197284|FG000|STARTED|Overall Study||50
6295214|NCT00303823|7197285|FG001|STARTED|Overall Study||48
6295215|NCT00303823|7197284|FG000|COMPLETED|Overall Study||35
6295216|NCT00303823|7197285|FG001|COMPLETED|Overall Study||38
6295217|NCT00303823|7197284|FG000|NOT COMPLETED|Overall Study||15
6295218|NCT00303823|7197285|FG001|NOT COMPLETED|Overall Study||10
6295219|NCT00303862|7197291|FG000|STARTED|Overall Study||10
6295220|NCT00303862|7197291|FG000|COMPLETED|Overall Study||10
6295221|NCT00303862|7197291|FG000|NOT COMPLETED|Overall Study||0
6295222|NCT00303901|7197295|FG000|STARTED|Overall Study||40
6295223|NCT00303901|7197295|FG000|COMPLETED|Overall Study||40
6295224|NCT00303901|7197295|FG000|NOT COMPLETED|Overall Study||0
6295225|NCT00303953|7197299|FG000|STARTED|Overall Study||22
6295226|NCT00303953|7197299|FG000|Eligible|Overall Study||21
6295227|NCT00303953|7197299|FG000|Eligible and Treated|Overall Study||20
6295228|NCT00303953|7197299|FG000|COMPLETED|Overall Study||3
6295229|NCT00303953|7197299|FG000|NOT COMPLETED|Overall Study||19
6295230|NCT00303966|7197303|FG000|STARTED|Overall Study||5
6295231|NCT00303966|7197303|FG000|COMPLETED|Overall Study||5
6400706|NCT00887562|7313588|FG002|NOT COMPLETED|Overall Study||1
6295232|NCT00303966|7197303|FG000|NOT COMPLETED|Overall Study||0
6295233|NCT00303979|7197310|FG000|STARTED|Overall Study|at baseline|15177
6295234|NCT00303979|7197311|FG001|STARTED|Overall Study|at 6 months|9992
6295235|NCT00303979|7197312|FG002|STARTED|Overall Study|at 18 months|9641
6295236|NCT00303979|7197310|FG000|COMPLETED|Overall Study|at 24 Months|7605
6295237|NCT00303979|7197311|FG001|COMPLETED|Overall Study|at 6 months|9992
6295238|NCT00303979|7197312|FG002|COMPLETED|Overall Study|at 18 months|9641
6295239|NCT00303979|7197310|FG000|NOT COMPLETED|Overall Study||7572
6400707|NCT00887575|7313598|FG000|STARTED|Phase I||6
6634961|NCT02300610|7563798|FG002|STARTED|Overall Study||4
6634962|NCT02300610|7563796|FG000|COMPLETED|Overall Study||2
6634963|NCT02300610|7563797|FG001|COMPLETED|Overall Study||3
6634964|NCT02300610|7563798|FG002|COMPLETED|Overall Study||3
6634965|NCT02300610|7563796|FG000|NOT COMPLETED|Overall Study||1
6634966|NCT02300610|7563797|FG001|NOT COMPLETED|Overall Study||0
6634967|NCT02300610|7563798|FG002|NOT COMPLETED|Overall Study||1
6634968|NCT02300727|7563814|FG000|STARTED|Overall Study||0
6634969|NCT02300727|7563815|FG001|STARTED|Overall Study||0
6634970|NCT02300727|7563816|FG002|STARTED|Overall Study||3
6634971|NCT02300727|7563817|FG003|STARTED|Overall Study||3
6634972|NCT02300727|7563818|FG004|STARTED|Overall Study||0
6634973|NCT02300727|7563819|FG005|STARTED|Overall Study||0
6634974|NCT02300727|7563814|FG000|COMPLETED|Overall Study||0
6634975|NCT02300727|7563815|FG001|COMPLETED|Overall Study||0
6634976|NCT02300727|7563816|FG002|COMPLETED|Overall Study||3
6295240|NCT00303979|7197311|FG001|NOT COMPLETED|Overall Study||0
6295241|NCT00303979|7197312|FG002|NOT COMPLETED|Overall Study||0
6295242|NCT00304031|7197332|FG000|STARTED|Concomitant RT+TMZ (Pre-randomization)|All participants registered to concomitant treatment; randomized after completing this treatment.|1125
6295243|NCT00304031|7197333|FG001|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
6295244|NCT00304031|7197334|FG002|STARTED|Concomitant RT+TMZ (Pre-randomization)|Participants were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
6295245|NCT00304031|7197332|FG000|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||1125
6295246|NCT00304031|7197333|FG001|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
6295247|NCT00304031|7197334|FG002|Eligible Pre-randomization Population|Concomitant RT+TMZ (Pre-randomization)||0
6295248|NCT00304031|7197332|FG000|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||1120
6295249|NCT00304031|7197333|FG001|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
6295250|NCT00304031|7197334|FG002|Eligible Pre-randomization Follow-up|Concomitant RT+TMZ (Pre-randomization)||0
6295251|NCT00304031|7197332|FG000|COMPLETED|Concomitant RT+TMZ (Pre-randomization)|These participants completed concomitant treatment and met requirements for randomization.|833
6295252|NCT00304031|7197333|FG001|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
6295253|NCT00304031|7197334|FG002|COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
6295254|NCT00304031|7197332|FG000|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||292
6295255|NCT00304031|7197333|FG001|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
6295256|NCT00304031|7197334|FG002|NOT COMPLETED|Concomitant RT+TMZ (Pre-randomization)||0
6295257|NCT00304031|7197332|FG000|STARTED|Randomization to Adjuvant TMZ Arm||0
6295258|NCT00304031|7197333|FG001|STARTED|Randomization to Adjuvant TMZ Arm||411
6295259|NCT00304031|7197334|FG002|STARTED|Randomization to Adjuvant TMZ Arm||422
6295260|NCT00304031|7197332|FG000|Eligible Population|Randomization to Adjuvant TMZ Arm||0
6295261|NCT00304031|7197333|FG001|Eligible Population|Randomization to Adjuvant TMZ Arm||411
6295262|NCT00304031|7197334|FG002|Eligible Population|Randomization to Adjuvant TMZ Arm||420
6295263|NCT00304031|7197332|FG000|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
6295264|NCT00304031|7197333|FG001|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||254
6295265|NCT00304031|7197334|FG002|Unmethylated MGMT Population|Randomization to Adjuvant TMZ Arm||262
6295266|NCT00304031|7197332|FG000|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||0
6295267|NCT00304031|7197333|FG001|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
6295268|NCT00304031|7197334|FG002|Methylated MGMT Population|Randomization to Adjuvant TMZ Arm||122
6295269|NCT00304031|7197332|FG000|Quality of Life Population|Randomization to Adjuvant TMZ Arm||0
6295270|NCT00304031|7197333|FG001|Quality of Life Population|Randomization to Adjuvant TMZ Arm||96
6295271|NCT00304031|7197334|FG002|Quality of Life Population|Randomization to Adjuvant TMZ Arm||95
6295272|NCT00304031|7197332|FG000|COMPLETED|Randomization to Adjuvant TMZ Arm||0
6295273|NCT00304031|7197333|FG001|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|411
6295274|NCT00304031|7197334|FG002|COMPLETED|Randomization to Adjuvant TMZ Arm|Randomized participants contributing data to results are considered to have completed the study.|420
6295275|NCT00304031|7197332|FG000|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
6295276|NCT00304031|7197333|FG001|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
6295277|NCT00304031|7197334|FG002|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
6295278|NCT00304083|7197351|FG000|STARTED|Overall Study||34
6295279|NCT00304083|7197352|FG001|STARTED|Overall Study||14
6295280|NCT00304083|7197351|FG000|Completed 4 Cycles|Overall Study||22
6295281|NCT00304083|7197352|FG001|Completed 4 Cycles|Overall Study||7
6295282|NCT00304083|7197351|FG000|Patients Treated With Surgery|Overall Study||7
6295283|NCT00304083|7197352|FG001|Patients Treated With Surgery|Overall Study||3
6295284|NCT00304083|7197351|FG000|Patients Treated With Surgery and RT|Overall Study||5
6295285|NCT00304083|7197352|FG001|Patients Treated With Surgery and RT|Overall Study||1
6295286|NCT00304083|7197351|FG000|Patients Treated With RT Only|Overall Study||4
6295287|NCT00304083|7197352|FG001|Patients Treated With RT Only|Overall Study||2
6295288|NCT00304083|7197351|FG000|Patients Had Neither RT or Surgery|Overall Study||6
6295289|NCT00304083|7197352|FG001|Patients Had Neither RT or Surgery|Overall Study||1
6295290|NCT00304083|7197351|FG000|COMPLETED|Overall Study||12
6295291|NCT00304083|7197352|FG001|COMPLETED|Overall Study||6
6295292|NCT00304083|7197351|FG000|NOT COMPLETED|Overall Study||22
6295293|NCT00304083|7197352|FG001|NOT COMPLETED|Overall Study||8
6295294|NCT00304096|7197360|FG000|STARTED|Overall Study||6
6295295|NCT00304096|7197361|FG001|STARTED|Overall Study||5
6295296|NCT00304096|7197360|FG000|COMPLETED|Overall Study||6
6295297|NCT00304096|7197361|FG001|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
6295298|NCT00304096|7197360|FG000|NOT COMPLETED|Overall Study||0
6295299|NCT00304096|7197361|FG001|NOT COMPLETED|Overall Study||0
6295300|NCT00304161|7197369|FG000|STARTED|Overall Study||28
6295301|NCT00304161|7197370|FG001|STARTED|Overall Study||27
6295302|NCT00304161|7197369|FG000|COMPLETED|Overall Study||22
6295303|NCT00304161|7197370|FG001|COMPLETED|Overall Study||21
6295304|NCT00304161|7197369|FG000|NOT COMPLETED|Overall Study||6
6295305|NCT00304161|7197370|FG001|NOT COMPLETED|Overall Study||6
6295306|NCT00304187|7197378|FG000|STARTED|Overall Study||15
6295307|NCT00304187|7197379|FG001|STARTED|Overall Study||14
6295308|NCT00304187|7197378|FG000|COMPLETED|Overall Study||13
6295309|NCT00304187|7197379|FG001|COMPLETED|Overall Study||13
6295310|NCT00304187|7197378|FG000|NOT COMPLETED|Overall Study||2
6295311|NCT00304187|7197379|FG001|NOT COMPLETED|Overall Study||1
6295312|NCT00304265|7197389|FG000|STARTED|Overall Study||117
6295313|NCT00304265|7197390|FG001|STARTED|Overall Study||98
6295314|NCT00304265|7197389|FG000|COMPLETED|Overall Study||117
6295315|NCT00304265|7197390|FG001|COMPLETED|Overall Study||98
6295316|NCT00304265|7197389|FG000|NOT COMPLETED|Overall Study||0
6295317|NCT00304265|7197390|FG001|NOT COMPLETED|Overall Study||0
6295318|NCT00304278|7197396|FG000|STARTED|Overall Study||21
6295319|NCT00304278|7197396|FG000|COMPLETED|Overall Study||19
6295320|NCT00304278|7197396|FG000|NOT COMPLETED|Overall Study||2
6295321|NCT00304356|7197400|FG000|STARTED|Nitazoxanide||27
6295322|NCT00304356|7197400|FG000|COMPLETED|Nitazoxanide||22
6295323|NCT00304356|7197400|FG000|NOT COMPLETED|Nitazoxanide||5
6295324|NCT00304356|7197400|FG000|STARTED|Nitazoxanide||27
6295325|NCT00304356|7197400|FG000|COMPLETED|Nitazoxanide||22
6295326|NCT00304356|7197400|FG000|NOT COMPLETED|Nitazoxanide||5
6295327|NCT00304512|7197407|FG000|STARTED|Treatment Period||2
6295328|NCT00304512|7197408|FG001|STARTED|Treatment Period||4
6295329|NCT00304512|7197409|FG002|STARTED|Treatment Period||3
6295330|NCT00304512|7197407|FG000|Safety Population|Treatment Period||2
6295331|NCT00304512|7197408|FG001|Safety Population|Treatment Period||4
6295332|NCT00304512|7197409|FG002|Safety Population|Treatment Period||3
6295333|NCT00304512|7197407|FG000|Pharmacokinetic (PK) Population|Treatment Period||2
6295334|NCT00304512|7197408|FG001|Pharmacokinetic (PK) Population|Treatment Period||4
6295335|NCT00304512|7197409|FG002|Pharmacokinetic (PK) Population|Treatment Period||3
6295336|NCT00304512|7197407|FG000|Pharmacodynamic (PD) Population|Treatment Period||2
6295337|NCT00304512|7197408|FG001|Pharmacodynamic (PD) Population|Treatment Period||4
6295338|NCT00304512|7197409|FG002|Pharmacodynamic (PD) Population|Treatment Period||3
6295339|NCT00304512|7197407|FG000|COMPLETED|Treatment Period||2
6295340|NCT00304512|7197408|FG001|COMPLETED|Treatment Period||4
6295341|NCT00304512|7197409|FG002|COMPLETED|Treatment Period||3
6295342|NCT00304512|7197407|FG000|NOT COMPLETED|Treatment Period||0
6295343|NCT00304512|7197408|FG001|NOT COMPLETED|Treatment Period||0
6295344|NCT00304512|7197409|FG002|NOT COMPLETED|Treatment Period||0
6295345|NCT00304512|7197407|FG000|STARTED|Extension Period||2
6295346|NCT00304512|7197408|FG001|STARTED|Extension Period||4
6295347|NCT00304512|7197409|FG002|STARTED|Extension Period||3
6295348|NCT00304512|7197407|FG000|COMPLETED|Extension Period||2
6295349|NCT00304512|7197408|FG001|COMPLETED|Extension Period||4
6295350|NCT00304512|7197409|FG002|COMPLETED|Extension Period||3
6295351|NCT00304512|7197407|FG000|NOT COMPLETED|Extension Period||0
6295352|NCT00304512|7197408|FG001|NOT COMPLETED|Extension Period||0
6295353|NCT00304512|7197409|FG002|NOT COMPLETED|Extension Period||0
6295354|NCT00304707|7197419|FG000|STARTED|Overall Study||73
6295355|NCT00304707|7197420|FG001|STARTED|Overall Study||70
6295356|NCT00304707|7197419|FG000|COMPLETED|Overall Study||66
6295357|NCT00304707|7197420|FG001|COMPLETED|Overall Study||64
6295358|NCT00304707|7197419|FG000|NOT COMPLETED|Overall Study||7
6295359|NCT00304707|7197420|FG001|NOT COMPLETED|Overall Study||6
6295360|NCT00304746|7197428|FG000|STARTED|Overall Study||50
6295361|NCT00304746|7197429|FG001|STARTED|Overall Study||50
6295362|NCT00304746|7197428|FG000|COMPLETED|Overall Study||50
6295363|NCT00304746|7197429|FG001|COMPLETED|Overall Study||50
6295364|NCT00304746|7197428|FG000|NOT COMPLETED|Overall Study||0
6295365|NCT00304746|7197429|FG001|NOT COMPLETED|Overall Study||0
6374233|NCT00749463|7284853|FG001|STARTED|Overall Study||64
6374234|NCT00749463|7284854|FG002|STARTED|Overall Study||150
6374235|NCT00749463|7284852|FG000|COMPLETED|Overall Study||85
6374236|NCT00749463|7284853|FG001|COMPLETED|Overall Study||60
6374237|NCT00749463|7284854|FG002|COMPLETED|Overall Study||149
6374238|NCT00749463|7284852|FG000|NOT COMPLETED|Overall Study||1
6374239|NCT00749463|7284853|FG001|NOT COMPLETED|Overall Study||4
6374240|NCT00749463|7284854|FG002|NOT COMPLETED|Overall Study||1
6374241|NCT00749515|7284864|FG000|STARTED|Overall Study||10
6374242|NCT00749515|7284865|FG001|STARTED|Overall Study||5
6374243|NCT00749515|7284864|FG000|COMPLETED|Overall Study||10
6374244|NCT00749515|7284865|FG001|COMPLETED|Overall Study||5
6374245|NCT00749515|7284864|FG000|NOT COMPLETED|Overall Study||0
6374246|NCT00749515|7284865|FG001|NOT COMPLETED|Overall Study||0
6374247|NCT00749580|7284873|FG000|STARTED|Overall Study|September 2008|21
6374248|NCT00749580|7284874|FG001|STARTED|Overall Study||25
6374249|NCT00749580|7284873|FG000|COMPLETED|Overall Study|December 2010|17
6374250|NCT00749580|7284874|FG001|COMPLETED|Overall Study||16
6295366|NCT04721171|7197437|FG000|STARTED|Overall Study||2
6295367|NCT04721171|7197438|FG001|STARTED|Overall Study||2
6295368|NCT04721171|7197437|FG000|COMPLETED|Overall Study||2
6295369|NCT04721171|7197438|FG001|COMPLETED|Overall Study||2
6295370|NCT04721171|7197437|FG000|NOT COMPLETED|Overall Study||0
6295371|NCT04721171|7197438|FG001|NOT COMPLETED|Overall Study||0
6295372|NCT04717323|7197448|FG000|STARTED|Overall Study||0
6295373|NCT04717323|7197449|FG001|STARTED|Overall Study||10
6295374|NCT04717323|7197448|FG000|COMPLETED|Overall Study||0
6295375|NCT04717323|7197449|FG001|COMPLETED|Overall Study||10
6295376|NCT04717323|7197448|FG000|NOT COMPLETED|Overall Study||0
6295377|NCT04717323|7197449|FG001|NOT COMPLETED|Overall Study||0
6374251|NCT00749580|7284873|FG000|NOT COMPLETED|Overall Study||4
6374252|NCT00749580|7284874|FG001|NOT COMPLETED|Overall Study||9
6374253|NCT00749606|7284882|FG000|STARTED|Year 1||129
6374254|NCT00749606|7284883|FG001|STARTED|Year 1||128
6374255|NCT00749606|7284882|FG000|COMPLETED|Year 1||74
6374256|NCT00749606|7284883|FG001|COMPLETED|Year 1||80
6374257|NCT00749606|7284882|FG000|NOT COMPLETED|Year 1||55
6374258|NCT00749606|7284883|FG001|NOT COMPLETED|Year 1||48
6374259|NCT00749606|7284882|FG000|STARTED|Year 2||74
6374260|NCT00749606|7284883|FG001|STARTED|Year 2||80
6374261|NCT00749606|7284882|FG000|COMPLETED|Year 2||63
6374262|NCT00749606|7284883|FG001|COMPLETED|Year 2||72
6374263|NCT00749606|7284882|FG000|NOT COMPLETED|Year 2||11
6374264|NCT00749606|7284883|FG001|NOT COMPLETED|Year 2||8
6374265|NCT00749606|7284882|FG000|STARTED|Year 3 (Observation)||63
6374266|NCT00749606|7284883|FG001|STARTED|Year 3 (Observation)||72
6374267|NCT00749606|7284882|FG000|COMPLETED|Year 3 (Observation)||63
6374268|NCT00749606|7284883|FG001|COMPLETED|Year 3 (Observation)||69
6374269|NCT00749606|7284882|FG000|NOT COMPLETED|Year 3 (Observation)||0
6374270|NCT00749606|7284883|FG001|NOT COMPLETED|Year 3 (Observation)||3
6374271|NCT00749671|7284893|FG000|STARTED|Overall Study||11
6374272|NCT00749671|7284894|FG001|STARTED|Overall Study||9
6374273|NCT00749671|7284893|FG000|COMPLETED|Overall Study||11
6374274|NCT00749671|7284894|FG001|COMPLETED|Overall Study||9
6374275|NCT00749671|7284893|FG000|NOT COMPLETED|Overall Study||0
6374276|NCT00749671|7284894|FG001|NOT COMPLETED|Overall Study||0
6374277|NCT00749684|7284902|FG000|STARTED|Overall Study||138
6374278|NCT00749684|7284902|FG000|COMPLETED|Overall Study||56
6374279|NCT00749684|7284902|FG000|NOT COMPLETED|Overall Study||82
6374280|NCT00749749|7284908|FG000|STARTED|Overall Study||14
6374281|NCT00749749|7284909|FG001|STARTED|Overall Study||13
6400708|NCT00887575|7313599|FG001|STARTED|Phase I||6
6400709|NCT00887575|7313600|FG002|STARTED|Phase I||3
6400710|NCT00887575|7313598|FG000|COMPLETED|Phase I||6
6400711|NCT00887575|7313599|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6634977|NCT02300727|7563817|FG003|COMPLETED|Overall Study||2
6634978|NCT02300727|7563818|FG004|COMPLETED|Overall Study||0
6374282|NCT00749749|7284908|FG000|COMPLETED|Overall Study||14
6374283|NCT00749749|7284909|FG001|COMPLETED|Overall Study||13
6374284|NCT00749749|7284908|FG000|NOT COMPLETED|Overall Study||0
6374285|NCT00749749|7284909|FG001|NOT COMPLETED|Overall Study||0
6374286|NCT00749775|7284915|FG000|STARTED|Overall Study||3317
6374287|NCT00749775|7284915|FG000|COMPLETED|Overall Study||3210
6374288|NCT00749775|7284915|FG000|NOT COMPLETED|Overall Study||107
6374289|NCT00749879|7284929|FG000|STARTED|Overall Study||12
6374290|NCT00749879|7284929|FG000|COMPLETED|Overall Study||12
6374291|NCT00749879|7284929|FG000|NOT COMPLETED|Overall Study||0
6374292|NCT00749892|7284941|FG000|STARTED|Overall Study||34
6374293|NCT00749892|7284941|FG000|COMPLETED|Overall Study||31
6374294|NCT00749892|7284941|FG000|NOT COMPLETED|Overall Study||3
6374295|NCT00749931|7284947|FG000|STARTED|Overall Study||298
6374296|NCT00749931|7284948|FG001|STARTED|Overall Study||298
6374297|NCT00749931|7284949|FG002|STARTED|Overall Study||68
6374298|NCT00749931|7284947|FG000|COMPLETED|Overall Study||298
6374299|NCT00749931|7284948|FG001|COMPLETED|Overall Study||298
6374300|NCT00749931|7284949|FG002|COMPLETED|Overall Study||68
6374301|NCT00749931|7284947|FG000|NOT COMPLETED|Overall Study||0
6374302|NCT00749931|7284948|FG001|NOT COMPLETED|Overall Study||0
6374303|NCT00749931|7284949|FG002|NOT COMPLETED|Overall Study||0
6374304|NCT00749944|7284958|FG000|STARTED|Overall Study||55
6374305|NCT00749944|7284959|FG001|STARTED|Overall Study||55
6634979|NCT02300727|7563819|FG005|COMPLETED|Overall Study||0
6634980|NCT02300727|7563814|FG000|NOT COMPLETED|Overall Study||0
6374306|NCT00749944|7284958|FG000|COMPLETED|Overall Study||50
6374307|NCT00749944|7284959|FG001|COMPLETED|Overall Study||54
6374308|NCT00749944|7284958|FG000|NOT COMPLETED|Overall Study||5
6374309|NCT00749944|7284959|FG001|NOT COMPLETED|Overall Study||1
6374310|NCT00749957|7284967|FG000|STARTED|Overall Study||6
6374311|NCT00749957|7284968|FG001|STARTED|Overall Study||6
6374312|NCT00749957|7284967|FG000|COMPLETED|Overall Study||6
6374313|NCT00749957|7284968|FG001|COMPLETED|Overall Study||6
6374314|NCT00749957|7284967|FG000|NOT COMPLETED|Overall Study||0
6400712|NCT00887575|7313600|FG002|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6400713|NCT00887575|7313598|FG000|NOT COMPLETED|Phase I||0
6374315|NCT00749957|7284968|FG001|NOT COMPLETED|Overall Study||0
6374316|NCT00749996|7284978|FG000|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
6374317|NCT00749996|7284979|FG001|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
6374318|NCT00749996|7284978|FG000|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
6295378|NCT04511338|7197457|FG000|STARTED|Period 1||8
6295379|NCT04511338|7197458|FG001|STARTED|Period 1||8
6295380|NCT04511338|7197457|FG000|COMPLETED|Period 1||7
6295381|NCT04511338|7197458|FG001|COMPLETED|Period 1||8
6295382|NCT04511338|7197457|FG000|NOT COMPLETED|Period 1||1
6295383|NCT04511338|7197458|FG001|NOT COMPLETED|Period 1||0
6295384|NCT04511338|7197457|FG000|STARTED|Washout|"We followed the rules in protocol (brief version in SARP sec. 3.1) to withdraw or move subjects to the next period.~Period 1:~Dialyzer with Endexo has grade 4 clotting, subjects is withdrawn from the study~CombiSet with grade 4 clotting only (not the dialyzer): subjects end Period 1, move to Washout, and then Period 2~There was a subject with CombiSet bloodline grade 4 clotting in the 50% heparin reduction HD. The subject was moved to washout period without any heparin free sessions."|8
6295385|NCT04511338|7197458|FG001|STARTED|Washout||8
6295386|NCT04511338|7197457|FG000|COMPLETED|Washout||8
6295387|NCT04511338|7197458|FG001|COMPLETED|Washout||8
6295388|NCT04511338|7197457|FG000|NOT COMPLETED|Washout||0
6295389|NCT04511338|7197458|FG001|NOT COMPLETED|Washout||0
6295390|NCT04511338|7197457|FG000|STARTED|Period 2||8
6295391|NCT04511338|7197458|FG001|STARTED|Period 2||8
6295392|NCT04511338|7197457|FG000|COMPLETED|Period 2||8
6295393|NCT04511338|7197458|FG001|COMPLETED|Period 2||5
6295394|NCT04511338|7197457|FG000|NOT COMPLETED|Period 2||0
6295395|NCT04511338|7197458|FG001|NOT COMPLETED|Period 2||3
6295396|NCT04496414|7197464|FG000|STARTED|Overall Study||50
6295397|NCT04496414|7197464|FG000|COMPLETED|Overall Study||50
6295398|NCT04496414|7197464|FG000|NOT COMPLETED|Overall Study||0
6295399|NCT04493931|7197475|FG000|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||14
6295400|NCT04493931|7197476|FG001|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295401|NCT04493931|7197477|FG002|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295402|NCT04493931|7197478|FG003|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295403|NCT04493931|7197479|FG004|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295404|NCT04493931|7197480|FG005|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295405|NCT04493931|7197481|FG006|STARTED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295406|NCT04493931|7197475|FG000|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||13
6295407|NCT04493931|7197476|FG001|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295408|NCT04493931|7197477|FG002|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295409|NCT04493931|7197478|FG003|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295410|NCT04493931|7197479|FG004|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295411|NCT04493931|7197480|FG005|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295412|NCT04493931|7197481|FG006|COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295413|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||1
6295414|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295415|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295416|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295417|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295418|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295419|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort1:Treatment Period 1(Up to 3 Days)||0
6295420|NCT04493931|7197475|FG000|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
6295421|NCT04493931|7197476|FG001|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295422|NCT04493931|7197477|FG002|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295423|NCT04493931|7197478|FG003|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295424|NCT04493931|7197479|FG004|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295425|NCT04493931|7197480|FG005|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295426|NCT04493931|7197481|FG006|STARTED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295427|NCT04493931|7197475|FG000|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||13
6295428|NCT04493931|7197476|FG001|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295429|NCT04493931|7197477|FG002|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295430|NCT04493931|7197478|FG003|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295431|NCT04493931|7197479|FG004|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295432|NCT04493931|7197480|FG005|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295433|NCT04493931|7197481|FG006|COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295434|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295435|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295436|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295437|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295438|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295439|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295440|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort 1:Washout Period 1 (Up to 3 Days)||0
6295441|NCT04493931|7197475|FG000|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||13
6295442|NCT04493931|7197476|FG001|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295443|NCT04493931|7197477|FG002|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295444|NCT04493931|7197478|FG003|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295445|NCT04493931|7197479|FG004|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295446|NCT04493931|7197480|FG005|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295447|NCT04493931|7197481|FG006|STARTED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295448|NCT04493931|7197475|FG000|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||13
6295449|NCT04493931|7197476|FG001|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295450|NCT04493931|7197477|FG002|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295451|NCT04493931|7197478|FG003|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295452|NCT04493931|7197479|FG004|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295453|NCT04493931|7197480|FG005|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295454|NCT04493931|7197481|FG006|COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295455|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295456|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295457|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295458|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295459|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6295460|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6634981|NCT02300727|7563815|FG001|NOT COMPLETED|Overall Study||0
6634982|NCT02300727|7563816|FG002|NOT COMPLETED|Overall Study||0
6634983|NCT02300727|7563817|FG003|NOT COMPLETED|Overall Study||1
6634984|NCT02300727|7563818|FG004|NOT COMPLETED|Overall Study||0
6634985|NCT02300727|7563819|FG005|NOT COMPLETED|Overall Study||0
6634986|NCT02300987|7563835|FG000|STARTED|Primary Phase : Prior to Cross-over||8
6634987|NCT02300987|7563836|FG001|STARTED|Primary Phase : Prior to Cross-over||2
6634988|NCT02300987|7563835|FG000|COMPLETED|Primary Phase : Prior to Cross-over||2
6634989|NCT02300987|7563836|FG001|COMPLETED|Primary Phase : Prior to Cross-over||0
6634990|NCT02300987|7563835|FG000|NOT COMPLETED|Primary Phase : Prior to Cross-over||6
6634991|NCT02300987|7563836|FG001|NOT COMPLETED|Primary Phase : Prior to Cross-over||2
6634992|NCT02300987|7563835|FG000|STARTED|Secondary Phase : Cross-over to LEE011||1
6634993|NCT02300987|7563836|FG001|STARTED|Secondary Phase : Cross-over to LEE011||2
6634994|NCT02300987|7563835|FG000|COMPLETED|Secondary Phase : Cross-over to LEE011||0
6634995|NCT02300987|7563836|FG001|COMPLETED|Secondary Phase : Cross-over to LEE011||1
6295461|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort1:Treatment Period 2(Up to 4 Days)||0
6400714|NCT00887575|7313599|FG001|NOT COMPLETED|Phase I||6
6400715|NCT00887575|7313600|FG002|NOT COMPLETED|Phase I||3
6634996|NCT02300987|7563835|FG000|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
6634997|NCT02300987|7563836|FG001|NOT COMPLETED|Secondary Phase : Cross-over to LEE011||1
6295462|NCT04493931|7197475|FG000|STARTED|Cohort 1: Follow-up (Up to 7 Days)||13
6295463|NCT04493931|7197476|FG001|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
6400716|NCT00887575|7313598|FG000|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
6400717|NCT00887575|7313599|FG001|STARTED|Phase II - Neoadjuvant Therapy||0
6400718|NCT00887575|7313600|FG002|STARTED|Phase II - Neoadjuvant Therapy||0
6400719|NCT00887575|7313598|FG000|COMPLETED|Phase II - Neoadjuvant Therapy||16
6400720|NCT00887575|7313599|FG001|COMPLETED|Phase II - Neoadjuvant Therapy||0
6400721|NCT00887575|7313600|FG002|COMPLETED|Phase II - Neoadjuvant Therapy||0
6400722|NCT00887575|7313598|FG000|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
6400723|NCT00887575|7313599|FG001|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
6400724|NCT00887575|7313600|FG002|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
6400725|NCT00887575|7313598|FG000|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
6400726|NCT00887575|7313599|FG001|STARTED|Phase II - Maintenance Therapy||0
6400727|NCT00887575|7313600|FG002|STARTED|Phase II - Maintenance Therapy||0
6400728|NCT00887575|7313598|FG000|COMPLETED|Phase II - Maintenance Therapy||6
6400729|NCT00887575|7313599|FG001|COMPLETED|Phase II - Maintenance Therapy||0
6400730|NCT00887575|7313600|FG002|COMPLETED|Phase II - Maintenance Therapy||0
6400731|NCT00887575|7313598|FG000|NOT COMPLETED|Phase II - Maintenance Therapy||2
6400732|NCT00887575|7313599|FG001|NOT COMPLETED|Phase II - Maintenance Therapy||0
6400733|NCT00887575|7313600|FG002|NOT COMPLETED|Phase II - Maintenance Therapy||0
6400734|NCT00887588|7313607|FG000|STARTED|Core Period||149
6400735|NCT00887588|7313608|FG001|STARTED|Core Period||152
6400736|NCT00887588|7313607|FG000|Extension Efficacy Set|Core Period||127
6400737|NCT00887588|7313608|FG001|Extension Efficacy Set|Core Period||125
6400738|NCT00887588|7313607|FG000|Full Analysis Set|Core Period||148
6400739|NCT00887588|7313608|FG001|Full Analysis Set|Core Period||146
6400740|NCT00887588|7313607|FG000|Arterial Stiffness Set|Core Period||86
6400741|NCT00887588|7313608|FG001|Arterial Stiffness Set|Core Period||94
6400742|NCT00887588|7313607|FG000|COMPLETED|Core Period||130
6400743|NCT00887588|7313608|FG001|COMPLETED|Core Period||131
6400744|NCT00887588|7313607|FG000|NOT COMPLETED|Core Period||19
6400745|NCT00887588|7313608|FG001|NOT COMPLETED|Core Period||21
6400746|NCT00887588|7313607|FG000|STARTED|Extension Period||127
6400747|NCT00887588|7313608|FG001|STARTED|Extension Period||125
6400748|NCT00887588|7313607|FG000|Arterial Stiffness Set|Extension Period||86
6400749|NCT00887588|7313608|FG001|Arterial Stiffness Set|Extension Period||94
6400750|NCT00887588|7313607|FG000|COMPLETED|Extension Period||121
6400751|NCT00887588|7313608|FG001|COMPLETED|Extension Period||120
6400752|NCT00887588|7313607|FG000|NOT COMPLETED|Extension Period||6
6400753|NCT00887588|7313608|FG001|NOT COMPLETED|Extension Period||5
6400754|NCT00887640|7313614|FG000|STARTED|Overall Study||11
6634998|NCT02301039|7563846|FG000|STARTED|Overall Study||42
6634999|NCT02301039|7563847|FG001|STARTED|Overall Study||42
6295464|NCT04493931|7197477|FG002|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
6295465|NCT04493931|7197478|FG003|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
6295466|NCT04493931|7197479|FG004|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
6295467|NCT04493931|7197480|FG005|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
6295468|NCT04493931|7197481|FG006|STARTED|Cohort 1: Follow-up (Up to 7 Days)||0
6295469|NCT04493931|7197475|FG000|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||13
6295470|NCT04493931|7197476|FG001|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295471|NCT04493931|7197477|FG002|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295472|NCT04493931|7197478|FG003|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295473|NCT04493931|7197479|FG004|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295474|NCT04493931|7197480|FG005|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295475|NCT04493931|7197481|FG006|COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295476|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295477|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295478|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295479|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295480|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295481|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295482|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort 1: Follow-up (Up to 7 Days)||0
6295483|NCT04493931|7197475|FG000|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295484|NCT04493931|7197476|FG001|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||17
6295485|NCT04493931|7197477|FG002|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295486|NCT04493931|7197478|FG003|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295487|NCT04493931|7197479|FG004|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295488|NCT04493931|7197480|FG005|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295489|NCT04493931|7197481|FG006|STARTED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295490|NCT04493931|7197475|FG000|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295491|NCT04493931|7197476|FG001|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||17
6295492|NCT04493931|7197477|FG002|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295493|NCT04493931|7197478|FG003|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295494|NCT04493931|7197479|FG004|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295495|NCT04493931|7197480|FG005|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295496|NCT04493931|7197481|FG006|COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295497|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295498|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295499|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295500|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295501|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295502|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295503|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort2:Treatment Period 1(Up to 3 Days)||0
6295504|NCT04493931|7197475|FG000|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295505|NCT04493931|7197476|FG001|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||17
6295506|NCT04493931|7197477|FG002|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295507|NCT04493931|7197478|FG003|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295508|NCT04493931|7197479|FG004|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295509|NCT04493931|7197480|FG005|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295510|NCT04493931|7197481|FG006|STARTED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295511|NCT04493931|7197475|FG000|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295512|NCT04493931|7197476|FG001|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||17
6295513|NCT04493931|7197477|FG002|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295514|NCT04493931|7197478|FG003|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295515|NCT04493931|7197479|FG004|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295516|NCT04493931|7197480|FG005|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295517|NCT04493931|7197481|FG006|COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295518|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295519|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295520|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295521|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295522|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295523|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295524|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort 2:Washout Period 1(Up to 3 Days)||0
6295525|NCT04493931|7197475|FG000|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295526|NCT04493931|7197476|FG001|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||17
6295527|NCT04493931|7197477|FG002|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295528|NCT04493931|7197478|FG003|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295529|NCT04493931|7197479|FG004|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295530|NCT04493931|7197480|FG005|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295531|NCT04493931|7197481|FG006|STARTED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295532|NCT04493931|7197475|FG000|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295533|NCT04493931|7197476|FG001|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||14
6295534|NCT04493931|7197477|FG002|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295535|NCT04493931|7197478|FG003|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295536|NCT04493931|7197479|FG004|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295537|NCT04493931|7197480|FG005|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295538|NCT04493931|7197481|FG006|COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295539|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295540|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||3
6295541|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295542|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295543|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295544|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295545|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort2:Treatment Period2(Up to 10 Days)||0
6295546|NCT04493931|7197475|FG000|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
6295547|NCT04493931|7197476|FG001|STARTED|Cohort 2: Follow-up (Up to 10 Days)||14
6295548|NCT04493931|7197477|FG002|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
6295549|NCT04493931|7197478|FG003|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
6295550|NCT04493931|7197479|FG004|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
6295551|NCT04493931|7197480|FG005|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
6635000|NCT02301039|7563848|FG002|STARTED|Overall Study||60
6635001|NCT02301039|7563846|FG000|COMPLETED|Overall Study||42
6295552|NCT04493931|7197481|FG006|STARTED|Cohort 2: Follow-up (Up to 10 Days)||0
6400755|NCT00887640|7313614|FG000|COMPLETED|Overall Study||11
6400756|NCT00887640|7313614|FG000|NOT COMPLETED|Overall Study||0
6400757|NCT00887653|7313618|FG000|STARTED|Overall Study||20
6400758|NCT00887653|7313618|FG000|COMPLETED|Overall Study||20
6400759|NCT00887653|7313618|FG000|NOT COMPLETED|Overall Study||0
6400760|NCT00887679|7313622|FG000|STARTED|Overall Study||30
6295553|NCT04493931|7197475|FG000|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295554|NCT04493931|7197476|FG001|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||14
6295555|NCT04493931|7197477|FG002|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295556|NCT04493931|7197478|FG003|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295557|NCT04493931|7197479|FG004|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295558|NCT04493931|7197480|FG005|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295559|NCT04493931|7197481|FG006|COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295560|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295561|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295562|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295563|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295564|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295565|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295566|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort 2: Follow-up (Up to 10 Days)||0
6295567|NCT04493931|7197475|FG000|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295568|NCT04493931|7197476|FG001|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295569|NCT04493931|7197477|FG002|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||10
6295570|NCT04493931|7197478|FG003|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||9
6400761|NCT00887679|7313622|FG000|COMPLETED|Overall Study|20 subjects completed the study.|20
6400762|NCT00887679|7313622|FG000|NOT COMPLETED|Overall Study||10
6400763|NCT00887744|7313627|FG000|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
6400764|NCT00887744|7313627|FG000|COMPLETED|Overall Study||128
6295571|NCT04493931|7197479|FG004|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295572|NCT04493931|7197480|FG005|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295573|NCT04493931|7197481|FG006|STARTED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295574|NCT04493931|7197475|FG000|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295575|NCT04493931|7197476|FG001|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295576|NCT04493931|7197477|FG002|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
6295577|NCT04493931|7197478|FG003|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||9
6295578|NCT04493931|7197479|FG004|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295579|NCT04493931|7197480|FG005|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295580|NCT04493931|7197481|FG006|COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295581|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295582|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295583|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||1
6295584|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295585|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295586|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295587|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort3:Treatment Period 1(Up to 5 Days)||0
6295588|NCT04493931|7197475|FG000|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295589|NCT04493931|7197476|FG001|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295590|NCT04493931|7197477|FG002|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
6295591|NCT04493931|7197478|FG003|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||9
6295592|NCT04493931|7197479|FG004|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295593|NCT04493931|7197480|FG005|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295594|NCT04493931|7197481|FG006|STARTED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295595|NCT04493931|7197475|FG000|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295596|NCT04493931|7197476|FG001|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295597|NCT04493931|7197477|FG002|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
6295598|NCT04493931|7197478|FG003|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||9
6400765|NCT00887744|7313627|FG000|NOT COMPLETED|Overall Study||34
6400766|NCT00887783|7313633|FG000|STARTED|Overall Study||58
6400767|NCT00887783|7313634|FG001|STARTED|Overall Study||59
6400768|NCT00887783|7313633|FG000|COMPLETED|Overall Study||58
6295599|NCT04493931|7197479|FG004|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295600|NCT04493931|7197480|FG005|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295601|NCT04493931|7197481|FG006|COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295602|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295603|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295604|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295605|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295606|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295607|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295608|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort3:Washout Period 1(Up to 10 Days)||0
6295609|NCT04493931|7197475|FG000|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295610|NCT04493931|7197476|FG001|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295611|NCT04493931|7197477|FG002|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
6295612|NCT04493931|7197478|FG003|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||9
6295613|NCT04493931|7197479|FG004|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295614|NCT04493931|7197480|FG005|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295615|NCT04493931|7197481|FG006|STARTED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295616|NCT04493931|7197475|FG000|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295617|NCT04493931|7197476|FG001|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295618|NCT04493931|7197477|FG002|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
6295619|NCT04493931|7197478|FG003|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||9
6295620|NCT04493931|7197479|FG004|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295621|NCT04493931|7197480|FG005|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295622|NCT04493931|7197481|FG006|COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295623|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295624|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295625|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295626|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295627|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295628|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295629|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort3:Treatment Period 2(Up to 5 Days)||0
6295630|NCT04493931|7197475|FG000|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
6295631|NCT04493931|7197476|FG001|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
6295632|NCT04493931|7197477|FG002|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
6295633|NCT04493931|7197478|FG003|STARTED|Cohort 3: Follow-up (Up to 10 Days)||9
6295634|NCT04493931|7197479|FG004|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
6295635|NCT04493931|7197480|FG005|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
6295636|NCT04493931|7197481|FG006|STARTED|Cohort 3: Follow-up (Up to 10 Days)||0
6295637|NCT04493931|7197475|FG000|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295638|NCT04493931|7197476|FG001|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295639|NCT04493931|7197477|FG002|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
6295640|NCT04493931|7197478|FG003|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||9
6295641|NCT04493931|7197479|FG004|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6400769|NCT00887783|7313634|FG001|COMPLETED|Overall Study||59
6400770|NCT00887783|7313633|FG000|NOT COMPLETED|Overall Study||0
6400771|NCT00887783|7313634|FG001|NOT COMPLETED|Overall Study||0
6400772|NCT00887809|7313642|FG000|STARTED|Overall Study||37
6400773|NCT00887809|7313643|FG001|STARTED|Overall Study||10
6400774|NCT00887809|7313642|FG000|COMPLETED|Overall Study||33
6400775|NCT00887809|7313643|FG001|COMPLETED|Overall Study||10
6400776|NCT00887809|7313642|FG000|NOT COMPLETED|Overall Study||4
6400777|NCT00887809|7313643|FG001|NOT COMPLETED|Overall Study||0
6400778|NCT00887822|7313651|FG000|STARTED|Overall Study||100
6400779|NCT00887822|7313652|FG001|STARTED|Overall Study||102
6400780|NCT00887822|7313651|FG000|Treated (Safety Population)|Overall Study||100
6400781|NCT00887822|7313652|FG001|Treated (Safety Population)|Overall Study||101
6400782|NCT00887822|7313651|FG000|COMPLETED|Overall Study||3
6400783|NCT00887822|7313652|FG001|COMPLETED|Overall Study||0
6400784|NCT00887822|7313651|FG000|NOT COMPLETED|Overall Study||97
6400785|NCT00887822|7313652|FG001|NOT COMPLETED|Overall Study||102
6400786|NCT00887913|7313658|FG000|STARTED|Overall Study||69
6400787|NCT00887913|7313658|FG000|COMPLETED|Overall Study||63
6400788|NCT00887913|7313658|FG000|NOT COMPLETED|Overall Study||6
6400789|NCT00887926|7313666|FG000|STARTED|Overall Study||3
6400790|NCT00887926|7313667|FG001|STARTED|Overall Study||14
6400791|NCT00887926|7313668|FG002|STARTED|Overall Study||3
6400792|NCT00887926|7313669|FG003|STARTED|Overall Study||5
6400793|NCT00887926|7313666|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6400794|NCT00887926|7313667|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
6400795|NCT00887926|7313668|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6400796|NCT00887926|7313669|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
6400797|NCT00887926|7313666|FG000|COMPLETED|Overall Study||3
6400798|NCT00887926|7313667|FG001|COMPLETED|Overall Study||13
6400799|NCT00887926|7313668|FG002|COMPLETED|Overall Study||3
6400800|NCT00887926|7313669|FG003|COMPLETED|Overall Study||5
6400801|NCT00887926|7313666|FG000|NOT COMPLETED|Overall Study||0
6400802|NCT00887926|7313667|FG001|NOT COMPLETED|Overall Study||1
6400803|NCT00887926|7313668|FG002|NOT COMPLETED|Overall Study||0
6400804|NCT00887926|7313669|FG003|NOT COMPLETED|Overall Study||0
6295642|NCT04493931|7197480|FG005|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295643|NCT04493931|7197481|FG006|COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295644|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295645|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295646|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295647|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295648|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295649|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295650|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort 3: Follow-up (Up to 10 Days)||0
6295651|NCT04493931|7197475|FG000|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295652|NCT04493931|7197476|FG001|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295653|NCT04493931|7197477|FG002|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295654|NCT04493931|7197478|FG003|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295655|NCT04493931|7197479|FG004|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||6
6295656|NCT04493931|7197480|FG005|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||5
6295657|NCT04493931|7197481|FG006|STARTED|Cohort4:Treatment Period 1(Up to 3 Days)||3
6295658|NCT04493931|7197475|FG000|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295659|NCT04493931|7197476|FG001|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295660|NCT04493931|7197477|FG002|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295661|NCT04493931|7197478|FG003|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295662|NCT04493931|7197479|FG004|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||6
6295663|NCT04493931|7197480|FG005|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||5
6295664|NCT04493931|7197481|FG006|COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||3
6295665|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295666|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295667|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295668|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295669|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295670|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295671|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort4:Treatment Period 1(Up to 3 Days)||0
6295672|NCT04493931|7197475|FG000|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295673|NCT04493931|7197476|FG001|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295674|NCT04493931|7197477|FG002|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295675|NCT04493931|7197478|FG003|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295676|NCT04493931|7197479|FG004|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||6
6295677|NCT04493931|7197480|FG005|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||5
6295678|NCT04493931|7197481|FG006|STARTED|Cohort4:Washout Period 1(Up to 3 Days)||3
6295679|NCT04493931|7197475|FG000|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295680|NCT04493931|7197476|FG001|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295681|NCT04493931|7197477|FG002|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295682|NCT04493931|7197478|FG003|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295683|NCT04493931|7197479|FG004|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||6
6295684|NCT04493931|7197480|FG005|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||5
6295685|NCT04493931|7197481|FG006|COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||3
6295686|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295687|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295688|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295689|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295690|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6635002|NCT02301039|7563847|FG001|COMPLETED|Overall Study||42
6635003|NCT02301039|7563848|FG002|COMPLETED|Overall Study||60
6635004|NCT02301039|7563846|FG000|NOT COMPLETED|Overall Study||0
6635005|NCT02301039|7563847|FG001|NOT COMPLETED|Overall Study||0
6635006|NCT02301039|7563848|FG002|NOT COMPLETED|Overall Study||0
6635007|NCT02301143|7563856|FG000|STARTED|Induction Period||107
6635008|NCT02301143|7563857|FG001|STARTED|Induction Period||0
6635009|NCT02301143|7563856|FG000|COMPLETED|Induction Period||62
6295691|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295692|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort4:Washout Period 1(Up to 3 Days)||0
6295693|NCT04493931|7197475|FG000|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295694|NCT04493931|7197476|FG001|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295695|NCT04493931|7197477|FG002|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295696|NCT04493931|7197478|FG003|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295697|NCT04493931|7197479|FG004|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||6
6295698|NCT04493931|7197480|FG005|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||5
6295699|NCT04493931|7197481|FG006|STARTED|Cohort4:Treatment Period 2(Up to 3 Days)||3
6295700|NCT04493931|7197475|FG000|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295701|NCT04493931|7197476|FG001|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295702|NCT04493931|7197477|FG002|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295703|NCT04493931|7197478|FG003|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295704|NCT04493931|7197479|FG004|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||6
6295705|NCT04493931|7197480|FG005|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||5
6635010|NCT02301143|7563857|FG001|COMPLETED|Induction Period||0
6635011|NCT02301143|7563856|FG000|NOT COMPLETED|Induction Period||45
6295706|NCT04493931|7197481|FG006|COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||3
6295707|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295708|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295709|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295710|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295711|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295712|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295713|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort4:Treatment Period 2(Up to 3 Days)||0
6295714|NCT04493931|7197475|FG000|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295715|NCT04493931|7197476|FG001|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295716|NCT04493931|7197477|FG002|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295717|NCT04493931|7197478|FG003|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295718|NCT04493931|7197479|FG004|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||6
6295719|NCT04493931|7197480|FG005|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||5
6295720|NCT04493931|7197481|FG006|STARTED|Cohort4:Washout Period 2(Up to 3 Days)||3
6295721|NCT04493931|7197475|FG000|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295722|NCT04493931|7197476|FG001|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295723|NCT04493931|7197477|FG002|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295724|NCT04493931|7197478|FG003|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295725|NCT04493931|7197479|FG004|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||6
6295726|NCT04493931|7197480|FG005|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||5
6295727|NCT04493931|7197481|FG006|COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||3
6295728|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295729|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295730|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295731|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295732|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295733|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295734|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort4:Washout Period 2(Up to 3 Days)||0
6295735|NCT04493931|7197475|FG000|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295736|NCT04493931|7197476|FG001|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295737|NCT04493931|7197477|FG002|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295738|NCT04493931|7197478|FG003|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295739|NCT04493931|7197479|FG004|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||6
6295740|NCT04493931|7197480|FG005|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||5
6295741|NCT04493931|7197481|FG006|STARTED|Cohort4:Treatment Period 3(Up to 3 Days)||3
6295742|NCT04493931|7197475|FG000|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295743|NCT04493931|7197476|FG001|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295744|NCT04493931|7197477|FG002|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295745|NCT04493931|7197478|FG003|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295746|NCT04493931|7197479|FG004|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||6
6295747|NCT04493931|7197480|FG005|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||5
6295748|NCT04493931|7197481|FG006|COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||3
6295749|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295750|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295751|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295752|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295753|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295754|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295755|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort4:Treatment Period 3(Up to 3 Days)||0
6295756|NCT04493931|7197475|FG000|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
6295757|NCT04493931|7197476|FG001|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
6295758|NCT04493931|7197477|FG002|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
6295759|NCT04493931|7197478|FG003|STARTED|Cohort 4: Follow-up (Up to 7 Days)||0
6295760|NCT04493931|7197479|FG004|STARTED|Cohort 4: Follow-up (Up to 7 Days)||6
6295761|NCT04493931|7197480|FG005|STARTED|Cohort 4: Follow-up (Up to 7 Days)||5
6295762|NCT04493931|7197481|FG006|STARTED|Cohort 4: Follow-up (Up to 7 Days)||3
6295763|NCT04493931|7197475|FG000|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295764|NCT04493931|7197476|FG001|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295765|NCT04493931|7197477|FG002|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295766|NCT04493931|7197478|FG003|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295767|NCT04493931|7197479|FG004|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||6
6295768|NCT04493931|7197480|FG005|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||5
6295769|NCT04493931|7197481|FG006|COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||3
6295770|NCT04493931|7197475|FG000|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295771|NCT04493931|7197476|FG001|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295772|NCT04493931|7197477|FG002|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295773|NCT04493931|7197478|FG003|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295774|NCT04493931|7197479|FG004|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295775|NCT04493931|7197480|FG005|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295776|NCT04493931|7197481|FG006|NOT COMPLETED|Cohort 4: Follow-up (Up to 7 Days)||0
6295777|NCT04428034|7197511|FG000|STARTED|Enrollment to Intervention Completion||45
6295778|NCT04428034|7197511|FG000|Attended at Least 2 Intervention Sessions in One Cohort|Enrollment to Intervention Completion|"Forty-five (45) participants enrolled and completed the baseline survey. Of those who completed they baseline survey, six participants of those who completed the baseline survey did not attend at least 2 sessions. Three participants started the intervention in one cohort, but completed in another (off-protocol). One participant was found to be a fraudulent case, identified through none-varying (straight line) responses to survey questions."|35
6295779|NCT04428034|7197511|FG000|COMPLETED|Enrollment to Intervention Completion||35
6295780|NCT04428034|7197511|FG000|NOT COMPLETED|Enrollment to Intervention Completion||10
6295781|NCT04428034|7197511|FG000|STARTED|4-Week Follow Up Survey||35
6295782|NCT04428034|7197511|FG000|COMPLETED|4-Week Follow Up Survey||29
6295783|NCT04428034|7197511|FG000|NOT COMPLETED|4-Week Follow Up Survey||6
6295784|NCT04428034|7197511|FG000|STARTED|8-Week Follow Up Survey||29
6400805|NCT00887965|7313681|FG000|STARTED|Overall Study||15
6400806|NCT00887965|7313681|FG000|COMPLETED|Overall Study||15
6400807|NCT00887965|7313681|FG000|NOT COMPLETED|Overall Study||0
6400808|NCT00887978|7313687|FG000|STARTED|Overall Study||157
6400809|NCT00887978|7313688|FG001|STARTED|Overall Study||153
6400810|NCT00887978|7313687|FG000|COMPLETED|Overall Study||132
6400811|NCT00887978|7313688|FG001|COMPLETED|Overall Study||138
6400812|NCT00887978|7313687|FG000|NOT COMPLETED|Overall Study||25
6295785|NCT04428034|7197511|FG000|COMPLETED|8-Week Follow Up Survey|Of those 27 who completed the 8-week follow up survey, one participant skipped the 4-week follow up survey but completed the 8-week survey.|27
6295786|NCT04428034|7197511|FG000|NOT COMPLETED|8-Week Follow Up Survey||2
6295787|NCT04262947|7197518|FG000|STARTED|Overall Study||13
6295788|NCT04262947|7197519|FG001|STARTED|Overall Study||13
6295789|NCT04262947|7197520|FG002|STARTED|Overall Study||12
6295790|NCT04262947|7197518|FG000|COMPLETED|Overall Study||13
6295791|NCT04262947|7197519|FG001|COMPLETED|Overall Study||13
6295792|NCT04262947|7197520|FG002|COMPLETED|Overall Study||12
6295793|NCT04262947|7197518|FG000|NOT COMPLETED|Overall Study||0
6295794|NCT04262947|7197519|FG001|NOT COMPLETED|Overall Study||0
6295795|NCT04262947|7197520|FG002|NOT COMPLETED|Overall Study||0
6295796|NCT04177680|7197528|FG000|STARTED|Overall Study||49
6295797|NCT04177680|7197529|FG001|STARTED|Overall Study||51
6295798|NCT04177680|7197528|FG000|COMPLETED|Overall Study||47
6295799|NCT04177680|7197529|FG001|COMPLETED|Overall Study||48
6295800|NCT04177680|7197528|FG000|NOT COMPLETED|Overall Study||2
6295801|NCT04177680|7197529|FG001|NOT COMPLETED|Overall Study||3
6374319|NCT00749996|7284979|FG001|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
6374320|NCT00749996|7284978|FG000|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
6374321|NCT00749996|7284979|FG001|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
6374322|NCT00749996|7284978|FG000|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
6374323|NCT00749996|7284979|FG001|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
6374324|NCT00749996|7284978|FG000|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
6374325|NCT00749996|7284979|FG001|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
6374326|NCT00749996|7284978|FG000|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
6374327|NCT00749996|7284979|FG001|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
6374328|NCT00749996|7284978|FG000|COMPLETED|Overall Study||57
6374329|NCT00749996|7284979|FG001|COMPLETED|Overall Study||58
6374330|NCT00749996|7284978|FG000|NOT COMPLETED|Overall Study||18
6374331|NCT00749996|7284979|FG001|NOT COMPLETED|Overall Study||13
6374332|NCT00750061|7284987|FG000|STARTED|Overall Study||20
6374333|NCT00750061|7284988|FG001|STARTED|Overall Study||20
6374334|NCT00750061|7284987|FG000|COMPLETED|Overall Study||18
6374335|NCT00750061|7284988|FG001|COMPLETED|Overall Study||18
6374336|NCT00750061|7284987|FG000|NOT COMPLETED|Overall Study||2
6374337|NCT00750061|7284988|FG001|NOT COMPLETED|Overall Study||2
6374338|NCT00750139|7284998|FG000|STARTED|Overall Study||234
6374339|NCT00750139|7284999|FG001|STARTED|Overall Study||118
6374340|NCT00750139|7285000|FG002|STARTED|Overall Study||236
6374341|NCT00750139|7285001|FG003|STARTED|Overall Study||119
6374342|NCT00750139|7284998|FG000|COMPLETED|Overall Study||145
6374343|NCT00750139|7284999|FG001|COMPLETED|Overall Study||59
6374344|NCT00750139|7285000|FG002|COMPLETED|Overall Study||135
6374345|NCT00750139|7285001|FG003|COMPLETED|Overall Study||73
6374346|NCT00750139|7284998|FG000|NOT COMPLETED|Overall Study||89
6374347|NCT00750139|7284999|FG001|NOT COMPLETED|Overall Study||59
6374348|NCT00750139|7285000|FG002|NOT COMPLETED|Overall Study||101
6374349|NCT00750139|7285001|FG003|NOT COMPLETED|Overall Study||46
6374350|NCT00750152|7285015|FG000|STARTED|Overall Study||166
6374351|NCT00750152|7285016|FG001|STARTED|Overall Study||168
6374352|NCT00750152|7285015|FG000|COMPLETED|Overall Study||144
6374353|NCT00750152|7285016|FG001|COMPLETED|Overall Study||141
6374354|NCT00750152|7285015|FG000|NOT COMPLETED|Overall Study||22
6374355|NCT00750152|7285016|FG001|NOT COMPLETED|Overall Study||27
6374356|NCT00750165|7285022|FG000|STARTED|Overall Study||32
6374357|NCT00750165|7285022|FG000|COMPLETED|Overall Study||21
6374358|NCT00750165|7285022|FG000|NOT COMPLETED|Overall Study||11
6374359|NCT00750191|7285028|FG000|STARTED|Overall Study||27
6374360|NCT00750191|7285029|FG001|STARTED|Overall Study||30
6374361|NCT00750191|7285028|FG000|COMPLETED|Overall Study||22
6374362|NCT00750191|7285029|FG001|COMPLETED|Overall Study||20
6400813|NCT00887978|7313688|FG001|NOT COMPLETED|Overall Study||15
6400814|NCT00888134|7313694|FG000|STARTED|Treatment With Study Drug||28
6498675|NCT01411852|7417317|FG001|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
6295802|NCT03999554|7197540|FG000|STARTED|Overall Study||42
6295803|NCT03999554|7197541|FG001|STARTED|Overall Study||41
6295804|NCT03999554|7197542|FG002|STARTED|Overall Study||40
6295805|NCT03999554|7197543|FG003|STARTED|Overall Study||42
6295806|NCT03999554|7197544|FG004|STARTED|Overall Study||41
6295807|NCT03999554|7197540|FG000|COMPLETED|Overall Study||36
6295808|NCT03999554|7197541|FG001|COMPLETED|Overall Study||34
6295809|NCT03999554|7197542|FG002|COMPLETED|Overall Study||28
6295810|NCT03999554|7197543|FG003|COMPLETED|Overall Study||35
6295811|NCT03999554|7197544|FG004|COMPLETED|Overall Study||32
6295812|NCT03999554|7197540|FG000|NOT COMPLETED|Overall Study||6
6295813|NCT03999554|7197541|FG001|NOT COMPLETED|Overall Study||7
6295814|NCT03999554|7197542|FG002|NOT COMPLETED|Overall Study||12
6295815|NCT03999554|7197543|FG003|NOT COMPLETED|Overall Study||7
6295816|NCT03999554|7197544|FG004|NOT COMPLETED|Overall Study||9
6295817|NCT03651622|7197560|FG000|STARTED|Diet Period 1 (Randomization 1)||23
6295818|NCT03651622|7197561|FG001|STARTED|Diet Period 1 (Randomization 1)||24
6295819|NCT03651622|7197562|FG002|STARTED|Diet Period 1 (Randomization 1)||21
6295820|NCT03651622|7197560|FG000|COMPLETED|Diet Period 1 (Randomization 1)||19
6295821|NCT03651622|7197561|FG001|COMPLETED|Diet Period 1 (Randomization 1)||17
6295822|NCT03651622|7197562|FG002|COMPLETED|Diet Period 1 (Randomization 1)||12
6295823|NCT03651622|7197560|FG000|NOT COMPLETED|Diet Period 1 (Randomization 1)||4
6295824|NCT03651622|7197561|FG001|NOT COMPLETED|Diet Period 1 (Randomization 1)||7
6295825|NCT03651622|7197562|FG002|NOT COMPLETED|Diet Period 1 (Randomization 1)||9
6295826|NCT03651622|7197560|FG000|STARTED|Diet Period 2 (Randomization 2)||19
6295827|NCT03651622|7197561|FG001|STARTED|Diet Period 2 (Randomization 2)||15
6295828|NCT03651622|7197562|FG002|STARTED|Diet Period 2 (Randomization 2)||14
6295829|NCT03651622|7197560|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||0
6295830|NCT03651622|7197561|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
6295831|NCT03651622|7197562|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 2 (Randomization 2)||5
6295832|NCT03651622|7197560|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||5
6295833|NCT03651622|7197561|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||0
6295834|NCT03651622|7197562|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 2 (Randomization 2)||6
6295835|NCT03651622|7197560|FG000|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||5
6295836|NCT03651622|7197561|FG001|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||4
6295837|NCT03651622|7197562|FG002|Number of Participants Rerandomized From Mediterranean, no Caloric Restriction Diet|Diet Period 2 (Randomization 2)||0
6295838|NCT03651622|7197560|FG000|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||9
6295839|NCT03651622|7197561|FG001|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||6
6295840|NCT03651622|7197562|FG002|Number of Participants Not Rerandomized|Diet Period 2 (Randomization 2)||3
6295841|NCT03651622|7197560|FG000|COMPLETED|Diet Period 2 (Randomization 2)||17
6295842|NCT03651622|7197561|FG001|COMPLETED|Diet Period 2 (Randomization 2)||13
6295843|NCT03651622|7197562|FG002|COMPLETED|Diet Period 2 (Randomization 2)||11
6295844|NCT03651622|7197560|FG000|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
6295845|NCT03651622|7197561|FG001|NOT COMPLETED|Diet Period 2 (Randomization 2)||2
6295846|NCT03651622|7197562|FG002|NOT COMPLETED|Diet Period 2 (Randomization 2)||3
6295847|NCT03651622|7197560|FG000|STARTED|Diet Period 3 (Randomization 3)||14
6295848|NCT03651622|7197561|FG001|STARTED|Diet Period 3 (Randomization 3)||9
6295849|NCT03651622|7197562|FG002|STARTED|Diet Period 3 (Randomization 3)||18
6295850|NCT03651622|7197560|FG000|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||0
6295851|NCT03651622|7197561|FG001|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||2
6295852|NCT03651622|7197562|FG002|Number of Participants Rerandomized From Hypocaloric, Low Carbohydrate Diet|Diet Period 3 (Randomization 3)||10
6295853|NCT03651622|7197560|FG000|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||4
6295854|NCT03651622|7197561|FG001|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||0
6295855|NCT03651622|7197562|FG002|Number of Participants Rerandomized From Hypocaloric, Moderate Low Fat Diet|Diet Period 3 (Randomization 3)||6
6295856|NCT03651622|7197560|FG000|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||6
6295857|NCT03651622|7197561|FG001|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||4
6295858|NCT03651622|7197562|FG002|Number of Participants Rerandomized From Mediterranean|Diet Period 3 (Randomization 3)||0
6295859|NCT03651622|7197560|FG000|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||4
6295860|NCT03651622|7197561|FG001|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||3
6295861|NCT03651622|7197562|FG002|Number of Participants Not Rerandomized|Diet Period 3 (Randomization 3)||2
6295862|NCT03651622|7197560|FG000|COMPLETED|Diet Period 3 (Randomization 3)||14
6295863|NCT03651622|7197561|FG001|COMPLETED|Diet Period 3 (Randomization 3)||9
6295864|NCT03651622|7197562|FG002|COMPLETED|Diet Period 3 (Randomization 3)||17
6295865|NCT03651622|7197560|FG000|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
6295866|NCT03651622|7197561|FG001|NOT COMPLETED|Diet Period 3 (Randomization 3)||0
6295867|NCT03651622|7197562|FG002|NOT COMPLETED|Diet Period 3 (Randomization 3)||1
6295868|NCT03563716|7197572|FG000|STARTED|Overall Study||68
6295869|NCT03563716|7197573|FG001|STARTED|Overall Study||67
6295870|NCT03563716|7197572|FG000|COMPLETED|Overall Study||0
6635012|NCT02301143|7563857|FG001|NOT COMPLETED|Induction Period||0
6635013|NCT02301143|7563856|FG000|STARTED|Investigator's Choice||0
6635014|NCT02301143|7563857|FG001|STARTED|Investigator's Choice|12 participants continued nab-Paclitaxel/Gemcitabine; 18 started chemoradiation;17 underwent surgery|47
6635015|NCT02301143|7563856|FG000|COMPLETED|Investigator's Choice||0
6635016|NCT02301143|7563857|FG001|COMPLETED|Investigator's Choice|3 participants completed nab-Paclitaxel+Gemcitabine,18 completed chemoradiation,16 had surgery.|37
6635017|NCT02301143|7563856|FG000|NOT COMPLETED|Investigator's Choice||0
6635018|NCT02301143|7563857|FG001|NOT COMPLETED|Investigator's Choice||10
6635019|NCT02301169|7563870|FG000|STARTED|Overall Study||21
6295871|NCT03563716|7197573|FG001|COMPLETED|Overall Study|"One participant who died had as reason for discontinuation Withdrawal by Subject"|0
6295872|NCT03563716|7197572|FG000|NOT COMPLETED|Overall Study||68
6295873|NCT03563716|7197573|FG001|NOT COMPLETED|Overall Study||67
6295874|NCT03410992|7197581|FG000|STARTED|Initial Treatment Period: up to Wk16||86
6295875|NCT03410992|7197582|FG001|STARTED|Initial Treatment Period: up to Wk16||349
6295876|NCT03410992|7197583|FG002|STARTED|Initial Treatment Period: up to Wk16||0
6295877|NCT03410992|7197584|FG003|STARTED|Initial Treatment Period: up to Wk16||0
6295878|NCT03410992|7197585|FG004|STARTED|Initial Treatment Period: up to Wk16||0
6635020|NCT02301169|7563871|FG001|STARTED|Overall Study||21
6635021|NCT02301169|7563870|FG000|COMPLETED|Overall Study||20
6295879|NCT03410992|7197586|FG005|STARTED|Initial Treatment Period: up to Wk16||0
6295880|NCT03410992|7197587|FG006|STARTED|Initial Treatment Period: up to Wk16||0
6295881|NCT03410992|7197588|FG007|STARTED|Initial Treatment Period: up to Wk16||0
6295882|NCT03410992|7197589|FG008|STARTED|Initial Treatment Period: up to Wk16||0
6295883|NCT03410992|7197590|FG009|STARTED|Initial Treatment Period: up to Wk16||0
6295884|NCT03410992|7197591|FG010|STARTED|Initial Treatment Period: up to Wk16||0
6295885|NCT03410992|7197581|FG000|COMPLETED|Initial Treatment Period: up to Wk16||82
6295886|NCT03410992|7197582|FG001|COMPLETED|Initial Treatment Period: up to Wk16||340
6295887|NCT03410992|7197583|FG002|COMPLETED|Initial Treatment Period: up to Wk16||0
6295888|NCT03410992|7197584|FG003|COMPLETED|Initial Treatment Period: up to Wk16||0
6295889|NCT03410992|7197585|FG004|COMPLETED|Initial Treatment Period: up to Wk16||0
6295890|NCT03410992|7197586|FG005|COMPLETED|Initial Treatment Period: up to Wk16||0
6295891|NCT03410992|7197587|FG006|COMPLETED|Initial Treatment Period: up to Wk16||0
6295892|NCT03410992|7197588|FG007|COMPLETED|Initial Treatment Period: up to Wk16||0
6295893|NCT03410992|7197589|FG008|COMPLETED|Initial Treatment Period: up to Wk16||0
6295894|NCT03410992|7197590|FG009|COMPLETED|Initial Treatment Period: up to Wk16||0
6295895|NCT03410992|7197591|FG010|COMPLETED|Initial Treatment Period: up to Wk16||0
6295896|NCT03410992|7197581|FG000|NOT COMPLETED|Initial Treatment Period: up to Wk16||4
6295897|NCT03410992|7197582|FG001|NOT COMPLETED|Initial Treatment Period: up to Wk16||9
6295898|NCT03410992|7197583|FG002|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295899|NCT03410992|7197584|FG003|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295900|NCT03410992|7197585|FG004|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295901|NCT03410992|7197586|FG005|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295902|NCT03410992|7197587|FG006|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295903|NCT03410992|7197588|FG007|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295904|NCT03410992|7197589|FG008|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295905|NCT03410992|7197590|FG009|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295906|NCT03410992|7197591|FG010|NOT COMPLETED|Initial Treatment Period: up to Wk16||0
6295907|NCT03410992|7197581|FG000|STARTED|Week 16 Assessment||82
6295908|NCT03410992|7197582|FG001|STARTED|Week 16 Assessment||340
6295909|NCT03410992|7197583|FG002|STARTED|Week 16 Assessment||0
6295910|NCT03410992|7197584|FG003|STARTED|Week 16 Assessment||0
6295911|NCT03410992|7197585|FG004|STARTED|Week 16 Assessment||0
6295912|NCT03410992|7197586|FG005|STARTED|Week 16 Assessment||0
6295913|NCT03410992|7197587|FG006|STARTED|Week 16 Assessment||0
6295914|NCT03410992|7197588|FG007|STARTED|Week 16 Assessment||0
6295915|NCT03410992|7197589|FG008|STARTED|Week 16 Assessment||0
6295916|NCT03410992|7197590|FG009|STARTED|Week 16 Assessment||0
6295917|NCT03410992|7197591|FG010|STARTED|Week 16 Assessment||0
6295918|NCT03410992|7197581|FG000|Received Escape Treatment|Week 16 Assessment||81
6295919|NCT03410992|7197582|FG001|Received Escape Treatment|Week 16 Assessment||23
6295920|NCT03410992|7197583|FG002|Received Escape Treatment|Week 16 Assessment||0
6295921|NCT03410992|7197584|FG003|Received Escape Treatment|Week 16 Assessment||0
6295922|NCT03410992|7197585|FG004|Received Escape Treatment|Week 16 Assessment||0
6295923|NCT03410992|7197586|FG005|Received Escape Treatment|Week 16 Assessment||0
6295924|NCT03410992|7197587|FG006|Received Escape Treatment|Week 16 Assessment||0
6295925|NCT03410992|7197588|FG007|Received Escape Treatment|Week 16 Assessment||0
6400815|NCT00888134|7313694|FG000|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
6400816|NCT00888134|7313694|FG000|NOT COMPLETED|Treatment With Study Drug||1
6400817|NCT00888134|7313694|FG000|STARTED|Follow-up||27
6400818|NCT00888134|7313694|FG000|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
6400819|NCT00888134|7313694|FG000|NOT COMPLETED|Follow-up||1
6400820|NCT00888173|7313699|FG000|STARTED|Overall Study||45
6635022|NCT02301169|7563871|FG001|COMPLETED|Overall Study||21
6635023|NCT02301169|7563870|FG000|NOT COMPLETED|Overall Study||1
6635024|NCT02301169|7563871|FG001|NOT COMPLETED|Overall Study||0
6295926|NCT03410992|7197589|FG008|Received Escape Treatment|Week 16 Assessment||0
6295927|NCT03410992|7197590|FG009|Received Escape Treatment|Week 16 Assessment||0
6295928|NCT03410992|7197591|FG010|Received Escape Treatment|Week 16 Assessment||0
6295929|NCT03410992|7197581|FG000|COMPLETED|Week 16 Assessment||1
6295930|NCT03410992|7197582|FG001|COMPLETED|Week 16 Assessment||311
6295931|NCT03410992|7197583|FG002|COMPLETED|Week 16 Assessment||0
6295932|NCT03410992|7197584|FG003|COMPLETED|Week 16 Assessment||0
6295933|NCT03410992|7197585|FG004|COMPLETED|Week 16 Assessment||0
6295934|NCT03410992|7197586|FG005|COMPLETED|Week 16 Assessment||0
6295935|NCT03410992|7197587|FG006|COMPLETED|Week 16 Assessment||0
6295936|NCT03410992|7197588|FG007|COMPLETED|Week 16 Assessment||0
6295937|NCT03410992|7197589|FG008|COMPLETED|Week 16 Assessment||0
6295938|NCT03410992|7197590|FG009|COMPLETED|Week 16 Assessment||0
6295939|NCT03410992|7197591|FG010|COMPLETED|Week 16 Assessment||0
6295940|NCT03410992|7197581|FG000|NOT COMPLETED|Week 16 Assessment||81
6295941|NCT03410992|7197582|FG001|NOT COMPLETED|Week 16 Assessment||29
6295942|NCT03410992|7197583|FG002|NOT COMPLETED|Week 16 Assessment||0
6295943|NCT03410992|7197584|FG003|NOT COMPLETED|Week 16 Assessment||0
6295944|NCT03410992|7197585|FG004|NOT COMPLETED|Week 16 Assessment||0
6295945|NCT03410992|7197586|FG005|NOT COMPLETED|Week 16 Assessment||0
6295946|NCT03410992|7197587|FG006|NOT COMPLETED|Week 16 Assessment||0
6295947|NCT03410992|7197588|FG007|NOT COMPLETED|Week 16 Assessment||0
6295948|NCT03410992|7197589|FG008|NOT COMPLETED|Week 16 Assessment||0
6295949|NCT03410992|7197590|FG009|NOT COMPLETED|Week 16 Assessment||0
6295950|NCT03410992|7197591|FG010|NOT COMPLETED|Week 16 Assessment||0
6295951|NCT03410992|7197581|FG000|STARTED|Randomized-Withdrawal Period: up to Wk56||0
6295952|NCT03410992|7197582|FG001|STARTED|Randomized-Withdrawal Period: up to Wk56||0
6295953|NCT03410992|7197583|FG002|STARTED|Randomized-Withdrawal Period: up to Wk56||1
6295954|NCT03410992|7197584|FG003|STARTED|Randomized-Withdrawal Period: up to Wk56||105
6295955|NCT03410992|7197585|FG004|STARTED|Randomized-Withdrawal Period: up to Wk56||100
6295956|NCT03410992|7197586|FG005|STARTED|Randomized-Withdrawal Period: up to Wk56||106
6295957|NCT03410992|7197587|FG006|STARTED|Randomized-Withdrawal Period: up to Wk56||0
6295958|NCT03410992|7197588|FG007|STARTED|Randomized-Withdrawal Period: up to Wk56||0
6295959|NCT03410992|7197589|FG008|STARTED|Randomized-Withdrawal Period: up to Wk56||0
6295960|NCT03410992|7197590|FG009|STARTED|Randomized-Withdrawal Period: up to Wk56||0
6295961|NCT03410992|7197591|FG010|STARTED|Randomized-Withdrawal Period: up to Wk56||0
6295962|NCT03410992|7197581|FG000|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
6295963|NCT03410992|7197582|FG001|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
6295964|NCT03410992|7197583|FG002|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
6295965|NCT03410992|7197584|FG003|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||67
6295966|NCT03410992|7197585|FG004|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||4
6295967|NCT03410992|7197586|FG005|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||7
6295968|NCT03410992|7197587|FG006|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
6295969|NCT03410992|7197588|FG007|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
6295970|NCT03410992|7197589|FG008|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
6295971|NCT03410992|7197590|FG009|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
6295972|NCT03410992|7197591|FG010|Received Escape Treatment|Randomized-Withdrawal Period: up to Wk56||0
6295973|NCT03410992|7197581|FG000|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295974|NCT03410992|7197582|FG001|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295975|NCT03410992|7197583|FG002|COMPLETED|Randomized-Withdrawal Period: up to Wk56||1
6295976|NCT03410992|7197584|FG003|COMPLETED|Randomized-Withdrawal Period: up to Wk56||33
6295977|NCT03410992|7197585|FG004|COMPLETED|Randomized-Withdrawal Period: up to Wk56||93
6295978|NCT03410992|7197586|FG005|COMPLETED|Randomized-Withdrawal Period: up to Wk56||94
6295979|NCT03410992|7197587|FG006|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295980|NCT03410992|7197588|FG007|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295981|NCT03410992|7197589|FG008|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295982|NCT03410992|7197590|FG009|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295983|NCT03410992|7197591|FG010|COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295984|NCT03410992|7197581|FG000|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295985|NCT03410992|7197582|FG001|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295986|NCT03410992|7197583|FG002|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295987|NCT03410992|7197584|FG003|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||72
6295988|NCT03410992|7197585|FG004|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||7
6295989|NCT03410992|7197586|FG005|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||12
6295990|NCT03410992|7197587|FG006|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295991|NCT03410992|7197588|FG007|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295992|NCT03410992|7197589|FG008|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295993|NCT03410992|7197590|FG009|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295994|NCT03410992|7197591|FG010|NOT COMPLETED|Randomized-Withdrawal Period: up to Wk56||0
6295995|NCT03410992|7197581|FG000|STARTED|Escape Treatment: 12 Weeks||0
6295996|NCT03410992|7197582|FG001|STARTED|Escape Treatment: 12 Weeks||0
6295997|NCT03410992|7197583|FG002|STARTED|Escape Treatment: 12 Weeks||0
6295998|NCT03410992|7197584|FG003|STARTED|Escape Treatment: 12 Weeks||0
6295999|NCT03410992|7197585|FG004|STARTED|Escape Treatment: 12 Weeks||0
6296000|NCT03410992|7197586|FG005|STARTED|Escape Treatment: 12 Weeks||0
6296001|NCT03410992|7197587|FG006|STARTED|Escape Treatment: 12 Weeks||81
6296002|NCT03410992|7197588|FG007|STARTED|Escape Treatment: 12 Weeks||23
6296003|NCT03410992|7197589|FG008|STARTED|Escape Treatment: 12 Weeks||67
6296004|NCT03410992|7197590|FG009|STARTED|Escape Treatment: 12 Weeks||4
6296005|NCT03410992|7197591|FG010|STARTED|Escape Treatment: 12 Weeks||7
6296006|NCT03410992|7197581|FG000|COMPLETED|Escape Treatment: 12 Weeks||0
6296007|NCT03410992|7197582|FG001|COMPLETED|Escape Treatment: 12 Weeks||0
6296008|NCT03410992|7197583|FG002|COMPLETED|Escape Treatment: 12 Weeks||0
6296009|NCT03410992|7197584|FG003|COMPLETED|Escape Treatment: 12 Weeks||0
6296010|NCT03410992|7197585|FG004|COMPLETED|Escape Treatment: 12 Weeks||0
6296011|NCT03410992|7197586|FG005|COMPLETED|Escape Treatment: 12 Weeks||0
6296012|NCT03410992|7197587|FG006|COMPLETED|Escape Treatment: 12 Weeks||81
6296013|NCT03410992|7197588|FG007|COMPLETED|Escape Treatment: 12 Weeks||22
6296014|NCT03410992|7197589|FG008|COMPLETED|Escape Treatment: 12 Weeks||66
6296015|NCT03410992|7197590|FG009|COMPLETED|Escape Treatment: 12 Weeks||4
6296016|NCT03410992|7197591|FG010|COMPLETED|Escape Treatment: 12 Weeks||7
6296017|NCT03410992|7197581|FG000|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296018|NCT03410992|7197582|FG001|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296019|NCT03410992|7197583|FG002|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296020|NCT03410992|7197584|FG003|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296021|NCT03410992|7197585|FG004|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296022|NCT03410992|7197586|FG005|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296023|NCT03410992|7197587|FG006|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296024|NCT03410992|7197588|FG007|NOT COMPLETED|Escape Treatment: 12 Weeks||1
6296025|NCT03410992|7197589|FG008|NOT COMPLETED|Escape Treatment: 12 Weeks||1
6296026|NCT03410992|7197590|FG009|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296027|NCT03410992|7197591|FG010|NOT COMPLETED|Escape Treatment: 12 Weeks||0
6296028|NCT03197935|7197623|FG000|STARTED|Overall Study||168
6296029|NCT03197935|7197624|FG001|STARTED|Overall Study||165
6296030|NCT03197935|7197623|FG000|COMPLETED|Overall Study||0
6296031|NCT03197935|7197624|FG001|COMPLETED|Overall Study||0
6296032|NCT03197935|7197623|FG000|NOT COMPLETED|Overall Study||168
6296033|NCT03197935|7197624|FG001|NOT COMPLETED|Overall Study||165
6296034|NCT03138096|7197636|FG000|STARTED|Overall Study||3
6296035|NCT03138096|7197637|FG001|STARTED|Overall Study||3
6296036|NCT03138096|7197638|FG002|STARTED|Overall Study||12
6296037|NCT03138096|7197639|FG003|STARTED|Overall Study||6
6296038|NCT03138096|7197640|FG004|STARTED|Overall Study|Phase 2 was not started because of unsufficient effectivity of the Pb(PfCS@UIS4) immunizations as pre-determined in the study protocol.|0
6296039|NCT03138096|7197636|FG000|COMPLETED|Overall Study||3
6296040|NCT03138096|7197637|FG001|COMPLETED|Overall Study||3
6296041|NCT03138096|7197638|FG002|COMPLETED|Overall Study||12
6296042|NCT03138096|7197639|FG003|COMPLETED|Overall Study||6
6296043|NCT03138096|7197640|FG004|COMPLETED|Overall Study||0
6296044|NCT03138096|7197636|FG000|NOT COMPLETED|Overall Study||0
6296045|NCT03138096|7197637|FG001|NOT COMPLETED|Overall Study||0
6296046|NCT03138096|7197638|FG002|NOT COMPLETED|Overall Study||0
6296047|NCT03138096|7197639|FG003|NOT COMPLETED|Overall Study||0
6296048|NCT03138096|7197640|FG004|NOT COMPLETED|Overall Study||0
6374363|NCT00750191|7285028|FG000|NOT COMPLETED|Overall Study||5
6374364|NCT00750191|7285029|FG001|NOT COMPLETED|Overall Study||10
6374365|NCT00750269|7285040|FG000|STARTED|Overall Study||8
6374366|NCT00750269|7285041|FG001|STARTED|Overall Study||8
6374367|NCT00750269|7285042|FG002|STARTED|Overall Study||18
6374368|NCT00750269|7285043|FG003|STARTED|Overall Study||43
6374369|NCT00750269|7285044|FG004|STARTED|Overall Study||43
6374370|NCT00750269|7285040|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
6374371|NCT00750269|7285041|FG001|COMPLETED|Overall Study||7
6400821|NCT00888173|7313699|FG000|COMPLETED|Overall Study||43
6400822|NCT00888173|7313699|FG000|NOT COMPLETED|Overall Study||2
6400823|NCT00888238|7313703|FG000|STARTED|First Period of Treatment Intervention||4
6400824|NCT00888238|7313704|FG001|STARTED|First Period of Treatment Intervention||4
6400825|NCT00888238|7313705|FG002|STARTED|First Period of Treatment Intervention||4
6400826|NCT00888238|7313703|FG000|COMPLETED|First Period of Treatment Intervention||4
6400827|NCT00888238|7313704|FG001|COMPLETED|First Period of Treatment Intervention||4
6400828|NCT00888238|7313705|FG002|COMPLETED|First Period of Treatment Intervention||4
6400829|NCT00888238|7313703|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
6400830|NCT00888238|7313704|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
6400831|NCT00888238|7313705|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
6400832|NCT00888238|7313703|FG000|STARTED|Washout Period After Period 1||4
6400833|NCT00888238|7313704|FG001|STARTED|Washout Period After Period 1||4
6400834|NCT00888238|7313705|FG002|STARTED|Washout Period After Period 1||4
6400835|NCT00888238|7313703|FG000|COMPLETED|Washout Period After Period 1||4
6374372|NCT00750269|7285042|FG002|COMPLETED|Overall Study||14
6374373|NCT00750269|7285043|FG003|COMPLETED|Overall Study||38
6374374|NCT00750269|7285044|FG004|COMPLETED|Overall Study||33
6374375|NCT00750269|7285040|FG000|NOT COMPLETED|Overall Study||0
6374376|NCT00750269|7285041|FG001|NOT COMPLETED|Overall Study||1
6374377|NCT00750269|7285042|FG002|NOT COMPLETED|Overall Study||4
6400836|NCT00888238|7313704|FG001|COMPLETED|Washout Period After Period 1||4
6400837|NCT00888238|7313705|FG002|COMPLETED|Washout Period After Period 1||4
6400838|NCT00888238|7313703|FG000|NOT COMPLETED|Washout Period After Period 1||0
6635025|NCT02301299|7563877|FG000|STARTED|Overall Study||1322
6635026|NCT02301299|7563877|FG000|COMPLETED|Overall Study||1322
6296049|NCT02678351|7197663|FG000|STARTED|Overall Study||74
6296050|NCT02678351|7197663|FG000|COMPLETED|Overall Study||73
6296051|NCT02678351|7197663|FG000|NOT COMPLETED|Overall Study||1
6296052|NCT02578732|7197667|FG000|STARTED|Overall Study||28
6296053|NCT02578732|7197667|FG000|COMPLETED|Overall Study||28
6296054|NCT02578732|7197667|FG000|NOT COMPLETED|Overall Study||0
6296055|NCT02272790|7197677|FG000|STARTED|Overall Study||9
6296056|NCT02272790|7197678|FG001|STARTED|Overall Study||39
6296057|NCT02272790|7197679|FG002|STARTED|Overall Study||23
6296058|NCT02272790|7197680|FG003|STARTED|Overall Study||12
6296059|NCT02272790|7197681|FG004|STARTED|Overall Study||6
6296060|NCT02272790|7197682|FG005|STARTED|Overall Study||6
6296061|NCT02272790|7197677|FG000|COMPLETED|Overall Study||9
6296062|NCT02272790|7197678|FG001|COMPLETED|Overall Study||38
6296063|NCT02272790|7197679|FG002|COMPLETED|Overall Study||23
6296064|NCT02272790|7197680|FG003|COMPLETED|Overall Study||12
6296065|NCT02272790|7197681|FG004|COMPLETED|Overall Study||6
6296066|NCT02272790|7197682|FG005|COMPLETED|Overall Study||6
6296067|NCT02272790|7197677|FG000|NOT COMPLETED|Overall Study||0
6296068|NCT02272790|7197678|FG001|NOT COMPLETED|Overall Study||1
6296069|NCT02272790|7197679|FG002|NOT COMPLETED|Overall Study||0
6296070|NCT02272790|7197680|FG003|NOT COMPLETED|Overall Study||0
6296071|NCT02272790|7197681|FG004|NOT COMPLETED|Overall Study||0
6296072|NCT02272790|7197682|FG005|NOT COMPLETED|Overall Study||0
6296073|NCT01961531|7197702|FG000|STARTED|Overall Study||40
6296074|NCT01961531|7197702|FG000|COMPLETED|Overall Study||40
6296075|NCT01961531|7197702|FG000|NOT COMPLETED|Overall Study||0
6296076|NCT01880541|7197708|FG000|STARTED|Overall Study||10
6296077|NCT01880541|7197709|FG001|STARTED|Overall Study||20
6296078|NCT01880541|7197708|FG000|COMPLETED|Overall Study||10
6296079|NCT01880541|7197709|FG001|COMPLETED|Overall Study||20
6296080|NCT01880541|7197708|FG000|NOT COMPLETED|Overall Study||0
6296081|NCT01880541|7197709|FG001|NOT COMPLETED|Overall Study||0
6296082|NCT01693692|7197718|FG000|STARTED|Overall Study||130
6296083|NCT01693692|7197719|FG001|STARTED|Overall Study||131
6296084|NCT01693692|7197720|FG002|STARTED|Overall Study||131
6296085|NCT01693692|7197718|FG000|Received Study Drug|Overall Study||128
6296086|NCT01693692|7197719|FG001|Received Study Drug|Overall Study||127
6296087|NCT01693692|7197720|FG002|Received Study Drug|Overall Study||128
6296088|NCT01693692|7197718|FG000|COMPLETED|Overall Study||100
6296089|NCT01693692|7197719|FG001|COMPLETED|Overall Study||97
6296090|NCT01693692|7197720|FG002|COMPLETED|Overall Study||95
6296091|NCT01693692|7197718|FG000|NOT COMPLETED|Overall Study||30
6296092|NCT01693692|7197719|FG001|NOT COMPLETED|Overall Study||34
6296093|NCT01693692|7197720|FG002|NOT COMPLETED|Overall Study||36
6296094|NCT01685606|7197728|FG000|STARTED|Overall Study||6
6296095|NCT01685606|7197728|FG000|COMPLETED|Overall Study||5
6296096|NCT01685606|7197728|FG000|NOT COMPLETED|Overall Study||1
6296097|NCT01650350|7197732|FG000|STARTED|Overall Study||7
6296098|NCT01650350|7197732|FG000|COMPLETED|Overall Study||7
6296099|NCT01650350|7197732|FG000|NOT COMPLETED|Overall Study||0
6296100|NCT01650285|7197738|FG000|STARTED|Overall Study||5
6296101|NCT01650285|7197738|FG000|COMPLETED|Overall Study||4
6296102|NCT01650285|7197738|FG000|NOT COMPLETED|Overall Study||1
6296103|NCT01083771|7197742|FG000|STARTED|Overall Study||21
6296104|NCT01083771|7197742|FG000|COMPLETED|Overall Study||16
6296105|NCT01083771|7197742|FG000|NOT COMPLETED|Overall Study||5
6296106|NCT00743197|7197748|FG000|STARTED|Overall Study||1
6296107|NCT00743197|7197749|FG001|STARTED|Overall Study||2
6296108|NCT00743197|7197748|FG000|COMPLETED|Overall Study||0
6296109|NCT00743197|7197749|FG001|COMPLETED|Overall Study||0
6296110|NCT00743197|7197748|FG000|NOT COMPLETED|Overall Study||1
6296111|NCT00743197|7197749|FG001|NOT COMPLETED|Overall Study||2
6296112|NCT00304915|7197757|FG000|STARTED|Overall Study||123
6296113|NCT00304915|7197758|FG001|STARTED|Overall Study||126
6296114|NCT00304915|7197757|FG000|COMPLETED|Overall Study||105
6296115|NCT00304915|7197758|FG001|COMPLETED|Overall Study||110
6296116|NCT00304915|7197757|FG000|NOT COMPLETED|Overall Study||18
6296117|NCT00304915|7197758|FG001|NOT COMPLETED|Overall Study||16
6296118|NCT00304954|7197768|FG000|STARTED|Overall Study||4
6296119|NCT00304954|7197769|FG001|STARTED|Overall Study||3
6296120|NCT00304954|7197770|FG002|STARTED|Overall Study||3
6296121|NCT00304954|7197771|FG003|STARTED|Overall Study||3
6296122|NCT00304954|7197768|FG000|COMPLETED|Overall Study||3
6296123|NCT00304954|7197769|FG001|COMPLETED|Overall Study||3
6296124|NCT00304954|7197770|FG002|COMPLETED|Overall Study||2
6296125|NCT00304954|7197771|FG003|COMPLETED|Overall Study||3
6296126|NCT00304954|7197768|FG000|NOT COMPLETED|Overall Study||1
6296127|NCT00304954|7197769|FG001|NOT COMPLETED|Overall Study||0
6296128|NCT00304954|7197770|FG002|NOT COMPLETED|Overall Study||1
6296129|NCT00304954|7197771|FG003|NOT COMPLETED|Overall Study||0
6296130|NCT00305006|7197791|FG000|STARTED|Overall Study||22
6296131|NCT00305006|7197792|FG001|STARTED|Overall Study||22
6296132|NCT00305006|7197791|FG000|COMPLETED|Overall Study||21
6296133|NCT00305006|7197792|FG001|COMPLETED|Overall Study||21
6296134|NCT00305006|7197791|FG000|NOT COMPLETED|Overall Study||1
6296135|NCT00305006|7197792|FG001|NOT COMPLETED|Overall Study||1
6296136|NCT00305058|7197800|FG000|STARTED|Overall Study||97
6296137|NCT00305058|7197801|FG001|STARTED|Overall Study||97
6296138|NCT00305058|7197800|FG000|Inclusion/Exclusion Verification|Overall Study||96
6635027|NCT02301299|7563877|FG000|NOT COMPLETED|Overall Study||0
6296139|NCT00305058|7197801|FG001|Inclusion/Exclusion Verification|Overall Study||97
6400839|NCT00888238|7313704|FG001|NOT COMPLETED|Washout Period After Period 1||0
6400840|NCT00888238|7313705|FG002|NOT COMPLETED|Washout Period After Period 1||0
6400841|NCT00888238|7313703|FG000|STARTED|Second Period of Treatment Intervention||4
6400842|NCT00888238|7313704|FG001|STARTED|Second Period of Treatment Intervention||4
6400843|NCT00888238|7313705|FG002|STARTED|Second Period of Treatment Intervention||4
6400844|NCT00888238|7313703|FG000|COMPLETED|Second Period of Treatment Intervention||4
6296140|NCT00305058|7197800|FG000|All Outcome Data Collected|Overall Study||93
6296141|NCT00305058|7197801|FG001|All Outcome Data Collected|Overall Study||95
6296142|NCT00305058|7197800|FG000|Data Collection Forms Filed for Analysis|Overall Study||90
6296143|NCT00305058|7197801|FG001|Data Collection Forms Filed for Analysis|Overall Study||93
6296144|NCT00305058|7197800|FG000|COMPLETED|Overall Study||90
6296145|NCT00305058|7197801|FG001|COMPLETED|Overall Study||93
6296146|NCT00305058|7197800|FG000|NOT COMPLETED|Overall Study||7
6296147|NCT00305058|7197801|FG001|NOT COMPLETED|Overall Study||4
6296148|NCT00305084|7197812|FG000|STARTED|Overall Study||3
6296149|NCT00305084|7197813|FG001|STARTED|Overall Study||3
6296150|NCT00305084|7197814|FG002|STARTED|Overall Study||3
6400845|NCT00888238|7313704|FG001|COMPLETED|Second Period of Treatment Intervention||4
6400846|NCT00888238|7313705|FG002|COMPLETED|Second Period of Treatment Intervention||4
6400847|NCT00888238|7313703|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
6400848|NCT00888238|7313704|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
6400849|NCT00888238|7313705|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
6400850|NCT00888238|7313703|FG000|STARTED|Washout Period After Period 2||4
6400851|NCT00888238|7313704|FG001|STARTED|Washout Period After Period 2||4
6400852|NCT00888238|7313705|FG002|STARTED|Washout Period After Period 2||4
6400853|NCT00888238|7313703|FG000|COMPLETED|Washout Period After Period 2||4
6400854|NCT00888238|7313704|FG001|COMPLETED|Washout Period After Period 2||4
6400855|NCT00888238|7313705|FG002|COMPLETED|Washout Period After Period 2||3
6400856|NCT00888238|7313703|FG000|NOT COMPLETED|Washout Period After Period 2||0
6296151|NCT00305084|7197815|FG003|STARTED|Overall Study||3
6296152|NCT00305084|7197816|FG004|STARTED|Overall Study||3
6296153|NCT00305084|7197812|FG000|COMPLETED|Overall Study||3
6296154|NCT00305084|7197813|FG001|COMPLETED|Overall Study||3
6296155|NCT00305084|7197814|FG002|COMPLETED|Overall Study||3
6296156|NCT00305084|7197815|FG003|COMPLETED|Overall Study||3
6296157|NCT00305084|7197816|FG004|COMPLETED|Overall Study||3
6296158|NCT00305084|7197812|FG000|NOT COMPLETED|Overall Study||0
6296159|NCT00305084|7197813|FG001|NOT COMPLETED|Overall Study||0
6296160|NCT00305084|7197814|FG002|NOT COMPLETED|Overall Study||0
6296161|NCT00305084|7197815|FG003|NOT COMPLETED|Overall Study||0
6296162|NCT00305084|7197816|FG004|NOT COMPLETED|Overall Study||0
6296163|NCT00305110|7197856|FG000|STARTED|Overall Study||298
6296164|NCT00305110|7197856|FG000|All Necessary Data Collected|Overall Study||269
6296165|NCT00305110|7197856|FG000|COMPLETED|Overall Study||269
6296166|NCT00305110|7197856|FG000|NOT COMPLETED|Overall Study||29
6296167|NCT00305162|7197862|FG000|STARTED|48 Hour Follow-up Period||4435
6296168|NCT00305162|7197863|FG001|STARTED|48 Hour Follow-up Period||4447
6296169|NCT00305162|7197862|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
6296170|NCT00305162|7197863|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
6296171|NCT00305162|7197862|FG000|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
6296172|NCT00305162|7197863|FG001|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
6296173|NCT00305162|7197862|FG000|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
6296174|NCT00305162|7197863|FG001|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
6296175|NCT00305162|7197862|FG000|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
6296176|NCT00305162|7197863|FG001|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
6296177|NCT00305162|7197862|FG000|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
6296178|NCT00305162|7197863|FG001|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
6296179|NCT00305162|7197862|FG000|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
6296180|NCT00305162|7197863|FG001|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
6296181|NCT00305162|7197862|FG000|NOT COMPLETED|48 Hour Follow-up Period||20
6296182|NCT00305162|7197863|FG001|NOT COMPLETED|48 Hour Follow-up Period||16
6296183|NCT00305162|7197862|FG000|STARTED|30-day Follow-up Period||4435
6296184|NCT00305162|7197863|FG001|STARTED|30-day Follow-up Period||4447
6296185|NCT00305162|7197862|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
6296186|NCT00305162|7197863|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
6374378|NCT00750269|7285043|FG003|NOT COMPLETED|Overall Study||5
6400857|NCT00888238|7313704|FG001|NOT COMPLETED|Washout Period After Period 2||0
6400858|NCT00888238|7313705|FG002|NOT COMPLETED|Washout Period After Period 2||1
6400859|NCT00888238|7313703|FG000|STARTED|Third Period of Treatment Intervention||4
6400860|NCT00888238|7313704|FG001|STARTED|Third Period of Treatment Intervention||4
6296187|NCT00305162|7197862|FG000|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
6296188|NCT00305162|7197863|FG001|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
6296189|NCT00305162|7197862|FG000|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
6296190|NCT00305162|7197863|FG001|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
6296191|NCT00305162|7197862|FG000|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
6296192|NCT00305162|7197863|FG001|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
6296193|NCT00305162|7197862|FG000|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
6296194|NCT00305162|7197863|FG001|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
6296195|NCT00305162|7197862|FG000|NOT COMPLETED|30-day Follow-up Period||62
6296196|NCT00305162|7197863|FG001|NOT COMPLETED|30-day Follow-up Period||63
6296197|NCT00305162|7197862|FG000|STARTED|1 Year Follow-up Period||4435
6296198|NCT00305162|7197863|FG001|STARTED|1 Year Follow-up Period||4447
6296199|NCT00305162|7197862|FG000|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
6296200|NCT00305162|7197863|FG001|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
6296201|NCT00305162|7197862|FG000|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
6296202|NCT00305162|7197863|FG001|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
6296203|NCT00305162|7197862|FG000|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
6296204|NCT00305162|7197863|FG001|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
6296205|NCT00305162|7197862|FG000|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
6296206|NCT00305162|7197863|FG001|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
6296207|NCT00305162|7197862|FG000|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
6296208|NCT00305162|7197863|FG001|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
6296209|NCT00305162|7197862|FG000|NOT COMPLETED|1 Year Follow-up Period||55
6296210|NCT00305162|7197863|FG001|NOT COMPLETED|1 Year Follow-up Period||65
6296211|NCT00305227|7197872|FG000|STARTED|Overall Study||50
6296212|NCT00305227|7197873|FG001|STARTED|Overall Study||50
6296213|NCT00305227|7197872|FG000|COMPLETED|Overall Study|with at least 8 weeks of observation|43
6296214|NCT00305227|7197873|FG001|COMPLETED|Overall Study|with at least 8 weeks of observation|44
6296215|NCT00305227|7197872|FG000|NOT COMPLETED|Overall Study||7
6296216|NCT00305227|7197873|FG001|NOT COMPLETED|Overall Study||6
6296217|NCT00305253|7197881|FG000|STARTED|Overall Study||432
6296218|NCT00305253|7197882|FG001|STARTED|Overall Study||559
6296219|NCT00305253|7197881|FG000|COMPLETED|Overall Study||432
6296220|NCT00305253|7197882|FG001|COMPLETED|Overall Study||558
6296221|NCT00305253|7197881|FG000|NOT COMPLETED|Overall Study||0
6296222|NCT00305253|7197882|FG001|NOT COMPLETED|Overall Study||1
6296223|NCT00305448|7197891|FG000|STARTED|Overall Study||45
6296224|NCT00305448|7197892|FG001|STARTED|Overall Study||51
6296225|NCT00305448|7197893|FG002|STARTED|Overall Study||47
6296226|NCT00305448|7197891|FG000|COMPLETED|Overall Study||14
6296227|NCT00305448|7197892|FG001|COMPLETED|Overall Study||17
6296228|NCT00305448|7197893|FG002|COMPLETED|Overall Study||14
6296229|NCT00305448|7197891|FG000|NOT COMPLETED|Overall Study||31
6296230|NCT00305448|7197892|FG001|NOT COMPLETED|Overall Study||34
6296231|NCT00305448|7197893|FG002|NOT COMPLETED|Overall Study||33
6296232|NCT00305565|7197905|FG000|STARTED|Overall Study (Safety Population)||111
6296233|NCT00305565|7197906|FG001|STARTED|Overall Study (Safety Population)||107
6296234|NCT00305565|7197907|FG002|STARTED|Overall Study (Safety Population)||113
6296235|NCT00305565|7197905|FG000|COMPLETED|Overall Study (Safety Population)||97
6296236|NCT00305565|7197906|FG001|COMPLETED|Overall Study (Safety Population)||95
6296237|NCT00305565|7197907|FG002|COMPLETED|Overall Study (Safety Population)||106
6296238|NCT00305565|7197905|FG000|NOT COMPLETED|Overall Study (Safety Population)||14
6296239|NCT00305565|7197906|FG001|NOT COMPLETED|Overall Study (Safety Population)||12
6296240|NCT00305565|7197907|FG002|NOT COMPLETED|Overall Study (Safety Population)||7
6296241|NCT00305565|7197905|FG000|STARTED|Overall Study (ITT Population)||102
6296242|NCT00305565|7197906|FG001|STARTED|Overall Study (ITT Population)||101
6296243|NCT00305565|7197907|FG002|STARTED|Overall Study (ITT Population)||107
6296244|NCT00305565|7197905|FG000|COMPLETED|Overall Study (ITT Population)||89
6296245|NCT00305565|7197906|FG001|COMPLETED|Overall Study (ITT Population)||90
6296246|NCT00305565|7197907|FG002|COMPLETED|Overall Study (ITT Population)||102
6296247|NCT00305565|7197905|FG000|NOT COMPLETED|Overall Study (ITT Population)||13
6296248|NCT00305565|7197906|FG001|NOT COMPLETED|Overall Study (ITT Population)||11
6296249|NCT00305565|7197907|FG002|NOT COMPLETED|Overall Study (ITT Population)||5
6296250|NCT00305578|7197918|FG000|STARTED|Overall Study||15
6296251|NCT00305578|7197919|FG001|STARTED|Overall Study||14
6296252|NCT00305578|7197918|FG000|COMPLETED|Overall Study||12
6296253|NCT00305578|7197919|FG001|COMPLETED|Overall Study||12
6296254|NCT00305578|7197918|FG000|NOT COMPLETED|Overall Study||3
6635028|NCT02301364|7563884|FG000|STARTED|Overall Study||4
6635029|NCT02301364|7563884|FG000|COMPLETED|Overall Study||4
6635030|NCT02301364|7563884|FG000|NOT COMPLETED|Overall Study||0
6296255|NCT00305578|7197919|FG001|NOT COMPLETED|Overall Study||2
6296256|NCT00305604|7197927|FG000|STARTED|Overall Study||102
6296257|NCT00305604|7197928|FG001|STARTED|Overall Study||104
6296258|NCT00305604|7197927|FG000|COMPLETED|Overall Study||70
6296259|NCT00305604|7197928|FG001|COMPLETED|Overall Study||57
6296260|NCT00305604|7197927|FG000|NOT COMPLETED|Overall Study||32
6296261|NCT00305604|7197928|FG001|NOT COMPLETED|Overall Study||47
6296262|NCT00305682|7197940|FG000|STARTED|Overall Study||98
6296263|NCT00305682|7197941|FG001|STARTED|Overall Study||71
6296264|NCT00305682|7197942|FG002|STARTED|Overall Study||7
6296265|NCT00305682|7197943|FG003|STARTED|Overall Study||34
6296266|NCT00305682|7197944|FG004|STARTED|Overall Study||39
6296267|NCT00305682|7197945|FG005|STARTED|Overall Study||35
6296268|NCT00305682|7197940|FG000|COMPLETED|Overall Study||98
6296269|NCT00305682|7197941|FG001|COMPLETED|Overall Study||71
6296270|NCT00305682|7197942|FG002|COMPLETED|Overall Study||7
6296271|NCT00305682|7197943|FG003|COMPLETED|Overall Study||34
6296272|NCT00305682|7197944|FG004|COMPLETED|Overall Study||39
6296273|NCT00305682|7197945|FG005|COMPLETED|Overall Study||35
6296274|NCT00305682|7197940|FG000|NOT COMPLETED|Overall Study||0
6296275|NCT00305682|7197941|FG001|NOT COMPLETED|Overall Study||0
6296276|NCT00305682|7197942|FG002|NOT COMPLETED|Overall Study||0
6296277|NCT00305682|7197943|FG003|NOT COMPLETED|Overall Study||0
6296278|NCT00305682|7197944|FG004|NOT COMPLETED|Overall Study||0
6296279|NCT00305682|7197945|FG005|NOT COMPLETED|Overall Study||0
6296280|NCT00305695|7197961|FG000|STARTED|Overall Study||81
6296281|NCT00305695|7197962|FG001|STARTED|Overall Study||79
6296282|NCT00305695|7197961|FG000|COMPLETED|Overall Study||40
6296283|NCT00305695|7197962|FG001|COMPLETED|Overall Study||52
6296284|NCT00305695|7197961|FG000|NOT COMPLETED|Overall Study||41
6296285|NCT00305695|7197962|FG001|NOT COMPLETED|Overall Study||27
6296286|NCT00305760|7197968|FG000|STARTED|Overall Study||60
6296287|NCT00305760|7197968|FG000|COMPLETED|Overall Study||13
6296288|NCT00305760|7197968|FG000|NOT COMPLETED|Overall Study||47
6296289|NCT00305773|7197974|FG000|STARTED|Overall Study||15
6296290|NCT00305773|7197975|FG001|STARTED|Overall Study||22
6296291|NCT00305773|7197974|FG000|COMPLETED|Overall Study||1
6296292|NCT00305773|7197975|FG001|COMPLETED|Overall Study||4
6296293|NCT00305773|7197974|FG000|NOT COMPLETED|Overall Study||14
6296294|NCT00305773|7197975|FG001|NOT COMPLETED|Overall Study||18
6296295|NCT00305864|7197985|FG000|STARTED|Overall Study||7
6296296|NCT00305864|7197986|FG001|STARTED|Overall Study||10
6296297|NCT00305864|7197987|FG002|STARTED|Overall Study||7
6296298|NCT00305864|7197988|FG003|STARTED|Overall Study||94
6296299|NCT00305864|7197985|FG000|COMPLETED|Overall Study||7
6296300|NCT00305864|7197986|FG001|COMPLETED|Overall Study||9
6296301|NCT00305864|7197987|FG002|COMPLETED|Overall Study||6
6296302|NCT00305864|7197988|FG003|COMPLETED|Overall Study||81
6296303|NCT00305864|7197985|FG000|NOT COMPLETED|Overall Study||0
6296304|NCT00305864|7197986|FG001|NOT COMPLETED|Overall Study||1
6296305|NCT00305864|7197987|FG002|NOT COMPLETED|Overall Study||1
6296306|NCT00305864|7197988|FG003|NOT COMPLETED|Overall Study||13
6296307|NCT00305877|7198000|FG000|STARTED|Overall Study||69
6296308|NCT00305877|7198001|FG001|STARTED|Overall Study||68
6296309|NCT00305877|7198000|FG000|Treated|Overall Study||67
6296310|NCT00305877|7198001|FG001|Treated|Overall Study||63
6296311|NCT00305877|7198000|FG000|Eligible|Overall Study||66
6296312|NCT00305877|7198001|FG001|Eligible|Overall Study||66
6296313|NCT00305877|7198000|FG000|Included in Efficacy Analysis|Overall Study||65
6296314|NCT00305877|7198001|FG001|Included in Efficacy Analysis|Overall Study||62
6296315|NCT00305877|7198000|FG000|COMPLETED|Overall Study||45
6296316|NCT00305877|7198001|FG001|COMPLETED|Overall Study||34
6296317|NCT00305877|7198000|FG000|NOT COMPLETED|Overall Study||24
6296318|NCT00305877|7198001|FG001|NOT COMPLETED|Overall Study||34
6296319|NCT00305942|7198007|FG000|STARTED|Overall Study||61
6296320|NCT00305942|7198007|FG000|COMPLETED|Overall Study||23
6296321|NCT00305942|7198007|FG000|NOT COMPLETED|Overall Study||38
6296322|NCT00306163|7198013|FG000|STARTED|Overall Study||19
6400861|NCT00888238|7313705|FG002|STARTED|Third Period of Treatment Intervention||3
6400862|NCT00888238|7313703|FG000|COMPLETED|Third Period of Treatment Intervention||4
6400863|NCT00888238|7313704|FG001|COMPLETED|Third Period of Treatment Intervention||4
6400864|NCT00888238|7313705|FG002|COMPLETED|Third Period of Treatment Intervention||3
6400865|NCT00888238|7313703|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
6400866|NCT00888238|7313704|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
6400867|NCT00888238|7313705|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
6400868|NCT00888329|7313713|FG000|STARTED|Overall Study||125
6400869|NCT00888329|7313714|FG001|STARTED|Overall Study||131
6400870|NCT00888329|7313713|FG000|COMPLETED|Overall Study||119
6400871|NCT00888329|7313714|FG001|COMPLETED|Overall Study||122
6400872|NCT00888329|7313713|FG000|NOT COMPLETED|Overall Study||6
6400873|NCT00888329|7313714|FG001|NOT COMPLETED|Overall Study||9
6400874|NCT00888381|7313722|FG000|STARTED|Overall Study||60
6400875|NCT00888381|7313723|FG001|STARTED|Overall Study||60
6400876|NCT00888381|7313722|FG000|COMPLETED|Overall Study||60
6400877|NCT00888381|7313723|FG001|COMPLETED|Overall Study||59
6400878|NCT00888381|7313722|FG000|NOT COMPLETED|Overall Study||0
6296323|NCT00306163|7198014|FG001|STARTED|Overall Study||18
6296324|NCT00306163|7198013|FG000|COMPLETED|Overall Study||19
6296325|NCT00306163|7198014|FG001|COMPLETED|Overall Study||18
6296326|NCT00306163|7198013|FG000|NOT COMPLETED|Overall Study||0
6296327|NCT00306163|7198014|FG001|NOT COMPLETED|Overall Study||0
6296328|NCT00306189|7198024|FG000|STARTED|Overall Study||57
6296329|NCT00306189|7198025|FG001|STARTED|Overall Study||56
6296330|NCT00306189|7198026|FG002|STARTED|Overall Study||56
6296331|NCT00306189|7198027|FG003|STARTED|Overall Study||57
6296332|NCT00306189|7198024|FG000|COMPLETED|Overall Study||48
6296333|NCT00306189|7198025|FG001|COMPLETED|Overall Study||50
6296334|NCT00306189|7198026|FG002|COMPLETED|Overall Study||45
6296335|NCT00306189|7198027|FG003|COMPLETED|Overall Study||52
6296336|NCT00306189|7198024|FG000|NOT COMPLETED|Overall Study||9
6296337|NCT00306189|7198025|FG001|NOT COMPLETED|Overall Study||6
6296338|NCT00306189|7198026|FG002|NOT COMPLETED|Overall Study||11
6296339|NCT00306189|7198027|FG003|NOT COMPLETED|Overall Study||5
6296340|NCT00306202|7198040|FG000|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
6296341|NCT00306202|7198041|FG001|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
6296342|NCT00306202|7198042|FG002|STARTED|Overall Study|Started = Treated. 25 were enrolled; 1 no longer met study criteria and was never treated|24
6296343|NCT00306202|7198040|FG000|COMPLETED|Overall Study|Completed = Off-treatment|17
6296344|NCT00306202|7198041|FG001|COMPLETED|Overall Study|Completed = Off-treatment|17
6296345|NCT00306202|7198042|FG002|COMPLETED|Overall Study|Completed = Off-treatment|24
6296346|NCT00306202|7198040|FG000|NOT COMPLETED|Overall Study||0
6296347|NCT00306202|7198041|FG001|NOT COMPLETED|Overall Study||0
6296348|NCT00306202|7198042|FG002|NOT COMPLETED|Overall Study||0
6296349|NCT00306293|7198088|FG000|STARTED|Period 1 (Day 1 to Day 60)||35
6296350|NCT00306293|7198089|FG001|STARTED|Period 1 (Day 1 to Day 60)||35
6296351|NCT00306293|7198088|FG000|COMPLETED|Period 1 (Day 1 to Day 60)||27
6296352|NCT00306293|7198089|FG001|COMPLETED|Period 1 (Day 1 to Day 60)||27
6296353|NCT00306293|7198088|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
6296354|NCT00306293|7198089|FG001|NOT COMPLETED|Period 1 (Day 1 to Day 60)||8
6296355|NCT00306293|7198088|FG000|STARTED|Washout (Day 61 to Day 66)||27
6296356|NCT00306293|7198089|FG001|STARTED|Washout (Day 61 to Day 66)||27
6296357|NCT00306293|7198088|FG000|COMPLETED|Washout (Day 61 to Day 66)||27
6296358|NCT00306293|7198089|FG001|COMPLETED|Washout (Day 61 to Day 66)||27
6296359|NCT00306293|7198088|FG000|NOT COMPLETED|Washout (Day 61 to Day 66)||0
6296360|NCT00306293|7198089|FG001|NOT COMPLETED|Washout (Day 61 to Day 66)||0
6296361|NCT00306293|7198088|FG000|STARTED|Period 2 (Day 67 to Day 126 )||27
6296362|NCT00306293|7198089|FG001|STARTED|Period 2 (Day 67 to Day 126 )||27
6296363|NCT00306293|7198088|FG000|COMPLETED|Period 2 (Day 67 to Day 126 )||24
6296364|NCT00306293|7198089|FG001|COMPLETED|Period 2 (Day 67 to Day 126 )||26
6296365|NCT00306293|7198088|FG000|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||3
6296366|NCT00306293|7198089|FG001|NOT COMPLETED|Period 2 (Day 67 to Day 126 )||1
6296367|NCT00306384|7198100|FG000|STARTED|Overall Study||1396
6296368|NCT00306384|7198101|FG001|STARTED|Overall Study||1399
6296369|NCT00306384|7198102|FG002|STARTED|Overall Study||528
6296370|NCT00306384|7198100|FG000|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
6296371|NCT00306384|7198101|FG001|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
6296372|NCT00306384|7198102|FG002|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
6296373|NCT00306384|7198100|FG000|COMPLETED|Overall Study||854
6296374|NCT00306384|7198101|FG001|COMPLETED|Overall Study||891
6296375|NCT00306384|7198102|FG002|COMPLETED|Overall Study||251
6296376|NCT00306384|7198100|FG000|NOT COMPLETED|Overall Study||542
6296377|NCT00306384|7198101|FG001|NOT COMPLETED|Overall Study||508
6296378|NCT00306384|7198102|FG002|NOT COMPLETED|Overall Study||277
6296379|NCT00306488|7198110|FG000|STARTED|Overall Study||11
6296380|NCT00306488|7198110|FG000|COMPLETED|Overall Study||10
6296381|NCT00306488|7198110|FG000|NOT COMPLETED|Overall Study||1
6296382|NCT00306527|7198119|FG000|STARTED|Overall Study||533
6296383|NCT00306527|7198120|FG001|STARTED|Overall Study||534
6635031|NCT02301377|7563890|FG000|STARTED|Overall Study||3
6635032|NCT02301377|7563891|FG001|STARTED|Overall Study||2
6635033|NCT02301377|7563890|FG000|COMPLETED|Overall Study||3
6635034|NCT02301377|7563891|FG001|COMPLETED|Overall Study||2
6635035|NCT02301377|7563890|FG000|NOT COMPLETED|Overall Study||0
6635036|NCT02301377|7563891|FG001|NOT COMPLETED|Overall Study||0
6635037|NCT02301390|7563899|FG000|STARTED|Overall Study||27
6635038|NCT02301390|7563900|FG001|STARTED|Overall Study||26
6635039|NCT02301390|7563899|FG000|COMPLETED|Overall Study||17
6296384|NCT00306527|7198121|FG002|STARTED|Overall Study||572
6296385|NCT00306527|7198122|FG003|STARTED|Overall Study||596
6296386|NCT00306527|7198119|FG000|COMPLETED|Overall Study||527
6296387|NCT00306527|7198120|FG001|COMPLETED|Overall Study||527
6296388|NCT00306527|7198121|FG002|COMPLETED|Overall Study|3 of 4 deaths in the elderly subjects resulted in premature discontinuation. Refer to OM2 .|567
6296389|NCT00306527|7198122|FG003|COMPLETED|Overall Study||590
6296390|NCT00306527|7198119|FG000|NOT COMPLETED|Overall Study||6
6296391|NCT00306527|7198120|FG001|NOT COMPLETED|Overall Study||7
6296392|NCT00306527|7198121|FG002|NOT COMPLETED|Overall Study||5
6296393|NCT00306527|7198122|FG003|NOT COMPLETED|Overall Study||6
6635040|NCT02301390|7563900|FG001|COMPLETED|Overall Study||13
6635041|NCT02301390|7563899|FG000|NOT COMPLETED|Overall Study||10
6635042|NCT02301390|7563900|FG001|NOT COMPLETED|Overall Study||13
6635043|NCT02301403|7563908|FG000|STARTED|Overall Study||315
6296394|NCT00306592|7198136|FG000|STARTED|Overall Study||404
6296395|NCT00306592|7198137|FG001|STARTED|Overall Study||690
6296396|NCT00306592|7198136|FG000|Completed at 24 Weeks|Overall Study||207
6400879|NCT00888381|7313723|FG001|NOT COMPLETED|Overall Study||1
6400880|NCT00888433|7313731|FG000|STARTED|Overall Study||52
6400881|NCT00888433|7313732|FG001|STARTED|Overall Study||54
6296397|NCT00306592|7198137|FG001|Completed at 24 Weeks|Overall Study||0
6296398|NCT00306592|7198136|FG000|Completed Between 24 and 48 Weeks|Overall Study||85
6296399|NCT00306592|7198137|FG001|Completed Between 24 and 48 Weeks|Overall Study||0
6400882|NCT00888433|7313731|FG000|COMPLETED|Overall Study||49
6400883|NCT00888433|7313732|FG001|COMPLETED|Overall Study||51
6400884|NCT00888433|7313731|FG000|NOT COMPLETED|Overall Study||3
6400885|NCT00888433|7313732|FG001|NOT COMPLETED|Overall Study||3
6296400|NCT00306592|7198136|FG000|Completed at 48 Weeks|Overall Study||81
6296401|NCT00306592|7198137|FG001|Completed at 48 Weeks|Overall Study||632
6296402|NCT00306592|7198136|FG000|Entered 101-MS-321 Extension Study|Overall Study||22
6296403|NCT00306592|7198137|FG001|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
6296404|NCT00306592|7198136|FG000|COMPLETED|Overall Study||373
6296405|NCT00306592|7198137|FG001|COMPLETED|Overall Study||632
6296406|NCT00306592|7198136|FG000|NOT COMPLETED|Overall Study||31
6296407|NCT00306592|7198137|FG001|NOT COMPLETED|Overall Study||58
6374379|NCT00750269|7285044|FG004|NOT COMPLETED|Overall Study||10
6374380|NCT00750282|7285067|FG000|STARTED|Overall Study||69
6374381|NCT00750282|7285068|FG001|STARTED|Overall Study||82
6374382|NCT00750282|7285069|FG002|STARTED|Overall Study||126
6374383|NCT00750282|7285070|FG003|STARTED|Overall Study||148
6374384|NCT00750282|7285067|FG000|COMPLETED|Overall Study||69
6374385|NCT00750282|7285068|FG001|COMPLETED|Overall Study||81
6374386|NCT00750282|7285069|FG002|COMPLETED|Overall Study||125
6374387|NCT00750282|7285070|FG003|COMPLETED|Overall Study||147
6374388|NCT00750282|7285067|FG000|NOT COMPLETED|Overall Study||0
6374389|NCT00750282|7285068|FG001|NOT COMPLETED|Overall Study||1
6374390|NCT00750282|7285069|FG002|NOT COMPLETED|Overall Study||1
6374391|NCT00750282|7285070|FG003|NOT COMPLETED|Overall Study||1
6374392|NCT00750308|7285094|FG000|STARTED|First Treatment|One female withdrew due to muscle pain|2
6374393|NCT00750308|7285095|FG001|STARTED|First Treatment||3
6374394|NCT00750308|7285096|FG002|STARTED|First Treatment||2
6374395|NCT00750308|7285097|FG003|STARTED|First Treatment||2
6374396|NCT00750308|7285098|FG004|STARTED|First Treatment||2
6374397|NCT00750308|7285099|FG005|STARTED|First Treatment||3
6374398|NCT00750308|7285100|FG006|STARTED|First Treatment||2
6374399|NCT00750308|7285101|FG007|STARTED|First Treatment||3
6374400|NCT00750308|7285102|FG008|STARTED|First Treatment||2
6374401|NCT00750308|7285103|FG009|STARTED|First Treatment||2
6374402|NCT00750308|7285104|FG010|STARTED|First Treatment||2
6374403|NCT00750308|7285105|FG011|STARTED|First Treatment||2
6374404|NCT00750308|7285094|FG000|COMPLETED|First Treatment||2
6374405|NCT00750308|7285095|FG001|COMPLETED|First Treatment||2
6374406|NCT00750308|7285096|FG002|COMPLETED|First Treatment||2
6374407|NCT00750308|7285097|FG003|COMPLETED|First Treatment||1
6374408|NCT00750308|7285098|FG004|COMPLETED|First Treatment||2
6374409|NCT00750308|7285099|FG005|COMPLETED|First Treatment||3
6374410|NCT00750308|7285100|FG006|COMPLETED|First Treatment||2
6374411|NCT00750308|7285101|FG007|COMPLETED|First Treatment||2
6374412|NCT00750308|7285102|FG008|COMPLETED|First Treatment||2
6374413|NCT00750308|7285103|FG009|COMPLETED|First Treatment||2
6374414|NCT00750308|7285104|FG010|COMPLETED|First Treatment||1
6374415|NCT00750308|7285105|FG011|COMPLETED|First Treatment||1
6374416|NCT00750308|7285094|FG000|NOT COMPLETED|First Treatment||0
6374417|NCT00750308|7285095|FG001|NOT COMPLETED|First Treatment||1
6374418|NCT00750308|7285096|FG002|NOT COMPLETED|First Treatment||0
6374419|NCT00750308|7285097|FG003|NOT COMPLETED|First Treatment||1
6374420|NCT00750308|7285098|FG004|NOT COMPLETED|First Treatment||0
6374421|NCT00750308|7285099|FG005|NOT COMPLETED|First Treatment||0
6374422|NCT00750308|7285100|FG006|NOT COMPLETED|First Treatment||0
6374423|NCT00750308|7285101|FG007|NOT COMPLETED|First Treatment||1
6374424|NCT00750308|7285102|FG008|NOT COMPLETED|First Treatment||0
6374425|NCT00750308|7285103|FG009|NOT COMPLETED|First Treatment||0
6374426|NCT00750308|7285104|FG010|NOT COMPLETED|First Treatment||1
6374427|NCT00750308|7285105|FG011|NOT COMPLETED|First Treatment||1
6374428|NCT00750308|7285094|FG000|STARTED|Washout||2
6374429|NCT00750308|7285095|FG001|STARTED|Washout||2
6400886|NCT00888459|7313740|FG000|STARTED|Overall Study||30
6400887|NCT00888459|7313741|FG001|STARTED|Overall Study||30
6374430|NCT00750308|7285096|FG002|STARTED|Washout||2
6374431|NCT00750308|7285097|FG003|STARTED|Washout||1
6374432|NCT00750308|7285098|FG004|STARTED|Washout||2
6374433|NCT00750308|7285099|FG005|STARTED|Washout||3
6374434|NCT00750308|7285100|FG006|STARTED|Washout||2
6374435|NCT00750308|7285101|FG007|STARTED|Washout||2
6374436|NCT00750308|7285102|FG008|STARTED|Washout||2
6374437|NCT00750308|7285103|FG009|STARTED|Washout||2
6374438|NCT00750308|7285104|FG010|STARTED|Washout||1
6374439|NCT00750308|7285105|FG011|STARTED|Washout||1
6374440|NCT00750308|7285094|FG000|COMPLETED|Washout||2
6374441|NCT00750308|7285095|FG001|COMPLETED|Washout||2
6374442|NCT00750308|7285096|FG002|COMPLETED|Washout||2
6374443|NCT00750308|7285097|FG003|COMPLETED|Washout||1
6374444|NCT00750308|7285098|FG004|COMPLETED|Washout||2
6374445|NCT00750308|7285099|FG005|COMPLETED|Washout||3
6400888|NCT00888459|7313740|FG000|COMPLETED|Overall Study||30
6400889|NCT00888459|7313741|FG001|COMPLETED|Overall Study||30
6400890|NCT00888459|7313740|FG000|NOT COMPLETED|Overall Study||0
6296408|NCT00306670|7198143|FG000|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
6296409|NCT00306670|7198144|FG001|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
6296410|NCT00306670|7198143|FG000|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
6296411|NCT00306670|7198144|FG001|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
6296412|NCT00306670|7198143|FG000|NOT COMPLETED|Overall Study||0
6296413|NCT00306670|7198144|FG001|NOT COMPLETED|Overall Study||2
6296414|NCT00306787|7198152|FG000|STARTED|Overall Study||579
6296415|NCT00306787|7198153|FG001|STARTED|Overall Study||600
6296416|NCT00306787|7198152|FG000|Received Study Drug (Safety Population)|Overall Study||371
6296417|NCT00306787|7198153|FG001|Received Study Drug (Safety Population)|Overall Study||385
6296418|NCT00306787|7198152|FG000|Intent to Treat (ITT) Population|Overall Study||370
6296419|NCT00306787|7198153|FG001|Intent to Treat (ITT) Population|Overall Study||381
6296420|NCT00306787|7198152|FG000|COMPLETED|Overall Study||345
6296421|NCT00306787|7198153|FG001|COMPLETED|Overall Study||359
6296422|NCT00306787|7198152|FG000|NOT COMPLETED|Overall Study||234
6296423|NCT00306787|7198153|FG001|NOT COMPLETED|Overall Study||241
6296424|NCT00306852|7198161|FG000|STARTED|Overall Study||105
6296425|NCT00306852|7198162|FG001|STARTED|Overall Study||107
6296426|NCT00306852|7198161|FG000|COMPLETED|Overall Study||76
6296427|NCT00306852|7198162|FG001|COMPLETED|Overall Study||69
6296428|NCT00306852|7198161|FG000|NOT COMPLETED|Overall Study||29
6296429|NCT00306852|7198162|FG001|NOT COMPLETED|Overall Study||38
6296430|NCT00306891|7198172|FG000|STARTED|Part A||23
6296431|NCT00306891|7198173|FG001|STARTED|Part A||22
6296432|NCT00306891|7198174|FG002|STARTED|Part A||0
6296433|NCT00306891|7198175|FG003|STARTED|Part A||0
6296434|NCT00306891|7198172|FG000|COMPLETED|Part A||18
6296435|NCT00306891|7198173|FG001|COMPLETED|Part A||16
6296436|NCT00306891|7198174|FG002|COMPLETED|Part A||0
6296437|NCT00306891|7198175|FG003|COMPLETED|Part A||0
6296438|NCT00306891|7198172|FG000|NOT COMPLETED|Part A||5
6296439|NCT00306891|7198173|FG001|NOT COMPLETED|Part A||6
6296440|NCT00306891|7198174|FG002|NOT COMPLETED|Part A||0
6296441|NCT00306891|7198175|FG003|NOT COMPLETED|Part A||0
6296442|NCT00306891|7198172|FG000|STARTED|Part B||0
6296443|NCT00306891|7198173|FG001|STARTED|Part B||0
6296444|NCT00306891|7198174|FG002|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
6296445|NCT00306891|7198175|FG003|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
6296446|NCT00306891|7198172|FG000|COMPLETED|Part B||0
6296447|NCT00306891|7198173|FG001|COMPLETED|Part B||0
6296448|NCT00306891|7198174|FG002|COMPLETED|Part B||5
6296449|NCT00306891|7198175|FG003|COMPLETED|Part B||14
6296450|NCT00306891|7198172|FG000|NOT COMPLETED|Part B||0
6296451|NCT00306891|7198173|FG001|NOT COMPLETED|Part B||0
6296452|NCT00306891|7198174|FG002|NOT COMPLETED|Part B||11
6296453|NCT00306891|7198175|FG003|NOT COMPLETED|Part B||17
6296454|NCT00306917|7198188|FG000|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
6296455|NCT00306917|7198189|FG001|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
6296456|NCT00306917|7198188|FG000|Postoperative to 6 Month Follow up|Overall Study||93
6296457|NCT00306917|7198189|FG001|Postoperative to 6 Month Follow up|Overall Study||100
6296458|NCT00306917|7198188|FG000|12 Month Follow|Overall Study||86
6296459|NCT00306917|7198189|FG001|12 Month Follow|Overall Study||94
6296460|NCT00306917|7198188|FG000|24 Month Follow up|Overall Study||60
6296461|NCT00306917|7198189|FG001|24 Month Follow up|Overall Study||71
6296462|NCT00306917|7198188|FG000|36 Month Follow up|Overall Study||56
6296463|NCT00306917|7198189|FG001|36 Month Follow up|Overall Study||42
6296464|NCT00306917|7198188|FG000|48 Month Follow up|Overall Study||29
6296465|NCT00306917|7198189|FG001|48 Month Follow up|Overall Study||22
6296466|NCT00306917|7198188|FG000|60 Month Follow up|Overall Study||13
6296467|NCT00306917|7198189|FG001|60 Month Follow up|Overall Study||15
6296468|NCT00306917|7198188|FG000|COMPLETED|Overall Study||13
6296469|NCT00306917|7198189|FG001|COMPLETED|Overall Study||15
6296470|NCT00306917|7198188|FG000|NOT COMPLETED|Overall Study||108
6296471|NCT00306917|7198189|FG001|NOT COMPLETED|Overall Study||109
6296472|NCT00306995|7198202|FG000|STARTED|Study Part I||55
6296473|NCT00306995|7198203|FG001|STARTED|Study Part I||55
6296474|NCT00306995|7198204|FG002|STARTED|Study Part I||55
6296475|NCT00306995|7198205|FG003|STARTED|Study Part I||55
6296476|NCT00306995|7198206|FG004|STARTED|Study Part I||55
6296477|NCT00306995|7198207|FG005|STARTED|Study Part I||55
6296478|NCT00306995|7198208|FG006|STARTED|Study Part I||55
6296479|NCT00306995|7198202|FG000|COMPLETED|Study Part I||55
6296480|NCT00306995|7198203|FG001|COMPLETED|Study Part I||55
6296481|NCT00306995|7198204|FG002|COMPLETED|Study Part I||55
6296482|NCT00306995|7198205|FG003|COMPLETED|Study Part I||55
6296483|NCT00306995|7198206|FG004|COMPLETED|Study Part I||55
6296484|NCT00306995|7198207|FG005|COMPLETED|Study Part I||55
6296485|NCT00306995|7198208|FG006|COMPLETED|Study Part I||54
6296486|NCT00306995|7198202|FG000|NOT COMPLETED|Study Part I||0
6296487|NCT00306995|7198203|FG001|NOT COMPLETED|Study Part I||0
6296488|NCT00306995|7198204|FG002|NOT COMPLETED|Study Part I||0
6296489|NCT00306995|7198205|FG003|NOT COMPLETED|Study Part I||0
6296490|NCT00306995|7198206|FG004|NOT COMPLETED|Study Part I||0
6296491|NCT00306995|7198207|FG005|NOT COMPLETED|Study Part I||0
6296492|NCT00306995|7198208|FG006|NOT COMPLETED|Study Part I||1
6296493|NCT00306995|7198202|FG000|STARTED|Study Part II for Subset 1||27
6296494|NCT00306995|7198203|FG001|STARTED|Study Part II for Subset 1||26
6296495|NCT00306995|7198204|FG002|STARTED|Study Part II for Subset 1||27
6296496|NCT00306995|7198205|FG003|STARTED|Study Part II for Subset 1||27
6296497|NCT00306995|7198206|FG004|STARTED|Study Part II for Subset 1||27
6296498|NCT00306995|7198207|FG005|STARTED|Study Part II for Subset 1||26
6296499|NCT00306995|7198208|FG006|STARTED|Study Part II for Subset 1||23
6296500|NCT00306995|7198202|FG000|COMPLETED|Study Part II for Subset 1||27
6296501|NCT00306995|7198203|FG001|COMPLETED|Study Part II for Subset 1||26
6296502|NCT00306995|7198204|FG002|COMPLETED|Study Part II for Subset 1||27
6296503|NCT00306995|7198205|FG003|COMPLETED|Study Part II for Subset 1||27
6296504|NCT00306995|7198206|FG004|COMPLETED|Study Part II for Subset 1||27
6296505|NCT00306995|7198207|FG005|COMPLETED|Study Part II for Subset 1||26
6296506|NCT00306995|7198208|FG006|COMPLETED|Study Part II for Subset 1||23
6296507|NCT00306995|7198202|FG000|NOT COMPLETED|Study Part II for Subset 1||0
6296508|NCT00306995|7198203|FG001|NOT COMPLETED|Study Part II for Subset 1||0
6296509|NCT00306995|7198204|FG002|NOT COMPLETED|Study Part II for Subset 1||0
6296510|NCT00306995|7198205|FG003|NOT COMPLETED|Study Part II for Subset 1||0
6296511|NCT00306995|7198206|FG004|NOT COMPLETED|Study Part II for Subset 1||0
6296512|NCT00306995|7198207|FG005|NOT COMPLETED|Study Part II for Subset 1||0
6296513|NCT00306995|7198208|FG006|NOT COMPLETED|Study Part II for Subset 1||0
6296514|NCT00306995|7198202|FG000|STARTED|Study Part II for Subset 2||23
6296515|NCT00306995|7198203|FG001|STARTED|Study Part II for Subset 2||24
6296516|NCT00306995|7198204|FG002|STARTED|Study Part II for Subset 2||23
6296517|NCT00306995|7198205|FG003|STARTED|Study Part II for Subset 2||22
6296518|NCT00306995|7198206|FG004|STARTED|Study Part II for Subset 2||23
6296519|NCT00306995|7198207|FG005|STARTED|Study Part II for Subset 2||26
6296520|NCT00306995|7198208|FG006|STARTED|Study Part II for Subset 2||24
6296521|NCT00306995|7198202|FG000|COMPLETED|Study Part II for Subset 2||23
6296522|NCT00306995|7198203|FG001|COMPLETED|Study Part II for Subset 2||23
6296523|NCT00306995|7198204|FG002|COMPLETED|Study Part II for Subset 2||23
6296524|NCT00306995|7198205|FG003|COMPLETED|Study Part II for Subset 2||22
6296525|NCT00306995|7198206|FG004|COMPLETED|Study Part II for Subset 2||23
6296526|NCT00306995|7198207|FG005|COMPLETED|Study Part II for Subset 2||26
6296527|NCT00306995|7198208|FG006|COMPLETED|Study Part II for Subset 2||24
6296528|NCT00306995|7198202|FG000|NOT COMPLETED|Study Part II for Subset 2||0
6296529|NCT00306995|7198203|FG001|NOT COMPLETED|Study Part II for Subset 2||1
6296530|NCT00306995|7198204|FG002|NOT COMPLETED|Study Part II for Subset 2||0
6296531|NCT00306995|7198205|FG003|NOT COMPLETED|Study Part II for Subset 2||0
6296532|NCT00306995|7198206|FG004|NOT COMPLETED|Study Part II for Subset 2||0
6296533|NCT00306995|7198207|FG005|NOT COMPLETED|Study Part II for Subset 2||0
6296534|NCT00306995|7198208|FG006|NOT COMPLETED|Study Part II for Subset 2||0
6296535|NCT00307034|7198255|FG000|STARTED|Overall Study||175
6296536|NCT00307034|7198256|FG001|STARTED|Overall Study||176
6296537|NCT00307034|7198255|FG000|COMPLETED|Overall Study||173
6296538|NCT00307034|7198256|FG001|COMPLETED|Overall Study||169
6296539|NCT00307034|7198255|FG000|NOT COMPLETED|Overall Study||2
6296540|NCT00307034|7198256|FG001|NOT COMPLETED|Overall Study||7
6296541|NCT00307047|7198264|FG000|STARTED|Overall Study||2458
6296542|NCT00307047|7198265|FG001|STARTED|Overall Study||1229
6296543|NCT00307047|7198264|FG000|COMPLETED|Overall Study||2389
6296544|NCT00307047|7198265|FG001|COMPLETED|Overall Study||1180
6296545|NCT00307047|7198264|FG000|NOT COMPLETED|Overall Study||69
6296546|NCT00307047|7198265|FG001|NOT COMPLETED|Overall Study||49
6296547|NCT00307086|7198271|FG000|STARTED|Overall Study||30
6296548|NCT00307086|7198271|FG000|COMPLETED|Overall Study||25
6296549|NCT00307086|7198271|FG000|NOT COMPLETED|Overall Study||5
6296550|NCT00307125|7198277|FG000|STARTED|Screening Phase||757
6296551|NCT00307125|7198278|FG001|STARTED|Screening Phase||0
6296552|NCT00307125|7198279|FG002|STARTED|Screening Phase||0
6296553|NCT00307125|7198277|FG000|COMPLETED|Screening Phase||303
6296554|NCT00307125|7198278|FG001|COMPLETED|Screening Phase||0
6296555|NCT00307125|7198279|FG002|COMPLETED|Screening Phase||0
6296556|NCT00307125|7198277|FG000|NOT COMPLETED|Screening Phase||454
6296557|NCT00307125|7198278|FG001|NOT COMPLETED|Screening Phase||0
6296558|NCT00307125|7198279|FG002|NOT COMPLETED|Screening Phase||0
6296559|NCT00307125|7198277|FG000|STARTED|Pilot Phase||0
6296560|NCT00307125|7198278|FG001|STARTED|Pilot Phase||15
6296561|NCT00307125|7198279|FG002|STARTED|Pilot Phase||7
6296562|NCT00307125|7198277|FG000|COMPLETED|Pilot Phase||0
6296563|NCT00307125|7198278|FG001|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
6296564|NCT00307125|7198279|FG002|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
6296565|NCT00307125|7198277|FG000|NOT COMPLETED|Pilot Phase||0
6296566|NCT00307125|7198278|FG001|NOT COMPLETED|Pilot Phase||2
6296567|NCT00307125|7198279|FG002|NOT COMPLETED|Pilot Phase||1
6296568|NCT00307151|7198293|FG000|STARTED|Overall Study||82
6296569|NCT00307151|7198294|FG001|STARTED|Overall Study||82
6296570|NCT00307151|7198295|FG002|STARTED|Overall Study||147
6296571|NCT00307151|7198296|FG003|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
6296572|NCT00307151|7198293|FG000|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
6296573|NCT00307151|7198294|FG001|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
6296574|NCT00307151|7198295|FG002|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
6374446|NCT00750308|7285100|FG006|COMPLETED|Washout||2
6296575|NCT00307151|7198296|FG003|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
6296576|NCT00307151|7198293|FG000|NOT COMPLETED|Overall Study||11
6296577|NCT00307151|7198294|FG001|NOT COMPLETED|Overall Study||7
6296578|NCT00307151|7198295|FG002|NOT COMPLETED|Overall Study||20
6296579|NCT00307151|7198296|FG003|NOT COMPLETED|Overall Study||11
6296580|NCT00307164|7198308|FG000|STARTED|Overall Study||83
6296581|NCT00307164|7198309|FG001|STARTED|Overall Study||82
6296582|NCT00307164|7198308|FG000|COMPLETED|Overall Study||68
6296583|NCT00307164|7198309|FG001|COMPLETED|Overall Study||68
6296584|NCT00307164|7198308|FG000|NOT COMPLETED|Overall Study||15
6296585|NCT00307164|7198309|FG001|NOT COMPLETED|Overall Study||14
6296586|NCT00307294|7198315|FG000|STARTED|Overall Study||40
6296587|NCT00307294|7198315|FG000|COMPLETED|Overall Study||39
6296588|NCT00307294|7198315|FG000|NOT COMPLETED|Overall Study||1
6296589|NCT00307333|7198322|FG000|STARTED|Overall Study||1511
6296590|NCT00307333|7198323|FG001|STARTED|Overall Study||1492
6296591|NCT00307333|7198322|FG000|COMPLETED|Overall Study||1500
6296592|NCT00307333|7198323|FG001|COMPLETED|Overall Study||1489
6296593|NCT00307333|7198322|FG000|NOT COMPLETED|Overall Study||11
6296594|NCT00307333|7198323|FG001|NOT COMPLETED|Overall Study||3
6296595|NCT00307437|7198332|FG000|STARTED|Controlled Period||410
6296596|NCT00307437|7198333|FG001|STARTED|Controlled Period||409
6296597|NCT00307437|7198334|FG002|STARTED|Controlled Period||411
6296598|NCT00307437|7198335|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6296599|NCT00307437|7198336|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6296600|NCT00307437|7198337|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6296601|NCT00307437|7198338|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6296602|NCT00307437|7198332|FG000|COMPLETED|Controlled Period||394
6296603|NCT00307437|7198333|FG001|COMPLETED|Controlled Period||403
6296604|NCT00307437|7198334|FG002|COMPLETED|Controlled Period||402
6296605|NCT00307437|7198335|FG003|COMPLETED|Controlled Period||0
6296606|NCT00307437|7198336|FG004|COMPLETED|Controlled Period||0
6296607|NCT00307437|7198337|FG005|COMPLETED|Controlled Period||0
6296608|NCT00307437|7198338|FG006|COMPLETED|Controlled Period||0
6296609|NCT00307437|7198332|FG000|NOT COMPLETED|Controlled Period||16
6296610|NCT00307437|7198333|FG001|NOT COMPLETED|Controlled Period||6
6635044|NCT02301403|7563909|FG001|STARTED|Overall Study||308
6296611|NCT00307437|7198334|FG002|NOT COMPLETED|Controlled Period||9
6296612|NCT00307437|7198335|FG003|NOT COMPLETED|Controlled Period||0
6296613|NCT00307437|7198336|FG004|NOT COMPLETED|Controlled Period||0
6296614|NCT00307437|7198337|FG005|NOT COMPLETED|Controlled Period||0
6296615|NCT00307437|7198338|FG006|NOT COMPLETED|Controlled Period||0
6296616|NCT00307437|7198332|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6296617|NCT00307437|7198333|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6296618|NCT00307437|7198334|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6296619|NCT00307437|7198335|FG003|STARTED|After Controlled Period||197
6296620|NCT00307437|7198336|FG004|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
6296621|NCT00307437|7198337|FG005|STARTED|After Controlled Period||403
6296622|NCT00307437|7198338|FG006|STARTED|After Controlled Period||402
6296623|NCT00307437|7198332|FG000|COMPLETED|After Controlled Period||0
6296624|NCT00307437|7198333|FG001|COMPLETED|After Controlled Period||0
6296625|NCT00307437|7198334|FG002|COMPLETED|After Controlled Period||0
6296626|NCT00307437|7198335|FG003|COMPLETED|After Controlled Period||139
6296627|NCT00307437|7198336|FG004|COMPLETED|After Controlled Period||140
6296628|NCT00307437|7198337|FG005|COMPLETED|After Controlled Period||281
6296629|NCT00307437|7198338|FG006|COMPLETED|After Controlled Period||289
6296630|NCT00307437|7198332|FG000|NOT COMPLETED|After Controlled Period||0
6296631|NCT00307437|7198333|FG001|NOT COMPLETED|After Controlled Period||0
6296632|NCT00307437|7198334|FG002|NOT COMPLETED|After Controlled Period||0
6296633|NCT00307437|7198335|FG003|NOT COMPLETED|After Controlled Period||58
6296634|NCT00307437|7198336|FG004|NOT COMPLETED|After Controlled Period||55
6296635|NCT00307437|7198337|FG005|NOT COMPLETED|After Controlled Period||122
6296636|NCT00307437|7198338|FG006|NOT COMPLETED|After Controlled Period||113
6296637|NCT00307489|7198362|FG000|STARTED|Baseline Through Week 48||53
6296638|NCT00307489|7198363|FG001|STARTED|Baseline Through Week 48||52
6296639|NCT00307489|7198362|FG000|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
6296640|NCT00307489|7198363|FG001|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
6296641|NCT00307489|7198362|FG000|NOT COMPLETED|Baseline Through Week 48||1
6296642|NCT00307489|7198363|FG001|NOT COMPLETED|Baseline Through Week 48||2
6296643|NCT00307489|7198362|FG000|STARTED|Week 48 Through Week 168||52
6296644|NCT00307489|7198363|FG001|STARTED|Week 48 Through Week 168||50
6296645|NCT00307489|7198362|FG000|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
6296646|NCT00307489|7198363|FG001|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
6296647|NCT00307489|7198362|FG000|NOT COMPLETED|Week 48 Through Week 168||6
6296648|NCT00307489|7198363|FG001|NOT COMPLETED|Week 48 Through Week 168||6
6296649|NCT00307684|7198369|FG000|STARTED|Open Label Phase||0
6635045|NCT02301403|7563908|FG000|COMPLETED|Overall Study||287
6296650|NCT00307684|7198370|FG001|STARTED|Open Label Phase||0
6296651|NCT00307684|7198371|FG002|STARTED|Open Label Phase|1 screening failure|155
6296652|NCT00307684|7198369|FG000|COMPLETED|Open Label Phase||0
6296653|NCT00307684|7198370|FG001|COMPLETED|Open Label Phase||0
6296654|NCT00307684|7198371|FG002|COMPLETED|Open Label Phase||99
6296655|NCT00307684|7198369|FG000|NOT COMPLETED|Open Label Phase||0
6296656|NCT00307684|7198370|FG001|NOT COMPLETED|Open Label Phase||0
6296657|NCT00307684|7198371|FG002|NOT COMPLETED|Open Label Phase||56
6296658|NCT00307684|7198369|FG000|STARTED|Double Blind Phase||23
6296659|NCT00307684|7198370|FG001|STARTED|Double Blind Phase||22
6296660|NCT00307684|7198371|FG002|STARTED|Double Blind Phase||0
6296661|NCT00307684|7198369|FG000|COMPLETED|Double Blind Phase||21
6296662|NCT00307684|7198370|FG001|COMPLETED|Double Blind Phase||17
6296663|NCT00307684|7198371|FG002|COMPLETED|Double Blind Phase||0
6296664|NCT00307684|7198369|FG000|NOT COMPLETED|Double Blind Phase||2
6296665|NCT00307684|7198370|FG001|NOT COMPLETED|Double Blind Phase||5
6296666|NCT00307684|7198371|FG002|NOT COMPLETED|Double Blind Phase||0
6296667|NCT00307736|7198379|FG000|STARTED|Overall Study||3
6296668|NCT00307736|7198380|FG001|STARTED|Overall Study||3
6296669|NCT00307736|7198381|FG002|STARTED|Overall Study||3
6296670|NCT00307736|7198382|FG003|STARTED|Overall Study||23
6296671|NCT00307736|7198379|FG000|COMPLETED|Overall Study||3
6296672|NCT00307736|7198380|FG001|COMPLETED|Overall Study||3
6296673|NCT00307736|7198381|FG002|COMPLETED|Overall Study||0
6296674|NCT00307736|7198382|FG003|COMPLETED|Overall Study||20
6296675|NCT00307736|7198379|FG000|NOT COMPLETED|Overall Study||0
6400891|NCT00888459|7313741|FG001|NOT COMPLETED|Overall Study||0
6400892|NCT00888511|7313747|FG000|STARTED|Overall Study||15
6400893|NCT00888511|7313747|FG000|COMPLETED|Overall Study||15
6400894|NCT00888511|7313747|FG000|NOT COMPLETED|Overall Study||0
6400895|NCT00888615|7313751|FG000|STARTED|Overall Study||58
6400896|NCT00888615|7313751|FG000|COMPLETED|Overall Study||56
6400897|NCT00888615|7313751|FG000|NOT COMPLETED|Overall Study||2
6400898|NCT00888628|7313755|FG000|STARTED|Overall Study||7
6400899|NCT00888628|7313755|FG000|Enrolled|Overall Study||7
6400900|NCT00888628|7313755|FG000|Screen Failure|Overall Study||2
6400901|NCT00888628|7313755|FG000|Withdrawn|Overall Study||1
6400902|NCT00888628|7313755|FG000|Transplanted|Overall Study||4
6400903|NCT00888628|7313755|FG000|COMPLETED|Overall Study||4
6400904|NCT00888628|7313755|FG000|NOT COMPLETED|Overall Study||3
6400905|NCT00888654|7313759|FG000|STARTED|Overall Study||41
6400906|NCT00888654|7313759|FG000|COMPLETED|Overall Study||31
6296676|NCT00307736|7198380|FG001|NOT COMPLETED|Overall Study||0
6296677|NCT00307736|7198381|FG002|NOT COMPLETED|Overall Study||3
6296678|NCT00307736|7198382|FG003|NOT COMPLETED|Overall Study||3
6296679|NCT00307801|7198395|FG000|STARTED|Overall Study||149
6296680|NCT00307801|7198396|FG001|STARTED|Overall Study||82
6296681|NCT00307801|7198395|FG000|Subjects Received Treatment|Overall Study||145
6296682|NCT00307801|7198396|FG001|Subjects Received Treatment|Overall Study||81
6296683|NCT00307801|7198395|FG000|Cycle 1, Visit 5, Baseline|Overall Study||145
6296684|NCT00307801|7198396|FG001|Cycle 1, Visit 5, Baseline|Overall Study||81
6296685|NCT00307801|7198395|FG000|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
6296686|NCT00307801|7198396|FG001|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
6296687|NCT00307801|7198395|FG000|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
6296688|NCT00307801|7198396|FG001|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
6296689|NCT00307801|7198395|FG000|COMPLETED|Overall Study||117
6296690|NCT00307801|7198396|FG001|COMPLETED|Overall Study||65
6296691|NCT00307801|7198395|FG000|NOT COMPLETED|Overall Study||32
6296692|NCT00307801|7198396|FG001|NOT COMPLETED|Overall Study||17
6296693|NCT00307931|7198403|FG000|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
6296694|NCT00307931|7198403|FG000|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
6296695|NCT00307931|7198403|FG000|NOT COMPLETED|Overall Study||1
6296696|NCT00308061|7198409|FG000|STARTED|Overall Study||20
6296697|NCT00308061|7198410|FG001|STARTED|Overall Study||20
6296698|NCT00308061|7198409|FG000|COMPLETED|Overall Study||20
6296699|NCT00308061|7198410|FG001|COMPLETED|Overall Study||20
6296700|NCT00308061|7198409|FG000|NOT COMPLETED|Overall Study||0
6296701|NCT00308061|7198410|FG001|NOT COMPLETED|Overall Study||0
6296702|NCT00308074|7198417|FG000|STARTED|Overall Study||14
6296703|NCT00308074|7198417|FG000|COMPLETED|Overall Study||13
6296704|NCT00308074|7198417|FG000|NOT COMPLETED|Overall Study||1
6296705|NCT00308087|7198423|FG000|STARTED|Overall Study||37
6296706|NCT00308087|7198424|FG001|STARTED|Overall Study||38
6296707|NCT00308087|7198423|FG000|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
6296708|NCT00308087|7198424|FG001|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
6296709|NCT00308087|7198423|FG000|NOT COMPLETED|Overall Study||36
6296710|NCT00308087|7198424|FG001|NOT COMPLETED|Overall Study||37
6296711|NCT00308139|7198432|FG000|STARTED|Overall Study||152
6296712|NCT00308139|7198433|FG001|STARTED|Overall Study||151
6400907|NCT00888654|7313759|FG000|NOT COMPLETED|Overall Study||10
6400908|NCT00888849|7313765|FG000|STARTED|Overall Study||142
6400909|NCT00888849|7313766|FG001|STARTED|Overall Study||138
6400910|NCT00888849|7313765|FG000|COMPLETED|Overall Study||137
6400911|NCT00888849|7313766|FG001|COMPLETED|Overall Study||129
6400912|NCT00888849|7313765|FG000|NOT COMPLETED|Overall Study||5
6296713|NCT00308139|7198432|FG000|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
6296714|NCT00308139|7198433|FG001|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
6296715|NCT00308139|7198432|FG000|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
6296716|NCT00308139|7198433|FG001|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
6296717|NCT00308139|7198432|FG000|Pharmacokinetics Population|Overall Study||129
6296718|NCT00308139|7198433|FG001|Pharmacokinetics Population|Overall Study||0
6296719|NCT00308139|7198432|FG000|Evaluable Meal Tolerance Cohort|Overall Study||27
6296720|NCT00308139|7198433|FG001|Evaluable Meal Tolerance Cohort|Overall Study||24
6296721|NCT00308139|7198432|FG000|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
6296722|NCT00308139|7198433|FG001|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
6296723|NCT00308139|7198432|FG000|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
6296724|NCT00308139|7198433|FG001|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
6296725|NCT00308139|7198432|FG000|NOT COMPLETED|Overall Study||94
6296726|NCT00308139|7198433|FG001|NOT COMPLETED|Overall Study||87
6296727|NCT00308230|7198462|FG000|STARTED|Overall Study||6
6296728|NCT00308230|7198463|FG001|STARTED|Overall Study||8
6296729|NCT00308230|7198464|FG002|STARTED|Overall Study||20
6296730|NCT00308230|7198462|FG000|COMPLETED|Overall Study||6
6296731|NCT00308230|7198463|FG001|COMPLETED|Overall Study||8
6296732|NCT00308230|7198464|FG002|COMPLETED|Overall Study||20
6296733|NCT00308230|7198462|FG000|NOT COMPLETED|Overall Study||0
6296734|NCT00308230|7198463|FG001|NOT COMPLETED|Overall Study||0
6296735|NCT00308230|7198464|FG002|NOT COMPLETED|Overall Study||0
6296736|NCT00308282|7198476|FG000|STARTED|Overall Study||34
6296737|NCT00308282|7198477|FG001|STARTED|Overall Study||34
6296738|NCT00308282|7198478|FG002|STARTED|Overall Study||34
6296739|NCT00308282|7198479|FG003|STARTED|Overall Study||34
6296740|NCT00308282|7198476|FG000|Received at Least One Dose of Study Drug|Overall Study||34
6296741|NCT00308282|7198477|FG001|Received at Least One Dose of Study Drug|Overall Study||34
6296742|NCT00308282|7198478|FG002|Received at Least One Dose of Study Drug|Overall Study||34
6296743|NCT00308282|7198479|FG003|Received at Least One Dose of Study Drug|Overall Study||34
6296744|NCT00308282|7198476|FG000|COMPLETED|Overall Study||31
6296745|NCT00308282|7198477|FG001|COMPLETED|Overall Study||30
6296746|NCT00308282|7198478|FG002|COMPLETED|Overall Study||33
6296747|NCT00308282|7198479|FG003|COMPLETED|Overall Study||32
6296748|NCT00308282|7198476|FG000|NOT COMPLETED|Overall Study||3
6296749|NCT00308282|7198477|FG001|NOT COMPLETED|Overall Study||4
6296750|NCT00308282|7198478|FG002|NOT COMPLETED|Overall Study||1
6296751|NCT00308282|7198479|FG003|NOT COMPLETED|Overall Study||2
6296752|NCT00308308|7198494|FG000|STARTED|Overall Study||301
6296753|NCT00308308|7198495|FG001|STARTED|Overall Study||288
6296754|NCT00308308|7198494|FG000|COMPLETED|Overall Study||198
6296755|NCT00308308|7198495|FG001|COMPLETED|Overall Study||220
6296756|NCT00308308|7198494|FG000|NOT COMPLETED|Overall Study||103
6296757|NCT00308308|7198495|FG001|NOT COMPLETED|Overall Study||68
6296758|NCT00308555|7198503|FG000|STARTED|Overall Study||13
6296759|NCT00308555|7198504|FG001|STARTED|Overall Study||11
6296760|NCT00308555|7198503|FG000|COMPLETED|Overall Study||10
6296761|NCT00308555|7198504|FG001|COMPLETED|Overall Study||11
6296762|NCT00308555|7198503|FG000|NOT COMPLETED|Overall Study||3
6296763|NCT00308555|7198504|FG001|NOT COMPLETED|Overall Study||0
6296764|NCT00308581|7198510|FG000|STARTED|Induction Phase|Not applicable in this period|0
6296765|NCT00308581|7198511|FG001|STARTED|Induction Phase|Not applicable in this period|0
6296766|NCT00308581|7198512|FG002|STARTED|Induction Phase||539
6296767|NCT00308581|7198510|FG000|COMPLETED|Induction Phase|Not applicable in this period|0
6296768|NCT00308581|7198511|FG001|COMPLETED|Induction Phase|Not applicable in this period|0
6296769|NCT00308581|7198512|FG002|COMPLETED|Induction Phase||373
6296770|NCT00308581|7198510|FG000|NOT COMPLETED|Induction Phase||0
6296771|NCT00308581|7198511|FG001|NOT COMPLETED|Induction Phase||0
6296772|NCT00308581|7198512|FG002|NOT COMPLETED|Induction Phase||166
6296773|NCT00308581|7198510|FG000|STARTED|Randomized Maintenance Phase||187
6296774|NCT00308581|7198511|FG001|STARTED|Randomized Maintenance Phase||186
6296775|NCT00308581|7198512|FG002|STARTED|Randomized Maintenance Phase||0
6296776|NCT00308581|7198510|FG000|COMPLETED|Randomized Maintenance Phase||82
6296777|NCT00308581|7198511|FG001|COMPLETED|Randomized Maintenance Phase||83
6296778|NCT00308581|7198512|FG002|COMPLETED|Randomized Maintenance Phase||0
6296779|NCT00308581|7198510|FG000|NOT COMPLETED|Randomized Maintenance Phase||105
6296780|NCT00308581|7198511|FG001|NOT COMPLETED|Randomized Maintenance Phase||103
6296781|NCT00308581|7198512|FG002|NOT COMPLETED|Randomized Maintenance Phase||0
6296782|NCT00308620|7198523|FG000|STARTED|Overall Study||3
6296783|NCT00308620|7198524|FG001|STARTED|Overall Study||4
6296784|NCT00308620|7198525|FG002|STARTED|Overall Study||6
6296785|NCT00308620|7198523|FG000|COMPLETED|Overall Study||2
6296786|NCT00308620|7198524|FG001|COMPLETED|Overall Study||3
6296787|NCT00308620|7198525|FG002|COMPLETED|Overall Study||5
6296788|NCT00308620|7198523|FG000|NOT COMPLETED|Overall Study||1
6296789|NCT00308620|7198524|FG001|NOT COMPLETED|Overall Study||1
6296790|NCT00308620|7198525|FG002|NOT COMPLETED|Overall Study||1
6296791|NCT00308711|7198536|FG000|STARTED|Overall Study||428
6296792|NCT00308711|7198537|FG001|STARTED|Overall Study||444
6296793|NCT00308711|7198538|FG002|STARTED|Overall Study||436
6296794|NCT00308711|7198536|FG000|COMPLETED|Overall Study||426
6296795|NCT00308711|7198537|FG001|COMPLETED|Overall Study||440
6296796|NCT00308711|7198538|FG002|COMPLETED|Overall Study||431
6296797|NCT00308711|7198536|FG000|NOT COMPLETED|Overall Study||2
6296798|NCT00308711|7198537|FG001|NOT COMPLETED|Overall Study||4
6296799|NCT00308711|7198538|FG002|NOT COMPLETED|Overall Study||5
6296800|NCT00308737|7198549|FG000|STARTED|Overall Study||938
6296801|NCT00308737|7198550|FG001|STARTED|Overall Study||951
6296802|NCT00308737|7198551|FG002|STARTED|Overall Study||164
6296803|NCT00308737|7198549|FG000|COMPLETED|Overall Study||475
6296804|NCT00308737|7198550|FG001|COMPLETED|Overall Study||662
6296805|NCT00308737|7198551|FG002|COMPLETED|Overall Study||127
6296806|NCT00308737|7198549|FG000|NOT COMPLETED|Overall Study||463
6296807|NCT00308737|7198550|FG001|NOT COMPLETED|Overall Study||289
6296808|NCT00308737|7198551|FG002|NOT COMPLETED|Overall Study||37
6296809|NCT00308750|7198562|FG000|STARTED|Overall Study||72
6296810|NCT00308750|7198563|FG001|STARTED|Overall Study||74
6296811|NCT00308750|7198564|FG002|STARTED|Overall Study||72
6296812|NCT00308750|7198562|FG000|Received at Least 1 Dose of Study Drug|Overall Study||67
6296813|NCT00308750|7198563|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
6296814|NCT00308750|7198564|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
6296815|NCT00308750|7198562|FG000|COMPLETED|Overall Study||0
6296816|NCT00308750|7198563|FG001|COMPLETED|Overall Study||34
6296817|NCT00308750|7198564|FG002|COMPLETED|Overall Study||23
6296818|NCT00308750|7198562|FG000|NOT COMPLETED|Overall Study||72
6296819|NCT00308750|7198563|FG001|NOT COMPLETED|Overall Study||40
6296820|NCT00308750|7198564|FG002|NOT COMPLETED|Overall Study||49
6296821|NCT00308997|7198575|FG000|STARTED|Overall Study||56
6296822|NCT00308997|7198576|FG001|STARTED|Overall Study||29
6296823|NCT00308997|7198575|FG000|COMPLETED|Overall Study||55
6296824|NCT00308997|7198576|FG001|COMPLETED|Overall Study||28
6296825|NCT00308997|7198575|FG000|NOT COMPLETED|Overall Study||1
6296826|NCT00308997|7198576|FG001|NOT COMPLETED|Overall Study||1
6296827|NCT00309140|7198582|FG000|STARTED|Overall Study||23
6296828|NCT00309140|7198582|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
6296829|NCT00309140|7198582|FG000|COMPLETED|Overall Study||23
6296830|NCT00309140|7198582|FG000|NOT COMPLETED|Overall Study||0
6296831|NCT00309166|7198588|FG000|STARTED|Overall Study||181
6296832|NCT00309166|7198589|FG001|STARTED|Overall Study||89
6296833|NCT00309166|7198588|FG000|COMPLETED|Overall Study||176
6296834|NCT00309166|7198589|FG001|COMPLETED|Overall Study||86
6296835|NCT00309166|7198588|FG000|NOT COMPLETED|Overall Study||5
6296836|NCT00309166|7198589|FG001|NOT COMPLETED|Overall Study||3
6635046|NCT02301403|7563909|FG001|COMPLETED|Overall Study||267
6296837|NCT00309244|7198597|FG000|STARTED|Overall Study||334
6296838|NCT00309244|7198598|FG001|STARTED|Overall Study||343
6296839|NCT00309244|7198597|FG000|COMPLETED|Overall Study||216
6296840|NCT00309244|7198598|FG001|COMPLETED|Overall Study||246
6296841|NCT00309244|7198597|FG000|NOT COMPLETED|Overall Study||118
6296842|NCT00309244|7198598|FG001|NOT COMPLETED|Overall Study||97
6296843|NCT00309387|7198606|FG000|STARTED|Overall Study||510
6296844|NCT00309387|7198607|FG001|STARTED|Overall Study||510
6296845|NCT00309387|7198606|FG000|COMPLETED|Overall Study||368
6296846|NCT00309387|7198607|FG001|COMPLETED|Overall Study||351
6296847|NCT00309387|7198606|FG000|NOT COMPLETED|Overall Study||142
6296848|NCT00309387|7198607|FG001|NOT COMPLETED|Overall Study||159
6296849|NCT00309452|7198616|FG000|STARTED|Overall Study||60
6296850|NCT00309452|7198617|FG001|STARTED|Overall Study||60
6296851|NCT00309452|7198616|FG000|COMPLETED|Overall Study||57
6296852|NCT00309452|7198617|FG001|COMPLETED|Overall Study||60
6296853|NCT00309452|7198616|FG000|NOT COMPLETED|Overall Study||3
6296854|NCT00309452|7198617|FG001|NOT COMPLETED|Overall Study||0
6296855|NCT00309465|7198629|FG000|STARTED|Overall Study||58
6296856|NCT00309465|7198630|FG001|STARTED|Overall Study||58
6296857|NCT00309465|7198631|FG002|STARTED|Overall Study||58
6296858|NCT00309465|7198632|FG003|STARTED|Overall Study||76
6296859|NCT00309465|7198633|FG004|STARTED|Overall Study||76
6296860|NCT00309465|7198634|FG005|STARTED|Overall Study||76
6296861|NCT00309465|7198629|FG000|COMPLETED|Overall Study||58
6296862|NCT00309465|7198630|FG001|COMPLETED|Overall Study||58
6296863|NCT00309465|7198631|FG002|COMPLETED|Overall Study||58
6296864|NCT00309465|7198632|FG003|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
6296865|NCT00309465|7198633|FG004|COMPLETED|Overall Study||76
6296866|NCT00309465|7198634|FG005|COMPLETED|Overall Study||76
6296867|NCT00309465|7198629|FG000|NOT COMPLETED|Overall Study||0
6296868|NCT00309465|7198630|FG001|NOT COMPLETED|Overall Study||0
6296869|NCT00309465|7198631|FG002|NOT COMPLETED|Overall Study||0
6296870|NCT00309465|7198632|FG003|NOT COMPLETED|Overall Study||1
6296871|NCT00309465|7198633|FG004|NOT COMPLETED|Overall Study||0
6296872|NCT00309465|7198634|FG005|NOT COMPLETED|Overall Study||0
6296873|NCT00309608|7198653|FG000|STARTED|Overall Study||71
6296874|NCT00309608|7198654|FG001|STARTED|Overall Study||65
6296875|NCT00309608|7198655|FG002|STARTED|Overall Study||66
6296876|NCT00309608|7198656|FG003|STARTED|Overall Study||66
6296877|NCT00309608|7198657|FG004|STARTED|Overall Study||65
6296878|NCT00309608|7198653|FG000|COMPLETED|Overall Study||57
6296879|NCT00309608|7198654|FG001|COMPLETED|Overall Study||52
6296880|NCT00309608|7198655|FG002|COMPLETED|Overall Study||56
6296881|NCT00309608|7198656|FG003|COMPLETED|Overall Study||60
6296882|NCT00309608|7198657|FG004|COMPLETED|Overall Study||61
6296883|NCT00309608|7198653|FG000|NOT COMPLETED|Overall Study||14
6296884|NCT00309608|7198654|FG001|NOT COMPLETED|Overall Study||13
6296885|NCT00309608|7198655|FG002|NOT COMPLETED|Overall Study||10
6296886|NCT00309608|7198656|FG003|NOT COMPLETED|Overall Study||6
6296887|NCT00309608|7198657|FG004|NOT COMPLETED|Overall Study||4
6296888|NCT00309738|7198671|FG000|STARTED|Overall Study||236
6296889|NCT00309738|7198672|FG001|STARTED|Overall Study||119
6296890|NCT00309738|7198671|FG000|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
6296891|NCT00309738|7198672|FG001|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
6296892|NCT00309738|7198671|FG000|COMPLETED|Overall Study||223
6296893|NCT00309738|7198672|FG001|COMPLETED|Overall Study||107
6296894|NCT00309738|7198671|FG000|NOT COMPLETED|Overall Study||13
6296895|NCT00309738|7198672|FG001|NOT COMPLETED|Overall Study||12
6296896|NCT00309751|7198680|FG000|STARTED|Overall Study||279
6296897|NCT00309751|7198681|FG001|STARTED|Overall Study||139
6296898|NCT00309751|7198680|FG000|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
6296899|NCT00309751|7198681|FG001|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
6635047|NCT02301403|7563908|FG000|NOT COMPLETED|Overall Study||28
6635048|NCT02301403|7563909|FG001|NOT COMPLETED|Overall Study||41
6635049|NCT02301416|7563917|FG000|STARTED|Overall Study||25
6635050|NCT02301416|7563918|FG001|STARTED|Overall Study||40
6635051|NCT02301416|7563917|FG000|COMPLETED|Overall Study||15
6296900|NCT00309751|7198680|FG000|COMPLETED|Overall Study||248
6296901|NCT00309751|7198681|FG001|COMPLETED|Overall Study||124
6296902|NCT00309751|7198680|FG000|NOT COMPLETED|Overall Study||31
6296903|NCT00309751|7198681|FG001|NOT COMPLETED|Overall Study||15
6296904|NCT00309777|7198691|FG000|STARTED|Overall Study||315
6296905|NCT00309777|7198692|FG001|STARTED|Overall Study||108
6296906|NCT00309777|7198693|FG002|STARTED|Overall Study||323
6296907|NCT00309777|7198694|FG003|STARTED|Overall Study||111
6296908|NCT00309777|7198691|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
6296909|NCT00309777|7198692|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
6296910|NCT00309777|7198693|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
6296911|NCT00309777|7198694|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
6296912|NCT00309777|7198691|FG000|COMPLETED|Overall Study||292
6296913|NCT00309777|7198692|FG001|COMPLETED|Overall Study||99
6296914|NCT00309777|7198693|FG002|COMPLETED|Overall Study||304
6296915|NCT00309777|7198694|FG003|COMPLETED|Overall Study||107
6296916|NCT00309777|7198691|FG000|NOT COMPLETED|Overall Study||23
6296917|NCT00309777|7198692|FG001|NOT COMPLETED|Overall Study||9
6296918|NCT00309777|7198693|FG002|NOT COMPLETED|Overall Study||19
6296919|NCT00309777|7198694|FG003|NOT COMPLETED|Overall Study||4
6296920|NCT00309842|7198704|FG000|STARTED|Overall Study||213
6296921|NCT00309842|7198704|FG000|COMPLETED|Overall Study||212
6296922|NCT00309842|7198704|FG000|NOT COMPLETED|Overall Study||1
6296923|NCT00309907|7198708|FG000|STARTED|Overall Study||39
6296924|NCT00309907|7198708|FG000|COMPLETED|Overall Study||19
6296925|NCT00309907|7198708|FG000|NOT COMPLETED|Overall Study||20
6296926|NCT00309946|7198713|FG000|STARTED|Overall Study||51
6296927|NCT00309946|7198713|FG000|COMPLETED|Overall Study||50
6296928|NCT00309946|7198713|FG000|NOT COMPLETED|Overall Study||1
6296929|NCT00309959|7198717|FG000|STARTED|Overall Study||37
6296930|NCT00309959|7198717|FG000|COMPLETED|Overall Study||35
6296931|NCT00309959|7198717|FG000|NOT COMPLETED|Overall Study||2
6296932|NCT00310037|7198728|FG000|STARTED|Overall Study||52
6296933|NCT00310037|7198729|FG001|STARTED|Overall Study||50
6296934|NCT00310037|7198728|FG000|COMPLETED|Overall Study||34
6296935|NCT00310037|7198729|FG001|COMPLETED|Overall Study||33
6296936|NCT00310037|7198728|FG000|NOT COMPLETED|Overall Study||18
6296937|NCT00310037|7198729|FG001|NOT COMPLETED|Overall Study||17
6635052|NCT02301416|7563918|FG001|COMPLETED|Overall Study||40
6635053|NCT02301416|7563917|FG000|NOT COMPLETED|Overall Study||10
6635054|NCT02301416|7563918|FG001|NOT COMPLETED|Overall Study||0
6635055|NCT02301429|7563924|FG000|STARTED|Overall Study||16
6635056|NCT02301429|7563924|FG000|COMPLETED|Overall Study||13
6635057|NCT02301429|7563924|FG000|NOT COMPLETED|Overall Study||3
6635058|NCT02301546|7563930|FG000|STARTED|Short-term Effectiveness (~13 Weeks)||73
6296938|NCT00310050|7198735|FG000|STARTED|Overall Study||4
6296939|NCT00310050|7198735|FG000|COMPLETED|Overall Study||3
6296940|NCT00310050|7198735|FG000|NOT COMPLETED|Overall Study||1
6296941|NCT00310076|7198739|FG000|STARTED|Overall Study||29
6296942|NCT00310076|7198739|FG000|COMPLETED|Overall Study||26
6296943|NCT00310076|7198739|FG000|NOT COMPLETED|Overall Study||3
6296944|NCT00310310|7198745|FG000|STARTED|Overall Study||120
6296945|NCT00310310|7198746|FG001|STARTED|Overall Study||120
6296946|NCT00310310|7198745|FG000|COMPLETED|Overall Study||90
6296947|NCT00310310|7198746|FG001|COMPLETED|Overall Study||100
6296948|NCT00310310|7198745|FG000|NOT COMPLETED|Overall Study||30
6296949|NCT00310310|7198746|FG001|NOT COMPLETED|Overall Study||20
6296950|NCT00310362|7198755|FG000|STARTED|Overall Study||1199
6296951|NCT00310362|7198756|FG001|STARTED|Overall Study||1205
6296952|NCT00310362|7198757|FG002|STARTED|Overall Study||1206
6296953|NCT00310362|7198755|FG000|COMPLETED|Overall Study||1199
6635059|NCT02301546|7563931|FG001|STARTED|Short-term Effectiveness (~13 Weeks)||73
6635060|NCT02301546|7563930|FG000|COMPLETED|Short-term Effectiveness (~13 Weeks)||55
6635061|NCT02301546|7563931|FG001|COMPLETED|Short-term Effectiveness (~13 Weeks)||58
6635062|NCT02301546|7563930|FG000|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||18
6635063|NCT02301546|7563931|FG001|NOT COMPLETED|Short-term Effectiveness (~13 Weeks)||15
6296954|NCT00310362|7198756|FG001|COMPLETED|Overall Study||1205
6296955|NCT00310362|7198757|FG002|COMPLETED|Overall Study||1206
6296956|NCT00310362|7198755|FG000|NOT COMPLETED|Overall Study||0
6296957|NCT00310362|7198756|FG001|NOT COMPLETED|Overall Study||0
6296958|NCT00310362|7198757|FG002|NOT COMPLETED|Overall Study||0
6296959|NCT00310375|7198773|FG000|STARTED|Primary Reporting Phase||102
6296960|NCT00310375|7198774|FG001|STARTED|Primary Reporting Phase||79
6296961|NCT00310375|7198775|FG002|STARTED|Primary Reporting Phase||0
6296962|NCT00310375|7198773|FG000|COMPLETED|Primary Reporting Phase||11
6296963|NCT00310375|7198774|FG001|COMPLETED|Primary Reporting Phase||11
6296964|NCT00310375|7198775|FG002|COMPLETED|Primary Reporting Phase||0
6296965|NCT00310375|7198773|FG000|NOT COMPLETED|Primary Reporting Phase||91
6296966|NCT00310375|7198774|FG001|NOT COMPLETED|Primary Reporting Phase||68
6296967|NCT00310375|7198775|FG002|NOT COMPLETED|Primary Reporting Phase||0
6296968|NCT00310375|7198773|FG000|STARTED|Safety Follow-up Continuation Phase||0
6296969|NCT00310375|7198774|FG001|STARTED|Safety Follow-up Continuation Phase||0
6296970|NCT00310375|7198775|FG002|STARTED|Safety Follow-up Continuation Phase||19
6296971|NCT00310375|7198773|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
6296972|NCT00310375|7198774|FG001|COMPLETED|Safety Follow-up Continuation Phase||0
6296973|NCT00310375|7198775|FG002|COMPLETED|Safety Follow-up Continuation Phase|Met the protocol defined stopping criteria|18
6296974|NCT00310375|7198773|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
6296975|NCT00310375|7198774|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||0
6296976|NCT00310375|7198775|FG002|NOT COMPLETED|Safety Follow-up Continuation Phase||1
6296977|NCT00310401|7198786|FG000|STARTED|Overall Study||260
6296978|NCT00310401|7198787|FG001|STARTED|Overall Study||246
6296979|NCT00310401|7198786|FG000|COMPLETED|Overall Study||260
6296980|NCT00310401|7198787|FG001|COMPLETED|Overall Study||246
6635064|NCT02301546|7563930|FG000|STARTED|Long Term Effectiveness (~1 Year)||55
6635065|NCT02301546|7563931|FG001|STARTED|Long Term Effectiveness (~1 Year)||58
6296981|NCT00310401|7198786|FG000|NOT COMPLETED|Overall Study||0
6296982|NCT00310401|7198787|FG001|NOT COMPLETED|Overall Study||0
6296983|NCT00310427|7198797|FG000|STARTED|Overall Study||27
6296984|NCT00310427|7198798|FG001|STARTED|Overall Study||26
6296985|NCT00310427|7198797|FG000|COMPLETED|Overall Study||25
6296986|NCT00310427|7198798|FG001|COMPLETED|Overall Study||25
6296987|NCT00310427|7198797|FG000|NOT COMPLETED|Overall Study||2
6296988|NCT00310427|7198798|FG001|NOT COMPLETED|Overall Study||1
6296989|NCT00310440|7198806|FG000|STARTED|Overall Study||165
6296990|NCT00310440|7198807|FG001|STARTED|Overall Study||154
6296991|NCT00310440|7198806|FG000|COMPLETED|Overall Study||139
6296992|NCT00310440|7198807|FG001|COMPLETED|Overall Study||141
6296993|NCT00310440|7198806|FG000|NOT COMPLETED|Overall Study||26
6296994|NCT00310440|7198807|FG001|NOT COMPLETED|Overall Study||13
6296995|NCT00310466|7198815|FG000|STARTED|Overall Study||113
6296996|NCT00310466|7198816|FG001|STARTED|Overall Study||113
6296997|NCT00310466|7198815|FG000|COMPLETED|Overall Study||95
6296998|NCT00310466|7198816|FG001|COMPLETED|Overall Study||101
6296999|NCT00310466|7198815|FG000|NOT COMPLETED|Overall Study||18
6297000|NCT00310466|7198816|FG001|NOT COMPLETED|Overall Study||12
6297001|NCT00310791|7198824|FG000|STARTED|Overall Study||40
6297002|NCT00310791|7198825|FG001|STARTED|Overall Study||40
6297003|NCT00310791|7198824|FG000|COMPLETED|Overall Study||30
6297004|NCT00310791|7198825|FG001|COMPLETED|Overall Study||30
6297005|NCT00310791|7198824|FG000|NOT COMPLETED|Overall Study||10
6297006|NCT00310791|7198825|FG001|NOT COMPLETED|Overall Study||10
6297007|NCT00310804|7198833|FG000|STARTED|Overall Study||1029
6297008|NCT00310804|7198834|FG001|STARTED|Overall Study||171
6297009|NCT00310804|7198833|FG000|COMPLETED|Overall Study||1024
6297010|NCT00310804|7198834|FG001|COMPLETED|Overall Study||171
6297011|NCT00310804|7198833|FG000|NOT COMPLETED|Overall Study||5
6297012|NCT00310804|7198834|FG001|NOT COMPLETED|Overall Study||0
6297013|NCT00310817|7198858|FG000|STARTED|Overall Study||207
6297014|NCT00310817|7198859|FG001|STARTED|Overall Study||206
6400913|NCT00888849|7313766|FG001|NOT COMPLETED|Overall Study||9
6400914|NCT00888927|7313776|FG000|STARTED|Overall Study||3
6400915|NCT00888927|7313777|FG001|STARTED|Overall Study||3
6297015|NCT00310817|7198860|FG002|STARTED|Overall Study||128
6297016|NCT00310817|7198861|FG003|STARTED|Overall Study||82
6297017|NCT00310817|7198858|FG000|COMPLETED|Overall Study||196
6297018|NCT00310817|7198859|FG001|COMPLETED|Overall Study||198
6297019|NCT00310817|7198860|FG002|COMPLETED|Overall Study||120
6297020|NCT00310817|7198861|FG003|COMPLETED|Overall Study||74
6297021|NCT00310817|7198858|FG000|NOT COMPLETED|Overall Study||11
6297022|NCT00310817|7198859|FG001|NOT COMPLETED|Overall Study||8
6297023|NCT00310817|7198860|FG002|NOT COMPLETED|Overall Study||8
6297024|NCT00310817|7198861|FG003|NOT COMPLETED|Overall Study||8
6297025|NCT00310856|7198907|FG000|STARTED|Overall Study||64
6297026|NCT00310856|7198908|FG001|STARTED|Overall Study||61
6297027|NCT00310856|7198909|FG002|STARTED|Overall Study||50
6297028|NCT00310856|7198907|FG000|COMPLETED|Overall Study||59
6297029|NCT00310856|7198908|FG001|COMPLETED|Overall Study||56
6297030|NCT00310856|7198909|FG002|COMPLETED|Overall Study||42
6297031|NCT00310856|7198907|FG000|NOT COMPLETED|Overall Study||5
6297032|NCT00310856|7198908|FG001|NOT COMPLETED|Overall Study||5
6297033|NCT00310856|7198909|FG002|NOT COMPLETED|Overall Study||8
6400916|NCT00888927|7313778|FG002|STARTED|Overall Study||3
6400917|NCT00888927|7313779|FG003|STARTED|Overall Study||33
6400918|NCT00888927|7313776|FG000|COMPLETED|Overall Study||3
6400919|NCT00888927|7313777|FG001|COMPLETED|Overall Study||3
6400920|NCT00888927|7313778|FG002|COMPLETED|Overall Study||3
6297034|NCT00311155|7198918|FG000|STARTED|Overall Study||694
6297035|NCT00311155|7198918|FG000|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
6297036|NCT00311155|7198918|FG000|NOT COMPLETED|Overall Study||93
6297037|NCT00311168|7198924|FG000|STARTED|First Intervention||66
6297038|NCT00311168|7198925|FG001|STARTED|First Intervention||68
6297039|NCT00311168|7198924|FG000|COMPLETED|First Intervention||59
6297040|NCT00311168|7198925|FG001|COMPLETED|First Intervention||62
6297041|NCT00311168|7198924|FG000|NOT COMPLETED|First Intervention||7
6297042|NCT00311168|7198925|FG001|NOT COMPLETED|First Intervention||6
6297043|NCT00311168|7198924|FG000|STARTED|Second Intervention||59
6297044|NCT00311168|7198925|FG001|STARTED|Second Intervention||62
6297045|NCT00311168|7198924|FG000|COMPLETED|Second Intervention||49
6297046|NCT00311168|7198925|FG001|COMPLETED|Second Intervention||58
6297047|NCT00311168|7198924|FG000|NOT COMPLETED|Second Intervention||10
6297048|NCT00311168|7198925|FG001|NOT COMPLETED|Second Intervention||4
6297049|NCT00311181|7198933|FG000|STARTED|Overall Study||217
6297050|NCT00311181|7198933|FG000|COMPLETED|Overall Study||121
6297051|NCT00311181|7198933|FG000|NOT COMPLETED|Overall Study||96
6297052|NCT00311246|7198937|FG000|STARTED|Overall Study||11
6297053|NCT00311246|7198937|FG000|COMPLETED|Overall Study||11
6297054|NCT00311246|7198937|FG000|NOT COMPLETED|Overall Study||0
6297055|NCT00311311|7198946|FG000|STARTED|Overall Study||37
6297056|NCT00311311|7198947|FG001|STARTED|Overall Study||35
6297057|NCT00311311|7198946|FG000|COMPLETED|Overall Study||29
6297058|NCT00311311|7198947|FG001|COMPLETED|Overall Study||26
6297059|NCT00311311|7198946|FG000|NOT COMPLETED|Overall Study||8
6297060|NCT00311311|7198947|FG001|NOT COMPLETED|Overall Study||9
6297061|NCT00311363|7198956|FG000|STARTED|24-Week Single-Blind Treatment Period||327
6297062|NCT00311363|7198957|FG001|STARTED|24-Week Single-Blind Treatment Period||0
6635066|NCT02301546|7563930|FG000|COMPLETED|Long Term Effectiveness (~1 Year)||43
6297063|NCT00311363|7198958|FG002|STARTED|24-Week Single-Blind Treatment Period||0
6297064|NCT00311363|7198956|FG000|COMPLETED|24-Week Single-Blind Treatment Period||221
6400921|NCT00888927|7313779|FG003|COMPLETED|Overall Study||31
6400922|NCT00888927|7313776|FG000|NOT COMPLETED|Overall Study||0
6297065|NCT00311363|7198957|FG001|COMPLETED|24-Week Single-Blind Treatment Period||0
6297066|NCT00311363|7198958|FG002|COMPLETED|24-Week Single-Blind Treatment Period||0
6297067|NCT00311363|7198956|FG000|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
6297068|NCT00311363|7198957|FG001|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
6297069|NCT00311363|7198958|FG002|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
6297070|NCT00311363|7198956|FG000|STARTED|12-Week Double-Blind Treatment Period||0
6297071|NCT00311363|7198957|FG001|STARTED|12-Week Double-Blind Treatment Period||98
6297072|NCT00311363|7198958|FG002|STARTED|12-Week Double-Blind Treatment Period||96
6297073|NCT00311363|7198956|FG000|COMPLETED|12-Week Double-Blind Treatment Period||0
6297074|NCT00311363|7198957|FG001|COMPLETED|12-Week Double-Blind Treatment Period||84
6297075|NCT00311363|7198958|FG002|COMPLETED|12-Week Double-Blind Treatment Period||84
6297076|NCT00311363|7198956|FG000|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
6297077|NCT00311363|7198957|FG001|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
6297078|NCT00311363|7198958|FG002|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
6297079|NCT00311376|7198971|FG000|STARTED|Treatment Cycle 1||132
6297080|NCT00311376|7198972|FG001|STARTED|Treatment Cycle 1||135
6297081|NCT00311376|7198973|FG002|STARTED|Treatment Cycle 1||149
6297082|NCT00311376|7198971|FG000|COMPLETED|Treatment Cycle 1||105
6297083|NCT00311376|7198972|FG001|COMPLETED|Treatment Cycle 1||118
6297084|NCT00311376|7198973|FG002|COMPLETED|Treatment Cycle 1||132
6297085|NCT00311376|7198971|FG000|NOT COMPLETED|Treatment Cycle 1||27
6297086|NCT00311376|7198972|FG001|NOT COMPLETED|Treatment Cycle 1||17
6297087|NCT00311376|7198973|FG002|NOT COMPLETED|Treatment Cycle 1||17
6297088|NCT00311376|7198971|FG000|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
6297089|NCT00311376|7198972|FG001|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
6297090|NCT00311376|7198973|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
6297091|NCT00311376|7198971|FG000|COMPLETED|Treatment Cycle 2||106
6297092|NCT00311376|7198972|FG001|COMPLETED|Treatment Cycle 2||112
6297093|NCT00311376|7198973|FG002|COMPLETED|Treatment Cycle 2||0
6297094|NCT00311376|7198971|FG000|NOT COMPLETED|Treatment Cycle 2||9
6297095|NCT00311376|7198972|FG001|NOT COMPLETED|Treatment Cycle 2||13
6297096|NCT00311376|7198973|FG002|NOT COMPLETED|Treatment Cycle 2||0
6297097|NCT00311402|7198983|FG000|STARTED|Overall Study||655
6297098|NCT00311402|7198984|FG001|STARTED|Overall Study||639
6297099|NCT00311402|7198983|FG000|COMPLETED|Overall Study||445
6297100|NCT00311402|7198984|FG001|COMPLETED|Overall Study||462
6297101|NCT00311402|7198983|FG000|NOT COMPLETED|Overall Study||210
6297102|NCT00311402|7198984|FG001|NOT COMPLETED|Overall Study||177
6297103|NCT00311584|7198992|FG000|STARTED|Overall Study||29
6297104|NCT00311584|7198993|FG001|STARTED|Overall Study||30
6297105|NCT00311584|7198992|FG000|COMPLETED|Overall Study||9
6297106|NCT00311584|7198993|FG001|COMPLETED|Overall Study||7
6297107|NCT00311584|7198992|FG000|NOT COMPLETED|Overall Study||20
6297108|NCT00311584|7198993|FG001|NOT COMPLETED|Overall Study||23
6297109|NCT00311623|7199002|FG000|STARTED|Overall Study||10
6297110|NCT00311623|7199003|FG001|STARTED|Overall Study||20
6400923|NCT00888927|7313777|FG001|NOT COMPLETED|Overall Study||0
6400924|NCT00888927|7313778|FG002|NOT COMPLETED|Overall Study||0
6635067|NCT02301546|7563931|FG001|COMPLETED|Long Term Effectiveness (~1 Year)||51
6297111|NCT00311623|7199004|FG002|STARTED|Overall Study||2
6297112|NCT00311623|7199002|FG000|COMPLETED|Overall Study||10
6297113|NCT00311623|7199003|FG001|COMPLETED|Overall Study||20
6297114|NCT00311623|7199004|FG002|COMPLETED|Overall Study||0
6297115|NCT00311623|7199002|FG000|NOT COMPLETED|Overall Study||0
6297116|NCT00311623|7199003|FG001|NOT COMPLETED|Overall Study||0
6297117|NCT00311623|7199004|FG002|NOT COMPLETED|Overall Study||2
6297118|NCT00311766|7199015|FG000|STARTED|Overall Study||8
6297119|NCT00311766|7199016|FG001|STARTED|Overall Study||22
6297120|NCT00311766|7199015|FG000|COMPLETED|Overall Study||8
6297121|NCT00311766|7199016|FG001|COMPLETED|Overall Study||17
6297122|NCT00311766|7199015|FG000|NOT COMPLETED|Overall Study||0
6297123|NCT00311766|7199016|FG001|NOT COMPLETED|Overall Study||5
6297124|NCT00312195|7199024|FG000|STARTED|Overall Study||138
6297125|NCT00312195|7199025|FG001|STARTED|Overall Study||129
6297126|NCT00312195|7199024|FG000|COMPLETED|Overall Study||132
6297127|NCT00312195|7199025|FG001|COMPLETED|Overall Study||123
6297128|NCT00312195|7199024|FG000|NOT COMPLETED|Overall Study||6
6297129|NCT00312195|7199025|FG001|NOT COMPLETED|Overall Study||6
6297130|NCT00312208|7199035|FG000|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
6297131|NCT00312208|7199036|FG001|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
6297132|NCT00312208|7199035|FG000|COMPLETED|Overall Study||1477
6297133|NCT00312208|7199036|FG001|COMPLETED|Overall Study||1526
6297134|NCT00312208|7199035|FG000|NOT COMPLETED|Overall Study||172
6297135|NCT00312208|7199036|FG001|NOT COMPLETED|Overall Study||123
6297136|NCT00312221|7199045|FG000|STARTED|Open-label Run-in Period||652
6297137|NCT00312221|7199046|FG001|STARTED|Open-label Run-in Period||0
6297138|NCT00312221|7199047|FG002|STARTED|Open-label Run-in Period||0
6297139|NCT00312221|7199048|FG003|STARTED|Open-label Run-in Period||0
6297140|NCT00312221|7199045|FG000|COMPLETED|Open-label Run-in Period||418
6297141|NCT00312221|7199046|FG001|COMPLETED|Open-label Run-in Period||0
6297142|NCT00312221|7199047|FG002|COMPLETED|Open-label Run-in Period||0
6297143|NCT00312221|7199048|FG003|COMPLETED|Open-label Run-in Period||0
6297144|NCT00312221|7199045|FG000|NOT COMPLETED|Open-label Run-in Period||234
6297145|NCT00312221|7199046|FG001|NOT COMPLETED|Open-label Run-in Period||0
6297146|NCT00312221|7199047|FG002|NOT COMPLETED|Open-label Run-in Period||0
6297147|NCT00312221|7199048|FG003|NOT COMPLETED|Open-label Run-in Period||0
6297148|NCT00312221|7199045|FG000|STARTED|Double-blind Phase||0
6297149|NCT00312221|7199046|FG001|STARTED|Double-blind Phase||136
6297150|NCT00312221|7199047|FG002|STARTED|Double-blind Phase||149
6297151|NCT00312221|7199048|FG003|STARTED|Double-blind Phase||133
6297152|NCT00312221|7199045|FG000|COMPLETED|Double-blind Phase||0
6297153|NCT00312221|7199046|FG001|COMPLETED|Double-blind Phase||77
6297154|NCT00312221|7199047|FG002|COMPLETED|Double-blind Phase||77
6297155|NCT00312221|7199048|FG003|COMPLETED|Double-blind Phase||63
6297156|NCT00312221|7199045|FG000|NOT COMPLETED|Double-blind Phase||0
6297157|NCT00312221|7199046|FG001|NOT COMPLETED|Double-blind Phase||59
6297158|NCT00312221|7199047|FG002|NOT COMPLETED|Double-blind Phase||72
6297159|NCT00312221|7199048|FG003|NOT COMPLETED|Double-blind Phase||70
6297160|NCT00312338|7199059|FG000|STARTED|Overall Study||105
6297161|NCT00312338|7199060|FG001|STARTED|Overall Study||57
6297162|NCT00312338|7199059|FG000|COMPLETED|Overall Study||83
6297163|NCT00312338|7199060|FG001|COMPLETED|Overall Study||54
6297164|NCT00312338|7199059|FG000|NOT COMPLETED|Overall Study||22
6297165|NCT00312338|7199060|FG001|NOT COMPLETED|Overall Study||3
6297166|NCT00312377|7199068|FG000|STARTED|Overall Study|randomised patients|694
6297167|NCT00312377|7199069|FG001|STARTED|Overall Study|randomised patients|697
6297168|NCT00312377|7199068|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
6297169|NCT00312377|7199069|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
6297170|NCT00312377|7199068|FG000|NOT COMPLETED|Overall Study||644
6297171|NCT00312377|7199069|FG001|NOT COMPLETED|Overall Study||668
6297172|NCT00312494|7199078|FG000|STARTED|Overall Study||232
6297173|NCT00312494|7199079|FG001|STARTED|Overall Study||226
6297174|NCT00312494|7199080|FG002|STARTED|Overall Study||222
6400925|NCT00888927|7313779|FG003|NOT COMPLETED|Overall Study||2
6297175|NCT00312494|7199078|FG000|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
6297176|NCT00312494|7199079|FG001|Received Study Treatment|Overall Study||216
6297177|NCT00312494|7199080|FG002|Received Study Treatment|Overall Study||217
6297178|NCT00312494|7199078|FG000|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
6297179|NCT00312494|7199079|FG001|COMPLETED|Overall Study||168
6297180|NCT00312494|7199080|FG002|COMPLETED|Overall Study||179
6297181|NCT00312494|7199078|FG000|NOT COMPLETED|Overall Study||71
6297182|NCT00312494|7199079|FG001|NOT COMPLETED|Overall Study||58
6297183|NCT00312494|7199080|FG002|NOT COMPLETED|Overall Study||43
6297184|NCT00312572|7199090|FG000|STARTED|Overall Study||101
6297185|NCT00312572|7199091|FG001|STARTED|Overall Study||103
6297186|NCT00312572|7199090|FG000|COMPLETED|Overall Study||85
6297187|NCT00312572|7199091|FG001|COMPLETED|Overall Study||82
6297188|NCT00312572|7199090|FG000|NOT COMPLETED|Overall Study||16
6297189|NCT00312572|7199091|FG001|NOT COMPLETED|Overall Study||21
6297190|NCT00312663|7199102|FG000|STARTED|Immunization Phase||5
6297191|NCT00312663|7199103|FG001|STARTED|Immunization Phase||13
6297192|NCT00312663|7199104|FG002|STARTED|Immunization Phase||0
6297193|NCT00312663|7199102|FG000|COMPLETED|Immunization Phase||5
6400926|NCT00888940|7313791|FG000|STARTED|Overall Study||120
6400927|NCT00888940|7313792|FG001|STARTED|Overall Study||122
6297194|NCT00312663|7199103|FG001|COMPLETED|Immunization Phase||12
6297195|NCT00312663|7199104|FG002|COMPLETED|Immunization Phase||0
6297196|NCT00312663|7199102|FG000|NOT COMPLETED|Immunization Phase||0
6297197|NCT00312663|7199103|FG001|NOT COMPLETED|Immunization Phase||1
6297198|NCT00312663|7199104|FG002|NOT COMPLETED|Immunization Phase||0
6297199|NCT00312663|7199102|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
6297200|NCT00312663|7199103|FG001|STARTED|Challenge Phase|10 subjects from the high dose group participated in the challenge phase|10
6635068|NCT02301546|7563930|FG000|NOT COMPLETED|Long Term Effectiveness (~1 Year)||12
6635069|NCT02301546|7563931|FG001|NOT COMPLETED|Long Term Effectiveness (~1 Year)||7
6635070|NCT02301624|7563939|FG000|STARTED|Blind Induction Phase||56
6635071|NCT02301624|7563940|FG001|STARTED|Blind Induction Phase||61
6635072|NCT02301624|7563939|FG000|Received at Least 1 Dose of Study Drug|Blind Induction Phase||56
6635073|NCT02301624|7563940|FG001|Received at Least 1 Dose of Study Drug|Blind Induction Phase||61
6635074|NCT02301624|7563939|FG000|COMPLETED|Blind Induction Phase||55
6635075|NCT02301624|7563940|FG001|COMPLETED|Blind Induction Phase||61
6635076|NCT02301624|7563939|FG000|NOT COMPLETED|Blind Induction Phase||1
6635077|NCT02301624|7563940|FG001|NOT COMPLETED|Blind Induction Phase||0
6635078|NCT02301624|7563939|FG000|STARTED|Open-label Maintenance Phase||55
6635079|NCT02301624|7563940|FG001|STARTED|Open-label Maintenance Phase||61
6635080|NCT02301624|7563939|FG000|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||55
6635081|NCT02301624|7563940|FG001|Received at Least 1 Dose of Study Drug|Open-label Maintenance Phase||61
6635082|NCT02301624|7563939|FG000|COMPLETED|Open-label Maintenance Phase||43
6297201|NCT00312663|7199104|FG002|STARTED|Challenge Phase|6 non-immunized subjects participated in the challenge phase|6
6297202|NCT00312663|7199102|FG000|COMPLETED|Challenge Phase||0
6297203|NCT00312663|7199103|FG001|COMPLETED|Challenge Phase||10
6297204|NCT00312663|7199104|FG002|COMPLETED|Challenge Phase||6
6297205|NCT00312663|7199102|FG000|NOT COMPLETED|Challenge Phase||0
6297206|NCT00312663|7199103|FG001|NOT COMPLETED|Challenge Phase||0
6297207|NCT00312663|7199104|FG002|NOT COMPLETED|Challenge Phase||0
6297208|NCT00312702|7199116|FG000|STARTED|Immunization Phase||5
6297209|NCT00312702|7199117|FG001|STARTED|Immunization Phase||13
6297210|NCT00312702|7199118|FG002|STARTED|Immunization Phase||0
6297211|NCT00312702|7199116|FG000|COMPLETED|Immunization Phase||5
6297212|NCT00312702|7199117|FG001|COMPLETED|Immunization Phase||12
6297213|NCT00312702|7199118|FG002|COMPLETED|Immunization Phase||0
6297214|NCT00312702|7199116|FG000|NOT COMPLETED|Immunization Phase||0
6297215|NCT00312702|7199117|FG001|NOT COMPLETED|Immunization Phase||1
6297216|NCT00312702|7199118|FG002|NOT COMPLETED|Immunization Phase||0
6297217|NCT00312702|7199116|FG000|STARTED|Challenge Phase|low dose subjects didn't participate in the challenge phase|0
6297218|NCT00312702|7199117|FG001|STARTED|Challenge Phase|12 subjects from the high dose group participated in the challenge phase|12
6297219|NCT00312702|7199118|FG002|STARTED|Challenge Phase|1 non-immunized subjects participated in the challenge phase.|1
6297220|NCT00312702|7199116|FG000|COMPLETED|Challenge Phase||0
6297221|NCT00312702|7199117|FG001|COMPLETED|Challenge Phase||12
6297222|NCT00312702|7199118|FG002|COMPLETED|Challenge Phase||1
6297223|NCT00312702|7199116|FG000|NOT COMPLETED|Challenge Phase||0
6297224|NCT00312702|7199117|FG001|NOT COMPLETED|Challenge Phase||0
6297225|NCT00312702|7199118|FG002|NOT COMPLETED|Challenge Phase||0
6297226|NCT00312728|7199126|FG000|STARTED|Overall Study||115
6297227|NCT00312728|7199126|FG000|COMPLETED|Overall Study||5
6297228|NCT00312728|7199126|FG000|NOT COMPLETED|Overall Study||110
6297229|NCT00312845|7199132|FG000|STARTED|Overall Study||336
6297230|NCT00312845|7199133|FG001|STARTED|Overall Study||340
6297231|NCT00312845|7199132|FG000|COMPLETED|Overall Study||237
6297232|NCT00312845|7199133|FG001|COMPLETED|Overall Study||245
6297233|NCT00312845|7199132|FG000|NOT COMPLETED|Overall Study||99
6400928|NCT00888940|7313791|FG000|Completed Therapy|Overall Study||107
6400929|NCT00888940|7313792|FG001|Completed Therapy|Overall Study||106
6400930|NCT00888940|7313791|FG000|COMPLETED|Overall Study||92
6400931|NCT00888940|7313792|FG001|COMPLETED|Overall Study||101
6400932|NCT00888940|7313791|FG000|NOT COMPLETED|Overall Study||28
6400933|NCT00888940|7313792|FG001|NOT COMPLETED|Overall Study||21
6400934|NCT00888979|7313798|FG000|STARTED|Overall Study||10
6297234|NCT00312845|7199133|FG001|NOT COMPLETED|Overall Study||95
6400935|NCT00888979|7313798|FG000|Received the Inhaler/Counseling|Overall Study||8
6400936|NCT00888979|7313798|FG000|COMPLETED|Overall Study||6
6635083|NCT02301624|7563940|FG001|COMPLETED|Open-label Maintenance Phase||44
6635084|NCT02301624|7563939|FG000|NOT COMPLETED|Open-label Maintenance Phase||12
6635085|NCT02301624|7563940|FG001|NOT COMPLETED|Open-label Maintenance Phase||17
6297235|NCT00312858|7199141|FG000|STARTED|Overall Study||330
6297236|NCT00312858|7199142|FG001|STARTED|Overall Study||323
6297237|NCT00312858|7199141|FG000|Visit 1|Overall Study||330
6297238|NCT00312858|7199142|FG001|Visit 1|Overall Study||323
6297239|NCT00312858|7199141|FG000|Visit 2|Overall Study||305
6297240|NCT00312858|7199142|FG001|Visit 2|Overall Study||294
6297241|NCT00312858|7199141|FG000|Visit 3|Overall Study||273
6297242|NCT00312858|7199142|FG001|Visit 3|Overall Study||261
6297243|NCT00312858|7199141|FG000|Visit 4|Overall Study||262
6297244|NCT00312858|7199142|FG001|Visit 4|Overall Study||240
6297245|NCT00312858|7199141|FG000|COMPLETED|Overall Study||262
6297246|NCT00312858|7199142|FG001|COMPLETED|Overall Study||230
6297247|NCT00312858|7199141|FG000|NOT COMPLETED|Overall Study||68
6297248|NCT00312858|7199142|FG001|NOT COMPLETED|Overall Study||93
6400937|NCT00888979|7313798|FG000|NOT COMPLETED|Overall Study||4
6400938|NCT00889005|7313804|FG000|STARTED|Overall Study||65
6297249|NCT00312884|7199150|FG000|STARTED|Overall Study||91
6297250|NCT00312884|7199151|FG001|STARTED|Overall Study||91
6297251|NCT00312884|7199150|FG000|COMPLETED|Overall Study||74
6297252|NCT00312884|7199151|FG001|COMPLETED|Overall Study||79
6297253|NCT00312884|7199150|FG000|NOT COMPLETED|Overall Study||17
6297254|NCT00312884|7199151|FG001|NOT COMPLETED|Overall Study||12
6297255|NCT00312897|7199159|FG000|STARTED|Overall Study||27
6297256|NCT00312897|7199160|FG001|STARTED|Overall Study||24
6297257|NCT00312897|7199159|FG000|COMPLETED|Overall Study||21
6297258|NCT00312897|7199160|FG001|COMPLETED|Overall Study||18
6297259|NCT00312897|7199159|FG000|NOT COMPLETED|Overall Study||6
6297260|NCT00312897|7199160|FG001|NOT COMPLETED|Overall Study||6
6297261|NCT00312923|7199168|FG000|STARTED|Overall Study||28
6297262|NCT00312923|7199169|FG001|STARTED|Overall Study||26
6297263|NCT00312923|7199168|FG000|COMPLETED|Overall Study||19
6297264|NCT00312923|7199169|FG001|COMPLETED|Overall Study||20
6297265|NCT00312923|7199168|FG000|NOT COMPLETED|Overall Study||9
6297266|NCT00312923|7199169|FG001|NOT COMPLETED|Overall Study||6
6297267|NCT00313014|7199178|FG000|STARTED|Overall Study||221
6297268|NCT00313014|7199179|FG001|STARTED|Overall Study||219
6297269|NCT00313014|7199180|FG002|STARTED|Overall Study||220
6297270|NCT00313014|7199178|FG000|COMPLETED|Overall Study||128
6297271|NCT00313014|7199179|FG001|COMPLETED|Overall Study||146
6297272|NCT00313014|7199180|FG002|COMPLETED|Overall Study||159
6297273|NCT00313014|7199178|FG000|NOT COMPLETED|Overall Study||93
6297274|NCT00313014|7199179|FG001|NOT COMPLETED|Overall Study||73
6297275|NCT00313014|7199180|FG002|NOT COMPLETED|Overall Study||61
6297276|NCT00313144|7199189|FG000|STARTED|Overall Study||127
6297277|NCT00313144|7199189|FG000|COMPLETED|Overall Study||17
6297278|NCT00313144|7199189|FG000|NOT COMPLETED|Overall Study||110
6297279|NCT00313170|7199205|FG000|STARTED|Overall Study||47
6297280|NCT00313170|7199206|FG001|STARTED|Overall Study||51
6297281|NCT00313170|7199207|FG002|STARTED|Overall Study||46
6297282|NCT00313170|7199205|FG000|COMPLETED|Overall Study||11
6400939|NCT00889005|7313805|FG001|STARTED|Overall Study||74
6400940|NCT00889005|7313804|FG000|COMPLETED|Overall Study||57
6400941|NCT00889005|7313805|FG001|COMPLETED|Overall Study||72
6400942|NCT00889005|7313804|FG000|NOT COMPLETED|Overall Study||8
6400943|NCT00889005|7313805|FG001|NOT COMPLETED|Overall Study||2
6400944|NCT00889187|7313811|FG000|STARTED|Overall Study||3
6400945|NCT00889187|7313812|FG001|STARTED|Overall Study||3
6400946|NCT00889187|7313813|FG002|STARTED|Overall Study||4
6400947|NCT00889187|7313814|FG003|STARTED|Overall Study||0
6400948|NCT00889187|7313811|FG000|COMPLETED|Overall Study||3
6400949|NCT00889187|7313812|FG001|COMPLETED|Overall Study||3
6400950|NCT00889187|7313813|FG002|COMPLETED|Overall Study||4
6400951|NCT00889187|7313814|FG003|COMPLETED|Overall Study||0
6400952|NCT00889187|7313811|FG000|NOT COMPLETED|Overall Study||0
6400953|NCT00889187|7313812|FG001|NOT COMPLETED|Overall Study||0
6400954|NCT00889187|7313813|FG002|NOT COMPLETED|Overall Study||0
6400955|NCT00889187|7313814|FG003|NOT COMPLETED|Overall Study||0
6400956|NCT00889200|7313824|FG000|STARTED|Overall Study||12
6400957|NCT00889200|7313824|FG000|COMPLETED|Overall Study||12
6400958|NCT00889200|7313824|FG000|NOT COMPLETED|Overall Study||0
6400959|NCT00889226|7313830|FG000|STARTED|Overall Study||83
6400960|NCT00889226|7313831|FG001|STARTED|Overall Study||78
6400961|NCT00889226|7313830|FG000|COMPLETED|Overall Study||58
6400962|NCT00889226|7313831|FG001|COMPLETED|Overall Study||43
6400963|NCT00889226|7313830|FG000|NOT COMPLETED|Overall Study||25
6400964|NCT00889226|7313831|FG001|NOT COMPLETED|Overall Study||35
6400965|NCT00889252|7313839|FG000|STARTED|Overall Study||168
6400966|NCT00889252|7313840|FG001|STARTED|Overall Study||82
6400967|NCT00889252|7313839|FG000|COMPLETED|Overall Study||161
6400968|NCT00889252|7313840|FG001|COMPLETED|Overall Study||78
6400969|NCT00889252|7313839|FG000|NOT COMPLETED|Overall Study||7
6400970|NCT00889252|7313840|FG001|NOT COMPLETED|Overall Study||4
6400971|NCT00889265|7313846|FG000|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
6400972|NCT00889265|7313846|FG000|COMPLETED|Overall Study||44
6400973|NCT00889265|7313846|FG000|NOT COMPLETED|Overall Study||7
6400974|NCT00889330|7313852|FG000|STARTED|Overall Study||30
6400975|NCT00889330|7313853|FG001|STARTED|Overall Study||30
6400976|NCT00889330|7313852|FG000|COMPLETED|Overall Study||30
6400977|NCT00889330|7313853|FG001|COMPLETED|Overall Study||30
6400978|NCT00889330|7313852|FG000|NOT COMPLETED|Overall Study||0
6400979|NCT00889330|7313853|FG001|NOT COMPLETED|Overall Study||0
6400980|NCT00889512|7313861|FG000|STARTED|Overall Study||5
6400981|NCT00889512|7313862|FG001|STARTED|Overall Study||9
6400982|NCT00889512|7313861|FG000|COMPLETED|Overall Study||5
6400983|NCT00889512|7313862|FG001|COMPLETED|Overall Study||9
6297283|NCT00313170|7199206|FG001|COMPLETED|Overall Study||17
6297284|NCT00313170|7199207|FG002|COMPLETED|Overall Study||14
6297285|NCT00313170|7199205|FG000|NOT COMPLETED|Overall Study||36
6297286|NCT00313170|7199206|FG001|NOT COMPLETED|Overall Study||34
6297287|NCT00313170|7199207|FG002|NOT COMPLETED|Overall Study||32
6297288|NCT00313209|7199218|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
6297289|NCT00313209|7199219|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
6297290|NCT00313209|7199218|FG000|COMPLETED|Overall Study||359
6400984|NCT00889512|7313861|FG000|NOT COMPLETED|Overall Study||0
6400985|NCT00889512|7313862|FG001|NOT COMPLETED|Overall Study||0
6400986|NCT00889603|7313868|FG000|STARTED|Overall Study||370
6400987|NCT00889603|7313868|FG000|COMPLETED|Overall Study||333
6297291|NCT00313209|7199219|FG001|COMPLETED|Overall Study||385
6297292|NCT00313209|7199218|FG000|NOT COMPLETED|Overall Study||107
6297293|NCT00313209|7199219|FG001|NOT COMPLETED|Overall Study||82
6297294|NCT00313300|7199230|FG000|STARTED|Randomized in Phase A (26 Weeks)||184
6297295|NCT00313300|7199231|FG001|STARTED|Randomized in Phase A (26 Weeks)||179
6297296|NCT00313300|7199232|FG002|STARTED|Randomized in Phase A (26 Weeks)||184
6297297|NCT00313300|7199233|FG003|STARTED|Randomized in Phase A (26 Weeks)||0
6297298|NCT00313300|7199234|FG004|STARTED|Randomized in Phase A (26 Weeks)||0
6297299|NCT00313300|7199230|FG000|COMPLETED|Randomized in Phase A (26 Weeks)||130
6297300|NCT00313300|7199231|FG001|COMPLETED|Randomized in Phase A (26 Weeks)||140
6297301|NCT00313300|7199232|FG002|COMPLETED|Randomized in Phase A (26 Weeks)||149
6297302|NCT00313300|7199233|FG003|COMPLETED|Randomized in Phase A (26 Weeks)||0
6297303|NCT00313300|7199234|FG004|COMPLETED|Randomized in Phase A (26 Weeks)||0
6297304|NCT00313300|7199230|FG000|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
6297305|NCT00313300|7199231|FG001|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
6297306|NCT00313300|7199232|FG002|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
6297307|NCT00313300|7199233|FG003|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
6297308|NCT00313300|7199234|FG004|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
6297309|NCT00313300|7199230|FG000|STARTED|Randomized in Phase B (26 Weeks)||427
6297310|NCT00313300|7199231|FG001|STARTED|Randomized in Phase B (26 Weeks)||138
6297311|NCT00313300|7199232|FG002|STARTED|Randomized in Phase B (26 Weeks)||134
6297312|NCT00313300|7199233|FG003|STARTED|Randomized in Phase B (26 Weeks)||248
6297313|NCT00313300|7199234|FG004|STARTED|Randomized in Phase B (26 Weeks)||221
6297314|NCT00313300|7199230|FG000|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
6297315|NCT00313300|7199231|FG001|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
6297316|NCT00313300|7199232|FG002|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
6297317|NCT00313300|7199233|FG003|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
6297318|NCT00313300|7199234|FG004|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
6635086|NCT02301793|7563949|FG000|STARTED|Pre Education Study Period|Nurses had not been randomized|
6635087|NCT02301793|7563950|FG001|STARTED|Pre Education Study Period|Nurses had not been randomized|
6635088|NCT02301793|7563949|FG000|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
6635089|NCT02301793|7563950|FG001|COMPLETED|Pre Education Study Period|Nurses had not been randomized|
6635090|NCT02301793|7563949|FG000|NOT COMPLETED|Pre Education Study Period||
6635091|NCT02301793|7563950|FG001|NOT COMPLETED|Pre Education Study Period||
6635092|NCT02301793|7563949|FG000|STARTED|During and Post Education Study Period||488
6635093|NCT02301793|7563950|FG001|STARTED|During and Post Education Study Period||445
6635094|NCT02301793|7563949|FG000|COMPLETED|During and Post Education Study Period||405
6635095|NCT02301793|7563950|FG001|COMPLETED|During and Post Education Study Period||396
6635096|NCT02301793|7563949|FG000|NOT COMPLETED|During and Post Education Study Period||83
6635097|NCT02301793|7563950|FG001|NOT COMPLETED|During and Post Education Study Period||49
6635098|NCT02301897|7563959|FG000|STARTED|Treatment Course 1||12
6635099|NCT02301897|7563960|FG001|STARTED|Treatment Course 1||17
6635100|NCT02301897|7563961|FG002|STARTED|Treatment Course 1||14
6635101|NCT02301897|7563959|FG000|COMPLETED|Treatment Course 1||9
6635102|NCT02301897|7563960|FG001|COMPLETED|Treatment Course 1||14
6635103|NCT02301897|7563961|FG002|COMPLETED|Treatment Course 1||8
6635104|NCT02301897|7563959|FG000|NOT COMPLETED|Treatment Course 1||3
6635105|NCT02301897|7563960|FG001|NOT COMPLETED|Treatment Course 1||3
6635106|NCT02301897|7563961|FG002|NOT COMPLETED|Treatment Course 1||6
6635107|NCT02301897|7563959|FG000|STARTED|Treatment Course 2||9
6635108|NCT02301897|7563960|FG001|STARTED|Treatment Course 2||14
6635109|NCT02301897|7563961|FG002|STARTED|Treatment Course 2||8
6635110|NCT02301897|7563959|FG000|COMPLETED|Treatment Course 2||8
6635111|NCT02301897|7563960|FG001|COMPLETED|Treatment Course 2||9
6635112|NCT02301897|7563961|FG002|COMPLETED|Treatment Course 2||7
6635113|NCT02301897|7563959|FG000|NOT COMPLETED|Treatment Course 2||1
6635114|NCT02301897|7563960|FG001|NOT COMPLETED|Treatment Course 2||5
6635115|NCT02301897|7563961|FG002|NOT COMPLETED|Treatment Course 2||1
6635116|NCT02301936|7563971|FG000|STARTED|Overall Study||9
6297319|NCT00313300|7199230|FG000|COMPLETED|Randomized in Phase B (26 Weeks)||333
6297320|NCT00313300|7199231|FG001|COMPLETED|Randomized in Phase B (26 Weeks)||105
6297321|NCT00313300|7199232|FG002|COMPLETED|Randomized in Phase B (26 Weeks)||94
6400988|NCT00889603|7313868|FG000|NOT COMPLETED|Overall Study||37
6400989|NCT00889681|7313872|FG000|STARTED|Overall Study||81
6400990|NCT00889681|7313872|FG000|Received Treatment|Overall Study||78
6400991|NCT00889681|7313872|FG000|COMPLETED|Overall Study||78
6400992|NCT00889681|7313872|FG000|NOT COMPLETED|Overall Study||3
6400993|NCT00889707|7313878|FG000|STARTED|Overall Study||61
6297322|NCT00313300|7199233|FG003|COMPLETED|Randomized in Phase B (26 Weeks)||15
6297323|NCT00313300|7199234|FG004|COMPLETED|Randomized in Phase B (26 Weeks)||13
6297324|NCT00313300|7199230|FG000|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
6400994|NCT00889707|7313879|FG001|STARTED|Overall Study||31
6400995|NCT00889707|7313878|FG000|COMPLETED|Overall Study||54
6635117|NCT02301936|7563972|FG001|STARTED|Overall Study||1
6635118|NCT02301936|7563971|FG000|COMPLETED|Overall Study||8
6635119|NCT02301936|7563972|FG001|COMPLETED|Overall Study||1
6297325|NCT00313300|7199231|FG001|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
6297326|NCT00313300|7199232|FG002|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
6297327|NCT00313300|7199233|FG003|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
6297328|NCT00313300|7199234|FG004|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
6297329|NCT00313300|7199230|FG000|STARTED|Follow-Up(30days)-Randomized Phase A||163
6297330|NCT00313300|7199231|FG001|STARTED|Follow-Up(30days)-Randomized Phase A||162
6297331|NCT00313300|7199232|FG002|STARTED|Follow-Up(30days)-Randomized Phase A||174
6297332|NCT00313300|7199233|FG003|STARTED|Follow-Up(30days)-Randomized Phase A||0
6297333|NCT00313300|7199234|FG004|STARTED|Follow-Up(30days)-Randomized Phase A||0
6297334|NCT00313300|7199230|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
6297335|NCT00313300|7199231|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
6297336|NCT00313300|7199232|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
6297337|NCT00313300|7199233|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
6297338|NCT00313300|7199234|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
6297339|NCT00313300|7199230|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
6297340|NCT00313300|7199231|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
6297341|NCT00313300|7199232|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
6297342|NCT00313300|7199233|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
6297343|NCT00313300|7199234|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
6297344|NCT00313300|7199230|FG000|STARTED|Follow-Up(30days)-Randomized Phase B||383
6297345|NCT00313300|7199231|FG001|STARTED|Follow-Up(30days)-Randomized Phase B||123
6297346|NCT00313300|7199232|FG002|STARTED|Follow-Up(30days)-Randomized Phase B||119
6297347|NCT00313300|7199233|FG003|STARTED|Follow-Up(30days)-Randomized Phase B||222
6297348|NCT00313300|7199234|FG004|STARTED|Follow-Up(30days)-Randomized Phase B||201
6297349|NCT00313300|7199230|FG000|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
6297350|NCT00313300|7199231|FG001|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
6297351|NCT00313300|7199232|FG002|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
6297352|NCT00313300|7199233|FG003|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
6297353|NCT00313300|7199234|FG004|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
6297354|NCT00313300|7199230|FG000|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
6297355|NCT00313300|7199231|FG001|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
6297356|NCT00313300|7199232|FG002|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
6297357|NCT00313300|7199233|FG003|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
6297358|NCT00313300|7199234|FG004|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
6297359|NCT00313313|7199255|FG000|STARTED|Overall Study||248
6297360|NCT00313313|7199256|FG001|STARTED|Overall Study||253
6297361|NCT00313313|7199257|FG002|STARTED|Overall Study||267
6297362|NCT00313313|7199255|FG000|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
6297363|NCT00313313|7199256|FG001|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
6297364|NCT00313313|7199257|FG002|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
6297365|NCT00313313|7199255|FG000|NOT COMPLETED|Overall Study||63
6297366|NCT00313313|7199256|FG001|NOT COMPLETED|Overall Study||66
6297367|NCT00313313|7199257|FG002|NOT COMPLETED|Overall Study||82
6297368|NCT00313443|7199265|FG000|STARTED|Overall Study||30
6297369|NCT00313443|7199265|FG000|COMPLETED|Overall Study||30
6297370|NCT00313443|7199265|FG000|NOT COMPLETED|Overall Study||0
6297371|NCT00313560|7199269|FG000|STARTED|Overall Study||48
6297372|NCT00313560|7199269|FG000|COMPLETED|Overall Study||48
6297373|NCT00313560|7199269|FG000|NOT COMPLETED|Overall Study||0
6297374|NCT00313586|7199281|FG000|STARTED|Overall Study||75
6297375|NCT00313586|7199282|FG001|STARTED|Overall Study||75
6297376|NCT00313586|7199283|FG002|STARTED|Overall Study||24
6297377|NCT00313586|7199284|FG003|STARTED|Overall Study||23
6297378|NCT00313586|7199281|FG000|Treated|Overall Study||74
6297379|NCT00313586|7199282|FG001|Treated|Overall Study||75
6297380|NCT00313586|7199283|FG002|Treated|Overall Study||24
6297381|NCT00313586|7199284|FG003|Treated|Overall Study||23
6297382|NCT00313586|7199281|FG000|COMPLETED|Overall Study||5
6297383|NCT00313586|7199282|FG001|COMPLETED|Overall Study||5
6297384|NCT00313586|7199283|FG002|COMPLETED|Overall Study||0
6297385|NCT00313586|7199284|FG003|COMPLETED|Overall Study||0
6297386|NCT00313586|7199281|FG000|NOT COMPLETED|Overall Study||70
6297387|NCT00313586|7199282|FG001|NOT COMPLETED|Overall Study||70
6297388|NCT00313586|7199283|FG002|NOT COMPLETED|Overall Study||24
6297389|NCT00313586|7199284|FG003|NOT COMPLETED|Overall Study||23
6297390|NCT00313612|7199294|FG000|STARTED|Overall Study||19
6297391|NCT00313612|7199295|FG001|STARTED|Overall Study||20
6297392|NCT00313612|7199294|FG000|COMPLETED|Overall Study||19
6297393|NCT00313612|7199295|FG001|COMPLETED|Overall Study||19
6297394|NCT00313612|7199294|FG000|NOT COMPLETED|Overall Study||0
6297395|NCT00313612|7199295|FG001|NOT COMPLETED|Overall Study||1
6297396|NCT00313703|7199305|FG000|STARTED|Overall Study||186
6297397|NCT00313703|7199306|FG001|STARTED|Overall Study||34
6297398|NCT00313703|7199307|FG002|STARTED|Overall Study||77
6297399|NCT00313703|7199308|FG003|STARTED|Overall Study||12
6297400|NCT00313703|7199305|FG000|COMPLETED|Overall Study|Some subjects lost to follow-up|175
6297401|NCT00313703|7199306|FG001|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
6297402|NCT00313703|7199307|FG002|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
6297403|NCT00313703|7199308|FG003|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
6297404|NCT00313703|7199305|FG000|NOT COMPLETED|Overall Study||11
6297405|NCT00313703|7199306|FG001|NOT COMPLETED|Overall Study||2
6297406|NCT00313703|7199307|FG002|NOT COMPLETED|Overall Study||5
6297407|NCT00313703|7199308|FG003|NOT COMPLETED|Overall Study||12
6297408|NCT00313716|7199324|FG000|STARTED|Overall Study||18
6297409|NCT00313716|7199325|FG001|STARTED|Overall Study||31
6297410|NCT00313716|7199326|FG002|STARTED|Overall Study||50
6297411|NCT00313716|7199327|FG003|STARTED|Overall Study||20
6297412|NCT00313716|7199328|FG004|STARTED|Overall Study||33
6297413|NCT00313716|7199329|FG005|STARTED|Overall Study||48
6297414|NCT00313716|7199324|FG000|COMPLETED|Overall Study||13
6297415|NCT00313716|7199325|FG001|COMPLETED|Overall Study||23
6297416|NCT00313716|7199326|FG002|COMPLETED|Overall Study||38
6297417|NCT00313716|7199327|FG003|COMPLETED|Overall Study||16
6297418|NCT00313716|7199328|FG004|COMPLETED|Overall Study||27
6297419|NCT00313716|7199329|FG005|COMPLETED|Overall Study||35
6297420|NCT00313716|7199324|FG000|NOT COMPLETED|Overall Study||5
6297421|NCT00313716|7199325|FG001|NOT COMPLETED|Overall Study||8
6297422|NCT00313716|7199326|FG002|NOT COMPLETED|Overall Study||12
6297423|NCT00313716|7199327|FG003|NOT COMPLETED|Overall Study||4
6297424|NCT00313716|7199328|FG004|NOT COMPLETED|Overall Study||6
6297425|NCT00313716|7199329|FG005|NOT COMPLETED|Overall Study||13
6374447|NCT00750308|7285101|FG007|COMPLETED|Washout||2
6374448|NCT00750308|7285102|FG008|COMPLETED|Washout||2
6374449|NCT00750308|7285103|FG009|COMPLETED|Washout||2
6374450|NCT00750308|7285104|FG010|COMPLETED|Washout||1
6374451|NCT00750308|7285105|FG011|COMPLETED|Washout||1
6374452|NCT00750308|7285094|FG000|NOT COMPLETED|Washout||0
6374453|NCT00750308|7285095|FG001|NOT COMPLETED|Washout||0
6374454|NCT00750308|7285096|FG002|NOT COMPLETED|Washout||0
6374455|NCT00750308|7285097|FG003|NOT COMPLETED|Washout||0
6374456|NCT00750308|7285098|FG004|NOT COMPLETED|Washout||0
6374457|NCT00750308|7285099|FG005|NOT COMPLETED|Washout||0
6374458|NCT00750308|7285100|FG006|NOT COMPLETED|Washout||0
6374459|NCT00750308|7285101|FG007|NOT COMPLETED|Washout||0
6374460|NCT00750308|7285102|FG008|NOT COMPLETED|Washout||0
6374461|NCT00750308|7285103|FG009|NOT COMPLETED|Washout||0
6374462|NCT00750308|7285104|FG010|NOT COMPLETED|Washout||0
6374463|NCT00750308|7285105|FG011|NOT COMPLETED|Washout||0
6374464|NCT00750308|7285094|FG000|STARTED|Second Treatment||2
6374465|NCT00750308|7285095|FG001|STARTED|Second Treatment||2
6374466|NCT00750308|7285096|FG002|STARTED|Second Treatment||2
6374467|NCT00750308|7285097|FG003|STARTED|Second Treatment||1
6374468|NCT00750308|7285098|FG004|STARTED|Second Treatment||2
6374469|NCT00750308|7285099|FG005|STARTED|Second Treatment||3
6374470|NCT00750308|7285100|FG006|STARTED|Second Treatment||2
6374471|NCT00750308|7285101|FG007|STARTED|Second Treatment||2
6374472|NCT00750308|7285102|FG008|STARTED|Second Treatment||2
6374473|NCT00750308|7285103|FG009|STARTED|Second Treatment||2
6374474|NCT00750308|7285104|FG010|STARTED|Second Treatment||1
6374475|NCT00750308|7285105|FG011|STARTED|Second Treatment||1
6374476|NCT00750308|7285094|FG000|COMPLETED|Second Treatment||2
6374477|NCT00750308|7285095|FG001|COMPLETED|Second Treatment||2
6374478|NCT00750308|7285096|FG002|COMPLETED|Second Treatment||2
6374479|NCT00750308|7285097|FG003|COMPLETED|Second Treatment||1
6374480|NCT00750308|7285098|FG004|COMPLETED|Second Treatment||1
6374481|NCT00750308|7285099|FG005|COMPLETED|Second Treatment||2
6374482|NCT00750308|7285100|FG006|COMPLETED|Second Treatment||2
6374483|NCT00750308|7285101|FG007|COMPLETED|Second Treatment||2
6374484|NCT00750308|7285102|FG008|COMPLETED|Second Treatment||1
6374485|NCT00750308|7285103|FG009|COMPLETED|Second Treatment||2
6374486|NCT00750308|7285104|FG010|COMPLETED|Second Treatment||1
6374487|NCT00750308|7285105|FG011|COMPLETED|Second Treatment||1
6374488|NCT00750308|7285094|FG000|NOT COMPLETED|Second Treatment||0
6374489|NCT00750308|7285095|FG001|NOT COMPLETED|Second Treatment||0
6374490|NCT00750308|7285096|FG002|NOT COMPLETED|Second Treatment||0
6374491|NCT00750308|7285097|FG003|NOT COMPLETED|Second Treatment||0
6374492|NCT00750308|7285098|FG004|NOT COMPLETED|Second Treatment||1
6374493|NCT00750308|7285099|FG005|NOT COMPLETED|Second Treatment||1
6374494|NCT00750308|7285100|FG006|NOT COMPLETED|Second Treatment||0
6374495|NCT00750308|7285101|FG007|NOT COMPLETED|Second Treatment||0
6374496|NCT00750308|7285102|FG008|NOT COMPLETED|Second Treatment||1
6374497|NCT00750308|7285103|FG009|NOT COMPLETED|Second Treatment||0
6374498|NCT00750308|7285104|FG010|NOT COMPLETED|Second Treatment||0
6374499|NCT00750308|7285105|FG011|NOT COMPLETED|Second Treatment||0
6374500|NCT00750308|7285094|FG000|STARTED|Washout||2
6374501|NCT00750308|7285095|FG001|STARTED|Washout||2
6374502|NCT00750308|7285096|FG002|STARTED|Washout||2
6374503|NCT00750308|7285097|FG003|STARTED|Washout||1
6374504|NCT00750308|7285098|FG004|STARTED|Washout||1
6374505|NCT00750308|7285099|FG005|STARTED|Washout||2
6374506|NCT00750308|7285100|FG006|STARTED|Washout||2
6374507|NCT00750308|7285101|FG007|STARTED|Washout||2
6374508|NCT00750308|7285102|FG008|STARTED|Washout||1
6374509|NCT00750308|7285103|FG009|STARTED|Washout||2
6374510|NCT00750308|7285104|FG010|STARTED|Washout||1
6374511|NCT00750308|7285105|FG011|STARTED|Washout||1
6374512|NCT00750308|7285094|FG000|COMPLETED|Washout||2
6374513|NCT00750308|7285095|FG001|COMPLETED|Washout||2
6374514|NCT00750308|7285096|FG002|COMPLETED|Washout||2
6374515|NCT00750308|7285097|FG003|COMPLETED|Washout||1
6374516|NCT00750308|7285098|FG004|COMPLETED|Washout||1
6374517|NCT00750308|7285099|FG005|COMPLETED|Washout||2
6374518|NCT00750308|7285100|FG006|COMPLETED|Washout||2
6374519|NCT00750308|7285101|FG007|COMPLETED|Washout||2
6374520|NCT00750308|7285102|FG008|COMPLETED|Washout||1
6374521|NCT00750308|7285103|FG009|COMPLETED|Washout||2
6374522|NCT00750308|7285104|FG010|COMPLETED|Washout||1
6374523|NCT00750308|7285105|FG011|COMPLETED|Washout||1
6374524|NCT00750308|7285094|FG000|NOT COMPLETED|Washout||0
6374525|NCT00750308|7285095|FG001|NOT COMPLETED|Washout||0
6374526|NCT00750308|7285096|FG002|NOT COMPLETED|Washout||0
6297426|NCT00313729|7199347|FG000|STARTED|Overall Study||120
6297427|NCT00313729|7199347|FG000|COMPLETED|Overall Study||120
6297428|NCT00313729|7199347|FG000|NOT COMPLETED|Overall Study||0
6297429|NCT00313781|7199353|FG000|STARTED|Before Crossover||102
6297430|NCT00313781|7199354|FG001|STARTED|Before Crossover||102
6297431|NCT00313781|7199355|FG002|STARTED|Before Crossover||0
6297432|NCT00313781|7199353|FG000|Treated|Before Crossover||97
6297433|NCT00313781|7199354|FG001|Treated|Before Crossover||102
6297434|NCT00313781|7199355|FG002|Treated|Before Crossover||0
6297435|NCT00313781|7199353|FG000|COMPLETED|Before Crossover||27
6297436|NCT00313781|7199354|FG001|COMPLETED|Before Crossover||23
6297437|NCT00313781|7199355|FG002|COMPLETED|Before Crossover||0
6297438|NCT00313781|7199353|FG000|NOT COMPLETED|Before Crossover||75
6297439|NCT00313781|7199354|FG001|NOT COMPLETED|Before Crossover||79
6297440|NCT00313781|7199355|FG002|NOT COMPLETED|Before Crossover||0
6297441|NCT00313781|7199353|FG000|STARTED|After Crossover||0
6297442|NCT00313781|7199354|FG001|STARTED|After Crossover||0
6297443|NCT00313781|7199355|FG002|STARTED|After Crossover||37
6297444|NCT00313781|7199353|FG000|COMPLETED|After Crossover||0
6297445|NCT00313781|7199354|FG001|COMPLETED|After Crossover||0
6297446|NCT00313781|7199355|FG002|COMPLETED|After Crossover||10
6297447|NCT00313781|7199353|FG000|NOT COMPLETED|After Crossover||0
6297448|NCT00313781|7199354|FG001|NOT COMPLETED|After Crossover||0
6297449|NCT00313781|7199355|FG002|NOT COMPLETED|After Crossover||27
6297450|NCT00313820|7199366|FG000|STARTED|Assigned to Treatment||111
6297451|NCT00313820|7199367|FG001|STARTED|Assigned to Treatment||109
6297452|NCT00313820|7199366|FG000|COMPLETED|Assigned to Treatment||110
6297453|NCT00313820|7199367|FG001|COMPLETED|Assigned to Treatment||109
6297454|NCT00313820|7199366|FG000|NOT COMPLETED|Assigned to Treatment||1
6297455|NCT00313820|7199367|FG001|NOT COMPLETED|Assigned to Treatment||0
6297456|NCT00313820|7199366|FG000|STARTED|Pregabalin or Placebo Treatment Period||110
6297457|NCT00313820|7199367|FG001|STARTED|Pregabalin or Placebo Treatment Period||109
6297458|NCT00313820|7199366|FG000|COMPLETED|Pregabalin or Placebo Treatment Period||93
6297459|NCT00313820|7199367|FG001|COMPLETED|Pregabalin or Placebo Treatment Period||90
6297460|NCT00313820|7199366|FG000|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
6297461|NCT00313820|7199367|FG001|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
6297462|NCT00313846|7199375|FG000|STARTED|Overall Study||162
6297463|NCT00313846|7199376|FG001|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
6297464|NCT00313846|7199375|FG000|COMPLETED|Overall Study||157
6297465|NCT00313846|7199376|FG001|COMPLETED|Overall Study||153
6297466|NCT00313846|7199375|FG000|NOT COMPLETED|Overall Study||5
6297467|NCT00313846|7199376|FG001|NOT COMPLETED|Overall Study||11
6297468|NCT00313911|7199385|FG000|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
6297469|NCT00313911|7199386|FG001|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
6297470|NCT00313911|7199385|FG000|COMPLETED|Overall Study||1328
6297471|NCT00313911|7199386|FG001|COMPLETED|Overall Study||670
6297472|NCT00313911|7199385|FG000|NOT COMPLETED|Overall Study||94
6297473|NCT00313911|7199386|FG001|NOT COMPLETED|Overall Study||41
6297474|NCT00314106|7199394|FG000|STARTED|Overall Study||18
6297475|NCT00314106|7199395|FG001|STARTED|Overall Study||8
6297476|NCT00314106|7199394|FG000|COMPLETED|Overall Study||18
6297477|NCT00314106|7199395|FG001|COMPLETED|Overall Study||8
6297478|NCT00314106|7199394|FG000|NOT COMPLETED|Overall Study||0
6297479|NCT00314106|7199395|FG001|NOT COMPLETED|Overall Study||0
6297480|NCT00314132|7199403|FG000|STARTED|Overall Study||403
6297481|NCT00314132|7199404|FG001|STARTED|Overall Study||1601
6297482|NCT00314132|7199403|FG000|COMPLETED|Overall Study||395
6297483|NCT00314132|7199404|FG001|COMPLETED|Overall Study||1583
6297484|NCT00314132|7199403|FG000|NOT COMPLETED|Overall Study||8
6297485|NCT00314132|7199404|FG001|NOT COMPLETED|Overall Study||18
6297486|NCT00314145|7199414|FG000|STARTED|Overall Study||410
6297487|NCT00314145|7199415|FG001|STARTED|Overall Study||410
6297488|NCT00314145|7199414|FG000|COMPLETED|Overall Study||389
6297489|NCT00314145|7199415|FG001|COMPLETED|Overall Study||381
6297490|NCT00314145|7199414|FG000|NOT COMPLETED|Overall Study||21
6297491|NCT00314145|7199415|FG001|NOT COMPLETED|Overall Study||29
6297492|NCT00314236|7199424|FG000|STARTED|Overall Study||41
6297493|NCT00314236|7199425|FG001|STARTED|Overall Study||39
6297494|NCT00314236|7199424|FG000|COMPLETED|Overall Study||41
6297495|NCT00314236|7199425|FG001|COMPLETED|Overall Study||37
6297496|NCT00314236|7199424|FG000|NOT COMPLETED|Overall Study||0
6297497|NCT00314236|7199425|FG001|NOT COMPLETED|Overall Study||2
6297498|NCT00314249|7199433|FG000|STARTED|Overall Study||509
6297499|NCT00314249|7199434|FG001|STARTED|Overall Study||516
6297500|NCT00314249|7199433|FG000|COMPLETED|Overall Study||357
6297501|NCT00314249|7199434|FG001|COMPLETED|Overall Study||353
6297502|NCT00314249|7199433|FG000|NOT COMPLETED|Overall Study||152
6297503|NCT00314249|7199434|FG001|NOT COMPLETED|Overall Study||163
6297504|NCT00314262|7199440|FG000|STARTED|Overall Study||12
6297505|NCT00314262|7199440|FG000|COMPLETED|Overall Study||7
6297506|NCT00314262|7199440|FG000|NOT COMPLETED|Overall Study||5
6297507|NCT00314340|7199444|FG000|STARTED|Overall Study||12
6297508|NCT00314340|7199444|FG000|ER Morphine|Overall Study||11
6297509|NCT00314340|7199444|FG000|Hydrocodone Plus APAP|Overall Study||12
6297510|NCT00314340|7199444|FG000|Placebo|Overall Study||12
6297511|NCT00314340|7199444|FG000|COMPLETED|Overall Study||11
6297512|NCT00314340|7199444|FG000|NOT COMPLETED|Overall Study||1
6297513|NCT00314366|7199452|FG000|STARTED|Overall Study||11
6297514|NCT00314366|7199453|FG001|STARTED|Overall Study||10
6297515|NCT00314366|7199452|FG000|COMPLETED|Overall Study||10
6297516|NCT00314366|7199453|FG001|COMPLETED|Overall Study||10
6297517|NCT00314366|7199452|FG000|NOT COMPLETED|Overall Study||1
6297518|NCT00314366|7199453|FG001|NOT COMPLETED|Overall Study||0
6297519|NCT00314574|7199464|FG000|STARTED|Overall Study||423
6297520|NCT00314574|7199465|FG001|STARTED|Overall Study||427
6297521|NCT00314574|7199464|FG000|Received at Least One Dose of Study Drug|Overall Study||421
6297522|NCT00314574|7199465|FG001|Received at Least One Dose of Study Drug|Overall Study||427
6297523|NCT00314574|7199464|FG000|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
6297524|NCT00314574|7199465|FG001|Safety Population|Overall Study||428
6297525|NCT00314574|7199464|FG000|COMPLETED|Overall Study||329
6297526|NCT00314574|7199465|FG001|COMPLETED|Overall Study||344
6297527|NCT00314574|7199464|FG000|NOT COMPLETED|Overall Study||94
6297528|NCT00314574|7199465|FG001|NOT COMPLETED|Overall Study||83
6297529|NCT00314795|7199471|FG000|STARTED|Overall Study||22
6297530|NCT00314795|7199471|FG000|COMPLETED|Overall Study||2
6297531|NCT00314795|7199471|FG000|NOT COMPLETED|Overall Study||20
6297532|NCT00314808|7199475|FG000|STARTED|Overall Study||33
6297533|NCT00314808|7199475|FG000|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
6297534|NCT00314808|7199475|FG000|NOT COMPLETED|Overall Study||8
6297535|NCT00314951|7199481|FG000|STARTED|Enrollment||323
6297536|NCT00314951|7199482|FG001|STARTED|Enrollment||306
6297537|NCT00314951|7199481|FG000|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
6297538|NCT00314951|7199482|FG001|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
6297539|NCT00314951|7199481|FG000|NOT COMPLETED|Enrollment||0
6297540|NCT00314951|7199482|FG001|NOT COMPLETED|Enrollment||6
6297541|NCT00314951|7199481|FG000|STARTED|Treatment||323
6297542|NCT00314951|7199482|FG001|STARTED|Treatment||300
6297543|NCT00314951|7199481|FG000|COMPLETED|Treatment||307
6297544|NCT00314951|7199482|FG001|COMPLETED|Treatment||289
6297545|NCT00314951|7199481|FG000|NOT COMPLETED|Treatment||16
6297546|NCT00314951|7199482|FG001|NOT COMPLETED|Treatment||11
6297547|NCT00314951|7199481|FG000|STARTED|Follow-up||307
6297548|NCT00314951|7199482|FG001|STARTED|Follow-up||289
6297549|NCT00314951|7199481|FG000|COMPLETED|Follow-up||263
6297550|NCT00314951|7199482|FG001|COMPLETED|Follow-up||255
6297551|NCT00314951|7199481|FG000|NOT COMPLETED|Follow-up||44
6297552|NCT00314951|7199482|FG001|NOT COMPLETED|Follow-up||34
6297553|NCT00315055|7199490|FG000|STARTED|Overall Study||155
6297554|NCT00315055|7199491|FG001|STARTED|Overall Study||155
6297555|NCT00315055|7199490|FG000|COMPLETED|Overall Study||152
6297556|NCT00315055|7199491|FG001|COMPLETED|Overall Study||150
6297557|NCT00315055|7199490|FG000|NOT COMPLETED|Overall Study||3
6297558|NCT00315055|7199491|FG001|NOT COMPLETED|Overall Study||5
6297559|NCT00315120|7199504|FG000|STARTED|Overall Study||115
6297560|NCT00315120|7199505|FG001|STARTED|Overall Study||118
6297561|NCT00315120|7199506|FG002|STARTED|Overall Study||115
6297562|NCT00315120|7199507|FG003|STARTED|Overall Study||107
6297563|NCT00315120|7199504|FG000|COMPLETED|Overall Study||115
6297564|NCT00315120|7199505|FG001|COMPLETED|Overall Study||118
6297565|NCT00315120|7199506|FG002|COMPLETED|Overall Study||115
6297566|NCT00315120|7199507|FG003|COMPLETED|Overall Study||107
6297567|NCT00315120|7199504|FG000|NOT COMPLETED|Overall Study||0
6297568|NCT00315120|7199505|FG001|NOT COMPLETED|Overall Study||0
6297569|NCT00315120|7199506|FG002|NOT COMPLETED|Overall Study||0
6297570|NCT00315120|7199507|FG003|NOT COMPLETED|Overall Study||0
6297571|NCT00315146|7199523|FG000|STARTED|Overall Study||22
6297572|NCT00315146|7199524|FG001|STARTED|Overall Study||22
6297573|NCT00315146|7199525|FG002|STARTED|Overall Study||22
6297574|NCT00315146|7199526|FG003|STARTED|Overall Study||22
6297575|NCT00315146|7199523|FG000|COMPLETED|Overall Study||20
6297576|NCT00315146|7199524|FG001|COMPLETED|Overall Study||19
6297577|NCT00315146|7199525|FG002|COMPLETED|Overall Study||20
6297578|NCT00315146|7199526|FG003|COMPLETED|Overall Study||22
6297579|NCT00315146|7199523|FG000|NOT COMPLETED|Overall Study||2
6297580|NCT00315146|7199524|FG001|NOT COMPLETED|Overall Study||3
6297581|NCT00315146|7199525|FG002|NOT COMPLETED|Overall Study||2
6297582|NCT00315146|7199526|FG003|NOT COMPLETED|Overall Study||0
6297583|NCT00315302|7199544|FG000|STARTED|Overall Study||90
6297584|NCT00315302|7199545|FG001|STARTED|Overall Study||90
6297585|NCT00315302|7199546|FG002|STARTED|Overall Study||26
6297586|NCT00315302|7199547|FG003|STARTED|Overall Study||34
6297587|NCT00315302|7199544|FG000|5 Week Visit|Overall Study||85
6297588|NCT00315302|7199545|FG001|5 Week Visit|Overall Study||86
6297589|NCT00315302|7199546|FG002|5 Week Visit|Overall Study||26
6297590|NCT00315302|7199547|FG003|5 Week Visit|Overall Study||30
6297591|NCT00315302|7199544|FG000|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
6297592|NCT00315302|7199545|FG001|10 Week Visit|Overall Study||85
6297593|NCT00315302|7199546|FG002|10 Week Visit|Overall Study||24
6297594|NCT00315302|7199547|FG003|10 Week Visit|Overall Study||29
6297595|NCT00315302|7199544|FG000|18 Week Primary Outcome Visit|Overall Study||84
6297596|NCT00315302|7199545|FG001|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
6297597|NCT00315302|7199546|FG002|18 Week Primary Outcome Visit|Overall Study||24
6297598|NCT00315302|7199547|FG003|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
6374527|NCT00750308|7285097|FG003|NOT COMPLETED|Washout||0
6297599|NCT00315302|7199544|FG000|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
6297600|NCT00315302|7199545|FG001|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
6297601|NCT00315302|7199546|FG002|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
6297602|NCT00315302|7199547|FG003|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
6297603|NCT00315302|7199544|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
6297604|NCT00315302|7199545|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
6297605|NCT00315302|7199546|FG002|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
6297606|NCT00315302|7199547|FG003|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
6297607|NCT00315302|7199544|FG000|NOT COMPLETED|Overall Study||6
6297608|NCT00315302|7199545|FG001|NOT COMPLETED|Overall Study||2
6297609|NCT00315302|7199546|FG002|NOT COMPLETED|Overall Study||2
6297610|NCT00315302|7199547|FG003|NOT COMPLETED|Overall Study||3
6297611|NCT00315328|7199561|FG000|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
6297612|NCT00315328|7199562|FG001|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
6297613|NCT00315328|7199563|FG002|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
6297614|NCT00315328|7199564|FG003|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
6297615|NCT00315328|7199561|FG000|5 Week Visit|Overall Study||91
6297616|NCT00315328|7199562|FG001|5 Week Visit|Overall Study||89
6297617|NCT00315328|7199563|FG002|5 Week Visit|Overall Study||17
6297618|NCT00315328|7199564|FG003|5 Week Visit|Overall Study||19
6297619|NCT00315328|7199561|FG000|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
6297620|NCT00315328|7199562|FG001|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
6297621|NCT00315328|7199563|FG002|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
6297622|NCT00315328|7199564|FG003|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
6297623|NCT00315328|7199561|FG000|NOT COMPLETED|Overall Study||14
6297624|NCT00315328|7199562|FG001|NOT COMPLETED|Overall Study||7
6297625|NCT00315328|7199563|FG002|NOT COMPLETED|Overall Study||5
6297626|NCT00315328|7199564|FG003|NOT COMPLETED|Overall Study||2
6297627|NCT00315341|7199576|FG000|STARTED|Overall Study||740
6297628|NCT00315341|7199577|FG001|STARTED|Overall Study||529
6297629|NCT00315341|7199576|FG000|COMPLETED|Overall Study||340
6297630|NCT00315341|7199577|FG001|COMPLETED|Overall Study||391
6297631|NCT00315341|7199576|FG000|NOT COMPLETED|Overall Study||400
6297632|NCT00315341|7199577|FG001|NOT COMPLETED|Overall Study||138
6297633|NCT00315445|7199586|FG000|STARTED|Overall Study||45
6297634|NCT00315445|7199587|FG001|STARTED|Overall Study||43
6297635|NCT00315445|7199588|FG002|STARTED|Overall Study||46
6297636|NCT00315445|7199586|FG000|COMPLETED|Overall Study||18
6297637|NCT00315445|7199587|FG001|COMPLETED|Overall Study||27
6297638|NCT00315445|7199588|FG002|COMPLETED|Overall Study||22
6297639|NCT00315445|7199586|FG000|NOT COMPLETED|Overall Study||27
6297640|NCT00315445|7199587|FG001|NOT COMPLETED|Overall Study||16
6297641|NCT00315445|7199588|FG002|NOT COMPLETED|Overall Study||24
6297642|NCT00315458|7199598|FG000|STARTED|Overall Study||51
6297643|NCT00315458|7199599|FG001|STARTED|Overall Study||56
6297644|NCT00315458|7199600|FG002|STARTED|Overall Study||159
6297645|NCT00315458|7199601|FG003|STARTED|Overall Study||39
6297646|NCT00315458|7199598|FG000|COMPLETED|Overall Study||48
6297647|NCT00315458|7199599|FG001|COMPLETED|Overall Study||44
6297648|NCT00315458|7199600|FG002|COMPLETED|Overall Study||107
6297649|NCT00315458|7199601|FG003|COMPLETED|Overall Study||10
6297650|NCT00315458|7199598|FG000|NOT COMPLETED|Overall Study||3
6297651|NCT00315458|7199599|FG001|NOT COMPLETED|Overall Study||12
6297652|NCT00315458|7199600|FG002|NOT COMPLETED|Overall Study||52
6297653|NCT00315458|7199601|FG003|NOT COMPLETED|Overall Study||29
6297654|NCT00315588|7199611|FG000|STARTED|Overall Study||7
6297655|NCT00315588|7199611|FG000|COMPLETED|Overall Study||7
6297656|NCT00315588|7199611|FG000|NOT COMPLETED|Overall Study||0
6297657|NCT00315614|7199617|FG000|STARTED|Overall Study||3
6297658|NCT00315614|7199617|FG000|COMPLETED|Overall Study||3
6297659|NCT00315614|7199617|FG000|NOT COMPLETED|Overall Study||0
6297660|NCT00315627|7199622|FG000|STARTED|Overall Study||3
6297661|NCT00315627|7199622|FG000|COMPLETED|Overall Study||3
6297662|NCT00315627|7199622|FG000|NOT COMPLETED|Overall Study||0
6297663|NCT00315705|7199630|FG000|STARTED|Phase 1||25
6297664|NCT00315705|7199630|FG000|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
6297665|NCT00315705|7199630|FG000|NOT COMPLETED|Phase 1||25
6297666|NCT00315705|7199630|FG000|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
6297667|NCT00315705|7199630|FG000|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
6297668|NCT00315705|7199630|FG000|NOT COMPLETED|Phase 2||25
6297669|NCT00315731|7199647|FG000|STARTED|Overall Study||15
6297670|NCT00315731|7199647|FG000|COMPLETED|Overall Study||9
6297671|NCT00315731|7199647|FG000|NOT COMPLETED|Overall Study||6
6297672|NCT00315822|7199655|FG000|STARTED|Overall Study||198
6297673|NCT00315822|7199656|FG001|STARTED|Overall Study||202
6297674|NCT00315822|7199655|FG000|COMPLETED|Overall Study||198
6297675|NCT00315822|7199656|FG001|COMPLETED|Overall Study||202
6297676|NCT00315822|7199655|FG000|NOT COMPLETED|Overall Study||0
6297677|NCT00315822|7199656|FG001|NOT COMPLETED|Overall Study||0
6297678|NCT00315939|7199664|FG000|STARTED|Admission 1 (3 Months)||59
6297679|NCT00315939|7199665|FG001|STARTED|Admission 1 (3 Months)||61
6297680|NCT00315939|7199664|FG000|COMPLETED|Admission 1 (3 Months)||56
6297681|NCT00315939|7199665|FG001|COMPLETED|Admission 1 (3 Months)||55
6297682|NCT00315939|7199664|FG000|NOT COMPLETED|Admission 1 (3 Months)||3
6297683|NCT00315939|7199665|FG001|NOT COMPLETED|Admission 1 (3 Months)||6
6297684|NCT00315939|7199664|FG000|STARTED|Admission 2 (3 Months)||56
6297685|NCT00315939|7199665|FG001|STARTED|Admission 2 (3 Months)||55
6297686|NCT00315939|7199664|FG000|COMPLETED|Admission 2 (3 Months)||52
6297687|NCT00315939|7199665|FG001|COMPLETED|Admission 2 (3 Months)||51
6297688|NCT00315939|7199664|FG000|NOT COMPLETED|Admission 2 (3 Months)||4
6297689|NCT00315939|7199665|FG001|NOT COMPLETED|Admission 2 (3 Months)||4
6297690|NCT00315939|7199664|FG000|STARTED|Admission 3 (3 Months)||52
6297691|NCT00315939|7199665|FG001|STARTED|Admission 3 (3 Months)||51
6297692|NCT00315939|7199664|FG000|COMPLETED|Admission 3 (3 Months)||48
6297693|NCT00315939|7199665|FG001|COMPLETED|Admission 3 (3 Months)||49
6297694|NCT00315939|7199664|FG000|NOT COMPLETED|Admission 3 (3 Months)||4
6297695|NCT00315939|7199665|FG001|NOT COMPLETED|Admission 3 (3 Months)||2
6297696|NCT00316004|7199673|FG000|STARTED|Overall Study||373
6297697|NCT00316004|7199674|FG001|STARTED|Overall Study||355
6297698|NCT00316004|7199675|FG002|STARTED|Overall Study||603
6297699|NCT00316004|7199673|FG000|COMPLETED|Overall Study||359
6297700|NCT00316004|7199674|FG001|COMPLETED|Overall Study||341
6297701|NCT00316004|7199675|FG002|COMPLETED|Overall Study||582
6297702|NCT00316004|7199673|FG000|NOT COMPLETED|Overall Study||14
6297703|NCT00316004|7199674|FG001|NOT COMPLETED|Overall Study||14
6297704|NCT00316004|7199675|FG002|NOT COMPLETED|Overall Study||21
6297705|NCT00316017|7199686|FG000|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
6297706|NCT00316017|7199687|FG001|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
6297707|NCT00316017|7199688|FG002|STARTED|Overall Study|19 of 19 not complete due to BONG|395
6297708|NCT00316017|7199686|FG000|COMPLETED|Overall Study||220
6297709|NCT00316017|7199687|FG001|COMPLETED|Overall Study||256
6297710|NCT00316017|7199688|FG002|COMPLETED|Overall Study||376
6297711|NCT00316017|7199686|FG000|NOT COMPLETED|Overall Study||11
6297712|NCT00316017|7199687|FG001|NOT COMPLETED|Overall Study||13
6297713|NCT00316017|7199688|FG002|NOT COMPLETED|Overall Study||19
6297714|NCT00316082|7199701|FG000|STARTED|Overall Study||74
6297715|NCT00316082|7199702|FG001|STARTED|Overall Study||74
6297716|NCT00316082|7199703|FG002|STARTED|Overall Study||71
6297717|NCT00316082|7199704|FG003|STARTED|Overall Study||72
6297718|NCT00316082|7199705|FG004|STARTED|Overall Study||74
6297719|NCT00316082|7199701|FG000|Completed Study Without Being Rescued|Overall Study||25
6297720|NCT00316082|7199702|FG001|Completed Study Without Being Rescued|Overall Study||35
6297721|NCT00316082|7199703|FG002|Completed Study Without Being Rescued|Overall Study||29
6297722|NCT00316082|7199704|FG003|Completed Study Without Being Rescued|Overall Study||27
6297723|NCT00316082|7199705|FG004|Completed Study Without Being Rescued|Overall Study||31
6297724|NCT00316082|7199701|FG000|COMPLETED|Overall Study||41
6297725|NCT00316082|7199702|FG001|COMPLETED|Overall Study||52
6297726|NCT00316082|7199703|FG002|COMPLETED|Overall Study||44
6297727|NCT00316082|7199704|FG003|COMPLETED|Overall Study||46
6297728|NCT00316082|7199705|FG004|COMPLETED|Overall Study||48
6297729|NCT00316082|7199701|FG000|NOT COMPLETED|Overall Study||33
6297730|NCT00316082|7199702|FG001|NOT COMPLETED|Overall Study||22
6297731|NCT00316082|7199703|FG002|NOT COMPLETED|Overall Study||27
6297732|NCT00316082|7199704|FG003|NOT COMPLETED|Overall Study||26
6297733|NCT00316082|7199705|FG004|NOT COMPLETED|Overall Study||26
6297734|NCT00316121|7199723|FG000|STARTED|Overall Study||92
6297735|NCT00316121|7199724|FG001|STARTED|Overall Study||46
6297736|NCT00316121|7199723|FG000|COMPLETED|Overall Study||70
6297737|NCT00316121|7199724|FG001|COMPLETED|Overall Study||37
6297738|NCT00316121|7199723|FG000|NOT COMPLETED|Overall Study||22
6297739|NCT00316121|7199724|FG001|NOT COMPLETED|Overall Study||9
6297740|NCT00316173|7199732|FG000|STARTED|Run-in Phase||22
6297741|NCT00316173|7199733|FG001|STARTED|Run-in Phase||0
6297742|NCT00316173|7199732|FG000|COMPLETED|Run-in Phase||15
6297743|NCT00316173|7199733|FG001|COMPLETED|Run-in Phase||0
6297744|NCT00316173|7199732|FG000|NOT COMPLETED|Run-in Phase||7
6297745|NCT00316173|7199733|FG001|NOT COMPLETED|Run-in Phase||0
6297746|NCT00316173|7199732|FG000|STARTED|Treatment Phase||0
6297747|NCT00316173|7199733|FG001|STARTED|Treatment Phase||55
6297748|NCT00316173|7199732|FG000|COMPLETED|Treatment Phase||0
6297749|NCT00316173|7199733|FG001|COMPLETED|Treatment Phase||13
6297750|NCT00316173|7199732|FG000|NOT COMPLETED|Treatment Phase||0
6297751|NCT00316173|7199733|FG001|NOT COMPLETED|Treatment Phase||42
6297752|NCT00316186|7199738|FG000|STARTED|Overall Study||33
6297753|NCT00316186|7199738|FG000|COMPLETED|Overall Study||21
6297754|NCT00316186|7199738|FG000|NOT COMPLETED|Overall Study||12
6297755|NCT00316199|7199742|FG000|STARTED|Overall Study||60
6297756|NCT00316199|7199742|FG000|COMPLETED|Overall Study||48
6297757|NCT00316199|7199742|FG000|NOT COMPLETED|Overall Study||12
6297758|NCT00316225|7199746|FG000|STARTED|Overall Study||31
6297759|NCT00316225|7199746|FG000|COMPLETED|Overall Study||6
6297760|NCT00316225|7199746|FG000|NOT COMPLETED|Overall Study||25
6297761|NCT00316264|7199753|FG000|STARTED|Overall Study||83
6297762|NCT00316264|7199754|FG001|STARTED|Overall Study||84
6297763|NCT00316264|7199755|FG002|STARTED|Overall Study||93
6297764|NCT00316264|7199753|FG000|COMPLETED|Overall Study||77
6297765|NCT00316264|7199754|FG001|COMPLETED|Overall Study||77
6297766|NCT00316264|7199755|FG002|COMPLETED|Overall Study||87
6297767|NCT00316264|7199753|FG000|NOT COMPLETED|Overall Study||6
6297768|NCT00316264|7199754|FG001|NOT COMPLETED|Overall Study||7
6297769|NCT00316264|7199755|FG002|NOT COMPLETED|Overall Study||6
6297770|NCT00316277|7199765|FG000|STARTED|Phase 1 (12 Weeks)||329
6297771|NCT00316277|7199766|FG001|STARTED|Phase 1 (12 Weeks)||324
6297772|NCT00316277|7199765|FG000|COMPLETED|Phase 1 (12 Weeks)||19
6297773|NCT00316277|7199766|FG001|COMPLETED|Phase 1 (12 Weeks)||24
6297774|NCT00316277|7199765|FG000|NOT COMPLETED|Phase 1 (12 Weeks)||310
6297775|NCT00316277|7199766|FG001|NOT COMPLETED|Phase 1 (12 Weeks)||300
6297776|NCT00316277|7199765|FG000|STARTED|Phase 2 (24 Weeks)||180
6297777|NCT00316277|7199766|FG001|STARTED|Phase 2 (24 Weeks)||180
6297778|NCT00316277|7199765|FG000|COMPLETED|Phase 2 (24 Weeks)||161
6297779|NCT00316277|7199766|FG001|COMPLETED|Phase 2 (24 Weeks)||161
6297780|NCT00316277|7199765|FG000|NOT COMPLETED|Phase 2 (24 Weeks)||19
6297781|NCT00316277|7199766|FG001|NOT COMPLETED|Phase 2 (24 Weeks)||19
6297782|NCT00316303|7199782|FG000|STARTED|Overall Study||118
6297783|NCT00316303|7199783|FG001|STARTED|Overall Study||118
6297784|NCT00316303|7199782|FG000|COMPLETED|Overall Study||107
6297785|NCT00316303|7199783|FG001|COMPLETED|Overall Study||102
6297786|NCT00316303|7199782|FG000|NOT COMPLETED|Overall Study||11
6297787|NCT00316303|7199783|FG001|NOT COMPLETED|Overall Study||16
6297788|NCT00316355|7199794|FG000|STARTED|Overall Study||15
6297789|NCT00316355|7199795|FG001|STARTED|Overall Study||19
6297790|NCT00316355|7199794|FG000|Started Treatment|Overall Study||12
6297791|NCT00316355|7199795|FG001|Started Treatment|Overall Study||18
6400996|NCT00889707|7313879|FG001|COMPLETED|Overall Study||21
6400997|NCT00889707|7313878|FG000|NOT COMPLETED|Overall Study||7
6400998|NCT00889707|7313879|FG001|NOT COMPLETED|Overall Study||10
6400999|NCT00889720|7313885|FG000|STARTED|Overall Study||16
6297792|NCT00316355|7199794|FG000|COMPLETED|Overall Study||10
6297793|NCT00316355|7199795|FG001|COMPLETED|Overall Study||12
6297794|NCT00316355|7199794|FG000|NOT COMPLETED|Overall Study||5
6297795|NCT00316355|7199795|FG001|NOT COMPLETED|Overall Study||7
6297796|NCT00316524|7199805|FG000|STARTED|Overall Study||183
6297797|NCT00316524|7199806|FG001|STARTED|Overall Study||181
6297798|NCT00316524|7199807|FG002|STARTED|Overall Study||181
6297799|NCT00316524|7199808|FG003|STARTED|Overall Study||200
6297800|NCT00316524|7199805|FG000|COMPLETED|Overall Study||175
6297801|NCT00316524|7199806|FG001|COMPLETED|Overall Study||173
6297802|NCT00316524|7199807|FG002|COMPLETED|Overall Study||175
6297803|NCT00316524|7199808|FG003|COMPLETED|Overall Study||200
6297804|NCT00316524|7199805|FG000|NOT COMPLETED|Overall Study||8
6297805|NCT00316524|7199806|FG001|NOT COMPLETED|Overall Study||8
6297806|NCT00316524|7199807|FG002|NOT COMPLETED|Overall Study||6
6297807|NCT00316524|7199808|FG003|NOT COMPLETED|Overall Study||0
6297808|NCT00316589|7199826|FG000|STARTED|Overall Study||88
6297809|NCT00316589|7199827|FG001|STARTED|Overall Study||352
6297810|NCT00316589|7199828|FG002|STARTED|Overall Study||9
6297811|NCT00316589|7199829|FG003|STARTED|Overall Study||132
6297812|NCT00316589|7199826|FG000|COMPLETED|Overall Study||87
6297813|NCT00316589|7199827|FG001|COMPLETED|Overall Study||328
6297814|NCT00316589|7199828|FG002|COMPLETED|Overall Study||8
6297815|NCT00316589|7199829|FG003|COMPLETED|Overall Study||127
6297816|NCT00316589|7199826|FG000|NOT COMPLETED|Overall Study||1
6297817|NCT00316589|7199827|FG001|NOT COMPLETED|Overall Study||24
6297818|NCT00316589|7199828|FG002|NOT COMPLETED|Overall Study||1
6297819|NCT00316589|7199829|FG003|NOT COMPLETED|Overall Study||5
6297820|NCT00316602|7199843|FG000|STARTED|Overall Study||282
6297821|NCT00316602|7199844|FG001|STARTED|Overall Study||350
6297822|NCT00316602|7199843|FG000|COMPLETED|Overall Study||272
6297823|NCT00316602|7199844|FG001|COMPLETED|Overall Study||325
6297824|NCT00316602|7199843|FG000|NOT COMPLETED|Overall Study||10
6297825|NCT00316602|7199844|FG001|NOT COMPLETED|Overall Study||25
6297826|NCT00316693|7199852|FG000|STARTED|Overall Study||519
6297827|NCT00316693|7199853|FG001|STARTED|Overall Study||521
6297828|NCT00316693|7199852|FG000|COMPLETED|Overall Study||442
6297829|NCT00316693|7199853|FG001|COMPLETED|Overall Study||436
6297830|NCT00316693|7199852|FG000|NOT COMPLETED|Overall Study||77
6297831|NCT00316693|7199853|FG001|NOT COMPLETED|Overall Study||85
6297832|NCT00316706|7199861|FG000|STARTED|Overall Study||626
6297833|NCT00316706|7199862|FG001|STARTED|Overall Study||619
6297834|NCT00316706|7199861|FG000|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
6297835|NCT00316706|7199862|FG001|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
6635120|NCT02301936|7563971|FG000|NOT COMPLETED|Overall Study||1
6635121|NCT02301936|7563972|FG001|NOT COMPLETED|Overall Study||0
6635122|NCT02301975|7563981|FG000|STARTED|Overall Study||504
6635123|NCT02301975|7563982|FG001|STARTED|Overall Study||501
6635124|NCT02301975|7563983|FG002|STARTED|Overall Study||499
6635125|NCT02301975|7563981|FG000|COMPLETED|Overall Study||473
6635126|NCT02301975|7563982|FG001|COMPLETED|Overall Study||476
6635127|NCT02301975|7563983|FG002|COMPLETED|Overall Study||477
6297836|NCT00316706|7199861|FG000|NOT COMPLETED|Overall Study||38
6297837|NCT00316706|7199862|FG001|NOT COMPLETED|Overall Study||48
6297838|NCT00316719|7199870|FG000|STARTED|Overall Study||52
6401000|NCT00889720|7313885|FG000|Surgical Population|Overall Study||12
6635128|NCT02301975|7563981|FG000|NOT COMPLETED|Overall Study||31
6297839|NCT00316719|7199871|FG001|STARTED|Overall Study||53
6297840|NCT00316719|7199870|FG000|COMPLETED|Overall Study||50
6297841|NCT00316719|7199871|FG001|COMPLETED|Overall Study||47
6297842|NCT00316719|7199870|FG000|NOT COMPLETED|Overall Study||2
6297843|NCT00316719|7199871|FG001|NOT COMPLETED|Overall Study||6
6297844|NCT00316862|7199877|FG000|STARTED|Overall Study||82
6297845|NCT00316862|7199877|FG000|COMPLETED|Overall Study||82
6297846|NCT00316862|7199877|FG000|NOT COMPLETED|Overall Study||0
6297847|NCT00316888|7199883|FG000|STARTED|Overall Study||28
6297848|NCT00316888|7199884|FG001|STARTED|Overall Study||35
6297849|NCT00316888|7199883|FG000|Eligible|Overall Study||28
6297850|NCT00316888|7199884|FG001|Eligible|Overall Study||35
6297851|NCT00316888|7199883|FG000|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
6297852|NCT00316888|7199884|FG001|Treated|Overall Study||34
6297853|NCT00316888|7199883|FG000|Started Induction Chemotherapy|Overall Study||28
6297854|NCT00316888|7199884|FG001|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
6297855|NCT00316888|7199883|FG000|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
6297856|NCT00316888|7199884|FG001|Started Chemo+Radiation+Cetuximab|Overall Study||34
6297857|NCT00316888|7199883|FG000|COMPLETED|Overall Study||22
6297858|NCT00316888|7199884|FG001|COMPLETED|Overall Study||27
6297859|NCT00316888|7199883|FG000|NOT COMPLETED|Overall Study||6
6297860|NCT00316888|7199884|FG001|NOT COMPLETED|Overall Study||8
6297861|NCT00316914|7199892|FG000|STARTED|Overall Study||50
6297862|NCT00316914|7199893|FG001|STARTED|Overall Study||52
6297863|NCT00316914|7199892|FG000|COMPLETED|Overall Study||17
6297864|NCT00316914|7199893|FG001|COMPLETED|Overall Study||16
6297865|NCT00316914|7199892|FG000|NOT COMPLETED|Overall Study||33
6297866|NCT00316914|7199893|FG001|NOT COMPLETED|Overall Study||36
6297867|NCT00317044|7199902|FG000|STARTED|Overall Study||320
6297868|NCT00317044|7199903|FG001|STARTED|Overall Study||313
6297869|NCT00317044|7199904|FG002|STARTED|Overall Study||328
6297870|NCT00317044|7199902|FG000|COMPLETED|Overall Study||272
6297871|NCT00317044|7199903|FG001|COMPLETED|Overall Study||273
6297872|NCT00317044|7199904|FG002|COMPLETED|Overall Study||283
6297873|NCT00317044|7199902|FG000|NOT COMPLETED|Overall Study||48
6297874|NCT00317044|7199903|FG001|NOT COMPLETED|Overall Study||40
6297875|NCT00317044|7199904|FG002|NOT COMPLETED|Overall Study||45
6297876|NCT00317109|7199914|FG000|STARTED|Overall Study||84
6297877|NCT00317109|7199915|FG001|STARTED|Overall Study||84
6297878|NCT00317109|7199914|FG000|COMPLETED|Overall Study||81
6297879|NCT00317109|7199915|FG001|COMPLETED|Overall Study||84
6297880|NCT00317109|7199914|FG000|NOT COMPLETED|Overall Study||3
6297881|NCT00317109|7199915|FG001|NOT COMPLETED|Overall Study||0
6401001|NCT00889720|7313885|FG000|COMPLETED|Overall Study||8
6401002|NCT00889720|7313885|FG000|NOT COMPLETED|Overall Study||8
6401003|NCT00889824|7313889|FG000|STARTED|Overall Study||5
6401004|NCT00889824|7313889|FG000|COMPLETED|Overall Study||5
6401005|NCT00889824|7313889|FG000|NOT COMPLETED|Overall Study||0
6401006|NCT00889863|7313893|FG000|STARTED|Part I: Open Label||177
6401007|NCT00889863|7313894|FG001|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
6401008|NCT00889863|7313893|FG000|Entered Part Ia|Part I: Open Label||145
6401009|NCT00889863|7313894|FG001|Entered Part Ia|Part I: Open Label||0
6401010|NCT00889863|7313893|FG000|Entered Part Ib|Part I: Open Label||142
6401011|NCT00889863|7313894|FG001|Entered Part Ib|Part I: Open Label||0
6401012|NCT00889863|7313893|FG000|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
6401013|NCT00889863|7313894|FG001|Entered Part Ic|Part I: Open Label||0
6401014|NCT00889863|7313893|FG000|Entered Part 1d|Part I: Open Label||103
6401015|NCT00889863|7313894|FG001|Entered Part 1d|Part I: Open Label||0
6401016|NCT00889863|7313893|FG000|COMPLETED|Part I: Open Label||100
6401017|NCT00889863|7313894|FG001|COMPLETED|Part I: Open Label||0
6401018|NCT00889863|7313893|FG000|NOT COMPLETED|Part I: Open Label||77
6401019|NCT00889863|7313894|FG001|NOT COMPLETED|Part I: Open Label||0
6401020|NCT00889863|7313893|FG000|STARTED|Part II: Randomized Double Blind||50
6401021|NCT00889863|7313894|FG001|STARTED|Part II: Randomized Double Blind||50
6401022|NCT00889863|7313893|FG000|COMPLETED|Part II: Randomized Double Blind||39
6401023|NCT00889863|7313894|FG001|COMPLETED|Part II: Randomized Double Blind||24
6401024|NCT00889863|7313893|FG000|NOT COMPLETED|Part II: Randomized Double Blind||11
6401025|NCT00889863|7313894|FG001|NOT COMPLETED|Part II: Randomized Double Blind||26
6401026|NCT00889915|7313906|FG000|STARTED|Overall Study||37
6401027|NCT00889915|7313907|FG001|STARTED|Overall Study||76
6401028|NCT00889915|7313908|FG002|STARTED|Overall Study||67
6401029|NCT00889915|7313909|FG003|STARTED|Overall Study||48
6401030|NCT00889915|7313906|FG000|COMPLETED|Overall Study||35
6401031|NCT00889915|7313907|FG001|COMPLETED|Overall Study||71
6401032|NCT00889915|7313908|FG002|COMPLETED|Overall Study||54
6401033|NCT00889915|7313909|FG003|COMPLETED|Overall Study||40
6401034|NCT00889915|7313906|FG000|NOT COMPLETED|Overall Study||2
6401035|NCT00889915|7313907|FG001|NOT COMPLETED|Overall Study||5
6401036|NCT00889915|7313908|FG002|NOT COMPLETED|Overall Study||13
6401037|NCT00889915|7313909|FG003|NOT COMPLETED|Overall Study||8
6401038|NCT00889928|7313919|FG000|STARTED|Overall Study||7
6401039|NCT00889928|7313919|FG000|COMPLETED|Overall Study||7
6401040|NCT00889928|7313919|FG000|NOT COMPLETED|Overall Study||0
6401041|NCT00890045|7313925|FG000|STARTED|Overall Study||20
6297882|NCT00317226|7199921|FG000|STARTED|Overall Study||127
6297883|NCT00317226|7199921|FG000|COMPLETED|Overall Study||104
6297884|NCT00317226|7199921|FG000|NOT COMPLETED|Overall Study||23
6297885|NCT00317239|7199927|FG000|STARTED|Overall Study||147
6297886|NCT00317239|7199928|FG001|STARTED|Overall Study||103
6297887|NCT00317239|7199927|FG000|COMPLETED|Overall Study||134
6297888|NCT00317239|7199928|FG001|COMPLETED|Overall Study||84
6297889|NCT00317239|7199927|FG000|NOT COMPLETED|Overall Study||13
6297890|NCT00317239|7199928|FG001|NOT COMPLETED|Overall Study||19
6297891|NCT00317356|7199938|FG000|STARTED|Overall Study||11
6297892|NCT00317356|7199939|FG001|STARTED|Overall Study||11
6297893|NCT00317356|7199940|FG002|STARTED|Overall Study||10
6297894|NCT00317356|7199941|FG003|STARTED|Overall Study||11
6297895|NCT00317356|7199938|FG000|COMPLETED|Overall Study||10
6297896|NCT00317356|7199939|FG001|COMPLETED|Overall Study||9
6297897|NCT00317356|7199940|FG002|COMPLETED|Overall Study||9
6297898|NCT00317356|7199941|FG003|COMPLETED|Overall Study||8
6297899|NCT00317356|7199938|FG000|NOT COMPLETED|Overall Study||1
6297900|NCT00317356|7199939|FG001|NOT COMPLETED|Overall Study||2
6297901|NCT00317356|7199940|FG002|NOT COMPLETED|Overall Study||1
6297902|NCT00317356|7199941|FG003|NOT COMPLETED|Overall Study||3
6297903|NCT00317369|7199954|FG000|STARTED|Overall Study||10
6297904|NCT00317369|7199955|FG001|STARTED|Overall Study||9
6297905|NCT00317369|7199956|FG002|STARTED|Overall Study||10
6635129|NCT02301975|7563982|FG001|NOT COMPLETED|Overall Study||25
6635130|NCT02301975|7563983|FG002|NOT COMPLETED|Overall Study||22
6635131|NCT02301988|7563993|FG000|STARTED|Overall Study||76
6635132|NCT02301988|7563994|FG001|STARTED|Overall Study||75
6635133|NCT02301988|7563993|FG000|COMPLETED|Overall Study||66
6297906|NCT00317369|7199954|FG000|COMPLETED|Overall Study||8
6297907|NCT00317369|7199955|FG001|COMPLETED|Overall Study||7
6297908|NCT00317369|7199956|FG002|COMPLETED|Overall Study||8
6297909|NCT00317369|7199954|FG000|NOT COMPLETED|Overall Study||2
6297910|NCT00317369|7199955|FG001|NOT COMPLETED|Overall Study||2
6297911|NCT00317369|7199956|FG002|NOT COMPLETED|Overall Study||2
6297912|NCT00317473|7199970|FG000|STARTED|Overall Study||30
6297913|NCT00317473|7199971|FG001|STARTED|Overall Study||15
6297914|NCT00317473|7199972|FG002|STARTED|Overall Study||30
6297915|NCT00317473|7199973|FG003|STARTED|Overall Study||15
6297916|NCT00317473|7199974|FG004|STARTED|Overall Study||30
6297917|NCT00317473|7199975|FG005|STARTED|Overall Study||15
6297918|NCT00317473|7199970|FG000|COMPLETED|Overall Study||26
6297919|NCT00317473|7199971|FG001|COMPLETED|Overall Study||12
6297920|NCT00317473|7199972|FG002|COMPLETED|Overall Study||27
6297921|NCT00317473|7199973|FG003|COMPLETED|Overall Study||13
6297922|NCT00317473|7199974|FG004|COMPLETED|Overall Study||22
6297923|NCT00317473|7199975|FG005|COMPLETED|Overall Study||12
6297924|NCT00317473|7199970|FG000|NOT COMPLETED|Overall Study||4
6297925|NCT00317473|7199971|FG001|NOT COMPLETED|Overall Study||3
6297926|NCT00317473|7199972|FG002|NOT COMPLETED|Overall Study||3
6297927|NCT00317473|7199973|FG003|NOT COMPLETED|Overall Study||2
6297928|NCT00317473|7199974|FG004|NOT COMPLETED|Overall Study||8
6297929|NCT00317473|7199975|FG005|NOT COMPLETED|Overall Study||3
6297930|NCT00317603|7199999|FG000|STARTED|Overall Study||15
6635134|NCT02301988|7563994|FG001|COMPLETED|Overall Study||66
6297931|NCT00317603|7199999|FG000|Treated|Overall Study||12
6297932|NCT00317603|7199999|FG000|COMPLETED|Overall Study||12
6297933|NCT00317603|7199999|FG000|NOT COMPLETED|Overall Study||3
6297934|NCT00317642|7200005|FG000|STARTED|Overall Study||163
6297935|NCT00317642|7200006|FG001|STARTED|Overall Study||163
6297936|NCT00317642|7200005|FG000|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
6297937|NCT00317642|7200006|FG001|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
6297938|NCT00317642|7200005|FG000|Received >= 1 Study Drug (Safety Set)|Overall Study||161
6297939|NCT00317642|7200006|FG001|Received >= 1 Study Drug (Safety Set)|Overall Study||155
6297940|NCT00317642|7200005|FG000|COMPLETED|Overall Study|achieved remission and completed consolidation|41
6297941|NCT00317642|7200006|FG001|COMPLETED|Overall Study|achieved remission and completed consolidation|28
6297942|NCT00317642|7200005|FG000|NOT COMPLETED|Overall Study||122
6297943|NCT00317642|7200006|FG001|NOT COMPLETED|Overall Study||135
6297944|NCT00317720|7200019|FG000|STARTED|Overall Study||40
6297945|NCT00317720|7200020|FG001|STARTED|Overall Study||7
6297946|NCT00317720|7200019|FG000|COMPLETED|Overall Study||40
6297947|NCT00317720|7200020|FG001|COMPLETED|Overall Study||7
6297948|NCT00317720|7200019|FG000|NOT COMPLETED|Overall Study||0
6297949|NCT00317720|7200020|FG001|NOT COMPLETED|Overall Study||0
6297950|NCT00317941|7200026|FG000|STARTED|Overall Study||73
6297951|NCT00317941|7200027|FG001|STARTED|Overall Study||79
6297952|NCT00317941|7200028|FG002|STARTED|Overall Study||68
6297953|NCT00317941|7200026|FG000|Participants Received Treatment|Overall Study||73
6297954|NCT00317941|7200027|FG001|Participants Received Treatment|Overall Study||79
6297955|NCT00317941|7200028|FG002|Participants Received Treatment|Overall Study||68
6297956|NCT00317941|7200026|FG000|Fulfilled Requirement Safety Population|Overall Study||73
6297957|NCT00317941|7200027|FG001|Fulfilled Requirement Safety Population|Overall Study||77
6297958|NCT00317941|7200028|FG002|Fulfilled Requirement Safety Population|Overall Study||65
6297959|NCT00317941|7200026|FG000|Fulfilled Requirements PP Population|Overall Study||66
6297960|NCT00317941|7200027|FG001|Fulfilled Requirements PP Population|Overall Study||76
6297961|NCT00317941|7200028|FG002|Fulfilled Requirements PP Population|Overall Study||63
6297962|NCT00317941|7200026|FG000|COMPLETED|Overall Study||66
6297963|NCT00317941|7200027|FG001|COMPLETED|Overall Study||74
6297964|NCT00317941|7200028|FG002|COMPLETED|Overall Study||60
6297965|NCT00317941|7200026|FG000|NOT COMPLETED|Overall Study||7
6297966|NCT00317941|7200027|FG001|NOT COMPLETED|Overall Study||5
6297967|NCT00317941|7200028|FG002|NOT COMPLETED|Overall Study||8
6297968|NCT00318136|7200037|FG000|STARTED|Overall Study||47
6297969|NCT00318136|7200037|FG000|COMPLETED|Overall Study||2
6297970|NCT00318136|7200037|FG000|NOT COMPLETED|Overall Study||45
6297971|NCT00318149|7200047|FG000|STARTED|Overall Study||75
6297972|NCT00318149|7200048|FG001|STARTED|Overall Study||50
6297973|NCT00318149|7200049|FG002|STARTED|Overall Study||75
6297974|NCT00318149|7200050|FG003|STARTED|Overall Study||75
6297975|NCT00318149|7200051|FG004|STARTED|Overall Study||75
6297976|NCT00318149|7200052|FG005|STARTED|Overall Study||75
6297977|NCT00318149|7200047|FG000|COMPLETED|Overall Study||75
6297978|NCT00318149|7200048|FG001|COMPLETED|Overall Study||50
6297979|NCT00318149|7200049|FG002|COMPLETED|Overall Study||75
6297980|NCT00318149|7200050|FG003|COMPLETED|Overall Study||75
6297981|NCT00318149|7200051|FG004|COMPLETED|Overall Study||75
6297982|NCT00318149|7200052|FG005|COMPLETED|Overall Study||73
6297983|NCT00318149|7200047|FG000|NOT COMPLETED|Overall Study||0
6297984|NCT00318149|7200048|FG001|NOT COMPLETED|Overall Study||0
6297985|NCT00318149|7200049|FG002|NOT COMPLETED|Overall Study||0
6297986|NCT00318149|7200050|FG003|NOT COMPLETED|Overall Study||0
6297987|NCT00318149|7200051|FG004|NOT COMPLETED|Overall Study||0
6297988|NCT00318149|7200052|FG005|NOT COMPLETED|Overall Study||2
6297989|NCT00318292|7200070|FG000|STARTED|Overall Study||45
6297990|NCT00318292|7200071|FG001|STARTED|Overall Study||45
6297991|NCT00318292|7200070|FG000|COMPLETED|Overall Study||45
6297992|NCT00318292|7200071|FG001|COMPLETED|Overall Study||45
6297993|NCT00318292|7200070|FG000|NOT COMPLETED|Overall Study||0
6297994|NCT00318292|7200071|FG001|NOT COMPLETED|Overall Study||0
6297995|NCT00318357|7200079|FG000|STARTED|Overall Study||173
6297996|NCT00318357|7200080|FG001|STARTED|Overall Study||136
6297997|NCT00318357|7200079|FG000|COMPLETED|Overall Study||134
6297998|NCT00318357|7200080|FG001|COMPLETED|Overall Study||104
6297999|NCT00318357|7200079|FG000|NOT COMPLETED|Overall Study||39
6298000|NCT00318357|7200080|FG001|NOT COMPLETED|Overall Study||32
6298001|NCT00318370|7200086|FG000|STARTED|Period 1||28
6298002|NCT00318370|7200087|FG001|STARTED|Period 1||0
6298003|NCT00318370|7200088|FG002|STARTED|Period 1||0
6298004|NCT00318370|7200086|FG000|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
6298005|NCT00318370|7200087|FG001|COMPLETED|Period 1||0
6298006|NCT00318370|7200088|FG002|COMPLETED|Period 1||0
6298007|NCT00318370|7200086|FG000|NOT COMPLETED|Period 1||7
6298008|NCT00318370|7200087|FG001|NOT COMPLETED|Period 1||0
6298009|NCT00318370|7200088|FG002|NOT COMPLETED|Period 1||0
6298010|NCT00318370|7200086|FG000|STARTED|Period 2||0
6401042|NCT00890045|7313926|FG001|STARTED|Overall Study|Of the 52 subjects randomized to the HeRO Graft, two implants were abandoned.|52
6401043|NCT00890045|7313925|FG000|COMPLETED|Overall Study||15
6401044|NCT00890045|7313926|FG001|COMPLETED|Overall Study||42
6401045|NCT00890045|7313925|FG000|NOT COMPLETED|Overall Study||5
6401046|NCT00890045|7313926|FG001|NOT COMPLETED|Overall Study||10
6401047|NCT00890084|7313932|FG000|STARTED|Overall Study||2913
6401048|NCT00890084|7313932|FG000|COMPLETED|Overall Study||2771
6401049|NCT00890084|7313932|FG000|NOT COMPLETED|Overall Study||142
6401050|NCT00890097|7313939|FG000|STARTED|Overall Study||252
6401051|NCT00890097|7313940|FG001|STARTED|Overall Study||259
6401052|NCT00890097|7313941|FG002|STARTED|Overall Study||261
6401053|NCT00890097|7313939|FG000|COMPLETED|Overall Study||184
6401054|NCT00890097|7313940|FG001|COMPLETED|Overall Study||173
6401055|NCT00890097|7313941|FG002|COMPLETED|Overall Study||184
6401056|NCT00890097|7313939|FG000|NOT COMPLETED|Overall Study||68
6401057|NCT00890097|7313940|FG001|NOT COMPLETED|Overall Study||86
6401058|NCT00890097|7313941|FG002|NOT COMPLETED|Overall Study||77
6401059|NCT00890162|7313951|FG000|STARTED|Overall Study||8
6401060|NCT00890162|7313952|FG001|STARTED|Overall Study||8
6401061|NCT00890162|7313951|FG000|COMPLETED|Overall Study||6
6401062|NCT00890162|7313952|FG001|COMPLETED|Overall Study||7
6401063|NCT00890162|7313951|FG000|NOT COMPLETED|Overall Study||2
6401064|NCT00890162|7313952|FG001|NOT COMPLETED|Overall Study||1
6401065|NCT00890201|7313960|FG000|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
6401066|NCT00890201|7313961|FG001|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
6635135|NCT02301988|7563993|FG000|NOT COMPLETED|Overall Study||10
6635136|NCT02301988|7563994|FG001|NOT COMPLETED|Overall Study||9
6635137|NCT02302066|7564004|FG000|STARTED|Overall Study||201
6635138|NCT02302066|7564005|FG001|STARTED|Overall Study||398
6298011|NCT00318370|7200087|FG001|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
6298012|NCT00318370|7200088|FG002|STARTED|Period 2||0
6298013|NCT00318370|7200086|FG000|COMPLETED|Period 2||0
6298014|NCT00318370|7200087|FG001|COMPLETED|Period 2||36
6298015|NCT00318370|7200088|FG002|COMPLETED|Period 2||0
6298016|NCT00318370|7200086|FG000|NOT COMPLETED|Period 2||0
6298017|NCT00318370|7200087|FG001|NOT COMPLETED|Period 2||11
6298018|NCT00318370|7200088|FG002|NOT COMPLETED|Period 2||0
6298019|NCT00318370|7200086|FG000|STARTED|Period 3||0
6298020|NCT00318370|7200087|FG001|STARTED|Period 3||0
6298021|NCT00318370|7200088|FG002|STARTED|Period 3||36
6298022|NCT00318370|7200086|FG000|COMPLETED|Period 3||0
6298023|NCT00318370|7200087|FG001|COMPLETED|Period 3||0
6298024|NCT00318370|7200088|FG002|COMPLETED|Period 3||3
6298025|NCT00318370|7200086|FG000|NOT COMPLETED|Period 3||0
6298026|NCT00318370|7200087|FG001|NOT COMPLETED|Period 3||0
6298027|NCT00318370|7200088|FG002|NOT COMPLETED|Period 3||33
6635139|NCT02302066|7564006|FG002|STARTED|Overall Study||1002
6298028|NCT00318409|7200096|FG000|STARTED|Overall Study||20
6298029|NCT00318409|7200097|FG001|STARTED|Overall Study||10
6298030|NCT00318409|7200096|FG000|COMPLETED|Overall Study||18
6298031|NCT00318409|7200097|FG001|COMPLETED|Overall Study||9
6298032|NCT00318409|7200096|FG000|NOT COMPLETED|Overall Study||2
6298033|NCT00318409|7200097|FG001|NOT COMPLETED|Overall Study||1
6298034|NCT00318461|7200109|FG000|STARTED|Double-Blind, 6 Months|Randomised|242
6298035|NCT00318461|7200110|FG001|STARTED|Double-Blind, 6 Months|Randomised|241
6298036|NCT00318461|7200111|FG002|STARTED|Double-Blind, 6 Months|Randomised|242
6298037|NCT00318461|7200112|FG003|STARTED|Double-Blind, 6 Months|Randomised|122
6298038|NCT00318461|7200113|FG004|STARTED|Double-Blind, 6 Months|Randomised|244
6298039|NCT00318461|7200109|FG000|Exposed to Study Drug|Double-Blind, 6 Months||242
6298040|NCT00318461|7200110|FG001|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
6298041|NCT00318461|7200111|FG002|Exposed to Study Drug|Double-Blind, 6 Months||242
6298042|NCT00318461|7200112|FG003|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
6298043|NCT00318461|7200113|FG004|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
6298044|NCT00318461|7200109|FG000|COMPLETED|Double-Blind, 6 Months||208
6298045|NCT00318461|7200110|FG001|COMPLETED|Double-Blind, 6 Months||197
6298046|NCT00318461|7200111|FG002|COMPLETED|Double-Blind, 6 Months||191
6298047|NCT00318461|7200112|FG003|COMPLETED|Double-Blind, 6 Months||74
6298048|NCT00318461|7200113|FG004|COMPLETED|Double-Blind, 6 Months||210
6298049|NCT00318461|7200109|FG000|NOT COMPLETED|Double-Blind, 6 Months||34
6298050|NCT00318461|7200110|FG001|NOT COMPLETED|Double-Blind, 6 Months||44
6298051|NCT00318461|7200111|FG002|NOT COMPLETED|Double-Blind, 6 Months||51
6298052|NCT00318461|7200112|FG003|NOT COMPLETED|Double-Blind, 6 Months||48
6298053|NCT00318461|7200113|FG004|NOT COMPLETED|Double-Blind, 6 Months||34
6298054|NCT00318461|7200109|FG000|STARTED|Open-Label Extension, 18 Months||208
6298055|NCT00318461|7200110|FG001|STARTED|Open-Label Extension, 18 Months||197
6298056|NCT00318461|7200111|FG002|STARTED|Open-Label Extension, 18 Months||191
6298057|NCT00318461|7200112|FG003|STARTED|Open-Label Extension, 18 Months||74
6298058|NCT00318461|7200113|FG004|STARTED|Open-Label Extension, 18 Months||210
6298059|NCT00318461|7200109|FG000|COMPLETED|Open-Label Extension, 18 Months||130
6298060|NCT00318461|7200110|FG001|COMPLETED|Open-Label Extension, 18 Months||137
6298061|NCT00318461|7200111|FG002|COMPLETED|Open-Label Extension, 18 Months||118
6298062|NCT00318461|7200112|FG003|COMPLETED|Open-Label Extension, 18 Months||31
6298063|NCT00318461|7200113|FG004|COMPLETED|Open-Label Extension, 18 Months||113
6298064|NCT00318461|7200109|FG000|NOT COMPLETED|Open-Label Extension, 18 Months||78
6298065|NCT00318461|7200110|FG001|NOT COMPLETED|Open-Label Extension, 18 Months||60
6298066|NCT00318461|7200111|FG002|NOT COMPLETED|Open-Label Extension, 18 Months||73
6298067|NCT00318461|7200112|FG003|NOT COMPLETED|Open-Label Extension, 18 Months||43
6298068|NCT00318461|7200113|FG004|NOT COMPLETED|Open-Label Extension, 18 Months||97
6298069|NCT00318474|7200127|FG000|STARTED|Overall Study||25
6298070|NCT00318474|7200128|FG001|STARTED|Overall Study||27
6298071|NCT00318474|7200127|FG000|COMPLETED|Overall Study||7
6298072|NCT00318474|7200128|FG001|COMPLETED|Overall Study||10
6298073|NCT00318474|7200127|FG000|NOT COMPLETED|Overall Study||18
6298074|NCT00318474|7200128|FG001|NOT COMPLETED|Overall Study||17
6298075|NCT00318565|7200134|FG000|STARTED|Overall Study||291
6298076|NCT00318565|7200134|FG000|COMPLETED|Overall Study||267
6298077|NCT00318565|7200134|FG000|NOT COMPLETED|Overall Study||24
6298078|NCT00318591|7200140|FG000|STARTED|Overall Study||105
6635140|NCT02302066|7564007|FG003|STARTED|Overall Study||199
6635141|NCT02302066|7564004|FG000|Safety Analysis Set|Overall Study||200
6635142|NCT02302066|7564005|FG001|Safety Analysis Set|Overall Study||398
6635143|NCT02302066|7564006|FG002|Safety Analysis Set|Overall Study||998
6635144|NCT02302066|7564007|FG003|Safety Analysis Set|Overall Study||198
6635145|NCT02302066|7564004|FG000|Immunogenicity Subset|Overall Study||92
6635146|NCT02302066|7564005|FG001|Immunogenicity Subset|Overall Study||187
6635147|NCT02302066|7564006|FG002|Immunogenicity Subset|Overall Study||192
6635148|NCT02302066|7564007|FG003|Immunogenicity Subset|Overall Study||94
6635149|NCT02302066|7564004|FG000|Per-Protocol Set (PPS)|Overall Study||83
6635150|NCT02302066|7564005|FG001|Per-Protocol Set (PPS)|Overall Study||171
6635151|NCT02302066|7564006|FG002|Per-Protocol Set (PPS)|Overall Study||174
6635152|NCT02302066|7564007|FG003|Per-Protocol Set (PPS)|Overall Study||81
6635153|NCT02302066|7564004|FG000|COMPLETED|Overall Study||168
6635154|NCT02302066|7564005|FG001|COMPLETED|Overall Study||323
6635155|NCT02302066|7564006|FG002|COMPLETED|Overall Study||830
6635156|NCT02302066|7564007|FG003|COMPLETED|Overall Study||158
6635157|NCT02302066|7564004|FG000|NOT COMPLETED|Overall Study||33
6635158|NCT02302066|7564005|FG001|NOT COMPLETED|Overall Study||75
6635159|NCT02302066|7564006|FG002|NOT COMPLETED|Overall Study||172
6635160|NCT02302066|7564007|FG003|NOT COMPLETED|Overall Study||41
6635161|NCT02302092|7564029|FG000|STARTED|Overall Study||6
6635162|NCT02302092|7564030|FG001|STARTED|Overall Study||7
6635163|NCT02302092|7564029|FG000|COMPLETED|Overall Study||6
6635164|NCT02302092|7564030|FG001|COMPLETED|Overall Study||7
6635165|NCT02302092|7564029|FG000|NOT COMPLETED|Overall Study||0
6635166|NCT02302092|7564030|FG001|NOT COMPLETED|Overall Study||0
6635167|NCT02302157|7564041|FG000|STARTED|Overall Study||3
6635168|NCT02302157|7564042|FG001|STARTED|Overall Study||6
6635169|NCT02302157|7564043|FG002|STARTED|Overall Study||6
6635170|NCT02302157|7564044|FG003|STARTED|Overall Study||6
6635171|NCT02302157|7564045|FG004|STARTED|Overall Study||4
6298079|NCT00318591|7200141|FG001|STARTED|Overall Study||114
6298080|NCT00318591|7200140|FG000|COMPLETED|Overall Study||45
6298081|NCT00318591|7200141|FG001|COMPLETED|Overall Study||69
6298082|NCT00318591|7200140|FG000|NOT COMPLETED|Overall Study||60
6298083|NCT00318591|7200141|FG001|NOT COMPLETED|Overall Study||45
6298084|NCT00318643|7200154|FG000|STARTED|Overall Study||3
6298085|NCT00318643|7200155|FG001|STARTED|Overall Study||3
6298086|NCT00318643|7200156|FG002|STARTED|Overall Study||6
6298087|NCT00318643|7200157|FG003|STARTED|Overall Study||3
6298088|NCT00318643|7200158|FG004|STARTED|Overall Study||12
6298089|NCT00318643|7200154|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6298090|NCT00318643|7200155|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6298091|NCT00318643|7200156|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6298092|NCT00318643|7200157|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6298093|NCT00318643|7200158|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
6298094|NCT00318643|7200154|FG000|COMPLETED|Overall Study||3
6298095|NCT00318643|7200155|FG001|COMPLETED|Overall Study||3
6298096|NCT00318643|7200156|FG002|COMPLETED|Overall Study||6
6298097|NCT00318643|7200157|FG003|COMPLETED|Overall Study||3
6298098|NCT00318643|7200158|FG004|COMPLETED|Overall Study||9
6298099|NCT00318643|7200154|FG000|NOT COMPLETED|Overall Study||0
6298100|NCT00318643|7200155|FG001|NOT COMPLETED|Overall Study||0
6298101|NCT00318643|7200156|FG002|NOT COMPLETED|Overall Study||0
6298102|NCT00318643|7200157|FG003|NOT COMPLETED|Overall Study||0
6298103|NCT00318643|7200158|FG004|NOT COMPLETED|Overall Study||3
6298104|NCT00318708|7200173|FG000|STARTED|Overall Study||47
6298105|NCT00318708|7200174|FG001|STARTED|Overall Study||45
6298106|NCT00318708|7200173|FG000|8-week Milestone|Overall Study||42
6298107|NCT00318708|7200174|FG001|8-week Milestone|Overall Study||42
6298108|NCT00318708|7200173|FG000|COMPLETED|Overall Study||39
6298109|NCT00318708|7200174|FG001|COMPLETED|Overall Study||40
6298110|NCT00318708|7200173|FG000|NOT COMPLETED|Overall Study||8
6298111|NCT00318708|7200174|FG001|NOT COMPLETED|Overall Study||5
6298112|NCT00318812|7200186|FG000|STARTED|Overall Study||18
6298113|NCT00318812|7200187|FG001|STARTED|Overall Study||22
6298114|NCT00318812|7200186|FG000|COMPLETED|Overall Study||18
6298115|NCT00318812|7200187|FG001|COMPLETED|Overall Study||22
6298116|NCT00318812|7200186|FG000|NOT COMPLETED|Overall Study||0
6298117|NCT00318812|7200187|FG001|NOT COMPLETED|Overall Study||0
6298118|NCT00318929|7200193|FG000|STARTED|Overall Study||14
6298119|NCT00318929|7200193|FG000|COMPLETED|Overall Study||14
6298120|NCT00318929|7200193|FG000|NOT COMPLETED|Overall Study||0
6298121|NCT00319020|7200199|FG000|STARTED|Overall Study||15
6298122|NCT00319020|7200200|FG001|STARTED|Overall Study||21
6298123|NCT00319020|7200199|FG000|Enrollment in FUTURE 2 (F-2)|Overall Study||13
6298124|NCT00319020|7200200|FG001|Enrollment in FUTURE 2 (F-2)|Overall Study||20
6298125|NCT00319020|7200199|FG000|COMPLETED|Overall Study||8
6298126|NCT00319020|7200200|FG001|COMPLETED|Overall Study||8
6298127|NCT00319020|7200199|FG000|NOT COMPLETED|Overall Study||7
6298128|NCT00319020|7200200|FG001|NOT COMPLETED|Overall Study||13
6298129|NCT00319046|7200208|FG000|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
6298130|NCT00319046|7200208|FG000|COMPLETED|Overall Study||34
6298131|NCT00319046|7200208|FG000|NOT COMPLETED|Overall Study||8
6298132|NCT00319098|7200216|FG000|STARTED|Overall Study||3802
6298133|NCT00319098|7200217|FG001|STARTED|Overall Study||1269
6298134|NCT00319098|7200216|FG000|COMPLETED|Overall Study||3667
6298135|NCT00319098|7200217|FG001|COMPLETED|Overall Study||1237
6298136|NCT00319098|7200216|FG000|NOT COMPLETED|Overall Study||135
6298137|NCT00319098|7200217|FG001|NOT COMPLETED|Overall Study||32
6298138|NCT00319111|7200227|FG000|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
6298139|NCT00319111|7200227|FG000|COMPLETED|Overall Study||104
6298140|NCT00319111|7200227|FG000|NOT COMPLETED|Overall Study||47
6298141|NCT00319254|7200231|FG000|STARTED|Overall Study||75
6298142|NCT00319254|7200231|FG000|Treated|Overall Study||73
6298143|NCT00319254|7200231|FG000|COMPLETED|Overall Study||21
6298144|NCT00319254|7200231|FG000|NOT COMPLETED|Overall Study||54
6298145|NCT00319436|7200237|FG000|STARTED|Overall Study||23
6298146|NCT00319436|7200238|FG001|STARTED|Overall Study||24
6298147|NCT00319436|7200237|FG000|COMPLETED|Overall Study||17
6298148|NCT00319436|7200238|FG001|COMPLETED|Overall Study||17
6298149|NCT00319436|7200237|FG000|NOT COMPLETED|Overall Study||6
6298150|NCT00319436|7200238|FG001|NOT COMPLETED|Overall Study||7
6298151|NCT00319501|7200246|FG000|STARTED|Double-blind Period|Randomized participants|124
6298152|NCT00319501|7200247|FG001|STARTED|Double-blind Period|Randomized participants|110
6298153|NCT00319501|7200246|FG000|Received Treatment|Double-blind Period||82
6298154|NCT00319501|7200247|FG001|Received Treatment|Double-blind Period||81
6298155|NCT00319501|7200246|FG000|COMPLETED|Double-blind Period||81
6298156|NCT00319501|7200247|FG001|COMPLETED|Double-blind Period||78
6298157|NCT00319501|7200246|FG000|NOT COMPLETED|Double-blind Period||43
6298158|NCT00319501|7200247|FG001|NOT COMPLETED|Double-blind Period||32
6298159|NCT00319501|7200246|FG000|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
6298160|NCT00319501|7200247|FG001|STARTED|Open-label Period||0
6298161|NCT00319501|7200246|FG000|Received Treatment|Open-label Period||128
6298162|NCT00319501|7200247|FG001|Received Treatment|Open-label Period||0
6298163|NCT00319501|7200246|FG000|COMPLETED|Open-label Period|Competed=continuing treatment|45
6635172|NCT02302157|7564041|FG000|COMPLETED|Overall Study||3
6298164|NCT00319501|7200247|FG001|COMPLETED|Open-label Period||0
6298165|NCT00319501|7200246|FG000|NOT COMPLETED|Open-label Period||116
6298166|NCT00319501|7200247|FG001|NOT COMPLETED|Open-label Period||0
6298167|NCT00319501|7200246|FG000|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
6298168|NCT00319501|7200247|FG001|STARTED|Open-label Extension Period||0
6298169|NCT00319501|7200246|FG000|Received Treatment|Open-label Extension Period||33
6298170|NCT00319501|7200247|FG001|Received Treatment|Open-label Extension Period||0
6298171|NCT00319501|7200246|FG000|COMPLETED|Open-label Extension Period||0
6298172|NCT00319501|7200247|FG001|COMPLETED|Open-label Extension Period||0
6298173|NCT00319501|7200246|FG000|NOT COMPLETED|Open-label Extension Period||51
6298174|NCT00319501|7200247|FG001|NOT COMPLETED|Open-label Extension Period||0
6298175|NCT00319553|7200260|FG000|STARTED|Overall Study||323
6298176|NCT00319553|7200261|FG001|STARTED|Overall Study||321
6298177|NCT00319553|7200260|FG000|COMPLETED|Overall Study||319
6298178|NCT00319553|7200261|FG001|COMPLETED|Overall Study||317
6298179|NCT00319553|7200260|FG000|NOT COMPLETED|Overall Study||4
6298180|NCT00319553|7200261|FG001|NOT COMPLETED|Overall Study||4
6298181|NCT00319592|7200269|FG000|STARTED|Overall Study||30
6298182|NCT00319592|7200270|FG001|STARTED|Overall Study||30
6298183|NCT00319592|7200269|FG000|COMPLETED|Overall Study||29
6298184|NCT00319592|7200270|FG001|COMPLETED|Overall Study||29
6298185|NCT00319592|7200269|FG000|NOT COMPLETED|Overall Study||1
6298186|NCT00319592|7200270|FG001|NOT COMPLETED|Overall Study||1
6298187|NCT00319644|7200278|FG000|STARTED|Overall Study||21
6298188|NCT00319644|7200279|FG001|STARTED|Overall Study||16
6298189|NCT00319644|7200278|FG000|COMPLETED|Overall Study||21
6298190|NCT00319644|7200279|FG001|COMPLETED|Overall Study||16
6298191|NCT00319644|7200278|FG000|NOT COMPLETED|Overall Study||0
6298192|NCT00319644|7200279|FG001|NOT COMPLETED|Overall Study||0
6298193|NCT00319696|7200285|FG000|STARTED|Overall Study||116
6298194|NCT00319696|7200285|FG000|COMPLETED|Overall Study||56
6298195|NCT00319696|7200285|FG000|NOT COMPLETED|Overall Study||60
6298196|NCT00319735|7200295|FG000|STARTED|Overall Study||41
6298197|NCT00319735|7200295|FG000|COMPLETED|Overall Study||39
6298198|NCT00319735|7200295|FG000|NOT COMPLETED|Overall Study||2
6298199|NCT00319748|7200300|FG000|STARTED|Overall Study||13
6298200|NCT00319748|7200300|FG000|COMPLETED|Overall Study||13
6298201|NCT00319748|7200300|FG000|NOT COMPLETED|Overall Study||0
6298202|NCT00319956|7200312|FG000|STARTED|Overall Study||111
6298203|NCT00319956|7200313|FG001|STARTED|Overall Study||109
6298204|NCT00319956|7200312|FG000|COMPLETED|Overall Study||91
6298205|NCT00319956|7200313|FG001|COMPLETED|Overall Study||85
6298206|NCT00319956|7200312|FG000|NOT COMPLETED|Overall Study||20
6298207|NCT00319956|7200313|FG001|NOT COMPLETED|Overall Study||24
6298208|NCT00319982|7200321|FG000|STARTED|Overall Study||19
6298209|NCT00319982|7200322|FG001|STARTED|Overall Study||20
6298210|NCT00319982|7200321|FG000|COMPLETED|Overall Study||18
6298211|NCT00319982|7200322|FG001|COMPLETED|Overall Study||20
6298212|NCT00319982|7200321|FG000|NOT COMPLETED|Overall Study||1
6298213|NCT00319982|7200322|FG001|NOT COMPLETED|Overall Study||0
6298214|NCT00320112|7200330|FG000|STARTED|Overall Study||125
6298215|NCT00320112|7200331|FG001|STARTED|Overall Study||119
6298216|NCT00320112|7200330|FG000|COMPLETED|Overall Study||117
6298217|NCT00320112|7200331|FG001|COMPLETED|Overall Study||114
6298218|NCT00320112|7200330|FG000|NOT COMPLETED|Overall Study||8
6298219|NCT00320112|7200331|FG001|NOT COMPLETED|Overall Study||5
6298220|NCT00320190|7200345|FG000|STARTED|First 12 Months||19
6298221|NCT00320190|7200346|FG001|STARTED|First 12 Months||13
6298222|NCT00320190|7200345|FG000|COMPLETED|First 12 Months||11
6298223|NCT00320190|7200346|FG001|COMPLETED|First 12 Months||3
6298224|NCT00320190|7200345|FG000|NOT COMPLETED|First 12 Months||8
6298225|NCT00320190|7200346|FG001|NOT COMPLETED|First 12 Months||10
6298226|NCT00320190|7200345|FG000|STARTED|Long-term (12-month) Extension||11
6298227|NCT00320190|7200346|FG001|STARTED|Long-term (12-month) Extension||3
6298228|NCT00320190|7200345|FG000|COMPLETED|Long-term (12-month) Extension||2
6298229|NCT00320190|7200346|FG001|COMPLETED|Long-term (12-month) Extension||1
6298230|NCT00320190|7200345|FG000|NOT COMPLETED|Long-term (12-month) Extension||9
6298231|NCT00320190|7200346|FG001|NOT COMPLETED|Long-term (12-month) Extension||2
6298232|NCT00320216|7200357|FG000|STARTED|Overall Study||64
6298233|NCT00320216|7200358|FG001|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
6298234|NCT00320216|7200359|FG002|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
6298235|NCT00320216|7200360|FG003|STARTED|Overall Study||64
6298236|NCT00320216|7200361|FG004|STARTED|Overall Study||64
6298237|NCT00320216|7200357|FG000|COMPLETED|Overall Study||48
6298238|NCT00320216|7200358|FG001|COMPLETED|Overall Study||54
6298239|NCT00320216|7200359|FG002|COMPLETED|Overall Study||58
6298240|NCT00320216|7200360|FG003|COMPLETED|Overall Study||61
6298241|NCT00320216|7200361|FG004|COMPLETED|Overall Study||58
6298242|NCT00320216|7200357|FG000|NOT COMPLETED|Overall Study||16
6298243|NCT00320216|7200358|FG001|NOT COMPLETED|Overall Study||10
6298244|NCT00320216|7200359|FG002|NOT COMPLETED|Overall Study||6
6298245|NCT00320216|7200360|FG003|NOT COMPLETED|Overall Study||3
6298246|NCT00320216|7200361|FG004|NOT COMPLETED|Overall Study||6
6298247|NCT00320242|7200378|FG000|STARTED|Overall Study||16
6298248|NCT00320242|7200379|FG001|STARTED|Overall Study||16
6298249|NCT00320242|7200378|FG000|COMPLETED|Overall Study||14
6298250|NCT00320242|7200379|FG001|COMPLETED|Overall Study||12
6298251|NCT00320242|7200378|FG000|NOT COMPLETED|Overall Study||2
6298252|NCT00320242|7200379|FG001|NOT COMPLETED|Overall Study||4
6298253|NCT00320255|7200392|FG000|STARTED|Overall Study||30
6298254|NCT00320255|7200393|FG001|STARTED|Overall Study||32
6298255|NCT00320255|7200394|FG002|STARTED|Overall Study||30
6298256|NCT00320255|7200395|FG003|STARTED|Overall Study||33
6298257|NCT00320255|7200396|FG004|STARTED|Overall Study||2
6298258|NCT00320255|7200397|FG005|STARTED|Overall Study||3
6298259|NCT00320255|7200392|FG000|Received Treatment|Overall Study||29
6298260|NCT00320255|7200393|FG001|Received Treatment|Overall Study||32
6298261|NCT00320255|7200394|FG002|Received Treatment|Overall Study||29
6298262|NCT00320255|7200395|FG003|Received Treatment|Overall Study||32
6298263|NCT00320255|7200396|FG004|Received Treatment|Overall Study||2
6298264|NCT00320255|7200397|FG005|Received Treatment|Overall Study||3
6298265|NCT00320255|7200392|FG000|COMPLETED|Overall Study||19
6298266|NCT00320255|7200393|FG001|COMPLETED|Overall Study||25
6298267|NCT00320255|7200394|FG002|COMPLETED|Overall Study||24
6298268|NCT00320255|7200395|FG003|COMPLETED|Overall Study||25
6298269|NCT00320255|7200396|FG004|COMPLETED|Overall Study||2
6298270|NCT00320255|7200397|FG005|COMPLETED|Overall Study||3
6298271|NCT00320255|7200392|FG000|NOT COMPLETED|Overall Study||11
6298272|NCT00320255|7200393|FG001|NOT COMPLETED|Overall Study||7
6298273|NCT00320255|7200394|FG002|NOT COMPLETED|Overall Study||6
6298274|NCT00320255|7200395|FG003|NOT COMPLETED|Overall Study||8
6298275|NCT00320255|7200396|FG004|NOT COMPLETED|Overall Study||0
6298276|NCT00320255|7200397|FG005|NOT COMPLETED|Overall Study||0
6298277|NCT00320281|7200414|FG000|STARTED|Overall Study||10
6298278|NCT00320281|7200415|FG001|STARTED|Overall Study||9
6298279|NCT00320281|7200414|FG000|COMPLETED|Overall Study||10
6298280|NCT00320281|7200415|FG001|COMPLETED|Overall Study||9
6298281|NCT00320281|7200414|FG000|NOT COMPLETED|Overall Study||0
6298282|NCT00320281|7200415|FG001|NOT COMPLETED|Overall Study||0
6298283|NCT00320372|7200426|FG000|STARTED|Overall Study||494
6298284|NCT00320372|7200427|FG001|STARTED|Overall Study||301
6298285|NCT00320372|7200426|FG000|VNS Therapy D-23 Original|Overall Study||335
6298286|NCT00320372|7200427|FG001|VNS Therapy D-23 Original|Overall Study||0
6298287|NCT00320372|7200426|FG000|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
6298288|NCT00320372|7200427|FG001|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
6298289|NCT00320372|7200426|FG000|COMPLETED|Overall Study||299
6298290|NCT00320372|7200427|FG001|COMPLETED|Overall Study||138
6298291|NCT00320372|7200426|FG000|NOT COMPLETED|Overall Study||195
6298292|NCT00320372|7200427|FG001|NOT COMPLETED|Overall Study||163
6374528|NCT00750308|7285098|FG004|NOT COMPLETED|Washout||0
6374529|NCT00750308|7285099|FG005|NOT COMPLETED|Washout||0
6374530|NCT00750308|7285100|FG006|NOT COMPLETED|Washout||0
6374531|NCT00750308|7285101|FG007|NOT COMPLETED|Washout||0
6374532|NCT00750308|7285102|FG008|NOT COMPLETED|Washout||0
6374533|NCT00750308|7285103|FG009|NOT COMPLETED|Washout||0
6374534|NCT00750308|7285104|FG010|NOT COMPLETED|Washout||0
6374535|NCT00750308|7285105|FG011|NOT COMPLETED|Washout||0
6374536|NCT00750308|7285094|FG000|STARTED|Third Treatment||2
6374537|NCT00750308|7285095|FG001|STARTED|Third Treatment||2
6374538|NCT00750308|7285096|FG002|STARTED|Third Treatment||2
6374539|NCT00750308|7285097|FG003|STARTED|Third Treatment||1
6374540|NCT00750308|7285098|FG004|STARTED|Third Treatment||1
6374541|NCT00750308|7285099|FG005|STARTED|Third Treatment||2
6374542|NCT00750308|7285100|FG006|STARTED|Third Treatment||2
6374543|NCT00750308|7285101|FG007|STARTED|Third Treatment||2
6374544|NCT00750308|7285102|FG008|STARTED|Third Treatment||1
6374545|NCT00750308|7285103|FG009|STARTED|Third Treatment||2
6374546|NCT00750308|7285104|FG010|STARTED|Third Treatment||1
6374547|NCT00750308|7285105|FG011|STARTED|Third Treatment||1
6374548|NCT00750308|7285094|FG000|COMPLETED|Third Treatment||2
6374549|NCT00750308|7285095|FG001|COMPLETED|Third Treatment||1
6374550|NCT00750308|7285096|FG002|COMPLETED|Third Treatment||2
6374551|NCT00750308|7285097|FG003|COMPLETED|Third Treatment||1
6374552|NCT00750308|7285098|FG004|COMPLETED|Third Treatment||1
6374553|NCT00750308|7285099|FG005|COMPLETED|Third Treatment||2
6374554|NCT00750308|7285100|FG006|COMPLETED|Third Treatment||2
6374555|NCT00750308|7285101|FG007|COMPLETED|Third Treatment||2
6374556|NCT00750308|7285102|FG008|COMPLETED|Third Treatment||1
6374557|NCT00750308|7285103|FG009|COMPLETED|Third Treatment||2
6374558|NCT00750308|7285104|FG010|COMPLETED|Third Treatment||1
6374559|NCT00750308|7285105|FG011|COMPLETED|Third Treatment||1
6374560|NCT00750308|7285094|FG000|NOT COMPLETED|Third Treatment||0
6374561|NCT00750308|7285095|FG001|NOT COMPLETED|Third Treatment||1
6374562|NCT00750308|7285096|FG002|NOT COMPLETED|Third Treatment||0
6374563|NCT00750308|7285097|FG003|NOT COMPLETED|Third Treatment||0
6374564|NCT00750308|7285098|FG004|NOT COMPLETED|Third Treatment||0
6374565|NCT00750308|7285099|FG005|NOT COMPLETED|Third Treatment||0
6374566|NCT00750308|7285100|FG006|NOT COMPLETED|Third Treatment||0
6374567|NCT00750308|7285101|FG007|NOT COMPLETED|Third Treatment||0
6374568|NCT00750308|7285102|FG008|NOT COMPLETED|Third Treatment||0
6374569|NCT00750308|7285103|FG009|NOT COMPLETED|Third Treatment||0
6374570|NCT00750308|7285104|FG010|NOT COMPLETED|Third Treatment||0
6374571|NCT00750308|7285105|FG011|NOT COMPLETED|Third Treatment||0
6374572|NCT00750308|7285094|FG000|STARTED|Washout||2
6374573|NCT00750308|7285095|FG001|STARTED|Washout||1
6374574|NCT00750308|7285096|FG002|STARTED|Washout||2
6374575|NCT00750308|7285097|FG003|STARTED|Washout||1
6374576|NCT00750308|7285098|FG004|STARTED|Washout||1
6374577|NCT00750308|7285099|FG005|STARTED|Washout||2
6374578|NCT00750308|7285100|FG006|STARTED|Washout||2
6374579|NCT00750308|7285101|FG007|STARTED|Washout||2
6374580|NCT00750308|7285102|FG008|STARTED|Washout||1
6298293|NCT00320385|7200443|FG000|STARTED|Overall Study||148
6298294|NCT00320385|7200444|FG001|STARTED|Overall Study||148
6298295|NCT00320385|7200443|FG000|COMPLETED|Overall Study||130
6298296|NCT00320385|7200444|FG001|COMPLETED|Overall Study||126
6298297|NCT00320385|7200443|FG000|NOT COMPLETED|Overall Study||18
6298298|NCT00320385|7200444|FG001|NOT COMPLETED|Overall Study||22
6298299|NCT00320398|7200452|FG000|STARTED|Overall Study||58
6298300|NCT00320398|7200453|FG001|STARTED|Overall Study||56
6298301|NCT00320398|7200452|FG000|COMPLETED|Overall Study||56
6298302|NCT00320398|7200453|FG001|COMPLETED|Overall Study||52
6298303|NCT00320398|7200452|FG000|NOT COMPLETED|Overall Study||2
6298304|NCT00320398|7200453|FG001|NOT COMPLETED|Overall Study||4
6298305|NCT00320411|7200460|FG000|STARTED|Overall Study||62
6298306|NCT00320411|7200460|FG000|COMPLETED|Overall Study||58
6298307|NCT00320411|7200460|FG000|NOT COMPLETED|Overall Study||4
6298308|NCT00320424|7200464|FG000|STARTED|Overall Study||48
6298309|NCT00320424|7200464|FG000|COMPLETED|Overall Study||42
6298310|NCT00320424|7200464|FG000|NOT COMPLETED|Overall Study||6
6298311|NCT00320489|7200470|FG000|STARTED|Overall Study||264
6298312|NCT00320489|7200471|FG001|STARTED|Overall Study||260
6298313|NCT00320489|7200470|FG000|COMPLETED|Overall Study||119
6298314|NCT00320489|7200471|FG001|COMPLETED|Overall Study||124
6298315|NCT00320489|7200470|FG000|NOT COMPLETED|Overall Study||145
6298316|NCT00320489|7200471|FG001|NOT COMPLETED|Overall Study||136
6298317|NCT00320515|7200477|FG000|STARTED|Overall Study||69
6298318|NCT00320515|7200477|FG000|COMPLETED|Overall Study||20
6298319|NCT00320515|7200477|FG000|NOT COMPLETED|Overall Study||49
6298320|NCT00320528|7200484|FG000|STARTED|Study Period II||98
6298321|NCT00320528|7200485|FG001|STARTED|Study Period II||41
6298322|NCT00320528|7200486|FG002|STARTED|Study Period II||130
6298323|NCT00320528|7200484|FG000|Received at Least One Dose of Study Drug|Study Period II||97
6298324|NCT00320528|7200485|FG001|Received at Least One Dose of Study Drug|Study Period II||38
6298325|NCT00320528|7200486|FG002|Received at Least One Dose of Study Drug|Study Period II||128
6298326|NCT00320528|7200484|FG000|COMPLETED|Study Period II||87
6298327|NCT00320528|7200485|FG001|COMPLETED|Study Period II||31
6298328|NCT00320528|7200486|FG002|COMPLETED|Study Period II||108
6298329|NCT00320528|7200484|FG000|NOT COMPLETED|Study Period II||11
6298330|NCT00320528|7200485|FG001|NOT COMPLETED|Study Period II||10
6298331|NCT00320528|7200486|FG002|NOT COMPLETED|Study Period II||22
6298332|NCT00320528|7200484|FG000|STARTED|Study Period III||87
6298333|NCT00320528|7200485|FG001|STARTED|Study Period III||31
6298334|NCT00320528|7200486|FG002|STARTED|Study Period III||108
6298335|NCT00320528|7200484|FG000|COMPLETED|Study Period III||0
6298336|NCT00320528|7200485|FG001|COMPLETED|Study Period III||0
6298337|NCT00320528|7200486|FG002|COMPLETED|Study Period III||2
6298338|NCT00320528|7200484|FG000|NOT COMPLETED|Study Period III||87
6298339|NCT00320528|7200485|FG001|NOT COMPLETED|Study Period III||31
6298340|NCT00320528|7200486|FG002|NOT COMPLETED|Study Period III||106
6298341|NCT00320541|7200496|FG000|STARTED|Overall Study||94
6298342|NCT00320541|7200497|FG001|STARTED|Overall Study||93
6298343|NCT00320541|7200496|FG000|COMPLETED|Overall Study||44
6298344|NCT00320541|7200497|FG001|COMPLETED|Overall Study||36
6298345|NCT00320541|7200496|FG000|NOT COMPLETED|Overall Study||50
6298346|NCT00320541|7200497|FG001|NOT COMPLETED|Overall Study||57
6298347|NCT00320593|7200505|FG000|STARTED|Overall Study||59
6298348|NCT00320593|7200506|FG001|STARTED|Overall Study||59
6298349|NCT00320593|7200505|FG000|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
6298350|NCT00320593|7200506|FG001|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
6298351|NCT00320593|7200505|FG000|NOT COMPLETED|Overall Study||7
6298352|NCT00320593|7200506|FG001|NOT COMPLETED|Overall Study||1
6298353|NCT00320606|7200512|FG000|STARTED|Overall Study||20
6298354|NCT00320606|7200512|FG000|COMPLETED|Overall Study||17
6298355|NCT00320606|7200512|FG000|NOT COMPLETED|Overall Study||3
6298356|NCT00320671|7200519|FG000|STARTED|Overall Study||102
6298357|NCT00320671|7200520|FG001|STARTED|Overall Study||96
6298358|NCT00320671|7200519|FG000|COMPLETED|Overall Study||69
6298359|NCT00320671|7200520|FG001|COMPLETED|Overall Study||58
6298360|NCT00320671|7200519|FG000|NOT COMPLETED|Overall Study||33
6298361|NCT00320671|7200520|FG001|NOT COMPLETED|Overall Study||38
6298362|NCT00320710|7200529|FG000|STARTED|Overall Study||200
6298363|NCT00320710|7200530|FG001|STARTED|Overall Study||203
6298364|NCT00320710|7200531|FG002|STARTED|Overall Study||13
6298365|NCT00320710|7200529|FG000|Treated (Safety Set)|Overall Study||198
6298366|NCT00320710|7200530|FG001|Treated (Safety Set)|Overall Study||202
6401067|NCT00890201|7313960|FG000|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
6401068|NCT00890201|7313961|FG001|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
6401069|NCT00890201|7313960|FG000|NOT COMPLETED|Overall Study||5
6401070|NCT00890201|7313961|FG001|NOT COMPLETED|Overall Study||56
6298367|NCT00320710|7200531|FG002|Treated (Safety Set)|Overall Study||13
6298368|NCT00320710|7200529|FG000|COMPLETED|Overall Study||106
6298369|NCT00320710|7200530|FG001|COMPLETED|Overall Study||127
6298370|NCT00320710|7200531|FG002|COMPLETED|Overall Study||8
6298371|NCT00320710|7200529|FG000|NOT COMPLETED|Overall Study||94
6298372|NCT00320710|7200530|FG001|NOT COMPLETED|Overall Study||76
6298373|NCT00320710|7200531|FG002|NOT COMPLETED|Overall Study||5
6298374|NCT00320749|7200538|FG000|STARTED|Overall Study||3
6298375|NCT00320749|7200539|FG001|STARTED|Overall Study||8
6298376|NCT00320749|7200540|FG002|STARTED|Overall Study||10
6298377|NCT00320749|7200538|FG000|COMPLETED|Overall Study||3
6298378|NCT00320749|7200539|FG001|COMPLETED|Overall Study||6
6298379|NCT00320749|7200540|FG002|COMPLETED|Overall Study||1
6298380|NCT00320749|7200538|FG000|NOT COMPLETED|Overall Study||0
6298381|NCT00320749|7200539|FG001|NOT COMPLETED|Overall Study||2
6298382|NCT00320749|7200540|FG002|NOT COMPLETED|Overall Study||9
6298383|NCT00320788|7200550|FG000|STARTED|Overall Study||32
6298384|NCT00320788|7200551|FG001|STARTED|Overall Study||32
6298385|NCT00320788|7200552|FG002|STARTED|Overall Study||32
6298386|NCT00320788|7200553|FG003|STARTED|Overall Study|Participants Randomized|32
6298387|NCT00320788|7200554|FG004|STARTED|Overall Study||31
6298388|NCT00320788|7200550|FG000|Participants Received Treatment (SAF)|Overall Study||32
6298389|NCT00320788|7200551|FG001|Participants Received Treatment (SAF)|Overall Study||32
6298390|NCT00320788|7200552|FG002|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
6298391|NCT00320788|7200553|FG003|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
6298392|NCT00320788|7200554|FG004|Participants Received Treatment (SAF)|Overall Study||31
6298393|NCT00320788|7200550|FG000|COMPLETED|Overall Study||26
6298394|NCT00320788|7200551|FG001|COMPLETED|Overall Study||26
6298395|NCT00320788|7200552|FG002|COMPLETED|Overall Study||29
6298396|NCT00320788|7200553|FG003|COMPLETED|Overall Study||27
6298397|NCT00320788|7200554|FG004|COMPLETED|Overall Study||26
6298398|NCT00320788|7200550|FG000|NOT COMPLETED|Overall Study||6
6298399|NCT00320788|7200551|FG001|NOT COMPLETED|Overall Study||6
6298400|NCT00320788|7200552|FG002|NOT COMPLETED|Overall Study||3
6298401|NCT00320788|7200553|FG003|NOT COMPLETED|Overall Study||5
6298402|NCT00320788|7200554|FG004|NOT COMPLETED|Overall Study||5
6298403|NCT00320801|7200574|FG000|STARTED|Open-label Run-in Period||188
6298404|NCT00320801|7200575|FG001|STARTED|Open-label Run-in Period||0
6298405|NCT00320801|7200576|FG002|STARTED|Open-label Run-in Period||0
6298406|NCT00320801|7200577|FG003|STARTED|Open-label Run-in Period||0
6298407|NCT00320801|7200574|FG000|COMPLETED|Open-label Run-in Period||96
6298408|NCT00320801|7200575|FG001|COMPLETED|Open-label Run-in Period||0
6298409|NCT00320801|7200576|FG002|COMPLETED|Open-label Run-in Period||0
6298410|NCT00320801|7200577|FG003|COMPLETED|Open-label Run-in Period||0
6298411|NCT00320801|7200574|FG000|NOT COMPLETED|Open-label Run-in Period||92
6298412|NCT00320801|7200575|FG001|NOT COMPLETED|Open-label Run-in Period||0
6298413|NCT00320801|7200576|FG002|NOT COMPLETED|Open-label Run-in Period||0
6298414|NCT00320801|7200577|FG003|NOT COMPLETED|Open-label Run-in Period||0
6298415|NCT00320801|7200574|FG000|STARTED|Double-blind Phase||0
6298416|NCT00320801|7200575|FG001|STARTED|Double-blind Phase||47
6298417|NCT00320801|7200576|FG002|STARTED|Double-blind Phase||49
6298418|NCT00320801|7200577|FG003|STARTED|Double-blind Phase||0
6298419|NCT00320801|7200574|FG000|COMPLETED|Double-blind Phase||0
6298420|NCT00320801|7200575|FG001|COMPLETED|Double-blind Phase||36
6298421|NCT00320801|7200576|FG002|COMPLETED|Double-blind Phase||35
6298422|NCT00320801|7200577|FG003|COMPLETED|Double-blind Phase||0
6298423|NCT00320801|7200574|FG000|NOT COMPLETED|Double-blind Phase||0
6298424|NCT00320801|7200575|FG001|NOT COMPLETED|Double-blind Phase||11
6298425|NCT00320801|7200576|FG002|NOT COMPLETED|Double-blind Phase||14
6298426|NCT00320801|7200577|FG003|NOT COMPLETED|Double-blind Phase||0
6298427|NCT00320801|7200574|FG000|STARTED|Extension Phase||0
6298428|NCT00320801|7200575|FG001|STARTED|Extension Phase||0
6298429|NCT00320801|7200576|FG002|STARTED|Extension Phase||0
6298430|NCT00320801|7200577|FG003|STARTED|Extension Phase||55
6298431|NCT00320801|7200574|FG000|COMPLETED|Extension Phase||0
6298432|NCT00320801|7200575|FG001|COMPLETED|Extension Phase||0
6298433|NCT00320801|7200576|FG002|COMPLETED|Extension Phase||0
6298434|NCT00320801|7200577|FG003|COMPLETED|Extension Phase||7
6298435|NCT00320801|7200574|FG000|NOT COMPLETED|Extension Phase||0
6298436|NCT00320801|7200575|FG001|NOT COMPLETED|Extension Phase||0
6298437|NCT00320801|7200576|FG002|NOT COMPLETED|Extension Phase||0
6298438|NCT00320801|7200577|FG003|NOT COMPLETED|Extension Phase||48
6298439|NCT00321048|7200589|FG000|STARTED|Overall Study||28
6298440|NCT00321048|7200590|FG001|STARTED|Overall Study||29
6298441|NCT00321048|7200589|FG000|COMPLETED|Overall Study||22
6298442|NCT00321048|7200590|FG001|COMPLETED|Overall Study||21
6298443|NCT00321048|7200589|FG000|NOT COMPLETED|Overall Study||6
6298444|NCT00321048|7200590|FG001|NOT COMPLETED|Overall Study||8
6298445|NCT00321269|7200598|FG000|STARTED|Overall Study||74
6298446|NCT00321269|7200599|FG001|STARTED|Overall Study||74
6298447|NCT00321269|7200598|FG000|COMPLETED|Overall Study||66
6298448|NCT00321269|7200599|FG001|COMPLETED|Overall Study||68
6298449|NCT00321269|7200598|FG000|NOT COMPLETED|Overall Study||8
6298450|NCT00321269|7200599|FG001|NOT COMPLETED|Overall Study||6
6298451|NCT00321321|7200607|FG000|STARTED|Overall Study||12
6298452|NCT00321321|7200607|FG000|COMPLETED|Overall Study||12
6298453|NCT00321321|7200607|FG000|NOT COMPLETED|Overall Study||0
6298454|NCT00321373|7200614|FG000|STARTED|Overall Study||407
6298455|NCT00321373|7200615|FG001|STARTED|Overall Study||406
6298456|NCT00321373|7200616|FG002|STARTED|Overall Study||407
6298457|NCT00321373|7200614|FG000|COMPLETED|Overall Study||405
6298458|NCT00321373|7200615|FG001|COMPLETED|Overall Study||406
6298459|NCT00321373|7200616|FG002|COMPLETED|Overall Study||404
6298460|NCT00321373|7200614|FG000|NOT COMPLETED|Overall Study||2
6298461|NCT00321373|7200615|FG001|NOT COMPLETED|Overall Study||0
6298462|NCT00321373|7200616|FG002|NOT COMPLETED|Overall Study||3
6298463|NCT00321464|7200626|FG000|STARTED|Overall Study||1020
6298464|NCT00321464|7200627|FG001|STARTED|Overall Study||1026
6298465|NCT00321464|7200626|FG000|Received Investigational Product|Overall Study||1014
6298466|NCT00321464|7200627|FG001|Received Investigational Product|Overall Study||1019
6298467|NCT00321464|7200626|FG000|COMPLETED|Overall Study||461
6298468|NCT00321464|7200627|FG001|COMPLETED|Overall Study||468
6298469|NCT00321464|7200626|FG000|NOT COMPLETED|Overall Study||559
6298470|NCT00321464|7200627|FG001|NOT COMPLETED|Overall Study||558
6298471|NCT00321555|7200633|FG000|STARTED|Overall Study||15
6298472|NCT00321555|7200633|FG000|COMPLETED|Overall Study||9
6298473|NCT00321555|7200633|FG000|NOT COMPLETED|Overall Study||6
6298474|NCT00321594|7200639|FG000|STARTED|Phase I, Level 1-4||3
6298475|NCT00321594|7200640|FG001|STARTED|Phase I, Level 1-4||3
6298476|NCT00321594|7200641|FG002|STARTED|Phase I, Level 1-4||6
6298477|NCT00321594|7200642|FG003|STARTED|Phase I, Level 1-4||6
6298478|NCT00321594|7200643|FG004|STARTED|Phase I, Level 1-4||0
6298479|NCT00321594|7200639|FG000|COMPLETED|Phase I, Level 1-4||3
6298480|NCT00321594|7200640|FG001|COMPLETED|Phase I, Level 1-4||3
6298481|NCT00321594|7200641|FG002|COMPLETED|Phase I, Level 1-4||6
6298482|NCT00321594|7200642|FG003|COMPLETED|Phase I, Level 1-4||6
6298483|NCT00321594|7200643|FG004|COMPLETED|Phase I, Level 1-4||0
6298484|NCT00321594|7200639|FG000|NOT COMPLETED|Phase I, Level 1-4||0
6298485|NCT00321594|7200640|FG001|NOT COMPLETED|Phase I, Level 1-4||0
6298486|NCT00321594|7200641|FG002|NOT COMPLETED|Phase I, Level 1-4||0
6298487|NCT00321594|7200642|FG003|NOT COMPLETED|Phase I, Level 1-4||0
6298488|NCT00321594|7200643|FG004|NOT COMPLETED|Phase I, Level 1-4||0
6298489|NCT00321594|7200639|FG000|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
6298490|NCT00321594|7200640|FG001|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
6298491|NCT00321594|7200641|FG002|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|0
6298492|NCT00321594|7200642|FG003|STARTED|Phase II, MTD Dose|Only last six patients in Phase I, Level 4 include in Phase II MTD Dose|6
6298493|NCT00321594|7200643|FG004|STARTED|Phase II, MTD Dose|last six patients in Phase I, Level 4 include in Phase II MTD Dose total number = 6 + 36 = 42|36
6298494|NCT00321594|7200639|FG000|COMPLETED|Phase II, MTD Dose||0
6298495|NCT00321594|7200640|FG001|COMPLETED|Phase II, MTD Dose||0
6298496|NCT00321594|7200641|FG002|COMPLETED|Phase II, MTD Dose||0
6298497|NCT00321594|7200642|FG003|COMPLETED|Phase II, MTD Dose||6
6298498|NCT00321594|7200643|FG004|COMPLETED|Phase II, MTD Dose||36
6298499|NCT00321594|7200639|FG000|NOT COMPLETED|Phase II, MTD Dose||0
6298500|NCT00321594|7200640|FG001|NOT COMPLETED|Phase II, MTD Dose||0
6298501|NCT00321594|7200641|FG002|NOT COMPLETED|Phase II, MTD Dose||0
6298502|NCT00321594|7200642|FG003|NOT COMPLETED|Phase II, MTD Dose||0
6298503|NCT00321594|7200643|FG004|NOT COMPLETED|Phase II, MTD Dose||0
6298504|NCT00321620|7200657|FG000|STARTED|Overall Study||951
6298505|NCT00321620|7200658|FG001|STARTED|Overall Study||950
6298506|NCT00321620|7200657|FG000|Received Investigational Product|Overall Study||946
6298507|NCT00321620|7200658|FG001|Received Investigational Product|Overall Study||942
6298508|NCT00321620|7200657|FG000|COMPLETED|Overall Study||208
6298509|NCT00321620|7200658|FG001|COMPLETED|Overall Study||228
6298510|NCT00321620|7200657|FG000|NOT COMPLETED|Overall Study||743
6298511|NCT00321620|7200658|FG001|NOT COMPLETED|Overall Study||722
6298512|NCT00321646|7200664|FG000|STARTED|Neoadjuvant Chemotherapy||42
6298513|NCT00321646|7200664|FG000|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
6298514|NCT00321646|7200664|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||4
6298515|NCT00321646|7200664|FG000|STARTED|Prostatectomy||37
6298516|NCT00321646|7200664|FG000|COMPLETED|Prostatectomy||37
6298517|NCT00321646|7200664|FG000|NOT COMPLETED|Prostatectomy||0
6298518|NCT00321672|7200672|FG000|STARTED|Overall Study||165
6298519|NCT00321672|7200673|FG001|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
6298520|NCT00321672|7200674|FG002|STARTED|Overall Study||167
6298521|NCT00321672|7200675|FG003|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
6298522|NCT00321672|7200672|FG000|COMPLETED|Overall Study||153
6298523|NCT00321672|7200673|FG001|COMPLETED|Overall Study||81
6298524|NCT00321672|7200674|FG002|COMPLETED|Overall Study||156
6298525|NCT00321672|7200675|FG003|COMPLETED|Overall Study||71
6298526|NCT00321672|7200672|FG000|NOT COMPLETED|Overall Study||12
6298527|NCT00321672|7200673|FG001|NOT COMPLETED|Overall Study||8
6298528|NCT00321672|7200674|FG002|NOT COMPLETED|Overall Study||11
6298529|NCT00321672|7200675|FG003|NOT COMPLETED|Overall Study||2
6298530|NCT00321685|7200689|FG000|STARTED|Overall Study||57
6298531|NCT00321685|7200689|FG000|Eligible|Overall Study||55
6298532|NCT00321685|7200689|FG000|Started Protocol Therapy|Overall Study||55
6298533|NCT00321685|7200689|FG000|Eligible and Treated|Overall Study||53
6298534|NCT00321685|7200689|FG000|COMPLETED|Overall Study||18
6298535|NCT00321685|7200689|FG000|NOT COMPLETED|Overall Study||39
6298536|NCT00321698|7200698|FG000|STARTED|Phase I, Rad Only & Dose 1-3||3
6298537|NCT00321698|7200699|FG001|STARTED|Phase I, Rad Only & Dose 1-3||3
6298538|NCT00321698|7200700|FG002|STARTED|Phase I, Rad Only & Dose 1-3||3
6298539|NCT00321698|7200701|FG003|STARTED|Phase I, Rad Only & Dose 1-3||3
6298540|NCT00321698|7200702|FG004|STARTED|Phase I, Rad Only & Dose 1-3||0
6298541|NCT00321698|7200698|FG000|COMPLETED|Phase I, Rad Only & Dose 1-3||3
6298542|NCT00321698|7200699|FG001|COMPLETED|Phase I, Rad Only & Dose 1-3||3
6298543|NCT00321698|7200700|FG002|COMPLETED|Phase I, Rad Only & Dose 1-3||3
6298544|NCT00321698|7200701|FG003|COMPLETED|Phase I, Rad Only & Dose 1-3||3
6298545|NCT00321698|7200702|FG004|COMPLETED|Phase I, Rad Only & Dose 1-3||0
6298546|NCT00321698|7200698|FG000|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6298547|NCT00321698|7200699|FG001|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6298548|NCT00321698|7200700|FG002|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6298549|NCT00321698|7200701|FG003|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6298550|NCT00321698|7200702|FG004|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
6298551|NCT00321698|7200698|FG000|STARTED|Phase II, MTD Dose||0
6298552|NCT00321698|7200699|FG001|STARTED|Phase II, MTD Dose||0
6298553|NCT00321698|7200700|FG002|STARTED|Phase II, MTD Dose||0
6298554|NCT00321698|7200701|FG003|STARTED|Phase II, MTD Dose||0
6298555|NCT00321698|7200702|FG004|STARTED|Phase II, MTD Dose|+1 screen failure|13
6298556|NCT00321698|7200698|FG000|COMPLETED|Phase II, MTD Dose||0
6298557|NCT00321698|7200699|FG001|COMPLETED|Phase II, MTD Dose||0
6298558|NCT00321698|7200700|FG002|COMPLETED|Phase II, MTD Dose||0
6298559|NCT00321698|7200701|FG003|COMPLETED|Phase II, MTD Dose||0
6298560|NCT00321698|7200702|FG004|COMPLETED|Phase II, MTD Dose||13
6298561|NCT00321698|7200698|FG000|NOT COMPLETED|Phase II, MTD Dose||0
6298562|NCT00321698|7200699|FG001|NOT COMPLETED|Phase II, MTD Dose||0
6298563|NCT00321698|7200700|FG002|NOT COMPLETED|Phase II, MTD Dose||0
6298564|NCT00321698|7200701|FG003|NOT COMPLETED|Phase II, MTD Dose||0
6298565|NCT00321698|7200702|FG004|NOT COMPLETED|Phase II, MTD Dose||0
6298566|NCT00321711|7200719|FG000|STARTED|Part A||13
6298567|NCT00321711|7200720|FG001|STARTED|Part A||13
6298568|NCT00321711|7200721|FG002|STARTED|Part A||14
6298569|NCT00321711|7200722|FG003|STARTED|Part A||0
6298570|NCT00321711|7200723|FG004|STARTED|Part A||0
6298571|NCT00321711|7200719|FG000|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
6298572|NCT00321711|7200720|FG001|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
6298573|NCT00321711|7200721|FG002|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
6298574|NCT00321711|7200722|FG003|COMPLETED|Part A||0
6298575|NCT00321711|7200723|FG004|COMPLETED|Part A||0
6298576|NCT00321711|7200719|FG000|NOT COMPLETED|Part A||5
6298577|NCT00321711|7200720|FG001|NOT COMPLETED|Part A||10
6298578|NCT00321711|7200721|FG002|NOT COMPLETED|Part A||11
6298579|NCT00321711|7200722|FG003|NOT COMPLETED|Part A||0
6298580|NCT00321711|7200723|FG004|NOT COMPLETED|Part A||0
6298581|NCT00321711|7200719|FG000|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
6298582|NCT00321711|7200720|FG001|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
6298583|NCT00321711|7200721|FG002|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
6298584|NCT00321711|7200722|FG003|STARTED|Part B||14
6298585|NCT00321711|7200723|FG004|STARTED|Part B||15
6298586|NCT00321711|7200719|FG000|COMPLETED|Part B||0
6298587|NCT00321711|7200720|FG001|COMPLETED|Part B||0
6298588|NCT00321711|7200721|FG002|COMPLETED|Part B||0
6298589|NCT00321711|7200722|FG003|COMPLETED|Part B||8
6298590|NCT00321711|7200723|FG004|COMPLETED|Part B||10
6298591|NCT00321711|7200719|FG000|NOT COMPLETED|Part B||0
6298592|NCT00321711|7200720|FG001|NOT COMPLETED|Part B||0
6298593|NCT00321711|7200721|FG002|NOT COMPLETED|Part B||0
6298594|NCT00321711|7200722|FG003|NOT COMPLETED|Part B||6
6298595|NCT00321711|7200723|FG004|NOT COMPLETED|Part B||5
6298596|NCT00321737|7200738|FG000|STARTED|Overall Study||147
6298597|NCT00321737|7200739|FG001|STARTED|Overall Study||140
6298598|NCT00321737|7200740|FG002|STARTED|Overall Study||158
6298599|NCT00321737|7200738|FG000|COMPLETED|Overall Study||25
6298600|NCT00321737|7200739|FG001|COMPLETED|Overall Study||92
6298601|NCT00321737|7200740|FG002|COMPLETED|Overall Study||104
6298602|NCT00321737|7200738|FG000|NOT COMPLETED|Overall Study||122
6298603|NCT00321737|7200739|FG001|NOT COMPLETED|Overall Study||48
6298604|NCT00321737|7200740|FG002|NOT COMPLETED|Overall Study||54
6298605|NCT00321763|7200752|FG000|STARTED|Overall Study||850
6298606|NCT00321763|7200753|FG001|STARTED|Overall Study||850
6298607|NCT00321763|7200754|FG002|STARTED|Overall Study||854
6298608|NCT00321763|7200755|FG003|STARTED|Overall Study||570
6298609|NCT00321763|7200752|FG000|COMPLETED|Overall Study||844
6298610|NCT00321763|7200753|FG001|COMPLETED|Overall Study||848
6298611|NCT00321763|7200754|FG002|COMPLETED|Overall Study||848
6298612|NCT00321763|7200755|FG003|COMPLETED|Overall Study||565
6298613|NCT00321763|7200752|FG000|NOT COMPLETED|Overall Study||6
6298614|NCT00321763|7200753|FG001|NOT COMPLETED|Overall Study||2
6298615|NCT00321763|7200754|FG002|NOT COMPLETED|Overall Study||6
6298616|NCT00321763|7200755|FG003|NOT COMPLETED|Overall Study||5
6298617|NCT00321789|7200769|FG000|STARTED|Overall Study||127
6298618|NCT00321789|7200770|FG001|STARTED|Overall Study||128
6298619|NCT00321789|7200769|FG000|COMPLETED|Overall Study||112
6298620|NCT00321789|7200770|FG001|COMPLETED|Overall Study||112
6298621|NCT00321789|7200769|FG000|NOT COMPLETED|Overall Study||15
6298622|NCT00321789|7200770|FG001|NOT COMPLETED|Overall Study||16
6298623|NCT00321828|7200776|FG000|STARTED|Overall Study||90
6298624|NCT00321828|7200776|FG000|COMPLETED|Overall Study||86
6298625|NCT00321828|7200776|FG000|NOT COMPLETED|Overall Study||4
6298626|NCT00321854|7200782|FG000|STARTED|Overall Study||261
6298627|NCT00321854|7200783|FG001|STARTED|Overall Study||274
6298628|NCT00321854|7200782|FG000|COMPLETED|Overall Study||198
6298629|NCT00321854|7200783|FG001|COMPLETED|Overall Study||192
6298630|NCT00321854|7200782|FG000|NOT COMPLETED|Overall Study||63
6298631|NCT00321854|7200783|FG001|NOT COMPLETED|Overall Study||82
6298632|NCT00321893|7200793|FG000|STARTED|Overall Study||101
6298633|NCT00321893|7200794|FG001|STARTED|Overall Study||101
6298634|NCT00321893|7200793|FG000|COMPLETED|Overall Study||77
6298635|NCT00321893|7200794|FG001|COMPLETED|Overall Study||87
6298636|NCT00321893|7200793|FG000|NOT COMPLETED|Overall Study||24
6298637|NCT00321893|7200794|FG001|NOT COMPLETED|Overall Study||14
6298638|NCT00321906|7200802|FG000|STARTED|Overall Study||94
6298639|NCT00321906|7200803|FG001|STARTED|Overall Study||87
6298640|NCT00321906|7200802|FG000|COMPLETED|Overall Study||48
6298641|NCT00321906|7200803|FG001|COMPLETED|Overall Study||31
6298642|NCT00321906|7200802|FG000|NOT COMPLETED|Overall Study||46
6298643|NCT00321906|7200803|FG001|NOT COMPLETED|Overall Study||56
6298644|NCT00321919|7200811|FG000|STARTED|Overall Study||301
6298645|NCT00321919|7200812|FG001|STARTED|Overall Study||302
6298646|NCT00321919|7200811|FG000|COMPLETED|Overall Study||226
6298647|NCT00321919|7200812|FG001|COMPLETED|Overall Study||250
6298648|NCT00321919|7200811|FG000|NOT COMPLETED|Overall Study||75
6298649|NCT00321919|7200812|FG001|NOT COMPLETED|Overall Study||52
6298650|NCT00321932|7200821|FG000|STARTED|Overall Study||29
6298651|NCT00321932|7200822|FG001|STARTED|Overall Study||32
6298652|NCT00321932|7200821|FG000|COMPLETED|Overall Study||19
6298653|NCT00321932|7200822|FG001|COMPLETED|Overall Study||11
6298654|NCT00321932|7200821|FG000|NOT COMPLETED|Overall Study||10
6298655|NCT00321932|7200822|FG001|NOT COMPLETED|Overall Study||21
6298656|NCT00321971|7200831|FG000|STARTED|Overall Study|Subject recruitment began in February 2007 and ended in December 2011|36
6298657|NCT00321971|7200832|FG001|STARTED|Overall Study||37
6298658|NCT00321971|7200831|FG000|COMPLETED|Overall Study||28
6298659|NCT00321971|7200832|FG001|COMPLETED|Overall Study||26
6298660|NCT00321971|7200831|FG000|NOT COMPLETED|Overall Study||8
6298661|NCT00321971|7200832|FG001|NOT COMPLETED|Overall Study||11
6298662|NCT00321984|7200841|FG000|STARTED|Overall Study||317
6298663|NCT00321984|7200842|FG001|STARTED|Overall Study||315
6298664|NCT00321984|7200843|FG002|STARTED|Overall Study||315
6298665|NCT00321984|7200841|FG000|COMPLETED|Overall Study||290
6298666|NCT00321984|7200842|FG001|COMPLETED|Overall Study||294
6298667|NCT00321984|7200843|FG002|COMPLETED|Overall Study||289
6298668|NCT00321984|7200841|FG000|NOT COMPLETED|Overall Study||27
6298669|NCT00321984|7200842|FG001|NOT COMPLETED|Overall Study||21
6298670|NCT00321984|7200843|FG002|NOT COMPLETED|Overall Study||26
6298671|NCT00322023|7200854|FG000|STARTED|Overall Study||12
6298672|NCT00322023|7200855|FG001|STARTED|Overall Study||21
6298673|NCT00322023|7200856|FG002|STARTED|Overall Study||22
6298674|NCT00322023|7200854|FG000|COMPLETED|Overall Study||12
6298675|NCT00322023|7200855|FG001|COMPLETED|Overall Study||19
6298676|NCT00322023|7200856|FG002|COMPLETED|Overall Study||16
6298677|NCT00322023|7200854|FG000|NOT COMPLETED|Overall Study||0
6298678|NCT00322023|7200855|FG001|NOT COMPLETED|Overall Study||2
6298679|NCT00322023|7200856|FG002|NOT COMPLETED|Overall Study||6
6298680|NCT00322049|7200868|FG000|STARTED|Overall Study||4
6298681|NCT00322049|7200869|FG001|STARTED|Overall Study||10
6298682|NCT00322049|7200870|FG002|STARTED|Overall Study||20
6298683|NCT00322049|7200871|FG003|STARTED|Overall Study||17
6298684|NCT00322049|7200868|FG000|COMPLETED|Overall Study||4
6298685|NCT00322049|7200869|FG001|COMPLETED|Overall Study||9
6298686|NCT00322049|7200870|FG002|COMPLETED|Overall Study||20
6298687|NCT00322049|7200871|FG003|COMPLETED|Overall Study||16
6298688|NCT00322049|7200868|FG000|NOT COMPLETED|Overall Study||0
6298689|NCT00322049|7200869|FG001|NOT COMPLETED|Overall Study||1
6298690|NCT00322049|7200870|FG002|NOT COMPLETED|Overall Study||0
6298691|NCT00322049|7200871|FG003|NOT COMPLETED|Overall Study||1
6298692|NCT00322101|7200892|FG000|STARTED|Overall Study||14
6298693|NCT00322101|7200893|FG001|STARTED|Overall Study||11
6298694|NCT00322101|7200892|FG000|COMPLETED|Overall Study||14
6298695|NCT00322101|7200893|FG001|COMPLETED|Overall Study||11
6298696|NCT00322101|7200892|FG000|NOT COMPLETED|Overall Study||0
6298697|NCT00322101|7200893|FG001|NOT COMPLETED|Overall Study||0
6298698|NCT00322153|7200901|FG000|STARTED|Overall Study|Randomized to placebo|335
6298699|NCT00322153|7200902|FG001|STARTED|Overall Study|Randomized to Memantine ER|342
6298700|NCT00322153|7200901|FG000|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
6298701|NCT00322153|7200902|FG001|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
6298702|NCT00322153|7200901|FG000|COMPLETED|Overall Study||272
6298703|NCT00322153|7200902|FG001|COMPLETED|Overall Study||273
6298704|NCT00322153|7200901|FG000|NOT COMPLETED|Overall Study||63
6298705|NCT00322153|7200902|FG001|NOT COMPLETED|Overall Study||69
6298706|NCT00322231|7200910|FG000|STARTED|Period 1||51
6298707|NCT00322231|7200911|FG001|STARTED|Period 1||50
6298708|NCT00322231|7200910|FG000|COMPLETED|Period 1||51
6298709|NCT00322231|7200911|FG001|COMPLETED|Period 1||50
6298710|NCT00322231|7200910|FG000|NOT COMPLETED|Period 1||0
6298711|NCT00322231|7200911|FG001|NOT COMPLETED|Period 1||0
6298712|NCT00322231|7200910|FG000|STARTED|Period 2||51
6298713|NCT00322231|7200911|FG001|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
6298714|NCT00322231|7200910|FG000|COMPLETED|Period 2||51
6298715|NCT00322231|7200911|FG001|COMPLETED|Period 2||49
6298716|NCT00322231|7200910|FG000|NOT COMPLETED|Period 2||0
6298717|NCT00322231|7200911|FG001|NOT COMPLETED|Period 2||0
6298718|NCT00322309|7200923|FG000|STARTED|Overall Study||11
6298719|NCT00322309|7200924|FG001|STARTED|Overall Study||13
6298720|NCT00322309|7200923|FG000|COMPLETED|Overall Study||9
6298721|NCT00322309|7200924|FG001|COMPLETED|Overall Study||9
6298722|NCT00322309|7200923|FG000|NOT COMPLETED|Overall Study||2
6298723|NCT00322309|7200924|FG001|NOT COMPLETED|Overall Study||4
6298724|NCT00322335|7200936|FG000|STARTED|Subjects 18 Months After Booster Dose||58
6298725|NCT00322335|7200937|FG001|STARTED|Subjects 18 Months After Booster Dose||123
6298726|NCT00322335|7200938|FG002|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
6298727|NCT00322335|7200936|FG000|COMPLETED|Subjects 18 Months After Booster Dose||58
6298728|NCT00322335|7200937|FG001|COMPLETED|Subjects 18 Months After Booster Dose||123
6298729|NCT00322335|7200938|FG002|COMPLETED|Subjects 18 Months After Booster Dose||3
6298730|NCT00322335|7200936|FG000|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
6298731|NCT00322335|7200937|FG001|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
6298732|NCT00322335|7200938|FG002|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
6298733|NCT00322335|7200936|FG000|STARTED|Subjects 30 Months After Booster Dose||54
6298734|NCT00322335|7200937|FG001|STARTED|Subjects 30 Months After Booster Dose||119
6298735|NCT00322335|7200938|FG002|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
6298736|NCT00322335|7200936|FG000|COMPLETED|Subjects 30 Months After Booster Dose||54
6298737|NCT00322335|7200937|FG001|COMPLETED|Subjects 30 Months After Booster Dose||119
6298738|NCT00322335|7200938|FG002|COMPLETED|Subjects 30 Months After Booster Dose||57
6298739|NCT00322335|7200936|FG000|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
6298740|NCT00322335|7200937|FG001|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
6298741|NCT00322335|7200938|FG002|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
6298742|NCT00322335|7200936|FG000|STARTED|Subjects 42 Months After Booster Dose||51
6298743|NCT00322335|7200937|FG001|STARTED|Subjects 42 Months After Booster Dose||113
6298744|NCT00322335|7200938|FG002|STARTED|Subjects 42 Months After Booster Dose||56
6298745|NCT00322335|7200936|FG000|COMPLETED|Subjects 42 Months After Booster Dose||51
6298746|NCT00322335|7200937|FG001|COMPLETED|Subjects 42 Months After Booster Dose||113
6298747|NCT00322335|7200938|FG002|COMPLETED|Subjects 42 Months After Booster Dose||56
6298748|NCT00322335|7200936|FG000|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
6298749|NCT00322335|7200937|FG001|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
6298750|NCT00322335|7200938|FG002|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
6298751|NCT00322335|7200936|FG000|STARTED|Subjects 54 Months After Booster Dose||50
6298752|NCT00322335|7200937|FG001|STARTED|Subjects 54 Months After Booster Dose||108
6298753|NCT00322335|7200938|FG002|STARTED|Subjects 54 Months After Booster Dose||56
6298754|NCT00322335|7200936|FG000|COMPLETED|Subjects 54 Months After Booster Dose||50
6298755|NCT00322335|7200937|FG001|COMPLETED|Subjects 54 Months After Booster Dose||108
6401071|NCT00890396|7313969|FG000|STARTED|Overall Study||127
6401072|NCT00890396|7313970|FG001|STARTED|Overall Study||36
6401073|NCT00890396|7313969|FG000|COMPLETED|Overall Study||122
6401074|NCT00890396|7313970|FG001|COMPLETED|Overall Study||34
6401075|NCT00890396|7313969|FG000|NOT COMPLETED|Overall Study||5
6401076|NCT00890396|7313970|FG001|NOT COMPLETED|Overall Study||2
6401077|NCT00890552|7313979|FG000|STARTED|Enrollment and Pre-treatment||25
6401078|NCT00890552|7313979|FG000|COMPLETED|Enrollment and Pre-treatment||24
6401079|NCT00890552|7313979|FG000|NOT COMPLETED|Enrollment and Pre-treatment||1
6401080|NCT00890552|7313979|FG000|STARTED|On-treatment||24
6401081|NCT00890552|7313979|FG000|COMPLETED|On-treatment||14
6401082|NCT00890552|7313979|FG000|NOT COMPLETED|On-treatment||10
6401083|NCT00890617|7313983|FG000|STARTED|Overall Study||9
6401084|NCT00890617|7313983|FG000|COMPLETED|Overall Study||9
6401085|NCT00890617|7313983|FG000|NOT COMPLETED|Overall Study||0
6401086|NCT00890656|7313987|FG000|STARTED|Overall Study||90
6401087|NCT00890656|7313987|FG000|COMPLETED|Overall Study||90
6401088|NCT00890656|7313987|FG000|NOT COMPLETED|Overall Study||0
6401089|NCT00890682|7313993|FG000|STARTED|Overall Study||97
6401090|NCT00890682|7313994|FG001|STARTED|Overall Study||96
6401091|NCT00890682|7313993|FG000|COMPLETED|Overall Study||93
6401092|NCT00890682|7313994|FG001|COMPLETED|Overall Study||94
6401093|NCT00890682|7313993|FG000|NOT COMPLETED|Overall Study||4
6401094|NCT00890682|7313994|FG001|NOT COMPLETED|Overall Study||2
6401095|NCT00890695|7314002|FG000|STARTED|Overall Study||32
6401096|NCT00890695|7314003|FG001|STARTED|Overall Study||33
6401097|NCT00890695|7314002|FG000|COMPLETED|Overall Study||31
6401098|NCT00890695|7314003|FG001|COMPLETED|Overall Study||33
6401099|NCT00890695|7314002|FG000|NOT COMPLETED|Overall Study||1
6401100|NCT00890695|7314003|FG001|NOT COMPLETED|Overall Study||0
6401101|NCT00890721|7314011|FG000|STARTED|Overall Study||95
6401102|NCT00890721|7314012|FG001|STARTED|Overall Study||94
6401103|NCT00890721|7314011|FG000|COMPLETED|Overall Study||94
6401104|NCT00890721|7314012|FG001|COMPLETED|Overall Study||93
6401105|NCT00890721|7314011|FG000|NOT COMPLETED|Overall Study||1
6401106|NCT00890721|7314012|FG001|NOT COMPLETED|Overall Study||1
6401107|NCT00890825|7314020|FG000|STARTED|Overall Study||44
6401108|NCT00890825|7314021|FG001|STARTED|Overall Study|A patient randomized to this arm was excluded from the safety population for not receiving treatment|43
6401109|NCT00890825|7314020|FG000|COMPLETED|Overall Study||30
6401110|NCT00890825|7314021|FG001|COMPLETED|Overall Study||29
6401111|NCT00890825|7314020|FG000|NOT COMPLETED|Overall Study||14
6401112|NCT00890825|7314021|FG001|NOT COMPLETED|Overall Study||14
6401113|NCT00890916|7314027|FG000|STARTED|"Rehab - Neuroprosthesis (NP) On"|First Implanted Stimulator-Telemeter (IST-12) Implant.|10
6401114|NCT00890916|7314027|FG000|"Grasp Release Pre-Test ON"|"Rehab - Neuroprosthesis (NP) On"||10
6401115|NCT00890916|7314027|FG000|COMPLETED|"Rehab - Neuroprosthesis (NP) On"||10
6401116|NCT00890916|7314027|FG000|NOT COMPLETED|"Rehab - Neuroprosthesis (NP) On"||0
6401117|NCT00890916|7314027|FG000|STARTED|"Rehab - NP Off"||10
6298756|NCT00322335|7200938|FG002|COMPLETED|Subjects 54 Months After Booster Dose||56
6298757|NCT00322335|7200936|FG000|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
6298758|NCT00322335|7200937|FG001|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
6298759|NCT00322335|7200938|FG002|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
6298760|NCT00322335|7200936|FG000|STARTED|Subjects 66 Months After Booster Dose||48
6298761|NCT00322335|7200937|FG001|STARTED|Subjects 66 Months After Booster Dose||104
6298762|NCT00322335|7200938|FG002|STARTED|Subjects 66 Months After Booster Dose||53
6298763|NCT00322335|7200936|FG000|COMPLETED|Subjects 66 Months After Booster Dose||48
6298764|NCT00322335|7200937|FG001|COMPLETED|Subjects 66 Months After Booster Dose||104
6298765|NCT00322335|7200938|FG002|COMPLETED|Subjects 66 Months After Booster Dose||53
6298766|NCT00322335|7200936|FG000|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
6298767|NCT00322335|7200937|FG001|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
6298768|NCT00322335|7200938|FG002|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
6298769|NCT00322348|7200948|FG000|STARTED|Overall Study||49
6298770|NCT00322348|7200949|FG001|STARTED|Overall Study||49
6298771|NCT00322348|7200948|FG000|Received Study Treatment|Overall Study||50
6298772|NCT00322348|7200949|FG001|Received Study Treatment|Overall Study||48
6298773|NCT00322348|7200948|FG000|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
6298774|NCT00322348|7200949|FG001|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
6298775|NCT00322348|7200948|FG000|NOT COMPLETED|Overall Study||37
6298776|NCT00322348|7200949|FG001|NOT COMPLETED|Overall Study||33
6298777|NCT00322374|7200958|FG000|STARTED|Enrollment||0
6298778|NCT00322374|7200959|FG001|STARTED|Enrollment||0
6298779|NCT00322374|7200960|FG002|STARTED|Enrollment||0
6298780|NCT00322374|7200961|FG003|STARTED|Enrollment||42
6298781|NCT00322374|7200958|FG000|COMPLETED|Enrollment||0
6298782|NCT00322374|7200959|FG001|COMPLETED|Enrollment||0
6298783|NCT00322374|7200960|FG002|COMPLETED|Enrollment||0
6298784|NCT00322374|7200961|FG003|COMPLETED|Enrollment||42
6298785|NCT00322374|7200958|FG000|NOT COMPLETED|Enrollment||0
6298786|NCT00322374|7200959|FG001|NOT COMPLETED|Enrollment||0
6298787|NCT00322374|7200960|FG002|NOT COMPLETED|Enrollment||0
6298788|NCT00322374|7200961|FG003|NOT COMPLETED|Enrollment||0
6298789|NCT00322374|7200958|FG000|STARTED|Starting Dose||6
6298790|NCT00322374|7200959|FG001|STARTED|Starting Dose||0
6298791|NCT00322374|7200960|FG002|STARTED|Starting Dose||0
6298792|NCT00322374|7200961|FG003|STARTED|Starting Dose||0
6298793|NCT00322374|7200958|FG000|COMPLETED|Starting Dose||0
6298794|NCT00322374|7200959|FG001|COMPLETED|Starting Dose||0
6298795|NCT00322374|7200960|FG002|COMPLETED|Starting Dose||0
6298796|NCT00322374|7200961|FG003|COMPLETED|Starting Dose||0
6298797|NCT00322374|7200958|FG000|NOT COMPLETED|Starting Dose||6
6298798|NCT00322374|7200959|FG001|NOT COMPLETED|Starting Dose||0
6298799|NCT00322374|7200960|FG002|NOT COMPLETED|Starting Dose||0
6298800|NCT00322374|7200961|FG003|NOT COMPLETED|Starting Dose||0
6298801|NCT00322374|7200958|FG000|STARTED|First Escalation||0
6298802|NCT00322374|7200959|FG001|STARTED|First Escalation||30
6298803|NCT00322374|7200960|FG002|STARTED|First Escalation||0
6298804|NCT00322374|7200961|FG003|STARTED|First Escalation||0
6298805|NCT00322374|7200958|FG000|COMPLETED|First Escalation||0
6298806|NCT00322374|7200959|FG001|COMPLETED|First Escalation||0
6298807|NCT00322374|7200960|FG002|COMPLETED|First Escalation||0
6298808|NCT00322374|7200961|FG003|COMPLETED|First Escalation||0
6298809|NCT00322374|7200958|FG000|NOT COMPLETED|First Escalation||0
6298810|NCT00322374|7200959|FG001|NOT COMPLETED|First Escalation||30
6298811|NCT00322374|7200960|FG002|NOT COMPLETED|First Escalation||0
6298812|NCT00322374|7200961|FG003|NOT COMPLETED|First Escalation||0
6298813|NCT00322374|7200958|FG000|STARTED|Second Escalation||0
6298814|NCT00322374|7200959|FG001|STARTED|Second Escalation||0
6298815|NCT00322374|7200960|FG002|STARTED|Second Escalation||6
6298816|NCT00322374|7200961|FG003|STARTED|Second Escalation||0
6298817|NCT00322374|7200958|FG000|COMPLETED|Second Escalation||0
6298818|NCT00322374|7200959|FG001|COMPLETED|Second Escalation||0
6298819|NCT00322374|7200960|FG002|COMPLETED|Second Escalation||0
6298820|NCT00322374|7200961|FG003|COMPLETED|Second Escalation||0
6298821|NCT00322374|7200958|FG000|NOT COMPLETED|Second Escalation||0
6298822|NCT00322374|7200959|FG001|NOT COMPLETED|Second Escalation||0
6298823|NCT00322374|7200960|FG002|NOT COMPLETED|Second Escalation||6
6298824|NCT00322374|7200961|FG003|NOT COMPLETED|Second Escalation||0
6298825|NCT00322387|7200976|FG000|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
6298826|NCT00322387|7200977|FG001|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
6298827|NCT00322387|7200976|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
6298828|NCT00322387|7200977|FG001|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
6298829|NCT00322387|7200976|FG000|NOT COMPLETED|Treatment Period||0
6298830|NCT00322387|7200977|FG001|NOT COMPLETED|Treatment Period||1
6298831|NCT00322387|7200976|FG000|STARTED|Follow-up Period|Participants who had transplants|14
6298832|NCT00322387|7200977|FG001|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
6298833|NCT00322387|7200976|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
6298834|NCT00322387|7200977|FG001|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
6298835|NCT00322387|7200976|FG000|NOT COMPLETED|Follow-up Period||2
6298836|NCT00322387|7200977|FG001|NOT COMPLETED|Follow-up Period||3
6298837|NCT00322439|7200994|FG000|STARTED|Overall Study||2511
6298838|NCT00322439|7200994|FG000|Received at Least 1 Dose of Etanercept|Overall Study||2510
6298839|NCT00322439|7200994|FG000|COMPLETED|Overall Study||1455
6298840|NCT00322439|7200994|FG000|NOT COMPLETED|Overall Study||1056
6298841|NCT00322452|7201000|FG000|STARTED|Overall Study|Number of patients randomized|609
6298842|NCT00322452|7201001|FG001|STARTED|Overall Study|Number of patients randomized|608
6298843|NCT00322452|7201000|FG000|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
6298844|NCT00322452|7201001|FG001|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
6298845|NCT00322452|7201000|FG000|NOT COMPLETED|Overall Study||247
6298846|NCT00322452|7201001|FG001|NOT COMPLETED|Overall Study||276
6298847|NCT00322465|7201011|FG000|STARTED|Overall Study|Randomized|76
6298848|NCT00322465|7201012|FG001|STARTED|Overall Study|Randomized|73
6298849|NCT00322465|7201013|FG002|STARTED|Overall Study|Randomized|77
6298850|NCT00322465|7201014|FG003|STARTED|Overall Study|Randomized|79
6298851|NCT00322465|7201011|FG000|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
6298852|NCT00322465|7201012|FG001|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
6298853|NCT00322465|7201013|FG002|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
6298854|NCT00322465|7201014|FG003|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
6298855|NCT00322465|7201011|FG000|NOT COMPLETED|Overall Study||20
6298856|NCT00322465|7201012|FG001|NOT COMPLETED|Overall Study||24
6298857|NCT00322465|7201013|FG002|NOT COMPLETED|Overall Study||26
6298858|NCT00322465|7201014|FG003|NOT COMPLETED|Overall Study||26
6298859|NCT00322491|7201029|FG000|STARTED|Overall Study||23
6298860|NCT00322491|7201030|FG001|STARTED|Overall Study||26
6298861|NCT00322491|7201029|FG000|COMPLETED|Overall Study||21
6298862|NCT00322491|7201030|FG001|COMPLETED|Overall Study||24
6298863|NCT00322491|7201029|FG000|NOT COMPLETED|Overall Study||2
6298864|NCT00322491|7201030|FG001|NOT COMPLETED|Overall Study||2
6298865|NCT00322556|7201037|FG000|STARTED|Overall Study||55
6298866|NCT00322556|7201037|FG000|COMPLETED|Overall Study||43
6298867|NCT00322556|7201037|FG000|NOT COMPLETED|Overall Study||12
6298868|NCT00322621|7201044|FG000|STARTED|Period II - Acute Therapy Phase||216
6298869|NCT00322621|7201045|FG001|STARTED|Period II - Acute Therapy Phase||0
6298870|NCT00322621|7201046|FG002|STARTED|Period II - Acute Therapy Phase||0
6298871|NCT00322621|7201044|FG000|COMPLETED|Period II - Acute Therapy Phase||184
6298872|NCT00322621|7201045|FG001|COMPLETED|Period II - Acute Therapy Phase||0
6298873|NCT00322621|7201046|FG002|COMPLETED|Period II - Acute Therapy Phase||0
6298874|NCT00322621|7201044|FG000|NOT COMPLETED|Period II - Acute Therapy Phase||32
6298875|NCT00322621|7201045|FG001|NOT COMPLETED|Period II - Acute Therapy Phase||0
6298876|NCT00322621|7201046|FG002|NOT COMPLETED|Period II - Acute Therapy Phase||0
6298877|NCT00322621|7201044|FG000|STARTED|Period III - Maintenance / Rescue Phase||0
6298878|NCT00322621|7201045|FG001|STARTED|Period III - Maintenance / Rescue Phase||115
6298879|NCT00322621|7201046|FG002|STARTED|Period III - Maintenance / Rescue Phase||69
6298880|NCT00322621|7201044|FG000|COMPLETED|Period III - Maintenance / Rescue Phase||0
6298881|NCT00322621|7201045|FG001|COMPLETED|Period III - Maintenance / Rescue Phase||86
6298882|NCT00322621|7201046|FG002|COMPLETED|Period III - Maintenance / Rescue Phase||33
6298883|NCT00322621|7201044|FG000|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
6298884|NCT00322621|7201045|FG001|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
6298885|NCT00322621|7201046|FG002|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
6298886|NCT00322712|7201059|FG000|STARTED|Overall Study||12
6298887|NCT00322712|7201059|FG000|COMPLETED|Overall Study||11
6298888|NCT00322712|7201059|FG000|NOT COMPLETED|Overall Study||1
6298889|NCT00322777|7201065|FG000|STARTED|Overall Study||39
6298890|NCT00322777|7201066|FG001|STARTED|Overall Study||45
6298891|NCT00322777|7201065|FG000|"Data Collection at BASELINE|"|Overall Study||39
6298892|NCT00322777|7201066|FG001|"Data Collection at BASELINE|"|Overall Study||45
6298893|NCT00322777|7201065|FG000|Data Collection at Week 8|Overall Study||39
6298894|NCT00322777|7201066|FG001|Data Collection at Week 8|Overall Study||45
6298895|NCT00322777|7201065|FG000|Data Collection at Week 16|Overall Study||39
6298896|NCT00322777|7201066|FG001|Data Collection at Week 16|Overall Study||45
6298897|NCT00322777|7201065|FG000|Data Collection at Week 24|Overall Study||39
6298898|NCT00322777|7201066|FG001|Data Collection at Week 24|Overall Study||45
6298899|NCT00322777|7201065|FG000|COMPLETED|Overall Study||39
6298900|NCT00322777|7201066|FG001|COMPLETED|Overall Study||45
6298901|NCT00322777|7201065|FG000|NOT COMPLETED|Overall Study||0
6298902|NCT00322777|7201066|FG001|NOT COMPLETED|Overall Study||0
6298903|NCT00322842|7201074|FG000|STARTED|Overall Study||4
6298904|NCT00322842|7201075|FG001|STARTED|Overall Study||31
6298905|NCT00322842|7201074|FG000|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
6298906|NCT00322842|7201075|FG001|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
6298907|NCT00322842|7201074|FG000|NOT COMPLETED|Overall Study||2
6298908|NCT00322842|7201075|FG001|NOT COMPLETED|Overall Study||2
6298909|NCT00322868|7201082|FG000|STARTED|Overall Study||21
6298910|NCT00322868|7201082|FG000|COMPLETED|Overall Study||20
6298911|NCT00322868|7201082|FG000|NOT COMPLETED|Overall Study||1
6298912|NCT00322881|7201087|FG000|STARTED|Overall Study||12
6298913|NCT00322881|7201087|FG000|COMPLETED|Overall Study||7
6298914|NCT00322881|7201087|FG000|NOT COMPLETED|Overall Study||5
6298915|NCT00323063|7201093|FG000|STARTED|Overall Study||26
6298916|NCT00323063|7201094|FG001|STARTED|Overall Study||23
6298917|NCT00323063|7201093|FG000|COMPLETED|Overall Study||24
6298918|NCT00323063|7201094|FG001|COMPLETED|Overall Study||23
6298919|NCT00323063|7201093|FG000|NOT COMPLETED|Overall Study||2
6298920|NCT00323063|7201094|FG001|NOT COMPLETED|Overall Study||0
6298921|NCT00323115|7201100|FG000|STARTED|Vaccine Administration||11
6298922|NCT00323115|7201100|FG000|COMPLETED|Vaccine Administration||10
6298923|NCT00323115|7201100|FG000|NOT COMPLETED|Vaccine Administration||1
6298924|NCT00323115|7201100|FG000|STARTED|Adjuvant Therapy & Survival Follow-Up||10
6298925|NCT00323115|7201100|FG000|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
6298926|NCT00323115|7201100|FG000|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
6298927|NCT00323193|7201111|FG000|STARTED|Overall Study||53
6298928|NCT00323193|7201112|FG001|STARTED|Overall Study||56
6298929|NCT00323193|7201111|FG000|COMPLETED|Overall Study||30
6298930|NCT00323193|7201112|FG001|COMPLETED|Overall Study||41
6298931|NCT00323193|7201111|FG000|NOT COMPLETED|Overall Study||23
6298932|NCT00323193|7201112|FG001|NOT COMPLETED|Overall Study||15
6298933|NCT00323258|7201120|FG000|STARTED|Primary Outcome (Phone Call at 6 Months)||71
6298934|NCT00323258|7201121|FG001|STARTED|Primary Outcome (Phone Call at 6 Months)||72
6298935|NCT00323258|7201120|FG000|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
6298936|NCT00323258|7201121|FG001|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
6298937|NCT00323258|7201120|FG000|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
6298938|NCT00323258|7201121|FG001|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
6298939|NCT00323258|7201120|FG000|STARTED|Secondary Outcome (6 Mon Refill Records)||71
6298940|NCT00323258|7201121|FG001|STARTED|Secondary Outcome (6 Mon Refill Records)||72
6298941|NCT00323258|7201120|FG000|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
6298942|NCT00323258|7201121|FG001|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
6298943|NCT00323258|7201120|FG000|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
6298944|NCT00323258|7201121|FG001|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
6298945|NCT00323271|7201129|FG000|STARTED|Overall Study||13
6298946|NCT00323271|7201130|FG001|STARTED|Overall Study||12
6298947|NCT00323271|7201129|FG000|COMPLETED|Overall Study||11
6298948|NCT00323271|7201130|FG001|COMPLETED|Overall Study||9
6298949|NCT00323271|7201129|FG000|NOT COMPLETED|Overall Study||2
6298950|NCT00323271|7201130|FG001|NOT COMPLETED|Overall Study||3
6298951|NCT00323284|7201138|FG000|STARTED|12 Months Follow-up||116
6298952|NCT00323284|7201139|FG001|STARTED|12 Months Follow-up||123
6298953|NCT00323284|7201138|FG000|COMPLETED|12 Months Follow-up||111
6298954|NCT00323284|7201139|FG001|COMPLETED|12 Months Follow-up||114
6298955|NCT00323284|7201138|FG000|NOT COMPLETED|12 Months Follow-up||5
6298956|NCT00323284|7201139|FG001|NOT COMPLETED|12 Months Follow-up||9
6298957|NCT00323284|7201138|FG000|STARTED|24 Months Follow-up||116
6298958|NCT00323284|7201139|FG001|STARTED|24 Months Follow-up||123
6298959|NCT00323284|7201138|FG000|COMPLETED|24 Months Follow-up||98
6298960|NCT00323284|7201139|FG001|COMPLETED|24 Months Follow-up||101
6298961|NCT00323284|7201138|FG000|NOT COMPLETED|24 Months Follow-up||18
6298962|NCT00323284|7201139|FG001|NOT COMPLETED|24 Months Follow-up||22
6298963|NCT00323297|7201147|FG000|STARTED|Part A (Double Blind Randomized)||53
6298964|NCT00323297|7201148|FG001|STARTED|Part A (Double Blind Randomized)||50
6298965|NCT00323297|7201147|FG000|COMPLETED|Part A (Double Blind Randomized)||48
6298966|NCT00323297|7201148|FG001|COMPLETED|Part A (Double Blind Randomized)||43
6298967|NCT00323297|7201147|FG000|NOT COMPLETED|Part A (Double Blind Randomized)||5
6298968|NCT00323297|7201148|FG001|NOT COMPLETED|Part A (Double Blind Randomized)||7
6298969|NCT00323297|7201147|FG000|STARTED|Part B (Open-label)||48
6298970|NCT00323297|7201148|FG001|STARTED|Part B (Open-label)||43
6298971|NCT00323297|7201147|FG000|COMPLETED|Part B (Open-label)||39
6298972|NCT00323297|7201148|FG001|COMPLETED|Part B (Open-label)||31
6298973|NCT00323297|7201147|FG000|NOT COMPLETED|Part B (Open-label)||9
6298974|NCT00323297|7201148|FG001|NOT COMPLETED|Part B (Open-label)||12
6298975|NCT00323310|7201154|FG000|STARTED|Overall Study||92
6298976|NCT00323310|7201154|FG000|COMPLETED|Overall Study||89
6298977|NCT00323310|7201154|FG000|NOT COMPLETED|Overall Study||3
6298978|NCT00323362|7201158|FG000|STARTED|Overall Study||17
6298979|NCT00323362|7201158|FG000|COMPLETED|Overall Study||17
6298980|NCT00323362|7201158|FG000|NOT COMPLETED|Overall Study||0
6298981|NCT00323414|7201164|FG000|STARTED|Overall Study||18
6298982|NCT00323414|7201165|FG001|STARTED|Overall Study||19
6298983|NCT00323414|7201164|FG000|COMPLETED|Overall Study||18
6298984|NCT00323414|7201165|FG001|COMPLETED|Overall Study||18
6298985|NCT00323414|7201164|FG000|NOT COMPLETED|Overall Study||0
6298986|NCT00323414|7201165|FG001|NOT COMPLETED|Overall Study||1
6298987|NCT00323427|7201173|FG000|STARTED|Overall Study||69
6298988|NCT00323427|7201174|FG001|STARTED|Overall Study||66
6298989|NCT00323427|7201173|FG000|COMPLETED|Overall Study||38
6298990|NCT00323427|7201174|FG001|COMPLETED|Overall Study||43
6298991|NCT00323427|7201173|FG000|NOT COMPLETED|Overall Study||31
6298992|NCT00323427|7201174|FG001|NOT COMPLETED|Overall Study||23
6298993|NCT00323453|7201182|FG000|STARTED|Overall Study||61
6298994|NCT00323453|7201183|FG001|STARTED|Overall Study||48
6298995|NCT00323453|7201182|FG000|COMPLETED|Overall Study||61
6298996|NCT00323453|7201183|FG001|COMPLETED|Overall Study||48
6298997|NCT00323453|7201182|FG000|NOT COMPLETED|Overall Study||0
6298998|NCT00323453|7201183|FG001|NOT COMPLETED|Overall Study||0
6298999|NCT00323479|7201189|FG000|STARTED|Overall Study||114
6299000|NCT00323479|7201189|FG000|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
6299001|NCT00323479|7201189|FG000|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
6299002|NCT00323479|7201189|FG000|NOT COMPLETED|Overall Study||8
6299003|NCT00323492|7201195|FG000|STARTED|Study Phase 1||47
6299004|NCT00323492|7201196|FG001|STARTED|Study Phase 1||45
6299005|NCT00323492|7201197|FG002|STARTED|Study Phase 1|Not applicable to Phase 1.|0
6299006|NCT00323492|7201195|FG000|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
6299007|NCT00323492|7201196|FG001|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
6299008|NCT00323492|7201197|FG002|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
6299009|NCT00323492|7201195|FG000|COMPLETED|Study Phase 1||45
6299010|NCT00323492|7201196|FG001|COMPLETED|Study Phase 1||45
6299011|NCT00323492|7201197|FG002|COMPLETED|Study Phase 1||0
6299012|NCT00323492|7201195|FG000|NOT COMPLETED|Study Phase 1||2
6299013|NCT00323492|7201196|FG001|NOT COMPLETED|Study Phase 1||0
6299014|NCT00323492|7201197|FG002|NOT COMPLETED|Study Phase 1||0
6299015|NCT00323492|7201195|FG000|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
6299016|NCT00323492|7201196|FG001|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
6299017|NCT00323492|7201197|FG002|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
6299018|NCT00323492|7201195|FG000|COMPLETED|Study Phase 2||40
6299019|NCT00323492|7201196|FG001|COMPLETED|Study Phase 2||17
6299020|NCT00323492|7201197|FG002|COMPLETED|Study Phase 2||24
6299021|NCT00323492|7201195|FG000|NOT COMPLETED|Study Phase 2||4
6299022|NCT00323492|7201196|FG001|NOT COMPLETED|Study Phase 2||1
6299023|NCT00323492|7201197|FG002|NOT COMPLETED|Study Phase 2||1
6299024|NCT00323557|7201206|FG000|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
6299025|NCT00323557|7201207|FG001|STARTED|Overall Study||7
6299026|NCT00323557|7201206|FG000|COMPLETED|Overall Study||24
6299027|NCT00323557|7201207|FG001|COMPLETED|Overall Study||7
6299028|NCT00323557|7201206|FG000|NOT COMPLETED|Overall Study||1
6299029|NCT00323557|7201207|FG001|NOT COMPLETED|Overall Study||0
6299030|NCT00323609|7201216|FG000|STARTED|Overall Study||191
6299031|NCT00323609|7201217|FG001|STARTED|Overall Study||190
6299032|NCT00323609|7201218|FG002|STARTED|Overall Study||8
6299033|NCT00323609|7201219|FG003|STARTED|Overall Study||15
6299034|NCT00323609|7201216|FG000|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
6299035|NCT00323609|7201217|FG001|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
6299036|NCT00323609|7201218|FG002|COMPLETED|Overall Study||0
6299037|NCT00323609|7201219|FG003|COMPLETED|Overall Study||0
6299038|NCT00323609|7201216|FG000|NOT COMPLETED|Overall Study||91
6299039|NCT00323609|7201217|FG001|NOT COMPLETED|Overall Study||99
6299040|NCT00323609|7201218|FG002|NOT COMPLETED|Overall Study||8
6299041|NCT00323609|7201219|FG003|NOT COMPLETED|Overall Study||15
6299042|NCT00323622|7201233|FG000|STARTED|Overall Study||176
6299043|NCT00323622|7201234|FG001|STARTED|Overall Study||515
6299044|NCT00323622|7201235|FG002|STARTED|Overall Study||42
6299045|NCT00323622|7201236|FG003|STARTED|Overall Study||134
6299046|NCT00323622|7201237|FG004|STARTED|Overall Study||159
6299047|NCT00323622|7201238|FG005|STARTED|Overall Study||528
6299048|NCT00323622|7201239|FG006|STARTED|Overall Study||43
6299049|NCT00323622|7201240|FG007|STARTED|Overall Study||140
6299050|NCT00323622|7201233|FG000|COMPLETED|Overall Study||145
6299051|NCT00323622|7201234|FG001|COMPLETED|Overall Study||423
6299052|NCT00323622|7201235|FG002|COMPLETED|Overall Study||38
6299053|NCT00323622|7201236|FG003|COMPLETED|Overall Study||122
6299054|NCT00323622|7201237|FG004|COMPLETED|Overall Study||120
6299055|NCT00323622|7201238|FG005|COMPLETED|Overall Study||454
6299056|NCT00323622|7201239|FG006|COMPLETED|Overall Study||38
6299057|NCT00323622|7201240|FG007|COMPLETED|Overall Study||125
6299058|NCT00323622|7201233|FG000|NOT COMPLETED|Overall Study||31
6299059|NCT00323622|7201234|FG001|NOT COMPLETED|Overall Study||92
6401118|NCT00890916|7314027|FG000|"Grasp Release Pre-Test OFF"|"Rehab - NP Off"||10
6401119|NCT00890916|7314027|FG000|COMPLETED|"Rehab - NP Off"||10
6401120|NCT00890916|7314027|FG000|NOT COMPLETED|"Rehab - NP Off"||0
6401121|NCT00890929|7314031|FG000|STARTED|Overall Study||45
6401122|NCT00890929|7314031|FG000|Consented & Enrolled|Overall Study||45
6401123|NCT00890929|7314031|FG000|Initiated Treatment|Overall Study||43
6401124|NCT00890929|7314031|FG000|COMPLETED|Overall Study||39
6401125|NCT00890929|7314031|FG000|NOT COMPLETED|Overall Study||6
6401126|NCT00890981|7314037|FG000|STARTED|Overall Study||39
6401127|NCT00890981|7314038|FG001|STARTED|Overall Study||40
6401128|NCT00890981|7314037|FG000|COMPLETED|Overall Study||39
6401129|NCT00890981|7314038|FG001|COMPLETED|Overall Study||40
6401130|NCT00890981|7314037|FG000|NOT COMPLETED|Overall Study||0
6401131|NCT00890981|7314038|FG001|NOT COMPLETED|Overall Study||0
6401132|NCT00891020|7314047|FG000|STARTED|24 Week Treatment Period||163
6401133|NCT00891020|7314048|FG001|STARTED|24 Week Treatment Period||363
6401134|NCT00891020|7314049|FG002|STARTED|24 Week Treatment Period||360
6401135|NCT00891020|7314047|FG000|Intent-to-Treat (ITT)|24 Week Treatment Period||163
6401136|NCT00891020|7314048|FG001|Intent-to-Treat (ITT)|24 Week Treatment Period||362
6401137|NCT00891020|7314049|FG002|Intent-to-Treat (ITT)|24 Week Treatment Period||358
6401138|NCT00891020|7314047|FG000|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
6401139|NCT00891020|7314048|FG001|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
6502049|NCT01432327|7420689|FG000|NOT COMPLETED|Posttest 6 Months||0
6299060|NCT00323622|7201235|FG002|NOT COMPLETED|Overall Study||4
6299061|NCT00323622|7201236|FG003|NOT COMPLETED|Overall Study||12
6299062|NCT00323622|7201237|FG004|NOT COMPLETED|Overall Study||39
6299063|NCT00323622|7201238|FG005|NOT COMPLETED|Overall Study||74
6299064|NCT00323622|7201239|FG006|NOT COMPLETED|Overall Study||5
6299065|NCT00323622|7201240|FG007|NOT COMPLETED|Overall Study||15
6299066|NCT00323739|7201266|FG000|STARTED|Overall Study||80
6299067|NCT00323739|7201266|FG000|COMPLETED|Overall Study||80
6299068|NCT00323739|7201266|FG000|NOT COMPLETED|Overall Study||0
6299069|NCT00323869|7201270|FG000|STARTED|Overall Study|Enrollment|48
6299070|NCT00323869|7201270|FG000|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
6299071|NCT00323869|7201270|FG000|COMPLETED|Overall Study||47
6299072|NCT00323869|7201270|FG000|NOT COMPLETED|Overall Study||1
6299073|NCT00323882|7201279|FG000|STARTED|Overall Study||8
6401140|NCT00891020|7314049|FG002|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
6401141|NCT00891020|7314047|FG000|COMPLETED|24 Week Treatment Period||126
6401142|NCT00891020|7314048|FG001|COMPLETED|24 Week Treatment Period||303
6401143|NCT00891020|7314049|FG002|COMPLETED|24 Week Treatment Period||302
6401144|NCT00891020|7314047|FG000|NOT COMPLETED|24 Week Treatment Period||37
6401145|NCT00891020|7314048|FG001|NOT COMPLETED|24 Week Treatment Period||60
6401146|NCT00891020|7314049|FG002|NOT COMPLETED|24 Week Treatment Period||58
6401147|NCT00891020|7314047|FG000|STARTED|Long-term Extension Period||55
6299074|NCT00323882|7201280|FG001|STARTED|Overall Study||6
6299075|NCT00323882|7201281|FG002|STARTED|Overall Study||16
6299076|NCT00323882|7201282|FG003|STARTED|Overall Study||7
6299077|NCT00323882|7201283|FG004|STARTED|Overall Study||34
6299078|NCT00323882|7201279|FG000|COMPLETED|Overall Study||0
6299079|NCT00323882|7201280|FG001|COMPLETED|Overall Study||0
6299080|NCT00323882|7201281|FG002|COMPLETED|Overall Study||3
6299081|NCT00323882|7201282|FG003|COMPLETED|Overall Study||0
6299082|NCT00323882|7201283|FG004|COMPLETED|Overall Study||2
6299083|NCT00323882|7201279|FG000|NOT COMPLETED|Overall Study||8
6299084|NCT00323882|7201280|FG001|NOT COMPLETED|Overall Study||6
6299085|NCT00323882|7201281|FG002|NOT COMPLETED|Overall Study||13
6299086|NCT00323882|7201282|FG003|NOT COMPLETED|Overall Study||7
6299087|NCT00323882|7201283|FG004|NOT COMPLETED|Overall Study||32
6299088|NCT00323960|7201307|FG000|STARTED|Overall Study||47
6401148|NCT00891020|7314048|FG001|STARTED|Long-term Extension Period||196
6299089|NCT00323960|7201308|FG001|STARTED|Overall Study||46
6299090|NCT00323960|7201309|FG002|STARTED|Overall Study||46
6299091|NCT00323960|7201307|FG000|COMPLETED|Overall Study||47
6299092|NCT00323960|7201308|FG001|COMPLETED|Overall Study||46
6299093|NCT00323960|7201309|FG002|COMPLETED|Overall Study||46
6299094|NCT00323960|7201307|FG000|NOT COMPLETED|Overall Study||0
6299095|NCT00323960|7201308|FG001|NOT COMPLETED|Overall Study||0
6299096|NCT00323960|7201309|FG002|NOT COMPLETED|Overall Study||0
6299097|NCT00324038|7201322|FG000|STARTED|Overall Study||110
6299098|NCT00324038|7201323|FG001|STARTED|Overall Study||109
6299099|NCT00324038|7201322|FG000|COMPLETED|Overall Study||61
6299100|NCT00324038|7201323|FG001|COMPLETED|Overall Study||58
6299101|NCT00324038|7201322|FG000|NOT COMPLETED|Overall Study||49
6299102|NCT00324038|7201323|FG001|NOT COMPLETED|Overall Study||51
6299103|NCT00324116|7201329|FG000|STARTED|Overall Study|subjects received treatment|81
6299104|NCT00324116|7201329|FG000|COMPLETED|Overall Study||49
6299105|NCT00324116|7201329|FG000|NOT COMPLETED|Overall Study||32
6299106|NCT00324155|7201335|FG000|STARTED|Enrolled and Randomized||250
6299107|NCT00324155|7201336|FG001|STARTED|Enrolled and Randomized||252
6299108|NCT00324155|7201335|FG000|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
6299109|NCT00324155|7201336|FG001|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
6299110|NCT00324155|7201335|FG000|NOT COMPLETED|Enrolled and Randomized||3
6299111|NCT00324155|7201336|FG001|NOT COMPLETED|Enrolled and Randomized||1
6299112|NCT00324155|7201335|FG000|STARTED|Received Treatment in Induction Phase||247
6299113|NCT00324155|7201336|FG001|STARTED|Received Treatment in Induction Phase||251
6299114|NCT00324155|7201335|FG000|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
6299115|NCT00324155|7201336|FG001|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
6299116|NCT00324155|7201335|FG000|NOT COMPLETED|Received Treatment in Induction Phase||202
6299117|NCT00324155|7201336|FG001|NOT COMPLETED|Received Treatment in Induction Phase||197
6299118|NCT00324155|7201335|FG000|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
6299119|NCT00324155|7201336|FG001|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
6299120|NCT00324155|7201335|FG000|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
6299121|NCT00324155|7201336|FG001|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
6299122|NCT00324155|7201335|FG000|NOT COMPLETED|Received Treatment in Maintenance Phase||32
6299123|NCT00324155|7201336|FG001|NOT COMPLETED|Received Treatment in Maintenance Phase||47
6299124|NCT00324155|7201335|FG000|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
6299125|NCT00324155|7201336|FG001|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
6299126|NCT00324155|7201335|FG000|COMPLETED|Follow-up Phase||236
6299127|NCT00324155|7201336|FG001|COMPLETED|Follow-up Phase||245
6299128|NCT00324155|7201335|FG000|NOT COMPLETED|Follow-up Phase||11
6299129|NCT00324155|7201336|FG001|NOT COMPLETED|Follow-up Phase||6
6299130|NCT00324168|7201357|FG000|STARTED|Overall Study||250
6299131|NCT00324168|7201358|FG001|STARTED|Overall Study||250
6299132|NCT00324168|7201357|FG000|COMPLETED|Overall Study||222
6299133|NCT00324168|7201358|FG001|COMPLETED|Overall Study||220
6299134|NCT00324168|7201357|FG000|NOT COMPLETED|Overall Study||28
6299135|NCT00324168|7201358|FG001|NOT COMPLETED|Overall Study||30
6299136|NCT00324233|7201366|FG000|STARTED|First Period||18
6299137|NCT00324233|7201367|FG001|STARTED|First Period||18
6299138|NCT00324233|7201366|FG000|COMPLETED|First Period||17
6299139|NCT00324233|7201367|FG001|COMPLETED|First Period||18
6299140|NCT00324233|7201366|FG000|NOT COMPLETED|First Period||1
6299141|NCT00324233|7201367|FG001|NOT COMPLETED|First Period||0
6299142|NCT00324233|7201366|FG000|STARTED|Second Period||17
6299143|NCT00324233|7201367|FG001|STARTED|Second Period||18
6299144|NCT00324233|7201366|FG000|COMPLETED|Second Period||12
6299145|NCT00324233|7201367|FG001|COMPLETED|Second Period||11
6299146|NCT00324233|7201366|FG000|NOT COMPLETED|Second Period||5
6299147|NCT00324233|7201367|FG001|NOT COMPLETED|Second Period||7
6299148|NCT00324259|7201375|FG000|STARTED|Overall Study||34
6299149|NCT00324259|7201376|FG001|STARTED|Overall Study||32
6299150|NCT00324259|7201375|FG000|COMPLETED|Overall Study||34
6299151|NCT00324259|7201376|FG001|COMPLETED|Overall Study||32
6299152|NCT00324259|7201375|FG000|NOT COMPLETED|Overall Study||0
6299153|NCT00324259|7201376|FG001|NOT COMPLETED|Overall Study||0
6299154|NCT00324272|7201387|FG000|STARTED|Overall Study||18
6299155|NCT00324272|7201388|FG001|STARTED|Overall Study||20
6299156|NCT00324272|7201389|FG002|STARTED|Overall Study||18
6299157|NCT00324272|7201390|FG003|STARTED|Overall Study||18
6299158|NCT00324272|7201387|FG000|COMPLETED|Overall Study||18
6299159|NCT00324272|7201388|FG001|COMPLETED|Overall Study||20
6299160|NCT00324272|7201389|FG002|COMPLETED|Overall Study||18
6299161|NCT00324272|7201390|FG003|COMPLETED|Overall Study||18
6299162|NCT00324272|7201387|FG000|NOT COMPLETED|Overall Study||0
6299163|NCT00324272|7201388|FG001|NOT COMPLETED|Overall Study||0
6299164|NCT00324272|7201389|FG002|NOT COMPLETED|Overall Study||0
6299165|NCT00324272|7201390|FG003|NOT COMPLETED|Overall Study||0
6299166|NCT00324350|7201402|FG000|STARTED|Overall Study||3655
6299167|NCT00324350|7201403|FG001|STARTED|Overall Study||3632
6299168|NCT00324350|7201402|FG000|Non-Vertebral Fracture Follow-Up|Overall Study||3655
6299169|NCT00324350|7201403|FG001|Non-Vertebral Fracture Follow-Up|Overall Study||3632
6401149|NCT00891020|7314049|FG002|STARTED|Long-term Extension Period||193
6401150|NCT00891020|7314047|FG000|COMPLETED|Long-term Extension Period||49
6401151|NCT00891020|7314048|FG001|COMPLETED|Long-term Extension Period||172
6299170|NCT00324350|7201402|FG000|Falls Follow-Up|Overall Study||3364
6299171|NCT00324350|7201403|FG001|Falls Follow-Up|Overall Study||3418
6299172|NCT00324350|7201402|FG000|COMPLETED|Overall Study||3655
6299173|NCT00324350|7201403|FG001|COMPLETED|Overall Study||3632
6299174|NCT00324350|7201402|FG000|NOT COMPLETED|Overall Study||0
6299175|NCT00324350|7201403|FG001|NOT COMPLETED|Overall Study||0
6299176|NCT00324415|7201410|FG000|STARTED|Overall Study||45
6299177|NCT00324415|7201410|FG000|COMPLETED|Overall Study||45
6299178|NCT00324415|7201410|FG000|NOT COMPLETED|Overall Study||0
6299179|NCT00324649|7201417|FG000|STARTED|Overall Study||39
6299180|NCT00324649|7201418|FG001|STARTED|Overall Study||41
6299181|NCT00324649|7201417|FG000|COMPLETED|Overall Study||37
6299182|NCT00324649|7201418|FG001|COMPLETED|Overall Study||36
6299183|NCT00324649|7201417|FG000|NOT COMPLETED|Overall Study||2
6299184|NCT00324649|7201418|FG001|NOT COMPLETED|Overall Study||5
6299185|NCT00324675|7201426|FG000|STARTED|Overall Study||14
6299186|NCT00324675|7201427|FG001|STARTED|Overall Study||14
6299187|NCT00324675|7201426|FG000|COMPLETED|Overall Study||13
6299188|NCT00324675|7201427|FG001|COMPLETED|Overall Study||14
6299189|NCT00324675|7201426|FG000|NOT COMPLETED|Overall Study||1
6299190|NCT00324675|7201427|FG001|NOT COMPLETED|Overall Study||0
6299191|NCT00324701|7201435|FG000|STARTED|Overall Study||120
6299192|NCT00324701|7201436|FG001|STARTED|Overall Study||121
6299193|NCT00324701|7201435|FG000|Week 8 Assessment|Overall Study||108
6299194|NCT00324701|7201436|FG001|Week 8 Assessment|Overall Study||107
6299195|NCT00324701|7201435|FG000|COMPLETED|Overall Study||100
6299196|NCT00324701|7201436|FG001|COMPLETED|Overall Study||104
6299197|NCT00324701|7201435|FG000|NOT COMPLETED|Overall Study||20
6299198|NCT00324701|7201436|FG001|NOT COMPLETED|Overall Study||17
6299199|NCT00324740|7201442|FG000|STARTED|Overall Study||7
6299200|NCT00324740|7201443|FG001|STARTED|Overall Study||3
6299201|NCT00324740|7201444|FG002|STARTED|Overall Study||4
6299202|NCT00324740|7201442|FG000|COMPLETED|Overall Study||6
6299203|NCT00324740|7201443|FG001|COMPLETED|Overall Study||3
6299204|NCT00324740|7201444|FG002|COMPLETED|Overall Study||3
6299205|NCT00324740|7201442|FG000|NOT COMPLETED|Overall Study||1
6299206|NCT00324740|7201443|FG001|NOT COMPLETED|Overall Study||0
6299207|NCT00324740|7201444|FG002|NOT COMPLETED|Overall Study||1
6299208|NCT00324753|7201453|FG000|STARTED|Overall Study||190
6299209|NCT00324753|7201454|FG001|STARTED|Overall Study||264
6299210|NCT00324753|7201453|FG000|COMPLETED|Overall Study||190
6299211|NCT00324753|7201454|FG001|COMPLETED|Overall Study||264
6299212|NCT00324753|7201453|FG000|NOT COMPLETED|Overall Study||0
6299213|NCT00324753|7201454|FG001|NOT COMPLETED|Overall Study||0
6299214|NCT00324857|7201466|FG000|STARTED|Overall Study||167
6299215|NCT00324857|7201467|FG001|STARTED|Overall Study||168
6299216|NCT00324857|7201468|FG002|STARTED|Overall Study||165
6299217|NCT00324857|7201469|FG003|STARTED|Overall Study||163
6299218|NCT00324857|7201466|FG000|COMPLETED|Overall Study||161
6299219|NCT00324857|7201467|FG001|COMPLETED|Overall Study||162
6299220|NCT00324857|7201468|FG002|COMPLETED|Overall Study||158
6299221|NCT00324857|7201469|FG003|COMPLETED|Overall Study||158
6299222|NCT00324857|7201466|FG000|NOT COMPLETED|Overall Study||6
6299223|NCT00324857|7201467|FG001|NOT COMPLETED|Overall Study||6
6299224|NCT00324857|7201468|FG002|NOT COMPLETED|Overall Study||7
6401152|NCT00891020|7314049|FG002|COMPLETED|Long-term Extension Period||170
6401153|NCT00891020|7314047|FG000|NOT COMPLETED|Long-term Extension Period||6
6401154|NCT00891020|7314048|FG001|NOT COMPLETED|Long-term Extension Period||24
6299225|NCT00324857|7201469|FG003|NOT COMPLETED|Overall Study||5
6299226|NCT00324870|7201483|FG000|STARTED|Overall Study||37
6299227|NCT00324870|7201483|FG000|COMPLETED|Overall Study||37
6299228|NCT00324870|7201483|FG000|NOT COMPLETED|Overall Study||0
6299229|NCT00324896|7201489|FG000|STARTED|Overall Study||15
6299230|NCT00324896|7201490|FG001|STARTED|Overall Study||15
6299231|NCT00324896|7201489|FG000|COMPLETED|Overall Study||12
6299232|NCT00324896|7201490|FG001|COMPLETED|Overall Study||7
6299233|NCT00324896|7201489|FG000|NOT COMPLETED|Overall Study||3
6299234|NCT00324896|7201490|FG001|NOT COMPLETED|Overall Study||8
6299235|NCT00324961|7201496|FG000|STARTED|Overall Study||533
6299236|NCT00324961|7201496|FG000|COMPLETED|Overall Study||490
6299237|NCT00324961|7201496|FG000|NOT COMPLETED|Overall Study||43
6299238|NCT00324987|7201504|FG000|STARTED|Overall Study||6
6299239|NCT00324987|7201505|FG001|STARTED|Overall Study||6
6299240|NCT00324987|7201504|FG000|COMPLETED|Overall Study|Patients were to be treated until progression|0
6299241|NCT00324987|7201505|FG001|COMPLETED|Overall Study|Patients were to be treated until progression|0
6299242|NCT00324987|7201504|FG000|NOT COMPLETED|Overall Study||6
6299243|NCT00324987|7201505|FG001|NOT COMPLETED|Overall Study||6
6374581|NCT00750308|7285103|FG009|STARTED|Washout||2
6374582|NCT00750308|7285104|FG010|STARTED|Washout||1
6374583|NCT00750308|7285105|FG011|STARTED|Washout||1
6374584|NCT00750308|7285094|FG000|COMPLETED|Washout||2
6374585|NCT00750308|7285095|FG001|COMPLETED|Washout||1
6374586|NCT00750308|7285096|FG002|COMPLETED|Washout||2
6374587|NCT00750308|7285097|FG003|COMPLETED|Washout||1
6374588|NCT00750308|7285098|FG004|COMPLETED|Washout||1
6374589|NCT00750308|7285099|FG005|COMPLETED|Washout||2
6374590|NCT00750308|7285100|FG006|COMPLETED|Washout||2
6374591|NCT00750308|7285101|FG007|COMPLETED|Washout||2
6374592|NCT00750308|7285102|FG008|COMPLETED|Washout||1
6374593|NCT00750308|7285103|FG009|COMPLETED|Washout||2
6374594|NCT00750308|7285104|FG010|COMPLETED|Washout||1
6374595|NCT00750308|7285105|FG011|COMPLETED|Washout||1
6374596|NCT00750308|7285094|FG000|NOT COMPLETED|Washout||0
6374597|NCT00750308|7285095|FG001|NOT COMPLETED|Washout||0
6374598|NCT00750308|7285096|FG002|NOT COMPLETED|Washout||0
6374599|NCT00750308|7285097|FG003|NOT COMPLETED|Washout||0
6374600|NCT00750308|7285098|FG004|NOT COMPLETED|Washout||0
6374601|NCT00750308|7285099|FG005|NOT COMPLETED|Washout||0
6374602|NCT00750308|7285100|FG006|NOT COMPLETED|Washout||0
6374603|NCT00750308|7285101|FG007|NOT COMPLETED|Washout||0
6374604|NCT00750308|7285102|FG008|NOT COMPLETED|Washout||0
6374605|NCT00750308|7285103|FG009|NOT COMPLETED|Washout||0
6374606|NCT00750308|7285104|FG010|NOT COMPLETED|Washout||0
6374607|NCT00750308|7285105|FG011|NOT COMPLETED|Washout||0
6374608|NCT00750308|7285094|FG000|STARTED|Fourth Treatment||2
6374609|NCT00750308|7285095|FG001|STARTED|Fourth Treatment||1
6374610|NCT00750308|7285096|FG002|STARTED|Fourth Treatment||2
6374611|NCT00750308|7285097|FG003|STARTED|Fourth Treatment||1
6374612|NCT00750308|7285098|FG004|STARTED|Fourth Treatment||1
6374613|NCT00750308|7285099|FG005|STARTED|Fourth Treatment||2
6374614|NCT00750308|7285100|FG006|STARTED|Fourth Treatment||2
6374615|NCT00750308|7285101|FG007|STARTED|Fourth Treatment||2
6374616|NCT00750308|7285102|FG008|STARTED|Fourth Treatment||1
6374617|NCT00750308|7285103|FG009|STARTED|Fourth Treatment||2
6374618|NCT00750308|7285104|FG010|STARTED|Fourth Treatment||1
6374619|NCT00750308|7285105|FG011|STARTED|Fourth Treatment||1
6374620|NCT00750308|7285094|FG000|COMPLETED|Fourth Treatment||2
6374621|NCT00750308|7285095|FG001|COMPLETED|Fourth Treatment||1
6374622|NCT00750308|7285096|FG002|COMPLETED|Fourth Treatment||2
6374623|NCT00750308|7285097|FG003|COMPLETED|Fourth Treatment||1
6374624|NCT00750308|7285098|FG004|COMPLETED|Fourth Treatment||1
6374625|NCT00750308|7285099|FG005|COMPLETED|Fourth Treatment||2
6374626|NCT00750308|7285100|FG006|COMPLETED|Fourth Treatment||2
6374627|NCT00750308|7285101|FG007|COMPLETED|Fourth Treatment||2
6374628|NCT00750308|7285102|FG008|COMPLETED|Fourth Treatment||1
6374629|NCT00750308|7285103|FG009|COMPLETED|Fourth Treatment||2
6374630|NCT00750308|7285104|FG010|COMPLETED|Fourth Treatment||1
6374631|NCT00750308|7285105|FG011|COMPLETED|Fourth Treatment||1
6374632|NCT00750308|7285094|FG000|NOT COMPLETED|Fourth Treatment||0
6374633|NCT00750308|7285095|FG001|NOT COMPLETED|Fourth Treatment||0
6374634|NCT00750308|7285096|FG002|NOT COMPLETED|Fourth Treatment||0
6374635|NCT00750308|7285097|FG003|NOT COMPLETED|Fourth Treatment||0
6374636|NCT00750308|7285098|FG004|NOT COMPLETED|Fourth Treatment||0
6374637|NCT00750308|7285099|FG005|NOT COMPLETED|Fourth Treatment||0
6374638|NCT00750308|7285100|FG006|NOT COMPLETED|Fourth Treatment||0
6374639|NCT00750308|7285101|FG007|NOT COMPLETED|Fourth Treatment||0
6374640|NCT00750308|7285102|FG008|NOT COMPLETED|Fourth Treatment||0
6374641|NCT00750308|7285103|FG009|NOT COMPLETED|Fourth Treatment||0
6374642|NCT00750308|7285104|FG010|NOT COMPLETED|Fourth Treatment||0
6299244|NCT00325039|7201513|FG000|STARTED|Overall Study||298
6299245|NCT00325039|7201514|FG001|STARTED|Overall Study||299
6299246|NCT00325039|7201513|FG000|COMPLETED|Overall Study||280
6299247|NCT00325039|7201514|FG001|COMPLETED|Overall Study||285
6299248|NCT00325039|7201513|FG000|NOT COMPLETED|Overall Study||18
6299249|NCT00325039|7201514|FG001|NOT COMPLETED|Overall Study||14
6299250|NCT00325078|7201523|FG000|STARTED|Overall Study||8
6299251|NCT00325078|7201524|FG001|STARTED|Overall Study||7
6299252|NCT00325078|7201525|FG002|STARTED|Overall Study||25
6299253|NCT00325078|7201523|FG000|COMPLETED|Overall Study||3
6299254|NCT00325078|7201524|FG001|COMPLETED|Overall Study||2
6299255|NCT00325078|7201525|FG002|COMPLETED|Overall Study||23
6299256|NCT00325078|7201523|FG000|NOT COMPLETED|Overall Study||5
6299257|NCT00325078|7201524|FG001|NOT COMPLETED|Overall Study||5
6299258|NCT00325078|7201525|FG002|NOT COMPLETED|Overall Study||2
6299259|NCT00325130|7201536|FG000|STARTED|Overall Study||518
6299260|NCT00325130|7201537|FG001|STARTED|Overall Study||524
6299261|NCT00325130|7201536|FG000|COMPLETED|Overall Study||499
6299262|NCT00325130|7201537|FG001|COMPLETED|Overall Study||494
6299263|NCT00325130|7201536|FG000|NOT COMPLETED|Overall Study||19
6299264|NCT00325130|7201537|FG001|NOT COMPLETED|Overall Study||30
6299265|NCT00325143|7201543|FG000|STARTED|Overall Study||702
6299266|NCT00325143|7201543|FG000|COMPLETED|Overall Study||676
6299267|NCT00325143|7201543|FG000|NOT COMPLETED|Overall Study||26
6299268|NCT00325156|7201547|FG000|STARTED|Overall Study||2590
6299269|NCT00325156|7201547|FG000|COMPLETED|Overall Study||2478
6299270|NCT00325156|7201547|FG000|NOT COMPLETED|Overall Study||112
6299271|NCT00325195|7201554|FG000|STARTED|Randomized||90
6299272|NCT00325195|7201555|FG001|STARTED|Randomized||89
6299273|NCT00325195|7201556|FG002|STARTED|Randomized||46
6299274|NCT00325195|7201554|FG000|COMPLETED|Randomized||85
6299275|NCT00325195|7201555|FG001|COMPLETED|Randomized||84
6299276|NCT00325195|7201556|FG002|COMPLETED|Randomized||43
6299277|NCT00325195|7201554|FG000|NOT COMPLETED|Randomized||5
6299278|NCT00325195|7201555|FG001|NOT COMPLETED|Randomized||5
6299279|NCT00325195|7201556|FG002|NOT COMPLETED|Randomized||3
6299280|NCT00325195|7201554|FG000|STARTED|Received Intervention: ITT Population||85
6299281|NCT00325195|7201555|FG001|STARTED|Received Intervention: ITT Population||84
6299282|NCT00325195|7201556|FG002|STARTED|Received Intervention: ITT Population||43
6299283|NCT00325195|7201554|FG000|COMPLETED|Received Intervention: ITT Population||59
6299284|NCT00325195|7201555|FG001|COMPLETED|Received Intervention: ITT Population||59
6299285|NCT00325195|7201556|FG002|COMPLETED|Received Intervention: ITT Population||39
6299286|NCT00325195|7201554|FG000|NOT COMPLETED|Received Intervention: ITT Population||26
6299287|NCT00325195|7201555|FG001|NOT COMPLETED|Received Intervention: ITT Population||25
6299288|NCT00325195|7201556|FG002|NOT COMPLETED|Received Intervention: ITT Population||4
6299289|NCT00325234|7201566|FG000|STARTED|Overall Study||69
6299290|NCT00325234|7201567|FG001|STARTED|Overall Study||66
6299291|NCT00325234|7201566|FG000|Received At Least 1 Dose of Study Drug|Overall Study||65
6299292|NCT00325234|7201567|FG001|Received At Least 1 Dose of Study Drug|Overall Study||66
6299293|NCT00325234|7201566|FG000|COMPLETED|Overall Study||0
6299294|NCT00325234|7201567|FG001|COMPLETED|Overall Study||0
6299295|NCT00325234|7201566|FG000|NOT COMPLETED|Overall Study||69
6299296|NCT00325234|7201567|FG001|NOT COMPLETED|Overall Study||66
6299297|NCT00325403|7201577|FG000|STARTED|Overall Study||116
6299298|NCT00325403|7201578|FG001|STARTED|Overall Study||233
6299299|NCT00325403|7201577|FG000|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
6299300|NCT00325403|7201578|FG001|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
6299301|NCT00325403|7201577|FG000|NOT COMPLETED|Overall Study||18
6299302|NCT00325403|7201578|FG001|NOT COMPLETED|Overall Study||51
6299303|NCT00325416|7201588|FG000|STARTED|Phase I: Dose Escalation||70
6299304|NCT00325416|7201589|FG001|STARTED|Phase I: Dose Escalation||60
6299305|NCT00325416|7201588|FG000|COMPLETED|Phase I: Dose Escalation||48
6299306|NCT00325416|7201589|FG001|COMPLETED|Phase I: Dose Escalation||44
6299307|NCT00325416|7201588|FG000|NOT COMPLETED|Phase I: Dose Escalation||22
6299308|NCT00325416|7201589|FG001|NOT COMPLETED|Phase I: Dose Escalation||16
6299309|NCT00325416|7201588|FG000|STARTED|Phase II: Treatment at MTD||78
6299310|NCT00325416|7201589|FG001|STARTED|Phase II: Treatment at MTD||42
6299311|NCT00325416|7201588|FG000|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
6299312|NCT00325416|7201589|FG001|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
6299313|NCT00325416|7201588|FG000|Enrolled During Phase II|Phase II: Treatment at MTD||40
6299314|NCT00325416|7201589|FG001|Enrolled During Phase II|Phase II: Treatment at MTD||8
6299315|NCT00325416|7201588|FG000|COMPLETED|Phase II: Treatment at MTD||78
6299316|NCT00325416|7201589|FG001|COMPLETED|Phase II: Treatment at MTD||40
6299317|NCT00325416|7201588|FG000|NOT COMPLETED|Phase II: Treatment at MTD||0
6299318|NCT00325416|7201589|FG001|NOT COMPLETED|Phase II: Treatment at MTD||2
6299319|NCT00325442|7201597|FG000|STARTED|Overall Study||176
6299320|NCT00325442|7201598|FG001|STARTED|Overall Study||174
6299321|NCT00325442|7201597|FG000|COMPLETED|Overall Study||167
6299322|NCT00325442|7201598|FG001|COMPLETED|Overall Study||153
6299323|NCT00325442|7201597|FG000|NOT COMPLETED|Overall Study||9
6299324|NCT00325442|7201598|FG001|NOT COMPLETED|Overall Study||21
6299325|NCT00325468|7201612|FG000|STARTED|Overall Study||23
6299326|NCT00325468|7201613|FG001|STARTED|Overall Study||17
6299327|NCT00325468|7201614|FG002|STARTED|Overall Study||14
6299328|NCT00325468|7201615|FG003|STARTED|Overall Study||124
6299329|NCT00325468|7201616|FG004|STARTED|Overall Study||22
6299330|NCT00325468|7201612|FG000|COMPLETED|Overall Study||12
6299331|NCT00325468|7201613|FG001|COMPLETED|Overall Study||12
6299332|NCT00325468|7201614|FG002|COMPLETED|Overall Study||10
6299333|NCT00325468|7201615|FG003|COMPLETED|Overall Study||90
6299334|NCT00325468|7201616|FG004|COMPLETED|Overall Study||14
6299335|NCT00325468|7201612|FG000|NOT COMPLETED|Overall Study||11
6299336|NCT00325468|7201613|FG001|NOT COMPLETED|Overall Study||5
6299337|NCT00325468|7201614|FG002|NOT COMPLETED|Overall Study||4
6299338|NCT00325468|7201615|FG003|NOT COMPLETED|Overall Study||34
6299339|NCT00325468|7201616|FG004|NOT COMPLETED|Overall Study||8
6299340|NCT00325598|7201631|FG000|STARTED|Overall Study||50
6299341|NCT00325598|7201632|FG001|STARTED|Overall Study||50
6299342|NCT00325598|7201631|FG000|COMPLETED|Overall Study||50
6299343|NCT00325598|7201632|FG001|COMPLETED|Overall Study||50
6299344|NCT00325598|7201631|FG000|NOT COMPLETED|Overall Study||0
6299345|NCT00325598|7201632|FG001|NOT COMPLETED|Overall Study||0
6299346|NCT00325754|7201642|FG000|STARTED|Overall Study||11
6299347|NCT00325754|7201643|FG001|STARTED|Overall Study||11
6299348|NCT00325754|7201642|FG000|COMPLETED|Overall Study||7
6299349|NCT00325754|7201643|FG001|COMPLETED|Overall Study||10
6299350|NCT00325754|7201642|FG000|NOT COMPLETED|Overall Study||4
6299351|NCT00325754|7201643|FG001|NOT COMPLETED|Overall Study||1
6299352|NCT00325780|7201649|FG000|STARTED|Overall Study||1355
6299353|NCT00325780|7201649|FG000|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
6299354|NCT00325780|7201649|FG000|COMPLETED|Overall Study||1200
6299355|NCT00325780|7201649|FG000|NOT COMPLETED|Overall Study||155
6299356|NCT00325819|7201655|FG000|STARTED|Overall Study||185
6299357|NCT00325819|7201656|FG001|STARTED|Overall Study||189
6299358|NCT00325819|7201655|FG000|COMPLETED|Overall Study||176
6299359|NCT00325819|7201656|FG001|COMPLETED|Overall Study||176
6299360|NCT00325819|7201655|FG000|NOT COMPLETED|Overall Study||9
6299361|NCT00325819|7201656|FG001|NOT COMPLETED|Overall Study||13
6299362|NCT00325897|7201666|FG000|STARTED|Overall Study||570
6299363|NCT00325897|7201667|FG001|STARTED|Overall Study||572
6299364|NCT00325897|7201666|FG000|COMPLETED|Overall Study||558
6299365|NCT00325897|7201667|FG001|COMPLETED|Overall Study||559
6299366|NCT00325897|7201666|FG000|NOT COMPLETED|Overall Study||12
6299367|NCT00325897|7201667|FG001|NOT COMPLETED|Overall Study||13
6299368|NCT00326001|7201678|FG000|STARTED|Overall Study||236
6299369|NCT00326001|7201679|FG001|STARTED|Overall Study||227
6299370|NCT00326001|7201678|FG000|COMPLETED|Overall Study||229
6299371|NCT00326001|7201679|FG001|COMPLETED|Overall Study||219
6299372|NCT00326001|7201678|FG000|NOT COMPLETED|Overall Study||7
6299373|NCT00326001|7201679|FG001|NOT COMPLETED|Overall Study||8
6299374|NCT00326118|7201687|FG000|STARTED|Active Phase||324
6299375|NCT00326118|7201688|FG001|STARTED|Active Phase||109
6299376|NCT00326118|7201687|FG000|COMPLETED|Active Phase||320
6299377|NCT00326118|7201688|FG001|COMPLETED|Active Phase||108
6299378|NCT00326118|7201687|FG000|NOT COMPLETED|Active Phase||4
6299379|NCT00326118|7201688|FG001|NOT COMPLETED|Active Phase||1
6299380|NCT00326118|7201687|FG000|STARTED|Year 1 Follow-up||295
6299381|NCT00326118|7201688|FG001|STARTED|Year 1 Follow-up||100
6299382|NCT00326118|7201687|FG000|COMPLETED|Year 1 Follow-up||295
6299383|NCT00326118|7201688|FG001|COMPLETED|Year 1 Follow-up||100
6299384|NCT00326118|7201687|FG000|NOT COMPLETED|Year 1 Follow-up||0
6299385|NCT00326118|7201688|FG001|NOT COMPLETED|Year 1 Follow-up||0
6299386|NCT00326118|7201687|FG000|STARTED|Year 2 Follow-up||270
6299387|NCT00326118|7201688|FG001|STARTED|Year 2 Follow-up||92
6299388|NCT00326118|7201687|FG000|COMPLETED|Year 2 Follow-up||270
6299389|NCT00326118|7201688|FG001|COMPLETED|Year 2 Follow-up||92
6299390|NCT00326118|7201687|FG000|NOT COMPLETED|Year 2 Follow-up||0
6299391|NCT00326118|7201688|FG001|NOT COMPLETED|Year 2 Follow-up||0
6299392|NCT00326118|7201687|FG000|STARTED|Year 3 Follow-up||256
6299393|NCT00326118|7201688|FG001|STARTED|Year 3 Follow-up||89
6299394|NCT00326118|7201687|FG000|COMPLETED|Year 3 Follow-up||256
6299395|NCT00326118|7201688|FG001|COMPLETED|Year 3 Follow-up||89
6299396|NCT00326118|7201687|FG000|NOT COMPLETED|Year 3 Follow-up||0
6299397|NCT00326118|7201688|FG001|NOT COMPLETED|Year 3 Follow-up||0
6299398|NCT00326118|7201687|FG000|STARTED|Year 4 Follow-up||228
6299399|NCT00326118|7201688|FG001|STARTED|Year 4 Follow-up||80
6299400|NCT00326118|7201687|FG000|COMPLETED|Year 4 Follow-up||228
6299401|NCT00326118|7201688|FG001|COMPLETED|Year 4 Follow-up||80
6299402|NCT00326118|7201687|FG000|NOT COMPLETED|Year 4 Follow-up||0
6299403|NCT00326118|7201688|FG001|NOT COMPLETED|Year 4 Follow-up||0
6299404|NCT00326118|7201687|FG000|STARTED|Year 5 Follow up||217
6299405|NCT00326118|7201688|FG001|STARTED|Year 5 Follow up||78
6299406|NCT00326118|7201687|FG000|COMPLETED|Year 5 Follow up||217
6299407|NCT00326118|7201688|FG001|COMPLETED|Year 5 Follow up||78
6299408|NCT00326118|7201687|FG000|NOT COMPLETED|Year 5 Follow up||0
6299409|NCT00326118|7201688|FG001|NOT COMPLETED|Year 5 Follow up||0
6299410|NCT00326170|7201695|FG000|STARTED|Overall Study||34
6299411|NCT00326170|7201695|FG000|COMPLETED|Overall Study||34
6299412|NCT00326170|7201695|FG000|NOT COMPLETED|Overall Study||0
6299413|NCT00326196|7201701|FG000|STARTED|Overall Study||101
6299414|NCT00326196|7201702|FG001|STARTED|Overall Study||97
6299415|NCT00326196|7201701|FG000|COMPLETED|Overall Study||101
6299416|NCT00326196|7201702|FG001|COMPLETED|Overall Study||97
6299417|NCT00326196|7201701|FG000|NOT COMPLETED|Overall Study||0
6299418|NCT00326196|7201702|FG001|NOT COMPLETED|Overall Study||0
6299419|NCT00326209|7201708|FG000|STARTED|Overall Study||393
6299420|NCT00326209|7201708|FG000|Safety Population|Overall Study||388
6299421|NCT00326209|7201708|FG000|COMPLETED|Overall Study||111
6299422|NCT00326209|7201708|FG000|NOT COMPLETED|Overall Study||282
6299423|NCT00326417|7201714|FG000|STARTED|Overall Study||14
6299424|NCT00326417|7201715|FG001|STARTED|Overall Study||41
6299425|NCT00326417|7201716|FG002|STARTED|Overall Study||39
6299426|NCT00326417|7201717|FG003|STARTED|Overall Study||3
6299427|NCT00326417|7201714|FG000|Phase I|Overall Study||6
6299428|NCT00326417|7201715|FG001|Phase I|Overall Study||6
6299429|NCT00326417|7201716|FG002|Phase I|Overall Study||6
6299430|NCT00326417|7201717|FG003|Phase I|Overall Study||3
6299431|NCT00326417|7201714|FG000|Phase II|Overall Study||8
6299432|NCT00326417|7201715|FG001|Phase II|Overall Study||35
6299433|NCT00326417|7201716|FG002|Phase II|Overall Study||33
6299434|NCT00326417|7201717|FG003|Phase II|Overall Study||0
6299435|NCT00326417|7201714|FG000|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
6299436|NCT00326417|7201715|FG001|COMPLETED|Overall Study||41
6299437|NCT00326417|7201716|FG002|COMPLETED|Overall Study||38
6299438|NCT00326417|7201717|FG003|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
6299439|NCT00326417|7201714|FG000|NOT COMPLETED|Overall Study||14
6299440|NCT00326417|7201715|FG001|NOT COMPLETED|Overall Study||0
6299441|NCT00326417|7201716|FG002|NOT COMPLETED|Overall Study||1
6299442|NCT00326417|7201717|FG003|NOT COMPLETED|Overall Study||3
6299443|NCT00326495|7201725|FG000|STARTED|Overall Study||51
6299444|NCT00326495|7201725|FG000|COMPLETED|Overall Study||46
6299445|NCT00326495|7201725|FG000|NOT COMPLETED|Overall Study||5
6299446|NCT00326599|7201733|FG000|STARTED|Overall Study||6
6299447|NCT00326599|7201734|FG001|STARTED|Overall Study||3
6299448|NCT00326599|7201735|FG002|STARTED|Overall Study||58
6299449|NCT00326599|7201736|FG003|STARTED|Overall Study||29
6299450|NCT00326599|7201733|FG000|COMPLETED|Overall Study||0
6299451|NCT00326599|7201734|FG001|COMPLETED|Overall Study||2
6299452|NCT00326599|7201735|FG002|COMPLETED|Overall Study||5
6299453|NCT00326599|7201736|FG003|COMPLETED|Overall Study||10
6299454|NCT00326599|7201733|FG000|NOT COMPLETED|Overall Study||6
6299455|NCT00326599|7201734|FG001|NOT COMPLETED|Overall Study||1
6299456|NCT00326599|7201735|FG002|NOT COMPLETED|Overall Study||53
6299457|NCT00326599|7201736|FG003|NOT COMPLETED|Overall Study||19
6299458|NCT00326612|7201747|FG000|STARTED|Overall Study||179
6299459|NCT00326612|7201748|FG001|STARTED|Overall Study||179
6299460|NCT00326612|7201747|FG000|COMPLETED|Overall Study||50
6299461|NCT00326612|7201748|FG001|COMPLETED|Overall Study||42
6299462|NCT00326612|7201747|FG000|NOT COMPLETED|Overall Study||129
6299463|NCT00326612|7201748|FG001|NOT COMPLETED|Overall Study||137
6299464|NCT00326625|7201760|FG000|STARTED|Overall Study||184
6299465|NCT00326625|7201761|FG001|STARTED|Overall Study||182
6299466|NCT00326625|7201760|FG000|COMPLETED|Overall Study||130
6299467|NCT00326625|7201761|FG001|COMPLETED|Overall Study||144
6299468|NCT00326625|7201760|FG000|NOT COMPLETED|Overall Study||54
6299469|NCT00326625|7201761|FG001|NOT COMPLETED|Overall Study||38
6299470|NCT00326716|7201769|FG000|STARTED|Pre-Natal Mothers||20
6299471|NCT00326716|7201770|FG001|STARTED|Pre-Natal Mothers||21
6299472|NCT00326716|7201771|FG002|STARTED|Pre-Natal Mothers||0
6299473|NCT00326716|7201772|FG003|STARTED|Pre-Natal Mothers||0
6299474|NCT00326716|7201769|FG000|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
6299475|NCT00326716|7201770|FG001|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
6299476|NCT00326716|7201771|FG002|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
6299477|NCT00326716|7201772|FG003|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
6299478|NCT00326716|7201769|FG000|NOT COMPLETED|Pre-Natal Mothers||1
6299479|NCT00326716|7201770|FG001|NOT COMPLETED|Pre-Natal Mothers||2
6299480|NCT00326716|7201771|FG002|NOT COMPLETED|Pre-Natal Mothers||0
6299481|NCT00326716|7201772|FG003|NOT COMPLETED|Pre-Natal Mothers||0
6299482|NCT00326716|7201769|FG000|STARTED|Infants||0
6299483|NCT00326716|7201770|FG001|STARTED|Infants||0
6299484|NCT00326716|7201771|FG002|STARTED|Infants|All infants were followed.|20
6299485|NCT00326716|7201772|FG003|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
6299486|NCT00326716|7201769|FG000|COMPLETED|Infants||0
6299487|NCT00326716|7201770|FG001|COMPLETED|Infants||0
6299488|NCT00326716|7201771|FG002|COMPLETED|Infants||20
6299489|NCT00326716|7201772|FG003|COMPLETED|Infants||20
6299490|NCT00326716|7201769|FG000|NOT COMPLETED|Infants||0
6299491|NCT00326716|7201770|FG001|NOT COMPLETED|Infants||0
6299492|NCT00326716|7201771|FG002|NOT COMPLETED|Infants||0
6299493|NCT00326716|7201772|FG003|NOT COMPLETED|Infants||0
6299494|NCT00326781|7201804|FG000|STARTED|Overall Study||344
6299495|NCT00326781|7201805|FG001|STARTED|Overall Study||330
6299496|NCT00326781|7201804|FG000|COMPLETED|Overall Study||302
6299497|NCT00326781|7201805|FG001|COMPLETED|Overall Study||298
6299498|NCT00326781|7201804|FG000|NOT COMPLETED|Overall Study||42
6299499|NCT00326781|7201805|FG001|NOT COMPLETED|Overall Study||32
6299500|NCT00326872|7201811|FG000|STARTED|Overall Study||26
6299501|NCT00326872|7201811|FG000|COMPLETED|Overall Study||26
6299502|NCT00326872|7201811|FG000|NOT COMPLETED|Overall Study||0
6299503|NCT00326885|7201815|FG000|STARTED|Overall Study||32
6299504|NCT00326885|7201815|FG000|COMPLETED|Overall Study||25
6299505|NCT00326885|7201815|FG000|NOT COMPLETED|Overall Study||7
6299506|NCT00326911|7201822|FG000|STARTED|Overall Study|This number reflects all randomized patients.|30
6299507|NCT00326911|7201823|FG001|STARTED|Overall Study|This number reflects all randomized patients.|31
6299508|NCT00326911|7201822|FG000|COMPLETED|Overall Study|This number reflects all treated patients.|29
6299509|NCT00326911|7201823|FG001|COMPLETED|Overall Study|This number reflects all treated patients.|29
6299510|NCT00326911|7201822|FG000|NOT COMPLETED|Overall Study||1
6299511|NCT00326911|7201823|FG001|NOT COMPLETED|Overall Study||2
6299512|NCT00326924|7201831|FG000|STARTED|Overall Study||188
6299513|NCT00326924|7201832|FG001|STARTED|Overall Study||189
6299514|NCT00326924|7201831|FG000|COMPLETED|Overall Study||187
6299515|NCT00326924|7201832|FG001|COMPLETED|Overall Study||188
6299516|NCT00326924|7201831|FG000|NOT COMPLETED|Overall Study||1
6299517|NCT00326924|7201832|FG001|NOT COMPLETED|Overall Study||1
6299518|NCT00326950|7201838|FG000|STARTED|Overall Study||15
6299519|NCT00326950|7201838|FG000|COMPLETED|Overall Study||14
6299520|NCT00326950|7201838|FG000|NOT COMPLETED|Overall Study||1
6299521|NCT00326963|7201842|FG000|STARTED|Overall Study||140
6299522|NCT00326963|7201842|FG000|COMPLETED|Overall Study||107
6299523|NCT00326963|7201842|FG000|NOT COMPLETED|Overall Study||33
6401155|NCT00891020|7314049|FG002|NOT COMPLETED|Long-term Extension Period||23
6401156|NCT00891046|7314064|FG000|STARTED|Overall Study||33
6401157|NCT00891046|7314065|FG001|STARTED|Overall Study||63
6401158|NCT00891046|7314066|FG002|STARTED|Overall Study||40
6401159|NCT00891046|7314067|FG003|STARTED|Overall Study||11
6401160|NCT00891046|7314068|FG004|STARTED|Overall Study||123
6401161|NCT00891046|7314064|FG000|COMPLETED|Overall Study||21
6401162|NCT00891046|7314065|FG001|COMPLETED|Overall Study||54
6401163|NCT00891046|7314066|FG002|COMPLETED|Overall Study||17
6401164|NCT00891046|7314067|FG003|COMPLETED|Overall Study||8
6401165|NCT00891046|7314068|FG004|COMPLETED|Overall Study||84
6401166|NCT00891046|7314064|FG000|NOT COMPLETED|Overall Study||12
6401167|NCT00891046|7314065|FG001|NOT COMPLETED|Overall Study||9
6401168|NCT00891046|7314066|FG002|NOT COMPLETED|Overall Study||23
6401169|NCT00891046|7314067|FG003|NOT COMPLETED|Overall Study||3
6401170|NCT00891046|7314068|FG004|NOT COMPLETED|Overall Study||39
6401171|NCT00891176|7314099|FG000|STARTED|At 3 Years of Age||144
6401172|NCT00891176|7314100|FG001|STARTED|At 3 Years of Age||147
6401173|NCT00891176|7314101|FG002|STARTED|At 3 Years of Age||149
6401174|NCT00891176|7314102|FG003|STARTED|At 3 Years of Age||141
6401175|NCT00891176|7314099|FG000|COMPLETED|At 3 Years of Age||144
6401176|NCT00891176|7314100|FG001|COMPLETED|At 3 Years of Age||147
6401177|NCT00891176|7314101|FG002|COMPLETED|At 3 Years of Age||149
6401178|NCT00891176|7314102|FG003|COMPLETED|At 3 Years of Age||141
6401179|NCT00891176|7314099|FG000|NOT COMPLETED|At 3 Years of Age||0
6401180|NCT00891176|7314100|FG001|NOT COMPLETED|At 3 Years of Age||0
6401181|NCT00891176|7314101|FG002|NOT COMPLETED|At 3 Years of Age||0
6299524|NCT00327015|7201851|FG000|STARTED|Overall Study||320
6299525|NCT00327015|7201852|FG001|STARTED|Overall Study||323
6299526|NCT00327015|7201853|FG002|STARTED|Overall Study||335
6299527|NCT00327015|7201854|FG003|STARTED|Overall Study||328
6299528|NCT00327015|7201851|FG000|Completed Study Without Being Rescued|Overall Study||179
6299529|NCT00327015|7201852|FG001|Completed Study Without Being Rescued|Overall Study||177
6299530|NCT00327015|7201853|FG002|Completed Study Without Being Rescued|Overall Study||113
6299531|NCT00327015|7201854|FG003|Completed Study Without Being Rescued|Overall Study||144
6299532|NCT00327015|7201851|FG000|COMPLETED|Overall Study||229
6299533|NCT00327015|7201852|FG001|COMPLETED|Overall Study||231
6299534|NCT00327015|7201853|FG002|COMPLETED|Overall Study||209
6299535|NCT00327015|7201854|FG003|COMPLETED|Overall Study||219
6299536|NCT00327015|7201851|FG000|NOT COMPLETED|Overall Study||91
6299537|NCT00327015|7201852|FG001|NOT COMPLETED|Overall Study||92
6299538|NCT00327015|7201853|FG002|NOT COMPLETED|Overall Study||126
6299539|NCT00327015|7201854|FG003|NOT COMPLETED|Overall Study||109
6299540|NCT00327171|7201866|FG000|STARTED|Overall Study||109
6299541|NCT00327171|7201867|FG001|STARTED|Overall Study||109
6299542|NCT00327171|7201866|FG000|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
6299543|NCT00327171|7201867|FG001|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
6299544|NCT00327171|7201866|FG000|NOT COMPLETED|Overall Study||108
6299545|NCT00327171|7201867|FG001|NOT COMPLETED|Overall Study||109
6299546|NCT00327340|7201875|FG000|STARTED|Overall Study||23
6299547|NCT00327340|7201876|FG001|STARTED|Overall Study||46
6299548|NCT00327340|7201875|FG000|COMPLETED|Overall Study||8
6299549|NCT00327340|7201876|FG001|COMPLETED|Overall Study||16
6299550|NCT00327340|7201875|FG000|NOT COMPLETED|Overall Study||15
6299551|NCT00327340|7201876|FG001|NOT COMPLETED|Overall Study||30
6299552|NCT00327392|7201884|FG000|STARTED|Overall Study||123
6299553|NCT00327392|7201884|FG000|COMPLETED|Overall Study||123
6299554|NCT00327392|7201884|FG000|NOT COMPLETED|Overall Study||0
6299555|NCT00327444|7201890|FG000|STARTED|Double Blind Treatment (DB) Period||26
6299556|NCT00327444|7201891|FG001|STARTED|Double Blind Treatment (DB) Period||29
6299557|NCT00327444|7201890|FG000|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
6299558|NCT00327444|7201891|FG001|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
6401182|NCT00891176|7314102|FG003|NOT COMPLETED|At 3 Years of Age||0
6401183|NCT00891176|7314099|FG000|STARTED|At 4 Years of Age||140
6401184|NCT00891176|7314100|FG001|STARTED|At 4 Years of Age||142
6401185|NCT00891176|7314101|FG002|STARTED|At 4 Years of Age||142
6401186|NCT00891176|7314102|FG003|STARTED|At 4 Years of Age||137
6401187|NCT00891176|7314099|FG000|COMPLETED|At 4 Years of Age||140
6299559|NCT00327444|7201890|FG000|COMPLETED|Double Blind Treatment (DB) Period||0
6299560|NCT00327444|7201891|FG001|COMPLETED|Double Blind Treatment (DB) Period||0
6299561|NCT00327444|7201890|FG000|NOT COMPLETED|Double Blind Treatment (DB) Period||26
6299562|NCT00327444|7201891|FG001|NOT COMPLETED|Double Blind Treatment (DB) Period||29
6299563|NCT00327444|7201890|FG000|STARTED|Open Label Treatment (OL) Period||11
6299564|NCT00327444|7201891|FG001|STARTED|Open Label Treatment (OL) Period||10
6299565|NCT00327444|7201890|FG000|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
6299566|NCT00327444|7201891|FG001|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
6299567|NCT00327444|7201890|FG000|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
6299568|NCT00327444|7201891|FG001|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
6299569|NCT00327444|7201890|FG000|NOT COMPLETED|Open Label Treatment (OL) Period||11
6299570|NCT00327444|7201891|FG001|NOT COMPLETED|Open Label Treatment (OL) Period||10
6299571|NCT00327470|7201901|FG000|STARTED|Overall Study||107
6299572|NCT00327470|7201902|FG001|STARTED|Overall Study||181
6299573|NCT00327470|7201901|FG000|Treated|Overall Study||107
6299574|NCT00327470|7201902|FG001|Treated|Overall Study||179
6299575|NCT00327470|7201901|FG000|COMPLETED|Overall Study||78
6299576|NCT00327470|7201902|FG001|COMPLETED|Overall Study||118
6299577|NCT00327470|7201901|FG000|NOT COMPLETED|Overall Study||29
6299578|NCT00327470|7201902|FG001|NOT COMPLETED|Overall Study||63
6299579|NCT00327717|7201910|FG000|STARTED|Overall Study||120
6299580|NCT00327717|7201911|FG001|STARTED|Overall Study||120
6299581|NCT00327717|7201910|FG000|COMPLETED|Overall Study||111
6299582|NCT00327717|7201911|FG001|COMPLETED|Overall Study||106
6299583|NCT00327717|7201910|FG000|NOT COMPLETED|Overall Study||9
6299584|NCT00327717|7201911|FG001|NOT COMPLETED|Overall Study||14
6299585|NCT00328016|7201919|FG000|STARTED|Overall Study||23
6299586|NCT00328016|7201920|FG001|STARTED|Overall Study||21
6299587|NCT00328016|7201919|FG000|COMPLETED|Overall Study||23
6299588|NCT00328016|7201920|FG001|COMPLETED|Overall Study||21
6299589|NCT00328016|7201919|FG000|NOT COMPLETED|Overall Study||0
6299590|NCT00328016|7201920|FG001|NOT COMPLETED|Overall Study||0
6299591|NCT00328042|7201929|FG000|STARTED|Overall Study||69
6299592|NCT00328042|7201930|FG001|STARTED|Overall Study||65
6299593|NCT00328042|7201929|FG000|COMPLETED|Overall Study||69
6299594|NCT00328042|7201930|FG001|COMPLETED|Overall Study||63
6299595|NCT00328042|7201929|FG000|NOT COMPLETED|Overall Study||0
6299596|NCT00328042|7201930|FG001|NOT COMPLETED|Overall Study||2
6299597|NCT00328094|7201940|FG000|STARTED|Overall Study||117
6299598|NCT00328094|7201941|FG001|STARTED|Overall Study||125
6299599|NCT00328094|7201940|FG000|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
6299600|NCT00328094|7201941|FG001|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
6299601|NCT00328094|7201940|FG000|NOT COMPLETED|Overall Study||3
6299602|NCT00328094|7201941|FG001|NOT COMPLETED|Overall Study||3
6299603|NCT00328172|7201952|FG000|STARTED|Overall Study||67
6299604|NCT00328172|7201953|FG001|STARTED|Overall Study||58
6299605|NCT00328172|7201954|FG002|STARTED|Overall Study||57
6299606|NCT00328172|7201955|FG003|STARTED|Overall Study||55
6299607|NCT00328172|7201956|FG004|STARTED|Overall Study||65
6299608|NCT00328172|7201952|FG000|COMPLETED|Overall Study||45
6299609|NCT00328172|7201953|FG001|COMPLETED|Overall Study||44
6299610|NCT00328172|7201954|FG002|COMPLETED|Overall Study||47
6299611|NCT00328172|7201955|FG003|COMPLETED|Overall Study||42
6299612|NCT00328172|7201956|FG004|COMPLETED|Overall Study||60
6299613|NCT00328172|7201952|FG000|NOT COMPLETED|Overall Study||22
6299614|NCT00328172|7201953|FG001|NOT COMPLETED|Overall Study||14
6299615|NCT00328172|7201954|FG002|NOT COMPLETED|Overall Study||10
6299616|NCT00328172|7201955|FG003|NOT COMPLETED|Overall Study||13
6299617|NCT00328172|7201956|FG004|NOT COMPLETED|Overall Study||5
6299618|NCT00328198|7201968|FG000|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
6299619|NCT00328198|7201968|FG000|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
6299620|NCT00328198|7201968|FG000|NOT COMPLETED|Treatment||38
6299621|NCT00328198|7201968|FG000|STARTED|Follow-up|Eight participants did not enter Follow-up|78
6299622|NCT00328198|7201968|FG000|COMPLETED|Follow-up||43
6299623|NCT00328198|7201968|FG000|NOT COMPLETED|Follow-up||35
6299624|NCT00328263|7201974|FG000|STARTED|Overall Study||216
6299625|NCT00328263|7201975|FG001|STARTED|Overall Study||221
6299626|NCT00328263|7201974|FG000|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
6299627|NCT00328263|7201975|FG001|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
6299628|NCT00328263|7201974|FG000|NOT COMPLETED|Overall Study||3
6299629|NCT00328263|7201975|FG001|NOT COMPLETED|Overall Study||4
6299630|NCT00328510|7201983|FG000|STARTED|Overall Study||42
6299631|NCT00328510|7201984|FG001|STARTED|Overall Study||41
6299632|NCT00328510|7201983|FG000|COMPLETED|Overall Study||32
6299633|NCT00328510|7201984|FG001|COMPLETED|Overall Study||37
6299634|NCT00328510|7201983|FG000|NOT COMPLETED|Overall Study||10
6299635|NCT00328510|7201984|FG001|NOT COMPLETED|Overall Study||4
6299636|NCT00328562|7201990|FG000|STARTED|Overall Study||13
6299637|NCT00328562|7201990|FG000|COMPLETED|Overall Study||12
6299638|NCT00328562|7201990|FG000|NOT COMPLETED|Overall Study||1
6299639|NCT00328614|7202000|FG000|STARTED|Overall Study||4
6299640|NCT00328614|7202001|FG001|STARTED|Overall Study||4
6299641|NCT00328614|7202002|FG002|STARTED|Overall Study||6
6299642|NCT00328614|7202003|FG003|STARTED|Overall Study||6
6299643|NCT00328614|7202004|FG004|STARTED|Overall Study||6
6299644|NCT00328614|7202005|FG005|STARTED|Overall Study||6
6299645|NCT00328614|7202000|FG000|COMPLETED|Overall Study||4
6299646|NCT00328614|7202001|FG001|COMPLETED|Overall Study||4
6299647|NCT00328614|7202002|FG002|COMPLETED|Overall Study||6
6299648|NCT00328614|7202003|FG003|COMPLETED|Overall Study||5
6299649|NCT00328614|7202004|FG004|COMPLETED|Overall Study||5
6299650|NCT00328614|7202005|FG005|COMPLETED|Overall Study||5
6299651|NCT00328614|7202000|FG000|NOT COMPLETED|Overall Study||0
6299652|NCT00328614|7202001|FG001|NOT COMPLETED|Overall Study||0
6299653|NCT00328614|7202002|FG002|NOT COMPLETED|Overall Study||0
6299654|NCT00328614|7202003|FG003|NOT COMPLETED|Overall Study||1
6299655|NCT00328614|7202004|FG004|NOT COMPLETED|Overall Study||1
6299656|NCT00328614|7202005|FG005|NOT COMPLETED|Overall Study||1
6299657|NCT00328627|7202026|FG000|STARTED|Overall Study||129
6299658|NCT00328627|7202027|FG001|STARTED|Overall Study||128
6299659|NCT00328627|7202028|FG002|STARTED|Overall Study||129
6299660|NCT00328627|7202029|FG003|STARTED|Overall Study||130
6299661|NCT00328627|7202030|FG004|STARTED|Overall Study||130
6299662|NCT00328627|7202031|FG005|STARTED|Overall Study||130
6299663|NCT00328627|7202032|FG006|STARTED|Overall Study||129
6299664|NCT00328627|7202033|FG007|STARTED|Overall Study||130
6299665|NCT00328627|7202034|FG008|STARTED|Overall Study||130
6299666|NCT00328627|7202035|FG009|STARTED|Overall Study||129
6299667|NCT00328627|7202036|FG010|STARTED|Overall Study||130
6299668|NCT00328627|7202037|FG011|STARTED|Overall Study||130
6299669|NCT00328627|7202026|FG000|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
6299670|NCT00328627|7202027|FG001|Safety Set|Overall Study||128
6299671|NCT00328627|7202028|FG002|Safety Set|Overall Study||129
6299672|NCT00328627|7202029|FG003|Safety Set|Overall Study||129
6299673|NCT00328627|7202030|FG004|Safety Set|Overall Study||130
6299674|NCT00328627|7202031|FG005|Safety Set|Overall Study||130
6299675|NCT00328627|7202032|FG006|Safety Set|Overall Study||129
6299676|NCT00328627|7202033|FG007|Safety Set|Overall Study||130
6635173|NCT02302157|7564042|FG001|COMPLETED|Overall Study||6
6635174|NCT02302157|7564043|FG002|COMPLETED|Overall Study||6
6635175|NCT02302157|7564044|FG003|COMPLETED|Overall Study||6
6635176|NCT02302157|7564045|FG004|COMPLETED|Overall Study||4
6635177|NCT02302157|7564041|FG000|NOT COMPLETED|Overall Study||0
6635178|NCT02302157|7564042|FG001|NOT COMPLETED|Overall Study||0
6299677|NCT00328627|7202034|FG008|Safety Set|Overall Study||130
6299678|NCT00328627|7202035|FG009|Safety Set|Overall Study||129
6299679|NCT00328627|7202036|FG010|Safety Set|Overall Study||130
6299680|NCT00328627|7202037|FG011|Safety Set|Overall Study||130
6299681|NCT00328627|7202026|FG000|COMPLETED|Overall Study||70
6299682|NCT00328627|7202027|FG001|COMPLETED|Overall Study||97
6299683|NCT00328627|7202028|FG002|COMPLETED|Overall Study||101
6299684|NCT00328627|7202029|FG003|COMPLETED|Overall Study||93
6299685|NCT00328627|7202030|FG004|COMPLETED|Overall Study||115
6299686|NCT00328627|7202031|FG005|COMPLETED|Overall Study||110
6299687|NCT00328627|7202032|FG006|COMPLETED|Overall Study||94
6299688|NCT00328627|7202033|FG007|COMPLETED|Overall Study||116
6299689|NCT00328627|7202034|FG008|COMPLETED|Overall Study||113
6299690|NCT00328627|7202035|FG009|COMPLETED|Overall Study||97
6299691|NCT00328627|7202036|FG010|COMPLETED|Overall Study||112
6635179|NCT02302157|7564043|FG002|NOT COMPLETED|Overall Study||0
6635180|NCT02302157|7564044|FG003|NOT COMPLETED|Overall Study||0
6635181|NCT02302157|7564045|FG004|NOT COMPLETED|Overall Study||0
6743358|NCT03334448|7671663|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
6299692|NCT00328627|7202037|FG011|COMPLETED|Overall Study||114
6299693|NCT00328627|7202026|FG000|NOT COMPLETED|Overall Study||59
6299694|NCT00328627|7202027|FG001|NOT COMPLETED|Overall Study||31
6299695|NCT00328627|7202028|FG002|NOT COMPLETED|Overall Study||28
6299696|NCT00328627|7202029|FG003|NOT COMPLETED|Overall Study||37
6299697|NCT00328627|7202030|FG004|NOT COMPLETED|Overall Study||15
6299698|NCT00328627|7202031|FG005|NOT COMPLETED|Overall Study||20
6299699|NCT00328627|7202032|FG006|NOT COMPLETED|Overall Study||35
6299700|NCT00328627|7202033|FG007|NOT COMPLETED|Overall Study||14
6299701|NCT00328627|7202034|FG008|NOT COMPLETED|Overall Study||17
6299702|NCT00328627|7202035|FG009|NOT COMPLETED|Overall Study||32
6299703|NCT00328627|7202036|FG010|NOT COMPLETED|Overall Study||18
6299704|NCT00328627|7202037|FG011|NOT COMPLETED|Overall Study||16
6299705|NCT00328770|7202071|FG000|STARTED|Overall Study||70
6299706|NCT00328770|7202071|FG000|COMPLETED|Overall Study||70
6299707|NCT00328770|7202071|FG000|NOT COMPLETED|Overall Study||0
6299708|NCT00328783|7202076|FG000|STARTED|Overall Study||112
6299709|NCT00328783|7202076|FG000|COMPLETED|Overall Study||86
6299710|NCT00328783|7202076|FG000|NOT COMPLETED|Overall Study||26
6635182|NCT02302222|7564064|FG000|STARTED|Overall Study||34
6743359|NCT03334448|7671660|FG000|COMPLETED|Period 1||12
6299711|NCT00328861|7202084|FG000|STARTED|Overall Study||7
6299712|NCT00328861|7202085|FG001|STARTED|Overall Study||1
6299713|NCT00328861|7202084|FG000|COMPLETED|Overall Study||7
6299714|NCT00328861|7202085|FG001|COMPLETED|Overall Study||1
6299715|NCT00328861|7202084|FG000|NOT COMPLETED|Overall Study||0
6299716|NCT00328861|7202085|FG001|NOT COMPLETED|Overall Study||0
6299717|NCT00328926|7202094|FG000|STARTED|Overall Study||5
6299718|NCT00328926|7202095|FG001|STARTED|Overall Study||3
6299719|NCT00328926|7202096|FG002|STARTED|Overall Study||3
6299720|NCT00328926|7202094|FG000|COMPLETED|Overall Study||3
6299721|NCT00328926|7202095|FG001|COMPLETED|Overall Study||0
6299722|NCT00328926|7202096|FG002|COMPLETED|Overall Study||1
6299723|NCT00328926|7202094|FG000|NOT COMPLETED|Overall Study||2
6299724|NCT00328926|7202095|FG001|NOT COMPLETED|Overall Study||3
6299725|NCT00328926|7202096|FG002|NOT COMPLETED|Overall Study||2
6299726|NCT00329030|7202106|FG000|STARTED|Overall Study||111
6299727|NCT00329030|7202107|FG001|STARTED|Overall Study||113
6299728|NCT00329030|7202106|FG000|COMPLETED|Overall Study||103
6299729|NCT00329030|7202107|FG001|COMPLETED|Overall Study||107
6299730|NCT00329030|7202106|FG000|NOT COMPLETED|Overall Study||8
6299731|NCT00329030|7202107|FG001|NOT COMPLETED|Overall Study||6
6299732|NCT00329160|7202113|FG000|STARTED|Overall Study||214
6299733|NCT00329160|7202113|FG000|Observation Period|Overall Study||214
6299734|NCT00329160|7202113|FG000|Treatment Period|Overall Study||214
6299735|NCT00329160|7202113|FG000|COMPLETED|Overall Study||126
6299736|NCT00329160|7202113|FG000|NOT COMPLETED|Overall Study||88
6299737|NCT00329238|7202119|FG000|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
6299738|NCT00329238|7202120|FG001|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
6299739|NCT00329238|7202119|FG000|COMPLETED|Overall Study||1154
6299740|NCT00329238|7202120|FG001|COMPLETED|Overall Study||1145
6299741|NCT00329238|7202119|FG000|NOT COMPLETED|Overall Study||276
6299742|NCT00329238|7202120|FG001|NOT COMPLETED|Overall Study||281
6299743|NCT00329303|7202130|FG000|STARTED|Overall Study||34
6299744|NCT00329303|7202131|FG001|STARTED|Overall Study||37
6299745|NCT00329303|7202130|FG000|COMPLETED|Overall Study||32
6299746|NCT00329303|7202131|FG001|COMPLETED|Overall Study||35
6299747|NCT00329303|7202130|FG000|NOT COMPLETED|Overall Study||2
6299748|NCT00329303|7202131|FG001|NOT COMPLETED|Overall Study||2
6299749|NCT00329407|7202138|FG000|STARTED|Overall Study||10
6299750|NCT00329407|7202138|FG000|COMPLETED|Overall Study||9
6299751|NCT00329407|7202138|FG000|NOT COMPLETED|Overall Study||1
6299752|NCT00329420|7202145|FG000|STARTED|Re-induction Phase||18
6299753|NCT00329420|7202146|FG001|STARTED|Re-induction Phase||13
6299754|NCT00329420|7202147|FG002|STARTED|Re-induction Phase||15
6299755|NCT00329420|7202145|FG000|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
6299756|NCT00329420|7202146|FG001|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
6299757|NCT00329420|7202147|FG002|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
6299758|NCT00329420|7202145|FG000|NOT COMPLETED|Re-induction Phase||6
6299759|NCT00329420|7202146|FG001|NOT COMPLETED|Re-induction Phase||6
6299760|NCT00329420|7202147|FG002|NOT COMPLETED|Re-induction Phase||8
6299761|NCT00329420|7202145|FG000|STARTED|4-weekly Dosing Phase (Responders Only)||12
6299762|NCT00329420|7202146|FG001|STARTED|4-weekly Dosing Phase (Responders Only)||7
6299763|NCT00329420|7202147|FG002|STARTED|4-weekly Dosing Phase (Responders Only)||7
6299764|NCT00329420|7202145|FG000|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
6299765|NCT00329420|7202146|FG001|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
6299766|NCT00329420|7202147|FG002|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
6299767|NCT00329420|7202145|FG000|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
6299768|NCT00329420|7202146|FG001|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
6299769|NCT00329420|7202147|FG002|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
6299770|NCT00329433|7202159|FG000|STARTED|Overall Study||61
6299771|NCT00329433|7202160|FG001|STARTED|Overall Study||59
6299772|NCT00329433|7202159|FG000|COMPLETED|Overall Study||61
6299773|NCT00329433|7202160|FG001|COMPLETED|Overall Study||59
6299774|NCT00329433|7202159|FG000|NOT COMPLETED|Overall Study||0
6299775|NCT00329433|7202160|FG001|NOT COMPLETED|Overall Study||0
6299776|NCT00329524|7202166|FG000|STARTED|Overall Study||5
6299777|NCT00329524|7202166|FG000|COMPLETED|Overall Study||5
6299778|NCT00329524|7202166|FG000|NOT COMPLETED|Overall Study||0
6299779|NCT00329550|7202173|FG000|STARTED|Overall Study||9
6299780|NCT00329550|7202174|FG001|STARTED|Overall Study||15
6299781|NCT00329550|7202175|FG002|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
6299782|NCT00329550|7202173|FG000|COMPLETED|Overall Study||5
6299783|NCT00329550|7202174|FG001|COMPLETED|Overall Study||11
6299784|NCT00329550|7202175|FG002|COMPLETED|Overall Study||12
6299785|NCT00329550|7202173|FG000|NOT COMPLETED|Overall Study||4
6299786|NCT00329550|7202174|FG001|NOT COMPLETED|Overall Study||4
6299787|NCT00329550|7202175|FG002|NOT COMPLETED|Overall Study||4
6299788|NCT00329602|7202187|FG000|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
6299789|NCT00329602|7202188|FG001|STARTED|26-Week Double-Blind Treatment Phase||197
6299790|NCT00329602|7202189|FG002|STARTED|26-Week Double-Blind Treatment Phase||0
6299791|NCT00329602|7202187|FG000|COMPLETED|26-Week Double-Blind Treatment Phase||88
6299792|NCT00329602|7202188|FG001|COMPLETED|26-Week Double-Blind Treatment Phase||98
6299793|NCT00329602|7202189|FG002|COMPLETED|26-Week Double-Blind Treatment Phase||0
6299794|NCT00329602|7202187|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
6299795|NCT00329602|7202188|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
6299796|NCT00329602|7202189|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
6299797|NCT00329602|7202187|FG000|STARTED|40-Week Open-Label Treatment Phase||0
6299798|NCT00329602|7202188|FG001|STARTED|40-Week Open-Label Treatment Phase||0
6299799|NCT00329602|7202189|FG002|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
6299800|NCT00329602|7202187|FG000|COMPLETED|40-Week Open-Label Treatment Phase||0
6299801|NCT00329602|7202188|FG001|COMPLETED|40-Week Open-Label Treatment Phase||0
6299802|NCT00329602|7202189|FG002|COMPLETED|40-Week Open-Label Treatment Phase||233
6299803|NCT00329602|7202187|FG000|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
6299804|NCT00329602|7202188|FG001|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
6299805|NCT00329602|7202189|FG002|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
6299806|NCT00329641|7202205|FG000|STARTED|Overall Study||25
6299807|NCT00329641|7202205|FG000|Eligible|Overall Study||25
6299808|NCT00329641|7202205|FG000|Eligible and Received Treatment|Overall Study||24
6299809|NCT00329641|7202205|FG000|COMPLETED|Overall Study||19
6299810|NCT00329641|7202205|FG000|NOT COMPLETED|Overall Study||6
6299811|NCT00329719|7202214|FG000|STARTED|Overall Study||12
6299812|NCT00329719|7202215|FG001|STARTED|Overall Study||49
6299813|NCT00329719|7202216|FG002|STARTED|Overall Study||9
6299814|NCT00329719|7202217|FG003|STARTED|Overall Study||45
6299815|NCT00329719|7202214|FG000|COMPLETED|Overall Study||12
6299816|NCT00329719|7202215|FG001|COMPLETED|Overall Study||49
6299817|NCT00329719|7202216|FG002|COMPLETED|Overall Study||9
6299818|NCT00329719|7202217|FG003|COMPLETED|Overall Study||44
6299819|NCT00329719|7202214|FG000|NOT COMPLETED|Overall Study||0
6299820|NCT00329719|7202215|FG001|NOT COMPLETED|Overall Study||0
6299821|NCT00329719|7202216|FG002|NOT COMPLETED|Overall Study||0
6299822|NCT00329719|7202217|FG003|NOT COMPLETED|Overall Study||1
6299823|NCT00329745|7202229|FG000|STARTED|Overall Study||4359
6299824|NCT00329745|7202230|FG001|STARTED|Overall Study||4328
6299825|NCT00329745|7202229|FG000|COMPLETED|Overall Study||4272
6299826|NCT00329745|7202230|FG001|COMPLETED|Overall Study||4226
6299827|NCT00329745|7202229|FG000|NOT COMPLETED|Overall Study||87
6299828|NCT00329745|7202230|FG001|NOT COMPLETED|Overall Study||102
6299829|NCT00329771|7202236|FG000|STARTED|Overall Study||28
6299830|NCT00329771|7202236|FG000|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
6299831|NCT00329771|7202236|FG000|NOT COMPLETED|Overall Study||3
6299832|NCT00329784|7202244|FG000|STARTED|Overall Study||270
6299833|NCT00329784|7202245|FG001|STARTED|Overall Study||272
6299834|NCT00329784|7202246|FG002|STARTED|Overall Study||51
6299835|NCT00329784|7202247|FG003|STARTED|Overall Study||47
6299836|NCT00329784|7202244|FG000|COMPLETED|Overall Study||265
6299837|NCT00329784|7202245|FG001|COMPLETED|Overall Study||267
6299838|NCT00329784|7202246|FG002|COMPLETED|Overall Study||51
6299839|NCT00329784|7202247|FG003|COMPLETED|Overall Study||47
6299840|NCT00329784|7202244|FG000|NOT COMPLETED|Overall Study||5
6299841|NCT00329784|7202245|FG001|NOT COMPLETED|Overall Study||5
6299842|NCT00329784|7202246|FG002|NOT COMPLETED|Overall Study||0
6299843|NCT00329784|7202247|FG003|NOT COMPLETED|Overall Study||0
6299844|NCT00329797|7202261|FG000|STARTED|Overall Study||57
6299845|NCT00329797|7202262|FG001|STARTED|Overall Study||52
6299846|NCT00329797|7202261|FG000|COMPLETED|Overall Study||50
6299847|NCT00329797|7202262|FG001|COMPLETED|Overall Study||46
6299848|NCT00329797|7202261|FG000|NOT COMPLETED|Overall Study||7
6299849|NCT00329797|7202262|FG001|NOT COMPLETED|Overall Study||6
6299850|NCT00329836|7202268|FG000|STARTED|Overall Study||41
6299851|NCT00329836|7202268|FG000|COMPLETED|Overall Study||41
6299852|NCT00329836|7202268|FG000|NOT COMPLETED|Overall Study||0
6299853|NCT00329849|7202274|FG000|STARTED|Overall Study||950
6299854|NCT00329849|7202275|FG001|STARTED|Overall Study||550
6299855|NCT00329849|7202274|FG000|COMPLETED|Overall Study||944
6299856|NCT00329849|7202275|FG001|COMPLETED|Overall Study||546
6299857|NCT00329849|7202274|FG000|NOT COMPLETED|Overall Study||6
6299858|NCT00329849|7202275|FG001|NOT COMPLETED|Overall Study||4
6299859|NCT00329901|7202288|FG000|STARTED|Overall Study||361
6299860|NCT00329901|7202289|FG001|STARTED|Overall Study||354
6299861|NCT00329901|7202290|FG002|STARTED|Overall Study||357
6299862|NCT00329901|7202288|FG000|COMPLETED|Overall Study||352
6299863|NCT00329901|7202289|FG001|COMPLETED|Overall Study||349
6299864|NCT00329901|7202290|FG002|COMPLETED|Overall Study||353
6299865|NCT00329901|7202288|FG000|NOT COMPLETED|Overall Study||9
6299866|NCT00329901|7202289|FG001|NOT COMPLETED|Overall Study||5
6299867|NCT00329901|7202290|FG002|NOT COMPLETED|Overall Study||4
6299868|NCT00330161|7202302|FG000|STARTED|Overall Study||29
6299869|NCT00330161|7202302|FG000|COMPLETED|Overall Study||29
6299870|NCT00330161|7202302|FG000|NOT COMPLETED|Overall Study||0
6299871|NCT00330174|7202308|FG000|STARTED|Overall Study||45
6299872|NCT00330174|7202309|FG001|STARTED|Overall Study||45
6299873|NCT00330174|7202308|FG000|COMPLETED|Overall Study||23
6299874|NCT00330174|7202309|FG001|COMPLETED|Overall Study||26
6299875|NCT00330174|7202308|FG000|NOT COMPLETED|Overall Study||22
6299876|NCT00330174|7202309|FG001|NOT COMPLETED|Overall Study||19
6299877|NCT00330187|7202319|FG000|STARTED|Overall Study||37
6299878|NCT00330187|7202320|FG001|STARTED|Overall Study||36
6299879|NCT00330187|7202321|FG002|STARTED|Overall Study||29
6299880|NCT00330187|7202322|FG003|STARTED|Overall Study||32
6299881|NCT00330187|7202319|FG000|COMPLETED|Overall Study||17
6299882|NCT00330187|7202320|FG001|COMPLETED|Overall Study||18
6299883|NCT00330187|7202321|FG002|COMPLETED|Overall Study||11
6299884|NCT00330187|7202322|FG003|COMPLETED|Overall Study||18
6299885|NCT00330187|7202319|FG000|NOT COMPLETED|Overall Study||20
6299886|NCT00330187|7202320|FG001|NOT COMPLETED|Overall Study||18
6299887|NCT00330187|7202321|FG002|NOT COMPLETED|Overall Study||18
6299888|NCT00330187|7202322|FG003|NOT COMPLETED|Overall Study||14
6299889|NCT00330343|7202332|FG000|STARTED|Overall Study||64
6299890|NCT00330343|7202332|FG000|COMPLETED|Overall Study||59
6299891|NCT00330343|7202332|FG000|NOT COMPLETED|Overall Study||5
6299892|NCT00330382|7202338|FG000|STARTED|Overall Study||67
6299893|NCT00330382|7202339|FG001|STARTED|Overall Study||65
6299894|NCT00330382|7202338|FG000|COMPLETED|Overall Study||43
6299895|NCT00330382|7202339|FG001|COMPLETED|Overall Study||48
6299896|NCT00330382|7202338|FG000|NOT COMPLETED|Overall Study||24
6299897|NCT00330382|7202339|FG001|NOT COMPLETED|Overall Study||17
6299898|NCT00330421|7202346|FG000|STARTED|Overall Study||15
6299899|NCT00330421|7202347|FG001|STARTED|Overall Study||0
6299900|NCT00330421|7202346|FG000|COMPLETED|Overall Study||15
6299901|NCT00330421|7202347|FG001|COMPLETED|Overall Study||0
6299902|NCT00330421|7202346|FG000|NOT COMPLETED|Overall Study||0
6299903|NCT00330421|7202347|FG001|NOT COMPLETED|Overall Study||0
6299904|NCT00330460|7202353|FG000|STARTED|Overall Study||595
6299905|NCT00330460|7202354|FG001|STARTED|Overall Study||594
6299906|NCT00330460|7202353|FG000|COMPLETED|Overall Study||553
6299907|NCT00330460|7202354|FG001|COMPLETED|Overall Study||561
6299908|NCT00330460|7202353|FG000|NOT COMPLETED|Overall Study||42
6299909|NCT00330460|7202354|FG001|NOT COMPLETED|Overall Study||33
6299910|NCT00330551|7202362|FG000|STARTED|Overall Study||40
6299911|NCT00330551|7202363|FG001|STARTED|Overall Study||43
6299912|NCT00330551|7202362|FG000|COMPLETED|Overall Study||30
6299913|NCT00330551|7202363|FG001|COMPLETED|Overall Study||27
6299914|NCT00330551|7202362|FG000|NOT COMPLETED|Overall Study||10
6299915|NCT00330551|7202363|FG001|NOT COMPLETED|Overall Study||16
6299916|NCT00330564|7202371|FG000|STARTED|Overall Study||15
6299917|NCT00330564|7202371|FG000|COMPLETED|Overall Study||15
6299918|NCT00330564|7202371|FG000|NOT COMPLETED|Overall Study||0
6299919|NCT00330616|7202375|FG000|STARTED|Overall Study||35
6299920|NCT00330616|7202375|FG000|COMPLETED|Overall Study||14
6299921|NCT00330616|7202375|FG000|NOT COMPLETED|Overall Study||21
6299922|NCT00330668|7202379|FG000|STARTED|BID Dosing Period||114
6299923|NCT00330668|7202379|FG000|COMPLETED|BID Dosing Period||78
6299924|NCT00330668|7202379|FG000|NOT COMPLETED|BID Dosing Period||36
6299925|NCT00330668|7202379|FG000|STARTED|QD Dosing Period||78
6299926|NCT00330668|7202379|FG000|COMPLETED|QD Dosing Period||0
6299927|NCT00330668|7202379|FG000|NOT COMPLETED|QD Dosing Period||78
6299928|NCT00330681|7202385|FG000|STARTED|Overall Study||102
6299929|NCT00330681|7202386|FG001|STARTED|Overall Study||104
6299930|NCT00330681|7202385|FG000|COMPLETED|Overall Study||93
6299931|NCT00330681|7202386|FG001|COMPLETED|Overall Study||90
6299932|NCT00330681|7202385|FG000|NOT COMPLETED|Overall Study||9
6299933|NCT00330681|7202386|FG001|NOT COMPLETED|Overall Study||14
6299934|NCT00330733|7202394|FG000|STARTED|Overall Study||37
6299935|NCT00330733|7202395|FG001|STARTED|Overall Study||34
6299936|NCT00330733|7202394|FG000|Received Study Medication|Overall Study||36
6299937|NCT00330733|7202395|FG001|Received Study Medication|Overall Study||34
6299938|NCT00330733|7202394|FG000|COMPLETED|Overall Study||30
6299939|NCT00330733|7202395|FG001|COMPLETED|Overall Study||29
6299940|NCT00330733|7202394|FG000|NOT COMPLETED|Overall Study||7
6299941|NCT00330733|7202395|FG001|NOT COMPLETED|Overall Study||5
6299942|NCT00330759|7202403|FG000|STARTED|Overall Study||890
6299943|NCT00330759|7202404|FG001|STARTED|Overall Study||886
6299944|NCT00330759|7202403|FG000|Received Investigational Product|Overall Study||878
6299945|NCT00330759|7202404|FG001|Received Investigational Product|Overall Study||878
6299946|NCT00330759|7202403|FG000|COMPLETED|Overall Study||178
6299947|NCT00330759|7202404|FG001|COMPLETED|Overall Study||180
6299948|NCT00330759|7202403|FG000|NOT COMPLETED|Overall Study||712
6299949|NCT00330759|7202404|FG001|NOT COMPLETED|Overall Study||706
6299950|NCT00330863|7202412|FG000|STARTED|Overall Study||153
6299951|NCT00330863|7202413|FG001|STARTED|Overall Study||152
6299952|NCT00330863|7202412|FG000|COMPLETED|Overall Study||72
6299953|NCT00330863|7202413|FG001|COMPLETED|Overall Study||72
6299954|NCT00330863|7202412|FG000|NOT COMPLETED|Overall Study||81
6299955|NCT00330863|7202413|FG001|NOT COMPLETED|Overall Study||80
6299956|NCT00330876|7202419|FG000|STARTED|Overall Study||449
6299957|NCT00330876|7202420|FG001|STARTED|Overall Study||90
6299958|NCT00330876|7202419|FG000|COMPLETED|Overall Study||378
6299959|NCT00330876|7202420|FG001|COMPLETED|Overall Study||77
6299960|NCT00330876|7202419|FG000|NOT COMPLETED|Overall Study||71
6299961|NCT00330876|7202420|FG001|NOT COMPLETED|Overall Study||13
6299962|NCT00330915|7202426|FG000|STARTED|Overall Study||37
6299963|NCT00330915|7202426|FG000|COMPLETED|Overall Study||37
6299964|NCT00330915|7202426|FG000|NOT COMPLETED|Overall Study||0
6299965|NCT00330928|7202430|FG000|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
6299966|NCT00330928|7202430|FG000|7 Day Phone Contact|Overall Study||99
6299967|NCT00330928|7202430|FG000|1 Year Phone Contact|Overall Study||89
6299968|NCT00330928|7202430|FG000|COMPLETED|Overall Study||89
6299969|NCT00330928|7202430|FG000|NOT COMPLETED|Overall Study||17
6299970|NCT00330967|7202436|FG000|STARTED|Overall Study||0
6299971|NCT00330967|7202437|FG001|STARTED|Overall Study||25
6299972|NCT00330967|7202436|FG000|COMPLETED|Overall Study||0
6299973|NCT00330967|7202437|FG001|COMPLETED|Overall Study||11
6299974|NCT00330967|7202436|FG000|NOT COMPLETED|Overall Study||0
6299975|NCT00330967|7202437|FG001|NOT COMPLETED|Overall Study||14
6299976|NCT00331006|7202443|FG000|STARTED|Screening Phase||23
6299977|NCT00331006|7202443|FG000|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
6299978|NCT00331006|7202443|FG000|NOT COMPLETED|Screening Phase||7
6299979|NCT00331006|7202443|FG000|STARTED|Treatment Phase||16
6299980|NCT00331006|7202443|FG000|COMPLETED|Treatment Phase||15
6299981|NCT00331006|7202443|FG000|NOT COMPLETED|Treatment Phase||1
6299982|NCT00331006|7202443|FG000|STARTED|Follow-Up Phase I||15
6299983|NCT00331006|7202443|FG000|COMPLETED|Follow-Up Phase I||14
6299984|NCT00331006|7202443|FG000|NOT COMPLETED|Follow-Up Phase I||1
6299985|NCT00331006|7202443|FG000|STARTED|Follow-Up Phase II||14
6299986|NCT00331006|7202443|FG000|COMPLETED|Follow-Up Phase II||11
6299987|NCT00331006|7202443|FG000|NOT COMPLETED|Follow-Up Phase II||3
6299988|NCT00331136|7202451|FG000|STARTED|Overall Study||15
6299989|NCT00331136|7202452|FG001|STARTED|Overall Study||15
6299990|NCT00331136|7202453|FG002|STARTED|Overall Study||15
6299991|NCT00331136|7202454|FG003|STARTED|Overall Study||15
6401188|NCT00891176|7314100|FG001|COMPLETED|At 4 Years of Age||142
6401189|NCT00891176|7314101|FG002|COMPLETED|At 4 Years of Age||142
6401190|NCT00891176|7314102|FG003|COMPLETED|At 4 Years of Age||137
6401191|NCT00891176|7314099|FG000|NOT COMPLETED|At 4 Years of Age||0
6299992|NCT00331136|7202451|FG000|COMPLETED|Overall Study||10
6299993|NCT00331136|7202452|FG001|COMPLETED|Overall Study||8
6299994|NCT00331136|7202453|FG002|COMPLETED|Overall Study||15
6299995|NCT00331136|7202454|FG003|COMPLETED|Overall Study||14
6299996|NCT00331136|7202451|FG000|NOT COMPLETED|Overall Study||5
6299997|NCT00331136|7202452|FG001|NOT COMPLETED|Overall Study||7
6299998|NCT00331136|7202453|FG002|NOT COMPLETED|Overall Study||0
6299999|NCT00331136|7202454|FG003|NOT COMPLETED|Overall Study||1
6300000|NCT00331162|7202466|FG000|STARTED|Overall Study||113
6300001|NCT00331162|7202467|FG001|STARTED|Overall Study||109
6300002|NCT00331162|7202466|FG000|COMPLETED|Overall Study||113
6300003|NCT00331162|7202467|FG001|COMPLETED|Overall Study||109
6300004|NCT00331162|7202466|FG000|NOT COMPLETED|Overall Study||0
6300005|NCT00331162|7202467|FG001|NOT COMPLETED|Overall Study||0
6300006|NCT00331344|7202473|FG000|STARTED|Phase I||3
6300007|NCT00331344|7202474|FG001|STARTED|Phase I||3
6300008|NCT00331344|7202475|FG002|STARTED|Phase I||3
6300009|NCT00331344|7202476|FG003|STARTED|Phase I||6
6300010|NCT00331344|7202477|FG004|STARTED|Phase I||6
6300011|NCT00331344|7202478|FG005|STARTED|Phase I||5
6300012|NCT00331344|7202479|FG006|STARTED|Phase I||4
6300013|NCT00331344|7202480|FG007|STARTED|Phase I|1 participant who was enrolled died prior to initiating protocol therapy.|6
6300014|NCT00331344|7202481|FG008|STARTED|Phase I||0
6300015|NCT00331344|7202473|FG000|COMPLETED|Phase I||3
6300016|NCT00331344|7202474|FG001|COMPLETED|Phase I||3
6300017|NCT00331344|7202475|FG002|COMPLETED|Phase I||3
6300018|NCT00331344|7202476|FG003|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
6300019|NCT00331344|7202477|FG004|COMPLETED|Phase I|2 participants reached dose limiting toxicity|4
6300020|NCT00331344|7202478|FG005|COMPLETED|Phase I|2 participants reached dose limiting toxicity|3
6300021|NCT00331344|7202479|FG006|COMPLETED|Phase I||4
6300022|NCT00331344|7202480|FG007|COMPLETED|Phase I|1 participant reached dose limiting toxicity|5
6300023|NCT00331344|7202481|FG008|COMPLETED|Phase I||0
6300024|NCT00331344|7202473|FG000|NOT COMPLETED|Phase I||0
6300025|NCT00331344|7202474|FG001|NOT COMPLETED|Phase I||0
6300026|NCT00331344|7202475|FG002|NOT COMPLETED|Phase I||0
6300027|NCT00331344|7202476|FG003|NOT COMPLETED|Phase I||1
6300028|NCT00331344|7202477|FG004|NOT COMPLETED|Phase I||2
6300029|NCT00331344|7202478|FG005|NOT COMPLETED|Phase I||2
6300030|NCT00331344|7202479|FG006|NOT COMPLETED|Phase I||0
6300031|NCT00331344|7202480|FG007|NOT COMPLETED|Phase I||1
6300032|NCT00331344|7202481|FG008|NOT COMPLETED|Phase I||0
6300033|NCT00331344|7202473|FG000|STARTED|Phase II||0
6300034|NCT00331344|7202474|FG001|STARTED|Phase II||0
6300035|NCT00331344|7202475|FG002|STARTED|Phase II||0
6300036|NCT00331344|7202476|FG003|STARTED|Phase II||0
6300037|NCT00331344|7202477|FG004|STARTED|Phase II||0
6300038|NCT00331344|7202478|FG005|STARTED|Phase II||0
6300039|NCT00331344|7202479|FG006|STARTED|Phase II||0
6300040|NCT00331344|7202480|FG007|STARTED|Phase II|6 patients in Phase I Group VIa continued to the Phase II period.|6
6300041|NCT00331344|7202481|FG008|STARTED|Phase II|Protocol enrollment (63) minus 11 ineligible prior to receiving treatment.|52
6300042|NCT00331344|7202473|FG000|COMPLETED|Phase II||0
6300043|NCT00331344|7202474|FG001|COMPLETED|Phase II||0
6300044|NCT00331344|7202475|FG002|COMPLETED|Phase II||0
6300045|NCT00331344|7202476|FG003|COMPLETED|Phase II||0
6300046|NCT00331344|7202477|FG004|COMPLETED|Phase II||0
6300047|NCT00331344|7202478|FG005|COMPLETED|Phase II||0
6300048|NCT00331344|7202479|FG006|COMPLETED|Phase II||0
6300049|NCT00331344|7202480|FG007|COMPLETED|Phase II||6
6300050|NCT00331344|7202481|FG008|COMPLETED|Phase II||48
6300051|NCT00331344|7202473|FG000|NOT COMPLETED|Phase II||0
6300052|NCT00331344|7202474|FG001|NOT COMPLETED|Phase II||0
6300053|NCT00331344|7202475|FG002|NOT COMPLETED|Phase II||0
6300054|NCT00331344|7202476|FG003|NOT COMPLETED|Phase II||0
6300055|NCT00331344|7202477|FG004|NOT COMPLETED|Phase II||0
6300056|NCT00331344|7202478|FG005|NOT COMPLETED|Phase II||0
6401192|NCT00891176|7314100|FG001|NOT COMPLETED|At 4 Years of Age||0
6300057|NCT00331344|7202479|FG006|NOT COMPLETED|Phase II||0
6300058|NCT00331344|7202480|FG007|NOT COMPLETED|Phase II||0
6300059|NCT00331344|7202481|FG008|NOT COMPLETED|Phase II||4
6300060|NCT00331409|7202494|FG000|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
6300061|NCT00331409|7202494|FG000|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
6300062|NCT00331409|7202494|FG000|NOT COMPLETED|Overall Study||4
6300063|NCT00331422|7202498|FG000|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
6300064|NCT00331422|7202498|FG000|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
6300065|NCT00331422|7202498|FG000|NOT COMPLETED|Overall Study||5
6300066|NCT00331552|7202505|FG000|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
6401193|NCT00891176|7314101|FG002|NOT COMPLETED|At 4 Years of Age||0
6401194|NCT00891176|7314102|FG003|NOT COMPLETED|At 4 Years of Age||0
6401195|NCT00891176|7314099|FG000|STARTED|At 6 Years of Age||131
6401196|NCT00891176|7314100|FG001|STARTED|At 6 Years of Age||138
6401197|NCT00891176|7314101|FG002|STARTED|At 6 Years of Age||135
6401198|NCT00891176|7314102|FG003|STARTED|At 6 Years of Age||135
6401199|NCT00891176|7314099|FG000|COMPLETED|At 6 Years of Age||131
6401200|NCT00891176|7314100|FG001|COMPLETED|At 6 Years of Age||138
6401201|NCT00891176|7314101|FG002|COMPLETED|At 6 Years of Age||135
6401202|NCT00891176|7314102|FG003|COMPLETED|At 6 Years of Age||135
6401203|NCT00891176|7314099|FG000|NOT COMPLETED|At 6 Years of Age||0
6401204|NCT00891176|7314100|FG001|NOT COMPLETED|At 6 Years of Age||0
6401205|NCT00891176|7314101|FG002|NOT COMPLETED|At 6 Years of Age||0
6401206|NCT00891176|7314102|FG003|NOT COMPLETED|At 6 Years of Age||0
6401207|NCT00891202|7314120|FG000|STARTED|PAP (Up To Week 39)||20
6401208|NCT00891202|7314121|FG001|STARTED|PAP (Up To Week 39)||20
6401209|NCT00891202|7314122|FG002|STARTED|PAP (Up To Week 39)||0
6401210|NCT00891202|7314123|FG003|STARTED|PAP (Up To Week 39)||0
6401211|NCT00891202|7314120|FG000|COMPLETED|PAP (Up To Week 39)||19
6401212|NCT00891202|7314121|FG001|COMPLETED|PAP (Up To Week 39)||20
6401213|NCT00891202|7314122|FG002|COMPLETED|PAP (Up To Week 39)||0
6401214|NCT00891202|7314123|FG003|COMPLETED|PAP (Up To Week 39)||0
6401215|NCT00891202|7314120|FG000|NOT COMPLETED|PAP (Up To Week 39)||1
6401216|NCT00891202|7314121|FG001|NOT COMPLETED|PAP (Up To Week 39)||0
6401217|NCT00891202|7314122|FG002|NOT COMPLETED|PAP (Up To Week 39)||0
6401218|NCT00891202|7314123|FG003|NOT COMPLETED|PAP (Up To Week 39)||0
6401219|NCT00891202|7314120|FG000|STARTED|LTTP (Post-Week 39 up to Week 312)||0
6401220|NCT00891202|7314121|FG001|STARTED|LTTP (Post-Week 39 up to Week 312)||0
6401221|NCT00891202|7314122|FG002|STARTED|LTTP (Post-Week 39 up to Week 312)||19
6401222|NCT00891202|7314123|FG003|STARTED|LTTP (Post-Week 39 up to Week 312)||20
6401223|NCT00891202|7314120|FG000|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
6401224|NCT00891202|7314121|FG001|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
6401225|NCT00891202|7314122|FG002|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
6401226|NCT00891202|7314123|FG003|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
6401227|NCT00891202|7314120|FG000|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
6401228|NCT00891202|7314121|FG001|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
6401229|NCT00891202|7314122|FG002|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
6401230|NCT00891202|7314123|FG003|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
6401231|NCT00891228|7314134|FG000|STARTED|Overall Study||32
6401232|NCT00891228|7314135|FG001|STARTED|Overall Study||33
6401233|NCT00891228|7314136|FG002|STARTED|Overall Study||34
6401234|NCT00891228|7314134|FG000|COMPLETED|Overall Study||21
6401235|NCT00891228|7314135|FG001|COMPLETED|Overall Study||20
6401236|NCT00891228|7314136|FG002|COMPLETED|Overall Study||19
6401237|NCT00891228|7314134|FG000|NOT COMPLETED|Overall Study||11
6401238|NCT00891228|7314135|FG001|NOT COMPLETED|Overall Study||13
6401239|NCT00891228|7314136|FG002|NOT COMPLETED|Overall Study||15
6401240|NCT00891293|7314144|FG000|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
6635183|NCT02302222|7564065|FG001|STARTED|Overall Study||37
6635184|NCT02302222|7564064|FG000|COMPLETED|Overall Study||33
6635185|NCT02302222|7564065|FG001|COMPLETED|Overall Study||31
6635186|NCT02302222|7564064|FG000|NOT COMPLETED|Overall Study||1
6635187|NCT02302222|7564065|FG001|NOT COMPLETED|Overall Study||6
6300067|NCT00331552|7202506|FG001|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
6401241|NCT00891293|7314144|FG000|COMPLETED|Overall Study||9
6401242|NCT00891293|7314144|FG000|NOT COMPLETED|Overall Study||84
6401243|NCT00891319|7314150|FG000|STARTED|Overall Study||40
6401244|NCT00891319|7314151|FG001|STARTED|Overall Study||40
6401245|NCT00891319|7314150|FG000|COMPLETED|Overall Study||32
6401246|NCT00891319|7314151|FG001|COMPLETED|Overall Study||40
6401247|NCT00891319|7314150|FG000|NOT COMPLETED|Overall Study||8
6401248|NCT00891319|7314151|FG001|NOT COMPLETED|Overall Study||0
6401249|NCT00891371|7314157|FG000|STARTED|Pre-assignment||42
6401250|NCT00891371|7314157|FG000|COMPLETED|Pre-assignment||36
6401251|NCT00891371|7314157|FG000|NOT COMPLETED|Pre-assignment||6
6401252|NCT00891371|7314157|FG000|STARTED|Treatment||36
6401253|NCT00891371|7314157|FG000|COMPLETED|Treatment||27
6401254|NCT00891371|7314157|FG000|NOT COMPLETED|Treatment||9
6635188|NCT02302339|7564075|FG000|STARTED|Overall Study||62
6635189|NCT02302339|7564076|FG001|STARTED|Overall Study||34
6635190|NCT02302339|7564077|FG002|STARTED|Overall Study||29
6635191|NCT02302339|7564078|FG003|STARTED|Overall Study||7
6635192|NCT02302339|7564075|FG000|COMPLETED|Overall Study||61
6300068|NCT00331552|7202505|FG000|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
6300069|NCT00331552|7202506|FG001|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
6300070|NCT00331552|7202505|FG000|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
6300071|NCT00331552|7202506|FG001|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
6300072|NCT00331552|7202505|FG000|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
6300073|NCT00331552|7202506|FG001|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
6300074|NCT00331552|7202505|FG000|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
6300075|NCT00331552|7202506|FG001|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
6300076|NCT00331552|7202505|FG000|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
6401255|NCT00891436|7314163|FG000|STARTED|Overall Study||10
6401256|NCT00891436|7314164|FG001|STARTED|Overall Study||10
6300077|NCT00331552|7202506|FG001|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
6300078|NCT00331552|7202505|FG000|STARTED|Period 3: Phase II||24
6300079|NCT00331552|7202506|FG001|STARTED|Period 3: Phase II||0
6300080|NCT00331552|7202505|FG000|COMPLETED|Period 3: Phase II||22
6300081|NCT00331552|7202506|FG001|COMPLETED|Period 3: Phase II||0
6300082|NCT00331552|7202505|FG000|NOT COMPLETED|Period 3: Phase II||2
6300083|NCT00331552|7202506|FG001|NOT COMPLETED|Period 3: Phase II||0
6374643|NCT00750308|7285105|FG011|NOT COMPLETED|Fourth Treatment||0
6374644|NCT00750360|7285125|FG000|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
6374645|NCT00750360|7285126|FG001|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
6374646|NCT00750360|7285127|FG002|STARTED|Overall Study||384
6374647|NCT00750360|7285128|FG003|STARTED|Overall Study||79
6374648|NCT00750360|7285129|FG004|STARTED|Overall Study||46
6374649|NCT00750360|7285130|FG005|STARTED|Overall Study||71
6374650|NCT00750360|7285125|FG000|COMPLETED|Overall Study||294
6374651|NCT00750360|7285126|FG001|COMPLETED|Overall Study||1
6374652|NCT00750360|7285127|FG002|COMPLETED|Overall Study||384
6374653|NCT00750360|7285128|FG003|COMPLETED|Overall Study||79
6374654|NCT00750360|7285129|FG004|COMPLETED|Overall Study||46
6374655|NCT00750360|7285130|FG005|COMPLETED|Overall Study||71
6635193|NCT02302339|7564076|FG001|COMPLETED|Overall Study||32
6635194|NCT02302339|7564077|FG002|COMPLETED|Overall Study||28
6635195|NCT02302339|7564078|FG003|COMPLETED|Overall Study||7
6635196|NCT02302339|7564075|FG000|NOT COMPLETED|Overall Study||1
6635197|NCT02302339|7564076|FG001|NOT COMPLETED|Overall Study||2
6635198|NCT02302339|7564077|FG002|NOT COMPLETED|Overall Study||1
6635199|NCT02302339|7564078|FG003|NOT COMPLETED|Overall Study||0
6635200|NCT02302365|7564089|FG000|STARTED|0-2 Hour Period|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
6635201|NCT02302365|7564089|FG000|COMPLETED|0-2 Hour Period|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
6635202|NCT02302365|7564089|FG000|NOT COMPLETED|0-2 Hour Period||2
6655637|NCT02454153|7585790|FG001|COMPLETED|Overall Study||92
6374656|NCT00750360|7285125|FG000|NOT COMPLETED|Overall Study||0
6374657|NCT00750360|7285126|FG001|NOT COMPLETED|Overall Study||0
6374658|NCT00750360|7285127|FG002|NOT COMPLETED|Overall Study||0
6374659|NCT00750360|7285128|FG003|NOT COMPLETED|Overall Study||0
6374660|NCT00750360|7285129|FG004|NOT COMPLETED|Overall Study||0
6374661|NCT00750360|7285130|FG005|NOT COMPLETED|Overall Study||0
6374662|NCT00750373|7285152|FG000|STARTED|Overall Study||39
6374663|NCT00750373|7285153|FG001|STARTED|Overall Study||37
6374664|NCT00750373|7285152|FG000|COMPLETED|Overall Study||39
6374665|NCT00750373|7285153|FG001|COMPLETED|Overall Study||37
6374666|NCT00750373|7285152|FG000|NOT COMPLETED|Overall Study||0
6374667|NCT00750373|7285153|FG001|NOT COMPLETED|Overall Study||0
6374668|NCT00750438|7285161|FG000|STARTED|Overall Study||31
6374669|NCT00750438|7285162|FG001|STARTED|Overall Study||29
6374670|NCT00750438|7285161|FG000|COMPLETED|Overall Study||24
6374671|NCT00750438|7285162|FG001|COMPLETED|Overall Study||25
6374672|NCT00750438|7285161|FG000|NOT COMPLETED|Overall Study||7
6374673|NCT00750438|7285162|FG001|NOT COMPLETED|Overall Study||4
6374674|NCT00750737|7285170|FG000|STARTED|Overall Study||24
6374675|NCT00750737|7285171|FG001|STARTED|Overall Study||22
6374676|NCT00750737|7285170|FG000|COMPLETED|Overall Study||21
6374677|NCT00750737|7285171|FG001|COMPLETED|Overall Study||19
6374678|NCT00750737|7285170|FG000|NOT COMPLETED|Overall Study||3
6374679|NCT00750737|7285171|FG001|NOT COMPLETED|Overall Study||3
6374680|NCT00750815|7285179|FG000|STARTED|Overall Study||12
6374681|NCT00750815|7285180|FG001|STARTED|Overall Study||46
6374682|NCT00750815|7285179|FG000|COMPLETED|Overall Study||12
6374683|NCT00750815|7285180|FG001|COMPLETED|Overall Study||46
6374684|NCT00750815|7285179|FG000|NOT COMPLETED|Overall Study||0
6374685|NCT00750815|7285180|FG001|NOT COMPLETED|Overall Study||0
6374686|NCT00750867|7285190|FG000|STARTED|Overall Study||9
6374687|NCT00750867|7285190|FG000|COMPLETED|Overall Study||7
6374688|NCT00750867|7285190|FG000|NOT COMPLETED|Overall Study||2
6374689|NCT00750880|7285194|FG000|STARTED|Overall Study||1681
6374690|NCT00750880|7285194|FG000|COMPLETED|Overall Study||1466
6374691|NCT00750880|7285194|FG000|NOT COMPLETED|Overall Study||215
6374692|NCT00750893|7285199|FG000|STARTED|Overall Study||3111
6374693|NCT00750893|7285199|FG000|COMPLETED|Overall Study||2569
6374694|NCT00750893|7285199|FG000|NOT COMPLETED|Overall Study||542
6374695|NCT00750919|7285203|FG000|STARTED|Overall Study||184
6374696|NCT00750919|7285203|FG000|COMPLETED|Overall Study||126
6374697|NCT00750919|7285203|FG000|NOT COMPLETED|Overall Study||58
6374698|NCT00751023|7285209|FG000|STARTED|Overall Study||20
6374699|NCT00751023|7285210|FG001|STARTED|Overall Study||20
6374700|NCT00751023|7285209|FG000|COMPLETED|Overall Study||9
6374701|NCT00751023|7285210|FG001|COMPLETED|Overall Study||13
6374702|NCT00751023|7285209|FG000|NOT COMPLETED|Overall Study||11
6374703|NCT00751023|7285210|FG001|NOT COMPLETED|Overall Study||7
6374704|NCT00751036|7285218|FG000|STARTED|Overall Study|Started = Treated|48
6374705|NCT00751036|7285219|FG001|STARTED|Overall Study|Started = Treated|46
6374706|NCT00751036|7285218|FG000|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
6374707|NCT00751036|7285219|FG001|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
6374708|NCT00751036|7285218|FG000|NOT COMPLETED|Overall Study||48
6374709|NCT00751036|7285219|FG001|NOT COMPLETED|Overall Study||46
6374710|NCT00751101|7285227|FG000|STARTED|Overall Study||12
6300084|NCT00331630|7202517|FG000|STARTED|Treatment on Study||30
6300085|NCT00331630|7202517|FG000|Completed 1st Cycle|Treatment on Study||30
6300086|NCT00331630|7202517|FG000|Completed 4 Cycles|Treatment on Study||30
6300087|NCT00331630|7202517|FG000|COMPLETED|Treatment on Study||30
6300088|NCT00331630|7202517|FG000|NOT COMPLETED|Treatment on Study||0
6300089|NCT00331630|7202517|FG000|STARTED|Evaluated for and Completed SOC Surgery||30
6300090|NCT00331630|7202517|FG000|COMPLETED|Evaluated for and Completed SOC Surgery||28
6300091|NCT00331630|7202517|FG000|NOT COMPLETED|Evaluated for and Completed SOC Surgery||2
6300092|NCT00331630|7202517|FG000|STARTED|Follow up for 5 Years|One patient did not enter follow up as was lost to follow up|29
6300093|NCT00331630|7202517|FG000|COMPLETED|Follow up for 5 Years||0
6401257|NCT00891436|7314163|FG000|COMPLETED|Overall Study||10
6401258|NCT00891436|7314164|FG001|COMPLETED|Overall Study||10
6401259|NCT00891436|7314163|FG000|NOT COMPLETED|Overall Study||0
6401260|NCT00891436|7314164|FG001|NOT COMPLETED|Overall Study||0
6401261|NCT00891462|7314173|FG000|STARTED|Overall Study||186
6401262|NCT00891462|7314174|FG001|STARTED|Overall Study||185
6401263|NCT00891462|7314175|FG002|STARTED|Overall Study||190
6635203|NCT02302365|7564089|FG000|STARTED|0-24 Hour Period|2 of 3 study sites collected additional safety data; 32 pts. 0-24 hour data, 43 pts. 0-2 hour data|32
6635204|NCT02302365|7564089|FG000|COMPLETED|0-24 Hour Period||32
6635205|NCT02302365|7564089|FG000|NOT COMPLETED|0-24 Hour Period||0
6300094|NCT00331630|7202517|FG000|NOT COMPLETED|Follow up for 5 Years||29
6300095|NCT00331682|7202521|FG000|STARTED|Overall Study||10
6300096|NCT00331682|7202521|FG000|COMPLETED|Overall Study||9
6300097|NCT00331682|7202521|FG000|NOT COMPLETED|Overall Study||1
6300098|NCT00331760|7202527|FG000|STARTED|Overall Study||58
6300099|NCT00331760|7202528|FG001|STARTED|Overall Study||48
6300100|NCT00331760|7202527|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
6300101|NCT00331760|7202528|FG001|COMPLETED|Overall Study||40
6300102|NCT00331760|7202527|FG000|NOT COMPLETED|Overall Study||15
6300103|NCT00331760|7202528|FG001|NOT COMPLETED|Overall Study||8
6300104|NCT00331773|7202537|FG000|STARTED|Overall Study||558
6300105|NCT00331773|7202538|FG001|STARTED|Overall Study||557
6300106|NCT00331773|7202537|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
6300107|NCT00331773|7202538|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
6300108|NCT00331773|7202537|FG000|NOT COMPLETED|Overall Study||16
6300109|NCT00331773|7202538|FG001|NOT COMPLETED|Overall Study||7
6300110|NCT00331799|7202545|FG000|STARTED|Overall Study||18
6300111|NCT00331799|7202545|FG000|COMPLETED|Overall Study||15
6300112|NCT00331799|7202545|FG000|NOT COMPLETED|Overall Study||3
6300113|NCT00331864|7202551|FG000|STARTED|Overall Study||513
6300114|NCT00331864|7202552|FG001|STARTED|Overall Study||18
6300115|NCT00331864|7202551|FG000|COMPLETED|Overall Study||455
6300116|NCT00331864|7202552|FG001|COMPLETED|Overall Study||14
6300117|NCT00331864|7202551|FG000|NOT COMPLETED|Overall Study||58
6300118|NCT00331864|7202552|FG001|NOT COMPLETED|Overall Study||4
6300119|NCT00332163|7202560|FG000|STARTED|Overall Study||48
6635206|NCT02302716|7564099|FG000|STARTED|Overall Study||249
6300120|NCT00332163|7202561|FG001|STARTED|Overall Study||47
6401264|NCT00891462|7314173|FG000|COMPLETED|Overall Study||149
6510129|NCT01479621|7429701|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6510130|NCT01479621|7429695|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
6510131|NCT01479621|7429696|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510132|NCT01479621|7429697|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510133|NCT01479621|7429698|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510134|NCT01479621|7429699|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510135|NCT01479621|7429700|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510136|NCT01479621|7429701|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510137|NCT01479621|7429695|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
6510138|NCT01479621|7429696|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510139|NCT01479621|7429697|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510140|NCT01479621|7429698|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510141|NCT01479621|7429699|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510142|NCT01479621|7429700|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510143|NCT01479621|7429701|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6510144|NCT01479621|7429695|FG000|STARTED|Treatment Period||0
6510145|NCT01479621|7429696|FG001|STARTED|Treatment Period||103
6510146|NCT01479621|7429697|FG002|STARTED|Treatment Period||104
6510147|NCT01479621|7429698|FG003|STARTED|Treatment Period||104
6510148|NCT01479621|7429699|FG004|STARTED|Treatment Period||103
6510149|NCT01479621|7429700|FG005|STARTED|Treatment Period||104
6300121|NCT00332163|7202560|FG000|Received Treatment|Overall Study||48
6300122|NCT00332163|7202561|FG001|Received Treatment|Overall Study||47
6300123|NCT00332163|7202560|FG000|COMPLETED|Overall Study||48
6300124|NCT00332163|7202561|FG001|COMPLETED|Overall Study||47
6401265|NCT00891462|7314174|FG001|COMPLETED|Overall Study||152
6401266|NCT00891462|7314175|FG002|COMPLETED|Overall Study||166
6401267|NCT00891462|7314173|FG000|NOT COMPLETED|Overall Study||37
6401268|NCT00891462|7314174|FG001|NOT COMPLETED|Overall Study||33
6401269|NCT00891462|7314175|FG002|NOT COMPLETED|Overall Study||24
6510150|NCT01479621|7429701|FG006|STARTED|Treatment Period||104
6510151|NCT01479621|7429695|FG000|Safety Population|Treatment Period||0
6510152|NCT01479621|7429696|FG001|Safety Population|Treatment Period||103
6300125|NCT00332163|7202560|FG000|NOT COMPLETED|Overall Study||0
6300126|NCT00332163|7202561|FG001|NOT COMPLETED|Overall Study||0
6300127|NCT00332189|7202567|FG000|STARTED|Overall Study||111
6300128|NCT00332189|7202567|FG000|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
6300129|NCT00332189|7202567|FG000|NOT COMPLETED|Overall Study||21
6300130|NCT00332202|7202574|FG000|STARTED|Overall Study||504
6300131|NCT00332202|7202575|FG001|STARTED|Overall Study||254
6300132|NCT00332202|7202574|FG000|Received At Least One Dose of Study Drug|Overall Study||493
6300133|NCT00332202|7202575|FG001|Received At Least One Dose of Study Drug|Overall Study||249
6300134|NCT00332202|7202574|FG000|COMPLETED|Overall Study||263
6300135|NCT00332202|7202575|FG001|COMPLETED|Overall Study||129
6300136|NCT00332202|7202574|FG000|NOT COMPLETED|Overall Study||241
6300137|NCT00332202|7202575|FG001|NOT COMPLETED|Overall Study||125
6300138|NCT00332241|7202592|FG000|STARTED|Overall Study||51
6300139|NCT00332241|7202593|FG001|STARTED|Overall Study||47
6300140|NCT00332241|7202592|FG000|COMPLETED|Overall Study||36
6300141|NCT00332241|7202593|FG001|COMPLETED|Overall Study||39
6743360|NCT03334448|7671661|FG001|COMPLETED|Period 1||12
6743361|NCT03334448|7671662|FG002|COMPLETED|Period 1||13
6743362|NCT03334448|7671663|FG003|COMPLETED|Period 1||12
6743363|NCT03334448|7671660|FG000|NOT COMPLETED|Period 1||0
6300142|NCT00332241|7202592|FG000|NOT COMPLETED|Overall Study||15
6300143|NCT00332241|7202593|FG001|NOT COMPLETED|Overall Study||8
6300144|NCT00332332|7202599|FG000|STARTED|Overall Study||246
6300145|NCT00332332|7202599|FG000|Received Study Medication|Overall Study||230
6300146|NCT00332332|7202599|FG000|COMPLETED|Overall Study||178
6300147|NCT00332332|7202599|FG000|NOT COMPLETED|Overall Study||68
6300148|NCT00332462|7202603|FG000|STARTED|Overall Study|Safety and Intention to treat population.|34
6300149|NCT00332462|7202603|FG000|Patients Treated With Sandimmun® i.v.|Overall Study||34
6300150|NCT00332462|7202603|FG000|Patients Treated With Sandimmun® Optoral|Overall Study||29
6300151|NCT00332462|7202603|FG000|COMPLETED|Overall Study||18
6300152|NCT00332462|7202603|FG000|NOT COMPLETED|Overall Study||16
6300153|NCT00332488|7202613|FG000|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
6300154|NCT00332488|7202614|FG001|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
6300155|NCT00332488|7202615|FG002|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
6300156|NCT00332488|7202613|FG000|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
6300157|NCT00332488|7202614|FG001|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
6300158|NCT00332488|7202615|FG002|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
6300159|NCT00332488|7202613|FG000|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
6300160|NCT00332488|7202614|FG001|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
6300161|NCT00332488|7202615|FG002|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
6300162|NCT00332488|7202613|FG000|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
6300163|NCT00332488|7202614|FG001|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
6300164|NCT00332488|7202615|FG002|STARTED|Transfer Treatment Phase (Weeks 12 - 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
6300165|NCT00332488|7202613|FG000|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||27
6300166|NCT00332488|7202614|FG001|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||70
6300167|NCT00332488|7202615|FG002|COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||233
6300168|NCT00332488|7202613|FG000|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
6300169|NCT00332488|7202614|FG001|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||2
6300170|NCT00332488|7202615|FG002|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 - 24)||21
6300171|NCT00332579|7202627|FG000|STARTED|Overall Study||12
6300172|NCT00332579|7202628|FG001|STARTED|Overall Study||13
6300173|NCT00332579|7202627|FG000|COMPLETED|Overall Study||11
6300174|NCT00332579|7202628|FG001|COMPLETED|Overall Study||12
6300175|NCT00332579|7202627|FG000|NOT COMPLETED|Overall Study||1
6300176|NCT00332579|7202628|FG001|NOT COMPLETED|Overall Study||1
6300177|NCT00332605|7202637|FG000|STARTED|Overall Study||14
6300178|NCT00332605|7202638|FG001|STARTED|Overall Study||14
6300179|NCT00332605|7202639|FG002|STARTED|Overall Study||17
6300180|NCT00332605|7202637|FG000|COMPLETED|Overall Study||12
6300181|NCT00332605|7202638|FG001|COMPLETED|Overall Study||12
6300182|NCT00332605|7202639|FG002|COMPLETED|Overall Study||9
6401270|NCT00891527|7314185|FG000|STARTED|Overall Study||50
6401271|NCT00891527|7314185|FG000|COMPLETED|Overall Study||48
6401272|NCT00891527|7314185|FG000|NOT COMPLETED|Overall Study||2
6401273|NCT00891618|7314190|FG000|STARTED|Overall Study||21
6401274|NCT00891618|7314190|FG000|COMPLETED|Overall Study||20
6300183|NCT00332605|7202637|FG000|NOT COMPLETED|Overall Study||2
6300184|NCT00332605|7202638|FG001|NOT COMPLETED|Overall Study||2
6300185|NCT00332605|7202639|FG002|NOT COMPLETED|Overall Study||8
6300186|NCT00332644|7202653|FG000|STARTED|Overall Study||262
6300187|NCT00332644|7202654|FG001|STARTED|Overall Study||260
6300188|NCT00332644|7202655|FG002|STARTED|Overall Study||267
6300189|NCT00332644|7202656|FG003|STARTED|Overall Study||264
6300190|NCT00332644|7202657|FG004|STARTED|Overall Study||262
6300191|NCT00332644|7202658|FG005|STARTED|Overall Study||189
6300192|NCT00332644|7202653|FG000|COMPLETED|Overall Study||250
6300193|NCT00332644|7202654|FG001|COMPLETED|Overall Study||238
6401275|NCT00891618|7314190|FG000|NOT COMPLETED|Overall Study||1
6401276|NCT00891657|7314196|FG000|STARTED|Overall Study||9
6743364|NCT03334448|7671661|FG001|NOT COMPLETED|Period 1||0
6743365|NCT03334448|7671662|FG002|NOT COMPLETED|Period 1||0
6300194|NCT00332644|7202655|FG002|COMPLETED|Overall Study||258
6300195|NCT00332644|7202656|FG003|COMPLETED|Overall Study||244
6300196|NCT00332644|7202657|FG004|COMPLETED|Overall Study||250
6300197|NCT00332644|7202658|FG005|COMPLETED|Overall Study||174
6300198|NCT00332644|7202653|FG000|NOT COMPLETED|Overall Study||12
6300199|NCT00332644|7202654|FG001|NOT COMPLETED|Overall Study||22
6300200|NCT00332644|7202655|FG002|NOT COMPLETED|Overall Study||9
6300201|NCT00332644|7202656|FG003|NOT COMPLETED|Overall Study||20
6300202|NCT00332644|7202657|FG004|NOT COMPLETED|Overall Study||12
6300203|NCT00332644|7202658|FG005|NOT COMPLETED|Overall Study||15
6300204|NCT00332696|7202674|FG000|STARTED|Overall Study||32
6300205|NCT00332696|7202675|FG001|STARTED|Overall Study||32
6300206|NCT00332696|7202674|FG000|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
6300207|NCT00332696|7202675|FG001|Completed Day 14 Visit|Overall Study||15
6300208|NCT00332696|7202674|FG000|COMPLETED|Overall Study|Completed Month 3 Visit|2
6300209|NCT00332696|7202675|FG001|COMPLETED|Overall Study||2
6300210|NCT00332696|7202674|FG000|NOT COMPLETED|Overall Study||30
6300211|NCT00332696|7202675|FG001|NOT COMPLETED|Overall Study||30
6300212|NCT00332709|7202683|FG000|STARTED|Overall Study||40
6300213|NCT00332709|7202684|FG001|STARTED|Overall Study||41
6300214|NCT00332709|7202683|FG000|COMPLETED|Overall Study||24
6300215|NCT00332709|7202684|FG001|COMPLETED|Overall Study||21
6300216|NCT00332709|7202683|FG000|NOT COMPLETED|Overall Study||16
6300217|NCT00332709|7202684|FG001|NOT COMPLETED|Overall Study||20
6300218|NCT00332722|7202692|FG000|STARTED|Overall Study||60
6300219|NCT00332722|7202693|FG001|STARTED|Overall Study||60
6300220|NCT00332722|7202692|FG000|COMPLETED|Overall Study||60
6300221|NCT00332722|7202693|FG001|COMPLETED|Overall Study||60
6300222|NCT00332722|7202692|FG000|NOT COMPLETED|Overall Study||0
6300223|NCT00332722|7202693|FG001|NOT COMPLETED|Overall Study||0
6300224|NCT00332839|7202701|FG000|STARTED|Core (Months 0 - 12)||47
6300225|NCT00332839|7202702|FG001|STARTED|Core (Months 0 - 12)||46
6300226|NCT00332839|7202701|FG000|Safety Set|Core (Months 0 - 12)||47
6300227|NCT00332839|7202702|FG001|Safety Set|Core (Months 0 - 12)||46
6300228|NCT00332839|7202701|FG000|COMPLETED|Core (Months 0 - 12)||37
6300229|NCT00332839|7202702|FG001|COMPLETED|Core (Months 0 - 12)||28
6300230|NCT00332839|7202701|FG000|NOT COMPLETED|Core (Months 0 - 12)||10
6300231|NCT00332839|7202702|FG001|NOT COMPLETED|Core (Months 0 - 12)||18
6300232|NCT00332839|7202701|FG000|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
6300233|NCT00332839|7202702|FG001|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
6300234|NCT00332839|7202701|FG000|COMPLETED|Follow-up (Months 12 - 60)||29
6300235|NCT00332839|7202702|FG001|COMPLETED|Follow-up (Months 12 - 60)||31
6300236|NCT00332839|7202701|FG000|NOT COMPLETED|Follow-up (Months 12 - 60)||4
6300237|NCT00332839|7202702|FG001|NOT COMPLETED|Follow-up (Months 12 - 60)||3
6300238|NCT00333138|7202711|FG000|STARTED|Core Study (6 Months)||93
6300239|NCT00333138|7202712|FG001|STARTED|Core Study (6 Months)||94
6300240|NCT00333138|7202713|FG002|STARTED|Core Study (6 Months)||94
6300241|NCT00333138|7202711|FG000|COMPLETED|Core Study (6 Months)||86
6300242|NCT00333138|7202712|FG001|COMPLETED|Core Study (6 Months)||88
6300243|NCT00333138|7202713|FG002|COMPLETED|Core Study (6 Months)||82
6300244|NCT00333138|7202711|FG000|NOT COMPLETED|Core Study (6 Months)||7
6300245|NCT00333138|7202712|FG001|NOT COMPLETED|Core Study (6 Months)||6
6300246|NCT00333138|7202713|FG002|NOT COMPLETED|Core Study (6 Months)||12
6300247|NCT00333138|7202711|FG000|STARTED|Extension Study (Month6 to End of Study)||83
6300248|NCT00333138|7202712|FG001|STARTED|Extension Study (Month6 to End of Study)||87
6300249|NCT00333138|7202713|FG002|STARTED|Extension Study (Month6 to End of Study)||80
6300250|NCT00333138|7202711|FG000|COMPLETED|Extension Study (Month6 to End of Study)||40
6300251|NCT00333138|7202712|FG001|COMPLETED|Extension Study (Month6 to End of Study)||45
6300252|NCT00333138|7202713|FG002|COMPLETED|Extension Study (Month6 to End of Study)||37
6300253|NCT00333138|7202711|FG000|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
6300254|NCT00333138|7202712|FG001|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
6300255|NCT00333138|7202713|FG002|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
6300256|NCT00333177|7202727|FG000|STARTED|Overall Study||12
6300257|NCT00333177|7202728|FG001|STARTED|Overall Study||17
6300258|NCT00333177|7202729|FG002|STARTED|Overall Study||17
6300259|NCT00333177|7202730|FG003|STARTED|Overall Study||14
6300260|NCT00333177|7202727|FG000|Received Intervention|Overall Study||12
6300261|NCT00333177|7202728|FG001|Received Intervention|Overall Study||16
6300262|NCT00333177|7202729|FG002|Received Intervention|Overall Study||16
6300263|NCT00333177|7202730|FG003|Received Intervention|Overall Study||12
6300264|NCT00333177|7202727|FG000|COMPLETED|Overall Study||12
6300265|NCT00333177|7202728|FG001|COMPLETED|Overall Study||16
6300266|NCT00333177|7202729|FG002|COMPLETED|Overall Study||16
6300267|NCT00333177|7202730|FG003|COMPLETED|Overall Study||12
6300268|NCT00333177|7202727|FG000|NOT COMPLETED|Overall Study||0
6300269|NCT00333177|7202728|FG001|NOT COMPLETED|Overall Study||1
6300270|NCT00333177|7202729|FG002|NOT COMPLETED|Overall Study||1
6300271|NCT00333177|7202730|FG003|NOT COMPLETED|Overall Study||2
6300272|NCT00333359|7202744|FG000|STARTED|Overall Study||199
6300273|NCT00333359|7202745|FG001|STARTED|Overall Study||382
6300274|NCT00333359|7202744|FG000|COMPLETED|Overall Study||126
6300275|NCT00333359|7202745|FG001|COMPLETED|Overall Study||260
6300276|NCT00333359|7202744|FG000|NOT COMPLETED|Overall Study||73
6300277|NCT00333359|7202745|FG001|NOT COMPLETED|Overall Study||122
6300278|NCT00333437|7202753|FG000|STARTED|Overall Study||7
6300279|NCT00333437|7202753|FG000|COMPLETED|Overall Study||7
6300280|NCT00333437|7202753|FG000|NOT COMPLETED|Overall Study||0
6300281|NCT00333606|7202760|FG000|STARTED|Overall Study||30
6300282|NCT00333606|7202761|FG001|STARTED|Overall Study||30
6300283|NCT00333606|7202760|FG000|COMPLETED|Overall Study||30
6300284|NCT00333606|7202761|FG001|COMPLETED|Overall Study||30
6300285|NCT00333606|7202760|FG000|NOT COMPLETED|Overall Study||0
6300286|NCT00333606|7202761|FG001|NOT COMPLETED|Overall Study||0
6300287|NCT00333619|7202771|FG000|STARTED|Overall Study||110
6300288|NCT00333619|7202772|FG001|STARTED|Overall Study||109
6300289|NCT00333619|7202771|FG000|Post-treatment|Overall Study||109
6300290|NCT00333619|7202772|FG001|Post-treatment|Overall Study||109
6300291|NCT00333619|7202771|FG000|3-month Follow-up|Overall Study||101
6300292|NCT00333619|7202772|FG001|3-month Follow-up|Overall Study||105
6300293|NCT00333619|7202771|FG000|COMPLETED|Overall Study||89
6300294|NCT00333619|7202772|FG001|COMPLETED|Overall Study||99
6300295|NCT00333619|7202771|FG000|NOT COMPLETED|Overall Study||21
6300296|NCT00333619|7202772|FG001|NOT COMPLETED|Overall Study||10
6300297|NCT00333710|7202783|FG000|STARTED|Overall Study||19
6300298|NCT00333710|7202784|FG001|STARTED|Overall Study||18
6300299|NCT00333710|7202785|FG002|STARTED|Overall Study||16
6300300|NCT00333710|7202783|FG000|COMPLETED|Overall Study||8
6300301|NCT00333710|7202784|FG001|COMPLETED|Overall Study||14
6300302|NCT00333710|7202785|FG002|COMPLETED|Overall Study||15
6300303|NCT00333710|7202783|FG000|NOT COMPLETED|Overall Study||11
6300304|NCT00333710|7202784|FG001|NOT COMPLETED|Overall Study||4
6300305|NCT00333710|7202785|FG002|NOT COMPLETED|Overall Study||1
6300306|NCT00333775|7202796|FG000|STARTED|Overall Study||241
6300307|NCT00333775|7202797|FG001|STARTED|Overall Study||248
6300308|NCT00333775|7202798|FG002|STARTED|Overall Study||247
6300309|NCT00333775|7202796|FG000|Received Treatment|Overall Study||238
6300310|NCT00333775|7202797|FG001|Received Treatment|Overall Study||247
6300311|NCT00333775|7202798|FG002|Received Treatment|Overall Study||245
6300312|NCT00333775|7202796|FG000|COMPLETED|Overall Study||0
6300313|NCT00333775|7202797|FG001|COMPLETED|Overall Study||0
6300314|NCT00333775|7202798|FG002|COMPLETED|Overall Study||0
6635207|NCT02302716|7564100|FG001|STARTED|Overall Study||244
6635208|NCT02302716|7564099|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
6635209|NCT02302716|7564100|FG001|Received at Least 1 Dose of Study Drug|Overall Study||244
6635210|NCT02302716|7564099|FG000|COMPLETED|Overall Study||230
6300315|NCT00333775|7202796|FG000|NOT COMPLETED|Overall Study||241
6300316|NCT00333775|7202797|FG001|NOT COMPLETED|Overall Study||248
6300317|NCT00333775|7202798|FG002|NOT COMPLETED|Overall Study||247
6300318|NCT00333788|7202806|FG000|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
6300319|NCT00333788|7202806|FG000|COMPLETED|Overall Study||71
6300320|NCT00333788|7202806|FG000|NOT COMPLETED|Overall Study||162
6300321|NCT00333801|7202812|FG000|STARTED|Overall Study||43
6300322|NCT00333801|7202813|FG001|STARTED|Overall Study||42
6300323|NCT00333801|7202812|FG000|COMPLETED|Overall Study||35
6300324|NCT00333801|7202813|FG001|COMPLETED|Overall Study||36
6300325|NCT00333801|7202812|FG000|NOT COMPLETED|Overall Study||8
6300326|NCT00333801|7202813|FG001|NOT COMPLETED|Overall Study||6
6300327|NCT00333814|7202822|FG000|STARTED|Overall Study||76
6300328|NCT00333814|7202823|FG001|STARTED|Overall Study||77
6300329|NCT00333814|7202824|FG002|STARTED|Overall Study||76
6300330|NCT00333814|7202822|FG000|COMPLETED|Overall Study||73
6300331|NCT00333814|7202823|FG001|COMPLETED|Overall Study||73
6300332|NCT00333814|7202824|FG002|COMPLETED|Overall Study||71
6300333|NCT00333814|7202822|FG000|NOT COMPLETED|Overall Study||3
6300334|NCT00333814|7202823|FG001|NOT COMPLETED|Overall Study||4
6300335|NCT00333814|7202824|FG002|NOT COMPLETED|Overall Study||5
6300336|NCT00333840|7202834|FG000|STARTED|First-line Treatment Period||553
6300337|NCT00333840|7202835|FG001|STARTED|First-line Treatment Period||553
6300338|NCT00333840|7202836|FG002|STARTED|First-line Treatment Period||0
6300339|NCT00333840|7202837|FG003|STARTED|First-line Treatment Period||0
6300340|NCT00333840|7202834|FG000|Safety Population; Received Study Drug|First-line Treatment Period||551
6300341|NCT00333840|7202835|FG001|Safety Population; Received Study Drug|First-line Treatment Period||533
6300342|NCT00333840|7202836|FG002|Safety Population; Received Study Drug|First-line Treatment Period||0
6635211|NCT02302716|7564100|FG001|COMPLETED|Overall Study||225
6300343|NCT00333840|7202837|FG003|Safety Population; Received Study Drug|First-line Treatment Period||0
6300344|NCT00333840|7202834|FG000|COMPLETED|First-line Treatment Period||267
6300345|NCT00333840|7202835|FG001|COMPLETED|First-line Treatment Period||7
6300346|NCT00333840|7202836|FG002|COMPLETED|First-line Treatment Period||0
6300347|NCT00333840|7202837|FG003|COMPLETED|First-line Treatment Period||0
6300348|NCT00333840|7202834|FG000|NOT COMPLETED|First-line Treatment Period||286
6300349|NCT00333840|7202835|FG001|NOT COMPLETED|First-line Treatment Period||546
6300350|NCT00333840|7202836|FG002|NOT COMPLETED|First-line Treatment Period||0
6300351|NCT00333840|7202837|FG003|NOT COMPLETED|First-line Treatment Period||0
6300352|NCT00333840|7202834|FG000|STARTED|Second-line Treatment Period||0
6300353|NCT00333840|7202835|FG001|STARTED|Second-line Treatment Period||0
6300354|NCT00333840|7202836|FG002|STARTED|Second-line Treatment Period||14
6300355|NCT00333840|7202837|FG003|STARTED|Second-line Treatment Period||363
6300356|NCT00333840|7202834|FG000|COMPLETED|Second-line Treatment Period||0
6300357|NCT00333840|7202835|FG001|COMPLETED|Second-line Treatment Period||0
6300358|NCT00333840|7202836|FG002|COMPLETED|Second-line Treatment Period||0
6300359|NCT00333840|7202837|FG003|COMPLETED|Second-line Treatment Period||175
6300360|NCT00333840|7202834|FG000|NOT COMPLETED|Second-line Treatment Period||0
6300361|NCT00333840|7202835|FG001|NOT COMPLETED|Second-line Treatment Period||0
6300362|NCT00333840|7202836|FG002|NOT COMPLETED|Second-line Treatment Period||14
6300363|NCT00333840|7202837|FG003|NOT COMPLETED|Second-line Treatment Period||188
6300364|NCT00333866|7202855|FG000|STARTED|Overall Study||189
6300365|NCT00333866|7202856|FG001|STARTED|Overall Study||187
6300366|NCT00333866|7202857|FG002|STARTED|Overall Study||184
6300367|NCT00333866|7202858|FG003|STARTED|Overall Study||187
6300368|NCT00333866|7202855|FG000|TREATED|Overall Study||184
6300369|NCT00333866|7202856|FG001|TREATED|Overall Study||184
6300370|NCT00333866|7202857|FG002|TREATED|Overall Study||182
6300371|NCT00333866|7202858|FG003|TREATED|Overall Study||186
6300372|NCT00333866|7202855|FG000|COMPLETED|Overall Study||141
6300373|NCT00333866|7202856|FG001|COMPLETED|Overall Study||123
6300374|NCT00333866|7202857|FG002|COMPLETED|Overall Study||133
6300375|NCT00333866|7202858|FG003|COMPLETED|Overall Study||121
6300376|NCT00333866|7202855|FG000|NOT COMPLETED|Overall Study||48
6300377|NCT00333866|7202856|FG001|NOT COMPLETED|Overall Study||64
6300378|NCT00333866|7202857|FG002|NOT COMPLETED|Overall Study||51
6300379|NCT00333866|7202858|FG003|NOT COMPLETED|Overall Study||66
6300380|NCT00333879|7202868|FG000|STARTED|Overall Study||4
6300381|NCT00333879|7202868|FG000|COMPLETED|Overall Study||4
6300382|NCT00333879|7202868|FG000|NOT COMPLETED|Overall Study||0
6300383|NCT00333970|7202874|FG000|STARTED|Overall Study||50
6300384|NCT00333970|7202875|FG001|STARTED|Overall Study||25
6300385|NCT00333970|7202874|FG000|COMPLETED|Overall Study||37
6300386|NCT00333970|7202875|FG001|COMPLETED|Overall Study||18
6300387|NCT00333970|7202874|FG000|NOT COMPLETED|Overall Study||13
6300388|NCT00333970|7202875|FG001|NOT COMPLETED|Overall Study||7
6300389|NCT00333983|7202884|FG000|STARTED|Overall Study||20
6300390|NCT00333983|7202885|FG001|STARTED|Overall Study||21
6300391|NCT00333983|7202886|FG002|STARTED|Overall Study||21
6300392|NCT00333983|7202884|FG000|COMPLETED|Overall Study||17
6300393|NCT00333983|7202885|FG001|COMPLETED|Overall Study||16
6300394|NCT00333983|7202886|FG002|COMPLETED|Overall Study||19
6300395|NCT00333983|7202884|FG000|NOT COMPLETED|Overall Study||3
6300396|NCT00333983|7202885|FG001|NOT COMPLETED|Overall Study||5
6300397|NCT00333983|7202886|FG002|NOT COMPLETED|Overall Study||2
6300398|NCT00334061|7202894|FG000|STARTED|Overall Study|June 2006|125
6300399|NCT00334061|7202894|FG000|COMPLETED|Overall Study|November 2007|125
6300400|NCT00334061|7202894|FG000|NOT COMPLETED|Overall Study||0
6300401|NCT00334074|7202898|FG000|STARTED|Overall Study||30
6300402|NCT00334074|7202898|FG000|COMPLETED|Overall Study||30
6300403|NCT00334074|7202898|FG000|NOT COMPLETED|Overall Study||0
6300404|NCT00334113|7202905|FG000|STARTED|Overall Study||32
6300405|NCT00334113|7202906|FG001|STARTED|Overall Study||34
6300406|NCT00334113|7202905|FG000|COMPLETED|Overall Study||30
6300407|NCT00334113|7202906|FG001|COMPLETED|Overall Study||31
6300408|NCT00334113|7202905|FG000|NOT COMPLETED|Overall Study||2
6300409|NCT00334113|7202906|FG001|NOT COMPLETED|Overall Study||3
6300410|NCT00334204|7202912|FG000|STARTED|Overall Study||58
6300411|NCT00334204|7202912|FG000|COMPLETED|Overall Study||56
6300412|NCT00334204|7202912|FG000|NOT COMPLETED|Overall Study||2
6300413|NCT00334282|7202919|FG000|STARTED|Overall Study||290
6300414|NCT00334282|7202920|FG001|STARTED|Overall Study||145
6300415|NCT00334282|7202919|FG000|COMPLETED|Overall Study||68
6300416|NCT00334282|7202920|FG001|COMPLETED|Overall Study||37
6300417|NCT00334282|7202919|FG000|NOT COMPLETED|Overall Study||222
6300418|NCT00334282|7202920|FG001|NOT COMPLETED|Overall Study||108
6300419|NCT00334295|7202930|FG000|STARTED|Overall Study||35
6300420|NCT00334295|7202930|FG000|COMPLETED|Overall Study||30
6300421|NCT00334295|7202930|FG000|NOT COMPLETED|Overall Study||5
6300422|NCT00334542|7202934|FG000|STARTED|Overall Study||50
6300423|NCT00334542|7202934|FG000|COMPLETED|Overall Study||45
6300424|NCT00334542|7202934|FG000|NOT COMPLETED|Overall Study||5
6300425|NCT00334633|7202942|FG000|STARTED|Overall Study||197
6300426|NCT00334633|7202943|FG001|STARTED|Overall Study||200
6300427|NCT00334633|7202944|FG002|STARTED|Overall Study||196
6300428|NCT00334633|7202942|FG000|COMPLETED|Overall Study||117
6300429|NCT00334633|7202943|FG001|COMPLETED|Overall Study||118
6300430|NCT00334633|7202944|FG002|COMPLETED|Overall Study||114
6300431|NCT00334633|7202942|FG000|NOT COMPLETED|Overall Study||80
6300432|NCT00334633|7202943|FG001|NOT COMPLETED|Overall Study||82
6300433|NCT00334633|7202944|FG002|NOT COMPLETED|Overall Study||82
6300434|NCT00334737|7202958|FG000|STARTED|Hospital Phase||34
6300435|NCT00334737|7202959|FG001|STARTED|Hospital Phase||34
6300436|NCT00334737|7202960|FG002|STARTED|Hospital Phase||34
6300437|NCT00334737|7202958|FG000|COMPLETED|Hospital Phase||32
6300438|NCT00334737|7202959|FG001|COMPLETED|Hospital Phase||32
6300439|NCT00334737|7202960|FG002|COMPLETED|Hospital Phase||30
6300440|NCT00334737|7202958|FG000|NOT COMPLETED|Hospital Phase||2
6300441|NCT00334737|7202959|FG001|NOT COMPLETED|Hospital Phase||2
6300442|NCT00334737|7202960|FG002|NOT COMPLETED|Hospital Phase||4
6300443|NCT00334737|7202958|FG000|STARTED|Follow up Phase||32
6300444|NCT00334737|7202959|FG001|STARTED|Follow up Phase||32
6300445|NCT00334737|7202960|FG002|STARTED|Follow up Phase||30
6300446|NCT00334737|7202958|FG000|COMPLETED|Follow up Phase||27
6300447|NCT00334737|7202959|FG001|COMPLETED|Follow up Phase||29
6300448|NCT00334737|7202960|FG002|COMPLETED|Follow up Phase||24
6300449|NCT00334737|7202958|FG000|NOT COMPLETED|Follow up Phase||5
6300450|NCT00334737|7202959|FG001|NOT COMPLETED|Follow up Phase||3
6300451|NCT00334737|7202960|FG002|NOT COMPLETED|Follow up Phase||6
6300452|NCT00334802|7202970|FG000|STARTED|Overall Study||6
6635212|NCT02302716|7564099|FG000|NOT COMPLETED|Overall Study||19
6635213|NCT02302716|7564100|FG001|NOT COMPLETED|Overall Study||19
6635214|NCT02302807|7564108|FG000|STARTED|Overall Study||464
6300453|NCT00334802|7202971|FG001|STARTED|Overall Study||56
6300454|NCT00334802|7202970|FG000|COMPLETED|Overall Study||0
6300455|NCT00334802|7202971|FG001|COMPLETED|Overall Study||16
6300456|NCT00334802|7202970|FG000|NOT COMPLETED|Overall Study||6
6300457|NCT00334802|7202971|FG001|NOT COMPLETED|Overall Study||40
6300458|NCT00334815|7202982|FG000|STARTED|Overall Study||16
6300459|NCT00334815|7202983|FG001|STARTED|Overall Study||13
6300460|NCT00334815|7202982|FG000|COMPLETED|Overall Study||9
6300461|NCT00334815|7202983|FG001|COMPLETED|Overall Study||3
6300462|NCT00334815|7202982|FG000|NOT COMPLETED|Overall Study||7
6300463|NCT00334815|7202983|FG001|NOT COMPLETED|Overall Study||10
6300464|NCT00334893|7202993|FG000|STARTED|Overall Study||37
6300465|NCT00334893|7202994|FG001|STARTED|Overall Study||37
6300466|NCT00334893|7202993|FG000|COMPLETED|Overall Study||36
6300467|NCT00334893|7202994|FG001|COMPLETED|Overall Study||37
6300468|NCT00334893|7202993|FG000|NOT COMPLETED|Overall Study||1
6300469|NCT00334893|7202994|FG001|NOT COMPLETED|Overall Study||0
6300470|NCT00334958|7203004|FG000|STARTED|Overall Study||176
6300471|NCT00334958|7203005|FG001|STARTED|Overall Study|1 participant withdrawn prior to study drug dosing due to not obtaining labs|180
6300472|NCT00334958|7203004|FG000|COMPLETED|Overall Study||139
6300473|NCT00334958|7203005|FG001|COMPLETED|Overall Study||156
6300474|NCT00334958|7203004|FG000|NOT COMPLETED|Overall Study||37
6300475|NCT00334958|7203005|FG001|NOT COMPLETED|Overall Study||24
6635215|NCT02302807|7564109|FG001|STARTED|Overall Study||467
6635216|NCT02302807|7564108|FG000|Received Treatment|Overall Study||443
6635217|NCT02302807|7564109|FG001|Received Treatment|Overall Study||459
6635218|NCT02302807|7564108|FG000|COMPLETED|Overall Study|Participants still on chemotherapy were discontinued where that treatment was available locally.|0
6635219|NCT02302807|7564109|FG001|COMPLETED|Overall Study|Participants still receiving atezolizumab had opportunity to continue treatment in extension study.|0
6635220|NCT02302807|7564108|FG000|NOT COMPLETED|Overall Study||464
6300476|NCT00335140|7203011|FG000|STARTED|Overall Study||26
6300477|NCT00335140|7203011|FG000|Eligible|Overall Study||25
6300478|NCT00335140|7203011|FG000|Treated|Overall Study||25
6300479|NCT00335140|7203011|FG000|COMPLETED|Overall Study||25
6300480|NCT00335140|7203011|FG000|NOT COMPLETED|Overall Study||1
6300481|NCT00335153|7203015|FG000|STARTED|Nasojejunal (NJ) Test Period||354
6635221|NCT02302807|7564109|FG001|NOT COMPLETED|Overall Study||467
6635222|NCT02302846|7564128|FG000|STARTED|Overall Study||5
6635223|NCT02302846|7564128|FG000|COMPLETED|Overall Study||4
6635224|NCT02302846|7564128|FG000|NOT COMPLETED|Overall Study||1
6635225|NCT02303041|7564134|FG000|STARTED|Overall Study||4
6635226|NCT02303041|7564135|FG001|STARTED|Overall Study||6
6300482|NCT00335153|7203015|FG000|COMPLETED|Nasojejunal (NJ) Test Period||324
6300483|NCT00335153|7203015|FG000|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
6300484|NCT00335153|7203015|FG000|STARTED|Post-PEG-J Long-Term Treatment Period||324
6300485|NCT00335153|7203015|FG000|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
6300486|NCT00335153|7203015|FG000|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
6300487|NCT00335257|7203022|FG000|STARTED|Overall Study||15542
6300488|NCT00335257|7203023|FG001|STARTED|Overall Study||9377
6300489|NCT00335257|7203024|FG002|STARTED|Overall Study||60190
6300490|NCT00335257|7203022|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
6300491|NCT00335257|7203023|FG001|COMPLETED|Overall Study||9377
6300492|NCT00335257|7203024|FG002|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
6300493|NCT00335257|7203022|FG000|NOT COMPLETED|Overall Study||0
6300494|NCT00335257|7203023|FG001|NOT COMPLETED|Overall Study||0
6300495|NCT00335257|7203024|FG002|NOT COMPLETED|Overall Study||0
6300496|NCT00335283|7203040|FG000|STARTED|Overall Study||36
6300497|NCT00335283|7203041|FG001|STARTED|Overall Study||39
6300498|NCT00335283|7203040|FG000|COMPLETED|Overall Study||30
6300499|NCT00335283|7203041|FG001|COMPLETED|Overall Study||34
6300500|NCT00335283|7203040|FG000|NOT COMPLETED|Overall Study||6
6300501|NCT00335283|7203041|FG001|NOT COMPLETED|Overall Study||5
6300502|NCT00335322|7203050|FG000|STARTED|Overall Study||115
6300503|NCT00335322|7203051|FG001|STARTED|Overall Study||107
6300504|NCT00335322|7203052|FG002|STARTED|Overall Study||105
6300505|NCT00335322|7203050|FG000|COMPLETED|Overall Study||114
6300506|NCT00335322|7203051|FG001|COMPLETED|Overall Study||105
6300507|NCT00335322|7203052|FG002|COMPLETED|Overall Study||103
6300508|NCT00335322|7203050|FG000|NOT COMPLETED|Overall Study||1
6300509|NCT00335322|7203051|FG001|NOT COMPLETED|Overall Study||2
6635227|NCT02303041|7564134|FG000|COMPLETED|Overall Study||3
6635228|NCT02303041|7564135|FG001|COMPLETED|Overall Study||4
6635229|NCT02303041|7564134|FG000|NOT COMPLETED|Overall Study||1
6635230|NCT02303041|7564135|FG001|NOT COMPLETED|Overall Study||2
6635231|NCT02303093|7564141|FG000|STARTED|Overall Study||344
6635232|NCT02303093|7564141|FG000|COMPLETED|Overall Study||344
6635233|NCT02303093|7564141|FG000|NOT COMPLETED|Overall Study||0
6300510|NCT00335322|7203052|FG002|NOT COMPLETED|Overall Study||2
6300511|NCT00335452|7203067|FG000|STARTED|Overall Study|Randomized|6312
6300512|NCT00335452|7203068|FG001|STARTED|Overall Study|Randomized|6254
6300513|NCT00335452|7203069|FG002|STARTED|Overall Study|Randomized|6267
6300514|NCT00335452|7203070|FG003|STARTED|Overall Study|Randomized|6253
6635234|NCT02303184|7564159|FG000|STARTED|Overall Study||23
6635235|NCT02303184|7564160|FG001|STARTED|Overall Study||23
6635236|NCT02303184|7564159|FG000|COMPLETED|Overall Study||23
6635237|NCT02303184|7564160|FG001|COMPLETED|Overall Study||23
6635238|NCT02303184|7564159|FG000|NOT COMPLETED|Overall Study||0
6635239|NCT02303184|7564160|FG001|NOT COMPLETED|Overall Study||0
6635240|NCT02303262|7564166|FG000|STARTED|Overall Study||20
6635241|NCT02303262|7564166|FG000|COMPLETED|Overall Study||18
6635242|NCT02303262|7564166|FG000|NOT COMPLETED|Overall Study||2
6635243|NCT02303574|7564182|FG000|STARTED|Part 1a (Fasted State)- SAD||6
6635244|NCT02303574|7564183|FG001|STARTED|Part 1a (Fasted State)- SAD||6
6635245|NCT02303574|7564184|FG002|STARTED|Part 1a (Fasted State)- SAD||6
6635246|NCT02303574|7564185|FG003|STARTED|Part 1a (Fasted State)- SAD||6
6635247|NCT02303574|7564186|FG004|STARTED|Part 1a (Fasted State)- SAD||6
6635248|NCT02303574|7564187|FG005|STARTED|Part 1a (Fasted State)- SAD||0
6635249|NCT02303574|7564188|FG006|STARTED|Part 1a (Fasted State)- SAD||0
6635250|NCT02303574|7564189|FG007|STARTED|Part 1a (Fasted State)- SAD||0
6635251|NCT02303574|7564190|FG008|STARTED|Part 1a (Fasted State)- SAD||0
6635252|NCT02303574|7564191|FG009|STARTED|Part 1a (Fasted State)- SAD|Participants received AZD7986 matching placebo on Day 1 in fasted state.|15
6635253|NCT02303574|7564182|FG000|COMPLETED|Part 1a (Fasted State)- SAD||6
6635254|NCT02303574|7564183|FG001|COMPLETED|Part 1a (Fasted State)- SAD||6
6300515|NCT00335452|7203067|FG000|TREATED WITH CLOPIDOGREL|Overall Study||6271
6300516|NCT00335452|7203068|FG001|TREATED WITH CLOPIDOGREL|Overall Study||6218
6300517|NCT00335452|7203069|FG002|TREATED WITH CLOPIDOGREL|Overall Study||6228
6300518|NCT00335452|7203070|FG003|TREATED WITH CLOPIDOGREL|Overall Study||6217
6300519|NCT00335452|7203067|FG000|TREATED WITH ASA|Overall Study||6302
6300520|NCT00335452|7203068|FG001|TREATED WITH ASA|Overall Study||6251
6300521|NCT00335452|7203069|FG002|TREATED WITH ASA|Overall Study||6261
6300522|NCT00335452|7203070|FG003|TREATED WITH ASA|Overall Study||6247
6300523|NCT00335452|7203067|FG000|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
6300524|NCT00335452|7203068|FG001|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
6300525|NCT00335452|7203069|FG002|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
6300526|NCT00335452|7203070|FG003|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
6300527|NCT00335452|7203067|FG000|NOT COMPLETED|Overall Study||158
6300528|NCT00335452|7203068|FG001|NOT COMPLETED|Overall Study||147
6300529|NCT00335452|7203069|FG002|NOT COMPLETED|Overall Study||159
6300530|NCT00335452|7203070|FG003|NOT COMPLETED|Overall Study||131
6300531|NCT00335478|7203085|FG000|STARTED|Overall Study||54
6300532|NCT00335478|7203085|FG000|COMPLETED|Overall Study||30
6300533|NCT00335478|7203085|FG000|NOT COMPLETED|Overall Study||24
6300534|NCT00335504|7203093|FG000|STARTED|Overall Study||22
6300535|NCT00335504|7203094|FG001|STARTED|Overall Study||21
6300536|NCT00335504|7203095|FG002|STARTED|Overall Study||20
6300537|NCT00335504|7203096|FG003|STARTED|Overall Study||22
6300538|NCT00335504|7203093|FG000|COMPLETED|Overall Study||22
6300539|NCT00335504|7203094|FG001|COMPLETED|Overall Study||21
6300540|NCT00335504|7203095|FG002|COMPLETED|Overall Study||20
6300541|NCT00335504|7203096|FG003|COMPLETED|Overall Study||22
6300542|NCT00335504|7203093|FG000|NOT COMPLETED|Overall Study||0
6300543|NCT00335504|7203094|FG001|NOT COMPLETED|Overall Study||0
6300544|NCT00335504|7203095|FG002|NOT COMPLETED|Overall Study||0
6300545|NCT00335504|7203096|FG003|NOT COMPLETED|Overall Study||0
6300546|NCT00335517|7203106|FG000|STARTED|Overall Study||100
6300547|NCT00335517|7203106|FG000|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
6300548|NCT00335517|7203106|FG000|NOT COMPLETED|Overall Study||2
6300549|NCT00335556|7203116|FG000|STARTED|Overall Study||68
6300550|NCT00335556|7203117|FG001|STARTED|Overall Study||98
6300551|NCT00335556|7203118|FG002|STARTED|Overall Study||7
6300552|NCT00335556|7203119|FG003|STARTED|Overall Study||10
6300553|NCT00335556|7203120|FG004|STARTED|Overall Study||78
6300554|NCT00335556|7203121|FG005|STARTED|Overall Study||30
6300555|NCT00335556|7203116|FG000|COMPLETED|Overall Study||66
6300556|NCT00335556|7203117|FG001|COMPLETED|Overall Study||64
6300557|NCT00335556|7203118|FG002|COMPLETED|Overall Study||2
6300558|NCT00335556|7203119|FG003|COMPLETED|Overall Study||5
6300559|NCT00335556|7203120|FG004|COMPLETED|Overall Study||77
6300560|NCT00335556|7203121|FG005|COMPLETED|Overall Study||29
6300561|NCT00335556|7203116|FG000|NOT COMPLETED|Overall Study||2
6300562|NCT00335556|7203117|FG001|NOT COMPLETED|Overall Study||34
6300563|NCT00335556|7203118|FG002|NOT COMPLETED|Overall Study||5
6300564|NCT00335556|7203119|FG003|NOT COMPLETED|Overall Study||5
6300565|NCT00335556|7203120|FG004|NOT COMPLETED|Overall Study||1
6300566|NCT00335556|7203121|FG005|NOT COMPLETED|Overall Study||1
6300567|NCT00335725|7203142|FG000|STARTED|Overall Study||75
6300568|NCT00335725|7203143|FG001|STARTED|Overall Study||76
6300569|NCT00335725|7203142|FG000|COMPLETED|Overall Study||71
6300570|NCT00335725|7203143|FG001|COMPLETED|Overall Study||71
6300571|NCT00335725|7203142|FG000|NOT COMPLETED|Overall Study||4
6300572|NCT00335725|7203143|FG001|NOT COMPLETED|Overall Study||5
6300573|NCT00335738|7203152|FG000|STARTED|Overall Study||108
6300574|NCT00335738|7203153|FG001|STARTED|Overall Study||223
6300575|NCT00335738|7203152|FG000|COMPLETED|Overall Study||97
6300576|NCT00335738|7203153|FG001|COMPLETED|Overall Study||219
6300577|NCT00335738|7203152|FG000|NOT COMPLETED|Overall Study||11
6300578|NCT00335738|7203153|FG001|NOT COMPLETED|Overall Study||4
6300579|NCT00335764|7203165|FG000|STARTED|Overall Study||17
6300580|NCT00335764|7203166|FG001|STARTED|Overall Study||13
6300581|NCT00335764|7203167|FG002|STARTED|Overall Study||24
6300582|NCT00335764|7203168|FG003|STARTED|Overall Study||19
6300583|NCT00335764|7203169|FG004|STARTED|Overall Study||19
6300584|NCT00335764|7203165|FG000|COMPLETED|Overall Study||16
6300585|NCT00335764|7203166|FG001|COMPLETED|Overall Study||13
6300586|NCT00335764|7203167|FG002|COMPLETED|Overall Study||24
6300587|NCT00335764|7203168|FG003|COMPLETED|Overall Study||19
6300588|NCT00335764|7203169|FG004|COMPLETED|Overall Study||18
6300589|NCT00335764|7203165|FG000|NOT COMPLETED|Overall Study||1
6300590|NCT00335764|7203166|FG001|NOT COMPLETED|Overall Study||0
6300591|NCT00335764|7203167|FG002|NOT COMPLETED|Overall Study||0
6300592|NCT00335764|7203168|FG003|NOT COMPLETED|Overall Study||0
6300593|NCT00335764|7203169|FG004|NOT COMPLETED|Overall Study||1
6300594|NCT00335829|7203205|FG000|STARTED|Overall Study||26
6300595|NCT00335829|7203205|FG000|Received Bevacizumab|Overall Study||26
6300596|NCT00335829|7203205|FG000|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
6300597|NCT00335829|7203205|FG000|COMPLETED|Overall Study||23
6300598|NCT00335829|7203205|FG000|NOT COMPLETED|Overall Study||3
6300599|NCT00335959|7203209|FG000|STARTED|Overall Study||7
6300600|NCT00335959|7203209|FG000|Eligible|Overall Study||6
6300601|NCT00335959|7203209|FG000|Eligible and Began Protocol Therapy|Overall Study||6
6300602|NCT00335959|7203209|FG000|COMPLETED|Overall Study||4
6300603|NCT00335959|7203209|FG000|NOT COMPLETED|Overall Study||3
6300604|NCT00335972|7203216|FG000|STARTED|Overall Study||71
6300605|NCT00335972|7203217|FG001|STARTED|Overall Study||71
6300606|NCT00335972|7203216|FG000|COMPLETED|Overall Study||71
6300607|NCT00335972|7203217|FG001|COMPLETED|Overall Study||68
6300608|NCT00335972|7203216|FG000|NOT COMPLETED|Overall Study||0
6300609|NCT00335972|7203217|FG001|NOT COMPLETED|Overall Study||3
6300610|NCT00336024|7203225|FG000|STARTED|Overall Study||46
6300611|NCT00336024|7203226|FG001|STARTED|Overall Study||45
6300612|NCT00336024|7203225|FG000|COMPLETED|Overall Study||26
6300613|NCT00336024|7203226|FG001|COMPLETED|Overall Study||26
6300614|NCT00336024|7203225|FG000|NOT COMPLETED|Overall Study||20
6300615|NCT00336024|7203226|FG001|NOT COMPLETED|Overall Study||19
6300616|NCT00336232|7203232|FG000|STARTED|Baseline (200mcg Daily)||59
6300617|NCT00336232|7203232|FG000|COMPLETED|Baseline (200mcg Daily)||42
6300618|NCT00336232|7203232|FG000|NOT COMPLETED|Baseline (200mcg Daily)||17
6300619|NCT00336232|7203232|FG000|STARTED|Low Vitamin K (10mcg Daily)||42
6300620|NCT00336232|7203232|FG000|COMPLETED|Low Vitamin K (10mcg Daily)||42
6300621|NCT00336232|7203232|FG000|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
6300622|NCT00336232|7203232|FG000|STARTED|High Vitamin K (500mcg Daily)||42
6300623|NCT00336232|7203232|FG000|COMPLETED|High Vitamin K (500mcg Daily)||42
6300624|NCT00336232|7203232|FG000|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
6300625|NCT00336284|7203238|FG000|STARTED|Overall Study||977
6300626|NCT00336284|7203239|FG001|STARTED|Overall Study||473
6300627|NCT00336284|7203238|FG000|COMPLETED|Overall Study||741
6300628|NCT00336284|7203239|FG001|COMPLETED|Overall Study||322
6300629|NCT00336284|7203238|FG000|NOT COMPLETED|Overall Study||236
6300630|NCT00336284|7203239|FG001|NOT COMPLETED|Overall Study||151
6300631|NCT00336323|7203250|FG000|STARTED|Overall Study||19
6300632|NCT00336323|7203251|FG001|STARTED|Overall Study||22
6300633|NCT00336323|7203252|FG002|STARTED|Overall Study||24
6300634|NCT00336323|7203253|FG003|STARTED|Overall Study||22
6300635|NCT00336323|7203254|FG004|STARTED|Overall Study||22
6300636|NCT00336323|7203250|FG000|3 Week Visit|Overall Study||18
6300637|NCT00336323|7203251|FG001|3 Week Visit|Overall Study||21
6300638|NCT00336323|7203252|FG002|3 Week Visit|Overall Study||24
6300639|NCT00336323|7203253|FG003|3 Week Visit|Overall Study||22
6300640|NCT00336323|7203254|FG004|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
6300641|NCT00336323|7203250|FG000|6 Week Visit|Overall Study||18
6300642|NCT00336323|7203251|FG001|6 Week Visit|Overall Study||22
6300643|NCT00336323|7203252|FG002|6 Week Visit|Overall Study||24
6300644|NCT00336323|7203253|FG003|6 Week Visit|Overall Study||22
6300645|NCT00336323|7203254|FG004|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
6300646|NCT00336323|7203250|FG000|9 Week Visit|Overall Study||18
6300647|NCT00336323|7203251|FG001|9 Week Visit|Overall Study||21
6300648|NCT00336323|7203252|FG002|9 Week Visit|Overall Study||23
6300649|NCT00336323|7203253|FG003|9 Week Visit|Overall Study||21
6300650|NCT00336323|7203254|FG004|9 Week Visit|Overall Study||19
6300651|NCT00336323|7203250|FG000|12 Week Visit|Overall Study||19
6300652|NCT00336323|7203251|FG001|12 Week Visit|Overall Study||21
6300653|NCT00336323|7203252|FG002|12 Week Visit|Overall Study||24
6300654|NCT00336323|7203253|FG003|12 Week Visit|Overall Study||22
6300655|NCT00336323|7203254|FG004|12 Week Visit|Overall Study|1 patient was dropped from study|20
6300656|NCT00336323|7203250|FG000|18 Week Visit|Overall Study||19
6300657|NCT00336323|7203251|FG001|18 Week Visit|Overall Study||22
6300658|NCT00336323|7203252|FG002|18 Week Visit|Overall Study||23
6300659|NCT00336323|7203253|FG003|18 Week Visit|Overall Study||21
6300660|NCT00336323|7203254|FG004|18 Week Visit|Overall Study|1 patient was dropped from the study|18
6300661|NCT00336323|7203250|FG000|24 Week Visit|Overall Study||18
6300662|NCT00336323|7203251|FG001|24 Week Visit|Overall Study|1 patient was dropped from the study|20
6300663|NCT00336323|7203252|FG002|24 Week Visit|Overall Study|1 patient was dropped from the study|22
6300664|NCT00336323|7203253|FG003|24 Week Visit|Overall Study||22
6300665|NCT00336323|7203254|FG004|24 Week Visit|Overall Study||19
6300666|NCT00336323|7203250|FG000|COMPLETED|Overall Study||19
6300667|NCT00336323|7203251|FG001|COMPLETED|Overall Study||21
6300668|NCT00336323|7203252|FG002|COMPLETED|Overall Study||23
6300669|NCT00336323|7203253|FG003|COMPLETED|Overall Study||22
6300670|NCT00336323|7203254|FG004|COMPLETED|Overall Study||19
6300671|NCT00336323|7203250|FG000|NOT COMPLETED|Overall Study||0
6300672|NCT00336323|7203251|FG001|NOT COMPLETED|Overall Study||1
6300673|NCT00336323|7203252|FG002|NOT COMPLETED|Overall Study||1
6300674|NCT00336323|7203253|FG003|NOT COMPLETED|Overall Study||0
6300675|NCT00336323|7203254|FG004|NOT COMPLETED|Overall Study||3
6300676|NCT00336479|7203274|FG000|STARTED|Overall Study||75
6300677|NCT00336479|7203275|FG001|STARTED|Overall Study||79
6300678|NCT00336479|7203276|FG002|STARTED|Overall Study||79
6300679|NCT00336479|7203277|FG003|STARTED|Overall Study||17
6300680|NCT00336479|7203274|FG000|COMPLETED|Overall Study||38
6300681|NCT00336479|7203275|FG001|COMPLETED|Overall Study||54
6300682|NCT00336479|7203276|FG002|COMPLETED|Overall Study||53
6300683|NCT00336479|7203277|FG003|COMPLETED|Overall Study||13
6300684|NCT00336479|7203274|FG000|NOT COMPLETED|Overall Study||37
6300685|NCT00336479|7203275|FG001|NOT COMPLETED|Overall Study||25
6300686|NCT00336479|7203276|FG002|NOT COMPLETED|Overall Study||26
6300687|NCT00336479|7203277|FG003|NOT COMPLETED|Overall Study||4
6300688|NCT00336492|7203291|FG000|STARTED|Overall Study||15
6300689|NCT00336492|7203292|FG001|STARTED|Overall Study||22
6300690|NCT00336492|7203293|FG002|STARTED|Overall Study||23
6300691|NCT00336492|7203291|FG000|COMPLETED|Overall Study||0
6300692|NCT00336492|7203292|FG001|COMPLETED|Overall Study||18
6300693|NCT00336492|7203293|FG002|COMPLETED|Overall Study||12
6300694|NCT00336492|7203291|FG000|NOT COMPLETED|Overall Study||15
6300695|NCT00336492|7203292|FG001|NOT COMPLETED|Overall Study||4
6300696|NCT00336492|7203293|FG002|NOT COMPLETED|Overall Study||11
6300697|NCT00336505|7203303|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|291
6300698|NCT00336505|7203304|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|291
6300699|NCT00336505|7203303|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
6300700|NCT00336505|7203304|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
6300701|NCT00336505|7203303|FG000|NOT COMPLETED|Overall Study||37
6300702|NCT00336505|7203304|FG001|NOT COMPLETED|Overall Study||27
6300703|NCT00336544|7203312|FG000|STARTED|Overall Study|All subjects who were randomized and dosed.|261
6300704|NCT00336544|7203313|FG001|STARTED|Overall Study|All subjects who were randomized and dosed.|260
6300705|NCT00336544|7203312|FG000|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
6300706|NCT00336544|7203313|FG001|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
6300707|NCT00336544|7203312|FG000|NOT COMPLETED|Overall Study||19
6300708|NCT00336544|7203313|FG001|NOT COMPLETED|Overall Study||22
6300709|NCT00336583|7203319|FG000|STARTED|Overall Study||27
6300710|NCT00336583|7203319|FG000|COMPLETED|Overall Study||25
6300711|NCT00336583|7203319|FG000|NOT COMPLETED|Overall Study||2
6300712|NCT00336700|7203323|FG000|STARTED|Overall Study||25
6300713|NCT00336700|7203323|FG000|COMPLETED|Overall Study||25
6300714|NCT00336700|7203323|FG000|NOT COMPLETED|Overall Study||0
6300715|NCT00336817|7203329|FG000|STARTED|Overall Study||15
6300716|NCT00336817|7203330|FG001|STARTED|Overall Study||15
6300717|NCT00336817|7203329|FG000|COMPLETED|Overall Study||14
6300718|NCT00336817|7203330|FG001|COMPLETED|Overall Study||13
6300719|NCT00336817|7203329|FG000|NOT COMPLETED|Overall Study||1
6300720|NCT00336817|7203330|FG001|NOT COMPLETED|Overall Study||2
6300721|NCT00336856|7203338|FG000|STARTED|Overall Study|Number of patients consented and registered for the study|35
6300722|NCT00336856|7203338|FG000|COMPLETED|Overall Study||31
6300723|NCT00336856|7203338|FG000|NOT COMPLETED|Overall Study||4
6300724|NCT00336895|7203342|FG000|STARTED|Overall Study||30
6300725|NCT00336895|7203342|FG000|COMPLETED|Overall Study||26
6635255|NCT02303574|7564184|FG002|COMPLETED|Part 1a (Fasted State)- SAD||5
6635256|NCT02303574|7564185|FG003|COMPLETED|Part 1a (Fasted State)- SAD||6
6635257|NCT02303574|7564186|FG004|COMPLETED|Part 1a (Fasted State)- SAD||6
6635258|NCT02303574|7564187|FG005|COMPLETED|Part 1a (Fasted State)- SAD||0
6635259|NCT02303574|7564188|FG006|COMPLETED|Part 1a (Fasted State)- SAD||0
6635260|NCT02303574|7564189|FG007|COMPLETED|Part 1a (Fasted State)- SAD||0
6635261|NCT02303574|7564190|FG008|COMPLETED|Part 1a (Fasted State)- SAD||0
6635262|NCT02303574|7564191|FG009|COMPLETED|Part 1a (Fasted State)- SAD||15
6635263|NCT02303574|7564182|FG000|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635264|NCT02303574|7564183|FG001|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635265|NCT02303574|7564184|FG002|NOT COMPLETED|Part 1a (Fasted State)- SAD||1
6635266|NCT02303574|7564185|FG003|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635267|NCT02303574|7564186|FG004|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635268|NCT02303574|7564187|FG005|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635269|NCT02303574|7564188|FG006|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635270|NCT02303574|7564189|FG007|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635271|NCT02303574|7564190|FG008|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635272|NCT02303574|7564191|FG009|NOT COMPLETED|Part 1a (Fasted State)- SAD||0
6635273|NCT02303574|7564182|FG000|STARTED|Part 1b (Fed State) - SAD||0
6635274|NCT02303574|7564183|FG001|STARTED|Part 1b (Fed State) - SAD||0
6635275|NCT02303574|7564184|FG002|STARTED|Part 1b (Fed State) - SAD||0
6635276|NCT02303574|7564185|FG003|STARTED|Part 1b (Fed State) - SAD||0
6635277|NCT02303574|7564186|FG004|STARTED|Part 1b (Fed State) - SAD||0
6635278|NCT02303574|7564187|FG005|STARTED|Part 1b (Fed State) - SAD||5
6635279|NCT02303574|7564188|FG006|STARTED|Part 1b (Fed State) - SAD||0
6635280|NCT02303574|7564189|FG007|STARTED|Part 1b (Fed State) - SAD||0
6635281|NCT02303574|7564190|FG008|STARTED|Part 1b (Fed State) - SAD||0
6635282|NCT02303574|7564191|FG009|STARTED|Part 1b (Fed State) - SAD|Participants received AZD7986 matching placebo on Day 1 in fed state.|3
6635283|NCT02303574|7564182|FG000|COMPLETED|Part 1b (Fed State) - SAD||0
6635284|NCT02303574|7564183|FG001|COMPLETED|Part 1b (Fed State) - SAD||0
6635285|NCT02303574|7564184|FG002|COMPLETED|Part 1b (Fed State) - SAD||0
6635286|NCT02303574|7564185|FG003|COMPLETED|Part 1b (Fed State) - SAD||0
6300726|NCT00336895|7203342|FG000|NOT COMPLETED|Overall Study||4
6300727|NCT00337077|7203349|FG000|STARTED|Overall Study||43
6300728|NCT00337077|7203350|FG001|STARTED|Overall Study||53
6300729|NCT00337077|7203351|FG002|STARTED|Overall Study||25
6300730|NCT00337077|7203349|FG000|Treated|Overall Study||42
6300731|NCT00337077|7203350|FG001|Treated|Overall Study||52
6300732|NCT00337077|7203351|FG002|Treated|Overall Study||25
6300733|NCT00337077|7203349|FG000|Toxicity Assessed|Overall Study||42
6300734|NCT00337077|7203350|FG001|Toxicity Assessed|Overall Study||51
6300735|NCT00337077|7203351|FG002|Toxicity Assessed|Overall Study||25
6300736|NCT00337077|7203349|FG000|Eligible and Treated|Overall Study||41
6300737|NCT00337077|7203350|FG001|Eligible and Treated|Overall Study||51
6300738|NCT00337077|7203351|FG002|Eligible and Treated|Overall Study||24
6300739|NCT00337077|7203349|FG000|Patients With Measurable Disease|Overall Study||26
6300740|NCT00337077|7203350|FG001|Patients With Measurable Disease|Overall Study||38
6300741|NCT00337077|7203351|FG002|Patients With Measurable Disease|Overall Study||13
6300742|NCT00337077|7203349|FG000|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
6300743|NCT00337077|7203350|FG001|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
6300744|NCT00337077|7203351|FG002|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
6300745|NCT00337077|7203349|FG000|NOT COMPLETED|Overall Study||43
6300746|NCT00337077|7203350|FG001|NOT COMPLETED|Overall Study||53
6300747|NCT00337077|7203351|FG002|NOT COMPLETED|Overall Study||25
6300748|NCT00337103|7203359|FG000|STARTED|Overall Study||554
6300749|NCT00337103|7203360|FG001|STARTED|Overall Study||548
6300750|NCT00337103|7203359|FG000|Treated (Safety Population)|Overall Study||544
6300751|NCT00337103|7203360|FG001|Treated (Safety Population)|Overall Study||546
6300752|NCT00337103|7203359|FG000|COMPLETED|Overall Study||0
6300753|NCT00337103|7203360|FG001|COMPLETED|Overall Study||0
6300754|NCT00337103|7203359|FG000|NOT COMPLETED|Overall Study||554
6300755|NCT00337103|7203360|FG001|NOT COMPLETED|Overall Study||548
6300756|NCT00337129|7203367|FG000|STARTED|Overall Study||40
6300757|NCT00337129|7203367|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
6300758|NCT00337129|7203367|FG000|NOT COMPLETED|Overall Study||40
6300759|NCT00337168|7203371|FG000|STARTED|Overall Study||37
6300760|NCT00337168|7203371|FG000|Eligible|Overall Study||37
6300761|NCT00337168|7203371|FG000|Eligible and Treated|Overall Study||36
6300762|NCT00337168|7203371|FG000|COMPLETED|Overall Study||29
6300763|NCT00337168|7203371|FG000|NOT COMPLETED|Overall Study||8
6300764|NCT00337181|7203378|FG000|STARTED|Overall Study||49
6300765|NCT00337181|7203379|FG001|STARTED|Overall Study||65
6300766|NCT00337181|7203378|FG000|COMPLETED|Overall Study||49
6300767|NCT00337181|7203379|FG001|COMPLETED|Overall Study||65
6300768|NCT00337181|7203378|FG000|NOT COMPLETED|Overall Study||0
6300769|NCT00337181|7203379|FG001|NOT COMPLETED|Overall Study||0
6300770|NCT00337194|7203387|FG000|STARTED|Overall Study||23
6300771|NCT00337194|7203388|FG001|STARTED|Overall Study||7
6300772|NCT00337194|7203387|FG000|COMPLETED|Overall Study||11
6300773|NCT00337194|7203388|FG001|COMPLETED|Overall Study||3
6300774|NCT00337194|7203387|FG000|NOT COMPLETED|Overall Study||12
6300775|NCT00337194|7203388|FG001|NOT COMPLETED|Overall Study||4
6300776|NCT00337207|7203396|FG000|STARTED|Overall Study||55
6300777|NCT00337207|7203396|FG000|COMPLETED|Overall Study||52
6300778|NCT00337207|7203396|FG000|NOT COMPLETED|Overall Study||3
6300779|NCT00337272|7203403|FG000|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
6300780|NCT00337272|7203404|FG001|STARTED|Screening Period (Pre-randomization)||0
6300781|NCT00337272|7203403|FG000|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
6300782|NCT00337272|7203404|FG001|COMPLETED|Screening Period (Pre-randomization)||0
6300783|NCT00337272|7203403|FG000|NOT COMPLETED|Screening Period (Pre-randomization)||6
6300784|NCT00337272|7203404|FG001|NOT COMPLETED|Screening Period (Pre-randomization)||0
6300785|NCT00337272|7203403|FG000|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
6300786|NCT00337272|7203404|FG001|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
6300787|NCT00337272|7203403|FG000|Randomization|Treatment Period||7
6300788|NCT00337272|7203404|FG001|Randomization|Treatment Period||9
6300789|NCT00337272|7203403|FG000|COMPLETED|Treatment Period||6
6300790|NCT00337272|7203404|FG001|COMPLETED|Treatment Period||7
6300791|NCT00337272|7203403|FG000|NOT COMPLETED|Treatment Period||1
6300792|NCT00337272|7203404|FG001|NOT COMPLETED|Treatment Period||2
6300793|NCT00337272|7203403|FG000|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
6300794|NCT00337272|7203404|FG001|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
6300795|NCT00337272|7203403|FG000|COMPLETED|Withdrawal Period||6
6635287|NCT02303574|7564186|FG004|COMPLETED|Part 1b (Fed State) - SAD||0
6300796|NCT00337272|7203404|FG001|COMPLETED|Withdrawal Period||6
6300797|NCT00337272|7203403|FG000|NOT COMPLETED|Withdrawal Period||0
6300798|NCT00337272|7203404|FG001|NOT COMPLETED|Withdrawal Period||1
6300799|NCT00337285|7203410|FG000|STARTED|Overall Study||349
6300800|NCT00337285|7203410|FG000|COMPLETED|Overall Study||191
6300801|NCT00337285|7203410|FG000|NOT COMPLETED|Overall Study||158
6300802|NCT00337350|7203416|FG000|STARTED|Overall Study||9
6300803|NCT00337350|7203417|FG001|STARTED|Overall Study||11
6300804|NCT00337350|7203416|FG000|COMPLETED|Overall Study||8
6300805|NCT00337350|7203417|FG001|COMPLETED|Overall Study||10
6300806|NCT00337350|7203416|FG000|NOT COMPLETED|Overall Study||1
6300807|NCT00337350|7203417|FG001|NOT COMPLETED|Overall Study||1
6300808|NCT00337428|7203425|FG000|STARTED|Overall Study||419
6300809|NCT00337428|7203426|FG001|STARTED|Overall Study||424
6300810|NCT00337428|7203425|FG000|COMPLETED|Overall Study||415
6300811|NCT00337428|7203426|FG001|COMPLETED|Overall Study||421
6300812|NCT00337428|7203425|FG000|NOT COMPLETED|Overall Study||4
6300813|NCT00337428|7203426|FG001|NOT COMPLETED|Overall Study||3
6300814|NCT00337467|7203432|FG000|STARTED|Overall Study||61
6300815|NCT00337467|7203432|FG000|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
6300816|NCT00337467|7203432|FG000|COMPLETED|Overall Study||51
6300817|NCT00337467|7203432|FG000|NOT COMPLETED|Overall Study||10
6300818|NCT00337571|7203443|FG000|STARTED|Overall Study||52
6300819|NCT00337571|7203444|FG001|STARTED|Overall Study||53
6300820|NCT00337571|7203445|FG002|STARTED|Overall Study||59
6300821|NCT00337571|7203446|FG003|STARTED|Overall Study||54
6300822|NCT00337571|7203443|FG000|COMPLETED|Overall Study||38
6300823|NCT00337571|7203444|FG001|COMPLETED|Overall Study||44
6300824|NCT00337571|7203445|FG002|COMPLETED|Overall Study||49
6300825|NCT00337571|7203446|FG003|COMPLETED|Overall Study||47
6300826|NCT00337571|7203443|FG000|NOT COMPLETED|Overall Study||14
6300827|NCT00337571|7203444|FG001|NOT COMPLETED|Overall Study||9
6300828|NCT00337571|7203445|FG002|NOT COMPLETED|Overall Study||10
6300829|NCT00337571|7203446|FG003|NOT COMPLETED|Overall Study||7
6300830|NCT00337610|7203458|FG000|STARTED|Overall Study||96
6300831|NCT00337610|7203459|FG001|STARTED|Overall Study||94
6300832|NCT00337610|7203458|FG000|Completed Week 18|Overall Study||89
6300833|NCT00337610|7203459|FG001|Completed Week 18|Overall Study||82
6300834|NCT00337610|7203458|FG000|COMPLETED|Overall Study||79
6300835|NCT00337610|7203459|FG001|COMPLETED|Overall Study||80
6300836|NCT00337610|7203458|FG000|NOT COMPLETED|Overall Study||17
6300837|NCT00337610|7203459|FG001|NOT COMPLETED|Overall Study||14
6300838|NCT00337662|7203468|FG000|STARTED|Study Period II||0
6300839|NCT00337662|7203469|FG001|STARTED|Study Period II||0
6300840|NCT00337662|7203470|FG002|STARTED|Study Period II||0
6300841|NCT00337662|7203471|FG003|STARTED|Study Period II||628
6300842|NCT00337662|7203468|FG000|COMPLETED|Study Period II||0
6300843|NCT00337662|7203469|FG001|COMPLETED|Study Period II||0
6300844|NCT00337662|7203470|FG002|COMPLETED|Study Period II||0
6300845|NCT00337662|7203471|FG003|COMPLETED|Study Period II||522
6300846|NCT00337662|7203468|FG000|NOT COMPLETED|Study Period II||0
6300847|NCT00337662|7203469|FG001|NOT COMPLETED|Study Period II||0
6300848|NCT00337662|7203470|FG002|NOT COMPLETED|Study Period II||0
6300849|NCT00337662|7203471|FG003|NOT COMPLETED|Study Period II||106
6300850|NCT00337662|7203468|FG000|STARTED|Study Period III||186
6300851|NCT00337662|7203469|FG001|STARTED|Study Period III||192
6300852|NCT00337662|7203470|FG002|STARTED|Study Period III||144
6300853|NCT00337662|7203471|FG003|STARTED|Study Period III||0
6300854|NCT00337662|7203468|FG000|COMPLETED|Study Period III||126
6300855|NCT00337662|7203469|FG001|COMPLETED|Study Period III||134
6300856|NCT00337662|7203470|FG002|COMPLETED|Study Period III||100
6300857|NCT00337662|7203471|FG003|COMPLETED|Study Period III||0
6300858|NCT00337662|7203468|FG000|NOT COMPLETED|Study Period III||60
6300859|NCT00337662|7203469|FG001|NOT COMPLETED|Study Period III||58
6300860|NCT00337662|7203470|FG002|NOT COMPLETED|Study Period III||44
6300861|NCT00337662|7203471|FG003|NOT COMPLETED|Study Period III||0
6300862|NCT00337727|7203484|FG000|STARTED|Overall Study||430
6300863|NCT00337727|7203485|FG001|STARTED|Overall Study||418
6300864|NCT00337727|7203484|FG000|COMPLETED|Overall Study||412
6300865|NCT00337727|7203485|FG001|COMPLETED|Overall Study||406
6300866|NCT00337727|7203484|FG000|NOT COMPLETED|Overall Study||18
6300867|NCT00337727|7203485|FG001|NOT COMPLETED|Overall Study||12
6300868|NCT00337779|7203493|FG000|STARTED|Overall Study||586
6300869|NCT00337779|7203494|FG001|STARTED|Overall Study||569
6300870|NCT00337779|7203493|FG000|COMPLETED|Overall Study||534
6300871|NCT00337779|7203494|FG001|COMPLETED|Overall Study||490
6300872|NCT00337779|7203493|FG000|NOT COMPLETED|Overall Study||52
6300873|NCT00337779|7203494|FG001|NOT COMPLETED|Overall Study||79
6300874|NCT00337818|7203503|FG000|STARTED|Overall Study||458
6300875|NCT00337818|7203504|FG001|STARTED|Overall Study||154
6300876|NCT00337818|7203505|FG002|STARTED|Overall Study||158
6300877|NCT00337818|7203503|FG000|COMPLETED|Overall Study||169
6300878|NCT00337818|7203504|FG001|COMPLETED|Overall Study||63
6300879|NCT00337818|7203505|FG002|COMPLETED|Overall Study||51
6300880|NCT00337818|7203503|FG000|NOT COMPLETED|Overall Study||289
6300881|NCT00337818|7203504|FG001|NOT COMPLETED|Overall Study||91
6300882|NCT00337818|7203505|FG002|NOT COMPLETED|Overall Study||107
6300883|NCT00337935|7203515|FG000|STARTED|Overall Study||39
6300884|NCT00337935|7203516|FG001|STARTED|Overall Study||118
6300885|NCT00337935|7203515|FG000|COMPLETED|Overall Study||29
6300886|NCT00337935|7203516|FG001|COMPLETED|Overall Study||91
6300887|NCT00337935|7203515|FG000|NOT COMPLETED|Overall Study||10
6300888|NCT00337935|7203516|FG001|NOT COMPLETED|Overall Study||27
6300889|NCT00337987|7203523|FG000|STARTED|Overall Study||49
6300890|NCT00337987|7203523|FG000|COMPLETED|Overall Study||49
6300891|NCT00337987|7203523|FG000|NOT COMPLETED|Overall Study||0
6300892|NCT00338039|7203527|FG000|STARTED|Overall Study||69
6300893|NCT00338039|7203527|FG000|COMPLETED|Overall Study||69
6300894|NCT00338039|7203527|FG000|NOT COMPLETED|Overall Study||0
6300895|NCT00338286|7203533|FG000|STARTED|Overall Study||1048
6300896|NCT00338286|7203534|FG001|STARTED|Overall Study||1050
6300897|NCT00338286|7203533|FG000|COMPLETED|Overall Study||815
6300898|NCT00338286|7203534|FG001|COMPLETED|Overall Study||837
6300899|NCT00338286|7203533|FG000|NOT COMPLETED|Overall Study||233
6401277|NCT00891657|7314197|FG001|STARTED|Overall Study||6
6401278|NCT00891657|7314196|FG000|COMPLETED|Overall Study||8
6401279|NCT00891657|7314197|FG001|COMPLETED|Overall Study||5
6401280|NCT00891657|7314196|FG000|NOT COMPLETED|Overall Study||1
6401281|NCT00891657|7314197|FG001|NOT COMPLETED|Overall Study||1
6401282|NCT00891735|7314207|FG000|STARTED|Overall Study||275
6401283|NCT00891735|7314208|FG001|STARTED|Overall Study||274
6401284|NCT00891735|7314209|FG002|STARTED|Overall Study||275
6401285|NCT00891735|7314210|FG003|STARTED|Overall Study||273
6401286|NCT00891735|7314207|FG000|COMPLETED|Overall Study||258
6401287|NCT00891735|7314208|FG001|COMPLETED|Overall Study||258
6401288|NCT00891735|7314209|FG002|COMPLETED|Overall Study||263
6401289|NCT00891735|7314210|FG003|COMPLETED|Overall Study||258
6401290|NCT00891735|7314207|FG000|NOT COMPLETED|Overall Study||17
6401291|NCT00891735|7314208|FG001|NOT COMPLETED|Overall Study||16
6401292|NCT00891735|7314209|FG002|NOT COMPLETED|Overall Study||12
6401293|NCT00891735|7314210|FG003|NOT COMPLETED|Overall Study||15
6401294|NCT00891774|7314220|FG000|STARTED|Overall Study||172
6401295|NCT00891774|7314220|FG000|COMPLETED|Overall Study||158
6401296|NCT00891774|7314220|FG000|NOT COMPLETED|Overall Study||14
6401297|NCT00891813|7314224|FG000|STARTED|Overall Study||100
6401298|NCT00891813|7314224|FG000|COMPLETED|Overall Study||88
6401299|NCT00891813|7314224|FG000|NOT COMPLETED|Overall Study||12
6401300|NCT00891839|7314228|FG000|STARTED|Overall Study||45
6401301|NCT00891839|7314228|FG000|COMPLETED|Overall Study|completed treatment|38
6401302|NCT00891839|7314228|FG000|NOT COMPLETED|Overall Study||7
6401303|NCT00891878|7314234|FG000|STARTED|Overall Study||6
6401304|NCT00891878|7314235|FG001|STARTED|Overall Study||6
6401305|NCT00891878|7314234|FG000|COMPLETED|Overall Study||6
6401306|NCT00891878|7314235|FG001|COMPLETED|Overall Study||6
6401307|NCT00891878|7314234|FG000|NOT COMPLETED|Overall Study||0
6401308|NCT00891878|7314235|FG001|NOT COMPLETED|Overall Study||0
6401309|NCT00891930|7314241|FG000|STARTED|Part 1: Panitumumab +Irinotecan||76
6401310|NCT00891930|7314241|FG000|Received Treatment|Part 1: Panitumumab +Irinotecan||74
6401311|NCT00891930|7314241|FG000|COMPLETED|Part 1: Panitumumab +Irinotecan||36
6401312|NCT00891930|7314241|FG000|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
6401313|NCT00891930|7314241|FG000|STARTED|Part 2: Panitumumab + Ganitumab||36
6401314|NCT00891930|7314241|FG000|COMPLETED|Part 2: Panitumumab + Ganitumab||5
6401315|NCT00891930|7314241|FG000|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
6401316|NCT00891982|7314251|FG000|STARTED|Overall Study||30
6401317|NCT00891982|7314252|FG001|STARTED|Overall Study||31
6401318|NCT00891982|7314251|FG000|COMPLETED|Overall Study||28
6401319|NCT00891982|7314252|FG001|COMPLETED|Overall Study||30
6401320|NCT00891982|7314251|FG000|NOT COMPLETED|Overall Study||2
6401321|NCT00891982|7314252|FG001|NOT COMPLETED|Overall Study||1
6401322|NCT00891995|7314260|FG000|STARTED|Overall Study||50
6401323|NCT00891995|7314261|FG001|STARTED|Overall Study||21
6401324|NCT00891995|7314260|FG000|COMPLETED|Overall Study||50
6401325|NCT00891995|7314261|FG001|COMPLETED|Overall Study||21
6401326|NCT00891995|7314260|FG000|NOT COMPLETED|Overall Study||0
6401327|NCT00891995|7314261|FG001|NOT COMPLETED|Overall Study||0
6401328|NCT00892008|7314267|FG000|STARTED|Overall Study||2278
6401329|NCT00892008|7314267|FG000|COMPLETED|Overall Study||1713
6401330|NCT00892008|7314267|FG000|NOT COMPLETED|Overall Study||565
6401331|NCT00892047|7314273|FG000|STARTED|Overall Study||91
6401332|NCT00892047|7314274|FG001|STARTED|Overall Study||90
6401333|NCT00892047|7314273|FG000|COMPLETED|Overall Study||87
6401334|NCT00892047|7314274|FG001|COMPLETED|Overall Study||83
6401335|NCT00892047|7314273|FG000|NOT COMPLETED|Overall Study||4
6401336|NCT00892047|7314274|FG001|NOT COMPLETED|Overall Study||7
6401337|NCT00892099|7314285|FG000|STARTED|Overall Study||36
6401338|NCT00892099|7314286|FG001|STARTED|Overall Study||33
6401339|NCT00892099|7314287|FG002|STARTED|Overall Study||36
6401340|NCT00892099|7314285|FG000|COMPLETED|Overall Study||31
6401341|NCT00892099|7314286|FG001|COMPLETED|Overall Study||32
6401342|NCT00892099|7314287|FG002|COMPLETED|Overall Study||29
6401343|NCT00892099|7314285|FG000|NOT COMPLETED|Overall Study||5
6401344|NCT00892099|7314286|FG001|NOT COMPLETED|Overall Study||1
6401345|NCT00892099|7314287|FG002|NOT COMPLETED|Overall Study||7
6401346|NCT00892151|7314295|FG000|STARTED|Overall Study||51
6401347|NCT00892151|7314295|FG000|COMPLETED|Overall Study||50
6401348|NCT00892151|7314295|FG000|NOT COMPLETED|Overall Study||1
6401349|NCT00892177|7314302|FG000|STARTED|Phase I: Dose Level 0||3
6401350|NCT00892177|7314303|FG001|STARTED|Phase I: Dose Level 0||0
6401351|NCT00892177|7314304|FG002|STARTED|Phase I: Dose Level 0||0
6401352|NCT00892177|7314305|FG003|STARTED|Phase I: Dose Level 0||0
6401353|NCT00892177|7314306|FG004|STARTED|Phase I: Dose Level 0||0
6401354|NCT00892177|7314307|FG005|STARTED|Phase I: Dose Level 0||0
6401355|NCT00892177|7314302|FG000|COMPLETED|Phase I: Dose Level 0||3
6300900|NCT00338286|7203534|FG001|NOT COMPLETED|Overall Study||213
6374711|NCT00751101|7285228|FG001|STARTED|Overall Study||12
6374712|NCT00751101|7285227|FG000|Started Capecitabine|Overall Study||11
6374713|NCT00751101|7285228|FG001|Started Capecitabine|Overall Study||11
6374714|NCT00751101|7285227|FG000|COMPLETED|Overall Study||10
6374715|NCT00751101|7285228|FG001|COMPLETED|Overall Study||7
6374716|NCT00751101|7285227|FG000|NOT COMPLETED|Overall Study||2
6374717|NCT00751101|7285228|FG001|NOT COMPLETED|Overall Study||5
6374718|NCT00751114|7285240|FG000|STARTED|Overall Study|randomized|250
6374719|NCT00751114|7285241|FG001|STARTED|Overall Study||265
6374720|NCT00751114|7285240|FG000|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
6374721|NCT00751114|7285241|FG001|TREATED = Safety Population|Overall Study||264
6374722|NCT00751114|7285240|FG000|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
6374723|NCT00751114|7285241|FG001|mITT Population|Overall Study||253
6374724|NCT00751114|7285240|FG000|COMPLETED|Overall Study||212
6374725|NCT00751114|7285241|FG001|COMPLETED|Overall Study||233
6374726|NCT00751114|7285240|FG000|NOT COMPLETED|Overall Study||38
6374727|NCT00751114|7285241|FG001|NOT COMPLETED|Overall Study||32
6374728|NCT00751140|7285247|FG000|STARTED|Overall Study||20
6374729|NCT00751140|7285247|FG000|COMPLETED|Overall Study||19
6374730|NCT00751140|7285247|FG000|NOT COMPLETED|Overall Study||1
6374731|NCT00751179|7285257|FG000|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
6374732|NCT00751179|7285258|FG001|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
6401356|NCT00892177|7314303|FG001|COMPLETED|Phase I: Dose Level 0||0
6401357|NCT00892177|7314304|FG002|COMPLETED|Phase I: Dose Level 0||0
6401358|NCT00892177|7314305|FG003|COMPLETED|Phase I: Dose Level 0||0
6374733|NCT00751179|7285257|FG000|COMPLETED|Overall Study||62
6374734|NCT00751179|7285258|FG001|COMPLETED|Overall Study||70
6374735|NCT00751179|7285257|FG000|NOT COMPLETED|Overall Study||14
6374736|NCT00751179|7285258|FG001|NOT COMPLETED|Overall Study||15
6374737|NCT00751296|7285265|FG000|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
6374738|NCT00751296|7285265|FG000|COMPLETED|Overall Study||25
6374739|NCT00751296|7285265|FG000|NOT COMPLETED|Overall Study||2
6374740|NCT00751348|7285271|FG000|STARTED|Overall Study||313
6374741|NCT00751348|7285272|FG001|STARTED|Overall Study||161
6374742|NCT00751348|7285271|FG000|COMPLETED|Overall Study||307
6374743|NCT00751348|7285272|FG001|COMPLETED|Overall Study||159
6374744|NCT00751348|7285271|FG000|NOT COMPLETED|Overall Study||6
6374745|NCT00751348|7285272|FG001|NOT COMPLETED|Overall Study||2
6374746|NCT00751400|7285278|FG000|STARTED|Overall Study||497
6374747|NCT00751400|7285278|FG000|Subjects Provided Drug|Overall Study||497
6374748|NCT00751400|7285278|FG000|Subjects Consumed Drug|Overall Study||485
6374749|NCT00751400|7285278|FG000|Subjects Provided Detailed Use Data|Overall Study||467
6374750|NCT00751400|7285278|FG000|COMPLETED|Overall Study||487
6374751|NCT00751400|7285278|FG000|NOT COMPLETED|Overall Study||10
6377832|NCT00765336|7288490|FG000|COMPLETED|Overall Study||72
6377833|NCT00765336|7288491|FG001|COMPLETED|Overall Study||73
6377834|NCT00765336|7288490|FG000|NOT COMPLETED|Overall Study||19
6377835|NCT00765336|7288491|FG001|NOT COMPLETED|Overall Study||16
6377836|NCT00765362|7288497|FG000|STARTED|Overall Study||419
6377837|NCT00765362|7288497|FG000|COMPLETED|Overall Study||282
6377838|NCT00765362|7288497|FG000|NOT COMPLETED|Overall Study||137
6377839|NCT00765375|7288501|FG000|STARTED|Overall Study||5
6377840|NCT00765375|7288501|FG000|COMPLETED|Overall Study||5
6401359|NCT00892177|7314306|FG004|COMPLETED|Phase I: Dose Level 0||0
6401360|NCT00892177|7314307|FG005|COMPLETED|Phase I: Dose Level 0||0
6401361|NCT00892177|7314302|FG000|NOT COMPLETED|Phase I: Dose Level 0||0
6401362|NCT00892177|7314303|FG001|NOT COMPLETED|Phase I: Dose Level 0||0
6401363|NCT00892177|7314304|FG002|NOT COMPLETED|Phase I: Dose Level 0||0
6401364|NCT00892177|7314305|FG003|NOT COMPLETED|Phase I: Dose Level 0||0
6401365|NCT00892177|7314306|FG004|NOT COMPLETED|Phase I: Dose Level 0||0
6401366|NCT00892177|7314307|FG005|NOT COMPLETED|Phase I: Dose Level 0||0
6401367|NCT00892177|7314302|FG000|STARTED|Phase I: Dose Level 1||0
6401368|NCT00892177|7314303|FG001|STARTED|Phase I: Dose Level 1||4
6401369|NCT00892177|7314304|FG002|STARTED|Phase I: Dose Level 1||0
6401370|NCT00892177|7314305|FG003|STARTED|Phase I: Dose Level 1||0
6401371|NCT00892177|7314306|FG004|STARTED|Phase I: Dose Level 1||0
6401372|NCT00892177|7314307|FG005|STARTED|Phase I: Dose Level 1||0
6401373|NCT00892177|7314302|FG000|COMPLETED|Phase I: Dose Level 1||0
6401374|NCT00892177|7314303|FG001|COMPLETED|Phase I: Dose Level 1||4
6401375|NCT00892177|7314304|FG002|COMPLETED|Phase I: Dose Level 1||0
6401376|NCT00892177|7314305|FG003|COMPLETED|Phase I: Dose Level 1||0
6401377|NCT00892177|7314306|FG004|COMPLETED|Phase I: Dose Level 1||0
6401378|NCT00892177|7314307|FG005|COMPLETED|Phase I: Dose Level 1||0
6401379|NCT00892177|7314302|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
6401380|NCT00892177|7314303|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
6401381|NCT00892177|7314304|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
6401382|NCT00892177|7314305|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
6401383|NCT00892177|7314306|FG004|NOT COMPLETED|Phase I: Dose Level 1||0
6401384|NCT00892177|7314307|FG005|NOT COMPLETED|Phase I: Dose Level 1||0
6401385|NCT00892177|7314302|FG000|STARTED|Phase I: Dose Level 2||0
6401386|NCT00892177|7314303|FG001|STARTED|Phase I: Dose Level 2||0
6401387|NCT00892177|7314304|FG002|STARTED|Phase I: Dose Level 2||3
6401388|NCT00892177|7314305|FG003|STARTED|Phase I: Dose Level 2||0
6300901|NCT00338598|7203542|FG000|STARTED|Overall Study||10
6300902|NCT00338598|7203543|FG001|STARTED|Overall Study||10
6300903|NCT00338598|7203542|FG000|COMPLETED|Overall Study||10
6300904|NCT00338598|7203543|FG001|COMPLETED|Overall Study||8
6300905|NCT00338598|7203542|FG000|NOT COMPLETED|Overall Study||0
6300906|NCT00338598|7203543|FG001|NOT COMPLETED|Overall Study||2
6300907|NCT00338728|7203549|FG000|STARTED|Overall Study||59
6300908|NCT00338728|7203549|FG000|COMPLETED|Overall Study||45
6300909|NCT00338728|7203549|FG000|NOT COMPLETED|Overall Study||14
6300910|NCT00338741|7203555|FG000|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
6300911|NCT00338741|7203556|FG001|STARTED|Overall Study||2
6300912|NCT00338741|7203555|FG000|COMPLETED|Overall Study||32
6300913|NCT00338741|7203556|FG001|COMPLETED|Overall Study||2
6300914|NCT00338741|7203555|FG000|NOT COMPLETED|Overall Study||2
6300915|NCT00338741|7203556|FG001|NOT COMPLETED|Overall Study||0
6300916|NCT00338806|7203564|FG000|STARTED|Acute Phase||2
6300917|NCT00338806|7203565|FG001|STARTED|Acute Phase||5
6300918|NCT00338806|7203564|FG000|COMPLETED|Acute Phase||2
6300919|NCT00338806|7203565|FG001|COMPLETED|Acute Phase||4
6300920|NCT00338806|7203564|FG000|NOT COMPLETED|Acute Phase||0
6300921|NCT00338806|7203565|FG001|NOT COMPLETED|Acute Phase||1
6300922|NCT00338806|7203564|FG000|STARTED|Follow-up||2
6300923|NCT00338806|7203565|FG001|STARTED|Follow-up||4
6300924|NCT00338806|7203564|FG000|COMPLETED|Follow-up||1
6300925|NCT00338806|7203565|FG001|COMPLETED|Follow-up||1
6300926|NCT00338806|7203564|FG000|NOT COMPLETED|Follow-up||1
6300927|NCT00338806|7203565|FG001|NOT COMPLETED|Follow-up||3
6300928|NCT00338884|7203573|FG000|STARTED|Overall Study||120
6300929|NCT00338884|7203573|FG000|Received Treatment|Overall Study||119
6300930|NCT00338884|7203573|FG000|COMPLETED|Overall Study||42
6300931|NCT00338884|7203573|FG000|NOT COMPLETED|Overall Study||78
6300932|NCT00338949|7203579|FG000|STARTED|Subject Screening||36
6300933|NCT00338949|7203580|FG001|STARTED|Subject Screening||41
6300934|NCT00338949|7203579|FG000|COMPLETED|Subject Screening||25
6300935|NCT00338949|7203580|FG001|COMPLETED|Subject Screening||30
6300936|NCT00338949|7203579|FG000|NOT COMPLETED|Subject Screening||11
6300937|NCT00338949|7203580|FG001|NOT COMPLETED|Subject Screening||11
6300938|NCT00338949|7203579|FG000|STARTED|Randomization||25
6300939|NCT00338949|7203580|FG001|STARTED|Randomization||30
6300940|NCT00338949|7203579|FG000|COMPLETED|Randomization|1 subject withdrew after relapse and hospitalization|24
6300941|NCT00338949|7203580|FG001|COMPLETED|Randomization|"Reasons for drop out:~2- insomnia 2- symptom exacerbation~1- akathisia"|25
6300942|NCT00338949|7203579|FG000|NOT COMPLETED|Randomization||1
6300943|NCT00338949|7203580|FG001|NOT COMPLETED|Randomization||5
6300944|NCT00338962|7203590|FG000|STARTED|Overall Study||22
6300945|NCT00338962|7203591|FG001|STARTED|Overall Study||20
6300946|NCT00338962|7203592|FG002|STARTED|Overall Study||22
6300947|NCT00338962|7203593|FG003|STARTED|Overall Study||24
6300948|NCT00338962|7203590|FG000|COMPLETED|Overall Study||14
6300949|NCT00338962|7203591|FG001|COMPLETED|Overall Study||16
6300950|NCT00338962|7203592|FG002|COMPLETED|Overall Study||16
6300951|NCT00338962|7203593|FG003|COMPLETED|Overall Study||21
6300952|NCT00338962|7203590|FG000|NOT COMPLETED|Overall Study||8
6300953|NCT00338962|7203591|FG001|NOT COMPLETED|Overall Study||4
6300954|NCT00338962|7203592|FG002|NOT COMPLETED|Overall Study||6
6300955|NCT00338962|7203593|FG003|NOT COMPLETED|Overall Study||3
6300956|NCT00338988|7203603|FG000|STARTED|Overall Study||44
6300957|NCT00338988|7203603|FG000|COMPLETED|Overall Study||43
6300958|NCT00338988|7203603|FG000|NOT COMPLETED|Overall Study||1
6300959|NCT00339040|7203610|FG000|STARTED|Stage I||96
6300960|NCT00339040|7203611|FG001|STARTED|Stage I||30
6300961|NCT00339040|7203610|FG000|Vaccination 1 at Week 0|Stage I||96
6300962|NCT00339040|7203611|FG001|Vaccination 1 at Week 0|Stage I||30
6300963|NCT00339040|7203610|FG000|Vaccination 2 at Week 8|Stage I||95
6300964|NCT00339040|7203611|FG001|Vaccination 2 at Week 8|Stage I||30
6300965|NCT00339040|7203610|FG000|Vaccination 3 at Week 24|Stage I||94
6300966|NCT00339040|7203611|FG001|Vaccination 3 at Week 24|Stage I||30
6300967|NCT00339040|7203610|FG000|COMPLETED|Stage I||94
6300968|NCT00339040|7203611|FG001|COMPLETED|Stage I||29
6300969|NCT00339040|7203610|FG000|NOT COMPLETED|Stage I||2
6300970|NCT00339040|7203611|FG001|NOT COMPLETED|Stage I||1
6300971|NCT00339040|7203610|FG000|STARTED|Stage II||94
6300972|NCT00339040|7203611|FG001|STARTED|Stage II||29
6300973|NCT00339040|7203610|FG000|Vaccination 4 at Week 96|Stage II||84
6300974|NCT00339040|7203611|FG001|Vaccination 4 at Week 96|Stage II||29
6300975|NCT00339040|7203610|FG000|Vaccination 5 at Week 104|Stage II||0
6300976|NCT00339040|7203611|FG001|Vaccination 5 at Week 104|Stage II||28
6300977|NCT00339040|7203610|FG000|Vaccination 6 at Week 120|Stage II||0
6300978|NCT00339040|7203611|FG001|Vaccination 6 at Week 120|Stage II||27
6300979|NCT00339040|7203610|FG000|COMPLETED|Stage II||84
6300980|NCT00339040|7203611|FG001|COMPLETED|Stage II||27
6300981|NCT00339040|7203610|FG000|NOT COMPLETED|Stage II||10
6300982|NCT00339040|7203611|FG001|NOT COMPLETED|Stage II||2
6300983|NCT00339079|7203621|FG000|STARTED|Overall Study||53
6300984|NCT00339079|7203622|FG001|STARTED|Overall Study||44
6300985|NCT00339079|7203623|FG002|STARTED|Overall Study||45
6300986|NCT00339079|7203624|FG003|STARTED|Overall Study||53
6300987|NCT00339079|7203621|FG000|COMPLETED|Overall Study||20
6300988|NCT00339079|7203622|FG001|COMPLETED|Overall Study||21
6300989|NCT00339079|7203623|FG002|COMPLETED|Overall Study||27
6300990|NCT00339079|7203624|FG003|COMPLETED|Overall Study||29
6300991|NCT00339079|7203621|FG000|NOT COMPLETED|Overall Study||33
6300992|NCT00339079|7203622|FG001|NOT COMPLETED|Overall Study||23
6300993|NCT00339079|7203623|FG002|NOT COMPLETED|Overall Study||18
6300994|NCT00339079|7203624|FG003|NOT COMPLETED|Overall Study||24
6300995|NCT00339144|7203641|FG000|STARTED|Overall Study|Number of participants enrolled and treated|9
6300996|NCT00339144|7203642|FG001|STARTED|Overall Study|Number of participants enrolled and treated|3
6300997|NCT00339144|7203643|FG002|STARTED|Overall Study|Number of participants enrolled and treated|4
6300998|NCT00339144|7203641|FG000|COMPLETED|Overall Study||0
6300999|NCT00339144|7203642|FG001|COMPLETED|Overall Study||0
6301000|NCT00339144|7203643|FG002|COMPLETED|Overall Study||0
6301001|NCT00339144|7203641|FG000|NOT COMPLETED|Overall Study||9
6301002|NCT00339144|7203642|FG001|NOT COMPLETED|Overall Study||3
6301003|NCT00339144|7203643|FG002|NOT COMPLETED|Overall Study||4
6301004|NCT00339183|7203654|FG000|STARTED|Overall Study||591
6301005|NCT00339183|7203655|FG001|STARTED|Overall Study||595
6301006|NCT00339183|7203654|FG000|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
6301007|NCT00339183|7203655|FG001|Received Study Drug|Overall Study||593
6301008|NCT00339183|7203654|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
6301009|NCT00339183|7203655|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
6301010|NCT00339183|7203654|FG000|NOT COMPLETED|Overall Study||121
6301011|NCT00339183|7203655|FG001|NOT COMPLETED|Overall Study||105
6301012|NCT00339833|7203667|FG000|STARTED|Overall Study||28
6301013|NCT00339833|7203668|FG001|STARTED|Overall Study||26
6301014|NCT00339833|7203667|FG000|COMPLETED|Overall Study||22
6301015|NCT00339833|7203668|FG001|COMPLETED|Overall Study||18
6301016|NCT00339833|7203667|FG000|NOT COMPLETED|Overall Study||6
6301017|NCT00339833|7203668|FG001|NOT COMPLETED|Overall Study||8
6301018|NCT00340379|7203676|FG000|STARTED|Overall Study||35
6301019|NCT00340379|7203677|FG001|STARTED|Overall Study||37
6301020|NCT00340379|7203676|FG000|COMPLETED|Overall Study||27
6301021|NCT00340379|7203677|FG001|COMPLETED|Overall Study||28
6301022|NCT00340379|7203676|FG000|NOT COMPLETED|Overall Study||8
6301023|NCT00340379|7203677|FG001|NOT COMPLETED|Overall Study||9
6301024|NCT00340678|7203687|FG000|STARTED|Overall Study||46
6301025|NCT00340678|7203688|FG001|STARTED|Overall Study||46
6301026|NCT00340678|7203689|FG002|STARTED|Overall Study||39
6301027|NCT00340678|7203690|FG003|STARTED|Overall Study||39
6301028|NCT00340678|7203687|FG000|COMPLETED|Overall Study||45
6301029|NCT00340678|7203688|FG001|COMPLETED|Overall Study||46
6301030|NCT00340678|7203689|FG002|COMPLETED|Overall Study||39
6301031|NCT00340678|7203690|FG003|COMPLETED|Overall Study||39
6301032|NCT00340678|7203687|FG000|NOT COMPLETED|Overall Study||1
6301033|NCT00340678|7203688|FG001|NOT COMPLETED|Overall Study||0
6301034|NCT00340678|7203689|FG002|NOT COMPLETED|Overall Study||0
6301035|NCT00340678|7203690|FG003|NOT COMPLETED|Overall Study||0
6301036|NCT00340704|7203707|FG000|STARTED|PK Study||10
6301037|NCT00340704|7203708|FG001|STARTED|PK Study||10
6301038|NCT00340704|7203709|FG002|STARTED|PK Study||11
6301039|NCT00340704|7203710|FG003|STARTED|PK Study||0
6301040|NCT00340704|7203711|FG004|STARTED|PK Study||0
6301041|NCT00340704|7203712|FG005|STARTED|PK Study||0
6301042|NCT00340704|7203713|FG006|STARTED|PK Study||0
6301043|NCT00340704|7203714|FG007|STARTED|PK Study||0
6301044|NCT00340704|7203715|FG008|STARTED|PK Study||0
6301045|NCT00340704|7203707|FG000|COMPLETED|PK Study||10
6301046|NCT00340704|7203708|FG001|COMPLETED|PK Study||9
6301047|NCT00340704|7203709|FG002|COMPLETED|PK Study||10
6301048|NCT00340704|7203710|FG003|COMPLETED|PK Study||0
6301049|NCT00340704|7203711|FG004|COMPLETED|PK Study||0
6301050|NCT00340704|7203712|FG005|COMPLETED|PK Study||0
6301051|NCT00340704|7203713|FG006|COMPLETED|PK Study||0
6301052|NCT00340704|7203714|FG007|COMPLETED|PK Study||0
6301053|NCT00340704|7203715|FG008|COMPLETED|PK Study||0
6301054|NCT00340704|7203707|FG000|NOT COMPLETED|PK Study||0
6301055|NCT00340704|7203708|FG001|NOT COMPLETED|PK Study||1
6301056|NCT00340704|7203709|FG002|NOT COMPLETED|PK Study||1
6301057|NCT00340704|7203710|FG003|NOT COMPLETED|PK Study||0
6301058|NCT00340704|7203711|FG004|NOT COMPLETED|PK Study||0
6301059|NCT00340704|7203712|FG005|NOT COMPLETED|PK Study||0
6301060|NCT00340704|7203713|FG006|NOT COMPLETED|PK Study||0
6301061|NCT00340704|7203714|FG007|NOT COMPLETED|PK Study||0
6301062|NCT00340704|7203715|FG008|NOT COMPLETED|PK Study||0
6301063|NCT00340704|7203707|FG000|STARTED|Group D- Denovo & 527.51 Rollover Study||0
6301064|NCT00340704|7203708|FG001|STARTED|Group D- Denovo & 527.51 Rollover Study||0
6301065|NCT00340704|7203709|FG002|STARTED|Group D- Denovo & 527.51 Rollover Study||0
6301066|NCT00340704|7203710|FG003|STARTED|Group D- Denovo & 527.51 Rollover Study||29
6301067|NCT00340704|7203711|FG004|STARTED|Group D- Denovo & 527.51 Rollover Study||21
6301068|NCT00340704|7203712|FG005|STARTED|Group D- Denovo & 527.51 Rollover Study||37
6301069|NCT00340704|7203713|FG006|STARTED|Group D- Denovo & 527.51 Rollover Study||54
6301070|NCT00340704|7203714|FG007|STARTED|Group D- Denovo & 527.51 Rollover Study||13
6301071|NCT00340704|7203715|FG008|STARTED|Group D- Denovo & 527.51 Rollover Study||29
6301072|NCT00340704|7203707|FG000|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6301073|NCT00340704|7203708|FG001|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6301074|NCT00340704|7203709|FG002|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6301075|NCT00340704|7203710|FG003|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
6301076|NCT00340704|7203711|FG004|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
6301077|NCT00340704|7203712|FG005|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
6301078|NCT00340704|7203713|FG006|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6301079|NCT00340704|7203714|FG007|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6301080|NCT00340704|7203715|FG008|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
6301081|NCT00340704|7203707|FG000|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6301082|NCT00340704|7203708|FG001|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6301083|NCT00340704|7203709|FG002|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6301084|NCT00340704|7203710|FG003|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
6301085|NCT00340704|7203711|FG004|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
6301086|NCT00340704|7203712|FG005|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
6301087|NCT00340704|7203713|FG006|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
6301088|NCT00340704|7203714|FG007|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
6301089|NCT00340704|7203715|FG008|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6301090|NCT00340704|7203707|FG000|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6301091|NCT00340704|7203708|FG001|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6301092|NCT00340704|7203709|FG002|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
6301093|NCT00340704|7203710|FG003|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
6301094|NCT00340704|7203711|FG004|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
6301095|NCT00340704|7203712|FG005|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
6301096|NCT00340704|7203713|FG006|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
6301097|NCT00340704|7203714|FG007|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
6301098|NCT00340704|7203715|FG008|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
6301099|NCT00340834|7203746|FG000|STARTED|Core Phase of Study||426
6301100|NCT00340834|7203747|FG001|STARTED|Core Phase of Study||431
6301101|NCT00340834|7203748|FG002|STARTED|Core Phase of Study||435
6301102|NCT00340834|7203749|FG003|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
6301103|NCT00340834|7203750|FG004|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
6301104|NCT00340834|7203746|FG000|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
6301105|NCT00340834|7203747|FG001|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
6301106|NCT00340834|7203748|FG002|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
6301107|NCT00340834|7203749|FG003|COMPLETED|Core Phase of Study||0
6301108|NCT00340834|7203750|FG004|COMPLETED|Core Phase of Study||0
6301109|NCT00340834|7203746|FG000|NOT COMPLETED|Core Phase of Study||57
6301110|NCT00340834|7203747|FG001|NOT COMPLETED|Core Phase of Study||33
6301111|NCT00340834|7203748|FG002|NOT COMPLETED|Core Phase of Study||49
6301112|NCT00340834|7203749|FG003|NOT COMPLETED|Core Phase of Study||0
6301113|NCT00340834|7203750|FG004|NOT COMPLETED|Core Phase of Study||0
6301114|NCT00340834|7203746|FG000|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
6301115|NCT00340834|7203747|FG001|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
6301116|NCT00340834|7203748|FG002|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
6301117|NCT00340834|7203749|FG003|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
6301118|NCT00340834|7203750|FG004|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
6301119|NCT00340834|7203746|FG000|Received Study Drug|Extension Phase of Study||330
6301120|NCT00340834|7203747|FG001|Received Study Drug|Extension Phase of Study||356
6301121|NCT00340834|7203748|FG002|Received Study Drug|Extension Phase of Study||0
6301122|NCT00340834|7203749|FG003|Received Study Drug|Extension Phase of Study||174
6301123|NCT00340834|7203750|FG004|Received Study Drug|Extension Phase of Study||167
6301124|NCT00340834|7203746|FG000|COMPLETED|Extension Phase of Study||245
6301125|NCT00340834|7203747|FG001|COMPLETED|Extension Phase of Study||281
6301126|NCT00340834|7203748|FG002|COMPLETED|Extension Phase of Study||0
6301127|NCT00340834|7203749|FG003|COMPLETED|Extension Phase of Study||123
6301128|NCT00340834|7203750|FG004|COMPLETED|Extension Phase of Study||123
6301129|NCT00340834|7203746|FG000|NOT COMPLETED|Extension Phase of Study||85
6301130|NCT00340834|7203747|FG001|NOT COMPLETED|Extension Phase of Study||76
6301131|NCT00340834|7203748|FG002|NOT COMPLETED|Extension Phase of Study||0
6301132|NCT00340834|7203749|FG003|NOT COMPLETED|Extension Phase of Study||53
6301133|NCT00340834|7203750|FG004|NOT COMPLETED|Extension Phase of Study||44
6301134|NCT00342355|7203764|FG000|STARTED|Overall Study||444
6301135|NCT00342355|7203765|FG001|STARTED|Overall Study||440
6301136|NCT00342355|7203766|FG002|STARTED|Overall Study||444
6301137|NCT00342355|7203767|FG003|STARTED|Overall Study||443
6301138|NCT00342355|7203764|FG000|COMPLETED|Overall Study||444
6301139|NCT00342355|7203765|FG001|COMPLETED|Overall Study||440
6301140|NCT00342355|7203766|FG002|COMPLETED|Overall Study||444
6301141|NCT00342355|7203767|FG003|COMPLETED|Overall Study||443
6301142|NCT00342355|7203764|FG000|NOT COMPLETED|Overall Study||0
6301143|NCT00342355|7203765|FG001|NOT COMPLETED|Overall Study||0
6301144|NCT00342355|7203766|FG002|NOT COMPLETED|Overall Study||0
6301145|NCT00342355|7203767|FG003|NOT COMPLETED|Overall Study||0
6301146|NCT00342563|7203781|FG000|STARTED|Overall Study||41
6301147|NCT00342563|7203782|FG001|STARTED|Overall Study||27
6301148|NCT00342563|7203783|FG002|STARTED|Overall Study||40
6301149|NCT00342563|7203784|FG003|STARTED|Overall Study||28
6301150|NCT00342563|7203781|FG000|COMPLETED|Overall Study||35
6301151|NCT00342563|7203782|FG001|COMPLETED|Overall Study||19
6301152|NCT00342563|7203783|FG002|COMPLETED|Overall Study||26
6301153|NCT00342563|7203784|FG003|COMPLETED|Overall Study||22
6301154|NCT00342563|7203781|FG000|NOT COMPLETED|Overall Study||6
6301155|NCT00342563|7203782|FG001|NOT COMPLETED|Overall Study||8
6301156|NCT00342563|7203783|FG002|NOT COMPLETED|Overall Study||14
6301157|NCT00342563|7203784|FG003|NOT COMPLETED|Overall Study||6
6301158|NCT00342628|7203799|FG000|STARTED|Overall Study||100
6301159|NCT00342628|7203800|FG001|STARTED|Overall Study||101
6301160|NCT00342628|7203801|FG002|STARTED|Overall Study||100
6301161|NCT00342628|7203799|FG000|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
6301162|NCT00342628|7203800|FG001|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
6301163|NCT00342628|7203801|FG002|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
6301164|NCT00342628|7203799|FG000|NOT COMPLETED|Overall Study||20
6301165|NCT00342628|7203800|FG001|NOT COMPLETED|Overall Study||21
6301166|NCT00342628|7203801|FG002|NOT COMPLETED|Overall Study||19
6301167|NCT00343044|7203809|FG000|STARTED|Overall Study||40
6301168|NCT00343044|7203809|FG000|COMPLETED|Overall Study||40
6301169|NCT00343044|7203809|FG000|NOT COMPLETED|Overall Study||0
6301170|NCT00343083|7203813|FG000|STARTED|Overall Study||43
6301171|NCT00343083|7203813|FG000|COMPLETED|Overall Study||22
6301172|NCT00343083|7203813|FG000|NOT COMPLETED|Overall Study||21
6301173|NCT00343252|7203820|FG000|STARTED|All Randomized Participants||361
6301174|NCT00343252|7203821|FG001|STARTED|All Randomized Participants||351
6301175|NCT00343252|7203820|FG000|COMPLETED|All Randomized Participants||259
6301176|NCT00343252|7203821|FG001|COMPLETED|All Randomized Participants||269
6301177|NCT00343252|7203820|FG000|NOT COMPLETED|All Randomized Participants||102
6301178|NCT00343252|7203821|FG001|NOT COMPLETED|All Randomized Participants||82
6301179|NCT00343252|7203820|FG000|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
6301180|NCT00343252|7203821|FG001|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
6301181|NCT00343252|7203820|FG000|COMPLETED|6 Months (All Treated Participants)||304
6301182|NCT00343252|7203821|FG001|COMPLETED|6 Months (All Treated Participants)||306
6301183|NCT00343252|7203820|FG000|NOT COMPLETED|6 Months (All Treated Participants)||56
6301184|NCT00343252|7203821|FG001|NOT COMPLETED|6 Months (All Treated Participants)||44
6301185|NCT00343252|7203820|FG000|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
6301186|NCT00343252|7203821|FG001|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
6301187|NCT00343252|7203820|FG000|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
6301188|NCT00343252|7203821|FG001|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
6301189|NCT00343252|7203820|FG000|NOT COMPLETED|12 Months (All Treated Participants)||86
6301190|NCT00343252|7203821|FG001|NOT COMPLETED|12 Months (All Treated Participants)||69
6301191|NCT00343252|7203820|FG000|STARTED|18 Months (All Treated Participants)||360
6301192|NCT00343252|7203821|FG001|STARTED|18 Months (All Treated Participants)||350
6301193|NCT00343252|7203820|FG000|COMPLETED|18 Months (All Treated Participants)||259
6301194|NCT00343252|7203821|FG001|COMPLETED|18 Months (All Treated Participants)||269
6301195|NCT00343252|7203820|FG000|NOT COMPLETED|18 Months (All Treated Participants)||101
6301196|NCT00343252|7203821|FG001|NOT COMPLETED|18 Months (All Treated Participants)||81
6301197|NCT00343291|7203829|FG000|STARTED|Overall Study||60
6301198|NCT00343291|7203830|FG001|STARTED|Overall Study||61
6301199|NCT00343291|7203829|FG000|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
6301200|NCT00343291|7203830|FG001|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
6301201|NCT00343291|7203829|FG000|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
6301202|NCT00343291|7203830|FG001|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
6301203|NCT00343291|7203829|FG000|NOT COMPLETED|Overall Study||57
6301204|NCT00343291|7203830|FG001|NOT COMPLETED|Overall Study||56
6301205|NCT00343382|7203839|FG000|STARTED|Overall Study||64
6301206|NCT00343382|7203840|FG001|STARTED|Overall Study||65
6301207|NCT00343382|7203841|FG002|STARTED|Overall Study||66
6301208|NCT00343382|7203839|FG000|COMPLETED|Overall Study||60
6301209|NCT00343382|7203840|FG001|COMPLETED|Overall Study||51
6301210|NCT00343382|7203841|FG002|COMPLETED|Overall Study||49
6301211|NCT00343382|7203839|FG000|NOT COMPLETED|Overall Study||4
6301212|NCT00343382|7203840|FG001|NOT COMPLETED|Overall Study||14
6301213|NCT00343382|7203841|FG002|NOT COMPLETED|Overall Study||17
6301214|NCT00343460|7203855|FG000|STARTED|Cycle 1||475
6301215|NCT00343460|7203856|FG001|STARTED|Cycle 1||481
6301216|NCT00343460|7203857|FG002|STARTED|Cycle 1||472
6301217|NCT00343460|7203855|FG000|COMPLETED|Cycle 1||453
6301218|NCT00343460|7203856|FG001|COMPLETED|Cycle 1||459
6301219|NCT00343460|7203857|FG002|COMPLETED|Cycle 1||454
6301220|NCT00343460|7203855|FG000|NOT COMPLETED|Cycle 1||22
6301221|NCT00343460|7203856|FG001|NOT COMPLETED|Cycle 1||22
6301222|NCT00343460|7203857|FG002|NOT COMPLETED|Cycle 1||18
6301223|NCT00343460|7203855|FG000|STARTED|Cycle 2 - 4||584
6301224|NCT00343460|7203856|FG001|STARTED|Cycle 2 - 4||565
6301225|NCT00343460|7203857|FG002|STARTED|Cycle 2 - 4||0
6301226|NCT00343460|7203855|FG000|COMPLETED|Cycle 2 - 4||528
6301227|NCT00343460|7203856|FG001|COMPLETED|Cycle 2 - 4||515
6301228|NCT00343460|7203857|FG002|COMPLETED|Cycle 2 - 4||0
6301229|NCT00343460|7203855|FG000|NOT COMPLETED|Cycle 2 - 4||56
6301230|NCT00343460|7203856|FG001|NOT COMPLETED|Cycle 2 - 4||50
6301231|NCT00343460|7203857|FG002|NOT COMPLETED|Cycle 2 - 4||0
6301232|NCT00343512|7203875|FG000|STARTED|Overall Study||34
6301233|NCT00343512|7203875|FG000|COMPLETED|Overall Study||32
6301234|NCT00343512|7203875|FG000|NOT COMPLETED|Overall Study||2
6301235|NCT00343564|7203891|FG000|STARTED|Overall Study||6
6301236|NCT00343564|7203892|FG001|STARTED|Overall Study||7
6301237|NCT00343564|7203893|FG002|STARTED|Overall Study||3
6301238|NCT00343564|7203894|FG003|STARTED|Overall Study||7
6301239|NCT00343564|7203895|FG004|STARTED|Overall Study||10
6301240|NCT00343564|7203896|FG005|STARTED|Overall Study||9
6301241|NCT00343564|7203897|FG006|STARTED|Overall Study||4
6301242|NCT00343564|7203898|FG007|STARTED|Overall Study||3
6301243|NCT00343564|7203899|FG008|STARTED|Overall Study||3
6301244|NCT00343564|7203900|FG009|STARTED|Overall Study||8
6301245|NCT00343564|7203901|FG010|STARTED|Overall Study||8
6301246|NCT00343564|7203891|FG000|COMPLETED|Overall Study||6
6301247|NCT00343564|7203892|FG001|COMPLETED|Overall Study||7
6301248|NCT00343564|7203893|FG002|COMPLETED|Overall Study||3
6301249|NCT00343564|7203894|FG003|COMPLETED|Overall Study||7
6301250|NCT00343564|7203895|FG004|COMPLETED|Overall Study||10
6301251|NCT00343564|7203896|FG005|COMPLETED|Overall Study||9
6301252|NCT00343564|7203897|FG006|COMPLETED|Overall Study||4
6301253|NCT00343564|7203898|FG007|COMPLETED|Overall Study||3
6301254|NCT00343564|7203899|FG008|COMPLETED|Overall Study||3
6301255|NCT00343564|7203900|FG009|COMPLETED|Overall Study||8
6301256|NCT00343564|7203901|FG010|COMPLETED|Overall Study||8
6301257|NCT00343564|7203891|FG000|NOT COMPLETED|Overall Study||0
6301258|NCT00343564|7203892|FG001|NOT COMPLETED|Overall Study||0
6301259|NCT00343564|7203893|FG002|NOT COMPLETED|Overall Study||0
6301260|NCT00343564|7203894|FG003|NOT COMPLETED|Overall Study||0
6301261|NCT00343564|7203895|FG004|NOT COMPLETED|Overall Study||0
6301262|NCT00343564|7203896|FG005|NOT COMPLETED|Overall Study||0
6301263|NCT00343564|7203897|FG006|NOT COMPLETED|Overall Study||0
6301264|NCT00343564|7203898|FG007|NOT COMPLETED|Overall Study||0
6301265|NCT00343564|7203899|FG008|NOT COMPLETED|Overall Study||0
6301266|NCT00343564|7203900|FG009|NOT COMPLETED|Overall Study||0
6301267|NCT00343564|7203901|FG010|NOT COMPLETED|Overall Study||0
6301268|NCT00343642|7203999|FG000|STARTED|Overall Study||19
6301269|NCT00343642|7204000|FG001|STARTED|Overall Study||19
6301270|NCT00343642|7204001|FG002|STARTED|Overall Study||16
6301271|NCT00343642|7203999|FG000|Upto 3 Months Complete or Flare|Overall Study||2
6301272|NCT00343642|7204000|FG001|Upto 3 Months Complete or Flare|Overall Study||0
6301273|NCT00343642|7204001|FG002|Upto 3 Months Complete or Flare|Overall Study||1
6301274|NCT00343642|7203999|FG000|3-6 Months Complete or Flare|Overall Study||4
6301275|NCT00343642|7204000|FG001|3-6 Months Complete or Flare|Overall Study||2
6301276|NCT00343642|7204001|FG002|3-6 Months Complete or Flare|Overall Study||2
6301277|NCT00343642|7203999|FG000|COMPLETED|Overall Study||10
6301278|NCT00343642|7204000|FG001|COMPLETED|Overall Study||11
6301279|NCT00343642|7204001|FG002|COMPLETED|Overall Study||9
6301280|NCT00343642|7203999|FG000|NOT COMPLETED|Overall Study||9
6301281|NCT00343642|7204000|FG001|NOT COMPLETED|Overall Study||8
6301282|NCT00343642|7204001|FG002|NOT COMPLETED|Overall Study||7
6301283|NCT00343785|7204012|FG000|STARTED|Overall Study||21
6301284|NCT00343785|7204012|FG000|COMPLETED|Overall Study||21
6301285|NCT00343785|7204012|FG000|NOT COMPLETED|Overall Study||0
6301286|NCT00343863|7204019|FG000|STARTED|Overall Study||7
6301287|NCT00343863|7204020|FG001|STARTED|Overall Study||34
6301288|NCT00343863|7204019|FG000|COMPLETED|Overall Study||7
6301289|NCT00343863|7204020|FG001|COMPLETED|Overall Study||34
6301290|NCT00343863|7204019|FG000|NOT COMPLETED|Overall Study||0
6301291|NCT00343863|7204020|FG001|NOT COMPLETED|Overall Study||0
6301292|NCT00343889|7204030|FG000|STARTED|Overall Study||190
6301293|NCT00343889|7204031|FG001|STARTED|Overall Study||189
6301294|NCT00343889|7204030|FG000|COMPLETED|Overall Study||187
6301295|NCT00343889|7204031|FG001|COMPLETED|Overall Study||188
6301296|NCT00343889|7204030|FG000|NOT COMPLETED|Overall Study||3
6301297|NCT00343889|7204031|FG001|NOT COMPLETED|Overall Study||1
6301298|NCT00343915|7204039|FG000|STARTED|Primary Study||258
6301299|NCT00343915|7204040|FG001|STARTED|Primary Study||126
6301300|NCT00343915|7204039|FG000|COMPLETED|Primary Study||254
6301301|NCT00343915|7204040|FG001|COMPLETED|Primary Study||123
6301302|NCT00343915|7204039|FG000|NOT COMPLETED|Primary Study||4
6301303|NCT00343915|7204040|FG001|NOT COMPLETED|Primary Study||3
6301304|NCT00343915|7204039|FG000|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
6301305|NCT00343915|7204040|FG001|STARTED|Month 30 Follow-up||88
6301306|NCT00343915|7204039|FG000|COMPLETED|Month 30 Follow-up||179
6301307|NCT00343915|7204040|FG001|COMPLETED|Month 30 Follow-up||88
6301308|NCT00343915|7204039|FG000|NOT COMPLETED|Month 30 Follow-up||0
6301309|NCT00343915|7204040|FG001|NOT COMPLETED|Month 30 Follow-up||0
6301310|NCT00343915|7204039|FG000|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
6301311|NCT00343915|7204040|FG001|STARTED|Month 42 Follow-up||84
6301312|NCT00343915|7204039|FG000|COMPLETED|Month 42 Follow-up||174
6301313|NCT00343915|7204040|FG001|COMPLETED|Month 42 Follow-up||84
6301314|NCT00343915|7204039|FG000|NOT COMPLETED|Month 42 Follow-up||0
6301315|NCT00343915|7204040|FG001|NOT COMPLETED|Month 42 Follow-up||0
6301316|NCT00343915|7204039|FG000|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
6301317|NCT00343915|7204040|FG001|STARTED|Month 54 Follow-up||79
6301318|NCT00343915|7204039|FG000|COMPLETED|Month 54 Follow-up||166
6301319|NCT00343915|7204040|FG001|COMPLETED|Month 54 Follow-up||79
6301320|NCT00343915|7204039|FG000|NOT COMPLETED|Month 54 Follow-up||0
6301321|NCT00343915|7204040|FG001|NOT COMPLETED|Month 54 Follow-up||0
6301322|NCT00343915|7204039|FG000|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
6301323|NCT00343915|7204040|FG001|STARTED|Month 66 Follow-up||76
6301324|NCT00343915|7204039|FG000|COMPLETED|Month 66 Follow-up||158
6301325|NCT00343915|7204040|FG001|COMPLETED|Month 66 Follow-up||76
6301326|NCT00343915|7204039|FG000|NOT COMPLETED|Month 66 Follow-up||0
6301327|NCT00343915|7204040|FG001|NOT COMPLETED|Month 66 Follow-up||0
6301328|NCT00344032|7204051|FG000|STARTED|Overall Study||176
6301329|NCT00344032|7204052|FG001|STARTED|Overall Study||178
6301330|NCT00344032|7204051|FG000|COMPLETED|Overall Study||162
6301331|NCT00344032|7204052|FG001|COMPLETED|Overall Study||168
6301332|NCT00344032|7204051|FG000|NOT COMPLETED|Overall Study||14
6301333|NCT00344032|7204052|FG001|NOT COMPLETED|Overall Study||10
6301334|NCT00344175|7204060|FG000|STARTED|Overall Study||121
6401389|NCT00892177|7314306|FG004|STARTED|Phase I: Dose Level 2||0
6401390|NCT00892177|7314307|FG005|STARTED|Phase I: Dose Level 2||0
6401391|NCT00892177|7314302|FG000|COMPLETED|Phase I: Dose Level 2||0
6401392|NCT00892177|7314303|FG001|COMPLETED|Phase I: Dose Level 2||0
6401393|NCT00892177|7314304|FG002|COMPLETED|Phase I: Dose Level 2||3
6401394|NCT00892177|7314305|FG003|COMPLETED|Phase I: Dose Level 2||0
6401395|NCT00892177|7314306|FG004|COMPLETED|Phase I: Dose Level 2||0
6401396|NCT00892177|7314307|FG005|COMPLETED|Phase I: Dose Level 2||0
6401397|NCT00892177|7314302|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
6401398|NCT00892177|7314303|FG001|NOT COMPLETED|Phase I: Dose Level 2||0
6301335|NCT00344175|7204061|FG001|STARTED|Overall Study||57
6301336|NCT00344175|7204060|FG000|COMPLETED|Overall Study||109
6301337|NCT00344175|7204061|FG001|COMPLETED|Overall Study||47
6301338|NCT00344175|7204060|FG000|NOT COMPLETED|Overall Study||12
6301339|NCT00344175|7204061|FG001|NOT COMPLETED|Overall Study||10
6301340|NCT00344305|7204069|FG000|STARTED|Overall Study||100
6301341|NCT00344305|7204070|FG001|STARTED|Overall Study||100
6301342|NCT00344305|7204069|FG000|COMPLETED|Overall Study||98
6301343|NCT00344305|7204070|FG001|COMPLETED|Overall Study||99
6301344|NCT00344305|7204069|FG000|NOT COMPLETED|Overall Study||2
6301345|NCT00344305|7204070|FG001|NOT COMPLETED|Overall Study||1
6301346|NCT00344318|7204081|FG000|STARTED|Overall Study||300
6301347|NCT00344318|7204082|FG001|STARTED|Overall Study||303
6301348|NCT00344318|7204083|FG002|STARTED|Overall Study||100
6301349|NCT00344318|7204084|FG003|STARTED|Overall Study||103
6301350|NCT00344318|7204081|FG000|COMPLETED|Overall Study||296
6301351|NCT00344318|7204082|FG001|COMPLETED|Overall Study||298
6301352|NCT00344318|7204083|FG002|COMPLETED|Overall Study||99
6301353|NCT00344318|7204084|FG003|COMPLETED|Overall Study||100
6301354|NCT00344318|7204081|FG000|NOT COMPLETED|Overall Study||4
6301355|NCT00344318|7204082|FG001|NOT COMPLETED|Overall Study||5
6301356|NCT00344318|7204083|FG002|NOT COMPLETED|Overall Study||1
6301357|NCT00344318|7204084|FG003|NOT COMPLETED|Overall Study||3
6301358|NCT00344370|7204098|FG000|STARTED|Overall Study||143
6301359|NCT00344370|7204099|FG001|STARTED|Overall Study||71
6301360|NCT00344370|7204098|FG000|COMPLETED|Overall Study||128
6301361|NCT00344370|7204099|FG001|COMPLETED|Overall Study||68
6301362|NCT00344370|7204098|FG000|NOT COMPLETED|Overall Study||15
6301363|NCT00344370|7204099|FG001|NOT COMPLETED|Overall Study||3
6301364|NCT00344448|7204107|FG000|STARTED|Screening|No randomization during the screening phase|6
6301365|NCT00344448|7204108|FG001|STARTED|Screening||4
6301366|NCT00344448|7204107|FG000|COMPLETED|Screening||6
6301367|NCT00344448|7204108|FG001|COMPLETED|Screening||3
6301368|NCT00344448|7204107|FG000|NOT COMPLETED|Screening||0
6301369|NCT00344448|7204108|FG001|NOT COMPLETED|Screening||1
6301370|NCT00344448|7204107|FG000|STARTED|Double Blind, Placebo Controlled||6
6301371|NCT00344448|7204108|FG001|STARTED|Double Blind, Placebo Controlled||3
6301372|NCT00344448|7204107|FG000|COMPLETED|Double Blind, Placebo Controlled||4
6301373|NCT00344448|7204108|FG001|COMPLETED|Double Blind, Placebo Controlled||3
6301374|NCT00344448|7204107|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||2
6301375|NCT00344448|7204108|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||0
6301376|NCT00344448|7204107|FG000|STARTED|Open Label||4
6301377|NCT00344448|7204108|FG001|STARTED|Open Label||3
6301378|NCT00344448|7204107|FG000|COMPLETED|Open Label||2
6301379|NCT00344448|7204108|FG001|COMPLETED|Open Label||2
6301380|NCT00344448|7204107|FG000|NOT COMPLETED|Open Label||2
6301381|NCT00344448|7204108|FG001|NOT COMPLETED|Open Label||1
6301382|NCT00344461|7204114|FG000|STARTED|Overall Study||54
6301383|NCT00344461|7204114|FG000|COMPLETED|Overall Study||33
6301384|NCT00344461|7204114|FG000|NOT COMPLETED|Overall Study||21
6301385|NCT00344500|7204121|FG000|STARTED|Overall Study||48
6301386|NCT00344500|7204122|FG001|STARTED|Overall Study||60
6301387|NCT00344500|7204123|FG002|STARTED|Overall Study||14
6301388|NCT00344500|7204121|FG000|COMPLETED|Overall Study||25
6301389|NCT00344500|7204122|FG001|COMPLETED|Overall Study||25
6301390|NCT00344500|7204123|FG002|COMPLETED|Overall Study||12
6301391|NCT00344500|7204121|FG000|NOT COMPLETED|Overall Study||23
6301392|NCT00344500|7204122|FG001|NOT COMPLETED|Overall Study||35
6301393|NCT00344500|7204123|FG002|NOT COMPLETED|Overall Study||2
6301394|NCT00344682|7204132|FG000|STARTED|Overall Study||16
6301395|NCT00344682|7204133|FG001|STARTED|Overall Study||15
6301396|NCT00344682|7204132|FG000|COMPLETED|Overall Study||12
6301397|NCT00344682|7204133|FG001|COMPLETED|Overall Study||14
6301398|NCT00344682|7204132|FG000|NOT COMPLETED|Overall Study||4
6301399|NCT00344682|7204133|FG001|NOT COMPLETED|Overall Study||1
6301400|NCT00344773|7204139|FG000|STARTED|Overall Study||46
6301401|NCT00344773|7204139|FG000|COMPLETED|Overall Study||25
6301402|NCT00344773|7204139|FG000|NOT COMPLETED|Overall Study||21
6301403|NCT00344968|7204146|FG000|STARTED|Overall Study||185
6301404|NCT00344968|7204147|FG001|STARTED|Overall Study||376
6301405|NCT00344968|7204148|FG002|STARTED|Overall Study||395
6301406|NCT00344968|7204146|FG000|COMPLETED|Overall Study||126
6301407|NCT00344968|7204147|FG001|COMPLETED|Overall Study||274
6301408|NCT00344968|7204148|FG002|COMPLETED|Overall Study||279
6301409|NCT00344968|7204146|FG000|NOT COMPLETED|Overall Study||59
6301410|NCT00344968|7204147|FG001|NOT COMPLETED|Overall Study||102
6301411|NCT00344968|7204148|FG002|NOT COMPLETED|Overall Study||116
6301412|NCT00345033|7204159|FG000|STARTED|Overall Study||20
6301413|NCT00345033|7204160|FG001|STARTED|Overall Study||18
6301414|NCT00345033|7204159|FG000|COMPLETED|Overall Study||16
6301415|NCT00345033|7204160|FG001|COMPLETED|Overall Study||14
6301416|NCT00345033|7204159|FG000|NOT COMPLETED|Overall Study||4
6301417|NCT00345033|7204160|FG001|NOT COMPLETED|Overall Study||4
6301418|NCT00345046|7204169|FG000|STARTED|Overall Study||18
6301419|NCT00345046|7204170|FG001|STARTED|Overall Study||22
6301420|NCT00345046|7204171|FG002|STARTED|Overall Study||16
6301421|NCT00345046|7204169|FG000|COMPLETED|Overall Study||17
6301422|NCT00345046|7204170|FG001|COMPLETED|Overall Study||21
6301423|NCT00345046|7204171|FG002|COMPLETED|Overall Study||14
6301424|NCT00345046|7204169|FG000|NOT COMPLETED|Overall Study||1
6301425|NCT00345046|7204170|FG001|NOT COMPLETED|Overall Study||1
6301426|NCT00345046|7204171|FG002|NOT COMPLETED|Overall Study||2
6301427|NCT00345176|7204183|FG000|STARTED|Overall Study||1012
6301428|NCT00345176|7204184|FG001|STARTED|Overall Study||1044
6301429|NCT00345176|7204185|FG002|STARTED|Overall Study||1068
6301430|NCT00345176|7204186|FG003|STARTED|Overall Study||1079
6301431|NCT00345176|7204183|FG000|COMPLETED|Overall Study||1007
6301432|NCT00345176|7204184|FG001|COMPLETED|Overall Study||1038
6301433|NCT00345176|7204185|FG002|COMPLETED|Overall Study||1062
6301434|NCT00345176|7204186|FG003|COMPLETED|Overall Study||1069
6301435|NCT00345176|7204183|FG000|NOT COMPLETED|Overall Study||5
6301436|NCT00345176|7204184|FG001|NOT COMPLETED|Overall Study||6
6301437|NCT00345176|7204185|FG002|NOT COMPLETED|Overall Study||6
6301438|NCT00345176|7204186|FG003|NOT COMPLETED|Overall Study||10
6301439|NCT00345254|7204200|FG000|STARTED|Overall Study||30
6301440|NCT00345254|7204201|FG001|STARTED|Overall Study||30
6301441|NCT00345254|7204200|FG000|COMPLETED|Overall Study||30
6301442|NCT00345254|7204201|FG001|COMPLETED|Overall Study||30
6301443|NCT00345254|7204200|FG000|NOT COMPLETED|Overall Study||0
6301444|NCT00345254|7204201|FG001|NOT COMPLETED|Overall Study||0
6301445|NCT00345293|7204207|FG000|STARTED|Overall Study||10
6301446|NCT00345293|7204208|FG001|STARTED|Overall Study||3
6301447|NCT00345293|7204207|FG000|COMPLETED|Overall Study||8
6301448|NCT00345293|7204208|FG001|COMPLETED|Overall Study||3
6301449|NCT00345293|7204207|FG000|NOT COMPLETED|Overall Study||2
6301450|NCT00345293|7204208|FG001|NOT COMPLETED|Overall Study||0
6301451|NCT00345332|7204216|FG000|STARTED|Overall Study||11
6301452|NCT00345332|7204217|FG001|STARTED|Overall Study||20
6301453|NCT00345332|7204216|FG000|COMPLETED|Overall Study||11
6301454|NCT00345332|7204217|FG001|COMPLETED|Overall Study||20
6301455|NCT00345332|7204216|FG000|NOT COMPLETED|Overall Study||0
6301456|NCT00345332|7204217|FG001|NOT COMPLETED|Overall Study||0
6301457|NCT00345371|7204225|FG000|STARTED|Overall Study||69
6301458|NCT00345371|7204226|FG001|STARTED|Overall Study||71
6301459|NCT00345371|7204225|FG000|COMPLETED|Overall Study||39
6301460|NCT00345371|7204226|FG001|COMPLETED|Overall Study||38
6301461|NCT00345371|7204225|FG000|NOT COMPLETED|Overall Study||30
6301462|NCT00345371|7204226|FG001|NOT COMPLETED|Overall Study||33
6301463|NCT00345384|7204234|FG000|STARTED|Overall Study||19
6301464|NCT00345384|7204235|FG001|STARTED|Overall Study||19
6301465|NCT00345384|7204234|FG000|COMPLETED|Overall Study||19
6301466|NCT00345384|7204235|FG001|COMPLETED|Overall Study||19
6301467|NCT00345384|7204234|FG000|NOT COMPLETED|Overall Study||0
6301468|NCT00345384|7204235|FG001|NOT COMPLETED|Overall Study||0
6301469|NCT00345397|7204243|FG000|STARTED|Overall Study||7
6301470|NCT00345397|7204243|FG000|COMPLETED|Overall Study||6
6301471|NCT00345397|7204243|FG000|NOT COMPLETED|Overall Study||1
6301472|NCT00345540|7204248|FG000|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
6301473|NCT00345540|7204248|FG000|COMPLETED|Overall Study||15
6301474|NCT00345540|7204248|FG000|NOT COMPLETED|Overall Study||1
6301475|NCT00345579|7204254|FG000|STARTED|Overall Study||3278
6301476|NCT00345579|7204255|FG001|STARTED|Overall Study||1113
6301477|NCT00345579|7204254|FG000|COMPLETED|Overall Study||3114
6301478|NCT00345579|7204255|FG001|COMPLETED|Overall Study||1048
6301479|NCT00345579|7204254|FG000|NOT COMPLETED|Overall Study||164
6301480|NCT00345579|7204255|FG001|NOT COMPLETED|Overall Study||65
6301481|NCT00345592|7204264|FG000|STARTED|Overall Study||199
6301482|NCT00345592|7204265|FG001|STARTED|Overall Study||197
6301483|NCT00345592|7204264|FG000|COMPLETED|Overall Study||174
6301484|NCT00345592|7204265|FG001|COMPLETED|Overall Study||173
6301485|NCT00345592|7204264|FG000|NOT COMPLETED|Overall Study||25
6301486|NCT00345592|7204265|FG001|NOT COMPLETED|Overall Study||24
6301487|NCT00345605|7204271|FG000|STARTED|Initial Washout||6
6301488|NCT00345605|7204272|FG001|STARTED|Initial Washout||6
6301489|NCT00345605|7204271|FG000|COMPLETED|Initial Washout||6
6301490|NCT00345605|7204272|FG001|COMPLETED|Initial Washout||6
6301491|NCT00345605|7204271|FG000|NOT COMPLETED|Initial Washout||0
6301492|NCT00345605|7204272|FG001|NOT COMPLETED|Initial Washout||0
6301493|NCT00345605|7204271|FG000|STARTED|Arm 1||6
6301494|NCT00345605|7204272|FG001|STARTED|Arm 1||6
6301495|NCT00345605|7204271|FG000|COMPLETED|Arm 1||6
6301496|NCT00345605|7204272|FG001|COMPLETED|Arm 1||5
6301497|NCT00345605|7204271|FG000|NOT COMPLETED|Arm 1||0
6301498|NCT00345605|7204272|FG001|NOT COMPLETED|Arm 1||1
6301499|NCT00345605|7204271|FG000|STARTED|Interval||6
6301500|NCT00345605|7204272|FG001|STARTED|Interval||6
6301501|NCT00345605|7204271|FG000|COMPLETED|Interval||6
6301502|NCT00345605|7204272|FG001|COMPLETED|Interval||6
6301503|NCT00345605|7204271|FG000|NOT COMPLETED|Interval||0
6301504|NCT00345605|7204272|FG001|NOT COMPLETED|Interval||0
6301505|NCT00345605|7204271|FG000|STARTED|Crossover Wash-out||6
6301506|NCT00345605|7204272|FG001|STARTED|Crossover Wash-out||6
6301507|NCT00345605|7204271|FG000|COMPLETED|Crossover Wash-out||6
6301508|NCT00345605|7204272|FG001|COMPLETED|Crossover Wash-out||6
6301509|NCT00345605|7204271|FG000|NOT COMPLETED|Crossover Wash-out||0
6301510|NCT00345605|7204272|FG001|NOT COMPLETED|Crossover Wash-out||0
6301511|NCT00345605|7204271|FG000|STARTED|Arm 2, Opposite Treatment||6
6301512|NCT00345605|7204272|FG001|STARTED|Arm 2, Opposite Treatment||6
6301513|NCT00345605|7204271|FG000|COMPLETED|Arm 2, Opposite Treatment||5
6301514|NCT00345605|7204272|FG001|COMPLETED|Arm 2, Opposite Treatment||6
6301515|NCT00345605|7204271|FG000|NOT COMPLETED|Arm 2, Opposite Treatment||1
6301516|NCT00345605|7204272|FG001|NOT COMPLETED|Arm 2, Opposite Treatment||0
6301517|NCT00345631|7204283|FG000|STARTED|Overall Study||87
6301518|NCT00345631|7204284|FG001|STARTED|Overall Study||267
6301519|NCT00345631|7204285|FG002|STARTED|Overall Study||134
6301520|NCT00345631|7204283|FG000|COMPLETED|Overall Study||83
6301521|NCT00345631|7204284|FG001|COMPLETED|Overall Study||259
6301522|NCT00345631|7204285|FG002|COMPLETED|Overall Study||128
6301523|NCT00345631|7204283|FG000|NOT COMPLETED|Overall Study||4
6301524|NCT00345631|7204284|FG001|NOT COMPLETED|Overall Study||8
6301525|NCT00345631|7204285|FG002|NOT COMPLETED|Overall Study||6
6301526|NCT00345683|7204297|FG000|STARTED|Overall Study||3010
6301527|NCT00345683|7204298|FG001|STARTED|Overall Study||1010
6301528|NCT00345683|7204297|FG000|COMPLETED|Overall Study||2985
6301529|NCT00345683|7204298|FG001|COMPLETED|Overall Study||1001
6301530|NCT00345683|7204297|FG000|NOT COMPLETED|Overall Study||25
6301531|NCT00345683|7204298|FG001|NOT COMPLETED|Overall Study||9
6301532|NCT00345839|7204306|FG000|STARTED|Overall Study|Randomized to cinacalcet|1948
6301533|NCT00345839|7204307|FG001|STARTED|Overall Study|Randomized to placebo|1935
6301534|NCT00345839|7204306|FG000|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
6301535|NCT00345839|7204307|FG001|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
6301536|NCT00345839|7204306|FG000|NOT COMPLETED|Overall Study||149
6301537|NCT00345839|7204307|FG001|NOT COMPLETED|Overall Study||159
6301538|NCT00345865|7204318|FG000|STARTED|Overall Study||171
6301539|NCT00345865|7204319|FG001|STARTED|Overall Study||149
6301540|NCT00345865|7204320|FG002|STARTED|Overall Study||2
6301541|NCT00345865|7204321|FG003|STARTED|Overall Study||5
6301542|NCT00345865|7204322|FG004|STARTED|Overall Study||146
6301543|NCT00345865|7204318|FG000|COMPLETED|Overall Study||171
6301544|NCT00345865|7204319|FG001|COMPLETED|Overall Study||149
6301545|NCT00345865|7204320|FG002|COMPLETED|Overall Study||2
6301546|NCT00345865|7204321|FG003|COMPLETED|Overall Study||5
6301547|NCT00345865|7204322|FG004|COMPLETED|Overall Study||146
6301548|NCT00345865|7204318|FG000|NOT COMPLETED|Overall Study||0
6301549|NCT00345865|7204319|FG001|NOT COMPLETED|Overall Study||0
6301550|NCT00345865|7204320|FG002|NOT COMPLETED|Overall Study||0
6301551|NCT00345865|7204321|FG003|NOT COMPLETED|Overall Study||0
6301552|NCT00345865|7204322|FG004|NOT COMPLETED|Overall Study||0
6301553|NCT00345878|7204336|FG000|STARTED|Overall Study||135
6301554|NCT00345878|7204337|FG001|STARTED|Overall Study||136
6301555|NCT00345878|7204336|FG000|COMPLETED|Overall Study||131
6301556|NCT00345878|7204337|FG001|COMPLETED|Overall Study||135
6301557|NCT00345878|7204336|FG000|NOT COMPLETED|Overall Study||4
6301558|NCT00345878|7204337|FG001|NOT COMPLETED|Overall Study||1
6301559|NCT00345969|7204345|FG000|STARTED|Overall Study||12
6301560|NCT00345969|7204346|FG001|STARTED|Overall Study||13
6301561|NCT00345969|7204345|FG000|COMPLETED|Overall Study||11
6301562|NCT00345969|7204346|FG001|COMPLETED|Overall Study||11
6301563|NCT00345969|7204345|FG000|NOT COMPLETED|Overall Study||1
6301564|NCT00345969|7204346|FG001|NOT COMPLETED|Overall Study||2
6301565|NCT00346034|7204352|FG000|STARTED|Overall Study||357
6301566|NCT00346034|7204352|FG000|COMPLETED|Overall Study||300
6301567|NCT00346034|7204352|FG000|NOT COMPLETED|Overall Study||57
6301568|NCT00346073|7204358|FG000|STARTED|Overall Study||1522
6301569|NCT00346073|7204359|FG001|STARTED|Overall Study||762
6301570|NCT00346073|7204358|FG000|COMPLETED|Overall Study||1481
6301571|NCT00346073|7204359|FG001|COMPLETED|Overall Study||738
6301572|NCT00346073|7204358|FG000|NOT COMPLETED|Overall Study||41
6301573|NCT00346073|7204359|FG001|NOT COMPLETED|Overall Study||24
6301574|NCT00346151|7204365|FG000|STARTED|Overall Study||5
6301575|NCT00346151|7204365|FG000|COMPLETED|Overall Study||2
6301576|NCT00346151|7204365|FG000|NOT COMPLETED|Overall Study||3
6301589|NCT00346216|7204405|FG000|STARTED|Overall Study||8072
6301590|NCT00346216|7204406|FG001|STARTED|Overall Study||8040
6301591|NCT00346216|7204407|FG002|STARTED|Overall Study||7969
6301592|NCT00346216|7204405|FG000|COMPLETED|Overall Study||5664
6301593|NCT00346216|7204406|FG001|COMPLETED|Overall Study||5580
6301594|NCT00346216|7204407|FG002|COMPLETED|Overall Study||5621
6301595|NCT00346216|7204405|FG000|NOT COMPLETED|Overall Study||2408
6301596|NCT00346216|7204406|FG001|NOT COMPLETED|Overall Study||2460
6301597|NCT00346216|7204407|FG002|NOT COMPLETED|Overall Study||2348
6301598|NCT00346268|7204417|FG000|STARTED|Overall Study||52
6301599|NCT00346268|7204418|FG001|STARTED|Overall Study||53
6301600|NCT00346268|7204417|FG000|COMPLETED|Overall Study||50
6301601|NCT00346268|7204418|FG001|COMPLETED|Overall Study||50
6301602|NCT00346268|7204417|FG000|NOT COMPLETED|Overall Study||2
6301603|NCT00346268|7204418|FG001|NOT COMPLETED|Overall Study||3
6301604|NCT00346333|7204426|FG000|STARTED|Overall Study||121
6301605|NCT00346333|7204427|FG001|STARTED|Overall Study||119
6301606|NCT00346333|7204426|FG000|COMPLETED|Overall Study||116
6301607|NCT00346333|7204427|FG001|COMPLETED|Overall Study||111
6301608|NCT00346333|7204426|FG000|NOT COMPLETED|Overall Study||5
6301609|NCT00346333|7204427|FG001|NOT COMPLETED|Overall Study||8
6301610|NCT00346398|7204437|FG000|STARTED|Overall Study||25
6301611|NCT00346398|7204438|FG001|STARTED|Overall Study||26
6301612|NCT00346398|7204437|FG000|COMPLETED|Overall Study||22
6301613|NCT00346398|7204438|FG001|COMPLETED|Overall Study||24
6301614|NCT00346398|7204437|FG000|NOT COMPLETED|Overall Study||3
6301615|NCT00346398|7204438|FG001|NOT COMPLETED|Overall Study||2
6301616|NCT00346476|7204444|FG000|STARTED|Overall Study||1250
6301617|NCT00346476|7204444|FG000|COMPLETED|Overall Study||1250
6301618|NCT00346476|7204444|FG000|NOT COMPLETED|Overall Study||0
6301619|NCT00346632|7204450|FG000|STARTED|Overall Study||3
6301620|NCT00346632|7204451|FG001|STARTED|Overall Study||3
6301621|NCT00346632|7204452|FG002|STARTED|Overall Study||6
6301622|NCT00346632|7204453|FG003|STARTED|Overall Study||3
6301623|NCT00346632|7204454|FG004|STARTED|Overall Study||4
6301624|NCT00346632|7204455|FG005|STARTED|Overall Study||2
6301625|NCT00346632|7204456|FG006|STARTED|Overall Study||5
6301626|NCT00346632|7204457|FG007|STARTED|Overall Study||4
6301627|NCT00346632|7204458|FG008|STARTED|Overall Study||4
6301628|NCT00346632|7204459|FG009|STARTED|Overall Study||3
6301629|NCT00346632|7204450|FG000|COMPLETED|Overall Study||0
6301630|NCT00346632|7204451|FG001|COMPLETED|Overall Study||0
6301631|NCT00346632|7204452|FG002|COMPLETED|Overall Study||0
6301632|NCT00346632|7204453|FG003|COMPLETED|Overall Study||0
6301633|NCT00346632|7204454|FG004|COMPLETED|Overall Study||0
6301634|NCT00346632|7204455|FG005|COMPLETED|Overall Study||0
6301635|NCT00346632|7204456|FG006|COMPLETED|Overall Study||0
6301636|NCT00346632|7204457|FG007|COMPLETED|Overall Study||0
6301637|NCT00346632|7204458|FG008|COMPLETED|Overall Study||0
6301638|NCT00346632|7204459|FG009|COMPLETED|Overall Study||0
6301639|NCT00346632|7204450|FG000|NOT COMPLETED|Overall Study||3
6301640|NCT00346632|7204451|FG001|NOT COMPLETED|Overall Study||3
6301641|NCT00346632|7204452|FG002|NOT COMPLETED|Overall Study||6
6301642|NCT00346632|7204453|FG003|NOT COMPLETED|Overall Study||3
6301643|NCT00346632|7204454|FG004|NOT COMPLETED|Overall Study||4
6301644|NCT00346632|7204455|FG005|NOT COMPLETED|Overall Study||2
6301645|NCT00346632|7204456|FG006|NOT COMPLETED|Overall Study||5
6301646|NCT00346632|7204457|FG007|NOT COMPLETED|Overall Study||4
6301647|NCT00346632|7204458|FG008|NOT COMPLETED|Overall Study||4
6301648|NCT00346632|7204459|FG009|NOT COMPLETED|Overall Study||3
6301649|NCT00346697|7204523|FG000|STARTED|Overall Study||24
6301650|NCT00346697|7204524|FG001|STARTED|Overall Study||24
6301651|NCT00346697|7204523|FG000|COMPLETED|Overall Study||24
6301652|NCT00346697|7204524|FG001|COMPLETED|Overall Study||23
6301653|NCT00346697|7204523|FG000|NOT COMPLETED|Overall Study||0
6301654|NCT00346697|7204524|FG001|NOT COMPLETED|Overall Study||1
6301655|NCT00346775|7204532|FG000|STARTED|Period 1: Intervention Period 1||49
6301656|NCT00346775|7204533|FG001|STARTED|Period 1: Intervention Period 1||48
6301657|NCT00346775|7204532|FG000|COMPLETED|Period 1: Intervention Period 1||44
6301658|NCT00346775|7204533|FG001|COMPLETED|Period 1: Intervention Period 1||45
6301659|NCT00346775|7204532|FG000|NOT COMPLETED|Period 1: Intervention Period 1||5
6301660|NCT00346775|7204533|FG001|NOT COMPLETED|Period 1: Intervention Period 1||3
6301661|NCT00346775|7204532|FG000|STARTED|Period 2: Washout Period (7 Days)||44
6301662|NCT00346775|7204533|FG001|STARTED|Period 2: Washout Period (7 Days)||45
6301663|NCT00346775|7204532|FG000|COMPLETED|Period 2: Washout Period (7 Days)||44
6301664|NCT00346775|7204533|FG001|COMPLETED|Period 2: Washout Period (7 Days)||45
6301665|NCT00346775|7204532|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6301666|NCT00346775|7204533|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6301667|NCT00346775|7204532|FG000|STARTED|Period 3: Intervention Period 2||44
6301668|NCT00346775|7204533|FG001|STARTED|Period 3: Intervention Period 2||45
6301669|NCT00346775|7204532|FG000|COMPLETED|Period 3: Intervention Period 2||44
6301670|NCT00346775|7204533|FG001|COMPLETED|Period 3: Intervention Period 2||45
6301671|NCT00346775|7204532|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
6301672|NCT00346775|7204533|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
6301673|NCT00346905|7204543|FG000|STARTED|Overall Study||16
6301674|NCT00346905|7204543|FG000|COMPLETED|Overall Study||12
6301675|NCT00346905|7204543|FG000|NOT COMPLETED|Overall Study||4
6301676|NCT00347009|7204547|FG000|STARTED|Overall Study||155
6301677|NCT00347009|7204547|FG000|COMPLETED|Overall Study||128
6301678|NCT00347009|7204547|FG000|NOT COMPLETED|Overall Study||27
6301679|NCT00347022|7204553|FG000|STARTED|Overall Study||74
6301680|NCT00347022|7204554|FG001|STARTED|Overall Study||71
6301681|NCT00347022|7204553|FG000|COMPLETED|Overall Study||62
6301682|NCT00347022|7204554|FG001|COMPLETED|Overall Study||66
6301683|NCT00347022|7204553|FG000|NOT COMPLETED|Overall Study||12
6301684|NCT00347022|7204554|FG001|NOT COMPLETED|Overall Study||5
6301685|NCT00347269|7204562|FG000|STARTED|Overall Study||503
6301686|NCT00347269|7204563|FG001|STARTED|Overall Study||501
6301687|NCT00347269|7204562|FG000|COMPLETED|Overall Study||409
6301688|NCT00347269|7204563|FG001|COMPLETED|Overall Study||395
6301689|NCT00347269|7204562|FG000|NOT COMPLETED|Overall Study||94
6301690|NCT00347269|7204563|FG001|NOT COMPLETED|Overall Study||106
6301691|NCT00347308|7204569|FG000|STARTED|Overall Study||40
6301692|NCT00347308|7204569|FG000|COMPLETED|Overall Study||40
6301693|NCT00347308|7204569|FG000|NOT COMPLETED|Overall Study||0
6301694|NCT00347360|7204588|FG000|STARTED|Overall Study||44
6301695|NCT00347360|7204589|FG001|STARTED|Overall Study||43
6301696|NCT00347360|7204590|FG002|STARTED|Overall Study||43
6301697|NCT00347360|7204591|FG003|STARTED|Overall Study||43
6301698|NCT00347360|7204592|FG004|STARTED|Overall Study||44
6301699|NCT00347360|7204593|FG005|STARTED|Overall Study||44
6301700|NCT00347360|7204594|FG006|STARTED|Overall Study||44
6301701|NCT00347360|7204595|FG007|STARTED|Overall Study||43
6301702|NCT00347360|7204596|FG008|STARTED|Overall Study||44
6301703|NCT00347360|7204597|FG009|STARTED|Overall Study||44
6301704|NCT00347360|7204598|FG010|STARTED|Overall Study||44
6301705|NCT00347360|7204599|FG011|STARTED|Overall Study||43
6301706|NCT00347360|7204600|FG012|STARTED|Overall Study||44
6301707|NCT00347360|7204601|FG013|STARTED|Overall Study||44
6301708|NCT00347360|7204602|FG014|STARTED|Overall Study||43
6301709|NCT00347360|7204588|FG000|COMPLETED|Overall Study||39
6301710|NCT00347360|7204589|FG001|COMPLETED|Overall Study||35
6301711|NCT00347360|7204590|FG002|COMPLETED|Overall Study||37
6301712|NCT00347360|7204591|FG003|COMPLETED|Overall Study||30
6301713|NCT00347360|7204592|FG004|COMPLETED|Overall Study||39
6301714|NCT00347360|7204593|FG005|COMPLETED|Overall Study||36
6301715|NCT00347360|7204594|FG006|COMPLETED|Overall Study||37
6301716|NCT00347360|7204595|FG007|COMPLETED|Overall Study||40
6301717|NCT00347360|7204596|FG008|COMPLETED|Overall Study||38
6301718|NCT00347360|7204597|FG009|COMPLETED|Overall Study||35
6301719|NCT00347360|7204598|FG010|COMPLETED|Overall Study||39
6301720|NCT00347360|7204599|FG011|COMPLETED|Overall Study||37
6301721|NCT00347360|7204600|FG012|COMPLETED|Overall Study||34
6301722|NCT00347360|7204601|FG013|COMPLETED|Overall Study||36
6301723|NCT00347360|7204602|FG014|COMPLETED|Overall Study||39
6301724|NCT00347360|7204588|FG000|NOT COMPLETED|Overall Study||5
6301725|NCT00347360|7204589|FG001|NOT COMPLETED|Overall Study||8
6301726|NCT00347360|7204590|FG002|NOT COMPLETED|Overall Study||6
6301727|NCT00347360|7204591|FG003|NOT COMPLETED|Overall Study||13
6301728|NCT00347360|7204592|FG004|NOT COMPLETED|Overall Study||5
6301729|NCT00347360|7204593|FG005|NOT COMPLETED|Overall Study||8
6301730|NCT00347360|7204594|FG006|NOT COMPLETED|Overall Study||7
6301731|NCT00347360|7204595|FG007|NOT COMPLETED|Overall Study||3
6301732|NCT00347360|7204596|FG008|NOT COMPLETED|Overall Study||6
6301733|NCT00347360|7204597|FG009|NOT COMPLETED|Overall Study||9
6301734|NCT00347360|7204598|FG010|NOT COMPLETED|Overall Study||5
6301735|NCT00347360|7204599|FG011|NOT COMPLETED|Overall Study||6
6301736|NCT00347360|7204600|FG012|NOT COMPLETED|Overall Study||10
6301737|NCT00347360|7204601|FG013|NOT COMPLETED|Overall Study||8
6301738|NCT00347360|7204602|FG014|NOT COMPLETED|Overall Study||4
6301739|NCT00347438|7204634|FG000|STARTED|Overall Study||18
6301740|NCT00347438|7204634|FG000|COMPLETED|Overall Study||16
6301741|NCT00347438|7204634|FG000|NOT COMPLETED|Overall Study||2
6301742|NCT00347776|7204641|FG000|STARTED|1.5 Month Follow-up||484
6301743|NCT00347776|7204642|FG001|STARTED|1.5 Month Follow-up||483
6301744|NCT00347776|7204643|FG002|STARTED|1.5 Month Follow-up||485
6301745|NCT00347776|7204641|FG000|COMPLETED|1.5 Month Follow-up||470
6301746|NCT00347776|7204642|FG001|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
6301747|NCT00347776|7204643|FG002|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
6301748|NCT00347776|7204641|FG000|NOT COMPLETED|1.5 Month Follow-up||14
6301749|NCT00347776|7204642|FG001|NOT COMPLETED|1.5 Month Follow-up||8
6301750|NCT00347776|7204643|FG002|NOT COMPLETED|1.5 Month Follow-up||12
6301751|NCT00347776|7204641|FG000|STARTED|6 Month Follow-up||470
6301752|NCT00347776|7204642|FG001|STARTED|6 Month Follow-up||475
6301753|NCT00347776|7204643|FG002|STARTED|6 Month Follow-up||473
6301754|NCT00347776|7204641|FG000|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
6301755|NCT00347776|7204642|FG001|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
6301756|NCT00347776|7204643|FG002|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
6301757|NCT00347776|7204641|FG000|NOT COMPLETED|6 Month Follow-up||22
6301758|NCT00347776|7204642|FG001|NOT COMPLETED|6 Month Follow-up||13
6301759|NCT00347776|7204643|FG002|NOT COMPLETED|6 Month Follow-up||18
6301760|NCT00347776|7204641|FG000|STARTED|12 Month Follow-up||448
6301761|NCT00347776|7204642|FG001|STARTED|12 Month Follow-up||462
6301762|NCT00347776|7204643|FG002|STARTED|12 Month Follow-up||455
6301763|NCT00347776|7204641|FG000|COMPLETED|12 Month Follow-up||425
6301764|NCT00347776|7204642|FG001|COMPLETED|12 Month Follow-up||446
6301765|NCT00347776|7204643|FG002|COMPLETED|12 Month Follow-up||436
6301766|NCT00347776|7204641|FG000|NOT COMPLETED|12 Month Follow-up||23
6301767|NCT00347776|7204642|FG001|NOT COMPLETED|12 Month Follow-up||16
6301768|NCT00347776|7204643|FG002|NOT COMPLETED|12 Month Follow-up||19
6301769|NCT00347919|7204654|FG000|STARTED|Overall Study|Safety Population|73
6301770|NCT00347919|7204655|FG001|STARTED|Overall Study|Safety Population|76
6301771|NCT00347919|7204656|FG002|STARTED|Overall Study|Safety Population|40
6301772|NCT00347919|7204654|FG000|COMPLETED|Overall Study||2
6301773|NCT00347919|7204655|FG001|COMPLETED|Overall Study||0
6301774|NCT00347919|7204656|FG002|COMPLETED|Overall Study||2
6301775|NCT00347919|7204654|FG000|NOT COMPLETED|Overall Study||71
6301776|NCT00347919|7204655|FG001|NOT COMPLETED|Overall Study||76
6301777|NCT00347919|7204656|FG002|NOT COMPLETED|Overall Study||38
6301778|NCT00347932|7204668|FG000|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
6301779|NCT00347932|7204669|FG001|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
6301780|NCT00347932|7204668|FG000|COMPLETED|Overall Study||444
6301781|NCT00347932|7204669|FG001|COMPLETED|Overall Study||430
6301782|NCT00347932|7204668|FG000|NOT COMPLETED|Overall Study||31
6301783|NCT00347932|7204669|FG001|NOT COMPLETED|Overall Study||52
6301784|NCT00347958|7204675|FG000|STARTED|Overall Study||544
6301785|NCT00347958|7204675|FG000|COMPLETED|Overall Study||540
6301786|NCT00347958|7204675|FG000|NOT COMPLETED|Overall Study||4
6301787|NCT00348140|7204682|FG000|STARTED|Overall Study||487
6301788|NCT00348140|7204683|FG001|STARTED|Overall Study||490
6301789|NCT00348140|7204684|FG002|STARTED|Overall Study||491
6301790|NCT00348140|7204682|FG000|COMPLETED|Overall Study||361
6301791|NCT00348140|7204683|FG001|COMPLETED|Overall Study||351
6301792|NCT00348140|7204684|FG002|COMPLETED|Overall Study||328
6301793|NCT00348140|7204682|FG000|NOT COMPLETED|Overall Study||126
6301794|NCT00348140|7204683|FG001|NOT COMPLETED|Overall Study||139
6301795|NCT00348140|7204684|FG002|NOT COMPLETED|Overall Study||163
6301796|NCT00348205|7204693|FG000|STARTED|Overall Study||80
6301797|NCT00348205|7204693|FG000|COMPLETED|Overall Study||78
6301798|NCT00348205|7204693|FG000|NOT COMPLETED|Overall Study||2
6301799|NCT00348283|7204699|FG000|STARTED|Induction||0
6301800|NCT00348283|7204700|FG001|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
6301801|NCT00348283|7204699|FG000|COMPLETED|Induction||0
6301802|NCT00348283|7204700|FG001|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
6301803|NCT00348283|7204699|FG000|NOT COMPLETED|Induction||0
6301804|NCT00348283|7204700|FG001|NOT COMPLETED|Induction||6
6301805|NCT00348283|7204699|FG000|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
6301806|NCT00348283|7204700|FG001|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
6301807|NCT00348283|7204699|FG000|COMPLETED|Double Blind||60
6301808|NCT00348283|7204700|FG001|COMPLETED|Double Blind||54
6301809|NCT00348283|7204699|FG000|NOT COMPLETED|Double Blind||5
6301810|NCT00348283|7204700|FG001|NOT COMPLETED|Double Blind||10
6301811|NCT00348283|7204699|FG000|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
6301812|NCT00348283|7204700|FG001|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
6301813|NCT00348283|7204699|FG000|COMPLETED|Open Label||0
6301814|NCT00348283|7204700|FG001|COMPLETED|Open Label||66
6301815|NCT00348283|7204699|FG000|NOT COMPLETED|Open Label||0
6301816|NCT00348283|7204700|FG001|NOT COMPLETED|Open Label||34
6301817|NCT00348309|7204709|FG000|STARTED|Overall Study||496
6301818|NCT00348309|7204710|FG001|STARTED|Overall Study||494
6301819|NCT00348309|7204711|FG002|STARTED|Overall Study||489
6301820|NCT00348309|7204709|FG000|COMPLETED|Overall Study||362
6301821|NCT00348309|7204710|FG001|COMPLETED|Overall Study||396
6301822|NCT00348309|7204711|FG002|COMPLETED|Overall Study||346
6301823|NCT00348309|7204709|FG000|NOT COMPLETED|Overall Study||134
6301824|NCT00348309|7204710|FG001|NOT COMPLETED|Overall Study||98
6301825|NCT00348309|7204711|FG002|NOT COMPLETED|Overall Study||143
6301826|NCT00348348|7204722|FG000|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
6301827|NCT00348348|7204723|FG001|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
6301828|NCT00348348|7204722|FG000|COMPLETED|Overall Study||554
6301829|NCT00348348|7204723|FG001|COMPLETED|Overall Study||555
6301830|NCT00348348|7204722|FG000|NOT COMPLETED|Overall Study||25
6301831|NCT00348348|7204723|FG001|NOT COMPLETED|Overall Study||27
6301832|NCT00348374|7204731|FG000|STARTED|Overall Study||88
6301833|NCT00348374|7204732|FG001|STARTED|Overall Study||103
6301834|NCT00348374|7204731|FG000|Received Study Treatment|Overall Study||88
6301835|NCT00348374|7204732|FG001|Received Study Treatment|Overall Study||96
6301836|NCT00348374|7204731|FG000|COMPLETED|Overall Study||69
6301837|NCT00348374|7204732|FG001|COMPLETED|Overall Study||71
6301838|NCT00348374|7204731|FG000|NOT COMPLETED|Overall Study||19
6301839|NCT00348374|7204732|FG001|NOT COMPLETED|Overall Study||32
6301840|NCT00348595|7204741|FG000|STARTED|Overall Study||26
6301841|NCT00348595|7204742|FG001|STARTED|Overall Study||34
6301842|NCT00348595|7204741|FG000|COMPLETED|Overall Study||21
6301843|NCT00348595|7204742|FG001|COMPLETED|Overall Study||26
6301844|NCT00348595|7204741|FG000|NOT COMPLETED|Overall Study||5
6301845|NCT00348595|7204742|FG001|NOT COMPLETED|Overall Study||8
6301846|NCT00348673|7204756|FG000|STARTED|Stage 1||6
6301847|NCT00348673|7204757|FG001|STARTED|Stage 1||6
6301848|NCT00348673|7204758|FG002|STARTED|Stage 1||7
6301849|NCT00348673|7204759|FG003|STARTED|Stage 1||6
6301850|NCT00348673|7204760|FG004|STARTED|Stage 1||4
6301851|NCT00348673|7204761|FG005|STARTED|Stage 1||0
6301852|NCT00348673|7204762|FG006|STARTED|Stage 1||0
6301853|NCT00348673|7204763|FG007|STARTED|Stage 1||0
6301854|NCT00348673|7204764|FG008|STARTED|Stage 1||0
6301855|NCT00348673|7204756|FG000|Treated|Stage 1||6
6301856|NCT00348673|7204757|FG001|Treated|Stage 1||6
6301857|NCT00348673|7204758|FG002|Treated|Stage 1||6
6301858|NCT00348673|7204759|FG003|Treated|Stage 1||6
6301859|NCT00348673|7204760|FG004|Treated|Stage 1||4
6301860|NCT00348673|7204761|FG005|Treated|Stage 1||0
6301861|NCT00348673|7204762|FG006|Treated|Stage 1||0
6301862|NCT00348673|7204763|FG007|Treated|Stage 1||0
6301863|NCT00348673|7204764|FG008|Treated|Stage 1||0
6301864|NCT00348673|7204756|FG000|COMPLETED|Stage 1||6
6301865|NCT00348673|7204757|FG001|COMPLETED|Stage 1||6
6301866|NCT00348673|7204758|FG002|COMPLETED|Stage 1||6
6301867|NCT00348673|7204759|FG003|COMPLETED|Stage 1||6
6301868|NCT00348673|7204760|FG004|COMPLETED|Stage 1||4
6301869|NCT00348673|7204761|FG005|COMPLETED|Stage 1||0
6301870|NCT00348673|7204762|FG006|COMPLETED|Stage 1||0
6301871|NCT00348673|7204763|FG007|COMPLETED|Stage 1||0
6301872|NCT00348673|7204764|FG008|COMPLETED|Stage 1||0
6301873|NCT00348673|7204756|FG000|NOT COMPLETED|Stage 1||0
6301874|NCT00348673|7204757|FG001|NOT COMPLETED|Stage 1||0
6301875|NCT00348673|7204758|FG002|NOT COMPLETED|Stage 1||1
6301876|NCT00348673|7204759|FG003|NOT COMPLETED|Stage 1||0
6301877|NCT00348673|7204760|FG004|NOT COMPLETED|Stage 1||0
6301878|NCT00348673|7204761|FG005|NOT COMPLETED|Stage 1||0
6301879|NCT00348673|7204762|FG006|NOT COMPLETED|Stage 1||0
6301880|NCT00348673|7204763|FG007|NOT COMPLETED|Stage 1||0
6301881|NCT00348673|7204764|FG008|NOT COMPLETED|Stage 1||0
6301882|NCT00348673|7204756|FG000|STARTED|Stage 2||0
6301883|NCT00348673|7204757|FG001|STARTED|Stage 2||0
6301884|NCT00348673|7204758|FG002|STARTED|Stage 2||0
6301885|NCT00348673|7204759|FG003|STARTED|Stage 2||0
6301886|NCT00348673|7204760|FG004|STARTED|Stage 2||0
6301887|NCT00348673|7204761|FG005|STARTED|Stage 2||6
6301888|NCT00348673|7204762|FG006|STARTED|Stage 2||6
6301889|NCT00348673|7204763|FG007|STARTED|Stage 2||6
6301890|NCT00348673|7204764|FG008|STARTED|Stage 2||2
6301891|NCT00348673|7204756|FG000|COMPLETED|Stage 2||0
6301892|NCT00348673|7204757|FG001|COMPLETED|Stage 2||0
6301893|NCT00348673|7204758|FG002|COMPLETED|Stage 2||0
6301894|NCT00348673|7204759|FG003|COMPLETED|Stage 2||0
6301895|NCT00348673|7204760|FG004|COMPLETED|Stage 2||0
6301896|NCT00348673|7204761|FG005|COMPLETED|Stage 2||6
6301897|NCT00348673|7204762|FG006|COMPLETED|Stage 2||6
6301898|NCT00348673|7204763|FG007|COMPLETED|Stage 2||6
6301899|NCT00348673|7204764|FG008|COMPLETED|Stage 2||2
6301900|NCT00348673|7204756|FG000|NOT COMPLETED|Stage 2||0
6301901|NCT00348673|7204757|FG001|NOT COMPLETED|Stage 2||0
6301902|NCT00348673|7204758|FG002|NOT COMPLETED|Stage 2||0
6301903|NCT00348673|7204759|FG003|NOT COMPLETED|Stage 2||0
6301904|NCT00348673|7204760|FG004|NOT COMPLETED|Stage 2||0
6301905|NCT00348673|7204761|FG005|NOT COMPLETED|Stage 2||0
6301906|NCT00348673|7204762|FG006|NOT COMPLETED|Stage 2||0
6301907|NCT00348673|7204763|FG007|NOT COMPLETED|Stage 2||0
6301908|NCT00348673|7204764|FG008|NOT COMPLETED|Stage 2||0
6301909|NCT00348686|7204782|FG000|STARTED|Overall Study||315
6301910|NCT00348686|7204782|FG000|COMPLETED|Overall Study||249
6301911|NCT00348686|7204782|FG000|NOT COMPLETED|Overall Study||66
6301912|NCT00348790|7204786|FG000|STARTED|Began Treatment||25
6301913|NCT00348790|7204786|FG000|COMPLETED|Began Treatment||25
6301914|NCT00348790|7204786|FG000|NOT COMPLETED|Began Treatment||0
6301915|NCT00348790|7204786|FG000|STARTED|Completed Treatment||25
6301916|NCT00348790|7204786|FG000|COMPLETED|Completed Treatment||0
6301917|NCT00348790|7204786|FG000|NOT COMPLETED|Completed Treatment||25
6301918|NCT00348816|7204791|FG000|STARTED|Overall Study||20
6301919|NCT00348816|7204791|FG000|COMPLETED|Overall Study||19
6301920|NCT00348816|7204791|FG000|NOT COMPLETED|Overall Study||1
6301921|NCT00348881|7204799|FG000|STARTED|Overall Study||1424
6301922|NCT00348881|7204800|FG001|STARTED|Overall Study||709
6301923|NCT00348881|7204799|FG000|COMPLETED|Overall Study||1407
6301924|NCT00348881|7204800|FG001|COMPLETED|Overall Study||697
6301925|NCT00348881|7204799|FG000|NOT COMPLETED|Overall Study||17
6301926|NCT00348881|7204800|FG001|NOT COMPLETED|Overall Study||12
6301927|NCT00348933|7204810|FG000|STARTED|Overall Study||90
6301928|NCT00348933|7204810|FG000|COMPLETED|Overall Study||65
6301929|NCT00348933|7204810|FG000|NOT COMPLETED|Overall Study||25
6301930|NCT00348946|7204817|FG000|STARTED|Overall Study||46
6301931|NCT00348946|7204818|FG001|STARTED|Overall Study||47
6301932|NCT00348946|7204817|FG000|COMPLETED|Overall Study||35
6301933|NCT00348946|7204818|FG001|COMPLETED|Overall Study||35
6301934|NCT00348946|7204817|FG000|NOT COMPLETED|Overall Study||11
6301935|NCT00348946|7204818|FG001|NOT COMPLETED|Overall Study||12
6374752|NCT00751530|7285284|FG000|STARTED|Overall Study||332
6374753|NCT00751530|7285285|FG001|STARTED|Overall Study||110
6374754|NCT00751530|7285284|FG000|COMPLETED|Overall Study||332
6374755|NCT00751530|7285285|FG001|COMPLETED|Overall Study||110
6374756|NCT00751530|7285284|FG000|NOT COMPLETED|Overall Study||0
6374757|NCT00751530|7285285|FG001|NOT COMPLETED|Overall Study||0
6374758|NCT00751621|7285291|FG000|STARTED|Overall Study||40
6374759|NCT00751621|7285291|FG000|COMPLETED|Overall Study||36
6301936|NCT00349336|7204828|FG000|STARTED|Overall Study||32
6301937|NCT00349336|7204829|FG001|STARTED|Overall Study||32
6301938|NCT00349336|7204828|FG000|COMPLETED|Overall Study||19
6301939|NCT00349336|7204829|FG001|COMPLETED|Overall Study||18
6301940|NCT00349336|7204828|FG000|NOT COMPLETED|Overall Study||13
6301941|NCT00349336|7204829|FG001|NOT COMPLETED|Overall Study||14
6301942|NCT00349349|7204838|FG000|STARTED|Overall Study||95
6301943|NCT00349349|7204839|FG001|STARTED|Overall Study||112
6301944|NCT00349349|7204840|FG002|STARTED|Overall Study||16
6301945|NCT00349349|7204838|FG000|COMPLETED|Overall Study||42
6301946|NCT00349349|7204839|FG001|COMPLETED|Overall Study||50
6301947|NCT00349349|7204840|FG002|COMPLETED|Overall Study||10
6301948|NCT00349349|7204838|FG000|NOT COMPLETED|Overall Study||53
6301949|NCT00349349|7204839|FG001|NOT COMPLETED|Overall Study||62
6301950|NCT00349349|7204840|FG002|NOT COMPLETED|Overall Study||6
6301951|NCT00349388|7204852|FG000|STARTED|Overall Study|no patients enrolled|0
6301952|NCT00349388|7204853|FG001|STARTED|Overall Study||1
6301953|NCT00349388|7204852|FG000|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
6301954|NCT00349388|7204853|FG001|COMPLETED|Overall Study||1
6301955|NCT00349388|7204852|FG000|NOT COMPLETED|Overall Study||0
6301956|NCT00349388|7204853|FG001|NOT COMPLETED|Overall Study||0
6301957|NCT00349466|7204861|FG000|STARTED|Overall Study||42
6301958|NCT00349466|7204862|FG001|STARTED|Overall Study||38
6301959|NCT00349466|7204861|FG000|COMPLETED|Overall Study||33
6301960|NCT00349466|7204862|FG001|COMPLETED|Overall Study||35
6301961|NCT00349466|7204861|FG000|NOT COMPLETED|Overall Study||9
6301962|NCT00349466|7204862|FG001|NOT COMPLETED|Overall Study||3
6301963|NCT00349622|7204870|FG000|STARTED|Overall Study||340
6301964|NCT00349622|7204871|FG001|STARTED|Overall Study||173
6301965|NCT00349622|7204870|FG000|COMPLETED|Overall Study||162
6301966|NCT00349622|7204871|FG001|COMPLETED|Overall Study||77
6301967|NCT00349622|7204870|FG000|NOT COMPLETED|Overall Study||178
6301968|NCT00349622|7204871|FG001|NOT COMPLETED|Overall Study||96
6301969|NCT00349713|7204880|FG000|STARTED|Overall Study||20
6301970|NCT00349713|7204881|FG001|STARTED|Overall Study||20
6301971|NCT00349713|7204882|FG002|STARTED|Overall Study||20
6301972|NCT00349713|7204880|FG000|COMPLETED|Overall Study||20
6301973|NCT00349713|7204881|FG001|COMPLETED|Overall Study||20
6301974|NCT00349713|7204882|FG002|COMPLETED|Overall Study||20
6401399|NCT00892177|7314304|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
6401400|NCT00892177|7314305|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
6401401|NCT00892177|7314306|FG004|NOT COMPLETED|Phase I: Dose Level 2||0
6401402|NCT00892177|7314307|FG005|NOT COMPLETED|Phase I: Dose Level 2||0
6401403|NCT00892177|7314302|FG000|STARTED|Phase I: Dose Level 3||0
6401404|NCT00892177|7314303|FG001|STARTED|Phase I: Dose Level 3||0
6401405|NCT00892177|7314304|FG002|STARTED|Phase I: Dose Level 3||0
6401406|NCT00892177|7314305|FG003|STARTED|Phase I: Dose Level 3||6
6401407|NCT00892177|7314306|FG004|STARTED|Phase I: Dose Level 3||0
6401408|NCT00892177|7314307|FG005|STARTED|Phase I: Dose Level 3||0
6401409|NCT00892177|7314302|FG000|COMPLETED|Phase I: Dose Level 3||0
6401410|NCT00892177|7314303|FG001|COMPLETED|Phase I: Dose Level 3||0
6401411|NCT00892177|7314304|FG002|COMPLETED|Phase I: Dose Level 3||0
6401412|NCT00892177|7314305|FG003|COMPLETED|Phase I: Dose Level 3||6
6401413|NCT00892177|7314306|FG004|COMPLETED|Phase I: Dose Level 3||0
6401414|NCT00892177|7314307|FG005|COMPLETED|Phase I: Dose Level 3||0
6401415|NCT00892177|7314302|FG000|NOT COMPLETED|Phase I: Dose Level 3||0
6401416|NCT00892177|7314303|FG001|NOT COMPLETED|Phase I: Dose Level 3||0
6401417|NCT00892177|7314304|FG002|NOT COMPLETED|Phase I: Dose Level 3||0
6401418|NCT00892177|7314305|FG003|NOT COMPLETED|Phase I: Dose Level 3||0
6401419|NCT00892177|7314306|FG004|NOT COMPLETED|Phase I: Dose Level 3||0
6401420|NCT00892177|7314307|FG005|NOT COMPLETED|Phase I: Dose Level 3||0
6401421|NCT00892177|7314302|FG000|STARTED|Phase II||0
6401422|NCT00892177|7314303|FG001|STARTED|Phase II||0
6401423|NCT00892177|7314304|FG002|STARTED|Phase II||0
6401424|NCT00892177|7314305|FG003|STARTED|Phase II||0
6401425|NCT00892177|7314306|FG004|STARTED|Phase II||88
6401426|NCT00892177|7314307|FG005|STARTED|Phase II||40
6401427|NCT00892177|7314302|FG000|COMPLETED|Phase II||0
6401428|NCT00892177|7314303|FG001|COMPLETED|Phase II||0
6401429|NCT00892177|7314304|FG002|COMPLETED|Phase II||0
6401430|NCT00892177|7314305|FG003|COMPLETED|Phase II||0
6401431|NCT00892177|7314306|FG004|COMPLETED|Phase II||83
6401432|NCT00892177|7314307|FG005|COMPLETED|Phase II||38
6401433|NCT00892177|7314302|FG000|NOT COMPLETED|Phase II||0
6401434|NCT00892177|7314303|FG001|NOT COMPLETED|Phase II||0
6401435|NCT00892177|7314304|FG002|NOT COMPLETED|Phase II||0
6401436|NCT00892177|7314305|FG003|NOT COMPLETED|Phase II||0
6401437|NCT00892177|7314306|FG004|NOT COMPLETED|Phase II||5
6401438|NCT00892177|7314307|FG005|NOT COMPLETED|Phase II||2
6401439|NCT00892281|7314324|FG000|STARTED|Overall Study||1197
6401440|NCT00892281|7314325|FG001|STARTED|Overall Study||224
6301975|NCT00349713|7204880|FG000|NOT COMPLETED|Overall Study||0
6301976|NCT00349713|7204881|FG001|NOT COMPLETED|Overall Study||0
6301977|NCT00349713|7204882|FG002|NOT COMPLETED|Overall Study||0
6301978|NCT00349752|7204892|FG000|STARTED|Overall Study||87
6401441|NCT00892281|7314324|FG000|COMPLETED|Overall Study||930
6401442|NCT00892281|7314325|FG001|COMPLETED|Overall Study||187
6401443|NCT00892281|7314324|FG000|NOT COMPLETED|Overall Study||267
6401444|NCT00892281|7314325|FG001|NOT COMPLETED|Overall Study||37
6401445|NCT00892437|7314333|FG000|STARTED|Randomized Phase||56
6401446|NCT00892437|7314334|FG001|STARTED|Randomized Phase||29
6301979|NCT00349752|7204893|FG001|STARTED|Overall Study||87
6301980|NCT00349752|7204892|FG000|COMPLETED|Overall Study||28
6301981|NCT00349752|7204893|FG001|COMPLETED|Overall Study||23
6301982|NCT00349752|7204892|FG000|NOT COMPLETED|Overall Study||59
6301983|NCT00349752|7204893|FG001|NOT COMPLETED|Overall Study||64
6301984|NCT00349778|7204899|FG000|STARTED|Overall Study||102
6301985|NCT00349778|7204899|FG000|COMPLETED|Overall Study||102
6301986|NCT00349778|7204899|FG000|NOT COMPLETED|Overall Study||0
6301987|NCT00349908|7204905|FG000|STARTED|Overall Study||10
6301988|NCT00349908|7204906|FG001|STARTED|Overall Study||10
6301989|NCT00349908|7204905|FG000|COMPLETED|Overall Study||10
6301990|NCT00349908|7204906|FG001|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
6301991|NCT00349908|7204905|FG000|NOT COMPLETED|Overall Study||0
6301992|NCT00349908|7204906|FG001|NOT COMPLETED|Overall Study||4
6301993|NCT00349921|7204917|FG000|STARTED|First Spinal Injection||10
6301994|NCT00349921|7204918|FG001|STARTED|First Spinal Injection||10
6301995|NCT00349921|7204919|FG002|STARTED|First Spinal Injection||1
6301996|NCT00349921|7204920|FG003|STARTED|First Spinal Injection||1
6301997|NCT00349921|7204917|FG000|COMPLETED|First Spinal Injection||9
6301998|NCT00349921|7204918|FG001|COMPLETED|First Spinal Injection||10
6301999|NCT00349921|7204919|FG002|COMPLETED|First Spinal Injection||0
6302000|NCT00349921|7204920|FG003|COMPLETED|First Spinal Injection||1
6302001|NCT00349921|7204917|FG000|NOT COMPLETED|First Spinal Injection||1
6302002|NCT00349921|7204918|FG001|NOT COMPLETED|First Spinal Injection||0
6302003|NCT00349921|7204919|FG002|NOT COMPLETED|First Spinal Injection||1
6302004|NCT00349921|7204920|FG003|NOT COMPLETED|First Spinal Injection||0
6302005|NCT00349921|7204917|FG000|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
6302006|NCT00349921|7204918|FG001|STARTED|Second Spinal Injection||10
6302007|NCT00349921|7204919|FG002|STARTED|Second Spinal Injection||0
6302008|NCT00349921|7204920|FG003|STARTED|Second Spinal Injection||1
6302009|NCT00349921|7204917|FG000|COMPLETED|Second Spinal Injection||9
6302010|NCT00349921|7204918|FG001|COMPLETED|Second Spinal Injection||10
6302011|NCT00349921|7204919|FG002|COMPLETED|Second Spinal Injection||0
6302012|NCT00349921|7204920|FG003|COMPLETED|Second Spinal Injection||1
6302013|NCT00349921|7204917|FG000|NOT COMPLETED|Second Spinal Injection||0
6302014|NCT00349921|7204918|FG001|NOT COMPLETED|Second Spinal Injection||0
6302015|NCT00349921|7204919|FG002|NOT COMPLETED|Second Spinal Injection||0
6302016|NCT00349921|7204920|FG003|NOT COMPLETED|Second Spinal Injection||0
6302017|NCT00349973|7204931|FG000|STARTED|Overall Study||12
6302018|NCT00349973|7204932|FG001|STARTED|Overall Study||8
6302019|NCT00349973|7204931|FG000|COMPLETED|Overall Study||8
6302020|NCT00349973|7204932|FG001|COMPLETED|Overall Study||5
6302021|NCT00349973|7204931|FG000|NOT COMPLETED|Overall Study||4
6302022|NCT00349973|7204932|FG001|NOT COMPLETED|Overall Study||3
6302023|NCT00350025|7204940|FG000|STARTED|Overall Study||11
6302024|NCT00350025|7204941|FG001|STARTED|Overall Study||30
6302025|NCT00350025|7204940|FG000|COMPLETED|Overall Study||11
6302026|NCT00350025|7204941|FG001|COMPLETED|Overall Study||28
6302027|NCT00350025|7204940|FG000|NOT COMPLETED|Overall Study||0
6302028|NCT00350025|7204941|FG001|NOT COMPLETED|Overall Study||2
6302029|NCT00350142|7204947|FG000|STARTED|Overall Study||20
6302030|NCT00350142|7204947|FG000|COMPLETED|Overall Study||20
6302031|NCT00350142|7204947|FG000|NOT COMPLETED|Overall Study||0
6302032|NCT00350207|7204955|FG000|STARTED|Overall Study||128
6302033|NCT00350207|7204956|FG001|STARTED|Overall Study||134
6302034|NCT00350207|7204957|FG002|STARTED|Overall Study||126
6302035|NCT00350207|7204955|FG000|COMPLETED|Overall Study||120
6302036|NCT00350207|7204956|FG001|COMPLETED|Overall Study||128
6302037|NCT00350207|7204957|FG002|COMPLETED|Overall Study||119
6302038|NCT00350207|7204955|FG000|NOT COMPLETED|Overall Study||8
6302039|NCT00350207|7204956|FG001|NOT COMPLETED|Overall Study||6
6302040|NCT00350207|7204957|FG002|NOT COMPLETED|Overall Study||7
6302041|NCT00350220|7204967|FG000|STARTED|Overall Study||30
6302042|NCT00350220|7204968|FG001|STARTED|Overall Study||30
6302043|NCT00350220|7204967|FG000|COMPLETED|Overall Study||30
6302044|NCT00350220|7204968|FG001|COMPLETED|Overall Study||30
6302045|NCT00350220|7204967|FG000|NOT COMPLETED|Overall Study||0
6302046|NCT00350220|7204968|FG001|NOT COMPLETED|Overall Study||0
6302047|NCT00350272|7204976|FG000|STARTED|Blinded 12 Week Treatment||39
6302048|NCT00350272|7204977|FG001|STARTED|Blinded 12 Week Treatment||37
6302049|NCT00350272|7204976|FG000|COMPLETED|Blinded 12 Week Treatment||30
6302050|NCT00350272|7204977|FG001|COMPLETED|Blinded 12 Week Treatment||35
6302051|NCT00350272|7204976|FG000|NOT COMPLETED|Blinded 12 Week Treatment||9
6302052|NCT00350272|7204977|FG001|NOT COMPLETED|Blinded 12 Week Treatment||2
6302053|NCT00350272|7204976|FG000|STARTED|Open-Label 84 Week Treatment||30
6302054|NCT00350272|7204977|FG001|STARTED|Open-Label 84 Week Treatment||35
6302055|NCT00350272|7204976|FG000|COMPLETED|Open-Label 84 Week Treatment||21
6302056|NCT00350272|7204977|FG001|COMPLETED|Open-Label 84 Week Treatment||27
6302057|NCT00350272|7204976|FG000|NOT COMPLETED|Open-Label 84 Week Treatment||9
6302058|NCT00350272|7204977|FG001|NOT COMPLETED|Open-Label 84 Week Treatment||8
6302059|NCT00350298|7204987|FG000|STARTED|Overall Study||101
6302060|NCT00350298|7204988|FG001|STARTED|Overall Study||99
6302061|NCT00350298|7204987|FG000|COMPLETED|Overall Study||92
6302062|NCT00350298|7204988|FG001|COMPLETED|Overall Study||86
6401447|NCT00892437|7314333|FG000|Randomized and Treated|Randomized Phase||50
6401448|NCT00892437|7314334|FG001|Randomized and Treated|Randomized Phase||29
6302063|NCT00350298|7204987|FG000|NOT COMPLETED|Overall Study||9
6302064|NCT00350298|7204988|FG001|NOT COMPLETED|Overall Study||13
6302065|NCT00350337|7204998|FG000|STARTED|Overall Study||22
6302066|NCT00350337|7204999|FG001|STARTED|Overall Study||22
6302067|NCT00350337|7205000|FG002|STARTED|Overall Study||21
6302068|NCT00350337|7205001|FG003|STARTED|Overall Study||21
6302069|NCT00350337|7204998|FG000|COMPLETED|Overall Study||17
6302070|NCT00350337|7204999|FG001|COMPLETED|Overall Study||19
6302071|NCT00350337|7205000|FG002|COMPLETED|Overall Study||18
6302072|NCT00350337|7205001|FG003|COMPLETED|Overall Study||21
6302073|NCT00350337|7204998|FG000|NOT COMPLETED|Overall Study||5
6302074|NCT00350337|7204999|FG001|NOT COMPLETED|Overall Study||3
6302075|NCT00350337|7205000|FG002|NOT COMPLETED|Overall Study||3
6302076|NCT00350337|7205001|FG003|NOT COMPLETED|Overall Study||0
6302077|NCT00350363|7205012|FG000|STARTED|Overall Study||60
6302078|NCT00350363|7205012|FG000|COMPLETED|Overall Study||60
6302079|NCT00350363|7205012|FG000|NOT COMPLETED|Overall Study||0
6302080|NCT00350402|7205018|FG000|STARTED|Overall Study||21
6302081|NCT00350402|7205019|FG001|STARTED|Overall Study||21
6302082|NCT00350402|7205018|FG000|COMPLETED|Overall Study||20
6302083|NCT00350402|7205019|FG001|COMPLETED|Overall Study||20
6302084|NCT00350402|7205018|FG000|NOT COMPLETED|Overall Study||1
6302085|NCT00350402|7205019|FG001|NOT COMPLETED|Overall Study||1
6302086|NCT00350519|7205033|FG000|STARTED|Overall Study||18
6302087|NCT00350519|7205034|FG001|STARTED|Overall Study||19
6302088|NCT00350519|7205033|FG000|COMPLETED|Overall Study||14
6302089|NCT00350519|7205034|FG001|COMPLETED|Overall Study||13
6302090|NCT00350519|7205033|FG000|NOT COMPLETED|Overall Study||4
6302091|NCT00350519|7205034|FG001|NOT COMPLETED|Overall Study||6
6302092|NCT00350532|7205042|FG000|STARTED|Overall Study||24
6302093|NCT00350532|7205043|FG001|STARTED|Overall Study||19
6302094|NCT00350532|7205042|FG000|COMPLETED|Overall Study||24
6302095|NCT00350532|7205043|FG001|COMPLETED|Overall Study||19
6302096|NCT00350532|7205042|FG000|NOT COMPLETED|Overall Study||0
6302097|NCT00350532|7205043|FG001|NOT COMPLETED|Overall Study||0
6401449|NCT00892437|7314333|FG000|COMPLETED|Randomized Phase||45
6401450|NCT00892437|7314334|FG001|COMPLETED|Randomized Phase||24
6401451|NCT00892437|7314333|FG000|NOT COMPLETED|Randomized Phase||11
6401452|NCT00892437|7314334|FG001|NOT COMPLETED|Randomized Phase||5
6401453|NCT00892437|7314333|FG000|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
6401454|NCT00892437|7314334|FG001|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
6401455|NCT00892437|7314333|FG000|COMPLETED|Open-Label Extension Phase||32
6401456|NCT00892437|7314334|FG001|COMPLETED|Open-Label Extension Phase||15
6401457|NCT00892437|7314333|FG000|NOT COMPLETED|Open-Label Extension Phase||12
6401458|NCT00892437|7314334|FG001|NOT COMPLETED|Open-Label Extension Phase||4
6401459|NCT00892606|7314343|FG000|STARTED|Overall Study||38
6401460|NCT00892606|7314344|FG001|STARTED|Overall Study||37
6401461|NCT00892606|7314343|FG000|COMPLETED|Overall Study||33
6401462|NCT00892606|7314344|FG001|COMPLETED|Overall Study||33
6401463|NCT00892606|7314343|FG000|NOT COMPLETED|Overall Study||5
6401464|NCT00892606|7314344|FG001|NOT COMPLETED|Overall Study||4
6401465|NCT00892697|7314350|FG000|STARTED|Overall Study||15
6401466|NCT00892697|7314350|FG000|COMPLETED|Overall Study||15
6401467|NCT00892697|7314350|FG000|NOT COMPLETED|Overall Study||0
6401468|NCT00892710|7314358|FG000|STARTED|Overall Study||48
6401469|NCT00892710|7314359|FG001|STARTED|Overall Study||59
6401470|NCT00892710|7314360|FG002|STARTED|Overall Study||55
6401471|NCT00892710|7314358|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
6401472|NCT00892710|7314359|FG001|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
6401473|NCT00892710|7314360|FG002|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
6401474|NCT00892710|7314358|FG000|NOT COMPLETED|Overall Study||48
6401475|NCT00892710|7314359|FG001|NOT COMPLETED|Overall Study||59
6401476|NCT00892710|7314360|FG002|NOT COMPLETED|Overall Study||55
6401477|NCT00892723|7314371|FG000|STARTED|Overall Study||21
6401478|NCT00892723|7314372|FG001|STARTED|Overall Study||19
6401479|NCT00892723|7314373|FG002|STARTED|Overall Study||19
6401480|NCT00892723|7314371|FG000|COMPLETED|Overall Study||19
6401481|NCT00892723|7314372|FG001|COMPLETED|Overall Study||15
6401482|NCT00892723|7314373|FG002|COMPLETED|Overall Study||17
6401483|NCT00892723|7314371|FG000|NOT COMPLETED|Overall Study||2
6401484|NCT00892723|7314372|FG001|NOT COMPLETED|Overall Study||4
6401485|NCT00892723|7314373|FG002|NOT COMPLETED|Overall Study||2
6401486|NCT00892775|7314416|FG000|STARTED|Overall Study||332
6401487|NCT00892775|7314417|FG001|STARTED|Overall Study||166
6401488|NCT00892775|7314416|FG000|COMPLETED|Overall Study||327
6401489|NCT00892775|7314417|FG001|COMPLETED|Overall Study||165
6401490|NCT00892775|7314416|FG000|NOT COMPLETED|Overall Study||5
6401491|NCT00892775|7314417|FG001|NOT COMPLETED|Overall Study||1
6401492|NCT00892957|7314425|FG000|STARTED|Intraoperative Day 0||70
6401493|NCT00892957|7314426|FG001|STARTED|Intraoperative Day 0||70
6401494|NCT00892957|7314425|FG000|COMPLETED|Intraoperative Day 0||70
6302098|NCT00350545|7205049|FG000|STARTED|Overall Study||37
6302099|NCT00350545|7205049|FG000|COMPLETED|Overall Study||35
6302100|NCT00350545|7205049|FG000|NOT COMPLETED|Overall Study||2
6302101|NCT00350636|7205055|FG000|STARTED|Overall Study||389
6302102|NCT00350636|7205056|FG001|STARTED|Overall Study||400
6302103|NCT00350636|7205055|FG000|COMPLETED|Overall Study||346
6302104|NCT00350636|7205056|FG001|COMPLETED|Overall Study||355
6302105|NCT00350636|7205055|FG000|NOT COMPLETED|Overall Study||43
6302106|NCT00350636|7205056|FG001|NOT COMPLETED|Overall Study||45
6302107|NCT00350727|7205065|FG000|STARTED|Phase I: Dose Escalation||34
6302108|NCT00350727|7205066|FG001|STARTED|Phase I: Dose Escalation||0
6302109|NCT00350727|7205067|FG002|STARTED|Phase I: Dose Escalation||0
6302110|NCT00350727|7205065|FG000|COMPLETED|Phase I: Dose Escalation||0
6302111|NCT00350727|7205066|FG001|COMPLETED|Phase I: Dose Escalation||0
6302112|NCT00350727|7205067|FG002|COMPLETED|Phase I: Dose Escalation||0
6302113|NCT00350727|7205065|FG000|NOT COMPLETED|Phase I: Dose Escalation||34
6302114|NCT00350727|7205066|FG001|NOT COMPLETED|Phase I: Dose Escalation||0
6302115|NCT00350727|7205067|FG002|NOT COMPLETED|Phase I: Dose Escalation||0
6302116|NCT00350727|7205065|FG000|STARTED|Phase II||0
6302117|NCT00350727|7205066|FG001|STARTED|Phase II||19
6302118|NCT00350727|7205067|FG002|STARTED|Phase II||22
6302119|NCT00350727|7205065|FG000|COMPLETED|Phase II||0
6302120|NCT00350727|7205066|FG001|COMPLETED|Phase II||0
6302121|NCT00350727|7205067|FG002|COMPLETED|Phase II||0
6302122|NCT00350727|7205065|FG000|NOT COMPLETED|Phase II||0
6302123|NCT00350727|7205066|FG001|NOT COMPLETED|Phase II||19
6302124|NCT00350727|7205067|FG002|NOT COMPLETED|Phase II||22
6302125|NCT00350779|7205088|FG000|STARTED|Overall Study||170
6302126|NCT00350779|7205089|FG001|STARTED|Overall Study||92
6302127|NCT00350779|7205088|FG000|COMPLETED|Overall Study||148
6302128|NCT00350779|7205089|FG001|COMPLETED|Overall Study||71
6302129|NCT00350779|7205088|FG000|NOT COMPLETED|Overall Study||22
6302130|NCT00350779|7205089|FG001|NOT COMPLETED|Overall Study||21
6302131|NCT00350792|7205097|FG000|STARTED|Overall Study||62
6302132|NCT00350792|7205097|FG000|COMPLETED|Overall Study||29
6302133|NCT00350792|7205097|FG000|NOT COMPLETED|Overall Study||33
6302134|NCT00350870|7205105|FG000|STARTED|Overall Study||27
6302135|NCT00350870|7205106|FG001|STARTED|Overall Study||28
6302136|NCT00350870|7205107|FG002|STARTED|Overall Study||22
6302137|NCT00350870|7205108|FG003|STARTED|Overall Study||22
6302138|NCT00350870|7205105|FG000|Had at Least 1 Day of Med|Overall Study||19
6302139|NCT00350870|7205106|FG001|Had at Least 1 Day of Med|Overall Study||24
6743366|NCT03334448|7671663|FG003|NOT COMPLETED|Period 1||0
6743367|NCT03334448|7671660|FG000|STARTED|Washout||12
6743368|NCT03334448|7671661|FG001|STARTED|Washout||12
6743369|NCT03334448|7671662|FG002|STARTED|Washout||13
6743370|NCT03334448|7671663|FG003|STARTED|Washout||12
6743371|NCT03334448|7671660|FG000|COMPLETED|Washout||12
6302140|NCT00350870|7205107|FG002|Had at Least 1 Day of Med|Overall Study||18
6302141|NCT00350870|7205108|FG003|Had at Least 1 Day of Med|Overall Study||19
6302142|NCT00350870|7205105|FG000|COMPLETED|Overall Study||5
6302143|NCT00350870|7205106|FG001|COMPLETED|Overall Study||11
6302144|NCT00350870|7205107|FG002|COMPLETED|Overall Study||6
6302145|NCT00350870|7205108|FG003|COMPLETED|Overall Study||7
6302146|NCT00350870|7205105|FG000|NOT COMPLETED|Overall Study||22
6302147|NCT00350870|7205106|FG001|NOT COMPLETED|Overall Study||17
6302148|NCT00350870|7205107|FG002|NOT COMPLETED|Overall Study||16
6302149|NCT00350870|7205108|FG003|NOT COMPLETED|Overall Study||15
6302150|NCT00351000|7205118|FG000|STARTED|Overall Study||24
6302151|NCT00351000|7205118|FG000|COMPLETED|Overall Study||21
6302152|NCT00351000|7205118|FG000|NOT COMPLETED|Overall Study||3
6302153|NCT00351039|7205125|FG000|STARTED|Overall Study||8
6302154|NCT00351039|7205125|FG000|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
6302155|NCT00351039|7205125|FG000|NOT COMPLETED|Overall Study||0
6302156|NCT00351273|7205133|FG000|STARTED|Overall Study||15
6302157|NCT00351273|7205134|FG001|STARTED|Overall Study||12
6302158|NCT00351273|7205135|FG002|STARTED|Overall Study||15
6302159|NCT00351273|7205133|FG000|COMPLETED|Overall Study||14
6302160|NCT00351273|7205134|FG001|COMPLETED|Overall Study||10
6302161|NCT00351273|7205135|FG002|COMPLETED|Overall Study||10
6302162|NCT00351273|7205133|FG000|NOT COMPLETED|Overall Study||1
6302163|NCT00351273|7205134|FG001|NOT COMPLETED|Overall Study||2
6302164|NCT00351273|7205135|FG002|NOT COMPLETED|Overall Study||5
6302165|NCT00351299|7205150|FG000|STARTED|Overall Study||25
6302166|NCT00351299|7205151|FG001|STARTED|Overall Study||28
6302167|NCT00351299|7205150|FG000|COMPLETED|Overall Study||25
6302168|NCT00351299|7205151|FG001|COMPLETED|Overall Study||28
6302169|NCT00351299|7205150|FG000|NOT COMPLETED|Overall Study||0
6302170|NCT00351299|7205151|FG001|NOT COMPLETED|Overall Study||0
6302171|NCT00351351|7205163|FG000|STARTED|Overall Study||34
6302172|NCT00351351|7205164|FG001|STARTED|Overall Study||36
6302173|NCT00351351|7205163|FG000|COMPLETED|Overall Study||25
6302174|NCT00351351|7205164|FG001|COMPLETED|Overall Study||32
6302175|NCT00351351|7205163|FG000|NOT COMPLETED|Overall Study||9
6302176|NCT00351351|7205164|FG001|NOT COMPLETED|Overall Study||4
6302177|NCT00351377|7205170|FG000|STARTED|Overall Study||111
6302178|NCT00351377|7205170|FG000|COMPLETED|Overall Study||104
6302179|NCT00351377|7205170|FG000|NOT COMPLETED|Overall Study||7
6302180|NCT00351416|7205176|FG000|STARTED|Overall Study||6
6302181|NCT00351416|7205177|FG001|STARTED|Overall Study||9
6302182|NCT00351416|7205176|FG000|COMPLETED|Overall Study||6
6302183|NCT00351416|7205177|FG001|COMPLETED|Overall Study||9
6302184|NCT00351416|7205176|FG000|NOT COMPLETED|Overall Study||0
6302185|NCT00351416|7205177|FG001|NOT COMPLETED|Overall Study||0
6302186|NCT00351468|7205183|FG000|STARTED|Overall Study||302
6302187|NCT00351468|7205183|FG000|Subjects From TRA100773A|Overall Study||51
6302188|NCT00351468|7205183|FG000|Subjects From TRA100773B|Overall Study||61
6302189|NCT00351468|7205183|FG000|Subjects From TRA102537 Raise|Overall Study||146
6743372|NCT03334448|7671661|FG001|COMPLETED|Washout||12
6302190|NCT00351468|7205183|FG000|Subjects From TRA108057 Repeat|Overall Study||43
6302191|NCT00351468|7205183|FG000|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
6302192|NCT00351468|7205183|FG000|COMPLETED|Overall Study||135
6302193|NCT00351468|7205183|FG000|NOT COMPLETED|Overall Study||167
6302194|NCT00351533|7205190|FG000|STARTED|Overall Study||41
6302195|NCT00351533|7205191|FG001|STARTED|Overall Study||49
6302196|NCT00351533|7205190|FG000|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
6302197|NCT00351533|7205191|FG001|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
6302198|NCT00351533|7205190|FG000|NOT COMPLETED|Overall Study||2
6302199|NCT00351533|7205191|FG001|NOT COMPLETED|Overall Study||5
6302200|NCT00351611|7205199|FG000|STARTED|Overall Study||89
6302201|NCT00351611|7205200|FG001|STARTED|Overall Study||98
6302202|NCT00351611|7205199|FG000|Treated|Overall Study||89
6302203|NCT00351611|7205200|FG001|Treated|Overall Study||98
6302204|NCT00351611|7205199|FG000|COMPLETED|Overall Study||75
6302205|NCT00351611|7205200|FG001|COMPLETED|Overall Study||88
6302206|NCT00351611|7205199|FG000|NOT COMPLETED|Overall Study||14
6302207|NCT00351611|7205200|FG001|NOT COMPLETED|Overall Study||10
6302208|NCT00351741|7205208|FG000|STARTED|Overall Study||31
6302209|NCT00351741|7205209|FG001|STARTED|Overall Study||31
6302210|NCT00351741|7205208|FG000|COMPLETED|Overall Study||31
6302211|NCT00351741|7205209|FG001|COMPLETED|Overall Study||31
6302212|NCT00351741|7205208|FG000|NOT COMPLETED|Overall Study||0
6302213|NCT00351741|7205209|FG001|NOT COMPLETED|Overall Study||0
6302214|NCT00351819|7205217|FG000|STARTED|Overall Study||43
6302215|NCT00351819|7205218|FG001|STARTED|Overall Study||41
6302216|NCT00351819|7205217|FG000|COMPLETED|Overall Study||36
6302217|NCT00351819|7205218|FG001|COMPLETED|Overall Study||29
6302218|NCT00351819|7205217|FG000|NOT COMPLETED|Overall Study||7
6302219|NCT00351819|7205218|FG001|NOT COMPLETED|Overall Study||12
6302220|NCT00351936|7205224|FG000|STARTED|Overall Study||15
6302221|NCT00351936|7205224|FG000|COMPLETED|Overall Study||15
6302222|NCT00351936|7205224|FG000|NOT COMPLETED|Overall Study||0
6302223|NCT00352001|7205229|FG000|STARTED|Overall Study||37
6302224|NCT00352001|7205229|FG000|Azacitidine 75mg/Lenalidomide 5mg-14 Day|Overall Study||3
6302225|NCT00352001|7205229|FG000|Azacitidine 75mg/Lenalidomide 5mg-21 Day|Overall Study||3
6302226|NCT00352001|7205229|FG000|Azacitidine 75mg/Lenalidomide 10mg-14day|Overall Study||3
6302227|NCT00352001|7205229|FG000|COMPLETED|Overall Study||37
6302228|NCT00352001|7205229|FG000|NOT COMPLETED|Overall Study||0
6302229|NCT00352027|7205233|FG000|STARTED|Overall Study||80
6302230|NCT00352027|7205233|FG000|COMPLETED|Overall Study||77
6302231|NCT00352027|7205233|FG000|NOT COMPLETED|Overall Study||3
6302232|NCT00352053|7205261|FG000|STARTED|Double-Blind Phase (Through Week 48)||45
6302233|NCT00352053|7205262|FG001|STARTED|Double-Blind Phase (Through Week 48)||42
6302234|NCT00352053|7205261|FG000|COMPLETED|Double-Blind Phase (Through Week 48)||27
6302235|NCT00352053|7205262|FG001|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
6302236|NCT00352053|7205261|FG000|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
6302237|NCT00352053|7205262|FG001|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
6302238|NCT00352053|7205261|FG000|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
6302239|NCT00352053|7205262|FG001|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
6302240|NCT00352053|7205261|FG000|COMPLETED|First Extension Phase (Weeks 48-144)||12
6302241|NCT00352053|7205262|FG001|COMPLETED|First Extension Phase (Weeks 48-144)||19
6302242|NCT00352053|7205261|FG000|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
6302243|NCT00352053|7205262|FG001|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
6302244|NCT00352053|7205261|FG000|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
6302245|NCT00352053|7205262|FG001|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
6302246|NCT00352053|7205261|FG000|COMPLETED|Second Extension Phase (Weeks 144-240)||4
6302247|NCT00352053|7205262|FG001|COMPLETED|Second Extension Phase (Weeks 144-240)||9
6302248|NCT00352053|7205261|FG000|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
6302249|NCT00352053|7205262|FG001|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
6302250|NCT00352053|7205261|FG000|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
6302251|NCT00352053|7205262|FG001|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
6302252|NCT00352053|7205261|FG000|COMPLETED|Third Extension Phase (Weeks 240-294)||0
6302253|NCT00352053|7205262|FG001|COMPLETED|Third Extension Phase (Weeks 240-294)||2
6302254|NCT00352053|7205261|FG000|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
6302255|NCT00352053|7205262|FG001|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
6302256|NCT00352105|7205276|FG000|STARTED|Overall Study||60
6302257|NCT00352105|7205276|FG000|COMPLETED|Overall Study||20
6302258|NCT00352105|7205276|FG000|NOT COMPLETED|Overall Study||40
6302259|NCT00352365|7205280|FG000|STARTED|Induction Therapy||41
6302260|NCT00352365|7205280|FG000|Eligible|Induction Therapy||38
6302261|NCT00352365|7205280|FG000|Eligible and Began Protocol Therapy|Induction Therapy||37
6302262|NCT00352365|7205280|FG000|COMPLETED|Induction Therapy||14
6302263|NCT00352365|7205280|FG000|NOT COMPLETED|Induction Therapy||27
6302264|NCT00352365|7205280|FG000|STARTED|Maintenance Therapy||12
6302265|NCT00352365|7205280|FG000|Eligible and Began Protocol Therapy|Maintenance Therapy||8
6302266|NCT00352365|7205280|FG000|COMPLETED|Maintenance Therapy||0
6302267|NCT00352365|7205280|FG000|NOT COMPLETED|Maintenance Therapy||12
6302268|NCT00352417|7205290|FG000|STARTED|Overall Study||24
6302269|NCT00352417|7205291|FG001|STARTED|Overall Study||26
6302270|NCT00352417|7205290|FG000|COMPLETED|Overall Study||19
6302271|NCT00352417|7205291|FG001|COMPLETED|Overall Study||21
6302272|NCT00352417|7205290|FG000|NOT COMPLETED|Overall Study||5
6302273|NCT00352417|7205291|FG001|NOT COMPLETED|Overall Study||5
6302274|NCT00352612|7205299|FG000|STARTED|Overall Study||100
6302275|NCT00352612|7205300|FG001|STARTED|Overall Study||100
6302276|NCT00352612|7205299|FG000|COMPLETED|Overall Study||100
6302277|NCT00352612|7205300|FG001|COMPLETED|Overall Study||100
6302278|NCT00352612|7205299|FG000|NOT COMPLETED|Overall Study||0
6302279|NCT00352612|7205300|FG001|NOT COMPLETED|Overall Study||0
6302280|NCT00352664|7205308|FG000|STARTED|Overall Study||27
6302281|NCT00352664|7205309|FG001|STARTED|Overall Study||0
6302282|NCT00352664|7205308|FG000|COMPLETED|Overall Study||20
6302283|NCT00352664|7205309|FG001|COMPLETED|Overall Study||0
6302284|NCT00352664|7205308|FG000|NOT COMPLETED|Overall Study||7
6302285|NCT00352664|7205309|FG001|NOT COMPLETED|Overall Study||0
6302286|NCT00352690|7205317|FG000|STARTED|Overall Study||10
6302287|NCT00352690|7205318|FG001|STARTED|Overall Study||0
6302288|NCT00352690|7205317|FG000|COMPLETED|Overall Study||8
6302289|NCT00352690|7205318|FG001|COMPLETED|Overall Study||0
6302290|NCT00352690|7205317|FG000|NOT COMPLETED|Overall Study||2
6302291|NCT00352690|7205318|FG001|NOT COMPLETED|Overall Study||0
6302292|NCT00352755|7205324|FG000|STARTED|Overall Study||18
6302293|NCT00352755|7205324|FG000|COMPLETED|Overall Study||16
6302294|NCT00352755|7205324|FG000|NOT COMPLETED|Overall Study||2
6302295|NCT00352781|7205328|FG000|STARTED|Overall Study||1767
6302296|NCT00352781|7205328|FG000|COMPLETED|Overall Study||884
6302297|NCT00352781|7205328|FG000|NOT COMPLETED|Overall Study||883
6302298|NCT00352794|7205332|FG000|STARTED|Overall Study||40
6302299|NCT00352794|7205332|FG000|COMPLETED|Overall Study||40
6302300|NCT00352794|7205332|FG000|NOT COMPLETED|Overall Study||0
6302301|NCT00352846|7205338|FG000|STARTED|Overall Study||37
6302302|NCT00352846|7205339|FG001|STARTED|Overall Study||37
6302303|NCT00352846|7205338|FG000|COMPLETED|Overall Study||29
6302304|NCT00352846|7205339|FG001|COMPLETED|Overall Study||24
6302305|NCT00352846|7205338|FG000|NOT COMPLETED|Overall Study||8
6302306|NCT00352846|7205339|FG001|NOT COMPLETED|Overall Study||13
6302307|NCT00352885|7205347|FG000|STARTED|Overall Study||9
6302308|NCT00352885|7205348|FG001|STARTED|Overall Study||11
6302309|NCT00352885|7205347|FG000|Completed Cycle 1 of IL-2 Treatment|Overall Study||9
6302310|NCT00352885|7205348|FG001|Completed Cycle 1 of IL-2 Treatment|Overall Study||11
6302311|NCT00352885|7205347|FG000|Completed Cycle 2 of IL-2 Treatment|Overall Study||8
6302312|NCT00352885|7205348|FG001|Completed Cycle 2 of IL-2 Treatment|Overall Study||9
6302313|NCT00352885|7205347|FG000|Completed Cycle 3 of IL-2 Treatment|Overall Study||4
6302314|NCT00352885|7205348|FG001|Completed Cycle 3 of IL-2 Treatment|Overall Study||7
6302315|NCT00352885|7205347|FG000|COMPLETED|Overall Study||3
6302316|NCT00352885|7205348|FG001|COMPLETED|Overall Study||4
6302317|NCT00352885|7205347|FG000|NOT COMPLETED|Overall Study||6
6302318|NCT00352885|7205348|FG001|NOT COMPLETED|Overall Study||7
6302319|NCT00352911|7205356|FG000|STARTED|150mg Twice Daily (14 Days)||16
6302320|NCT00352911|7205357|FG001|STARTED|150mg Twice Daily (14 Days)||3
6302321|NCT00352911|7205356|FG000|COMPLETED|150mg Twice Daily (14 Days)||16
6302322|NCT00352911|7205357|FG001|COMPLETED|150mg Twice Daily (14 Days)||3
6302323|NCT00352911|7205356|FG000|NOT COMPLETED|150mg Twice Daily (14 Days)||0
6302324|NCT00352911|7205357|FG001|NOT COMPLETED|150mg Twice Daily (14 Days)||0
6302325|NCT00352911|7205356|FG000|STARTED|300mg Twice Daily (14 Days)||16
6302326|NCT00352911|7205357|FG001|STARTED|300mg Twice Daily (14 Days)||3
6302327|NCT00352911|7205356|FG000|COMPLETED|300mg Twice Daily (14 Days)||15
6302328|NCT00352911|7205357|FG001|COMPLETED|300mg Twice Daily (14 Days)||3
6302329|NCT00352911|7205356|FG000|NOT COMPLETED|300mg Twice Daily (14 Days)||1
6302330|NCT00352911|7205357|FG001|NOT COMPLETED|300mg Twice Daily (14 Days)||0
6302331|NCT00352976|7205363|FG000|STARTED|Overall Study||83
6302332|NCT00352976|7205363|FG000|COMPLETED|Overall Study||83
6302333|NCT00352976|7205363|FG000|NOT COMPLETED|Overall Study||0
6302334|NCT00353119|7205370|FG000|STARTED|First Intervention Day 0 to Week 12||5
6302335|NCT00353119|7205371|FG001|STARTED|First Intervention Day 0 to Week 12||10
6302336|NCT00353119|7205370|FG000|COMPLETED|First Intervention Day 0 to Week 12||5
6302337|NCT00353119|7205371|FG001|COMPLETED|First Intervention Day 0 to Week 12||10
6302338|NCT00353119|7205370|FG000|NOT COMPLETED|First Intervention Day 0 to Week 12||0
6302339|NCT00353119|7205371|FG001|NOT COMPLETED|First Intervention Day 0 to Week 12||0
6302340|NCT00353119|7205370|FG000|STARTED|Second Intervention Week 12 to Week 28||5
6302341|NCT00353119|7205371|FG001|STARTED|Second Intervention Week 12 to Week 28||10
6302342|NCT00353119|7205370|FG000|COMPLETED|Second Intervention Week 12 to Week 28||5
6302343|NCT00353119|7205371|FG001|COMPLETED|Second Intervention Week 12 to Week 28||10
6302344|NCT00353119|7205370|FG000|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
6302345|NCT00353119|7205371|FG001|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
6302346|NCT00353262|7205380|FG000|STARTED|Overall Study||36
6302347|NCT00353262|7205380|FG000|COMPLETED|Overall Study||7
6302348|NCT00353262|7205380|FG000|NOT COMPLETED|Overall Study||29
6302349|NCT00353301|7205384|FG000|STARTED|Overall Study||25
6302350|NCT00353301|7205384|FG000|COMPLETED|Overall Study||25
6302351|NCT00353301|7205384|FG000|NOT COMPLETED|Overall Study||0
6302352|NCT00353366|7205388|FG000|STARTED|Overall Study||1439
6302353|NCT00353366|7205388|FG000|COMPLETED|Overall Study||1296
6302354|NCT00353366|7205388|FG000|NOT COMPLETED|Overall Study||143
6302355|NCT00353418|7205394|FG000|STARTED|Overall Study||138
6302356|NCT00353418|7205395|FG001|STARTED|Overall Study||277
6302357|NCT00353418|7205394|FG000|COMPLETED|Overall Study||55
6302358|NCT00353418|7205395|FG001|COMPLETED|Overall Study||119
6302359|NCT00353418|7205394|FG000|NOT COMPLETED|Overall Study||83
6302360|NCT00353418|7205395|FG001|NOT COMPLETED|Overall Study||158
6302361|NCT00353431|7205403|FG000|STARTED|Overall Study||63
6302362|NCT00353431|7205404|FG001|STARTED|Overall Study||67
6302363|NCT00353431|7205403|FG000|COMPLETED|Overall Study||63
6302364|NCT00353431|7205404|FG001|COMPLETED|Overall Study||67
6302365|NCT00353431|7205403|FG000|NOT COMPLETED|Overall Study||0
6302366|NCT00353431|7205404|FG001|NOT COMPLETED|Overall Study||0
6302367|NCT00353496|7205412|FG000|STARTED|Overall Study||101
6302368|NCT00353496|7205413|FG001|STARTED|Overall Study||103
6302369|NCT00353496|7205412|FG000|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
6302370|NCT00353496|7205413|FG001|COMPLETED|Overall Study||86
6302371|NCT00353496|7205412|FG000|NOT COMPLETED|Overall Study||16
6302372|NCT00353496|7205413|FG001|NOT COMPLETED|Overall Study||17
6302373|NCT00353522|7205422|FG000|STARTED|Overall Study||89
6302374|NCT00353522|7205423|FG001|STARTED|Overall Study||46
6302375|NCT00353522|7205422|FG000|COMPLETED|Overall Study||74
6302376|NCT00353522|7205423|FG001|COMPLETED|Overall Study||37
6302377|NCT00353522|7205422|FG000|NOT COMPLETED|Overall Study||15
6302378|NCT00353522|7205423|FG001|NOT COMPLETED|Overall Study||9
6302379|NCT00353652|7205431|FG000|STARTED|First Intervention - 3 Months||15
6302380|NCT00353652|7205432|FG001|STARTED|First Intervention - 3 Months||15
6302381|NCT00353652|7205433|FG002|STARTED|First Intervention - 3 Months||6
6302382|NCT00353652|7205434|FG003|STARTED|First Intervention - 3 Months||7
6302383|NCT00353652|7205435|FG004|STARTED|First Intervention - 3 Months||3
6302384|NCT00353652|7205436|FG005|STARTED|First Intervention - 3 Months||0
6302385|NCT00353652|7205437|FG006|STARTED|First Intervention - 3 Months||1
6302386|NCT00353652|7205438|FG007|STARTED|First Intervention - 3 Months||0
6302387|NCT00353652|7205431|FG000|COMPLETED|First Intervention - 3 Months||12
6302388|NCT00353652|7205432|FG001|COMPLETED|First Intervention - 3 Months||11
6302389|NCT00353652|7205433|FG002|COMPLETED|First Intervention - 3 Months||6
6302390|NCT00353652|7205434|FG003|COMPLETED|First Intervention - 3 Months||7
6302391|NCT00353652|7205435|FG004|COMPLETED|First Intervention - 3 Months||3
6302392|NCT00353652|7205436|FG005|COMPLETED|First Intervention - 3 Months||0
6302393|NCT00353652|7205437|FG006|COMPLETED|First Intervention - 3 Months||1
6302394|NCT00353652|7205438|FG007|COMPLETED|First Intervention - 3 Months||0
6302395|NCT00353652|7205431|FG000|NOT COMPLETED|First Intervention - 3 Months||3
6302396|NCT00353652|7205432|FG001|NOT COMPLETED|First Intervention - 3 Months||4
6302397|NCT00353652|7205433|FG002|NOT COMPLETED|First Intervention - 3 Months||0
6302398|NCT00353652|7205434|FG003|NOT COMPLETED|First Intervention - 3 Months||0
6302399|NCT00353652|7205435|FG004|NOT COMPLETED|First Intervention - 3 Months||0
6302400|NCT00353652|7205436|FG005|NOT COMPLETED|First Intervention - 3 Months||0
6302401|NCT00353652|7205437|FG006|NOT COMPLETED|First Intervention - 3 Months||0
6302402|NCT00353652|7205438|FG007|NOT COMPLETED|First Intervention - 3 Months||0
6302403|NCT00353652|7205431|FG000|STARTED|Second Intervention - 3 Months||12
6302404|NCT00353652|7205432|FG001|STARTED|Second Intervention - 3 Months||11
6302405|NCT00353652|7205433|FG002|STARTED|Second Intervention - 3 Months||6
6302406|NCT00353652|7205434|FG003|STARTED|Second Intervention - 3 Months||7
6302407|NCT00353652|7205435|FG004|STARTED|Second Intervention - 3 Months||3
6302408|NCT00353652|7205436|FG005|STARTED|Second Intervention - 3 Months||0
6302409|NCT00353652|7205437|FG006|STARTED|Second Intervention - 3 Months||1
6302410|NCT00353652|7205438|FG007|STARTED|Second Intervention - 3 Months||0
6302411|NCT00353652|7205431|FG000|COMPLETED|Second Intervention - 3 Months||12
6302412|NCT00353652|7205432|FG001|COMPLETED|Second Intervention - 3 Months||11
6302413|NCT00353652|7205433|FG002|COMPLETED|Second Intervention - 3 Months||6
6302414|NCT00353652|7205434|FG003|COMPLETED|Second Intervention - 3 Months||7
6302415|NCT00353652|7205435|FG004|COMPLETED|Second Intervention - 3 Months||3
6302416|NCT00353652|7205436|FG005|COMPLETED|Second Intervention - 3 Months||0
6302417|NCT00353652|7205437|FG006|COMPLETED|Second Intervention - 3 Months||1
6302418|NCT00353652|7205438|FG007|COMPLETED|Second Intervention - 3 Months||0
6302419|NCT00353652|7205431|FG000|NOT COMPLETED|Second Intervention - 3 Months||0
6302420|NCT00353652|7205432|FG001|NOT COMPLETED|Second Intervention - 3 Months||0
6302421|NCT00353652|7205433|FG002|NOT COMPLETED|Second Intervention - 3 Months||0
6302422|NCT00353652|7205434|FG003|NOT COMPLETED|Second Intervention - 3 Months||0
6302423|NCT00353652|7205435|FG004|NOT COMPLETED|Second Intervention - 3 Months||0
6302424|NCT00353652|7205436|FG005|NOT COMPLETED|Second Intervention - 3 Months||0
6302425|NCT00353652|7205437|FG006|NOT COMPLETED|Second Intervention - 3 Months||0
6302426|NCT00353652|7205438|FG007|NOT COMPLETED|Second Intervention - 3 Months||0
6302427|NCT00353652|7205431|FG000|STARTED|Third Intervention - 3 Months||0
6302428|NCT00353652|7205432|FG001|STARTED|Third Intervention - 3 Months||0
6302429|NCT00353652|7205433|FG002|STARTED|Third Intervention - 3 Months||6
6302430|NCT00353652|7205434|FG003|STARTED|Third Intervention - 3 Months||7
6302431|NCT00353652|7205435|FG004|STARTED|Third Intervention - 3 Months||3
6302432|NCT00353652|7205436|FG005|STARTED|Third Intervention - 3 Months||0
6302433|NCT00353652|7205437|FG006|STARTED|Third Intervention - 3 Months||1
6302434|NCT00353652|7205438|FG007|STARTED|Third Intervention - 3 Months||0
6302435|NCT00353652|7205431|FG000|COMPLETED|Third Intervention - 3 Months||0
6302436|NCT00353652|7205432|FG001|COMPLETED|Third Intervention - 3 Months||0
6302437|NCT00353652|7205433|FG002|COMPLETED|Third Intervention - 3 Months||6
6302438|NCT00353652|7205434|FG003|COMPLETED|Third Intervention - 3 Months||6
6302439|NCT00353652|7205435|FG004|COMPLETED|Third Intervention - 3 Months||3
6302440|NCT00353652|7205436|FG005|COMPLETED|Third Intervention - 3 Months||0
6302441|NCT00353652|7205437|FG006|COMPLETED|Third Intervention - 3 Months||1
6302442|NCT00353652|7205438|FG007|COMPLETED|Third Intervention - 3 Months||0
6302443|NCT00353652|7205431|FG000|NOT COMPLETED|Third Intervention - 3 Months||0
6302444|NCT00353652|7205432|FG001|NOT COMPLETED|Third Intervention - 3 Months||0
6302445|NCT00353652|7205433|FG002|NOT COMPLETED|Third Intervention - 3 Months||0
6302446|NCT00353652|7205434|FG003|NOT COMPLETED|Third Intervention - 3 Months||1
6302447|NCT00353652|7205435|FG004|NOT COMPLETED|Third Intervention - 3 Months||0
6302448|NCT00353652|7205436|FG005|NOT COMPLETED|Third Intervention - 3 Months||0
6302449|NCT00353652|7205437|FG006|NOT COMPLETED|Third Intervention - 3 Months||0
6302450|NCT00353652|7205438|FG007|NOT COMPLETED|Third Intervention - 3 Months||0
6302451|NCT00353704|7205455|FG000|STARTED|Overall Study||25
6302452|NCT00353704|7205456|FG001|STARTED|Overall Study||25
6302453|NCT00353704|7205455|FG000|COMPLETED|Overall Study||22
6302454|NCT00353704|7205456|FG001|COMPLETED|Overall Study||24
6302455|NCT00353704|7205455|FG000|NOT COMPLETED|Overall Study||3
6302456|NCT00353704|7205456|FG001|NOT COMPLETED|Overall Study||1
6302457|NCT00353795|7205462|FG000|STARTED|Overall Study||179
6302458|NCT00353795|7205462|FG000|COMPLETED|Overall Study||179
6302459|NCT00353795|7205462|FG000|NOT COMPLETED|Overall Study||0
6302460|NCT00353834|7205468|FG000|STARTED|Overall Study||26
6302461|NCT00353834|7205469|FG001|STARTED|Overall Study||27
6302462|NCT00353834|7205468|FG000|COMPLETED|Overall Study||26
6302463|NCT00353834|7205469|FG001|COMPLETED|Overall Study||27
6302464|NCT00353834|7205468|FG000|NOT COMPLETED|Overall Study||0
6302465|NCT00353834|7205469|FG001|NOT COMPLETED|Overall Study||0
6302466|NCT00353873|7205477|FG000|STARTED|Overall Study||153
6302467|NCT00353873|7205478|FG001|STARTED|Overall Study||150
6302468|NCT00353873|7205477|FG000|COMPLETED|Overall Study||147
6302469|NCT00353873|7205478|FG001|COMPLETED|Overall Study||147
6302470|NCT00353873|7205477|FG000|NOT COMPLETED|Overall Study||6
6302471|NCT00353873|7205478|FG001|NOT COMPLETED|Overall Study||3
6302472|NCT00353977|7205484|FG000|STARTED|Overall Study||38
6302473|NCT00353977|7205484|FG000|COMPLETED|Overall Study||38
6302474|NCT00353977|7205484|FG000|NOT COMPLETED|Overall Study||0
6302475|NCT00354029|7205490|FG000|STARTED|Overall Study||43
6302476|NCT00354029|7205491|FG001|STARTED|Overall Study||40
6302477|NCT00354029|7205490|FG000|COMPLETED|Overall Study||39
6302478|NCT00354029|7205491|FG001|COMPLETED|Overall Study||38
6302479|NCT00354029|7205490|FG000|NOT COMPLETED|Overall Study||4
6302480|NCT00354029|7205491|FG001|NOT COMPLETED|Overall Study||2
6302481|NCT00354107|7205497|FG000|STARTED|Overall Study||5
6302482|NCT00354107|7205497|FG000|COMPLETED|Overall Study||0
6302483|NCT00354107|7205497|FG000|NOT COMPLETED|Overall Study||5
6302484|NCT00354159|7205503|FG000|STARTED|Randomized Study Period||202
6302485|NCT00354159|7205504|FG001|STARTED|Randomized Study Period||198
6302486|NCT00354159|7205503|FG000|COMPLETED|Randomized Study Period||180
6302487|NCT00354159|7205504|FG001|COMPLETED|Randomized Study Period||176
6302488|NCT00354159|7205503|FG000|NOT COMPLETED|Randomized Study Period||22
6302489|NCT00354159|7205504|FG001|NOT COMPLETED|Randomized Study Period||22
6302490|NCT00354159|7205503|FG000|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
6302491|NCT00354159|7205504|FG001|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
6302492|NCT00354159|7205503|FG000|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
6302493|NCT00354159|7205504|FG001|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
6302494|NCT00354159|7205503|FG000|NOT COMPLETED|Long-term Follow-up||180
6302495|NCT00354159|7205504|FG001|NOT COMPLETED|Long-term Follow-up||176
6302496|NCT00354172|7205517|FG000|STARTED|Overall Study||16
6302497|NCT00354172|7205517|FG000|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
6302498|NCT00354172|7205517|FG000|NOT COMPLETED|Overall Study||1
6302499|NCT00354224|7205521|FG000|STARTED|Overall Study||10
6302500|NCT00354224|7205521|FG000|COMPLETED|Overall Study||10
6302501|NCT00354224|7205521|FG000|NOT COMPLETED|Overall Study||0
6302502|NCT00354341|7205527|FG000|STARTED|Overall Study||88
6302503|NCT00354341|7205528|FG001|STARTED|Overall Study||82
6302504|NCT00354341|7205527|FG000|COMPLETED|Overall Study||85
6302505|NCT00354341|7205528|FG001|COMPLETED|Overall Study||75
6302506|NCT00354341|7205527|FG000|NOT COMPLETED|Overall Study||3
6302507|NCT00354341|7205528|FG001|NOT COMPLETED|Overall Study||7
6302508|NCT00354432|7205538|FG000|STARTED|Overall Study||30
6302509|NCT00354432|7205539|FG001|STARTED|Overall Study||30
6302510|NCT00354432|7205540|FG002|STARTED|Overall Study||30
6302511|NCT00354432|7205541|FG003|STARTED|Overall Study||30
6302512|NCT00354432|7205538|FG000|COMPLETED|Overall Study||24
6302513|NCT00354432|7205539|FG001|COMPLETED|Overall Study||22
6302514|NCT00354432|7205540|FG002|COMPLETED|Overall Study||20
6302515|NCT00354432|7205541|FG003|COMPLETED|Overall Study||20
6302516|NCT00354432|7205538|FG000|NOT COMPLETED|Overall Study||6
6302517|NCT00354432|7205539|FG001|NOT COMPLETED|Overall Study||8
6302518|NCT00354432|7205540|FG002|NOT COMPLETED|Overall Study||10
6302519|NCT00354432|7205541|FG003|NOT COMPLETED|Overall Study||10
6302520|NCT00354484|7205553|FG000|STARTED|Overall Study||142
6302521|NCT00354484|7205554|FG001|STARTED|Overall Study||147
6302522|NCT00354484|7205553|FG000|COMPLETED|Overall Study||138
6302523|NCT00354484|7205554|FG001|COMPLETED|Overall Study||144
6302524|NCT00354484|7205553|FG000|NOT COMPLETED|Overall Study||4
6302525|NCT00354484|7205554|FG001|NOT COMPLETED|Overall Study||3
6302526|NCT00354601|7205560|FG000|STARTED|Overall Study||2
6302527|NCT00354601|7205560|FG000|COMPLETED|Overall Study||0
6302528|NCT00354601|7205560|FG000|NOT COMPLETED|Overall Study||2
6302529|NCT00354614|7205564|FG000|STARTED|Overall Study||81
6302530|NCT00354614|7205564|FG000|COMPLETED|Overall Study||53
6302531|NCT00354614|7205564|FG000|NOT COMPLETED|Overall Study||28
6302532|NCT00354640|7205568|FG000|STARTED|Overall Study||11
6302533|NCT00354640|7205568|FG000|COMPLETED|Overall Study||11
6302534|NCT00354640|7205568|FG000|NOT COMPLETED|Overall Study||0
6302535|NCT00354679|7205572|FG000|STARTED|Overall Study||34
6302536|NCT00354679|7205572|FG000|COMPLETED|Overall Study||33
6302537|NCT00354679|7205572|FG000|NOT COMPLETED|Overall Study||1
6302538|NCT00354744|7205576|FG000|STARTED|Overall Study||109
6302539|NCT00354744|7205576|FG000|COMPLETED|Overall Study||67
6302540|NCT00354744|7205576|FG000|NOT COMPLETED|Overall Study||42
6302541|NCT00354770|7205584|FG000|STARTED|Overall Study||25
6302542|NCT00354770|7205585|FG001|STARTED|Overall Study||25
6302543|NCT00354770|7205584|FG000|COMPLETED|Overall Study||22
6302544|NCT00354770|7205585|FG001|COMPLETED|Overall Study||22
6302545|NCT00354770|7205584|FG000|NOT COMPLETED|Overall Study||3
6302546|NCT00354770|7205585|FG001|NOT COMPLETED|Overall Study||3
6302547|NCT00354887|7205591|FG000|STARTED|Overall Study||30
6302548|NCT00354887|7205591|FG000|COMPLETED|Overall Study||29
6302549|NCT00354887|7205591|FG000|NOT COMPLETED|Overall Study||1
6302550|NCT00354913|7205595|FG000|STARTED|Overall Study||21
6302551|NCT00354913|7205595|FG000|COMPLETED|Overall Study||21
6302552|NCT00354913|7205595|FG000|NOT COMPLETED|Overall Study||0
6302553|NCT00354978|7205599|FG000|STARTED|Overall Study||43
6302554|NCT00354978|7205599|FG000|COMPLETED|Overall Study||43
6302555|NCT00354978|7205599|FG000|NOT COMPLETED|Overall Study||0
6302556|NCT00355030|7205605|FG000|STARTED|Study Period 1 Treatment||46
6302557|NCT00355030|7205606|FG001|STARTED|Study Period 1 Treatment||45
6302558|NCT00355030|7205605|FG000|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
6302559|NCT00355030|7205606|FG001|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
6302560|NCT00355030|7205605|FG000|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
6302561|NCT00355030|7205606|FG001|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
6302562|NCT00355030|7205605|FG000|NOT COMPLETED|Study Period 1 Treatment||45
6302563|NCT00355030|7205606|FG001|NOT COMPLETED|Study Period 1 Treatment||44
6302564|NCT00355030|7205605|FG000|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
6302565|NCT00355030|7205606|FG001|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
6302566|NCT00355030|7205605|FG000|COMPLETED|Study Period 2 Long Term Follow-Up||19
6302567|NCT00355030|7205606|FG001|COMPLETED|Study Period 2 Long Term Follow-Up||17
6302568|NCT00355030|7205605|FG000|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
6302569|NCT00355030|7205606|FG001|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
6302570|NCT00355056|7205614|FG000|STARTED|Randomization Period||107
6302571|NCT00355056|7205615|FG001|STARTED|Randomization Period||123
6302572|NCT00355056|7205614|FG000|COMPLETED|Randomization Period||103
6302573|NCT00355056|7205615|FG001|COMPLETED|Randomization Period||117
6302574|NCT00355056|7205614|FG000|NOT COMPLETED|Randomization Period||4
6302575|NCT00355056|7205615|FG001|NOT COMPLETED|Randomization Period||6
6302576|NCT00355056|7205614|FG000|STARTED|Optional Patent Foramen Ovale Closure|A sham procedure was not part of this period.|0
6302577|NCT00355056|7205615|FG001|STARTED|Optional Patent Foramen Ovale Closure|Participants who completed Sham Procedure randomization Arm were eligible. 87/103 consented.|87
6302578|NCT00355056|7205614|FG000|COMPLETED|Optional Patent Foramen Ovale Closure||0
6302579|NCT00355056|7205615|FG001|COMPLETED|Optional Patent Foramen Ovale Closure||84
6302580|NCT00355056|7205614|FG000|NOT COMPLETED|Optional Patent Foramen Ovale Closure||0
6302581|NCT00355056|7205615|FG001|NOT COMPLETED|Optional Patent Foramen Ovale Closure||3
6302582|NCT00355082|7205631|FG000|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
6302583|NCT00355082|7205632|FG001|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
6302584|NCT00355082|7205633|FG002|STARTED|Double-Blind (DB) Treatment Phase||0
6302585|NCT00355082|7205631|FG000|COMPLETED|Double-Blind (DB) Treatment Phase||94
6302586|NCT00355082|7205632|FG001|COMPLETED|Double-Blind (DB) Treatment Phase||79
6302587|NCT00355082|7205633|FG002|COMPLETED|Double-Blind (DB) Treatment Phase||0
6302588|NCT00355082|7205631|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
6302589|NCT00355082|7205632|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
6302590|NCT00355082|7205633|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
6302591|NCT00355082|7205631|FG000|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
6302592|NCT00355082|7205632|FG001|STARTED|Continuation Phase||0
6302593|NCT00355082|7205633|FG002|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
6302594|NCT00355082|7205631|FG000|COMPLETED|Continuation Phase||160
6302595|NCT00355082|7205632|FG001|COMPLETED|Continuation Phase||0
6302596|NCT00355082|7205633|FG002|COMPLETED|Continuation Phase||8
6302597|NCT00355082|7205631|FG000|NOT COMPLETED|Continuation Phase||24
6302598|NCT00355082|7205632|FG001|NOT COMPLETED|Continuation Phase||0
6302599|NCT00355082|7205633|FG002|NOT COMPLETED|Continuation Phase||3
6302600|NCT00355121|7205647|FG000|STARTED|Overall Study||353
6302601|NCT00355121|7205648|FG001|STARTED|Overall Study||353
6302602|NCT00355121|7205649|FG002|STARTED|Overall Study||175
6302603|NCT00355121|7205647|FG000|COMPLETED|Overall Study||332
6302604|NCT00355121|7205648|FG001|COMPLETED|Overall Study||324
6302605|NCT00355121|7205649|FG002|COMPLETED|Overall Study||170
6302606|NCT00355121|7205647|FG000|NOT COMPLETED|Overall Study||21
6302607|NCT00355121|7205648|FG001|NOT COMPLETED|Overall Study||29
6302608|NCT00355121|7205649|FG002|NOT COMPLETED|Overall Study||5
6302609|NCT00355134|7205665|FG000|STARTED|Core Phase||370
6302610|NCT00355134|7205666|FG001|STARTED|Core Phase||358
6302611|NCT00355134|7205667|FG002|STARTED|Core Phase||355
6302612|NCT00355134|7205668|FG003|STARTED|Core Phase||0
6302613|NCT00355134|7205669|FG004|STARTED|Core Phase||0
6302614|NCT00355134|7205665|FG000|COMPLETED|Core Phase||251
6302615|NCT00355134|7205666|FG001|COMPLETED|Core Phase||272
6302616|NCT00355134|7205667|FG002|COMPLETED|Core Phase||255
6302617|NCT00355134|7205668|FG003|COMPLETED|Core Phase||0
6302618|NCT00355134|7205669|FG004|COMPLETED|Core Phase||0
6302619|NCT00355134|7205665|FG000|NOT COMPLETED|Core Phase||119
6302620|NCT00355134|7205666|FG001|NOT COMPLETED|Core Phase||86
6302621|NCT00355134|7205667|FG002|NOT COMPLETED|Core Phase||100
6302622|NCT00355134|7205668|FG003|NOT COMPLETED|Core Phase||0
6302623|NCT00355134|7205669|FG004|NOT COMPLETED|Core Phase||0
6302624|NCT00355134|7205665|FG000|STARTED|Extension Phase||203
6302625|NCT00355134|7205666|FG001|STARTED|Extension Phase||217
6302626|NCT00355134|7205667|FG002|STARTED|Extension Phase||0
6302627|NCT00355134|7205668|FG003|STARTED|Extension Phase||105
6302628|NCT00355134|7205669|FG004|STARTED|Extension Phase||107
6302629|NCT00355134|7205665|FG000|COMPLETED|Extension Phase||172
6302630|NCT00355134|7205666|FG001|COMPLETED|Extension Phase||180
6302631|NCT00355134|7205667|FG002|COMPLETED|Extension Phase||0
6302632|NCT00355134|7205668|FG003|COMPLETED|Extension Phase||89
6302633|NCT00355134|7205669|FG004|COMPLETED|Extension Phase||88
6302634|NCT00355134|7205665|FG000|NOT COMPLETED|Extension Phase||31
6302635|NCT00355134|7205666|FG001|NOT COMPLETED|Extension Phase||37
6302636|NCT00355134|7205667|FG002|NOT COMPLETED|Extension Phase||0
6302637|NCT00355134|7205668|FG003|NOT COMPLETED|Extension Phase||16
6302638|NCT00355134|7205669|FG004|NOT COMPLETED|Extension Phase||19
6302639|NCT00355147|7205681|FG000|STARTED|Overall Study||87
6302640|NCT00355147|7205682|FG001|STARTED|Overall Study||87
6302641|NCT00355147|7205681|FG000|COMPLETED|Overall Study||69
6302642|NCT00355147|7205682|FG001|COMPLETED|Overall Study||67
6302643|NCT00355147|7205681|FG000|NOT COMPLETED|Overall Study||18
6302644|NCT00355147|7205682|FG001|NOT COMPLETED|Overall Study||20
6302645|NCT00355199|7205694|FG000|STARTED|Overall Study||120
6302646|NCT00355199|7205695|FG001|STARTED|Overall Study||126
6302647|NCT00355199|7205694|FG000|COMPLETED|Overall Study||113
6302648|NCT00355199|7205695|FG001|COMPLETED|Overall Study||122
6302649|NCT00355199|7205694|FG000|NOT COMPLETED|Overall Study||7
6302650|NCT00355199|7205695|FG001|NOT COMPLETED|Overall Study||4
6302651|NCT00355264|7205701|FG000|STARTED|Part 1 (2 Weeks)||12
6302652|NCT00355264|7205701|FG000|COMPLETED|Part 1 (2 Weeks)||12
6302653|NCT00355264|7205701|FG000|NOT COMPLETED|Part 1 (2 Weeks)||0
6302654|NCT00355264|7205701|FG000|STARTED|Part 2 (8 Weeks)||12
6302655|NCT00355264|7205701|FG000|COMPLETED|Part 2 (8 Weeks)||12
6302656|NCT00355264|7205701|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
6302657|NCT00355264|7205701|FG000|STARTED|Part 3 (7 Weeks of Extension)||2
6302658|NCT00355264|7205701|FG000|COMPLETED|Part 3 (7 Weeks of Extension)||2
6302659|NCT00355264|7205701|FG000|NOT COMPLETED|Part 3 (7 Weeks of Extension)||0
6302660|NCT00355264|7205701|FG000|STARTED|Extension (Variable Duration)||12
6302661|NCT00355264|7205701|FG000|COMPLETED|Extension (Variable Duration)||10
6302662|NCT00355264|7205701|FG000|NOT COMPLETED|Extension (Variable Duration)||2
6302663|NCT00355342|7205712|FG000|STARTED|Overall Study||94
6302664|NCT00355342|7205713|FG001|STARTED|Overall Study||92
6302665|NCT00355342|7205712|FG000|COMPLETED|Overall Study||55
6302666|NCT00355342|7205713|FG001|COMPLETED|Overall Study||56
6302667|NCT00355342|7205712|FG000|NOT COMPLETED|Overall Study||39
6302668|NCT00355342|7205713|FG001|NOT COMPLETED|Overall Study||36
6302669|NCT00355368|7205721|FG000|STARTED|Overall Study||210
6302670|NCT00355368|7205722|FG001|STARTED|Overall Study||210
6302671|NCT00355368|7205721|FG000|COMPLETED|Overall Study||200
6302672|NCT00355368|7205722|FG001|COMPLETED|Overall Study||201
6302673|NCT00355368|7205721|FG000|NOT COMPLETED|Overall Study||10
6302674|NCT00355368|7205722|FG001|NOT COMPLETED|Overall Study||9
6302675|NCT00355394|7205730|FG000|STARTED|Overall Study||15
6302676|NCT00355394|7205731|FG001|STARTED|Overall Study||16
6302677|NCT00355394|7205730|FG000|COMPLETED|Overall Study||15
6302678|NCT00355394|7205731|FG001|COMPLETED|Overall Study||16
6302679|NCT00355394|7205730|FG000|NOT COMPLETED|Overall Study||0
6302680|NCT00355394|7205731|FG001|NOT COMPLETED|Overall Study||0
6302681|NCT00355472|7205739|FG000|STARTED|Overall Study||16
6302682|NCT00355472|7205739|FG000|COMPLETED|Overall Study||15
6302683|NCT00355472|7205739|FG000|NOT COMPLETED|Overall Study||1
6302684|NCT00355615|7205755|FG000|STARTED|Randomized Double Blind Period||42
6302685|NCT00355615|7205756|FG001|STARTED|Randomized Double Blind Period||44
6302686|NCT00355615|7205757|FG002|STARTED|Randomized Double Blind Period||45
6302687|NCT00355615|7205758|FG003|STARTED|Randomized Double Blind Period||46
6302688|NCT00355615|7205759|FG004|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
6302689|NCT00355615|7205755|FG000|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
6302690|NCT00355615|7205756|FG001|COMPLETED|Randomized Double Blind Period||44
6302691|NCT00355615|7205757|FG002|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
6302692|NCT00355615|7205758|FG003|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
6302693|NCT00355615|7205759|FG004|COMPLETED|Randomized Double Blind Period||0
6302694|NCT00355615|7205755|FG000|NOT COMPLETED|Randomized Double Blind Period||1
6302695|NCT00355615|7205756|FG001|NOT COMPLETED|Randomized Double Blind Period||0
6302696|NCT00355615|7205757|FG002|NOT COMPLETED|Randomized Double Blind Period||1
6302697|NCT00355615|7205758|FG003|NOT COMPLETED|Randomized Double Blind Period||1
6302698|NCT00355615|7205759|FG004|NOT COMPLETED|Randomized Double Blind Period||0
6302699|NCT00355615|7205755|FG000|STARTED|40-week Rosuvastatin Open Label Period||0
6302700|NCT00355615|7205756|FG001|STARTED|40-week Rosuvastatin Open Label Period||0
6302701|NCT00355615|7205757|FG002|STARTED|40-week Rosuvastatin Open Label Period||0
6302702|NCT00355615|7205758|FG003|STARTED|40-week Rosuvastatin Open Label Period||0
6302703|NCT00355615|7205759|FG004|STARTED|40-week Rosuvastatin Open Label Period||173
6302704|NCT00355615|7205755|FG000|COMPLETED|40-week Rosuvastatin Open Label Period||0
6302705|NCT00355615|7205756|FG001|COMPLETED|40-week Rosuvastatin Open Label Period||0
6302706|NCT00355615|7205757|FG002|COMPLETED|40-week Rosuvastatin Open Label Period||0
6302707|NCT00355615|7205758|FG003|COMPLETED|40-week Rosuvastatin Open Label Period||0
6302708|NCT00355615|7205759|FG004|COMPLETED|40-week Rosuvastatin Open Label Period||164
6302709|NCT00355615|7205755|FG000|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
6302710|NCT00355615|7205756|FG001|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
6302711|NCT00355615|7205757|FG002|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
6302712|NCT00355615|7205758|FG003|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
6302713|NCT00355615|7205759|FG004|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
6302714|NCT00355706|7205772|FG000|STARTED|Overall Study||50
6302715|NCT00355706|7205773|FG001|STARTED|Overall Study||50
6302716|NCT00355706|7205772|FG000|COMPLETED|Overall Study||50
6302717|NCT00355706|7205773|FG001|COMPLETED|Overall Study||50
6302718|NCT00355706|7205772|FG000|NOT COMPLETED|Overall Study||0
6302719|NCT00355706|7205773|FG001|NOT COMPLETED|Overall Study||0
6302720|NCT00355784|7205784|FG000|STARTED|Overall Study||9
6302721|NCT00355784|7205785|FG001|STARTED|Overall Study||8
6302722|NCT00355784|7205786|FG002|STARTED|Overall Study||7
6302723|NCT00355784|7205784|FG000|COMPLETED|Overall Study||9
6302724|NCT00355784|7205785|FG001|COMPLETED|Overall Study||8
6302725|NCT00355784|7205786|FG002|COMPLETED|Overall Study||5
6302726|NCT00355784|7205784|FG000|NOT COMPLETED|Overall Study||0
6302727|NCT00355784|7205785|FG001|NOT COMPLETED|Overall Study||0
6302728|NCT00355784|7205786|FG002|NOT COMPLETED|Overall Study||2
6302729|NCT00355797|7205798|FG000|STARTED|Overall Study||741
6302730|NCT00355797|7205799|FG001|STARTED|Overall Study||369
6302731|NCT00355797|7205800|FG002|STARTED|Overall Study||381
6302732|NCT00355797|7205798|FG000|COMPLETED|Overall Study||501
6302733|NCT00355797|7205799|FG001|COMPLETED|Overall Study||221
6302734|NCT00355797|7205800|FG002|COMPLETED|Overall Study||239
6302735|NCT00355797|7205798|FG000|NOT COMPLETED|Overall Study||240
6302736|NCT00355797|7205799|FG001|NOT COMPLETED|Overall Study||148
6302737|NCT00355797|7205800|FG002|NOT COMPLETED|Overall Study||142
6302738|NCT00355914|7205810|FG000|STARTED|Overall Study||60
6302739|NCT00355914|7205811|FG001|STARTED|Overall Study||60
6302740|NCT00355914|7205810|FG000|COMPLETED|Overall Study||60
6302741|NCT00355914|7205811|FG001|COMPLETED|Overall Study||60
6302742|NCT00355914|7205810|FG000|NOT COMPLETED|Overall Study||0
6302743|NCT00355914|7205811|FG001|NOT COMPLETED|Overall Study||0
6302744|NCT00356031|7205819|FG000|STARTED|Overall Study||20
6302745|NCT00356031|7205819|FG000|COMPLETED|Overall Study||20
6302746|NCT00356031|7205819|FG000|NOT COMPLETED|Overall Study||0
6302747|NCT00356057|7205828|FG000|STARTED|Overall Study||58
6302748|NCT00356057|7205829|FG001|STARTED|Overall Study||61
6302749|NCT00356057|7205830|FG002|STARTED|Overall Study||34
6302750|NCT00356057|7205828|FG000|IMPLANTED|Overall Study||49
6302751|NCT00356057|7205829|FG001|IMPLANTED|Overall Study||52
6302752|NCT00356057|7205830|FG002|IMPLANTED|Overall Study||25
6302753|NCT00356057|7205828|FG000|COMPLETED|Overall Study||45
6302754|NCT00356057|7205829|FG001|COMPLETED|Overall Study||47
6302755|NCT00356057|7205830|FG002|COMPLETED|Overall Study||22
6302756|NCT00356057|7205828|FG000|NOT COMPLETED|Overall Study||13
6302757|NCT00356057|7205829|FG001|NOT COMPLETED|Overall Study||14
6302758|NCT00356057|7205830|FG002|NOT COMPLETED|Overall Study||12
6302759|NCT00356122|7205842|FG000|STARTED|TREATMENT||53
6302760|NCT00356122|7205842|FG000|COMPLETED|TREATMENT||8
6302761|NCT00356122|7205842|FG000|NOT COMPLETED|TREATMENT||45
6302762|NCT00356122|7205842|FG000|STARTED|FOLLOW-UP||53
6302763|NCT00356122|7205842|FG000|COMPLETED|FOLLOW-UP||12
6302764|NCT00356122|7205842|FG000|NOT COMPLETED|FOLLOW-UP||41
6302765|NCT00356135|7205849|FG000|STARTED|Overall Study||47
6302766|NCT00356135|7205850|FG001|STARTED|Overall Study||48
6302767|NCT00356135|7205851|FG002|STARTED|Overall Study||44
6302768|NCT00356135|7205849|FG000|COMPLETED|Overall Study||43
6302769|NCT00356135|7205850|FG001|COMPLETED|Overall Study||46
6302770|NCT00356135|7205851|FG002|COMPLETED|Overall Study||39
6302771|NCT00356135|7205849|FG000|NOT COMPLETED|Overall Study||4
6302772|NCT00356135|7205850|FG001|NOT COMPLETED|Overall Study||2
6302773|NCT00356135|7205851|FG002|NOT COMPLETED|Overall Study||5
6302774|NCT00356148|7205863|FG000|STARTED|Overall Study||189
6302775|NCT00356148|7205864|FG001|STARTED|Overall Study||183
6302776|NCT00356148|7205863|FG000|COMPLETED|Overall Study||187
6302777|NCT00356148|7205864|FG001|COMPLETED|Overall Study||182
6302778|NCT00356148|7205863|FG000|NOT COMPLETED|Overall Study||2
6302779|NCT00356148|7205864|FG001|NOT COMPLETED|Overall Study||1
6302780|NCT00356200|7205873|FG000|STARTED|Cohort 1: 10 ug/ml||5
6302781|NCT00356200|7205874|FG001|STARTED|Cohort 1: 10 ug/ml||0
6302782|NCT00356200|7205873|FG000|COMPLETED|Cohort 1: 10 ug/ml||4
6302783|NCT00356200|7205874|FG001|COMPLETED|Cohort 1: 10 ug/ml||0
6302784|NCT00356200|7205873|FG000|NOT COMPLETED|Cohort 1: 10 ug/ml||1
6302785|NCT00356200|7205874|FG001|NOT COMPLETED|Cohort 1: 10 ug/ml||0
6302786|NCT00356200|7205873|FG000|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
6302787|NCT00356200|7205874|FG001|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
6302788|NCT00356200|7205873|FG000|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
6302789|NCT00356200|7205874|FG001|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
6302790|NCT00356200|7205873|FG000|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
6302791|NCT00356200|7205874|FG001|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
6302792|NCT00356265|7205889|FG000|STARTED|Overall Study||7
6302793|NCT00356265|7205890|FG001|STARTED|Overall Study||2
6302794|NCT00356265|7205891|FG002|STARTED|Overall Study||6
6302795|NCT00356265|7205889|FG000|COMPLETED|Overall Study||7
6302796|NCT00356265|7205890|FG001|COMPLETED|Overall Study||2
6302797|NCT00356265|7205891|FG002|COMPLETED|Overall Study||5
6302798|NCT00356265|7205889|FG000|NOT COMPLETED|Overall Study||0
6302799|NCT00356265|7205890|FG001|NOT COMPLETED|Overall Study||0
6302800|NCT00356265|7205891|FG002|NOT COMPLETED|Overall Study||1
6302801|NCT00356278|7205903|FG000|STARTED|Overall Study||53
6302802|NCT00356278|7205904|FG001|STARTED|Overall Study||50
6302803|NCT00356278|7205905|FG002|STARTED|Overall Study||53
6302804|NCT00356278|7205903|FG000|COMPLETED|Overall Study||28
6302805|NCT00356278|7205904|FG001|COMPLETED|Overall Study||35
6302806|NCT00356278|7205905|FG002|COMPLETED|Overall Study||34
6302807|NCT00356278|7205903|FG000|NOT COMPLETED|Overall Study||25
6302808|NCT00356278|7205904|FG001|NOT COMPLETED|Overall Study||15
6302809|NCT00356278|7205905|FG002|NOT COMPLETED|Overall Study||19
6302810|NCT00356304|7205915|FG000|STARTED|Overall Study||26
6302811|NCT00356304|7205916|FG001|STARTED|Overall Study||24
6302812|NCT00356304|7205915|FG000|COMPLETED|Overall Study||24
6302813|NCT00356304|7205916|FG001|COMPLETED|Overall Study||20
6302814|NCT00356304|7205915|FG000|NOT COMPLETED|Overall Study||2
6302815|NCT00356304|7205916|FG001|NOT COMPLETED|Overall Study||4
6302816|NCT00356369|7205924|FG000|STARTED|Active Phase||374
6302817|NCT00356369|7205925|FG001|STARTED|Active Phase||126
6302818|NCT00356369|7205924|FG000|COMPLETED|Active Phase||372
6302819|NCT00356369|7205925|FG001|COMPLETED|Active Phase||125
6302820|NCT00356369|7205924|FG000|NOT COMPLETED|Active Phase||2
6302821|NCT00356369|7205925|FG001|NOT COMPLETED|Active Phase||1
6302822|NCT00356369|7205924|FG000|STARTED|Year 1||364
6302823|NCT00356369|7205925|FG001|STARTED|Year 1||121
6302824|NCT00356369|7205924|FG000|COMPLETED|Year 1||364
6302825|NCT00356369|7205925|FG001|COMPLETED|Year 1||121
6302826|NCT00356369|7205924|FG000|NOT COMPLETED|Year 1||0
6302827|NCT00356369|7205925|FG001|NOT COMPLETED|Year 1||0
6302828|NCT00356369|7205924|FG000|STARTED|Year 2||354
6302829|NCT00356369|7205925|FG001|STARTED|Year 2||117
6302830|NCT00356369|7205924|FG000|COMPLETED|Year 2||354
6302831|NCT00356369|7205925|FG001|COMPLETED|Year 2||117
6302832|NCT00356369|7205924|FG000|NOT COMPLETED|Year 2||0
6302833|NCT00356369|7205925|FG001|NOT COMPLETED|Year 2||0
6302834|NCT00356369|7205924|FG000|STARTED|Year 3||344
6302835|NCT00356369|7205925|FG001|STARTED|Year 3||116
6302836|NCT00356369|7205924|FG000|COMPLETED|Year 3||344
6302837|NCT00356369|7205925|FG001|COMPLETED|Year 3||116
6302838|NCT00356369|7205924|FG000|NOT COMPLETED|Year 3||0
6302839|NCT00356369|7205925|FG001|NOT COMPLETED|Year 3||0
6302840|NCT00356369|7205924|FG000|STARTED|Year 4||317
6302841|NCT00356369|7205925|FG001|STARTED|Year 4||109
6401495|NCT00892957|7314426|FG001|COMPLETED|Intraoperative Day 0||70
6401496|NCT00892957|7314425|FG000|NOT COMPLETED|Intraoperative Day 0||0
6401497|NCT00892957|7314426|FG001|NOT COMPLETED|Intraoperative Day 0||0
6401498|NCT00892957|7314425|FG000|STARTED|Postoperative Day 1 Assessment||70
6401499|NCT00892957|7314426|FG001|STARTED|Postoperative Day 1 Assessment||70
6401500|NCT00892957|7314425|FG000|COMPLETED|Postoperative Day 1 Assessment||70
6401501|NCT00892957|7314426|FG001|COMPLETED|Postoperative Day 1 Assessment||70
6401502|NCT00892957|7314425|FG000|NOT COMPLETED|Postoperative Day 1 Assessment||0
6401503|NCT00892957|7314426|FG001|NOT COMPLETED|Postoperative Day 1 Assessment||0
6401504|NCT00892957|7314425|FG000|STARTED|Between Postoperative Day 1 and Day 14||70
6401505|NCT00892957|7314426|FG001|STARTED|Between Postoperative Day 1 and Day 14||70
6302842|NCT00356369|7205924|FG000|COMPLETED|Year 4||317
6302843|NCT00356369|7205925|FG001|COMPLETED|Year 4||109
6302844|NCT00356369|7205924|FG000|NOT COMPLETED|Year 4||0
6302845|NCT00356369|7205925|FG001|NOT COMPLETED|Year 4||0
6302846|NCT00356369|7205924|FG000|STARTED|Year 5||299
6302847|NCT00356369|7205925|FG001|STARTED|Year 5||105
6302848|NCT00356369|7205924|FG000|COMPLETED|Year 5||299
6302849|NCT00356369|7205925|FG001|COMPLETED|Year 5||105
6302850|NCT00356369|7205924|FG000|NOT COMPLETED|Year 5||0
6302851|NCT00356369|7205925|FG001|NOT COMPLETED|Year 5||0
6302852|NCT00356408|7205935|FG000|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
6302853|NCT00356408|7205935|FG000|COMPLETED|Overall Study||43
6302854|NCT00356408|7205935|FG000|NOT COMPLETED|Overall Study||60
6302855|NCT00356434|7205948|FG000|STARTED|Overall Study||4
6302856|NCT00356434|7205949|FG001|STARTED|Overall Study||7
6302857|NCT00356434|7205948|FG000|COMPLETED|Overall Study||4
6302858|NCT00356434|7205949|FG001|COMPLETED|Overall Study||7
6302859|NCT00356434|7205948|FG000|NOT COMPLETED|Overall Study||0
6302860|NCT00356434|7205949|FG001|NOT COMPLETED|Overall Study||0
6302861|NCT00356525|7205960|FG000|STARTED|Overall Study||14
6302862|NCT00356525|7205961|FG001|STARTED|Overall Study||11
6302863|NCT00356525|7205962|FG002|STARTED|Overall Study||7
6510153|NCT01479621|7429697|FG002|Safety Population|Treatment Period||104
6510154|NCT01479621|7429698|FG003|Safety Population|Treatment Period||104
6510155|NCT01479621|7429699|FG004|Safety Population|Treatment Period||103
6510156|NCT01479621|7429700|FG005|Safety Population|Treatment Period||104
6510157|NCT01479621|7429701|FG006|Safety Population|Treatment Period||104
6510158|NCT01479621|7429695|FG000|Full Analysis Set|Treatment Period||0
6510159|NCT01479621|7429696|FG001|Full Analysis Set|Treatment Period||102
6510160|NCT01479621|7429697|FG002|Full Analysis Set|Treatment Period||101
6510161|NCT01479621|7429698|FG003|Full Analysis Set|Treatment Period||102
6510162|NCT01479621|7429699|FG004|Full Analysis Set|Treatment Period||102
6302864|NCT00356525|7205963|FG003|STARTED|Overall Study||9
6302865|NCT00356525|7205960|FG000|COMPLETED|Overall Study||0
6302866|NCT00356525|7205961|FG001|COMPLETED|Overall Study||0
6302867|NCT00356525|7205962|FG002|COMPLETED|Overall Study||0
6302868|NCT00356525|7205963|FG003|COMPLETED|Overall Study||0
6302869|NCT00356525|7205960|FG000|NOT COMPLETED|Overall Study||14
6302870|NCT00356525|7205961|FG001|NOT COMPLETED|Overall Study||11
6302871|NCT00356525|7205962|FG002|NOT COMPLETED|Overall Study||7
6302872|NCT00356525|7205963|FG003|NOT COMPLETED|Overall Study||9
6302873|NCT00356590|7205973|FG000|STARTED|Overall Study||468
6302874|NCT00356590|7205973|FG000|COMPLETED|Overall Study||194
6302875|NCT00356590|7205973|FG000|NOT COMPLETED|Overall Study||274
6302876|NCT00356603|7205979|FG000|STARTED|Overall Study||39
6302877|NCT00356603|7205980|FG001|STARTED|Overall Study||36
6302878|NCT00356603|7205979|FG000|COMPLETED|Overall Study||33
6302879|NCT00356603|7205980|FG001|COMPLETED|Overall Study||33
6302880|NCT00356603|7205979|FG000|NOT COMPLETED|Overall Study||6
6302881|NCT00356603|7205980|FG001|NOT COMPLETED|Overall Study||3
6302882|NCT00356759|7205990|FG000|STARTED|Overall Study||126
6302883|NCT00356759|7205991|FG001|STARTED|Overall Study||124
6302884|NCT00356759|7205990|FG000|COMPLETED|Overall Study||112
6302885|NCT00356759|7205991|FG001|COMPLETED|Overall Study||114
6302886|NCT00356759|7205990|FG000|NOT COMPLETED|Overall Study||14
6302887|NCT00356759|7205991|FG001|NOT COMPLETED|Overall Study||10
6302888|NCT00356811|7205997|FG000|STARTED|Overall Study||57
6302889|NCT00356811|7205997|FG000|COMPLETED|Overall Study||8
6302890|NCT00356811|7205997|FG000|NOT COMPLETED|Overall Study||49
6302891|NCT00356863|7206004|FG000|STARTED|Overall Study||504
6302892|NCT00356863|7206005|FG001|STARTED|Overall Study||520
6302893|NCT00356863|7206004|FG000|COMPLETED|Overall Study||412
6302894|NCT00356863|7206005|FG001|COMPLETED|Overall Study||445
6302895|NCT00356863|7206004|FG000|NOT COMPLETED|Overall Study||92
6302896|NCT00356863|7206005|FG001|NOT COMPLETED|Overall Study||75
6302897|NCT00356889|7206015|FG000|STARTED|Overall Study||56
6302898|NCT00356889|7206015|FG000|COMPLETED|Overall Study||53
6302899|NCT00356889|7206015|FG000|NOT COMPLETED|Overall Study||3
6302900|NCT00356915|7206023|FG000|STARTED|Overall Study||593
6302901|NCT00356915|7206024|FG001|STARTED|Overall Study||590
6302902|NCT00356915|7206025|FG002|STARTED|Overall Study||198
6302903|NCT00356915|7206023|FG000|COMPLETED|Overall Study||517
6302904|NCT00356915|7206024|FG001|COMPLETED|Overall Study||496
6302905|NCT00356915|7206025|FG002|COMPLETED|Overall Study||156
6302906|NCT00356915|7206023|FG000|NOT COMPLETED|Overall Study||76
6302907|NCT00356915|7206024|FG001|NOT COMPLETED|Overall Study||94
6302908|NCT00356915|7206025|FG002|NOT COMPLETED|Overall Study||42
6302909|NCT00356993|7206039|FG000|STARTED|Overall Study||6009
6302910|NCT00356993|7206039|FG000|COMPLETED|Overall Study||2088
6302911|NCT00356993|7206039|FG000|NOT COMPLETED|Overall Study||3921
6302912|NCT00357006|7206046|FG000|STARTED|Overall Study||62
6302913|NCT00357006|7206047|FG001|STARTED|Overall Study||56
6302914|NCT00357006|7206048|FG002|STARTED|Overall Study||62
6302915|NCT00357006|7206046|FG000|COMPLETED|Overall Study||60
6302916|NCT00357006|7206047|FG001|COMPLETED|Overall Study||51
6302917|NCT00357006|7206048|FG002|COMPLETED|Overall Study||59
6302918|NCT00357006|7206046|FG000|NOT COMPLETED|Overall Study||2
6302919|NCT00357006|7206047|FG001|NOT COMPLETED|Overall Study||5
6302920|NCT00357006|7206048|FG002|NOT COMPLETED|Overall Study||3
6302921|NCT00357032|7206056|FG000|STARTED|Overall Study||12
6302922|NCT00357032|7206056|FG000|COMPLETED|Overall Study||12
6302923|NCT00357032|7206056|FG000|NOT COMPLETED|Overall Study||0
6302924|NCT00357097|7206062|FG000|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
6302925|NCT00357097|7206063|FG001|STARTED|Overall Study||67
6302926|NCT00357097|7206062|FG000|COMPLETED|Overall Study||145
6302927|NCT00357097|7206063|FG001|COMPLETED|Overall Study||38
6302928|NCT00357097|7206062|FG000|NOT COMPLETED|Overall Study||54
6302929|NCT00357097|7206063|FG001|NOT COMPLETED|Overall Study||29
6302930|NCT00357110|7206071|FG000|STARTED|Overall Study||6
6302931|NCT00357110|7206072|FG001|STARTED|Overall Study||7
6302932|NCT00357110|7206071|FG000|COMPLETED|Overall Study||1
6302933|NCT00357110|7206072|FG001|COMPLETED|Overall Study||2
6302934|NCT00357110|7206071|FG000|NOT COMPLETED|Overall Study||5
6302935|NCT00357110|7206072|FG001|NOT COMPLETED|Overall Study||5
6302936|NCT00357162|7206078|FG000|STARTED|Overall Study||21
6302937|NCT00357162|7206078|FG000|COMPLETED|Overall Study||21
6302938|NCT00357162|7206078|FG000|NOT COMPLETED|Overall Study||0
6302939|NCT00357214|7206086|FG000|STARTED|Overall Study||43
6302940|NCT00357214|7206087|FG001|STARTED|Overall Study||43
6302941|NCT00357214|7206088|FG002|STARTED|Overall Study||42
6302942|NCT00357214|7206089|FG003|STARTED|Overall Study||43
6401506|NCT00892957|7314425|FG000|COMPLETED|Between Postoperative Day 1 and Day 14||70
6401507|NCT00892957|7314426|FG001|COMPLETED|Between Postoperative Day 1 and Day 14||66
6401508|NCT00892957|7314425|FG000|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
6302943|NCT00357214|7206086|FG000|COMPLETED|Overall Study||39
6302944|NCT00357214|7206087|FG001|COMPLETED|Overall Study||39
6302945|NCT00357214|7206088|FG002|COMPLETED|Overall Study||42
6302946|NCT00357214|7206089|FG003|COMPLETED|Overall Study||42
6302947|NCT00357214|7206086|FG000|NOT COMPLETED|Overall Study||4
6302948|NCT00357214|7206087|FG001|NOT COMPLETED|Overall Study||4
6302949|NCT00357214|7206088|FG002|NOT COMPLETED|Overall Study||0
6302950|NCT00357214|7206089|FG003|NOT COMPLETED|Overall Study||1
6302951|NCT00357331|7206101|FG000|STARTED|Overall Study||42
6302952|NCT00357331|7206102|FG001|STARTED|Overall Study||41
6302953|NCT00357331|7206101|FG000|COMPLETED|Overall Study||42
6302954|NCT00357331|7206102|FG001|COMPLETED|Overall Study||41
6302955|NCT00357331|7206101|FG000|NOT COMPLETED|Overall Study||0
6302956|NCT00357331|7206102|FG001|NOT COMPLETED|Overall Study||0
6302957|NCT00357370|7206111|FG000|STARTED|Cohort 1||4
6302958|NCT00357370|7206112|FG001|STARTED|Cohort 1||0
6302959|NCT00357370|7206113|FG002|STARTED|Cohort 1||0
6302960|NCT00357370|7206111|FG000|COMPLETED|Cohort 1||4
6302961|NCT00357370|7206112|FG001|COMPLETED|Cohort 1||0
6302962|NCT00357370|7206113|FG002|COMPLETED|Cohort 1||0
6302963|NCT00357370|7206111|FG000|NOT COMPLETED|Cohort 1||0
6302964|NCT00357370|7206112|FG001|NOT COMPLETED|Cohort 1||0
6302965|NCT00357370|7206113|FG002|NOT COMPLETED|Cohort 1||0
6302966|NCT00357370|7206111|FG000|STARTED|Cohort 2||24
6302967|NCT00357370|7206112|FG001|STARTED|Cohort 2||23
6302968|NCT00357370|7206113|FG002|STARTED|Cohort 2||24
6302969|NCT00357370|7206111|FG000|COMPLETED|Cohort 2||22
6302970|NCT00357370|7206112|FG001|COMPLETED|Cohort 2||16
6302971|NCT00357370|7206113|FG002|COMPLETED|Cohort 2||22
6302972|NCT00357370|7206111|FG000|NOT COMPLETED|Cohort 2||2
6302973|NCT00357370|7206112|FG001|NOT COMPLETED|Cohort 2||7
6302974|NCT00357370|7206113|FG002|NOT COMPLETED|Cohort 2||2
6302975|NCT00357396|7206123|FG000|STARTED|Overall Study||6
6302976|NCT00357396|7206124|FG001|STARTED|Overall Study||4
6302977|NCT00357396|7206123|FG000|COMPLETED|Overall Study||5
6302978|NCT00357396|7206124|FG001|COMPLETED|Overall Study||4
6302979|NCT00357396|7206123|FG000|NOT COMPLETED|Overall Study||1
6302980|NCT00357396|7206124|FG001|NOT COMPLETED|Overall Study||0
6302981|NCT00357500|7206129|FG000|STARTED|Overall Study||101
6302982|NCT00357500|7206129|FG000|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
6302983|NCT00357500|7206129|FG000|COMPLETED|Overall Study||24
6302984|NCT00357500|7206129|FG000|NOT COMPLETED|Overall Study||77
6302985|NCT00357552|7206133|FG000|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
6302986|NCT00357552|7206133|FG000|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
6302987|NCT00357552|7206133|FG000|NOT COMPLETED|Screening||84
6302988|NCT00357552|7206133|FG000|STARTED|Weeks 0 to 24||123
6302989|NCT00357552|7206133|FG000|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
6302990|NCT00357552|7206133|FG000|NOT COMPLETED|Weeks 0 to 24||1
6302991|NCT00357552|7206133|FG000|STARTED|Weeks 24 to 104||122
6302992|NCT00357552|7206133|FG000|COMPLETED|Weeks 24 to 104||117
6302993|NCT00357552|7206133|FG000|NOT COMPLETED|Weeks 24 to 104||5
6302994|NCT00357656|7206143|FG000|STARTED|Overall Study||31
6302995|NCT00357656|7206144|FG001|STARTED|Overall Study||32
6302996|NCT00357656|7206143|FG000|COMPLETED|Overall Study||31
6302997|NCT00357656|7206144|FG001|COMPLETED|Overall Study||29
6302998|NCT00357656|7206143|FG000|NOT COMPLETED|Overall Study||0
6302999|NCT00357656|7206144|FG001|NOT COMPLETED|Overall Study||3
6303000|NCT00357734|7206162|FG000|STARTED|Overall Study||14
6303001|NCT00357734|7206162|FG000|Patients Received 250 mg of ZD1839|Overall Study||13
6303002|NCT00357734|7206162|FG000|Patient Received 500 mg of ZD1839|Overall Study||1
6303003|NCT00357734|7206162|FG000|COMPLETED|Overall Study||10
6303004|NCT00357734|7206162|FG000|NOT COMPLETED|Overall Study||4
6303005|NCT00357760|7206168|FG000|STARTED|Overall Study||59
6303006|NCT00357760|7206169|FG001|STARTED|Overall Study||35
6303007|NCT00357760|7206168|FG000|Patients Who Started Treatment|Overall Study||57
6303008|NCT00357760|7206169|FG001|Patients Who Started Treatment|Overall Study||34
6303009|NCT00357760|7206168|FG000|Eligible and Treated Patients|Overall Study||57
6303010|NCT00357760|7206169|FG001|Eligible and Treated Patients|Overall Study||32
6303011|NCT00357760|7206168|FG000|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
6303012|NCT00357760|7206169|FG001|Patients Who Undergo Dose Escalation|Overall Study||16
6303013|NCT00357760|7206168|FG000|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
6303014|NCT00357760|7206169|FG001|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
6303015|NCT00357760|7206168|FG000|NOT COMPLETED|Overall Study||59
6303016|NCT00357760|7206169|FG001|NOT COMPLETED|Overall Study||35
6303017|NCT00357877|7206177|FG000|STARTED|Overall Study||493
6303018|NCT00357877|7206178|FG001|STARTED|Overall Study||490
6303019|NCT00357877|7206177|FG000|COMPLETED|Overall Study||467
6303020|NCT00357877|7206178|FG001|COMPLETED|Overall Study||460
6303021|NCT00357877|7206177|FG000|NOT COMPLETED|Overall Study||26
6303022|NCT00357877|7206178|FG001|NOT COMPLETED|Overall Study||30
6303023|NCT00357903|7206188|FG000|STARTED|Overall Study||581
6303024|NCT00357903|7206189|FG001|STARTED|Overall Study||58
6303025|NCT00357903|7206188|FG000|COMPLETED|Overall Study||218
6303026|NCT00357903|7206189|FG001|COMPLETED|Overall Study||15
6303027|NCT00357903|7206188|FG000|NOT COMPLETED|Overall Study||363
6303028|NCT00357903|7206189|FG001|NOT COMPLETED|Overall Study||43
6303029|NCT00357955|7206198|FG000|STARTED|Overall Study||64
6303030|NCT00357955|7206199|FG001|STARTED|Overall Study||54
6303031|NCT00357955|7206198|FG000|COMPLETED|Overall Study||58
6303032|NCT00357955|7206199|FG001|COMPLETED|Overall Study||51
6303033|NCT00357955|7206198|FG000|NOT COMPLETED|Overall Study||6
6303034|NCT00357955|7206199|FG001|NOT COMPLETED|Overall Study||3
6303035|NCT00357968|7206207|FG000|STARTED|First Maintenance Dose Phase||102
6303036|NCT00357968|7206208|FG001|STARTED|First Maintenance Dose Phase||99
6303037|NCT00357968|7206207|FG000|Received Loading Dose|First Maintenance Dose Phase||102
6303038|NCT00357968|7206208|FG001|Received Loading Dose|First Maintenance Dose Phase||99
6303039|NCT00357968|7206207|FG000|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
6303040|NCT00357968|7206208|FG001|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
6303041|NCT00357968|7206207|FG000|Started Maintenance Dose|First Maintenance Dose Phase||55
6303042|NCT00357968|7206208|FG001|Started Maintenance Dose|First Maintenance Dose Phase||55
6303043|NCT00357968|7206207|FG000|COMPLETED|First Maintenance Dose Phase||54
6303044|NCT00357968|7206208|FG001|COMPLETED|First Maintenance Dose Phase||55
6303045|NCT00357968|7206207|FG000|NOT COMPLETED|First Maintenance Dose Phase||48
6303046|NCT00357968|7206208|FG001|NOT COMPLETED|First Maintenance Dose Phase||44
6303047|NCT00357968|7206207|FG000|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
6303048|NCT00357968|7206208|FG001|STARTED|Crossover Maintenance Dose Phase||55
6303049|NCT00357968|7206207|FG000|COMPLETED|Crossover Maintenance Dose Phase||54
6303050|NCT00357968|7206208|FG001|COMPLETED|Crossover Maintenance Dose Phase||55
6303051|NCT00357968|7206207|FG000|NOT COMPLETED|Crossover Maintenance Dose Phase||0
6303052|NCT00357968|7206208|FG001|NOT COMPLETED|Crossover Maintenance Dose Phase||0
6303053|NCT00357994|7206231|FG000|STARTED|Overall Study||37
6743373|NCT03334448|7671662|FG002|COMPLETED|Washout||13
6743374|NCT03334448|7671663|FG003|COMPLETED|Washout||12
6743375|NCT03334448|7671660|FG000|NOT COMPLETED|Washout||0
6303054|NCT00357994|7206232|FG001|STARTED|Overall Study||34
6303055|NCT00357994|7206231|FG000|COMPLETED|Overall Study||35
6303056|NCT00357994|7206232|FG001|COMPLETED|Overall Study||31
6303057|NCT00357994|7206231|FG000|NOT COMPLETED|Overall Study||2
6303058|NCT00357994|7206232|FG001|NOT COMPLETED|Overall Study||3
6303059|NCT00358007|7206238|FG000|STARTED|Overall Study||30
6303060|NCT00358007|7206238|FG000|COMPLETED|Overall Study||28
6303061|NCT00358007|7206238|FG000|NOT COMPLETED|Overall Study||2
6303062|NCT00358150|7206242|FG000|STARTED|Overall Study||26
6303063|NCT00358150|7206242|FG000|COMPLETED|Overall Study||19
6303064|NCT00358150|7206242|FG000|NOT COMPLETED|Overall Study||7
6303065|NCT00358215|7206251|FG000|STARTED|Overall Study||1142
6303066|NCT00358215|7206252|FG001|STARTED|Overall Study||1136
6303067|NCT00358215|7206251|FG000|Received Investigational Product|Overall Study||1140
6303068|NCT00358215|7206252|FG001|Received Investigational Product|Overall Study||1133
6303069|NCT00358215|7206251|FG000|COMPLETED|Overall Study|Participants who completed investigational product|463
6303070|NCT00358215|7206252|FG001|COMPLETED|Overall Study|Participants who completed investigational product|484
6303071|NCT00358215|7206251|FG000|NOT COMPLETED|Overall Study||679
6303072|NCT00358215|7206252|FG001|NOT COMPLETED|Overall Study||652
6303073|NCT00358332|7206262|FG000|STARTED|Overall Study||15
6303074|NCT00358332|7206263|FG001|STARTED|Overall Study||30
6303075|NCT00358332|7206264|FG002|STARTED|Overall Study||30
6303076|NCT00358332|7206265|FG003|STARTED|Overall Study||25
6303077|NCT00358332|7206262|FG000|COMPLETED|Overall Study||15
6303078|NCT00358332|7206263|FG001|COMPLETED|Overall Study||27
6303079|NCT00358332|7206264|FG002|COMPLETED|Overall Study||29
6303080|NCT00358332|7206265|FG003|COMPLETED|Overall Study||25
6303081|NCT00358332|7206262|FG000|NOT COMPLETED|Overall Study||0
6303082|NCT00358332|7206263|FG001|NOT COMPLETED|Overall Study||3
6303083|NCT00358332|7206264|FG002|NOT COMPLETED|Overall Study||1
6303084|NCT00358332|7206265|FG003|NOT COMPLETED|Overall Study||0
6303085|NCT00358436|7206277|FG000|STARTED|Overall Study||600
6303086|NCT00358436|7206278|FG001|STARTED|Overall Study||204
6303087|NCT00358436|7206277|FG000|COMPLETED|Overall Study||446
6303088|NCT00358436|7206278|FG001|COMPLETED|Overall Study||118
6303089|NCT00358436|7206277|FG000|NOT COMPLETED|Overall Study||154
6743376|NCT03334448|7671661|FG001|NOT COMPLETED|Washout||0
6743377|NCT03334448|7671662|FG002|NOT COMPLETED|Washout||0
6743378|NCT03334448|7671663|FG003|NOT COMPLETED|Washout||0
6743379|NCT03334448|7671660|FG000|STARTED|Period 2||12
6303090|NCT00358436|7206278|FG001|NOT COMPLETED|Overall Study||86
6303091|NCT00358449|7206289|FG000|STARTED|Overall Study||19
6303092|NCT00358449|7206290|FG001|STARTED|Overall Study||20
6303093|NCT00358449|7206291|FG002|STARTED|Overall Study||20
6303094|NCT00358449|7206289|FG000|COMPLETED|Overall Study||15
6303095|NCT00358449|7206290|FG001|COMPLETED|Overall Study||19
6303096|NCT00358449|7206291|FG002|COMPLETED|Overall Study||18
6303097|NCT00358449|7206289|FG000|NOT COMPLETED|Overall Study||4
6303098|NCT00358449|7206290|FG001|NOT COMPLETED|Overall Study||1
6303099|NCT00358449|7206291|FG002|NOT COMPLETED|Overall Study||2
6303100|NCT00358462|7206303|FG000|STARTED|Overall Study||304
6303101|NCT00358462|7206304|FG001|STARTED|Overall Study||302
6303102|NCT00358462|7206303|FG000|COMPLETED|Overall Study||245
6303103|NCT00358462|7206304|FG001|COMPLETED|Overall Study||238
6303104|NCT00358462|7206303|FG000|NOT COMPLETED|Overall Study||59
6303105|NCT00358462|7206304|FG001|NOT COMPLETED|Overall Study||64
6303106|NCT00358501|7206322|FG000|STARTED|Overall Study||102
6303107|NCT00358501|7206323|FG001|STARTED|Overall Study||32
6303108|NCT00358501|7206322|FG000|COMPLETED|Overall Study||102
6303109|NCT00358501|7206323|FG001|COMPLETED|Overall Study||32
6303110|NCT00358501|7206322|FG000|NOT COMPLETED|Overall Study||0
6303111|NCT00358501|7206323|FG001|NOT COMPLETED|Overall Study||0
6303112|NCT00358579|7206332|FG000|STARTED|Overall Study||353
6303113|NCT00358579|7206333|FG001|STARTED|Overall Study||374
6303114|NCT00358579|7206332|FG000|COMPLETED|Overall Study||353
6303115|NCT00358579|7206333|FG001|COMPLETED|Overall Study||374
6303116|NCT00358579|7206332|FG000|NOT COMPLETED|Overall Study||0
6303117|NCT00358579|7206333|FG001|NOT COMPLETED|Overall Study||0
6303118|NCT00358644|7206339|FG000|STARTED|Overall Study||55
6303119|NCT00358644|7206339|FG000|COMPLETED|Overall Study||5
6303120|NCT00358644|7206339|FG000|NOT COMPLETED|Overall Study||50
6303121|NCT00358657|7206343|FG000|STARTED|Overall Study||14
6303122|NCT00358657|7206343|FG000|COMPLETED|Overall Study||14
6303123|NCT00358657|7206343|FG000|NOT COMPLETED|Overall Study||0
6303124|NCT00358670|7206349|FG000|STARTED|Overall Study||222
6303125|NCT00358670|7206350|FG001|STARTED|Overall Study||219
6303126|NCT00358670|7206349|FG000|COMPLETED|Overall Study||0
6303127|NCT00358670|7206350|FG001|COMPLETED|Overall Study||0
6303128|NCT00358670|7206349|FG000|NOT COMPLETED|Overall Study||222
6303129|NCT00358670|7206350|FG001|NOT COMPLETED|Overall Study||219
6303130|NCT00358735|7206358|FG000|STARTED|Overall Study||204
6303131|NCT00358735|7206359|FG001|STARTED|Overall Study||207
6303132|NCT00358735|7206358|FG000|Completed Safety|Overall Study||198
6303133|NCT00358735|7206359|FG001|Completed Safety|Overall Study||194
6303134|NCT00358735|7206358|FG000|Not Completed Safety|Overall Study||6
6303135|NCT00358735|7206359|FG001|Not Completed Safety|Overall Study||13
6303136|NCT00358735|7206358|FG000|COMPLETED|Overall Study|Efficacy|196
6303137|NCT00358735|7206359|FG001|COMPLETED|Overall Study|Efficacy|190
6303138|NCT00358735|7206358|FG000|NOT COMPLETED|Overall Study||8
6303139|NCT00358735|7206359|FG001|NOT COMPLETED|Overall Study||17
6303140|NCT00358826|7206369|FG000|STARTED|Core Study||49
6303141|NCT00358826|7206370|FG001|STARTED|Core Study||46
6303142|NCT00358826|7206371|FG002|STARTED|Core Study||44
6303143|NCT00358826|7206372|FG003|STARTED|Core Study||52
6303144|NCT00358826|7206373|FG004|STARTED|Core Study||0
6303145|NCT00358826|7206374|FG005|STARTED|Core Study||0
6303146|NCT00358826|7206375|FG006|STARTED|Core Study||0
6303147|NCT00358826|7206376|FG007|STARTED|Core Study||0
6303148|NCT00358826|7206369|FG000|COMPLETED|Core Study||46
6303149|NCT00358826|7206370|FG001|COMPLETED|Core Study||41
6303150|NCT00358826|7206371|FG002|COMPLETED|Core Study||42
6303151|NCT00358826|7206372|FG003|COMPLETED|Core Study||50
6303152|NCT00358826|7206373|FG004|COMPLETED|Core Study||0
6303153|NCT00358826|7206374|FG005|COMPLETED|Core Study||0
6303154|NCT00358826|7206375|FG006|COMPLETED|Core Study||0
6303155|NCT00358826|7206376|FG007|COMPLETED|Core Study||0
6303156|NCT00358826|7206369|FG000|NOT COMPLETED|Core Study||3
6303157|NCT00358826|7206370|FG001|NOT COMPLETED|Core Study||5
6303158|NCT00358826|7206371|FG002|NOT COMPLETED|Core Study||2
6303159|NCT00358826|7206372|FG003|NOT COMPLETED|Core Study||2
6303160|NCT00358826|7206373|FG004|NOT COMPLETED|Core Study||0
6303161|NCT00358826|7206374|FG005|NOT COMPLETED|Core Study||0
6303162|NCT00358826|7206375|FG006|NOT COMPLETED|Core Study||0
6303163|NCT00358826|7206376|FG007|NOT COMPLETED|Core Study||0
6303164|NCT00358826|7206369|FG000|STARTED|MDCT Substudy||0
6303165|NCT00358826|7206370|FG001|STARTED|MDCT Substudy||0
6303166|NCT00358826|7206371|FG002|STARTED|MDCT Substudy||0
6303167|NCT00358826|7206372|FG003|STARTED|MDCT Substudy||0
6303168|NCT00358826|7206373|FG004|STARTED|MDCT Substudy||25
6303169|NCT00358826|7206374|FG005|STARTED|MDCT Substudy||22
6303170|NCT00358826|7206375|FG006|STARTED|MDCT Substudy||19
6303171|NCT00358826|7206376|FG007|STARTED|MDCT Substudy||27
6303172|NCT00358826|7206369|FG000|COMPLETED|MDCT Substudy||0
6303173|NCT00358826|7206370|FG001|COMPLETED|MDCT Substudy||0
6303174|NCT00358826|7206371|FG002|COMPLETED|MDCT Substudy||0
6303175|NCT00358826|7206372|FG003|COMPLETED|MDCT Substudy||0
6303176|NCT00358826|7206373|FG004|COMPLETED|MDCT Substudy||24
6303177|NCT00358826|7206374|FG005|COMPLETED|MDCT Substudy||20
6303178|NCT00358826|7206375|FG006|COMPLETED|MDCT Substudy||19
6303179|NCT00358826|7206376|FG007|COMPLETED|MDCT Substudy||27
6303180|NCT00358826|7206369|FG000|NOT COMPLETED|MDCT Substudy||0
6303181|NCT00358826|7206370|FG001|NOT COMPLETED|MDCT Substudy||0
6303182|NCT00358826|7206371|FG002|NOT COMPLETED|MDCT Substudy||0
6303183|NCT00358826|7206372|FG003|NOT COMPLETED|MDCT Substudy||0
6303184|NCT00358826|7206373|FG004|NOT COMPLETED|MDCT Substudy||1
6303185|NCT00358826|7206374|FG005|NOT COMPLETED|MDCT Substudy||2
6303186|NCT00358826|7206375|FG006|NOT COMPLETED|MDCT Substudy||0
6303187|NCT00358826|7206376|FG007|NOT COMPLETED|MDCT Substudy||0
6303188|NCT00358917|7206392|FG000|STARTED|Overall Study||300
6303189|NCT00358917|7206393|FG001|STARTED|Overall Study||299
6303190|NCT00358917|7206392|FG000|COMPLETED|Overall Study||234
6303191|NCT00358917|7206393|FG001|COMPLETED|Overall Study||230
6303192|NCT00358917|7206392|FG000|NOT COMPLETED|Overall Study||66
6303193|NCT00358917|7206393|FG001|NOT COMPLETED|Overall Study||69
6303194|NCT00358956|7206401|FG000|STARTED|Overall Study||19
6303195|NCT00358956|7206401|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
6303196|NCT00358956|7206401|FG000|NOT COMPLETED|Overall Study||8
6303197|NCT00359021|7206407|FG000|STARTED|Overall Study||256
6303198|NCT00359021|7206408|FG001|STARTED|Overall Study||247
6303199|NCT00359021|7206407|FG000|COMPLETED|Overall Study||175
6303200|NCT00359021|7206408|FG001|COMPLETED|Overall Study||195
6303201|NCT00359021|7206407|FG000|NOT COMPLETED|Overall Study||81
6303202|NCT00359021|7206408|FG001|NOT COMPLETED|Overall Study||52
6303203|NCT00359073|7206418|FG000|STARTED|Overall Study||12
6303204|NCT00359073|7206419|FG001|STARTED|Overall Study||13
6635288|NCT02303574|7564187|FG005|COMPLETED|Part 1b (Fed State) - SAD||5
6635289|NCT02303574|7564188|FG006|COMPLETED|Part 1b (Fed State) - SAD||0
6635290|NCT02303574|7564189|FG007|COMPLETED|Part 1b (Fed State) - SAD||0
6635291|NCT02303574|7564190|FG008|COMPLETED|Part 1b (Fed State) - SAD||0
6635292|NCT02303574|7564191|FG009|COMPLETED|Part 1b (Fed State) - SAD||3
6635293|NCT02303574|7564182|FG000|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635294|NCT02303574|7564183|FG001|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635295|NCT02303574|7564184|FG002|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635296|NCT02303574|7564185|FG003|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635297|NCT02303574|7564186|FG004|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635298|NCT02303574|7564187|FG005|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635299|NCT02303574|7564188|FG006|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635300|NCT02303574|7564189|FG007|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635301|NCT02303574|7564190|FG008|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6303205|NCT00359073|7206418|FG000|COMPLETED|Overall Study||8
6303206|NCT00359073|7206419|FG001|COMPLETED|Overall Study||11
6303207|NCT00359073|7206418|FG000|NOT COMPLETED|Overall Study||4
6303208|NCT00359073|7206419|FG001|NOT COMPLETED|Overall Study||2
6303209|NCT00359203|7206429|FG000|STARTED|Overall Study||39
6303210|NCT00359203|7206430|FG001|STARTED|Overall Study||38
6303211|NCT00359203|7206429|FG000|COMPLETED|Overall Study||39
6303212|NCT00359203|7206430|FG001|COMPLETED|Overall Study||38
6303213|NCT00359203|7206429|FG000|NOT COMPLETED|Overall Study||0
6303214|NCT00359203|7206430|FG001|NOT COMPLETED|Overall Study||0
6303215|NCT00359281|7206445|FG000|STARTED|Overall Study||16
6303216|NCT00359281|7206446|FG001|STARTED|Overall Study||15
6303217|NCT00359281|7206447|FG002|STARTED|Overall Study||10
6303218|NCT00359281|7206448|FG003|STARTED|Overall Study||10
6303219|NCT00359281|7206449|FG004|STARTED|Overall Study||10
6303220|NCT00359281|7206450|FG005|STARTED|Overall Study||15
6303221|NCT00359281|7206451|FG006|STARTED|Overall Study||18
6303222|NCT00359281|7206452|FG007|STARTED|Overall Study||15
6303223|NCT00359281|7206453|FG008|STARTED|Overall Study||20
6303224|NCT00359281|7206445|FG000|COMPLETED|Overall Study||15
6303225|NCT00359281|7206446|FG001|COMPLETED|Overall Study||15
6303226|NCT00359281|7206447|FG002|COMPLETED|Overall Study||10
6303227|NCT00359281|7206448|FG003|COMPLETED|Overall Study||10
6303228|NCT00359281|7206449|FG004|COMPLETED|Overall Study||10
6303229|NCT00359281|7206450|FG005|COMPLETED|Overall Study||15
6303230|NCT00359281|7206451|FG006|COMPLETED|Overall Study||16
6303231|NCT00359281|7206452|FG007|COMPLETED|Overall Study||15
6303232|NCT00359281|7206453|FG008|COMPLETED|Overall Study||20
6303233|NCT00359281|7206445|FG000|NOT COMPLETED|Overall Study||1
6303234|NCT00359281|7206446|FG001|NOT COMPLETED|Overall Study||0
6303235|NCT00359281|7206447|FG002|NOT COMPLETED|Overall Study||0
6303236|NCT00359281|7206448|FG003|NOT COMPLETED|Overall Study||0
6635302|NCT02303574|7564191|FG009|NOT COMPLETED|Part 1b (Fed State) - SAD||0
6635303|NCT02303574|7564182|FG000|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6635304|NCT02303574|7564183|FG001|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6303237|NCT00359281|7206449|FG004|NOT COMPLETED|Overall Study||0
6303238|NCT00359281|7206450|FG005|NOT COMPLETED|Overall Study||0
6303239|NCT00359281|7206451|FG006|NOT COMPLETED|Overall Study||2
6303240|NCT00359281|7206452|FG007|NOT COMPLETED|Overall Study||0
6303241|NCT00359281|7206453|FG008|NOT COMPLETED|Overall Study||0
6303242|NCT00359294|7206485|FG000|STARTED|Overall Study||1
6303243|NCT00359294|7206486|FG001|STARTED|Overall Study||1
6303244|NCT00359294|7206487|FG002|STARTED|Overall Study||3
6303245|NCT00359294|7206488|FG003|STARTED|Overall Study||4
6303246|NCT00359294|7206489|FG004|STARTED|Overall Study||3
6303247|NCT00359294|7206485|FG000|COMPLETED|Overall Study||0
6303248|NCT00359294|7206486|FG001|COMPLETED|Overall Study||0
6303249|NCT00359294|7206487|FG002|COMPLETED|Overall Study||0
6303250|NCT00359294|7206488|FG003|COMPLETED|Overall Study||0
6303251|NCT00359294|7206489|FG004|COMPLETED|Overall Study||0
6303252|NCT00359294|7206485|FG000|NOT COMPLETED|Overall Study||1
6303253|NCT00359294|7206486|FG001|NOT COMPLETED|Overall Study||1
6303254|NCT00359294|7206487|FG002|NOT COMPLETED|Overall Study||3
6303255|NCT00359294|7206488|FG003|NOT COMPLETED|Overall Study||4
6303256|NCT00359294|7206489|FG004|NOT COMPLETED|Overall Study||3
6303257|NCT00359424|7206499|FG000|STARTED|Overall Study||434
6303258|NCT00359424|7206500|FG001|STARTED|Overall Study||222
6303259|NCT00359424|7206499|FG000|90 Day Follow up|Overall Study||343
6303260|NCT00359424|7206500|FG001|90 Day Follow up|Overall Study||172
6303261|NCT00359424|7206499|FG000|180 Day Follow up|Overall Study||325
6303262|NCT00359424|7206500|FG001|180 Day Follow up|Overall Study||167
6303263|NCT00359424|7206499|FG000|270 Day Follow up|Overall Study||313
6303264|NCT00359424|7206500|FG001|270 Day Follow up|Overall Study||159
6303265|NCT00359424|7206499|FG000|COMPLETED|Overall Study||304
6303266|NCT00359424|7206500|FG001|COMPLETED|Overall Study||155
6303267|NCT00359424|7206499|FG000|NOT COMPLETED|Overall Study||130
6303268|NCT00359424|7206500|FG001|NOT COMPLETED|Overall Study||67
6303269|NCT00359619|7206513|FG000|STARTED|Overall Study||88
6303270|NCT00359619|7206514|FG001|STARTED|Overall Study||50
6303271|NCT00359619|7206515|FG002|STARTED|Overall Study||49
6303272|NCT00359619|7206516|FG003|STARTED|Overall Study||48
6303273|NCT00359619|7206517|FG004|STARTED|Overall Study||48
6303274|NCT00359619|7206518|FG005|STARTED|Overall Study||50
6303275|NCT00359619|7206519|FG006|STARTED|Overall Study||50
6303276|NCT00359619|7206513|FG000|COMPLETED|Overall Study||80
6303277|NCT00359619|7206514|FG001|COMPLETED|Overall Study||45
6303278|NCT00359619|7206515|FG002|COMPLETED|Overall Study||42
6303279|NCT00359619|7206516|FG003|COMPLETED|Overall Study||45
6303280|NCT00359619|7206517|FG004|COMPLETED|Overall Study||45
6303281|NCT00359619|7206518|FG005|COMPLETED|Overall Study||45
6303282|NCT00359619|7206519|FG006|COMPLETED|Overall Study||46
6303283|NCT00359619|7206513|FG000|NOT COMPLETED|Overall Study||8
6303284|NCT00359619|7206514|FG001|NOT COMPLETED|Overall Study||5
6303285|NCT00359619|7206515|FG002|NOT COMPLETED|Overall Study||7
6303286|NCT00359619|7206516|FG003|NOT COMPLETED|Overall Study||3
6303287|NCT00359619|7206517|FG004|NOT COMPLETED|Overall Study||3
6303288|NCT00359619|7206518|FG005|NOT COMPLETED|Overall Study||5
6303289|NCT00359619|7206519|FG006|NOT COMPLETED|Overall Study||4
6303290|NCT00359632|7206537|FG000|STARTED|Overall Study||24
6303291|NCT00359632|7206538|FG001|STARTED|Overall Study||9
6303292|NCT00359632|7206537|FG000|COMPLETED|Overall Study||20
6303293|NCT00359632|7206538|FG001|COMPLETED|Overall Study||9
6303294|NCT00359632|7206537|FG000|NOT COMPLETED|Overall Study||4
6303295|NCT00359632|7206538|FG001|NOT COMPLETED|Overall Study||0
6303296|NCT00359736|7206546|FG000|STARTED|Overall Study||14
6303297|NCT00359736|7206547|FG001|STARTED|Overall Study||15
6303298|NCT00359736|7206546|FG000|COMPLETED|Overall Study||14
6303299|NCT00359736|7206547|FG001|COMPLETED|Overall Study||15
6303300|NCT00359736|7206546|FG000|NOT COMPLETED|Overall Study||0
6303301|NCT00359736|7206547|FG001|NOT COMPLETED|Overall Study||0
6303302|NCT00359762|7206557|FG000|STARTED|Period II||514
6303303|NCT00359762|7206558|FG001|STARTED|Period II||0
6303304|NCT00359762|7206559|FG002|STARTED|Period II||0
6303305|NCT00359762|7206560|FG003|STARTED|Period II||0
6303306|NCT00359762|7206561|FG004|STARTED|Period II||515
6303307|NCT00359762|7206557|FG000|Intent to Treat (ITT) Safety Population|Period II||508
6303308|NCT00359762|7206558|FG001|Intent to Treat (ITT) Safety Population|Period II||0
6303309|NCT00359762|7206559|FG002|Intent to Treat (ITT) Safety Population|Period II||0
6303310|NCT00359762|7206560|FG003|Intent to Treat (ITT) Safety Population|Period II||0
6303311|NCT00359762|7206561|FG004|Intent to Treat (ITT) Safety Population|Period II||511
6303312|NCT00359762|7206557|FG000|ITT Efficacy Population|Period II||487
6303313|NCT00359762|7206558|FG001|ITT Efficacy Population|Period II||0
6303314|NCT00359762|7206559|FG002|ITT Efficacy Population|Period II||0
6303315|NCT00359762|7206560|FG003|ITT Efficacy Population|Period II||0
6303316|NCT00359762|7206561|FG004|ITT Efficacy Population|Period II||490
6303317|NCT00359762|7206557|FG000|Met Primary Endpoint|Period II||262
6303318|NCT00359762|7206558|FG001|Met Primary Endpoint|Period II||0
6303319|NCT00359762|7206559|FG002|Met Primary Endpoint|Period II||0
6303320|NCT00359762|7206560|FG003|Met Primary Endpoint|Period II||0
6303321|NCT00359762|7206561|FG004|Met Primary Endpoint|Period II||203
6303322|NCT00359762|7206557|FG000|Without Treatment Failure|Period II||124
6303323|NCT00359762|7206558|FG001|Without Treatment Failure|Period II||0
6303324|NCT00359762|7206559|FG002|Without Treatment Failure|Period II||0
6303325|NCT00359762|7206560|FG003|Without Treatment Failure|Period II||0
6303326|NCT00359762|7206561|FG004|Without Treatment Failure|Period II||138
6303327|NCT00359762|7206557|FG000|COMPLETED|Period II||386
6303328|NCT00359762|7206558|FG001|COMPLETED|Period II||0
6303329|NCT00359762|7206559|FG002|COMPLETED|Period II||0
6303330|NCT00359762|7206560|FG003|COMPLETED|Period II||0
6303331|NCT00359762|7206561|FG004|COMPLETED|Period II||341
6303332|NCT00359762|7206557|FG000|NOT COMPLETED|Period II||128
6303333|NCT00359762|7206558|FG001|NOT COMPLETED|Period II||0
6303334|NCT00359762|7206559|FG002|NOT COMPLETED|Period II||0
6303335|NCT00359762|7206560|FG003|NOT COMPLETED|Period II||0
6303336|NCT00359762|7206561|FG004|NOT COMPLETED|Period II||174
6303337|NCT00359762|7206557|FG000|STARTED|Period III||0
6303338|NCT00359762|7206558|FG001|STARTED|Period III||77
6303339|NCT00359762|7206559|FG002|STARTED|Period III||77
6303340|NCT00359762|7206560|FG003|STARTED|Period III||166
6303341|NCT00359762|7206561|FG004|STARTED|Period III||0
6303342|NCT00359762|7206557|FG000|Extension ITT Safety Population|Period III||0
6303343|NCT00359762|7206558|FG001|Extension ITT Safety Population|Period III||74
6303344|NCT00359762|7206559|FG002|Extension ITT Safety Population|Period III||76
6303345|NCT00359762|7206560|FG003|Extension ITT Safety Population|Period III||166
6303346|NCT00359762|7206561|FG004|Extension ITT Safety Population|Period III||0
6303347|NCT00359762|7206557|FG000|Extension ITT Efficacy Population|Period III||0
6303348|NCT00359762|7206558|FG001|Extension ITT Efficacy Population|Period III||73
6303349|NCT00359762|7206559|FG002|Extension ITT Efficacy Population|Period III||75
6303350|NCT00359762|7206560|FG003|Extension ITT Efficacy Population|Period III||164
6303351|NCT00359762|7206561|FG004|Extension ITT Efficacy Population|Period III||0
6401509|NCT00892957|7314426|FG001|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
6401510|NCT00892957|7314425|FG000|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
6401511|NCT00892957|7314426|FG001|STARTED|Postoperative Day 14 Assessment||66
6401512|NCT00892957|7314425|FG000|COMPLETED|Postoperative Day 14 Assessment||68
6401513|NCT00892957|7314426|FG001|COMPLETED|Postoperative Day 14 Assessment||66
6401514|NCT00892957|7314425|FG000|NOT COMPLETED|Postoperative Day 14 Assessment||0
6401515|NCT00892957|7314426|FG001|NOT COMPLETED|Postoperative Day 14 Assessment||0
6401516|NCT00892957|7314425|FG000|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
6401517|NCT00892957|7314426|FG001|STARTED|Postoperative Day 30 Assessment||66
6401518|NCT00892957|7314425|FG000|COMPLETED|Postoperative Day 30 Assessment||70
6401519|NCT00892957|7314426|FG001|COMPLETED|Postoperative Day 30 Assessment||66
6401520|NCT00892957|7314425|FG000|NOT COMPLETED|Postoperative Day 30 Assessment||0
6401521|NCT00892957|7314426|FG001|NOT COMPLETED|Postoperative Day 30 Assessment||0
6401522|NCT00893074|7314446|FG000|STARTED|Overall Study||24
6401523|NCT00893074|7314446|FG000|COMPLETED|Overall Study||13
6401524|NCT00893074|7314446|FG000|NOT COMPLETED|Overall Study||11
6401525|NCT00893113|7314463|FG000|STARTED|Overall Study||36
6401526|NCT00893113|7314464|FG001|STARTED|Overall Study||38
6401527|NCT00893113|7314463|FG000|COMPLETED|Overall Study||23
6401528|NCT00893113|7314464|FG001|COMPLETED|Overall Study||22
6401529|NCT00893113|7314463|FG000|NOT COMPLETED|Overall Study||13
6401530|NCT00893113|7314464|FG001|NOT COMPLETED|Overall Study||16
6401531|NCT00893152|7314472|FG000|STARTED|Overall Study||47
6401532|NCT00893152|7314473|FG001|STARTED|Overall Study||36
6401533|NCT00893152|7314472|FG000|COMPLETED|Overall Study||47
6401534|NCT00893152|7314473|FG001|COMPLETED|Overall Study||36
6401535|NCT00893152|7314472|FG000|NOT COMPLETED|Overall Study||0
6401536|NCT00893152|7314473|FG001|NOT COMPLETED|Overall Study||0
6401537|NCT00893464|7314487|FG000|STARTED|Overall Study||1
6401538|NCT00893464|7314488|FG001|STARTED|Overall Study||1
6401539|NCT00893464|7314489|FG002|STARTED|Overall Study||1
6401540|NCT00893464|7314490|FG003|STARTED|Overall Study||1
6401541|NCT00893464|7314491|FG004|STARTED|Overall Study||4
6401542|NCT00893464|7314492|FG005|STARTED|Overall Study||7
6401543|NCT00893464|7314493|FG006|STARTED|Overall Study||10
6401544|NCT00893464|7314494|FG007|STARTED|Overall Study||5
6401545|NCT00893464|7314487|FG000|COMPLETED|Overall Study||1
6401546|NCT00893464|7314488|FG001|COMPLETED|Overall Study||1
6401547|NCT00893464|7314489|FG002|COMPLETED|Overall Study||1
6401548|NCT00893464|7314490|FG003|COMPLETED|Overall Study||1
6401549|NCT00893464|7314491|FG004|COMPLETED|Overall Study||4
6401550|NCT00893464|7314492|FG005|COMPLETED|Overall Study||7
6401551|NCT00893464|7314493|FG006|COMPLETED|Overall Study||8
6401552|NCT00893464|7314494|FG007|COMPLETED|Overall Study||3
6401553|NCT00893464|7314487|FG000|NOT COMPLETED|Overall Study||0
6401554|NCT00893464|7314488|FG001|NOT COMPLETED|Overall Study||0
6401555|NCT00893464|7314489|FG002|NOT COMPLETED|Overall Study||0
6401556|NCT00893464|7314490|FG003|NOT COMPLETED|Overall Study||0
6401557|NCT00893464|7314491|FG004|NOT COMPLETED|Overall Study||0
6401558|NCT00893464|7314492|FG005|NOT COMPLETED|Overall Study||0
6401559|NCT00893464|7314493|FG006|NOT COMPLETED|Overall Study||2
6401560|NCT00893464|7314494|FG007|NOT COMPLETED|Overall Study||2
6401561|NCT00893737|7314517|FG000|STARTED|Overall Study||147
6401562|NCT00893737|7314517|FG000|COMPLETED|Overall Study||135
6401563|NCT00893737|7314517|FG000|NOT COMPLETED|Overall Study||12
6401564|NCT00893763|7314523|FG000|STARTED|Overall Study||157
6401565|NCT00893763|7314524|FG001|STARTED|Overall Study||157
6401566|NCT00893763|7314523|FG000|COMPLETED|Overall Study||47
6401567|NCT00893763|7314524|FG001|COMPLETED|Overall Study||47
6401568|NCT00893763|7314523|FG000|NOT COMPLETED|Overall Study||110
6401569|NCT00893763|7314524|FG001|NOT COMPLETED|Overall Study||110
6401570|NCT00893971|7314532|FG000|STARTED|Overall Study||16
6401571|NCT00893971|7314532|FG000|Placebo + GP MDI (PT001)|Overall Study||15
6401572|NCT00893971|7314532|FG000|Placebo + GFF MDI (PT003)|Overall Study||15
6401573|NCT00893971|7314532|FG000|Placebo + FF MDI (PT005)|Overall Study||13
6401574|NCT00893971|7314532|FG000|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
6401575|NCT00893971|7314532|FG000|COMPLETED|Overall Study||13
6401576|NCT00893971|7314532|FG000|NOT COMPLETED|Overall Study||3
6401577|NCT00893984|7314545|FG000|STARTED|Overall Study||6
6401578|NCT00893984|7314545|FG000|COMPLETED|Overall Study||0
6401579|NCT00893984|7314545|FG000|NOT COMPLETED|Overall Study||6
6401580|NCT00893997|7314549|FG000|STARTED|Overall Study||10
6401581|NCT00893997|7314549|FG000|COMPLETED|Overall Study||10
6303352|NCT00359762|7206557|FG000|COMPLETED|Period III||0
6303353|NCT00359762|7206558|FG001|COMPLETED|Period III||48
6303354|NCT00359762|7206559|FG002|COMPLETED|Period III||47
6303355|NCT00359762|7206560|FG003|COMPLETED|Period III||101
6303356|NCT00359762|7206561|FG004|COMPLETED|Period III||0
6303357|NCT00359762|7206557|FG000|NOT COMPLETED|Period III||0
6303358|NCT00359762|7206558|FG001|NOT COMPLETED|Period III||29
6303359|NCT00359762|7206559|FG002|NOT COMPLETED|Period III||30
6303360|NCT00359762|7206560|FG003|NOT COMPLETED|Period III||65
6303361|NCT00359762|7206561|FG004|NOT COMPLETED|Period III||0
6303362|NCT00359762|7206557|FG000|STARTED|Period I||0
6303363|NCT00359762|7206558|FG001|STARTED|Period I||0
6303364|NCT00359762|7206559|FG002|STARTED|Period I||0
6303365|NCT00359762|7206560|FG003|STARTED|Period I||0
6303366|NCT00359762|7206561|FG004|STARTED|Period I||0
6303367|NCT00359762|7206557|FG000|COMPLETED|Period I||0
6303368|NCT00359762|7206558|FG001|COMPLETED|Period I||0
6303369|NCT00359762|7206559|FG002|COMPLETED|Period I||0
6303370|NCT00359762|7206560|FG003|COMPLETED|Period I||0
6303371|NCT00359762|7206561|FG004|COMPLETED|Period I||0
6303372|NCT00359762|7206557|FG000|NOT COMPLETED|Period I||0
6303373|NCT00359762|7206558|FG001|NOT COMPLETED|Period I||0
6303374|NCT00359762|7206559|FG002|NOT COMPLETED|Period I||0
6303375|NCT00359762|7206560|FG003|NOT COMPLETED|Period I||0
6303376|NCT00359762|7206561|FG004|NOT COMPLETED|Period I||0
6303377|NCT00359788|7206577|FG000|STARTED|Overall Study||173
6303378|NCT00359788|7206578|FG001|STARTED|Overall Study||176
6303379|NCT00359788|7206577|FG000|COMPLETED|Overall Study||150
6303380|NCT00359788|7206578|FG001|COMPLETED|Overall Study||159
6303381|NCT00359788|7206577|FG000|NOT COMPLETED|Overall Study||23
6303382|NCT00359788|7206578|FG001|NOT COMPLETED|Overall Study||17
6303383|NCT00359801|7206586|FG000|STARTED|Overall Study||987
6303384|NCT00359801|7206587|FG001|STARTED|Overall Study||989
6303385|NCT00359801|7206586|FG000|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
6303386|NCT00359801|7206587|FG001|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
6303387|NCT00359801|7206586|FG000|NOT COMPLETED|Overall Study||305
6303388|NCT00359801|7206587|FG001|NOT COMPLETED|Overall Study||220
6303389|NCT00359944|7206596|FG000|STARTED|Overall Study||50
6303390|NCT00359944|7206597|FG001|STARTED|Overall Study||47
6303391|NCT00359944|7206598|FG002|STARTED|Overall Study||57
6303392|NCT00359944|7206596|FG000|COMPLETED|Overall Study||34
6303393|NCT00359944|7206597|FG001|COMPLETED|Overall Study||28
6303394|NCT00359944|7206598|FG002|COMPLETED|Overall Study||38
6303395|NCT00359944|7206596|FG000|NOT COMPLETED|Overall Study||16
6303396|NCT00359944|7206597|FG001|NOT COMPLETED|Overall Study||19
6303397|NCT00359944|7206598|FG002|NOT COMPLETED|Overall Study||19
6303398|NCT00359983|7206609|FG000|STARTED|Year 1 Persistence Follow-up||138
6303399|NCT00359983|7206610|FG001|STARTED|Year 1 Persistence Follow-up||70
6303400|NCT00359983|7206611|FG002|STARTED|Year 1 Persistence Follow-up||62
6303401|NCT00359983|7206609|FG000|COMPLETED|Year 1 Persistence Follow-up||138
6303402|NCT00359983|7206610|FG001|COMPLETED|Year 1 Persistence Follow-up||70
6303403|NCT00359983|7206611|FG002|COMPLETED|Year 1 Persistence Follow-up||62
6303404|NCT00359983|7206609|FG000|NOT COMPLETED|Year 1 Persistence Follow-up||0
6303405|NCT00359983|7206610|FG001|NOT COMPLETED|Year 1 Persistence Follow-up||0
6303406|NCT00359983|7206611|FG002|NOT COMPLETED|Year 1 Persistence Follow-up||0
6303407|NCT00359983|7206609|FG000|STARTED|Year 3 Persistence Follow-up||103
6303408|NCT00359983|7206610|FG001|STARTED|Year 3 Persistence Follow-up||47
6303409|NCT00359983|7206611|FG002|STARTED|Year 3 Persistence Follow-up||51
6303410|NCT00359983|7206609|FG000|COMPLETED|Year 3 Persistence Follow-up||103
6303411|NCT00359983|7206610|FG001|COMPLETED|Year 3 Persistence Follow-up||47
6303412|NCT00359983|7206611|FG002|COMPLETED|Year 3 Persistence Follow-up||51
6303413|NCT00359983|7206609|FG000|NOT COMPLETED|Year 3 Persistence Follow-up||0
6303414|NCT00359983|7206610|FG001|NOT COMPLETED|Year 3 Persistence Follow-up||0
6303415|NCT00359983|7206611|FG002|NOT COMPLETED|Year 3 Persistence Follow-up||0
6303416|NCT00359983|7206609|FG000|STARTED|Year 5 Persistence Follow-up||95
6303417|NCT00359983|7206610|FG001|STARTED|Year 5 Persistence Follow-up||44
6303418|NCT00359983|7206611|FG002|STARTED|Year 5 Persistence Follow-up||42
6303419|NCT00359983|7206609|FG000|COMPLETED|Year 5 Persistence Follow-up||95
6303420|NCT00359983|7206610|FG001|COMPLETED|Year 5 Persistence Follow-up||44
6303421|NCT00359983|7206611|FG002|COMPLETED|Year 5 Persistence Follow-up||42
6303422|NCT00359983|7206609|FG000|NOT COMPLETED|Year 5 Persistence Follow-up||0
6303423|NCT00359983|7206610|FG001|NOT COMPLETED|Year 5 Persistence Follow-up||0
6303424|NCT00359983|7206611|FG002|NOT COMPLETED|Year 5 Persistence Follow-up||0
6303425|NCT00360009|7206622|FG000|STARTED|Overall Study||10
6303426|NCT00360009|7206623|FG001|STARTED|Overall Study||26
6303427|NCT00360009|7206624|FG002|STARTED|Overall Study||26
6303428|NCT00360009|7206622|FG000|COMPLETED|Overall Study||10
6303429|NCT00360009|7206623|FG001|COMPLETED|Overall Study||22
6303430|NCT00360009|7206624|FG002|COMPLETED|Overall Study||23
6303431|NCT00360009|7206622|FG000|NOT COMPLETED|Overall Study||0
6303432|NCT00360009|7206623|FG001|NOT COMPLETED|Overall Study||4
6303433|NCT00360009|7206624|FG002|NOT COMPLETED|Overall Study||3
6303434|NCT00360126|7206632|FG000|STARTED|Overall Study||11
6303435|NCT00360126|7206632|FG000|COMPLETED|Overall Study||11
6303436|NCT00360126|7206632|FG000|NOT COMPLETED|Overall Study||0
6303437|NCT00360230|7206643|FG000|STARTED|Overall Study||90
6303438|NCT00360230|7206644|FG001|STARTED|Overall Study||90
6303439|NCT00360230|7206645|FG002|STARTED|Overall Study||45
6303440|NCT00360230|7206646|FG003|STARTED|Overall Study||90
6303441|NCT00360230|7206647|FG004|STARTED|Overall Study||90
6303442|NCT00360230|7206648|FG005|STARTED|Overall Study||90
6303443|NCT00360230|7206649|FG006|STARTED|Overall Study||45
6303444|NCT00360230|7206643|FG000|COMPLETED|Overall Study||84
6303445|NCT00360230|7206644|FG001|COMPLETED|Overall Study||87
6303446|NCT00360230|7206645|FG002|COMPLETED|Overall Study||42
6303447|NCT00360230|7206646|FG003|COMPLETED|Overall Study||88
6303448|NCT00360230|7206647|FG004|COMPLETED|Overall Study||85
6303449|NCT00360230|7206648|FG005|COMPLETED|Overall Study||86
6303450|NCT00360230|7206649|FG006|COMPLETED|Overall Study||43
6303451|NCT00360230|7206643|FG000|NOT COMPLETED|Overall Study||6
6303452|NCT00360230|7206644|FG001|NOT COMPLETED|Overall Study||3
6303453|NCT00360230|7206645|FG002|NOT COMPLETED|Overall Study||3
6303454|NCT00360230|7206646|FG003|NOT COMPLETED|Overall Study||2
6303455|NCT00360230|7206647|FG004|NOT COMPLETED|Overall Study||5
6303456|NCT00360230|7206648|FG005|NOT COMPLETED|Overall Study||4
6303457|NCT00360230|7206649|FG006|NOT COMPLETED|Overall Study||2
6303458|NCT00360243|7206671|FG000|STARTED|Overall Study||337
6303459|NCT00360243|7206672|FG001|STARTED|Overall Study||363
6303460|NCT00360243|7206673|FG002|STARTED|Overall Study||336
6303461|NCT00360243|7206674|FG003|STARTED|Overall Study||349
6303462|NCT00360243|7206671|FG000|COMPLETED|Overall Study||235
6303463|NCT00360243|7206672|FG001|COMPLETED|Overall Study||243
6303464|NCT00360243|7206673|FG002|COMPLETED|Overall Study||180
6303465|NCT00360243|7206674|FG003|COMPLETED|Overall Study||224
6303466|NCT00360243|7206671|FG000|NOT COMPLETED|Overall Study||102
6303467|NCT00360243|7206672|FG001|NOT COMPLETED|Overall Study||120
6303468|NCT00360243|7206673|FG002|NOT COMPLETED|Overall Study||156
6303469|NCT00360243|7206674|FG003|NOT COMPLETED|Overall Study||125
6303470|NCT00360269|7206686|FG000|STARTED|Overall Study||19
6303471|NCT00360269|7206687|FG001|STARTED|Overall Study||19
6303472|NCT00360269|7206686|FG000|COMPLETED|Overall Study||9
6303473|NCT00360269|7206687|FG001|COMPLETED|Overall Study||7
6303474|NCT00360269|7206686|FG000|NOT COMPLETED|Overall Study||10
6303475|NCT00360269|7206687|FG001|NOT COMPLETED|Overall Study||12
6303476|NCT00360282|7206693|FG000|STARTED|First Intervention||6
6303477|NCT00360282|7206694|FG001|STARTED|First Intervention||8
6303478|NCT00360282|7206695|FG002|STARTED|First Intervention||7
6303479|NCT00360282|7206696|FG003|STARTED|First Intervention||6
6303480|NCT00360282|7206693|FG000|COMPLETED|First Intervention||6
6303481|NCT00360282|7206694|FG001|COMPLETED|First Intervention||8
6303482|NCT00360282|7206695|FG002|COMPLETED|First Intervention||7
6303483|NCT00360282|7206696|FG003|COMPLETED|First Intervention||6
6303484|NCT00360282|7206693|FG000|NOT COMPLETED|First Intervention||0
6303485|NCT00360282|7206694|FG001|NOT COMPLETED|First Intervention||0
6303486|NCT00360282|7206695|FG002|NOT COMPLETED|First Intervention||0
6303487|NCT00360282|7206696|FG003|NOT COMPLETED|First Intervention||0
6303488|NCT00360282|7206693|FG000|STARTED|Washout 1-3 Weeks||6
6303489|NCT00360282|7206694|FG001|STARTED|Washout 1-3 Weeks||8
6303490|NCT00360282|7206695|FG002|STARTED|Washout 1-3 Weeks||7
6303491|NCT00360282|7206696|FG003|STARTED|Washout 1-3 Weeks||6
6303492|NCT00360282|7206693|FG000|COMPLETED|Washout 1-3 Weeks||6
6303493|NCT00360282|7206694|FG001|COMPLETED|Washout 1-3 Weeks||8
6303494|NCT00360282|7206695|FG002|COMPLETED|Washout 1-3 Weeks||6
6303495|NCT00360282|7206696|FG003|COMPLETED|Washout 1-3 Weeks||6
6303496|NCT00360282|7206693|FG000|NOT COMPLETED|Washout 1-3 Weeks||0
6303497|NCT00360282|7206694|FG001|NOT COMPLETED|Washout 1-3 Weeks||0
6303498|NCT00360282|7206695|FG002|NOT COMPLETED|Washout 1-3 Weeks||1
6303499|NCT00360282|7206696|FG003|NOT COMPLETED|Washout 1-3 Weeks||0
6303500|NCT00360282|7206693|FG000|STARTED|Second Intervention||6
6303501|NCT00360282|7206694|FG001|STARTED|Second Intervention||8
6303502|NCT00360282|7206695|FG002|STARTED|Second Intervention||6
6303503|NCT00360282|7206696|FG003|STARTED|Second Intervention||6
6303504|NCT00360282|7206693|FG000|COMPLETED|Second Intervention||6
6303505|NCT00360282|7206694|FG001|COMPLETED|Second Intervention||7
6303506|NCT00360282|7206695|FG002|COMPLETED|Second Intervention||6
6303507|NCT00360282|7206696|FG003|COMPLETED|Second Intervention||6
6303508|NCT00360282|7206693|FG000|NOT COMPLETED|Second Intervention||0
6303509|NCT00360282|7206694|FG001|NOT COMPLETED|Second Intervention||1
6303510|NCT00360282|7206695|FG002|NOT COMPLETED|Second Intervention||0
6303511|NCT00360282|7206696|FG003|NOT COMPLETED|Second Intervention||0
6303512|NCT00360308|7206707|FG000|STARTED|Overall Study||247
6303513|NCT00360308|7206708|FG001|STARTED|Overall Study||234
6303514|NCT00360308|7206709|FG002|STARTED|Overall Study||242
6303515|NCT00360308|7206707|FG000|COMPLETED|Overall Study||171
6303516|NCT00360308|7206708|FG001|COMPLETED|Overall Study||155
6303517|NCT00360308|7206709|FG002|COMPLETED|Overall Study||154
6303518|NCT00360308|7206707|FG000|NOT COMPLETED|Overall Study||76
6303519|NCT00360308|7206708|FG001|NOT COMPLETED|Overall Study||79
6303520|NCT00360308|7206709|FG002|NOT COMPLETED|Overall Study||88
6303521|NCT00360334|7206723|FG000|STARTED|Overall Study||118
6303522|NCT00360334|7206724|FG001|STARTED|Overall Study||117
6303523|NCT00360334|7206723|FG000|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
6303524|NCT00360334|7206724|FG001|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
6303525|NCT00360334|7206723|FG000|COMPLETED|Overall Study||99
6303526|NCT00360334|7206724|FG001|COMPLETED|Overall Study||104
6303527|NCT00360334|7206723|FG000|NOT COMPLETED|Overall Study||19
6303528|NCT00360334|7206724|FG001|NOT COMPLETED|Overall Study||13
6303529|NCT00360360|7206730|FG000|STARTED|Overall Study||60
6303530|NCT00360360|7206730|FG000|COMPLETED|Overall Study||54
6303531|NCT00360360|7206730|FG000|NOT COMPLETED|Overall Study||6
6303532|NCT00360399|7206737|FG000|STARTED|Overall Study||114
6303533|NCT00360399|7206738|FG001|STARTED|Overall Study||115
6303534|NCT00360399|7206739|FG002|STARTED|Overall Study||115
6303535|NCT00360399|7206737|FG000|Had Post-randomization Assessment|Overall Study||105
6303536|NCT00360399|7206738|FG001|Had Post-randomization Assessment|Overall Study||106
6303537|NCT00360399|7206739|FG002|Had Post-randomization Assessment|Overall Study||105
6303538|NCT00360399|7206737|FG000|COMPLETED|Overall Study||86
6303539|NCT00360399|7206738|FG001|COMPLETED|Overall Study||79
6303540|NCT00360399|7206739|FG002|COMPLETED|Overall Study||69
6303541|NCT00360399|7206737|FG000|NOT COMPLETED|Overall Study||28
6303542|NCT00360399|7206738|FG001|NOT COMPLETED|Overall Study||36
6303543|NCT00360399|7206739|FG002|NOT COMPLETED|Overall Study||46
6303544|NCT00360412|7206749|FG000|STARTED|Overall Study||333
6303545|NCT00360412|7206750|FG001|STARTED|Overall Study||664
6303546|NCT00360412|7206749|FG000|COMPLETED|Overall Study||0
6303547|NCT00360412|7206750|FG001|COMPLETED|Overall Study||2
6303548|NCT00360412|7206749|FG000|NOT COMPLETED|Overall Study||333
6303549|NCT00360412|7206750|FG001|NOT COMPLETED|Overall Study||662
6303550|NCT00360490|7206758|FG000|STARTED|Overall Study||82
6303551|NCT00360490|7206759|FG001|STARTED|Overall Study||83
6303552|NCT00360490|7206758|FG000|COMPLETED|Overall Study||73
6303553|NCT00360490|7206759|FG001|COMPLETED|Overall Study||72
6303554|NCT00360490|7206758|FG000|NOT COMPLETED|Overall Study||9
6303555|NCT00360490|7206759|FG001|NOT COMPLETED|Overall Study||11
6303556|NCT00360529|7206768|FG000|STARTED|Overall Study||295
6303557|NCT00360529|7206769|FG001|STARTED|Overall Study||295
6303558|NCT00360529|7206770|FG002|STARTED|Overall Study||290
6303559|NCT00360529|7206768|FG000|COMPLETED|Overall Study||234
6303560|NCT00360529|7206769|FG001|COMPLETED|Overall Study||230
6303561|NCT00360529|7206770|FG002|COMPLETED|Overall Study||199
6303562|NCT00360529|7206768|FG000|NOT COMPLETED|Overall Study||61
6303563|NCT00360529|7206769|FG001|NOT COMPLETED|Overall Study||65
6303564|NCT00360529|7206770|FG002|NOT COMPLETED|Overall Study||91
6303565|NCT00360555|7206782|FG000|STARTED|Overall Study||396
6303566|NCT00360555|7206783|FG001|STARTED|Overall Study||393
6303567|NCT00360555|7206784|FG002|STARTED|Overall Study||396
6303568|NCT00360555|7206785|FG003|STARTED|Overall Study||399
6303569|NCT00360555|7206782|FG000|COMPLETED|Overall Study||274
6303570|NCT00360555|7206783|FG001|COMPLETED|Overall Study||259
6303571|NCT00360555|7206784|FG002|COMPLETED|Overall Study||251
6303572|NCT00360555|7206785|FG003|COMPLETED|Overall Study||287
6303573|NCT00360555|7206782|FG000|NOT COMPLETED|Overall Study||122
6303574|NCT00360555|7206783|FG001|NOT COMPLETED|Overall Study||134
6303575|NCT00360555|7206784|FG002|NOT COMPLETED|Overall Study||145
6303576|NCT00360555|7206785|FG003|NOT COMPLETED|Overall Study||112
6303577|NCT00360568|7206797|FG000|STARTED|Overall Study||33
6303578|NCT00360568|7206798|FG001|STARTED|Overall Study||29
6303579|NCT00360568|7206797|FG000|COMPLETED|Overall Study||31
6303580|NCT00360568|7206798|FG001|COMPLETED|Overall Study||24
6303581|NCT00360568|7206797|FG000|NOT COMPLETED|Overall Study||2
6303582|NCT00360568|7206798|FG001|NOT COMPLETED|Overall Study||5
6303583|NCT00360672|7206806|FG000|STARTED|Overall Study||27
6303584|NCT00360672|7206806|FG000|COMPLETED|Overall Study||27
6303585|NCT00360672|7206806|FG000|NOT COMPLETED|Overall Study||0
6303586|NCT00360685|7206812|FG000|STARTED|Overall Study||47
6303587|NCT00360685|7206813|FG001|STARTED|Overall Study||42
6303588|NCT00360685|7206812|FG000|COMPLETED|Overall Study||47
6303589|NCT00360685|7206813|FG001|COMPLETED|Overall Study||42
6303590|NCT00360685|7206812|FG000|NOT COMPLETED|Overall Study||0
6303591|NCT00360685|7206813|FG001|NOT COMPLETED|Overall Study||0
6303592|NCT00360698|7206822|FG000|STARTED|Run-In||0
6303593|NCT00360698|7206823|FG001|STARTED|Run-In||135
6303594|NCT00360698|7206822|FG000|COMPLETED|Run-In||0
6303595|NCT00360698|7206823|FG001|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
6303596|NCT00360698|7206822|FG000|NOT COMPLETED|Run-In||0
6303597|NCT00360698|7206823|FG001|NOT COMPLETED|Run-In||10
6303598|NCT00360698|7206822|FG000|STARTED|Treatment Period||49
6303599|NCT00360698|7206823|FG001|STARTED|Treatment Period||57
6303600|NCT00360698|7206822|FG000|COMPLETED|Treatment Period||48
6303601|NCT00360698|7206823|FG001|COMPLETED|Treatment Period||56
6303602|NCT00360698|7206822|FG000|NOT COMPLETED|Treatment Period||1
6303603|NCT00360698|7206823|FG001|NOT COMPLETED|Treatment Period||1
6303604|NCT00360724|7206831|FG000|STARTED|Overall Study||33
6303605|NCT00360724|7206832|FG001|STARTED|Overall Study||32
6303606|NCT00360724|7206831|FG000|COMPLETED|Overall Study||29
6303607|NCT00360724|7206832|FG001|COMPLETED|Overall Study||28
6303608|NCT00360724|7206831|FG000|NOT COMPLETED|Overall Study||4
6303609|NCT00360724|7206832|FG001|NOT COMPLETED|Overall Study||4
6303610|NCT00360828|7206841|FG000|STARTED|Overall Study||10
6303611|NCT00360828|7206841|FG000|COMPLETED|Overall Study||9
6303612|NCT00360828|7206841|FG000|NOT COMPLETED|Overall Study||1
6303613|NCT00360971|7206847|FG000|STARTED|Overall Study||10
6303614|NCT00360971|7206848|FG001|STARTED|Overall Study||11
6303615|NCT00360971|7206847|FG000|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
6303616|NCT00360971|7206848|FG001|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
6303617|NCT00360971|7206847|FG000|NOT COMPLETED|Overall Study||0
6303618|NCT00360971|7206848|FG001|NOT COMPLETED|Overall Study||0
6303619|NCT00361140|7206857|FG000|STARTED|Overall Study||40
6303620|NCT00361140|7206858|FG001|STARTED|Overall Study||29
6303621|NCT00361140|7206859|FG002|STARTED|Overall Study||3
6303622|NCT00361140|7206857|FG000|COMPLETED|Overall Study||40
6303623|NCT00361140|7206858|FG001|COMPLETED|Overall Study||29
6303624|NCT00361140|7206859|FG002|COMPLETED|Overall Study||3
6303625|NCT00361140|7206857|FG000|NOT COMPLETED|Overall Study||0
6303626|NCT00361140|7206858|FG001|NOT COMPLETED|Overall Study||0
6303627|NCT00361140|7206859|FG002|NOT COMPLETED|Overall Study||0
6303628|NCT00361218|7206867|FG000|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
6303629|NCT00361218|7206867|FG000|Completed Baseline Assessment|Overall Study||47
6303630|NCT00361218|7206867|FG000|COMPLETED|Overall Study||30
6303631|NCT00361218|7206867|FG000|NOT COMPLETED|Overall Study||23
6303632|NCT00361231|7206871|FG000|STARTED|Overall Study||35
6303633|NCT00361231|7206871|FG000|COMPLETED|Overall Study||1
6303634|NCT00361231|7206871|FG000|NOT COMPLETED|Overall Study||34
6303635|NCT00361257|7206877|FG000|STARTED|Step 1: Minocycline vs. Placebo||52
6303636|NCT00361257|7206878|FG001|STARTED|Step 1: Minocycline vs. Placebo||55
6303637|NCT00361257|7206877|FG000|COMPLETED|Step 1: Minocycline vs. Placebo||40
6303638|NCT00361257|7206878|FG001|COMPLETED|Step 1: Minocycline vs. Placebo||43
6303639|NCT00361257|7206877|FG000|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
6303640|NCT00361257|7206878|FG001|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
6303641|NCT00361257|7206877|FG000|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
6303642|NCT00361257|7206878|FG001|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
6303643|NCT00361257|7206877|FG000|COMPLETED|Step 2: Minocycline(Open Label) for All||13
6303644|NCT00361257|7206878|FG001|COMPLETED|Step 2: Minocycline(Open Label) for All||19
6303645|NCT00361257|7206877|FG000|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
6303646|NCT00361257|7206878|FG001|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
6374760|NCT00751621|7285291|FG000|NOT COMPLETED|Overall Study||4
6374761|NCT00751634|7285297|FG000|STARTED|Overall Study||20
6374762|NCT00751634|7285297|FG000|COMPLETED|Overall Study||20
6374763|NCT00751634|7285297|FG000|NOT COMPLETED|Overall Study||0
6374764|NCT00751777|7285304|FG000|STARTED|Overall Study||81
6374765|NCT00751777|7285305|FG001|STARTED|Overall Study||39
6374766|NCT00751777|7285304|FG000|COMPLETED|Overall Study|Day 380: study completion for LT group|70
6374767|NCT00751777|7285305|FG001|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
6374768|NCT00751777|7285304|FG000|NOT COMPLETED|Overall Study||11
6374769|NCT00751777|7285305|FG001|NOT COMPLETED|Overall Study||3
6374770|NCT00751790|7285311|FG000|STARTED|Overall Study||120
6374771|NCT00751790|7285311|FG000|COMPLETED|Overall Study||115
6374772|NCT00751790|7285311|FG000|NOT COMPLETED|Overall Study||5
6374773|NCT00751881|7285318|FG000|STARTED|Core Treatment Period|Randomized|389
6374774|NCT00751881|7285319|FG001|STARTED|Core Treatment Period|Randomized|408
6374775|NCT00751881|7285320|FG002|STARTED|Core Treatment Period|Randomized|372
6374776|NCT00751881|7285318|FG000|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
6374777|NCT00751881|7285319|FG001|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
6374778|NCT00751881|7285320|FG002|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
6374779|NCT00751881|7285318|FG000|COMPLETED|Core Treatment Period||263
6374780|NCT00751881|7285319|FG001|COMPLETED|Core Treatment Period||273
6374781|NCT00751881|7285320|FG002|COMPLETED|Core Treatment Period||244
6374782|NCT00751881|7285318|FG000|NOT COMPLETED|Core Treatment Period||126
6374783|NCT00751881|7285319|FG001|NOT COMPLETED|Core Treatment Period||135
6374784|NCT00751881|7285320|FG002|NOT COMPLETED|Core Treatment Period||128
6374785|NCT00751881|7285318|FG000|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
6374786|NCT00751881|7285319|FG001|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
6374787|NCT00751881|7285320|FG002|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
6374788|NCT00751881|7285318|FG000|COMPLETED|Extension Study Period||188
6374789|NCT00751881|7285319|FG001|COMPLETED|Extension Study Period||194
6374790|NCT00751881|7285320|FG002|COMPLETED|Extension Study Period||167
6374791|NCT00751881|7285318|FG000|NOT COMPLETED|Extension Study Period||65
6374792|NCT00751881|7285319|FG001|NOT COMPLETED|Extension Study Period||71
6374793|NCT00751881|7285320|FG002|NOT COMPLETED|Extension Study Period||66
6374794|NCT00751972|7285336|FG000|STARTED|Overall Study||140
6374795|NCT00751972|7285337|FG001|STARTED|Overall Study||499
6374796|NCT00751972|7285336|FG000|COMPLETED|Overall Study||140
6374797|NCT00751972|7285337|FG001|COMPLETED|Overall Study||499
6374798|NCT00751972|7285336|FG000|NOT COMPLETED|Overall Study||0
6374799|NCT00751972|7285337|FG001|NOT COMPLETED|Overall Study||0
6374800|NCT00751998|7285342|FG000|STARTED|Overall Study||297
6374801|NCT00751998|7285342|FG000|COMPLETED|Overall Study||277
6374802|NCT00751998|7285342|FG000|NOT COMPLETED|Overall Study||20
6374803|NCT00752089|7285346|FG000|STARTED|Overall Study||20
6374804|NCT00752089|7285346|FG000|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
6374805|NCT00752089|7285346|FG000|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
6374806|NCT00752089|7285346|FG000|Received NaF|Overall Study||18
6374807|NCT00752089|7285346|FG000|Received Placebo|Overall Study||18
6374808|NCT00752089|7285346|FG000|COMPLETED|Overall Study||14
6374809|NCT00752089|7285346|FG000|NOT COMPLETED|Overall Study||6
6374810|NCT00752102|7285359|FG000|STARTED|Overall Study||22
6374811|NCT00752102|7285360|FG001|STARTED|Overall Study||22
6374812|NCT00752102|7285359|FG000|COMPLETED|Overall Study||19
6374813|NCT00752102|7285360|FG001|COMPLETED|Overall Study||21
6374814|NCT00752102|7285359|FG000|NOT COMPLETED|Overall Study||3
6374815|NCT00752102|7285360|FG001|NOT COMPLETED|Overall Study||1
6374816|NCT00752128|7285366|FG000|STARTED|Overall Study||2349
6374817|NCT00752128|7285366|FG000|COMPLETED|Overall Study||2345
6303647|NCT00361270|7206890|FG000|STARTED|Overall Study||49
6303648|NCT00361270|7206891|FG001|STARTED|Overall Study||39
6303649|NCT00361270|7206892|FG002|STARTED|Overall Study||35
6303650|NCT00361270|7206893|FG003|STARTED|Overall Study||38
6303651|NCT00361270|7206890|FG000|COMPLETED|Overall Study||25
6303652|NCT00361270|7206891|FG001|COMPLETED|Overall Study||25
6303653|NCT00361270|7206892|FG002|COMPLETED|Overall Study||25
6303654|NCT00361270|7206893|FG003|COMPLETED|Overall Study||25
6303655|NCT00361270|7206890|FG000|NOT COMPLETED|Overall Study||24
6303656|NCT00361270|7206891|FG001|NOT COMPLETED|Overall Study||14
6303657|NCT00361270|7206892|FG002|NOT COMPLETED|Overall Study||10
6303658|NCT00361270|7206893|FG003|NOT COMPLETED|Overall Study||13
6303659|NCT00361283|7206910|FG000|STARTED|Overall Study||108
6303660|NCT00361283|7206910|FG000|COMPLETED|Overall Study||81
6303661|NCT00361283|7206910|FG000|NOT COMPLETED|Overall Study||27
6303662|NCT00361296|7206914|FG000|STARTED|Overall Study||5
6303663|NCT00361296|7206914|FG000|COMPLETED|Overall Study||2
6303664|NCT00361296|7206914|FG000|NOT COMPLETED|Overall Study||3
6303665|NCT00361335|7206923|FG000|STARTED|IV Period: Baseline to E0||129
6303666|NCT00361335|7206924|FG001|STARTED|IV Period: Baseline to E0||128
6303667|NCT00361335|7206925|FG002|STARTED|IV Period: Baseline to E0||128
6303668|NCT00361335|7206926|FG003|STARTED|IV Period: Baseline to E0||129
6303669|NCT00361335|7206927|FG004|STARTED|IV Period: Baseline to E0||129
6303670|NCT00361335|7206928|FG005|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
6303671|NCT00361335|7206929|FG006|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
6303672|NCT00361335|7206923|FG000|COMPLETED|IV Period: Baseline to E0||109
6303673|NCT00361335|7206924|FG001|COMPLETED|IV Period: Baseline to E0||99
6303674|NCT00361335|7206925|FG002|COMPLETED|IV Period: Baseline to E0||107
6303675|NCT00361335|7206926|FG003|COMPLETED|IV Period: Baseline to E0||102
6303676|NCT00361335|7206927|FG004|COMPLETED|IV Period: Baseline to E0||105
6303677|NCT00361335|7206928|FG005|COMPLETED|IV Period: Baseline to E0||0
6303678|NCT00361335|7206929|FG006|COMPLETED|IV Period: Baseline to E0||0
6303679|NCT00361335|7206923|FG000|NOT COMPLETED|IV Period: Baseline to E0||20
6303680|NCT00361335|7206924|FG001|NOT COMPLETED|IV Period: Baseline to E0||29
6303681|NCT00361335|7206925|FG002|NOT COMPLETED|IV Period: Baseline to E0||21
6303682|NCT00361335|7206926|FG003|NOT COMPLETED|IV Period: Baseline to E0||27
6303683|NCT00361335|7206927|FG004|NOT COMPLETED|IV Period: Baseline to E0||24
6303684|NCT00361335|7206928|FG005|NOT COMPLETED|IV Period: Baseline to E0||0
6303685|NCT00361335|7206929|FG006|NOT COMPLETED|IV Period: Baseline to E0||0
6303686|NCT00361335|7206923|FG000|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
6303687|NCT00361335|7206924|FG001|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
6303688|NCT00361335|7206925|FG002|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
6303689|NCT00361335|7206926|FG003|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
6303690|NCT00361335|7206927|FG004|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
6303691|NCT00361335|7206928|FG005|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
6303692|NCT00361335|7206929|FG006|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
6303693|NCT00361335|7206923|FG000|COMPLETED|SC Period: Week E0 to Week E24||80
6303694|NCT00361335|7206924|FG001|COMPLETED|SC Period: Week E0 to Week E24||56
6303695|NCT00361335|7206925|FG002|COMPLETED|SC Period: Week E0 to Week E24||99
6303696|NCT00361335|7206926|FG003|COMPLETED|SC Period: Week E0 to Week E24||59
6303697|NCT00361335|7206927|FG004|COMPLETED|SC Period: Week E0 to Week E24||3
6303698|NCT00361335|7206928|FG005|COMPLETED|SC Period: Week E0 to Week E24||23
6303699|NCT00361335|7206929|FG006|COMPLETED|SC Period: Week E0 to Week E24||164
6303700|NCT00361335|7206923|FG000|NOT COMPLETED|SC Period: Week E0 to Week E24||2
6303701|NCT00361335|7206924|FG001|NOT COMPLETED|SC Period: Week E0 to Week E24||3
6303702|NCT00361335|7206925|FG002|NOT COMPLETED|SC Period: Week E0 to Week E24||5
6303703|NCT00361335|7206926|FG003|NOT COMPLETED|SC Period: Week E0 to Week E24||4
6303704|NCT00361335|7206927|FG004|NOT COMPLETED|SC Period: Week E0 to Week E24||0
6303705|NCT00361335|7206928|FG005|NOT COMPLETED|SC Period: Week E0 to Week E24||1
6303706|NCT00361335|7206929|FG006|NOT COMPLETED|SC Period: Week E0 to Week E24||9
6303707|NCT00361374|7206948|FG000|STARTED|Overall Study||66
6303708|NCT00361374|7206949|FG001|STARTED|Overall Study||65
6303709|NCT00361374|7206950|FG002|STARTED|Overall Study||65
6303710|NCT00361374|7206948|FG000|COMPLETED|Overall Study||51
6303711|NCT00361374|7206949|FG001|COMPLETED|Overall Study||50
6303712|NCT00361374|7206950|FG002|COMPLETED|Overall Study||53
6303713|NCT00361374|7206948|FG000|NOT COMPLETED|Overall Study||15
6303714|NCT00361374|7206949|FG001|NOT COMPLETED|Overall Study||15
6303715|NCT00361374|7206950|FG002|NOT COMPLETED|Overall Study||12
6303716|NCT00361439|7206960|FG000|STARTED|Overall Study||8
6303717|NCT00361439|7206961|FG001|STARTED|Overall Study||9
6303718|NCT00361439|7206960|FG000|COMPLETED|Overall Study||8
6635305|NCT02303574|7564184|FG002|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6635306|NCT02303574|7564185|FG003|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6635307|NCT02303574|7564186|FG004|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6635308|NCT02303574|7564187|FG005|STARTED|Part 2 - Multiple Ascending Dose (MAD)||0
6635309|NCT02303574|7564188|FG006|STARTED|Part 2 - Multiple Ascending Dose (MAD)||6
6635310|NCT02303574|7564189|FG007|STARTED|Part 2 - Multiple Ascending Dose (MAD)||8
6635311|NCT02303574|7564190|FG008|STARTED|Part 2 - Multiple Ascending Dose (MAD)||10
6635312|NCT02303574|7564191|FG009|STARTED|Part 2 - Multiple Ascending Dose (MAD)|Participants took AZD7986 matching placebo for 28 days (fasted/fed state, based on part 1b results)|12
6635313|NCT02303574|7564182|FG000|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635314|NCT02303574|7564183|FG001|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6303719|NCT00361439|7206961|FG001|COMPLETED|Overall Study||9
6303720|NCT00361439|7206960|FG000|NOT COMPLETED|Overall Study||0
6303721|NCT00361439|7206961|FG001|NOT COMPLETED|Overall Study||0
6303722|NCT00361504|7206969|FG000|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
6303723|NCT00361504|7206970|FG001|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
6303724|NCT00361504|7206969|FG000|COMPLETED|Overall Study||413
6303725|NCT00361504|7206970|FG001|COMPLETED|Overall Study||78
6303726|NCT00361504|7206969|FG000|NOT COMPLETED|Overall Study||481
6303727|NCT00361504|7206970|FG001|NOT COMPLETED|Overall Study||145
6303728|NCT00361569|7206980|FG000|STARTED|Overall Study||150
6303729|NCT00361569|7206981|FG001|STARTED|Overall Study||161
6303730|NCT00361569|7206982|FG002|STARTED|Overall Study||155
6303731|NCT00361569|7206983|FG003|STARTED|Overall Study||156
6303732|NCT00361569|7206980|FG000|COMPLETED|Overall Study||138
6303733|NCT00361569|7206981|FG001|COMPLETED|Overall Study||150
6303734|NCT00361569|7206982|FG002|COMPLETED|Overall Study||137
6303735|NCT00361569|7206983|FG003|COMPLETED|Overall Study||135
6303736|NCT00361569|7206980|FG000|NOT COMPLETED|Overall Study||12
6303737|NCT00361569|7206981|FG001|NOT COMPLETED|Overall Study||11
6303738|NCT00361569|7206982|FG002|NOT COMPLETED|Overall Study||18
6303739|NCT00361569|7206983|FG003|NOT COMPLETED|Overall Study||21
6303740|NCT00361595|7206993|FG000|STARTED|Overall Study||35
6303741|NCT00361595|7206993|FG000|COMPLETED|Overall Study||35
6303742|NCT00361595|7206993|FG000|NOT COMPLETED|Overall Study||0
6303743|NCT00361634|7206997|FG000|STARTED|Overall Study||14
6303744|NCT00361634|7206997|FG000|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
6303745|NCT00361634|7206997|FG000|COMPLETED|Overall Study||12
6303746|NCT00361634|7206997|FG000|NOT COMPLETED|Overall Study||2
6303747|NCT00361712|7207003|FG000|STARTED|Overall Study||20
6303748|NCT00361712|7207004|FG001|STARTED|Overall Study||21
6303749|NCT00361712|7207003|FG000|COMPLETED|Overall Study||20
6303750|NCT00361712|7207004|FG001|COMPLETED|Overall Study||21
6303751|NCT00361712|7207003|FG000|NOT COMPLETED|Overall Study||0
6303752|NCT00361712|7207004|FG001|NOT COMPLETED|Overall Study||0
6303753|NCT00361842|7207012|FG000|STARTED|Overall Study||28
6303754|NCT00361842|7207013|FG001|STARTED|Overall Study||35
6303755|NCT00361842|7207012|FG000|COMPLETED|Overall Study||1
6303756|NCT00361842|7207013|FG001|COMPLETED|Overall Study||1
6303757|NCT00361842|7207012|FG000|NOT COMPLETED|Overall Study||27
6303758|NCT00361842|7207013|FG001|NOT COMPLETED|Overall Study||34
6303759|NCT00361972|7207023|FG000|STARTED|Overall Study||8
6303760|NCT00361972|7207024|FG001|STARTED|Overall Study||9
6303761|NCT00361972|7207023|FG000|COMPLETED|Overall Study||8
6303762|NCT00361972|7207024|FG001|COMPLETED|Overall Study||9
6303763|NCT00361972|7207023|FG000|NOT COMPLETED|Overall Study||0
6303764|NCT00361972|7207024|FG001|NOT COMPLETED|Overall Study||0
6303765|NCT00362115|7207038|FG000|STARTED|Overall Study||65
6303766|NCT00362115|7207039|FG001|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
6303767|NCT00362115|7207040|FG002|STARTED|Overall Study||64
6303768|NCT00362115|7207041|FG003|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
6303769|NCT00362115|7207042|FG004|STARTED|Overall Study||64
6303770|NCT00362115|7207043|FG005|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
6303771|NCT00362115|7207044|FG006|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
6303772|NCT00362115|7207038|FG000|COMPLETED|Overall Study||63
6303773|NCT00362115|7207039|FG001|COMPLETED|Overall Study||59
6303774|NCT00362115|7207040|FG002|COMPLETED|Overall Study||57
6303775|NCT00362115|7207041|FG003|COMPLETED|Overall Study||59
6303776|NCT00362115|7207042|FG004|COMPLETED|Overall Study||57
6303777|NCT00362115|7207043|FG005|COMPLETED|Overall Study||57
6303778|NCT00362115|7207044|FG006|COMPLETED|Overall Study||52
6303779|NCT00362115|7207038|FG000|NOT COMPLETED|Overall Study||2
6303780|NCT00362115|7207039|FG001|NOT COMPLETED|Overall Study||6
6303781|NCT00362115|7207040|FG002|NOT COMPLETED|Overall Study||7
6303782|NCT00362115|7207041|FG003|NOT COMPLETED|Overall Study||4
6303783|NCT00362115|7207042|FG004|NOT COMPLETED|Overall Study||7
6303784|NCT00362115|7207043|FG005|NOT COMPLETED|Overall Study||7
6303785|NCT00362115|7207044|FG006|NOT COMPLETED|Overall Study||12
6303786|NCT00362128|7207060|FG000|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
6303787|NCT00362128|7207060|FG000|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
6303788|NCT00362128|7207060|FG000|NOT COMPLETED|Overall Study||0
6303789|NCT00362180|7207073|FG000|STARTED|Treated Period||4
6303790|NCT00362180|7207074|FG001|STARTED|Treated Period||2
6303791|NCT00362180|7207075|FG002|STARTED|Treated Period||1
6303792|NCT00362180|7207076|FG003|STARTED|Treated Period||0
6303793|NCT00362180|7207077|FG004|STARTED|Treated Period||11
6303794|NCT00362180|7207078|FG005|STARTED|Treated Period||10
6303795|NCT00362180|7207079|FG006|STARTED|Treated Period||6
6303796|NCT00362180|7207080|FG007|STARTED|Treated Period||3
6303797|NCT00362180|7207081|FG008|STARTED|Treated Period||1
6303798|NCT00362180|7207073|FG000|COMPLETED|Treated Period||3
6303799|NCT00362180|7207074|FG001|COMPLETED|Treated Period||2
6303800|NCT00362180|7207075|FG002|COMPLETED|Treated Period||1
6303801|NCT00362180|7207076|FG003|COMPLETED|Treated Period||0
6303802|NCT00362180|7207077|FG004|COMPLETED|Treated Period||11
6303803|NCT00362180|7207078|FG005|COMPLETED|Treated Period||9
6303804|NCT00362180|7207079|FG006|COMPLETED|Treated Period||6
6303805|NCT00362180|7207080|FG007|COMPLETED|Treated Period||2
6303806|NCT00362180|7207081|FG008|COMPLETED|Treated Period||1
6303807|NCT00362180|7207073|FG000|NOT COMPLETED|Treated Period||1
6303808|NCT00362180|7207074|FG001|NOT COMPLETED|Treated Period||0
6303809|NCT00362180|7207075|FG002|NOT COMPLETED|Treated Period||0
6303810|NCT00362180|7207076|FG003|NOT COMPLETED|Treated Period||0
6303811|NCT00362180|7207077|FG004|NOT COMPLETED|Treated Period||0
6303812|NCT00362180|7207078|FG005|NOT COMPLETED|Treated Period||1
6303813|NCT00362180|7207079|FG006|NOT COMPLETED|Treated Period||0
6303814|NCT00362180|7207080|FG007|NOT COMPLETED|Treated Period||1
6303815|NCT00362180|7207081|FG008|NOT COMPLETED|Treated Period||0
6303816|NCT00362180|7207073|FG000|STARTED|20 Week Safety Follow-up||3
6303817|NCT00362180|7207074|FG001|STARTED|20 Week Safety Follow-up||2
6303818|NCT00362180|7207075|FG002|STARTED|20 Week Safety Follow-up||1
6303819|NCT00362180|7207076|FG003|STARTED|20 Week Safety Follow-up||0
6303820|NCT00362180|7207077|FG004|STARTED|20 Week Safety Follow-up||11
6303821|NCT00362180|7207078|FG005|STARTED|20 Week Safety Follow-up||9
6303822|NCT00362180|7207079|FG006|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
6303823|NCT00362180|7207080|FG007|STARTED|20 Week Safety Follow-up||3
6303824|NCT00362180|7207081|FG008|STARTED|20 Week Safety Follow-up||1
6303825|NCT00362180|7207073|FG000|COMPLETED|20 Week Safety Follow-up||3
6303826|NCT00362180|7207074|FG001|COMPLETED|20 Week Safety Follow-up||2
6303827|NCT00362180|7207075|FG002|COMPLETED|20 Week Safety Follow-up||1
6303828|NCT00362180|7207076|FG003|COMPLETED|20 Week Safety Follow-up||0
6303829|NCT00362180|7207077|FG004|COMPLETED|20 Week Safety Follow-up||11
6303830|NCT00362180|7207078|FG005|COMPLETED|20 Week Safety Follow-up||9
6303831|NCT00362180|7207079|FG006|COMPLETED|20 Week Safety Follow-up||0
6303832|NCT00362180|7207080|FG007|COMPLETED|20 Week Safety Follow-up||3
6303833|NCT00362180|7207081|FG008|COMPLETED|20 Week Safety Follow-up||1
6303834|NCT00362180|7207073|FG000|NOT COMPLETED|20 Week Safety Follow-up||0
6303835|NCT00362180|7207074|FG001|NOT COMPLETED|20 Week Safety Follow-up||0
6303836|NCT00362180|7207075|FG002|NOT COMPLETED|20 Week Safety Follow-up||0
6303837|NCT00362180|7207076|FG003|NOT COMPLETED|20 Week Safety Follow-up||0
6303838|NCT00362180|7207077|FG004|NOT COMPLETED|20 Week Safety Follow-up||0
6303839|NCT00362180|7207078|FG005|NOT COMPLETED|20 Week Safety Follow-up||0
6303840|NCT00362180|7207079|FG006|NOT COMPLETED|20 Week Safety Follow-up||0
6303841|NCT00362180|7207080|FG007|NOT COMPLETED|20 Week Safety Follow-up||0
6303842|NCT00362180|7207081|FG008|NOT COMPLETED|20 Week Safety Follow-up||0
6303843|NCT00362232|7207101|FG000|STARTED|Treatment (12 +/- 2 Days)||1584
6303844|NCT00362232|7207102|FG001|STARTED|Treatment (12 +/- 2 Days)||1564
6303845|NCT00362232|7207101|FG000|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
6303846|NCT00362232|7207102|FG001|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
6303847|NCT00362232|7207101|FG000|COMPLETED|Treatment (12 +/- 2 Days)||1425
6303848|NCT00362232|7207102|FG001|COMPLETED|Treatment (12 +/- 2 Days)||1413
6303849|NCT00362232|7207101|FG000|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
6303850|NCT00362232|7207102|FG001|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
6303851|NCT00362232|7207101|FG000|STARTED|Follow-up (30 (+ 5) Days)||1471
6303852|NCT00362232|7207102|FG001|STARTED|Follow-up (30 (+ 5) Days)||1455
6303853|NCT00362232|7207101|FG000|COMPLETED|Follow-up (30 (+ 5) Days)||1433
6303854|NCT00362232|7207102|FG001|COMPLETED|Follow-up (30 (+ 5) Days)||1416
6303855|NCT00362232|7207101|FG000|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
6303856|NCT00362232|7207102|FG001|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
6303857|NCT00362297|7207110|FG000|STARTED|Treatment 1 (Initial Drug Assignment)||16
6303858|NCT00362297|7207111|FG001|STARTED|Treatment 1 (Initial Drug Assignment)||15
6303859|NCT00362297|7207110|FG000|COMPLETED|Treatment 1 (Initial Drug Assignment)||16
6303860|NCT00362297|7207111|FG001|COMPLETED|Treatment 1 (Initial Drug Assignment)||11
6303861|NCT00362297|7207110|FG000|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||0
6303862|NCT00362297|7207111|FG001|NOT COMPLETED|Treatment 1 (Initial Drug Assignment)||4
6303863|NCT00362297|7207110|FG000|STARTED|Treatment 2||16
6303864|NCT00362297|7207111|FG001|STARTED|Treatment 2||11
6303865|NCT00362297|7207110|FG000|COMPLETED|Treatment 2||16
6303866|NCT00362297|7207111|FG001|COMPLETED|Treatment 2||11
6303867|NCT00362297|7207110|FG000|NOT COMPLETED|Treatment 2||0
6303868|NCT00362297|7207111|FG001|NOT COMPLETED|Treatment 2||0
6303869|NCT00362336|7207120|FG000|STARTED|Overall Study||243
6303870|NCT00362336|7207121|FG001|STARTED|Overall Study||242
6303871|NCT00362336|7207122|FG002|STARTED|Overall Study||137
6303872|NCT00362336|7207120|FG000|COMPLETED|Overall Study||233
6303873|NCT00362336|7207121|FG001|COMPLETED|Overall Study||235
6303874|NCT00362336|7207122|FG002|COMPLETED|Overall Study||134
6303875|NCT00362336|7207120|FG000|NOT COMPLETED|Overall Study||10
6303876|NCT00362336|7207121|FG001|NOT COMPLETED|Overall Study||7
6303877|NCT00362336|7207122|FG002|NOT COMPLETED|Overall Study||3
6303878|NCT00362375|7207139|FG000|STARTED|Overall Study|Number eligible and randomized|161
6303879|NCT00362375|7207140|FG001|STARTED|Overall Study|Number eligible and randomized|152
6303880|NCT00362375|7207139|FG000|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
6374818|NCT00752128|7285366|FG000|NOT COMPLETED|Overall Study||4
6303881|NCT00362375|7207140|FG001|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
6303882|NCT00362375|7207139|FG000|NOT COMPLETED|Overall Study||40
6303883|NCT00362375|7207140|FG001|NOT COMPLETED|Overall Study||35
6303884|NCT00362414|7207146|FG000|STARTED|Overall Study||15
6303885|NCT00362414|7207146|FG000|COMPLETED|Overall Study||12
6303886|NCT00362414|7207146|FG000|NOT COMPLETED|Overall Study||3
6303887|NCT00362440|7207155|FG000|STARTED|Overall Study||5
6303888|NCT00362440|7207156|FG001|STARTED|Overall Study||4
6303889|NCT00362440|7207155|FG000|COMPLETED|Overall Study||3
6303890|NCT00362440|7207156|FG001|COMPLETED|Overall Study||3
6303891|NCT00362440|7207155|FG000|NOT COMPLETED|Overall Study||2
6303892|NCT00362440|7207156|FG001|NOT COMPLETED|Overall Study||1
6303893|NCT00362453|7207164|FG000|STARTED|Overall Study||20
6303894|NCT00362453|7207165|FG001|STARTED|Overall Study||20
6303895|NCT00362453|7207164|FG000|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
6303896|NCT00362453|7207165|FG001|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
6303897|NCT00362453|7207164|FG000|NOT COMPLETED|Overall Study||0
6303898|NCT00362453|7207165|FG001|NOT COMPLETED|Overall Study||0
6303899|NCT00362466|7207173|FG000|STARTED|Overall Study||2
6303900|NCT00362466|7207174|FG001|STARTED|Overall Study||1
6303901|NCT00362466|7207173|FG000|COMPLETED|Overall Study||2
6303902|NCT00362466|7207174|FG001|COMPLETED|Overall Study||1
6303903|NCT00362466|7207173|FG000|NOT COMPLETED|Overall Study||0
6303904|NCT00362466|7207174|FG001|NOT COMPLETED|Overall Study||0
6303905|NCT00362609|7207182|FG000|STARTED|Overall Study||19
6303906|NCT00362609|7207183|FG001|STARTED|Overall Study||40
6303907|NCT00362609|7207182|FG000|COMPLETED|Overall Study||19
6303908|NCT00362609|7207183|FG001|COMPLETED|Overall Study||38
6303909|NCT00362609|7207182|FG000|NOT COMPLETED|Overall Study||0
6303910|NCT00362609|7207183|FG001|NOT COMPLETED|Overall Study||2
6303911|NCT00362648|7207193|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
6303912|NCT00362648|7207194|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
6303913|NCT00362648|7207195|FG002|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
6303914|NCT00362648|7207196|FG003|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
6303915|NCT00362648|7207193|FG000|Vaccinated at Visit 1|Overall Study||2733
6303916|NCT00362648|7207194|FG001|Vaccinated at Visit 1|Overall Study||2735
6303917|NCT00362648|7207195|FG002|Vaccinated at Visit 1|Overall Study||1018
6303918|NCT00362648|7207196|FG003|Vaccinated at Visit 1|Overall Study||1018
6303919|NCT00362648|7207193|FG000|Vaccinated at Visit 2|Overall Study||2657
6303920|NCT00362648|7207194|FG001|Vaccinated at Visit 2|Overall Study||2666
6303921|NCT00362648|7207195|FG002|Vaccinated at Visit 2|Overall Study||1013
6303922|NCT00362648|7207196|FG003|Vaccinated at Visit 2|Overall Study||1009
6303923|NCT00362648|7207193|FG000|Vaccinated at Visit 3|Overall Study||2613
6303924|NCT00362648|7207194|FG001|Vaccinated at Visit 3|Overall Study||2612
6303925|NCT00362648|7207195|FG002|Vaccinated at Visit 3|Overall Study||1009
6303926|NCT00362648|7207196|FG003|Vaccinated at Visit 3|Overall Study||1007
6303927|NCT00362648|7207193|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
6303928|NCT00362648|7207194|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
6303929|NCT00362648|7207195|FG002|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
6303930|NCT00362648|7207196|FG003|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
6303931|NCT00362648|7207193|FG000|NOT COMPLETED|Overall Study||126
6303932|NCT00362648|7207194|FG001|NOT COMPLETED|Overall Study||134
6303933|NCT00362648|7207195|FG002|NOT COMPLETED|Overall Study||9
6303934|NCT00362648|7207196|FG003|NOT COMPLETED|Overall Study||11
6303935|NCT00362817|7207210|FG000|STARTED|Overall Study||17
6303936|NCT00362817|7207210|FG000|COMPLETED|Overall Study||17
6303937|NCT00362817|7207210|FG000|NOT COMPLETED|Overall Study||0
6303938|NCT00362882|7207217|FG000|STARTED|Overall Study||40
6303939|NCT00362882|7207218|FG001|STARTED|Overall Study||41
6303940|NCT00362882|7207217|FG000|COMPLETED|Overall Study||40
6303941|NCT00362882|7207218|FG001|COMPLETED|Overall Study||41
6303942|NCT00362882|7207217|FG000|NOT COMPLETED|Overall Study||0
6303943|NCT00362882|7207218|FG001|NOT COMPLETED|Overall Study||0
6303944|NCT00363051|7207226|FG000|STARTED|Overall Study||115
6303945|NCT00363051|7207227|FG001|STARTED|Overall Study||45
6303946|NCT00363051|7207226|FG000|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
6303947|NCT00363051|7207227|FG001|COMPLETED|Overall Study||23
6303948|NCT00363051|7207226|FG000|NOT COMPLETED|Overall Study||38
6303949|NCT00363051|7207227|FG001|NOT COMPLETED|Overall Study||22
6303950|NCT00363077|7207237|FG000|STARTED|Overall Study||75
6303951|NCT00363077|7207238|FG001|STARTED|Overall Study||75
6303952|NCT00363077|7207237|FG000|COMPLETED|Overall Study||75
6303953|NCT00363077|7207238|FG001|COMPLETED|Overall Study||75
6303954|NCT00363077|7207237|FG000|NOT COMPLETED|Overall Study||0
6303955|NCT00363077|7207238|FG001|NOT COMPLETED|Overall Study||0
6303956|NCT00363129|7207246|FG000|STARTED|Overall Study||96
6303957|NCT00363129|7207247|FG001|STARTED|Overall Study||93
6303958|NCT00363129|7207246|FG000|COMPLETED|Overall Study||67
6303959|NCT00363129|7207247|FG001|COMPLETED|Overall Study||60
6303960|NCT00363129|7207246|FG000|NOT COMPLETED|Overall Study||29
6303961|NCT00363129|7207247|FG001|NOT COMPLETED|Overall Study||33
6303962|NCT00363142|7207255|FG000|STARTED|Overall Study||140
6303963|NCT00363142|7207256|FG001|STARTED|Overall Study||69
6303964|NCT00363142|7207255|FG000|COMPLETED|Overall Study||133
6303965|NCT00363142|7207256|FG001|COMPLETED|Overall Study||66
6303966|NCT00363142|7207255|FG000|NOT COMPLETED|Overall Study||7
6303967|NCT00363142|7207256|FG001|NOT COMPLETED|Overall Study||3
6303968|NCT00363168|7207267|FG000|STARTED|Overall Study||5
6303969|NCT00363168|7207268|FG001|STARTED|Overall Study||2
6303970|NCT00363168|7207267|FG000|COMPLETED|Overall Study||5
6303971|NCT00363168|7207268|FG001|COMPLETED|Overall Study||2
6303972|NCT00363168|7207267|FG000|NOT COMPLETED|Overall Study||0
6303973|NCT00363168|7207268|FG001|NOT COMPLETED|Overall Study||0
6303974|NCT00363246|7207274|FG000|STARTED|Overall Study||766
6303975|NCT00363246|7207274|FG000|COMPLETED|Overall Study||669
6303976|NCT00363246|7207274|FG000|NOT COMPLETED|Overall Study||97
6303977|NCT00363298|7207281|FG000|STARTED|First Study Week||12
6303978|NCT00363298|7207282|FG001|STARTED|First Study Week||12
6303979|NCT00363298|7207281|FG000|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
6303980|NCT00363298|7207282|FG001|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
6303981|NCT00363298|7207281|FG000|NOT COMPLETED|First Study Week||6
6303982|NCT00363298|7207282|FG001|NOT COMPLETED|First Study Week||5
6303983|NCT00363298|7207281|FG000|STARTED|4-week Study Continuation Phase||6
6303984|NCT00363298|7207282|FG001|STARTED|4-week Study Continuation Phase||7
6303985|NCT00363298|7207281|FG000|COMPLETED|4-week Study Continuation Phase||5
6303986|NCT00363298|7207282|FG001|COMPLETED|4-week Study Continuation Phase||7
6303987|NCT00363298|7207281|FG000|NOT COMPLETED|4-week Study Continuation Phase||1
6303988|NCT00363298|7207282|FG001|NOT COMPLETED|4-week Study Continuation Phase||0
6303989|NCT00363311|7207291|FG000|STARTED|Overall Study||155
6303990|NCT00363311|7207292|FG001|STARTED|Overall Study||147
6303991|NCT00363311|7207291|FG000|COMPLETED|Overall Study||79
6303992|NCT00363311|7207292|FG001|COMPLETED|Overall Study||102
6303993|NCT00363311|7207291|FG000|NOT COMPLETED|Overall Study||76
6303994|NCT00363311|7207292|FG001|NOT COMPLETED|Overall Study||45
6303995|NCT00363415|7207300|FG000|STARTED|Overall Study||453
6303996|NCT00363415|7207301|FG001|STARTED|Overall Study||455
6303997|NCT00363415|7207300|FG000|Received at Least One Dose of Study Drug|Overall Study||433
6303998|NCT00363415|7207301|FG001|Received at Least One Dose of Study Drug|Overall Study||447
6303999|NCT00363415|7207300|FG000|COMPLETED|Overall Study||92
6304000|NCT00363415|7207301|FG001|COMPLETED|Overall Study||206
6304001|NCT00363415|7207300|FG000|NOT COMPLETED|Overall Study||361
6304002|NCT00363415|7207301|FG001|NOT COMPLETED|Overall Study||249
6304003|NCT00363467|7207307|FG000|STARTED|Overall Study||3
6304004|NCT00363467|7207307|FG000|COMPLETED|Overall Study||2
6304005|NCT00363467|7207307|FG000|NOT COMPLETED|Overall Study||1
6304006|NCT00363480|7207311|FG000|STARTED|Overall Study||221
6304007|NCT00363480|7207311|FG000|COMPLETED|Overall Study||204
6304008|NCT00363480|7207311|FG000|NOT COMPLETED|Overall Study||17
6304009|NCT00363545|7207317|FG000|STARTED|Overall Study||636
6304010|NCT00363545|7207318|FG001|STARTED|Overall Study||638
6304011|NCT00363545|7207317|FG000|COMPLETED|Overall Study||592
6304012|NCT00363545|7207318|FG001|COMPLETED|Overall Study||581
6304013|NCT00363545|7207317|FG000|NOT COMPLETED|Overall Study||44
6304014|NCT00363545|7207318|FG001|NOT COMPLETED|Overall Study||57
6304015|NCT00363649|7207326|FG000|STARTED|Overall Study||18
6304016|NCT00363649|7207327|FG001|STARTED|Overall Study||16
6304017|NCT00363649|7207326|FG000|Crossed Over to Arm B|Overall Study||9
6304018|NCT00363649|7207327|FG001|Crossed Over to Arm B|Overall Study||0
6304019|NCT00363649|7207326|FG000|Crossed Over to Arm A|Overall Study||0
6304020|NCT00363649|7207327|FG001|Crossed Over to Arm A|Overall Study||12
6304021|NCT00363649|7207326|FG000|Did Not Cross Over|Overall Study||2
6304022|NCT00363649|7207327|FG001|Did Not Cross Over|Overall Study||3
6304023|NCT00363649|7207326|FG000|COMPLETED|Overall Study||11
6304024|NCT00363649|7207327|FG001|COMPLETED|Overall Study||15
6304025|NCT00363649|7207326|FG000|NOT COMPLETED|Overall Study||7
6304026|NCT00363649|7207327|FG001|NOT COMPLETED|Overall Study||1
6304027|NCT00363675|7207333|FG000|STARTED|Overall Study||3
6304028|NCT00363675|7207333|FG000|Completed Testing|Overall Study||3
6304029|NCT00363675|7207333|FG000|COMPLETED|Overall Study||3
6304030|NCT00363675|7207333|FG000|NOT COMPLETED|Overall Study||0
6304031|NCT00363766|7207340|FG000|STARTED|Overall Study||32
6304032|NCT00363766|7207341|FG001|STARTED|Overall Study||20
6304033|NCT00363766|7207340|FG000|COMPLETED|Overall Study||0
6304034|NCT00363766|7207341|FG001|COMPLETED|Overall Study||0
6304035|NCT00363766|7207340|FG000|NOT COMPLETED|Overall Study||32
6304036|NCT00363766|7207341|FG001|NOT COMPLETED|Overall Study||20
6304037|NCT00363779|7207348|FG000|STARTED|Overall Study||5
6304038|NCT00363779|7207348|FG000|COMPLETED|Overall Study||5
6304039|NCT00363779|7207348|FG000|NOT COMPLETED|Overall Study||0
6304040|NCT00363805|7207355|FG000|STARTED|Overall Study||42
6304041|NCT00363805|7207356|FG001|STARTED|Overall Study||63
6304042|NCT00363805|7207357|FG002|STARTED|Overall Study||73
6304043|NCT00363805|7207355|FG000|COMPLETED|Overall Study||38
6304044|NCT00363805|7207356|FG001|COMPLETED|Overall Study||57
6304045|NCT00363805|7207357|FG002|COMPLETED|Overall Study||70
6304046|NCT00363805|7207355|FG000|NOT COMPLETED|Overall Study||4
6304047|NCT00363805|7207356|FG001|NOT COMPLETED|Overall Study||6
6304048|NCT00363805|7207357|FG002|NOT COMPLETED|Overall Study||3
6304049|NCT00363883|7207365|FG000|STARTED|Overall Study||14
6304050|NCT00363883|7207365|FG000|COMPLETED|Overall Study||14
6304051|NCT00363883|7207365|FG000|NOT COMPLETED|Overall Study||0
6304052|NCT00363896|7207371|FG000|STARTED|Overall Study||627
6304053|NCT00363896|7207372|FG001|STARTED|Overall Study||216
6304054|NCT00363896|7207371|FG000|COMPLETED|Overall Study||538
6304055|NCT00363896|7207372|FG001|COMPLETED|Overall Study||169
6304056|NCT00363896|7207371|FG000|NOT COMPLETED|Overall Study||89
6304057|NCT00363896|7207372|FG001|NOT COMPLETED|Overall Study||47
6304058|NCT00364013|7207383|FG000|STARTED|Overall Study||593
6304059|NCT00364013|7207384|FG001|STARTED|Overall Study||590
6304060|NCT00364013|7207383|FG000|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
6304061|NCT00364013|7207384|FG001|Received Study Drug|Overall Study||583
6304062|NCT00364013|7207383|FG000|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
6304063|NCT00364013|7207384|FG001|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
6304064|NCT00364013|7207383|FG000|NOT COMPLETED|Overall Study||101
6304065|NCT00364013|7207384|FG001|NOT COMPLETED|Overall Study||95
6304066|NCT00364130|7207396|FG000|STARTED|Intervention Period||69
6304067|NCT00364130|7207397|FG001|STARTED|Intervention Period||69
6304068|NCT00364130|7207396|FG000|COMPLETED|Intervention Period||60
6304069|NCT00364130|7207397|FG001|COMPLETED|Intervention Period||61
6304070|NCT00364130|7207396|FG000|NOT COMPLETED|Intervention Period||9
6304071|NCT00364130|7207397|FG001|NOT COMPLETED|Intervention Period||8
6304072|NCT00364130|7207396|FG000|STARTED|Post Intervention Follow-up Period||60
6304073|NCT00364130|7207397|FG001|STARTED|Post Intervention Follow-up Period||61
6401582|NCT00893997|7314549|FG000|NOT COMPLETED|Overall Study||0
6401583|NCT00894127|7314553|FG000|STARTED|Overall Study||128
6401584|NCT00894127|7314553|FG000|COMPLETED|Overall Study||128
6401585|NCT00894127|7314553|FG000|NOT COMPLETED|Overall Study||0
6401586|NCT00894166|7314565|FG000|STARTED|Overall Study||132
6401587|NCT00894166|7314566|FG001|STARTED|Overall Study||109
6401588|NCT00894166|7314567|FG002|STARTED|Overall Study||112
6401589|NCT00894166|7314568|FG003|STARTED|Overall Study||114
6401590|NCT00894166|7314569|FG004|STARTED|Overall Study||34
6401591|NCT00894166|7314570|FG005|STARTED|Overall Study||36
6401592|NCT00894166|7314571|FG006|STARTED|Overall Study||35
6401593|NCT00894166|7314572|FG007|STARTED|Overall Study||34
6401594|NCT00894166|7314565|FG000|COMPLETED|Overall Study||71
6401595|NCT00894166|7314566|FG001|COMPLETED|Overall Study||46
6401596|NCT00894166|7314567|FG002|COMPLETED|Overall Study||50
6401597|NCT00894166|7314568|FG003|COMPLETED|Overall Study||45
6401598|NCT00894166|7314569|FG004|COMPLETED|Overall Study||10
6401599|NCT00894166|7314570|FG005|COMPLETED|Overall Study||20
6401600|NCT00894166|7314571|FG006|COMPLETED|Overall Study||19
6401601|NCT00894166|7314572|FG007|COMPLETED|Overall Study||0
6401602|NCT00894166|7314565|FG000|NOT COMPLETED|Overall Study||61
6401603|NCT00894166|7314566|FG001|NOT COMPLETED|Overall Study||63
6401604|NCT00894166|7314567|FG002|NOT COMPLETED|Overall Study||62
6401605|NCT00894166|7314568|FG003|NOT COMPLETED|Overall Study||69
6401606|NCT00894166|7314569|FG004|NOT COMPLETED|Overall Study||24
6401607|NCT00894166|7314570|FG005|NOT COMPLETED|Overall Study||16
6401608|NCT00894166|7314571|FG006|NOT COMPLETED|Overall Study||16
6401609|NCT00894166|7314572|FG007|NOT COMPLETED|Overall Study||34
6401610|NCT00894322|7314598|FG000|STARTED|Overall Study||30
6401611|NCT00894322|7314599|FG001|STARTED|Overall Study||23
6401612|NCT00894322|7314600|FG002|STARTED|Overall Study||12
6401613|NCT00894322|7314598|FG000|COMPLETED|Overall Study||29
6401614|NCT00894322|7314599|FG001|COMPLETED|Overall Study||23
6401615|NCT00894322|7314600|FG002|COMPLETED|Overall Study||12
6401616|NCT00894322|7314598|FG000|NOT COMPLETED|Overall Study||1
6401617|NCT00894322|7314599|FG001|NOT COMPLETED|Overall Study||0
6401618|NCT00894322|7314600|FG002|NOT COMPLETED|Overall Study||0
6401619|NCT00894361|7314612|FG000|STARTED|Overall Study||200
6401620|NCT00894361|7314613|FG001|STARTED|Overall Study||200
6401621|NCT00894361|7314612|FG000|COMPLETED|Overall Study||176
6401622|NCT00894361|7314613|FG001|COMPLETED|Overall Study||136
6401623|NCT00894361|7314612|FG000|NOT COMPLETED|Overall Study||24
6401624|NCT00894361|7314613|FG001|NOT COMPLETED|Overall Study||64
6401625|NCT00894387|7314623|FG000|STARTED|Overall Study|"Started indicates all randomized patients"|821
6401626|NCT00894387|7314624|FG001|STARTED|Overall Study||818
6401627|NCT00894387|7314623|FG000|Safety Set|Overall Study||808
6401628|NCT00894387|7314624|FG001|Safety Set|Overall Study||810
6401629|NCT00894387|7314623|FG000|Full Analysis Set|Overall Study||808
6401630|NCT00894387|7314624|FG001|Full Analysis Set|Overall Study||807
6401631|NCT00894387|7314623|FG000|Completed Primary Efficacy Phase (6 m)|Overall Study||717
6401632|NCT00894387|7314624|FG001|Completed Primary Efficacy Phase (6 m)|Overall Study||707
6401633|NCT00894387|7314623|FG000|Completed Secondary Efficacy Phase (12m)|Overall Study||654
6401634|NCT00894387|7314624|FG001|Completed Secondary Efficacy Phase (12m)|Overall Study||640
6401635|NCT00894387|7314623|FG000|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
6401636|NCT00894387|7314624|FG001|COMPLETED|Overall Study||643
6401637|NCT00894387|7314623|FG000|NOT COMPLETED|Overall Study||175
6401638|NCT00894387|7314624|FG001|NOT COMPLETED|Overall Study||175
6401639|NCT00894413|7314632|FG000|STARTED|Overall Study||15
6401640|NCT00894413|7314633|FG001|STARTED|Overall Study||25
6401641|NCT00894413|7314632|FG000|COMPLETED|Overall Study||15
6401642|NCT00894413|7314633|FG001|COMPLETED|Overall Study||17
6401643|NCT00894413|7314632|FG000|NOT COMPLETED|Overall Study||0
6401644|NCT00894413|7314633|FG001|NOT COMPLETED|Overall Study||8
6304074|NCT00364130|7207396|FG000|COMPLETED|Post Intervention Follow-up Period||55
6304075|NCT00364130|7207397|FG001|COMPLETED|Post Intervention Follow-up Period||50
6304076|NCT00364130|7207396|FG000|NOT COMPLETED|Post Intervention Follow-up Period||5
6304077|NCT00364130|7207397|FG001|NOT COMPLETED|Post Intervention Follow-up Period||11
6304078|NCT00364156|7207407|FG000|STARTED|Overall Study||282
6304079|NCT00364156|7207408|FG001|STARTED|Overall Study||286
6304080|NCT00364156|7207407|FG000|COMPLETED|Overall Study||203
6304081|NCT00364156|7207408|FG001|COMPLETED|Overall Study||205
6304082|NCT00364156|7207407|FG000|NOT COMPLETED|Overall Study||79
6304083|NCT00364156|7207408|FG001|NOT COMPLETED|Overall Study||81
6304084|NCT00364182|7207417|FG000|STARTED|First Intervention||3
6304085|NCT00364182|7207418|FG001|STARTED|First Intervention||22
6304086|NCT00364182|7207419|FG002|STARTED|First Intervention||25
6304087|NCT00364182|7207417|FG000|COMPLETED|First Intervention||0
6304088|NCT00364182|7207418|FG001|COMPLETED|First Intervention||22
6304089|NCT00364182|7207419|FG002|COMPLETED|First Intervention||25
6304090|NCT00364182|7207417|FG000|NOT COMPLETED|First Intervention||3
6304091|NCT00364182|7207418|FG001|NOT COMPLETED|First Intervention||0
6304092|NCT00364182|7207419|FG002|NOT COMPLETED|First Intervention||0
6304093|NCT00364182|7207417|FG000|STARTED|Second Intervention||0
6304094|NCT00364182|7207418|FG001|STARTED|Second Intervention||22
6304095|NCT00364182|7207419|FG002|STARTED|Second Intervention||25
6304096|NCT00364182|7207417|FG000|Randomized|Second Intervention||0
6304097|NCT00364182|7207418|FG001|Randomized|Second Intervention||22
6304098|NCT00364182|7207419|FG002|Randomized|Second Intervention||25
6304099|NCT00364182|7207417|FG000|COMPLETED|Second Intervention||0
6304100|NCT00364182|7207418|FG001|COMPLETED|Second Intervention||20
6304101|NCT00364182|7207419|FG002|COMPLETED|Second Intervention||23
6304102|NCT00364182|7207417|FG000|NOT COMPLETED|Second Intervention||0
6304103|NCT00364182|7207418|FG001|NOT COMPLETED|Second Intervention||2
6304104|NCT00364182|7207419|FG002|NOT COMPLETED|Second Intervention||2
6304105|NCT00364182|7207417|FG000|STARTED|Third Intervention||0
6304106|NCT00364182|7207418|FG001|STARTED|Third Intervention||20
6304107|NCT00364182|7207419|FG002|STARTED|Third Intervention||23
6304108|NCT00364182|7207417|FG000|COMPLETED|Third Intervention||0
6304109|NCT00364182|7207418|FG001|COMPLETED|Third Intervention||19
6304110|NCT00364182|7207419|FG002|COMPLETED|Third Intervention||22
6304111|NCT00364182|7207417|FG000|NOT COMPLETED|Third Intervention||0
6304112|NCT00364182|7207418|FG001|NOT COMPLETED|Third Intervention||1
6304113|NCT00364182|7207419|FG002|NOT COMPLETED|Third Intervention||1
6304114|NCT00364182|7207417|FG000|STARTED|Fourth Intervention||0
6304115|NCT00364182|7207418|FG001|STARTED|Fourth Intervention||19
6304116|NCT00364182|7207419|FG002|STARTED|Fourth Intervention||22
6304117|NCT00364182|7207417|FG000|COMPLETED|Fourth Intervention||0
6304118|NCT00364182|7207418|FG001|COMPLETED|Fourth Intervention||19
6304119|NCT00364182|7207419|FG002|COMPLETED|Fourth Intervention||22
6304120|NCT00364182|7207417|FG000|NOT COMPLETED|Fourth Intervention||0
6304121|NCT00364182|7207418|FG001|NOT COMPLETED|Fourth Intervention||0
6304122|NCT00364182|7207419|FG002|NOT COMPLETED|Fourth Intervention||0
6304123|NCT00364286|7207429|FG000|STARTED|Overall Study||17
6304124|NCT00364286|7207429|FG000|COMPLETED|Overall Study||14
6304125|NCT00364286|7207429|FG000|NOT COMPLETED|Overall Study||3
6304126|NCT00364351|7207435|FG000|STARTED|Overall Study|randomised patients|623
6304127|NCT00364351|7207436|FG001|STARTED|Overall Study|randomised patients|617
6304128|NCT00364351|7207435|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|31
6304129|NCT00364351|7207436|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 26 Sep 2008.|34
6304130|NCT00364351|7207435|FG000|NOT COMPLETED|Overall Study||592
6304131|NCT00364351|7207436|FG001|NOT COMPLETED|Overall Study||583
6304132|NCT00364377|7207444|FG000|STARTED|Overall Study||11
6304133|NCT00364377|7207445|FG001|STARTED|Overall Study||11
6304134|NCT00364377|7207444|FG000|COMPLETED|Overall Study||11
6304135|NCT00364377|7207445|FG001|COMPLETED|Overall Study||11
6304136|NCT00364377|7207444|FG000|NOT COMPLETED|Overall Study||0
6304137|NCT00364377|7207445|FG001|NOT COMPLETED|Overall Study||0
6304138|NCT00364533|7207456|FG000|STARTED|Overall Study||77
6304139|NCT00364533|7207457|FG001|STARTED|Overall Study||71
6304140|NCT00364533|7207458|FG002|STARTED|Overall Study||75
6304141|NCT00364533|7207459|FG003|STARTED|Overall Study||67
6304142|NCT00364533|7207460|FG004|STARTED|Overall Study||75
6304143|NCT00364533|7207456|FG000|COMPLETED|Overall Study||35
6304144|NCT00364533|7207457|FG001|COMPLETED|Overall Study||31
6304145|NCT00364533|7207458|FG002|COMPLETED|Overall Study||30
6401645|NCT00894465|7314641|FG000|STARTED|Overall Study||22
6401646|NCT00894465|7314642|FG001|STARTED|Overall Study||22
6401647|NCT00894465|7314641|FG000|COMPLETED|Overall Study||22
6401648|NCT00894465|7314642|FG001|COMPLETED|Overall Study||22
6401649|NCT00894465|7314641|FG000|NOT COMPLETED|Overall Study||0
6401650|NCT00894465|7314642|FG001|NOT COMPLETED|Overall Study||0
6401651|NCT00894504|7314650|FG000|STARTED|Overall Study||71
6401652|NCT00894504|7314650|FG000|COMPLETED|Overall Study||0
6401653|NCT00894504|7314650|FG000|NOT COMPLETED|Overall Study||71
6401654|NCT00894517|7314666|FG000|STARTED|Overall Study||30
6401655|NCT00894517|7314667|FG001|STARTED|Overall Study||31
6401656|NCT00894517|7314666|FG000|COMPLETED|Overall Study||28
6401657|NCT00894517|7314667|FG001|COMPLETED|Overall Study||26
6401658|NCT00894517|7314666|FG000|NOT COMPLETED|Overall Study||2
6304146|NCT00364533|7207459|FG003|COMPLETED|Overall Study||36
6304147|NCT00364533|7207460|FG004|COMPLETED|Overall Study||24
6401659|NCT00894517|7314667|FG001|NOT COMPLETED|Overall Study||5
6401660|NCT00894543|7314675|FG000|STARTED|Baseline||104
6401661|NCT00894543|7314676|FG001|STARTED|Baseline||101
6401662|NCT00894543|7314675|FG000|COMPLETED|Baseline||104
6401663|NCT00894543|7314676|FG001|COMPLETED|Baseline||101
6401664|NCT00894543|7314675|FG000|NOT COMPLETED|Baseline||0
6401665|NCT00894543|7314676|FG001|NOT COMPLETED|Baseline||0
6401666|NCT00894543|7314675|FG000|STARTED|Baseline to Week 4||104
6401667|NCT00894543|7314676|FG001|STARTED|Baseline to Week 4||101
6401668|NCT00894543|7314675|FG000|COMPLETED|Baseline to Week 4||101
6401669|NCT00894543|7314676|FG001|COMPLETED|Baseline to Week 4||99
6401670|NCT00894543|7314675|FG000|NOT COMPLETED|Baseline to Week 4||3
6401671|NCT00894543|7314676|FG001|NOT COMPLETED|Baseline to Week 4||2
6401672|NCT00894543|7314675|FG000|STARTED|Week 4 to Week 8||101
6401673|NCT00894543|7314676|FG001|STARTED|Week 4 to Week 8||99
6401674|NCT00894543|7314675|FG000|COMPLETED|Week 4 to Week 8||97
6401675|NCT00894543|7314676|FG001|COMPLETED|Week 4 to Week 8||97
6401676|NCT00894543|7314675|FG000|NOT COMPLETED|Week 4 to Week 8||4
6401677|NCT00894543|7314676|FG001|NOT COMPLETED|Week 4 to Week 8||2
6401678|NCT00894647|7314684|FG000|STARTED|Overall Study||121
6401679|NCT00894647|7314685|FG001|STARTED|Overall Study||126
6401680|NCT00894647|7314684|FG000|COMPLETED|Overall Study||111
6401681|NCT00894647|7314685|FG001|COMPLETED|Overall Study||112
6401682|NCT00894647|7314684|FG000|NOT COMPLETED|Overall Study||10
6401683|NCT00894647|7314685|FG001|NOT COMPLETED|Overall Study||14
6401684|NCT00894686|7314691|FG000|STARTED|Overall Study||179
6401685|NCT00894686|7314691|FG000|COMPLETED|Overall Study||123
6401686|NCT00894686|7314691|FG000|NOT COMPLETED|Overall Study||56
6401687|NCT00894699|7314697|FG000|STARTED|Overall Study||21
6401688|NCT00894699|7314698|FG001|STARTED|Overall Study||19
6401689|NCT00894699|7314697|FG000|COMPLETED|Overall Study||21
6401690|NCT00894699|7314698|FG001|COMPLETED|Overall Study||19
6401691|NCT00894699|7314697|FG000|NOT COMPLETED|Overall Study||0
6401692|NCT00894699|7314698|FG001|NOT COMPLETED|Overall Study||0
6401693|NCT00894738|7314706|FG000|STARTED|Overall Study||25
6401694|NCT00894738|7314707|FG001|STARTED|Overall Study||19
6401695|NCT00894738|7314706|FG000|COMPLETED|Overall Study||25
6401696|NCT00894738|7314707|FG001|COMPLETED|Overall Study||19
6401697|NCT00894738|7314706|FG000|NOT COMPLETED|Overall Study||0
6401698|NCT00894738|7314707|FG001|NOT COMPLETED|Overall Study||0
6401699|NCT00894803|7314715|FG000|STARTED|Overall Study||101
6401700|NCT00894803|7314716|FG001|STARTED|Overall Study||25
6401701|NCT00894803|7314715|FG000|COMPLETED|Overall Study||81
6401702|NCT00894803|7314716|FG001|COMPLETED|Overall Study||20
6401703|NCT00894803|7314715|FG000|NOT COMPLETED|Overall Study||20
6401704|NCT00894803|7314716|FG001|NOT COMPLETED|Overall Study||5
6401705|NCT00894933|7314722|FG000|STARTED|Overall Study||33
6401706|NCT00894933|7314722|FG000|COMPLETED|Overall Study||29
6401707|NCT00894933|7314722|FG000|NOT COMPLETED|Overall Study||4
6401708|NCT00895011|7314729|FG000|STARTED|Overall Study||100
6401709|NCT00895011|7314730|FG001|STARTED|Overall Study||99
6401710|NCT00895011|7314731|FG002|STARTED|Overall Study||99
6401711|NCT00895011|7314729|FG000|COMPLETED|Overall Study||76
6401712|NCT00895011|7314730|FG001|COMPLETED|Overall Study||85
6401713|NCT00895011|7314731|FG002|COMPLETED|Overall Study||91
6401714|NCT00895011|7314729|FG000|NOT COMPLETED|Overall Study||24
6401715|NCT00895011|7314730|FG001|NOT COMPLETED|Overall Study||14
6401716|NCT00895011|7314731|FG002|NOT COMPLETED|Overall Study||8
6401717|NCT00895037|7314743|FG000|STARTED|Overall Study||22
6401718|NCT00895037|7314744|FG001|STARTED|Overall Study||77
6401719|NCT00895037|7314745|FG002|STARTED|Overall Study||2
6401720|NCT00895037|7314743|FG000|COMPLETED|Overall Study||22
6401721|NCT00895037|7314744|FG001|COMPLETED|Overall Study||75
6401722|NCT00895037|7314745|FG002|COMPLETED|Overall Study||1
6401723|NCT00895037|7314743|FG000|NOT COMPLETED|Overall Study||0
6401724|NCT00895037|7314744|FG001|NOT COMPLETED|Overall Study||2
6401725|NCT00895037|7314745|FG002|NOT COMPLETED|Overall Study||1
6401726|NCT00895154|7314755|FG000|STARTED|Overall Study||8
6401727|NCT00895154|7314756|FG001|STARTED|Overall Study||10
6401728|NCT00895154|7314755|FG000|Follow Up|Overall Study||7
6401729|NCT00895154|7314756|FG001|Follow Up|Overall Study||8
6401730|NCT00895154|7314755|FG000|COMPLETED|Overall Study||7
6401731|NCT00895154|7314756|FG001|COMPLETED|Overall Study||8
6401732|NCT00895154|7314755|FG000|NOT COMPLETED|Overall Study||1
6401733|NCT00895154|7314756|FG001|NOT COMPLETED|Overall Study||2
6401734|NCT00895180|7314764|FG000|STARTED|Overall Study||40
6401735|NCT00895180|7314765|FG001|STARTED|Overall Study||40
6401736|NCT00895180|7314764|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
6401737|NCT00895180|7314765|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
6401738|NCT00895180|7314764|FG000|COMPLETED|Overall Study||40
6401739|NCT00895180|7314765|FG001|COMPLETED|Overall Study||40
6401740|NCT00895180|7314764|FG000|NOT COMPLETED|Overall Study||0
6401741|NCT00895180|7314765|FG001|NOT COMPLETED|Overall Study||0
6401742|NCT00895193|7314777|FG000|STARTED|Overall Study||25
6401743|NCT00895193|7314778|FG001|STARTED|Overall Study||25
6401744|NCT00895193|7314779|FG002|STARTED|Overall Study||25
6401745|NCT00895193|7314780|FG003|STARTED|Overall Study||25
6401746|NCT00895193|7314777|FG000|COMPLETED|Overall Study||25
6401747|NCT00895193|7314778|FG001|COMPLETED|Overall Study||25
6401748|NCT00895193|7314779|FG002|COMPLETED|Overall Study||25
6401749|NCT00895193|7314780|FG003|COMPLETED|Overall Study||25
6401750|NCT00895193|7314777|FG000|NOT COMPLETED|Overall Study||0
6401751|NCT00895193|7314778|FG001|NOT COMPLETED|Overall Study||0
6401752|NCT00895193|7314779|FG002|NOT COMPLETED|Overall Study||0
6401753|NCT00895193|7314780|FG003|NOT COMPLETED|Overall Study||0
6401754|NCT00895232|7314793|FG000|STARTED|Overall Study||7
6401755|NCT00895232|7314794|FG001|STARTED|Overall Study||6
6401756|NCT00895232|7314795|FG002|STARTED|Overall Study||8
6401757|NCT00895232|7314793|FG000|COMPLETED|Overall Study||4
6401758|NCT00895232|7314794|FG001|COMPLETED|Overall Study||2
6401759|NCT00895232|7314795|FG002|COMPLETED|Overall Study||3
6401760|NCT00895232|7314793|FG000|NOT COMPLETED|Overall Study||3
6401761|NCT00895232|7314794|FG001|NOT COMPLETED|Overall Study||4
6401762|NCT00895232|7314795|FG002|NOT COMPLETED|Overall Study||5
6401763|NCT00895245|7314803|FG000|STARTED|Overall Study||6
6401764|NCT00895245|7314803|FG000|COMPLETED|Overall Study||0
6401765|NCT00895245|7314803|FG000|NOT COMPLETED|Overall Study||6
6401766|NCT00895310|7314807|FG000|STARTED|Overall Study||30
6401767|NCT00895310|7314807|FG000|COMPLETED|Overall Study||29
6401768|NCT00895310|7314807|FG000|NOT COMPLETED|Overall Study||1
6401769|NCT00895414|7314811|FG000|STARTED|First Intervention (14 Days)||9
6401770|NCT00895414|7314812|FG001|STARTED|First Intervention (14 Days)||10
6401771|NCT00895414|7314811|FG000|COMPLETED|First Intervention (14 Days)||8
6401772|NCT00895414|7314812|FG001|COMPLETED|First Intervention (14 Days)||9
6401773|NCT00895414|7314811|FG000|NOT COMPLETED|First Intervention (14 Days)||1
6401774|NCT00895414|7314812|FG001|NOT COMPLETED|First Intervention (14 Days)||1
6401775|NCT00895414|7314811|FG000|STARTED|Second Intervention (14 Days)||8
6401776|NCT00895414|7314812|FG001|STARTED|Second Intervention (14 Days)||9
6401777|NCT00895414|7314811|FG000|COMPLETED|Second Intervention (14 Days)||8
6401778|NCT00895414|7314812|FG001|COMPLETED|Second Intervention (14 Days)||9
6401779|NCT00895414|7314811|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
6401780|NCT00895414|7314812|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
6401781|NCT00895453|7314821|FG000|STARTED|Overall Study||48
6401782|NCT00895453|7314822|FG001|STARTED|Overall Study||50
6401783|NCT00895453|7314823|FG002|STARTED|Overall Study||46
6401784|NCT00895453|7314821|FG000|COMPLETED|Overall Study||23
6401785|NCT00895453|7314822|FG001|COMPLETED|Overall Study||25
6401786|NCT00895453|7314823|FG002|COMPLETED|Overall Study||23
6401787|NCT00895453|7314821|FG000|NOT COMPLETED|Overall Study||25
6401788|NCT00895453|7314822|FG001|NOT COMPLETED|Overall Study||25
6401789|NCT00895453|7314823|FG002|NOT COMPLETED|Overall Study||23
6401790|NCT00895531|7314833|FG000|STARTED|Overall Study||38
6401791|NCT00895531|7314834|FG001|STARTED|Overall Study||37
6401792|NCT00895531|7314833|FG000|COMPLETED|Overall Study||38
6401793|NCT00895531|7314834|FG001|COMPLETED|Overall Study||37
6401794|NCT00895531|7314833|FG000|NOT COMPLETED|Overall Study||0
6401795|NCT00895531|7314834|FG001|NOT COMPLETED|Overall Study||0
6401796|NCT00895583|7314842|FG000|STARTED|Overall Study||131
6401797|NCT00895583|7314843|FG001|STARTED|Overall Study||123
6401798|NCT00895583|7314842|FG000|COMPLETED|Overall Study||87
6401799|NCT00895583|7314843|FG001|COMPLETED|Overall Study||111
6401800|NCT00895583|7314842|FG000|NOT COMPLETED|Overall Study||44
6401801|NCT00895583|7314843|FG001|NOT COMPLETED|Overall Study||12
6401802|NCT00895622|7314852|FG000|STARTED|Overall Study||65
6401803|NCT00895622|7314853|FG001|STARTED|Overall Study||56
6401804|NCT00895622|7314854|FG002|STARTED|Overall Study||57
6401805|NCT00895622|7314852|FG000|COMPLETED|Overall Study||60
6401806|NCT00895622|7314853|FG001|COMPLETED|Overall Study||52
6401807|NCT00895622|7314854|FG002|COMPLETED|Overall Study||53
6401808|NCT00895622|7314852|FG000|NOT COMPLETED|Overall Study||5
6401809|NCT00895622|7314853|FG001|NOT COMPLETED|Overall Study||4
6401810|NCT00895622|7314854|FG002|NOT COMPLETED|Overall Study||4
6401811|NCT00895661|7314870|FG000|STARTED|Overall Study||40
6401812|NCT00895661|7314870|FG000|COMPLETED|Overall Study||37
6401813|NCT00895661|7314870|FG000|NOT COMPLETED|Overall Study||3
6401814|NCT00895752|7314874|FG000|STARTED|Overall Study||6
6401815|NCT00895752|7314874|FG000|COMPLETED|Overall Study||6
6401816|NCT00895752|7314874|FG000|NOT COMPLETED|Overall Study||0
6401817|NCT00895817|7314882|FG000|STARTED|Overall Study||21
6401818|NCT00895817|7314883|FG001|STARTED|Overall Study||21
6401819|NCT00895817|7314882|FG000|COMPLETED|Overall Study||21
6401820|NCT00895817|7314883|FG001|COMPLETED|Overall Study||21
6401821|NCT00895817|7314882|FG000|NOT COMPLETED|Overall Study||0
6635315|NCT02303574|7564184|FG002|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635316|NCT02303574|7564185|FG003|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6401822|NCT00895817|7314883|FG001|NOT COMPLETED|Overall Study||0
6401823|NCT00895830|7314894|FG000|STARTED|Overall Study||51
6401824|NCT00895830|7314895|FG001|STARTED|Overall Study||50
6401825|NCT00895830|7314896|FG002|STARTED|Overall Study||49
6401826|NCT00895830|7314897|FG003|STARTED|Overall Study||52
6401827|NCT00895830|7314898|FG004|STARTED|Overall Study||55
6401828|NCT00895830|7314894|FG000|COMPLETED|Overall Study||51
6401829|NCT00895830|7314895|FG001|COMPLETED|Overall Study||50
6401830|NCT00895830|7314896|FG002|COMPLETED|Overall Study||49
6401831|NCT00895830|7314897|FG003|COMPLETED|Overall Study||52
6401832|NCT00895830|7314898|FG004|COMPLETED|Overall Study||55
6401833|NCT00895830|7314894|FG000|NOT COMPLETED|Overall Study||0
6401834|NCT00895830|7314895|FG001|NOT COMPLETED|Overall Study||0
6401835|NCT00895830|7314896|FG002|NOT COMPLETED|Overall Study||0
6401836|NCT00895830|7314897|FG003|NOT COMPLETED|Overall Study||0
6401837|NCT00895830|7314898|FG004|NOT COMPLETED|Overall Study||0
6401838|NCT00895843|7314912|FG000|STARTED|Overall Study||60
6401839|NCT00895843|7314913|FG001|STARTED|Overall Study||62
6401840|NCT00895843|7314912|FG000|COMPLETED|Overall Study||48
6635317|NCT02303574|7564186|FG004|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635318|NCT02303574|7564187|FG005|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635319|NCT02303574|7564188|FG006|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||6
6401841|NCT00895843|7314913|FG001|COMPLETED|Overall Study||50
6401842|NCT00895843|7314912|FG000|NOT COMPLETED|Overall Study||12
6401843|NCT00895843|7314913|FG001|NOT COMPLETED|Overall Study||12
6401844|NCT00895895|7314924|FG000|STARTED|Period 1||107
6401845|NCT00895895|7314925|FG001|STARTED|Period 1||105
6401846|NCT00895895|7314926|FG002|STARTED|Period 1||104
6401847|NCT00895895|7314927|FG003|STARTED|Period 1||104
6401848|NCT00895895|7314928|FG004|STARTED|Period 1||106
6401849|NCT00895895|7314924|FG000|Randomized But Not Treated|Period 1||1
6401850|NCT00895895|7314925|FG001|Randomized But Not Treated|Period 1||3
6401851|NCT00895895|7314926|FG002|Randomized But Not Treated|Period 1||1
6401852|NCT00895895|7314927|FG003|Randomized But Not Treated|Period 1||1
6401853|NCT00895895|7314928|FG004|Randomized But Not Treated|Period 1||2
6401854|NCT00895895|7314924|FG000|COMPLETED|Period 1||86
6401855|NCT00895895|7314925|FG001|COMPLETED|Period 1||84
6401856|NCT00895895|7314926|FG002|COMPLETED|Period 1||84
6401857|NCT00895895|7314927|FG003|COMPLETED|Period 1||91
6401858|NCT00895895|7314928|FG004|COMPLETED|Period 1||86
6401859|NCT00895895|7314924|FG000|NOT COMPLETED|Period 1||21
6401860|NCT00895895|7314925|FG001|NOT COMPLETED|Period 1||21
6401861|NCT00895895|7314926|FG002|NOT COMPLETED|Period 1||20
6401862|NCT00895895|7314927|FG003|NOT COMPLETED|Period 1||13
6401863|NCT00895895|7314928|FG004|NOT COMPLETED|Period 1||20
6401864|NCT00895895|7314924|FG000|STARTED|After Period 1, Prior to Period 2||86
6401865|NCT00895895|7314925|FG001|STARTED|After Period 1, Prior to Period 2||84
6401866|NCT00895895|7314926|FG002|STARTED|After Period 1, Prior to Period 2||84
6401867|NCT00895895|7314927|FG003|STARTED|After Period 1, Prior to Period 2||91
6401868|NCT00895895|7314928|FG004|STARTED|After Period 1, Prior to Period 2||86
6401869|NCT00895895|7314924|FG000|COMPLETED|After Period 1, Prior to Period 2||86
6401870|NCT00895895|7314925|FG001|COMPLETED|After Period 1, Prior to Period 2||84
6401871|NCT00895895|7314926|FG002|COMPLETED|After Period 1, Prior to Period 2||82
6401872|NCT00895895|7314927|FG003|COMPLETED|After Period 1, Prior to Period 2||91
6401873|NCT00895895|7314928|FG004|COMPLETED|After Period 1, Prior to Period 2||84
6401874|NCT00895895|7314924|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||0
6401875|NCT00895895|7314925|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
6401876|NCT00895895|7314926|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||2
6401877|NCT00895895|7314927|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
6401878|NCT00895895|7314928|FG004|NOT COMPLETED|After Period 1, Prior to Period 2||2
6401879|NCT00895895|7314924|FG000|STARTED|Period 2||86
6401880|NCT00895895|7314925|FG001|STARTED|Period 2||84
6401881|NCT00895895|7314926|FG002|STARTED|Period 2||82
6401882|NCT00895895|7314927|FG003|STARTED|Period 2||91
6401883|NCT00895895|7314928|FG004|STARTED|Period 2||84
6401884|NCT00895895|7314924|FG000|COMPLETED|Period 2||30
6401885|NCT00895895|7314925|FG001|COMPLETED|Period 2||31
6401886|NCT00895895|7314926|FG002|COMPLETED|Period 2||33
6401887|NCT00895895|7314927|FG003|COMPLETED|Period 2||37
6401888|NCT00895895|7314928|FG004|COMPLETED|Period 2||35
6401889|NCT00895895|7314924|FG000|NOT COMPLETED|Period 2||56
6401890|NCT00895895|7314925|FG001|NOT COMPLETED|Period 2||53
6401891|NCT00895895|7314926|FG002|NOT COMPLETED|Period 2||49
6401892|NCT00895895|7314927|FG003|NOT COMPLETED|Period 2||54
6401893|NCT00895895|7314928|FG004|NOT COMPLETED|Period 2||49
6401894|NCT00895921|7314948|FG000|STARTED|Overall Study||15
6401895|NCT00895921|7314949|FG001|STARTED|Overall Study||15
6401896|NCT00895921|7314948|FG000|COMPLETED|Overall Study||15
6401897|NCT00895921|7314949|FG001|COMPLETED|Overall Study||15
6401898|NCT00895921|7314948|FG000|NOT COMPLETED|Overall Study||0
6401899|NCT00895921|7314949|FG001|NOT COMPLETED|Overall Study||0
6401900|NCT00895934|7314957|FG000|STARTED|Dose Escalation||3
6401901|NCT00895934|7314958|FG001|STARTED|Dose Escalation||3
6401902|NCT00895934|7314959|FG002|STARTED|Dose Escalation||3
6401903|NCT00895934|7314960|FG003|STARTED|Dose Escalation||6
6401904|NCT00895934|7314957|FG000|COMPLETED|Dose Escalation||3
6401905|NCT00895934|7314958|FG001|COMPLETED|Dose Escalation||3
6401906|NCT00895934|7314959|FG002|COMPLETED|Dose Escalation||3
6401907|NCT00895934|7314960|FG003|COMPLETED|Dose Escalation||6
6401908|NCT00895934|7314957|FG000|NOT COMPLETED|Dose Escalation||0
6401909|NCT00895934|7314958|FG001|NOT COMPLETED|Dose Escalation||0
6401910|NCT00895934|7314959|FG002|NOT COMPLETED|Dose Escalation||0
6401911|NCT00895934|7314960|FG003|NOT COMPLETED|Dose Escalation||0
6401912|NCT00895934|7314957|FG000|STARTED|Efficacy of Most Tolerated Dose||0
6401913|NCT00895934|7314958|FG001|STARTED|Efficacy of Most Tolerated Dose||0
6401914|NCT00895934|7314959|FG002|STARTED|Efficacy of Most Tolerated Dose||0
6401915|NCT00895934|7314960|FG003|STARTED|Efficacy of Most Tolerated Dose||37
6401916|NCT00895934|7314957|FG000|COMPLETED|Efficacy of Most Tolerated Dose||0
6401917|NCT00895934|7314958|FG001|COMPLETED|Efficacy of Most Tolerated Dose||0
6401918|NCT00895934|7314959|FG002|COMPLETED|Efficacy of Most Tolerated Dose||0
6401919|NCT00895934|7314960|FG003|COMPLETED|Efficacy of Most Tolerated Dose||37
6401920|NCT00895934|7314957|FG000|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
6401921|NCT00895934|7314958|FG001|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
6401922|NCT00895934|7314959|FG002|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
6401923|NCT00895934|7314960|FG003|NOT COMPLETED|Efficacy of Most Tolerated Dose||0
6401924|NCT00895947|7314973|FG000|STARTED|Overall Study||100
6401925|NCT00895947|7314974|FG001|STARTED|Overall Study||100
6401926|NCT00895947|7314973|FG000|COMPLETED|Overall Study||88
6635320|NCT02303574|7564189|FG007|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||7
6401927|NCT00895947|7314974|FG001|COMPLETED|Overall Study||90
6401928|NCT00895947|7314973|FG000|NOT COMPLETED|Overall Study||12
6401929|NCT00895947|7314974|FG001|NOT COMPLETED|Overall Study||10
6401930|NCT00896012|7314982|FG000|STARTED|Overall Study||29
6401931|NCT00896012|7314983|FG001|STARTED|Overall Study||23
6401932|NCT00896012|7314982|FG000|COMPLETED|Overall Study||18
6401933|NCT00896012|7314983|FG001|COMPLETED|Overall Study||12
6401934|NCT00896012|7314982|FG000|NOT COMPLETED|Overall Study||11
6401935|NCT00896012|7314983|FG001|NOT COMPLETED|Overall Study||11
6401936|NCT00896038|7314991|FG000|STARTED|Overall Study||30
6401937|NCT00896038|7314992|FG001|STARTED|Overall Study||28
6401938|NCT00896038|7314991|FG000|COMPLETED|Overall Study||26
6401939|NCT00896038|7314992|FG001|COMPLETED|Overall Study||27
6401940|NCT00896038|7314991|FG000|NOT COMPLETED|Overall Study||4
6401941|NCT00896038|7314992|FG001|NOT COMPLETED|Overall Study||1
6401942|NCT00896051|7315000|FG000|STARTED|Overall Study||25
6401943|NCT00896051|7315001|FG001|STARTED|Overall Study||25
6401944|NCT00896051|7315000|FG000|COMPLETED|Overall Study||15
6401945|NCT00896051|7315001|FG001|COMPLETED|Overall Study||16
6401946|NCT00896051|7315000|FG000|NOT COMPLETED|Overall Study||10
6401947|NCT00896051|7315001|FG001|NOT COMPLETED|Overall Study||9
6401948|NCT00896064|7315018|FG000|STARTED|Overall Study||22
6401949|NCT00896064|7315019|FG001|STARTED|Overall Study||21
6401950|NCT00896064|7315018|FG000|COMPLETED|Overall Study||22
6401951|NCT00896064|7315019|FG001|COMPLETED|Overall Study||21
6401952|NCT00896064|7315018|FG000|NOT COMPLETED|Overall Study||0
6401953|NCT00896064|7315019|FG001|NOT COMPLETED|Overall Study||0
6401954|NCT00896168|7315027|FG000|STARTED|Overall Study||104
6401955|NCT00896168|7315028|FG001|STARTED|Overall Study||130
6401956|NCT00896168|7315027|FG000|COMPLETED|Overall Study||90
6401957|NCT00896168|7315028|FG001|COMPLETED|Overall Study||111
6401958|NCT00896168|7315027|FG000|NOT COMPLETED|Overall Study||14
6401959|NCT00896168|7315028|FG001|NOT COMPLETED|Overall Study||19
6401960|NCT00896181|7315034|FG000|STARTED|Overall Study||26
6401961|NCT00896181|7315034|FG000|COMPLETED|Overall Study||26
6401962|NCT00896181|7315034|FG000|NOT COMPLETED|Overall Study||0
6401963|NCT00896233|7315038|FG000|STARTED|Overall Study||10
6401964|NCT00896233|7315038|FG000|COMPLETED|Overall Study||9
6401965|NCT00896233|7315038|FG000|NOT COMPLETED|Overall Study||1
6401966|NCT00896298|7315045|FG000|STARTED|Overall Study||13
6401967|NCT00896298|7315046|FG001|STARTED|Overall Study||12
6401968|NCT00896298|7315045|FG000|COMPLETED|Overall Study||10
6401969|NCT00896298|7315046|FG001|COMPLETED|Overall Study||9
6401970|NCT00896298|7315045|FG000|NOT COMPLETED|Overall Study||3
6401971|NCT00896298|7315046|FG001|NOT COMPLETED|Overall Study||3
6498676|NCT01411852|7417316|FG000|NOT COMPLETED|Prehospital Intervention Phase||12
6498677|NCT01411852|7417317|FG001|NOT COMPLETED|Prehospital Intervention Phase||7
6498678|NCT01411852|7417316|FG000|STARTED|Hospital Intervention Phase||83
6498679|NCT01411852|7417317|FG001|STARTED|Hospital Intervention Phase||89
6498680|NCT01411852|7417316|FG000|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
6498681|NCT01411852|7417317|FG001|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
6498682|NCT01411852|7417316|FG000|NOT COMPLETED|Hospital Intervention Phase||24
6498683|NCT01411852|7417317|FG001|NOT COMPLETED|Hospital Intervention Phase||18
6498684|NCT01411891|7417327|FG000|STARTED|Overall Study||50
6498685|NCT01411891|7417328|FG001|STARTED|Overall Study||50
6498686|NCT01411891|7417327|FG000|COMPLETED|Overall Study||47
6498687|NCT01411891|7417328|FG001|COMPLETED|Overall Study||48
6498688|NCT01411891|7417327|FG000|NOT COMPLETED|Overall Study||3
6498689|NCT01411891|7417328|FG001|NOT COMPLETED|Overall Study||2
6498690|NCT01411917|7417336|FG000|STARTED|Overall Study||32
6498691|NCT01411917|7417337|FG001|STARTED|Overall Study||37
6498692|NCT01411917|7417336|FG000|COMPLETED|Overall Study||32
6498693|NCT01411917|7417337|FG001|COMPLETED|Overall Study||36
6498694|NCT01411917|7417336|FG000|NOT COMPLETED|Overall Study||0
6498695|NCT01411917|7417337|FG001|NOT COMPLETED|Overall Study||1
6498696|NCT01411995|7417345|FG000|STARTED|Overall Study||100
6498697|NCT01411995|7417346|FG001|STARTED|Overall Study||100
6498698|NCT01411995|7417345|FG000|COMPLETED|Overall Study||100
6498699|NCT01411995|7417346|FG001|COMPLETED|Overall Study||99
6498700|NCT01411995|7417345|FG000|NOT COMPLETED|Overall Study||0
6498701|NCT01411995|7417346|FG001|NOT COMPLETED|Overall Study||1
6498702|NCT01412021|7417352|FG000|STARTED|Overall Study||375
6498703|NCT01412021|7417352|FG000|Case Report Forms Locked|Overall Study||368
6498704|NCT01412021|7417352|FG000|COMPLETED|Overall Study||356
6498705|NCT01412021|7417352|FG000|NOT COMPLETED|Overall Study||19
6498706|NCT01412060|7417356|FG000|STARTED|Open-label Run-in Period (RIP)||765
6498707|NCT01412060|7417357|FG001|STARTED|Open-label Run-in Period (RIP)||0
6498708|NCT01412060|7417358|FG002|STARTED|Open-label Run-in Period (RIP)||0
6498709|NCT01412060|7417356|FG000|COMPLETED|Open-label Run-in Period (RIP)||418
6498710|NCT01412060|7417357|FG001|COMPLETED|Open-label Run-in Period (RIP)||0
6498711|NCT01412060|7417358|FG002|COMPLETED|Open-label Run-in Period (RIP)||0
6498712|NCT01412060|7417356|FG000|NOT COMPLETED|Open-label Run-in Period (RIP)||347
6498713|NCT01412060|7417357|FG001|NOT COMPLETED|Open-label Run-in Period (RIP)||0
6498714|NCT01412060|7417358|FG002|NOT COMPLETED|Open-label Run-in Period (RIP)||0
6498715|NCT01412060|7417356|FG000|STARTED|Period Between RIP and SP||418
6498716|NCT01412060|7417357|FG001|STARTED|Period Between RIP and SP||0
6498717|NCT01412060|7417358|FG002|STARTED|Period Between RIP and SP||0
6498718|NCT01412060|7417356|FG000|COMPLETED|Period Between RIP and SP||364
6401972|NCT00896337|7315052|FG000|STARTED|Overall Study||125
6401973|NCT00896337|7315052|FG000|COMPLETED|Overall Study||100
6401974|NCT00896337|7315052|FG000|NOT COMPLETED|Overall Study||25
6401975|NCT00896363|7315064|FG000|STARTED|Overall Study||31
6401976|NCT00896363|7315065|FG001|STARTED|Overall Study||36
6401977|NCT00896363|7315066|FG002|STARTED|Overall Study||32
6401978|NCT00896363|7315064|FG000|COMPLETED|Overall Study||25
6401979|NCT00896363|7315065|FG001|COMPLETED|Overall Study||25
6401980|NCT00896363|7315066|FG002|COMPLETED|Overall Study||24
6401981|NCT00896363|7315064|FG000|NOT COMPLETED|Overall Study||6
6401982|NCT00896363|7315065|FG001|NOT COMPLETED|Overall Study||11
6401983|NCT00896363|7315066|FG002|NOT COMPLETED|Overall Study||8
6401984|NCT00896441|7315079|FG000|STARTED|Overall Study||17
6401985|NCT00896441|7315080|FG001|STARTED|Overall Study||9
6401986|NCT00896441|7315079|FG000|COMPLETED|Overall Study||15
6401987|NCT00896441|7315080|FG001|COMPLETED|Overall Study||9
6401988|NCT00896441|7315079|FG000|NOT COMPLETED|Overall Study||2
6401989|NCT00896441|7315080|FG001|NOT COMPLETED|Overall Study||0
6401990|NCT00896454|7315085|FG000|STARTED|Overall Study||33
6401991|NCT00896454|7315085|FG000|COMPLETED|Overall Study||0
6401992|NCT00896454|7315085|FG000|NOT COMPLETED|Overall Study||33
6401993|NCT00896480|7315089|FG000|STARTED|Overall Study||24
6401994|NCT00896480|7315089|FG000|COMPLETED|Overall Study||3
6401995|NCT00896480|7315089|FG000|NOT COMPLETED|Overall Study||21
6401996|NCT00896532|7315104|FG000|STARTED|Months 1-24: Romosozumab Treatment Phase||52
6401997|NCT00896532|7315105|FG001|STARTED|Months 1-24: Romosozumab Treatment Phase||51
6401998|NCT00896532|7315106|FG002|STARTED|Months 1-24: Romosozumab Treatment Phase||55
6401999|NCT00896532|7315107|FG003|STARTED|Months 1-24: Romosozumab Treatment Phase||51
6402000|NCT00896532|7315108|FG004|STARTED|Months 1-24: Romosozumab Treatment Phase||54
6402001|NCT00896532|7315109|FG005|STARTED|Months 1-24: Romosozumab Treatment Phase||51
6402002|NCT00896532|7315110|FG006|STARTED|Months 1-24: Romosozumab Treatment Phase||53
6402003|NCT00896532|7315111|FG007|STARTED|Months 1-24: Romosozumab Treatment Phase||52
6402004|NCT00896532|7315112|FG008|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402005|NCT00896532|7315113|FG009|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402006|NCT00896532|7315114|FG010|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402007|NCT00896532|7315115|FG011|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402008|NCT00896532|7315116|FG012|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402009|NCT00896532|7315117|FG013|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402010|NCT00896532|7315118|FG014|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402011|NCT00896532|7315119|FG015|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402012|NCT00896532|7315120|FG016|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402013|NCT00896532|7315121|FG017|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402014|NCT00896532|7315122|FG018|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402015|NCT00896532|7315123|FG019|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402016|NCT00896532|7315124|FG020|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402017|NCT00896532|7315125|FG021|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402018|NCT00896532|7315126|FG022|STARTED|Months 1-24: Romosozumab Treatment Phase||0
6402019|NCT00896532|7315104|FG000|Received Treatment|Months 1-24: Romosozumab Treatment Phase|One participant received 1 dose of romosozumab 70 mg in error|51
6402020|NCT00896532|7315105|FG001|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
6402021|NCT00896532|7315106|FG002|Received Treatment|Months 1-24: Romosozumab Treatment Phase||54
6402022|NCT00896532|7315107|FG003|Received Treatment|Months 1-24: Romosozumab Treatment Phase||49
6402023|NCT00896532|7315108|FG004|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
6402024|NCT00896532|7315109|FG005|Received Treatment|Months 1-24: Romosozumab Treatment Phase||48
6402025|NCT00896532|7315110|FG006|Received Treatment|Months 1-24: Romosozumab Treatment Phase||53
6402026|NCT00896532|7315111|FG007|Received Treatment|Months 1-24: Romosozumab Treatment Phase||51
6402027|NCT00896532|7315112|FG008|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402028|NCT00896532|7315113|FG009|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402029|NCT00896532|7315114|FG010|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402030|NCT00896532|7315115|FG011|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402031|NCT00896532|7315116|FG012|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402032|NCT00896532|7315117|FG013|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402033|NCT00896532|7315118|FG014|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402034|NCT00896532|7315119|FG015|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402035|NCT00896532|7315120|FG016|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402036|NCT00896532|7315121|FG017|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402037|NCT00896532|7315122|FG018|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402038|NCT00896532|7315123|FG019|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402039|NCT00896532|7315124|FG020|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402040|NCT00896532|7315125|FG021|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402041|NCT00896532|7315126|FG022|Received Treatment|Months 1-24: Romosozumab Treatment Phase||0
6402042|NCT00896532|7315104|FG000|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||47
6402043|NCT00896532|7315105|FG001|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
6402044|NCT00896532|7315106|FG002|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
6402045|NCT00896532|7315107|FG003|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||45
6402046|NCT00896532|7315108|FG004|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||50
6402047|NCT00896532|7315109|FG005|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||46
6402048|NCT00896532|7315110|FG006|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||51
6402049|NCT00896532|7315111|FG007|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||49
6402050|NCT00896532|7315112|FG008|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402051|NCT00896532|7315113|FG009|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402052|NCT00896532|7315114|FG010|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402053|NCT00896532|7315115|FG011|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402054|NCT00896532|7315116|FG012|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402055|NCT00896532|7315117|FG013|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402056|NCT00896532|7315118|FG014|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402057|NCT00896532|7315119|FG015|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402058|NCT00896532|7315120|FG016|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402059|NCT00896532|7315121|FG017|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402060|NCT00896532|7315122|FG018|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402061|NCT00896532|7315123|FG019|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402062|NCT00896532|7315124|FG020|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402063|NCT00896532|7315125|FG021|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402064|NCT00896532|7315126|FG022|Completed 12 Months|Months 1-24: Romosozumab Treatment Phase||0
6402065|NCT00896532|7315104|FG000|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
6402066|NCT00896532|7315105|FG001|COMPLETED|Months 1-24: Romosozumab Treatment Phase||45
6402067|NCT00896532|7315106|FG002|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
6402068|NCT00896532|7315107|FG003|COMPLETED|Months 1-24: Romosozumab Treatment Phase||39
6402069|NCT00896532|7315108|FG004|COMPLETED|Months 1-24: Romosozumab Treatment Phase||46
6402070|NCT00896532|7315109|FG005|COMPLETED|Months 1-24: Romosozumab Treatment Phase||43
6402071|NCT00896532|7315110|FG006|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
6402072|NCT00896532|7315111|FG007|COMPLETED|Months 1-24: Romosozumab Treatment Phase||48
6402073|NCT00896532|7315112|FG008|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402074|NCT00896532|7315113|FG009|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402075|NCT00896532|7315114|FG010|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402076|NCT00896532|7315115|FG011|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402077|NCT00896532|7315116|FG012|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402078|NCT00896532|7315117|FG013|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402079|NCT00896532|7315118|FG014|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402080|NCT00896532|7315119|FG015|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402081|NCT00896532|7315120|FG016|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402082|NCT00896532|7315121|FG017|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402083|NCT00896532|7315122|FG018|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402084|NCT00896532|7315123|FG019|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402085|NCT00896532|7315124|FG020|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402086|NCT00896532|7315125|FG021|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402087|NCT00896532|7315126|FG022|COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402088|NCT00896532|7315104|FG000|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
6402089|NCT00896532|7315105|FG001|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||6
6402090|NCT00896532|7315106|FG002|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||9
6402091|NCT00896532|7315107|FG003|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||12
6402092|NCT00896532|7315108|FG004|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
6402093|NCT00896532|7315109|FG005|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||8
6402094|NCT00896532|7315110|FG006|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||5
6402095|NCT00896532|7315111|FG007|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||4
6402096|NCT00896532|7315112|FG008|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402097|NCT00896532|7315113|FG009|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402098|NCT00896532|7315114|FG010|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402099|NCT00896532|7315115|FG011|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402100|NCT00896532|7315116|FG012|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402101|NCT00896532|7315117|FG013|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402102|NCT00896532|7315118|FG014|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402103|NCT00896532|7315119|FG015|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402104|NCT00896532|7315120|FG016|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402105|NCT00896532|7315121|FG017|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402106|NCT00896532|7315122|FG018|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402107|NCT00896532|7315123|FG019|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402108|NCT00896532|7315124|FG020|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402109|NCT00896532|7315125|FG021|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402110|NCT00896532|7315126|FG022|NOT COMPLETED|Months 1-24: Romosozumab Treatment Phase||0
6402111|NCT00896532|7315104|FG000|STARTED|Months 24-36: Denosumab Extension Phase||0
6402112|NCT00896532|7315105|FG001|STARTED|Months 24-36: Denosumab Extension Phase||0
6402113|NCT00896532|7315106|FG002|STARTED|Months 24-36: Denosumab Extension Phase||0
6402114|NCT00896532|7315107|FG003|STARTED|Months 24-36: Denosumab Extension Phase||0
6402115|NCT00896532|7315108|FG004|STARTED|Months 24-36: Denosumab Extension Phase||0
6402116|NCT00896532|7315109|FG005|STARTED|Months 24-36: Denosumab Extension Phase||0
6402117|NCT00896532|7315110|FG006|STARTED|Months 24-36: Denosumab Extension Phase||0
6402118|NCT00896532|7315111|FG007|STARTED|Months 24-36: Denosumab Extension Phase||0
6402119|NCT00896532|7315112|FG008|STARTED|Months 24-36: Denosumab Extension Phase||18
6402120|NCT00896532|7315113|FG009|STARTED|Months 24-36: Denosumab Extension Phase||18
6402121|NCT00896532|7315114|FG010|STARTED|Months 24-36: Denosumab Extension Phase||20
6402122|NCT00896532|7315115|FG011|STARTED|Months 24-36: Denosumab Extension Phase||21
6402123|NCT00896532|7315116|FG012|STARTED|Months 24-36: Denosumab Extension Phase||93
6402124|NCT00896532|7315117|FG013|STARTED|Months 24-36: Denosumab Extension Phase||90
6402125|NCT00896532|7315118|FG014|STARTED|Months 24-36: Denosumab Extension Phase||0
6402126|NCT00896532|7315119|FG015|STARTED|Months 24-36: Denosumab Extension Phase||0
6402127|NCT00896532|7315120|FG016|STARTED|Months 24-36: Denosumab Extension Phase||0
6402128|NCT00896532|7315121|FG017|STARTED|Months 24-36: Denosumab Extension Phase||0
6402129|NCT00896532|7315122|FG018|STARTED|Months 24-36: Denosumab Extension Phase||0
6402130|NCT00896532|7315123|FG019|STARTED|Months 24-36: Denosumab Extension Phase||0
6402131|NCT00896532|7315124|FG020|STARTED|Months 24-36: Denosumab Extension Phase||0
6402132|NCT00896532|7315125|FG021|STARTED|Months 24-36: Denosumab Extension Phase||0
6402133|NCT00896532|7315126|FG022|STARTED|Months 24-36: Denosumab Extension Phase||0
6402134|NCT00896532|7315104|FG000|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402135|NCT00896532|7315105|FG001|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402136|NCT00896532|7315106|FG002|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402137|NCT00896532|7315107|FG003|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402138|NCT00896532|7315108|FG004|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402139|NCT00896532|7315109|FG005|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402140|NCT00896532|7315110|FG006|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402141|NCT00896532|7315111|FG007|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402142|NCT00896532|7315112|FG008|Received Treatment|Months 24-36: Denosumab Extension Phase||18
6402143|NCT00896532|7315113|FG009|Received Treatment|Months 24-36: Denosumab Extension Phase|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|18
6402144|NCT00896532|7315114|FG010|Received Treatment|Months 24-36: Denosumab Extension Phase||19
6402145|NCT00896532|7315115|FG011|Received Treatment|Months 24-36: Denosumab Extension Phase||19
6402146|NCT00896532|7315116|FG012|Received Treatment|Months 24-36: Denosumab Extension Phase||90
6402147|NCT00896532|7315117|FG013|Received Treatment|Months 24-36: Denosumab Extension Phase||88
6402148|NCT00896532|7315118|FG014|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402149|NCT00896532|7315119|FG015|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402150|NCT00896532|7315120|FG016|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402151|NCT00896532|7315121|FG017|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402152|NCT00896532|7315122|FG018|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402153|NCT00896532|7315123|FG019|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402154|NCT00896532|7315124|FG020|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402155|NCT00896532|7315125|FG021|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402156|NCT00896532|7315126|FG022|Received Treatment|Months 24-36: Denosumab Extension Phase||0
6402157|NCT00896532|7315104|FG000|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402158|NCT00896532|7315105|FG001|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402159|NCT00896532|7315106|FG002|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402160|NCT00896532|7315107|FG003|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402161|NCT00896532|7315108|FG004|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402162|NCT00896532|7315109|FG005|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402163|NCT00896532|7315110|FG006|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402164|NCT00896532|7315111|FG007|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402165|NCT00896532|7315112|FG008|COMPLETED|Months 24-36: Denosumab Extension Phase||17
6402166|NCT00896532|7315113|FG009|COMPLETED|Months 24-36: Denosumab Extension Phase||18
6402167|NCT00896532|7315114|FG010|COMPLETED|Months 24-36: Denosumab Extension Phase||18
6402168|NCT00896532|7315115|FG011|COMPLETED|Months 24-36: Denosumab Extension Phase||19
6402169|NCT00896532|7315116|FG012|COMPLETED|Months 24-36: Denosumab Extension Phase||88
6402170|NCT00896532|7315117|FG013|COMPLETED|Months 24-36: Denosumab Extension Phase||88
6402171|NCT00896532|7315118|FG014|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402172|NCT00896532|7315119|FG015|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402173|NCT00896532|7315120|FG016|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402174|NCT00896532|7315121|FG017|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402175|NCT00896532|7315122|FG018|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402176|NCT00896532|7315123|FG019|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402177|NCT00896532|7315124|FG020|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402178|NCT00896532|7315125|FG021|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402179|NCT00896532|7315126|FG022|COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402180|NCT00896532|7315104|FG000|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402181|NCT00896532|7315105|FG001|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402182|NCT00896532|7315106|FG002|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402183|NCT00896532|7315107|FG003|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6498719|NCT01412060|7417357|FG001|COMPLETED|Period Between RIP and SP||0
6402184|NCT00896532|7315108|FG004|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402185|NCT00896532|7315109|FG005|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402186|NCT00896532|7315110|FG006|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402187|NCT00896532|7315111|FG007|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402188|NCT00896532|7315112|FG008|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||1
6402189|NCT00896532|7315113|FG009|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402190|NCT00896532|7315114|FG010|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
6402191|NCT00896532|7315115|FG011|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
6402192|NCT00896532|7315116|FG012|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||5
6402193|NCT00896532|7315117|FG013|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||2
6402194|NCT00896532|7315118|FG014|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402195|NCT00896532|7315119|FG015|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402196|NCT00896532|7315120|FG016|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402197|NCT00896532|7315121|FG017|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402198|NCT00896532|7315122|FG018|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402199|NCT00896532|7315123|FG019|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402200|NCT00896532|7315124|FG020|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402201|NCT00896532|7315125|FG021|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402202|NCT00896532|7315126|FG022|NOT COMPLETED|Months 24-36: Denosumab Extension Phase||0
6402203|NCT00896532|7315104|FG000|STARTED|Months 36-48: Romosozumab Retreatment||0
6402204|NCT00896532|7315105|FG001|STARTED|Months 36-48: Romosozumab Retreatment||0
6402205|NCT00896532|7315106|FG002|STARTED|Months 36-48: Romosozumab Retreatment||0
6402206|NCT00896532|7315107|FG003|STARTED|Months 36-48: Romosozumab Retreatment||0
6402207|NCT00896532|7315108|FG004|STARTED|Months 36-48: Romosozumab Retreatment||0
6402208|NCT00896532|7315109|FG005|STARTED|Months 36-48: Romosozumab Retreatment||0
6402209|NCT00896532|7315110|FG006|STARTED|Months 36-48: Romosozumab Retreatment||0
6402210|NCT00896532|7315111|FG007|STARTED|Months 36-48: Romosozumab Retreatment||0
6402211|NCT00896532|7315112|FG008|STARTED|Months 36-48: Romosozumab Retreatment||0
6402212|NCT00896532|7315113|FG009|STARTED|Months 36-48: Romosozumab Retreatment||0
6402213|NCT00896532|7315114|FG010|STARTED|Months 36-48: Romosozumab Retreatment||0
6402214|NCT00896532|7315115|FG011|STARTED|Months 36-48: Romosozumab Retreatment||0
6402215|NCT00896532|7315116|FG012|STARTED|Months 36-48: Romosozumab Retreatment||0
6402216|NCT00896532|7315117|FG013|STARTED|Months 36-48: Romosozumab Retreatment||0
6402217|NCT00896532|7315118|FG014|STARTED|Months 36-48: Romosozumab Retreatment||12
6402218|NCT00896532|7315119|FG015|STARTED|Months 36-48: Romosozumab Retreatment||16
6402219|NCT00896532|7315120|FG016|STARTED|Months 36-48: Romosozumab Retreatment||72
6402220|NCT00896532|7315121|FG017|STARTED|Months 36-48: Romosozumab Retreatment||67
6402221|NCT00896532|7315122|FG018|STARTED|Months 36-48: Romosozumab Retreatment||0
6402222|NCT00896532|7315123|FG019|STARTED|Months 36-48: Romosozumab Retreatment||0
6402223|NCT00896532|7315124|FG020|STARTED|Months 36-48: Romosozumab Retreatment||0
6402224|NCT00896532|7315125|FG021|STARTED|Months 36-48: Romosozumab Retreatment||0
6402225|NCT00896532|7315126|FG022|STARTED|Months 36-48: Romosozumab Retreatment||0
6402226|NCT00896532|7315104|FG000|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402227|NCT00896532|7315105|FG001|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402228|NCT00896532|7315106|FG002|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402229|NCT00896532|7315107|FG003|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402230|NCT00896532|7315108|FG004|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402231|NCT00896532|7315109|FG005|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402232|NCT00896532|7315110|FG006|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402233|NCT00896532|7315111|FG007|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402234|NCT00896532|7315112|FG008|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402235|NCT00896532|7315113|FG009|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402236|NCT00896532|7315114|FG010|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402237|NCT00896532|7315115|FG011|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402238|NCT00896532|7315116|FG012|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402239|NCT00896532|7315117|FG013|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402240|NCT00896532|7315118|FG014|Received Romosozumab|Months 36-48: Romosozumab Retreatment||12
6402241|NCT00896532|7315119|FG015|Received Romosozumab|Months 36-48: Romosozumab Retreatment|Includes one participant who received 1 dose of romosozumab 70 mg in error in first 12 months|16
6402242|NCT00896532|7315120|FG016|Received Romosozumab|Months 36-48: Romosozumab Retreatment||72
6402243|NCT00896532|7315121|FG017|Received Romosozumab|Months 36-48: Romosozumab Retreatment||67
6402244|NCT00896532|7315122|FG018|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402245|NCT00896532|7315123|FG019|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402246|NCT00896532|7315124|FG020|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402247|NCT00896532|7315125|FG021|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402248|NCT00896532|7315126|FG022|Received Romosozumab|Months 36-48: Romosozumab Retreatment||0
6402249|NCT00896532|7315104|FG000|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402250|NCT00896532|7315105|FG001|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402251|NCT00896532|7315106|FG002|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6498720|NCT01412060|7417358|FG002|COMPLETED|Period Between RIP and SP||0
6402252|NCT00896532|7315107|FG003|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402253|NCT00896532|7315108|FG004|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402254|NCT00896532|7315109|FG005|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402255|NCT00896532|7315110|FG006|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402256|NCT00896532|7315111|FG007|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402257|NCT00896532|7315112|FG008|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402258|NCT00896532|7315113|FG009|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402259|NCT00896532|7315114|FG010|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402260|NCT00896532|7315115|FG011|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402261|NCT00896532|7315116|FG012|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402262|NCT00896532|7315117|FG013|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402263|NCT00896532|7315118|FG014|COMPLETED|Months 36-48: Romosozumab Retreatment||12
6402264|NCT00896532|7315119|FG015|COMPLETED|Months 36-48: Romosozumab Retreatment||14
6402265|NCT00896532|7315120|FG016|COMPLETED|Months 36-48: Romosozumab Retreatment||65
6402266|NCT00896532|7315121|FG017|COMPLETED|Months 36-48: Romosozumab Retreatment||64
6402267|NCT00896532|7315122|FG018|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402268|NCT00896532|7315123|FG019|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402269|NCT00896532|7315124|FG020|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402270|NCT00896532|7315125|FG021|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402271|NCT00896532|7315126|FG022|COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402272|NCT00896532|7315104|FG000|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402273|NCT00896532|7315105|FG001|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402274|NCT00896532|7315106|FG002|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402275|NCT00896532|7315107|FG003|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402276|NCT00896532|7315108|FG004|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402277|NCT00896532|7315109|FG005|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402278|NCT00896532|7315110|FG006|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402279|NCT00896532|7315111|FG007|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402280|NCT00896532|7315112|FG008|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402281|NCT00896532|7315113|FG009|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402282|NCT00896532|7315114|FG010|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402283|NCT00896532|7315115|FG011|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402284|NCT00896532|7315116|FG012|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402285|NCT00896532|7315117|FG013|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402286|NCT00896532|7315118|FG014|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402287|NCT00896532|7315119|FG015|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||2
6402288|NCT00896532|7315120|FG016|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||7
6402289|NCT00896532|7315121|FG017|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||3
6402290|NCT00896532|7315122|FG018|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402291|NCT00896532|7315123|FG019|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402292|NCT00896532|7315124|FG020|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402293|NCT00896532|7315125|FG021|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402294|NCT00896532|7315126|FG022|NOT COMPLETED|Months 36-48: Romosozumab Retreatment||0
6402295|NCT00896532|7315104|FG000|STARTED|Months 48-72: Follow-on Phase||0
6402296|NCT00896532|7315105|FG001|STARTED|Months 48-72: Follow-on Phase||0
6402297|NCT00896532|7315106|FG002|STARTED|Months 48-72: Follow-on Phase||0
6402298|NCT00896532|7315107|FG003|STARTED|Months 48-72: Follow-on Phase||0
6402299|NCT00896532|7315108|FG004|STARTED|Months 48-72: Follow-on Phase||0
6402300|NCT00896532|7315109|FG005|STARTED|Months 48-72: Follow-on Phase||0
6402301|NCT00896532|7315110|FG006|STARTED|Months 48-72: Follow-on Phase||0
6402302|NCT00896532|7315111|FG007|STARTED|Months 48-72: Follow-on Phase||0
6402303|NCT00896532|7315112|FG008|STARTED|Months 48-72: Follow-on Phase||0
6402304|NCT00896532|7315113|FG009|STARTED|Months 48-72: Follow-on Phase||0
6402305|NCT00896532|7315114|FG010|STARTED|Months 48-72: Follow-on Phase||0
6402306|NCT00896532|7315115|FG011|STARTED|Months 48-72: Follow-on Phase||0
6402307|NCT00896532|7315116|FG012|STARTED|Months 48-72: Follow-on Phase||0
6402308|NCT00896532|7315117|FG013|STARTED|Months 48-72: Follow-on Phase||0
6402309|NCT00896532|7315118|FG014|STARTED|Months 48-72: Follow-on Phase||0
6402310|NCT00896532|7315119|FG015|STARTED|Months 48-72: Follow-on Phase||0
6402311|NCT00896532|7315120|FG016|STARTED|Months 48-72: Follow-on Phase||0
6402312|NCT00896532|7315121|FG017|STARTED|Months 48-72: Follow-on Phase||0
6402313|NCT00896532|7315122|FG018|STARTED|Months 48-72: Follow-on Phase||51
6402314|NCT00896532|7315123|FG019|STARTED|Months 48-72: Follow-on Phase||11
6402315|NCT00896532|7315124|FG020|STARTED|Months 48-72: Follow-on Phase||12
6402316|NCT00896532|7315125|FG021|STARTED|Months 48-72: Follow-on Phase||59
6402317|NCT00896532|7315126|FG022|STARTED|Months 48-72: Follow-on Phase||8
6402318|NCT00896532|7315104|FG000|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402319|NCT00896532|7315105|FG001|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402320|NCT00896532|7315106|FG002|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402321|NCT00896532|7315107|FG003|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402322|NCT00896532|7315108|FG004|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6635321|NCT02303574|7564190|FG008|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||10
6635322|NCT02303574|7564191|FG009|COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||12
6402323|NCT00896532|7315109|FG005|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402324|NCT00896532|7315110|FG006|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402325|NCT00896532|7315111|FG007|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402326|NCT00896532|7315112|FG008|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402327|NCT00896532|7315113|FG009|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402328|NCT00896532|7315114|FG010|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402329|NCT00896532|7315115|FG011|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402330|NCT00896532|7315116|FG012|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402331|NCT00896532|7315117|FG013|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402332|NCT00896532|7315118|FG014|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402333|NCT00896532|7315119|FG015|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402334|NCT00896532|7315120|FG016|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402335|NCT00896532|7315121|FG017|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402336|NCT00896532|7315122|FG018|Received Zoledronic Acid|Months 48-72: Follow-on Phase||0
6402337|NCT00896532|7315123|FG019|Received Zoledronic Acid|Months 48-72: Follow-on Phase||11
6402338|NCT00896532|7315124|FG020|Received Zoledronic Acid|Months 48-72: Follow-on Phase||12
6402339|NCT00896532|7315125|FG021|Received Zoledronic Acid|Months 48-72: Follow-on Phase||56
6635323|NCT02303574|7564182|FG000|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635324|NCT02303574|7564183|FG001|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635325|NCT02303574|7564184|FG002|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635326|NCT02303574|7564185|FG003|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635327|NCT02303574|7564186|FG004|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635328|NCT02303574|7564187|FG005|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6402340|NCT00896532|7315126|FG022|Received Zoledronic Acid|Months 48-72: Follow-on Phase||8
6402341|NCT00896532|7315104|FG000|COMPLETED|Months 48-72: Follow-on Phase||0
6402342|NCT00896532|7315105|FG001|COMPLETED|Months 48-72: Follow-on Phase||0
6402343|NCT00896532|7315106|FG002|COMPLETED|Months 48-72: Follow-on Phase||0
6402344|NCT00896532|7315107|FG003|COMPLETED|Months 48-72: Follow-on Phase||0
6402345|NCT00896532|7315108|FG004|COMPLETED|Months 48-72: Follow-on Phase||0
6402346|NCT00896532|7315109|FG005|COMPLETED|Months 48-72: Follow-on Phase||0
6402347|NCT00896532|7315110|FG006|COMPLETED|Months 48-72: Follow-on Phase||0
6402348|NCT00896532|7315111|FG007|COMPLETED|Months 48-72: Follow-on Phase||0
6402349|NCT00896532|7315112|FG008|COMPLETED|Months 48-72: Follow-on Phase||0
6402350|NCT00896532|7315113|FG009|COMPLETED|Months 48-72: Follow-on Phase||0
6402351|NCT00896532|7315114|FG010|COMPLETED|Months 48-72: Follow-on Phase||0
6402352|NCT00896532|7315115|FG011|COMPLETED|Months 48-72: Follow-on Phase||0
6402353|NCT00896532|7315116|FG012|COMPLETED|Months 48-72: Follow-on Phase||0
6402354|NCT00896532|7315117|FG013|COMPLETED|Months 48-72: Follow-on Phase||0
6402355|NCT00896532|7315118|FG014|COMPLETED|Months 48-72: Follow-on Phase||0
6402356|NCT00896532|7315119|FG015|COMPLETED|Months 48-72: Follow-on Phase||0
6402357|NCT00896532|7315120|FG016|COMPLETED|Months 48-72: Follow-on Phase||0
6402358|NCT00896532|7315121|FG017|COMPLETED|Months 48-72: Follow-on Phase||0
6402359|NCT00896532|7315122|FG018|COMPLETED|Months 48-72: Follow-on Phase||50
6402360|NCT00896532|7315123|FG019|COMPLETED|Months 48-72: Follow-on Phase||11
6402361|NCT00896532|7315124|FG020|COMPLETED|Months 48-72: Follow-on Phase||12
6402362|NCT00896532|7315125|FG021|COMPLETED|Months 48-72: Follow-on Phase||57
6402363|NCT00896532|7315126|FG022|COMPLETED|Months 48-72: Follow-on Phase||8
6402364|NCT00896532|7315104|FG000|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402365|NCT00896532|7315105|FG001|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402366|NCT00896532|7315106|FG002|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402367|NCT00896532|7315107|FG003|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402368|NCT00896532|7315108|FG004|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402369|NCT00896532|7315109|FG005|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402370|NCT00896532|7315110|FG006|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402371|NCT00896532|7315111|FG007|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402372|NCT00896532|7315112|FG008|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402373|NCT00896532|7315113|FG009|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402374|NCT00896532|7315114|FG010|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402375|NCT00896532|7315115|FG011|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402376|NCT00896532|7315116|FG012|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402377|NCT00896532|7315117|FG013|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402378|NCT00896532|7315118|FG014|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402379|NCT00896532|7315119|FG015|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402380|NCT00896532|7315120|FG016|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402381|NCT00896532|7315121|FG017|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402382|NCT00896532|7315122|FG018|NOT COMPLETED|Months 48-72: Follow-on Phase||1
6402383|NCT00896532|7315123|FG019|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402384|NCT00896532|7315124|FG020|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6635329|NCT02303574|7564188|FG006|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635330|NCT02303574|7564189|FG007|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||1
6402385|NCT00896532|7315125|FG021|NOT COMPLETED|Months 48-72: Follow-on Phase||2
6402386|NCT00896532|7315126|FG022|NOT COMPLETED|Months 48-72: Follow-on Phase||0
6402387|NCT00896649|7315173|FG000|STARTED|Overall Study||193
6402388|NCT00896649|7315173|FG000|COMPLETED|Overall Study||188
6402389|NCT00896649|7315173|FG000|NOT COMPLETED|Overall Study||5
6402390|NCT00896779|7315180|FG000|STARTED|Overall Study||8
6402391|NCT00896779|7315181|FG001|STARTED|Overall Study||12
6402392|NCT00896779|7315180|FG000|COMPLETED|Overall Study||8
6402393|NCT00896779|7315181|FG001|COMPLETED|Overall Study||11
6402394|NCT00896779|7315180|FG000|NOT COMPLETED|Overall Study||0
6402395|NCT00896779|7315181|FG001|NOT COMPLETED|Overall Study||1
6402396|NCT00897390|7315187|FG000|STARTED|Overall Study||24
6402397|NCT00897390|7315187|FG000|COMPLETED|Overall Study||18
6402398|NCT00897390|7315187|FG000|NOT COMPLETED|Overall Study||6
6402399|NCT00897676|7315198|FG000|STARTED|Intervention 1(6 Hours)||9
6402400|NCT00897676|7315199|FG001|STARTED|Intervention 1(6 Hours)||7
6402401|NCT00897676|7315198|FG000|COMPLETED|Intervention 1(6 Hours)||9
6402402|NCT00897676|7315199|FG001|COMPLETED|Intervention 1(6 Hours)||7
6402403|NCT00897676|7315198|FG000|NOT COMPLETED|Intervention 1(6 Hours)||0
6402404|NCT00897676|7315199|FG001|NOT COMPLETED|Intervention 1(6 Hours)||0
6402405|NCT00897676|7315198|FG000|STARTED|Intervention 2(6 Hours)||9
6402406|NCT00897676|7315199|FG001|STARTED|Intervention 2(6 Hours)||7
6402407|NCT00897676|7315198|FG000|COMPLETED|Intervention 2(6 Hours)||9
6402408|NCT00897676|7315199|FG001|COMPLETED|Intervention 2(6 Hours)||7
6402409|NCT00897676|7315198|FG000|NOT COMPLETED|Intervention 2(6 Hours)||0
6402410|NCT00897676|7315199|FG001|NOT COMPLETED|Intervention 2(6 Hours)||0
6402411|NCT00897715|7315214|FG000|STARTED|Overall Study||8
6402412|NCT00897715|7315215|FG001|STARTED|Overall Study||7
6402413|NCT00897715|7315214|FG000|COMPLETED|Overall Study||6
6402414|NCT00897715|7315215|FG001|COMPLETED|Overall Study||6
6402415|NCT00897715|7315214|FG000|NOT COMPLETED|Overall Study||2
6402416|NCT00897715|7315215|FG001|NOT COMPLETED|Overall Study||1
6402417|NCT00897897|7315221|FG000|STARTED|Overall Study||33
6402418|NCT00897897|7315221|FG000|COMPLETED|Overall Study||33
6402419|NCT00897897|7315221|FG000|NOT COMPLETED|Overall Study||0
6402420|NCT00898222|7315225|FG000|STARTED|Overall Study||4
6402421|NCT00898222|7315225|FG000|COMPLETED|Overall Study||4
6402422|NCT00898222|7315225|FG000|NOT COMPLETED|Overall Study||0
6402423|NCT00898443|7315231|FG000|STARTED|Overall Study||10
6402424|NCT00898443|7315232|FG001|STARTED|Overall Study||8
6402425|NCT00898443|7315231|FG000|COMPLETED|Overall Study||9
6402426|NCT00898443|7315232|FG001|COMPLETED|Overall Study||8
6402427|NCT00898443|7315231|FG000|NOT COMPLETED|Overall Study||1
6402428|NCT00898443|7315232|FG001|NOT COMPLETED|Overall Study||0
6402429|NCT00898560|7315238|FG000|STARTED|Overall Study||20
6402430|NCT00898560|7315238|FG000|COMPLETED|Overall Study||19
6402431|NCT00898560|7315238|FG000|NOT COMPLETED|Overall Study||1
6304148|NCT00364533|7207456|FG000|NOT COMPLETED|Overall Study||42
6304149|NCT00364533|7207457|FG001|NOT COMPLETED|Overall Study||40
6304150|NCT00364533|7207458|FG002|NOT COMPLETED|Overall Study||45
6402432|NCT00898807|7315246|FG000|STARTED|Overall Study||94
6402433|NCT00898807|7315247|FG001|STARTED|Overall Study||92
6402434|NCT00898807|7315246|FG000|COMPLETED|Overall Study||86
6402435|NCT00898807|7315247|FG001|COMPLETED|Overall Study||83
6402436|NCT00898807|7315246|FG000|NOT COMPLETED|Overall Study||8
6402437|NCT00898807|7315247|FG001|NOT COMPLETED|Overall Study||9
6402438|NCT00898937|7315256|FG000|STARTED|Overall Study||25
6402439|NCT00898937|7315257|FG001|STARTED|Overall Study||21
6402440|NCT00898937|7315258|FG002|STARTED|Overall Study||9
6402441|NCT00898937|7315256|FG000|COMPLETED|Overall Study||25
6402442|NCT00898937|7315257|FG001|COMPLETED|Overall Study||21
6402443|NCT00898937|7315258|FG002|COMPLETED|Overall Study||9
6402444|NCT00898937|7315256|FG000|NOT COMPLETED|Overall Study||0
6402445|NCT00898937|7315257|FG001|NOT COMPLETED|Overall Study||0
6402446|NCT00898937|7315258|FG002|NOT COMPLETED|Overall Study||0
6402447|NCT00899353|7315266|FG000|STARTED|Overall Study||16
6402448|NCT00899353|7315266|FG000|COMPLETED|Overall Study||11
6402449|NCT00899353|7315266|FG000|NOT COMPLETED|Overall Study||5
6402450|NCT00899392|7315289|FG000|STARTED|Overall Study||68
6402451|NCT00899392|7315290|FG001|STARTED|Overall Study||74
6510163|NCT01479621|7429700|FG005|Full Analysis Set|Treatment Period||102
6510164|NCT01479621|7429701|FG006|Full Analysis Set|Treatment Period||102
6510165|NCT01479621|7429695|FG000|COMPLETED|Treatment Period||0
6510166|NCT01479621|7429696|FG001|COMPLETED|Treatment Period||79
6510167|NCT01479621|7429697|FG002|COMPLETED|Treatment Period||83
6510168|NCT01479621|7429698|FG003|COMPLETED|Treatment Period||92
6510169|NCT01479621|7429699|FG004|COMPLETED|Treatment Period||82
6402452|NCT00899392|7315289|FG000|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
6402453|NCT00899392|7315290|FG001|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
6402454|NCT00899392|7315289|FG000|NOT COMPLETED|Overall Study||21
6402455|NCT00899392|7315290|FG001|NOT COMPLETED|Overall Study||24
6402456|NCT00899431|7315299|FG000|STARTED|Overall Study||22
6402457|NCT00899431|7315300|FG001|STARTED|Overall Study||8
6304151|NCT00364533|7207459|FG003|NOT COMPLETED|Overall Study||31
6304152|NCT00364533|7207460|FG004|NOT COMPLETED|Overall Study||51
6304153|NCT00364611|7207474|FG000|STARTED|Overall Study||52
6304154|NCT00364611|7207475|FG001|STARTED|Overall Study||21
6304155|NCT00364611|7207474|FG000|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
6304156|NCT00364611|7207475|FG001|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
6304157|NCT00364611|7207474|FG000|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
6304158|NCT00364611|7207475|FG001|COMPLETED|Overall Study||0
6304159|NCT00364611|7207474|FG000|NOT COMPLETED|Overall Study||51
6402458|NCT00899431|7315301|FG002|STARTED|Overall Study||9
6402459|NCT00899431|7315299|FG000|COMPLETED|Overall Study||21
6402460|NCT00899431|7315300|FG001|COMPLETED|Overall Study||8
6402461|NCT00899431|7315301|FG002|COMPLETED|Overall Study||9
6402462|NCT00899431|7315299|FG000|NOT COMPLETED|Overall Study||1
6402463|NCT00899431|7315300|FG001|NOT COMPLETED|Overall Study||0
6402464|NCT00899431|7315301|FG002|NOT COMPLETED|Overall Study||0
6402465|NCT00899470|7315312|FG000|STARTED|First Therapy||6
6402466|NCT00899470|7315313|FG001|STARTED|First Therapy||6
6402467|NCT00899470|7315314|FG002|STARTED|First Therapy||6
6402468|NCT00899470|7315315|FG003|STARTED|First Therapy||6
6402469|NCT00899470|7315312|FG000|COMPLETED|First Therapy||6
6402470|NCT00899470|7315313|FG001|COMPLETED|First Therapy||6
6402471|NCT00899470|7315314|FG002|COMPLETED|First Therapy||6
6402472|NCT00899470|7315315|FG003|COMPLETED|First Therapy||6
6402473|NCT00899470|7315312|FG000|NOT COMPLETED|First Therapy||0
6402474|NCT00899470|7315313|FG001|NOT COMPLETED|First Therapy||0
6402475|NCT00899470|7315314|FG002|NOT COMPLETED|First Therapy||0
6402476|NCT00899470|7315315|FG003|NOT COMPLETED|First Therapy||0
6402477|NCT00899470|7315312|FG000|STARTED|First Washout Period||6
6402478|NCT00899470|7315313|FG001|STARTED|First Washout Period||6
6402479|NCT00899470|7315314|FG002|STARTED|First Washout Period||6
6402480|NCT00899470|7315315|FG003|STARTED|First Washout Period||6
6402481|NCT00899470|7315312|FG000|COMPLETED|First Washout Period||6
6402482|NCT00899470|7315313|FG001|COMPLETED|First Washout Period||6
6402483|NCT00899470|7315314|FG002|COMPLETED|First Washout Period||6
6402484|NCT00899470|7315315|FG003|COMPLETED|First Washout Period||6
6402485|NCT00899470|7315312|FG000|NOT COMPLETED|First Washout Period||0
6402486|NCT00899470|7315313|FG001|NOT COMPLETED|First Washout Period||0
6402487|NCT00899470|7315314|FG002|NOT COMPLETED|First Washout Period||0
6402488|NCT00899470|7315315|FG003|NOT COMPLETED|First Washout Period||0
6402489|NCT00899470|7315312|FG000|STARTED|Second Therapy||6
6402490|NCT00899470|7315313|FG001|STARTED|Second Therapy||6
6402491|NCT00899470|7315314|FG002|STARTED|Second Therapy||6
6402492|NCT00899470|7315315|FG003|STARTED|Second Therapy||6
6402493|NCT00899470|7315312|FG000|COMPLETED|Second Therapy||6
6402494|NCT00899470|7315313|FG001|COMPLETED|Second Therapy||6
6402495|NCT00899470|7315314|FG002|COMPLETED|Second Therapy||6
6402496|NCT00899470|7315315|FG003|COMPLETED|Second Therapy||6
6402497|NCT00899470|7315312|FG000|NOT COMPLETED|Second Therapy||0
6402498|NCT00899470|7315313|FG001|NOT COMPLETED|Second Therapy||0
6402499|NCT00899470|7315314|FG002|NOT COMPLETED|Second Therapy||0
6402500|NCT00899470|7315315|FG003|NOT COMPLETED|Second Therapy||0
6402501|NCT00899470|7315312|FG000|STARTED|Second Washout||6
6402502|NCT00899470|7315313|FG001|STARTED|Second Washout||6
6402503|NCT00899470|7315314|FG002|STARTED|Second Washout||6
6402504|NCT00899470|7315315|FG003|STARTED|Second Washout||6
6402505|NCT00899470|7315312|FG000|COMPLETED|Second Washout||6
6402506|NCT00899470|7315313|FG001|COMPLETED|Second Washout||6
6402507|NCT00899470|7315314|FG002|COMPLETED|Second Washout||6
6402508|NCT00899470|7315315|FG003|COMPLETED|Second Washout||6
6402509|NCT00899470|7315312|FG000|NOT COMPLETED|Second Washout||0
6402510|NCT00899470|7315313|FG001|NOT COMPLETED|Second Washout||0
6402511|NCT00899470|7315314|FG002|NOT COMPLETED|Second Washout||0
6402512|NCT00899470|7315315|FG003|NOT COMPLETED|Second Washout||0
6402513|NCT00899470|7315312|FG000|STARTED|Third Therapy||6
6402514|NCT00899470|7315313|FG001|STARTED|Third Therapy||6
6402515|NCT00899470|7315314|FG002|STARTED|Third Therapy||6
6402516|NCT00899470|7315315|FG003|STARTED|Third Therapy||6
6402517|NCT00899470|7315312|FG000|COMPLETED|Third Therapy||6
6402518|NCT00899470|7315313|FG001|COMPLETED|Third Therapy||6
6402519|NCT00899470|7315314|FG002|COMPLETED|Third Therapy||6
6402520|NCT00899470|7315315|FG003|COMPLETED|Third Therapy||6
6402521|NCT00899470|7315312|FG000|NOT COMPLETED|Third Therapy||0
6402522|NCT00899470|7315313|FG001|NOT COMPLETED|Third Therapy||0
6402523|NCT00899470|7315314|FG002|NOT COMPLETED|Third Therapy||0
6402524|NCT00899470|7315315|FG003|NOT COMPLETED|Third Therapy||0
6402525|NCT00899470|7315312|FG000|STARTED|Third Washout||6
6402526|NCT00899470|7315313|FG001|STARTED|Third Washout||6
6402527|NCT00899470|7315314|FG002|STARTED|Third Washout||6
6402528|NCT00899470|7315315|FG003|STARTED|Third Washout||6
6402529|NCT00899470|7315312|FG000|COMPLETED|Third Washout||6
6402530|NCT00899470|7315313|FG001|COMPLETED|Third Washout||6
6402531|NCT00899470|7315314|FG002|COMPLETED|Third Washout||6
6402532|NCT00899470|7315315|FG003|COMPLETED|Third Washout||6
6402533|NCT00899470|7315312|FG000|NOT COMPLETED|Third Washout||0
6402534|NCT00899470|7315313|FG001|NOT COMPLETED|Third Washout||0
6402535|NCT00899470|7315314|FG002|NOT COMPLETED|Third Washout||0
6402536|NCT00899470|7315315|FG003|NOT COMPLETED|Third Washout||0
6402537|NCT00899470|7315312|FG000|STARTED|Fourth Therapy||6
6402538|NCT00899470|7315313|FG001|STARTED|Fourth Therapy||6
6402539|NCT00899470|7315314|FG002|STARTED|Fourth Therapy||6
6402540|NCT00899470|7315315|FG003|STARTED|Fourth Therapy||6
6402541|NCT00899470|7315312|FG000|COMPLETED|Fourth Therapy||6
6402542|NCT00899470|7315313|FG001|COMPLETED|Fourth Therapy||6
6402543|NCT00899470|7315314|FG002|COMPLETED|Fourth Therapy||6
6402544|NCT00899470|7315315|FG003|COMPLETED|Fourth Therapy||6
6402545|NCT00899470|7315312|FG000|NOT COMPLETED|Fourth Therapy||0
6402546|NCT00899470|7315313|FG001|NOT COMPLETED|Fourth Therapy||0
6402547|NCT00899470|7315314|FG002|NOT COMPLETED|Fourth Therapy||0
6402548|NCT00899470|7315315|FG003|NOT COMPLETED|Fourth Therapy||0
6402549|NCT00899548|7315330|FG000|STARTED|Overall Study||182
6402550|NCT00899548|7315330|FG000|COMPLETED|Overall Study||179
6402551|NCT00899548|7315330|FG000|NOT COMPLETED|Overall Study||3
6402552|NCT00899574|7315338|FG000|STARTED|Overall Study||10
6402553|NCT00899574|7315338|FG000|COMPLETED|Overall Study||10
6402554|NCT00899574|7315338|FG000|NOT COMPLETED|Overall Study||0
6402555|NCT00899600|7315344|FG000|STARTED|Overall Study||50
6402556|NCT00899600|7315345|FG001|STARTED|Overall Study||52
6635331|NCT02303574|7564190|FG008|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635332|NCT02303574|7564191|FG009|NOT COMPLETED|Part 2 - Multiple Ascending Dose (MAD)||0
6635333|NCT02303704|7564226|FG000|STARTED|Overall Study||220
6635334|NCT02303704|7564227|FG001|STARTED|Overall Study||228
6402557|NCT00899600|7315344|FG000|COMPLETED|Overall Study||50
6402558|NCT00899600|7315345|FG001|COMPLETED|Overall Study||52
6402559|NCT00899600|7315344|FG000|NOT COMPLETED|Overall Study||0
6402560|NCT00899600|7315345|FG001|NOT COMPLETED|Overall Study||0
6402561|NCT00899678|7315354|FG000|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
6402562|NCT00899678|7315355|FG001|STARTED|Induction Period (Weeks 0 to 6)||37
6402563|NCT00899678|7315356|FG002|STARTED|Induction Period (Weeks 0 to 6)||35
6402564|NCT00899678|7315354|FG000|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
6402565|NCT00899678|7315355|FG001|COMPLETED|Induction Period (Weeks 0 to 6)||37
6402566|NCT00899678|7315356|FG002|COMPLETED|Induction Period (Weeks 0 to 6)||35
6402567|NCT00899678|7315354|FG000|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
6402568|NCT00899678|7315355|FG001|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
6402569|NCT00899678|7315356|FG002|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
6402570|NCT00899678|7315354|FG000|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
6402571|NCT00899678|7315355|FG001|STARTED|Maintenance Period (Weeks 8 to 62)||37
6402572|NCT00899678|7315356|FG002|STARTED|Maintenance Period (Weeks 8 to 62)||35
6402573|NCT00899678|7315354|FG000|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
6402574|NCT00899678|7315355|FG001|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
6402575|NCT00899678|7315356|FG002|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
6402576|NCT00899678|7315354|FG000|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
6402577|NCT00899678|7315355|FG001|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
6402578|NCT00899678|7315356|FG002|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
6402579|NCT00899717|7315366|FG000|STARTED|Overall Study||10
6402580|NCT00899717|7315367|FG001|STARTED|Overall Study||11
6402581|NCT00899717|7315366|FG000|COMPLETED|Overall Study||10
6402582|NCT00899717|7315367|FG001|COMPLETED|Overall Study||11
6402583|NCT00899717|7315366|FG000|NOT COMPLETED|Overall Study||0
6402584|NCT00899717|7315367|FG001|NOT COMPLETED|Overall Study||0
6402585|NCT00899847|7315379|FG000|STARTED|Overall Study||9
6402586|NCT00899847|7315379|FG000|COMPLETED|Overall Study||7
6402587|NCT00899847|7315379|FG000|NOT COMPLETED|Overall Study||2
6402588|NCT00900029|7315390|FG000|STARTED|Overall Study||38
6402589|NCT00900029|7315391|FG001|STARTED|Overall Study||41
6402590|NCT00900029|7315392|FG002|STARTED|Overall Study||41
6402591|NCT00900029|7315393|FG003|STARTED|Overall Study||42
6402592|NCT00900029|7315394|FG004|STARTED|Overall Study||44
6402593|NCT00900029|7315390|FG000|COMPLETED|Overall Study||35
6402594|NCT00900029|7315391|FG001|COMPLETED|Overall Study||37
6402595|NCT00900029|7315392|FG002|COMPLETED|Overall Study||38
6402596|NCT00900029|7315393|FG003|COMPLETED|Overall Study||35
6402597|NCT00900029|7315394|FG004|COMPLETED|Overall Study||38
6402598|NCT00900029|7315390|FG000|NOT COMPLETED|Overall Study||3
6402599|NCT00900029|7315391|FG001|NOT COMPLETED|Overall Study||4
6402600|NCT00900029|7315392|FG002|NOT COMPLETED|Overall Study||3
6402601|NCT00900029|7315393|FG003|NOT COMPLETED|Overall Study||7
6402602|NCT00900029|7315394|FG004|NOT COMPLETED|Overall Study||6
6402603|NCT00900146|7315411|FG000|STARTED|Dose Finding: Period II (4 Months)||93
6402604|NCT00900146|7315412|FG001|STARTED|Dose Finding: Period II (4 Months)||95
6402605|NCT00900146|7315413|FG002|STARTED|Dose Finding: Period II (4 Months)||92
6402606|NCT00900146|7315414|FG003|STARTED|Dose Finding: Period II (4 Months)||92
6402607|NCT00900146|7315415|FG004|STARTED|Dose Finding: Period II (4 Months)||179
6402608|NCT00900146|7315411|FG000|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
6402609|NCT00900146|7315412|FG001|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
6402610|NCT00900146|7315413|FG002|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
6402611|NCT00900146|7315414|FG003|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
6402612|NCT00900146|7315415|FG004|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
6402613|NCT00900146|7315411|FG000|COMPLETED|Dose Finding: Period II (4 Months)||88
6402614|NCT00900146|7315412|FG001|COMPLETED|Dose Finding: Period II (4 Months)||93
6402615|NCT00900146|7315413|FG002|COMPLETED|Dose Finding: Period II (4 Months)||87
6402616|NCT00900146|7315414|FG003|COMPLETED|Dose Finding: Period II (4 Months)||90
6402617|NCT00900146|7315415|FG004|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
6402618|NCT00900146|7315411|FG000|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
6402619|NCT00900146|7315412|FG001|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
6402620|NCT00900146|7315413|FG002|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
6402621|NCT00900146|7315414|FG003|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
6402622|NCT00900146|7315415|FG004|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
6402623|NCT00900146|7315411|FG000|STARTED|Intermediate: Period III||87
6635335|NCT02303704|7564226|FG000|COMPLETED|Overall Study||215
6402624|NCT00900146|7315412|FG001|STARTED|Intermediate: Period III||93
6402625|NCT00900146|7315413|FG002|STARTED|Intermediate: Period III||84
6402626|NCT00900146|7315414|FG003|STARTED|Intermediate: Period III||90
6402627|NCT00900146|7315415|FG004|STARTED|Intermediate: Period III||167
6402628|NCT00900146|7315411|FG000|Safety Set|Intermediate: Period III||86
6402629|NCT00900146|7315412|FG001|Safety Set|Intermediate: Period III||92
6402630|NCT00900146|7315413|FG002|Safety Set|Intermediate: Period III||84
6402631|NCT00900146|7315414|FG003|Safety Set|Intermediate: Period III||90
6402632|NCT00900146|7315415|FG004|Safety Set|Intermediate: Period III||166
6402633|NCT00900146|7315411|FG000|COMPLETED|Intermediate: Period III||0
6402634|NCT00900146|7315412|FG001|COMPLETED|Intermediate: Period III||0
6402635|NCT00900146|7315413|FG002|COMPLETED|Intermediate: Period III||0
6402636|NCT00900146|7315414|FG003|COMPLETED|Intermediate: Period III||0
6402637|NCT00900146|7315415|FG004|COMPLETED|Intermediate: Period III||0
6402638|NCT00900146|7315411|FG000|NOT COMPLETED|Intermediate: Period III||87
6402639|NCT00900146|7315412|FG001|NOT COMPLETED|Intermediate: Period III||93
6402640|NCT00900146|7315413|FG002|NOT COMPLETED|Intermediate: Period III||84
6402641|NCT00900146|7315414|FG003|NOT COMPLETED|Intermediate: Period III||90
6402642|NCT00900146|7315415|FG004|NOT COMPLETED|Intermediate: Period III||167
6402643|NCT00900159|7315429|FG000|STARTED|First Intervention||11
6402644|NCT00900159|7315430|FG001|STARTED|First Intervention||13
6402645|NCT00900159|7315429|FG000|COMPLETED|First Intervention||11
6402646|NCT00900159|7315430|FG001|COMPLETED|First Intervention||13
6402647|NCT00900159|7315429|FG000|NOT COMPLETED|First Intervention||0
6402648|NCT00900159|7315430|FG001|NOT COMPLETED|First Intervention||0
6402649|NCT00900159|7315429|FG000|STARTED|Washout||11
6402650|NCT00900159|7315430|FG001|STARTED|Washout||13
6402651|NCT00900159|7315429|FG000|COMPLETED|Washout||11
6402652|NCT00900159|7315430|FG001|COMPLETED|Washout||13
6402653|NCT00900159|7315429|FG000|NOT COMPLETED|Washout||0
6402654|NCT00900159|7315430|FG001|NOT COMPLETED|Washout||0
6402655|NCT00900159|7315429|FG000|STARTED|Second Intervention||11
6402656|NCT00900159|7315430|FG001|STARTED|Second Intervention||13
6402657|NCT00900159|7315429|FG000|COMPLETED|Second Intervention||10
6402658|NCT00900159|7315430|FG001|COMPLETED|Second Intervention||13
6402659|NCT00900159|7315429|FG000|NOT COMPLETED|Second Intervention||1
6402660|NCT00900159|7315430|FG001|NOT COMPLETED|Second Intervention||0
6402661|NCT00900237|7315438|FG000|STARTED|Overall Study||7
6402662|NCT00900237|7315439|FG001|STARTED|Overall Study||7
6402663|NCT00900237|7315438|FG000|COMPLETED|Overall Study||7
6402664|NCT00900237|7315439|FG001|COMPLETED|Overall Study||7
6402665|NCT00900237|7315438|FG000|NOT COMPLETED|Overall Study||0
6402666|NCT00900237|7315439|FG001|NOT COMPLETED|Overall Study||0
6402667|NCT00900562|7315447|FG000|STARTED|Overall Study||12
6402668|NCT00900562|7315448|FG001|STARTED|Overall Study||7
6402669|NCT00900562|7315447|FG000|COMPLETED|Overall Study||0
6402670|NCT00900562|7315448|FG001|COMPLETED|Overall Study||0
6402671|NCT00900562|7315447|FG000|NOT COMPLETED|Overall Study||12
6402672|NCT00900562|7315448|FG001|NOT COMPLETED|Overall Study||7
6402673|NCT00900601|7315455|FG000|STARTED|Overall Study||9
6402674|NCT00900601|7315455|FG000|COMPLETED|Overall Study||8
6402675|NCT00900601|7315455|FG000|NOT COMPLETED|Overall Study||1
6402676|NCT00900627|7315465|FG000|STARTED|Overall Study||6
6402677|NCT00900627|7315466|FG001|STARTED|Overall Study||2
6402678|NCT00900627|7315467|FG002|STARTED|Overall Study||6
6402679|NCT00900627|7315468|FG003|STARTED|Overall Study||6
6402680|NCT00900627|7315469|FG004|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
6402681|NCT00900627|7315470|FG005|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
6402682|NCT00900627|7315465|FG000|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
6402683|NCT00900627|7315466|FG001|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
6402684|NCT00900627|7315467|FG002|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
6402685|NCT00900627|7315468|FG003|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
6402686|NCT00900627|7315469|FG004|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
6402687|NCT00900627|7315470|FG005|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
6402688|NCT00900627|7315465|FG000|NOT COMPLETED|Overall Study||6
6402689|NCT00900627|7315466|FG001|NOT COMPLETED|Overall Study||2
6402690|NCT00900627|7315467|FG002|NOT COMPLETED|Overall Study||6
6402691|NCT00900627|7315468|FG003|NOT COMPLETED|Overall Study||6
6402692|NCT00900627|7315469|FG004|NOT COMPLETED|Overall Study||29
6402693|NCT00900627|7315470|FG005|NOT COMPLETED|Overall Study||26
6402694|NCT00900666|7315486|FG000|STARTED|Overall Study||10
6402695|NCT00900666|7315487|FG001|STARTED|Overall Study||9
6402696|NCT00900666|7315486|FG000|COMPLETED|Overall Study||10
6402697|NCT00900666|7315487|FG001|COMPLETED|Overall Study||9
6402698|NCT00900666|7315486|FG000|NOT COMPLETED|Overall Study||0
6402699|NCT00900666|7315487|FG001|NOT COMPLETED|Overall Study||0
6402700|NCT00900731|7315495|FG000|STARTED|Overall Study|Randomized participants|797
6402701|NCT00900731|7315496|FG001|STARTED|Overall Study||801
6402702|NCT00900731|7315495|FG000|Safety Set: Received Study Drug|Overall Study||794
6402703|NCT00900731|7315496|FG001|Safety Set: Received Study Drug|Overall Study||799
6402704|NCT00900731|7315495|FG000|COMPLETED|Overall Study||737
6402705|NCT00900731|7315496|FG001|COMPLETED|Overall Study||740
6402706|NCT00900731|7315495|FG000|NOT COMPLETED|Overall Study||60
6402707|NCT00900731|7315496|FG001|NOT COMPLETED|Overall Study||61
6402708|NCT00900757|7315502|FG000|STARTED|Overall Study||57
6402709|NCT00900757|7315502|FG000|COMPLETED|Overall Study||38
6402710|NCT00900757|7315502|FG000|NOT COMPLETED|Overall Study||19
6402711|NCT00900796|7315506|FG000|STARTED|Phase 1||132
6402712|NCT00900796|7315506|FG000|COMPLETED|Phase 1||121
6402713|NCT00900796|7315506|FG000|NOT COMPLETED|Phase 1||11
6402714|NCT00900796|7315506|FG000|STARTED|Between Phase 1 and Phase 2||121
6402715|NCT00900796|7315506|FG000|COMPLETED|Between Phase 1 and Phase 2||11
6402716|NCT00900796|7315506|FG000|NOT COMPLETED|Between Phase 1 and Phase 2||110
6402717|NCT00900796|7315506|FG000|STARTED|Phase 2||11
6402718|NCT00900796|7315506|FG000|COMPLETED|Phase 2||6
6402719|NCT00900796|7315506|FG000|NOT COMPLETED|Phase 2||5
6402720|NCT00900822|7315511|FG000|STARTED|9 Months Histological Evaluation||11
6402721|NCT00900822|7315511|FG000|COMPLETED|9 Months Histological Evaluation||11
6402722|NCT00900822|7315511|FG000|NOT COMPLETED|9 Months Histological Evaluation||0
6402723|NCT00900822|7315511|FG000|STARTED|12 Months Clinical Evaluation||11
6402724|NCT00900822|7315511|FG000|COMPLETED|12 Months Clinical Evaluation||11
6402725|NCT00900822|7315511|FG000|NOT COMPLETED|12 Months Clinical Evaluation||0
6402726|NCT00901017|7315518|FG000|STARTED|Overall Study||14
6402727|NCT00901017|7315518|FG000|COMPLETED|Overall Study||14
6402728|NCT00901017|7315518|FG000|NOT COMPLETED|Overall Study||0
6402729|NCT00901186|7315527|FG000|STARTED|Overall Study||40
6402730|NCT00901186|7315528|FG001|STARTED|Overall Study||43
6402731|NCT00901186|7315527|FG000|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
6402732|NCT00901186|7315528|FG001|Safety Set|Overall Study||43
6402733|NCT00901186|7315527|FG000|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
6402734|NCT00901186|7315528|FG001|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
6402735|NCT00901186|7315527|FG000|COMPLETED|Overall Study||31
6402736|NCT00901186|7315528|FG001|COMPLETED|Overall Study||32
6402737|NCT00901186|7315527|FG000|NOT COMPLETED|Overall Study||9
6402738|NCT00901186|7315528|FG001|NOT COMPLETED|Overall Study||11
6402739|NCT00901199|7315534|FG000|STARTED|Overall Study||22
6402740|NCT00901199|7315534|FG000|COMPLETED|Overall Study||18
6402741|NCT00901199|7315534|FG000|NOT COMPLETED|Overall Study||4
6402742|NCT00901225|7315538|FG000|STARTED|Overall Study||21
6402743|NCT00901225|7315538|FG000|COMPLETED|Overall Study||20
6402744|NCT00901225|7315538|FG000|NOT COMPLETED|Overall Study||1
6402745|NCT00901316|7315544|FG000|STARTED|Overall Study||492
6402746|NCT00901316|7315545|FG001|STARTED|Overall Study||495
6402747|NCT00901316|7315544|FG000|COMPLETED|Overall Study||492
6402748|NCT00901316|7315545|FG001|COMPLETED|Overall Study||495
6402749|NCT00901316|7315544|FG000|NOT COMPLETED|Overall Study||0
6402750|NCT00901316|7315545|FG001|NOT COMPLETED|Overall Study||0
6402751|NCT00901342|7315551|FG000|STARTED|Overall Study||104
6402752|NCT00901342|7315551|FG000|Received at Least 1 Infusion|Overall Study||98
6402753|NCT00901342|7315551|FG000|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
6402754|NCT00901342|7315551|FG000|NOT COMPLETED|Overall Study||15
6402755|NCT00901394|7315558|FG000|STARTED|Overall Study||21
6402756|NCT00901394|7315559|FG001|STARTED|Overall Study||20
6402757|NCT00901394|7315560|FG002|STARTED|Overall Study||22
6402758|NCT00901394|7315558|FG000|COMPLETED|Overall Study||20
6402759|NCT00901394|7315559|FG001|COMPLETED|Overall Study||19
6402760|NCT00901394|7315560|FG002|COMPLETED|Overall Study||20
6402761|NCT00901394|7315558|FG000|NOT COMPLETED|Overall Study||1
6635336|NCT02303704|7564227|FG001|COMPLETED|Overall Study||219
6635337|NCT02303704|7564226|FG000|NOT COMPLETED|Overall Study||5
6635338|NCT02303704|7564227|FG001|NOT COMPLETED|Overall Study||9
6635339|NCT02303743|7564235|FG000|STARTED|Overall Study||108
6635340|NCT02303743|7564236|FG001|STARTED|Overall Study||152
6635341|NCT02303743|7564235|FG000|COMPLETED|Overall Study||108
6635342|NCT02303743|7564236|FG001|COMPLETED|Overall Study||152
6635343|NCT02303743|7564235|FG000|NOT COMPLETED|Overall Study||0
6635344|NCT02303743|7564236|FG001|NOT COMPLETED|Overall Study||0
6635345|NCT02303977|7564242|FG000|STARTED|Overall Study||37
6402762|NCT00901394|7315559|FG001|NOT COMPLETED|Overall Study||1
6402763|NCT00901394|7315560|FG002|NOT COMPLETED|Overall Study||2
6402764|NCT00901459|7315568|FG000|STARTED|Overall Study||21
6402765|NCT00901459|7315568|FG000|COMPLETED|Overall Study||15
6402766|NCT00901459|7315568|FG000|NOT COMPLETED|Overall Study||6
6402767|NCT00901485|7315579|FG000|STARTED|Overall Study||10
6402768|NCT00901485|7315580|FG001|STARTED|Overall Study||13
6402769|NCT00901485|7315579|FG000|COMPLETED|Overall Study||9
6402770|NCT00901485|7315580|FG001|COMPLETED|Overall Study||9
6402771|NCT00901485|7315579|FG000|NOT COMPLETED|Overall Study||1
6402772|NCT00901485|7315580|FG001|NOT COMPLETED|Overall Study||4
6402773|NCT00901576|7315592|FG000|STARTED|First Intervention||6
6635346|NCT02303977|7564242|FG000|COMPLETED|Overall Study||37
6402774|NCT00901576|7315593|FG001|STARTED|First Intervention||7
6635347|NCT02303977|7564242|FG000|NOT COMPLETED|Overall Study||0
6635348|NCT02303990|7564247|FG000|STARTED|Overall Study||59
6402775|NCT00901576|7315594|FG002|STARTED|First Intervention||7
6402776|NCT00901576|7315595|FG003|STARTED|First Intervention||6
6402777|NCT00901576|7315596|FG004|STARTED|First Intervention||6
6402778|NCT00901576|7315597|FG005|STARTED|First Intervention||6
6402779|NCT00901576|7315592|FG000|COMPLETED|First Intervention||6
6402780|NCT00901576|7315593|FG001|COMPLETED|First Intervention||7
6402781|NCT00901576|7315594|FG002|COMPLETED|First Intervention||7
6402782|NCT00901576|7315595|FG003|COMPLETED|First Intervention||6
6402783|NCT00901576|7315596|FG004|COMPLETED|First Intervention||6
6402784|NCT00901576|7315597|FG005|COMPLETED|First Intervention||6
6402785|NCT00901576|7315592|FG000|NOT COMPLETED|First Intervention||0
6402786|NCT00901576|7315593|FG001|NOT COMPLETED|First Intervention||0
6402787|NCT00901576|7315594|FG002|NOT COMPLETED|First Intervention||0
6402788|NCT00901576|7315595|FG003|NOT COMPLETED|First Intervention||0
6402789|NCT00901576|7315596|FG004|NOT COMPLETED|First Intervention||0
6402790|NCT00901576|7315597|FG005|NOT COMPLETED|First Intervention||0
6402791|NCT00901576|7315592|FG000|STARTED|Washout||6
6402792|NCT00901576|7315593|FG001|STARTED|Washout||7
6402793|NCT00901576|7315594|FG002|STARTED|Washout||7
6402794|NCT00901576|7315595|FG003|STARTED|Washout||6
6402795|NCT00901576|7315596|FG004|STARTED|Washout||6
6402796|NCT00901576|7315597|FG005|STARTED|Washout||6
6402797|NCT00901576|7315592|FG000|COMPLETED|Washout||6
6402798|NCT00901576|7315593|FG001|COMPLETED|Washout||7
6402799|NCT00901576|7315594|FG002|COMPLETED|Washout||7
6402800|NCT00901576|7315595|FG003|COMPLETED|Washout||6
6402801|NCT00901576|7315596|FG004|COMPLETED|Washout||6
6402802|NCT00901576|7315597|FG005|COMPLETED|Washout||6
6402803|NCT00901576|7315592|FG000|NOT COMPLETED|Washout||0
6402804|NCT00901576|7315593|FG001|NOT COMPLETED|Washout||0
6402805|NCT00901576|7315594|FG002|NOT COMPLETED|Washout||0
6402806|NCT00901576|7315595|FG003|NOT COMPLETED|Washout||0
6402807|NCT00901576|7315596|FG004|NOT COMPLETED|Washout||0
6402808|NCT00901576|7315597|FG005|NOT COMPLETED|Washout||0
6402809|NCT00901576|7315592|FG000|STARTED|Second Intervention||6
6402810|NCT00901576|7315593|FG001|STARTED|Second Intervention||7
6402811|NCT00901576|7315594|FG002|STARTED|Second Intervention||7
6402812|NCT00901576|7315595|FG003|STARTED|Second Intervention||6
6402813|NCT00901576|7315596|FG004|STARTED|Second Intervention||6
6402814|NCT00901576|7315597|FG005|STARTED|Second Intervention||6
6402815|NCT00901576|7315592|FG000|COMPLETED|Second Intervention||5
6402816|NCT00901576|7315593|FG001|COMPLETED|Second Intervention||7
6402817|NCT00901576|7315594|FG002|COMPLETED|Second Intervention||7
6402818|NCT00901576|7315595|FG003|COMPLETED|Second Intervention||5
6402819|NCT00901576|7315596|FG004|COMPLETED|Second Intervention||6
6402820|NCT00901576|7315597|FG005|COMPLETED|Second Intervention||5
6402821|NCT00901576|7315592|FG000|NOT COMPLETED|Second Intervention||1
6402822|NCT00901576|7315593|FG001|NOT COMPLETED|Second Intervention||0
6402823|NCT00901576|7315594|FG002|NOT COMPLETED|Second Intervention||0
6402824|NCT00901576|7315595|FG003|NOT COMPLETED|Second Intervention||1
6402825|NCT00901576|7315596|FG004|NOT COMPLETED|Second Intervention||0
6402826|NCT00901576|7315597|FG005|NOT COMPLETED|Second Intervention||1
6402827|NCT00901576|7315592|FG000|STARTED|Washout||5
6402828|NCT00901576|7315593|FG001|STARTED|Washout||7
6402829|NCT00901576|7315594|FG002|STARTED|Washout||7
6402830|NCT00901576|7315595|FG003|STARTED|Washout||5
6402831|NCT00901576|7315596|FG004|STARTED|Washout||6
6402832|NCT00901576|7315597|FG005|STARTED|Washout||5
6402833|NCT00901576|7315592|FG000|COMPLETED|Washout||5
6402834|NCT00901576|7315593|FG001|COMPLETED|Washout||7
6402835|NCT00901576|7315594|FG002|COMPLETED|Washout||7
6402836|NCT00901576|7315595|FG003|COMPLETED|Washout||5
6402837|NCT00901576|7315596|FG004|COMPLETED|Washout||6
6402838|NCT00901576|7315597|FG005|COMPLETED|Washout||5
6402839|NCT00901576|7315592|FG000|NOT COMPLETED|Washout||0
6402840|NCT00901576|7315593|FG001|NOT COMPLETED|Washout||0
6402841|NCT00901576|7315594|FG002|NOT COMPLETED|Washout||0
6402842|NCT00901576|7315595|FG003|NOT COMPLETED|Washout||0
6402843|NCT00901576|7315596|FG004|NOT COMPLETED|Washout||0
6402844|NCT00901576|7315597|FG005|NOT COMPLETED|Washout||0
6402845|NCT00901576|7315592|FG000|STARTED|Third Intervention||5
6402846|NCT00901576|7315593|FG001|STARTED|Third Intervention||7
6402847|NCT00901576|7315594|FG002|STARTED|Third Intervention||7
6402848|NCT00901576|7315595|FG003|STARTED|Third Intervention||5
6402849|NCT00901576|7315596|FG004|STARTED|Third Intervention||6
6402850|NCT00901576|7315597|FG005|STARTED|Third Intervention||5
6402851|NCT00901576|7315592|FG000|COMPLETED|Third Intervention||5
6402852|NCT00901576|7315593|FG001|COMPLETED|Third Intervention||7
6402853|NCT00901576|7315594|FG002|COMPLETED|Third Intervention||7
6402854|NCT00901576|7315595|FG003|COMPLETED|Third Intervention||5
6402855|NCT00901576|7315596|FG004|COMPLETED|Third Intervention||6
6402856|NCT00901576|7315597|FG005|COMPLETED|Third Intervention||5
6402857|NCT00901576|7315592|FG000|NOT COMPLETED|Third Intervention||0
6402858|NCT00901576|7315593|FG001|NOT COMPLETED|Third Intervention||0
6402859|NCT00901576|7315594|FG002|NOT COMPLETED|Third Intervention||0
6402860|NCT00901576|7315595|FG003|NOT COMPLETED|Third Intervention||0
6402861|NCT00901576|7315596|FG004|NOT COMPLETED|Third Intervention||0
6402862|NCT00901576|7315597|FG005|NOT COMPLETED|Third Intervention||0
6402863|NCT00901628|7315607|FG000|STARTED|Overall Study||49
6402864|NCT00901628|7315608|FG001|STARTED|Overall Study||52
6402865|NCT00901628|7315607|FG000|COMPLETED|Overall Study||45
6402866|NCT00901628|7315608|FG001|COMPLETED|Overall Study||42
6402867|NCT00901628|7315607|FG000|NOT COMPLETED|Overall Study||4
6402868|NCT00901628|7315608|FG001|NOT COMPLETED|Overall Study||10
6402869|NCT00901901|7315616|FG000|STARTED|Treatment Period||362
6402870|NCT00901901|7315617|FG001|STARTED|Treatment Period||358
6402871|NCT00901901|7315616|FG000|Participants Received Treatment|Treatment Period||362
6402872|NCT00901901|7315617|FG001|Participants Received Treatment|Treatment Period||355
6402873|NCT00901901|7315616|FG000|COMPLETED|Treatment Period||193
6402874|NCT00901901|7315617|FG001|COMPLETED|Treatment Period||181
6402875|NCT00901901|7315616|FG000|NOT COMPLETED|Treatment Period||169
6402876|NCT00901901|7315617|FG001|NOT COMPLETED|Treatment Period||177
6402877|NCT00901901|7315616|FG000|STARTED|Follow-up Period||340
6402878|NCT00901901|7315617|FG001|STARTED|Follow-up Period||341
6402879|NCT00901901|7315616|FG000|COMPLETED|Follow-up Period||0
6402880|NCT00901901|7315617|FG001|COMPLETED|Follow-up Period||0
6402881|NCT00901901|7315616|FG000|NOT COMPLETED|Follow-up Period||340
6402882|NCT00901901|7315617|FG001|NOT COMPLETED|Follow-up Period||341
6402883|NCT00901927|7315625|FG000|STARTED|Overall Study||14
6402884|NCT00901927|7315625|FG000|COMPLETED|Overall Study||8
6402885|NCT00901927|7315625|FG000|NOT COMPLETED|Overall Study||6
6402886|NCT00902018|7315632|FG000|STARTED|Overall Study||7
6402887|NCT00902018|7315633|FG001|STARTED|Overall Study||3
6402888|NCT00902018|7315634|FG002|STARTED|Overall Study||10
6402889|NCT00902018|7315632|FG000|COMPLETED|Overall Study||7
6402890|NCT00902018|7315633|FG001|COMPLETED|Overall Study||3
6402891|NCT00902018|7315634|FG002|COMPLETED|Overall Study||10
6402892|NCT00902018|7315632|FG000|NOT COMPLETED|Overall Study||0
6402893|NCT00902018|7315633|FG001|NOT COMPLETED|Overall Study||0
6402894|NCT00902018|7315634|FG002|NOT COMPLETED|Overall Study||0
6402895|NCT00902161|7315650|FG000|STARTED|Pre-study Washout/Propanolol Run-in||0
6402896|NCT00902161|7315651|FG001|STARTED|Pre-study Washout/Propanolol Run-in||0
6402897|NCT00902161|7315652|FG002|STARTED|Pre-study Washout/Propanolol Run-in||22
6402898|NCT00902161|7315650|FG000|COMPLETED|Pre-study Washout/Propanolol Run-in||0
6402899|NCT00902161|7315651|FG001|COMPLETED|Pre-study Washout/Propanolol Run-in||0
6402900|NCT00902161|7315652|FG002|COMPLETED|Pre-study Washout/Propanolol Run-in||22
6402901|NCT00902161|7315650|FG000|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
6402902|NCT00902161|7315651|FG001|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
6402903|NCT00902161|7315652|FG002|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
6402904|NCT00902161|7315650|FG000|STARTED|Period 1||12
6402905|NCT00902161|7315651|FG001|STARTED|Period 1||10
6402906|NCT00902161|7315652|FG002|STARTED|Period 1||0
6402907|NCT00902161|7315650|FG000|COMPLETED|Period 1||12
6402908|NCT00902161|7315651|FG001|COMPLETED|Period 1||10
6402909|NCT00902161|7315652|FG002|COMPLETED|Period 1||0
6402910|NCT00902161|7315650|FG000|NOT COMPLETED|Period 1||0
6402911|NCT00902161|7315651|FG001|NOT COMPLETED|Period 1||0
6402912|NCT00902161|7315652|FG002|NOT COMPLETED|Period 1||0
6402913|NCT00902161|7315650|FG000|STARTED|Post-clamp Washout||0
6402914|NCT00902161|7315651|FG001|STARTED|Post-clamp Washout||0
6402915|NCT00902161|7315652|FG002|STARTED|Post-clamp Washout||22
6402916|NCT00902161|7315650|FG000|COMPLETED|Post-clamp Washout||0
6402917|NCT00902161|7315651|FG001|COMPLETED|Post-clamp Washout||0
6402918|NCT00902161|7315652|FG002|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
6402919|NCT00902161|7315650|FG000|NOT COMPLETED|Post-clamp Washout||0
6402920|NCT00902161|7315651|FG001|NOT COMPLETED|Post-clamp Washout||0
6402921|NCT00902161|7315652|FG002|NOT COMPLETED|Post-clamp Washout||0
6402922|NCT00902161|7315650|FG000|STARTED|Period 2||8
6402923|NCT00902161|7315651|FG001|STARTED|Period 2||9
6402924|NCT00902161|7315652|FG002|STARTED|Period 2||0
6402925|NCT00902161|7315650|FG000|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
6402926|NCT00902161|7315651|FG001|COMPLETED|Period 2||9
6402927|NCT00902161|7315652|FG002|COMPLETED|Period 2||0
6402928|NCT00902161|7315650|FG000|NOT COMPLETED|Period 2||0
6402929|NCT00902161|7315651|FG001|NOT COMPLETED|Period 2||0
6402930|NCT00902161|7315652|FG002|NOT COMPLETED|Period 2||0
6402931|NCT00902174|7315664|FG000|STARTED|Overall Study||103
6402932|NCT00902174|7315665|FG001|STARTED|Overall Study||99
6402933|NCT00902174|7315664|FG000|COMPLETED|Overall Study||69
6402934|NCT00902174|7315665|FG001|COMPLETED|Overall Study||81
6402935|NCT00902174|7315664|FG000|NOT COMPLETED|Overall Study||34
6402936|NCT00902174|7315665|FG001|NOT COMPLETED|Overall Study||18
6402937|NCT00902226|7315674|FG000|STARTED|Overall Study||30
6402938|NCT00902226|7315674|FG000|COMPLETED|Overall Study||30
6402939|NCT00902226|7315674|FG000|NOT COMPLETED|Overall Study||0
6402940|NCT00902265|7315678|FG000|STARTED|Overall Study||138
6402941|NCT00902265|7315678|FG000|Participants Who Received Treatment|Overall Study||137
6402942|NCT00902265|7315678|FG000|COMPLETED|Overall Study||132
6402943|NCT00902265|7315678|FG000|NOT COMPLETED|Overall Study||6
6402944|NCT00902278|7315687|FG000|STARTED|Overall Study||54
6402945|NCT00902278|7315688|FG001|STARTED|Overall Study||36
6402946|NCT00902278|7315689|FG002|STARTED|Overall Study||54
6402947|NCT00902278|7315690|FG003|STARTED|Overall Study||12
6402948|NCT00902278|7315691|FG004|STARTED|Overall Study||37
6402949|NCT00902278|7315687|FG000|COMPLETED|Overall Study||50
6402950|NCT00902278|7315688|FG001|COMPLETED|Overall Study||34
6402951|NCT00902278|7315689|FG002|COMPLETED|Overall Study||49
6402952|NCT00902278|7315690|FG003|COMPLETED|Overall Study||12
6402953|NCT00902278|7315691|FG004|COMPLETED|Overall Study||35
6402954|NCT00902278|7315687|FG000|NOT COMPLETED|Overall Study||4
6402955|NCT00902278|7315688|FG001|NOT COMPLETED|Overall Study||2
6402956|NCT00902278|7315689|FG002|NOT COMPLETED|Overall Study||5
6402957|NCT00902278|7315690|FG003|NOT COMPLETED|Overall Study||0
6402958|NCT00902278|7315691|FG004|NOT COMPLETED|Overall Study||2
6402959|NCT00902304|7315706|FG000|STARTED|Overall Study||524
6402960|NCT00902304|7315707|FG001|STARTED|Overall Study||360
6402961|NCT00902304|7315708|FG002|STARTED|Overall Study||678
6402962|NCT00902304|7315706|FG000|COMPLETED|Overall Study||466
6402963|NCT00902304|7315707|FG001|COMPLETED|Overall Study||289
6402964|NCT00902304|7315708|FG002|COMPLETED|Overall Study||568
6402965|NCT00902304|7315706|FG000|NOT COMPLETED|Overall Study||58
6402966|NCT00902304|7315707|FG001|NOT COMPLETED|Overall Study||71
6402967|NCT00902304|7315708|FG002|NOT COMPLETED|Overall Study||110
6402968|NCT00902330|7315719|FG000|STARTED|Overall Study||81
6402969|NCT00902330|7315720|FG001|STARTED|Overall Study||80
6402970|NCT00902330|7315719|FG000|COMPLETED|Overall Study||77
6402971|NCT00902330|7315720|FG001|COMPLETED|Overall Study||75
6402972|NCT00902330|7315719|FG000|NOT COMPLETED|Overall Study||4
6402973|NCT00902330|7315720|FG001|NOT COMPLETED|Overall Study||5
6402974|NCT00902486|7315733|FG000|STARTED|Treatment Period (Weeks 0 Through 12)||31
6402975|NCT00902486|7315734|FG001|STARTED|Treatment Period (Weeks 0 Through 12)||0
6402976|NCT00902486|7315735|FG002|STARTED|Treatment Period (Weeks 0 Through 12)||0
6402977|NCT00902486|7315736|FG003|STARTED|Treatment Period (Weeks 0 Through 12)||32
6402978|NCT00902486|7315737|FG004|STARTED|Treatment Period (Weeks 0 Through 12)||32
6402979|NCT00902486|7315738|FG005|STARTED|Treatment Period (Weeks 0 Through 12)||32
6402980|NCT00902486|7315733|FG000|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
6402981|NCT00902486|7315734|FG001|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
6402982|NCT00902486|7315735|FG002|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||0
6402983|NCT00902486|7315736|FG003|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
6402984|NCT00902486|7315737|FG004|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||32
6402985|NCT00902486|7315738|FG005|Safety Evaluable Participants|Treatment Period (Weeks 0 Through 12)||31
6402986|NCT00902486|7315733|FG000|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
6402987|NCT00902486|7315734|FG001|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
6402988|NCT00902486|7315735|FG002|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||0
6402989|NCT00902486|7315736|FG003|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||31
6402990|NCT00902486|7315737|FG004|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||32
6402991|NCT00902486|7315738|FG005|Modified Intent-to-Treat Participants|Treatment Period (Weeks 0 Through 12)||30
6402992|NCT00902486|7315733|FG000|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
6402993|NCT00902486|7315734|FG001|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
6402994|NCT00902486|7315735|FG002|COMPLETED|Treatment Period (Weeks 0 Through 12)||0
6402995|NCT00902486|7315736|FG003|COMPLETED|Treatment Period (Weeks 0 Through 12)||29
6402996|NCT00902486|7315737|FG004|COMPLETED|Treatment Period (Weeks 0 Through 12)||30
6402997|NCT00902486|7315738|FG005|COMPLETED|Treatment Period (Weeks 0 Through 12)||27
6402998|NCT00902486|7315733|FG000|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
6402999|NCT00902486|7315734|FG001|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
6403000|NCT00902486|7315735|FG002|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||0
6403001|NCT00902486|7315736|FG003|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||3
6403002|NCT00902486|7315737|FG004|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||2
6403003|NCT00902486|7315738|FG005|NOT COMPLETED|Treatment Period (Weeks 0 Through 12)||5
6403004|NCT00902486|7315733|FG000|STARTED|Extension Period (Weeks 12 Through 24)||0
6403005|NCT00902486|7315734|FG001|STARTED|Extension Period (Weeks 12 Through 24)||14
6403006|NCT00902486|7315735|FG002|STARTED|Extension Period (Weeks 12 Through 24)||15
6403007|NCT00902486|7315736|FG003|STARTED|Extension Period (Weeks 12 Through 24)||29
6403008|NCT00902486|7315737|FG004|STARTED|Extension Period (Weeks 12 Through 24)||30
6403009|NCT00902486|7315738|FG005|STARTED|Extension Period (Weeks 12 Through 24)||27
6403010|NCT00902486|7315733|FG000|COMPLETED|Extension Period (Weeks 12 Through 24)||0
6403011|NCT00902486|7315734|FG001|COMPLETED|Extension Period (Weeks 12 Through 24)||14
6403012|NCT00902486|7315735|FG002|COMPLETED|Extension Period (Weeks 12 Through 24)||13
6403013|NCT00902486|7315736|FG003|COMPLETED|Extension Period (Weeks 12 Through 24)||27
6403014|NCT00902486|7315737|FG004|COMPLETED|Extension Period (Weeks 12 Through 24)||29
6403015|NCT00902486|7315738|FG005|COMPLETED|Extension Period (Weeks 12 Through 24)||24
6403016|NCT00902486|7315733|FG000|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
6403017|NCT00902486|7315734|FG001|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||0
6403018|NCT00902486|7315735|FG002|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
6403019|NCT00902486|7315736|FG003|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||2
6403020|NCT00902486|7315737|FG004|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||1
6403021|NCT00902486|7315738|FG005|NOT COMPLETED|Extension Period (Weeks 12 Through 24)||3
6403022|NCT00902486|7315733|FG000|STARTED|Follow-up (After Week 24)||0
6403023|NCT00902486|7315734|FG001|STARTED|Follow-up (After Week 24)||14
6403024|NCT00902486|7315735|FG002|STARTED|Follow-up (After Week 24)||13
6403025|NCT00902486|7315736|FG003|STARTED|Follow-up (After Week 24)||27
6403026|NCT00902486|7315737|FG004|STARTED|Follow-up (After Week 24)||29
6403027|NCT00902486|7315738|FG005|STARTED|Follow-up (After Week 24)||24
6403028|NCT00902486|7315733|FG000|Safety Evaluable Participants|Follow-up (After Week 24)||0
6403029|NCT00902486|7315734|FG001|Safety Evaluable Participants|Follow-up (After Week 24)||14
6403030|NCT00902486|7315735|FG002|Safety Evaluable Participants|Follow-up (After Week 24)||15
6403031|NCT00902486|7315736|FG003|Safety Evaluable Participants|Follow-up (After Week 24)||29
6403032|NCT00902486|7315737|FG004|Safety Evaluable Participants|Follow-up (After Week 24)||30
6403033|NCT00902486|7315738|FG005|Safety Evaluable Participants|Follow-up (After Week 24)||27
6403034|NCT00902486|7315733|FG000|COMPLETED|Follow-up (After Week 24)||0
6403035|NCT00902486|7315734|FG001|COMPLETED|Follow-up (After Week 24)||14
6403036|NCT00902486|7315735|FG002|COMPLETED|Follow-up (After Week 24)||13
6403037|NCT00902486|7315736|FG003|COMPLETED|Follow-up (After Week 24)||26
6403038|NCT00902486|7315737|FG004|COMPLETED|Follow-up (After Week 24)||29
6403039|NCT00902486|7315738|FG005|COMPLETED|Follow-up (After Week 24)||24
6403040|NCT00902486|7315733|FG000|NOT COMPLETED|Follow-up (After Week 24)||0
6403041|NCT00902486|7315734|FG001|NOT COMPLETED|Follow-up (After Week 24)||0
6403042|NCT00902486|7315735|FG002|NOT COMPLETED|Follow-up (After Week 24)||0
6403043|NCT00902486|7315736|FG003|NOT COMPLETED|Follow-up (After Week 24)||1
6403044|NCT00902486|7315737|FG004|NOT COMPLETED|Follow-up (After Week 24)||0
6403045|NCT00902486|7315738|FG005|NOT COMPLETED|Follow-up (After Week 24)||0
6403046|NCT00902538|7315771|FG000|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
6403047|NCT00902538|7315772|FG001|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6403048|NCT00902538|7315773|FG002|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6403049|NCT00902538|7315774|FG003|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6403050|NCT00902538|7315775|FG004|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6403051|NCT00902538|7315776|FG005|STARTED|1-Single-blind, Run-in, Single-Treatment||0
6403052|NCT00902538|7315771|FG000|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
6403053|NCT00902538|7315772|FG001|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403054|NCT00902538|7315773|FG002|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403055|NCT00902538|7315774|FG003|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403056|NCT00902538|7315775|FG004|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403057|NCT00902538|7315776|FG005|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403058|NCT00902538|7315771|FG000|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
6403059|NCT00902538|7315772|FG001|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403060|NCT00902538|7315773|FG002|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403061|NCT00902538|7315774|FG003|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403062|NCT00902538|7315775|FG004|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403063|NCT00902538|7315776|FG005|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
6403064|NCT00902538|7315771|FG000|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
6403065|NCT00902538|7315772|FG001|STARTED|2-Randomized Double-blind 3 Treatments||269
6403066|NCT00902538|7315773|FG002|STARTED|2-Randomized Double-blind 3 Treatments||270
6403067|NCT00902538|7315774|FG003|STARTED|2-Randomized Double-blind 3 Treatments||0
6403068|NCT00902538|7315775|FG004|STARTED|2-Randomized Double-blind 3 Treatments||0
6403069|NCT00902538|7315776|FG005|STARTED|2-Randomized Double-blind 3 Treatments||0
6403070|NCT00902538|7315771|FG000|COMPLETED|2-Randomized Double-blind 3 Treatments||260
6403071|NCT00902538|7315772|FG001|COMPLETED|2-Randomized Double-blind 3 Treatments||263
6403072|NCT00902538|7315773|FG002|COMPLETED|2-Randomized Double-blind 3 Treatments||262
6403073|NCT00902538|7315774|FG003|COMPLETED|2-Randomized Double-blind 3 Treatments||0
6403074|NCT00902538|7315775|FG004|COMPLETED|2-Randomized Double-blind 3 Treatments||0
6403075|NCT00902538|7315776|FG005|COMPLETED|2-Randomized Double-blind 3 Treatments||0
6403076|NCT00902538|7315771|FG000|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
6403077|NCT00902538|7315772|FG001|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
6403078|NCT00902538|7315773|FG002|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
6403079|NCT00902538|7315774|FG003|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
6403080|NCT00902538|7315775|FG004|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
6403081|NCT00902538|7315776|FG005|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
6403082|NCT00902538|7315771|FG000|STARTED|3-Single-blind, Single Treatment||0
6403083|NCT00902538|7315772|FG001|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
6403084|NCT00902538|7315773|FG002|STARTED|3-Single-blind, Single Treatment||0
6403085|NCT00902538|7315774|FG003|STARTED|3-Single-blind, Single Treatment||0
6403086|NCT00902538|7315775|FG004|STARTED|3-Single-blind, Single Treatment||0
6403087|NCT00902538|7315776|FG005|STARTED|3-Single-blind, Single Treatment||0
6403088|NCT00902538|7315771|FG000|COMPLETED|3-Single-blind, Single Treatment||0
6403089|NCT00902538|7315772|FG001|COMPLETED|3-Single-blind, Single Treatment||767
6403090|NCT00902538|7315773|FG002|COMPLETED|3-Single-blind, Single Treatment||0
6403091|NCT00902538|7315774|FG003|COMPLETED|3-Single-blind, Single Treatment||0
6403092|NCT00902538|7315775|FG004|COMPLETED|3-Single-blind, Single Treatment||0
6403093|NCT00902538|7315776|FG005|COMPLETED|3-Single-blind, Single Treatment||0
6403094|NCT00902538|7315771|FG000|NOT COMPLETED|3-Single-blind, Single Treatment||0
6403095|NCT00902538|7315772|FG001|NOT COMPLETED|3-Single-blind, Single Treatment||15
6403096|NCT00902538|7315773|FG002|NOT COMPLETED|3-Single-blind, Single Treatment||0
6403097|NCT00902538|7315774|FG003|NOT COMPLETED|3-Single-blind, Single Treatment||0
6403098|NCT00902538|7315775|FG004|NOT COMPLETED|3-Single-blind, Single Treatment||0
6403099|NCT00902538|7315776|FG005|NOT COMPLETED|3-Single-blind, Single Treatment||0
6403100|NCT00902538|7315771|FG000|STARTED|4-Randomized Double-blind 2 Treatments||0
6403101|NCT00902538|7315772|FG001|STARTED|4-Randomized Double-blind 2 Treatments||0
6403102|NCT00902538|7315773|FG002|STARTED|4-Randomized Double-blind 2 Treatments||0
6403103|NCT00902538|7315774|FG003|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
6403104|NCT00902538|7315775|FG004|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
6403105|NCT00902538|7315776|FG005|STARTED|4-Randomized Double-blind 2 Treatments||197
6403106|NCT00902538|7315771|FG000|COMPLETED|4-Randomized Double-blind 2 Treatments||0
6403107|NCT00902538|7315772|FG001|COMPLETED|4-Randomized Double-blind 2 Treatments||0
6403108|NCT00902538|7315773|FG002|COMPLETED|4-Randomized Double-blind 2 Treatments||0
6403109|NCT00902538|7315774|FG003|COMPLETED|4-Randomized Double-blind 2 Treatments||458
6403110|NCT00902538|7315775|FG004|COMPLETED|4-Randomized Double-blind 2 Treatments||95
6403111|NCT00902538|7315776|FG005|COMPLETED|4-Randomized Double-blind 2 Treatments||196
6403112|NCT00902538|7315771|FG000|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
6403113|NCT00902538|7315772|FG001|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
6403114|NCT00902538|7315773|FG002|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
6403115|NCT00902538|7315774|FG003|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
6403116|NCT00902538|7315775|FG004|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
6403117|NCT00902538|7315776|FG005|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
6403118|NCT00902564|7315788|FG000|STARTED|Overall Study||30
6403119|NCT00902564|7315788|FG000|COMPLETED|Overall Study||28
6403120|NCT00902564|7315788|FG000|NOT COMPLETED|Overall Study||2
6403121|NCT00902577|7315792|FG000|STARTED|Overall Study||50
6403122|NCT00902577|7315792|FG000|FMISO/PET|Overall Study||38
6403123|NCT00902577|7315792|FG000|DCE MRI|Overall Study||31
6403124|NCT00902577|7315792|FG000|DSE MRI|Overall Study||37
6403125|NCT00902577|7315792|FG000|DWI MRI|Overall Study||39
6403126|NCT00902577|7315792|FG000|COMPLETED|Overall Study||42
6403127|NCT00902577|7315792|FG000|NOT COMPLETED|Overall Study||8
6403128|NCT00902746|7315815|FG000|STARTED|Overall Study||149
6403129|NCT00902746|7315815|FG000|Initiation of Study Drug Administration|Overall Study||148
6403130|NCT00902746|7315815|FG000|Transfer to Step 2|Overall Study||133
6403131|NCT00902746|7315815|FG000|COMPLETED|Overall Study||113
6403132|NCT00902746|7315815|FG000|NOT COMPLETED|Overall Study||36
6403133|NCT00902850|7315821|FG000|STARTED|Overall Study||14
6403134|NCT00902850|7315822|FG001|STARTED|Overall Study||14
6403135|NCT00902850|7315821|FG000|COMPLETED|Overall Study||12
6403136|NCT00902850|7315822|FG001|COMPLETED|Overall Study||12
6403137|NCT00902850|7315821|FG000|NOT COMPLETED|Overall Study||2
6403138|NCT00902850|7315822|FG001|NOT COMPLETED|Overall Study||2
6403139|NCT00903032|7315830|FG000|STARTED|Overall Study||129
6403140|NCT00903032|7315831|FG001|STARTED|Overall Study||124
6403141|NCT00903032|7315830|FG000|COMPLETED|Overall Study||122
6403142|NCT00903032|7315831|FG001|COMPLETED|Overall Study||119
6403143|NCT00903032|7315830|FG000|NOT COMPLETED|Overall Study||7
6403144|NCT00903032|7315831|FG001|NOT COMPLETED|Overall Study||5
6403145|NCT00903162|7315837|FG000|STARTED|Overall Study||16
6403146|NCT00903162|7315837|FG000|COMPLETED|Overall Study||12
6403147|NCT00903162|7315837|FG000|NOT COMPLETED|Overall Study||4
6403148|NCT00903175|7315843|FG000|STARTED|Period 1 - First Line||238
6403149|NCT00903175|7315844|FG001|STARTED|Period 1 - First Line||231
6403150|NCT00903175|7315843|FG000|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
6403151|NCT00903175|7315844|FG001|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
6403152|NCT00903175|7315843|FG000|NOT COMPLETED|Period 1 - First Line||77
6403153|NCT00903175|7315844|FG001|NOT COMPLETED|Period 1 - First Line||89
6403154|NCT00903175|7315843|FG000|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
6403155|NCT00903175|7315844|FG001|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
6403156|NCT00903175|7315843|FG000|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
6403157|NCT00903175|7315844|FG001|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
6403158|NCT00903175|7315843|FG000|NOT COMPLETED|Period 2 - Second Line||49
6403159|NCT00903175|7315844|FG001|NOT COMPLETED|Period 2 - Second Line||36
6403160|NCT00903201|7315853|FG000|STARTED|Overall Study||61
6403161|NCT00903201|7315854|FG001|STARTED|Overall Study||44
6403162|NCT00903201|7315855|FG002|STARTED|Overall Study||41
6403163|NCT00903201|7315853|FG000|COMPLETED|Overall Study||56
6403164|NCT00903201|7315854|FG001|COMPLETED|Overall Study||38
6403165|NCT00903201|7315855|FG002|COMPLETED|Overall Study||39
6403166|NCT00903201|7315853|FG000|NOT COMPLETED|Overall Study||5
6403167|NCT00903201|7315854|FG001|NOT COMPLETED|Overall Study||6
6403168|NCT00903201|7315855|FG002|NOT COMPLETED|Overall Study||2
6403169|NCT00903331|7315867|FG000|STARTED|Overall Study||59
6403170|NCT00903331|7315868|FG001|STARTED|Overall Study||119
6403171|NCT00903331|7315867|FG000|COMPLETED|Overall Study||54
6403172|NCT00903331|7315868|FG001|COMPLETED|Overall Study||101
6403173|NCT00903331|7315867|FG000|NOT COMPLETED|Overall Study||5
6403174|NCT00903331|7315868|FG001|NOT COMPLETED|Overall Study||18
6403175|NCT00903344|7315876|FG000|STARTED|Overall Study||12
6403176|NCT00903344|7315877|FG001|STARTED|Overall Study||10
6403177|NCT00903344|7315876|FG000|3 Month Visit|Overall Study||10
6403178|NCT00903344|7315877|FG001|3 Month Visit|Overall Study||10
6403179|NCT00903344|7315876|FG000|6 Month Visit|Overall Study||9
6403180|NCT00903344|7315877|FG001|6 Month Visit|Overall Study||10
6403181|NCT00903344|7315876|FG000|COMPLETED|Overall Study||7
6403182|NCT00903344|7315877|FG001|COMPLETED|Overall Study||7
6403183|NCT00903344|7315876|FG000|NOT COMPLETED|Overall Study||5
6403184|NCT00903344|7315877|FG001|NOT COMPLETED|Overall Study||3
6403185|NCT00903357|7315883|FG000|STARTED|First Intervention||27
6403186|NCT00903357|7315884|FG001|STARTED|First Intervention||27
6403187|NCT00903357|7315883|FG000|COMPLETED|First Intervention||22
6403188|NCT00903357|7315884|FG001|COMPLETED|First Intervention||23
6403189|NCT00903357|7315883|FG000|NOT COMPLETED|First Intervention||5
6403190|NCT00903357|7315884|FG001|NOT COMPLETED|First Intervention||4
6403191|NCT00903357|7315883|FG000|STARTED|Wash Out Period of 2 Weeks||22
6403192|NCT00903357|7315884|FG001|STARTED|Wash Out Period of 2 Weeks||23
6403193|NCT00903357|7315883|FG000|COMPLETED|Wash Out Period of 2 Weeks||22
6403194|NCT00903357|7315884|FG001|COMPLETED|Wash Out Period of 2 Weeks||22
6403195|NCT00903357|7315883|FG000|NOT COMPLETED|Wash Out Period of 2 Weeks||0
6403196|NCT00903357|7315884|FG001|NOT COMPLETED|Wash Out Period of 2 Weeks||1
6403197|NCT00903357|7315883|FG000|STARTED|Second Intervention||22
6403198|NCT00903357|7315884|FG001|STARTED|Second Intervention||22
6403199|NCT00903357|7315883|FG000|COMPLETED|Second Intervention||21
6403200|NCT00903357|7315884|FG001|COMPLETED|Second Intervention||22
6403201|NCT00903357|7315883|FG000|NOT COMPLETED|Second Intervention||1
6403202|NCT00903357|7315884|FG001|NOT COMPLETED|Second Intervention||0
6403203|NCT00903370|7315896|FG000|STARTED|Overall Study||127
6403204|NCT00903370|7315897|FG001|STARTED|Overall Study||133
6403205|NCT00903370|7315896|FG000|COMPLETED|Overall Study||99
6403206|NCT00903370|7315897|FG001|COMPLETED|Overall Study||109
6403207|NCT00903370|7315896|FG000|NOT COMPLETED|Overall Study||28
6403208|NCT00903370|7315897|FG001|NOT COMPLETED|Overall Study||24
6403209|NCT00903383|7315907|FG000|STARTED|Overall Study||55
6403210|NCT00903383|7315908|FG001|STARTED|Overall Study||54
6403211|NCT00903383|7315909|FG002|STARTED|Overall Study||50
6403212|NCT00903383|7315910|FG003|STARTED|Overall Study||49
6403213|NCT00903383|7315907|FG000|COMPLETED|Overall Study||48
6403214|NCT00903383|7315908|FG001|COMPLETED|Overall Study||48
6403215|NCT00903383|7315909|FG002|COMPLETED|Overall Study||47
6403216|NCT00903383|7315910|FG003|COMPLETED|Overall Study||44
6403217|NCT00903383|7315907|FG000|NOT COMPLETED|Overall Study||7
6403218|NCT00903383|7315908|FG001|NOT COMPLETED|Overall Study||6
6403219|NCT00903383|7315909|FG002|NOT COMPLETED|Overall Study||3
6403220|NCT00903383|7315910|FG003|NOT COMPLETED|Overall Study||5
6403221|NCT00903409|7315922|FG000|STARTED|Overall Study||88
6403222|NCT00903409|7315923|FG001|STARTED|Overall Study||100
6403223|NCT00903409|7315922|FG000|COMPLETED|Overall Study||62
6403224|NCT00903409|7315923|FG001|COMPLETED|Overall Study||73
6403225|NCT00903409|7315922|FG000|NOT COMPLETED|Overall Study||26
6403226|NCT00903409|7315923|FG001|NOT COMPLETED|Overall Study||27
6403227|NCT00903448|7315931|FG000|STARTED|Period 1: 5 Days Then 10 Day Washout||20
6403228|NCT00903448|7315932|FG001|STARTED|Period 1: 5 Days Then 10 Day Washout||20
6403229|NCT00903448|7315931|FG000|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
6403230|NCT00903448|7315932|FG001|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
6403231|NCT00903448|7315931|FG000|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
6403232|NCT00903448|7315932|FG001|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
6403233|NCT00903448|7315931|FG000|STARTED|Period 2: 5 Days Then 10 Day Washout||20
6403234|NCT00903448|7315932|FG001|STARTED|Period 2: 5 Days Then 10 Day Washout||20
6403235|NCT00903448|7315931|FG000|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
6403236|NCT00903448|7315932|FG001|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
6403237|NCT00903448|7315931|FG000|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
6403238|NCT00903448|7315932|FG001|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
6403239|NCT00903448|7315931|FG000|STARTED|Period 3: 5 Days||20
6403240|NCT00903448|7315932|FG001|STARTED|Period 3: 5 Days||20
6403241|NCT00903448|7315931|FG000|COMPLETED|Period 3: 5 Days||20
6403242|NCT00903448|7315932|FG001|COMPLETED|Period 3: 5 Days||20
6403243|NCT00903448|7315931|FG000|NOT COMPLETED|Period 3: 5 Days||0
6403244|NCT00903448|7315932|FG001|NOT COMPLETED|Period 3: 5 Days||0
6403245|NCT00903617|7315942|FG000|STARTED|Overall Study||19
6403246|NCT00903617|7315943|FG001|STARTED|Overall Study||20
6403247|NCT00903617|7315944|FG002|STARTED|Overall Study||20
6403248|NCT00903617|7315945|FG003|STARTED|Overall Study||21
6403249|NCT00903617|7315942|FG000|COMPLETED|Overall Study||16
6403250|NCT00903617|7315943|FG001|COMPLETED|Overall Study||15
6403251|NCT00903617|7315944|FG002|COMPLETED|Overall Study||15
6403252|NCT00903617|7315945|FG003|COMPLETED|Overall Study||20
6403253|NCT00903617|7315942|FG000|NOT COMPLETED|Overall Study||3
6403254|NCT00903617|7315943|FG001|NOT COMPLETED|Overall Study||5
6403255|NCT00903617|7315944|FG002|NOT COMPLETED|Overall Study||5
6403256|NCT00903617|7315945|FG003|NOT COMPLETED|Overall Study||1
6403257|NCT00903630|7315959|FG000|STARTED|Phase l||6
6403258|NCT00903630|7315960|FG001|STARTED|Phase l||5
6403259|NCT00903630|7315961|FG002|STARTED|Phase l||0
6403260|NCT00903630|7315959|FG000|COMPLETED|Phase l||6
6403261|NCT00903630|7315960|FG001|COMPLETED|Phase l||5
6403262|NCT00903630|7315961|FG002|COMPLETED|Phase l||0
6403263|NCT00903630|7315959|FG000|NOT COMPLETED|Phase l||0
6403264|NCT00903630|7315960|FG001|NOT COMPLETED|Phase l||0
6403265|NCT00903630|7315961|FG002|NOT COMPLETED|Phase l||0
6403266|NCT00903630|7315959|FG000|STARTED|Phase 2||6
6403267|NCT00903630|7315960|FG001|STARTED|Phase 2||0
6403268|NCT00903630|7315961|FG002|STARTED|Phase 2||4
6403269|NCT00903630|7315959|FG000|COMPLETED|Phase 2||6
6403270|NCT00903630|7315960|FG001|COMPLETED|Phase 2||0
6403271|NCT00903630|7315961|FG002|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
6403272|NCT00903630|7315959|FG000|NOT COMPLETED|Phase 2||0
6403273|NCT00903630|7315960|FG001|NOT COMPLETED|Phase 2||0
6403274|NCT00903630|7315961|FG002|NOT COMPLETED|Phase 2||1
6403275|NCT00903682|7315973|FG000|STARTED|Overall Study||79
6403276|NCT00903682|7315974|FG001|STARTED|Overall Study||78
6403277|NCT00903682|7315973|FG000|COMPLETED|Overall Study||63
6403278|NCT00903682|7315974|FG001|COMPLETED|Overall Study||63
6403279|NCT00903682|7315973|FG000|NOT COMPLETED|Overall Study||16
6403280|NCT00903682|7315974|FG001|NOT COMPLETED|Overall Study||15
6403281|NCT00903695|7315982|FG000|STARTED|Overall Study||8
6403282|NCT00903695|7315983|FG001|STARTED|Overall Study||2
6403283|NCT00903695|7315982|FG000|COMPLETED|Overall Study||6
6403284|NCT00903695|7315983|FG001|COMPLETED|Overall Study||2
6403285|NCT00903695|7315982|FG000|NOT COMPLETED|Overall Study||2
6403286|NCT00903695|7315983|FG001|NOT COMPLETED|Overall Study||0
6403287|NCT00903760|7315993|FG000|STARTED|Overall Study||19
6403288|NCT00903760|7315994|FG001|STARTED|Overall Study||18
6403289|NCT00903760|7315993|FG000|COMPLETED|Overall Study|Completed all 24 courses|0
6403290|NCT00903760|7315994|FG001|COMPLETED|Overall Study|Completed all 24 courses|2
6403291|NCT00903760|7315993|FG000|NOT COMPLETED|Overall Study||19
6403292|NCT00903760|7315994|FG001|NOT COMPLETED|Overall Study||16
6403293|NCT00903786|7316000|FG000|STARTED|Overall Study||21
6403294|NCT00903786|7316000|FG000|COMPLETED|Overall Study||6
6403295|NCT00903786|7316000|FG000|NOT COMPLETED|Overall Study||15
6403296|NCT00903877|7316005|FG000|STARTED|Overall Study||51
6403297|NCT00903877|7316005|FG000|COMPLETED|Overall Study||8
6403298|NCT00903877|7316005|FG000|NOT COMPLETED|Overall Study||43
6403299|NCT00903929|7316009|FG000|STARTED|Overall Study||3
6403300|NCT00903929|7316010|FG001|STARTED|Overall Study||3
6403301|NCT00903929|7316011|FG002|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
6403302|NCT00903929|7316012|FG003|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
6403303|NCT00903929|7316009|FG000|COMPLETED|Overall Study||3
6403304|NCT00903929|7316010|FG001|COMPLETED|Overall Study||3
6403305|NCT00903929|7316011|FG002|COMPLETED|Overall Study||3
6403306|NCT00903929|7316012|FG003|COMPLETED|Overall Study||6
6403307|NCT00903929|7316009|FG000|NOT COMPLETED|Overall Study||0
6403308|NCT00903929|7316010|FG001|NOT COMPLETED|Overall Study||0
6403309|NCT00903929|7316011|FG002|NOT COMPLETED|Overall Study||1
6403310|NCT00903929|7316012|FG003|NOT COMPLETED|Overall Study||3
6403311|NCT00903968|7316019|FG000|STARTED|Overall Study||3
6403312|NCT00903968|7316020|FG001|STARTED|Overall Study||3
6403313|NCT00903968|7316021|FG002|STARTED|Overall Study||3
6403314|NCT00903968|7316022|FG003|STARTED|Overall Study||3
6403315|NCT00903968|7316023|FG004|STARTED|Overall Study||4
6403316|NCT00903968|7316024|FG005|STARTED|Overall Study||6
6403317|NCT00903968|7316025|FG006|STARTED|Overall Study||3
6403318|NCT00903968|7316026|FG007|STARTED|Overall Study||33
6403319|NCT00903968|7316019|FG000|COMPLETED|Overall Study||0
6403320|NCT00903968|7316020|FG001|COMPLETED|Overall Study||0
6403321|NCT00903968|7316021|FG002|COMPLETED|Overall Study||0
6403322|NCT00903968|7316022|FG003|COMPLETED|Overall Study||0
6403323|NCT00903968|7316023|FG004|COMPLETED|Overall Study||0
6403324|NCT00903968|7316024|FG005|COMPLETED|Overall Study||0
6403325|NCT00903968|7316025|FG006|COMPLETED|Overall Study||0
6403326|NCT00903968|7316026|FG007|COMPLETED|Overall Study||0
6403327|NCT00903968|7316019|FG000|NOT COMPLETED|Overall Study||3
6403328|NCT00903968|7316020|FG001|NOT COMPLETED|Overall Study||3
6403329|NCT00903968|7316021|FG002|NOT COMPLETED|Overall Study||3
6403330|NCT00903968|7316022|FG003|NOT COMPLETED|Overall Study||3
6403331|NCT00903968|7316023|FG004|NOT COMPLETED|Overall Study||4
6403332|NCT00903968|7316024|FG005|NOT COMPLETED|Overall Study||6
6403333|NCT00903968|7316025|FG006|NOT COMPLETED|Overall Study||3
6403334|NCT00903968|7316026|FG007|NOT COMPLETED|Overall Study||33
6403335|NCT00904007|7316049|FG000|STARTED|Overall Study||55
6403336|NCT00904007|7316050|FG001|STARTED|Overall Study||56
6403337|NCT00904007|7316049|FG000|COMPLETED|Overall Study||55
6403338|NCT00904007|7316050|FG001|COMPLETED|Overall Study||56
6403339|NCT00904007|7316049|FG000|NOT COMPLETED|Overall Study||0
6403340|NCT00904007|7316050|FG001|NOT COMPLETED|Overall Study||0
6403341|NCT00904033|7316062|FG000|STARTED|Overall Study||10
6403342|NCT00904033|7316063|FG001|STARTED|Overall Study||10
6403343|NCT00904033|7316064|FG002|STARTED|Overall Study||10
6403344|NCT00904033|7316065|FG003|STARTED|Overall Study||11
6403345|NCT00904033|7316062|FG000|COMPLETED|Overall Study||9
6403346|NCT00904033|7316063|FG001|COMPLETED|Overall Study||9
6403347|NCT00904033|7316064|FG002|COMPLETED|Overall Study||9
6403348|NCT00904033|7316065|FG003|COMPLETED|Overall Study||9
6403349|NCT00904033|7316062|FG000|NOT COMPLETED|Overall Study||1
6403350|NCT00904033|7316063|FG001|NOT COMPLETED|Overall Study||1
6403351|NCT00904033|7316064|FG002|NOT COMPLETED|Overall Study||1
6403352|NCT00904033|7316065|FG003|NOT COMPLETED|Overall Study||2
6403353|NCT00904150|7316078|FG000|STARTED|Saliva Samples (DNA)||285
6403354|NCT00904150|7316079|FG001|STARTED|Saliva Samples (DNA)||300
6403355|NCT00904150|7316078|FG000|COMPLETED|Saliva Samples (DNA)||282
6403356|NCT00904150|7316079|FG001|COMPLETED|Saliva Samples (DNA)||155
6403357|NCT00904150|7316078|FG000|NOT COMPLETED|Saliva Samples (DNA)||3
6403358|NCT00904150|7316079|FG001|NOT COMPLETED|Saliva Samples (DNA)||145
6403359|NCT00904150|7316078|FG000|STARTED|Blood Samples (RNA): Follicular Phase||37
6403360|NCT00904150|7316079|FG001|STARTED|Blood Samples (RNA): Follicular Phase||32
6403361|NCT00904150|7316078|FG000|COMPLETED|Blood Samples (RNA): Follicular Phase||37
6403362|NCT00904150|7316079|FG001|COMPLETED|Blood Samples (RNA): Follicular Phase||32
6403363|NCT00904150|7316078|FG000|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
6403364|NCT00904150|7316079|FG001|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
6403365|NCT00904150|7316078|FG000|STARTED|Blood Samples (RNA): Luteal Phase||34
6403366|NCT00904150|7316079|FG001|STARTED|Blood Samples (RNA): Luteal Phase||30
6403367|NCT00904150|7316078|FG000|COMPLETED|Blood Samples (RNA): Luteal Phase||34
6403368|NCT00904150|7316079|FG001|COMPLETED|Blood Samples (RNA): Luteal Phase||30
6498721|NCT01412060|7417356|FG000|NOT COMPLETED|Period Between RIP and SP||54
6403369|NCT00904150|7316078|FG000|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
6403370|NCT00904150|7316079|FG001|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
6403371|NCT00904215|7316085|FG000|STARTED|Overall Study||1095
6403372|NCT00904215|7316085|FG000|COMPLETED|Overall Study||960
6403373|NCT00904215|7316085|FG000|NOT COMPLETED|Overall Study||135
6403374|NCT00904345|7316089|FG000|STARTED|Overall Study||21
6403375|NCT00904345|7316089|FG000|Stopped or Modified Treatment Due to Toxicity|Overall Study||3
6403376|NCT00904345|7316089|FG000|COMPLETED|Overall Study||18
6403377|NCT00904345|7316089|FG000|NOT COMPLETED|Overall Study||3
6403378|NCT00904371|7316093|FG000|STARTED|Overall Study||211
6403379|NCT00904371|7316093|FG000|COMPLETED|Overall Study||202
6403380|NCT00904371|7316093|FG000|NOT COMPLETED|Overall Study||9
6403381|NCT00904488|7316099|FG000|STARTED|Overall Study||5
6403382|NCT00904488|7316100|FG001|STARTED|Overall Study||6
6635349|NCT02303990|7564247|FG000|COMPLETED|Overall Study||59
6635350|NCT02303990|7564247|FG000|NOT COMPLETED|Overall Study||0
6635351|NCT02304159|7564253|FG000|STARTED|Overall Study||21
6635352|NCT02304159|7564254|FG001|STARTED|Overall Study||18
6635353|NCT02304159|7564253|FG000|COMPLETED|Overall Study||19
6635354|NCT02304159|7564254|FG001|COMPLETED|Overall Study||16
6635355|NCT02304159|7564253|FG000|NOT COMPLETED|Overall Study||2
6635356|NCT02304159|7564254|FG001|NOT COMPLETED|Overall Study||2
6635357|NCT02304380|7564266|FG000|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
6635358|NCT02304380|7564267|FG001|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
6635359|NCT02304380|7564268|FG002|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
6635360|NCT02304380|7564269|FG003|STARTED|Pediatric Claims Data Analysis (Aim 3)||0
6635361|NCT02304380|7564270|FG004|STARTED|Pediatric Claims Data Analysis (Aim 3)||17356
6635362|NCT02304380|7564271|FG005|STARTED|Pediatric Claims Data Analysis (Aim 3)||47026
6635363|NCT02304380|7564266|FG000|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635364|NCT02304380|7564267|FG001|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635365|NCT02304380|7564268|FG002|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635366|NCT02304380|7564269|FG003|COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635367|NCT02304380|7564270|FG004|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|2,096 Caregivers of the 17,356 claims were included in the Caregiver Survey.|17356
6635368|NCT02304380|7564271|FG005|COMPLETED|Pediatric Claims Data Analysis (Aim 3)|Not included in any other portion of the study.|47026
6635369|NCT02304380|7564266|FG000|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635370|NCT02304380|7564267|FG001|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635371|NCT02304380|7564268|FG002|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635372|NCT02304380|7564269|FG003|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635373|NCT02304380|7564270|FG004|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635374|NCT02304380|7564271|FG005|NOT COMPLETED|Pediatric Claims Data Analysis (Aim 3)||0
6635375|NCT02304380|7564266|FG000|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635376|NCT02304380|7564267|FG001|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635377|NCT02304380|7564268|FG002|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635378|NCT02304380|7564269|FG003|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||2096
6635379|NCT02304380|7564270|FG004|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635380|NCT02304380|7564271|FG005|STARTED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635381|NCT02304380|7564266|FG000|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635382|NCT02304380|7564267|FG001|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635383|NCT02304380|7564268|FG002|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635384|NCT02304380|7564269|FG003|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)|68 Caregivers/Patients of the 2,062 surveyed were included in the Interviews and Focus Group .|2062
6635385|NCT02304380|7564270|FG004|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635386|NCT02304380|7564271|FG005|COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635387|NCT02304380|7564266|FG000|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635388|NCT02304380|7564267|FG001|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635389|NCT02304380|7564268|FG002|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635390|NCT02304380|7564269|FG003|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||34
6635391|NCT02304380|7564270|FG004|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635392|NCT02304380|7564271|FG005|NOT COMPLETED|Pediatric Adult Caregiver Survey (Aim 2)||0
6635393|NCT02304380|7564266|FG000|STARTED|Interviews & Focus Groups (Aim 1)||0
6635394|NCT02304380|7564267|FG001|STARTED|Interviews & Focus Groups (Aim 1)||35
6635395|NCT02304380|7564268|FG002|STARTED|Interviews & Focus Groups (Aim 1)||33
6635396|NCT02304380|7564269|FG003|STARTED|Interviews & Focus Groups (Aim 1)||0
6635397|NCT02304380|7564270|FG004|STARTED|Interviews & Focus Groups (Aim 1)||0
6635398|NCT02304380|7564271|FG005|STARTED|Interviews & Focus Groups (Aim 1)||0
6635399|NCT02304380|7564266|FG000|COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635400|NCT02304380|7564267|FG001|COMPLETED|Interviews & Focus Groups (Aim 1)||35
6635401|NCT02304380|7564268|FG002|COMPLETED|Interviews & Focus Groups (Aim 1)||33
6635402|NCT02304380|7564269|FG003|COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635403|NCT02304380|7564270|FG004|COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635404|NCT02304380|7564271|FG005|COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635405|NCT02304380|7564266|FG000|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635406|NCT02304380|7564267|FG001|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635407|NCT02304380|7564268|FG002|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6403383|NCT00904488|7316099|FG000|COMPLETED|Overall Study||5
6403384|NCT00904488|7316100|FG001|COMPLETED|Overall Study||6
6403385|NCT00904488|7316099|FG000|NOT COMPLETED|Overall Study||0
6403386|NCT00904488|7316100|FG001|NOT COMPLETED|Overall Study||0
6403387|NCT00904618|7316106|FG000|STARTED|Overall Study||48
6403388|NCT00904618|7316106|FG000|COMPLETED|Overall Study||48
6403389|NCT00904618|7316106|FG000|NOT COMPLETED|Overall Study||0
6403390|NCT00904670|7316113|FG000|STARTED|Open Label Phase||23
6403391|NCT00904670|7316114|FG001|STARTED|Open Label Phase||22
6403392|NCT00904670|7316113|FG000|COMPLETED|Open Label Phase||17
6403393|NCT00904670|7316114|FG001|COMPLETED|Open Label Phase||22
6403394|NCT00904670|7316113|FG000|NOT COMPLETED|Open Label Phase||6
6403395|NCT00904670|7316114|FG001|NOT COMPLETED|Open Label Phase||0
6403396|NCT00904670|7316113|FG000|STARTED|First Intervention Period||17
6403397|NCT00904670|7316114|FG001|STARTED|First Intervention Period||22
6403398|NCT00904670|7316113|FG000|COMPLETED|First Intervention Period||17
6403399|NCT00904670|7316114|FG001|COMPLETED|First Intervention Period||22
6403400|NCT00904670|7316113|FG000|NOT COMPLETED|First Intervention Period||0
6403401|NCT00904670|7316114|FG001|NOT COMPLETED|First Intervention Period||0
6403402|NCT00904670|7316113|FG000|STARTED|Second Intervention Period||17
6403403|NCT00904670|7316114|FG001|STARTED|Second Intervention Period||22
6403404|NCT00904670|7316113|FG000|COMPLETED|Second Intervention Period||17
6403405|NCT00904670|7316114|FG001|COMPLETED|Second Intervention Period||22
6403406|NCT00904670|7316113|FG000|NOT COMPLETED|Second Intervention Period||0
6403407|NCT00904670|7316114|FG001|NOT COMPLETED|Second Intervention Period||0
6403408|NCT00904722|7316122|FG000|STARTED|Overall Study||30
6403409|NCT00904722|7316122|FG000|COMPLETED|Overall Study||29
6403410|NCT00904722|7316122|FG000|NOT COMPLETED|Overall Study||1
6403411|NCT00904748|7316126|FG000|STARTED|Overall Study||8
6403412|NCT00904748|7316127|FG001|STARTED|Overall Study||8
6403413|NCT00904748|7316128|FG002|STARTED|Overall Study||8
6403414|NCT00904748|7316129|FG003|STARTED|Overall Study||8
6403415|NCT00904748|7316130|FG004|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
6403416|NCT00904748|7316131|FG005|STARTED|Overall Study||8
6403417|NCT00904748|7316126|FG000|Received Treatment|Overall Study||8
6403418|NCT00904748|7316127|FG001|Received Treatment|Overall Study||8
6403419|NCT00904748|7316128|FG002|Received Treatment|Overall Study||8
6403420|NCT00904748|7316129|FG003|Received Treatment|Overall Study||8
6403421|NCT00904748|7316130|FG004|Received Treatment|Overall Study||7
6403422|NCT00904748|7316131|FG005|Received Treatment|Overall Study||8
6403423|NCT00904748|7316126|FG000|COMPLETED|Overall Study||7
6403424|NCT00904748|7316127|FG001|COMPLETED|Overall Study||7
6403425|NCT00904748|7316128|FG002|COMPLETED|Overall Study||7
6403426|NCT00904748|7316129|FG003|COMPLETED|Overall Study||6
6403427|NCT00904748|7316130|FG004|COMPLETED|Overall Study||7
6403428|NCT00904748|7316131|FG005|COMPLETED|Overall Study||8
6403429|NCT00904748|7316126|FG000|NOT COMPLETED|Overall Study||1
6403430|NCT00904748|7316127|FG001|NOT COMPLETED|Overall Study||1
6403431|NCT00904748|7316128|FG002|NOT COMPLETED|Overall Study||1
6403432|NCT00904748|7316129|FG003|NOT COMPLETED|Overall Study||2
6635408|NCT02304380|7564269|FG003|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635409|NCT02304380|7564270|FG004|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635410|NCT02304380|7564271|FG005|NOT COMPLETED|Interviews & Focus Groups (Aim 1)||0
6635411|NCT02304380|7564266|FG000|STARTED|ACO Stakeholder Interviews (Aim 1)||24
6635412|NCT02304380|7564267|FG001|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6635413|NCT02304380|7564268|FG002|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6635414|NCT02304380|7564269|FG003|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6635415|NCT02304380|7564270|FG004|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6635416|NCT02304380|7564271|FG005|STARTED|ACO Stakeholder Interviews (Aim 1)||0
6635417|NCT02304380|7564266|FG000|COMPLETED|ACO Stakeholder Interviews (Aim 1)||24
6635418|NCT02304380|7564267|FG001|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635419|NCT02304380|7564268|FG002|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635420|NCT02304380|7564269|FG003|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635421|NCT02304380|7564270|FG004|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635422|NCT02304380|7564271|FG005|COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635423|NCT02304380|7564266|FG000|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635424|NCT02304380|7564267|FG001|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635425|NCT02304380|7564268|FG002|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635426|NCT02304380|7564269|FG003|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635427|NCT02304380|7564270|FG004|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635428|NCT02304380|7564271|FG005|NOT COMPLETED|ACO Stakeholder Interviews (Aim 1)||0
6635429|NCT02304406|7564285|FG000|STARTED|Overall Study||449
6635430|NCT02304406|7564285|FG000|COMPLETED|Overall Study||449
6635431|NCT02304406|7564285|FG000|NOT COMPLETED|Overall Study||0
6635432|NCT02304432|7564289|FG000|STARTED|Open Label DCS||2
6635433|NCT02304432|7564290|FG001|STARTED|Open Label DCS||0
6635434|NCT02304432|7564291|FG002|STARTED|Open Label DCS||0
6635435|NCT02304432|7564292|FG003|STARTED|Open Label DCS||0
6635436|NCT02304432|7564289|FG000|COMPLETED|Open Label DCS||2
6635437|NCT02304432|7564290|FG001|COMPLETED|Open Label DCS||0
6635438|NCT02304432|7564291|FG002|COMPLETED|Open Label DCS||0
6403433|NCT00904748|7316130|FG004|NOT COMPLETED|Overall Study||1
6403434|NCT00904748|7316131|FG005|NOT COMPLETED|Overall Study||0
6403435|NCT00904813|7316145|FG000|STARTED|Overall Study||129
6403436|NCT00904813|7316146|FG001|STARTED|Overall Study||128
6403437|NCT00904813|7316147|FG002|STARTED|Overall Study||128
6403438|NCT00904813|7316148|FG003|STARTED|Overall Study||228
6403439|NCT00904813|7316149|FG004|STARTED|Overall Study||227
6635439|NCT02304432|7564292|FG003|COMPLETED|Open Label DCS||0
6635440|NCT02304432|7564289|FG000|NOT COMPLETED|Open Label DCS||0
6635441|NCT02304432|7564290|FG001|NOT COMPLETED|Open Label DCS||0
6635442|NCT02304432|7564291|FG002|NOT COMPLETED|Open Label DCS||0
6635443|NCT02304432|7564292|FG003|NOT COMPLETED|Open Label DCS||0
6635444|NCT02304432|7564289|FG000|STARTED|Double-Blind DCS Placebo Crossover||0
6635445|NCT02304432|7564290|FG001|STARTED|Double-Blind DCS Placebo Crossover||1
6635446|NCT02304432|7564291|FG002|STARTED|Double-Blind DCS Placebo Crossover||1
6635447|NCT02304432|7564292|FG003|STARTED|Double-Blind DCS Placebo Crossover||0
6635448|NCT02304432|7564289|FG000|COMPLETED|Double-Blind DCS Placebo Crossover||0
6635449|NCT02304432|7564290|FG001|COMPLETED|Double-Blind DCS Placebo Crossover||1
6635450|NCT02304432|7564291|FG002|COMPLETED|Double-Blind DCS Placebo Crossover||1
6635451|NCT02304432|7564292|FG003|COMPLETED|Double-Blind DCS Placebo Crossover||0
6635452|NCT02304432|7564289|FG000|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
6635453|NCT02304432|7564290|FG001|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
6635454|NCT02304432|7564291|FG002|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
6635455|NCT02304432|7564292|FG003|NOT COMPLETED|Double-Blind DCS Placebo Crossover||0
6635456|NCT02304432|7564289|FG000|STARTED|Second Open Label DCS||0
6635457|NCT02304432|7564290|FG001|STARTED|Second Open Label DCS||0
6635458|NCT02304432|7564291|FG002|STARTED|Second Open Label DCS||0
6635459|NCT02304432|7564292|FG003|STARTED|Second Open Label DCS||2
6635460|NCT02304432|7564289|FG000|COMPLETED|Second Open Label DCS||0
6635461|NCT02304432|7564290|FG001|COMPLETED|Second Open Label DCS||0
6635462|NCT02304432|7564291|FG002|COMPLETED|Second Open Label DCS||0
6635463|NCT02304432|7564292|FG003|COMPLETED|Second Open Label DCS||2
6635464|NCT02304432|7564289|FG000|NOT COMPLETED|Second Open Label DCS||0
6635465|NCT02304432|7564290|FG001|NOT COMPLETED|Second Open Label DCS||0
6635466|NCT02304432|7564291|FG002|NOT COMPLETED|Second Open Label DCS||0
6635467|NCT02304432|7564292|FG003|NOT COMPLETED|Second Open Label DCS||0
6635468|NCT02304484|7564307|FG000|STARTED|Overall Study||770
6635469|NCT02304484|7564307|FG000|COMPLETED|Overall Study||745
6635470|NCT02304484|7564307|FG000|NOT COMPLETED|Overall Study||25
6635471|NCT02304705|7564313|FG000|STARTED|Overall Study||16
6635472|NCT02304705|7564314|FG001|STARTED|Overall Study||17
6635473|NCT02304705|7564313|FG000|COMPLETED|Overall Study||12
6635474|NCT02304705|7564314|FG001|COMPLETED|Overall Study||10
6635475|NCT02304705|7564313|FG000|NOT COMPLETED|Overall Study||4
6635476|NCT02304705|7564314|FG001|NOT COMPLETED|Overall Study||7
6635477|NCT02304757|7564322|FG000|STARTED|Overall Study||70
6635478|NCT02304757|7564323|FG001|STARTED|Overall Study||72
6635479|NCT02304757|7564322|FG000|COMPLETED|Overall Study||70
6635480|NCT02304757|7564323|FG001|COMPLETED|Overall Study||72
6635481|NCT02304757|7564322|FG000|NOT COMPLETED|Overall Study||0
6635482|NCT02304757|7564323|FG001|NOT COMPLETED|Overall Study||0
6635483|NCT02304926|7564331|FG000|STARTED|Overall Study||22
6635484|NCT02304926|7564332|FG001|STARTED|Overall Study||20
6635485|NCT02304926|7564331|FG000|COMPLETED|Overall Study||20
6635486|NCT02304926|7564332|FG001|COMPLETED|Overall Study||19
6635487|NCT02304926|7564331|FG000|NOT COMPLETED|Overall Study||2
6635488|NCT02304926|7564332|FG001|NOT COMPLETED|Overall Study||1
6635489|NCT02305017|7564342|FG000|STARTED|Overall Study||14
6635490|NCT02305017|7564343|FG001|STARTED|Overall Study||14
6635491|NCT02305017|7564342|FG000|COMPLETED|Overall Study||14
6635492|NCT02305017|7564343|FG001|COMPLETED|Overall Study||14
6635493|NCT02305017|7564342|FG000|NOT COMPLETED|Overall Study||0
6635494|NCT02305017|7564343|FG001|NOT COMPLETED|Overall Study||0
6635495|NCT02305238|7564356|FG000|STARTED|Overall Study||124
6635496|NCT02305238|7564357|FG001|STARTED|Overall Study||123
6635497|NCT02305238|7564358|FG002|STARTED|Overall Study||8
6635498|NCT02305238|7564356|FG000|Treated|Overall Study||124
6635499|NCT02305238|7564357|FG001|Treated|Overall Study||123
6635500|NCT02305238|7564358|FG002|Treated|Overall Study||7
6743380|NCT03334448|7671661|FG001|STARTED|Period 2||12
6743381|NCT03334448|7671662|FG002|STARTED|Period 2||13
6743382|NCT03334448|7671663|FG003|STARTED|Period 2||12
6743383|NCT03334448|7671660|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
6743384|NCT03334448|7671661|FG001|Received at Least 1 Dose of Study Drug|Period 2||12
6743385|NCT03334448|7671662|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
6743386|NCT03334448|7671663|FG003|Received at Least 1 Dose of Study Drug|Period 2||12
6743387|NCT03334448|7671660|FG000|COMPLETED|Period 2||12
6743388|NCT03334448|7671661|FG001|COMPLETED|Period 2||12
6743389|NCT03334448|7671662|FG002|COMPLETED|Period 2||13
6743390|NCT03334448|7671663|FG003|COMPLETED|Period 2||12
6743391|NCT03334448|7671660|FG000|NOT COMPLETED|Period 2||0
6743392|NCT03334448|7671661|FG001|NOT COMPLETED|Period 2||0
6743393|NCT03334448|7671662|FG002|NOT COMPLETED|Period 2||0
6743394|NCT03334448|7671663|FG003|NOT COMPLETED|Period 2||0
6743395|NCT03334448|7671660|FG000|STARTED|Washout||12
6743396|NCT03334448|7671661|FG001|STARTED|Washout||12
6743397|NCT03334448|7671662|FG002|STARTED|Washout||13
6743398|NCT03334448|7671663|FG003|STARTED|Washout||12
6743399|NCT03334448|7671660|FG000|COMPLETED|Washout||12
6743400|NCT03334448|7671661|FG001|COMPLETED|Washout||11
6743401|NCT03334448|7671662|FG002|COMPLETED|Washout||13
6743402|NCT03334448|7671663|FG003|COMPLETED|Washout||12
6743403|NCT03334448|7671660|FG000|NOT COMPLETED|Washout||0
6743404|NCT03334448|7671661|FG001|NOT COMPLETED|Washout||1
6743405|NCT03334448|7671662|FG002|NOT COMPLETED|Washout||0
6635501|NCT02305238|7564356|FG000|Randomized|Overall Study||124
6743406|NCT03334448|7671663|FG003|NOT COMPLETED|Washout||0
6635502|NCT02305238|7564357|FG001|Randomized|Overall Study||123
6635503|NCT02305238|7564358|FG002|Randomized|Overall Study||0
6403440|NCT00904813|7316145|FG000|COMPLETED|Overall Study||129
6403441|NCT00904813|7316146|FG001|COMPLETED|Overall Study||128
6403442|NCT00904813|7316147|FG002|COMPLETED|Overall Study||128
6403443|NCT00904813|7316148|FG003|COMPLETED|Overall Study||228
6403444|NCT00904813|7316149|FG004|COMPLETED|Overall Study||227
6403445|NCT00904813|7316145|FG000|NOT COMPLETED|Overall Study||0
6635504|NCT02305238|7564356|FG000|BCVA Post-randomization Assessment|Overall Study||123
6635505|NCT02305238|7564357|FG001|BCVA Post-randomization Assessment|Overall Study||123
6635506|NCT02305238|7564358|FG002|BCVA Post-randomization Assessment|Overall Study||0
6635507|NCT02305238|7564356|FG000|COMPLETED|Overall Study||108
6635508|NCT02305238|7564357|FG001|COMPLETED|Overall Study||104
6635509|NCT02305238|7564358|FG002|COMPLETED|Overall Study||0
6635510|NCT02305238|7564356|FG000|NOT COMPLETED|Overall Study||16
6635511|NCT02305238|7564357|FG001|NOT COMPLETED|Overall Study||19
6635512|NCT02305238|7564358|FG002|NOT COMPLETED|Overall Study||8
6635513|NCT02305277|7564371|FG000|STARTED|Overall Study||15
6635514|NCT02305277|7564372|FG001|STARTED|Overall Study||14
6635515|NCT02305277|7564373|FG002|STARTED|Overall Study||14
6635516|NCT02305277|7564374|FG003|STARTED|Overall Study||14
6635517|NCT02305277|7564375|FG004|STARTED|Overall Study||14
6635518|NCT02305277|7564376|FG005|STARTED|Overall Study||14
6635519|NCT02305277|7564371|FG000|Received CM|Overall Study||15
6635520|NCT02305277|7564372|FG001|Received CM|Overall Study||14
6635521|NCT02305277|7564373|FG002|Received CM|Overall Study||14
6635522|NCT02305277|7564374|FG003|Received CM|Overall Study||14
6635523|NCT02305277|7564375|FG004|Received CM|Overall Study||14
6635524|NCT02305277|7564376|FG005|Received CM|Overall Study||14
6635525|NCT02305277|7564371|FG000|Received TBM|Overall Study||15
6635526|NCT02305277|7564372|FG001|Received TBM|Overall Study||14
6635527|NCT02305277|7564373|FG002|Received TBM|Overall Study||14
6635528|NCT02305277|7564374|FG003|Received TBM|Overall Study||14
6635529|NCT02305277|7564375|FG004|Received TBM|Overall Study||14
6635530|NCT02305277|7564376|FG005|Received TBM|Overall Study||14
6635531|NCT02305277|7564371|FG000|COMPLETED|Overall Study||14
6635532|NCT02305277|7564372|FG001|COMPLETED|Overall Study||14
6635533|NCT02305277|7564373|FG002|COMPLETED|Overall Study||14
6635534|NCT02305277|7564374|FG003|COMPLETED|Overall Study||14
6635535|NCT02305277|7564375|FG004|COMPLETED|Overall Study||13
6635536|NCT02305277|7564376|FG005|COMPLETED|Overall Study||14
6635537|NCT02305277|7564371|FG000|NOT COMPLETED|Overall Study||1
6635538|NCT02305277|7564372|FG001|NOT COMPLETED|Overall Study||0
6635539|NCT02305277|7564373|FG002|NOT COMPLETED|Overall Study||0
6635540|NCT02305277|7564374|FG003|NOT COMPLETED|Overall Study||0
6635541|NCT02305277|7564375|FG004|NOT COMPLETED|Overall Study||1
6635542|NCT02305277|7564376|FG005|NOT COMPLETED|Overall Study||0
6655638|NCT02454153|7585789|FG000|NOT COMPLETED|Overall Study||0
6655639|NCT02454153|7585790|FG001|NOT COMPLETED|Overall Study||0
6655640|NCT02454179|7585799|FG000|STARTED|Overall Study||39
6655641|NCT02454179|7585800|FG001|STARTED|Overall Study||39
6655642|NCT02454179|7585799|FG000|Enrolled|Overall Study||39
6655643|NCT02454179|7585800|FG001|Enrolled|Overall Study||39
6655644|NCT02454179|7585799|FG000|Received Study Medication|Overall Study||39
6655645|NCT02454179|7585800|FG001|Received Study Medication|Overall Study||37
6655646|NCT02454179|7585799|FG000|Discontinue Study|Overall Study||39
6655647|NCT02454179|7585800|FG001|Discontinue Study|Overall Study||39
6655648|NCT02454179|7585799|FG000|COMPLETED|Overall Study||0
6655649|NCT02454179|7585800|FG001|COMPLETED|Overall Study||0
6655650|NCT02454179|7585799|FG000|NOT COMPLETED|Overall Study||39
6655651|NCT02454179|7585800|FG001|NOT COMPLETED|Overall Study||39
6655652|NCT02454283|7585808|FG000|STARTED|Overall Study||26
6655653|NCT02454283|7585809|FG001|STARTED|Overall Study||15
6655654|NCT02454283|7585808|FG000|COMPLETED|Overall Study||26
6655655|NCT02454283|7585809|FG001|COMPLETED|Overall Study||15
6655656|NCT02454283|7585808|FG000|NOT COMPLETED|Overall Study||0
6655657|NCT02454283|7585809|FG001|NOT COMPLETED|Overall Study||0
6655658|NCT02454296|7585817|FG000|STARTED|Overall Study||20
6655659|NCT02454296|7585818|FG001|STARTED|Overall Study||21
6655660|NCT02454296|7585817|FG000|COMPLETED|Overall Study||20
6655661|NCT02454296|7585818|FG001|COMPLETED|Overall Study||21
6655662|NCT02454296|7585817|FG000|NOT COMPLETED|Overall Study||0
6655663|NCT02454296|7585818|FG001|NOT COMPLETED|Overall Study||0
6655664|NCT02454478|7585826|FG000|STARTED|Overall Study||7
6403446|NCT00904813|7316146|FG001|NOT COMPLETED|Overall Study||0
6403447|NCT00904813|7316147|FG002|NOT COMPLETED|Overall Study||0
6403448|NCT00904813|7316148|FG003|NOT COMPLETED|Overall Study||0
6655665|NCT02454478|7585826|FG000|COMPLETED|Overall Study||6
6655666|NCT02454478|7585826|FG000|NOT COMPLETED|Overall Study||1
6655667|NCT02454530|7585832|FG000|STARTED|Overall Study||552
6655668|NCT02454530|7585833|FG001|STARTED|Overall Study||608
6655669|NCT02454530|7585832|FG000|COMPLETED|Overall Study||482
6655670|NCT02454530|7585833|FG001|COMPLETED|Overall Study||481
6655671|NCT02454530|7585832|FG000|NOT COMPLETED|Overall Study||70
6655672|NCT02454530|7585833|FG001|NOT COMPLETED|Overall Study||127
6655673|NCT02454608|7585843|FG000|STARTED|Double-Blind Period||15
6655674|NCT02454608|7585844|FG001|STARTED|Double-Blind Period||14
6655675|NCT02454608|7585845|FG002|STARTED|Double-Blind Period|This arm is not part of this period of the study|0
6655676|NCT02454608|7585843|FG000|COMPLETED|Double-Blind Period||15
6655677|NCT02454608|7585844|FG001|COMPLETED|Double-Blind Period||12
6655678|NCT02454608|7585845|FG002|COMPLETED|Double-Blind Period|This arm is not part of this period of the study|0
6635543|NCT02305316|7564392|FG000|STARTED|Overall Study||14
6635544|NCT02305316|7564393|FG001|STARTED|Overall Study||14
6635545|NCT02305316|7564392|FG000|COMPLETED|Overall Study||14
6635546|NCT02305316|7564393|FG001|COMPLETED|Overall Study||14
6635547|NCT02305316|7564392|FG000|NOT COMPLETED|Overall Study||0
6635548|NCT02305316|7564393|FG001|NOT COMPLETED|Overall Study||0
6635549|NCT02305329|7564403|FG000|STARTED|Overall Study||14
6635550|NCT02305329|7564404|FG001|STARTED|Overall Study||14
6635551|NCT02305329|7564405|FG002|STARTED|Overall Study||14
6635552|NCT02305329|7564406|FG003|STARTED|Overall Study||14
6635553|NCT02305329|7564403|FG000|Period 1|Overall Study||14
6635554|NCT02305329|7564404|FG001|Period 1|Overall Study||14
6635555|NCT02305329|7564405|FG002|Period 1|Overall Study||14
6635556|NCT02305329|7564406|FG003|Period 1|Overall Study||14
6635557|NCT02305329|7564403|FG000|Period 2|Overall Study||14
6635558|NCT02305329|7564404|FG001|Period 2|Overall Study||13
6635559|NCT02305329|7564405|FG002|Period 2|Overall Study||14
6635560|NCT02305329|7564406|FG003|Period 2|Overall Study||14
6635561|NCT02305329|7564403|FG000|COMPLETED|Overall Study||14
6635562|NCT02305329|7564404|FG001|COMPLETED|Overall Study||13
6635563|NCT02305329|7564405|FG002|COMPLETED|Overall Study||14
6635564|NCT02305329|7564406|FG003|COMPLETED|Overall Study||14
6635565|NCT02305329|7564403|FG000|NOT COMPLETED|Overall Study||0
6635566|NCT02305329|7564404|FG001|NOT COMPLETED|Overall Study||1
6635567|NCT02305329|7564405|FG002|NOT COMPLETED|Overall Study||0
6635568|NCT02305329|7564406|FG003|NOT COMPLETED|Overall Study||0
6635569|NCT02305381|7564419|FG000|STARTED|Overall Study||132
6635570|NCT02305381|7564420|FG001|STARTED|Overall Study||132
6635571|NCT02305381|7564421|FG002|STARTED|Overall Study||133
6635572|NCT02305381|7564419|FG000|Exposed|Overall Study||132
6635573|NCT02305381|7564420|FG001|Exposed|Overall Study||131
6635574|NCT02305381|7564421|FG002|Exposed|Overall Study||133
6635575|NCT02305381|7564419|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|14
6635576|NCT02305381|7564420|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial|16
6635577|NCT02305381|7564421|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|13
6635578|NCT02305381|7564419|FG000|COMPLETED|Overall Study|Subjects who completed the trial.|127
6635579|NCT02305381|7564420|FG001|COMPLETED|Overall Study|Subjects who completed the trial.|127
6635580|NCT02305381|7564421|FG002|COMPLETED|Overall Study|Subjects who completed the trial.|126
6635581|NCT02305381|7564419|FG000|NOT COMPLETED|Overall Study||5
6635582|NCT02305381|7564420|FG001|NOT COMPLETED|Overall Study||5
6635583|NCT02305381|7564421|FG002|NOT COMPLETED|Overall Study||7
6635584|NCT02305446|7564429|FG000|STARTED|Overall Study||55
6635585|NCT02305446|7564429|FG000|COMPLETED|Overall Study||54
6635586|NCT02305446|7564429|FG000|NOT COMPLETED|Overall Study||1
6635587|NCT02305563|7564438|FG000|STARTED|Treatment Period||3
6635588|NCT02305563|7564439|FG001|STARTED|Treatment Period||3
6635589|NCT02305563|7564440|FG002|STARTED|Treatment Period||26
6635590|NCT02305563|7564441|FG003|STARTED|Treatment Period||14
6635591|NCT02305563|7564442|FG004|STARTED|Treatment Period||24
6635592|NCT02305563|7564438|FG000|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
6635593|NCT02305563|7564439|FG001|COMPLETED|Treatment Period|At the time of the Phase 1 lock, 1 participant was still continuing on treatment|1
6635594|NCT02305563|7564440|FG002|COMPLETED|Treatment Period||0
6635595|NCT02305563|7564441|FG003|COMPLETED|Treatment Period||0
6635596|NCT02305563|7564442|FG004|COMPLETED|Treatment Period||0
6635597|NCT02305563|7564438|FG000|NOT COMPLETED|Treatment Period||2
6635598|NCT02305563|7564439|FG001|NOT COMPLETED|Treatment Period||2
6635599|NCT02305563|7564440|FG002|NOT COMPLETED|Treatment Period||26
6635600|NCT02305563|7564441|FG003|NOT COMPLETED|Treatment Period||14
6635601|NCT02305563|7564442|FG004|NOT COMPLETED|Treatment Period||24
6635602|NCT02305563|7564438|FG000|STARTED|Follow-up Period||3
6635603|NCT02305563|7564439|FG001|STARTED|Follow-up Period||3
6635604|NCT02305563|7564440|FG002|STARTED|Follow-up Period||11
6635605|NCT02305563|7564441|FG003|STARTED|Follow-up Period||6
6635606|NCT02305563|7564442|FG004|STARTED|Follow-up Period||12
6635607|NCT02305563|7564438|FG000|COMPLETED|Follow-up Period||0
6635608|NCT02305563|7564439|FG001|COMPLETED|Follow-up Period||0
6635609|NCT02305563|7564440|FG002|COMPLETED|Follow-up Period||0
6635610|NCT02305563|7564441|FG003|COMPLETED|Follow-up Period||0
6635611|NCT02305563|7564442|FG004|COMPLETED|Follow-up Period||0
6635612|NCT02305563|7564438|FG000|NOT COMPLETED|Follow-up Period||3
6635613|NCT02305563|7564439|FG001|NOT COMPLETED|Follow-up Period||3
6635614|NCT02305563|7564440|FG002|NOT COMPLETED|Follow-up Period||11
6635615|NCT02305563|7564441|FG003|NOT COMPLETED|Follow-up Period||6
6635616|NCT02305563|7564442|FG004|NOT COMPLETED|Follow-up Period||12
6635617|NCT02305732|7564458|FG000|STARTED|Overall Study||90
6635618|NCT02305732|7564458|FG000|COMPLETED|Overall Study||72
6635619|NCT02305732|7564458|FG000|NOT COMPLETED|Overall Study||18
6635620|NCT02305758|7564465|FG000|STARTED|Overall Study||65
6635621|NCT02305758|7564466|FG001|STARTED|Overall Study||65
6635622|NCT02305758|7564465|FG000|COMPLETED|Overall Study||0
6635623|NCT02305758|7564466|FG001|COMPLETED|Overall Study||0
6635624|NCT02305758|7564465|FG000|NOT COMPLETED|Overall Study||65
6635625|NCT02305758|7564466|FG001|NOT COMPLETED|Overall Study||65
6635626|NCT02305797|7564474|FG000|STARTED|Overall Study||247
6635627|NCT02305797|7564475|FG001|STARTED|Overall Study||248
6635628|NCT02305797|7564474|FG000|COMPLETED|Overall Study||202
6635629|NCT02305797|7564475|FG001|COMPLETED|Overall Study||210
6635630|NCT02305797|7564474|FG000|NOT COMPLETED|Overall Study||45
6635631|NCT02305797|7564475|FG001|NOT COMPLETED|Overall Study||38
6635632|NCT02305849|7564484|FG000|STARTED|Overall Study||175
6403449|NCT00904813|7316149|FG004|NOT COMPLETED|Overall Study||0
6403450|NCT00904826|7316172|FG000|STARTED|Overall Study||14
6403451|NCT00904826|7316172|FG000|COMPLETED|Overall Study||14
6403452|NCT00904826|7316172|FG000|NOT COMPLETED|Overall Study||0
6403453|NCT00904839|7316178|FG000|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
6403454|NCT00904839|7316179|FG001|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
6403455|NCT00904839|7316180|FG002|STARTED|Overall Study|Randomised|42
6403456|NCT00904839|7316178|FG000|COMPLETED|Overall Study||3
6403457|NCT00904839|7316179|FG001|COMPLETED|Overall Study||64
6403458|NCT00904839|7316180|FG002|COMPLETED|Overall Study||27
6403459|NCT00904839|7316178|FG000|NOT COMPLETED|Overall Study||1
6403460|NCT00904839|7316179|FG001|NOT COMPLETED|Overall Study||18
6403461|NCT00904839|7316180|FG002|NOT COMPLETED|Overall Study||15
6498722|NCT01412060|7417357|FG001|NOT COMPLETED|Period Between RIP and SP||0
6498723|NCT01412060|7417358|FG002|NOT COMPLETED|Period Between RIP and SP||0
6498724|NCT01412060|7417356|FG000|STARTED|Open-label Stabilization Period (SP)||364
6498725|NCT01412060|7417357|FG001|STARTED|Open-label Stabilization Period (SP)||0
6498726|NCT01412060|7417358|FG002|STARTED|Open-label Stabilization Period (SP)||0
6498727|NCT01412060|7417356|FG000|COMPLETED|Open-label Stabilization Period (SP)||264
6498728|NCT01412060|7417357|FG001|COMPLETED|Open-label Stabilization Period (SP)||0
6498729|NCT01412060|7417358|FG002|COMPLETED|Open-label Stabilization Period (SP)||0
6498730|NCT01412060|7417356|FG000|NOT COMPLETED|Open-label Stabilization Period (SP)||100
6498731|NCT01412060|7417357|FG001|NOT COMPLETED|Open-label Stabilization Period (SP)||0
6510170|NCT01479621|7429700|FG005|COMPLETED|Treatment Period||63
6510171|NCT01479621|7429701|FG006|COMPLETED|Treatment Period||84
6510172|NCT01479621|7429695|FG000|NOT COMPLETED|Treatment Period||0
6510173|NCT01479621|7429696|FG001|NOT COMPLETED|Treatment Period||24
6510174|NCT01479621|7429697|FG002|NOT COMPLETED|Treatment Period||21
6510175|NCT01479621|7429698|FG003|NOT COMPLETED|Treatment Period||12
6510176|NCT01479621|7429699|FG004|NOT COMPLETED|Treatment Period||21
6510177|NCT01479621|7429700|FG005|NOT COMPLETED|Treatment Period||41
6510178|NCT01479621|7429701|FG006|NOT COMPLETED|Treatment Period||20
6510179|NCT01479725|7429717|FG000|STARTED|Overall Study||6
6510180|NCT01479725|7429718|FG001|STARTED|Overall Study||2
6510181|NCT01479725|7429717|FG000|COMPLETED|Overall Study||4
6510182|NCT01479725|7429718|FG001|COMPLETED|Overall Study||1
6510183|NCT01479725|7429717|FG000|NOT COMPLETED|Overall Study||2
6510184|NCT01479725|7429718|FG001|NOT COMPLETED|Overall Study||1
6510185|NCT01479764|7429726|FG000|STARTED|Randomized||76
6510186|NCT01479764|7429727|FG001|STARTED|Randomized||78
6510187|NCT01479764|7429726|FG000|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
6510188|NCT01479764|7429727|FG001|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
6510189|NCT01479764|7429726|FG000|NOT COMPLETED|Randomized||2
6510190|NCT01479764|7429727|FG001|NOT COMPLETED|Randomized||1
6510191|NCT01479764|7429726|FG000|STARTED|Treated||74
6510192|NCT01479764|7429727|FG001|STARTED|Treated||77
6510193|NCT01479764|7429726|FG000|COMPLETED|Treated||74
6510194|NCT01479764|7429727|FG001|COMPLETED|Treated||75
6510195|NCT01479764|7429726|FG000|NOT COMPLETED|Treated||0
6510196|NCT01479764|7429727|FG001|NOT COMPLETED|Treated||2
6510197|NCT01479777|7429733|FG000|STARTED|Overall Study||12
6510198|NCT01479777|7429733|FG000|COMPLETED|Overall Study||10
6510199|NCT01479777|7429733|FG000|NOT COMPLETED|Overall Study||2
6510200|NCT01479868|7429737|FG000|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
6510201|NCT01479868|7429737|FG000|COMPLETED|Overall Study||97
6510202|NCT01479868|7429737|FG000|NOT COMPLETED|Overall Study||9
6561191|NCT01791517|7484041|FG000|STARTED|Phase I: Period 4||17
6561192|NCT01791517|7484042|FG001|STARTED|Phase I: Period 4||14
6561193|NCT01791517|7484043|FG002|STARTED|Phase I: Period 4||16
6561194|NCT01791517|7484044|FG003|STARTED|Phase I: Period 4||15
6561195|NCT01791517|7484045|FG004|STARTED|Phase I: Period 4||18
6561196|NCT01791517|7484046|FG005|STARTED|Phase I: Period 4||18
6561197|NCT01791517|7484047|FG006|STARTED|Phase I: Period 4||19
6561198|NCT01791517|7484048|FG007|STARTED|Phase I: Period 4||20
6561199|NCT01791517|7484049|FG008|STARTED|Phase I: Period 4||19
6561200|NCT01791517|7484050|FG009|STARTED|Phase I: Period 4||18
6561201|NCT01791517|7484051|FG010|STARTED|Phase I: Period 4||16
6561202|NCT01791517|7484052|FG011|STARTED|Phase I: Period 4||18
6561203|NCT01791517|7484041|FG000|COMPLETED|Phase I: Period 4||17
6561204|NCT01791517|7484042|FG001|COMPLETED|Phase I: Period 4||14
6561205|NCT01791517|7484043|FG002|COMPLETED|Phase I: Period 4||16
6561206|NCT01791517|7484044|FG003|COMPLETED|Phase I: Period 4||15
6561207|NCT01791517|7484045|FG004|COMPLETED|Phase I: Period 4||18
6561208|NCT01791517|7484046|FG005|COMPLETED|Phase I: Period 4||18
6561209|NCT01791517|7484047|FG006|COMPLETED|Phase I: Period 4||19
6561210|NCT01791517|7484048|FG007|COMPLETED|Phase I: Period 4||20
6561211|NCT01791517|7484049|FG008|COMPLETED|Phase I: Period 4||19
6561212|NCT01791517|7484050|FG009|COMPLETED|Phase I: Period 4||18
6561213|NCT01791517|7484051|FG010|COMPLETED|Phase I: Period 4||16
6561214|NCT01791517|7484052|FG011|COMPLETED|Phase I: Period 4||18
6561215|NCT01791517|7484041|FG000|NOT COMPLETED|Phase I: Period 4||0
6561216|NCT01791517|7484042|FG001|NOT COMPLETED|Phase I: Period 4||0
6561217|NCT01791517|7484043|FG002|NOT COMPLETED|Phase I: Period 4||0
6403462|NCT00904917|7316195|FG000|STARTED|Overall Study||7
6403463|NCT00904917|7316196|FG001|STARTED|Overall Study||11
6403464|NCT00904917|7316197|FG002|STARTED|Overall Study||8
6403465|NCT00904917|7316198|FG003|STARTED|Overall Study||8
6403466|NCT00904917|7316195|FG000|COMPLETED|Overall Study||5
6403467|NCT00904917|7316196|FG001|COMPLETED|Overall Study||9
6403468|NCT00904917|7316197|FG002|COMPLETED|Overall Study||6
6403469|NCT00904917|7316198|FG003|COMPLETED|Overall Study||6
6403470|NCT00904917|7316195|FG000|NOT COMPLETED|Overall Study||2
6403471|NCT00904917|7316196|FG001|NOT COMPLETED|Overall Study||2
6403472|NCT00904917|7316197|FG002|NOT COMPLETED|Overall Study||2
6403473|NCT00904917|7316198|FG003|NOT COMPLETED|Overall Study||2
6403474|NCT00904969|7316211|FG000|STARTED|Overall Study|Number of patients with an attempted implant; 1 subject with procedure aborted|50
6403475|NCT00904969|7316211|FG000|COMPLETED|Overall Study|# of Implanted Subjects Who Completed the Study|31
6403476|NCT00904969|7316211|FG000|NOT COMPLETED|Overall Study||19
6403477|NCT00904982|7316234|FG000|STARTED|Overall Study||68
6403478|NCT00904982|7316235|FG001|STARTED|Overall Study||67
6403479|NCT00904982|7316236|FG002|STARTED|Overall Study||67
6403480|NCT00904982|7316237|FG003|STARTED|Overall Study||68
6403481|NCT00904982|7316234|FG000|COMPLETED|Overall Study||66
6403482|NCT00904982|7316235|FG001|COMPLETED|Overall Study||67
6403483|NCT00904982|7316236|FG002|COMPLETED|Overall Study||67
6403484|NCT00904982|7316237|FG003|COMPLETED|Overall Study||68
6403485|NCT00904982|7316234|FG000|NOT COMPLETED|Overall Study||2
6403486|NCT00904982|7316235|FG001|NOT COMPLETED|Overall Study||0
6403487|NCT00904982|7316236|FG002|NOT COMPLETED|Overall Study||0
6403488|NCT00904982|7316237|FG003|NOT COMPLETED|Overall Study||0
6403489|NCT00904995|7316249|FG000|STARTED|Overall Study||10
6403490|NCT00904995|7316250|FG001|STARTED|Overall Study||11
6403491|NCT00904995|7316249|FG000|COMPLETED|Overall Study||10
6403492|NCT00904995|7316250|FG001|COMPLETED|Overall Study||11
6403493|NCT00904995|7316249|FG000|NOT COMPLETED|Overall Study||0
6403494|NCT00904995|7316250|FG001|NOT COMPLETED|Overall Study||0
6403495|NCT00905021|7316256|FG000|STARTED|Overall Study||4
6403496|NCT00905021|7316256|FG000|COMPLETED|Overall Study|2 patients were off study due to AE.|2
6403497|NCT00905021|7316256|FG000|NOT COMPLETED|Overall Study||2
6403498|NCT00905034|7316261|FG000|STARTED|Overall Study||37
6403499|NCT00905034|7316261|FG000|COMPLETED|Overall Study||36
6403500|NCT00905034|7316261|FG000|NOT COMPLETED|Overall Study||1
6403501|NCT00905060|7316265|FG000|STARTED|Surgical Resection||70
6403502|NCT00905060|7316265|FG000|COMPLETED|Surgical Resection||46
6403503|NCT00905060|7316265|FG000|NOT COMPLETED|Surgical Resection||24
6403504|NCT00905060|7316265|FG000|STARTED|Vaccination Treatment Period||46
6403505|NCT00905060|7316265|FG000|COMPLETED|Vaccination Treatment Period||46
6403506|NCT00905060|7316265|FG000|NOT COMPLETED|Vaccination Treatment Period||0
6403507|NCT00905125|7316271|FG000|STARTED|Overall Study||46
6403508|NCT00905125|7316272|FG001|STARTED|Overall Study||56
6403509|NCT00905125|7316271|FG000|COMPLETED|Overall Study||42
6403510|NCT00905125|7316272|FG001|COMPLETED|Overall Study||53
6403511|NCT00905125|7316271|FG000|NOT COMPLETED|Overall Study||4
6403512|NCT00905125|7316272|FG001|NOT COMPLETED|Overall Study||3
6403513|NCT00905151|7316278|FG000|STARTED|Overall Study||206
6403514|NCT00905151|7316278|FG000|COMPLETED|Overall Study||200
6403515|NCT00905151|7316278|FG000|NOT COMPLETED|Overall Study||6
6403516|NCT00905255|7316284|FG000|STARTED|Overall Study|Randomized.|33
6403517|NCT00905255|7316285|FG001|STARTED|Overall Study||36
6403518|NCT00905255|7316284|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
6403519|NCT00905255|7316285|FG001|Safety Population|Overall Study||36
6403520|NCT00905255|7316284|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
6403521|NCT00905255|7316285|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||36
6403522|NCT00905255|7316284|FG000|COMPLETED|Overall Study||20
6403523|NCT00905255|7316285|FG001|COMPLETED|Overall Study||27
6403524|NCT00905255|7316284|FG000|NOT COMPLETED|Overall Study||13
6403525|NCT00905255|7316285|FG001|NOT COMPLETED|Overall Study||9
6403526|NCT00905268|7316296|FG000|STARTED|Overall Study||57
6403527|NCT00905268|7316297|FG001|STARTED|Overall Study||57
6403528|NCT00905268|7316298|FG002|STARTED|Overall Study||59
6403529|NCT00905268|7316299|FG003|STARTED|Overall Study||59
6403530|NCT00905268|7316296|FG000|COMPLETED|Overall Study||53
6403531|NCT00905268|7316297|FG001|COMPLETED|Overall Study||56
6403532|NCT00905268|7316298|FG002|COMPLETED|Overall Study||59
6403533|NCT00905268|7316299|FG003|COMPLETED|Overall Study||57
6403534|NCT00905268|7316296|FG000|NOT COMPLETED|Overall Study||4
6403535|NCT00905268|7316297|FG001|NOT COMPLETED|Overall Study||1
6403536|NCT00905268|7316298|FG002|NOT COMPLETED|Overall Study||0
6403537|NCT00905268|7316299|FG003|NOT COMPLETED|Overall Study||2
6403538|NCT00905307|7316315|FG000|STARTED|Overall Study||42
6403539|NCT00905307|7316316|FG001|STARTED|Overall Study||89
6403540|NCT00905307|7316317|FG002|STARTED|Overall Study||90
6403541|NCT00905307|7316318|FG003|STARTED|Overall Study||93
6403542|NCT00905307|7316319|FG004|STARTED|Overall Study||50
6403543|NCT00905307|7316320|FG005|STARTED|Overall Study||95
6403544|NCT00905307|7316315|FG000|COMPLETED|Overall Study||20
6403545|NCT00905307|7316316|FG001|COMPLETED|Overall Study||52
6403546|NCT00905307|7316317|FG002|COMPLETED|Overall Study||53
6403547|NCT00905307|7316318|FG003|COMPLETED|Overall Study||56
6403548|NCT00905307|7316319|FG004|COMPLETED|Overall Study||34
6403549|NCT00905307|7316320|FG005|COMPLETED|Overall Study||53
6403550|NCT00905307|7316315|FG000|NOT COMPLETED|Overall Study||22
6403551|NCT00905307|7316316|FG001|NOT COMPLETED|Overall Study||37
6403552|NCT00905307|7316317|FG002|NOT COMPLETED|Overall Study||37
6403553|NCT00905307|7316318|FG003|NOT COMPLETED|Overall Study||37
6403554|NCT00905307|7316319|FG004|NOT COMPLETED|Overall Study||16
6403555|NCT00905307|7316320|FG005|NOT COMPLETED|Overall Study||42
6403556|NCT00905359|7316349|FG000|STARTED|Overall Study||82
6403557|NCT00905359|7316350|FG001|STARTED|Overall Study||81
6403558|NCT00905359|7316349|FG000|12 Months Follow up|Overall Study||68
6403559|NCT00905359|7316350|FG001|12 Months Follow up|Overall Study||72
6403560|NCT00905359|7316349|FG000|24 Months Follow up|Overall Study||58
6403561|NCT00905359|7316350|FG001|24 Months Follow up|Overall Study||65
6403562|NCT00905359|7316349|FG000|COMPLETED|Overall Study||58
6403563|NCT00905359|7316350|FG001|COMPLETED|Overall Study||65
6403564|NCT00905359|7316349|FG000|NOT COMPLETED|Overall Study||24
6403565|NCT00905359|7316350|FG001|NOT COMPLETED|Overall Study||16
6403566|NCT00905424|7316358|FG000|STARTED|Overall Study||89
6403567|NCT00905424|7316359|FG001|STARTED|Overall Study||88
6403568|NCT00905424|7316358|FG000|COMPLETED|Overall Study||78
6403569|NCT00905424|7316359|FG001|COMPLETED|Overall Study||79
6403570|NCT00905424|7316358|FG000|NOT COMPLETED|Overall Study||11
6403571|NCT00905424|7316359|FG001|NOT COMPLETED|Overall Study||9
6403572|NCT00905437|7316369|FG000|STARTED|Overall Study||35
6403573|NCT00905437|7316370|FG001|STARTED|Overall Study||37
6403574|NCT00905437|7316369|FG000|COMPLETED|Overall Study||27
6403575|NCT00905437|7316370|FG001|COMPLETED|Overall Study||27
6403576|NCT00905437|7316369|FG000|NOT COMPLETED|Overall Study||8
6403577|NCT00905437|7316370|FG001|NOT COMPLETED|Overall Study||10
6403578|NCT00905450|7316384|FG000|STARTED|Overall Study||60
6403579|NCT00905450|7316385|FG001|STARTED|Overall Study||28
6403580|NCT00905450|7316386|FG002|STARTED|Overall Study||28
6403581|NCT00905450|7316387|FG003|STARTED|Overall Study||60
6403582|NCT00905450|7316388|FG004|STARTED|Overall Study||59
6403583|NCT00905450|7316389|FG005|STARTED|Overall Study||60
6403584|NCT00905450|7316390|FG006|STARTED|Overall Study||60
6403585|NCT00905450|7316391|FG007|STARTED|Overall Study||60
6403586|NCT00905450|7316384|FG000|COMPLETED|Overall Study||59
6403587|NCT00905450|7316385|FG001|COMPLETED|Overall Study||27
6403588|NCT00905450|7316386|FG002|COMPLETED|Overall Study||28
6403589|NCT00905450|7316387|FG003|COMPLETED|Overall Study||60
6403590|NCT00905450|7316388|FG004|COMPLETED|Overall Study||59
6403591|NCT00905450|7316389|FG005|COMPLETED|Overall Study||58
6403592|NCT00905450|7316390|FG006|COMPLETED|Overall Study||58
6403593|NCT00905450|7316391|FG007|COMPLETED|Overall Study||59
6403594|NCT00905450|7316384|FG000|NOT COMPLETED|Overall Study||1
6403595|NCT00905450|7316385|FG001|NOT COMPLETED|Overall Study||1
6403596|NCT00905450|7316386|FG002|NOT COMPLETED|Overall Study||0
6403597|NCT00905450|7316387|FG003|NOT COMPLETED|Overall Study||0
6403598|NCT00905450|7316388|FG004|NOT COMPLETED|Overall Study||0
6403599|NCT00905450|7316389|FG005|NOT COMPLETED|Overall Study||2
6403600|NCT00905450|7316390|FG006|NOT COMPLETED|Overall Study||2
6403601|NCT00905450|7316391|FG007|NOT COMPLETED|Overall Study||1
6403602|NCT00905489|7316409|FG000|STARTED|Pharmaco-kinetic (PK) Phase||85
6403603|NCT00905489|7316409|FG000|COMPLETED|Pharmaco-kinetic (PK) Phase||80
6403604|NCT00905489|7316409|FG000|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
6403605|NCT00905489|7316409|FG000|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
6403606|NCT00905489|7316409|FG000|COMPLETED|Optional Extension Phase (OEP)||39
6403607|NCT00905489|7316409|FG000|NOT COMPLETED|Optional Extension Phase (OEP)||1
6403608|NCT00905515|7316421|FG000|STARTED|Overall Study||21
6403609|NCT00905515|7316422|FG001|STARTED|Overall Study||20
6403610|NCT00905515|7316423|FG002|STARTED|Overall Study||22
6403611|NCT00905515|7316421|FG000|COMPLETED|Overall Study||19
6403612|NCT00905515|7316422|FG001|COMPLETED|Overall Study||20
6403613|NCT00905515|7316423|FG002|COMPLETED|Overall Study||20
6403614|NCT00905515|7316421|FG000|NOT COMPLETED|Overall Study||2
6403615|NCT00905515|7316422|FG001|NOT COMPLETED|Overall Study||0
6403616|NCT00905515|7316423|FG002|NOT COMPLETED|Overall Study||2
6403617|NCT00905554|7316433|FG000|STARTED|Overall Study||116
6403618|NCT00905554|7316434|FG001|STARTED|Overall Study||114
6403619|NCT00905554|7316433|FG000|COMPLETED|Overall Study||116
6403620|NCT00905554|7316434|FG001|COMPLETED|Overall Study||114
6403621|NCT00905554|7316433|FG000|NOT COMPLETED|Overall Study||0
6403622|NCT00905554|7316434|FG001|NOT COMPLETED|Overall Study||0
6403623|NCT00905580|7316442|FG000|STARTED|Overall Study||49
6403624|NCT00905580|7316443|FG001|STARTED|Overall Study||50
6403625|NCT00905580|7316442|FG000|COMPLETED|Overall Study||47
6403626|NCT00905580|7316443|FG001|COMPLETED|Overall Study||47
6403627|NCT00905580|7316442|FG000|NOT COMPLETED|Overall Study||2
6403628|NCT00905580|7316443|FG001|NOT COMPLETED|Overall Study||3
6403629|NCT00905632|7316456|FG000|STARTED|Overall Study||8
6403630|NCT00905632|7316457|FG001|STARTED|Overall Study||6
6403631|NCT00905632|7316458|FG002|STARTED|Overall Study||7
6403632|NCT00905632|7316459|FG003|STARTED|Overall Study||6
6403633|NCT00905632|7316460|FG004|STARTED|Overall Study||10
6403634|NCT00905632|7316461|FG005|STARTED|Overall Study||9
6403635|NCT00905632|7316462|FG006|STARTED|Overall Study||11
6403636|NCT00905632|7316456|FG000|COMPLETED|Overall Study||8
6403637|NCT00905632|7316457|FG001|COMPLETED|Overall Study||6
6403638|NCT00905632|7316458|FG002|COMPLETED|Overall Study||7
6403639|NCT00905632|7316459|FG003|COMPLETED|Overall Study||6
6403640|NCT00905632|7316460|FG004|COMPLETED|Overall Study||10
6403641|NCT00905632|7316461|FG005|COMPLETED|Overall Study||8
6403642|NCT00905632|7316462|FG006|COMPLETED|Overall Study||7
6403643|NCT00905632|7316456|FG000|NOT COMPLETED|Overall Study||0
6403644|NCT00905632|7316457|FG001|NOT COMPLETED|Overall Study||0
6403645|NCT00905632|7316458|FG002|NOT COMPLETED|Overall Study||0
6403646|NCT00905632|7316459|FG003|NOT COMPLETED|Overall Study||0
6403647|NCT00905632|7316460|FG004|NOT COMPLETED|Overall Study||0
6403648|NCT00905632|7316461|FG005|NOT COMPLETED|Overall Study||1
6403649|NCT00905632|7316462|FG006|NOT COMPLETED|Overall Study||4
6403650|NCT00905827|7316488|FG000|STARTED|Overall Study||70
6403651|NCT00905827|7316489|FG001|STARTED|Overall Study||69
6403652|NCT00905827|7316490|FG002|STARTED|Overall Study||73
6403653|NCT00905827|7316488|FG000|COMPLETED|Overall Study||70
6403654|NCT00905827|7316489|FG001|COMPLETED|Overall Study||69
6403655|NCT00905827|7316490|FG002|COMPLETED|Overall Study||73
6403656|NCT00905827|7316488|FG000|NOT COMPLETED|Overall Study||0
6403657|NCT00905827|7316489|FG001|NOT COMPLETED|Overall Study||0
6403658|NCT00905827|7316490|FG002|NOT COMPLETED|Overall Study||0
6403659|NCT00905840|7316498|FG000|STARTED|Overall Study||91
6403660|NCT00905840|7316498|FG000|COMPLETED|Overall Study||75
6403661|NCT00905840|7316498|FG000|NOT COMPLETED|Overall Study||16
6403662|NCT00906074|7316507|FG000|STARTED|Overall Study||90
6403663|NCT00906074|7316508|FG001|STARTED|Overall Study||90
6403664|NCT00906074|7316507|FG000|COMPLETED|Overall Study||90
6403665|NCT00906074|7316508|FG001|COMPLETED|Overall Study||90
6403666|NCT00906074|7316507|FG000|NOT COMPLETED|Overall Study||0
6403667|NCT00906074|7316508|FG001|NOT COMPLETED|Overall Study||0
6403668|NCT00906087|7316514|FG000|STARTED|Initial Washout||14
6403669|NCT00906087|7316514|FG000|Completed Screening|Initial Washout||14
6403670|NCT00906087|7316514|FG000|Begin Washout|Initial Washout||13
6403671|NCT00906087|7316514|FG000|Completed Washout and Continue Protocol|Initial Washout||12
6403672|NCT00906087|7316514|FG000|COMPLETED|Initial Washout||12
6403673|NCT00906087|7316514|FG000|NOT COMPLETED|Initial Washout||2
6403674|NCT00906087|7316514|FG000|STARTED|Cosopt Treatment 6 Weeks||12
6403675|NCT00906087|7316514|FG000|COMPLETED|Cosopt Treatment 6 Weeks||12
6403676|NCT00906087|7316514|FG000|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
6403677|NCT00906087|7316514|FG000|STARTED|Final Washout Period 4 Weeks||12
6403678|NCT00906087|7316514|FG000|COMPLETED|Final Washout Period 4 Weeks||12
6403679|NCT00906087|7316514|FG000|NOT COMPLETED|Final Washout Period 4 Weeks||0
6403680|NCT00906165|7316523|FG000|STARTED|Overall Study||14
6403681|NCT00906165|7316524|FG001|STARTED|Overall Study||14
6403682|NCT00906165|7316523|FG000|COMPLETED|Overall Study||10
6403683|NCT00906165|7316524|FG001|COMPLETED|Overall Study||14
6403684|NCT00906165|7316523|FG000|NOT COMPLETED|Overall Study||4
6403685|NCT00906165|7316524|FG001|NOT COMPLETED|Overall Study||0
6403686|NCT00906178|7316532|FG000|STARTED|Overall Study||183
6403687|NCT00906178|7316533|FG001|STARTED|Overall Study||183
6403688|NCT00906178|7316532|FG000|COMPLETED|Overall Study||168
6403689|NCT00906178|7316533|FG001|COMPLETED|Overall Study||167
6403690|NCT00906178|7316532|FG000|NOT COMPLETED|Overall Study||15
6403691|NCT00906178|7316533|FG001|NOT COMPLETED|Overall Study||16
6403692|NCT00906204|7316541|FG000|STARTED|Primary Endpoint (Early Safety)||45
6403693|NCT00906204|7316542|FG001|STARTED|Primary Endpoint (Early Safety)||52
6403694|NCT00906204|7316541|FG000|COMPLETED|Primary Endpoint (Early Safety)||43
6403695|NCT00906204|7316542|FG001|COMPLETED|Primary Endpoint (Early Safety)||51
6403696|NCT00906204|7316541|FG000|NOT COMPLETED|Primary Endpoint (Early Safety)||2
6403697|NCT00906204|7316542|FG001|NOT COMPLETED|Primary Endpoint (Early Safety)||1
6403698|NCT00906204|7316541|FG000|STARTED|Secondary Endpoints (Long-term Safety)||43
6403699|NCT00906204|7316542|FG001|STARTED|Secondary Endpoints (Long-term Safety)||51
6403700|NCT00906204|7316541|FG000|COMPLETED|Secondary Endpoints (Long-term Safety)||41
6403701|NCT00906204|7316542|FG001|COMPLETED|Secondary Endpoints (Long-term Safety)||48
6403702|NCT00906204|7316541|FG000|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
6403703|NCT00906204|7316542|FG001|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
6403704|NCT00906243|7316548|FG000|STARTED|Overall Study||6
6403705|NCT00906243|7316548|FG000|COMPLETED|Overall Study||6
6403706|NCT00906243|7316548|FG000|NOT COMPLETED|Overall Study||0
6403707|NCT00906282|7316552|FG000|STARTED|Preoperative Chemotherapy||46
6403708|NCT00906282|7316552|FG000|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
6403709|NCT00906282|7316552|FG000|NOT COMPLETED|Preoperative Chemotherapy||19
6403710|NCT00906282|7316552|FG000|STARTED|Surgical Resection||27
6403711|NCT00906282|7316552|FG000|COMPLETED|Surgical Resection||27
6403712|NCT00906282|7316552|FG000|NOT COMPLETED|Surgical Resection||0
6403713|NCT00906347|7316559|FG000|STARTED|Randomized||176
6403714|NCT00906347|7316560|FG001|STARTED|Randomized||174
6403715|NCT00906347|7316559|FG000|COMPLETED|Randomized||176
6403716|NCT00906347|7316560|FG001|COMPLETED|Randomized||174
6403717|NCT00906347|7316559|FG000|NOT COMPLETED|Randomized||0
6403718|NCT00906347|7316560|FG001|NOT COMPLETED|Randomized||0
6403719|NCT00906347|7316559|FG000|STARTED|Received Study Drug||176
6403720|NCT00906347|7316560|FG001|STARTED|Received Study Drug||174
6403721|NCT00906347|7316559|FG000|COMPLETED|Received Study Drug||136
6403722|NCT00906347|7316560|FG001|COMPLETED|Received Study Drug||143
6403723|NCT00906347|7316559|FG000|NOT COMPLETED|Received Study Drug||40
6403724|NCT00906347|7316560|FG001|NOT COMPLETED|Received Study Drug||31
6403725|NCT00906373|7316568|FG000|STARTED|Overall Study||6
6403726|NCT00906373|7316569|FG001|STARTED|Overall Study||41
6403727|NCT00906373|7316568|FG000|Received Any Amount of Study Drug|Overall Study||6
6403728|NCT00906373|7316569|FG001|Received Any Amount of Study Drug|Overall Study||41
6403729|NCT00906373|7316568|FG000|COMPLETED|Overall Study||6
6403730|NCT00906373|7316569|FG001|COMPLETED|Overall Study||33
6403731|NCT00906373|7316568|FG000|NOT COMPLETED|Overall Study||0
6403732|NCT00906373|7316569|FG001|NOT COMPLETED|Overall Study||8
6403733|NCT00906399|7316579|FG000|STARTED|Year 1||500
6403734|NCT00906399|7316580|FG001|STARTED|Year 1||501
6403735|NCT00906399|7316581|FG002|STARTED|Year 1||515
6403736|NCT00906399|7316582|FG003|STARTED|Year 1||0
6403737|NCT00906399|7316583|FG004|STARTED|Year 1||0
6403738|NCT00906399|7316584|FG005|STARTED|Year 1||0
6403739|NCT00906399|7316585|FG006|STARTED|Year 1||0
6403740|NCT00906399|7316579|FG000|Completed Year 1 Study Treatment|Year 1||456
6403741|NCT00906399|7316580|FG001|Completed Year 1 Study Treatment|Year 1||438
6403742|NCT00906399|7316581|FG002|Completed Year 1 Study Treatment|Year 1||438
6403743|NCT00906399|7316582|FG003|Completed Year 1 Study Treatment|Year 1||0
6403744|NCT00906399|7316583|FG004|Completed Year 1 Study Treatment|Year 1||0
6403745|NCT00906399|7316584|FG005|Completed Year 1 Study Treatment|Year 1||0
6403746|NCT00906399|7316585|FG006|Completed Year 1 Study Treatment|Year 1||0
6403747|NCT00906399|7316579|FG000|COMPLETED|Year 1||456
6403748|NCT00906399|7316580|FG001|COMPLETED|Year 1||438
6403749|NCT00906399|7316581|FG002|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
6403750|NCT00906399|7316582|FG003|COMPLETED|Year 1||0
6403751|NCT00906399|7316583|FG004|COMPLETED|Year 1||0
6403752|NCT00906399|7316584|FG005|COMPLETED|Year 1||0
6403753|NCT00906399|7316585|FG006|COMPLETED|Year 1||0
6403754|NCT00906399|7316579|FG000|NOT COMPLETED|Year 1||44
6403755|NCT00906399|7316580|FG001|NOT COMPLETED|Year 1||63
6403756|NCT00906399|7316581|FG002|NOT COMPLETED|Year 1||76
6403757|NCT00906399|7316582|FG003|NOT COMPLETED|Year 1||0
6403758|NCT00906399|7316583|FG004|NOT COMPLETED|Year 1||0
6403759|NCT00906399|7316584|FG005|NOT COMPLETED|Year 1||0
6403760|NCT00906399|7316585|FG006|NOT COMPLETED|Year 1||0
6403761|NCT00906399|7316579|FG000|STARTED|Year 2||0
6403762|NCT00906399|7316580|FG001|STARTED|Year 2||0
6403763|NCT00906399|7316581|FG002|STARTED|Year 2||0
6403764|NCT00906399|7316582|FG003|STARTED|Year 2||228
6403765|NCT00906399|7316583|FG004|STARTED|Year 2||228
6403766|NCT00906399|7316584|FG005|STARTED|Year 2||438
6403767|NCT00906399|7316585|FG006|STARTED|Year 2||438
6403768|NCT00906399|7316579|FG000|Completed Year 2 Study Treatment|Year 2||0
6403769|NCT00906399|7316580|FG001|Completed Year 2 Study Treatment|Year 2||0
6403770|NCT00906399|7316581|FG002|Completed Year 2 Study Treatment|Year 2||0
6403771|NCT00906399|7316582|FG003|Completed Year 2 Study Treatment|Year 2||200
6403772|NCT00906399|7316583|FG004|Completed Year 2 Study Treatment|Year 2||196
6403773|NCT00906399|7316584|FG005|Completed Year 2 Study Treatment|Year 2||391
6403774|NCT00906399|7316585|FG006|Completed Year 2 Study Treatment|Year 2||411
6403775|NCT00906399|7316579|FG000|COMPLETED|Year 2||0
6403776|NCT00906399|7316580|FG001|COMPLETED|Year 2||0
6403777|NCT00906399|7316581|FG002|COMPLETED|Year 2||0
6403778|NCT00906399|7316582|FG003|COMPLETED|Year 2||198
6403779|NCT00906399|7316583|FG004|COMPLETED|Year 2||193
6403780|NCT00906399|7316584|FG005|COMPLETED|Year 2||391
6403781|NCT00906399|7316585|FG006|COMPLETED|Year 2||409
6403782|NCT00906399|7316579|FG000|NOT COMPLETED|Year 2||0
6403783|NCT00906399|7316580|FG001|NOT COMPLETED|Year 2||0
6403784|NCT00906399|7316581|FG002|NOT COMPLETED|Year 2||0
6403785|NCT00906399|7316582|FG003|NOT COMPLETED|Year 2||30
6403786|NCT00906399|7316583|FG004|NOT COMPLETED|Year 2||35
6403787|NCT00906399|7316584|FG005|NOT COMPLETED|Year 2||47
6403788|NCT00906399|7316585|FG006|NOT COMPLETED|Year 2||29
6403789|NCT00906425|7316599|FG000|STARTED|Overall Study||73
6403790|NCT00906425|7316600|FG001|STARTED|Overall Study||72
6403791|NCT00906425|7316599|FG000|6 Months|Overall Study|ITT population|69
6403792|NCT00906425|7316600|FG001|6 Months|Overall Study|ITT population|64
6403793|NCT00906425|7316599|FG000|1 Year|Overall Study|ITT population|67
6403794|NCT00906425|7316600|FG001|1 Year|Overall Study|ITT population|60
6403795|NCT00906425|7316599|FG000|2 Year|Overall Study|ITT population|62
6403796|NCT00906425|7316600|FG001|2 Year|Overall Study|ITT population|58
6403797|NCT00906425|7316599|FG000|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
6403798|NCT00906425|7316600|FG001|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
6403799|NCT00906425|7316599|FG000|NOT COMPLETED|Overall Study||73
6403800|NCT00906425|7316600|FG001|NOT COMPLETED|Overall Study||72
6403801|NCT00906503|7316606|FG000|STARTED|Overall Study||9
6403802|NCT00906503|7316606|FG000|COMPLETED|Overall Study||9
6403803|NCT00906503|7316606|FG000|NOT COMPLETED|Overall Study||0
6403804|NCT00906698|7316616|FG000|STARTED|Overall Study||3
6403805|NCT00906698|7316617|FG001|STARTED|Overall Study||19
6403806|NCT00906698|7316618|FG002|STARTED|Overall Study||6
6403807|NCT00906698|7316619|FG003|STARTED|Overall Study||4
6403808|NCT00906698|7316620|FG004|STARTED|Overall Study||18
6403809|NCT00906698|7316621|FG005|STARTED|Overall Study||5
6403810|NCT00906698|7316616|FG000|COMPLETED|Overall Study||0
6403811|NCT00906698|7316617|FG001|COMPLETED|Overall Study||0
6403812|NCT00906698|7316618|FG002|COMPLETED|Overall Study||0
6403813|NCT00906698|7316619|FG003|COMPLETED|Overall Study||0
6403814|NCT00906698|7316620|FG004|COMPLETED|Overall Study||0
6403815|NCT00906698|7316621|FG005|COMPLETED|Overall Study||0
6403816|NCT00906698|7316616|FG000|NOT COMPLETED|Overall Study||3
6403817|NCT00906698|7316617|FG001|NOT COMPLETED|Overall Study||19
6403818|NCT00906698|7316618|FG002|NOT COMPLETED|Overall Study||6
6403819|NCT00906698|7316619|FG003|NOT COMPLETED|Overall Study||4
6403820|NCT00906698|7316620|FG004|NOT COMPLETED|Overall Study||18
6403821|NCT00906698|7316621|FG005|NOT COMPLETED|Overall Study||5
6403822|NCT00906776|7316655|FG000|STARTED|Overall Study||11
6403823|NCT00906776|7316656|FG001|STARTED|Overall Study||8
6403824|NCT00906776|7316655|FG000|COMPLETED|Overall Study||11
6403825|NCT00906776|7316656|FG001|COMPLETED|Overall Study||8
6403826|NCT00906776|7316655|FG000|NOT COMPLETED|Overall Study||0
6403827|NCT00906776|7316656|FG001|NOT COMPLETED|Overall Study||0
6403828|NCT00906789|7316662|FG000|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
6403829|NCT00906789|7316662|FG000|COMPLETED|Overall Study||15
6403830|NCT00906789|7316662|FG000|NOT COMPLETED|Overall Study||0
6403831|NCT00906945|7316673|FG000|STARTED|Overall Study||3
6403832|NCT00906945|7316674|FG001|STARTED|Overall Study||3
6403833|NCT00906945|7316675|FG002|STARTED|Overall Study||3
6403834|NCT00906945|7316676|FG003|STARTED|Overall Study||7
6403835|NCT00906945|7316677|FG004|STARTED|Overall Study||7
6403836|NCT00906945|7316678|FG005|STARTED|Overall Study||16
6403837|NCT00906945|7316673|FG000|COMPLETED|Overall Study||3
6403838|NCT00906945|7316674|FG001|COMPLETED|Overall Study||3
6403839|NCT00906945|7316675|FG002|COMPLETED|Overall Study||3
6403840|NCT00906945|7316676|FG003|COMPLETED|Overall Study||6
6403841|NCT00906945|7316677|FG004|COMPLETED|Overall Study||6
6403842|NCT00906945|7316678|FG005|COMPLETED|Overall Study||14
6403843|NCT00906945|7316673|FG000|NOT COMPLETED|Overall Study||0
6403844|NCT00906945|7316674|FG001|NOT COMPLETED|Overall Study||0
6403845|NCT00906945|7316675|FG002|NOT COMPLETED|Overall Study||0
6403846|NCT00906945|7316676|FG003|NOT COMPLETED|Overall Study||1
6403847|NCT00906945|7316677|FG004|NOT COMPLETED|Overall Study||1
6403848|NCT00906945|7316678|FG005|NOT COMPLETED|Overall Study||2
6403849|NCT00906958|7316694|FG000|STARTED|Overall Study||10
6403850|NCT00906958|7316695|FG001|STARTED|Overall Study||10
6403851|NCT00906958|7316694|FG000|COMPLETED|Overall Study||10
6403852|NCT00906958|7316695|FG001|COMPLETED|Overall Study||10
6403853|NCT00906958|7316694|FG000|NOT COMPLETED|Overall Study||0
6403854|NCT00906958|7316695|FG001|NOT COMPLETED|Overall Study||0
6403855|NCT00906971|7316705|FG000|STARTED|Overall Study||36
6403856|NCT00906971|7316706|FG001|STARTED|Overall Study||36
6403857|NCT00906971|7316705|FG000|COMPLETED|Overall Study||28
6403858|NCT00906971|7316706|FG001|COMPLETED|Overall Study||33
6403859|NCT00906971|7316705|FG000|NOT COMPLETED|Overall Study||8
6403860|NCT00906971|7316706|FG001|NOT COMPLETED|Overall Study||3
6403861|NCT00907088|7316714|FG000|STARTED|Overall Study||122
6403862|NCT00907088|7316715|FG001|STARTED|Overall Study||129
6403863|NCT00907088|7316714|FG000|COMPLETED|Overall Study||102
6403864|NCT00907088|7316715|FG001|COMPLETED|Overall Study||99
6403865|NCT00907088|7316714|FG000|NOT COMPLETED|Overall Study||20
6403866|NCT00907088|7316715|FG001|NOT COMPLETED|Overall Study||30
6403867|NCT00907101|7316721|FG000|STARTED|Overall Study||30
6403868|NCT00907101|7316721|FG000|COMPLETED|Overall Study||30
6403869|NCT00907101|7316721|FG000|NOT COMPLETED|Overall Study||0
6403870|NCT00907153|7316727|FG000|STARTED|Overall Study||13
6403871|NCT00907153|7316728|FG001|STARTED|Overall Study||15
6403872|NCT00907153|7316727|FG000|COMPLETED|Overall Study||11
6403873|NCT00907153|7316728|FG001|COMPLETED|Overall Study||11
6403874|NCT00907153|7316727|FG000|NOT COMPLETED|Overall Study||2
6403875|NCT00907153|7316728|FG001|NOT COMPLETED|Overall Study||4
6403876|NCT00907257|7316736|FG000|STARTED|Overall Study||123
6403877|NCT00907257|7316737|FG001|STARTED|Overall Study||124
6403878|NCT00907257|7316736|FG000|COMPLETED|Overall Study||110
6403879|NCT00907257|7316737|FG001|COMPLETED|Overall Study||112
6403880|NCT00907257|7316736|FG000|NOT COMPLETED|Overall Study||13
6403881|NCT00907257|7316737|FG001|NOT COMPLETED|Overall Study||12
6403882|NCT00907296|7316753|FG000|STARTED|Overall Study||103
6403883|NCT00907296|7316754|FG001|STARTED|Overall Study||34
6403884|NCT00907296|7316755|FG002|STARTED|Overall Study||34
6403885|NCT00907296|7316756|FG003|STARTED|Overall Study||33
6403886|NCT00907296|7316757|FG004|STARTED|Overall Study||33
6403887|NCT00907296|7316758|FG005|STARTED|Overall Study||33
6403888|NCT00907296|7316759|FG006|STARTED|Overall Study||33
6403889|NCT00907296|7316760|FG007|STARTED|Overall Study||33
6403890|NCT00907296|7316761|FG008|STARTED|Overall Study||31
6403891|NCT00907296|7316762|FG009|STARTED|Overall Study||35
6403892|NCT00907296|7316753|FG000|Received Treatment|Overall Study||100
6403893|NCT00907296|7316754|FG001|Received Treatment|Overall Study||34
6403894|NCT00907296|7316755|FG002|Received Treatment|Overall Study||34
6403895|NCT00907296|7316756|FG003|Received Treatment|Overall Study||32
6403896|NCT00907296|7316757|FG004|Received Treatment|Overall Study||33
6403897|NCT00907296|7316758|FG005|Received Treatment|Overall Study||32
6403898|NCT00907296|7316759|FG006|Received Treatment|Overall Study||31
6403899|NCT00907296|7316760|FG007|Received Treatment|Overall Study||32
6403900|NCT00907296|7316761|FG008|Received Treatment|Overall Study||30
6403901|NCT00907296|7316762|FG009|Received Treatment|Overall Study||35
6403902|NCT00907296|7316753|FG000|COMPLETED|Overall Study||83
6403903|NCT00907296|7316754|FG001|COMPLETED|Overall Study||29
6403904|NCT00907296|7316755|FG002|COMPLETED|Overall Study||32
6403905|NCT00907296|7316756|FG003|COMPLETED|Overall Study||29
6403906|NCT00907296|7316757|FG004|COMPLETED|Overall Study||32
6403907|NCT00907296|7316758|FG005|COMPLETED|Overall Study||24
6403908|NCT00907296|7316759|FG006|COMPLETED|Overall Study||27
6403909|NCT00907296|7316760|FG007|COMPLETED|Overall Study||26
6403910|NCT00907296|7316761|FG008|COMPLETED|Overall Study||27
6403911|NCT00907296|7316762|FG009|COMPLETED|Overall Study||28
6403912|NCT00907296|7316753|FG000|NOT COMPLETED|Overall Study||20
6403913|NCT00907296|7316754|FG001|NOT COMPLETED|Overall Study||5
6403914|NCT00907296|7316755|FG002|NOT COMPLETED|Overall Study||2
6403915|NCT00907296|7316756|FG003|NOT COMPLETED|Overall Study||4
6403916|NCT00907296|7316757|FG004|NOT COMPLETED|Overall Study||1
6403917|NCT00907296|7316758|FG005|NOT COMPLETED|Overall Study||9
6403918|NCT00907296|7316759|FG006|NOT COMPLETED|Overall Study||6
6403919|NCT00907296|7316760|FG007|NOT COMPLETED|Overall Study||7
6403920|NCT00907296|7316761|FG008|NOT COMPLETED|Overall Study||4
6403921|NCT00907296|7316762|FG009|NOT COMPLETED|Overall Study||7
6403922|NCT00907335|7316786|FG000|STARTED|Overall Study||55
6403923|NCT00907335|7316787|FG001|STARTED|Overall Study||55
6403924|NCT00907335|7316786|FG000|COMPLETED|Overall Study||47
6403925|NCT00907335|7316787|FG001|COMPLETED|Overall Study||54
6403926|NCT00907335|7316786|FG000|NOT COMPLETED|Overall Study||8
6403927|NCT00907335|7316787|FG001|NOT COMPLETED|Overall Study||1
6403928|NCT00907374|7316795|FG000|STARTED|Overall Study||14
6403929|NCT00907374|7316796|FG001|STARTED|Overall Study||13
6403930|NCT00907374|7316795|FG000|COMPLETED|Overall Study||12
6403931|NCT00907374|7316796|FG001|COMPLETED|Overall Study||11
6403932|NCT00907374|7316795|FG000|NOT COMPLETED|Overall Study||2
6403933|NCT00907374|7316796|FG001|NOT COMPLETED|Overall Study||2
6403934|NCT00907426|7316805|FG000|STARTED|Treatment Period 1 (0 to 6 Months)||215
6403935|NCT00907426|7316806|FG001|STARTED|Treatment Period 1 (0 to 6 Months)||60
6403936|NCT00907426|7316807|FG002|STARTED|Treatment Period 1 (0 to 6 Months)||93
6403937|NCT00907426|7316805|FG000|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
6403938|NCT00907426|7316806|FG001|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
6403939|NCT00907426|7316807|FG002|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
6403940|NCT00907426|7316805|FG000|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
6403941|NCT00907426|7316806|FG001|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
6403942|NCT00907426|7316807|FG002|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
6403943|NCT00907426|7316805|FG000|STARTED|Treatment Period 2 (6 to 12 Months)||195
6403944|NCT00907426|7316806|FG001|STARTED|Treatment Period 2 (6 to 12 Months)||55
6403945|NCT00907426|7316807|FG002|STARTED|Treatment Period 2 (6 to 12 Months)||84
6403946|NCT00907426|7316805|FG000|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
6403947|NCT00907426|7316806|FG001|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
6403948|NCT00907426|7316807|FG002|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
6403949|NCT00907426|7316805|FG000|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
6403950|NCT00907426|7316806|FG001|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
6403951|NCT00907426|7316807|FG002|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
6403952|NCT00907478|7316817|FG000|STARTED|Overall Study||50
6403953|NCT00907478|7316818|FG001|STARTED|Overall Study||50
6403954|NCT00907478|7316819|FG002|STARTED|Overall Study||69
6403955|NCT00907478|7316817|FG000|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
6403956|NCT00907478|7316818|FG001|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
6403957|NCT00907478|7316819|FG002|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
6403958|NCT00907478|7316817|FG000|NOT COMPLETED|Overall Study||27
6403959|NCT00907478|7316818|FG001|NOT COMPLETED|Overall Study||17
6403960|NCT00907478|7316819|FG002|NOT COMPLETED|Overall Study||22
6403961|NCT00907517|7316834|FG000|STARTED|Overall Study||3
6403962|NCT00907517|7316835|FG001|STARTED|Overall Study||3
6403963|NCT00907517|7316836|FG002|STARTED|Overall Study||6
6403964|NCT00907517|7316837|FG003|STARTED|Overall Study||6
6403965|NCT00907517|7316838|FG004|STARTED|Overall Study||6
6403966|NCT00907517|7316834|FG000|COMPLETED|Overall Study||0
6403967|NCT00907517|7316835|FG001|COMPLETED|Overall Study||0
6403968|NCT00907517|7316836|FG002|COMPLETED|Overall Study||2
6403969|NCT00907517|7316837|FG003|COMPLETED|Overall Study||2
6403970|NCT00907517|7316838|FG004|COMPLETED|Overall Study||1
6403971|NCT00907517|7316834|FG000|NOT COMPLETED|Overall Study||3
6403972|NCT00907517|7316835|FG001|NOT COMPLETED|Overall Study||3
6403973|NCT00907517|7316836|FG002|NOT COMPLETED|Overall Study||4
6403974|NCT00907517|7316837|FG003|NOT COMPLETED|Overall Study||4
6403975|NCT00907517|7316838|FG004|NOT COMPLETED|Overall Study||5
6403976|NCT00907621|7316852|FG000|STARTED|Overall Study||45
6403977|NCT00907621|7316853|FG001|STARTED|Overall Study||45
6403978|NCT00907621|7316852|FG000|COMPLETED|Overall Study||38
6403979|NCT00907621|7316853|FG001|COMPLETED|Overall Study||41
6403980|NCT00907621|7316852|FG000|NOT COMPLETED|Overall Study||7
6403981|NCT00907621|7316853|FG001|NOT COMPLETED|Overall Study||4
6403982|NCT00907738|7316864|FG000|STARTED|Overall Study||13
6403983|NCT00907738|7316865|FG001|STARTED|Overall Study||1
6403984|NCT00907738|7316866|FG002|STARTED|Overall Study||7
6403985|NCT00907738|7316867|FG003|STARTED|Overall Study||4
6403986|NCT00907738|7316868|FG004|STARTED|Overall Study||2
6403987|NCT00907738|7316864|FG000|COMPLETED|Overall Study||0
6403988|NCT00907738|7316865|FG001|COMPLETED|Overall Study||0
6403989|NCT00907738|7316866|FG002|COMPLETED|Overall Study||0
6403990|NCT00907738|7316867|FG003|COMPLETED|Overall Study||0
6403991|NCT00907738|7316868|FG004|COMPLETED|Overall Study||0
6403992|NCT00907738|7316864|FG000|NOT COMPLETED|Overall Study||13
6403993|NCT00907738|7316865|FG001|NOT COMPLETED|Overall Study||1
6403994|NCT00907738|7316866|FG002|NOT COMPLETED|Overall Study||7
6403995|NCT00907738|7316867|FG003|NOT COMPLETED|Overall Study||4
6403996|NCT00907738|7316868|FG004|NOT COMPLETED|Overall Study||2
6403997|NCT00907777|7316886|FG000|STARTED|Overall Study||25
6403998|NCT00907777|7316887|FG001|STARTED|Overall Study||27
6403999|NCT00907777|7316886|FG000|COMPLETED|Overall Study||25
6404000|NCT00907777|7316887|FG001|COMPLETED|Overall Study||26
6404001|NCT00907777|7316886|FG000|NOT COMPLETED|Overall Study||0
6404002|NCT00907777|7316887|FG001|NOT COMPLETED|Overall Study||1
6404003|NCT00907803|7316896|FG000|STARTED|Overall Study||45
6404004|NCT00907803|7316897|FG001|STARTED|Overall Study||46
6404005|NCT00907803|7316898|FG002|STARTED|Overall Study||16
6404006|NCT00907803|7316896|FG000|COMPLETED|Overall Study||42
6404007|NCT00907803|7316897|FG001|COMPLETED|Overall Study||43
6404008|NCT00907803|7316898|FG002|COMPLETED|Overall Study||16
6404009|NCT00907803|7316896|FG000|NOT COMPLETED|Overall Study||3
6404010|NCT00907803|7316897|FG001|NOT COMPLETED|Overall Study||3
6404011|NCT00907803|7316898|FG002|NOT COMPLETED|Overall Study||0
6404012|NCT00907881|7316906|FG000|STARTED|Overall Study||1069
6404013|NCT00907881|7316906|FG000|COMPLETED|Overall Study||984
6404014|NCT00907881|7316906|FG000|NOT COMPLETED|Overall Study||85
6404015|NCT00908011|7316912|FG000|STARTED|Overall Study||23
6404016|NCT00908011|7316913|FG001|STARTED|Overall Study||20
6404017|NCT00908011|7316912|FG000|COMPLETED|Overall Study||21
6404018|NCT00908011|7316913|FG001|COMPLETED|Overall Study||18
6404019|NCT00908011|7316912|FG000|NOT COMPLETED|Overall Study||2
6404020|NCT00908011|7316913|FG001|NOT COMPLETED|Overall Study||2
6404021|NCT00908037|7316926|FG000|STARTED|Part1 (24 Week Dose-Finding Period)||5
6404022|NCT00908037|7316927|FG001|STARTED|Part1 (24 Week Dose-Finding Period)||5
6404023|NCT00908037|7316928|FG002|STARTED|Part1 (24 Week Dose-Finding Period)||5
6404024|NCT00908037|7316929|FG003|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404025|NCT00908037|7316930|FG004|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404026|NCT00908037|7316931|FG005|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404027|NCT00908037|7316932|FG006|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404028|NCT00908037|7316933|FG007|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404029|NCT00908037|7316934|FG008|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404030|NCT00908037|7316935|FG009|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404031|NCT00908037|7316936|FG010|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404032|NCT00908037|7316937|FG011|STARTED|Part1 (24 Week Dose-Finding Period)||0
6404033|NCT00908037|7316926|FG000|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
6404034|NCT00908037|7316927|FG001|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
6404035|NCT00908037|7316928|FG002|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
6404036|NCT00908037|7316929|FG003|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404037|NCT00908037|7316930|FG004|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404038|NCT00908037|7316931|FG005|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404039|NCT00908037|7316932|FG006|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404040|NCT00908037|7316933|FG007|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404041|NCT00908037|7316934|FG008|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404042|NCT00908037|7316935|FG009|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404043|NCT00908037|7316936|FG010|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404044|NCT00908037|7316937|FG011|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404045|NCT00908037|7316926|FG000|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404046|NCT00908037|7316927|FG001|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404047|NCT00908037|7316928|FG002|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404048|NCT00908037|7316929|FG003|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404049|NCT00908037|7316930|FG004|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404050|NCT00908037|7316931|FG005|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404051|NCT00908037|7316932|FG006|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404052|NCT00908037|7316933|FG007|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404053|NCT00908037|7316934|FG008|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404054|NCT00908037|7316935|FG009|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404055|NCT00908037|7316936|FG010|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404056|NCT00908037|7316937|FG011|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
6404057|NCT00908037|7316926|FG000|STARTED|Part 2 (7 Week Randomized Period)||0
6404058|NCT00908037|7316927|FG001|STARTED|Part 2 (7 Week Randomized Period)||0
6404059|NCT00908037|7316928|FG002|STARTED|Part 2 (7 Week Randomized Period)||0
6404060|NCT00908037|7316929|FG003|STARTED|Part 2 (7 Week Randomized Period)||8
6404061|NCT00908037|7316930|FG004|STARTED|Part 2 (7 Week Randomized Period)||16
6404062|NCT00908037|7316931|FG005|STARTED|Part 2 (7 Week Randomized Period)||9
6404063|NCT00908037|7316932|FG006|STARTED|Part 2 (7 Week Randomized Period)||19
6404064|NCT00908037|7316933|FG007|STARTED|Part 2 (7 Week Randomized Period)||5
6404065|NCT00908037|7316934|FG008|STARTED|Part 2 (7 Week Randomized Period)||10
6404066|NCT00908037|7316935|FG009|STARTED|Part 2 (7 Week Randomized Period)||0
6404067|NCT00908037|7316936|FG010|STARTED|Part 2 (7 Week Randomized Period)||0
6404068|NCT00908037|7316937|FG011|STARTED|Part 2 (7 Week Randomized Period)||0
6404069|NCT00908037|7316926|FG000|COMPLETED|Part 2 (7 Week Randomized Period)||0
6404070|NCT00908037|7316927|FG001|COMPLETED|Part 2 (7 Week Randomized Period)||0
6404071|NCT00908037|7316928|FG002|COMPLETED|Part 2 (7 Week Randomized Period)||0
6404072|NCT00908037|7316929|FG003|COMPLETED|Part 2 (7 Week Randomized Period)||7
6404073|NCT00908037|7316930|FG004|COMPLETED|Part 2 (7 Week Randomized Period)||13
6404074|NCT00908037|7316931|FG005|COMPLETED|Part 2 (7 Week Randomized Period)||9
6404075|NCT00908037|7316932|FG006|COMPLETED|Part 2 (7 Week Randomized Period)||15
6404076|NCT00908037|7316933|FG007|COMPLETED|Part 2 (7 Week Randomized Period)||5
6404077|NCT00908037|7316934|FG008|COMPLETED|Part 2 (7 Week Randomized Period)||5
6404078|NCT00908037|7316935|FG009|COMPLETED|Part 2 (7 Week Randomized Period)||0
6404079|NCT00908037|7316936|FG010|COMPLETED|Part 2 (7 Week Randomized Period)||0
6404080|NCT00908037|7316937|FG011|COMPLETED|Part 2 (7 Week Randomized Period)||0
6743407|NCT03334448|7671660|FG000|STARTED|Period 3||12
6743408|NCT03334448|7671661|FG001|STARTED|Period 3||11
6743409|NCT03334448|7671662|FG002|STARTED|Period 3||13
6743410|NCT03334448|7671663|FG003|STARTED|Period 3||12
6743411|NCT03334448|7671660|FG000|Received at Least 1 Dose of Study Drug|Period 3||12
6743412|NCT03334448|7671661|FG001|Received at Least 1 Dose of Study Drug|Period 3||11
6404081|NCT00908037|7316926|FG000|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6404082|NCT00908037|7316927|FG001|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6404083|NCT00908037|7316928|FG002|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6404084|NCT00908037|7316929|FG003|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
6404085|NCT00908037|7316930|FG004|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
6404086|NCT00908037|7316931|FG005|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6404087|NCT00908037|7316932|FG006|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
6404088|NCT00908037|7316933|FG007|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6404089|NCT00908037|7316934|FG008|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
6404090|NCT00908037|7316935|FG009|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6404091|NCT00908037|7316936|FG010|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6404092|NCT00908037|7316937|FG011|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
6404093|NCT00908037|7316926|FG000|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404094|NCT00908037|7316927|FG001|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404095|NCT00908037|7316928|FG002|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404096|NCT00908037|7316929|FG003|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404097|NCT00908037|7316930|FG004|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404098|NCT00908037|7316931|FG005|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404099|NCT00908037|7316932|FG006|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404100|NCT00908037|7316933|FG007|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404101|NCT00908037|7316934|FG008|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
6404102|NCT00908037|7316935|FG009|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
6404103|NCT00908037|7316936|FG010|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
6404104|NCT00908037|7316937|FG011|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
6404105|NCT00908037|7316926|FG000|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404106|NCT00908037|7316927|FG001|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404107|NCT00908037|7316928|FG002|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404108|NCT00908037|7316929|FG003|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404109|NCT00908037|7316930|FG004|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404110|NCT00908037|7316931|FG005|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404111|NCT00908037|7316932|FG006|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404112|NCT00908037|7316933|FG007|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404113|NCT00908037|7316934|FG008|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404114|NCT00908037|7316935|FG009|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
6404115|NCT00908037|7316936|FG010|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
6404116|NCT00908037|7316937|FG011|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
6404117|NCT00908037|7316926|FG000|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404118|NCT00908037|7316927|FG001|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404119|NCT00908037|7316928|FG002|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404120|NCT00908037|7316929|FG003|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404121|NCT00908037|7316930|FG004|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404122|NCT00908037|7316931|FG005|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404123|NCT00908037|7316932|FG006|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404124|NCT00908037|7316933|FG007|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404125|NCT00908037|7316934|FG008|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
6404126|NCT00908037|7316935|FG009|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
6404127|NCT00908037|7316936|FG010|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
6404128|NCT00908037|7316937|FG011|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
6404129|NCT00908076|7316991|FG000|STARTED|Overall Study||27
6404130|NCT00908076|7316992|FG001|STARTED|Overall Study||27
6404131|NCT00908076|7316991|FG000|COMPLETED|Overall Study||26
6404132|NCT00908076|7316992|FG001|COMPLETED|Overall Study||26
6404133|NCT00908076|7316991|FG000|NOT COMPLETED|Overall Study||1
6404134|NCT00908076|7316992|FG001|NOT COMPLETED|Overall Study||1
6404135|NCT00908115|7316998|FG000|STARTED|Overall Study||1258
6404136|NCT00908115|7316998|FG000|COMPLETED|Overall Study||1244
6404137|NCT00908115|7316998|FG000|NOT COMPLETED|Overall Study||14
6404138|NCT00908141|7317004|FG000|STARTED|Overall Study||8
6404139|NCT00908141|7317005|FG001|STARTED|Overall Study||9
6404140|NCT00908141|7317004|FG000|COMPLETED|Overall Study||8
6404141|NCT00908141|7317005|FG001|COMPLETED|Overall Study||8
6404142|NCT00908141|7317004|FG000|NOT COMPLETED|Overall Study||0
6743413|NCT03334448|7671662|FG002|Received at Least 1 Dose of Study Drug|Period 3||13
6743414|NCT03334448|7671663|FG003|Received at Least 1 Dose of Study Drug|Period 3||12
6743415|NCT03334448|7671660|FG000|COMPLETED|Period 3||12
6743416|NCT03334448|7671661|FG001|COMPLETED|Period 3||11
6404143|NCT00908141|7317005|FG001|NOT COMPLETED|Overall Study||1
6404144|NCT00908232|7317011|FG000|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
6404145|NCT00908232|7317012|FG001|STARTED|Cycle 1 to 4||0
6404146|NCT00908232|7317013|FG002|STARTED|Cycle 1 to 4||0
6404147|NCT00908232|7317014|FG003|STARTED|Cycle 1 to 4||0
6404148|NCT00908232|7317011|FG000|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
6404149|NCT00908232|7317012|FG001|COMPLETED|Cycle 1 to 4||0
6404150|NCT00908232|7317013|FG002|COMPLETED|Cycle 1 to 4||0
6404151|NCT00908232|7317014|FG003|COMPLETED|Cycle 1 to 4||0
6404152|NCT00908232|7317011|FG000|NOT COMPLETED|Cycle 1 to 4||28
6404153|NCT00908232|7317012|FG001|NOT COMPLETED|Cycle 1 to 4||0
6404154|NCT00908232|7317013|FG002|NOT COMPLETED|Cycle 1 to 4||0
6404155|NCT00908232|7317014|FG003|NOT COMPLETED|Cycle 1 to 4||0
6404156|NCT00908232|7317011|FG000|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
6404157|NCT00908232|7317012|FG001|STARTED|Randomization (Cycle 5) to Cycle 8||7
6404158|NCT00908232|7317013|FG002|STARTED|Randomization (Cycle 5) to Cycle 8||8
6404159|NCT00908232|7317014|FG003|STARTED|Randomization (Cycle 5) to Cycle 8||4
6404160|NCT00908232|7317011|FG000|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
6404161|NCT00908232|7317012|FG001|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
6404162|NCT00908232|7317013|FG002|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
6404163|NCT00908232|7317014|FG003|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
6404164|NCT00908232|7317011|FG000|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
6404165|NCT00908232|7317012|FG001|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
6404166|NCT00908232|7317013|FG002|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
6404167|NCT00908232|7317014|FG003|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
6404168|NCT00908310|7317020|FG000|STARTED|Overall Study||213
6404169|NCT00908310|7317020|FG000|COMPLETED|Overall Study||153
6404170|NCT00908310|7317020|FG000|NOT COMPLETED|Overall Study||60
6404171|NCT00908349|7317024|FG000|STARTED|Overall Study||214
6404172|NCT00908349|7317024|FG000|COMPLETED|Overall Study||179
6404173|NCT00908349|7317024|FG000|NOT COMPLETED|Overall Study||35
6404174|NCT00908375|7317030|FG000|STARTED|Overall Study||20
6404175|NCT00908375|7317031|FG001|STARTED|Overall Study||19
6404176|NCT00908375|7317030|FG000|COMPLETED|Overall Study||10
6404177|NCT00908375|7317031|FG001|COMPLETED|Overall Study||9
6404178|NCT00908375|7317030|FG000|NOT COMPLETED|Overall Study||10
6404179|NCT00908375|7317031|FG001|NOT COMPLETED|Overall Study||10
6404180|NCT00908388|7317037|FG000|STARTED|Overall Study||50
6404181|NCT00908388|7317037|FG000|COMPLETED|Overall Study||40
6404182|NCT00908388|7317037|FG000|NOT COMPLETED|Overall Study||10
6404183|NCT00908466|7317043|FG000|STARTED|Overall Study||15
6404184|NCT00908466|7317044|FG001|STARTED|Overall Study||15
6404185|NCT00908466|7317043|FG000|COMPLETED|Overall Study||14
6404186|NCT00908466|7317044|FG001|COMPLETED|Overall Study||14
6404187|NCT00908466|7317043|FG000|NOT COMPLETED|Overall Study||1
6404188|NCT00908466|7317044|FG001|NOT COMPLETED|Overall Study||1
6404189|NCT00908544|7317052|FG000|STARTED|Overall Study||20
6404190|NCT00908544|7317053|FG001|STARTED|Overall Study||22
6404191|NCT00908544|7317052|FG000|COMPLETED|Overall Study||15
6404192|NCT00908544|7317053|FG001|COMPLETED|Overall Study||16
6404193|NCT00908544|7317052|FG000|NOT COMPLETED|Overall Study||5
6404194|NCT00908544|7317053|FG001|NOT COMPLETED|Overall Study||6
6404195|NCT00908583|7317059|FG000|STARTED|Phase 1||20
6404196|NCT00908583|7317059|FG000|COMPLETED|Phase 1||15
6404197|NCT00908583|7317059|FG000|NOT COMPLETED|Phase 1||5
6404198|NCT00908583|7317059|FG000|STARTED|Phase 2||12
6404199|NCT00908583|7317059|FG000|COMPLETED|Phase 2||10
6404200|NCT00908583|7317059|FG000|NOT COMPLETED|Phase 2||2
6404201|NCT00908583|7317059|FG000|STARTED|Phase 3||10
6404202|NCT00908583|7317059|FG000|COMPLETED|Phase 3||8
6404203|NCT00908583|7317059|FG000|NOT COMPLETED|Phase 3||2
6404204|NCT00908583|7317059|FG000|STARTED|Phase 4||5
6404205|NCT00908583|7317059|FG000|COMPLETED|Phase 4||3
6404206|NCT00908583|7317059|FG000|NOT COMPLETED|Phase 4||2
6404207|NCT00908583|7317059|FG000|STARTED|Phase 5||5
6404208|NCT00908583|7317059|FG000|COMPLETED|Phase 5||2
6404209|NCT00908583|7317059|FG000|NOT COMPLETED|Phase 5||3
6404210|NCT00908596|7317081|FG000|STARTED|Overall Study||47
6404211|NCT00908596|7317082|FG001|STARTED|Overall Study||32
6404212|NCT00908596|7317083|FG002|STARTED|Overall Study||193
6404213|NCT00908596|7317084|FG003|STARTED|Overall Study||85
6404214|NCT00908596|7317081|FG000|COMPLETED|Overall Study||0
6404215|NCT00908596|7317082|FG001|COMPLETED|Overall Study||19
6404216|NCT00908596|7317083|FG002|COMPLETED|Overall Study||119
6404217|NCT00908596|7317084|FG003|COMPLETED|Overall Study||48
6404218|NCT00908596|7317081|FG000|NOT COMPLETED|Overall Study||47
6404219|NCT00908596|7317082|FG001|NOT COMPLETED|Overall Study||13
6404220|NCT00908596|7317083|FG002|NOT COMPLETED|Overall Study||74
6404221|NCT00908596|7317084|FG003|NOT COMPLETED|Overall Study||37
6404222|NCT00908791|7317094|FG000|STARTED|Overall Study||24
6404223|NCT00908791|7317094|FG000|COMPLETED|Overall Study||24
6404224|NCT00908791|7317094|FG000|NOT COMPLETED|Overall Study||0
6404225|NCT00908830|7317109|FG000|STARTED|Overall Study||5
6404226|NCT00908830|7317110|FG001|STARTED|Overall Study||5
6404227|NCT00908830|7317109|FG000|COMPLETED|Overall Study||5
6404228|NCT00908830|7317110|FG001|COMPLETED|Overall Study||5
6404229|NCT00908830|7317109|FG000|NOT COMPLETED|Overall Study||0
6404230|NCT00908830|7317110|FG001|NOT COMPLETED|Overall Study||0
6404231|NCT00908882|7317118|FG000|STARTED|Overall Study||89
6404232|NCT00908882|7317119|FG001|STARTED|Overall Study||89
6404233|NCT00908882|7317118|FG000|COMPLETED|Overall Study||61
6404234|NCT00908882|7317119|FG001|COMPLETED|Overall Study||59
6404235|NCT00908882|7317118|FG000|NOT COMPLETED|Overall Study||28
6404236|NCT00908882|7317119|FG001|NOT COMPLETED|Overall Study||30
6404237|NCT00908895|7317127|FG000|STARTED|Overall Study||57
6404238|NCT00908895|7317128|FG001|STARTED|Overall Study||63
6404239|NCT00908895|7317127|FG000|COMPLETED|Overall Study||53
6404240|NCT00908895|7317128|FG001|COMPLETED|Overall Study||57
6404241|NCT00908895|7317127|FG000|NOT COMPLETED|Overall Study||4
6404242|NCT00908895|7317128|FG001|NOT COMPLETED|Overall Study||6
6404243|NCT00908908|7317134|FG000|STARTED|Overall Study||6
6404244|NCT00908908|7317134|FG000|Adverse Event|Overall Study||0
6404245|NCT00908908|7317134|FG000|Withdrawl by Subject|Overall Study||0
6404246|NCT00908908|7317134|FG000|Administrative/Other|Overall Study||0
6404247|NCT00908908|7317134|FG000|Physician Decision|Overall Study||0
6404248|NCT00908908|7317134|FG000|COMPLETED|Overall Study||6
6404249|NCT00908908|7317134|FG000|NOT COMPLETED|Overall Study||0
6404250|NCT00908947|7317138|FG000|STARTED|Overall Study||173
6404251|NCT00908947|7317138|FG000|COMPLETED|Overall Study||83
6404252|NCT00908947|7317138|FG000|NOT COMPLETED|Overall Study||90
6404253|NCT00908960|7317146|FG000|STARTED|Overall Study||24
6404254|NCT00908960|7317147|FG001|STARTED|Overall Study||12
6404255|NCT00908960|7317148|FG002|STARTED|Overall Study||34
6404256|NCT00908960|7317146|FG000|Evaluable|Overall Study||23
6404257|NCT00908960|7317147|FG001|Evaluable|Overall Study||11
6404258|NCT00908960|7317148|FG002|Evaluable|Overall Study||32
6404259|NCT00908960|7317146|FG000|COMPLETED|Overall Study||23
6404260|NCT00908960|7317147|FG001|COMPLETED|Overall Study||11
6404261|NCT00908960|7317148|FG002|COMPLETED|Overall Study||32
6404262|NCT00908960|7317146|FG000|NOT COMPLETED|Overall Study||1
6404263|NCT00908960|7317147|FG001|NOT COMPLETED|Overall Study||1
6404264|NCT00908960|7317148|FG002|NOT COMPLETED|Overall Study||2
6404265|NCT00909038|7317156|FG000|STARTED|Overall Study||2411
6404266|NCT00909038|7317156|FG000|COMPLETED|Overall Study||1994
6404267|NCT00909038|7317156|FG000|NOT COMPLETED|Overall Study||417
6404268|NCT00909064|7317160|FG000|STARTED|Overall Study||114
6404269|NCT00909064|7317160|FG000|COMPLETED|Overall Study||114
6404270|NCT00909064|7317160|FG000|NOT COMPLETED|Overall Study||0
6404271|NCT00909090|7317166|FG000|STARTED|Overall Study||53
6404272|NCT00909090|7317167|FG001|STARTED|Overall Study||56
6404273|NCT00909090|7317166|FG000|COMPLETED|Overall Study||36
6404274|NCT00909090|7317167|FG001|COMPLETED|Overall Study||39
6404275|NCT00909090|7317166|FG000|NOT COMPLETED|Overall Study||17
6404276|NCT00909090|7317167|FG001|NOT COMPLETED|Overall Study||17
6404277|NCT00909155|7317179|FG000|STARTED|Overall Study||15
6404278|NCT00909155|7317180|FG001|STARTED|Overall Study||14
6404279|NCT00909155|7317181|FG002|STARTED|Overall Study||21
6404280|NCT00909155|7317179|FG000|COMPLETED|Overall Study||12
6404281|NCT00909155|7317180|FG001|COMPLETED|Overall Study||9
6404282|NCT00909155|7317181|FG002|COMPLETED|Overall Study||14
6404283|NCT00909155|7317179|FG000|NOT COMPLETED|Overall Study||3
6404284|NCT00909155|7317180|FG001|NOT COMPLETED|Overall Study||5
6404285|NCT00909155|7317181|FG002|NOT COMPLETED|Overall Study||7
6404286|NCT00909181|7317195|FG000|STARTED|Overall Study||210
6404287|NCT00909181|7317196|FG001|STARTED|Overall Study||214
6404288|NCT00909181|7317197|FG002|STARTED|Overall Study||202
6404289|NCT00909181|7317195|FG000|COMPLETED|Overall Study||171
6404290|NCT00909181|7317196|FG001|COMPLETED|Overall Study||196
6404291|NCT00909181|7317197|FG002|COMPLETED|Overall Study||169
6404292|NCT00909181|7317195|FG000|NOT COMPLETED|Overall Study||39
6404293|NCT00909181|7317196|FG001|NOT COMPLETED|Overall Study||18
6404294|NCT00909181|7317197|FG002|NOT COMPLETED|Overall Study||33
6404295|NCT00909220|7317207|FG000|STARTED|Overall Study|Started enrolling participants May 2009|41
6404296|NCT00909220|7317208|FG001|STARTED|Overall Study|Started enrolling participants May 2009|36
6404297|NCT00909220|7317207|FG000|Data Entry|Overall Study||41
6404298|NCT00909220|7317208|FG001|Data Entry|Overall Study||36
6404299|NCT00909220|7317207|FG000|Data Analyses|Overall Study||41
6404300|NCT00909220|7317208|FG001|Data Analyses|Overall Study||36
6404301|NCT00909220|7317207|FG000|Submission for Publication|Overall Study||41
6404302|NCT00909220|7317208|FG001|Submission for Publication|Overall Study||36
6404303|NCT00909220|7317207|FG000|COMPLETED|Overall Study||41
6404304|NCT00909220|7317208|FG001|COMPLETED|Overall Study||36
6404305|NCT00909220|7317207|FG000|NOT COMPLETED|Overall Study||0
6404306|NCT00909220|7317208|FG001|NOT COMPLETED|Overall Study||0
6404307|NCT00909324|7317218|FG000|STARTED|Overall Study||72
6635633|NCT02305849|7564485|FG001|STARTED|Overall Study||174
6635634|NCT02305849|7564486|FG002|STARTED|Overall Study||85
6635635|NCT02305849|7564487|FG003|STARTED|Overall Study||85
6635636|NCT02305849|7564484|FG000|COMPLETED|Overall Study||148
6404308|NCT00909324|7317219|FG001|STARTED|Overall Study||90
6404309|NCT00909324|7317218|FG000|COMPLETED|Overall Study||72
6404310|NCT00909324|7317219|FG001|COMPLETED|Overall Study||90
6404311|NCT00909324|7317218|FG000|NOT COMPLETED|Overall Study||0
6404312|NCT00909324|7317219|FG001|NOT COMPLETED|Overall Study||0
6404313|NCT00909363|7317228|FG000|STARTED|Overall Study||11
6404314|NCT00909363|7317229|FG001|STARTED|Overall Study||8
6404315|NCT00909363|7317230|FG002|STARTED|Overall Study||5
6404316|NCT00909363|7317228|FG000|COMPLETED|Overall Study|1 patient started bleeding 3 days after starting eltrombopag; he underwent bone marrow transplant|9
6404317|NCT00909363|7317229|FG001|COMPLETED|Overall Study||8
6404318|NCT00909363|7317230|FG002|COMPLETED|Overall Study||5
6404319|NCT00909363|7317228|FG000|NOT COMPLETED|Overall Study||2
6404320|NCT00909363|7317229|FG001|NOT COMPLETED|Overall Study||0
6404321|NCT00909363|7317230|FG002|NOT COMPLETED|Overall Study||0
6404322|NCT00909428|7317244|FG000|STARTED|Overall Study||18
6404323|NCT00909428|7317245|FG001|STARTED|Overall Study||15
6404324|NCT00909428|7317246|FG002|STARTED|Overall Study||9
6404325|NCT00909428|7317244|FG000|COMPLETED|Overall Study||5
6404326|NCT00909428|7317245|FG001|COMPLETED|Overall Study||5
6404327|NCT00909428|7317246|FG002|COMPLETED|Overall Study||0
6404328|NCT00909428|7317244|FG000|NOT COMPLETED|Overall Study||13
6404329|NCT00909428|7317245|FG001|NOT COMPLETED|Overall Study||10
6404330|NCT00909428|7317246|FG002|NOT COMPLETED|Overall Study||9
6404331|NCT00909480|7317255|FG000|STARTED|Overall Study||228
6404332|NCT00909480|7317256|FG001|STARTED|Overall Study||229
6404333|NCT00909480|7317255|FG000|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
6404334|NCT00909480|7317256|FG001|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
6404335|NCT00909480|7317255|FG000|COMPLETED|Overall Study||190
6404336|NCT00909480|7317256|FG001|COMPLETED|Overall Study||188
6404337|NCT00909480|7317255|FG000|NOT COMPLETED|Overall Study||38
6404338|NCT00909480|7317256|FG001|NOT COMPLETED|Overall Study||41
6404339|NCT00909532|7317264|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
6404340|NCT00909532|7317265|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
6404341|NCT00909532|7317264|FG000|Completed Treatment Period, Week 24|Overall Study||71
6404342|NCT00909532|7317265|FG001|Completed Treatment Period, Week 24|Overall Study||80
6404343|NCT00909532|7317264|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
6404344|NCT00909532|7317265|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
6404345|NCT00909532|7317264|FG000|NOT COMPLETED|Overall Study||10
6404346|NCT00909532|7317265|FG001|NOT COMPLETED|Overall Study||6
6404347|NCT00909545|7317276|FG000|STARTED|Overall Study||26
6404348|NCT00909545|7317277|FG001|STARTED|Overall Study||23
6404349|NCT00909545|7317278|FG002|STARTED|Overall Study||26
6404350|NCT00909545|7317279|FG003|STARTED|Overall Study||24
6404351|NCT00909545|7317276|FG000|COMPLETED|Overall Study||25
6404352|NCT00909545|7317277|FG001|COMPLETED|Overall Study||22
6404353|NCT00909545|7317278|FG002|COMPLETED|Overall Study||25
6404354|NCT00909545|7317279|FG003|COMPLETED|Overall Study||19
6404355|NCT00909545|7317276|FG000|NOT COMPLETED|Overall Study||1
6404356|NCT00909545|7317277|FG001|NOT COMPLETED|Overall Study||1
6404357|NCT00909545|7317278|FG002|NOT COMPLETED|Overall Study||1
6404358|NCT00909545|7317279|FG003|NOT COMPLETED|Overall Study||5
6404359|NCT00909727|7317292|FG000|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
6404360|NCT00909727|7317293|FG001|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
6404361|NCT00909727|7317292|FG000|Completed Treatment Period, Week 24|Overall Study||23
6404362|NCT00909727|7317293|FG001|Completed Treatment Period, Week 24|Overall Study||26
6404363|NCT00909727|7317292|FG000|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
6404364|NCT00909727|7317293|FG001|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
6404365|NCT00909727|7317292|FG000|NOT COMPLETED|Overall Study||4
6404366|NCT00909727|7317293|FG001|NOT COMPLETED|Overall Study||0
6404367|NCT00909779|7317301|FG000|STARTED|Overall Study||421
6404368|NCT00909779|7317302|FG001|STARTED|Overall Study||420
6404369|NCT00909779|7317301|FG000|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
6404370|NCT00909779|7317302|FG001|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
6404371|NCT00909779|7317301|FG000|NOT COMPLETED|Overall Study||210
6404372|NCT00909779|7317302|FG001|NOT COMPLETED|Overall Study||165
6404373|NCT00909792|7317310|FG000|STARTED|Period 1||130
6404374|NCT00909792|7317311|FG001|STARTED|Period 1||128
6404375|NCT00909792|7317310|FG000|COMPLETED|Period 1||130
6404376|NCT00909792|7317311|FG001|COMPLETED|Period 1||127
6404377|NCT00909792|7317310|FG000|NOT COMPLETED|Period 1||0
6404378|NCT00909792|7317311|FG001|NOT COMPLETED|Period 1||1
6404379|NCT00909792|7317310|FG000|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
6404380|NCT00909792|7317311|FG001|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
6404381|NCT00909792|7317310|FG000|COMPLETED|Period 2||128
6404382|NCT00909792|7317311|FG001|COMPLETED|Period 2||124
6404383|NCT00909792|7317310|FG000|NOT COMPLETED|Period 2||1
6404384|NCT00909792|7317311|FG001|NOT COMPLETED|Period 2||1
6404385|NCT00909844|7317317|FG000|STARTED|Overall Study||35
6404386|NCT00909844|7317317|FG000|COMPLETED|Overall Study||31
6404387|NCT00909844|7317317|FG000|NOT COMPLETED|Overall Study||4
6404388|NCT00909857|7317324|FG000|STARTED|Overall Study||253
6404389|NCT00909857|7317325|FG001|STARTED|Overall Study||254
6404390|NCT00909857|7317324|FG000|Treated|Overall Study||234
6404391|NCT00909857|7317325|FG001|Treated|Overall Study||230
6404392|NCT00909857|7317324|FG000|COMPLETED|Overall Study||217
6404393|NCT00909857|7317325|FG001|COMPLETED|Overall Study||209
6404394|NCT00909857|7317324|FG000|NOT COMPLETED|Overall Study||36
6404395|NCT00909857|7317325|FG001|NOT COMPLETED|Overall Study||45
6404396|NCT00909870|7317333|FG000|STARTED|Overall Study||274
6404397|NCT00909870|7317334|FG001|STARTED|Overall Study||263
6404398|NCT00909870|7317333|FG000|COMPLETED|Overall Study||251
6404399|NCT00909870|7317334|FG001|COMPLETED|Overall Study||236
6404400|NCT00909870|7317333|FG000|NOT COMPLETED|Overall Study||23
6404401|NCT00909870|7317334|FG001|NOT COMPLETED|Overall Study||27
6404402|NCT00910000|7317347|FG000|STARTED|Overall Study||3
6404403|NCT00910000|7317348|FG001|STARTED|Overall Study||3
6404404|NCT00910000|7317349|FG002|STARTED|Overall Study||3
6404405|NCT00910000|7317350|FG003|STARTED|Overall Study||2
6404406|NCT00910000|7317351|FG004|STARTED|Overall Study||3
6404407|NCT00910000|7317352|FG005|STARTED|Overall Study||1
6404408|NCT00910000|7317347|FG000|COMPLETED|Overall Study||3
6404409|NCT00910000|7317348|FG001|COMPLETED|Overall Study||0
6404410|NCT00910000|7317349|FG002|COMPLETED|Overall Study||0
6404411|NCT00910000|7317350|FG003|COMPLETED|Overall Study||0
6404412|NCT00910000|7317351|FG004|COMPLETED|Overall Study||2
6404413|NCT00910000|7317352|FG005|COMPLETED|Overall Study||0
6404414|NCT00910000|7317347|FG000|NOT COMPLETED|Overall Study||0
6404415|NCT00910000|7317348|FG001|NOT COMPLETED|Overall Study||3
6404416|NCT00910000|7317349|FG002|NOT COMPLETED|Overall Study||3
6404417|NCT00910000|7317350|FG003|NOT COMPLETED|Overall Study||2
6404418|NCT00910000|7317351|FG004|NOT COMPLETED|Overall Study||1
6404419|NCT00910000|7317352|FG005|NOT COMPLETED|Overall Study||1
6404420|NCT00910039|7317362|FG000|STARTED|Overall Study||14
6404421|NCT00910039|7317362|FG000|COMPLETED|Overall Study||13
6404422|NCT00910039|7317362|FG000|NOT COMPLETED|Overall Study||1
6404423|NCT00910091|7317369|FG000|STARTED|Pre-assignment||36
6404424|NCT00910091|7317370|FG001|STARTED|Pre-assignment||37
6404425|NCT00910091|7317369|FG000|COMPLETED|Pre-assignment||36
6404426|NCT00910091|7317370|FG001|COMPLETED|Pre-assignment||35
6404427|NCT00910091|7317369|FG000|NOT COMPLETED|Pre-assignment||0
6404428|NCT00910091|7317370|FG001|NOT COMPLETED|Pre-assignment||2
6404429|NCT00910091|7317369|FG000|STARTED|Treatment and Survival||36
6404430|NCT00910091|7317370|FG001|STARTED|Treatment and Survival||35
6404431|NCT00910091|7317369|FG000|COMPLETED|Treatment and Survival||32
6404432|NCT00910091|7317370|FG001|COMPLETED|Treatment and Survival||31
6404433|NCT00910091|7317369|FG000|NOT COMPLETED|Treatment and Survival||4
6404434|NCT00910091|7317370|FG001|NOT COMPLETED|Treatment and Survival||4
6404435|NCT00910208|7317380|FG000|STARTED|Overall Study||69
6404436|NCT00910208|7317381|FG001|STARTED|Overall Study||72
6404437|NCT00910208|7317382|FG002|STARTED|Overall Study||70
6404438|NCT00910208|7317380|FG000|COMPLETED|Overall Study||67
6404439|NCT00910208|7317381|FG001|COMPLETED|Overall Study||70
6404440|NCT00910208|7317382|FG002|COMPLETED|Overall Study||69
6404441|NCT00910208|7317380|FG000|NOT COMPLETED|Overall Study||2
6404442|NCT00910208|7317381|FG001|NOT COMPLETED|Overall Study||2
6404443|NCT00910208|7317382|FG002|NOT COMPLETED|Overall Study||1
6404444|NCT00910247|7317390|FG000|STARTED|Overall Study||274
6404445|NCT00910247|7317390|FG000|COMPLETED|Overall Study||205
6404446|NCT00910247|7317390|FG000|NOT COMPLETED|Overall Study||69
6498732|NCT01412060|7417358|FG002|NOT COMPLETED|Open-label Stabilization Period (SP)||0
6498733|NCT01412060|7417356|FG000|STARTED|Period Between SP and DBP||264
6498734|NCT01412060|7417357|FG001|STARTED|Period Between SP and DBP||0
6498735|NCT01412060|7417358|FG002|STARTED|Period Between SP and DBP||0
6498736|NCT01412060|7417356|FG000|COMPLETED|Period Between SP and DBP||200
6498737|NCT01412060|7417357|FG001|COMPLETED|Period Between SP and DBP||0
6498738|NCT01412060|7417358|FG002|COMPLETED|Period Between SP and DBP||0
6498739|NCT01412060|7417356|FG000|NOT COMPLETED|Period Between SP and DBP||64
6498740|NCT01412060|7417357|FG001|NOT COMPLETED|Period Between SP and DBP||0
6498741|NCT01412060|7417358|FG002|NOT COMPLETED|Period Between SP and DBP||0
6498742|NCT01412060|7417356|FG000|STARTED|Double-blind Treatment Phase (DBP)||0
6498743|NCT01412060|7417357|FG001|STARTED|Double-blind Treatment Phase (DBP)||99
6498744|NCT01412060|7417358|FG002|STARTED|Double-blind Treatment Phase (DBP)||101
6498745|NCT01412060|7417356|FG000|COMPLETED|Double-blind Treatment Phase (DBP)||0
6498746|NCT01412060|7417357|FG001|COMPLETED|Double-blind Treatment Phase (DBP)||16
6498747|NCT01412060|7417358|FG002|COMPLETED|Double-blind Treatment Phase (DBP)||18
6498748|NCT01412060|7417356|FG000|NOT COMPLETED|Double-blind Treatment Phase (DBP)||0
6498749|NCT01412060|7417357|FG001|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
6498750|NCT01412060|7417358|FG002|NOT COMPLETED|Double-blind Treatment Phase (DBP)||83
6498751|NCT01412086|7417368|FG000|STARTED|Overall Study||112
6498752|NCT01412086|7417368|FG000|COMPLETED|Overall Study||112
6498753|NCT01412086|7417368|FG000|NOT COMPLETED|Overall Study||0
6498754|NCT01412151|7417372|FG000|STARTED|Week 0 - 306 - Treatment Period||10
6498755|NCT01412151|7417372|FG000|COMPLETED|Week 0 - 306 - Treatment Period||5
6498756|NCT01412151|7417372|FG000|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
6498757|NCT01412151|7417372|FG000|STARTED|Week 306 - 310 - Washout Period||5
6498758|NCT01412151|7417372|FG000|COMPLETED|Week 306 - 310 - Washout Period||3
6498759|NCT01412151|7417372|FG000|NOT COMPLETED|Week 306 - 310 - Washout Period||2
6498760|NCT01412164|7417378|FG000|STARTED|Overall Study||730
6498761|NCT01412164|7417378|FG000|COMPLETED|Overall Study||683
6498762|NCT01412164|7417378|FG000|NOT COMPLETED|Overall Study||47
6498763|NCT01412229|7417382|FG000|STARTED|Overall Study||39
6498764|NCT01412229|7417382|FG000|COMPLETED|Overall Study||38
6498765|NCT01412229|7417382|FG000|NOT COMPLETED|Overall Study||1
6498766|NCT01412281|7417391|FG000|STARTED|Overall Study||110
6498767|NCT01412281|7417392|FG001|STARTED|Overall Study||110
6498768|NCT01412281|7417393|FG002|STARTED|Overall Study||110
6498769|NCT01412281|7417394|FG003|STARTED|Overall Study||110
6498770|NCT01412281|7417391|FG000|COMPLETED|Overall Study||110
6498771|NCT01412281|7417392|FG001|COMPLETED|Overall Study||110
6498772|NCT01412281|7417393|FG002|COMPLETED|Overall Study||110
6404447|NCT00910273|7317396|FG000|STARTED|Overall Study||18
6404448|NCT00910273|7317397|FG001|STARTED|Overall Study||16
6404449|NCT00910273|7317396|FG000|COMPLETED|Overall Study||0
6404450|NCT00910273|7317397|FG001|COMPLETED|Overall Study||3
6404451|NCT00910273|7317396|FG000|NOT COMPLETED|Overall Study||18
6404452|NCT00910273|7317397|FG001|NOT COMPLETED|Overall Study||13
6404453|NCT00910299|7317405|FG000|STARTED|Overall Study||212
6404454|NCT00910299|7317406|FG001|STARTED|Overall Study||211
6404455|NCT00910299|7317405|FG000|Received at Least 1 Dose of Study Drug|Overall Study||210
6404456|NCT00910299|7317406|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
6404457|NCT00910299|7317405|FG000|COMPLETED|Overall Study||136
6404458|NCT00910299|7317406|FG001|COMPLETED|Overall Study|"1 participant died of sepsis while on study drug and was considered a protocol completer."|137
6404459|NCT00910299|7317405|FG000|NOT COMPLETED|Overall Study||76
6404460|NCT00910299|7317406|FG001|NOT COMPLETED|Overall Study||74
6404461|NCT00910429|7317414|FG000|STARTED|Overall Study||155
6404462|NCT00910429|7317415|FG001|STARTED|Overall Study||82
6404463|NCT00910429|7317414|FG000|COMPLETED|Overall Study|Completed treatment|116
6404464|NCT00910429|7317415|FG001|COMPLETED|Overall Study|Completed treatment|61
6404465|NCT00910429|7317414|FG000|NOT COMPLETED|Overall Study||39
6404466|NCT00910429|7317415|FG001|NOT COMPLETED|Overall Study||21
6404467|NCT00910481|7317423|FG000|STARTED|Overall Study||151
6404468|NCT00910481|7317424|FG001|STARTED|Overall Study||150
6404469|NCT00910481|7317423|FG000|COMPLETED|Overall Study||151
6404470|NCT00910481|7317424|FG001|COMPLETED|Overall Study||150
6404471|NCT00910481|7317423|FG000|NOT COMPLETED|Overall Study||0
6404472|NCT00910481|7317424|FG001|NOT COMPLETED|Overall Study||0
6404473|NCT00910520|7317432|FG000|STARTED|Treatment Cycle 1||277
6404474|NCT00910520|7317433|FG001|STARTED|Treatment Cycle 1||271
6404475|NCT00910520|7317432|FG000|COMPLETED|Treatment Cycle 1||257
6404476|NCT00910520|7317433|FG001|COMPLETED|Treatment Cycle 1||247
6404477|NCT00910520|7317432|FG000|NOT COMPLETED|Treatment Cycle 1||20
6404478|NCT00910520|7317433|FG001|NOT COMPLETED|Treatment Cycle 1||24
6404479|NCT00910520|7317432|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
6404480|NCT00910520|7317433|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
6404481|NCT00910520|7317432|FG000|COMPLETED|Treatment Cycle 2||156
6404482|NCT00910520|7317433|FG001|COMPLETED|Treatment Cycle 2||215
6404483|NCT00910520|7317432|FG000|NOT COMPLETED|Treatment Cycle 2||7
6404484|NCT00910520|7317433|FG001|NOT COMPLETED|Treatment Cycle 2||8
6404485|NCT00910624|7317443|FG000|STARTED|Treatment Phase||52
6404486|NCT00910624|7317444|FG001|STARTED|Treatment Phase||85
6404487|NCT00910624|7317445|FG002|STARTED|Treatment Phase||29
6404488|NCT00910624|7317446|FG003|STARTED|Treatment Phase||2
6404489|NCT00910624|7317443|FG000|COMPLETED|Treatment Phase||22
6404490|NCT00910624|7317444|FG001|COMPLETED|Treatment Phase||64
6404491|NCT00910624|7317445|FG002|COMPLETED|Treatment Phase||20
6404492|NCT00910624|7317446|FG003|COMPLETED|Treatment Phase||2
6404493|NCT00910624|7317443|FG000|NOT COMPLETED|Treatment Phase||30
6404494|NCT00910624|7317444|FG001|NOT COMPLETED|Treatment Phase||21
6404495|NCT00910624|7317445|FG002|NOT COMPLETED|Treatment Phase||9
6404496|NCT00910624|7317446|FG003|NOT COMPLETED|Treatment Phase||0
6404497|NCT00910624|7317443|FG000|STARTED|Follow-Up Phase||48
6404498|NCT00910624|7317444|FG001|STARTED|Follow-Up Phase||80
6404499|NCT00910624|7317445|FG002|STARTED|Follow-Up Phase||29
6404500|NCT00910624|7317446|FG003|STARTED|Follow-Up Phase||2
6404501|NCT00910624|7317443|FG000|COMPLETED|Follow-Up Phase||42
6404502|NCT00910624|7317444|FG001|COMPLETED|Follow-Up Phase||76
6404503|NCT00910624|7317445|FG002|COMPLETED|Follow-Up Phase||25
6404504|NCT00910624|7317446|FG003|COMPLETED|Follow-Up Phase||2
6404505|NCT00910624|7317443|FG000|NOT COMPLETED|Follow-Up Phase||6
6404506|NCT00910624|7317444|FG001|NOT COMPLETED|Follow-Up Phase||4
6404507|NCT00910624|7317445|FG002|NOT COMPLETED|Follow-Up Phase||4
6404508|NCT00910624|7317446|FG003|NOT COMPLETED|Follow-Up Phase||0
6404509|NCT00910663|7317456|FG000|STARTED|Period 1||30
6404510|NCT00910663|7317457|FG001|STARTED|Period 1||30
6404511|NCT00910663|7317456|FG000|COMPLETED|Period 1||30
6404512|NCT00910663|7317457|FG001|COMPLETED|Period 1||29
6404513|NCT00910663|7317456|FG000|NOT COMPLETED|Period 1||0
6404514|NCT00910663|7317457|FG001|NOT COMPLETED|Period 1||1
6404515|NCT00910663|7317456|FG000|STARTED|Period 2||30
6404516|NCT00910663|7317457|FG001|STARTED|Period 2||29
6404517|NCT00910663|7317456|FG000|COMPLETED|Period 2||30
6404518|NCT00910663|7317457|FG001|COMPLETED|Period 2||29
6404519|NCT00910663|7317456|FG000|NOT COMPLETED|Period 2||0
6404520|NCT00910663|7317457|FG001|NOT COMPLETED|Period 2||0
6404521|NCT00910689|7317467|FG000|STARTED|Month 1: Optimal Acute Therapy Run in||55
6404522|NCT00910689|7317468|FG001|STARTED|Month 1: Optimal Acute Therapy Run in||53
6404523|NCT00910689|7317469|FG002|STARTED|Month 1: Optimal Acute Therapy Run in||55
6404524|NCT00910689|7317470|FG003|STARTED|Month 1: Optimal Acute Therapy Run in||69
6404525|NCT00910689|7317467|FG000|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
6404526|NCT00910689|7317468|FG001|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
6404527|NCT00910689|7317469|FG002|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
6404528|NCT00910689|7317470|FG003|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
6404529|NCT00910689|7317467|FG000|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
6404530|NCT00910689|7317468|FG001|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
6404531|NCT00910689|7317469|FG002|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
6404532|NCT00910689|7317470|FG003|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
6404533|NCT00910689|7317467|FG000|STARTED|Month 2- 4: Treatment Period||53
6404534|NCT00910689|7317468|FG001|STARTED|Month 2- 4: Treatment Period||52
6404535|NCT00910689|7317469|FG002|STARTED|Month 2- 4: Treatment Period||50
6510203|NCT01479985|7429743|FG000|STARTED|Overall Study||167
6510204|NCT01479985|7429744|FG001|STARTED|Overall Study||86
6510205|NCT01479985|7429743|FG000|Baseline Survey|Overall Study||166
6510206|NCT01479985|7429744|FG001|Baseline Survey|Overall Study||85
6510207|NCT01479985|7429743|FG000|COMPLETED|Overall Study||161
6510208|NCT01479985|7429744|FG001|COMPLETED|Overall Study||80
6510209|NCT01479985|7429743|FG000|NOT COMPLETED|Overall Study||6
6510210|NCT01479985|7429744|FG001|NOT COMPLETED|Overall Study||6
6510211|NCT01480076|7429752|FG000|STARTED|Overall Study|enrolled and started run-in treatment|901
6510212|NCT01480076|7429752|FG000|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
6510213|NCT01480076|7429752|FG000|COMPLETED|Overall Study||611
6510214|NCT01480076|7429752|FG000|NOT COMPLETED|Overall Study||290
6510215|NCT01480089|7429770|FG000|STARTED|Overall Study||25
6510216|NCT01480089|7429771|FG001|STARTED|Overall Study||30
6510217|NCT01480089|7429770|FG000|COMPLETED|Overall Study||25
6510218|NCT01480089|7429771|FG001|COMPLETED|Overall Study||30
6510219|NCT01480089|7429770|FG000|NOT COMPLETED|Overall Study||0
6510220|NCT01480089|7429771|FG001|NOT COMPLETED|Overall Study||0
6510221|NCT01480219|7429779|FG000|STARTED|Overall Study||325
6510222|NCT01480219|7429780|FG001|STARTED|Overall Study||142
6510223|NCT01480219|7429779|FG000|COMPLETED|Overall Study||325
6510224|NCT01480219|7429780|FG001|COMPLETED|Overall Study||142
6510225|NCT01480219|7429779|FG000|NOT COMPLETED|Overall Study||0
6510226|NCT01480219|7429780|FG001|NOT COMPLETED|Overall Study||0
6510227|NCT01480232|7429790|FG000|STARTED|Overall Study||40
6510228|NCT01480232|7429791|FG001|STARTED|Overall Study||41
6510229|NCT01480232|7429792|FG002|STARTED|Overall Study||38
6510230|NCT01480232|7429793|FG003|STARTED|Overall Study||41
6510231|NCT01480232|7429790|FG000|COMPLETED|Overall Study||22
6510232|NCT01480232|7429791|FG001|COMPLETED|Overall Study||19
6510233|NCT01480232|7429792|FG002|COMPLETED|Overall Study||21
6510234|NCT01480232|7429793|FG003|COMPLETED|Overall Study||22
6510235|NCT01480232|7429790|FG000|NOT COMPLETED|Overall Study||18
6510236|NCT01480232|7429791|FG001|NOT COMPLETED|Overall Study||22
6510237|NCT01480232|7429792|FG002|NOT COMPLETED|Overall Study||17
6510238|NCT01480232|7429793|FG003|NOT COMPLETED|Overall Study||19
6510239|NCT01480258|7429805|FG000|STARTED|Infant Series||656
6635637|NCT02305849|7564485|FG001|COMPLETED|Overall Study||146
6635638|NCT02305849|7564486|FG002|COMPLETED|Overall Study||67
6635639|NCT02305849|7564487|FG003|COMPLETED|Overall Study||66
6635640|NCT02305849|7564484|FG000|NOT COMPLETED|Overall Study||27
6635641|NCT02305849|7564485|FG001|NOT COMPLETED|Overall Study||28
6510240|NCT01480258|7429806|FG001|STARTED|Infant Series||659
6510241|NCT01480258|7429805|FG000|Vaccinated|Infant Series||653
6510242|NCT01480258|7429806|FG001|Vaccinated|Infant Series||659
6510243|NCT01480258|7429805|FG000|COMPLETED|Infant Series||649
6510244|NCT01480258|7429806|FG001|COMPLETED|Infant Series||651
6510245|NCT01480258|7429805|FG000|NOT COMPLETED|Infant Series||7
6510246|NCT01480258|7429806|FG001|NOT COMPLETED|Infant Series||8
6510247|NCT01480258|7429805|FG000|STARTED|Interim Period||649
6510248|NCT01480258|7429806|FG001|STARTED|Interim Period||651
6510249|NCT01480258|7429805|FG000|COMPLETED|Interim Period||639
6510250|NCT01480258|7429806|FG001|COMPLETED|Interim Period||642
6510251|NCT01480258|7429805|FG000|NOT COMPLETED|Interim Period||10
6510252|NCT01480258|7429806|FG001|NOT COMPLETED|Interim Period||9
6510253|NCT01480258|7429805|FG000|STARTED|Toddler Dose||639
6510254|NCT01480258|7429806|FG001|STARTED|Toddler Dose||642
6510255|NCT01480258|7429805|FG000|COMPLETED|Toddler Dose||639
6510256|NCT01480258|7429806|FG001|COMPLETED|Toddler Dose||642
6510257|NCT01480258|7429805|FG000|NOT COMPLETED|Toddler Dose||0
6510258|NCT01480258|7429806|FG001|NOT COMPLETED|Toddler Dose||0
6510259|NCT01480284|7429814|FG000|STARTED|Overall Study||110
6404536|NCT00910689|7317470|FG003|STARTED|Month 2- 4: Treatment Period||59
6404537|NCT00910689|7317467|FG000|COMPLETED|Month 2- 4: Treatment Period||44
6404538|NCT00910689|7317468|FG001|COMPLETED|Month 2- 4: Treatment Period||42
6404539|NCT00910689|7317469|FG002|COMPLETED|Month 2- 4: Treatment Period||42
6404540|NCT00910689|7317470|FG003|COMPLETED|Month 2- 4: Treatment Period||48
6404541|NCT00910689|7317467|FG000|NOT COMPLETED|Month 2- 4: Treatment Period||9
6404542|NCT00910689|7317468|FG001|NOT COMPLETED|Month 2- 4: Treatment Period||10
6404543|NCT00910689|7317469|FG002|NOT COMPLETED|Month 2- 4: Treatment Period||8
6404544|NCT00910689|7317470|FG003|NOT COMPLETED|Month 2- 4: Treatment Period||11
6404545|NCT00910689|7317467|FG000|STARTED|Months 5 - 10: Evaluation Period I||44
6404546|NCT00910689|7317468|FG001|STARTED|Months 5 - 10: Evaluation Period I||42
6404547|NCT00910689|7317469|FG002|STARTED|Months 5 - 10: Evaluation Period I||42
6404548|NCT00910689|7317470|FG003|STARTED|Months 5 - 10: Evaluation Period I||48
6404549|NCT00910689|7317467|FG000|COMPLETED|Months 5 - 10: Evaluation Period I||40
6404550|NCT00910689|7317468|FG001|COMPLETED|Months 5 - 10: Evaluation Period I||35
6404551|NCT00910689|7317469|FG002|COMPLETED|Months 5 - 10: Evaluation Period I||35
6404552|NCT00910689|7317470|FG003|COMPLETED|Months 5 - 10: Evaluation Period I||41
6404553|NCT00910689|7317467|FG000|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
6404554|NCT00910689|7317468|FG001|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
6404555|NCT00910689|7317469|FG002|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
6635642|NCT02305849|7564486|FG002|NOT COMPLETED|Overall Study||18
6404556|NCT00910689|7317470|FG003|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
6404557|NCT00910689|7317467|FG000|STARTED|Months 11- 16: Evaluation Period II||40
6404558|NCT00910689|7317468|FG001|STARTED|Months 11- 16: Evaluation Period II||35
6404559|NCT00910689|7317469|FG002|STARTED|Months 11- 16: Evaluation Period II||35
6404560|NCT00910689|7317470|FG003|STARTED|Months 11- 16: Evaluation Period II||41
6404561|NCT00910689|7317467|FG000|COMPLETED|Months 11- 16: Evaluation Period II||30
6404562|NCT00910689|7317468|FG001|COMPLETED|Months 11- 16: Evaluation Period II||25
6404563|NCT00910689|7317469|FG002|COMPLETED|Months 11- 16: Evaluation Period II||28
6404564|NCT00910689|7317470|FG003|COMPLETED|Months 11- 16: Evaluation Period II||35
6404565|NCT00910689|7317467|FG000|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
6404566|NCT00910689|7317468|FG001|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
6404567|NCT00910689|7317469|FG002|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
6404568|NCT00910689|7317470|FG003|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
6404569|NCT00910715|7317483|FG000|STARTED|Overall Study||108
6404570|NCT00910715|7317484|FG001|STARTED|Overall Study||117
6404571|NCT00910715|7317485|FG002|STARTED|Overall Study||81
6404572|NCT00910715|7317483|FG000|COMPLETED|Overall Study||86
6404573|NCT00910715|7317484|FG001|COMPLETED|Overall Study||91
6404574|NCT00910715|7317485|FG002|COMPLETED|Overall Study||81
6404575|NCT00910715|7317483|FG000|NOT COMPLETED|Overall Study||22
6404576|NCT00910715|7317484|FG001|NOT COMPLETED|Overall Study||26
6404577|NCT00910715|7317485|FG002|NOT COMPLETED|Overall Study||0
6404578|NCT00910728|7317504|FG000|STARTED|Overall Study||6
6404579|NCT00910728|7317505|FG001|STARTED|Overall Study||3
6404580|NCT00910728|7317506|FG002|STARTED|Overall Study||3
6404581|NCT00910728|7317507|FG003|STARTED|Overall Study||3
6404582|NCT00910728|7317508|FG004|STARTED|Overall Study||6
6404583|NCT00910728|7317509|FG005|STARTED|Overall Study||1
6404584|NCT00910728|7317510|FG006|STARTED|Overall Study||6
6404585|NCT00910728|7317511|FG007|STARTED|Overall Study||4
6404586|NCT00910728|7317512|FG008|STARTED|Overall Study||3
6404587|NCT00910728|7317504|FG000|COMPLETED|Overall Study||0
6404588|NCT00910728|7317505|FG001|COMPLETED|Overall Study||0
6404589|NCT00910728|7317506|FG002|COMPLETED|Overall Study||0
6404590|NCT00910728|7317507|FG003|COMPLETED|Overall Study||0
6404591|NCT00910728|7317508|FG004|COMPLETED|Overall Study||1
6404592|NCT00910728|7317509|FG005|COMPLETED|Overall Study||0
6404593|NCT00910728|7317510|FG006|COMPLETED|Overall Study||0
6404594|NCT00910728|7317511|FG007|COMPLETED|Overall Study||1
6404595|NCT00910728|7317512|FG008|COMPLETED|Overall Study||0
6404596|NCT00910728|7317504|FG000|NOT COMPLETED|Overall Study||6
6404597|NCT00910728|7317505|FG001|NOT COMPLETED|Overall Study||3
6404598|NCT00910728|7317506|FG002|NOT COMPLETED|Overall Study||3
6404599|NCT00910728|7317507|FG003|NOT COMPLETED|Overall Study||3
6404600|NCT00910728|7317508|FG004|NOT COMPLETED|Overall Study||5
6404601|NCT00910728|7317509|FG005|NOT COMPLETED|Overall Study||1
6404602|NCT00910728|7317510|FG006|NOT COMPLETED|Overall Study||6
6404603|NCT00910728|7317511|FG007|NOT COMPLETED|Overall Study||3
6404604|NCT00910728|7317512|FG008|NOT COMPLETED|Overall Study||3
6404605|NCT00910845|7317534|FG000|STARTED|Treatment Cycle 1||280
6404606|NCT00910845|7317535|FG001|STARTED|Treatment Cycle 1||277
6404607|NCT00910845|7317534|FG000|COMPLETED|Treatment Cycle 1||249
6404608|NCT00910845|7317535|FG001|COMPLETED|Treatment Cycle 1||243
6404609|NCT00910845|7317534|FG000|NOT COMPLETED|Treatment Cycle 1||31
6404610|NCT00910845|7317535|FG001|NOT COMPLETED|Treatment Cycle 1||34
6404611|NCT00910845|7317534|FG000|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
6404612|NCT00910845|7317535|FG001|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
6404613|NCT00910845|7317534|FG000|COMPLETED|Treatment Cycle 2||136
6404614|NCT00910845|7317535|FG001|COMPLETED|Treatment Cycle 2||203
6404615|NCT00910845|7317534|FG000|NOT COMPLETED|Treatment Cycle 2||5
6404616|NCT00910845|7317535|FG001|NOT COMPLETED|Treatment Cycle 2||9
6404617|NCT00910858|7317544|FG000|STARTED|Pharmacokinetic Phase||9
6404618|NCT00910858|7317545|FG001|STARTED|Pharmacokinetic Phase||0
6404619|NCT00910858|7317546|FG002|STARTED|Pharmacokinetic Phase||3
6404620|NCT00910858|7317544|FG000|COMPLETED|Pharmacokinetic Phase||8
6404621|NCT00910858|7317545|FG001|COMPLETED|Pharmacokinetic Phase||0
6404622|NCT00910858|7317546|FG002|COMPLETED|Pharmacokinetic Phase||3
6404623|NCT00910858|7317544|FG000|NOT COMPLETED|Pharmacokinetic Phase||1
6404624|NCT00910858|7317545|FG001|NOT COMPLETED|Pharmacokinetic Phase||0
6404625|NCT00910858|7317546|FG002|NOT COMPLETED|Pharmacokinetic Phase||0
6404626|NCT00910858|7317544|FG000|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
6404627|NCT00910858|7317545|FG001|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
6404628|NCT00910858|7317546|FG002|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
6404629|NCT00910858|7317544|FG000|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
6404630|NCT00910858|7317545|FG001|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
6404631|NCT00910858|7317546|FG002|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
6404632|NCT00910858|7317544|FG000|Pharmacokinetic Population|Monotherapy Phase||17
6404633|NCT00910858|7317545|FG001|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
6404634|NCT00910858|7317546|FG002|Pharmacokinetic Population|Monotherapy Phase||7
6404635|NCT00910858|7317544|FG000|COMPLETED|Monotherapy Phase||0
6404636|NCT00910858|7317545|FG001|COMPLETED|Monotherapy Phase||0
6404637|NCT00910858|7317546|FG002|COMPLETED|Monotherapy Phase||0
6404638|NCT00910858|7317544|FG000|NOT COMPLETED|Monotherapy Phase||17
6404639|NCT00910858|7317545|FG001|NOT COMPLETED|Monotherapy Phase||15
6404640|NCT00910858|7317546|FG002|NOT COMPLETED|Monotherapy Phase||7
6404641|NCT00910858|7317544|FG000|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
6404642|NCT00910858|7317545|FG001|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
6404643|NCT00910858|7317546|FG002|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
6404644|NCT00910858|7317544|FG000|COMPLETED|Combined Treatment Phase||0
6404645|NCT00910858|7317545|FG001|COMPLETED|Combined Treatment Phase||0
6404646|NCT00910858|7317546|FG002|COMPLETED|Combined Treatment Phase||0
6404647|NCT00910858|7317544|FG000|NOT COMPLETED|Combined Treatment Phase||9
6404648|NCT00910858|7317545|FG001|NOT COMPLETED|Combined Treatment Phase||10
6404649|NCT00910858|7317546|FG002|NOT COMPLETED|Combined Treatment Phase||4
6404650|NCT00910871|7317562|FG000|STARTED|Overall Study||233
6404651|NCT00910871|7317562|FG000|COMPLETED|Overall Study||179
6404652|NCT00910871|7317562|FG000|NOT COMPLETED|Overall Study||54
6404653|NCT00910910|7317568|FG000|STARTED|Overall Study||225
6404654|NCT00910910|7317569|FG001|STARTED|Overall Study||225
6404655|NCT00910910|7317568|FG000|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
6404656|NCT00910910|7317569|FG001|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
6404657|NCT00910910|7317568|FG000|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|0
6404658|NCT00910910|7317569|FG001|COMPLETED|Overall Study|Completed includes participants who continued with ongoing treatment|1
6404659|NCT00910910|7317568|FG000|NOT COMPLETED|Overall Study||225
6404660|NCT00910910|7317569|FG001|NOT COMPLETED|Overall Study||224
6404661|NCT00910962|7317578|FG000|STARTED|Overall Study||135
6404662|NCT00910962|7317579|FG001|STARTED|Overall Study||199
6404663|NCT00910962|7317580|FG002|STARTED|Overall Study||192
6404664|NCT00910962|7317578|FG000|COMPLETED|Overall Study||92
6404665|NCT00910962|7317579|FG001|COMPLETED|Overall Study||121
6404666|NCT00910962|7317580|FG002|COMPLETED|Overall Study||116
6404667|NCT00910962|7317578|FG000|NOT COMPLETED|Overall Study||43
6404668|NCT00910962|7317579|FG001|NOT COMPLETED|Overall Study||78
6404669|NCT00910962|7317580|FG002|NOT COMPLETED|Overall Study||76
6404670|NCT00910988|7317594|FG000|STARTED|Overall Study||16
6404671|NCT00910988|7317595|FG001|STARTED|Overall Study||16
6404672|NCT00910988|7317596|FG002|STARTED|Overall Study||8
6404673|NCT00910988|7317597|FG003|STARTED|Overall Study||6
6404674|NCT00910988|7317594|FG000|COMPLETED|Overall Study||14
6404675|NCT00910988|7317595|FG001|COMPLETED|Overall Study||12
6404676|NCT00910988|7317596|FG002|COMPLETED|Overall Study||5
6404677|NCT00910988|7317597|FG003|COMPLETED|Overall Study||6
6404678|NCT00910988|7317594|FG000|NOT COMPLETED|Overall Study||2
6404679|NCT00910988|7317595|FG001|NOT COMPLETED|Overall Study||4
6404680|NCT00910988|7317596|FG002|NOT COMPLETED|Overall Study||3
6404681|NCT00910988|7317597|FG003|NOT COMPLETED|Overall Study||0
6404682|NCT00911144|7317625|FG000|STARTED|Overall Study||335
6404683|NCT00911144|7317626|FG001|STARTED|Overall Study||113
6404684|NCT00911144|7317625|FG000|COMPLETED|Overall Study||319
6404685|NCT00911144|7317626|FG001|COMPLETED|Overall Study||108
6404686|NCT00911144|7317625|FG000|NOT COMPLETED|Overall Study||16
6404687|NCT00911144|7317626|FG001|NOT COMPLETED|Overall Study||5
6404688|NCT00911157|7317634|FG000|STARTED|Overall Study||29
6404689|NCT00911157|7317635|FG001|STARTED|Overall Study||10
6404690|NCT00911157|7317634|FG000|COMPLETED|Overall Study||22
6404691|NCT00911157|7317635|FG001|COMPLETED|Overall Study||8
6404692|NCT00911157|7317634|FG000|NOT COMPLETED|Overall Study||7
6404693|NCT00911157|7317635|FG001|NOT COMPLETED|Overall Study||2
6404694|NCT00911170|7317643|FG000|STARTED|Treatment Period||424
6404695|NCT00911170|7317644|FG001|STARTED|Treatment Period||423
6404696|NCT00911170|7317643|FG000|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
6404697|NCT00911170|7317644|FG001|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
6404698|NCT00911170|7317643|FG000|Received Bevacizumab|Treatment Period||423
6404699|NCT00911170|7317644|FG001|Received Bevacizumab|Treatment Period||420
6404700|NCT00911170|7317643|FG000|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
6404701|NCT00911170|7317644|FG001|Received Investigational Product|Treatment Period||419
6404702|NCT00911170|7317643|FG000|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
6404703|NCT00911170|7317644|FG001|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
6404704|NCT00911170|7317643|FG000|NOT COMPLETED|Treatment Period||27
6404705|NCT00911170|7317644|FG001|NOT COMPLETED|Treatment Period||37
6404706|NCT00911170|7317643|FG000|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
6404707|NCT00911170|7317644|FG001|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
6404708|NCT00911170|7317643|FG000|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
6404709|NCT00911170|7317644|FG001|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
6404710|NCT00911170|7317643|FG000|NOT COMPLETED|Long Term Follow-Up||423
6404711|NCT00911170|7317644|FG001|NOT COMPLETED|Long Term Follow-Up||422
6404712|NCT00911300|7317652|FG000|STARTED|Overall Study||175
6404713|NCT00911300|7317653|FG001|STARTED|Overall Study||174
6404714|NCT00911300|7317652|FG000|COMPLETED|Overall Study||140
6404715|NCT00911300|7317653|FG001|COMPLETED|Overall Study||131
6404716|NCT00911300|7317652|FG000|NOT COMPLETED|Overall Study||35
6404717|NCT00911300|7317653|FG001|NOT COMPLETED|Overall Study||43
6404718|NCT00911326|7317660|FG000|STARTED|Overall Study||101
6404719|NCT00911326|7317660|FG000|COMPLETED|Overall Study||85
6404720|NCT00911326|7317660|FG000|NOT COMPLETED|Overall Study||16
6404721|NCT00911495|7317664|FG000|STARTED|Overall Study||15
6404722|NCT00911495|7317664|FG000|COMPLETED|Overall Study||14
6404723|NCT00911495|7317664|FG000|NOT COMPLETED|Overall Study||1
6404724|NCT00911508|7317670|FG000|STARTED|Overall Study||1108
6404725|NCT00911508|7317671|FG001|STARTED|Overall Study||1096
6404726|NCT00911508|7317670|FG000|COMPLETED|Overall Study||1002
6404727|NCT00911508|7317671|FG001|COMPLETED|Overall Study||966
6404728|NCT00911508|7317670|FG000|NOT COMPLETED|Overall Study||106
6404729|NCT00911508|7317671|FG001|NOT COMPLETED|Overall Study||130
6404730|NCT00911534|7317679|FG000|STARTED|Overall Study|Randomized (treated)|147
6404731|NCT00911534|7317680|FG001|STARTED|Overall Study|Randomized (treated)|153
6404732|NCT00911534|7317679|FG000|COMPLETED|Overall Study||132
6404733|NCT00911534|7317680|FG001|COMPLETED|Overall Study||137
6404734|NCT00911534|7317679|FG000|NOT COMPLETED|Overall Study||15
6404735|NCT00911534|7317680|FG001|NOT COMPLETED|Overall Study||16
6404736|NCT00911586|7317686|FG000|STARTED|Overall Study||15
6404737|NCT00911586|7317686|FG000|COMPLETED|Overall Study||15
6404738|NCT00911586|7317686|FG000|NOT COMPLETED|Overall Study||0
6404739|NCT00911612|7317693|FG000|STARTED|Overall Study||12
6404740|NCT00911612|7317694|FG001|STARTED|Overall Study||12
6404741|NCT00911612|7317693|FG000|COMPLETED|Overall Study||12
6404742|NCT00911612|7317694|FG001|COMPLETED|Overall Study||12
6404743|NCT00911612|7317693|FG000|NOT COMPLETED|Overall Study||0
6404744|NCT00911612|7317694|FG001|NOT COMPLETED|Overall Study||0
6404745|NCT00911625|7317702|FG000|STARTED|Overall Study||57
6404746|NCT00911625|7317703|FG001|STARTED|Overall Study||57
6404747|NCT00911625|7317702|FG000|COMPLETED|Overall Study||50
6404748|NCT00911625|7317703|FG001|COMPLETED|Overall Study||57
6404749|NCT00911625|7317702|FG000|NOT COMPLETED|Overall Study||7
6404750|NCT00911625|7317703|FG001|NOT COMPLETED|Overall Study||0
6404751|NCT00911742|7317711|FG000|STARTED|Treatment Phase I||13
6404752|NCT00911742|7317712|FG001|STARTED|Treatment Phase I||13
6404753|NCT00911742|7317711|FG000|COMPLETED|Treatment Phase I||13
6404754|NCT00911742|7317712|FG001|COMPLETED|Treatment Phase I||13
6404755|NCT00911742|7317711|FG000|NOT COMPLETED|Treatment Phase I||0
6404756|NCT00911742|7317712|FG001|NOT COMPLETED|Treatment Phase I||0
6404757|NCT00911742|7317711|FG000|STARTED|Treatment Phase II||13
6404758|NCT00911742|7317712|FG001|STARTED|Treatment Phase II||13
6404759|NCT00911742|7317711|FG000|COMPLETED|Treatment Phase II||13
6404760|NCT00911742|7317712|FG001|COMPLETED|Treatment Phase II||13
6404761|NCT00911742|7317711|FG000|NOT COMPLETED|Treatment Phase II||0
6404762|NCT00911742|7317712|FG001|NOT COMPLETED|Treatment Phase II||0
6404763|NCT00911768|7317720|FG000|STARTED|Overall Study||50
6404764|NCT00911768|7317721|FG001|STARTED|Overall Study||50
6404765|NCT00911768|7317720|FG000|COMPLETED|Overall Study||44
6404766|NCT00911768|7317721|FG001|COMPLETED|Overall Study||46
6404767|NCT00911768|7317720|FG000|NOT COMPLETED|Overall Study||6
6404768|NCT00911768|7317721|FG001|NOT COMPLETED|Overall Study||4
6404769|NCT00911807|7317730|FG000|STARTED|Overall Study||72
6404770|NCT00911807|7317731|FG001|STARTED|Overall Study||70
6404771|NCT00911807|7317732|FG002|STARTED|Overall Study||75
6404772|NCT00911807|7317730|FG000|COMPLETED|Overall Study||55
6404773|NCT00911807|7317731|FG001|COMPLETED|Overall Study||52
6404774|NCT00911807|7317732|FG002|COMPLETED|Overall Study||52
6404775|NCT00911807|7317730|FG000|NOT COMPLETED|Overall Study||17
6404776|NCT00911807|7317731|FG001|NOT COMPLETED|Overall Study||18
6404777|NCT00911807|7317732|FG002|NOT COMPLETED|Overall Study||23
6404778|NCT00911820|7317742|FG000|STARTED|Overall Study||45
6404779|NCT00911820|7317743|FG001|STARTED|Overall Study||43
6404780|NCT00911820|7317742|FG000|Treated|Overall Study|Randomized patients not treated: unable to confirm pathology (n=1)|44
6404781|NCT00911820|7317743|FG001|Treated|Overall Study|Randomized patients not treated: withdrew consent (n=2)|41
6404782|NCT00911820|7317742|FG000|COMPLETED|Overall Study||0
6404783|NCT00911820|7317743|FG001|COMPLETED|Overall Study||0
6404784|NCT00911820|7317742|FG000|NOT COMPLETED|Overall Study||45
6404785|NCT00911820|7317743|FG001|NOT COMPLETED|Overall Study||43
6404786|NCT00911859|7317752|FG000|STARTED|Treatment Period||12
6404787|NCT00911859|7317753|FG001|STARTED|Treatment Period||54
6404788|NCT00911859|7317754|FG002|STARTED|Treatment Period||52
6404789|NCT00911859|7317752|FG000|Received Treatment|Treatment Period||12
6404790|NCT00911859|7317753|FG001|Received Treatment|Treatment Period||53
6404791|NCT00911859|7317754|FG002|Received Treatment|Treatment Period||52
6404792|NCT00911859|7317752|FG000|COMPLETED|Treatment Period||4
6404793|NCT00911859|7317753|FG001|COMPLETED|Treatment Period||33
6404794|NCT00911859|7317754|FG002|COMPLETED|Treatment Period||27
6404795|NCT00911859|7317752|FG000|NOT COMPLETED|Treatment Period||8
6404796|NCT00911859|7317753|FG001|NOT COMPLETED|Treatment Period||21
6404797|NCT00911859|7317754|FG002|NOT COMPLETED|Treatment Period||25
6404798|NCT00911859|7317752|FG000|STARTED|Maintainance Period||0
6404799|NCT00911859|7317753|FG001|STARTED|Maintainance Period||0
6404800|NCT00911859|7317754|FG002|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
6404801|NCT00911859|7317752|FG000|COMPLETED|Maintainance Period||0
6404802|NCT00911859|7317753|FG001|COMPLETED|Maintainance Period||0
6404803|NCT00911859|7317754|FG002|COMPLETED|Maintainance Period||0
6404804|NCT00911859|7317752|FG000|NOT COMPLETED|Maintainance Period||0
6404805|NCT00911859|7317753|FG001|NOT COMPLETED|Maintainance Period||0
6404806|NCT00911859|7317754|FG002|NOT COMPLETED|Maintainance Period||21
6404807|NCT00911859|7317752|FG000|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
6404808|NCT00911859|7317753|FG001|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
6404809|NCT00911859|7317754|FG002|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
6404810|NCT00911859|7317752|FG000|COMPLETED|Follow-up Period||1
6404811|NCT00911859|7317753|FG001|COMPLETED|Follow-up Period||7
6404812|NCT00911859|7317754|FG002|COMPLETED|Follow-up Period||11
6404813|NCT00911859|7317752|FG000|NOT COMPLETED|Follow-up Period||11
6404814|NCT00911859|7317753|FG001|NOT COMPLETED|Follow-up Period||46
6404815|NCT00911859|7317754|FG002|NOT COMPLETED|Follow-up Period||41
6404816|NCT00911898|7317762|FG000|STARTED|Overall Study||20
6404817|NCT00911898|7317762|FG000|COMPLETED|Overall Study||20
6404818|NCT00911898|7317762|FG000|NOT COMPLETED|Overall Study||0
6404819|NCT00911937|7317768|FG000|STARTED|Overall Study||487
6404820|NCT00911937|7317769|FG001|STARTED|Overall Study||476
6404821|NCT00911937|7317768|FG000|Treated|Overall Study||474
6404822|NCT00911937|7317769|FG001|Treated|Overall Study||463
6404823|NCT00911937|7317768|FG000|COMPLETED|Overall Study||400
6404824|NCT00911937|7317769|FG001|COMPLETED|Overall Study||381
6404825|NCT00911937|7317768|FG000|NOT COMPLETED|Overall Study||87
6404826|NCT00911937|7317769|FG001|NOT COMPLETED|Overall Study||95
6404827|NCT00911989|7317775|FG000|STARTED|Overall Study||4
6404828|NCT00911989|7317775|FG000|COMPLETED|Overall Study||3
6404829|NCT00911989|7317775|FG000|NOT COMPLETED|Overall Study||1
6404830|NCT00912002|7317779|FG000|STARTED|Overall Study||6
6404831|NCT00912002|7317779|FG000|COMPLETED|Overall Study||6
6404832|NCT00912002|7317779|FG000|NOT COMPLETED|Overall Study||0
6404833|NCT00912015|7317788|FG000|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
6404834|NCT00912015|7317789|FG001|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
6404835|NCT00912015|7317790|FG002|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
6404836|NCT00912015|7317791|FG003|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
6404837|NCT00912015|7317788|FG000|COMPLETED|Overall Study||125
6404838|NCT00912015|7317789|FG001|COMPLETED|Overall Study||62
6404839|NCT00912015|7317790|FG002|COMPLETED|Overall Study||22
6404840|NCT00912015|7317791|FG003|COMPLETED|Overall Study||0
6404841|NCT00912015|7317788|FG000|NOT COMPLETED|Overall Study||16
6404842|NCT00912015|7317789|FG001|NOT COMPLETED|Overall Study||8
6404843|NCT00912015|7317790|FG002|NOT COMPLETED|Overall Study||3
6404844|NCT00912015|7317791|FG003|NOT COMPLETED|Overall Study||2
6404845|NCT00912028|7317804|FG000|STARTED|Overall Study||35
6404846|NCT00912028|7317805|FG001|STARTED|Overall Study||3
6404847|NCT00912028|7317806|FG002|STARTED|Overall Study||13
6404848|NCT00912028|7317807|FG003|STARTED|Overall Study||17
6404849|NCT00912028|7317808|FG004|STARTED|Overall Study||3
6404850|NCT00912028|7317804|FG000|COMPLETED|Overall Study||30
6404851|NCT00912028|7317805|FG001|COMPLETED|Overall Study||0
6404852|NCT00912028|7317806|FG002|COMPLETED|Overall Study||13
6404853|NCT00912028|7317807|FG003|COMPLETED|Overall Study||16
6404854|NCT00912028|7317808|FG004|COMPLETED|Overall Study||0
6404855|NCT00912028|7317804|FG000|NOT COMPLETED|Overall Study||5
6404856|NCT00912028|7317805|FG001|NOT COMPLETED|Overall Study||3
6404857|NCT00912028|7317806|FG002|NOT COMPLETED|Overall Study||0
6404858|NCT00912028|7317807|FG003|NOT COMPLETED|Overall Study||1
6404859|NCT00912028|7317808|FG004|NOT COMPLETED|Overall Study||3
6404860|NCT00912093|7317823|FG000|STARTED|The Controlled Phase||43
6404861|NCT00912093|7317824|FG001|STARTED|The Controlled Phase||45
6404862|NCT00912093|7317825|FG002|STARTED|The Controlled Phase||3
6404863|NCT00912093|7317826|FG003|STARTED|The Controlled Phase||2
6404864|NCT00912093|7317827|FG004|STARTED|The Controlled Phase||5
6404865|NCT00912093|7317823|FG000|COMPLETED|The Controlled Phase||43
6404866|NCT00912093|7317824|FG001|COMPLETED|The Controlled Phase||43
6404867|NCT00912093|7317825|FG002|COMPLETED|The Controlled Phase||3
6404868|NCT00912093|7317826|FG003|COMPLETED|The Controlled Phase||2
6404869|NCT00912093|7317827|FG004|COMPLETED|The Controlled Phase||4
6404870|NCT00912093|7317823|FG000|NOT COMPLETED|The Controlled Phase||0
6404871|NCT00912093|7317824|FG001|NOT COMPLETED|The Controlled Phase||2
6404872|NCT00912093|7317825|FG002|NOT COMPLETED|The Controlled Phase||0
6404873|NCT00912093|7317826|FG003|NOT COMPLETED|The Controlled Phase||0
6404874|NCT00912093|7317827|FG004|NOT COMPLETED|The Controlled Phase||1
6404875|NCT00912093|7317823|FG000|STARTED|The Open Label Extension (OLE) Phase||38
6404876|NCT00912093|7317824|FG001|STARTED|The Open Label Extension (OLE) Phase||35
6404877|NCT00912093|7317825|FG002|STARTED|The Open Label Extension (OLE) Phase||3
6404878|NCT00912093|7317826|FG003|STARTED|The Open Label Extension (OLE) Phase||2
6404879|NCT00912093|7317827|FG004|STARTED|The Open Label Extension (OLE) Phase||4
6404880|NCT00912093|7317823|FG000|COMPLETED|The Open Label Extension (OLE) Phase||38
6404881|NCT00912093|7317824|FG001|COMPLETED|The Open Label Extension (OLE) Phase||35
6404882|NCT00912093|7317825|FG002|COMPLETED|The Open Label Extension (OLE) Phase||3
6404883|NCT00912093|7317826|FG003|COMPLETED|The Open Label Extension (OLE) Phase||2
6404884|NCT00912093|7317827|FG004|COMPLETED|The Open Label Extension (OLE) Phase||4
6404885|NCT00912093|7317823|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6404886|NCT00912093|7317824|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6404887|NCT00912093|7317825|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6404888|NCT00912093|7317826|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6404889|NCT00912093|7317827|FG004|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
6404890|NCT00912197|7317837|FG000|STARTED|Overall Study||15
6404891|NCT00912197|7317838|FG001|STARTED|Overall Study||13
6404892|NCT00912197|7317837|FG000|COMPLETED|Overall Study||12
6404893|NCT00912197|7317838|FG001|COMPLETED|Overall Study||10
6404894|NCT00912197|7317837|FG000|NOT COMPLETED|Overall Study||3
6404895|NCT00912197|7317838|FG001|NOT COMPLETED|Overall Study||3
6404896|NCT00912288|7317848|FG000|STARTED|Overall Study||44
6404897|NCT00912288|7317849|FG001|STARTED|Overall Study||42
6404898|NCT00912288|7317848|FG000|COMPLETED|Overall Study||3
6404899|NCT00912288|7317849|FG001|COMPLETED|Overall Study||2
6404900|NCT00912288|7317848|FG000|NOT COMPLETED|Overall Study||41
6404901|NCT00912288|7317849|FG001|NOT COMPLETED|Overall Study||40
6404902|NCT00912301|7317858|FG000|STARTED|Overall Study||11
6404903|NCT00912301|7317859|FG001|STARTED|Overall Study||12
6404904|NCT00912301|7317860|FG002|STARTED|Overall Study||13
6404905|NCT00912301|7317858|FG000|COMPLETED|Overall Study||11
6404906|NCT00912301|7317859|FG001|COMPLETED|Overall Study||12
6404907|NCT00912301|7317860|FG002|COMPLETED|Overall Study||13
6404908|NCT00912301|7317858|FG000|NOT COMPLETED|Overall Study||0
6404909|NCT00912301|7317859|FG001|NOT COMPLETED|Overall Study||0
6404910|NCT00912301|7317860|FG002|NOT COMPLETED|Overall Study||0
6404911|NCT00912340|7317871|FG000|STARTED|Overall Study||24
6404912|NCT00912340|7317872|FG001|STARTED|Overall Study||30
6404913|NCT00912340|7317873|FG002|STARTED|Overall Study||4
6404914|NCT00912340|7317871|FG000|COMPLETED|Overall Study||22
6404915|NCT00912340|7317872|FG001|COMPLETED|Overall Study||26
6404916|NCT00912340|7317873|FG002|COMPLETED|Overall Study||0
6404917|NCT00912340|7317871|FG000|NOT COMPLETED|Overall Study||2
6404918|NCT00912340|7317872|FG001|NOT COMPLETED|Overall Study||4
6404919|NCT00912340|7317873|FG002|NOT COMPLETED|Overall Study||4
6404920|NCT00912405|7317881|FG000|STARTED|Overall Study||50
6404921|NCT00912405|7317881|FG000|COMPLETED|Overall Study||45
6404922|NCT00912405|7317881|FG000|NOT COMPLETED|Overall Study||5
6404923|NCT00912509|7317887|FG000|STARTED|Overall Study||20
6404924|NCT00912509|7317888|FG001|STARTED|Overall Study||10
6404925|NCT00912509|7317887|FG000|COMPLETED|Overall Study||15
6404926|NCT00912509|7317888|FG001|COMPLETED|Overall Study||7
6404927|NCT00912509|7317887|FG000|NOT COMPLETED|Overall Study||5
6404928|NCT00912509|7317888|FG001|NOT COMPLETED|Overall Study||3
6404929|NCT00912743|7317897|FG000|STARTED|Overall Study||13
6404930|NCT00912743|7317898|FG001|STARTED|Overall Study||20
6404931|NCT00912743|7317897|FG000|COMPLETED|Overall Study||0
6404932|NCT00912743|7317898|FG001|COMPLETED|Overall Study||0
6404933|NCT00912743|7317897|FG000|NOT COMPLETED|Overall Study||13
6404934|NCT00912743|7317898|FG001|NOT COMPLETED|Overall Study||20
6404935|NCT00912782|7317906|FG000|STARTED|Overall Study||27
6404936|NCT00912782|7317907|FG001|STARTED|Overall Study||25
6404937|NCT00912782|7317906|FG000|COMPLETED|Overall Study||24
6404938|NCT00912782|7317907|FG001|COMPLETED|Overall Study||20
6404939|NCT00912782|7317906|FG000|NOT COMPLETED|Overall Study||3
6404940|NCT00912782|7317907|FG001|NOT COMPLETED|Overall Study||5
6404941|NCT00912795|7317915|FG000|STARTED|Overall Study||76
6404942|NCT00912795|7317916|FG001|STARTED|Overall Study||75
6404943|NCT00912795|7317915|FG000|COMPLETED|Overall Study||29
6404944|NCT00912795|7317916|FG001|COMPLETED|Overall Study||17
6404945|NCT00912795|7317915|FG000|NOT COMPLETED|Overall Study||47
6404946|NCT00912795|7317916|FG001|NOT COMPLETED|Overall Study||58
6404947|NCT00912808|7317924|FG000|STARTED|First Intervention (6 Weeks)||11
6404948|NCT00912808|7317925|FG001|STARTED|First Intervention (6 Weeks)||12
6404949|NCT00912808|7317924|FG000|Received Intervention|First Intervention (6 Weeks)||11
6404950|NCT00912808|7317925|FG001|Received Intervention|First Intervention (6 Weeks)||12
6404951|NCT00912808|7317924|FG000|COMPLETED|First Intervention (6 Weeks)||9
6404952|NCT00912808|7317925|FG001|COMPLETED|First Intervention (6 Weeks)||11
6404953|NCT00912808|7317924|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
6404954|NCT00912808|7317925|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
6404955|NCT00912808|7317924|FG000|STARTED|Washout||9
6404956|NCT00912808|7317925|FG001|STARTED|Washout||11
6404957|NCT00912808|7317924|FG000|COMPLETED|Washout||9
6404958|NCT00912808|7317925|FG001|COMPLETED|Washout||10
6404959|NCT00912808|7317924|FG000|NOT COMPLETED|Washout||0
6404960|NCT00912808|7317925|FG001|NOT COMPLETED|Washout||1
6404961|NCT00912808|7317924|FG000|STARTED|Second Intervention (6 Weeks)||9
6404962|NCT00912808|7317925|FG001|STARTED|Second Intervention (6 Weeks)||10
6404963|NCT00912808|7317924|FG000|Received Intervention|Second Intervention (6 Weeks)||9
6404964|NCT00912808|7317925|FG001|Received Intervention|Second Intervention (6 Weeks)||10
6404965|NCT00912808|7317924|FG000|COMPLETED|Second Intervention (6 Weeks)||8
6404966|NCT00912808|7317925|FG001|COMPLETED|Second Intervention (6 Weeks)||9
6404967|NCT00912808|7317924|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||1
6404968|NCT00912808|7317925|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||1
6404969|NCT00912873|7317934|FG000|STARTED|Overall Study||26
6404970|NCT00912873|7317935|FG001|STARTED|Overall Study||24
6404971|NCT00912873|7317934|FG000|COMPLETED|Overall Study||26
6404972|NCT00912873|7317935|FG001|COMPLETED|Overall Study||24
6404973|NCT00912873|7317934|FG000|NOT COMPLETED|Overall Study||0
6404974|NCT00912873|7317935|FG001|NOT COMPLETED|Overall Study||0
6404975|NCT00912912|7317945|FG000|STARTED|Overall Study||5
6404976|NCT00912912|7317945|FG000|COMPLETED|Overall Study||1
6404977|NCT00912912|7317945|FG000|NOT COMPLETED|Overall Study||4
6404978|NCT00912925|7317951|FG000|STARTED|Overall Study||23
6404979|NCT00912925|7317952|FG001|STARTED|Overall Study||22
6404980|NCT00912925|7317951|FG000|COMPLETED|Overall Study||23
6404981|NCT00912925|7317952|FG001|COMPLETED|Overall Study||22
6404982|NCT00912925|7317951|FG000|NOT COMPLETED|Overall Study||0
6404983|NCT00912925|7317952|FG001|NOT COMPLETED|Overall Study||0
6404984|NCT00912964|7317961|FG000|STARTED|Overall Study||433
6404985|NCT00912964|7317962|FG001|STARTED|Overall Study||433
6404986|NCT00912964|7317963|FG002|STARTED|Overall Study||440
6404987|NCT00912964|7317961|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
6404988|NCT00912964|7317962|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
6404989|NCT00912964|7317963|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
6404990|NCT00912964|7317961|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
6404991|NCT00912964|7317962|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
6404992|NCT00912964|7317963|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
6404993|NCT00912964|7317961|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
6404994|NCT00912964|7317962|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
6404995|NCT00912964|7317963|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
6404996|NCT00912964|7317961|FG000|COMPLETED|Overall Study||367
6635643|NCT02305849|7564487|FG003|NOT COMPLETED|Overall Study||19
6635644|NCT02305888|7564521|FG000|STARTED|Overall Study||63
6635645|NCT02305888|7564522|FG001|STARTED|Overall Study||63
6404997|NCT00912964|7317962|FG001|COMPLETED|Overall Study||387
6404998|NCT00912964|7317963|FG002|COMPLETED|Overall Study||386
6404999|NCT00912964|7317961|FG000|NOT COMPLETED|Overall Study||66
6405000|NCT00912964|7317962|FG001|NOT COMPLETED|Overall Study||46
6405001|NCT00912964|7317963|FG002|NOT COMPLETED|Overall Study||54
6405002|NCT00912990|7317973|FG000|STARTED|Overall Study||16
6405003|NCT00912990|7317974|FG001|STARTED|Overall Study||18
6405004|NCT00912990|7317973|FG000|COMPLETED|Overall Study||16
6405005|NCT00912990|7317974|FG001|COMPLETED|Overall Study||18
6405006|NCT00912990|7317973|FG000|NOT COMPLETED|Overall Study||0
6405007|NCT00912990|7317974|FG001|NOT COMPLETED|Overall Study||0
6405008|NCT00913003|7317982|FG000|STARTED|Overall Study||11
6405009|NCT00913003|7317983|FG001|STARTED|Overall Study||11
6405010|NCT00913003|7317982|FG000|COMPLETED|Overall Study||11
6405011|NCT00913003|7317983|FG001|COMPLETED|Overall Study||11
6405012|NCT00913003|7317982|FG000|NOT COMPLETED|Overall Study||0
6405013|NCT00913003|7317983|FG001|NOT COMPLETED|Overall Study||0
6405014|NCT00913068|7317991|FG000|STARTED|Overall Study||56
6405015|NCT00913068|7317992|FG001|STARTED|Overall Study||54
6405016|NCT00913068|7317991|FG000|COMPLETED|Overall Study||48
6405017|NCT00913068|7317992|FG001|COMPLETED|Overall Study||46
6405018|NCT00913068|7317991|FG000|NOT COMPLETED|Overall Study||8
6405019|NCT00913068|7317992|FG001|NOT COMPLETED|Overall Study||8
6405020|NCT00913081|7317998|FG000|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
6405021|NCT00913081|7317998|FG000|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
6405022|NCT00913081|7317998|FG000|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
6405023|NCT00913081|7317998|FG000|STARTED|Washout #1 (7 Days)||17
6405024|NCT00913081|7317998|FG000|COMPLETED|Washout #1 (7 Days)||17
6405025|NCT00913081|7317998|FG000|NOT COMPLETED|Washout #1 (7 Days)||0
6405026|NCT00913081|7317998|FG000|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
6405027|NCT00913081|7317998|FG000|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
6405028|NCT00913081|7317998|FG000|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
6405029|NCT00913081|7317998|FG000|STARTED|Washout #2 (7 Days)||17
6405030|NCT00913081|7317998|FG000|COMPLETED|Washout #2 (7 Days)||17
6405031|NCT00913081|7317998|FG000|NOT COMPLETED|Washout #2 (7 Days)||0
6405032|NCT00913081|7317998|FG000|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
6405033|NCT00913081|7317998|FG000|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
6405034|NCT00913081|7317998|FG000|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
6405035|NCT00913081|7317998|FG000|STARTED|Washout #3 (7days)||17
6405036|NCT00913081|7317998|FG000|COMPLETED|Washout #3 (7days)||17
6405037|NCT00913081|7317998|FG000|NOT COMPLETED|Washout #3 (7days)||0
6405038|NCT00913081|7317998|FG000|STARTED|Placebo + Niacin 500 mg (1day)||17
6405039|NCT00913081|7317998|FG000|COMPLETED|Placebo + Niacin 500 mg (1day)||17
6405040|NCT00913081|7317998|FG000|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
6405041|NCT00913133|7318008|FG000|STARTED|Overall Study||516
6405042|NCT00913133|7318008|FG000|COMPLETED|Overall Study||516
6405043|NCT00913133|7318008|FG000|NOT COMPLETED|Overall Study||0
6405044|NCT00913263|7318012|FG000|STARTED|Overall Study||24
6635646|NCT02305888|7564523|FG002|STARTED|Overall Study||63
6405045|NCT00913263|7318012|FG000|COMPLETED|Overall Study||24
6405046|NCT00913263|7318012|FG000|NOT COMPLETED|Overall Study||0
6405047|NCT00913380|7318022|FG000|STARTED|CT Examination||444
6405048|NCT00913380|7318023|FG001|STARTED|CT Examination||447
6405049|NCT00913380|7318022|FG000|COMPLETED|CT Examination||444
6405050|NCT00913380|7318023|FG001|COMPLETED|CT Examination||447
6405051|NCT00913380|7318022|FG000|NOT COMPLETED|CT Examination||0
6405052|NCT00913380|7318023|FG001|NOT COMPLETED|CT Examination||0
6405053|NCT00913380|7318022|FG000|STARTED|Clinical Outcomes||444
6405054|NCT00913380|7318023|FG001|STARTED|Clinical Outcomes||447
6405055|NCT00913380|7318022|FG000|COMPLETED|Clinical Outcomes||438
6405056|NCT00913380|7318023|FG001|COMPLETED|Clinical Outcomes||441
6405057|NCT00913380|7318022|FG000|NOT COMPLETED|Clinical Outcomes||6
6405058|NCT00913380|7318023|FG001|NOT COMPLETED|Clinical Outcomes||6
6405059|NCT00913458|7318029|FG000|STARTED|Phase 1||306
6405060|NCT00913458|7318030|FG001|STARTED|Phase 1|This arm is part of Phase 2 study|0
6405061|NCT00913458|7318031|FG002|STARTED|Phase 1|This arm is part of Phase 2 study|0
6405062|NCT00913458|7318032|FG003|STARTED|Phase 1|This arm is part of Phase 2 study|0
6405063|NCT00913458|7318033|FG004|STARTED|Phase 1|This arm is part of Phase 3 study|0
6405064|NCT00913458|7318034|FG005|STARTED|Phase 1|This arm is part of Phase 3 study|0
6405065|NCT00913458|7318035|FG006|STARTED|Phase 1|This arm is part of Phase 3 study|0
6405066|NCT00913458|7318029|FG000|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
6405067|NCT00913458|7318030|FG001|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
6405068|NCT00913458|7318031|FG002|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
6405069|NCT00913458|7318032|FG003|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
6405070|NCT00913458|7318033|FG004|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
6405071|NCT00913458|7318034|FG005|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
6405072|NCT00913458|7318035|FG006|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
6405073|NCT00913458|7318029|FG000|NOT COMPLETED|Phase 1||112
6405074|NCT00913458|7318030|FG001|NOT COMPLETED|Phase 1||0
6405075|NCT00913458|7318031|FG002|NOT COMPLETED|Phase 1||0
6405076|NCT00913458|7318032|FG003|NOT COMPLETED|Phase 1||0
6405077|NCT00913458|7318033|FG004|NOT COMPLETED|Phase 1||0
6405078|NCT00913458|7318034|FG005|NOT COMPLETED|Phase 1||0
6405079|NCT00913458|7318035|FG006|NOT COMPLETED|Phase 1||0
6405080|NCT00913458|7318029|FG000|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
6405081|NCT00913458|7318030|FG001|STARTED|Phase 2||63
6405082|NCT00913458|7318031|FG002|STARTED|Phase 2||65
6405083|NCT00913458|7318032|FG003|STARTED|Phase 2||65
6405084|NCT00913458|7318033|FG004|STARTED|Phase 2||0
6405085|NCT00913458|7318034|FG005|STARTED|Phase 2||0
6405086|NCT00913458|7318035|FG006|STARTED|Phase 2||0
6405087|NCT00913458|7318029|FG000|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
6405088|NCT00913458|7318030|FG001|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
6405089|NCT00913458|7318031|FG002|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
6405090|NCT00913458|7318032|FG003|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
6405091|NCT00913458|7318033|FG004|COMPLETED|Phase 2||0
6405092|NCT00913458|7318034|FG005|COMPLETED|Phase 2||0
6405093|NCT00913458|7318035|FG006|COMPLETED|Phase 2||0
6405094|NCT00913458|7318029|FG000|NOT COMPLETED|Phase 2||0
6405095|NCT00913458|7318030|FG001|NOT COMPLETED|Phase 2||10
6405096|NCT00913458|7318031|FG002|NOT COMPLETED|Phase 2||19
6405097|NCT00913458|7318032|FG003|NOT COMPLETED|Phase 2||33
6405098|NCT00913458|7318033|FG004|NOT COMPLETED|Phase 2||0
6405099|NCT00913458|7318034|FG005|NOT COMPLETED|Phase 2||0
6405100|NCT00913458|7318035|FG006|NOT COMPLETED|Phase 2||0
6405101|NCT00913458|7318029|FG000|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
6405102|NCT00913458|7318030|FG001|STARTED|Phase 3||0
6405103|NCT00913458|7318031|FG002|STARTED|Phase 3||0
6405104|NCT00913458|7318032|FG003|STARTED|Phase 3||0
6405105|NCT00913458|7318033|FG004|STARTED|Phase 3|Participants who completed Phase 2 study|53
6405106|NCT00913458|7318034|FG005|STARTED|Phase 3|Participants who completed Phase 2 study|46
6405107|NCT00913458|7318035|FG006|STARTED|Phase 3|Participants who completed Phase 2 study|32
6405108|NCT00913458|7318029|FG000|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
6405109|NCT00913458|7318030|FG001|COMPLETED|Phase 3||0
6405110|NCT00913458|7318031|FG002|COMPLETED|Phase 3||0
6405111|NCT00913458|7318032|FG003|COMPLETED|Phase 3||0
6405112|NCT00913458|7318033|FG004|COMPLETED|Phase 3||31
6405113|NCT00913458|7318034|FG005|COMPLETED|Phase 3||28
6405114|NCT00913458|7318035|FG006|COMPLETED|Phase 3||24
6405115|NCT00913458|7318029|FG000|NOT COMPLETED|Phase 3||0
6405116|NCT00913458|7318030|FG001|NOT COMPLETED|Phase 3||0
6405117|NCT00913458|7318031|FG002|NOT COMPLETED|Phase 3||0
6405118|NCT00913458|7318032|FG003|NOT COMPLETED|Phase 3||0
6405119|NCT00913458|7318033|FG004|NOT COMPLETED|Phase 3||22
6405120|NCT00913458|7318034|FG005|NOT COMPLETED|Phase 3||18
6405121|NCT00913458|7318035|FG006|NOT COMPLETED|Phase 3||8
6405122|NCT00913510|7318054|FG000|STARTED|Overall Study||13
6405123|NCT00913510|7318055|FG001|STARTED|Overall Study||7
6405124|NCT00913510|7318054|FG000|COMPLETED|Overall Study||5
6405125|NCT00913510|7318055|FG001|COMPLETED|Overall Study||3
6405126|NCT00913510|7318054|FG000|NOT COMPLETED|Overall Study||8
6405127|NCT00913510|7318055|FG001|NOT COMPLETED|Overall Study||4
6405128|NCT00913523|7318064|FG000|STARTED|Overall Study||162
6405129|NCT00913523|7318065|FG001|STARTED|Overall Study||159
6405130|NCT00913523|7318066|FG002|STARTED|Overall Study||161
6405131|NCT00913523|7318064|FG000|COMPLETED|Overall Study||144
6405132|NCT00913523|7318065|FG001|COMPLETED|Overall Study||143
6405133|NCT00913523|7318066|FG002|COMPLETED|Overall Study||147
6405134|NCT00913523|7318064|FG000|NOT COMPLETED|Overall Study||18
6405135|NCT00913523|7318065|FG001|NOT COMPLETED|Overall Study||16
6405136|NCT00913523|7318066|FG002|NOT COMPLETED|Overall Study||14
6405137|NCT00913627|7318078|FG000|STARTED|Overall Study||29
6405138|NCT00913627|7318079|FG001|STARTED|Overall Study||53
6405139|NCT00913627|7318080|FG002|STARTED|Overall Study||56
6405140|NCT00913627|7318081|FG003|STARTED|Overall Study||58
6405141|NCT00913627|7318078|FG000|COMPLETED|Overall Study||29
6405142|NCT00913627|7318079|FG001|COMPLETED|Overall Study||53
6405143|NCT00913627|7318080|FG002|COMPLETED|Overall Study||56
6405144|NCT00913627|7318081|FG003|COMPLETED|Overall Study||58
6405145|NCT00913627|7318078|FG000|NOT COMPLETED|Overall Study||0
6405146|NCT00913627|7318079|FG001|NOT COMPLETED|Overall Study||0
6405147|NCT00913627|7318080|FG002|NOT COMPLETED|Overall Study||0
6405148|NCT00913627|7318081|FG003|NOT COMPLETED|Overall Study||0
6405149|NCT00913744|7318093|FG000|STARTED|Overall Study||75
6405150|NCT00913744|7318094|FG001|STARTED|Overall Study||25
6405151|NCT00913744|7318093|FG000|COMPLETED|Overall Study||70
6405152|NCT00913744|7318094|FG001|COMPLETED|Overall Study||24
6405153|NCT00913744|7318093|FG000|NOT COMPLETED|Overall Study||5
6405154|NCT00913744|7318094|FG001|NOT COMPLETED|Overall Study||1
6405155|NCT00913770|7318103|FG000|STARTED|Overall Study||104
6405156|NCT00913770|7318104|FG001|STARTED|Overall Study||111
6405157|NCT00913770|7318105|FG002|STARTED|Overall Study||114
6405158|NCT00913770|7318103|FG000|COMPLETED|Overall Study||69
6405159|NCT00913770|7318104|FG001|COMPLETED|Overall Study||82
6405160|NCT00913770|7318105|FG002|COMPLETED|Overall Study||93
6405161|NCT00913770|7318103|FG000|NOT COMPLETED|Overall Study||35
6405162|NCT00913770|7318104|FG001|NOT COMPLETED|Overall Study||29
6405163|NCT00913770|7318105|FG002|NOT COMPLETED|Overall Study||21
6405164|NCT00913835|7318115|FG000|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
6405165|NCT00913835|7318116|FG001|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
6405166|NCT00913835|7318115|FG000|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
6405167|NCT00913835|7318116|FG001|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
6405168|NCT00913835|7318115|FG000|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
6405169|NCT00913835|7318116|FG001|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
6405170|NCT00913835|7318115|FG000|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
6405171|NCT00913835|7318116|FG001|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
6405172|NCT00913835|7318115|FG000|STARTED|Lip Dox: Olaratumab Monotherapy||0
6405173|NCT00913835|7318116|FG001|STARTED|Lip Dox: Olaratumab Monotherapy||28
6405174|NCT00913835|7318115|FG000|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
6405175|NCT00913835|7318116|FG001|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
6405176|NCT00913835|7318115|FG000|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
6405177|NCT00913835|7318116|FG001|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
6405178|NCT00913835|7318115|FG000|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
6405179|NCT00913835|7318116|FG001|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
6405180|NCT00913913|7318129|FG000|STARTED|Overall Study||8
6405181|NCT00913913|7318129|FG000|COMPLETED|Overall Study||0
6405182|NCT00913913|7318129|FG000|NOT COMPLETED|Overall Study||8
6405183|NCT00913978|7318135|FG000|STARTED|Overall Study||26
6405184|NCT00913978|7318136|FG001|STARTED|Overall Study||24
6405185|NCT00913978|7318135|FG000|COMPLETED|Overall Study||25
6405186|NCT00913978|7318136|FG001|COMPLETED|Overall Study||21
6405187|NCT00913978|7318135|FG000|NOT COMPLETED|Overall Study||1
6405188|NCT00913978|7318136|FG001|NOT COMPLETED|Overall Study||3
6405189|NCT00914069|7318144|FG000|STARTED|Overall Study||84
6405190|NCT00914069|7318145|FG001|STARTED|Overall Study||88
6405191|NCT00914069|7318144|FG000|COMPLETED|Overall Study||84
6405192|NCT00914069|7318145|FG001|COMPLETED|Overall Study||88
6405193|NCT00914069|7318144|FG000|NOT COMPLETED|Overall Study||0
6405194|NCT00914069|7318145|FG001|NOT COMPLETED|Overall Study||0
6405195|NCT00914186|7318155|FG000|STARTED|Overall Study||31
6405196|NCT00914186|7318156|FG001|STARTED|Overall Study||30
6405197|NCT00914186|7318157|FG002|STARTED|Overall Study||31
6405198|NCT00914186|7318158|FG003|STARTED|Overall Study||30
6405199|NCT00914186|7318155|FG000|COMPLETED|Overall Study||28
6405200|NCT00914186|7318156|FG001|COMPLETED|Overall Study||28
6405201|NCT00914186|7318157|FG002|COMPLETED|Overall Study||29
6405202|NCT00914186|7318158|FG003|COMPLETED|Overall Study||20
6405203|NCT00914186|7318155|FG000|NOT COMPLETED|Overall Study||3
6405204|NCT00914186|7318156|FG001|NOT COMPLETED|Overall Study||2
6405205|NCT00914186|7318157|FG002|NOT COMPLETED|Overall Study||2
6405206|NCT00914186|7318158|FG003|NOT COMPLETED|Overall Study||10
6405207|NCT00914316|7318173|FG000|STARTED|Phase 1||7
6405208|NCT00914316|7318174|FG001|STARTED|Phase 1||6
6405209|NCT00914316|7318175|FG002|STARTED|Phase 1||8
6405210|NCT00914316|7318176|FG003|STARTED|Phase 1||8
6405211|NCT00914316|7318173|FG000|COMPLETED|Phase 1||2
6405212|NCT00914316|7318174|FG001|COMPLETED|Phase 1||4
6405213|NCT00914316|7318175|FG002|COMPLETED|Phase 1||3
6405214|NCT00914316|7318176|FG003|COMPLETED|Phase 1||6
6405215|NCT00914316|7318173|FG000|NOT COMPLETED|Phase 1||5
6405216|NCT00914316|7318174|FG001|NOT COMPLETED|Phase 1||2
6405217|NCT00914316|7318175|FG002|NOT COMPLETED|Phase 1||5
6405218|NCT00914316|7318176|FG003|NOT COMPLETED|Phase 1||2
6405219|NCT00914316|7318173|FG000|STARTED|Phase 2||2
6405220|NCT00914316|7318174|FG001|STARTED|Phase 2||4
6405221|NCT00914316|7318175|FG002|STARTED|Phase 2||3
6405222|NCT00914316|7318176|FG003|STARTED|Phase 2||6
6405223|NCT00914316|7318173|FG000|COMPLETED|Phase 2||1
6405224|NCT00914316|7318174|FG001|COMPLETED|Phase 2||4
6405225|NCT00914316|7318175|FG002|COMPLETED|Phase 2||2
6405226|NCT00914316|7318176|FG003|COMPLETED|Phase 2||6
6405227|NCT00914316|7318173|FG000|NOT COMPLETED|Phase 2||1
6405228|NCT00914316|7318174|FG001|NOT COMPLETED|Phase 2||0
6405229|NCT00914316|7318175|FG002|NOT COMPLETED|Phase 2||1
6405230|NCT00914316|7318176|FG003|NOT COMPLETED|Phase 2||0
6405231|NCT00914459|7318188|FG000|STARTED|Overall Study||18
6405232|NCT00914459|7318189|FG001|STARTED|Overall Study||19
6405233|NCT00914459|7318188|FG000|COMPLETED|Overall Study||17
6405234|NCT00914459|7318189|FG001|COMPLETED|Overall Study||18
6405235|NCT00914459|7318188|FG000|NOT COMPLETED|Overall Study||1
6405236|NCT00914459|7318189|FG001|NOT COMPLETED|Overall Study||1
6405237|NCT00914485|7318197|FG000|STARTED|Overall Study||369
6405238|NCT00914485|7318197|FG000|COMPLETED|Overall Study||369
6405239|NCT00914485|7318197|FG000|NOT COMPLETED|Overall Study||0
6405240|NCT00914589|7318204|FG000|STARTED|Overall Study||128
6405241|NCT00914589|7318205|FG001|STARTED|Overall Study||143
6405242|NCT00914589|7318206|FG002|STARTED|Overall Study||138
6405243|NCT00914589|7318204|FG000|COMPLETED|Overall Study||103
6405244|NCT00914589|7318205|FG001|COMPLETED|Overall Study||127
6635647|NCT02305888|7564521|FG000|COMPLETED|Overall Study||63
6635648|NCT02305888|7564522|FG001|COMPLETED|Overall Study||62
6635649|NCT02305888|7564523|FG002|COMPLETED|Overall Study||62
6635650|NCT02305888|7564521|FG000|NOT COMPLETED|Overall Study||0
6635651|NCT02305888|7564522|FG001|NOT COMPLETED|Overall Study||1
6635652|NCT02305888|7564523|FG002|NOT COMPLETED|Overall Study||1
6635653|NCT02306265|7564531|FG000|STARTED|Overall Study||250
6635654|NCT02306265|7564531|FG000|COMPLETED|Overall Study||249
6635655|NCT02306265|7564531|FG000|NOT COMPLETED|Overall Study||1
6635656|NCT02306694|7564536|FG000|STARTED|Overall Study||16
6405245|NCT00914589|7318206|FG002|COMPLETED|Overall Study||126
6405246|NCT00914589|7318204|FG000|NOT COMPLETED|Overall Study||25
6405247|NCT00914589|7318205|FG001|NOT COMPLETED|Overall Study||16
6405248|NCT00914589|7318206|FG002|NOT COMPLETED|Overall Study||12
6405249|NCT00914628|7318216|FG000|STARTED|Overall Study|Referred to all randomized patient|64
6405250|NCT00914628|7318217|FG001|STARTED|Overall Study|Referred to all randomized patient|28
6405251|NCT00914628|7318216|FG000|COMPLETED|Overall Study|Early termination of the Study|0
6405252|NCT00914628|7318217|FG001|COMPLETED|Overall Study|Early termination of the Study|0
6405253|NCT00914628|7318216|FG000|NOT COMPLETED|Overall Study||64
6405254|NCT00914628|7318217|FG001|NOT COMPLETED|Overall Study||28
6405255|NCT00914732|7318230|FG000|STARTED|Overall Study||165
6405256|NCT00914732|7318231|FG001|STARTED|Overall Study||167
6405257|NCT00914732|7318232|FG002|STARTED|Overall Study||191
6405258|NCT00914732|7318230|FG000|Received Second Vaccination|Overall Study||150
6405259|NCT00914732|7318231|FG001|Received Second Vaccination|Overall Study||157
6405260|NCT00914732|7318232|FG002|Received Second Vaccination|Overall Study||153
6405261|NCT00914732|7318230|FG000|COMPLETED|Overall Study||155
6405262|NCT00914732|7318231|FG001|COMPLETED|Overall Study||160
6405263|NCT00914732|7318232|FG002|COMPLETED|Overall Study||180
6405264|NCT00914732|7318230|FG000|NOT COMPLETED|Overall Study||10
6405265|NCT00914732|7318231|FG001|NOT COMPLETED|Overall Study||7
6405266|NCT00914732|7318232|FG002|NOT COMPLETED|Overall Study||11
6405267|NCT00914810|7318243|FG000|STARTED|Overall Study||20
6405268|NCT00914810|7318244|FG001|STARTED|Overall Study||19
6405269|NCT00914810|7318243|FG000|COMPLETED|Overall Study||18
6405270|NCT00914810|7318244|FG001|COMPLETED|Overall Study||18
6405271|NCT00914810|7318243|FG000|NOT COMPLETED|Overall Study||2
6405272|NCT00914810|7318244|FG001|NOT COMPLETED|Overall Study||1
6405273|NCT00914849|7318252|FG000|STARTED|Overall Study||34
6405274|NCT00914849|7318253|FG001|STARTED|Overall Study||34
6405275|NCT00914849|7318252|FG000|COMPLETED|Overall Study||33
6405276|NCT00914849|7318253|FG001|COMPLETED|Overall Study||33
6405277|NCT00914849|7318252|FG000|NOT COMPLETED|Overall Study||1
6405278|NCT00914849|7318253|FG001|NOT COMPLETED|Overall Study||1
6405279|NCT00914862|7318264|FG000|STARTED|Overall Study||6
6405280|NCT00914862|7318265|FG001|STARTED|Overall Study||6
6405281|NCT00914862|7318266|FG002|STARTED|Overall Study||8
6405282|NCT00914862|7318267|FG003|STARTED|Overall Study||8
6405283|NCT00914862|7318268|FG004|STARTED|Overall Study||28
6405284|NCT00914862|7318264|FG000|COMPLETED|Overall Study||6
6405285|NCT00914862|7318265|FG001|COMPLETED|Overall Study||6
6405286|NCT00914862|7318266|FG002|COMPLETED|Overall Study||8
6405287|NCT00914862|7318267|FG003|COMPLETED|Overall Study||8
6405288|NCT00914862|7318268|FG004|COMPLETED|Overall Study||28
6405289|NCT00914862|7318264|FG000|NOT COMPLETED|Overall Study||0
6405290|NCT00914862|7318265|FG001|NOT COMPLETED|Overall Study||0
6405291|NCT00914862|7318266|FG002|NOT COMPLETED|Overall Study||0
6405292|NCT00914862|7318267|FG003|NOT COMPLETED|Overall Study||0
6405293|NCT00914862|7318268|FG004|NOT COMPLETED|Overall Study||0
6405294|NCT00914927|7318287|FG000|STARTED|Overall Study||18
6405295|NCT00914927|7318288|FG001|STARTED|Overall Study||16
6405296|NCT00914927|7318289|FG002|STARTED|Overall Study||17
6405297|NCT00914927|7318290|FG003|STARTED|Overall Study||16
6405298|NCT00914927|7318291|FG004|STARTED|Overall Study||21
6405299|NCT00914927|7318292|FG005|STARTED|Overall Study||21
6635657|NCT02306694|7564536|FG000|COMPLETED|Overall Study||12
6405300|NCT00914927|7318293|FG006|STARTED|Overall Study||21
6405301|NCT00914927|7318287|FG000|COMPLETED|Overall Study||16
6405302|NCT00914927|7318288|FG001|COMPLETED|Overall Study||14
6635658|NCT02306694|7564536|FG000|NOT COMPLETED|Overall Study||4
6405303|NCT00914927|7318289|FG002|COMPLETED|Overall Study||17
6405304|NCT00914927|7318290|FG003|COMPLETED|Overall Study||14
6405305|NCT00914927|7318291|FG004|COMPLETED|Overall Study||19
6405306|NCT00914927|7318292|FG005|COMPLETED|Overall Study||21
6405307|NCT00914927|7318293|FG006|COMPLETED|Overall Study||21
6405308|NCT00914927|7318287|FG000|NOT COMPLETED|Overall Study||2
6405309|NCT00914927|7318288|FG001|NOT COMPLETED|Overall Study||2
6405310|NCT00914927|7318289|FG002|NOT COMPLETED|Overall Study||0
6405311|NCT00914927|7318290|FG003|NOT COMPLETED|Overall Study||2
6405312|NCT00914927|7318291|FG004|NOT COMPLETED|Overall Study||2
6405313|NCT00914927|7318292|FG005|NOT COMPLETED|Overall Study||0
6405314|NCT00914927|7318293|FG006|NOT COMPLETED|Overall Study||0
6405315|NCT00914940|7318318|FG000|STARTED|D0 to D100 Post-transplant||41
6405316|NCT00914940|7318318|FG000|COMPLETED|D0 to D100 Post-transplant||39
6405317|NCT00914940|7318318|FG000|NOT COMPLETED|D0 to D100 Post-transplant||2
6405318|NCT00914940|7318318|FG000|STARTED|D101 to 2 Years Post-transplant||39
6405319|NCT00914940|7318318|FG000|COMPLETED|D101 to 2 Years Post-transplant||31
6405320|NCT00914940|7318318|FG000|NOT COMPLETED|D101 to 2 Years Post-transplant||8
6405321|NCT00914940|7318318|FG000|STARTED|2 Years to 5 Years Post-transplant||31
6405322|NCT00914940|7318318|FG000|COMPLETED|2 Years to 5 Years Post-transplant||28
6405323|NCT00914940|7318318|FG000|NOT COMPLETED|2 Years to 5 Years Post-transplant||3
6405324|NCT00914966|7318322|FG000|STARTED|Step 1: 1500 Units||20
6405325|NCT00914966|7318322|FG000|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
6405326|NCT00914966|7318322|FG000|NOT COMPLETED|Step 1: 1500 Units||2
6405327|NCT00914966|7318322|FG000|STARTED|Step 2: 2000 Units||13
6405328|NCT00914966|7318322|FG000|COMPLETED|Step 2: 2000 Units||12
6405329|NCT00914966|7318322|FG000|NOT COMPLETED|Step 2: 2000 Units||1
6405330|NCT00914966|7318322|FG000|STARTED|Step 3: 2500 Units||12
6405331|NCT00914966|7318322|FG000|COMPLETED|Step 3: 2500 Units||12
6405332|NCT00914966|7318322|FG000|NOT COMPLETED|Step 3: 2500 Units||0
6405333|NCT00915005|7318333|FG000|STARTED|Overall Study||105
6405334|NCT00915005|7318334|FG001|STARTED|Overall Study||76
6405335|NCT00915005|7318333|FG000|COMPLETED|Overall Study||92
6405336|NCT00915005|7318334|FG001|COMPLETED|Overall Study||57
6405337|NCT00915005|7318333|FG000|NOT COMPLETED|Overall Study||13
6405338|NCT00915005|7318334|FG001|NOT COMPLETED|Overall Study||19
6405339|NCT00915018|7318342|FG000|STARTED|Overall Study||242
6405340|NCT00915018|7318343|FG001|STARTED|Overall Study||237
6405341|NCT00915018|7318342|FG000|Received Treatment|Overall Study||240
6405342|NCT00915018|7318343|FG001|Received Treatment|Overall Study||234
6405343|NCT00915018|7318342|FG000|COMPLETED|Overall Study||27
6405344|NCT00915018|7318343|FG001|COMPLETED|Overall Study||30
6405345|NCT00915018|7318342|FG000|NOT COMPLETED|Overall Study||215
6405346|NCT00915018|7318343|FG001|NOT COMPLETED|Overall Study||207
6405347|NCT00915031|7318351|FG000|STARTED|Overall Study||714
6405348|NCT00915031|7318352|FG001|STARTED|Overall Study||24
6405349|NCT00915031|7318351|FG000|COMPLETED|Overall Study||714
6405350|NCT00915031|7318352|FG001|COMPLETED|Overall Study||24
6405351|NCT00915031|7318351|FG000|NOT COMPLETED|Overall Study||0
6405352|NCT00915031|7318352|FG001|NOT COMPLETED|Overall Study||0
6405353|NCT00915148|7318357|FG000|STARTED|Overall Study|October 2009|110
6405354|NCT00915148|7318357|FG000|COMPLETED|Overall Study|August 2010|110
6405355|NCT00915148|7318357|FG000|NOT COMPLETED|Overall Study||0
6405356|NCT00915278|7318368|FG000|STARTED|Overall Study||8
6405357|NCT00915278|7318369|FG001|STARTED|Overall Study||5
6405358|NCT00915278|7318370|FG002|STARTED|Overall Study||3
6405359|NCT00915278|7318371|FG003|STARTED|Overall Study||5
6405360|NCT00915278|7318372|FG004|STARTED|Overall Study||3
6405361|NCT00915278|7318373|FG005|STARTED|Overall Study||9
6405362|NCT00915278|7318368|FG000|COMPLETED|Overall Study||3
6405363|NCT00915278|7318369|FG001|COMPLETED|Overall Study||2
6405364|NCT00915278|7318370|FG002|COMPLETED|Overall Study||2
6405365|NCT00915278|7318371|FG003|COMPLETED|Overall Study||2
6405366|NCT00915278|7318372|FG004|COMPLETED|Overall Study||1
6405367|NCT00915278|7318373|FG005|COMPLETED|Overall Study||1
6405368|NCT00915278|7318368|FG000|NOT COMPLETED|Overall Study||5
6405369|NCT00915278|7318369|FG001|NOT COMPLETED|Overall Study||3
6405370|NCT00915278|7318370|FG002|NOT COMPLETED|Overall Study||1
6405371|NCT00915278|7318371|FG003|NOT COMPLETED|Overall Study||3
6405372|NCT00915278|7318372|FG004|NOT COMPLETED|Overall Study||2
6405373|NCT00915278|7318373|FG005|NOT COMPLETED|Overall Study||8
6405374|NCT00915343|7318387|FG000|STARTED|Part A - First Intervention Period||32
6405375|NCT00915343|7318388|FG001|STARTED|Part A - First Intervention Period||32
6405376|NCT00915343|7318389|FG002|STARTED|Part A - First Intervention Period||0
6405377|NCT00915343|7318387|FG000|COMPLETED|Part A - First Intervention Period||32
6405378|NCT00915343|7318388|FG001|COMPLETED|Part A - First Intervention Period||32
6405379|NCT00915343|7318389|FG002|COMPLETED|Part A - First Intervention Period||0
6405380|NCT00915343|7318387|FG000|NOT COMPLETED|Part A - First Intervention Period||0
6405381|NCT00915343|7318388|FG001|NOT COMPLETED|Part A - First Intervention Period||0
6405382|NCT00915343|7318389|FG002|NOT COMPLETED|Part A - First Intervention Period||0
6405383|NCT00915343|7318387|FG000|STARTED|Part A - Second Intervention Period||32
6405384|NCT00915343|7318388|FG001|STARTED|Part A - Second Intervention Period||32
6405385|NCT00915343|7318389|FG002|STARTED|Part A - Second Intervention Period||0
6405386|NCT00915343|7318387|FG000|COMPLETED|Part A - Second Intervention Period||32
6405387|NCT00915343|7318388|FG001|COMPLETED|Part A - Second Intervention Period||32
6405388|NCT00915343|7318389|FG002|COMPLETED|Part A - Second Intervention Period||0
6405389|NCT00915343|7318387|FG000|NOT COMPLETED|Part A - Second Intervention Period||0
6405390|NCT00915343|7318388|FG001|NOT COMPLETED|Part A - Second Intervention Period||0
6405391|NCT00915343|7318389|FG002|NOT COMPLETED|Part A - Second Intervention Period||0
6405392|NCT00915343|7318387|FG000|STARTED|Part B - Open Label Period||0
6405393|NCT00915343|7318388|FG001|STARTED|Part B - Open Label Period||0
6405394|NCT00915343|7318389|FG002|STARTED|Part B - Open Label Period||59
6405395|NCT00915343|7318387|FG000|COMPLETED|Part B - Open Label Period||0
6405396|NCT00915343|7318388|FG001|COMPLETED|Part B - Open Label Period||0
6405397|NCT00915343|7318389|FG002|COMPLETED|Part B - Open Label Period||57
6405398|NCT00915343|7318387|FG000|NOT COMPLETED|Part B - Open Label Period||0
6405399|NCT00915343|7318388|FG001|NOT COMPLETED|Part B - Open Label Period||0
6405400|NCT00915343|7318389|FG002|NOT COMPLETED|Part B - Open Label Period||2
6405401|NCT00915356|7318406|FG000|STARTED|Overall Study||26
6405402|NCT00915356|7318407|FG001|STARTED|Overall Study||45
6405403|NCT00915356|7318408|FG002|STARTED|Overall Study||45
6405404|NCT00915356|7318409|FG003|STARTED|Overall Study||12
6405405|NCT00915356|7318410|FG004|STARTED|Overall Study||43
6405406|NCT00915356|7318406|FG000|COMPLETED|Overall Study||25
6405407|NCT00915356|7318407|FG001|COMPLETED|Overall Study||45
6405408|NCT00915356|7318408|FG002|COMPLETED|Overall Study||45
6405409|NCT00915356|7318409|FG003|COMPLETED|Overall Study||12
6405410|NCT00915356|7318410|FG004|COMPLETED|Overall Study||43
6405411|NCT00915356|7318406|FG000|NOT COMPLETED|Overall Study||1
6405412|NCT00915356|7318407|FG001|NOT COMPLETED|Overall Study||0
6405413|NCT00915356|7318408|FG002|NOT COMPLETED|Overall Study||0
6405414|NCT00915356|7318409|FG003|NOT COMPLETED|Overall Study||0
6405415|NCT00915356|7318410|FG004|NOT COMPLETED|Overall Study||0
6405416|NCT00915473|7318424|FG000|STARTED|Screening||35
6405417|NCT00915473|7318425|FG001|STARTED|Screening||35
6405418|NCT00915473|7318424|FG000|COMPLETED|Screening||34
6405419|NCT00915473|7318425|FG001|COMPLETED|Screening||35
6405420|NCT00915473|7318424|FG000|NOT COMPLETED|Screening||1
6405421|NCT00915473|7318425|FG001|NOT COMPLETED|Screening||0
6405422|NCT00915473|7318424|FG000|STARTED|Injection||34
6405423|NCT00915473|7318425|FG001|STARTED|Injection||35
6405424|NCT00915473|7318424|FG000|COMPLETED|Injection||34
6405425|NCT00915473|7318425|FG001|COMPLETED|Injection||35
6405426|NCT00915473|7318424|FG000|NOT COMPLETED|Injection||0
6405427|NCT00915473|7318425|FG001|NOT COMPLETED|Injection||0
6405428|NCT00915473|7318424|FG000|STARTED|4-week Follow Up||34
6405429|NCT00915473|7318425|FG001|STARTED|4-week Follow Up||35
6405430|NCT00915473|7318424|FG000|COMPLETED|4-week Follow Up||33
6405431|NCT00915473|7318425|FG001|COMPLETED|4-week Follow Up||30
6405432|NCT00915473|7318424|FG000|NOT COMPLETED|4-week Follow Up||1
6405433|NCT00915473|7318425|FG001|NOT COMPLETED|4-week Follow Up||5
6405434|NCT00915499|7318433|FG000|STARTED|Overall Study||33
6405435|NCT00915499|7318434|FG001|STARTED|Overall Study||33
6405436|NCT00915499|7318433|FG000|COMPLETED|Overall Study||29
6405437|NCT00915499|7318434|FG001|COMPLETED|Overall Study||31
6405438|NCT00915499|7318433|FG000|NOT COMPLETED|Overall Study||4
6405439|NCT00915499|7318434|FG001|NOT COMPLETED|Overall Study||2
6405440|NCT00915525|7318442|FG000|STARTED|Overall Study||543
6405441|NCT00915525|7318443|FG001|STARTED|Overall Study||286
6405442|NCT00915525|7318442|FG000|COMPLETED|Overall Study||278
6405443|NCT00915525|7318443|FG001|COMPLETED|Overall Study||151
6405444|NCT00915525|7318442|FG000|NOT COMPLETED|Overall Study||265
6405445|NCT00915525|7318443|FG001|NOT COMPLETED|Overall Study||135
6405446|NCT00915538|7318471|FG000|STARTED|Overall Study||8
6405447|NCT00915538|7318472|FG001|STARTED|Overall Study||8
6405448|NCT00915538|7318471|FG000|COMPLETED|Overall Study||8
6405449|NCT00915538|7318472|FG001|COMPLETED|Overall Study||8
6405450|NCT00915538|7318471|FG000|NOT COMPLETED|Overall Study||0
6405451|NCT00915538|7318472|FG001|NOT COMPLETED|Overall Study||0
6405452|NCT00915551|7318482|FG000|STARTED|Overall Study||142
6405453|NCT00915551|7318483|FG001|STARTED|Overall Study||136
6405454|NCT00915551|7318482|FG000|COMPLETED|Overall Study||142
6405455|NCT00915551|7318483|FG001|COMPLETED|Overall Study||135
6405456|NCT00915551|7318482|FG000|NOT COMPLETED|Overall Study||0
6405457|NCT00915551|7318483|FG001|NOT COMPLETED|Overall Study||1
6405458|NCT00915590|7318491|FG000|STARTED|Overall Study||5
6405459|NCT00915590|7318492|FG001|STARTED|Overall Study||5
6405460|NCT00915590|7318491|FG000|COMPLETED|Overall Study||3
6405461|NCT00915590|7318492|FG001|COMPLETED|Overall Study||4
6405462|NCT00915590|7318491|FG000|NOT COMPLETED|Overall Study||2
6405463|NCT00915590|7318492|FG001|NOT COMPLETED|Overall Study||1
6405464|NCT00915603|7318505|FG000|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
6405465|NCT00915603|7318506|FG001|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
6405466|NCT00915603|7318505|FG000|COMPLETED|Overall Study||0
6405467|NCT00915603|7318506|FG001|COMPLETED|Overall Study||0
6405468|NCT00915603|7318505|FG000|NOT COMPLETED|Overall Study||56
6405469|NCT00915603|7318506|FG001|NOT COMPLETED|Overall Study||55
6405470|NCT00915655|7318512|FG000|STARTED|Overall Study||12
6405471|NCT00915655|7318512|FG000|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
6405472|NCT00915655|7318512|FG000|NOT COMPLETED|Overall Study||0
6405473|NCT00915759|7318516|FG000|STARTED|Overall Study|number of participants|40
6405474|NCT00915759|7318516|FG000|COMPLETED|Overall Study|number of participants|40
6405475|NCT00915759|7318516|FG000|NOT COMPLETED|Overall Study||0
6405476|NCT00915772|7318529|FG000|STARTED|Overall Study||170
6405477|NCT00915772|7318530|FG001|STARTED|Overall Study||225
6405478|NCT00915772|7318531|FG002|STARTED|Overall Study||171
6405479|NCT00915772|7318529|FG000|COMPLETED|Overall Study||134
6405480|NCT00915772|7318530|FG001|COMPLETED|Overall Study||179
6405481|NCT00915772|7318531|FG002|COMPLETED|Overall Study||142
6405482|NCT00915772|7318529|FG000|NOT COMPLETED|Overall Study||36
6405483|NCT00915772|7318530|FG001|NOT COMPLETED|Overall Study||46
6405484|NCT00915772|7318531|FG002|NOT COMPLETED|Overall Study||29
6498773|NCT01412281|7417394|FG003|COMPLETED|Overall Study||110
6498774|NCT01412281|7417391|FG000|NOT COMPLETED|Overall Study||0
6498775|NCT01412281|7417392|FG001|NOT COMPLETED|Overall Study||0
6498776|NCT01412281|7417393|FG002|NOT COMPLETED|Overall Study||0
6498777|NCT01412281|7417394|FG003|NOT COMPLETED|Overall Study||0
6498778|NCT01412372|7417406|FG000|STARTED|Overall Study||30
6498779|NCT01412372|7417407|FG001|STARTED|Overall Study||31
6498780|NCT01412372|7417406|FG000|COMPLETED|Overall Study||26
6498781|NCT01412372|7417407|FG001|COMPLETED|Overall Study||28
6498782|NCT01412372|7417406|FG000|NOT COMPLETED|Overall Study||4
6498783|NCT01412372|7417407|FG001|NOT COMPLETED|Overall Study||3
6498784|NCT01412424|7417413|FG000|STARTED|Core Treatment Period||155
6498785|NCT01412424|7417413|FG000|COMPLETED|Core Treatment Period||102
6498786|NCT01412424|7417413|FG000|NOT COMPLETED|Core Treatment Period||53
6498787|NCT01412424|7417413|FG000|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
6498788|NCT01412424|7417413|FG000|COMPLETED|Extension Treatment Period||82
6498789|NCT01412424|7417413|FG000|NOT COMPLETED|Extension Treatment Period||6
6498790|NCT01412541|7417425|FG000|STARTED|Overall Study||372
6498791|NCT01412541|7417426|FG001|STARTED|Overall Study||160
6498792|NCT01412541|7417425|FG000|COMPLETED|Overall Study||246
6510260|NCT01480284|7429815|FG001|STARTED|Overall Study||56
6510261|NCT01480284|7429814|FG000|COMPLETED|Overall Study||102
6510262|NCT01480284|7429815|FG001|COMPLETED|Overall Study||56
6510263|NCT01480284|7429814|FG000|NOT COMPLETED|Overall Study||8
6510264|NCT01480284|7429815|FG001|NOT COMPLETED|Overall Study||0
6510265|NCT01480297|7429821|FG000|STARTED|Overall Study||8
6510266|NCT01480297|7429821|FG000|COMPLETED|Overall Study||8
6510267|NCT01480297|7429821|FG000|NOT COMPLETED|Overall Study||0
6510268|NCT01480596|7429827|FG000|STARTED|Overall Study||22
6510269|NCT01480596|7429828|FG001|STARTED|Overall Study||18
6510270|NCT01480596|7429827|FG000|COMPLETED|Overall Study||17
6510271|NCT01480596|7429828|FG001|COMPLETED|Overall Study||16
6510272|NCT01480596|7429827|FG000|NOT COMPLETED|Overall Study||5
6510273|NCT01480596|7429828|FG001|NOT COMPLETED|Overall Study||2
6510274|NCT01480674|7429834|FG000|STARTED|Overall Study||160
6510275|NCT01480674|7429834|FG000|Safety Set|Overall Study||154
6510276|NCT01480674|7429834|FG000|Analysed Set|Overall Study||128
6510277|NCT01480674|7429834|FG000|COMPLETED|Overall Study||125
6510278|NCT01480674|7429834|FG000|NOT COMPLETED|Overall Study||35
6510279|NCT01480843|7429838|FG000|STARTED|Overall Study||65
6510280|NCT01480843|7429838|FG000|COMPLETED|Overall Study||60
6510281|NCT01480843|7429838|FG000|NOT COMPLETED|Overall Study||5
6510282|NCT01481116|7429845|FG000|STARTED|Overall Study||824
6510283|NCT01481116|7429846|FG001|STARTED|Overall Study||817
6510284|NCT01481116|7429847|FG002|STARTED|Overall Study||813
6510285|NCT01481116|7429845|FG000|Treated|Overall Study||822
6510286|NCT01481116|7429846|FG001|Treated|Overall Study||816
6510287|NCT01481116|7429847|FG002|Treated|Overall Study||813
6510288|NCT01481116|7429845|FG000|COMPLETED|Overall Study||0
6510289|NCT01481116|7429846|FG001|COMPLETED|Overall Study||0
6510290|NCT01481116|7429847|FG002|COMPLETED|Overall Study||0
6510291|NCT01481116|7429845|FG000|NOT COMPLETED|Overall Study||824
6510292|NCT01481116|7429846|FG001|NOT COMPLETED|Overall Study||817
6510293|NCT01481116|7429847|FG002|NOT COMPLETED|Overall Study||813
6510294|NCT01481129|7429855|FG000|STARTED|Overall Study||22
6510295|NCT01481129|7429855|FG000|COMPLETED|Overall Study||22
6510296|NCT01481129|7429855|FG000|NOT COMPLETED|Overall Study||0
6510297|NCT01481324|7429862|FG000|STARTED|Overall Study||21
6510298|NCT01481324|7429863|FG001|STARTED|Overall Study||24
6510299|NCT01481324|7429864|FG002|STARTED|Overall Study||22
6510300|NCT01481324|7429862|FG000|Month 1-Wear Rate Data|Overall Study||15
6510301|NCT01481324|7429863|FG001|Month 1-Wear Rate Data|Overall Study||16
6510302|NCT01481324|7429864|FG002|Month 1-Wear Rate Data|Overall Study||8
6510303|NCT01481324|7429862|FG000|Month 2-Wear Rate Data|Overall Study||9
6510304|NCT01481324|7429863|FG001|Month 2-Wear Rate Data|Overall Study||13
6510305|NCT01481324|7429864|FG002|Month 2-Wear Rate Data|Overall Study||7
6510306|NCT01481324|7429862|FG000|Month 3-Wear Rate Data|Overall Study||7
6510307|NCT01481324|7429863|FG001|Month 3-Wear Rate Data|Overall Study||11
6510308|NCT01481324|7429864|FG002|Month 3-Wear Rate Data|Overall Study||6
6510309|NCT01481324|7429862|FG000|COMPLETED|Overall Study||21
6510310|NCT01481324|7429863|FG001|COMPLETED|Overall Study||22
6510311|NCT01481324|7429864|FG002|COMPLETED|Overall Study||20
6510312|NCT01481324|7429862|FG000|NOT COMPLETED|Overall Study||0
6510313|NCT01481324|7429863|FG001|NOT COMPLETED|Overall Study||2
6510314|NCT01481324|7429864|FG002|NOT COMPLETED|Overall Study||2
6510315|NCT01481376|7429872|FG000|STARTED|Overall Study||200
6510316|NCT01481376|7429872|FG000|COMPLETED|Overall Study||169
6510317|NCT01481376|7429872|FG000|NOT COMPLETED|Overall Study||31
6510318|NCT01481545|7429878|FG000|STARTED|Overall Study||16
6510319|NCT01481545|7429879|FG001|STARTED|Overall Study||46
6510320|NCT01481545|7429878|FG000|COMPLETED|Overall Study||11
6510321|NCT01481545|7429879|FG001|COMPLETED|Overall Study||40
6405485|NCT00915798|7318544|FG000|STARTED|Overall Study||19
6405486|NCT00915798|7318545|FG001|STARTED|Overall Study||21
6405487|NCT00915798|7318546|FG002|STARTED|Overall Study||23
6405488|NCT00915798|7318547|FG003|STARTED|Overall Study||26
6405489|NCT00915798|7318544|FG000|COMPLETED|Overall Study||19
6405490|NCT00915798|7318545|FG001|COMPLETED|Overall Study||21
6405491|NCT00915798|7318546|FG002|COMPLETED|Overall Study||23
6405492|NCT00915798|7318547|FG003|COMPLETED|Overall Study||26
6405493|NCT00915798|7318544|FG000|NOT COMPLETED|Overall Study||0
6405494|NCT00915798|7318545|FG001|NOT COMPLETED|Overall Study||0
6405495|NCT00915798|7318546|FG002|NOT COMPLETED|Overall Study||0
6405496|NCT00915798|7318547|FG003|NOT COMPLETED|Overall Study||0
6405497|NCT00915876|7318569|FG000|STARTED|Overall Study||20
6405498|NCT00915876|7318570|FG001|STARTED|Overall Study||21
6405499|NCT00915876|7318569|FG000|Moving Beyond First Dose|Overall Study||20
6405500|NCT00915876|7318570|FG001|Moving Beyond First Dose|Overall Study||20
6405501|NCT00915876|7318569|FG000|COMPLETED|Overall Study||20
6405502|NCT00915876|7318570|FG001|COMPLETED|Overall Study||20
6405503|NCT00915876|7318569|FG000|NOT COMPLETED|Overall Study||0
6405504|NCT00915876|7318570|FG001|NOT COMPLETED|Overall Study||1
6405505|NCT00915902|7318578|FG000|STARTED|1st Treatment Period||20
6405506|NCT00915902|7318579|FG001|STARTED|1st Treatment Period||22
6405507|NCT00915902|7318578|FG000|COMPLETED|1st Treatment Period||19
6405508|NCT00915902|7318579|FG001|COMPLETED|1st Treatment Period||22
6405509|NCT00915902|7318578|FG000|NOT COMPLETED|1st Treatment Period||1
6405510|NCT00915902|7318579|FG001|NOT COMPLETED|1st Treatment Period||0
6405511|NCT00915902|7318578|FG000|STARTED|Washout (4 Weeks)||19
6405512|NCT00915902|7318579|FG001|STARTED|Washout (4 Weeks)||22
6405513|NCT00915902|7318578|FG000|COMPLETED|Washout (4 Weeks)||19
6405514|NCT00915902|7318579|FG001|COMPLETED|Washout (4 Weeks)||21
6405515|NCT00915902|7318578|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6405516|NCT00915902|7318579|FG001|NOT COMPLETED|Washout (4 Weeks)||1
6405517|NCT00915902|7318578|FG000|STARTED|2nd Treatment Period||19
6405518|NCT00915902|7318579|FG001|STARTED|2nd Treatment Period||21
6405519|NCT00915902|7318578|FG000|COMPLETED|2nd Treatment Period||19
6405520|NCT00915902|7318579|FG001|COMPLETED|2nd Treatment Period||20
6405521|NCT00915902|7318578|FG000|NOT COMPLETED|2nd Treatment Period||0
6405522|NCT00915902|7318579|FG001|NOT COMPLETED|2nd Treatment Period||1
6405523|NCT00915928|7318589|FG000|STARTED|Overall Study||25
6405524|NCT00915928|7318590|FG001|STARTED|Overall Study||22
6405525|NCT00915928|7318589|FG000|COMPLETED|Overall Study||25
6405526|NCT00915928|7318590|FG001|COMPLETED|Overall Study||22
6405527|NCT00915928|7318589|FG000|NOT COMPLETED|Overall Study||0
6405528|NCT00915928|7318590|FG001|NOT COMPLETED|Overall Study||0
6405529|NCT00915954|7318600|FG000|STARTED|Overall Study||10
6405530|NCT00915954|7318601|FG001|STARTED|Overall Study||8
6405531|NCT00915954|7318602|FG002|STARTED|Overall Study||10
6405532|NCT00915954|7318600|FG000|COMPLETED|Overall Study||10
6405533|NCT00915954|7318601|FG001|COMPLETED|Overall Study||8
6405534|NCT00915954|7318602|FG002|COMPLETED|Overall Study||10
6405535|NCT00915954|7318600|FG000|NOT COMPLETED|Overall Study||0
6405536|NCT00915954|7318601|FG001|NOT COMPLETED|Overall Study||0
6405537|NCT00915954|7318602|FG002|NOT COMPLETED|Overall Study||0
6405538|NCT00915967|7318612|FG000|STARTED|Overall Study||98
6405539|NCT00915967|7318613|FG001|STARTED|Overall Study||100
6405540|NCT00915967|7318612|FG000|COMPLETED|Overall Study||97
6405541|NCT00915967|7318613|FG001|COMPLETED|Overall Study||98
6405542|NCT00915967|7318612|FG000|NOT COMPLETED|Overall Study||1
6405543|NCT00915967|7318613|FG001|NOT COMPLETED|Overall Study||2
6405544|NCT00916006|7318621|FG000|STARTED|Overall Study||135
6405545|NCT00916006|7318622|FG001|STARTED|Overall Study||134
6405546|NCT00916006|7318621|FG000|COMPLETED|Overall Study||132
6405547|NCT00916006|7318622|FG001|COMPLETED|Overall Study||127
6405548|NCT00916006|7318621|FG000|NOT COMPLETED|Overall Study||3
6405549|NCT00916006|7318622|FG001|NOT COMPLETED|Overall Study||7
6405550|NCT00916032|7318628|FG000|STARTED|Overall Study||12
6405551|NCT00916032|7318629|FG001|STARTED|Overall Study||11
6405552|NCT00916032|7318628|FG000|COMPLETED|Overall Study||12
6405553|NCT00916032|7318629|FG001|COMPLETED|Overall Study||11
6405554|NCT00916032|7318628|FG000|NOT COMPLETED|Overall Study||0
6405555|NCT00916032|7318629|FG001|NOT COMPLETED|Overall Study||0
6405556|NCT00916058|7318642|FG000|STARTED|Phase 1||3
6405557|NCT00916058|7318643|FG001|STARTED|Phase 1||6
6405558|NCT00916058|7318644|FG002|STARTED|Phase 1||3
6405559|NCT00916058|7318645|FG003|STARTED|Phase 1||3
6405560|NCT00916058|7318646|FG004|STARTED|Phase 1||3
6405561|NCT00916058|7318647|FG005|STARTED|Phase 1||8
6405562|NCT00916058|7318648|FG006|STARTED|Phase 1||0
6405563|NCT00916058|7318642|FG000|COMPLETED|Phase 1||3
6405564|NCT00916058|7318643|FG001|COMPLETED|Phase 1||6
6405565|NCT00916058|7318644|FG002|COMPLETED|Phase 1||3
6405566|NCT00916058|7318645|FG003|COMPLETED|Phase 1||3
6405567|NCT00916058|7318646|FG004|COMPLETED|Phase 1||3
6405568|NCT00916058|7318647|FG005|COMPLETED|Phase 1||7
6405569|NCT00916058|7318648|FG006|COMPLETED|Phase 1||0
6405570|NCT00916058|7318642|FG000|NOT COMPLETED|Phase 1||0
6405571|NCT00916058|7318643|FG001|NOT COMPLETED|Phase 1||0
6405572|NCT00916058|7318644|FG002|NOT COMPLETED|Phase 1||0
6405573|NCT00916058|7318645|FG003|NOT COMPLETED|Phase 1||0
6405574|NCT00916058|7318646|FG004|NOT COMPLETED|Phase 1||0
6405575|NCT00916058|7318647|FG005|NOT COMPLETED|Phase 1||1
6405576|NCT00916058|7318648|FG006|NOT COMPLETED|Phase 1||0
6405577|NCT00916058|7318642|FG000|STARTED|Phase 2||0
6405578|NCT00916058|7318643|FG001|STARTED|Phase 2||0
6405579|NCT00916058|7318644|FG002|STARTED|Phase 2||0
6405580|NCT00916058|7318645|FG003|STARTED|Phase 2||0
6405581|NCT00916058|7318646|FG004|STARTED|Phase 2||0
6405582|NCT00916058|7318647|FG005|STARTED|Phase 2||0
6405583|NCT00916058|7318648|FG006|STARTED|Phase 2||31
6405584|NCT00916058|7318642|FG000|COMPLETED|Phase 2||0
6405585|NCT00916058|7318643|FG001|COMPLETED|Phase 2||0
6405586|NCT00916058|7318644|FG002|COMPLETED|Phase 2||0
6405587|NCT00916058|7318645|FG003|COMPLETED|Phase 2||0
6405588|NCT00916058|7318646|FG004|COMPLETED|Phase 2||0
6405589|NCT00916058|7318647|FG005|COMPLETED|Phase 2||0
6405590|NCT00916058|7318648|FG006|COMPLETED|Phase 2||28
6405591|NCT00916058|7318642|FG000|NOT COMPLETED|Phase 2||0
6405592|NCT00916058|7318643|FG001|NOT COMPLETED|Phase 2||0
6405593|NCT00916058|7318644|FG002|NOT COMPLETED|Phase 2||0
6405594|NCT00916058|7318645|FG003|NOT COMPLETED|Phase 2||0
6405595|NCT00916058|7318646|FG004|NOT COMPLETED|Phase 2||0
6405596|NCT00916058|7318647|FG005|NOT COMPLETED|Phase 2||0
6405597|NCT00916058|7318648|FG006|NOT COMPLETED|Phase 2||3
6405598|NCT00916136|7318668|FG000|STARTED|Overall Study||37
6405599|NCT00916136|7318669|FG001|STARTED|Overall Study||29
6405600|NCT00916136|7318668|FG000|COMPLETED|Overall Study||37
6405601|NCT00916136|7318669|FG001|COMPLETED|Overall Study||29
6405602|NCT00916136|7318668|FG000|NOT COMPLETED|Overall Study||0
6405603|NCT00916136|7318669|FG001|NOT COMPLETED|Overall Study||0
6405604|NCT00916149|7318678|FG000|STARTED|Overall Study||16
6405605|NCT00916149|7318679|FG001|STARTED|Overall Study||10
6405606|NCT00916149|7318680|FG002|STARTED|Overall Study||5
6405607|NCT00916149|7318678|FG000|COMPLETED|Overall Study||12
6405608|NCT00916149|7318679|FG001|COMPLETED|Overall Study||8
6405609|NCT00916149|7318680|FG002|COMPLETED|Overall Study||5
6405610|NCT00916149|7318678|FG000|NOT COMPLETED|Overall Study||4
6405611|NCT00916149|7318679|FG001|NOT COMPLETED|Overall Study||2
6405612|NCT00916149|7318680|FG002|NOT COMPLETED|Overall Study||0
6405613|NCT00916279|7318687|FG000|STARTED|Overall Study||41
6405614|NCT00916279|7318687|FG000|30 Days|Overall Study||41
6405615|NCT00916279|7318687|FG000|6 Months|Overall Study||41
6405616|NCT00916279|7318687|FG000|24 Months|Overall Study||37
6405617|NCT00916279|7318687|FG000|COMPLETED|Overall Study||37
6405618|NCT00916279|7318687|FG000|NOT COMPLETED|Overall Study||4
6405619|NCT00916305|7318696|FG000|STARTED|Overall Study||28
6405620|NCT00916305|7318697|FG001|STARTED|Overall Study||37
6405621|NCT00916305|7318696|FG000|COMPLETED|Overall Study||7
6405622|NCT00916305|7318697|FG001|COMPLETED|Overall Study||9
6405623|NCT00916305|7318696|FG000|NOT COMPLETED|Overall Study||21
6405624|NCT00916305|7318697|FG001|NOT COMPLETED|Overall Study||28
6405625|NCT00916344|7318703|FG000|STARTED|Overall Study||175
6405626|NCT00916344|7318703|FG000|COMPLETED|Overall Study||167
6405627|NCT00916344|7318703|FG000|NOT COMPLETED|Overall Study||8
6405628|NCT00916357|7318707|FG000|STARTED|Period 1||4
6405629|NCT00916357|7318708|FG001|STARTED|Period 1||4
6405630|NCT00916357|7318709|FG002|STARTED|Period 1||4
6405631|NCT00916357|7318710|FG003|STARTED|Period 1||4
6405632|NCT00916357|7318711|FG004|STARTED|Period 1||3
6405633|NCT00916357|7318712|FG005|STARTED|Period 1||4
6405634|NCT00916357|7318707|FG000|Received at Least 1 Dose of Study Drug|Period 1||4
6405635|NCT00916357|7318708|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
6405636|NCT00916357|7318709|FG002|Received at Least 1 Dose of Study Drug|Period 1||4
6405637|NCT00916357|7318710|FG003|Received at Least 1 Dose of Study Drug|Period 1||4
6405638|NCT00916357|7318711|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
6405639|NCT00916357|7318712|FG005|Received at Least 1 Dose of Study Drug|Period 1||4
6405640|NCT00916357|7318707|FG000|COMPLETED|Period 1||3
6405641|NCT00916357|7318708|FG001|COMPLETED|Period 1||4
6405642|NCT00916357|7318709|FG002|COMPLETED|Period 1||4
6405643|NCT00916357|7318710|FG003|COMPLETED|Period 1||4
6405644|NCT00916357|7318711|FG004|COMPLETED|Period 1||3
6405645|NCT00916357|7318712|FG005|COMPLETED|Period 1||4
6405646|NCT00916357|7318707|FG000|NOT COMPLETED|Period 1||1
6405647|NCT00916357|7318708|FG001|NOT COMPLETED|Period 1||0
6405648|NCT00916357|7318709|FG002|NOT COMPLETED|Period 1||0
6405649|NCT00916357|7318710|FG003|NOT COMPLETED|Period 1||0
6405650|NCT00916357|7318711|FG004|NOT COMPLETED|Period 1||0
6405651|NCT00916357|7318712|FG005|NOT COMPLETED|Period 1||0
6405652|NCT00916357|7318707|FG000|STARTED|Washout (3 to 14 Days)||3
6405653|NCT00916357|7318708|FG001|STARTED|Washout (3 to 14 Days)||4
6405654|NCT00916357|7318709|FG002|STARTED|Washout (3 to 14 Days)||4
6405655|NCT00916357|7318710|FG003|STARTED|Washout (3 to 14 Days)||4
6405656|NCT00916357|7318711|FG004|STARTED|Washout (3 to 14 Days)||3
6405657|NCT00916357|7318712|FG005|STARTED|Washout (3 to 14 Days)||4
6405658|NCT00916357|7318707|FG000|COMPLETED|Washout (3 to 14 Days)||3
6405659|NCT00916357|7318708|FG001|COMPLETED|Washout (3 to 14 Days)||4
6405660|NCT00916357|7318709|FG002|COMPLETED|Washout (3 to 14 Days)||4
6405661|NCT00916357|7318710|FG003|COMPLETED|Washout (3 to 14 Days)||4
6405662|NCT00916357|7318711|FG004|COMPLETED|Washout (3 to 14 Days)||3
6405663|NCT00916357|7318712|FG005|COMPLETED|Washout (3 to 14 Days)||4
6405664|NCT00916357|7318707|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
6405665|NCT00916357|7318708|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
6405666|NCT00916357|7318709|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
6405667|NCT00916357|7318710|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
6405668|NCT00916357|7318711|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
6405669|NCT00916357|7318712|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
6405670|NCT00916357|7318707|FG000|STARTED|Period 2||3
6405671|NCT00916357|7318708|FG001|STARTED|Period 2||4
6405672|NCT00916357|7318709|FG002|STARTED|Period 2||4
6405673|NCT00916357|7318710|FG003|STARTED|Period 2||4
6405674|NCT00916357|7318711|FG004|STARTED|Period 2||3
6405675|NCT00916357|7318712|FG005|STARTED|Period 2||4
6405676|NCT00916357|7318707|FG000|COMPLETED|Period 2||3
6405677|NCT00916357|7318708|FG001|COMPLETED|Period 2||4
6405678|NCT00916357|7318709|FG002|COMPLETED|Period 2||4
6405679|NCT00916357|7318710|FG003|COMPLETED|Period 2||3
6405680|NCT00916357|7318711|FG004|COMPLETED|Period 2||3
6405681|NCT00916357|7318712|FG005|COMPLETED|Period 2||4
6405682|NCT00916357|7318707|FG000|NOT COMPLETED|Period 2||0
6405683|NCT00916357|7318708|FG001|NOT COMPLETED|Period 2||0
6405684|NCT00916357|7318709|FG002|NOT COMPLETED|Period 2||0
6405685|NCT00916357|7318710|FG003|NOT COMPLETED|Period 2||1
6405686|NCT00916357|7318711|FG004|NOT COMPLETED|Period 2||0
6405687|NCT00916357|7318712|FG005|NOT COMPLETED|Period 2||0
6405688|NCT00916357|7318707|FG000|STARTED|Washout (3 to 14 Days)||3
6405689|NCT00916357|7318708|FG001|STARTED|Washout (3 to 14 Days)||4
6405690|NCT00916357|7318709|FG002|STARTED|Washout (3 to 14 Days)||4
6405691|NCT00916357|7318710|FG003|STARTED|Washout (3 to 14 Days)||3
6405692|NCT00916357|7318711|FG004|STARTED|Washout (3 to 14 Days)||3
6405693|NCT00916357|7318712|FG005|STARTED|Washout (3 to 14 Days)||4
6405694|NCT00916357|7318707|FG000|COMPLETED|Washout (3 to 14 Days)||3
6405695|NCT00916357|7318708|FG001|COMPLETED|Washout (3 to 14 Days)||4
6405696|NCT00916357|7318709|FG002|COMPLETED|Washout (3 to 14 Days)||4
6405697|NCT00916357|7318710|FG003|COMPLETED|Washout (3 to 14 Days)||3
6405698|NCT00916357|7318711|FG004|COMPLETED|Washout (3 to 14 Days)||3
6405699|NCT00916357|7318712|FG005|COMPLETED|Washout (3 to 14 Days)||4
6405700|NCT00916357|7318707|FG000|NOT COMPLETED|Washout (3 to 14 Days)||0
6405701|NCT00916357|7318708|FG001|NOT COMPLETED|Washout (3 to 14 Days)||0
6405702|NCT00916357|7318709|FG002|NOT COMPLETED|Washout (3 to 14 Days)||0
6405703|NCT00916357|7318710|FG003|NOT COMPLETED|Washout (3 to 14 Days)||0
6405704|NCT00916357|7318711|FG004|NOT COMPLETED|Washout (3 to 14 Days)||0
6405705|NCT00916357|7318712|FG005|NOT COMPLETED|Washout (3 to 14 Days)||0
6405706|NCT00916357|7318707|FG000|STARTED|Period 3||3
6405707|NCT00916357|7318708|FG001|STARTED|Period 3||4
6405708|NCT00916357|7318709|FG002|STARTED|Period 3||4
6405709|NCT00916357|7318710|FG003|STARTED|Period 3||3
6405710|NCT00916357|7318711|FG004|STARTED|Period 3||3
6405711|NCT00916357|7318712|FG005|STARTED|Period 3||4
6405712|NCT00916357|7318707|FG000|COMPLETED|Period 3||3
6405713|NCT00916357|7318708|FG001|COMPLETED|Period 3||4
6405714|NCT00916357|7318709|FG002|COMPLETED|Period 3||4
6405715|NCT00916357|7318710|FG003|COMPLETED|Period 3||3
6405716|NCT00916357|7318711|FG004|COMPLETED|Period 3||3
6405717|NCT00916357|7318712|FG005|COMPLETED|Period 3||4
6405718|NCT00916357|7318707|FG000|NOT COMPLETED|Period 3||0
6405719|NCT00916357|7318708|FG001|NOT COMPLETED|Period 3||0
6405720|NCT00916357|7318709|FG002|NOT COMPLETED|Period 3||0
6405721|NCT00916357|7318710|FG003|NOT COMPLETED|Period 3||0
6405722|NCT00916357|7318711|FG004|NOT COMPLETED|Period 3||0
6405723|NCT00916357|7318712|FG005|NOT COMPLETED|Period 3||0
6405724|NCT00916370|7318723|FG000|STARTED|Overall Study||401
6405725|NCT00916370|7318724|FG001|STARTED|Overall Study||104
6405726|NCT00916370|7318723|FG000|COMPLETED|Overall Study||396
6405727|NCT00916370|7318724|FG001|COMPLETED|Overall Study||102
6405728|NCT00916370|7318723|FG000|NOT COMPLETED|Overall Study||5
6405729|NCT00916370|7318724|FG001|NOT COMPLETED|Overall Study||2
6405730|NCT00916383|7318731|FG000|STARTED|Overall Study||49
6405731|NCT00916383|7318731|FG000|COMPLETED|Overall Study||46
6405732|NCT00916383|7318731|FG000|NOT COMPLETED|Overall Study||3
6405733|NCT00916539|7318741|FG000|STARTED|Overall Study||31
6405734|NCT00916539|7318742|FG001|STARTED|Overall Study||31
6405735|NCT00916539|7318741|FG000|COMPLETED|Overall Study||31
6405736|NCT00916539|7318742|FG001|COMPLETED|Overall Study||31
6405737|NCT00916539|7318741|FG000|NOT COMPLETED|Overall Study||0
6405738|NCT00916539|7318742|FG001|NOT COMPLETED|Overall Study||0
6405739|NCT00916578|7318748|FG000|STARTED|Overall Study||33
6405740|NCT00916578|7318748|FG000|COMPLETED|Overall Study||26
6405741|NCT00916578|7318748|FG000|NOT COMPLETED|Overall Study||7
6405742|NCT00916617|7318756|FG000|STARTED|Overall Study||24
6405743|NCT00916617|7318757|FG001|STARTED|Overall Study||21
6405744|NCT00916617|7318758|FG002|STARTED|Overall Study||10
6405745|NCT00916617|7318759|FG003|STARTED|Overall Study||7
6405746|NCT00916617|7318756|FG000|COMPLETED|Overall Study||1
6405747|NCT00916617|7318757|FG001|COMPLETED|Overall Study||0
6405748|NCT00916617|7318758|FG002|COMPLETED|Overall Study||0
6405749|NCT00916617|7318759|FG003|COMPLETED|Overall Study||0
6405750|NCT00916617|7318756|FG000|NOT COMPLETED|Overall Study||23
6405751|NCT00916617|7318757|FG001|NOT COMPLETED|Overall Study||21
6405752|NCT00916617|7318758|FG002|NOT COMPLETED|Overall Study||10
6405753|NCT00916617|7318759|FG003|NOT COMPLETED|Overall Study||7
6405754|NCT00916643|7318769|FG000|STARTED|Overall Study||113
6405755|NCT00916643|7318769|FG000|COMPLETED|Overall Study||113
6405756|NCT00916643|7318769|FG000|NOT COMPLETED|Overall Study||0
6405757|NCT00916721|7318775|FG000|STARTED|Overall Study||35
6405758|NCT00916721|7318776|FG001|STARTED|Overall Study||39
6405759|NCT00916721|7318775|FG000|COMPLETED|Overall Study||25
6405760|NCT00916721|7318776|FG001|COMPLETED|Overall Study||29
6405761|NCT00916721|7318775|FG000|NOT COMPLETED|Overall Study||10
6405762|NCT00916721|7318776|FG001|NOT COMPLETED|Overall Study||10
6405763|NCT00916929|7318784|FG000|STARTED|Overall Study||80
6405764|NCT00916929|7318785|FG001|STARTED|Overall Study||82
6405765|NCT00916929|7318784|FG000|COMPLETED|Overall Study||70
6405766|NCT00916929|7318785|FG001|COMPLETED|Overall Study||53
6405767|NCT00916929|7318784|FG000|NOT COMPLETED|Overall Study||10
6405768|NCT00916929|7318785|FG001|NOT COMPLETED|Overall Study||29
6405769|NCT00917124|7318795|FG000|STARTED|Overall Study||100
6405770|NCT00917124|7318796|FG001|STARTED|Overall Study||100
6405771|NCT00917124|7318795|FG000|COMPLETED|Overall Study||96
6405772|NCT00917124|7318796|FG001|COMPLETED|Overall Study||94
6405773|NCT00917124|7318795|FG000|NOT COMPLETED|Overall Study||4
6405774|NCT00917124|7318796|FG001|NOT COMPLETED|Overall Study||6
6405775|NCT00917150|7318806|FG000|STARTED|Overall Study||192
6405776|NCT00917150|7318807|FG001|STARTED|Overall Study||198
6405777|NCT00917150|7318808|FG002|STARTED|Overall Study||191
6405778|NCT00917150|7318809|FG003|STARTED|Overall Study||190
6405779|NCT00917150|7318806|FG000|COMPLETED|Overall Study||155
6405780|NCT00917150|7318807|FG001|COMPLETED|Overall Study||161
6405781|NCT00917150|7318808|FG002|COMPLETED|Overall Study||149
6405782|NCT00917150|7318809|FG003|COMPLETED|Overall Study||156
6405783|NCT00917150|7318806|FG000|NOT COMPLETED|Overall Study||37
6405784|NCT00917150|7318807|FG001|NOT COMPLETED|Overall Study||37
6405785|NCT00917150|7318808|FG002|NOT COMPLETED|Overall Study||42
6405786|NCT00917150|7318809|FG003|NOT COMPLETED|Overall Study||34
6405787|NCT00917267|7318821|FG000|STARTED|Overall Study||346
6405788|NCT00917267|7318822|FG001|STARTED|Overall Study||345
6405789|NCT00917267|7318821|FG000|Intent to Treat (ITT)|Overall Study||340
6405790|NCT00917267|7318822|FG001|Intent to Treat (ITT)|Overall Study||338
6405791|NCT00917267|7318821|FG000|COMPLETED|Overall Study||307
6405792|NCT00917267|7318822|FG001|COMPLETED|Overall Study||266
6405793|NCT00917267|7318821|FG000|NOT COMPLETED|Overall Study||39
6405794|NCT00917267|7318822|FG001|NOT COMPLETED|Overall Study||79
6405795|NCT00917384|7318834|FG000|STARTED|Overall Study||238
6405796|NCT00917384|7318835|FG001|STARTED|Overall Study||117
6405797|NCT00917384|7318834|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
6405798|NCT00917384|7318835|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
6405799|NCT00917384|7318834|FG000|COMPLETED|Overall Study||224
6405800|NCT00917384|7318835|FG001|COMPLETED|Overall Study||113
6405801|NCT00917384|7318834|FG000|NOT COMPLETED|Overall Study||14
6405802|NCT00917384|7318835|FG001|NOT COMPLETED|Overall Study||4
6405803|NCT00917462|7318841|FG000|STARTED|Overall Study||35
6405804|NCT00917462|7318841|FG000|COMPLETED|Overall Study||34
6405805|NCT00917462|7318841|FG000|NOT COMPLETED|Overall Study||1
6405806|NCT00917501|7318847|FG000|STARTED|Overall Study||29
6405807|NCT00917501|7318848|FG001|STARTED|Overall Study||26
6405808|NCT00917501|7318847|FG000|COMPLETED|Overall Study||21
6405809|NCT00917501|7318848|FG001|COMPLETED|Overall Study||21
6405810|NCT00917501|7318847|FG000|NOT COMPLETED|Overall Study||8
6405811|NCT00917501|7318848|FG001|NOT COMPLETED|Overall Study||5
6405812|NCT00917553|7318856|FG000|STARTED|Overall Study||17
6405813|NCT00917553|7318857|FG001|STARTED|Overall Study||16
6405814|NCT00917553|7318856|FG000|COMPLETED|Overall Study||15
6405815|NCT00917553|7318857|FG001|COMPLETED|Overall Study||15
6405816|NCT00917553|7318856|FG000|NOT COMPLETED|Overall Study||2
6405817|NCT00917553|7318857|FG001|NOT COMPLETED|Overall Study||1
6405818|NCT00917579|7318863|FG000|STARTED|Period 1: 1st Intervention||39
6405819|NCT00917579|7318864|FG001|STARTED|Period 1: 1st Intervention||37
6405820|NCT00917579|7318863|FG000|COMPLETED|Period 1: 1st Intervention||39
6405821|NCT00917579|7318864|FG001|COMPLETED|Period 1: 1st Intervention||37
6405822|NCT00917579|7318863|FG000|NOT COMPLETED|Period 1: 1st Intervention||0
6405823|NCT00917579|7318864|FG001|NOT COMPLETED|Period 1: 1st Intervention||0
6405824|NCT00917579|7318863|FG000|STARTED|Washout >= 2 Weeks||39
6405825|NCT00917579|7318864|FG001|STARTED|Washout >= 2 Weeks||37
6405826|NCT00917579|7318863|FG000|COMPLETED|Washout >= 2 Weeks||37
6405827|NCT00917579|7318864|FG001|COMPLETED|Washout >= 2 Weeks||37
6405828|NCT00917579|7318863|FG000|NOT COMPLETED|Washout >= 2 Weeks||2
6405829|NCT00917579|7318864|FG001|NOT COMPLETED|Washout >= 2 Weeks||0
6405830|NCT00917579|7318863|FG000|STARTED|Period 2: 2nd Intervention||37
6405831|NCT00917579|7318864|FG001|STARTED|Period 2: 2nd Intervention||37
6405832|NCT00917579|7318863|FG000|COMPLETED|Period 2: 2nd Intervention||37
6405833|NCT00917579|7318864|FG001|COMPLETED|Period 2: 2nd Intervention||37
6405834|NCT00917579|7318863|FG000|NOT COMPLETED|Period 2: 2nd Intervention||0
6405835|NCT00917579|7318864|FG001|NOT COMPLETED|Period 2: 2nd Intervention||0
6405836|NCT00917644|7318870|FG000|STARTED|Period 1: First Intervention||39
6405837|NCT00917644|7318871|FG001|STARTED|Period 1: First Intervention||37
6405838|NCT00917644|7318870|FG000|COMPLETED|Period 1: First Intervention||39
6405839|NCT00917644|7318871|FG001|COMPLETED|Period 1: First Intervention||37
6405840|NCT00917644|7318870|FG000|NOT COMPLETED|Period 1: First Intervention||0
6405841|NCT00917644|7318871|FG001|NOT COMPLETED|Period 1: First Intervention||0
6405842|NCT00917644|7318870|FG000|STARTED|Period: Washout Period of > = 2 Weeks||39
6405843|NCT00917644|7318871|FG001|STARTED|Period: Washout Period of > = 2 Weeks||37
6405844|NCT00917644|7318870|FG000|COMPLETED|Period: Washout Period of > = 2 Weeks||37
6405845|NCT00917644|7318871|FG001|COMPLETED|Period: Washout Period of > = 2 Weeks||37
6405846|NCT00917644|7318870|FG000|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
6405847|NCT00917644|7318871|FG001|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
6405848|NCT00917644|7318870|FG000|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
6405849|NCT00917644|7318871|FG001|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
6405850|NCT00917644|7318870|FG000|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
6405851|NCT00917644|7318871|FG001|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
6405852|NCT00917644|7318870|FG000|NOT COMPLETED|Period 2: Second Intervention||1
6405853|NCT00917644|7318871|FG001|NOT COMPLETED|Period 2: Second Intervention||0
6405854|NCT00917735|7318879|FG000|STARTED|Overall Study||538
6405855|NCT00917735|7318880|FG001|STARTED|Overall Study||537
6405856|NCT00917735|7318879|FG000|COMPLETED|Overall Study||463
6405857|NCT00917735|7318880|FG001|COMPLETED|Overall Study||474
6405858|NCT00917735|7318879|FG000|NOT COMPLETED|Overall Study||75
6405859|NCT00917735|7318880|FG001|NOT COMPLETED|Overall Study||63
6405860|NCT00917852|7318886|FG000|STARTED|Overall Study||51
6405861|NCT00917852|7318886|FG000|COMPLETED|Overall Study||45
6405862|NCT00917852|7318886|FG000|NOT COMPLETED|Overall Study||6
6405863|NCT00917865|7318891|FG000|STARTED|Overall Study||11
6405864|NCT00917865|7318891|FG000|COMPLETED|Overall Study||11
6405865|NCT00917865|7318891|FG000|NOT COMPLETED|Overall Study||0
6405866|NCT00918125|7318904|FG000|STARTED|Overall Study||20
6405867|NCT00918125|7318905|FG001|STARTED|Overall Study||39
6405868|NCT00918125|7318904|FG000|COMPLETED|Overall Study||20
6405869|NCT00918125|7318905|FG001|COMPLETED|Overall Study||39
6405870|NCT00918125|7318904|FG000|NOT COMPLETED|Overall Study||0
6405871|NCT00918125|7318905|FG001|NOT COMPLETED|Overall Study||0
6405872|NCT00918138|7318916|FG000|STARTED|Overall Study||46
6405873|NCT00918138|7318917|FG001|STARTED|Overall Study||47
6405874|NCT00918138|7318916|FG000|COMPLETED|Overall Study||44
6405875|NCT00918138|7318917|FG001|COMPLETED|Overall Study||46
6405876|NCT00918138|7318916|FG000|NOT COMPLETED|Overall Study||2
6405877|NCT00918138|7318917|FG001|NOT COMPLETED|Overall Study||1
6405878|NCT00918203|7318925|FG000|STARTED|Treatment With or Without Olaratumab||70
6405879|NCT00918203|7318926|FG001|STARTED|Treatment With or Without Olaratumab||67
6405880|NCT00918203|7318927|FG002|STARTED|Treatment With or Without Olaratumab||0
6405881|NCT00918203|7318925|FG000|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
6405882|NCT00918203|7318926|FG001|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
6405883|NCT00918203|7318927|FG002|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
6405884|NCT00918203|7318925|FG000|Death Due to Any Cause|Treatment With or Without Olaratumab||53
6405885|NCT00918203|7318926|FG001|Death Due to Any Cause|Treatment With or Without Olaratumab||47
6405886|NCT00918203|7318927|FG002|Death Due to Any Cause|Treatment With or Without Olaratumab||0
6405887|NCT00918203|7318925|FG000|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||11
6405888|NCT00918203|7318926|FG001|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||10
6405889|NCT00918203|7318927|FG002|Alive/On Study at End/Off Treatment|Treatment With or Without Olaratumab||0
6405890|NCT00918203|7318925|FG000|COMPLETED|Treatment With or Without Olaratumab||64
6405891|NCT00918203|7318926|FG001|COMPLETED|Treatment With or Without Olaratumab||57
6405892|NCT00918203|7318927|FG002|COMPLETED|Treatment With or Without Olaratumab||0
6405893|NCT00918203|7318925|FG000|NOT COMPLETED|Treatment With or Without Olaratumab||6
6405894|NCT00918203|7318926|FG001|NOT COMPLETED|Treatment With or Without Olaratumab||10
6405895|NCT00918203|7318927|FG002|NOT COMPLETED|Treatment With or Without Olaratumab||0
6405896|NCT00918203|7318925|FG000|STARTED|Crossover to Olaratumab Monotherapy||0
6405897|NCT00918203|7318926|FG001|STARTED|Crossover to Olaratumab Monotherapy||0
6405898|NCT00918203|7318927|FG002|STARTED|Crossover to Olaratumab Monotherapy|18 participants who had progressive disease crossed over to monotherapy.|18
6405899|NCT00918203|7318925|FG000|COMPLETED|Crossover to Olaratumab Monotherapy||0
6405900|NCT00918203|7318926|FG001|COMPLETED|Crossover to Olaratumab Monotherapy||0
6405901|NCT00918203|7318927|FG002|COMPLETED|Crossover to Olaratumab Monotherapy||18
6405902|NCT00918203|7318925|FG000|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
6405903|NCT00918203|7318926|FG001|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
6405904|NCT00918203|7318927|FG002|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
6405905|NCT00918229|7318939|FG000|STARTED|Overall Study||24
6405906|NCT00918229|7318939|FG000|COMPLETED|Overall Study||24
6405907|NCT00918229|7318939|FG000|NOT COMPLETED|Overall Study||0
6405908|NCT00918255|7318946|FG000|STARTED|Overall Study||51
6405909|NCT00918255|7318947|FG001|STARTED|Overall Study||52
6405910|NCT00918255|7318948|FG002|STARTED|Overall Study||51
6405911|NCT00918255|7318946|FG000|COMPLETED|Overall Study||45
6405912|NCT00918255|7318947|FG001|COMPLETED|Overall Study||52
6405913|NCT00918255|7318948|FG002|COMPLETED|Overall Study||46
6405914|NCT00918255|7318946|FG000|NOT COMPLETED|Overall Study||6
6405915|NCT00918255|7318947|FG001|NOT COMPLETED|Overall Study||0
6405916|NCT00918255|7318948|FG002|NOT COMPLETED|Overall Study||5
6405917|NCT00918281|7318956|FG000|STARTED|Overall Study||70
6405918|NCT00918281|7318956|FG000|COMPLETED|Overall Study||41
6405919|NCT00918281|7318956|FG000|NOT COMPLETED|Overall Study||29
6405920|NCT00918333|7318965|FG000|STARTED|Overall Study||26
6405921|NCT00918333|7318966|FG001|STARTED|Overall Study||98
6405922|NCT00918333|7318965|FG000|COMPLETED|Overall Study||23
6405923|NCT00918333|7318966|FG001|COMPLETED|Overall Study||93
6405924|NCT00918333|7318965|FG000|NOT COMPLETED|Overall Study||3
6405925|NCT00918333|7318966|FG001|NOT COMPLETED|Overall Study||5
6405926|NCT00918346|7318975|FG000|STARTED|First Treatment Period (4 Weeks)||21
6405927|NCT00918346|7318976|FG001|STARTED|First Treatment Period (4 Weeks)||22
6405928|NCT00918346|7318975|FG000|COMPLETED|First Treatment Period (4 Weeks)||21
6405929|NCT00918346|7318976|FG001|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
6405930|NCT00918346|7318975|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||0
6405931|NCT00918346|7318976|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||1
6405932|NCT00918346|7318975|FG000|STARTED|Washout (at Least 4 Weeks)||21
6405933|NCT00918346|7318976|FG001|STARTED|Washout (at Least 4 Weeks)||21
6405934|NCT00918346|7318975|FG000|COMPLETED|Washout (at Least 4 Weeks)||21
6405935|NCT00918346|7318976|FG001|COMPLETED|Washout (at Least 4 Weeks)||21
6405936|NCT00918346|7318975|FG000|NOT COMPLETED|Washout (at Least 4 Weeks)||0
6405937|NCT00918346|7318976|FG001|NOT COMPLETED|Washout (at Least 4 Weeks)||0
6405938|NCT00918346|7318975|FG000|STARTED|Second Treatment Period (4 Weeks)||21
6405939|NCT00918346|7318976|FG001|STARTED|Second Treatment Period (4 Weeks)||21
6405940|NCT00918346|7318975|FG000|COMPLETED|Second Treatment Period (4 Weeks)||21
6405941|NCT00918346|7318976|FG001|COMPLETED|Second Treatment Period (4 Weeks)||21
6405942|NCT00918346|7318975|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
6405943|NCT00918346|7318976|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
6405944|NCT00918346|7318975|FG000|STARTED|Post Study Period||21
6405945|NCT00918346|7318976|FG001|STARTED|Post Study Period||21
6405946|NCT00918346|7318975|FG000|COMPLETED|Post Study Period||21
6405947|NCT00918346|7318976|FG001|COMPLETED|Post Study Period||21
6405948|NCT00918346|7318975|FG000|NOT COMPLETED|Post Study Period||0
6405949|NCT00918346|7318976|FG001|NOT COMPLETED|Post Study Period||0
6405950|NCT00918385|7318987|FG000|STARTED|Monotherapy||14
6405951|NCT00918385|7318988|FG001|STARTED|Monotherapy||17
6405952|NCT00918385|7318987|FG000|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
6405953|NCT00918385|7318988|FG001|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
6405954|NCT00918385|7318987|FG000|NOT COMPLETED|Monotherapy||2
6405955|NCT00918385|7318988|FG001|NOT COMPLETED|Monotherapy||6
6405956|NCT00918385|7318987|FG000|STARTED|Combination Nilutamide and Dasatinib||12
6405957|NCT00918385|7318988|FG001|STARTED|Combination Nilutamide and Dasatinib||11
6405958|NCT00918385|7318987|FG000|COMPLETED|Combination Nilutamide and Dasatinib||6
6405959|NCT00918385|7318988|FG001|COMPLETED|Combination Nilutamide and Dasatinib||3
6405960|NCT00918385|7318987|FG000|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
6405961|NCT00918385|7318988|FG001|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
6405962|NCT00918567|7318998|FG000|STARTED|Overall Study||29
6405963|NCT00918567|7318999|FG001|STARTED|Overall Study||27
6405964|NCT00918567|7318998|FG000|COMPLETED|Overall Study||24
6405965|NCT00918567|7318999|FG001|COMPLETED|Overall Study||25
6405966|NCT00918567|7318998|FG000|NOT COMPLETED|Overall Study||5
6405967|NCT00918567|7318999|FG001|NOT COMPLETED|Overall Study||2
6405968|NCT00918580|7319005|FG000|STARTED|Up to 6-month Follow-up(FU)||158
6405969|NCT00918580|7319005|FG000|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
6405970|NCT00918580|7319005|FG000|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
6405971|NCT00918580|7319005|FG000|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
6405972|NCT00918580|7319005|FG000|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
6405973|NCT00918580|7319005|FG000|STARTED|After 6-month FU to 1-year FU||147
6405974|NCT00918580|7319005|FG000|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
6405975|NCT00918580|7319005|FG000|COMPLETED|After 6-month FU to 1-year FU||87
6405976|NCT00918580|7319005|FG000|NOT COMPLETED|After 6-month FU to 1-year FU||60
6405977|NCT00918671|7319012|FG000|STARTED|Overall Study||60
6405978|NCT00918671|7319012|FG000|COMPLETED|Overall Study||60
6405979|NCT00918671|7319012|FG000|NOT COMPLETED|Overall Study||0
6405980|NCT00918684|7319016|FG000|STARTED|Two Week Drug Washout and Placebo Phase||106
6405981|NCT00918684|7319016|FG000|COMPLETED|Two Week Drug Washout and Placebo Phase||90
6405982|NCT00918684|7319016|FG000|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
6405983|NCT00918684|7319016|FG000|STARTED|Treatment Phase||90
6405984|NCT00918684|7319016|FG000|COMPLETED|Treatment Phase||65
6405985|NCT00918684|7319016|FG000|NOT COMPLETED|Treatment Phase||25
6405986|NCT00918723|7319020|FG000|STARTED|Overall Study||40
6405987|NCT00918723|7319020|FG000|COMPLETED|Overall Study||40
6405988|NCT00918723|7319020|FG000|NOT COMPLETED|Overall Study||0
6405989|NCT00918736|7319026|FG000|STARTED|Overall Study|October, 2007|50
6405990|NCT00918736|7319026|FG000|COMPLETED|Overall Study|October, 2008|46
6405991|NCT00918736|7319026|FG000|NOT COMPLETED|Overall Study||4
6405992|NCT00918749|7319033|FG000|STARTED|Overall Study||70
6405993|NCT00918749|7319034|FG001|STARTED|Overall Study||66
6405994|NCT00918749|7319035|FG002|STARTED|Overall Study||69
6405995|NCT00918749|7319033|FG000|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
6405996|NCT00918749|7319034|FG001|ITT (Intent to Treat) Population|Overall Study||66
6405997|NCT00918749|7319035|FG002|ITT (Intent to Treat) Population|Overall Study||69
6405998|NCT00918749|7319033|FG000|COMPLETED|Overall Study||63
6405999|NCT00918749|7319034|FG001|COMPLETED|Overall Study||63
6406000|NCT00918749|7319035|FG002|COMPLETED|Overall Study||62
6406001|NCT00918749|7319033|FG000|NOT COMPLETED|Overall Study||7
6406002|NCT00918749|7319034|FG001|NOT COMPLETED|Overall Study||3
6406003|NCT00918749|7319035|FG002|NOT COMPLETED|Overall Study||7
6406004|NCT00918866|7319045|FG000|STARTED|Overall Study||16
6406005|NCT00918866|7319046|FG001|STARTED|Overall Study||16
6406006|NCT00918866|7319045|FG000|COMPLETED|Overall Study||16
6406007|NCT00918866|7319046|FG001|COMPLETED|Overall Study||16
6406008|NCT00918866|7319045|FG000|NOT COMPLETED|Overall Study||0
6406009|NCT00918866|7319046|FG001|NOT COMPLETED|Overall Study||0
6406010|NCT00918879|7319054|FG000|STARTED|Overall Study|Randomized and treated|107
6406011|NCT00918879|7319055|FG001|STARTED|Overall Study|Randomized and treated|106
6406012|NCT00918879|7319054|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
6406013|NCT00918879|7319055|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
6406014|NCT00918879|7319054|FG000|NOT COMPLETED|Overall Study||6
6406015|NCT00918879|7319055|FG001|NOT COMPLETED|Overall Study||6
6406016|NCT00918931|7319061|FG000|STARTED|Overall Study||3
6406017|NCT00918931|7319061|FG000|COMPLETED|Overall Study||3
6406018|NCT00918931|7319061|FG000|NOT COMPLETED|Overall Study||0
6406019|NCT00918957|7319067|FG000|STARTED|Overall Study||32
6406020|NCT00918957|7319068|FG001|STARTED|Overall Study||30
6406021|NCT00918957|7319067|FG000|COMPLETED|Overall Study||29
6406022|NCT00918957|7319068|FG001|COMPLETED|Overall Study||30
6406023|NCT00918957|7319067|FG000|NOT COMPLETED|Overall Study||3
6406024|NCT00918957|7319068|FG001|NOT COMPLETED|Overall Study||0
6406025|NCT00919035|7319074|FG000|STARTED|Overall Study||21
6406026|NCT00919035|7319074|FG000|COMPLETED|Overall Study||21
6406027|NCT00919035|7319074|FG000|NOT COMPLETED|Overall Study||0
6406028|NCT00919061|7319078|FG000|STARTED|Overall Study||39
6406029|NCT00919061|7319078|FG000|COMPLETED|Overall Study||37
6406030|NCT00919061|7319078|FG000|NOT COMPLETED|Overall Study||2
6406031|NCT00919100|7319084|FG000|STARTED|Overall Study||40
6406032|NCT00919100|7319085|FG001|STARTED|Overall Study||41
6406033|NCT00919100|7319084|FG000|COMPLETED|Overall Study||40
6406034|NCT00919100|7319085|FG001|COMPLETED|Overall Study||41
6406035|NCT00919100|7319084|FG000|NOT COMPLETED|Overall Study||0
6406036|NCT00919100|7319085|FG001|NOT COMPLETED|Overall Study||0
6406037|NCT00919113|7319093|FG000|STARTED|Overall Study||50
6406038|NCT00919113|7319094|FG001|STARTED|Overall Study||48
6406039|NCT00919113|7319093|FG000|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
6406040|NCT00919113|7319094|FG001|Received Uracyst|Overall Study||0
6406041|NCT00919113|7319093|FG000|Received Placebo|Overall Study||0
6406042|NCT00919113|7319094|FG001|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
6406043|NCT00919113|7319093|FG000|COMPLETED|Overall Study||41
6406044|NCT00919113|7319094|FG001|COMPLETED|Overall Study||40
6406045|NCT00919113|7319093|FG000|NOT COMPLETED|Overall Study||9
6406046|NCT00919113|7319094|FG001|NOT COMPLETED|Overall Study||8
6406047|NCT00919126|7319103|FG000|STARTED|Overall Study||32
6406048|NCT00919126|7319104|FG001|STARTED|Overall Study||37
6406049|NCT00919126|7319105|FG002|STARTED|Overall Study||33
6406050|NCT00919126|7319103|FG000|COMPLETED|Overall Study||31
6406051|NCT00919126|7319104|FG001|COMPLETED|Overall Study||32
6406052|NCT00919126|7319105|FG002|COMPLETED|Overall Study||32
6406053|NCT00919126|7319103|FG000|NOT COMPLETED|Overall Study||1
6635659|NCT02306759|7564542|FG000|STARTED|Overall Study||30
6635660|NCT02306759|7564543|FG001|STARTED|Overall Study||30
6635661|NCT02306759|7564542|FG000|COMPLETED|Overall Study||30
6635662|NCT02306759|7564543|FG001|COMPLETED|Overall Study||30
6635663|NCT02306759|7564542|FG000|NOT COMPLETED|Overall Study||0
6635664|NCT02306759|7564543|FG001|NOT COMPLETED|Overall Study||0
6635665|NCT02306850|7564551|FG000|STARTED|Overall Study||10
6635666|NCT02306850|7564551|FG000|COMPLETED|Overall Study||8
6635667|NCT02306850|7564551|FG000|NOT COMPLETED|Overall Study||2
6635668|NCT02306928|7564556|FG000|STARTED|Overall Study||15
6635669|NCT02306928|7564556|FG000|COMPLETED|Overall Study||15
6635670|NCT02306928|7564556|FG000|NOT COMPLETED|Overall Study||0
6635671|NCT02307123|7564560|FG000|STARTED|Overall Study||483
6635672|NCT02307123|7564560|FG000|COMPLETED|Overall Study||483
6635673|NCT02307123|7564560|FG000|NOT COMPLETED|Overall Study||0
6635674|NCT02307266|7564567|FG000|STARTED|Overall Study||33
6635675|NCT02307266|7564568|FG001|STARTED|Overall Study||33
6635676|NCT02307266|7564569|FG002|STARTED|Overall Study||31
6635677|NCT02307266|7564567|FG000|COMPLETED|Overall Study||25
6635678|NCT02307266|7564568|FG001|COMPLETED|Overall Study||32
6635679|NCT02307266|7564569|FG002|COMPLETED|Overall Study||25
6635680|NCT02307266|7564567|FG000|NOT COMPLETED|Overall Study||8
6635681|NCT02307266|7564568|FG001|NOT COMPLETED|Overall Study||1
6635682|NCT02307266|7564569|FG002|NOT COMPLETED|Overall Study||6
6635683|NCT02307318|7564577|FG000|STARTED|Overall Study||51
6635684|NCT02307318|7564577|FG000|COMPLETED|Overall Study||51
6406054|NCT00919126|7319104|FG001|NOT COMPLETED|Overall Study||5
6406055|NCT00919126|7319105|FG002|NOT COMPLETED|Overall Study||1
6406056|NCT00919191|7319114|FG000|STARTED|Overall Study||26
6406057|NCT00919191|7319114|FG000|COMPLETED|Overall Study||26
6406058|NCT00919191|7319114|FG000|NOT COMPLETED|Overall Study||0
6406059|NCT00919503|7319122|FG000|STARTED|Overall Study||84
6406060|NCT00919503|7319123|FG001|STARTED|Overall Study||14
6406061|NCT00919503|7319122|FG000|COMPLETED|Overall Study||84
6406062|NCT00919503|7319123|FG001|COMPLETED|Overall Study||14
6406063|NCT00919503|7319122|FG000|NOT COMPLETED|Overall Study||0
6406064|NCT00919503|7319123|FG001|NOT COMPLETED|Overall Study||0
6635685|NCT02307318|7564577|FG000|NOT COMPLETED|Overall Study||0
6635686|NCT02307370|7564581|FG000|STARTED|Overall Study||44
6406065|NCT00919633|7319133|FG000|STARTED|Overall Study||28
6406066|NCT00919633|7319134|FG001|STARTED|Overall Study||25
6406067|NCT00919633|7319135|FG002|STARTED|Overall Study||27
6406068|NCT00919633|7319136|FG003|STARTED|Overall Study||26
6406069|NCT00919633|7319133|FG000|COMPLETED|Overall Study||6
6406070|NCT00919633|7319134|FG001|COMPLETED|Overall Study||10
6406071|NCT00919633|7319135|FG002|COMPLETED|Overall Study||4
6635687|NCT02307370|7564581|FG000|30 Day Follow-up|Overall Study||40
6406072|NCT00919633|7319136|FG003|COMPLETED|Overall Study||5
6406073|NCT00919633|7319133|FG000|NOT COMPLETED|Overall Study||22
6406074|NCT00919633|7319134|FG001|NOT COMPLETED|Overall Study||15
6406075|NCT00919633|7319135|FG002|NOT COMPLETED|Overall Study||23
6406076|NCT00919633|7319136|FG003|NOT COMPLETED|Overall Study||21
6406077|NCT00919711|7319148|FG000|STARTED|Overall Study||435
6406078|NCT00919711|7319149|FG001|STARTED|Overall Study||435
6406079|NCT00919711|7319148|FG000|COMPLETED|Overall Study||402
6406080|NCT00919711|7319149|FG001|COMPLETED|Overall Study||422
6406081|NCT00919711|7319148|FG000|NOT COMPLETED|Overall Study||33
6406082|NCT00919711|7319149|FG001|NOT COMPLETED|Overall Study||13
6406083|NCT00919724|7319157|FG000|STARTED|Overall Study||45
6406084|NCT00919724|7319158|FG001|STARTED|Overall Study||44
6406085|NCT00919724|7319157|FG000|COMPLETED|Overall Study||45
6406086|NCT00919724|7319158|FG001|COMPLETED|Overall Study||44
6406087|NCT00919724|7319157|FG000|NOT COMPLETED|Overall Study||0
6406088|NCT00919724|7319158|FG001|NOT COMPLETED|Overall Study||0
6406089|NCT00919763|7319166|FG000|STARTED|Overall Study||53
6406090|NCT00919763|7319167|FG001|STARTED|Overall Study||49
6406091|NCT00919763|7319166|FG000|COMPLETED|Overall Study||41
6406092|NCT00919763|7319167|FG001|COMPLETED|Overall Study||45
6406093|NCT00919763|7319166|FG000|NOT COMPLETED|Overall Study||12
6406094|NCT00919763|7319167|FG001|NOT COMPLETED|Overall Study||4
6406095|NCT00919802|7319173|FG000|STARTED|First Intervention - (24 Hours)||12
6406096|NCT00919802|7319174|FG001|STARTED|First Intervention - (24 Hours)||13
6406097|NCT00919802|7319173|FG000|COMPLETED|First Intervention - (24 Hours)||12
6406098|NCT00919802|7319174|FG001|COMPLETED|First Intervention - (24 Hours)||13
6406099|NCT00919802|7319173|FG000|NOT COMPLETED|First Intervention - (24 Hours)||0
6406100|NCT00919802|7319174|FG001|NOT COMPLETED|First Intervention - (24 Hours)||0
6406101|NCT00919802|7319173|FG000|STARTED|Second Intervention - (24 Hours)||12
6406102|NCT00919802|7319174|FG001|STARTED|Second Intervention - (24 Hours)||13
6406103|NCT00919802|7319173|FG000|COMPLETED|Second Intervention - (24 Hours)||12
6406104|NCT00919802|7319174|FG001|COMPLETED|Second Intervention - (24 Hours)||13
6406105|NCT00919802|7319173|FG000|NOT COMPLETED|Second Intervention - (24 Hours)||0
6406106|NCT00919802|7319174|FG001|NOT COMPLETED|Second Intervention - (24 Hours)||0
6406107|NCT00919854|7319180|FG000|STARTED|Overall Study||21
6406108|NCT00919854|7319180|FG000|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
6406109|NCT00919854|7319180|FG000|NOT COMPLETED|Overall Study||1
6406110|NCT00919867|7319190|FG000|STARTED|First Intervention||7
6406111|NCT00919867|7319191|FG001|STARTED|First Intervention||7
6406112|NCT00919867|7319192|FG002|STARTED|First Intervention||7
6406113|NCT00919867|7319193|FG003|STARTED|First Intervention||7
6406114|NCT00919867|7319194|FG004|STARTED|First Intervention||7
6406115|NCT00919867|7319195|FG005|STARTED|First Intervention||7
6406116|NCT00919867|7319190|FG000|COMPLETED|First Intervention||7
6406117|NCT00919867|7319191|FG001|COMPLETED|First Intervention||7
6406118|NCT00919867|7319192|FG002|COMPLETED|First Intervention||6
6406119|NCT00919867|7319193|FG003|COMPLETED|First Intervention||7
6406120|NCT00919867|7319194|FG004|COMPLETED|First Intervention||7
6406121|NCT00919867|7319195|FG005|COMPLETED|First Intervention||6
6406122|NCT00919867|7319190|FG000|NOT COMPLETED|First Intervention||0
6406123|NCT00919867|7319191|FG001|NOT COMPLETED|First Intervention||0
6406124|NCT00919867|7319192|FG002|NOT COMPLETED|First Intervention||1
6406125|NCT00919867|7319193|FG003|NOT COMPLETED|First Intervention||0
6406126|NCT00919867|7319194|FG004|NOT COMPLETED|First Intervention||0
6406127|NCT00919867|7319195|FG005|NOT COMPLETED|First Intervention||1
6406128|NCT00919867|7319190|FG000|STARTED|Washout||7
6406129|NCT00919867|7319191|FG001|STARTED|Washout||7
6406130|NCT00919867|7319192|FG002|STARTED|Washout||6
6406131|NCT00919867|7319193|FG003|STARTED|Washout||7
6406132|NCT00919867|7319194|FG004|STARTED|Washout||7
6406133|NCT00919867|7319195|FG005|STARTED|Washout||6
6406134|NCT00919867|7319190|FG000|COMPLETED|Washout||7
6406135|NCT00919867|7319191|FG001|COMPLETED|Washout||7
6406136|NCT00919867|7319192|FG002|COMPLETED|Washout||6
6406137|NCT00919867|7319193|FG003|COMPLETED|Washout||7
6406138|NCT00919867|7319194|FG004|COMPLETED|Washout||7
6406139|NCT00919867|7319195|FG005|COMPLETED|Washout||6
6406140|NCT00919867|7319190|FG000|NOT COMPLETED|Washout||0
6406141|NCT00919867|7319191|FG001|NOT COMPLETED|Washout||0
6406142|NCT00919867|7319192|FG002|NOT COMPLETED|Washout||0
6406143|NCT00919867|7319193|FG003|NOT COMPLETED|Washout||0
6406144|NCT00919867|7319194|FG004|NOT COMPLETED|Washout||0
6406145|NCT00919867|7319195|FG005|NOT COMPLETED|Washout||0
6406146|NCT00919867|7319190|FG000|STARTED|Second Intervention||7
6406147|NCT00919867|7319191|FG001|STARTED|Second Intervention||7
6406148|NCT00919867|7319192|FG002|STARTED|Second Intervention||6
6406149|NCT00919867|7319193|FG003|STARTED|Second Intervention||7
6406150|NCT00919867|7319194|FG004|STARTED|Second Intervention||7
6406151|NCT00919867|7319195|FG005|STARTED|Second Intervention||6
6406152|NCT00919867|7319190|FG000|COMPLETED|Second Intervention||7
6406153|NCT00919867|7319191|FG001|COMPLETED|Second Intervention||7
6406154|NCT00919867|7319192|FG002|COMPLETED|Second Intervention||6
6406155|NCT00919867|7319193|FG003|COMPLETED|Second Intervention||7
6406156|NCT00919867|7319194|FG004|COMPLETED|Second Intervention||7
6406157|NCT00919867|7319195|FG005|COMPLETED|Second Intervention||6
6406158|NCT00919867|7319190|FG000|NOT COMPLETED|Second Intervention||0
6406159|NCT00919867|7319191|FG001|NOT COMPLETED|Second Intervention||0
6406160|NCT00919867|7319192|FG002|NOT COMPLETED|Second Intervention||0
6406161|NCT00919867|7319193|FG003|NOT COMPLETED|Second Intervention||0
6406162|NCT00919867|7319194|FG004|NOT COMPLETED|Second Intervention||0
6406163|NCT00919867|7319195|FG005|NOT COMPLETED|Second Intervention||0
6406164|NCT00919867|7319190|FG000|STARTED|Washout||7
6406165|NCT00919867|7319191|FG001|STARTED|Washout||7
6406166|NCT00919867|7319192|FG002|STARTED|Washout||6
6406167|NCT00919867|7319193|FG003|STARTED|Washout||7
6406168|NCT00919867|7319194|FG004|STARTED|Washout||7
6406169|NCT00919867|7319195|FG005|STARTED|Washout||6
6406170|NCT00919867|7319190|FG000|COMPLETED|Washout||7
6406171|NCT00919867|7319191|FG001|COMPLETED|Washout||7
6406172|NCT00919867|7319192|FG002|COMPLETED|Washout||6
6406173|NCT00919867|7319193|FG003|COMPLETED|Washout||7
6406174|NCT00919867|7319194|FG004|COMPLETED|Washout||7
6406175|NCT00919867|7319195|FG005|COMPLETED|Washout||6
6406176|NCT00919867|7319190|FG000|NOT COMPLETED|Washout||0
6406177|NCT00919867|7319191|FG001|NOT COMPLETED|Washout||0
6406178|NCT00919867|7319192|FG002|NOT COMPLETED|Washout||0
6406179|NCT00919867|7319193|FG003|NOT COMPLETED|Washout||0
6406180|NCT00919867|7319194|FG004|NOT COMPLETED|Washout||0
6406181|NCT00919867|7319195|FG005|NOT COMPLETED|Washout||0
6406182|NCT00919867|7319190|FG000|STARTED|Third Intervention||7
6406183|NCT00919867|7319191|FG001|STARTED|Third Intervention||7
6406184|NCT00919867|7319192|FG002|STARTED|Third Intervention||6
6406185|NCT00919867|7319193|FG003|STARTED|Third Intervention||7
6406186|NCT00919867|7319194|FG004|STARTED|Third Intervention||7
6406187|NCT00919867|7319195|FG005|STARTED|Third Intervention||6
6406188|NCT00919867|7319190|FG000|COMPLETED|Third Intervention||7
6406189|NCT00919867|7319191|FG001|COMPLETED|Third Intervention||7
6406190|NCT00919867|7319192|FG002|COMPLETED|Third Intervention||6
6406191|NCT00919867|7319193|FG003|COMPLETED|Third Intervention||7
6406192|NCT00919867|7319194|FG004|COMPLETED|Third Intervention||7
6406193|NCT00919867|7319195|FG005|COMPLETED|Third Intervention||6
6406194|NCT00919867|7319190|FG000|NOT COMPLETED|Third Intervention||0
6406195|NCT00919867|7319191|FG001|NOT COMPLETED|Third Intervention||0
6406196|NCT00919867|7319192|FG002|NOT COMPLETED|Third Intervention||0
6406197|NCT00919867|7319193|FG003|NOT COMPLETED|Third Intervention||0
6406198|NCT00919867|7319194|FG004|NOT COMPLETED|Third Intervention||0
6406199|NCT00919867|7319195|FG005|NOT COMPLETED|Third Intervention||0
6406200|NCT00919932|7319205|FG000|STARTED|Overall Study||4
6406201|NCT00919932|7319206|FG001|STARTED|Overall Study||5
6406202|NCT00919932|7319205|FG000|COMPLETED|Overall Study||4
6406203|NCT00919932|7319206|FG001|COMPLETED|Overall Study||5
6406204|NCT00919932|7319205|FG000|NOT COMPLETED|Overall Study||0
6406205|NCT00919932|7319206|FG001|NOT COMPLETED|Overall Study||0
6406206|NCT00920023|7319212|FG000|STARTED|Overall Study||15
6406207|NCT00920023|7319212|FG000|COMPLETED|Overall Study||15
6406208|NCT00920023|7319212|FG000|NOT COMPLETED|Overall Study||0
6406209|NCT00920075|7319216|FG000|STARTED|Last Study, 25 Pts Invited,11 Responded||11
6406210|NCT00920075|7319216|FG000|COMPLETED|Last Study, 25 Pts Invited,11 Responded||11
6406211|NCT00920075|7319216|FG000|NOT COMPLETED|Last Study, 25 Pts Invited,11 Responded||0
6406212|NCT00920075|7319216|FG000|STARTED|Post Study, 11 Pts Responded||11
6406213|NCT00920075|7319216|FG000|COMPLETED|Post Study, 11 Pts Responded||11
6406214|NCT00920075|7319216|FG000|NOT COMPLETED|Post Study, 11 Pts Responded||0
6406215|NCT00920140|7319225|FG000|STARTED|Phase 1 (Dose Escalation)||5
6406216|NCT00920140|7319226|FG001|STARTED|Phase 1 (Dose Escalation)||9
6406217|NCT00920140|7319227|FG002|STARTED|Phase 1 (Dose Escalation)||0
6406218|NCT00920140|7319228|FG003|STARTED|Phase 1 (Dose Escalation)||0
6406219|NCT00920140|7319229|FG004|STARTED|Phase 1 (Dose Escalation)||0
6406220|NCT00920140|7319225|FG000|COMPLETED|Phase 1 (Dose Escalation)||0
6406221|NCT00920140|7319226|FG001|COMPLETED|Phase 1 (Dose Escalation)||0
6406222|NCT00920140|7319227|FG002|COMPLETED|Phase 1 (Dose Escalation)||0
6406223|NCT00920140|7319228|FG003|COMPLETED|Phase 1 (Dose Escalation)||0
6406224|NCT00920140|7319229|FG004|COMPLETED|Phase 1 (Dose Escalation)||0
6406225|NCT00920140|7319225|FG000|NOT COMPLETED|Phase 1 (Dose Escalation)||5
6406226|NCT00920140|7319226|FG001|NOT COMPLETED|Phase 1 (Dose Escalation)||9
6406227|NCT00920140|7319227|FG002|NOT COMPLETED|Phase 1 (Dose Escalation)||0
6406228|NCT00920140|7319228|FG003|NOT COMPLETED|Phase 1 (Dose Escalation)||0
6406229|NCT00920140|7319229|FG004|NOT COMPLETED|Phase 1 (Dose Escalation)||0
6406230|NCT00920140|7319225|FG000|STARTED|Phase 2||0
6406231|NCT00920140|7319226|FG001|STARTED|Phase 2||0
6406232|NCT00920140|7319227|FG002|STARTED|Phase 2||50
6406233|NCT00920140|7319228|FG003|STARTED|Phase 2||22
6406234|NCT00920140|7319229|FG004|STARTED|Phase 2||11
6406235|NCT00920140|7319225|FG000|COMPLETED|Phase 2||0
6406236|NCT00920140|7319226|FG001|COMPLETED|Phase 2||0
6406237|NCT00920140|7319227|FG002|COMPLETED|Phase 2||0
6406238|NCT00920140|7319228|FG003|COMPLETED|Phase 2||0
6406239|NCT00920140|7319229|FG004|COMPLETED|Phase 2||0
6406240|NCT00920140|7319225|FG000|NOT COMPLETED|Phase 2||0
6406241|NCT00920140|7319226|FG001|NOT COMPLETED|Phase 2||0
6406242|NCT00920140|7319227|FG002|NOT COMPLETED|Phase 2||50
6406243|NCT00920140|7319228|FG003|NOT COMPLETED|Phase 2||22
6406244|NCT00920140|7319229|FG004|NOT COMPLETED|Phase 2||11
6406245|NCT00920218|7319246|FG000|STARTED|Overall Study||30
6406246|NCT00920218|7319247|FG001|STARTED|Overall Study||29
6406247|NCT00920218|7319248|FG002|STARTED|Overall Study||31
6406248|NCT00920218|7319249|FG003|STARTED|Overall Study||30
6406249|NCT00920218|7319246|FG000|COMPLETED|Overall Study||28
6406250|NCT00920218|7319247|FG001|COMPLETED|Overall Study||24
6406251|NCT00920218|7319248|FG002|COMPLETED|Overall Study||23
6406252|NCT00920218|7319249|FG003|COMPLETED|Overall Study||23
6406253|NCT00920218|7319246|FG000|NOT COMPLETED|Overall Study||2
6406254|NCT00920218|7319247|FG001|NOT COMPLETED|Overall Study||5
6406255|NCT00920218|7319248|FG002|NOT COMPLETED|Overall Study||8
6406256|NCT00920218|7319249|FG003|NOT COMPLETED|Overall Study||7
6406257|NCT00920231|7319265|FG000|STARTED|Overall Study||8
6406258|NCT00920231|7319266|FG001|STARTED|Overall Study||8
6406259|NCT00920231|7319265|FG000|COMPLETED|Overall Study||8
6406260|NCT00920231|7319266|FG001|COMPLETED|Overall Study||8
6406261|NCT00920231|7319265|FG000|NOT COMPLETED|Overall Study||0
6406262|NCT00920231|7319266|FG001|NOT COMPLETED|Overall Study||0
6406263|NCT00920374|7319276|FG000|STARTED|Overall Study||61
6406264|NCT00920374|7319277|FG001|STARTED|Overall Study||57
6406265|NCT00920374|7319276|FG000|COMPLETED|Overall Study||61
6406266|NCT00920374|7319277|FG001|COMPLETED|Overall Study||57
6406267|NCT00920374|7319276|FG000|NOT COMPLETED|Overall Study||0
6406268|NCT00920374|7319277|FG001|NOT COMPLETED|Overall Study||0
6406269|NCT00920426|7319286|FG000|STARTED|ITZ111451||8
6406270|NCT00920426|7319287|FG001|STARTED|ITZ111451||0
6406271|NCT00920426|7319288|FG002|STARTED|ITZ111451||0
6406272|NCT00920426|7319289|FG003|STARTED|ITZ111451||0
6406273|NCT00920426|7319286|FG000|COMPLETED|ITZ111451||7
6406274|NCT00920426|7319287|FG001|COMPLETED|ITZ111451||0
6406275|NCT00920426|7319288|FG002|COMPLETED|ITZ111451||0
6406276|NCT00920426|7319289|FG003|COMPLETED|ITZ111451||0
6406277|NCT00920426|7319286|FG000|NOT COMPLETED|ITZ111451||1
6406278|NCT00920426|7319287|FG001|NOT COMPLETED|ITZ111451||0
6406279|NCT00920426|7319288|FG002|NOT COMPLETED|ITZ111451||0
6406280|NCT00920426|7319289|FG003|NOT COMPLETED|ITZ111451||0
6406281|NCT00920426|7319286|FG000|STARTED|ITZ112929: Randomized Regimen||0
6406282|NCT00920426|7319287|FG001|STARTED|ITZ112929: Randomized Regimen||7
6406283|NCT00920426|7319288|FG002|STARTED|ITZ112929: Randomized Regimen||2
6406284|NCT00920426|7319289|FG003|STARTED|ITZ112929: Randomized Regimen||0
6406285|NCT00920426|7319286|FG000|COMPLETED|ITZ112929: Randomized Regimen||0
6406286|NCT00920426|7319287|FG001|COMPLETED|ITZ112929: Randomized Regimen||7
6406287|NCT00920426|7319288|FG002|COMPLETED|ITZ112929: Randomized Regimen||2
6635688|NCT02307370|7564581|FG000|180 Day Patient Telephone Contact|Overall Study||25
6635689|NCT02307370|7564581|FG000|COMPLETED|Overall Study||25
6635690|NCT02307370|7564581|FG000|NOT COMPLETED|Overall Study||19
6406288|NCT00920426|7319289|FG003|COMPLETED|ITZ112929: Randomized Regimen||0
6406289|NCT00920426|7319286|FG000|NOT COMPLETED|ITZ112929: Randomized Regimen||0
6406290|NCT00920426|7319287|FG001|NOT COMPLETED|ITZ112929: Randomized Regimen||0
6406291|NCT00920426|7319288|FG002|NOT COMPLETED|ITZ112929: Randomized Regimen||0
6406292|NCT00920426|7319289|FG003|NOT COMPLETED|ITZ112929: Randomized Regimen||0
6406293|NCT00920426|7319286|FG000|STARTED|ITZ112929: Optimized Therapy (OT)||0
6406294|NCT00920426|7319287|FG001|STARTED|ITZ112929: Optimized Therapy (OT)||0
6406295|NCT00920426|7319288|FG002|STARTED|ITZ112929: Optimized Therapy (OT)||0
6406296|NCT00920426|7319289|FG003|STARTED|ITZ112929: Optimized Therapy (OT)|Out of 9 participants receiving randomized regimen, 8 participants continued to receive OT.|8
6406297|NCT00920426|7319286|FG000|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6406298|NCT00920426|7319287|FG001|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6406299|NCT00920426|7319288|FG002|COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6406300|NCT00920426|7319289|FG003|COMPLETED|ITZ112929: Optimized Therapy (OT)||8
6406301|NCT00920426|7319286|FG000|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6406302|NCT00920426|7319287|FG001|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6406303|NCT00920426|7319288|FG002|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6406304|NCT00920426|7319289|FG003|NOT COMPLETED|ITZ112929: Optimized Therapy (OT)||0
6406305|NCT00920439|7319301|FG000|STARTED|Overall Study||25
6406306|NCT00920439|7319301|FG000|COMPLETED|Overall Study||25
6406307|NCT00920439|7319301|FG000|NOT COMPLETED|Overall Study||0
6406308|NCT00920556|7319305|FG000|STARTED|Overall Study||24
6406309|NCT00920556|7319305|FG000|COMPLETED|Overall Study||0
6406310|NCT00920556|7319305|FG000|NOT COMPLETED|Overall Study||24
6406311|NCT00920647|7319317|FG000|STARTED|Overall Study||4
6406312|NCT00920647|7319318|FG001|STARTED|Overall Study||4
6406313|NCT00920647|7319319|FG002|STARTED|Overall Study||4
6406314|NCT00920647|7319320|FG003|STARTED|Overall Study||4
6406315|NCT00920647|7319317|FG000|COMPLETED|Overall Study||4
6406316|NCT00920647|7319318|FG001|COMPLETED|Overall Study||4
6406317|NCT00920647|7319319|FG002|COMPLETED|Overall Study||4
6406318|NCT00920647|7319320|FG003|COMPLETED|Overall Study||4
6406319|NCT00920647|7319317|FG000|NOT COMPLETED|Overall Study||0
6406320|NCT00920647|7319318|FG001|NOT COMPLETED|Overall Study||0
6406321|NCT00920647|7319319|FG002|NOT COMPLETED|Overall Study||0
6406322|NCT00920647|7319320|FG003|NOT COMPLETED|Overall Study||0
6406323|NCT00920686|7319343|FG000|STARTED|Overall Study||82
6406324|NCT00920686|7319344|FG001|STARTED|Overall Study||82
6406325|NCT00920686|7319345|FG002|STARTED|Overall Study||75
6406326|NCT00920686|7319343|FG000|COMPLETED|Overall Study||63
6406327|NCT00920686|7319344|FG001|COMPLETED|Overall Study||60
6406328|NCT00920686|7319345|FG002|COMPLETED|Overall Study||62
6406329|NCT00920686|7319343|FG000|NOT COMPLETED|Overall Study||19
6635691|NCT02307513|7564589|FG000|STARTED|Placebo Controlled Phase (Weeks 0-12)||103
6406330|NCT00920686|7319344|FG001|NOT COMPLETED|Overall Study||22
6406331|NCT00920686|7319345|FG002|NOT COMPLETED|Overall Study||13
6406332|NCT00920699|7319360|FG000|STARTED|Overall Study||29
6406333|NCT00920699|7319361|FG001|STARTED|Overall Study||30
6406334|NCT00920699|7319362|FG002|STARTED|Overall Study||32
6406335|NCT00920699|7319360|FG000|COMPLETED|Overall Study||27
6406336|NCT00920699|7319361|FG001|COMPLETED|Overall Study||29
6406337|NCT00920699|7319362|FG002|COMPLETED|Overall Study||28
6406338|NCT00920699|7319360|FG000|NOT COMPLETED|Overall Study||2
6406339|NCT00920699|7319361|FG001|NOT COMPLETED|Overall Study||1
6406340|NCT00920699|7319362|FG002|NOT COMPLETED|Overall Study||4
6635692|NCT02307513|7564590|FG001|STARTED|Placebo Controlled Phase (Weeks 0-12)||104
6635693|NCT02307513|7564589|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||83
6635694|NCT02307513|7564590|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-12)||96
6635695|NCT02307513|7564589|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||20
6655679|NCT02454608|7585843|FG000|NOT COMPLETED|Double-Blind Period||0
6406341|NCT00920790|7319370|FG000|STARTED|Overall Study||27
6406342|NCT00920790|7319370|FG000|COMPLETED|Overall Study||13
6406343|NCT00920790|7319370|FG000|NOT COMPLETED|Overall Study||14
6406344|NCT00920816|7319378|FG000|STARTED|Overall Study||192
6406345|NCT00920816|7319379|FG001|STARTED|Overall Study||96
6406346|NCT00920816|7319380|FG002|STARTED|Overall Study||135
6406347|NCT00920816|7319381|FG003|STARTED|Overall Study||69
6406348|NCT00920816|7319378|FG000|Treated|Overall Study||189
6406349|NCT00920816|7319379|FG001|Treated|Overall Study||96
6406350|NCT00920816|7319380|FG002|Treated|Overall Study||135
6406351|NCT00920816|7319381|FG003|Treated|Overall Study||69
6406352|NCT00920816|7319378|FG000|COMPLETED|Overall Study||0
6406353|NCT00920816|7319379|FG001|COMPLETED|Overall Study||0
6406354|NCT00920816|7319380|FG002|COMPLETED|Overall Study||0
6406355|NCT00920816|7319381|FG003|COMPLETED|Overall Study||0
6406356|NCT00920816|7319378|FG000|NOT COMPLETED|Overall Study||192
6406357|NCT00920816|7319379|FG001|NOT COMPLETED|Overall Study||96
6406358|NCT00920816|7319380|FG002|NOT COMPLETED|Overall Study||135
6406359|NCT00920816|7319381|FG003|NOT COMPLETED|Overall Study||69
6406360|NCT00920829|7319395|FG000|STARTED|Allocation||38
6406361|NCT00920829|7319396|FG001|STARTED|Allocation||39
6406362|NCT00920829|7319397|FG002|STARTED|Allocation||38
6406363|NCT00920829|7319398|FG003|STARTED|Allocation||37
6406364|NCT00920829|7319395|FG000|COMPLETED|Allocation||35
6406365|NCT00920829|7319396|FG001|COMPLETED|Allocation||38
6406366|NCT00920829|7319397|FG002|COMPLETED|Allocation||38
6406367|NCT00920829|7319398|FG003|COMPLETED|Allocation||35
6406368|NCT00920829|7319395|FG000|NOT COMPLETED|Allocation||3
6406369|NCT00920829|7319396|FG001|NOT COMPLETED|Allocation||1
6406370|NCT00920829|7319397|FG002|NOT COMPLETED|Allocation||0
6406371|NCT00920829|7319398|FG003|NOT COMPLETED|Allocation||2
6406372|NCT00920829|7319395|FG000|STARTED|Available for Analysis||35
6406373|NCT00920829|7319396|FG001|STARTED|Available for Analysis||38
6406374|NCT00920829|7319397|FG002|STARTED|Available for Analysis||38
6406375|NCT00920829|7319398|FG003|STARTED|Available for Analysis||35
6406376|NCT00920829|7319395|FG000|COMPLETED|Available for Analysis||27
6406377|NCT00920829|7319396|FG001|COMPLETED|Available for Analysis||27
6406378|NCT00920829|7319397|FG002|COMPLETED|Available for Analysis||28
6406379|NCT00920829|7319398|FG003|COMPLETED|Available for Analysis||24
6406380|NCT00920829|7319395|FG000|NOT COMPLETED|Available for Analysis||8
6406381|NCT00920829|7319396|FG001|NOT COMPLETED|Available for Analysis||11
6406382|NCT00920829|7319397|FG002|NOT COMPLETED|Available for Analysis||10
6406383|NCT00920829|7319398|FG003|NOT COMPLETED|Available for Analysis||11
6406384|NCT00920855|7319411|FG000|STARTED|Overall Study||5
6406385|NCT00920855|7319412|FG001|STARTED|Overall Study||4
6406386|NCT00920855|7319413|FG002|STARTED|Overall Study||31
6406387|NCT00920855|7319411|FG000|Safety and Efficacy Populations|Overall Study||5
6406388|NCT00920855|7319412|FG001|Safety and Efficacy Populations|Overall Study||4
6406389|NCT00920855|7319413|FG002|Safety and Efficacy Populations|Overall Study||31
6406390|NCT00920855|7319411|FG000|COMPLETED|Overall Study|completed eight cycles of treatment|0
6406391|NCT00920855|7319412|FG001|COMPLETED|Overall Study|completed eight cycles of treatment|1
6406392|NCT00920855|7319413|FG002|COMPLETED|Overall Study|completed eight cycles of treatment|9
6406393|NCT00920855|7319411|FG000|NOT COMPLETED|Overall Study||5
6406394|NCT00920855|7319412|FG001|NOT COMPLETED|Overall Study||3
6406395|NCT00920855|7319413|FG002|NOT COMPLETED|Overall Study||22
6406396|NCT00920907|7319424|FG000|STARTED|Induction Period||37
6406397|NCT00920907|7319425|FG001|STARTED|Induction Period||38
6406398|NCT00920907|7319424|FG000|COMPLETED|Induction Period||15
6406399|NCT00920907|7319425|FG001|COMPLETED|Induction Period||16
6406400|NCT00920907|7319424|FG000|NOT COMPLETED|Induction Period||22
6406401|NCT00920907|7319425|FG001|NOT COMPLETED|Induction Period||22
6406402|NCT00920907|7319424|FG000|STARTED|Maintenance Period||15
6406403|NCT00920907|7319425|FG001|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
6406404|NCT00920907|7319424|FG000|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
6406405|NCT00920907|7319425|FG001|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
6406406|NCT00920907|7319424|FG000|NOT COMPLETED|Maintenance Period||12
6406407|NCT00920907|7319425|FG001|NOT COMPLETED|Maintenance Period||13
6406408|NCT00921024|7319435|FG000|STARTED|Overall Study||85
6406409|NCT00921024|7319436|FG001|STARTED|Overall Study||42
6406410|NCT00921024|7319435|FG000|COMPLETED|Overall Study||81
6406411|NCT00921024|7319436|FG001|COMPLETED|Overall Study||39
6406412|NCT00921024|7319435|FG000|NOT COMPLETED|Overall Study||4
6406413|NCT00921024|7319436|FG001|NOT COMPLETED|Overall Study||3
6406414|NCT00921115|7319442|FG000|STARTED|Overall Study||42
6406415|NCT00921115|7319442|FG000|COMPLETED|Overall Study||42
6406416|NCT00921115|7319442|FG000|NOT COMPLETED|Overall Study||0
6406417|NCT00921310|7319448|FG000|STARTED|Overall Study||2
6406418|NCT00921310|7319449|FG001|STARTED|Overall Study||6
6406419|NCT00921310|7319450|FG002|STARTED|Overall Study||4
6406420|NCT00921310|7319448|FG000|COMPLETED|Overall Study||2
6406421|NCT00921310|7319449|FG001|COMPLETED|Overall Study||6
6406422|NCT00921310|7319450|FG002|COMPLETED|Overall Study||4
6406423|NCT00921310|7319448|FG000|NOT COMPLETED|Overall Study||0
6406424|NCT00921310|7319449|FG001|NOT COMPLETED|Overall Study||0
6406425|NCT00921310|7319450|FG002|NOT COMPLETED|Overall Study||0
6406426|NCT00921518|7319464|FG000|STARTED|Overall Study||48
6406427|NCT00921518|7319465|FG001|STARTED|Overall Study||44
6406428|NCT00921518|7319464|FG000|COMPLETED|Overall Study||48
6406429|NCT00921518|7319465|FG001|COMPLETED|Overall Study||44
6406430|NCT00921518|7319464|FG000|NOT COMPLETED|Overall Study||0
6406431|NCT00921518|7319465|FG001|NOT COMPLETED|Overall Study||0
6406432|NCT00921557|7319474|FG000|STARTED|Weeks 0-48 (on Study Treatment)||17
6406433|NCT00921557|7319475|FG001|STARTED|Weeks 0-48 (on Study Treatment)||17
6406434|NCT00921557|7319476|FG002|STARTED|Weeks 0-48 (on Study Treatment)||18
6406435|NCT00921557|7319474|FG000|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
6406436|NCT00921557|7319475|FG001|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
6406437|NCT00921557|7319476|FG002|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
6406438|NCT00921557|7319474|FG000|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
6406439|NCT00921557|7319475|FG001|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
6406440|NCT00921557|7319476|FG002|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
6406441|NCT00921557|7319474|FG000|STARTED|Weeks 48-96 (on Study Treatment)||15
6406442|NCT00921557|7319475|FG001|STARTED|Weeks 48-96 (on Study Treatment)||17
6406443|NCT00921557|7319476|FG002|STARTED|Weeks 48-96 (on Study Treatment)||18
6406444|NCT00921557|7319474|FG000|COMPLETED|Weeks 48-96 (on Study Treatment)||15
6406445|NCT00921557|7319475|FG001|COMPLETED|Weeks 48-96 (on Study Treatment)||16
6406446|NCT00921557|7319476|FG002|COMPLETED|Weeks 48-96 (on Study Treatment)||17
6406447|NCT00921557|7319474|FG000|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
6406448|NCT00921557|7319475|FG001|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
6406449|NCT00921557|7319476|FG002|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
6406450|NCT00921557|7319474|FG000|STARTED|Weeks 96-144 (Off Study Treatment)||15
6406451|NCT00921557|7319475|FG001|STARTED|Weeks 96-144 (Off Study Treatment)||16
6406452|NCT00921557|7319476|FG002|STARTED|Weeks 96-144 (Off Study Treatment)||17
6406453|NCT00921557|7319474|FG000|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
6406454|NCT00921557|7319475|FG001|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
6406455|NCT00921557|7319476|FG002|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
6406456|NCT00921557|7319474|FG000|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
6406457|NCT00921557|7319475|FG001|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
6406458|NCT00921557|7319476|FG002|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
6406459|NCT00921687|7319491|FG000|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
6406460|NCT00921687|7319492|FG001|STARTED|Overall Study||363
6406461|NCT00921687|7319491|FG000|COMPLETED|Overall Study||418
6406462|NCT00921687|7319492|FG001|COMPLETED|Overall Study||363
6406463|NCT00921687|7319491|FG000|NOT COMPLETED|Overall Study||0
6406464|NCT00921687|7319492|FG001|NOT COMPLETED|Overall Study||0
6406465|NCT00921843|7319502|FG000|STARTED|Overall Study||10
6406466|NCT00921843|7319503|FG001|STARTED|Overall Study||10
6406467|NCT00921843|7319504|FG002|STARTED|Overall Study||11
6406468|NCT00921843|7319505|FG003|STARTED|Overall Study||30
6406469|NCT00921843|7319502|FG000|COMPLETED|Overall Study||10
6406470|NCT00921843|7319503|FG001|COMPLETED|Overall Study||10
6406471|NCT00921843|7319504|FG002|COMPLETED|Overall Study||11
6406472|NCT00921843|7319505|FG003|COMPLETED|Overall Study||30
6406473|NCT00921843|7319502|FG000|NOT COMPLETED|Overall Study||0
6406474|NCT00921843|7319503|FG001|NOT COMPLETED|Overall Study||0
6406475|NCT00921843|7319504|FG002|NOT COMPLETED|Overall Study||0
6406476|NCT00921843|7319505|FG003|NOT COMPLETED|Overall Study||0
6406477|NCT00921895|7319515|FG000|STARTED|Overall Study||128
6406478|NCT00921895|7319515|FG000|COMPLETED|Overall Study||128
6406479|NCT00921895|7319515|FG000|NOT COMPLETED|Overall Study||0
6406480|NCT00921934|7319520|FG000|STARTED|Overall Study||68
6406481|NCT00921934|7319520|FG000|COMPLETED|Overall Study||68
6406482|NCT00921934|7319520|FG000|NOT COMPLETED|Overall Study||0
6406483|NCT00921947|7319526|FG000|STARTED|Day 0||30
6406484|NCT00921947|7319527|FG001|STARTED|Day 0||30
6406485|NCT00921947|7319526|FG000|COMPLETED|Day 0||30
6406486|NCT00921947|7319527|FG001|COMPLETED|Day 0||30
6406487|NCT00921947|7319526|FG000|NOT COMPLETED|Day 0||0
6406488|NCT00921947|7319527|FG001|NOT COMPLETED|Day 0||0
6406489|NCT00921947|7319526|FG000|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
6406490|NCT00921947|7319527|FG001|STARTED|Day 28||30
6406491|NCT00921947|7319526|FG000|COMPLETED|Day 28||28
6406492|NCT00921947|7319527|FG001|COMPLETED|Day 28||30
6406493|NCT00921947|7319526|FG000|NOT COMPLETED|Day 28||0
6406494|NCT00921947|7319527|FG001|NOT COMPLETED|Day 28||0
6406495|NCT00922116|7319533|FG000|STARTED|Overall Study||191
6406496|NCT00922116|7319533|FG000|COMPLETED|Overall Study||176
6406497|NCT00922116|7319533|FG000|NOT COMPLETED|Overall Study||15
6406498|NCT00922194|7319537|FG000|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
6406499|NCT00922194|7319537|FG000|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
6406500|NCT00922194|7319537|FG000|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
6406501|NCT00922194|7319537|FG000|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
6406502|NCT00922194|7319537|FG000|COMPLETED|Metformin for 12 Months or More||102
6406503|NCT00922194|7319537|FG000|NOT COMPLETED|Metformin for 12 Months or More||0
6406504|NCT00922207|7319544|FG000|STARTED|Overall Study||91
6406505|NCT00922207|7319545|FG001|STARTED|Overall Study||95
6406506|NCT00922207|7319546|FG002|STARTED|Overall Study||94
6406507|NCT00922207|7319544|FG000|COMPLETED|Overall Study||85
6406508|NCT00922207|7319545|FG001|COMPLETED|Overall Study||88
6510322|NCT01481545|7429878|FG000|NOT COMPLETED|Overall Study||5
6510323|NCT01481545|7429879|FG001|NOT COMPLETED|Overall Study||6
6510324|NCT01481558|7429889|FG000|STARTED|Overall Study||20
6510325|NCT01481558|7429890|FG001|STARTED|Overall Study||20
6510326|NCT01481558|7429889|FG000|COMPLETED|Overall Study||20
6510327|NCT01481558|7429890|FG001|COMPLETED|Overall Study||20
6510328|NCT01481558|7429889|FG000|NOT COMPLETED|Overall Study||0
6510329|NCT01481558|7429890|FG001|NOT COMPLETED|Overall Study||0
6510330|NCT01481740|7429898|FG000|STARTED|Overall Study||90
6510331|NCT01481740|7429899|FG001|STARTED|Overall Study||88
6510332|NCT01481740|7429898|FG000|COMPLETED|Overall Study||79
6510333|NCT01481740|7429899|FG001|COMPLETED|Overall Study||81
6510334|NCT01481740|7429898|FG000|NOT COMPLETED|Overall Study||11
6510335|NCT01481740|7429899|FG001|NOT COMPLETED|Overall Study||7
6510336|NCT01481779|7429907|FG000|STARTED|Overall Study||295
6510337|NCT01481779|7429908|FG001|STARTED|Overall Study||160
6510338|NCT01481779|7429907|FG000|Received at Least 1 Dose of Study Drug|Overall Study||294
6510339|NCT01481779|7429908|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
6510340|NCT01481779|7429907|FG000|COMPLETED|Overall Study||225
6510341|NCT01481779|7429908|FG001|COMPLETED|Overall Study||132
6510342|NCT01481779|7429907|FG000|NOT COMPLETED|Overall Study||70
6510343|NCT01481779|7429908|FG001|NOT COMPLETED|Overall Study||28
6510344|NCT01481896|7429914|FG000|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
6510345|NCT01481896|7429914|FG000|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
6510346|NCT01481896|7429914|FG000|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
6510347|NCT01481896|7429914|FG000|NOT COMPLETED|Overall Study||12
6510348|NCT01482065|7429930|FG000|STARTED|Overall Study||4
6510349|NCT01482065|7429931|FG001|STARTED|Overall Study||5
6510350|NCT01482065|7429930|FG000|COMPLETED|Overall Study||4
6510351|NCT01482065|7429931|FG001|COMPLETED|Overall Study||4
6510352|NCT01482065|7429930|FG000|NOT COMPLETED|Overall Study||0
6510353|NCT01482065|7429931|FG001|NOT COMPLETED|Overall Study||1
6510354|NCT01482091|7429939|FG000|STARTED|Overall Study||25
6510355|NCT01482091|7429940|FG001|STARTED|Overall Study||24
6510356|NCT01482091|7429939|FG000|COMPLETED|Overall Study||25
6510357|NCT01482091|7429940|FG001|COMPLETED|Overall Study||24
6510358|NCT01482091|7429939|FG000|NOT COMPLETED|Overall Study||0
6510359|NCT01482091|7429940|FG001|NOT COMPLETED|Overall Study||0
6510360|NCT01482169|7429946|FG000|STARTED|Overall Study||48
6510361|NCT01482169|7429946|FG000|COMPLETED|Overall Study||46
6510362|NCT01482169|7429946|FG000|NOT COMPLETED|Overall Study||2
6510363|NCT01482221|7429956|FG000|STARTED|Overall Study||101
6510364|NCT01482221|7429957|FG001|STARTED|Overall Study||101
6510365|NCT01482221|7429958|FG002|STARTED|Overall Study||100
6510366|NCT01482221|7429956|FG000|COMPLETED|Overall Study||80
6510367|NCT01482221|7429957|FG001|COMPLETED|Overall Study||81
6510368|NCT01482221|7429958|FG002|COMPLETED|Overall Study||77
6510369|NCT01482221|7429956|FG000|NOT COMPLETED|Overall Study||21
6510370|NCT01482221|7429957|FG001|NOT COMPLETED|Overall Study||20
6510371|NCT01482221|7429958|FG002|NOT COMPLETED|Overall Study||23
6510372|NCT01482312|7429966|FG000|STARTED|Period 1, 90 Minutes of Wear||10
6510373|NCT01482312|7429967|FG001|STARTED|Period 1, 90 Minutes of Wear||9
6510374|NCT01482312|7429968|FG002|STARTED|Period 1, 90 Minutes of Wear||10
6510375|NCT01482312|7429966|FG000|COMPLETED|Period 1, 90 Minutes of Wear||9
6510376|NCT01482312|7429967|FG001|COMPLETED|Period 1, 90 Minutes of Wear||9
6510377|NCT01482312|7429968|FG002|COMPLETED|Period 1, 90 Minutes of Wear||10
6510378|NCT01482312|7429966|FG000|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
6510379|NCT01482312|7429967|FG001|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
6510380|NCT01482312|7429968|FG002|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
6510381|NCT01482312|7429966|FG000|STARTED|Period 2, 90 Minutes of Wear||9
6510382|NCT01482312|7429967|FG001|STARTED|Period 2, 90 Minutes of Wear||9
6510383|NCT01482312|7429968|FG002|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
6510384|NCT01482312|7429966|FG000|COMPLETED|Period 2, 90 Minutes of Wear||8
6510385|NCT01482312|7429967|FG001|COMPLETED|Period 2, 90 Minutes of Wear||9
6510386|NCT01482312|7429968|FG002|COMPLETED|Period 2, 90 Minutes of Wear||9
6510387|NCT01482312|7429966|FG000|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
6510388|NCT01482312|7429967|FG001|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
6510389|NCT01482312|7429968|FG002|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
6510390|NCT01482312|7429966|FG000|STARTED|Period 3, 90 Minutes of Wear||8
6510391|NCT01482312|7429967|FG001|STARTED|Period 3, 90 Minutes of Wear||9
6510392|NCT01482312|7429968|FG002|STARTED|Period 3, 90 Minutes of Wear||9
6510393|NCT01482312|7429966|FG000|COMPLETED|Period 3, 90 Minutes of Wear||8
6510394|NCT01482312|7429967|FG001|COMPLETED|Period 3, 90 Minutes of Wear||9
6406509|NCT00922207|7319546|FG002|COMPLETED|Overall Study||90
6406510|NCT00922207|7319544|FG000|NOT COMPLETED|Overall Study||6
6406511|NCT00922207|7319545|FG001|NOT COMPLETED|Overall Study||7
6406512|NCT00922207|7319546|FG002|NOT COMPLETED|Overall Study||4
6406513|NCT00922233|7319554|FG000|STARTED|Overall Study||72
6406514|NCT00922233|7319554|FG000|COMPLETED|Overall Study||68
6406515|NCT00922233|7319554|FG000|NOT COMPLETED|Overall Study||4
6406516|NCT00922272|7319559|FG000|STARTED|Open-label Phase||92
6406517|NCT00922272|7319560|FG001|STARTED|Open-label Phase||0
6406518|NCT00922272|7319559|FG000|COMPLETED|Open-label Phase||69
6406519|NCT00922272|7319560|FG001|COMPLETED|Open-label Phase||0
6406520|NCT00922272|7319559|FG000|NOT COMPLETED|Open-label Phase||23
6406521|NCT00922272|7319560|FG001|NOT COMPLETED|Open-label Phase||0
6406522|NCT00922272|7319559|FG000|STARTED|Double-blind Phase||34
6406523|NCT00922272|7319560|FG001|STARTED|Double-blind Phase||35
6406524|NCT00922272|7319559|FG000|COMPLETED|Double-blind Phase||27
6406525|NCT00922272|7319560|FG001|COMPLETED|Double-blind Phase||29
6406526|NCT00922272|7319559|FG000|NOT COMPLETED|Double-blind Phase||7
6406527|NCT00922272|7319560|FG001|NOT COMPLETED|Double-blind Phase||6
6406528|NCT00922428|7319568|FG000|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
6406529|NCT00922428|7319568|FG000|COMPLETED|Overall Study|for 11 participants no gender was given|1374
6406530|NCT00922428|7319568|FG000|NOT COMPLETED|Overall Study||15
6406531|NCT00922441|7319581|FG000|STARTED|Overall Study||30
6406532|NCT00922441|7319582|FG001|STARTED|Overall Study||30
6406533|NCT00922441|7319583|FG002|STARTED|Overall Study||32
6406534|NCT00922441|7319581|FG000|COMPLETED|Overall Study||30
6406535|NCT00922441|7319582|FG001|COMPLETED|Overall Study||30
6406536|NCT00922441|7319583|FG002|COMPLETED|Overall Study||29
6406537|NCT00922441|7319581|FG000|NOT COMPLETED|Overall Study||0
6406538|NCT00922441|7319582|FG001|NOT COMPLETED|Overall Study||0
6406539|NCT00922441|7319583|FG002|NOT COMPLETED|Overall Study||3
6406540|NCT00922480|7319593|FG000|STARTED|Main Study||250
6406541|NCT00922480|7319594|FG001|STARTED|Main Study||255
6406542|NCT00922480|7319593|FG000|COMPLETED|Main Study||213
6406543|NCT00922480|7319594|FG001|COMPLETED|Main Study||226
6406544|NCT00922480|7319593|FG000|NOT COMPLETED|Main Study||37
6406545|NCT00922480|7319594|FG001|NOT COMPLETED|Main Study||29
6406546|NCT00922480|7319593|FG000|STARTED|Extension Study||73
6406547|NCT00922480|7319594|FG001|STARTED|Extension Study||85
6406548|NCT00922480|7319593|FG000|COMPLETED|Extension Study||68
6406549|NCT00922480|7319594|FG001|COMPLETED|Extension Study||82
6406550|NCT00922480|7319593|FG000|NOT COMPLETED|Extension Study||5
6406551|NCT00922480|7319594|FG001|NOT COMPLETED|Extension Study||3
6406552|NCT00922623|7319602|FG000|STARTED|Overall Study||93
6406553|NCT00922623|7319602|FG000|COMPLETED|Overall Study||88
6406554|NCT00922623|7319602|FG000|NOT COMPLETED|Overall Study||5
6406555|NCT00922636|7319613|FG000|STARTED|Overall Study||36
6406556|NCT00922636|7319614|FG001|STARTED|Overall Study||78
6406557|NCT00922636|7319615|FG002|STARTED|Overall Study||76
6406558|NCT00922636|7319616|FG003|STARTED|Overall Study||75
6406559|NCT00922636|7319617|FG004|STARTED|Overall Study||75
6406560|NCT00922636|7319613|FG000|Entered Optional Taper Phase|Overall Study||4
6406561|NCT00922636|7319614|FG001|Entered Optional Taper Phase|Overall Study||10
6406562|NCT00922636|7319615|FG002|Entered Optional Taper Phase|Overall Study||15
6406563|NCT00922636|7319616|FG003|Entered Optional Taper Phase|Overall Study||7
6406564|NCT00922636|7319617|FG004|Entered Optional Taper Phase|Overall Study||12
6406565|NCT00922636|7319613|FG000|COMPLETED|Overall Study||29
6406566|NCT00922636|7319614|FG001|COMPLETED|Overall Study||62
6406567|NCT00922636|7319615|FG002|COMPLETED|Overall Study||56
6406568|NCT00922636|7319616|FG003|COMPLETED|Overall Study||58
6406569|NCT00922636|7319617|FG004|COMPLETED|Overall Study||59
6406570|NCT00922636|7319613|FG000|NOT COMPLETED|Overall Study||7
6406571|NCT00922636|7319614|FG001|NOT COMPLETED|Overall Study||16
6406572|NCT00922636|7319615|FG002|NOT COMPLETED|Overall Study||20
6406573|NCT00922636|7319616|FG003|NOT COMPLETED|Overall Study||17
6406574|NCT00922636|7319617|FG004|NOT COMPLETED|Overall Study||16
6406575|NCT00922701|7319634|FG000|STARTED|Overall Study||4
6406576|NCT00922701|7319634|FG000|COMPLETED|Overall Study||4
6406577|NCT00922701|7319634|FG000|NOT COMPLETED|Overall Study||0
6406578|NCT00922766|7319638|FG000|STARTED|Overall Study||617
6406579|NCT00922766|7319638|FG000|COMPLETED|Overall Study||610
6406580|NCT00922766|7319638|FG000|NOT COMPLETED|Overall Study||7
6406581|NCT00922779|7319642|FG000|STARTED|Overall Study||6661
6406582|NCT00922779|7319642|FG000|COMPLETED|Overall Study||4334
6406583|NCT00922779|7319642|FG000|NOT COMPLETED|Overall Study||2327
6406584|NCT00922883|7319646|FG000|STARTED|Overall Study||43
6406585|NCT00922883|7319646|FG000|COMPLETED|Overall Study||43
6406586|NCT00922883|7319646|FG000|NOT COMPLETED|Overall Study||0
6406587|NCT00922935|7319653|FG000|STARTED|Overall Study||10
6406588|NCT00922935|7319654|FG001|STARTED|Overall Study||16
6406589|NCT00922935|7319655|FG002|STARTED|Overall Study||10
6406590|NCT00922935|7319653|FG000|COMPLETED|Overall Study||9
6406591|NCT00922935|7319654|FG001|COMPLETED|Overall Study||11
6406592|NCT00922935|7319655|FG002|COMPLETED|Overall Study||10
6406593|NCT00922935|7319653|FG000|NOT COMPLETED|Overall Study||1
6406594|NCT00922935|7319654|FG001|NOT COMPLETED|Overall Study||5
6406595|NCT00922935|7319655|FG002|NOT COMPLETED|Overall Study||0
6406596|NCT00922974|7319666|FG000|STARTED|Phase II Component||46
6406597|NCT00922974|7319667|FG001|STARTED|Phase II Component||0
6406598|NCT00922974|7319666|FG000|Eligible|Phase II Component||44
6406599|NCT00922974|7319667|FG001|Eligible|Phase II Component||0
6406600|NCT00922974|7319666|FG000|Eligible and Started Treatment|Phase II Component||39
6406601|NCT00922974|7319667|FG001|Eligible and Started Treatment|Phase II Component||0
6498793|NCT01412541|7417426|FG001|COMPLETED|Overall Study||117
6406602|NCT00922974|7319666|FG000|Eligible, Treated, Adverse Event Data|Phase II Component||34
6406603|NCT00922974|7319667|FG001|Eligible, Treated, Adverse Event Data|Phase II Component||0
6406604|NCT00922974|7319666|FG000|COMPLETED|Phase II Component|These subjects do not participate in the phase III component.|39
6406605|NCT00922974|7319667|FG001|COMPLETED|Phase II Component||0
6406606|NCT00922974|7319666|FG000|NOT COMPLETED|Phase II Component||7
6406607|NCT00922974|7319667|FG001|NOT COMPLETED|Phase II Component||0
6406608|NCT00922974|7319666|FG000|STARTED|Phase III Component|The phase III component accrues new subjects; these are not continuing phase II subjects.|217
6406609|NCT00922974|7319667|FG001|STARTED|Phase III Component||136
6406610|NCT00922974|7319666|FG000|Eligible|Phase III Component||209
6406611|NCT00922974|7319667|FG001|Eligible|Phase III Component||130
6406612|NCT00922974|7319666|FG000|Eligible With 3 mo. NRPS Data|Phase III Component||139
6406613|NCT00922974|7319667|FG001|Eligible With 3 mo. NRPS Data|Phase III Component||76
6406614|NCT00922974|7319666|FG000|Eligible With 3 mo. FACT-G Data|Phase III Component||87
6406615|NCT00922974|7319667|FG001|Eligible With 3 mo. FACT-G Data|Phase III Component||58
6406616|NCT00922974|7319666|FG000|Eligible With Adverse Event Data|Phase III Component||202
6406617|NCT00922974|7319667|FG001|Eligible With Adverse Event Data|Phase III Component||117
6406618|NCT00922974|7319666|FG000|Eligible, Treated, Adverse Event Data|Phase III Component||148
6406619|NCT00922974|7319667|FG001|Eligible, Treated, Adverse Event Data|Phase III Component||83
6406620|NCT00922974|7319666|FG000|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||152
6406621|NCT00922974|7319667|FG001|Eligible and Consented to Quality of Life Participate in Quality of Life (QOL) Study Component|Phase III Component||100
6406622|NCT00922974|7319666|FG000|COMPLETED|Phase III Component||209
6406623|NCT00922974|7319667|FG001|COMPLETED|Phase III Component||130
6406624|NCT00922974|7319666|FG000|NOT COMPLETED|Phase III Component||8
6406625|NCT00922974|7319667|FG001|NOT COMPLETED|Phase III Component||6
6406626|NCT00922987|7319675|FG000|STARTED|Overall Study||281
6406627|NCT00922987|7319675|FG000|COMPLETED|Overall Study||277
6406628|NCT00922987|7319675|FG000|NOT COMPLETED|Overall Study||4
6406629|NCT00923078|7319682|FG000|STARTED|First Intervention (Weeks 1-4)||20
6406630|NCT00923078|7319683|FG001|STARTED|First Intervention (Weeks 1-4)||20
6406631|NCT00923078|7319684|FG002|STARTED|First Intervention (Weeks 1-4)||20
6406632|NCT00923078|7319682|FG000|COMPLETED|First Intervention (Weeks 1-4)||19
6406633|NCT00923078|7319683|FG001|COMPLETED|First Intervention (Weeks 1-4)||19
6406634|NCT00923078|7319684|FG002|COMPLETED|First Intervention (Weeks 1-4)||0
6406635|NCT00923078|7319682|FG000|NOT COMPLETED|First Intervention (Weeks 1-4)||1
6406636|NCT00923078|7319683|FG001|NOT COMPLETED|First Intervention (Weeks 1-4)||1
6406637|NCT00923078|7319684|FG002|NOT COMPLETED|First Intervention (Weeks 1-4)||20
6406638|NCT00923078|7319682|FG000|STARTED|Second Intervention (Weeks 5-8)||19
6406639|NCT00923078|7319683|FG001|STARTED|Second Intervention (Weeks 5-8)||19
6406640|NCT00923078|7319684|FG002|STARTED|Second Intervention (Weeks 5-8)|Healthy Comparison sample subjects completed only a single test session (baseline)|0
6406641|NCT00923078|7319682|FG000|COMPLETED|Second Intervention (Weeks 5-8)||19
6406642|NCT00923078|7319683|FG001|COMPLETED|Second Intervention (Weeks 5-8)||19
6406643|NCT00923078|7319684|FG002|COMPLETED|Second Intervention (Weeks 5-8)||0
6406644|NCT00923078|7319682|FG000|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
6406645|NCT00923078|7319683|FG001|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
6406646|NCT00923078|7319684|FG002|NOT COMPLETED|Second Intervention (Weeks 5-8)||0
6406647|NCT00923091|7319699|FG000|STARTED|PeriodI-II (Randomized, Double-Blind)||335
6406648|NCT00923091|7319700|FG001|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6406649|NCT00923091|7319701|FG002|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6406650|NCT00923091|7319702|FG003|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6406651|NCT00923091|7319703|FG004|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6406652|NCT00923091|7319704|FG005|STARTED|PeriodI-II (Randomized, Double-Blind)||337
6406653|NCT00923091|7319705|FG006|STARTED|PeriodI-II (Randomized, Double-Blind)||337
6406654|NCT00923091|7319706|FG007|STARTED|PeriodI-II (Randomized, Double-Blind)||336
6406655|NCT00923091|7319707|FG008|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6406656|NCT00923091|7319708|FG009|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6406657|NCT00923091|7319709|FG010|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6406658|NCT00923091|7319710|FG011|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6406659|NCT00923091|7319711|FG012|STARTED|PeriodI-II (Randomized, Double-Blind)||0
6406660|NCT00923091|7319699|FG000|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
6406661|NCT00923091|7319700|FG001|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
6406662|NCT00923091|7319701|FG002|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
6406663|NCT00923091|7319702|FG003|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
6406664|NCT00923091|7319703|FG004|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
6406665|NCT00923091|7319704|FG005|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
6406666|NCT00923091|7319705|FG006|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
6406667|NCT00923091|7319706|FG007|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
6406668|NCT00923091|7319707|FG008|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406669|NCT00923091|7319708|FG009|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406670|NCT00923091|7319709|FG010|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406671|NCT00923091|7319710|FG011|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406672|NCT00923091|7319711|FG012|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406673|NCT00923091|7319699|FG000|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
6406674|NCT00923091|7319700|FG001|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
6406675|NCT00923091|7319701|FG002|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
6406676|NCT00923091|7319702|FG003|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
6406677|NCT00923091|7319703|FG004|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
6406678|NCT00923091|7319704|FG005|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
6406679|NCT00923091|7319705|FG006|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
6406680|NCT00923091|7319706|FG007|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
6406681|NCT00923091|7319707|FG008|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406682|NCT00923091|7319708|FG009|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406683|NCT00923091|7319709|FG010|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406684|NCT00923091|7319710|FG011|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406685|NCT00923091|7319711|FG012|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
6406686|NCT00923091|7319699|FG000|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
6406687|NCT00923091|7319700|FG001|STARTED|Period III (Single-Blind)||0
6406688|NCT00923091|7319701|FG002|STARTED|Period III (Single-Blind)||0
6406689|NCT00923091|7319702|FG003|STARTED|Period III (Single-Blind)||0
6406690|NCT00923091|7319703|FG004|STARTED|Period III (Single-Blind)||0
6406691|NCT00923091|7319704|FG005|STARTED|Period III (Single-Blind)||0
6406692|NCT00923091|7319705|FG006|STARTED|Period III (Single-Blind)||0
6406693|NCT00923091|7319706|FG007|STARTED|Period III (Single-Blind)||0
6406694|NCT00923091|7319707|FG008|STARTED|Period III (Single-Blind)||0
6406695|NCT00923091|7319708|FG009|STARTED|Period III (Single-Blind)||0
6406696|NCT00923091|7319709|FG010|STARTED|Period III (Single-Blind)||0
6406697|NCT00923091|7319710|FG011|STARTED|Period III (Single-Blind)||0
6406698|NCT00923091|7319711|FG012|STARTED|Period III (Single-Blind)||0
6406699|NCT00923091|7319699|FG000|COMPLETED|Period III (Single-Blind)||2520
6406700|NCT00923091|7319700|FG001|COMPLETED|Period III (Single-Blind)||0
6406701|NCT00923091|7319701|FG002|COMPLETED|Period III (Single-Blind)||0
6406702|NCT00923091|7319702|FG003|COMPLETED|Period III (Single-Blind)||0
6406703|NCT00923091|7319703|FG004|COMPLETED|Period III (Single-Blind)||0
6406704|NCT00923091|7319704|FG005|COMPLETED|Period III (Single-Blind)||0
6406705|NCT00923091|7319705|FG006|COMPLETED|Period III (Single-Blind)||0
6406706|NCT00923091|7319706|FG007|COMPLETED|Period III (Single-Blind)||0
6406707|NCT00923091|7319707|FG008|COMPLETED|Period III (Single-Blind)||0
6406708|NCT00923091|7319708|FG009|COMPLETED|Period III (Single-Blind)||0
6406709|NCT00923091|7319709|FG010|COMPLETED|Period III (Single-Blind)||0
6406710|NCT00923091|7319710|FG011|COMPLETED|Period III (Single-Blind)||0
6406711|NCT00923091|7319711|FG012|COMPLETED|Period III (Single-Blind)||0
6406712|NCT00923091|7319699|FG000|NOT COMPLETED|Period III (Single-Blind)||20
6406713|NCT00923091|7319700|FG001|NOT COMPLETED|Period III (Single-Blind)||0
6406714|NCT00923091|7319701|FG002|NOT COMPLETED|Period III (Single-Blind)||0
6406715|NCT00923091|7319702|FG003|NOT COMPLETED|Period III (Single-Blind)||0
6406716|NCT00923091|7319703|FG004|NOT COMPLETED|Period III (Single-Blind)||0
6406717|NCT00923091|7319704|FG005|NOT COMPLETED|Period III (Single-Blind)||0
6406718|NCT00923091|7319705|FG006|NOT COMPLETED|Period III (Single-Blind)||0
6406719|NCT00923091|7319706|FG007|NOT COMPLETED|Period III (Single-Blind)||0
6406720|NCT00923091|7319707|FG008|NOT COMPLETED|Period III (Single-Blind)||0
6406721|NCT00923091|7319708|FG009|NOT COMPLETED|Period III (Single-Blind)||0
6406722|NCT00923091|7319709|FG010|NOT COMPLETED|Period III (Single-Blind)||0
6406723|NCT00923091|7319710|FG011|NOT COMPLETED|Period III (Single-Blind)||0
6406724|NCT00923091|7319711|FG012|NOT COMPLETED|Period III (Single-Blind)||0
6635696|NCT02307513|7564590|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-12)||8
6635697|NCT02307513|7564589|FG000|STARTED|Active Treatment Phase (Weeks 13-64)||83
6635698|NCT02307513|7564590|FG001|STARTED|Active Treatment Phase (Weeks 13-64)|1 participant completed Week 12; did not enter into active treatment|95
6635699|NCT02307513|7564589|FG000|COMPLETED|Active Treatment Phase (Weeks 13-64)||68
6635700|NCT02307513|7564590|FG001|COMPLETED|Active Treatment Phase (Weeks 13-64)||75
6635701|NCT02307513|7564589|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||15
6635702|NCT02307513|7564590|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 13-64)||20
6635703|NCT02307513|7564589|FG000|STARTED|Long-term Extension||2
6635704|NCT02307513|7564590|FG001|STARTED|Long-term Extension||0
6635705|NCT02307513|7564589|FG000|COMPLETED|Long-term Extension||1
6635706|NCT02307513|7564590|FG001|COMPLETED|Long-term Extension||0
6635707|NCT02307513|7564589|FG000|NOT COMPLETED|Long-term Extension||1
6635708|NCT02307513|7564590|FG001|NOT COMPLETED|Long-term Extension||0
6635709|NCT02307526|7564600|FG000|STARTED|Day 1 - No Drug||10
6635710|NCT02307526|7564600|FG000|COMPLETED|Day 1 - No Drug||10
6635711|NCT02307526|7564600|FG000|NOT COMPLETED|Day 1 - No Drug||0
6635712|NCT02307526|7564600|FG000|STARTED|Day 2 - 60 mg of Pyridostigmine||10
6743417|NCT03334448|7671662|FG002|COMPLETED|Period 3||13
6743418|NCT03334448|7671663|FG003|COMPLETED|Period 3||12
6743419|NCT03334448|7671660|FG000|NOT COMPLETED|Period 3||0
6743420|NCT03334448|7671661|FG001|NOT COMPLETED|Period 3||0
6406725|NCT00923091|7319699|FG000|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
6406726|NCT00923091|7319700|FG001|STARTED|Period IV (Double-Blind)||453
6406727|NCT00923091|7319701|FG002|STARTED|Period IV (Double-Blind)||0
6406728|NCT00923091|7319702|FG003|STARTED|Period IV (Double-Blind)||0
6406729|NCT00923091|7319703|FG004|STARTED|Period IV (Double-Blind)||0
6406730|NCT00923091|7319704|FG005|STARTED|Period IV (Double-Blind)||0
6406731|NCT00923091|7319705|FG006|STARTED|Period IV (Double-Blind)||0
6406732|NCT00923091|7319706|FG007|STARTED|Period IV (Double-Blind)||0
6406733|NCT00923091|7319707|FG008|STARTED|Period IV (Double-Blind)||0
6406734|NCT00923091|7319708|FG009|STARTED|Period IV (Double-Blind)||0
6406735|NCT00923091|7319709|FG010|STARTED|Period IV (Double-Blind)||0
6406736|NCT00923091|7319710|FG011|STARTED|Period IV (Double-Blind)||0
6406737|NCT00923091|7319711|FG012|STARTED|Period IV (Double-Blind)||0
6406738|NCT00923091|7319699|FG000|COMPLETED|Period IV (Double-Blind)||226
6406739|NCT00923091|7319700|FG001|COMPLETED|Period IV (Double-Blind)||451
6406740|NCT00923091|7319701|FG002|COMPLETED|Period IV (Double-Blind)||0
6406741|NCT00923091|7319702|FG003|COMPLETED|Period IV (Double-Blind)||0
6406742|NCT00923091|7319703|FG004|COMPLETED|Period IV (Double-Blind)||0
6406743|NCT00923091|7319704|FG005|COMPLETED|Period IV (Double-Blind)||0
6406744|NCT00923091|7319705|FG006|COMPLETED|Period IV (Double-Blind)||0
6406745|NCT00923091|7319706|FG007|COMPLETED|Period IV (Double-Blind)||0
6406746|NCT00923091|7319707|FG008|COMPLETED|Period IV (Double-Blind)||0
6406747|NCT00923091|7319708|FG009|COMPLETED|Period IV (Double-Blind)||0
6406748|NCT00923091|7319709|FG010|COMPLETED|Period IV (Double-Blind)||0
6406749|NCT00923091|7319710|FG011|COMPLETED|Period IV (Double-Blind)||0
6406750|NCT00923091|7319711|FG012|COMPLETED|Period IV (Double-Blind)||0
6406751|NCT00923091|7319699|FG000|NOT COMPLETED|Period IV (Double-Blind)||2
6406752|NCT00923091|7319700|FG001|NOT COMPLETED|Period IV (Double-Blind)||2
6406753|NCT00923091|7319701|FG002|NOT COMPLETED|Period IV (Double-Blind)||0
6406754|NCT00923091|7319702|FG003|NOT COMPLETED|Period IV (Double-Blind)||0
6406755|NCT00923091|7319703|FG004|NOT COMPLETED|Period IV (Double-Blind)||0
6406756|NCT00923091|7319704|FG005|NOT COMPLETED|Period IV (Double-Blind)||0
6406757|NCT00923091|7319705|FG006|NOT COMPLETED|Period IV (Double-Blind)||0
6406758|NCT00923091|7319706|FG007|NOT COMPLETED|Period IV (Double-Blind)||0
6406759|NCT00923091|7319707|FG008|NOT COMPLETED|Period IV (Double-Blind)||0
6406760|NCT00923091|7319708|FG009|NOT COMPLETED|Period IV (Double-Blind)||0
6406761|NCT00923091|7319709|FG010|NOT COMPLETED|Period IV (Double-Blind)||0
6406762|NCT00923091|7319710|FG011|NOT COMPLETED|Period IV (Double-Blind)||0
6406763|NCT00923091|7319711|FG012|NOT COMPLETED|Period IV (Double-Blind)||0
6406764|NCT00923091|7319699|FG000|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
6406765|NCT00923091|7319700|FG001|STARTED|Period V (Double -Blind)||0
6406766|NCT00923091|7319701|FG002|STARTED|Period V (Double -Blind)||0
6406767|NCT00923091|7319702|FG003|STARTED|Period V (Double -Blind)||0
6406768|NCT00923091|7319703|FG004|STARTED|Period V (Double -Blind)||0
6406769|NCT00923091|7319704|FG005|STARTED|Period V (Double -Blind)||0
6406770|NCT00923091|7319705|FG006|STARTED|Period V (Double -Blind)||0
6406771|NCT00923091|7319706|FG007|STARTED|Period V (Double -Blind)||0
6406772|NCT00923091|7319707|FG008|STARTED|Period V (Double -Blind)||135
6406773|NCT00923091|7319708|FG009|STARTED|Period V (Double -Blind)||119
6406774|NCT00923091|7319709|FG010|STARTED|Period V (Double -Blind)||194
6406775|NCT00923091|7319710|FG011|STARTED|Period V (Double -Blind)||151
6406776|NCT00923091|7319711|FG012|STARTED|Period V (Double -Blind)||75
6406777|NCT00923091|7319699|FG000|COMPLETED|Period V (Double -Blind)||0
6406778|NCT00923091|7319700|FG001|COMPLETED|Period V (Double -Blind)||0
6406779|NCT00923091|7319701|FG002|COMPLETED|Period V (Double -Blind)||0
6406780|NCT00923091|7319702|FG003|COMPLETED|Period V (Double -Blind)||0
6406781|NCT00923091|7319703|FG004|COMPLETED|Period V (Double -Blind)||0
6406782|NCT00923091|7319704|FG005|COMPLETED|Period V (Double -Blind)||0
6406783|NCT00923091|7319705|FG006|COMPLETED|Period V (Double -Blind)||0
6406784|NCT00923091|7319706|FG007|COMPLETED|Period V (Double -Blind)||0
6406785|NCT00923091|7319707|FG008|COMPLETED|Period V (Double -Blind)||134
6406786|NCT00923091|7319708|FG009|COMPLETED|Period V (Double -Blind)||119
6406787|NCT00923091|7319709|FG010|COMPLETED|Period V (Double -Blind)||193
6406788|NCT00923091|7319710|FG011|COMPLETED|Period V (Double -Blind)||151
6406789|NCT00923091|7319711|FG012|COMPLETED|Period V (Double -Blind)||73
6406790|NCT00923091|7319699|FG000|NOT COMPLETED|Period V (Double -Blind)||0
6406791|NCT00923091|7319700|FG001|NOT COMPLETED|Period V (Double -Blind)||0
6406792|NCT00923091|7319701|FG002|NOT COMPLETED|Period V (Double -Blind)||0
6406793|NCT00923091|7319702|FG003|NOT COMPLETED|Period V (Double -Blind)||0
6406794|NCT00923091|7319703|FG004|NOT COMPLETED|Period V (Double -Blind)||0
6406795|NCT00923091|7319704|FG005|NOT COMPLETED|Period V (Double -Blind)||0
6406796|NCT00923091|7319705|FG006|NOT COMPLETED|Period V (Double -Blind)||0
6406797|NCT00923091|7319706|FG007|NOT COMPLETED|Period V (Double -Blind)||0
6406798|NCT00923091|7319707|FG008|NOT COMPLETED|Period V (Double -Blind)||1
6406799|NCT00923091|7319708|FG009|NOT COMPLETED|Period V (Double -Blind)||0
6406800|NCT00923091|7319709|FG010|NOT COMPLETED|Period V (Double -Blind)||1
6406801|NCT00923091|7319710|FG011|NOT COMPLETED|Period V (Double -Blind)||0
6406802|NCT00923091|7319711|FG012|NOT COMPLETED|Period V (Double -Blind)||2
6406803|NCT00923091|7319699|FG000|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
6406804|NCT00923091|7319700|FG001|STARTED|Period VI (Open-Label)||272
6406805|NCT00923091|7319701|FG002|STARTED|Period VI (Open-Label)||480
6406806|NCT00923091|7319702|FG003|STARTED|Period VI (Open-Label)||146
6406807|NCT00923091|7319703|FG004|STARTED|Period VI (Open-Label)||164
6406808|NCT00923091|7319704|FG005|STARTED|Period VI (Open-Label)||0
6406809|NCT00923091|7319705|FG006|STARTED|Period VI (Open-Label)||0
6406810|NCT00923091|7319706|FG007|STARTED|Period VI (Open-Label)||0
6406811|NCT00923091|7319707|FG008|STARTED|Period VI (Open-Label)||0
6406812|NCT00923091|7319708|FG009|STARTED|Period VI (Open-Label)||0
6406813|NCT00923091|7319709|FG010|STARTED|Period VI (Open-Label)||0
6406814|NCT00923091|7319710|FG011|STARTED|Period VI (Open-Label)||0
6406815|NCT00923091|7319711|FG012|STARTED|Period VI (Open-Label)||0
6406816|NCT00923091|7319699|FG000|COMPLETED|Period VI (Open-Label)||1408
6406817|NCT00923091|7319700|FG001|COMPLETED|Period VI (Open-Label)||264
6406818|NCT00923091|7319701|FG002|COMPLETED|Period VI (Open-Label)||467
6406819|NCT00923091|7319702|FG003|COMPLETED|Period VI (Open-Label)||143
6406820|NCT00923091|7319703|FG004|COMPLETED|Period VI (Open-Label)||157
6406821|NCT00923091|7319704|FG005|COMPLETED|Period VI (Open-Label)||0
6406822|NCT00923091|7319705|FG006|COMPLETED|Period VI (Open-Label)||0
6406823|NCT00923091|7319706|FG007|COMPLETED|Period VI (Open-Label)||0
6406824|NCT00923091|7319707|FG008|COMPLETED|Period VI (Open-Label)||0
6406825|NCT00923091|7319708|FG009|COMPLETED|Period VI (Open-Label)||0
6406826|NCT00923091|7319709|FG010|COMPLETED|Period VI (Open-Label)||0
6406827|NCT00923091|7319710|FG011|COMPLETED|Period VI (Open-Label)||0
6406828|NCT00923091|7319711|FG012|COMPLETED|Period VI (Open-Label)||0
6406829|NCT00923091|7319699|FG000|NOT COMPLETED|Period VI (Open-Label)||39
6406830|NCT00923091|7319700|FG001|NOT COMPLETED|Period VI (Open-Label)||8
6406831|NCT00923091|7319701|FG002|NOT COMPLETED|Period VI (Open-Label)||13
6406832|NCT00923091|7319702|FG003|NOT COMPLETED|Period VI (Open-Label)||3
6406833|NCT00923091|7319703|FG004|NOT COMPLETED|Period VI (Open-Label)||7
6406834|NCT00923091|7319704|FG005|NOT COMPLETED|Period VI (Open-Label)||0
6406835|NCT00923091|7319705|FG006|NOT COMPLETED|Period VI (Open-Label)||0
6406836|NCT00923091|7319706|FG007|NOT COMPLETED|Period VI (Open-Label)||0
6406837|NCT00923091|7319707|FG008|NOT COMPLETED|Period VI (Open-Label)||0
6406838|NCT00923091|7319708|FG009|NOT COMPLETED|Period VI (Open-Label)||0
6406839|NCT00923091|7319709|FG010|NOT COMPLETED|Period VI (Open-Label)||0
6406840|NCT00923091|7319710|FG011|NOT COMPLETED|Period VI (Open-Label)||0
6406841|NCT00923091|7319711|FG012|NOT COMPLETED|Period VI (Open-Label)||0
6406842|NCT00923117|7319738|FG000|STARTED|Overall Study||44
6406843|NCT00923117|7319739|FG001|STARTED|Overall Study||43
6406844|NCT00923117|7319738|FG000|COMPLETED|Overall Study||44
6406845|NCT00923117|7319739|FG001|COMPLETED|Overall Study||43
6406846|NCT00923117|7319738|FG000|NOT COMPLETED|Overall Study||0
6406847|NCT00923117|7319739|FG001|NOT COMPLETED|Overall Study||0
6406848|NCT00923130|7319745|FG000|STARTED|Overall Study||30
6406849|NCT00923130|7319745|FG000|COMPLETED|Overall Study||5
6406850|NCT00923130|7319745|FG000|NOT COMPLETED|Overall Study||25
6406851|NCT00923156|7319752|FG000|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
6406852|NCT00923156|7319753|FG001|STARTED|Overall Study||42
6406853|NCT00923156|7319754|FG002|STARTED|Overall Study||41
6406854|NCT00923156|7319752|FG000|COMPLETED|Overall Study||40
6406855|NCT00923156|7319753|FG001|COMPLETED|Overall Study||38
6406856|NCT00923156|7319754|FG002|COMPLETED|Overall Study||38
6406857|NCT00923156|7319752|FG000|NOT COMPLETED|Overall Study||0
6406858|NCT00923156|7319753|FG001|NOT COMPLETED|Overall Study||4
6406859|NCT00923156|7319754|FG002|NOT COMPLETED|Overall Study||3
6406860|NCT00923195|7319764|FG000|STARTED|Overall Study||2
6406861|NCT00923195|7319765|FG001|STARTED|Overall Study||2
6406862|NCT00923195|7319764|FG000|COMPLETED|Overall Study||2
6406863|NCT00923195|7319765|FG001|COMPLETED|Overall Study||1
6406864|NCT00923195|7319764|FG000|NOT COMPLETED|Overall Study||0
6406865|NCT00923195|7319765|FG001|NOT COMPLETED|Overall Study||1
6406866|NCT00923260|7319773|FG000|STARTED|Overall Study||12
6406867|NCT00923260|7319774|FG001|STARTED|Overall Study||12
6406868|NCT00923260|7319773|FG000|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
6406869|NCT00923260|7319774|FG001|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
6406870|NCT00923260|7319773|FG000|NOT COMPLETED|Overall Study||1
6406871|NCT00923260|7319774|FG001|NOT COMPLETED|Overall Study||1
6406872|NCT00923273|7319785|FG000|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
6406873|NCT00923273|7319786|FG001|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
6406874|NCT00923273|7319787|FG002|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
6406875|NCT00923273|7319788|FG003|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
6406876|NCT00923273|7319789|FG004|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
6406877|NCT00923273|7319785|FG000|COMPLETED|Phase I Treatment Period||4
6406878|NCT00923273|7319786|FG001|COMPLETED|Phase I Treatment Period||3
6406879|NCT00923273|7319787|FG002|COMPLETED|Phase I Treatment Period||3
6406880|NCT00923273|7319788|FG003|COMPLETED|Phase I Treatment Period||7
6406881|NCT00923273|7319789|FG004|COMPLETED|Phase I Treatment Period||5
6406882|NCT00923273|7319785|FG000|NOT COMPLETED|Phase I Treatment Period||0
6406883|NCT00923273|7319786|FG001|NOT COMPLETED|Phase I Treatment Period||0
6406884|NCT00923273|7319787|FG002|NOT COMPLETED|Phase I Treatment Period||0
6406885|NCT00923273|7319788|FG003|NOT COMPLETED|Phase I Treatment Period||0
6406886|NCT00923273|7319789|FG004|NOT COMPLETED|Phase I Treatment Period||0
6406887|NCT00923273|7319785|FG000|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
6406888|NCT00923273|7319786|FG001|STARTED|Phase II Treatment Period||0
6406889|NCT00923273|7319787|FG002|STARTED|Phase II Treatment Period||0
6406890|NCT00923273|7319788|FG003|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
6406891|NCT00923273|7319789|FG004|STARTED|Phase II Treatment Period||0
6406892|NCT00923273|7319785|FG000|COMPLETED|Phase II Treatment Period||0
6406893|NCT00923273|7319786|FG001|COMPLETED|Phase II Treatment Period||0
6406894|NCT00923273|7319787|FG002|COMPLETED|Phase II Treatment Period||0
6406895|NCT00923273|7319788|FG003|COMPLETED|Phase II Treatment Period||20
6406896|NCT00923273|7319789|FG004|COMPLETED|Phase II Treatment Period||0
6406897|NCT00923273|7319785|FG000|NOT COMPLETED|Phase II Treatment Period||0
6406898|NCT00923273|7319786|FG001|NOT COMPLETED|Phase II Treatment Period||0
6406899|NCT00923273|7319787|FG002|NOT COMPLETED|Phase II Treatment Period||0
6406900|NCT00923273|7319788|FG003|NOT COMPLETED|Phase II Treatment Period||7
6406901|NCT00923273|7319789|FG004|NOT COMPLETED|Phase II Treatment Period||0
6406902|NCT00923351|7319809|FG000|STARTED|Overall Study||6
6406903|NCT00923351|7319810|FG001|STARTED|Overall Study||26
6406904|NCT00923351|7319811|FG002|STARTED|Overall Study||12
6406905|NCT00923351|7319809|FG000|COMPLETED|Overall Study||6
6406906|NCT00923351|7319810|FG001|COMPLETED|Overall Study||26
6406907|NCT00923351|7319811|FG002|COMPLETED|Overall Study||0
6406908|NCT00923351|7319809|FG000|NOT COMPLETED|Overall Study||0
6406909|NCT00923351|7319810|FG001|NOT COMPLETED|Overall Study||0
6406910|NCT00923351|7319811|FG002|NOT COMPLETED|Overall Study||12
6406911|NCT00923364|7319817|FG000|STARTED|Overall Study||14
6406912|NCT00923364|7319818|FG001|STARTED|Overall Study||5
6406913|NCT00923364|7319817|FG000|COMPLETED|Overall Study||10
6406914|NCT00923364|7319818|FG001|COMPLETED|Overall Study||5
6406915|NCT00923364|7319817|FG000|NOT COMPLETED|Overall Study||4
6406916|NCT00923364|7319818|FG001|NOT COMPLETED|Overall Study||0
6406917|NCT00923481|7319823|FG000|STARTED|Overall Study||37
6406918|NCT00923481|7319823|FG000|COMPLETED|Overall Study||37
6406919|NCT00923481|7319823|FG000|NOT COMPLETED|Overall Study||0
6406920|NCT00923559|7319829|FG000|STARTED|Overall Study||40
6406921|NCT00923559|7319830|FG001|STARTED|Overall Study||40
6406922|NCT00923559|7319829|FG000|COMPLETED|Overall Study||38
6406923|NCT00923559|7319830|FG001|COMPLETED|Overall Study||37
6406924|NCT00923559|7319829|FG000|NOT COMPLETED|Overall Study||2
6406925|NCT00923559|7319830|FG001|NOT COMPLETED|Overall Study||3
6406926|NCT00923598|7319840|FG000|STARTED|Overall Study||23
6406927|NCT00923598|7319841|FG001|STARTED|Overall Study||22
6406928|NCT00923598|7319840|FG000|COMPLETED|Overall Study||19
6406929|NCT00923598|7319841|FG001|COMPLETED|Overall Study||17
6406930|NCT00923598|7319840|FG000|NOT COMPLETED|Overall Study||4
6406931|NCT00923598|7319841|FG001|NOT COMPLETED|Overall Study||5
6406932|NCT00923845|7319849|FG000|STARTED|Donor Lymphocyte Harvest||13
6406933|NCT00923845|7319850|FG001|STARTED|Donor Lymphocyte Harvest||0
6406934|NCT00923845|7319849|FG000|COMPLETED|Donor Lymphocyte Harvest||13
6635713|NCT02307526|7564600|FG000|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
6635714|NCT02307526|7564600|FG000|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
6635715|NCT02307552|7564606|FG000|STARTED|Overall Study||1
6635716|NCT02307552|7564606|FG000|COMPLETED|Overall Study||1
6635717|NCT02307552|7564606|FG000|NOT COMPLETED|Overall Study||0
6635718|NCT02307682|7564613|FG000|STARTED|Overall Study||360
6635719|NCT02307682|7564614|FG001|STARTED|Overall Study||361
6635720|NCT02307682|7564615|FG002|STARTED|Overall Study||361
6635721|NCT02307682|7564613|FG000|Randomized and Treated|Overall Study||358
6635722|NCT02307682|7564614|FG001|Randomized and Treated|Overall Study||360
6635723|NCT02307682|7564615|FG002|Randomized and Treated|Overall Study||360
6635724|NCT02307682|7564613|FG000|COMPLETED|Overall Study||310
6635725|NCT02307682|7564614|FG001|COMPLETED|Overall Study||304
6635726|NCT02307682|7564615|FG002|COMPLETED|Overall Study||297
6635727|NCT02307682|7564613|FG000|NOT COMPLETED|Overall Study||50
6406935|NCT00923845|7319850|FG001|COMPLETED|Donor Lymphocyte Harvest||0
6635728|NCT02307682|7564614|FG001|NOT COMPLETED|Overall Study||57
6635729|NCT02307682|7564615|FG002|NOT COMPLETED|Overall Study||64
6635730|NCT02307838|7564626|FG000|STARTED|Overall Study||56
6635731|NCT02307838|7564627|FG001|STARTED|Overall Study||64
6635732|NCT02307838|7564628|FG002|STARTED|Overall Study||55
6635733|NCT02307838|7564626|FG000|COMPLETED|Overall Study||56
6635734|NCT02307838|7564627|FG001|COMPLETED|Overall Study||64
6635735|NCT02307838|7564628|FG002|COMPLETED|Overall Study||55
6635736|NCT02307838|7564626|FG000|NOT COMPLETED|Overall Study||0
6635737|NCT02307838|7564627|FG001|NOT COMPLETED|Overall Study||0
6635738|NCT02307838|7564628|FG002|NOT COMPLETED|Overall Study||0
6635739|NCT02307916|7564639|FG000|STARTED|Overall Study||42
6635740|NCT02307916|7564640|FG001|STARTED|Overall Study||15
6635741|NCT02307916|7564639|FG000|COMPLETED|Overall Study||40
6406936|NCT00923845|7319849|FG000|NOT COMPLETED|Donor Lymphocyte Harvest||0
6635742|NCT02307916|7564640|FG001|COMPLETED|Overall Study||14
6635743|NCT02307916|7564639|FG000|NOT COMPLETED|Overall Study||2
6635744|NCT02307916|7564640|FG001|NOT COMPLETED|Overall Study||1
6635745|NCT02308007|7564649|FG000|STARTED|Overall Study||159
6635746|NCT02308007|7564650|FG001|STARTED|Overall Study||159
6635747|NCT02308007|7564651|FG002|STARTED|Overall Study||157
6635748|NCT02308007|7564649|FG000|COMPLETED|Overall Study||83
6635749|NCT02308007|7564650|FG001|COMPLETED|Overall Study||84
6635750|NCT02308007|7564651|FG002|COMPLETED|Overall Study||82
6635751|NCT02308007|7564649|FG000|NOT COMPLETED|Overall Study||76
6635752|NCT02308007|7564650|FG001|NOT COMPLETED|Overall Study||75
6635753|NCT02308007|7564651|FG002|NOT COMPLETED|Overall Study||75
6406937|NCT00923845|7319850|FG001|NOT COMPLETED|Donor Lymphocyte Harvest||0
6406938|NCT00923845|7319849|FG000|STARTED|Donor Hematopoietic Stem Cell Harvest||13
6406939|NCT00923845|7319850|FG001|STARTED|Donor Hematopoietic Stem Cell Harvest||0
6406940|NCT00923845|7319849|FG000|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
6406941|NCT00923845|7319850|FG001|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
6406942|NCT00923845|7319849|FG000|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
6635754|NCT02308020|7564665|FG000|STARTED|Overall Study||27
6406943|NCT00923845|7319850|FG001|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
6406944|NCT00923845|7319849|FG000|STARTED|Induction Therapy||0
6406945|NCT00923845|7319850|FG001|STARTED|Induction Therapy||12
6406946|NCT00923845|7319849|FG000|COMPLETED|Induction Therapy||0
6406947|NCT00923845|7319850|FG001|COMPLETED|Induction Therapy||10
6406948|NCT00923845|7319849|FG000|NOT COMPLETED|Induction Therapy||0
6406949|NCT00923845|7319850|FG001|NOT COMPLETED|Induction Therapy||2
6406950|NCT00923845|7319849|FG000|STARTED|Allogeneic Stem Cell Therapy||0
6406951|NCT00923845|7319850|FG001|STARTED|Allogeneic Stem Cell Therapy||10
6406952|NCT00923845|7319849|FG000|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
6406953|NCT00923845|7319850|FG001|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
6406954|NCT00923845|7319849|FG000|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
6406955|NCT00923845|7319850|FG001|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
6406956|NCT00923845|7319849|FG000|COMPLETED|Allogeneic Stem Cell Therapy||0
6406957|NCT00923845|7319850|FG001|COMPLETED|Allogeneic Stem Cell Therapy||10
6406958|NCT00923845|7319849|FG000|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
6406959|NCT00923845|7319850|FG001|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
6406960|NCT00923910|7319859|FG000|STARTED|Period 1||5
6406961|NCT00923910|7319860|FG001|STARTED|Period 1||5
6406962|NCT00923910|7319859|FG000|COMPLETED|Period 1||5
6406963|NCT00923910|7319860|FG001|COMPLETED|Period 1||5
6406964|NCT00923910|7319859|FG000|NOT COMPLETED|Period 1||0
6406965|NCT00923910|7319860|FG001|NOT COMPLETED|Period 1||0
6406966|NCT00923910|7319859|FG000|STARTED|Period 2||5
6406967|NCT00923910|7319860|FG001|STARTED|Period 2||5
6406968|NCT00923910|7319859|FG000|COMPLETED|Period 2||5
6406969|NCT00923910|7319860|FG001|COMPLETED|Period 2||5
6406970|NCT00923910|7319859|FG000|NOT COMPLETED|Period 2||0
6406971|NCT00923910|7319860|FG001|NOT COMPLETED|Period 2||0
6406972|NCT00923936|7319867|FG000|STARTED|Overall Study||10
6406973|NCT00923936|7319868|FG001|STARTED|Overall Study||6
6406974|NCT00923936|7319867|FG000|COMPLETED|Overall Study||2
6406975|NCT00923936|7319868|FG001|COMPLETED|Overall Study||3
6406976|NCT00923936|7319867|FG000|NOT COMPLETED|Overall Study||8
6406977|NCT00923936|7319868|FG001|NOT COMPLETED|Overall Study||3
6406978|NCT00923949|7319876|FG000|STARTED|Overall Study||1
6406979|NCT00923949|7319876|FG000|COMPLETED|Overall Study||1
6406980|NCT00923949|7319876|FG000|NOT COMPLETED|Overall Study||0
6406981|NCT00923975|7319880|FG000|STARTED|Overall Study||51
6406982|NCT00923975|7319880|FG000|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
6406983|NCT00923975|7319880|FG000|NOT COMPLETED|Overall Study||1
6406984|NCT00924001|7319884|FG000|STARTED|Overall Study||1
6406985|NCT00924001|7319884|FG000|COMPLETED|Overall Study||1
6406986|NCT00924001|7319884|FG000|NOT COMPLETED|Overall Study||0
6406987|NCT00924040|7319888|FG000|STARTED|Overall Study||1
6406988|NCT00924040|7319888|FG000|COMPLETED|Overall Study||1
6406989|NCT00924040|7319888|FG000|NOT COMPLETED|Overall Study||0
6406990|NCT00924053|7319896|FG000|STARTED|Overall Study||6
6406991|NCT00924053|7319897|FG001|STARTED|Overall Study||6
6406992|NCT00924053|7319898|FG002|STARTED|Overall Study||6
6406993|NCT00924053|7319899|FG003|STARTED|Overall Study||6
6406994|NCT00924053|7319896|FG000|COMPLETED|Overall Study||6
6406995|NCT00924053|7319897|FG001|COMPLETED|Overall Study||6
6406996|NCT00924053|7319898|FG002|COMPLETED|Overall Study||6
6406997|NCT00924053|7319899|FG003|COMPLETED|Overall Study||6
6406998|NCT00924053|7319896|FG000|NOT COMPLETED|Overall Study||0
6406999|NCT00924053|7319897|FG001|NOT COMPLETED|Overall Study||0
6407000|NCT00924053|7319898|FG002|NOT COMPLETED|Overall Study||0
6407001|NCT00924053|7319899|FG003|NOT COMPLETED|Overall Study||0
6407002|NCT00924066|7319909|FG000|STARTED|Overall Study||41
6407003|NCT00924066|7319909|FG000|COMPLETED|Overall Study||41
6407004|NCT00924066|7319909|FG000|NOT COMPLETED|Overall Study||0
6407005|NCT00924118|7319916|FG000|STARTED|Overall Study||15
6407006|NCT00924118|7319917|FG001|STARTED|Overall Study||15
6407007|NCT00924118|7319916|FG000|COMPLETED|Overall Study||15
6407008|NCT00924118|7319917|FG001|COMPLETED|Overall Study||15
6407009|NCT00924118|7319916|FG000|NOT COMPLETED|Overall Study||0
6407010|NCT00924118|7319917|FG001|NOT COMPLETED|Overall Study||0
6407011|NCT00924209|7319923|FG000|STARTED|Overall Study||7
6407012|NCT00924209|7319923|FG000|COMPLETED|Overall Study||7
6407013|NCT00924209|7319923|FG000|NOT COMPLETED|Overall Study||0
6407014|NCT00924287|7319927|FG000|STARTED|Overall Study||1
6407015|NCT00924287|7319927|FG000|COMPLETED|Overall Study||0
6407016|NCT00924287|7319927|FG000|NOT COMPLETED|Overall Study||1
6407017|NCT00924313|7319931|FG000|STARTED|Overall Study||40
6407018|NCT00924313|7319931|FG000|COMPLETED|Overall Study||39
6407019|NCT00924313|7319931|FG000|NOT COMPLETED|Overall Study||1
6407020|NCT00924352|7319935|FG000|STARTED|Overall Study||12
6407021|NCT00924352|7319936|FG001|STARTED|Overall Study||44
6407022|NCT00924352|7319935|FG000|COMPLETED|Overall Study||12
6407023|NCT00924352|7319936|FG001|COMPLETED|Overall Study||44
6407024|NCT00924352|7319935|FG000|NOT COMPLETED|Overall Study||0
6407025|NCT00924352|7319936|FG001|NOT COMPLETED|Overall Study||0
6407026|NCT00924404|7319945|FG000|STARTED|Overall Study||27
6407027|NCT00924404|7319946|FG001|STARTED|Overall Study||26
6407028|NCT00924404|7319945|FG000|COMPLETED|Overall Study||21
6407029|NCT00924404|7319946|FG001|COMPLETED|Overall Study||22
6407030|NCT00924404|7319945|FG000|NOT COMPLETED|Overall Study||6
6407031|NCT00924404|7319946|FG001|NOT COMPLETED|Overall Study||4
6407032|NCT00924443|7319952|FG000|STARTED|Overall Study||69
6407033|NCT00924443|7319952|FG000|Full Analysis Set (Received Study Drug)|Overall Study||66
6407034|NCT00924443|7319952|FG000|COMPLETED|Overall Study||66
6407035|NCT00924443|7319952|FG000|NOT COMPLETED|Overall Study||3
6407036|NCT00924469|7319958|FG000|STARTED|Overall Study||30
6407037|NCT00924469|7319959|FG001|STARTED|Overall Study||28
6407038|NCT00924469|7319958|FG000|COMPLETED|Overall Study||28
6407039|NCT00924469|7319959|FG001|COMPLETED|Overall Study||26
6407040|NCT00924469|7319958|FG000|NOT COMPLETED|Overall Study||2
6407041|NCT00924469|7319959|FG001|NOT COMPLETED|Overall Study||2
6407042|NCT00924482|7319965|FG000|STARTED|Overall Study||261
6407043|NCT00924482|7319965|FG000|COMPLETED|Overall Study||261
6407044|NCT00924482|7319965|FG000|NOT COMPLETED|Overall Study||0
6407045|NCT00924508|7319970|FG000|STARTED|Overall Study||23
6407046|NCT00924508|7319970|FG000|COMPLETED|Overall Study||20
6407047|NCT00924508|7319970|FG000|NOT COMPLETED|Overall Study||3
6407048|NCT00924560|7319980|FG000|STARTED|Overall Study||458
6407049|NCT00924560|7319981|FG001|STARTED|Overall Study||448
6407050|NCT00924560|7319982|FG002|STARTED|Overall Study||455
6407051|NCT00924560|7319980|FG000|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
6407052|NCT00924560|7319981|FG001|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
6407053|NCT00924560|7319982|FG002|Received Treatment|Overall Study||0
6407054|NCT00924560|7319980|FG000|COMPLETED|Overall Study||247
6407055|NCT00924560|7319981|FG001|COMPLETED|Overall Study||240
6407056|NCT00924560|7319982|FG002|COMPLETED|Overall Study||372
6407057|NCT00924560|7319980|FG000|NOT COMPLETED|Overall Study||211
6407058|NCT00924560|7319981|FG001|NOT COMPLETED|Overall Study||208
6407059|NCT00924560|7319982|FG002|NOT COMPLETED|Overall Study||83
6407060|NCT00924612|7319992|FG000|STARTED|Overall Study||4
6407061|NCT00924612|7319993|FG001|STARTED|Overall Study||4
6407062|NCT00924612|7319994|FG002|STARTED|Overall Study||4
6407063|NCT00924612|7319995|FG003|STARTED|Overall Study||4
6407064|NCT00924612|7319992|FG000|COMPLETED|Overall Study||4
6407065|NCT00924612|7319993|FG001|COMPLETED|Overall Study||4
6407066|NCT00924612|7319994|FG002|COMPLETED|Overall Study||4
6407067|NCT00924612|7319995|FG003|COMPLETED|Overall Study||4
6407068|NCT00924612|7319992|FG000|NOT COMPLETED|Overall Study||0
6407069|NCT00924612|7319993|FG001|NOT COMPLETED|Overall Study||0
6407070|NCT00924612|7319994|FG002|NOT COMPLETED|Overall Study||0
6407071|NCT00924612|7319995|FG003|NOT COMPLETED|Overall Study||0
6407072|NCT00924638|7320009|FG000|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
6407073|NCT00924638|7320010|FG001|STARTED|Overall Study|Randomized to Control Arm|220
6407074|NCT00924638|7320009|FG000|COMPLETED|Overall Study|Completed 6 months of follow-up|209
6407075|NCT00924638|7320010|FG001|COMPLETED|Overall Study|Completed 6 months of follow-up|207
6407076|NCT00924638|7320009|FG000|NOT COMPLETED|Overall Study||12
6407077|NCT00924638|7320010|FG001|NOT COMPLETED|Overall Study||13
6407078|NCT00924651|7320018|FG000|STARTED|Overall Study||356
6407079|NCT00924651|7320019|FG001|STARTED|Overall Study||337
6407080|NCT00924651|7320018|FG000|COMPLETED|Overall Study||331
6407081|NCT00924651|7320019|FG001|COMPLETED|Overall Study||312
6407082|NCT00924651|7320018|FG000|NOT COMPLETED|Overall Study||25
6407083|NCT00924651|7320019|FG001|NOT COMPLETED|Overall Study||25
6407084|NCT00924664|7320027|FG000|STARTED|Overall Study||322
6407085|NCT00924664|7320028|FG001|STARTED|Overall Study||527
6407086|NCT00924664|7320027|FG000|Treated|Overall Study||321
6407087|NCT00924664|7320028|FG001|Treated|Overall Study||527
6407088|NCT00924664|7320027|FG000|COMPLETED|Overall Study||0
6407089|NCT00924664|7320028|FG001|COMPLETED|Overall Study||0
6407090|NCT00924664|7320027|FG000|NOT COMPLETED|Overall Study||322
6407091|NCT00924664|7320028|FG001|NOT COMPLETED|Overall Study||527
6407092|NCT00924703|7320034|FG000|STARTED|Overall Study||68
6407093|NCT00924703|7320034|FG000|COMPLETED|Overall Study||46
6407094|NCT00924703|7320034|FG000|NOT COMPLETED|Overall Study||22
6407095|NCT00924729|7320040|FG000|STARTED|Overall Study||25
6407096|NCT00924729|7320041|FG001|STARTED|Overall Study||25
6407097|NCT00924729|7320040|FG000|COMPLETED|Overall Study||23
6407098|NCT00924729|7320041|FG001|COMPLETED|Overall Study||25
6407099|NCT00924729|7320040|FG000|NOT COMPLETED|Overall Study||2
6407100|NCT00924729|7320041|FG001|NOT COMPLETED|Overall Study||0
6407101|NCT00924781|7320053|FG000|STARTED|Overall Study||20
6407102|NCT00924781|7320054|FG001|STARTED|Overall Study||19
6407103|NCT00924781|7320053|FG000|COMPLETED|Overall Study||8
6407104|NCT00924781|7320054|FG001|COMPLETED|Overall Study||9
6407105|NCT00924781|7320053|FG000|NOT COMPLETED|Overall Study||12
6407106|NCT00924781|7320054|FG001|NOT COMPLETED|Overall Study||10
6407107|NCT00924820|7320070|FG000|STARTED|Overall Study||20
6407108|NCT00924820|7320070|FG000|COMPLETED|Overall Study||13
6407109|NCT00924820|7320070|FG000|NOT COMPLETED|Overall Study||7
6407110|NCT00924885|7320076|FG000|STARTED|Overall Study||129
6407111|NCT00924885|7320077|FG001|STARTED|Overall Study||128
6407112|NCT00924885|7320076|FG000|COMPLETED|Overall Study||126
6407113|NCT00924885|7320077|FG001|COMPLETED|Overall Study||124
6407114|NCT00924885|7320076|FG000|NOT COMPLETED|Overall Study||3
6407115|NCT00924885|7320077|FG001|NOT COMPLETED|Overall Study||4
6407116|NCT00924898|7320085|FG000|STARTED|Overall Study||92
6407117|NCT00924898|7320085|FG000|COMPLETED|Overall Study||90
6407118|NCT00924898|7320085|FG000|NOT COMPLETED|Overall Study||2
6407119|NCT00924950|7320094|FG000|STARTED|Overall Study||30
6407120|NCT00924950|7320094|FG000|COMPLETED|Overall Study||28
6407121|NCT00924950|7320094|FG000|NOT COMPLETED|Overall Study||2
6407122|NCT00925002|7320104|FG000|STARTED|Overall Study||38
6407123|NCT00925002|7320105|FG001|STARTED|Overall Study||37
6407124|NCT00925002|7320106|FG002|STARTED|Overall Study||18
6407125|NCT00925002|7320104|FG000|Treated|Overall Study||38
6407126|NCT00925002|7320105|FG001|Treated|Overall Study||37
6407127|NCT00925002|7320106|FG002|Treated|Overall Study||18
6407128|NCT00925002|7320104|FG000|COMPLETED|Overall Study||32
6407129|NCT00925002|7320105|FG001|COMPLETED|Overall Study||28
6407130|NCT00925002|7320106|FG002|COMPLETED|Overall Study||8
6407131|NCT00925002|7320104|FG000|NOT COMPLETED|Overall Study||6
6407132|NCT00925002|7320105|FG001|NOT COMPLETED|Overall Study||9
6407133|NCT00925002|7320106|FG002|NOT COMPLETED|Overall Study||10
6407134|NCT00925015|7320118|FG000|STARTED|Overall Study||8
6407135|NCT00925015|7320119|FG001|STARTED|Overall Study||6
6407136|NCT00925015|7320120|FG002|STARTED|Overall Study||6
6407137|NCT00925015|7320118|FG000|COMPLETED|Overall Study||0
6407138|NCT00925015|7320119|FG001|COMPLETED|Overall Study||0
6407139|NCT00925015|7320120|FG002|COMPLETED|Overall Study||0
6407140|NCT00925015|7320118|FG000|NOT COMPLETED|Overall Study||8
6407141|NCT00925015|7320119|FG001|NOT COMPLETED|Overall Study||6
6407142|NCT00925015|7320120|FG002|NOT COMPLETED|Overall Study||6
6407143|NCT00925054|7320137|FG000|STARTED|Overall Study||7
6407144|NCT00925054|7320138|FG001|STARTED|Overall Study||9
6407145|NCT00925054|7320139|FG002|STARTED|Overall Study||13
6407146|NCT00925054|7320140|FG003|STARTED|Overall Study||1
6407147|NCT00925054|7320141|FG004|STARTED|Overall Study||10
6407148|NCT00925054|7320137|FG000|COMPLETED|Overall Study||7
6407149|NCT00925054|7320138|FG001|COMPLETED|Overall Study||8
6407150|NCT00925054|7320139|FG002|COMPLETED|Overall Study||12
6407151|NCT00925054|7320140|FG003|COMPLETED|Overall Study||0
6407152|NCT00925054|7320141|FG004|COMPLETED|Overall Study||10
6407153|NCT00925054|7320137|FG000|NOT COMPLETED|Overall Study||0
6407154|NCT00925054|7320138|FG001|NOT COMPLETED|Overall Study||1
6407155|NCT00925054|7320139|FG002|NOT COMPLETED|Overall Study||1
6407156|NCT00925054|7320140|FG003|NOT COMPLETED|Overall Study||1
6407157|NCT00925054|7320141|FG004|NOT COMPLETED|Overall Study||0
6407158|NCT00925119|7320154|FG000|STARTED|Overall Study||31
6407159|NCT00925119|7320154|FG000|COMPLETED|Overall Study||19
6407160|NCT00925119|7320154|FG000|NOT COMPLETED|Overall Study||12
6407161|NCT00925132|7320158|FG000|STARTED|Overall Study||5
6407162|NCT00925132|7320159|FG001|STARTED|Overall Study||4
6407163|NCT00925132|7320160|FG002|STARTED|Overall Study||4
6407164|NCT00925132|7320161|FG003|STARTED|Overall Study||4
6407165|NCT00925132|7320162|FG004|STARTED|Overall Study||22
6407166|NCT00925132|7320158|FG000|COMPLETED|Overall Study||3
6407167|NCT00925132|7320159|FG001|COMPLETED|Overall Study||4
6407168|NCT00925132|7320160|FG002|COMPLETED|Overall Study||4
6407169|NCT00925132|7320161|FG003|COMPLETED|Overall Study||4
6407170|NCT00925132|7320162|FG004|COMPLETED|Overall Study||17
6407171|NCT00925132|7320158|FG000|NOT COMPLETED|Overall Study||2
6407172|NCT00925132|7320159|FG001|NOT COMPLETED|Overall Study||0
6407173|NCT00925132|7320160|FG002|NOT COMPLETED|Overall Study||0
6407174|NCT00925132|7320161|FG003|NOT COMPLETED|Overall Study||0
6407175|NCT00925132|7320162|FG004|NOT COMPLETED|Overall Study||5
6407176|NCT00925288|7320170|FG000|STARTED|Overall Study||100
6407177|NCT00925288|7320171|FG001|STARTED|Overall Study||100
6407178|NCT00925288|7320170|FG000|COMPLETED|Overall Study||91
6407179|NCT00925288|7320171|FG001|COMPLETED|Overall Study||93
6407180|NCT00925288|7320170|FG000|NOT COMPLETED|Overall Study||9
6407181|NCT00925288|7320171|FG001|NOT COMPLETED|Overall Study||7
6407182|NCT00925301|7320181|FG000|STARTED|6-Month Double-blind (Stage 1)||34
6407183|NCT00925301|7320182|FG001|STARTED|6-Month Double-blind (Stage 1)||33
6407184|NCT00925301|7320183|FG002|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start Stage 2 yet.|0
6407185|NCT00925301|7320184|FG003|STARTED|6-Month Double-blind (Stage 1)|Zero participants noted because participants did not start the OLE yet.|0
6407186|NCT00925301|7320181|FG000|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||34
6407187|NCT00925301|7320182|FG001|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||33
6407188|NCT00925301|7320183|FG002|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
6407189|NCT00925301|7320184|FG003|Received at Least 1 Dose of Study Drug|6-Month Double-blind (Stage 1)||0
6407190|NCT00925301|7320181|FG000|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||34
6407191|NCT00925301|7320182|FG001|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||33
6407192|NCT00925301|7320183|FG002|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
6407193|NCT00925301|7320184|FG003|Intent-to-Treat (ITT)|6-Month Double-blind (Stage 1)||0
6407194|NCT00925301|7320181|FG000|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
6407195|NCT00925301|7320182|FG001|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||30
6407196|NCT00925301|7320183|FG002|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
6407197|NCT00925301|7320184|FG003|Modified Intent-to-Treat (mITT)|6-Month Double-blind (Stage 1)||0
6407198|NCT00925301|7320181|FG000|COMPLETED|6-Month Double-blind (Stage 1)||34
6407199|NCT00925301|7320182|FG001|COMPLETED|6-Month Double-blind (Stage 1)||30
6407200|NCT00925301|7320183|FG002|COMPLETED|6-Month Double-blind (Stage 1)||0
6407201|NCT00925301|7320184|FG003|COMPLETED|6-Month Double-blind (Stage 1)||0
6407202|NCT00925301|7320181|FG000|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
6407203|NCT00925301|7320182|FG001|NOT COMPLETED|6-Month Double-blind (Stage 1)||3
6407204|NCT00925301|7320183|FG002|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
6407205|NCT00925301|7320184|FG003|NOT COMPLETED|6-Month Double-blind (Stage 1)||0
6498794|NCT01412541|7417425|FG000|NOT COMPLETED|Overall Study||126
6407206|NCT00925301|7320181|FG000|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
6407207|NCT00925301|7320182|FG001|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants had completed Stage 1.|0
6407208|NCT00925301|7320183|FG002|STARTED|6-Month Open-label (Stage 2)|One participant (Migalastat [0-6 Months]) withdrew consent after completing Month 6.|63
6407209|NCT00925301|7320184|FG003|STARTED|6-Month Open-label (Stage 2)|Zero participants noted because participants did not start the OLE yet.|0
6407210|NCT00925301|7320181|FG000|ITT-amenable|6-Month Open-label (Stage 2)||0
6407211|NCT00925301|7320182|FG001|ITT-amenable|6-Month Open-label (Stage 2)||0
6407212|NCT00925301|7320183|FG002|ITT-amenable|6-Month Open-label (Stage 2)||47
6407213|NCT00925301|7320184|FG003|ITT-amenable|6-Month Open-label (Stage 2)||0
6407214|NCT00925301|7320181|FG000|COMPLETED|6-Month Open-label (Stage 2)||0
6407215|NCT00925301|7320182|FG001|COMPLETED|6-Month Open-label (Stage 2)||0
6407216|NCT00925301|7320183|FG002|COMPLETED|6-Month Open-label (Stage 2)||60
6407217|NCT00925301|7320184|FG003|COMPLETED|6-Month Open-label (Stage 2)||0
6407218|NCT00925301|7320181|FG000|NOT COMPLETED|6-Month Open-label (Stage 2)||0
6407219|NCT00925301|7320182|FG001|NOT COMPLETED|6-Month Open-label (Stage 2)||0
6407220|NCT00925301|7320183|FG002|NOT COMPLETED|6-Month Open-label (Stage 2)||3
6407221|NCT00925301|7320184|FG003|NOT COMPLETED|6-Month Open-label (Stage 2)||0
6407222|NCT00925301|7320181|FG000|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
6407223|NCT00925301|7320182|FG001|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 1.|0
6407224|NCT00925301|7320183|FG002|STARTED|12-Month Open-label Extension (Optional)|Zero participants noted because participants had completed Stage 2.|0
6407225|NCT00925301|7320184|FG003|STARTED|12-Month Open-label Extension (Optional)|The OLE was optional for those who completed Stage 2. Reasons for not entering were not recorded.|57
6407226|NCT00925301|7320181|FG000|ITT-amenable|12-Month Open-label Extension (Optional)||0
6407227|NCT00925301|7320182|FG001|ITT-amenable|12-Month Open-label Extension (Optional)||0
6407228|NCT00925301|7320183|FG002|ITT-amenable|12-Month Open-label Extension (Optional)||0
6407229|NCT00925301|7320184|FG003|ITT-amenable|12-Month Open-label Extension (Optional)||42
6407230|NCT00925301|7320181|FG000|COMPLETED|12-Month Open-label Extension (Optional)||0
6407231|NCT00925301|7320182|FG001|COMPLETED|12-Month Open-label Extension (Optional)||0
6407232|NCT00925301|7320183|FG002|COMPLETED|12-Month Open-label Extension (Optional)||0
6407233|NCT00925301|7320184|FG003|COMPLETED|12-Month Open-label Extension (Optional)||54
6407234|NCT00925301|7320181|FG000|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
6407235|NCT00925301|7320182|FG001|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
6407236|NCT00925301|7320183|FG002|NOT COMPLETED|12-Month Open-label Extension (Optional)||0
6407237|NCT00925301|7320184|FG003|NOT COMPLETED|12-Month Open-label Extension (Optional)||3
6407238|NCT00925353|7320195|FG000|STARTED|Overall Study||13
6407239|NCT00925353|7320195|FG000|COMPLETED|Overall Study||10
6407240|NCT00925353|7320195|FG000|NOT COMPLETED|Overall Study||3
6407241|NCT00925522|7320199|FG000|STARTED|Overall Study||20
6407242|NCT00925522|7320199|FG000|COMPLETED|Overall Study||0
6407243|NCT00925522|7320199|FG000|NOT COMPLETED|Overall Study||20
6407244|NCT00925587|7320205|FG000|STARTED|Overall Study||178
6407245|NCT00925587|7320206|FG001|STARTED|Overall Study||180
6407246|NCT00925587|7320205|FG000|COMPLETED|Overall Study||142
6407247|NCT00925587|7320206|FG001|COMPLETED|Overall Study||155
6407248|NCT00925587|7320205|FG000|NOT COMPLETED|Overall Study||36
6407249|NCT00925587|7320206|FG001|NOT COMPLETED|Overall Study||25
6407250|NCT00925600|7320214|FG000|STARTED|Overall Study||386
6407251|NCT00925600|7320215|FG001|STARTED|Overall Study||383
6407252|NCT00925600|7320214|FG000|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
6407253|NCT00925600|7320215|FG001|Received Treatment|Overall Study||382
6407254|NCT00925600|7320214|FG000|COMPLETED|Overall Study||354
6407255|NCT00925600|7320215|FG001|COMPLETED|Overall Study||355
6407256|NCT00925600|7320214|FG000|NOT COMPLETED|Overall Study||32
6407257|NCT00925600|7320215|FG001|NOT COMPLETED|Overall Study||28
6407258|NCT00925704|7320231|FG000|STARTED|First Intervention||6
6407259|NCT00925704|7320232|FG001|STARTED|First Intervention||7
6407260|NCT00925704|7320233|FG002|STARTED|First Intervention||7
6407261|NCT00925704|7320234|FG003|STARTED|First Intervention||7
6407262|NCT00925704|7320235|FG004|STARTED|First Intervention||7
6510395|NCT01482312|7429968|FG002|COMPLETED|Period 3, 90 Minutes of Wear||9
6635755|NCT02308020|7564666|FG001|STARTED|Overall Study||58
6635756|NCT02308020|7564667|FG002|STARTED|Overall Study||9
6635757|NCT02308020|7564668|FG003|STARTED|Overall Study||28
6635758|NCT02308020|7564669|FG004|STARTED|Overall Study||23
6635759|NCT02308020|7564670|FG005|STARTED|Overall Study||17
6635760|NCT02308020|7564665|FG000|Received at Least One Dose of Study Drug|Overall Study||27
6635761|NCT02308020|7564666|FG001|Received at Least One Dose of Study Drug|Overall Study||58
6635762|NCT02308020|7564667|FG002|Received at Least One Dose of Study Drug|Overall Study||9
6635763|NCT02308020|7564668|FG003|Received at Least One Dose of Study Drug|Overall Study||28
6635764|NCT02308020|7564669|FG004|Received at Least One Dose of Study Drug|Overall Study||23
6635765|NCT02308020|7564670|FG005|Received at Least One Dose of Study Drug|Overall Study||17
6635766|NCT02308020|7564665|FG000|COMPLETED|Overall Study||23
6635767|NCT02308020|7564666|FG001|COMPLETED|Overall Study||38
6635768|NCT02308020|7564667|FG002|COMPLETED|Overall Study||6
6635769|NCT02308020|7564668|FG003|COMPLETED|Overall Study||24
6635770|NCT02308020|7564669|FG004|COMPLETED|Overall Study||19
6635771|NCT02308020|7564670|FG005|COMPLETED|Overall Study||12
6407263|NCT00925704|7320236|FG005|STARTED|First Intervention||7
6407264|NCT00925704|7320231|FG000|COMPLETED|First Intervention||6
6407265|NCT00925704|7320232|FG001|COMPLETED|First Intervention||7
6407266|NCT00925704|7320233|FG002|COMPLETED|First Intervention||7
6407267|NCT00925704|7320234|FG003|COMPLETED|First Intervention||6
6407268|NCT00925704|7320235|FG004|COMPLETED|First Intervention||6
6407269|NCT00925704|7320236|FG005|COMPLETED|First Intervention||7
6407270|NCT00925704|7320231|FG000|NOT COMPLETED|First Intervention||0
6407271|NCT00925704|7320232|FG001|NOT COMPLETED|First Intervention||0
6407272|NCT00925704|7320233|FG002|NOT COMPLETED|First Intervention||0
6407273|NCT00925704|7320234|FG003|NOT COMPLETED|First Intervention||1
6407274|NCT00925704|7320235|FG004|NOT COMPLETED|First Intervention||1
6407275|NCT00925704|7320236|FG005|NOT COMPLETED|First Intervention||0
6407276|NCT00925704|7320231|FG000|STARTED|Washout||6
6407277|NCT00925704|7320232|FG001|STARTED|Washout||7
6407278|NCT00925704|7320233|FG002|STARTED|Washout||7
6407279|NCT00925704|7320234|FG003|STARTED|Washout||6
6407280|NCT00925704|7320235|FG004|STARTED|Washout||6
6407281|NCT00925704|7320236|FG005|STARTED|Washout||7
6407282|NCT00925704|7320231|FG000|COMPLETED|Washout||6
6407283|NCT00925704|7320232|FG001|COMPLETED|Washout||7
6407284|NCT00925704|7320233|FG002|COMPLETED|Washout||7
6407285|NCT00925704|7320234|FG003|COMPLETED|Washout||6
6407286|NCT00925704|7320235|FG004|COMPLETED|Washout||6
6407287|NCT00925704|7320236|FG005|COMPLETED|Washout||7
6407288|NCT00925704|7320231|FG000|NOT COMPLETED|Washout||0
6407289|NCT00925704|7320232|FG001|NOT COMPLETED|Washout||0
6407290|NCT00925704|7320233|FG002|NOT COMPLETED|Washout||0
6407291|NCT00925704|7320234|FG003|NOT COMPLETED|Washout||0
6407292|NCT00925704|7320235|FG004|NOT COMPLETED|Washout||0
6407293|NCT00925704|7320236|FG005|NOT COMPLETED|Washout||0
6407294|NCT00925704|7320231|FG000|STARTED|Second Intervention||6
6635772|NCT02308020|7564665|FG000|NOT COMPLETED|Overall Study||4
6635773|NCT02308020|7564666|FG001|NOT COMPLETED|Overall Study||20
6635774|NCT02308020|7564667|FG002|NOT COMPLETED|Overall Study||3
6635775|NCT02308020|7564668|FG003|NOT COMPLETED|Overall Study||4
6635776|NCT02308020|7564669|FG004|NOT COMPLETED|Overall Study||4
6635777|NCT02308020|7564670|FG005|NOT COMPLETED|Overall Study||5
6635778|NCT02308033|7564692|FG000|STARTED|Overall Study||102
6635779|NCT02308033|7564693|FG001|STARTED|Overall Study||102
6635780|NCT02308033|7564692|FG000|COMPLETED|Overall Study||76
6635781|NCT02308033|7564693|FG001|COMPLETED|Overall Study||83
6635782|NCT02308033|7564692|FG000|NOT COMPLETED|Overall Study||26
6635783|NCT02308033|7564693|FG001|NOT COMPLETED|Overall Study||19
6635784|NCT02308046|7564701|FG000|STARTED|Overall Study||107
6635785|NCT02308046|7564702|FG001|STARTED|Overall Study||105
6635786|NCT02308046|7564701|FG000|COMPLETED|Overall Study||73
6635787|NCT02308046|7564702|FG001|COMPLETED|Overall Study||67
6635788|NCT02308046|7564701|FG000|NOT COMPLETED|Overall Study||34
6635789|NCT02308046|7564702|FG001|NOT COMPLETED|Overall Study||38
6635790|NCT02308124|7564711|FG000|STARTED|Overall Study||29
6635791|NCT02308124|7564712|FG001|STARTED|Overall Study||29
6635792|NCT02308124|7564713|FG002|STARTED|Overall Study||29
6635793|NCT02308124|7564711|FG000|COMPLETED|Overall Study||23
6635794|NCT02308124|7564712|FG001|COMPLETED|Overall Study||21
6635795|NCT02308124|7564713|FG002|COMPLETED|Overall Study||21
6635796|NCT02308124|7564711|FG000|NOT COMPLETED|Overall Study||6
6635797|NCT02308124|7564712|FG001|NOT COMPLETED|Overall Study||8
6635798|NCT02308124|7564713|FG002|NOT COMPLETED|Overall Study||8
6635799|NCT02308163|7564725|FG000|STARTED|Overall Study||104
6635800|NCT02308163|7564726|FG001|STARTED|Overall Study||102
6635801|NCT02308163|7564727|FG002|STARTED|Overall Study||50
6635802|NCT02308163|7564728|FG003|STARTED|Overall Study||52
6635803|NCT02308163|7564729|FG004|STARTED|Overall Study||201
6635804|NCT02308163|7564725|FG000|COMPLETED|Overall Study||73
6635805|NCT02308163|7564726|FG001|COMPLETED|Overall Study||84
6635806|NCT02308163|7564727|FG002|COMPLETED|Overall Study||36
6635807|NCT02308163|7564728|FG003|COMPLETED|Overall Study||39
6635808|NCT02308163|7564729|FG004|COMPLETED|Overall Study||167
6635809|NCT02308163|7564725|FG000|NOT COMPLETED|Overall Study||31
6635810|NCT02308163|7564726|FG001|NOT COMPLETED|Overall Study||18
6635811|NCT02308163|7564727|FG002|NOT COMPLETED|Overall Study||14
6635812|NCT02308163|7564728|FG003|NOT COMPLETED|Overall Study||13
6635813|NCT02308163|7564729|FG004|NOT COMPLETED|Overall Study||34
6635814|NCT02308189|7564758|FG000|STARTED|Overall Study||17
6635815|NCT02308189|7564759|FG001|STARTED|Overall Study||15
6635816|NCT02308189|7564758|FG000|COMPLETED|Overall Study||16
6635817|NCT02308189|7564759|FG001|COMPLETED|Overall Study||14
6407295|NCT00925704|7320232|FG001|STARTED|Second Intervention||7
6635818|NCT02308189|7564758|FG000|NOT COMPLETED|Overall Study||1
6407296|NCT00925704|7320233|FG002|STARTED|Second Intervention||7
6407297|NCT00925704|7320234|FG003|STARTED|Second Intervention||6
6407298|NCT00925704|7320235|FG004|STARTED|Second Intervention||6
6407299|NCT00925704|7320236|FG005|STARTED|Second Intervention||7
6407300|NCT00925704|7320231|FG000|COMPLETED|Second Intervention||5
6407301|NCT00925704|7320232|FG001|COMPLETED|Second Intervention||7
6407302|NCT00925704|7320233|FG002|COMPLETED|Second Intervention||7
6407303|NCT00925704|7320234|FG003|COMPLETED|Second Intervention||6
6407304|NCT00925704|7320235|FG004|COMPLETED|Second Intervention||5
6407305|NCT00925704|7320236|FG005|COMPLETED|Second Intervention||7
6407306|NCT00925704|7320231|FG000|NOT COMPLETED|Second Intervention||1
6635819|NCT02308189|7564759|FG001|NOT COMPLETED|Overall Study||1
6635820|NCT02308228|7564767|FG000|STARTED|Overall Study||54
6407307|NCT00925704|7320232|FG001|NOT COMPLETED|Second Intervention||0
6407308|NCT00925704|7320233|FG002|NOT COMPLETED|Second Intervention||0
6407309|NCT00925704|7320234|FG003|NOT COMPLETED|Second Intervention||0
6407310|NCT00925704|7320235|FG004|NOT COMPLETED|Second Intervention||1
6407311|NCT00925704|7320236|FG005|NOT COMPLETED|Second Intervention||0
6407312|NCT00925704|7320231|FG000|STARTED|Washout||5
6407313|NCT00925704|7320232|FG001|STARTED|Washout||7
6407314|NCT00925704|7320233|FG002|STARTED|Washout||7
6407315|NCT00925704|7320234|FG003|STARTED|Washout||6
6407316|NCT00925704|7320235|FG004|STARTED|Washout||5
6407317|NCT00925704|7320236|FG005|STARTED|Washout||7
6407318|NCT00925704|7320231|FG000|COMPLETED|Washout||5
6407319|NCT00925704|7320232|FG001|COMPLETED|Washout||7
6407320|NCT00925704|7320233|FG002|COMPLETED|Washout||7
6407321|NCT00925704|7320234|FG003|COMPLETED|Washout||6
6407322|NCT00925704|7320235|FG004|COMPLETED|Washout||5
6407323|NCT00925704|7320236|FG005|COMPLETED|Washout||7
6407324|NCT00925704|7320231|FG000|NOT COMPLETED|Washout||0
6407325|NCT00925704|7320232|FG001|NOT COMPLETED|Washout||0
6407326|NCT00925704|7320233|FG002|NOT COMPLETED|Washout||0
6407327|NCT00925704|7320234|FG003|NOT COMPLETED|Washout||0
6407328|NCT00925704|7320235|FG004|NOT COMPLETED|Washout||0
6407329|NCT00925704|7320236|FG005|NOT COMPLETED|Washout||0
6407330|NCT00925704|7320231|FG000|STARTED|Third Intervention||5
6407331|NCT00925704|7320232|FG001|STARTED|Third Intervention||7
6407332|NCT00925704|7320233|FG002|STARTED|Third Intervention||7
6407333|NCT00925704|7320234|FG003|STARTED|Third Intervention||6
6407334|NCT00925704|7320235|FG004|STARTED|Third Intervention||5
6407335|NCT00925704|7320236|FG005|STARTED|Third Intervention||7
6407336|NCT00925704|7320231|FG000|COMPLETED|Third Intervention||5
6407337|NCT00925704|7320232|FG001|COMPLETED|Third Intervention||7
6407338|NCT00925704|7320233|FG002|COMPLETED|Third Intervention||7
6407339|NCT00925704|7320234|FG003|COMPLETED|Third Intervention||6
6407340|NCT00925704|7320235|FG004|COMPLETED|Third Intervention||5
6407341|NCT00925704|7320236|FG005|COMPLETED|Third Intervention||6
6407342|NCT00925704|7320231|FG000|NOT COMPLETED|Third Intervention||0
6407343|NCT00925704|7320232|FG001|NOT COMPLETED|Third Intervention||0
6407344|NCT00925704|7320233|FG002|NOT COMPLETED|Third Intervention||0
6407345|NCT00925704|7320234|FG003|NOT COMPLETED|Third Intervention||0
6407346|NCT00925704|7320235|FG004|NOT COMPLETED|Third Intervention||0
6407347|NCT00925704|7320236|FG005|NOT COMPLETED|Third Intervention||1
6407348|NCT00925756|7320247|FG000|STARTED|Overall Study||32
6407349|NCT00925756|7320247|FG000|COMPLETED|Overall Study||32
6407350|NCT00925756|7320247|FG000|NOT COMPLETED|Overall Study||0
6407351|NCT00925769|7320251|FG000|STARTED|Overall Study||6
6407352|NCT00925769|7320252|FG001|STARTED|Overall Study||6
6407353|NCT00925769|7320253|FG002|STARTED|Overall Study||6
6407354|NCT00925769|7320254|FG003|STARTED|Overall Study||6
6407355|NCT00925769|7320255|FG004|STARTED|Overall Study||3
6407356|NCT00925769|7320256|FG005|STARTED|Overall Study||3
6407357|NCT00925769|7320251|FG000|COMPLETED|Overall Study||0
6407358|NCT00925769|7320252|FG001|COMPLETED|Overall Study||0
6407359|NCT00925769|7320253|FG002|COMPLETED|Overall Study||0
6407360|NCT00925769|7320254|FG003|COMPLETED|Overall Study||0
6407361|NCT00925769|7320255|FG004|COMPLETED|Overall Study||0
6407362|NCT00925769|7320256|FG005|COMPLETED|Overall Study||0
6407363|NCT00925769|7320251|FG000|NOT COMPLETED|Overall Study||6
6407364|NCT00925769|7320252|FG001|NOT COMPLETED|Overall Study||6
6407365|NCT00925769|7320253|FG002|NOT COMPLETED|Overall Study||6
6407366|NCT00925769|7320254|FG003|NOT COMPLETED|Overall Study||6
6407367|NCT00925769|7320255|FG004|NOT COMPLETED|Overall Study||3
6407368|NCT00925769|7320256|FG005|NOT COMPLETED|Overall Study||3
6407369|NCT00925782|7320272|FG000|STARTED|Pretreatment (Day -30 to Day -3)||12
6407370|NCT00925782|7320273|FG001|STARTED|Pretreatment (Day -30 to Day -3)||12
6407371|NCT00925782|7320272|FG000|COMPLETED|Pretreatment (Day -30 to Day -3)||12
6407372|NCT00925782|7320273|FG001|COMPLETED|Pretreatment (Day -30 to Day -3)||12
6407373|NCT00925782|7320272|FG000|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
6407374|NCT00925782|7320273|FG001|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
6407375|NCT00925782|7320272|FG000|STARTED|Study Period (Day -3 to Day 0)||12
6407376|NCT00925782|7320273|FG001|STARTED|Study Period (Day -3 to Day 0)||12
6407377|NCT00925782|7320272|FG000|COMPLETED|Study Period (Day -3 to Day 0)||12
6407378|NCT00925782|7320273|FG001|COMPLETED|Study Period (Day -3 to Day 0)||12
6407379|NCT00925782|7320272|FG000|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
6407380|NCT00925782|7320273|FG001|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
6407381|NCT00925782|7320272|FG000|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
6407382|NCT00925782|7320273|FG001|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
6407383|NCT00925782|7320272|FG000|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
6407384|NCT00925782|7320273|FG001|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
6407385|NCT00925782|7320272|FG000|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
6407386|NCT00925782|7320273|FG001|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
6407387|NCT00925899|7320282|FG000|STARTED|Part 1||34
6407388|NCT00925899|7320283|FG001|STARTED|Part 1||38
6407389|NCT00925899|7320282|FG000|COMPLETED|Part 1||23
6407390|NCT00925899|7320283|FG001|COMPLETED|Part 1||27
6407391|NCT00925899|7320282|FG000|NOT COMPLETED|Part 1||11
6407392|NCT00925899|7320283|FG001|NOT COMPLETED|Part 1||11
6407393|NCT00925899|7320282|FG000|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
6407394|NCT00925899|7320283|FG001|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
6407395|NCT00925899|7320282|FG000|COMPLETED|Part 2||9
6407396|NCT00925899|7320283|FG001|COMPLETED|Part 2||9
6407397|NCT00925899|7320282|FG000|NOT COMPLETED|Part 2||6
6407398|NCT00925899|7320283|FG001|NOT COMPLETED|Part 2||12
6407399|NCT00925938|7320293|FG000|STARTED|Overall Study||9
6407400|NCT00925938|7320294|FG001|STARTED|Overall Study||25
6407401|NCT00925938|7320295|FG002|STARTED|Overall Study||17
6407402|NCT00925938|7320293|FG000|COMPLETED|Overall Study||9
6407403|NCT00925938|7320294|FG001|COMPLETED|Overall Study||25
6407404|NCT00925938|7320295|FG002|COMPLETED|Overall Study||17
6407405|NCT00925938|7320293|FG000|NOT COMPLETED|Overall Study||0
6407406|NCT00925938|7320294|FG001|NOT COMPLETED|Overall Study||0
6407407|NCT00925938|7320295|FG002|NOT COMPLETED|Overall Study||0
6407408|NCT00925990|7320305|FG000|STARTED|Overall Study||35
6407409|NCT00925990|7320306|FG001|STARTED|Overall Study||35
6407410|NCT00925990|7320305|FG000|COMPLETED|Overall Study||30
6407411|NCT00925990|7320306|FG001|COMPLETED|Overall Study||24
6407412|NCT00925990|7320305|FG000|NOT COMPLETED|Overall Study||5
6407413|NCT00925990|7320306|FG001|NOT COMPLETED|Overall Study||11
6407414|NCT00926003|7320315|FG000|STARTED|Baseline||53
6407415|NCT00926003|7320316|FG001|STARTED|Baseline||54
6407416|NCT00926003|7320317|FG002|STARTED|Baseline||52
6407417|NCT00926003|7320315|FG000|COMPLETED|Baseline||53
6407418|NCT00926003|7320316|FG001|COMPLETED|Baseline||54
6407419|NCT00926003|7320317|FG002|COMPLETED|Baseline||52
6407420|NCT00926003|7320315|FG000|NOT COMPLETED|Baseline||0
6407421|NCT00926003|7320316|FG001|NOT COMPLETED|Baseline||0
6407422|NCT00926003|7320317|FG002|NOT COMPLETED|Baseline||0
6407423|NCT00926003|7320315|FG000|STARTED|Post-Training Evaluation||53
6407424|NCT00926003|7320316|FG001|STARTED|Post-Training Evaluation||54
6407425|NCT00926003|7320317|FG002|STARTED|Post-Training Evaluation||52
6407426|NCT00926003|7320315|FG000|COMPLETED|Post-Training Evaluation||52
6407427|NCT00926003|7320316|FG001|COMPLETED|Post-Training Evaluation||54
6407428|NCT00926003|7320317|FG002|COMPLETED|Post-Training Evaluation||52
6407429|NCT00926003|7320315|FG000|NOT COMPLETED|Post-Training Evaluation||1
6407430|NCT00926003|7320316|FG001|NOT COMPLETED|Post-Training Evaluation||0
6407431|NCT00926003|7320317|FG002|NOT COMPLETED|Post-Training Evaluation||0
6407432|NCT00926003|7320315|FG000|STARTED|Post-Training 3-month Follow-up||52
6407433|NCT00926003|7320316|FG001|STARTED|Post-Training 3-month Follow-up||54
6407434|NCT00926003|7320317|FG002|STARTED|Post-Training 3-month Follow-up||52
6407435|NCT00926003|7320315|FG000|COMPLETED|Post-Training 3-month Follow-up||51
6407436|NCT00926003|7320316|FG001|COMPLETED|Post-Training 3-month Follow-up||54
6407437|NCT00926003|7320317|FG002|COMPLETED|Post-Training 3-month Follow-up||52
6407438|NCT00926003|7320315|FG000|NOT COMPLETED|Post-Training 3-month Follow-up||1
6407439|NCT00926003|7320316|FG001|NOT COMPLETED|Post-Training 3-month Follow-up||0
6407440|NCT00926003|7320317|FG002|NOT COMPLETED|Post-Training 3-month Follow-up||0
6407441|NCT00926029|7320328|FG000|STARTED|Overall Study||34
6407442|NCT00926029|7320329|FG001|STARTED|Overall Study||34
6407443|NCT00926029|7320330|FG002|STARTED|Overall Study||34
6407444|NCT00926029|7320328|FG000|COMPLETED|Overall Study||32
6407445|NCT00926029|7320329|FG001|COMPLETED|Overall Study||33
6407446|NCT00926029|7320330|FG002|COMPLETED|Overall Study||33
6407447|NCT00926029|7320328|FG000|NOT COMPLETED|Overall Study||2
6407448|NCT00926029|7320329|FG001|NOT COMPLETED|Overall Study||1
6407449|NCT00926029|7320330|FG002|NOT COMPLETED|Overall Study||1
6407450|NCT00926185|7320344|FG000|STARTED|Overall Study||57
6407451|NCT00926185|7320345|FG001|STARTED|Overall Study||57
6407452|NCT00926185|7320346|FG002|STARTED|Overall Study||58
6407453|NCT00926185|7320347|FG003|STARTED|Overall Study||58
6407454|NCT00926185|7320344|FG000|COMPLETED|Overall Study||54
6407455|NCT00926185|7320345|FG001|COMPLETED|Overall Study||51
6407456|NCT00926185|7320346|FG002|COMPLETED|Overall Study||48
6407457|NCT00926185|7320347|FG003|COMPLETED|Overall Study||48
6407458|NCT00926185|7320344|FG000|NOT COMPLETED|Overall Study||3
6407459|NCT00926185|7320345|FG001|NOT COMPLETED|Overall Study||6
6407460|NCT00926185|7320346|FG002|NOT COMPLETED|Overall Study||10
6407461|NCT00926185|7320347|FG003|NOT COMPLETED|Overall Study||10
6407462|NCT00926211|7320357|FG000|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
6407463|NCT00926211|7320357|FG000|COMPLETED|Overall Study||35
6407464|NCT00926211|7320357|FG000|NOT COMPLETED|Overall Study||1
6407465|NCT00926237|7320362|FG000|STARTED|Overall Study|Two subjects withdrew after receiving sham rTMS but before receiving active rTMS.|19
6407466|NCT00926237|7320363|FG001|STARTED|Overall Study|One subjects withdrew after receiving sham rTMS but before receiving active rTMS.|20
6407467|NCT00926237|7320362|FG000|COMPLETED|Overall Study||17
6407468|NCT00926237|7320363|FG001|COMPLETED|Overall Study||19
6407469|NCT00926237|7320362|FG000|NOT COMPLETED|Overall Study||2
6407470|NCT00926237|7320363|FG001|NOT COMPLETED|Overall Study||1
6407471|NCT00926263|7320375|FG000|STARTED|Overall Study||16
6407472|NCT00926263|7320376|FG001|STARTED|Overall Study||12
6407473|NCT00926263|7320375|FG000|COMPLETED|Overall Study||16
6407474|NCT00926263|7320376|FG001|COMPLETED|Overall Study||12
6407475|NCT00926263|7320375|FG000|NOT COMPLETED|Overall Study||0
6407476|NCT00926263|7320376|FG001|NOT COMPLETED|Overall Study||0
6407477|NCT00926289|7320385|FG000|STARTED|Overall Study|Number of treated patients|294
6407478|NCT00926289|7320386|FG001|STARTED|Overall Study|Number of treated patients|594
6407479|NCT00926289|7320385|FG000|COMPLETED|Overall Study||269
6407480|NCT00926289|7320386|FG001|COMPLETED|Overall Study||558
6407481|NCT00926289|7320385|FG000|NOT COMPLETED|Overall Study||25
6407482|NCT00926289|7320386|FG001|NOT COMPLETED|Overall Study||36
6407483|NCT00926328|7320394|FG000|STARTED|Overall Study||60
6407484|NCT00926328|7320395|FG001|STARTED|Overall Study||60
6407485|NCT00926328|7320394|FG000|COMPLETED|Overall Study||48
6407486|NCT00926328|7320395|FG001|COMPLETED|Overall Study||46
6407487|NCT00926328|7320394|FG000|NOT COMPLETED|Overall Study||12
6407488|NCT00926328|7320395|FG001|NOT COMPLETED|Overall Study||14
6407489|NCT00926367|7320403|FG000|STARTED|Overall Study||25
6407490|NCT00926367|7320404|FG001|STARTED|Overall Study||27
6407491|NCT00926367|7320403|FG000|COMPLETED|Overall Study||23
6407492|NCT00926367|7320404|FG001|COMPLETED|Overall Study||24
6407493|NCT00926367|7320403|FG000|NOT COMPLETED|Overall Study||2
6407494|NCT00926367|7320404|FG001|NOT COMPLETED|Overall Study||3
6407495|NCT00926380|7320415|FG000|STARTED|Year 1||33
6407496|NCT00926380|7320416|FG001|STARTED|Year 1||31
6407497|NCT00926380|7320417|FG002|STARTED|Year 1||30
6407498|NCT00926380|7320415|FG000|COMPLETED|Year 1||33
6407499|NCT00926380|7320416|FG001|COMPLETED|Year 1||30
6407500|NCT00926380|7320417|FG002|COMPLETED|Year 1||29
6407501|NCT00926380|7320415|FG000|NOT COMPLETED|Year 1||0
6407502|NCT00926380|7320416|FG001|NOT COMPLETED|Year 1||1
6407503|NCT00926380|7320417|FG002|NOT COMPLETED|Year 1||1
6407504|NCT00926380|7320415|FG000|STARTED|Year 2||33
6407505|NCT00926380|7320416|FG001|STARTED|Year 2||30
6407506|NCT00926380|7320417|FG002|STARTED|Year 2||29
6407507|NCT00926380|7320415|FG000|COMPLETED|Year 2||31
6407508|NCT00926380|7320416|FG001|COMPLETED|Year 2||28
6407509|NCT00926380|7320417|FG002|COMPLETED|Year 2||24
6407510|NCT00926380|7320415|FG000|NOT COMPLETED|Year 2||2
6407511|NCT00926380|7320416|FG001|NOT COMPLETED|Year 2||2
6407512|NCT00926380|7320417|FG002|NOT COMPLETED|Year 2||5
6407513|NCT00926393|7320427|FG000|STARTED|Overall Study||69
6407514|NCT00926393|7320428|FG001|STARTED|Overall Study||70
6407515|NCT00926393|7320427|FG000|COMPLETED|Overall Study||67
6407516|NCT00926393|7320428|FG001|COMPLETED|Overall Study||67
6407517|NCT00926393|7320427|FG000|NOT COMPLETED|Overall Study||2
6407518|NCT00926393|7320428|FG001|NOT COMPLETED|Overall Study||3
6407519|NCT00926497|7320436|FG000|STARTED|Overall Study||60
6407520|NCT00926497|7320437|FG001|STARTED|Overall Study||61
6407521|NCT00926497|7320436|FG000|COMPLETED|Overall Study||60
6407522|NCT00926497|7320437|FG001|COMPLETED|Overall Study||61
6407523|NCT00926497|7320436|FG000|NOT COMPLETED|Overall Study||0
6407524|NCT00926497|7320437|FG001|NOT COMPLETED|Overall Study||0
6407525|NCT00926536|7320445|FG000|STARTED|Overall Study||44
6407526|NCT00926536|7320446|FG001|STARTED|Overall Study||43
6407527|NCT00926536|7320445|FG000|COMPLETED|Overall Study||43
6407528|NCT00926536|7320446|FG001|COMPLETED|Overall Study||41
6407529|NCT00926536|7320445|FG000|NOT COMPLETED|Overall Study||1
6407530|NCT00926536|7320446|FG001|NOT COMPLETED|Overall Study||2
6407531|NCT00926588|7320454|FG000|STARTED|Overall Study||124
6407532|NCT00926588|7320455|FG001|STARTED|Overall Study||126
6407533|NCT00926588|7320454|FG000|COMPLETED|Overall Study||116
6407534|NCT00926588|7320455|FG001|COMPLETED|Overall Study||122
6407535|NCT00926588|7320454|FG000|NOT COMPLETED|Overall Study||8
6407536|NCT00926588|7320455|FG001|NOT COMPLETED|Overall Study||4
6407537|NCT00926783|7320463|FG000|STARTED|Overall Study||42
6407538|NCT00926783|7320464|FG001|STARTED|Overall Study||41
6407539|NCT00926783|7320463|FG000|COMPLETED|Overall Study||39
6407540|NCT00926783|7320464|FG001|COMPLETED|Overall Study||38
6407541|NCT00926783|7320463|FG000|NOT COMPLETED|Overall Study||3
6407542|NCT00926783|7320464|FG001|NOT COMPLETED|Overall Study||3
6407543|NCT00926796|7320472|FG000|STARTED|Overall Study|Number randomized|309
6407544|NCT00926796|7320473|FG001|STARTED|Overall Study|Number randomized|305
6407545|NCT00926796|7320472|FG000|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
6407546|NCT00926796|7320473|FG001|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
6407547|NCT00926796|7320472|FG000|NOT COMPLETED|Overall Study||107
6407548|NCT00926796|7320473|FG001|NOT COMPLETED|Overall Study||106
6407549|NCT00926848|7320483|FG000|STARTED|Overall Study||34
6407550|NCT00926848|7320484|FG001|STARTED|Overall Study||34
6407551|NCT00926848|7320483|FG000|COMPLETED|Overall Study||34
6407552|NCT00926848|7320484|FG001|COMPLETED|Overall Study||34
6407553|NCT00926848|7320483|FG000|NOT COMPLETED|Overall Study||0
6407554|NCT00926848|7320484|FG001|NOT COMPLETED|Overall Study||0
6407555|NCT00926887|7320502|FG000|STARTED|Overall Study||54
6407556|NCT00926887|7320503|FG001|STARTED|Overall Study||50
6407557|NCT00926887|7320502|FG000|COMPLETED|Overall Study||54
6407558|NCT00926887|7320503|FG001|COMPLETED|Overall Study||50
6407559|NCT00926887|7320502|FG000|NOT COMPLETED|Overall Study||0
6407560|NCT00926887|7320503|FG001|NOT COMPLETED|Overall Study||0
6407561|NCT00926952|7320509|FG000|STARTED|Overall Study||20
6407562|NCT00926952|7320509|FG000|COMPLETED|Overall Study||20
6407563|NCT00926952|7320509|FG000|NOT COMPLETED|Overall Study||0
6407564|NCT00927069|7320515|FG000|STARTED|Week 0 to Week 12||50
6407565|NCT00927069|7320516|FG001|STARTED|Week 0 to Week 12||35
6407566|NCT00927069|7320517|FG002|STARTED|Week 0 to Week 12||0
6407567|NCT00927069|7320518|FG003|STARTED|Week 0 to Week 12||0
6407568|NCT00927069|7320515|FG000|COMPLETED|Week 0 to Week 12||49
6407569|NCT00927069|7320516|FG001|COMPLETED|Week 0 to Week 12||34
6407570|NCT00927069|7320517|FG002|COMPLETED|Week 0 to Week 12||0
6407571|NCT00927069|7320518|FG003|COMPLETED|Week 0 to Week 12||0
6407572|NCT00927069|7320515|FG000|NOT COMPLETED|Week 0 to Week 12||1
6407573|NCT00927069|7320516|FG001|NOT COMPLETED|Week 0 to Week 12||1
6407574|NCT00927069|7320517|FG002|NOT COMPLETED|Week 0 to Week 12||0
6407575|NCT00927069|7320518|FG003|NOT COMPLETED|Week 0 to Week 12||0
6407576|NCT00927069|7320515|FG000|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
6407577|NCT00927069|7320516|FG001|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
6407578|NCT00927069|7320517|FG002|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
6407579|NCT00927069|7320518|FG003|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
6407580|NCT00927069|7320515|FG000|COMPLETED|Week 12 to Week 24||16
6407581|NCT00927069|7320516|FG001|COMPLETED|Week 12 to Week 24||11
6407582|NCT00927069|7320517|FG002|COMPLETED|Week 12 to Week 24||28
6407583|NCT00927069|7320518|FG003|COMPLETED|Week 12 to Week 24||20
6407584|NCT00927069|7320515|FG000|NOT COMPLETED|Week 12 to Week 24||2
6407585|NCT00927069|7320516|FG001|NOT COMPLETED|Week 12 to Week 24||0
6407586|NCT00927069|7320517|FG002|NOT COMPLETED|Week 12 to Week 24||3
6407587|NCT00927069|7320518|FG003|NOT COMPLETED|Week 12 to Week 24||3
6407588|NCT00927082|7320532|FG000|STARTED|Overall Study||91
6407589|NCT00927082|7320533|FG001|STARTED|Overall Study||87
6407590|NCT00927082|7320534|FG002|STARTED|Overall Study||108
6407591|NCT00927082|7320535|FG003|STARTED|Overall Study||97
6407592|NCT00927082|7320532|FG000|COMPLETED|Overall Study||79
6407593|NCT00927082|7320533|FG001|COMPLETED|Overall Study||77
6407594|NCT00927082|7320534|FG002|COMPLETED|Overall Study||86
6407595|NCT00927082|7320535|FG003|COMPLETED|Overall Study||78
6407596|NCT00927082|7320532|FG000|NOT COMPLETED|Overall Study||12
6407597|NCT00927082|7320533|FG001|NOT COMPLETED|Overall Study||10
6407598|NCT00927082|7320534|FG002|NOT COMPLETED|Overall Study||22
6407599|NCT00927082|7320535|FG003|NOT COMPLETED|Overall Study||19
6407600|NCT00927095|7320552|FG000|STARTED|Overall Study||22
6407601|NCT00927095|7320553|FG001|STARTED|Overall Study||21
6407602|NCT00927095|7320554|FG002|STARTED|Overall Study||24
6407603|NCT00927095|7320552|FG000|COMPLETED|Overall Study||16
6407604|NCT00927095|7320553|FG001|COMPLETED|Overall Study||17
6407605|NCT00927095|7320554|FG002|COMPLETED|Overall Study||22
6407606|NCT00927095|7320552|FG000|NOT COMPLETED|Overall Study||6
6407607|NCT00927095|7320553|FG001|NOT COMPLETED|Overall Study||4
6407608|NCT00927095|7320554|FG002|NOT COMPLETED|Overall Study||2
6407609|NCT00927160|7320564|FG000|STARTED|Overall Study||173
6407610|NCT00927160|7320565|FG001|STARTED|Overall Study||173
6407611|NCT00927160|7320564|FG000|COMPLETED|Overall Study||173
6407612|NCT00927160|7320565|FG001|COMPLETED|Overall Study||173
6407613|NCT00927160|7320564|FG000|NOT COMPLETED|Overall Study||0
6407614|NCT00927160|7320565|FG001|NOT COMPLETED|Overall Study||0
6407615|NCT00927186|7320573|FG000|STARTED|12 Months Primary Study||34
6407616|NCT00927186|7320574|FG001|STARTED|12 Months Primary Study||35
6407617|NCT00927186|7320573|FG000|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
6407618|NCT00927186|7320574|FG001|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
6407619|NCT00927186|7320573|FG000|COMPLETED|12 Months Primary Study||27
6407620|NCT00927186|7320574|FG001|COMPLETED|12 Months Primary Study||31
6407621|NCT00927186|7320573|FG000|NOT COMPLETED|12 Months Primary Study||7
6407622|NCT00927186|7320574|FG001|NOT COMPLETED|12 Months Primary Study||4
6407623|NCT00927186|7320573|FG000|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
6407624|NCT00927186|7320574|FG001|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
6407625|NCT00927186|7320573|FG000|COMPLETED|12 - 24 Months Extension Treatment||10
6407626|NCT00927186|7320574|FG001|COMPLETED|12 - 24 Months Extension Treatment||11
6407627|NCT00927186|7320573|FG000|NOT COMPLETED|12 - 24 Months Extension Treatment||0
6407628|NCT00927186|7320574|FG001|NOT COMPLETED|12 - 24 Months Extension Treatment||0
6498795|NCT01412541|7417426|FG001|NOT COMPLETED|Overall Study||43
6498796|NCT01412554|7417435|FG000|STARTED|Overall Study|103 persons re-examined in 2012-13 out of 158 persons originally examined in 1991-96.|103
6498797|NCT01412554|7417435|FG000|COMPLETED|Overall Study||103
6498798|NCT01412554|7417435|FG000|NOT COMPLETED|Overall Study||0
6498799|NCT01412710|7417441|FG000|STARTED|Overall Study||50
6498800|NCT01412710|7417442|FG001|STARTED|Overall Study||27
6498801|NCT01412710|7417441|FG000|COMPLETED|Overall Study||46
6498802|NCT01412710|7417442|FG001|COMPLETED|Overall Study||22
6498803|NCT01412710|7417441|FG000|NOT COMPLETED|Overall Study||4
6498804|NCT01412710|7417442|FG001|NOT COMPLETED|Overall Study||5
6498805|NCT01412801|7417454|FG000|STARTED|Overall Study||91
6498806|NCT01412801|7417455|FG001|STARTED|Overall Study||89
6635821|NCT02308228|7564768|FG001|STARTED|Overall Study||55
6635822|NCT02308228|7564767|FG000|COMPLETED|Overall Study||46
6635823|NCT02308228|7564768|FG001|COMPLETED|Overall Study||48
6635824|NCT02308228|7564767|FG000|NOT COMPLETED|Overall Study||8
6635825|NCT02308228|7564768|FG001|NOT COMPLETED|Overall Study||7
6635826|NCT02308371|7564776|FG000|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
6635827|NCT02308371|7564777|FG001|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
6635828|NCT02308371|7564776|FG000|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
6635829|NCT02308371|7564777|FG001|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
6635830|NCT02308371|7564776|FG000|NOT COMPLETED|Overall Study||0
6498807|NCT01412801|7417456|FG002|STARTED|Overall Study||90
6498808|NCT01412801|7417457|FG003|STARTED|Overall Study||91
6498809|NCT01412801|7417458|FG004|STARTED|Overall Study||88
6498810|NCT01412801|7417459|FG005|STARTED|Overall Study||87
6498811|NCT01412801|7417454|FG000|COMPLETED|Overall Study||87
6407629|NCT00927251|7320583|FG000|STARTED|Overall Study||90
6407630|NCT00927251|7320583|FG000|COMPLETED|Overall Study||82
6407631|NCT00927251|7320583|FG000|NOT COMPLETED|Overall Study||8
6407632|NCT00927264|7320589|FG000|STARTED|Overall Study||165
6407633|NCT00927264|7320590|FG001|STARTED|Overall Study||165
6407634|NCT00927264|7320589|FG000|COMPLETED|Overall Study||109
6407635|NCT00927264|7320590|FG001|COMPLETED|Overall Study||140
6407636|NCT00927264|7320589|FG000|NOT COMPLETED|Overall Study||56
6407637|NCT00927264|7320590|FG001|NOT COMPLETED|Overall Study||25
6407638|NCT00927355|7320600|FG000|STARTED|Overall Study||5
6407639|NCT00927355|7320601|FG001|STARTED|Overall Study||5
6407640|NCT00927355|7320600|FG000|COMPLETED|Overall Study||4
6407641|NCT00927355|7320601|FG001|COMPLETED|Overall Study||4
6407642|NCT00927355|7320600|FG000|NOT COMPLETED|Overall Study||1
6407643|NCT00927355|7320601|FG001|NOT COMPLETED|Overall Study||1
6407644|NCT00927368|7320622|FG000|STARTED|Overall Study||153
6407645|NCT00927368|7320623|FG001|STARTED|Overall Study||157
6407646|NCT00927368|7320624|FG002|STARTED|Overall Study||143
6407647|NCT00927368|7320622|FG000|COMPLETED|Overall Study||147
6407648|NCT00927368|7320623|FG001|COMPLETED|Overall Study||152
6407649|NCT00927368|7320624|FG002|COMPLETED|Overall Study||138
6407650|NCT00927368|7320622|FG000|NOT COMPLETED|Overall Study||6
6407651|NCT00927368|7320623|FG001|NOT COMPLETED|Overall Study||5
6407652|NCT00927368|7320624|FG002|NOT COMPLETED|Overall Study||5
6407653|NCT00927394|7320634|FG000|STARTED|Overall Study||575
6407654|NCT00927394|7320635|FG001|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
6407655|NCT00927394|7320634|FG000|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
6407656|NCT00927394|7320635|FG001|Cohort 1 (Randomized)|Overall Study||165
6407657|NCT00927394|7320634|FG000|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
6407658|NCT00927394|7320635|FG001|Cohort 2 (Randomized)|Overall Study||403
6407659|NCT00927394|7320634|FG000|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
6407660|NCT00927394|7320635|FG001|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
6407661|NCT00927394|7320634|FG000|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
6407662|NCT00927394|7320635|FG001|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
6407663|NCT00927394|7320634|FG000|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
6407664|NCT00927394|7320635|FG001|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
6407665|NCT00927394|7320634|FG000|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
6407666|NCT00927394|7320635|FG001|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
6407667|NCT00927394|7320634|FG000|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
6407668|NCT00927394|7320635|FG001|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
6407669|NCT00927394|7320634|FG000|COMPLETED|Overall Study||498
6407670|NCT00927394|7320635|FG001|COMPLETED|Overall Study||483
6407671|NCT00927394|7320634|FG000|NOT COMPLETED|Overall Study||77
6407672|NCT00927394|7320635|FG001|NOT COMPLETED|Overall Study||85
6407673|NCT00927472|7320644|FG000|STARTED|Overall Study||126
6407674|NCT00927472|7320645|FG001|STARTED|Overall Study||128
6407675|NCT00927472|7320644|FG000|COMPLETED|Overall Study||115
6407676|NCT00927472|7320645|FG001|COMPLETED|Overall Study||106
6407677|NCT00927472|7320644|FG000|NOT COMPLETED|Overall Study||11
6407678|NCT00927472|7320645|FG001|NOT COMPLETED|Overall Study||22
6407679|NCT00927485|7320653|FG000|STARTED|Overall Study||21
6407680|NCT00927485|7320654|FG001|STARTED|Overall Study||23
6407681|NCT00927485|7320653|FG000|COMPLETED|Overall Study||15
6407682|NCT00927485|7320654|FG001|COMPLETED|Overall Study||19
6407683|NCT00927485|7320653|FG000|NOT COMPLETED|Overall Study||6
6407684|NCT00927485|7320654|FG001|NOT COMPLETED|Overall Study||4
6407685|NCT00927563|7320660|FG000|STARTED|Overall Study||24
6407686|NCT00927563|7320660|FG000|COMPLETED|Overall Study||22
6407687|NCT00927563|7320660|FG000|NOT COMPLETED|Overall Study||2
6407688|NCT00927576|7320666|FG000|STARTED|Overall Study||237
6407689|NCT00927576|7320667|FG001|STARTED|Overall Study||28
6407690|NCT00927576|7320666|FG000|Cognitive Testing|Overall Study||237
6407691|NCT00927576|7320667|FG001|Cognitive Testing|Overall Study||28
6407692|NCT00927576|7320666|FG000|COMPLETED|Overall Study||237
6407693|NCT00927576|7320667|FG001|COMPLETED|Overall Study||28
6407694|NCT00927576|7320666|FG000|NOT COMPLETED|Overall Study||0
6407695|NCT00927576|7320667|FG001|NOT COMPLETED|Overall Study||0
6407696|NCT00927589|7320672|FG000|STARTED|Overall Study||59
6407697|NCT00927589|7320672|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
6407698|NCT00927589|7320672|FG000|NOT COMPLETED|Overall Study||16
6407699|NCT00927758|7320676|FG000|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
6407700|NCT00927758|7320677|FG001|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
6407701|NCT00927758|7320678|FG002|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
6407702|NCT00927758|7320679|FG003|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
6407703|NCT00927758|7320680|FG004|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
6407704|NCT00927758|7320681|FG005|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
6407705|NCT00927758|7320676|FG000|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
6407706|NCT00927758|7320677|FG001|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
6407707|NCT00927758|7320678|FG002|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
6407708|NCT00927758|7320679|FG003|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
6407709|NCT00927758|7320680|FG004|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
6407710|NCT00927758|7320681|FG005|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
6407711|NCT00927758|7320676|FG000|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
6407712|NCT00927758|7320677|FG001|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
6407713|NCT00927758|7320678|FG002|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
6407714|NCT00927758|7320679|FG003|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
6407715|NCT00927758|7320680|FG004|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
6407716|NCT00927758|7320681|FG005|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
6407717|NCT00927758|7320676|FG000|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
6407718|NCT00927758|7320677|FG001|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
6407719|NCT00927758|7320678|FG002|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
6407720|NCT00927758|7320679|FG003|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
6407721|NCT00927758|7320680|FG004|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
6407722|NCT00927758|7320681|FG005|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
6407723|NCT00927758|7320676|FG000|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
6407724|NCT00927758|7320677|FG001|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
6407725|NCT00927758|7320678|FG002|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
6407726|NCT00927758|7320679|FG003|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
6407727|NCT00927758|7320680|FG004|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
6407728|NCT00927758|7320681|FG005|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
6407729|NCT00927758|7320676|FG000|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
6407730|NCT00927758|7320677|FG001|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
6407731|NCT00927758|7320678|FG002|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
6407732|NCT00927758|7320679|FG003|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
6407733|NCT00927758|7320680|FG004|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
6407734|NCT00927758|7320681|FG005|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
6407735|NCT00927758|7320676|FG000|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
6407736|NCT00927758|7320677|FG001|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
6407737|NCT00927758|7320678|FG002|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
6407738|NCT00927758|7320679|FG003|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
6407739|NCT00927758|7320680|FG004|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
6407740|NCT00927758|7320681|FG005|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
6407741|NCT00927758|7320676|FG000|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
6407742|NCT00927758|7320677|FG001|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
6407743|NCT00927758|7320678|FG002|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
6635831|NCT02308371|7564777|FG001|NOT COMPLETED|Overall Study||0
6655680|NCT02454608|7585844|FG001|NOT COMPLETED|Double-Blind Period||2
6407744|NCT00927758|7320679|FG003|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
6407745|NCT00927758|7320680|FG004|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
6407746|NCT00927758|7320681|FG005|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
6407747|NCT00927758|7320676|FG000|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
6407748|NCT00927758|7320677|FG001|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
6407749|NCT00927758|7320678|FG002|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
6407750|NCT00927758|7320679|FG003|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
6407751|NCT00927758|7320680|FG004|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
6407752|NCT00927758|7320681|FG005|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
6407753|NCT00927758|7320676|FG000|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
6407754|NCT00927758|7320677|FG001|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
6407755|NCT00927758|7320678|FG002|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
6407756|NCT00927758|7320679|FG003|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
6407757|NCT00927758|7320680|FG004|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
6407758|NCT00927758|7320681|FG005|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
6407759|NCT00927758|7320676|FG000|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6407760|NCT00927758|7320677|FG001|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6407761|NCT00927758|7320678|FG002|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6407762|NCT00927758|7320679|FG003|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6407763|NCT00927758|7320680|FG004|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6407764|NCT00927758|7320681|FG005|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
6407765|NCT00927784|7320691|FG000|STARTED|Overall Study||8
6407766|NCT00927784|7320692|FG001|STARTED|Overall Study||2
6407767|NCT00927784|7320691|FG000|COMPLETED|Overall Study||6
6407768|NCT00927784|7320692|FG001|COMPLETED|Overall Study||2
6407769|NCT00927784|7320691|FG000|NOT COMPLETED|Overall Study||2
6407770|NCT00927784|7320692|FG001|NOT COMPLETED|Overall Study||0
6407771|NCT00927810|7320702|FG000|STARTED|Overall Study||75
6407772|NCT00927810|7320703|FG001|STARTED|Overall Study||181
6407773|NCT00927810|7320704|FG002|STARTED|Overall Study||25
6407774|NCT00927810|7320705|FG003|STARTED|Overall Study||60
6407775|NCT00927810|7320702|FG000|COMPLETED|Overall Study||75
6510396|NCT01482312|7429966|FG000|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
6510397|NCT01482312|7429967|FG001|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
6510398|NCT01482312|7429968|FG002|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
6407776|NCT00927810|7320703|FG001|COMPLETED|Overall Study||173
6407777|NCT00927810|7320704|FG002|COMPLETED|Overall Study||24
6407778|NCT00927810|7320705|FG003|COMPLETED|Overall Study||58
6407779|NCT00927810|7320702|FG000|NOT COMPLETED|Overall Study||0
6407780|NCT00927810|7320703|FG001|NOT COMPLETED|Overall Study||8
6407781|NCT00927810|7320704|FG002|NOT COMPLETED|Overall Study||1
6407782|NCT00927810|7320705|FG003|NOT COMPLETED|Overall Study||2
6407783|NCT00927823|7320723|FG000|STARTED|Lead-In Period||3
6407784|NCT00927823|7320724|FG001|STARTED|Lead-In Period||3
6407785|NCT00927823|7320725|FG002|STARTED|Lead-In Period||26
6407786|NCT00927823|7320726|FG003|STARTED|Lead-In Period||5
6407787|NCT00927823|7320723|FG000|COMPLETED|Lead-In Period||3
6407788|NCT00927823|7320724|FG001|COMPLETED|Lead-In Period||3
6407789|NCT00927823|7320725|FG002|COMPLETED|Lead-In Period||26
6407790|NCT00927823|7320726|FG003|COMPLETED|Lead-In Period||5
6407791|NCT00927823|7320723|FG000|NOT COMPLETED|Lead-In Period||0
6407792|NCT00927823|7320724|FG001|NOT COMPLETED|Lead-In Period||0
6407793|NCT00927823|7320725|FG002|NOT COMPLETED|Lead-In Period||0
6407794|NCT00927823|7320726|FG003|NOT COMPLETED|Lead-In Period||0
6407795|NCT00927823|7320723|FG000|STARTED|Continuous Dosing Period||3
6407796|NCT00927823|7320724|FG001|STARTED|Continuous Dosing Period||3
6407797|NCT00927823|7320725|FG002|STARTED|Continuous Dosing Period||26
6407798|NCT00927823|7320726|FG003|STARTED|Continuous Dosing Period||5
6407799|NCT00927823|7320723|FG000|Treated|Continuous Dosing Period||3
6407800|NCT00927823|7320724|FG001|Treated|Continuous Dosing Period||3
6407801|NCT00927823|7320725|FG002|Treated|Continuous Dosing Period||23
6407802|NCT00927823|7320726|FG003|Treated|Continuous Dosing Period||5
6407803|NCT00927823|7320723|FG000|COMPLETED|Continuous Dosing Period||0
6407804|NCT00927823|7320724|FG001|COMPLETED|Continuous Dosing Period||0
6407805|NCT00927823|7320725|FG002|COMPLETED|Continuous Dosing Period||0
6407806|NCT00927823|7320726|FG003|COMPLETED|Continuous Dosing Period||0
6407807|NCT00927823|7320723|FG000|NOT COMPLETED|Continuous Dosing Period||3
6407808|NCT00927823|7320724|FG001|NOT COMPLETED|Continuous Dosing Period||3
6407809|NCT00927823|7320725|FG002|NOT COMPLETED|Continuous Dosing Period||26
6407810|NCT00927823|7320726|FG003|NOT COMPLETED|Continuous Dosing Period||5
6407811|NCT00927849|7320746|FG000|STARTED|Overall Study||21
6407812|NCT00927849|7320747|FG001|STARTED|Overall Study||21
6407813|NCT00927849|7320748|FG002|STARTED|Overall Study||21
6407814|NCT00927849|7320746|FG000|COMPLETED|Overall Study||21
6407815|NCT00927849|7320747|FG001|COMPLETED|Overall Study||21
6407816|NCT00927849|7320748|FG002|COMPLETED|Overall Study||21
6407817|NCT00927849|7320746|FG000|NOT COMPLETED|Overall Study||0
6407818|NCT00927849|7320747|FG001|NOT COMPLETED|Overall Study||0
6407819|NCT00927849|7320748|FG002|NOT COMPLETED|Overall Study||0
6407820|NCT00927862|7320758|FG000|STARTED|Overall Study||504
6407821|NCT00927862|7320759|FG001|STARTED|Overall Study||1911
6407822|NCT00927862|7320758|FG000|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
6407823|NCT00927862|7320759|FG001|COMPLETED|Overall Study||1866
6407824|NCT00927862|7320758|FG000|NOT COMPLETED|Overall Study||27
6407825|NCT00927862|7320759|FG001|NOT COMPLETED|Overall Study||45
6407826|NCT00927888|7320769|FG000|STARTED|Overall Study||29
6407827|NCT00927888|7320770|FG001|STARTED|Overall Study||27
6407828|NCT00927888|7320769|FG000|COMPLETED|Overall Study||29
6407829|NCT00927888|7320770|FG001|COMPLETED|Overall Study||27
6407830|NCT00927888|7320769|FG000|NOT COMPLETED|Overall Study||0
6407831|NCT00927888|7320770|FG001|NOT COMPLETED|Overall Study||0
6407832|NCT00927901|7320778|FG000|STARTED|Treatment Period 1||7
6407833|NCT00927901|7320779|FG001|STARTED|Treatment Period 1||7
6407834|NCT00927901|7320780|FG002|STARTED|Treatment Period 1||7
6407835|NCT00927901|7320781|FG003|STARTED|Treatment Period 1||9
6407836|NCT00927901|7320778|FG000|COMPLETED|Treatment Period 1||7
6407837|NCT00927901|7320779|FG001|COMPLETED|Treatment Period 1||7
6407838|NCT00927901|7320780|FG002|COMPLETED|Treatment Period 1||6
6407839|NCT00927901|7320781|FG003|COMPLETED|Treatment Period 1||9
6407840|NCT00927901|7320778|FG000|NOT COMPLETED|Treatment Period 1||0
6407841|NCT00927901|7320779|FG001|NOT COMPLETED|Treatment Period 1||0
6407842|NCT00927901|7320780|FG002|NOT COMPLETED|Treatment Period 1||1
6407843|NCT00927901|7320781|FG003|NOT COMPLETED|Treatment Period 1||0
6407844|NCT00927901|7320778|FG000|STARTED|Treatment Period 2||7
6407845|NCT00927901|7320779|FG001|STARTED|Treatment Period 2||7
6407846|NCT00927901|7320780|FG002|STARTED|Treatment Period 2||6
6407847|NCT00927901|7320781|FG003|STARTED|Treatment Period 2||9
6407848|NCT00927901|7320778|FG000|COMPLETED|Treatment Period 2||7
6407849|NCT00927901|7320779|FG001|COMPLETED|Treatment Period 2||7
6407850|NCT00927901|7320780|FG002|COMPLETED|Treatment Period 2||6
6407851|NCT00927901|7320781|FG003|COMPLETED|Treatment Period 2||9
6407852|NCT00927901|7320778|FG000|NOT COMPLETED|Treatment Period 2||0
6407853|NCT00927901|7320779|FG001|NOT COMPLETED|Treatment Period 2||0
6407854|NCT00927901|7320780|FG002|NOT COMPLETED|Treatment Period 2||0
6407855|NCT00927901|7320781|FG003|NOT COMPLETED|Treatment Period 2||0
6407856|NCT00927901|7320778|FG000|STARTED|Treatment Period 3||7
6407857|NCT00927901|7320779|FG001|STARTED|Treatment Period 3||7
6407858|NCT00927901|7320780|FG002|STARTED|Treatment Period 3||6
6407859|NCT00927901|7320781|FG003|STARTED|Treatment Period 3||9
6407860|NCT00927901|7320778|FG000|COMPLETED|Treatment Period 3||7
6407861|NCT00927901|7320779|FG001|COMPLETED|Treatment Period 3||7
6407862|NCT00927901|7320780|FG002|COMPLETED|Treatment Period 3||6
6407863|NCT00927901|7320781|FG003|COMPLETED|Treatment Period 3||9
6407864|NCT00927901|7320778|FG000|NOT COMPLETED|Treatment Period 3||0
6407865|NCT00927901|7320779|FG001|NOT COMPLETED|Treatment Period 3||0
6407866|NCT00927901|7320780|FG002|NOT COMPLETED|Treatment Period 3||0
6407867|NCT00927901|7320781|FG003|NOT COMPLETED|Treatment Period 3||0
6407868|NCT00927901|7320778|FG000|STARTED|Treatment Period 4||7
6407869|NCT00927901|7320779|FG001|STARTED|Treatment Period 4||7
6407870|NCT00927901|7320780|FG002|STARTED|Treatment Period 4||6
6407871|NCT00927901|7320781|FG003|STARTED|Treatment Period 4||9
6407872|NCT00927901|7320778|FG000|COMPLETED|Treatment Period 4||7
6407873|NCT00927901|7320779|FG001|COMPLETED|Treatment Period 4||7
6407874|NCT00927901|7320780|FG002|COMPLETED|Treatment Period 4||5
6407875|NCT00927901|7320781|FG003|COMPLETED|Treatment Period 4||8
6407876|NCT00927901|7320778|FG000|NOT COMPLETED|Treatment Period 4||0
6407877|NCT00927901|7320779|FG001|NOT COMPLETED|Treatment Period 4||0
6407878|NCT00927901|7320780|FG002|NOT COMPLETED|Treatment Period 4||1
6407879|NCT00927901|7320781|FG003|NOT COMPLETED|Treatment Period 4||1
6407880|NCT00927927|7320809|FG000|STARTED|Overall Study||3
6407881|NCT00927927|7320810|FG001|STARTED|Overall Study||3
6407882|NCT00927927|7320811|FG002|STARTED|Overall Study||3
6407883|NCT00927927|7320812|FG003|STARTED|Overall Study||3
6407884|NCT00927927|7320813|FG004|STARTED|Overall Study||3
6407885|NCT00927927|7320814|FG005|STARTED|Overall Study||3
6407886|NCT00927927|7320815|FG006|STARTED|Overall Study||3
6407887|NCT00927927|7320816|FG007|STARTED|Overall Study||3
6407888|NCT00927927|7320817|FG008|STARTED|Overall Study||8
6635832|NCT02308501|7564787|FG000|STARTED|Overall Study|25 participants received one drop of Lastacaft in one eye and Tears Naturale in the other eye.|25
6635833|NCT02308501|7564788|FG001|STARTED|Overall Study||25
6635834|NCT02308501|7564787|FG000|Randomized Participant Eyes|Overall Study||25
6635835|NCT02308501|7564788|FG001|Randomized Participant Eyes|Overall Study||25
6635836|NCT02308501|7564787|FG000|COMPLETED|Overall Study||25
6635837|NCT02308501|7564788|FG001|COMPLETED|Overall Study||25
6635838|NCT02308501|7564787|FG000|NOT COMPLETED|Overall Study||0
6635839|NCT02308501|7564788|FG001|NOT COMPLETED|Overall Study||0
6635840|NCT02308540|7564806|FG000|STARTED|Overall Study||17
6635841|NCT02308540|7564807|FG001|STARTED|Overall Study||17
6635842|NCT02308540|7564808|FG002|STARTED|Overall Study||56
6635843|NCT02308540|7564809|FG003|STARTED|Overall Study||56
6635844|NCT02308540|7564810|FG004|STARTED|Overall Study||100
6635845|NCT02308540|7564811|FG005|STARTED|Overall Study||100
6635846|NCT02308540|7564806|FG000|Randomized|Overall Study||17
6635847|NCT02308540|7564807|FG001|Randomized|Overall Study||17
6635848|NCT02308540|7564808|FG002|Randomized|Overall Study||56
6635849|NCT02308540|7564809|FG003|Randomized|Overall Study||56
6635850|NCT02308540|7564810|FG004|Randomized|Overall Study||100
6635851|NCT02308540|7564811|FG005|Randomized|Overall Study||100
6635852|NCT02308540|7564806|FG000|Vaccinated|Overall Study||17
6635853|NCT02308540|7564807|FG001|Vaccinated|Overall Study||17
6635854|NCT02308540|7564808|FG002|Vaccinated|Overall Study||56
6635855|NCT02308540|7564809|FG003|Vaccinated|Overall Study||56
6635856|NCT02308540|7564810|FG004|Vaccinated|Overall Study||100
6635857|NCT02308540|7564811|FG005|Vaccinated|Overall Study||100
6635858|NCT02308540|7564806|FG000|COMPLETED|Overall Study||17
6635859|NCT02308540|7564807|FG001|COMPLETED|Overall Study||17
6635860|NCT02308540|7564808|FG002|COMPLETED|Overall Study||56
6635861|NCT02308540|7564809|FG003|COMPLETED|Overall Study||56
6635862|NCT02308540|7564810|FG004|COMPLETED|Overall Study||100
6635863|NCT02308540|7564811|FG005|COMPLETED|Overall Study||99
6635864|NCT02308540|7564806|FG000|NOT COMPLETED|Overall Study||0
6635865|NCT02308540|7564807|FG001|NOT COMPLETED|Overall Study||0
6635866|NCT02308540|7564808|FG002|NOT COMPLETED|Overall Study||0
6635867|NCT02308540|7564809|FG003|NOT COMPLETED|Overall Study||0
6635868|NCT02308540|7564810|FG004|NOT COMPLETED|Overall Study||0
6635869|NCT02308540|7564811|FG005|NOT COMPLETED|Overall Study||1
6635870|NCT02308696|7564862|FG000|STARTED|Overall Study||222
6635871|NCT02308696|7564863|FG001|STARTED|Overall Study||234
6635872|NCT02308696|7564862|FG000|COMPLETED|Overall Study||169
6635873|NCT02308696|7564863|FG001|COMPLETED|Overall Study||203
6635874|NCT02308696|7564862|FG000|NOT COMPLETED|Overall Study||53
6635875|NCT02308696|7564863|FG001|NOT COMPLETED|Overall Study||31
6635876|NCT02308748|7564869|FG000|STARTED|Period 1||2
6635877|NCT02308748|7564870|FG001|STARTED|Period 1||2
6635878|NCT02308748|7564871|FG002|STARTED|Period 1||2
6635879|NCT02308748|7564872|FG003|STARTED|Period 1||2
6635880|NCT02308748|7564873|FG004|STARTED|Period 1||2
6635881|NCT02308748|7564874|FG005|STARTED|Period 1||3
6635882|NCT02308748|7564875|FG006|STARTED|Period 1||2
6635883|NCT02308748|7564876|FG007|STARTED|Period 1||2
6635884|NCT02308748|7564877|FG008|STARTED|Period 1||2
6635885|NCT02308748|7564878|FG009|STARTED|Period 1||3
6635886|NCT02308748|7564869|FG000|COMPLETED|Period 1||2
6635887|NCT02308748|7564870|FG001|COMPLETED|Period 1||2
6635888|NCT02308748|7564871|FG002|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
6635889|NCT02308748|7564872|FG003|COMPLETED|Period 1||2
6635890|NCT02308748|7564873|FG004|COMPLETED|Period 1||2
6635891|NCT02308748|7564874|FG005|COMPLETED|Period 1||3
6635892|NCT02308748|7564875|FG006|COMPLETED|Period 1||2
6635893|NCT02308748|7564876|FG007|COMPLETED|Period 1||2
6635894|NCT02308748|7564877|FG008|COMPLETED|Period 1||2
6635895|NCT02308748|7564878|FG009|COMPLETED|Period 1||3
6635896|NCT02308748|7564869|FG000|NOT COMPLETED|Period 1||0
6635897|NCT02308748|7564870|FG001|NOT COMPLETED|Period 1||0
6407889|NCT00927927|7320818|FG009|STARTED|Overall Study||3
6407890|NCT00927927|7320819|FG010|STARTED|Overall Study||5
6407891|NCT00927927|7320820|FG011|STARTED|Overall Study||6
6407892|NCT00927927|7320821|FG012|STARTED|Overall Study||5
6407893|NCT00927927|7320822|FG013|STARTED|Overall Study||5
6407894|NCT00927927|7320823|FG014|STARTED|Overall Study||9
6635898|NCT02308748|7564871|FG002|NOT COMPLETED|Period 1||1
6635899|NCT02308748|7564872|FG003|NOT COMPLETED|Period 1||0
6407895|NCT00927927|7320809|FG000|Exposed|Overall Study||3
6407896|NCT00927927|7320810|FG001|Exposed|Overall Study||3
6407897|NCT00927927|7320811|FG002|Exposed|Overall Study||3
6407898|NCT00927927|7320812|FG003|Exposed|Overall Study||3
6407899|NCT00927927|7320813|FG004|Exposed|Overall Study||3
6407900|NCT00927927|7320814|FG005|Exposed|Overall Study||3
6407901|NCT00927927|7320815|FG006|Exposed|Overall Study||3
6407902|NCT00927927|7320816|FG007|Exposed|Overall Study||3
6407903|NCT00927927|7320817|FG008|Exposed|Overall Study||8
6407904|NCT00927927|7320818|FG009|Exposed|Overall Study||3
6407905|NCT00927927|7320819|FG010|Exposed|Overall Study||5
6407906|NCT00927927|7320820|FG011|Exposed|Overall Study||5
6407907|NCT00927927|7320821|FG012|Exposed|Overall Study||5
6407908|NCT00927927|7320822|FG013|Exposed|Overall Study||5
6407909|NCT00927927|7320823|FG014|Exposed|Overall Study||9
6407910|NCT00927927|7320809|FG000|COMPLETED|Overall Study||3
6407911|NCT00927927|7320810|FG001|COMPLETED|Overall Study||3
6407912|NCT00927927|7320811|FG002|COMPLETED|Overall Study||3
6407913|NCT00927927|7320812|FG003|COMPLETED|Overall Study||3
6407914|NCT00927927|7320813|FG004|COMPLETED|Overall Study||3
6407915|NCT00927927|7320814|FG005|COMPLETED|Overall Study||3
6407916|NCT00927927|7320815|FG006|COMPLETED|Overall Study||3
6407917|NCT00927927|7320816|FG007|COMPLETED|Overall Study||1
6407918|NCT00927927|7320817|FG008|COMPLETED|Overall Study||8
6407919|NCT00927927|7320818|FG009|COMPLETED|Overall Study||3
6407920|NCT00927927|7320819|FG010|COMPLETED|Overall Study||5
6407921|NCT00927927|7320820|FG011|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
6407922|NCT00927927|7320821|FG012|COMPLETED|Overall Study||5
6407923|NCT00927927|7320822|FG013|COMPLETED|Overall Study||5
6407924|NCT00927927|7320823|FG014|COMPLETED|Overall Study||9
6407925|NCT00927927|7320809|FG000|NOT COMPLETED|Overall Study||0
6407926|NCT00927927|7320810|FG001|NOT COMPLETED|Overall Study||0
6407927|NCT00927927|7320811|FG002|NOT COMPLETED|Overall Study||0
6635900|NCT02308748|7564873|FG004|NOT COMPLETED|Period 1||0
6635901|NCT02308748|7564874|FG005|NOT COMPLETED|Period 1||0
6635902|NCT02308748|7564875|FG006|NOT COMPLETED|Period 1||0
6635903|NCT02308748|7564876|FG007|NOT COMPLETED|Period 1||0
6635904|NCT02308748|7564877|FG008|NOT COMPLETED|Period 1||0
6635905|NCT02308748|7564878|FG009|NOT COMPLETED|Period 1||0
6407928|NCT00927927|7320812|FG003|NOT COMPLETED|Overall Study||0
6407929|NCT00927927|7320813|FG004|NOT COMPLETED|Overall Study||0
6407930|NCT00927927|7320814|FG005|NOT COMPLETED|Overall Study||0
6407931|NCT00927927|7320815|FG006|NOT COMPLETED|Overall Study||0
6407932|NCT00927927|7320816|FG007|NOT COMPLETED|Overall Study||2
6407933|NCT00927927|7320817|FG008|NOT COMPLETED|Overall Study||0
6407934|NCT00927927|7320818|FG009|NOT COMPLETED|Overall Study||0
6407935|NCT00927927|7320819|FG010|NOT COMPLETED|Overall Study||0
6407936|NCT00927927|7320820|FG011|NOT COMPLETED|Overall Study||2
6407937|NCT00927927|7320821|FG012|NOT COMPLETED|Overall Study||0
6407938|NCT00927927|7320822|FG013|NOT COMPLETED|Overall Study||0
6407939|NCT00927927|7320823|FG014|NOT COMPLETED|Overall Study||0
6407940|NCT00927940|7320855|FG000|STARTED|Overall Study||100
6407941|NCT00927940|7320855|FG000|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
6407942|NCT00927940|7320855|FG000|NOT COMPLETED|Overall Study||1
6407943|NCT00927992|7320860|FG000|STARTED|Overall Study||11
6407944|NCT00927992|7320860|FG000|COMPLETED|Overall Study||11
6407945|NCT00927992|7320860|FG000|NOT COMPLETED|Overall Study||0
6407946|NCT00928018|7320866|FG000|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
6407947|NCT00928018|7320867|FG001|STARTED|Overall Study||73
6407948|NCT00928018|7320866|FG000|COMPLETED|Overall Study||65
6407949|NCT00928018|7320867|FG001|COMPLETED|Overall Study||73
6407950|NCT00928018|7320866|FG000|NOT COMPLETED|Overall Study||1
6407951|NCT00928018|7320867|FG001|NOT COMPLETED|Overall Study||0
6407952|NCT00928057|7320879|FG000|STARTED|Overall Study||84
6407953|NCT00928057|7320880|FG001|STARTED|Overall Study||89
6407954|NCT00928057|7320879|FG000|COMPLETED|Overall Study||82
6407955|NCT00928057|7320880|FG001|COMPLETED|Overall Study||85
6407956|NCT00928057|7320879|FG000|NOT COMPLETED|Overall Study||2
6407957|NCT00928057|7320880|FG001|NOT COMPLETED|Overall Study||4
6407958|NCT00928070|7320898|FG000|STARTED|Overall Study||283
6407959|NCT00928070|7320899|FG001|STARTED|Overall Study||283
6407960|NCT00928070|7320898|FG000|Treated|Overall Study||281
6635906|NCT02308748|7564869|FG000|STARTED|Period 2||2
6635907|NCT02308748|7564870|FG001|STARTED|Period 2||2
6407961|NCT00928070|7320899|FG001|Treated|Overall Study||281
6407962|NCT00928070|7320898|FG000|COMPLETED|Overall Study||220
6407963|NCT00928070|7320899|FG001|COMPLETED|Overall Study||226
6407964|NCT00928070|7320898|FG000|NOT COMPLETED|Overall Study||63
6407965|NCT00928070|7320899|FG001|NOT COMPLETED|Overall Study||57
6407966|NCT00928083|7320908|FG000|STARTED|Overall Study||10
6407967|NCT00928083|7320909|FG001|STARTED|Overall Study||8
6407968|NCT00928083|7320910|FG002|STARTED|Overall Study||8
6407969|NCT00928083|7320911|FG003|STARTED|Overall Study||6
6407970|NCT00928083|7320912|FG004|STARTED|Overall Study||7
6407971|NCT00928083|7320913|FG005|STARTED|Overall Study||6
6407972|NCT00928083|7320914|FG006|STARTED|Overall Study||6
6407973|NCT00928083|7320915|FG007|STARTED|Overall Study||6
6407974|NCT00928083|7320916|FG008|STARTED|Overall Study||6
6407975|NCT00928083|7320908|FG000|COMPLETED|Overall Study||6
6407976|NCT00928083|7320909|FG001|COMPLETED|Overall Study||8
6407977|NCT00928083|7320910|FG002|COMPLETED|Overall Study||8
6407978|NCT00928083|7320911|FG003|COMPLETED|Overall Study||5
6407979|NCT00928083|7320912|FG004|COMPLETED|Overall Study||6
6407980|NCT00928083|7320913|FG005|COMPLETED|Overall Study||6
6407981|NCT00928083|7320914|FG006|COMPLETED|Overall Study||6
6407982|NCT00928083|7320915|FG007|COMPLETED|Overall Study||6
6407983|NCT00928083|7320916|FG008|COMPLETED|Overall Study||6
6407984|NCT00928083|7320908|FG000|NOT COMPLETED|Overall Study||4
6407985|NCT00928083|7320909|FG001|NOT COMPLETED|Overall Study||0
6407986|NCT00928083|7320910|FG002|NOT COMPLETED|Overall Study||0
6407987|NCT00928083|7320911|FG003|NOT COMPLETED|Overall Study||1
6407988|NCT00928083|7320912|FG004|NOT COMPLETED|Overall Study||1
6407989|NCT00928083|7320913|FG005|NOT COMPLETED|Overall Study||0
6407990|NCT00928083|7320914|FG006|NOT COMPLETED|Overall Study||0
6407991|NCT00928083|7320915|FG007|NOT COMPLETED|Overall Study||0
6407992|NCT00928083|7320916|FG008|NOT COMPLETED|Overall Study||0
6407993|NCT00928135|7320967|FG000|STARTED|Overall Study||30
6407994|NCT00928135|7320968|FG001|STARTED|Overall Study||30
6407995|NCT00928135|7320967|FG000|COMPLETED|Overall Study||29
6407996|NCT00928135|7320968|FG001|COMPLETED|Overall Study||30
6407997|NCT00928135|7320967|FG000|NOT COMPLETED|Overall Study||1
6407998|NCT00928135|7320968|FG001|NOT COMPLETED|Overall Study||0
6407999|NCT00928174|7320974|FG000|STARTED|Overall Study||27
6408000|NCT00928174|7320974|FG000|COMPLETED|Overall Study|3 withdrawn before start of participation|22
6408001|NCT00928174|7320974|FG000|NOT COMPLETED|Overall Study||5
6408002|NCT00928187|7320981|FG000|STARTED|Overall Study||152
6408003|NCT00928187|7320982|FG001|STARTED|Overall Study||147
6408004|NCT00928187|7320983|FG002|STARTED|Overall Study||155
6408005|NCT00928187|7320981|FG000|Analysed|Overall Study||152
6408006|NCT00928187|7320982|FG001|Analysed|Overall Study||145
6408007|NCT00928187|7320983|FG002|Analysed|Overall Study||154
6408008|NCT00928187|7320981|FG000|COMPLETED|Overall Study||150
6408009|NCT00928187|7320982|FG001|COMPLETED|Overall Study||141
6408010|NCT00928187|7320983|FG002|COMPLETED|Overall Study||150
6408011|NCT00928187|7320981|FG000|NOT COMPLETED|Overall Study||2
6408012|NCT00928187|7320982|FG001|NOT COMPLETED|Overall Study||6
6408013|NCT00928187|7320983|FG002|NOT COMPLETED|Overall Study||5
6408014|NCT00928200|7320991|FG000|STARTED|Overall Study||1
6408015|NCT00928200|7320991|FG000|COMPLETED|Overall Study||1
6408016|NCT00928200|7320991|FG000|NOT COMPLETED|Overall Study||0
6408017|NCT00928252|7320995|FG000|STARTED|Overall Study||45
6408018|NCT00928252|7320995|FG000|COMPLETED|Overall Study||42
6408019|NCT00928252|7320995|FG000|NOT COMPLETED|Overall Study||3
6408020|NCT00928304|7321001|FG000|STARTED|Overall Study||39
6408021|NCT00928304|7321002|FG001|STARTED|Overall Study||70
6408022|NCT00928304|7321001|FG000|COMPLETED|Overall Study||39
6408023|NCT00928304|7321002|FG001|COMPLETED|Overall Study||70
6408024|NCT00928304|7321001|FG000|NOT COMPLETED|Overall Study||0
6408025|NCT00928304|7321002|FG001|NOT COMPLETED|Overall Study||0
6408026|NCT00928395|7321014|FG000|STARTED|Overall Study||50
6408027|NCT00928395|7321014|FG000|COMPLETED|Overall Study||29
6408028|NCT00928395|7321014|FG000|NOT COMPLETED|Overall Study||21
6408029|NCT00928408|7321018|FG000|STARTED|Overall Study|Number Enrolled|305
6408030|NCT00928408|7321018|FG000|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
6408031|NCT00928408|7321018|FG000|COMPLETED|Overall Study||282
6408032|NCT00928408|7321018|FG000|NOT COMPLETED|Overall Study||23
6408033|NCT00928421|7321022|FG000|STARTED|Overall Study||16
6408034|NCT00928421|7321022|FG000|Treated With Study Drug|Overall Study||16
6635908|NCT02308748|7564871|FG002|STARTED|Period 2||1
6635909|NCT02308748|7564872|FG003|STARTED|Period 2||2
6635910|NCT02308748|7564873|FG004|STARTED|Period 2||2
6635911|NCT02308748|7564874|FG005|STARTED|Period 2||3
6635912|NCT02308748|7564875|FG006|STARTED|Period 2||2
6635913|NCT02308748|7564876|FG007|STARTED|Period 2||2
6635914|NCT02308748|7564877|FG008|STARTED|Period 2||2
6635915|NCT02308748|7564878|FG009|STARTED|Period 2||3
6635916|NCT02308748|7564869|FG000|COMPLETED|Period 2||2
6635917|NCT02308748|7564870|FG001|COMPLETED|Period 2||2
6635918|NCT02308748|7564871|FG002|COMPLETED|Period 2||1
6635919|NCT02308748|7564872|FG003|COMPLETED|Period 2||2
6635920|NCT02308748|7564873|FG004|COMPLETED|Period 2||2
6635921|NCT02308748|7564874|FG005|COMPLETED|Period 2||3
6635922|NCT02308748|7564875|FG006|COMPLETED|Period 2||2
6635923|NCT02308748|7564876|FG007|COMPLETED|Period 2||1
6635924|NCT02308748|7564877|FG008|COMPLETED|Period 2||2
6635925|NCT02308748|7564878|FG009|COMPLETED|Period 2||3
6635926|NCT02308748|7564869|FG000|NOT COMPLETED|Period 2||0
6408035|NCT00928421|7321022|FG000|COMPLETED|Overall Study||16
6408036|NCT00928421|7321022|FG000|NOT COMPLETED|Overall Study||0
6408037|NCT00928434|7321029|FG000|STARTED|Overall Study|Full Analysis Set Patients|175
6408038|NCT00928434|7321030|FG001|STARTED|Overall Study|Full Analysis Set Patients|50
6408039|NCT00928434|7321031|FG002|STARTED|Overall Study|Full Analysis Set Patients|178
6408040|NCT00928434|7321029|FG000|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
6408041|NCT00928434|7321030|FG001|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
6408042|NCT00928434|7321031|FG002|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
6408043|NCT00928434|7321029|FG000|COMPLETED|Overall Study||131
6408044|NCT00928434|7321030|FG001|COMPLETED|Overall Study||36
6635927|NCT02308748|7564870|FG001|NOT COMPLETED|Period 2||0
6635928|NCT02308748|7564871|FG002|NOT COMPLETED|Period 2||0
6408045|NCT00928434|7321031|FG002|COMPLETED|Overall Study||134
6408046|NCT00928434|7321029|FG000|NOT COMPLETED|Overall Study||44
6408047|NCT00928434|7321030|FG001|NOT COMPLETED|Overall Study||14
6408048|NCT00928434|7321031|FG002|NOT COMPLETED|Overall Study||44
6408049|NCT00928486|7321047|FG000|STARTED|Overall Study||25
6408050|NCT00928486|7321047|FG000|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
6408051|NCT00928486|7321047|FG000|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
6408052|NCT00928486|7321047|FG000|NOT COMPLETED|Overall Study||10
6408053|NCT00928512|7321056|FG000|STARTED|Overall Study||41
6408054|NCT00928512|7321057|FG001|STARTED|Overall Study||43
6408055|NCT00928512|7321058|FG002|STARTED|Overall Study||49
6408056|NCT00928512|7321059|FG003|STARTED|Overall Study||54
6408057|NCT00928512|7321060|FG004|STARTED|Overall Study||50
6408058|NCT00928512|7321056|FG000|Discontinued Prior to Week 16|Overall Study||3
6408059|NCT00928512|7321057|FG001|Discontinued Prior to Week 16|Overall Study||0
6408060|NCT00928512|7321058|FG002|Discontinued Prior to Week 16|Overall Study||2
6408061|NCT00928512|7321059|FG003|Discontinued Prior to Week 16|Overall Study||6
6408062|NCT00928512|7321060|FG004|Discontinued Prior to Week 16|Overall Study||5
6408063|NCT00928512|7321056|FG000|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
6408064|NCT00928512|7321057|FG001|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
6408065|NCT00928512|7321058|FG002|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
6408066|NCT00928512|7321059|FG003|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
6408067|NCT00928512|7321060|FG004|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
6408068|NCT00928512|7321056|FG000|Not Reassigned at Week 20 (Responders)|Overall Study||37
6408069|NCT00928512|7321057|FG001|Not Reassigned at Week 20 (Responders)|Overall Study||20
6408070|NCT00928512|7321058|FG002|Not Reassigned at Week 20 (Responders)|Overall Study||23
6408071|NCT00928512|7321059|FG003|Not Reassigned at Week 20 (Responders)|Overall Study||18
6408072|NCT00928512|7321060|FG004|Not Reassigned at Week 20 (Responders)|Overall Study||0
6408073|NCT00928512|7321056|FG000|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
6408074|NCT00928512|7321057|FG001|New Groups After Reassignment|Overall Study||115
6408075|NCT00928512|7321058|FG002|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
6408076|NCT00928512|7321059|FG003|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
6408077|NCT00928512|7321060|FG004|New Groups After Reassignment|Overall Study||0
6408078|NCT00928512|7321056|FG000|Completed Week 16|Overall Study||38
6408079|NCT00928512|7321057|FG001|Completed Week 16|Overall Study||43
6408080|NCT00928512|7321058|FG002|Completed Week 16|Overall Study||47
6408081|NCT00928512|7321059|FG003|Completed Week 16|Overall Study||48
6408082|NCT00928512|7321060|FG004|Completed Week 16|Overall Study||45
6408083|NCT00928512|7321056|FG000|Entered/Continued to Week 20 (All)|Overall Study||37
6408084|NCT00928512|7321057|FG001|Entered/Continued to Week 20 (All)|Overall Study||43
6635929|NCT02308748|7564872|FG003|NOT COMPLETED|Period 2||0
6635930|NCT02308748|7564873|FG004|NOT COMPLETED|Period 2||0
6635931|NCT02308748|7564874|FG005|NOT COMPLETED|Period 2||0
6408085|NCT00928512|7321058|FG002|Entered/Continued to Week 20 (All)|Overall Study||46
6408086|NCT00928512|7321059|FG003|Entered/Continued to Week 20 (All)|Overall Study||45
6408087|NCT00928512|7321060|FG004|Entered/Continued to Week 20 (All)|Overall Study||45
6408088|NCT00928512|7321056|FG000|COMPLETED|Overall Study||31
6408089|NCT00928512|7321057|FG001|COMPLETED|Overall Study||37
6408090|NCT00928512|7321058|FG002|COMPLETED|Overall Study||38
6408091|NCT00928512|7321059|FG003|COMPLETED|Overall Study||33
6408092|NCT00928512|7321060|FG004|COMPLETED|Overall Study||35
6408093|NCT00928512|7321056|FG000|NOT COMPLETED|Overall Study||10
6408094|NCT00928512|7321057|FG001|NOT COMPLETED|Overall Study||6
6408095|NCT00928512|7321058|FG002|NOT COMPLETED|Overall Study||11
6408096|NCT00928512|7321059|FG003|NOT COMPLETED|Overall Study||21
6408097|NCT00928512|7321060|FG004|NOT COMPLETED|Overall Study||15
6408098|NCT00928564|7321078|FG000|STARTED|Overall Study||28
6408099|NCT00928564|7321079|FG001|STARTED|Overall Study||12
6408100|NCT00928564|7321078|FG000|COMPLETED|Overall Study||22
6408101|NCT00928564|7321079|FG001|COMPLETED|Overall Study||12
6408102|NCT00928564|7321078|FG000|NOT COMPLETED|Overall Study||6
6408103|NCT00928564|7321079|FG001|NOT COMPLETED|Overall Study||0
6408104|NCT00928642|7321085|FG000|STARTED|Overall Study||8
6408105|NCT00928642|7321085|FG000|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
6408106|NCT00928642|7321085|FG000|NOT COMPLETED|Overall Study||0
6408107|NCT00928668|7321092|FG000|STARTED|Overall Study||7
6408108|NCT00928668|7321093|FG001|STARTED|Overall Study||7
6635932|NCT02308748|7564875|FG006|NOT COMPLETED|Period 2||0
6408109|NCT00928668|7321094|FG002|STARTED|Overall Study||7
6408110|NCT00928668|7321095|FG003|STARTED|Overall Study||4
6408111|NCT00928668|7321096|FG004|STARTED|Overall Study||6
6408112|NCT00928668|7321092|FG000|COMPLETED|Overall Study||6
6408113|NCT00928668|7321093|FG001|COMPLETED|Overall Study||6
6408114|NCT00928668|7321094|FG002|COMPLETED|Overall Study||6
6408115|NCT00928668|7321095|FG003|COMPLETED|Overall Study||3
6408116|NCT00928668|7321096|FG004|COMPLETED|Overall Study||5
6408117|NCT00928668|7321092|FG000|NOT COMPLETED|Overall Study||1
6408118|NCT00928668|7321093|FG001|NOT COMPLETED|Overall Study||1
6408119|NCT00928668|7321094|FG002|NOT COMPLETED|Overall Study||1
6408120|NCT00928668|7321095|FG003|NOT COMPLETED|Overall Study||1
6408121|NCT00928668|7321096|FG004|NOT COMPLETED|Overall Study||1
6408122|NCT00928694|7321113|FG000|STARTED|First Intervention||7
6408123|NCT00928694|7321114|FG001|STARTED|First Intervention||7
6408124|NCT00928694|7321113|FG000|COMPLETED|First Intervention||7
6408125|NCT00928694|7321114|FG001|COMPLETED|First Intervention||7
6408126|NCT00928694|7321113|FG000|NOT COMPLETED|First Intervention||0
6408127|NCT00928694|7321114|FG001|NOT COMPLETED|First Intervention||0
6408128|NCT00928694|7321113|FG000|STARTED|Second Intervention||7
6408129|NCT00928694|7321114|FG001|STARTED|Second Intervention||7
6408130|NCT00928694|7321113|FG000|COMPLETED|Second Intervention||7
6408131|NCT00928694|7321114|FG001|COMPLETED|Second Intervention||7
6408132|NCT00928694|7321113|FG000|NOT COMPLETED|Second Intervention||0
6408133|NCT00928694|7321114|FG001|NOT COMPLETED|Second Intervention||0
6408134|NCT00928707|7321122|FG000|STARTED|Overall Study||23
6408135|NCT00928707|7321123|FG001|STARTED|Overall Study||22
6408136|NCT00928707|7321122|FG000|COMPLETED|Overall Study||22
6408137|NCT00928707|7321123|FG001|COMPLETED|Overall Study||22
6408138|NCT00928707|7321122|FG000|NOT COMPLETED|Overall Study||1
6408139|NCT00928707|7321123|FG001|NOT COMPLETED|Overall Study||0
6408140|NCT00928720|7321132|FG000|STARTED|Overall Study||19
6408141|NCT00928720|7321133|FG001|STARTED|Overall Study||20
6408142|NCT00928720|7321134|FG002|STARTED|Overall Study||18
6408143|NCT00928720|7321132|FG000|COMPLETED|Overall Study||17
6408144|NCT00928720|7321133|FG001|COMPLETED|Overall Study||14
6408145|NCT00928720|7321134|FG002|COMPLETED|Overall Study||15
6408146|NCT00928720|7321132|FG000|NOT COMPLETED|Overall Study||2
6408147|NCT00928720|7321133|FG001|NOT COMPLETED|Overall Study||6
6408148|NCT00928720|7321134|FG002|NOT COMPLETED|Overall Study||3
6408149|NCT00928746|7321145|FG000|STARTED|Overall Study||142
6408150|NCT00928746|7321145|FG000|COMPLETED|Overall Study||136
6408151|NCT00928746|7321145|FG000|NOT COMPLETED|Overall Study||6
6408152|NCT00928772|7321154|FG000|STARTED|Overall Study||39
6408153|NCT00928772|7321155|FG001|STARTED|Overall Study||38
6408154|NCT00928772|7321156|FG002|STARTED|Overall Study||38
6408155|NCT00928772|7321154|FG000|COMPLETED|Overall Study||39
6408156|NCT00928772|7321155|FG001|COMPLETED|Overall Study||38
6408157|NCT00928772|7321156|FG002|COMPLETED|Overall Study||38
6408158|NCT00928772|7321154|FG000|NOT COMPLETED|Overall Study||0
6408159|NCT00928772|7321155|FG001|NOT COMPLETED|Overall Study||0
6408160|NCT00928772|7321156|FG002|NOT COMPLETED|Overall Study||0
6408161|NCT00928889|7321166|FG000|STARTED|Overall Study||80
6408162|NCT00928889|7321167|FG001|STARTED|Overall Study||80
6408163|NCT00928889|7321166|FG000|COMPLETED|Overall Study||75
6408164|NCT00928889|7321167|FG001|COMPLETED|Overall Study||78
6408165|NCT00928889|7321166|FG000|NOT COMPLETED|Overall Study||5
6408166|NCT00928889|7321167|FG001|NOT COMPLETED|Overall Study||2
6408167|NCT00928954|7321173|FG000|STARTED|Overall Study||4
6408168|NCT00928954|7321174|FG001|STARTED|Overall Study||6
6408169|NCT00928954|7321173|FG000|COMPLETED|Overall Study||4
6408170|NCT00928954|7321174|FG001|COMPLETED|Overall Study||6
6408171|NCT00928954|7321173|FG000|NOT COMPLETED|Overall Study||0
6408172|NCT00928954|7321174|FG001|NOT COMPLETED|Overall Study||0
6408173|NCT00929071|7321180|FG000|STARTED|Overall Study||10
6408174|NCT00929071|7321180|FG000|COMPLETED|Overall Study||10
6408175|NCT00929071|7321180|FG000|NOT COMPLETED|Overall Study||0
6408176|NCT00929110|7321190|FG000|STARTED|Overall Study||529
6408177|NCT00929110|7321191|FG001|STARTED|Overall Study||269
6408178|NCT00929110|7321192|FG002|STARTED|Overall Study||268
6408179|NCT00929110|7321190|FG000|COMPLETED|Overall Study||411
6408180|NCT00929110|7321191|FG001|COMPLETED|Overall Study||193
6408181|NCT00929110|7321192|FG002|COMPLETED|Overall Study||206
6408182|NCT00929110|7321190|FG000|NOT COMPLETED|Overall Study||118
6408183|NCT00929110|7321191|FG001|NOT COMPLETED|Overall Study||76
6408184|NCT00929110|7321192|FG002|NOT COMPLETED|Overall Study||62
6408185|NCT00929162|7321202|FG000|STARTED|Overall Study||59
6408186|NCT00929162|7321203|FG001|STARTED|Overall Study||61
6408187|NCT00929162|7321202|FG000|Patients Who Received Treatment|Overall Study||58
6408188|NCT00929162|7321203|FG001|Patients Who Received Treatment|Overall Study||58
6408189|NCT00929162|7321202|FG000|COMPLETED|Overall Study||11
6408190|NCT00929162|7321203|FG001|COMPLETED|Overall Study||19
6408191|NCT00929162|7321202|FG000|NOT COMPLETED|Overall Study||48
6408192|NCT00929162|7321203|FG001|NOT COMPLETED|Overall Study||42
6408193|NCT00929201|7321209|FG000|STARTED|Period 1||30
6408194|NCT00929201|7321210|FG001|STARTED|Period 1||31
6408195|NCT00929201|7321209|FG000|COMPLETED|Period 1||30
6408196|NCT00929201|7321210|FG001|COMPLETED|Period 1||30
6408197|NCT00929201|7321209|FG000|NOT COMPLETED|Period 1||0
6408198|NCT00929201|7321210|FG001|NOT COMPLETED|Period 1||1
6408199|NCT00929201|7321209|FG000|STARTED|7-day Washout||30
6408200|NCT00929201|7321210|FG001|STARTED|7-day Washout||30
6408201|NCT00929201|7321209|FG000|COMPLETED|7-day Washout||30
6408202|NCT00929201|7321210|FG001|COMPLETED|7-day Washout||30
6408203|NCT00929201|7321209|FG000|NOT COMPLETED|7-day Washout||0
6408204|NCT00929201|7321210|FG001|NOT COMPLETED|7-day Washout||0
6408205|NCT00929201|7321209|FG000|STARTED|Period 2||30
6408206|NCT00929201|7321210|FG001|STARTED|Period 2||30
6408207|NCT00929201|7321209|FG000|COMPLETED|Period 2||30
6408208|NCT00929201|7321210|FG001|COMPLETED|Period 2||30
6408209|NCT00929201|7321209|FG000|NOT COMPLETED|Period 2||0
6408210|NCT00929201|7321210|FG001|NOT COMPLETED|Period 2||0
6408211|NCT00929240|7321217|FG000|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
6408212|NCT00929240|7321218|FG001|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
6408213|NCT00929240|7321219|FG002|STARTED|Initial Treatment Phase||0
6408214|NCT00929240|7321217|FG000|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
6408215|NCT00929240|7321218|FG001|COMPLETED|Initial Treatment Phase||0
6408216|NCT00929240|7321219|FG002|COMPLETED|Initial Treatment Phase||0
6408217|NCT00929240|7321217|FG000|NOT COMPLETED|Initial Treatment Phase||99
6408218|NCT00929240|7321218|FG001|NOT COMPLETED|Initial Treatment Phase||0
6408219|NCT00929240|7321219|FG002|NOT COMPLETED|Initial Treatment Phase||0
6408220|NCT00929240|7321217|FG000|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
6408221|NCT00929240|7321218|FG001|STARTED|Maintenance Phase||94
6408222|NCT00929240|7321219|FG002|STARTED|Maintenance Phase||91
6408223|NCT00929240|7321217|FG000|COMPLETED|Maintenance Phase||0
6408224|NCT00929240|7321218|FG001|COMPLETED|Maintenance Phase||0
6408225|NCT00929240|7321219|FG002|COMPLETED|Maintenance Phase||0
6408226|NCT00929240|7321217|FG000|NOT COMPLETED|Maintenance Phase||0
6408227|NCT00929240|7321218|FG001|NOT COMPLETED|Maintenance Phase||94
6408228|NCT00929240|7321219|FG002|NOT COMPLETED|Maintenance Phase||91
6408229|NCT00929305|7321230|FG000|STARTED|Overall Study||43
6408230|NCT00929305|7321231|FG001|STARTED|Overall Study||43
6408231|NCT00929305|7321230|FG000|COMPLETED|Overall Study||43
6408232|NCT00929305|7321231|FG001|COMPLETED|Overall Study||43
6408233|NCT00929305|7321230|FG000|NOT COMPLETED|Overall Study||0
6408234|NCT00929305|7321231|FG001|NOT COMPLETED|Overall Study||0
6408235|NCT00929331|7321240|FG000|STARTED|Overall Study||55
6408236|NCT00929331|7321241|FG001|STARTED|Overall Study||55
6408237|NCT00929331|7321240|FG000|COMPLETED|Overall Study||55
6408238|NCT00929331|7321241|FG001|COMPLETED|Overall Study||55
6408239|NCT00929331|7321240|FG000|NOT COMPLETED|Overall Study||0
6408240|NCT00929331|7321241|FG001|NOT COMPLETED|Overall Study||0
6408241|NCT00929344|7321250|FG000|STARTED|Overall Study||50
6408242|NCT00929344|7321251|FG001|STARTED|Overall Study||50
6408243|NCT00929344|7321252|FG002|STARTED|Overall Study||50
6408244|NCT00929344|7321250|FG000|COMPLETED|Overall Study||28
6408245|NCT00929344|7321251|FG001|COMPLETED|Overall Study||37
6408246|NCT00929344|7321252|FG002|COMPLETED|Overall Study||29
6408247|NCT00929344|7321250|FG000|NOT COMPLETED|Overall Study||22
6408248|NCT00929344|7321251|FG001|NOT COMPLETED|Overall Study||13
6408249|NCT00929344|7321252|FG002|NOT COMPLETED|Overall Study||21
6408250|NCT00929357|7321262|FG000|STARTED|Overall Study||92
6635933|NCT02308748|7564876|FG007|NOT COMPLETED|Period 2||1
6635934|NCT02308748|7564877|FG008|NOT COMPLETED|Period 2||0
6635935|NCT02308748|7564878|FG009|NOT COMPLETED|Period 2||0
6635936|NCT02308748|7564869|FG000|STARTED|Period 3||2
6635937|NCT02308748|7564870|FG001|STARTED|Period 3||2
6635938|NCT02308748|7564871|FG002|STARTED|Period 3||1
6635939|NCT02308748|7564872|FG003|STARTED|Period 3||2
6635940|NCT02308748|7564873|FG004|STARTED|Period 3||2
6635941|NCT02308748|7564874|FG005|STARTED|Period 3||3
6635942|NCT02308748|7564875|FG006|STARTED|Period 3||2
6635943|NCT02308748|7564876|FG007|STARTED|Period 3||1
6635944|NCT02308748|7564877|FG008|STARTED|Period 3||2
6635945|NCT02308748|7564878|FG009|STARTED|Period 3||3
6635946|NCT02308748|7564869|FG000|COMPLETED|Period 3||2
6635947|NCT02308748|7564870|FG001|COMPLETED|Period 3||2
6635948|NCT02308748|7564871|FG002|COMPLETED|Period 3||1
6635949|NCT02308748|7564872|FG003|COMPLETED|Period 3||2
6635950|NCT02308748|7564873|FG004|COMPLETED|Period 3||2
6635951|NCT02308748|7564874|FG005|COMPLETED|Period 3||3
6635952|NCT02308748|7564875|FG006|COMPLETED|Period 3||2
6635953|NCT02308748|7564876|FG007|COMPLETED|Period 3||1
6635954|NCT02308748|7564877|FG008|COMPLETED|Period 3||2
6635955|NCT02308748|7564878|FG009|COMPLETED|Period 3||2
6635956|NCT02308748|7564869|FG000|NOT COMPLETED|Period 3||0
6635957|NCT02308748|7564870|FG001|NOT COMPLETED|Period 3||0
6635958|NCT02308748|7564871|FG002|NOT COMPLETED|Period 3||0
6635959|NCT02308748|7564872|FG003|NOT COMPLETED|Period 3||0
6408251|NCT00929357|7321263|FG001|STARTED|Overall Study||64
6408252|NCT00929357|7321262|FG000|COMPLETED|Overall Study||92
6408253|NCT00929357|7321263|FG001|COMPLETED|Overall Study||64
6408254|NCT00929357|7321262|FG000|NOT COMPLETED|Overall Study||0
6408255|NCT00929357|7321263|FG001|NOT COMPLETED|Overall Study||0
6408256|NCT00929383|7321269|FG000|STARTED|Overall Study||82
6408257|NCT00929383|7321269|FG000|COMPLETED|Overall Study||67
6408258|NCT00929383|7321269|FG000|NOT COMPLETED|Overall Study||15
6408259|NCT00929500|7321275|FG000|STARTED|Overall Study||8
6408260|NCT00929500|7321276|FG001|STARTED|Overall Study||4
6408261|NCT00929500|7321275|FG000|COMPLETED|Overall Study||4
6408262|NCT00929500|7321276|FG001|COMPLETED|Overall Study||4
6408263|NCT00929500|7321275|FG000|NOT COMPLETED|Overall Study||4
6408264|NCT00929500|7321276|FG001|NOT COMPLETED|Overall Study||0
6408265|NCT00929526|7321284|FG000|STARTED|Overall Study||375
6408266|NCT00929526|7321285|FG001|STARTED|Overall Study||377
6408267|NCT00929526|7321284|FG000|COMPLETED|Overall Study||358
6408268|NCT00929526|7321285|FG001|COMPLETED|Overall Study||348
6408269|NCT00929526|7321284|FG000|NOT COMPLETED|Overall Study||17
6635960|NCT02308748|7564873|FG004|NOT COMPLETED|Period 3||0
6408270|NCT00929526|7321285|FG001|NOT COMPLETED|Overall Study||29
6408271|NCT00929578|7321291|FG000|STARTED|Overall Study||15
6408272|NCT00929578|7321291|FG000|COMPLETED|Overall Study||15
6408273|NCT00929578|7321291|FG000|NOT COMPLETED|Overall Study||0
6408274|NCT00929643|7321300|FG000|STARTED|Overall Study||203
6408275|NCT00929643|7321300|FG000|COMPLETED|Overall Study||201
6408276|NCT00929643|7321300|FG000|NOT COMPLETED|Overall Study||2
6408277|NCT00929656|7321306|FG000|STARTED|Overall Study||13
6408278|NCT00929656|7321307|FG001|STARTED|Overall Study||9
6408279|NCT00929656|7321306|FG000|COMPLETED|Overall Study||13
6408280|NCT00929656|7321307|FG001|COMPLETED|Overall Study||8
6408281|NCT00929656|7321306|FG000|NOT COMPLETED|Overall Study||0
6408282|NCT00929656|7321307|FG001|NOT COMPLETED|Overall Study||1
6408283|NCT00929669|7321313|FG000|STARTED|Overall Study||2
6408284|NCT00929669|7321313|FG000|COMPLETED|Overall Study||1
6408285|NCT00929669|7321313|FG000|NOT COMPLETED|Overall Study||1
6408286|NCT00929695|7321319|FG000|STARTED|Overall Study||81
6408287|NCT00929695|7321320|FG001|STARTED|Overall Study||83
6408288|NCT00929695|7321319|FG000|COMPLETED|Overall Study||73
6408289|NCT00929695|7321320|FG001|COMPLETED|Overall Study||77
6408290|NCT00929695|7321319|FG000|NOT COMPLETED|Overall Study||8
6408291|NCT00929695|7321320|FG001|NOT COMPLETED|Overall Study||6
6408292|NCT00929708|7321336|FG000|STARTED|Overall Study||65
6408293|NCT00929708|7321337|FG001|STARTED|Overall Study||69
6408294|NCT00929708|7321338|FG002|STARTED|Overall Study||65
6408295|NCT00929708|7321339|FG003|STARTED|Overall Study||67
6408296|NCT00929708|7321340|FG004|STARTED|Overall Study||63
6408297|NCT00929708|7321336|FG000|COMPLETED|Overall Study||61
6408298|NCT00929708|7321337|FG001|COMPLETED|Overall Study||66
6408299|NCT00929708|7321338|FG002|COMPLETED|Overall Study||62
6408300|NCT00929708|7321339|FG003|COMPLETED|Overall Study||61
6408301|NCT00929708|7321340|FG004|COMPLETED|Overall Study||57
6408302|NCT00929708|7321336|FG000|NOT COMPLETED|Overall Study||4
6408303|NCT00929708|7321337|FG001|NOT COMPLETED|Overall Study||3
6408304|NCT00929708|7321338|FG002|NOT COMPLETED|Overall Study||3
6408305|NCT00929708|7321339|FG003|NOT COMPLETED|Overall Study||6
6408306|NCT00929708|7321340|FG004|NOT COMPLETED|Overall Study||6
6408307|NCT00929734|7321354|FG000|STARTED|Overall Study||49
6408308|NCT00929734|7321355|FG001|STARTED|Overall Study||50
6408309|NCT00929734|7321354|FG000|COMPLETED|Overall Study||47
6408310|NCT00929734|7321355|FG001|COMPLETED|Overall Study||47
6408311|NCT00929734|7321354|FG000|NOT COMPLETED|Overall Study||2
6408312|NCT00929734|7321355|FG001|NOT COMPLETED|Overall Study||3
6408313|NCT00929773|7321363|FG000|STARTED|Overall Study||50
6408314|NCT00929773|7321364|FG001|STARTED|Overall Study||50
6408315|NCT00929773|7321363|FG000|COMPLETED|Overall Study||50
6408316|NCT00929773|7321364|FG001|COMPLETED|Overall Study||50
6408317|NCT00929773|7321363|FG000|NOT COMPLETED|Overall Study||0
6408318|NCT00929773|7321364|FG001|NOT COMPLETED|Overall Study||0
6408319|NCT00929838|7321375|FG000|STARTED|Overall Study||63
6408320|NCT00929838|7321376|FG001|STARTED|Overall Study||65
6408321|NCT00929838|7321377|FG002|STARTED|Overall Study||63
6408322|NCT00929838|7321378|FG003|STARTED|Overall Study||64
6408323|NCT00929838|7321375|FG000|COMPLETED|Overall Study||53
6408324|NCT00929838|7321376|FG001|COMPLETED|Overall Study||56
6408325|NCT00929838|7321377|FG002|COMPLETED|Overall Study||53
6408326|NCT00929838|7321378|FG003|COMPLETED|Overall Study||55
6408327|NCT00929838|7321375|FG000|NOT COMPLETED|Overall Study||10
6408328|NCT00929838|7321376|FG001|NOT COMPLETED|Overall Study||9
6408329|NCT00929838|7321377|FG002|NOT COMPLETED|Overall Study||10
6408330|NCT00929838|7321378|FG003|NOT COMPLETED|Overall Study||9
6408331|NCT00929864|7321390|FG000|STARTED|Overall Study||318
6408332|NCT00929864|7321391|FG001|STARTED|Overall Study||328
6408333|NCT00929864|7321390|FG000|COMPLETED|Overall Study||252
6408334|NCT00929864|7321391|FG001|COMPLETED|Overall Study||245
6408335|NCT00929864|7321390|FG000|NOT COMPLETED|Overall Study||66
6408336|NCT00929864|7321391|FG001|NOT COMPLETED|Overall Study||83
6408337|NCT00929981|7321397|FG000|STARTED|Overall Study||80
6408338|NCT00929981|7321397|FG000|COMPLETED|Overall Study||80
6408339|NCT00929981|7321397|FG000|NOT COMPLETED|Overall Study||0
6408340|NCT00929994|7321401|FG000|STARTED|Overall Study||20
6408341|NCT00929994|7321401|FG000|COMPLETED|Overall Study||14
6408342|NCT00929994|7321401|FG000|NOT COMPLETED|Overall Study||6
6408343|NCT00930046|7321410|FG000|STARTED|Overall Study||8
6408344|NCT00930046|7321411|FG001|STARTED|Overall Study||7
6408345|NCT00930046|7321410|FG000|COMPLETED|Overall Study||7
6408346|NCT00930046|7321411|FG001|COMPLETED|Overall Study||5
6408347|NCT00930046|7321410|FG000|NOT COMPLETED|Overall Study||1
6408348|NCT00930046|7321411|FG001|NOT COMPLETED|Overall Study||2
6408349|NCT00930059|7321419|FG000|STARTED|Overall Study||100
6408350|NCT00930059|7321420|FG001|STARTED|Overall Study||91
6408351|NCT00930059|7321419|FG000|COMPLETED|Overall Study||92
6408352|NCT00930059|7321420|FG001|COMPLETED|Overall Study||79
6408353|NCT00930059|7321419|FG000|NOT COMPLETED|Overall Study||8
6408354|NCT00930059|7321420|FG001|NOT COMPLETED|Overall Study||12
6408355|NCT00930176|7321426|FG000|STARTED|Overall Study||16
6408356|NCT00930176|7321426|FG000|COMPLETED|Overall Study||15
6408357|NCT00930176|7321426|FG000|NOT COMPLETED|Overall Study||1
6408358|NCT00930293|7321432|FG000|STARTED|Overall Study||24
6408359|NCT00930293|7321433|FG001|STARTED|Overall Study||26
6408360|NCT00930293|7321432|FG000|COMPLETED|Overall Study||17
6408361|NCT00930293|7321433|FG001|COMPLETED|Overall Study||19
6408362|NCT00930293|7321432|FG000|NOT COMPLETED|Overall Study||7
6408363|NCT00930293|7321433|FG001|NOT COMPLETED|Overall Study||7
6408364|NCT00930553|7321439|FG000|STARTED|Overall Study||1314
6408365|NCT00930553|7321439|FG000|Participants Entered From CAMMS223|Overall Study||141
6408366|NCT00930553|7321439|FG000|Participants Entered From CAMMS323|Overall Study||488
6408367|NCT00930553|7321439|FG000|Participants Entered From CAMMS324|Overall Study||685
6408368|NCT00930553|7321439|FG000|COMPLETED|Overall Study||1091
6408369|NCT00930553|7321439|FG000|NOT COMPLETED|Overall Study||223
6408370|NCT00930644|7321461|FG000|STARTED|Overall Study||88
6408371|NCT00930644|7321461|FG000|COMPLETED|Overall Study||65
6408372|NCT00930644|7321461|FG000|NOT COMPLETED|Overall Study||23
6408373|NCT00930761|7321470|FG000|STARTED|Overall Study||50
6408374|NCT00930761|7321471|FG001|STARTED|Overall Study||51
6408375|NCT00930761|7321470|FG000|COMPLETED|Overall Study||46
6408376|NCT00930761|7321471|FG001|COMPLETED|Overall Study||48
6408377|NCT00930761|7321470|FG000|NOT COMPLETED|Overall Study||4
6408378|NCT00930761|7321471|FG001|NOT COMPLETED|Overall Study||3
6408379|NCT00930774|7321481|FG000|STARTED|Overall Study||25
6408380|NCT00930774|7321482|FG001|STARTED|Overall Study||25
6408381|NCT00930774|7321483|FG002|STARTED|Overall Study||24
6408382|NCT00930774|7321484|FG003|STARTED|Overall Study||25
6408383|NCT00930774|7321481|FG000|COMPLETED|Overall Study||24
6408384|NCT00930774|7321482|FG001|COMPLETED|Overall Study||16
6408385|NCT00930774|7321483|FG002|COMPLETED|Overall Study||22
6408386|NCT00930774|7321484|FG003|COMPLETED|Overall Study||25
6408387|NCT00930774|7321481|FG000|NOT COMPLETED|Overall Study||1
6408388|NCT00930774|7321482|FG001|NOT COMPLETED|Overall Study||9
6408389|NCT00930774|7321483|FG002|NOT COMPLETED|Overall Study||2
6408390|NCT00930774|7321484|FG003|NOT COMPLETED|Overall Study||0
6408391|NCT00930813|7321497|FG000|STARTED|Overall Study||49
6408392|NCT00930813|7321498|FG001|STARTED|Overall Study||52
6408393|NCT00930813|7321497|FG000|COMPLETED|Overall Study||41
6408394|NCT00930813|7321498|FG001|COMPLETED|Overall Study||38
6408395|NCT00930813|7321497|FG000|NOT COMPLETED|Overall Study||8
6408396|NCT00930813|7321498|FG001|NOT COMPLETED|Overall Study||14
6408397|NCT00930930|7321508|FG000|STARTED|Overall Study||96
6408398|NCT00930930|7321509|FG001|STARTED|Overall Study||49
6408399|NCT00930930|7321508|FG000|COMPLETED|Overall Study||75
6408400|NCT00930930|7321509|FG001|COMPLETED|Overall Study||40
6408401|NCT00930930|7321508|FG000|NOT COMPLETED|Overall Study||21
6408402|NCT00930930|7321509|FG001|NOT COMPLETED|Overall Study||9
6408403|NCT00930969|7321515|FG000|STARTED|Overall Study||175
6408404|NCT00930969|7321515|FG000|COMPLETED|Overall Study||137
6408405|NCT00930969|7321515|FG000|NOT COMPLETED|Overall Study||38
6408406|NCT00930982|7321521|FG000|STARTED|Overall Study||60
6408407|NCT00930982|7321522|FG001|STARTED|Overall Study||64
6408408|NCT00930982|7321521|FG000|COMPLETED|Overall Study||39
6408409|NCT00930982|7321522|FG001|COMPLETED|Overall Study||35
6408410|NCT00930982|7321521|FG000|NOT COMPLETED|Overall Study||21
6408411|NCT00930982|7321522|FG001|NOT COMPLETED|Overall Study||29
6408412|NCT00931164|7321528|FG000|STARTED|Overall Study||6
6408413|NCT00931164|7321528|FG000|COMPLETED|Overall Study||6
6408414|NCT00931164|7321528|FG000|NOT COMPLETED|Overall Study||0
6408415|NCT00931242|7321534|FG000|STARTED|Overall Study||10
6408416|NCT00931242|7321535|FG001|STARTED|Overall Study||2
6408417|NCT00931242|7321534|FG000|COMPLETED|Overall Study||5
6408418|NCT00931242|7321535|FG001|COMPLETED|Overall Study||0
6408419|NCT00931242|7321534|FG000|NOT COMPLETED|Overall Study||5
6408420|NCT00931242|7321535|FG001|NOT COMPLETED|Overall Study||2
6408421|NCT00931268|7321539|FG000|STARTED|Overall Study||10
6408422|NCT00931268|7321539|FG000|COMPLETED|Overall Study||4
6408423|NCT00931268|7321539|FG000|NOT COMPLETED|Overall Study||6
6408424|NCT00931307|7321543|FG000|STARTED|Overall Study||22
6408425|NCT00931307|7321543|FG000|COMPLETED|Overall Study||9
6408426|NCT00931307|7321543|FG000|NOT COMPLETED|Overall Study||13
6408427|NCT00931359|7321549|FG000|STARTED|Overall Study||39
6408428|NCT00931359|7321550|FG001|STARTED|Overall Study||81
6408429|NCT00931359|7321549|FG000|COMPLETED|Overall Study||33
6408430|NCT00931359|7321550|FG001|COMPLETED|Overall Study||68
6408431|NCT00931359|7321549|FG000|NOT COMPLETED|Overall Study||6
6408432|NCT00931359|7321550|FG001|NOT COMPLETED|Overall Study||13
6408433|NCT00931385|7321556|FG000|STARTED|Overall Study||25
6408434|NCT00931385|7321557|FG001|STARTED|Overall Study||23
6408435|NCT00931385|7321558|FG002|STARTED|Overall Study||25
6408436|NCT00931385|7321559|FG003|STARTED|Overall Study||26
6408437|NCT00931385|7321556|FG000|COMPLETED|Overall Study||23
6408438|NCT00931385|7321557|FG001|COMPLETED|Overall Study||21
6408439|NCT00931385|7321558|FG002|COMPLETED|Overall Study||24
6408440|NCT00931385|7321559|FG003|COMPLETED|Overall Study||21
6408441|NCT00931385|7321556|FG000|NOT COMPLETED|Overall Study||2
6408442|NCT00931385|7321557|FG001|NOT COMPLETED|Overall Study||2
6408443|NCT00931385|7321558|FG002|NOT COMPLETED|Overall Study||1
6408444|NCT00931385|7321559|FG003|NOT COMPLETED|Overall Study||5
6408445|NCT00931411|7321575|FG000|STARTED|First Intervention - 42 Days||35
6408446|NCT00931411|7321576|FG001|STARTED|First Intervention - 42 Days||38
6408447|NCT00931411|7321575|FG000|COMPLETED|First Intervention - 42 Days||31
6408448|NCT00931411|7321576|FG001|COMPLETED|First Intervention - 42 Days||35
6408449|NCT00931411|7321575|FG000|NOT COMPLETED|First Intervention - 42 Days||4
6408450|NCT00931411|7321576|FG001|NOT COMPLETED|First Intervention - 42 Days||3
6408451|NCT00931411|7321575|FG000|STARTED|After Crossover - 14 Days (up to Day 56)||31
6408452|NCT00931411|7321576|FG001|STARTED|After Crossover - 14 Days (up to Day 56)||35
6408453|NCT00931411|7321575|FG000|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
6408454|NCT00931411|7321576|FG001|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
6408455|NCT00931411|7321575|FG000|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
6408456|NCT00931411|7321576|FG001|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
6408457|NCT00931463|7321588|FG000|STARTED|Overall Study||271
6408458|NCT00931463|7321589|FG001|STARTED|Overall Study||270
6408459|NCT00931463|7321588|FG000|COMPLETED|Overall Study||254
6408460|NCT00931463|7321589|FG001|COMPLETED|Overall Study||265
6408461|NCT00931463|7321588|FG000|NOT COMPLETED|Overall Study||17
6408462|NCT00931463|7321589|FG001|NOT COMPLETED|Overall Study||5
6408463|NCT00931489|7321600|FG000|STARTED|Overall Study||40
6408464|NCT00931489|7321601|FG001|STARTED|Overall Study||40
6408465|NCT00931489|7321602|FG002|STARTED|Overall Study||5
6408466|NCT00931489|7321603|FG003|STARTED|Overall Study||39
6408467|NCT00931489|7321604|FG004|STARTED|Overall Study||7
6408468|NCT00931489|7321600|FG000|COMPLETED|Overall Study||40
6408469|NCT00931489|7321601|FG001|COMPLETED|Overall Study||40
6408470|NCT00931489|7321602|FG002|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
6408471|NCT00931489|7321603|FG003|COMPLETED|Overall Study||39
6408472|NCT00931489|7321604|FG004|COMPLETED|Overall Study||7
6408473|NCT00931489|7321600|FG000|NOT COMPLETED|Overall Study||0
6408474|NCT00931489|7321601|FG001|NOT COMPLETED|Overall Study||0
6408475|NCT00931489|7321602|FG002|NOT COMPLETED|Overall Study||0
6408476|NCT00931489|7321603|FG003|NOT COMPLETED|Overall Study||0
6408477|NCT00931489|7321604|FG004|NOT COMPLETED|Overall Study||0
6408478|NCT00931515|7321617|FG000|STARTED|Overall Study||15
6408479|NCT00931515|7321618|FG001|STARTED|Overall Study||15
6408480|NCT00931515|7321617|FG000|COMPLETED|Overall Study||13
6408481|NCT00931515|7321618|FG001|COMPLETED|Overall Study||10
6408482|NCT00931515|7321617|FG000|NOT COMPLETED|Overall Study||2
6408483|NCT00931515|7321618|FG001|NOT COMPLETED|Overall Study||5
6408484|NCT00931528|7321626|FG000|STARTED|Overall Study||121
6408485|NCT00931528|7321627|FG001|STARTED|Overall Study||121
6408486|NCT00931528|7321626|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
6408487|NCT00931528|7321627|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
6408488|NCT00931528|7321626|FG000|NOT COMPLETED|Overall Study||41
6408489|NCT00931528|7321627|FG001|NOT COMPLETED|Overall Study||60
6408490|NCT00931632|7321636|FG000|STARTED|Overall Study|Randomized|229
6408491|NCT00931632|7321637|FG001|STARTED|Overall Study|Randomized|222
6408492|NCT00931632|7321636|FG000|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
6408493|NCT00931632|7321637|FG001|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
6408494|NCT00931632|7321636|FG000|NOT COMPLETED|Overall Study||21
6408495|NCT00931632|7321637|FG001|NOT COMPLETED|Overall Study||18
6408496|NCT00931710|7321645|FG000|STARTED|Overall Study||241
6408497|NCT00931710|7321646|FG001|STARTED|Overall Study||247
6408498|NCT00931710|7321645|FG000|COMPLETED|Overall Study||207
6408499|NCT00931710|7321646|FG001|COMPLETED|Overall Study||209
6408500|NCT00931710|7321645|FG000|NOT COMPLETED|Overall Study||34
6408501|NCT00931710|7321646|FG001|NOT COMPLETED|Overall Study||38
6408502|NCT00931723|7321654|FG000|STARTED|Overall Study||173
6408503|NCT00931723|7321655|FG001|STARTED|Overall Study||183
6635961|NCT02308748|7564874|FG005|NOT COMPLETED|Period 3||0
6635962|NCT02308748|7564875|FG006|NOT COMPLETED|Period 3||0
6635963|NCT02308748|7564876|FG007|NOT COMPLETED|Period 3||0
6635964|NCT02308748|7564877|FG008|NOT COMPLETED|Period 3||0
6408504|NCT00931723|7321654|FG000|COMPLETED|Overall Study||147
6408505|NCT00931723|7321655|FG001|COMPLETED|Overall Study||144
6408506|NCT00931723|7321654|FG000|NOT COMPLETED|Overall Study||26
6408507|NCT00931723|7321655|FG001|NOT COMPLETED|Overall Study||39
6408508|NCT00931762|7321661|FG000|STARTED|Overall Study||35
6408509|NCT00931762|7321661|FG000|COMPLETED|Overall Study||0
6408510|NCT00931762|7321661|FG000|NOT COMPLETED|Overall Study||35
6408511|NCT00931801|7321668|FG000|STARTED|Overall Study||14
6635965|NCT02308748|7564878|FG009|NOT COMPLETED|Period 3||1
6635966|NCT02308748|7564869|FG000|STARTED|Period 4||2
6408512|NCT00931801|7321669|FG001|STARTED|Overall Study||15
6408513|NCT00931801|7321670|FG002|STARTED|Overall Study||14
6408514|NCT00931801|7321668|FG000|COMPLETED|Overall Study||13
6408515|NCT00931801|7321669|FG001|COMPLETED|Overall Study||14
6408516|NCT00931801|7321670|FG002|COMPLETED|Overall Study||10
6408517|NCT00931801|7321668|FG000|NOT COMPLETED|Overall Study||1
6408518|NCT00931801|7321669|FG001|NOT COMPLETED|Overall Study||1
6408519|NCT00931801|7321670|FG002|NOT COMPLETED|Overall Study||4
6408520|NCT00931879|7321684|FG000|STARTED|Overall Study||22
6408521|NCT00931879|7321685|FG001|STARTED|Overall Study||22
6408522|NCT00931879|7321684|FG000|COMPLETED|Overall Study||19
6408523|NCT00931879|7321685|FG001|COMPLETED|Overall Study||19
6408524|NCT00931879|7321684|FG000|NOT COMPLETED|Overall Study||3
6408525|NCT00931879|7321685|FG001|NOT COMPLETED|Overall Study||3
6498812|NCT01412801|7417455|FG001|COMPLETED|Overall Study||84
6498813|NCT01412801|7417456|FG002|COMPLETED|Overall Study||83
6498814|NCT01412801|7417457|FG003|COMPLETED|Overall Study||87
6498815|NCT01412801|7417458|FG004|COMPLETED|Overall Study||85
6498816|NCT01412801|7417459|FG005|COMPLETED|Overall Study||84
6498817|NCT01412801|7417454|FG000|NOT COMPLETED|Overall Study||4
6498818|NCT01412801|7417455|FG001|NOT COMPLETED|Overall Study||5
6498819|NCT01412801|7417456|FG002|NOT COMPLETED|Overall Study||7
6498820|NCT01412801|7417457|FG003|NOT COMPLETED|Overall Study||4
6498821|NCT01412801|7417458|FG004|NOT COMPLETED|Overall Study||3
6498822|NCT01412801|7417459|FG005|NOT COMPLETED|Overall Study||3
6498823|NCT01412866|7417484|FG000|STARTED|Overall Study||58
6498824|NCT01412866|7417485|FG001|STARTED|Overall Study||66
6498825|NCT01412866|7417484|FG000|COMPLETED|Overall Study||57
6498826|NCT01412866|7417485|FG001|COMPLETED|Overall Study||64
6498827|NCT01412866|7417484|FG000|NOT COMPLETED|Overall Study||1
6498828|NCT01412866|7417485|FG001|NOT COMPLETED|Overall Study||2
6498829|NCT01412879|7417493|FG000|STARTED|Initial Registration (Induction Therapy)||18
6498830|NCT01412879|7417494|FG001|STARTED|Initial Registration (Induction Therapy)||35
6498831|NCT01412879|7417495|FG002|STARTED|Initial Registration (Induction Therapy)||0
6498832|NCT01412879|7417493|FG000|Treatment Started|Initial Registration (Induction Therapy)||17
6498833|NCT01412879|7417494|FG001|Treatment Started|Initial Registration (Induction Therapy)||35
6498834|NCT01412879|7417495|FG002|Treatment Started|Initial Registration (Induction Therapy)||0
6498835|NCT01412879|7417493|FG000|COMPLETED|Initial Registration (Induction Therapy)||5
6498836|NCT01412879|7417494|FG001|COMPLETED|Initial Registration (Induction Therapy)||27
6498837|NCT01412879|7417495|FG002|COMPLETED|Initial Registration (Induction Therapy)||0
6498838|NCT01412879|7417493|FG000|NOT COMPLETED|Initial Registration (Induction Therapy)||13
6498839|NCT01412879|7417494|FG001|NOT COMPLETED|Initial Registration (Induction Therapy)||8
6498840|NCT01412879|7417495|FG002|NOT COMPLETED|Initial Registration (Induction Therapy)||0
6498841|NCT01412879|7417493|FG000|STARTED|Consolidation Therapy||0
6498842|NCT01412879|7417494|FG001|STARTED|Consolidation Therapy||0
6498843|NCT01412879|7417495|FG002|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
6498844|NCT01412879|7417493|FG000|COMPLETED|Consolidation Therapy||0
6498845|NCT01412879|7417494|FG001|COMPLETED|Consolidation Therapy||0
6498846|NCT01412879|7417495|FG002|COMPLETED|Consolidation Therapy||26
6498847|NCT01412879|7417493|FG000|NOT COMPLETED|Consolidation Therapy||0
6498848|NCT01412879|7417494|FG001|NOT COMPLETED|Consolidation Therapy||0
6498849|NCT01412879|7417495|FG002|NOT COMPLETED|Consolidation Therapy||0
6498850|NCT01412918|7417507|FG000|STARTED|Overall Study||20
6498851|NCT01412918|7417508|FG001|STARTED|Overall Study||1
6498852|NCT01412918|7417507|FG000|COMPLETED|Overall Study||20
6498853|NCT01412918|7417508|FG001|COMPLETED|Overall Study||1
6498854|NCT01412918|7417507|FG000|NOT COMPLETED|Overall Study||0
6498855|NCT01412918|7417508|FG001|NOT COMPLETED|Overall Study||0
6498856|NCT01412944|7417517|FG000|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
6498857|NCT01412944|7417518|FG001|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
6498858|NCT01412944|7417519|FG002|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
6498859|NCT01412944|7417520|FG003|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
6498860|NCT01412944|7417521|FG004|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
6498861|NCT01412944|7417522|FG005|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
6498862|NCT01412944|7417517|FG000|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6498863|NCT01412944|7417518|FG001|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6498864|NCT01412944|7417519|FG002|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
6498865|NCT01412944|7417520|FG003|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
6498866|NCT01412944|7417521|FG004|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
6498867|NCT01412944|7417522|FG005|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
6498868|NCT01412944|7417517|FG000|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6498869|NCT01412944|7417518|FG001|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6498870|NCT01412944|7417519|FG002|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
6498871|NCT01412944|7417520|FG003|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6498872|NCT01412944|7417521|FG004|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
6498873|NCT01412944|7417522|FG005|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
6498874|NCT01412944|7417517|FG000|STARTED|IV: Per CAIN457A2307||21
6498875|NCT01412944|7417518|FG001|STARTED|IV: Per CAIN457A2307||22
6498876|NCT01412944|7417519|FG002|STARTED|IV: Per CAIN457A2307||0
6498877|NCT01412944|7417520|FG003|STARTED|IV: Per CAIN457A2307||0
6498878|NCT01412944|7417521|FG004|STARTED|IV: Per CAIN457A2307||0
6498879|NCT01412944|7417522|FG005|STARTED|IV: Per CAIN457A2307||0
6408526|NCT00931892|7321694|FG000|STARTED|Completed Gluten Challenge||10
6408527|NCT00931892|7321695|FG001|STARTED|Completed Gluten Challenge||10
6408528|NCT00931892|7321694|FG000|COMPLETED|Completed Gluten Challenge||10
6408529|NCT00931892|7321695|FG001|COMPLETED|Completed Gluten Challenge||10
6408530|NCT00931892|7321694|FG000|NOT COMPLETED|Completed Gluten Challenge||0
6408531|NCT00931892|7321695|FG001|NOT COMPLETED|Completed Gluten Challenge||0
6408532|NCT00931892|7321694|FG000|STARTED|Completed Endoscopies||10
6408533|NCT00931892|7321695|FG001|STARTED|Completed Endoscopies||10
6408534|NCT00931892|7321694|FG000|First Endoscopy|Completed Endoscopies||10
6408535|NCT00931892|7321695|FG001|First Endoscopy|Completed Endoscopies||10
6408536|NCT00931892|7321694|FG000|Second Endoscopy|Completed Endoscopies||10
6408537|NCT00931892|7321695|FG001|Second Endoscopy|Completed Endoscopies||10
6408538|NCT00931892|7321694|FG000|Third Endoscopy|Completed Endoscopies||10
6408539|NCT00931892|7321695|FG001|Third Endoscopy|Completed Endoscopies||9
6408540|NCT00931892|7321694|FG000|COMPLETED|Completed Endoscopies||10
6408541|NCT00931892|7321695|FG001|COMPLETED|Completed Endoscopies||9
6408542|NCT00931892|7321694|FG000|NOT COMPLETED|Completed Endoscopies||0
6408543|NCT00931892|7321695|FG001|NOT COMPLETED|Completed Endoscopies||1
6408544|NCT00931918|7321743|FG000|STARTED|Overall Study||103
6408545|NCT00931918|7321744|FG001|STARTED|Overall Study||103
6408546|NCT00931918|7321743|FG000|Safety Population: Received Study Drug|Overall Study||100
6408547|NCT00931918|7321744|FG001|Safety Population: Received Study Drug|Overall Study||101
6408548|NCT00931918|7321743|FG000|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
6408549|NCT00931918|7321744|FG001|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
6408550|NCT00931918|7321743|FG000|NOT COMPLETED|Overall Study||17
6408551|NCT00931918|7321744|FG001|NOT COMPLETED|Overall Study||17
6408552|NCT00931944|7321750|FG000|STARTED|Overall Study||74
6408553|NCT00931944|7321750|FG000|COMPLETED|Overall Study||19
6408554|NCT00931944|7321750|FG000|NOT COMPLETED|Overall Study||55
6408555|NCT00931996|7321754|FG000|STARTED|Overall Study||12
6408556|NCT00931996|7321754|FG000|COMPLETED|Overall Study||5
6408557|NCT00931996|7321754|FG000|NOT COMPLETED|Overall Study||7
6408558|NCT00932022|7321760|FG000|STARTED|Overall Study||64
6408559|NCT00932022|7321761|FG001|STARTED|Overall Study||63
6408560|NCT00932022|7321760|FG000|COMPLETED|Overall Study||59
6408561|NCT00932022|7321761|FG001|COMPLETED|Overall Study||59
6408562|NCT00932022|7321760|FG000|NOT COMPLETED|Overall Study||5
6408563|NCT00932022|7321761|FG001|NOT COMPLETED|Overall Study||4
6408564|NCT00932035|7321769|FG000|STARTED|Overall Study||18
6408565|NCT00932035|7321770|FG001|STARTED|Overall Study||21
6408566|NCT00932035|7321769|FG000|COMPLETED|Overall Study||18
6408567|NCT00932035|7321770|FG001|COMPLETED|Overall Study||21
6408568|NCT00932035|7321769|FG000|NOT COMPLETED|Overall Study||0
6408569|NCT00932035|7321770|FG001|NOT COMPLETED|Overall Study||0
6408570|NCT00932113|7321778|FG000|STARTED|Overall Study||15
6408571|NCT00932113|7321779|FG001|STARTED|Overall Study||15
6408572|NCT00932113|7321778|FG000|COMPLETED|Overall Study||14
6408573|NCT00932113|7321779|FG001|COMPLETED|Overall Study||15
6408574|NCT00932113|7321778|FG000|NOT COMPLETED|Overall Study||1
6408575|NCT00932113|7321779|FG001|NOT COMPLETED|Overall Study||0
6408576|NCT00932126|7321785|FG000|STARTED|Overall Study||3
6408577|NCT00932126|7321786|FG001|STARTED|Overall Study||3
6408578|NCT00932126|7321787|FG002|STARTED|Overall Study||3
6408579|NCT00932126|7321788|FG003|STARTED|Overall Study||3
6408580|NCT00932126|7321789|FG004|STARTED|Overall Study||5
6408581|NCT00932126|7321790|FG005|STARTED|Overall Study||3
6408582|NCT00932126|7321791|FG006|STARTED|Overall Study||5
6408583|NCT00932126|7321792|FG007|STARTED|Overall Study||10
6408584|NCT00932126|7321785|FG000|COMPLETED|Overall Study||0
6408585|NCT00932126|7321786|FG001|COMPLETED|Overall Study||0
6408586|NCT00932126|7321787|FG002|COMPLETED|Overall Study||0
6408587|NCT00932126|7321788|FG003|COMPLETED|Overall Study||0
6408588|NCT00932126|7321789|FG004|COMPLETED|Overall Study||0
6408589|NCT00932126|7321790|FG005|COMPLETED|Overall Study||0
6635967|NCT02308748|7564870|FG001|STARTED|Period 4||2
6635968|NCT02308748|7564871|FG002|STARTED|Period 4||1
6635969|NCT02308748|7564872|FG003|STARTED|Period 4||2
6635970|NCT02308748|7564873|FG004|STARTED|Period 4||2
6635971|NCT02308748|7564874|FG005|STARTED|Period 4||3
6635972|NCT02308748|7564875|FG006|STARTED|Period 4||2
6635973|NCT02308748|7564876|FG007|STARTED|Period 4||1
6635974|NCT02308748|7564877|FG008|STARTED|Period 4||2
6635975|NCT02308748|7564878|FG009|STARTED|Period 4||2
6635976|NCT02308748|7564869|FG000|COMPLETED|Period 4||2
6635977|NCT02308748|7564870|FG001|COMPLETED|Period 4||2
6635978|NCT02308748|7564871|FG002|COMPLETED|Period 4||1
6408590|NCT00932126|7321791|FG006|COMPLETED|Overall Study||0
6408591|NCT00932126|7321792|FG007|COMPLETED|Overall Study||0
6408592|NCT00932126|7321785|FG000|NOT COMPLETED|Overall Study||3
6408593|NCT00932126|7321786|FG001|NOT COMPLETED|Overall Study||3
6408594|NCT00932126|7321787|FG002|NOT COMPLETED|Overall Study||3
6408595|NCT00932126|7321788|FG003|NOT COMPLETED|Overall Study||3
6408596|NCT00932126|7321789|FG004|NOT COMPLETED|Overall Study||5
6408597|NCT00932126|7321790|FG005|NOT COMPLETED|Overall Study||3
6408598|NCT00932126|7321791|FG006|NOT COMPLETED|Overall Study||5
6408599|NCT00932126|7321792|FG007|NOT COMPLETED|Overall Study||10
6408600|NCT00932165|7321812|FG000|STARTED|Overall Study||451
6408601|NCT00932165|7321812|FG000|COMPLETED|Overall Study||450
6635979|NCT02308748|7564872|FG003|COMPLETED|Period 4||2
6635980|NCT02308748|7564873|FG004|COMPLETED|Period 4||2
6635981|NCT02308748|7564874|FG005|COMPLETED|Period 4||3
6408602|NCT00932165|7321812|FG000|NOT COMPLETED|Overall Study||1
6408603|NCT00932282|7321819|FG000|STARTED|Pre-OIT Anti-IgE Therapy Phase||7
6408604|NCT00932282|7321820|FG001|STARTED|Pre-OIT Anti-IgE Therapy Phase||6
6408605|NCT00932282|7321819|FG000|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||6
6408606|NCT00932282|7321820|FG001|COMPLETED|Pre-OIT Anti-IgE Therapy Phase||5
6408607|NCT00932282|7321819|FG000|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
6408608|NCT00932282|7321820|FG001|NOT COMPLETED|Pre-OIT Anti-IgE Therapy Phase||1
6408609|NCT00932282|7321819|FG000|STARTED|Modified OIT Rush Desensitization Phase||6
6408610|NCT00932282|7321820|FG001|STARTED|Modified OIT Rush Desensitization Phase||5
6408611|NCT00932282|7321819|FG000|COMPLETED|Modified OIT Rush Desensitization Phase||6
6408612|NCT00932282|7321820|FG001|COMPLETED|Modified OIT Rush Desensitization Phase||5
6408613|NCT00932282|7321819|FG000|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
6408614|NCT00932282|7321820|FG001|NOT COMPLETED|Modified OIT Rush Desensitization Phase||0
6408615|NCT00932282|7321819|FG000|STARTED|Biweekly OIT Buildup Phase||6
6408616|NCT00932282|7321820|FG001|STARTED|Biweekly OIT Buildup Phase||5
6408617|NCT00932282|7321819|FG000|COMPLETED|Biweekly OIT Buildup Phase||5
6408618|NCT00932282|7321820|FG001|COMPLETED|Biweekly OIT Buildup Phase||4
6408619|NCT00932282|7321819|FG000|NOT COMPLETED|Biweekly OIT Buildup Phase||1
6408620|NCT00932282|7321820|FG001|NOT COMPLETED|Biweekly OIT Buildup Phase||1
6408621|NCT00932282|7321819|FG000|STARTED|OIT Maintenance Phase||5
6408622|NCT00932282|7321820|FG001|STARTED|OIT Maintenance Phase||4
6408623|NCT00932282|7321819|FG000|COMPLETED|OIT Maintenance Phase||4
6408624|NCT00932282|7321820|FG001|COMPLETED|OIT Maintenance Phase||2
6408625|NCT00932282|7321819|FG000|NOT COMPLETED|OIT Maintenance Phase||1
6408626|NCT00932282|7321820|FG001|NOT COMPLETED|OIT Maintenance Phase||2
6408627|NCT00932321|7321828|FG000|STARTED|Overall Study||751
6408628|NCT00932321|7321829|FG001|STARTED|Overall Study||187
6408629|NCT00932321|7321828|FG000|MITT Population|Overall Study||705
6408630|NCT00932321|7321829|FG001|MITT Population|Overall Study||181
6408631|NCT00932321|7321828|FG000|COMPLETED|Overall Study||580
6408632|NCT00932321|7321829|FG001|COMPLETED|Overall Study||141
6408633|NCT00932321|7321828|FG000|NOT COMPLETED|Overall Study||171
6408634|NCT00932321|7321829|FG001|NOT COMPLETED|Overall Study||46
6408635|NCT00932360|7321835|FG000|STARTED|1: Visit 1/Week1||10
6408636|NCT00932360|7321836|FG001|STARTED|1: Visit 1/Week1||6
6408637|NCT00932360|7321837|FG002|STARTED|1: Visit 1/Week1||3
6408638|NCT00932360|7321838|FG003|STARTED|1: Visit 1/Week1||13
6408639|NCT00932360|7321839|FG004|STARTED|1: Visit 1/Week1||4
6408640|NCT00932360|7321840|FG005|STARTED|1: Visit 1/Week1||7
6408641|NCT00932360|7321835|FG000|COMPLETED|1: Visit 1/Week1||10
6408642|NCT00932360|7321836|FG001|COMPLETED|1: Visit 1/Week1||6
6408643|NCT00932360|7321837|FG002|COMPLETED|1: Visit 1/Week1||3
6408644|NCT00932360|7321838|FG003|COMPLETED|1: Visit 1/Week1||13
6408645|NCT00932360|7321839|FG004|COMPLETED|1: Visit 1/Week1||4
6408646|NCT00932360|7321840|FG005|COMPLETED|1: Visit 1/Week1||7
6408647|NCT00932360|7321835|FG000|NOT COMPLETED|1: Visit 1/Week1||0
6408648|NCT00932360|7321836|FG001|NOT COMPLETED|1: Visit 1/Week1||0
6408649|NCT00932360|7321837|FG002|NOT COMPLETED|1: Visit 1/Week1||0
6408650|NCT00932360|7321838|FG003|NOT COMPLETED|1: Visit 1/Week1||0
6408651|NCT00932360|7321839|FG004|NOT COMPLETED|1: Visit 1/Week1||0
6408652|NCT00932360|7321840|FG005|NOT COMPLETED|1: Visit 1/Week1||0
6408653|NCT00932360|7321835|FG000|STARTED|Washout (One Week)||10
6408654|NCT00932360|7321836|FG001|STARTED|Washout (One Week)||6
6408655|NCT00932360|7321837|FG002|STARTED|Washout (One Week)||3
6408656|NCT00932360|7321838|FG003|STARTED|Washout (One Week)||13
6408657|NCT00932360|7321839|FG004|STARTED|Washout (One Week)||4
6408658|NCT00932360|7321840|FG005|STARTED|Washout (One Week)||7
6408659|NCT00932360|7321835|FG000|COMPLETED|Washout (One Week)||10
6408660|NCT00932360|7321836|FG001|COMPLETED|Washout (One Week)||6
6408661|NCT00932360|7321837|FG002|COMPLETED|Washout (One Week)||3
6408662|NCT00932360|7321838|FG003|COMPLETED|Washout (One Week)||13
6408663|NCT00932360|7321839|FG004|COMPLETED|Washout (One Week)||2
6408664|NCT00932360|7321840|FG005|COMPLETED|Washout (One Week)||7
6408665|NCT00932360|7321835|FG000|NOT COMPLETED|Washout (One Week)||0
6408666|NCT00932360|7321836|FG001|NOT COMPLETED|Washout (One Week)||0
6408667|NCT00932360|7321837|FG002|NOT COMPLETED|Washout (One Week)||0
6408668|NCT00932360|7321838|FG003|NOT COMPLETED|Washout (One Week)||0
6408669|NCT00932360|7321839|FG004|NOT COMPLETED|Washout (One Week)||2
6408670|NCT00932360|7321840|FG005|NOT COMPLETED|Washout (One Week)||0
6408671|NCT00932360|7321835|FG000|STARTED|Visit 2/Week 2||10
6408672|NCT00932360|7321836|FG001|STARTED|Visit 2/Week 2||6
6408673|NCT00932360|7321837|FG002|STARTED|Visit 2/Week 2||3
6408674|NCT00932360|7321838|FG003|STARTED|Visit 2/Week 2||13
6408675|NCT00932360|7321839|FG004|STARTED|Visit 2/Week 2||2
6408676|NCT00932360|7321840|FG005|STARTED|Visit 2/Week 2||7
6408677|NCT00932360|7321835|FG000|COMPLETED|Visit 2/Week 2||10
6408678|NCT00932360|7321836|FG001|COMPLETED|Visit 2/Week 2||6
6408679|NCT00932360|7321837|FG002|COMPLETED|Visit 2/Week 2||3
6408680|NCT00932360|7321838|FG003|COMPLETED|Visit 2/Week 2||13
6408681|NCT00932360|7321839|FG004|COMPLETED|Visit 2/Week 2||2
6408682|NCT00932360|7321840|FG005|COMPLETED|Visit 2/Week 2||7
6408683|NCT00932360|7321835|FG000|NOT COMPLETED|Visit 2/Week 2||0
6408684|NCT00932360|7321836|FG001|NOT COMPLETED|Visit 2/Week 2||0
6408685|NCT00932360|7321837|FG002|NOT COMPLETED|Visit 2/Week 2||0
6408686|NCT00932360|7321838|FG003|NOT COMPLETED|Visit 2/Week 2||0
6408687|NCT00932360|7321839|FG004|NOT COMPLETED|Visit 2/Week 2||0
6408688|NCT00932360|7321840|FG005|NOT COMPLETED|Visit 2/Week 2||0
6408689|NCT00932360|7321835|FG000|STARTED|Washout (One Week)||10
6408690|NCT00932360|7321836|FG001|STARTED|Washout (One Week)||6
6408691|NCT00932360|7321837|FG002|STARTED|Washout (One Week)||3
6408692|NCT00932360|7321838|FG003|STARTED|Washout (One Week)||13
6408693|NCT00932360|7321839|FG004|STARTED|Washout (One Week)||2
6408694|NCT00932360|7321840|FG005|STARTED|Washout (One Week)||7
6408695|NCT00932360|7321835|FG000|COMPLETED|Washout (One Week)||10
6408696|NCT00932360|7321836|FG001|COMPLETED|Washout (One Week)||6
6408697|NCT00932360|7321837|FG002|COMPLETED|Washout (One Week)||3
6408698|NCT00932360|7321838|FG003|COMPLETED|Washout (One Week)||13
6408699|NCT00932360|7321839|FG004|COMPLETED|Washout (One Week)||2
6408700|NCT00932360|7321840|FG005|COMPLETED|Washout (One Week)||7
6408701|NCT00932360|7321835|FG000|NOT COMPLETED|Washout (One Week)||0
6408702|NCT00932360|7321836|FG001|NOT COMPLETED|Washout (One Week)||0
6408703|NCT00932360|7321837|FG002|NOT COMPLETED|Washout (One Week)||0
6408704|NCT00932360|7321838|FG003|NOT COMPLETED|Washout (One Week)||0
6408705|NCT00932360|7321839|FG004|NOT COMPLETED|Washout (One Week)||0
6408706|NCT00932360|7321840|FG005|NOT COMPLETED|Washout (One Week)||0
6408707|NCT00932360|7321835|FG000|STARTED|Visit 3/Week 3||10
6408708|NCT00932360|7321836|FG001|STARTED|Visit 3/Week 3||6
6408709|NCT00932360|7321837|FG002|STARTED|Visit 3/Week 3||3
6408710|NCT00932360|7321838|FG003|STARTED|Visit 3/Week 3||13
6408711|NCT00932360|7321839|FG004|STARTED|Visit 3/Week 3||2
6408712|NCT00932360|7321840|FG005|STARTED|Visit 3/Week 3||7
6408713|NCT00932360|7321835|FG000|COMPLETED|Visit 3/Week 3||10
6408714|NCT00932360|7321836|FG001|COMPLETED|Visit 3/Week 3||6
6408715|NCT00932360|7321837|FG002|COMPLETED|Visit 3/Week 3||3
6408716|NCT00932360|7321838|FG003|COMPLETED|Visit 3/Week 3||13
6408717|NCT00932360|7321839|FG004|COMPLETED|Visit 3/Week 3||2
6408718|NCT00932360|7321840|FG005|COMPLETED|Visit 3/Week 3||7
6408719|NCT00932360|7321835|FG000|NOT COMPLETED|Visit 3/Week 3||0
6408720|NCT00932360|7321836|FG001|NOT COMPLETED|Visit 3/Week 3||0
6408721|NCT00932360|7321837|FG002|NOT COMPLETED|Visit 3/Week 3||0
6408722|NCT00932360|7321838|FG003|NOT COMPLETED|Visit 3/Week 3||0
6408723|NCT00932360|7321839|FG004|NOT COMPLETED|Visit 3/Week 3||0
6408724|NCT00932360|7321840|FG005|NOT COMPLETED|Visit 3/Week 3||0
6408725|NCT00932373|7321865|FG000|STARTED|Overall Study||3
6408726|NCT00932373|7321866|FG001|STARTED|Overall Study||1
6408727|NCT00932373|7321867|FG002|STARTED|Overall Study||1
6635982|NCT02308748|7564875|FG006|COMPLETED|Period 4||2
6635983|NCT02308748|7564876|FG007|COMPLETED|Period 4||1
6635984|NCT02308748|7564877|FG008|COMPLETED|Period 4||2
6635985|NCT02308748|7564878|FG009|COMPLETED|Period 4||2
6408728|NCT00932373|7321868|FG003|STARTED|Overall Study||1
6408729|NCT00932373|7321869|FG004|STARTED|Overall Study||15
6408730|NCT00932373|7321870|FG005|STARTED|Overall Study||3
6408731|NCT00932373|7321871|FG006|STARTED|Overall Study||3
6408732|NCT00932373|7321872|FG007|STARTED|Overall Study||3
6408733|NCT00932373|7321873|FG008|STARTED|Overall Study||3
6408734|NCT00932373|7321874|FG009|STARTED|Overall Study||16
6408735|NCT00932373|7321875|FG010|STARTED|Overall Study||3
6408736|NCT00932373|7321865|FG000|COMPLETED|Overall Study||0
6408737|NCT00932373|7321866|FG001|COMPLETED|Overall Study||0
6408738|NCT00932373|7321867|FG002|COMPLETED|Overall Study||0
6408739|NCT00932373|7321868|FG003|COMPLETED|Overall Study||1
6408740|NCT00932373|7321869|FG004|COMPLETED|Overall Study||1
6408741|NCT00932373|7321870|FG005|COMPLETED|Overall Study||0
6408742|NCT00932373|7321871|FG006|COMPLETED|Overall Study||2
6408743|NCT00932373|7321872|FG007|COMPLETED|Overall Study||0
6408744|NCT00932373|7321873|FG008|COMPLETED|Overall Study||1
6408745|NCT00932373|7321874|FG009|COMPLETED|Overall Study||3
6408746|NCT00932373|7321875|FG010|COMPLETED|Overall Study||0
6408747|NCT00932373|7321865|FG000|NOT COMPLETED|Overall Study||3
6408748|NCT00932373|7321866|FG001|NOT COMPLETED|Overall Study||1
6408749|NCT00932373|7321867|FG002|NOT COMPLETED|Overall Study||1
6408750|NCT00932373|7321868|FG003|NOT COMPLETED|Overall Study||0
6408751|NCT00932373|7321869|FG004|NOT COMPLETED|Overall Study||14
6408752|NCT00932373|7321870|FG005|NOT COMPLETED|Overall Study||3
6635986|NCT02308748|7564869|FG000|NOT COMPLETED|Period 4||0
6408753|NCT00932373|7321871|FG006|NOT COMPLETED|Overall Study||1
6408754|NCT00932373|7321872|FG007|NOT COMPLETED|Overall Study||3
6408755|NCT00932373|7321873|FG008|NOT COMPLETED|Overall Study||2
6408756|NCT00932373|7321874|FG009|NOT COMPLETED|Overall Study||13
6408757|NCT00932373|7321875|FG010|NOT COMPLETED|Overall Study||3
6408758|NCT00932399|7321909|FG000|STARTED|Overall Study||759
6408759|NCT00932399|7321910|FG001|STARTED|Overall Study||3790
6408760|NCT00932399|7321909|FG000|COMPLETED|Overall Study||759
6408761|NCT00932399|7321910|FG001|COMPLETED|Overall Study||3790
6408762|NCT00932399|7321909|FG000|NOT COMPLETED|Overall Study||0
6408763|NCT00932399|7321910|FG001|NOT COMPLETED|Overall Study||0
6408764|NCT00932425|7321918|FG000|STARTED|Overall Study||20
6408765|NCT00932425|7321919|FG001|STARTED|Overall Study||20
6408766|NCT00932425|7321918|FG000|COMPLETED|Overall Study||20
6408767|NCT00932425|7321919|FG001|COMPLETED|Overall Study||18
6408768|NCT00932425|7321918|FG000|NOT COMPLETED|Overall Study||0
6408769|NCT00932425|7321919|FG001|NOT COMPLETED|Overall Study||2
6408770|NCT00932438|7321927|FG000|STARTED|Overall Study||40
6408771|NCT00932438|7321928|FG001|STARTED|Overall Study||30
6408772|NCT00932438|7321927|FG000|COMPLETED|Overall Study||39
6408773|NCT00932438|7321928|FG001|COMPLETED|Overall Study||30
6408774|NCT00932438|7321927|FG000|NOT COMPLETED|Overall Study||1
6408775|NCT00932438|7321928|FG001|NOT COMPLETED|Overall Study||0
6408776|NCT00932451|7321936|FG000|STARTED|Overall Study||1066
6408777|NCT00932451|7321936|FG000|COMPLETED|Overall Study||244
6408778|NCT00932451|7321936|FG000|NOT COMPLETED|Overall Study||822
6408779|NCT00932477|7321944|FG000|STARTED|Treatment 1||7
6408780|NCT00932477|7321945|FG001|STARTED|Treatment 1||8
6408781|NCT00932477|7321946|FG002|STARTED|Treatment 1||9
6408782|NCT00932477|7321947|FG003|STARTED|Treatment 1||7
6635987|NCT02308748|7564870|FG001|NOT COMPLETED|Period 4||0
6635988|NCT02308748|7564871|FG002|NOT COMPLETED|Period 4||0
6635989|NCT02308748|7564872|FG003|NOT COMPLETED|Period 4||0
6635990|NCT02308748|7564873|FG004|NOT COMPLETED|Period 4||0
6635991|NCT02308748|7564874|FG005|NOT COMPLETED|Period 4||0
6635992|NCT02308748|7564875|FG006|NOT COMPLETED|Period 4||0
6635993|NCT02308748|7564876|FG007|NOT COMPLETED|Period 4||0
6635994|NCT02308748|7564877|FG008|NOT COMPLETED|Period 4||0
6635995|NCT02308748|7564878|FG009|NOT COMPLETED|Period 4||0
6635996|NCT02308748|7564869|FG000|STARTED|Period 5||2
6635997|NCT02308748|7564870|FG001|STARTED|Period 5||2
6635998|NCT02308748|7564871|FG002|STARTED|Period 5||1
6635999|NCT02308748|7564872|FG003|STARTED|Period 5||2
6636000|NCT02308748|7564873|FG004|STARTED|Period 5||2
6636001|NCT02308748|7564874|FG005|STARTED|Period 5||3
6636002|NCT02308748|7564875|FG006|STARTED|Period 5||2
6636003|NCT02308748|7564876|FG007|STARTED|Period 5||1
6636004|NCT02308748|7564877|FG008|STARTED|Period 5||2
6636005|NCT02308748|7564878|FG009|STARTED|Period 5||2
6636006|NCT02308748|7564869|FG000|COMPLETED|Period 5||1
6636007|NCT02308748|7564870|FG001|COMPLETED|Period 5||2
6636008|NCT02308748|7564871|FG002|COMPLETED|Period 5||1
6636009|NCT02308748|7564872|FG003|COMPLETED|Period 5||2
6636010|NCT02308748|7564873|FG004|COMPLETED|Period 5||2
6636011|NCT02308748|7564874|FG005|COMPLETED|Period 5||3
6636012|NCT02308748|7564875|FG006|COMPLETED|Period 5||2
6636013|NCT02308748|7564876|FG007|COMPLETED|Period 5||1
6636014|NCT02308748|7564877|FG008|COMPLETED|Period 5||1
6636015|NCT02308748|7564878|FG009|COMPLETED|Period 5||2
6636016|NCT02308748|7564869|FG000|NOT COMPLETED|Period 5||1
6636017|NCT02308748|7564870|FG001|NOT COMPLETED|Period 5||0
6636018|NCT02308748|7564871|FG002|NOT COMPLETED|Period 5||0
6636019|NCT02308748|7564872|FG003|NOT COMPLETED|Period 5||0
6636020|NCT02308748|7564873|FG004|NOT COMPLETED|Period 5||0
6636021|NCT02308748|7564874|FG005|NOT COMPLETED|Period 5||0
6636022|NCT02308748|7564875|FG006|NOT COMPLETED|Period 5||0
6636023|NCT02308748|7564876|FG007|NOT COMPLETED|Period 5||0
6636024|NCT02308748|7564877|FG008|NOT COMPLETED|Period 5||1
6636025|NCT02308748|7564878|FG009|NOT COMPLETED|Period 5||0
6636026|NCT02308787|7564890|FG000|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
6636027|NCT02308787|7564890|FG000|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
6636028|NCT02308787|7564890|FG000|NOT COMPLETED|Overall Study||0
6636029|NCT02308839|7564894|FG000|STARTED|Overall Study||181
6636030|NCT02308839|7564894|FG000|COMPLETED|Overall Study||72
6636031|NCT02308839|7564894|FG000|NOT COMPLETED|Overall Study||109
6636032|NCT02309099|7564900|FG000|STARTED|Overall Study||7
6636033|NCT02309099|7564901|FG001|STARTED|Overall Study||3
6636034|NCT02309099|7564900|FG000|Cochlear Implantation|Overall Study||7
6636035|NCT02309099|7564901|FG001|Cochlear Implantation|Overall Study||3
6636036|NCT02309099|7564900|FG000|Initial Activation|Overall Study||7
6636037|NCT02309099|7564901|FG001|Initial Activation|Overall Study||3
6636038|NCT02309099|7564900|FG000|Cochlear Implant Use/Follow-Up|Overall Study|5 participants completed cochlear implant use/follow-up (2 did not complete due to adverse event)|5
6636039|NCT02309099|7564901|FG001|Cochlear Implant Use/Follow-Up|Overall Study||3
6636040|NCT02309099|7564900|FG000|COMPLETED|Overall Study|5 participants completed the study (2 did not complete due to adverse event)|5
6636041|NCT02309099|7564901|FG001|COMPLETED|Overall Study||3
6636042|NCT02309099|7564900|FG000|NOT COMPLETED|Overall Study||2
6636043|NCT02309099|7564901|FG001|NOT COMPLETED|Overall Study||0
6636044|NCT02309112|7564910|FG000|STARTED|Overall Study||5
6636045|NCT02309112|7564911|FG001|STARTED|Overall Study||5
6408783|NCT00932477|7321948|FG004|STARTED|Treatment 1||8
6408784|NCT00932477|7321949|FG005|STARTED|Treatment 1||8
6636046|NCT02309112|7564912|FG002|STARTED|Overall Study||5
6636047|NCT02309112|7564910|FG000|Completed Yoga Intervention|Overall Study||4
6636048|NCT02309112|7564911|FG001|Completed Yoga Intervention|Overall Study||5
6636049|NCT02309112|7564912|FG002|Completed Yoga Intervention|Overall Study||4
6636050|NCT02309112|7564910|FG000|COMPLETED|Overall Study||4
6636051|NCT02309112|7564911|FG001|COMPLETED|Overall Study||4
6636052|NCT02309112|7564912|FG002|COMPLETED|Overall Study||4
6636053|NCT02309112|7564910|FG000|NOT COMPLETED|Overall Study||1
6636054|NCT02309112|7564911|FG001|NOT COMPLETED|Overall Study||1
6636055|NCT02309112|7564912|FG002|NOT COMPLETED|Overall Study||1
6408785|NCT00932477|7321944|FG000|COMPLETED|Treatment 1||7
6408786|NCT00932477|7321945|FG001|COMPLETED|Treatment 1||8
6408787|NCT00932477|7321946|FG002|COMPLETED|Treatment 1||9
6408788|NCT00932477|7321947|FG003|COMPLETED|Treatment 1||7
6636056|NCT02309138|7564924|FG000|STARTED|Overall Study||460
6636057|NCT02309138|7564925|FG001|STARTED|Overall Study||461
6636058|NCT02309138|7564924|FG000|COMPLETED|Overall Study||412
6408789|NCT00932477|7321948|FG004|COMPLETED|Treatment 1||8
6408790|NCT00932477|7321949|FG005|COMPLETED|Treatment 1||8
6408791|NCT00932477|7321944|FG000|NOT COMPLETED|Treatment 1||0
6408792|NCT00932477|7321945|FG001|NOT COMPLETED|Treatment 1||0
6408793|NCT00932477|7321946|FG002|NOT COMPLETED|Treatment 1||0
6408794|NCT00932477|7321947|FG003|NOT COMPLETED|Treatment 1||0
6408795|NCT00932477|7321948|FG004|NOT COMPLETED|Treatment 1||0
6408796|NCT00932477|7321949|FG005|NOT COMPLETED|Treatment 1||0
6408797|NCT00932477|7321944|FG000|STARTED|Treatment 2||7
6408798|NCT00932477|7321945|FG001|STARTED|Treatment 2||8
6408799|NCT00932477|7321946|FG002|STARTED|Treatment 2||9
6408800|NCT00932477|7321947|FG003|STARTED|Treatment 2||7
6408801|NCT00932477|7321948|FG004|STARTED|Treatment 2||8
6408802|NCT00932477|7321949|FG005|STARTED|Treatment 2||8
6408803|NCT00932477|7321944|FG000|COMPLETED|Treatment 2||7
6408804|NCT00932477|7321945|FG001|COMPLETED|Treatment 2||8
6408805|NCT00932477|7321946|FG002|COMPLETED|Treatment 2||9
6408806|NCT00932477|7321947|FG003|COMPLETED|Treatment 2||7
6408807|NCT00932477|7321948|FG004|COMPLETED|Treatment 2||8
6408808|NCT00932477|7321949|FG005|COMPLETED|Treatment 2||8
6408809|NCT00932477|7321944|FG000|NOT COMPLETED|Treatment 2||0
6408810|NCT00932477|7321945|FG001|NOT COMPLETED|Treatment 2||0
6408811|NCT00932477|7321946|FG002|NOT COMPLETED|Treatment 2||0
6408812|NCT00932477|7321947|FG003|NOT COMPLETED|Treatment 2||0
6408813|NCT00932477|7321948|FG004|NOT COMPLETED|Treatment 2||0
6408814|NCT00932477|7321949|FG005|NOT COMPLETED|Treatment 2||0
6510399|NCT01482351|7429978|FG000|STARTED|Overall Study||68
6510400|NCT01482351|7429978|FG000|6 Months|Overall Study|14 dropped out|54
6510401|NCT01482351|7429978|FG000|12 Months|Overall Study||54
6510402|NCT01482351|7429978|FG000|COMPLETED|Overall Study||54
6510403|NCT01482351|7429978|FG000|NOT COMPLETED|Overall Study||14
6510404|NCT01482429|7429988|FG000|STARTED|Care Usual||0
6510405|NCT01482429|7429989|FG001|STARTED|Care Usual||269
6510406|NCT01482429|7429988|FG000|COMPLETED|Care Usual||0
6510407|NCT01482429|7429989|FG001|COMPLETED|Care Usual||96
6510408|NCT01482429|7429988|FG000|NOT COMPLETED|Care Usual||0
6510409|NCT01482429|7429989|FG001|NOT COMPLETED|Care Usual||173
6510410|NCT01482429|7429988|FG000|STARTED|Protocol||414
6510411|NCT01482429|7429989|FG001|STARTED|Protocol||0
6510412|NCT01482429|7429988|FG000|COMPLETED|Protocol||139
6510413|NCT01482429|7429989|FG001|COMPLETED|Protocol||0
6510414|NCT01482429|7429988|FG000|NOT COMPLETED|Protocol||275
6510415|NCT01482429|7429989|FG001|NOT COMPLETED|Protocol||0
6510416|NCT01482715|7430008|FG000|STARTED|Overall Study||6
6510417|NCT01482715|7430009|FG001|STARTED|Overall Study||3
6510418|NCT01482715|7430010|FG002|STARTED|Overall Study||4
6636059|NCT02309138|7564925|FG001|COMPLETED|Overall Study||443
6636060|NCT02309138|7564924|FG000|NOT COMPLETED|Overall Study||48
6636061|NCT02309138|7564925|FG001|NOT COMPLETED|Overall Study||18
6636062|NCT02309294|7564941|FG000|STARTED|Overall Study||43
6636063|NCT02309294|7564941|FG000|COMPLETED|Overall Study||41
6636064|NCT02309294|7564941|FG000|NOT COMPLETED|Overall Study||2
6636065|NCT02309359|7564950|FG000|STARTED|Overall Study||69
6636066|NCT02309359|7564951|FG001|STARTED|Overall Study||70
6636067|NCT02309359|7564952|FG002|STARTED|Overall Study||68
6636068|NCT02309359|7564953|FG003|STARTED|Overall Study||69
6636069|NCT02309359|7564954|FG004|STARTED|Overall Study||69
6636070|NCT02309359|7564950|FG000|COMPLETED|Overall Study||57
6636071|NCT02309359|7564951|FG001|COMPLETED|Overall Study||62
6636072|NCT02309359|7564952|FG002|COMPLETED|Overall Study||57
6636073|NCT02309359|7564953|FG003|COMPLETED|Overall Study||57
6636074|NCT02309359|7564954|FG004|COMPLETED|Overall Study||60
6636075|NCT02309359|7564950|FG000|NOT COMPLETED|Overall Study||12
6636076|NCT02309359|7564951|FG001|NOT COMPLETED|Overall Study||8
6636077|NCT02309359|7564952|FG002|NOT COMPLETED|Overall Study||11
6636078|NCT02309359|7564953|FG003|NOT COMPLETED|Overall Study||12
6636079|NCT02309359|7564954|FG004|NOT COMPLETED|Overall Study||9
6636080|NCT02309372|7564969|FG000|STARTED|Overall Study||27
6636081|NCT02309372|7564970|FG001|STARTED|Overall Study||27
6636082|NCT02309372|7564969|FG000|COMPLETED|Overall Study||24
6636083|NCT02309372|7564970|FG001|COMPLETED|Overall Study||25
6636084|NCT02309372|7564969|FG000|NOT COMPLETED|Overall Study||3
6636085|NCT02309372|7564970|FG001|NOT COMPLETED|Overall Study||2
6636086|NCT02309411|7564979|FG000|STARTED|Overall Study||25
6636087|NCT02309411|7564980|FG001|STARTED|Overall Study||15
6636088|NCT02309411|7564981|FG002|STARTED|Overall Study||6
6636089|NCT02309411|7564979|FG000|COMPLETED|Overall Study||23
6636090|NCT02309411|7564980|FG001|COMPLETED|Overall Study||14
6636091|NCT02309411|7564981|FG002|COMPLETED|Overall Study||6
6408815|NCT00932477|7321944|FG000|STARTED|Treatment 3||7
6408816|NCT00932477|7321945|FG001|STARTED|Treatment 3||8
6408817|NCT00932477|7321946|FG002|STARTED|Treatment 3||9
6510419|NCT01482715|7430011|FG003|STARTED|Overall Study||9
6510420|NCT01482715|7430012|FG004|STARTED|Overall Study||4
6510421|NCT01482715|7430013|FG005|STARTED|Overall Study||3
6510422|NCT01482715|7430014|FG006|STARTED|Overall Study||8
6636092|NCT02309411|7564979|FG000|NOT COMPLETED|Overall Study||2
6636093|NCT02309411|7564980|FG001|NOT COMPLETED|Overall Study||1
6636094|NCT02309411|7564981|FG002|NOT COMPLETED|Overall Study||0
6636095|NCT02309489|7564990|FG000|STARTED|Overall Study||583
6636096|NCT02309489|7564991|FG001|STARTED|Overall Study||561
6408818|NCT00932477|7321947|FG003|STARTED|Treatment 3||7
6408819|NCT00932477|7321948|FG004|STARTED|Treatment 3||8
6408820|NCT00932477|7321949|FG005|STARTED|Treatment 3||8
6510423|NCT01482715|7430015|FG007|STARTED|Overall Study||9
6408821|NCT00932477|7321944|FG000|COMPLETED|Treatment 3||7
6408822|NCT00932477|7321945|FG001|COMPLETED|Treatment 3||8
6408823|NCT00932477|7321946|FG002|COMPLETED|Treatment 3||9
6408824|NCT00932477|7321947|FG003|COMPLETED|Treatment 3||7
6408825|NCT00932477|7321948|FG004|COMPLETED|Treatment 3||8
6408826|NCT00932477|7321949|FG005|COMPLETED|Treatment 3||8
6408827|NCT00932477|7321944|FG000|NOT COMPLETED|Treatment 3||0
6408828|NCT00932477|7321945|FG001|NOT COMPLETED|Treatment 3||0
6408829|NCT00932477|7321946|FG002|NOT COMPLETED|Treatment 3||0
6408830|NCT00932477|7321947|FG003|NOT COMPLETED|Treatment 3||0
6408831|NCT00932477|7321948|FG004|NOT COMPLETED|Treatment 3||0
6408832|NCT00932477|7321949|FG005|NOT COMPLETED|Treatment 3||0
6408833|NCT00932620|7321959|FG000|STARTED|Overall Study||50
6408834|NCT00932620|7321960|FG001|STARTED|Overall Study||50
6408835|NCT00932620|7321959|FG000|COMPLETED|Overall Study||50
6408836|NCT00932620|7321960|FG001|COMPLETED|Overall Study||50
6408837|NCT00932620|7321959|FG000|NOT COMPLETED|Overall Study||0
6408838|NCT00932620|7321960|FG001|NOT COMPLETED|Overall Study||0
6408839|NCT00932646|7321968|FG000|STARTED|Overall Study||25
6408840|NCT00932646|7321969|FG001|STARTED|Overall Study||25
6408841|NCT00932646|7321970|FG002|STARTED|Overall Study||25
6408842|NCT00932646|7321971|FG003|STARTED|Overall Study||25
6408843|NCT00932646|7321968|FG000|COMPLETED|Overall Study||20
6408844|NCT00932646|7321969|FG001|COMPLETED|Overall Study||22
6408845|NCT00932646|7321970|FG002|COMPLETED|Overall Study||21
6408846|NCT00932646|7321971|FG003|COMPLETED|Overall Study||24
6408847|NCT00932646|7321968|FG000|NOT COMPLETED|Overall Study||5
6636097|NCT02309489|7564990|FG000|Follow-up at 3 Months Postpartum|Overall Study||560
6636098|NCT02309489|7564991|FG001|Follow-up at 3 Months Postpartum|Overall Study||541
6636099|NCT02309489|7564990|FG000|COMPLETED|Overall Study||568
6636100|NCT02309489|7564991|FG001|COMPLETED|Overall Study||547
6636101|NCT02309489|7564990|FG000|NOT COMPLETED|Overall Study||15
6636102|NCT02309489|7564991|FG001|NOT COMPLETED|Overall Study||14
6636103|NCT02309515|7564999|FG000|STARTED|Overall Study||5
6636104|NCT02309515|7565000|FG001|STARTED|Overall Study||7
6636105|NCT02309515|7564999|FG000|COMPLETED|Overall Study||5
6636106|NCT02309515|7565000|FG001|COMPLETED|Overall Study||6
6636107|NCT02309515|7564999|FG000|NOT COMPLETED|Overall Study||0
6636108|NCT02309515|7565000|FG001|NOT COMPLETED|Overall Study||1
6636109|NCT02309723|7565009|FG000|STARTED|Overall Study||129
6636110|NCT02309723|7565010|FG001|STARTED|Overall Study||128
6636111|NCT02309723|7565011|FG002|STARTED|Overall Study||129
6636112|NCT02309723|7565009|FG000|COMPLETED|Overall Study||105
6636113|NCT02309723|7565010|FG001|COMPLETED|Overall Study||105
6636114|NCT02309723|7565011|FG002|COMPLETED|Overall Study||105
6636115|NCT02309723|7565009|FG000|NOT COMPLETED|Overall Study||24
6636116|NCT02309723|7565010|FG001|NOT COMPLETED|Overall Study||23
6636117|NCT02309723|7565011|FG002|NOT COMPLETED|Overall Study||24
6636118|NCT02309944|7565021|FG000|STARTED|Overall Study||38
6636119|NCT02309944|7565022|FG001|STARTED|Overall Study||43
6636120|NCT02309944|7565021|FG000|COMPLETED|Overall Study||38
6636121|NCT02309944|7565022|FG001|COMPLETED|Overall Study||43
6636122|NCT02309944|7565021|FG000|NOT COMPLETED|Overall Study||0
6636123|NCT02309944|7565022|FG001|NOT COMPLETED|Overall Study||0
6636124|NCT02310100|7565028|FG000|STARTED|Overall Study|First enrollment|178
6636125|NCT02310100|7565028|FG000|COMPLETED|Overall Study||160
6636126|NCT02310100|7565028|FG000|NOT COMPLETED|Overall Study||18
6636127|NCT02310126|7565035|FG000|STARTED|Period 1 (15 Minutes)||94
6636128|NCT02310126|7565036|FG001|STARTED|Period 1 (15 Minutes)||97
6636129|NCT02310126|7565035|FG000|Hyperopes|Period 1 (15 Minutes)||38
6636130|NCT02310126|7565036|FG001|Hyperopes|Period 1 (15 Minutes)||33
6636131|NCT02310126|7565035|FG000|Myopes|Period 1 (15 Minutes)||56
6636132|NCT02310126|7565036|FG001|Myopes|Period 1 (15 Minutes)||64
6636133|NCT02310126|7565035|FG000|COMPLETED|Period 1 (15 Minutes)||94
6636134|NCT02310126|7565036|FG001|COMPLETED|Period 1 (15 Minutes)||95
6636135|NCT02310126|7565035|FG000|NOT COMPLETED|Period 1 (15 Minutes)||0
6636136|NCT02310126|7565036|FG001|NOT COMPLETED|Period 1 (15 Minutes)||2
6636137|NCT02310126|7565035|FG000|STARTED|Period 2 (15 Minutes)||94
6636138|NCT02310126|7565036|FG001|STARTED|Period 2 (15 Minutes)||95
6636139|NCT02310126|7565035|FG000|Hyperopes|Period 2 (15 Minutes)||38
6636140|NCT02310126|7565036|FG001|Hyperopes|Period 2 (15 Minutes)||32
6636141|NCT02310126|7565035|FG000|Myopes|Period 2 (15 Minutes)||56
6636142|NCT02310126|7565036|FG001|Myopes|Period 2 (15 Minutes)||63
6636143|NCT02310126|7565035|FG000|COMPLETED|Period 2 (15 Minutes)||94
6636144|NCT02310126|7565036|FG001|COMPLETED|Period 2 (15 Minutes)||95
6636145|NCT02310126|7565035|FG000|NOT COMPLETED|Period 2 (15 Minutes)||0
6636146|NCT02310126|7565036|FG001|NOT COMPLETED|Period 2 (15 Minutes)||0
6636147|NCT02310568|7565047|FG000|STARTED|Stage 1 ( 4 Weeks)||15
6636148|NCT02310568|7565048|FG001|STARTED|Stage 1 ( 4 Weeks)||15
6636149|NCT02310568|7565049|FG002|STARTED|Stage 1 ( 4 Weeks)||15
6636150|NCT02310568|7565050|FG003|STARTED|Stage 1 ( 4 Weeks)||24
6636151|NCT02310568|7565051|FG004|STARTED|Stage 1 ( 4 Weeks)||21
6408848|NCT00932646|7321969|FG001|NOT COMPLETED|Overall Study||3
6408849|NCT00932646|7321970|FG002|NOT COMPLETED|Overall Study||4
6408850|NCT00932646|7321971|FG003|NOT COMPLETED|Overall Study||1
6408851|NCT00932659|7321985|FG000|STARTED|Overall Study||8
6408852|NCT00932659|7321985|FG000|COMPLETED|Overall Study||8
6408853|NCT00932659|7321985|FG000|NOT COMPLETED|Overall Study||0
6408854|NCT00932698|7322000|FG000|STARTED|Part 1 (Dose Escalation)||3
6408855|NCT00932698|7322001|FG001|STARTED|Part 1 (Dose Escalation)||3
6408856|NCT00932698|7322002|FG002|STARTED|Part 1 (Dose Escalation)||3
6408857|NCT00932698|7322003|FG003|STARTED|Part 1 (Dose Escalation)||3
6408858|NCT00932698|7322004|FG004|STARTED|Part 1 (Dose Escalation)||3
6408859|NCT00932698|7322005|FG005|STARTED|Part 1 (Dose Escalation)||7
6408860|NCT00932698|7322006|FG006|STARTED|Part 1 (Dose Escalation)||4
6408861|NCT00932698|7322007|FG007|STARTED|Part 1 (Dose Escalation)||0
6408862|NCT00932698|7322008|FG008|STARTED|Part 1 (Dose Escalation)||0
6408863|NCT00932698|7322009|FG009|STARTED|Part 1 (Dose Escalation)||0
6408864|NCT00932698|7322010|FG010|STARTED|Part 1 (Dose Escalation)||0
6408865|NCT00932698|7322000|FG000|COMPLETED|Part 1 (Dose Escalation)||0
6408866|NCT00932698|7322001|FG001|COMPLETED|Part 1 (Dose Escalation)||0
6408867|NCT00932698|7322002|FG002|COMPLETED|Part 1 (Dose Escalation)||0
6408868|NCT00932698|7322003|FG003|COMPLETED|Part 1 (Dose Escalation)||0
6408869|NCT00932698|7322004|FG004|COMPLETED|Part 1 (Dose Escalation)||0
6408870|NCT00932698|7322005|FG005|COMPLETED|Part 1 (Dose Escalation)|6 participants from 2.0 mg/m^2 dose cohort transitioned to dose expansion cohort: 5 in RR, 1 in VR.|0
6408871|NCT00932698|7322006|FG006|COMPLETED|Part 1 (Dose Escalation)||0
6408872|NCT00932698|7322007|FG007|COMPLETED|Part 1 (Dose Escalation)||0
6408873|NCT00932698|7322008|FG008|COMPLETED|Part 1 (Dose Escalation)||0
6408874|NCT00932698|7322009|FG009|COMPLETED|Part 1 (Dose Escalation)||0
6408875|NCT00932698|7322010|FG010|COMPLETED|Part 1 (Dose Escalation)||0
6408876|NCT00932698|7322000|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||3
6408877|NCT00932698|7322001|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||3
6408878|NCT00932698|7322002|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||3
6408879|NCT00932698|7322003|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||3
6408880|NCT00932698|7322004|FG004|NOT COMPLETED|Part 1 (Dose Escalation)||3
6408881|NCT00932698|7322005|FG005|NOT COMPLETED|Part 1 (Dose Escalation)||7
6408882|NCT00932698|7322006|FG006|NOT COMPLETED|Part 1 (Dose Escalation)||4
6408883|NCT00932698|7322007|FG007|NOT COMPLETED|Part 1 (Dose Escalation)||0
6408884|NCT00932698|7322008|FG008|NOT COMPLETED|Part 1 (Dose Escalation)||0
6408885|NCT00932698|7322009|FG009|NOT COMPLETED|Part 1 (Dose Escalation)||0
6408886|NCT00932698|7322010|FG010|NOT COMPLETED|Part 1 (Dose Escalation)||0
6408887|NCT00932698|7322000|FG000|STARTED|Part 2 (Dose Expansion)||0
6408888|NCT00932698|7322001|FG001|STARTED|Part 2 (Dose Expansion)||0
6408889|NCT00932698|7322002|FG002|STARTED|Part 2 (Dose Expansion)||0
6408890|NCT00932698|7322003|FG003|STARTED|Part 2 (Dose Expansion)||0
6408891|NCT00932698|7322004|FG004|STARTED|Part 2 (Dose Expansion)||0
6408892|NCT00932698|7322005|FG005|STARTED|Part 2 (Dose Expansion)||0
6408893|NCT00932698|7322006|FG006|STARTED|Part 2 (Dose Expansion)||0
6408894|NCT00932698|7322007|FG007|STARTED|Part 2 (Dose Expansion)||20
6408895|NCT00932698|7322008|FG008|STARTED|Part 2 (Dose Expansion)||12
6408896|NCT00932698|7322009|FG009|STARTED|Part 2 (Dose Expansion)||6
6408897|NCT00932698|7322010|FG010|STARTED|Part 2 (Dose Expansion)||2
6408898|NCT00932698|7322000|FG000|COMPLETED|Part 2 (Dose Expansion)||0
6408899|NCT00932698|7322001|FG001|COMPLETED|Part 2 (Dose Expansion)||0
6408900|NCT00932698|7322002|FG002|COMPLETED|Part 2 (Dose Expansion)||0
6408901|NCT00932698|7322003|FG003|COMPLETED|Part 2 (Dose Expansion)||0
6408902|NCT00932698|7322004|FG004|COMPLETED|Part 2 (Dose Expansion)||0
6408903|NCT00932698|7322005|FG005|COMPLETED|Part 2 (Dose Expansion)||0
6408904|NCT00932698|7322006|FG006|COMPLETED|Part 2 (Dose Expansion)||0
6408905|NCT00932698|7322007|FG007|COMPLETED|Part 2 (Dose Expansion)||0
6408906|NCT00932698|7322008|FG008|COMPLETED|Part 2 (Dose Expansion)||0
6408907|NCT00932698|7322009|FG009|COMPLETED|Part 2 (Dose Expansion)||0
6408908|NCT00932698|7322010|FG010|COMPLETED|Part 2 (Dose Expansion)||0
6408909|NCT00932698|7322000|FG000|NOT COMPLETED|Part 2 (Dose Expansion)||0
6408910|NCT00932698|7322001|FG001|NOT COMPLETED|Part 2 (Dose Expansion)||0
6408911|NCT00932698|7322002|FG002|NOT COMPLETED|Part 2 (Dose Expansion)||0
6408912|NCT00932698|7322003|FG003|NOT COMPLETED|Part 2 (Dose Expansion)||0
6408913|NCT00932698|7322004|FG004|NOT COMPLETED|Part 2 (Dose Expansion)||0
6408914|NCT00932698|7322005|FG005|NOT COMPLETED|Part 2 (Dose Expansion)||0
6408915|NCT00932698|7322006|FG006|NOT COMPLETED|Part 2 (Dose Expansion)||0
6408916|NCT00932698|7322007|FG007|NOT COMPLETED|Part 2 (Dose Expansion)||20
6408917|NCT00932698|7322008|FG008|NOT COMPLETED|Part 2 (Dose Expansion)||12
6408918|NCT00932698|7322009|FG009|NOT COMPLETED|Part 2 (Dose Expansion)||6
6408919|NCT00932698|7322010|FG010|NOT COMPLETED|Part 2 (Dose Expansion)||2
6408920|NCT00932828|7322036|FG000|STARTED|Overall Study||37
6408921|NCT00932828|7322036|FG000|COMPLETED|Overall Study|5 subjects who did not complete the protocol were considered in an ITT analysis.|32
6408922|NCT00932828|7322036|FG000|NOT COMPLETED|Overall Study||5
6408923|NCT00932893|7322042|FG000|STARTED|Overall Study||173
6408924|NCT00932893|7322043|FG001|STARTED|Overall Study||174
6408925|NCT00932893|7322042|FG000|Treated|Overall Study||172
6408926|NCT00932893|7322043|FG001|Treated|Overall Study||171
6408927|NCT00932893|7322042|FG000|COMPLETED|Overall Study||40
6408928|NCT00932893|7322043|FG001|COMPLETED|Overall Study||4
6408929|NCT00932893|7322042|FG000|NOT COMPLETED|Overall Study||133
6408930|NCT00932893|7322043|FG001|NOT COMPLETED|Overall Study||170
6408931|NCT00933166|7322050|FG000|STARTED|Overall Study||169
6408932|NCT00933166|7322050|FG000|COMPLETED|Overall Study||151
6408933|NCT00933166|7322050|FG000|NOT COMPLETED|Overall Study||18
6408934|NCT00933244|7322057|FG000|STARTED|Overall Study||79
6408935|NCT00933244|7322058|FG001|STARTED|Overall Study||75
6408936|NCT00933244|7322059|FG002|STARTED|Overall Study||76
6408937|NCT00933244|7322057|FG000|COMPLETED|Overall Study||74
6408938|NCT00933244|7322058|FG001|COMPLETED|Overall Study||74
6408939|NCT00933244|7322059|FG002|COMPLETED|Overall Study||73
6408940|NCT00933244|7322057|FG000|NOT COMPLETED|Overall Study||5
6408941|NCT00933244|7322058|FG001|NOT COMPLETED|Overall Study||1
6408942|NCT00933244|7322059|FG002|NOT COMPLETED|Overall Study||3
6408943|NCT00933270|7322067|FG000|STARTED|Overall Study|ITT population|264
6408944|NCT00933270|7322067|FG000|COMPLETED|Overall Study||177
6408945|NCT00933270|7322067|FG000|NOT COMPLETED|Overall Study||87
6408946|NCT00933335|7322074|FG000|STARTED|Overall Study||2
6408947|NCT00933335|7322075|FG001|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
6408948|NCT00933335|7322074|FG000|COMPLETED|Overall Study||0
6408949|NCT00933335|7322075|FG001|COMPLETED|Overall Study||20
6408950|NCT00933335|7322074|FG000|NOT COMPLETED|Overall Study||2
6408951|NCT00933335|7322075|FG001|NOT COMPLETED|Overall Study||16
6408952|NCT00933491|7322089|FG000|STARTED|Overall Study||14
6408953|NCT00933491|7322090|FG001|STARTED|Overall Study||18
6408954|NCT00933491|7322089|FG000|COMPLETED|Overall Study||14
6408955|NCT00933491|7322090|FG001|COMPLETED|Overall Study||18
6408956|NCT00933491|7322089|FG000|NOT COMPLETED|Overall Study||0
6408957|NCT00933491|7322090|FG001|NOT COMPLETED|Overall Study||0
6408958|NCT00933543|7322098|FG000|STARTED|Overall Study||54
6408959|NCT00933543|7322099|FG001|STARTED|Overall Study||53
6408960|NCT00933543|7322098|FG000|COMPLETED|Overall Study||51
6408961|NCT00933543|7322099|FG001|COMPLETED|Overall Study||46
6408962|NCT00933543|7322098|FG000|NOT COMPLETED|Overall Study||3
6408963|NCT00933543|7322099|FG001|NOT COMPLETED|Overall Study||7
6408964|NCT00933608|7322107|FG000|STARTED|Overall Study||7
6408965|NCT00933608|7322108|FG001|STARTED|Overall Study||10
6408966|NCT00933608|7322107|FG000|COMPLETED|Overall Study||2
6408967|NCT00933608|7322108|FG001|COMPLETED|Overall Study||8
6636152|NCT02310568|7565047|FG000|COMPLETED|Stage 1 ( 4 Weeks)||12
6636153|NCT02310568|7565048|FG001|COMPLETED|Stage 1 ( 4 Weeks)||13
6636154|NCT02310568|7565049|FG002|COMPLETED|Stage 1 ( 4 Weeks)||14
6636155|NCT02310568|7565050|FG003|COMPLETED|Stage 1 ( 4 Weeks)||22
6636156|NCT02310568|7565051|FG004|COMPLETED|Stage 1 ( 4 Weeks)||20
6636157|NCT02310568|7565047|FG000|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
6636158|NCT02310568|7565048|FG001|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
6636159|NCT02310568|7565049|FG002|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
6636160|NCT02310568|7565050|FG003|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
6636161|NCT02310568|7565051|FG004|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
6636162|NCT02310568|7565047|FG000|STARTED|Stage 2 (4 Weeks)||12
6636163|NCT02310568|7565048|FG001|STARTED|Stage 2 (4 Weeks)||13
6636164|NCT02310568|7565049|FG002|STARTED|Stage 2 (4 Weeks)||14
6636165|NCT02310568|7565050|FG003|STARTED|Stage 2 (4 Weeks)||22
6636166|NCT02310568|7565051|FG004|STARTED|Stage 2 (4 Weeks)||20
6636167|NCT02310568|7565047|FG000|COMPLETED|Stage 2 (4 Weeks)||11
6636168|NCT02310568|7565048|FG001|COMPLETED|Stage 2 (4 Weeks)||12
6636169|NCT02310568|7565049|FG002|COMPLETED|Stage 2 (4 Weeks)||13
6636170|NCT02310568|7565050|FG003|COMPLETED|Stage 2 (4 Weeks)||17
6636171|NCT02310568|7565051|FG004|COMPLETED|Stage 2 (4 Weeks)||19
6636172|NCT02310568|7565047|FG000|NOT COMPLETED|Stage 2 (4 Weeks)||1
6636173|NCT02310568|7565048|FG001|NOT COMPLETED|Stage 2 (4 Weeks)||1
6636174|NCT02310568|7565049|FG002|NOT COMPLETED|Stage 2 (4 Weeks)||1
6636175|NCT02310568|7565050|FG003|NOT COMPLETED|Stage 2 (4 Weeks)||5
6636176|NCT02310568|7565051|FG004|NOT COMPLETED|Stage 2 (4 Weeks)||1
6636177|NCT02310581|7565073|FG000|STARTED|Overall Study||9
6636178|NCT02310581|7565074|FG001|STARTED|Overall Study||11
6636179|NCT02310581|7565075|FG002|STARTED|Overall Study||10
6636180|NCT02310581|7565076|FG003|STARTED|Overall Study||10
6636181|NCT02310581|7565073|FG000|COMPLETED|Overall Study||6
6636182|NCT02310581|7565074|FG001|COMPLETED|Overall Study||9
6636183|NCT02310581|7565075|FG002|COMPLETED|Overall Study||9
6636184|NCT02310581|7565076|FG003|COMPLETED|Overall Study||9
6636185|NCT02310581|7565073|FG000|NOT COMPLETED|Overall Study||3
6636186|NCT02310581|7565074|FG001|NOT COMPLETED|Overall Study||2
6636187|NCT02310581|7565075|FG002|NOT COMPLETED|Overall Study||1
6636188|NCT02310581|7565076|FG003|NOT COMPLETED|Overall Study||1
6636189|NCT02310646|7565088|FG000|STARTED|First Intervention (Day 1 - Day 7)||109
6636190|NCT02310646|7565089|FG001|STARTED|First Intervention (Day 1 - Day 7)||104
6636191|NCT02310646|7565088|FG000|COMPLETED|First Intervention (Day 1 - Day 7)||107
6636192|NCT02310646|7565089|FG001|COMPLETED|First Intervention (Day 1 - Day 7)||104
6636193|NCT02310646|7565088|FG000|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
6636194|NCT02310646|7565089|FG001|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
6636195|NCT02310646|7565088|FG000|STARTED|Second Intervention (Day 8 - Day 14)||107
6636196|NCT02310646|7565089|FG001|STARTED|Second Intervention (Day 8 - Day 14)||104
6636197|NCT02310646|7565088|FG000|COMPLETED|Second Intervention (Day 8 - Day 14)||107
6636198|NCT02310646|7565089|FG001|COMPLETED|Second Intervention (Day 8 - Day 14)||104
6636199|NCT02310646|7565088|FG000|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
6636200|NCT02310646|7565089|FG001|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
6408968|NCT00933608|7322107|FG000|NOT COMPLETED|Overall Study||5
6636201|NCT02310672|7565111|FG000|STARTED|Overall Study||87
6636202|NCT02310672|7565111|FG000|COMPLETED|Overall Study||72
6636203|NCT02310672|7565111|FG000|NOT COMPLETED|Overall Study||15
6636204|NCT02310750|7565126|FG000|STARTED|HP Period 1||7
6636205|NCT02310750|7565127|FG001|STARTED|HP Period 1||6
6636206|NCT02310750|7565128|FG002|STARTED|HP Period 1||6
6636207|NCT02310750|7565129|FG003|STARTED|HP Period 1||6
6636208|NCT02310750|7565130|FG004|STARTED|HP Period 1||8
6408969|NCT00933608|7322108|FG001|NOT COMPLETED|Overall Study||2
6408970|NCT00933686|7322116|FG000|STARTED|Overall Study||55
6636209|NCT02310750|7565131|FG005|STARTED|HP Period 1||8
6408971|NCT00933686|7322117|FG001|STARTED|Overall Study||58
6408972|NCT00933686|7322116|FG000|COMPLETED|Overall Study||45
6408973|NCT00933686|7322117|FG001|COMPLETED|Overall Study||47
6408974|NCT00933686|7322116|FG000|NOT COMPLETED|Overall Study||10
6408975|NCT00933686|7322117|FG001|NOT COMPLETED|Overall Study||11
6408976|NCT00933933|7322128|FG000|STARTED|General Population From 16 to 89 Years||6164
6408977|NCT00933933|7322129|FG001|STARTED|General Population From 16 to 89 Years||1287
6408978|NCT00933933|7322130|FG002|STARTED|General Population From 16 to 89 Years||1206
6408979|NCT00933933|7322128|FG000|COMPLETED|General Population From 16 to 89 Years||6164
6408980|NCT00933933|7322129|FG001|COMPLETED|General Population From 16 to 89 Years||1267
6408981|NCT00933933|7322130|FG002|COMPLETED|General Population From 16 to 89 Years||1206
6408982|NCT00933933|7322128|FG000|NOT COMPLETED|General Population From 16 to 89 Years||0
6408983|NCT00933933|7322129|FG001|NOT COMPLETED|General Population From 16 to 89 Years||20
6408984|NCT00933933|7322130|FG002|NOT COMPLETED|General Population From 16 to 89 Years||0
6408985|NCT00933933|7322128|FG000|STARTED|Pregnant Females Between 16-44 Years||448
6636210|NCT02310750|7565132|FG006|STARTED|HP Period 1||13
6636211|NCT02310750|7565133|FG007|STARTED|HP Period 1||0
6636212|NCT02310750|7565134|FG008|STARTED|HP Period 1||0
6636213|NCT02310750|7565135|FG009|STARTED|HP Period 1||0
6636214|NCT02310750|7565136|FG010|STARTED|HP Period 1||2
6408986|NCT00933933|7322129|FG001|STARTED|Pregnant Females Between 16-44 Years||67
6408987|NCT00933933|7322130|FG002|STARTED|Pregnant Females Between 16-44 Years||203
6408988|NCT00933933|7322128|FG000|COMPLETED|Pregnant Females Between 16-44 Years||448
6408989|NCT00933933|7322129|FG001|COMPLETED|Pregnant Females Between 16-44 Years||65
6408990|NCT00933933|7322130|FG002|COMPLETED|Pregnant Females Between 16-44 Years||203
6408991|NCT00933933|7322128|FG000|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
6408992|NCT00933933|7322129|FG001|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
6408993|NCT00933933|7322130|FG002|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
6408994|NCT00933933|7322128|FG000|STARTED|Pediatric From 2 to 21 Years||588
6408995|NCT00933933|7322129|FG001|STARTED|Pediatric From 2 to 21 Years||64
6408996|NCT00933933|7322130|FG002|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
6408997|NCT00933933|7322128|FG000|COMPLETED|Pediatric From 2 to 21 Years||588
6408998|NCT00933933|7322129|FG001|COMPLETED|Pediatric From 2 to 21 Years||64
6408999|NCT00933933|7322130|FG002|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
6409000|NCT00933933|7322128|FG000|NOT COMPLETED|Pediatric From 2 to 21 Years||0
6409001|NCT00933933|7322129|FG001|NOT COMPLETED|Pediatric From 2 to 21 Years||0
6409002|NCT00933933|7322130|FG002|NOT COMPLETED|Pediatric From 2 to 21 Years||0
6409003|NCT00934024|7322148|FG000|STARTED|Overall Study||10
6409004|NCT00934024|7322149|FG001|STARTED|Overall Study||11
6409005|NCT00934024|7322148|FG000|COMPLETED|Overall Study||10
6409006|NCT00934024|7322149|FG001|COMPLETED|Overall Study||6
6409007|NCT00934024|7322148|FG000|NOT COMPLETED|Overall Study||0
6409008|NCT00934024|7322149|FG001|NOT COMPLETED|Overall Study||5
6409009|NCT00934050|7322160|FG000|STARTED|Enrolled Prior to 15 Dec 2009||12
6409010|NCT00934050|7322161|FG001|STARTED|Enrolled Prior to 15 Dec 2009||12
6409011|NCT00934050|7322162|FG002|STARTED|Enrolled Prior to 15 Dec 2009||12
6409012|NCT00934050|7322163|FG003|STARTED|Enrolled Prior to 15 Dec 2009||14
6636215|NCT02310750|7565137|FG011|STARTED|HP Period 1||2
6636216|NCT02310750|7565138|FG012|STARTED|HP Period 1||2
6636217|NCT02310750|7565139|FG013|STARTED|HP Period 1||2
6636218|NCT02310750|7565140|FG014|STARTED|HP Period 1||2
6636219|NCT02310750|7565141|FG015|STARTED|HP Period 1||2
6636220|NCT02310750|7565126|FG000|COMPLETED|HP Period 1||6
6636221|NCT02310750|7565127|FG001|COMPLETED|HP Period 1||6
6636222|NCT02310750|7565128|FG002|COMPLETED|HP Period 1||6
6636223|NCT02310750|7565129|FG003|COMPLETED|HP Period 1||5
6636224|NCT02310750|7565130|FG004|COMPLETED|HP Period 1||8
6636225|NCT02310750|7565131|FG005|COMPLETED|HP Period 1||8
6636226|NCT02310750|7565132|FG006|COMPLETED|HP Period 1||12
6636227|NCT02310750|7565133|FG007|COMPLETED|HP Period 1||0
6636228|NCT02310750|7565134|FG008|COMPLETED|HP Period 1||0
6636229|NCT02310750|7565135|FG009|COMPLETED|HP Period 1||0
6636230|NCT02310750|7565136|FG010|COMPLETED|HP Period 1||2
6636231|NCT02310750|7565137|FG011|COMPLETED|HP Period 1||2
6636232|NCT02310750|7565138|FG012|COMPLETED|HP Period 1||2
6636233|NCT02310750|7565139|FG013|COMPLETED|HP Period 1||2
6636234|NCT02310750|7565140|FG014|COMPLETED|HP Period 1||2
6636235|NCT02310750|7565141|FG015|COMPLETED|HP Period 1||2
6636236|NCT02310750|7565126|FG000|NOT COMPLETED|HP Period 1||1
6636237|NCT02310750|7565127|FG001|NOT COMPLETED|HP Period 1||0
6636238|NCT02310750|7565128|FG002|NOT COMPLETED|HP Period 1||0
6636239|NCT02310750|7565129|FG003|NOT COMPLETED|HP Period 1||1
6636240|NCT02310750|7565130|FG004|NOT COMPLETED|HP Period 1||0
6636241|NCT02310750|7565131|FG005|NOT COMPLETED|HP Period 1||0
6636242|NCT02310750|7565132|FG006|NOT COMPLETED|HP Period 1||1
6636243|NCT02310750|7565133|FG007|NOT COMPLETED|HP Period 1||0
6636244|NCT02310750|7565134|FG008|NOT COMPLETED|HP Period 1||0
6636245|NCT02310750|7565135|FG009|NOT COMPLETED|HP Period 1||0
6636246|NCT02310750|7565136|FG010|NOT COMPLETED|HP Period 1||0
6636247|NCT02310750|7565137|FG011|NOT COMPLETED|HP Period 1||0
6636248|NCT02310750|7565138|FG012|NOT COMPLETED|HP Period 1||0
6636249|NCT02310750|7565139|FG013|NOT COMPLETED|HP Period 1||0
6636250|NCT02310750|7565140|FG014|NOT COMPLETED|HP Period 1||0
6636251|NCT02310750|7565141|FG015|NOT COMPLETED|HP Period 1||0
6636252|NCT02310750|7565126|FG000|STARTED|HP Washout 1||0
6409013|NCT00934050|7322164|FG004|STARTED|Enrolled Prior to 15 Dec 2009||0
6409014|NCT00934050|7322165|FG005|STARTED|Enrolled Prior to 15 Dec 2009||0
6409015|NCT00934050|7322160|FG000|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6409016|NCT00934050|7322161|FG001|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6409017|NCT00934050|7322162|FG002|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6409018|NCT00934050|7322163|FG003|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6409019|NCT00934050|7322164|FG004|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6409020|NCT00934050|7322165|FG005|COMPLETED|Enrolled Prior to 15 Dec 2009||0
6409021|NCT00934050|7322160|FG000|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
6409022|NCT00934050|7322161|FG001|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
6409023|NCT00934050|7322162|FG002|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
6409024|NCT00934050|7322163|FG003|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
6409025|NCT00934050|7322164|FG004|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
6409026|NCT00934050|7322165|FG005|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
6409027|NCT00934050|7322160|FG000|STARTED|Enrolled After 15 Dec 2009||0
6409028|NCT00934050|7322161|FG001|STARTED|Enrolled After 15 Dec 2009||0
6409029|NCT00934050|7322162|FG002|STARTED|Enrolled After 15 Dec 2009||0
6409030|NCT00934050|7322163|FG003|STARTED|Enrolled After 15 Dec 2009||0
6409031|NCT00934050|7322164|FG004|STARTED|Enrolled After 15 Dec 2009||26
6409032|NCT00934050|7322165|FG005|STARTED|Enrolled After 15 Dec 2009||27
6409033|NCT00934050|7322160|FG000|COMPLETED|Enrolled After 15 Dec 2009||0
6409034|NCT00934050|7322161|FG001|COMPLETED|Enrolled After 15 Dec 2009||0
6409035|NCT00934050|7322162|FG002|COMPLETED|Enrolled After 15 Dec 2009||0
6409036|NCT00934050|7322163|FG003|COMPLETED|Enrolled After 15 Dec 2009||0
6409037|NCT00934050|7322164|FG004|COMPLETED|Enrolled After 15 Dec 2009||19
6409038|NCT00934050|7322165|FG005|COMPLETED|Enrolled After 15 Dec 2009||23
6409039|NCT00934050|7322160|FG000|NOT COMPLETED|Enrolled After 15 Dec 2009||0
6409040|NCT00934050|7322161|FG001|NOT COMPLETED|Enrolled After 15 Dec 2009||0
6409041|NCT00934050|7322162|FG002|NOT COMPLETED|Enrolled After 15 Dec 2009||0
6409042|NCT00934050|7322163|FG003|NOT COMPLETED|Enrolled After 15 Dec 2009||0
6409043|NCT00934050|7322164|FG004|NOT COMPLETED|Enrolled After 15 Dec 2009||7
6409044|NCT00934050|7322165|FG005|NOT COMPLETED|Enrolled After 15 Dec 2009||4
6409045|NCT00934089|7322177|FG000|STARTED|First Intervention Period (14 Days)||15
6409046|NCT00934089|7322178|FG001|STARTED|First Intervention Period (14 Days)||16
6409047|NCT00934089|7322177|FG000|Treated|First Intervention Period (14 Days)||14
6409048|NCT00934089|7322178|FG001|Treated|First Intervention Period (14 Days)||16
6409049|NCT00934089|7322177|FG000|COMPLETED|First Intervention Period (14 Days)||13
6409050|NCT00934089|7322178|FG001|COMPLETED|First Intervention Period (14 Days)||16
6409051|NCT00934089|7322177|FG000|NOT COMPLETED|First Intervention Period (14 Days)||2
6409052|NCT00934089|7322178|FG001|NOT COMPLETED|First Intervention Period (14 Days)||0
6409053|NCT00934089|7322177|FG000|STARTED|Washout Period (28 Days)||13
6409054|NCT00934089|7322178|FG001|STARTED|Washout Period (28 Days)||16
6409055|NCT00934089|7322177|FG000|COMPLETED|Washout Period (28 Days)||13
6409056|NCT00934089|7322178|FG001|COMPLETED|Washout Period (28 Days)||16
6409057|NCT00934089|7322177|FG000|NOT COMPLETED|Washout Period (28 Days)||0
6409058|NCT00934089|7322178|FG001|NOT COMPLETED|Washout Period (28 Days)||0
6409059|NCT00934089|7322177|FG000|STARTED|Second Intervention Period (14 Days)||13
6409060|NCT00934089|7322178|FG001|STARTED|Second Intervention Period (14 Days)||16
6409061|NCT00934089|7322177|FG000|COMPLETED|Second Intervention Period (14 Days)||13
6409062|NCT00934089|7322178|FG001|COMPLETED|Second Intervention Period (14 Days)||16
6409063|NCT00934089|7322177|FG000|NOT COMPLETED|Second Intervention Period (14 Days)||0
6409064|NCT00934089|7322178|FG001|NOT COMPLETED|Second Intervention Period (14 Days)||0
6409065|NCT00934102|7322184|FG000|STARTED|Period 1, One Night of Wear||16
6409066|NCT00934102|7322185|FG001|STARTED|Period 1, One Night of Wear||15
6409067|NCT00934102|7322186|FG002|STARTED|Period 1, One Night of Wear||15
6409068|NCT00934102|7322184|FG000|COMPLETED|Period 1, One Night of Wear||15
6409069|NCT00934102|7322185|FG001|COMPLETED|Period 1, One Night of Wear||15
6409070|NCT00934102|7322186|FG002|COMPLETED|Period 1, One Night of Wear||15
6409071|NCT00934102|7322184|FG000|NOT COMPLETED|Period 1, One Night of Wear||1
6409072|NCT00934102|7322185|FG001|NOT COMPLETED|Period 1, One Night of Wear||0
6409073|NCT00934102|7322186|FG002|NOT COMPLETED|Period 1, One Night of Wear||0
6409074|NCT00934102|7322184|FG000|STARTED|Period 2, 7 Days/6 Nights of Wear||15
6409075|NCT00934102|7322185|FG001|STARTED|Period 2, 7 Days/6 Nights of Wear||15
6409076|NCT00934102|7322186|FG002|STARTED|Period 2, 7 Days/6 Nights of Wear||15
6409077|NCT00934102|7322184|FG000|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
6409078|NCT00934102|7322185|FG001|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
6409079|NCT00934102|7322186|FG002|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
6409080|NCT00934102|7322184|FG000|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
6409081|NCT00934102|7322185|FG001|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
6409082|NCT00934102|7322186|FG002|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
6409083|NCT00934128|7322196|FG000|STARTED|First Intervention (2 Hours)||15
6409084|NCT00934128|7322197|FG001|STARTED|First Intervention (2 Hours)||15
6409085|NCT00934128|7322196|FG000|COMPLETED|First Intervention (2 Hours)||10
6409086|NCT00934128|7322197|FG001|COMPLETED|First Intervention (2 Hours)||13
6409087|NCT00934128|7322196|FG000|NOT COMPLETED|First Intervention (2 Hours)||5
6409088|NCT00934128|7322197|FG001|NOT COMPLETED|First Intervention (2 Hours)||2
6409089|NCT00934128|7322196|FG000|STARTED|Washout Period (1 Hour)||10
6409090|NCT00934128|7322197|FG001|STARTED|Washout Period (1 Hour)||13
6510424|NCT01482715|7430016|FG008|STARTED|Overall Study||7
6409091|NCT00934128|7322196|FG000|COMPLETED|Washout Period (1 Hour)||3
6409092|NCT00934128|7322197|FG001|COMPLETED|Washout Period (1 Hour)||8
6409093|NCT00934128|7322196|FG000|NOT COMPLETED|Washout Period (1 Hour)||7
6409094|NCT00934128|7322197|FG001|NOT COMPLETED|Washout Period (1 Hour)||5
6409095|NCT00934128|7322196|FG000|STARTED|Second Intervention (2 Hours)||3
6409096|NCT00934128|7322197|FG001|STARTED|Second Intervention (2 Hours)||8
6409097|NCT00934128|7322196|FG000|COMPLETED|Second Intervention (2 Hours)||3
6409098|NCT00934128|7322197|FG001|COMPLETED|Second Intervention (2 Hours)||5
6409099|NCT00934128|7322196|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
6409100|NCT00934128|7322197|FG001|NOT COMPLETED|Second Intervention (2 Hours)||3
6409101|NCT00934141|7322207|FG000|STARTED|Overall Study||49
6409102|NCT00934141|7322208|FG001|STARTED|Overall Study||50
6409103|NCT00934141|7322209|FG002|STARTED|Overall Study||48
6409104|NCT00934141|7322210|FG003|STARTED|Overall Study||54
6409105|NCT00934141|7322207|FG000|COMPLETED|Overall Study||45
6409106|NCT00934141|7322208|FG001|COMPLETED|Overall Study||47
6409107|NCT00934141|7322209|FG002|COMPLETED|Overall Study||48
6409108|NCT00934141|7322210|FG003|COMPLETED|Overall Study||51
6409109|NCT00934141|7322207|FG000|NOT COMPLETED|Overall Study||4
6409110|NCT00934141|7322208|FG001|NOT COMPLETED|Overall Study||3
6409111|NCT00934141|7322209|FG002|NOT COMPLETED|Overall Study||0
6409112|NCT00934141|7322210|FG003|NOT COMPLETED|Overall Study||3
6409113|NCT00934362|7322224|FG000|STARTED|Overall Study||8
6409114|NCT00934362|7322225|FG001|STARTED|Overall Study||8
6409115|NCT00934362|7322224|FG000|COMPLETED|Overall Study||7
6409116|NCT00934362|7322225|FG001|COMPLETED|Overall Study||8
6409117|NCT00934362|7322224|FG000|NOT COMPLETED|Overall Study||1
6409118|NCT00934362|7322225|FG001|NOT COMPLETED|Overall Study||0
6409119|NCT00934375|7322233|FG000|STARTED|Overall Study||68
6409120|NCT00934375|7322234|FG001|STARTED|Overall Study||77
6409121|NCT00934375|7322233|FG000|COMPLETED|Overall Study||55
6409122|NCT00934375|7322234|FG001|COMPLETED|Overall Study||55
6409123|NCT00934375|7322233|FG000|NOT COMPLETED|Overall Study||13
6409124|NCT00934375|7322234|FG001|NOT COMPLETED|Overall Study||22
6409125|NCT00934440|7322240|FG000|STARTED|Overall Study||11
6409126|NCT00934440|7322240|FG000|COMPLETED|Overall Study||10
6636253|NCT02310750|7565127|FG001|STARTED|HP Washout 1||0
6636254|NCT02310750|7565128|FG002|STARTED|HP Washout 1||6
6636255|NCT02310750|7565129|FG003|STARTED|HP Washout 1||5
6636256|NCT02310750|7565130|FG004|STARTED|HP Washout 1||8
6636257|NCT02310750|7565131|FG005|STARTED|HP Washout 1||8
6636258|NCT02310750|7565132|FG006|STARTED|HP Washout 1||12
6636259|NCT02310750|7565133|FG007|STARTED|HP Washout 1||0
6636260|NCT02310750|7565134|FG008|STARTED|HP Washout 1||0
6636261|NCT02310750|7565135|FG009|STARTED|HP Washout 1||0
6636262|NCT02310750|7565136|FG010|STARTED|HP Washout 1||2
6636263|NCT02310750|7565137|FG011|STARTED|HP Washout 1||2
6636264|NCT02310750|7565138|FG012|STARTED|HP Washout 1||2
6636265|NCT02310750|7565139|FG013|STARTED|HP Washout 1||2
6636266|NCT02310750|7565140|FG014|STARTED|HP Washout 1||2
6636267|NCT02310750|7565141|FG015|STARTED|HP Washout 1||2
6636268|NCT02310750|7565126|FG000|COMPLETED|HP Washout 1||0
6636269|NCT02310750|7565127|FG001|COMPLETED|HP Washout 1||0
6636270|NCT02310750|7565128|FG002|COMPLETED|HP Washout 1||5
6636271|NCT02310750|7565129|FG003|COMPLETED|HP Washout 1||4
6636272|NCT02310750|7565130|FG004|COMPLETED|HP Washout 1||6
6636273|NCT02310750|7565131|FG005|COMPLETED|HP Washout 1||6
6636274|NCT02310750|7565132|FG006|COMPLETED|HP Washout 1||9
6636275|NCT02310750|7565133|FG007|COMPLETED|HP Washout 1||0
6636276|NCT02310750|7565134|FG008|COMPLETED|HP Washout 1||0
6636277|NCT02310750|7565135|FG009|COMPLETED|HP Washout 1||0
6636278|NCT02310750|7565136|FG010|COMPLETED|HP Washout 1||2
6636279|NCT02310750|7565137|FG011|COMPLETED|HP Washout 1||2
6636280|NCT02310750|7565138|FG012|COMPLETED|HP Washout 1||2
6636281|NCT02310750|7565139|FG013|COMPLETED|HP Washout 1||2
6636282|NCT02310750|7565140|FG014|COMPLETED|HP Washout 1||2
6636283|NCT02310750|7565141|FG015|COMPLETED|HP Washout 1||2
6636284|NCT02310750|7565126|FG000|NOT COMPLETED|HP Washout 1||0
6636285|NCT02310750|7565127|FG001|NOT COMPLETED|HP Washout 1||0
6636286|NCT02310750|7565128|FG002|NOT COMPLETED|HP Washout 1||1
6636287|NCT02310750|7565129|FG003|NOT COMPLETED|HP Washout 1||1
6636288|NCT02310750|7565130|FG004|NOT COMPLETED|HP Washout 1||2
6636289|NCT02310750|7565131|FG005|NOT COMPLETED|HP Washout 1||2
6636290|NCT02310750|7565132|FG006|NOT COMPLETED|HP Washout 1||3
6636291|NCT02310750|7565133|FG007|NOT COMPLETED|HP Washout 1||0
6636292|NCT02310750|7565134|FG008|NOT COMPLETED|HP Washout 1||0
6409127|NCT00934440|7322240|FG000|NOT COMPLETED|Overall Study||1
6409128|NCT00934544|7322247|FG000|STARTED|Primary Endpoint Analysis (Interim)||146
6409129|NCT00934544|7322248|FG001|STARTED|Primary Endpoint Analysis (Interim)||73
6409130|NCT00934544|7322249|FG002|STARTED|Primary Endpoint Analysis (Interim)||0
6409131|NCT00934544|7322247|FG000|COMPLETED|Primary Endpoint Analysis (Interim)||91
6409132|NCT00934544|7322248|FG001|COMPLETED|Primary Endpoint Analysis (Interim)||31
6636293|NCT02310750|7565135|FG009|NOT COMPLETED|HP Washout 1||0
6636294|NCT02310750|7565136|FG010|NOT COMPLETED|HP Washout 1||0
6636295|NCT02310750|7565137|FG011|NOT COMPLETED|HP Washout 1||0
6636296|NCT02310750|7565138|FG012|NOT COMPLETED|HP Washout 1||0
6636297|NCT02310750|7565139|FG013|NOT COMPLETED|HP Washout 1||0
6636298|NCT02310750|7565140|FG014|NOT COMPLETED|HP Washout 1||0
6636299|NCT02310750|7565141|FG015|NOT COMPLETED|HP Washout 1||0
6636300|NCT02310750|7565126|FG000|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6409133|NCT00934544|7322249|FG002|COMPLETED|Primary Endpoint Analysis (Interim)||0
6409134|NCT00934544|7322247|FG000|NOT COMPLETED|Primary Endpoint Analysis (Interim)||55
6409135|NCT00934544|7322248|FG001|NOT COMPLETED|Primary Endpoint Analysis (Interim)||42
6409136|NCT00934544|7322249|FG002|NOT COMPLETED|Primary Endpoint Analysis (Interim)||0
6409137|NCT00934544|7322247|FG000|STARTED|Overall Disposition at 5 Year Follow-up||146
6409138|NCT00934544|7322248|FG001|STARTED|Overall Disposition at 5 Year Follow-up||28
6409139|NCT00934544|7322249|FG002|STARTED|Overall Disposition at 5 Year Follow-up||45
6409140|NCT00934544|7322247|FG000|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
6409141|NCT00934544|7322248|FG001|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||0
6409142|NCT00934544|7322249|FG002|Crossed Over After Qualifying Event|Overall Disposition at 5 Year Follow-up||27
6409143|NCT00934544|7322247|FG000|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
6409144|NCT00934544|7322248|FG001|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||0
6409145|NCT00934544|7322249|FG002|Crossed Over After AMEND 5|Overall Disposition at 5 Year Follow-up||12
6409146|NCT00934544|7322247|FG000|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
6409147|NCT00934544|7322248|FG001|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||0
6409148|NCT00934544|7322249|FG002|Crossed Over: Other|Overall Disposition at 5 Year Follow-up||6
6409149|NCT00934544|7322247|FG000|COMPLETED|Overall Disposition at 5 Year Follow-up||39
6409150|NCT00934544|7322248|FG001|COMPLETED|Overall Disposition at 5 Year Follow-up||0
6409151|NCT00934544|7322249|FG002|COMPLETED|Overall Disposition at 5 Year Follow-up||11
6409152|NCT00934544|7322247|FG000|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||107
6409153|NCT00934544|7322248|FG001|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||28
6409154|NCT00934544|7322249|FG002|NOT COMPLETED|Overall Disposition at 5 Year Follow-up||34
6409155|NCT00934596|7322268|FG000|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
6409156|NCT00934596|7322269|FG001|STARTED|Overall Study||10
6409157|NCT00934596|7322268|FG000|COMPLETED|Overall Study||10
6409158|NCT00934596|7322269|FG001|COMPLETED|Overall Study||10
6409159|NCT00934596|7322268|FG000|NOT COMPLETED|Overall Study||0
6409160|NCT00934596|7322269|FG001|NOT COMPLETED|Overall Study||0
6409161|NCT00934622|7322279|FG000|STARTED|Overall Study||76
6409162|NCT00934622|7322279|FG000|COMPLETED|Overall Study||68
6409163|NCT00934622|7322279|FG000|NOT COMPLETED|Overall Study||8
6409164|NCT00934635|7322292|FG000|STARTED|Overall Study||0
6409165|NCT00934635|7322293|FG001|STARTED|Overall Study||1
6409166|NCT00934635|7322294|FG002|STARTED|Overall Study||0
6409167|NCT00934635|7322295|FG003|STARTED|Overall Study||0
6409168|NCT00934635|7322296|FG004|STARTED|Overall Study||0
6409169|NCT00934635|7322297|FG005|STARTED|Overall Study||0
6409170|NCT00934635|7322298|FG006|STARTED|Overall Study||0
6409171|NCT00934635|7322299|FG007|STARTED|Overall Study||0
6409172|NCT00934635|7322300|FG008|STARTED|Overall Study||1
6409173|NCT00934635|7322292|FG000|COMPLETED|Overall Study||0
6409174|NCT00934635|7322293|FG001|COMPLETED|Overall Study||1
6409175|NCT00934635|7322294|FG002|COMPLETED|Overall Study||0
6409176|NCT00934635|7322295|FG003|COMPLETED|Overall Study||0
6409177|NCT00934635|7322296|FG004|COMPLETED|Overall Study||0
6409178|NCT00934635|7322297|FG005|COMPLETED|Overall Study||0
6409179|NCT00934635|7322298|FG006|COMPLETED|Overall Study||0
6409180|NCT00934635|7322299|FG007|COMPLETED|Overall Study||0
6409181|NCT00934635|7322300|FG008|COMPLETED|Overall Study||1
6409182|NCT00934635|7322292|FG000|NOT COMPLETED|Overall Study||0
6409183|NCT00934635|7322293|FG001|NOT COMPLETED|Overall Study||0
6409184|NCT00934635|7322294|FG002|NOT COMPLETED|Overall Study||0
6409185|NCT00934635|7322295|FG003|NOT COMPLETED|Overall Study||0
6409186|NCT00934635|7322296|FG004|NOT COMPLETED|Overall Study||0
6409187|NCT00934635|7322297|FG005|NOT COMPLETED|Overall Study||0
6409188|NCT00934635|7322298|FG006|NOT COMPLETED|Overall Study||0
6409189|NCT00934635|7322299|FG007|NOT COMPLETED|Overall Study||0
6409190|NCT00934635|7322300|FG008|NOT COMPLETED|Overall Study||0
6409191|NCT00934648|7322320|FG000|STARTED|Overall Study||15
6409192|NCT00934648|7322320|FG000|COMPLETED|Overall Study||6
6409193|NCT00934648|7322320|FG000|NOT COMPLETED|Overall Study||9
6409194|NCT00934661|7322326|FG000|STARTED|Overall Study||20
6409195|NCT00934661|7322327|FG001|STARTED|Overall Study||20
6409196|NCT00934661|7322326|FG000|COMPLETED|Overall Study||19
6409197|NCT00934661|7322327|FG001|COMPLETED|Overall Study||20
6409198|NCT00934661|7322326|FG000|NOT COMPLETED|Overall Study||1
6409199|NCT00934661|7322327|FG001|NOT COMPLETED|Overall Study||0
6409200|NCT00934843|7322335|FG000|STARTED|Overall Study||37
6409201|NCT00934843|7322336|FG001|STARTED|Overall Study||40
6409202|NCT00934843|7322335|FG000|COMPLETED|Overall Study||37
6409203|NCT00934843|7322336|FG001|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
6409204|NCT00934843|7322335|FG000|NOT COMPLETED|Overall Study||0
6409205|NCT00934843|7322336|FG001|NOT COMPLETED|Overall Study||1
6409206|NCT00934856|7322348|FG000|STARTED|Feasibility Part||6
6409207|NCT00934856|7322349|FG001|STARTED|Feasibility Part||6
6409208|NCT00934856|7322350|FG002|STARTED|Feasibility Part||3
6409209|NCT00934856|7322351|FG003|STARTED|Feasibility Part||6
6409210|NCT00934856|7322352|FG004|STARTED|Feasibility Part||12
6409211|NCT00934856|7322353|FG005|STARTED|Feasibility Part||9
6409212|NCT00934856|7322348|FG000|COMPLETED|Feasibility Part||1
6409213|NCT00934856|7322349|FG001|COMPLETED|Feasibility Part||1
6409214|NCT00934856|7322350|FG002|COMPLETED|Feasibility Part||0
6409215|NCT00934856|7322351|FG003|COMPLETED|Feasibility Part||1
6409216|NCT00934856|7322352|FG004|COMPLETED|Feasibility Part||12
6409217|NCT00934856|7322353|FG005|COMPLETED|Feasibility Part||6
6409218|NCT00934856|7322348|FG000|NOT COMPLETED|Feasibility Part||5
6409219|NCT00934856|7322349|FG001|NOT COMPLETED|Feasibility Part||5
6409220|NCT00934856|7322350|FG002|NOT COMPLETED|Feasibility Part||3
6409221|NCT00934856|7322351|FG003|NOT COMPLETED|Feasibility Part||5
6409222|NCT00934856|7322352|FG004|NOT COMPLETED|Feasibility Part||0
6409223|NCT00934856|7322353|FG005|NOT COMPLETED|Feasibility Part||3
6409224|NCT00934856|7322348|FG000|STARTED|Extension Part||0
6409225|NCT00934856|7322349|FG001|STARTED|Extension Part||0
6409226|NCT00934856|7322350|FG002|STARTED|Extension Part||0
6409227|NCT00934856|7322351|FG003|STARTED|Extension Part|New participants were enrolled in the extension part.|4
6409228|NCT00934856|7322352|FG004|STARTED|Extension Part|New participants were enrolled in the extension part.|28
6409229|NCT00934856|7322353|FG005|STARTED|Extension Part|New participants were enrolled in the extension part.|24
6409230|NCT00934856|7322348|FG000|COMPLETED|Extension Part||0
6409231|NCT00934856|7322349|FG001|COMPLETED|Extension Part||0
6409232|NCT00934856|7322350|FG002|COMPLETED|Extension Part||0
6636301|NCT02310750|7565127|FG001|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636302|NCT02310750|7565128|FG002|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
6636303|NCT02310750|7565129|FG003|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
6636304|NCT02310750|7565130|FG004|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
6636305|NCT02310750|7565131|FG005|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
6636306|NCT02310750|7565132|FG006|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
6636307|NCT02310750|7565133|FG007|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
6636308|NCT02310750|7565134|FG008|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
6636309|NCT02310750|7565135|FG009|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
6636310|NCT02310750|7565136|FG010|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636311|NCT02310750|7565137|FG011|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636312|NCT02310750|7565138|FG012|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636313|NCT02310750|7565139|FG013|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636314|NCT02310750|7565140|FG014|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636315|NCT02310750|7565141|FG015|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636316|NCT02310750|7565126|FG000|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636317|NCT02310750|7565127|FG001|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636318|NCT02310750|7565128|FG002|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
6636319|NCT02310750|7565129|FG003|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
6636320|NCT02310750|7565130|FG004|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
6636321|NCT02310750|7565131|FG005|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
6636322|NCT02310750|7565132|FG006|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
6636323|NCT02310750|7565133|FG007|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
6636324|NCT02310750|7565134|FG008|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
6636325|NCT02310750|7565135|FG009|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
6636326|NCT02310750|7565136|FG010|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636327|NCT02310750|7565137|FG011|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636328|NCT02310750|7565138|FG012|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636329|NCT02310750|7565139|FG013|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636330|NCT02310750|7565140|FG014|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636331|NCT02310750|7565141|FG015|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636332|NCT02310750|7565126|FG000|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636333|NCT02310750|7565127|FG001|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636334|NCT02310750|7565128|FG002|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636335|NCT02310750|7565129|FG003|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
6636336|NCT02310750|7565130|FG004|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636337|NCT02310750|7565131|FG005|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636338|NCT02310750|7565132|FG006|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636339|NCT02310750|7565133|FG007|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
6636340|NCT02310750|7565134|FG008|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
6636341|NCT02310750|7565135|FG009|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
6636342|NCT02310750|7565136|FG010|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636343|NCT02310750|7565137|FG011|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636344|NCT02310750|7565138|FG012|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636345|NCT02310750|7565139|FG013|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636346|NCT02310750|7565140|FG014|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636347|NCT02310750|7565141|FG015|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
6636348|NCT02310750|7565126|FG000|STARTED|HP Washout 2||0
6636349|NCT02310750|7565127|FG001|STARTED|HP Washout 2||0
6636350|NCT02310750|7565128|FG002|STARTED|HP Washout 2||0
6636351|NCT02310750|7565129|FG003|STARTED|HP Washout 2||0
6636352|NCT02310750|7565130|FG004|STARTED|HP Washout 2||6
6636353|NCT02310750|7565131|FG005|STARTED|HP Washout 2||0
6636354|NCT02310750|7565132|FG006|STARTED|HP Washout 2||9
6636355|NCT02310750|7565133|FG007|STARTED|HP Washout 2||0
6636356|NCT02310750|7565134|FG008|STARTED|HP Washout 2||0
6409233|NCT00934856|7322351|FG003|COMPLETED|Extension Part||2
6636357|NCT02310750|7565135|FG009|STARTED|HP Washout 2||0
6636358|NCT02310750|7565136|FG010|STARTED|HP Washout 2||2
6636359|NCT02310750|7565137|FG011|STARTED|HP Washout 2||2
6636360|NCT02310750|7565138|FG012|STARTED|HP Washout 2||2
6636361|NCT02310750|7565139|FG013|STARTED|HP Washout 2||2
6636362|NCT02310750|7565140|FG014|STARTED|HP Washout 2||2
6409234|NCT00934856|7322352|FG004|COMPLETED|Extension Part||24
6409235|NCT00934856|7322353|FG005|COMPLETED|Extension Part||19
6409236|NCT00934856|7322348|FG000|NOT COMPLETED|Extension Part||0
6409237|NCT00934856|7322349|FG001|NOT COMPLETED|Extension Part||0
6409238|NCT00934856|7322350|FG002|NOT COMPLETED|Extension Part||0
6409239|NCT00934856|7322351|FG003|NOT COMPLETED|Extension Part||2
6409240|NCT00934856|7322352|FG004|NOT COMPLETED|Extension Part||4
6409241|NCT00934856|7322353|FG005|NOT COMPLETED|Extension Part||5
6409242|NCT00934934|7322387|FG000|STARTED|Overall Study||30
6409243|NCT00934934|7322388|FG001|STARTED|Overall Study||31
6409244|NCT00934934|7322387|FG000|COMPLETED|Overall Study||29
6409245|NCT00934934|7322388|FG001|COMPLETED|Overall Study||31
6409246|NCT00934934|7322387|FG000|NOT COMPLETED|Overall Study||1
6409247|NCT00934934|7322388|FG001|NOT COMPLETED|Overall Study||0
6409248|NCT00934947|7322399|FG000|STARTED|Overall Study||23
6409249|NCT00934947|7322400|FG001|STARTED|Overall Study||22
6409250|NCT00934947|7322399|FG000|COMPLETED|Overall Study||23
6409251|NCT00934947|7322400|FG001|COMPLETED|Overall Study||20
6409252|NCT00934947|7322399|FG000|NOT COMPLETED|Overall Study||0
6409253|NCT00934947|7322400|FG001|NOT COMPLETED|Overall Study||2
6409254|NCT00935012|7322408|FG000|STARTED|Overall Study||31
6409255|NCT00935012|7322408|FG000|COMPLETED|Overall Study||2
6409256|NCT00935012|7322408|FG000|NOT COMPLETED|Overall Study||29
6409257|NCT00935064|7322414|FG000|STARTED|Overall Study||30
6409258|NCT00935064|7322415|FG001|STARTED|Overall Study||30
6409259|NCT00935064|7322414|FG000|COMPLETED|Overall Study||30
6409260|NCT00935064|7322415|FG001|COMPLETED|Overall Study||30
6409261|NCT00935064|7322414|FG000|NOT COMPLETED|Overall Study||0
6409262|NCT00935064|7322415|FG001|NOT COMPLETED|Overall Study||0
6409263|NCT00935220|7322421|FG000|STARTED|Overall Study||41
6409264|NCT00935220|7322421|FG000|COMPLETED|Overall Study||39
6409265|NCT00935220|7322421|FG000|NOT COMPLETED|Overall Study||2
6409266|NCT00935259|7322425|FG000|STARTED|Period 1||16
6409267|NCT00935259|7322426|FG001|STARTED|Period 1||15
6409268|NCT00935259|7322425|FG000|COMPLETED|Period 1||15
6409269|NCT00935259|7322426|FG001|COMPLETED|Period 1||14
6409270|NCT00935259|7322425|FG000|NOT COMPLETED|Period 1||1
6409271|NCT00935259|7322426|FG001|NOT COMPLETED|Period 1||1
6409272|NCT00935259|7322425|FG000|STARTED|Period 2||15
6409273|NCT00935259|7322426|FG001|STARTED|Period 2||14
6409274|NCT00935259|7322425|FG000|COMPLETED|Period 2||15
6409275|NCT00935259|7322426|FG001|COMPLETED|Period 2||14
6409276|NCT00935259|7322425|FG000|NOT COMPLETED|Period 2||0
6409277|NCT00935259|7322426|FG001|NOT COMPLETED|Period 2||0
6409278|NCT00935272|7322436|FG000|STARTED|Overall Study||135
6409279|NCT00935272|7322437|FG001|STARTED|Overall Study||45
6409280|NCT00935272|7322436|FG000|COMPLETED|Overall Study||116
6409281|NCT00935272|7322437|FG001|COMPLETED|Overall Study||39
6409282|NCT00935272|7322436|FG000|NOT COMPLETED|Overall Study||19
6409283|NCT00935272|7322437|FG001|NOT COMPLETED|Overall Study||6
6409284|NCT00935311|7322447|FG000|STARTED|Overall Study||43
6409285|NCT00935311|7322448|FG001|STARTED|Overall Study||39
6409286|NCT00935311|7322449|FG002|STARTED|Overall Study||40
6409287|NCT00935311|7322447|FG000|COMPLETED|Overall Study||43
6409288|NCT00935311|7322448|FG001|COMPLETED|Overall Study||39
6409289|NCT00935311|7322449|FG002|COMPLETED|Overall Study||40
6409290|NCT00935311|7322447|FG000|NOT COMPLETED|Overall Study||0
6409291|NCT00935311|7322448|FG001|NOT COMPLETED|Overall Study||0
6409292|NCT00935311|7322449|FG002|NOT COMPLETED|Overall Study||0
6409293|NCT00935428|7322457|FG000|STARTED|Overall Study||231
6409294|NCT00935428|7322457|FG000|COMPLETED|Overall Study||231
6409295|NCT00935428|7322457|FG000|NOT COMPLETED|Overall Study||0
6409296|NCT00935493|7322470|FG000|STARTED|Overall Study||41
6409297|NCT00935493|7322471|FG001|STARTED|Overall Study||41
6409298|NCT00935493|7322472|FG002|STARTED|Overall Study||41
6409299|NCT00935493|7322470|FG000|COMPLETED|Overall Study||40
6409300|NCT00935493|7322471|FG001|COMPLETED|Overall Study||39
6409301|NCT00935493|7322472|FG002|COMPLETED|Overall Study||40
6409302|NCT00935493|7322470|FG000|NOT COMPLETED|Overall Study||1
6409303|NCT00935493|7322471|FG001|NOT COMPLETED|Overall Study||2
6409304|NCT00935493|7322472|FG002|NOT COMPLETED|Overall Study||1
6409305|NCT00935532|7322482|FG000|STARTED|Overall Study||215
6409306|NCT00935532|7322483|FG001|STARTED|Overall Study||212
6409307|NCT00935532|7322482|FG000|COMPLETED|Overall Study||193
6409308|NCT00935532|7322483|FG001|COMPLETED|Overall Study||201
6409309|NCT00935532|7322482|FG000|NOT COMPLETED|Overall Study||22
6409310|NCT00935532|7322483|FG001|NOT COMPLETED|Overall Study||11
6409311|NCT00935584|7322491|FG000|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
6409312|NCT00935584|7322492|FG001|STARTED|Overall Study||23
6409313|NCT00935584|7322491|FG000|COMPLETED|Overall Study||77
6409314|NCT00935584|7322492|FG001|COMPLETED|Overall Study||19
6409315|NCT00935584|7322491|FG000|NOT COMPLETED|Overall Study||49
6409316|NCT00935584|7322492|FG001|NOT COMPLETED|Overall Study||4
6409317|NCT00935701|7322496|FG000|STARTED|Overall Study||10
6409318|NCT00935701|7322496|FG000|Transition Acupressure to Acupuncture|Overall Study||9
6409319|NCT00935701|7322496|FG000|COMPLETED|Overall Study||9
6409320|NCT00935701|7322496|FG000|NOT COMPLETED|Overall Study||1
6409321|NCT00935766|7322503|FG000|STARTED|Overall Study||42
6409322|NCT00935766|7322504|FG001|STARTED|Overall Study||34
6409323|NCT00935766|7322503|FG000|COMPLETED|Overall Study||35
6409324|NCT00935766|7322504|FG001|COMPLETED|Overall Study||27
6409325|NCT00935766|7322503|FG000|NOT COMPLETED|Overall Study||7
6409326|NCT00935766|7322504|FG001|NOT COMPLETED|Overall Study||7
6409327|NCT00935792|7322513|FG000|STARTED|Overall Study||7
6409328|NCT00935792|7322514|FG001|STARTED|Overall Study||9
6409329|NCT00935792|7322515|FG002|STARTED|Overall Study||12
6409330|NCT00935792|7322513|FG000|COMPLETED|Overall Study||6
6409331|NCT00935792|7322514|FG001|COMPLETED|Overall Study||6
6409332|NCT00935792|7322515|FG002|COMPLETED|Overall Study||12
6409333|NCT00935792|7322513|FG000|NOT COMPLETED|Overall Study||1
6409334|NCT00935792|7322514|FG001|NOT COMPLETED|Overall Study||3
6409335|NCT00935792|7322515|FG002|NOT COMPLETED|Overall Study||0
6409336|NCT00935818|7322527|FG000|STARTED|Overall Study||249
6409337|NCT00935818|7322528|FG001|STARTED|Overall Study||257
6409338|NCT00935818|7322527|FG000|End of Medication Phase|Overall Study||182
6409339|NCT00935818|7322528|FG001|End of Medication Phase|Overall Study||184
6409340|NCT00935818|7322527|FG000|COMPLETED|Overall Study||158
6409341|NCT00935818|7322528|FG001|COMPLETED|Overall Study||157
6409342|NCT00935818|7322527|FG000|NOT COMPLETED|Overall Study||91
6409343|NCT00935818|7322528|FG001|NOT COMPLETED|Overall Study||100
6409344|NCT00935857|7322536|FG000|STARTED|Overall Study||14
6409345|NCT00935857|7322537|FG001|STARTED|Overall Study||16
6409346|NCT00935857|7322536|FG000|COMPLETED|Overall Study||14
6409347|NCT00935857|7322537|FG001|COMPLETED|Overall Study||16
6409348|NCT00935857|7322536|FG000|NOT COMPLETED|Overall Study||0
6409349|NCT00935857|7322537|FG001|NOT COMPLETED|Overall Study||0
6636363|NCT02310750|7565141|FG015|STARTED|HP Washout 2||2
6636364|NCT02310750|7565126|FG000|COMPLETED|HP Washout 2||0
6636365|NCT02310750|7565127|FG001|COMPLETED|HP Washout 2||0
6636366|NCT02310750|7565128|FG002|COMPLETED|HP Washout 2||0
6636367|NCT02310750|7565129|FG003|COMPLETED|HP Washout 2||0
6636368|NCT02310750|7565130|FG004|COMPLETED|HP Washout 2||5
6636369|NCT02310750|7565131|FG005|COMPLETED|HP Washout 2||0
6636370|NCT02310750|7565132|FG006|COMPLETED|HP Washout 2||2
6636371|NCT02310750|7565133|FG007|COMPLETED|HP Washout 2||0
6636372|NCT02310750|7565134|FG008|COMPLETED|HP Washout 2||0
6636373|NCT02310750|7565135|FG009|COMPLETED|HP Washout 2||0
6636374|NCT02310750|7565136|FG010|COMPLETED|HP Washout 2||2
6636375|NCT02310750|7565137|FG011|COMPLETED|HP Washout 2||2
6636376|NCT02310750|7565138|FG012|COMPLETED|HP Washout 2||2
6636377|NCT02310750|7565139|FG013|COMPLETED|HP Washout 2||2
6636378|NCT02310750|7565140|FG014|COMPLETED|HP Washout 2||2
6743421|NCT03334448|7671662|FG002|NOT COMPLETED|Period 3||0
6743422|NCT03334448|7671663|FG003|NOT COMPLETED|Period 3||0
6743423|NCT03334448|7671660|FG000|STARTED|Washout||12
6743424|NCT03334448|7671661|FG001|STARTED|Washout||11
6743425|NCT03334448|7671662|FG002|STARTED|Washout||13
6743426|NCT03334448|7671663|FG003|STARTED|Washout||12
6743427|NCT03334448|7671660|FG000|COMPLETED|Washout||12
6743428|NCT03334448|7671661|FG001|COMPLETED|Washout||11
6743429|NCT03334448|7671662|FG002|COMPLETED|Washout||13
6743430|NCT03334448|7671663|FG003|COMPLETED|Washout||11
6743431|NCT03334448|7671660|FG000|NOT COMPLETED|Washout||0
6743432|NCT03334448|7671661|FG001|NOT COMPLETED|Washout||0
6743433|NCT03334448|7671662|FG002|NOT COMPLETED|Washout||0
6743434|NCT03334448|7671663|FG003|NOT COMPLETED|Washout||1
6743435|NCT03334448|7671660|FG000|STARTED|Period 4||12
6743436|NCT03334448|7671661|FG001|STARTED|Period 4||11
6743437|NCT03334448|7671662|FG002|STARTED|Period 4||13
6743438|NCT03334448|7671663|FG003|STARTED|Period 4||11
6743439|NCT03334448|7671660|FG000|Received at Least 1 Dose of Study Drug|Period 4||12
6743440|NCT03334448|7671661|FG001|Received at Least 1 Dose of Study Drug|Period 4||11
6743441|NCT03334448|7671662|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
6743442|NCT03334448|7671663|FG003|Received at Least 1 Dose of Study Drug|Period 4||11
6743443|NCT03334448|7671660|FG000|COMPLETED|Period 4||12
6743444|NCT03334448|7671661|FG001|COMPLETED|Period 4||11
6743445|NCT03334448|7671662|FG002|COMPLETED|Period 4||13
6743446|NCT03334448|7671663|FG003|COMPLETED|Period 4||11
6743447|NCT03334448|7671660|FG000|NOT COMPLETED|Period 4||0
6743448|NCT03334448|7671661|FG001|NOT COMPLETED|Period 4||0
6743449|NCT03334448|7671662|FG002|NOT COMPLETED|Period 4||0
6743450|NCT03334448|7671663|FG003|NOT COMPLETED|Period 4||0
6743451|NCT03334630|7671671|FG000|STARTED|Overall Study||239
6743452|NCT03334630|7671672|FG001|STARTED|Overall Study||243
6743453|NCT03334630|7671671|FG000|COMPLETED|Overall Study||225
6743454|NCT03334630|7671672|FG001|COMPLETED|Overall Study||230
6743455|NCT03334630|7671671|FG000|NOT COMPLETED|Overall Study||14
6743456|NCT03334630|7671672|FG001|NOT COMPLETED|Overall Study||13
6409350|NCT00935883|7322545|FG000|STARTED|Treatment Period||20
6409351|NCT00935883|7322546|FG001|STARTED|Treatment Period||40
6409352|NCT00935883|7322545|FG000|COMPLETED|Treatment Period||19
6409353|NCT00935883|7322546|FG001|COMPLETED|Treatment Period||38
6409354|NCT00935883|7322545|FG000|NOT COMPLETED|Treatment Period||1
6636379|NCT02310750|7565141|FG015|COMPLETED|HP Washout 2||2
6743457|NCT03334695|7671680|FG000|STARTED|Overall Study||31
6743458|NCT03334695|7671681|FG001|STARTED|Overall Study||32
6409355|NCT00935883|7322546|FG001|NOT COMPLETED|Treatment Period||2
6409356|NCT00935883|7322545|FG000|STARTED|Follow-Up Period||19
6636380|NCT02310750|7565126|FG000|NOT COMPLETED|HP Washout 2||0
6636381|NCT02310750|7565127|FG001|NOT COMPLETED|HP Washout 2||0
6636382|NCT02310750|7565128|FG002|NOT COMPLETED|HP Washout 2||0
6636383|NCT02310750|7565129|FG003|NOT COMPLETED|HP Washout 2||0
6743459|NCT03334695|7671680|FG000|COMPLETED|Overall Study||27
6743460|NCT03334695|7671681|FG001|COMPLETED|Overall Study||26
6743461|NCT03334695|7671680|FG000|NOT COMPLETED|Overall Study||4
6743462|NCT03334695|7671681|FG001|NOT COMPLETED|Overall Study||6
6743463|NCT03334721|7671691|FG000|STARTED|Overall Study||12
6743464|NCT03334721|7671692|FG001|STARTED|Overall Study||11
6409357|NCT00935883|7322546|FG001|STARTED|Follow-Up Period||38
6409358|NCT00935883|7322545|FG000|COMPLETED|Follow-Up Period||19
6409359|NCT00935883|7322546|FG001|COMPLETED|Follow-Up Period||38
6409360|NCT00935883|7322545|FG000|NOT COMPLETED|Follow-Up Period||0
6409361|NCT00935883|7322546|FG001|NOT COMPLETED|Follow-Up Period||0
6409362|NCT00936065|7322555|FG000|STARTED|Overall Study||21
6409363|NCT00936065|7322556|FG001|STARTED|Overall Study||20
6409364|NCT00936065|7322557|FG002|STARTED|Overall Study||19
6409365|NCT00936065|7322555|FG000|Received Treatment|Overall Study||21
6409366|NCT00936065|7322556|FG001|Received Treatment|Overall Study||20
6409367|NCT00936065|7322557|FG002|Received Treatment|Overall Study||18
6409368|NCT00936065|7322555|FG000|Study Assessments Performed|Overall Study||21
6409369|NCT00936065|7322556|FG001|Study Assessments Performed|Overall Study||19
6409370|NCT00936065|7322557|FG002|Study Assessments Performed|Overall Study||18
6409371|NCT00936065|7322555|FG000|COMPLETED|Overall Study||17
6409372|NCT00936065|7322556|FG001|COMPLETED|Overall Study||16
6409373|NCT00936065|7322557|FG002|COMPLETED|Overall Study||12
6409374|NCT00936065|7322555|FG000|NOT COMPLETED|Overall Study||4
6409375|NCT00936065|7322556|FG001|NOT COMPLETED|Overall Study||4
6409376|NCT00936065|7322557|FG002|NOT COMPLETED|Overall Study||7
6409377|NCT00936117|7322565|FG000|STARTED|Overall Study||20
6409378|NCT00936117|7322565|FG000|COMPLETED|Overall Study|Completed 42 days on study drug|10
6409379|NCT00936117|7322565|FG000|NOT COMPLETED|Overall Study||10
6409380|NCT00936208|7322572|FG000|STARTED|Overall Study||1499
6409381|NCT00936208|7322573|FG001|STARTED|Overall Study||1596
6409382|NCT00936208|7322572|FG000|COMPLETED|Overall Study||1462
6409383|NCT00936208|7322573|FG001|COMPLETED|Overall Study||1574
6409384|NCT00936208|7322572|FG000|NOT COMPLETED|Overall Study||37
6409385|NCT00936208|7322573|FG001|NOT COMPLETED|Overall Study||22
6409386|NCT00936221|7322581|FG000|STARTED|Overall Study||45
6409387|NCT00936221|7322582|FG001|STARTED|Overall Study||46
6409388|NCT00936221|7322581|FG000|Received Treatment|Overall Study||44
6409389|NCT00936221|7322582|FG001|Received Treatment|Overall Study||45
6409390|NCT00936221|7322581|FG000|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
6409391|NCT00936221|7322582|FG001|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
6409392|NCT00936221|7322581|FG000|NOT COMPLETED|Overall Study||1
6409393|NCT00936221|7322582|FG001|NOT COMPLETED|Overall Study||1
6636384|NCT02310750|7565130|FG004|NOT COMPLETED|HP Washout 2||1
6636385|NCT02310750|7565131|FG005|NOT COMPLETED|HP Washout 2||0
6636386|NCT02310750|7565132|FG006|NOT COMPLETED|HP Washout 2||7
6636387|NCT02310750|7565133|FG007|NOT COMPLETED|HP Washout 2||0
6636388|NCT02310750|7565134|FG008|NOT COMPLETED|HP Washout 2||0
6636389|NCT02310750|7565135|FG009|NOT COMPLETED|HP Washout 2||0
6636390|NCT02310750|7565136|FG010|NOT COMPLETED|HP Washout 2||0
6636391|NCT02310750|7565137|FG011|NOT COMPLETED|HP Washout 2||0
6636392|NCT02310750|7565138|FG012|NOT COMPLETED|HP Washout 2||0
6636393|NCT02310750|7565139|FG013|NOT COMPLETED|HP Washout 2||0
6636394|NCT02310750|7565140|FG014|NOT COMPLETED|HP Washout 2||0
6636395|NCT02310750|7565141|FG015|NOT COMPLETED|HP Washout 2||0
6636396|NCT02310750|7565126|FG000|STARTED|HP MAD and Fasted/Fed||0
6636397|NCT02310750|7565127|FG001|STARTED|HP MAD and Fasted/Fed||0
6636398|NCT02310750|7565128|FG002|STARTED|HP MAD and Fasted/Fed||0
6636399|NCT02310750|7565129|FG003|STARTED|HP MAD and Fasted/Fed||0
6636400|NCT02310750|7565130|FG004|STARTED|HP MAD and Fasted/Fed||5
6636401|NCT02310750|7565131|FG005|STARTED|HP MAD and Fasted/Fed||0
6636402|NCT02310750|7565132|FG006|STARTED|HP MAD and Fasted/Fed||2
6636403|NCT02310750|7565133|FG007|STARTED|HP MAD and Fasted/Fed||0
6636404|NCT02310750|7565134|FG008|STARTED|HP MAD and Fasted/Fed||0
6636405|NCT02310750|7565135|FG009|STARTED|HP MAD and Fasted/Fed||0
6636406|NCT02310750|7565136|FG010|STARTED|HP MAD and Fasted/Fed||2
6636407|NCT02310750|7565137|FG011|STARTED|HP MAD and Fasted/Fed||2
6636408|NCT02310750|7565138|FG012|STARTED|HP MAD and Fasted/Fed||2
6636409|NCT02310750|7565139|FG013|STARTED|HP MAD and Fasted/Fed||2
6636410|NCT02310750|7565140|FG014|STARTED|HP MAD and Fasted/Fed||2
6636411|NCT02310750|7565141|FG015|STARTED|HP MAD and Fasted/Fed||2
6636412|NCT02310750|7565126|FG000|COMPLETED|HP MAD and Fasted/Fed||0
6636413|NCT02310750|7565127|FG001|COMPLETED|HP MAD and Fasted/Fed||0
6636414|NCT02310750|7565128|FG002|COMPLETED|HP MAD and Fasted/Fed||0
6636415|NCT02310750|7565129|FG003|COMPLETED|HP MAD and Fasted/Fed||0
6636416|NCT02310750|7565130|FG004|COMPLETED|HP MAD and Fasted/Fed||4
6636417|NCT02310750|7565131|FG005|COMPLETED|HP MAD and Fasted/Fed||0
6636418|NCT02310750|7565132|FG006|COMPLETED|HP MAD and Fasted/Fed||2
6636419|NCT02310750|7565133|FG007|COMPLETED|HP MAD and Fasted/Fed||0
6636420|NCT02310750|7565134|FG008|COMPLETED|HP MAD and Fasted/Fed||0
6636421|NCT02310750|7565135|FG009|COMPLETED|HP MAD and Fasted/Fed||0
6636422|NCT02310750|7565136|FG010|COMPLETED|HP MAD and Fasted/Fed||2
6636423|NCT02310750|7565137|FG011|COMPLETED|HP MAD and Fasted/Fed||2
6636424|NCT02310750|7565138|FG012|COMPLETED|HP MAD and Fasted/Fed||2
6636425|NCT02310750|7565139|FG013|COMPLETED|HP MAD and Fasted/Fed||2
6636426|NCT02310750|7565140|FG014|COMPLETED|HP MAD and Fasted/Fed||2
6409394|NCT00936299|7322590|FG000|STARTED|Overall Study||53
6409395|NCT00936299|7322591|FG001|STARTED|Overall Study||52
6409396|NCT00936299|7322590|FG000|COMPLETED|Overall Study||40
6409397|NCT00936299|7322591|FG001|COMPLETED|Overall Study||40
6409398|NCT00936299|7322590|FG000|NOT COMPLETED|Overall Study||13
6636427|NCT02310750|7565141|FG015|COMPLETED|HP MAD and Fasted/Fed||2
6636428|NCT02310750|7565126|FG000|NOT COMPLETED|HP MAD and Fasted/Fed||0
6409399|NCT00936299|7322591|FG001|NOT COMPLETED|Overall Study||12
6409400|NCT00936351|7322601|FG000|STARTED|Overall Study||18
6409401|NCT00936351|7322602|FG001|STARTED|Overall Study||16
6409402|NCT00936351|7322601|FG000|COMPLETED|Overall Study||15
6409403|NCT00936351|7322602|FG001|COMPLETED|Overall Study||14
6409404|NCT00936351|7322601|FG000|NOT COMPLETED|Overall Study||3
6409405|NCT00936351|7322602|FG001|NOT COMPLETED|Overall Study||2
6409406|NCT00936377|7322611|FG000|STARTED|Overall Study||8
6409407|NCT00936377|7322612|FG001|STARTED|Overall Study||8
6409408|NCT00936377|7322613|FG002|STARTED|Overall Study||8
6409409|NCT00936377|7322611|FG000|COMPLETED|Overall Study||8
6409410|NCT00936377|7322612|FG001|COMPLETED|Overall Study||8
6409411|NCT00936377|7322613|FG002|COMPLETED|Overall Study||8
6409412|NCT00936377|7322611|FG000|NOT COMPLETED|Overall Study||0
6409413|NCT00936377|7322612|FG001|NOT COMPLETED|Overall Study||0
6409414|NCT00936377|7322613|FG002|NOT COMPLETED|Overall Study||0
6636429|NCT02310750|7565127|FG001|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636430|NCT02310750|7565128|FG002|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636431|NCT02310750|7565129|FG003|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636432|NCT02310750|7565130|FG004|NOT COMPLETED|HP MAD and Fasted/Fed||1
6636433|NCT02310750|7565131|FG005|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636434|NCT02310750|7565132|FG006|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636435|NCT02310750|7565133|FG007|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636436|NCT02310750|7565134|FG008|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636437|NCT02310750|7565135|FG009|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636438|NCT02310750|7565136|FG010|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636439|NCT02310750|7565137|FG011|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636440|NCT02310750|7565138|FG012|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636441|NCT02310750|7565139|FG013|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636442|NCT02310750|7565140|FG014|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636443|NCT02310750|7565141|FG015|NOT COMPLETED|HP MAD and Fasted/Fed||0
6636444|NCT02310763|7565225|FG000|STARTED|Period 1 (Weeks 1 to 48)||41
6636445|NCT02310763|7565226|FG001|STARTED|Period 1 (Weeks 1 to 48)||39
6636446|NCT02310763|7565227|FG002|STARTED|Period 1 (Weeks 1 to 48)||40
6636447|NCT02310763|7565225|FG000|COMPLETED|Period 1 (Weeks 1 to 48)||38
6636448|NCT02310763|7565226|FG001|COMPLETED|Period 1 (Weeks 1 to 48)||37
6636449|NCT02310763|7565227|FG002|COMPLETED|Period 1 (Weeks 1 to 48)||38
6636450|NCT02310763|7565225|FG000|NOT COMPLETED|Period 1 (Weeks 1 to 48)||3
6636451|NCT02310763|7565226|FG001|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
6636452|NCT02310763|7565227|FG002|NOT COMPLETED|Period 1 (Weeks 1 to 48)||2
6636453|NCT02310763|7565225|FG000|STARTED|Period 2 (Weeks 49 to 96)||38
6636454|NCT02310763|7565226|FG001|STARTED|Period 2 (Weeks 49 to 96)||37
6636455|NCT02310763|7565227|FG002|STARTED|Period 2 (Weeks 49 to 96)||38
6636456|NCT02310763|7565225|FG000|COMPLETED|Period 2 (Weeks 49 to 96)||22
6636457|NCT02310763|7565226|FG001|COMPLETED|Period 2 (Weeks 49 to 96)||21
6636458|NCT02310763|7565227|FG002|COMPLETED|Period 2 (Weeks 49 to 96)||22
6636459|NCT02310763|7565225|FG000|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
6636460|NCT02310763|7565226|FG001|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
6636461|NCT02310763|7565227|FG002|NOT COMPLETED|Period 2 (Weeks 49 to 96)||16
6636462|NCT02310776|7565253|FG000|STARTED|Overall Study||501
6636463|NCT02310776|7565253|FG000|COMPLETED|Overall Study||501
6636464|NCT02310776|7565253|FG000|NOT COMPLETED|Overall Study||0
6636465|NCT02310789|7565257|FG000|STARTED|Overall Study||8
6636466|NCT02310789|7565257|FG000|COMPLETED|Overall Study||7
6636467|NCT02310789|7565257|FG000|NOT COMPLETED|Overall Study||1
6636468|NCT02310906|7565265|FG000|STARTED|Part 1: Double Blind Phase (12 Weeks)||4
6636469|NCT02310906|7565266|FG001|STARTED|Part 1: Double Blind Phase (12 Weeks)||8
6636470|NCT02310906|7565267|FG002|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
6636471|NCT02310906|7565268|FG003|STARTED|Part 1: Double Blind Phase (12 Weeks)||0
6636472|NCT02310906|7565265|FG000|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636473|NCT02310906|7565266|FG001|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
6636474|NCT02310906|7565267|FG002|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636475|NCT02310906|7565268|FG003|Received 4 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636476|NCT02310906|7565265|FG000|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636477|NCT02310906|7565266|FG001|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
6636478|NCT02310906|7565267|FG002|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636479|NCT02310906|7565268|FG003|Received 10 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636480|NCT02310906|7565265|FG000|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636481|NCT02310906|7565266|FG001|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
6636482|NCT02310906|7565267|FG002|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636483|NCT02310906|7565268|FG003|Received 20 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636484|NCT02310906|7565265|FG000|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636485|NCT02310906|7565266|FG001|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||8
6636486|NCT02310906|7565267|FG002|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636487|NCT02310906|7565268|FG003|Received 30 mg/kg|Part 1: Double Blind Phase (12 Weeks)||0
6636488|NCT02310906|7565265|FG000|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||4
6636489|NCT02310906|7565266|FG001|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||8
6409415|NCT00936455|7322623|FG000|STARTED|Overall Study||37
6409416|NCT00936455|7322624|FG001|STARTED|Overall Study||38
6409417|NCT00936455|7322623|FG000|COMPLETED|Overall Study||37
6409418|NCT00936455|7322624|FG001|COMPLETED|Overall Study||38
6409419|NCT00936455|7322623|FG000|NOT COMPLETED|Overall Study||0
6409420|NCT00936455|7322624|FG001|NOT COMPLETED|Overall Study||0
6409421|NCT00936481|7322638|FG000|STARTED|Overall Study||17
6409422|NCT00936481|7322639|FG001|STARTED|Overall Study||17
6409423|NCT00936481|7322638|FG000|COMPLETED|Overall Study||17
6409424|NCT00936481|7322639|FG001|COMPLETED|Overall Study||17
6409425|NCT00936481|7322638|FG000|NOT COMPLETED|Overall Study||0
6409426|NCT00936481|7322639|FG001|NOT COMPLETED|Overall Study||0
6409427|NCT00936611|7322645|FG000|STARTED|Overall Study||39
6409428|NCT00936611|7322645|FG000|Treated|Overall Study||36
6409429|NCT00936611|7322645|FG000|Starting Dose Reduction: 30 mg to 25 mg|Overall Study||12
6409430|NCT00936611|7322645|FG000|COMPLETED|Overall Study||0
6409431|NCT00936611|7322645|FG000|NOT COMPLETED|Overall Study||39
6409432|NCT00936663|7322651|FG000|STARTED|Overall Study||1
6409433|NCT00936663|7322652|FG001|STARTED|Overall Study||2
6409434|NCT00936663|7322651|FG000|COMPLETED|Overall Study||1
6409435|NCT00936663|7322652|FG001|COMPLETED|Overall Study||2
6409436|NCT00936663|7322651|FG000|NOT COMPLETED|Overall Study||0
6409437|NCT00936663|7322652|FG001|NOT COMPLETED|Overall Study||0
6409438|NCT00936702|7322658|FG000|STARTED|Overall Study||46
6409439|NCT00936702|7322658|FG000|COMPLETED|Overall Study||0
6409440|NCT00936702|7322658|FG000|NOT COMPLETED|Overall Study||46
6409441|NCT00936715|7322662|FG000|STARTED|Overall Study||24
6409442|NCT00936715|7322662|FG000|COMPLETED|Overall Study||18
6409443|NCT00936715|7322662|FG000|NOT COMPLETED|Overall Study||6
6409444|NCT00936741|7322666|FG000|STARTED|Overall Study||30
6409445|NCT00936741|7322666|FG000|COMPLETED|Overall Study||21
6409446|NCT00936741|7322666|FG000|NOT COMPLETED|Overall Study||9
6409447|NCT00936858|7322670|FG000|STARTED|Overall Study||50
6409448|NCT00936858|7322670|FG000|Participants With Medullary Thyroid Cancer|Overall Study||10
6409449|NCT00936858|7322670|FG000|COMPLETED|Overall Study||0
6409450|NCT00936858|7322670|FG000|NOT COMPLETED|Overall Study||50
6636490|NCT02310906|7565267|FG002|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6636491|NCT02310906|7565268|FG003|COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6636492|NCT02310906|7565265|FG000|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6636493|NCT02310906|7565266|FG001|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6636494|NCT02310906|7565267|FG002|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6636495|NCT02310906|7565268|FG003|NOT COMPLETED|Part 1: Double Blind Phase (12 Weeks)||0
6636496|NCT02310906|7565265|FG000|STARTED|Part 2: Open Label Phase (168 Weeks)||0
6636497|NCT02310906|7565266|FG001|STARTED|Part 2: Open Label Phase (168 Weeks)||0
6636498|NCT02310906|7565267|FG002|STARTED|Part 2: Open Label Phase (168 Weeks)|4 participants from Part 1(Placebo) + 8 participants from Part 1(Golodirsen) +13 new participants|25
6636499|NCT02310906|7565268|FG003|STARTED|Part 2: Open Label Phase (168 Weeks)||14
6636500|NCT02310906|7565265|FG000|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
6636501|NCT02310906|7565266|FG001|COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
6636502|NCT02310906|7565267|FG002|COMPLETED|Part 2: Open Label Phase (168 Weeks)||23
6636503|NCT02310906|7565268|FG003|COMPLETED|Part 2: Open Label Phase (168 Weeks)||6
6636504|NCT02310906|7565265|FG000|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
6636505|NCT02310906|7565266|FG001|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||0
6636506|NCT02310906|7565267|FG002|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||2
6636507|NCT02310906|7565268|FG003|NOT COMPLETED|Part 2: Open Label Phase (168 Weeks)||8
6636508|NCT02311153|7565291|FG000|STARTED|Overall Study||53
6636509|NCT02311153|7565292|FG001|STARTED|Overall Study||49
6636510|NCT02311153|7565291|FG000|COMPLETED|Overall Study||48
6636511|NCT02311153|7565292|FG001|COMPLETED|Overall Study||42
6636512|NCT02311153|7565291|FG000|NOT COMPLETED|Overall Study||5
6636513|NCT02311153|7565292|FG001|NOT COMPLETED|Overall Study||7
6636514|NCT02311309|7565301|FG000|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
6636515|NCT02311309|7565302|FG001|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
6636516|NCT02311309|7565303|FG002|STARTED|Overall Study||863
6636517|NCT02311309|7565301|FG000|COMPLETED|Overall Study||541
6636518|NCT02311309|7565302|FG001|COMPLETED|Overall Study||35
6636519|NCT02311309|7565303|FG002|COMPLETED|Overall Study||863
6636520|NCT02311309|7565301|FG000|NOT COMPLETED|Overall Study||0
6636521|NCT02311309|7565302|FG001|NOT COMPLETED|Overall Study||0
6636522|NCT02311309|7565303|FG002|NOT COMPLETED|Overall Study||0
6636523|NCT02311361|7565315|FG000|STARTED|Overall Study||14
6636524|NCT02311361|7565316|FG001|STARTED|Overall Study||11
6636525|NCT02311361|7565317|FG002|STARTED|Overall Study||19
6636526|NCT02311361|7565318|FG003|STARTED|Overall Study||21
6636527|NCT02311361|7565315|FG000|Received Radiation Therapy Only|Overall Study||0
6636528|NCT02311361|7565316|FG001|Received Radiation Therapy Only|Overall Study||1
6636529|NCT02311361|7565317|FG002|Received Radiation Therapy Only|Overall Study||1
6636530|NCT02311361|7565318|FG003|Received Radiation Therapy Only|Overall Study||1
6636531|NCT02311361|7565315|FG000|COMPLETED|Overall Study||14
6636532|NCT02311361|7565316|FG001|COMPLETED|Overall Study||10
6636533|NCT02311361|7565317|FG002|COMPLETED|Overall Study||19
6636534|NCT02311361|7565318|FG003|COMPLETED|Overall Study||20
6636535|NCT02311361|7565315|FG000|NOT COMPLETED|Overall Study||0
6636536|NCT02311361|7565316|FG001|NOT COMPLETED|Overall Study||1
6636537|NCT02311361|7565317|FG002|NOT COMPLETED|Overall Study||0
6636538|NCT02311361|7565318|FG003|NOT COMPLETED|Overall Study||1
6409451|NCT00936884|7322677|FG000|STARTED|Double-blind|Twenty-five subjects received MNTX, and 24 had ≥ 1 post baseline diary assessment.|25
6409452|NCT00936884|7322678|FG001|STARTED|Double-blind|Twenty-four subjects received placebo, and 23 had ≥ 1 post baseline diary assessment.|25
6409453|NCT00936884|7322679|FG002|STARTED|Double-blind|Thirteen subjects from the MNTX group and 18 from the placebo group entered the 12-week extension.|0
6409454|NCT00936884|7322677|FG000|COMPLETED|Double-blind||13
6409455|NCT00936884|7322678|FG001|COMPLETED|Double-blind||18
6409456|NCT00936884|7322679|FG002|COMPLETED|Double-blind||0
6409457|NCT00936884|7322677|FG000|NOT COMPLETED|Double-blind||12
6409458|NCT00936884|7322678|FG001|NOT COMPLETED|Double-blind||7
6409459|NCT00936884|7322679|FG002|NOT COMPLETED|Double-blind||0
6409460|NCT00936884|7322677|FG000|STARTED|Open-label||0
6409461|NCT00936884|7322678|FG001|STARTED|Open-label||0
6409462|NCT00936884|7322679|FG002|STARTED|Open-label||31
6409463|NCT00936884|7322677|FG000|COMPLETED|Open-label||0
6409464|NCT00936884|7322678|FG001|COMPLETED|Open-label||0
6409465|NCT00936884|7322679|FG002|COMPLETED|Open-label||12
6409466|NCT00936884|7322677|FG000|NOT COMPLETED|Open-label||0
6409467|NCT00936884|7322678|FG001|NOT COMPLETED|Open-label||0
6409468|NCT00936884|7322679|FG002|NOT COMPLETED|Open-label||19
6409469|NCT00936897|7322688|FG000|STARTED|Overall Study|Randomized|417
6409470|NCT00936897|7322689|FG001|STARTED|Overall Study|Randomized|416
6409471|NCT00936897|7322688|FG000|COMPLETED|Overall Study||398
6409472|NCT00936897|7322689|FG001|COMPLETED|Overall Study||356
6409473|NCT00936897|7322688|FG000|NOT COMPLETED|Overall Study||19
6409474|NCT00936897|7322689|FG001|NOT COMPLETED|Overall Study||60
6409475|NCT00936910|7322695|FG000|STARTED|Overall Study||13
6409476|NCT00936910|7322695|FG000|COMPLETED|Overall Study|The primary endpt. of 2 (-) cultures within 5 d of lock therapy was met for 10 patients|10
6409477|NCT00936910|7322695|FG000|NOT COMPLETED|Overall Study||3
6409478|NCT00936975|7322700|FG000|STARTED|Overall Study||18
6409479|NCT00936975|7322700|FG000|COMPLETED|Overall Study||12
6409480|NCT00936975|7322700|FG000|NOT COMPLETED|Overall Study||6
6409481|NCT00937040|7322707|FG000|STARTED|Overall Study||179
6409482|NCT00937040|7322708|FG001|STARTED|Overall Study||178
6409483|NCT00937040|7322707|FG000|COMPLETED|Overall Study||138
6409484|NCT00937040|7322708|FG001|COMPLETED|Overall Study||141
6409485|NCT00937040|7322707|FG000|NOT COMPLETED|Overall Study||41
6409486|NCT00937040|7322708|FG001|NOT COMPLETED|Overall Study||37
6409487|NCT00937105|7322716|FG000|STARTED|Overall Study||109
6409488|NCT00937105|7322717|FG001|STARTED|Overall Study||109
6409489|NCT00937105|7322716|FG000|COMPLETED|Overall Study||69
6409490|NCT00937105|7322717|FG001|COMPLETED|Overall Study||70
6409491|NCT00937105|7322716|FG000|NOT COMPLETED|Overall Study||40
6409492|NCT00937105|7322717|FG001|NOT COMPLETED|Overall Study||39
6409493|NCT00937118|7322732|FG000|STARTED|Overall Study||41
6409494|NCT00937118|7322732|FG000|COMPLETED|Overall Study||41
6409495|NCT00937118|7322732|FG000|NOT COMPLETED|Overall Study||0
6409496|NCT00937157|7322739|FG000|STARTED|Overall Study||12
6409497|NCT00937157|7322739|FG000|COMPLETED|Overall Study||8
6409498|NCT00937157|7322739|FG000|NOT COMPLETED|Overall Study||4
6409499|NCT00937235|7322745|FG000|STARTED|Overall Study||72
6409500|NCT00937235|7322746|FG001|STARTED|Overall Study||70
6409501|NCT00937235|7322745|FG000|COMPLETED|Overall Study||72
6409502|NCT00937235|7322746|FG001|COMPLETED|Overall Study||70
6409503|NCT00937235|7322745|FG000|NOT COMPLETED|Overall Study||0
6409504|NCT00937235|7322746|FG001|NOT COMPLETED|Overall Study||0
6409505|NCT00937326|7322757|FG000|STARTED|Overall Study||46
6409506|NCT00937326|7322758|FG001|STARTED|Overall Study||45
6409507|NCT00937326|7322759|FG002|STARTED|Overall Study||46
6409508|NCT00937326|7322760|FG003|STARTED|Overall Study||45
6409509|NCT00937326|7322761|FG004|STARTED|Overall Study||45
6409510|NCT00937326|7322757|FG000|COMPLETED|Overall Study||43
6409511|NCT00937326|7322758|FG001|COMPLETED|Overall Study||38
6409512|NCT00937326|7322759|FG002|COMPLETED|Overall Study||42
6409513|NCT00937326|7322760|FG003|COMPLETED|Overall Study||40
6409514|NCT00937326|7322761|FG004|COMPLETED|Overall Study||40
6409515|NCT00937326|7322757|FG000|NOT COMPLETED|Overall Study||3
6409516|NCT00937326|7322758|FG001|NOT COMPLETED|Overall Study||7
6409517|NCT00937326|7322759|FG002|NOT COMPLETED|Overall Study||4
6409518|NCT00937326|7322760|FG003|NOT COMPLETED|Overall Study||5
6409519|NCT00937326|7322761|FG004|NOT COMPLETED|Overall Study||5
6409520|NCT00937378|7322780|FG000|STARTED|Overall Study||167
6409521|NCT00937378|7322781|FG001|STARTED|Overall Study||159
6409522|NCT00937378|7322780|FG000|COMPLETED|Overall Study||149
6409523|NCT00937378|7322781|FG001|COMPLETED|Overall Study||141
6409524|NCT00937378|7322780|FG000|NOT COMPLETED|Overall Study||18
6409525|NCT00937378|7322781|FG001|NOT COMPLETED|Overall Study||18
6409526|NCT00937391|7322789|FG000|STARTED|Stage 1||20
6409527|NCT00937391|7322789|FG000|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
6409528|NCT00937391|7322789|FG000|COMPLETED|Stage 1||20
6409529|NCT00937391|7322789|FG000|NOT COMPLETED|Stage 1||0
6409530|NCT00937391|7322789|FG000|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
6409531|NCT00937391|7322789|FG000|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
6409532|NCT00937391|7322789|FG000|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
6409533|NCT00937391|7322789|FG000|NOT COMPLETED|Stage 2||1
6409534|NCT00937404|7322806|FG000|STARTED|Overall Study||25
6409535|NCT00937404|7322806|FG000|COMPLETED|Overall Study||23
6409536|NCT00937404|7322806|FG000|NOT COMPLETED|Overall Study||2
6409537|NCT00937495|7322810|FG000|STARTED|Overall Study||16
6409538|NCT00937495|7322810|FG000|COMPLETED|Overall Study||14
6409539|NCT00937495|7322810|FG000|NOT COMPLETED|Overall Study||2
6498880|NCT01412944|7417517|FG000|COMPLETED|IV: Per CAIN457A2307||20
6409540|NCT00937521|7322822|FG000|STARTED|Overall Study - Prior to Booster Dose||188
6409541|NCT00937521|7322823|FG001|STARTED|Overall Study - Prior to Booster Dose||190
6409542|NCT00937521|7322824|FG002|STARTED|Overall Study - Prior to Booster Dose||192
6409543|NCT00937521|7322825|FG003|STARTED|Overall Study - Prior to Booster Dose||188
6409544|NCT00937521|7322826|FG004|STARTED|Overall Study - Prior to Booster Dose||191
6409545|NCT00937521|7322827|FG005|STARTED|Overall Study - Prior to Booster Dose||188
6409546|NCT00937521|7322828|FG006|STARTED|Overall Study - Prior to Booster Dose||186
6409547|NCT00937521|7322829|FG007|STARTED|Overall Study - Prior to Booster Dose||184
6409548|NCT00937521|7322822|FG000|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
6409549|NCT00937521|7322823|FG001|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
6409550|NCT00937521|7322824|FG002|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
6409551|NCT00937521|7322825|FG003|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
6409552|NCT00937521|7322826|FG004|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
6409553|NCT00937521|7322827|FG005|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
6409554|NCT00937521|7322828|FG006|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
6409555|NCT00937521|7322829|FG007|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
6409556|NCT00937521|7322822|FG000|COMPLETED|Overall Study - Prior to Booster Dose||185
6409557|NCT00937521|7322823|FG001|COMPLETED|Overall Study - Prior to Booster Dose||185
6409558|NCT00937521|7322824|FG002|COMPLETED|Overall Study - Prior to Booster Dose||186
6409559|NCT00937521|7322825|FG003|COMPLETED|Overall Study - Prior to Booster Dose||187
6409560|NCT00937521|7322826|FG004|COMPLETED|Overall Study - Prior to Booster Dose||188
6409561|NCT00937521|7322827|FG005|COMPLETED|Overall Study - Prior to Booster Dose||187
6409562|NCT00937521|7322828|FG006|COMPLETED|Overall Study - Prior to Booster Dose||181
6409563|NCT00937521|7322829|FG007|COMPLETED|Overall Study - Prior to Booster Dose||183
6409564|NCT00937521|7322822|FG000|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
6409565|NCT00937521|7322823|FG001|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
6409566|NCT00937521|7322824|FG002|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
6409567|NCT00937521|7322825|FG003|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
6409568|NCT00937521|7322826|FG004|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
6409569|NCT00937521|7322827|FG005|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
6409570|NCT00937521|7322828|FG006|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
6409571|NCT00937521|7322829|FG007|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
6409572|NCT00937521|7322822|FG000|STARTED|Booster Phase||155
6409573|NCT00937521|7322823|FG001|STARTED|Booster Phase||163
6409574|NCT00937521|7322824|FG002|STARTED|Booster Phase||169
6409575|NCT00937521|7322825|FG003|STARTED|Booster Phase||170
6409576|NCT00937521|7322826|FG004|STARTED|Booster Phase||168
6409577|NCT00937521|7322827|FG005|STARTED|Booster Phase||165
6409578|NCT00937521|7322828|FG006|STARTED|Booster Phase||165
6409579|NCT00937521|7322829|FG007|STARTED|Booster Phase||161
6409580|NCT00937521|7322822|FG000|Premature Withdrawal|Booster Phase||3
6409581|NCT00937521|7322823|FG001|Premature Withdrawal|Booster Phase||2
6409582|NCT00937521|7322824|FG002|Premature Withdrawal|Booster Phase||5
6409583|NCT00937521|7322825|FG003|Premature Withdrawal|Booster Phase||3
6409584|NCT00937521|7322826|FG004|Premature Withdrawal|Booster Phase||5
6409585|NCT00937521|7322827|FG005|Premature Withdrawal|Booster Phase||5
6409586|NCT00937521|7322828|FG006|Premature Withdrawal|Booster Phase||5
6409587|NCT00937521|7322829|FG007|Premature Withdrawal|Booster Phase||2
6409588|NCT00937521|7322822|FG000|COMPLETED|Booster Phase||152
6409589|NCT00937521|7322823|FG001|COMPLETED|Booster Phase||161
6409590|NCT00937521|7322824|FG002|COMPLETED|Booster Phase||164
6409591|NCT00937521|7322825|FG003|COMPLETED|Booster Phase||167
6409592|NCT00937521|7322826|FG004|COMPLETED|Booster Phase||163
6409593|NCT00937521|7322827|FG005|COMPLETED|Booster Phase||160
6409594|NCT00937521|7322828|FG006|COMPLETED|Booster Phase||160
6409595|NCT00937521|7322829|FG007|COMPLETED|Booster Phase||159
6409596|NCT00937521|7322822|FG000|NOT COMPLETED|Booster Phase||3
6409597|NCT00937521|7322823|FG001|NOT COMPLETED|Booster Phase||2
6409598|NCT00937521|7322824|FG002|NOT COMPLETED|Booster Phase||5
6409599|NCT00937521|7322825|FG003|NOT COMPLETED|Booster Phase||3
6409600|NCT00937521|7322826|FG004|NOT COMPLETED|Booster Phase||5
6409601|NCT00937521|7322827|FG005|NOT COMPLETED|Booster Phase||5
6409602|NCT00937521|7322828|FG006|NOT COMPLETED|Booster Phase||5
6409603|NCT00937521|7322829|FG007|NOT COMPLETED|Booster Phase||2
6409604|NCT00937547|7322865|FG000|STARTED|Overall Study||96
6409605|NCT00937547|7322866|FG001|STARTED|Overall Study||84
6409606|NCT00937547|7322867|FG002|STARTED|Overall Study||149
6409607|NCT00937547|7322865|FG000|Histological Samples|Overall Study||95
6409608|NCT00937547|7322866|FG001|Histological Samples|Overall Study||78
6409609|NCT00937547|7322867|FG002|Histological Samples|Overall Study||142
6409610|NCT00937547|7322865|FG000|COMPLETED|Overall Study||95
6409611|NCT00937547|7322866|FG001|COMPLETED|Overall Study||78
6409612|NCT00937547|7322867|FG002|COMPLETED|Overall Study||142
6409613|NCT00937547|7322865|FG000|NOT COMPLETED|Overall Study||1
6409614|NCT00937547|7322866|FG001|NOT COMPLETED|Overall Study||6
6409615|NCT00937547|7322867|FG002|NOT COMPLETED|Overall Study||7
6409616|NCT00937560|7322875|FG000|STARTED|Initial Treatment||189
6409617|NCT00937560|7322875|FG000|Received Treatment|Initial Treatment||189
6409618|NCT00937560|7322875|FG000|COMPLETED|Initial Treatment||168
6409619|NCT00937560|7322875|FG000|NOT COMPLETED|Initial Treatment||21
6409620|NCT00937560|7322875|FG000|STARTED|Maintenance Treatment||168
6409621|NCT00937560|7322875|FG000|COMPLETED|Maintenance Treatment||150
6409622|NCT00937560|7322875|FG000|NOT COMPLETED|Maintenance Treatment||18
6498881|NCT01412944|7417518|FG001|COMPLETED|IV: Per CAIN457A2307||20
6498882|NCT01412944|7417519|FG002|COMPLETED|IV: Per CAIN457A2307||0
6498883|NCT01412944|7417520|FG003|COMPLETED|IV: Per CAIN457A2307||0
6498884|NCT01412944|7417521|FG004|COMPLETED|IV: Per CAIN457A2307||0
6498885|NCT01412944|7417522|FG005|COMPLETED|IV: Per CAIN457A2307||0
6498886|NCT01412944|7417517|FG000|NOT COMPLETED|IV: Per CAIN457A2307||1
6498887|NCT01412944|7417518|FG001|NOT COMPLETED|IV: Per CAIN457A2307||2
6498888|NCT01412944|7417519|FG002|NOT COMPLETED|IV: Per CAIN457A2307||0
6498889|NCT01412944|7417520|FG003|NOT COMPLETED|IV: Per CAIN457A2307||0
6498890|NCT01412944|7417521|FG004|NOT COMPLETED|IV: Per CAIN457A2307||0
6498891|NCT01412944|7417522|FG005|NOT COMPLETED|IV: Per CAIN457A2307||0
6498892|NCT01412944|7417517|FG000|STARTED|Entire: IV + Maintenance||0
6498893|NCT01412944|7417518|FG001|STARTED|Entire: IV + Maintenance||0
6498894|NCT01412944|7417519|FG002|STARTED|Entire: IV + Maintenance||15
6498895|NCT01412944|7417520|FG003|STARTED|Entire: IV + Maintenance||6
6498896|NCT01412944|7417521|FG004|STARTED|Entire: IV + Maintenance||14
6498897|NCT01412944|7417522|FG005|STARTED|Entire: IV + Maintenance||8
6498898|NCT01412944|7417517|FG000|COMPLETED|Entire: IV + Maintenance||0
6498899|NCT01412944|7417518|FG001|COMPLETED|Entire: IV + Maintenance||0
6498900|NCT01412944|7417519|FG002|COMPLETED|Entire: IV + Maintenance||14
6498901|NCT01412944|7417520|FG003|COMPLETED|Entire: IV + Maintenance||5
6498902|NCT01412944|7417521|FG004|COMPLETED|Entire: IV + Maintenance||11
6498903|NCT01412944|7417522|FG005|COMPLETED|Entire: IV + Maintenance||6
6498904|NCT01412944|7417517|FG000|NOT COMPLETED|Entire: IV + Maintenance||0
6498905|NCT01412944|7417518|FG001|NOT COMPLETED|Entire: IV + Maintenance||0
6498906|NCT01412944|7417519|FG002|NOT COMPLETED|Entire: IV + Maintenance||1
6498907|NCT01412944|7417520|FG003|NOT COMPLETED|Entire: IV + Maintenance||1
6498908|NCT01412944|7417521|FG004|NOT COMPLETED|Entire: IV + Maintenance||3
6498909|NCT01412944|7417522|FG005|NOT COMPLETED|Entire: IV + Maintenance||2
6498910|NCT01412944|7417517|FG000|STARTED|Entire: IV + Maintenance||21
6498911|NCT01412944|7417518|FG001|STARTED|Entire: IV + Maintenance||22
6498912|NCT01412944|7417519|FG002|STARTED|Entire: IV + Maintenance||0
6498913|NCT01412944|7417520|FG003|STARTED|Entire: IV + Maintenance||0
6498914|NCT01412944|7417521|FG004|STARTED|Entire: IV + Maintenance||0
6498915|NCT01412944|7417522|FG005|STARTED|Entire: IV + Maintenance||0
6498916|NCT01412944|7417517|FG000|COMPLETED|Entire: IV + Maintenance||19
6498917|NCT01412944|7417518|FG001|COMPLETED|Entire: IV + Maintenance||17
6498918|NCT01412944|7417519|FG002|COMPLETED|Entire: IV + Maintenance||0
6498919|NCT01412944|7417520|FG003|COMPLETED|Entire: IV + Maintenance||0
6498920|NCT01412944|7417521|FG004|COMPLETED|Entire: IV + Maintenance||0
6498921|NCT01412944|7417522|FG005|COMPLETED|Entire: IV + Maintenance||0
6498922|NCT01412944|7417517|FG000|NOT COMPLETED|Entire: IV + Maintenance||2
6498923|NCT01412944|7417518|FG001|NOT COMPLETED|Entire: IV + Maintenance||5
6498924|NCT01412944|7417519|FG002|NOT COMPLETED|Entire: IV + Maintenance||0
6498925|NCT01412944|7417520|FG003|NOT COMPLETED|Entire: IV + Maintenance||0
6498926|NCT01412944|7417521|FG004|NOT COMPLETED|Entire: IV + Maintenance||0
6498927|NCT01412944|7417522|FG005|NOT COMPLETED|Entire: IV + Maintenance||0
6498928|NCT01412944|7417517|FG000|STARTED|Follow-up||0
6498929|NCT01412944|7417518|FG001|STARTED|Follow-up||0
6498930|NCT01412944|7417519|FG002|STARTED|Follow-up||2
6498931|NCT01412944|7417520|FG003|STARTED|Follow-up||1
6498932|NCT01412944|7417521|FG004|STARTED|Follow-up||2
6498933|NCT01412944|7417522|FG005|STARTED|Follow-up||0
6498934|NCT01412944|7417517|FG000|COMPLETED|Follow-up||0
6498935|NCT01412944|7417518|FG001|COMPLETED|Follow-up||0
6498936|NCT01412944|7417519|FG002|COMPLETED|Follow-up||2
6498937|NCT01412944|7417520|FG003|COMPLETED|Follow-up||1
6498938|NCT01412944|7417521|FG004|COMPLETED|Follow-up||2
6498939|NCT01412944|7417522|FG005|COMPLETED|Follow-up||0
6498940|NCT01412944|7417517|FG000|NOT COMPLETED|Follow-up||0
6498941|NCT01412944|7417518|FG001|NOT COMPLETED|Follow-up||0
6498942|NCT01412944|7417519|FG002|NOT COMPLETED|Follow-up||0
6498943|NCT01412944|7417520|FG003|NOT COMPLETED|Follow-up||0
6498944|NCT01412944|7417521|FG004|NOT COMPLETED|Follow-up||0
6498945|NCT01412944|7417522|FG005|NOT COMPLETED|Follow-up||0
6498946|NCT01412957|7417540|FG000|STARTED|Overall Study||189
6498947|NCT01412957|7417541|FG001|STARTED|Overall Study||188
6498948|NCT01412957|7417540|FG000|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
6498949|NCT01412957|7417541|FG001|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
6498950|NCT01412957|7417540|FG000|NOT COMPLETED|Overall Study||149
6498951|NCT01412957|7417541|FG001|NOT COMPLETED|Overall Study||157
6498952|NCT01412983|7417547|FG000|STARTED|1st Period||50
6498953|NCT01412983|7417548|FG001|STARTED|1st Period||50
6498954|NCT01412983|7417547|FG000|COMPLETED|1st Period||50
6498955|NCT01412983|7417548|FG001|COMPLETED|1st Period||46
6498956|NCT01412983|7417547|FG000|NOT COMPLETED|1st Period||0
6498957|NCT01412983|7417548|FG001|NOT COMPLETED|1st Period||4
6498958|NCT01412983|7417547|FG000|STARTED|2nd Period||50
6498959|NCT01412983|7417548|FG001|STARTED|2nd Period||46
6498960|NCT01412983|7417547|FG000|COMPLETED|2nd Period||50
6498961|NCT01412983|7417548|FG001|COMPLETED|2nd Period||46
6498962|NCT01412983|7417547|FG000|NOT COMPLETED|2nd Period||0
6498963|NCT01412983|7417548|FG001|NOT COMPLETED|2nd Period||0
6498964|NCT01413087|7417557|FG000|STARTED|Overall Study||6
6498965|NCT01413087|7417558|FG001|STARTED|Overall Study||6
6498966|NCT01413087|7417557|FG000|COMPLETED|Overall Study||6
6409623|NCT00937768|7322881|FG000|STARTED|Overall Study||8
6409624|NCT00937768|7322882|FG001|STARTED|Overall Study||8
6409625|NCT00937768|7322881|FG000|COMPLETED|Overall Study||0
6409626|NCT00937768|7322882|FG001|COMPLETED|Overall Study||0
6409627|NCT00937768|7322881|FG000|NOT COMPLETED|Overall Study||8
6409628|NCT00937768|7322882|FG001|NOT COMPLETED|Overall Study||8
6409629|NCT00937794|7322888|FG000|STARTED|Overall Study||33
6409630|NCT00937794|7322888|FG000|COMPLETED|Overall Study||33
6409631|NCT00937794|7322888|FG000|NOT COMPLETED|Overall Study||0
6409632|NCT00937833|7322894|FG000|STARTED|Overall Study||73
6409633|NCT00937833|7322895|FG001|STARTED|Overall Study||77
6409634|NCT00937833|7322894|FG000|COMPLETED|Overall Study||58
6409635|NCT00937833|7322895|FG001|COMPLETED|Overall Study||60
6409636|NCT00937833|7322894|FG000|NOT COMPLETED|Overall Study||15
6409637|NCT00937833|7322895|FG001|NOT COMPLETED|Overall Study||17
6409638|NCT00937859|7322903|FG000|STARTED|Overall Study||148
6409639|NCT00937859|7322904|FG001|STARTED|Overall Study||153
6409640|NCT00937859|7322903|FG000|COMPLETED|Overall Study||129
6409641|NCT00937859|7322904|FG001|COMPLETED|Overall Study||134
6409642|NCT00937859|7322903|FG000|NOT COMPLETED|Overall Study||19
6409643|NCT00937859|7322904|FG001|NOT COMPLETED|Overall Study||19
6409644|NCT00937950|7322910|FG000|STARTED|Overall Study||2003
6409645|NCT00937950|7322910|FG000|COMPLETED|Overall Study||1787
6409646|NCT00937950|7322910|FG000|NOT COMPLETED|Overall Study||216
6409647|NCT00938015|7322914|FG000|STARTED|Overall Study||303
6409648|NCT00938015|7322914|FG000|COMPLETED|Overall Study||156
6409649|NCT00938015|7322914|FG000|NOT COMPLETED|Overall Study||147
6409650|NCT00938041|7322918|FG000|STARTED|Overall Study||32
6409651|NCT00938041|7322918|FG000|COMPLETED|Overall Study||5
6409652|NCT00938041|7322918|FG000|NOT COMPLETED|Overall Study||27
6409653|NCT00938314|7322926|FG000|STARTED|Cohort 1||24
6409654|NCT00938314|7322927|FG001|STARTED|Cohort 1||0
6409655|NCT00938314|7322928|FG002|STARTED|Cohort 1||0
6409656|NCT00938314|7322929|FG003|STARTED|Cohort 1||8
6409657|NCT00938314|7322926|FG000|COMPLETED|Cohort 1||22
6409658|NCT00938314|7322927|FG001|COMPLETED|Cohort 1||0
6409659|NCT00938314|7322928|FG002|COMPLETED|Cohort 1||0
6409660|NCT00938314|7322929|FG003|COMPLETED|Cohort 1||6
6409661|NCT00938314|7322926|FG000|NOT COMPLETED|Cohort 1||2
6409662|NCT00938314|7322927|FG001|NOT COMPLETED|Cohort 1||0
6409663|NCT00938314|7322928|FG002|NOT COMPLETED|Cohort 1||0
6409664|NCT00938314|7322929|FG003|NOT COMPLETED|Cohort 1||2
6409665|NCT00938314|7322926|FG000|STARTED|Cohort 2||0
6409666|NCT00938314|7322927|FG001|STARTED|Cohort 2||24
6636539|NCT02311478|7565332|FG000|STARTED|Overall Study||79
6636540|NCT02311478|7565332|FG000|IUD Insertion|Overall Study||78
6636541|NCT02311478|7565332|FG000|COMPLETED|Overall Study||72
6636542|NCT02311478|7565332|FG000|NOT COMPLETED|Overall Study||7
6636543|NCT02311881|7565339|FG000|STARTED|Overall Study|Started refers to all randomized participants.|235
6636544|NCT02311881|7565340|FG001|STARTED|Overall Study|Started refers to all randomized participants.|236
6636545|NCT02311881|7565341|FG002|STARTED|Overall Study|Started refers to all randomized participants.|237
6636546|NCT02311881|7565339|FG000|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
6636547|NCT02311881|7565340|FG001|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
6636548|NCT02311881|7565341|FG002|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
6636549|NCT02311881|7565339|FG000|COMPLETED|Overall Study||200
6636550|NCT02311881|7565340|FG001|COMPLETED|Overall Study||193
6636551|NCT02311881|7565341|FG002|COMPLETED|Overall Study||196
6636552|NCT02311881|7565339|FG000|NOT COMPLETED|Overall Study||35
6636553|NCT02311881|7565340|FG001|NOT COMPLETED|Overall Study||43
6636554|NCT02311881|7565341|FG002|NOT COMPLETED|Overall Study||41
6636555|NCT02311894|7565352|FG000|STARTED|Overall Study||82
6636556|NCT02311894|7565352|FG000|Modified ITT Population|Overall Study||81
6636557|NCT02311894|7565352|FG000|COMPLETED|Overall Study||78
6636558|NCT02311894|7565352|FG000|NOT COMPLETED|Overall Study||4
6636559|NCT02311907|7565358|FG000|STARTED|Overall Study||94
6636560|NCT02311907|7565359|FG001|STARTED|Overall Study||91
6636561|NCT02311907|7565358|FG000|COMPLETED|Overall Study||94
6636562|NCT02311907|7565359|FG001|COMPLETED|Overall Study||91
6636563|NCT02311907|7565358|FG000|NOT COMPLETED|Overall Study||0
6636564|NCT02311907|7565359|FG001|NOT COMPLETED|Overall Study||0
6636565|NCT02311933|7565367|FG000|STARTED|Overall Study||41
6409667|NCT00938314|7322928|FG002|STARTED|Cohort 2||0
6409668|NCT00938314|7322929|FG003|STARTED|Cohort 2||8
6409669|NCT00938314|7322926|FG000|COMPLETED|Cohort 2||0
6409670|NCT00938314|7322927|FG001|COMPLETED|Cohort 2||18
6409671|NCT00938314|7322928|FG002|COMPLETED|Cohort 2||0
6409672|NCT00938314|7322929|FG003|COMPLETED|Cohort 2||6
6409673|NCT00938314|7322926|FG000|NOT COMPLETED|Cohort 2||0
6409674|NCT00938314|7322927|FG001|NOT COMPLETED|Cohort 2||6
6409675|NCT00938314|7322928|FG002|NOT COMPLETED|Cohort 2||0
6409676|NCT00938314|7322929|FG003|NOT COMPLETED|Cohort 2||2
6636566|NCT02311933|7565368|FG001|STARTED|Overall Study||40
6636567|NCT02311933|7565367|FG000|COMPLETED|Overall Study||41
6636568|NCT02311933|7565368|FG001|COMPLETED|Overall Study||40
6636569|NCT02311933|7565367|FG000|NOT COMPLETED|Overall Study||0
6409677|NCT00938314|7322926|FG000|STARTED|Cohort 3||0
6409678|NCT00938314|7322927|FG001|STARTED|Cohort 3||0
6409679|NCT00938314|7322928|FG002|STARTED|Cohort 3||24
6409680|NCT00938314|7322929|FG003|STARTED|Cohort 3||8
6409681|NCT00938314|7322926|FG000|COMPLETED|Cohort 3||0
6409682|NCT00938314|7322927|FG001|COMPLETED|Cohort 3||0
6409683|NCT00938314|7322928|FG002|COMPLETED|Cohort 3||20
6409684|NCT00938314|7322929|FG003|COMPLETED|Cohort 3||7
6409685|NCT00938314|7322926|FG000|NOT COMPLETED|Cohort 3||0
6409686|NCT00938314|7322927|FG001|NOT COMPLETED|Cohort 3||0
6409687|NCT00938314|7322928|FG002|NOT COMPLETED|Cohort 3||4
6409688|NCT00938314|7322929|FG003|NOT COMPLETED|Cohort 3||1
6409689|NCT00938327|7322939|FG000|STARTED|Overall Study||332
6409690|NCT00938327|7322939|FG000|COMPLETED|Overall Study||272
6409691|NCT00938327|7322939|FG000|NOT COMPLETED|Overall Study||60
6409692|NCT00938340|7322943|FG000|STARTED|Overall Study||20
6409693|NCT00938340|7322943|FG000|Received Whole Walnut Intervention|Overall Study||16
6409694|NCT00938340|7322943|FG000|Received Walnut Nutmeat Intervention|Overall Study||19
6409695|NCT00938340|7322943|FG000|Received Walnut Skins Intervention|Overall Study||15
6409696|NCT00938340|7322943|FG000|Received Walnut Oil Intervention|Overall Study||15
6409697|NCT00938340|7322943|FG000|COMPLETED|Overall Study||15
6409698|NCT00938340|7322943|FG000|NOT COMPLETED|Overall Study||5
6409699|NCT00938366|7322991|FG000|STARTED|Overall Study||9
6409700|NCT00938366|7322992|FG001|STARTED|Overall Study||9
6409701|NCT00938366|7322991|FG000|COMPLETED|Overall Study||8
6409702|NCT00938366|7322992|FG001|COMPLETED|Overall Study||9
6409703|NCT00938366|7322991|FG000|NOT COMPLETED|Overall Study||1
6409704|NCT00938366|7322992|FG001|NOT COMPLETED|Overall Study||0
6409705|NCT00938392|7323000|FG000|STARTED|Overall Study||362
6409706|NCT00938392|7323001|FG001|STARTED|Overall Study||362
6409707|NCT00938392|7323000|FG000|COMPLETED|Overall Study||360
6409708|NCT00938392|7323001|FG001|COMPLETED|Overall Study||358
6409709|NCT00938392|7323000|FG000|NOT COMPLETED|Overall Study||2
6409710|NCT00938392|7323001|FG001|NOT COMPLETED|Overall Study||4
6409711|NCT00938431|7323010|FG000|STARTED|Overall Study||15
6409712|NCT00938431|7323011|FG001|STARTED|Overall Study||23
6409713|NCT00938431|7323012|FG002|STARTED|Overall Study||9
6409714|NCT00938431|7323010|FG000|COMPLETED|Overall Study||9
6409715|NCT00938431|7323011|FG001|COMPLETED|Overall Study||14
6409716|NCT00938431|7323012|FG002|COMPLETED|Overall Study||1
6409717|NCT00938431|7323010|FG000|NOT COMPLETED|Overall Study||6
6409718|NCT00938431|7323011|FG001|NOT COMPLETED|Overall Study||9
6409719|NCT00938431|7323012|FG002|NOT COMPLETED|Overall Study||8
6409720|NCT00938457|7323024|FG000|STARTED|Overall Study||3
6409721|NCT00938457|7323024|FG000|COMPLETED|Overall Study||3
6409722|NCT00938457|7323024|FG000|NOT COMPLETED|Overall Study||0
6409723|NCT00938470|7323030|FG000|STARTED|Overall Study||34
6409724|NCT00938470|7323031|FG001|STARTED|Overall Study||28
6409725|NCT00938470|7323030|FG000|COMPLETED|Overall Study||27
6409726|NCT00938470|7323031|FG001|COMPLETED|Overall Study||25
6409727|NCT00938470|7323030|FG000|NOT COMPLETED|Overall Study||7
6409728|NCT00938470|7323031|FG001|NOT COMPLETED|Overall Study||3
6409729|NCT00938548|7323039|FG000|STARTED|Overall Study||35
6409730|NCT00938548|7323040|FG001|STARTED|Overall Study||35
6409731|NCT00938548|7323039|FG000|COMPLETED|Overall Study||35
6409732|NCT00938548|7323040|FG001|COMPLETED|Overall Study||35
6409733|NCT00938548|7323039|FG000|NOT COMPLETED|Overall Study||0
6409734|NCT00938548|7323040|FG001|NOT COMPLETED|Overall Study||0
6409735|NCT00938639|7323048|FG000|STARTED|Overall Study||120
6409736|NCT00938639|7323049|FG001|STARTED|Overall Study||120
6409737|NCT00938639|7323048|FG000|COMPLETED|Overall Study||117
6409738|NCT00938639|7323049|FG001|COMPLETED|Overall Study||116
6409739|NCT00938639|7323048|FG000|NOT COMPLETED|Overall Study||3
6409740|NCT00938639|7323049|FG001|NOT COMPLETED|Overall Study||4
6409741|NCT00938704|7323061|FG000|STARTED|Overall Study||33
6409742|NCT00938704|7323062|FG001|STARTED|Overall Study||37
6409743|NCT00938704|7323061|FG000|COMPLETED|Overall Study||33
6409744|NCT00938704|7323062|FG001|COMPLETED|Overall Study||37
6409745|NCT00938704|7323061|FG000|NOT COMPLETED|Overall Study||0
6409746|NCT00938704|7323062|FG001|NOT COMPLETED|Overall Study||0
6409747|NCT00938717|7323070|FG000|STARTED|Overall Study||403
6409748|NCT00938717|7323071|FG001|STARTED|Overall Study||402
6409749|NCT00938717|7323070|FG000|COMPLETED|Overall Study||305
6409750|NCT00938717|7323071|FG001|COMPLETED|Overall Study||294
6409751|NCT00938717|7323070|FG000|NOT COMPLETED|Overall Study||98
6409752|NCT00938717|7323071|FG001|NOT COMPLETED|Overall Study||108
6409753|NCT00938782|7323079|FG000|STARTED|Overall Study|Pre-induction of anesthesia|32
6409754|NCT00938782|7323080|FG001|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
6409755|NCT00938782|7323079|FG000|COMPLETED|Overall Study|Upon discharge from PACU|32
6409756|NCT00938782|7323080|FG001|COMPLETED|Overall Study|Upon discharge from PACU|35
6409757|NCT00938782|7323079|FG000|NOT COMPLETED|Overall Study||0
6409758|NCT00938782|7323080|FG001|NOT COMPLETED|Overall Study||0
6409759|NCT00938860|7323088|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
6409760|NCT00938860|7323089|FG001|STARTED|Overall Study||42
6409761|NCT00938860|7323088|FG000|Efficacy Population|Overall Study||40
6409762|NCT00938860|7323089|FG001|Efficacy Population|Overall Study||41
6409763|NCT00938860|7323088|FG000|COMPLETED|Overall Study||25
6409764|NCT00938860|7323089|FG001|COMPLETED|Overall Study||25
6409765|NCT00938860|7323088|FG000|NOT COMPLETED|Overall Study||25
6409766|NCT00938860|7323089|FG001|NOT COMPLETED|Overall Study||17
6409767|NCT00938886|7323097|FG000|STARTED|Overall Study||75
6409768|NCT00938886|7323098|FG001|STARTED|Overall Study||75
6409769|NCT00938886|7323097|FG000|Attended 1 Counseling Session|Overall Study||70
6409770|NCT00938886|7323098|FG001|Attended 1 Counseling Session|Overall Study||70
6409771|NCT00938886|7323097|FG000|COMPLETED|Overall Study||68
6409772|NCT00938886|7323098|FG001|COMPLETED|Overall Study||65
6409773|NCT00938886|7323097|FG000|NOT COMPLETED|Overall Study||7
6409774|NCT00938886|7323098|FG001|NOT COMPLETED|Overall Study||10
6409775|NCT00938964|7323106|FG000|STARTED|Overall Study||241
6409776|NCT00938964|7323107|FG001|STARTED|Overall Study||237
6409777|NCT00938964|7323106|FG000|COMPLETED|Overall Study||211
6409778|NCT00938964|7323107|FG001|COMPLETED|Overall Study||209
6409779|NCT00938964|7323106|FG000|NOT COMPLETED|Overall Study||30
6409780|NCT00938964|7323107|FG001|NOT COMPLETED|Overall Study||28
6409781|NCT00939003|7323115|FG000|STARTED|Double-blind Treatment Period||97
6409782|NCT00939003|7323116|FG001|STARTED|Double-blind Treatment Period||95
6409783|NCT00939003|7323115|FG000|COMPLETED|Double-blind Treatment Period||95
6409784|NCT00939003|7323116|FG001|COMPLETED|Double-blind Treatment Period||91
6409785|NCT00939003|7323115|FG000|NOT COMPLETED|Double-blind Treatment Period||2
6409786|NCT00939003|7323116|FG001|NOT COMPLETED|Double-blind Treatment Period||4
6409787|NCT00939003|7323115|FG000|STARTED|Open-label Treatment Period||95
6409788|NCT00939003|7323116|FG001|STARTED|Open-label Treatment Period||91
6409789|NCT00939003|7323115|FG000|COMPLETED|Open-label Treatment Period||66
6409790|NCT00939003|7323116|FG001|COMPLETED|Open-label Treatment Period||62
6409791|NCT00939003|7323115|FG000|NOT COMPLETED|Open-label Treatment Period||29
6409792|NCT00939003|7323116|FG001|NOT COMPLETED|Open-label Treatment Period||29
6409793|NCT00939029|7323127|FG000|STARTED|Overall Study||25
6409794|NCT00939029|7323128|FG001|STARTED|Overall Study||27
6409795|NCT00939029|7323127|FG000|COMPLETED|Overall Study||19
6409796|NCT00939029|7323128|FG001|COMPLETED|Overall Study||15
6409797|NCT00939029|7323127|FG000|NOT COMPLETED|Overall Study||6
6409798|NCT00939029|7323128|FG001|NOT COMPLETED|Overall Study||12
6409799|NCT00939055|7323136|FG000|STARTED|Overall Study||73
6409800|NCT00939055|7323137|FG001|STARTED|Overall Study||39
6409801|NCT00939055|7323136|FG000|COMPLETED|Overall Study||69
6409802|NCT00939055|7323137|FG001|COMPLETED|Overall Study||39
6409803|NCT00939055|7323136|FG000|NOT COMPLETED|Overall Study||4
6409804|NCT00939055|7323137|FG001|NOT COMPLETED|Overall Study||0
6409805|NCT00939094|7323146|FG000|STARTED|Overall Study||42
6409806|NCT00939094|7323147|FG001|STARTED|Overall Study||45
6409807|NCT00939094|7323146|FG000|COMPLETED|Overall Study||28
6409808|NCT00939094|7323147|FG001|COMPLETED|Overall Study||35
6409809|NCT00939094|7323146|FG000|NOT COMPLETED|Overall Study||14
6409810|NCT00939094|7323147|FG001|NOT COMPLETED|Overall Study||10
6409811|NCT00939107|7323155|FG000|STARTED|Overall Study||175
6409812|NCT00939107|7323156|FG001|STARTED|Overall Study||175
6409813|NCT00939107|7323155|FG000|12 Months Follow-up|Overall Study||161
6409814|NCT00939107|7323156|FG001|12 Months Follow-up|Overall Study||163
6409815|NCT00939107|7323155|FG000|COMPLETED|Overall Study||161
6409816|NCT00939107|7323156|FG001|COMPLETED|Overall Study||163
6409817|NCT00939107|7323155|FG000|NOT COMPLETED|Overall Study||14
6409818|NCT00939107|7323156|FG001|NOT COMPLETED|Overall Study||12
6409819|NCT00939120|7323164|FG000|STARTED|Overall Study||23
6409820|NCT00939120|7323165|FG001|STARTED|Overall Study||23
6409821|NCT00939120|7323164|FG000|COMPLETED|Overall Study||15
6409822|NCT00939120|7323165|FG001|COMPLETED|Overall Study||18
6409823|NCT00939120|7323164|FG000|NOT COMPLETED|Overall Study||8
6409824|NCT00939120|7323165|FG001|NOT COMPLETED|Overall Study||5
6409825|NCT00939159|7323171|FG000|STARTED|Overall Study||13
6409826|NCT00939159|7323171|FG000|COMPLETED|Overall Study||13
6409827|NCT00939159|7323171|FG000|NOT COMPLETED|Overall Study||0
6409828|NCT00939185|7323175|FG000|STARTED|Overall Study||400
6409829|NCT00939185|7323175|FG000|Received Treatment|Overall Study||390
6409830|NCT00939185|7323175|FG000|COMPLETED|Overall Study||375
6409831|NCT00939185|7323175|FG000|NOT COMPLETED|Overall Study||25
6409832|NCT00939198|7323179|FG000|STARTED|Overall Study||87
6409833|NCT00939198|7323179|FG000|COMPLETED|Overall Study||87
6409834|NCT00939198|7323179|FG000|NOT COMPLETED|Overall Study||0
6409835|NCT00939211|7323184|FG000|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
6409836|NCT00939211|7323184|FG000|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
6409837|NCT00939211|7323184|FG000|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
6409838|NCT00939211|7323184|FG000|STARTED|AZD9164 400 Mcg First, Then Placebo||28
6409839|NCT00939211|7323184|FG000|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
6409840|NCT00939211|7323184|FG000|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
6409841|NCT00939211|7323184|FG000|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
6409842|NCT00939211|7323184|FG000|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
6409843|NCT00939211|7323184|FG000|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
6409844|NCT00939211|7323184|FG000|STARTED|Spiriva 18 Mcg First, Then Placebo||28
6409845|NCT00939211|7323184|FG000|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
6409846|NCT00939211|7323184|FG000|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
6409847|NCT00939211|7323184|FG000|STARTED|Placebo||28
6409848|NCT00939211|7323184|FG000|COMPLETED|Placebo||28
6409849|NCT00939211|7323184|FG000|NOT COMPLETED|Placebo||0
6409850|NCT00939341|7323196|FG000|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
6409851|NCT00939341|7323196|FG000|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
6409852|NCT00939341|7323196|FG000|NOT COMPLETED|Overall Study||66
6409853|NCT00939367|7323200|FG000|STARTED|First Intervention||15
6409854|NCT00939367|7323201|FG001|STARTED|First Intervention||15
6409855|NCT00939367|7323200|FG000|COMPLETED|First Intervention||15
6409856|NCT00939367|7323201|FG001|COMPLETED|First Intervention||15
6409857|NCT00939367|7323200|FG000|NOT COMPLETED|First Intervention||0
6409858|NCT00939367|7323201|FG001|NOT COMPLETED|First Intervention||0
6409859|NCT00939367|7323200|FG000|STARTED|Second Intervention||15
6409860|NCT00939367|7323201|FG001|STARTED|Second Intervention||15
6409861|NCT00939367|7323200|FG000|COMPLETED|Second Intervention||15
6409862|NCT00939367|7323201|FG001|COMPLETED|Second Intervention||15
6409863|NCT00939367|7323200|FG000|NOT COMPLETED|Second Intervention||0
6409864|NCT00939367|7323201|FG001|NOT COMPLETED|Second Intervention||0
6409865|NCT00939393|7323209|FG000|STARTED|Overall Study||37
6409866|NCT00939393|7323210|FG001|STARTED|Overall Study||35
6409867|NCT00939393|7323209|FG000|COMPLETED|Overall Study||33
6409868|NCT00939393|7323210|FG001|COMPLETED|Overall Study||35
6409869|NCT00939393|7323209|FG000|NOT COMPLETED|Overall Study||4
6409870|NCT00939393|7323210|FG001|NOT COMPLETED|Overall Study||0
6409871|NCT00939471|7323218|FG000|STARTED|Overall Study||44
6409872|NCT00939471|7323218|FG000|COMPLETED|Overall Study||33
6409873|NCT00939471|7323218|FG000|NOT COMPLETED|Overall Study||11
6409874|NCT00939484|7323225|FG000|STARTED|Overall Study||8
6409875|NCT00939484|7323226|FG001|STARTED|Overall Study||20
6409876|NCT00939484|7323227|FG002|STARTED|Overall Study||3
6409877|NCT00939484|7323225|FG000|COMPLETED|Overall Study||0
6409878|NCT00939484|7323226|FG001|COMPLETED|Overall Study||0
6409879|NCT00939484|7323227|FG002|COMPLETED|Overall Study||0
6409880|NCT00939484|7323225|FG000|NOT COMPLETED|Overall Study||8
6409881|NCT00939484|7323226|FG001|NOT COMPLETED|Overall Study||20
6409882|NCT00939484|7323227|FG002|NOT COMPLETED|Overall Study||3
6409883|NCT00939510|7323237|FG000|STARTED|Overall Study||32
6409884|NCT00939510|7323237|FG000|COMPLETED|Overall Study||31
6409885|NCT00939510|7323237|FG000|NOT COMPLETED|Overall Study||1
6409886|NCT00939523|7323241|FG000|STARTED|Overall Study||9
6409887|NCT00939523|7323241|FG000|COMPLETED|Overall Study||6
6409888|NCT00939523|7323241|FG000|NOT COMPLETED|Overall Study||3
6409889|NCT00939536|7323247|FG000|STARTED|First Intervention||12
6409890|NCT00939536|7323248|FG001|STARTED|First Intervention||12
6409891|NCT00939536|7323247|FG000|COMPLETED|First Intervention||12
6409892|NCT00939536|7323248|FG001|COMPLETED|First Intervention||12
6409893|NCT00939536|7323247|FG000|NOT COMPLETED|First Intervention||0
6409894|NCT00939536|7323248|FG001|NOT COMPLETED|First Intervention||0
6409895|NCT00939536|7323247|FG000|STARTED|Second Intervention||12
6409896|NCT00939536|7323248|FG001|STARTED|Second Intervention||12
6409897|NCT00939536|7323247|FG000|COMPLETED|Second Intervention||12
6409898|NCT00939536|7323248|FG001|COMPLETED|Second Intervention||12
6409899|NCT00939536|7323247|FG000|NOT COMPLETED|Second Intervention||0
6409900|NCT00939536|7323248|FG001|NOT COMPLETED|Second Intervention||0
6409901|NCT00939562|7323254|FG000|STARTED|Period 1||12
6409902|NCT00939562|7323255|FG001|STARTED|Period 1||12
6409903|NCT00939562|7323254|FG000|COMPLETED|Period 1||12
6409904|NCT00939562|7323255|FG001|COMPLETED|Period 1||12
6409905|NCT00939562|7323254|FG000|NOT COMPLETED|Period 1||0
6409906|NCT00939562|7323255|FG001|NOT COMPLETED|Period 1||0
6409907|NCT00939562|7323254|FG000|STARTED|Period 2||12
6409908|NCT00939562|7323255|FG001|STARTED|Period 2||12
6409909|NCT00939562|7323254|FG000|COMPLETED|Period 2||12
6409910|NCT00939562|7323255|FG001|COMPLETED|Period 2||12
6409911|NCT00939562|7323254|FG000|NOT COMPLETED|Period 2||0
6409912|NCT00939562|7323255|FG001|NOT COMPLETED|Period 2||0
6409913|NCT00939627|7323263|FG000|STARTED|Overall Study||27
6409914|NCT00939627|7323264|FG001|STARTED|Overall Study||28
6409915|NCT00939627|7323265|FG002|STARTED|Overall Study||0
6409916|NCT00939627|7323263|FG000|COMPLETED|Overall Study||0
6409917|NCT00939627|7323264|FG001|COMPLETED|Overall Study||0
6409918|NCT00939627|7323265|FG002|COMPLETED|Overall Study||0
6409919|NCT00939627|7323263|FG000|NOT COMPLETED|Overall Study||27
6409920|NCT00939627|7323264|FG001|NOT COMPLETED|Overall Study||28
6409921|NCT00939627|7323265|FG002|NOT COMPLETED|Overall Study||0
6409922|NCT00939640|7323271|FG000|STARTED|Overall Study||14
6409923|NCT00939640|7323271|FG000|COMPLETED|Overall Study||13
6409924|NCT00939640|7323271|FG000|NOT COMPLETED|Overall Study||1
6409925|NCT00939653|7323280|FG000|STARTED|Treatment Course 1||6
6409926|NCT00939653|7323280|FG000|COMPLETED|Treatment Course 1||6
6409927|NCT00939653|7323280|FG000|NOT COMPLETED|Treatment Course 1||0
6409928|NCT00939653|7323280|FG000|STARTED|Treatment Course 2||2
6409929|NCT00939653|7323280|FG000|COMPLETED|Treatment Course 2||2
6409930|NCT00939653|7323280|FG000|NOT COMPLETED|Treatment Course 2||0
6409931|NCT00939653|7323280|FG000|STARTED|Treatment Course 3||0
6409932|NCT00939653|7323280|FG000|COMPLETED|Treatment Course 3||0
6409933|NCT00939653|7323280|FG000|NOT COMPLETED|Treatment Course 3||0
6409934|NCT00939653|7323280|FG000|STARTED|Treatment Course 4||0
6409935|NCT00939653|7323280|FG000|COMPLETED|Treatment Course 4||0
6409936|NCT00939653|7323280|FG000|NOT COMPLETED|Treatment Course 4||0
6409937|NCT00939692|7323287|FG000|STARTED|Period 1 - First Intervention - 5 Days||13
6409938|NCT00939692|7323288|FG001|STARTED|Period 1 - First Intervention - 5 Days||13
6409939|NCT00939692|7323287|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||12
6409940|NCT00939692|7323288|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||13
6409941|NCT00939692|7323287|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
6409942|NCT00939692|7323288|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
6409943|NCT00939692|7323287|FG000|STARTED|Period 2 - Second Intervent - 5 Days||12
6409944|NCT00939692|7323288|FG001|STARTED|Period 2 - Second Intervent - 5 Days||13
6409945|NCT00939692|7323287|FG000|COMPLETED|Period 2 - Second Intervent - 5 Days||12
6409946|NCT00939692|7323288|FG001|COMPLETED|Period 2 - Second Intervent - 5 Days||12
6498967|NCT01413087|7417558|FG001|COMPLETED|Overall Study||6
6409947|NCT00939692|7323287|FG000|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
6409948|NCT00939692|7323288|FG001|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
6409949|NCT00939705|7323296|FG000|STARTED|Period 1 - First Intervention - 5 Days||9
6409950|NCT00939705|7323297|FG001|STARTED|Period 1 - First Intervention - 5 Days||9
6409951|NCT00939705|7323296|FG000|COMPLETED|Period 1 - First Intervention - 5 Days||9
6409952|NCT00939705|7323297|FG001|COMPLETED|Period 1 - First Intervention - 5 Days||9
6409953|NCT00939705|7323296|FG000|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
6409954|NCT00939705|7323297|FG001|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
6409955|NCT00939705|7323296|FG000|STARTED|Period 2 - Washout Period - 21 Days||9
6409956|NCT00939705|7323297|FG001|STARTED|Period 2 - Washout Period - 21 Days||9
6409957|NCT00939705|7323296|FG000|COMPLETED|Period 2 - Washout Period - 21 Days||9
6409958|NCT00939705|7323297|FG001|COMPLETED|Period 2 - Washout Period - 21 Days||9
6409959|NCT00939705|7323296|FG000|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
6409960|NCT00939705|7323297|FG001|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
6510425|NCT01482715|7430017|FG009|STARTED|Overall Study||3
6510426|NCT01482715|7430018|FG010|STARTED|Overall Study||42
6510427|NCT01482715|7430019|FG011|STARTED|Overall Study||12
6510428|NCT01482715|7430020|FG012|STARTED|Overall Study||26
6510429|NCT01482715|7430008|FG000|COMPLETED|Overall Study||6
6510430|NCT01482715|7430009|FG001|COMPLETED|Overall Study||3
6510431|NCT01482715|7430010|FG002|COMPLETED|Overall Study||4
6510432|NCT01482715|7430011|FG003|COMPLETED|Overall Study||9
6510433|NCT01482715|7430012|FG004|COMPLETED|Overall Study||4
6510434|NCT01482715|7430013|FG005|COMPLETED|Overall Study||3
6510435|NCT01482715|7430014|FG006|COMPLETED|Overall Study||8
6510436|NCT01482715|7430015|FG007|COMPLETED|Overall Study||9
6510437|NCT01482715|7430016|FG008|COMPLETED|Overall Study||7
6510438|NCT01482715|7430017|FG009|COMPLETED|Overall Study||3
6510439|NCT01482715|7430018|FG010|COMPLETED|Overall Study||42
6510440|NCT01482715|7430019|FG011|COMPLETED|Overall Study||12
6510441|NCT01482715|7430020|FG012|COMPLETED|Overall Study||26
6510442|NCT01482715|7430008|FG000|NOT COMPLETED|Overall Study||0
6510443|NCT01482715|7430009|FG001|NOT COMPLETED|Overall Study||0
6510444|NCT01482715|7430010|FG002|NOT COMPLETED|Overall Study||0
6510445|NCT01482715|7430011|FG003|NOT COMPLETED|Overall Study||0
6510446|NCT01482715|7430012|FG004|NOT COMPLETED|Overall Study||0
6510447|NCT01482715|7430013|FG005|NOT COMPLETED|Overall Study||0
6510448|NCT01482715|7430014|FG006|NOT COMPLETED|Overall Study||0
6510449|NCT01482715|7430015|FG007|NOT COMPLETED|Overall Study||0
6510450|NCT01482715|7430016|FG008|NOT COMPLETED|Overall Study||0
6510451|NCT01482715|7430017|FG009|NOT COMPLETED|Overall Study||0
6510452|NCT01482715|7430018|FG010|NOT COMPLETED|Overall Study||0
6510453|NCT01482715|7430019|FG011|NOT COMPLETED|Overall Study||0
6510454|NCT01482715|7430020|FG012|NOT COMPLETED|Overall Study||0
6510455|NCT01482767|7430063|FG000|STARTED|Overall Study||135
6510456|NCT01482767|7430064|FG001|STARTED|Overall Study||127
6510457|NCT01482767|7430063|FG000|COMPLETED|Overall Study||81
6510458|NCT01482767|7430064|FG001|COMPLETED|Overall Study||78
6510459|NCT01482767|7430063|FG000|NOT COMPLETED|Overall Study||54
6510460|NCT01482767|7430064|FG001|NOT COMPLETED|Overall Study||49
6510461|NCT01482819|7430070|FG000|STARTED|Overall Study||21
6510462|NCT01482819|7430070|FG000|COMPLETED|Overall Study||19
6510463|NCT01482819|7430070|FG000|NOT COMPLETED|Overall Study||2
6510464|NCT01482884|7430080|FG000|STARTED|Overall Study|One participant did not receive study treatment|56
6510465|NCT01482884|7430081|FG001|STARTED|Overall Study||55
6510466|NCT01482884|7430080|FG000|COMPLETED|Overall Study||43
6510467|NCT01482884|7430081|FG001|COMPLETED|Overall Study||37
6510468|NCT01482884|7430080|FG000|NOT COMPLETED|Overall Study||13
6510469|NCT01482884|7430081|FG001|NOT COMPLETED|Overall Study||18
6510470|NCT01482910|7430089|FG000|STARTED|Overall Study||228
6510471|NCT01482910|7430090|FG001|STARTED|Overall Study||76
6510472|NCT01482910|7430089|FG000|Completed Week 28|Overall Study||216
6510473|NCT01482910|7430090|FG001|Completed Week 28|Overall Study||71
6636570|NCT02311933|7565368|FG001|NOT COMPLETED|Overall Study||0
6636571|NCT02311972|7565376|FG000|STARTED|Overall Study||12
6636572|NCT02311972|7565377|FG001|STARTED|Overall Study||8
6636573|NCT02311972|7565376|FG000|COMPLETED|Overall Study||12
6636574|NCT02311972|7565377|FG001|COMPLETED|Overall Study||8
6510474|NCT01482910|7430089|FG000|COMPLETED|Overall Study||213
6510475|NCT01482910|7430090|FG001|COMPLETED|Overall Study||67
6510476|NCT01482910|7430089|FG000|NOT COMPLETED|Overall Study||15
6510477|NCT01482910|7430090|FG001|NOT COMPLETED|Overall Study||9
6510478|NCT01482962|7430100|FG000|STARTED|Overall Study||138
6510479|NCT01482962|7430101|FG001|STARTED|Overall Study||133
6510480|NCT01482962|7430100|FG000|Safety Population: Received Study Drug|Overall Study||137
6510481|NCT01482962|7430101|FG001|Safety Population: Received Study Drug|Overall Study||127
6510482|NCT01482962|7430100|FG000|COMPLETED|Overall Study||0
6510483|NCT01482962|7430101|FG001|COMPLETED|Overall Study||0
6636575|NCT02311972|7565376|FG000|NOT COMPLETED|Overall Study||0
6636576|NCT02311972|7565377|FG001|NOT COMPLETED|Overall Study||0
6510484|NCT01482962|7430100|FG000|NOT COMPLETED|Overall Study||138
6510485|NCT01482962|7430101|FG001|NOT COMPLETED|Overall Study||133
6510486|NCT01483118|7430111|FG000|STARTED|Overall Study||23
6510487|NCT01483118|7430112|FG001|STARTED|Overall Study||22
6510488|NCT01483118|7430111|FG000|Completed 3 Months|Overall Study||15
6510489|NCT01483118|7430112|FG001|Completed 3 Months|Overall Study||11
6510490|NCT01483118|7430111|FG000|COMPLETED|Overall Study||11
6510491|NCT01483118|7430112|FG001|COMPLETED|Overall Study||6
6636577|NCT02312063|7565386|FG000|STARTED|Overall Study||23
6636578|NCT02312063|7565387|FG001|STARTED|Overall Study||25
6636579|NCT02312063|7565386|FG000|COMPLETED|Overall Study||23
6636580|NCT02312063|7565387|FG001|COMPLETED|Overall Study||24
6636581|NCT02312063|7565386|FG000|NOT COMPLETED|Overall Study||0
6636582|NCT02312063|7565387|FG001|NOT COMPLETED|Overall Study||1
6636583|NCT02312154|7565394|FG000|STARTED|Overall Study||25
6636584|NCT02312154|7565394|FG000|COMPLETED|Overall Study||24
6636585|NCT02312154|7565394|FG000|NOT COMPLETED|Overall Study||1
6636586|NCT02312206|7565401|FG000|STARTED|Overall Study||130
6409961|NCT00939705|7323296|FG000|STARTED|Period 3 - Second Intervent - 5 Days||9
6409962|NCT00939705|7323297|FG001|STARTED|Period 3 - Second Intervent - 5 Days||9
6409963|NCT00939705|7323296|FG000|COMPLETED|Period 3 - Second Intervent - 5 Days||9
6409964|NCT00939705|7323297|FG001|COMPLETED|Period 3 - Second Intervent - 5 Days||9
6409965|NCT00939705|7323296|FG000|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
6409966|NCT00939705|7323297|FG001|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
6409967|NCT00939731|7323303|FG000|STARTED|First Intervention Period||12
6409968|NCT00939731|7323304|FG001|STARTED|First Intervention Period||12
6409969|NCT00939731|7323303|FG000|COMPLETED|First Intervention Period||12
6409970|NCT00939731|7323304|FG001|COMPLETED|First Intervention Period||12
6409971|NCT00939731|7323303|FG000|NOT COMPLETED|First Intervention Period||0
6409972|NCT00939731|7323304|FG001|NOT COMPLETED|First Intervention Period||0
6409973|NCT00939731|7323303|FG000|STARTED|Washout Period (at Least 14 Days)||12
6409974|NCT00939731|7323304|FG001|STARTED|Washout Period (at Least 14 Days)||12
6409975|NCT00939731|7323303|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
6409976|NCT00939731|7323304|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
6409977|NCT00939731|7323303|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6409978|NCT00939731|7323304|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6409979|NCT00939731|7323303|FG000|STARTED|Second Intervention Period||12
6409980|NCT00939731|7323304|FG001|STARTED|Second Intervention Period||12
6636587|NCT02312206|7565402|FG001|STARTED|Overall Study||130
6636588|NCT02312206|7565401|FG000|Informed Consent Obtained|Overall Study||130
6636589|NCT02312206|7565402|FG001|Informed Consent Obtained|Overall Study||130
6636590|NCT02312206|7565401|FG000|COMPLETED|Overall Study||0
6636591|NCT02312206|7565402|FG001|COMPLETED|Overall Study||0
6636592|NCT02312206|7565401|FG000|NOT COMPLETED|Overall Study||130
6636593|NCT02312206|7565402|FG001|NOT COMPLETED|Overall Study||130
6636594|NCT02312219|7565410|FG000|STARTED|Overall Study||13
6636595|NCT02312219|7565411|FG001|STARTED|Overall Study||22
6636596|NCT02312219|7565410|FG000|COMPLETED|Overall Study||12
6636597|NCT02312219|7565411|FG001|COMPLETED|Overall Study||16
6636598|NCT02312219|7565410|FG000|NOT COMPLETED|Overall Study||1
6636599|NCT02312219|7565411|FG001|NOT COMPLETED|Overall Study||6
6636600|NCT02312310|7565421|FG000|STARTED|Overall Study||53
6636601|NCT02312310|7565422|FG001|STARTED|Overall Study||53
6636602|NCT02312310|7565423|FG002|STARTED|Overall Study||53
6636603|NCT02312310|7565424|FG003|STARTED|Overall Study||52
6636604|NCT02312310|7565421|FG000|COMPLETED|Overall Study||51
6636605|NCT02312310|7565422|FG001|COMPLETED|Overall Study||51
6636606|NCT02312310|7565423|FG002|COMPLETED|Overall Study||50
6636607|NCT02312310|7565424|FG003|COMPLETED|Overall Study||52
6636608|NCT02312310|7565421|FG000|NOT COMPLETED|Overall Study||2
6636609|NCT02312310|7565422|FG001|NOT COMPLETED|Overall Study||2
6636610|NCT02312310|7565423|FG002|NOT COMPLETED|Overall Study||3
6636611|NCT02312310|7565424|FG003|NOT COMPLETED|Overall Study||0
6636612|NCT02312622|7565441|FG000|STARTED|Overall Study||12
6636613|NCT02312622|7565442|FG001|STARTED|Overall Study||3
6636614|NCT02312622|7565443|FG002|STARTED|Overall Study||12
6636615|NCT02312622|7565441|FG000|COMPLETED|Overall Study||12
6636616|NCT02312622|7565442|FG001|COMPLETED|Overall Study||3
6636617|NCT02312622|7565443|FG002|COMPLETED|Overall Study||12
6636618|NCT02312622|7565441|FG000|NOT COMPLETED|Overall Study||0
6636619|NCT02312622|7565442|FG001|NOT COMPLETED|Overall Study||0
6636620|NCT02312622|7565443|FG002|NOT COMPLETED|Overall Study||0
6636621|NCT02312687|7565454|FG000|STARTED|Overall Study||20
6636622|NCT02312687|7565454|FG000|COMPLETED|Overall Study||19
6636623|NCT02312687|7565454|FG000|NOT COMPLETED|Overall Study||1
6636624|NCT02312713|7565461|FG000|STARTED|Overall Study||140
6636625|NCT02312713|7565462|FG001|STARTED|Overall Study||142
6636626|NCT02312713|7565463|FG002|STARTED|Overall Study||68
6636627|NCT02312713|7565461|FG000|COMPLETED|Overall Study||129
6636628|NCT02312713|7565462|FG001|COMPLETED|Overall Study||112
6636629|NCT02312713|7565463|FG002|COMPLETED|Overall Study||63
6636630|NCT02312713|7565461|FG000|NOT COMPLETED|Overall Study||11
6409981|NCT00939731|7323303|FG000|COMPLETED|Second Intervention Period||12
6409982|NCT00939731|7323304|FG001|COMPLETED|Second Intervention Period||12
6409983|NCT00939731|7323303|FG000|NOT COMPLETED|Second Intervention Period||0
6409984|NCT00939731|7323304|FG001|NOT COMPLETED|Second Intervention Period||0
6409985|NCT00939770|7323318|FG000|STARTED|Overall Study||6
6636631|NCT02312713|7565462|FG001|NOT COMPLETED|Overall Study||30
6636632|NCT02312713|7565463|FG002|NOT COMPLETED|Overall Study||5
6636633|NCT02312726|7565471|FG000|STARTED|Overall Study||38
6636634|NCT02312726|7565472|FG001|STARTED|Overall Study||30
6636635|NCT02312726|7565473|FG002|STARTED|Overall Study||67
6636636|NCT02312726|7565471|FG000|COMPLETED|Overall Study||38
6636637|NCT02312726|7565472|FG001|COMPLETED|Overall Study||30
6636638|NCT02312726|7565473|FG002|COMPLETED|Overall Study||0
6636639|NCT02312726|7565471|FG000|NOT COMPLETED|Overall Study||0
6636640|NCT02312726|7565472|FG001|NOT COMPLETED|Overall Study||0
6409986|NCT00939770|7323319|FG001|STARTED|Overall Study||8
6409987|NCT00939770|7323320|FG002|STARTED|Overall Study||23
6409988|NCT00939770|7323321|FG003|STARTED|Overall Study||12
6409989|NCT00939770|7323322|FG004|STARTED|Overall Study||38
6409990|NCT00939770|7323323|FG005|STARTED|Overall Study||11
6409991|NCT00939770|7323324|FG006|STARTED|Overall Study||14
6409992|NCT00939770|7323325|FG007|STARTED|Overall Study||10
6409993|NCT00939770|7323318|FG000|COMPLETED|Overall Study||1
6409994|NCT00939770|7323319|FG001|COMPLETED|Overall Study||0
6409995|NCT00939770|7323320|FG002|COMPLETED|Overall Study||3
6409996|NCT00939770|7323321|FG003|COMPLETED|Overall Study||1
6409997|NCT00939770|7323322|FG004|COMPLETED|Overall Study||1
6409998|NCT00939770|7323323|FG005|COMPLETED|Overall Study||0
6409999|NCT00939770|7323324|FG006|COMPLETED|Overall Study||0
6410000|NCT00939770|7323325|FG007|COMPLETED|Overall Study||0
6410001|NCT00939770|7323318|FG000|NOT COMPLETED|Overall Study||5
6636641|NCT02312726|7565473|FG002|NOT COMPLETED|Overall Study||67
6636642|NCT02312739|7565482|FG000|STARTED|Overall Study||36
6636643|NCT02312739|7565483|FG001|STARTED|Overall Study||36
6636644|NCT02312739|7565482|FG000|Withdrawn Prior to Procedure|Overall Study||6
6636645|NCT02312739|7565483|FG001|Withdrawn Prior to Procedure|Overall Study||2
6636646|NCT02312739|7565482|FG000|COMPLETED|Overall Study||30
6636647|NCT02312739|7565483|FG001|COMPLETED|Overall Study||34
6636648|NCT02312739|7565482|FG000|NOT COMPLETED|Overall Study||6
6636649|NCT02312739|7565483|FG001|NOT COMPLETED|Overall Study||2
6636650|NCT02312765|7565491|FG000|STARTED|Overall Study||74
6636651|NCT02312765|7565492|FG001|STARTED|Overall Study||72
6636652|NCT02312765|7565491|FG000|COMPLETED|Overall Study||19
6636653|NCT02312765|7565492|FG001|COMPLETED|Overall Study||36
6636654|NCT02312765|7565491|FG000|NOT COMPLETED|Overall Study||55
6636655|NCT02312765|7565492|FG001|NOT COMPLETED|Overall Study||36
6636656|NCT02312856|7565498|FG000|STARTED|Overall Study||34
6636657|NCT02312856|7565498|FG000|COMPLETED|Overall Study||30
6636658|NCT02312856|7565498|FG000|NOT COMPLETED|Overall Study||4
6636659|NCT02312882|7565502|FG000|STARTED|Overall Study||40
6636660|NCT02312882|7565502|FG000|COMPLETED|Overall Study||36
6636661|NCT02312882|7565502|FG000|NOT COMPLETED|Overall Study||4
6636662|NCT02312934|7565508|FG000|STARTED|Overall Study||11
6636663|NCT02312934|7565509|FG001|STARTED|Overall Study||11
6636664|NCT02312934|7565508|FG000|COMPLETED|Overall Study||9
6636665|NCT02312934|7565509|FG001|COMPLETED|Overall Study||11
6636666|NCT02312934|7565508|FG000|NOT COMPLETED|Overall Study||2
6636667|NCT02312934|7565509|FG001|NOT COMPLETED|Overall Study||0
6636668|NCT02312986|7565516|FG000|STARTED|Overall Study||1
6636669|NCT02312986|7565516|FG000|COMPLETED|Overall Study||1
6636670|NCT02312986|7565516|FG000|NOT COMPLETED|Overall Study||0
6636671|NCT02313155|7565522|FG000|STARTED|Overall Study||55
6636672|NCT02313155|7565523|FG001|STARTED|Overall Study||55
6636673|NCT02313155|7565522|FG000|COMPLETED|Overall Study||55
6636674|NCT02313155|7565523|FG001|COMPLETED|Overall Study||54
6636675|NCT02313155|7565522|FG000|NOT COMPLETED|Overall Study||0
6636676|NCT02313155|7565523|FG001|NOT COMPLETED|Overall Study||1
6636677|NCT02313233|7565531|FG000|STARTED|Overall Study||20
6636678|NCT02313233|7565532|FG001|STARTED|Overall Study||21
6636679|NCT02313233|7565531|FG000|COMPLETED|Overall Study||18
6636680|NCT02313233|7565532|FG001|COMPLETED|Overall Study||18
6636681|NCT02313233|7565531|FG000|NOT COMPLETED|Overall Study||2
6636682|NCT02313233|7565532|FG001|NOT COMPLETED|Overall Study||3
6636683|NCT02313454|7565540|FG000|STARTED|Treatment 1||9
6636684|NCT02313454|7565541|FG001|STARTED|Treatment 1||11
6636685|NCT02313454|7565540|FG000|COMPLETED|Treatment 1||9
6636686|NCT02313454|7565541|FG001|COMPLETED|Treatment 1||11
6636687|NCT02313454|7565540|FG000|NOT COMPLETED|Treatment 1||0
6636688|NCT02313454|7565541|FG001|NOT COMPLETED|Treatment 1||0
6636689|NCT02313454|7565540|FG000|STARTED|Treatment 2|1 participant did not receive the second application.|8
6636690|NCT02313454|7565541|FG001|STARTED|Treatment 2|1 participant did not receive the second application.|10
6636691|NCT02313454|7565540|FG000|COMPLETED|Treatment 2||8
6410002|NCT00939770|7323319|FG001|NOT COMPLETED|Overall Study||8
6410003|NCT00939770|7323320|FG002|NOT COMPLETED|Overall Study||20
6410004|NCT00939770|7323321|FG003|NOT COMPLETED|Overall Study||11
6410005|NCT00939770|7323322|FG004|NOT COMPLETED|Overall Study||37
6410006|NCT00939770|7323323|FG005|NOT COMPLETED|Overall Study||11
6410007|NCT00939770|7323324|FG006|NOT COMPLETED|Overall Study||14
6410008|NCT00939770|7323325|FG007|NOT COMPLETED|Overall Study||10
6636692|NCT02313454|7565541|FG001|COMPLETED|Treatment 2||10
6636693|NCT02313454|7565540|FG000|NOT COMPLETED|Treatment 2||0
6636694|NCT02313454|7565541|FG001|NOT COMPLETED|Treatment 2||0
6636695|NCT02313506|7565549|FG000|STARTED|Overall Study||17
6636696|NCT02313506|7565550|FG001|STARTED|Overall Study||17
6636697|NCT02313506|7565549|FG000|COMPLETED|Overall Study||17
6636698|NCT02313506|7565550|FG001|COMPLETED|Overall Study||17
6636699|NCT02313506|7565549|FG000|NOT COMPLETED|Overall Study||0
6636700|NCT02313506|7565550|FG001|NOT COMPLETED|Overall Study||0
6636701|NCT02313558|7565559|FG000|STARTED|Overall Study||50
6636702|NCT02313558|7565560|FG001|STARTED|Overall Study||50
6636703|NCT02313558|7565559|FG000|COMPLETED|Overall Study||44
6636704|NCT02313558|7565560|FG001|COMPLETED|Overall Study||46
6636705|NCT02313558|7565559|FG000|NOT COMPLETED|Overall Study||6
6410009|NCT00939783|7323356|FG000|STARTED|Overall Study||649
6410010|NCT00939783|7323356|FG000|Treated|Overall Study||648
6410011|NCT00939783|7323356|FG000|COMPLETED|Overall Study||0
6410012|NCT00939783|7323356|FG000|NOT COMPLETED|Overall Study||649
6410013|NCT00939796|7323360|FG000|STARTED|Overall Study||16
6410014|NCT00939796|7323360|FG000|COMPLETED|Overall Study||16
6410015|NCT00939796|7323360|FG000|NOT COMPLETED|Overall Study||0
6410016|NCT00939809|7323364|FG000|STARTED|Overall Study||31
6410017|NCT00939809|7323364|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
6410018|NCT00939809|7323364|FG000|NOT COMPLETED|Overall Study||3
6410019|NCT00939822|7323370|FG000|STARTED|Overall Study||44
6410020|NCT00939822|7323371|FG001|STARTED|Overall Study||44
6410021|NCT00939822|7323370|FG000|COMPLETED|Overall Study||42
6410022|NCT00939822|7323371|FG001|COMPLETED|Overall Study||41
6410023|NCT00939822|7323370|FG000|NOT COMPLETED|Overall Study||2
6410024|NCT00939822|7323371|FG001|NOT COMPLETED|Overall Study||3
6410025|NCT00939874|7323377|FG000|STARTED|Overall Study||52
6410026|NCT00939874|7323377|FG000|Completed Week 48|Overall Study||37
6410027|NCT00939874|7323377|FG000|COMPLETED|Overall Study||32
6410028|NCT00939874|7323377|FG000|NOT COMPLETED|Overall Study||20
6410029|NCT00939900|7323383|FG000|STARTED|Overall Study||55
6410030|NCT00939900|7323384|FG001|STARTED|Overall Study||55
6410031|NCT00939900|7323383|FG000|COMPLETED|Overall Study||53
6410032|NCT00939900|7323384|FG001|COMPLETED|Overall Study||48
6410033|NCT00939900|7323383|FG000|NOT COMPLETED|Overall Study||2
6410034|NCT00939900|7323384|FG001|NOT COMPLETED|Overall Study||7
6410035|NCT00939952|7323390|FG000|STARTED|Overall Study||7
6410036|NCT00939952|7323390|FG000|COMPLETED|Overall Study||7
6410037|NCT00939952|7323390|FG000|NOT COMPLETED|Overall Study||0
6410038|NCT00939991|7323396|FG000|STARTED|Overall Study||9
6410039|NCT00939991|7323397|FG001|STARTED|Overall Study||39
6410040|NCT00939991|7323396|FG000|COMPLETED|Overall Study||9
6410041|NCT00939991|7323397|FG001|COMPLETED|Overall Study||39
6410042|NCT00939991|7323396|FG000|NOT COMPLETED|Overall Study||0
6410043|NCT00939991|7323397|FG001|NOT COMPLETED|Overall Study||0
6410044|NCT00940017|7323403|FG000|STARTED|Overall Study||24
6410045|NCT00940017|7323403|FG000|Subjects Treated|Overall Study||21
6410046|NCT00940017|7323403|FG000|COMPLETED|Overall Study||20
6410047|NCT00940017|7323403|FG000|NOT COMPLETED|Overall Study||4
6410048|NCT00940108|7323411|FG000|STARTED|Overall Study||82
6410049|NCT00940108|7323412|FG001|STARTED|Overall Study||80
6410050|NCT00940108|7323413|FG002|STARTED|Overall Study||103
6410051|NCT00940108|7323414|FG003|STARTED|Overall Study||104
6410052|NCT00940108|7323411|FG000|COMPLETED|Overall Study||77
6410053|NCT00940108|7323412|FG001|COMPLETED|Overall Study||71
6410054|NCT00940108|7323413|FG002|COMPLETED|Overall Study||100
6410055|NCT00940108|7323414|FG003|COMPLETED|Overall Study||99
6410056|NCT00940108|7323411|FG000|NOT COMPLETED|Overall Study||5
6410057|NCT00940108|7323412|FG001|NOT COMPLETED|Overall Study||9
6636706|NCT02313558|7565560|FG001|NOT COMPLETED|Overall Study||4
6636707|NCT02313597|7565568|FG000|STARTED|Overall Study||40
6636708|NCT02313597|7565569|FG001|STARTED|Overall Study||40
6636709|NCT02313597|7565568|FG000|COMPLETED|Overall Study||40
6636710|NCT02313597|7565569|FG001|COMPLETED|Overall Study||40
6636711|NCT02313597|7565568|FG000|NOT COMPLETED|Overall Study||0
6636712|NCT02313597|7565569|FG001|NOT COMPLETED|Overall Study||0
6636713|NCT02313675|7565579|FG000|STARTED|Overall Study||11
6636714|NCT02313675|7565580|FG001|STARTED|Overall Study||11
6636715|NCT02313675|7565581|FG002|STARTED|Overall Study||11
6636716|NCT02313675|7565582|FG003|STARTED|Overall Study||11
6636717|NCT02313675|7565579|FG000|COMPLETED|Overall Study||11
6636718|NCT02313675|7565580|FG001|COMPLETED|Overall Study||11
6636719|NCT02313675|7565581|FG002|COMPLETED|Overall Study||11
6636720|NCT02313675|7565582|FG003|COMPLETED|Overall Study||11
6636721|NCT02313675|7565579|FG000|NOT COMPLETED|Overall Study||0
6636722|NCT02313675|7565580|FG001|NOT COMPLETED|Overall Study||0
6636723|NCT02313675|7565581|FG002|NOT COMPLETED|Overall Study||0
6636724|NCT02313675|7565582|FG003|NOT COMPLETED|Overall Study||0
6636725|NCT02313766|7565595|FG000|STARTED|Overall Study||50
6636726|NCT02313766|7565596|FG001|STARTED|Overall Study||50
6636727|NCT02313766|7565597|FG002|STARTED|Overall Study||50
6636728|NCT02313766|7565595|FG000|COMPLETED|Overall Study||49
6636729|NCT02313766|7565596|FG001|COMPLETED|Overall Study||47
6636730|NCT02313766|7565597|FG002|COMPLETED|Overall Study||50
6636731|NCT02313766|7565595|FG000|NOT COMPLETED|Overall Study||1
6636732|NCT02313766|7565596|FG001|NOT COMPLETED|Overall Study||3
6410058|NCT00940108|7323413|FG002|NOT COMPLETED|Overall Study||3
6410059|NCT00940108|7323414|FG003|NOT COMPLETED|Overall Study||5
6410060|NCT00940290|7323428|FG000|STARTED|Overall Study||54
6410061|NCT00940290|7323429|FG001|STARTED|Overall Study||53
6410062|NCT00940290|7323430|FG002|STARTED|Overall Study||55
6410063|NCT00940290|7323431|FG003|STARTED|Overall Study||54
6410064|NCT00940290|7323428|FG000|COMPLETED|Overall Study||54
6410065|NCT00940290|7323429|FG001|COMPLETED|Overall Study||53
6410066|NCT00940290|7323430|FG002|COMPLETED|Overall Study||55
6410067|NCT00940290|7323431|FG003|COMPLETED|Overall Study||54
6410068|NCT00940290|7323428|FG000|NOT COMPLETED|Overall Study||0
6410069|NCT00940290|7323429|FG001|NOT COMPLETED|Overall Study||0
6410070|NCT00940290|7323430|FG002|NOT COMPLETED|Overall Study||0
6410071|NCT00940290|7323431|FG003|NOT COMPLETED|Overall Study||0
6410072|NCT00940316|7323444|FG000|STARTED|Reached First Response at 8 Weeks||13
6410073|NCT00940316|7323445|FG001|STARTED|Reached First Response at 8 Weeks||13
6410074|NCT00940316|7323446|FG002|STARTED|Reached First Response at 8 Weeks||2
6410075|NCT00940316|7323444|FG000|COMPLETED|Reached First Response at 8 Weeks||10
6636733|NCT02313766|7565597|FG002|NOT COMPLETED|Overall Study||0
6636734|NCT02313909|7565607|FG000|STARTED|Overall Study||3609
6410076|NCT00940316|7323445|FG001|COMPLETED|Reached First Response at 8 Weeks||9
6410077|NCT00940316|7323446|FG002|COMPLETED|Reached First Response at 8 Weeks||2
6410078|NCT00940316|7323444|FG000|NOT COMPLETED|Reached First Response at 8 Weeks||3
6410079|NCT00940316|7323445|FG001|NOT COMPLETED|Reached First Response at 8 Weeks||4
6636735|NCT02313909|7565608|FG001|STARTED|Overall Study||3604
6636736|NCT02313909|7565607|FG000|Treated|Overall Study||3562
6636737|NCT02313909|7565608|FG001|Treated|Overall Study||3559
6636738|NCT02313909|7565607|FG000|COMPLETED|Overall Study||3552
6636739|NCT02313909|7565608|FG001|COMPLETED|Overall Study||3554
6636740|NCT02313909|7565607|FG000|NOT COMPLETED|Overall Study||57
6636741|NCT02313909|7565608|FG001|NOT COMPLETED|Overall Study||50
6636742|NCT02314000|7565616|FG000|STARTED|Overall Study||75
6636743|NCT02314000|7565617|FG001|STARTED|Overall Study||65
6636744|NCT02314000|7565616|FG000|COMPLETED|Overall Study||62
6636745|NCT02314000|7565617|FG001|COMPLETED|Overall Study||57
6636746|NCT02314000|7565616|FG000|NOT COMPLETED|Overall Study||13
6636747|NCT02314000|7565617|FG001|NOT COMPLETED|Overall Study||8
6636748|NCT02314026|7565624|FG000|STARTED|Overall Study||135
6636749|NCT02314026|7565624|FG000|COMPLETED|Overall Study||107
6636750|NCT02314026|7565624|FG000|NOT COMPLETED|Overall Study||28
6636751|NCT02314052|7565628|FG000|STARTED|Cycle One||3
6636752|NCT02314052|7565629|FG001|STARTED|Cycle One||3
6636753|NCT02314052|7565630|FG002|STARTED|Cycle One||3
6636754|NCT02314052|7565631|FG003|STARTED|Cycle One||3
6636755|NCT02314052|7565632|FG004|STARTED|Cycle One||6
6636756|NCT02314052|7565633|FG005|STARTED|Cycle One||3
6636757|NCT02314052|7565628|FG000|COMPLETED|Cycle One||3
6636758|NCT02314052|7565629|FG001|COMPLETED|Cycle One||3
6636759|NCT02314052|7565630|FG002|COMPLETED|Cycle One||3
6636760|NCT02314052|7565631|FG003|COMPLETED|Cycle One||2
6636761|NCT02314052|7565632|FG004|COMPLETED|Cycle One||6
6636762|NCT02314052|7565633|FG005|COMPLETED|Cycle One||3
6636763|NCT02314052|7565628|FG000|NOT COMPLETED|Cycle One||0
6636764|NCT02314052|7565629|FG001|NOT COMPLETED|Cycle One||0
6636765|NCT02314052|7565630|FG002|NOT COMPLETED|Cycle One||0
6636766|NCT02314052|7565631|FG003|NOT COMPLETED|Cycle One||1
6636767|NCT02314052|7565632|FG004|NOT COMPLETED|Cycle One||0
6636768|NCT02314052|7565633|FG005|NOT COMPLETED|Cycle One||0
6636769|NCT02314052|7565628|FG000|STARTED|Cycle Two||3
6636770|NCT02314052|7565629|FG001|STARTED|Cycle Two||3
6636771|NCT02314052|7565630|FG002|STARTED|Cycle Two||3
6636772|NCT02314052|7565631|FG003|STARTED|Cycle Two||2
6636773|NCT02314052|7565632|FG004|STARTED|Cycle Two||6
6636774|NCT02314052|7565633|FG005|STARTED|Cycle Two||3
6636775|NCT02314052|7565628|FG000|COMPLETED|Cycle Two||3
6636776|NCT02314052|7565629|FG001|COMPLETED|Cycle Two||2
6636777|NCT02314052|7565630|FG002|COMPLETED|Cycle Two||2
6636778|NCT02314052|7565631|FG003|COMPLETED|Cycle Two||1
6636779|NCT02314052|7565632|FG004|COMPLETED|Cycle Two||2
6636780|NCT02314052|7565633|FG005|COMPLETED|Cycle Two||3
6636781|NCT02314052|7565628|FG000|NOT COMPLETED|Cycle Two||0
6636782|NCT02314052|7565629|FG001|NOT COMPLETED|Cycle Two||1
6636783|NCT02314052|7565630|FG002|NOT COMPLETED|Cycle Two||1
6636784|NCT02314052|7565631|FG003|NOT COMPLETED|Cycle Two||1
6636785|NCT02314052|7565632|FG004|NOT COMPLETED|Cycle Two||4
6636786|NCT02314052|7565633|FG005|NOT COMPLETED|Cycle Two||0
6636787|NCT02314052|7565628|FG000|STARTED|Cycle Three||3
6636788|NCT02314052|7565629|FG001|STARTED|Cycle Three||2
6636789|NCT02314052|7565630|FG002|STARTED|Cycle Three||2
6636790|NCT02314052|7565631|FG003|STARTED|Cycle Three||1
6636791|NCT02314052|7565632|FG004|STARTED|Cycle Three||2
6636792|NCT02314052|7565633|FG005|STARTED|Cycle Three||3
6636793|NCT02314052|7565628|FG000|COMPLETED|Cycle Three||3
6636794|NCT02314052|7565629|FG001|COMPLETED|Cycle Three|1 of 2 completers in cohort 2 (subject 02-005) only completed 1 of 2 infusions during this cycle|2
6636795|NCT02314052|7565630|FG002|COMPLETED|Cycle Three||2
6636796|NCT02314052|7565631|FG003|COMPLETED|Cycle Three||1
6636797|NCT02314052|7565632|FG004|COMPLETED|Cycle Three||2
6636798|NCT02314052|7565633|FG005|COMPLETED|Cycle Three||3
6636799|NCT02314052|7565628|FG000|NOT COMPLETED|Cycle Three||0
6636800|NCT02314052|7565629|FG001|NOT COMPLETED|Cycle Three||0
6636801|NCT02314052|7565630|FG002|NOT COMPLETED|Cycle Three||0
6636802|NCT02314052|7565631|FG003|NOT COMPLETED|Cycle Three||0
6636803|NCT02314052|7565632|FG004|NOT COMPLETED|Cycle Three||0
6636804|NCT02314052|7565633|FG005|NOT COMPLETED|Cycle Three||0
6636805|NCT02314052|7565628|FG000|STARTED|Cycle Four||3
6636806|NCT02314052|7565629|FG001|STARTED|Cycle Four||2
6636807|NCT02314052|7565630|FG002|STARTED|Cycle Four||2
6636808|NCT02314052|7565631|FG003|STARTED|Cycle Four||1
6636809|NCT02314052|7565632|FG004|STARTED|Cycle Four||2
6636810|NCT02314052|7565633|FG005|STARTED|Cycle Four||3
6636811|NCT02314052|7565628|FG000|COMPLETED|Cycle Four||0
6636812|NCT02314052|7565629|FG001|COMPLETED|Cycle Four||2
6636813|NCT02314052|7565630|FG002|COMPLETED|Cycle Four||1
6636814|NCT02314052|7565631|FG003|COMPLETED|Cycle Four||0
6636815|NCT02314052|7565632|FG004|COMPLETED|Cycle Four||2
6636816|NCT02314052|7565633|FG005|COMPLETED|Cycle Four||0
6636817|NCT02314052|7565628|FG000|NOT COMPLETED|Cycle Four||3
6636818|NCT02314052|7565629|FG001|NOT COMPLETED|Cycle Four||0
6636819|NCT02314052|7565630|FG002|NOT COMPLETED|Cycle Four||1
6636820|NCT02314052|7565631|FG003|NOT COMPLETED|Cycle Four||1
6636821|NCT02314052|7565632|FG004|NOT COMPLETED|Cycle Four||0
6636822|NCT02314052|7565633|FG005|NOT COMPLETED|Cycle Four||3
6636823|NCT02314052|7565628|FG000|STARTED|Cycle Five||0
6636824|NCT02314052|7565629|FG001|STARTED|Cycle Five||2
6636825|NCT02314052|7565630|FG002|STARTED|Cycle Five||1
6410080|NCT00940316|7323446|FG002|NOT COMPLETED|Reached First Response at 8 Weeks||0
6410081|NCT00940316|7323444|FG000|STARTED|Moved on to be Treated Cycle 5||10
6410082|NCT00940316|7323445|FG001|STARTED|Moved on to be Treated Cycle 5||9
6410083|NCT00940316|7323446|FG002|STARTED|Moved on to be Treated Cycle 5||2
6410084|NCT00940316|7323444|FG000|COMPLETED|Moved on to be Treated Cycle 5||8
6410085|NCT00940316|7323445|FG001|COMPLETED|Moved on to be Treated Cycle 5||9
6410086|NCT00940316|7323446|FG002|COMPLETED|Moved on to be Treated Cycle 5||2
6410087|NCT00940316|7323444|FG000|NOT COMPLETED|Moved on to be Treated Cycle 5||2
6410088|NCT00940316|7323445|FG001|NOT COMPLETED|Moved on to be Treated Cycle 5||0
6410089|NCT00940316|7323446|FG002|NOT COMPLETED|Moved on to be Treated Cycle 5||0
6410090|NCT00940316|7323444|FG000|STARTED|Treated After Cycle 5||8
6410091|NCT00940316|7323445|FG001|STARTED|Treated After Cycle 5||9
6410092|NCT00940316|7323446|FG002|STARTED|Treated After Cycle 5||2
6410093|NCT00940316|7323444|FG000|COMPLETED|Treated After Cycle 5||8
6410094|NCT00940316|7323445|FG001|COMPLETED|Treated After Cycle 5||8
6410095|NCT00940316|7323446|FG002|COMPLETED|Treated After Cycle 5||1
6410096|NCT00940316|7323444|FG000|NOT COMPLETED|Treated After Cycle 5||0
6410097|NCT00940316|7323445|FG001|NOT COMPLETED|Treated After Cycle 5||1
6410098|NCT00940316|7323446|FG002|NOT COMPLETED|Treated After Cycle 5||1
6410099|NCT00940316|7323444|FG000|STARTED|Crossed Over to Arm A After Progression||0
6410100|NCT00940316|7323445|FG001|STARTED|Crossed Over to Arm A After Progression||3
6410101|NCT00940316|7323446|FG002|STARTED|Crossed Over to Arm A After Progression||0
6410102|NCT00940316|7323444|FG000|Treated for Cycle One|Crossed Over to Arm A After Progression||0
6410103|NCT00940316|7323445|FG001|Treated for Cycle One|Crossed Over to Arm A After Progression||3
6410104|NCT00940316|7323446|FG002|Treated for Cycle One|Crossed Over to Arm A After Progression||0
6410105|NCT00940316|7323444|FG000|COMPLETED|Crossed Over to Arm A After Progression||0
6410106|NCT00940316|7323445|FG001|COMPLETED|Crossed Over to Arm A After Progression||3
6410107|NCT00940316|7323446|FG002|COMPLETED|Crossed Over to Arm A After Progression||0
6410108|NCT00940316|7323444|FG000|NOT COMPLETED|Crossed Over to Arm A After Progression||0
6410109|NCT00940316|7323445|FG001|NOT COMPLETED|Crossed Over to Arm A After Progression||0
6410110|NCT00940316|7323446|FG002|NOT COMPLETED|Crossed Over to Arm A After Progression||0
6410111|NCT00940316|7323444|FG000|STARTED|Follow up Every 3 Months||13
6410112|NCT00940316|7323445|FG001|STARTED|Follow up Every 3 Months||13
6410113|NCT00940316|7323446|FG002|STARTED|Follow up Every 3 Months||2
6410114|NCT00940316|7323444|FG000|COMPLETED|Follow up Every 3 Months||13
6410115|NCT00940316|7323445|FG001|COMPLETED|Follow up Every 3 Months||13
6410116|NCT00940316|7323446|FG002|COMPLETED|Follow up Every 3 Months||2
6410117|NCT00940316|7323444|FG000|NOT COMPLETED|Follow up Every 3 Months||0
6410118|NCT00940316|7323445|FG001|NOT COMPLETED|Follow up Every 3 Months||0
6410119|NCT00940316|7323446|FG002|NOT COMPLETED|Follow up Every 3 Months||0
6410120|NCT00940342|7323465|FG000|STARTED|Overall Study||50
6410121|NCT00940342|7323466|FG001|STARTED|Overall Study||40
6410122|NCT00940342|7323467|FG002|STARTED|Overall Study||40
6410123|NCT00940342|7323465|FG000|COMPLETED|Overall Study||50
6410124|NCT00940342|7323466|FG001|COMPLETED|Overall Study||38
6410125|NCT00940342|7323467|FG002|COMPLETED|Overall Study||39
6410126|NCT00940342|7323465|FG000|NOT COMPLETED|Overall Study||0
6410127|NCT00940342|7323466|FG001|NOT COMPLETED|Overall Study||2
6410128|NCT00940342|7323467|FG002|NOT COMPLETED|Overall Study||1
6410129|NCT00940446|7323477|FG000|STARTED|Overall Study||30
6410130|NCT00940446|7323478|FG001|STARTED|Overall Study||30
6636826|NCT02314052|7565631|FG003|STARTED|Cycle Five|subject missed cycle four but returned for cycle 5|1
6636827|NCT02314052|7565632|FG004|STARTED|Cycle Five||2
6636828|NCT02314052|7565633|FG005|STARTED|Cycle Five||0
6636829|NCT02314052|7565628|FG000|COMPLETED|Cycle Five||0
6636830|NCT02314052|7565629|FG001|COMPLETED|Cycle Five||0
6636831|NCT02314052|7565630|FG002|COMPLETED|Cycle Five||0
6636832|NCT02314052|7565631|FG003|COMPLETED|Cycle Five|subject missed cycle four but returned for cycle 5|1
6636833|NCT02314052|7565632|FG004|COMPLETED|Cycle Five||2
6636834|NCT02314052|7565633|FG005|COMPLETED|Cycle Five||0
6636835|NCT02314052|7565628|FG000|NOT COMPLETED|Cycle Five||0
6636836|NCT02314052|7565629|FG001|NOT COMPLETED|Cycle Five||2
6636837|NCT02314052|7565630|FG002|NOT COMPLETED|Cycle Five||1
6636838|NCT02314052|7565631|FG003|NOT COMPLETED|Cycle Five||0
6636839|NCT02314052|7565632|FG004|NOT COMPLETED|Cycle Five||0
6636840|NCT02314052|7565633|FG005|NOT COMPLETED|Cycle Five||0
6636841|NCT02314052|7565628|FG000|STARTED|Cycles 6 -10.5||0
6636842|NCT02314052|7565629|FG001|STARTED|Cycles 6 -10.5||0
6636843|NCT02314052|7565630|FG002|STARTED|Cycles 6 -10.5||0
6636844|NCT02314052|7565631|FG003|STARTED|Cycles 6 -10.5||1
6636845|NCT02314052|7565632|FG004|STARTED|Cycles 6 -10.5||2
6636846|NCT02314052|7565633|FG005|STARTED|Cycles 6 -10.5||0
6636847|NCT02314052|7565628|FG000|COMPLETED|Cycles 6 -10.5||0
6636848|NCT02314052|7565629|FG001|COMPLETED|Cycles 6 -10.5||0
6410131|NCT00940446|7323477|FG000|COMPLETED|Overall Study||30
6410132|NCT00940446|7323478|FG001|COMPLETED|Overall Study||30
6410133|NCT00940446|7323477|FG000|NOT COMPLETED|Overall Study||0
6410134|NCT00940446|7323478|FG001|NOT COMPLETED|Overall Study||0
6410135|NCT00940485|7323488|FG000|STARTED|Overall Study||97
6410136|NCT00940485|7323489|FG001|STARTED|Overall Study||100
6410137|NCT00940485|7323488|FG000|COMPLETED|Overall Study||82
6410138|NCT00940485|7323489|FG001|COMPLETED|Overall Study||93
6636849|NCT02314052|7565630|FG002|COMPLETED|Cycles 6 -10.5||0
6636850|NCT02314052|7565631|FG003|COMPLETED|Cycles 6 -10.5||1
6636851|NCT02314052|7565632|FG004|COMPLETED|Cycles 6 -10.5|Subject 02-014 only completed 1 of 2 doses in cycle 6|2
6410139|NCT00940485|7323488|FG000|NOT COMPLETED|Overall Study||15
6410140|NCT00940485|7323489|FG001|NOT COMPLETED|Overall Study||7
6410141|NCT00940537|7323497|FG000|STARTED|Overall Study||5
6410142|NCT00940537|7323498|FG001|STARTED|Overall Study||9
6410143|NCT00940537|7323497|FG000|COMPLETED|Overall Study||5
6410144|NCT00940537|7323498|FG001|COMPLETED|Overall Study||9
6410145|NCT00940537|7323497|FG000|NOT COMPLETED|Overall Study||0
6410146|NCT00940537|7323498|FG001|NOT COMPLETED|Overall Study||0
6410147|NCT00940576|7323505|FG000|STARTED|Overall Study||8
6410148|NCT00940576|7323506|FG001|STARTED|Overall Study||9
6410149|NCT00940576|7323505|FG000|COMPLETED|Overall Study||8
6410150|NCT00940576|7323506|FG001|COMPLETED|Overall Study||9
6410151|NCT00940576|7323505|FG000|NOT COMPLETED|Overall Study||0
6410152|NCT00940576|7323506|FG001|NOT COMPLETED|Overall Study||0
6410153|NCT00940589|7323515|FG000|STARTED|Overall Study||39
6410154|NCT00940589|7323516|FG001|STARTED|Overall Study||34
6410155|NCT00940589|7323515|FG000|COMPLETED|Overall Study||31
6410156|NCT00940589|7323516|FG001|COMPLETED|Overall Study||29
6410157|NCT00940589|7323515|FG000|NOT COMPLETED|Overall Study||8
6410158|NCT00940589|7323516|FG001|NOT COMPLETED|Overall Study||5
6410159|NCT00940602|7323524|FG000|STARTED|Overall Study||149
6410160|NCT00940602|7323525|FG001|STARTED|Overall Study||76
6410161|NCT00940602|7323524|FG000|Safety Analysis Set|Overall Study||148
6410162|NCT00940602|7323525|FG001|Safety Analysis Set|Overall Study||76
6410163|NCT00940602|7323524|FG000|Full Analysis Set|Overall Study||149
6410164|NCT00940602|7323525|FG001|Full Analysis Set|Overall Study||76
6636852|NCT02314052|7565633|FG005|COMPLETED|Cycles 6 -10.5||0
6636853|NCT02314052|7565628|FG000|NOT COMPLETED|Cycles 6 -10.5||0
6636854|NCT02314052|7565629|FG001|NOT COMPLETED|Cycles 6 -10.5||0
6636855|NCT02314052|7565630|FG002|NOT COMPLETED|Cycles 6 -10.5||0
6636856|NCT02314052|7565631|FG003|NOT COMPLETED|Cycles 6 -10.5||0
6636857|NCT02314052|7565632|FG004|NOT COMPLETED|Cycles 6 -10.5||0
6636858|NCT02314052|7565633|FG005|NOT COMPLETED|Cycles 6 -10.5||0
6636859|NCT02314104|7565650|FG000|STARTED|Overall Study||71
6636860|NCT02314104|7565651|FG001|STARTED|Overall Study||78
6636861|NCT02314104|7565652|FG002|STARTED|Overall Study||71
6636862|NCT02314104|7565650|FG000|COMPLETED|Overall Study||57
6636863|NCT02314104|7565651|FG001|COMPLETED|Overall Study||58
6636864|NCT02314104|7565652|FG002|COMPLETED|Overall Study||53
6636865|NCT02314104|7565650|FG000|NOT COMPLETED|Overall Study||14
6636866|NCT02314104|7565651|FG001|NOT COMPLETED|Overall Study||20
6636867|NCT02314104|7565652|FG002|NOT COMPLETED|Overall Study||18
6636868|NCT02314117|7565662|FG000|STARTED|Overall Study||326
6636869|NCT02314117|7565663|FG001|STARTED|Overall Study||319
6636870|NCT02314117|7565662|FG000|Received at Least One Dose of Study Drug|Overall Study||323
6636871|NCT02314117|7565663|FG001|Received at Least One Dose of Study Drug|Overall Study||315
6636872|NCT02314117|7565662|FG000|COMPLETED|Overall Study||314
6636873|NCT02314117|7565663|FG001|COMPLETED|Overall Study||303
6636874|NCT02314117|7565662|FG000|NOT COMPLETED|Overall Study||12
6636875|NCT02314117|7565663|FG001|NOT COMPLETED|Overall Study||16
6655681|NCT02454608|7585845|FG002|NOT COMPLETED|Double-Blind Period||0
6655682|NCT02454608|7585843|FG000|STARTED|Open Label Period|This arm is not part of this period of the study|0
6655683|NCT02454608|7585844|FG001|STARTED|Open Label Period|This arm is not part of this period of the study|0
6655684|NCT02454608|7585845|FG002|STARTED|Open Label Period||29
6655685|NCT02454608|7585843|FG000|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
6655686|NCT02454608|7585844|FG001|COMPLETED|Open Label Period|This arm is not part of this period of the study|0
6655687|NCT02454608|7585845|FG002|COMPLETED|Open Label Period||10
6655688|NCT02454608|7585843|FG000|NOT COMPLETED|Open Label Period||0
6655689|NCT02454608|7585844|FG001|NOT COMPLETED|Open Label Period||0
6655690|NCT02454608|7585845|FG002|NOT COMPLETED|Open Label Period||19
6655691|NCT02454959|7585853|FG000|STARTED|Overall Study||79
6655692|NCT02454959|7585853|FG000|GFF MDI (PT003) With Aerochamber|Overall Study||73
6655693|NCT02454959|7585853|FG000|GFF MDI (PT003) Without Aerochamber|Overall Study||77
6655694|NCT02454959|7585853|FG000|COMPLETED|Overall Study||70
6655695|NCT02454959|7585853|FG000|NOT COMPLETED|Overall Study||9
6655696|NCT02454972|7585868|FG000|STARTED|Overall Study||19
6655697|NCT02454972|7585869|FG001|STARTED|Overall Study||19
6655698|NCT02454972|7585870|FG002|STARTED|Overall Study||76
6655699|NCT02454972|7585871|FG003|STARTED|Overall Study||29
6655700|NCT02454972|7585872|FG004|STARTED|Overall Study||24
6655701|NCT02454972|7585873|FG005|STARTED|Overall Study||15
6655702|NCT02454972|7585874|FG006|STARTED|Overall Study||21
6655703|NCT02454972|7585875|FG007|STARTED|Overall Study||32
6655704|NCT02454972|7585876|FG008|STARTED|Overall Study||110
6655705|NCT02454972|7585868|FG000|Treated|Overall Study||19
6655706|NCT02454972|7585869|FG001|Treated|Overall Study||19
6655707|NCT02454972|7585870|FG002|Treated|Overall Study||73
6410165|NCT00940602|7323524|FG000|Treated|Overall Study||148
6655708|NCT02454972|7585871|FG003|Treated|Overall Study||28
6655709|NCT02454972|7585872|FG004|Treated|Overall Study||23
6655710|NCT02454972|7585873|FG005|Treated|Overall Study||15
6655711|NCT02454972|7585874|FG006|Treated|Overall Study||21
6655712|NCT02454972|7585875|FG007|Treated|Overall Study||32
6655713|NCT02454972|7585876|FG008|Treated|Overall Study||105
6655714|NCT02454972|7585868|FG000|COMPLETED|Overall Study||0
6410166|NCT00940602|7323525|FG001|Treated|Overall Study||76
6410167|NCT00940602|7323524|FG000|Untreated|Overall Study||1
6410168|NCT00940602|7323525|FG001|Untreated|Overall Study||0
6655715|NCT02454972|7585869|FG001|COMPLETED|Overall Study||0
6655716|NCT02454972|7585870|FG002|COMPLETED|Overall Study||0
6410169|NCT00940602|7323524|FG000|COMPLETED|Overall Study||0
6410170|NCT00940602|7323525|FG001|COMPLETED|Overall Study||0
6410171|NCT00940602|7323524|FG000|NOT COMPLETED|Overall Study||149
6410172|NCT00940602|7323525|FG001|NOT COMPLETED|Overall Study||76
6410173|NCT00940771|7323532|FG000|STARTED|Pre-Entry||10
6636876|NCT02314143|7565673|FG000|STARTED|Overall Study||16
6636877|NCT02314143|7565674|FG001|STARTED|Overall Study||16
6636878|NCT02314143|7565675|FG002|STARTED|Overall Study||16
6636879|NCT02314143|7565673|FG000|COMPLETED|Overall Study||8
6636880|NCT02314143|7565674|FG001|COMPLETED|Overall Study||6
6636881|NCT02314143|7565675|FG002|COMPLETED|Overall Study||7
6636882|NCT02314143|7565673|FG000|NOT COMPLETED|Overall Study||8
6636883|NCT02314143|7565674|FG001|NOT COMPLETED|Overall Study||10
6636884|NCT02314143|7565675|FG002|NOT COMPLETED|Overall Study||9
6636885|NCT02314247|7565686|FG000|STARTED|Overall Study||9
6636886|NCT02314247|7565687|FG001|STARTED|Overall Study||6
6636887|NCT02314247|7565688|FG002|STARTED|Overall Study||1
6636888|NCT02314247|7565686|FG000|COMPLETED|Overall Study||0
6636889|NCT02314247|7565687|FG001|COMPLETED|Overall Study||0
6636890|NCT02314247|7565688|FG002|COMPLETED|Overall Study||0
6636891|NCT02314247|7565686|FG000|NOT COMPLETED|Overall Study||9
6636892|NCT02314247|7565687|FG001|NOT COMPLETED|Overall Study||6
6636893|NCT02314247|7565688|FG002|NOT COMPLETED|Overall Study||1
6636894|NCT02314260|7565698|FG000|STARTED|Overall Study||80
6636895|NCT02314260|7565698|FG000|COMPLETED|Overall Study||80
6636896|NCT02314260|7565698|FG000|NOT COMPLETED|Overall Study||0
6636897|NCT02314403|7565702|FG000|STARTED|Overall Study||2
6636898|NCT02314403|7565702|FG000|COMPLETED|Overall Study||2
6636899|NCT02314403|7565702|FG000|NOT COMPLETED|Overall Study||0
6636900|NCT02314520|7565708|FG000|STARTED|Overall Study||72
6636901|NCT02314520|7565709|FG001|STARTED|Overall Study||80
6636902|NCT02314520|7565708|FG000|COMPLETED|Overall Study||72
6636903|NCT02314520|7565709|FG001|COMPLETED|Overall Study||80
6636904|NCT02314520|7565708|FG000|NOT COMPLETED|Overall Study||0
6636905|NCT02314520|7565709|FG001|NOT COMPLETED|Overall Study||0
6636906|NCT02314546|7565718|FG000|STARTED|Overall Study||5
6636907|NCT02314546|7565719|FG001|STARTED|Overall Study||5
6636908|NCT02314546|7565720|FG002|STARTED|Overall Study||5
6636909|NCT02314546|7565718|FG000|COMPLETED|Overall Study||5
6636910|NCT02314546|7565719|FG001|COMPLETED|Overall Study||5
6636911|NCT02314546|7565720|FG002|COMPLETED|Overall Study||5
6636912|NCT02314546|7565718|FG000|NOT COMPLETED|Overall Study||0
6636913|NCT02314546|7565719|FG001|NOT COMPLETED|Overall Study||0
6636914|NCT02314546|7565720|FG002|NOT COMPLETED|Overall Study||0
6636915|NCT02314598|7565729|FG000|STARTED|Overall Study||46
6636916|NCT02314598|7565729|FG000|COMPLETED|Overall Study||46
6636917|NCT02314598|7565729|FG000|NOT COMPLETED|Overall Study||0
6636918|NCT02314637|7565735|FG000|STARTED|Overall Study||151
6636919|NCT02314637|7565736|FG001|STARTED|Overall Study||89
6636920|NCT02314637|7565735|FG000|COMPLETED|Overall Study||135
6636921|NCT02314637|7565736|FG001|COMPLETED|Overall Study||75
6636922|NCT02314637|7565735|FG000|NOT COMPLETED|Overall Study||16
6636923|NCT02314637|7565736|FG001|NOT COMPLETED|Overall Study||14
6636924|NCT02314689|7565742|FG000|STARTED|Overall Study||4
6636925|NCT02314689|7565742|FG000|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
6636926|NCT02314689|7565742|FG000|NOT COMPLETED|Overall Study||0
6636927|NCT02314728|7565748|FG000|STARTED|Overall Study||117
6636928|NCT02314728|7565749|FG001|STARTED|Overall Study||113
6636929|NCT02314728|7565748|FG000|COMPLETED|Overall Study||116
6636930|NCT02314728|7565749|FG001|COMPLETED|Overall Study||112
6636931|NCT02314728|7565748|FG000|NOT COMPLETED|Overall Study||1
6636932|NCT02314728|7565749|FG001|NOT COMPLETED|Overall Study||1
6636933|NCT02314780|7565760|FG000|STARTED|Overall Study||9
6636934|NCT02314780|7565761|FG001|STARTED|Overall Study||10
6636935|NCT02314780|7565762|FG002|STARTED|Overall Study||8
6636936|NCT02314780|7565760|FG000|COMPLETED|Overall Study||9
6636937|NCT02314780|7565761|FG001|COMPLETED|Overall Study||7
6636938|NCT02314780|7565762|FG002|COMPLETED|Overall Study||8
6636939|NCT02314780|7565760|FG000|NOT COMPLETED|Overall Study||0
6636940|NCT02314780|7565761|FG001|NOT COMPLETED|Overall Study||3
6636941|NCT02314780|7565762|FG002|NOT COMPLETED|Overall Study||0
6636942|NCT02314936|7565774|FG000|STARTED|Overall Study||48
6636943|NCT02314936|7565775|FG001|STARTED|Overall Study||48
6636944|NCT02314936|7565776|FG002|STARTED|Overall Study||48
6636945|NCT02314936|7565777|FG003|STARTED|Overall Study||48
6636946|NCT02314936|7565774|FG000|COMPLETED|Overall Study||48
6636947|NCT02314936|7565775|FG001|COMPLETED|Overall Study||48
6636948|NCT02314936|7565776|FG002|COMPLETED|Overall Study||46
6410174|NCT00940771|7323532|FG000|COMPLETED|Pre-Entry||10
6410175|NCT00940771|7323532|FG000|NOT COMPLETED|Pre-Entry||0
6636949|NCT02314936|7565777|FG003|COMPLETED|Overall Study||48
6636950|NCT02314936|7565774|FG000|NOT COMPLETED|Overall Study||0
6636951|NCT02314936|7565775|FG001|NOT COMPLETED|Overall Study||0
6636952|NCT02314936|7565776|FG002|NOT COMPLETED|Overall Study||2
6636953|NCT02314936|7565777|FG003|NOT COMPLETED|Overall Study||0
6636954|NCT02315170|7565787|FG000|STARTED|Overall Study||50
6636955|NCT02315170|7565788|FG001|STARTED|Overall Study||50
6410176|NCT00940771|7323532|FG000|STARTED|4 Weeks||10
6636956|NCT02315170|7565787|FG000|COMPLETED|Overall Study||50
6636957|NCT02315170|7565788|FG001|COMPLETED|Overall Study||50
6636958|NCT02315170|7565787|FG000|NOT COMPLETED|Overall Study||0
6636959|NCT02315170|7565788|FG001|NOT COMPLETED|Overall Study||0
6636960|NCT02315261|7565794|FG000|STARTED|Overall Study||364
6410177|NCT00940771|7323532|FG000|COMPLETED|4 Weeks||10
6410178|NCT00940771|7323532|FG000|NOT COMPLETED|4 Weeks||0
6410179|NCT00940771|7323532|FG000|STARTED|12 Weeks||10
6410180|NCT00940771|7323532|FG000|COMPLETED|12 Weeks||10
6410181|NCT00940771|7323532|FG000|NOT COMPLETED|12 Weeks||0
6410182|NCT00940771|7323532|FG000|STARTED|24 Weeks||10
6410183|NCT00940771|7323532|FG000|COMPLETED|24 Weeks||10
6410184|NCT00940771|7323532|FG000|NOT COMPLETED|24 Weeks||0
6410185|NCT00940823|7323538|FG000|STARTED|Overall Study||124
6410186|NCT00940823|7323539|FG001|STARTED|Overall Study||114
6410187|NCT00940823|7323538|FG000|COMPLETED|Overall Study||89
6410188|NCT00940823|7323539|FG001|COMPLETED|Overall Study||82
6410189|NCT00940823|7323538|FG000|NOT COMPLETED|Overall Study||35
6410190|NCT00940823|7323539|FG001|NOT COMPLETED|Overall Study||32
6410191|NCT00940875|7323549|FG000|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
6410192|NCT00940875|7323550|FG001|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
6410193|NCT00940875|7323549|FG000|COMPLETED|Treatment Phase||5
6410194|NCT00940875|7323550|FG001|COMPLETED|Treatment Phase||4
6410195|NCT00940875|7323549|FG000|NOT COMPLETED|Treatment Phase||26
6410196|NCT00940875|7323550|FG001|NOT COMPLETED|Treatment Phase||19
6410197|NCT00940875|7323549|FG000|STARTED|Post-Study Treatment||0
6410198|NCT00940875|7323550|FG001|STARTED|Post-Study Treatment||4
6410199|NCT00940875|7323549|FG000|COMPLETED|Post-Study Treatment||0
6410200|NCT00940875|7323550|FG001|COMPLETED|Post-Study Treatment||1
6410201|NCT00940875|7323549|FG000|NOT COMPLETED|Post-Study Treatment||0
6410202|NCT00940875|7323550|FG001|NOT COMPLETED|Post-Study Treatment||3
6410203|NCT00940888|7323557|FG000|STARTED|Overall Study|Total number of subjects consented|1701
6410204|NCT00940888|7323557|FG000|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
6410205|NCT00940888|7323557|FG000|NOT COMPLETED|Overall Study||835
6410206|NCT00940901|7323563|FG000|STARTED|Weeks 1-8 (Phase 1)||6
6410207|NCT00940901|7323564|FG001|STARTED|Weeks 1-8 (Phase 1)||7
6410208|NCT00940901|7323563|FG000|COMPLETED|Weeks 1-8 (Phase 1)||6
6410209|NCT00940901|7323564|FG001|COMPLETED|Weeks 1-8 (Phase 1)||7
6410210|NCT00940901|7323563|FG000|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
6410211|NCT00940901|7323564|FG001|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
6410212|NCT00940901|7323563|FG000|STARTED|Week 9-16 (Phase 2)||6
6410213|NCT00940901|7323564|FG001|STARTED|Week 9-16 (Phase 2)||7
6410214|NCT00940901|7323563|FG000|COMPLETED|Week 9-16 (Phase 2)||4
6410215|NCT00940901|7323564|FG001|COMPLETED|Week 9-16 (Phase 2)||4
6410216|NCT00940901|7323563|FG000|NOT COMPLETED|Week 9-16 (Phase 2)||2
6410217|NCT00940901|7323564|FG001|NOT COMPLETED|Week 9-16 (Phase 2)||3
6410218|NCT00940927|7323572|FG000|STARTED|Overall Study||81
6410219|NCT00940927|7323572|FG000|COMPLETED|Overall Study||81
6410220|NCT00940927|7323572|FG000|NOT COMPLETED|Overall Study||0
6410221|NCT00940992|7323579|FG000|STARTED|Overall Study||32
6410222|NCT00940992|7323580|FG001|STARTED|Overall Study||30
6410223|NCT00940992|7323581|FG002|STARTED|Overall Study||30
6410224|NCT00940992|7323579|FG000|COMPLETED|Overall Study||28
6410225|NCT00940992|7323580|FG001|COMPLETED|Overall Study||28
6410226|NCT00940992|7323581|FG002|COMPLETED|Overall Study||28
6410227|NCT00940992|7323579|FG000|NOT COMPLETED|Overall Study||4
6410228|NCT00940992|7323580|FG001|NOT COMPLETED|Overall Study||2
6410229|NCT00940992|7323581|FG002|NOT COMPLETED|Overall Study||2
6410230|NCT00941005|7323591|FG000|STARTED|Overall Study||61
6410231|NCT00941005|7323592|FG001|STARTED|Overall Study||61
6410232|NCT00941005|7323591|FG000|COMPLETED|Overall Study||61
6410233|NCT00941005|7323592|FG001|COMPLETED|Overall Study||61
6410234|NCT00941005|7323591|FG000|NOT COMPLETED|Overall Study||0
6410235|NCT00941005|7323592|FG001|NOT COMPLETED|Overall Study||0
6410236|NCT00941031|7323604|FG000|STARTED|Induction Period||66
6410237|NCT00941031|7323605|FG001|STARTED|Induction Period||138
6410238|NCT00941031|7323606|FG002|STARTED|Induction Period||133
6410239|NCT00941031|7323607|FG003|STARTED|Induction Period||67
6410240|NCT00941031|7323608|FG004|STARTED|Induction Period||0
6410241|NCT00941031|7323609|FG005|STARTED|Induction Period||0
6410242|NCT00941031|7323610|FG006|STARTED|Induction Period||0
6410243|NCT00941031|7323604|FG000|COMPLETED|Induction Period||61
6410244|NCT00941031|7323605|FG001|COMPLETED|Induction Period||134
6410245|NCT00941031|7323606|FG002|COMPLETED|Induction Period||127
6410246|NCT00941031|7323607|FG003|COMPLETED|Induction Period||58
6410247|NCT00941031|7323608|FG004|COMPLETED|Induction Period||0
6410248|NCT00941031|7323609|FG005|COMPLETED|Induction Period||0
6410249|NCT00941031|7323610|FG006|COMPLETED|Induction Period||0
6410250|NCT00941031|7323604|FG000|NOT COMPLETED|Induction Period||5
6410251|NCT00941031|7323605|FG001|NOT COMPLETED|Induction Period||4
6410252|NCT00941031|7323606|FG002|NOT COMPLETED|Induction Period||6
6410253|NCT00941031|7323607|FG003|NOT COMPLETED|Induction Period||9
6410254|NCT00941031|7323608|FG004|NOT COMPLETED|Induction Period||0
6410255|NCT00941031|7323609|FG005|NOT COMPLETED|Induction Period||0
6410256|NCT00941031|7323610|FG006|NOT COMPLETED|Induction Period||0
6410257|NCT00941031|7323604|FG000|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6410258|NCT00941031|7323605|FG001|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6410259|NCT00941031|7323606|FG002|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6410260|NCT00941031|7323607|FG003|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
6410261|NCT00941031|7323608|FG004|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
6410262|NCT00941031|7323609|FG005|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
6410263|NCT00941031|7323610|FG006|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
6410264|NCT00941031|7323604|FG000|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6410265|NCT00941031|7323605|FG001|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6410266|NCT00941031|7323606|FG002|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
6410267|NCT00941031|7323607|FG003|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
6410268|NCT00941031|7323608|FG004|COMPLETED|Maintenance Period||56
6410269|NCT00941031|7323609|FG005|COMPLETED|Maintenance Period||61
6410270|NCT00941031|7323610|FG006|COMPLETED|Maintenance Period||204
6410271|NCT00941031|7323604|FG000|NOT COMPLETED|Maintenance Period||0
6410272|NCT00941031|7323605|FG001|NOT COMPLETED|Maintenance Period||0
6410273|NCT00941031|7323606|FG002|NOT COMPLETED|Maintenance Period||0
6410274|NCT00941031|7323607|FG003|NOT COMPLETED|Maintenance Period||0
6410275|NCT00941031|7323608|FG004|NOT COMPLETED|Maintenance Period||9
6410276|NCT00941031|7323609|FG005|NOT COMPLETED|Maintenance Period||6
6410277|NCT00941031|7323610|FG006|NOT COMPLETED|Maintenance Period||43
6410278|NCT00941070|7323629|FG000|STARTED|Overall Study||26
6410279|NCT00941070|7323629|FG000|COMPLETED|Overall Study||25
6410280|NCT00941070|7323629|FG000|NOT COMPLETED|Overall Study||1
6410281|NCT00941304|7323640|FG000|STARTED|Overall Study||31
6410282|NCT00941304|7323641|FG001|STARTED|Overall Study||30
6410283|NCT00941304|7323642|FG002|STARTED|Overall Study||31
6410284|NCT00941304|7323643|FG003|STARTED|Overall Study||30
6410285|NCT00941304|7323644|FG004|STARTED|Overall Study||31
6410286|NCT00941304|7323640|FG000|COMPLETED|Overall Study||30
6410287|NCT00941304|7323641|FG001|COMPLETED|Overall Study||30
6410288|NCT00941304|7323642|FG002|COMPLETED|Overall Study||31
6410289|NCT00941304|7323643|FG003|COMPLETED|Overall Study||30
6410290|NCT00941304|7323644|FG004|COMPLETED|Overall Study||31
6410291|NCT00941304|7323640|FG000|NOT COMPLETED|Overall Study||1
6410292|NCT00941304|7323641|FG001|NOT COMPLETED|Overall Study||0
6410293|NCT00941304|7323642|FG002|NOT COMPLETED|Overall Study||0
6410294|NCT00941304|7323643|FG003|NOT COMPLETED|Overall Study||0
6410295|NCT00941304|7323644|FG004|NOT COMPLETED|Overall Study||0
6410296|NCT00941330|7323658|FG000|STARTED|Overall Study||15
6410297|NCT00941330|7323659|FG001|STARTED|Overall Study||11
6410298|NCT00941330|7323658|FG000|COMPLETED|Overall Study||14
6410299|NCT00941330|7323659|FG001|COMPLETED|Overall Study||9
6410300|NCT00941330|7323658|FG000|NOT COMPLETED|Overall Study||1
6410301|NCT00941330|7323659|FG001|NOT COMPLETED|Overall Study||2
6410302|NCT00941603|7323671|FG000|STARTED|Overall Study||104
6410303|NCT00941603|7323672|FG001|STARTED|Overall Study||105
6410304|NCT00941603|7323673|FG002|STARTED|Overall Study||104
6410305|NCT00941603|7323674|FG003|STARTED|Overall Study||104
6410306|NCT00941603|7323675|FG004|STARTED|Overall Study||105
6410307|NCT00941603|7323676|FG005|STARTED|Overall Study||97
6410308|NCT00941603|7323671|FG000|COMPLETED|Overall Study||93
6410309|NCT00941603|7323672|FG001|COMPLETED|Overall Study||89
6410310|NCT00941603|7323673|FG002|COMPLETED|Overall Study||99
6410311|NCT00941603|7323674|FG003|COMPLETED|Overall Study||100
6410312|NCT00941603|7323675|FG004|COMPLETED|Overall Study||101
6410313|NCT00941603|7323676|FG005|COMPLETED|Overall Study||94
6410314|NCT00941603|7323671|FG000|NOT COMPLETED|Overall Study||11
6410315|NCT00941603|7323672|FG001|NOT COMPLETED|Overall Study||16
6410316|NCT00941603|7323673|FG002|NOT COMPLETED|Overall Study||5
6410317|NCT00941603|7323674|FG003|NOT COMPLETED|Overall Study||4
6410318|NCT00941603|7323675|FG004|NOT COMPLETED|Overall Study||4
6410319|NCT00941603|7323676|FG005|NOT COMPLETED|Overall Study||3
6410320|NCT00941655|7323692|FG000|STARTED|Overall Study||8
6410321|NCT00941655|7323693|FG001|STARTED|Overall Study||7
6410322|NCT00941655|7323692|FG000|COMPLETED|Overall Study||3
6410323|NCT00941655|7323693|FG001|COMPLETED|Overall Study||2
6410324|NCT00941655|7323692|FG000|NOT COMPLETED|Overall Study||5
6410325|NCT00941655|7323693|FG001|NOT COMPLETED|Overall Study||5
6410326|NCT00941668|7323702|FG000|STARTED|Overall Study||24
6410327|NCT00941668|7323703|FG001|STARTED|Overall Study||25
6410328|NCT00941668|7323702|FG000|COMPLETED|Overall Study||0
6410329|NCT00941668|7323703|FG001|COMPLETED|Overall Study||0
6410330|NCT00941668|7323702|FG000|NOT COMPLETED|Overall Study||24
6410331|NCT00941668|7323703|FG001|NOT COMPLETED|Overall Study||25
6410332|NCT00941681|7323712|FG000|STARTED|Overall Study||12
6410333|NCT00941681|7323713|FG001|STARTED|Overall Study||11
6410334|NCT00941681|7323714|FG002|STARTED|Overall Study||12
6410335|NCT00941681|7323712|FG000|COMPLETED|Overall Study||12
6410336|NCT00941681|7323713|FG001|COMPLETED|Overall Study||10
6410337|NCT00941681|7323714|FG002|COMPLETED|Overall Study||12
6410338|NCT00941681|7323712|FG000|NOT COMPLETED|Overall Study||0
6410339|NCT00941681|7323713|FG001|NOT COMPLETED|Overall Study||1
6410340|NCT00941681|7323714|FG002|NOT COMPLETED|Overall Study||0
6410341|NCT00941720|7323722|FG000|STARTED|Overall Study||71
6410342|NCT00941720|7323722|FG000|COMPLETED|Overall Study||57
6410343|NCT00941720|7323722|FG000|NOT COMPLETED|Overall Study||14
6410344|NCT00941733|7323728|FG000|STARTED|Overall Study||239
6410345|NCT00941733|7323729|FG001|STARTED|Overall Study||119
6410346|NCT00941733|7323728|FG000|COMPLETED|Overall Study|1 year follow-up|165
6410347|NCT00941733|7323729|FG001|COMPLETED|Overall Study|1 year follow-up|91
6410348|NCT00941733|7323728|FG000|NOT COMPLETED|Overall Study||74
6410349|NCT00941733|7323729|FG001|NOT COMPLETED|Overall Study||28
6410350|NCT00941798|7323737|FG000|STARTED|Overall Study||755
6410351|NCT00941798|7323738|FG001|STARTED|Overall Study||763
6410352|NCT00941798|7323737|FG000|Full Analysis Set|Overall Study||749
6410353|NCT00941798|7323738|FG001|Full Analysis Set|Overall Study||759
6410354|NCT00941798|7323737|FG000|COMPLETED|Overall Study||561
6410355|NCT00941798|7323738|FG001|COMPLETED|Overall Study||578
6410356|NCT00941798|7323737|FG000|NOT COMPLETED|Overall Study||194
6410357|NCT00941798|7323738|FG001|NOT COMPLETED|Overall Study||185
6410358|NCT00941863|7323749|FG000|STARTED|Until Primary Completion Date (PCD)||7
6410359|NCT00941863|7323750|FG001|STARTED|Until Primary Completion Date (PCD)||3
6410360|NCT00941863|7323751|FG002|STARTED|Until Primary Completion Date (PCD)||12
6410361|NCT00941863|7323752|FG003|STARTED|Until Primary Completion Date (PCD)||17
6410362|NCT00941863|7323753|FG004|STARTED|Until Primary Completion Date (PCD)||119
6410363|NCT00941863|7323749|FG000|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
6410364|NCT00941863|7323750|FG001|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
6410365|NCT00941863|7323751|FG002|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
6410366|NCT00941863|7323752|FG003|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
6410367|NCT00941863|7323753|FG004|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
6410368|NCT00941863|7323749|FG000|COMPLETED|Until Primary Completion Date (PCD)||0
6410369|NCT00941863|7323750|FG001|COMPLETED|Until Primary Completion Date (PCD)||0
6410370|NCT00941863|7323751|FG002|COMPLETED|Until Primary Completion Date (PCD)||0
6410371|NCT00941863|7323752|FG003|COMPLETED|Until Primary Completion Date (PCD)||0
6410372|NCT00941863|7323753|FG004|COMPLETED|Until Primary Completion Date (PCD)||25
6410373|NCT00941863|7323749|FG000|NOT COMPLETED|Until Primary Completion Date (PCD)||7
6410374|NCT00941863|7323750|FG001|NOT COMPLETED|Until Primary Completion Date (PCD)||3
6410375|NCT00941863|7323751|FG002|NOT COMPLETED|Until Primary Completion Date (PCD)||12
6410376|NCT00941863|7323752|FG003|NOT COMPLETED|Until Primary Completion Date (PCD)||17
6410377|NCT00941863|7323753|FG004|NOT COMPLETED|Until Primary Completion Date (PCD)||94
6410378|NCT00941863|7323749|FG000|STARTED|Continued After PCD||0
6410379|NCT00941863|7323750|FG001|STARTED|Continued After PCD||0
6410380|NCT00941863|7323751|FG002|STARTED|Continued After PCD||0
6410381|NCT00941863|7323752|FG003|STARTED|Continued After PCD||0
6410382|NCT00941863|7323753|FG004|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
6410383|NCT00941863|7323749|FG000|COMPLETED|Continued After PCD||0
6410384|NCT00941863|7323750|FG001|COMPLETED|Continued After PCD||0
6410385|NCT00941863|7323751|FG002|COMPLETED|Continued After PCD||0
6410386|NCT00941863|7323752|FG003|COMPLETED|Continued After PCD||0
6410387|NCT00941863|7323753|FG004|COMPLETED|Continued After PCD||6
6410388|NCT00941863|7323749|FG000|NOT COMPLETED|Continued After PCD||0
6410389|NCT00941863|7323750|FG001|NOT COMPLETED|Continued After PCD||0
6410390|NCT00941863|7323751|FG002|NOT COMPLETED|Continued After PCD||0
6410391|NCT00941863|7323752|FG003|NOT COMPLETED|Continued After PCD||0
6410392|NCT00941863|7323753|FG004|NOT COMPLETED|Continued After PCD||19
6410393|NCT00941889|7323771|FG000|STARTED|Overall Study||17
6410394|NCT00941889|7323772|FG001|STARTED|Overall Study||15
6410395|NCT00941889|7323771|FG000|COMPLETED|Overall Study||5
6410396|NCT00941889|7323772|FG001|COMPLETED|Overall Study||3
6410397|NCT00941889|7323771|FG000|NOT COMPLETED|Overall Study||12
6410398|NCT00941889|7323772|FG001|NOT COMPLETED|Overall Study||12
6410399|NCT00941993|7323778|FG000|STARTED|Overall Study||109
6410400|NCT00941993|7323778|FG000|COMPLETED|Overall Study||109
6410401|NCT00941993|7323778|FG000|NOT COMPLETED|Overall Study||0
6410402|NCT00942084|7323783|FG000|STARTED|Overall Study||32
6410403|NCT00942084|7323783|FG000|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
6410404|NCT00942084|7323783|FG000|NOT COMPLETED|Overall Study||2
6410405|NCT00942149|7323787|FG000|STARTED|Overall Study||20
6410406|NCT00942149|7323787|FG000|COMPLETED|Overall Study||20
6410407|NCT00942149|7323787|FG000|NOT COMPLETED|Overall Study||0
6410408|NCT00942162|7323794|FG000|STARTED|Overall Study||71
6410409|NCT00942162|7323795|FG001|STARTED|Overall Study||50
6410410|NCT00942162|7323796|FG002|STARTED|Overall Study||2
6410411|NCT00942162|7323794|FG000|COMPLETED|Overall Study||1
6410412|NCT00942162|7323795|FG001|COMPLETED|Overall Study||0
6410413|NCT00942162|7323796|FG002|COMPLETED|Overall Study||0
6410414|NCT00942162|7323794|FG000|NOT COMPLETED|Overall Study||70
6410415|NCT00942162|7323795|FG001|NOT COMPLETED|Overall Study||50
6410416|NCT00942162|7323796|FG002|NOT COMPLETED|Overall Study||2
6410417|NCT00942175|7323810|FG000|STARTED|Overall Study||40
6410418|NCT00942175|7323811|FG001|STARTED|Overall Study||40
6410419|NCT00942175|7323812|FG002|STARTED|Overall Study||40
6410420|NCT00942175|7323813|FG003|STARTED|Overall Study||40
6410421|NCT00942175|7323810|FG000|COMPLETED|Overall Study||38
6410422|NCT00942175|7323811|FG001|COMPLETED|Overall Study||36
6410423|NCT00942175|7323812|FG002|COMPLETED|Overall Study||38
6410424|NCT00942175|7323813|FG003|COMPLETED|Overall Study||38
6410425|NCT00942175|7323810|FG000|NOT COMPLETED|Overall Study||2
6410426|NCT00942175|7323811|FG001|NOT COMPLETED|Overall Study||4
6410427|NCT00942175|7323812|FG002|NOT COMPLETED|Overall Study||2
6410428|NCT00942175|7323813|FG003|NOT COMPLETED|Overall Study||2
6410429|NCT00942188|7323835|FG000|STARTED|Overall Study||26
6410430|NCT00942188|7323836|FG001|STARTED|Overall Study||26
6410431|NCT00942188|7323837|FG002|STARTED|Overall Study||27
6410432|NCT00942188|7323838|FG003|STARTED|Overall Study||27
6410433|NCT00942188|7323835|FG000|COMPLETED|Overall Study||22
6410434|NCT00942188|7323836|FG001|COMPLETED|Overall Study||16
6410435|NCT00942188|7323837|FG002|COMPLETED|Overall Study||18
6410436|NCT00942188|7323838|FG003|COMPLETED|Overall Study||23
6410437|NCT00942188|7323835|FG000|NOT COMPLETED|Overall Study||4
6410438|NCT00942188|7323836|FG001|NOT COMPLETED|Overall Study||10
6410439|NCT00942188|7323837|FG002|NOT COMPLETED|Overall Study||9
6410440|NCT00942188|7323838|FG003|NOT COMPLETED|Overall Study||4
6410441|NCT00942266|7323850|FG000|STARTED|Overall Study||43
6410442|NCT00942266|7323851|FG001|STARTED|Overall Study||15
6410443|NCT00942266|7323850|FG000|COMPLETED|Overall Study||0
6410444|NCT00942266|7323851|FG001|COMPLETED|Overall Study||0
6410445|NCT00942266|7323850|FG000|NOT COMPLETED|Overall Study||43
6410446|NCT00942266|7323851|FG001|NOT COMPLETED|Overall Study||15
6410447|NCT00942305|7323867|FG000|STARTED|Overall Study||30
6410448|NCT00942305|7323868|FG001|STARTED|Overall Study||10
6410449|NCT00942305|7323869|FG002|STARTED|Overall Study||29
6410450|NCT00942305|7323870|FG003|STARTED|Overall Study||10
6410451|NCT00942305|7323871|FG004|STARTED|Overall Study||39
6410452|NCT00942305|7323872|FG005|STARTED|Overall Study||14
6410453|NCT00942305|7323873|FG006|STARTED|Overall Study||30
6410454|NCT00942305|7323874|FG007|STARTED|Overall Study||10
6410455|NCT00942305|7323875|FG008|STARTED|Overall Study||50
6410456|NCT00942305|7323876|FG009|STARTED|Overall Study||17
6410457|NCT00942305|7323867|FG000|COMPLETED|Overall Study||7
6410458|NCT00942305|7323868|FG001|COMPLETED|Overall Study||5
6410459|NCT00942305|7323869|FG002|COMPLETED|Overall Study||14
6410460|NCT00942305|7323870|FG003|COMPLETED|Overall Study||4
6410461|NCT00942305|7323871|FG004|COMPLETED|Overall Study||14
6410462|NCT00942305|7323872|FG005|COMPLETED|Overall Study||9
6410463|NCT00942305|7323873|FG006|COMPLETED|Overall Study||6
6410464|NCT00942305|7323874|FG007|COMPLETED|Overall Study||5
6410465|NCT00942305|7323875|FG008|COMPLETED|Overall Study||25
6410466|NCT00942305|7323876|FG009|COMPLETED|Overall Study||7
6410467|NCT00942305|7323867|FG000|NOT COMPLETED|Overall Study||23
6410468|NCT00942305|7323868|FG001|NOT COMPLETED|Overall Study||5
6410469|NCT00942305|7323869|FG002|NOT COMPLETED|Overall Study||15
6410470|NCT00942305|7323870|FG003|NOT COMPLETED|Overall Study||6
6410471|NCT00942305|7323871|FG004|NOT COMPLETED|Overall Study||25
6410472|NCT00942305|7323872|FG005|NOT COMPLETED|Overall Study||5
6410473|NCT00942305|7323873|FG006|NOT COMPLETED|Overall Study||24
6410474|NCT00942305|7323874|FG007|NOT COMPLETED|Overall Study||5
6410475|NCT00942305|7323875|FG008|NOT COMPLETED|Overall Study||25
6410476|NCT00942305|7323876|FG009|NOT COMPLETED|Overall Study||10
6410477|NCT00942357|7323900|FG000|STARTED|Overall Study||407
6410478|NCT00942357|7323901|FG001|STARTED|Overall Study||406
6410479|NCT00942357|7323900|FG000|COMPLETED|Overall Study||370
6410480|NCT00942357|7323901|FG001|COMPLETED|Overall Study||366
6410481|NCT00942357|7323900|FG000|NOT COMPLETED|Overall Study||37
6410482|NCT00942357|7323901|FG001|NOT COMPLETED|Overall Study||40
6410483|NCT00942422|7323907|FG000|STARTED|Overall Study||8
6410484|NCT00942422|7323907|FG000|COMPLETED|Overall Study||5
6410485|NCT00942422|7323907|FG000|NOT COMPLETED|Overall Study||3
6410486|NCT00942448|7323915|FG000|STARTED|Overall Study||77
6410487|NCT00942448|7323916|FG001|STARTED|Overall Study||76
6410488|NCT00942448|7323917|FG002|STARTED|Overall Study||78
6410489|NCT00942448|7323918|FG003|STARTED|Overall Study||75
6410490|NCT00942448|7323915|FG000|COMPLETED|Overall Study||77
6410491|NCT00942448|7323916|FG001|COMPLETED|Overall Study||76
6410492|NCT00942448|7323917|FG002|COMPLETED|Overall Study||78
6410493|NCT00942448|7323918|FG003|COMPLETED|Overall Study||75
6410494|NCT00942448|7323915|FG000|NOT COMPLETED|Overall Study||0
6410495|NCT00942448|7323916|FG001|NOT COMPLETED|Overall Study||0
6410496|NCT00942448|7323917|FG002|NOT COMPLETED|Overall Study||0
6410497|NCT00942448|7323918|FG003|NOT COMPLETED|Overall Study||0
6498968|NCT01413087|7417557|FG000|NOT COMPLETED|Overall Study||0
6498969|NCT01413087|7417558|FG001|NOT COMPLETED|Overall Study||0
6498970|NCT01413178|7417566|FG000|STARTED|Overall Study||105
6498971|NCT01413178|7417567|FG001|STARTED|Overall Study||100
6498972|NCT01413178|7417566|FG000|COMPLETED|Overall Study||104
6498973|NCT01413178|7417567|FG001|COMPLETED|Overall Study||98
6498974|NCT01413178|7417566|FG000|NOT COMPLETED|Overall Study||1
6498975|NCT01413178|7417567|FG001|NOT COMPLETED|Overall Study||2
6498976|NCT01413191|7417573|FG000|STARTED|Overall Study||18
6498977|NCT01413191|7417573|FG000|COMPLETED|Overall Study||7
6498978|NCT01413191|7417573|FG000|NOT COMPLETED|Overall Study||11
6498979|NCT01413204|7417580|FG000|STARTED|Overall Study||90
6498980|NCT01413204|7417581|FG001|STARTED|Overall Study||89
6498981|NCT01413204|7417582|FG002|STARTED|Overall Study||93
6498982|NCT01413204|7417580|FG000|COMPLETED|Overall Study||84
6498983|NCT01413204|7417581|FG001|COMPLETED|Overall Study||83
6498984|NCT01413204|7417582|FG002|COMPLETED|Overall Study||74
6498985|NCT01413204|7417580|FG000|NOT COMPLETED|Overall Study||6
6498986|NCT01413204|7417581|FG001|NOT COMPLETED|Overall Study||6
6498987|NCT01413204|7417582|FG002|NOT COMPLETED|Overall Study||19
6498988|NCT01413360|7417590|FG000|STARTED|Overall Study||10
6498989|NCT01413360|7417590|FG000|COMPLETED|Overall Study||7
6410498|NCT00942578|7323935|FG000|STARTED|Dose Escalation Phase||3
6410499|NCT00942578|7323936|FG001|STARTED|Dose Escalation Phase||3
6636961|NCT02315261|7565794|FG000|COMPLETED|Overall Study||364
6636962|NCT02315261|7565794|FG000|NOT COMPLETED|Overall Study||0
6636963|NCT02315352|7565800|FG000|STARTED|First Intervention (Day 1)||24
6636964|NCT02315352|7565801|FG001|STARTED|First Intervention (Day 1)||24
6636965|NCT02315352|7565802|FG002|STARTED|First Intervention (Day 1)||0
6636966|NCT02315352|7565803|FG003|STARTED|First Intervention (Day 1)||0
6410500|NCT00942578|7323937|FG002|STARTED|Dose Escalation Phase||3
6410501|NCT00942578|7323935|FG000|COMPLETED|Dose Escalation Phase||3
6410502|NCT00942578|7323936|FG001|COMPLETED|Dose Escalation Phase||3
6410503|NCT00942578|7323937|FG002|COMPLETED|Dose Escalation Phase||3
6410504|NCT00942578|7323935|FG000|NOT COMPLETED|Dose Escalation Phase||0
6410505|NCT00942578|7323936|FG001|NOT COMPLETED|Dose Escalation Phase||0
6410506|NCT00942578|7323937|FG002|NOT COMPLETED|Dose Escalation Phase||0
6410507|NCT00942578|7323935|FG000|STARTED|Expansion Phase||11
6410508|NCT00942578|7323936|FG001|STARTED|Expansion Phase||0
6410509|NCT00942578|7323937|FG002|STARTED|Expansion Phase||43
6410510|NCT00942578|7323935|FG000|COMPLETED|Expansion Phase||11
6410511|NCT00942578|7323936|FG001|COMPLETED|Expansion Phase||0
6410512|NCT00942578|7323937|FG002|COMPLETED|Expansion Phase||43
6410513|NCT00942578|7323935|FG000|NOT COMPLETED|Expansion Phase||0
6410514|NCT00942578|7323936|FG001|NOT COMPLETED|Expansion Phase||0
6410515|NCT00942578|7323937|FG002|NOT COMPLETED|Expansion Phase||0
6410516|NCT00942604|7323952|FG000|STARTED|Overall Study||100
6410517|NCT00942604|7323953|FG001|STARTED|Overall Study||103
6410518|NCT00942604|7323952|FG000|COMPLETED|Overall Study||98
6410519|NCT00942604|7323953|FG001|COMPLETED|Overall Study||99
6410520|NCT00942604|7323952|FG000|NOT COMPLETED|Overall Study||2
6410521|NCT00942604|7323953|FG001|NOT COMPLETED|Overall Study||4
6410522|NCT00942708|7323959|FG000|STARTED|Overall Study||6
6410523|NCT00942708|7323959|FG000|COMPLETED|Overall Study||5
6410524|NCT00942708|7323959|FG000|NOT COMPLETED|Overall Study||1
6410525|NCT00942734|7323964|FG000|STARTED|Overall Study||43
6410526|NCT00942734|7323964|FG000|COMPLETED|Overall Study||35
6410527|NCT00942734|7323964|FG000|NOT COMPLETED|Overall Study||8
6410528|NCT00942786|7323968|FG000|STARTED|Overall Study||297
6410529|NCT00942786|7323968|FG000|COMPLETED|Overall Study|date of last follow-up|297
6410530|NCT00942786|7323968|FG000|NOT COMPLETED|Overall Study||0
6410531|NCT00942825|7323977|FG000|STARTED|Overall Study||97
6410532|NCT00942825|7323978|FG001|STARTED|Overall Study||98
6410533|NCT00942825|7323977|FG000|COMPLETED|Overall Study||97
6410534|NCT00942825|7323978|FG001|COMPLETED|Overall Study||98
6410535|NCT00942825|7323977|FG000|NOT COMPLETED|Overall Study||0
6410536|NCT00942825|7323978|FG001|NOT COMPLETED|Overall Study||0
6410537|NCT00942851|7323986|FG000|STARTED|Overall Study||12
6410538|NCT00942851|7323987|FG001|STARTED|Overall Study||12
6410539|NCT00942851|7323986|FG000|COMPLETED|Overall Study||12
6410540|NCT00942851|7323987|FG001|COMPLETED|Overall Study||11
6410541|NCT00942851|7323986|FG000|NOT COMPLETED|Overall Study||0
6410542|NCT00942851|7323987|FG001|NOT COMPLETED|Overall Study||1
6410543|NCT00942890|7323999|FG000|STARTED|Overall Study||21
6410544|NCT00942890|7324000|FG001|STARTED|Overall Study||23
6410545|NCT00942890|7323999|FG000|COMPLETED|Overall Study||21
6410546|NCT00942890|7324000|FG001|COMPLETED|Overall Study||23
6410547|NCT00942890|7323999|FG000|NOT COMPLETED|Overall Study||0
6410548|NCT00942890|7324000|FG001|NOT COMPLETED|Overall Study||0
6410549|NCT00942903|7324007|FG000|STARTED|Overall Study||20
6410550|NCT00942903|7324007|FG000|COMPLETED|Overall Study||20
6410551|NCT00942903|7324007|FG000|NOT COMPLETED|Overall Study||0
6410552|NCT00942968|7324011|FG000|STARTED|Overall Study||338
6410553|NCT00942968|7324011|FG000|Treated|Overall Study||334
6410554|NCT00942968|7324011|FG000|COMPLETED|Overall Study||109
6410555|NCT00942968|7324011|FG000|NOT COMPLETED|Overall Study||229
6410556|NCT00942994|7324017|FG000|STARTED|Overall Study||203
6410557|NCT00942994|7324018|FG001|STARTED|Overall Study||209
6410558|NCT00942994|7324017|FG000|COMPLETED|Overall Study||187
6410559|NCT00942994|7324018|FG001|COMPLETED|Overall Study||190
6410560|NCT00942994|7324017|FG000|NOT COMPLETED|Overall Study||16
6410561|NCT00942994|7324018|FG001|NOT COMPLETED|Overall Study||19
6410562|NCT00943072|7324026|FG000|STARTED|Overall Study||115
6410563|NCT00943072|7324027|FG001|STARTED|Overall Study||74
6410564|NCT00943072|7324026|FG000|Participants Received Treatment|Overall Study|Safety population (SAF)|114
6410565|NCT00943072|7324027|FG001|Participants Received Treatment|Overall Study||74
6410566|NCT00943072|7324026|FG000|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
6410567|NCT00943072|7324027|FG001|Full Analysis Set (FAS) Population|Overall Study||73
6410568|NCT00943072|7324026|FG000|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
6410569|NCT00943072|7324027|FG001|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
6636967|NCT02315352|7565804|FG004|STARTED|First Intervention (Day 1)||0
6636968|NCT02315352|7565805|FG005|STARTED|First Intervention (Day 1)||0
6636969|NCT02315352|7565806|FG006|STARTED|First Intervention (Day 1)||0
6410570|NCT00943072|7324026|FG000|NOT COMPLETED|Overall Study||5
6410571|NCT00943072|7324027|FG001|NOT COMPLETED|Overall Study||14
6410572|NCT00943098|7324037|FG000|STARTED|Overall Study||70
6410573|NCT00943098|7324038|FG001|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
6410574|NCT00943098|7324037|FG000|COMPLETED|Overall Study||70
6410575|NCT00943098|7324038|FG001|COMPLETED|Overall Study||72
6410576|NCT00943098|7324037|FG000|NOT COMPLETED|Overall Study||0
6410577|NCT00943098|7324038|FG001|NOT COMPLETED|Overall Study||0
6410578|NCT00943111|7324046|FG000|STARTED|52-Weeks Primary Analysis Period||106
6410579|NCT00943111|7324047|FG001|STARTED|52-Weeks Primary Analysis Period||54
6410580|NCT00943111|7324048|FG002|STARTED|52-Weeks Primary Analysis Period||0
6410581|NCT00943111|7324046|FG000|Treated|52-Weeks Primary Analysis Period||106
6410582|NCT00943111|7324047|FG001|Treated|52-Weeks Primary Analysis Period||53
6410583|NCT00943111|7324048|FG002|Treated|52-Weeks Primary Analysis Period||0
6410584|NCT00943111|7324046|FG000|COMPLETED|52-Weeks Primary Analysis Period||104
6410585|NCT00943111|7324047|FG001|COMPLETED|52-Weeks Primary Analysis Period||52
6410586|NCT00943111|7324048|FG002|COMPLETED|52-Weeks Primary Analysis Period||0
6410587|NCT00943111|7324046|FG000|NOT COMPLETED|52-Weeks Primary Analysis Period||2
6410588|NCT00943111|7324047|FG001|NOT COMPLETED|52-Weeks Primary Analysis Period||2
6410589|NCT00943111|7324048|FG002|NOT COMPLETED|52-Weeks Primary Analysis Period||0
6410590|NCT00943111|7324046|FG000|STARTED|5 Years Long-term Treatment Period||0
6410591|NCT00943111|7324047|FG001|STARTED|5 Years Long-term Treatment Period||0
6410592|NCT00943111|7324048|FG002|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
6410593|NCT00943111|7324046|FG000|COMPLETED|5 Years Long-term Treatment Period||0
6410594|NCT00943111|7324047|FG001|COMPLETED|5 Years Long-term Treatment Period||0
6410595|NCT00943111|7324048|FG002|COMPLETED|5 Years Long-term Treatment Period||77
6410596|NCT00943111|7324046|FG000|NOT COMPLETED|5 Years Long-term Treatment Period||0
6410597|NCT00943111|7324047|FG001|NOT COMPLETED|5 Years Long-term Treatment Period||0
6410598|NCT00943111|7324048|FG002|NOT COMPLETED|5 Years Long-term Treatment Period||75
6410599|NCT00943124|7324055|FG000|STARTED|Period 1||110
6410600|NCT00943124|7324056|FG001|STARTED|Period 1||110
6410601|NCT00943124|7324055|FG000|COMPLETED|Period 1||108
6410602|NCT00943124|7324056|FG001|COMPLETED|Period 1||108
6410603|NCT00943124|7324055|FG000|NOT COMPLETED|Period 1||2
6410604|NCT00943124|7324056|FG001|NOT COMPLETED|Period 1||2
6410605|NCT00943124|7324055|FG000|STARTED|Period 2||108
6410606|NCT00943124|7324056|FG001|STARTED|Period 2||108
6410607|NCT00943124|7324055|FG000|COMPLETED|Period 2||108
6410608|NCT00943124|7324056|FG001|COMPLETED|Period 2||108
6410609|NCT00943124|7324055|FG000|NOT COMPLETED|Period 2||0
6410610|NCT00943124|7324056|FG001|NOT COMPLETED|Period 2||0
6410611|NCT00943150|7324064|FG000|STARTED|Overall Study||10
6410612|NCT00943150|7324065|FG001|STARTED|Overall Study||10
6410613|NCT00943150|7324064|FG000|COMPLETED|Overall Study||10
6410614|NCT00943150|7324065|FG001|COMPLETED|Overall Study||10
6410615|NCT00943150|7324064|FG000|NOT COMPLETED|Overall Study||0
6410616|NCT00943150|7324065|FG001|NOT COMPLETED|Overall Study||0
6410617|NCT00943202|7324079|FG000|STARTED|Overall Study||133
6410618|NCT00943202|7324080|FG001|STARTED|Overall Study||133
6410619|NCT00943202|7324081|FG002|STARTED|Overall Study||133
6410620|NCT00943202|7324082|FG003|STARTED|Overall Study||132
6410621|NCT00943202|7324079|FG000|COMPLETED|Overall Study||132
6410622|NCT00943202|7324080|FG001|COMPLETED|Overall Study||131
6410623|NCT00943202|7324081|FG002|COMPLETED|Overall Study||133
6410624|NCT00943202|7324082|FG003|COMPLETED|Overall Study||131
6410625|NCT00943202|7324079|FG000|NOT COMPLETED|Overall Study||1
6410626|NCT00943202|7324080|FG001|NOT COMPLETED|Overall Study||2
6410627|NCT00943202|7324081|FG002|NOT COMPLETED|Overall Study||0
6410628|NCT00943202|7324082|FG003|NOT COMPLETED|Overall Study||1
6410629|NCT00943306|7324093|FG000|STARTED|Overall Study||19
6410630|NCT00943306|7324093|FG000|COMPLETED|Overall Study||16
6410631|NCT00943306|7324093|FG000|NOT COMPLETED|Overall Study||3
6410632|NCT00943319|7324097|FG000|STARTED|Overall Study||50
6410633|NCT00943319|7324097|FG000|COMPLETED|Overall Study||49
6410634|NCT00943319|7324097|FG000|NOT COMPLETED|Overall Study||1
6410635|NCT00943384|7324101|FG000|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
6410636|NCT00943384|7324101|FG000|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
6410637|NCT00943384|7324101|FG000|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
6410638|NCT00943384|7324101|FG000|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
6410639|NCT00943384|7324101|FG000|NOT COMPLETED|Overall Study||49
6410640|NCT00943436|7324107|FG000|STARTED|Exercise Session: 45 Minutes of Activity||10
6410641|NCT00943436|7324108|FG001|STARTED|Exercise Session: 45 Minutes of Activity||10
6410642|NCT00943436|7324107|FG000|COMPLETED|Exercise Session: 45 Minutes of Activity||10
6410643|NCT00943436|7324108|FG001|COMPLETED|Exercise Session: 45 Minutes of Activity||10
6410644|NCT00943436|7324107|FG000|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
6410645|NCT00943436|7324108|FG001|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
6410646|NCT00943436|7324107|FG000|STARTED|Rest Session: 45 Minutes of Reading||10
6410647|NCT00943436|7324108|FG001|STARTED|Rest Session: 45 Minutes of Reading||10
6410648|NCT00943436|7324107|FG000|COMPLETED|Rest Session: 45 Minutes of Reading||10
6410649|NCT00943436|7324108|FG001|COMPLETED|Rest Session: 45 Minutes of Reading||10
6410650|NCT00943436|7324107|FG000|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
6410651|NCT00943436|7324108|FG001|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
6410652|NCT00943488|7324116|FG000|STARTED|Overall Study||204
6410653|NCT00943488|7324117|FG001|STARTED|Overall Study||204
6410654|NCT00943488|7324116|FG000|COMPLETED|Overall Study||203
6410655|NCT00943488|7324117|FG001|COMPLETED|Overall Study||202
6410656|NCT00943488|7324116|FG000|NOT COMPLETED|Overall Study||1
6410657|NCT00943488|7324117|FG001|NOT COMPLETED|Overall Study||2
6410658|NCT00943579|7324125|FG000|STARTED|Overall Study||21
6410659|NCT00943579|7324126|FG001|STARTED|Overall Study||20
6410660|NCT00943579|7324125|FG000|COMPLETED|Overall Study||15
6410661|NCT00943579|7324126|FG001|COMPLETED|Overall Study||15
6410662|NCT00943579|7324125|FG000|NOT COMPLETED|Overall Study||6
6410663|NCT00943579|7324126|FG001|NOT COMPLETED|Overall Study||5
6410664|NCT00943592|7324135|FG000|STARTED|Overall Study||82
6410665|NCT00943592|7324135|FG000|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
6410666|NCT00943592|7324135|FG000|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
6410667|NCT00943592|7324135|FG000|NOT COMPLETED|Overall Study||3
6410668|NCT00943631|7324141|FG000|STARTED|Overall Study||202
6410669|NCT00943631|7324142|FG001|STARTED|Overall Study||204
6410670|NCT00943631|7324141|FG000|COMPLETED|Overall Study||198
6410671|NCT00943631|7324142|FG001|COMPLETED|Overall Study||202
6410672|NCT00943631|7324141|FG000|NOT COMPLETED|Overall Study||4
6410673|NCT00943631|7324142|FG001|NOT COMPLETED|Overall Study||2
6410674|NCT00943670|7324148|FG000|STARTED|Single-agent Trastuzumab Emtansine||51
6410675|NCT00943670|7324148|FG000|Treated|Single-agent Trastuzumab Emtansine||51
6410676|NCT00943670|7324148|FG000|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
6410677|NCT00943670|7324148|FG000|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
6410678|NCT00943670|7324148|FG000|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
6410679|NCT00943670|7324148|FG000|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
6410680|NCT00943670|7324148|FG000|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
6636970|NCT02315352|7565807|FG007|STARTED|First Intervention (Day 1)||0
6636971|NCT02315352|7565800|FG000|COMPLETED|First Intervention (Day 1)||24
6410681|NCT00943722|7324168|FG000|STARTED|Overall Study||648
6410682|NCT00943722|7324169|FG001|STARTED|Overall Study||643
6410683|NCT00943722|7324170|FG002|STARTED|Overall Study||644
6410684|NCT00943722|7324171|FG003|STARTED|Overall Study||669
6410685|NCT00943722|7324172|FG004|STARTED|Overall Study||470
6410686|NCT00943722|7324168|FG000|Vaccination 1|Overall Study||646
6410687|NCT00943722|7324169|FG001|Vaccination 1|Overall Study||642
6410688|NCT00943722|7324170|FG002|Vaccination 1|Overall Study||644
6410689|NCT00943722|7324171|FG003|Vaccination 1|Overall Study||666
6410690|NCT00943722|7324172|FG004|Vaccination 1|Overall Study||468
6410691|NCT00943722|7324168|FG000|Vaccination 2|Overall Study||637
6410692|NCT00943722|7324169|FG001|Vaccination 2|Overall Study||633
6410693|NCT00943722|7324170|FG002|Vaccination 2|Overall Study||638
6410694|NCT00943722|7324171|FG003|Vaccination 2|Overall Study||658
6510492|NCT01483118|7430111|FG000|NOT COMPLETED|Overall Study||12
6510493|NCT01483118|7430112|FG001|NOT COMPLETED|Overall Study||16
6510494|NCT01483144|7430123|FG000|STARTED|Overall Study||56
6510495|NCT01483144|7430124|FG001|STARTED|Overall Study||57
6510496|NCT01483144|7430125|FG002|STARTED|Overall Study||58
6510497|NCT01483144|7430123|FG000|COMPLETED|Overall Study||41
6510498|NCT01483144|7430124|FG001|COMPLETED|Overall Study||44
6510499|NCT01483144|7430125|FG002|COMPLETED|Overall Study||43
6510500|NCT01483144|7430123|FG000|NOT COMPLETED|Overall Study||15
6510501|NCT01483144|7430124|FG001|NOT COMPLETED|Overall Study||13
6510502|NCT01483144|7430125|FG002|NOT COMPLETED|Overall Study||15
6510503|NCT01483183|7430143|FG000|STARTED|Overall Study||4
6510504|NCT01483183|7430144|FG001|STARTED|Overall Study||1
6510505|NCT01483183|7430145|FG002|STARTED|Overall Study||5
6510506|NCT01483183|7430146|FG003|STARTED|Overall Study||3
6510507|NCT01483183|7430147|FG004|STARTED|Overall Study||4
6510508|NCT01483183|7430148|FG005|STARTED|Overall Study||4
6510509|NCT01483183|7430149|FG006|STARTED|Overall Study||6
6510510|NCT01483183|7430150|FG007|STARTED|Overall Study||4
6510511|NCT01483183|7430151|FG008|STARTED|Overall Study||4
6510512|NCT01483183|7430152|FG009|STARTED|Overall Study||5
6510513|NCT01483183|7430143|FG000|COMPLETED|Overall Study||4
6510514|NCT01483183|7430144|FG001|COMPLETED|Overall Study||1
6510515|NCT01483183|7430145|FG002|COMPLETED|Overall Study||5
6510516|NCT01483183|7430146|FG003|COMPLETED|Overall Study||3
6510517|NCT01483183|7430147|FG004|COMPLETED|Overall Study||4
6510518|NCT01483183|7430148|FG005|COMPLETED|Overall Study||4
6510519|NCT01483183|7430149|FG006|COMPLETED|Overall Study||4
6510520|NCT01483183|7430150|FG007|COMPLETED|Overall Study||4
6510521|NCT01483183|7430151|FG008|COMPLETED|Overall Study||4
6510522|NCT01483183|7430152|FG009|COMPLETED|Overall Study||4
6510523|NCT01483183|7430143|FG000|NOT COMPLETED|Overall Study||0
6510524|NCT01483183|7430144|FG001|NOT COMPLETED|Overall Study||0
6510525|NCT01483183|7430145|FG002|NOT COMPLETED|Overall Study||0
6510526|NCT01483183|7430146|FG003|NOT COMPLETED|Overall Study||0
6510527|NCT01483183|7430147|FG004|NOT COMPLETED|Overall Study||0
6510528|NCT01483183|7430148|FG005|NOT COMPLETED|Overall Study||0
6510529|NCT01483183|7430149|FG006|NOT COMPLETED|Overall Study||2
6510530|NCT01483183|7430150|FG007|NOT COMPLETED|Overall Study||0
6510531|NCT01483183|7430151|FG008|NOT COMPLETED|Overall Study||0
6510532|NCT01483183|7430152|FG009|NOT COMPLETED|Overall Study||1
6636972|NCT02315352|7565801|FG001|COMPLETED|First Intervention (Day 1)||24
6636973|NCT02315352|7565802|FG002|COMPLETED|First Intervention (Day 1)||0
6636974|NCT02315352|7565803|FG003|COMPLETED|First Intervention (Day 1)||0
6410695|NCT00943722|7324172|FG004|Vaccination 2|Overall Study||462
6410696|NCT00943722|7324168|FG000|Vaccination 3|Overall Study||635
6410697|NCT00943722|7324169|FG001|Vaccination 3|Overall Study||627
6410698|NCT00943722|7324170|FG002|Vaccination 3|Overall Study||637
6410699|NCT00943722|7324171|FG003|Vaccination 3|Overall Study||653
6410700|NCT00943722|7324172|FG004|Vaccination 3|Overall Study||455
6410701|NCT00943722|7324168|FG000|COMPLETED|Overall Study||623
6410702|NCT00943722|7324169|FG001|COMPLETED|Overall Study||621
6410703|NCT00943722|7324170|FG002|COMPLETED|Overall Study||631
6410704|NCT00943722|7324171|FG003|COMPLETED|Overall Study||647
6410705|NCT00943722|7324172|FG004|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
6410706|NCT00943722|7324168|FG000|NOT COMPLETED|Overall Study||25
6410707|NCT00943722|7324169|FG001|NOT COMPLETED|Overall Study||22
6410708|NCT00943722|7324170|FG002|NOT COMPLETED|Overall Study||13
6410709|NCT00943722|7324171|FG003|NOT COMPLETED|Overall Study||22
6410710|NCT00943722|7324172|FG004|NOT COMPLETED|Overall Study||22
6410711|NCT00943735|7324186|FG000|STARTED|Overall Study||774
6410712|NCT00943735|7324186|FG000|Per Protocol Population|Overall Study||500
6410713|NCT00943735|7324186|FG000|COMPLETED|Overall Study||742
6410714|NCT00943735|7324186|FG000|NOT COMPLETED|Overall Study||32
6410715|NCT00943761|7324192|FG000|STARTED|Overall Study||21
6410716|NCT00943761|7324193|FG001|STARTED|Overall Study||24
6410717|NCT00943761|7324192|FG000|COMPLETED|Overall Study||17
6410718|NCT00943761|7324193|FG001|COMPLETED|Overall Study||23
6410719|NCT00943761|7324192|FG000|NOT COMPLETED|Overall Study||4
6410720|NCT00943761|7324193|FG001|NOT COMPLETED|Overall Study||1
6410721|NCT00943787|7324199|FG000|STARTED|Overall Study||41
6410722|NCT00943787|7324199|FG000|COMPLETED|Overall Study||34
6410723|NCT00943787|7324199|FG000|NOT COMPLETED|Overall Study||7
6410724|NCT00943800|7324203|FG000|STARTED|Overall Study||87
6410725|NCT00943800|7324203|FG000|COMPLETED|Overall Study||87
6410726|NCT00943800|7324203|FG000|NOT COMPLETED|Overall Study||0
6410727|NCT00943826|7324209|FG000|STARTED|Concurrent Phase||458
6410728|NCT00943826|7324210|FG001|STARTED|Concurrent Phase||463
6410729|NCT00943826|7324209|FG000|Treated|Concurrent Phase||452
6410730|NCT00943826|7324210|FG001|Treated|Concurrent Phase||459
6410731|NCT00943826|7324209|FG000|COMPLETED|Concurrent Phase||397
6410732|NCT00943826|7324210|FG001|COMPLETED|Concurrent Phase||421
6410733|NCT00943826|7324209|FG000|NOT COMPLETED|Concurrent Phase||61
6410734|NCT00943826|7324210|FG001|NOT COMPLETED|Concurrent Phase||42
6410735|NCT00943826|7324209|FG000|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
6410736|NCT00943826|7324210|FG001|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
6410737|NCT00943826|7324209|FG000|COMPLETED|Maintenance Phase||353
6410738|NCT00943826|7324210|FG001|COMPLETED|Maintenance Phase||331
6410739|NCT00943826|7324209|FG000|NOT COMPLETED|Maintenance Phase||43
6410740|NCT00943826|7324210|FG001|NOT COMPLETED|Maintenance Phase||39
6410741|NCT00943826|7324209|FG000|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
6410742|NCT00943826|7324210|FG001|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
6410743|NCT00943826|7324209|FG000|COMPLETED|Monotherapy Phase||204
6410744|NCT00943826|7324210|FG001|COMPLETED|Monotherapy Phase||143
6410745|NCT00943826|7324209|FG000|NOT COMPLETED|Monotherapy Phase||65
6410746|NCT00943826|7324210|FG001|NOT COMPLETED|Monotherapy Phase||16
6410747|NCT00943826|7324209|FG000|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
6410748|NCT00943826|7324210|FG001|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
6410749|NCT00943826|7324209|FG000|COMPLETED|After Primary Overall Survival Analysis||0
6410750|NCT00943826|7324210|FG001|COMPLETED|After Primary Overall Survival Analysis||0
6410751|NCT00943826|7324209|FG000|NOT COMPLETED|After Primary Overall Survival Analysis||27
6410752|NCT00943826|7324210|FG001|NOT COMPLETED|After Primary Overall Survival Analysis||20
6410753|NCT00943878|7324221|FG000|STARTED|Overall Study||202
6410754|NCT00943878|7324222|FG001|STARTED|Overall Study||200
6410755|NCT00943878|7324223|FG002|STARTED|Overall Study||203
6410756|NCT00943878|7324224|FG003|STARTED|Overall Study||200
6410757|NCT00943878|7324221|FG000|COMPLETED|Overall Study||200
6410758|NCT00943878|7324222|FG001|COMPLETED|Overall Study||198
6410759|NCT00943878|7324223|FG002|COMPLETED|Overall Study||197
6410760|NCT00943878|7324224|FG003|COMPLETED|Overall Study||198
6410761|NCT00943878|7324221|FG000|NOT COMPLETED|Overall Study||2
6410762|NCT00943878|7324222|FG001|NOT COMPLETED|Overall Study||2
6410763|NCT00943878|7324223|FG002|NOT COMPLETED|Overall Study||6
6410764|NCT00943878|7324224|FG003|NOT COMPLETED|Overall Study||2
6410765|NCT00943904|7324234|FG000|STARTED|Overall Study||31
6410766|NCT00943904|7324234|FG000|COMPLETED|Overall Study||31
6410767|NCT00943904|7324234|FG000|NOT COMPLETED|Overall Study||0
6410768|NCT00943917|7324253|FG000|STARTED|Stage I||51
6410769|NCT00943917|7324254|FG001|STARTED|Stage I||51
6410770|NCT00943917|7324255|FG002|STARTED|Stage I||53
6410771|NCT00943917|7324256|FG003|STARTED|Stage I||0
6410772|NCT00943917|7324257|FG004|STARTED|Stage I||0
6410773|NCT00943917|7324258|FG005|STARTED|Stage I||0
6410774|NCT00943917|7324259|FG006|STARTED|Stage I||0
6410775|NCT00943917|7324260|FG007|STARTED|Stage I||0
6410776|NCT00943917|7324261|FG008|STARTED|Stage I||0
6410777|NCT00943917|7324262|FG009|STARTED|Stage I||0
6410778|NCT00943917|7324263|FG010|STARTED|Stage I||0
6410779|NCT00943917|7324264|FG011|STARTED|Stage I||0
6410780|NCT00943917|7324265|FG012|STARTED|Stage I||0
6410781|NCT00943917|7324266|FG013|STARTED|Stage I||0
6410782|NCT00943917|7324267|FG014|STARTED|Stage I||0
6410783|NCT00943917|7324253|FG000|COMPLETED|Stage I||47
6410784|NCT00943917|7324254|FG001|COMPLETED|Stage I||48
6410785|NCT00943917|7324255|FG002|COMPLETED|Stage I||47
6410786|NCT00943917|7324256|FG003|COMPLETED|Stage I||0
6410787|NCT00943917|7324257|FG004|COMPLETED|Stage I||0
6410788|NCT00943917|7324258|FG005|COMPLETED|Stage I||0
6410789|NCT00943917|7324259|FG006|COMPLETED|Stage I||0
6410790|NCT00943917|7324260|FG007|COMPLETED|Stage I||0
6410791|NCT00943917|7324261|FG008|COMPLETED|Stage I||0
6410792|NCT00943917|7324262|FG009|COMPLETED|Stage I||0
6410793|NCT00943917|7324263|FG010|COMPLETED|Stage I||0
6410794|NCT00943917|7324264|FG011|COMPLETED|Stage I||0
6410795|NCT00943917|7324265|FG012|COMPLETED|Stage I||0
6410796|NCT00943917|7324266|FG013|COMPLETED|Stage I||0
6410797|NCT00943917|7324267|FG014|COMPLETED|Stage I||0
6410798|NCT00943917|7324253|FG000|NOT COMPLETED|Stage I||4
6410799|NCT00943917|7324254|FG001|NOT COMPLETED|Stage I||3
6410800|NCT00943917|7324255|FG002|NOT COMPLETED|Stage I||6
6410801|NCT00943917|7324256|FG003|NOT COMPLETED|Stage I||0
6410802|NCT00943917|7324257|FG004|NOT COMPLETED|Stage I||0
6410803|NCT00943917|7324258|FG005|NOT COMPLETED|Stage I||0
6410804|NCT00943917|7324259|FG006|NOT COMPLETED|Stage I||0
6410805|NCT00943917|7324260|FG007|NOT COMPLETED|Stage I||0
6410806|NCT00943917|7324261|FG008|NOT COMPLETED|Stage I||0
6410807|NCT00943917|7324262|FG009|NOT COMPLETED|Stage I||0
6410808|NCT00943917|7324263|FG010|NOT COMPLETED|Stage I||0
6636975|NCT02315352|7565804|FG004|COMPLETED|First Intervention (Day 1)||0
6636976|NCT02315352|7565805|FG005|COMPLETED|First Intervention (Day 1)||0
6636977|NCT02315352|7565806|FG006|COMPLETED|First Intervention (Day 1)||0
6636978|NCT02315352|7565807|FG007|COMPLETED|First Intervention (Day 1)||0
6636979|NCT02315352|7565800|FG000|NOT COMPLETED|First Intervention (Day 1)||0
6636980|NCT02315352|7565801|FG001|NOT COMPLETED|First Intervention (Day 1)||0
6636981|NCT02315352|7565802|FG002|NOT COMPLETED|First Intervention (Day 1)||0
6636982|NCT02315352|7565803|FG003|NOT COMPLETED|First Intervention (Day 1)||0
6636983|NCT02315352|7565804|FG004|NOT COMPLETED|First Intervention (Day 1)||0
6636984|NCT02315352|7565805|FG005|NOT COMPLETED|First Intervention (Day 1)||0
6636985|NCT02315352|7565806|FG006|NOT COMPLETED|First Intervention (Day 1)||0
6636986|NCT02315352|7565807|FG007|NOT COMPLETED|First Intervention (Day 1)||0
6636987|NCT02315352|7565800|FG000|STARTED|Second Intervention (Day 1)||24
6636988|NCT02315352|7565801|FG001|STARTED|Second Intervention (Day 1)||24
6636989|NCT02315352|7565802|FG002|STARTED|Second Intervention (Day 1)||0
6636990|NCT02315352|7565803|FG003|STARTED|Second Intervention (Day 1)||0
6410809|NCT00943917|7324264|FG011|NOT COMPLETED|Stage I||0
6410810|NCT00943917|7324265|FG012|NOT COMPLETED|Stage I||0
6410811|NCT00943917|7324266|FG013|NOT COMPLETED|Stage I||0
6410812|NCT00943917|7324267|FG014|NOT COMPLETED|Stage I||0
6410813|NCT00943917|7324253|FG000|STARTED|Stage II||0
6410814|NCT00943917|7324254|FG001|STARTED|Stage II||0
6410815|NCT00943917|7324255|FG002|STARTED|Stage II||0
6410816|NCT00943917|7324256|FG003|STARTED|Stage II||20
6410817|NCT00943917|7324257|FG004|STARTED|Stage II||21
6410818|NCT00943917|7324258|FG005|STARTED|Stage II||23
6410819|NCT00943917|7324259|FG006|STARTED|Stage II||23
6410820|NCT00943917|7324260|FG007|STARTED|Stage II||23
6410821|NCT00943917|7324261|FG008|STARTED|Stage II||21
6410822|NCT00943917|7324262|FG009|STARTED|Stage II||0
6410823|NCT00943917|7324263|FG010|STARTED|Stage II||0
6410824|NCT00943917|7324264|FG011|STARTED|Stage II||0
6410825|NCT00943917|7324265|FG012|STARTED|Stage II||0
6410826|NCT00943917|7324266|FG013|STARTED|Stage II||0
6410827|NCT00943917|7324267|FG014|STARTED|Stage II||0
6410828|NCT00943917|7324253|FG000|COMPLETED|Stage II||0
6410829|NCT00943917|7324254|FG001|COMPLETED|Stage II||0
6410830|NCT00943917|7324255|FG002|COMPLETED|Stage II||0
6410831|NCT00943917|7324256|FG003|COMPLETED|Stage II||20
6410832|NCT00943917|7324257|FG004|COMPLETED|Stage II||21
6410833|NCT00943917|7324258|FG005|COMPLETED|Stage II||20
6410834|NCT00943917|7324259|FG006|COMPLETED|Stage II||20
6410835|NCT00943917|7324260|FG007|COMPLETED|Stage II||23
6636991|NCT02315352|7565804|FG004|STARTED|Second Intervention (Day 1)||0
6636992|NCT02315352|7565805|FG005|STARTED|Second Intervention (Day 1)||0
6636993|NCT02315352|7565806|FG006|STARTED|Second Intervention (Day 1)||0
6636994|NCT02315352|7565807|FG007|STARTED|Second Intervention (Day 1)||0
6636995|NCT02315352|7565800|FG000|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
6636996|NCT02315352|7565801|FG001|COMPLETED|Second Intervention (Day 1)||24
6636997|NCT02315352|7565802|FG002|COMPLETED|Second Intervention (Day 1)||0
6636998|NCT02315352|7565803|FG003|COMPLETED|Second Intervention (Day 1)||0
6636999|NCT02315352|7565804|FG004|COMPLETED|Second Intervention (Day 1)||0
6410836|NCT00943917|7324261|FG008|COMPLETED|Stage II||20
6410837|NCT00943917|7324262|FG009|COMPLETED|Stage II||0
6410838|NCT00943917|7324263|FG010|COMPLETED|Stage II||0
6410839|NCT00943917|7324264|FG011|COMPLETED|Stage II||0
6410840|NCT00943917|7324265|FG012|COMPLETED|Stage II||0
6410841|NCT00943917|7324266|FG013|COMPLETED|Stage II||0
6410842|NCT00943917|7324267|FG014|COMPLETED|Stage II||0
6410843|NCT00943917|7324253|FG000|NOT COMPLETED|Stage II||0
6410844|NCT00943917|7324254|FG001|NOT COMPLETED|Stage II||0
6410845|NCT00943917|7324255|FG002|NOT COMPLETED|Stage II||0
6410846|NCT00943917|7324256|FG003|NOT COMPLETED|Stage II||0
6410847|NCT00943917|7324257|FG004|NOT COMPLETED|Stage II||0
6410848|NCT00943917|7324258|FG005|NOT COMPLETED|Stage II||3
6410849|NCT00943917|7324259|FG006|NOT COMPLETED|Stage II||3
6410850|NCT00943917|7324260|FG007|NOT COMPLETED|Stage II||0
6410851|NCT00943917|7324261|FG008|NOT COMPLETED|Stage II||1
6410852|NCT00943917|7324262|FG009|NOT COMPLETED|Stage II||0
6410853|NCT00943917|7324263|FG010|NOT COMPLETED|Stage II||0
6410854|NCT00943917|7324264|FG011|NOT COMPLETED|Stage II||0
6410855|NCT00943917|7324265|FG012|NOT COMPLETED|Stage II||0
6410856|NCT00943917|7324266|FG013|NOT COMPLETED|Stage II||0
6410857|NCT00943917|7324267|FG014|NOT COMPLETED|Stage II||0
6410858|NCT00943917|7324253|FG000|STARTED|Stage II Continuation||0
6410859|NCT00943917|7324254|FG001|STARTED|Stage II Continuation||0
6410860|NCT00943917|7324255|FG002|STARTED|Stage II Continuation||0
6410861|NCT00943917|7324256|FG003|STARTED|Stage II Continuation||0
6410862|NCT00943917|7324257|FG004|STARTED|Stage II Continuation||0
6410863|NCT00943917|7324258|FG005|STARTED|Stage II Continuation||0
6410864|NCT00943917|7324259|FG006|STARTED|Stage II Continuation||0
6410865|NCT00943917|7324260|FG007|STARTED|Stage II Continuation||0
6410866|NCT00943917|7324261|FG008|STARTED|Stage II Continuation||0
6410867|NCT00943917|7324262|FG009|STARTED|Stage II Continuation||15
6410868|NCT00943917|7324263|FG010|STARTED|Stage II Continuation||15
6410869|NCT00943917|7324264|FG011|STARTED|Stage II Continuation||13
6410870|NCT00943917|7324265|FG012|STARTED|Stage II Continuation||16
6410871|NCT00943917|7324266|FG013|STARTED|Stage II Continuation||15
6410872|NCT00943917|7324267|FG014|STARTED|Stage II Continuation||12
6410873|NCT00943917|7324253|FG000|COMPLETED|Stage II Continuation||0
6410874|NCT00943917|7324254|FG001|COMPLETED|Stage II Continuation||0
6410875|NCT00943917|7324255|FG002|COMPLETED|Stage II Continuation||0
6410876|NCT00943917|7324256|FG003|COMPLETED|Stage II Continuation||0
6410877|NCT00943917|7324257|FG004|COMPLETED|Stage II Continuation||0
6410878|NCT00943917|7324258|FG005|COMPLETED|Stage II Continuation||0
6410879|NCT00943917|7324259|FG006|COMPLETED|Stage II Continuation||0
6410880|NCT00943917|7324260|FG007|COMPLETED|Stage II Continuation||0
6410881|NCT00943917|7324261|FG008|COMPLETED|Stage II Continuation||0
6410882|NCT00943917|7324262|FG009|COMPLETED|Stage II Continuation||14
6410883|NCT00943917|7324263|FG010|COMPLETED|Stage II Continuation||15
6410884|NCT00943917|7324264|FG011|COMPLETED|Stage II Continuation||11
6410885|NCT00943917|7324265|FG012|COMPLETED|Stage II Continuation||13
6410886|NCT00943917|7324266|FG013|COMPLETED|Stage II Continuation||12
6410887|NCT00943917|7324267|FG014|COMPLETED|Stage II Continuation||8
6410888|NCT00943917|7324253|FG000|NOT COMPLETED|Stage II Continuation||0
6410889|NCT00943917|7324254|FG001|NOT COMPLETED|Stage II Continuation||0
6410890|NCT00943917|7324255|FG002|NOT COMPLETED|Stage II Continuation||0
6410891|NCT00943917|7324256|FG003|NOT COMPLETED|Stage II Continuation||0
6410892|NCT00943917|7324257|FG004|NOT COMPLETED|Stage II Continuation||0
6410893|NCT00943917|7324258|FG005|NOT COMPLETED|Stage II Continuation||0
6410894|NCT00943917|7324259|FG006|NOT COMPLETED|Stage II Continuation||0
6410895|NCT00943917|7324260|FG007|NOT COMPLETED|Stage II Continuation||0
6410896|NCT00943917|7324261|FG008|NOT COMPLETED|Stage II Continuation||0
6410897|NCT00943917|7324262|FG009|NOT COMPLETED|Stage II Continuation||1
6410898|NCT00943917|7324263|FG010|NOT COMPLETED|Stage II Continuation||0
6410899|NCT00943917|7324264|FG011|NOT COMPLETED|Stage II Continuation||2
6410900|NCT00943917|7324265|FG012|NOT COMPLETED|Stage II Continuation||3
6410901|NCT00943917|7324266|FG013|NOT COMPLETED|Stage II Continuation||3
6410902|NCT00943917|7324267|FG014|NOT COMPLETED|Stage II Continuation||4
6410903|NCT00944021|7324305|FG000|STARTED|Overall Study||15
6410904|NCT00944021|7324306|FG001|STARTED|Overall Study||15
6410905|NCT00944021|7324307|FG002|STARTED|Overall Study||15
6410906|NCT00944021|7324308|FG003|STARTED|Overall Study||16
6410907|NCT00944021|7324309|FG004|STARTED|Overall Study||8
6410908|NCT00944021|7324305|FG000|COMPLETED|Overall Study||14
6410909|NCT00944021|7324306|FG001|COMPLETED|Overall Study||15
6410910|NCT00944021|7324307|FG002|COMPLETED|Overall Study||15
6410911|NCT00944021|7324308|FG003|COMPLETED|Overall Study||16
6410912|NCT00944021|7324309|FG004|COMPLETED|Overall Study||8
6410913|NCT00944021|7324305|FG000|NOT COMPLETED|Overall Study||1
6410914|NCT00944021|7324306|FG001|NOT COMPLETED|Overall Study||0
6410915|NCT00944021|7324307|FG002|NOT COMPLETED|Overall Study||0
6410916|NCT00944021|7324308|FG003|NOT COMPLETED|Overall Study||0
6410917|NCT00944021|7324309|FG004|NOT COMPLETED|Overall Study||0
6637000|NCT02315352|7565805|FG005|COMPLETED|Second Intervention (Day 1)||0
6637001|NCT02315352|7565806|FG006|COMPLETED|Second Intervention (Day 1)||0
6637002|NCT02315352|7565807|FG007|COMPLETED|Second Intervention (Day 1)||0
6410918|NCT00944034|7324333|FG000|STARTED|Overall Study||188
6410919|NCT00944034|7324334|FG001|STARTED|Overall Study||157
6410920|NCT00944034|7324335|FG002|STARTED|Overall Study||152
6410921|NCT00944034|7324336|FG003|STARTED|Overall Study||174
6410922|NCT00944034|7324337|FG004|STARTED|Overall Study||164
6410923|NCT00944034|7324338|FG005|STARTED|Overall Study||143
6410924|NCT00944034|7324339|FG006|STARTED|Overall Study||106
6410925|NCT00944034|7324340|FG007|STARTED|Overall Study||78
6410926|NCT00944034|7324341|FG008|STARTED|Overall Study||73
6410927|NCT00944034|7324342|FG009|STARTED|Overall Study||246
6410928|NCT00944034|7324343|FG010|STARTED|Overall Study||51
6410929|NCT00944034|7324344|FG011|STARTED|Overall Study||56
6410930|NCT00944034|7324333|FG000|COMPLETED|Overall Study||183
6637003|NCT02315352|7565800|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
6410931|NCT00944034|7324334|FG001|COMPLETED|Overall Study||150
6410932|NCT00944034|7324335|FG002|COMPLETED|Overall Study||143
6410933|NCT00944034|7324336|FG003|COMPLETED|Overall Study||170
6410934|NCT00944034|7324337|FG004|COMPLETED|Overall Study||150
6410935|NCT00944034|7324338|FG005|COMPLETED|Overall Study||123
6410936|NCT00944034|7324339|FG006|COMPLETED|Overall Study||102
6410937|NCT00944034|7324340|FG007|COMPLETED|Overall Study||73
6410938|NCT00944034|7324341|FG008|COMPLETED|Overall Study||63
6410939|NCT00944034|7324342|FG009|COMPLETED|Overall Study||236
6410940|NCT00944034|7324343|FG010|COMPLETED|Overall Study||50
6410941|NCT00944034|7324344|FG011|COMPLETED|Overall Study||52
6410942|NCT00944034|7324333|FG000|NOT COMPLETED|Overall Study||5
6410943|NCT00944034|7324334|FG001|NOT COMPLETED|Overall Study||7
6410944|NCT00944034|7324335|FG002|NOT COMPLETED|Overall Study||9
6410945|NCT00944034|7324336|FG003|NOT COMPLETED|Overall Study||4
6410946|NCT00944034|7324337|FG004|NOT COMPLETED|Overall Study||14
6410947|NCT00944034|7324338|FG005|NOT COMPLETED|Overall Study||20
6410948|NCT00944034|7324339|FG006|NOT COMPLETED|Overall Study||4
6410949|NCT00944034|7324340|FG007|NOT COMPLETED|Overall Study||5
6410950|NCT00944034|7324341|FG008|NOT COMPLETED|Overall Study||10
6410951|NCT00944034|7324342|FG009|NOT COMPLETED|Overall Study||10
6410952|NCT00944034|7324343|FG010|NOT COMPLETED|Overall Study||1
6410953|NCT00944034|7324344|FG011|NOT COMPLETED|Overall Study||4
6410954|NCT00944047|7324387|FG000|STARTED|Overall Study||32
6410955|NCT00944047|7324387|FG000|COMPLETED|Overall Study||27
6410956|NCT00944047|7324387|FG000|NOT COMPLETED|Overall Study||5
6637004|NCT02315352|7565801|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
6637005|NCT02315352|7565802|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
6637006|NCT02315352|7565803|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
6637007|NCT02315352|7565804|FG004|NOT COMPLETED|Second Intervention (Day 1)||0
6637008|NCT02315352|7565805|FG005|NOT COMPLETED|Second Intervention (Day 1)||0
6637009|NCT02315352|7565806|FG006|NOT COMPLETED|Second Intervention (Day 1)||0
6637010|NCT02315352|7565807|FG007|NOT COMPLETED|Second Intervention (Day 1)||0
6637011|NCT02315352|7565800|FG000|STARTED|Third Intervention (Day 2)||0
6637012|NCT02315352|7565801|FG001|STARTED|Third Intervention (Day 2)||0
6410957|NCT00944073|7324393|FG000|STARTED|Overall Study||292
6410958|NCT00944073|7324394|FG001|STARTED|Overall Study||291
6410959|NCT00944073|7324393|FG000|COMPLETED|Overall Study||287
6410960|NCT00944073|7324394|FG001|COMPLETED|Overall Study||287
6410961|NCT00944073|7324393|FG000|NOT COMPLETED|Overall Study||5
6410962|NCT00944073|7324394|FG001|NOT COMPLETED|Overall Study||4
6410963|NCT00944125|7324400|FG000|STARTED|Baseline to 3 Months||19
6410964|NCT00944125|7324401|FG001|STARTED|Baseline to 3 Months||22
6410965|NCT00944125|7324400|FG000|COMPLETED|Baseline to 3 Months||19
6410966|NCT00944125|7324401|FG001|COMPLETED|Baseline to 3 Months||22
6410967|NCT00944125|7324400|FG000|NOT COMPLETED|Baseline to 3 Months||0
6410968|NCT00944125|7324401|FG001|NOT COMPLETED|Baseline to 3 Months||0
6410969|NCT00944125|7324400|FG000|STARTED|3 to 6 Months||19
6410970|NCT00944125|7324401|FG001|STARTED|3 to 6 Months||22
6410971|NCT00944125|7324400|FG000|COMPLETED|3 to 6 Months||19
6410972|NCT00944125|7324401|FG001|COMPLETED|3 to 6 Months||20
6410973|NCT00944125|7324400|FG000|NOT COMPLETED|3 to 6 Months||0
6410974|NCT00944125|7324401|FG001|NOT COMPLETED|3 to 6 Months||2
6410975|NCT00944125|7324400|FG000|STARTED|6 Months to Study Completion||19
6410976|NCT00944125|7324401|FG001|STARTED|6 Months to Study Completion||20
6410977|NCT00944125|7324400|FG000|COMPLETED|6 Months to Study Completion||19
6410978|NCT00944125|7324401|FG001|COMPLETED|6 Months to Study Completion||18
6410979|NCT00944125|7324400|FG000|NOT COMPLETED|6 Months to Study Completion||0
6410980|NCT00944125|7324401|FG001|NOT COMPLETED|6 Months to Study Completion||2
6410981|NCT00944450|7324407|FG000|STARTED|Period 1||6
6410982|NCT00944450|7324408|FG001|STARTED|Period 1||6
6410983|NCT00944450|7324407|FG000|COMPLETED|Period 1||6
6410984|NCT00944450|7324408|FG001|COMPLETED|Period 1||6
6410985|NCT00944450|7324407|FG000|NOT COMPLETED|Period 1||0
6410986|NCT00944450|7324408|FG001|NOT COMPLETED|Period 1||0
6410987|NCT00944450|7324407|FG000|STARTED|Period 2||6
6410988|NCT00944450|7324408|FG001|STARTED|Period 2||6
6410989|NCT00944450|7324407|FG000|COMPLETED|Period 2||6
6410990|NCT00944450|7324408|FG001|COMPLETED|Period 2||6
6410991|NCT00944450|7324407|FG000|NOT COMPLETED|Period 2||0
6410992|NCT00944450|7324408|FG001|NOT COMPLETED|Period 2||0
6410993|NCT00944554|7324416|FG000|STARTED|Overall Study||50
6410994|NCT00944554|7324417|FG001|STARTED|Overall Study||54
6410995|NCT00944554|7324416|FG000|COMPLETED|Overall Study||22
6410996|NCT00944554|7324417|FG001|COMPLETED|Overall Study||25
6410997|NCT00944554|7324416|FG000|NOT COMPLETED|Overall Study||28
6410998|NCT00944554|7324417|FG001|NOT COMPLETED|Overall Study||29
6410999|NCT00944645|7324423|FG000|STARTED|Period 1||94
6411000|NCT00944645|7324424|FG001|STARTED|Period 1||94
6411001|NCT00944645|7324423|FG000|COMPLETED|Period 1||94
6411002|NCT00944645|7324424|FG001|COMPLETED|Period 1||94
6411003|NCT00944645|7324423|FG000|NOT COMPLETED|Period 1||0
6637013|NCT02315352|7565802|FG002|STARTED|Third Intervention (Day 2)||7
6411004|NCT00944645|7324424|FG001|NOT COMPLETED|Period 1||0
6411005|NCT00944645|7324423|FG000|STARTED|Period 2||94
6411006|NCT00944645|7324424|FG001|STARTED|Period 2||94
6411007|NCT00944645|7324423|FG000|COMPLETED|Period 2||86
6411008|NCT00944645|7324424|FG001|COMPLETED|Period 2||85
6411009|NCT00944645|7324423|FG000|NOT COMPLETED|Period 2||8
6411010|NCT00944645|7324424|FG001|NOT COMPLETED|Period 2||9
6411011|NCT00944658|7324432|FG000|STARTED|Treatment 12 Weeks||19
6411012|NCT00944658|7324433|FG001|STARTED|Treatment 12 Weeks||19
6411013|NCT00944658|7324432|FG000|COMPLETED|Treatment 12 Weeks||19
6411014|NCT00944658|7324433|FG001|COMPLETED|Treatment 12 Weeks||17
6411015|NCT00944658|7324432|FG000|NOT COMPLETED|Treatment 12 Weeks||0
6411016|NCT00944658|7324433|FG001|NOT COMPLETED|Treatment 12 Weeks||2
6411017|NCT00944658|7324432|FG000|STARTED|Follow up 4 Weeks||19
6411018|NCT00944658|7324433|FG001|STARTED|Follow up 4 Weeks||17
6411019|NCT00944658|7324432|FG000|COMPLETED|Follow up 4 Weeks||19
6411020|NCT00944658|7324433|FG001|COMPLETED|Follow up 4 Weeks||17
6411021|NCT00944658|7324432|FG000|NOT COMPLETED|Follow up 4 Weeks||0
6411022|NCT00944658|7324433|FG001|NOT COMPLETED|Follow up 4 Weeks||0
6411023|NCT00944671|7324445|FG000|STARTED|Period I||4
6411024|NCT00944671|7324446|FG001|STARTED|Period I||4
6411025|NCT00944671|7324447|FG002|STARTED|Period I||4
6411026|NCT00944671|7324448|FG003|STARTED|Period I||4
6411027|NCT00944671|7324449|FG004|STARTED|Period I||4
6411028|NCT00944671|7324450|FG005|STARTED|Period I||4
6411029|NCT00944671|7324445|FG000|COMPLETED|Period I||4
6411030|NCT00944671|7324446|FG001|COMPLETED|Period I||4
6411031|NCT00944671|7324447|FG002|COMPLETED|Period I||4
6411032|NCT00944671|7324448|FG003|COMPLETED|Period I||4
6411033|NCT00944671|7324449|FG004|COMPLETED|Period I||4
6411034|NCT00944671|7324450|FG005|COMPLETED|Period I||4
6411035|NCT00944671|7324445|FG000|NOT COMPLETED|Period I||0
6411036|NCT00944671|7324446|FG001|NOT COMPLETED|Period I||0
6411037|NCT00944671|7324447|FG002|NOT COMPLETED|Period I||0
6411038|NCT00944671|7324448|FG003|NOT COMPLETED|Period I||0
6411039|NCT00944671|7324449|FG004|NOT COMPLETED|Period I||0
6411040|NCT00944671|7324450|FG005|NOT COMPLETED|Period I||0
6411041|NCT00944671|7324445|FG000|STARTED|Period II||4
6411042|NCT00944671|7324446|FG001|STARTED|Period II||4
6411043|NCT00944671|7324447|FG002|STARTED|Period II||4
6411044|NCT00944671|7324448|FG003|STARTED|Period II||4
6411045|NCT00944671|7324449|FG004|STARTED|Period II||4
6411046|NCT00944671|7324450|FG005|STARTED|Period II||4
6411047|NCT00944671|7324445|FG000|COMPLETED|Period II||4
6411048|NCT00944671|7324446|FG001|COMPLETED|Period II||4
6411049|NCT00944671|7324447|FG002|COMPLETED|Period II||4
6411050|NCT00944671|7324448|FG003|COMPLETED|Period II||4
6411051|NCT00944671|7324449|FG004|COMPLETED|Period II||4
6411052|NCT00944671|7324450|FG005|COMPLETED|Period II||4
6411053|NCT00944671|7324445|FG000|NOT COMPLETED|Period II||0
6411054|NCT00944671|7324446|FG001|NOT COMPLETED|Period II||0
6411055|NCT00944671|7324447|FG002|NOT COMPLETED|Period II||0
6411056|NCT00944671|7324448|FG003|NOT COMPLETED|Period II||0
6411057|NCT00944671|7324449|FG004|NOT COMPLETED|Period II||0
6411058|NCT00944671|7324450|FG005|NOT COMPLETED|Period II||0
6411059|NCT00944671|7324445|FG000|STARTED|Period III||4
6411060|NCT00944671|7324446|FG001|STARTED|Period III||4
6411061|NCT00944671|7324447|FG002|STARTED|Period III||4
6411062|NCT00944671|7324448|FG003|STARTED|Period III||4
6411063|NCT00944671|7324449|FG004|STARTED|Period III||4
6411064|NCT00944671|7324450|FG005|STARTED|Period III||4
6411065|NCT00944671|7324445|FG000|COMPLETED|Period III||4
6411066|NCT00944671|7324446|FG001|COMPLETED|Period III||4
6411067|NCT00944671|7324447|FG002|COMPLETED|Period III||4
6411068|NCT00944671|7324448|FG003|COMPLETED|Period III||4
6411069|NCT00944671|7324449|FG004|COMPLETED|Period III||4
6411070|NCT00944671|7324450|FG005|COMPLETED|Period III||4
6411071|NCT00944671|7324445|FG000|NOT COMPLETED|Period III||0
6411072|NCT00944671|7324446|FG001|NOT COMPLETED|Period III||0
6411073|NCT00944671|7324447|FG002|NOT COMPLETED|Period III||0
6411074|NCT00944671|7324448|FG003|NOT COMPLETED|Period III||0
6411075|NCT00944671|7324449|FG004|NOT COMPLETED|Period III||0
6411076|NCT00944671|7324450|FG005|NOT COMPLETED|Period III||0
6411077|NCT00944697|7324460|FG000|STARTED|Overall Study||50
6411078|NCT00944697|7324461|FG001|STARTED|Overall Study||48
6411079|NCT00944697|7324460|FG000|COMPLETED|Overall Study||48
6411080|NCT00944697|7324461|FG001|COMPLETED|Overall Study||43
6411081|NCT00944697|7324460|FG000|NOT COMPLETED|Overall Study||2
6411082|NCT00944697|7324461|FG001|NOT COMPLETED|Overall Study||5
6411083|NCT00944710|7324469|FG000|STARTED|10-week Primary Outcome||40
6411084|NCT00944710|7324470|FG001|STARTED|10-week Primary Outcome||33
6411085|NCT00944710|7324469|FG000|COMPLETED|10-week Primary Outcome||40
6411086|NCT00944710|7324470|FG001|COMPLETED|10-week Primary Outcome||33
6411087|NCT00944710|7324469|FG000|NOT COMPLETED|10-week Primary Outcome||0
6411088|NCT00944710|7324470|FG001|NOT COMPLETED|10-week Primary Outcome||0
6411089|NCT00944710|7324469|FG000|STARTED|12-week Visit (Off-treatment)||40
6411090|NCT00944710|7324470|FG001|STARTED|12-week Visit (Off-treatment)||33
6411091|NCT00944710|7324469|FG000|COMPLETED|12-week Visit (Off-treatment)||40
6411092|NCT00944710|7324470|FG001|COMPLETED|12-week Visit (Off-treatment)||33
6411093|NCT00944710|7324469|FG000|NOT COMPLETED|12-week Visit (Off-treatment)||0
6411094|NCT00944710|7324470|FG001|NOT COMPLETED|12-week Visit (Off-treatment)||0
6411095|NCT00944710|7324469|FG000|STARTED|Additional Post 10-week Primary Outcome||40
6510533|NCT01483352|7430180|FG000|STARTED|Overall Study||12
6510534|NCT01483352|7430180|FG000|COMPLETED|Overall Study||12
6411096|NCT00944710|7324470|FG001|STARTED|Additional Post 10-week Primary Outcome||33
6411097|NCT00944710|7324469|FG000|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
6411098|NCT00944710|7324470|FG001|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
6411099|NCT00944710|7324469|FG000|COMPLETED|Additional Post 10-week Primary Outcome||23
6510535|NCT01483352|7430180|FG000|NOT COMPLETED|Overall Study||0
6411100|NCT00944710|7324470|FG001|COMPLETED|Additional Post 10-week Primary Outcome||22
6411101|NCT00944710|7324469|FG000|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
6411102|NCT00944710|7324470|FG001|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
6411103|NCT00944749|7324476|FG000|STARTED|Overall Study||23
6637014|NCT02315352|7565803|FG003|STARTED|Third Intervention (Day 2)||8
6743465|NCT03334721|7671691|FG000|COMPLETED|Overall Study||10
6411104|NCT00944749|7324476|FG000|COMPLETED|Overall Study||22
6411105|NCT00944749|7324476|FG000|NOT COMPLETED|Overall Study||1
6411106|NCT00945061|7324482|FG000|STARTED|Overall Study||12
6411107|NCT00945061|7324483|FG001|STARTED|Overall Study||1
6411108|NCT00945061|7324482|FG000|COMPLETED|Overall Study||12
6411109|NCT00945061|7324483|FG001|COMPLETED|Overall Study||1
6411110|NCT00945061|7324482|FG000|NOT COMPLETED|Overall Study||0
6411111|NCT00945061|7324483|FG001|NOT COMPLETED|Overall Study||0
6411112|NCT00945100|7324500|FG000|STARTED|10-week Primary Outcome||83
6411113|NCT00945100|7324501|FG001|STARTED|10-week Primary Outcome||86
6411114|NCT00945100|7324500|FG000|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
6411115|NCT00945100|7324501|FG001|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
6411116|NCT00945100|7324500|FG000|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
6411117|NCT00945100|7324501|FG001|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
6411118|NCT00945100|7324500|FG000|COMPLETED|10-week Primary Outcome||82
6411119|NCT00945100|7324501|FG001|COMPLETED|10-week Primary Outcome||83
6411120|NCT00945100|7324500|FG000|NOT COMPLETED|10-week Primary Outcome||1
6411121|NCT00945100|7324501|FG001|NOT COMPLETED|10-week Primary Outcome||3
6411122|NCT00945100|7324500|FG000|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
6411123|NCT00945100|7324501|FG001|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
6411124|NCT00945100|7324500|FG000|COMPLETED|Post-10 Week Primary Outcome||51
6411125|NCT00945100|7324501|FG001|COMPLETED|Post-10 Week Primary Outcome||56
6411126|NCT00945100|7324500|FG000|NOT COMPLETED|Post-10 Week Primary Outcome||4
6411127|NCT00945100|7324501|FG001|NOT COMPLETED|Post-10 Week Primary Outcome||7
6411128|NCT00945139|7324507|FG000|STARTED|Overall Study||46
6411129|NCT00945139|7324507|FG000|COMPLETED|Overall Study||46
6411130|NCT00945139|7324507|FG000|NOT COMPLETED|Overall Study||0
6411131|NCT00945191|7324512|FG000|STARTED|Overall Study||24
6411132|NCT00945191|7324512|FG000|COMPLETED|Overall Study||0
6411133|NCT00945191|7324512|FG000|NOT COMPLETED|Overall Study||24
6411134|NCT00945243|7324516|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
6411135|NCT00945243|7324516|FG000|COMPLETED|Overall Study||8
6411136|NCT00945243|7324516|FG000|NOT COMPLETED|Overall Study||3
6411137|NCT00945256|7324525|FG000|STARTED|Overall Study||13
6411138|NCT00945256|7324526|FG001|STARTED|Overall Study||10
6411139|NCT00945256|7324527|FG002|STARTED|Overall Study||15
6411140|NCT00945256|7324528|FG003|STARTED|Overall Study||16
6411141|NCT00945256|7324529|FG004|STARTED|Overall Study||8
6411142|NCT00945256|7324525|FG000|COMPLETED|Overall Study||9
6411143|NCT00945256|7324526|FG001|COMPLETED|Overall Study||8
6411144|NCT00945256|7324527|FG002|COMPLETED|Overall Study||7
6411145|NCT00945256|7324528|FG003|COMPLETED|Overall Study||7
6411146|NCT00945256|7324529|FG004|COMPLETED|Overall Study||7
6411147|NCT00945256|7324525|FG000|NOT COMPLETED|Overall Study||4
6411148|NCT00945256|7324526|FG001|NOT COMPLETED|Overall Study||2
6411149|NCT00945256|7324527|FG002|NOT COMPLETED|Overall Study||8
6411150|NCT00945256|7324528|FG003|NOT COMPLETED|Overall Study||9
6411151|NCT00945256|7324529|FG004|NOT COMPLETED|Overall Study||1
6411152|NCT00945282|7324543|FG000|STARTED|Overall Study||6
6411153|NCT00945282|7324544|FG001|STARTED|Overall Study||2
6411154|NCT00945282|7324543|FG000|COMPLETED|Overall Study||6
6411155|NCT00945282|7324544|FG001|COMPLETED|Overall Study||2
6411156|NCT00945282|7324543|FG000|NOT COMPLETED|Overall Study||0
6411157|NCT00945282|7324544|FG001|NOT COMPLETED|Overall Study||0
6411158|NCT00945295|7324560|FG000|STARTED|Overall Study||15
6411159|NCT00945295|7324561|FG001|STARTED|Overall Study||16
6411160|NCT00945295|7324560|FG000|COMPLETED|Overall Study||15
6411161|NCT00945295|7324561|FG001|COMPLETED|Overall Study||14
6411162|NCT00945295|7324560|FG000|NOT COMPLETED|Overall Study||0
6411163|NCT00945295|7324561|FG001|NOT COMPLETED|Overall Study||2
6411164|NCT00945321|7324567|FG000|STARTED|Period 1||7
6411165|NCT00945321|7324568|FG001|STARTED|Period 1||7
6411166|NCT00945321|7324569|FG002|STARTED|Period 1||7
6411167|NCT00945321|7324570|FG003|STARTED|Period 1||7
6411168|NCT00945321|7324571|FG004|STARTED|Period 1||7
6411169|NCT00945321|7324572|FG005|STARTED|Period 1||7
6411170|NCT00945321|7324567|FG000|COMPLETED|Period 1||7
6411171|NCT00945321|7324568|FG001|COMPLETED|Period 1||7
6411172|NCT00945321|7324569|FG002|COMPLETED|Period 1||7
6411173|NCT00945321|7324570|FG003|COMPLETED|Period 1||7
6411174|NCT00945321|7324571|FG004|COMPLETED|Period 1||6
6411175|NCT00945321|7324572|FG005|COMPLETED|Period 1||7
6411176|NCT00945321|7324567|FG000|NOT COMPLETED|Period 1||0
6411177|NCT00945321|7324568|FG001|NOT COMPLETED|Period 1||0
6411178|NCT00945321|7324569|FG002|NOT COMPLETED|Period 1||0
6411179|NCT00945321|7324570|FG003|NOT COMPLETED|Period 1||0
6411180|NCT00945321|7324571|FG004|NOT COMPLETED|Period 1||1
6411181|NCT00945321|7324572|FG005|NOT COMPLETED|Period 1||0
6411182|NCT00945321|7324567|FG000|STARTED|Period 2||7
6411183|NCT00945321|7324568|FG001|STARTED|Period 2||7
6411184|NCT00945321|7324569|FG002|STARTED|Period 2||7
6411185|NCT00945321|7324570|FG003|STARTED|Period 2||7
6411186|NCT00945321|7324571|FG004|STARTED|Period 2||6
6411187|NCT00945321|7324572|FG005|STARTED|Period 2||7
6411188|NCT00945321|7324567|FG000|COMPLETED|Period 2||7
6411189|NCT00945321|7324568|FG001|COMPLETED|Period 2||7
6637015|NCT02315352|7565804|FG004|STARTED|Third Intervention (Day 2)||8
6510536|NCT01483378|7430184|FG000|STARTED|Overall Study||100
6510537|NCT01483378|7430185|FG001|STARTED|Overall Study||66
6510538|NCT01483378|7430184|FG000|COMPLETED|Overall Study||100
6510539|NCT01483378|7430185|FG001|COMPLETED|Overall Study||66
6510540|NCT01483378|7430184|FG000|NOT COMPLETED|Overall Study||0
6637016|NCT02315352|7565805|FG005|STARTED|Third Intervention (Day 2)||7
6411190|NCT00945321|7324569|FG002|COMPLETED|Period 2||7
6411191|NCT00945321|7324570|FG003|COMPLETED|Period 2||7
6411192|NCT00945321|7324571|FG004|COMPLETED|Period 2||6
6411193|NCT00945321|7324572|FG005|COMPLETED|Period 2||7
6411194|NCT00945321|7324567|FG000|NOT COMPLETED|Period 2||0
6411195|NCT00945321|7324568|FG001|NOT COMPLETED|Period 2||0
6411196|NCT00945321|7324569|FG002|NOT COMPLETED|Period 2||0
6411197|NCT00945321|7324570|FG003|NOT COMPLETED|Period 2||0
6411198|NCT00945321|7324571|FG004|NOT COMPLETED|Period 2||0
6411199|NCT00945321|7324572|FG005|NOT COMPLETED|Period 2||0
6411200|NCT00945321|7324567|FG000|STARTED|Period 3||7
6411201|NCT00945321|7324568|FG001|STARTED|Period 3||7
6411202|NCT00945321|7324569|FG002|STARTED|Period 3||7
6411203|NCT00945321|7324570|FG003|STARTED|Period 3||7
6411204|NCT00945321|7324571|FG004|STARTED|Period 3||6
6637017|NCT02315352|7565806|FG006|STARTED|Third Intervention (Day 2)||9
6637018|NCT02315352|7565807|FG007|STARTED|Third Intervention (Day 2)||8
6637019|NCT02315352|7565800|FG000|COMPLETED|Third Intervention (Day 2)||0
6637020|NCT02315352|7565801|FG001|COMPLETED|Third Intervention (Day 2)||0
6637021|NCT02315352|7565802|FG002|COMPLETED|Third Intervention (Day 2)||7
6637022|NCT02315352|7565803|FG003|COMPLETED|Third Intervention (Day 2)||8
6637023|NCT02315352|7565804|FG004|COMPLETED|Third Intervention (Day 2)||8
6637024|NCT02315352|7565805|FG005|COMPLETED|Third Intervention (Day 2)||7
6637025|NCT02315352|7565806|FG006|COMPLETED|Third Intervention (Day 2)||9
6637026|NCT02315352|7565807|FG007|COMPLETED|Third Intervention (Day 2)||8
6637027|NCT02315352|7565800|FG000|NOT COMPLETED|Third Intervention (Day 2)||0
6637028|NCT02315352|7565801|FG001|NOT COMPLETED|Third Intervention (Day 2)||0
6637029|NCT02315352|7565802|FG002|NOT COMPLETED|Third Intervention (Day 2)||0
6637030|NCT02315352|7565803|FG003|NOT COMPLETED|Third Intervention (Day 2)||0
6637031|NCT02315352|7565804|FG004|NOT COMPLETED|Third Intervention (Day 2)||0
6637032|NCT02315352|7565805|FG005|NOT COMPLETED|Third Intervention (Day 2)||0
6637033|NCT02315352|7565806|FG006|NOT COMPLETED|Third Intervention (Day 2)||0
6637034|NCT02315352|7565807|FG007|NOT COMPLETED|Third Intervention (Day 2)||0
6637035|NCT02315352|7565800|FG000|STARTED|Fourth Intervention (Day 2)||0
6637036|NCT02315352|7565801|FG001|STARTED|Fourth Intervention (Day 2)||0
6411205|NCT00945321|7324572|FG005|STARTED|Period 3||7
6411206|NCT00945321|7324567|FG000|COMPLETED|Period 3||7
6411207|NCT00945321|7324568|FG001|COMPLETED|Period 3||7
6411208|NCT00945321|7324569|FG002|COMPLETED|Period 3||7
6411209|NCT00945321|7324570|FG003|COMPLETED|Period 3||7
6411210|NCT00945321|7324571|FG004|COMPLETED|Period 3||6
6411211|NCT00945321|7324572|FG005|COMPLETED|Period 3||7
6411212|NCT00945321|7324567|FG000|NOT COMPLETED|Period 3||0
6411213|NCT00945321|7324568|FG001|NOT COMPLETED|Period 3||0
6411214|NCT00945321|7324569|FG002|NOT COMPLETED|Period 3||0
6411215|NCT00945321|7324570|FG003|NOT COMPLETED|Period 3||0
6411216|NCT00945321|7324571|FG004|NOT COMPLETED|Period 3||0
6411217|NCT00945321|7324572|FG005|NOT COMPLETED|Period 3||0
6411218|NCT00945321|7324567|FG000|STARTED|Period 4||7
6411219|NCT00945321|7324568|FG001|STARTED|Period 4||7
6411220|NCT00945321|7324569|FG002|STARTED|Period 4||7
6411221|NCT00945321|7324570|FG003|STARTED|Period 4||7
6411222|NCT00945321|7324571|FG004|STARTED|Period 4||6
6411223|NCT00945321|7324572|FG005|STARTED|Period 4||7
6411224|NCT00945321|7324567|FG000|COMPLETED|Period 4||7
6411225|NCT00945321|7324568|FG001|COMPLETED|Period 4||7
6411226|NCT00945321|7324569|FG002|COMPLETED|Period 4||7
6411227|NCT00945321|7324570|FG003|COMPLETED|Period 4||7
6411228|NCT00945321|7324571|FG004|COMPLETED|Period 4||6
6411229|NCT00945321|7324572|FG005|COMPLETED|Period 4||6
6411230|NCT00945321|7324567|FG000|NOT COMPLETED|Period 4||0
6411231|NCT00945321|7324568|FG001|NOT COMPLETED|Period 4||0
6411232|NCT00945321|7324569|FG002|NOT COMPLETED|Period 4||0
6411233|NCT00945321|7324570|FG003|NOT COMPLETED|Period 4||0
6411234|NCT00945321|7324571|FG004|NOT COMPLETED|Period 4||0
6411235|NCT00945321|7324572|FG005|NOT COMPLETED|Period 4||1
6411236|NCT00945334|7324592|FG000|STARTED|Overall Study||19
6411237|NCT00945334|7324593|FG001|STARTED|Overall Study||18
6411238|NCT00945334|7324592|FG000|COMPLETED|Overall Study||16
6411239|NCT00945334|7324593|FG001|COMPLETED|Overall Study||15
6411240|NCT00945334|7324592|FG000|NOT COMPLETED|Overall Study||3
6411241|NCT00945334|7324593|FG001|NOT COMPLETED|Overall Study||3
6411242|NCT00945477|7324599|FG000|STARTED|Overall Study||11
6411243|NCT00945477|7324599|FG000|COMPLETED|Overall Study||5
6411244|NCT00945477|7324599|FG000|NOT COMPLETED|Overall Study||6
6411245|NCT00945555|7324604|FG000|STARTED|Overall Study||264
6411246|NCT00945555|7324604|FG000|COMPLETED|Overall Study||236
6510541|NCT01483378|7430185|FG001|NOT COMPLETED|Overall Study||0
6637037|NCT02315352|7565802|FG002|STARTED|Fourth Intervention (Day 2)||7
6411247|NCT00945555|7324604|FG000|NOT COMPLETED|Overall Study||28
6411248|NCT00945594|7324610|FG000|STARTED|Overall Study||50
6411249|NCT00945594|7324611|FG001|STARTED|Overall Study||50
6411250|NCT00945594|7324610|FG000|COMPLETED|Overall Study||50
6411251|NCT00945594|7324611|FG001|COMPLETED|Overall Study||50
6411252|NCT00945594|7324610|FG000|NOT COMPLETED|Overall Study||0
6411253|NCT00945594|7324611|FG001|NOT COMPLETED|Overall Study||0
6411254|NCT00945659|7324622|FG000|STARTED|Overall Study||39
6637038|NCT02315352|7565803|FG003|STARTED|Fourth Intervention (Day 2)||8
6637039|NCT02315352|7565804|FG004|STARTED|Fourth Intervention (Day 2)||8
6637040|NCT02315352|7565805|FG005|STARTED|Fourth Intervention (Day 2)||7
6411255|NCT00945659|7324623|FG001|STARTED|Overall Study||40
6411256|NCT00945659|7324624|FG002|STARTED|Overall Study||37
6411257|NCT00945659|7324622|FG000|Baseline|Overall Study||39
6411258|NCT00945659|7324623|FG001|Baseline|Overall Study||40
6411259|NCT00945659|7324624|FG002|Baseline|Overall Study||37
6411260|NCT00945659|7324622|FG000|3-Months|Overall Study||38
6411261|NCT00945659|7324623|FG001|3-Months|Overall Study||39
6411262|NCT00945659|7324624|FG002|3-Months|Overall Study||35
6411263|NCT00945659|7324622|FG000|6-Months|Overall Study||31
6411264|NCT00945659|7324623|FG001|6-Months|Overall Study||29
6411265|NCT00945659|7324624|FG002|6-Months|Overall Study||25
6411266|NCT00945659|7324622|FG000|9-Months|Overall Study||32
6411267|NCT00945659|7324623|FG001|9-Months|Overall Study||20
6411268|NCT00945659|7324624|FG002|9-Months|Overall Study||20
6411269|NCT00945659|7324622|FG000|12-Months|Overall Study||32
6411270|NCT00945659|7324623|FG001|12-Months|Overall Study||20
6411271|NCT00945659|7324624|FG002|12-Months|Overall Study||20
6411272|NCT00945659|7324622|FG000|COMPLETED|Overall Study||32
6411273|NCT00945659|7324623|FG001|COMPLETED|Overall Study||20
6411274|NCT00945659|7324624|FG002|COMPLETED|Overall Study||20
6411275|NCT00945659|7324622|FG000|NOT COMPLETED|Overall Study||7
6411276|NCT00945659|7324623|FG001|NOT COMPLETED|Overall Study||20
6411277|NCT00945659|7324624|FG002|NOT COMPLETED|Overall Study||17
6411278|NCT00945750|7324638|FG000|STARTED|Period I||5
6411279|NCT00945750|7324639|FG001|STARTED|Period I||5
6411280|NCT00945750|7324640|FG002|STARTED|Period I||5
6411281|NCT00945750|7324641|FG003|STARTED|Period I||5
6411282|NCT00945750|7324642|FG004|STARTED|Period I||5
6411283|NCT00945750|7324643|FG005|STARTED|Period I||5
6411284|NCT00945750|7324638|FG000|COMPLETED|Period I||5
6411285|NCT00945750|7324639|FG001|COMPLETED|Period I||5
6411286|NCT00945750|7324640|FG002|COMPLETED|Period I||5
6411287|NCT00945750|7324641|FG003|COMPLETED|Period I||5
6411288|NCT00945750|7324642|FG004|COMPLETED|Period I||5
6411289|NCT00945750|7324643|FG005|COMPLETED|Period I||5
6411290|NCT00945750|7324638|FG000|NOT COMPLETED|Period I||0
6411291|NCT00945750|7324639|FG001|NOT COMPLETED|Period I||0
6411292|NCT00945750|7324640|FG002|NOT COMPLETED|Period I||0
6411293|NCT00945750|7324641|FG003|NOT COMPLETED|Period I||0
6411294|NCT00945750|7324642|FG004|NOT COMPLETED|Period I||0
6411295|NCT00945750|7324643|FG005|NOT COMPLETED|Period I||0
6411296|NCT00945750|7324638|FG000|STARTED|Period II||5
6411297|NCT00945750|7324639|FG001|STARTED|Period II||5
6411298|NCT00945750|7324640|FG002|STARTED|Period II||5
6411299|NCT00945750|7324641|FG003|STARTED|Period II||5
6411300|NCT00945750|7324642|FG004|STARTED|Period II||5
6411301|NCT00945750|7324643|FG005|STARTED|Period II||5
6411302|NCT00945750|7324638|FG000|COMPLETED|Period II||5
6411303|NCT00945750|7324639|FG001|COMPLETED|Period II||5
6411304|NCT00945750|7324640|FG002|COMPLETED|Period II||5
6411305|NCT00945750|7324641|FG003|COMPLETED|Period II||5
6510542|NCT01483560|7430193|FG000|STARTED|Overall Study||219
6510543|NCT01483560|7430194|FG001|STARTED|Overall Study||209
6510544|NCT01483560|7430193|FG000|COMPLETED|Overall Study||193
6510545|NCT01483560|7430194|FG001|COMPLETED|Overall Study||194
6510546|NCT01483560|7430193|FG000|NOT COMPLETED|Overall Study||26
6510547|NCT01483560|7430194|FG001|NOT COMPLETED|Overall Study||15
6411306|NCT00945750|7324642|FG004|COMPLETED|Period II||5
6411307|NCT00945750|7324643|FG005|COMPLETED|Period II||5
6411308|NCT00945750|7324638|FG000|NOT COMPLETED|Period II||0
6411309|NCT00945750|7324639|FG001|NOT COMPLETED|Period II||0
6411310|NCT00945750|7324640|FG002|NOT COMPLETED|Period II||0
6510548|NCT01483599|7430207|FG000|STARTED|Controlled Period (CP) (up to Week 16)||42
6510549|NCT01483599|7430208|FG001|STARTED|Controlled Period (CP) (up to Week 16)||41
6510550|NCT01483599|7430209|FG002|STARTED|Controlled Period (CP) (up to Week 16)||41
6510551|NCT01483599|7430210|FG003|STARTED|Controlled Period (CP) (up to Week 16)||42
6510552|NCT01483599|7430211|FG004|STARTED|Controlled Period (CP) (up to Week 16)||42
6510553|NCT01483599|7430212|FG005|STARTED|Controlled Period (CP) (up to Week 16)||42
6510554|NCT01483599|7430213|FG006|STARTED|Controlled Period (CP) (up to Week 16)||43
6510555|NCT01483599|7430214|FG007|STARTED|Controlled Period (CP) (up to Week 16)||0
6510556|NCT01483599|7430215|FG008|STARTED|Controlled Period (CP) (up to Week 16)||0
6510557|NCT01483599|7430216|FG009|STARTED|Controlled Period (CP) (up to Week 16)||0
6510558|NCT01483599|7430217|FG010|STARTED|Controlled Period (CP) (up to Week 16)||0
6411311|NCT00945750|7324641|FG003|NOT COMPLETED|Period II||0
6411312|NCT00945750|7324642|FG004|NOT COMPLETED|Period II||0
6411313|NCT00945750|7324643|FG005|NOT COMPLETED|Period II||0
6411314|NCT00945750|7324638|FG000|STARTED|Period III||5
6411315|NCT00945750|7324639|FG001|STARTED|Period III||5
6411316|NCT00945750|7324640|FG002|STARTED|Period III||5
6411317|NCT00945750|7324641|FG003|STARTED|Period III||5
6411318|NCT00945750|7324642|FG004|STARTED|Period III||5
6411319|NCT00945750|7324643|FG005|STARTED|Period III||5
6411320|NCT00945750|7324638|FG000|COMPLETED|Period III||5
6411321|NCT00945750|7324639|FG001|COMPLETED|Period III||5
6411322|NCT00945750|7324640|FG002|COMPLETED|Period III||5
6411323|NCT00945750|7324641|FG003|COMPLETED|Period III||5
6411324|NCT00945750|7324642|FG004|COMPLETED|Period III||5
6411325|NCT00945750|7324643|FG005|COMPLETED|Period III||5
6411326|NCT00945750|7324638|FG000|NOT COMPLETED|Period III||0
6411327|NCT00945750|7324639|FG001|NOT COMPLETED|Period III||0
6411328|NCT00945750|7324640|FG002|NOT COMPLETED|Period III||0
6411329|NCT00945750|7324641|FG003|NOT COMPLETED|Period III||0
6411330|NCT00945750|7324642|FG004|NOT COMPLETED|Period III||0
6411331|NCT00945750|7324643|FG005|NOT COMPLETED|Period III||0
6411332|NCT00945815|7324651|FG000|STARTED|Overall Study||35
6411333|NCT00945815|7324651|FG000|Eligible|Overall Study||32
6411334|NCT00945815|7324651|FG000|Eligible and Began Protocol Therapy|Overall Study||31
6411335|NCT00945815|7324651|FG000|COMPLETED|Overall Study||27
6411336|NCT00945815|7324651|FG000|NOT COMPLETED|Overall Study||8
6411337|NCT00945854|7324657|FG000|STARTED|Overall Study||30
6411338|NCT00945854|7324658|FG001|STARTED|Overall Study||30
6411339|NCT00945854|7324657|FG000|COMPLETED|Overall Study||28
6411340|NCT00945854|7324658|FG001|COMPLETED|Overall Study||26
6411341|NCT00945854|7324657|FG000|NOT COMPLETED|Overall Study||2
6411342|NCT00945854|7324658|FG001|NOT COMPLETED|Overall Study||4
6411343|NCT00945893|7324666|FG000|STARTED|Overall Study||60
6411344|NCT00945893|7324667|FG001|STARTED|Overall Study||240
6411345|NCT00945893|7324666|FG000|Day 15 Post Dose 1|Overall Study||60
6411346|NCT00945893|7324667|FG001|Day 15 Post Dose 1|Overall Study||238
6411347|NCT00945893|7324666|FG000|Day 15 Post Dose 2|Overall Study||54
6411348|NCT00945893|7324667|FG001|Day 15 Post Dose 2|Overall Study||226
6411349|NCT00945893|7324666|FG000|COMPLETED|Overall Study||57
6411350|NCT00945893|7324667|FG001|COMPLETED|Overall Study||230
6411351|NCT00945893|7324666|FG000|NOT COMPLETED|Overall Study||3
6411352|NCT00945893|7324667|FG001|NOT COMPLETED|Overall Study||10
6411353|NCT00945906|7324677|FG000|STARTED|Overall Study||61
6411354|NCT00945906|7324677|FG000|COMPLETED|Overall Study||54
6411355|NCT00945906|7324677|FG000|NOT COMPLETED|Overall Study||7
6411356|NCT00945945|7324683|FG000|STARTED|Overall Study||207
6411357|NCT00945945|7324684|FG001|STARTED|Overall Study||217
6411358|NCT00945945|7324683|FG000|COMPLETED|Overall Study||171
6411359|NCT00945945|7324684|FG001|COMPLETED|Overall Study||162
6411360|NCT00945945|7324683|FG000|NOT COMPLETED|Overall Study||36
6411361|NCT00945945|7324684|FG001|NOT COMPLETED|Overall Study||55
6411362|NCT00945958|7324690|FG000|STARTED|Overall Study||161
6411363|NCT00945958|7324690|FG000|COMPLETED|Overall Study||149
6411364|NCT00945958|7324690|FG000|NOT COMPLETED|Overall Study||12
6411365|NCT00946023|7324695|FG000|STARTED|Overall Study||83
6411366|NCT00946023|7324695|FG000|COMPLETED|Overall Study||83
6411367|NCT00946023|7324695|FG000|NOT COMPLETED|Overall Study||0
6411368|NCT00946088|7324701|FG000|STARTED|Overall Study||4
6411369|NCT00946088|7324702|FG001|STARTED|Overall Study||3
6411370|NCT00946088|7324701|FG000|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
6411371|NCT00946088|7324702|FG001|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
6411372|NCT00946088|7324701|FG000|NOT COMPLETED|Overall Study||0
6411373|NCT00946088|7324702|FG001|NOT COMPLETED|Overall Study||1
6411374|NCT00946101|7324712|FG000|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
6411375|NCT00946101|7324713|FG001|STARTED|Overall Study||65
6411376|NCT00946101|7324712|FG000|Day 15 Post Dose 1|Overall Study||260
6411377|NCT00946101|7324713|FG001|Day 15 Post Dose 1|Overall Study||64
6411378|NCT00946101|7324712|FG000|Day 15 Post Dose 2|Overall Study||254
6411379|NCT00946101|7324713|FG001|Day 15 Post Dose 2|Overall Study||63
6411380|NCT00946101|7324712|FG000|COMPLETED|Overall Study||257
6411381|NCT00946101|7324713|FG001|COMPLETED|Overall Study||63
6411382|NCT00946101|7324712|FG000|NOT COMPLETED|Overall Study||4
6411383|NCT00946101|7324713|FG001|NOT COMPLETED|Overall Study||2
6411384|NCT00946114|7324725|FG000|STARTED|Overall Study||20
6411385|NCT00946114|7324726|FG001|STARTED|Overall Study||12
6411386|NCT00946114|7324725|FG000|COMPLETED|Overall Study||12
6411387|NCT00946114|7324726|FG001|COMPLETED|Overall Study||10
6411388|NCT00946114|7324725|FG000|NOT COMPLETED|Overall Study||8
6411389|NCT00946114|7324726|FG001|NOT COMPLETED|Overall Study||2
6411390|NCT00946153|7324737|FG000|STARTED|Phase 1||6
6411391|NCT00946153|7324738|FG001|STARTED|Phase 1||3
6411392|NCT00946153|7324739|FG002|STARTED|Phase 1||6
6411393|NCT00946153|7324740|FG003|STARTED|Phase 1||5
6411394|NCT00946153|7324741|FG004|STARTED|Phase 1||0
6411395|NCT00946153|7324737|FG000|COMPLETED|Phase 1||6
6411396|NCT00946153|7324738|FG001|COMPLETED|Phase 1||3
6411397|NCT00946153|7324739|FG002|COMPLETED|Phase 1||6
6411398|NCT00946153|7324740|FG003|COMPLETED|Phase 1||5
6411399|NCT00946153|7324741|FG004|COMPLETED|Phase 1||0
6411400|NCT00946153|7324737|FG000|NOT COMPLETED|Phase 1||0
6411401|NCT00946153|7324738|FG001|NOT COMPLETED|Phase 1||0
6411402|NCT00946153|7324739|FG002|NOT COMPLETED|Phase 1||0
6411403|NCT00946153|7324740|FG003|NOT COMPLETED|Phase 1||0
6411404|NCT00946153|7324741|FG004|NOT COMPLETED|Phase 1||0
6411405|NCT00946153|7324737|FG000|STARTED|Phase 2||0
6411406|NCT00946153|7324738|FG001|STARTED|Phase 2||0
6411407|NCT00946153|7324739|FG002|STARTED|Phase 2||0
6411408|NCT00946153|7324740|FG003|STARTED|Phase 2||0
6411409|NCT00946153|7324741|FG004|STARTED|Phase 2||46
6411410|NCT00946153|7324737|FG000|COMPLETED|Phase 2||0
6411411|NCT00946153|7324738|FG001|COMPLETED|Phase 2||0
6411412|NCT00946153|7324739|FG002|COMPLETED|Phase 2||0
6411413|NCT00946153|7324740|FG003|COMPLETED|Phase 2||0
6411414|NCT00946153|7324741|FG004|COMPLETED|Phase 2||33
6411415|NCT00946153|7324737|FG000|NOT COMPLETED|Phase 2||0
6411416|NCT00946153|7324738|FG001|NOT COMPLETED|Phase 2||0
6411417|NCT00946153|7324739|FG002|NOT COMPLETED|Phase 2||0
6411418|NCT00946153|7324740|FG003|NOT COMPLETED|Phase 2||0
6411419|NCT00946153|7324741|FG004|NOT COMPLETED|Phase 2||13
6411420|NCT00946192|7324761|FG000|STARTED|Overall Study||43
6411421|NCT00946192|7324762|FG001|STARTED|Overall Study||40
6411422|NCT00946192|7324763|FG002|STARTED|Overall Study||38
6411423|NCT00946192|7324761|FG000|COMPLETED|Overall Study||25
6411424|NCT00946192|7324762|FG001|COMPLETED|Overall Study||22
6411425|NCT00946192|7324763|FG002|COMPLETED|Overall Study||26
6411426|NCT00946192|7324761|FG000|NOT COMPLETED|Overall Study||18
6411427|NCT00946192|7324762|FG001|NOT COMPLETED|Overall Study||18
6411428|NCT00946192|7324763|FG002|NOT COMPLETED|Overall Study||12
6411429|NCT00946270|7324774|FG000|STARTED|Overall Study||21
6411430|NCT00946270|7324775|FG001|STARTED|Overall Study||20
6411431|NCT00946270|7324776|FG002|STARTED|Overall Study||29
6411432|NCT00946270|7324774|FG000|COMPLETED|Overall Study||21
6411433|NCT00946270|7324775|FG001|COMPLETED|Overall Study||20
6411434|NCT00946270|7324776|FG002|COMPLETED|Overall Study||29
6411435|NCT00946270|7324774|FG000|NOT COMPLETED|Overall Study||0
6411436|NCT00946270|7324775|FG001|NOT COMPLETED|Overall Study||0
6411437|NCT00946270|7324776|FG002|NOT COMPLETED|Overall Study||0
6411438|NCT00946296|7324786|FG000|STARTED|Overall Study||21
6411439|NCT00946296|7324787|FG001|STARTED|Overall Study||15
6411440|NCT00946296|7324786|FG000|COMPLETED|Overall Study||18
6411441|NCT00946296|7324787|FG001|COMPLETED|Overall Study||15
6411442|NCT00946296|7324786|FG000|NOT COMPLETED|Overall Study||3
6411443|NCT00946296|7324787|FG001|NOT COMPLETED|Overall Study||0
6411444|NCT00946309|7324795|FG000|STARTED|Overall Study||22
6411445|NCT00946309|7324796|FG001|STARTED|Overall Study||23
6411446|NCT00946309|7324795|FG000|COMPLETED|Overall Study||21
6411447|NCT00946309|7324796|FG001|COMPLETED|Overall Study||19
6411448|NCT00946309|7324795|FG000|NOT COMPLETED|Overall Study||1
6411449|NCT00946309|7324796|FG001|NOT COMPLETED|Overall Study||4
6411450|NCT00946322|7324803|FG000|STARTED|Pre-treatment||12
6411451|NCT00946322|7324803|FG000|COMPLETED|Pre-treatment||11
6411452|NCT00946322|7324803|FG000|NOT COMPLETED|Pre-treatment||1
6411453|NCT00946322|7324803|FG000|STARTED|Post-treatment||11
6411454|NCT00946322|7324803|FG000|COMPLETED|Post-treatment||9
6411455|NCT00946322|7324803|FG000|NOT COMPLETED|Post-treatment||2
6411456|NCT00946348|7324809|FG000|STARTED|Overall Study||6
6411457|NCT00946348|7324810|FG001|STARTED|Overall Study||6
6411458|NCT00946348|7324809|FG000|COMPLETED|Overall Study||6
6411459|NCT00946348|7324810|FG001|COMPLETED|Overall Study||6
6411460|NCT00946348|7324809|FG000|NOT COMPLETED|Overall Study||0
6411461|NCT00946348|7324810|FG001|NOT COMPLETED|Overall Study||0
6411462|NCT00946478|7324818|FG000|STARTED|Overall Study||20
6411463|NCT00946478|7324819|FG001|STARTED|Overall Study||20
6411464|NCT00946478|7324818|FG000|COMPLETED|Overall Study||20
6411465|NCT00946478|7324819|FG001|COMPLETED|Overall Study||20
6411466|NCT00946478|7324818|FG000|NOT COMPLETED|Overall Study||0
6411467|NCT00946478|7324819|FG001|NOT COMPLETED|Overall Study||0
6411468|NCT00946530|7324829|FG000|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
6411469|NCT00946530|7324830|FG001|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
6411470|NCT00946530|7324831|FG002|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
6411471|NCT00946530|7324832|FG003|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
6411472|NCT00946530|7324829|FG000|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
6411473|NCT00946530|7324830|FG001|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
6411474|NCT00946530|7324831|FG002|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
6411475|NCT00946530|7324832|FG003|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
6411476|NCT00946530|7324829|FG000|NOT COMPLETED|Overall Study||1
6411477|NCT00946530|7324830|FG001|NOT COMPLETED|Overall Study||4
6411478|NCT00946530|7324831|FG002|NOT COMPLETED|Overall Study||1
6411479|NCT00946530|7324832|FG003|NOT COMPLETED|Overall Study||4
6411480|NCT00946647|7324851|FG000|STARTED|Phase 1 Part||6
6411481|NCT00946647|7324852|FG001|STARTED|Phase 1 Part||18
6411482|NCT00946647|7324853|FG002|STARTED|Phase 1 Part||7
6411483|NCT00946647|7324854|FG003|STARTED|Phase 1 Part||0
6411484|NCT00946647|7324855|FG004|STARTED|Phase 1 Part||0
6411485|NCT00946647|7324851|FG000|COMPLETED|Phase 1 Part||0
6411486|NCT00946647|7324852|FG001|COMPLETED|Phase 1 Part||0
6411487|NCT00946647|7324853|FG002|COMPLETED|Phase 1 Part||0
6411488|NCT00946647|7324854|FG003|COMPLETED|Phase 1 Part||0
6411489|NCT00946647|7324855|FG004|COMPLETED|Phase 1 Part||0
6411490|NCT00946647|7324851|FG000|NOT COMPLETED|Phase 1 Part||6
6411491|NCT00946647|7324852|FG001|NOT COMPLETED|Phase 1 Part||18
6411492|NCT00946647|7324853|FG002|NOT COMPLETED|Phase 1 Part||7
6411493|NCT00946647|7324854|FG003|NOT COMPLETED|Phase 1 Part||0
6411494|NCT00946647|7324855|FG004|NOT COMPLETED|Phase 1 Part||0
6411495|NCT00946647|7324851|FG000|STARTED|Phase ll Part||0
6411496|NCT00946647|7324852|FG001|STARTED|Phase ll Part||0
6411497|NCT00946647|7324853|FG002|STARTED|Phase ll Part||0
6411498|NCT00946647|7324854|FG003|STARTED|Phase ll Part||40
6411499|NCT00946647|7324855|FG004|STARTED|Phase ll Part||42
6411500|NCT00946647|7324851|FG000|Safety Set|Phase ll Part||0
6411501|NCT00946647|7324852|FG001|Safety Set|Phase ll Part||0
6411502|NCT00946647|7324853|FG002|Safety Set|Phase ll Part||0
6411503|NCT00946647|7324854|FG003|Safety Set|Phase ll Part|2 pts rand. to this grp did not receive PAN|38
6411504|NCT00946647|7324855|FG004|Safety Set|Phase ll Part|2 pts rand. to PAN+5AZA, did not receive PAN but received 5AZA|42
6411505|NCT00946647|7324851|FG000|COMPLETED|Phase ll Part||0
6411506|NCT00946647|7324852|FG001|COMPLETED|Phase ll Part||0
6411507|NCT00946647|7324853|FG002|COMPLETED|Phase ll Part||0
6411508|NCT00946647|7324854|FG003|COMPLETED|Phase ll Part||0
6411509|NCT00946647|7324855|FG004|COMPLETED|Phase ll Part||0
6411510|NCT00946647|7324851|FG000|NOT COMPLETED|Phase ll Part||0
6411511|NCT00946647|7324852|FG001|NOT COMPLETED|Phase ll Part||0
6411512|NCT00946647|7324853|FG002|NOT COMPLETED|Phase ll Part||0
6411513|NCT00946647|7324854|FG003|NOT COMPLETED|Phase ll Part||40
6411514|NCT00946647|7324855|FG004|NOT COMPLETED|Phase ll Part||42
6411515|NCT00946712|7324870|FG000|STARTED|Overall Study||671
6411516|NCT00946712|7324871|FG001|STARTED|Overall Study||662
6411517|NCT00946712|7324870|FG000|COMPLETED|Overall Study||124
6411518|NCT00946712|7324871|FG001|COMPLETED|Overall Study||0
6411519|NCT00946712|7324870|FG000|NOT COMPLETED|Overall Study||547
6411520|NCT00946712|7324871|FG001|NOT COMPLETED|Overall Study||662
6411521|NCT00946881|7324878|FG000|STARTED|First Treatment||30
6411522|NCT00946881|7324878|FG000|COMPLETED|First Treatment||28
6411523|NCT00946881|7324878|FG000|NOT COMPLETED|First Treatment||2
6411524|NCT00946881|7324878|FG000|STARTED|Retreatment||8
6411525|NCT00946881|7324878|FG000|COMPLETED|Retreatment||7
6411526|NCT00946881|7324878|FG000|NOT COMPLETED|Retreatment||1
6411527|NCT00946920|7324905|FG000|STARTED|Overall Study|Received at least one dose of degarelix.|565
6411528|NCT00946920|7324906|FG001|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
6411529|NCT00946920|7324905|FG000|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
6411530|NCT00946920|7324906|FG001|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
6411531|NCT00946920|7324905|FG000|COMPLETED|Overall Study||455
6411532|NCT00946920|7324906|FG001|COMPLETED|Overall Study||239
6411533|NCT00946920|7324905|FG000|NOT COMPLETED|Overall Study||110
6411534|NCT00946920|7324906|FG001|NOT COMPLETED|Overall Study||44
6411535|NCT00946998|7324914|FG000|STARTED|Overall Study||102
6411536|NCT00946998|7324915|FG001|STARTED|Overall Study||99
6411537|NCT00946998|7324914|FG000|Received Treatment as Randomized|Overall Study||102
6411538|NCT00946998|7324915|FG001|Received Treatment as Randomized|Overall Study||99
6411539|NCT00946998|7324914|FG000|COMPLETED|Overall Study||97
6411540|NCT00946998|7324915|FG001|COMPLETED|Overall Study||96
6411541|NCT00946998|7324914|FG000|NOT COMPLETED|Overall Study||5
6411542|NCT00946998|7324915|FG001|NOT COMPLETED|Overall Study||3
6411543|NCT00947115|7324924|FG000|STARTED|Overall Study||159
6411544|NCT00947115|7324925|FG001|STARTED|Overall Study||194
6411545|NCT00947115|7324926|FG002|STARTED|Overall Study||171
6411546|NCT00947115|7324924|FG000|COMPLETED|Overall Study||142
6411547|NCT00947115|7324925|FG001|COMPLETED|Overall Study||172
6411548|NCT00947115|7324926|FG002|COMPLETED|Overall Study||156
6411549|NCT00947115|7324924|FG000|NOT COMPLETED|Overall Study||17
6411550|NCT00947115|7324925|FG001|NOT COMPLETED|Overall Study||22
6411551|NCT00947115|7324926|FG002|NOT COMPLETED|Overall Study||15
6411552|NCT00947154|7324934|FG000|STARTED|Overall Study||12
6411553|NCT00947154|7324934|FG000|COMPLETED|Overall Study||11
6411554|NCT00947154|7324934|FG000|NOT COMPLETED|Overall Study||1
6411555|NCT00947167|7324939|FG000|STARTED|Pertuzumab Alone||4
6411556|NCT00947167|7324939|FG000|COMPLETED|Pertuzumab Alone||4
6411557|NCT00947167|7324939|FG000|NOT COMPLETED|Pertuzumab Alone||0
6411558|NCT00947167|7324939|FG000|STARTED|Erlotinib Added to Pertuzumab||3
6411559|NCT00947167|7324939|FG000|COMPLETED|Erlotinib Added to Pertuzumab||3
6411560|NCT00947167|7324939|FG000|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
6411561|NCT00947193|7324943|FG000|STARTED|Overall Study||3
6411562|NCT00947193|7324944|FG001|STARTED|Overall Study||10
6411563|NCT00947193|7324943|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6411564|NCT00947193|7324944|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
6411565|NCT00947193|7324943|FG000|COMPLETED|Overall Study||0
6411566|NCT00947193|7324944|FG001|COMPLETED|Overall Study||10
6411567|NCT00947193|7324943|FG000|NOT COMPLETED|Overall Study||3
6411568|NCT00947193|7324944|FG001|NOT COMPLETED|Overall Study||0
6411569|NCT00947219|7324952|FG000|STARTED|Overall Study||28
6411570|NCT00947219|7324953|FG001|STARTED|Overall Study||25
6411571|NCT00947219|7324954|FG002|STARTED|Overall Study||26
6411572|NCT00947219|7324952|FG000|COMPLETED|Overall Study||22
6411573|NCT00947219|7324953|FG001|COMPLETED|Overall Study||21
6411574|NCT00947219|7324954|FG002|COMPLETED|Overall Study||22
6411575|NCT00947219|7324952|FG000|NOT COMPLETED|Overall Study||6
6411576|NCT00947219|7324953|FG001|NOT COMPLETED|Overall Study||4
6411577|NCT00947219|7324954|FG002|NOT COMPLETED|Overall Study||4
6411578|NCT00947271|7324966|FG000|STARTED|3 Months Post Intervention||254
6411579|NCT00947271|7324967|FG001|STARTED|3 Months Post Intervention||252
6411580|NCT00947271|7324968|FG002|STARTED|3 Months Post Intervention||254
6411581|NCT00947271|7324969|FG003|STARTED|3 Months Post Intervention||250
6411582|NCT00947271|7324966|FG000|COMPLETED|3 Months Post Intervention||202
6411583|NCT00947271|7324967|FG001|COMPLETED|3 Months Post Intervention||204
6411584|NCT00947271|7324968|FG002|COMPLETED|3 Months Post Intervention||218
6411585|NCT00947271|7324969|FG003|COMPLETED|3 Months Post Intervention||206
6411586|NCT00947271|7324966|FG000|NOT COMPLETED|3 Months Post Intervention||52
6411587|NCT00947271|7324967|FG001|NOT COMPLETED|3 Months Post Intervention||48
6411588|NCT00947271|7324968|FG002|NOT COMPLETED|3 Months Post Intervention||36
6411589|NCT00947271|7324969|FG003|NOT COMPLETED|3 Months Post Intervention||44
6411590|NCT00947271|7324966|FG000|STARTED|6 Months Post Intervention||254
6411591|NCT00947271|7324967|FG001|STARTED|6 Months Post Intervention||252
6411592|NCT00947271|7324968|FG002|STARTED|6 Months Post Intervention||254
6411593|NCT00947271|7324969|FG003|STARTED|6 Months Post Intervention||250
6411594|NCT00947271|7324966|FG000|COMPLETED|6 Months Post Intervention||199
6411595|NCT00947271|7324967|FG001|COMPLETED|6 Months Post Intervention||199
6411596|NCT00947271|7324968|FG002|COMPLETED|6 Months Post Intervention||196
6411597|NCT00947271|7324969|FG003|COMPLETED|6 Months Post Intervention||196
6411598|NCT00947271|7324966|FG000|NOT COMPLETED|6 Months Post Intervention||55
6411599|NCT00947271|7324967|FG001|NOT COMPLETED|6 Months Post Intervention||53
6411600|NCT00947271|7324968|FG002|NOT COMPLETED|6 Months Post Intervention||58
6411601|NCT00947271|7324969|FG003|NOT COMPLETED|6 Months Post Intervention||54
6411602|NCT00947271|7324966|FG000|STARTED|9 Months Post Intervention||254
6411603|NCT00947271|7324967|FG001|STARTED|9 Months Post Intervention||252
6411604|NCT00947271|7324968|FG002|STARTED|9 Months Post Intervention||254
6411605|NCT00947271|7324969|FG003|STARTED|9 Months Post Intervention||250
6411606|NCT00947271|7324966|FG000|COMPLETED|9 Months Post Intervention||184
6411607|NCT00947271|7324967|FG001|COMPLETED|9 Months Post Intervention||192
6411608|NCT00947271|7324968|FG002|COMPLETED|9 Months Post Intervention||193
6411609|NCT00947271|7324969|FG003|COMPLETED|9 Months Post Intervention||191
6411610|NCT00947271|7324966|FG000|NOT COMPLETED|9 Months Post Intervention||70
6411611|NCT00947271|7324967|FG001|NOT COMPLETED|9 Months Post Intervention||60
6411612|NCT00947271|7324968|FG002|NOT COMPLETED|9 Months Post Intervention||61
6411613|NCT00947271|7324969|FG003|NOT COMPLETED|9 Months Post Intervention||59
6411614|NCT00947271|7324966|FG000|STARTED|12 Months Post Intervention||254
6411615|NCT00947271|7324967|FG001|STARTED|12 Months Post Intervention||252
6411616|NCT00947271|7324968|FG002|STARTED|12 Months Post Intervention||254
6411617|NCT00947271|7324969|FG003|STARTED|12 Months Post Intervention||250
6411618|NCT00947271|7324966|FG000|COMPLETED|12 Months Post Intervention||183
6411619|NCT00947271|7324967|FG001|COMPLETED|12 Months Post Intervention||192
6411620|NCT00947271|7324968|FG002|COMPLETED|12 Months Post Intervention||195
6411621|NCT00947271|7324969|FG003|COMPLETED|12 Months Post Intervention||188
6411622|NCT00947271|7324966|FG000|NOT COMPLETED|12 Months Post Intervention||71
6411623|NCT00947271|7324967|FG001|NOT COMPLETED|12 Months Post Intervention||60
6411624|NCT00947271|7324968|FG002|NOT COMPLETED|12 Months Post Intervention||59
6411625|NCT00947271|7324969|FG003|NOT COMPLETED|12 Months Post Intervention||62
6411626|NCT00947297|7324979|FG000|STARTED|Overall Study||60
6411627|NCT00947297|7324979|FG000|COMPLETED|Overall Study||53
6411628|NCT00947297|7324979|FG000|NOT COMPLETED|Overall Study||7
6411629|NCT00947310|7324987|FG000|STARTED|Overall Study||514
6411630|NCT00947310|7324988|FG001|STARTED|Overall Study||500
6411631|NCT00947310|7324989|FG002|STARTED|Overall Study||486
6411632|NCT00947310|7324987|FG000|COMPLETED|Overall Study||514
6411633|NCT00947310|7324988|FG001|COMPLETED|Overall Study||500
6411634|NCT00947310|7324989|FG002|COMPLETED|Overall Study||486
6411635|NCT00947310|7324987|FG000|NOT COMPLETED|Overall Study||0
6411636|NCT00947310|7324988|FG001|NOT COMPLETED|Overall Study||0
6411637|NCT00947310|7324989|FG002|NOT COMPLETED|Overall Study||0
6411638|NCT00947349|7325001|FG000|STARTED|Triple Treatment Combination Period||4
6510559|NCT01483599|7430218|FG011|STARTED|Controlled Period (CP) (up to Week 16)||0
6510560|NCT01483599|7430219|FG012|STARTED|Controlled Period (CP) (up to Week 16)||0
6510561|NCT01483599|7430220|FG013|STARTED|Controlled Period (CP) (up to Week 16)||0
6510562|NCT01483599|7430207|FG000|Treated|Controlled Period (CP) (up to Week 16)||42
6510563|NCT01483599|7430208|FG001|Treated|Controlled Period (CP) (up to Week 16)||41
6510564|NCT01483599|7430209|FG002|Treated|Controlled Period (CP) (up to Week 16)||41
6510565|NCT01483599|7430210|FG003|Treated|Controlled Period (CP) (up to Week 16)||42
6510566|NCT01483599|7430211|FG004|Treated|Controlled Period (CP) (up to Week 16)||42
6510567|NCT01483599|7430212|FG005|Treated|Controlled Period (CP) (up to Week 16)||41
6510568|NCT01483599|7430213|FG006|Treated|Controlled Period (CP) (up to Week 16)||43
6510569|NCT01483599|7430214|FG007|Treated|Controlled Period (CP) (up to Week 16)||0
6510570|NCT01483599|7430215|FG008|Treated|Controlled Period (CP) (up to Week 16)||0
6510571|NCT01483599|7430216|FG009|Treated|Controlled Period (CP) (up to Week 16)||0
6510572|NCT01483599|7430217|FG010|Treated|Controlled Period (CP) (up to Week 16)||0
6510573|NCT01483599|7430218|FG011|Treated|Controlled Period (CP) (up to Week 16)||0
6510574|NCT01483599|7430219|FG012|Treated|Controlled Period (CP) (up to Week 16)||0
6510575|NCT01483599|7430220|FG013|Treated|Controlled Period (CP) (up to Week 16)||0
6510576|NCT01483599|7430207|FG000|COMPLETED|Controlled Period (CP) (up to Week 16)||39
6510577|NCT01483599|7430208|FG001|COMPLETED|Controlled Period (CP) (up to Week 16)||38
6510578|NCT01483599|7430209|FG002|COMPLETED|Controlled Period (CP) (up to Week 16)||41
6510579|NCT01483599|7430210|FG003|COMPLETED|Controlled Period (CP) (up to Week 16)||39
6510580|NCT01483599|7430211|FG004|COMPLETED|Controlled Period (CP) (up to Week 16)||40
6510581|NCT01483599|7430212|FG005|COMPLETED|Controlled Period (CP) (up to Week 16)||38
6510582|NCT01483599|7430213|FG006|COMPLETED|Controlled Period (CP) (up to Week 16)||39
6411639|NCT00947349|7325002|FG001|STARTED|Triple Treatment Combination Period||6
6411640|NCT00947349|7325003|FG002|STARTED|Triple Treatment Combination Period||6
6411641|NCT00947349|7325004|FG003|STARTED|Triple Treatment Combination Period||6
6411642|NCT00947349|7325001|FG000|COMPLETED|Triple Treatment Combination Period||4
6411643|NCT00947349|7325002|FG001|COMPLETED|Triple Treatment Combination Period||5
6411644|NCT00947349|7325003|FG002|COMPLETED|Triple Treatment Combination Period||6
6411645|NCT00947349|7325004|FG003|COMPLETED|Triple Treatment Combination Period||6
6411646|NCT00947349|7325001|FG000|NOT COMPLETED|Triple Treatment Combination Period||0
6411647|NCT00947349|7325002|FG001|NOT COMPLETED|Triple Treatment Combination Period||1
6411648|NCT00947349|7325003|FG002|NOT COMPLETED|Triple Treatment Combination Period||0
6411649|NCT00947349|7325004|FG003|NOT COMPLETED|Triple Treatment Combination Period||0
6411650|NCT00947349|7325001|FG000|STARTED|Overall Study Standard of Care||4
6411651|NCT00947349|7325002|FG001|STARTED|Overall Study Standard of Care||5
6411652|NCT00947349|7325003|FG002|STARTED|Overall Study Standard of Care||6
6411653|NCT00947349|7325004|FG003|STARTED|Overall Study Standard of Care||6
6411654|NCT00947349|7325001|FG000|COMPLETED|Overall Study Standard of Care||4
6411655|NCT00947349|7325002|FG001|COMPLETED|Overall Study Standard of Care||5
6411656|NCT00947349|7325003|FG002|COMPLETED|Overall Study Standard of Care||4
6411657|NCT00947349|7325004|FG003|COMPLETED|Overall Study Standard of Care||4
6411658|NCT00947349|7325001|FG000|NOT COMPLETED|Overall Study Standard of Care||0
6411659|NCT00947349|7325002|FG001|NOT COMPLETED|Overall Study Standard of Care||0
6411660|NCT00947349|7325003|FG002|NOT COMPLETED|Overall Study Standard of Care||2
6411661|NCT00947349|7325004|FG003|NOT COMPLETED|Overall Study Standard of Care||2
6411662|NCT00947427|7325034|FG000|STARTED|Overall Study||22
6411663|NCT00947427|7325035|FG001|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
6637041|NCT02315352|7565806|FG006|STARTED|Fourth Intervention (Day 2)||9
6637042|NCT02315352|7565807|FG007|STARTED|Fourth Intervention (Day 2)||8
6637043|NCT02315352|7565800|FG000|COMPLETED|Fourth Intervention (Day 2)||0
6637044|NCT02315352|7565801|FG001|COMPLETED|Fourth Intervention (Day 2)||0
6637045|NCT02315352|7565802|FG002|COMPLETED|Fourth Intervention (Day 2)||7
6637046|NCT02315352|7565803|FG003|COMPLETED|Fourth Intervention (Day 2)||8
6637047|NCT02315352|7565804|FG004|COMPLETED|Fourth Intervention (Day 2)||8
6637048|NCT02315352|7565805|FG005|COMPLETED|Fourth Intervention (Day 2)||7
6637049|NCT02315352|7565806|FG006|COMPLETED|Fourth Intervention (Day 2)||9
6637050|NCT02315352|7565807|FG007|COMPLETED|Fourth Intervention (Day 2)||8
6637051|NCT02315352|7565800|FG000|NOT COMPLETED|Fourth Intervention (Day 2)||0
6637052|NCT02315352|7565801|FG001|NOT COMPLETED|Fourth Intervention (Day 2)||0
6637053|NCT02315352|7565802|FG002|NOT COMPLETED|Fourth Intervention (Day 2)||0
6637054|NCT02315352|7565803|FG003|NOT COMPLETED|Fourth Intervention (Day 2)||0
6637055|NCT02315352|7565804|FG004|NOT COMPLETED|Fourth Intervention (Day 2)||0
6637056|NCT02315352|7565805|FG005|NOT COMPLETED|Fourth Intervention (Day 2)||0
6637057|NCT02315352|7565806|FG006|NOT COMPLETED|Fourth Intervention (Day 2)||0
6637058|NCT02315352|7565807|FG007|NOT COMPLETED|Fourth Intervention (Day 2)||0
6637059|NCT02315352|7565800|FG000|STARTED|Fifth Intervention (Day 2)||0
6637060|NCT02315352|7565801|FG001|STARTED|Fifth Intervention (Day 2)||0
6637061|NCT02315352|7565802|FG002|STARTED|Fifth Intervention (Day 2)||7
6637062|NCT02315352|7565803|FG003|STARTED|Fifth Intervention (Day 2)||8
6637063|NCT02315352|7565804|FG004|STARTED|Fifth Intervention (Day 2)||8
6637064|NCT02315352|7565805|FG005|STARTED|Fifth Intervention (Day 2)||7
6637065|NCT02315352|7565806|FG006|STARTED|Fifth Intervention (Day 2)||9
6637066|NCT02315352|7565807|FG007|STARTED|Fifth Intervention (Day 2)||8
6637067|NCT02315352|7565800|FG000|COMPLETED|Fifth Intervention (Day 2)||0
6637068|NCT02315352|7565801|FG001|COMPLETED|Fifth Intervention (Day 2)||0
6637069|NCT02315352|7565802|FG002|COMPLETED|Fifth Intervention (Day 2)||7
6637070|NCT02315352|7565803|FG003|COMPLETED|Fifth Intervention (Day 2)||8
6637071|NCT02315352|7565804|FG004|COMPLETED|Fifth Intervention (Day 2)||8
6637072|NCT02315352|7565805|FG005|COMPLETED|Fifth Intervention (Day 2)||7
6637073|NCT02315352|7565806|FG006|COMPLETED|Fifth Intervention (Day 2)||9
6637074|NCT02315352|7565807|FG007|COMPLETED|Fifth Intervention (Day 2)||8
6637075|NCT02315352|7565800|FG000|NOT COMPLETED|Fifth Intervention (Day 2)||0
6637076|NCT02315352|7565801|FG001|NOT COMPLETED|Fifth Intervention (Day 2)||0
6637077|NCT02315352|7565802|FG002|NOT COMPLETED|Fifth Intervention (Day 2)||0
6637078|NCT02315352|7565803|FG003|NOT COMPLETED|Fifth Intervention (Day 2)||0
6637079|NCT02315352|7565804|FG004|NOT COMPLETED|Fifth Intervention (Day 2)||0
6637080|NCT02315352|7565805|FG005|NOT COMPLETED|Fifth Intervention (Day 2)||0
6637081|NCT02315352|7565806|FG006|NOT COMPLETED|Fifth Intervention (Day 2)||0
6637082|NCT02315352|7565807|FG007|NOT COMPLETED|Fifth Intervention (Day 2)||0
6637083|NCT02315430|7565819|FG000|STARTED|Overall Study||13
6637084|NCT02315430|7565819|FG000|COMPLETED|Overall Study||13
6637085|NCT02315430|7565819|FG000|NOT COMPLETED|Overall Study||0
6637086|NCT02315560|7565823|FG000|STARTED|Overall Study||25
6637087|NCT02315560|7565823|FG000|COMPLETED|Overall Study||22
6637088|NCT02315560|7565823|FG000|NOT COMPLETED|Overall Study||3
6637089|NCT02315625|7565829|FG000|STARTED|First Intervention||14
6637090|NCT02315625|7565830|FG001|STARTED|First Intervention||2
6637091|NCT02315625|7565829|FG000|COMPLETED|First Intervention||13
6637092|NCT02315625|7565830|FG001|COMPLETED|First Intervention||2
6637093|NCT02315625|7565829|FG000|NOT COMPLETED|First Intervention||1
6637094|NCT02315625|7565830|FG001|NOT COMPLETED|First Intervention||0
6637095|NCT02315625|7565829|FG000|STARTED|Second Intervention||13
6411664|NCT00947427|7325034|FG000|COMPLETED|Overall Study||21
6637096|NCT02315625|7565830|FG001|STARTED|Second Intervention||2
6637097|NCT02315625|7565829|FG000|COMPLETED|Second Intervention||9
6637098|NCT02315625|7565830|FG001|COMPLETED|Second Intervention||1
6637099|NCT02315625|7565829|FG000|NOT COMPLETED|Second Intervention||4
6637100|NCT02315625|7565830|FG001|NOT COMPLETED|Second Intervention||1
6637101|NCT02315664|7565840|FG000|STARTED|Overall Study||30
6637102|NCT02315664|7565841|FG001|STARTED|Overall Study||31
6411665|NCT00947427|7325035|FG001|COMPLETED|Overall Study||45
6411666|NCT00947427|7325034|FG000|NOT COMPLETED|Overall Study||1
6411667|NCT00947427|7325035|FG001|NOT COMPLETED|Overall Study||4
6411668|NCT00947505|7325043|FG000|STARTED|Overall Study||33
6411669|NCT00947505|7325044|FG001|STARTED|Overall Study||16
6411670|NCT00947505|7325043|FG000|COMPLETED|Overall Study||24
6411671|NCT00947505|7325044|FG001|COMPLETED|Overall Study||14
6411672|NCT00947505|7325043|FG000|NOT COMPLETED|Overall Study||9
6411673|NCT00947505|7325044|FG001|NOT COMPLETED|Overall Study||2
6411674|NCT00947531|7325052|FG000|STARTED|Overall Study||121
6637103|NCT02315664|7565840|FG000|COMPLETED|Overall Study||29
6637104|NCT02315664|7565841|FG001|COMPLETED|Overall Study||27
6637105|NCT02315664|7565840|FG000|NOT COMPLETED|Overall Study||1
6411675|NCT00947531|7325053|FG001|STARTED|Overall Study||121
6411676|NCT00947531|7325052|FG000|COMPLETED|Overall Study||107
6411677|NCT00947531|7325053|FG001|COMPLETED|Overall Study||110
6411678|NCT00947531|7325052|FG000|NOT COMPLETED|Overall Study||14
6411679|NCT00947531|7325053|FG001|NOT COMPLETED|Overall Study||11
6411680|NCT00947544|7325059|FG000|STARTED|Switch-Over Period (2 Weeks)||11
6411681|NCT00947544|7325060|FG001|STARTED|Switch-Over Period (2 Weeks)||0
6411682|NCT00947544|7325059|FG000|COMPLETED|Switch-Over Period (2 Weeks)||11
6411683|NCT00947544|7325060|FG001|COMPLETED|Switch-Over Period (2 Weeks)||0
6411684|NCT00947544|7325059|FG000|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
6411685|NCT00947544|7325060|FG001|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
6411686|NCT00947544|7325059|FG000|STARTED|Safety-Extension Period (12 Months)||11
6411687|NCT00947544|7325060|FG001|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
6411688|NCT00947544|7325059|FG000|COMPLETED|Safety-Extension Period (12 Months)||10
6411689|NCT00947544|7325060|FG001|COMPLETED|Safety-Extension Period (12 Months)||6
6411690|NCT00947544|7325059|FG000|NOT COMPLETED|Safety-Extension Period (12 Months)||1
6411691|NCT00947544|7325060|FG001|NOT COMPLETED|Safety-Extension Period (12 Months)||0
6498990|NCT01413360|7417590|FG000|NOT COMPLETED|Overall Study||3
6498991|NCT01413503|7417594|FG000|STARTED|Overall Study||50
6498992|NCT01413503|7417594|FG000|COMPLETED|Overall Study||49
6498993|NCT01413503|7417594|FG000|NOT COMPLETED|Overall Study||1
6498994|NCT01413516|7417600|FG000|STARTED|Overall Study||8
6498995|NCT01413516|7417601|FG001|STARTED|Overall Study||9
6498996|NCT01413516|7417600|FG000|COMPLETED|Overall Study||8
6498997|NCT01413516|7417601|FG001|COMPLETED|Overall Study||9
6498998|NCT01413516|7417600|FG000|NOT COMPLETED|Overall Study||0
6498999|NCT01413516|7417601|FG001|NOT COMPLETED|Overall Study||0
6499000|NCT01413542|7417609|FG000|STARTED|Overall Study||6
6499001|NCT01413542|7417610|FG001|STARTED|Overall Study||6
6499002|NCT01413542|7417611|FG002|STARTED|Overall Study||9
6499003|NCT01413542|7417612|FG003|STARTED|Overall Study||8
6499004|NCT01413542|7417609|FG000|COMPLETED|Overall Study||5
6499005|NCT01413542|7417610|FG001|COMPLETED|Overall Study||6
6499006|NCT01413542|7417611|FG002|COMPLETED|Overall Study||6
6499007|NCT01413542|7417612|FG003|COMPLETED|Overall Study||7
6499008|NCT01413542|7417609|FG000|NOT COMPLETED|Overall Study||1
6499009|NCT01413542|7417610|FG001|NOT COMPLETED|Overall Study||0
6499010|NCT01413542|7417611|FG002|NOT COMPLETED|Overall Study||3
6499011|NCT01413542|7417612|FG003|NOT COMPLETED|Overall Study||1
6499012|NCT01413750|7417628|FG000|STARTED|Overall Study||6
6499013|NCT01413750|7417629|FG001|STARTED|Overall Study||6
6499014|NCT01413750|7417630|FG002|STARTED|Overall Study||4
6499015|NCT01413750|7417631|FG003|STARTED|Overall Study||7
6499016|NCT01413750|7417628|FG000|COMPLETED|Overall Study||6
6499017|NCT01413750|7417629|FG001|COMPLETED|Overall Study||6
6499018|NCT01413750|7417630|FG002|COMPLETED|Overall Study||4
6499019|NCT01413750|7417631|FG003|COMPLETED|Overall Study||7
6499020|NCT01413750|7417628|FG000|NOT COMPLETED|Overall Study||0
6499021|NCT01413750|7417629|FG001|NOT COMPLETED|Overall Study||0
6499022|NCT01413750|7417630|FG002|NOT COMPLETED|Overall Study||0
6499023|NCT01413750|7417631|FG003|NOT COMPLETED|Overall Study||0
6499024|NCT01413958|7417644|FG000|STARTED|Overall Study||288
6499025|NCT01413958|7417645|FG001|STARTED|Overall Study||287
6499026|NCT01413958|7417644|FG000|COMPLETED|Overall Study||288
6499027|NCT01413958|7417645|FG001|COMPLETED|Overall Study||286
6499028|NCT01413958|7417644|FG000|NOT COMPLETED|Overall Study||0
6499029|NCT01413958|7417645|FG001|NOT COMPLETED|Overall Study||1
6499030|NCT01414010|7417656|FG000|STARTED|Overall Study||8
6499031|NCT01414010|7417657|FG001|STARTED|Overall Study||8
6499032|NCT01414010|7417658|FG002|STARTED|Overall Study||8
6499033|NCT01414010|7417659|FG003|STARTED|Overall Study||8
6499034|NCT01414010|7417656|FG000|COMPLETED|Overall Study||6
6499035|NCT01414010|7417657|FG001|COMPLETED|Overall Study||8
6499036|NCT01414010|7417658|FG002|COMPLETED|Overall Study||8
6499037|NCT01414010|7417659|FG003|COMPLETED|Overall Study||8
6499038|NCT01414010|7417656|FG000|NOT COMPLETED|Overall Study||2
6499039|NCT01414010|7417657|FG001|NOT COMPLETED|Overall Study||0
6637106|NCT02315664|7565841|FG001|NOT COMPLETED|Overall Study||4
6499040|NCT01414010|7417658|FG002|NOT COMPLETED|Overall Study||0
6499041|NCT01414010|7417659|FG003|NOT COMPLETED|Overall Study||0
6499042|NCT01414036|7417677|FG000|STARTED|Received Allocated Intervention||23
6499043|NCT01414036|7417678|FG001|STARTED|Received Allocated Intervention||24
6499044|NCT01414036|7417677|FG000|COMPLETED|Received Allocated Intervention||23
6499045|NCT01414036|7417678|FG001|COMPLETED|Received Allocated Intervention||11
6499046|NCT01414036|7417677|FG000|NOT COMPLETED|Received Allocated Intervention||0
6499047|NCT01414036|7417678|FG001|NOT COMPLETED|Received Allocated Intervention||13
6499048|NCT01414036|7417677|FG000|STARTED|Completed 3 Month Survey||23
6637107|NCT02315755|7565847|FG000|STARTED|Overall Study||102
6637108|NCT02315755|7565847|FG000|COMPLETED|Overall Study|Participants who died, were considered as 'completed'.|102
6637109|NCT02315755|7565847|FG000|NOT COMPLETED|Overall Study||0
6411692|NCT00947661|7325072|FG000|STARTED|Overall Study||289
6411693|NCT00947661|7325073|FG001|STARTED|Overall Study||289
6411694|NCT00947661|7325072|FG000|COMPLETED|Overall Study||276
6411695|NCT00947661|7325073|FG001|COMPLETED|Overall Study||274
6411696|NCT00947661|7325072|FG000|NOT COMPLETED|Overall Study||13
6411697|NCT00947661|7325073|FG001|NOT COMPLETED|Overall Study||15
6411698|NCT00947752|7325081|FG000|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
6411699|NCT00947752|7325082|FG001|STARTED|7-Day Run-in Treatment Period||0
6411700|NCT00947752|7325081|FG000|COMPLETED|7-Day Run-in Treatment Period||147
6411701|NCT00947752|7325082|FG001|COMPLETED|7-Day Run-in Treatment Period||0
6411702|NCT00947752|7325081|FG000|NOT COMPLETED|7-Day Run-in Treatment Period||0
6411703|NCT00947752|7325082|FG001|NOT COMPLETED|7-Day Run-in Treatment Period||0
6411704|NCT00947752|7325081|FG000|STARTED|1st 14-day Treatment Period||76
6411705|NCT00947752|7325082|FG001|STARTED|1st 14-day Treatment Period||71
6411706|NCT00947752|7325081|FG000|COMPLETED|1st 14-day Treatment Period||76
6411707|NCT00947752|7325082|FG001|COMPLETED|1st 14-day Treatment Period||71
6411708|NCT00947752|7325081|FG000|NOT COMPLETED|1st 14-day Treatment Period||0
6411709|NCT00947752|7325082|FG001|NOT COMPLETED|1st 14-day Treatment Period||0
6411710|NCT00947752|7325081|FG000|STARTED|Crossover to 2nd 14-day Treatment Period||71
6411711|NCT00947752|7325082|FG001|STARTED|Crossover to 2nd 14-day Treatment Period||76
6411712|NCT00947752|7325081|FG000|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
6411713|NCT00947752|7325082|FG001|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
6411714|NCT00947752|7325081|FG000|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
6411715|NCT00947752|7325082|FG001|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
6411716|NCT00947765|7325090|FG000|STARTED|Overall Study||30
6411717|NCT00947765|7325091|FG001|STARTED|Overall Study||30
6411718|NCT00947765|7325090|FG000|COMPLETED|Overall Study||30
6411719|NCT00947765|7325091|FG001|COMPLETED|Overall Study||30
6411720|NCT00947765|7325090|FG000|NOT COMPLETED|Overall Study||0
6411721|NCT00947765|7325091|FG001|NOT COMPLETED|Overall Study||0
6411722|NCT00947856|7325099|FG000|STARTED|Treatment Period||78
6411723|NCT00947856|7325100|FG001|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
6411724|NCT00947856|7325099|FG000|COMPLETED|Treatment Period||0
6411725|NCT00947856|7325100|FG001|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
6411726|NCT00947856|7325099|FG000|NOT COMPLETED|Treatment Period||78
6411727|NCT00947856|7325100|FG001|NOT COMPLETED|Treatment Period||32
6411728|NCT00947856|7325099|FG000|STARTED|Follow-up Period||78
6411729|NCT00947856|7325100|FG001|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
6411730|NCT00947856|7325099|FG000|COMPLETED|Follow-up Period||27
6411731|NCT00947856|7325100|FG001|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
6411732|NCT00947856|7325099|FG000|NOT COMPLETED|Follow-up Period||51
6411733|NCT00947856|7325100|FG001|NOT COMPLETED|Follow-up Period||23
6411734|NCT00947882|7325119|FG000|STARTED|Overall Study|Started: Randomised.|100
6411735|NCT00947882|7325120|FG001|STARTED|Overall Study||101
6411736|NCT00947882|7325121|FG002|STARTED|Overall Study||101
6411737|NCT00947882|7325122|FG003|STARTED|Overall Study||102
6637110|NCT02315872|7565853|FG000|STARTED|Overall Study||4
6637111|NCT02315872|7565854|FG001|STARTED|Overall Study||4
6637112|NCT02315872|7565853|FG000|COMPLETED|Overall Study||1
6637113|NCT02315872|7565854|FG001|COMPLETED|Overall Study||3
6637114|NCT02315872|7565853|FG000|NOT COMPLETED|Overall Study||3
6637115|NCT02315872|7565854|FG001|NOT COMPLETED|Overall Study||1
6637116|NCT02315989|7565860|FG000|STARTED|Overall Study||6
6637117|NCT02315989|7565860|FG000|COMPLETED|Overall Study||6
6637118|NCT02315989|7565860|FG000|NOT COMPLETED|Overall Study||0
6637119|NCT02316171|7565870|FG000|STARTED|Overall Study||4
6637120|NCT02316171|7565871|FG001|STARTED|Overall Study||6
6637121|NCT02316171|7565872|FG002|STARTED|Overall Study||3
6637122|NCT02316171|7565873|FG003|STARTED|Overall Study||3
6637123|NCT02316171|7565870|FG000|COMPLETED|Overall Study||3
6637124|NCT02316171|7565871|FG001|COMPLETED|Overall Study||6
6637125|NCT02316171|7565872|FG002|COMPLETED|Overall Study||3
6637126|NCT02316171|7565873|FG003|COMPLETED|Overall Study||3
6637127|NCT02316171|7565870|FG000|NOT COMPLETED|Overall Study||1
6637128|NCT02316171|7565871|FG001|NOT COMPLETED|Overall Study||0
6637129|NCT02316171|7565872|FG002|NOT COMPLETED|Overall Study||0
6637130|NCT02316171|7565873|FG003|NOT COMPLETED|Overall Study||0
6637131|NCT02316223|7565882|FG000|STARTED|Overall Study||134
6637132|NCT02316223|7565883|FG001|STARTED|Overall Study||133
6637133|NCT02316223|7565884|FG002|STARTED|Overall Study||139
6637134|NCT02316223|7565882|FG000|COMPLETED|Overall Study||90
6637135|NCT02316223|7565883|FG001|COMPLETED|Overall Study||76
6637136|NCT02316223|7565884|FG002|COMPLETED|Overall Study||95
6637137|NCT02316223|7565882|FG000|NOT COMPLETED|Overall Study||44
6411738|NCT00947882|7325119|FG000|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
6411739|NCT00947882|7325120|FG001|Full Analysis Set (FAS)|Overall Study||101
6499049|NCT01414036|7417678|FG001|STARTED|Completed 3 Month Survey||24
6637138|NCT02316223|7565883|FG001|NOT COMPLETED|Overall Study||57
6637139|NCT02316223|7565884|FG002|NOT COMPLETED|Overall Study||44
6411740|NCT00947882|7325121|FG002|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
6411741|NCT00947882|7325122|FG003|Full Analysis Set (FAS)|Overall Study||102
6411742|NCT00947882|7325119|FG000|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
6411743|NCT00947882|7325120|FG001|Actual Treatment|Overall Study||101
6411744|NCT00947882|7325121|FG002|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
6411745|NCT00947882|7325122|FG003|Actual Treatment|Overall Study||105
6411746|NCT00947882|7325119|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
6411747|NCT00947882|7325120|FG001|Safety Analysis Set|Overall Study||101
6411748|NCT00947882|7325121|FG002|Safety Analysis Set|Overall Study||100
6411749|NCT00947882|7325122|FG003|Safety Analysis Set|Overall Study||105
6411750|NCT00947882|7325119|FG000|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
6411751|NCT00947882|7325120|FG001|Visit 12, Month 6|Overall Study||91
6411752|NCT00947882|7325121|FG002|Visit 12, Month 6|Overall Study||90
6411753|NCT00947882|7325122|FG003|Visit 12, Month 6|Overall Study||95
6411754|NCT00947882|7325119|FG000|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
6411755|NCT00947882|7325120|FG001|COMPLETED|Overall Study||24
6411756|NCT00947882|7325121|FG002|COMPLETED|Overall Study||22
6411757|NCT00947882|7325122|FG003|COMPLETED|Overall Study||20
6411758|NCT00947882|7325119|FG000|NOT COMPLETED|Overall Study||74
6411759|NCT00947882|7325120|FG001|NOT COMPLETED|Overall Study||77
6411760|NCT00947882|7325121|FG002|NOT COMPLETED|Overall Study||79
6411761|NCT00947882|7325122|FG003|NOT COMPLETED|Overall Study||82
6411762|NCT00948025|7325135|FG000|STARTED|Phase 1 (Pilot Phase)||14
6411763|NCT00948025|7325136|FG001|STARTED|Phase 1 (Pilot Phase)||9
6411764|NCT00948025|7325135|FG000|COMPLETED|Phase 1 (Pilot Phase)||5
6411765|NCT00948025|7325136|FG001|COMPLETED|Phase 1 (Pilot Phase)||6
6411766|NCT00948025|7325135|FG000|NOT COMPLETED|Phase 1 (Pilot Phase)||9
6411767|NCT00948025|7325136|FG001|NOT COMPLETED|Phase 1 (Pilot Phase)||3
6411768|NCT00948025|7325135|FG000|STARTED|Phase 2 (Comparative Phase)||0
6411769|NCT00948025|7325136|FG001|STARTED|Phase 2 (Comparative Phase)||0
6411770|NCT00948025|7325135|FG000|COMPLETED|Phase 2 (Comparative Phase)||0
6411771|NCT00948025|7325136|FG001|COMPLETED|Phase 2 (Comparative Phase)||0
6411772|NCT00948025|7325135|FG000|NOT COMPLETED|Phase 2 (Comparative Phase)||0
6411773|NCT00948025|7325136|FG001|NOT COMPLETED|Phase 2 (Comparative Phase)||0
6411774|NCT00948064|7325146|FG000|STARTED|Phase I||31
6411775|NCT00948064|7325147|FG001|STARTED|Phase I||0
6411776|NCT00948064|7325148|FG002|STARTED|Phase I||0
6411777|NCT00948064|7325146|FG000|COMPLETED|Phase I||30
6411778|NCT00948064|7325147|FG001|COMPLETED|Phase I||0
6411779|NCT00948064|7325148|FG002|COMPLETED|Phase I||0
6411780|NCT00948064|7325146|FG000|NOT COMPLETED|Phase I||1
6411781|NCT00948064|7325147|FG001|NOT COMPLETED|Phase I||0
6411782|NCT00948064|7325148|FG002|NOT COMPLETED|Phase I||0
6411783|NCT00948064|7325146|FG000|STARTED|Phase II||0
6411784|NCT00948064|7325147|FG001|STARTED|Phase II||52
6411785|NCT00948064|7325148|FG002|STARTED|Phase II||27
6411786|NCT00948064|7325146|FG000|COMPLETED|Phase II||0
6411787|NCT00948064|7325147|FG001|COMPLETED|Phase II||51
6411788|NCT00948064|7325148|FG002|COMPLETED|Phase II||26
6411789|NCT00948064|7325146|FG000|NOT COMPLETED|Phase II||0
6411790|NCT00948064|7325147|FG001|NOT COMPLETED|Phase II||1
6411791|NCT00948064|7325148|FG002|NOT COMPLETED|Phase II||1
6411792|NCT00948090|7325160|FG000|STARTED|Overall Study||65
6411793|NCT00948090|7325161|FG001|STARTED|Overall Study||1
6411794|NCT00948090|7325162|FG002|STARTED|Overall Study||123
6411795|NCT00948090|7325163|FG003|STARTED|Overall Study||18
6411796|NCT00948090|7325160|FG000|COMPLETED|Overall Study||22
6411797|NCT00948090|7325161|FG001|COMPLETED|Overall Study||0
6411798|NCT00948090|7325162|FG002|COMPLETED|Overall Study||67
6411799|NCT00948090|7325163|FG003|COMPLETED|Overall Study||7
6637140|NCT02316353|7565894|FG000|STARTED|Overall Study|7 subjects assigned to the CSL830 (40) Arm, were titrated up to the 60 IU/kg arm during the study|63
6637141|NCT02316353|7565895|FG001|STARTED|Overall Study||63
6637142|NCT02316353|7565894|FG000|COMPLETED|Overall Study||55
6637143|NCT02316353|7565895|FG001|COMPLETED|Overall Study||55
6637144|NCT02316353|7565894|FG000|NOT COMPLETED|Overall Study||8
6637145|NCT02316353|7565895|FG001|NOT COMPLETED|Overall Study||8
6637146|NCT02316366|7565906|FG000|STARTED|Overall Study||40
6637147|NCT02316366|7565907|FG001|STARTED|Overall Study||40
6411800|NCT00948090|7325160|FG000|NOT COMPLETED|Overall Study||43
6411801|NCT00948090|7325161|FG001|NOT COMPLETED|Overall Study||1
6411802|NCT00948090|7325162|FG002|NOT COMPLETED|Overall Study||56
6411803|NCT00948090|7325163|FG003|NOT COMPLETED|Overall Study||11
6411804|NCT00948155|7325172|FG000|STARTED|First Intervention 21 Days||14
6411805|NCT00948155|7325173|FG001|STARTED|First Intervention 21 Days||15
6637148|NCT02316366|7565906|FG000|COMPLETED|Overall Study||40
6637149|NCT02316366|7565907|FG001|COMPLETED|Overall Study||40
6637150|NCT02316366|7565906|FG000|NOT COMPLETED|Overall Study||0
6411806|NCT00948155|7325172|FG000|COMPLETED|First Intervention 21 Days||12
6411807|NCT00948155|7325173|FG001|COMPLETED|First Intervention 21 Days||13
6411808|NCT00948155|7325172|FG000|NOT COMPLETED|First Intervention 21 Days||2
6411809|NCT00948155|7325173|FG001|NOT COMPLETED|First Intervention 21 Days||2
6411810|NCT00948155|7325172|FG000|STARTED|Washout 14 Days||12
6411811|NCT00948155|7325173|FG001|STARTED|Washout 14 Days||13
6411812|NCT00948155|7325172|FG000|COMPLETED|Washout 14 Days||11
6411813|NCT00948155|7325173|FG001|COMPLETED|Washout 14 Days||11
6411814|NCT00948155|7325172|FG000|NOT COMPLETED|Washout 14 Days||1
6411815|NCT00948155|7325173|FG001|NOT COMPLETED|Washout 14 Days||2
6411816|NCT00948155|7325172|FG000|STARTED|Second Intervention 21 Days||11
6411817|NCT00948155|7325173|FG001|STARTED|Second Intervention 21 Days||11
6411818|NCT00948155|7325172|FG000|COMPLETED|Second Intervention 21 Days||9
6411819|NCT00948155|7325173|FG001|COMPLETED|Second Intervention 21 Days||8
6411820|NCT00948155|7325172|FG000|NOT COMPLETED|Second Intervention 21 Days||2
6411821|NCT00948155|7325173|FG001|NOT COMPLETED|Second Intervention 21 Days||3
6411822|NCT00948246|7325181|FG000|STARTED|Overall Study||110
6411823|NCT00948246|7325181|FG000|COMPLETED|Overall Study||86
6411824|NCT00948246|7325181|FG000|NOT COMPLETED|Overall Study||24
6411825|NCT00948298|7325187|FG000|STARTED|Overall Study||65
6411826|NCT00948298|7325188|FG001|STARTED|Overall Study||65
6411827|NCT00948298|7325187|FG000|COMPLETED|Overall Study||55
6411828|NCT00948298|7325188|FG001|COMPLETED|Overall Study||60
6411829|NCT00948298|7325187|FG000|NOT COMPLETED|Overall Study||10
6411830|NCT00948298|7325188|FG001|NOT COMPLETED|Overall Study||5
6411831|NCT00948389|7325199|FG000|STARTED|Overall Study||6
6411832|NCT00948389|7325200|FG001|STARTED|Overall Study||3
6411833|NCT00948389|7325201|FG002|STARTED|Overall Study||7
6411834|NCT00948389|7325202|FG003|STARTED|Overall Study||9
6411835|NCT00948389|7325203|FG004|STARTED|Overall Study||1
6411836|NCT00948389|7325199|FG000|COMPLETED|Overall Study||0
6411837|NCT00948389|7325200|FG001|COMPLETED|Overall Study||0
6411838|NCT00948389|7325201|FG002|COMPLETED|Overall Study||0
6411839|NCT00948389|7325202|FG003|COMPLETED|Overall Study||0
6411840|NCT00948389|7325203|FG004|COMPLETED|Overall Study||0
6411841|NCT00948389|7325199|FG000|NOT COMPLETED|Overall Study||6
6411842|NCT00948389|7325200|FG001|NOT COMPLETED|Overall Study||3
6411843|NCT00948389|7325201|FG002|NOT COMPLETED|Overall Study||7
6411844|NCT00948389|7325202|FG003|NOT COMPLETED|Overall Study||9
6411845|NCT00948389|7325203|FG004|NOT COMPLETED|Overall Study||1
6411846|NCT00948428|7325220|FG000|STARTED|Overall Study||185
6411847|NCT00948428|7325221|FG001|STARTED|Overall Study||185
6411848|NCT00948428|7325222|FG002|STARTED|Overall Study||92
6411849|NCT00948428|7325220|FG000|COMPLETED|Overall Study||167
6411850|NCT00948428|7325221|FG001|COMPLETED|Overall Study||167
6411851|NCT00948428|7325222|FG002|COMPLETED|Overall Study||84
6411852|NCT00948428|7325220|FG000|NOT COMPLETED|Overall Study||18
6411853|NCT00948428|7325221|FG001|NOT COMPLETED|Overall Study||18
6411854|NCT00948428|7325222|FG002|NOT COMPLETED|Overall Study||8
6411855|NCT00948441|7325232|FG000|STARTED|Overall Study||8
6411856|NCT00948441|7325233|FG001|STARTED|Overall Study||8
6411857|NCT00948441|7325232|FG000|COMPLETED|Overall Study||7
6411858|NCT00948441|7325233|FG001|COMPLETED|Overall Study||4
6411859|NCT00948441|7325232|FG000|NOT COMPLETED|Overall Study||1
6411860|NCT00948441|7325233|FG001|NOT COMPLETED|Overall Study||4
6411861|NCT00948506|7325243|FG000|STARTED|Overall Study||11
6411862|NCT00948506|7325244|FG001|STARTED|Overall Study||9
6411863|NCT00948506|7325243|FG000|COMPLETED|Overall Study||8
6411864|NCT00948506|7325244|FG001|COMPLETED|Overall Study||8
6411865|NCT00948506|7325243|FG000|NOT COMPLETED|Overall Study||3
6411866|NCT00948506|7325244|FG001|NOT COMPLETED|Overall Study||1
6411867|NCT00948610|7325255|FG000|STARTED|Overall Study||10
6411868|NCT00948610|7325256|FG001|STARTED|Overall Study||10
6411869|NCT00948610|7325255|FG000|COMPLETED|Overall Study||9
6411870|NCT00948610|7325256|FG001|COMPLETED|Overall Study||9
6411871|NCT00948610|7325255|FG000|NOT COMPLETED|Overall Study||1
6411872|NCT00948610|7325256|FG001|NOT COMPLETED|Overall Study||1
6411873|NCT00948675|7325264|FG000|STARTED|Overall Study||182
6411874|NCT00948675|7325265|FG001|STARTED|Overall Study||179
6411875|NCT00948675|7325264|FG000|Received Any Amount of Study Drug|Overall Study||171
6411876|NCT00948675|7325265|FG001|Received Any Amount of Study Drug|Overall Study||166
6411877|NCT00948675|7325264|FG000|COMPLETED|Overall Study||181
6411878|NCT00948675|7325265|FG001|COMPLETED|Overall Study||179
6411879|NCT00948675|7325264|FG000|NOT COMPLETED|Overall Study||1
6411880|NCT00948675|7325265|FG001|NOT COMPLETED|Overall Study||0
6411881|NCT00948688|7325271|FG000|STARTED|Period 1: 200 mg Vorinostat||4
6411882|NCT00948688|7325272|FG001|STARTED|Period 1: 200 mg Vorinostat||0
6411883|NCT00948688|7325271|FG000|COMPLETED|Period 1: 200 mg Vorinostat||2
6411884|NCT00948688|7325272|FG001|COMPLETED|Period 1: 200 mg Vorinostat||0
6411885|NCT00948688|7325271|FG000|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
6411886|NCT00948688|7325272|FG001|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
6411887|NCT00948688|7325271|FG000|STARTED|Period 2: 100 mg Vorinostat||0
6411888|NCT00948688|7325272|FG001|STARTED|Period 2: 100 mg Vorinostat||6
6411889|NCT00948688|7325271|FG000|COMPLETED|Period 2: 100 mg Vorinostat||0
6411890|NCT00948688|7325272|FG001|COMPLETED|Period 2: 100 mg Vorinostat||5
6411891|NCT00948688|7325271|FG000|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
6411892|NCT00948688|7325272|FG001|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
6411893|NCT00948766|7325281|FG000|STARTED|Core Study||356
6411894|NCT00948766|7325282|FG001|STARTED|Core Study||360
6411895|NCT00948766|7325281|FG000|Exposed to Study Medication|Core Study||355
6411896|NCT00948766|7325282|FG001|Exposed to Study Medication|Core Study||359
6411897|NCT00948766|7325281|FG000|COMPLETED|Core Study||229
6411898|NCT00948766|7325282|FG001|COMPLETED|Core Study||234
6411899|NCT00948766|7325281|FG000|NOT COMPLETED|Core Study||127
6411900|NCT00948766|7325282|FG001|NOT COMPLETED|Core Study||126
6411901|NCT00948766|7325281|FG000|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
6411902|NCT00948766|7325282|FG001|STARTED|Extension Study|No patients received this treatment in the extension study.|0
6411903|NCT00948766|7325281|FG000|Exposed to Study Medication|Extension Study||396
6411904|NCT00948766|7325282|FG001|Exposed to Study Medication|Extension Study||0
6411905|NCT00948766|7325281|FG000|COMPLETED|Extension Study||306
6411906|NCT00948766|7325282|FG001|COMPLETED|Extension Study||0
6411907|NCT00948766|7325281|FG000|NOT COMPLETED|Extension Study||91
6411908|NCT00948766|7325282|FG001|NOT COMPLETED|Extension Study||0
6411909|NCT00948792|7325289|FG000|STARTED|Overall Study||21
6411910|NCT00948792|7325289|FG000|COMPLETED|Overall Study||21
6411911|NCT00948792|7325289|FG000|NOT COMPLETED|Overall Study||0
6411912|NCT00948818|7325297|FG000|STARTED|Overall Study||397
6411913|NCT00948818|7325298|FG001|STARTED|Overall Study||406
6411914|NCT00948818|7325297|FG000|COMPLETED|Overall Study||335
6411915|NCT00948818|7325298|FG001|COMPLETED|Overall Study||312
6411916|NCT00948818|7325297|FG000|NOT COMPLETED|Overall Study||62
6411917|NCT00948818|7325298|FG001|NOT COMPLETED|Overall Study||94
6411918|NCT00948857|7325309|FG000|STARTED|Overall Study||3
6411919|NCT00948857|7325310|FG001|STARTED|Overall Study||2
6411920|NCT00948857|7325309|FG000|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
6411921|NCT00948857|7325310|FG001|COMPLETED|Overall Study||2
6411922|NCT00948857|7325309|FG000|NOT COMPLETED|Overall Study||1
6411923|NCT00948857|7325310|FG001|NOT COMPLETED|Overall Study||0
6411924|NCT00948896|7325324|FG000|STARTED|Randomization to 24 Months of Age||98
6411925|NCT00948896|7325325|FG001|STARTED|Randomization to 24 Months of Age||98
6411926|NCT00948896|7325326|FG002|STARTED|Randomization to 24 Months of Age||99
6411927|NCT00948896|7325327|FG003|STARTED|Randomization to 24 Months of Age||98
6411928|NCT00948896|7325328|FG004|STARTED|Randomization to 24 Months of Age||46
6411929|NCT00948896|7325329|FG005|STARTED|Randomization to 24 Months of Age||46
6411930|NCT00948896|7325330|FG006|STARTED|Randomization to 24 Months of Age||47
6411931|NCT00948896|7325331|FG007|STARTED|Randomization to 24 Months of Age||47
6411932|NCT00948896|7325324|FG000|COMPLETED|Randomization to 24 Months of Age||90
6411933|NCT00948896|7325325|FG001|COMPLETED|Randomization to 24 Months of Age||85
6411934|NCT00948896|7325326|FG002|COMPLETED|Randomization to 24 Months of Age||90
6411935|NCT00948896|7325327|FG003|COMPLETED|Randomization to 24 Months of Age||87
6411936|NCT00948896|7325328|FG004|COMPLETED|Randomization to 24 Months of Age||44
6411937|NCT00948896|7325329|FG005|COMPLETED|Randomization to 24 Months of Age||42
6411938|NCT00948896|7325330|FG006|COMPLETED|Randomization to 24 Months of Age||43
6411939|NCT00948896|7325331|FG007|COMPLETED|Randomization to 24 Months of Age||45
6411940|NCT00948896|7325324|FG000|NOT COMPLETED|Randomization to 24 Months of Age||8
6411941|NCT00948896|7325325|FG001|NOT COMPLETED|Randomization to 24 Months of Age||13
6411942|NCT00948896|7325326|FG002|NOT COMPLETED|Randomization to 24 Months of Age||9
6411943|NCT00948896|7325327|FG003|NOT COMPLETED|Randomization to 24 Months of Age||11
6411944|NCT00948896|7325328|FG004|NOT COMPLETED|Randomization to 24 Months of Age||2
6411945|NCT00948896|7325329|FG005|NOT COMPLETED|Randomization to 24 Months of Age||4
6411946|NCT00948896|7325330|FG006|NOT COMPLETED|Randomization to 24 Months of Age||4
6411947|NCT00948896|7325331|FG007|NOT COMPLETED|Randomization to 24 Months of Age||2
6411948|NCT00948896|7325324|FG000|STARTED|24 Months of Age to 36 Months of Age||90
6411949|NCT00948896|7325325|FG001|STARTED|24 Months of Age to 36 Months of Age||85
6411950|NCT00948896|7325326|FG002|STARTED|24 Months of Age to 36 Months of Age||90
6411951|NCT00948896|7325327|FG003|STARTED|24 Months of Age to 36 Months of Age||87
6411952|NCT00948896|7325328|FG004|STARTED|24 Months of Age to 36 Months of Age||44
6411953|NCT00948896|7325329|FG005|STARTED|24 Months of Age to 36 Months of Age||42
6411954|NCT00948896|7325330|FG006|STARTED|24 Months of Age to 36 Months of Age||43
6637151|NCT02316366|7565907|FG001|NOT COMPLETED|Overall Study||0
6637152|NCT02316470|7565917|FG000|STARTED|Overall Study||148
6637153|NCT02316470|7565918|FG001|STARTED|Overall Study||152
6637154|NCT02316470|7565919|FG002|STARTED|Overall Study||152
6637155|NCT02316470|7565920|FG003|STARTED|Overall Study||48
6637156|NCT02316470|7565917|FG000|COMPLETED|Overall Study||143
6637157|NCT02316470|7565918|FG001|COMPLETED|Overall Study||146
6637158|NCT02316470|7565919|FG002|COMPLETED|Overall Study||147
6411955|NCT00948896|7325331|FG007|STARTED|24 Months of Age to 36 Months of Age||45
6411956|NCT00948896|7325324|FG000|COMPLETED|24 Months of Age to 36 Months of Age||87
6411957|NCT00948896|7325325|FG001|COMPLETED|24 Months of Age to 36 Months of Age||83
6411958|NCT00948896|7325326|FG002|COMPLETED|24 Months of Age to 36 Months of Age||85
6411959|NCT00948896|7325327|FG003|COMPLETED|24 Months of Age to 36 Months of Age||85
6499050|NCT01414036|7417677|FG000|COMPLETED|Completed 3 Month Survey||14
6637159|NCT02316470|7565920|FG003|COMPLETED|Overall Study||46
6637160|NCT02316470|7565917|FG000|NOT COMPLETED|Overall Study||5
6637161|NCT02316470|7565918|FG001|NOT COMPLETED|Overall Study||6
6637162|NCT02316470|7565919|FG002|NOT COMPLETED|Overall Study||5
6637163|NCT02316470|7565920|FG003|NOT COMPLETED|Overall Study||2
6637164|NCT02316548|7565932|FG000|STARTED|Overall Study|Randomized|6
6637165|NCT02316548|7565933|FG001|STARTED|Overall Study|Randomized|7
6637166|NCT02316548|7565932|FG000|Eligible Population|Overall Study||6
6637167|NCT02316548|7565933|FG001|Eligible Population|Overall Study||6
6637168|NCT02316548|7565932|FG000|Eligible With Disease Assessment|Overall Study||4
6637169|NCT02316548|7565933|FG001|Eligible With Disease Assessment|Overall Study||1
6637170|NCT02316548|7565932|FG000|Eligible With Adverse Event Data|Overall Study||4
6637171|NCT02316548|7565933|FG001|Eligible With Adverse Event Data|Overall Study||2
6637172|NCT02316548|7565932|FG000|COMPLETED|Overall Study|Eligible patients on study until study termination|6
6637173|NCT02316548|7565933|FG001|COMPLETED|Overall Study|Eligible patients on study until study termination|6
6637174|NCT02316548|7565932|FG000|NOT COMPLETED|Overall Study||0
6637175|NCT02316548|7565933|FG001|NOT COMPLETED|Overall Study||1
6637176|NCT02316613|7565939|FG000|STARTED|Overall Study||260
6637177|NCT02316613|7565939|FG000|Safety Population|Overall Study||255
6411960|NCT00948896|7325328|FG004|COMPLETED|24 Months of Age to 36 Months of Age||43
6411961|NCT00948896|7325329|FG005|COMPLETED|24 Months of Age to 36 Months of Age||40
6411962|NCT00948896|7325330|FG006|COMPLETED|24 Months of Age to 36 Months of Age||43
6411963|NCT00948896|7325331|FG007|COMPLETED|24 Months of Age to 36 Months of Age||45
6411964|NCT00948896|7325324|FG000|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
6411965|NCT00948896|7325325|FG001|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
6411966|NCT00948896|7325326|FG002|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
6411967|NCT00948896|7325327|FG003|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
6411968|NCT00948896|7325328|FG004|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
6411969|NCT00948896|7325329|FG005|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
6411970|NCT00948896|7325330|FG006|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
6411971|NCT00948896|7325331|FG007|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
6411972|NCT00948922|7325356|FG000|STARTED|Overall Study||34
6411973|NCT00948922|7325357|FG001|STARTED|Overall Study||51
6411974|NCT00948922|7325358|FG002|STARTED|Overall Study||39
6411975|NCT00948922|7325356|FG000|COMPLETED|Overall Study||26
6411976|NCT00948922|7325357|FG001|COMPLETED|Overall Study||37
6411977|NCT00948922|7325358|FG002|COMPLETED|Overall Study||38
6411978|NCT00948922|7325356|FG000|NOT COMPLETED|Overall Study||8
6411979|NCT00948922|7325357|FG001|NOT COMPLETED|Overall Study||14
6411980|NCT00948922|7325358|FG002|NOT COMPLETED|Overall Study||1
6411981|NCT00948935|7325370|FG000|STARTED|Overall Study||35
6411982|NCT00948935|7325370|FG000|COMPLETED|Overall Study||35
6411983|NCT00948935|7325370|FG000|NOT COMPLETED|Overall Study||0
6411984|NCT00948974|7325376|FG000|STARTED|Overall Study||40
6411985|NCT00948974|7325377|FG001|STARTED|Overall Study||48
6411986|NCT00948974|7325376|FG000|COMPLETED|Overall Study||17
6411987|NCT00948974|7325377|FG001|COMPLETED|Overall Study||28
6411988|NCT00948974|7325376|FG000|NOT COMPLETED|Overall Study||23
6411989|NCT00948974|7325377|FG001|NOT COMPLETED|Overall Study||20
6411990|NCT00949078|7325385|FG000|STARTED|Overall Study||5
6411991|NCT00949078|7325386|FG001|STARTED|Overall Study||9
6411992|NCT00949078|7325385|FG000|COMPLETED|Overall Study||5
6411993|NCT00949078|7325386|FG001|COMPLETED|Overall Study||9
6411994|NCT00949078|7325385|FG000|NOT COMPLETED|Overall Study||0
6411995|NCT00949078|7325386|FG001|NOT COMPLETED|Overall Study||0
6411996|NCT00949117|7325394|FG000|STARTED|Overall Study||4
6411997|NCT00949117|7325395|FG001|STARTED|Overall Study||5
6411998|NCT00949117|7325394|FG000|COMPLETED|Overall Study||1
6411999|NCT00949117|7325395|FG001|COMPLETED|Overall Study||0
6412000|NCT00949117|7325394|FG000|NOT COMPLETED|Overall Study||3
6412001|NCT00949117|7325395|FG001|NOT COMPLETED|Overall Study||5
6412002|NCT00949234|7325403|FG000|STARTED|Overall Study||267
6412003|NCT00949234|7325403|FG000|COMPLETED|Overall Study||225
6412004|NCT00949234|7325403|FG000|NOT COMPLETED|Overall Study||42
6412005|NCT00949325|7325407|FG000|STARTED|Overall Study||3
6412006|NCT00949325|7325408|FG001|STARTED|Overall Study||18
6412007|NCT00949325|7325409|FG002|STARTED|Overall Study||3
6412008|NCT00949325|7325407|FG000|COMPLETED|Overall Study||3
6412009|NCT00949325|7325408|FG001|COMPLETED|Overall Study||16
6412010|NCT00949325|7325409|FG002|COMPLETED|Overall Study||3
6412011|NCT00949325|7325407|FG000|NOT COMPLETED|Overall Study||0
6412012|NCT00949325|7325408|FG001|NOT COMPLETED|Overall Study||2
6412013|NCT00949325|7325409|FG002|NOT COMPLETED|Overall Study||0
6412014|NCT00949533|7325427|FG000|STARTED|Overall Study||19
6412015|NCT00949533|7325428|FG001|STARTED|Overall Study||18
6412016|NCT00949533|7325427|FG000|COMPLETED|Overall Study||19
6412017|NCT00949533|7325428|FG001|COMPLETED|Overall Study||17
6412018|NCT00949533|7325427|FG000|NOT COMPLETED|Overall Study||0
6412019|NCT00949533|7325428|FG001|NOT COMPLETED|Overall Study||1
6412020|NCT00949650|7325436|FG000|STARTED|Overall Study|Treated patients.|230
6412021|NCT00949650|7325437|FG001|STARTED|Overall Study|Treated patients.|115
6412022|NCT00949650|7325436|FG000|COMPLETED|Overall Study|On treatment at the cut-off date 17MAR2017.|0
6412023|NCT00949650|7325437|FG001|COMPLETED|Overall Study||0
6412024|NCT00949650|7325436|FG000|NOT COMPLETED|Overall Study||230
6412025|NCT00949650|7325437|FG001|NOT COMPLETED|Overall Study||115
6412026|NCT00949702|7325447|FG000|STARTED|Overall Study||132
6412027|NCT00949702|7325447|FG000|COMPLETED|Overall Study||84
6412028|NCT00949702|7325447|FG000|NOT COMPLETED|Overall Study||48
6412029|NCT00949715|7325453|FG000|STARTED|Overall Study||32
6412030|NCT00949715|7325454|FG001|STARTED|Overall Study||33
6412031|NCT00949715|7325453|FG000|COMPLETED|Overall Study||28
6412032|NCT00949715|7325454|FG001|COMPLETED|Overall Study||33
6412033|NCT00949715|7325453|FG000|NOT COMPLETED|Overall Study||4
6412034|NCT00949715|7325454|FG001|NOT COMPLETED|Overall Study||0
6412035|NCT00949884|7325462|FG000|STARTED|Overall Study||420
6637178|NCT02316613|7565939|FG000|Overall Population|Overall Study||241
6637179|NCT02316613|7565939|FG000|COMPLETED|Overall Study||156
6637180|NCT02316613|7565939|FG000|NOT COMPLETED|Overall Study||104
6412036|NCT00949884|7325463|FG001|STARTED|Overall Study||52
6412037|NCT00949884|7325464|FG002|STARTED|Overall Study||469
6412038|NCT00949884|7325462|FG000|COMPLETED|Overall Study||370
6412039|NCT00949884|7325463|FG001|COMPLETED|Overall Study||37
6412040|NCT00949884|7325464|FG002|COMPLETED|Overall Study||411
6412041|NCT00949884|7325462|FG000|NOT COMPLETED|Overall Study||50
6412042|NCT00949884|7325463|FG001|NOT COMPLETED|Overall Study||15
6412043|NCT00949884|7325464|FG002|NOT COMPLETED|Overall Study||58
6412044|NCT00949910|7325473|FG000|STARTED|Overall Study||6586
6412045|NCT00949910|7325473|FG000|COMPLETED|Overall Study||10
6412046|NCT00949910|7325473|FG000|NOT COMPLETED|Overall Study||6576
6412047|NCT00949975|7325481|FG000|STARTED|Overall Study||212
6412048|NCT00949975|7325482|FG001|STARTED|Overall Study||206
6412049|NCT00949975|7325483|FG002|STARTED|Overall Study||202
6412050|NCT00949975|7325484|FG003|STARTED|Overall Study||218
6412051|NCT00949975|7325481|FG000|COMPLETED|Overall Study||185
6412052|NCT00949975|7325482|FG001|COMPLETED|Overall Study||177
6412053|NCT00949975|7325483|FG002|COMPLETED|Overall Study||183
6412054|NCT00949975|7325484|FG003|COMPLETED|Overall Study||190
6412055|NCT00949975|7325481|FG000|NOT COMPLETED|Overall Study||27
6412056|NCT00949975|7325482|FG001|NOT COMPLETED|Overall Study||29
6412057|NCT00949975|7325483|FG002|NOT COMPLETED|Overall Study||19
6412058|NCT00949975|7325484|FG003|NOT COMPLETED|Overall Study||28
6412059|NCT00950170|7325494|FG000|STARTED|Overall Study||23
6412060|NCT00950170|7325494|FG000|COMPLETED|Overall Study||19
6412061|NCT00950170|7325494|FG000|NOT COMPLETED|Overall Study||4
6412062|NCT00950235|7325518|FG000|STARTED|Overall Study||60
6412063|NCT00950235|7325519|FG001|STARTED|Overall Study||58
6412064|NCT00950235|7325518|FG000|COMPLETED|Overall Study||58
6412065|NCT00950235|7325519|FG001|COMPLETED|Overall Study||54
6412066|NCT00950235|7325518|FG000|NOT COMPLETED|Overall Study||2
6412067|NCT00950235|7325519|FG001|NOT COMPLETED|Overall Study||4
6412068|NCT00950248|7325527|FG000|STARTED|Year 1: Baseline||85
6412069|NCT00950248|7325528|FG001|STARTED|Year 1: Baseline||0
6412070|NCT00950248|7325529|FG002|STARTED|Year 1: Baseline||0
6412071|NCT00950248|7325527|FG000|COMPLETED|Year 1: Baseline||77
6412072|NCT00950248|7325528|FG001|COMPLETED|Year 1: Baseline||0
6412073|NCT00950248|7325529|FG002|COMPLETED|Year 1: Baseline||0
6412074|NCT00950248|7325527|FG000|NOT COMPLETED|Year 1: Baseline||8
6412075|NCT00950248|7325528|FG001|NOT COMPLETED|Year 1: Baseline||0
6412076|NCT00950248|7325529|FG002|NOT COMPLETED|Year 1: Baseline||0
6412077|NCT00950248|7325527|FG000|STARTED|Year 2&3 Treatment Randomization||0
6412078|NCT00950248|7325528|FG001|STARTED|Year 2&3 Treatment Randomization||39
6412079|NCT00950248|7325529|FG002|STARTED|Year 2&3 Treatment Randomization||38
6412080|NCT00950248|7325527|FG000|COMPLETED|Year 2&3 Treatment Randomization||0
6412081|NCT00950248|7325528|FG001|COMPLETED|Year 2&3 Treatment Randomization||33
6412082|NCT00950248|7325529|FG002|COMPLETED|Year 2&3 Treatment Randomization||33
6412083|NCT00950248|7325527|FG000|NOT COMPLETED|Year 2&3 Treatment Randomization||0
6412084|NCT00950248|7325528|FG001|NOT COMPLETED|Year 2&3 Treatment Randomization||6
6412085|NCT00950248|7325529|FG002|NOT COMPLETED|Year 2&3 Treatment Randomization||5
6412086|NCT00950300|7325538|FG000|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
6412087|NCT00950300|7325539|FG001|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
6412088|NCT00950300|7325538|FG000|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||298
6412089|NCT00950300|7325539|FG001|Received Neoadjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||297
6412090|NCT00950300|7325538|FG000|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||277
6412091|NCT00950300|7325539|FG001|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
6412092|NCT00950300|7325538|FG000|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
6412093|NCT00950300|7325539|FG001|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
6412094|NCT00950300|7325538|FG000|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
6412095|NCT00950300|7325539|FG001|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
6637181|NCT02316678|7565956|FG000|STARTED|Overall Study||1879
6637182|NCT02316678|7565957|FG001|STARTED|Overall Study||7694
6637183|NCT02316678|7565956|FG000|COMPLETED|Overall Study||1879
6637184|NCT02316678|7565957|FG001|COMPLETED|Overall Study||7694
6637185|NCT02316678|7565956|FG000|NOT COMPLETED|Overall Study||0
6412096|NCT00950300|7325538|FG000|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
6412097|NCT00950300|7325539|FG001|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
6412098|NCT00950300|7325538|FG000|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
6412099|NCT00950300|7325539|FG001|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
6412100|NCT00950300|7325538|FG000|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|165
6412101|NCT00950300|7325539|FG001|COMPLETED|TFFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|161
6412102|NCT00950300|7325538|FG000|NOT COMPLETED|TFFU Period||100
6412103|NCT00950300|7325539|FG001|NOT COMPLETED|TFFU Period||107
6412104|NCT00950300|7325538|FG000|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|118
6412105|NCT00950300|7325539|FG001|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|123
6499051|NCT01414036|7417678|FG001|COMPLETED|Completed 3 Month Survey||19
6637186|NCT02316678|7565957|FG001|NOT COMPLETED|Overall Study||0
6412106|NCT00950300|7325538|FG000|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|40
6412107|NCT00950300|7325539|FG001|COMPLETED|SFU Period|Includes participants who completed either 2 years of follow-up or 5 years of follow-up.|45
6412108|NCT00950300|7325538|FG000|NOT COMPLETED|SFU Period||78
6412109|NCT00950300|7325539|FG001|NOT COMPLETED|SFU Period||78
6412110|NCT00950352|7325548|FG000|STARTED|Overall Study||72
6412111|NCT00950352|7325549|FG001|STARTED|Overall Study||32
6412112|NCT00950352|7325548|FG000|COMPLETED|Overall Study||30
6412113|NCT00950352|7325549|FG001|COMPLETED|Overall Study||21
6412114|NCT00950352|7325548|FG000|NOT COMPLETED|Overall Study||42
6412115|NCT00950352|7325549|FG001|NOT COMPLETED|Overall Study||11
6412116|NCT00950365|7325557|FG000|STARTED|Overall Study||27
6412117|NCT00950365|7325558|FG001|STARTED|Overall Study||52
6412118|NCT00950365|7325557|FG000|COMPLETED|Overall Study||25
6412119|NCT00950365|7325558|FG001|COMPLETED|Overall Study||50
6412120|NCT00950365|7325557|FG000|NOT COMPLETED|Overall Study||2
6412121|NCT00950365|7325558|FG001|NOT COMPLETED|Overall Study||2
6412122|NCT00950599|7325572|FG000|STARTED|Double-Blind Treatment Period||55
6412123|NCT00950599|7325573|FG001|STARTED|Double-Blind Treatment Period||47
6412124|NCT00950599|7325574|FG002|STARTED|Double-Blind Treatment Period||63
6412125|NCT00950599|7325575|FG003|STARTED|Double-Blind Treatment Period||54
6412126|NCT00950599|7325576|FG004|STARTED|Double-Blind Treatment Period||52
6412127|NCT00950599|7325577|FG005|STARTED|Double-Blind Treatment Period||67
6412128|NCT00950599|7325578|FG006|STARTED|Double-Blind Treatment Period||44
6412129|NCT00950599|7325579|FG007|STARTED|Double-Blind Treatment Period||41
6412130|NCT00950599|7325580|FG008|STARTED|Double-Blind Treatment Period||0
6412131|NCT00950599|7325581|FG009|STARTED|Double-Blind Treatment Period||0
6412132|NCT00950599|7325572|FG000|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
6412133|NCT00950599|7325573|FG001|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
6412134|NCT00950599|7325574|FG002|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
6412135|NCT00950599|7325575|FG003|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
6412136|NCT00950599|7325576|FG004|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
6412137|NCT00950599|7325577|FG005|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
6412138|NCT00950599|7325578|FG006|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
6412139|NCT00950599|7325579|FG007|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
6412140|NCT00950599|7325580|FG008|COMPLETED|Double-Blind Treatment Period||0
6412141|NCT00950599|7325581|FG009|COMPLETED|Double-Blind Treatment Period||0
6412142|NCT00950599|7325572|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
6412143|NCT00950599|7325573|FG001|NOT COMPLETED|Double-Blind Treatment Period||10
6412144|NCT00950599|7325574|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
6412145|NCT00950599|7325575|FG003|NOT COMPLETED|Double-Blind Treatment Period||11
6412146|NCT00950599|7325576|FG004|NOT COMPLETED|Double-Blind Treatment Period||7
6412147|NCT00950599|7325577|FG005|NOT COMPLETED|Double-Blind Treatment Period||12
6412148|NCT00950599|7325578|FG006|NOT COMPLETED|Double-Blind Treatment Period||0
6412149|NCT00950599|7325579|FG007|NOT COMPLETED|Double-Blind Treatment Period||6
6412150|NCT00950599|7325580|FG008|NOT COMPLETED|Double-Blind Treatment Period||0
6412151|NCT00950599|7325581|FG009|NOT COMPLETED|Double-Blind Treatment Period||0
6412152|NCT00950599|7325572|FG000|STARTED|Follow-Up Period||0
6412153|NCT00950599|7325573|FG001|STARTED|Follow-Up Period||0
6412154|NCT00950599|7325574|FG002|STARTED|Follow-Up Period||0
6412155|NCT00950599|7325575|FG003|STARTED|Follow-Up Period||0
6412156|NCT00950599|7325576|FG004|STARTED|Follow-Up Period||0
6412157|NCT00950599|7325577|FG005|STARTED|Follow-Up Period||0
6412158|NCT00950599|7325578|FG006|STARTED|Follow-Up Period||0
6412159|NCT00950599|7325579|FG007|STARTED|Follow-Up Period||0
6412160|NCT00950599|7325580|FG008|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
6412161|NCT00950599|7325581|FG009|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
6412162|NCT00950599|7325572|FG000|COMPLETED|Follow-Up Period||0
6412163|NCT00950599|7325573|FG001|COMPLETED|Follow-Up Period||0
6412164|NCT00950599|7325574|FG002|COMPLETED|Follow-Up Period||0
6412165|NCT00950599|7325575|FG003|COMPLETED|Follow-Up Period||0
6412166|NCT00950599|7325576|FG004|COMPLETED|Follow-Up Period||0
6412167|NCT00950599|7325577|FG005|COMPLETED|Follow-Up Period||0
6412168|NCT00950599|7325578|FG006|COMPLETED|Follow-Up Period||0
6412169|NCT00950599|7325579|FG007|COMPLETED|Follow-Up Period||0
6412170|NCT00950599|7325580|FG008|COMPLETED|Follow-Up Period||296
6412171|NCT00950599|7325581|FG009|COMPLETED|Follow-Up Period||78
6412172|NCT00950599|7325572|FG000|NOT COMPLETED|Follow-Up Period||0
6412173|NCT00950599|7325573|FG001|NOT COMPLETED|Follow-Up Period||0
6412174|NCT00950599|7325574|FG002|NOT COMPLETED|Follow-Up Period||0
6412175|NCT00950599|7325575|FG003|NOT COMPLETED|Follow-Up Period||0
6412176|NCT00950599|7325576|FG004|NOT COMPLETED|Follow-Up Period||0
6412177|NCT00950599|7325577|FG005|NOT COMPLETED|Follow-Up Period||0
6412178|NCT00950599|7325578|FG006|NOT COMPLETED|Follow-Up Period||0
6412179|NCT00950599|7325579|FG007|NOT COMPLETED|Follow-Up Period||0
6412180|NCT00950599|7325580|FG008|NOT COMPLETED|Follow-Up Period||13
6412181|NCT00950599|7325581|FG009|NOT COMPLETED|Follow-Up Period||2
6412182|NCT00950612|7325606|FG000|STARTED|Overall Study||40
6412183|NCT00950612|7325607|FG001|STARTED|Overall Study||20
6412184|NCT00950612|7325606|FG000|COMPLETED|Overall Study||40
6412185|NCT00950612|7325607|FG001|COMPLETED|Overall Study||20
6412186|NCT00950612|7325606|FG000|NOT COMPLETED|Overall Study||0
6412187|NCT00950612|7325607|FG001|NOT COMPLETED|Overall Study||0
6412188|NCT00950651|7325615|FG000|STARTED|Overall Study||215
6412189|NCT00950651|7325616|FG001|STARTED|Overall Study|216 patients randomized but one never took study medication|216
6412190|NCT00950651|7325615|FG000|COMPLETED|Overall Study||184
6412191|NCT00950651|7325616|FG001|COMPLETED|Overall Study||181
6412192|NCT00950651|7325615|FG000|NOT COMPLETED|Overall Study||31
6412193|NCT00950651|7325616|FG001|NOT COMPLETED|Overall Study||35
6412194|NCT00950664|7325624|FG000|STARTED|First Intervention||49
6412195|NCT00950664|7325625|FG001|STARTED|First Intervention||53
6412196|NCT00950664|7325624|FG000|COMPLETED|First Intervention||46
6412197|NCT00950664|7325625|FG001|COMPLETED|First Intervention||48
6412198|NCT00950664|7325624|FG000|NOT COMPLETED|First Intervention||3
6412199|NCT00950664|7325625|FG001|NOT COMPLETED|First Intervention||5
6412200|NCT00950664|7325624|FG000|STARTED|Washout Period of 4 Weeks||46
6412201|NCT00950664|7325625|FG001|STARTED|Washout Period of 4 Weeks||48
6412202|NCT00950664|7325624|FG000|COMPLETED|Washout Period of 4 Weeks||46
6412203|NCT00950664|7325625|FG001|COMPLETED|Washout Period of 4 Weeks||48
6412204|NCT00950664|7325624|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
6412205|NCT00950664|7325625|FG001|NOT COMPLETED|Washout Period of 4 Weeks||0
6412206|NCT00950664|7325624|FG000|STARTED|Second Intervention||46
6412207|NCT00950664|7325625|FG001|STARTED|Second Intervention||48
6412208|NCT00950664|7325624|FG000|COMPLETED|Second Intervention||0
6412209|NCT00950664|7325625|FG001|COMPLETED|Second Intervention||0
6412210|NCT00950664|7325624|FG000|NOT COMPLETED|Second Intervention||46
6412211|NCT00950664|7325625|FG001|NOT COMPLETED|Second Intervention||48
6412212|NCT00950729|7325631|FG000|STARTED|Driving With Running Shoes|March 2007|48
6412213|NCT00950729|7325631|FG000|COMPLETED|Driving With Running Shoes|June 2007|48
6412214|NCT00950729|7325631|FG000|NOT COMPLETED|Driving With Running Shoes||0
6412215|NCT00950729|7325631|FG000|STARTED|Driving With Plaster Cast||48
6412216|NCT00950729|7325631|FG000|COMPLETED|Driving With Plaster Cast||48
6412217|NCT00950729|7325631|FG000|NOT COMPLETED|Driving With Plaster Cast||0
6412218|NCT00950729|7325631|FG000|STARTED|Driving With Aircast||48
6412219|NCT00950729|7325631|FG000|COMPLETED|Driving With Aircast||48
6412220|NCT00950729|7325631|FG000|NOT COMPLETED|Driving With Aircast||0
6412221|NCT00950742|7325637|FG000|STARTED|Overall Study|entered and treated|16
6412222|NCT00950742|7325638|FG001|STARTED|Overall Study|entered and treated|2
6412223|NCT00950742|7325637|FG000|COMPLETED|Overall Study||0
6412224|NCT00950742|7325638|FG001|COMPLETED|Overall Study||0
6412225|NCT00950742|7325637|FG000|NOT COMPLETED|Overall Study||16
6412226|NCT00950742|7325638|FG001|NOT COMPLETED|Overall Study||2
6412227|NCT00950755|7325648|FG000|STARTED|Dosimetric and Therapeutic Treatment||41
6412228|NCT00950755|7325648|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
6412229|NCT00950755|7325648|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
6412230|NCT00950755|7325648|FG000|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
6637187|NCT02316717|7565966|FG000|STARTED|Overall Study||43
6637188|NCT02316717|7565967|FG001|STARTED|Overall Study||46
6637189|NCT02316717|7565968|FG002|STARTED|Overall Study||44
6637190|NCT02316717|7565966|FG000|COMPLETED|Overall Study||32
6637191|NCT02316717|7565967|FG001|COMPLETED|Overall Study||39
6637192|NCT02316717|7565968|FG002|COMPLETED|Overall Study||41
6637193|NCT02316717|7565966|FG000|NOT COMPLETED|Overall Study||11
6637194|NCT02316717|7565967|FG001|NOT COMPLETED|Overall Study||7
6637195|NCT02316717|7565968|FG002|NOT COMPLETED|Overall Study||3
6637196|NCT02316769|7565981|FG000|STARTED|Overall Study||33
6637197|NCT02316769|7565982|FG001|STARTED|Overall Study||33
6637198|NCT02316769|7565981|FG000|COMPLETED|Overall Study||31
6637199|NCT02316769|7565982|FG001|COMPLETED|Overall Study||33
6637200|NCT02316769|7565981|FG000|NOT COMPLETED|Overall Study||2
6637201|NCT02316769|7565982|FG001|NOT COMPLETED|Overall Study||0
6637202|NCT02316847|7565990|FG000|STARTED|Overall Study||9
6637203|NCT02316847|7565991|FG001|STARTED|Overall Study||99
6637204|NCT02316847|7565990|FG000|COMPLETED|Overall Study||0
6637205|NCT02316847|7565991|FG001|COMPLETED|Overall Study||13
6637206|NCT02316847|7565990|FG000|NOT COMPLETED|Overall Study||9
6637207|NCT02316847|7565991|FG001|NOT COMPLETED|Overall Study||86
6637208|NCT02317016|7565999|FG000|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
6637209|NCT02317016|7565999|FG000|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
6637210|NCT02317016|7565999|FG000|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
6637211|NCT02317016|7565999|FG000|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
6637212|NCT02317016|7565999|FG000|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
6637213|NCT02317016|7565999|FG000|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
6637214|NCT02317016|7565999|FG000|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
6637215|NCT02317016|7565999|FG000|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
6637216|NCT02317016|7565999|FG000|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
6637217|NCT02317016|7565999|FG000|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
6637218|NCT02317016|7565999|FG000|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
6637219|NCT02317016|7565999|FG000|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
6637220|NCT02317042|7566007|FG000|STARTED|Overall Study||11
6412231|NCT00950755|7325648|FG000|COMPLETED|Long-Term Follow-Up||9
6412232|NCT00950755|7325648|FG000|NOT COMPLETED|Long-Term Follow-Up||9
6412233|NCT00950807|7325652|FG000|STARTED|Treatment Period 1||59
6412234|NCT00950807|7325653|FG001|STARTED|Treatment Period 1||13
6412235|NCT00950807|7325654|FG002|STARTED|Treatment Period 1||14
6412236|NCT00950807|7325655|FG003|STARTED|Treatment Period 1||12
6412237|NCT00950807|7325656|FG004|STARTED|Treatment Period 1||13
6412238|NCT00950807|7325657|FG005|STARTED|Treatment Period 1||13
6412239|NCT00950807|7325658|FG006|STARTED|Treatment Period 1||12
6412240|NCT00950807|7325659|FG007|STARTED|Treatment Period 1||14
6412241|NCT00950807|7325660|FG008|STARTED|Treatment Period 1||13
6412242|NCT00950807|7325661|FG009|STARTED|Treatment Period 1||13
6412243|NCT00950807|7325652|FG000|COMPLETED|Treatment Period 1||56
6412244|NCT00950807|7325653|FG001|COMPLETED|Treatment Period 1||13
6412245|NCT00950807|7325654|FG002|COMPLETED|Treatment Period 1||13
6412246|NCT00950807|7325655|FG003|COMPLETED|Treatment Period 1||12
6412247|NCT00950807|7325656|FG004|COMPLETED|Treatment Period 1||12
6412248|NCT00950807|7325657|FG005|COMPLETED|Treatment Period 1||11
6412249|NCT00950807|7325658|FG006|COMPLETED|Treatment Period 1||12
6412250|NCT00950807|7325659|FG007|COMPLETED|Treatment Period 1||14
6412251|NCT00950807|7325660|FG008|COMPLETED|Treatment Period 1||12
6412252|NCT00950807|7325661|FG009|COMPLETED|Treatment Period 1||13
6412253|NCT00950807|7325652|FG000|NOT COMPLETED|Treatment Period 1||3
6412254|NCT00950807|7325653|FG001|NOT COMPLETED|Treatment Period 1||0
6412255|NCT00950807|7325654|FG002|NOT COMPLETED|Treatment Period 1||1
6412256|NCT00950807|7325655|FG003|NOT COMPLETED|Treatment Period 1||0
6412257|NCT00950807|7325656|FG004|NOT COMPLETED|Treatment Period 1||1
6412258|NCT00950807|7325657|FG005|NOT COMPLETED|Treatment Period 1||2
6412259|NCT00950807|7325658|FG006|NOT COMPLETED|Treatment Period 1||0
6412260|NCT00950807|7325659|FG007|NOT COMPLETED|Treatment Period 1||0
6412261|NCT00950807|7325660|FG008|NOT COMPLETED|Treatment Period 1||1
6412262|NCT00950807|7325661|FG009|NOT COMPLETED|Treatment Period 1||0
6412263|NCT00950807|7325652|FG000|STARTED|Washout Period 1||56
6412264|NCT00950807|7325653|FG001|STARTED|Washout Period 1||13
6412265|NCT00950807|7325654|FG002|STARTED|Washout Period 1||13
6412266|NCT00950807|7325655|FG003|STARTED|Washout Period 1||12
6412267|NCT00950807|7325656|FG004|STARTED|Washout Period 1||12
6412268|NCT00950807|7325657|FG005|STARTED|Washout Period 1||11
6412269|NCT00950807|7325658|FG006|STARTED|Washout Period 1||12
6412270|NCT00950807|7325659|FG007|STARTED|Washout Period 1||14
6412271|NCT00950807|7325660|FG008|STARTED|Washout Period 1||12
6637221|NCT02317042|7566008|FG001|STARTED|Overall Study||14
6637222|NCT02317042|7566007|FG000|COMPLETED|Overall Study||11
6637223|NCT02317042|7566008|FG001|COMPLETED|Overall Study||14
6637224|NCT02317042|7566007|FG000|NOT COMPLETED|Overall Study||0
6637225|NCT02317042|7566008|FG001|NOT COMPLETED|Overall Study||0
6637226|NCT02317432|7566018|FG000|STARTED|Overall Study||153
6637227|NCT02317432|7566019|FG001|STARTED|Overall Study||154
6637228|NCT02317432|7566018|FG000|Completed CBT|Overall Study||118
6637229|NCT02317432|7566019|FG001|Completed CBT|Overall Study|Participants in Enhanced Usual Care did not receive CBT sessions.|0
6637230|NCT02317432|7566018|FG000|Completed InVEST|Overall Study||63
6637231|NCT02317432|7566019|FG001|Completed InVEST|Overall Study|Participants in Enhanced Usual Care did not receive InVEST sessions.|0
6637232|NCT02317432|7566018|FG000|Completed CBT + InVEST Exercise|Overall Study||122
6637233|NCT02317432|7566019|FG001|Completed CBT + InVEST Exercise|Overall Study|Participants in Enhanced Usual Care did not receive either CBT or InVEST sessions.|0
6637234|NCT02317432|7566018|FG000|Completed Enhanced Usual Care|Overall Study|Participants in CBT + InVEST exercise did not receive Enhanced Usual Care.|0
6637235|NCT02317432|7566019|FG001|Completed Enhanced Usual Care|Overall Study||148
6637236|NCT02317432|7566018|FG000|COMPLETED|Overall Study||122
6637237|NCT02317432|7566019|FG001|COMPLETED|Overall Study||148
6637238|NCT02317432|7566018|FG000|NOT COMPLETED|Overall Study||31
6637239|NCT02317432|7566019|FG001|NOT COMPLETED|Overall Study||6
6637240|NCT02317510|7566027|FG000|STARTED|Overall Study||25
6637241|NCT02317510|7566028|FG001|STARTED|Overall Study||25
6637242|NCT02317510|7566027|FG000|COMPLETED|Overall Study||25
6637243|NCT02317510|7566028|FG001|COMPLETED|Overall Study||24
6637244|NCT02317510|7566027|FG000|NOT COMPLETED|Overall Study||0
6637245|NCT02317510|7566028|FG001|NOT COMPLETED|Overall Study||1
6637246|NCT02317549|7566039|FG000|STARTED|Overall Study||5
6637247|NCT02317549|7566040|FG001|STARTED|Overall Study||3
6637248|NCT02317549|7566039|FG000|COMPLETED|Overall Study||5
6637249|NCT02317549|7566040|FG001|COMPLETED|Overall Study||3
6637250|NCT02317549|7566039|FG000|NOT COMPLETED|Overall Study||0
6637251|NCT02317549|7566040|FG001|NOT COMPLETED|Overall Study||0
6637252|NCT02317562|7566046|FG000|STARTED|Overall Study||19
6637253|NCT02317562|7566046|FG000|COMPLETED|Overall Study||5
6637254|NCT02317562|7566046|FG000|NOT COMPLETED|Overall Study||14
6637255|NCT02317575|7566050|FG000|STARTED|Period 1||5
6637256|NCT02317575|7566051|FG001|STARTED|Period 1||6
6637257|NCT02317575|7566052|FG002|STARTED|Period 1||6
6637258|NCT02317575|7566053|FG003|STARTED|Period 1||6
6743466|NCT03334721|7671692|FG001|COMPLETED|Overall Study||11
6412272|NCT00950807|7325661|FG009|STARTED|Washout Period 1||13
6412273|NCT00950807|7325652|FG000|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
6412274|NCT00950807|7325653|FG001|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
6412275|NCT00950807|7325654|FG002|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
6412276|NCT00950807|7325655|FG003|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
6499052|NCT01414036|7417677|FG000|NOT COMPLETED|Completed 3 Month Survey||9
6412277|NCT00950807|7325656|FG004|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
6412278|NCT00950807|7325657|FG005|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
6412279|NCT00950807|7325658|FG006|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
6412280|NCT00950807|7325659|FG007|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
6412281|NCT00950807|7325660|FG008|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
6412282|NCT00950807|7325661|FG009|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
6412283|NCT00950807|7325652|FG000|NOT COMPLETED|Washout Period 1||5
6412284|NCT00950807|7325653|FG001|NOT COMPLETED|Washout Period 1||0
6412285|NCT00950807|7325654|FG002|NOT COMPLETED|Washout Period 1||0
6412286|NCT00950807|7325655|FG003|NOT COMPLETED|Washout Period 1||1
6412287|NCT00950807|7325656|FG004|NOT COMPLETED|Washout Period 1||1
6412288|NCT00950807|7325657|FG005|NOT COMPLETED|Washout Period 1||0
6412289|NCT00950807|7325658|FG006|NOT COMPLETED|Washout Period 1||2
6412290|NCT00950807|7325659|FG007|NOT COMPLETED|Washout Period 1||1
6412291|NCT00950807|7325660|FG008|NOT COMPLETED|Washout Period 1||1
6412292|NCT00950807|7325661|FG009|NOT COMPLETED|Washout Period 1||0
6412293|NCT00950807|7325652|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
6412294|NCT00950807|7325653|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
6412295|NCT00950807|7325654|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
6412296|NCT00950807|7325655|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
6412297|NCT00950807|7325656|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
6412298|NCT00950807|7325657|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
6412299|NCT00950807|7325658|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
6412300|NCT00950807|7325659|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
6412301|NCT00950807|7325660|FG008|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
6412302|NCT00950807|7325661|FG009|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
6412303|NCT00950807|7325652|FG000|COMPLETED|Treatment Period 2||51
6412304|NCT00950807|7325653|FG001|COMPLETED|Treatment Period 2||12
6412305|NCT00950807|7325654|FG002|COMPLETED|Treatment Period 2||10
6412306|NCT00950807|7325655|FG003|COMPLETED|Treatment Period 2||12
6412307|NCT00950807|7325656|FG004|COMPLETED|Treatment Period 2||13
6412308|NCT00950807|7325657|FG005|COMPLETED|Treatment Period 2||9
6412309|NCT00950807|7325658|FG006|COMPLETED|Treatment Period 2||9
6412310|NCT00950807|7325659|FG007|COMPLETED|Treatment Period 2||10
6412311|NCT00950807|7325660|FG008|COMPLETED|Treatment Period 2||11
6412312|NCT00950807|7325661|FG009|COMPLETED|Treatment Period 2||11
6412313|NCT00950807|7325652|FG000|NOT COMPLETED|Treatment Period 2||2
6412314|NCT00950807|7325653|FG001|NOT COMPLETED|Treatment Period 2||1
6412315|NCT00950807|7325654|FG002|NOT COMPLETED|Treatment Period 2||0
6412316|NCT00950807|7325655|FG003|NOT COMPLETED|Treatment Period 2||1
6412317|NCT00950807|7325656|FG004|NOT COMPLETED|Treatment Period 2||0
6412318|NCT00950807|7325657|FG005|NOT COMPLETED|Treatment Period 2||1
6412319|NCT00950807|7325658|FG006|NOT COMPLETED|Treatment Period 2||1
6412320|NCT00950807|7325659|FG007|NOT COMPLETED|Treatment Period 2||3
6412321|NCT00950807|7325660|FG008|NOT COMPLETED|Treatment Period 2||0
6412322|NCT00950807|7325661|FG009|NOT COMPLETED|Treatment Period 2||0
6412323|NCT00950807|7325652|FG000|STARTED|Washout Period 2||51
6412324|NCT00950807|7325653|FG001|STARTED|Washout Period 2||12
6412325|NCT00950807|7325654|FG002|STARTED|Washout Period 2||10
6412326|NCT00950807|7325655|FG003|STARTED|Washout Period 2||12
6412327|NCT00950807|7325656|FG004|STARTED|Washout Period 2||13
6412328|NCT00950807|7325657|FG005|STARTED|Washout Period 2||9
6412329|NCT00950807|7325658|FG006|STARTED|Washout Period 2||9
6412330|NCT00950807|7325659|FG007|STARTED|Washout Period 2||10
6412331|NCT00950807|7325660|FG008|STARTED|Washout Period 2||11
6412332|NCT00950807|7325661|FG009|STARTED|Washout Period 2||11
6412333|NCT00950807|7325652|FG000|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
6412334|NCT00950807|7325653|FG001|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
6412335|NCT00950807|7325654|FG002|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
6499053|NCT01414036|7417678|FG001|NOT COMPLETED|Completed 3 Month Survey||5
6637259|NCT02317575|7566054|FG004|STARTED|Period 1||6
6637260|NCT02317575|7566050|FG000|Received at Least 1 Dose of Study Drug|Period 1||5
6637261|NCT02317575|7566051|FG001|Received at Least 1 Dose of Study Drug|Period 1||5
6637262|NCT02317575|7566052|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
6637263|NCT02317575|7566053|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
6637264|NCT02317575|7566054|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
6637265|NCT02317575|7566050|FG000|COMPLETED|Period 1||4
6637266|NCT02317575|7566051|FG001|COMPLETED|Period 1||5
6637267|NCT02317575|7566052|FG002|COMPLETED|Period 1||6
6637268|NCT02317575|7566053|FG003|COMPLETED|Period 1||6
6412336|NCT00950807|7325655|FG003|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
6412337|NCT00950807|7325656|FG004|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
6412338|NCT00950807|7325657|FG005|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
6412339|NCT00950807|7325658|FG006|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
6412340|NCT00950807|7325659|FG007|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
6412341|NCT00950807|7325660|FG008|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
6412342|NCT00950807|7325661|FG009|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
6412343|NCT00950807|7325652|FG000|NOT COMPLETED|Washout Period 2||4
6412344|NCT00950807|7325653|FG001|NOT COMPLETED|Washout Period 2||1
6412345|NCT00950807|7325654|FG002|NOT COMPLETED|Washout Period 2||0
6412346|NCT00950807|7325655|FG003|NOT COMPLETED|Washout Period 2||1
6412347|NCT00950807|7325656|FG004|NOT COMPLETED|Washout Period 2||1
6412348|NCT00950807|7325657|FG005|NOT COMPLETED|Washout Period 2||0
6412349|NCT00950807|7325658|FG006|NOT COMPLETED|Washout Period 2||1
6412350|NCT00950807|7325659|FG007|NOT COMPLETED|Washout Period 2||1
6412351|NCT00950807|7325660|FG008|NOT COMPLETED|Washout Period 2||0
6412352|NCT00950807|7325661|FG009|NOT COMPLETED|Washout Period 2||0
6412353|NCT00950807|7325652|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
6412354|NCT00950807|7325653|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
6412355|NCT00950807|7325654|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
6412356|NCT00950807|7325655|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
6412357|NCT00950807|7325656|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
6412358|NCT00950807|7325657|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
6412359|NCT00950807|7325658|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
6412360|NCT00950807|7325659|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
6412361|NCT00950807|7325660|FG008|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
6412362|NCT00950807|7325661|FG009|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
6412363|NCT00950807|7325652|FG000|COMPLETED|Treatment Period 3||45
6412364|NCT00950807|7325653|FG001|COMPLETED|Treatment Period 3||9
6412365|NCT00950807|7325654|FG002|COMPLETED|Treatment Period 3||10
6412366|NCT00950807|7325655|FG003|COMPLETED|Treatment Period 3||11
6412367|NCT00950807|7325656|FG004|COMPLETED|Treatment Period 3||12
6412368|NCT00950807|7325657|FG005|COMPLETED|Treatment Period 3||9
6412369|NCT00950807|7325658|FG006|COMPLETED|Treatment Period 3||11
6412370|NCT00950807|7325659|FG007|COMPLETED|Treatment Period 3||9
6412371|NCT00950807|7325660|FG008|COMPLETED|Treatment Period 3||9
6412372|NCT00950807|7325661|FG009|COMPLETED|Treatment Period 3||10
6412373|NCT00950807|7325652|FG000|NOT COMPLETED|Treatment Period 3||1
6412374|NCT00950807|7325653|FG001|NOT COMPLETED|Treatment Period 3||0
6412375|NCT00950807|7325654|FG002|NOT COMPLETED|Treatment Period 3||0
6412376|NCT00950807|7325655|FG003|NOT COMPLETED|Treatment Period 3||0
6412377|NCT00950807|7325656|FG004|NOT COMPLETED|Treatment Period 3||0
6412378|NCT00950807|7325657|FG005|NOT COMPLETED|Treatment Period 3||0
6412379|NCT00950807|7325658|FG006|NOT COMPLETED|Treatment Period 3||1
6412380|NCT00950807|7325659|FG007|NOT COMPLETED|Treatment Period 3||1
6412381|NCT00950807|7325660|FG008|NOT COMPLETED|Treatment Period 3||0
6412382|NCT00950807|7325661|FG009|NOT COMPLETED|Treatment Period 3||1
6412383|NCT00950833|7325686|FG000|STARTED|Overall Study||112
6412384|NCT00950833|7325687|FG001|STARTED|Overall Study||108
6412385|NCT00950833|7325688|FG002|STARTED|Overall Study||223
6412386|NCT00950833|7325686|FG000|COMPLETED|Overall Study||112
6412387|NCT00950833|7325687|FG001|COMPLETED|Overall Study||108
6412388|NCT00950833|7325688|FG002|COMPLETED|Overall Study||223
6412389|NCT00950833|7325686|FG000|NOT COMPLETED|Overall Study||0
6412390|NCT00950833|7325687|FG001|NOT COMPLETED|Overall Study||0
6412391|NCT00950833|7325688|FG002|NOT COMPLETED|Overall Study||0
6412392|NCT00950859|7325700|FG000|STARTED|Overall Study||27
6412393|NCT00950859|7325701|FG001|STARTED|Overall Study||24
6412394|NCT00950859|7325700|FG000|COMPLETED|Overall Study||11
6412395|NCT00950859|7325701|FG001|COMPLETED|Overall Study||14
6412396|NCT00950859|7325700|FG000|NOT COMPLETED|Overall Study||16
6412397|NCT00950859|7325701|FG001|NOT COMPLETED|Overall Study||10
6412398|NCT00950872|7325707|FG000|STARTED|Overall Study||29
6412399|NCT00950872|7325707|FG000|COMPLETED|Overall Study||26
6412400|NCT00950872|7325707|FG000|NOT COMPLETED|Overall Study||3
6412401|NCT00950911|7325713|FG000|STARTED|Overall Study||17
6412402|NCT00950911|7325714|FG001|STARTED|Overall Study||18
6412403|NCT00950911|7325713|FG000|COMPLETED|Overall Study||5
6412404|NCT00950911|7325714|FG001|COMPLETED|Overall Study||3
6412405|NCT00950911|7325713|FG000|NOT COMPLETED|Overall Study||12
6412406|NCT00950911|7325714|FG001|NOT COMPLETED|Overall Study||15
6412407|NCT00950950|7325722|FG000|STARTED|Overall Study||12
6412408|NCT00950950|7325723|FG001|STARTED|Overall Study||12
6412409|NCT00950950|7325722|FG000|COMPLETED|Overall Study||11
6412410|NCT00950950|7325723|FG001|COMPLETED|Overall Study||11
6412411|NCT00950950|7325722|FG000|NOT COMPLETED|Overall Study||1
6412412|NCT00950950|7325723|FG001|NOT COMPLETED|Overall Study||1
6412413|NCT00950963|7325732|FG000|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
6412414|NCT00950963|7325733|FG001|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
6412415|NCT00950963|7325732|FG000|COMPLETED|Overall Study||352
6412416|NCT00950963|7325733|FG001|COMPLETED|Overall Study||357
6412417|NCT00950963|7325732|FG000|NOT COMPLETED|Overall Study||29
6412418|NCT00950963|7325733|FG001|NOT COMPLETED|Overall Study||24
6412419|NCT00951015|7325743|FG000|STARTED|Randomization Phase 96 Week||53
6412420|NCT00951015|7325744|FG001|STARTED|Randomization Phase 96 Week||51
6412421|NCT00951015|7325745|FG002|STARTED|Randomization Phase 96 Week||51
6412422|NCT00951015|7325746|FG003|STARTED|Randomization Phase 96 Week||50
6412423|NCT00951015|7325747|FG004|STARTED|Randomization Phase 96 Week||0
6412424|NCT00951015|7325743|FG000|COMPLETED|Randomization Phase 96 Week||48
6412425|NCT00951015|7325744|FG001|COMPLETED|Randomization Phase 96 Week||44
6412426|NCT00951015|7325745|FG002|COMPLETED|Randomization Phase 96 Week||46
6412427|NCT00951015|7325746|FG003|COMPLETED|Randomization Phase 96 Week||40
6412428|NCT00951015|7325747|FG004|COMPLETED|Randomization Phase 96 Week||0
6412429|NCT00951015|7325743|FG000|NOT COMPLETED|Randomization Phase 96 Week||5
6637269|NCT02317575|7566054|FG004|COMPLETED|Period 1||6
6637270|NCT02317575|7566050|FG000|NOT COMPLETED|Period 1||1
6637271|NCT02317575|7566051|FG001|NOT COMPLETED|Period 1||1
6637272|NCT02317575|7566052|FG002|NOT COMPLETED|Period 1||0
6637273|NCT02317575|7566053|FG003|NOT COMPLETED|Period 1||0
6637274|NCT02317575|7566054|FG004|NOT COMPLETED|Period 1||0
6637275|NCT02317575|7566050|FG000|STARTED|Period 2||4
6412430|NCT00951015|7325744|FG001|NOT COMPLETED|Randomization Phase 96 Week||7
6412431|NCT00951015|7325745|FG002|NOT COMPLETED|Randomization Phase 96 Week||5
6412432|NCT00951015|7325746|FG003|NOT COMPLETED|Randomization Phase 96 Week||10
6412433|NCT00951015|7325747|FG004|NOT COMPLETED|Randomization Phase 96 Week||0
6412434|NCT00951015|7325743|FG000|STARTED|Open-label Phase||0
6412435|NCT00951015|7325744|FG001|STARTED|Open-label Phase||0
6412436|NCT00951015|7325745|FG002|STARTED|Open-label Phase||0
6412437|NCT00951015|7325746|FG003|STARTED|Open-label Phase||0
6412438|NCT00951015|7325747|FG004|STARTED|Open-label Phase||138
6412439|NCT00951015|7325743|FG000|COMPLETED|Open-label Phase||0
6412440|NCT00951015|7325744|FG001|COMPLETED|Open-label Phase||0
6412441|NCT00951015|7325745|FG002|COMPLETED|Open-label Phase||0
6412442|NCT00951015|7325746|FG003|COMPLETED|Open-label Phase||0
6412443|NCT00951015|7325747|FG004|COMPLETED|Open-label Phase||88
6412444|NCT00951015|7325743|FG000|NOT COMPLETED|Open-label Phase||0
6412445|NCT00951015|7325744|FG001|NOT COMPLETED|Open-label Phase||0
6412446|NCT00951015|7325745|FG002|NOT COMPLETED|Open-label Phase||0
6412447|NCT00951015|7325746|FG003|NOT COMPLETED|Open-label Phase||0
6412448|NCT00951015|7325747|FG004|NOT COMPLETED|Open-label Phase||50
6412449|NCT00951041|7325772|FG000|STARTED|Overall Study||64
6412450|NCT00951041|7325773|FG001|STARTED|Overall Study||66
6412451|NCT00951041|7325772|FG000|COMPLETED|Overall Study||59
6412452|NCT00951041|7325773|FG001|COMPLETED|Overall Study||65
6412453|NCT00951041|7325772|FG000|NOT COMPLETED|Overall Study||5
6412454|NCT00951041|7325773|FG001|NOT COMPLETED|Overall Study||1
6412455|NCT00951080|7325782|FG000|STARTED|Overall Study||64
6412456|NCT00951080|7325783|FG001|STARTED|Overall Study||68
6412457|NCT00951080|7325782|FG000|COMPLETED|Overall Study||38
6412458|NCT00951080|7325783|FG001|COMPLETED|Overall Study||41
6412459|NCT00951080|7325782|FG000|NOT COMPLETED|Overall Study||26
6412460|NCT00951080|7325783|FG001|NOT COMPLETED|Overall Study||27
6412461|NCT00951093|7325789|FG000|STARTED|Before GBP||53
6412462|NCT00951093|7325789|FG000|COMPLETED|Before GBP||53
6412463|NCT00951093|7325789|FG000|NOT COMPLETED|Before GBP||0
6412464|NCT00951093|7325789|FG000|STARTED|6 Months After GBP||53
6412465|NCT00951093|7325789|FG000|COMPLETED|6 Months After GBP||53
6412466|NCT00951093|7325789|FG000|NOT COMPLETED|6 Months After GBP||0
6412467|NCT00951171|7325797|FG000|STARTED|Overall Study||40
6412468|NCT00951171|7325798|FG001|STARTED|Overall Study||55
6412469|NCT00951171|7325797|FG000|Pregnancy|Overall Study||1
6412470|NCT00951171|7325798|FG001|Pregnancy|Overall Study||7
6412471|NCT00951171|7325797|FG000|COMPLETED|Overall Study||38
6412472|NCT00951171|7325798|FG001|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
6412473|NCT00951171|7325797|FG000|NOT COMPLETED|Overall Study||2
6412474|NCT00951171|7325798|FG001|NOT COMPLETED|Overall Study||0
6412475|NCT00951275|7325804|FG000|STARTED|Overall Study||105
6412476|NCT00951275|7325804|FG000|COMPLETED|Overall Study||92
6412477|NCT00951275|7325804|FG000|NOT COMPLETED|Overall Study||13
6637276|NCT02317575|7566051|FG001|STARTED|Period 2||5
6412478|NCT00951379|7325810|FG000|STARTED|Overall Study||27
6412479|NCT00951379|7325811|FG001|STARTED|Overall Study||25
6412480|NCT00951379|7325810|FG000|COMPLETED|Overall Study||21
6412481|NCT00951379|7325811|FG001|COMPLETED|Overall Study||23
6412482|NCT00951379|7325810|FG000|NOT COMPLETED|Overall Study||6
6412483|NCT00951379|7325811|FG001|NOT COMPLETED|Overall Study||2
6412484|NCT00951483|7325827|FG000|STARTED|Overall Study||47
6412485|NCT00951483|7325828|FG001|STARTED|Overall Study||44
6637277|NCT02317575|7566052|FG002|STARTED|Period 2||6
6637278|NCT02317575|7566053|FG003|STARTED|Period 2||6
6637279|NCT02317575|7566054|FG004|STARTED|Period 2||6
6412486|NCT00951483|7325827|FG000|COMPLETED|Overall Study||28
6412487|NCT00951483|7325828|FG001|COMPLETED|Overall Study||44
6412488|NCT00951483|7325827|FG000|NOT COMPLETED|Overall Study||19
6412489|NCT00951483|7325828|FG001|NOT COMPLETED|Overall Study||0
6412490|NCT00951496|7325839|FG000|STARTED|Overall Study||521
6412491|NCT00951496|7325840|FG001|STARTED|Overall Study||518
6412492|NCT00951496|7325841|FG002|STARTED|Overall Study||521
6412493|NCT00951496|7325839|FG000|COMPLETED|Overall Study||511
6412494|NCT00951496|7325840|FG001|COMPLETED|Overall Study||510
6412495|NCT00951496|7325841|FG002|COMPLETED|Overall Study||508
6412496|NCT00951496|7325839|FG000|NOT COMPLETED|Overall Study||10
6412497|NCT00951496|7325840|FG001|NOT COMPLETED|Overall Study||8
6412498|NCT00951496|7325841|FG002|NOT COMPLETED|Overall Study||13
6412499|NCT00951509|7325852|FG000|STARTED|Overall Study||31
6412500|NCT00951509|7325852|FG000|Driving Condition 1|Overall Study||29
6412501|NCT00951509|7325852|FG000|Driving Condition 2|Overall Study||29
6412502|NCT00951509|7325852|FG000|Driving Condition 3|Overall Study||25
6412503|NCT00951509|7325852|FG000|Driving Condition 4|Overall Study||28
6412504|NCT00951509|7325852|FG000|Driving Condition 5|Overall Study||30
6412505|NCT00951509|7325852|FG000|COMPLETED|Overall Study||29
6412506|NCT00951509|7325852|FG000|NOT COMPLETED|Overall Study||2
6412507|NCT00951561|7325860|FG000|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
6412508|NCT00951561|7325861|FG001|STARTED|Overall Study||29
6412509|NCT00951561|7325862|FG002|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
6412510|NCT00951561|7325863|FG003|STARTED|Overall Study||27
6412511|NCT00951561|7325860|FG000|COMPLETED|Overall Study||25
6412512|NCT00951561|7325861|FG001|COMPLETED|Overall Study||29
6412513|NCT00951561|7325862|FG002|COMPLETED|Overall Study|3 subjects dropped after period 2|18
6412514|NCT00951561|7325863|FG003|COMPLETED|Overall Study|1 subject dropped after period 2|26
6412515|NCT00951561|7325860|FG000|NOT COMPLETED|Overall Study||0
6412516|NCT00951561|7325861|FG001|NOT COMPLETED|Overall Study||0
6412517|NCT00951561|7325862|FG002|NOT COMPLETED|Overall Study||3
6412518|NCT00951561|7325863|FG003|NOT COMPLETED|Overall Study||1
6412519|NCT00951665|7325874|FG000|STARTED|Phase 1b||29
6412520|NCT00951665|7325875|FG001|STARTED|Phase 1b||10
6412521|NCT00951665|7325876|FG002|STARTED|Phase 1b||21
6412522|NCT00951665|7325877|FG003|STARTED|Phase 1b||3
6412523|NCT00951665|7325878|FG004|STARTED|Phase 1b||0
6412524|NCT00951665|7325879|FG005|STARTED|Phase 1b||0
6412525|NCT00951665|7325874|FG000|Started Treatment|Phase 1b||26
6412526|NCT00951665|7325875|FG001|Started Treatment|Phase 1b||10
6412527|NCT00951665|7325876|FG002|Started Treatment|Phase 1b||21
6412528|NCT00951665|7325877|FG003|Started Treatment|Phase 1b||3
6412529|NCT00951665|7325878|FG004|Started Treatment|Phase 1b||0
6412530|NCT00951665|7325879|FG005|Started Treatment|Phase 1b||0
6412531|NCT00951665|7325874|FG000|COMPLETED|Phase 1b||7
6412532|NCT00951665|7325875|FG001|COMPLETED|Phase 1b||6
6412533|NCT00951665|7325876|FG002|COMPLETED|Phase 1b||4
6412534|NCT00951665|7325877|FG003|COMPLETED|Phase 1b||2
6412535|NCT00951665|7325878|FG004|COMPLETED|Phase 1b||0
6412536|NCT00951665|7325879|FG005|COMPLETED|Phase 1b||0
6412537|NCT00951665|7325874|FG000|NOT COMPLETED|Phase 1b||22
6412538|NCT00951665|7325875|FG001|NOT COMPLETED|Phase 1b||4
6412539|NCT00951665|7325876|FG002|NOT COMPLETED|Phase 1b||17
6412540|NCT00951665|7325877|FG003|NOT COMPLETED|Phase 1b||1
6412541|NCT00951665|7325878|FG004|NOT COMPLETED|Phase 1b||0
6412542|NCT00951665|7325879|FG005|NOT COMPLETED|Phase 1b||0
6412543|NCT00951665|7325874|FG000|STARTED|Phase 2a||0
6412544|NCT00951665|7325875|FG001|STARTED|Phase 2a||0
6412545|NCT00951665|7325876|FG002|STARTED|Phase 2a||0
6412546|NCT00951665|7325877|FG003|STARTED|Phase 2a||0
6412547|NCT00951665|7325878|FG004|STARTED|Phase 2a||22
6412548|NCT00951665|7325879|FG005|STARTED|Phase 2a||22
6412549|NCT00951665|7325874|FG000|COMPLETED|Phase 2a||0
6412550|NCT00951665|7325875|FG001|COMPLETED|Phase 2a||0
6412551|NCT00951665|7325876|FG002|COMPLETED|Phase 2a||0
6412552|NCT00951665|7325877|FG003|COMPLETED|Phase 2a||0
6412553|NCT00951665|7325878|FG004|COMPLETED|Phase 2a||10
6412554|NCT00951665|7325879|FG005|COMPLETED|Phase 2a||15
6412555|NCT00951665|7325874|FG000|NOT COMPLETED|Phase 2a||0
6412556|NCT00951665|7325875|FG001|NOT COMPLETED|Phase 2a||0
6412557|NCT00951665|7325876|FG002|NOT COMPLETED|Phase 2a||0
6412558|NCT00951665|7325877|FG003|NOT COMPLETED|Phase 2a||0
6412559|NCT00951665|7325878|FG004|NOT COMPLETED|Phase 2a||12
6412560|NCT00951665|7325879|FG005|NOT COMPLETED|Phase 2a||7
6412561|NCT00951808|7325913|FG000|STARTED|Overall Study||4
6412562|NCT00951808|7325914|FG001|STARTED|Overall Study||6
6412563|NCT00951808|7325915|FG002|STARTED|Overall Study||227
6412564|NCT00951808|7325913|FG000|COMPLETED|Overall Study||4
6412565|NCT00951808|7325914|FG001|COMPLETED|Overall Study||6
6412566|NCT00951808|7325915|FG002|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
6412567|NCT00951808|7325913|FG000|NOT COMPLETED|Overall Study||0
6412568|NCT00951808|7325914|FG001|NOT COMPLETED|Overall Study||0
6412569|NCT00951808|7325915|FG002|NOT COMPLETED|Overall Study||4
6412570|NCT00951821|7325923|FG000|STARTED|Overall Study||16
6412571|NCT00951821|7325924|FG001|STARTED|Overall Study||8
6412572|NCT00951821|7325923|FG000|COMPLETED|Overall Study||16
6412573|NCT00951821|7325924|FG001|COMPLETED|Overall Study||8
6412574|NCT00951821|7325923|FG000|NOT COMPLETED|Overall Study||0
6412575|NCT00951821|7325924|FG001|NOT COMPLETED|Overall Study||0
6412576|NCT00951899|7325932|FG000|STARTED|Overall Study||19
6412577|NCT00951899|7325933|FG001|STARTED|Overall Study||19
6412578|NCT00951899|7325932|FG000|COMPLETED|Overall Study||19
6412579|NCT00951899|7325933|FG001|COMPLETED|Overall Study||19
6412580|NCT00951899|7325932|FG000|NOT COMPLETED|Overall Study||0
6412581|NCT00951899|7325933|FG001|NOT COMPLETED|Overall Study||0
6412582|NCT00951912|7325942|FG000|STARTED|Overall Study||54
6412583|NCT00951912|7325943|FG001|STARTED|Overall Study||55
6412584|NCT00951912|7325944|FG002|STARTED|Overall Study||56
6412585|NCT00951912|7325942|FG000|COMPLETED|Overall Study||47
6412586|NCT00951912|7325943|FG001|COMPLETED|Overall Study||50
6412587|NCT00951912|7325944|FG002|COMPLETED|Overall Study||54
6412588|NCT00951912|7325942|FG000|NOT COMPLETED|Overall Study||7
6412589|NCT00951912|7325943|FG001|NOT COMPLETED|Overall Study||5
6412590|NCT00951912|7325944|FG002|NOT COMPLETED|Overall Study||2
6412591|NCT00952068|7325952|FG000|STARTED|Overall Study||47
6412592|NCT00952068|7325952|FG000|COMPLETED|Overall Study||40
6412593|NCT00952068|7325952|FG000|NOT COMPLETED|Overall Study||7
6412594|NCT00952081|7325956|FG000|STARTED|Overall Study||22
6412595|NCT00952081|7325956|FG000|COMPLETED|Overall Study||22
6412596|NCT00952081|7325956|FG000|NOT COMPLETED|Overall Study||0
6412597|NCT00952120|7325963|FG000|STARTED|Overall Study||52
6412598|NCT00952120|7325964|FG001|STARTED|Overall Study||47
6412599|NCT00952120|7325965|FG002|STARTED|Overall Study||5
6412600|NCT00952120|7325963|FG000|COMPLETED|Overall Study||52
6412601|NCT00952120|7325964|FG001|COMPLETED|Overall Study||47
6412602|NCT00952120|7325965|FG002|COMPLETED|Overall Study||5
6412603|NCT00952120|7325963|FG000|NOT COMPLETED|Overall Study||0
6412604|NCT00952120|7325964|FG001|NOT COMPLETED|Overall Study||0
6412605|NCT00952120|7325965|FG002|NOT COMPLETED|Overall Study||0
6637280|NCT02317575|7566050|FG000|COMPLETED|Period 2||4
6637281|NCT02317575|7566051|FG001|COMPLETED|Period 2||5
6637282|NCT02317575|7566052|FG002|COMPLETED|Period 2||6
6637283|NCT02317575|7566053|FG003|COMPLETED|Period 2||6
6637284|NCT02317575|7566054|FG004|COMPLETED|Period 2||6
6637285|NCT02317575|7566050|FG000|NOT COMPLETED|Period 2||0
6637286|NCT02317575|7566051|FG001|NOT COMPLETED|Period 2||0
6637287|NCT02317575|7566052|FG002|NOT COMPLETED|Period 2||0
6637288|NCT02317575|7566053|FG003|NOT COMPLETED|Period 2||0
6637289|NCT02317575|7566054|FG004|NOT COMPLETED|Period 2||0
6637290|NCT02317575|7566050|FG000|STARTED|Period 3||4
6637291|NCT02317575|7566051|FG001|STARTED|Period 3||5
6637292|NCT02317575|7566052|FG002|STARTED|Period 3||6
6637293|NCT02317575|7566053|FG003|STARTED|Period 3||6
6637294|NCT02317575|7566054|FG004|STARTED|Period 3||6
6637295|NCT02317575|7566050|FG000|COMPLETED|Period 3||4
6637296|NCT02317575|7566051|FG001|COMPLETED|Period 3||5
6637297|NCT02317575|7566052|FG002|COMPLETED|Period 3||6
6637298|NCT02317575|7566053|FG003|COMPLETED|Period 3||6
6637299|NCT02317575|7566054|FG004|COMPLETED|Period 3||6
6637300|NCT02317575|7566050|FG000|NOT COMPLETED|Period 3||0
6637301|NCT02317575|7566051|FG001|NOT COMPLETED|Period 3||0
6637302|NCT02317575|7566052|FG002|NOT COMPLETED|Period 3||0
6637303|NCT02317575|7566053|FG003|NOT COMPLETED|Period 3||0
6637304|NCT02317575|7566054|FG004|NOT COMPLETED|Period 3||0
6637305|NCT02317575|7566050|FG000|STARTED|Period 4||4
6637306|NCT02317575|7566051|FG001|STARTED|Period 4||5
6637307|NCT02317575|7566052|FG002|STARTED|Period 4||6
6637308|NCT02317575|7566053|FG003|STARTED|Period 4||6
6637309|NCT02317575|7566054|FG004|STARTED|Period 4||6
6637310|NCT02317575|7566050|FG000|COMPLETED|Period 4||4
6637311|NCT02317575|7566051|FG001|COMPLETED|Period 4||5
6637312|NCT02317575|7566052|FG002|COMPLETED|Period 4||6
6637313|NCT02317575|7566053|FG003|COMPLETED|Period 4||6
6637314|NCT02317575|7566054|FG004|COMPLETED|Period 4||6
6637315|NCT02317575|7566050|FG000|NOT COMPLETED|Period 4||0
6637316|NCT02317575|7566051|FG001|NOT COMPLETED|Period 4||0
6637317|NCT02317575|7566052|FG002|NOT COMPLETED|Period 4||0
6637318|NCT02317575|7566053|FG003|NOT COMPLETED|Period 4||0
6637319|NCT02317575|7566054|FG004|NOT COMPLETED|Period 4||0
6637320|NCT02317575|7566050|FG000|STARTED|Period 5||4
6637321|NCT02317575|7566051|FG001|STARTED|Period 5||5
6412606|NCT00952133|7325973|FG000|STARTED|Overall Study||59
6412607|NCT00952133|7325974|FG001|STARTED|Overall Study||59
6412608|NCT00952133|7325973|FG000|COMPLETED|Overall Study||59
6412609|NCT00952133|7325974|FG001|COMPLETED|Overall Study||59
6412610|NCT00952133|7325973|FG000|NOT COMPLETED|Overall Study||0
6412611|NCT00952133|7325974|FG001|NOT COMPLETED|Overall Study||0
6412612|NCT00952211|7325984|FG000|STARTED|Overall Study||3
6412613|NCT00952211|7325985|FG001|STARTED|Overall Study||0
6412614|NCT00952211|7325984|FG000|COMPLETED|Overall Study||3
6412615|NCT00952211|7325985|FG001|COMPLETED|Overall Study||0
6637322|NCT02317575|7566052|FG002|STARTED|Period 5||6
6637323|NCT02317575|7566053|FG003|STARTED|Period 5||6
6637324|NCT02317575|7566054|FG004|STARTED|Period 5||6
6637325|NCT02317575|7566050|FG000|COMPLETED|Period 5||4
6637326|NCT02317575|7566051|FG001|COMPLETED|Period 5||5
6637327|NCT02317575|7566052|FG002|COMPLETED|Period 5||6
6637328|NCT02317575|7566053|FG003|COMPLETED|Period 5||6
6637329|NCT02317575|7566054|FG004|COMPLETED|Period 5||6
6637330|NCT02317575|7566050|FG000|NOT COMPLETED|Period 5||0
6637331|NCT02317575|7566051|FG001|NOT COMPLETED|Period 5||0
6637332|NCT02317575|7566052|FG002|NOT COMPLETED|Period 5||0
6637333|NCT02317575|7566053|FG003|NOT COMPLETED|Period 5||0
6637334|NCT02317575|7566054|FG004|NOT COMPLETED|Period 5||0
6637335|NCT02317614|7566074|FG000|STARTED|Overall Study||26
6637336|NCT02317614|7566075|FG001|STARTED|Overall Study||25
6637337|NCT02317614|7566074|FG000|COMPLETED|Overall Study||23
6637338|NCT02317614|7566075|FG001|COMPLETED|Overall Study||23
6412616|NCT00952211|7325984|FG000|NOT COMPLETED|Overall Study||0
6412617|NCT00952211|7325985|FG001|NOT COMPLETED|Overall Study||0
6412618|NCT00952276|7325996|FG000|STARTED|Overall Study||127
6412619|NCT00952276|7325997|FG001|STARTED|Overall Study||115
6412620|NCT00952276|7325998|FG002|STARTED|Overall Study||122
6412621|NCT00952276|7325999|FG003|STARTED|Overall Study||121
6412622|NCT00952276|7326000|FG004|STARTED|Overall Study||63
6412623|NCT00952276|7325996|FG000|COMPLETED|Overall Study||126
6412624|NCT00952276|7325997|FG001|COMPLETED|Overall Study||115
6412625|NCT00952276|7325998|FG002|COMPLETED|Overall Study||122
6412626|NCT00952276|7325999|FG003|COMPLETED|Overall Study||120
6412627|NCT00952276|7326000|FG004|COMPLETED|Overall Study||63
6412628|NCT00952276|7325996|FG000|NOT COMPLETED|Overall Study||1
6412629|NCT00952276|7325997|FG001|NOT COMPLETED|Overall Study||0
6412630|NCT00952276|7325998|FG002|NOT COMPLETED|Overall Study||0
6412631|NCT00952276|7325999|FG003|NOT COMPLETED|Overall Study||1
6412632|NCT00952276|7326000|FG004|NOT COMPLETED|Overall Study||0
6412633|NCT00952289|7326014|FG000|STARTED|All Participants||155
6412634|NCT00952289|7326015|FG001|STARTED|All Participants||154
6412635|NCT00952289|7326014|FG000|Safety Population|All Participants||155
6412636|NCT00952289|7326015|FG001|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
6412637|NCT00952289|7326014|FG000|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
6412638|NCT00952289|7326015|FG001|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
6412639|NCT00952289|7326014|FG000|NOT COMPLETED|All Participants||21
6412640|NCT00952289|7326015|FG001|NOT COMPLETED|All Participants||40
6412641|NCT00952289|7326014|FG000|STARTED|Patients Who Crossed Over to Ruxolitinib||0
6412642|NCT00952289|7326015|FG001|STARTED|Patients Who Crossed Over to Ruxolitinib||111
6412643|NCT00952289|7326014|FG000|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
6412644|NCT00952289|7326015|FG001|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
6412645|NCT00952289|7326014|FG000|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
6412646|NCT00952289|7326015|FG001|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
6412647|NCT00952315|7326024|FG000|STARTED|Overall Study||90
6412648|NCT00952315|7326025|FG001|STARTED|Overall Study||90
6412649|NCT00952315|7326026|FG002|STARTED|Overall Study||90
6412650|NCT00952315|7326024|FG000|COMPLETED|Overall Study||64
6412651|NCT00952315|7326025|FG001|COMPLETED|Overall Study||66
6412652|NCT00952315|7326026|FG002|COMPLETED|Overall Study||71
6412653|NCT00952315|7326024|FG000|NOT COMPLETED|Overall Study||26
6412654|NCT00952315|7326025|FG001|NOT COMPLETED|Overall Study||24
6412655|NCT00952315|7326026|FG002|NOT COMPLETED|Overall Study||19
6412656|NCT00952341|7326039|FG000|STARTED|Cycle 1||209
6412657|NCT00952341|7326040|FG001|STARTED|Cycle 1||212
6412658|NCT00952341|7326039|FG000|COMPLETED|Cycle 1||189
6412659|NCT00952341|7326040|FG001|COMPLETED|Cycle 1||199
6412660|NCT00952341|7326039|FG000|NOT COMPLETED|Cycle 1||20
6412661|NCT00952341|7326040|FG001|NOT COMPLETED|Cycle 1||13
6412662|NCT00952341|7326039|FG000|STARTED|Cycle 2||110
6412663|NCT00952341|7326040|FG001|STARTED|Cycle 2||130
6412664|NCT00952341|7326039|FG000|COMPLETED|Cycle 2||101
6412665|NCT00952341|7326040|FG001|COMPLETED|Cycle 2||118
6412666|NCT00952341|7326039|FG000|NOT COMPLETED|Cycle 2||9
6412667|NCT00952341|7326040|FG001|NOT COMPLETED|Cycle 2||12
6412668|NCT00952367|7326046|FG000|STARTED|Overall Study||3641
6412669|NCT00952367|7326046|FG000|COMPLETED|Overall Study||3635
6412670|NCT00952367|7326046|FG000|NOT COMPLETED|Overall Study||6
6412671|NCT00952380|7326055|FG000|STARTED|Overall Study||1
6412672|NCT00952380|7326056|FG001|STARTED|Overall Study||2
6412673|NCT00952380|7326057|FG002|STARTED|Overall Study||8
6412674|NCT00952380|7326058|FG003|STARTED|Overall Study||7
6412675|NCT00952380|7326059|FG004|STARTED|Overall Study||20
6412676|NCT00952380|7326055|FG000|COMPLETED|Overall Study||1
6412677|NCT00952380|7326056|FG001|COMPLETED|Overall Study||1
6412678|NCT00952380|7326057|FG002|COMPLETED|Overall Study||6
6412679|NCT00952380|7326058|FG003|COMPLETED|Overall Study||4
6412680|NCT00952380|7326059|FG004|COMPLETED|Overall Study||14
6412681|NCT00952380|7326055|FG000|NOT COMPLETED|Overall Study||0
6412682|NCT00952380|7326056|FG001|NOT COMPLETED|Overall Study||1
6412683|NCT00952380|7326057|FG002|NOT COMPLETED|Overall Study||2
6412684|NCT00952380|7326058|FG003|NOT COMPLETED|Overall Study||3
6412685|NCT00952380|7326059|FG004|NOT COMPLETED|Overall Study||6
6412686|NCT00952393|7326076|FG000|STARTED|Overall Study|10|10
6412687|NCT00952393|7326076|FG000|COMPLETED|Overall Study||10
6412688|NCT00952393|7326076|FG000|NOT COMPLETED|Overall Study||0
6412689|NCT00952419|7326083|FG000|STARTED|Overall Study||215
6412690|NCT00952419|7326084|FG001|STARTED|Overall Study||208
6412691|NCT00952419|7326085|FG002|STARTED|Overall Study||51
6412692|NCT00952419|7326083|FG000|COMPLETED|Overall Study||209
6412693|NCT00952419|7326084|FG001|COMPLETED|Overall Study||198
6412694|NCT00952419|7326085|FG002|COMPLETED|Overall Study||51
6412695|NCT00952419|7326083|FG000|NOT COMPLETED|Overall Study||6
6412696|NCT00952419|7326084|FG001|NOT COMPLETED|Overall Study||10
6412697|NCT00952419|7326085|FG002|NOT COMPLETED|Overall Study||0
6412698|NCT00952484|7326096|FG000|STARTED|Overall Study||6
6412699|NCT00952484|7326097|FG001|STARTED|Overall Study||7
6412700|NCT00952484|7326098|FG002|STARTED|Overall Study||16
6412701|NCT00952484|7326096|FG000|COMPLETED|Overall Study||6
6412702|NCT00952484|7326097|FG001|COMPLETED|Overall Study||6
6412703|NCT00952484|7326098|FG002|COMPLETED|Overall Study||16
6412704|NCT00952484|7326096|FG000|NOT COMPLETED|Overall Study||0
6412705|NCT00952484|7326097|FG001|NOT COMPLETED|Overall Study||1
6412706|NCT00952484|7326098|FG002|NOT COMPLETED|Overall Study||0
6412707|NCT00952523|7326107|FG000|STARTED|Overall Study||162
6412708|NCT00952523|7326107|FG000|COMPLETED|Overall Study||155
6412709|NCT00952523|7326107|FG000|NOT COMPLETED|Overall Study||7
6412710|NCT00952588|7326115|FG000|STARTED|Overall Study||48
6412711|NCT00952588|7326116|FG001|STARTED|Overall Study||26
6412712|NCT00952588|7326115|FG000|COMPLETED|Overall Study||12
6412713|NCT00952588|7326116|FG001|COMPLETED|Overall Study||2
6412714|NCT00952588|7326115|FG000|NOT COMPLETED|Overall Study||36
6412715|NCT00952588|7326116|FG001|NOT COMPLETED|Overall Study||24
6412716|NCT00952614|7326122|FG000|STARTED|Overall Study||30
6412717|NCT00952614|7326122|FG000|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
6412718|NCT00952614|7326122|FG000|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
6412719|NCT00952614|7326122|FG000|NOT COMPLETED|Overall Study||7
6412720|NCT00952653|7326127|FG000|STARTED|Period 1: MDZ Alone||28
6412721|NCT00952653|7326127|FG000|COMPLETED|Period 1: MDZ Alone||28
6412722|NCT00952653|7326127|FG000|NOT COMPLETED|Period 1: MDZ Alone||0
6412723|NCT00952653|7326127|FG000|STARTED|Period 2: Coadministration DVS SR, MDZ||28
6412724|NCT00952653|7326127|FG000|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
6412725|NCT00952653|7326127|FG000|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
6412726|NCT00952705|7326137|FG000|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
6412727|NCT00952705|7326138|FG001|STARTED|Overall Study||300
6412728|NCT00952705|7326139|FG002|STARTED|Overall Study||298
6412729|NCT00952705|7326137|FG000|COMPLETED|Overall Study||1169
6412730|NCT00952705|7326138|FG001|COMPLETED|Overall Study||290
6412731|NCT00952705|7326139|FG002|COMPLETED|Overall Study||288
6412732|NCT00952705|7326137|FG000|NOT COMPLETED|Overall Study||33
6412733|NCT00952705|7326138|FG001|NOT COMPLETED|Overall Study||10
6412734|NCT00952705|7326139|FG002|NOT COMPLETED|Overall Study||10
6412735|NCT00952718|7326153|FG000|STARTED|Overall Study||19
6412736|NCT00952718|7326154|FG001|STARTED|Overall Study||19
6412737|NCT00952718|7326153|FG000|COMPLETED|Overall Study||13
6412738|NCT00952718|7326154|FG001|COMPLETED|Overall Study||13
6412739|NCT00952718|7326153|FG000|NOT COMPLETED|Overall Study||6
6412740|NCT00952718|7326154|FG001|NOT COMPLETED|Overall Study||6
6412741|NCT00952731|7326164|FG000|STARTED|Overall Study||13
6412742|NCT00952731|7326165|FG001|STARTED|Overall Study||14
6412743|NCT00952731|7326164|FG000|Randomization|Overall Study||13
6412744|NCT00952731|7326165|FG001|Randomization|Overall Study||14
6412745|NCT00952731|7326164|FG000|Treatment & Pre-Surgery|Overall Study||12
6412746|NCT00952731|7326165|FG001|Treatment & Pre-Surgery|Overall Study||14
6412747|NCT00952731|7326164|FG000|Surgery|Overall Study||12
6412748|NCT00952731|7326165|FG001|Surgery|Overall Study||14
6412749|NCT00952731|7326164|FG000|Follow-up|Overall Study||12
6412750|NCT00952731|7326165|FG001|Follow-up|Overall Study||14
6412751|NCT00952731|7326164|FG000|COMPLETED|Overall Study||12
6412752|NCT00952731|7326165|FG001|COMPLETED|Overall Study||14
6412753|NCT00952731|7326164|FG000|NOT COMPLETED|Overall Study||1
6412754|NCT00952731|7326165|FG001|NOT COMPLETED|Overall Study||0
6412755|NCT00952822|7326171|FG000|STARTED|1st Pharmacokinetic Evaluation||9
6412756|NCT00952822|7326172|FG001|STARTED|1st Pharmacokinetic Evaluation||18
6412757|NCT00952822|7326173|FG002|STARTED|1st Pharmacokinetic Evaluation||11
6412758|NCT00952822|7326174|FG003|STARTED|1st Pharmacokinetic Evaluation||4
6412759|NCT00952822|7326171|FG000|COMPLETED|1st Pharmacokinetic Evaluation||9
6412760|NCT00952822|7326172|FG001|COMPLETED|1st Pharmacokinetic Evaluation||17
6412761|NCT00952822|7326173|FG002|COMPLETED|1st Pharmacokinetic Evaluation||11
6412762|NCT00952822|7326174|FG003|COMPLETED|1st Pharmacokinetic Evaluation||4
6412763|NCT00952822|7326171|FG000|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
6412764|NCT00952822|7326172|FG001|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
6412765|NCT00952822|7326173|FG002|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
6412766|NCT00952822|7326174|FG003|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
6412767|NCT00952822|7326171|FG000|STARTED|2nd Pharmacokinetic Evaluation||9
6412768|NCT00952822|7326172|FG001|STARTED|2nd Pharmacokinetic Evaluation||17
6412769|NCT00952822|7326173|FG002|STARTED|2nd Pharmacokinetic Evaluation||11
6412770|NCT00952822|7326174|FG003|STARTED|2nd Pharmacokinetic Evaluation||4
6412771|NCT00952822|7326171|FG000|COMPLETED|2nd Pharmacokinetic Evaluation||9
6412772|NCT00952822|7326172|FG001|COMPLETED|2nd Pharmacokinetic Evaluation||17
6412773|NCT00952822|7326173|FG002|COMPLETED|2nd Pharmacokinetic Evaluation||10
6412774|NCT00952822|7326174|FG003|COMPLETED|2nd Pharmacokinetic Evaluation||4
6412775|NCT00952822|7326171|FG000|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
6412776|NCT00952822|7326172|FG001|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
6412777|NCT00952822|7326173|FG002|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
6412778|NCT00952822|7326174|FG003|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
6412779|NCT00952848|7326185|FG000|STARTED|Overall Study||18
6412780|NCT00952848|7326185|FG000|COMPLETED|Overall Study||14
6412781|NCT00952848|7326185|FG000|NOT COMPLETED|Overall Study||4
6412782|NCT00953017|7326193|FG000|STARTED|Overall Study||106
6412783|NCT00953017|7326194|FG001|STARTED|Overall Study||107
6412784|NCT00953017|7326195|FG002|STARTED|Overall Study||106
6412785|NCT00953017|7326196|FG003|STARTED|Overall Study||106
6412786|NCT00953017|7326193|FG000|COMPLETED|Overall Study||101
6412787|NCT00953017|7326194|FG001|COMPLETED|Overall Study||101
6412788|NCT00953017|7326195|FG002|COMPLETED|Overall Study||100
6412789|NCT00953017|7326196|FG003|COMPLETED|Overall Study||101
6412790|NCT00953017|7326193|FG000|NOT COMPLETED|Overall Study||5
6412791|NCT00953017|7326194|FG001|NOT COMPLETED|Overall Study||6
6412792|NCT00953017|7326195|FG002|NOT COMPLETED|Overall Study||6
6412793|NCT00953017|7326196|FG003|NOT COMPLETED|Overall Study||5
6412794|NCT00953043|7326208|FG000|STARTED|Overall Study||30
6412795|NCT00953043|7326209|FG001|STARTED|Overall Study||30
6412796|NCT00953043|7326208|FG000|COMPLETED|Overall Study||26
6412797|NCT00953043|7326209|FG001|COMPLETED|Overall Study||28
6412798|NCT00953043|7326208|FG000|NOT COMPLETED|Overall Study||4
6412799|NCT00953043|7326209|FG001|NOT COMPLETED|Overall Study||2
6412800|NCT00953056|7326221|FG000|STARTED|Overall Study||24
6412801|NCT00953056|7326222|FG001|STARTED|Overall Study||24
6412802|NCT00953056|7326223|FG002|STARTED|Overall Study||24
6412803|NCT00953056|7326224|FG003|STARTED|Overall Study||24
6412804|NCT00953056|7326225|FG004|STARTED|Overall Study||24
6412805|NCT00953056|7326226|FG005|STARTED|Overall Study||24
6412806|NCT00953056|7326221|FG000|COMPLETED|Overall Study||24
6412807|NCT00953056|7326222|FG001|COMPLETED|Overall Study||24
6412808|NCT00953056|7326223|FG002|COMPLETED|Overall Study||24
6412809|NCT00953056|7326224|FG003|COMPLETED|Overall Study||24
6412810|NCT00953056|7326225|FG004|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
6412811|NCT00953056|7326226|FG005|COMPLETED|Overall Study||20
6412812|NCT00953056|7326221|FG000|NOT COMPLETED|Overall Study||0
6412813|NCT00953056|7326222|FG001|NOT COMPLETED|Overall Study||0
6412814|NCT00953056|7326223|FG002|NOT COMPLETED|Overall Study||0
6412815|NCT00953056|7326224|FG003|NOT COMPLETED|Overall Study||0
6412816|NCT00953056|7326225|FG004|NOT COMPLETED|Overall Study||2
6412817|NCT00953056|7326226|FG005|NOT COMPLETED|Overall Study||4
6412818|NCT00953121|7326245|FG000|STARTED|Overall Study||40
6637339|NCT02317614|7566074|FG000|NOT COMPLETED|Overall Study||3
6637340|NCT02317614|7566075|FG001|NOT COMPLETED|Overall Study||2
6637341|NCT02317627|7566084|FG000|STARTED|Overall Study||13
6637342|NCT02317627|7566085|FG001|STARTED|Overall Study||13
6637343|NCT02317627|7566086|FG002|STARTED|Overall Study||12
6637344|NCT02317627|7566084|FG000|COMPLETED|Overall Study||11
6637345|NCT02317627|7566085|FG001|COMPLETED|Overall Study||8
6637346|NCT02317627|7566086|FG002|COMPLETED|Overall Study||8
6637347|NCT02317627|7566084|FG000|NOT COMPLETED|Overall Study||2
6637348|NCT02317627|7566085|FG001|NOT COMPLETED|Overall Study||5
6637349|NCT02317627|7566086|FG002|NOT COMPLETED|Overall Study||4
6637350|NCT02317692|7566102|FG000|STARTED|Overall Study||69
6637351|NCT02317692|7566103|FG001|STARTED|Overall Study||77
6637352|NCT02317692|7566102|FG000|COMPLETED|Overall Study||63
6637353|NCT02317692|7566103|FG001|COMPLETED|Overall Study||77
6637354|NCT02317692|7566102|FG000|NOT COMPLETED|Overall Study||6
6637355|NCT02317692|7566103|FG001|NOT COMPLETED|Overall Study||0
6637356|NCT02317744|7566111|FG000|STARTED|Overall Study||12
6637357|NCT02317744|7566112|FG001|STARTED|Overall Study||10
6637358|NCT02317744|7566111|FG000|Completed Treatment|Overall Study||10
6637359|NCT02317744|7566112|FG001|Completed Treatment|Overall Study||7
6637360|NCT02317744|7566111|FG000|COMPLETED|Overall Study|One NB participant stopped the treatment but completed assessments.|11
6637361|NCT02317744|7566112|FG001|COMPLETED|Overall Study|One Placebo participant stopped the treatment but completed assessments.|8
6637362|NCT02317744|7566111|FG000|NOT COMPLETED|Overall Study||1
6637363|NCT02317744|7566112|FG001|NOT COMPLETED|Overall Study||2
6637364|NCT02317809|7566118|FG000|STARTED|First Intervention Period (8 Days)||17
6637365|NCT02317809|7566119|FG001|STARTED|First Intervention Period (8 Days)||17
6637366|NCT02317809|7566118|FG000|COMPLETED|First Intervention Period (8 Days)||14
6637367|NCT02317809|7566119|FG001|COMPLETED|First Intervention Period (8 Days)||17
6637368|NCT02317809|7566118|FG000|NOT COMPLETED|First Intervention Period (8 Days)||3
6637369|NCT02317809|7566119|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
6637370|NCT02317809|7566118|FG000|STARTED|Second Intervention Period (8 Days)||14
6637371|NCT02317809|7566119|FG001|STARTED|Second Intervention Period (8 Days)||17
6637372|NCT02317809|7566118|FG000|COMPLETED|Second Intervention Period (8 Days)||14
6637373|NCT02317809|7566119|FG001|COMPLETED|Second Intervention Period (8 Days)||17
6637374|NCT02317809|7566118|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
6637375|NCT02317809|7566119|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
6637376|NCT02318095|7566128|FG000|STARTED|Overall Study||40
6637377|NCT02318095|7566128|FG000|COMPLETED|Overall Study||39
6637378|NCT02318095|7566128|FG000|NOT COMPLETED|Overall Study||1
6637379|NCT02318134|7566135|FG000|STARTED|Overall Study||30
6637380|NCT02318134|7566136|FG001|STARTED|Overall Study||30
6637381|NCT02318134|7566135|FG000|COMPLETED|Overall Study||28
6412819|NCT00953121|7326246|FG001|STARTED|Overall Study||39
6412820|NCT00953121|7326247|FG002|STARTED|Overall Study||25
6412821|NCT00953121|7326245|FG000|COMPLETED|Overall Study||40
6412822|NCT00953121|7326246|FG001|COMPLETED|Overall Study||39
6412823|NCT00953121|7326247|FG002|COMPLETED|Overall Study||25
6412824|NCT00953121|7326245|FG000|NOT COMPLETED|Overall Study||0
6412825|NCT00953121|7326246|FG001|NOT COMPLETED|Overall Study||0
6412826|NCT00953121|7326247|FG002|NOT COMPLETED|Overall Study||0
6499054|NCT01414075|7417688|FG000|STARTED|Overall Study||24
6637382|NCT02318134|7566136|FG001|COMPLETED|Overall Study||29
6637383|NCT02318134|7566135|FG000|NOT COMPLETED|Overall Study||2
6637384|NCT02318134|7566136|FG001|NOT COMPLETED|Overall Study||1
6637385|NCT02318303|7566151|FG000|STARTED|Overall Study||159
6499055|NCT01414075|7417689|FG001|STARTED|Overall Study||12
6412827|NCT00953147|7326258|FG000|STARTED|Overall Study||298
6412828|NCT00953147|7326259|FG001|STARTED|Overall Study||505
6412829|NCT00953147|7326260|FG002|STARTED|Overall Study||307
6412830|NCT00953147|7326258|FG000|COMPLETED|Overall Study||261
6412831|NCT00953147|7326259|FG001|COMPLETED|Overall Study||439
6412832|NCT00953147|7326260|FG002|COMPLETED|Overall Study||265
6412833|NCT00953147|7326258|FG000|NOT COMPLETED|Overall Study||37
6412834|NCT00953147|7326259|FG001|NOT COMPLETED|Overall Study||66
6412835|NCT00953147|7326260|FG002|NOT COMPLETED|Overall Study||42
6412836|NCT00953160|7326268|FG000|STARTED|Overall Study||76
6412837|NCT00953160|7326268|FG000|COMPLETED|Overall Study||49
6412838|NCT00953160|7326268|FG000|NOT COMPLETED|Overall Study||27
6412839|NCT00953173|7326272|FG000|STARTED|Overall Study||671
6412840|NCT00953173|7326272|FG000|COMPLETED|Overall Study||389
6412841|NCT00953173|7326272|FG000|NOT COMPLETED|Overall Study||282
6412842|NCT00953199|7326278|FG000|STARTED|Overall Study||254
6412843|NCT00953199|7326279|FG001|STARTED|Overall Study||252
6412844|NCT00953199|7326278|FG000|COMPLETED|Overall Study||254
6412845|NCT00953199|7326279|FG001|COMPLETED|Overall Study||252
6412846|NCT00953199|7326278|FG000|NOT COMPLETED|Overall Study||0
6412847|NCT00953199|7326279|FG001|NOT COMPLETED|Overall Study||0
6412848|NCT00953212|7326291|FG000|STARTED|Overall Study||76
6412849|NCT00953212|7326292|FG001|STARTED|Overall Study||74
6412850|NCT00953212|7326293|FG002|STARTED|Overall Study||78
6412851|NCT00953212|7326294|FG003|STARTED|Overall Study||76
6412852|NCT00953212|7326291|FG000|COMPLETED|Overall Study||76
6412853|NCT00953212|7326292|FG001|COMPLETED|Overall Study||74
6412854|NCT00953212|7326293|FG002|COMPLETED|Overall Study||78
6412855|NCT00953212|7326294|FG003|COMPLETED|Overall Study||76
6412856|NCT00953212|7326291|FG000|NOT COMPLETED|Overall Study||0
6412857|NCT00953212|7326292|FG001|NOT COMPLETED|Overall Study||0
6412858|NCT00953212|7326293|FG002|NOT COMPLETED|Overall Study||0
6412859|NCT00953212|7326294|FG003|NOT COMPLETED|Overall Study||0
6412860|NCT00953225|7326310|FG000|STARTED|Overall Study||46
6412861|NCT00953225|7326311|FG001|STARTED|Overall Study||37
6412862|NCT00953225|7326310|FG000|COMPLETED|Overall Study||44
6412863|NCT00953225|7326311|FG001|COMPLETED|Overall Study||37
6412864|NCT00953225|7326310|FG000|NOT COMPLETED|Overall Study||2
6412865|NCT00953225|7326311|FG001|NOT COMPLETED|Overall Study||0
6412866|NCT00953290|7326317|FG000|STARTED|Overall Study||4
6412867|NCT00953290|7326317|FG000|COMPLETED|Overall Study||4
6412868|NCT00953290|7326317|FG000|NOT COMPLETED|Overall Study||0
6412869|NCT00953407|7326329|FG000|STARTED|Overall Study||26
6412870|NCT00953407|7326330|FG001|STARTED|Overall Study||25
6412871|NCT00953407|7326331|FG002|STARTED|Overall Study||26
6412872|NCT00953407|7326332|FG003|STARTED|Overall Study||25
6412873|NCT00953407|7326333|FG004|STARTED|Overall Study||24
6412874|NCT00953407|7326329|FG000|COMPLETED|Overall Study||25
6412875|NCT00953407|7326330|FG001|COMPLETED|Overall Study||24
6412876|NCT00953407|7326331|FG002|COMPLETED|Overall Study||25
6412877|NCT00953407|7326332|FG003|COMPLETED|Overall Study||23
6412878|NCT00953407|7326333|FG004|COMPLETED|Overall Study||23
6412879|NCT00953407|7326329|FG000|NOT COMPLETED|Overall Study||1
6412880|NCT00953407|7326330|FG001|NOT COMPLETED|Overall Study||1
6412881|NCT00953407|7326331|FG002|NOT COMPLETED|Overall Study||1
6412882|NCT00953407|7326332|FG003|NOT COMPLETED|Overall Study||2
6412883|NCT00953407|7326333|FG004|NOT COMPLETED|Overall Study||1
6412884|NCT00953524|7326349|FG000|STARTED|Overall Study||249
6412885|NCT00953524|7326350|FG001|STARTED|Overall Study||254
6412886|NCT00953524|7326351|FG002|STARTED|Overall Study||247
6412887|NCT00953524|7326352|FG003|STARTED|Overall Study||99
6412888|NCT00953524|7326349|FG000|COMPLETED|Overall Study||227
6412889|NCT00953524|7326350|FG001|COMPLETED|Overall Study||239
6412890|NCT00953524|7326351|FG002|COMPLETED|Overall Study||233
6412891|NCT00953524|7326352|FG003|COMPLETED|Overall Study||91
6412892|NCT00953524|7326349|FG000|NOT COMPLETED|Overall Study||22
6412893|NCT00953524|7326350|FG001|NOT COMPLETED|Overall Study||15
6412894|NCT00953524|7326351|FG002|NOT COMPLETED|Overall Study||14
6412895|NCT00953524|7326352|FG003|NOT COMPLETED|Overall Study||8
6412896|NCT00953576|7326364|FG000|STARTED|Overall Study||6
6412897|NCT00953576|7326365|FG001|STARTED|Overall Study||5
6412898|NCT00953576|7326364|FG000|DLT Evaluable|Overall Study||3
6637386|NCT02318303|7566152|FG001|STARTED|Overall Study||158
6637387|NCT02318303|7566153|FG002|STARTED|Overall Study||160
6637388|NCT02318303|7566154|FG003|STARTED|Overall Study||158
6637389|NCT02318303|7566155|FG004|STARTED|Overall Study||157
6637390|NCT02318303|7566156|FG005|STARTED|Overall Study||159
6637391|NCT02318303|7566157|FG006|STARTED|Overall Study||160
6412899|NCT00953576|7326365|FG001|DLT Evaluable|Overall Study||5
6412900|NCT00953576|7326364|FG000|Treated|Overall Study||4
6412901|NCT00953576|7326365|FG001|Treated|Overall Study||5
6412902|NCT00953576|7326364|FG000|Pharmacokinetic (PK) Evaluable|Overall Study||4
6412903|NCT00953576|7326365|FG001|Pharmacokinetic (PK) Evaluable|Overall Study||3
6412904|NCT00953576|7326364|FG000|COMPLETED|Overall Study|One participant enrolled on dose level 1 did not receive full dose ketoconazole and was replaced.|4
6637392|NCT02318303|7566151|FG000|COMPLETED|Overall Study||155
6637393|NCT02318303|7566152|FG001|COMPLETED|Overall Study||155
6637394|NCT02318303|7566153|FG002|COMPLETED|Overall Study||157
6412905|NCT00953576|7326365|FG001|COMPLETED|Overall Study||4
6412906|NCT00953576|7326364|FG000|NOT COMPLETED|Overall Study||2
6412907|NCT00953576|7326365|FG001|NOT COMPLETED|Overall Study||1
6412908|NCT00953654|7326377|FG000|STARTED|Overall Study||10
6412909|NCT00953654|7326378|FG001|STARTED|Overall Study||10
6412910|NCT00953654|7326379|FG002|STARTED|Overall Study||10
6412911|NCT00953654|7326377|FG000|COMPLETED|Overall Study||10
6412912|NCT00953654|7326378|FG001|COMPLETED|Overall Study||10
6412913|NCT00953654|7326379|FG002|COMPLETED|Overall Study||10
6412914|NCT00953654|7326377|FG000|NOT COMPLETED|Overall Study||0
6412915|NCT00953654|7326378|FG001|NOT COMPLETED|Overall Study||0
6412916|NCT00953654|7326379|FG002|NOT COMPLETED|Overall Study||0
6412917|NCT00953667|7326387|FG000|STARTED|Overall Study||400
6412918|NCT00953667|7326387|FG000|COMPLETED|Overall Study||277
6412919|NCT00953667|7326387|FG000|NOT COMPLETED|Overall Study||123
6412920|NCT00953706|7326393|FG000|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
6412921|NCT00953706|7326394|FG001|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
6412922|NCT00953706|7326395|FG002|STARTED|Part A (16-Week Double-Blind Treatment)||0
6412923|NCT00953706|7326396|FG003|STARTED|Part A (16-Week Double-Blind Treatment)||0
6412924|NCT00953706|7326393|FG000|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
6412925|NCT00953706|7326394|FG001|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
6412926|NCT00953706|7326395|FG002|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
6412927|NCT00953706|7326396|FG003|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
6412928|NCT00953706|7326393|FG000|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
6412929|NCT00953706|7326394|FG001|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
6412930|NCT00953706|7326395|FG002|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
6412931|NCT00953706|7326396|FG003|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
6412932|NCT00953706|7326393|FG000|STARTED|Part B (96-Week Open-Label Extension)||0
6412933|NCT00953706|7326394|FG001|STARTED|Part B (96-Week Open-Label Extension)||0
6412934|NCT00953706|7326395|FG002|STARTED|Part B (96-Week Open-Label Extension)||5
6412935|NCT00953706|7326396|FG003|STARTED|Part B (96-Week Open-Label Extension)||33
6412936|NCT00953706|7326393|FG000|COMPLETED|Part B (96-Week Open-Label Extension)||0
6412937|NCT00953706|7326394|FG001|COMPLETED|Part B (96-Week Open-Label Extension)||0
6412938|NCT00953706|7326395|FG002|COMPLETED|Part B (96-Week Open-Label Extension)||0
6412939|NCT00953706|7326396|FG003|COMPLETED|Part B (96-Week Open-Label Extension)||0
6412940|NCT00953706|7326393|FG000|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
6412941|NCT00953706|7326394|FG001|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
6412942|NCT00953706|7326395|FG002|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
6412943|NCT00953706|7326396|FG003|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
6412944|NCT00953719|7326408|FG000|STARTED|Overall Study||169
6412945|NCT00953719|7326409|FG001|STARTED|Overall Study||74
6412946|NCT00953719|7326408|FG000|COMPLETED|Overall Study||150
6412947|NCT00953719|7326409|FG001|COMPLETED|Overall Study||69
6637395|NCT02318303|7566154|FG003|COMPLETED|Overall Study||155
6637396|NCT02318303|7566155|FG004|COMPLETED|Overall Study||152
6637397|NCT02318303|7566156|FG005|COMPLETED|Overall Study||153
6637398|NCT02318303|7566157|FG006|COMPLETED|Overall Study||158
6637399|NCT02318303|7566151|FG000|NOT COMPLETED|Overall Study||4
6637400|NCT02318303|7566152|FG001|NOT COMPLETED|Overall Study||3
6637401|NCT02318303|7566153|FG002|NOT COMPLETED|Overall Study||3
6637402|NCT02318303|7566154|FG003|NOT COMPLETED|Overall Study||3
6637403|NCT02318303|7566155|FG004|NOT COMPLETED|Overall Study||5
6637404|NCT02318303|7566156|FG005|NOT COMPLETED|Overall Study||6
6637405|NCT02318303|7566157|FG006|NOT COMPLETED|Overall Study||2
6637406|NCT02318368|7566175|FG000|STARTED|Overall Study||7
6637407|NCT02318368|7566176|FG001|STARTED|Overall Study||3
6637408|NCT02318368|7566175|FG000|COMPLETED|Overall Study||0
6637409|NCT02318368|7566176|FG001|COMPLETED|Overall Study||0
6637410|NCT02318368|7566175|FG000|NOT COMPLETED|Overall Study||7
6637411|NCT02318368|7566176|FG001|NOT COMPLETED|Overall Study||3
6637412|NCT02318550|7566182|FG000|STARTED|Overall Study||262
6637413|NCT02318550|7566182|FG000|COMPLETED|Overall Study||262
6637414|NCT02318550|7566182|FG000|NOT COMPLETED|Overall Study||0
6637415|NCT02318602|7566189|FG000|STARTED|Overall Study||9
6637416|NCT02318602|7566190|FG001|STARTED|Overall Study||26
6637417|NCT02318602|7566191|FG002|STARTED|Overall Study||17
6637418|NCT02318602|7566189|FG000|COMPLETED|Overall Study||8
6637419|NCT02318602|7566190|FG001|COMPLETED|Overall Study||22
6637420|NCT02318602|7566191|FG002|COMPLETED|Overall Study||15
6637421|NCT02318602|7566189|FG000|NOT COMPLETED|Overall Study||1
6637422|NCT02318602|7566190|FG001|NOT COMPLETED|Overall Study||4
6637423|NCT02318602|7566191|FG002|NOT COMPLETED|Overall Study||2
6637424|NCT02318667|7566205|FG000|STARTED|Overall Study||38
6637425|NCT02318667|7566205|FG000|COMPLETED|Overall Study||29
6637426|NCT02318667|7566205|FG000|NOT COMPLETED|Overall Study||9
6412948|NCT00953719|7326408|FG000|NOT COMPLETED|Overall Study||19
6412949|NCT00953719|7326409|FG001|NOT COMPLETED|Overall Study||5
6412950|NCT00953745|7326417|FG000|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||37
6412951|NCT00953745|7326418|FG001|STARTED|Phase 1: 8 Weeks Escitalopram + Placebo||6
6637427|NCT02318693|7566215|FG000|STARTED|Overall Study||26
6637428|NCT02318693|7566216|FG001|STARTED|Overall Study||27
6637429|NCT02318693|7566215|FG000|Treated|Overall Study||26
6637430|NCT02318693|7566216|FG001|Treated|Overall Study|1 randomized participant did not receive treatment.|26
6637431|NCT02318693|7566215|FG000|COMPLETED|Overall Study||26
6637432|NCT02318693|7566216|FG001|COMPLETED|Overall Study||26
6637433|NCT02318693|7566215|FG000|NOT COMPLETED|Overall Study||0
6637434|NCT02318693|7566216|FG001|NOT COMPLETED|Overall Study||1
6637435|NCT02318706|7566226|FG000|STARTED|Double-blind Phase||334
6412952|NCT00953745|7326417|FG000|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||24
6412953|NCT00953745|7326418|FG001|COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||6
6412954|NCT00953745|7326417|FG000|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||13
6412955|NCT00953745|7326418|FG001|NOT COMPLETED|Phase 1: 8 Weeks Escitalopram + Placebo||0
6412956|NCT00953745|7326417|FG000|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||18
6412957|NCT00953745|7326418|FG001|STARTED|Phase 2: 2 Weeks Escitalopram + Placebo||0
6412958|NCT00953745|7326417|FG000|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||17
6412959|NCT00953745|7326418|FG001|COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
6412960|NCT00953745|7326417|FG000|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||1
6412961|NCT00953745|7326418|FG001|NOT COMPLETED|Phase 2: 2 Weeks Escitalopram + Placebo||0
6412962|NCT00953745|7326417|FG000|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||17
6412963|NCT00953745|7326418|FG001|STARTED|ARP Phase: 6 Weeks Escitalopram + ARP||0
6412964|NCT00953745|7326417|FG000|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||17
6412965|NCT00953745|7326418|FG001|COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
6412966|NCT00953745|7326417|FG000|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
6412967|NCT00953745|7326418|FG001|NOT COMPLETED|ARP Phase: 6 Weeks Escitalopram + ARP||0
6412968|NCT00953849|7326430|FG000|STARTED|Overall Study||6
6412969|NCT00953849|7326431|FG001|STARTED|Overall Study||6
6412970|NCT00953849|7326432|FG002|STARTED|Overall Study||4
6412971|NCT00953849|7326433|FG003|STARTED|Overall Study||5
6412972|NCT00953849|7326430|FG000|COMPLETED|Overall Study||6
6412973|NCT00953849|7326431|FG001|COMPLETED|Overall Study||6
6412974|NCT00953849|7326432|FG002|COMPLETED|Overall Study||4
6412975|NCT00953849|7326433|FG003|COMPLETED|Overall Study||5
6412976|NCT00953849|7326430|FG000|NOT COMPLETED|Overall Study||0
6412977|NCT00953849|7326431|FG001|NOT COMPLETED|Overall Study||0
6412978|NCT00953849|7326432|FG002|NOT COMPLETED|Overall Study||0
6412979|NCT00953849|7326433|FG003|NOT COMPLETED|Overall Study||0
6412980|NCT00953862|7326447|FG000|STARTED|Overall Study||18
6412981|NCT00953862|7326447|FG000|COMPLETED|Overall Study||12
6412982|NCT00953862|7326447|FG000|NOT COMPLETED|Overall Study||6
6412983|NCT00953927|7326455|FG000|STARTED|Overall Study||1399
6412984|NCT00953927|7326456|FG001|STARTED|Overall Study||1398
6412985|NCT00953927|7326455|FG000|COMPLETED|Overall Study||1294
6412986|NCT00953927|7326456|FG001|COMPLETED|Overall Study||1303
6412987|NCT00953927|7326455|FG000|NOT COMPLETED|Overall Study||105
6412988|NCT00953927|7326456|FG001|NOT COMPLETED|Overall Study||95
6637436|NCT02318706|7566227|FG001|STARTED|Double-blind Phase||166
6637437|NCT02318706|7566228|FG002|STARTED|Double-blind Phase||168
6637438|NCT02318706|7566229|FG003|STARTED|Double-blind Phase||166
6637439|NCT02318706|7566230|FG004|STARTED|Double-blind Phase||0
6637440|NCT02318706|7566226|FG000|COMPLETED|Double-blind Phase||309
6637441|NCT02318706|7566227|FG001|COMPLETED|Double-blind Phase||154
6637442|NCT02318706|7566228|FG002|COMPLETED|Double-blind Phase||150
6637443|NCT02318706|7566229|FG003|COMPLETED|Double-blind Phase||142
6637444|NCT02318706|7566230|FG004|COMPLETED|Double-blind Phase||0
6637445|NCT02318706|7566226|FG000|NOT COMPLETED|Double-blind Phase||25
6637446|NCT02318706|7566227|FG001|NOT COMPLETED|Double-blind Phase||12
6637447|NCT02318706|7566228|FG002|NOT COMPLETED|Double-blind Phase||18
6637448|NCT02318706|7566229|FG003|NOT COMPLETED|Double-blind Phase||24
6637449|NCT02318706|7566230|FG004|NOT COMPLETED|Double-blind Phase||0
6637450|NCT02318706|7566226|FG000|STARTED|Open-label Extension Phase||0
6637451|NCT02318706|7566227|FG001|STARTED|Open-label Extension Phase||0
6637452|NCT02318706|7566228|FG002|STARTED|Open-label Extension Phase||0
6637453|NCT02318706|7566229|FG003|STARTED|Open-label Extension Phase||0
6637454|NCT02318706|7566230|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|214
6637455|NCT02318706|7566226|FG000|COMPLETED|Open-label Extension Phase||0
6637456|NCT02318706|7566227|FG001|COMPLETED|Open-label Extension Phase||0
6637457|NCT02318706|7566228|FG002|COMPLETED|Open-label Extension Phase||0
6637458|NCT02318706|7566229|FG003|COMPLETED|Open-label Extension Phase||0
6637459|NCT02318706|7566230|FG004|COMPLETED|Open-label Extension Phase||172
6637460|NCT02318706|7566226|FG000|NOT COMPLETED|Open-label Extension Phase||0
6637461|NCT02318706|7566227|FG001|NOT COMPLETED|Open-label Extension Phase||0
6637462|NCT02318706|7566228|FG002|NOT COMPLETED|Open-label Extension Phase||0
6637463|NCT02318706|7566229|FG003|NOT COMPLETED|Open-label Extension Phase||0
6637464|NCT02318706|7566230|FG004|NOT COMPLETED|Open-label Extension Phase||42
6637465|NCT02318719|7566246|FG000|STARTED|Double-blind Phase||304
6637466|NCT02318719|7566247|FG001|STARTED|Double-blind Phase||153
6637467|NCT02318719|7566248|FG002|STARTED|Double-blind Phase||153
6637468|NCT02318719|7566249|FG003|STARTED|Double-blind Phase||155
6637469|NCT02318719|7566250|FG004|STARTED|Double-blind Phase||0
6637470|NCT02318719|7566246|FG000|Did Not Receive Treatment|Double-blind Phase||1
6637471|NCT02318719|7566247|FG001|Did Not Receive Treatment|Double-blind Phase||1
6637472|NCT02318719|7566248|FG002|Did Not Receive Treatment|Double-blind Phase||0
6637473|NCT02318719|7566249|FG003|Did Not Receive Treatment|Double-blind Phase||0
6637474|NCT02318719|7566250|FG004|Did Not Receive Treatment|Double-blind Phase||0
6637475|NCT02318719|7566246|FG000|COMPLETED|Double-blind Phase||266
6637476|NCT02318719|7566247|FG001|COMPLETED|Double-blind Phase||137
6637477|NCT02318719|7566248|FG002|COMPLETED|Double-blind Phase||128
6637478|NCT02318719|7566249|FG003|COMPLETED|Double-blind Phase||140
6637479|NCT02318719|7566250|FG004|COMPLETED|Double-blind Phase||0
6637480|NCT02318719|7566246|FG000|NOT COMPLETED|Double-blind Phase||38
6412989|NCT00954109|7326462|FG000|STARTED|Overall Study||11
6412990|NCT00954109|7326462|FG000|COMPLETED|Overall Study||11
6412991|NCT00954109|7326462|FG000|NOT COMPLETED|Overall Study||0
6412992|NCT00954122|7326466|FG000|STARTED|Overall Study||35
6412993|NCT00954122|7326466|FG000|COMPLETED|Overall Study||28
6412994|NCT00954122|7326466|FG000|NOT COMPLETED|Overall Study||7
6510583|NCT01483599|7430214|FG007|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510584|NCT01483599|7430215|FG008|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510585|NCT01483599|7430216|FG009|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510586|NCT01483599|7430217|FG010|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510587|NCT01483599|7430218|FG011|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510588|NCT01483599|7430219|FG012|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510589|NCT01483599|7430220|FG013|COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510590|NCT01483599|7430207|FG000|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
6510591|NCT01483599|7430208|FG001|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
6510592|NCT01483599|7430209|FG002|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510593|NCT01483599|7430210|FG003|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
6510594|NCT01483599|7430211|FG004|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
6510595|NCT01483599|7430212|FG005|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
6510596|NCT01483599|7430213|FG006|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
6510597|NCT01483599|7430214|FG007|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510598|NCT01483599|7430215|FG008|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510599|NCT01483599|7430216|FG009|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510600|NCT01483599|7430217|FG010|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510601|NCT01483599|7430218|FG011|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510602|NCT01483599|7430219|FG012|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510603|NCT01483599|7430220|FG013|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
6510604|NCT01483599|7430207|FG000|STARTED|After Controlled Period(Week 16-Week 40)||0
6510605|NCT01483599|7430208|FG001|STARTED|After Controlled Period(Week 16-Week 40)||0
6510606|NCT01483599|7430209|FG002|STARTED|After Controlled Period(Week 16-Week 40)||0
6510607|NCT01483599|7430210|FG003|STARTED|After Controlled Period(Week 16-Week 40)||0
6510608|NCT01483599|7430211|FG004|STARTED|After Controlled Period(Week 16-Week 40)||0
6510609|NCT01483599|7430212|FG005|STARTED|After Controlled Period(Week 16-Week 40)||0
6510610|NCT01483599|7430213|FG006|STARTED|After Controlled Period(Week 16-Week 40)||0
6510611|NCT01483599|7430214|FG007|STARTED|After Controlled Period(Week 16-Week 40)||39
6510612|NCT01483599|7430215|FG008|STARTED|After Controlled Period(Week 16-Week 40)||38
6510613|NCT01483599|7430216|FG009|STARTED|After Controlled Period(Week 16-Week 40)||41
6510614|NCT01483599|7430217|FG010|STARTED|After Controlled Period(Week 16-Week 40)||39
6510615|NCT01483599|7430218|FG011|STARTED|After Controlled Period(Week 16-Week 40)||40
6510616|NCT01483599|7430219|FG012|STARTED|After Controlled Period(Week 16-Week 40)||38
6510617|NCT01483599|7430220|FG013|STARTED|After Controlled Period(Week 16-Week 40)||39
6510618|NCT01483599|7430207|FG000|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510619|NCT01483599|7430208|FG001|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510620|NCT01483599|7430209|FG002|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510621|NCT01483599|7430210|FG003|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510622|NCT01483599|7430211|FG004|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510623|NCT01483599|7430212|FG005|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510624|NCT01483599|7430213|FG006|COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510625|NCT01483599|7430214|FG007|COMPLETED|After Controlled Period(Week 16-Week 40)||37
6510626|NCT01483599|7430215|FG008|COMPLETED|After Controlled Period(Week 16-Week 40)||29
6510627|NCT01483599|7430216|FG009|COMPLETED|After Controlled Period(Week 16-Week 40)||37
6510628|NCT01483599|7430217|FG010|COMPLETED|After Controlled Period(Week 16-Week 40)||37
6510629|NCT01483599|7430218|FG011|COMPLETED|After Controlled Period(Week 16-Week 40)||39
6510630|NCT01483599|7430219|FG012|COMPLETED|After Controlled Period(Week 16-Week 40)||35
6510631|NCT01483599|7430220|FG013|COMPLETED|After Controlled Period(Week 16-Week 40)||32
6510632|NCT01483599|7430207|FG000|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510633|NCT01483599|7430208|FG001|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510634|NCT01483599|7430209|FG002|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510635|NCT01483599|7430210|FG003|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510636|NCT01483599|7430211|FG004|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510637|NCT01483599|7430212|FG005|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510638|NCT01483599|7430213|FG006|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
6510639|NCT01483599|7430214|FG007|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
6510640|NCT01483599|7430215|FG008|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
6510641|NCT01483599|7430216|FG009|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
6510642|NCT01483599|7430217|FG010|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
6510643|NCT01483599|7430218|FG011|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
6637481|NCT02318719|7566247|FG001|NOT COMPLETED|Double-blind Phase||16
6637482|NCT02318719|7566248|FG002|NOT COMPLETED|Double-blind Phase||25
6637483|NCT02318719|7566249|FG003|NOT COMPLETED|Double-blind Phase||15
6412995|NCT00954174|7326475|FG000|STARTED|Overall Study||268
6412996|NCT00954174|7326476|FG001|STARTED|Overall Study||268
6412997|NCT00954174|7326477|FG002|STARTED|Overall Study||51
6412998|NCT00954174|7326478|FG003|STARTED|Overall Study||50
6412999|NCT00954174|7326475|FG000|COMPLETED|Overall Study||142
6413000|NCT00954174|7326476|FG001|COMPLETED|Overall Study||145
6413001|NCT00954174|7326477|FG002|COMPLETED|Overall Study||27
6413002|NCT00954174|7326478|FG003|COMPLETED|Overall Study||25
6413003|NCT00954174|7326475|FG000|NOT COMPLETED|Overall Study||126
6413004|NCT00954174|7326476|FG001|NOT COMPLETED|Overall Study||123
6413005|NCT00954174|7326477|FG002|NOT COMPLETED|Overall Study||24
6413006|NCT00954174|7326478|FG003|NOT COMPLETED|Overall Study||25
6413007|NCT00954356|7326493|FG000|STARTED|Overall Study||41
6413008|NCT00954356|7326494|FG001|STARTED|Overall Study||20
6413009|NCT00954356|7326493|FG000|COMPLETED|Overall Study||41
6413010|NCT00954356|7326494|FG001|COMPLETED|Overall Study||20
6413011|NCT00954356|7326493|FG000|NOT COMPLETED|Overall Study||0
6413012|NCT00954356|7326494|FG001|NOT COMPLETED|Overall Study||0
6413013|NCT00954421|7326500|FG000|STARTED|Screening||16
6413014|NCT00954421|7326500|FG000|COMPLETED|Screening||13
6413015|NCT00954421|7326500|FG000|NOT COMPLETED|Screening||3
6413016|NCT00954421|7326500|FG000|STARTED|Baseline||13
6413017|NCT00954421|7326500|FG000|COMPLETED|Baseline||13
6413018|NCT00954421|7326500|FG000|NOT COMPLETED|Baseline||0
6413019|NCT00954421|7326500|FG000|STARTED|6 Months of DBS||13
6413020|NCT00954421|7326500|FG000|COMPLETED|6 Months of DBS||12
6413021|NCT00954421|7326500|FG000|NOT COMPLETED|6 Months of DBS||1
6413022|NCT00954421|7326500|FG000|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
6413023|NCT00954421|7326500|FG000|COMPLETED|VIM=ON VO=ON at 6 Months||12
6413024|NCT00954421|7326500|FG000|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
6413025|NCT00954421|7326500|FG000|STARTED|VIM=OFF VO=OFF at 6 Months||12
6413026|NCT00954421|7326500|FG000|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
6413027|NCT00954421|7326500|FG000|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
6413028|NCT00954421|7326500|FG000|STARTED|VIM=OFF VO=ON at 6 Months||12
6413029|NCT00954421|7326500|FG000|COMPLETED|VIM=OFF VO=ON at 6 Months||12
6413030|NCT00954421|7326500|FG000|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
6413031|NCT00954421|7326500|FG000|STARTED|VIM=ON VO=OFF at 6 Months||12
6413032|NCT00954421|7326500|FG000|COMPLETED|VIM=ON VO=OFF at 6 Months||11
6413033|NCT00954421|7326500|FG000|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
6413034|NCT00954447|7326508|FG000|STARTED|Overall Study||630
6413035|NCT00954447|7326509|FG001|STARTED|Overall Study||631
6413036|NCT00954447|7326508|FG000|COMPLETED|Overall Study||520
6413037|NCT00954447|7326509|FG001|COMPLETED|Overall Study||543
6413038|NCT00954447|7326508|FG000|NOT COMPLETED|Overall Study||110
6413039|NCT00954447|7326509|FG001|NOT COMPLETED|Overall Study||88
6413040|NCT00954512|7326521|FG000|STARTED|Overall Study||2
6413041|NCT00954512|7326522|FG001|STARTED|Overall Study||3
6413042|NCT00954512|7326523|FG002|STARTED|Overall Study||0
6413043|NCT00954512|7326524|FG003|STARTED|Overall Study||2
6413044|NCT00954512|7326525|FG004|STARTED|Overall Study||4
6413045|NCT00954512|7326526|FG005|STARTED|Overall Study||4
6413046|NCT00954512|7326521|FG000|COMPLETED|Overall Study||0
6413047|NCT00954512|7326522|FG001|COMPLETED|Overall Study||0
6413048|NCT00954512|7326523|FG002|COMPLETED|Overall Study||0
6413049|NCT00954512|7326524|FG003|COMPLETED|Overall Study||0
6413050|NCT00954512|7326525|FG004|COMPLETED|Overall Study||0
6413051|NCT00954512|7326526|FG005|COMPLETED|Overall Study||0
6413052|NCT00954512|7326521|FG000|NOT COMPLETED|Overall Study||2
6413053|NCT00954512|7326522|FG001|NOT COMPLETED|Overall Study||3
6413054|NCT00954512|7326523|FG002|NOT COMPLETED|Overall Study||0
6413055|NCT00954512|7326524|FG003|NOT COMPLETED|Overall Study||2
6413056|NCT00954512|7326525|FG004|NOT COMPLETED|Overall Study||4
6413057|NCT00954512|7326526|FG005|NOT COMPLETED|Overall Study||4
6413058|NCT00954538|7326541|FG000|STARTED|Part I|These subjects did not participate in Part II or III|3
6413059|NCT00954538|7326542|FG001|STARTED|Part I||0
6413060|NCT00954538|7326543|FG002|STARTED|Part I||0
6413061|NCT00954538|7326544|FG003|STARTED|Part I||0
6413062|NCT00954538|7326545|FG004|STARTED|Part I||0
6413063|NCT00954538|7326546|FG005|STARTED|Part I||0
6413064|NCT00954538|7326541|FG000|COMPLETED|Part I||3
6413065|NCT00954538|7326542|FG001|COMPLETED|Part I||0
6413066|NCT00954538|7326543|FG002|COMPLETED|Part I||0
6413067|NCT00954538|7326544|FG003|COMPLETED|Part I||0
6413068|NCT00954538|7326545|FG004|COMPLETED|Part I||0
6413069|NCT00954538|7326546|FG005|COMPLETED|Part I||0
6413070|NCT00954538|7326541|FG000|NOT COMPLETED|Part I||0
6413071|NCT00954538|7326542|FG001|NOT COMPLETED|Part I||0
6413072|NCT00954538|7326543|FG002|NOT COMPLETED|Part I||0
6413073|NCT00954538|7326544|FG003|NOT COMPLETED|Part I||0
6413074|NCT00954538|7326545|FG004|NOT COMPLETED|Part I||0
6413075|NCT00954538|7326546|FG005|NOT COMPLETED|Part I||0
6413076|NCT00954538|7326541|FG000|STARTED|Part II||0
6413077|NCT00954538|7326542|FG001|STARTED|Part II|This subject did not participate in Part I or III|1
6413078|NCT00954538|7326543|FG002|STARTED|Part II|These subjects did not participate in Part I or III|3
6413079|NCT00954538|7326544|FG003|STARTED|Part II||0
6413080|NCT00954538|7326545|FG004|STARTED|Part II||0
6413081|NCT00954538|7326546|FG005|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
6413082|NCT00954538|7326541|FG000|COMPLETED|Part II||0
6413083|NCT00954538|7326542|FG001|COMPLETED|Part II||1
6413084|NCT00954538|7326543|FG002|COMPLETED|Part II||3
6413085|NCT00954538|7326544|FG003|COMPLETED|Part II||0
6413086|NCT00954538|7326545|FG004|COMPLETED|Part II||0
6413087|NCT00954538|7326546|FG005|COMPLETED|Part II||2
6413088|NCT00954538|7326541|FG000|NOT COMPLETED|Part II||0
6413089|NCT00954538|7326542|FG001|NOT COMPLETED|Part II||0
6413090|NCT00954538|7326543|FG002|NOT COMPLETED|Part II||0
6413091|NCT00954538|7326544|FG003|NOT COMPLETED|Part II||0
6413092|NCT00954538|7326545|FG004|NOT COMPLETED|Part II||0
6413093|NCT00954538|7326546|FG005|NOT COMPLETED|Part II||0
6413094|NCT00954538|7326541|FG000|STARTED|Part III||0
6413095|NCT00954538|7326542|FG001|STARTED|Part III||0
6413096|NCT00954538|7326543|FG002|STARTED|Part III||0
6413097|NCT00954538|7326544|FG003|STARTED|Part III|These subjects did not participate in Part I or II|4
6413098|NCT00954538|7326545|FG004|STARTED|Part III|These subjects did not participate in Part I or II|6
6413099|NCT00954538|7326546|FG005|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
6413100|NCT00954538|7326541|FG000|COMPLETED|Part III||0
6413101|NCT00954538|7326542|FG001|COMPLETED|Part III||0
6413102|NCT00954538|7326543|FG002|COMPLETED|Part III||0
6413103|NCT00954538|7326544|FG003|COMPLETED|Part III||4
6413104|NCT00954538|7326545|FG004|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
6413105|NCT00954538|7326546|FG005|COMPLETED|Part III||2
6413106|NCT00954538|7326541|FG000|NOT COMPLETED|Part III||0
6413107|NCT00954538|7326542|FG001|NOT COMPLETED|Part III||0
6413108|NCT00954538|7326543|FG002|NOT COMPLETED|Part III||0
6413109|NCT00954538|7326544|FG003|NOT COMPLETED|Part III||0
6413110|NCT00954538|7326545|FG004|NOT COMPLETED|Part III||1
6413111|NCT00954538|7326546|FG005|NOT COMPLETED|Part III||0
6413112|NCT00954681|7326555|FG000|STARTED|Overall Study||15
6413113|NCT00954681|7326555|FG000|COMPLETED|Overall Study||10
6413114|NCT00954681|7326555|FG000|NOT COMPLETED|Overall Study||5
6413115|NCT00954707|7326559|FG000|STARTED|Overall Study||2509
6413116|NCT00954707|7326559|FG000|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
6413117|NCT00954707|7326559|FG000|NOT COMPLETED|Overall Study||167
6413118|NCT00954733|7326563|FG000|STARTED|Overall Study||40
6413119|NCT00954733|7326563|FG000|COMPLETED|Overall Study||39
6413120|NCT00954733|7326563|FG000|NOT COMPLETED|Overall Study||1
6413121|NCT00954824|7326567|FG000|STARTED|Overall Study||100
6413122|NCT00954824|7326567|FG000|COMPLETED|Overall Study||50
6413123|NCT00954824|7326567|FG000|NOT COMPLETED|Overall Study||50
6413124|NCT00954941|7326573|FG000|STARTED|Overall Study||50
6413125|NCT00954941|7326574|FG001|STARTED|Overall Study||48
6413126|NCT00954941|7326573|FG000|COMPLETED|Overall Study||42
6413127|NCT00954941|7326574|FG001|COMPLETED|Overall Study||41
6413128|NCT00954941|7326573|FG000|NOT COMPLETED|Overall Study||8
6413129|NCT00954941|7326574|FG001|NOT COMPLETED|Overall Study||7
6413130|NCT00954993|7326580|FG000|STARTED|Period 1||3
6413131|NCT00954993|7326580|FG000|COMPLETED|Period 1||3
6413132|NCT00954993|7326580|FG000|NOT COMPLETED|Period 1||0
6413133|NCT00954993|7326580|FG000|STARTED|Washout||3
6413134|NCT00954993|7326580|FG000|COMPLETED|Washout||3
6413135|NCT00954993|7326580|FG000|NOT COMPLETED|Washout||0
6413136|NCT00954993|7326580|FG000|STARTED|Period 2||3
6413137|NCT00954993|7326580|FG000|COMPLETED|Period 2||3
6413138|NCT00954993|7326580|FG000|NOT COMPLETED|Period 2||0
6413139|NCT00955032|7326588|FG000|STARTED|Overall Study||16
6413140|NCT00955032|7326589|FG001|STARTED|Overall Study||8
6413141|NCT00955032|7326588|FG000|COMPLETED|Overall Study||16
6413142|NCT00955032|7326589|FG001|COMPLETED|Overall Study||8
6413143|NCT00955032|7326588|FG000|NOT COMPLETED|Overall Study||0
6413144|NCT00955032|7326589|FG001|NOT COMPLETED|Overall Study||0
6413145|NCT00955110|7326604|FG000|STARTED|Qualification Phase||78
6413146|NCT00955110|7326604|FG000|COMPLETED|Qualification Phase||54
6413147|NCT00955110|7326604|FG000|NOT COMPLETED|Qualification Phase||24
6413148|NCT00955110|7326604|FG000|STARTED|Treatment Phase||41
6413149|NCT00955110|7326604|FG000|Placebo|Treatment Phase||38
6413150|NCT00955110|7326604|FG000|Oxymorphone ER 15 mg|Treatment Phase||37
6413151|NCT00955110|7326604|FG000|Oxymorphone ER 30 mg|Treatment Phase||38
6413152|NCT00955110|7326604|FG000|Oxycodone CR 30 mg|Treatment Phase||40
6413153|NCT00955110|7326604|FG000|Oxycodone CR 60 mg|Treatment Phase||40
6413154|NCT00955110|7326604|FG000|COMPLETED|Treatment Phase||35
6413155|NCT00955110|7326604|FG000|NOT COMPLETED|Treatment Phase||6
6413156|NCT00955201|7326620|FG000|STARTED|Overall Study||12
6413157|NCT00955201|7326621|FG001|STARTED|Overall Study||11
6413158|NCT00955201|7326622|FG002|STARTED|Overall Study||11
6413159|NCT00955201|7326623|FG003|STARTED|Overall Study||11
6413160|NCT00955201|7326620|FG000|COMPLETED|Overall Study||8
6413161|NCT00955201|7326621|FG001|COMPLETED|Overall Study||11
6413162|NCT00955201|7326622|FG002|COMPLETED|Overall Study||10
6637484|NCT02318719|7566250|FG004|NOT COMPLETED|Double-blind Phase||0
6637485|NCT02318719|7566246|FG000|STARTED|Open-label Extension Phase||0
6637486|NCT02318719|7566247|FG001|STARTED|Open-label Extension Phase||0
6637487|NCT02318719|7566248|FG002|STARTED|Open-label Extension Phase||0
6637488|NCT02318719|7566249|FG003|STARTED|Open-label Extension Phase||0
6637489|NCT02318719|7566250|FG004|STARTED|Open-label Extension Phase|A portion of participants who completed the double-blind phase enrolled in the open-label extension.|239
6637490|NCT02318719|7566246|FG000|COMPLETED|Open-label Extension Phase||0
6637491|NCT02318719|7566247|FG001|COMPLETED|Open-label Extension Phase||0
6637492|NCT02318719|7566248|FG002|COMPLETED|Open-label Extension Phase||0
6637493|NCT02318719|7566249|FG003|COMPLETED|Open-label Extension Phase||0
6413163|NCT00955201|7326623|FG003|COMPLETED|Overall Study||7
6413164|NCT00955201|7326620|FG000|NOT COMPLETED|Overall Study||4
6413165|NCT00955201|7326621|FG001|NOT COMPLETED|Overall Study||0
6413166|NCT00955201|7326622|FG002|NOT COMPLETED|Overall Study||1
6413167|NCT00955201|7326623|FG003|NOT COMPLETED|Overall Study||4
6413168|NCT00955253|7326642|FG000|STARTED|First Intervention (Day 2)||7
6413169|NCT00955253|7326643|FG001|STARTED|First Intervention (Day 2)||6
6413170|NCT00955253|7326642|FG000|COMPLETED|First Intervention (Day 2)||7
6413171|NCT00955253|7326643|FG001|COMPLETED|First Intervention (Day 2)||6
6413172|NCT00955253|7326642|FG000|NOT COMPLETED|First Intervention (Day 2)||0
6413173|NCT00955253|7326643|FG001|NOT COMPLETED|First Intervention (Day 2)||0
6413174|NCT00955253|7326642|FG000|STARTED|Second Intervention (Day 4)||7
6413175|NCT00955253|7326643|FG001|STARTED|Second Intervention (Day 4)||6
6413176|NCT00955253|7326642|FG000|COMPLETED|Second Intervention (Day 4)||7
6413177|NCT00955253|7326643|FG001|COMPLETED|Second Intervention (Day 4)||6
6413178|NCT00955253|7326642|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
6413179|NCT00955253|7326643|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
6413180|NCT00955266|7326650|FG000|STARTED|Overall Study||4
6413181|NCT00955266|7326651|FG001|STARTED|Overall Study||4
6413182|NCT00955266|7326650|FG000|COMPLETED|Overall Study||4
6413183|NCT00955266|7326651|FG001|COMPLETED|Overall Study||4
6413184|NCT00955266|7326650|FG000|NOT COMPLETED|Overall Study||0
6413185|NCT00955266|7326651|FG001|NOT COMPLETED|Overall Study||0
6413186|NCT00955279|7326660|FG000|STARTED|Overall Study||58
6413187|NCT00955279|7326661|FG001|STARTED|Overall Study||55
6413188|NCT00955279|7326662|FG002|STARTED|Overall Study||60
6413189|NCT00955279|7326660|FG000|COMPLETED|Overall Study||55
6413190|NCT00955279|7326661|FG001|COMPLETED|Overall Study||51
6413191|NCT00955279|7326662|FG002|COMPLETED|Overall Study||52
6413192|NCT00955279|7326660|FG000|NOT COMPLETED|Overall Study||3
6413193|NCT00955279|7326661|FG001|NOT COMPLETED|Overall Study||4
6413194|NCT00955279|7326662|FG002|NOT COMPLETED|Overall Study||8
6413195|NCT00955305|7326672|FG000|STARTED|Overall Study||88
6413196|NCT00955305|7326673|FG001|STARTED|Overall Study||87
6413197|NCT00955305|7326672|FG000|Treated|Overall Study||83
6413198|NCT00955305|7326673|FG001|Treated|Overall Study||82
6413199|NCT00955305|7326672|FG000|Eligible and Treated|Overall Study||78
6413200|NCT00955305|7326673|FG001|Eligible and Treated|Overall Study||75
6413201|NCT00955305|7326672|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
6413202|NCT00955305|7326673|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
6413203|NCT00955305|7326672|FG000|NOT COMPLETED|Overall Study||88
6413204|NCT00955305|7326673|FG001|NOT COMPLETED|Overall Study||87
6413205|NCT00955357|7326681|FG000|STARTED|Titration Phase||96
6637494|NCT02318719|7566250|FG004|COMPLETED|Open-label Extension Phase||184
6637495|NCT02318719|7566246|FG000|NOT COMPLETED|Open-label Extension Phase||0
6637496|NCT02318719|7566247|FG001|NOT COMPLETED|Open-label Extension Phase||0
6637497|NCT02318719|7566248|FG002|NOT COMPLETED|Open-label Extension Phase||0
6637498|NCT02318719|7566249|FG003|NOT COMPLETED|Open-label Extension Phase||0
6637499|NCT02318719|7566250|FG004|NOT COMPLETED|Open-label Extension Phase||55
6637500|NCT02318797|7566264|FG000|STARTED|Overall Study||516
6637501|NCT02318797|7566265|FG001|STARTED|Overall Study||713
6637502|NCT02318797|7566264|FG000|COMPLETED|Overall Study||428
6637503|NCT02318797|7566265|FG001|COMPLETED|Overall Study||611
6637504|NCT02318797|7566264|FG000|NOT COMPLETED|Overall Study||88
6637505|NCT02318797|7566265|FG001|NOT COMPLETED|Overall Study||102
6637506|NCT02318940|7566273|FG000|STARTED|Overall Study|in the last patient we lost the record.|50
6637507|NCT02318940|7566274|FG001|STARTED|Overall Study||50
6637508|NCT02318940|7566273|FG000|COMPLETED|Overall Study||49
6637509|NCT02318940|7566274|FG001|COMPLETED|Overall Study||50
6637510|NCT02318940|7566273|FG000|NOT COMPLETED|Overall Study||1
6637511|NCT02318940|7566274|FG001|NOT COMPLETED|Overall Study||0
6637512|NCT02318979|7566282|FG000|STARTED|Overall Study||15
6637513|NCT02318979|7566283|FG001|STARTED|Overall Study||15
6637514|NCT02318979|7566282|FG000|COMPLETED|Overall Study||15
6637515|NCT02318979|7566283|FG001|COMPLETED|Overall Study||15
6637516|NCT02318979|7566282|FG000|NOT COMPLETED|Overall Study||0
6637517|NCT02318979|7566283|FG001|NOT COMPLETED|Overall Study||0
6637518|NCT02318992|7566296|FG000|STARTED|Overall Study||27
6637519|NCT02318992|7566297|FG001|STARTED|Overall Study||27
6637520|NCT02318992|7566298|FG002|STARTED|Overall Study||24
6637521|NCT02318992|7566296|FG000|COMPLETED|Overall Study||25
6637522|NCT02318992|7566297|FG001|COMPLETED|Overall Study||25
6637523|NCT02318992|7566298|FG002|COMPLETED|Overall Study||20
6637524|NCT02318992|7566296|FG000|NOT COMPLETED|Overall Study||2
6637525|NCT02318992|7566297|FG001|NOT COMPLETED|Overall Study||2
6637526|NCT02318992|7566298|FG002|NOT COMPLETED|Overall Study||4
6637527|NCT02319031|7566308|FG000|STARTED|Treatment Period||24
6637528|NCT02319031|7566309|FG001|STARTED|Treatment Period||26
6637529|NCT02319031|7566308|FG000|COMPLETED|Treatment Period||23
6637530|NCT02319031|7566309|FG001|COMPLETED|Treatment Period||26
6637531|NCT02319031|7566308|FG000|NOT COMPLETED|Treatment Period||1
6637532|NCT02319031|7566309|FG001|NOT COMPLETED|Treatment Period||0
6637533|NCT02319031|7566308|FG000|STARTED|Follow-Up Period||23
6637534|NCT02319031|7566309|FG001|STARTED|Follow-Up Period||26
6413206|NCT00955357|7326682|FG001|STARTED|Titration Phase||360
6413207|NCT00955357|7326681|FG000|COMPLETED|Titration Phase||80
6413208|NCT00955357|7326682|FG001|COMPLETED|Titration Phase||294
6637535|NCT02319031|7566308|FG000|COMPLETED|Follow-Up Period||23
6637536|NCT02319031|7566309|FG001|COMPLETED|Follow-Up Period||26
6637537|NCT02319031|7566308|FG000|NOT COMPLETED|Follow-Up Period||0
6637538|NCT02319031|7566309|FG001|NOT COMPLETED|Follow-Up Period||0
6637539|NCT02319044|7566318|FG000|STARTED|Overall Study||133
6637540|NCT02319044|7566319|FG001|STARTED|Overall Study||67
6637541|NCT02319044|7566320|FG002|STARTED|Overall Study||67
6637542|NCT02319044|7566318|FG000|COMPLETED|Overall Study||11
6637543|NCT02319044|7566319|FG001|COMPLETED|Overall Study||7
6413209|NCT00955357|7326681|FG000|NOT COMPLETED|Titration Phase||16
6413210|NCT00955357|7326682|FG001|NOT COMPLETED|Titration Phase||66
6413211|NCT00955357|7326681|FG000|STARTED|Maintenance Phase||80
6413212|NCT00955357|7326682|FG001|STARTED|Maintenance Phase||294
6413213|NCT00955357|7326681|FG000|COMPLETED|Maintenance Phase||68
6413214|NCT00955357|7326682|FG001|COMPLETED|Maintenance Phase||249
6413215|NCT00955357|7326681|FG000|NOT COMPLETED|Maintenance Phase||12
6413216|NCT00955357|7326682|FG001|NOT COMPLETED|Maintenance Phase||45
6413217|NCT00955409|7326698|FG000|STARTED|Overall Study|Started=Randomized|21
6413218|NCT00955409|7326699|FG001|STARTED|Overall Study|Started=Randomized|6
6413219|NCT00955409|7326700|FG002|STARTED|Overall Study|Started=Randomized|41
6413220|NCT00955409|7326701|FG003|STARTED|Overall Study|Started=Randomized.|25
6413221|NCT00955409|7326702|FG004|STARTED|Overall Study|Started=Randomized|5
6413222|NCT00955409|7326703|FG005|STARTED|Overall Study|Started=Randomized|9
6413223|NCT00955409|7326704|FG006|STARTED|Overall Study|Started=Randomized|27
6413224|NCT00955409|7326705|FG007|STARTED|Overall Study|Started=Randomized|6
6637544|NCT02319044|7566320|FG002|COMPLETED|Overall Study||0
6637545|NCT02319044|7566318|FG000|NOT COMPLETED|Overall Study||122
6637546|NCT02319044|7566319|FG001|NOT COMPLETED|Overall Study||60
6637547|NCT02319044|7566320|FG002|NOT COMPLETED|Overall Study||67
6637548|NCT02319148|7566332|FG000|STARTED|First Intervention Period||22
6637549|NCT02319148|7566333|FG001|STARTED|First Intervention Period||0
6637550|NCT02319148|7566334|FG002|STARTED|First Intervention Period||0
6637551|NCT02319148|7566335|FG003|STARTED|First Intervention Period||0
6637552|NCT02319148|7566332|FG000|COMPLETED|First Intervention Period||22
6637553|NCT02319148|7566333|FG001|COMPLETED|First Intervention Period||0
6637554|NCT02319148|7566334|FG002|COMPLETED|First Intervention Period||0
6637555|NCT02319148|7566335|FG003|COMPLETED|First Intervention Period||0
6637556|NCT02319148|7566332|FG000|NOT COMPLETED|First Intervention Period||0
6637557|NCT02319148|7566333|FG001|NOT COMPLETED|First Intervention Period||0
6637558|NCT02319148|7566334|FG002|NOT COMPLETED|First Intervention Period||0
6637559|NCT02319148|7566335|FG003|NOT COMPLETED|First Intervention Period||0
6637560|NCT02319148|7566332|FG000|STARTED|Washout Period 4 Days||22
6637561|NCT02319148|7566333|FG001|STARTED|Washout Period 4 Days||0
6637562|NCT02319148|7566334|FG002|STARTED|Washout Period 4 Days||0
6637563|NCT02319148|7566335|FG003|STARTED|Washout Period 4 Days||0
6637564|NCT02319148|7566332|FG000|COMPLETED|Washout Period 4 Days||22
6637565|NCT02319148|7566333|FG001|COMPLETED|Washout Period 4 Days||0
6637566|NCT02319148|7566334|FG002|COMPLETED|Washout Period 4 Days||0
6637567|NCT02319148|7566335|FG003|COMPLETED|Washout Period 4 Days||0
6637568|NCT02319148|7566332|FG000|NOT COMPLETED|Washout Period 4 Days||0
6637569|NCT02319148|7566333|FG001|NOT COMPLETED|Washout Period 4 Days||0
6637570|NCT02319148|7566334|FG002|NOT COMPLETED|Washout Period 4 Days||0
6637571|NCT02319148|7566335|FG003|NOT COMPLETED|Washout Period 4 Days||0
6637572|NCT02319148|7566332|FG000|STARTED|Second Intervention Period||0
6637573|NCT02319148|7566333|FG001|STARTED|Second Intervention Period||7
6637574|NCT02319148|7566334|FG002|STARTED|Second Intervention Period||7
6637575|NCT02319148|7566335|FG003|STARTED|Second Intervention Period||8
6637576|NCT02319148|7566332|FG000|COMPLETED|Second Intervention Period||0
6637577|NCT02319148|7566333|FG001|COMPLETED|Second Intervention Period||6
6637578|NCT02319148|7566334|FG002|COMPLETED|Second Intervention Period||6
6637579|NCT02319148|7566335|FG003|COMPLETED|Second Intervention Period||6
6637580|NCT02319148|7566332|FG000|NOT COMPLETED|Second Intervention Period||0
6637581|NCT02319148|7566333|FG001|NOT COMPLETED|Second Intervention Period||1
6637582|NCT02319148|7566334|FG002|NOT COMPLETED|Second Intervention Period||1
6637583|NCT02319148|7566335|FG003|NOT COMPLETED|Second Intervention Period||2
6637584|NCT02319174|7566354|FG000|STARTED|Overall Study||43
6637585|NCT02319174|7566354|FG000|COMPLETED|Overall Study||42
6637586|NCT02319174|7566354|FG000|NOT COMPLETED|Overall Study||1
6637587|NCT02319304|7566359|FG000|STARTED|Overall Study||3
6637588|NCT02319304|7566359|FG000|COMPLETED|Overall Study||2
6637589|NCT02319304|7566359|FG000|NOT COMPLETED|Overall Study||1
6637590|NCT02319317|7566365|FG000|STARTED|Overall Study||31
6637591|NCT02319317|7566366|FG001|STARTED|Overall Study||29
6637592|NCT02319317|7566365|FG000|COMPLETED|Overall Study||31
6637593|NCT02319317|7566366|FG001|COMPLETED|Overall Study||29
6637594|NCT02319317|7566365|FG000|NOT COMPLETED|Overall Study||0
6637595|NCT02319317|7566366|FG001|NOT COMPLETED|Overall Study||0
6637596|NCT02319369|7566385|FG000|STARTED|Overall Study||7
6637597|NCT02319369|7566386|FG001|STARTED|Overall Study||6
6637598|NCT02319369|7566387|FG002|STARTED|Overall Study||11
6637599|NCT02319369|7566388|FG003|STARTED|Overall Study||8
6637600|NCT02319369|7566389|FG004|STARTED|Overall Study||5
6637601|NCT02319369|7566390|FG005|STARTED|Overall Study||7
6637602|NCT02319369|7566391|FG006|STARTED|Overall Study||3
6637603|NCT02319369|7566392|FG007|STARTED|Overall Study||6
6637604|NCT02319369|7566393|FG008|STARTED|Overall Study||4
6637605|NCT02319369|7566394|FG009|STARTED|Overall Study||9
6413225|NCT00955409|7326706|FG008|STARTED|Overall Study|Started=Randomized|16
6413226|NCT00955409|7326707|FG009|STARTED|Overall Study|Started=Randomized|4
6637606|NCT02319369|7566395|FG010|STARTED|Overall Study||3
6637607|NCT02319369|7566396|FG011|STARTED|Overall Study||4
6637608|NCT02319369|7566397|FG012|STARTED|Overall Study||1
6637609|NCT02319369|7566385|FG000|COMPLETED|Overall Study||7
6637610|NCT02319369|7566386|FG001|COMPLETED|Overall Study||6
6637611|NCT02319369|7566387|FG002|COMPLETED|Overall Study||11
6413227|NCT00955409|7326698|FG000|Treated|Overall Study||21
6413228|NCT00955409|7326699|FG001|Treated|Overall Study||6
6413229|NCT00955409|7326700|FG002|Treated|Overall Study||41
6413230|NCT00955409|7326701|FG003|Treated|Overall Study||24
6413231|NCT00955409|7326702|FG004|Treated|Overall Study||5
6413232|NCT00955409|7326703|FG005|Treated|Overall Study||9
6413233|NCT00955409|7326704|FG006|Treated|Overall Study||27
6413234|NCT00955409|7326705|FG007|Treated|Overall Study||6
6413235|NCT00955409|7326706|FG008|Treated|Overall Study||16
6413236|NCT00955409|7326707|FG009|Treated|Overall Study||4
6413237|NCT00955409|7326698|FG000|Completed Treatment|Overall Study||12
6413238|NCT00955409|7326699|FG001|Completed Treatment|Overall Study||5
6413239|NCT00955409|7326700|FG002|Completed Treatment|Overall Study||15
6413240|NCT00955409|7326701|FG003|Completed Treatment|Overall Study||17
6413241|NCT00955409|7326702|FG004|Completed Treatment|Overall Study||3
6413242|NCT00955409|7326703|FG005|Completed Treatment|Overall Study||7
6413243|NCT00955409|7326704|FG006|Completed Treatment|Overall Study||4
6413244|NCT00955409|7326705|FG007|Completed Treatment|Overall Study||3
6413245|NCT00955409|7326706|FG008|Completed Treatment|Overall Study||2
6413246|NCT00955409|7326707|FG009|Completed Treatment|Overall Study||4
6413247|NCT00955409|7326698|FG000|COMPLETED|Overall Study|Completed study|11
6413248|NCT00955409|7326699|FG001|COMPLETED|Overall Study|Completed study|5
6413249|NCT00955409|7326700|FG002|COMPLETED|Overall Study|Completed study|15
6413250|NCT00955409|7326701|FG003|COMPLETED|Overall Study|Completed study|17
6413251|NCT00955409|7326702|FG004|COMPLETED|Overall Study|Completed study|3
6413252|NCT00955409|7326703|FG005|COMPLETED|Overall Study|Completed study|6
6413253|NCT00955409|7326704|FG006|COMPLETED|Overall Study|Completed study|3
6637612|NCT02319369|7566388|FG003|COMPLETED|Overall Study||8
6637613|NCT02319369|7566389|FG004|COMPLETED|Overall Study||5
6637614|NCT02319369|7566390|FG005|COMPLETED|Overall Study||7
6637615|NCT02319369|7566391|FG006|COMPLETED|Overall Study||3
6637616|NCT02319369|7566392|FG007|COMPLETED|Overall Study||6
6637617|NCT02319369|7566393|FG008|COMPLETED|Overall Study||4
6637618|NCT02319369|7566394|FG009|COMPLETED|Overall Study||9
6637619|NCT02319369|7566395|FG010|COMPLETED|Overall Study||3
6637620|NCT02319369|7566396|FG011|COMPLETED|Overall Study||4
6637621|NCT02319369|7566397|FG012|COMPLETED|Overall Study||1
6637622|NCT02319369|7566385|FG000|NOT COMPLETED|Overall Study||0
6637623|NCT02319369|7566386|FG001|NOT COMPLETED|Overall Study||0
6637624|NCT02319369|7566387|FG002|NOT COMPLETED|Overall Study||0
6637625|NCT02319369|7566388|FG003|NOT COMPLETED|Overall Study||0
6637626|NCT02319369|7566389|FG004|NOT COMPLETED|Overall Study||0
6637627|NCT02319369|7566390|FG005|NOT COMPLETED|Overall Study||0
6637628|NCT02319369|7566391|FG006|NOT COMPLETED|Overall Study||0
6637629|NCT02319369|7566392|FG007|NOT COMPLETED|Overall Study||0
6637630|NCT02319369|7566393|FG008|NOT COMPLETED|Overall Study||0
6637631|NCT02319369|7566394|FG009|NOT COMPLETED|Overall Study||0
6637632|NCT02319369|7566395|FG010|NOT COMPLETED|Overall Study||0
6637633|NCT02319369|7566396|FG011|NOT COMPLETED|Overall Study||0
6637634|NCT02319369|7566397|FG012|NOT COMPLETED|Overall Study||0
6637635|NCT02319486|7566435|FG000|STARTED|Overall Study||26
6637636|NCT02319486|7566435|FG000|COMPLETED|Overall Study||26
6637637|NCT02319486|7566435|FG000|NOT COMPLETED|Overall Study||0
6637638|NCT02319525|7566443|FG000|STARTED|Overall Study||153
6637639|NCT02319525|7566444|FG001|STARTED|Overall Study||148
6637640|NCT02319525|7566443|FG000|Primary Research Completion|Overall Study||151
6637641|NCT02319525|7566444|FG001|Primary Research Completion|Overall Study||147
6637642|NCT02319525|7566443|FG000|COMPLETED|Overall Study||151
6637643|NCT02319525|7566444|FG001|COMPLETED|Overall Study||147
6637644|NCT02319525|7566443|FG000|NOT COMPLETED|Overall Study||2
6637645|NCT02319525|7566444|FG001|NOT COMPLETED|Overall Study||1
6637646|NCT02319642|7566452|FG000|STARTED|Overall Study||95
6637647|NCT02319642|7566453|FG001|STARTED|Overall Study||251
6637648|NCT02319642|7566452|FG000|COMPLETED|Overall Study||91
6637649|NCT02319642|7566453|FG001|COMPLETED|Overall Study||245
6637650|NCT02319642|7566452|FG000|NOT COMPLETED|Overall Study||4
6637651|NCT02319642|7566453|FG001|NOT COMPLETED|Overall Study||6
6637652|NCT02319668|7566463|FG000|STARTED|Overall Study||19
6637653|NCT02319668|7566464|FG001|STARTED|Overall Study||19
6637654|NCT02319668|7566463|FG000|COMPLETED|Overall Study||19
6637655|NCT02319668|7566464|FG001|COMPLETED|Overall Study||17
6637656|NCT02319668|7566463|FG000|NOT COMPLETED|Overall Study||0
6637657|NCT02319668|7566464|FG001|NOT COMPLETED|Overall Study||2
6637658|NCT02319759|7566475|FG000|STARTED|Week 0 - 16||49
6637659|NCT02319759|7566476|FG001|STARTED|Week 0 - 16||0
6637660|NCT02319759|7566477|FG002|STARTED|Week 0 - 16||100
6637661|NCT02319759|7566478|FG003|STARTED|Week 0 - 16||0
6637662|NCT02319759|7566479|FG004|STARTED|Week 0 - 16||0
6637663|NCT02319759|7566475|FG000|COMPLETED|Week 0 - 16||48
6637664|NCT02319759|7566476|FG001|COMPLETED|Week 0 - 16||0
6637665|NCT02319759|7566477|FG002|COMPLETED|Week 0 - 16||99
6637666|NCT02319759|7566478|FG003|COMPLETED|Week 0 - 16||0
6637667|NCT02319759|7566479|FG004|COMPLETED|Week 0 - 16||0
6637668|NCT02319759|7566475|FG000|NOT COMPLETED|Week 0 - 16||1
6637669|NCT02319759|7566476|FG001|NOT COMPLETED|Week 0 - 16||0
6637670|NCT02319759|7566477|FG002|NOT COMPLETED|Week 0 - 16||1
6637671|NCT02319759|7566478|FG003|NOT COMPLETED|Week 0 - 16||0
6637672|NCT02319759|7566479|FG004|NOT COMPLETED|Week 0 - 16||0
6413254|NCT00955409|7326705|FG007|COMPLETED|Overall Study|Completed study|2
6413255|NCT00955409|7326706|FG008|COMPLETED|Overall Study|Completed study|2
6413256|NCT00955409|7326707|FG009|COMPLETED|Overall Study|Completed study|3
6413257|NCT00955409|7326698|FG000|NOT COMPLETED|Overall Study||10
6637673|NCT02319759|7566475|FG000|STARTED|Week 16 - 24||31
6413258|NCT00955409|7326699|FG001|NOT COMPLETED|Overall Study||1
6413259|NCT00955409|7326700|FG002|NOT COMPLETED|Overall Study||26
6413260|NCT00955409|7326701|FG003|NOT COMPLETED|Overall Study||8
6413261|NCT00955409|7326702|FG004|NOT COMPLETED|Overall Study||2
6413262|NCT00955409|7326703|FG005|NOT COMPLETED|Overall Study||3
6413263|NCT00955409|7326704|FG006|NOT COMPLETED|Overall Study||24
6413264|NCT00955409|7326705|FG007|NOT COMPLETED|Overall Study||4
6413265|NCT00955409|7326706|FG008|NOT COMPLETED|Overall Study||14
6413266|NCT00955409|7326707|FG009|NOT COMPLETED|Overall Study||1
6413267|NCT00955474|7326735|FG000|STARTED|Overall Study||12
6413268|NCT00955474|7326736|FG001|STARTED|Overall Study||13
6413269|NCT00955474|7326735|FG000|COMPLETED|Overall Study||5
6413270|NCT00955474|7326736|FG001|COMPLETED|Overall Study||8
6413271|NCT00955474|7326735|FG000|NOT COMPLETED|Overall Study||7
6413272|NCT00955474|7326736|FG001|NOT COMPLETED|Overall Study||5
6413273|NCT00955487|7326746|FG000|STARTED|Overall Study||10
6413274|NCT00955487|7326747|FG001|STARTED|Overall Study||9
6413275|NCT00955487|7326748|FG002|STARTED|Overall Study||17
6413276|NCT00955487|7326749|FG003|STARTED|Overall Study||21
6413277|NCT00955487|7326750|FG004|STARTED|Overall Study||32
6637674|NCT02319759|7566476|FG001|STARTED|Week 16 - 24||0
6637675|NCT02319759|7566477|FG002|STARTED|Week 16 - 24||89
6637676|NCT02319759|7566478|FG003|STARTED|Week 16 - 24||17
6637677|NCT02319759|7566479|FG004|STARTED|Week 16 - 24||10
6637678|NCT02319759|7566475|FG000|COMPLETED|Week 16 - 24||29
6637679|NCT02319759|7566476|FG001|COMPLETED|Week 16 - 24||0
6637680|NCT02319759|7566477|FG002|COMPLETED|Week 16 - 24||86
6637681|NCT02319759|7566478|FG003|COMPLETED|Week 16 - 24||17
6637682|NCT02319759|7566479|FG004|COMPLETED|Week 16 - 24||10
6637683|NCT02319759|7566475|FG000|NOT COMPLETED|Week 16 - 24||2
6637684|NCT02319759|7566476|FG001|NOT COMPLETED|Week 16 - 24||0
6637685|NCT02319759|7566477|FG002|NOT COMPLETED|Week 16 - 24||3
6637686|NCT02319759|7566478|FG003|NOT COMPLETED|Week 16 - 24||0
6637687|NCT02319759|7566479|FG004|NOT COMPLETED|Week 16 - 24||0
6637688|NCT02319759|7566475|FG000|STARTED|Week 24 - 56||0
6637689|NCT02319759|7566476|FG001|STARTED|Week 24 - 56||29
6637690|NCT02319759|7566477|FG002|STARTED|Week 24 - 56||86
6637691|NCT02319759|7566478|FG003|STARTED|Week 24 - 56||17
6637692|NCT02319759|7566479|FG004|STARTED|Week 24 - 56||10
6637693|NCT02319759|7566475|FG000|COMPLETED|Week 24 - 56||0
6637694|NCT02319759|7566476|FG001|COMPLETED|Week 24 - 56||28
6637695|NCT02319759|7566477|FG002|COMPLETED|Week 24 - 56||84
6637696|NCT02319759|7566478|FG003|COMPLETED|Week 24 - 56||15
6637697|NCT02319759|7566479|FG004|COMPLETED|Week 24 - 56||8
6637698|NCT02319759|7566475|FG000|NOT COMPLETED|Week 24 - 56||0
6637699|NCT02319759|7566476|FG001|NOT COMPLETED|Week 24 - 56||1
6637700|NCT02319759|7566477|FG002|NOT COMPLETED|Week 24 - 56||2
6637701|NCT02319759|7566478|FG003|NOT COMPLETED|Week 24 - 56||2
6637702|NCT02319759|7566479|FG004|NOT COMPLETED|Week 24 - 56||2
6637703|NCT02319824|7566492|FG000|STARTED|Overall Study||2
6637704|NCT02319824|7566492|FG000|COMPLETED|Overall Study||2
6637705|NCT02319824|7566492|FG000|NOT COMPLETED|Overall Study||0
6637706|NCT02319967|7566500|FG000|STARTED|Overall Study||126
6637707|NCT02319967|7566501|FG001|STARTED|Overall Study||126
6637708|NCT02319967|7566502|FG002|STARTED|Overall Study||121
6637709|NCT02319967|7566500|FG000|COMPLETED|Overall Study||78
6637710|NCT02319967|7566501|FG001|COMPLETED|Overall Study||82
6637711|NCT02319967|7566502|FG002|COMPLETED|Overall Study||76
6637712|NCT02319967|7566500|FG000|NOT COMPLETED|Overall Study||48
6637713|NCT02319967|7566501|FG001|NOT COMPLETED|Overall Study||44
6637714|NCT02319967|7566502|FG002|NOT COMPLETED|Overall Study||45
6637715|NCT02320058|7566512|FG000|STARTED|Overall Study||101
6637716|NCT02320058|7566513|FG001|STARTED|Overall Study||18
6637717|NCT02320058|7566512|FG000|COMPLETED|Overall Study||59
6637718|NCT02320058|7566513|FG001|COMPLETED|Overall Study||5
6637719|NCT02320058|7566512|FG000|NOT COMPLETED|Overall Study||42
6637720|NCT02320058|7566513|FG001|NOT COMPLETED|Overall Study||13
6637721|NCT02320123|7566521|FG000|STARTED|Overall Study||10
6637722|NCT02320123|7566522|FG001|STARTED|Overall Study||12
6637723|NCT02320123|7566521|FG000|COMPLETED|Overall Study||0
6637724|NCT02320123|7566522|FG001|COMPLETED|Overall Study||1
6637725|NCT02320123|7566521|FG000|NOT COMPLETED|Overall Study||10
6637726|NCT02320123|7566522|FG001|NOT COMPLETED|Overall Study||11
6637727|NCT02320149|7566534|FG000|STARTED|Overall Study||483
6637728|NCT02320149|7566535|FG001|STARTED|Overall Study||485
6637729|NCT02320149|7566534|FG000|COMPLETED|Overall Study||420
6413278|NCT00955487|7326751|FG005|STARTED|Overall Study||35
6413279|NCT00955487|7326746|FG000|COMPLETED|Overall Study||10
6413280|NCT00955487|7326747|FG001|COMPLETED|Overall Study||9
6413281|NCT00955487|7326748|FG002|COMPLETED|Overall Study||17
6413282|NCT00955487|7326749|FG003|COMPLETED|Overall Study||21
6413283|NCT00955487|7326750|FG004|COMPLETED|Overall Study||32
6413284|NCT00955487|7326751|FG005|COMPLETED|Overall Study||35
6413285|NCT00955487|7326746|FG000|NOT COMPLETED|Overall Study||0
6413286|NCT00955487|7326747|FG001|NOT COMPLETED|Overall Study||0
6637730|NCT02320149|7566535|FG001|COMPLETED|Overall Study||405
6637731|NCT02320149|7566534|FG000|NOT COMPLETED|Overall Study||63
6637732|NCT02320149|7566535|FG001|NOT COMPLETED|Overall Study||80
6637733|NCT02320175|7566543|FG000|STARTED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
6637734|NCT02320175|7566544|FG001|STARTED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
6637735|NCT02320175|7566543|FG000|COMPLETED|Overall Study|Patients (n=1574); Parents (n=1222); Physicians (n=478); Nurses (n=264).|3538
6413287|NCT00955487|7326748|FG002|NOT COMPLETED|Overall Study||0
6413288|NCT00955487|7326749|FG003|NOT COMPLETED|Overall Study||0
6413289|NCT00955487|7326750|FG004|NOT COMPLETED|Overall Study||0
6413290|NCT00955487|7326751|FG005|NOT COMPLETED|Overall Study||0
6413291|NCT00955513|7326766|FG000|STARTED|Overall Study||80
6413292|NCT00955513|7326767|FG001|STARTED|Overall Study||80
6413293|NCT00955513|7326768|FG002|STARTED|Overall Study||82
6413294|NCT00955513|7326766|FG000|COMPLETED|Overall Study||79
6413295|NCT00955513|7326767|FG001|COMPLETED|Overall Study||78
6413296|NCT00955513|7326768|FG002|COMPLETED|Overall Study||79
6413297|NCT00955513|7326766|FG000|NOT COMPLETED|Overall Study||1
6413298|NCT00955513|7326767|FG001|NOT COMPLETED|Overall Study||2
6413299|NCT00955513|7326768|FG002|NOT COMPLETED|Overall Study||3
6413300|NCT00955617|7326776|FG000|STARTED|First MRA (Between Day0 and Day21)||10
6413301|NCT00955617|7326777|FG001|STARTED|First MRA (Between Day0 and Day21)||10
6413302|NCT00955617|7326776|FG000|COMPLETED|First MRA (Between Day0 and Day21)||10
6413303|NCT00955617|7326777|FG001|COMPLETED|First MRA (Between Day0 and Day21)||10
6413304|NCT00955617|7326776|FG000|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
6413305|NCT00955617|7326777|FG001|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
6413306|NCT00955617|7326776|FG000|STARTED|Second MRA (Between Day 1 and Day 51)||10
6413307|NCT00955617|7326777|FG001|STARTED|Second MRA (Between Day 1 and Day 51)||10
6413308|NCT00955617|7326776|FG000|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
6413309|NCT00955617|7326777|FG001|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
6413310|NCT00955617|7326776|FG000|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
6413311|NCT00955617|7326777|FG001|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
6413312|NCT00955682|7326785|FG000|STARTED|Year 2 Period||253
6413313|NCT00955682|7326786|FG001|STARTED|Year 2 Period||42
6413314|NCT00955682|7326785|FG000|COMPLETED|Year 2 Period||253
6413315|NCT00955682|7326786|FG001|COMPLETED|Year 2 Period||42
6413316|NCT00955682|7326785|FG000|NOT COMPLETED|Year 2 Period||0
6413317|NCT00955682|7326786|FG001|NOT COMPLETED|Year 2 Period||0
6413318|NCT00955682|7326785|FG000|STARTED|Year 3 Period||273
6413319|NCT00955682|7326786|FG001|STARTED|Year 3 Period||47
6413320|NCT00955682|7326785|FG000|COMPLETED|Year 3 Period||273
6413321|NCT00955682|7326786|FG001|COMPLETED|Year 3 Period||47
6413322|NCT00955682|7326785|FG000|NOT COMPLETED|Year 3 Period||0
6413323|NCT00955682|7326786|FG001|NOT COMPLETED|Year 3 Period||0
6413324|NCT00955682|7326785|FG000|STARTED|Year 4 Period||246
6413325|NCT00955682|7326786|FG001|STARTED|Year 4 Period||48
6413326|NCT00955682|7326785|FG000|COMPLETED|Year 4 Period||246
6413327|NCT00955682|7326786|FG001|COMPLETED|Year 4 Period||48
6413328|NCT00955682|7326785|FG000|NOT COMPLETED|Year 4 Period||0
6413329|NCT00955682|7326786|FG001|NOT COMPLETED|Year 4 Period||0
6413330|NCT00955682|7326785|FG000|STARTED|Booster Period (Month 48- 49)||245
6413331|NCT00955682|7326786|FG001|STARTED|Booster Period (Month 48- 49)||48
6413332|NCT00955682|7326785|FG000|COMPLETED|Booster Period (Month 48- 49)||244
6413333|NCT00955682|7326786|FG001|COMPLETED|Booster Period (Month 48- 49)||47
6413334|NCT00955682|7326785|FG000|NOT COMPLETED|Booster Period (Month 48- 49)||1
6413335|NCT00955682|7326786|FG001|NOT COMPLETED|Booster Period (Month 48- 49)||1
6413336|NCT00955682|7326785|FG000|STARTED|Year 5 Period||239
6413337|NCT00955682|7326786|FG001|STARTED|Year 5 Period||47
6413338|NCT00955682|7326785|FG000|COMPLETED|Year 5 Period||239
6413339|NCT00955682|7326786|FG001|COMPLETED|Year 5 Period||47
6413340|NCT00955682|7326785|FG000|NOT COMPLETED|Year 5 Period||0
6413341|NCT00955682|7326786|FG001|NOT COMPLETED|Year 5 Period||0
6413342|NCT00955708|7326800|FG000|STARTED|Overall Study||1308
6413343|NCT00955708|7326800|FG000|COMPLETED|Overall Study||250
6413344|NCT00955708|7326800|FG000|NOT COMPLETED|Overall Study||1058
6413345|NCT00955721|7326806|FG000|STARTED|Overall Study||9
6413346|NCT00955721|7326807|FG001|STARTED|Overall Study||0
6413347|NCT00955721|7326806|FG000|COMPLETED|Overall Study||6
6413348|NCT00955721|7326807|FG001|COMPLETED|Overall Study||0
6413349|NCT00955721|7326806|FG000|NOT COMPLETED|Overall Study||3
6413350|NCT00955721|7326807|FG001|NOT COMPLETED|Overall Study||0
6413351|NCT00955747|7326816|FG000|STARTED|Overall Study||253
6413352|NCT00955747|7326817|FG001|STARTED|Overall Study||241
6413353|NCT00955747|7326816|FG000|COMPLETED|Overall Study||184
6413354|NCT00955747|7326817|FG001|COMPLETED|Overall Study||172
6413355|NCT00955747|7326816|FG000|NOT COMPLETED|Overall Study||69
6413356|NCT00955747|7326817|FG001|NOT COMPLETED|Overall Study||69
6413357|NCT00955825|7326825|FG000|STARTED|Overall Study||233
6413358|NCT00955825|7326826|FG001|STARTED|Overall Study||240
6413359|NCT00955825|7326825|FG000|COMPLETED|Overall Study||207
6413360|NCT00955825|7326826|FG001|COMPLETED|Overall Study||223
6413361|NCT00955825|7326825|FG000|NOT COMPLETED|Overall Study||26
6413362|NCT00955825|7326826|FG001|NOT COMPLETED|Overall Study||17
6413363|NCT00955877|7326835|FG000|STARTED|Overall Study|Drug manufacturer ceased producing the drug prior to completion of 10 enrolled in this arm.|6
6413364|NCT00955877|7326836|FG001|STARTED|Overall Study|No patients were enrolled because analysis of previous arm wasn't completed.|0
6413365|NCT00955877|7326837|FG002|STARTED|Overall Study||7
6413366|NCT00955877|7326835|FG000|COMPLETED|Overall Study||6
6413367|NCT00955877|7326836|FG001|COMPLETED|Overall Study||0
6413368|NCT00955877|7326837|FG002|COMPLETED|Overall Study||7
6413369|NCT00955877|7326835|FG000|NOT COMPLETED|Overall Study||0
6413370|NCT00955877|7326836|FG001|NOT COMPLETED|Overall Study||0
6413371|NCT00955877|7326837|FG002|NOT COMPLETED|Overall Study||0
6413372|NCT00955903|7326848|FG000|STARTED|Overall Study||55
6413373|NCT00955903|7326849|FG001|STARTED|Overall Study||54
6413374|NCT00955903|7326850|FG002|STARTED|Overall Study||55
6413375|NCT00955903|7326848|FG000|COMPLETED|Overall Study||49
6413376|NCT00955903|7326849|FG001|COMPLETED|Overall Study||51
6413377|NCT00955903|7326850|FG002|COMPLETED|Overall Study||48
6413378|NCT00955903|7326848|FG000|NOT COMPLETED|Overall Study||6
6413379|NCT00955903|7326849|FG001|NOT COMPLETED|Overall Study||3
6413380|NCT00955903|7326850|FG002|NOT COMPLETED|Overall Study||7
6413381|NCT00955916|7326858|FG000|STARTED|Overall Study||38
6413382|NCT00955916|7326858|FG000|COMPLETED|Overall Study||38
6413383|NCT00955916|7326858|FG000|NOT COMPLETED|Overall Study||0
6413384|NCT00955955|7326865|FG000|STARTED|Overall Study||19
6413385|NCT00955955|7326866|FG001|STARTED|Overall Study||28
6413386|NCT00955955|7326867|FG002|STARTED|Overall Study||28
6413387|NCT00955955|7326865|FG000|COMPLETED|Overall Study||17
6413388|NCT00955955|7326866|FG001|COMPLETED|Overall Study||28
6413389|NCT00955955|7326867|FG002|COMPLETED|Overall Study||28
6637736|NCT02320175|7566544|FG001|COMPLETED|Overall Study|Patients (n=1532); Parents (n=926); Physicians (n=311); Nurses (n=171).|2940
6637737|NCT02320175|7566543|FG000|NOT COMPLETED|Overall Study||0
6637738|NCT02320175|7566544|FG001|NOT COMPLETED|Overall Study||0
6637739|NCT02320214|7566553|FG000|STARTED|Overall Study||30
6637740|NCT02320214|7566553|FG000|COMPLETED|Overall Study||30
6637741|NCT02320214|7566553|FG000|NOT COMPLETED|Overall Study||0
6637742|NCT02320227|7566557|FG000|STARTED|Overall Study||30
6637743|NCT02320227|7566557|FG000|COMPLETED|Overall Study||30
6637744|NCT02320227|7566557|FG000|NOT COMPLETED|Overall Study||0
6637745|NCT02320253|7566565|FG000|STARTED|Overall Study||69
6743467|NCT03334721|7671691|FG000|NOT COMPLETED|Overall Study||2
6743468|NCT03334721|7671692|FG001|NOT COMPLETED|Overall Study||0
6743469|NCT03334734|7671702|FG000|STARTED|Overall Study||4
6743470|NCT03334734|7671703|FG001|STARTED|Overall Study||4
6743471|NCT03334734|7671704|FG002|STARTED|Overall Study||7
6743472|NCT03334734|7671705|FG003|STARTED|Overall Study||1
6743473|NCT03334734|7671702|FG000|COMPLETED|Overall Study||4
6743474|NCT03334734|7671703|FG001|COMPLETED|Overall Study||4
6743475|NCT03334734|7671704|FG002|COMPLETED|Overall Study||5
6743476|NCT03334734|7671705|FG003|COMPLETED|Overall Study||1
6743477|NCT03334734|7671702|FG000|NOT COMPLETED|Overall Study||0
6743478|NCT03334734|7671703|FG001|NOT COMPLETED|Overall Study||0
6743479|NCT03334734|7671704|FG002|NOT COMPLETED|Overall Study||2
6743480|NCT03334734|7671705|FG003|NOT COMPLETED|Overall Study||0
6743481|NCT03334747|7671724|FG000|STARTED|Treatment Phase||10
6743482|NCT03334747|7671725|FG001|STARTED|Treatment Phase||10
6743483|NCT03334747|7671726|FG002|STARTED|Treatment Phase||12
6743484|NCT03334747|7671727|FG003|STARTED|Treatment Phase||20
6743485|NCT03334747|7671728|FG004|STARTED|Treatment Phase||22
6743486|NCT03334747|7671729|FG005|STARTED|Treatment Phase||20
6743487|NCT03334747|7671730|FG006|STARTED|Treatment Phase||21
6743488|NCT03334747|7671731|FG007|STARTED|Treatment Phase||22
6743489|NCT03334747|7671732|FG008|STARTED|Treatment Phase||51
6743490|NCT03334747|7671724|FG000|COMPLETED|Treatment Phase||9
6743491|NCT03334747|7671725|FG001|COMPLETED|Treatment Phase||10
6743492|NCT03334747|7671726|FG002|COMPLETED|Treatment Phase||12
6743493|NCT03334747|7671727|FG003|COMPLETED|Treatment Phase||20
6743494|NCT03334747|7671728|FG004|COMPLETED|Treatment Phase||21
6743495|NCT03334747|7671729|FG005|COMPLETED|Treatment Phase||19
6743496|NCT03334747|7671730|FG006|COMPLETED|Treatment Phase||21
6743497|NCT03334747|7671731|FG007|COMPLETED|Treatment Phase||22
6743498|NCT03334747|7671732|FG008|COMPLETED|Treatment Phase||51
6743499|NCT03334747|7671724|FG000|NOT COMPLETED|Treatment Phase||1
6743500|NCT03334747|7671725|FG001|NOT COMPLETED|Treatment Phase||0
6743501|NCT03334747|7671726|FG002|NOT COMPLETED|Treatment Phase||0
6743502|NCT03334747|7671727|FG003|NOT COMPLETED|Treatment Phase||0
6743503|NCT03334747|7671728|FG004|NOT COMPLETED|Treatment Phase||1
6743504|NCT03334747|7671729|FG005|NOT COMPLETED|Treatment Phase||1
6743505|NCT03334747|7671730|FG006|NOT COMPLETED|Treatment Phase||0
6743506|NCT03334747|7671731|FG007|NOT COMPLETED|Treatment Phase||0
6743507|NCT03334747|7671732|FG008|NOT COMPLETED|Treatment Phase||0
6743508|NCT03334747|7671724|FG000|STARTED|Follow-Up Phase||9
6743509|NCT03334747|7671725|FG001|STARTED|Follow-Up Phase||10
6743510|NCT03334747|7671726|FG002|STARTED|Follow-Up Phase||12
6743511|NCT03334747|7671727|FG003|STARTED|Follow-Up Phase||20
6743512|NCT03334747|7671728|FG004|STARTED|Follow-Up Phase||21
6743513|NCT03334747|7671729|FG005|STARTED|Follow-Up Phase||19
6413390|NCT00955955|7326865|FG000|NOT COMPLETED|Overall Study||2
6413391|NCT00955955|7326866|FG001|NOT COMPLETED|Overall Study||0
6413392|NCT00955955|7326867|FG002|NOT COMPLETED|Overall Study||0
6413393|NCT00955968|7326883|FG000|STARTED|Overall Study||828
6413394|NCT00955968|7326884|FG001|STARTED|Overall Study||825
6413395|NCT00955968|7326883|FG000|COMPLETED|Overall Study||691
6413396|NCT00955968|7326884|FG001|COMPLETED|Overall Study||699
6413397|NCT00955968|7326883|FG000|NOT COMPLETED|Overall Study||137
6413398|NCT00955968|7326884|FG001|NOT COMPLETED|Overall Study||126
6743514|NCT03334747|7671730|FG006|STARTED|Follow-Up Phase||21
6743515|NCT03334747|7671731|FG007|STARTED|Follow-Up Phase||22
6743516|NCT03334747|7671732|FG008|STARTED|Follow-Up Phase||51
6413399|NCT00956020|7326893|FG000|STARTED|Overall Study||4
6413400|NCT00956020|7326893|FG000|COMPLETED|Overall Study||4
6743517|NCT03334747|7671724|FG000|COMPLETED|Follow-Up Phase||9
6743518|NCT03334747|7671725|FG001|COMPLETED|Follow-Up Phase||10
6743519|NCT03334747|7671726|FG002|COMPLETED|Follow-Up Phase||12
6743520|NCT03334747|7671727|FG003|COMPLETED|Follow-Up Phase||20
6743521|NCT03334747|7671728|FG004|COMPLETED|Follow-Up Phase||21
6413401|NCT00956020|7326893|FG000|NOT COMPLETED|Overall Study||0
6413402|NCT00956085|7326906|FG000|STARTED|Overall Study||12
6413403|NCT00956085|7326906|FG000|COMPLETED|Overall Study||12
6413404|NCT00956085|7326906|FG000|NOT COMPLETED|Overall Study||0
6413405|NCT00956254|7326910|FG000|STARTED|Overall Study||18
6413406|NCT00956254|7326910|FG000|COMPLETED|Overall Study||18
6413407|NCT00956254|7326910|FG000|NOT COMPLETED|Overall Study||0
6413408|NCT00956293|7326918|FG000|STARTED|Main Period (Pre-randomization)||0
6413409|NCT00956293|7326919|FG001|STARTED|Main Period (Pre-randomization)||0
6413410|NCT00956293|7326920|FG002|STARTED|Main Period (Pre-randomization)||207
6413411|NCT00956293|7326918|FG000|Enrolled Safety Set|Main Period (Pre-randomization)||0
6413412|NCT00956293|7326919|FG001|Enrolled Safety Set|Main Period (Pre-randomization)||0
6413413|NCT00956293|7326920|FG002|Enrolled Safety Set|Main Period (Pre-randomization)||203
6637746|NCT02320253|7566566|FG001|STARTED|Overall Study||70
6637747|NCT02320253|7566567|FG002|STARTED|Overall Study||72
6637748|NCT02320253|7566565|FG000|COMPLETED|Overall Study||63
6637749|NCT02320253|7566566|FG001|COMPLETED|Overall Study||68
6637750|NCT02320253|7566567|FG002|COMPLETED|Overall Study||70
6637751|NCT02320253|7566565|FG000|NOT COMPLETED|Overall Study||6
6637752|NCT02320253|7566566|FG001|NOT COMPLETED|Overall Study||2
6413414|NCT00956293|7326918|FG000|COMPLETED|Main Period (Pre-randomization)||0
6413415|NCT00956293|7326919|FG001|COMPLETED|Main Period (Pre-randomization)||0
6413416|NCT00956293|7326920|FG002|COMPLETED|Main Period (Pre-randomization)||77
6413417|NCT00956293|7326918|FG000|NOT COMPLETED|Main Period (Pre-randomization)||0
6413418|NCT00956293|7326919|FG001|NOT COMPLETED|Main Period (Pre-randomization)||0
6413419|NCT00956293|7326920|FG002|NOT COMPLETED|Main Period (Pre-randomization)||130
6413420|NCT00956293|7326918|FG000|STARTED|Main Period (Randomization)||24
6413421|NCT00956293|7326919|FG001|STARTED|Main Period (Randomization)||53
6413422|NCT00956293|7326920|FG002|STARTED|Main Period (Randomization)||0
6413423|NCT00956293|7326918|FG000|Full Analysis Set|Main Period (Randomization)||24
6413424|NCT00956293|7326919|FG001|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
6413425|NCT00956293|7326920|FG002|Full Analysis Set|Main Period (Randomization)||0
6413426|NCT00956293|7326918|FG000|Randomized Safety Set|Main Period (Randomization)||24
6413427|NCT00956293|7326919|FG001|Randomized Safety Set|Main Period (Randomization)||51
6413428|NCT00956293|7326920|FG002|Randomized Safety Set|Main Period (Randomization)||0
6413429|NCT00956293|7326918|FG000|COMPLETED|Main Period (Randomization)||23
6413430|NCT00956293|7326919|FG001|COMPLETED|Main Period (Randomization)||26
6413431|NCT00956293|7326920|FG002|COMPLETED|Main Period (Randomization)||0
6413432|NCT00956293|7326918|FG000|NOT COMPLETED|Main Period (Randomization)||1
6413433|NCT00956293|7326919|FG001|NOT COMPLETED|Main Period (Randomization)||27
6413434|NCT00956293|7326920|FG002|NOT COMPLETED|Main Period (Randomization)||0
6413435|NCT00956293|7326918|FG000|STARTED|Follow-up Period||20
6413436|NCT00956293|7326919|FG001|STARTED|Follow-up Period||32
6413437|NCT00956293|7326920|FG002|STARTED|Follow-up Period||0
6413438|NCT00956293|7326918|FG000|COMPLETED|Follow-up Period||0
6413439|NCT00956293|7326919|FG001|COMPLETED|Follow-up Period||0
6413440|NCT00956293|7326920|FG002|COMPLETED|Follow-up Period||0
6413441|NCT00956293|7326918|FG000|NOT COMPLETED|Follow-up Period||20
6413442|NCT00956293|7326919|FG001|NOT COMPLETED|Follow-up Period||32
6413443|NCT00956293|7326920|FG002|NOT COMPLETED|Follow-up Period||0
6413444|NCT00956540|7326930|FG000|STARTED|Overall Study||54
6413445|NCT00956540|7326931|FG001|STARTED|Overall Study||50
6413446|NCT00956540|7326932|FG002|STARTED|Overall Study||46
6413447|NCT00956540|7326933|FG003|STARTED|Overall Study||45
6413448|NCT00956540|7326930|FG000|COMPLETED|Overall Study||51
6413449|NCT00956540|7326931|FG001|COMPLETED|Overall Study||46
6413450|NCT00956540|7326932|FG002|COMPLETED|Overall Study||43
6413451|NCT00956540|7326933|FG003|COMPLETED|Overall Study||41
6413452|NCT00956540|7326930|FG000|NOT COMPLETED|Overall Study||3
6413453|NCT00956540|7326931|FG001|NOT COMPLETED|Overall Study||4
6413454|NCT00956540|7326932|FG002|NOT COMPLETED|Overall Study||3
6413455|NCT00956540|7326933|FG003|NOT COMPLETED|Overall Study||4
6413456|NCT00956592|7326945|FG000|STARTED|Overall Study||150
6413457|NCT00956592|7326946|FG001|STARTED|Overall Study||150
6413458|NCT00956592|7326945|FG000|COMPLETED|Overall Study||149
6413459|NCT00956592|7326946|FG001|COMPLETED|Overall Study||147
6413460|NCT00956592|7326945|FG000|NOT COMPLETED|Overall Study||1
6413461|NCT00956592|7326946|FG001|NOT COMPLETED|Overall Study||3
6413462|NCT00956631|7326954|FG000|STARTED|Overall Study||78
6413463|NCT00956631|7326954|FG000|COMPLETED|Overall Study||62
6413464|NCT00956631|7326954|FG000|NOT COMPLETED|Overall Study||16
6413465|NCT00956657|7326962|FG000|STARTED|Overall Study||18
6413466|NCT00956657|7326963|FG001|STARTED|Overall Study||13
6413467|NCT00956657|7326962|FG000|COMPLETED|Overall Study||18
6413468|NCT00956657|7326963|FG001|COMPLETED|Overall Study||13
6413469|NCT00956657|7326962|FG000|NOT COMPLETED|Overall Study||0
6413470|NCT00956657|7326963|FG001|NOT COMPLETED|Overall Study||0
6413471|NCT00956709|7326971|FG000|STARTED|Overall Study||16
6413472|NCT00956709|7326972|FG001|STARTED|Overall Study||19
6413473|NCT00956709|7326971|FG000|COMPLETED|Overall Study||16
6413474|NCT00956709|7326972|FG001|COMPLETED|Overall Study||19
6413475|NCT00956709|7326971|FG000|NOT COMPLETED|Overall Study||0
6413476|NCT00956709|7326972|FG001|NOT COMPLETED|Overall Study||0
6413477|NCT00956761|7326978|FG000|STARTED|Overall Study||63
6413478|NCT00956761|7326978|FG000|COMPLETED|Overall Study||63
6413479|NCT00956761|7326978|FG000|NOT COMPLETED|Overall Study||0
6637753|NCT02320253|7566567|FG002|NOT COMPLETED|Overall Study||2
6413480|NCT00956813|7326985|FG000|STARTED|Flaxseed and Placebo||105
6413481|NCT00956813|7326986|FG001|STARTED|Flaxseed and Placebo||105
6413482|NCT00956813|7326985|FG000|COMPLETED|Flaxseed and Placebo||97
6413483|NCT00956813|7326986|FG001|COMPLETED|Flaxseed and Placebo||100
6413484|NCT00956813|7326985|FG000|NOT COMPLETED|Flaxseed and Placebo||8
6413485|NCT00956813|7326986|FG001|NOT COMPLETED|Flaxseed and Placebo||5
6413486|NCT00956813|7326985|FG000|STARTED|Continuation Phase||80
6413487|NCT00956813|7326986|FG001|STARTED|Continuation Phase||0
6413488|NCT00956813|7326985|FG000|COMPLETED|Continuation Phase||80
6413489|NCT00956813|7326986|FG001|COMPLETED|Continuation Phase||0
6413490|NCT00956813|7326985|FG000|NOT COMPLETED|Continuation Phase||0
6413491|NCT00956813|7326986|FG001|NOT COMPLETED|Continuation Phase||0
6413492|NCT00956839|7326996|FG000|STARTED|Overall Study||14
6413493|NCT00956839|7326997|FG001|STARTED|Overall Study||13
6413494|NCT00956839|7326998|FG002|STARTED|Overall Study||13
6413495|NCT00956839|7326996|FG000|COMPLETED|Overall Study||11
6413496|NCT00956839|7326997|FG001|COMPLETED|Overall Study||13
6413497|NCT00956839|7326998|FG002|COMPLETED|Overall Study||10
6413498|NCT00956839|7326996|FG000|NOT COMPLETED|Overall Study||3
6413499|NCT00956839|7326997|FG001|NOT COMPLETED|Overall Study||0
6413500|NCT00956839|7326998|FG002|NOT COMPLETED|Overall Study||3
6413501|NCT00956930|7327008|FG000|STARTED|Overall Study||24
6413502|NCT00956930|7327009|FG001|STARTED|Overall Study||21
6413503|NCT00956930|7327008|FG000|COMPLETED|Overall Study||24
6413504|NCT00956930|7327009|FG001|COMPLETED|Overall Study||21
6413505|NCT00956930|7327008|FG000|NOT COMPLETED|Overall Study||0
6413506|NCT00956930|7327009|FG001|NOT COMPLETED|Overall Study||0
6413507|NCT00956943|7327019|FG000|STARTED|Overall Study||43
6413508|NCT00956943|7327020|FG001|STARTED|Overall Study||44
6637754|NCT02320487|7566575|FG000|STARTED|Overall Study||102
6637755|NCT02320487|7566575|FG000|COMPLETED|Overall Study|Completed = completed the 6-cycle Treatment Period.|81
6637756|NCT02320487|7566575|FG000|NOT COMPLETED|Overall Study||21
6637757|NCT02320695|7566579|FG000|STARTED|Overall Study||60
6637758|NCT02320695|7566579|FG000|Saline|Overall Study||60
6637759|NCT02320695|7566579|FG000|Alcohol|Overall Study||60
6637760|NCT02320695|7566579|FG000|Pain Relieving Cream|Overall Study||59
6637761|NCT02320695|7566579|FG000|Antibiotic/Pain Relieving Ointment|Overall Study||60
6637762|NCT02320695|7566579|FG000|Original Ointment|Overall Study||60
6637763|NCT02320695|7566579|FG000|Pain Relief Ointment|Overall Study||60
6637764|NCT02320695|7566579|FG000|COMPLETED|Overall Study||60
6637765|NCT02320695|7566579|FG000|NOT COMPLETED|Overall Study||0
6637766|NCT02320721|7566590|FG000|STARTED|Overall Study||508
6637767|NCT02320721|7566591|FG001|STARTED|Overall Study||506
6637768|NCT02320721|7566590|FG000|Treated (Safety Population)|Overall Study||508
6637769|NCT02320721|7566591|FG001|Treated (Safety Population)|Overall Study||505
6637770|NCT02320721|7566590|FG000|COMPLETED|Overall Study||481
6637771|NCT02320721|7566591|FG001|COMPLETED|Overall Study||472
6637772|NCT02320721|7566590|FG000|NOT COMPLETED|Overall Study||27
6637773|NCT02320721|7566591|FG001|NOT COMPLETED|Overall Study||34
6637774|NCT02320812|7566597|FG000|STARTED|Overall Study||28
6637775|NCT02320812|7566597|FG000|COMPLETED|Overall Study||28
6637776|NCT02320812|7566597|FG000|NOT COMPLETED|Overall Study||0
6637777|NCT02320838|7566605|FG000|STARTED|First Intervention (1 Day)||8
6637778|NCT02320838|7566606|FG001|STARTED|First Intervention (1 Day)||8
6637779|NCT02320838|7566607|FG002|STARTED|First Intervention (1 Day)||8
6637780|NCT02320838|7566608|FG003|STARTED|First Intervention (1 Day)||7
6637781|NCT02320838|7566609|FG004|STARTED|First Intervention (1 Day)||7
6637782|NCT02320838|7566605|FG000|COMPLETED|First Intervention (1 Day)||8
6637783|NCT02320838|7566606|FG001|COMPLETED|First Intervention (1 Day)||8
6637784|NCT02320838|7566607|FG002|COMPLETED|First Intervention (1 Day)||8
6637785|NCT02320838|7566608|FG003|COMPLETED|First Intervention (1 Day)||7
6637786|NCT02320838|7566609|FG004|COMPLETED|First Intervention (1 Day)||7
6637787|NCT02320838|7566605|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6637788|NCT02320838|7566606|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6637789|NCT02320838|7566607|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6637790|NCT02320838|7566608|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6637791|NCT02320838|7566609|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6637792|NCT02320838|7566605|FG000|STARTED|Washout (1 Day)||8
6637793|NCT02320838|7566606|FG001|STARTED|Washout (1 Day)||8
6637794|NCT02320838|7566607|FG002|STARTED|Washout (1 Day)||8
6637795|NCT02320838|7566608|FG003|STARTED|Washout (1 Day)||7
6637796|NCT02320838|7566609|FG004|STARTED|Washout (1 Day)||7
6637797|NCT02320838|7566605|FG000|COMPLETED|Washout (1 Day)||8
6637798|NCT02320838|7566606|FG001|COMPLETED|Washout (1 Day)||8
6637799|NCT02320838|7566607|FG002|COMPLETED|Washout (1 Day)||8
6637800|NCT02320838|7566608|FG003|COMPLETED|Washout (1 Day)||7
6637801|NCT02320838|7566609|FG004|COMPLETED|Washout (1 Day)||7
6637802|NCT02320838|7566605|FG000|NOT COMPLETED|Washout (1 Day)||0
6637803|NCT02320838|7566606|FG001|NOT COMPLETED|Washout (1 Day)||0
6637804|NCT02320838|7566607|FG002|NOT COMPLETED|Washout (1 Day)||0
6637805|NCT02320838|7566608|FG003|NOT COMPLETED|Washout (1 Day)||0
6637806|NCT02320838|7566609|FG004|NOT COMPLETED|Washout (1 Day)||0
6637807|NCT02320838|7566605|FG000|STARTED|Second Intervention (1 Day)||8
6637808|NCT02320838|7566606|FG001|STARTED|Second Intervention (1 Day)||8
6413509|NCT00956943|7327019|FG000|Baseline|Overall Study||43
6413510|NCT00956943|7327020|FG001|Baseline|Overall Study||44
6413511|NCT00956943|7327019|FG000|COMPLETED|Overall Study||34
6413512|NCT00956943|7327020|FG001|COMPLETED|Overall Study||34
6413513|NCT00956943|7327019|FG000|NOT COMPLETED|Overall Study||9
6413514|NCT00956943|7327020|FG001|NOT COMPLETED|Overall Study||10
6413515|NCT00957008|7327030|FG000|STARTED|Overall Study||49
6413516|NCT00957008|7327031|FG001|STARTED|Overall Study||49
6413517|NCT00957008|7327032|FG002|STARTED|Overall Study||49
6413518|NCT00957008|7327033|FG003|STARTED|Overall Study||50
6413519|NCT00957008|7327030|FG000|COMPLETED|Overall Study||28
6413520|NCT00957008|7327031|FG001|COMPLETED|Overall Study||37
6413521|NCT00957008|7327032|FG002|COMPLETED|Overall Study||32
6637809|NCT02320838|7566607|FG002|STARTED|Second Intervention (1 Day)||8
6637810|NCT02320838|7566608|FG003|STARTED|Second Intervention (1 Day)||7
6637811|NCT02320838|7566609|FG004|STARTED|Second Intervention (1 Day)||7
6637812|NCT02320838|7566605|FG000|COMPLETED|Second Intervention (1 Day)||8
6637813|NCT02320838|7566606|FG001|COMPLETED|Second Intervention (1 Day)||8
6637814|NCT02320838|7566607|FG002|COMPLETED|Second Intervention (1 Day)||8
6637815|NCT02320838|7566608|FG003|COMPLETED|Second Intervention (1 Day)||7
6637816|NCT02320838|7566609|FG004|COMPLETED|Second Intervention (1 Day)||7
6637817|NCT02320838|7566605|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6637818|NCT02320838|7566606|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6637819|NCT02320838|7566607|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6637820|NCT02320838|7566608|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6637821|NCT02320838|7566609|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6637822|NCT02320838|7566605|FG000|STARTED|Washout (1 Day)||8
6637823|NCT02320838|7566606|FG001|STARTED|Washout (1 Day)||8
6637824|NCT02320838|7566607|FG002|STARTED|Washout (1 Day)||8
6637825|NCT02320838|7566608|FG003|STARTED|Washout (1 Day)||7
6637826|NCT02320838|7566609|FG004|STARTED|Washout (1 Day)||7
6637827|NCT02320838|7566605|FG000|COMPLETED|Washout (1 Day)||8
6637828|NCT02320838|7566606|FG001|COMPLETED|Washout (1 Day)||8
6637829|NCT02320838|7566607|FG002|COMPLETED|Washout (1 Day)||8
6637830|NCT02320838|7566608|FG003|COMPLETED|Washout (1 Day)||7
6637831|NCT02320838|7566609|FG004|COMPLETED|Washout (1 Day)||7
6637832|NCT02320838|7566605|FG000|NOT COMPLETED|Washout (1 Day)||0
6637833|NCT02320838|7566606|FG001|NOT COMPLETED|Washout (1 Day)||0
6637834|NCT02320838|7566607|FG002|NOT COMPLETED|Washout (1 Day)||0
6637835|NCT02320838|7566608|FG003|NOT COMPLETED|Washout (1 Day)||0
6637836|NCT02320838|7566609|FG004|NOT COMPLETED|Washout (1 Day)||0
6637837|NCT02320838|7566605|FG000|STARTED|Third Intervention (1 Day)||8
6637838|NCT02320838|7566606|FG001|STARTED|Third Intervention (1 Day)||8
6637839|NCT02320838|7566607|FG002|STARTED|Third Intervention (1 Day)||8
6637840|NCT02320838|7566608|FG003|STARTED|Third Intervention (1 Day)||7
6637841|NCT02320838|7566609|FG004|STARTED|Third Intervention (1 Day)||7
6637842|NCT02320838|7566605|FG000|COMPLETED|Third Intervention (1 Day)||8
6637843|NCT02320838|7566606|FG001|COMPLETED|Third Intervention (1 Day)||8
6637844|NCT02320838|7566607|FG002|COMPLETED|Third Intervention (1 Day)||8
6637845|NCT02320838|7566608|FG003|COMPLETED|Third Intervention (1 Day)||7
6637846|NCT02320838|7566609|FG004|COMPLETED|Third Intervention (1 Day)||7
6637847|NCT02320838|7566605|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6637848|NCT02320838|7566606|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6637849|NCT02320838|7566607|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6637850|NCT02320838|7566608|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6637851|NCT02320838|7566609|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
6637852|NCT02320903|7566620|FG000|STARTED|Overall Study||24
6637853|NCT02320903|7566621|FG001|STARTED|Overall Study||32
6637854|NCT02320903|7566622|FG002|STARTED|Overall Study||32
6637855|NCT02320903|7566620|FG000|COMPLETED|Overall Study||16
6637856|NCT02320903|7566621|FG001|COMPLETED|Overall Study||16
6637857|NCT02320903|7566622|FG002|COMPLETED|Overall Study||16
6637858|NCT02320903|7566620|FG000|NOT COMPLETED|Overall Study||8
6637859|NCT02320903|7566621|FG001|NOT COMPLETED|Overall Study||16
6637860|NCT02320903|7566622|FG002|NOT COMPLETED|Overall Study||16
6637861|NCT02321098|7566634|FG000|STARTED|12 Weeks Treament||26
6637862|NCT02321098|7566635|FG001|STARTED|12 Weeks Treament||24
6637863|NCT02321098|7566636|FG002|STARTED|12 Weeks Treament||0
6637864|NCT02321098|7566634|FG000|COMPLETED|12 Weeks Treament||25
6637865|NCT02321098|7566635|FG001|COMPLETED|12 Weeks Treament||23
6637866|NCT02321098|7566636|FG002|COMPLETED|12 Weeks Treament||0
6637867|NCT02321098|7566634|FG000|NOT COMPLETED|12 Weeks Treament||1
6637868|NCT02321098|7566635|FG001|NOT COMPLETED|12 Weeks Treament||1
6637869|NCT02321098|7566636|FG002|NOT COMPLETED|12 Weeks Treament||0
6637870|NCT02321098|7566634|FG000|STARTED|Additional 15 Months Treatment||0
6637871|NCT02321098|7566635|FG001|STARTED|Additional 15 Months Treatment||0
6637872|NCT02321098|7566636|FG002|STARTED|Additional 15 Months Treatment||29
6637873|NCT02321098|7566634|FG000|COMPLETED|Additional 15 Months Treatment||0
6637874|NCT02321098|7566635|FG001|COMPLETED|Additional 15 Months Treatment||0
6637875|NCT02321098|7566636|FG002|COMPLETED|Additional 15 Months Treatment||21
6637876|NCT02321098|7566634|FG000|NOT COMPLETED|Additional 15 Months Treatment||0
6637877|NCT02321098|7566635|FG001|NOT COMPLETED|Additional 15 Months Treatment||0
6637878|NCT02321098|7566636|FG002|NOT COMPLETED|Additional 15 Months Treatment||8
6413522|NCT00957008|7327033|FG003|COMPLETED|Overall Study||26
6413523|NCT00957008|7327030|FG000|NOT COMPLETED|Overall Study||21
6413524|NCT00957008|7327031|FG001|NOT COMPLETED|Overall Study||12
6413525|NCT00957008|7327032|FG002|NOT COMPLETED|Overall Study||17
6637879|NCT02321111|7566645|FG000|STARTED|Infusion1||1
6637880|NCT02321111|7566646|FG001|STARTED|Infusion1||4
6637881|NCT02321111|7566647|FG002|STARTED|Infusion1||4
6637882|NCT02321111|7566648|FG003|STARTED|Infusion1||1
6637883|NCT02321111|7566649|FG004|STARTED|Infusion1||0
6637884|NCT02321111|7566650|FG005|STARTED|Infusion1||0
6413526|NCT00957008|7327033|FG003|NOT COMPLETED|Overall Study||24
6413527|NCT00957021|7327047|FG000|STARTED|Overall Study||354
6413528|NCT00957021|7327047|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
6413529|NCT00957021|7327047|FG000|NOT COMPLETED|Overall Study||117
6413530|NCT00957047|7327056|FG000|STARTED|PART I||100
6413531|NCT00957047|7327057|FG001|STARTED|PART I||96
6413532|NCT00957047|7327058|FG002|STARTED|PART I||101
6413533|NCT00957047|7327059|FG003|STARTED|PART I||98
6413534|NCT00957047|7327060|FG004|STARTED|PART I||0
6413535|NCT00957047|7327056|FG000|Randomized/Safety Population|PART I||100
6413536|NCT00957047|7327057|FG001|Randomized/Safety Population|PART I||96
6413537|NCT00957047|7327058|FG002|Randomized/Safety Population|PART I||101
6413538|NCT00957047|7327059|FG003|Randomized/Safety Population|PART I||98
6413539|NCT00957047|7327060|FG004|Randomized/Safety Population|PART I||0
6413540|NCT00957047|7327056|FG000|Intention-to-treat (ITT) Population|PART I||100
6413541|NCT00957047|7327057|FG001|Intention-to-treat (ITT) Population|PART I||96
6413542|NCT00957047|7327058|FG002|Intention-to-treat (ITT) Population|PART I||100
6413543|NCT00957047|7327059|FG003|Intention-to-treat (ITT) Population|PART I||97
6413544|NCT00957047|7327060|FG004|Intention-to-treat (ITT) Population|PART I||0
6413545|NCT00957047|7327056|FG000|Per-Protocol Population|PART I||81
6413546|NCT00957047|7327057|FG001|Per-Protocol Population|PART I||70
6413547|NCT00957047|7327058|FG002|Per-Protocol Population|PART I||75
6413548|NCT00957047|7327059|FG003|Per-Protocol Population|PART I||54
6413549|NCT00957047|7327060|FG004|Per-Protocol Population|PART I||0
6413550|NCT00957047|7327056|FG000|COMPLETED|PART I||94
6413551|NCT00957047|7327057|FG001|COMPLETED|PART I||83
6413552|NCT00957047|7327058|FG002|COMPLETED|PART I||80
6413553|NCT00957047|7327059|FG003|COMPLETED|PART I||68
6413554|NCT00957047|7327060|FG004|COMPLETED|PART I||0
6413555|NCT00957047|7327056|FG000|NOT COMPLETED|PART I||6
6413556|NCT00957047|7327057|FG001|NOT COMPLETED|PART I||13
6413557|NCT00957047|7327058|FG002|NOT COMPLETED|PART I||21
6413558|NCT00957047|7327059|FG003|NOT COMPLETED|PART I||30
6413559|NCT00957047|7327060|FG004|NOT COMPLETED|PART I||0
6413560|NCT00957047|7327056|FG000|STARTED|PART II||0
6413561|NCT00957047|7327057|FG001|STARTED|PART II||0
6413562|NCT00957047|7327058|FG002|STARTED|PART II||0
6413563|NCT00957047|7327059|FG003|STARTED|PART II||0
6413564|NCT00957047|7327060|FG004|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
6637885|NCT02321111|7566645|FG000|COMPLETED|Infusion1||1
6637886|NCT02321111|7566646|FG001|COMPLETED|Infusion1||4
6637887|NCT02321111|7566647|FG002|COMPLETED|Infusion1||4
6637888|NCT02321111|7566648|FG003|COMPLETED|Infusion1||1
6637889|NCT02321111|7566649|FG004|COMPLETED|Infusion1||0
6637890|NCT02321111|7566650|FG005|COMPLETED|Infusion1||0
6637891|NCT02321111|7566645|FG000|NOT COMPLETED|Infusion1||0
6637892|NCT02321111|7566646|FG001|NOT COMPLETED|Infusion1||0
6637893|NCT02321111|7566647|FG002|NOT COMPLETED|Infusion1||0
6637894|NCT02321111|7566648|FG003|NOT COMPLETED|Infusion1||0
6637895|NCT02321111|7566649|FG004|NOT COMPLETED|Infusion1||0
6637896|NCT02321111|7566650|FG005|NOT COMPLETED|Infusion1||0
6637897|NCT02321111|7566645|FG000|STARTED|Washout1 (3-4weeks Between Infusions)||1
6637898|NCT02321111|7566646|FG001|STARTED|Washout1 (3-4weeks Between Infusions)||4
6637899|NCT02321111|7566647|FG002|STARTED|Washout1 (3-4weeks Between Infusions)||4
6637900|NCT02321111|7566648|FG003|STARTED|Washout1 (3-4weeks Between Infusions)||1
6637901|NCT02321111|7566649|FG004|STARTED|Washout1 (3-4weeks Between Infusions)||0
6637902|NCT02321111|7566650|FG005|STARTED|Washout1 (3-4weeks Between Infusions)||0
6637903|NCT02321111|7566645|FG000|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
6637904|NCT02321111|7566646|FG001|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
6637905|NCT02321111|7566647|FG002|COMPLETED|Washout1 (3-4weeks Between Infusions)||4
6637906|NCT02321111|7566648|FG003|COMPLETED|Washout1 (3-4weeks Between Infusions)||1
6637907|NCT02321111|7566649|FG004|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6637908|NCT02321111|7566650|FG005|COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6637909|NCT02321111|7566645|FG000|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6637910|NCT02321111|7566646|FG001|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6637911|NCT02321111|7566647|FG002|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6637912|NCT02321111|7566648|FG003|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6637913|NCT02321111|7566649|FG004|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6637914|NCT02321111|7566650|FG005|NOT COMPLETED|Washout1 (3-4weeks Between Infusions)||0
6637915|NCT02321111|7566645|FG000|STARTED|Infusion2||1
6637916|NCT02321111|7566646|FG001|STARTED|Infusion2||4
6637917|NCT02321111|7566647|FG002|STARTED|Infusion2||4
6637918|NCT02321111|7566648|FG003|STARTED|Infusion2||1
6637919|NCT02321111|7566649|FG004|STARTED|Infusion2||0
6637920|NCT02321111|7566650|FG005|STARTED|Infusion2||0
6637921|NCT02321111|7566645|FG000|COMPLETED|Infusion2||1
6637922|NCT02321111|7566646|FG001|COMPLETED|Infusion2||4
6637923|NCT02321111|7566647|FG002|COMPLETED|Infusion2||4
6637924|NCT02321111|7566648|FG003|COMPLETED|Infusion2||1
6413565|NCT00957047|7327056|FG000|Terminated Prematurely|PART II||0
6413566|NCT00957047|7327057|FG001|Terminated Prematurely|PART II||0
6413567|NCT00957047|7327058|FG002|Terminated Prematurely|PART II||0
6413568|NCT00957047|7327059|FG003|Terminated Prematurely|PART II||0
6413569|NCT00957047|7327060|FG004|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
6413570|NCT00957047|7327056|FG000|COMPLETED|PART II||0
6413571|NCT00957047|7327057|FG001|COMPLETED|PART II||0
6413572|NCT00957047|7327058|FG002|COMPLETED|PART II||0
6413573|NCT00957047|7327059|FG003|COMPLETED|PART II||0
6413574|NCT00957047|7327060|FG004|COMPLETED|PART II||223
6413575|NCT00957047|7327056|FG000|NOT COMPLETED|PART II||0
6413576|NCT00957047|7327057|FG001|NOT COMPLETED|PART II||0
6413577|NCT00957047|7327058|FG002|NOT COMPLETED|PART II||0
6413578|NCT00957047|7327059|FG003|NOT COMPLETED|PART II||0
6413579|NCT00957047|7327060|FG004|NOT COMPLETED|PART II||102
6413580|NCT00957229|7327080|FG000|STARTED|Study Start||15
6413581|NCT00957229|7327081|FG001|STARTED|Study Start||26
6413582|NCT00957229|7327080|FG000|COMPLETED|Study Start||14
6413583|NCT00957229|7327081|FG001|COMPLETED|Study Start||23
6413584|NCT00957229|7327080|FG000|NOT COMPLETED|Study Start||1
6413585|NCT00957229|7327081|FG001|NOT COMPLETED|Study Start||3
6413586|NCT00957229|7327080|FG000|STARTED|Reallocated to or Continued Vismodegib||14
6413587|NCT00957229|7327081|FG001|STARTED|Reallocated to or Continued Vismodegib||23
6413588|NCT00957229|7327080|FG000|COMPLETED|Reallocated to or Continued Vismodegib||11
6413589|NCT00957229|7327081|FG001|COMPLETED|Reallocated to or Continued Vismodegib||21
6413590|NCT00957229|7327080|FG000|NOT COMPLETED|Reallocated to or Continued Vismodegib||3
6413591|NCT00957229|7327081|FG001|NOT COMPLETED|Reallocated to or Continued Vismodegib||2
6413592|NCT00957242|7327089|FG000|STARTED|Overall Study||73
6413593|NCT00957242|7327090|FG001|STARTED|Overall Study||72
6413594|NCT00957242|7327089|FG000|COMPLETED|Overall Study||73
6413595|NCT00957242|7327090|FG001|COMPLETED|Overall Study||72
6413596|NCT00957242|7327089|FG000|NOT COMPLETED|Overall Study||0
6413597|NCT00957242|7327090|FG001|NOT COMPLETED|Overall Study||0
6413598|NCT00957268|7327103|FG000|STARTED|Overall Study||5
6413599|NCT00957268|7327104|FG001|STARTED|Overall Study||4
6413600|NCT00957268|7327105|FG002|STARTED|Overall Study||8
6413601|NCT00957268|7327106|FG003|STARTED|Overall Study||7
6413602|NCT00957268|7327107|FG004|STARTED|Overall Study||22
6413603|NCT00957268|7327103|FG000|COMPLETED|Overall Study||5
6413604|NCT00957268|7327104|FG001|COMPLETED|Overall Study||4
6413605|NCT00957268|7327105|FG002|COMPLETED|Overall Study||7
6413606|NCT00957268|7327106|FG003|COMPLETED|Overall Study||7
6413607|NCT00957268|7327107|FG004|COMPLETED|Overall Study||22
6413608|NCT00957268|7327103|FG000|NOT COMPLETED|Overall Study||0
6413609|NCT00957268|7327104|FG001|NOT COMPLETED|Overall Study||0
6637925|NCT02321111|7566649|FG004|COMPLETED|Infusion2||0
6637926|NCT02321111|7566650|FG005|COMPLETED|Infusion2||0
6637927|NCT02321111|7566645|FG000|NOT COMPLETED|Infusion2||0
6637928|NCT02321111|7566646|FG001|NOT COMPLETED|Infusion2||0
6637929|NCT02321111|7566647|FG002|NOT COMPLETED|Infusion2||0
6637930|NCT02321111|7566648|FG003|NOT COMPLETED|Infusion2||0
6637931|NCT02321111|7566649|FG004|NOT COMPLETED|Infusion2||0
6637932|NCT02321111|7566650|FG005|NOT COMPLETED|Infusion2||0
6637933|NCT02321111|7566645|FG000|STARTED|Washout2 (3-4weeks Between Infusions)||1
6637934|NCT02321111|7566646|FG001|STARTED|Washout2 (3-4weeks Between Infusions)||4
6637935|NCT02321111|7566647|FG002|STARTED|Washout2 (3-4weeks Between Infusions)||4
6637936|NCT02321111|7566648|FG003|STARTED|Washout2 (3-4weeks Between Infusions)||1
6637937|NCT02321111|7566649|FG004|STARTED|Washout2 (3-4weeks Between Infusions)||0
6637938|NCT02321111|7566650|FG005|STARTED|Washout2 (3-4weeks Between Infusions)||0
6637939|NCT02321111|7566645|FG000|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
6637940|NCT02321111|7566646|FG001|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
6637941|NCT02321111|7566647|FG002|COMPLETED|Washout2 (3-4weeks Between Infusions)||4
6637942|NCT02321111|7566648|FG003|COMPLETED|Washout2 (3-4weeks Between Infusions)||1
6637943|NCT02321111|7566649|FG004|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6637944|NCT02321111|7566650|FG005|COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6637945|NCT02321111|7566645|FG000|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6637946|NCT02321111|7566646|FG001|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6637947|NCT02321111|7566647|FG002|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6637948|NCT02321111|7566648|FG003|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6637949|NCT02321111|7566649|FG004|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6637950|NCT02321111|7566650|FG005|NOT COMPLETED|Washout2 (3-4weeks Between Infusions)||0
6637951|NCT02321111|7566645|FG000|STARTED|Infusion3||1
6637952|NCT02321111|7566646|FG001|STARTED|Infusion3||4
6637953|NCT02321111|7566647|FG002|STARTED|Infusion3||4
6637954|NCT02321111|7566648|FG003|STARTED|Infusion3||1
6637955|NCT02321111|7566649|FG004|STARTED|Infusion3||0
6637956|NCT02321111|7566650|FG005|STARTED|Infusion3||0
6637957|NCT02321111|7566645|FG000|COMPLETED|Infusion3||1
6637958|NCT02321111|7566646|FG001|COMPLETED|Infusion3||4
6637959|NCT02321111|7566647|FG002|COMPLETED|Infusion3||4
6637960|NCT02321111|7566648|FG003|COMPLETED|Infusion3||1
6637961|NCT02321111|7566649|FG004|COMPLETED|Infusion3||0
6637962|NCT02321111|7566650|FG005|COMPLETED|Infusion3||0
6637963|NCT02321111|7566645|FG000|NOT COMPLETED|Infusion3||0
6637964|NCT02321111|7566646|FG001|NOT COMPLETED|Infusion3||0
6637965|NCT02321111|7566647|FG002|NOT COMPLETED|Infusion3||0
6413610|NCT00957268|7327105|FG002|NOT COMPLETED|Overall Study||1
6413611|NCT00957268|7327106|FG003|NOT COMPLETED|Overall Study||0
6413612|NCT00957268|7327107|FG004|NOT COMPLETED|Overall Study||0
6413613|NCT00957333|7327119|FG000|STARTED|Overall Study||44
6413614|NCT00957333|7327119|FG000|COMPLETED|Overall Study||44
6413615|NCT00957333|7327119|FG000|NOT COMPLETED|Overall Study||0
6413616|NCT00957359|7327125|FG000|STARTED|Overall Study||14
6413617|NCT00957359|7327126|FG001|STARTED|Overall Study||15
6413618|NCT00957359|7327125|FG000|COMPLETED|Overall Study||14
6413619|NCT00957359|7327126|FG001|COMPLETED|Overall Study||15
6413620|NCT00957359|7327125|FG000|NOT COMPLETED|Overall Study||0
6413621|NCT00957359|7327126|FG001|NOT COMPLETED|Overall Study||0
6413622|NCT00957372|7327135|FG000|STARTED|PART I||80
6413623|NCT00957372|7327136|FG001|STARTED|PART I||85
6413624|NCT00957372|7327137|FG002|STARTED|PART I||88
6413625|NCT00957372|7327138|FG003|STARTED|PART I||0
6413626|NCT00957372|7327135|FG000|Safety Population|PART I||80
6413627|NCT00957372|7327136|FG001|Safety Population|PART I||85
6413628|NCT00957372|7327137|FG002|Safety Population|PART I||87
6413629|NCT00957372|7327138|FG003|Safety Population|PART I||0
6413630|NCT00957372|7327135|FG000|Intention-to-Treat Population|PART I||77
6413631|NCT00957372|7327136|FG001|Intention-to-Treat Population|PART I||84
6413632|NCT00957372|7327137|FG002|Intention-to-Treat Population|PART I||84
6413633|NCT00957372|7327138|FG003|Intention-to-Treat Population|PART I||0
6413634|NCT00957372|7327135|FG000|Per-Protocol Population|PART I||35
6413635|NCT00957372|7327136|FG001|Per-Protocol Population|PART I||47
6413636|NCT00957372|7327137|FG002|Per-Protocol Population|PART I||51
6413637|NCT00957372|7327138|FG003|Per-Protocol Population|PART I||0
6413638|NCT00957372|7327135|FG000|Randomized But Not Treated|PART I||0
6637966|NCT02321111|7566648|FG003|NOT COMPLETED|Infusion3||0
6637967|NCT02321111|7566649|FG004|NOT COMPLETED|Infusion3||0
6637968|NCT02321111|7566650|FG005|NOT COMPLETED|Infusion3||0
6637969|NCT02321319|7566658|FG000|STARTED|Overall Study||5
6637970|NCT02321319|7566658|FG000|COMPLETED|Overall Study||0
6637971|NCT02321319|7566658|FG000|NOT COMPLETED|Overall Study||5
6637972|NCT02321436|7566664|FG000|STARTED|Overall Study||28
6637973|NCT02321436|7566665|FG001|STARTED|Overall Study||14
6637974|NCT02321436|7566664|FG000|COMPLETED|Overall Study||27
6637975|NCT02321436|7566665|FG001|COMPLETED|Overall Study||13
6637976|NCT02321436|7566664|FG000|NOT COMPLETED|Overall Study||1
6637977|NCT02321436|7566665|FG001|NOT COMPLETED|Overall Study||1
6637978|NCT02321462|7566674|FG000|STARTED|Overall Study||147
6637979|NCT02321462|7566675|FG001|STARTED|Overall Study||149
6637980|NCT02321462|7566674|FG000|ITT Population|Overall Study||146
6637981|NCT02321462|7566675|FG001|ITT Population|Overall Study||148
6637982|NCT02321462|7566674|FG000|Treated Patients|Overall Study||147
6637983|NCT02321462|7566675|FG001|Treated Patients|Overall Study||147
6637984|NCT02321462|7566674|FG000|Safety Population|Overall Study||147
6637985|NCT02321462|7566675|FG001|Safety Population|Overall Study||147
6637986|NCT02321462|7566674|FG000|COMPLETED|Overall Study||141
6637987|NCT02321462|7566675|FG001|COMPLETED|Overall Study||146
6637988|NCT02321462|7566674|FG000|NOT COMPLETED|Overall Study||6
6637989|NCT02321462|7566675|FG001|NOT COMPLETED|Overall Study||3
6637990|NCT02321527|7566682|FG000|STARTED|Overall Study||21
6637991|NCT02321527|7566682|FG000|COMPLETED|Overall Study||20
6637992|NCT02321527|7566682|FG000|NOT COMPLETED|Overall Study||1
6637993|NCT02321748|7566688|FG000|STARTED|Overall Study||12
6637994|NCT02321748|7566689|FG001|STARTED|Overall Study||12
6637995|NCT02321748|7566688|FG000|First Intervention (4 Days)|Overall Study||12
6637996|NCT02321748|7566689|FG001|First Intervention (4 Days)|Overall Study||12
6637997|NCT02321748|7566688|FG000|Wasout (2weeks)|Overall Study||12
6637998|NCT02321748|7566689|FG001|Wasout (2weeks)|Overall Study||12
6637999|NCT02321748|7566688|FG000|Second Intervention (4 Days)|Overall Study||12
6638000|NCT02321748|7566689|FG001|Second Intervention (4 Days)|Overall Study||12
6638001|NCT02321748|7566688|FG000|COMPLETED|Overall Study||12
6638002|NCT02321748|7566689|FG001|COMPLETED|Overall Study||12
6638003|NCT02321748|7566688|FG000|NOT COMPLETED|Overall Study||0
6638004|NCT02321748|7566689|FG001|NOT COMPLETED|Overall Study||0
6638005|NCT02321800|7566700|FG000|STARTED|Overall Study||303
6638006|NCT02321800|7566701|FG001|STARTED|Overall Study||149
6638007|NCT02321800|7566700|FG000|Received Study Drug|Overall Study||300
6638008|NCT02321800|7566701|FG001|Received Study Drug|Overall Study||148
6638009|NCT02321800|7566700|FG000|COMPLETED|Overall Study||283
6638010|NCT02321800|7566701|FG001|COMPLETED|Overall Study||138
6638011|NCT02321800|7566700|FG000|NOT COMPLETED|Overall Study||20
6638012|NCT02321800|7566701|FG001|NOT COMPLETED|Overall Study||11
6638013|NCT02321930|7566707|FG000|STARTED|Overall Study||25
6638014|NCT02321930|7566707|FG000|COMPLETED|Overall Study||24
6638015|NCT02321930|7566707|FG000|NOT COMPLETED|Overall Study||1
6638016|NCT02322021|7566715|FG000|STARTED|Core Phase||17
6638017|NCT02322021|7566716|FG001|STARTED|Core Phase||17
6638018|NCT02322021|7566717|FG002|STARTED|Core Phase||19
6638019|NCT02322021|7566718|FG003|STARTED|Core Phase||17
6638020|NCT02322021|7566719|FG004|STARTED|Core Phase||0
6638021|NCT02322021|7566715|FG000|COMPLETED|Core Phase||12
6638022|NCT02322021|7566716|FG001|COMPLETED|Core Phase||9
6638023|NCT02322021|7566717|FG002|COMPLETED|Core Phase||10
6638024|NCT02322021|7566718|FG003|COMPLETED|Core Phase||12
6638025|NCT02322021|7566719|FG004|COMPLETED|Core Phase||0
6638026|NCT02322021|7566715|FG000|NOT COMPLETED|Core Phase||5
6638027|NCT02322021|7566716|FG001|NOT COMPLETED|Core Phase||8
6638028|NCT02322021|7566717|FG002|NOT COMPLETED|Core Phase||9
6638029|NCT02322021|7566718|FG003|NOT COMPLETED|Core Phase||5
6638030|NCT02322021|7566719|FG004|NOT COMPLETED|Core Phase||0
6638031|NCT02322021|7566715|FG000|STARTED|Extension Phase||0
6413639|NCT00957372|7327136|FG001|Randomized But Not Treated|PART I||0
6413640|NCT00957372|7327137|FG002|Randomized But Not Treated|PART I||1
6413641|NCT00957372|7327138|FG003|Randomized But Not Treated|PART I||0
6413642|NCT00957372|7327135|FG000|COMPLETED|PART I||80
6413643|NCT00957372|7327136|FG001|COMPLETED|PART I||85
6413644|NCT00957372|7327137|FG002|COMPLETED|PART I||87
6413645|NCT00957372|7327138|FG003|COMPLETED|PART I||0
6413646|NCT00957372|7327135|FG000|NOT COMPLETED|PART I||0
6413647|NCT00957372|7327136|FG001|NOT COMPLETED|PART I||0
6413648|NCT00957372|7327137|FG002|NOT COMPLETED|PART I||1
6413649|NCT00957372|7327138|FG003|NOT COMPLETED|PART I||0
6413650|NCT00957372|7327135|FG000|STARTED|PART II||0
6413651|NCT00957372|7327136|FG001|STARTED|PART II||0
6413652|NCT00957372|7327137|FG002|STARTED|PART II||0
6413653|NCT00957372|7327138|FG003|STARTED|PART II||194
6413654|NCT00957372|7327135|FG000|Safety Population|PART II||0
6413655|NCT00957372|7327136|FG001|Safety Population|PART II||0
6413656|NCT00957372|7327137|FG002|Safety Population|PART II||0
6413657|NCT00957372|7327138|FG003|Safety Population|PART II||194
6413658|NCT00957372|7327135|FG000|Intention-to-treat (ITT) Population|PART II||0
6413659|NCT00957372|7327136|FG001|Intention-to-treat (ITT) Population|PART II||0
6413660|NCT00957372|7327137|FG002|Intention-to-treat (ITT) Population|PART II||0
6413661|NCT00957372|7327138|FG003|Intention-to-treat (ITT) Population|PART II||191
6413662|NCT00957372|7327135|FG000|Per-Protocol Population|PART II||0
6413663|NCT00957372|7327136|FG001|Per-Protocol Population|PART II||0
6413664|NCT00957372|7327137|FG002|Per-Protocol Population|PART II||0
6413665|NCT00957372|7327138|FG003|Per-Protocol Population|PART II||108
6413666|NCT00957372|7327135|FG000|COMPLETED|PART II||0
6413667|NCT00957372|7327136|FG001|COMPLETED|PART II||0
6413668|NCT00957372|7327137|FG002|COMPLETED|PART II||0
6413669|NCT00957372|7327138|FG003|COMPLETED|PART II||150
6413670|NCT00957372|7327135|FG000|NOT COMPLETED|PART II||0
6413671|NCT00957372|7327136|FG001|NOT COMPLETED|PART II||0
6413672|NCT00957372|7327137|FG002|NOT COMPLETED|PART II||0
6413673|NCT00957372|7327138|FG003|NOT COMPLETED|PART II||44
6413674|NCT00957424|7327154|FG000|STARTED|Overall Study||67
6413675|NCT00957424|7327154|FG000|Follow-up #1|Overall Study||59
6638032|NCT02322021|7566716|FG001|STARTED|Extension Phase||0
6638033|NCT02322021|7566717|FG002|STARTED|Extension Phase||0
6638034|NCT02322021|7566718|FG003|STARTED|Extension Phase||0
6638035|NCT02322021|7566719|FG004|STARTED|Extension Phase|Participants who completed Core Phase, were eligible and gave consent, entered Extension Phase.|41
6638036|NCT02322021|7566715|FG000|COMPLETED|Extension Phase||0
6638037|NCT02322021|7566716|FG001|COMPLETED|Extension Phase||0
6638038|NCT02322021|7566717|FG002|COMPLETED|Extension Phase||0
6638039|NCT02322021|7566718|FG003|COMPLETED|Extension Phase||0
6638040|NCT02322021|7566719|FG004|COMPLETED|Extension Phase||0
6638041|NCT02322021|7566715|FG000|NOT COMPLETED|Extension Phase||0
6638042|NCT02322021|7566716|FG001|NOT COMPLETED|Extension Phase||0
6638043|NCT02322021|7566717|FG002|NOT COMPLETED|Extension Phase||0
6638044|NCT02322021|7566718|FG003|NOT COMPLETED|Extension Phase||0
6638045|NCT02322021|7566719|FG004|NOT COMPLETED|Extension Phase||41
6638046|NCT02322047|7566738|FG000|STARTED|Overall Study||8
6638047|NCT02322047|7566739|FG001|STARTED|Overall Study||7
6638048|NCT02322047|7566740|FG002|STARTED|Overall Study||7
6638049|NCT02322047|7566741|FG003|STARTED|Overall Study||9
6638050|NCT02322047|7566738|FG000|COMPLETED|Overall Study||6
6638051|NCT02322047|7566739|FG001|COMPLETED|Overall Study||6
6638052|NCT02322047|7566740|FG002|COMPLETED|Overall Study||6
6638053|NCT02322047|7566741|FG003|COMPLETED|Overall Study||7
6638054|NCT02322047|7566738|FG000|NOT COMPLETED|Overall Study||2
6638055|NCT02322047|7566739|FG001|NOT COMPLETED|Overall Study||1
6638056|NCT02322047|7566740|FG002|NOT COMPLETED|Overall Study||1
6638057|NCT02322047|7566741|FG003|NOT COMPLETED|Overall Study||2
6638058|NCT02322125|7566751|FG000|STARTED|Overall Study||12
6638059|NCT02322125|7566751|FG000|COMPLETED|Overall Study||10
6638060|NCT02322125|7566751|FG000|NOT COMPLETED|Overall Study||2
6638061|NCT02322190|7566755|FG000|STARTED|Overall Study||5
6638062|NCT02322190|7566756|FG001|STARTED|Overall Study||0
6638063|NCT02322190|7566755|FG000|COMPLETED|Overall Study||4
6638064|NCT02322190|7566756|FG001|COMPLETED|Overall Study||0
6638065|NCT02322190|7566755|FG000|NOT COMPLETED|Overall Study||1
6638066|NCT02322190|7566756|FG001|NOT COMPLETED|Overall Study||0
6638067|NCT02322216|7566763|FG000|STARTED|Overall Study||126
6638068|NCT02322216|7566764|FG001|STARTED|Overall Study||127
6638069|NCT02322216|7566763|FG000|Treated (Safety Set)|Overall Study||126
6638070|NCT02322216|7566764|FG001|Treated (Safety Set)|Overall Study||126
6638071|NCT02322216|7566763|FG000|Per Protocol Set (PPS)|Overall Study||123
6638072|NCT02322216|7566764|FG001|Per Protocol Set (PPS)|Overall Study||122
6638073|NCT02322216|7566763|FG000|COMPLETED|Overall Study||124
6638074|NCT02322216|7566764|FG001|COMPLETED|Overall Study||123
6638075|NCT02322216|7566763|FG000|NOT COMPLETED|Overall Study||2
6638076|NCT02322216|7566764|FG001|NOT COMPLETED|Overall Study||4
6655717|NCT02454972|7585871|FG003|COMPLETED|Overall Study||0
6655718|NCT02454972|7585872|FG004|COMPLETED|Overall Study||0
6655719|NCT02454972|7585873|FG005|COMPLETED|Overall Study||0
6655720|NCT02454972|7585874|FG006|COMPLETED|Overall Study||0
6655721|NCT02454972|7585875|FG007|COMPLETED|Overall Study||0
6655722|NCT02454972|7585876|FG008|COMPLETED|Overall Study||0
6655723|NCT02454972|7585868|FG000|NOT COMPLETED|Overall Study||19
6655724|NCT02454972|7585869|FG001|NOT COMPLETED|Overall Study||19
6655725|NCT02454972|7585870|FG002|NOT COMPLETED|Overall Study||76
6413676|NCT00957424|7327154|FG000|Follow-up #2|Overall Study||50
6655726|NCT02454972|7585871|FG003|NOT COMPLETED|Overall Study||29
6413677|NCT00957424|7327154|FG000|COMPLETED|Overall Study||44
6413678|NCT00957424|7327154|FG000|NOT COMPLETED|Overall Study||23
6413679|NCT00957528|7327161|FG000|STARTED|Overall Study||8
6413680|NCT00957528|7327162|FG001|STARTED|Overall Study||9
6413681|NCT00957528|7327163|FG002|STARTED|Overall Study||9
6413682|NCT00957528|7327161|FG000|COMPLETED|Overall Study||8
6413683|NCT00957528|7327162|FG001|COMPLETED|Overall Study||8
6413684|NCT00957528|7327163|FG002|COMPLETED|Overall Study||8
6413685|NCT00957528|7327161|FG000|NOT COMPLETED|Overall Study||0
6413686|NCT00957528|7327162|FG001|NOT COMPLETED|Overall Study||1
6413687|NCT00957528|7327163|FG002|NOT COMPLETED|Overall Study||1
6413688|NCT00957580|7327174|FG000|STARTED|Overall Study||33
6413689|NCT00957580|7327175|FG001|STARTED|Overall Study||33
6413690|NCT00957580|7327176|FG002|STARTED|Overall Study||15
6413691|NCT00957580|7327174|FG000|Treated|Overall Study||33
6413692|NCT00957580|7327175|FG001|Treated|Overall Study||32
6413693|NCT00957580|7327176|FG002|Treated|Overall Study||15
6413694|NCT00957580|7327174|FG000|COMPLETED|Overall Study||33
6413695|NCT00957580|7327175|FG001|COMPLETED|Overall Study||31
6413696|NCT00957580|7327176|FG002|COMPLETED|Overall Study||15
6413697|NCT00957580|7327174|FG000|NOT COMPLETED|Overall Study||0
6413698|NCT00957580|7327175|FG001|NOT COMPLETED|Overall Study||2
6413699|NCT00957580|7327176|FG002|NOT COMPLETED|Overall Study||0
6413700|NCT00957593|7327199|FG000|STARTED|Overall Study||127
6413701|NCT00957593|7327200|FG001|STARTED|Overall Study||125
6413702|NCT00957593|7327199|FG000|COMPLETED|Overall Study||127
6413703|NCT00957593|7327200|FG001|COMPLETED|Overall Study||125
6413704|NCT00957593|7327199|FG000|NOT COMPLETED|Overall Study||0
6413705|NCT00957593|7327200|FG001|NOT COMPLETED|Overall Study||0
6413706|NCT00957658|7327208|FG000|STARTED|Overall Study||234
6413707|NCT00957658|7327208|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
6413708|NCT00957658|7327208|FG000|NOT COMPLETED|Overall Study||65
6413709|NCT00957671|7327214|FG000|STARTED|Overall Study|15 subjects began the treatment phase.|15
6413710|NCT00957671|7327214|FG000|COMPLETED|Overall Study|15 subjects completed the treatment phase of the study.|15
6413711|NCT00957671|7327214|FG000|NOT COMPLETED|Overall Study||0
6413712|NCT00957684|7327223|FG000|STARTED|PART I||102
6413713|NCT00957684|7327224|FG001|STARTED|PART I||98
6413714|NCT00957684|7327225|FG002|STARTED|PART I||100
6413715|NCT00957684|7327226|FG003|STARTED|PART I||102
6413716|NCT00957684|7327227|FG004|STARTED|PART I||0
6413717|NCT00957684|7327223|FG000|Randomised (Safety Population)|PART I||102
6413718|NCT00957684|7327224|FG001|Randomised (Safety Population)|PART I||98
6413719|NCT00957684|7327225|FG002|Randomised (Safety Population)|PART I||100
6413720|NCT00957684|7327226|FG003|Randomised (Safety Population)|PART I||102
6413721|NCT00957684|7327227|FG004|Randomised (Safety Population)|PART I||0
6413722|NCT00957684|7327223|FG000|Intention-to-treat (ITT) Population|PART I||98
6413723|NCT00957684|7327224|FG001|Intention-to-treat (ITT) Population|PART I||98
6413724|NCT00957684|7327225|FG002|Intention-to-treat (ITT) Population|PART I||99
6413725|NCT00957684|7327226|FG003|Intention-to-treat (ITT) Population|PART I||102
6413726|NCT00957684|7327227|FG004|Intention-to-treat (ITT) Population|PART I||0
6413727|NCT00957684|7327223|FG000|Per-protocol (PP)Population|PART I||72
6638077|NCT02322229|7566771|FG000|STARTED|Overall Study||52
6638078|NCT02322229|7566771|FG000|COMPLETED|Overall Study||50
6638079|NCT02322229|7566771|FG000|NOT COMPLETED|Overall Study||2
6638080|NCT02322242|7566778|FG000|STARTED|Overall Study||92
6638081|NCT02322242|7566779|FG001|STARTED|Overall Study||90
6638082|NCT02322242|7566778|FG000|Primary Outcome|Overall Study||92
6638083|NCT02322242|7566779|FG001|Primary Outcome|Overall Study||90
6638084|NCT02322242|7566778|FG000|1 Week Follow-up|Overall Study|2 lost to follow-up for secondary outcomes|90
6638085|NCT02322242|7566779|FG001|1 Week Follow-up|Overall Study|1 lost to follow-up for secondary outcomes|89
6638086|NCT02322242|7566778|FG000|COMPLETED|Overall Study||92
6638087|NCT02322242|7566779|FG001|COMPLETED|Overall Study||90
6638088|NCT02322242|7566778|FG000|NOT COMPLETED|Overall Study||0
6638089|NCT02322242|7566779|FG001|NOT COMPLETED|Overall Study||0
6638090|NCT02322281|7566788|FG000|STARTED|Overall Study||53
6638091|NCT02322281|7566789|FG001|STARTED|Overall Study||22
6638092|NCT02322281|7566790|FG002|STARTED|Overall Study||74
6638093|NCT02322281|7566788|FG000|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
6638094|NCT02322281|7566789|FG001|Crossed Over to Rociletinib 500 mg BID|Overall Study||0
6638095|NCT02322281|7566790|FG002|Crossed Over to Rociletinib 500 mg BID|Overall Study||36
6638096|NCT02322281|7566788|FG000|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
6638097|NCT02322281|7566789|FG001|Crossed Over to Rociletinib 625 mg BID|Overall Study||0
6638098|NCT02322281|7566790|FG002|Crossed Over to Rociletinib 625 mg BID|Overall Study||3
6638099|NCT02322281|7566788|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6638100|NCT02322281|7566789|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6638101|NCT02322281|7566790|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6638102|NCT02322281|7566788|FG000|NOT COMPLETED|Overall Study||53
6638103|NCT02322281|7566789|FG001|NOT COMPLETED|Overall Study||22
6638104|NCT02322281|7566790|FG002|NOT COMPLETED|Overall Study||74
6638105|NCT02322320|7566803|FG000|STARTED|Overall Study||98
6638106|NCT02322320|7566804|FG001|STARTED|Overall Study||86
6638107|NCT02322320|7566805|FG002|STARTED|Overall Study||89
6638108|NCT02322320|7566803|FG000|COMPLETED|Overall Study||98
6413728|NCT00957684|7327224|FG001|Per-protocol (PP)Population|PART I||86
6413729|NCT00957684|7327225|FG002|Per-protocol (PP)Population|PART I||94
6413730|NCT00957684|7327226|FG003|Per-protocol (PP)Population|PART I||91
6413731|NCT00957684|7327227|FG004|Per-protocol (PP)Population|PART I||0
6413732|NCT00957684|7327223|FG000|COMPLETED|PART I||71
6638109|NCT02322320|7566804|FG001|COMPLETED|Overall Study||86
6638110|NCT02322320|7566805|FG002|COMPLETED|Overall Study||89
6413733|NCT00957684|7327224|FG001|COMPLETED|PART I||85
6413734|NCT00957684|7327225|FG002|COMPLETED|PART I||90
6413735|NCT00957684|7327226|FG003|COMPLETED|PART I||84
6413736|NCT00957684|7327227|FG004|COMPLETED|PART I||0
6413737|NCT00957684|7327223|FG000|NOT COMPLETED|PART I||31
6413738|NCT00957684|7327224|FG001|NOT COMPLETED|PART I||13
6413739|NCT00957684|7327225|FG002|NOT COMPLETED|PART I||10
6413740|NCT00957684|7327226|FG003|NOT COMPLETED|PART I||18
6413741|NCT00957684|7327227|FG004|NOT COMPLETED|PART I||0
6413742|NCT00957684|7327223|FG000|STARTED|PART II||0
6413743|NCT00957684|7327224|FG001|STARTED|PART II||0
6413744|NCT00957684|7327225|FG002|STARTED|PART II||0
6413745|NCT00957684|7327226|FG003|STARTED|PART II||0
6413746|NCT00957684|7327227|FG004|STARTED|PART II||314
6638111|NCT02322320|7566803|FG000|NOT COMPLETED|Overall Study||0
6638112|NCT02322320|7566804|FG001|NOT COMPLETED|Overall Study||0
6638113|NCT02322320|7566805|FG002|NOT COMPLETED|Overall Study||0
6638114|NCT02322333|7566815|FG000|STARTED|Overall Study||80
6638115|NCT02322333|7566816|FG001|STARTED|Overall Study||77
6638116|NCT02322333|7566815|FG000|COMPLETED|Overall Study||63
6638117|NCT02322333|7566816|FG001|COMPLETED|Overall Study||61
6638118|NCT02322333|7566815|FG000|NOT COMPLETED|Overall Study||17
6638119|NCT02322333|7566816|FG001|NOT COMPLETED|Overall Study||16
6638120|NCT02322411|7566824|FG000|STARTED|Overall Study||14
6638121|NCT02322411|7566825|FG001|STARTED|Overall Study||16
6638122|NCT02322411|7566824|FG000|Randomized|Overall Study||14
6638123|NCT02322411|7566825|FG001|Randomized|Overall Study||16
6638124|NCT02322411|7566824|FG000|All Baseline Measures Analyzed|Overall Study||13
6638125|NCT02322411|7566825|FG001|All Baseline Measures Analyzed|Overall Study||16
6638126|NCT02322411|7566824|FG000|COMPLETED|Overall Study||9
6638127|NCT02322411|7566825|FG001|COMPLETED|Overall Study||9
6638128|NCT02322411|7566824|FG000|NOT COMPLETED|Overall Study||5
6638129|NCT02322411|7566825|FG001|NOT COMPLETED|Overall Study||7
6638130|NCT02322528|7566831|FG000|STARTED|Overall Study||10
6638131|NCT02322528|7566831|FG000|COMPLETED|Overall Study||10
6638132|NCT02322528|7566831|FG000|NOT COMPLETED|Overall Study||0
6638133|NCT02322749|7566835|FG000|STARTED|Period 1||8
6638134|NCT02322749|7566836|FG001|STARTED|Period 1||8
6638135|NCT02322749|7566837|FG002|STARTED|Period 1||8
6638136|NCT02322749|7566838|FG003|STARTED|Period 1||8
6638137|NCT02322749|7566839|FG004|STARTED|Period 1||8
6638138|NCT02322749|7566840|FG005|STARTED|Period 1||8
6638139|NCT02322749|7566835|FG000|COMPLETED|Period 1||8
6638140|NCT02322749|7566836|FG001|COMPLETED|Period 1||8
6638141|NCT02322749|7566837|FG002|COMPLETED|Period 1||8
6638142|NCT02322749|7566838|FG003|COMPLETED|Period 1||8
6638143|NCT02322749|7566839|FG004|COMPLETED|Period 1||8
6638144|NCT02322749|7566840|FG005|COMPLETED|Period 1||8
6638145|NCT02322749|7566835|FG000|NOT COMPLETED|Period 1||0
6638146|NCT02322749|7566836|FG001|NOT COMPLETED|Period 1||0
6638147|NCT02322749|7566837|FG002|NOT COMPLETED|Period 1||0
6638148|NCT02322749|7566838|FG003|NOT COMPLETED|Period 1||0
6638149|NCT02322749|7566839|FG004|NOT COMPLETED|Period 1||0
6638150|NCT02322749|7566840|FG005|NOT COMPLETED|Period 1||0
6638151|NCT02322749|7566835|FG000|STARTED|Period 2||8
6638152|NCT02322749|7566836|FG001|STARTED|Period 2||8
6638153|NCT02322749|7566837|FG002|STARTED|Period 2||8
6638154|NCT02322749|7566838|FG003|STARTED|Period 2||8
6638155|NCT02322749|7566839|FG004|STARTED|Period 2||8
6638156|NCT02322749|7566840|FG005|STARTED|Period 2||8
6638157|NCT02322749|7566835|FG000|COMPLETED|Period 2||8
6638158|NCT02322749|7566836|FG001|COMPLETED|Period 2||8
6638159|NCT02322749|7566837|FG002|COMPLETED|Period 2||8
6638160|NCT02322749|7566838|FG003|COMPLETED|Period 2||6
6638161|NCT02322749|7566839|FG004|COMPLETED|Period 2||8
6638162|NCT02322749|7566840|FG005|COMPLETED|Period 2||8
6638163|NCT02322749|7566835|FG000|NOT COMPLETED|Period 2||0
6638164|NCT02322749|7566836|FG001|NOT COMPLETED|Period 2||0
6638165|NCT02322749|7566837|FG002|NOT COMPLETED|Period 2||0
6638166|NCT02322749|7566838|FG003|NOT COMPLETED|Period 2||2
6638167|NCT02322749|7566839|FG004|NOT COMPLETED|Period 2||0
6638168|NCT02322749|7566840|FG005|NOT COMPLETED|Period 2||0
6638169|NCT02322749|7566835|FG000|STARTED|Period 3||8
6638170|NCT02322749|7566836|FG001|STARTED|Period 3||8
6638171|NCT02322749|7566837|FG002|STARTED|Period 3||8
6638172|NCT02322749|7566838|FG003|STARTED|Period 3||6
6638173|NCT02322749|7566839|FG004|STARTED|Period 3||8
6413747|NCT00957684|7327223|FG000|Patients Entered Part II|PART II||0
6638174|NCT02322749|7566840|FG005|STARTED|Period 3||8
6638175|NCT02322749|7566835|FG000|COMPLETED|Period 3||8
6638176|NCT02322749|7566836|FG001|COMPLETED|Period 3||8
6638177|NCT02322749|7566837|FG002|COMPLETED|Period 3||7
6638178|NCT02322749|7566838|FG003|COMPLETED|Period 3||6
6638179|NCT02322749|7566839|FG004|COMPLETED|Period 3||8
6638180|NCT02322749|7566840|FG005|COMPLETED|Period 3||8
6638181|NCT02322749|7566835|FG000|NOT COMPLETED|Period 3||0
6638182|NCT02322749|7566836|FG001|NOT COMPLETED|Period 3||0
6638183|NCT02322749|7566837|FG002|NOT COMPLETED|Period 3||1
6638184|NCT02322749|7566838|FG003|NOT COMPLETED|Period 3||0
6638185|NCT02322749|7566839|FG004|NOT COMPLETED|Period 3||0
6638186|NCT02322749|7566840|FG005|NOT COMPLETED|Period 3||0
6638187|NCT02322775|7566851|FG000|STARTED|Overall Study||106
6638188|NCT02322775|7566852|FG001|STARTED|Overall Study||105
6413748|NCT00957684|7327224|FG001|Patients Entered Part II|PART II||0
6413749|NCT00957684|7327225|FG002|Patients Entered Part II|PART II||0
6413750|NCT00957684|7327226|FG003|Patients Entered Part II|PART II||0
6638189|NCT02322775|7566851|FG000|COMPLETED|Overall Study||101
6638190|NCT02322775|7566852|FG001|COMPLETED|Overall Study||99
6638191|NCT02322775|7566851|FG000|NOT COMPLETED|Overall Study||5
6638192|NCT02322775|7566852|FG001|NOT COMPLETED|Overall Study||6
6413751|NCT00957684|7327227|FG004|Patients Entered Part II|PART II||314
6413752|NCT00957684|7327223|FG000|COMPLETED|PART II||0
6413753|NCT00957684|7327224|FG001|COMPLETED|PART II||0
6413754|NCT00957684|7327225|FG002|COMPLETED|PART II||0
6413755|NCT00957684|7327226|FG003|COMPLETED|PART II||0
6413756|NCT00957684|7327227|FG004|COMPLETED|PART II||239
6638193|NCT02322788|7566858|FG000|STARTED|Visit 3||15
6638194|NCT02322788|7566859|FG001|STARTED|Visit 3||15
6638195|NCT02322788|7566860|FG002|STARTED|Visit 3||14
6638196|NCT02322788|7566861|FG003|STARTED|Visit 3||16
6638197|NCT02322788|7566858|FG000|COMPLETED|Visit 3||15
6638198|NCT02322788|7566859|FG001|COMPLETED|Visit 3||15
6638199|NCT02322788|7566860|FG002|COMPLETED|Visit 3||14
6638200|NCT02322788|7566861|FG003|COMPLETED|Visit 3||16
6638201|NCT02322788|7566858|FG000|NOT COMPLETED|Visit 3||0
6638202|NCT02322788|7566859|FG001|NOT COMPLETED|Visit 3||0
6638203|NCT02322788|7566860|FG002|NOT COMPLETED|Visit 3||0
6638204|NCT02322788|7566861|FG003|NOT COMPLETED|Visit 3||0
6638205|NCT02322788|7566858|FG000|STARTED|Visit 4||15
6638206|NCT02322788|7566859|FG001|STARTED|Visit 4||14
6638207|NCT02322788|7566860|FG002|STARTED|Visit 4||16
6638208|NCT02322788|7566861|FG003|STARTED|Visit 4||15
6638209|NCT02322788|7566858|FG000|COMPLETED|Visit 4||15
6638210|NCT02322788|7566859|FG001|COMPLETED|Visit 4||14
6638211|NCT02322788|7566860|FG002|COMPLETED|Visit 4||16
6638212|NCT02322788|7566861|FG003|COMPLETED|Visit 4||15
6638213|NCT02322788|7566858|FG000|NOT COMPLETED|Visit 4||0
6638214|NCT02322788|7566859|FG001|NOT COMPLETED|Visit 4||0
6638215|NCT02322788|7566860|FG002|NOT COMPLETED|Visit 4||0
6638216|NCT02322788|7566861|FG003|NOT COMPLETED|Visit 4||0
6638217|NCT02322788|7566858|FG000|STARTED|Visit 5||16
6638218|NCT02322788|7566859|FG001|STARTED|Visit 5||15
6638219|NCT02322788|7566860|FG002|STARTED|Visit 5||15
6638220|NCT02322788|7566861|FG003|STARTED|Visit 5||14
6638221|NCT02322788|7566858|FG000|COMPLETED|Visit 5||16
6638222|NCT02322788|7566859|FG001|COMPLETED|Visit 5||15
6638223|NCT02322788|7566860|FG002|COMPLETED|Visit 5||15
6638224|NCT02322788|7566861|FG003|COMPLETED|Visit 5||14
6638225|NCT02322788|7566858|FG000|NOT COMPLETED|Visit 5||0
6638226|NCT02322788|7566859|FG001|NOT COMPLETED|Visit 5||0
6638227|NCT02322788|7566860|FG002|NOT COMPLETED|Visit 5||0
6638228|NCT02322788|7566861|FG003|NOT COMPLETED|Visit 5||0
6638229|NCT02322788|7566858|FG000|STARTED|Visit 6||14
6638230|NCT02322788|7566859|FG001|STARTED|Visit 6||16
6638231|NCT02322788|7566860|FG002|STARTED|Visit 6||15
6638232|NCT02322788|7566861|FG003|STARTED|Visit 6||15
6638233|NCT02322788|7566858|FG000|COMPLETED|Visit 6||14
6638234|NCT02322788|7566859|FG001|COMPLETED|Visit 6||16
6638235|NCT02322788|7566860|FG002|COMPLETED|Visit 6||15
6638236|NCT02322788|7566861|FG003|COMPLETED|Visit 6||15
6638237|NCT02322788|7566858|FG000|NOT COMPLETED|Visit 6||0
6638238|NCT02322788|7566859|FG001|NOT COMPLETED|Visit 6||0
6638239|NCT02322788|7566860|FG002|NOT COMPLETED|Visit 6||0
6638240|NCT02322788|7566861|FG003|NOT COMPLETED|Visit 6||0
6638241|NCT02322814|7566876|FG000|STARTED|Overall Study||16
6638242|NCT02322814|7566877|FG001|STARTED|Overall Study||43
6638243|NCT02322814|7566878|FG002|STARTED|Overall Study||47
6638244|NCT02322814|7566879|FG003|STARTED|Overall Study||32
6638245|NCT02322814|7566880|FG004|STARTED|Overall Study||31
6638246|NCT02322814|7566876|FG000|COMPLETED|Overall Study||0
6638247|NCT02322814|7566877|FG001|COMPLETED|Overall Study||0
6638248|NCT02322814|7566878|FG002|COMPLETED|Overall Study||0
6638249|NCT02322814|7566879|FG003|COMPLETED|Overall Study||0
6638250|NCT02322814|7566880|FG004|COMPLETED|Overall Study||0
6638251|NCT02322814|7566876|FG000|NOT COMPLETED|Overall Study||16
6638252|NCT02322814|7566877|FG001|NOT COMPLETED|Overall Study||43
6638253|NCT02322814|7566878|FG002|NOT COMPLETED|Overall Study||47
6638254|NCT02322814|7566879|FG003|NOT COMPLETED|Overall Study||32
6638255|NCT02322814|7566880|FG004|NOT COMPLETED|Overall Study||31
6638256|NCT02322866|7566893|FG000|STARTED|Overall Study||515
6638257|NCT02322866|7566894|FG001|STARTED|Overall Study||519
6638258|NCT02322866|7566893|FG000|COMPLETED|Overall Study||444
6638259|NCT02322866|7566894|FG001|COMPLETED|Overall Study||433
6638260|NCT02322866|7566893|FG000|NOT COMPLETED|Overall Study||71
6638261|NCT02322866|7566894|FG001|NOT COMPLETED|Overall Study||86
6638262|NCT02322879|7566902|FG000|STARTED|First Intervention||11
6638263|NCT02322879|7566903|FG001|STARTED|First Intervention||10
6638264|NCT02322879|7566902|FG000|COMPLETED|First Intervention||10
6413757|NCT00957684|7327223|FG000|NOT COMPLETED|PART II||0
6413758|NCT00957684|7327224|FG001|NOT COMPLETED|PART II||0
6638265|NCT02322879|7566903|FG001|COMPLETED|First Intervention||10
6638266|NCT02322879|7566902|FG000|NOT COMPLETED|First Intervention||1
6638267|NCT02322879|7566903|FG001|NOT COMPLETED|First Intervention||0
6638268|NCT02322879|7566902|FG000|STARTED|Washout||10
6638269|NCT02322879|7566903|FG001|STARTED|Washout||10
6638270|NCT02322879|7566902|FG000|COMPLETED|Washout||10
6413759|NCT00957684|7327225|FG002|NOT COMPLETED|PART II||0
6413760|NCT00957684|7327226|FG003|NOT COMPLETED|PART II||0
6413761|NCT00957684|7327227|FG004|NOT COMPLETED|PART II||75
6413762|NCT00957723|7327237|FG000|STARTED|Overall Study||411
6638271|NCT02322879|7566903|FG001|COMPLETED|Washout||10
6638272|NCT02322879|7566902|FG000|NOT COMPLETED|Washout||0
6638273|NCT02322879|7566903|FG001|NOT COMPLETED|Washout||0
6638274|NCT02322879|7566902|FG000|STARTED|Second Intervention||10
6638275|NCT02322879|7566903|FG001|STARTED|Second Intervention||10
6638276|NCT02322879|7566902|FG000|COMPLETED|Second Intervention||10
6638277|NCT02322879|7566903|FG001|COMPLETED|Second Intervention||10
6638278|NCT02322879|7566902|FG000|NOT COMPLETED|Second Intervention||0
6638279|NCT02322879|7566903|FG001|NOT COMPLETED|Second Intervention||0
6413763|NCT00957723|7327237|FG000|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
6413764|NCT00957723|7327237|FG000|NOT COMPLETED|Overall Study||113
6413765|NCT00957801|7327247|FG000|STARTED|Overall Study||7
6413766|NCT00957801|7327248|FG001|STARTED|Overall Study||7
6413767|NCT00957801|7327249|FG002|STARTED|Overall Study||7
6413768|NCT00957801|7327250|FG003|STARTED|Overall Study||8
6638280|NCT02322892|7566911|FG000|STARTED|Overall Study|Number randomized|35
6638281|NCT02322892|7566912|FG001|STARTED|Overall Study|Number randomized|34
6638282|NCT02322892|7566911|FG000|COMPLETED|Overall Study|Received placebo|33
6638283|NCT02322892|7566912|FG001|COMPLETED|Overall Study|Received thiamine|31
6638284|NCT02322892|7566911|FG000|NOT COMPLETED|Overall Study||2
6638285|NCT02322892|7566912|FG001|NOT COMPLETED|Overall Study||3
6638286|NCT02323048|7566923|FG000|STARTED|Overall Study||25
6638287|NCT02323048|7566924|FG001|STARTED|Overall Study||26
6638288|NCT02323048|7566925|FG002|STARTED|Overall Study||23
6638289|NCT02323048|7566926|FG003|STARTED|Overall Study||7
6638290|NCT02323048|7566927|FG004|STARTED|Overall Study||9
6638291|NCT02323048|7566923|FG000|COMPLETED|Overall Study||24
6638292|NCT02323048|7566924|FG001|COMPLETED|Overall Study||24
6638293|NCT02323048|7566925|FG002|COMPLETED|Overall Study||23
6638294|NCT02323048|7566926|FG003|COMPLETED|Overall Study||7
6638295|NCT02323048|7566927|FG004|COMPLETED|Overall Study||9
6638296|NCT02323048|7566923|FG000|NOT COMPLETED|Overall Study||1
6638297|NCT02323048|7566924|FG001|NOT COMPLETED|Overall Study||2
6638298|NCT02323048|7566925|FG002|NOT COMPLETED|Overall Study||0
6638299|NCT02323048|7566926|FG003|NOT COMPLETED|Overall Study||0
6638300|NCT02323048|7566927|FG004|NOT COMPLETED|Overall Study||0
6638301|NCT02323113|7566946|FG000|STARTED|Overall Study||4
6638302|NCT02323113|7566947|FG001|STARTED|Overall Study||7
6638303|NCT02323113|7566948|FG002|STARTED|Overall Study||4
6638304|NCT02323113|7566949|FG003|STARTED|Overall Study||5
6638305|NCT02323113|7566950|FG004|STARTED|Overall Study||9
6638306|NCT02323113|7566951|FG005|STARTED|Overall Study||8
6638307|NCT02323113|7566952|FG006|STARTED|Overall Study||6
6638308|NCT02323113|7566953|FG007|STARTED|Overall Study||0
6638309|NCT02323113|7566946|FG000|COMPLETED|Overall Study||0
6638310|NCT02323113|7566947|FG001|COMPLETED|Overall Study||0
6638311|NCT02323113|7566948|FG002|COMPLETED|Overall Study||0
6638312|NCT02323113|7566949|FG003|COMPLETED|Overall Study||0
6638313|NCT02323113|7566950|FG004|COMPLETED|Overall Study||0
6638314|NCT02323113|7566951|FG005|COMPLETED|Overall Study||0
6638315|NCT02323113|7566952|FG006|COMPLETED|Overall Study||0
6638316|NCT02323113|7566953|FG007|COMPLETED|Overall Study||0
6638317|NCT02323113|7566946|FG000|NOT COMPLETED|Overall Study||4
6638318|NCT02323113|7566947|FG001|NOT COMPLETED|Overall Study||7
6638319|NCT02323113|7566948|FG002|NOT COMPLETED|Overall Study||4
6638320|NCT02323113|7566949|FG003|NOT COMPLETED|Overall Study||5
6638321|NCT02323113|7566950|FG004|NOT COMPLETED|Overall Study||9
6638322|NCT02323113|7566951|FG005|NOT COMPLETED|Overall Study||8
6638323|NCT02323113|7566952|FG006|NOT COMPLETED|Overall Study||6
6638324|NCT02323113|7566953|FG007|NOT COMPLETED|Overall Study||0
6638325|NCT02323204|7566976|FG000|STARTED|Baseline Survey Completion||155
6638326|NCT02323204|7566977|FG001|STARTED|Baseline Survey Completion||155
6638327|NCT02323204|7566978|FG002|STARTED|Baseline Survey Completion||159
6638328|NCT02323204|7566979|FG003|STARTED|Baseline Survey Completion||159
6638329|NCT02323204|7566976|FG000|COMPLETED|Baseline Survey Completion||145
6638330|NCT02323204|7566977|FG001|COMPLETED|Baseline Survey Completion||146
6638331|NCT02323204|7566978|FG002|COMPLETED|Baseline Survey Completion||154
6638332|NCT02323204|7566979|FG003|COMPLETED|Baseline Survey Completion||156
6638333|NCT02323204|7566976|FG000|NOT COMPLETED|Baseline Survey Completion||10
6638334|NCT02323204|7566977|FG001|NOT COMPLETED|Baseline Survey Completion||9
6638335|NCT02323204|7566978|FG002|NOT COMPLETED|Baseline Survey Completion||5
6638336|NCT02323204|7566979|FG003|NOT COMPLETED|Baseline Survey Completion||3
6638337|NCT02323204|7566976|FG000|STARTED|6-week Follow-up Survey Completion||145
6413769|NCT00957801|7327247|FG000|COMPLETED|Overall Study||7
6413770|NCT00957801|7327248|FG001|COMPLETED|Overall Study||7
6413771|NCT00957801|7327249|FG002|COMPLETED|Overall Study||7
6413772|NCT00957801|7327250|FG003|COMPLETED|Overall Study||7
6413773|NCT00957801|7327247|FG000|NOT COMPLETED|Overall Study||0
6413774|NCT00957801|7327248|FG001|NOT COMPLETED|Overall Study||0
6413775|NCT00957801|7327249|FG002|NOT COMPLETED|Overall Study||0
6413776|NCT00957801|7327250|FG003|NOT COMPLETED|Overall Study||1
6413777|NCT00957853|7327263|FG000|STARTED|Overall Study||4
6413778|NCT00957853|7327264|FG001|STARTED|Overall Study||6
6413779|NCT00957853|7327265|FG002|STARTED|Overall Study||5
6413780|NCT00957853|7327263|FG000|Randomization|Overall Study||4
6413781|NCT00957853|7327264|FG001|Randomization|Overall Study||6
6413782|NCT00957853|7327265|FG002|Randomization|Overall Study||5
6413783|NCT00957853|7327263|FG000|Neoadjuvant Tx Completion|Overall Study||3
6413784|NCT00957853|7327264|FG001|Neoadjuvant Tx Completion|Overall Study||6
6510644|NCT01483599|7430219|FG012|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
6638338|NCT02323204|7566977|FG001|STARTED|6-week Follow-up Survey Completion||146
6413785|NCT00957853|7327265|FG002|Neoadjuvant Tx Completion|Overall Study||5
6413786|NCT00957853|7327263|FG000|COMPLETED|Overall Study||3
6638339|NCT02323204|7566978|FG002|STARTED|6-week Follow-up Survey Completion||154
6638340|NCT02323204|7566979|FG003|STARTED|6-week Follow-up Survey Completion||156
6638341|NCT02323204|7566976|FG000|COMPLETED|6-week Follow-up Survey Completion||104
6413787|NCT00957853|7327264|FG001|COMPLETED|Overall Study||6
6413788|NCT00957853|7327265|FG002|COMPLETED|Overall Study||5
6413789|NCT00957853|7327263|FG000|NOT COMPLETED|Overall Study||1
6638342|NCT02323204|7566977|FG001|COMPLETED|6-week Follow-up Survey Completion||110
6638343|NCT02323204|7566978|FG002|COMPLETED|6-week Follow-up Survey Completion||112
6638344|NCT02323204|7566979|FG003|COMPLETED|6-week Follow-up Survey Completion||119
6638345|NCT02323204|7566976|FG000|NOT COMPLETED|6-week Follow-up Survey Completion||41
6638346|NCT02323204|7566977|FG001|NOT COMPLETED|6-week Follow-up Survey Completion||36
6638347|NCT02323204|7566978|FG002|NOT COMPLETED|6-week Follow-up Survey Completion||42
6638348|NCT02323204|7566979|FG003|NOT COMPLETED|6-week Follow-up Survey Completion||37
6638349|NCT02323204|7566976|FG000|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
6638350|NCT02323204|7566977|FG001|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|146
6638351|NCT02323204|7566978|FG002|STARTED|6-week Follow-up Intervention Booster|Child participants did not receive intervention booster training.|0
6638352|NCT02323204|7566979|FG003|STARTED|6-week Follow-up Intervention Booster|Received intervention-specific booster training via phone between 6-weeks and 1 year post-enrollment|156
6638353|NCT02323204|7566976|FG000|COMPLETED|6-week Follow-up Intervention Booster||0
6638354|NCT02323204|7566977|FG001|COMPLETED|6-week Follow-up Intervention Booster||103
6638355|NCT02323204|7566978|FG002|COMPLETED|6-week Follow-up Intervention Booster||0
6638356|NCT02323204|7566979|FG003|COMPLETED|6-week Follow-up Intervention Booster||120
6638357|NCT02323204|7566976|FG000|NOT COMPLETED|6-week Follow-up Intervention Booster||0
6638358|NCT02323204|7566977|FG001|NOT COMPLETED|6-week Follow-up Intervention Booster||43
6638359|NCT02323204|7566978|FG002|NOT COMPLETED|6-week Follow-up Intervention Booster||0
6638360|NCT02323204|7566979|FG003|NOT COMPLETED|6-week Follow-up Intervention Booster||36
6638361|NCT02323204|7566976|FG000|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
6638362|NCT02323204|7566977|FG001|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
6638363|NCT02323204|7566978|FG002|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
6638364|NCT02323204|7566979|FG003|STARTED|3-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
6638365|NCT02323204|7566976|FG000|COMPLETED|3-month Follow-up Survey Completion||91
6638366|NCT02323204|7566977|FG001|COMPLETED|3-month Follow-up Survey Completion||99
6638367|NCT02323204|7566978|FG002|COMPLETED|3-month Follow-up Survey Completion||113
6638368|NCT02323204|7566979|FG003|COMPLETED|3-month Follow-up Survey Completion||112
6638369|NCT02323204|7566976|FG000|NOT COMPLETED|3-month Follow-up Survey Completion||54
6638370|NCT02323204|7566977|FG001|NOT COMPLETED|3-month Follow-up Survey Completion||47
6638371|NCT02323204|7566978|FG002|NOT COMPLETED|3-month Follow-up Survey Completion||41
6638372|NCT02323204|7566979|FG003|NOT COMPLETED|3-month Follow-up Survey Completion||44
6638373|NCT02323204|7566976|FG000|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|145
6638374|NCT02323204|7566977|FG001|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|146
6638375|NCT02323204|7566978|FG002|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|154
6638376|NCT02323204|7566979|FG003|STARTED|6-month Follow-up Survey Completion|Participants who completed baseline questionnaires were eligible to complete all subsequent surveys.|156
6638377|NCT02323204|7566976|FG000|COMPLETED|6-month Follow-up Survey Completion||96
6638378|NCT02323204|7566977|FG001|COMPLETED|6-month Follow-up Survey Completion||96
6638379|NCT02323204|7566978|FG002|COMPLETED|6-month Follow-up Survey Completion||113
6638380|NCT02323204|7566979|FG003|COMPLETED|6-month Follow-up Survey Completion||112
6638381|NCT02323204|7566976|FG000|NOT COMPLETED|6-month Follow-up Survey Completion||49
6638382|NCT02323204|7566977|FG001|NOT COMPLETED|6-month Follow-up Survey Completion||50
6638383|NCT02323204|7566978|FG002|NOT COMPLETED|6-month Follow-up Survey Completion||41
6638384|NCT02323204|7566979|FG003|NOT COMPLETED|6-month Follow-up Survey Completion||44
6638385|NCT02323217|7566989|FG000|STARTED|Overall Study||18
6638386|NCT02323217|7566989|FG000|COMPLETED|Overall Study||18
6638387|NCT02323217|7566989|FG000|NOT COMPLETED|Overall Study||0
6638388|NCT02323334|7567003|FG000|STARTED|Period 1||4
6638389|NCT02323334|7567004|FG001|STARTED|Period 1||4
6638390|NCT02323334|7567005|FG002|STARTED|Period 1||4
6638391|NCT02323334|7567006|FG003|STARTED|Period 1||4
6638392|NCT02323334|7567007|FG004|STARTED|Period 1||4
6638393|NCT02323334|7567008|FG005|STARTED|Period 1||4
6638394|NCT02323334|7567009|FG006|STARTED|Period 1||6
6638395|NCT02323334|7567010|FG007|STARTED|Period 1||6
6638396|NCT02323334|7567011|FG008|STARTED|Period 1||5
6638397|NCT02323334|7567012|FG009|STARTED|Period 1||7
6638398|NCT02323334|7567013|FG010|STARTED|Period 1||5
6638399|NCT02323334|7567014|FG011|STARTED|Period 1||3
6638400|NCT02323334|7567015|FG012|STARTED|Period 1||9
6638401|NCT02323334|7567016|FG013|STARTED|Period 1||9
6638402|NCT02323334|7567017|FG014|STARTED|Period 1||9
6638403|NCT02323334|7567018|FG015|STARTED|Period 1||9
6638404|NCT02323334|7567019|FG016|STARTED|Period 1||2
6638405|NCT02323334|7567003|FG000|Received at Least One Dose of Study Drug|Period 1||4
6638406|NCT02323334|7567004|FG001|Received at Least One Dose of Study Drug|Period 1||4
6413790|NCT00957853|7327264|FG001|NOT COMPLETED|Overall Study||0
6413791|NCT00957853|7327265|FG002|NOT COMPLETED|Overall Study||0
6413792|NCT00957905|7327275|FG000|STARTED|Part A||7
6413793|NCT00957905|7327276|FG001|STARTED|Part A||0
6413794|NCT00957905|7327275|FG000|COMPLETED|Part A||7
6413795|NCT00957905|7327276|FG001|COMPLETED|Part A||0
6413796|NCT00957905|7327275|FG000|NOT COMPLETED|Part A||0
6638407|NCT02323334|7567005|FG002|Received at Least One Dose of Study Drug|Period 1||4
6638408|NCT02323334|7567006|FG003|Received at Least One Dose of Study Drug|Period 1||4
6638409|NCT02323334|7567007|FG004|Received at Least One Dose of Study Drug|Period 1||4
6638410|NCT02323334|7567008|FG005|Received at Least One Dose of Study Drug|Period 1||4
6638411|NCT02323334|7567009|FG006|Received at Least One Dose of Study Drug|Period 1||6
6638412|NCT02323334|7567010|FG007|Received at Least One Dose of Study Drug|Period 1||6
6638413|NCT02323334|7567011|FG008|Received at Least One Dose of Study Drug|Period 1||5
6638414|NCT02323334|7567012|FG009|Received at Least One Dose of Study Drug|Period 1||7
6638415|NCT02323334|7567013|FG010|Received at Least One Dose of Study Drug|Period 1||5
6638416|NCT02323334|7567014|FG011|Received at Least One Dose of Study Drug|Period 1||3
6638417|NCT02323334|7567015|FG012|Received at Least One Dose of Study Drug|Period 1||9
6638418|NCT02323334|7567016|FG013|Received at Least One Dose of Study Drug|Period 1||9
6638419|NCT02323334|7567017|FG014|Received at Least One Dose of Study Drug|Period 1||9
6638420|NCT02323334|7567018|FG015|Received at Least One Dose of Study Drug|Period 1||9
6638421|NCT02323334|7567019|FG016|Received at Least One Dose of Study Drug|Period 1||2
6638422|NCT02323334|7567003|FG000|COMPLETED|Period 1||4
6638423|NCT02323334|7567004|FG001|COMPLETED|Period 1||4
6638424|NCT02323334|7567005|FG002|COMPLETED|Period 1||4
6638425|NCT02323334|7567006|FG003|COMPLETED|Period 1||4
6638426|NCT02323334|7567007|FG004|COMPLETED|Period 1||4
6638427|NCT02323334|7567008|FG005|COMPLETED|Period 1||4
6638428|NCT02323334|7567009|FG006|COMPLETED|Period 1||6
6638429|NCT02323334|7567010|FG007|COMPLETED|Period 1||6
6638430|NCT02323334|7567011|FG008|COMPLETED|Period 1||5
6638431|NCT02323334|7567012|FG009|COMPLETED|Period 1||7
6638432|NCT02323334|7567013|FG010|COMPLETED|Period 1||5
6638433|NCT02323334|7567014|FG011|COMPLETED|Period 1||3
6638434|NCT02323334|7567015|FG012|COMPLETED|Period 1||9
6638435|NCT02323334|7567016|FG013|COMPLETED|Period 1||9
6638436|NCT02323334|7567017|FG014|COMPLETED|Period 1||9
6638437|NCT02323334|7567018|FG015|COMPLETED|Period 1||9
6638438|NCT02323334|7567019|FG016|COMPLETED|Period 1||2
6638439|NCT02323334|7567003|FG000|NOT COMPLETED|Period 1||0
6638440|NCT02323334|7567004|FG001|NOT COMPLETED|Period 1||0
6638441|NCT02323334|7567005|FG002|NOT COMPLETED|Period 1||0
6638442|NCT02323334|7567006|FG003|NOT COMPLETED|Period 1||0
6638443|NCT02323334|7567007|FG004|NOT COMPLETED|Period 1||0
6638444|NCT02323334|7567008|FG005|NOT COMPLETED|Period 1||0
6638445|NCT02323334|7567009|FG006|NOT COMPLETED|Period 1||0
6638446|NCT02323334|7567010|FG007|NOT COMPLETED|Period 1||0
6638447|NCT02323334|7567011|FG008|NOT COMPLETED|Period 1||0
6638448|NCT02323334|7567012|FG009|NOT COMPLETED|Period 1||0
6638449|NCT02323334|7567013|FG010|NOT COMPLETED|Period 1||0
6638450|NCT02323334|7567014|FG011|NOT COMPLETED|Period 1||0
6638451|NCT02323334|7567015|FG012|NOT COMPLETED|Period 1||0
6638452|NCT02323334|7567016|FG013|NOT COMPLETED|Period 1||0
6638453|NCT02323334|7567017|FG014|NOT COMPLETED|Period 1||0
6638454|NCT02323334|7567018|FG015|NOT COMPLETED|Period 1||0
6638455|NCT02323334|7567019|FG016|NOT COMPLETED|Period 1||0
6638456|NCT02323334|7567003|FG000|STARTED|Period 2||4
6638457|NCT02323334|7567004|FG001|STARTED|Period 2||4
6638458|NCT02323334|7567005|FG002|STARTED|Period 2||4
6638459|NCT02323334|7567006|FG003|STARTED|Period 2||4
6638460|NCT02323334|7567007|FG004|STARTED|Period 2||4
6638461|NCT02323334|7567008|FG005|STARTED|Period 2||4
6638462|NCT02323334|7567009|FG006|STARTED|Period 2||6
6638463|NCT02323334|7567010|FG007|STARTED|Period 2||6
6638464|NCT02323334|7567011|FG008|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638465|NCT02323334|7567012|FG009|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638466|NCT02323334|7567013|FG010|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638467|NCT02323334|7567014|FG011|STARTED|Period 2|Part B was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638468|NCT02323334|7567015|FG012|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638469|NCT02323334|7567016|FG013|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638470|NCT02323334|7567017|FG014|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638471|NCT02323334|7567018|FG015|STARTED|Period 2|Part C was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638472|NCT02323334|7567019|FG016|STARTED|Period 2|Part D was a single period conducted in parallel to Part A and received last dose in Period 1.|0
6638473|NCT02323334|7567003|FG000|COMPLETED|Period 2||4
6638474|NCT02323334|7567004|FG001|COMPLETED|Period 2||4
6638475|NCT02323334|7567005|FG002|COMPLETED|Period 2||4
6638476|NCT02323334|7567006|FG003|COMPLETED|Period 2||4
6638477|NCT02323334|7567007|FG004|COMPLETED|Period 2||4
6638478|NCT02323334|7567008|FG005|COMPLETED|Period 2||4
6413797|NCT00957905|7327276|FG001|NOT COMPLETED|Part A||0
6413798|NCT00957905|7327275|FG000|STARTED|Part B||0
6413799|NCT00957905|7327276|FG001|STARTED|Part B||29
6413800|NCT00957905|7327275|FG000|COMPLETED|Part B||0
6638479|NCT02323334|7567009|FG006|COMPLETED|Period 2||6
6638480|NCT02323334|7567010|FG007|COMPLETED|Period 2||6
6638481|NCT02323334|7567011|FG008|COMPLETED|Period 2||0
6413801|NCT00957905|7327276|FG001|COMPLETED|Part B||25
6413802|NCT00957905|7327275|FG000|NOT COMPLETED|Part B||0
6413803|NCT00957905|7327276|FG001|NOT COMPLETED|Part B||4
6413804|NCT00957931|7327282|FG000|STARTED|Overall Study||6
6413805|NCT00957931|7327282|FG000|COMPLETED|Overall Study||2
6413806|NCT00957931|7327282|FG000|NOT COMPLETED|Overall Study||4
6413807|NCT00957944|7327288|FG000|STARTED|First Intervention- 24 Hours||20
6413808|NCT00957944|7327289|FG001|STARTED|First Intervention- 24 Hours||20
6413809|NCT00957944|7327288|FG000|COMPLETED|First Intervention- 24 Hours||20
6413810|NCT00957944|7327289|FG001|COMPLETED|First Intervention- 24 Hours||19
6413811|NCT00957944|7327288|FG000|NOT COMPLETED|First Intervention- 24 Hours||0
6413812|NCT00957944|7327289|FG001|NOT COMPLETED|First Intervention- 24 Hours||1
6413813|NCT00957944|7327288|FG000|STARTED|Washout Period of at Least 5 Days||20
6413814|NCT00957944|7327289|FG001|STARTED|Washout Period of at Least 5 Days||19
6413815|NCT00957944|7327288|FG000|COMPLETED|Washout Period of at Least 5 Days||20
6413816|NCT00957944|7327289|FG001|COMPLETED|Washout Period of at Least 5 Days||19
6413817|NCT00957944|7327288|FG000|NOT COMPLETED|Washout Period of at Least 5 Days||0
6413818|NCT00957944|7327289|FG001|NOT COMPLETED|Washout Period of at Least 5 Days||0
6413819|NCT00957944|7327288|FG000|STARTED|Second Intervention- 24 Hours||20
6413820|NCT00957944|7327289|FG001|STARTED|Second Intervention- 24 Hours||19
6413821|NCT00957944|7327288|FG000|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
6413822|NCT00957944|7327289|FG001|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
6413823|NCT00957944|7327288|FG000|COMPLETED|Second Intervention- 24 Hours||20
6413824|NCT00957944|7327289|FG001|COMPLETED|Second Intervention- 24 Hours||19
6413825|NCT00957944|7327288|FG000|NOT COMPLETED|Second Intervention- 24 Hours||0
6413826|NCT00957944|7327289|FG001|NOT COMPLETED|Second Intervention- 24 Hours||0
6413827|NCT00957996|7327297|FG000|STARTED|Overall Study||117
6413828|NCT00957996|7327298|FG001|STARTED|Overall Study||117
6413829|NCT00957996|7327297|FG000|COMPLETED|Overall Study||91
6413830|NCT00957996|7327298|FG001|COMPLETED|Overall Study||89
6413831|NCT00957996|7327297|FG000|NOT COMPLETED|Overall Study||26
6413832|NCT00957996|7327298|FG001|NOT COMPLETED|Overall Study||28
6413833|NCT00958009|7327306|FG000|STARTED|Overall Study||109
6413834|NCT00958009|7327306|FG000|COMPLETED|Overall Study||107
6413835|NCT00958009|7327306|FG000|NOT COMPLETED|Overall Study||2
6413836|NCT00958035|7327312|FG000|STARTED|Overall Study||46
6413837|NCT00958035|7327313|FG001|STARTED|Overall Study||43
6413838|NCT00958035|7327312|FG000|COMPLETED|Overall Study||43
6413839|NCT00958035|7327313|FG001|COMPLETED|Overall Study||39
6413840|NCT00958035|7327312|FG000|NOT COMPLETED|Overall Study||3
6413841|NCT00958035|7327313|FG001|NOT COMPLETED|Overall Study||4
6413842|NCT00958074|7327321|FG000|STARTED|Overall Study||4
6413843|NCT00958074|7327322|FG001|STARTED|Overall Study||7
6413844|NCT00958074|7327321|FG000|COMPLETED|Overall Study||4
6413845|NCT00958074|7327322|FG001|COMPLETED|Overall Study||6
6413846|NCT00958074|7327321|FG000|NOT COMPLETED|Overall Study||0
6413847|NCT00958074|7327322|FG001|NOT COMPLETED|Overall Study||1
6413848|NCT00958126|7327336|FG000|STARTED|Overall Study||49
6413849|NCT00958126|7327337|FG001|STARTED|Overall Study||205
6413850|NCT00958126|7327338|FG002|STARTED|Overall Study||201
6413851|NCT00958126|7327339|FG003|STARTED|Overall Study||203
6413852|NCT00958126|7327340|FG004|STARTED|Overall Study||50
6413853|NCT00958126|7327341|FG005|STARTED|Overall Study||203
6413854|NCT00958126|7327342|FG006|STARTED|Overall Study||200
6413855|NCT00958126|7327343|FG007|STARTED|Overall Study||202
6413856|NCT00958126|7327336|FG000|COMPLETED|Overall Study||48
6413857|NCT00958126|7327337|FG001|COMPLETED|Overall Study||196
6413858|NCT00958126|7327338|FG002|COMPLETED|Overall Study||191
6413859|NCT00958126|7327339|FG003|COMPLETED|Overall Study||192
6413860|NCT00958126|7327340|FG004|COMPLETED|Overall Study||50
6413861|NCT00958126|7327341|FG005|COMPLETED|Overall Study||202
6413862|NCT00958126|7327342|FG006|COMPLETED|Overall Study||199
6413863|NCT00958126|7327343|FG007|COMPLETED|Overall Study||202
6413864|NCT00958126|7327336|FG000|NOT COMPLETED|Overall Study||1
6413865|NCT00958126|7327337|FG001|NOT COMPLETED|Overall Study||9
6413866|NCT00958126|7327338|FG002|NOT COMPLETED|Overall Study||10
6413867|NCT00958126|7327339|FG003|NOT COMPLETED|Overall Study||11
6413868|NCT00958126|7327340|FG004|NOT COMPLETED|Overall Study||0
6413869|NCT00958126|7327341|FG005|NOT COMPLETED|Overall Study||1
6413870|NCT00958126|7327342|FG006|NOT COMPLETED|Overall Study||1
6413871|NCT00958126|7327343|FG007|NOT COMPLETED|Overall Study||0
6413872|NCT00958165|7327365|FG000|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
6413873|NCT00958165|7327365|FG000|Treated|Overall Study||72
6413874|NCT00958165|7327365|FG000|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
6413875|NCT00958165|7327365|FG000|NOT COMPLETED|Overall Study||14
6413876|NCT00958191|7327369|FG000|STARTED|Overall Study||221
6413877|NCT00958191|7327369|FG000|COMPLETED|Overall Study||110
6413878|NCT00958191|7327369|FG000|NOT COMPLETED|Overall Study||111
6413879|NCT00958217|7327377|FG000|STARTED|Overall Study||61
6413880|NCT00958217|7327378|FG001|STARTED|Overall Study||62
6413881|NCT00958217|7327377|FG000|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
6413882|NCT00958217|7327378|FG001|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
6413883|NCT00958217|7327377|FG000|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
6499056|NCT01414075|7417690|FG002|STARTED|Overall Study||12
6413884|NCT00958217|7327378|FG001|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
6413885|NCT00958217|7327377|FG000|NOT COMPLETED|Overall Study||24
6413886|NCT00958217|7327378|FG001|NOT COMPLETED|Overall Study||25
6413887|NCT00958243|7327391|FG000|STARTED|Overall Study||26
6413888|NCT00958243|7327392|FG001|STARTED|Overall Study||105
6413889|NCT00958243|7327393|FG002|STARTED|Overall Study||96
6413890|NCT00958243|7327394|FG003|STARTED|Overall Study||28
6413891|NCT00958243|7327395|FG004|STARTED|Overall Study||109
6413892|NCT00958243|7327396|FG005|STARTED|Overall Study||109
6413893|NCT00958243|7327391|FG000|COMPLETED|Overall Study||24
6413894|NCT00958243|7327392|FG001|COMPLETED|Overall Study||99
6413895|NCT00958243|7327393|FG002|COMPLETED|Overall Study||82
6413896|NCT00958243|7327394|FG003|COMPLETED|Overall Study||25
6413897|NCT00958243|7327395|FG004|COMPLETED|Overall Study||100
6413898|NCT00958243|7327396|FG005|COMPLETED|Overall Study||99
6413899|NCT00958243|7327391|FG000|NOT COMPLETED|Overall Study||2
6413900|NCT00958243|7327392|FG001|NOT COMPLETED|Overall Study||6
6413901|NCT00958243|7327393|FG002|NOT COMPLETED|Overall Study||14
6413902|NCT00958243|7327394|FG003|NOT COMPLETED|Overall Study||3
6413903|NCT00958243|7327395|FG004|NOT COMPLETED|Overall Study||9
6413904|NCT00958243|7327396|FG005|NOT COMPLETED|Overall Study||10
6499057|NCT01414075|7417691|FG003|STARTED|Overall Study||12
6499058|NCT01414075|7417688|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
6499059|NCT01414075|7417689|FG001|Efficacy Evaluable (EE) Population|Overall Study||12
6499060|NCT01414075|7417690|FG002|Efficacy Evaluable (EE) Population|Overall Study||10
6499061|NCT01414075|7417691|FG003|Efficacy Evaluable (EE) Population|Overall Study||10
6499062|NCT01414075|7417688|FG000|COMPLETED|Overall Study||21
6499063|NCT01414075|7417689|FG001|COMPLETED|Overall Study||12
6499064|NCT01414075|7417690|FG002|COMPLETED|Overall Study||10
6499065|NCT01414075|7417691|FG003|COMPLETED|Overall Study||10
6499066|NCT01414075|7417688|FG000|NOT COMPLETED|Overall Study||3
6499067|NCT01414075|7417689|FG001|NOT COMPLETED|Overall Study||0
6499068|NCT01414075|7417690|FG002|NOT COMPLETED|Overall Study||2
6499069|NCT01414075|7417691|FG003|NOT COMPLETED|Overall Study||2
6499070|NCT01414114|7417701|FG000|STARTED|Overall Study||37
6499071|NCT01414114|7417701|FG000|COMPLETED|Overall Study|Completed 12-week treatment period|32
6499072|NCT01414114|7417701|FG000|NOT COMPLETED|Overall Study||5
6499073|NCT01414153|7417711|FG000|STARTED|Overall Study||38
6499074|NCT01414153|7417712|FG001|STARTED|Overall Study||40
6499075|NCT01414153|7417713|FG002|STARTED|Overall Study||39
6499076|NCT01414153|7417714|FG003|STARTED|Overall Study||41
6499077|NCT01414153|7417711|FG000|COMPLETED|Overall Study||30
6499078|NCT01414153|7417712|FG001|COMPLETED|Overall Study||38
6499079|NCT01414153|7417713|FG002|COMPLETED|Overall Study||35
6499080|NCT01414153|7417714|FG003|COMPLETED|Overall Study||37
6499081|NCT01414153|7417711|FG000|NOT COMPLETED|Overall Study||8
6499082|NCT01414153|7417712|FG001|NOT COMPLETED|Overall Study||2
6499083|NCT01414153|7417713|FG002|NOT COMPLETED|Overall Study||4
6499084|NCT01414153|7417714|FG003|NOT COMPLETED|Overall Study||4
6499085|NCT01414205|7417726|FG000|STARTED|Overall Study||41
6499086|NCT01414205|7417727|FG001|STARTED|Overall Study||39
6499087|NCT01414205|7417726|FG000|Received Study Drug|Overall Study||40
6499088|NCT01414205|7417727|FG001|Received Study Drug|Overall Study||38
6499089|NCT01414205|7417726|FG000|COMPLETED|Overall Study||34
6499090|NCT01414205|7417727|FG001|COMPLETED|Overall Study||32
6499091|NCT01414205|7417726|FG000|NOT COMPLETED|Overall Study||7
6499092|NCT01414205|7417727|FG001|NOT COMPLETED|Overall Study||7
6499093|NCT01414244|7417735|FG000|STARTED|Overall Study||54
6499094|NCT01414244|7417736|FG001|STARTED|Overall Study||52
6499095|NCT01414244|7417735|FG000|COMPLETED|Overall Study||54
6499096|NCT01414244|7417736|FG001|COMPLETED|Overall Study||52
6499097|NCT01414244|7417735|FG000|NOT COMPLETED|Overall Study||0
6499098|NCT01414244|7417736|FG001|NOT COMPLETED|Overall Study||0
6499099|NCT01414257|7417742|FG000|STARTED|Overall Study||2860
6499100|NCT01414257|7417742|FG000|COMPLETED|Overall Study||2838
6499101|NCT01414257|7417742|FG000|NOT COMPLETED|Overall Study||22
6499102|NCT01414413|7417748|FG000|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
6499103|NCT01414413|7417749|FG001|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
6499104|NCT01414413|7417748|FG000|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
6499105|NCT01414413|7417749|FG001|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
6499106|NCT01414413|7417748|FG000|NOT COMPLETED|Overall Study||0
6499107|NCT01414413|7417749|FG001|NOT COMPLETED|Overall Study||0
6499108|NCT01414426|7417757|FG000|STARTED|Overall Study||10
6499109|NCT01414426|7417758|FG001|STARTED|Overall Study||10
6499110|NCT01414426|7417757|FG000|COMPLETED|Overall Study||9
6499111|NCT01414426|7417758|FG001|COMPLETED|Overall Study||8
6499112|NCT01414426|7417757|FG000|NOT COMPLETED|Overall Study||1
6499113|NCT01414426|7417758|FG001|NOT COMPLETED|Overall Study||2
6499114|NCT01414634|7417764|FG000|STARTED|Overall Study||1
6499115|NCT01414634|7417765|FG001|STARTED|Overall Study||1
6499116|NCT01414634|7417766|FG002|STARTED|Overall Study||1
6499117|NCT01414634|7417767|FG003|STARTED|Overall Study||1
6499118|NCT01414634|7417768|FG004|STARTED|Overall Study||1
6499119|NCT01414634|7417769|FG005|STARTED|Overall Study||2
6499120|NCT01414634|7417770|FG006|STARTED|Overall Study||1
6499121|NCT01414634|7417771|FG007|STARTED|Overall Study||1
6499122|NCT01414634|7417764|FG000|COMPLETED|Overall Study||1
6499123|NCT01414634|7417765|FG001|COMPLETED|Overall Study||1
6499124|NCT01414634|7417766|FG002|COMPLETED|Overall Study||1
6413905|NCT00958256|7327416|FG000|STARTED|Overall Study||21
6413906|NCT00958256|7327416|FG000|COMPLETED|Overall Study||18
6413907|NCT00958256|7327416|FG000|NOT COMPLETED|Overall Study||3
6413908|NCT00958282|7327422|FG000|STARTED|Overall Study||22
6413909|NCT00958282|7327423|FG001|STARTED|Overall Study||21
6413910|NCT00958282|7327422|FG000|COMPLETED|Overall Study||12
6413911|NCT00958282|7327423|FG001|COMPLETED|Overall Study||15
6413912|NCT00958282|7327422|FG000|NOT COMPLETED|Overall Study||10
6413913|NCT00958282|7327423|FG001|NOT COMPLETED|Overall Study||6
6413914|NCT00958308|7327432|FG000|STARTED|Overall Study||84
6413915|NCT00958308|7327433|FG001|STARTED|Overall Study||85
6413916|NCT00958308|7327434|FG002|STARTED|Overall Study||86
6413917|NCT00958308|7327432|FG000|COMPLETED|Overall Study||84
6413918|NCT00958308|7327433|FG001|COMPLETED|Overall Study||85
6413919|NCT00958308|7327434|FG002|COMPLETED|Overall Study||86
6413920|NCT00958308|7327432|FG000|NOT COMPLETED|Overall Study||0
6413921|NCT00958308|7327433|FG001|NOT COMPLETED|Overall Study||0
6413922|NCT00958308|7327434|FG002|NOT COMPLETED|Overall Study||0
6413923|NCT00958334|7327445|FG000|STARTED|Overall Study||22
6413924|NCT00958334|7327446|FG001|STARTED|Overall Study||22
6413925|NCT00958334|7327447|FG002|STARTED|Overall Study||21
6413926|NCT00958334|7327445|FG000|COMPLETED|Overall Study||8
6413927|NCT00958334|7327446|FG001|COMPLETED|Overall Study||5
6413928|NCT00958334|7327447|FG002|COMPLETED|Overall Study||8
6413929|NCT00958334|7327445|FG000|NOT COMPLETED|Overall Study||14
6413930|NCT00958334|7327446|FG001|NOT COMPLETED|Overall Study||17
6413931|NCT00958334|7327447|FG002|NOT COMPLETED|Overall Study||13
6413932|NCT00958360|7327457|FG000|STARTED|Overall Study||163
6413933|NCT00958360|7327458|FG001|STARTED|Overall Study||160
6413934|NCT00958360|7327457|FG000|COMPLETED|Overall Study||152
6413935|NCT00958360|7327458|FG001|COMPLETED|Overall Study||150
6413936|NCT00958360|7327457|FG000|NOT COMPLETED|Overall Study||11
6413937|NCT00958360|7327458|FG001|NOT COMPLETED|Overall Study||10
6413938|NCT00958412|7327464|FG000|STARTED|Overall Study||18
6413939|NCT00958412|7327464|FG000|COMPLETED|Overall Study||0
6413940|NCT00958412|7327464|FG000|NOT COMPLETED|Overall Study||18
6413941|NCT00958438|7327471|FG000|STARTED|Overall Study||82
6413942|NCT00958438|7327472|FG001|STARTED|Overall Study||82
6413943|NCT00958438|7327473|FG002|STARTED|Overall Study||84
6413944|NCT00958438|7327471|FG000|COMPLETED|Overall Study||72
6413945|NCT00958438|7327472|FG001|COMPLETED|Overall Study||72
6413946|NCT00958438|7327473|FG002|COMPLETED|Overall Study||78
6413947|NCT00958438|7327471|FG000|NOT COMPLETED|Overall Study||10
6413948|NCT00958438|7327472|FG001|NOT COMPLETED|Overall Study||10
6413949|NCT00958438|7327473|FG002|NOT COMPLETED|Overall Study||6
6413950|NCT00958477|7327485|FG000|STARTED|Overall Study||8
6413951|NCT00958477|7327486|FG001|STARTED|Overall Study||6
6413952|NCT00958477|7327487|FG002|STARTED|Overall Study||6
6413953|NCT00958477|7327488|FG003|STARTED|Overall Study||6
6413954|NCT00958477|7327485|FG000|COMPLETED|Overall Study||8
6413955|NCT00958477|7327486|FG001|COMPLETED|Overall Study||6
6413956|NCT00958477|7327487|FG002|COMPLETED|Overall Study||6
6413957|NCT00958477|7327488|FG003|COMPLETED|Overall Study||6
6413958|NCT00958477|7327485|FG000|NOT COMPLETED|Overall Study||0
6413959|NCT00958477|7327486|FG001|NOT COMPLETED|Overall Study||0
6413960|NCT00958477|7327487|FG002|NOT COMPLETED|Overall Study||0
6413961|NCT00958477|7327488|FG003|NOT COMPLETED|Overall Study||0
6413962|NCT00958568|7327504|FG000|STARTED|SPII (Wk 0-8, Acute Open-label)||892
6413963|NCT00958568|7327505|FG001|STARTED|SPII (Wk 0-8, Acute Open-label)||0
6413964|NCT00958568|7327506|FG002|STARTED|SPII (Wk 0-8, Acute Open-label)||0
6413965|NCT00958568|7327507|FG003|STARTED|SPII (Wk 0-8, Acute Open-label)||0
6413966|NCT00958568|7327504|FG000|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
6413967|NCT00958568|7327505|FG001|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6413968|NCT00958568|7327506|FG002|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6413969|NCT00958568|7327507|FG003|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6413970|NCT00958568|7327504|FG000|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
6413971|NCT00958568|7327505|FG001|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6413972|NCT00958568|7327506|FG002|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6413973|NCT00958568|7327507|FG003|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
6413974|NCT00958568|7327504|FG000|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413975|NCT00958568|7327505|FG001|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
6413976|NCT00958568|7327506|FG002|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413977|NCT00958568|7327507|FG003|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413978|NCT00958568|7327504|FG000|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413979|NCT00958568|7327505|FG001|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
6413980|NCT00958568|7327506|FG002|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413981|NCT00958568|7327507|FG003|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413982|NCT00958568|7327504|FG000|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413983|NCT00958568|7327505|FG001|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
6413984|NCT00958568|7327506|FG002|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413985|NCT00958568|7327507|FG003|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
6413986|NCT00958568|7327504|FG000|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6413987|NCT00958568|7327505|FG001|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6413988|NCT00958568|7327506|FG002|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
6413989|NCT00958568|7327507|FG003|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
6413990|NCT00958568|7327504|FG000|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6413991|NCT00958568|7327505|FG001|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6413992|NCT00958568|7327506|FG002|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
6413993|NCT00958568|7327507|FG003|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
6413994|NCT00958568|7327504|FG000|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6413995|NCT00958568|7327505|FG001|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
6413996|NCT00958568|7327506|FG002|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
6413997|NCT00958568|7327507|FG003|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
6413998|NCT00958581|7327521|FG000|STARTED|Overall Study||61
6413999|NCT00958581|7327522|FG001|STARTED|Overall Study||61
6414000|NCT00958581|7327523|FG002|STARTED|Overall Study||55
6414001|NCT00958581|7327521|FG000|COMPLETED|Overall Study||61
6414002|NCT00958581|7327522|FG001|COMPLETED|Overall Study||61
6414003|NCT00958581|7327523|FG002|COMPLETED|Overall Study||55
6414004|NCT00958581|7327521|FG000|NOT COMPLETED|Overall Study||0
6414005|NCT00958581|7327522|FG001|NOT COMPLETED|Overall Study||0
6414006|NCT00958581|7327523|FG002|NOT COMPLETED|Overall Study||0
6414007|NCT00958711|7327536|FG000|STARTED|Overall Study||42
6414008|NCT00958711|7327537|FG001|STARTED|Overall Study||48
6414009|NCT00958711|7327536|FG000|COMPLETED|Overall Study||29
6414010|NCT00958711|7327537|FG001|COMPLETED|Overall Study||27
6414011|NCT00958711|7327536|FG000|NOT COMPLETED|Overall Study||13
6414012|NCT00958711|7327537|FG001|NOT COMPLETED|Overall Study||21
6414013|NCT00958724|7327543|FG000|STARTED|Overall Study||6
6414014|NCT00958724|7327543|FG000|COMPLETED|Overall Study||0
6414015|NCT00958724|7327543|FG000|NOT COMPLETED|Overall Study||6
6414016|NCT00958776|7327549|FG000|STARTED|Overall Study||137
6414017|NCT00958776|7327550|FG001|STARTED|Overall Study||268
6414018|NCT00958776|7327549|FG000|COMPLETED|Overall Study||121
6414019|NCT00958776|7327550|FG001|COMPLETED|Overall Study||239
6414020|NCT00958776|7327549|FG000|NOT COMPLETED|Overall Study||16
6414021|NCT00958776|7327550|FG001|NOT COMPLETED|Overall Study||29
6414022|NCT00958789|7327557|FG000|STARTED|Overall Study||180
6414023|NCT00958789|7327557|FG000|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
6414024|NCT00958789|7327557|FG000|NOT COMPLETED|Overall Study||50
6414025|NCT00958828|7327566|FG000|STARTED|Period 1, 1 Week of Wear||89
6414026|NCT00958828|7327567|FG001|STARTED|Period 1, 1 Week of Wear||89
6414027|NCT00958828|7327566|FG000|COMPLETED|Period 1, 1 Week of Wear||89
6414028|NCT00958828|7327567|FG001|COMPLETED|Period 1, 1 Week of Wear||88
6414029|NCT00958828|7327566|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
6414030|NCT00958828|7327567|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||1
6414031|NCT00958828|7327566|FG000|STARTED|Period 2, 1 Week of Wear||89
6414032|NCT00958828|7327567|FG001|STARTED|Period 2, 1 Week of Wear||88
6414033|NCT00958828|7327566|FG000|COMPLETED|Period 2, 1 Week of Wear||89
6414034|NCT00958828|7327567|FG001|COMPLETED|Period 2, 1 Week of Wear||87
6414035|NCT00958828|7327566|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||0
6414036|NCT00958828|7327567|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
6414037|NCT00958841|7327573|FG000|STARTED|Overall Study||118
6414038|NCT00958841|7327573|FG000|Completed Month 6 (M6)|Overall Study||90
6414039|NCT00958841|7327573|FG000|Entered in Extension|Overall Study||63
6414040|NCT00958841|7327573|FG000|COMPLETED|Overall Study|Completed = Completed extension|22
6414041|NCT00958841|7327573|FG000|NOT COMPLETED|Overall Study||96
6414042|NCT00958880|7327589|FG000|STARTED|Overall Study||20
6414043|NCT00958880|7327590|FG001|STARTED|Overall Study||20
6414044|NCT00958880|7327589|FG000|COMPLETED|Overall Study||18
6414045|NCT00958880|7327590|FG001|COMPLETED|Overall Study||18
6414046|NCT00958880|7327589|FG000|NOT COMPLETED|Overall Study||2
6414047|NCT00958880|7327590|FG001|NOT COMPLETED|Overall Study||2
6414048|NCT00958919|7327596|FG000|STARTED|First Intervention||7
6414049|NCT00958919|7327597|FG001|STARTED|First Intervention||7
6414050|NCT00958919|7327596|FG000|COMPLETED|First Intervention||7
6414051|NCT00958919|7327597|FG001|COMPLETED|First Intervention||7
6414052|NCT00958919|7327596|FG000|NOT COMPLETED|First Intervention||0
6414053|NCT00958919|7327597|FG001|NOT COMPLETED|First Intervention||0
6414054|NCT00958919|7327596|FG000|STARTED|Second Intervention||7
6414055|NCT00958919|7327597|FG001|STARTED|Second Intervention||7
6414056|NCT00958919|7327596|FG000|COMPLETED|Second Intervention||7
6414057|NCT00958919|7327597|FG001|COMPLETED|Second Intervention||7
6414058|NCT00958919|7327596|FG000|NOT COMPLETED|Second Intervention||0
6414059|NCT00958919|7327597|FG001|NOT COMPLETED|Second Intervention||0
6414060|NCT00959049|7327616|FG000|STARTED|Overall Study||231
6414061|NCT00959049|7327617|FG001|STARTED|Overall Study||254
6414062|NCT00959049|7327618|FG002|STARTED|Overall Study||254
6414063|NCT00959049|7327619|FG003|STARTED|Overall Study||228
6414064|NCT00959049|7327620|FG004|STARTED|Overall Study||257
6414065|NCT00959049|7327621|FG005|STARTED|Overall Study||250
6414066|NCT00959049|7327616|FG000|COMPLETED|Overall Study||213
6414067|NCT00959049|7327617|FG001|COMPLETED|Overall Study||247
6414068|NCT00959049|7327618|FG002|COMPLETED|Overall Study||253
6414069|NCT00959049|7327619|FG003|COMPLETED|Overall Study||217
6414070|NCT00959049|7327620|FG004|COMPLETED|Overall Study||248
6414071|NCT00959049|7327621|FG005|COMPLETED|Overall Study||249
6414072|NCT00959049|7327616|FG000|NOT COMPLETED|Overall Study||18
6414073|NCT00959049|7327617|FG001|NOT COMPLETED|Overall Study||7
6414074|NCT00959049|7327618|FG002|NOT COMPLETED|Overall Study||1
6414075|NCT00959049|7327619|FG003|NOT COMPLETED|Overall Study||11
6414076|NCT00959049|7327620|FG004|NOT COMPLETED|Overall Study||9
6414077|NCT00959049|7327621|FG005|NOT COMPLETED|Overall Study||1
6414078|NCT00959166|7327648|FG000|STARTED|Overall Study||24
6414079|NCT00959166|7327649|FG001|STARTED|Overall Study||57
6414080|NCT00959166|7327648|FG000|COMPLETED|Overall Study||24
6414081|NCT00959166|7327649|FG001|COMPLETED|Overall Study||57
6414082|NCT00959166|7327648|FG000|NOT COMPLETED|Overall Study||0
6414083|NCT00959166|7327649|FG001|NOT COMPLETED|Overall Study||0
6414084|NCT00959192|7327659|FG000|STARTED|Overall Study||6
6414085|NCT00959192|7327660|FG001|STARTED|Overall Study||9
6414086|NCT00959192|7327661|FG002|STARTED|Overall Study||9
6414087|NCT00959192|7327662|FG003|STARTED|Overall Study||8
6414088|NCT00959192|7327659|FG000|COMPLETED|Overall Study||4
6414089|NCT00959192|7327660|FG001|COMPLETED|Overall Study||8
6414090|NCT00959192|7327661|FG002|COMPLETED|Overall Study||6
6414091|NCT00959192|7327662|FG003|COMPLETED|Overall Study||7
6414092|NCT00959192|7327659|FG000|NOT COMPLETED|Overall Study||2
6414093|NCT00959192|7327660|FG001|NOT COMPLETED|Overall Study||1
6414094|NCT00959192|7327661|FG002|NOT COMPLETED|Overall Study||3
6414095|NCT00959192|7327662|FG003|NOT COMPLETED|Overall Study||1
6414096|NCT00959374|7327673|FG000|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
6414097|NCT00959374|7327673|FG000|COMPLETED|Overall Study||218
6414098|NCT00959374|7327673|FG000|NOT COMPLETED|Overall Study||23
6414099|NCT00959647|7327681|FG000|STARTED|Overall Study||19
6414100|NCT00959647|7327681|FG000|COMPLETED|Overall Study||0
6414101|NCT00959647|7327681|FG000|NOT COMPLETED|Overall Study||19
6414102|NCT00959660|7327689|FG000|STARTED|Overall Study||26
6414103|NCT00959660|7327690|FG001|STARTED|Overall Study||24
6414104|NCT00959660|7327691|FG002|STARTED|Overall Study||25
6414105|NCT00959660|7327692|FG003|STARTED|Overall Study||25
6414106|NCT00959660|7327689|FG000|COMPLETED|Overall Study||24
6414107|NCT00959660|7327690|FG001|COMPLETED|Overall Study||24
6414108|NCT00959660|7327691|FG002|COMPLETED|Overall Study||22
6414109|NCT00959660|7327692|FG003|COMPLETED|Overall Study||22
6414110|NCT00959660|7327689|FG000|NOT COMPLETED|Overall Study||2
6414111|NCT00959660|7327690|FG001|NOT COMPLETED|Overall Study||0
6414112|NCT00959660|7327691|FG002|NOT COMPLETED|Overall Study||3
6414113|NCT00959660|7327692|FG003|NOT COMPLETED|Overall Study||3
6414114|NCT00959699|7327704|FG000|STARTED|Treatment Period||34
6414115|NCT00959699|7327705|FG001|STARTED|Treatment Period||65
6414116|NCT00959699|7327704|FG000|Treated|Treatment Period||34
6414117|NCT00959699|7327705|FG001|Treated|Treatment Period||64
6414118|NCT00959699|7327704|FG000|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
6414119|NCT00959699|7327705|FG001|COMPLETED|Treatment Period||40
6414120|NCT00959699|7327704|FG000|NOT COMPLETED|Treatment Period||23
6414121|NCT00959699|7327705|FG001|NOT COMPLETED|Treatment Period||25
6414122|NCT00959699|7327704|FG000|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
6414123|NCT00959699|7327705|FG001|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
6414124|NCT00959699|7327704|FG000|COMPLETED|Follow-up Period||27
6414125|NCT00959699|7327705|FG001|COMPLETED|Follow-up Period||56
6414126|NCT00959699|7327704|FG000|NOT COMPLETED|Follow-up Period||6
6414127|NCT00959699|7327705|FG001|NOT COMPLETED|Follow-up Period||6
6414128|NCT00959751|7327714|FG000|STARTED|Overall Study||97
6414129|NCT00959751|7327715|FG001|STARTED|Overall Study||98
6414130|NCT00959751|7327714|FG000|COMPLETED|Overall Study||88
6414131|NCT00959751|7327715|FG001|COMPLETED|Overall Study||86
6414132|NCT00959751|7327714|FG000|NOT COMPLETED|Overall Study||9
6414133|NCT00959751|7327715|FG001|NOT COMPLETED|Overall Study||12
6414134|NCT00959764|7327724|FG000|STARTED|Overall Study||271
6414135|NCT00959764|7327725|FG001|STARTED|Overall Study||185
6414136|NCT00959764|7327726|FG002|STARTED|Overall Study||109
6414137|NCT00959764|7327724|FG000|COMPLETED|Overall Study||176
6414138|NCT00959764|7327725|FG001|COMPLETED|Overall Study||128
6414139|NCT00959764|7327726|FG002|COMPLETED|Overall Study||73
6414140|NCT00959764|7327724|FG000|NOT COMPLETED|Overall Study||95
6414141|NCT00959764|7327725|FG001|NOT COMPLETED|Overall Study||57
6414142|NCT00959764|7327726|FG002|NOT COMPLETED|Overall Study||36
6414143|NCT00959842|7327737|FG000|STARTED|Overall Study|17 were recruited and at baseline. 2 dropped out before starting the study drug. 15 finished|15
6414144|NCT00959842|7327737|FG000|COMPLETED|Overall Study||15
6414145|NCT00959842|7327737|FG000|NOT COMPLETED|Overall Study||0
6414146|NCT00959894|7327741|FG000|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
6414147|NCT00959894|7327741|FG000|COMPLETED|Overall Study||63
6414148|NCT00959894|7327741|FG000|NOT COMPLETED|Overall Study||16
6414149|NCT00959907|7327748|FG000|STARTED|Overall Study||30
6414150|NCT00959907|7327749|FG001|STARTED|Overall Study||29
6414151|NCT00959907|7327748|FG000|COMPLETED|Overall Study||27
6414152|NCT00959907|7327749|FG001|COMPLETED|Overall Study||28
6414153|NCT00959907|7327748|FG000|NOT COMPLETED|Overall Study||3
6414154|NCT00959907|7327749|FG001|NOT COMPLETED|Overall Study||1
6414155|NCT00959920|7327757|FG000|STARTED|Overall Study||72
6414156|NCT00959920|7327758|FG001|STARTED|Overall Study||67
6414157|NCT00959920|7327757|FG000|COMPLETED|Overall Study||72
6414158|NCT00959920|7327758|FG001|COMPLETED|Overall Study||66
6414159|NCT00959920|7327757|FG000|NOT COMPLETED|Overall Study||0
6414160|NCT00959920|7327758|FG001|NOT COMPLETED|Overall Study||1
6414161|NCT00959946|7327774|FG000|STARTED|Overall Study||2
6414162|NCT00959946|7327775|FG001|STARTED|Overall Study||4
6414163|NCT00959946|7327776|FG002|STARTED|Overall Study||4
6414164|NCT00959946|7327777|FG003|STARTED|Overall Study||5
6414165|NCT00959946|7327778|FG004|STARTED|Overall Study||4
6414166|NCT00959946|7327779|FG005|STARTED|Overall Study||9
6414167|NCT00959946|7327780|FG006|STARTED|Overall Study||2
6414168|NCT00959946|7327781|FG007|STARTED|Overall Study||2
6414169|NCT00959946|7327774|FG000|COMPLETED|Overall Study||0
6414170|NCT00959946|7327775|FG001|COMPLETED|Overall Study||0
6414171|NCT00959946|7327776|FG002|COMPLETED|Overall Study||0
6414172|NCT00959946|7327777|FG003|COMPLETED|Overall Study||0
6414173|NCT00959946|7327778|FG004|COMPLETED|Overall Study||0
6414174|NCT00959946|7327779|FG005|COMPLETED|Overall Study||0
6414175|NCT00959946|7327780|FG006|COMPLETED|Overall Study||0
6414176|NCT00959946|7327781|FG007|COMPLETED|Overall Study||0
6414177|NCT00959946|7327774|FG000|NOT COMPLETED|Overall Study||2
6414178|NCT00959946|7327775|FG001|NOT COMPLETED|Overall Study||4
6414179|NCT00959946|7327776|FG002|NOT COMPLETED|Overall Study||4
6414180|NCT00959946|7327777|FG003|NOT COMPLETED|Overall Study||5
6414181|NCT00959946|7327778|FG004|NOT COMPLETED|Overall Study||4
6414182|NCT00959946|7327779|FG005|NOT COMPLETED|Overall Study||9
6414183|NCT00959946|7327780|FG006|NOT COMPLETED|Overall Study||2
6414184|NCT00959946|7327781|FG007|NOT COMPLETED|Overall Study||2
6414185|NCT00959985|7327808|FG000|STARTED|Overall Study||8
6414186|NCT00959985|7327809|FG001|STARTED|Overall Study||7
6414187|NCT00959985|7327810|FG002|STARTED|Overall Study||4
6414188|NCT00959985|7327811|FG003|STARTED|Overall Study||4
6414189|NCT00959985|7327808|FG000|COMPLETED|Overall Study||8
6414190|NCT00959985|7327809|FG001|COMPLETED|Overall Study||7
6414191|NCT00959985|7327810|FG002|COMPLETED|Overall Study||4
6414192|NCT00959985|7327811|FG003|COMPLETED|Overall Study||4
6414193|NCT00959985|7327808|FG000|NOT COMPLETED|Overall Study||0
6414194|NCT00959985|7327809|FG001|NOT COMPLETED|Overall Study||0
6414195|NCT00959985|7327810|FG002|NOT COMPLETED|Overall Study||0
6414196|NCT00959985|7327811|FG003|NOT COMPLETED|Overall Study||0
6414197|NCT00960011|7327823|FG000|STARTED|Overall Study||33
6414198|NCT00960011|7327824|FG001|STARTED|Overall Study||25
6414199|NCT00960011|7327823|FG000|COMPLETED|Overall Study||22
6414200|NCT00960011|7327824|FG001|COMPLETED|Overall Study||23
6414201|NCT00960011|7327823|FG000|NOT COMPLETED|Overall Study||11
6414202|NCT00960011|7327824|FG001|NOT COMPLETED|Overall Study||2
6414203|NCT00960063|7327867|FG000|STARTED|Overall Study||1
6414204|NCT00960063|7327868|FG001|STARTED|Overall Study||0
6414205|NCT00960063|7327869|FG002|STARTED|Overall Study||3
6414206|NCT00960063|7327867|FG000|COMPLETED|Overall Study||0
6414207|NCT00960063|7327868|FG001|COMPLETED|Overall Study||0
6414208|NCT00960063|7327869|FG002|COMPLETED|Overall Study||0
6414209|NCT00960063|7327867|FG000|NOT COMPLETED|Overall Study||1
6414210|NCT00960063|7327868|FG001|NOT COMPLETED|Overall Study||0
6414211|NCT00960063|7327869|FG002|NOT COMPLETED|Overall Study||3
6414212|NCT00960076|7327879|FG000|STARTED|Overall Study|Randomized and treated|138
6414213|NCT00960076|7327880|FG001|STARTED|Overall Study|Randomized and treated|144
6414214|NCT00960076|7327879|FG000|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
6414215|NCT00960076|7327880|FG001|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
6414216|NCT00960076|7327879|FG000|NOT COMPLETED|Overall Study||8
6414217|NCT00960076|7327880|FG001|NOT COMPLETED|Overall Study||25
6414218|NCT00960115|7327888|FG000|STARTED|Overall Study||114
6414219|NCT00960115|7327889|FG001|STARTED|Overall Study||58
6414220|NCT00960115|7327888|FG000|COMPLETED|Overall Study||95
6414221|NCT00960115|7327889|FG001|COMPLETED|Overall Study||43
6414222|NCT00960115|7327888|FG000|NOT COMPLETED|Overall Study||19
6414223|NCT00960115|7327889|FG001|NOT COMPLETED|Overall Study||15
6414224|NCT00960193|7327895|FG000|STARTED|Colchicine Alone||24
6414225|NCT00960193|7327895|FG000|COMPLETED|Colchicine Alone||24
6414226|NCT00960193|7327895|FG000|NOT COMPLETED|Colchicine Alone||0
6414227|NCT00960193|7327895|FG000|STARTED|14 Day Washout Period||24
6414228|NCT00960193|7327895|FG000|COMPLETED|14 Day Washout Period||23
6414229|NCT00960193|7327895|FG000|NOT COMPLETED|14 Day Washout Period||1
6414230|NCT00960193|7327895|FG000|STARTED|Seville Orange Juice Alone||23
6414231|NCT00960193|7327895|FG000|COMPLETED|Seville Orange Juice Alone||23
6414232|NCT00960193|7327895|FG000|NOT COMPLETED|Seville Orange Juice Alone||0
6414233|NCT00960193|7327895|FG000|STARTED|Colchicine With Seville Orange Juice||23
6414234|NCT00960193|7327895|FG000|COMPLETED|Colchicine With Seville Orange Juice||23
6414235|NCT00960193|7327895|FG000|NOT COMPLETED|Colchicine With Seville Orange Juice||0
6414236|NCT00960206|7327905|FG000|STARTED|Overall Study||190
6414237|NCT00960206|7327906|FG001|STARTED|Overall Study||185
6414238|NCT00960206|7327907|FG002|STARTED|Overall Study||89
6414239|NCT00960206|7327905|FG000|COMPLETED|Overall Study||150
6414240|NCT00960206|7327906|FG001|COMPLETED|Overall Study||158
6414241|NCT00960206|7327907|FG002|COMPLETED|Overall Study||77
6414242|NCT00960206|7327905|FG000|NOT COMPLETED|Overall Study||40
6414243|NCT00960206|7327906|FG001|NOT COMPLETED|Overall Study||27
6414244|NCT00960206|7327907|FG002|NOT COMPLETED|Overall Study||12
6414245|NCT00960323|7327916|FG000|STARTED|Colchicine Alone||24
6414246|NCT00960323|7327916|FG000|COMPLETED|Colchicine Alone||24
6414247|NCT00960323|7327916|FG000|NOT COMPLETED|Colchicine Alone||0
6414248|NCT00960323|7327916|FG000|STARTED|14 Day Washout Period||24
6414249|NCT00960323|7327916|FG000|COMPLETED|14 Day Washout Period||24
6414250|NCT00960323|7327916|FG000|NOT COMPLETED|14 Day Washout Period||0
6414251|NCT00960323|7327916|FG000|STARTED|Atorvastatin Alone||24
6414252|NCT00960323|7327916|FG000|COMPLETED|Atorvastatin Alone||23
6414253|NCT00960323|7327916|FG000|NOT COMPLETED|Atorvastatin Alone||1
6414254|NCT00960323|7327916|FG000|STARTED|Colchicine and Atorvastatin||23
6414255|NCT00960323|7327916|FG000|COMPLETED|Colchicine and Atorvastatin||23
6414256|NCT00960323|7327916|FG000|NOT COMPLETED|Colchicine and Atorvastatin||0
6414257|NCT00960375|7327926|FG000|STARTED|Overall Study||92
6414258|NCT00960375|7327927|FG001|STARTED|Overall Study||87
6414259|NCT00960375|7327926|FG000|COMPLETED|Overall Study||72
6414260|NCT00960375|7327927|FG001|COMPLETED|Overall Study||65
6414261|NCT00960375|7327926|FG000|NOT COMPLETED|Overall Study||20
6414262|NCT00960375|7327927|FG001|NOT COMPLETED|Overall Study||22
6414263|NCT00960440|7327937|FG000|STARTED|Overall Study||133
6414264|NCT00960440|7327938|FG001|STARTED|Overall Study||134
6414265|NCT00960440|7327939|FG002|STARTED|Overall Study||66
6414266|NCT00960440|7327940|FG003|STARTED|Overall Study||66
6414267|NCT00960440|7327937|FG000|COMPLETED|Overall Study||107
6414268|NCT00960440|7327938|FG001|COMPLETED|Overall Study||103
6414269|NCT00960440|7327939|FG002|COMPLETED|Overall Study||53
6414270|NCT00960440|7327940|FG003|COMPLETED|Overall Study||48
6414271|NCT00960440|7327937|FG000|NOT COMPLETED|Overall Study||26
6414272|NCT00960440|7327938|FG001|NOT COMPLETED|Overall Study||31
6414273|NCT00960440|7327939|FG002|NOT COMPLETED|Overall Study||13
6414274|NCT00960440|7327940|FG003|NOT COMPLETED|Overall Study||18
6414275|NCT00960505|7327955|FG000|STARTED|Overall Study||34
6414276|NCT00960505|7327956|FG001|STARTED|Overall Study||35
6414277|NCT00960505|7327957|FG002|STARTED|Overall Study||31
6414278|NCT00960505|7327955|FG000|COMPLETED|Overall Study||21
6414279|NCT00960505|7327956|FG001|COMPLETED|Overall Study||25
6414280|NCT00960505|7327957|FG002|COMPLETED|Overall Study||23
6414281|NCT00960505|7327955|FG000|NOT COMPLETED|Overall Study||13
6414282|NCT00960505|7327956|FG001|NOT COMPLETED|Overall Study||10
6414283|NCT00960505|7327957|FG002|NOT COMPLETED|Overall Study||8
6414284|NCT00960531|7327975|FG000|STARTED|Overall Study|Started=Randomized|21
6414285|NCT00960531|7327976|FG001|STARTED|Overall Study|Started=Randomized|6
6414286|NCT00960531|7327977|FG002|STARTED|Overall Study|Started=Randomized|41
6414287|NCT00960531|7327978|FG003|STARTED|Overall Study|Started=Randomized.|25
6414288|NCT00960531|7327979|FG004|STARTED|Overall Study|Started=Randomized|5
6414289|NCT00960531|7327980|FG005|STARTED|Overall Study|Started=Randomized|9
6414290|NCT00960531|7327981|FG006|STARTED|Overall Study|Started=Randomized|27
6414291|NCT00960531|7327982|FG007|STARTED|Overall Study|Started=Randomized|6
6414292|NCT00960531|7327983|FG008|STARTED|Overall Study|Started=Randomized|16
6414293|NCT00960531|7327984|FG009|STARTED|Overall Study|Started=Randomized|4
6414294|NCT00960531|7327975|FG000|Treated|Overall Study||21
6414295|NCT00960531|7327976|FG001|Treated|Overall Study||6
6414296|NCT00960531|7327977|FG002|Treated|Overall Study||41
6414297|NCT00960531|7327978|FG003|Treated|Overall Study||24
6414298|NCT00960531|7327979|FG004|Treated|Overall Study||5
6414299|NCT00960531|7327980|FG005|Treated|Overall Study||9
6414300|NCT00960531|7327981|FG006|Treated|Overall Study||27
6414301|NCT00960531|7327982|FG007|Treated|Overall Study||6
6414302|NCT00960531|7327983|FG008|Treated|Overall Study||16
6414303|NCT00960531|7327984|FG009|Treated|Overall Study||4
6414304|NCT00960531|7327975|FG000|Completed Treatment|Overall Study||12
6414305|NCT00960531|7327976|FG001|Completed Treatment|Overall Study||5
6414306|NCT00960531|7327977|FG002|Completed Treatment|Overall Study||15
6414307|NCT00960531|7327978|FG003|Completed Treatment|Overall Study||17
6414308|NCT00960531|7327979|FG004|Completed Treatment|Overall Study||3
6414309|NCT00960531|7327980|FG005|Completed Treatment|Overall Study||7
6414310|NCT00960531|7327981|FG006|Completed Treatment|Overall Study||4
6414311|NCT00960531|7327982|FG007|Completed Treatment|Overall Study||3
6414312|NCT00960531|7327983|FG008|Completed Treatment|Overall Study||2
6414313|NCT00960531|7327984|FG009|Completed Treatment|Overall Study||4
6414314|NCT00960531|7327975|FG000|COMPLETED|Overall Study|Completed study|11
6414315|NCT00960531|7327976|FG001|COMPLETED|Overall Study|Completed study|5
6414316|NCT00960531|7327977|FG002|COMPLETED|Overall Study|Completed study|15
6414317|NCT00960531|7327978|FG003|COMPLETED|Overall Study|Completed study|17
6414318|NCT00960531|7327979|FG004|COMPLETED|Overall Study|Completed study|3
6414319|NCT00960531|7327980|FG005|COMPLETED|Overall Study|Completed study|6
6414320|NCT00960531|7327981|FG006|COMPLETED|Overall Study|Completed study|3
6414321|NCT00960531|7327982|FG007|COMPLETED|Overall Study|Completed study|2
6414322|NCT00960531|7327983|FG008|COMPLETED|Overall Study|Completed study|2
6414323|NCT00960531|7327984|FG009|COMPLETED|Overall Study|Completed study|3
6414324|NCT00960531|7327975|FG000|NOT COMPLETED|Overall Study||10
6414325|NCT00960531|7327976|FG001|NOT COMPLETED|Overall Study||1
6414326|NCT00960531|7327977|FG002|NOT COMPLETED|Overall Study||26
6414327|NCT00960531|7327978|FG003|NOT COMPLETED|Overall Study||8
6414328|NCT00960531|7327979|FG004|NOT COMPLETED|Overall Study||2
6414329|NCT00960531|7327980|FG005|NOT COMPLETED|Overall Study||3
6414330|NCT00960531|7327981|FG006|NOT COMPLETED|Overall Study||24
6414331|NCT00960531|7327982|FG007|NOT COMPLETED|Overall Study||4
6414332|NCT00960531|7327983|FG008|NOT COMPLETED|Overall Study||14
6414333|NCT00960531|7327984|FG009|NOT COMPLETED|Overall Study||1
6414334|NCT00960570|7328010|FG000|STARTED|Efavirenz Alone||30
6414335|NCT00960570|7328010|FG000|COMPLETED|Efavirenz Alone||30
6414336|NCT00960570|7328010|FG000|NOT COMPLETED|Efavirenz Alone||0
6414337|NCT00960570|7328010|FG000|STARTED|21 Day Washout Period||30
6414338|NCT00960570|7328010|FG000|COMPLETED|21 Day Washout Period||28
6414339|NCT00960570|7328010|FG000|NOT COMPLETED|21 Day Washout Period||2
6414340|NCT00960570|7328010|FG000|STARTED|Fenofibric Acid Alone||28
6414341|NCT00960570|7328010|FG000|COMPLETED|Fenofibric Acid Alone||28
6414342|NCT00960570|7328010|FG000|NOT COMPLETED|Fenofibric Acid Alone||0
6414343|NCT00960570|7328010|FG000|STARTED|1 Day Period Between Dosing||28
6414344|NCT00960570|7328010|FG000|COMPLETED|1 Day Period Between Dosing||25
6414345|NCT00960570|7328010|FG000|NOT COMPLETED|1 Day Period Between Dosing||3
6414346|NCT00960570|7328010|FG000|STARTED|Efavirenz and Fenofibric Acid||25
6414347|NCT00960570|7328010|FG000|COMPLETED|Efavirenz and Fenofibric Acid||25
6414348|NCT00960570|7328010|FG000|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
6414349|NCT00960622|7328019|FG000|STARTED|Overall Study||10
6414350|NCT00960622|7328020|FG001|STARTED|Overall Study||10
6414351|NCT00960622|7328019|FG000|COMPLETED|Overall Study||10
6414352|NCT00960622|7328020|FG001|COMPLETED|Overall Study||7
6414353|NCT00960622|7328019|FG000|NOT COMPLETED|Overall Study||0
6414354|NCT00960622|7328020|FG001|NOT COMPLETED|Overall Study||3
6414355|NCT00960661|7328028|FG000|STARTED|Basal Insulin Optimization Phase (BIO)||1036
6414356|NCT00960661|7328029|FG001|STARTED|Basal Insulin Optimization Phase (BIO)||0
6414357|NCT00960661|7328030|FG002|STARTED|Basal Insulin Optimization Phase (BIO)||0
6414358|NCT00960661|7328028|FG000|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
6414359|NCT00960661|7328029|FG001|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
6414360|NCT00960661|7328030|FG002|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
6414361|NCT00960661|7328028|FG000|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
6414362|NCT00960661|7328029|FG001|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
6414363|NCT00960661|7328030|FG002|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
6414364|NCT00960661|7328028|FG000|STARTED|Interventional Phase||0
6414365|NCT00960661|7328029|FG001|STARTED|Interventional Phase||316
6414366|NCT00960661|7328030|FG002|STARTED|Interventional Phase||321
6414367|NCT00960661|7328028|FG000|Intent to Treat Population|Interventional Phase||0
6414368|NCT00960661|7328029|FG001|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
6414369|NCT00960661|7328030|FG002|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
6414370|NCT00960661|7328028|FG000|Per Protocol Population|Interventional Phase||0
6414371|NCT00960661|7328029|FG001|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
6414372|NCT00960661|7328030|FG002|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
6414373|NCT00960661|7328028|FG000|COMPLETED|Interventional Phase||0
6414374|NCT00960661|7328029|FG001|COMPLETED|Interventional Phase||264
6414375|NCT00960661|7328030|FG002|COMPLETED|Interventional Phase||275
6414376|NCT00960661|7328028|FG000|NOT COMPLETED|Interventional Phase||0
6414377|NCT00960661|7328029|FG001|NOT COMPLETED|Interventional Phase||52
6414378|NCT00960661|7328030|FG002|NOT COMPLETED|Interventional Phase||46
6414379|NCT00960687|7328036|FG000|STARTED|First Intervention||27
6414380|NCT00960687|7328037|FG001|STARTED|First Intervention||27
6414381|NCT00960687|7328036|FG000|COMPLETED|First Intervention||27
6414382|NCT00960687|7328037|FG001|COMPLETED|First Intervention||27
6414383|NCT00960687|7328036|FG000|NOT COMPLETED|First Intervention||0
6414384|NCT00960687|7328037|FG001|NOT COMPLETED|First Intervention||0
6414385|NCT00960687|7328036|FG000|STARTED|Washout Period of 7 Days||27
6414386|NCT00960687|7328037|FG001|STARTED|Washout Period of 7 Days||27
6414387|NCT00960687|7328036|FG000|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
6414388|NCT00960687|7328037|FG001|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
6414389|NCT00960687|7328036|FG000|NOT COMPLETED|Washout Period of 7 Days||4
6414390|NCT00960687|7328037|FG001|NOT COMPLETED|Washout Period of 7 Days||3
6414391|NCT00960687|7328036|FG000|STARTED|Second Intervention||23
6414392|NCT00960687|7328037|FG001|STARTED|Second Intervention||24
6414393|NCT00960687|7328036|FG000|COMPLETED|Second Intervention||23
6414394|NCT00960687|7328037|FG001|COMPLETED|Second Intervention||24
6414395|NCT00960687|7328036|FG000|NOT COMPLETED|Second Intervention||0
6414396|NCT00960687|7328037|FG001|NOT COMPLETED|Second Intervention||0
6414397|NCT00960778|7328045|FG000|STARTED|Overall Study||17
6414398|NCT00960778|7328046|FG001|STARTED|Overall Study||16
6414399|NCT00960778|7328045|FG000|COMPLETED|Overall Study||8
6414400|NCT00960778|7328046|FG001|COMPLETED|Overall Study||13
6414401|NCT00960778|7328045|FG000|NOT COMPLETED|Overall Study||9
6414402|NCT00960778|7328046|FG001|NOT COMPLETED|Overall Study||3
6414403|NCT00960804|7328055|FG000|STARTED|Overall Study||7
6414404|NCT00960804|7328056|FG001|STARTED|Overall Study||4
6414405|NCT00960804|7328057|FG002|STARTED|Overall Study||10
6414406|NCT00960804|7328055|FG000|COMPLETED|Overall Study||0
6414407|NCT00960804|7328056|FG001|COMPLETED|Overall Study||0
6414408|NCT00960804|7328057|FG002|COMPLETED|Overall Study||0
6414409|NCT00960804|7328055|FG000|NOT COMPLETED|Overall Study||7
6414410|NCT00960804|7328056|FG001|NOT COMPLETED|Overall Study||4
6414411|NCT00960804|7328057|FG002|NOT COMPLETED|Overall Study||10
6414412|NCT00960843|7328067|FG000|STARTED|Overall Study||25
6414413|NCT00960843|7328068|FG001|STARTED|Overall Study||26
6414414|NCT00960843|7328067|FG000|COMPLETED|Overall Study||23
6414415|NCT00960843|7328068|FG001|COMPLETED|Overall Study||21
6414416|NCT00960843|7328067|FG000|NOT COMPLETED|Overall Study||2
6414417|NCT00960843|7328068|FG001|NOT COMPLETED|Overall Study||5
6414418|NCT00960856|7328074|FG000|STARTED|Period I||10
6414419|NCT00960856|7328075|FG001|STARTED|Period I||9
6414420|NCT00960856|7328076|FG002|STARTED|Period I||9
6414421|NCT00960856|7328077|FG003|STARTED|Period I||9
6414422|NCT00960856|7328074|FG000|COMPLETED|Period I||10
6414423|NCT00960856|7328075|FG001|COMPLETED|Period I||9
6414424|NCT00960856|7328076|FG002|COMPLETED|Period I||9
6414425|NCT00960856|7328077|FG003|COMPLETED|Period I||9
6414426|NCT00960856|7328074|FG000|NOT COMPLETED|Period I||0
6414427|NCT00960856|7328075|FG001|NOT COMPLETED|Period I||0
6414428|NCT00960856|7328076|FG002|NOT COMPLETED|Period I||0
6414429|NCT00960856|7328077|FG003|NOT COMPLETED|Period I||0
6414430|NCT00960856|7328074|FG000|STARTED|Washout Period of 7 Days||10
6414431|NCT00960856|7328075|FG001|STARTED|Washout Period of 7 Days||9
6414432|NCT00960856|7328076|FG002|STARTED|Washout Period of 7 Days||9
6414433|NCT00960856|7328077|FG003|STARTED|Washout Period of 7 Days||9
6414434|NCT00960856|7328074|FG000|COMPLETED|Washout Period of 7 Days||10
6414435|NCT00960856|7328075|FG001|COMPLETED|Washout Period of 7 Days|personal reasons|7
6414436|NCT00960856|7328076|FG002|COMPLETED|Washout Period of 7 Days||9
6414437|NCT00960856|7328077|FG003|COMPLETED|Washout Period of 7 Days||9
6414438|NCT00960856|7328074|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6414439|NCT00960856|7328075|FG001|NOT COMPLETED|Washout Period of 7 Days||2
6414440|NCT00960856|7328076|FG002|NOT COMPLETED|Washout Period of 7 Days||0
6414441|NCT00960856|7328077|FG003|NOT COMPLETED|Washout Period of 7 Days||0
6414442|NCT00960856|7328074|FG000|STARTED|Period II||10
6414443|NCT00960856|7328075|FG001|STARTED|Period II||7
6414444|NCT00960856|7328076|FG002|STARTED|Period II||9
6414445|NCT00960856|7328077|FG003|STARTED|Period II||9
6414446|NCT00960856|7328074|FG000|COMPLETED|Period II||10
6414447|NCT00960856|7328075|FG001|COMPLETED|Period II||7
6414448|NCT00960856|7328076|FG002|COMPLETED|Period II||9
6414449|NCT00960856|7328077|FG003|COMPLETED|Period II||9
6414450|NCT00960856|7328074|FG000|NOT COMPLETED|Period II||0
6414451|NCT00960856|7328075|FG001|NOT COMPLETED|Period II||0
6414452|NCT00960856|7328076|FG002|NOT COMPLETED|Period II||0
6414453|NCT00960856|7328077|FG003|NOT COMPLETED|Period II||0
6414454|NCT00960856|7328074|FG000|STARTED|Washout Period of 7 Days||10
6414455|NCT00960856|7328075|FG001|STARTED|Washout Period of 7 Days||7
6414456|NCT00960856|7328076|FG002|STARTED|Washout Period of 7 Days||9
6414457|NCT00960856|7328077|FG003|STARTED|Washout Period of 7 Days||9
6414458|NCT00960856|7328074|FG000|COMPLETED|Washout Period of 7 Days||10
6414459|NCT00960856|7328075|FG001|COMPLETED|Washout Period of 7 Days||7
6414460|NCT00960856|7328076|FG002|COMPLETED|Washout Period of 7 Days||9
6414461|NCT00960856|7328077|FG003|COMPLETED|Washout Period of 7 Days||9
6414462|NCT00960856|7328074|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6414463|NCT00960856|7328075|FG001|NOT COMPLETED|Washout Period of 7 Days||0
6414464|NCT00960856|7328076|FG002|NOT COMPLETED|Washout Period of 7 Days||0
6414465|NCT00960856|7328077|FG003|NOT COMPLETED|Washout Period of 7 Days||0
6414466|NCT00960856|7328074|FG000|STARTED|Period III||10
6414467|NCT00960856|7328075|FG001|STARTED|Period III||7
6414468|NCT00960856|7328076|FG002|STARTED|Period III||9
6414469|NCT00960856|7328077|FG003|STARTED|Period III||9
6414470|NCT00960856|7328074|FG000|COMPLETED|Period III||10
6414471|NCT00960856|7328075|FG001|COMPLETED|Period III||7
6414472|NCT00960856|7328076|FG002|COMPLETED|Period III||9
6414473|NCT00960856|7328077|FG003|COMPLETED|Period III||9
6414474|NCT00960856|7328074|FG000|NOT COMPLETED|Period III||0
6414475|NCT00960856|7328075|FG001|NOT COMPLETED|Period III||0
6414476|NCT00960856|7328076|FG002|NOT COMPLETED|Period III||0
6414477|NCT00960856|7328077|FG003|NOT COMPLETED|Period III||0
6414478|NCT00960856|7328074|FG000|STARTED|Washout Period of 7 Days||10
6414479|NCT00960856|7328075|FG001|STARTED|Washout Period of 7 Days||7
6414480|NCT00960856|7328076|FG002|STARTED|Washout Period of 7 Days||9
6414481|NCT00960856|7328077|FG003|STARTED|Washout Period of 7 Days||9
6414482|NCT00960856|7328074|FG000|COMPLETED|Washout Period of 7 Days||10
6414483|NCT00960856|7328075|FG001|COMPLETED|Washout Period of 7 Days||7
6414484|NCT00960856|7328076|FG002|COMPLETED|Washout Period of 7 Days||8
6414485|NCT00960856|7328077|FG003|COMPLETED|Washout Period of 7 Days||9
6414486|NCT00960856|7328074|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6414487|NCT00960856|7328075|FG001|NOT COMPLETED|Washout Period of 7 Days||0
6414488|NCT00960856|7328076|FG002|NOT COMPLETED|Washout Period of 7 Days||1
6414489|NCT00960856|7328077|FG003|NOT COMPLETED|Washout Period of 7 Days||0
6414490|NCT00960856|7328074|FG000|STARTED|Period IV||10
6414491|NCT00960856|7328075|FG001|STARTED|Period IV||7
6414492|NCT00960856|7328076|FG002|STARTED|Period IV||8
6414493|NCT00960856|7328077|FG003|STARTED|Period IV||9
6414494|NCT00960856|7328074|FG000|COMPLETED|Period IV||10
6414495|NCT00960856|7328075|FG001|COMPLETED|Period IV||7
6414496|NCT00960856|7328076|FG002|COMPLETED|Period IV||8
6414497|NCT00960856|7328077|FG003|COMPLETED|Period IV||9
6414498|NCT00960856|7328074|FG000|NOT COMPLETED|Period IV||0
6414499|NCT00960856|7328075|FG001|NOT COMPLETED|Period IV||0
6414500|NCT00960856|7328076|FG002|NOT COMPLETED|Period IV||0
6414501|NCT00960856|7328077|FG003|NOT COMPLETED|Period IV||0
6414502|NCT00960869|7328089|FG000|STARTED|Overall Study||259
6414503|NCT00960869|7328090|FG001|STARTED|Overall Study||260
6414504|NCT00960869|7328089|FG000|Intent-to-Treat Population (ITT)|Overall Study||259
6414505|NCT00960869|7328090|FG001|Intent-to-Treat Population (ITT)|Overall Study||260
6414506|NCT00960869|7328089|FG000|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
6414507|NCT00960869|7328090|FG001|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
6414508|NCT00960869|7328089|FG000|COMPLETED|Overall Study||206
6414509|NCT00960869|7328090|FG001|COMPLETED|Overall Study||198
6414510|NCT00960869|7328089|FG000|NOT COMPLETED|Overall Study||53
6414511|NCT00960869|7328090|FG001|NOT COMPLETED|Overall Study||62
6414512|NCT00960934|7328102|FG000|STARTED|Overall Study||64
6414513|NCT00960934|7328103|FG001|STARTED|Overall Study||63
6414514|NCT00960934|7328104|FG002|STARTED|Overall Study||64
6414515|NCT00960934|7328105|FG003|STARTED|Overall Study||64
6414516|NCT00960934|7328106|FG004|STARTED|Overall Study||64
6414517|NCT00960934|7328107|FG005|STARTED|Overall Study||64
6414518|NCT00960934|7328102|FG000|Number Treated|Overall Study||64
6414519|NCT00960934|7328103|FG001|Number Treated|Overall Study|1 participant was randomized but not treated|62
6414520|NCT00960934|7328104|FG002|Number Treated|Overall Study||64
6414521|NCT00960934|7328105|FG003|Number Treated|Overall Study||64
6414522|NCT00960934|7328106|FG004|Number Treated|Overall Study|1 participant was randomized but not treated|63
6414523|NCT00960934|7328107|FG005|Number Treated|Overall Study|1 participant was randomized but not treated|63
6414524|NCT00960934|7328102|FG000|COMPLETED|Overall Study||0
6414525|NCT00960934|7328103|FG001|COMPLETED|Overall Study||0
6414526|NCT00960934|7328104|FG002|COMPLETED|Overall Study||0
6414527|NCT00960934|7328105|FG003|COMPLETED|Overall Study||0
6414528|NCT00960934|7328106|FG004|COMPLETED|Overall Study||0
6414529|NCT00960934|7328107|FG005|COMPLETED|Overall Study||0
6414530|NCT00960934|7328102|FG000|NOT COMPLETED|Overall Study||64
6414531|NCT00960934|7328103|FG001|NOT COMPLETED|Overall Study||63
6414532|NCT00960934|7328104|FG002|NOT COMPLETED|Overall Study||64
6414533|NCT00960934|7328105|FG003|NOT COMPLETED|Overall Study||64
6414534|NCT00960934|7328106|FG004|NOT COMPLETED|Overall Study||64
6414535|NCT00960934|7328107|FG005|NOT COMPLETED|Overall Study||64
6414536|NCT00960986|7328125|FG000|STARTED|Period 1 (Screening and Washout)||59
6414537|NCT00960986|7328126|FG001|STARTED|Period 1 (Screening and Washout)||63
6414538|NCT00960986|7328127|FG002|STARTED|Period 1 (Screening and Washout)||63
6414539|NCT00960986|7328128|FG003|STARTED|Period 1 (Screening and Washout)||64
6414540|NCT00960986|7328125|FG000|COMPLETED|Period 1 (Screening and Washout)||56
6414541|NCT00960986|7328126|FG001|COMPLETED|Period 1 (Screening and Washout)||59
6414542|NCT00960986|7328127|FG002|COMPLETED|Period 1 (Screening and Washout)||59
6414543|NCT00960986|7328128|FG003|COMPLETED|Period 1 (Screening and Washout)||61
6414544|NCT00960986|7328125|FG000|NOT COMPLETED|Period 1 (Screening and Washout)||3
6414545|NCT00960986|7328126|FG001|NOT COMPLETED|Period 1 (Screening and Washout)||4
6414546|NCT00960986|7328127|FG002|NOT COMPLETED|Period 1 (Screening and Washout)||4
6414547|NCT00960986|7328128|FG003|NOT COMPLETED|Period 1 (Screening and Washout)||3
6414548|NCT00960986|7328125|FG000|STARTED|Period 2 (1-week Initial Dosing Period)||56
6414549|NCT00960986|7328126|FG001|STARTED|Period 2 (1-week Initial Dosing Period)||59
6414550|NCT00960986|7328127|FG002|STARTED|Period 2 (1-week Initial Dosing Period)||59
6414551|NCT00960986|7328128|FG003|STARTED|Period 2 (1-week Initial Dosing Period)||61
6414552|NCT00960986|7328125|FG000|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
6414553|NCT00960986|7328126|FG001|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
6414554|NCT00960986|7328127|FG002|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
6414555|NCT00960986|7328128|FG003|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
6414556|NCT00960986|7328125|FG000|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
6414557|NCT00960986|7328126|FG001|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
6414558|NCT00960986|7328127|FG002|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
6414559|NCT00960986|7328128|FG003|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
6414560|NCT00960986|7328125|FG000|STARTED|Period 3 (7-week Therapy Period)||56
6414561|NCT00960986|7328126|FG001|STARTED|Period 3 (7-week Therapy Period)||59
6414562|NCT00960986|7328127|FG002|STARTED|Period 3 (7-week Therapy Period)||59
6414563|NCT00960986|7328128|FG003|STARTED|Period 3 (7-week Therapy Period)||61
6414564|NCT00960986|7328125|FG000|COMPLETED|Period 3 (7-week Therapy Period)||26
6414565|NCT00960986|7328126|FG001|COMPLETED|Period 3 (7-week Therapy Period)||36
6414566|NCT00960986|7328127|FG002|COMPLETED|Period 3 (7-week Therapy Period)||39
6414567|NCT00960986|7328128|FG003|COMPLETED|Period 3 (7-week Therapy Period)||36
6414568|NCT00960986|7328125|FG000|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
6414569|NCT00960986|7328126|FG001|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
6414570|NCT00960986|7328127|FG002|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
6414571|NCT00960986|7328128|FG003|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
6414572|NCT00960999|7328140|FG000|STARTED|Overall Study||47
6414573|NCT00960999|7328141|FG001|STARTED|Overall Study||47
6414574|NCT00960999|7328140|FG000|Eligible|Overall Study||39
6414575|NCT00960999|7328141|FG001|Eligible|Overall Study||45
6414576|NCT00960999|7328140|FG000|Started Protocol Treatment|Overall Study||39
6414577|NCT00960999|7328141|FG001|Started Protocol Treatment|Overall Study||45
6414578|NCT00960999|7328140|FG000|Primary Endpoint Population|Overall Study||38
6414579|NCT00960999|7328141|FG001|Primary Endpoint Population|Overall Study||38
6414580|NCT00960999|7328140|FG000|Peak SUV at 8 Weeks|Overall Study||3
6414581|NCT00960999|7328141|FG001|Peak SUV at 8 Weeks|Overall Study||11
6414582|NCT00960999|7328140|FG000|Peak SUV at 1 Year|Overall Study||4
6414583|NCT00960999|7328141|FG001|Peak SUV at 1 Year|Overall Study||7
6414584|NCT00960999|7328140|FG000|Normalized SUV at 8 Weeks|Overall Study||3
6414585|NCT00960999|7328141|FG001|Normalized SUV at 8 Weeks|Overall Study||9
6414586|NCT00960999|7328140|FG000|Normalized SUV at 1 Year|Overall Study||4
6414587|NCT00960999|7328141|FG001|Normalized SUV at 1 Year|Overall Study||7
6414588|NCT00960999|7328140|FG000|FEV1 by Best Response|Overall Study||26
6414589|NCT00960999|7328141|FG001|FEV1 by Best Response|Overall Study||33
6414590|NCT00960999|7328140|FG000|DLCO by Best Response|Overall Study||23
6414591|NCT00960999|7328141|FG001|DLCO by Best Response|Overall Study||28
6414592|NCT00960999|7328140|FG000|COMPLETED|Overall Study||39
6414593|NCT00960999|7328141|FG001|COMPLETED|Overall Study||45
6414594|NCT00960999|7328140|FG000|NOT COMPLETED|Overall Study||8
6414595|NCT00960999|7328141|FG001|NOT COMPLETED|Overall Study||2
6414596|NCT00961051|7328149|FG000|STARTED|Overall Study||177
6414597|NCT00961051|7328150|FG001|STARTED|Overall Study||93
6414598|NCT00961051|7328149|FG000|COMPLETED|Overall Study||165
6414599|NCT00961051|7328150|FG001|COMPLETED|Overall Study||79
6414600|NCT00961051|7328149|FG000|NOT COMPLETED|Overall Study||12
6414601|NCT00961051|7328150|FG001|NOT COMPLETED|Overall Study||14
6414602|NCT00961116|7328156|FG000|STARTED|First Intervention||27
6414603|NCT00961116|7328157|FG001|STARTED|First Intervention||27
6414604|NCT00961116|7328156|FG000|COMPLETED|First Intervention||27
6414605|NCT00961116|7328157|FG001|COMPLETED|First Intervention||27
6414606|NCT00961116|7328156|FG000|NOT COMPLETED|First Intervention||0
6414607|NCT00961116|7328157|FG001|NOT COMPLETED|First Intervention||0
6414608|NCT00961116|7328156|FG000|STARTED|Washout Period of 7 Days||27
6414609|NCT00961116|7328157|FG001|STARTED|Washout Period of 7 Days||27
6414610|NCT00961116|7328156|FG000|COMPLETED|Washout Period of 7 Days||25
6414611|NCT00961116|7328157|FG001|COMPLETED|Washout Period of 7 Days||24
6414612|NCT00961116|7328156|FG000|NOT COMPLETED|Washout Period of 7 Days||2
6414613|NCT00961116|7328157|FG001|NOT COMPLETED|Washout Period of 7 Days||3
6414614|NCT00961116|7328156|FG000|STARTED|Second Intervention||25
6414615|NCT00961116|7328157|FG001|STARTED|Second Intervention||24
6414616|NCT00961116|7328156|FG000|COMPLETED|Second Intervention||25
6414617|NCT00961116|7328157|FG001|COMPLETED|Second Intervention||24
6414618|NCT00961116|7328156|FG000|NOT COMPLETED|Second Intervention||0
6414619|NCT00961116|7328157|FG001|NOT COMPLETED|Second Intervention||0
6414620|NCT00961181|7328164|FG000|STARTED|Overall Study||81
6414621|NCT00961181|7328164|FG000|COMPLETED|Overall Study||76
6414622|NCT00961181|7328164|FG000|NOT COMPLETED|Overall Study||5
6414623|NCT00961220|7328168|FG000|STARTED|Overall Study||17
6414624|NCT00961220|7328168|FG000|COMPLETED|Overall Study||10
6414625|NCT00961220|7328168|FG000|NOT COMPLETED|Overall Study||7
6414626|NCT00961233|7328176|FG000|STARTED|Overall Study||13
6414627|NCT00961233|7328177|FG001|STARTED|Overall Study||12
6414628|NCT00961233|7328176|FG000|COMPLETED|Overall Study||11
6414629|NCT00961233|7328177|FG001|COMPLETED|Overall Study||11
6414630|NCT00961233|7328176|FG000|NOT COMPLETED|Overall Study||2
6414631|NCT00961233|7328177|FG001|NOT COMPLETED|Overall Study||1
6414632|NCT00961259|7328185|FG000|STARTED|First Intervention||18
6414633|NCT00961259|7328186|FG001|STARTED|First Intervention||18
6414634|NCT00961259|7328187|FG002|STARTED|First Intervention||18
6414635|NCT00961259|7328185|FG000|COMPLETED|First Intervention||18
6414636|NCT00961259|7328186|FG001|COMPLETED|First Intervention||18
6414637|NCT00961259|7328187|FG002|COMPLETED|First Intervention||18
6414638|NCT00961259|7328185|FG000|NOT COMPLETED|First Intervention||0
6510645|NCT01483599|7430220|FG013|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
6510646|NCT01483625|7430251|FG000|STARTED|Overall Study||72
6510647|NCT01483625|7430252|FG001|STARTED|Overall Study||68
6510648|NCT01483625|7430251|FG000|COMPLETED|Overall Study||68
6510649|NCT01483625|7430252|FG001|COMPLETED|Overall Study||66
6510650|NCT01483625|7430251|FG000|NOT COMPLETED|Overall Study||4
6510651|NCT01483625|7430252|FG001|NOT COMPLETED|Overall Study||2
6510652|NCT01483651|7430258|FG000|STARTED|Overall Study||1
6510653|NCT01483651|7430259|FG001|STARTED|Overall Study||3
6510654|NCT01483651|7430260|FG002|STARTED|Overall Study||2
6510655|NCT01483651|7430261|FG003|STARTED|Overall Study||1
6510656|NCT01483651|7430262|FG004|STARTED|Overall Study||2
6510657|NCT01483651|7430263|FG005|STARTED|Overall Study||2
6510658|NCT01483651|7430258|FG000|COMPLETED|Overall Study||1
6510659|NCT01483651|7430259|FG001|COMPLETED|Overall Study||2
6510660|NCT01483651|7430260|FG002|COMPLETED|Overall Study||1
6510661|NCT01483651|7430261|FG003|COMPLETED|Overall Study||1
6510662|NCT01483651|7430262|FG004|COMPLETED|Overall Study||2
6510663|NCT01483651|7430263|FG005|COMPLETED|Overall Study||1
6510664|NCT01483651|7430258|FG000|NOT COMPLETED|Overall Study||0
6510665|NCT01483651|7430259|FG001|NOT COMPLETED|Overall Study||1
6510666|NCT01483651|7430260|FG002|NOT COMPLETED|Overall Study||1
6510667|NCT01483651|7430261|FG003|NOT COMPLETED|Overall Study||0
6510668|NCT01483651|7430262|FG004|NOT COMPLETED|Overall Study||0
6510669|NCT01483651|7430263|FG005|NOT COMPLETED|Overall Study||1
6510670|NCT01483690|7430273|FG000|STARTED|Overall Study||5
6510671|NCT01483690|7430274|FG001|STARTED|Overall Study||18
6510672|NCT01483690|7430273|FG000|COMPLETED|Overall Study||3
6510673|NCT01483690|7430274|FG001|COMPLETED|Overall Study||13
6510674|NCT01483690|7430273|FG000|NOT COMPLETED|Overall Study||2
6510675|NCT01483690|7430274|FG001|NOT COMPLETED|Overall Study||5
6510676|NCT01483807|7430280|FG000|STARTED|First Treatment Phase (7 Weeks)||10
6414639|NCT00961259|7328186|FG001|NOT COMPLETED|First Intervention||0
6414640|NCT00961259|7328187|FG002|NOT COMPLETED|First Intervention||0
6414641|NCT00961259|7328185|FG000|STARTED|Washout Period of 7 Days||18
6414642|NCT00961259|7328186|FG001|STARTED|Washout Period of 7 Days||18
6414643|NCT00961259|7328187|FG002|STARTED|Washout Period of 7 Days||18
6414644|NCT00961259|7328185|FG000|COMPLETED|Washout Period of 7 Days||18
6414645|NCT00961259|7328186|FG001|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
6414646|NCT00961259|7328187|FG002|COMPLETED|Washout Period of 7 Days||18
6414647|NCT00961259|7328185|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6414648|NCT00961259|7328186|FG001|NOT COMPLETED|Washout Period of 7 Days||1
6414649|NCT00961259|7328187|FG002|NOT COMPLETED|Washout Period of 7 Days||0
6414650|NCT00961259|7328185|FG000|STARTED|Second Intervention||18
6414651|NCT00961259|7328186|FG001|STARTED|Second Intervention||17
6414652|NCT00961259|7328187|FG002|STARTED|Second Intervention||18
6414653|NCT00961259|7328185|FG000|COMPLETED|Second Intervention||18
6414654|NCT00961259|7328186|FG001|COMPLETED|Second Intervention||17
6414655|NCT00961259|7328187|FG002|COMPLETED|Second Intervention||18
6414656|NCT00961259|7328185|FG000|NOT COMPLETED|Second Intervention||0
6414657|NCT00961259|7328186|FG001|NOT COMPLETED|Second Intervention||0
6414658|NCT00961259|7328187|FG002|NOT COMPLETED|Second Intervention||0
6414659|NCT00961259|7328185|FG000|STARTED|Washout Period of 7 Days||18
6414660|NCT00961259|7328186|FG001|STARTED|Washout Period of 7 Days||17
6414661|NCT00961259|7328187|FG002|STARTED|Washout Period of 7 Days||18
6414662|NCT00961259|7328185|FG000|COMPLETED|Washout Period of 7 Days||18
6414663|NCT00961259|7328186|FG001|COMPLETED|Washout Period of 7 Days||17
6414664|NCT00961259|7328187|FG002|COMPLETED|Washout Period of 7 Days||18
6414665|NCT00961259|7328185|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6414666|NCT00961259|7328186|FG001|NOT COMPLETED|Washout Period of 7 Days||0
6414667|NCT00961259|7328187|FG002|NOT COMPLETED|Washout Period of 7 Days||0
6414668|NCT00961259|7328185|FG000|STARTED|Third Intervention||18
6414669|NCT00961259|7328186|FG001|STARTED|Third Intervention||17
6414670|NCT00961259|7328187|FG002|STARTED|Third Intervention||18
6414671|NCT00961259|7328185|FG000|COMPLETED|Third Intervention||18
6414672|NCT00961259|7328186|FG001|COMPLETED|Third Intervention||17
6414673|NCT00961259|7328187|FG002|COMPLETED|Third Intervention||18
6414674|NCT00961259|7328185|FG000|NOT COMPLETED|Third Intervention||0
6414675|NCT00961259|7328186|FG001|NOT COMPLETED|Third Intervention||0
6414676|NCT00961259|7328187|FG002|NOT COMPLETED|Third Intervention||0
6414677|NCT00961298|7328196|FG000|STARTED|Two Week Placebo Run in||15
6414678|NCT00961298|7328196|FG000|COMPLETED|Two Week Placebo Run in||14
6414679|NCT00961298|7328196|FG000|NOT COMPLETED|Two Week Placebo Run in||1
6414680|NCT00961298|7328196|FG000|STARTED|12 Weeks Duloxetine Treatment Phase||14
6414681|NCT00961298|7328196|FG000|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
6414682|NCT00961298|7328196|FG000|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
6414683|NCT00961311|7328200|FG000|STARTED|Overall Study||51
6414684|NCT00961311|7328200|FG000|COMPLETED|Overall Study||51
6638482|NCT02323334|7567012|FG009|COMPLETED|Period 2||0
6638483|NCT02323334|7567013|FG010|COMPLETED|Period 2||0
6638484|NCT02323334|7567014|FG011|COMPLETED|Period 2||0
6638485|NCT02323334|7567015|FG012|COMPLETED|Period 2||0
6414685|NCT00961311|7328200|FG000|NOT COMPLETED|Overall Study||0
6414686|NCT00961350|7328206|FG000|STARTED|Overall Study||265
6414687|NCT00961350|7328207|FG001|STARTED|Overall Study||265
6414688|NCT00961350|7328206|FG000|Intent-to-Treat Population (ITT)|Overall Study||265
6414689|NCT00961350|7328207|FG001|Intent-to-Treat Population (ITT)|Overall Study||265
6414690|NCT00961350|7328206|FG000|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
6414691|NCT00961350|7328207|FG001|Safety Population|Overall Study||265
6414692|NCT00961350|7328206|FG000|COMPLETED|Overall Study||218
6414693|NCT00961350|7328207|FG001|COMPLETED|Overall Study||198
6414694|NCT00961350|7328206|FG000|NOT COMPLETED|Overall Study||47
6414695|NCT00961350|7328207|FG001|NOT COMPLETED|Overall Study||67
6414696|NCT00961402|7328215|FG000|STARTED|Overall Study||64
6414697|NCT00961402|7328216|FG001|STARTED|Overall Study||66
6414698|NCT00961402|7328215|FG000|Randomized|Overall Study||64
6414699|NCT00961402|7328216|FG001|Randomized|Overall Study||66
6414700|NCT00961402|7328215|FG000|COMPLETED|Overall Study||63
6414701|NCT00961402|7328216|FG001|COMPLETED|Overall Study||61
6414702|NCT00961402|7328215|FG000|NOT COMPLETED|Overall Study||1
6414703|NCT00961402|7328216|FG001|NOT COMPLETED|Overall Study||5
6414704|NCT00961415|7328224|FG000|STARTED|Induction Treatment Phase||376
6414705|NCT00961415|7328225|FG001|STARTED|Induction Treatment Phase||0
6414706|NCT00961415|7328226|FG002|STARTED|Induction Treatment Phase||0
6414707|NCT00961415|7328224|FG000|COMPLETED|Induction Treatment Phase||253
6414708|NCT00961415|7328225|FG001|COMPLETED|Induction Treatment Phase||0
6414709|NCT00961415|7328226|FG002|COMPLETED|Induction Treatment Phase||0
6414710|NCT00961415|7328224|FG000|NOT COMPLETED|Induction Treatment Phase||123
6414711|NCT00961415|7328225|FG001|NOT COMPLETED|Induction Treatment Phase||0
6414712|NCT00961415|7328226|FG002|NOT COMPLETED|Induction Treatment Phase||0
6414713|NCT00961415|7328224|FG000|STARTED|Maintenance Treatment Phase||0
6414714|NCT00961415|7328225|FG001|STARTED|Maintenance Treatment Phase||125
6414715|NCT00961415|7328226|FG002|STARTED|Maintenance Treatment Phase||128
6414716|NCT00961415|7328224|FG000|COMPLETED|Maintenance Treatment Phase||0
6414717|NCT00961415|7328225|FG001|COMPLETED|Maintenance Treatment Phase||77
6638486|NCT02323334|7567016|FG013|COMPLETED|Period 2||0
6638487|NCT02323334|7567017|FG014|COMPLETED|Period 2||0
6414718|NCT00961415|7328226|FG002|COMPLETED|Maintenance Treatment Phase||83
6414719|NCT00961415|7328224|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
6638488|NCT02323334|7567018|FG015|COMPLETED|Period 2||0
6414720|NCT00961415|7328225|FG001|NOT COMPLETED|Maintenance Treatment Phase||48
6414721|NCT00961415|7328226|FG002|NOT COMPLETED|Maintenance Treatment Phase||45
6414722|NCT00961441|7328242|FG000|STARTED|Overall Study||12
6414723|NCT00961441|7328243|FG001|STARTED|Overall Study||13
6414724|NCT00961441|7328242|FG000|Pharmacokinetic (PK-PP) Population|Overall Study||12
6414725|NCT00961441|7328243|FG001|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
6414726|NCT00961441|7328242|FG000|COMPLETED|Overall Study||12
6414727|NCT00961441|7328243|FG001|COMPLETED|Overall Study||13
6414728|NCT00961441|7328242|FG000|NOT COMPLETED|Overall Study||0
6414729|NCT00961441|7328243|FG001|NOT COMPLETED|Overall Study||0
6414730|NCT00961532|7328249|FG000|STARTED|Overall Study||14
6414731|NCT00961532|7328249|FG000|COMPLETED|Overall Study||14
6414732|NCT00961532|7328249|FG000|NOT COMPLETED|Overall Study||0
6414733|NCT00961571|7328253|FG000|STARTED|Overall Study||50
6414734|NCT00961571|7328253|FG000|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
6414735|NCT00961571|7328253|FG000|NOT COMPLETED|Overall Study||39
6414736|NCT00961636|7328260|FG000|STARTED|Overall Study||463
6414737|NCT00961636|7328261|FG001|STARTED|Overall Study||456
6414738|NCT00961636|7328262|FG002|STARTED|Overall Study||233
6414739|NCT00961636|7328260|FG000|COMPLETED|Overall Study||356
6414740|NCT00961636|7328261|FG001|COMPLETED|Overall Study||325
6414741|NCT00961636|7328262|FG002|COMPLETED|Overall Study||201
6414742|NCT00961636|7328260|FG000|NOT COMPLETED|Overall Study||107
6414743|NCT00961636|7328261|FG001|NOT COMPLETED|Overall Study||131
6414744|NCT00961636|7328262|FG002|NOT COMPLETED|Overall Study||32
6414745|NCT00961649|7328274|FG000|STARTED|Overall Study||41
6414746|NCT00961649|7328275|FG001|STARTED|Overall Study||44
6414747|NCT00961649|7328276|FG002|STARTED|Overall Study||44
6414748|NCT00961649|7328277|FG003|STARTED|Overall Study||41
6414749|NCT00961649|7328274|FG000|COMPLETED|Overall Study||32
6414750|NCT00961649|7328275|FG001|COMPLETED|Overall Study||40
6414751|NCT00961649|7328276|FG002|COMPLETED|Overall Study||39
6414752|NCT00961649|7328277|FG003|COMPLETED|Overall Study||37
6414753|NCT00961649|7328274|FG000|NOT COMPLETED|Overall Study||9
6414754|NCT00961649|7328275|FG001|NOT COMPLETED|Overall Study||4
6414755|NCT00961649|7328276|FG002|NOT COMPLETED|Overall Study||5
6414756|NCT00961649|7328277|FG003|NOT COMPLETED|Overall Study||4
6414757|NCT00961662|7328290|FG000|STARTED|Overall Study||57
6414758|NCT00961662|7328291|FG001|STARTED|Overall Study||51
6414759|NCT00961662|7328292|FG002|STARTED|Overall Study||53
6414760|NCT00961662|7328290|FG000|COMPLETED|Overall Study||35
6414761|NCT00961662|7328291|FG001|COMPLETED|Overall Study||32
6414762|NCT00961662|7328292|FG002|COMPLETED|Overall Study||34
6414763|NCT00961662|7328290|FG000|NOT COMPLETED|Overall Study||22
6414764|NCT00961662|7328291|FG001|NOT COMPLETED|Overall Study||19
6414765|NCT00961662|7328292|FG002|NOT COMPLETED|Overall Study||19
6414766|NCT00961896|7328303|FG000|STARTED|Overall Study||8
6414767|NCT00961896|7328304|FG001|STARTED|Overall Study||3
6414768|NCT00961896|7328305|FG002|STARTED|Overall Study||7
6414769|NCT00961896|7328303|FG000|COMPLETED|Overall Study||8
6414770|NCT00961896|7328304|FG001|COMPLETED|Overall Study||3
6414771|NCT00961896|7328305|FG002|COMPLETED|Overall Study||6
6414772|NCT00961896|7328303|FG000|NOT COMPLETED|Overall Study||0
6414773|NCT00961896|7328304|FG001|NOT COMPLETED|Overall Study||0
6414774|NCT00961896|7328305|FG002|NOT COMPLETED|Overall Study||1
6414775|NCT00961961|7328320|FG000|STARTED|Phase I||177
6414776|NCT00961961|7328321|FG001|STARTED|Phase I||0
6414777|NCT00961961|7328322|FG002|STARTED|Phase I||0
6414778|NCT00961961|7328323|FG003|STARTED|Phase I||0
6414779|NCT00961961|7328320|FG000|COMPLETED|Phase I||51
6414780|NCT00961961|7328321|FG001|COMPLETED|Phase I||0
6414781|NCT00961961|7328322|FG002|COMPLETED|Phase I||0
6414782|NCT00961961|7328323|FG003|COMPLETED|Phase I||0
6414783|NCT00961961|7328320|FG000|NOT COMPLETED|Phase I||126
6414784|NCT00961961|7328321|FG001|NOT COMPLETED|Phase I||0
6414785|NCT00961961|7328322|FG002|NOT COMPLETED|Phase I||0
6414786|NCT00961961|7328323|FG003|NOT COMPLETED|Phase I||0
6414787|NCT00961961|7328320|FG000|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
6414788|NCT00961961|7328321|FG001|STARTED|Phase II|This is a Phase I category. Not relevant in Phase II.|0
6414789|NCT00961961|7328322|FG002|STARTED|Phase II||29
6414790|NCT00961961|7328323|FG003|STARTED|Phase II||22
6414791|NCT00961961|7328320|FG000|COMPLETED|Phase II||0
6414792|NCT00961961|7328321|FG001|COMPLETED|Phase II||0
6414793|NCT00961961|7328322|FG002|COMPLETED|Phase II||17
6414794|NCT00961961|7328323|FG003|COMPLETED|Phase II||14
6414795|NCT00961961|7328320|FG000|NOT COMPLETED|Phase II||0
6414796|NCT00961961|7328321|FG001|NOT COMPLETED|Phase II||0
6414797|NCT00961961|7328322|FG002|NOT COMPLETED|Phase II||12
6414798|NCT00961961|7328323|FG003|NOT COMPLETED|Phase II||8
6414799|NCT00962000|7328343|FG000|STARTED|Period 1 - 1 Week||21
6414800|NCT00962000|7328344|FG001|STARTED|Period 1 - 1 Week||21
6414801|NCT00962000|7328343|FG000|COMPLETED|Period 1 - 1 Week||21
6414802|NCT00962000|7328344|FG001|COMPLETED|Period 1 - 1 Week||21
6414803|NCT00962000|7328343|FG000|NOT COMPLETED|Period 1 - 1 Week||0
6414804|NCT00962000|7328344|FG001|NOT COMPLETED|Period 1 - 1 Week||0
6414805|NCT00962000|7328343|FG000|STARTED|Period 2 - 1 Week||21
6414806|NCT00962000|7328344|FG001|STARTED|Period 2 - 1 Week||21
6414807|NCT00962000|7328343|FG000|COMPLETED|Period 2 - 1 Week||21
6414808|NCT00962000|7328344|FG001|COMPLETED|Period 2 - 1 Week||21
6414809|NCT00962000|7328343|FG000|NOT COMPLETED|Period 2 - 1 Week||0
6414810|NCT00962000|7328344|FG001|NOT COMPLETED|Period 2 - 1 Week||0
6414811|NCT00962000|7328343|FG000|STARTED|Period 3 - 1 Week||21
6414812|NCT00962000|7328344|FG001|STARTED|Period 3 - 1 Week||21
6414813|NCT00962000|7328343|FG000|COMPLETED|Period 3 - 1 Week||21
6414814|NCT00962000|7328344|FG001|COMPLETED|Period 3 - 1 Week||21
6414815|NCT00962000|7328343|FG000|NOT COMPLETED|Period 3 - 1 Week||0
6414816|NCT00962000|7328344|FG001|NOT COMPLETED|Period 3 - 1 Week||0
6414817|NCT00962000|7328343|FG000|STARTED|Period 4 - 1 Week||21
6414818|NCT00962000|7328344|FG001|STARTED|Period 4 - 1 Week||21
6414819|NCT00962000|7328343|FG000|COMPLETED|Period 4 - 1 Week||21
6414820|NCT00962000|7328344|FG001|COMPLETED|Period 4 - 1 Week||21
6414821|NCT00962000|7328343|FG000|NOT COMPLETED|Period 4 - 1 Week||0
6414822|NCT00962000|7328344|FG001|NOT COMPLETED|Period 4 - 1 Week||0
6414823|NCT00962013|7328350|FG000|STARTED|Overall Study||120
6414824|NCT00962013|7328350|FG000|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
6414825|NCT00962013|7328350|FG000|NOT COMPLETED|Overall Study||68
6414826|NCT00962039|7328356|FG000|STARTED|Overall Study||40
6414827|NCT00962039|7328357|FG001|STARTED|Overall Study||41
6414828|NCT00962039|7328356|FG000|COMPLETED|Overall Study||35
6414829|NCT00962039|7328357|FG001|COMPLETED|Overall Study||37
6414830|NCT00962039|7328356|FG000|NOT COMPLETED|Overall Study||5
6414831|NCT00962039|7328357|FG001|NOT COMPLETED|Overall Study||4
6414832|NCT00962065|7328366|FG000|STARTED|Overall Study||12
6414833|NCT00962065|7328367|FG001|STARTED|Overall Study||12
6414834|NCT00962065|7328368|FG002|STARTED|Overall Study||12
6414835|NCT00962065|7328366|FG000|COMPLETED|Overall Study||12
6414836|NCT00962065|7328367|FG001|COMPLETED|Overall Study||12
6414837|NCT00962065|7328368|FG002|COMPLETED|Overall Study||12
6414838|NCT00962065|7328366|FG000|NOT COMPLETED|Overall Study||0
6414839|NCT00962065|7328367|FG001|NOT COMPLETED|Overall Study||0
6414840|NCT00962065|7328368|FG002|NOT COMPLETED|Overall Study||0
6414841|NCT00962078|7328378|FG000|STARTED|Overall Study||35
6414842|NCT00962078|7328379|FG001|STARTED|Overall Study||36
6414843|NCT00962078|7328378|FG000|COMPLETED|Overall Study||30
6414844|NCT00962078|7328379|FG001|COMPLETED|Overall Study||30
6414845|NCT00962078|7328378|FG000|NOT COMPLETED|Overall Study||5
6414846|NCT00962078|7328379|FG001|NOT COMPLETED|Overall Study||6
6414847|NCT00962091|7328392|FG000|STARTED|Overall Study||4
6414848|NCT00962091|7328393|FG001|STARTED|Overall Study||9
6414849|NCT00962091|7328394|FG002|STARTED|Overall Study||10
6414850|NCT00962091|7328395|FG003|STARTED|Overall Study||3
6414851|NCT00962091|7328396|FG004|STARTED|Overall Study||3
6414852|NCT00962091|7328397|FG005|STARTED|Overall Study||12
6414853|NCT00962091|7328398|FG006|STARTED|Overall Study||12
6414854|NCT00962091|7328392|FG000|COMPLETED|Overall Study||3
6414855|NCT00962091|7328393|FG001|COMPLETED|Overall Study||7
6414856|NCT00962091|7328394|FG002|COMPLETED|Overall Study||9
6414857|NCT00962091|7328395|FG003|COMPLETED|Overall Study||2
6414858|NCT00962091|7328396|FG004|COMPLETED|Overall Study||3
6414859|NCT00962091|7328397|FG005|COMPLETED|Overall Study||11
6414860|NCT00962091|7328398|FG006|COMPLETED|Overall Study||11
6414861|NCT00962091|7328392|FG000|NOT COMPLETED|Overall Study||1
6414862|NCT00962091|7328393|FG001|NOT COMPLETED|Overall Study||2
6414863|NCT00962091|7328394|FG002|NOT COMPLETED|Overall Study||1
6414864|NCT00962091|7328395|FG003|NOT COMPLETED|Overall Study||1
6414865|NCT00962091|7328396|FG004|NOT COMPLETED|Overall Study||0
6414866|NCT00962091|7328397|FG005|NOT COMPLETED|Overall Study||1
6414867|NCT00962091|7328398|FG006|NOT COMPLETED|Overall Study||1
6414868|NCT00962104|7328424|FG000|STARTED|Overall Study||195
6414869|NCT00962104|7328425|FG001|STARTED|Overall Study||196
6414870|NCT00962104|7328424|FG000|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
6414871|NCT00962104|7328425|FG001|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
6414872|NCT00962104|7328424|FG000|COMPLETED|Overall Study||155
6414873|NCT00962104|7328425|FG001|COMPLETED|Overall Study||171
6414874|NCT00962104|7328424|FG000|NOT COMPLETED|Overall Study||40
6414875|NCT00962104|7328425|FG001|NOT COMPLETED|Overall Study||25
6414876|NCT00962208|7328433|FG000|STARTED|Overall Study||51
6414877|NCT00962208|7328434|FG001|STARTED|Overall Study||51
6414878|NCT00962208|7328433|FG000|COMPLETED|Overall Study||37
6414879|NCT00962208|7328434|FG001|COMPLETED|Overall Study||41
6414880|NCT00962208|7328433|FG000|NOT COMPLETED|Overall Study||14
6414881|NCT00962208|7328434|FG001|NOT COMPLETED|Overall Study||10
6414882|NCT00962247|7328440|FG000|STARTED|Usual Sedentary||61
6414883|NCT00962247|7328440|FG000|COMPLETED|Usual Sedentary||61
6414884|NCT00962247|7328440|FG000|NOT COMPLETED|Usual Sedentary||0
6414885|NCT00962247|7328440|FG000|STARTED|25% Reduction of Sedentary Activity||61
6414886|NCT00962247|7328440|FG000|COMPLETED|25% Reduction of Sedentary Activity||56
6414887|NCT00962247|7328440|FG000|NOT COMPLETED|25% Reduction of Sedentary Activity||5
6414888|NCT00962247|7328440|FG000|STARTED|50% Reduction of Sedentary Activity||56
6414889|NCT00962247|7328440|FG000|COMPLETED|50% Reduction of Sedentary Activity||56
6414890|NCT00962247|7328440|FG000|NOT COMPLETED|50% Reduction of Sedentary Activity||0
6414891|NCT00962390|7328450|FG000|STARTED|Overall Study||29
6414892|NCT00962390|7328451|FG001|STARTED|Overall Study||29
6414893|NCT00962390|7328452|FG002|STARTED|Overall Study||29
6414894|NCT00962390|7328453|FG003|STARTED|Overall Study||29
6414895|NCT00962390|7328450|FG000|COMPLETED|Overall Study||25
6414896|NCT00962390|7328451|FG001|COMPLETED|Overall Study||26
6414897|NCT00962390|7328452|FG002|COMPLETED|Overall Study||25
6414898|NCT00962390|7328453|FG003|COMPLETED|Overall Study||28
6414899|NCT00962390|7328450|FG000|NOT COMPLETED|Overall Study||4
6414900|NCT00962390|7328451|FG001|NOT COMPLETED|Overall Study||3
6414901|NCT00962390|7328452|FG002|NOT COMPLETED|Overall Study||4
6414902|NCT00962390|7328453|FG003|NOT COMPLETED|Overall Study||1
6414903|NCT00962585|7328467|FG000|STARTED|Overall Study||43
6414904|NCT00962585|7328468|FG001|STARTED|Overall Study||42
6414905|NCT00962585|7328469|FG002|STARTED|Overall Study||42
6414906|NCT00962585|7328470|FG003|STARTED|Overall Study||42
6414907|NCT00962585|7328467|FG000|COMPLETED|Overall Study||37
6414908|NCT00962585|7328468|FG001|COMPLETED|Overall Study||40
6414909|NCT00962585|7328469|FG002|COMPLETED|Overall Study||39
6414910|NCT00962585|7328470|FG003|COMPLETED|Overall Study||42
6414911|NCT00962585|7328467|FG000|NOT COMPLETED|Overall Study||6
6414912|NCT00962585|7328468|FG001|NOT COMPLETED|Overall Study||2
6414913|NCT00962585|7328469|FG002|NOT COMPLETED|Overall Study||3
6414914|NCT00962585|7328470|FG003|NOT COMPLETED|Overall Study||0
6414915|NCT00962598|7328484|FG000|STARTED|Overall Study||7
6414916|NCT00962598|7328485|FG001|STARTED|Overall Study||9
6414917|NCT00962598|7328484|FG000|COMPLETED|Overall Study||7
6414918|NCT00962598|7328485|FG001|COMPLETED|Overall Study||9
6414919|NCT00962598|7328484|FG000|NOT COMPLETED|Overall Study||0
6414920|NCT00962598|7328485|FG001|NOT COMPLETED|Overall Study||0
6414921|NCT00962650|7328491|FG000|STARTED|Overall Study||10
6414922|NCT00962650|7328491|FG000|COMPLETED|Overall Study||8
6414923|NCT00962650|7328491|FG000|NOT COMPLETED|Overall Study||2
6414924|NCT00962741|7328495|FG000|STARTED|Overall Study||127
6414925|NCT00962741|7328495|FG000|COMPLETED|Overall Study||119
6414926|NCT00962741|7328495|FG000|NOT COMPLETED|Overall Study||8
6414927|NCT00962754|7328501|FG000|STARTED|Overall Study||86
6414928|NCT00962754|7328502|FG001|STARTED|Overall Study||84
6414929|NCT00962754|7328501|FG000|COMPLETED|Overall Study||86
6414930|NCT00962754|7328502|FG001|COMPLETED|Overall Study||84
6414931|NCT00962754|7328501|FG000|NOT COMPLETED|Overall Study||0
6414932|NCT00962754|7328502|FG001|NOT COMPLETED|Overall Study||0
6414933|NCT00962780|7328514|FG000|STARTED|Overall Study||151
6414934|NCT00962780|7328515|FG001|STARTED|Overall Study||152
6414935|NCT00962780|7328514|FG000|Vaccinated 13vPnC Dose 1|Overall Study||150
6414936|NCT00962780|7328515|FG001|Vaccinated 13vPnC Dose 1|Overall Study||151
6414937|NCT00962780|7328514|FG000|Vaccinated 13vPnC Dose 2|Overall Study||145
6414938|NCT00962780|7328515|FG001|Vaccinated 13vPnC Dose 2|Overall Study||145
6414939|NCT00962780|7328514|FG000|Vaccinated 13vPnC Dose 3|Overall Study||144
6638489|NCT02323334|7567019|FG016|COMPLETED|Period 2||0
6638490|NCT02323334|7567003|FG000|NOT COMPLETED|Period 2||0
6638491|NCT02323334|7567004|FG001|NOT COMPLETED|Period 2||0
6638492|NCT02323334|7567005|FG002|NOT COMPLETED|Period 2||0
6638493|NCT02323334|7567006|FG003|NOT COMPLETED|Period 2||0
6638494|NCT02323334|7567007|FG004|NOT COMPLETED|Period 2||0
6638495|NCT02323334|7567008|FG005|NOT COMPLETED|Period 2||0
6638496|NCT02323334|7567009|FG006|NOT COMPLETED|Period 2||0
6638497|NCT02323334|7567010|FG007|NOT COMPLETED|Period 2||0
6414940|NCT00962780|7328515|FG001|Vaccinated 13vPnC Dose 3|Overall Study||142
6414941|NCT00962780|7328514|FG000|Vaccinated 23vPS Dose|Overall Study||143
6414942|NCT00962780|7328515|FG001|Vaccinated 23vPS Dose|Overall Study||139
6414943|NCT00962780|7328514|FG000|COMPLETED|Overall Study||141
6414944|NCT00962780|7328515|FG001|COMPLETED|Overall Study||138
6414945|NCT00962780|7328514|FG000|NOT COMPLETED|Overall Study||10
6414946|NCT00962780|7328515|FG001|NOT COMPLETED|Overall Study||14
6414947|NCT00962871|7328531|FG000|STARTED|Overall Study||6
6414948|NCT00962871|7328532|FG001|STARTED|Overall Study||6
6414949|NCT00962871|7328533|FG002|STARTED|Overall Study||12
6414950|NCT00962871|7328534|FG003|STARTED|Overall Study||6
6414951|NCT00962871|7328531|FG000|COMPLETED|Overall Study||6
6414952|NCT00962871|7328532|FG001|COMPLETED|Overall Study||6
6414953|NCT00962871|7328533|FG002|COMPLETED|Overall Study||12
6414954|NCT00962871|7328534|FG003|COMPLETED|Overall Study||6
6414955|NCT00962871|7328531|FG000|NOT COMPLETED|Overall Study||0
6414956|NCT00962871|7328532|FG001|NOT COMPLETED|Overall Study||0
6414957|NCT00962871|7328533|FG002|NOT COMPLETED|Overall Study||0
6414958|NCT00962871|7328534|FG003|NOT COMPLETED|Overall Study||0
6414959|NCT00962949|7328546|FG000|STARTED|Overall Study||13
6414960|NCT00962949|7328547|FG001|STARTED|Overall Study||15
6414961|NCT00962949|7328546|FG000|COMPLETED|Overall Study||13
6414962|NCT00962949|7328547|FG001|COMPLETED|Overall Study||15
6638498|NCT02323334|7567011|FG008|NOT COMPLETED|Period 2||0
6414963|NCT00962949|7328546|FG000|NOT COMPLETED|Overall Study||0
6414964|NCT00962949|7328547|FG001|NOT COMPLETED|Overall Study||0
6414965|NCT00963105|7328556|FG000|STARTED|Overall Study||34
6414966|NCT00963105|7328557|FG001|STARTED|Overall Study||35
6414967|NCT00963105|7328558|FG002|STARTED|Overall Study||35
6638499|NCT02323334|7567012|FG009|NOT COMPLETED|Period 2||0
6638500|NCT02323334|7567013|FG010|NOT COMPLETED|Period 2||0
6638501|NCT02323334|7567014|FG011|NOT COMPLETED|Period 2||0
6414968|NCT00963105|7328556|FG000|Received Treatment|Overall Study||34
6414969|NCT00963105|7328557|FG001|Received Treatment|Overall Study||34
6414970|NCT00963105|7328558|FG002|Received Treatment|Overall Study||35
6414971|NCT00963105|7328556|FG000|COMPLETED|Overall Study||34
6414972|NCT00963105|7328557|FG001|COMPLETED|Overall Study||35
6414973|NCT00963105|7328558|FG002|COMPLETED|Overall Study||35
6414974|NCT00963105|7328556|FG000|NOT COMPLETED|Overall Study||0
6414975|NCT00963105|7328557|FG001|NOT COMPLETED|Overall Study||0
6414976|NCT00963105|7328558|FG002|NOT COMPLETED|Overall Study||0
6414977|NCT00963157|7328571|FG000|STARTED|Overall Study||156
6638502|NCT02323334|7567015|FG012|NOT COMPLETED|Period 2||0
6414978|NCT00963157|7328572|FG001|STARTED|Overall Study||163
6414979|NCT00963157|7328573|FG002|STARTED|Overall Study||160
6414980|NCT00963157|7328574|FG003|STARTED|Overall Study||157
6414981|NCT00963157|7328575|FG004|STARTED|Overall Study||153
6414982|NCT00963157|7328571|FG000|COMPLETED|Overall Study||151
6414983|NCT00963157|7328572|FG001|COMPLETED|Overall Study||159
6414984|NCT00963157|7328573|FG002|COMPLETED|Overall Study||155
6414985|NCT00963157|7328574|FG003|COMPLETED|Overall Study||150
6414986|NCT00963157|7328575|FG004|COMPLETED|Overall Study||151
6414987|NCT00963157|7328571|FG000|NOT COMPLETED|Overall Study||5
6414988|NCT00963157|7328572|FG001|NOT COMPLETED|Overall Study||4
6414989|NCT00963157|7328573|FG002|NOT COMPLETED|Overall Study||5
6414990|NCT00963157|7328574|FG003|NOT COMPLETED|Overall Study||7
6414991|NCT00963157|7328575|FG004|NOT COMPLETED|Overall Study||2
6414992|NCT00963235|7328587|FG000|STARTED|Overall Study||331
6414993|NCT00963235|7328587|FG000|Vaccinated Dose 1|Overall Study||329
6414994|NCT00963235|7328587|FG000|Vaccinated Dose 2|Overall Study||300
6414995|NCT00963235|7328587|FG000|Vaccinated Dose 3|Overall Study||279
6414996|NCT00963235|7328587|FG000|Completed Dose 3 1-month Blood Draw|Overall Study||277
6414997|NCT00963235|7328587|FG000|COMPLETED|Overall Study||271
6414998|NCT00963235|7328587|FG000|NOT COMPLETED|Overall Study||60
6414999|NCT00963430|7328596|FG000|STARTED|Overall Study||60
6415000|NCT00963430|7328597|FG001|STARTED|Overall Study||60
6415001|NCT00963430|7328596|FG000|COMPLETED|Overall Study||59
6415002|NCT00963430|7328597|FG001|COMPLETED|Overall Study||57
6415003|NCT00963430|7328596|FG000|NOT COMPLETED|Overall Study||1
6415004|NCT00963430|7328597|FG001|NOT COMPLETED|Overall Study||3
6415005|NCT00963482|7328605|FG000|STARTED|Overall Study||53
6415006|NCT00963482|7328606|FG001|STARTED|Overall Study||50
6415007|NCT00963482|7328605|FG000|COMPLETED|Overall Study||25
6415008|NCT00963482|7328606|FG001|COMPLETED|Overall Study||33
6415009|NCT00963482|7328605|FG000|NOT COMPLETED|Overall Study||28
6415010|NCT00963482|7328606|FG001|NOT COMPLETED|Overall Study||17
6415011|NCT00963508|7328614|FG000|STARTED|Overall Study||206
6415012|NCT00963508|7328615|FG001|STARTED|Overall Study||197
6415013|NCT00963508|7328614|FG000|COMPLETED|Overall Study||196
6415014|NCT00963508|7328615|FG001|COMPLETED|Overall Study||169
6415015|NCT00963508|7328614|FG000|NOT COMPLETED|Overall Study||10
6415016|NCT00963508|7328615|FG001|NOT COMPLETED|Overall Study||28
6415017|NCT00963547|7328625|FG000|STARTED|Overall Study||4
6415018|NCT00963547|7328626|FG001|STARTED|Overall Study||11
6415019|NCT00963547|7328627|FG002|STARTED|Overall Study||12
6415020|NCT00963547|7328628|FG003|STARTED|Overall Study||6
6415021|NCT00963547|7328629|FG004|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
6415022|NCT00963547|7328630|FG005|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
6415023|NCT00963547|7328631|FG006|STARTED|Overall Study|Study terminated before Part 2 enrollment.|0
6415024|NCT00963547|7328625|FG000|Treated|Overall Study||3
6415025|NCT00963547|7328626|FG001|Treated|Overall Study||11
6415026|NCT00963547|7328627|FG002|Treated|Overall Study||11
6415027|NCT00963547|7328628|FG003|Treated|Overall Study||6
6415028|NCT00963547|7328629|FG004|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
6415029|NCT00963547|7328630|FG005|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
6415030|NCT00963547|7328631|FG006|Treated|Overall Study|Study terminated before Part 2 enrollment.|0
6415031|NCT00963547|7328625|FG000|COMPLETED|Overall Study||0
6415032|NCT00963547|7328626|FG001|COMPLETED|Overall Study||0
6415033|NCT00963547|7328627|FG002|COMPLETED|Overall Study||0
6415034|NCT00963547|7328628|FG003|COMPLETED|Overall Study||0
6415035|NCT00963547|7328629|FG004|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
6415036|NCT00963547|7328630|FG005|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
6415037|NCT00963547|7328631|FG006|COMPLETED|Overall Study|Study terminated before Part 2 enrollment.|0
6415038|NCT00963547|7328625|FG000|NOT COMPLETED|Overall Study||4
6415039|NCT00963547|7328626|FG001|NOT COMPLETED|Overall Study||11
6415040|NCT00963547|7328627|FG002|NOT COMPLETED|Overall Study||12
6415041|NCT00963547|7328628|FG003|NOT COMPLETED|Overall Study||6
6415042|NCT00963547|7328629|FG004|NOT COMPLETED|Overall Study||0
6415043|NCT00963547|7328630|FG005|NOT COMPLETED|Overall Study||0
6415044|NCT00963547|7328631|FG006|NOT COMPLETED|Overall Study||0
6499125|NCT01414634|7417767|FG003|COMPLETED|Overall Study||1
6499126|NCT01414634|7417768|FG004|COMPLETED|Overall Study||1
6499127|NCT01414634|7417769|FG005|COMPLETED|Overall Study||2
6499128|NCT01414634|7417770|FG006|COMPLETED|Overall Study||1
6499129|NCT01414634|7417771|FG007|COMPLETED|Overall Study||1
6499130|NCT01414634|7417764|FG000|NOT COMPLETED|Overall Study||0
6499131|NCT01414634|7417765|FG001|NOT COMPLETED|Overall Study||0
6499132|NCT01414634|7417766|FG002|NOT COMPLETED|Overall Study||0
6499133|NCT01414634|7417767|FG003|NOT COMPLETED|Overall Study||0
6499134|NCT01414634|7417768|FG004|NOT COMPLETED|Overall Study||0
6499135|NCT01414634|7417769|FG005|NOT COMPLETED|Overall Study||0
6499136|NCT01414634|7417770|FG006|NOT COMPLETED|Overall Study||0
6499137|NCT01414634|7417771|FG007|NOT COMPLETED|Overall Study||0
6499138|NCT01414738|7417782|FG000|STARTED|Overall Study||49
6499139|NCT01414738|7417782|FG000|Follow-up (3 Months)|Overall Study||18
6499140|NCT01414738|7417782|FG000|Follow-up (6 Months)|Overall Study||8
6499141|NCT01414738|7417782|FG000|Follow-up (9 Months)|Overall Study||5
6499142|NCT01414738|7417782|FG000|COMPLETED|Overall Study||5
6499143|NCT01414738|7417782|FG000|NOT COMPLETED|Overall Study||44
6499144|NCT01414855|7417786|FG000|STARTED|Overall Study||100
6499145|NCT01414855|7417786|FG000|COMPLETED|Overall Study||71
6415045|NCT00963560|7328647|FG000|STARTED|Overall Study||47
6415046|NCT00963560|7328648|FG001|STARTED|Overall Study||44
6415047|NCT00963560|7328649|FG002|STARTED|Overall Study||41
6415048|NCT00963560|7328647|FG000|COMPLETED|Overall Study||44
6415049|NCT00963560|7328648|FG001|COMPLETED|Overall Study||41
6415050|NCT00963560|7328649|FG002|COMPLETED|Overall Study||41
6415051|NCT00963560|7328647|FG000|NOT COMPLETED|Overall Study||3
6415052|NCT00963560|7328648|FG001|NOT COMPLETED|Overall Study||3
6415053|NCT00963560|7328649|FG002|NOT COMPLETED|Overall Study||0
6415054|NCT00963638|7328659|FG000|STARTED|Overall Study||20
6415055|NCT00963638|7328660|FG001|STARTED|Overall Study||20
6415056|NCT00963638|7328659|FG000|COMPLETED|Overall Study||20
6415057|NCT00963638|7328660|FG001|COMPLETED|Overall Study||20
6415058|NCT00963638|7328659|FG000|NOT COMPLETED|Overall Study||0
6415059|NCT00963638|7328660|FG001|NOT COMPLETED|Overall Study||0
6415060|NCT00963677|7328668|FG000|STARTED|Overall Study|Patients without predicted difficult intubation|35
6415061|NCT00963677|7328669|FG001|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
6415062|NCT00963677|7328668|FG000|COMPLETED|Overall Study||35
6415063|NCT00963677|7328669|FG001|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
6415064|NCT00963677|7328668|FG000|NOT COMPLETED|Overall Study||0
6415065|NCT00963677|7328669|FG001|NOT COMPLETED|Overall Study||2
6415066|NCT00963807|7328675|FG000|STARTED|Overall Study||26
6415067|NCT00963807|7328675|FG000|Completed Baseline Imaging|Overall Study||11
6415068|NCT00963807|7328675|FG000|Completed Post-Cycle 1 Imaging|Overall Study||9
6415069|NCT00963807|7328675|FG000|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
6415070|NCT00963807|7328675|FG000|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
6415071|NCT00963807|7328675|FG000|COMPLETED|Overall Study||8
6415072|NCT00963807|7328675|FG000|NOT COMPLETED|Overall Study||18
6415073|NCT00963820|7328681|FG000|STARTED|Dose Escalation Phase||3
6415074|NCT00963820|7328682|FG001|STARTED|Dose Escalation Phase||3
6415075|NCT00963820|7328683|FG002|STARTED|Dose Escalation Phase||3
6415076|NCT00963820|7328684|FG003|STARTED|Dose Escalation Phase||3
6415077|NCT00963820|7328685|FG004|STARTED|Dose Escalation Phase||4
6415078|NCT00963820|7328686|FG005|STARTED|Dose Escalation Phase||3
6415079|NCT00963820|7328687|FG006|STARTED|Dose Escalation Phase||8
6415080|NCT00963820|7328688|FG007|STARTED|Dose Escalation Phase||5
6415081|NCT00963820|7328689|FG008|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
6415082|NCT00963820|7328690|FG009|STARTED|Dose Escalation Phase||0
6415083|NCT00963820|7328691|FG010|STARTED|Dose Escalation Phase||0
6415084|NCT00963820|7328692|FG011|STARTED|Dose Escalation Phase||0
6415085|NCT00963820|7328681|FG000|COMPLETED|Dose Escalation Phase||0
6415086|NCT00963820|7328682|FG001|COMPLETED|Dose Escalation Phase||0
6415087|NCT00963820|7328683|FG002|COMPLETED|Dose Escalation Phase||0
6415088|NCT00963820|7328684|FG003|COMPLETED|Dose Escalation Phase||0
6415089|NCT00963820|7328685|FG004|COMPLETED|Dose Escalation Phase||0
6415090|NCT00963820|7328686|FG005|COMPLETED|Dose Escalation Phase||0
6415091|NCT00963820|7328687|FG006|COMPLETED|Dose Escalation Phase||0
6415092|NCT00963820|7328688|FG007|COMPLETED|Dose Escalation Phase||0
6415093|NCT00963820|7328689|FG008|COMPLETED|Dose Escalation Phase||0
6415094|NCT00963820|7328690|FG009|COMPLETED|Dose Escalation Phase||0
6415095|NCT00963820|7328691|FG010|COMPLETED|Dose Escalation Phase||0
6415096|NCT00963820|7328692|FG011|COMPLETED|Dose Escalation Phase||0
6415097|NCT00963820|7328681|FG000|NOT COMPLETED|Dose Escalation Phase||3
6415098|NCT00963820|7328682|FG001|NOT COMPLETED|Dose Escalation Phase||3
6415099|NCT00963820|7328683|FG002|NOT COMPLETED|Dose Escalation Phase||3
6415100|NCT00963820|7328684|FG003|NOT COMPLETED|Dose Escalation Phase||3
6415101|NCT00963820|7328685|FG004|NOT COMPLETED|Dose Escalation Phase||4
6415102|NCT00963820|7328686|FG005|NOT COMPLETED|Dose Escalation Phase||3
6415103|NCT00963820|7328687|FG006|NOT COMPLETED|Dose Escalation Phase||8
6415104|NCT00963820|7328688|FG007|NOT COMPLETED|Dose Escalation Phase||5
6415105|NCT00963820|7328689|FG008|NOT COMPLETED|Dose Escalation Phase||0
6415106|NCT00963820|7328690|FG009|NOT COMPLETED|Dose Escalation Phase||0
6415107|NCT00963820|7328691|FG010|NOT COMPLETED|Dose Escalation Phase||0
6415108|NCT00963820|7328692|FG011|NOT COMPLETED|Dose Escalation Phase||0
6415109|NCT00963820|7328681|FG000|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
6415110|NCT00963820|7328682|FG001|STARTED|Expansion Phase||0
6415111|NCT00963820|7328683|FG002|STARTED|Expansion Phase||0
6415112|NCT00963820|7328684|FG003|STARTED|Expansion Phase||0
6415113|NCT00963820|7328685|FG004|STARTED|Expansion Phase||0
6415114|NCT00963820|7328686|FG005|STARTED|Expansion Phase||0
6415115|NCT00963820|7328687|FG006|STARTED|Expansion Phase||0
6415116|NCT00963820|7328688|FG007|STARTED|Expansion Phase||0
6415117|NCT00963820|7328689|FG008|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
6415118|NCT00963820|7328690|FG009|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
6415119|NCT00963820|7328691|FG010|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
6415120|NCT00963820|7328692|FG011|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
6415121|NCT00963820|7328681|FG000|COMPLETED|Expansion Phase||0
6415122|NCT00963820|7328682|FG001|COMPLETED|Expansion Phase||0
6415123|NCT00963820|7328683|FG002|COMPLETED|Expansion Phase||0
6415124|NCT00963820|7328684|FG003|COMPLETED|Expansion Phase||0
6415125|NCT00963820|7328685|FG004|COMPLETED|Expansion Phase||0
6415126|NCT00963820|7328686|FG005|COMPLETED|Expansion Phase||0
6415127|NCT00963820|7328687|FG006|COMPLETED|Expansion Phase||0
6415128|NCT00963820|7328688|FG007|COMPLETED|Expansion Phase||0
6415129|NCT00963820|7328689|FG008|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
6415130|NCT00963820|7328690|FG009|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
6415131|NCT00963820|7328691|FG010|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
6415132|NCT00963820|7328692|FG011|COMPLETED|Expansion Phase||0
6415133|NCT00963820|7328681|FG000|NOT COMPLETED|Expansion Phase||0
6415134|NCT00963820|7328682|FG001|NOT COMPLETED|Expansion Phase||0
6415135|NCT00963820|7328683|FG002|NOT COMPLETED|Expansion Phase||0
6415136|NCT00963820|7328684|FG003|NOT COMPLETED|Expansion Phase||0
6415137|NCT00963820|7328685|FG004|NOT COMPLETED|Expansion Phase||0
6415138|NCT00963820|7328686|FG005|NOT COMPLETED|Expansion Phase||0
6415139|NCT00963820|7328687|FG006|NOT COMPLETED|Expansion Phase||0
6415140|NCT00963820|7328688|FG007|NOT COMPLETED|Expansion Phase||0
6415141|NCT00963820|7328689|FG008|NOT COMPLETED|Expansion Phase||10
6415142|NCT00963820|7328690|FG009|NOT COMPLETED|Expansion Phase||9
6415143|NCT00963820|7328691|FG010|NOT COMPLETED|Expansion Phase||5
6415144|NCT00963820|7328692|FG011|NOT COMPLETED|Expansion Phase||4
6415145|NCT00963859|7328709|FG000|STARTED|Overall Study||11
6415146|NCT00963859|7328709|FG000|COMPLETED|Overall Study||11
6415147|NCT00963859|7328709|FG000|NOT COMPLETED|Overall Study||0
6415148|NCT00963872|7328715|FG000|STARTED|Overall Study||25
6415149|NCT00963872|7328716|FG001|STARTED|Overall Study||6
6415150|NCT00963872|7328715|FG000|COMPLETED|Overall Study||24
6415151|NCT00963872|7328716|FG001|COMPLETED|Overall Study||5
6415152|NCT00963872|7328715|FG000|NOT COMPLETED|Overall Study||1
6415153|NCT00963872|7328716|FG001|NOT COMPLETED|Overall Study||1
6415154|NCT00963911|7328722|FG000|STARTED|Overall Study||1674
6415155|NCT00963911|7328722|FG000|COMPLETED|Overall Study||1674
6415156|NCT00963911|7328722|FG000|NOT COMPLETED|Overall Study||0
6415157|NCT00963924|7328728|FG000|STARTED|Overall Study||18
6415158|NCT00963924|7328729|FG001|STARTED|Overall Study||18
6415159|NCT00963924|7328728|FG000|COMPLETED|Overall Study||17
6415160|NCT00963924|7328729|FG001|COMPLETED|Overall Study||15
6415161|NCT00963924|7328728|FG000|NOT COMPLETED|Overall Study||1
6415162|NCT00963924|7328729|FG001|NOT COMPLETED|Overall Study||3
6415163|NCT00963937|7328740|FG000|STARTED|Overall Study||89
6415164|NCT00963937|7328741|FG001|STARTED|Overall Study||44
6415165|NCT00963937|7328742|FG002|STARTED|Overall Study||45
6415166|NCT00963937|7328740|FG000|COMPLETED|Overall Study||70
6415167|NCT00963937|7328741|FG001|COMPLETED|Overall Study||33
6415168|NCT00963937|7328742|FG002|COMPLETED|Overall Study||41
6415169|NCT00963937|7328740|FG000|NOT COMPLETED|Overall Study||19
6415170|NCT00963937|7328741|FG001|NOT COMPLETED|Overall Study||11
6415171|NCT00963937|7328742|FG002|NOT COMPLETED|Overall Study||4
6415172|NCT00963989|7328753|FG000|STARTED|Overall Study||146
6415173|NCT00963989|7328753|FG000|COMPLETED|Overall Study||127
6415174|NCT00963989|7328753|FG000|NOT COMPLETED|Overall Study||19
6415175|NCT00964028|7328759|FG000|STARTED|Overall Study||25
6415176|NCT00964028|7328760|FG001|STARTED|Overall Study||25
6415177|NCT00964028|7328759|FG000|COMPLETED|Overall Study||25
6415178|NCT00964028|7328760|FG001|COMPLETED|Overall Study||24
6415179|NCT00964028|7328759|FG000|NOT COMPLETED|Overall Study||0
6415180|NCT00964028|7328760|FG001|NOT COMPLETED|Overall Study||1
6415181|NCT00964119|7328766|FG000|STARTED|Overall Study||15
6415182|NCT00964119|7328766|FG000|COMPLETED|Overall Study||15
6415183|NCT00964119|7328766|FG000|NOT COMPLETED|Overall Study||0
6415184|NCT00964158|7328773|FG000|STARTED|Overall Study||53
6415185|NCT00964158|7328774|FG001|STARTED|Overall Study||57
6415186|NCT00964158|7328775|FG002|STARTED|Overall Study||100
6415187|NCT00964158|7328773|FG000|COMPLETED|Overall Study||53
6415188|NCT00964158|7328774|FG001|COMPLETED|Overall Study||56
6415189|NCT00964158|7328775|FG002|COMPLETED|Overall Study||92
6415190|NCT00964158|7328773|FG000|NOT COMPLETED|Overall Study||0
6415191|NCT00964158|7328774|FG001|NOT COMPLETED|Overall Study||1
6415192|NCT00964158|7328775|FG002|NOT COMPLETED|Overall Study||8
6415193|NCT00964223|7328786|FG000|STARTED|Split Face Treatment (Weeks 1 and 2)||28
6415194|NCT00964223|7328786|FG000|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
6415195|NCT00964223|7328786|FG000|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
6415196|NCT00964223|7328786|FG000|STARTED|Full Face Treatment (Weeks 5 and 8)||28
6415197|NCT00964223|7328786|FG000|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
6415198|NCT00964223|7328786|FG000|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
6415199|NCT00964353|7328793|FG000|STARTED|Overall Study||181
6415200|NCT00964353|7328794|FG001|STARTED|Overall Study||178
6415201|NCT00964353|7328793|FG000|COMPLETED|Overall Study||181
6415202|NCT00964353|7328794|FG001|COMPLETED|Overall Study||178
6415203|NCT00964353|7328793|FG000|NOT COMPLETED|Overall Study||0
6415204|NCT00964353|7328794|FG001|NOT COMPLETED|Overall Study||0
6415205|NCT00964366|7328802|FG000|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
6415206|NCT00964366|7328803|FG001|STARTED|Overall Study||25
6415207|NCT00964366|7328802|FG000|COMPLETED|Overall Study||27
6415208|NCT00964366|7328803|FG001|COMPLETED|Overall Study||24
6415209|NCT00964366|7328802|FG000|NOT COMPLETED|Overall Study||1
6415210|NCT00964366|7328803|FG001|NOT COMPLETED|Overall Study||1
6415211|NCT00964392|7328811|FG000|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
6499146|NCT01414855|7417786|FG000|NOT COMPLETED|Overall Study||29
6415212|NCT00964392|7328812|FG001|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
6415213|NCT00964392|7328811|FG000|COMPLETED|Overall Study||72
6415214|NCT00964392|7328812|FG001|COMPLETED|Overall Study||92
6415215|NCT00964392|7328811|FG000|NOT COMPLETED|Overall Study||53
6415216|NCT00964392|7328812|FG001|NOT COMPLETED|Overall Study||190
6415217|NCT00964431|7328822|FG000|STARTED|Overall Study||50
6415218|NCT00964431|7328823|FG001|STARTED|Overall Study||51
6415219|NCT00964431|7328824|FG002|STARTED|Overall Study||51
6415220|NCT00964431|7328825|FG003|STARTED|Overall Study||51
6415221|NCT00964431|7328822|FG000|COMPLETED|Overall Study||50
6415222|NCT00964431|7328823|FG001|COMPLETED|Overall Study||51
6415223|NCT00964431|7328824|FG002|COMPLETED|Overall Study||51
6415224|NCT00964431|7328825|FG003|COMPLETED|Overall Study||51
6415225|NCT00964431|7328822|FG000|NOT COMPLETED|Overall Study||0
6415226|NCT00964431|7328823|FG001|NOT COMPLETED|Overall Study||0
6415227|NCT00964431|7328824|FG002|NOT COMPLETED|Overall Study||0
6415228|NCT00964431|7328825|FG003|NOT COMPLETED|Overall Study||0
6415229|NCT00964444|7328835|FG000|STARTED|Overall Study||10
6415230|NCT00964444|7328835|FG000|COMPLETED|Overall Study||10
6415231|NCT00964444|7328835|FG000|NOT COMPLETED|Overall Study||0
6415232|NCT00964496|7328841|FG000|STARTED|Overall Study||28
6415233|NCT00964496|7328842|FG001|STARTED|Overall Study||27
6415234|NCT00964496|7328841|FG000|COMPLETED|Overall Study||26
6415235|NCT00964496|7328842|FG001|COMPLETED|Overall Study||26
6415236|NCT00964496|7328841|FG000|NOT COMPLETED|Overall Study||2
6415237|NCT00964496|7328842|FG001|NOT COMPLETED|Overall Study||1
6415238|NCT00964548|7328850|FG000|STARTED|Overall Study||5
6415239|NCT00964548|7328851|FG001|STARTED|Overall Study||5
6415240|NCT00964548|7328850|FG000|COMPLETED|Overall Study||5
6415241|NCT00964548|7328851|FG001|COMPLETED|Overall Study||5
6415242|NCT00964548|7328850|FG000|NOT COMPLETED|Overall Study||0
6415243|NCT00964548|7328851|FG001|NOT COMPLETED|Overall Study||0
6415244|NCT00964678|7328857|FG000|STARTED|Overall Study||10
6415245|NCT00964678|7328857|FG000|COMPLETED|Overall Study||6
6415246|NCT00964678|7328857|FG000|NOT COMPLETED|Overall Study||4
6415247|NCT00964743|7328862|FG000|STARTED|Overall Study||2
6415248|NCT00964743|7328862|FG000|COMPLETED|Overall Study||0
6415249|NCT00964743|7328862|FG000|NOT COMPLETED|Overall Study||2
6415250|NCT00964782|7328868|FG000|STARTED|Overall Study||8
6415251|NCT00964782|7328869|FG001|STARTED|Overall Study||8
6415252|NCT00964782|7328868|FG000|COMPLETED|Overall Study||7
6415253|NCT00964782|7328869|FG001|COMPLETED|Overall Study||8
6415254|NCT00964782|7328868|FG000|NOT COMPLETED|Overall Study||1
6415255|NCT00964782|7328869|FG001|NOT COMPLETED|Overall Study||0
6415256|NCT00964795|7328877|FG000|STARTED|Overall Study|randomized|323
6415257|NCT00964795|7328877|FG000|Number of Participants Treated|Overall Study||320
6415258|NCT00964795|7328877|FG000|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
6415259|NCT00964795|7328877|FG000|NOT COMPLETED|Overall Study||307
6415260|NCT00964860|7328884|FG000|STARTED|Overall Study||30
6415261|NCT00964860|7328885|FG001|STARTED|Overall Study||30
6415262|NCT00964860|7328884|FG000|COMPLETED|Overall Study||30
6415263|NCT00964860|7328885|FG001|COMPLETED|Overall Study||29
6415264|NCT00964860|7328884|FG000|NOT COMPLETED|Overall Study||0
6415265|NCT00964860|7328885|FG001|NOT COMPLETED|Overall Study||1
6415266|NCT00964886|7328895|FG000|STARTED|Overall Study||38
6415267|NCT00964886|7328896|FG001|STARTED|Overall Study||34
6415268|NCT00964886|7328897|FG002|STARTED|Overall Study||37
6415269|NCT00964886|7328898|FG003|STARTED|Overall Study||33
6415270|NCT00964886|7328895|FG000|COMPLETED|Overall Study||27
6415271|NCT00964886|7328896|FG001|COMPLETED|Overall Study||27
6415272|NCT00964886|7328897|FG002|COMPLETED|Overall Study||21
6415273|NCT00964886|7328898|FG003|COMPLETED|Overall Study||24
6415274|NCT00964886|7328895|FG000|NOT COMPLETED|Overall Study||11
6415275|NCT00964886|7328896|FG001|NOT COMPLETED|Overall Study||7
6415276|NCT00964886|7328897|FG002|NOT COMPLETED|Overall Study||16
6415277|NCT00964886|7328898|FG003|NOT COMPLETED|Overall Study||9
6415278|NCT00965081|7328914|FG000|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
6415279|NCT00965081|7328915|FG001|STARTED|Overall Study||153
6415280|NCT00965081|7328914|FG000|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
6415281|NCT00965081|7328915|FG001|COMPLETED|Overall Study||110
6638503|NCT02323334|7567016|FG013|NOT COMPLETED|Period 2||0
6638504|NCT02323334|7567017|FG014|NOT COMPLETED|Period 2||0
6415282|NCT00965081|7328914|FG000|NOT COMPLETED|Overall Study||34
6415283|NCT00965081|7328915|FG001|NOT COMPLETED|Overall Study||43
6415284|NCT00965094|7328924|FG000|STARTED|Overall Study||19
6415285|NCT00965094|7328925|FG001|STARTED|Overall Study||17
6415286|NCT00965094|7328924|FG000|COMPLETED|Overall Study||14
6638505|NCT02323334|7567018|FG015|NOT COMPLETED|Period 2||0
6415287|NCT00965094|7328925|FG001|COMPLETED|Overall Study||16
6415288|NCT00965094|7328924|FG000|NOT COMPLETED|Overall Study||5
6415289|NCT00965094|7328925|FG001|NOT COMPLETED|Overall Study||1
6415290|NCT00965185|7328934|FG000|STARTED|Overall Study||19
6415291|NCT00965185|7328935|FG001|STARTED|Overall Study||21
6415292|NCT00965185|7328934|FG000|1 Month Visit|Overall Study||18
6415293|NCT00965185|7328935|FG001|1 Month Visit|Overall Study||21
6415294|NCT00965185|7328934|FG000|3 Month Visit|Overall Study||18
6638506|NCT02323334|7567019|FG016|NOT COMPLETED|Period 2||0
6638507|NCT02323334|7567003|FG000|STARTED|Period 3||4
6638508|NCT02323334|7567004|FG001|STARTED|Period 3||4
6415295|NCT00965185|7328935|FG001|3 Month Visit|Overall Study||21
6415296|NCT00965185|7328934|FG000|6 Month Visit|Overall Study||18
6415297|NCT00965185|7328935|FG001|6 Month Visit|Overall Study||21
6415298|NCT00965185|7328934|FG000|9 Month Visit|Overall Study||18
6415299|NCT00965185|7328935|FG001|9 Month Visit|Overall Study||21
6415300|NCT00965185|7328934|FG000|COMPLETED|Overall Study||17
6415301|NCT00965185|7328935|FG001|COMPLETED|Overall Study||20
6415302|NCT00965185|7328934|FG000|NOT COMPLETED|Overall Study||2
6415303|NCT00965185|7328935|FG001|NOT COMPLETED|Overall Study||1
6415304|NCT00965237|7328943|FG000|STARTED|Period 1, One Week of Wear||8
6415305|NCT00965237|7328944|FG001|STARTED|Period 1, One Week of Wear||8
6415306|NCT00965237|7328943|FG000|COMPLETED|Period 1, One Week of Wear||8
6415307|NCT00965237|7328944|FG001|COMPLETED|Period 1, One Week of Wear||8
6415308|NCT00965237|7328943|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
6415309|NCT00965237|7328944|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
6415310|NCT00965237|7328943|FG000|STARTED|Period 2, One Week of Wear||8
6415311|NCT00965237|7328944|FG001|STARTED|Period 2, One Week of Wear||8
6415312|NCT00965237|7328943|FG000|COMPLETED|Period 2, One Week of Wear||8
6415313|NCT00965237|7328944|FG001|COMPLETED|Period 2, One Week of Wear||8
6415314|NCT00965237|7328943|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
6415315|NCT00965237|7328944|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
6415316|NCT00965250|7328952|FG000|STARTED|Overall Study||37
6415317|NCT00965250|7328953|FG001|STARTED|Overall Study||12
6415318|NCT00965250|7328952|FG000|COMPLETED|Overall Study||37
6415319|NCT00965250|7328953|FG001|COMPLETED|Overall Study||12
6415320|NCT00965250|7328952|FG000|NOT COMPLETED|Overall Study||0
6415321|NCT00965250|7328953|FG001|NOT COMPLETED|Overall Study||0
6415322|NCT00965263|7328961|FG000|STARTED|Overall Study||6
6415323|NCT00965263|7328962|FG001|STARTED|Overall Study||9
6415324|NCT00965263|7328961|FG000|COMPLETED|Overall Study||4
6415325|NCT00965263|7328962|FG001|COMPLETED|Overall Study||6
6415326|NCT00965263|7328961|FG000|NOT COMPLETED|Overall Study||2
6415327|NCT00965263|7328962|FG001|NOT COMPLETED|Overall Study||3
6415328|NCT00965341|7328988|FG000|STARTED|Overall Study||19
6415329|NCT00965341|7328989|FG001|STARTED|Overall Study||24
6415330|NCT00965341|7328988|FG000|COMPLETED|Overall Study||13
6415331|NCT00965341|7328989|FG001|COMPLETED|Overall Study||16
6415332|NCT00965341|7328988|FG000|NOT COMPLETED|Overall Study||6
6415333|NCT00965341|7328989|FG001|NOT COMPLETED|Overall Study||8
6415334|NCT00965419|7328995|FG000|STARTED|Open Label Treatment for Responders||267
6415335|NCT00965419|7328995|FG000|Not Lost to f/u at First Post-baseline|Open Label Treatment for Responders||264
6415336|NCT00965419|7328995|FG000|COMPLETED|Open Label Treatment for Responders||20
6415337|NCT00965419|7328995|FG000|NOT COMPLETED|Open Label Treatment for Responders||247
6415338|NCT00965419|7328995|FG000|STARTED|Follow-up Phase||80
6415339|NCT00965419|7328995|FG000|COMPLETED|Follow-up Phase||18
6415340|NCT00965419|7328995|FG000|NOT COMPLETED|Follow-up Phase||62
6415341|NCT00965458|7329002|FG000|STARTED|Overall Study||33
6415342|NCT00965458|7329003|FG001|STARTED|Overall Study||16
6415343|NCT00965458|7329002|FG000|COMPLETED|Overall Study||31
6415344|NCT00965458|7329003|FG001|COMPLETED|Overall Study||12
6415345|NCT00965458|7329002|FG000|NOT COMPLETED|Overall Study||2
6415346|NCT00965458|7329003|FG001|NOT COMPLETED|Overall Study||4
6415347|NCT00965484|7329011|FG000|STARTED|Overall Study||136
6415348|NCT00965484|7329011|FG000|COMPLETED|Overall Study||134
6415349|NCT00965484|7329011|FG000|NOT COMPLETED|Overall Study||2
6415350|NCT00965497|7329015|FG000|STARTED|Overall Study||14
6415351|NCT00965497|7329015|FG000|COMPLETED|Overall Study||13
6415352|NCT00965497|7329015|FG000|NOT COMPLETED|Overall Study||1
6415353|NCT00965523|7329019|FG000|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
6415354|NCT00965523|7329019|FG000|COMPLETED|Study 221||74
6415355|NCT00965523|7329019|FG000|NOT COMPLETED|Study 221||7
6415356|NCT00965523|7329019|FG000|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
6415357|NCT00965523|7329019|FG000|COMPLETED|Study 224||0
6415358|NCT00965523|7329019|FG000|NOT COMPLETED|Study 224||6
6415359|NCT00965562|7329026|FG000|STARTED|Overall Study||16
6415360|NCT00965562|7329027|FG001|STARTED|Overall Study||17
6415361|NCT00965562|7329028|FG002|STARTED|Overall Study||16
6415362|NCT00965562|7329026|FG000|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
6415363|NCT00965562|7329027|FG001|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
6415364|NCT00965562|7329028|FG002|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
6415365|NCT00965562|7329026|FG000|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
6415366|NCT00965562|7329027|FG001|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
6415367|NCT00965562|7329028|FG002|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
6415368|NCT00965562|7329026|FG000|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
6415369|NCT00965562|7329027|FG001|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
6415370|NCT00965562|7329028|FG002|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
6415371|NCT00965562|7329026|FG000|NOT COMPLETED|Overall Study||3
6638509|NCT02323334|7567005|FG002|STARTED|Period 3||4
6638510|NCT02323334|7567006|FG003|STARTED|Period 3||4
6638511|NCT02323334|7567007|FG004|STARTED|Period 3||4
6638512|NCT02323334|7567008|FG005|STARTED|Period 3||4
6638513|NCT02323334|7567009|FG006|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
6638514|NCT02323334|7567010|FG007|STARTED|Period 3|Part A Cohort 3 Food Effect participated in Period 1 and Period 2 only.|0
6415372|NCT00965562|7329027|FG001|NOT COMPLETED|Overall Study||4
6415373|NCT00965562|7329028|FG002|NOT COMPLETED|Overall Study||3
6415374|NCT00965575|7329039|FG000|STARTED|Overall Study|cross over, total enrolled 11|6
6415375|NCT00965575|7329040|FG001|STARTED|Overall Study|cross over, total enrolled 11|5
6415376|NCT00965575|7329039|FG000|COMPLETED|Overall Study||5
6415377|NCT00965575|7329040|FG001|COMPLETED|Overall Study||5
6415378|NCT00965575|7329039|FG000|NOT COMPLETED|Overall Study||1
6415379|NCT00965575|7329040|FG001|NOT COMPLETED|Overall Study||0
6415380|NCT00965718|7329048|FG000|STARTED|Overall Study||20
6638515|NCT02323334|7567011|FG008|STARTED|Period 3||0
6638516|NCT02323334|7567012|FG009|STARTED|Period 3||0
6638517|NCT02323334|7567013|FG010|STARTED|Period 3||0
6415381|NCT00965718|7329048|FG000|COMPLETED|Overall Study||16
6415382|NCT00965718|7329048|FG000|NOT COMPLETED|Overall Study||4
6415383|NCT00965731|7329054|FG000|STARTED|Overall Study||7
6415384|NCT00965731|7329055|FG001|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
6415385|NCT00965731|7329054|FG000|COMPLETED|Overall Study||0
6415386|NCT00965731|7329055|FG001|COMPLETED|Overall Study||0
6415387|NCT00965731|7329054|FG000|NOT COMPLETED|Overall Study||7
6415388|NCT00965731|7329055|FG001|NOT COMPLETED|Overall Study||20
6415389|NCT00965848|7329066|FG000|STARTED|Overall Study||107
6415390|NCT00965848|7329067|FG001|STARTED|Overall Study||34
6415391|NCT00965848|7329068|FG002|STARTED|Overall Study||127
6415392|NCT00965848|7329066|FG000|COMPLETED|Overall Study||78
6415393|NCT00965848|7329067|FG001|COMPLETED|Overall Study||32
6415394|NCT00965848|7329068|FG002|COMPLETED|Overall Study||117
6415395|NCT00965848|7329066|FG000|NOT COMPLETED|Overall Study||29
6415396|NCT00965848|7329067|FG001|NOT COMPLETED|Overall Study||2
6415397|NCT00965848|7329068|FG002|NOT COMPLETED|Overall Study||10
6415398|NCT00966186|7329078|FG000|STARTED|Overall Study||60
6415399|NCT00966186|7329079|FG001|STARTED|Overall Study||60
6415400|NCT00966186|7329078|FG000|COMPLETED|Overall Study||60
6415401|NCT00966186|7329079|FG001|COMPLETED|Overall Study||60
6415402|NCT00966186|7329078|FG000|NOT COMPLETED|Overall Study||0
6415403|NCT00966186|7329079|FG001|NOT COMPLETED|Overall Study||0
6415404|NCT00966238|7329091|FG000|STARTED|Overall Study||20
6415405|NCT00966238|7329092|FG001|STARTED|Overall Study||20
6415406|NCT00966238|7329093|FG002|STARTED|Overall Study||20
6415407|NCT00966238|7329094|FG003|STARTED|Overall Study||20
6415408|NCT00966238|7329095|FG004|STARTED|Overall Study||20
6415409|NCT00966238|7329096|FG005|STARTED|Overall Study||20
6415410|NCT00966238|7329091|FG000|COMPLETED|Overall Study||20
6415411|NCT00966238|7329092|FG001|COMPLETED|Overall Study||20
6415412|NCT00966238|7329093|FG002|COMPLETED|Overall Study||20
6415413|NCT00966238|7329094|FG003|COMPLETED|Overall Study||20
6415414|NCT00966238|7329095|FG004|COMPLETED|Overall Study||20
6415415|NCT00966238|7329096|FG005|COMPLETED|Overall Study||20
6415416|NCT00966238|7329091|FG000|NOT COMPLETED|Overall Study||0
6415417|NCT00966238|7329092|FG001|NOT COMPLETED|Overall Study||0
6415418|NCT00966238|7329093|FG002|NOT COMPLETED|Overall Study||0
6415419|NCT00966238|7329094|FG003|NOT COMPLETED|Overall Study||0
6415420|NCT00966238|7329095|FG004|NOT COMPLETED|Overall Study||0
6415421|NCT00966238|7329096|FG005|NOT COMPLETED|Overall Study||0
6415422|NCT00966264|7329112|FG000|STARTED|Overall Study||119
6415423|NCT00966264|7329113|FG001|STARTED|Overall Study||117
6415424|NCT00966264|7329112|FG000|COMPLETED|Overall Study|5 years results|115
6415425|NCT00966264|7329113|FG001|COMPLETED|Overall Study|5 years results|114
6415426|NCT00966264|7329112|FG000|NOT COMPLETED|Overall Study||4
6415427|NCT00966264|7329113|FG001|NOT COMPLETED|Overall Study||3
6415428|NCT00966277|7329121|FG000|STARTED|Overall Study||38
6415429|NCT00966277|7329122|FG001|STARTED|Overall Study||37
6415430|NCT00966277|7329121|FG000|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
6415431|NCT00966277|7329122|FG001|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
6638518|NCT02323334|7567014|FG011|STARTED|Period 3||0
6638519|NCT02323334|7567015|FG012|STARTED|Period 3||0
6638520|NCT02323334|7567016|FG013|STARTED|Period 3||0
6415432|NCT00966277|7329121|FG000|NOT COMPLETED|Overall Study||4
6415433|NCT00966277|7329122|FG001|NOT COMPLETED|Overall Study||4
6415434|NCT00966355|7329131|FG000|STARTED|Overall Study||344
6415435|NCT00966355|7329132|FG001|STARTED|Overall Study||345
6415436|NCT00966355|7329133|FG002|STARTED|Overall Study||345
6415437|NCT00966355|7329131|FG000|COMPLETED|Overall Study||260
6415438|NCT00966355|7329132|FG001|COMPLETED|Overall Study||259
6415439|NCT00966355|7329133|FG002|COMPLETED|Overall Study||261
6415440|NCT00966355|7329131|FG000|NOT COMPLETED|Overall Study||84
6415441|NCT00966355|7329132|FG001|NOT COMPLETED|Overall Study||86
6415442|NCT00966355|7329133|FG002|NOT COMPLETED|Overall Study||84
6415443|NCT00966433|7329144|FG000|STARTED|Overall Study||11
6638521|NCT02323334|7567017|FG014|STARTED|Period 3||0
6638522|NCT02323334|7567018|FG015|STARTED|Period 3||0
6638523|NCT02323334|7567019|FG016|STARTED|Period 3||0
6638524|NCT02323334|7567003|FG000|COMPLETED|Period 3||3
6638525|NCT02323334|7567004|FG001|COMPLETED|Period 3||4
6415444|NCT00966433|7329145|FG001|STARTED|Overall Study||11
6415445|NCT00966433|7329146|FG002|STARTED|Overall Study||11
6415446|NCT00966433|7329144|FG000|COMPLETED|Overall Study||10
6638526|NCT02323334|7567005|FG002|COMPLETED|Period 3||3
6415447|NCT00966433|7329145|FG001|COMPLETED|Overall Study||10
6415448|NCT00966433|7329146|FG002|COMPLETED|Overall Study||11
6415449|NCT00966433|7329144|FG000|NOT COMPLETED|Overall Study||1
6415450|NCT00966433|7329145|FG001|NOT COMPLETED|Overall Study||1
6415451|NCT00966433|7329146|FG002|NOT COMPLETED|Overall Study||0
6415452|NCT00966446|7329159|FG000|STARTED|Overall Study||76
6415453|NCT00966446|7329160|FG001|STARTED|Overall Study||74
6415454|NCT00966446|7329161|FG002|STARTED|Overall Study||73
6415455|NCT00966446|7329159|FG000|COMPLETED|Overall Study||48
6415456|NCT00966446|7329160|FG001|COMPLETED|Overall Study||49
6415457|NCT00966446|7329161|FG002|COMPLETED|Overall Study||52
6415458|NCT00966446|7329159|FG000|NOT COMPLETED|Overall Study||28
6415459|NCT00966446|7329160|FG001|NOT COMPLETED|Overall Study||25
6415460|NCT00966446|7329161|FG002|NOT COMPLETED|Overall Study||21
6415461|NCT00966550|7329171|FG000|STARTED|Overall Study||13
6415462|NCT00966550|7329172|FG001|STARTED|Overall Study||12
6415463|NCT00966550|7329171|FG000|COMPLETED|Overall Study||13
6415464|NCT00966550|7329172|FG001|COMPLETED|Overall Study||12
6415465|NCT00966550|7329171|FG000|NOT COMPLETED|Overall Study||0
6415466|NCT00966550|7329172|FG001|NOT COMPLETED|Overall Study||0
6415467|NCT00966641|7329178|FG000|STARTED|First Intervention||17
6415468|NCT00966641|7329179|FG001|STARTED|First Intervention||17
6415469|NCT00966641|7329178|FG000|COMPLETED|First Intervention||17
6415470|NCT00966641|7329179|FG001|COMPLETED|First Intervention||17
6415471|NCT00966641|7329178|FG000|NOT COMPLETED|First Intervention||0
6415472|NCT00966641|7329179|FG001|NOT COMPLETED|First Intervention||0
6415473|NCT00966641|7329178|FG000|STARTED|Second Intervention||17
6415474|NCT00966641|7329179|FG001|STARTED|Second Intervention||17
6415475|NCT00966641|7329178|FG000|COMPLETED|Second Intervention||17
6415476|NCT00966641|7329179|FG001|COMPLETED|Second Intervention||17
6415477|NCT00966641|7329178|FG000|NOT COMPLETED|Second Intervention||0
6415478|NCT00966641|7329179|FG001|NOT COMPLETED|Second Intervention||0
6415479|NCT00966693|7329189|FG000|STARTED|Overall Study||3
6415480|NCT00966693|7329190|FG001|STARTED|Overall Study||3
6415481|NCT00966693|7329191|FG002|STARTED|Overall Study||9
6415482|NCT00966693|7329192|FG003|STARTED|Overall Study||49
6415483|NCT00966693|7329189|FG000|Phase 1 Completed|Overall Study||2
6415484|NCT00966693|7329190|FG001|Phase 1 Completed|Overall Study||3
6415485|NCT00966693|7329191|FG002|Phase 1 Completed|Overall Study||6
6415486|NCT00966693|7329192|FG003|Phase 1 Completed|Overall Study||0
6415487|NCT00966693|7329189|FG000|Phase 2 Completed|Overall Study||0
6415488|NCT00966693|7329190|FG001|Phase 2 Completed|Overall Study||0
6415489|NCT00966693|7329191|FG002|Phase 2 Completed|Overall Study||0
6415490|NCT00966693|7329192|FG003|Phase 2 Completed|Overall Study||46
6415491|NCT00966693|7329189|FG000|COMPLETED|Overall Study||2
6415492|NCT00966693|7329190|FG001|COMPLETED|Overall Study||3
6415493|NCT00966693|7329191|FG002|COMPLETED|Overall Study||6
6415494|NCT00966693|7329192|FG003|COMPLETED|Overall Study||26
6415495|NCT00966693|7329189|FG000|NOT COMPLETED|Overall Study||1
6415496|NCT00966693|7329190|FG001|NOT COMPLETED|Overall Study||0
6415497|NCT00966693|7329191|FG002|NOT COMPLETED|Overall Study||3
6415498|NCT00966693|7329192|FG003|NOT COMPLETED|Overall Study||23
6415499|NCT00966719|7329204|FG000|STARTED|Overall Study||50
6415500|NCT00966719|7329205|FG001|STARTED|Overall Study||49
6415501|NCT00966719|7329204|FG000|COMPLETED|Overall Study||44
6415502|NCT00966719|7329205|FG001|COMPLETED|Overall Study||38
6415503|NCT00966719|7329204|FG000|NOT COMPLETED|Overall Study||6
6415504|NCT00966719|7329205|FG001|NOT COMPLETED|Overall Study||11
6415505|NCT00966823|7329211|FG000|STARTED|Overall Study||3
6415506|NCT00966823|7329211|FG000|COMPLETED|Overall Study||2
6415507|NCT00966823|7329211|FG000|NOT COMPLETED|Overall Study||1
6415508|NCT00966849|7329218|FG000|STARTED|Overall Study||3660
6415509|NCT00966849|7329219|FG001|STARTED|Overall Study||3976
6415510|NCT00966849|7329220|FG002|STARTED|Overall Study||3169
6415511|NCT00966849|7329218|FG000|COMPLETED|Overall Study||2119
6415512|NCT00966849|7329219|FG001|COMPLETED|Overall Study||2498
6415513|NCT00966849|7329220|FG002|COMPLETED|Overall Study||1876
6415514|NCT00966849|7329218|FG000|NOT COMPLETED|Overall Study||1541
6415515|NCT00966849|7329219|FG001|NOT COMPLETED|Overall Study||1478
6415516|NCT00966849|7329220|FG002|NOT COMPLETED|Overall Study||1293
6415517|NCT00966875|7329237|FG000|STARTED|Part A||54
6415518|NCT00966875|7329238|FG001|STARTED|Part A||40
6415519|NCT00966875|7329239|FG002|STARTED|Part A||35
6415520|NCT00966875|7329240|FG003|STARTED|Part A||37
6415521|NCT00966875|7329241|FG004|STARTED|Part A||57
6415522|NCT00966875|7329242|FG005|STARTED|Part A||37
6638527|NCT02323334|7567006|FG003|COMPLETED|Period 3||4
6638528|NCT02323334|7567007|FG004|COMPLETED|Period 3||4
6415523|NCT00966875|7329243|FG006|STARTED|Part A||64
6415524|NCT00966875|7329244|FG007|STARTED|Part A||65
6415525|NCT00966875|7329245|FG008|STARTED|Part A||59
6415526|NCT00966875|7329237|FG000|Received ≥1 Doses of Study Drug|Part A||54
6415527|NCT00966875|7329238|FG001|Received ≥1 Doses of Study Drug|Part A||40
6415528|NCT00966875|7329239|FG002|Received ≥1 Doses of Study Drug|Part A||35
6415529|NCT00966875|7329240|FG003|Received ≥1 Doses of Study Drug|Part A||37
6415530|NCT00966875|7329241|FG004|Received ≥1 Doses of Study Drug|Part A||57
6415531|NCT00966875|7329242|FG005|Received ≥1 Doses of Study Drug|Part A||37
6415532|NCT00966875|7329243|FG006|Received ≥1 Doses of Study Drug|Part A||64
6415533|NCT00966875|7329244|FG007|Received ≥1 Doses of Study Drug|Part A||65
6415534|NCT00966875|7329245|FG008|Received ≥1 Doses of Study Drug|Part A||59
6638529|NCT02323334|7567008|FG005|COMPLETED|Period 3||4
6638530|NCT02323334|7567009|FG006|COMPLETED|Period 3||0
6638531|NCT02323334|7567010|FG007|COMPLETED|Period 3||0
6638532|NCT02323334|7567011|FG008|COMPLETED|Period 3||0
6415535|NCT00966875|7329237|FG000|COMPLETED|Part A||48
6415536|NCT00966875|7329238|FG001|COMPLETED|Part A||36
6415537|NCT00966875|7329239|FG002|COMPLETED|Part A||33
6415538|NCT00966875|7329240|FG003|COMPLETED|Part A||34
6415539|NCT00966875|7329241|FG004|COMPLETED|Part A||52
6415540|NCT00966875|7329242|FG005|COMPLETED|Part A||33
6415541|NCT00966875|7329243|FG006|COMPLETED|Part A||52
6415542|NCT00966875|7329244|FG007|COMPLETED|Part A||58
6415543|NCT00966875|7329245|FG008|COMPLETED|Part A||51
6415544|NCT00966875|7329237|FG000|NOT COMPLETED|Part A||6
6415545|NCT00966875|7329238|FG001|NOT COMPLETED|Part A||4
6415546|NCT00966875|7329239|FG002|NOT COMPLETED|Part A||2
6415547|NCT00966875|7329240|FG003|NOT COMPLETED|Part A||3
6415548|NCT00966875|7329241|FG004|NOT COMPLETED|Part A||5
6415549|NCT00966875|7329242|FG005|NOT COMPLETED|Part A||4
6415550|NCT00966875|7329243|FG006|NOT COMPLETED|Part A||12
6415551|NCT00966875|7329244|FG007|NOT COMPLETED|Part A||7
6415552|NCT00966875|7329245|FG008|NOT COMPLETED|Part A||8
6415553|NCT00966875|7329237|FG000|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
6415554|NCT00966875|7329238|FG001|STARTED|Part B||36
6415555|NCT00966875|7329239|FG002|STARTED|Part B||33
6415556|NCT00966875|7329240|FG003|STARTED|Part B||34
6415557|NCT00966875|7329241|FG004|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
6415558|NCT00966875|7329242|FG005|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
6415559|NCT00966875|7329243|FG006|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
6415560|NCT00966875|7329244|FG007|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
6415561|NCT00966875|7329245|FG008|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
6415562|NCT00966875|7329237|FG000|COMPLETED|Part B||41
6415563|NCT00966875|7329238|FG001|COMPLETED|Part B||33
6415564|NCT00966875|7329239|FG002|COMPLETED|Part B||27
6415565|NCT00966875|7329240|FG003|COMPLETED|Part B||31
6415566|NCT00966875|7329241|FG004|COMPLETED|Part B||44
6415567|NCT00966875|7329242|FG005|COMPLETED|Part B||26
6415568|NCT00966875|7329243|FG006|COMPLETED|Part B||29
6415569|NCT00966875|7329244|FG007|COMPLETED|Part B||38
6415570|NCT00966875|7329245|FG008|COMPLETED|Part B||32
6415571|NCT00966875|7329237|FG000|NOT COMPLETED|Part B||5
6415572|NCT00966875|7329238|FG001|NOT COMPLETED|Part B||3
6415573|NCT00966875|7329239|FG002|NOT COMPLETED|Part B||6
6415574|NCT00966875|7329240|FG003|NOT COMPLETED|Part B||3
6415575|NCT00966875|7329241|FG004|NOT COMPLETED|Part B||7
6415576|NCT00966875|7329242|FG005|NOT COMPLETED|Part B||6
6415577|NCT00966875|7329243|FG006|NOT COMPLETED|Part B||22
6415578|NCT00966875|7329244|FG007|NOT COMPLETED|Part B||19
6415579|NCT00966875|7329245|FG008|NOT COMPLETED|Part B||18
6415580|NCT00966940|7329320|FG000|STARTED|Period 1, First 6 Weeks||28
6415581|NCT00966940|7329321|FG001|STARTED|Period 1, First 6 Weeks||23
6415582|NCT00966940|7329320|FG000|COMPLETED|Period 1, First 6 Weeks||25
6415583|NCT00966940|7329321|FG001|COMPLETED|Period 1, First 6 Weeks||23
6415584|NCT00966940|7329320|FG000|NOT COMPLETED|Period 1, First 6 Weeks||3
6415585|NCT00966940|7329321|FG001|NOT COMPLETED|Period 1, First 6 Weeks||0
6415586|NCT00966940|7329320|FG000|STARTED|Period 2, Second 6 Weeks||25
6415587|NCT00966940|7329321|FG001|STARTED|Period 2, Second 6 Weeks||23
6415588|NCT00966940|7329320|FG000|COMPLETED|Period 2, Second 6 Weeks||25
6415589|NCT00966940|7329321|FG001|COMPLETED|Period 2, Second 6 Weeks||23
6415590|NCT00966940|7329320|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
6415591|NCT00966940|7329321|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
6415592|NCT00967005|7329329|FG000|STARTED|Overall Study||13
6415593|NCT00967005|7329330|FG001|STARTED|Overall Study||15
6415594|NCT00967005|7329329|FG000|Treatment Completion|Overall Study||10
6415595|NCT00967005|7329330|FG001|Treatment Completion|Overall Study||10
6415596|NCT00967005|7329329|FG000|COMPLETED|Overall Study||6
6415597|NCT00967005|7329330|FG001|COMPLETED|Overall Study||5
6415598|NCT00967005|7329329|FG000|NOT COMPLETED|Overall Study||7
6415599|NCT00967005|7329330|FG001|NOT COMPLETED|Overall Study||10
6415600|NCT00967018|7329336|FG000|STARTED|Overall Study||77
6415601|NCT00967018|7329336|FG000|COMPLETED|Overall Study||56
6415602|NCT00967018|7329336|FG000|NOT COMPLETED|Overall Study||21
6415603|NCT00967044|7329340|FG000|STARTED|Overall Study||30
6415604|NCT00967044|7329340|FG000|COMPLETED|Overall Study||30
6415605|NCT00967044|7329340|FG000|NOT COMPLETED|Overall Study||0
6415606|NCT00967226|7329346|FG000|STARTED|Overall Study||11
6415607|NCT00967226|7329347|FG001|STARTED|Overall Study||8
6415608|NCT00967226|7329346|FG000|COMPLETED|Overall Study||9
6415609|NCT00967226|7329347|FG001|COMPLETED|Overall Study||2
6415610|NCT00967226|7329346|FG000|NOT COMPLETED|Overall Study||2
6415611|NCT00967226|7329347|FG001|NOT COMPLETED|Overall Study||6
6415612|NCT00967330|7329379|FG000|STARTED|Overall Study||122
6415613|NCT00967330|7329380|FG001|STARTED|Overall Study||60
6415614|NCT00967330|7329379|FG000|COMPLETED|Overall Study||0
6415615|NCT00967330|7329380|FG001|COMPLETED|Overall Study||0
6415616|NCT00967330|7329379|FG000|NOT COMPLETED|Overall Study||122
6415617|NCT00967330|7329380|FG001|NOT COMPLETED|Overall Study||60
6415618|NCT00967343|7329386|FG000|STARTED|Overall Study||40
6415619|NCT00967343|7329386|FG000|COMPLETED|Overall Study||2
6415620|NCT00967343|7329386|FG000|NOT COMPLETED|Overall Study||38
6415621|NCT00967369|7329392|FG000|STARTED|Overall Study||10
6415622|NCT00967369|7329393|FG001|STARTED|Overall Study||10
6638533|NCT02323334|7567012|FG009|COMPLETED|Period 3||0
6638534|NCT02323334|7567013|FG010|COMPLETED|Period 3||0
6415623|NCT00967369|7329392|FG000|Relapsed|Overall Study||4
6415624|NCT00967369|7329393|FG001|Relapsed|Overall Study||7
6415625|NCT00967369|7329392|FG000|Refractory|Overall Study||6
6415626|NCT00967369|7329393|FG001|Refractory|Overall Study||3
6415627|NCT00967369|7329392|FG000|COMPLETED|Overall Study||10
6415628|NCT00967369|7329393|FG001|COMPLETED|Overall Study||10
6415629|NCT00967369|7329392|FG000|NOT COMPLETED|Overall Study||0
6415630|NCT00967369|7329393|FG001|NOT COMPLETED|Overall Study||0
6415631|NCT00967473|7329399|FG000|STARTED|Overall Study||15
6415632|NCT00967473|7329399|FG000|COMPLETED|Overall Study||15
6415633|NCT00967473|7329399|FG000|NOT COMPLETED|Overall Study||0
6415634|NCT00967486|7329405|FG000|STARTED|Overall Study||98
6415635|NCT00967486|7329406|FG001|STARTED|Overall Study||102
6415636|NCT00967486|7329405|FG000|COMPLETED|Overall Study||98
6415637|NCT00967486|7329406|FG001|COMPLETED|Overall Study||102
6415638|NCT00967486|7329405|FG000|NOT COMPLETED|Overall Study||0
6415639|NCT00967486|7329406|FG001|NOT COMPLETED|Overall Study||0
6415640|NCT00967499|7329414|FG000|STARTED|Overall Study||111
6415641|NCT00967499|7329415|FG001|STARTED|Overall Study||109
6415642|NCT00967499|7329414|FG000|Treated (Full Analysis Set)|Overall Study||48
6415643|NCT00967499|7329415|FG001|Treated (Full Analysis Set)|Overall Study||50
6415644|NCT00967499|7329414|FG000|COMPLETED|Overall Study||46
6415645|NCT00967499|7329415|FG001|COMPLETED|Overall Study||49
6415646|NCT00967499|7329414|FG000|NOT COMPLETED|Overall Study||65
6415647|NCT00967499|7329415|FG001|NOT COMPLETED|Overall Study||60
6415648|NCT00967551|7329423|FG000|STARTED|Overall Study||68
6415649|NCT00967551|7329424|FG001|STARTED|Overall Study||75
6415650|NCT00967551|7329423|FG000|COMPLETED|Overall Study||68
6415651|NCT00967551|7329424|FG001|COMPLETED|Overall Study||75
6415652|NCT00967551|7329423|FG000|NOT COMPLETED|Overall Study||0
6415653|NCT00967551|7329424|FG001|NOT COMPLETED|Overall Study||0
6415654|NCT00967616|7329432|FG000|STARTED|Overall Study||50
6415655|NCT00967616|7329433|FG001|STARTED|Overall Study||50
6415656|NCT00967616|7329432|FG000|COMPLETED|Overall Study||0
6415657|NCT00967616|7329433|FG001|COMPLETED|Overall Study||0
6415658|NCT00967616|7329432|FG000|NOT COMPLETED|Overall Study||50
6510677|NCT01483807|7430281|FG001|STARTED|First Treatment Phase (7 Weeks)||10
6510678|NCT01483807|7430280|FG000|COMPLETED|First Treatment Phase (7 Weeks)||10
6510679|NCT01483807|7430281|FG001|COMPLETED|First Treatment Phase (7 Weeks)||10
6510680|NCT01483807|7430280|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
6510681|NCT01483807|7430281|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
6510682|NCT01483807|7430280|FG000|STARTED|Washout (2 Weeks)||10
6510683|NCT01483807|7430281|FG001|STARTED|Washout (2 Weeks)||10
6510684|NCT01483807|7430280|FG000|COMPLETED|Washout (2 Weeks)||10
6510685|NCT01483807|7430281|FG001|COMPLETED|Washout (2 Weeks)||10
6510686|NCT01483807|7430280|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6510687|NCT01483807|7430281|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6510688|NCT01483807|7430280|FG000|STARTED|Second Treatment Phase (7 Weeks)||10
6510689|NCT01483807|7430281|FG001|STARTED|Second Treatment Phase (7 Weeks)||10
6510690|NCT01483807|7430280|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||10
6510691|NCT01483807|7430281|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||10
6510692|NCT01483807|7430280|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
6510693|NCT01483807|7430281|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
6510694|NCT01483924|7430294|FG000|STARTED|Overall Study||12
6510695|NCT01483924|7430295|FG001|STARTED|Overall Study||12
6510696|NCT01483924|7430296|FG002|STARTED|Overall Study||12
6510697|NCT01483924|7430297|FG003|STARTED|Overall Study||12
6510698|NCT01483924|7430298|FG004|STARTED|Overall Study||12
6510699|NCT01483924|7430294|FG000|COMPLETED|Overall Study||10
6510700|NCT01483924|7430295|FG001|COMPLETED|Overall Study||12
6510701|NCT01483924|7430296|FG002|COMPLETED|Overall Study||11
6510702|NCT01483924|7430297|FG003|COMPLETED|Overall Study||8
6510703|NCT01483924|7430298|FG004|COMPLETED|Overall Study||10
6510704|NCT01483924|7430294|FG000|NOT COMPLETED|Overall Study||2
6510705|NCT01483924|7430295|FG001|NOT COMPLETED|Overall Study||0
6510706|NCT01483924|7430296|FG002|NOT COMPLETED|Overall Study||1
6510707|NCT01483924|7430297|FG003|NOT COMPLETED|Overall Study||4
6510708|NCT01483924|7430298|FG004|NOT COMPLETED|Overall Study||2
6510709|NCT01483937|7430321|FG000|STARTED|Overall Study||15
6510710|NCT01483937|7430322|FG001|STARTED|Overall Study||17
6510711|NCT01483937|7430321|FG000|COMPLETED|Overall Study||11
6510712|NCT01483937|7430322|FG001|COMPLETED|Overall Study||14
6510713|NCT01483937|7430321|FG000|NOT COMPLETED|Overall Study||4
6510714|NCT01483937|7430322|FG001|NOT COMPLETED|Overall Study||3
6510715|NCT01483963|7430336|FG000|STARTED|Overall Study||10
6510716|NCT01483963|7430337|FG001|STARTED|Overall Study||10
6510717|NCT01483963|7430338|FG002|STARTED|Overall Study||10
6510718|NCT01483963|7430339|FG003|STARTED|Overall Study||10
6510719|NCT01483963|7430340|FG004|STARTED|Overall Study||10
6510720|NCT01483963|7430336|FG000|COMPLETED|Overall Study||10
6510721|NCT01483963|7430337|FG001|COMPLETED|Overall Study||10
6415659|NCT00967616|7329433|FG001|NOT COMPLETED|Overall Study||50
6415660|NCT00967668|7329442|FG000|STARTED|Overall Study||162
6415661|NCT00967668|7329443|FG001|STARTED|Overall Study||160
6415662|NCT00967668|7329444|FG002|STARTED|Overall Study||159
6415663|NCT00967668|7329442|FG000|3-mo Assessment|Overall Study||131
6415664|NCT00967668|7329443|FG001|3-mo Assessment|Overall Study||127
6415665|NCT00967668|7329444|FG002|3-mo Assessment|Overall Study||115
6415666|NCT00967668|7329442|FG000|Completed Year 1 - 12-mo Assessment|Overall Study||120
6510722|NCT01483963|7430338|FG002|COMPLETED|Overall Study||10
6510723|NCT01483963|7430339|FG003|COMPLETED|Overall Study||10
6415667|NCT00967668|7329443|FG001|Completed Year 1 - 12-mo Assessment|Overall Study||122
6415668|NCT00967668|7329444|FG002|Completed Year 1 - 12-mo Assessment|Overall Study||119
6415669|NCT00967668|7329442|FG000|18-mo Assessment|Overall Study||95
6415670|NCT00967668|7329443|FG001|18-mo Assessment|Overall Study||102
6415671|NCT00967668|7329444|FG002|18-mo Assessment|Overall Study||92
6415672|NCT00967668|7329442|FG000|COMPLETED|Overall Study||91
6415673|NCT00967668|7329443|FG001|COMPLETED|Overall Study||104
6415674|NCT00967668|7329444|FG002|COMPLETED|Overall Study||90
6415675|NCT00967668|7329442|FG000|NOT COMPLETED|Overall Study||71
6415676|NCT00967668|7329443|FG001|NOT COMPLETED|Overall Study||56
6415677|NCT00967668|7329444|FG002|NOT COMPLETED|Overall Study||69
6415678|NCT00967694|7329455|FG000|STARTED|Overall Study||26
6415679|NCT00967694|7329455|FG000|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
6415680|NCT00967694|7329455|FG000|NOT COMPLETED|Overall Study||6
6415681|NCT00967798|7329461|FG000|STARTED|Overall Study||17
6415682|NCT00967798|7329462|FG001|STARTED|Overall Study||16
6415683|NCT00967798|7329461|FG000|COMPLETED|Overall Study||8
6415684|NCT00967798|7329462|FG001|COMPLETED|Overall Study||13
6415685|NCT00967798|7329461|FG000|NOT COMPLETED|Overall Study||9
6415686|NCT00967798|7329462|FG001|NOT COMPLETED|Overall Study||3
6415687|NCT00967941|7329471|FG000|STARTED|Overall Study||67
6415688|NCT00967941|7329472|FG001|STARTED|Overall Study||54
6415689|NCT00967941|7329473|FG002|STARTED|Overall Study||60
6415690|NCT00967941|7329471|FG000|COMPLETED|Overall Study||62
6415691|NCT00967941|7329472|FG001|COMPLETED|Overall Study||51
6415692|NCT00967941|7329473|FG002|COMPLETED|Overall Study||56
6415693|NCT00967941|7329471|FG000|NOT COMPLETED|Overall Study||5
6415694|NCT00967941|7329472|FG001|NOT COMPLETED|Overall Study||3
6415695|NCT00967941|7329473|FG002|NOT COMPLETED|Overall Study||4
6415696|NCT00967993|7329481|FG000|STARTED|Overall Study||22
6415697|NCT00967993|7329481|FG000|COMPLETED|Overall Study||18
6415698|NCT00967993|7329481|FG000|NOT COMPLETED|Overall Study||4
6415699|NCT00968019|7329485|FG000|STARTED|Overall Study||318
6415700|NCT00968019|7329485|FG000|COMPLETED|Overall Study||303
6415701|NCT00968019|7329485|FG000|NOT COMPLETED|Overall Study||15
6415702|NCT00968032|7329489|FG000|STARTED|Overall Study||63
6415703|NCT00968032|7329489|FG000|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage~1 patient denied latest FU"|61
6415704|NCT00968032|7329489|FG000|NOT COMPLETED|Overall Study||2
6415705|NCT00968071|7329493|FG000|STARTED|Overall Study||71
6415706|NCT00968071|7329493|FG000|COMPLETED|Overall Study||71
6415707|NCT00968071|7329493|FG000|NOT COMPLETED|Overall Study||0
6415708|NCT00968227|7329497|FG000|STARTED|Overall Study||56
6415709|NCT00968227|7329497|FG000|COMPLETED|Overall Study||56
6415710|NCT00968227|7329497|FG000|NOT COMPLETED|Overall Study||0
6415711|NCT00968253|7329504|FG000|STARTED|Overall Study||3
6415712|NCT00968253|7329505|FG001|STARTED|Overall Study||9
6415713|NCT00968253|7329506|FG002|STARTED|Overall Study||12
6415714|NCT00968253|7329504|FG000|COMPLETED|Overall Study||3
6415715|NCT00968253|7329505|FG001|COMPLETED|Overall Study||6
6415716|NCT00968253|7329506|FG002|COMPLETED|Overall Study||5
6415717|NCT00968253|7329504|FG000|NOT COMPLETED|Overall Study||0
6415718|NCT00968253|7329505|FG001|NOT COMPLETED|Overall Study||3
6415719|NCT00968253|7329506|FG002|NOT COMPLETED|Overall Study||7
6415720|NCT00968344|7329517|FG000|STARTED|Overall Study|Includes screen fails|20
6415721|NCT00968344|7329518|FG001|STARTED|Overall Study|Includes screen fails|20
6415722|NCT00968344|7329517|FG000|COMPLETED|Overall Study||10
6415723|NCT00968344|7329518|FG001|COMPLETED|Overall Study||9
6415724|NCT00968344|7329517|FG000|NOT COMPLETED|Overall Study||10
6415725|NCT00968344|7329518|FG001|NOT COMPLETED|Overall Study||11
6415726|NCT00968526|7329526|FG000|STARTED|Overall Study||138
6415727|NCT00968526|7329527|FG001|STARTED|Overall Study||102
6415728|NCT00968526|7329526|FG000|COMPLETED|Overall Study||135
6415729|NCT00968526|7329527|FG001|COMPLETED|Overall Study||102
6415730|NCT00968526|7329526|FG000|NOT COMPLETED|Overall Study||3
6415731|NCT00968526|7329527|FG001|NOT COMPLETED|Overall Study||0
6415732|NCT00968539|7329544|FG000|STARTED|Overall Study||64
6415733|NCT00968539|7329545|FG001|STARTED|Overall Study||66
6415734|NCT00968539|7329544|FG000|COMPLETED|Overall Study||63
6415735|NCT00968539|7329545|FG001|COMPLETED|Overall Study||66
6415736|NCT00968539|7329544|FG000|NOT COMPLETED|Overall Study||1
6415737|NCT00968539|7329545|FG001|NOT COMPLETED|Overall Study||0
6415738|NCT00968617|7329552|FG000|STARTED|Overall Study||7
6415739|NCT00968617|7329552|FG000|COMPLETED|Overall Study||1
6415740|NCT00968617|7329552|FG000|NOT COMPLETED|Overall Study||6
6415741|NCT00968669|7329560|FG000|STARTED|Overall Study||82
6415742|NCT00968669|7329561|FG001|STARTED|Overall Study||81
6415743|NCT00968669|7329562|FG002|STARTED|Overall Study||83
6415744|NCT00968669|7329563|FG003|STARTED|Overall Study||81
6415745|NCT00968669|7329560|FG000|COMPLETED|Overall Study||64
6415746|NCT00968669|7329561|FG001|COMPLETED|Overall Study||63
6415747|NCT00968669|7329562|FG002|COMPLETED|Overall Study||72
6415748|NCT00968669|7329563|FG003|COMPLETED|Overall Study||72
6415749|NCT00968669|7329560|FG000|NOT COMPLETED|Overall Study||18
6415750|NCT00968669|7329561|FG001|NOT COMPLETED|Overall Study||18
6415751|NCT00968669|7329562|FG002|NOT COMPLETED|Overall Study||11
6415752|NCT00968669|7329563|FG003|NOT COMPLETED|Overall Study||9
6415753|NCT00968708|7329575|FG000|STARTED|Overall Study||2679
6415754|NCT00968708|7329576|FG001|STARTED|Overall Study||2701
6415755|NCT00968708|7329575|FG000|Treated|Overall Study||2676
6415756|NCT00968708|7329576|FG001|Treated|Overall Study||2698
6415757|NCT00968708|7329575|FG000|COMPLETED|Overall Study||2361
6415758|NCT00968708|7329576|FG001|COMPLETED|Overall Study||2403
6415759|NCT00968708|7329575|FG000|NOT COMPLETED|Overall Study||318
6415760|NCT00968708|7329576|FG001|NOT COMPLETED|Overall Study||298
6415761|NCT00968799|7329582|FG000|STARTED|Overall Study||6
6415762|NCT00968799|7329582|FG000|COMPLETED|Overall Study||4
6415763|NCT00968799|7329582|FG000|NOT COMPLETED|Overall Study||2
6415764|NCT00968812|7329589|FG000|STARTED|Overall Study||483
6415765|NCT00968812|7329590|FG001|STARTED|Overall Study||485
6415766|NCT00968812|7329591|FG002|STARTED|Overall Study||482
6415767|NCT00968812|7329589|FG000|COMPLETED|Overall Study||343
6415768|NCT00968812|7329590|FG001|COMPLETED|Overall Study||323
6415769|NCT00968812|7329591|FG002|COMPLETED|Overall Study||314
6415770|NCT00968812|7329589|FG000|NOT COMPLETED|Overall Study||140
6415771|NCT00968812|7329590|FG001|NOT COMPLETED|Overall Study||162
6415772|NCT00968812|7329591|FG002|NOT COMPLETED|Overall Study||168
6415773|NCT00968838|7329604|FG000|STARTED|Overall Study||50
6415774|NCT00968838|7329605|FG001|STARTED|Overall Study||58
6415775|NCT00968838|7329604|FG000|COMPLETED|Overall Study||50
6415776|NCT00968838|7329605|FG001|COMPLETED|Overall Study||58
6415777|NCT00968838|7329604|FG000|NOT COMPLETED|Overall Study||0
6415778|NCT00968838|7329605|FG001|NOT COMPLETED|Overall Study||0
6415779|NCT00968890|7329613|FG000|STARTED|Overall Study||84
6415780|NCT00968890|7329614|FG001|STARTED|Overall Study||84
6415781|NCT00968890|7329613|FG000|COMPLETED|Overall Study||84
6415782|NCT00968890|7329614|FG001|COMPLETED|Overall Study||84
6415783|NCT00968890|7329613|FG000|NOT COMPLETED|Overall Study||0
6415784|NCT00968890|7329614|FG001|NOT COMPLETED|Overall Study||0
6415785|NCT00968968|7329622|FG000|STARTED|Overall Study||20
6415786|NCT00968968|7329623|FG001|STARTED|Overall Study||17
6415787|NCT00968968|7329622|FG000|COMPLETED|Overall Study||4
6415788|NCT00968968|7329623|FG001|COMPLETED|Overall Study||3
6415789|NCT00968968|7329622|FG000|NOT COMPLETED|Overall Study||16
6415790|NCT00968968|7329623|FG001|NOT COMPLETED|Overall Study||14
6415791|NCT00968981|7329633|FG000|STARTED|Overall Study||23
6415792|NCT00968981|7329634|FG001|STARTED|Overall Study||22
6415793|NCT00968981|7329635|FG002|STARTED|Overall Study||22
6415794|NCT00968981|7329633|FG000|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
6415795|NCT00968981|7329634|FG001|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
6415796|NCT00968981|7329635|FG002|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
6415797|NCT00968981|7329633|FG000|COMPLETED|Overall Study||1
6415798|NCT00968981|7329634|FG001|COMPLETED|Overall Study||0
6415799|NCT00968981|7329635|FG002|COMPLETED|Overall Study||0
6415800|NCT00968981|7329633|FG000|NOT COMPLETED|Overall Study||22
6415801|NCT00968981|7329634|FG001|NOT COMPLETED|Overall Study||22
6415802|NCT00968981|7329635|FG002|NOT COMPLETED|Overall Study||22
6415803|NCT00969124|7329644|FG000|STARTED|Overall Study||328
6415804|NCT00969124|7329644|FG000|COMPLETED|Overall Study||298
6415805|NCT00969124|7329644|FG000|NOT COMPLETED|Overall Study||30
6415806|NCT00969150|7329651|FG000|STARTED|Overall Study||182
6415807|NCT00969150|7329652|FG001|STARTED|Overall Study||175
6415808|NCT00969150|7329651|FG000|COMPLETED|Overall Study||149
6415809|NCT00969150|7329652|FG001|COMPLETED|Overall Study||135
6415810|NCT00969150|7329651|FG000|NOT COMPLETED|Overall Study||33
6415811|NCT00969150|7329652|FG001|NOT COMPLETED|Overall Study||40
6415812|NCT00969228|7329660|FG000|STARTED|Overall Study||508
6415813|NCT00969228|7329661|FG001|STARTED|Overall Study||176
6415814|NCT00969228|7329660|FG000|COMPLETED|Overall Study||465
6415815|NCT00969228|7329661|FG001|COMPLETED|Overall Study||162
6415816|NCT00969228|7329660|FG000|NOT COMPLETED|Overall Study||43
6415817|NCT00969228|7329661|FG001|NOT COMPLETED|Overall Study||14
6415818|NCT00969280|7329669|FG000|STARTED|Overall Study||21
6415819|NCT00969280|7329670|FG001|STARTED|Overall Study||21
6415820|NCT00969280|7329669|FG000|COMPLETED|Overall Study||19
6415821|NCT00969280|7329670|FG001|COMPLETED|Overall Study||18
6415822|NCT00969280|7329669|FG000|NOT COMPLETED|Overall Study||2
6415823|NCT00969280|7329670|FG001|NOT COMPLETED|Overall Study||3
6415824|NCT00969332|7329676|FG000|STARTED|Overall Study||62
6415825|NCT00969332|7329676|FG000|COMPLETED|Overall Study||51
6415826|NCT00969332|7329676|FG000|NOT COMPLETED|Overall Study||11
6415827|NCT00969436|7329684|FG000|STARTED|Overall Study||180
6415828|NCT00969436|7329685|FG001|STARTED|Overall Study||180
6415829|NCT00969436|7329686|FG002|STARTED|Overall Study||90
6415830|NCT00969436|7329684|FG000|COMPLETED|Overall Study||155
6415831|NCT00969436|7329685|FG001|COMPLETED|Overall Study||159
6415832|NCT00969436|7329686|FG002|COMPLETED|Overall Study||79
6415833|NCT00969436|7329684|FG000|NOT COMPLETED|Overall Study||25
6415834|NCT00969436|7329685|FG001|NOT COMPLETED|Overall Study||21
6415835|NCT00969436|7329686|FG002|NOT COMPLETED|Overall Study||11
6499147|NCT01415232|7417790|FG000|STARTED|Overall Study||160
6499148|NCT01415232|7417790|FG000|COMPLETED|Overall Study||160
6499149|NCT01415232|7417790|FG000|NOT COMPLETED|Overall Study||0
6499150|NCT01415349|7417794|FG000|STARTED|Treatment Period 1||21
6499151|NCT01415349|7417795|FG001|STARTED|Treatment Period 1||21
6499152|NCT01415349|7417794|FG000|COMPLETED|Treatment Period 1||21
6499153|NCT01415349|7417795|FG001|COMPLETED|Treatment Period 1||19
6499154|NCT01415349|7417794|FG000|NOT COMPLETED|Treatment Period 1||0
6499155|NCT01415349|7417795|FG001|NOT COMPLETED|Treatment Period 1||2
6415836|NCT00969501|7329694|FG000|STARTED|Overall Study||32
6415837|NCT00969501|7329694|FG000|COMPLETED|Overall Study||27
6415838|NCT00969501|7329694|FG000|NOT COMPLETED|Overall Study||5
6415839|NCT00969540|7329700|FG000|STARTED|Overall Study||4
6415840|NCT00969540|7329701|FG001|STARTED|Overall Study||4
6415841|NCT00969540|7329700|FG000|COMPLETED|Overall Study||3
6415842|NCT00969540|7329701|FG001|COMPLETED|Overall Study||3
6415843|NCT00969540|7329700|FG000|NOT COMPLETED|Overall Study||1
6415844|NCT00969540|7329701|FG001|NOT COMPLETED|Overall Study||1
6415845|NCT00969553|7329728|FG000|STARTED|Overall Study||3
6415846|NCT00969553|7329729|FG001|STARTED|Overall Study||3
6415847|NCT00969553|7329730|FG002|STARTED|Overall Study||6
6415848|NCT00969553|7329731|FG003|STARTED|Overall Study||17
6415849|NCT00969553|7329732|FG004|STARTED|Overall Study||3
6415850|NCT00969553|7329733|FG005|STARTED|Overall Study||4
6415851|NCT00969553|7329734|FG006|STARTED|Overall Study||4
6415852|NCT00969553|7329735|FG007|STARTED|Overall Study||16
6415853|NCT00969553|7329736|FG008|STARTED|Overall Study||3
6415854|NCT00969553|7329728|FG000|COMPLETED|Overall Study||0
6415855|NCT00969553|7329729|FG001|COMPLETED|Overall Study||0
6415856|NCT00969553|7329730|FG002|COMPLETED|Overall Study||0
6415857|NCT00969553|7329731|FG003|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|1
6415858|NCT00969553|7329732|FG004|COMPLETED|Overall Study||0
6415859|NCT00969553|7329733|FG005|COMPLETED|Overall Study||0
6415860|NCT00969553|7329734|FG006|COMPLETED|Overall Study||0
6415861|NCT00969553|7329735|FG007|COMPLETED|Overall Study|on-treatment at analysis data base lock date (27-Oct-2011)|2
6415862|NCT00969553|7329736|FG008|COMPLETED|Overall Study||0
6415863|NCT00969553|7329728|FG000|NOT COMPLETED|Overall Study||3
6415864|NCT00969553|7329729|FG001|NOT COMPLETED|Overall Study||3
6415865|NCT00969553|7329730|FG002|NOT COMPLETED|Overall Study||6
6415866|NCT00969553|7329731|FG003|NOT COMPLETED|Overall Study||16
6415867|NCT00969553|7329732|FG004|NOT COMPLETED|Overall Study||3
6415868|NCT00969553|7329733|FG005|NOT COMPLETED|Overall Study||4
6415869|NCT00969553|7329734|FG006|NOT COMPLETED|Overall Study||4
6415870|NCT00969553|7329735|FG007|NOT COMPLETED|Overall Study||14
6415871|NCT00969553|7329736|FG008|NOT COMPLETED|Overall Study||3
6415872|NCT00969618|7329764|FG000|STARTED|Overall Study||211
6415873|NCT00969618|7329764|FG000|COMPLETED|Overall Study||133
6415874|NCT00969618|7329764|FG000|NOT COMPLETED|Overall Study||78
6415875|NCT00969709|7329772|FG000|STARTED|Overall Study||176
6415876|NCT00969709|7329773|FG001|STARTED|Overall Study||178
6415877|NCT00969709|7329774|FG002|STARTED|Overall Study||179
6415878|NCT00969709|7329775|FG003|STARTED|Overall Study||180
6415879|NCT00969709|7329772|FG000|COMPLETED|Overall Study||138
6415880|NCT00969709|7329773|FG001|COMPLETED|Overall Study||130
6415881|NCT00969709|7329774|FG002|COMPLETED|Overall Study||121
6415882|NCT00969709|7329775|FG003|COMPLETED|Overall Study||117
6415883|NCT00969709|7329772|FG000|NOT COMPLETED|Overall Study||38
6415884|NCT00969709|7329773|FG001|NOT COMPLETED|Overall Study||48
6415885|NCT00969709|7329774|FG002|NOT COMPLETED|Overall Study||58
6415886|NCT00969709|7329775|FG003|NOT COMPLETED|Overall Study||63
6415887|NCT00969761|7329801|FG000|STARTED|Discont. Before Start of Treat. Cycle 2||3
6415888|NCT00969761|7329802|FG001|STARTED|Discont. Before Start of Treat. Cycle 2||3
6415889|NCT00969761|7329803|FG002|STARTED|Discont. Before Start of Treat. Cycle 2||12
6415890|NCT00969761|7329804|FG003|STARTED|Discont. Before Start of Treat. Cycle 2||6
6415891|NCT00969761|7329805|FG004|STARTED|Discont. Before Start of Treat. Cycle 2||3
6415892|NCT00969761|7329806|FG005|STARTED|Discont. Before Start of Treat. Cycle 2||3
6415893|NCT00969761|7329807|FG006|STARTED|Discont. Before Start of Treat. Cycle 2||3
6415894|NCT00969761|7329808|FG007|STARTED|Discont. Before Start of Treat. Cycle 2||6
6415895|NCT00969761|7329809|FG008|STARTED|Discont. Before Start of Treat. Cycle 2||13
6415896|NCT00969761|7329810|FG009|STARTED|Discont. Before Start of Treat. Cycle 2||3
6415897|NCT00969761|7329811|FG010|STARTED|Discont. Before Start of Treat. Cycle 2||3
6415898|NCT00969761|7329812|FG011|STARTED|Discont. Before Start of Treat. Cycle 2||3
6415899|NCT00969761|7329801|FG000|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
6415900|NCT00969761|7329802|FG001|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6415901|NCT00969761|7329803|FG002|COMPLETED|Discont. Before Start of Treat. Cycle 2||10
6415902|NCT00969761|7329804|FG003|COMPLETED|Discont. Before Start of Treat. Cycle 2||5
6415903|NCT00969761|7329805|FG004|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6415904|NCT00969761|7329806|FG005|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6415905|NCT00969761|7329807|FG006|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6415906|NCT00969761|7329808|FG007|COMPLETED|Discont. Before Start of Treat. Cycle 2||6
6415907|NCT00969761|7329809|FG008|COMPLETED|Discont. Before Start of Treat. Cycle 2||11
6415908|NCT00969761|7329810|FG009|COMPLETED|Discont. Before Start of Treat. Cycle 2||2
6415909|NCT00969761|7329811|FG010|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6415910|NCT00969761|7329812|FG011|COMPLETED|Discont. Before Start of Treat. Cycle 2||3
6415911|NCT00969761|7329801|FG000|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
6638535|NCT02323334|7567014|FG011|COMPLETED|Period 3||0
6638536|NCT02323334|7567015|FG012|COMPLETED|Period 3||0
6415912|NCT00969761|7329802|FG001|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6415913|NCT00969761|7329803|FG002|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
6415914|NCT00969761|7329804|FG003|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
6415915|NCT00969761|7329805|FG004|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6415916|NCT00969761|7329806|FG005|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6638537|NCT02323334|7567016|FG013|COMPLETED|Period 3||0
6415917|NCT00969761|7329807|FG006|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6415918|NCT00969761|7329808|FG007|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6415919|NCT00969761|7329809|FG008|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||2
6415920|NCT00969761|7329810|FG009|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||1
6415921|NCT00969761|7329811|FG010|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6415922|NCT00969761|7329812|FG011|NOT COMPLETED|Discont. Before Start of Treat. Cycle 2||0
6415923|NCT00969761|7329801|FG000|STARTED|Treated in and Beyond Treat. Cycle 2||2
6415924|NCT00969761|7329802|FG001|STARTED|Treated in and Beyond Treat. Cycle 2||3
6415925|NCT00969761|7329803|FG002|STARTED|Treated in and Beyond Treat. Cycle 2||10
6415926|NCT00969761|7329804|FG003|STARTED|Treated in and Beyond Treat. Cycle 2||5
6415927|NCT00969761|7329805|FG004|STARTED|Treated in and Beyond Treat. Cycle 2||3
6415928|NCT00969761|7329806|FG005|STARTED|Treated in and Beyond Treat. Cycle 2||3
6415929|NCT00969761|7329807|FG006|STARTED|Treated in and Beyond Treat. Cycle 2||3
6415930|NCT00969761|7329808|FG007|STARTED|Treated in and Beyond Treat. Cycle 2||6
6415931|NCT00969761|7329809|FG008|STARTED|Treated in and Beyond Treat. Cycle 2||11
6415932|NCT00969761|7329810|FG009|STARTED|Treated in and Beyond Treat. Cycle 2||2
6415933|NCT00969761|7329811|FG010|STARTED|Treated in and Beyond Treat. Cycle 2||3
6415934|NCT00969761|7329812|FG011|STARTED|Treated in and Beyond Treat. Cycle 2||3
6415935|NCT00969761|7329801|FG000|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415936|NCT00969761|7329802|FG001|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415937|NCT00969761|7329803|FG002|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415938|NCT00969761|7329804|FG003|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415939|NCT00969761|7329805|FG004|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415940|NCT00969761|7329806|FG005|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415941|NCT00969761|7329807|FG006|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415942|NCT00969761|7329808|FG007|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415943|NCT00969761|7329809|FG008|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415944|NCT00969761|7329810|FG009|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415945|NCT00969761|7329811|FG010|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415946|NCT00969761|7329812|FG011|COMPLETED|Treated in and Beyond Treat. Cycle 2||0
6415947|NCT00969761|7329801|FG000|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
6415948|NCT00969761|7329802|FG001|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6415949|NCT00969761|7329803|FG002|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||10
6415950|NCT00969761|7329804|FG003|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||5
6415951|NCT00969761|7329805|FG004|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6415952|NCT00969761|7329806|FG005|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6415953|NCT00969761|7329807|FG006|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6415954|NCT00969761|7329808|FG007|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||6
6415955|NCT00969761|7329809|FG008|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||11
6415956|NCT00969761|7329810|FG009|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||2
6415957|NCT00969761|7329811|FG010|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6415958|NCT00969761|7329812|FG011|NOT COMPLETED|Treated in and Beyond Treat. Cycle 2||3
6415959|NCT00969878|7329840|FG000|STARTED|Overall Study||148
6415960|NCT00969878|7329841|FG001|STARTED|Overall Study||152
6415961|NCT00969878|7329840|FG000|COMPLETED|Overall Study||118
6415962|NCT00969878|7329841|FG001|COMPLETED|Overall Study||126
6415963|NCT00969878|7329840|FG000|NOT COMPLETED|Overall Study||30
6415964|NCT00969878|7329841|FG001|NOT COMPLETED|Overall Study||26
6415965|NCT00970073|7329852|FG000|STARTED|Overall Study||10
6415966|NCT00970073|7329853|FG001|STARTED|Overall Study||10
6415967|NCT00970073|7329854|FG002|STARTED|Overall Study||10
6415968|NCT00970073|7329852|FG000|COMPLETED|Overall Study||10
6415969|NCT00970073|7329853|FG001|COMPLETED|Overall Study||10
6415970|NCT00970073|7329854|FG002|COMPLETED|Overall Study||10
6415971|NCT00970073|7329852|FG000|NOT COMPLETED|Overall Study||0
6415972|NCT00970073|7329853|FG001|NOT COMPLETED|Overall Study||0
6415973|NCT00970073|7329854|FG002|NOT COMPLETED|Overall Study||0
6415974|NCT00970203|7329864|FG000|STARTED|Overall Study||7
6415975|NCT00970203|7329865|FG001|STARTED|Overall Study||6
6415976|NCT00970203|7329864|FG000|COMPLETED|Overall Study||7
6415977|NCT00970203|7329865|FG001|COMPLETED|Overall Study||6
6415978|NCT00970203|7329864|FG000|NOT COMPLETED|Overall Study||0
6415979|NCT00970203|7329865|FG001|NOT COMPLETED|Overall Study||0
6415980|NCT00970216|7329871|FG000|STARTED|Overall Study||160
6415981|NCT00970216|7329871|FG000|COMPLETED|Overall Study||80
6415982|NCT00970216|7329871|FG000|NOT COMPLETED|Overall Study||80
6415983|NCT00970268|7329877|FG000|STARTED|Overall Study||139
6415984|NCT00970268|7329878|FG001|STARTED|Overall Study||152
6415985|NCT00970268|7329877|FG000|COMPLETED|Overall Study||96
6415986|NCT00970268|7329878|FG001|COMPLETED|Overall Study||103
6415987|NCT00970268|7329877|FG000|NOT COMPLETED|Overall Study||43
6415988|NCT00970268|7329878|FG001|NOT COMPLETED|Overall Study||49
6415989|NCT00970281|7329892|FG000|STARTED|Overall Study||46
6415990|NCT00970281|7329893|FG001|STARTED|Overall Study||45
6415991|NCT00970281|7329892|FG000|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
6415992|NCT00970281|7329893|FG001|Full Analysis Set|Overall Study||45
6415993|NCT00970281|7329892|FG000|COMPLETED|Overall Study||44
6415994|NCT00970281|7329893|FG001|COMPLETED|Overall Study||29
6415995|NCT00970281|7329892|FG000|NOT COMPLETED|Overall Study||2
6415996|NCT00970281|7329893|FG001|NOT COMPLETED|Overall Study||16
6415997|NCT00970294|7329899|FG000|STARTED|Overall Study||11
6415998|NCT00970294|7329899|FG000|COMPLETED|Overall Study||6
6415999|NCT00970294|7329899|FG000|NOT COMPLETED|Overall Study||5
6416000|NCT00970307|7329906|FG000|STARTED|Overall Study||141
6416001|NCT00970307|7329907|FG001|STARTED|Overall Study||139
6416002|NCT00970307|7329908|FG002|STARTED|Overall Study||141
6416003|NCT00970307|7329906|FG000|COMPLETED|Overall Study||138
6416004|NCT00970307|7329907|FG001|COMPLETED|Overall Study||136
6416005|NCT00970307|7329908|FG002|COMPLETED|Overall Study||139
6416006|NCT00970307|7329906|FG000|NOT COMPLETED|Overall Study||3
6416007|NCT00970307|7329907|FG001|NOT COMPLETED|Overall Study||3
6416008|NCT00970307|7329908|FG002|NOT COMPLETED|Overall Study||2
6416009|NCT00970320|7329921|FG000|STARTED|Overall Study||25
6416010|NCT00970320|7329922|FG001|STARTED|Overall Study||24
6416011|NCT00970320|7329923|FG002|STARTED|Overall Study||48
6416012|NCT00970320|7329924|FG003|STARTED|Overall Study||50
6416013|NCT00970320|7329925|FG004|STARTED|Overall Study||1571
6416014|NCT00970320|7329921|FG000|COMPLETED|Overall Study||25
6416015|NCT00970320|7329922|FG001|COMPLETED|Overall Study||13
6416016|NCT00970320|7329923|FG002|COMPLETED|Overall Study||35
6416017|NCT00970320|7329924|FG003|COMPLETED|Overall Study||36
6416018|NCT00970320|7329925|FG004|COMPLETED|Overall Study||1031
6416019|NCT00970320|7329921|FG000|NOT COMPLETED|Overall Study||0
6416020|NCT00970320|7329922|FG001|NOT COMPLETED|Overall Study||11
6416021|NCT00970320|7329923|FG002|NOT COMPLETED|Overall Study||13
6416022|NCT00970320|7329924|FG003|NOT COMPLETED|Overall Study||14
6416023|NCT00970320|7329925|FG004|NOT COMPLETED|Overall Study||540
6416024|NCT00970359|7329937|FG000|STARTED|Overall Study||24
6416025|NCT00970359|7329937|FG000|COMPLETED|Overall Study||20
6416026|NCT00970359|7329937|FG000|NOT COMPLETED|Overall Study||4
6416027|NCT00970489|7329943|FG000|STARTED|Overall Study||758
6416028|NCT00970489|7329944|FG001|STARTED|Overall Study||758
6416029|NCT00970489|7329943|FG000|COMPLETED|Overall Study||704
6416030|NCT00970489|7329944|FG001|COMPLETED|Overall Study||717
6416031|NCT00970489|7329943|FG000|NOT COMPLETED|Overall Study||54
6416032|NCT00970489|7329944|FG001|NOT COMPLETED|Overall Study||41
6416033|NCT00970502|7329950|FG000|STARTED|Overall Study||15
6416034|NCT00970502|7329950|FG000|COMPLETED|Overall Study||14
6416035|NCT00970502|7329950|FG000|NOT COMPLETED|Overall Study||1
6416036|NCT00970593|7329965|FG000|STARTED|Overall Study||11
6416037|NCT00970593|7329966|FG001|STARTED|Overall Study||15
6416038|NCT00970593|7329967|FG002|STARTED|Overall Study||13
6416039|NCT00970593|7329968|FG003|STARTED|Overall Study||12
6416040|NCT00970593|7329969|FG004|STARTED|Overall Study||20
6416041|NCT00970593|7329970|FG005|STARTED|Overall Study||5
6416042|NCT00970593|7329971|FG006|STARTED|Overall Study||16
6416043|NCT00970593|7329965|FG000|COMPLETED|Overall Study||10
6416044|NCT00970593|7329966|FG001|COMPLETED|Overall Study||14
6416045|NCT00970593|7329967|FG002|COMPLETED|Overall Study||7
6416046|NCT00970593|7329968|FG003|COMPLETED|Overall Study||12
6416047|NCT00970593|7329969|FG004|COMPLETED|Overall Study||20
6416048|NCT00970593|7329970|FG005|COMPLETED|Overall Study||5
6416049|NCT00970593|7329971|FG006|COMPLETED|Overall Study||14
6638538|NCT02323334|7567017|FG014|COMPLETED|Period 3||0
6638539|NCT02323334|7567018|FG015|COMPLETED|Period 3||0
6638540|NCT02323334|7567019|FG016|COMPLETED|Period 3||0
6638541|NCT02323334|7567003|FG000|NOT COMPLETED|Period 3||1
6638542|NCT02323334|7567004|FG001|NOT COMPLETED|Period 3||0
6638543|NCT02323334|7567005|FG002|NOT COMPLETED|Period 3||1
6638544|NCT02323334|7567006|FG003|NOT COMPLETED|Period 3||0
6638545|NCT02323334|7567007|FG004|NOT COMPLETED|Period 3||0
6638546|NCT02323334|7567008|FG005|NOT COMPLETED|Period 3||0
6638547|NCT02323334|7567009|FG006|NOT COMPLETED|Period 3||0
6638548|NCT02323334|7567010|FG007|NOT COMPLETED|Period 3||0
6638549|NCT02323334|7567011|FG008|NOT COMPLETED|Period 3||0
6638550|NCT02323334|7567012|FG009|NOT COMPLETED|Period 3||0
6638551|NCT02323334|7567013|FG010|NOT COMPLETED|Period 3||0
6638552|NCT02323334|7567014|FG011|NOT COMPLETED|Period 3||0
6638553|NCT02323334|7567015|FG012|NOT COMPLETED|Period 3||0
6638554|NCT02323334|7567016|FG013|NOT COMPLETED|Period 3||0
6638555|NCT02323334|7567017|FG014|NOT COMPLETED|Period 3||0
6638556|NCT02323334|7567018|FG015|NOT COMPLETED|Period 3||0
6638557|NCT02323334|7567019|FG016|NOT COMPLETED|Period 3||0
6638558|NCT02323334|7567003|FG000|STARTED|Period 4||3
6416050|NCT00970593|7329965|FG000|NOT COMPLETED|Overall Study||1
6416051|NCT00970593|7329966|FG001|NOT COMPLETED|Overall Study||1
6416052|NCT00970593|7329967|FG002|NOT COMPLETED|Overall Study||6
6416053|NCT00970593|7329968|FG003|NOT COMPLETED|Overall Study||0
6416054|NCT00970593|7329969|FG004|NOT COMPLETED|Overall Study||0
6416055|NCT00970593|7329970|FG005|NOT COMPLETED|Overall Study||0
6416056|NCT00970593|7329971|FG006|NOT COMPLETED|Overall Study||2
6416057|NCT00970632|7329994|FG000|STARTED|Overall Study||172
6416058|NCT00970632|7329995|FG001|STARTED|Overall Study||171
6638559|NCT02323334|7567004|FG001|STARTED|Period 4||4
6638560|NCT02323334|7567005|FG002|STARTED|Period 4||3
6638561|NCT02323334|7567006|FG003|STARTED|Period 4||4
6638562|NCT02323334|7567007|FG004|STARTED|Period 4||4
6638563|NCT02323334|7567008|FG005|STARTED|Period 4||4
6638564|NCT02323334|7567009|FG006|STARTED|Period 4||0
6638565|NCT02323334|7567010|FG007|STARTED|Period 4||0
6638566|NCT02323334|7567011|FG008|STARTED|Period 4||0
6416059|NCT00970632|7329996|FG002|STARTED|Overall Study||168
6416060|NCT00970632|7329994|FG000|COMPLETED|Overall Study||148
6416061|NCT00970632|7329995|FG001|COMPLETED|Overall Study||156
6416062|NCT00970632|7329996|FG002|COMPLETED|Overall Study||150
6638567|NCT02323334|7567012|FG009|STARTED|Period 4||0
6416063|NCT00970632|7329994|FG000|NOT COMPLETED|Overall Study||24
6416064|NCT00970632|7329995|FG001|NOT COMPLETED|Overall Study||15
6416065|NCT00970632|7329996|FG002|NOT COMPLETED|Overall Study||18
6416066|NCT00970684|7330004|FG000|STARTED|Overall Study||13
6416067|NCT00970684|7330004|FG000|COMPLETED|Overall Study||3
6416068|NCT00970684|7330004|FG000|NOT COMPLETED|Overall Study||10
6416069|NCT00970814|7330010|FG000|STARTED|Overall Study||66
6416070|NCT00970814|7330011|FG001|STARTED|Overall Study||64
6416071|NCT00970814|7330010|FG000|COMPLETED|Overall Study||58
6416072|NCT00970814|7330011|FG001|COMPLETED|Overall Study||50
6416073|NCT00970814|7330010|FG000|NOT COMPLETED|Overall Study||8
6416074|NCT00970814|7330011|FG001|NOT COMPLETED|Overall Study||14
6416075|NCT00970853|7330019|FG000|STARTED|Overall Study||89
6416076|NCT00970853|7330020|FG001|STARTED|Overall Study||98
6416077|NCT00970853|7330019|FG000|COMPLETED|Overall Study||89
6416078|NCT00970853|7330020|FG001|COMPLETED|Overall Study||98
6416079|NCT00970853|7330019|FG000|NOT COMPLETED|Overall Study||0
6416080|NCT00970853|7330020|FG001|NOT COMPLETED|Overall Study||0
6416081|NCT00970944|7330028|FG000|STARTED|Overall Study||87
6416082|NCT00970944|7330029|FG001|STARTED|Overall Study||97
6416083|NCT00970944|7330028|FG000|COMPLETED|Overall Study||86
6416084|NCT00970944|7330029|FG001|COMPLETED|Overall Study||95
6416085|NCT00970944|7330028|FG000|NOT COMPLETED|Overall Study||1
6416086|NCT00970944|7330029|FG001|NOT COMPLETED|Overall Study||2
6416087|NCT00971048|7330040|FG000|STARTED|Overall Study||30
6416088|NCT00971048|7330041|FG001|STARTED|Overall Study||33
6416089|NCT00971048|7330042|FG002|STARTED|Overall Study||12
6416090|NCT00971048|7330043|FG003|STARTED|Overall Study||13
6416091|NCT00971048|7330040|FG000|COMPLETED|Overall Study||29
6416092|NCT00971048|7330041|FG001|COMPLETED|Overall Study||31
6416093|NCT00971048|7330042|FG002|COMPLETED|Overall Study||11
6416094|NCT00971048|7330043|FG003|COMPLETED|Overall Study||11
6416095|NCT00971048|7330040|FG000|NOT COMPLETED|Overall Study||1
6416096|NCT00971048|7330041|FG001|NOT COMPLETED|Overall Study||2
6416097|NCT00971048|7330042|FG002|NOT COMPLETED|Overall Study||1
6416098|NCT00971048|7330043|FG003|NOT COMPLETED|Overall Study||2
6416099|NCT00971178|7330058|FG000|STARTED|Overall Study||35
6416100|NCT00971178|7330059|FG001|STARTED|Overall Study||35
6416101|NCT00971178|7330060|FG002|STARTED|Overall Study||35
6416102|NCT00971178|7330058|FG000|COMPLETED|Overall Study||33
6416103|NCT00971178|7330059|FG001|COMPLETED|Overall Study||33
6416104|NCT00971178|7330060|FG002|COMPLETED|Overall Study||33
6416105|NCT00971178|7330058|FG000|NOT COMPLETED|Overall Study||2
6416106|NCT00971178|7330059|FG001|NOT COMPLETED|Overall Study||2
6416107|NCT00971178|7330060|FG002|NOT COMPLETED|Overall Study||2
6416108|NCT00971204|7330068|FG000|STARTED|Overall Study|100 enrolled participants|100
6416109|NCT00971204|7330068|FG000|Treated|Overall Study||86
6416110|NCT00971204|7330068|FG000|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
6416111|NCT00971204|7330068|FG000|NOT COMPLETED|Overall Study||24
6416112|NCT00971243|7330077|FG000|STARTED|Double Blind Period||87
6416113|NCT00971243|7330078|FG001|STARTED|Double Blind Period||93
6416114|NCT00971243|7330079|FG002|STARTED|Double Blind Period||91
6416115|NCT00971243|7330080|FG003|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
6416116|NCT00971243|7330081|FG004|STARTED|Double Blind Period||88
6416117|NCT00971243|7330077|FG000|COMPLETED|Double Blind Period||68
6416118|NCT00971243|7330078|FG001|COMPLETED|Double Blind Period||82
6416119|NCT00971243|7330079|FG002|COMPLETED|Double Blind Period||72
6416120|NCT00971243|7330080|FG003|COMPLETED|Double Blind Period||74
6416121|NCT00971243|7330081|FG004|COMPLETED|Double Blind Period||70
6416122|NCT00971243|7330077|FG000|NOT COMPLETED|Double Blind Period||19
6416123|NCT00971243|7330078|FG001|NOT COMPLETED|Double Blind Period||11
6416124|NCT00971243|7330079|FG002|NOT COMPLETED|Double Blind Period||19
6416125|NCT00971243|7330080|FG003|NOT COMPLETED|Double Blind Period||14
6416126|NCT00971243|7330081|FG004|NOT COMPLETED|Double Blind Period||18
6416127|NCT00971243|7330077|FG000|STARTED|Open-label Period||68
6416128|NCT00971243|7330078|FG001|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
6416129|NCT00971243|7330079|FG002|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
6416130|NCT00971243|7330080|FG003|STARTED|Open-label Period||74
6416131|NCT00971243|7330081|FG004|STARTED|Open-label Period||70
6416132|NCT00971243|7330077|FG000|COMPLETED|Open-label Period||60
6416133|NCT00971243|7330078|FG001|COMPLETED|Open-label Period||71
6416134|NCT00971243|7330079|FG002|COMPLETED|Open-label Period||66
6416135|NCT00971243|7330080|FG003|COMPLETED|Open-label Period||64
6416136|NCT00971243|7330081|FG004|COMPLETED|Open-label Period||64
6416137|NCT00971243|7330077|FG000|NOT COMPLETED|Open-label Period||8
6416138|NCT00971243|7330078|FG001|NOT COMPLETED|Open-label Period||10
6416139|NCT00971243|7330079|FG002|NOT COMPLETED|Open-label Period||5
6416140|NCT00971243|7330080|FG003|NOT COMPLETED|Open-label Period||10
6416141|NCT00971243|7330081|FG004|NOT COMPLETED|Open-label Period||6
6416142|NCT00971282|7330093|FG000|STARTED|Overall Study||30
6416143|NCT00971282|7330093|FG000|COMPLETED|Overall Study||30
6416144|NCT00971282|7330093|FG000|NOT COMPLETED|Overall Study||0
6416145|NCT00971295|7330099|FG000|STARTED|Overall Study||10
6416146|NCT00971295|7330100|FG001|STARTED|Overall Study||10
6416147|NCT00971295|7330099|FG000|COMPLETED|Overall Study||10
6416148|NCT00971295|7330100|FG001|COMPLETED|Overall Study||9
6416149|NCT00971295|7330099|FG000|NOT COMPLETED|Overall Study||0
6416150|NCT00971295|7330100|FG001|NOT COMPLETED|Overall Study||1
6416151|NCT00971321|7330108|FG000|STARTED|Up to Day 42||104
6416152|NCT00971321|7330109|FG001|STARTED|Up to Day 42||53
6416153|NCT00971321|7330108|FG000|COMPLETED|Up to Day 42||104
6416154|NCT00971321|7330109|FG001|COMPLETED|Up to Day 42||53
6416155|NCT00971321|7330108|FG000|NOT COMPLETED|Up to Day 42||0
6416156|NCT00971321|7330109|FG001|NOT COMPLETED|Up to Day 42||0
6416157|NCT00971321|7330108|FG000|STARTED|Up to Month 7||104
6416158|NCT00971321|7330109|FG001|STARTED|Up to Month 7||53
6416159|NCT00971321|7330108|FG000|COMPLETED|Up to Month 7||100
6416160|NCT00971321|7330109|FG001|COMPLETED|Up to Month 7||51
6416161|NCT00971321|7330108|FG000|NOT COMPLETED|Up to Month 7||4
6416162|NCT00971321|7330109|FG001|NOT COMPLETED|Up to Month 7||2
6416163|NCT00971321|7330108|FG000|STARTED|Up to Month 11-12||104
6416164|NCT00971321|7330109|FG001|STARTED|Up to Month 11-12||53
6416165|NCT00971321|7330108|FG000|COMPLETED|Up to Month 11-12||99
6416166|NCT00971321|7330109|FG001|COMPLETED|Up to Month 11-12||50
6416167|NCT00971321|7330108|FG000|NOT COMPLETED|Up to Month 11-12||5
6416168|NCT00971321|7330109|FG001|NOT COMPLETED|Up to Month 11-12||3
6416169|NCT00971425|7330117|FG000|STARTED|Overall Study||72
6416170|NCT00971425|7330118|FG001|STARTED|Overall Study||73
6416171|NCT00971425|7330117|FG000|COMPLETED|Overall Study||71
6416172|NCT00971425|7330118|FG001|COMPLETED|Overall Study||71
6638568|NCT02323334|7567013|FG010|STARTED|Period 4||0
6638569|NCT02323334|7567014|FG011|STARTED|Period 4||0
6416173|NCT00971425|7330117|FG000|NOT COMPLETED|Overall Study||1
6416174|NCT00971425|7330118|FG001|NOT COMPLETED|Overall Study||2
6416175|NCT00971620|7330126|FG000|STARTED|Overall Study||9
6416176|NCT00971620|7330127|FG001|STARTED|Overall Study||9
6416177|NCT00971620|7330126|FG000|COMPLETED|Overall Study||9
6416178|NCT00971620|7330127|FG001|COMPLETED|Overall Study||9
6416179|NCT00971620|7330126|FG000|NOT COMPLETED|Overall Study||0
6416180|NCT00971620|7330127|FG001|NOT COMPLETED|Overall Study||0
6416181|NCT00971633|7330133|FG000|STARTED|Period 1||2
6416182|NCT00971633|7330134|FG001|STARTED|Period 1||2
6416183|NCT00971633|7330135|FG002|STARTED|Period 1||2
6416184|NCT00971633|7330136|FG003|STARTED|Period 1||2
6416185|NCT00971633|7330137|FG004|STARTED|Period 1||2
6416186|NCT00971633|7330138|FG005|STARTED|Period 1||2
6416187|NCT00971633|7330133|FG000|COMPLETED|Period 1||2
6416188|NCT00971633|7330134|FG001|COMPLETED|Period 1||2
6416189|NCT00971633|7330135|FG002|COMPLETED|Period 1||2
6416190|NCT00971633|7330136|FG003|COMPLETED|Period 1||2
6416191|NCT00971633|7330137|FG004|COMPLETED|Period 1||2
6416192|NCT00971633|7330138|FG005|COMPLETED|Period 1||2
6416193|NCT00971633|7330133|FG000|NOT COMPLETED|Period 1||0
6416194|NCT00971633|7330134|FG001|NOT COMPLETED|Period 1||0
6416195|NCT00971633|7330135|FG002|NOT COMPLETED|Period 1||0
6416196|NCT00971633|7330136|FG003|NOT COMPLETED|Period 1||0
6416197|NCT00971633|7330137|FG004|NOT COMPLETED|Period 1||0
6416198|NCT00971633|7330138|FG005|NOT COMPLETED|Period 1||0
6416199|NCT00971633|7330133|FG000|STARTED|Period 2||2
6416200|NCT00971633|7330134|FG001|STARTED|Period 2||2
6416201|NCT00971633|7330135|FG002|STARTED|Period 2||2
6416202|NCT00971633|7330136|FG003|STARTED|Period 2||2
6416203|NCT00971633|7330137|FG004|STARTED|Period 2||2
6416204|NCT00971633|7330138|FG005|STARTED|Period 2||2
6416205|NCT00971633|7330133|FG000|COMPLETED|Period 2||2
6416206|NCT00971633|7330134|FG001|COMPLETED|Period 2||2
6416207|NCT00971633|7330135|FG002|COMPLETED|Period 2||2
6416208|NCT00971633|7330136|FG003|COMPLETED|Period 2||2
6416209|NCT00971633|7330137|FG004|COMPLETED|Period 2||2
6416210|NCT00971633|7330138|FG005|COMPLETED|Period 2||2
6416211|NCT00971633|7330133|FG000|NOT COMPLETED|Period 2||0
6416212|NCT00971633|7330134|FG001|NOT COMPLETED|Period 2||0
6416213|NCT00971633|7330135|FG002|NOT COMPLETED|Period 2||0
6416214|NCT00971633|7330136|FG003|NOT COMPLETED|Period 2||0
6416215|NCT00971633|7330137|FG004|NOT COMPLETED|Period 2||0
6416216|NCT00971633|7330138|FG005|NOT COMPLETED|Period 2||0
6416217|NCT00971633|7330133|FG000|STARTED|Period 3||2
6416218|NCT00971633|7330134|FG001|STARTED|Period 3||2
6416219|NCT00971633|7330135|FG002|STARTED|Period 3||2
6416220|NCT00971633|7330136|FG003|STARTED|Period 3||2
6638570|NCT02323334|7567015|FG012|STARTED|Period 4||0
6416221|NCT00971633|7330137|FG004|STARTED|Period 3||2
6416222|NCT00971633|7330138|FG005|STARTED|Period 3||2
6416223|NCT00971633|7330133|FG000|COMPLETED|Period 3||2
6416224|NCT00971633|7330134|FG001|COMPLETED|Period 3||2
6416225|NCT00971633|7330135|FG002|COMPLETED|Period 3||2
6416226|NCT00971633|7330136|FG003|COMPLETED|Period 3||2
6416227|NCT00971633|7330137|FG004|COMPLETED|Period 3||2
6416228|NCT00971633|7330138|FG005|COMPLETED|Period 3||2
6416229|NCT00971633|7330133|FG000|NOT COMPLETED|Period 3||0
6416230|NCT00971633|7330134|FG001|NOT COMPLETED|Period 3||0
6416231|NCT00971633|7330135|FG002|NOT COMPLETED|Period 3||0
6416232|NCT00971633|7330136|FG003|NOT COMPLETED|Period 3||0
6416233|NCT00971633|7330137|FG004|NOT COMPLETED|Period 3||0
6416234|NCT00971633|7330138|FG005|NOT COMPLETED|Period 3||0
6416235|NCT00971737|7330148|FG000|STARTED|Overall Study||30
6416236|NCT00971737|7330149|FG001|STARTED|Overall Study||30
6416237|NCT00971737|7330148|FG000|COMPLETED|Overall Study||30
6416238|NCT00971737|7330149|FG001|COMPLETED|Overall Study||30
6416239|NCT00971737|7330148|FG000|NOT COMPLETED|Overall Study||0
6416240|NCT00971737|7330149|FG001|NOT COMPLETED|Overall Study||0
6416241|NCT00971750|7330155|FG000|STARTED|Overall Study||253
6416242|NCT00971750|7330155|FG000|COMPLETED|Overall Study||253
6416243|NCT00971750|7330155|FG000|NOT COMPLETED|Overall Study||0
6416244|NCT00971789|7330161|FG000|STARTED|Overall Study||18
6416245|NCT00971789|7330161|FG000|COMPLETED|Overall Study||18
6416246|NCT00971789|7330161|FG000|NOT COMPLETED|Overall Study||0
6416247|NCT00971841|7330165|FG000|STARTED|Overall Study||1
6416248|NCT00971841|7330165|FG000|COMPLETED|Overall Study||1
6416249|NCT00971841|7330165|FG000|NOT COMPLETED|Overall Study||0
6416250|NCT00971932|7330169|FG000|STARTED|Overall Study|Number of participants treated.|33
6416251|NCT00971932|7330169|FG000|COMPLETED|Overall Study||26
6416252|NCT00971932|7330169|FG000|NOT COMPLETED|Overall Study||7
6416253|NCT00971945|7330173|FG000|STARTED|Overall Study||6
6416254|NCT00971945|7330173|FG000|COMPLETED|Overall Study||0
6416255|NCT00971945|7330173|FG000|NOT COMPLETED|Overall Study||6
6416256|NCT00971997|7330177|FG000|STARTED|Overall Study||135
6416257|NCT00971997|7330177|FG000|COMPLETED|Overall Study||116
6416258|NCT00971997|7330177|FG000|NOT COMPLETED|Overall Study||19
6416259|NCT00972088|7330184|FG000|STARTED|Overall Study||26
6416260|NCT00972088|7330184|FG000|COMPLETED|Overall Study||26
6416261|NCT00972088|7330184|FG000|NOT COMPLETED|Overall Study||0
6416262|NCT00972153|7330191|FG000|STARTED|Overall Study||12
6416263|NCT00972153|7330192|FG001|STARTED|Overall Study||12
6416264|NCT00972153|7330193|FG002|STARTED|Overall Study||12
6416265|NCT00972153|7330191|FG000|COMPLETED|Overall Study||12
6416266|NCT00972153|7330192|FG001|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
6416267|NCT00972153|7330193|FG002|COMPLETED|Overall Study||12
6416268|NCT00972153|7330191|FG000|NOT COMPLETED|Overall Study||0
6416269|NCT00972153|7330192|FG001|NOT COMPLETED|Overall Study||1
6416270|NCT00972153|7330193|FG002|NOT COMPLETED|Overall Study||0
6416271|NCT00972205|7330201|FG000|STARTED|Overall Study||12
6416272|NCT00972205|7330201|FG000|COMPLETED|Overall Study||12
6416273|NCT00972205|7330201|FG000|NOT COMPLETED|Overall Study||0
6416274|NCT00972244|7330210|FG000|STARTED|Overall Study||59
6416275|NCT00972244|7330211|FG001|STARTED|Overall Study||56
6416276|NCT00972244|7330212|FG002|STARTED|Overall Study||58
6416277|NCT00972244|7330213|FG003|STARTED|Overall Study||52
6416278|NCT00972244|7330214|FG004|STARTED|Overall Study||54
6416279|NCT00972244|7330210|FG000|COMPLETED|Overall Study||54
6416280|NCT00972244|7330211|FG001|COMPLETED|Overall Study||51
6416281|NCT00972244|7330212|FG002|COMPLETED|Overall Study||56
6416282|NCT00972244|7330213|FG003|COMPLETED|Overall Study||52
6416283|NCT00972244|7330214|FG004|COMPLETED|Overall Study||45
6416284|NCT00972244|7330210|FG000|NOT COMPLETED|Overall Study||5
6416285|NCT00972244|7330211|FG001|NOT COMPLETED|Overall Study||5
6416286|NCT00972244|7330212|FG002|NOT COMPLETED|Overall Study||2
6416287|NCT00972244|7330213|FG003|NOT COMPLETED|Overall Study||0
6416288|NCT00972244|7330214|FG004|NOT COMPLETED|Overall Study||9
6416289|NCT00972283|7330228|FG000|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
6416290|NCT00972283|7330229|FG001|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
6416291|NCT00972283|7330228|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
6416292|NCT00972283|7330229|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
6416293|NCT00972283|7330228|FG000|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
6416294|NCT00972283|7330229|FG001|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
6416295|NCT00972283|7330228|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
6416296|NCT00972283|7330229|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
6416297|NCT00972283|7330228|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
6416298|NCT00972283|7330229|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
6416299|NCT00972283|7330228|FG000|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
6416300|NCT00972283|7330229|FG001|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
6416301|NCT00972283|7330228|FG000|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
6416302|NCT00972283|7330229|FG001|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
6416303|NCT00972283|7330228|FG000|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
6416304|NCT00972283|7330229|FG001|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
6416305|NCT00972322|7330237|FG000|STARTED|Overall Study||28
6416306|NCT00972322|7330238|FG001|STARTED|Overall Study||28
6416307|NCT00972322|7330237|FG000|COMPLETED|Overall Study||25
6416308|NCT00972322|7330238|FG001|COMPLETED|Overall Study||25
6416309|NCT00972322|7330237|FG000|NOT COMPLETED|Overall Study||3
6416310|NCT00972322|7330238|FG001|NOT COMPLETED|Overall Study||3
6416311|NCT00972335|7330244|FG000|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
6416312|NCT00972335|7330244|FG000|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
6416313|NCT00972335|7330244|FG000|NOT COMPLETED|Overall Study||17
6416314|NCT00972374|7330251|FG000|STARTED|Overall Study||15
6416315|NCT00972374|7330252|FG001|STARTED|Overall Study||15
6416316|NCT00972374|7330253|FG002|STARTED|Overall Study||14
6416317|NCT00972374|7330251|FG000|COMPLETED|Overall Study||13
6416318|NCT00972374|7330252|FG001|COMPLETED|Overall Study||15
6416319|NCT00972374|7330253|FG002|COMPLETED|Overall Study||13
6416320|NCT00972374|7330251|FG000|NOT COMPLETED|Overall Study||2
6416321|NCT00972374|7330252|FG001|NOT COMPLETED|Overall Study||0
6416322|NCT00972374|7330253|FG002|NOT COMPLETED|Overall Study||1
6416323|NCT00972439|7330263|FG000|STARTED|Overall Study||17
6416324|NCT00972439|7330264|FG001|STARTED|Overall Study||16
6416325|NCT00972439|7330263|FG000|COMPLETED|Overall Study||17
6416326|NCT00972439|7330264|FG001|COMPLETED|Overall Study||16
6416327|NCT00972439|7330263|FG000|NOT COMPLETED|Overall Study||0
6416328|NCT00972439|7330264|FG001|NOT COMPLETED|Overall Study||0
6416329|NCT00972478|7330272|FG000|STARTED|Overall Study||11
6416330|NCT00972478|7330273|FG001|STARTED|Overall Study||72
6416331|NCT00972478|7330272|FG000|Eligible and Began Protocol Therapy|Overall Study||9
6416332|NCT00972478|7330273|FG001|Eligible and Began Protocol Therapy|Overall Study||63
6416333|NCT00972478|7330272|FG000|COMPLETED|Overall Study||4
6416334|NCT00972478|7330273|FG001|COMPLETED|Overall Study||34
6416335|NCT00972478|7330272|FG000|NOT COMPLETED|Overall Study||7
6416336|NCT00972478|7330273|FG001|NOT COMPLETED|Overall Study||38
6416337|NCT00972504|7330280|FG000|STARTED|Overall Study||54
6416338|NCT00972504|7330280|FG000|COMPLETED|Overall Study||51
6416339|NCT00972504|7330280|FG000|NOT COMPLETED|Overall Study||3
6416340|NCT00972517|7330290|FG000|STARTED|Overall Study||31
6416341|NCT00972517|7330291|FG001|STARTED|Overall Study||31
6416342|NCT00972517|7330292|FG002|STARTED|Overall Study||60
6416343|NCT00972517|7330293|FG003|STARTED|Overall Study||30
6416344|NCT00972517|7330294|FG004|STARTED|Overall Study||34
6416345|NCT00972517|7330295|FG005|STARTED|Overall Study||58
6416346|NCT00972517|7330290|FG000|COMPLETED|Overall Study||31
6416347|NCT00972517|7330291|FG001|COMPLETED|Overall Study||30
6416348|NCT00972517|7330292|FG002|COMPLETED|Overall Study||60
6416349|NCT00972517|7330293|FG003|COMPLETED|Overall Study||27
6416350|NCT00972517|7330294|FG004|COMPLETED|Overall Study||33
6416351|NCT00972517|7330295|FG005|COMPLETED|Overall Study||58
6416352|NCT00972517|7330290|FG000|NOT COMPLETED|Overall Study||0
6416353|NCT00972517|7330291|FG001|NOT COMPLETED|Overall Study||1
6416354|NCT00972517|7330292|FG002|NOT COMPLETED|Overall Study||0
6416355|NCT00972517|7330293|FG003|NOT COMPLETED|Overall Study||3
6416356|NCT00972517|7330294|FG004|NOT COMPLETED|Overall Study||1
6416357|NCT00972517|7330295|FG005|NOT COMPLETED|Overall Study||0
6416358|NCT00972530|7330317|FG000|STARTED|Overall Study||44
6416359|NCT00972530|7330318|FG001|STARTED|Overall Study||46
6416360|NCT00972530|7330317|FG000|COMPLETED|Overall Study||44
6416361|NCT00972530|7330318|FG001|COMPLETED|Overall Study||46
6416362|NCT00972530|7330317|FG000|NOT COMPLETED|Overall Study||0
6416363|NCT00972530|7330318|FG001|NOT COMPLETED|Overall Study||0
6416364|NCT00972543|7330326|FG000|STARTED|Overall Study||5
6416365|NCT00972543|7330327|FG001|STARTED|Overall Study||1
6416366|NCT00972543|7330326|FG000|COMPLETED|Overall Study||0
6416367|NCT00972543|7330327|FG001|COMPLETED|Overall Study||0
6416368|NCT00972543|7330326|FG000|NOT COMPLETED|Overall Study||5
6416369|NCT00972543|7330327|FG001|NOT COMPLETED|Overall Study||1
6416370|NCT00972595|7330333|FG000|STARTED|Period 1||23
6416371|NCT00972595|7330334|FG001|STARTED|Period 1||22
6416372|NCT00972595|7330333|FG000|COMPLETED|Period 1||22
6416373|NCT00972595|7330334|FG001|COMPLETED|Period 1||22
6416374|NCT00972595|7330333|FG000|NOT COMPLETED|Period 1||1
6416375|NCT00972595|7330334|FG001|NOT COMPLETED|Period 1||0
6416376|NCT00972595|7330333|FG000|STARTED|Period 2||22
6416377|NCT00972595|7330334|FG001|STARTED|Period 2||22
6416378|NCT00972595|7330333|FG000|COMPLETED|Period 2||22
6416379|NCT00972595|7330334|FG001|COMPLETED|Period 2||22
6416380|NCT00972595|7330333|FG000|NOT COMPLETED|Period 2||0
6416381|NCT00972595|7330334|FG001|NOT COMPLETED|Period 2||0
6416382|NCT00972621|7330342|FG000|STARTED|Overall Study||200
6416383|NCT00972621|7330343|FG001|STARTED|Overall Study||200
6638571|NCT02323334|7567016|FG013|STARTED|Period 4||0
6638572|NCT02323334|7567017|FG014|STARTED|Period 4||0
6638573|NCT02323334|7567018|FG015|STARTED|Period 4||0
6638574|NCT02323334|7567019|FG016|STARTED|Period 4||0
6638575|NCT02323334|7567003|FG000|COMPLETED|Period 4||3
6638576|NCT02323334|7567004|FG001|COMPLETED|Period 4||4
6638577|NCT02323334|7567005|FG002|COMPLETED|Period 4||3
6638578|NCT02323334|7567006|FG003|COMPLETED|Period 4||4
6638579|NCT02323334|7567007|FG004|COMPLETED|Period 4||4
6638580|NCT02323334|7567008|FG005|COMPLETED|Period 4||4
6638581|NCT02323334|7567009|FG006|COMPLETED|Period 4||0
6638582|NCT02323334|7567010|FG007|COMPLETED|Period 4||0
6638583|NCT02323334|7567011|FG008|COMPLETED|Period 4||0
6638584|NCT02323334|7567012|FG009|COMPLETED|Period 4||0
6638585|NCT02323334|7567013|FG010|COMPLETED|Period 4||0
6638586|NCT02323334|7567014|FG011|COMPLETED|Period 4||0
6638587|NCT02323334|7567015|FG012|COMPLETED|Period 4||0
6638588|NCT02323334|7567016|FG013|COMPLETED|Period 4||0
6638589|NCT02323334|7567017|FG014|COMPLETED|Period 4||0
6638590|NCT02323334|7567018|FG015|COMPLETED|Period 4||0
6638591|NCT02323334|7567019|FG016|COMPLETED|Period 4||0
6638592|NCT02323334|7567003|FG000|NOT COMPLETED|Period 4||0
6638593|NCT02323334|7567004|FG001|NOT COMPLETED|Period 4||0
6638594|NCT02323334|7567005|FG002|NOT COMPLETED|Period 4||0
6416384|NCT00972621|7330342|FG000|COMPLETED|Overall Study||200
6416385|NCT00972621|7330343|FG001|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
6416386|NCT00972621|7330342|FG000|NOT COMPLETED|Overall Study||0
6638595|NCT02323334|7567006|FG003|NOT COMPLETED|Period 4||0
6416387|NCT00972621|7330343|FG001|NOT COMPLETED|Overall Study||1
6416388|NCT00972725|7330351|FG000|STARTED|Overall Study||13
6416389|NCT00972725|7330352|FG001|STARTED|Overall Study||15
6416390|NCT00972725|7330351|FG000|COMPLETED|Overall Study||13
6416391|NCT00972725|7330352|FG001|COMPLETED|Overall Study||15
6416392|NCT00972725|7330351|FG000|NOT COMPLETED|Overall Study||0
6416393|NCT00972725|7330352|FG001|NOT COMPLETED|Overall Study||0
6638596|NCT02323334|7567007|FG004|NOT COMPLETED|Period 4||0
6638597|NCT02323334|7567008|FG005|NOT COMPLETED|Period 4||0
6638598|NCT02323334|7567009|FG006|NOT COMPLETED|Period 4||0
6638599|NCT02323334|7567010|FG007|NOT COMPLETED|Period 4||0
6416394|NCT00972777|7330360|FG000|STARTED|Overall Study||231
6416395|NCT00972777|7330361|FG001|STARTED|Overall Study||243
6416396|NCT00972777|7330360|FG000|COMPLETED|Overall Study||217
6416397|NCT00972777|7330361|FG001|COMPLETED|Overall Study||229
6416398|NCT00972777|7330360|FG000|NOT COMPLETED|Overall Study||14
6416399|NCT00972777|7330361|FG001|NOT COMPLETED|Overall Study||14
6416400|NCT00972816|7330375|FG000|STARTED|Overall Study||173
6416401|NCT00972816|7330376|FG001|STARTED|Overall Study||169
6416402|NCT00972816|7330377|FG002|STARTED|Overall Study||169
6416403|NCT00972816|7330378|FG003|STARTED|Overall Study||169
6416404|NCT00972816|7330379|FG004|STARTED|Overall Study||169
6416405|NCT00972816|7330380|FG005|STARTED|Overall Study||169
6416406|NCT00972816|7330381|FG006|STARTED|Overall Study||169
6416407|NCT00972816|7330382|FG007|STARTED|Overall Study||170
6416408|NCT00972816|7330375|FG000|COMPLETED|Overall Study||156
6416409|NCT00972816|7330376|FG001|COMPLETED|Overall Study||158
6416410|NCT00972816|7330377|FG002|COMPLETED|Overall Study||160
6416411|NCT00972816|7330378|FG003|COMPLETED|Overall Study||161
6416412|NCT00972816|7330379|FG004|COMPLETED|Overall Study||157
6416413|NCT00972816|7330380|FG005|COMPLETED|Overall Study||158
6416414|NCT00972816|7330381|FG006|COMPLETED|Overall Study||159
6416415|NCT00972816|7330382|FG007|COMPLETED|Overall Study||161
6416416|NCT00972816|7330375|FG000|NOT COMPLETED|Overall Study||17
6416417|NCT00972816|7330376|FG001|NOT COMPLETED|Overall Study||11
6416418|NCT00972816|7330377|FG002|NOT COMPLETED|Overall Study||9
6416419|NCT00972816|7330378|FG003|NOT COMPLETED|Overall Study||8
6416420|NCT00972816|7330379|FG004|NOT COMPLETED|Overall Study||12
6416421|NCT00972816|7330380|FG005|NOT COMPLETED|Overall Study||11
6416422|NCT00972816|7330381|FG006|NOT COMPLETED|Overall Study||10
6416423|NCT00972816|7330382|FG007|NOT COMPLETED|Overall Study||9
6416424|NCT00972959|7330400|FG000|STARTED|Overall Study||17
6416425|NCT00972959|7330400|FG000|COMPLETED|Overall Study||17
6416426|NCT00972959|7330400|FG000|NOT COMPLETED|Overall Study||0
6416427|NCT00973102|7330406|FG000|STARTED|Overall Study||24
6416428|NCT00973102|7330407|FG001|STARTED|Overall Study||26
6416429|NCT00973102|7330406|FG000|COMPLETED|Overall Study||23
6416430|NCT00973102|7330407|FG001|COMPLETED|Overall Study||25
6416431|NCT00973102|7330406|FG000|NOT COMPLETED|Overall Study||1
6416432|NCT00973102|7330407|FG001|NOT COMPLETED|Overall Study||1
6416433|NCT00973349|7330429|FG000|STARTED|Overall Study||170
6416434|NCT00973349|7330430|FG001|STARTED|Overall Study||168
6416435|NCT00973349|7330431|FG002|STARTED|Overall Study||171
6416436|NCT00973349|7330432|FG003|STARTED|Overall Study||168
6416437|NCT00973349|7330433|FG004|STARTED|Overall Study||170
6416438|NCT00973349|7330434|FG005|STARTED|Overall Study||169
6416439|NCT00973349|7330435|FG006|STARTED|Overall Study||174
6416440|NCT00973349|7330436|FG007|STARTED|Overall Study||169
6416441|NCT00973349|7330437|FG008|STARTED|Overall Study||171
6416442|NCT00973349|7330438|FG009|STARTED|Overall Study||169
6416443|NCT00973349|7330439|FG010|STARTED|Overall Study||174
6416444|NCT00973349|7330440|FG011|STARTED|Overall Study||169
6416445|NCT00973349|7330441|FG012|STARTED|Overall Study||169
6416446|NCT00973349|7330442|FG013|STARTED|Overall Study||171
6416447|NCT00973349|7330443|FG014|STARTED|Overall Study||170
6416448|NCT00973349|7330444|FG015|STARTED|Overall Study||167
6416449|NCT00973349|7330429|FG000|COMPLETED|Overall Study||166
6416450|NCT00973349|7330430|FG001|COMPLETED|Overall Study||165
6416451|NCT00973349|7330431|FG002|COMPLETED|Overall Study||166
6416452|NCT00973349|7330432|FG003|COMPLETED|Overall Study||163
6416453|NCT00973349|7330433|FG004|COMPLETED|Overall Study||165
6416454|NCT00973349|7330434|FG005|COMPLETED|Overall Study||165
6416455|NCT00973349|7330435|FG006|COMPLETED|Overall Study||172
6416456|NCT00973349|7330436|FG007|COMPLETED|Overall Study||166
6416457|NCT00973349|7330437|FG008|COMPLETED|Overall Study||167
6416458|NCT00973349|7330438|FG009|COMPLETED|Overall Study||163
6416459|NCT00973349|7330439|FG010|COMPLETED|Overall Study||174
6416460|NCT00973349|7330440|FG011|COMPLETED|Overall Study||167
6416461|NCT00973349|7330441|FG012|COMPLETED|Overall Study||168
6416462|NCT00973349|7330442|FG013|COMPLETED|Overall Study||171
6416463|NCT00973349|7330443|FG014|COMPLETED|Overall Study||168
6416464|NCT00973349|7330444|FG015|COMPLETED|Overall Study||165
6416465|NCT00973349|7330429|FG000|NOT COMPLETED|Overall Study||4
6416466|NCT00973349|7330430|FG001|NOT COMPLETED|Overall Study||3
6416467|NCT00973349|7330431|FG002|NOT COMPLETED|Overall Study||5
6416468|NCT00973349|7330432|FG003|NOT COMPLETED|Overall Study||5
6416469|NCT00973349|7330433|FG004|NOT COMPLETED|Overall Study||5
6416470|NCT00973349|7330434|FG005|NOT COMPLETED|Overall Study||4
6416471|NCT00973349|7330435|FG006|NOT COMPLETED|Overall Study||2
6416472|NCT00973349|7330436|FG007|NOT COMPLETED|Overall Study||3
6416473|NCT00973349|7330437|FG008|NOT COMPLETED|Overall Study||4
6416474|NCT00973349|7330438|FG009|NOT COMPLETED|Overall Study||6
6416475|NCT00973349|7330439|FG010|NOT COMPLETED|Overall Study||0
6416476|NCT00973349|7330440|FG011|NOT COMPLETED|Overall Study||2
6416477|NCT00973349|7330441|FG012|NOT COMPLETED|Overall Study||1
6416478|NCT00973349|7330442|FG013|NOT COMPLETED|Overall Study||0
6416479|NCT00973349|7330443|FG014|NOT COMPLETED|Overall Study||2
6416480|NCT00973349|7330444|FG015|NOT COMPLETED|Overall Study||2
6416481|NCT00973362|7330472|FG000|STARTED|Baseline Evaluation||11644
6416482|NCT00973362|7330473|FG001|STARTED|Baseline Evaluation||1252
6416483|NCT00973362|7330472|FG000|Evaluable for Analysis|Baseline Evaluation||10871
6416484|NCT00973362|7330473|FG001|Evaluable for Analysis|Baseline Evaluation||958
6416485|NCT00973362|7330472|FG000|Conclusive Disease Status|Baseline Evaluation||819
6416486|NCT00973362|7330473|FG001|Conclusive Disease Status|Baseline Evaluation||939
6416487|NCT00973362|7330472|FG000|COMPLETED|Baseline Evaluation||10871
6416488|NCT00973362|7330473|FG001|COMPLETED|Baseline Evaluation||1029
6416489|NCT00973362|7330472|FG000|NOT COMPLETED|Baseline Evaluation||773
6416490|NCT00973362|7330473|FG001|NOT COMPLETED|Baseline Evaluation||223
6416491|NCT00973362|7330472|FG000|STARTED|3-Year Follow-up||10871
6416492|NCT00973362|7330473|FG001|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
6416493|NCT00973362|7330472|FG000|COMPLETED|3-Year Follow-up||10854
6416494|NCT00973362|7330473|FG001|COMPLETED|3-Year Follow-up||0
6416495|NCT00973362|7330472|FG000|NOT COMPLETED|3-Year Follow-up||17
6416496|NCT00973362|7330473|FG001|NOT COMPLETED|3-Year Follow-up||0
6416497|NCT00973479|7330484|FG000|STARTED|Overall Study||197
6416498|NCT00973479|7330485|FG001|STARTED|Overall Study||395
6416499|NCT00973479|7330484|FG000|COMPLETED|Overall Study||160
6416500|NCT00973479|7330485|FG001|COMPLETED|Overall Study||326
6416501|NCT00973479|7330484|FG000|NOT COMPLETED|Overall Study||37
6416502|NCT00973479|7330485|FG001|NOT COMPLETED|Overall Study||69
6416503|NCT00973622|7330495|FG000|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
6416504|NCT00973622|7330496|FG001|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
6416505|NCT00973622|7330495|FG000|COMPLETED|Overall Study|Completed three sessions of rTMS|16
6416506|NCT00973622|7330496|FG001|COMPLETED|Overall Study|Completed three sessions of rTMS|14
6416507|NCT00973622|7330495|FG000|NOT COMPLETED|Overall Study||31
6416508|NCT00973622|7330496|FG001|NOT COMPLETED|Overall Study||5
6416509|NCT00973674|7330504|FG000|STARTED|Overall Study||24
6416510|NCT00973674|7330505|FG001|STARTED|Overall Study||26
6416511|NCT00973674|7330504|FG000|COMPLETED|Overall Study||22
6416512|NCT00973674|7330505|FG001|COMPLETED|Overall Study||26
6416513|NCT00973674|7330504|FG000|NOT COMPLETED|Overall Study||2
6416514|NCT00973674|7330505|FG001|NOT COMPLETED|Overall Study||0
6416515|NCT00973700|7330517|FG000|STARTED|Overall Study||56
6416516|NCT00973700|7330518|FG001|STARTED|Overall Study||56
6416517|NCT00973700|7330519|FG002|STARTED|Overall Study||168
6416518|NCT00973700|7330520|FG003|STARTED|Overall Study||336
6416519|NCT00973700|7330521|FG004|STARTED|Overall Study||168
6416520|NCT00973700|7330517|FG000|COMPLETED|Overall Study||49
6416521|NCT00973700|7330518|FG001|COMPLETED|Overall Study||54
6416522|NCT00973700|7330519|FG002|COMPLETED|Overall Study||158
6416523|NCT00973700|7330520|FG003|COMPLETED|Overall Study||318
6416524|NCT00973700|7330521|FG004|COMPLETED|Overall Study||158
6416525|NCT00973700|7330517|FG000|NOT COMPLETED|Overall Study||7
6416526|NCT00973700|7330518|FG001|NOT COMPLETED|Overall Study||2
6416527|NCT00973700|7330519|FG002|NOT COMPLETED|Overall Study||10
6416528|NCT00973700|7330520|FG003|NOT COMPLETED|Overall Study||18
6416529|NCT00973700|7330521|FG004|NOT COMPLETED|Overall Study||10
6416530|NCT00973739|7330548|FG000|STARTED|Overall Study||21
6416531|NCT00973739|7330548|FG000|COMPLETED|Overall Study||17
6416532|NCT00973739|7330548|FG000|NOT COMPLETED|Overall Study||4
6416533|NCT00973752|7330552|FG000|STARTED|Overall Study||30
6416534|NCT00973752|7330552|FG000|COMPLETED|Overall Study||30
6416535|NCT00973752|7330552|FG000|NOT COMPLETED|Overall Study||0
6416536|NCT00973765|7330558|FG000|STARTED|Overall Study|96|96
6638600|NCT02323334|7567011|FG008|NOT COMPLETED|Period 4||0
6638601|NCT02323334|7567012|FG009|NOT COMPLETED|Period 4||0
6638602|NCT02323334|7567013|FG010|NOT COMPLETED|Period 4||0
6638603|NCT02323334|7567014|FG011|NOT COMPLETED|Period 4||0
6638604|NCT02323334|7567015|FG012|NOT COMPLETED|Period 4||0
6638605|NCT02323334|7567016|FG013|NOT COMPLETED|Period 4||0
6638606|NCT02323334|7567017|FG014|NOT COMPLETED|Period 4||0
6638607|NCT02323334|7567018|FG015|NOT COMPLETED|Period 4||0
6416537|NCT00973765|7330559|FG001|STARTED|Overall Study|116|116
6416538|NCT00973765|7330558|FG000|COMPLETED|Overall Study|88|88
6416539|NCT00973765|7330559|FG001|COMPLETED|Overall Study|102|102
6416540|NCT00973765|7330558|FG000|NOT COMPLETED|Overall Study||8
6416541|NCT00973765|7330559|FG001|NOT COMPLETED|Overall Study||14
6416542|NCT00973921|7330565|FG000|STARTED|Overall Study||40
6416543|NCT00973921|7330565|FG000|COMPLETED|Overall Study||31
6416544|NCT00973921|7330565|FG000|NOT COMPLETED|Overall Study||9
6416545|NCT00973973|7330571|FG000|STARTED|Double-blind Treatment Phase (Weeks 1-8)||69
6416546|NCT00973973|7330572|FG001|STARTED|Double-blind Treatment Phase (Weeks 1-8)||68
6416547|NCT00973973|7330571|FG000|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||69
6638608|NCT02323334|7567019|FG016|NOT COMPLETED|Period 4||0
6638609|NCT02323646|7567084|FG000|STARTED|Treatment Course 1||14
6638610|NCT02323646|7567085|FG001|STARTED|Treatment Course 1||13
6638611|NCT02323646|7567086|FG002|STARTED|Treatment Course 1||15
6638612|NCT02323646|7567084|FG000|COMPLETED|Treatment Course 1||11
6638613|NCT02323646|7567085|FG001|COMPLETED|Treatment Course 1||10
6638614|NCT02323646|7567086|FG002|COMPLETED|Treatment Course 1||12
6743522|NCT03334747|7671729|FG005|COMPLETED|Follow-Up Phase||19
6743523|NCT03334747|7671730|FG006|COMPLETED|Follow-Up Phase||20
6416548|NCT00973973|7330572|FG001|Received Study Drug|Double-blind Treatment Phase (Weeks 1-8)||68
6416549|NCT00973973|7330571|FG000|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||63
6416550|NCT00973973|7330572|FG001|COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||60
6416551|NCT00973973|7330571|FG000|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||6
6416552|NCT00973973|7330572|FG001|NOT COMPLETED|Double-blind Treatment Phase (Weeks 1-8)||8
6638615|NCT02323646|7567084|FG000|NOT COMPLETED|Treatment Course 1||3
6638616|NCT02323646|7567085|FG001|NOT COMPLETED|Treatment Course 1||3
6638617|NCT02323646|7567086|FG002|NOT COMPLETED|Treatment Course 1||3
6416553|NCT00973973|7330571|FG000|STARTED|Open-label Treatment Phase (Weeks 8-24)||63
6416554|NCT00973973|7330572|FG001|STARTED|Open-label Treatment Phase (Weeks 8-24)||60
6416555|NCT00973973|7330571|FG000|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||57
6416556|NCT00973973|7330572|FG001|COMPLETED|Open-label Treatment Phase (Weeks 8-24)||55
6416557|NCT00973973|7330571|FG000|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||6
6416558|NCT00973973|7330572|FG001|NOT COMPLETED|Open-label Treatment Phase (Weeks 8-24)||5
6416559|NCT00974051|7330578|FG000|STARTED|Overall Study||6
6416560|NCT00974051|7330579|FG001|STARTED|Overall Study||4
6416561|NCT00974051|7330580|FG002|STARTED|Overall Study||6
6416562|NCT00974051|7330578|FG000|COMPLETED|Overall Study||6
6416563|NCT00974051|7330579|FG001|COMPLETED|Overall Study||4
6416564|NCT00974051|7330580|FG002|COMPLETED|Overall Study||6
6416565|NCT00974051|7330578|FG000|NOT COMPLETED|Overall Study||0
6416566|NCT00974051|7330579|FG001|NOT COMPLETED|Overall Study||0
6416567|NCT00974051|7330580|FG002|NOT COMPLETED|Overall Study||0
6416568|NCT00974090|7330591|FG000|STARTED|Period 1: Double Blind Period||98
6416569|NCT00974090|7330592|FG001|STARTED|Period 1: Double Blind Period||96
6416570|NCT00974090|7330591|FG000|COMPLETED|Period 1: Double Blind Period||95
6416571|NCT00974090|7330592|FG001|COMPLETED|Period 1: Double Blind Period||95
6416572|NCT00974090|7330591|FG000|NOT COMPLETED|Period 1: Double Blind Period||3
6416573|NCT00974090|7330592|FG001|NOT COMPLETED|Period 1: Double Blind Period||1
6416574|NCT00974090|7330591|FG000|STARTED|Period 2: Open-label Period||95
6416575|NCT00974090|7330592|FG001|STARTED|Period 2: Open-label Period||95
6416576|NCT00974090|7330591|FG000|COMPLETED|Period 2: Open-label Period||87
6416577|NCT00974090|7330592|FG001|COMPLETED|Period 2: Open-label Period||85
6416578|NCT00974090|7330591|FG000|NOT COMPLETED|Period 2: Open-label Period||8
6416579|NCT00974090|7330592|FG001|NOT COMPLETED|Period 2: Open-label Period||10
6416580|NCT00974142|7330602|FG000|STARTED|Overall Study||8
6416581|NCT00974142|7330603|FG001|STARTED|Overall Study||9
6416582|NCT00974142|7330602|FG000|COMPLETED|Overall Study||8
6416583|NCT00974142|7330603|FG001|COMPLETED|Overall Study||9
6416584|NCT00974142|7330602|FG000|NOT COMPLETED|Overall Study||0
6416585|NCT00974142|7330603|FG001|NOT COMPLETED|Overall Study||0
6416586|NCT00974220|7330611|FG000|STARTED|Treatment Period 1||9
6416587|NCT00974220|7330612|FG001|STARTED|Treatment Period 1||7
6416588|NCT00974220|7330611|FG000|COMPLETED|Treatment Period 1||7
6416589|NCT00974220|7330612|FG001|COMPLETED|Treatment Period 1||5
6416590|NCT00974220|7330611|FG000|NOT COMPLETED|Treatment Period 1||2
6416591|NCT00974220|7330612|FG001|NOT COMPLETED|Treatment Period 1||2
6416592|NCT00974220|7330611|FG000|STARTED|Treatment Period 2||7
6416593|NCT00974220|7330612|FG001|STARTED|Treatment Period 2||5
6416594|NCT00974220|7330611|FG000|COMPLETED|Treatment Period 2||7
6416595|NCT00974220|7330612|FG001|COMPLETED|Treatment Period 2||5
6416596|NCT00974220|7330611|FG000|NOT COMPLETED|Treatment Period 2||0
6416597|NCT00974220|7330612|FG001|NOT COMPLETED|Treatment Period 2||0
6416598|NCT00974233|7330618|FG000|STARTED|Induction Chemoimmunotherapy||34
6416599|NCT00974233|7330618|FG000|COMPLETED|Induction Chemoimmunotherapy||19
6416600|NCT00974233|7330618|FG000|NOT COMPLETED|Induction Chemoimmunotherapy||15
6416601|NCT00974233|7330618|FG000|STARTED|Maintenance Lenalidomide||19
6416602|NCT00974233|7330618|FG000|COMPLETED|Maintenance Lenalidomide||6
6416603|NCT00974233|7330618|FG000|NOT COMPLETED|Maintenance Lenalidomide||13
6416604|NCT00974246|7330630|FG000|STARTED|Overall Study||27
6416605|NCT00974246|7330630|FG000|COMPLETED|Overall Study||27
6416606|NCT00974246|7330630|FG000|NOT COMPLETED|Overall Study||0
6416607|NCT00974259|7330637|FG000|STARTED|Overall Study||59
6416608|NCT00974259|7330638|FG001|STARTED|Overall Study||63
6416609|NCT00974259|7330637|FG000|COMPLETED|Overall Study||57
6416610|NCT00974259|7330638|FG001|COMPLETED|Overall Study||62
6416611|NCT00974259|7330637|FG000|NOT COMPLETED|Overall Study||2
6416612|NCT00974259|7330638|FG001|NOT COMPLETED|Overall Study||1
6416613|NCT00974311|7330646|FG000|STARTED|DB Phase (up to 24 Months)||800
6416614|NCT00974311|7330647|FG001|STARTED|DB Phase (up to 24 Months)||399
6416615|NCT00974311|7330646|FG000|COMPLETED|DB Phase (up to 24 Months)||109
6416616|NCT00974311|7330647|FG001|COMPLETED|DB Phase (up to 24 Months)||50
6416617|NCT00974311|7330646|FG000|NOT COMPLETED|DB Phase (up to 24 Months)||691
6416618|NCT00974311|7330647|FG001|NOT COMPLETED|DB Phase (up to 24 Months)||349
6416619|NCT00974311|7330646|FG000|STARTED|OLE Phase (up to 77 Months)||109
6416620|NCT00974311|7330647|FG001|STARTED|OLE Phase (up to 77 Months)||50
6416621|NCT00974311|7330646|FG000|COMPLETED|OLE Phase (up to 77 Months)||0
6416622|NCT00974311|7330647|FG001|COMPLETED|OLE Phase (up to 77 Months)||0
6416623|NCT00974311|7330646|FG000|NOT COMPLETED|OLE Phase (up to 77 Months)||109
6416624|NCT00974311|7330647|FG001|NOT COMPLETED|OLE Phase (up to 77 Months)||50
6416625|NCT00974350|7330659|FG000|STARTED|Overall Study||45
6416626|NCT00974350|7330660|FG001|STARTED|Overall Study||47
6416627|NCT00974350|7330661|FG002|STARTED|Overall Study||32
6416628|NCT00974350|7330659|FG000|COMPLETED|Overall Study||42
6416629|NCT00974350|7330660|FG001|COMPLETED|Overall Study||47
6416630|NCT00974350|7330661|FG002|COMPLETED|Overall Study||31
6416631|NCT00974350|7330659|FG000|NOT COMPLETED|Overall Study||3
6416632|NCT00974350|7330660|FG001|NOT COMPLETED|Overall Study||0
6416633|NCT00974350|7330661|FG002|NOT COMPLETED|Overall Study||1
6416634|NCT00974363|7330672|FG000|STARTED|Overall Study||521
6416635|NCT00974363|7330673|FG001|STARTED|Overall Study||168
6416636|NCT00974363|7330672|FG000|COMPLETED|Overall Study||521
6416637|NCT00974363|7330673|FG001|COMPLETED|Overall Study||168
6416638|NCT00974363|7330672|FG000|NOT COMPLETED|Overall Study||0
6416639|NCT00974363|7330673|FG001|NOT COMPLETED|Overall Study||0
6416640|NCT00974376|7330681|FG000|STARTED|Overall Study||75
6416641|NCT00974376|7330682|FG001|STARTED|Overall Study||75
6416642|NCT00974376|7330681|FG000|COMPLETED|Overall Study||41
6416643|NCT00974376|7330682|FG001|COMPLETED|Overall Study||42
6416644|NCT00974376|7330681|FG000|NOT COMPLETED|Overall Study||34
6416645|NCT00974376|7330682|FG001|NOT COMPLETED|Overall Study||33
6416646|NCT00974480|7330691|FG000|STARTED|Overall Study||40
6416647|NCT00974480|7330692|FG001|STARTED|Overall Study||40
6416648|NCT00974480|7330693|FG002|STARTED|Overall Study||40
6416649|NCT00974480|7330691|FG000|COMPLETED|Overall Study||29
6416650|NCT00974480|7330692|FG001|COMPLETED|Overall Study||33
6416651|NCT00974480|7330693|FG002|COMPLETED|Overall Study||30
6416652|NCT00974480|7330691|FG000|NOT COMPLETED|Overall Study||11
6416653|NCT00974480|7330692|FG001|NOT COMPLETED|Overall Study||7
6416654|NCT00974480|7330693|FG002|NOT COMPLETED|Overall Study||10
6416655|NCT00974493|7330709|FG000|STARTED|Overall Study||527
6416656|NCT00974493|7330710|FG001|STARTED|Overall Study||527
6416657|NCT00974493|7330709|FG000|COMPLETED|Overall Study||509
6416658|NCT00974493|7330710|FG001|COMPLETED|Overall Study||506
6416659|NCT00974493|7330709|FG000|NOT COMPLETED|Overall Study||18
6416660|NCT00974493|7330710|FG001|NOT COMPLETED|Overall Study||21
6416661|NCT00974675|7330720|FG000|STARTED|Overall Study||8
6416662|NCT00974675|7330721|FG001|STARTED|Overall Study||8
6416663|NCT00974675|7330722|FG002|STARTED|Overall Study||3
6416664|NCT00974675|7330723|FG003|STARTED|Overall Study||4
6416665|NCT00974675|7330720|FG000|COMPLETED|Overall Study||6
6416666|NCT00974675|7330721|FG001|COMPLETED|Overall Study||7
6416667|NCT00974675|7330722|FG002|COMPLETED|Overall Study||1
6416668|NCT00974675|7330723|FG003|COMPLETED|Overall Study||2
6416669|NCT00974675|7330720|FG000|NOT COMPLETED|Overall Study||2
6416670|NCT00974675|7330721|FG001|NOT COMPLETED|Overall Study||1
6416671|NCT00974675|7330722|FG002|NOT COMPLETED|Overall Study||2
6416672|NCT00974675|7330723|FG003|NOT COMPLETED|Overall Study||2
6416673|NCT00974818|7330735|FG000|STARTED|Overall Study||25
6416674|NCT00974818|7330736|FG001|STARTED|Overall Study||25
6416675|NCT00974818|7330735|FG000|COMPLETED|Overall Study||25
6416676|NCT00974818|7330736|FG001|COMPLETED|Overall Study||25
6416677|NCT00974818|7330735|FG000|NOT COMPLETED|Overall Study||0
6416678|NCT00974818|7330736|FG001|NOT COMPLETED|Overall Study||0
6416679|NCT00974974|7330744|FG000|STARTED|IR CD-LD Dose Adjustment||0
6416680|NCT00974974|7330745|FG001|STARTED|IR CD-LD Dose Adjustment||471
6416681|NCT00974974|7330744|FG000|COMPLETED|IR CD-LD Dose Adjustment||0
6416682|NCT00974974|7330745|FG001|COMPLETED|IR CD-LD Dose Adjustment||450
6416683|NCT00974974|7330744|FG000|NOT COMPLETED|IR CD-LD Dose Adjustment||0
6416684|NCT00974974|7330745|FG001|NOT COMPLETED|IR CD-LD Dose Adjustment||21
6416685|NCT00974974|7330744|FG000|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
6416686|NCT00974974|7330745|FG001|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
6416687|NCT00974974|7330744|FG000|COMPLETED|IPX066 Dose Conversion||393
6416688|NCT00974974|7330745|FG001|COMPLETED|IPX066 Dose Conversion||0
6416689|NCT00974974|7330744|FG000|NOT COMPLETED|IPX066 Dose Conversion||57
6416690|NCT00974974|7330745|FG001|NOT COMPLETED|IPX066 Dose Conversion||0
6416691|NCT00974974|7330744|FG000|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
6416692|NCT00974974|7330745|FG001|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
6416693|NCT00974974|7330744|FG000|COMPLETED|Maintenance - Double Blind Treatment||186
6416694|NCT00974974|7330745|FG001|COMPLETED|Maintenance - Double Blind Treatment||182
6416695|NCT00974974|7330744|FG000|NOT COMPLETED|Maintenance - Double Blind Treatment||15
6416696|NCT00974974|7330745|FG001|NOT COMPLETED|Maintenance - Double Blind Treatment||10
6416697|NCT00975000|7330753|FG000|STARTED|Overall Study||57
6416698|NCT00975000|7330754|FG001|STARTED|Overall Study||57
6416699|NCT00975000|7330753|FG000|Completed Titration Phase|Overall Study||54
6416700|NCT00975000|7330754|FG001|Completed Titration Phase|Overall Study||55
6416701|NCT00975000|7330753|FG000|Completed Efficacy Assessment Phase|Overall Study||54
6416702|NCT00975000|7330754|FG001|Completed Efficacy Assessment Phase|Overall Study||54
6416703|NCT00975000|7330753|FG000|Completed Maintenance Phase|Overall Study||52
6416704|NCT00975000|7330754|FG001|Completed Maintenance Phase|Overall Study||52
6416705|NCT00975000|7330753|FG000|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
6416706|NCT00975000|7330754|FG001|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
6416707|NCT00975000|7330753|FG000|NOT COMPLETED|Overall Study||5
6416708|NCT00975000|7330754|FG001|NOT COMPLETED|Overall Study||5
6416709|NCT00975130|7330760|FG000|STARTED|Study Part 1||3366
6416710|NCT00975130|7330761|FG001|STARTED|Study Part 1||0
6416711|NCT00975130|7330762|FG002|STARTED|Study Part 1||0
6416712|NCT00975130|7330760|FG000|COMPLETED|Study Part 1||3086
6416713|NCT00975130|7330761|FG001|COMPLETED|Study Part 1||0
6416714|NCT00975130|7330762|FG002|COMPLETED|Study Part 1||0
6416715|NCT00975130|7330760|FG000|NOT COMPLETED|Study Part 1||280
6416716|NCT00975130|7330761|FG001|NOT COMPLETED|Study Part 1||0
6416717|NCT00975130|7330762|FG002|NOT COMPLETED|Study Part 1||0
6416718|NCT00975130|7330760|FG000|STARTED|Study Part 2||0
6499156|NCT01415349|7417794|FG000|STARTED|Treatment Period 2||21
6416719|NCT00975130|7330761|FG001|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
6416720|NCT00975130|7330762|FG002|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
6416721|NCT00975130|7330760|FG000|COMPLETED|Study Part 2||0
6416722|NCT00975130|7330761|FG001|COMPLETED|Study Part 2||212
6416723|NCT00975130|7330762|FG002|COMPLETED|Study Part 2||238
6416724|NCT00975130|7330760|FG000|NOT COMPLETED|Study Part 2||0
6416725|NCT00975130|7330761|FG001|NOT COMPLETED|Study Part 2||38
6416726|NCT00975130|7330762|FG002|NOT COMPLETED|Study Part 2||17
6416727|NCT00975143|7330777|FG000|STARTED|Overall Study||464
6416728|NCT00975143|7330778|FG001|STARTED|Overall Study||461
6416729|NCT00975143|7330777|FG000|Completed Treatment (Week 20)|Overall Study||403
6416730|NCT00975143|7330778|FG001|Completed Treatment (Week 20)|Overall Study||410
6416731|NCT00975143|7330777|FG000|COMPLETED|Overall Study||394
6416732|NCT00975143|7330778|FG001|COMPLETED|Overall Study||401
6416733|NCT00975143|7330777|FG000|NOT COMPLETED|Overall Study||70
6416734|NCT00975143|7330778|FG001|NOT COMPLETED|Overall Study||60
6416735|NCT00975156|7330786|FG000|STARTED|Overall Study||11
6416736|NCT00975156|7330787|FG001|STARTED|Overall Study||10
6416737|NCT00975156|7330786|FG000|COMPLETED|Overall Study||11
6416738|NCT00975156|7330787|FG001|COMPLETED|Overall Study||9
6416739|NCT00975156|7330786|FG000|NOT COMPLETED|Overall Study||0
6416740|NCT00975156|7330787|FG001|NOT COMPLETED|Overall Study||1
6416741|NCT00975195|7330799|FG000|STARTED|Overall Study||1244
6416742|NCT00975195|7330800|FG001|STARTED|Overall Study||1244
6416743|NCT00975195|7330799|FG000|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
6416744|NCT00975195|7330800|FG001|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
6416745|NCT00975195|7330799|FG000|NOT COMPLETED|Overall Study||228
6416746|NCT00975195|7330800|FG001|NOT COMPLETED|Overall Study||233
6416747|NCT00975221|7330808|FG000|STARTED|Titration Phase (Weeks 1-12)||34
6416748|NCT00975221|7330809|FG001|STARTED|Titration Phase (Weeks 1-12)||33
6416749|NCT00975221|7330808|FG000|Received Study Drug|Titration Phase (Weeks 1-12)||34
6416750|NCT00975221|7330809|FG001|Received Study Drug|Titration Phase (Weeks 1-12)||33
6416751|NCT00975221|7330808|FG000|COMPLETED|Titration Phase (Weeks 1-12)||31
6416752|NCT00975221|7330809|FG001|COMPLETED|Titration Phase (Weeks 1-12)||29
6416753|NCT00975221|7330808|FG000|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
6416754|NCT00975221|7330809|FG001|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
6416755|NCT00975221|7330808|FG000|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
6416756|NCT00975221|7330809|FG001|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
6416757|NCT00975221|7330808|FG000|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
6416758|NCT00975221|7330809|FG001|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
6416759|NCT00975221|7330808|FG000|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
6416760|NCT00975221|7330809|FG001|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
6416761|NCT00975221|7330808|FG000|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
6416762|NCT00975221|7330809|FG001|STARTED|Open-label Extension Phase (Weeks 29-52)||28
6416763|NCT00975221|7330808|FG000|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
6416764|NCT00975221|7330809|FG001|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
6416765|NCT00975221|7330808|FG000|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
6416766|NCT00975221|7330809|FG001|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
6416767|NCT00975286|7330819|FG000|STARTED|Overall Study|Randomized.|223
6416768|NCT00975286|7330820|FG001|STARTED|Overall Study||223
6416769|NCT00975286|7330819|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
6416770|NCT00975286|7330820|FG001|Safety Population|Overall Study||223
6416771|NCT00975286|7330819|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
6416772|NCT00975286|7330820|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||223
6416773|NCT00975286|7330819|FG000|COMPLETED|Overall Study||211
6416774|NCT00975286|7330820|FG001|COMPLETED|Overall Study||194
6416775|NCT00975286|7330819|FG000|NOT COMPLETED|Overall Study||12
6416776|NCT00975286|7330820|FG001|NOT COMPLETED|Overall Study||29
6416777|NCT00975416|7330828|FG000|STARTED|Overall Study||14
6416778|NCT00975416|7330829|FG001|STARTED|Overall Study||16
6416779|NCT00975416|7330828|FG000|COMPLETED|Overall Study||11
6416780|NCT00975416|7330829|FG001|COMPLETED|Overall Study||11
6416781|NCT00975416|7330828|FG000|NOT COMPLETED|Overall Study||3
6416782|NCT00975416|7330829|FG001|NOT COMPLETED|Overall Study||5
6416783|NCT00975481|7330836|FG000|STARTED|First Intervention Period||6
6416784|NCT00975481|7330837|FG001|STARTED|First Intervention Period||6
6416785|NCT00975481|7330838|FG002|STARTED|First Intervention Period||6
6416786|NCT00975481|7330839|FG003|STARTED|First Intervention Period||6
6416787|NCT00975481|7330840|FG004|STARTED|First Intervention Period||6
6416788|NCT00975481|7330841|FG005|STARTED|First Intervention Period||6
6416789|NCT00975481|7330836|FG000|COMPLETED|First Intervention Period||6
6416790|NCT00975481|7330837|FG001|COMPLETED|First Intervention Period||6
6416791|NCT00975481|7330838|FG002|COMPLETED|First Intervention Period||6
6416792|NCT00975481|7330839|FG003|COMPLETED|First Intervention Period||6
6416793|NCT00975481|7330840|FG004|COMPLETED|First Intervention Period||6
6416794|NCT00975481|7330841|FG005|COMPLETED|First Intervention Period||6
6416795|NCT00975481|7330836|FG000|NOT COMPLETED|First Intervention Period||0
6416796|NCT00975481|7330837|FG001|NOT COMPLETED|First Intervention Period||0
6416797|NCT00975481|7330838|FG002|NOT COMPLETED|First Intervention Period||0
6416798|NCT00975481|7330839|FG003|NOT COMPLETED|First Intervention Period||0
6416799|NCT00975481|7330840|FG004|NOT COMPLETED|First Intervention Period||0
6416800|NCT00975481|7330841|FG005|NOT COMPLETED|First Intervention Period||0
6416801|NCT00975481|7330836|FG000|STARTED|Washout Period (at Least 7 Days)||6
6416802|NCT00975481|7330837|FG001|STARTED|Washout Period (at Least 7 Days)||6
6416803|NCT00975481|7330838|FG002|STARTED|Washout Period (at Least 7 Days)||6
6416804|NCT00975481|7330839|FG003|STARTED|Washout Period (at Least 7 Days)||6
6416805|NCT00975481|7330840|FG004|STARTED|Washout Period (at Least 7 Days)||6
6416806|NCT00975481|7330841|FG005|STARTED|Washout Period (at Least 7 Days)||6
6416807|NCT00975481|7330836|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
6416808|NCT00975481|7330837|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
6416809|NCT00975481|7330838|FG002|COMPLETED|Washout Period (at Least 7 Days)||6
6416810|NCT00975481|7330839|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
6416811|NCT00975481|7330840|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
6416812|NCT00975481|7330841|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
6416813|NCT00975481|7330836|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416814|NCT00975481|7330837|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416815|NCT00975481|7330838|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416816|NCT00975481|7330839|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416817|NCT00975481|7330840|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416818|NCT00975481|7330841|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416819|NCT00975481|7330836|FG000|STARTED|Second Intervention Period||6
6416820|NCT00975481|7330837|FG001|STARTED|Second Intervention Period||6
6416821|NCT00975481|7330838|FG002|STARTED|Second Intervention Period||6
6416822|NCT00975481|7330839|FG003|STARTED|Second Intervention Period||6
6416823|NCT00975481|7330840|FG004|STARTED|Second Intervention Period||6
6416824|NCT00975481|7330841|FG005|STARTED|Second Intervention Period||6
6416825|NCT00975481|7330836|FG000|COMPLETED|Second Intervention Period||4
6416826|NCT00975481|7330837|FG001|COMPLETED|Second Intervention Period||5
6416827|NCT00975481|7330838|FG002|COMPLETED|Second Intervention Period||5
6416828|NCT00975481|7330839|FG003|COMPLETED|Second Intervention Period||6
6416829|NCT00975481|7330840|FG004|COMPLETED|Second Intervention Period||6
6416830|NCT00975481|7330841|FG005|COMPLETED|Second Intervention Period||6
6416831|NCT00975481|7330836|FG000|NOT COMPLETED|Second Intervention Period||2
6416832|NCT00975481|7330837|FG001|NOT COMPLETED|Second Intervention Period||1
6416833|NCT00975481|7330838|FG002|NOT COMPLETED|Second Intervention Period||1
6416834|NCT00975481|7330839|FG003|NOT COMPLETED|Second Intervention Period||0
6416835|NCT00975481|7330840|FG004|NOT COMPLETED|Second Intervention Period||0
6416836|NCT00975481|7330841|FG005|NOT COMPLETED|Second Intervention Period||0
6416837|NCT00975481|7330836|FG000|STARTED|Washout Period (at Least 7 Days)||4
6416838|NCT00975481|7330837|FG001|STARTED|Washout Period (at Least 7 Days)||5
6416839|NCT00975481|7330838|FG002|STARTED|Washout Period (at Least 7 Days)||5
6416840|NCT00975481|7330839|FG003|STARTED|Washout Period (at Least 7 Days)||6
6416841|NCT00975481|7330840|FG004|STARTED|Washout Period (at Least 7 Days)||6
6416842|NCT00975481|7330841|FG005|STARTED|Washout Period (at Least 7 Days)||6
6416843|NCT00975481|7330836|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
6416844|NCT00975481|7330837|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
6416845|NCT00975481|7330838|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
6416846|NCT00975481|7330839|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
6416847|NCT00975481|7330840|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
6416848|NCT00975481|7330841|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
6416849|NCT00975481|7330836|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416850|NCT00975481|7330837|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416851|NCT00975481|7330838|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416852|NCT00975481|7330839|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416853|NCT00975481|7330840|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416854|NCT00975481|7330841|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416855|NCT00975481|7330836|FG000|STARTED|Third Intervention Period||4
6416856|NCT00975481|7330837|FG001|STARTED|Third Intervention Period||5
6416857|NCT00975481|7330838|FG002|STARTED|Third Intervention Period||5
6416858|NCT00975481|7330839|FG003|STARTED|Third Intervention Period||6
6416859|NCT00975481|7330840|FG004|STARTED|Third Intervention Period||6
6416860|NCT00975481|7330841|FG005|STARTED|Third Intervention Period||6
6416861|NCT00975481|7330836|FG000|COMPLETED|Third Intervention Period||4
6416862|NCT00975481|7330837|FG001|COMPLETED|Third Intervention Period||5
6416863|NCT00975481|7330838|FG002|COMPLETED|Third Intervention Period||5
6638618|NCT02323646|7567084|FG000|STARTED|Treatment Course 2||11
6638619|NCT02323646|7567085|FG001|STARTED|Treatment Course 2||10
6638620|NCT02323646|7567086|FG002|STARTED|Treatment Course 2||12
6638621|NCT02323646|7567084|FG000|COMPLETED|Treatment Course 2||10
6638622|NCT02323646|7567085|FG001|COMPLETED|Treatment Course 2||9
6638623|NCT02323646|7567086|FG002|COMPLETED|Treatment Course 2||9
6638624|NCT02323646|7567084|FG000|NOT COMPLETED|Treatment Course 2||1
6638625|NCT02323646|7567085|FG001|NOT COMPLETED|Treatment Course 2||1
6416864|NCT00975481|7330839|FG003|COMPLETED|Third Intervention Period||6
6416865|NCT00975481|7330840|FG004|COMPLETED|Third Intervention Period||6
6638626|NCT02323646|7567086|FG002|NOT COMPLETED|Treatment Course 2||3
6638627|NCT02323854|7567094|FG000|STARTED|Overall Study||15
6416866|NCT00975481|7330841|FG005|COMPLETED|Third Intervention Period||6
6416867|NCT00975481|7330836|FG000|NOT COMPLETED|Third Intervention Period||0
6416868|NCT00975481|7330837|FG001|NOT COMPLETED|Third Intervention Period||0
6416869|NCT00975481|7330838|FG002|NOT COMPLETED|Third Intervention Period||0
6416870|NCT00975481|7330839|FG003|NOT COMPLETED|Third Intervention Period||0
6510724|NCT01483963|7430340|FG004|COMPLETED|Overall Study||10
6510725|NCT01483963|7430336|FG000|NOT COMPLETED|Overall Study||0
6510726|NCT01483963|7430337|FG001|NOT COMPLETED|Overall Study||0
6510727|NCT01483963|7430338|FG002|NOT COMPLETED|Overall Study||0
6510728|NCT01483963|7430339|FG003|NOT COMPLETED|Overall Study||0
6510729|NCT01483963|7430340|FG004|NOT COMPLETED|Overall Study||0
6416871|NCT00975481|7330840|FG004|NOT COMPLETED|Third Intervention Period||0
6510730|NCT01484028|7430353|FG000|STARTED|Period 1||66
6510731|NCT01484028|7430354|FG001|STARTED|Period 1||70
6510732|NCT01484028|7430355|FG002|STARTED|Period 1||64
6510733|NCT01484028|7430356|FG003|STARTED|Period 1||67
6510734|NCT01484028|7430353|FG000|COMPLETED|Period 1||66
6510735|NCT01484028|7430354|FG001|COMPLETED|Period 1||67
6510736|NCT01484028|7430355|FG002|COMPLETED|Period 1||64
6510737|NCT01484028|7430356|FG003|COMPLETED|Period 1||66
6510738|NCT01484028|7430353|FG000|NOT COMPLETED|Period 1||0
6510739|NCT01484028|7430354|FG001|NOT COMPLETED|Period 1||3
6510740|NCT01484028|7430355|FG002|NOT COMPLETED|Period 1||0
6510741|NCT01484028|7430356|FG003|NOT COMPLETED|Period 1||1
6510742|NCT01484028|7430353|FG000|STARTED|Period 2||66
6510743|NCT01484028|7430354|FG001|STARTED|Period 2||67
6510744|NCT01484028|7430355|FG002|STARTED|Period 2||64
6510745|NCT01484028|7430356|FG003|STARTED|Period 2||66
6510746|NCT01484028|7430353|FG000|COMPLETED|Period 2||66
6510747|NCT01484028|7430354|FG001|COMPLETED|Period 2||67
6510748|NCT01484028|7430355|FG002|COMPLETED|Period 2||64
6510749|NCT01484028|7430356|FG003|COMPLETED|Period 2||66
6510750|NCT01484028|7430353|FG000|NOT COMPLETED|Period 2||0
6510751|NCT01484028|7430354|FG001|NOT COMPLETED|Period 2||0
6510752|NCT01484028|7430355|FG002|NOT COMPLETED|Period 2||0
6510753|NCT01484028|7430356|FG003|NOT COMPLETED|Period 2||0
6510754|NCT01484041|7430364|FG000|STARTED|Overall Study||12
6510755|NCT01484041|7430364|FG000|COMPLETED|Overall Study||12
6510756|NCT01484041|7430364|FG000|NOT COMPLETED|Overall Study||0
6510757|NCT01484054|7430368|FG000|STARTED|Period 1||50
6510758|NCT01484054|7430369|FG001|STARTED|Period 1||50
6510759|NCT01484054|7430368|FG000|COMPLETED|Period 1||50
6510760|NCT01484054|7430369|FG001|COMPLETED|Period 1||49
6510761|NCT01484054|7430368|FG000|NOT COMPLETED|Period 1||0
6510762|NCT01484054|7430369|FG001|NOT COMPLETED|Period 1||1
6510763|NCT01484054|7430368|FG000|STARTED|Period 2||50
6510764|NCT01484054|7430369|FG001|STARTED|Period 2||49
6510765|NCT01484054|7430368|FG000|COMPLETED|Period 2||50
6510766|NCT01484054|7430369|FG001|COMPLETED|Period 2||49
6510767|NCT01484054|7430368|FG000|NOT COMPLETED|Period 2||0
6638628|NCT02323854|7567094|FG000|COMPLETED|Overall Study||15
6638629|NCT02323854|7567094|FG000|NOT COMPLETED|Overall Study||0
6638630|NCT02324049|7567098|FG000|STARTED|Part A||11
6638631|NCT02324049|7567098|FG000|Safety Analysis Set|Part A|Participants with informed consent, confirmed MPS IIIB diagnosis, and received any amount of SBC-103|11
6638632|NCT02324049|7567098|FG000|COMPLETED|Part A||11
6638633|NCT02324049|7567098|FG000|NOT COMPLETED|Part A||0
6638634|NCT02324049|7567098|FG000|STARTED|Part B||11
6638635|NCT02324049|7567098|FG000|Safety Analysis Set|Part B||11
6638636|NCT02324049|7567098|FG000|COMPLETED|Part B||11
6416872|NCT00975481|7330841|FG005|NOT COMPLETED|Third Intervention Period||0
6416873|NCT00975481|7330836|FG000|STARTED|Washout Period (at Least 7 Days)||4
6416874|NCT00975481|7330837|FG001|STARTED|Washout Period (at Least 7 Days)||5
6416875|NCT00975481|7330838|FG002|STARTED|Washout Period (at Least 7 Days)||5
6416876|NCT00975481|7330839|FG003|STARTED|Washout Period (at Least 7 Days)||6
6416877|NCT00975481|7330840|FG004|STARTED|Washout Period (at Least 7 Days)||6
6416878|NCT00975481|7330841|FG005|STARTED|Washout Period (at Least 7 Days)||6
6416879|NCT00975481|7330836|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
6416880|NCT00975481|7330837|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
6416881|NCT00975481|7330838|FG002|COMPLETED|Washout Period (at Least 7 Days)||5
6416882|NCT00975481|7330839|FG003|COMPLETED|Washout Period (at Least 7 Days)||6
6416883|NCT00975481|7330840|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
6416884|NCT00975481|7330841|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
6416885|NCT00975481|7330836|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416886|NCT00975481|7330837|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416887|NCT00975481|7330838|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416888|NCT00975481|7330839|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416889|NCT00975481|7330840|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416890|NCT00975481|7330841|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416891|NCT00975481|7330836|FG000|STARTED|Fourth Intervention Period||4
6416892|NCT00975481|7330837|FG001|STARTED|Fourth Intervention Period||5
6510768|NCT01484054|7430369|FG001|NOT COMPLETED|Period 2||0
6510769|NCT01484132|7430376|FG000|STARTED|Overall Study||113
6510770|NCT01484132|7430376|FG000|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
6510771|NCT01484132|7430376|FG000|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
6638637|NCT02324049|7567098|FG000|NOT COMPLETED|Part B||0
6416893|NCT00975481|7330838|FG002|STARTED|Fourth Intervention Period||5
6416894|NCT00975481|7330839|FG003|STARTED|Fourth Intervention Period||6
6416895|NCT00975481|7330840|FG004|STARTED|Fourth Intervention Period||6
6416896|NCT00975481|7330841|FG005|STARTED|Fourth Intervention Period||6
6416897|NCT00975481|7330836|FG000|COMPLETED|Fourth Intervention Period||4
6416898|NCT00975481|7330837|FG001|COMPLETED|Fourth Intervention Period||5
6416899|NCT00975481|7330838|FG002|COMPLETED|Fourth Intervention Period||4
6416900|NCT00975481|7330839|FG003|COMPLETED|Fourth Intervention Period||5
6416901|NCT00975481|7330840|FG004|COMPLETED|Fourth Intervention Period||6
6416902|NCT00975481|7330841|FG005|COMPLETED|Fourth Intervention Period||6
6416903|NCT00975481|7330836|FG000|NOT COMPLETED|Fourth Intervention Period||0
6416904|NCT00975481|7330837|FG001|NOT COMPLETED|Fourth Intervention Period||0
6416905|NCT00975481|7330838|FG002|NOT COMPLETED|Fourth Intervention Period||1
6416906|NCT00975481|7330839|FG003|NOT COMPLETED|Fourth Intervention Period||1
6416907|NCT00975481|7330840|FG004|NOT COMPLETED|Fourth Intervention Period||0
6416908|NCT00975481|7330841|FG005|NOT COMPLETED|Fourth Intervention Period||0
6416909|NCT00975481|7330836|FG000|STARTED|Washout Period (at Least 7 Days)||4
6416910|NCT00975481|7330837|FG001|STARTED|Washout Period (at Least 7 Days)||5
6416911|NCT00975481|7330838|FG002|STARTED|Washout Period (at Least 7 Days)||4
6416912|NCT00975481|7330839|FG003|STARTED|Washout Period (at Least 7 Days)||5
6416913|NCT00975481|7330840|FG004|STARTED|Washout Period (at Least 7 Days)||6
6416914|NCT00975481|7330841|FG005|STARTED|Washout Period (at Least 7 Days)||6
6416915|NCT00975481|7330836|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
6638638|NCT02324049|7567098|FG000|STARTED|Part C||11
6638639|NCT02324049|7567098|FG000|Safety Analysis Set|Part C||11
6416916|NCT00975481|7330837|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
6416917|NCT00975481|7330838|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
6416918|NCT00975481|7330839|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
6416919|NCT00975481|7330840|FG004|COMPLETED|Washout Period (at Least 7 Days)||6
6416920|NCT00975481|7330841|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
6416921|NCT00975481|7330836|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416922|NCT00975481|7330837|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416923|NCT00975481|7330838|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416924|NCT00975481|7330839|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416925|NCT00975481|7330840|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416926|NCT00975481|7330841|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416927|NCT00975481|7330836|FG000|STARTED|Fifth Intervention Period||4
6416928|NCT00975481|7330837|FG001|STARTED|Fifth Intervention Period||5
6416929|NCT00975481|7330838|FG002|STARTED|Fifth Intervention Period||4
6416930|NCT00975481|7330839|FG003|STARTED|Fifth Intervention Period||5
6416931|NCT00975481|7330840|FG004|STARTED|Fifth Intervention Period||6
6416932|NCT00975481|7330841|FG005|STARTED|Fifth Intervention Period||6
6416933|NCT00975481|7330836|FG000|COMPLETED|Fifth Intervention Period||4
6416934|NCT00975481|7330837|FG001|COMPLETED|Fifth Intervention Period||5
6416935|NCT00975481|7330838|FG002|COMPLETED|Fifth Intervention Period||4
6416936|NCT00975481|7330839|FG003|COMPLETED|Fifth Intervention Period||5
6416937|NCT00975481|7330840|FG004|COMPLETED|Fifth Intervention Period||5
6416938|NCT00975481|7330841|FG005|COMPLETED|Fifth Intervention Period||6
6416939|NCT00975481|7330836|FG000|NOT COMPLETED|Fifth Intervention Period||0
6416940|NCT00975481|7330837|FG001|NOT COMPLETED|Fifth Intervention Period||0
6416941|NCT00975481|7330838|FG002|NOT COMPLETED|Fifth Intervention Period||0
6416942|NCT00975481|7330839|FG003|NOT COMPLETED|Fifth Intervention Period||0
6416943|NCT00975481|7330840|FG004|NOT COMPLETED|Fifth Intervention Period||1
6416944|NCT00975481|7330841|FG005|NOT COMPLETED|Fifth Intervention Period||0
6416945|NCT00975481|7330836|FG000|STARTED|Washout Period (at Least 7 Days)||4
6416946|NCT00975481|7330837|FG001|STARTED|Washout Period (at Least 7 Days)||5
6416947|NCT00975481|7330838|FG002|STARTED|Washout Period (at Least 7 Days)||4
6416948|NCT00975481|7330839|FG003|STARTED|Washout Period (at Least 7 Days)||5
6416949|NCT00975481|7330840|FG004|STARTED|Washout Period (at Least 7 Days)||5
6416950|NCT00975481|7330841|FG005|STARTED|Washout Period (at Least 7 Days)||6
6416951|NCT00975481|7330836|FG000|COMPLETED|Washout Period (at Least 7 Days)||4
6416952|NCT00975481|7330837|FG001|COMPLETED|Washout Period (at Least 7 Days)||5
6416953|NCT00975481|7330838|FG002|COMPLETED|Washout Period (at Least 7 Days)||4
6416954|NCT00975481|7330839|FG003|COMPLETED|Washout Period (at Least 7 Days)||5
6416955|NCT00975481|7330840|FG004|COMPLETED|Washout Period (at Least 7 Days)||5
6416956|NCT00975481|7330841|FG005|COMPLETED|Washout Period (at Least 7 Days)||6
6416957|NCT00975481|7330836|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416958|NCT00975481|7330837|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416959|NCT00975481|7330838|FG002|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416960|NCT00975481|7330839|FG003|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416961|NCT00975481|7330840|FG004|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416962|NCT00975481|7330841|FG005|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6416963|NCT00975481|7330836|FG000|STARTED|Sixth Intervention Period||4
6416964|NCT00975481|7330837|FG001|STARTED|Sixth Intervention Period||5
6416965|NCT00975481|7330838|FG002|STARTED|Sixth Intervention Period||4
6416966|NCT00975481|7330839|FG003|STARTED|Sixth Intervention Period||5
6416967|NCT00975481|7330840|FG004|STARTED|Sixth Intervention Period||5
6416968|NCT00975481|7330841|FG005|STARTED|Sixth Intervention Period||6
6416969|NCT00975481|7330836|FG000|COMPLETED|Sixth Intervention Period||4
6638640|NCT02324049|7567098|FG000|COMPLETED|Part C||0
6416970|NCT00975481|7330837|FG001|COMPLETED|Sixth Intervention Period||5
6416971|NCT00975481|7330838|FG002|COMPLETED|Sixth Intervention Period||4
6416972|NCT00975481|7330839|FG003|COMPLETED|Sixth Intervention Period||5
6416973|NCT00975481|7330840|FG004|COMPLETED|Sixth Intervention Period||5
6416974|NCT00975481|7330841|FG005|COMPLETED|Sixth Intervention Period||6
6416975|NCT00975481|7330836|FG000|NOT COMPLETED|Sixth Intervention Period||0
6416976|NCT00975481|7330837|FG001|NOT COMPLETED|Sixth Intervention Period||0
6416977|NCT00975481|7330838|FG002|NOT COMPLETED|Sixth Intervention Period||0
6416978|NCT00975481|7330839|FG003|NOT COMPLETED|Sixth Intervention Period||0
6416979|NCT00975481|7330840|FG004|NOT COMPLETED|Sixth Intervention Period||0
6416980|NCT00975481|7330841|FG005|NOT COMPLETED|Sixth Intervention Period||0
6416981|NCT00975507|7330861|FG000|STARTED|Overall Study||323
6416982|NCT00975507|7330862|FG001|STARTED|Overall Study||157
6416983|NCT00975507|7330861|FG000|Vaccinated at Visit 1|Overall Study||323
6416984|NCT00975507|7330862|FG001|Vaccinated at Visit 1|Overall Study||157
6416985|NCT00975507|7330861|FG000|Vaccinated at Visit 2|Overall Study||310
6416986|NCT00975507|7330862|FG001|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
6416987|NCT00975507|7330861|FG000|COMPLETED|Overall Study||303
6416988|NCT00975507|7330862|FG001|COMPLETED|Overall Study||153
6416989|NCT00975507|7330861|FG000|NOT COMPLETED|Overall Study||20
6416990|NCT00975507|7330862|FG001|NOT COMPLETED|Overall Study||4
6416991|NCT00975585|7330872|FG000|STARTED|Overall Study||184
6416992|NCT00975585|7330873|FG001|STARTED|Overall Study||195
6416993|NCT00975585|7330872|FG000|COMPLETED|Overall Study||177
6416994|NCT00975585|7330873|FG001|COMPLETED|Overall Study||183
6416995|NCT00975585|7330872|FG000|NOT COMPLETED|Overall Study||7
6416996|NCT00975585|7330873|FG001|NOT COMPLETED|Overall Study||12
6499157|NCT01415349|7417795|FG001|STARTED|Treatment Period 2||19
6499158|NCT01415349|7417794|FG000|COMPLETED|Treatment Period 2||21
6499159|NCT01415349|7417795|FG001|COMPLETED|Treatment Period 2||19
6499160|NCT01415349|7417794|FG000|NOT COMPLETED|Treatment Period 2||0
6499161|NCT01415349|7417795|FG001|NOT COMPLETED|Treatment Period 2||0
6499162|NCT01415401|7417801|FG000|STARTED|Overall Study||54
6499163|NCT01415401|7417801|FG000|COMPLETED|Overall Study||47
6499164|NCT01415401|7417801|FG000|NOT COMPLETED|Overall Study||7
6499165|NCT01415427|7417809|FG000|STARTED|Overall Study||29
6499166|NCT01415427|7417810|FG001|STARTED|Overall Study||29
6499167|NCT01415427|7417811|FG002|STARTED|Overall Study||59
6499168|NCT01415427|7417812|FG003|STARTED|Overall Study||56
6499169|NCT01415427|7417809|FG000|COMPLETED|Overall Study||0
6499170|NCT01415427|7417810|FG001|COMPLETED|Overall Study||0
6499171|NCT01415427|7417811|FG002|COMPLETED|Overall Study||1
6499172|NCT01415427|7417812|FG003|COMPLETED|Overall Study||0
6499173|NCT01415427|7417809|FG000|NOT COMPLETED|Overall Study||29
6499174|NCT01415427|7417810|FG001|NOT COMPLETED|Overall Study||29
6499175|NCT01415427|7417811|FG002|NOT COMPLETED|Overall Study||58
6499176|NCT01415427|7417812|FG003|NOT COMPLETED|Overall Study||56
6499177|NCT01415440|7417827|FG000|STARTED|Overall Study||41
6499178|NCT01415440|7417828|FG001|STARTED|Overall Study||29
6499179|NCT01415440|7417829|FG002|STARTED|Overall Study||29
6499180|NCT01415440|7417827|FG000|COMPLETED|Overall Study||37
6499181|NCT01415440|7417828|FG001|COMPLETED|Overall Study||28
6499182|NCT01415440|7417829|FG002|COMPLETED|Overall Study||27
6499183|NCT01415440|7417827|FG000|NOT COMPLETED|Overall Study||4
6499184|NCT01415440|7417828|FG001|NOT COMPLETED|Overall Study||1
6499185|NCT01415440|7417829|FG002|NOT COMPLETED|Overall Study||2
6499186|NCT01415453|7417836|FG000|STARTED|Overall Study||1
6499187|NCT01415453|7417836|FG000|Imaging Study|Overall Study||1
6499188|NCT01415453|7417836|FG000|COMPLETED|Overall Study||1
6499189|NCT01415453|7417836|FG000|NOT COMPLETED|Overall Study||0
6499190|NCT01415518|7417842|FG000|STARTED|Overall Study||292
6499191|NCT01415518|7417843|FG001|STARTED|Overall Study||292
6499192|NCT01415518|7417842|FG000|Patients Who Received Study Treatment|Overall Study||290
6499193|NCT01415518|7417843|FG001|Patients Who Received Study Treatment|Overall Study||292
6499194|NCT01415518|7417842|FG000|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
6499195|NCT01415518|7417843|FG001|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
6499196|NCT01415518|7417842|FG000|COMPLETED|Overall Study||276
6499197|NCT01415518|7417843|FG001|COMPLETED|Overall Study||261
6499198|NCT01415518|7417842|FG000|NOT COMPLETED|Overall Study||16
6499199|NCT01415518|7417843|FG001|NOT COMPLETED|Overall Study||31
6499200|NCT01415531|7417851|FG000|STARTED|Overall Study||214
6499201|NCT01415531|7417852|FG001|STARTED|Overall Study||427
6499202|NCT01415531|7417851|FG000|COMPLETED|Overall Study||189
6499203|NCT01415531|7417852|FG001|COMPLETED|Overall Study||390
6499204|NCT01415531|7417851|FG000|NOT COMPLETED|Overall Study||25
6499205|NCT01415531|7417852|FG001|NOT COMPLETED|Overall Study||37
6499206|NCT01415583|7417860|FG000|STARTED|Overall Study||157
6499207|NCT01415583|7417861|FG001|STARTED|Overall Study||157
6499208|NCT01415583|7417860|FG000|COMPLETED|Overall Study||157
6499209|NCT01415583|7417861|FG001|COMPLETED|Overall Study||157
6499210|NCT01415583|7417860|FG000|NOT COMPLETED|Overall Study||0
6499211|NCT01415583|7417861|FG001|NOT COMPLETED|Overall Study||0
6499212|NCT01415908|7417869|FG000|STARTED|Overall Study||11
6499213|NCT01415908|7417870|FG001|STARTED|Overall Study||4
6499214|NCT01415908|7417869|FG000|COMPLETED|Overall Study||10
6499215|NCT01415908|7417870|FG001|COMPLETED|Overall Study||4
6638641|NCT02324049|7567098|FG000|NOT COMPLETED|Part C||11
6638642|NCT02324075|7567104|FG000|STARTED|Overall Study||612
6638643|NCT02324075|7567105|FG001|STARTED|Overall Study||614
6638644|NCT02324075|7567104|FG000|COMPLETED|Overall Study||609
6638645|NCT02324075|7567105|FG001|COMPLETED|Overall Study||605
6638646|NCT02324075|7567104|FG000|NOT COMPLETED|Overall Study||3
6638647|NCT02324075|7567105|FG001|NOT COMPLETED|Overall Study||9
6638648|NCT02324153|7567114|FG000|STARTED|Overall Study||41
6638649|NCT02324153|7567115|FG001|STARTED|Overall Study||39
6416997|NCT00975637|7330886|FG000|STARTED|Overall Study||40
6416998|NCT00975637|7330887|FG001|STARTED|Overall Study||39
6416999|NCT00975637|7330888|FG002|STARTED|Overall Study||42
6417000|NCT00975637|7330889|FG003|STARTED|Overall Study||38
6417001|NCT00975637|7330890|FG004|STARTED|Overall Study||39
6417002|NCT00975637|7330886|FG000|COMPLETED|Overall Study||37
6417003|NCT00975637|7330887|FG001|COMPLETED|Overall Study||38
6417004|NCT00975637|7330888|FG002|COMPLETED|Overall Study||40
6417005|NCT00975637|7330889|FG003|COMPLETED|Overall Study||32
6417006|NCT00975637|7330890|FG004|COMPLETED|Overall Study||37
6417007|NCT00975637|7330886|FG000|NOT COMPLETED|Overall Study||3
6417008|NCT00975637|7330887|FG001|NOT COMPLETED|Overall Study||1
6417009|NCT00975637|7330888|FG002|NOT COMPLETED|Overall Study||2
6417010|NCT00975637|7330889|FG003|NOT COMPLETED|Overall Study||6
6417011|NCT00975637|7330890|FG004|NOT COMPLETED|Overall Study||2
6417012|NCT00975650|7330902|FG000|STARTED|Period 1||13
6417013|NCT00975650|7330903|FG001|STARTED|Period 1||16
6417014|NCT00975650|7330904|FG002|STARTED|Period 1||14
6417015|NCT00975650|7330905|FG003|STARTED|Period 1||14
6417016|NCT00975650|7330902|FG000|COMPLETED|Period 1||13
6417017|NCT00975650|7330903|FG001|COMPLETED|Period 1||16
6417018|NCT00975650|7330904|FG002|COMPLETED|Period 1||14
6417019|NCT00975650|7330905|FG003|COMPLETED|Period 1||14
6417020|NCT00975650|7330902|FG000|NOT COMPLETED|Period 1||0
6417021|NCT00975650|7330903|FG001|NOT COMPLETED|Period 1||0
6417022|NCT00975650|7330904|FG002|NOT COMPLETED|Period 1||0
6417023|NCT00975650|7330905|FG003|NOT COMPLETED|Period 1||0
6417024|NCT00975650|7330902|FG000|STARTED|Period 2||13
6417025|NCT00975650|7330903|FG001|STARTED|Period 2||16
6417026|NCT00975650|7330904|FG002|STARTED|Period 2||14
6417027|NCT00975650|7330905|FG003|STARTED|Period 2||14
6417028|NCT00975650|7330902|FG000|COMPLETED|Period 2||12
6417029|NCT00975650|7330903|FG001|COMPLETED|Period 2||14
6417030|NCT00975650|7330904|FG002|COMPLETED|Period 2||14
6417031|NCT00975650|7330905|FG003|COMPLETED|Period 2||14
6417032|NCT00975650|7330902|FG000|NOT COMPLETED|Period 2||1
6417033|NCT00975650|7330903|FG001|NOT COMPLETED|Period 2||2
6417034|NCT00975650|7330904|FG002|NOT COMPLETED|Period 2||0
6417035|NCT00975650|7330905|FG003|NOT COMPLETED|Period 2||0
6417036|NCT00975650|7330902|FG000|STARTED|Period 3||12
6417037|NCT00975650|7330903|FG001|STARTED|Period 3||14
6417038|NCT00975650|7330904|FG002|STARTED|Period 3||14
6417039|NCT00975650|7330905|FG003|STARTED|Period 3||14
6417040|NCT00975650|7330902|FG000|COMPLETED|Period 3||12
6417041|NCT00975650|7330903|FG001|COMPLETED|Period 3||14
6417042|NCT00975650|7330904|FG002|COMPLETED|Period 3||14
6417043|NCT00975650|7330905|FG003|COMPLETED|Period 3||14
6417044|NCT00975650|7330902|FG000|NOT COMPLETED|Period 3||0
6417045|NCT00975650|7330903|FG001|NOT COMPLETED|Period 3||0
6417046|NCT00975650|7330904|FG002|NOT COMPLETED|Period 3||0
6417047|NCT00975650|7330905|FG003|NOT COMPLETED|Period 3||0
6417048|NCT00975650|7330902|FG000|STARTED|Period 4||12
6417049|NCT00975650|7330903|FG001|STARTED|Period 4||14
6417050|NCT00975650|7330904|FG002|STARTED|Period 4||14
6417051|NCT00975650|7330905|FG003|STARTED|Period 4||14
6417052|NCT00975650|7330902|FG000|COMPLETED|Period 4||12
6417053|NCT00975650|7330903|FG001|COMPLETED|Period 4||14
6417054|NCT00975650|7330904|FG002|COMPLETED|Period 4||14
6417055|NCT00975650|7330905|FG003|COMPLETED|Period 4||14
6417056|NCT00975650|7330902|FG000|NOT COMPLETED|Period 4||0
6417057|NCT00975650|7330903|FG001|NOT COMPLETED|Period 4||0
6417058|NCT00975650|7330904|FG002|NOT COMPLETED|Period 4||0
6417059|NCT00975650|7330905|FG003|NOT COMPLETED|Period 4||0
6417060|NCT00975676|7330917|FG000|STARTED|Overall Study||32
6417061|NCT00975676|7330918|FG001|STARTED|Overall Study||91
6417062|NCT00975676|7330917|FG000|COMPLETED|Overall Study||26
6417063|NCT00975676|7330918|FG001|COMPLETED|Overall Study||83
6417064|NCT00975676|7330917|FG000|NOT COMPLETED|Overall Study||6
6417065|NCT00975676|7330918|FG001|NOT COMPLETED|Overall Study||8
6417066|NCT00975689|7330931|FG000|STARTED|Overall Study||17
6417067|NCT00975689|7330932|FG001|STARTED|Overall Study||18
6510772|NCT01484132|7430376|FG000|NOT COMPLETED|Overall Study||22
6638650|NCT02324153|7567114|FG000|COMPLETED|Overall Study||33
6638651|NCT02324153|7567115|FG001|COMPLETED|Overall Study||38
6638652|NCT02324153|7567114|FG000|NOT COMPLETED|Overall Study||8
6417068|NCT00975689|7330931|FG000|COMPLETED|Overall Study||15
6417069|NCT00975689|7330932|FG001|COMPLETED|Overall Study||15
6417070|NCT00975689|7330931|FG000|NOT COMPLETED|Overall Study||2
6417071|NCT00975689|7330932|FG001|NOT COMPLETED|Overall Study||3
6417072|NCT00975715|7330940|FG000|STARTED|Titration Period||48
6417073|NCT00975715|7330941|FG001|STARTED|Titration Period||51
6417074|NCT00975715|7330940|FG000|COMPLETED|Titration Period||41
6417075|NCT00975715|7330941|FG001|COMPLETED|Titration Period||51
6417076|NCT00975715|7330940|FG000|NOT COMPLETED|Titration Period||7
6417077|NCT00975715|7330941|FG001|NOT COMPLETED|Titration Period||0
6417078|NCT00975715|7330940|FG000|STARTED|Maintenance Period||41
6638653|NCT02324153|7567115|FG001|NOT COMPLETED|Overall Study||1
6417079|NCT00975715|7330941|FG001|STARTED|Maintenance Period||51
6417080|NCT00975715|7330940|FG000|COMPLETED|Maintenance Period||39
6417081|NCT00975715|7330941|FG001|COMPLETED|Maintenance Period||50
6417082|NCT00975715|7330940|FG000|NOT COMPLETED|Maintenance Period||2
6417083|NCT00975715|7330941|FG001|NOT COMPLETED|Maintenance Period||1
6417084|NCT00975780|7330949|FG000|STARTED|Allocation||400
6417085|NCT00975780|7330950|FG001|STARTED|Allocation||434
6417086|NCT00975780|7330949|FG000|COMPLETED|Allocation||400
6417087|NCT00975780|7330950|FG001|COMPLETED|Allocation||434
6417088|NCT00975780|7330949|FG000|NOT COMPLETED|Allocation||0
6417089|NCT00975780|7330950|FG001|NOT COMPLETED|Allocation||0
6417090|NCT00975780|7330949|FG000|STARTED|Follow Up||400
6417091|NCT00975780|7330950|FG001|STARTED|Follow Up||434
6417092|NCT00975780|7330949|FG000|COMPLETED|Follow Up||298
6417093|NCT00975780|7330950|FG001|COMPLETED|Follow Up||277
6417094|NCT00975780|7330949|FG000|NOT COMPLETED|Follow Up||102
6417095|NCT00975780|7330950|FG001|NOT COMPLETED|Follow Up||157
6417096|NCT00975806|7330959|FG000|STARTED|Overall Study||5
6417097|NCT00975806|7330960|FG001|STARTED|Overall Study||7
6417098|NCT00975806|7330961|FG002|STARTED|Overall Study||4
6417099|NCT00975806|7330959|FG000|COMPLETED|Overall Study|Participants were prematurely discontinued|0
6417100|NCT00975806|7330960|FG001|COMPLETED|Overall Study|Participants were prematurely discontinued|0
6417101|NCT00975806|7330961|FG002|COMPLETED|Overall Study|Participants were prematurely discontinued|0
6417102|NCT00975806|7330959|FG000|NOT COMPLETED|Overall Study||5
6417103|NCT00975806|7330960|FG001|NOT COMPLETED|Overall Study||7
6417104|NCT00975806|7330961|FG002|NOT COMPLETED|Overall Study||4
6417105|NCT00975884|7330973|FG000|STARTED|Overall Study||184
6417106|NCT00975884|7330974|FG001|STARTED|Overall Study||122
6417107|NCT00975884|7330973|FG000|COMPLETED|Overall Study||168
6417108|NCT00975884|7330974|FG001|COMPLETED|Overall Study||107
6417109|NCT00975884|7330973|FG000|NOT COMPLETED|Overall Study||16
6417110|NCT00975884|7330974|FG001|NOT COMPLETED|Overall Study||15
6417111|NCT00975923|7330992|FG000|STARTED|Overall Study||30
6417112|NCT00975923|7330993|FG001|STARTED|Overall Study||30
6417113|NCT00975923|7330992|FG000|COMPLETED|Overall Study||30
6417114|NCT00975923|7330993|FG001|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
6417115|NCT00975923|7330992|FG000|NOT COMPLETED|Overall Study||0
6417116|NCT00975923|7330993|FG001|NOT COMPLETED|Overall Study||1
6417117|NCT00975975|7331000|FG000|STARTED|Overall Study||17
6417118|NCT00975975|7331000|FG000|COMPLETED|Overall Study||11
6417119|NCT00975975|7331000|FG000|NOT COMPLETED|Overall Study||6
6417120|NCT00976027|7331006|FG000|STARTED|Overall Study||6108
6417121|NCT00976027|7331007|FG001|STARTED|Overall Study||3050
6417122|NCT00976027|7331006|FG000|COMPLETED|Overall Study||5697
6417123|NCT00976027|7331007|FG001|COMPLETED|Overall Study||2835
6417124|NCT00976027|7331006|FG000|NOT COMPLETED|Overall Study||411
6417125|NCT00976027|7331007|FG001|NOT COMPLETED|Overall Study||215
6417126|NCT00976183|7331013|FG000|STARTED|Overall Study||18
6417127|NCT00976183|7331013|FG000|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
6417128|NCT00976183|7331013|FG000|NOT COMPLETED|Overall Study||0
6417129|NCT00976209|7331019|FG000|STARTED|Treatment Period 1||165
6417130|NCT00976209|7331020|FG001|STARTED|Treatment Period 1||166
6417131|NCT00976209|7331019|FG000|COMPLETED|Treatment Period 1||162
6417132|NCT00976209|7331020|FG001|COMPLETED|Treatment Period 1||165
6417133|NCT00976209|7331019|FG000|NOT COMPLETED|Treatment Period 1||3
6417134|NCT00976209|7331020|FG001|NOT COMPLETED|Treatment Period 1||1
6417135|NCT00976209|7331019|FG000|STARTED|Wash-out Period||162
6417136|NCT00976209|7331020|FG001|STARTED|Wash-out Period||165
6417137|NCT00976209|7331019|FG000|COMPLETED|Wash-out Period||158
6417138|NCT00976209|7331020|FG001|COMPLETED|Wash-out Period||163
6417139|NCT00976209|7331019|FG000|NOT COMPLETED|Wash-out Period||4
6417140|NCT00976209|7331020|FG001|NOT COMPLETED|Wash-out Period||2
6417141|NCT00976209|7331019|FG000|STARTED|Treatment Period 2||158
6417142|NCT00976209|7331020|FG001|STARTED|Treatment Period 2||163
6417143|NCT00976209|7331019|FG000|COMPLETED|Treatment Period 2||158
6417144|NCT00976209|7331020|FG001|COMPLETED|Treatment Period 2||161
6417145|NCT00976209|7331019|FG000|NOT COMPLETED|Treatment Period 2||0
6417146|NCT00976209|7331020|FG001|NOT COMPLETED|Treatment Period 2||2
6417147|NCT00976248|7331025|FG000|STARTED|Overall Study||33
6417148|NCT00976248|7331025|FG000|COMPLETED|Overall Study||33
6417149|NCT00976248|7331025|FG000|NOT COMPLETED|Overall Study||0
6417150|NCT00976274|7331032|FG000|STARTED|Overall Study||31
6417151|NCT00976274|7331033|FG001|STARTED|Overall Study||29
6417152|NCT00976274|7331032|FG000|COMPLETED|Overall Study||24
6417153|NCT00976274|7331033|FG001|COMPLETED|Overall Study||21
6417154|NCT00976274|7331032|FG000|NOT COMPLETED|Overall Study||7
6417155|NCT00976274|7331033|FG001|NOT COMPLETED|Overall Study||8
6417156|NCT00976352|7331041|FG000|STARTED|Overall Study||3
6417157|NCT00976352|7331042|FG001|STARTED|Overall Study||10
6417158|NCT00976352|7331041|FG000|COMPLETED|Overall Study||3
6417159|NCT00976352|7331042|FG001|COMPLETED|Overall Study|Last evaluation of last subject in cohort.|6
6417160|NCT00976352|7331041|FG000|NOT COMPLETED|Overall Study||0
6417161|NCT00976352|7331042|FG001|NOT COMPLETED|Overall Study||4
6417162|NCT00976391|7331054|FG000|STARTED|Treatment Period (52 Weeks)||285
6417163|NCT00976391|7331055|FG001|STARTED|Treatment Period (52 Weeks)||281
6417164|NCT00976391|7331054|FG000|COMPLETED|Treatment Period (52 Weeks)||243
6417165|NCT00976391|7331055|FG001|COMPLETED|Treatment Period (52 Weeks)||242
6417166|NCT00976391|7331054|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||42
6417167|NCT00976391|7331055|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||39
6417168|NCT00976391|7331054|FG000|STARTED|Follow-up Period (8 Weeks)||285
6417169|NCT00976391|7331055|FG001|STARTED|Follow-up Period (8 Weeks)||281
6417170|NCT00976391|7331054|FG000|COMPLETED|Follow-up Period (8 Weeks)||256
6417171|NCT00976391|7331055|FG001|COMPLETED|Follow-up Period (8 Weeks)||247
6417172|NCT00976391|7331054|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||29
6417173|NCT00976391|7331055|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||34
6417174|NCT00976404|7331063|FG000|STARTED|Overall Study||14
6417175|NCT00976404|7331064|FG001|STARTED|Overall Study||14
6417176|NCT00976404|7331063|FG000|COMPLETED|Overall Study||14
6417177|NCT00976404|7331064|FG001|COMPLETED|Overall Study||14
6417178|NCT00976404|7331063|FG000|NOT COMPLETED|Overall Study||0
6417179|NCT00976404|7331064|FG001|NOT COMPLETED|Overall Study||0
6417180|NCT00976456|7331074|FG000|STARTED|Overall Study||135
6417181|NCT00976456|7331075|FG001|STARTED|Overall Study||136
6417182|NCT00976456|7331074|FG000|COMPLETED|Overall Study||92
6417183|NCT00976456|7331075|FG001|COMPLETED|Overall Study||98
6417184|NCT00976456|7331074|FG000|NOT COMPLETED|Overall Study||43
6417185|NCT00976456|7331075|FG001|NOT COMPLETED|Overall Study||38
6417186|NCT00976482|7331081|FG000|STARTED|Overall Study||1745
6417187|NCT00976482|7331081|FG000|Eligible for Last Follow up|Overall Study||1487
6417188|NCT00976482|7331081|FG000|COMPLETED|Overall Study||1486
6417189|NCT00976482|7331081|FG000|NOT COMPLETED|Overall Study||259
6417190|NCT00976495|7331088|FG000|STARTED|Overall Study||25
6417191|NCT00976495|7331089|FG001|STARTED|Overall Study||24
6417192|NCT00976495|7331090|FG002|STARTED|Overall Study||26
6417193|NCT00976495|7331088|FG000|COMPLETED|Overall Study||25
6417194|NCT00976495|7331089|FG001|COMPLETED|Overall Study||23
6417195|NCT00976495|7331090|FG002|COMPLETED|Overall Study||26
6417196|NCT00976495|7331088|FG000|NOT COMPLETED|Overall Study||0
6417197|NCT00976495|7331089|FG001|NOT COMPLETED|Overall Study||1
6417198|NCT00976495|7331090|FG002|NOT COMPLETED|Overall Study||0
6417199|NCT00976508|7331100|FG000|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
6417200|NCT00976508|7331101|FG001|STARTED|Overall Study||6
6417201|NCT00976508|7331100|FG000|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
6417202|NCT00976508|7331101|FG001|COMPLETED|Overall Study||0
6417203|NCT00976508|7331100|FG000|NOT COMPLETED|Overall Study||14
6417204|NCT00976508|7331101|FG001|NOT COMPLETED|Overall Study||6
6417205|NCT00976521|7331114|FG000|STARTED|Overall Study||118
6417206|NCT00976521|7331115|FG001|STARTED|Overall Study||111
6417207|NCT00976521|7331116|FG002|STARTED|Overall Study||111
6417208|NCT00976521|7331117|FG003|STARTED|Overall Study||112
6417209|NCT00976521|7331114|FG000|COMPLETED|Overall Study||109
6417210|NCT00976521|7331115|FG001|COMPLETED|Overall Study||99
6417211|NCT00976521|7331116|FG002|COMPLETED|Overall Study||102
6417212|NCT00976521|7331117|FG003|COMPLETED|Overall Study||93
6417213|NCT00976521|7331114|FG000|NOT COMPLETED|Overall Study||9
6417214|NCT00976521|7331115|FG001|NOT COMPLETED|Overall Study||12
6417215|NCT00976521|7331116|FG002|NOT COMPLETED|Overall Study||9
6417216|NCT00976521|7331117|FG003|NOT COMPLETED|Overall Study||19
6417217|NCT00976560|7331130|FG000|STARTED|Overall Study||64
6417218|NCT00976560|7331131|FG001|STARTED|Overall Study||64
6417219|NCT00976560|7331130|FG000|COMPLETED|Overall Study||50
6417220|NCT00976560|7331131|FG001|COMPLETED|Overall Study||51
6417221|NCT00976560|7331130|FG000|NOT COMPLETED|Overall Study||14
6417222|NCT00976560|7331131|FG001|NOT COMPLETED|Overall Study||13
6417223|NCT00976573|7331139|FG000|STARTED|Overall Study||75
6417224|NCT00976573|7331140|FG001|STARTED|Overall Study||74
6417225|NCT00976573|7331139|FG000|COMPLETED|Overall Study||71
6417226|NCT00976573|7331140|FG001|COMPLETED|Overall Study||71
6417227|NCT00976573|7331139|FG000|NOT COMPLETED|Overall Study||4
6417228|NCT00976573|7331140|FG001|NOT COMPLETED|Overall Study||3
6417229|NCT00976599|7331148|FG000|STARTED|Overall Study||15
6417230|NCT00976599|7331149|FG001|STARTED|Overall Study||14
6417231|NCT00976599|7331148|FG000|COMPLETED|Overall Study||15
6417232|NCT00976599|7331149|FG001|COMPLETED|Overall Study||14
6417233|NCT00976599|7331148|FG000|NOT COMPLETED|Overall Study||0
6417234|NCT00976599|7331149|FG001|NOT COMPLETED|Overall Study||0
6417235|NCT00976664|7331157|FG000|STARTED|Overall Study||25
6417236|NCT00976664|7331158|FG001|STARTED|Overall Study||25
6417237|NCT00976664|7331157|FG000|COMPLETED|Overall Study||22
6417238|NCT00976664|7331158|FG001|COMPLETED|Overall Study||24
6417239|NCT00976664|7331157|FG000|NOT COMPLETED|Overall Study||3
6417240|NCT00976664|7331158|FG001|NOT COMPLETED|Overall Study||1
6417241|NCT00976677|7331166|FG000|STARTED|Overall Study||5
6417242|NCT00976677|7331167|FG001|STARTED|Overall Study||5
6417243|NCT00976677|7331166|FG000|COMPLETED|Overall Study||0
6417244|NCT00976677|7331167|FG001|COMPLETED|Overall Study||0
6417245|NCT00976677|7331166|FG000|NOT COMPLETED|Overall Study||5
6417246|NCT00976677|7331167|FG001|NOT COMPLETED|Overall Study||5
6417247|NCT00976703|7331175|FG000|STARTED|Overall Study||99
6417248|NCT00976703|7331176|FG001|STARTED|Overall Study||98
6417249|NCT00976703|7331175|FG000|COMPLETED|Overall Study||96
6417250|NCT00976703|7331176|FG001|COMPLETED|Overall Study||95
6417251|NCT00976703|7331175|FG000|NOT COMPLETED|Overall Study||3
6417252|NCT00976703|7331176|FG001|NOT COMPLETED|Overall Study||3
6417253|NCT00976716|7331182|FG000|STARTED|Overall Study||80
6417254|NCT00976716|7331182|FG000|COMPLETED|Overall Study||79
6417255|NCT00976716|7331182|FG000|NOT COMPLETED|Overall Study||1
6417256|NCT00976820|7331191|FG000|STARTED|Overall Study||67
6417257|NCT00976820|7331192|FG001|STARTED|Overall Study||128
6417258|NCT00976820|7331193|FG002|STARTED|Overall Study||64
6417259|NCT00976820|7331194|FG003|STARTED|Overall Study||63
6417260|NCT00976820|7331191|FG000|COMPLETED|Overall Study||59
6417261|NCT00976820|7331192|FG001|COMPLETED|Overall Study||108
6417262|NCT00976820|7331193|FG002|COMPLETED|Overall Study||60
6417263|NCT00976820|7331194|FG003|COMPLETED|Overall Study||56
6417264|NCT00976820|7331191|FG000|NOT COMPLETED|Overall Study||8
6417265|NCT00976820|7331192|FG001|NOT COMPLETED|Overall Study||20
6417266|NCT00976820|7331193|FG002|NOT COMPLETED|Overall Study||4
6417267|NCT00976820|7331194|FG003|NOT COMPLETED|Overall Study||7
6417268|NCT00976898|7331245|FG000|STARTED|Overall Study||83
6417269|NCT00976898|7331245|FG000|COMPLETED|Overall Study||78
6417270|NCT00976898|7331245|FG000|NOT COMPLETED|Overall Study||5
6417271|NCT00976911|7331251|FG000|STARTED|Overall Study||182
6417272|NCT00976911|7331252|FG001|STARTED|Overall Study||179
6417273|NCT00976911|7331251|FG000|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
6417274|NCT00976911|7331252|FG001|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
6417275|NCT00976911|7331251|FG000|NOT COMPLETED|Overall Study||182
6417276|NCT00976911|7331252|FG001|NOT COMPLETED|Overall Study||179
6417277|NCT00976937|7331260|FG000|STARTED|Overall Study|Randomized|158
6417278|NCT00976937|7331261|FG001|STARTED|Overall Study||161
6417279|NCT00976937|7331260|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
6417280|NCT00976937|7331261|FG001|Treated/Safety Population|Overall Study||161
6417281|NCT00976937|7331260|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
6417282|NCT00976937|7331261|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||161
6417283|NCT00976937|7331260|FG000|COMPLETED|Overall Study||142
6417284|NCT00976937|7331261|FG001|COMPLETED|Overall Study||150
6417285|NCT00976937|7331260|FG000|NOT COMPLETED|Overall Study||16
6417286|NCT00976937|7331261|FG001|NOT COMPLETED|Overall Study||11
6417287|NCT00976950|7331267|FG000|STARTED|Overall Study||42
6417288|NCT00976950|7331267|FG000|COMPLETED|Overall Study||36
6417289|NCT00976950|7331267|FG000|NOT COMPLETED|Overall Study||6
6417290|NCT00976989|7331274|FG000|STARTED|Overall Study||73
6417291|NCT00976989|7331275|FG001|STARTED|Overall Study||75
6417292|NCT00976989|7331276|FG002|STARTED|Overall Study||77
6417293|NCT00976989|7331274|FG000|COMPLETED|Overall Study||60
6417294|NCT00976989|7331275|FG001|COMPLETED|Overall Study||63
6417295|NCT00976989|7331276|FG002|COMPLETED|Overall Study||60
6417296|NCT00976989|7331274|FG000|NOT COMPLETED|Overall Study||13
6417297|NCT00976989|7331275|FG001|NOT COMPLETED|Overall Study||12
6417298|NCT00976989|7331276|FG002|NOT COMPLETED|Overall Study||17
6417299|NCT00977080|7331288|FG000|STARTED|Overall Study||62
6417300|NCT00977080|7331289|FG001|STARTED|Overall Study||64
6417301|NCT00977080|7331290|FG002|STARTED|Overall Study||72
6417302|NCT00977080|7331291|FG003|STARTED|Overall Study||70
6417303|NCT00977080|7331288|FG000|COMPLETED|Overall Study||50
6417304|NCT00977080|7331289|FG001|COMPLETED|Overall Study||44
6417305|NCT00977080|7331290|FG002|COMPLETED|Overall Study||56
6417306|NCT00977080|7331291|FG003|COMPLETED|Overall Study||53
6417307|NCT00977080|7331288|FG000|NOT COMPLETED|Overall Study||12
6417308|NCT00977080|7331289|FG001|NOT COMPLETED|Overall Study||20
6417309|NCT00977080|7331290|FG002|NOT COMPLETED|Overall Study||16
6417310|NCT00977080|7331291|FG003|NOT COMPLETED|Overall Study||17
6417311|NCT00977106|7331303|FG000|STARTED|Overall Study||47
6417312|NCT00977106|7331304|FG001|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
6417313|NCT00977106|7331303|FG000|COMPLETED|Overall Study||37
6417314|NCT00977106|7331304|FG001|COMPLETED|Overall Study||45
6417315|NCT00977106|7331303|FG000|NOT COMPLETED|Overall Study||10
6417316|NCT00977106|7331304|FG001|NOT COMPLETED|Overall Study||11
6417317|NCT00977171|7331312|FG000|STARTED|Overall Study||3
6417318|NCT00977171|7331312|FG000|COMPLETED|Overall Study||3
6417319|NCT00977171|7331312|FG000|NOT COMPLETED|Overall Study||0
6417320|NCT00977184|7331318|FG000|STARTED|Overall Study||13
6417321|NCT00977184|7331319|FG001|STARTED|Overall Study||13
6417322|NCT00977184|7331318|FG000|COMPLETED|Overall Study||13
6417323|NCT00977184|7331319|FG001|COMPLETED|Overall Study||13
6417324|NCT00977184|7331318|FG000|NOT COMPLETED|Overall Study||0
6417325|NCT00977184|7331319|FG001|NOT COMPLETED|Overall Study||0
6417326|NCT00977197|7331334|FG000|STARTED|Overall Study||41
6417327|NCT00977197|7331335|FG001|STARTED|Overall Study||44
6417328|NCT00977197|7331334|FG000|COMPLETED|Overall Study||32
6417329|NCT00977197|7331335|FG001|COMPLETED|Overall Study||35
6417330|NCT00977197|7331334|FG000|NOT COMPLETED|Overall Study||9
6417331|NCT00977197|7331335|FG001|NOT COMPLETED|Overall Study||9
6417332|NCT00977314|7331343|FG000|STARTED|Overall Study||30
6417333|NCT00977314|7331344|FG001|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
6417334|NCT00977314|7331343|FG000|COMPLETED|Overall Study||28
6417335|NCT00977314|7331344|FG001|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
6417336|NCT00977314|7331343|FG000|NOT COMPLETED|Overall Study||2
6417337|NCT00977314|7331344|FG001|NOT COMPLETED|Overall Study||0
6417338|NCT00977379|7331352|FG000|STARTED|Overall Study|Randomized|12
6417339|NCT00977379|7331353|FG001|STARTED|Overall Study|Randomized|12
6417340|NCT00977379|7331352|FG000|Treated|Overall Study||12
6417341|NCT00977379|7331353|FG001|Treated|Overall Study||11
6417342|NCT00977379|7331352|FG000|COMPLETED|Overall Study||0
6417343|NCT00977379|7331353|FG001|COMPLETED|Overall Study||0
6417344|NCT00977379|7331352|FG000|NOT COMPLETED|Overall Study||12
6417345|NCT00977379|7331353|FG001|NOT COMPLETED|Overall Study||12
6417346|NCT00977431|7331364|FG000|STARTED|Overall Study||7
6417347|NCT00977431|7331365|FG001|STARTED|Overall Study||6
6417348|NCT00977431|7331366|FG002|STARTED|Overall Study||7
6417349|NCT00977431|7331367|FG003|STARTED|Overall Study||3
6417350|NCT00977431|7331368|FG004|STARTED|Overall Study||13
6417351|NCT00977431|7331364|FG000|Discontinued Afatinib Before/on Day 42|Overall Study||1
6417352|NCT00977431|7331365|FG001|Discontinued Afatinib Before/on Day 42|Overall Study||0
6417353|NCT00977431|7331366|FG002|Discontinued Afatinib Before/on Day 42|Overall Study||4
6417354|NCT00977431|7331367|FG003|Discontinued Afatinib Before/on Day 42|Overall Study||0
6417355|NCT00977431|7331368|FG004|Discontinued Afatinib Before/on Day 42|Overall Study||3
6417356|NCT00977431|7331364|FG000|COMPLETED|Overall Study||0
6417357|NCT00977431|7331365|FG001|COMPLETED|Overall Study||0
6417358|NCT00977431|7331366|FG002|COMPLETED|Overall Study||0
6417359|NCT00977431|7331367|FG003|COMPLETED|Overall Study||0
6417360|NCT00977431|7331368|FG004|COMPLETED|Overall Study||0
6417361|NCT00977431|7331364|FG000|NOT COMPLETED|Overall Study||7
6417362|NCT00977431|7331365|FG001|NOT COMPLETED|Overall Study||6
6417363|NCT00977431|7331366|FG002|NOT COMPLETED|Overall Study||7
6417364|NCT00977431|7331367|FG003|NOT COMPLETED|Overall Study||3
6417365|NCT00977431|7331368|FG004|NOT COMPLETED|Overall Study||13
6417366|NCT00977470|7331386|FG000|STARTED|Overall Study||38
6417367|NCT00977470|7331387|FG001|STARTED|Overall Study||38
6638654|NCT02324205|7567121|FG000|STARTED|Overall Study||196
6638655|NCT02324205|7567121|FG000|COMPLETED|Overall Study||159
6638656|NCT02324205|7567121|FG000|NOT COMPLETED|Overall Study||37
6638657|NCT02324270|7567128|FG000|STARTED|Overall Study||218
6638658|NCT02324270|7567129|FG001|STARTED|Overall Study||219
6638659|NCT02324270|7567130|FG002|STARTED|Overall Study||221
6417368|NCT00977470|7331386|FG000|COMPLETED|Overall Study||0
6417369|NCT00977470|7331387|FG001|COMPLETED|Overall Study||0
6417370|NCT00977470|7331386|FG000|NOT COMPLETED|Overall Study||38
6417371|NCT00977470|7331387|FG001|NOT COMPLETED|Overall Study||38
6417372|NCT00977548|7331393|FG000|STARTED|Overall Study||39
6417373|NCT00977548|7331393|FG000|COMPLETED|Overall Study||26
6417374|NCT00977548|7331393|FG000|NOT COMPLETED|Overall Study||13
6417375|NCT00977561|7331399|FG000|STARTED|Overall Study||5
6417376|NCT00977561|7331400|FG001|STARTED|Overall Study||4
6417377|NCT00977561|7331399|FG000|COMPLETED|Overall Study||0
6417378|NCT00977561|7331400|FG001|COMPLETED|Overall Study||0
6417379|NCT00977561|7331399|FG000|NOT COMPLETED|Overall Study||5
6417380|NCT00977561|7331400|FG001|NOT COMPLETED|Overall Study||4
6417381|NCT00977613|7331408|FG000|STARTED|Overall Study||50
6638660|NCT02324270|7567128|FG000|Safety Population|Overall Study||214
6638661|NCT02324270|7567129|FG001|Safety Population|Overall Study||216
6638662|NCT02324270|7567130|FG002|Safety Population|Overall Study||217
6417382|NCT00977613|7331408|FG000|COMPLETED|Overall Study||34
6417383|NCT00977613|7331408|FG000|NOT COMPLETED|Overall Study||16
6417384|NCT00977665|7331414|FG000|STARTED|Overall Study||84
6417385|NCT00977665|7331415|FG001|STARTED|Overall Study||90
6417386|NCT00977665|7331414|FG000|COMPLETED|Overall Study||63
6417387|NCT00977665|7331415|FG001|COMPLETED|Overall Study||75
6417388|NCT00977665|7331414|FG000|NOT COMPLETED|Overall Study||21
6417389|NCT00977665|7331415|FG001|NOT COMPLETED|Overall Study||15
6417390|NCT00977691|7331424|FG000|STARTED|Overall Study||3
6417391|NCT00977691|7331425|FG001|STARTED|Overall Study||8
6417392|NCT00977691|7331426|FG002|STARTED|Overall Study||12
6417393|NCT00977691|7331424|FG000|COMPLETED|Overall Study||3
6417394|NCT00977691|7331425|FG001|COMPLETED|Overall Study||7
6417395|NCT00977691|7331426|FG002|COMPLETED|Overall Study||12
6417396|NCT00977691|7331424|FG000|NOT COMPLETED|Overall Study||0
6417397|NCT00977691|7331425|FG001|NOT COMPLETED|Overall Study||1
6417398|NCT00977691|7331426|FG002|NOT COMPLETED|Overall Study||0
6417399|NCT00977704|7331436|FG000|STARTED|Overall Study||20
6417400|NCT00977704|7331436|FG000|COMPLETED|Overall Study||20
6417401|NCT00977704|7331436|FG000|NOT COMPLETED|Overall Study||0
6417402|NCT00977769|7331443|FG000|STARTED|Overall Study||25
6417403|NCT00977769|7331444|FG001|STARTED|Overall Study||26
6417404|NCT00977769|7331445|FG002|STARTED|Overall Study||25
6417405|NCT00977769|7331443|FG000|COMPLETED|Overall Study||25
6417406|NCT00977769|7331444|FG001|COMPLETED|Overall Study||26
6417407|NCT00977769|7331445|FG002|COMPLETED|Overall Study||25
6417408|NCT00977769|7331443|FG000|NOT COMPLETED|Overall Study||0
6417409|NCT00977769|7331444|FG001|NOT COMPLETED|Overall Study||0
6417410|NCT00977769|7331445|FG002|NOT COMPLETED|Overall Study||0
6417411|NCT00977808|7331453|FG000|STARTED|Overall Study||12
6417412|NCT00977808|7331453|FG000|Completion of Open-Loop Admission|Overall Study||12
6638663|NCT02324270|7567128|FG000|mITT Population|Overall Study||214
6638664|NCT02324270|7567129|FG001|mITT Population|Overall Study||216
6638665|NCT02324270|7567130|FG002|mITT Population|Overall Study||217
6638666|NCT02324270|7567128|FG000|PP Population|Overall Study||180
6638667|NCT02324270|7567129|FG001|PP Population|Overall Study||177
6417413|NCT00977808|7331453|FG000|Completion of Closed-Loop Admission|Overall Study||11
6417414|NCT00977808|7331453|FG000|COMPLETED|Overall Study||11
6417415|NCT00977808|7331453|FG000|NOT COMPLETED|Overall Study||1
6417416|NCT00977938|7331462|FG000|STARTED|Treatment (12-30 mo. Post Procedure)||5020
6417417|NCT00977938|7331463|FG001|STARTED|Treatment (12-30 mo. Post Procedure)||4941
6417418|NCT00977938|7331464|FG002|STARTED|Treatment (12-30 mo. Post Procedure)||842
6499216|NCT01415908|7417869|FG000|NOT COMPLETED|Overall Study||1
6638668|NCT02324270|7567130|FG002|PP Population|Overall Study||171
6638669|NCT02324270|7567128|FG000|COMPLETED|Overall Study||213
6638670|NCT02324270|7567129|FG001|COMPLETED|Overall Study||212
6638671|NCT02324270|7567130|FG002|COMPLETED|Overall Study||216
6638672|NCT02324270|7567128|FG000|NOT COMPLETED|Overall Study||5
6638673|NCT02324270|7567129|FG001|NOT COMPLETED|Overall Study||7
6638674|NCT02324270|7567130|FG002|NOT COMPLETED|Overall Study||5
6638675|NCT02324335|7567140|FG000|STARTED|Overall Study||30
6638676|NCT02324335|7567141|FG001|STARTED|Overall Study||29
6638677|NCT02324335|7567140|FG000|COMPLETED|Overall Study||21
6638678|NCT02324335|7567141|FG001|COMPLETED|Overall Study||20
6638679|NCT02324335|7567140|FG000|NOT COMPLETED|Overall Study||9
6638680|NCT02324335|7567141|FG001|NOT COMPLETED|Overall Study||9
6638681|NCT02324361|7567149|FG000|STARTED|Overall Study||24
6638682|NCT02324361|7567150|FG001|STARTED|Overall Study||24
6638683|NCT02324361|7567149|FG000|COMPLETED|Overall Study||19
6638684|NCT02324361|7567150|FG001|COMPLETED|Overall Study||22
6638685|NCT02324361|7567149|FG000|NOT COMPLETED|Overall Study||5
6638686|NCT02324361|7567150|FG001|NOT COMPLETED|Overall Study||2
6638687|NCT02324465|7567158|FG000|STARTED|Overall Study||18
6638688|NCT02324465|7567159|FG001|STARTED|Overall Study||22
6638689|NCT02324465|7567158|FG000|COMPLETED|Overall Study||18
6638690|NCT02324465|7567159|FG001|COMPLETED|Overall Study||21
6638691|NCT02324465|7567158|FG000|NOT COMPLETED|Overall Study||0
6638692|NCT02324465|7567159|FG001|NOT COMPLETED|Overall Study||1
6638693|NCT02324504|7567165|FG000|STARTED|Overall Study||60
6638694|NCT02324504|7567165|FG000|COMPLETED|Overall Study||60
6638695|NCT02324504|7567165|FG000|NOT COMPLETED|Overall Study||0
6638696|NCT02324543|7567178|FG000|STARTED|Overall Study||6
6638697|NCT02324543|7567179|FG001|STARTED|Overall Study||6
6638698|NCT02324543|7567180|FG002|STARTED|Overall Study||3
6638699|NCT02324543|7567181|FG003|STARTED|Overall Study||4
6638700|NCT02324543|7567182|FG004|STARTED|Overall Study||4
6638701|NCT02324543|7567183|FG005|STARTED|Overall Study||24
6638702|NCT02324543|7567178|FG000|COMPLETED|Overall Study||6
6638703|NCT02324543|7567179|FG001|COMPLETED|Overall Study||6
6638704|NCT02324543|7567180|FG002|COMPLETED|Overall Study||3
6638705|NCT02324543|7567181|FG003|COMPLETED|Overall Study||4
6638706|NCT02324543|7567182|FG004|COMPLETED|Overall Study||4
6638707|NCT02324543|7567183|FG005|COMPLETED|Overall Study||24
6638708|NCT02324543|7567178|FG000|NOT COMPLETED|Overall Study||0
6638709|NCT02324543|7567179|FG001|NOT COMPLETED|Overall Study||0
6638710|NCT02324543|7567180|FG002|NOT COMPLETED|Overall Study||0
6638711|NCT02324543|7567181|FG003|NOT COMPLETED|Overall Study||0
6638712|NCT02324543|7567182|FG004|NOT COMPLETED|Overall Study||0
6638713|NCT02324543|7567183|FG005|NOT COMPLETED|Overall Study||0
6638714|NCT02324569|7567195|FG000|STARTED|Overall Study||116
6417419|NCT00977938|7331465|FG003|STARTED|Treatment (12-30 mo. Post Procedure)||845
6417420|NCT00977938|7331462|FG000|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
6417421|NCT00977938|7331463|FG001|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
6417422|NCT00977938|7331464|FG002|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
6417423|NCT00977938|7331465|FG003|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
6417424|NCT00977938|7331462|FG000|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
6417425|NCT00977938|7331463|FG001|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
6417426|NCT00977938|7331464|FG002|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
6417427|NCT00977938|7331465|FG003|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
6417428|NCT00977938|7331462|FG000|STARTED|Observation (30-33 mo. Post Procedure)||4783
6417429|NCT00977938|7331463|FG001|STARTED|Observation (30-33 mo. Post Procedure)||4716
6417430|NCT00977938|7331464|FG002|STARTED|Observation (30-33 mo. Post Procedure)||796
6417431|NCT00977938|7331465|FG003|STARTED|Observation (30-33 mo. Post Procedure)||784
6417432|NCT00977938|7331462|FG000|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
6417433|NCT00977938|7331463|FG001|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
6417434|NCT00977938|7331464|FG002|COMPLETED|Observation (30-33 mo. Post Procedure)||784
6417435|NCT00977938|7331465|FG003|COMPLETED|Observation (30-33 mo. Post Procedure)||781
6417436|NCT00977938|7331462|FG000|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
6417437|NCT00977938|7331463|FG001|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
6417438|NCT00977938|7331464|FG002|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
6417439|NCT00977938|7331465|FG003|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
6417440|NCT00978029|7331480|FG000|STARTED|Overall Study||65
6417441|NCT00978029|7331481|FG001|STARTED|Overall Study||66
6417442|NCT00978029|7331482|FG002|STARTED|Overall Study||65
6417443|NCT00978029|7331480|FG000|COMPLETED|Overall Study||64
6417444|NCT00978029|7331481|FG001|COMPLETED|Overall Study||63
6417445|NCT00978029|7331482|FG002|COMPLETED|Overall Study||59
6417446|NCT00978029|7331480|FG000|NOT COMPLETED|Overall Study||1
6417447|NCT00978029|7331481|FG001|NOT COMPLETED|Overall Study||3
6417448|NCT00978029|7331482|FG002|NOT COMPLETED|Overall Study||6
6417449|NCT00978042|7331492|FG000|STARTED|Initial Treatment Period||235
6638715|NCT02324569|7567196|FG001|STARTED|Overall Study||124
6638716|NCT02324569|7567195|FG000|COMPLETED|Overall Study||100
6638717|NCT02324569|7567196|FG001|COMPLETED|Overall Study||103
6638718|NCT02324569|7567195|FG000|NOT COMPLETED|Overall Study||16
6638719|NCT02324569|7567196|FG001|NOT COMPLETED|Overall Study||21
6638720|NCT02324660|7567202|FG000|STARTED|Overall Study||169
6638721|NCT02324660|7567202|FG000|COMPLETED|Overall Study||137
6638722|NCT02324660|7567202|FG000|NOT COMPLETED|Overall Study||32
6638723|NCT02324673|7567210|FG000|STARTED|Overall Study||20
6417450|NCT00978042|7331493|FG001|STARTED|Initial Treatment Period||47
6417451|NCT00978042|7331492|FG000|MITT_treated With VOLUMA XC|Initial Treatment Period||235
6417452|NCT00978042|7331493|FG001|MITT_treated With VOLUMA XC|Initial Treatment Period||35
6417453|NCT00978042|7331492|FG000|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
6417454|NCT00978042|7331493|FG001|COMPLETED|Initial Treatment Period||32
6417455|NCT00978042|7331492|FG000|NOT COMPLETED|Initial Treatment Period||61
6417456|NCT00978042|7331493|FG001|NOT COMPLETED|Initial Treatment Period||15
6417457|NCT00978042|7331492|FG000|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
6417458|NCT00978042|7331493|FG001|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
6417459|NCT00978042|7331492|FG000|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
6417460|NCT00978042|7331493|FG001|COMPLETED|Received Repeat Treatment||23
6417461|NCT00978042|7331492|FG000|NOT COMPLETED|Received Repeat Treatment||43
6417462|NCT00978042|7331493|FG001|NOT COMPLETED|Received Repeat Treatment||3
6417463|NCT00978068|7331501|FG000|STARTED|Overall Study||87
6417464|NCT00978068|7331502|FG001|STARTED|Overall Study||89
6417465|NCT00978068|7331501|FG000|Initiated Study Drugs|Overall Study||84
6417466|NCT00978068|7331502|FG001|Initiated Study Drugs|Overall Study||86
6417467|NCT00978068|7331501|FG000|COMPLETED|Overall Study||83
6417468|NCT00978068|7331502|FG001|COMPLETED|Overall Study||80
6417469|NCT00978068|7331501|FG000|NOT COMPLETED|Overall Study||4
6417470|NCT00978068|7331502|FG001|NOT COMPLETED|Overall Study||9
6417471|NCT00978120|7331516|FG000|STARTED|Overall Study||110
6417472|NCT00978120|7331517|FG001|STARTED|Overall Study||107
6417473|NCT00978120|7331518|FG002|STARTED|Overall Study||87
6417474|NCT00978120|7331519|FG003|STARTED|Overall Study||86
6417475|NCT00978120|7331516|FG000|COMPLETED|Overall Study||108
6417476|NCT00978120|7331517|FG001|COMPLETED|Overall Study||107
6417477|NCT00978120|7331518|FG002|COMPLETED|Overall Study||84
6417478|NCT00978120|7331519|FG003|COMPLETED|Overall Study||84
6417479|NCT00978120|7331516|FG000|NOT COMPLETED|Overall Study||2
6417480|NCT00978120|7331517|FG001|NOT COMPLETED|Overall Study||0
6417481|NCT00978120|7331518|FG002|NOT COMPLETED|Overall Study||3
6417482|NCT00978120|7331519|FG003|NOT COMPLETED|Overall Study||2
6417483|NCT00978250|7331537|FG000|STARTED|Overall Study||25
6417484|NCT00978250|7331538|FG001|STARTED|Overall Study||30
6417485|NCT00978250|7331539|FG002|STARTED|Overall Study||18
6417486|NCT00978250|7331540|FG003|STARTED|Overall Study||22
6417487|NCT00978250|7331537|FG000|COMPLETED|Overall Study||25
6417488|NCT00978250|7331538|FG001|COMPLETED|Overall Study||29
6417489|NCT00978250|7331539|FG002|COMPLETED|Overall Study||18
6417490|NCT00978250|7331540|FG003|COMPLETED|Overall Study||21
6417491|NCT00978250|7331537|FG000|NOT COMPLETED|Overall Study||0
6417492|NCT00978250|7331538|FG001|NOT COMPLETED|Overall Study||1
6417493|NCT00978250|7331539|FG002|NOT COMPLETED|Overall Study||0
6417494|NCT00978250|7331540|FG003|NOT COMPLETED|Overall Study||1
6417495|NCT00978341|7331552|FG000|STARTED|First Intervention||8
6417496|NCT00978341|7331553|FG001|STARTED|First Intervention||7
6417497|NCT00978341|7331552|FG000|COMPLETED|First Intervention||8
6417498|NCT00978341|7331553|FG001|COMPLETED|First Intervention||7
6417499|NCT00978341|7331552|FG000|NOT COMPLETED|First Intervention||0
6417500|NCT00978341|7331553|FG001|NOT COMPLETED|First Intervention||0
6417501|NCT00978341|7331552|FG000|STARTED|Washout Period of 2 Weeks||8
6417502|NCT00978341|7331553|FG001|STARTED|Washout Period of 2 Weeks||7
6417503|NCT00978341|7331552|FG000|COMPLETED|Washout Period of 2 Weeks||7
6417504|NCT00978341|7331553|FG001|COMPLETED|Washout Period of 2 Weeks||7
6417505|NCT00978341|7331552|FG000|NOT COMPLETED|Washout Period of 2 Weeks||1
6417506|NCT00978341|7331553|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6417507|NCT00978341|7331552|FG000|STARTED|Second Intervention||7
6417508|NCT00978341|7331553|FG001|STARTED|Second Intervention||7
6417509|NCT00978341|7331552|FG000|COMPLETED|Second Intervention||7
6417510|NCT00978341|7331553|FG001|COMPLETED|Second Intervention||7
6417511|NCT00978341|7331552|FG000|NOT COMPLETED|Second Intervention||0
6417512|NCT00978341|7331553|FG001|NOT COMPLETED|Second Intervention||0
6417513|NCT00978380|7331560|FG000|STARTED|Overall Study||63
6417514|NCT00978380|7331560|FG000|COMPLETED|Overall Study||44
6417515|NCT00978380|7331560|FG000|NOT COMPLETED|Overall Study||19
6417516|NCT00978432|7331568|FG000|STARTED|Overall Study||10
6417517|NCT00978432|7331569|FG001|STARTED|Overall Study||5
6417518|NCT00978432|7331570|FG002|STARTED|Overall Study||18
6417519|NCT00978432|7331568|FG000|COMPLETED|Overall Study||7
6417520|NCT00978432|7331569|FG001|COMPLETED|Overall Study||4
6417521|NCT00978432|7331570|FG002|COMPLETED|Overall Study||13
6417522|NCT00978432|7331568|FG000|NOT COMPLETED|Overall Study||3
6417523|NCT00978432|7331569|FG001|NOT COMPLETED|Overall Study||1
6417524|NCT00978432|7331570|FG002|NOT COMPLETED|Overall Study||5
6417525|NCT00978445|7331578|FG000|STARTED|Overall Study||12
6417526|NCT00978445|7331579|FG001|STARTED|Overall Study||13
6417527|NCT00978445|7331578|FG000|COMPLETED|Overall Study||10
6417528|NCT00978445|7331579|FG001|COMPLETED|Overall Study||12
6417529|NCT00978445|7331578|FG000|NOT COMPLETED|Overall Study||2
6417530|NCT00978445|7331579|FG001|NOT COMPLETED|Overall Study||1
6304160|NCT00364611|7207475|FG001|NOT COMPLETED|Overall Study||21
6304161|NCT00364793|7207485|FG000|STARTED|Overall Study||15
6304162|NCT00364793|7207486|FG001|STARTED|Overall Study||10
6304163|NCT00364793|7207487|FG002|STARTED|Overall Study||4
6304164|NCT00364793|7207488|FG003|STARTED|Overall Study||8
6304165|NCT00364793|7207485|FG000|COMPLETED|Overall Study||7
6304166|NCT00364793|7207486|FG001|COMPLETED|Overall Study||5
6417531|NCT00978562|7331586|FG000|STARTED|Overall Study||7
6417532|NCT00978562|7331586|FG000|COMPLETED|Overall Study||7
6417533|NCT00978562|7331586|FG000|NOT COMPLETED|Overall Study||0
6417534|NCT00978627|7331593|FG000|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
6417535|NCT00978627|7331594|FG001|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
6417536|NCT00978627|7331593|FG000|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
6417537|NCT00978627|7331594|FG001|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
6417538|NCT00978627|7331593|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
6417539|NCT00978627|7331594|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
6417540|NCT00978627|7331593|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
6417541|NCT00978627|7331594|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
6417542|NCT00978627|7331593|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
6417543|NCT00978627|7331594|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
6417544|NCT00978627|7331593|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
6417545|NCT00978627|7331594|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
6417546|NCT00978627|7331593|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
6417547|NCT00978627|7331594|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
6417548|NCT00978731|7331604|FG000|STARTED|Overall Study||22
6417549|NCT00978731|7331605|FG001|STARTED|Overall Study||15
6417550|NCT00978731|7331606|FG002|STARTED|Overall Study||5
6417551|NCT00978731|7331607|FG003|STARTED|Overall Study||4
6417552|NCT00978731|7331604|FG000|COMPLETED|Overall Study||0
6417553|NCT00978731|7331605|FG001|COMPLETED|Overall Study||0
6417554|NCT00978731|7331606|FG002|COMPLETED|Overall Study||0
6417555|NCT00978731|7331607|FG003|COMPLETED|Overall Study||0
6417556|NCT00978731|7331604|FG000|NOT COMPLETED|Overall Study||22
6417557|NCT00978731|7331605|FG001|NOT COMPLETED|Overall Study||15
6417558|NCT00978731|7331606|FG002|NOT COMPLETED|Overall Study||5
6417559|NCT00978731|7331607|FG003|NOT COMPLETED|Overall Study||4
6417560|NCT00978757|7331623|FG000|STARTED|Overall Study|June 2001|22
6417561|NCT00978757|7331624|FG001|STARTED|Overall Study|June 2001|20
6417562|NCT00978757|7331623|FG000|COMPLETED|Overall Study|June 2008|21
6417563|NCT00978757|7331624|FG001|COMPLETED|Overall Study|June 2008|17
6417564|NCT00978757|7331623|FG000|NOT COMPLETED|Overall Study||1
6417565|NCT00978757|7331624|FG001|NOT COMPLETED|Overall Study||3
6417566|NCT00979017|7331630|FG000|STARTED|Overall Study||41
6417567|NCT00979017|7331630|FG000|COMPLETED|Overall Study||41
6417568|NCT00979017|7331630|FG000|NOT COMPLETED|Overall Study||0
6417569|NCT00979069|7331636|FG000|STARTED|Overall Study||10
6417570|NCT00979069|7331637|FG001|STARTED|Overall Study||10
6417571|NCT00979069|7331636|FG000|COMPLETED|Overall Study||10
6417572|NCT00979069|7331637|FG001|COMPLETED|Overall Study||8
6417573|NCT00979069|7331636|FG000|NOT COMPLETED|Overall Study||0
6417574|NCT00979069|7331637|FG001|NOT COMPLETED|Overall Study||2
6417575|NCT00979121|7331645|FG000|STARTED|Overall Study||379
6417576|NCT00979121|7331646|FG001|STARTED|Overall Study||366
6417577|NCT00979121|7331645|FG000|COMPLETED|Overall Study||379
6417578|NCT00979121|7331646|FG001|COMPLETED|Overall Study||366
6417579|NCT00979121|7331645|FG000|NOT COMPLETED|Overall Study||0
6417580|NCT00979121|7331646|FG001|NOT COMPLETED|Overall Study||0
6417581|NCT00979134|7331661|FG000|STARTED|Overall Study||43
6417582|NCT00979134|7331662|FG001|STARTED|Overall Study||6
6417583|NCT00979134|7331663|FG002|STARTED|Overall Study||45
6417584|NCT00979134|7331661|FG000|COMPLETED|Overall Study|At DCO|10
6417585|NCT00979134|7331662|FG001|COMPLETED|Overall Study|At DCO|0
6417586|NCT00979134|7331663|FG002|COMPLETED|Overall Study|At DCO|5
6417587|NCT00979134|7331661|FG000|NOT COMPLETED|Overall Study||33
6417588|NCT00979134|7331662|FG001|NOT COMPLETED|Overall Study||6
6417589|NCT00979134|7331663|FG002|NOT COMPLETED|Overall Study||40
6417590|NCT00979199|7331676|FG000|STARTED|Overall Study||697
6417591|NCT00979199|7331676|FG000|COMPLETED|Overall Study||475
6417592|NCT00979199|7331676|FG000|NOT COMPLETED|Overall Study||222
6417593|NCT00979212|7331682|FG000|STARTED|Overall Study||24
6417594|NCT00979212|7331683|FG001|STARTED|Overall Study||47
6417595|NCT00979212|7331682|FG000|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
6417596|NCT00979212|7331683|FG001|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
6417597|NCT00979212|7331682|FG000|NOT COMPLETED|Overall Study||2
6417598|NCT00979212|7331683|FG001|NOT COMPLETED|Overall Study||8
6417599|NCT00979303|7331691|FG000|STARTED|Overall Study||37
6417600|NCT00979303|7331692|FG001|STARTED|Overall Study||37
6417601|NCT00979303|7331691|FG000|COMPLETED|Overall Study||37
6417602|NCT00979303|7331692|FG001|COMPLETED|Overall Study||37
6417603|NCT00979303|7331691|FG000|NOT COMPLETED|Overall Study||0
6417604|NCT00979303|7331692|FG001|NOT COMPLETED|Overall Study||0
6417605|NCT00979407|7331700|FG000|STARTED|Overall Study||167
6417606|NCT00979407|7331701|FG001|STARTED|Overall Study||167
6417607|NCT00979407|7331700|FG000|COMPLETED|Overall Study||161
6417608|NCT00979407|7331701|FG001|COMPLETED|Overall Study||160
6417609|NCT00979407|7331700|FG000|NOT COMPLETED|Overall Study||6
6417610|NCT00979407|7331701|FG001|NOT COMPLETED|Overall Study||7
6417611|NCT00979420|7331713|FG000|STARTED|Overall Study||178
6417612|NCT00979420|7331714|FG001|STARTED|Overall Study||57
6417613|NCT00979420|7331715|FG002|STARTED|Overall Study||60
6417614|NCT00979420|7331716|FG003|STARTED|Overall Study||61
6417615|NCT00979420|7331713|FG000|COMPLETED|Overall Study||171
6417616|NCT00979420|7331714|FG001|COMPLETED|Overall Study||57
6417617|NCT00979420|7331715|FG002|COMPLETED|Overall Study||59
6417618|NCT00979420|7331716|FG003|COMPLETED|Overall Study||59
6417619|NCT00979420|7331713|FG000|NOT COMPLETED|Overall Study||7
6417620|NCT00979420|7331714|FG001|NOT COMPLETED|Overall Study||0
6417621|NCT00979420|7331715|FG002|NOT COMPLETED|Overall Study||1
6417622|NCT00979420|7331716|FG003|NOT COMPLETED|Overall Study||2
6417623|NCT00979459|7331724|FG000|STARTED|First Intervention||6
6417624|NCT00979459|7331725|FG001|STARTED|First Intervention||6
6417625|NCT00979459|7331724|FG000|COMPLETED|First Intervention||6
6417626|NCT00979459|7331725|FG001|COMPLETED|First Intervention||6
6417627|NCT00979459|7331724|FG000|NOT COMPLETED|First Intervention||0
6417628|NCT00979459|7331725|FG001|NOT COMPLETED|First Intervention||0
6417629|NCT00979459|7331724|FG000|STARTED|7-day Washout Period||6
6417630|NCT00979459|7331725|FG001|STARTED|7-day Washout Period||6
6417631|NCT00979459|7331724|FG000|COMPLETED|7-day Washout Period||6
6417632|NCT00979459|7331725|FG001|COMPLETED|7-day Washout Period||6
6417633|NCT00979459|7331724|FG000|NOT COMPLETED|7-day Washout Period||0
6417634|NCT00979459|7331725|FG001|NOT COMPLETED|7-day Washout Period||0
6417635|NCT00979459|7331724|FG000|STARTED|Second Intervention||6
6417636|NCT00979459|7331725|FG001|STARTED|Second Intervention||6
6417637|NCT00979459|7331724|FG000|COMPLETED|Second Intervention||6
6417638|NCT00979459|7331725|FG001|COMPLETED|Second Intervention||6
6417639|NCT00979459|7331724|FG000|NOT COMPLETED|Second Intervention||0
6417640|NCT00979459|7331725|FG001|NOT COMPLETED|Second Intervention||0
6417641|NCT00979576|7331736|FG000|STARTED|Combination Treatment Phase||3
6417642|NCT00979576|7331737|FG001|STARTED|Combination Treatment Phase||6
6417643|NCT00979576|7331738|FG002|STARTED|Combination Treatment Phase||9
6417644|NCT00979576|7331736|FG000|COMPLETED|Combination Treatment Phase||0
6417645|NCT00979576|7331737|FG001|COMPLETED|Combination Treatment Phase||0
6417646|NCT00979576|7331738|FG002|COMPLETED|Combination Treatment Phase||0
6417647|NCT00979576|7331736|FG000|NOT COMPLETED|Combination Treatment Phase||3
6417648|NCT00979576|7331737|FG001|NOT COMPLETED|Combination Treatment Phase||6
6417649|NCT00979576|7331738|FG002|NOT COMPLETED|Combination Treatment Phase||9
6417650|NCT00979576|7331736|FG000|STARTED|Combination Followed by Monotherapy||0
6417651|NCT00979576|7331737|FG001|STARTED|Combination Followed by Monotherapy||2
6417652|NCT00979576|7331738|FG002|STARTED|Combination Followed by Monotherapy||1
6417653|NCT00979576|7331736|FG000|COMPLETED|Combination Followed by Monotherapy||0
6417654|NCT00979576|7331737|FG001|COMPLETED|Combination Followed by Monotherapy||0
6417655|NCT00979576|7331738|FG002|COMPLETED|Combination Followed by Monotherapy||0
6417656|NCT00979576|7331736|FG000|NOT COMPLETED|Combination Followed by Monotherapy||0
6417657|NCT00979576|7331737|FG001|NOT COMPLETED|Combination Followed by Monotherapy||2
6417658|NCT00979576|7331738|FG002|NOT COMPLETED|Combination Followed by Monotherapy||1
6417659|NCT00979602|7331749|FG000|STARTED|Overall Study||2025
6417660|NCT00979602|7331750|FG001|STARTED|Overall Study||2023
6417661|NCT00979602|7331749|FG000|COMPLETED|Overall Study||1880
6417662|NCT00979602|7331750|FG001|COMPLETED|Overall Study||1890
6417663|NCT00979602|7331749|FG000|NOT COMPLETED|Overall Study||145
6417664|NCT00979602|7331750|FG001|NOT COMPLETED|Overall Study||133
6417665|NCT00979615|7331770|FG000|STARTED|Overall Study||63
6417666|NCT00979615|7331771|FG001|STARTED|Overall Study||66
6417667|NCT00979615|7331770|FG000|COMPLETED|Overall Study||57
6417668|NCT00979615|7331771|FG001|COMPLETED|Overall Study||58
6417669|NCT00979615|7331770|FG000|NOT COMPLETED|Overall Study||6
6417670|NCT00979615|7331771|FG001|NOT COMPLETED|Overall Study||8
6417671|NCT00979628|7331780|FG000|STARTED|Overall Study||153
6417672|NCT00979628|7331781|FG001|STARTED|Overall Study||142
6417673|NCT00979628|7331782|FG002|STARTED|Overall Study||80
6417674|NCT00979628|7331780|FG000|COMPLETED|Overall Study||144
6417675|NCT00979628|7331781|FG001|COMPLETED|Overall Study||133
6417676|NCT00979628|7331782|FG002|COMPLETED|Overall Study||74
6417677|NCT00979628|7331780|FG000|NOT COMPLETED|Overall Study||9
6417678|NCT00979628|7331781|FG001|NOT COMPLETED|Overall Study||9
6417679|NCT00979628|7331782|FG002|NOT COMPLETED|Overall Study||6
6417680|NCT00979654|7331793|FG000|STARTED|Overall Study||103
6417681|NCT00979654|7331793|FG000|COMPLETED|Overall Study||67
6417682|NCT00979654|7331793|FG000|NOT COMPLETED|Overall Study||36
6417683|NCT00979732|7331799|FG000|STARTED|Overall Study||15
6417684|NCT00979732|7331800|FG001|STARTED|Overall Study||18
6417685|NCT00979732|7331799|FG000|COMPLETED|Overall Study||12
6417686|NCT00979732|7331800|FG001|COMPLETED|Overall Study||17
6417687|NCT00979732|7331799|FG000|NOT COMPLETED|Overall Study||3
6417688|NCT00979732|7331800|FG001|NOT COMPLETED|Overall Study||1
6417689|NCT00979745|7331808|FG000|STARTED|Overall Study||38
6417690|NCT00979745|7331809|FG001|STARTED|Overall Study||36
6417691|NCT00979745|7331808|FG000|COMPLETED|Overall Study||34
6417692|NCT00979745|7331809|FG001|COMPLETED|Overall Study||34
6417693|NCT00979745|7331808|FG000|NOT COMPLETED|Overall Study||4
6417694|NCT00979745|7331809|FG001|NOT COMPLETED|Overall Study||2
6417695|NCT00979875|7331815|FG000|STARTED|Intervention 1||2
6417696|NCT00979875|7331816|FG001|STARTED|Intervention 1||2
6417697|NCT00979875|7331817|FG002|STARTED|Intervention 1||3
6417698|NCT00979875|7331818|FG003|STARTED|Intervention 1||2
6417699|NCT00979875|7331819|FG004|STARTED|Intervention 1||3
6417700|NCT00979875|7331820|FG005|STARTED|Intervention 1||2
6417701|NCT00979875|7331815|FG000|Received at Least 1 Dose of Study Drug|Intervention 1||2
6417702|NCT00979875|7331816|FG001|Received at Least 1 Dose of Study Drug|Intervention 1||2
6417703|NCT00979875|7331817|FG002|Received at Least 1 Dose of Study Drug|Intervention 1||3
6417704|NCT00979875|7331818|FG003|Received at Least 1 Dose of Study Drug|Intervention 1||2
6417705|NCT00979875|7331819|FG004|Received at Least 1 Dose of Study Drug|Intervention 1||3
6417706|NCT00979875|7331820|FG005|Received at Least 1 Dose of Study Drug|Intervention 1||2
6417707|NCT00979875|7331815|FG000|COMPLETED|Intervention 1||2
6417708|NCT00979875|7331816|FG001|COMPLETED|Intervention 1||2
6417709|NCT00979875|7331817|FG002|COMPLETED|Intervention 1||3
6417710|NCT00979875|7331818|FG003|COMPLETED|Intervention 1||2
6417711|NCT00979875|7331819|FG004|COMPLETED|Intervention 1||3
6417712|NCT00979875|7331820|FG005|COMPLETED|Intervention 1||2
6417713|NCT00979875|7331815|FG000|NOT COMPLETED|Intervention 1||0
6417714|NCT00979875|7331816|FG001|NOT COMPLETED|Intervention 1||0
6417715|NCT00979875|7331817|FG002|NOT COMPLETED|Intervention 1||0
6417716|NCT00979875|7331818|FG003|NOT COMPLETED|Intervention 1||0
6417717|NCT00979875|7331819|FG004|NOT COMPLETED|Intervention 1||0
6417718|NCT00979875|7331820|FG005|NOT COMPLETED|Intervention 1||0
6417719|NCT00979875|7331815|FG000|STARTED|Washout 1 (3 to 14 Days)||2
6417720|NCT00979875|7331816|FG001|STARTED|Washout 1 (3 to 14 Days)||2
6417721|NCT00979875|7331817|FG002|STARTED|Washout 1 (3 to 14 Days)||3
6417722|NCT00979875|7331818|FG003|STARTED|Washout 1 (3 to 14 Days)||2
6417723|NCT00979875|7331819|FG004|STARTED|Washout 1 (3 to 14 Days)||3
6417724|NCT00979875|7331820|FG005|STARTED|Washout 1 (3 to 14 Days)||2
6417725|NCT00979875|7331815|FG000|COMPLETED|Washout 1 (3 to 14 Days)||2
6417726|NCT00979875|7331816|FG001|COMPLETED|Washout 1 (3 to 14 Days)||2
6417727|NCT00979875|7331817|FG002|COMPLETED|Washout 1 (3 to 14 Days)||3
6417728|NCT00979875|7331818|FG003|COMPLETED|Washout 1 (3 to 14 Days)||2
6417729|NCT00979875|7331819|FG004|COMPLETED|Washout 1 (3 to 14 Days)||3
6417730|NCT00979875|7331820|FG005|COMPLETED|Washout 1 (3 to 14 Days)||2
6417731|NCT00979875|7331815|FG000|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6417732|NCT00979875|7331816|FG001|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6417733|NCT00979875|7331817|FG002|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6417734|NCT00979875|7331818|FG003|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6417735|NCT00979875|7331819|FG004|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6417736|NCT00979875|7331820|FG005|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
6417737|NCT00979875|7331815|FG000|STARTED|Intervention 2||2
6417738|NCT00979875|7331816|FG001|STARTED|Intervention 2||2
6417739|NCT00979875|7331817|FG002|STARTED|Intervention 2||3
6417740|NCT00979875|7331818|FG003|STARTED|Intervention 2||2
6417741|NCT00979875|7331819|FG004|STARTED|Intervention 2||3
6417742|NCT00979875|7331820|FG005|STARTED|Intervention 2||2
6417743|NCT00979875|7331815|FG000|COMPLETED|Intervention 2||2
6417744|NCT00979875|7331816|FG001|COMPLETED|Intervention 2||2
6417745|NCT00979875|7331817|FG002|COMPLETED|Intervention 2||3
6417746|NCT00979875|7331818|FG003|COMPLETED|Intervention 2||2
6417747|NCT00979875|7331819|FG004|COMPLETED|Intervention 2||3
6417748|NCT00979875|7331820|FG005|COMPLETED|Intervention 2||2
6417749|NCT00979875|7331815|FG000|NOT COMPLETED|Intervention 2||0
6417750|NCT00979875|7331816|FG001|NOT COMPLETED|Intervention 2||0
6417751|NCT00979875|7331817|FG002|NOT COMPLETED|Intervention 2||0
6417752|NCT00979875|7331818|FG003|NOT COMPLETED|Intervention 2||0
6417753|NCT00979875|7331819|FG004|NOT COMPLETED|Intervention 2||0
6417754|NCT00979875|7331820|FG005|NOT COMPLETED|Intervention 2||0
6417755|NCT00979875|7331815|FG000|STARTED|Washout 2 (3 to 14 Days)||2
6417756|NCT00979875|7331816|FG001|STARTED|Washout 2 (3 to 14 Days)||2
6417757|NCT00979875|7331817|FG002|STARTED|Washout 2 (3 to 14 Days)||3
6417758|NCT00979875|7331818|FG003|STARTED|Washout 2 (3 to 14 Days)||2
6417759|NCT00979875|7331819|FG004|STARTED|Washout 2 (3 to 14 Days)||3
6417760|NCT00979875|7331820|FG005|STARTED|Washout 2 (3 to 14 Days)||2
6417761|NCT00979875|7331815|FG000|COMPLETED|Washout 2 (3 to 14 Days)||2
6417762|NCT00979875|7331816|FG001|COMPLETED|Washout 2 (3 to 14 Days)||2
6417763|NCT00979875|7331817|FG002|COMPLETED|Washout 2 (3 to 14 Days)||3
6417764|NCT00979875|7331818|FG003|COMPLETED|Washout 2 (3 to 14 Days)||2
6417765|NCT00979875|7331819|FG004|COMPLETED|Washout 2 (3 to 14 Days)||3
6417766|NCT00979875|7331820|FG005|COMPLETED|Washout 2 (3 to 14 Days)||2
6417767|NCT00979875|7331815|FG000|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6417768|NCT00979875|7331816|FG001|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6417769|NCT00979875|7331817|FG002|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6417770|NCT00979875|7331818|FG003|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6417771|NCT00979875|7331819|FG004|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6417772|NCT00979875|7331820|FG005|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
6417773|NCT00979875|7331815|FG000|STARTED|Intervention 3||2
6417774|NCT00979875|7331816|FG001|STARTED|Intervention 3||2
6417775|NCT00979875|7331817|FG002|STARTED|Intervention 3||3
6417776|NCT00979875|7331818|FG003|STARTED|Intervention 3||2
6417777|NCT00979875|7331819|FG004|STARTED|Intervention 3||3
6417778|NCT00979875|7331820|FG005|STARTED|Intervention 3||2
6417779|NCT00979875|7331815|FG000|COMPLETED|Intervention 3||2
6638724|NCT02324673|7567211|FG001|STARTED|Overall Study||20
6638725|NCT02324673|7567212|FG002|STARTED|Overall Study||21
6638726|NCT02324673|7567210|FG000|COMPLETED|Overall Study||20
6638727|NCT02324673|7567211|FG001|COMPLETED|Overall Study||20
6638728|NCT02324673|7567212|FG002|COMPLETED|Overall Study||21
6638729|NCT02324673|7567210|FG000|NOT COMPLETED|Overall Study||0
6417780|NCT00979875|7331816|FG001|COMPLETED|Intervention 3||2
6417781|NCT00979875|7331817|FG002|COMPLETED|Intervention 3||3
6417782|NCT00979875|7331818|FG003|COMPLETED|Intervention 3||2
6638730|NCT02324673|7567211|FG001|NOT COMPLETED|Overall Study||0
6638731|NCT02324673|7567212|FG002|NOT COMPLETED|Overall Study||0
6417783|NCT00979875|7331819|FG004|COMPLETED|Intervention 3||3
6417784|NCT00979875|7331820|FG005|COMPLETED|Intervention 3||2
6417785|NCT00979875|7331815|FG000|NOT COMPLETED|Intervention 3||0
6417786|NCT00979875|7331816|FG001|NOT COMPLETED|Intervention 3||0
6417787|NCT00979875|7331817|FG002|NOT COMPLETED|Intervention 3||0
6417788|NCT00979875|7331818|FG003|NOT COMPLETED|Intervention 3||0
6417789|NCT00979875|7331819|FG004|NOT COMPLETED|Intervention 3||0
6417790|NCT00979875|7331820|FG005|NOT COMPLETED|Intervention 3||0
6417791|NCT00979940|7331836|FG000|STARTED|Overall Study||32
6417792|NCT00979940|7331837|FG001|STARTED|Overall Study||28
6417793|NCT00979940|7331836|FG000|COMPLETED|Overall Study||32
6510773|NCT01484197|7430380|FG000|STARTED|Treatment Period 1||9
6510774|NCT01484197|7430381|FG001|STARTED|Treatment Period 1||9
6510775|NCT01484197|7430382|FG002|STARTED|Treatment Period 1||9
6510776|NCT01484197|7430383|FG003|STARTED|Treatment Period 1||9
6510777|NCT01484197|7430380|FG000|COMPLETED|Treatment Period 1||8
6510778|NCT01484197|7430381|FG001|COMPLETED|Treatment Period 1||9
6510779|NCT01484197|7430382|FG002|COMPLETED|Treatment Period 1||9
6510780|NCT01484197|7430383|FG003|COMPLETED|Treatment Period 1||9
6510781|NCT01484197|7430380|FG000|NOT COMPLETED|Treatment Period 1||1
6510782|NCT01484197|7430381|FG001|NOT COMPLETED|Treatment Period 1||0
6510783|NCT01484197|7430382|FG002|NOT COMPLETED|Treatment Period 1||0
6510784|NCT01484197|7430383|FG003|NOT COMPLETED|Treatment Period 1||0
6561218|NCT01791517|7484044|FG003|NOT COMPLETED|Phase I: Period 4||0
6638732|NCT02324699|7567220|FG000|STARTED|Overall Study||1
6638733|NCT02324699|7567220|FG000|COMPLETED|Overall Study||0
6638734|NCT02324699|7567220|FG000|NOT COMPLETED|Overall Study||1
6638735|NCT02324842|7567227|FG000|STARTED|Overall Study||15
6638736|NCT02324842|7567228|FG001|STARTED|Overall Study||15
6638737|NCT02324842|7567229|FG002|STARTED|Overall Study||15
6638738|NCT02324842|7567227|FG000|COMPLETED|Overall Study||14
6638739|NCT02324842|7567228|FG001|COMPLETED|Overall Study||14
6638740|NCT02324842|7567229|FG002|COMPLETED|Overall Study||13
6417794|NCT00979940|7331837|FG001|COMPLETED|Overall Study||28
6417795|NCT00979940|7331836|FG000|NOT COMPLETED|Overall Study||0
6417796|NCT00979940|7331837|FG001|NOT COMPLETED|Overall Study||0
6417797|NCT00979953|7331847|FG000|STARTED|Overall Study||101
6417798|NCT00979953|7331848|FG001|STARTED|Overall Study||99
6417799|NCT00979953|7331849|FG002|STARTED|Overall Study||104
6417800|NCT00979953|7331850|FG003|STARTED|Overall Study||104
6417801|NCT00979953|7331847|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
6417802|NCT00979953|7331848|FG001|Received at Least 1 Dose of Study Drug|Overall Study||99
6417803|NCT00979953|7331849|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
6417804|NCT00979953|7331850|FG003|Received at Least 1 Dose of Study Drug|Overall Study||104
6417805|NCT00979953|7331847|FG000|COMPLETED|Overall Study||93
6417806|NCT00979953|7331848|FG001|COMPLETED|Overall Study||94
6417807|NCT00979953|7331849|FG002|COMPLETED|Overall Study||82
6417808|NCT00979953|7331850|FG003|COMPLETED|Overall Study||97
6417809|NCT00979953|7331847|FG000|NOT COMPLETED|Overall Study||8
6417810|NCT00979953|7331848|FG001|NOT COMPLETED|Overall Study||5
6417811|NCT00979953|7331849|FG002|NOT COMPLETED|Overall Study||22
6417812|NCT00979953|7331850|FG003|NOT COMPLETED|Overall Study||7
6417813|NCT00979992|7331860|FG000|STARTED|Overall Study||35
6417814|NCT00979992|7331860|FG000|COMPLETED|Overall Study||30
6417815|NCT00979992|7331860|FG000|NOT COMPLETED|Overall Study||5
6417816|NCT00980005|7331866|FG000|STARTED|Overall Study||1055
6417817|NCT00980005|7331867|FG001|STARTED|Overall Study||1061
6417818|NCT00980005|7331866|FG000|COMPLETED|Overall Study||1008
6417819|NCT00980005|7331867|FG001|COMPLETED|Overall Study||998
6417820|NCT00980005|7331866|FG000|NOT COMPLETED|Overall Study||47
6417821|NCT00980005|7331867|FG001|NOT COMPLETED|Overall Study||63
6417822|NCT00980018|7331877|FG000|STARTED|Overall Study||52
6417823|NCT00980018|7331877|FG000|COMPLETED|Overall Study||40
6417824|NCT00980018|7331877|FG000|NOT COMPLETED|Overall Study||12
6417825|NCT00980044|7331884|FG000|STARTED|Overall Study||17
6417826|NCT00980044|7331885|FG001|STARTED|Overall Study||19
6417827|NCT00980044|7331886|FG002|STARTED|Overall Study||17
6561219|NCT01791517|7484045|FG004|NOT COMPLETED|Phase I: Period 4||0
6561220|NCT01791517|7484046|FG005|NOT COMPLETED|Phase I: Period 4||0
6561221|NCT01791517|7484047|FG006|NOT COMPLETED|Phase I: Period 4||0
6561222|NCT01791517|7484048|FG007|NOT COMPLETED|Phase I: Period 4||0
6561223|NCT01791517|7484049|FG008|NOT COMPLETED|Phase I: Period 4||0
6561224|NCT01791517|7484050|FG009|NOT COMPLETED|Phase I: Period 4||0
6561225|NCT01791517|7484051|FG010|NOT COMPLETED|Phase I: Period 4||0
6561226|NCT01791517|7484052|FG011|NOT COMPLETED|Phase I: Period 4||0
6561227|NCT01791517|7484041|FG000|STARTED|Phase II||17
6561228|NCT01791517|7484042|FG001|STARTED|Phase II||14
6561229|NCT01791517|7484043|FG002|STARTED|Phase II||16
6561230|NCT01791517|7484044|FG003|STARTED|Phase II||15
6561231|NCT01791517|7484045|FG004|STARTED|Phase II||18
6561232|NCT01791517|7484046|FG005|STARTED|Phase II||18
6561233|NCT01791517|7484047|FG006|STARTED|Phase II||19
6561234|NCT01791517|7484048|FG007|STARTED|Phase II||20
6561235|NCT01791517|7484049|FG008|STARTED|Phase II||19
6561236|NCT01791517|7484050|FG009|STARTED|Phase II||18
6561237|NCT01791517|7484051|FG010|STARTED|Phase II||16
6561238|NCT01791517|7484052|FG011|STARTED|Phase II||18
6561239|NCT01791517|7484041|FG000|COMPLETED|Phase II||15
6561240|NCT01791517|7484042|FG001|COMPLETED|Phase II||14
6561241|NCT01791517|7484043|FG002|COMPLETED|Phase II||15
6417828|NCT00980044|7331884|FG000|COMPLETED|Overall Study||12
6417829|NCT00980044|7331885|FG001|COMPLETED|Overall Study||12
6417830|NCT00980044|7331886|FG002|COMPLETED|Overall Study||12
6417831|NCT00980044|7331884|FG000|NOT COMPLETED|Overall Study||5
6417832|NCT00980044|7331885|FG001|NOT COMPLETED|Overall Study||7
6417833|NCT00980044|7331886|FG002|NOT COMPLETED|Overall Study||5
6417834|NCT00980057|7331899|FG000|STARTED|Overall Study||318
6417835|NCT00980057|7331900|FG001|STARTED|Overall Study||160
6417836|NCT00980057|7331899|FG000|COMPLETED|Overall Study||299
6417837|NCT00980057|7331900|FG001|COMPLETED|Overall Study||155
6417838|NCT00980057|7331899|FG000|NOT COMPLETED|Overall Study||19
6417839|NCT00980057|7331900|FG001|NOT COMPLETED|Overall Study||5
6417840|NCT00980148|7331909|FG000|STARTED|Overall Study||284
6417841|NCT00980148|7331910|FG001|STARTED|Overall Study||283
6417842|NCT00980148|7331909|FG000|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
6417843|NCT00980148|7331910|FG001|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
6417844|NCT00980148|7331909|FG000|NOT COMPLETED|Overall Study||129
6638741|NCT02324842|7567227|FG000|NOT COMPLETED|Overall Study||1
6638742|NCT02324842|7567228|FG001|NOT COMPLETED|Overall Study||1
6638743|NCT02324842|7567229|FG002|NOT COMPLETED|Overall Study||2
6638744|NCT02324920|7567239|FG000|STARTED|Overall Study||64
6638745|NCT02324920|7567240|FG001|STARTED|Overall Study||64
6638746|NCT02324920|7567239|FG000|COMPLETED|Overall Study||63
6417845|NCT00980148|7331910|FG001|NOT COMPLETED|Overall Study||128
6417846|NCT00980174|7331918|FG000|STARTED|Overall Study||121
6417847|NCT00980174|7331919|FG001|STARTED|Overall Study||121
6417848|NCT00980174|7331918|FG000|COMPLETED|Overall Study||117
6417849|NCT00980174|7331919|FG001|COMPLETED|Overall Study||111
6417850|NCT00980174|7331918|FG000|NOT COMPLETED|Overall Study||4
6417851|NCT00980174|7331919|FG001|NOT COMPLETED|Overall Study||10
6417852|NCT00980200|7331925|FG000|STARTED|7-day Treatment Period 1||15
6417853|NCT00980200|7331926|FG001|STARTED|7-day Treatment Period 1||14
6638747|NCT02324920|7567240|FG001|COMPLETED|Overall Study||64
6638748|NCT02324920|7567239|FG000|NOT COMPLETED|Overall Study||1
6638749|NCT02324920|7567240|FG001|NOT COMPLETED|Overall Study||0
6638750|NCT02324972|7567248|FG000|STARTED|Overall Study||26
6638751|NCT02324972|7567249|FG001|STARTED|Overall Study||28
6638752|NCT02324972|7567248|FG000|COMPLETED|Overall Study||19
6638753|NCT02324972|7567249|FG001|COMPLETED|Overall Study||23
6638754|NCT02324972|7567248|FG000|NOT COMPLETED|Overall Study||7
6638755|NCT02324972|7567249|FG001|NOT COMPLETED|Overall Study||5
6638756|NCT02325219|7567258|FG000|STARTED|Controlled Period (Week 0 - 16)||64
6638757|NCT02325219|7567259|FG001|STARTED|Controlled Period (Week 0 - 16)||65
6638758|NCT02325219|7567260|FG002|STARTED|Controlled Period (Week 0 - 16)||63
6638759|NCT02325219|7567261|FG003|STARTED|Controlled Period (Week 0 - 16)||0
6638760|NCT02325219|7567262|FG004|STARTED|Controlled Period (Week 0 - 16)||0
6638761|NCT02325219|7567258|FG000|COMPLETED|Controlled Period (Week 0 - 16)||52
6638762|NCT02325219|7567259|FG001|COMPLETED|Controlled Period (Week 0 - 16)||63
6638763|NCT02325219|7567260|FG002|COMPLETED|Controlled Period (Week 0 - 16)||62
6638764|NCT02325219|7567261|FG003|COMPLETED|Controlled Period (Week 0 - 16)||0
6638765|NCT02325219|7567262|FG004|COMPLETED|Controlled Period (Week 0 - 16)||0
6638766|NCT02325219|7567258|FG000|NOT COMPLETED|Controlled Period (Week 0 - 16)||12
6638767|NCT02325219|7567259|FG001|NOT COMPLETED|Controlled Period (Week 0 - 16)||2
6638768|NCT02325219|7567260|FG002|NOT COMPLETED|Controlled Period (Week 0 - 16)||1
6638769|NCT02325219|7567261|FG003|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
6638770|NCT02325219|7567262|FG004|NOT COMPLETED|Controlled Period (Week 0 - 16)||0
6638771|NCT02325219|7567258|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
6638772|NCT02325219|7567259|FG001|STARTED|After Controlled Period (Week 16 - 52)||63
6638773|NCT02325219|7567260|FG002|STARTED|After Controlled Period (Week 16 - 52)||62
6638774|NCT02325219|7567261|FG003|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 50 mg.|26
6638775|NCT02325219|7567262|FG004|STARTED|After Controlled Period (Week 16 - 52)|Participants who completed CP and re-randomized to Guselkumab 100 mg.|26
6638776|NCT02325219|7567258|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
6638777|NCT02325219|7567259|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||60
6638778|NCT02325219|7567260|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||62
6638779|NCT02325219|7567261|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||26
6638780|NCT02325219|7567262|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||25
6638781|NCT02325219|7567258|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
6638782|NCT02325219|7567259|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||3
6638783|NCT02325219|7567260|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
6638784|NCT02325219|7567261|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
6638785|NCT02325219|7567262|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||1
6638786|NCT02325401|7567278|FG000|STARTED|Overall Study||6
6638787|NCT02325401|7567279|FG001|STARTED|Overall Study||9
6638788|NCT02325401|7567280|FG002|STARTED|Overall Study||5
6638789|NCT02325401|7567278|FG000|COMPLETED|Overall Study||6
6638790|NCT02325401|7567279|FG001|COMPLETED|Overall Study||8
6638791|NCT02325401|7567280|FG002|COMPLETED|Overall Study||4
6638792|NCT02325401|7567278|FG000|NOT COMPLETED|Overall Study||0
6638793|NCT02325401|7567279|FG001|NOT COMPLETED|Overall Study||1
6417854|NCT00980200|7331927|FG002|STARTED|7-day Treatment Period 1||15
6638794|NCT02325401|7567280|FG002|NOT COMPLETED|Overall Study||1
6638795|NCT02325414|7567296|FG000|STARTED|Overall Study||30
6417855|NCT00980200|7331928|FG003|STARTED|7-day Treatment Period 1||16
6417856|NCT00980200|7331929|FG004|STARTED|7-day Treatment Period 1||15
6417857|NCT00980200|7331925|FG000|COMPLETED|7-day Treatment Period 1||15
6417858|NCT00980200|7331926|FG001|COMPLETED|7-day Treatment Period 1||13
6417859|NCT00980200|7331927|FG002|COMPLETED|7-day Treatment Period 1||15
6417860|NCT00980200|7331928|FG003|COMPLETED|7-day Treatment Period 1||16
6417861|NCT00980200|7331929|FG004|COMPLETED|7-day Treatment Period 1||15
6417862|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Treatment Period 1||0
6417863|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Treatment Period 1||1
6417864|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Treatment Period 1||0
6417865|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Treatment Period 1||0
6417866|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Treatment Period 1||0
6417867|NCT00980200|7331925|FG000|STARTED|7-day Washout Period 1||15
6417868|NCT00980200|7331926|FG001|STARTED|7-day Washout Period 1||13
6417869|NCT00980200|7331927|FG002|STARTED|7-day Washout Period 1||15
6417870|NCT00980200|7331928|FG003|STARTED|7-day Washout Period 1||16
6417871|NCT00980200|7331929|FG004|STARTED|7-day Washout Period 1||15
6417872|NCT00980200|7331925|FG000|COMPLETED|7-day Washout Period 1||15
6417873|NCT00980200|7331926|FG001|COMPLETED|7-day Washout Period 1||13
6417874|NCT00980200|7331927|FG002|COMPLETED|7-day Washout Period 1||15
6417875|NCT00980200|7331928|FG003|COMPLETED|7-day Washout Period 1||16
6417876|NCT00980200|7331929|FG004|COMPLETED|7-day Washout Period 1||15
6417877|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Washout Period 1||0
6417878|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Washout Period 1||0
6638796|NCT02325414|7567297|FG001|STARTED|Overall Study||30
6638797|NCT02325414|7567296|FG000|COMPLETED|Overall Study||22
6638798|NCT02325414|7567297|FG001|COMPLETED|Overall Study||24
6638799|NCT02325414|7567296|FG000|NOT COMPLETED|Overall Study||8
6638800|NCT02325414|7567297|FG001|NOT COMPLETED|Overall Study||6
6638801|NCT02325518|7567307|FG000|STARTED|Overall Study||98
6638802|NCT02325518|7567308|FG001|STARTED|Overall Study||103
6638803|NCT02325518|7567307|FG000|Safety Set|Overall Study||98
6638804|NCT02325518|7567308|FG001|Safety Set|Overall Study||103
6638805|NCT02325518|7567307|FG000|Full Analysis Set (FAS)|Overall Study||98
6638806|NCT02325518|7567308|FG001|Full Analysis Set (FAS)|Overall Study||101
6638807|NCT02325518|7567307|FG000|Per Protocol Set (PPS)|Overall Study||92
6417879|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Washout Period 1||0
6417880|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Washout Period 1||0
6417881|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Washout Period 1||0
6417882|NCT00980200|7331925|FG000|STARTED|7-day Treatment Period 2||15
6417883|NCT00980200|7331926|FG001|STARTED|7-day Treatment Period 2||13
6417884|NCT00980200|7331927|FG002|STARTED|7-day Treatment Period 2||15
6417885|NCT00980200|7331928|FG003|STARTED|7-day Treatment Period 2||16
6417886|NCT00980200|7331929|FG004|STARTED|7-day Treatment Period 2||15
6417887|NCT00980200|7331925|FG000|COMPLETED|7-day Treatment Period 2||15
6417888|NCT00980200|7331926|FG001|COMPLETED|7-day Treatment Period 2||13
6417889|NCT00980200|7331927|FG002|COMPLETED|7-day Treatment Period 2||15
6417890|NCT00980200|7331928|FG003|COMPLETED|7-day Treatment Period 2||16
6417891|NCT00980200|7331929|FG004|COMPLETED|7-day Treatment Period 2||15
6417892|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Treatment Period 2||0
6417893|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Treatment Period 2||0
6417894|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Treatment Period 2||0
6417895|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Treatment Period 2||0
6417896|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Treatment Period 2||0
6417897|NCT00980200|7331925|FG000|STARTED|7-day Washout Period 2||15
6417898|NCT00980200|7331926|FG001|STARTED|7-day Washout Period 2||13
6417899|NCT00980200|7331927|FG002|STARTED|7-day Washout Period 2||15
6417900|NCT00980200|7331928|FG003|STARTED|7-day Washout Period 2||16
6417901|NCT00980200|7331929|FG004|STARTED|7-day Washout Period 2||15
6417902|NCT00980200|7331925|FG000|COMPLETED|7-day Washout Period 2||15
6417903|NCT00980200|7331926|FG001|COMPLETED|7-day Washout Period 2||13
6417904|NCT00980200|7331927|FG002|COMPLETED|7-day Washout Period 2||15
6417905|NCT00980200|7331928|FG003|COMPLETED|7-day Washout Period 2||16
6417906|NCT00980200|7331929|FG004|COMPLETED|7-day Washout Period 2||15
6417907|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Washout Period 2||0
6417908|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Washout Period 2||0
6417909|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Washout Period 2||0
6417910|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Washout Period 2||0
6417911|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Washout Period 2||0
6417912|NCT00980200|7331925|FG000|STARTED|7-day Treatment Period 3||15
6417913|NCT00980200|7331926|FG001|STARTED|7-day Treatment Period 3||13
6417914|NCT00980200|7331927|FG002|STARTED|7-day Treatment Period 3||15
6417915|NCT00980200|7331928|FG003|STARTED|7-day Treatment Period 3||16
6417916|NCT00980200|7331929|FG004|STARTED|7-day Treatment Period 3||15
6638808|NCT02325518|7567308|FG001|Per Protocol Set (PPS)|Overall Study||97
6417917|NCT00980200|7331925|FG000|COMPLETED|7-day Treatment Period 3||15
6417918|NCT00980200|7331926|FG001|COMPLETED|7-day Treatment Period 3||12
6417919|NCT00980200|7331927|FG002|COMPLETED|7-day Treatment Period 3||15
6417920|NCT00980200|7331928|FG003|COMPLETED|7-day Treatment Period 3||16
6417921|NCT00980200|7331929|FG004|COMPLETED|7-day Treatment Period 3||14
6417922|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Treatment Period 3||0
6417923|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Treatment Period 3||1
6638809|NCT02325518|7567307|FG000|COMPLETED|Overall Study||94
6638810|NCT02325518|7567308|FG001|COMPLETED|Overall Study||100
6638811|NCT02325518|7567307|FG000|NOT COMPLETED|Overall Study||4
6417924|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Treatment Period 3||0
6417925|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Treatment Period 3||0
6417926|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Treatment Period 3||1
6417927|NCT00980200|7331925|FG000|STARTED|7-day Washout Period 3||15
6417928|NCT00980200|7331926|FG001|STARTED|7-day Washout Period 3||12
6417929|NCT00980200|7331927|FG002|STARTED|7-day Washout Period 3||15
6417930|NCT00980200|7331928|FG003|STARTED|7-day Washout Period 3||16
6417931|NCT00980200|7331929|FG004|STARTED|7-day Washout Period 3||14
6417932|NCT00980200|7331925|FG000|COMPLETED|7-day Washout Period 3||15
6417933|NCT00980200|7331926|FG001|COMPLETED|7-day Washout Period 3||12
6417934|NCT00980200|7331927|FG002|COMPLETED|7-day Washout Period 3||15
6417935|NCT00980200|7331928|FG003|COMPLETED|7-day Washout Period 3||16
6417936|NCT00980200|7331929|FG004|COMPLETED|7-day Washout Period 3||14
6417937|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Washout Period 3||0
6417938|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Washout Period 3||0
6417939|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Washout Period 3||0
6417940|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Washout Period 3||0
6417941|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Washout Period 3||0
6417942|NCT00980200|7331925|FG000|STARTED|7-day Treatment Period 4||15
6417943|NCT00980200|7331926|FG001|STARTED|7-day Treatment Period 4||12
6417944|NCT00980200|7331927|FG002|STARTED|7-day Treatment Period 4||15
6417945|NCT00980200|7331928|FG003|STARTED|7-day Treatment Period 4||16
6417946|NCT00980200|7331929|FG004|STARTED|7-day Treatment Period 4||14
6417947|NCT00980200|7331925|FG000|COMPLETED|7-day Treatment Period 4||15
6417948|NCT00980200|7331926|FG001|COMPLETED|7-day Treatment Period 4||12
6417949|NCT00980200|7331927|FG002|COMPLETED|7-day Treatment Period 4||15
6417950|NCT00980200|7331928|FG003|COMPLETED|7-day Treatment Period 4||16
6417951|NCT00980200|7331929|FG004|COMPLETED|7-day Treatment Period 4||14
6417952|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Treatment Period 4||0
6417953|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Treatment Period 4||0
6417954|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Treatment Period 4||0
6417955|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Treatment Period 4||0
6417956|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Treatment Period 4||0
6417957|NCT00980200|7331925|FG000|STARTED|7-day Washout Period 4||15
6417958|NCT00980200|7331926|FG001|STARTED|7-day Washout Period 4||12
6417959|NCT00980200|7331927|FG002|STARTED|7-day Washout Period 4||15
6417960|NCT00980200|7331928|FG003|STARTED|7-day Washout Period 4||16
6417961|NCT00980200|7331929|FG004|STARTED|7-day Washout Period 4||14
6417962|NCT00980200|7331925|FG000|COMPLETED|7-day Washout Period 4||15
6417963|NCT00980200|7331926|FG001|COMPLETED|7-day Washout Period 4||12
6417964|NCT00980200|7331927|FG002|COMPLETED|7-day Washout Period 4||15
6417965|NCT00980200|7331928|FG003|COMPLETED|7-day Washout Period 4||16
6417966|NCT00980200|7331929|FG004|COMPLETED|7-day Washout Period 4||14
6417967|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Washout Period 4||0
6417968|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Washout Period 4||0
6417969|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Washout Period 4||0
6417970|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Washout Period 4||0
6417971|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Washout Period 4||0
6417972|NCT00980200|7331925|FG000|STARTED|7-day Treatment Period 5||15
6417973|NCT00980200|7331926|FG001|STARTED|7-day Treatment Period 5||12
6417974|NCT00980200|7331927|FG002|STARTED|7-day Treatment Period 5||15
6417975|NCT00980200|7331928|FG003|STARTED|7-day Treatment Period 5||16
6417976|NCT00980200|7331929|FG004|STARTED|7-day Treatment Period 5||14
6417977|NCT00980200|7331925|FG000|COMPLETED|7-day Treatment Period 5||15
6417978|NCT00980200|7331926|FG001|COMPLETED|7-day Treatment Period 5||12
6417979|NCT00980200|7331927|FG002|COMPLETED|7-day Treatment Period 5||15
6417980|NCT00980200|7331928|FG003|COMPLETED|7-day Treatment Period 5||16
6417981|NCT00980200|7331929|FG004|COMPLETED|7-day Treatment Period 5||14
6417982|NCT00980200|7331925|FG000|NOT COMPLETED|7-day Treatment Period 5||0
6417983|NCT00980200|7331926|FG001|NOT COMPLETED|7-day Treatment Period 5||0
6417984|NCT00980200|7331927|FG002|NOT COMPLETED|7-day Treatment Period 5||0
6417985|NCT00980200|7331928|FG003|NOT COMPLETED|7-day Treatment Period 5||0
6417986|NCT00980200|7331929|FG004|NOT COMPLETED|7-day Treatment Period 5||0
6417987|NCT00980278|7331943|FG000|STARTED|Overall Study||13
6417988|NCT00980278|7331944|FG001|STARTED|Overall Study||13
6417989|NCT00980278|7331943|FG000|COMPLETED|Overall Study||11
6417990|NCT00980278|7331944|FG001|COMPLETED|Overall Study||13
6417991|NCT00980278|7331943|FG000|NOT COMPLETED|Overall Study||2
6417992|NCT00980278|7331944|FG001|NOT COMPLETED|Overall Study||0
6417993|NCT00980330|7331957|FG000|STARTED|Overall Study||66
6417994|NCT00980330|7331958|FG001|STARTED|Overall Study||65
6417995|NCT00980330|7331959|FG002|STARTED|Overall Study||66
6417996|NCT00980330|7331960|FG003|STARTED|Overall Study||66
6417997|NCT00980330|7331961|FG004|STARTED|Overall Study||68
6417998|NCT00980330|7331962|FG005|STARTED|Overall Study||65
6417999|NCT00980330|7331963|FG006|STARTED|Overall Study||66
6418000|NCT00980330|7331957|FG000|COMPLETED|Overall Study||61
6418001|NCT00980330|7331958|FG001|COMPLETED|Overall Study||60
6418002|NCT00980330|7331959|FG002|COMPLETED|Overall Study||58
6418003|NCT00980330|7331960|FG003|COMPLETED|Overall Study||61
6418004|NCT00980330|7331961|FG004|COMPLETED|Overall Study||63
6418005|NCT00980330|7331962|FG005|COMPLETED|Overall Study||61
6418006|NCT00980330|7331963|FG006|COMPLETED|Overall Study||59
6418007|NCT00980330|7331957|FG000|NOT COMPLETED|Overall Study||5
6418008|NCT00980330|7331958|FG001|NOT COMPLETED|Overall Study||5
6418009|NCT00980330|7331959|FG002|NOT COMPLETED|Overall Study||8
6418010|NCT00980330|7331960|FG003|NOT COMPLETED|Overall Study||5
6418011|NCT00980330|7331961|FG004|NOT COMPLETED|Overall Study||5
6418012|NCT00980330|7331962|FG005|NOT COMPLETED|Overall Study||4
6418013|NCT00980330|7331963|FG006|NOT COMPLETED|Overall Study||7
6418014|NCT00980343|7331982|FG000|STARTED|Overall Study||21
6418015|NCT00980343|7331983|FG001|STARTED|Overall Study||23
6418016|NCT00980343|7331982|FG000|COMPLETED|Overall Study||20
6418017|NCT00980343|7331983|FG001|COMPLETED|Overall Study||20
6418018|NCT00980343|7331982|FG000|NOT COMPLETED|Overall Study||1
6418019|NCT00980343|7331983|FG001|NOT COMPLETED|Overall Study||3
6418020|NCT00980395|7331990|FG000|STARTED|Overall Study||24
6418021|NCT00980395|7331990|FG000|COMPLETED|Overall Study||24
6418022|NCT00980395|7331990|FG000|NOT COMPLETED|Overall Study||0
6418023|NCT00980590|7331996|FG000|STARTED|Overall Study||50
6418024|NCT00980590|7331997|FG001|STARTED|Overall Study||50
6418025|NCT00980590|7331996|FG000|COMPLETED|Overall Study||50
6418026|NCT00980590|7331997|FG001|COMPLETED|Overall Study||50
6418027|NCT00980590|7331996|FG000|NOT COMPLETED|Overall Study||0
6418028|NCT00980590|7331997|FG001|NOT COMPLETED|Overall Study||0
6499217|NCT01415908|7417870|FG001|NOT COMPLETED|Overall Study||0
6499218|NCT01415921|7417878|FG000|STARTED|Overall Study||16
6499219|NCT01415921|7417879|FG001|STARTED|Overall Study||17
6499220|NCT01415921|7417878|FG000|COMPLETED|Overall Study||13
6499221|NCT01415921|7417879|FG001|COMPLETED|Overall Study||14
6499222|NCT01415921|7417878|FG000|NOT COMPLETED|Overall Study||3
6499223|NCT01415921|7417879|FG001|NOT COMPLETED|Overall Study||3
6499224|NCT01415934|7417887|FG000|STARTED|Overall Study||192
6499225|NCT01415934|7417888|FG001|STARTED|Overall Study||189
6499226|NCT01415934|7417887|FG000|COMPLETED|Overall Study||189
6499227|NCT01415934|7417888|FG001|COMPLETED|Overall Study||182
6499228|NCT01415934|7417887|FG000|NOT COMPLETED|Overall Study||3
6499229|NCT01415934|7417888|FG001|NOT COMPLETED|Overall Study||7
6499230|NCT01415960|7417894|FG000|STARTED|Overall Study||163
6499231|NCT01415960|7417894|FG000|ITT|Overall Study||161
6499232|NCT01415960|7417894|FG000|PK Subgroup|Overall Study||30
6499233|NCT01415960|7417894|FG000|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
6499234|NCT01415960|7417894|FG000|NOT COMPLETED|Overall Study||12
6638812|NCT02325518|7567308|FG001|NOT COMPLETED|Overall Study||3
6638813|NCT02325687|7567318|FG000|STARTED|Overall Study||16
6638814|NCT02325687|7567319|FG001|STARTED|Overall Study||15
6638815|NCT02325687|7567320|FG002|STARTED|Overall Study||19
6638816|NCT02325687|7567318|FG000|COMPLETED|Overall Study||12
6638817|NCT02325687|7567319|FG001|COMPLETED|Overall Study||12
6499235|NCT01416025|7417900|FG000|STARTED|Overall Study||14
6499236|NCT01416025|7417901|FG001|STARTED|Overall Study||15
6499237|NCT01416025|7417900|FG000|COMPLETED|Overall Study||14
6499238|NCT01416025|7417901|FG001|COMPLETED|Overall Study||15
6499239|NCT01416025|7417900|FG000|NOT COMPLETED|Overall Study||0
6499240|NCT01416025|7417901|FG001|NOT COMPLETED|Overall Study||0
6499241|NCT01416129|7417909|FG000|STARTED|Control Condition: Ischial Containment||5
6638818|NCT02325687|7567320|FG002|COMPLETED|Overall Study||13
6638819|NCT02325687|7567318|FG000|NOT COMPLETED|Overall Study||4
6638820|NCT02325687|7567319|FG001|NOT COMPLETED|Overall Study||3
6638821|NCT02325687|7567320|FG002|NOT COMPLETED|Overall Study||6
6638822|NCT02325713|7567344|FG000|STARTED|Intervention Period 1 (2 Days)||2
6638823|NCT02325713|7567345|FG001|STARTED|Intervention Period 1 (2 Days)||2
6638824|NCT02325713|7567346|FG002|STARTED|Intervention Period 1 (2 Days)||2
6638825|NCT02325713|7567347|FG003|STARTED|Intervention Period 1 (2 Days)||2
6638826|NCT02325713|7567348|FG004|STARTED|Intervention Period 1 (2 Days)||2
6638827|NCT02325713|7567349|FG005|STARTED|Intervention Period 1 (2 Days)||2
6638828|NCT02325713|7567350|FG006|STARTED|Intervention Period 1 (2 Days)||2
6638829|NCT02325713|7567351|FG007|STARTED|Intervention Period 1 (2 Days)||2
6638830|NCT02325713|7567352|FG008|STARTED|Intervention Period 1 (2 Days)||2
6638831|NCT02325713|7567353|FG009|STARTED|Intervention Period 1 (2 Days)||2
6638832|NCT02325713|7567354|FG010|STARTED|Intervention Period 1 (2 Days)||2
6638833|NCT02325713|7567355|FG011|STARTED|Intervention Period 1 (2 Days)||2
6638834|NCT02325713|7567356|FG012|STARTED|Intervention Period 1 (2 Days)||2
6638835|NCT02325713|7567357|FG013|STARTED|Intervention Period 1 (2 Days)||2
6499242|NCT01416129|7417910|FG001|STARTED|Control Condition: Ischial Containment||5
6499243|NCT01416129|7417909|FG000|COMPLETED|Control Condition: Ischial Containment||5
6499244|NCT01416129|7417910|FG001|COMPLETED|Control Condition: Ischial Containment||5
6499245|NCT01416129|7417909|FG000|NOT COMPLETED|Control Condition: Ischial Containment||0
6499246|NCT01416129|7417910|FG001|NOT COMPLETED|Control Condition: Ischial Containment||0
6499247|NCT01416129|7417909|FG000|STARTED|Experimental Condition: Brimless||5
6499248|NCT01416129|7417910|FG001|STARTED|Experimental Condition: Brimless||5
6499249|NCT01416129|7417909|FG000|COMPLETED|Experimental Condition: Brimless||5
6499250|NCT01416129|7417910|FG001|COMPLETED|Experimental Condition: Brimless||5
6499251|NCT01416129|7417909|FG000|NOT COMPLETED|Experimental Condition: Brimless||0
6638836|NCT02325713|7567358|FG014|STARTED|Intervention Period 1 (2 Days)||2
6638837|NCT02325713|7567359|FG015|STARTED|Intervention Period 1 (2 Days)||2
6638838|NCT02325713|7567344|FG000|COMPLETED|Intervention Period 1 (2 Days)||2
6638839|NCT02325713|7567345|FG001|COMPLETED|Intervention Period 1 (2 Days)||2
6638840|NCT02325713|7567346|FG002|COMPLETED|Intervention Period 1 (2 Days)||2
6638841|NCT02325713|7567347|FG003|COMPLETED|Intervention Period 1 (2 Days)||2
6638842|NCT02325713|7567348|FG004|COMPLETED|Intervention Period 1 (2 Days)||2
6638843|NCT02325713|7567349|FG005|COMPLETED|Intervention Period 1 (2 Days)||2
6418029|NCT00980642|7332005|FG000|STARTED|Overall Study||36
6418030|NCT00980642|7332006|FG001|STARTED|Overall Study||20
6418031|NCT00980642|7332005|FG000|COMPLETED|Overall Study||36
6418032|NCT00980642|7332006|FG001|COMPLETED|Overall Study||20
6418033|NCT00980642|7332005|FG000|NOT COMPLETED|Overall Study||0
6418034|NCT00980642|7332006|FG001|NOT COMPLETED|Overall Study||0
6418035|NCT00980655|7332015|FG000|STARTED|Overall Study||61
6418036|NCT00980655|7332016|FG001|STARTED|Overall Study||190
6418037|NCT00980655|7332015|FG000|Vaccinated 13vPnC Dose 1|Overall Study||59
6418038|NCT00980655|7332016|FG001|Vaccinated 13vPnC Dose 1|Overall Study||188
6418039|NCT00980655|7332015|FG000|Vaccinated 13vPnC Dose 2|Overall Study||55
6418040|NCT00980655|7332016|FG001|Vaccinated 13vPnC Dose 2|Overall Study||176
6418041|NCT00980655|7332015|FG000|Vaccinated 13vPnC Dose 3|Overall Study||54
6418042|NCT00980655|7332016|FG001|Vaccinated 13vPnC Dose 3|Overall Study||167
6418043|NCT00980655|7332015|FG000|Vaccinated 13vPnC Dose 4|Overall Study||46
6418044|NCT00980655|7332016|FG001|Vaccinated 13vPnC Dose 4|Overall Study||146
6418045|NCT00980655|7332015|FG000|Vaccinated 23vPS Dose|Overall Study||45
6418046|NCT00980655|7332016|FG001|Vaccinated 23vPS Dose|Overall Study||140
6418047|NCT00980655|7332015|FG000|COMPLETED|Overall Study||45
6418048|NCT00980655|7332016|FG001|COMPLETED|Overall Study||139
6418049|NCT00980655|7332015|FG000|NOT COMPLETED|Overall Study||16
6418050|NCT00980655|7332016|FG001|NOT COMPLETED|Overall Study||51
6418051|NCT00980681|7332027|FG000|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
6418052|NCT00980681|7332027|FG000|COMPLETED|TOF MRA||10
6418053|NCT00980681|7332027|FG000|NOT COMPLETED|TOF MRA||0
6418054|NCT00980681|7332027|FG000|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
6418055|NCT00980681|7332027|FG000|COMPLETED|Dotarem MRA||10
6418056|NCT00980681|7332027|FG000|NOT COMPLETED|Dotarem MRA||0
6418057|NCT00980746|7332039|FG000|STARTED|Overall Study||85
6418058|NCT00980746|7332040|FG001|STARTED|Overall Study||89
6418059|NCT00980746|7332041|FG002|STARTED|Overall Study||95
6418060|NCT00980746|7332042|FG003|STARTED|Overall Study||100
6418061|NCT00980746|7332043|FG004|STARTED|Overall Study||92
6418062|NCT00980746|7332044|FG005|STARTED|Overall Study||96
6418063|NCT00980746|7332039|FG000|Randomized|Overall Study||85
6418064|NCT00980746|7332040|FG001|Randomized|Overall Study||89
6418065|NCT00980746|7332041|FG002|Randomized|Overall Study||95
6418066|NCT00980746|7332042|FG003|Randomized|Overall Study||100
6418067|NCT00980746|7332043|FG004|Randomized|Overall Study||92
6418068|NCT00980746|7332044|FG005|Randomized|Overall Study||96
6418069|NCT00980746|7332039|FG000|Safety Population|Overall Study||85
6418070|NCT00980746|7332040|FG001|Safety Population|Overall Study||89
6418071|NCT00980746|7332041|FG002|Safety Population|Overall Study||95
6418072|NCT00980746|7332042|FG003|Safety Population|Overall Study||100
6418073|NCT00980746|7332043|FG004|Safety Population|Overall Study||92
6418074|NCT00980746|7332044|FG005|Safety Population|Overall Study||96
6418075|NCT00980746|7332039|FG000|Per-protocol|Overall Study||55
6418076|NCT00980746|7332040|FG001|Per-protocol|Overall Study||66
6418077|NCT00980746|7332041|FG002|Per-protocol|Overall Study||73
6418078|NCT00980746|7332042|FG003|Per-protocol|Overall Study||62
6418079|NCT00980746|7332043|FG004|Per-protocol|Overall Study||73
6418080|NCT00980746|7332044|FG005|Per-protocol|Overall Study||74
6418081|NCT00980746|7332039|FG000|COMPLETED|Overall Study||58
6418082|NCT00980746|7332040|FG001|COMPLETED|Overall Study||67
6418083|NCT00980746|7332041|FG002|COMPLETED|Overall Study||75
6418084|NCT00980746|7332042|FG003|COMPLETED|Overall Study||64
6418085|NCT00980746|7332043|FG004|COMPLETED|Overall Study||75
6418086|NCT00980746|7332044|FG005|COMPLETED|Overall Study||78
6418087|NCT00980746|7332039|FG000|NOT COMPLETED|Overall Study||27
6418088|NCT00980746|7332040|FG001|NOT COMPLETED|Overall Study||22
6418089|NCT00980746|7332041|FG002|NOT COMPLETED|Overall Study||20
6418090|NCT00980746|7332042|FG003|NOT COMPLETED|Overall Study||36
6418091|NCT00980746|7332043|FG004|NOT COMPLETED|Overall Study||17
6418092|NCT00980746|7332044|FG005|NOT COMPLETED|Overall Study||18
6418093|NCT00980785|7332060|FG000|STARTED|Overall Study||6
6418094|NCT00980785|7332061|FG001|STARTED|Overall Study||8
6418095|NCT00980785|7332060|FG000|COMPLETED|Overall Study||6
6418096|NCT00980785|7332061|FG001|COMPLETED|Overall Study||8
6418097|NCT00980785|7332060|FG000|NOT COMPLETED|Overall Study||0
6418098|NCT00980785|7332061|FG001|NOT COMPLETED|Overall Study||0
6418099|NCT00980798|7332069|FG000|STARTED|Overall Study||149
6418100|NCT00980798|7332070|FG001|STARTED|Overall Study||139
6418101|NCT00980798|7332069|FG000|COMPLETED|Overall Study||116
6418102|NCT00980798|7332070|FG001|COMPLETED|Overall Study||84
6418103|NCT00980798|7332069|FG000|NOT COMPLETED|Overall Study||33
6418104|NCT00980798|7332070|FG001|NOT COMPLETED|Overall Study||55
6418105|NCT00980980|7332079|FG000|STARTED|Overall Study||16
6418106|NCT00980980|7332080|FG001|STARTED|Overall Study||14
6418107|NCT00980980|7332081|FG002|STARTED|Overall Study||13
6418108|NCT00980980|7332079|FG000|COMPLETED|Overall Study||16
6418109|NCT00980980|7332080|FG001|COMPLETED|Overall Study||13
6418110|NCT00980980|7332081|FG002|COMPLETED|Overall Study||13
6418111|NCT00980980|7332079|FG000|NOT COMPLETED|Overall Study||0
6418112|NCT00980980|7332080|FG001|NOT COMPLETED|Overall Study||1
6418113|NCT00980980|7332081|FG002|NOT COMPLETED|Overall Study||0
6418114|NCT00981019|7332092|FG000|STARTED|Overall Study||778
6418115|NCT00981019|7332092|FG000|COMPLETED|Overall Study||301
6418116|NCT00981019|7332092|FG000|NOT COMPLETED|Overall Study||477
6418117|NCT00981045|7332098|FG000|STARTED|Overall Study||1290
6418118|NCT00981045|7332099|FG001|STARTED|Overall Study||1294
6418119|NCT00981045|7332098|FG000|COMPLETED|Overall Study||1276
6418120|NCT00981045|7332099|FG001|COMPLETED|Overall Study||1285
6418121|NCT00981045|7332098|FG000|NOT COMPLETED|Overall Study||14
6418122|NCT00981045|7332099|FG001|NOT COMPLETED|Overall Study||9
6418123|NCT00981084|7332107|FG000|STARTED|First Intervention (One Day)||16
6418124|NCT00981084|7332108|FG001|STARTED|First Intervention (One Day)||17
6418125|NCT00981084|7332107|FG000|COMPLETED|First Intervention (One Day)||16
6418126|NCT00981084|7332108|FG001|COMPLETED|First Intervention (One Day)||17
6418127|NCT00981084|7332107|FG000|NOT COMPLETED|First Intervention (One Day)||0
6418128|NCT00981084|7332108|FG001|NOT COMPLETED|First Intervention (One Day)||0
6418129|NCT00981084|7332107|FG000|STARTED|Washout Period (7 Days)||16
6418130|NCT00981084|7332108|FG001|STARTED|Washout Period (7 Days)||17
6418131|NCT00981084|7332107|FG000|COMPLETED|Washout Period (7 Days)||16
6418132|NCT00981084|7332108|FG001|COMPLETED|Washout Period (7 Days)||17
6418133|NCT00981084|7332107|FG000|NOT COMPLETED|Washout Period (7 Days)||0
6418134|NCT00981084|7332108|FG001|NOT COMPLETED|Washout Period (7 Days)||0
6418135|NCT00981084|7332107|FG000|STARTED|Second Intervention (One Day)||16
6418136|NCT00981084|7332108|FG001|STARTED|Second Intervention (One Day)||17
6418137|NCT00981084|7332107|FG000|COMPLETED|Second Intervention (One Day)||16
6418138|NCT00981084|7332108|FG001|COMPLETED|Second Intervention (One Day)||17
6418139|NCT00981084|7332107|FG000|NOT COMPLETED|Second Intervention (One Day)||0
6418140|NCT00981084|7332108|FG001|NOT COMPLETED|Second Intervention (One Day)||0
6418141|NCT00981084|7332107|FG000|STARTED|Post Intervention (Data Analysis)||16
6418142|NCT00981084|7332108|FG001|STARTED|Post Intervention (Data Analysis)||17
6418143|NCT00981084|7332107|FG000|COMPLETED|Post Intervention (Data Analysis)||14
6418144|NCT00981084|7332108|FG001|COMPLETED|Post Intervention (Data Analysis)||16
6418145|NCT00981084|7332107|FG000|NOT COMPLETED|Post Intervention (Data Analysis)||2
6418146|NCT00981084|7332108|FG001|NOT COMPLETED|Post Intervention (Data Analysis)||1
6418147|NCT00981149|7332118|FG000|STARTED|Overall Study||12
6418148|NCT00981149|7332119|FG001|STARTED|Overall Study||12
6418149|NCT00981149|7332118|FG000|COMPLETED|Overall Study||10
6418150|NCT00981149|7332119|FG001|COMPLETED|Overall Study||9
6418151|NCT00981149|7332118|FG000|NOT COMPLETED|Overall Study||2
6418152|NCT00981149|7332119|FG001|NOT COMPLETED|Overall Study||3
6418153|NCT00981175|7332128|FG000|STARTED|Primary Dose Vaccination||101
6418154|NCT00981175|7332129|FG001|STARTED|Primary Dose Vaccination||101
6418155|NCT00981175|7332128|FG000|COMPLETED|Primary Dose Vaccination||98
6418156|NCT00981175|7332129|FG001|COMPLETED|Primary Dose Vaccination||99
6418157|NCT00981175|7332128|FG000|NOT COMPLETED|Primary Dose Vaccination||3
6418158|NCT00981175|7332129|FG001|NOT COMPLETED|Primary Dose Vaccination||2
6418159|NCT00981175|7332128|FG000|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
6418160|NCT00981175|7332129|FG001|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
6418161|NCT00981175|7332128|FG000|COMPLETED|Booster Dose Vaccination||53
6418162|NCT00981175|7332129|FG001|COMPLETED|Booster Dose Vaccination||40
6418163|NCT00981175|7332128|FG000|NOT COMPLETED|Booster Dose Vaccination||2
6418164|NCT00981175|7332129|FG001|NOT COMPLETED|Booster Dose Vaccination||3
6418165|NCT00981214|7332142|FG000|STARTED|Overall Study||19
6418166|NCT00981214|7332142|FG000|COMPLETED|Overall Study||19
6418167|NCT00981214|7332142|FG000|NOT COMPLETED|Overall Study||0
6418168|NCT00981227|7332152|FG000|STARTED|Overall Study||102
6418169|NCT00981227|7332153|FG001|STARTED|Overall Study||94
6418170|NCT00981227|7332154|FG002|STARTED|Overall Study||94
6418171|NCT00981227|7332155|FG003|STARTED|Overall Study||94
6418172|NCT00981227|7332156|FG004|STARTED|Overall Study||90
6418173|NCT00981227|7332157|FG005|STARTED|Overall Study||93
6418174|NCT00981227|7332152|FG000|Randomized|Overall Study||102
6418175|NCT00981227|7332153|FG001|Randomized|Overall Study||94
6418176|NCT00981227|7332154|FG002|Randomized|Overall Study||94
6418177|NCT00981227|7332155|FG003|Randomized|Overall Study||94
6418178|NCT00981227|7332156|FG004|Randomized|Overall Study||90
6418179|NCT00981227|7332157|FG005|Randomized|Overall Study||93
6418180|NCT00981227|7332152|FG000|Safety Population|Overall Study||102
6418181|NCT00981227|7332153|FG001|Safety Population|Overall Study||94
6418182|NCT00981227|7332154|FG002|Safety Population|Overall Study||94
6418183|NCT00981227|7332155|FG003|Safety Population|Overall Study||94
6418184|NCT00981227|7332156|FG004|Safety Population|Overall Study||90
6418185|NCT00981227|7332157|FG005|Safety Population|Overall Study||93
6418186|NCT00981227|7332152|FG000|Per-Protocol|Overall Study||69
6418187|NCT00981227|7332153|FG001|Per-Protocol|Overall Study||72
6418188|NCT00981227|7332154|FG002|Per-Protocol|Overall Study||67
6418189|NCT00981227|7332155|FG003|Per-Protocol|Overall Study||68
6418190|NCT00981227|7332156|FG004|Per-Protocol|Overall Study||50
6418191|NCT00981227|7332157|FG005|Per-Protocol|Overall Study||70
6638844|NCT02325713|7567350|FG006|COMPLETED|Intervention Period 1 (2 Days)||2
6638845|NCT02325713|7567351|FG007|COMPLETED|Intervention Period 1 (2 Days)||2
6638846|NCT02325713|7567352|FG008|COMPLETED|Intervention Period 1 (2 Days)||2
6418192|NCT00981227|7332152|FG000|COMPLETED|Overall Study||80
6418193|NCT00981227|7332153|FG001|COMPLETED|Overall Study||75
6418194|NCT00981227|7332154|FG002|COMPLETED|Overall Study||73
6638847|NCT02325713|7567353|FG009|COMPLETED|Intervention Period 1 (2 Days)||2
6304167|NCT00364793|7207487|FG002|COMPLETED|Overall Study||0
6304168|NCT00364793|7207488|FG003|COMPLETED|Overall Study||5
6304169|NCT00364793|7207485|FG000|NOT COMPLETED|Overall Study||8
6304170|NCT00364793|7207486|FG001|NOT COMPLETED|Overall Study||5
6304171|NCT00364793|7207487|FG002|NOT COMPLETED|Overall Study||4
6418195|NCT00981227|7332155|FG003|COMPLETED|Overall Study||73
6418196|NCT00981227|7332156|FG004|COMPLETED|Overall Study||60
6418197|NCT00981227|7332157|FG005|COMPLETED|Overall Study||75
6418198|NCT00981227|7332152|FG000|NOT COMPLETED|Overall Study||22
6418199|NCT00981227|7332153|FG001|NOT COMPLETED|Overall Study||19
6418200|NCT00981227|7332154|FG002|NOT COMPLETED|Overall Study||21
6418201|NCT00981227|7332155|FG003|NOT COMPLETED|Overall Study||21
6418202|NCT00981227|7332156|FG004|NOT COMPLETED|Overall Study||30
6418203|NCT00981227|7332157|FG005|NOT COMPLETED|Overall Study||18
6418204|NCT00981253|7332177|FG000|STARTED|Overall Study||76
6418205|NCT00981253|7332178|FG001|STARTED|Overall Study||75
6418206|NCT00981253|7332177|FG000|COMPLETED|Overall Study||73
6418207|NCT00981253|7332178|FG001|COMPLETED|Overall Study||72
6418208|NCT00981253|7332177|FG000|NOT COMPLETED|Overall Study||3
6418209|NCT00981253|7332178|FG001|NOT COMPLETED|Overall Study||3
6418210|NCT00981292|7332191|FG000|STARTED|Day 1||7
6418211|NCT00981292|7332192|FG001|STARTED|Day 1||4
6418212|NCT00981292|7332193|FG002|STARTED|Day 1||6
6418213|NCT00981292|7332194|FG003|STARTED|Day 1||4
6418214|NCT00981292|7332195|FG004|STARTED|Day 1||4
6418215|NCT00981292|7332196|FG005|STARTED|Day 1||7
6418216|NCT00981292|7332191|FG000|COMPLETED|Day 1||6
6418217|NCT00981292|7332192|FG001|COMPLETED|Day 1||4
6418218|NCT00981292|7332193|FG002|COMPLETED|Day 1||6
6418219|NCT00981292|7332194|FG003|COMPLETED|Day 1||4
6418220|NCT00981292|7332195|FG004|COMPLETED|Day 1||4
6418221|NCT00981292|7332196|FG005|COMPLETED|Day 1||5
6418222|NCT00981292|7332191|FG000|NOT COMPLETED|Day 1||1
6418223|NCT00981292|7332192|FG001|NOT COMPLETED|Day 1||0
6418224|NCT00981292|7332193|FG002|NOT COMPLETED|Day 1||0
6418225|NCT00981292|7332194|FG003|NOT COMPLETED|Day 1||0
6418226|NCT00981292|7332195|FG004|NOT COMPLETED|Day 1||0
6418227|NCT00981292|7332196|FG005|NOT COMPLETED|Day 1||2
6418228|NCT00981292|7332191|FG000|STARTED|Day 2||6
6418229|NCT00981292|7332192|FG001|STARTED|Day 2||4
6418230|NCT00981292|7332193|FG002|STARTED|Day 2||6
6418231|NCT00981292|7332194|FG003|STARTED|Day 2||4
6418232|NCT00981292|7332195|FG004|STARTED|Day 2||4
6418233|NCT00981292|7332196|FG005|STARTED|Day 2||5
6418234|NCT00981292|7332191|FG000|COMPLETED|Day 2||4
6418235|NCT00981292|7332192|FG001|COMPLETED|Day 2||4
6418236|NCT00981292|7332193|FG002|COMPLETED|Day 2||6
6418237|NCT00981292|7332194|FG003|COMPLETED|Day 2||4
6418238|NCT00981292|7332195|FG004|COMPLETED|Day 2||4
6418239|NCT00981292|7332196|FG005|COMPLETED|Day 2||5
6418240|NCT00981292|7332191|FG000|NOT COMPLETED|Day 2||2
6418241|NCT00981292|7332192|FG001|NOT COMPLETED|Day 2||0
6418242|NCT00981292|7332193|FG002|NOT COMPLETED|Day 2||0
6418243|NCT00981292|7332194|FG003|NOT COMPLETED|Day 2||0
6418244|NCT00981292|7332195|FG004|NOT COMPLETED|Day 2||0
6418245|NCT00981292|7332196|FG005|NOT COMPLETED|Day 2||0
6418246|NCT00981292|7332191|FG000|STARTED|Day 3||4
6418247|NCT00981292|7332192|FG001|STARTED|Day 3||4
6418248|NCT00981292|7332193|FG002|STARTED|Day 3||6
6418249|NCT00981292|7332194|FG003|STARTED|Day 3||4
6418250|NCT00981292|7332195|FG004|STARTED|Day 3||4
6418251|NCT00981292|7332196|FG005|STARTED|Day 3||5
6418252|NCT00981292|7332191|FG000|COMPLETED|Day 3||4
6418253|NCT00981292|7332192|FG001|COMPLETED|Day 3||4
6638848|NCT02325713|7567354|FG010|COMPLETED|Intervention Period 1 (2 Days)||1
6638849|NCT02325713|7567355|FG011|COMPLETED|Intervention Period 1 (2 Days)||2
6638850|NCT02325713|7567356|FG012|COMPLETED|Intervention Period 1 (2 Days)||2
6638851|NCT02325713|7567357|FG013|COMPLETED|Intervention Period 1 (2 Days)||2
6638852|NCT02325713|7567358|FG014|COMPLETED|Intervention Period 1 (2 Days)||2
6638853|NCT02325713|7567359|FG015|COMPLETED|Intervention Period 1 (2 Days)||2
6638854|NCT02325713|7567344|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638855|NCT02325713|7567345|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638856|NCT02325713|7567346|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638857|NCT02325713|7567347|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638858|NCT02325713|7567348|FG004|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638859|NCT02325713|7567349|FG005|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638860|NCT02325713|7567350|FG006|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638861|NCT02325713|7567351|FG007|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638862|NCT02325713|7567352|FG008|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638863|NCT02325713|7567353|FG009|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638864|NCT02325713|7567354|FG010|NOT COMPLETED|Intervention Period 1 (2 Days)||1
6638865|NCT02325713|7567355|FG011|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638866|NCT02325713|7567356|FG012|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638867|NCT02325713|7567357|FG013|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6418254|NCT00981292|7332193|FG002|COMPLETED|Day 3||6
6418255|NCT00981292|7332194|FG003|COMPLETED|Day 3||4
6418256|NCT00981292|7332195|FG004|COMPLETED|Day 3||4
6418257|NCT00981292|7332196|FG005|COMPLETED|Day 3||4
6418258|NCT00981292|7332191|FG000|NOT COMPLETED|Day 3||0
6418259|NCT00981292|7332192|FG001|NOT COMPLETED|Day 3||0
6418260|NCT00981292|7332193|FG002|NOT COMPLETED|Day 3||0
6418261|NCT00981292|7332194|FG003|NOT COMPLETED|Day 3||0
6418262|NCT00981292|7332195|FG004|NOT COMPLETED|Day 3||0
6418263|NCT00981292|7332196|FG005|NOT COMPLETED|Day 3||1
6418264|NCT00981305|7332210|FG000|STARTED|Overall Study||69
6418265|NCT00981305|7332211|FG001|STARTED|Overall Study||67
6418266|NCT00981305|7332210|FG000|COMPLETED|Overall Study||50
6418267|NCT00981305|7332211|FG001|COMPLETED|Overall Study||57
6638868|NCT02325713|7567358|FG014|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6418268|NCT00981305|7332210|FG000|NOT COMPLETED|Overall Study||19
6418269|NCT00981305|7332211|FG001|NOT COMPLETED|Overall Study||10
6418270|NCT00981409|7332219|FG000|STARTED|Overall Study||30
6418271|NCT00981409|7332220|FG001|STARTED|Overall Study||11
6418272|NCT00981409|7332219|FG000|COMPLETED|Overall Study||24
6418273|NCT00981409|7332220|FG001|COMPLETED|Overall Study||10
6418274|NCT00981409|7332219|FG000|NOT COMPLETED|Overall Study||6
6418275|NCT00981409|7332220|FG001|NOT COMPLETED|Overall Study||1
6418276|NCT00981435|7332229|FG000|STARTED|Overall Study||31
6418277|NCT00981435|7332230|FG001|STARTED|Overall Study||29
6418278|NCT00981435|7332231|FG002|STARTED|Overall Study||37
6418279|NCT00981435|7332229|FG000|COMPLETED|Overall Study||31
6418280|NCT00981435|7332230|FG001|COMPLETED|Overall Study||29
6418281|NCT00981435|7332231|FG002|COMPLETED|Overall Study||37
6418282|NCT00981435|7332229|FG000|NOT COMPLETED|Overall Study||0
6418283|NCT00981435|7332230|FG001|NOT COMPLETED|Overall Study||0
6418284|NCT00981435|7332231|FG002|NOT COMPLETED|Overall Study||0
6418285|NCT00981461|7332241|FG000|STARTED|Overall Study||48
6418286|NCT00981461|7332242|FG001|STARTED|Overall Study||24
6418287|NCT00981461|7332241|FG000|COMPLETED|Overall Study||43
6418288|NCT00981461|7332242|FG001|COMPLETED|Overall Study||22
6418289|NCT00981461|7332241|FG000|NOT COMPLETED|Overall Study||5
6418290|NCT00981461|7332242|FG001|NOT COMPLETED|Overall Study||2
6418291|NCT00981474|7332250|FG000|STARTED|Overall Study||228
6418292|NCT00981474|7332251|FG001|STARTED|Overall Study||232
6418293|NCT00981474|7332250|FG000|COMPLETED|Overall Study||228
6418294|NCT00981474|7332251|FG001|COMPLETED|Overall Study||232
6418295|NCT00981474|7332250|FG000|NOT COMPLETED|Overall Study||0
6418296|NCT00981474|7332251|FG001|NOT COMPLETED|Overall Study||0
6418297|NCT00981526|7332261|FG000|STARTED|Overall Study||26
6418298|NCT00981526|7332262|FG001|STARTED|Overall Study||28
6418299|NCT00981526|7332261|FG000|COMPLETED|Overall Study||22
6418300|NCT00981526|7332262|FG001|COMPLETED|Overall Study||22
6418301|NCT00981526|7332261|FG000|NOT COMPLETED|Overall Study||4
6418302|NCT00981526|7332262|FG001|NOT COMPLETED|Overall Study||6
6418303|NCT00981578|7332270|FG000|STARTED|Overall Study||17
6418304|NCT00981578|7332270|FG000|COMPLETED|Overall Study||14
6418305|NCT00981578|7332270|FG000|NOT COMPLETED|Overall Study||3
6418306|NCT00981630|7332278|FG000|STARTED|Overall Study||32
6418307|NCT00981630|7332279|FG001|STARTED|Overall Study||32
6418308|NCT00981630|7332280|FG002|STARTED|Overall Study||32
6418309|NCT00981630|7332281|FG003|STARTED|Overall Study||32
6418310|NCT00981630|7332278|FG000|COMPLETED|Overall Study||32
6418311|NCT00981630|7332279|FG001|COMPLETED|Overall Study||32
6418312|NCT00981630|7332280|FG002|COMPLETED|Overall Study||32
6418313|NCT00981630|7332281|FG003|COMPLETED|Overall Study||32
6418314|NCT00981630|7332278|FG000|NOT COMPLETED|Overall Study||0
6418315|NCT00981630|7332279|FG001|NOT COMPLETED|Overall Study||0
6418316|NCT00981630|7332280|FG002|NOT COMPLETED|Overall Study||0
6418317|NCT00981630|7332281|FG003|NOT COMPLETED|Overall Study||0
6418318|NCT00981669|7332293|FG000|STARTED|Overall Study||40
6418319|NCT00981669|7332294|FG001|STARTED|Overall Study||40
6418320|NCT00981669|7332293|FG000|COMPLETED|Overall Study||39
6638869|NCT02325713|7567359|FG015|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6638870|NCT02325713|7567344|FG000|STARTED|Intervention Period 2 (2 Days)||2
6638871|NCT02325713|7567345|FG001|STARTED|Intervention Period 2 (2 Days)||2
6638872|NCT02325713|7567346|FG002|STARTED|Intervention Period 2 (2 Days)||2
6638873|NCT02325713|7567347|FG003|STARTED|Intervention Period 2 (2 Days)||2
6638874|NCT02325713|7567348|FG004|STARTED|Intervention Period 2 (2 Days)||2
6638875|NCT02325713|7567349|FG005|STARTED|Intervention Period 2 (2 Days)||2
6638876|NCT02325713|7567350|FG006|STARTED|Intervention Period 2 (2 Days)||2
6638877|NCT02325713|7567351|FG007|STARTED|Intervention Period 2 (2 Days)||2
6638878|NCT02325713|7567352|FG008|STARTED|Intervention Period 2 (2 Days)||2
6638879|NCT02325713|7567353|FG009|STARTED|Intervention Period 2 (2 Days)||2
6638880|NCT02325713|7567354|FG010|STARTED|Intervention Period 2 (2 Days)||1
6638881|NCT02325713|7567355|FG011|STARTED|Intervention Period 2 (2 Days)||2
6638882|NCT02325713|7567356|FG012|STARTED|Intervention Period 2 (2 Days)||2
6638883|NCT02325713|7567357|FG013|STARTED|Intervention Period 2 (2 Days)||2
6638884|NCT02325713|7567358|FG014|STARTED|Intervention Period 2 (2 Days)||2
6638885|NCT02325713|7567359|FG015|STARTED|Intervention Period 2 (2 Days)||2
6638886|NCT02325713|7567344|FG000|COMPLETED|Intervention Period 2 (2 Days)||1
6638887|NCT02325713|7567345|FG001|COMPLETED|Intervention Period 2 (2 Days)||2
6638888|NCT02325713|7567346|FG002|COMPLETED|Intervention Period 2 (2 Days)||2
6638889|NCT02325713|7567347|FG003|COMPLETED|Intervention Period 2 (2 Days)||2
6638890|NCT02325713|7567348|FG004|COMPLETED|Intervention Period 2 (2 Days)||2
6638891|NCT02325713|7567349|FG005|COMPLETED|Intervention Period 2 (2 Days)||2
6638892|NCT02325713|7567350|FG006|COMPLETED|Intervention Period 2 (2 Days)||2
6638893|NCT02325713|7567351|FG007|COMPLETED|Intervention Period 2 (2 Days)||2
6743524|NCT03334747|7671731|FG007|COMPLETED|Follow-Up Phase||22
6743525|NCT03334747|7671732|FG008|COMPLETED|Follow-Up Phase||50
6418321|NCT00981669|7332294|FG001|COMPLETED|Overall Study||40
6418322|NCT00981669|7332293|FG000|NOT COMPLETED|Overall Study||1
6418323|NCT00981669|7332294|FG001|NOT COMPLETED|Overall Study||0
6638894|NCT02325713|7567352|FG008|COMPLETED|Intervention Period 2 (2 Days)||2
6638895|NCT02325713|7567353|FG009|COMPLETED|Intervention Period 2 (2 Days)||2
6743526|NCT03334747|7671724|FG000|NOT COMPLETED|Follow-Up Phase||0
6418324|NCT00981682|7332300|FG000|STARTED|Overall Study||376
6418325|NCT00981682|7332300|FG000|COMPLETED|Overall Study||234
6418326|NCT00981682|7332300|FG000|NOT COMPLETED|Overall Study||142
6418327|NCT00981747|7332304|FG000|STARTED|Losartan||12
6418328|NCT00981747|7332304|FG000|Started Losartan|Losartan||12
6418329|NCT00981747|7332304|FG000|Completed Losartan|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
6418330|NCT00981747|7332304|FG000|COMPLETED|Losartan|Only 9 were analyzed because only 9 completed all four interventions.|10
6418331|NCT00981747|7332304|FG000|NOT COMPLETED|Losartan||2
6418332|NCT00981747|7332304|FG000|STARTED|Placebo Oral Tablet||10
6418333|NCT00981747|7332304|FG000|Started Placebo Oral Tablet|Placebo Oral Tablet||10
6418334|NCT00981747|7332304|FG000|Completed Placebo Oral Tablet|Placebo Oral Tablet||9
6418335|NCT00981747|7332304|FG000|COMPLETED|Placebo Oral Tablet||9
6418336|NCT00981747|7332304|FG000|NOT COMPLETED|Placebo Oral Tablet||1
6418337|NCT00981747|7332304|FG000|STARTED|Sildenafil||9
6418338|NCT00981747|7332304|FG000|Started Sildenafil|Sildenafil||9
6418339|NCT00981747|7332304|FG000|Completed Sildenafil|Sildenafil||9
6418340|NCT00981747|7332304|FG000|COMPLETED|Sildenafil||9
6418341|NCT00981747|7332304|FG000|NOT COMPLETED|Sildenafil||0
6418342|NCT00981747|7332304|FG000|STARTED|Sildenafil and Losartan||9
6418343|NCT00981747|7332304|FG000|Started Sildenafil and Losartan|Sildenafil and Losartan||9
6418344|NCT00981747|7332304|FG000|Completed Sildenafil and Losartan|Sildenafil and Losartan||9
6418345|NCT00981747|7332304|FG000|COMPLETED|Sildenafil and Losartan||9
6418346|NCT00981747|7332304|FG000|NOT COMPLETED|Sildenafil and Losartan||0
6418347|NCT00981799|7332318|FG000|STARTED|Overall Study||6
6418348|NCT00981799|7332319|FG001|STARTED|Overall Study||7
6418349|NCT00981799|7332320|FG002|STARTED|Overall Study||10
6418350|NCT00981799|7332321|FG003|STARTED|Overall Study||0
6418351|NCT00981799|7332318|FG000|COMPLETED|Overall Study||5
6418352|NCT00981799|7332319|FG001|COMPLETED|Overall Study||6
6418353|NCT00981799|7332320|FG002|COMPLETED|Overall Study||10
6418354|NCT00981799|7332321|FG003|COMPLETED|Overall Study||0
6418355|NCT00981799|7332318|FG000|NOT COMPLETED|Overall Study||1
6418356|NCT00981799|7332319|FG001|NOT COMPLETED|Overall Study||1
6418357|NCT00981799|7332320|FG002|NOT COMPLETED|Overall Study||0
6418358|NCT00981799|7332321|FG003|NOT COMPLETED|Overall Study||0
6418359|NCT00981812|7332332|FG000|STARTED|Overall Study||20
6418360|NCT00981812|7332332|FG000|COMPLETED|Overall Study||20
6418361|NCT00981812|7332332|FG000|NOT COMPLETED|Overall Study||0
6418362|NCT00981825|7332338|FG000|STARTED|First Intervention||11
6418363|NCT00981825|7332339|FG001|STARTED|First Intervention||11
6418364|NCT00981825|7332338|FG000|COMPLETED|First Intervention||11
6418365|NCT00981825|7332339|FG001|COMPLETED|First Intervention||11
6418366|NCT00981825|7332338|FG000|NOT COMPLETED|First Intervention||0
6418367|NCT00981825|7332339|FG001|NOT COMPLETED|First Intervention||0
6418368|NCT00981825|7332338|FG000|STARTED|Washout After 1st Intervention||11
6418369|NCT00981825|7332339|FG001|STARTED|Washout After 1st Intervention||11
6418370|NCT00981825|7332338|FG000|COMPLETED|Washout After 1st Intervention||11
6418371|NCT00981825|7332339|FG001|COMPLETED|Washout After 1st Intervention||11
6418372|NCT00981825|7332338|FG000|NOT COMPLETED|Washout After 1st Intervention||0
6418373|NCT00981825|7332339|FG001|NOT COMPLETED|Washout After 1st Intervention||0
6418374|NCT00981825|7332338|FG000|STARTED|Second Intervention||11
6418375|NCT00981825|7332339|FG001|STARTED|Second Intervention||11
6418376|NCT00981825|7332338|FG000|COMPLETED|Second Intervention||11
6418377|NCT00981825|7332339|FG001|COMPLETED|Second Intervention||11
6418378|NCT00981825|7332338|FG000|NOT COMPLETED|Second Intervention||0
6418379|NCT00981825|7332339|FG001|NOT COMPLETED|Second Intervention||0
6418380|NCT00982007|7332349|FG000|STARTED|Overall Study||250
6418381|NCT00982007|7332350|FG001|STARTED|Overall Study||257
6418382|NCT00982007|7332351|FG002|STARTED|Overall Study||253
6418383|NCT00982007|7332352|FG003|STARTED|Overall Study||251
6418384|NCT00982007|7332349|FG000|COMPLETED|Overall Study||246
6418385|NCT00982007|7332350|FG001|COMPLETED|Overall Study||253
6418386|NCT00982007|7332351|FG002|COMPLETED|Overall Study||253
6418387|NCT00982007|7332352|FG003|COMPLETED|Overall Study||245
6418388|NCT00982007|7332349|FG000|NOT COMPLETED|Overall Study||4
6638896|NCT02325713|7567354|FG010|COMPLETED|Intervention Period 2 (2 Days)||1
6638897|NCT02325713|7567355|FG011|COMPLETED|Intervention Period 2 (2 Days)||2
6418389|NCT00982007|7332350|FG001|NOT COMPLETED|Overall Study||4
6561242|NCT01791517|7484044|FG003|COMPLETED|Phase II||15
6418390|NCT00982007|7332351|FG002|NOT COMPLETED|Overall Study||0
6418391|NCT00982007|7332352|FG003|NOT COMPLETED|Overall Study||6
6561243|NCT01791517|7484045|FG004|COMPLETED|Phase II||16
6561244|NCT01791517|7484046|FG005|COMPLETED|Phase II||14
6561245|NCT01791517|7484047|FG006|COMPLETED|Phase II||17
6561246|NCT01791517|7484048|FG007|COMPLETED|Phase II||17
6561247|NCT01791517|7484049|FG008|COMPLETED|Phase II||17
6561248|NCT01791517|7484050|FG009|COMPLETED|Phase II||15
6561249|NCT01791517|7484051|FG010|COMPLETED|Phase II||15
6561250|NCT01791517|7484052|FG011|COMPLETED|Phase II||17
6561251|NCT01791517|7484041|FG000|NOT COMPLETED|Phase II||2
6561252|NCT01791517|7484042|FG001|NOT COMPLETED|Phase II||0
6561253|NCT01791517|7484043|FG002|NOT COMPLETED|Phase II||1
6561254|NCT01791517|7484044|FG003|NOT COMPLETED|Phase II||0
6561255|NCT01791517|7484045|FG004|NOT COMPLETED|Phase II||2
6561256|NCT01791517|7484046|FG005|NOT COMPLETED|Phase II||4
6561257|NCT01791517|7484047|FG006|NOT COMPLETED|Phase II||2
6561258|NCT01791517|7484048|FG007|NOT COMPLETED|Phase II||3
6561259|NCT01791517|7484049|FG008|NOT COMPLETED|Phase II||2
6561260|NCT01791517|7484050|FG009|NOT COMPLETED|Phase II||3
6561261|NCT01791517|7484051|FG010|NOT COMPLETED|Phase II||1
6561262|NCT01791517|7484052|FG011|NOT COMPLETED|Phase II||1
6418392|NCT00982020|7332364|FG000|STARTED|Overall Study||102
6418393|NCT00982020|7332365|FG001|STARTED|Overall Study||101
6418394|NCT00982020|7332364|FG000|Received at Least 1 Dose of Study Drug|Overall Study||102
6418395|NCT00982020|7332365|FG001|Received at Least 1 Dose of Study Drug|Overall Study||101
6418396|NCT00982020|7332364|FG000|COMPLETED|Overall Study||45
6418397|NCT00982020|7332365|FG001|COMPLETED|Overall Study||37
6418398|NCT00982020|7332364|FG000|NOT COMPLETED|Overall Study||57
6418399|NCT00982020|7332365|FG001|NOT COMPLETED|Overall Study||64
6418400|NCT00982033|7332378|FG000|STARTED|Overall Study||25
6418401|NCT00982033|7332379|FG001|STARTED|Overall Study||27
6418402|NCT00982033|7332378|FG000|COMPLETED|Overall Study||25
6418403|NCT00982033|7332379|FG001|COMPLETED|Overall Study||27
6418404|NCT00982033|7332378|FG000|NOT COMPLETED|Overall Study||0
6418405|NCT00982033|7332379|FG001|NOT COMPLETED|Overall Study||0
6418406|NCT00982072|7332387|FG000|STARTED|Overall Study||25
6418407|NCT00982072|7332388|FG001|STARTED|Overall Study||27
6418408|NCT00982072|7332387|FG000|COMPLETED|Overall Study||25
6418409|NCT00982072|7332388|FG001|COMPLETED|Overall Study||25
6418410|NCT00982072|7332387|FG000|NOT COMPLETED|Overall Study||0
6418411|NCT00982072|7332388|FG001|NOT COMPLETED|Overall Study||2
6418412|NCT00982137|7332398|FG000|STARTED|Overall Study||36
6418413|NCT00982137|7332399|FG001|STARTED|Overall Study||36
6418414|NCT00982137|7332400|FG002|STARTED|Overall Study||18
6418415|NCT00982137|7332401|FG003|STARTED|Overall Study||18
6418416|NCT00982137|7332398|FG000|COMPLETED|Overall Study||36
6418417|NCT00982137|7332399|FG001|COMPLETED|Overall Study||35
6418418|NCT00982137|7332400|FG002|COMPLETED|Overall Study||18
6418419|NCT00982137|7332401|FG003|COMPLETED|Overall Study||17
6418420|NCT00982137|7332398|FG000|NOT COMPLETED|Overall Study||0
6418421|NCT00982137|7332399|FG001|NOT COMPLETED|Overall Study||1
6418422|NCT00982137|7332400|FG002|NOT COMPLETED|Overall Study||0
6418423|NCT00982137|7332401|FG003|NOT COMPLETED|Overall Study||1
6418424|NCT00982189|7332422|FG000|STARTED|Overall Study||10
6418425|NCT00982189|7332423|FG001|STARTED|Overall Study||9
6418426|NCT00982189|7332424|FG002|STARTED|Overall Study||9
6418427|NCT00982189|7332425|FG003|STARTED|Overall Study||9
6418428|NCT00982189|7332422|FG000|COMPLETED|Overall Study||10
6418429|NCT00982189|7332423|FG001|COMPLETED|Overall Study||9
6418430|NCT00982189|7332424|FG002|COMPLETED|Overall Study||9
6418431|NCT00982189|7332425|FG003|COMPLETED|Overall Study||9
6418432|NCT00982189|7332422|FG000|NOT COMPLETED|Overall Study||0
6418433|NCT00982189|7332423|FG001|NOT COMPLETED|Overall Study||0
6418434|NCT00982189|7332424|FG002|NOT COMPLETED|Overall Study||0
6418435|NCT00982189|7332425|FG003|NOT COMPLETED|Overall Study||0
6418436|NCT00982228|7332439|FG000|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
6418437|NCT00982228|7332440|FG001|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
6418438|NCT00982228|7332439|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
6418439|NCT00982228|7332440|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
6418440|NCT00982228|7332439|FG000|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
6418441|NCT00982228|7332440|FG001|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
6418442|NCT00982228|7332439|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
6418443|NCT00982228|7332440|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
6418444|NCT00982228|7332439|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
6418445|NCT00982228|7332440|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
6418446|NCT00982228|7332439|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
6418447|NCT00982228|7332440|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
6418448|NCT00982228|7332439|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
6418449|NCT00982228|7332440|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
6418450|NCT00982228|7332439|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
6418451|NCT00982228|7332440|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
6418452|NCT00982280|7332446|FG000|STARTED|Observation Period||82
6418453|NCT00982280|7332446|FG000|COMPLETED|Observation Period||63
6418454|NCT00982280|7332446|FG000|NOT COMPLETED|Observation Period||19
6418455|NCT00982280|7332446|FG000|STARTED|Titration and Optimal Dose Period||63
6418456|NCT00982280|7332446|FG000|COMPLETED|Titration and Optimal Dose Period||55
6418457|NCT00982280|7332446|FG000|NOT COMPLETED|Titration and Optimal Dose Period||8
6418458|NCT00982280|7332446|FG000|STARTED|Maintenance Period||55
6418459|NCT00982280|7332446|FG000|COMPLETED|Maintenance Period||54
6418460|NCT00982280|7332446|FG000|NOT COMPLETED|Maintenance Period||1
6418461|NCT00982319|7332453|FG000|STARTED|Overall Study||17
6418462|NCT00982319|7332454|FG001|STARTED|Overall Study||17
6418463|NCT00982319|7332453|FG000|COMPLETED|Overall Study||15
6418464|NCT00982319|7332454|FG001|COMPLETED|Overall Study||15
6418465|NCT00982319|7332453|FG000|NOT COMPLETED|Overall Study||2
6418466|NCT00982319|7332454|FG001|NOT COMPLETED|Overall Study||2
6418467|NCT00982345|7332460|FG000|STARTED|Overall Study||20
6418468|NCT00982345|7332460|FG000|COMPLETED|Overall Study||18
6418469|NCT00982345|7332460|FG000|NOT COMPLETED|Overall Study||2
6418470|NCT00982397|7332466|FG000|STARTED|Phase I||236
6418471|NCT00982397|7332467|FG001|STARTED|Phase I||0
6418472|NCT00982397|7332466|FG000|COMPLETED|Phase I||236
6418473|NCT00982397|7332467|FG001|COMPLETED|Phase I||0
6418474|NCT00982397|7332466|FG000|NOT COMPLETED|Phase I||0
6418475|NCT00982397|7332467|FG001|NOT COMPLETED|Phase I||0
6418476|NCT00982397|7332466|FG000|STARTED|Phase II/Overall Study||2019
6638898|NCT02325713|7567356|FG012|COMPLETED|Intervention Period 2 (2 Days)||2
6638899|NCT02325713|7567357|FG013|COMPLETED|Intervention Period 2 (2 Days)||2
6638900|NCT02325713|7567358|FG014|COMPLETED|Intervention Period 2 (2 Days)||2
6638901|NCT02325713|7567359|FG015|COMPLETED|Intervention Period 2 (2 Days)||2
6638902|NCT02325713|7567344|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
6638903|NCT02325713|7567345|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638904|NCT02325713|7567346|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638905|NCT02325713|7567347|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638906|NCT02325713|7567348|FG004|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6418477|NCT00982397|7332467|FG001|STARTED|Phase II/Overall Study||751
6418478|NCT00982397|7332466|FG000|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||231
6418479|NCT00982397|7332467|FG001|Secondary Prevention Randomized 18/24NID|Phase II/Overall Study||122
6418480|NCT00982397|7332466|FG000|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||221
6418481|NCT00982397|7332467|FG001|Secondary Prevention Randomized 30/40NID|Phase II/Overall Study||131
6418482|NCT00982397|7332466|FG000|COMPLETED|Phase II/Overall Study||2019
6418483|NCT00982397|7332467|FG001|COMPLETED|Phase II/Overall Study||751
6418484|NCT00982397|7332466|FG000|NOT COMPLETED|Phase II/Overall Study||0
6418485|NCT00982397|7332467|FG001|NOT COMPLETED|Phase II/Overall Study||0
6418486|NCT00982410|7332478|FG000|STARTED|3-month Follow-up Assessment||65
6418487|NCT00982410|7332479|FG001|STARTED|3-month Follow-up Assessment||66
6418488|NCT00982410|7332478|FG000|COMPLETED|3-month Follow-up Assessment||56
6418489|NCT00982410|7332479|FG001|COMPLETED|3-month Follow-up Assessment||53
6418490|NCT00982410|7332478|FG000|NOT COMPLETED|3-month Follow-up Assessment||9
6418491|NCT00982410|7332479|FG001|NOT COMPLETED|3-month Follow-up Assessment||13
6418492|NCT00982410|7332478|FG000|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
6418493|NCT00982410|7332479|FG001|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
6418494|NCT00982410|7332478|FG000|COMPLETED|6-month Follow-up Assessment||59
6418495|NCT00982410|7332479|FG001|COMPLETED|6-month Follow-up Assessment||53
6418496|NCT00982410|7332478|FG000|NOT COMPLETED|6-month Follow-up Assessment||6
6418497|NCT00982410|7332479|FG001|NOT COMPLETED|6-month Follow-up Assessment||11
6418498|NCT00982410|7332478|FG000|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
6418499|NCT00982410|7332479|FG001|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
6418500|NCT00982410|7332478|FG000|COMPLETED|12-month Follow-up Assessment||56
6418501|NCT00982410|7332479|FG001|COMPLETED|12-month Follow-up Assessment||55
6418502|NCT00982410|7332478|FG000|NOT COMPLETED|12-month Follow-up Assessment||9
6418503|NCT00982410|7332479|FG001|NOT COMPLETED|12-month Follow-up Assessment||9
6418504|NCT00982423|7332488|FG000|STARTED|Overall Study||13
6418505|NCT00982423|7332489|FG001|STARTED|Overall Study||19
6418506|NCT00982423|7332488|FG000|COMPLETED|Overall Study||13
6418507|NCT00982423|7332489|FG001|COMPLETED|Overall Study||19
6418508|NCT00982423|7332488|FG000|NOT COMPLETED|Overall Study||0
6418509|NCT00982423|7332489|FG001|NOT COMPLETED|Overall Study||0
6418510|NCT00982488|7332501|FG000|STARTED|Overall Study|Received treatment|185
6418511|NCT00982488|7332502|FG001|STARTED|Overall Study|Received treatment|14
6418512|NCT00982488|7332503|FG002|STARTED|Overall Study|Received treatment|34
6418513|NCT00982488|7332504|FG003|STARTED|Overall Study|Received treatment|3
6418514|NCT00982488|7332505|FG004|STARTED|Overall Study|Received treatment|1
6418515|NCT00982488|7332501|FG000|COMPLETED|Overall Study|Still receiving treatment|0
6418516|NCT00982488|7332502|FG001|COMPLETED|Overall Study|Still receiving treatment|0
6418517|NCT00982488|7332503|FG002|COMPLETED|Overall Study|Still receiving treatment|0
6418518|NCT00982488|7332504|FG003|COMPLETED|Overall Study|Still receiving treatment|0
6418519|NCT00982488|7332505|FG004|COMPLETED|Overall Study|Still receiving treatment|0
6418520|NCT00982488|7332501|FG000|NOT COMPLETED|Overall Study||185
6418521|NCT00982488|7332502|FG001|NOT COMPLETED|Overall Study||14
6418522|NCT00982488|7332503|FG002|NOT COMPLETED|Overall Study||34
6418523|NCT00982488|7332504|FG003|NOT COMPLETED|Overall Study||3
6418524|NCT00982488|7332505|FG004|NOT COMPLETED|Overall Study||1
6418525|NCT00982553|7332517|FG000|STARTED|Phase1||14
6418526|NCT00982553|7332517|FG000|COMPLETED|Phase1||14
6418527|NCT00982553|7332517|FG000|NOT COMPLETED|Phase1||0
6418528|NCT00982553|7332517|FG000|STARTED|Phase2||14
6418529|NCT00982553|7332517|FG000|COMPLETED|Phase2||14
6418530|NCT00982553|7332517|FG000|NOT COMPLETED|Phase2||0
6418531|NCT00982553|7332517|FG000|STARTED|Phase3||14
6638907|NCT02325713|7567349|FG005|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638908|NCT02325713|7567350|FG006|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638909|NCT02325713|7567351|FG007|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638910|NCT02325713|7567352|FG008|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638911|NCT02325713|7567353|FG009|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638912|NCT02325713|7567354|FG010|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638913|NCT02325713|7567355|FG011|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638914|NCT02325713|7567356|FG012|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638915|NCT02325713|7567357|FG013|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638916|NCT02325713|7567358|FG014|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638917|NCT02325713|7567359|FG015|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6638918|NCT02325713|7567344|FG000|STARTED|Intervention Period 3 (2 Days)||1
6638919|NCT02325713|7567345|FG001|STARTED|Intervention Period 3 (2 Days)||2
6418532|NCT00982553|7332517|FG000|COMPLETED|Phase3||14
6418533|NCT00982553|7332517|FG000|NOT COMPLETED|Phase3||0
6418534|NCT00982592|7332528|FG000|STARTED|Overall Study||64
6418535|NCT00982592|7332529|FG001|STARTED|Overall Study||60
6418536|NCT00982592|7332528|FG000|Treatment Received|Overall Study||63
6418537|NCT00982592|7332529|FG001|Treatment Received|Overall Study||52
6418538|NCT00982592|7332528|FG000|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
6418539|NCT00982592|7332529|FG001|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
6418540|NCT00982592|7332528|FG000|NOT COMPLETED|Overall Study||31
6418541|NCT00982592|7332529|FG001|NOT COMPLETED|Overall Study||33
6418542|NCT00982644|7332537|FG000|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
6418543|NCT00982644|7332538|FG001|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
6418544|NCT00982644|7332537|FG000|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
6418545|NCT00982644|7332538|FG001|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
6418546|NCT00982644|7332537|FG000|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
6418547|NCT00982644|7332538|FG001|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
6418548|NCT00982644|7332537|FG000|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
6638920|NCT02325713|7567346|FG002|STARTED|Intervention Period 3 (2 Days)||2
6638921|NCT02325713|7567347|FG003|STARTED|Intervention Period 3 (2 Days)||2
6638922|NCT02325713|7567348|FG004|STARTED|Intervention Period 3 (2 Days)||2
6638923|NCT02325713|7567349|FG005|STARTED|Intervention Period 3 (2 Days)||2
6638924|NCT02325713|7567350|FG006|STARTED|Intervention Period 3 (2 Days)||2
6638925|NCT02325713|7567351|FG007|STARTED|Intervention Period 3 (2 Days)||2
6638926|NCT02325713|7567352|FG008|STARTED|Intervention Period 3 (2 Days)||2
6638927|NCT02325713|7567353|FG009|STARTED|Intervention Period 3 (2 Days)||2
6638928|NCT02325713|7567354|FG010|STARTED|Intervention Period 3 (2 Days)||1
6638929|NCT02325713|7567355|FG011|STARTED|Intervention Period 3 (2 Days)||2
6638930|NCT02325713|7567356|FG012|STARTED|Intervention Period 3 (2 Days)||2
6638931|NCT02325713|7567357|FG013|STARTED|Intervention Period 3 (2 Days)||2
6638932|NCT02325713|7567358|FG014|STARTED|Intervention Period 3 (2 Days)||2
6638933|NCT02325713|7567359|FG015|STARTED|Intervention Period 3 (2 Days)||2
6638934|NCT02325713|7567344|FG000|COMPLETED|Intervention Period 3 (2 Days)||1
6638935|NCT02325713|7567345|FG001|COMPLETED|Intervention Period 3 (2 Days)||2
6638936|NCT02325713|7567346|FG002|COMPLETED|Intervention Period 3 (2 Days)||2
6638937|NCT02325713|7567347|FG003|COMPLETED|Intervention Period 3 (2 Days)||2
6638938|NCT02325713|7567348|FG004|COMPLETED|Intervention Period 3 (2 Days)||2
6638939|NCT02325713|7567349|FG005|COMPLETED|Intervention Period 3 (2 Days)||2
6638940|NCT02325713|7567350|FG006|COMPLETED|Intervention Period 3 (2 Days)||2
6638941|NCT02325713|7567351|FG007|COMPLETED|Intervention Period 3 (2 Days)||2
6638942|NCT02325713|7567352|FG008|COMPLETED|Intervention Period 3 (2 Days)||2
6638943|NCT02325713|7567353|FG009|COMPLETED|Intervention Period 3 (2 Days)||1
6638944|NCT02325713|7567354|FG010|COMPLETED|Intervention Period 3 (2 Days)||1
6638945|NCT02325713|7567355|FG011|COMPLETED|Intervention Period 3 (2 Days)||2
6638946|NCT02325713|7567356|FG012|COMPLETED|Intervention Period 3 (2 Days)||2
6638947|NCT02325713|7567357|FG013|COMPLETED|Intervention Period 3 (2 Days)||2
6638948|NCT02325713|7567358|FG014|COMPLETED|Intervention Period 3 (2 Days)||2
6638949|NCT02325713|7567359|FG015|COMPLETED|Intervention Period 3 (2 Days)||2
6638950|NCT02325713|7567344|FG000|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638951|NCT02325713|7567345|FG001|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638952|NCT02325713|7567346|FG002|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638953|NCT02325713|7567347|FG003|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638954|NCT02325713|7567348|FG004|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638955|NCT02325713|7567349|FG005|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638956|NCT02325713|7567350|FG006|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638957|NCT02325713|7567351|FG007|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638958|NCT02325713|7567352|FG008|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638959|NCT02325713|7567353|FG009|NOT COMPLETED|Intervention Period 3 (2 Days)||1
6638960|NCT02325713|7567354|FG010|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638961|NCT02325713|7567355|FG011|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638962|NCT02325713|7567356|FG012|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638963|NCT02325713|7567357|FG013|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638964|NCT02325713|7567358|FG014|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638965|NCT02325713|7567359|FG015|NOT COMPLETED|Intervention Period 3 (2 Days)||0
6638966|NCT02325713|7567344|FG000|STARTED|Intervention Period 4 (2 Days)||1
6638967|NCT02325713|7567345|FG001|STARTED|Intervention Period 4 (2 Days)||2
6638968|NCT02325713|7567346|FG002|STARTED|Intervention Period 4 (2 Days)||2
6638969|NCT02325713|7567347|FG003|STARTED|Intervention Period 4 (2 Days)||2
6638970|NCT02325713|7567348|FG004|STARTED|Intervention Period 4 (2 Days)||2
6638971|NCT02325713|7567349|FG005|STARTED|Intervention Period 4 (2 Days)||2
6638972|NCT02325713|7567350|FG006|STARTED|Intervention Period 4 (2 Days)||2
6638973|NCT02325713|7567351|FG007|STARTED|Intervention Period 4 (2 Days)||2
6638974|NCT02325713|7567352|FG008|STARTED|Intervention Period 4 (2 Days)||2
6638975|NCT02325713|7567353|FG009|STARTED|Intervention Period 4 (2 Days)||1
6638976|NCT02325713|7567354|FG010|STARTED|Intervention Period 4 (2 Days)||1
6638977|NCT02325713|7567355|FG011|STARTED|Intervention Period 4 (2 Days)||2
6638978|NCT02325713|7567356|FG012|STARTED|Intervention Period 4 (2 Days)||2
6638979|NCT02325713|7567357|FG013|STARTED|Intervention Period 4 (2 Days)||2
6638980|NCT02325713|7567358|FG014|STARTED|Intervention Period 4 (2 Days)||2
6418549|NCT00982644|7332538|FG001|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
6418550|NCT00982644|7332537|FG000|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
6418551|NCT00982644|7332538|FG001|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
6418552|NCT00982644|7332537|FG000|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
6418553|NCT00982644|7332538|FG001|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
6418554|NCT00982644|7332537|FG000|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
6418555|NCT00982644|7332538|FG001|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
6418556|NCT00982644|7332537|FG000|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
6418557|NCT00982644|7332538|FG001|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
6418558|NCT00982657|7332548|FG000|STARTED|Overall Study||12
6418559|NCT00982657|7332549|FG001|STARTED|Overall Study||3
6418560|NCT00982657|7332550|FG002|STARTED|Overall Study||3
6418561|NCT00982657|7332551|FG003|STARTED|Overall Study||16
6418562|NCT00982657|7332548|FG000|COMPLETED|Overall Study||11
6418563|NCT00982657|7332549|FG001|COMPLETED|Overall Study||3
6418564|NCT00982657|7332550|FG002|COMPLETED|Overall Study||1
6418565|NCT00982657|7332551|FG003|COMPLETED|Overall Study||7
6418566|NCT00982657|7332548|FG000|NOT COMPLETED|Overall Study||1
6418567|NCT00982657|7332549|FG001|NOT COMPLETED|Overall Study||0
6418568|NCT00982657|7332550|FG002|NOT COMPLETED|Overall Study||2
6418569|NCT00982657|7332551|FG003|NOT COMPLETED|Overall Study||9
6418570|NCT00982735|7332571|FG000|STARTED|Overall Study||987
6418571|NCT00982735|7332571|FG000|COMPLETED|Overall Study||757
6418572|NCT00982735|7332571|FG000|NOT COMPLETED|Overall Study||230
6418573|NCT00982865|7332579|FG000|STARTED|Overall Study||49
6418574|NCT00982865|7332580|FG001|STARTED|Overall Study||82
6418575|NCT00982865|7332581|FG002|STARTED|Overall Study||15
6418576|NCT00982865|7332582|FG003|STARTED|Overall Study||34
6418577|NCT00982865|7332579|FG000|COMPLETED|Overall Study||49
6418578|NCT00982865|7332580|FG001|COMPLETED|Overall Study||82
6418579|NCT00982865|7332581|FG002|COMPLETED|Overall Study||15
6418580|NCT00982865|7332582|FG003|COMPLETED|Overall Study||34
6418581|NCT00982865|7332579|FG000|NOT COMPLETED|Overall Study||0
6418582|NCT00982865|7332580|FG001|NOT COMPLETED|Overall Study||0
6418583|NCT00982865|7332581|FG002|NOT COMPLETED|Overall Study||0
6418584|NCT00982865|7332582|FG003|NOT COMPLETED|Overall Study||0
6418585|NCT00982878|7332629|FG000|STARTED|Overall Study||13
6418586|NCT00982878|7332629|FG000|COMPLETED|Overall Study||12
6418587|NCT00982878|7332629|FG000|NOT COMPLETED|Overall Study||1
6418588|NCT00982930|7332633|FG000|STARTED|Overall Study||55
6418589|NCT00982930|7332633|FG000|COMPLETED|Overall Study||51
6418590|NCT00982930|7332633|FG000|NOT COMPLETED|Overall Study||4
6418591|NCT00983073|7332637|FG000|STARTED|Observation Period||224
6418592|NCT00983073|7332637|FG000|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
6418593|NCT00983073|7332637|FG000|NOT COMPLETED|Observation Period||24
6418594|NCT00983073|7332637|FG000|STARTED|Titration and Optimal Dose Period||200
6418595|NCT00983073|7332637|FG000|COMPLETED|Titration and Optimal Dose Period||160
6418596|NCT00983073|7332637|FG000|NOT COMPLETED|Titration and Optimal Dose Period||40
6418597|NCT00983073|7332637|FG000|STARTED|Maintenance Period||160
6418598|NCT00983073|7332637|FG000|COMPLETED|Maintenance Period||144
6418599|NCT00983073|7332637|FG000|NOT COMPLETED|Maintenance Period||16
6418600|NCT00983216|7332642|FG000|STARTED|Colchicine Alone||24
6418601|NCT00983216|7332642|FG000|COMPLETED|Colchicine Alone||24
6418602|NCT00983216|7332642|FG000|NOT COMPLETED|Colchicine Alone||0
6418603|NCT00983216|7332642|FG000|STARTED|14 Day Washout Period||24
6418604|NCT00983216|7332642|FG000|COMPLETED|14 Day Washout Period||24
6418605|NCT00983216|7332642|FG000|NOT COMPLETED|14 Day Washout Period||0
6418606|NCT00983216|7332642|FG000|STARTED|Ketoconazole Alone||24
6418607|NCT00983216|7332642|FG000|COMPLETED|Ketoconazole Alone||24
6418608|NCT00983216|7332642|FG000|NOT COMPLETED|Ketoconazole Alone||0
6418609|NCT00983216|7332642|FG000|STARTED|Colchicine With Ketoconazole||24
6418610|NCT00983216|7332642|FG000|COMPLETED|Colchicine With Ketoconazole||24
6638981|NCT02325713|7567359|FG015|STARTED|Intervention Period 4 (2 Days)||2
6638982|NCT02325713|7567344|FG000|COMPLETED|Intervention Period 4 (2 Days)||1
6638983|NCT02325713|7567345|FG001|COMPLETED|Intervention Period 4 (2 Days)||2
6638984|NCT02325713|7567346|FG002|COMPLETED|Intervention Period 4 (2 Days)||2
6638985|NCT02325713|7567347|FG003|COMPLETED|Intervention Period 4 (2 Days)||2
6638986|NCT02325713|7567348|FG004|COMPLETED|Intervention Period 4 (2 Days)||2
6418611|NCT00983216|7332642|FG000|NOT COMPLETED|Colchicine With Ketoconazole||0
6418612|NCT00983242|7332649|FG000|STARTED|Colchicine Alone||24
6418613|NCT00983242|7332649|FG000|COMPLETED|Colchicine Alone||24
6418614|NCT00983242|7332649|FG000|NOT COMPLETED|Colchicine Alone||0
6418615|NCT00983242|7332649|FG000|STARTED|14 Day Washout Period||24
6418616|NCT00983242|7332649|FG000|COMPLETED|14 Day Washout Period||24
6418617|NCT00983242|7332649|FG000|NOT COMPLETED|14 Day Washout Period||0
6418618|NCT00983242|7332649|FG000|STARTED|Verapamil HCl ER Alone||24
6418619|NCT00983242|7332649|FG000|COMPLETED|Verapamil HCl ER Alone||24
6418620|NCT00983242|7332649|FG000|NOT COMPLETED|Verapamil HCl ER Alone||0
6418621|NCT00983242|7332649|FG000|STARTED|Colchicine With Verapamil HCl ER||24
6418622|NCT00983242|7332649|FG000|COMPLETED|Colchicine With Verapamil HCl ER||24
6418623|NCT00983242|7332649|FG000|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
6418624|NCT00983281|7332658|FG000|STARTED|Overall Study||805
6418625|NCT00983281|7332659|FG001|STARTED|Overall Study||909
6418626|NCT00983281|7332658|FG000|COMPLETED|Overall Study||805
6418627|NCT00983281|7332659|FG001|COMPLETED|Overall Study||909
6418628|NCT00983281|7332658|FG000|NOT COMPLETED|Overall Study||0
6418629|NCT00983281|7332659|FG001|NOT COMPLETED|Overall Study||0
6418630|NCT00983294|7332665|FG000|STARTED|Colchicine Alone||24
6418631|NCT00983294|7332665|FG000|COMPLETED|Colchicine Alone||24
6418632|NCT00983294|7332665|FG000|NOT COMPLETED|Colchicine Alone||0
6418633|NCT00983294|7332665|FG000|STARTED|14 Day Washout Period||24
6418634|NCT00983294|7332665|FG000|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
6418635|NCT00983294|7332665|FG000|NOT COMPLETED|14 Day Washout Period||2
6418636|NCT00983294|7332665|FG000|STARTED|Azithromycin Alone||22
6418637|NCT00983294|7332665|FG000|COMPLETED|Azithromycin Alone||22
6418638|NCT00983294|7332665|FG000|NOT COMPLETED|Azithromycin Alone||0
6418639|NCT00983294|7332665|FG000|STARTED|Colchicine With Azithromycin||22
6418640|NCT00983294|7332665|FG000|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
6418641|NCT00983294|7332665|FG000|NOT COMPLETED|Colchicine With Azithromycin||1
6418642|NCT00983307|7332672|FG000|STARTED|Overall Study||17
6418643|NCT00983307|7332672|FG000|COMPLETED|Overall Study||17
6418644|NCT00983307|7332672|FG000|NOT COMPLETED|Overall Study||0
6418645|NCT00983346|7332676|FG000|STARTED|Overall Study||17
6418646|NCT00983346|7332676|FG000|COMPLETED|Overall Study||17
6418647|NCT00983346|7332676|FG000|NOT COMPLETED|Overall Study||0
6418648|NCT00983359|7332680|FG000|STARTED|Overall Study||40
6418649|NCT00983359|7332680|FG000|Not Eligible for Analysis|Overall Study||1
6418650|NCT00983359|7332680|FG000|COMPLETED|Overall Study||39
6418651|NCT00983359|7332680|FG000|NOT COMPLETED|Overall Study||1
6418652|NCT00983372|7332684|FG000|STARTED|Colchicine Alone||24
6418653|NCT00983372|7332684|FG000|COMPLETED|Colchicine Alone||24
6418654|NCT00983372|7332684|FG000|NOT COMPLETED|Colchicine Alone||0
6418655|NCT00983372|7332684|FG000|STARTED|14 Day Washout Period||24
6418656|NCT00983372|7332684|FG000|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
6418657|NCT00983372|7332684|FG000|NOT COMPLETED|14 Day Washout Period||1
6418658|NCT00983372|7332684|FG000|STARTED|Diltiazem ER Alone||23
6418659|NCT00983372|7332684|FG000|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
6418660|NCT00983372|7332684|FG000|NOT COMPLETED|Diltiazem ER Alone||3
6418661|NCT00983372|7332684|FG000|STARTED|Colchicine With Diltiazem ER||20
6418662|NCT00983372|7332684|FG000|COMPLETED|Colchicine With Diltiazem ER||20
6418663|NCT00983372|7332684|FG000|NOT COMPLETED|Colchicine With Diltiazem ER||0
6418664|NCT00983385|7332691|FG000|STARTED|Observation Period||208
6418665|NCT00983385|7332691|FG000|COMPLETED|Observation Period||176
6418666|NCT00983385|7332691|FG000|NOT COMPLETED|Observation Period||32
6418667|NCT00983385|7332691|FG000|STARTED|Titration and Optimal Dose Period||176
6418668|NCT00983385|7332691|FG000|COMPLETED|Titration and Optimal Dose Period||140
6418669|NCT00983385|7332691|FG000|NOT COMPLETED|Titration and Optimal Dose Period||36
6418670|NCT00983385|7332691|FG000|STARTED|Maintenance Period||140
6418671|NCT00983385|7332691|FG000|COMPLETED|Maintenance Period||117
6418672|NCT00983385|7332691|FG000|NOT COMPLETED|Maintenance Period||23
6418673|NCT00983476|7332713|FG000|STARTED|Overall Study||95
6418674|NCT00983476|7332714|FG001|STARTED|Overall Study||93
6418675|NCT00983476|7332715|FG002|STARTED|Overall Study||88
6418676|NCT00983476|7332713|FG000|6 Month Follow up Assessment|Overall Study||71
6418677|NCT00983476|7332714|FG001|6 Month Follow up Assessment|Overall Study||62
6638987|NCT02325713|7567349|FG005|COMPLETED|Intervention Period 4 (2 Days)||2
6638988|NCT02325713|7567350|FG006|COMPLETED|Intervention Period 4 (2 Days)||2
6638989|NCT02325713|7567351|FG007|COMPLETED|Intervention Period 4 (2 Days)||2
6638990|NCT02325713|7567352|FG008|COMPLETED|Intervention Period 4 (2 Days)||2
6638991|NCT02325713|7567353|FG009|COMPLETED|Intervention Period 4 (2 Days)||1
6638992|NCT02325713|7567354|FG010|COMPLETED|Intervention Period 4 (2 Days)||1
6638993|NCT02325713|7567355|FG011|COMPLETED|Intervention Period 4 (2 Days)||2
6638994|NCT02325713|7567356|FG012|COMPLETED|Intervention Period 4 (2 Days)||2
6638995|NCT02325713|7567357|FG013|COMPLETED|Intervention Period 4 (2 Days)||2
6638996|NCT02325713|7567358|FG014|COMPLETED|Intervention Period 4 (2 Days)||2
6638997|NCT02325713|7567359|FG015|COMPLETED|Intervention Period 4 (2 Days)||2
6638998|NCT02325713|7567344|FG000|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6638999|NCT02325713|7567345|FG001|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639000|NCT02325713|7567346|FG002|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639001|NCT02325713|7567347|FG003|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639002|NCT02325713|7567348|FG004|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639003|NCT02325713|7567349|FG005|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639004|NCT02325713|7567350|FG006|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639005|NCT02325713|7567351|FG007|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639006|NCT02325713|7567352|FG008|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639007|NCT02325713|7567353|FG009|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639008|NCT02325713|7567354|FG010|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639009|NCT02325713|7567355|FG011|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639010|NCT02325713|7567356|FG012|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639011|NCT02325713|7567357|FG013|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639012|NCT02325713|7567358|FG014|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639013|NCT02325713|7567359|FG015|NOT COMPLETED|Intervention Period 4 (2 Days)||0
6639014|NCT02325739|7567385|FG000|STARTED|Phase I Part||11
6639015|NCT02325739|7567386|FG001|STARTED|Phase I Part||6
6418678|NCT00983476|7332715|FG002|6 Month Follow up Assessment|Overall Study||74
6418679|NCT00983476|7332713|FG000|COMPLETED|Overall Study||78
6418680|NCT00983476|7332714|FG001|COMPLETED|Overall Study||71
6418681|NCT00983476|7332715|FG002|COMPLETED|Overall Study||88
6418682|NCT00983476|7332713|FG000|NOT COMPLETED|Overall Study||17
6418683|NCT00983476|7332714|FG001|NOT COMPLETED|Overall Study||22
6418684|NCT00983476|7332715|FG002|NOT COMPLETED|Overall Study||0
6418685|NCT00983489|7332732|FG000|STARTED|Overall Study||511
6418686|NCT00983489|7332733|FG001|STARTED|Overall Study||453
6418687|NCT00983489|7332734|FG002|STARTED|Overall Study||447
6418688|NCT00983489|7332732|FG000|COMPLETED|Overall Study||326
6418689|NCT00983489|7332733|FG001|COMPLETED|Overall Study||168
6418690|NCT00983489|7332734|FG002|COMPLETED|Overall Study||135
6418691|NCT00983489|7332732|FG000|NOT COMPLETED|Overall Study||185
6418692|NCT00983489|7332733|FG001|NOT COMPLETED|Overall Study||285
6418693|NCT00983489|7332734|FG002|NOT COMPLETED|Overall Study||312
6418694|NCT00983515|7332742|FG000|STARTED|Colchicine Alone||24
6418695|NCT00983515|7332742|FG000|COMPLETED|Colchicine Alone||24
6418696|NCT00983515|7332742|FG000|NOT COMPLETED|Colchicine Alone||0
6418697|NCT00983515|7332742|FG000|STARTED|14 Day Washout Period||24
6418698|NCT00983515|7332742|FG000|COMPLETED|14 Day Washout Period||24
6418699|NCT00983515|7332742|FG000|NOT COMPLETED|14 Day Washout Period||0
6418700|NCT00983515|7332742|FG000|STARTED|Ritonavir Alone||24
6418701|NCT00983515|7332742|FG000|COMPLETED|Ritonavir Alone||18
6418702|NCT00983515|7332742|FG000|NOT COMPLETED|Ritonavir Alone||6
6418703|NCT00983515|7332742|FG000|STARTED|Colchicine With Ritonavir||18
6418704|NCT00983515|7332742|FG000|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
6418705|NCT00983515|7332742|FG000|NOT COMPLETED|Colchicine With Ritonavir||1
6418706|NCT00983528|7332749|FG000|STARTED|Overall Study||6
6418707|NCT00983528|7332749|FG000|COMPLETED|Overall Study||0
6418708|NCT00983528|7332749|FG000|NOT COMPLETED|Overall Study||6
6418709|NCT00983541|7332753|FG000|STARTED|Overall Study||1
6418710|NCT00983541|7332753|FG000|COMPLETED|Overall Study||1
6418711|NCT00983541|7332753|FG000|NOT COMPLETED|Overall Study||0
6418712|NCT00983580|7332759|FG000|STARTED|Overall Study||54
6418713|NCT00983580|7332760|FG001|STARTED|Overall Study||53
6418714|NCT00983580|7332759|FG000|COMPLETED|Overall Study||49
6418715|NCT00983580|7332760|FG001|COMPLETED|Overall Study||49
6418716|NCT00983580|7332759|FG000|NOT COMPLETED|Overall Study||5
6418717|NCT00983580|7332760|FG001|NOT COMPLETED|Overall Study||4
6418718|NCT00983619|7332779|FG000|STARTED|Overall Study||3
6418719|NCT00983619|7332780|FG001|STARTED|Overall Study||4
6418720|NCT00983619|7332781|FG002|STARTED|Overall Study||3
6418721|NCT00983619|7332782|FG003|STARTED|Overall Study||6
6418722|NCT00983619|7332783|FG004|STARTED|Overall Study||3
6418723|NCT00983619|7332784|FG005|STARTED|Overall Study||76
6418724|NCT00983619|7332785|FG006|STARTED|Overall Study||3
6418725|NCT00983619|7332786|FG007|STARTED|Overall Study||3
6418726|NCT00983619|7332787|FG008|STARTED|Overall Study||1
6418727|NCT00983619|7332788|FG009|STARTED|Overall Study||3
6418728|NCT00983619|7332789|FG010|STARTED|Overall Study||17
6418729|NCT00983619|7332790|FG011|STARTED|Overall Study||14
6418730|NCT00983619|7332779|FG000|COMPLETED|Overall Study||0
6418731|NCT00983619|7332780|FG001|COMPLETED|Overall Study||0
6418732|NCT00983619|7332781|FG002|COMPLETED|Overall Study||0
6418733|NCT00983619|7332782|FG003|COMPLETED|Overall Study||1
6418734|NCT00983619|7332783|FG004|COMPLETED|Overall Study||0
6418735|NCT00983619|7332784|FG005|COMPLETED|Overall Study||9
6418736|NCT00983619|7332785|FG006|COMPLETED|Overall Study||0
6418737|NCT00983619|7332786|FG007|COMPLETED|Overall Study||1
6418738|NCT00983619|7332787|FG008|COMPLETED|Overall Study||0
6418739|NCT00983619|7332788|FG009|COMPLETED|Overall Study||0
6418740|NCT00983619|7332789|FG010|COMPLETED|Overall Study||6
6418741|NCT00983619|7332790|FG011|COMPLETED|Overall Study||3
6418742|NCT00983619|7332779|FG000|NOT COMPLETED|Overall Study||3
6418743|NCT00983619|7332780|FG001|NOT COMPLETED|Overall Study||4
6418744|NCT00983619|7332781|FG002|NOT COMPLETED|Overall Study||3
6418745|NCT00983619|7332782|FG003|NOT COMPLETED|Overall Study||5
6418746|NCT00983619|7332783|FG004|NOT COMPLETED|Overall Study||3
6418747|NCT00983619|7332784|FG005|NOT COMPLETED|Overall Study||67
6418748|NCT00983619|7332785|FG006|NOT COMPLETED|Overall Study||3
6418749|NCT00983619|7332786|FG007|NOT COMPLETED|Overall Study||2
6418750|NCT00983619|7332787|FG008|NOT COMPLETED|Overall Study||1
6418751|NCT00983619|7332788|FG009|NOT COMPLETED|Overall Study||3
6418752|NCT00983619|7332789|FG010|NOT COMPLETED|Overall Study||11
6418753|NCT00983619|7332790|FG011|NOT COMPLETED|Overall Study||11
6418754|NCT00983749|7332838|FG000|STARTED|Acute Phase (Enrollment to Hospital DC)||13
6418755|NCT00983749|7332839|FG001|STARTED|Acute Phase (Enrollment to Hospital DC)||10
6418756|NCT00983749|7332838|FG000|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
6418757|NCT00983749|7332839|FG001|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
6418758|NCT00983749|7332838|FG000|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
6418759|NCT00983749|7332839|FG001|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
6418760|NCT00983749|7332838|FG000|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
6418761|NCT00983749|7332839|FG001|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
6418762|NCT00983749|7332838|FG000|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
6418763|NCT00983749|7332839|FG001|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
6418764|NCT00983749|7332838|FG000|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
6418765|NCT00983749|7332839|FG001|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
6418766|NCT00983801|7332845|FG000|STARTED|Overall Study|Participants who received treatment.|52
6418767|NCT00983801|7332845|FG000|COMPLETED|Overall Study|Participants who were taken off treatment.|52
6418768|NCT00983801|7332845|FG000|NOT COMPLETED|Overall Study||0
6418769|NCT00983827|7332849|FG000|STARTED|Overall Study||8
6418770|NCT00983827|7332849|FG000|COMPLETED|Overall Study||7
6418771|NCT00983827|7332849|FG000|NOT COMPLETED|Overall Study||1
6418772|NCT00983853|7332859|FG000|STARTED|Overall Study||7
6418773|NCT00983853|7332860|FG001|STARTED|Overall Study|1 subject was randomized but not dosed|7
6418774|NCT00983853|7332861|FG002|STARTED|Overall Study|1 subject was randomized but not dosed|17
6418775|NCT00983853|7332862|FG003|STARTED|Overall Study||8
6418776|NCT00983853|7332863|FG004|STARTED|Overall Study||15
6418777|NCT00983853|7332864|FG005|STARTED|Overall Study||8
6418778|NCT00983853|7332859|FG000|COMPLETED|Overall Study||6
6418779|NCT00983853|7332860|FG001|COMPLETED|Overall Study||5
6418780|NCT00983853|7332861|FG002|COMPLETED|Overall Study||14
6418781|NCT00983853|7332862|FG003|COMPLETED|Overall Study||6
6418782|NCT00983853|7332863|FG004|COMPLETED|Overall Study||12
6510785|NCT01484197|7430380|FG000|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
6510786|NCT01484197|7430381|FG001|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
6510787|NCT01484197|7430382|FG002|STARTED|Treatment Period 2||9
6418783|NCT00983853|7332864|FG005|COMPLETED|Overall Study||7
6418784|NCT00983853|7332859|FG000|NOT COMPLETED|Overall Study||1
6418785|NCT00983853|7332860|FG001|NOT COMPLETED|Overall Study||2
6418786|NCT00983853|7332861|FG002|NOT COMPLETED|Overall Study||3
6418787|NCT00983853|7332862|FG003|NOT COMPLETED|Overall Study||2
6418788|NCT00983853|7332863|FG004|NOT COMPLETED|Overall Study||3
6418789|NCT00983853|7332864|FG005|NOT COMPLETED|Overall Study||1
6418790|NCT00983892|7332882|FG000|STARTED|Overall Study||66
6418791|NCT00983892|7332883|FG001|STARTED|Overall Study||68
6418792|NCT00983892|7332882|FG000|COMPLETED|Overall Study||56
6418793|NCT00983892|7332883|FG001|COMPLETED|Overall Study||56
6418794|NCT00983892|7332882|FG000|NOT COMPLETED|Overall Study||10
6418795|NCT00983892|7332883|FG001|NOT COMPLETED|Overall Study||12
6418796|NCT00983905|7332889|FG000|STARTED|Theophylline Alone||30
6418797|NCT00983905|7332889|FG000|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
6418798|NCT00983905|7332889|FG000|NOT COMPLETED|Theophylline Alone||1
6418799|NCT00983905|7332889|FG000|STARTED|4 Day Washout Period||29
6418800|NCT00983905|7332889|FG000|COMPLETED|4 Day Washout Period||29
6418801|NCT00983905|7332889|FG000|NOT COMPLETED|4 Day Washout Period||0
6418802|NCT00983905|7332889|FG000|STARTED|Colchicine Alone||29
6418803|NCT00983905|7332889|FG000|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
6418804|NCT00983905|7332889|FG000|NOT COMPLETED|Colchicine Alone||2
6418805|NCT00983905|7332889|FG000|STARTED|Theophylline With Colchicine||27
6418806|NCT00983905|7332889|FG000|COMPLETED|Theophylline With Colchicine||27
6418807|NCT00983905|7332889|FG000|NOT COMPLETED|Theophylline With Colchicine||0
6418808|NCT00983918|7332900|FG000|STARTED|Overall Study||20
6418809|NCT00983918|7332901|FG001|STARTED|Overall Study||20
6418810|NCT00983918|7332902|FG002|STARTED|Overall Study||20
6418811|NCT00983918|7332903|FG003|STARTED|Overall Study||20
6418812|NCT00983918|7332900|FG000|COMPLETED|Overall Study||20
6418813|NCT00983918|7332901|FG001|COMPLETED|Overall Study||18
6418814|NCT00983918|7332902|FG002|COMPLETED|Overall Study||18
6418815|NCT00983918|7332903|FG003|COMPLETED|Overall Study||18
6418816|NCT00983918|7332900|FG000|NOT COMPLETED|Overall Study||0
6418817|NCT00983918|7332901|FG001|NOT COMPLETED|Overall Study||2
6418818|NCT00983918|7332902|FG002|NOT COMPLETED|Overall Study||2
6418819|NCT00983918|7332903|FG003|NOT COMPLETED|Overall Study||2
6418820|NCT00983931|7332913|FG000|STARTED|Colchicine Alone||24
6418821|NCT00983931|7332913|FG000|COMPLETED|Colchicine Alone||24
6418822|NCT00983931|7332913|FG000|NOT COMPLETED|Colchicine Alone||0
6418823|NCT00983931|7332913|FG000|STARTED|14 Day Washout Period||24
6418824|NCT00983931|7332913|FG000|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
6418825|NCT00983931|7332913|FG000|NOT COMPLETED|14 Day Washout Period||1
6418826|NCT00983931|7332913|FG000|STARTED|Colchicine With Cyclosporine||23
6418827|NCT00983931|7332913|FG000|COMPLETED|Colchicine With Cyclosporine||23
6418828|NCT00983931|7332913|FG000|NOT COMPLETED|Colchicine With Cyclosporine||0
6418829|NCT00983957|7332919|FG000|STARTED|Overall Study||20
6418830|NCT00983957|7332919|FG000|Treatment A|Overall Study||20
6418831|NCT00983957|7332919|FG000|Treatment B|Overall Study||20
6418832|NCT00983957|7332919|FG000|Treatment C|Overall Study||18
6510788|NCT01484197|7430383|FG003|STARTED|Treatment Period 2||9
6510789|NCT01484197|7430380|FG000|COMPLETED|Treatment Period 2||7
6510790|NCT01484197|7430381|FG001|COMPLETED|Treatment Period 2||8
6510791|NCT01484197|7430382|FG002|COMPLETED|Treatment Period 2||9
6510792|NCT01484197|7430383|FG003|COMPLETED|Treatment Period 2||8
6418833|NCT00983957|7332919|FG000|COMPLETED|Overall Study||18
6418834|NCT00983957|7332919|FG000|NOT COMPLETED|Overall Study||2
6418835|NCT00983983|7332932|FG000|STARTED|Overall Study||8
6418836|NCT00983983|7332933|FG001|STARTED|Overall Study||9
6418837|NCT00983983|7332934|FG002|STARTED|Overall Study||7
6418838|NCT00983983|7332932|FG000|COMPLETED|Overall Study||6
6418839|NCT00983983|7332933|FG001|COMPLETED|Overall Study||8
6639016|NCT02325739|7567387|FG002|STARTED|Phase I Part||5
6639017|NCT02325739|7567388|FG003|STARTED|Phase I Part||26
6639018|NCT02325739|7567389|FG004|STARTED|Phase I Part||19
6418840|NCT00983983|7332934|FG002|COMPLETED|Overall Study||6
6418841|NCT00983983|7332932|FG000|NOT COMPLETED|Overall Study||2
6418842|NCT00983983|7332933|FG001|NOT COMPLETED|Overall Study||1
6418843|NCT00983983|7332934|FG002|NOT COMPLETED|Overall Study||1
6418844|NCT00984009|7332943|FG000|STARTED|Colchicine Alone||22
6418845|NCT00984009|7332943|FG000|COMPLETED|Colchicine Alone||22
6418846|NCT00984009|7332943|FG000|NOT COMPLETED|Colchicine Alone||0
6418847|NCT00984009|7332943|FG000|STARTED|14 Day Washout Period||22
6418848|NCT00984009|7332943|FG000|COMPLETED|14 Day Washout Period||22
6418849|NCT00984009|7332943|FG000|NOT COMPLETED|14 Day Washout Period||0
6418850|NCT00984009|7332943|FG000|STARTED|Grapefruit Juice Alone||22
6639019|NCT02325739|7567390|FG005|STARTED|Phase I Part||7
6639020|NCT02325739|7567391|FG006|STARTED|Phase I Part||6
6639021|NCT02325739|7567392|FG007|STARTED|Phase I Part||6
6639022|NCT02325739|7567393|FG008|STARTED|Phase I Part||0
6639023|NCT02325739|7567394|FG009|STARTED|Phase I Part||0
6639024|NCT02325739|7567395|FG010|STARTED|Phase I Part||0
6639025|NCT02325739|7567385|FG000|COMPLETED|Phase I Part||0
6639026|NCT02325739|7567386|FG001|COMPLETED|Phase I Part||0
6639027|NCT02325739|7567387|FG002|COMPLETED|Phase I Part||0
6639028|NCT02325739|7567388|FG003|COMPLETED|Phase I Part||0
6639029|NCT02325739|7567389|FG004|COMPLETED|Phase I Part||0
6639030|NCT02325739|7567390|FG005|COMPLETED|Phase I Part||0
6639031|NCT02325739|7567391|FG006|COMPLETED|Phase I Part||0
6639032|NCT02325739|7567392|FG007|COMPLETED|Phase I Part||0
6639033|NCT02325739|7567393|FG008|COMPLETED|Phase I Part||0
6639034|NCT02325739|7567394|FG009|COMPLETED|Phase I Part||0
6639035|NCT02325739|7567395|FG010|COMPLETED|Phase I Part||0
6639036|NCT02325739|7567385|FG000|NOT COMPLETED|Phase I Part||11
6639037|NCT02325739|7567386|FG001|NOT COMPLETED|Phase I Part||6
6639038|NCT02325739|7567387|FG002|NOT COMPLETED|Phase I Part||5
6639039|NCT02325739|7567388|FG003|NOT COMPLETED|Phase I Part||26
6639040|NCT02325739|7567389|FG004|NOT COMPLETED|Phase I Part||19
6639041|NCT02325739|7567390|FG005|NOT COMPLETED|Phase I Part||7
6639042|NCT02325739|7567391|FG006|NOT COMPLETED|Phase I Part||6
6639043|NCT02325739|7567392|FG007|NOT COMPLETED|Phase I Part||6
6639044|NCT02325739|7567393|FG008|NOT COMPLETED|Phase I Part||0
6639045|NCT02325739|7567394|FG009|NOT COMPLETED|Phase I Part||0
6639046|NCT02325739|7567395|FG010|NOT COMPLETED|Phase I Part||0
6639047|NCT02325739|7567385|FG000|STARTED|Phase II Part||0
6639048|NCT02325739|7567386|FG001|STARTED|Phase II Part||0
6639049|NCT02325739|7567387|FG002|STARTED|Phase II Part||0
6639050|NCT02325739|7567388|FG003|STARTED|Phase II Part||0
6639051|NCT02325739|7567389|FG004|STARTED|Phase II Part||0
6639052|NCT02325739|7567390|FG005|STARTED|Phase II Part||0
6639053|NCT02325739|7567391|FG006|STARTED|Phase II Part||0
6639054|NCT02325739|7567392|FG007|STARTED|Phase II Part||0
6639055|NCT02325739|7567393|FG008|STARTED|Phase II Part||30
6639056|NCT02325739|7567394|FG009|STARTED|Phase II Part||36
6639057|NCT02325739|7567395|FG010|STARTED|Phase II Part||20
6639058|NCT02325739|7567385|FG000|COMPLETED|Phase II Part||0
6639059|NCT02325739|7567386|FG001|COMPLETED|Phase II Part||0
6639060|NCT02325739|7567387|FG002|COMPLETED|Phase II Part||0
6639061|NCT02325739|7567388|FG003|COMPLETED|Phase II Part||0
6639062|NCT02325739|7567389|FG004|COMPLETED|Phase II Part||0
6639063|NCT02325739|7567390|FG005|COMPLETED|Phase II Part||0
6639064|NCT02325739|7567391|FG006|COMPLETED|Phase II Part||0
6639065|NCT02325739|7567392|FG007|COMPLETED|Phase II Part||0
6639066|NCT02325739|7567393|FG008|COMPLETED|Phase II Part||0
6639067|NCT02325739|7567394|FG009|COMPLETED|Phase II Part||0
6639068|NCT02325739|7567395|FG010|COMPLETED|Phase II Part||0
6639069|NCT02325739|7567385|FG000|NOT COMPLETED|Phase II Part||0
6639070|NCT02325739|7567386|FG001|NOT COMPLETED|Phase II Part||0
6639071|NCT02325739|7567387|FG002|NOT COMPLETED|Phase II Part||0
6639072|NCT02325739|7567388|FG003|NOT COMPLETED|Phase II Part||0
6639073|NCT02325739|7567389|FG004|NOT COMPLETED|Phase II Part||0
6639074|NCT02325739|7567390|FG005|NOT COMPLETED|Phase II Part||0
6639075|NCT02325739|7567391|FG006|NOT COMPLETED|Phase II Part||0
6639076|NCT02325739|7567392|FG007|NOT COMPLETED|Phase II Part||0
6639077|NCT02325739|7567393|FG008|NOT COMPLETED|Phase II Part||30
6743527|NCT03334747|7671725|FG001|NOT COMPLETED|Follow-Up Phase||0
6418851|NCT00984009|7332943|FG000|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
6418852|NCT00984009|7332943|FG000|NOT COMPLETED|Grapefruit Juice Alone||1
6418853|NCT00984009|7332943|FG000|STARTED|Colchicine With Grapefruit Juice||21
6418854|NCT00984009|7332943|FG000|COMPLETED|Colchicine With Grapefruit Juice||21
6418855|NCT00984009|7332943|FG000|NOT COMPLETED|Colchicine With Grapefruit Juice||0
6639078|NCT02325739|7567394|FG009|NOT COMPLETED|Phase II Part||36
6639079|NCT02325739|7567395|FG010|NOT COMPLETED|Phase II Part||20
6639080|NCT02325791|7567444|FG000|STARTED|Overall Study||23
6639081|NCT02325791|7567445|FG001|STARTED|Overall Study||383
6639082|NCT02325791|7567446|FG002|STARTED|Overall Study||385
6418856|NCT00984022|7332952|FG000|STARTED|Overall Study||43
6418857|NCT00984022|7332953|FG001|STARTED|Overall Study||49
6418858|NCT00984022|7332952|FG000|COMPLETED|Overall Study||33
6418859|NCT00984022|7332953|FG001|COMPLETED|Overall Study||35
6418860|NCT00984022|7332952|FG000|NOT COMPLETED|Overall Study||10
6418861|NCT00984022|7332953|FG001|NOT COMPLETED|Overall Study||14
6418862|NCT00984061|7332959|FG000|STARTED|Colchicine Alone||24
6418863|NCT00984061|7332959|FG000|COMPLETED|Colchicine Alone||24
6418864|NCT00984061|7332959|FG000|NOT COMPLETED|Colchicine Alone||0
6418865|NCT00984061|7332959|FG000|STARTED|21 Day Washout Period||24
6418866|NCT00984061|7332959|FG000|COMPLETED|21 Day Washout Period||24
6418867|NCT00984061|7332959|FG000|NOT COMPLETED|21 Day Washout Period||0
6418868|NCT00984061|7332959|FG000|STARTED|Clarithromycin Alone||24
6418869|NCT00984061|7332959|FG000|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
6418870|NCT00984061|7332959|FG000|NOT COMPLETED|Clarithromycin Alone||1
6418871|NCT00984061|7332959|FG000|STARTED|Colchicine With Clarithromycin||23
6418872|NCT00984061|7332959|FG000|COMPLETED|Colchicine With Clarithromycin||23
6418873|NCT00984061|7332959|FG000|NOT COMPLETED|Colchicine With Clarithromycin||0
6418874|NCT00984126|7332970|FG000|STARTED|Overall Study||27
6418875|NCT00984126|7332971|FG001|STARTED|Overall Study||28
6418876|NCT00984126|7332972|FG002|STARTED|Overall Study||23
6418877|NCT00984126|7332973|FG003|STARTED|Overall Study||135
6639083|NCT02325791|7567447|FG003|STARTED|Overall Study||381
6639084|NCT02325791|7567444|FG000|COMPLETED|Overall Study||23
6639085|NCT02325791|7567445|FG001|COMPLETED|Overall Study||358
6639086|NCT02325791|7567446|FG002|COMPLETED|Overall Study||360
6639087|NCT02325791|7567447|FG003|COMPLETED|Overall Study||355
6639088|NCT02325791|7567444|FG000|NOT COMPLETED|Overall Study||0
6639089|NCT02325791|7567445|FG001|NOT COMPLETED|Overall Study||25
6639090|NCT02325791|7567446|FG002|NOT COMPLETED|Overall Study||25
6639091|NCT02325791|7567447|FG003|NOT COMPLETED|Overall Study||26
6639092|NCT02325856|7567462|FG000|STARTED|Overall Study||148
6639093|NCT02325856|7567463|FG001|STARTED|Overall Study||150
6639094|NCT02325856|7567462|FG000|COMPLETED|Overall Study||128
6639095|NCT02325856|7567463|FG001|COMPLETED|Overall Study||123
6639096|NCT02325856|7567462|FG000|NOT COMPLETED|Overall Study||20
6639097|NCT02325856|7567463|FG001|NOT COMPLETED|Overall Study||27
6639098|NCT02326025|7567471|FG000|STARTED|Overall Study||25
6639099|NCT02326025|7567472|FG001|STARTED|Overall Study||24
6639100|NCT02326025|7567471|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
6639101|NCT02326025|7567472|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
6639102|NCT02326025|7567471|FG000|COMPLETED|Overall Study||20
6639103|NCT02326025|7567472|FG001|COMPLETED|Overall Study||19
6639104|NCT02326025|7567471|FG000|NOT COMPLETED|Overall Study||5
6639105|NCT02326025|7567472|FG001|NOT COMPLETED|Overall Study||5
6639106|NCT02326220|7567493|FG000|STARTED|Double-blind Treatment Period|Out of 21 participants, 9 participants entered in open label treatment period|21
6639107|NCT02326220|7567494|FG001|STARTED|Double-blind Treatment Period|Out of 41 participants, 20 participants entered in open label treatment period.|41
6639108|NCT02326220|7567495|FG002|STARTED|Double-blind Treatment Period||0
6639109|NCT02326220|7567493|FG000|COMPLETED|Double-blind Treatment Period||20
6639110|NCT02326220|7567494|FG001|COMPLETED|Double-blind Treatment Period||37
6639111|NCT02326220|7567495|FG002|COMPLETED|Double-blind Treatment Period||0
6639112|NCT02326220|7567493|FG000|NOT COMPLETED|Double-blind Treatment Period||1
6639113|NCT02326220|7567494|FG001|NOT COMPLETED|Double-blind Treatment Period||4
6639114|NCT02326220|7567495|FG002|NOT COMPLETED|Double-blind Treatment Period||0
6639115|NCT02326220|7567493|FG000|STARTED|Open-label Treatment Period||0
6639116|NCT02326220|7567494|FG001|STARTED|Open-label Treatment Period||0
6639117|NCT02326220|7567495|FG002|STARTED|Open-label Treatment Period|29 participants: 9 from Placebo and 20 from Alirocumab 150 mg arm entered in open-label period.|29
6639118|NCT02326220|7567493|FG000|COMPLETED|Open-label Treatment Period||0
6639119|NCT02326220|7567494|FG001|COMPLETED|Open-label Treatment Period||0
6639120|NCT02326220|7567495|FG002|COMPLETED|Open-label Treatment Period||27
6639121|NCT02326220|7567493|FG000|NOT COMPLETED|Open-label Treatment Period||0
6639122|NCT02326220|7567494|FG001|NOT COMPLETED|Open-label Treatment Period||0
6639123|NCT02326220|7567495|FG002|NOT COMPLETED|Open-label Treatment Period||2
6639124|NCT02326233|7567507|FG000|STARTED|Overall Study||95
6639125|NCT02326233|7567508|FG001|STARTED|Overall Study||95
6639126|NCT02326233|7567507|FG000|COMPLETED|Overall Study||95
6639127|NCT02326233|7567508|FG001|COMPLETED|Overall Study||94
6639128|NCT02326233|7567507|FG000|NOT COMPLETED|Overall Study||0
6639129|NCT02326233|7567508|FG001|NOT COMPLETED|Overall Study||1
6639130|NCT02326272|7567517|FG000|STARTED|Initial Period (Week 0 to Week 16)||49
6639131|NCT02326272|7567518|FG001|STARTED|Initial Period (Week 0 to Week 16)||91
6639132|NCT02326272|7567519|FG002|STARTED|Initial Period (Week 0 to Week 16)||87
6639133|NCT02326272|7567520|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
6639134|NCT02326272|7567521|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
6639135|NCT02326272|7567522|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
6639136|NCT02326272|7567523|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
6639137|NCT02326272|7567524|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
6418878|NCT00984126|7332970|FG000|COMPLETED|Overall Study||20
6418879|NCT00984126|7332971|FG001|COMPLETED|Overall Study||20
6418880|NCT00984126|7332972|FG002|COMPLETED|Overall Study||16
6418881|NCT00984126|7332973|FG003|COMPLETED|Overall Study||76
6418882|NCT00984126|7332970|FG000|NOT COMPLETED|Overall Study||7
6418883|NCT00984126|7332971|FG001|NOT COMPLETED|Overall Study||8
6418884|NCT00984126|7332972|FG002|NOT COMPLETED|Overall Study||7
6418885|NCT00984126|7332973|FG003|NOT COMPLETED|Overall Study||59
6418886|NCT00984139|7332992|FG000|STARTED|Overall Study||306
6418887|NCT00984139|7332992|FG000|COMPLETED|Overall Study||306
6418888|NCT00984139|7332992|FG000|NOT COMPLETED|Overall Study||0
6418889|NCT00984165|7333000|FG000|STARTED|Overall Study||9
6418890|NCT00984165|7333001|FG001|STARTED|Overall Study||1
6418891|NCT00984165|7333002|FG002|STARTED|Overall Study||4
6639138|NCT02326272|7567525|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
6639139|NCT02326272|7567526|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
6639140|NCT02326272|7567527|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
6639141|NCT02326272|7567528|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
6639142|NCT02326272|7567529|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
6639143|NCT02326272|7567530|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
6639144|NCT02326272|7567531|FG014|STARTED|Initial Period (Week 0 to Week 16)||0
6639145|NCT02326272|7567517|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||45
6639146|NCT02326272|7567518|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||84
6639147|NCT02326272|7567519|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||83
6639148|NCT02326272|7567520|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639149|NCT02326272|7567521|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639150|NCT02326272|7567522|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639151|NCT02326272|7567523|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639152|NCT02326272|7567524|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639153|NCT02326272|7567525|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639154|NCT02326272|7567526|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639155|NCT02326272|7567527|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639156|NCT02326272|7567528|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639157|NCT02326272|7567529|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639158|NCT02326272|7567530|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639159|NCT02326272|7567531|FG014|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639160|NCT02326272|7567517|FG000|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||45
6639161|NCT02326272|7567518|FG001|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||84
6639162|NCT02326272|7567519|FG002|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||81
6639163|NCT02326272|7567520|FG003|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639164|NCT02326272|7567521|FG004|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639165|NCT02326272|7567522|FG005|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639166|NCT02326272|7567523|FG006|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639167|NCT02326272|7567524|FG007|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639168|NCT02326272|7567525|FG008|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639169|NCT02326272|7567526|FG009|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639170|NCT02326272|7567527|FG010|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639171|NCT02326272|7567528|FG011|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639172|NCT02326272|7567529|FG012|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639173|NCT02326272|7567530|FG013|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639174|NCT02326272|7567531|FG014|Finished Wk16 Entered Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639175|NCT02326272|7567517|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||45
6639176|NCT02326272|7567518|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||84
6639177|NCT02326272|7567519|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||81
6639178|NCT02326272|7567520|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639179|NCT02326272|7567521|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639180|NCT02326272|7567522|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639181|NCT02326272|7567523|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639182|NCT02326272|7567524|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639183|NCT02326272|7567525|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639184|NCT02326272|7567526|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639185|NCT02326272|7567527|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639186|NCT02326272|7567528|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639187|NCT02326272|7567529|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639188|NCT02326272|7567530|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639189|NCT02326272|7567531|FG014|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639190|NCT02326272|7567517|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||4
6639191|NCT02326272|7567518|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||7
6639192|NCT02326272|7567519|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||6
6639193|NCT02326272|7567520|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639194|NCT02326272|7567521|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639195|NCT02326272|7567522|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639196|NCT02326272|7567523|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6418892|NCT00984165|7333003|FG003|STARTED|Overall Study||4
6418893|NCT00984165|7333000|FG000|COMPLETED|Overall Study||2
6418894|NCT00984165|7333001|FG001|COMPLETED|Overall Study||0
6418895|NCT00984165|7333002|FG002|COMPLETED|Overall Study||4
6418896|NCT00984165|7333003|FG003|COMPLETED|Overall Study||0
6418897|NCT00984165|7333000|FG000|NOT COMPLETED|Overall Study||7
6418898|NCT00984165|7333001|FG001|NOT COMPLETED|Overall Study||1
6418899|NCT00984165|7333002|FG002|NOT COMPLETED|Overall Study||0
6418900|NCT00984165|7333003|FG003|NOT COMPLETED|Overall Study||4
6418901|NCT00984204|7333014|FG000|STARTED|Overall Study||188
6418902|NCT00984204|7333014|FG000|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
6418903|NCT00984204|7333014|FG000|NOT COMPLETED|Overall Study||15
6418904|NCT00984256|7333020|FG000|STARTED|Overall Study||6
6418905|NCT00984256|7333021|FG001|STARTED|Overall Study||30
6418906|NCT00984256|7333020|FG000|COMPLETED|Overall Study||6
6418907|NCT00984256|7333021|FG001|COMPLETED|Overall Study||29
6418908|NCT00984256|7333020|FG000|NOT COMPLETED|Overall Study||0
6418909|NCT00984256|7333021|FG001|NOT COMPLETED|Overall Study||1
6418910|NCT00984282|7333038|FG000|STARTED|Double Blind Treatment||207
6418911|NCT00984282|7333039|FG001|STARTED|Double Blind Treatment||210
6418912|NCT00984282|7333038|FG000|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
6418913|NCT00984282|7333039|FG001|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
6418914|NCT00984282|7333038|FG000|COMPLETED|Double Blind Treatment||103
6418915|NCT00984282|7333039|FG001|COMPLETED|Double Blind Treatment||172
6418916|NCT00984282|7333038|FG000|NOT COMPLETED|Double Blind Treatment||104
6418917|NCT00984282|7333039|FG001|NOT COMPLETED|Double Blind Treatment||38
6418918|NCT00984282|7333038|FG000|STARTED|Open-label Treatment||86
6418919|NCT00984282|7333039|FG001|STARTED|Open-label Treatment||161
6418920|NCT00984282|7333038|FG000|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
6639197|NCT02326272|7567524|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639198|NCT02326272|7567525|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639199|NCT02326272|7567526|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639200|NCT02326272|7567527|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639201|NCT02326272|7567528|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639202|NCT02326272|7567529|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639203|NCT02326272|7567530|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639204|NCT02326272|7567531|FG014|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639205|NCT02326272|7567517|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639206|NCT02326272|7567518|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639207|NCT02326272|7567519|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639208|NCT02326272|7567520|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||6
6639209|NCT02326272|7567521|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
6639210|NCT02326272|7567522|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||76
6639211|NCT02326272|7567523|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||69
6639212|NCT02326272|7567524|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||34
6639213|NCT02326272|7567525|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||8
6639214|NCT02326272|7567526|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||12
6639215|NCT02326272|7567527|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639216|NCT02326272|7567528|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639217|NCT02326272|7567529|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639218|NCT02326272|7567530|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639219|NCT02326272|7567531|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639220|NCT02326272|7567517|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639221|NCT02326272|7567518|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639222|NCT02326272|7567519|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639223|NCT02326272|7567520|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
6639224|NCT02326272|7567521|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
6639225|NCT02326272|7567522|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||64
6639226|NCT02326272|7567523|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||61
6639227|NCT02326272|7567524|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||27
6639228|NCT02326272|7567525|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
6639229|NCT02326272|7567526|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||10
6639230|NCT02326272|7567527|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639231|NCT02326272|7567528|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639232|NCT02326272|7567529|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639233|NCT02326272|7567530|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639234|NCT02326272|7567531|FG014|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639235|NCT02326272|7567517|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639236|NCT02326272|7567518|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639237|NCT02326272|7567519|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639238|NCT02326272|7567520|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
6639239|NCT02326272|7567521|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
6639240|NCT02326272|7567522|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||63
6655727|NCT02454972|7585872|FG004|NOT COMPLETED|Overall Study||24
6418921|NCT00984282|7333039|FG001|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
6418922|NCT00984282|7333038|FG000|COMPLETED|Open-label Treatment||0
6418923|NCT00984282|7333039|FG001|COMPLETED|Open-label Treatment||0
6639241|NCT02326272|7567523|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||60
6639242|NCT02326272|7567524|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||27
6639243|NCT02326272|7567525|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
6639244|NCT02326272|7567526|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||10
6639245|NCT02326272|7567527|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639246|NCT02326272|7567528|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6418924|NCT00984282|7333038|FG000|NOT COMPLETED|Open-label Treatment||86
6418925|NCT00984282|7333039|FG001|NOT COMPLETED|Open-label Treatment||161
6418926|NCT00984282|7333038|FG000|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|72
6639247|NCT02326272|7567529|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639248|NCT02326272|7567530|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639249|NCT02326272|7567531|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6418927|NCT00984282|7333039|FG001|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|124
6418928|NCT00984282|7333038|FG000|COMPLETED|Long Term Follow-up||3
6418929|NCT00984282|7333039|FG001|COMPLETED|Long Term Follow-up||4
6418930|NCT00984282|7333038|FG000|NOT COMPLETED|Long Term Follow-up||69
6418931|NCT00984282|7333039|FG001|NOT COMPLETED|Long Term Follow-up||120
6418932|NCT00984295|7333050|FG000|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
6639250|NCT02326272|7567517|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639251|NCT02326272|7567518|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639252|NCT02326272|7567519|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639253|NCT02326272|7567520|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6639254|NCT02326272|7567521|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
6639255|NCT02326272|7567522|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||63
6639256|NCT02326272|7567523|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||60
6639257|NCT02326272|7567524|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||27
6639258|NCT02326272|7567525|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
6639259|NCT02326272|7567526|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||10
6639260|NCT02326272|7567527|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639261|NCT02326272|7567528|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639262|NCT02326272|7567529|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639263|NCT02326272|7567530|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639264|NCT02326272|7567531|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639265|NCT02326272|7567517|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639266|NCT02326272|7567518|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639267|NCT02326272|7567519|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639268|NCT02326272|7567520|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
6639269|NCT02326272|7567521|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6639270|NCT02326272|7567522|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||13
6639271|NCT02326272|7567523|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||9
6639272|NCT02326272|7567524|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
6639273|NCT02326272|7567525|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6639274|NCT02326272|7567526|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6639275|NCT02326272|7567527|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639276|NCT02326272|7567528|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639277|NCT02326272|7567529|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639278|NCT02326272|7567530|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639279|NCT02326272|7567531|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639280|NCT02326272|7567517|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
6639281|NCT02326272|7567518|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
6639282|NCT02326272|7567519|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
6418933|NCT00984295|7333051|FG001|STARTED|Overall Study||485
6418934|NCT00984295|7333052|FG002|STARTED|Overall Study||479
6418935|NCT00984295|7333050|FG000|Visit 1|Overall Study||949
6639283|NCT02326272|7567520|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
6639284|NCT02326272|7567521|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
6639285|NCT02326272|7567522|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
6639286|NCT02326272|7567523|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
6639287|NCT02326272|7567524|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
6639288|NCT02326272|7567525|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
6639289|NCT02326272|7567526|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
6639290|NCT02326272|7567527|FG010|STARTED|Open-label Period (Week 48 to Week 144)||5
6639291|NCT02326272|7567528|FG011|STARTED|Open-label Period (Week 48 to Week 144)||66
6639292|NCT02326272|7567529|FG012|STARTED|Open-label Period (Week 48 to Week 144)||59
6639293|NCT02326272|7567530|FG013|STARTED|Open-label Period (Week 48 to Week 144)||1
6639294|NCT02326272|7567531|FG014|STARTED|Open-label Period (Week 48 to Week 144)||40
6639295|NCT02326272|7567517|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639296|NCT02326272|7567518|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6418936|NCT00984295|7333051|FG001|Visit 1|Overall Study||485
6418937|NCT00984295|7333052|FG002|Visit 1|Overall Study||479
6418938|NCT00984295|7333050|FG000|Visit 2|Overall Study||909
6418939|NCT00984295|7333051|FG001|Visit 2|Overall Study||468
6418940|NCT00984295|7333052|FG002|Visit 2|Overall Study||453
6418941|NCT00984295|7333050|FG000|COMPLETED|Overall Study||884
6418942|NCT00984295|7333051|FG001|COMPLETED|Overall Study||453
6418943|NCT00984295|7333052|FG002|COMPLETED|Overall Study||442
6418944|NCT00984295|7333050|FG000|NOT COMPLETED|Overall Study||65
6418945|NCT00984295|7333051|FG001|NOT COMPLETED|Overall Study||32
6418946|NCT00984295|7333052|FG002|NOT COMPLETED|Overall Study||37
6418947|NCT00984308|7333062|FG000|STARTED|Overall Study||110
6418948|NCT00984308|7333063|FG001|STARTED|Overall Study||115
6418949|NCT00984308|7333062|FG000|COMPLETED|Overall Study||92
6418950|NCT00984308|7333063|FG001|COMPLETED|Overall Study||109
6418951|NCT00984308|7333062|FG000|NOT COMPLETED|Overall Study||18
6418952|NCT00984308|7333063|FG001|NOT COMPLETED|Overall Study||6
6418953|NCT00984334|7333074|FG000|STARTED|Overall Study||8
6418954|NCT00984334|7333075|FG001|STARTED|Overall Study||8
6418955|NCT00984334|7333076|FG002|STARTED|Overall Study||8
6418956|NCT00984334|7333077|FG003|STARTED|Overall Study||8
6418957|NCT00984334|7333078|FG004|STARTED|Overall Study||8
6418958|NCT00984334|7333074|FG000|COMPLETED|Overall Study||7
6418959|NCT00984334|7333075|FG001|COMPLETED|Overall Study||7
6418960|NCT00984334|7333076|FG002|COMPLETED|Overall Study||8
6418961|NCT00984334|7333077|FG003|COMPLETED|Overall Study||7
6418962|NCT00984334|7333078|FG004|COMPLETED|Overall Study||7
6418963|NCT00984334|7333074|FG000|NOT COMPLETED|Overall Study||1
6418964|NCT00984334|7333075|FG001|NOT COMPLETED|Overall Study||1
6418965|NCT00984334|7333076|FG002|NOT COMPLETED|Overall Study||0
6418966|NCT00984334|7333077|FG003|NOT COMPLETED|Overall Study||1
6418967|NCT00984334|7333078|FG004|NOT COMPLETED|Overall Study||1
6418968|NCT00984542|7333090|FG000|STARTED|Overall Study||50
6418969|NCT00984542|7333090|FG000|COMPLETED|Overall Study||9
6418970|NCT00984542|7333090|FG000|NOT COMPLETED|Overall Study||41
6418971|NCT00984568|7333097|FG000|STARTED|Overall Study||15
6418972|NCT00984568|7333098|FG001|STARTED|Overall Study||13
6418973|NCT00984568|7333097|FG000|COMPLETED|Overall Study||7
6418974|NCT00984568|7333098|FG001|COMPLETED|Overall Study||7
6418975|NCT00984568|7333097|FG000|NOT COMPLETED|Overall Study||8
6418976|NCT00984568|7333098|FG001|NOT COMPLETED|Overall Study||6
6418977|NCT00984594|7333106|FG000|STARTED|Overall Study||2
6418978|NCT00984594|7333107|FG001|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
6418979|NCT00984594|7333106|FG000|COMPLETED|Overall Study||1
6418980|NCT00984594|7333107|FG001|COMPLETED|Overall Study||1
6418981|NCT00984594|7333106|FG000|NOT COMPLETED|Overall Study||1
6418982|NCT00984594|7333107|FG001|NOT COMPLETED|Overall Study||1
6418983|NCT00984620|7333117|FG000|STARTED|Overall Study||81
6418984|NCT00984620|7333118|FG001|STARTED|Overall Study||79
6418985|NCT00984620|7333117|FG000|COMPLETED|Overall Study||75
6418986|NCT00984620|7333118|FG001|COMPLETED|Overall Study||67
6418987|NCT00984620|7333117|FG000|NOT COMPLETED|Overall Study||6
6418988|NCT00984620|7333118|FG001|NOT COMPLETED|Overall Study||12
6418989|NCT00984659|7333130|FG000|STARTED|2-week Run-in Period||418
6418990|NCT00984659|7333131|FG001|STARTED|2-week Run-in Period||0
6418991|NCT00984659|7333132|FG002|STARTED|2-week Run-in Period||0
6418992|NCT00984659|7333133|FG003|STARTED|2-week Run-in Period||0
6418993|NCT00984659|7333130|FG000|COMPLETED|2-week Run-in Period||366
6418994|NCT00984659|7333131|FG001|COMPLETED|2-week Run-in Period||0
6418995|NCT00984659|7333132|FG002|COMPLETED|2-week Run-in Period||0
6418996|NCT00984659|7333133|FG003|COMPLETED|2-week Run-in Period||0
6418997|NCT00984659|7333130|FG000|NOT COMPLETED|2-week Run-in Period||52
6418998|NCT00984659|7333131|FG001|NOT COMPLETED|2-week Run-in Period||0
6418999|NCT00984659|7333132|FG002|NOT COMPLETED|2-week Run-in Period||0
6419000|NCT00984659|7333133|FG003|NOT COMPLETED|2-week Run-in Period||0
6419001|NCT00984659|7333130|FG000|STARTED|6-week Double-blind Treatment Period||0
6419002|NCT00984659|7333131|FG001|STARTED|6-week Double-blind Treatment Period||75
6419003|NCT00984659|7333132|FG002|STARTED|6-week Double-blind Treatment Period||152
6419004|NCT00984659|7333133|FG003|STARTED|6-week Double-blind Treatment Period||139
6419005|NCT00984659|7333130|FG000|COMPLETED|6-week Double-blind Treatment Period||0
6419006|NCT00984659|7333131|FG001|COMPLETED|6-week Double-blind Treatment Period||69
6419007|NCT00984659|7333132|FG002|COMPLETED|6-week Double-blind Treatment Period||141
6419008|NCT00984659|7333133|FG003|COMPLETED|6-week Double-blind Treatment Period||126
6419009|NCT00984659|7333130|FG000|NOT COMPLETED|6-week Double-blind Treatment Period||0
6419010|NCT00984659|7333131|FG001|NOT COMPLETED|6-week Double-blind Treatment Period||6
6419011|NCT00984659|7333132|FG002|NOT COMPLETED|6-week Double-blind Treatment Period||11
6419012|NCT00984659|7333133|FG003|NOT COMPLETED|6-week Double-blind Treatment Period||13
6419013|NCT00984698|7333142|FG000|STARTED|Overall Study||21
6419014|NCT00984698|7333143|FG001|STARTED|Overall Study||22
6419015|NCT00984698|7333142|FG000|COMPLETED|Overall Study||18
6419016|NCT00984698|7333143|FG001|COMPLETED|Overall Study||14
6419017|NCT00984698|7333142|FG000|NOT COMPLETED|Overall Study||3
6419018|NCT00984698|7333143|FG001|NOT COMPLETED|Overall Study||8
6419019|NCT00984815|7333149|FG000|STARTED|Overall Study||86
6419020|NCT00984815|7333149|FG000|COMPLETED|Overall Study||56
6419021|NCT00984815|7333149|FG000|NOT COMPLETED|Overall Study||30
6419022|NCT00984867|7333155|FG000|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
6499252|NCT01416129|7417910|FG001|NOT COMPLETED|Experimental Condition: Brimless||0
6419023|NCT00984867|7333156|FG001|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
6419024|NCT00984867|7333155|FG000|COMPLETED|Overall Study||203
6419025|NCT00984867|7333156|FG001|COMPLETED|Overall Study||208
6419026|NCT00984867|7333155|FG000|NOT COMPLETED|Overall Study||23
6419027|NCT00984867|7333156|FG001|NOT COMPLETED|Overall Study||17
6419028|NCT00985010|7333166|FG000|STARTED|Overall Study||4
6419029|NCT00985010|7333167|FG001|STARTED|Overall Study||5
6419030|NCT00985010|7333166|FG000|COMPLETED|Overall Study||4
6419031|NCT00985010|7333167|FG001|COMPLETED|Overall Study||5
6419032|NCT00985010|7333166|FG000|NOT COMPLETED|Overall Study||0
6419033|NCT00985010|7333167|FG001|NOT COMPLETED|Overall Study||0
6499253|NCT01416142|7417916|FG000|STARTED|Cross Over at Movie Intermission||32
6499254|NCT01416142|7417917|FG001|STARTED|Cross Over at Movie Intermission||31
6499255|NCT01416142|7417918|FG002|STARTED|Cross Over at Movie Intermission||0
6499256|NCT01416142|7417916|FG000|COMPLETED|Cross Over at Movie Intermission||32
6499257|NCT01416142|7417917|FG001|COMPLETED|Cross Over at Movie Intermission||31
6499258|NCT01416142|7417918|FG002|COMPLETED|Cross Over at Movie Intermission||0
6499259|NCT01416142|7417916|FG000|NOT COMPLETED|Cross Over at Movie Intermission||0
6499260|NCT01416142|7417917|FG001|NOT COMPLETED|Cross Over at Movie Intermission||0
6499261|NCT01416142|7417918|FG002|NOT COMPLETED|Cross Over at Movie Intermission||0
6499262|NCT01416142|7417916|FG000|STARTED|PureVision2 HD||0
6499263|NCT01416142|7417917|FG001|STARTED|PureVision2 HD||0
6499264|NCT01416142|7417918|FG002|STARTED|PureVision2 HD||63
6499265|NCT01416142|7417916|FG000|COMPLETED|PureVision2 HD||0
6499266|NCT01416142|7417917|FG001|COMPLETED|PureVision2 HD||0
6499267|NCT01416142|7417918|FG002|COMPLETED|PureVision2 HD||62
6499268|NCT01416142|7417916|FG000|NOT COMPLETED|PureVision2 HD||0
6499269|NCT01416142|7417917|FG001|NOT COMPLETED|PureVision2 HD||0
6499270|NCT01416142|7417918|FG002|NOT COMPLETED|PureVision2 HD||1
6499271|NCT01416155|7417926|FG000|STARTED|Overall Study||97
6499272|NCT01416155|7417926|FG000|COMPLETED|Overall Study||39
6499273|NCT01416155|7417926|FG000|NOT COMPLETED|Overall Study||58
6499274|NCT01416181|7417932|FG000|STARTED|Part 1||449
6499275|NCT01416181|7417933|FG001|STARTED|Part 1||440
6499276|NCT01416181|7417932|FG000|Withdrew Prior to Dosing|Part 1||0
6499277|NCT01416181|7417933|FG001|Withdrew Prior to Dosing|Part 1||1
6499278|NCT01416181|7417932|FG000|COMPLETED|Part 1|Completed Study through Week 108|312
6499279|NCT01416181|7417933|FG001|COMPLETED|Part 1|Completed Study through Week 108|326
6499280|NCT01416181|7417932|FG000|NOT COMPLETED|Part 1||137
6499281|NCT01416181|7417933|FG001|NOT COMPLETED|Part 1||114
6499282|NCT01416181|7417932|FG000|STARTED|Part 2||274
6499283|NCT01416181|7417933|FG001|STARTED|Part 2||292
6499284|NCT01416181|7417932|FG000|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
6499285|NCT01416181|7417933|FG001|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
6499286|NCT01416181|7417932|FG000|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
6499287|NCT01416181|7417933|FG001|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
6499288|NCT01416181|7417932|FG000|Completed Treatment for > 96 Weeks|Part 2||1
6499289|NCT01416181|7417933|FG001|Completed Treatment for > 96 Weeks|Part 2||0
6499290|NCT01416181|7417932|FG000|COMPLETED|Part 2||3
6499291|NCT01416181|7417933|FG001|COMPLETED|Part 2||6
6499292|NCT01416181|7417932|FG000|NOT COMPLETED|Part 2||271
6499293|NCT01416181|7417933|FG001|NOT COMPLETED|Part 2||286
6499294|NCT01416194|7417942|FG000|STARTED|Overall Study||1111
6499295|NCT01416194|7417943|FG001|STARTED|Overall Study||2720
6499296|NCT01416194|7417944|FG002|STARTED|Overall Study||6666
6499297|NCT01416194|7417942|FG000|COMPLETED|Overall Study||1111
6499298|NCT01416194|7417943|FG001|COMPLETED|Overall Study||2720
6499299|NCT01416194|7417944|FG002|COMPLETED|Overall Study||6666
6499300|NCT01416194|7417942|FG000|NOT COMPLETED|Overall Study||0
6499301|NCT01416194|7417943|FG001|NOT COMPLETED|Overall Study||0
6499302|NCT01416194|7417944|FG002|NOT COMPLETED|Overall Study||0
6499303|NCT01416389|7417956|FG000|STARTED|Overall Study||26
6499304|NCT01416389|7417957|FG001|STARTED|Overall Study||13
6499305|NCT01416389|7417956|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
6499306|NCT01416389|7417957|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
6499307|NCT01416389|7417956|FG000|COMPLETED|Overall Study||23
6499308|NCT01416389|7417957|FG001|COMPLETED|Overall Study||13
6499309|NCT01416389|7417956|FG000|NOT COMPLETED|Overall Study||3
6499310|NCT01416389|7417957|FG001|NOT COMPLETED|Overall Study||0
6499311|NCT01416441|7417965|FG000|STARTED|Overall Study||170
6499312|NCT01416441|7417965|FG000|COMPLETED|Overall Study||89
6499313|NCT01416441|7417965|FG000|NOT COMPLETED|Overall Study||81
6499314|NCT01416571|7417969|FG000|STARTED|Overall Study||78
6499315|NCT01416571|7417969|FG000|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
6499316|NCT01416571|7417969|FG000|NOT COMPLETED|Overall Study||2
6499317|NCT01416584|7417976|FG000|STARTED|Overall Study||30
6499318|NCT01416584|7417977|FG001|STARTED|Overall Study||35
6499319|NCT01416584|7417978|FG002|STARTED|Overall Study||33
6499320|NCT01416584|7417976|FG000|COMPLETED|Overall Study||27
6499321|NCT01416584|7417977|FG001|COMPLETED|Overall Study||33
6499322|NCT01416584|7417978|FG002|COMPLETED|Overall Study||32
6499323|NCT01416584|7417976|FG000|NOT COMPLETED|Overall Study||3
6499324|NCT01416584|7417977|FG001|NOT COMPLETED|Overall Study||2
6499325|NCT01416584|7417978|FG002|NOT COMPLETED|Overall Study||1
6499326|NCT01416610|7417992|FG000|STARTED|Overall Study||88
6499327|NCT01416610|7417992|FG000|Intention to Treat|Overall Study||88
6419034|NCT00985088|7333181|FG000|STARTED|Overall Study||222
6419035|NCT00985088|7333182|FG001|STARTED|Overall Study||114
6419036|NCT00985088|7333183|FG002|STARTED|Overall Study||112
6419037|NCT00985088|7333184|FG003|STARTED|Overall Study||221
6419038|NCT00985088|7333185|FG004|STARTED|Overall Study||223
6419039|NCT00985088|7333186|FG005|STARTED|Overall Study||115
6419040|NCT00985088|7333187|FG006|STARTED|Overall Study||111
6419041|NCT00985088|7333188|FG007|STARTED|Overall Study||222
6419042|NCT00985088|7333181|FG000|COMPLETED|Overall Study||211
6419043|NCT00985088|7333182|FG001|COMPLETED|Overall Study||112
6419044|NCT00985088|7333183|FG002|COMPLETED|Overall Study||108
6419045|NCT00985088|7333184|FG003|COMPLETED|Overall Study||214
6419046|NCT00985088|7333185|FG004|COMPLETED|Overall Study||214
6419047|NCT00985088|7333186|FG005|COMPLETED|Overall Study||108
6419048|NCT00985088|7333187|FG006|COMPLETED|Overall Study||107
6419049|NCT00985088|7333188|FG007|COMPLETED|Overall Study||216
6419050|NCT00985088|7333181|FG000|NOT COMPLETED|Overall Study||11
6419051|NCT00985088|7333182|FG001|NOT COMPLETED|Overall Study||2
6419052|NCT00985088|7333183|FG002|NOT COMPLETED|Overall Study||4
6419053|NCT00985088|7333184|FG003|NOT COMPLETED|Overall Study||7
6419054|NCT00985088|7333185|FG004|NOT COMPLETED|Overall Study||9
6419055|NCT00985088|7333186|FG005|NOT COMPLETED|Overall Study||7
6419056|NCT00985088|7333187|FG006|NOT COMPLETED|Overall Study||4
6419057|NCT00985088|7333188|FG007|NOT COMPLETED|Overall Study||6
6419058|NCT00985114|7333218|FG000|STARTED|Overall Study|38 randomized, 34 received the device|34
6419059|NCT00985114|7333219|FG001|STARTED|Overall Study||39
6419060|NCT00985114|7333218|FG000|Diet + Lifestyle Counseling Cross-over|Overall Study||0
6419061|NCT00985114|7333219|FG001|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
6419062|NCT00985114|7333218|FG000|COMPLETED|Overall Study||33
6419063|NCT00985114|7333219|FG001|COMPLETED|Overall Study||37
6419064|NCT00985114|7333218|FG000|NOT COMPLETED|Overall Study||1
6419065|NCT00985114|7333219|FG001|NOT COMPLETED|Overall Study||2
6419066|NCT00985140|7333225|FG000|STARTED|Overall Study||15
6419067|NCT00985140|7333225|FG000|COMPLETED|Overall Study||15
6419068|NCT00985140|7333225|FG000|NOT COMPLETED|Overall Study||0
6419069|NCT00985153|7333233|FG000|STARTED|Overall Study||985
6419070|NCT00985153|7333234|FG001|STARTED|Overall Study||968
6419071|NCT00985153|7333235|FG002|STARTED|Overall Study||962
6419072|NCT00985153|7333236|FG003|STARTED|Overall Study||1012
6419073|NCT00985153|7333233|FG000|Vaccinated at Visit 1|Overall Study||985
6419074|NCT00985153|7333234|FG001|Vaccinated at Visit 1|Overall Study||968
6419075|NCT00985153|7333235|FG002|Vaccinated at Visit 1|Overall Study||962
6419076|NCT00985153|7333236|FG003|Vaccinated at Visit 1|Overall Study||1012
6419077|NCT00985153|7333233|FG000|COMPLETED|Overall Study||950
6419078|NCT00985153|7333234|FG001|COMPLETED|Overall Study||924
6419079|NCT00985153|7333235|FG002|COMPLETED|Overall Study||918
6419080|NCT00985153|7333236|FG003|COMPLETED|Overall Study||965
6419081|NCT00985153|7333233|FG000|NOT COMPLETED|Overall Study||35
6419082|NCT00985153|7333234|FG001|NOT COMPLETED|Overall Study||44
6419083|NCT00985153|7333235|FG002|NOT COMPLETED|Overall Study||44
6419084|NCT00985153|7333236|FG003|NOT COMPLETED|Overall Study||47
6419085|NCT00985166|7333249|FG000|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
6419086|NCT00985166|7333250|FG001|STARTED|Overall Study||205
6419087|NCT00985166|7333251|FG002|STARTED|Overall Study||195
6419088|NCT00985166|7333249|FG000|Vaccinated at Visit 1|Overall Study||399
6419089|NCT00985166|7333250|FG001|Vaccinated at Visit 1|Overall Study||205
6419090|NCT00985166|7333251|FG002|Vaccinated at Visit 1|Overall Study||195
6419091|NCT00985166|7333249|FG000|COMPLETED|Overall Study||392
6419092|NCT00985166|7333250|FG001|COMPLETED|Overall Study||201
6419093|NCT00985166|7333251|FG002|COMPLETED|Overall Study||188
6419094|NCT00985166|7333249|FG000|NOT COMPLETED|Overall Study||9
6419095|NCT00985166|7333250|FG001|NOT COMPLETED|Overall Study||4
6419096|NCT00985166|7333251|FG002|NOT COMPLETED|Overall Study||7
6419097|NCT00985192|7333261|FG000|STARTED|Overall Study||49
6419098|NCT00985192|7333261|FG000|COMPLETED|Overall Study||45
6419099|NCT00985192|7333261|FG000|NOT COMPLETED|Overall Study||4
6419100|NCT00985231|7333267|FG000|STARTED|Overall Study||133
6419101|NCT00985231|7333268|FG001|STARTED|Overall Study||132
6419102|NCT00985231|7333267|FG000|COMPLETED|Overall Study||130
6419103|NCT00985231|7333268|FG001|COMPLETED|Overall Study||129
6419104|NCT00985231|7333267|FG000|NOT COMPLETED|Overall Study||3
6419105|NCT00985231|7333268|FG001|NOT COMPLETED|Overall Study||3
6419106|NCT00985257|7333274|FG000|STARTED|Overall Study||123
6419107|NCT00985257|7333274|FG000|COMPLETED|Overall Study||123
6419108|NCT00985257|7333274|FG000|NOT COMPLETED|Overall Study||0
6419109|NCT00985426|7333280|FG000|STARTED|Overall Study||258
6419110|NCT00985426|7333281|FG001|STARTED|Overall Study||263
6419111|NCT00985426|7333280|FG000|COMPLETED|Overall Study||215
6419112|NCT00985426|7333281|FG001|COMPLETED|Overall Study||219
6419113|NCT00985426|7333280|FG000|NOT COMPLETED|Overall Study||43
6419114|NCT00985426|7333281|FG001|NOT COMPLETED|Overall Study||44
6419115|NCT00985439|7333291|FG000|STARTED|Overall Study||49
6419116|NCT00985439|7333292|FG001|STARTED|Overall Study||51
6419117|NCT00985439|7333293|FG002|STARTED|Overall Study||51
6419118|NCT00985439|7333294|FG003|STARTED|Overall Study||51
6419119|NCT00985439|7333291|FG000|COMPLETED|Overall Study||49
6419120|NCT00985439|7333292|FG001|COMPLETED|Overall Study||51
6419121|NCT00985439|7333293|FG002|COMPLETED|Overall Study||50
6419122|NCT00985439|7333294|FG003|COMPLETED|Overall Study||51
6419123|NCT00985439|7333291|FG000|NOT COMPLETED|Overall Study||0
6419124|NCT00985439|7333292|FG001|NOT COMPLETED|Overall Study||0
6419125|NCT00985439|7333293|FG002|NOT COMPLETED|Overall Study||1
6419126|NCT00985439|7333294|FG003|NOT COMPLETED|Overall Study||0
6419127|NCT00985465|7333306|FG000|STARTED|Overall Study||141
6419128|NCT00985465|7333307|FG001|STARTED|Overall Study||69
6419129|NCT00985465|7333306|FG000|COMPLETED|Overall Study||140
6419130|NCT00985465|7333307|FG001|COMPLETED|Overall Study||66
6419131|NCT00985465|7333306|FG000|NOT COMPLETED|Overall Study||1
6419132|NCT00985465|7333307|FG001|NOT COMPLETED|Overall Study||3
6419133|NCT00985491|7333314|FG000|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
6419134|NCT00985491|7333314|FG000|Received Device|Overall Study||43
6419135|NCT00985491|7333314|FG000|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
6419136|NCT00985491|7333314|FG000|NOT COMPLETED|Overall Study||19
6419137|NCT00985504|7333321|FG000|STARTED|Acute Treatment Period||244
6419138|NCT00985504|7333322|FG001|STARTED|Acute Treatment Period||239
6419139|NCT00985504|7333321|FG000|COMPLETED|Acute Treatment Period||229
6419140|NCT00985504|7333322|FG001|COMPLETED|Acute Treatment Period||227
6419141|NCT00985504|7333321|FG000|NOT COMPLETED|Acute Treatment Period||15
6419142|NCT00985504|7333322|FG001|NOT COMPLETED|Acute Treatment Period||12
6419143|NCT00985504|7333321|FG000|STARTED|Optimization Period||229
6419144|NCT00985504|7333322|FG001|STARTED|Optimization Period||227
6419145|NCT00985504|7333321|FG000|COMPLETED|Optimization Period||203
6419146|NCT00985504|7333322|FG001|COMPLETED|Optimization Period||204
6419147|NCT00985504|7333321|FG000|NOT COMPLETED|Optimization Period||26
6419148|NCT00985504|7333322|FG001|NOT COMPLETED|Optimization Period||23
6419149|NCT00985517|7333332|FG000|STARTED|Overall Study||3
6419150|NCT00985517|7333333|FG001|STARTED|Overall Study||3
6419151|NCT00985517|7333334|FG002|STARTED|Overall Study||24
6419152|NCT00985517|7333335|FG003|STARTED|Overall Study||27
6639297|NCT02326272|7567519|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639298|NCT02326272|7567520|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639299|NCT02326272|7567521|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639300|NCT02326272|7567522|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639301|NCT02326272|7567523|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639302|NCT02326272|7567524|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639303|NCT02326272|7567525|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639304|NCT02326272|7567526|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639305|NCT02326272|7567527|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||2
6639306|NCT02326272|7567528|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||51
6639307|NCT02326272|7567529|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||48
6639308|NCT02326272|7567530|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||1
6639309|NCT02326272|7567531|FG014|COMPLETED|Open-label Period (Week 48 to Week 144)||31
6639310|NCT02326272|7567517|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639311|NCT02326272|7567518|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639312|NCT02326272|7567519|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639313|NCT02326272|7567520|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639314|NCT02326272|7567521|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639315|NCT02326272|7567522|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639316|NCT02326272|7567523|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639317|NCT02326272|7567524|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639318|NCT02326272|7567525|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639319|NCT02326272|7567526|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639320|NCT02326272|7567527|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||3
6639321|NCT02326272|7567528|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||15
6639322|NCT02326272|7567529|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||11
6639323|NCT02326272|7567530|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639324|NCT02326272|7567531|FG014|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
6639325|NCT02326298|7567543|FG000|STARTED|Initial Period (Week 0 to Week 16)||51
6639326|NCT02326298|7567544|FG001|STARTED|Initial Period (Week 0 to Week 16)||95
6639327|NCT02326298|7567545|FG002|STARTED|Initial Period (Week 0 to Week 16)||88
6639328|NCT02326298|7567546|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
6639329|NCT02326298|7567547|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
6639330|NCT02326298|7567548|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
6639331|NCT02326298|7567549|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
6639332|NCT02326298|7567550|FG007|STARTED|Initial Period (Week 0 to Week 16)||0
6639333|NCT02326298|7567551|FG008|STARTED|Initial Period (Week 0 to Week 16)||0
6639334|NCT02326298|7567552|FG009|STARTED|Initial Period (Week 0 to Week 16)||0
6639335|NCT02326298|7567553|FG010|STARTED|Initial Period (Week 0 to Week 16)||0
6639336|NCT02326298|7567554|FG011|STARTED|Initial Period (Week 0 to Week 16)||0
6639337|NCT02326298|7567555|FG012|STARTED|Initial Period (Week 0 to Week 16)||0
6639338|NCT02326298|7567556|FG013|STARTED|Initial Period (Week 0 to Week 16)||0
6639339|NCT02326298|7567543|FG000|Completed Week 16|Initial Period (Week 0 to Week 16)||46
6639340|NCT02326298|7567544|FG001|Completed Week 16|Initial Period (Week 0 to Week 16)||92
6639341|NCT02326298|7567545|FG002|Completed Week 16|Initial Period (Week 0 to Week 16)||87
6419153|NCT00985517|7333332|FG000|COMPLETED|Overall Study||3
6419154|NCT00985517|7333333|FG001|COMPLETED|Overall Study||3
6419155|NCT00985517|7333334|FG002|COMPLETED|Overall Study||23
6419156|NCT00985517|7333335|FG003|COMPLETED|Overall Study||24
6419157|NCT00985517|7333332|FG000|NOT COMPLETED|Overall Study||0
6419158|NCT00985517|7333333|FG001|NOT COMPLETED|Overall Study||0
6419159|NCT00985517|7333334|FG002|NOT COMPLETED|Overall Study||1
6419160|NCT00985517|7333335|FG003|NOT COMPLETED|Overall Study||3
6419161|NCT00985543|7333346|FG000|STARTED|Overall Study||22
6419162|NCT00985543|7333346|FG000|COMPLETED|Overall Study||22
6419163|NCT00985543|7333346|FG000|NOT COMPLETED|Overall Study||0
6419164|NCT00985621|7333356|FG000|STARTED|Overall Study||142
6419165|NCT00985621|7333357|FG001|STARTED|Overall Study||161
6419166|NCT00985621|7333358|FG002|STARTED|Overall Study||152
6419167|NCT00985621|7333359|FG003|STARTED|Overall Study||159
6419168|NCT00985621|7333356|FG000|Treated|Overall Study||141
6419169|NCT00985621|7333357|FG001|Treated|Overall Study||161
6419170|NCT00985621|7333358|FG002|Treated|Overall Study||150
6419171|NCT00985621|7333359|FG003|Treated|Overall Study||158
6419172|NCT00985621|7333356|FG000|COMPLETED|Overall Study||28
6419173|NCT00985621|7333357|FG001|COMPLETED|Overall Study||30
6419174|NCT00985621|7333358|FG002|COMPLETED|Overall Study||29
6419175|NCT00985621|7333359|FG003|COMPLETED|Overall Study||22
6419176|NCT00985621|7333356|FG000|NOT COMPLETED|Overall Study||114
6419177|NCT00985621|7333357|FG001|NOT COMPLETED|Overall Study||131
6419178|NCT00985621|7333358|FG002|NOT COMPLETED|Overall Study||123
6419179|NCT00985621|7333359|FG003|NOT COMPLETED|Overall Study||137
6419180|NCT00985673|7333377|FG000|STARTED|Overall Study||102
6419181|NCT00985673|7333378|FG001|STARTED|Overall Study||104
6419182|NCT00985673|7333379|FG002|STARTED|Overall Study||102
6419183|NCT00985673|7333380|FG003|STARTED|Overall Study||100
6419184|NCT00985673|7333381|FG004|STARTED|Overall Study||101
6419185|NCT00985673|7333382|FG005|STARTED|Overall Study||102
6419186|NCT00985673|7333377|FG000|COMPLETED|Overall Study||95
6419187|NCT00985673|7333378|FG001|COMPLETED|Overall Study||93
6419188|NCT00985673|7333379|FG002|COMPLETED|Overall Study||90
6419189|NCT00985673|7333380|FG003|COMPLETED|Overall Study||88
6639342|NCT02326298|7567546|FG003|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639343|NCT02326298|7567547|FG004|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639344|NCT02326298|7567548|FG005|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639345|NCT02326298|7567549|FG006|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639346|NCT02326298|7567550|FG007|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639347|NCT02326298|7567551|FG008|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639348|NCT02326298|7567552|FG009|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639349|NCT02326298|7567553|FG010|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639350|NCT02326298|7567554|FG011|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639351|NCT02326298|7567555|FG012|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639352|NCT02326298|7567556|FG013|Completed Week 16|Initial Period (Week 0 to Week 16)||0
6639353|NCT02326298|7567543|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||46
6639354|NCT02326298|7567544|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||92
6639355|NCT02326298|7567545|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||85
6639356|NCT02326298|7567546|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639357|NCT02326298|7567547|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639358|NCT02326298|7567548|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639359|NCT02326298|7567549|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639360|NCT02326298|7567550|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639361|NCT02326298|7567551|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639362|NCT02326298|7567552|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639363|NCT02326298|7567553|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639364|NCT02326298|7567554|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639365|NCT02326298|7567555|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639366|NCT02326298|7567556|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Week 0 to Week 16)||0
6639367|NCT02326298|7567543|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||46
6639368|NCT02326298|7567544|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||92
6639369|NCT02326298|7567545|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||85
6639370|NCT02326298|7567546|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639371|NCT02326298|7567547|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639372|NCT02326298|7567548|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639373|NCT02326298|7567549|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639374|NCT02326298|7567550|FG007|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639375|NCT02326298|7567551|FG008|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639376|NCT02326298|7567552|FG009|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639377|NCT02326298|7567553|FG010|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639378|NCT02326298|7567554|FG011|COMPLETED|Initial Period (Week 0 to Week 16)||0
6419190|NCT00985673|7333381|FG004|COMPLETED|Overall Study||93
6419191|NCT00985673|7333382|FG005|COMPLETED|Overall Study||96
6419192|NCT00985673|7333377|FG000|NOT COMPLETED|Overall Study||7
6419193|NCT00985673|7333378|FG001|NOT COMPLETED|Overall Study||11
6419194|NCT00985673|7333379|FG002|NOT COMPLETED|Overall Study||12
6419195|NCT00985673|7333380|FG003|NOT COMPLETED|Overall Study||12
6419196|NCT00985673|7333381|FG004|NOT COMPLETED|Overall Study||8
6419197|NCT00985673|7333382|FG005|NOT COMPLETED|Overall Study||6
6419198|NCT00985686|7333401|FG000|STARTED|Overall Study||18
6419199|NCT00985686|7333402|FG001|STARTED|Overall Study||16
6419200|NCT00985686|7333403|FG002|STARTED|Overall Study||13
6419201|NCT00985686|7333404|FG003|STARTED|Overall Study||16
6419202|NCT00985686|7333401|FG000|Visit 1: Baseline Data Collection|Overall Study||18
6419203|NCT00985686|7333402|FG001|Visit 1: Baseline Data Collection|Overall Study||15
6419204|NCT00985686|7333403|FG002|Visit 1: Baseline Data Collection|Overall Study||13
6419205|NCT00985686|7333404|FG003|Visit 1: Baseline Data Collection|Overall Study||16
6419206|NCT00985686|7333401|FG000|Visit 2: Data Collection at 8 Weeks|Overall Study||18
6419207|NCT00985686|7333402|FG001|Visit 2: Data Collection at 8 Weeks|Overall Study||15
6419208|NCT00985686|7333403|FG002|Visit 2: Data Collection at 8 Weeks|Overall Study||13
6419209|NCT00985686|7333404|FG003|Visit 2: Data Collection at 8 Weeks|Overall Study||16
6419210|NCT00985686|7333401|FG000|Visit 3: Data Collection at 16 Weeks|Overall Study||17
6419211|NCT00985686|7333402|FG001|Visit 3: Data Collection at 16 Weeks|Overall Study||15
6419212|NCT00985686|7333403|FG002|Visit 3: Data Collection at 16 Weeks|Overall Study||13
6419213|NCT00985686|7333404|FG003|Visit 3: Data Collection at 16 Weeks|Overall Study||16
6419214|NCT00985686|7333401|FG000|Visit 4: Data Collection at 24 Weeks|Overall Study||17
6419215|NCT00985686|7333402|FG001|Visit 4: Data Collection at 24 Weeks|Overall Study||15
6419216|NCT00985686|7333403|FG002|Visit 4: Data Collection at 24 Weeks|Overall Study||13
6419217|NCT00985686|7333404|FG003|Visit 4: Data Collection at 24 Weeks|Overall Study||14
6419218|NCT00985686|7333401|FG000|COMPLETED|Overall Study||17
6419219|NCT00985686|7333402|FG001|COMPLETED|Overall Study||15
6419220|NCT00985686|7333403|FG002|COMPLETED|Overall Study||13
6419221|NCT00985686|7333404|FG003|COMPLETED|Overall Study||14
6419222|NCT00985686|7333401|FG000|NOT COMPLETED|Overall Study||1
6419223|NCT00985686|7333402|FG001|NOT COMPLETED|Overall Study||1
6419224|NCT00985686|7333403|FG002|NOT COMPLETED|Overall Study||0
6639379|NCT02326298|7567555|FG012|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639380|NCT02326298|7567556|FG013|COMPLETED|Initial Period (Week 0 to Week 16)||0
6639381|NCT02326298|7567543|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||5
6639382|NCT02326298|7567544|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
6639383|NCT02326298|7567545|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
6639384|NCT02326298|7567546|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639385|NCT02326298|7567547|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639386|NCT02326298|7567548|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639387|NCT02326298|7567549|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639388|NCT02326298|7567550|FG007|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639389|NCT02326298|7567551|FG008|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639390|NCT02326298|7567552|FG009|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639391|NCT02326298|7567553|FG010|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639392|NCT02326298|7567554|FG011|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639393|NCT02326298|7567555|FG012|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639394|NCT02326298|7567556|FG013|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6639395|NCT02326298|7567543|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639396|NCT02326298|7567544|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639397|NCT02326298|7567545|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639398|NCT02326298|7567546|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||3
6639399|NCT02326298|7567547|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||5
6639400|NCT02326298|7567548|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||74
6639401|NCT02326298|7567549|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||77
6639402|NCT02326298|7567550|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||38
6639403|NCT02326298|7567551|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||18
6639404|NCT02326298|7567552|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||8
6639405|NCT02326298|7567553|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639406|NCT02326298|7567554|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639407|NCT02326298|7567555|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639408|NCT02326298|7567556|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||0
6639409|NCT02326298|7567543|FG000|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639410|NCT02326298|7567544|FG001|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639411|NCT02326298|7567545|FG002|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639412|NCT02326298|7567546|FG003|Completed Week 48|Maintenance Period (Week 16 to Week 48)||3
6639413|NCT02326298|7567547|FG004|Completed Week 48|Maintenance Period (Week 16 to Week 48)||5
6639414|NCT02326298|7567548|FG005|Completed Week 48|Maintenance Period (Week 16 to Week 48)||71
6639415|NCT02326298|7567549|FG006|Completed Week 48|Maintenance Period (Week 16 to Week 48)||70
6639416|NCT02326298|7567550|FG007|Completed Week 48|Maintenance Period (Week 16 to Week 48)||33
6639417|NCT02326298|7567551|FG008|Completed Week 48|Maintenance Period (Week 16 to Week 48)||13
6639418|NCT02326298|7567552|FG009|Completed Week 48|Maintenance Period (Week 16 to Week 48)||7
6639419|NCT02326298|7567553|FG010|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639420|NCT02326298|7567554|FG011|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639421|NCT02326298|7567555|FG012|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639422|NCT02326298|7567556|FG013|Completed Week 48|Maintenance Period (Week 16 to Week 48)||0
6639423|NCT02326298|7567543|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639424|NCT02326298|7567544|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639425|NCT02326298|7567545|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6419225|NCT00985686|7333404|FG003|NOT COMPLETED|Overall Study||2
6419226|NCT00985712|7333414|FG000|STARTED|Overall Study||133
6419227|NCT00985712|7333415|FG001|STARTED|Overall Study||130
6419228|NCT00985712|7333414|FG000|Received at Least One Dose of Study Drug|Overall Study||131
6419229|NCT00985712|7333415|FG001|Received at Least One Dose of Study Drug|Overall Study||130
6419230|NCT00985712|7333414|FG000|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
6419231|NCT00985712|7333415|FG001|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
6419232|NCT00985712|7333414|FG000|COMPLETED|Overall Study||127
6419233|NCT00985712|7333415|FG001|COMPLETED|Overall Study||123
6419234|NCT00985712|7333414|FG000|NOT COMPLETED|Overall Study||6
6419235|NCT00985712|7333415|FG001|NOT COMPLETED|Overall Study||7
6639426|NCT02326298|7567546|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||3
6639427|NCT02326298|7567547|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||5
6639428|NCT02326298|7567548|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||69
6639429|NCT02326298|7567549|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||70
6639430|NCT02326298|7567550|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||33
6639431|NCT02326298|7567551|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||13
6639432|NCT02326298|7567552|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||7
6639433|NCT02326298|7567553|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639434|NCT02326298|7567554|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639435|NCT02326298|7567555|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639436|NCT02326298|7567556|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6639437|NCT02326298|7567543|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639438|NCT02326298|7567544|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639439|NCT02326298|7567545|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639440|NCT02326298|7567546|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||3
6639441|NCT02326298|7567547|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6639442|NCT02326298|7567548|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||69
6639443|NCT02326298|7567549|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||70
6639444|NCT02326298|7567550|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||33
6639445|NCT02326298|7567551|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||13
6639446|NCT02326298|7567552|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||7
6639447|NCT02326298|7567553|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639448|NCT02326298|7567554|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639449|NCT02326298|7567555|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639450|NCT02326298|7567556|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639451|NCT02326298|7567543|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639452|NCT02326298|7567544|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639453|NCT02326298|7567545|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639454|NCT02326298|7567546|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639455|NCT02326298|7567547|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639456|NCT02326298|7567548|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6639457|NCT02326298|7567549|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
6639458|NCT02326298|7567550|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6639459|NCT02326298|7567551|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||5
6639460|NCT02326298|7567552|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
6639461|NCT02326298|7567553|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639462|NCT02326298|7567554|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639463|NCT02326298|7567555|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639464|NCT02326298|7567556|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6639465|NCT02326298|7567543|FG000|STARTED|Open-label Period (Week 48 to Week 144)||0
6639466|NCT02326298|7567544|FG001|STARTED|Open-label Period (Week 48 to Week 144)||0
6639467|NCT02326298|7567545|FG002|STARTED|Open-label Period (Week 48 to Week 144)||0
6639468|NCT02326298|7567546|FG003|STARTED|Open-label Period (Week 48 to Week 144)||0
6639469|NCT02326298|7567547|FG004|STARTED|Open-label Period (Week 48 to Week 144)||0
6639470|NCT02326298|7567548|FG005|STARTED|Open-label Period (Week 48 to Week 144)||0
6639471|NCT02326298|7567549|FG006|STARTED|Open-label Period (Week 48 to Week 144)||0
6639472|NCT02326298|7567550|FG007|STARTED|Open-label Period (Week 48 to Week 144)||0
6639473|NCT02326298|7567551|FG008|STARTED|Open-label Period (Week 48 to Week 144)||0
6639474|NCT02326298|7567552|FG009|STARTED|Open-label Period (Week 48 to Week 144)||0
6639475|NCT02326298|7567553|FG010|STARTED|Open-label Period (Week 48 to Week 144)||3
6639476|NCT02326298|7567554|FG011|STARTED|Open-label Period (Week 48 to Week 144)||74
6639477|NCT02326298|7567555|FG012|STARTED|Open-label Period (Week 48 to Week 144)||70
6639478|NCT02326298|7567556|FG013|STARTED|Open-label Period (Week 48 to Week 144)||53
6639479|NCT02326298|7567543|FG000|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639480|NCT02326298|7567544|FG001|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639481|NCT02326298|7567545|FG002|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639482|NCT02326298|7567546|FG003|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639483|NCT02326298|7567547|FG004|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6419236|NCT00985725|7333423|FG000|STARTED|Overall Study||71
6419237|NCT00985725|7333424|FG001|STARTED|Overall Study||72
6419238|NCT00985725|7333423|FG000|COMPLETED|Overall Study||60
6419239|NCT00985725|7333424|FG001|COMPLETED|Overall Study||59
6419240|NCT00985725|7333423|FG000|NOT COMPLETED|Overall Study||11
6419241|NCT00985725|7333424|FG001|NOT COMPLETED|Overall Study||13
6419242|NCT00985751|7333435|FG000|STARTED|Overall Study||51
6419243|NCT00985751|7333436|FG001|STARTED|Overall Study||52
6639484|NCT02326298|7567548|FG005|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639485|NCT02326298|7567549|FG006|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639486|NCT02326298|7567550|FG007|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639487|NCT02326298|7567551|FG008|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639488|NCT02326298|7567552|FG009|COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639489|NCT02326298|7567553|FG010|COMPLETED|Open-label Period (Week 48 to Week 144)||3
6639490|NCT02326298|7567554|FG011|COMPLETED|Open-label Period (Week 48 to Week 144)||54
6639491|NCT02326298|7567555|FG012|COMPLETED|Open-label Period (Week 48 to Week 144)||51
6639492|NCT02326298|7567556|FG013|COMPLETED|Open-label Period (Week 48 to Week 144)||44
6639493|NCT02326298|7567543|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639494|NCT02326298|7567544|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639495|NCT02326298|7567545|FG002|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639496|NCT02326298|7567546|FG003|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639497|NCT02326298|7567547|FG004|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639498|NCT02326298|7567548|FG005|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639499|NCT02326298|7567549|FG006|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639500|NCT02326298|7567550|FG007|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639501|NCT02326298|7567551|FG008|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639502|NCT02326298|7567552|FG009|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639503|NCT02326298|7567553|FG010|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||0
6639504|NCT02326298|7567554|FG011|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||20
6639505|NCT02326298|7567555|FG012|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||19
6639506|NCT02326298|7567556|FG013|NOT COMPLETED|Open-label Period (Week 48 to Week 144)||9
6639507|NCT02326363|7567567|FG000|STARTED|Overall Study||98
6639508|NCT02326363|7567568|FG001|STARTED|Overall Study||106
6639509|NCT02326363|7567567|FG000|COMPLETED|Overall Study||47
6639510|NCT02326363|7567568|FG001|COMPLETED|Overall Study||50
6639511|NCT02326363|7567567|FG000|NOT COMPLETED|Overall Study||51
6639512|NCT02326363|7567568|FG001|NOT COMPLETED|Overall Study||56
6639513|NCT02326467|7567576|FG000|STARTED|Overall Study||10
6639514|NCT02326467|7567576|FG000|COMPLETED|Overall Study||9
6639515|NCT02326467|7567576|FG000|NOT COMPLETED|Overall Study||1
6639516|NCT02326597|7567583|FG000|STARTED|Overall Study||60
6639517|NCT02326597|7567584|FG001|STARTED|Overall Study||60
6639518|NCT02326597|7567583|FG000|COMPLETED|Overall Study||18
6639519|NCT02326597|7567584|FG001|COMPLETED|Overall Study||28
6639520|NCT02326597|7567583|FG000|NOT COMPLETED|Overall Study||42
6639521|NCT02326597|7567584|FG001|NOT COMPLETED|Overall Study||32
6639522|NCT02326649|7567592|FG000|STARTED|Overall Study||33
6639523|NCT02326649|7567592|FG000|COMPLETED|Overall Study||21
6639524|NCT02326649|7567592|FG000|NOT COMPLETED|Overall Study||12
6639525|NCT02326805|7567598|FG000|STARTED|Overall Study||106
6639526|NCT02326805|7567599|FG001|STARTED|Overall Study||48
6639527|NCT02326805|7567598|FG000|COMPLETED|Overall Study||103
6639528|NCT02326805|7567599|FG001|COMPLETED|Overall Study||47
6639529|NCT02326805|7567598|FG000|NOT COMPLETED|Overall Study||3
6639530|NCT02326805|7567599|FG001|NOT COMPLETED|Overall Study||1
6639531|NCT02326844|7567605|FG000|STARTED|Overall Study||3
6639532|NCT02326844|7567605|FG000|COMPLETED|Overall Study||3
6639533|NCT02326844|7567605|FG000|NOT COMPLETED|Overall Study||0
6639534|NCT02326883|7567612|FG000|STARTED|Overall Study||6314
6639535|NCT02326883|7567613|FG001|STARTED|Overall Study||6312
6639536|NCT02326883|7567614|FG002|STARTED|Overall Study||6256
6639537|NCT02326883|7567612|FG000|COMPLETED|Overall Study||6230
6639538|NCT02326883|7567613|FG001|COMPLETED|Overall Study||6227
6639539|NCT02326883|7567614|FG002|COMPLETED|Overall Study||6187
6639540|NCT02326883|7567612|FG000|NOT COMPLETED|Overall Study||84
6639541|NCT02326883|7567613|FG001|NOT COMPLETED|Overall Study||85
6639542|NCT02326883|7567614|FG002|NOT COMPLETED|Overall Study||69
6639543|NCT02327013|7567625|FG000|STARTED|Overall Study||49
6639544|NCT02327013|7567626|FG001|STARTED|Overall Study||45
6639545|NCT02327013|7567627|FG002|STARTED|Overall Study||96
6639546|NCT02327013|7567628|FG003|STARTED|Overall Study||21
6639547|NCT02327013|7567629|FG004|STARTED|Overall Study||16
6639548|NCT02327013|7567625|FG000|COMPLETED|Overall Study||36
6639549|NCT02327013|7567626|FG001|COMPLETED|Overall Study||29
6419244|NCT00985751|7333437|FG002|STARTED|Overall Study||52
6639550|NCT02327013|7567627|FG002|COMPLETED|Overall Study||54
6639551|NCT02327013|7567628|FG003|COMPLETED|Overall Study||20
6639552|NCT02327013|7567629|FG004|COMPLETED|Overall Study||12
6639553|NCT02327013|7567625|FG000|NOT COMPLETED|Overall Study||13
6639554|NCT02327013|7567626|FG001|NOT COMPLETED|Overall Study||16
6639555|NCT02327013|7567627|FG002|NOT COMPLETED|Overall Study||42
6639556|NCT02327013|7567628|FG003|NOT COMPLETED|Overall Study||1
6639557|NCT02327013|7567629|FG004|NOT COMPLETED|Overall Study||4
6639558|NCT02327052|7567649|FG000|STARTED|Overall Study||58
6639559|NCT02327052|7567649|FG000|COMPLETED|Overall Study||58
6639560|NCT02327052|7567649|FG000|NOT COMPLETED|Overall Study||0
6639561|NCT02327117|7567655|FG000|STARTED|Overall Study||45
6419245|NCT00985751|7333438|FG003|STARTED|Overall Study||51
6419246|NCT00985751|7333439|FG004|STARTED|Overall Study||51
6419247|NCT00985751|7333435|FG000|COMPLETED|Overall Study||51
6419248|NCT00985751|7333436|FG001|COMPLETED|Overall Study||52
6419249|NCT00985751|7333437|FG002|COMPLETED|Overall Study||52
6419250|NCT00985751|7333438|FG003|COMPLETED|Overall Study||51
6419251|NCT00985751|7333439|FG004|COMPLETED|Overall Study||50
6419252|NCT00985751|7333435|FG000|NOT COMPLETED|Overall Study||0
6419253|NCT00985751|7333436|FG001|NOT COMPLETED|Overall Study||0
6419254|NCT00985751|7333437|FG002|NOT COMPLETED|Overall Study||0
6419255|NCT00985751|7333438|FG003|NOT COMPLETED|Overall Study||0
6419256|NCT00985751|7333439|FG004|NOT COMPLETED|Overall Study||1
6639562|NCT02327117|7567656|FG001|STARTED|Overall Study||45
6639563|NCT02327117|7567655|FG000|COMPLETED|Overall Study||45
6639564|NCT02327117|7567656|FG001|COMPLETED|Overall Study||45
6639565|NCT02327117|7567655|FG000|NOT COMPLETED|Overall Study||0
6639566|NCT02327117|7567656|FG001|NOT COMPLETED|Overall Study||0
6639567|NCT02327130|7567662|FG000|STARTED|Overall Study||32
6639568|NCT02327130|7567662|FG000|COMPLETED|Overall Study||20
6639569|NCT02327130|7567662|FG000|NOT COMPLETED|Overall Study||12
6639570|NCT02327143|7567669|FG000|STARTED|Day 1: Time 0 Hrs to 6 Hrs||11
6639571|NCT02327143|7567670|FG001|STARTED|Day 1: Time 0 Hrs to 6 Hrs||0
6639572|NCT02327143|7567669|FG000|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||11
6639573|NCT02327143|7567670|FG001|COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
6639574|NCT02327143|7567669|FG000|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
6639575|NCT02327143|7567670|FG001|NOT COMPLETED|Day 1: Time 0 Hrs to 6 Hrs||0
6639576|NCT02327143|7567669|FG000|STARTED|Day 1: Time 6 Hrs - to Day 9||0
6639577|NCT02327143|7567670|FG001|STARTED|Day 1: Time 6 Hrs - to Day 9||11
6639578|NCT02327143|7567669|FG000|COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
6639579|NCT02327143|7567670|FG001|COMPLETED|Day 1: Time 6 Hrs - to Day 9||11
6639580|NCT02327143|7567669|FG000|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
6639581|NCT02327143|7567670|FG001|NOT COMPLETED|Day 1: Time 6 Hrs - to Day 9||0
6639582|NCT02327169|7567691|FG000|STARTED|Overall Study||4
6639583|NCT02327169|7567692|FG001|STARTED|Overall Study||3
6639584|NCT02327169|7567693|FG002|STARTED|Overall Study||7
6639585|NCT02327169|7567694|FG003|STARTED|Overall Study||3
6743528|NCT03334747|7671726|FG002|NOT COMPLETED|Follow-Up Phase||0
6743529|NCT03334747|7671727|FG003|NOT COMPLETED|Follow-Up Phase||0
6743530|NCT03334747|7671728|FG004|NOT COMPLETED|Follow-Up Phase||0
6743531|NCT03334747|7671729|FG005|NOT COMPLETED|Follow-Up Phase||0
6743532|NCT03334747|7671730|FG006|NOT COMPLETED|Follow-Up Phase||1
6743533|NCT03334747|7671731|FG007|NOT COMPLETED|Follow-Up Phase||0
6743534|NCT03334747|7671732|FG008|NOT COMPLETED|Follow-Up Phase||1
6743535|NCT03334812|7671754|FG000|STARTED|Overall Study||9
6743536|NCT03334812|7671755|FG001|STARTED|Overall Study||5
6743537|NCT03334812|7671756|FG002|STARTED|Overall Study||0
6743538|NCT03334812|7671757|FG003|STARTED|Overall Study||0
6743539|NCT03334812|7671754|FG000|COMPLETED|Overall Study||9
6743540|NCT03334812|7671755|FG001|COMPLETED|Overall Study||5
6743541|NCT03334812|7671756|FG002|COMPLETED|Overall Study||0
6743542|NCT03334812|7671757|FG003|COMPLETED|Overall Study||0
6743543|NCT03334812|7671754|FG000|NOT COMPLETED|Overall Study||0
6743544|NCT03334812|7671755|FG001|NOT COMPLETED|Overall Study||0
6743545|NCT03334812|7671756|FG002|NOT COMPLETED|Overall Study||0
6743546|NCT03334812|7671757|FG003|NOT COMPLETED|Overall Study||0
6743547|NCT03334825|7671765|FG000|STARTED|Overall Study||119
6743548|NCT03334825|7671766|FG001|STARTED|Overall Study||117
6743549|NCT03334825|7671765|FG000|COMPLETED|Overall Study||112
6743550|NCT03334825|7671766|FG001|COMPLETED|Overall Study||113
6743551|NCT03334825|7671765|FG000|NOT COMPLETED|Overall Study||7
6743552|NCT03334825|7671766|FG001|NOT COMPLETED|Overall Study||4
6743553|NCT03334903|7671774|FG000|STARTED|Overall Study||39
6743554|NCT03334903|7671775|FG001|STARTED|Overall Study||38
6743555|NCT03334903|7671774|FG000|COMPLETED|Overall Study||35
6743556|NCT03334903|7671775|FG001|COMPLETED|Overall Study||33
6743557|NCT03334903|7671774|FG000|NOT COMPLETED|Overall Study||4
6743558|NCT03334903|7671775|FG001|NOT COMPLETED|Overall Study||5
6743559|NCT03335150|7671783|FG000|STARTED|Overall Study||55
6743560|NCT03335150|7671784|FG001|STARTED|Overall Study||55
6743561|NCT03335150|7671783|FG000|Enrolled + Assigned Group|Overall Study||54
6743562|NCT03335150|7671784|FG001|Enrolled + Assigned Group|Overall Study||55
6743563|NCT03335150|7671783|FG000|PRE Testing Session|Overall Study||53
6743564|NCT03335150|7671784|FG001|PRE Testing Session|Overall Study||55
6743565|NCT03335150|7671783|FG000|Commenced Group|Overall Study||47
6419257|NCT00985790|7333456|FG000|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
6419258|NCT00985790|7333457|FG001|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
6419259|NCT00985790|7333456|FG000|COMPLETED|Overall Study||291
6419260|NCT00985790|7333457|FG001|COMPLETED|Overall Study||293
6639586|NCT02327169|7567695|FG004|STARTED|Overall Study||8
6639587|NCT02327169|7567696|FG005|STARTED|Overall Study||4
6639588|NCT02327169|7567697|FG006|STARTED|Overall Study||3
6743566|NCT03335150|7671784|FG001|Commenced Group|Overall Study||52
6743567|NCT03335150|7671783|FG000|POST Testing Session|Overall Study||45
6743568|NCT03335150|7671784|FG001|POST Testing Session|Overall Study||50
6743569|NCT03335150|7671783|FG000|COMPLETED|Overall Study||45
6743570|NCT03335150|7671784|FG001|COMPLETED|Overall Study||50
6743571|NCT03335150|7671783|FG000|NOT COMPLETED|Overall Study||10
6743572|NCT03335150|7671784|FG001|NOT COMPLETED|Overall Study||5
6743573|NCT03335254|7671810|FG000|STARTED|Period 1||9
6743574|NCT03335254|7671811|FG001|STARTED|Period 1||0
6419261|NCT00985790|7333456|FG000|NOT COMPLETED|Overall Study||7
6419262|NCT00985790|7333457|FG001|NOT COMPLETED|Overall Study||8
6419263|NCT00985829|7333468|FG000|STARTED|Overall Study||28
6419264|NCT00985829|7333468|FG000|COMPLETED|Overall Study||28
6419265|NCT00985829|7333468|FG000|NOT COMPLETED|Overall Study||0
6639589|NCT02327169|7567698|FG007|STARTED|Overall Study||4
6639590|NCT02327169|7567699|FG008|STARTED|Overall Study||6
6639591|NCT02327169|7567700|FG009|STARTED|Overall Study||8
6639592|NCT02327169|7567701|FG010|STARTED|Overall Study||6
6639593|NCT02327169|7567702|FG011|STARTED|Overall Study||7
6639594|NCT02327169|7567703|FG012|STARTED|Overall Study||1
6639595|NCT02327169|7567704|FG013|STARTED|Overall Study||7
6639596|NCT02327169|7567705|FG014|STARTED|Overall Study||10
6639597|NCT02327169|7567691|FG000|COMPLETED|Overall Study||0
6639598|NCT02327169|7567692|FG001|COMPLETED|Overall Study||0
6639599|NCT02327169|7567693|FG002|COMPLETED|Overall Study||0
6639600|NCT02327169|7567694|FG003|COMPLETED|Overall Study||0
6639601|NCT02327169|7567695|FG004|COMPLETED|Overall Study||0
6639602|NCT02327169|7567696|FG005|COMPLETED|Overall Study||0
6639603|NCT02327169|7567697|FG006|COMPLETED|Overall Study||0
6639604|NCT02327169|7567698|FG007|COMPLETED|Overall Study||0
6639605|NCT02327169|7567699|FG008|COMPLETED|Overall Study||0
6639606|NCT02327169|7567700|FG009|COMPLETED|Overall Study||0
6639607|NCT02327169|7567701|FG010|COMPLETED|Overall Study||0
6639608|NCT02327169|7567702|FG011|COMPLETED|Overall Study||0
6639609|NCT02327169|7567703|FG012|COMPLETED|Overall Study||0
6639610|NCT02327169|7567704|FG013|COMPLETED|Overall Study||0
6639611|NCT02327169|7567705|FG014|COMPLETED|Overall Study||0
6639612|NCT02327169|7567691|FG000|NOT COMPLETED|Overall Study||4
6639613|NCT02327169|7567692|FG001|NOT COMPLETED|Overall Study||3
6639614|NCT02327169|7567693|FG002|NOT COMPLETED|Overall Study||7
6639615|NCT02327169|7567694|FG003|NOT COMPLETED|Overall Study||3
6639616|NCT02327169|7567695|FG004|NOT COMPLETED|Overall Study||8
6639617|NCT02327169|7567696|FG005|NOT COMPLETED|Overall Study||4
6639618|NCT02327169|7567697|FG006|NOT COMPLETED|Overall Study||3
6639619|NCT02327169|7567698|FG007|NOT COMPLETED|Overall Study||4
6639620|NCT02327169|7567699|FG008|NOT COMPLETED|Overall Study||6
6639621|NCT02327169|7567700|FG009|NOT COMPLETED|Overall Study||8
6639622|NCT02327169|7567701|FG010|NOT COMPLETED|Overall Study||6
6639623|NCT02327169|7567702|FG011|NOT COMPLETED|Overall Study||7
6639624|NCT02327169|7567703|FG012|NOT COMPLETED|Overall Study||1
6639625|NCT02327169|7567704|FG013|NOT COMPLETED|Overall Study||7
6639626|NCT02327169|7567705|FG014|NOT COMPLETED|Overall Study||10
6639627|NCT02327260|7567750|FG000|STARTED|Overall Study||20
6639628|NCT02327260|7567751|FG001|STARTED|Overall Study||24
6639629|NCT02327260|7567752|FG002|STARTED|Overall Study||17
6639630|NCT02327260|7567750|FG000|COMPLETED|Overall Study||14
6639631|NCT02327260|7567751|FG001|COMPLETED|Overall Study||20
6639632|NCT02327260|7567752|FG002|COMPLETED|Overall Study||15
6639633|NCT02327260|7567750|FG000|NOT COMPLETED|Overall Study||6
6639634|NCT02327260|7567751|FG001|NOT COMPLETED|Overall Study||4
6639635|NCT02327260|7567752|FG002|NOT COMPLETED|Overall Study||2
6639636|NCT02327325|7567764|FG000|STARTED|Overall Study||20
6639637|NCT02327325|7567765|FG001|STARTED|Overall Study||20
6639638|NCT02327325|7567766|FG002|STARTED|Overall Study||20
6639639|NCT02327325|7567764|FG000|COMPLETED|Overall Study||19
6639640|NCT02327325|7567765|FG001|COMPLETED|Overall Study||16
6639641|NCT02327325|7567766|FG002|COMPLETED|Overall Study||15
6639642|NCT02327325|7567764|FG000|NOT COMPLETED|Overall Study||1
6639643|NCT02327325|7567765|FG001|NOT COMPLETED|Overall Study||4
6639644|NCT02327325|7567766|FG002|NOT COMPLETED|Overall Study||5
6639645|NCT02327351|7567774|FG000|STARTED|Overall Study||98
6639646|NCT02327351|7567774|FG000|COMPLETED|Overall Study||98
6639647|NCT02327351|7567774|FG000|NOT COMPLETED|Overall Study||0
6639648|NCT02327429|7567782|FG000|STARTED|Overall Study||19
6639649|NCT02327429|7567782|FG000|COMPLETED|Overall Study||17
6639650|NCT02327429|7567782|FG000|NOT COMPLETED|Overall Study||2
6639651|NCT02327741|7567788|FG000|STARTED|Overall Study||502
6639652|NCT02327741|7567789|FG001|STARTED|Overall Study||508
6639653|NCT02327741|7567788|FG000|COMPLETED|Overall Study||502
6639654|NCT02327741|7567789|FG001|COMPLETED|Overall Study||508
6639655|NCT02327741|7567788|FG000|NOT COMPLETED|Overall Study||0
6639656|NCT02327741|7567789|FG001|NOT COMPLETED|Overall Study||0
6639657|NCT02328027|7567797|FG000|STARTED|Overall Study||5
6639658|NCT02328027|7567798|FG001|STARTED|Overall Study||11
6639659|NCT02328027|7567797|FG000|COMPLETED|Overall Study||5
6639660|NCT02328027|7567798|FG001|COMPLETED|Overall Study||10
6639661|NCT02328027|7567797|FG000|NOT COMPLETED|Overall Study||0
6419266|NCT00985907|7333473|FG000|STARTED|Overall Study||13
6639662|NCT02328027|7567798|FG001|NOT COMPLETED|Overall Study||1
6639663|NCT02328040|7567805|FG000|STARTED|First Intervention (2 Days)||8
6639664|NCT02328040|7567806|FG001|STARTED|First Intervention (2 Days)||9
6639665|NCT02328040|7567805|FG000|COMPLETED|First Intervention (2 Days)||7
6639666|NCT02328040|7567806|FG001|COMPLETED|First Intervention (2 Days)||8
6639667|NCT02328040|7567805|FG000|NOT COMPLETED|First Intervention (2 Days)||1
6639668|NCT02328040|7567806|FG001|NOT COMPLETED|First Intervention (2 Days)||1
6639669|NCT02328040|7567805|FG000|STARTED|Second Intervention (2 Days)||7
6639670|NCT02328040|7567806|FG001|STARTED|Second Intervention (2 Days)||8
6639671|NCT02328040|7567805|FG000|COMPLETED|Second Intervention (2 Days)||7
6639672|NCT02328040|7567806|FG001|COMPLETED|Second Intervention (2 Days)||8
6419267|NCT00985907|7333473|FG000|COMPLETED|Overall Study||0
6419268|NCT00985907|7333473|FG000|NOT COMPLETED|Overall Study||13
6419269|NCT00985946|7333477|FG000|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
6419270|NCT00985946|7333477|FG000|COMPLETED|Overall Study||8
6419271|NCT00985946|7333477|FG000|NOT COMPLETED|Overall Study||7
6419272|NCT00985959|7333484|FG000|STARTED|Overall Study|Number of participants treated|6
6419273|NCT00985959|7333485|FG001|STARTED|Overall Study|Number of participants treated|6
6419274|NCT00985959|7333486|FG002|STARTED|Overall Study|Number of participants treated|87
6419275|NCT00985959|7333484|FG000|COMPLETED|Overall Study|Completed all 9 cycles|3
6419276|NCT00985959|7333485|FG001|COMPLETED|Overall Study|Completed all 9 cycles|3
6419277|NCT00985959|7333486|FG002|COMPLETED|Overall Study||28
6419278|NCT00985959|7333484|FG000|NOT COMPLETED|Overall Study||3
6419279|NCT00985959|7333485|FG001|NOT COMPLETED|Overall Study||3
6419280|NCT00985959|7333486|FG002|NOT COMPLETED|Overall Study||59
6419281|NCT00985985|7333504|FG000|STARTED|Overall Study||241
6419282|NCT00985985|7333505|FG001|STARTED|Overall Study||242
6419283|NCT00985985|7333506|FG002|STARTED|Overall Study||120
6419284|NCT00985985|7333507|FG003|STARTED|Overall Study||120
6419285|NCT00985985|7333504|FG000|Safety Population|Overall Study||241
6419286|NCT00985985|7333505|FG001|Safety Population|Overall Study||242
6419287|NCT00985985|7333506|FG002|Safety Population|Overall Study||119
6419288|NCT00985985|7333507|FG003|Safety Population|Overall Study||118
6419289|NCT00985985|7333504|FG000|Full Analysis Set (FAS) Population|Overall Study||241
6419290|NCT00985985|7333505|FG001|Full Analysis Set (FAS) Population|Overall Study||242
6419291|NCT00985985|7333506|FG002|Full Analysis Set (FAS) Population|Overall Study||120
6419292|NCT00985985|7333507|FG003|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
6419293|NCT00985985|7333504|FG000|COMPLETED|Overall Study||217
6419294|NCT00985985|7333505|FG001|COMPLETED|Overall Study||218
6419295|NCT00985985|7333506|FG002|COMPLETED|Overall Study||109
6419296|NCT00985985|7333507|FG003|COMPLETED|Overall Study||107
6419297|NCT00985985|7333504|FG000|NOT COMPLETED|Overall Study||24
6419298|NCT00985985|7333505|FG001|NOT COMPLETED|Overall Study||24
6419299|NCT00985985|7333506|FG002|NOT COMPLETED|Overall Study||11
6419300|NCT00985985|7333507|FG003|NOT COMPLETED|Overall Study||13
6419301|NCT00986102|7333526|FG000|STARTED|Overall Study|Number of participants who received study medication|53
6419302|NCT00986102|7333527|FG001|STARTED|Overall Study|Number of participants who received study medication|77
6419303|NCT00986102|7333528|FG002|STARTED|Overall Study|Number of participants who received study medication|19
6419304|NCT00986102|7333529|FG003|STARTED|Overall Study|Number of participants who received study medication|67
6419305|NCT00986102|7333526|FG000|COMPLETED|Overall Study||52
6419306|NCT00986102|7333527|FG001|COMPLETED|Overall Study||75
6419307|NCT00986102|7333528|FG002|COMPLETED|Overall Study||19
6419308|NCT00986102|7333529|FG003|COMPLETED|Overall Study||66
6419309|NCT00986102|7333526|FG000|NOT COMPLETED|Overall Study||1
6419310|NCT00986102|7333527|FG001|NOT COMPLETED|Overall Study||2
6419311|NCT00986102|7333528|FG002|NOT COMPLETED|Overall Study||0
6419312|NCT00986102|7333529|FG003|NOT COMPLETED|Overall Study||1
6419313|NCT00986154|7333541|FG000|STARTED|Overall Study||4143
6419314|NCT00986154|7333542|FG001|STARTED|Overall Study||4149
6419315|NCT00986154|7333541|FG000|Safety Analysis Set (Received Drug)|Overall Study||4118
6419316|NCT00986154|7333542|FG001|Safety Analysis Set (Received Drug)|Overall Study||4122
6419317|NCT00986154|7333541|FG000|COMPLETED|Overall Study||3937
6419318|NCT00986154|7333542|FG001|COMPLETED|Overall Study||3955
6419319|NCT00986154|7333541|FG000|NOT COMPLETED|Overall Study||206
6419320|NCT00986154|7333542|FG001|NOT COMPLETED|Overall Study||194
6419321|NCT00986180|7333550|FG000|STARTED|Overall Study||321
6419322|NCT00986180|7333551|FG001|STARTED|Overall Study||324
6419323|NCT00986180|7333550|FG000|COMPLETED|Overall Study||277
6419324|NCT00986180|7333551|FG001|COMPLETED|Overall Study||268
6639673|NCT02328040|7567805|FG000|NOT COMPLETED|Second Intervention (2 Days)||0
6639674|NCT02328040|7567806|FG001|NOT COMPLETED|Second Intervention (2 Days)||0
6639675|NCT02328326|7567814|FG000|STARTED|Overall Study|3 participant dyads withdrew before 6-month follow up. 3 more care partners withdrew and 1 died.|246
6639676|NCT02328326|7567815|FG001|STARTED|Overall Study|1 participant dyad withdrew from the study between assignment to control arm and 6-month follow up.|232
6639677|NCT02328326|7567814|FG000|6-month Follow Up|Overall Study|We were unable to reach 15 participants. 1 patient died, 1 care partner withdrew before completion.|221
6639678|NCT02328326|7567815|FG001|6-month Follow Up|Overall Study|We were unable to reach 9 participants. 1 patient died, 1 care partner withdrew before completion.|221
6639679|NCT02328326|7567814|FG000|COMPLETED|Overall Study||224
6639680|NCT02328326|7567815|FG001|COMPLETED|Overall Study||224
6639681|NCT02328326|7567814|FG000|NOT COMPLETED|Overall Study||22
6639682|NCT02328326|7567815|FG001|NOT COMPLETED|Overall Study||8
6639683|NCT02328404|7567825|FG000|STARTED|Overall Study||30
6639684|NCT02328404|7567826|FG001|STARTED|Overall Study||30
6639685|NCT02328404|7567825|FG000|COMPLETED|Overall Study||29
6639686|NCT02328404|7567826|FG001|COMPLETED|Overall Study||29
6639687|NCT02328404|7567825|FG000|NOT COMPLETED|Overall Study||1
6639688|NCT02328404|7567826|FG001|NOT COMPLETED|Overall Study||1
6639689|NCT02328547|7567838|FG000|STARTED|First Intervention (12 Weeks)||25
6639690|NCT02328547|7567839|FG001|STARTED|First Intervention (12 Weeks)||23
6419325|NCT00986180|7333550|FG000|NOT COMPLETED|Overall Study||44
6419326|NCT00986180|7333551|FG001|NOT COMPLETED|Overall Study||56
6419327|NCT00986232|7333561|FG000|STARTED|Overall Study||387
6419328|NCT00986232|7333562|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
6419329|NCT00986232|7333563|FG002|STARTED|Overall Study||381
6419330|NCT00986232|7333564|FG003|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
6419331|NCT00986232|7333561|FG000|Vaccination Visit 1|Overall Study||387
6419332|NCT00986232|7333562|FG001|Vaccination Visit 1|Overall Study||393
6419333|NCT00986232|7333563|FG002|Vaccination Visit 1|Overall Study||381
6419334|NCT00986232|7333564|FG003|Vaccination Visit 1|Overall Study||390
6419335|NCT00986232|7333561|FG000|Vaccination Visit 2|Overall Study||360
6419336|NCT00986232|7333562|FG001|Vaccination Visit 2|Overall Study||365
6419337|NCT00986232|7333563|FG002|Vaccination Visit 2|Overall Study||360
6419338|NCT00986232|7333564|FG003|Vaccination Visit 2|Overall Study||0
6639691|NCT02328547|7567838|FG000|COMPLETED|First Intervention (12 Weeks)||22
6639692|NCT02328547|7567839|FG001|COMPLETED|First Intervention (12 Weeks)||23
6639693|NCT02328547|7567838|FG000|NOT COMPLETED|First Intervention (12 Weeks)||3
6639694|NCT02328547|7567839|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
6639695|NCT02328547|7567838|FG000|STARTED|Second Intervention (12 Weeks)||22
6639696|NCT02328547|7567839|FG001|STARTED|Second Intervention (12 Weeks)||23
6639697|NCT02328547|7567838|FG000|COMPLETED|Second Intervention (12 Weeks)||22
6639698|NCT02328547|7567839|FG001|COMPLETED|Second Intervention (12 Weeks)||23
6639699|NCT02328547|7567838|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
6639700|NCT02328547|7567839|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
6639701|NCT02328755|7567853|FG000|STARTED|Overall Study||3
6639702|NCT02328755|7567854|FG001|STARTED|Overall Study||33
6639703|NCT02328755|7567853|FG000|COMPLETED|Overall Study|Evaluable for the phase II primary endpoint of relapse at 6-months post-HCT|0
6639704|NCT02328755|7567854|FG001|COMPLETED|Overall Study||31
6639705|NCT02328755|7567853|FG000|NOT COMPLETED|Overall Study||3
6639706|NCT02328755|7567854|FG001|NOT COMPLETED|Overall Study||2
6639707|NCT02328807|7567866|FG000|STARTED|Overall Study||6
6639708|NCT02328807|7567866|FG000|COMPLETED|Overall Study||6
6639709|NCT02328807|7567866|FG000|NOT COMPLETED|Overall Study||0
6639710|NCT02328937|7567872|FG000|STARTED|Period 1||7
6639711|NCT02328937|7567873|FG001|STARTED|Period 1||6
6639712|NCT02328937|7567874|FG002|STARTED|Period 1||7
6639713|NCT02328937|7567875|FG003|STARTED|Period 1||6
6639714|NCT02328937|7567876|FG004|STARTED|Period 1||6
6639715|NCT02328937|7567877|FG005|STARTED|Period 1||6
6639716|NCT02328937|7567872|FG000|COMPLETED|Period 1||7
6639717|NCT02328937|7567873|FG001|COMPLETED|Period 1||6
6639718|NCT02328937|7567874|FG002|COMPLETED|Period 1||7
6639719|NCT02328937|7567875|FG003|COMPLETED|Period 1||5
6639720|NCT02328937|7567876|FG004|COMPLETED|Period 1||6
6639721|NCT02328937|7567877|FG005|COMPLETED|Period 1||6
6639722|NCT02328937|7567872|FG000|NOT COMPLETED|Period 1||0
6639723|NCT02328937|7567873|FG001|NOT COMPLETED|Period 1||0
6639724|NCT02328937|7567874|FG002|NOT COMPLETED|Period 1||0
6639725|NCT02328937|7567875|FG003|NOT COMPLETED|Period 1||1
6639726|NCT02328937|7567876|FG004|NOT COMPLETED|Period 1||0
6639727|NCT02328937|7567877|FG005|NOT COMPLETED|Period 1||0
6639728|NCT02328937|7567872|FG000|STARTED|Period 2||7
6639729|NCT02328937|7567873|FG001|STARTED|Period 2||6
6639730|NCT02328937|7567874|FG002|STARTED|Period 2||7
6639731|NCT02328937|7567875|FG003|STARTED|Period 2||5
6639732|NCT02328937|7567876|FG004|STARTED|Period 2||6
6639733|NCT02328937|7567877|FG005|STARTED|Period 2||6
6639734|NCT02328937|7567872|FG000|COMPLETED|Period 2||7
6639735|NCT02328937|7567873|FG001|COMPLETED|Period 2||6
6639736|NCT02328937|7567874|FG002|COMPLETED|Period 2||6
6639737|NCT02328937|7567875|FG003|COMPLETED|Period 2||5
6639738|NCT02328937|7567876|FG004|COMPLETED|Period 2||6
6639739|NCT02328937|7567877|FG005|COMPLETED|Period 2||6
6639740|NCT02328937|7567872|FG000|NOT COMPLETED|Period 2||0
6639741|NCT02328937|7567873|FG001|NOT COMPLETED|Period 2||0
6639742|NCT02328937|7567874|FG002|NOT COMPLETED|Period 2||1
6639743|NCT02328937|7567875|FG003|NOT COMPLETED|Period 2||0
6639744|NCT02328937|7567876|FG004|NOT COMPLETED|Period 2||0
6639745|NCT02328937|7567877|FG005|NOT COMPLETED|Period 2||0
6639746|NCT02328937|7567872|FG000|STARTED|Period 3||7
6639747|NCT02328937|7567873|FG001|STARTED|Period 3||6
6639748|NCT02328937|7567874|FG002|STARTED|Period 3||6
6639749|NCT02328937|7567875|FG003|STARTED|Period 3||5
6639750|NCT02328937|7567876|FG004|STARTED|Period 3||6
6639751|NCT02328937|7567877|FG005|STARTED|Period 3||6
6419339|NCT00986232|7333561|FG000|COMPLETED|Overall Study||336
6419340|NCT00986232|7333562|FG001|COMPLETED|Overall Study||343
6639752|NCT02328937|7567872|FG000|COMPLETED|Period 3||7
6639753|NCT02328937|7567873|FG001|COMPLETED|Period 3||6
6639754|NCT02328937|7567874|FG002|COMPLETED|Period 3||6
6639755|NCT02328937|7567875|FG003|COMPLETED|Period 3||5
6639756|NCT02328937|7567876|FG004|COMPLETED|Period 3||6
6639757|NCT02328937|7567877|FG005|COMPLETED|Period 3||6
6639758|NCT02328937|7567872|FG000|NOT COMPLETED|Period 3||0
6639759|NCT02328937|7567873|FG001|NOT COMPLETED|Period 3||0
6639760|NCT02328937|7567874|FG002|NOT COMPLETED|Period 3||0
6639761|NCT02328937|7567875|FG003|NOT COMPLETED|Period 3||0
6639762|NCT02328937|7567876|FG004|NOT COMPLETED|Period 3||0
6639763|NCT02328937|7567877|FG005|NOT COMPLETED|Period 3||0
6639764|NCT02329015|7567887|FG000|STARTED|Overall Study||48
6639765|NCT02329015|7567888|FG001|STARTED|Overall Study||64
6639766|NCT02329015|7567887|FG000|COMPLETED|Overall Study||48
6639767|NCT02329015|7567888|FG001|COMPLETED|Overall Study||64
6639768|NCT02329015|7567887|FG000|NOT COMPLETED|Overall Study||0
6639769|NCT02329015|7567888|FG001|NOT COMPLETED|Overall Study||0
6639770|NCT02329223|7567897|FG000|STARTED|Overall Study||73
6639771|NCT02329223|7567898|FG001|STARTED|Overall Study||71
6419341|NCT00986232|7333563|FG002|COMPLETED|Overall Study||346
6419342|NCT00986232|7333564|FG003|COMPLETED|Overall Study||370
6419343|NCT00986232|7333561|FG000|NOT COMPLETED|Overall Study||51
6419344|NCT00986232|7333562|FG001|NOT COMPLETED|Overall Study||50
6639772|NCT02329223|7567899|FG002|STARTED|Overall Study||74
6639773|NCT02329223|7567897|FG000|Full Analysis Set|Overall Study||73
6639774|NCT02329223|7567898|FG001|Full Analysis Set|Overall Study||70
6639775|NCT02329223|7567899|FG002|Full Analysis Set|Overall Study||74
6639776|NCT02329223|7567897|FG000|Safety Set|Overall Study||73
6639777|NCT02329223|7567898|FG001|Safety Set|Overall Study||71
6639778|NCT02329223|7567899|FG002|Safety Set|Overall Study||74
6639779|NCT02329223|7567897|FG000|COMPLETED|Overall Study||72
6639780|NCT02329223|7567898|FG001|COMPLETED|Overall Study||68
6639781|NCT02329223|7567899|FG002|COMPLETED|Overall Study||68
6639782|NCT02329223|7567897|FG000|NOT COMPLETED|Overall Study||1
6639783|NCT02329223|7567898|FG001|NOT COMPLETED|Overall Study||3
6639784|NCT02329223|7567899|FG002|NOT COMPLETED|Overall Study||6
6639785|NCT02329431|7567909|FG000|STARTED|Overall Study||92
6639786|NCT02329431|7567910|FG001|STARTED|Overall Study||89
6639787|NCT02329431|7567909|FG000|Baseline Interview|Overall Study||87
6639788|NCT02329431|7567910|FG001|Baseline Interview|Overall Study||85
6639789|NCT02329431|7567909|FG000|COMPLETED|Overall Study||72
6639790|NCT02329431|7567910|FG001|COMPLETED|Overall Study||76
6639791|NCT02329431|7567909|FG000|NOT COMPLETED|Overall Study||20
6639792|NCT02329431|7567910|FG001|NOT COMPLETED|Overall Study||13
6639793|NCT02329587|7567918|FG000|STARTED|Baseline Thru Post-treatment Assessment||5
6639794|NCT02329587|7567919|FG001|STARTED|Baseline Thru Post-treatment Assessment||7
6639795|NCT02329587|7567918|FG000|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||3
6639796|NCT02329587|7567919|FG001|Completed All Intervention Sessions|Baseline Thru Post-treatment Assessment||4
6639797|NCT02329587|7567918|FG000|COMPLETED|Baseline Thru Post-treatment Assessment||4
6639798|NCT02329587|7567919|FG001|COMPLETED|Baseline Thru Post-treatment Assessment||6
6639799|NCT02329587|7567918|FG000|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
6639800|NCT02329587|7567919|FG001|NOT COMPLETED|Baseline Thru Post-treatment Assessment||1
6639801|NCT02329587|7567918|FG000|STARTED|1-month Follow-up||4
6639802|NCT02329587|7567919|FG001|STARTED|1-month Follow-up||6
6639803|NCT02329587|7567918|FG000|COMPLETED|1-month Follow-up||4
6639804|NCT02329587|7567919|FG001|COMPLETED|1-month Follow-up||5
6639805|NCT02329587|7567918|FG000|NOT COMPLETED|1-month Follow-up||0
6639806|NCT02329587|7567919|FG001|NOT COMPLETED|1-month Follow-up||1
6639807|NCT02329600|7567928|FG000|STARTED|Overall Study||10
6639808|NCT02329600|7567929|FG001|STARTED|Overall Study||15
6639809|NCT02329600|7567930|FG002|STARTED|Overall Study||15
6639810|NCT02329600|7567928|FG000|COMPLETED|Overall Study||10
6639811|NCT02329600|7567929|FG001|COMPLETED|Overall Study||15
6639812|NCT02329600|7567930|FG002|COMPLETED|Overall Study||15
6639813|NCT02329600|7567928|FG000|NOT COMPLETED|Overall Study||0
6639814|NCT02329600|7567929|FG001|NOT COMPLETED|Overall Study||0
6639815|NCT02329600|7567930|FG002|NOT COMPLETED|Overall Study||0
6639816|NCT02329730|7567942|FG000|STARTED|Overall Study||14
6639817|NCT02329730|7567943|FG001|STARTED|Overall Study||14
6639818|NCT02329730|7567944|FG002|STARTED|Overall Study||14
6639819|NCT02329730|7567945|FG003|STARTED|Overall Study||14
6639820|NCT02329730|7567946|FG004|STARTED|Overall Study||14
6639821|NCT02329730|7567947|FG005|STARTED|Overall Study||14
6639822|NCT02329730|7567948|FG006|STARTED|Overall Study||14
6639823|NCT02329730|7567949|FG007|STARTED|Overall Study||14
6639824|NCT02329730|7567950|FG008|STARTED|Overall Study||8
6639825|NCT02329730|7567951|FG009|STARTED|Overall Study||8
6639826|NCT02329730|7567952|FG010|STARTED|Overall Study||8
6639827|NCT02329730|7567953|FG011|STARTED|Overall Study||8
6639828|NCT02329730|7567942|FG000|COMPLETED|Overall Study||14
6639829|NCT02329730|7567943|FG001|COMPLETED|Overall Study||14
6639830|NCT02329730|7567944|FG002|COMPLETED|Overall Study||14
6639831|NCT02329730|7567945|FG003|COMPLETED|Overall Study||14
6639832|NCT02329730|7567946|FG004|COMPLETED|Overall Study||11
6639833|NCT02329730|7567947|FG005|COMPLETED|Overall Study||12
6639834|NCT02329730|7567948|FG006|COMPLETED|Overall Study||13
6639835|NCT02329730|7567949|FG007|COMPLETED|Overall Study||13
6639836|NCT02329730|7567950|FG008|COMPLETED|Overall Study||7
6639837|NCT02329730|7567951|FG009|COMPLETED|Overall Study||7
6639838|NCT02329730|7567952|FG010|COMPLETED|Overall Study||8
6639839|NCT02329730|7567953|FG011|COMPLETED|Overall Study||8
6639840|NCT02329730|7567942|FG000|NOT COMPLETED|Overall Study||0
6639841|NCT02329730|7567943|FG001|NOT COMPLETED|Overall Study||0
6639842|NCT02329730|7567944|FG002|NOT COMPLETED|Overall Study||0
6639843|NCT02329730|7567945|FG003|NOT COMPLETED|Overall Study||0
6639844|NCT02329730|7567946|FG004|NOT COMPLETED|Overall Study||3
6639845|NCT02329730|7567947|FG005|NOT COMPLETED|Overall Study||2
6639846|NCT02329730|7567948|FG006|NOT COMPLETED|Overall Study||1
6639847|NCT02329730|7567949|FG007|NOT COMPLETED|Overall Study||1
6419345|NCT00986232|7333563|FG002|NOT COMPLETED|Overall Study||35
6639848|NCT02329730|7567950|FG008|NOT COMPLETED|Overall Study||1
6639849|NCT02329730|7567951|FG009|NOT COMPLETED|Overall Study||1
6639850|NCT02329730|7567952|FG010|NOT COMPLETED|Overall Study||0
6639851|NCT02329730|7567953|FG011|NOT COMPLETED|Overall Study||0
6639852|NCT02329743|7567974|FG000|STARTED|Overall Study||84
6639853|NCT02329743|7567975|FG001|STARTED|Overall Study||87
6639854|NCT02329743|7567976|FG002|STARTED|Overall Study||85
6639855|NCT02329743|7567974|FG000|COMPLETED|Overall Study||78
6639856|NCT02329743|7567975|FG001|COMPLETED|Overall Study||80
6419346|NCT00986232|7333564|FG003|NOT COMPLETED|Overall Study||20
6419347|NCT00986245|7333580|FG000|STARTED|First Intervention||41
6419348|NCT00986245|7333581|FG001|STARTED|First Intervention||41
6419349|NCT00986245|7333580|FG000|COMPLETED|First Intervention||31
6419350|NCT00986245|7333581|FG001|COMPLETED|First Intervention||33
6419351|NCT00986245|7333580|FG000|NOT COMPLETED|First Intervention||10
6419352|NCT00986245|7333581|FG001|NOT COMPLETED|First Intervention||8
6419353|NCT00986245|7333580|FG000|STARTED|Second Intervention||31
6419354|NCT00986245|7333581|FG001|STARTED|Second Intervention||33
6419355|NCT00986245|7333580|FG000|COMPLETED|Second Intervention||29
6419356|NCT00986245|7333581|FG001|COMPLETED|Second Intervention||32
6419357|NCT00986245|7333580|FG000|NOT COMPLETED|Second Intervention||2
6639857|NCT02329743|7567976|FG002|COMPLETED|Overall Study||77
6639858|NCT02329743|7567974|FG000|NOT COMPLETED|Overall Study||6
6639859|NCT02329743|7567975|FG001|NOT COMPLETED|Overall Study||7
6639860|NCT02329743|7567976|FG002|NOT COMPLETED|Overall Study||8
6639861|NCT02329964|7567986|FG000|STARTED|Overall Study||40
6639862|NCT02329964|7567987|FG001|STARTED|Overall Study||40
6639863|NCT02329964|7567986|FG000|COMPLETED|Overall Study||40
6639864|NCT02329964|7567987|FG001|COMPLETED|Overall Study||40
6639865|NCT02329964|7567986|FG000|NOT COMPLETED|Overall Study||0
6639866|NCT02329964|7567987|FG001|NOT COMPLETED|Overall Study||0
6639867|NCT02330055|7567995|FG000|STARTED|Overall Study||50
6639868|NCT02330055|7567996|FG001|STARTED|Overall Study||49
6639869|NCT02330055|7567995|FG000|COMPLETED|Overall Study||40
6639870|NCT02330055|7567996|FG001|COMPLETED|Overall Study||40
6639871|NCT02330055|7567995|FG000|NOT COMPLETED|Overall Study||10
6639872|NCT02330055|7567996|FG001|NOT COMPLETED|Overall Study||9
6639873|NCT02330081|7568002|FG000|STARTED|Overall Study||22
6639874|NCT02330081|7568002|FG000|COMPLETED|Overall Study||14
6639875|NCT02330081|7568002|FG000|NOT COMPLETED|Overall Study||8
6639876|NCT02330094|7568011|FG000|STARTED|Overall Study||8
6639877|NCT02330094|7568012|FG001|STARTED|Overall Study||8
6639878|NCT02330094|7568011|FG000|COMPLETED|Overall Study||8
6639879|NCT02330094|7568012|FG001|COMPLETED|Overall Study||8
6639880|NCT02330094|7568011|FG000|NOT COMPLETED|Overall Study||0
6639881|NCT02330094|7568012|FG001|NOT COMPLETED|Overall Study||0
6639882|NCT02330172|7568020|FG000|STARTED|Overall Study||22
6639883|NCT02330172|7568021|FG001|STARTED|Overall Study||22
6639884|NCT02330172|7568020|FG000|COMPLETED|Overall Study||19
6639885|NCT02330172|7568021|FG001|COMPLETED|Overall Study||21
6639886|NCT02330172|7568020|FG000|NOT COMPLETED|Overall Study||3
6639887|NCT02330172|7568021|FG001|NOT COMPLETED|Overall Study||1
6639888|NCT02330276|7568030|FG000|STARTED|Overall Study||4
6639889|NCT02330276|7568031|FG001|STARTED|Overall Study||4
6639890|NCT02330276|7568032|FG002|STARTED|Overall Study||4
6639891|NCT02330276|7568030|FG000|COMPLETED|Overall Study||4
6639892|NCT02330276|7568031|FG001|COMPLETED|Overall Study||4
6639893|NCT02330276|7568032|FG002|COMPLETED|Overall Study||4
6639894|NCT02330276|7568030|FG000|NOT COMPLETED|Overall Study||0
6639895|NCT02330276|7568031|FG001|NOT COMPLETED|Overall Study||0
6639896|NCT02330276|7568032|FG002|NOT COMPLETED|Overall Study||0
6639897|NCT02330341|7568042|FG000|STARTED|Overall Study||12
6639898|NCT02330341|7568043|FG001|STARTED|Overall Study||12
6639899|NCT02330341|7568042|FG000|COMPLETED|Overall Study||12
6639900|NCT02330341|7568043|FG001|COMPLETED|Overall Study||11
6639901|NCT02330341|7568042|FG000|NOT COMPLETED|Overall Study||0
6639902|NCT02330341|7568043|FG001|NOT COMPLETED|Overall Study||1
6639903|NCT02330523|7568051|FG000|STARTED|Overall Study||21
6639904|NCT02330523|7568052|FG001|STARTED|Overall Study||19
6639905|NCT02330523|7568051|FG000|COMPLETED|Overall Study||21
6639906|NCT02330523|7568052|FG001|COMPLETED|Overall Study||19
6639907|NCT02330523|7568051|FG000|NOT COMPLETED|Overall Study||0
6639908|NCT02330523|7568052|FG001|NOT COMPLETED|Overall Study||0
6639909|NCT02330549|7568060|FG000|STARTED|Overall Study||20
6639910|NCT02330549|7568061|FG001|STARTED|Overall Study||25
6639911|NCT02330549|7568060|FG000|COMPLETED|Overall Study||16
6639912|NCT02330549|7568061|FG001|COMPLETED|Overall Study||24
6639913|NCT02330549|7568060|FG000|NOT COMPLETED|Overall Study||4
6639914|NCT02330549|7568061|FG001|NOT COMPLETED|Overall Study||1
6639915|NCT02330588|7568072|FG000|STARTED|Overall Study||44
6639916|NCT02330588|7568073|FG001|STARTED|Overall Study||43
6639917|NCT02330588|7568074|FG002|STARTED|Overall Study||46
6419358|NCT00986245|7333581|FG001|NOT COMPLETED|Second Intervention||1
6419359|NCT00986258|7333592|FG000|STARTED|Observation Period||136
6419360|NCT00986258|7333592|FG000|COMPLETED|Observation Period||125
6419361|NCT00986258|7333592|FG000|NOT COMPLETED|Observation Period||11
6639918|NCT02330588|7568075|FG003|STARTED|Overall Study||46
6639919|NCT02330588|7568076|FG004|STARTED|Overall Study||47
6639920|NCT02330588|7568072|FG000|COMPLETED|Overall Study||28
6639921|NCT02330588|7568073|FG001|COMPLETED|Overall Study||25
6639922|NCT02330588|7568074|FG002|COMPLETED|Overall Study||31
6639923|NCT02330588|7568075|FG003|COMPLETED|Overall Study||24
6639924|NCT02330588|7568076|FG004|COMPLETED|Overall Study||28
6639925|NCT02330588|7568072|FG000|NOT COMPLETED|Overall Study||16
6639926|NCT02330588|7568073|FG001|NOT COMPLETED|Overall Study||18
6639927|NCT02330588|7568074|FG002|NOT COMPLETED|Overall Study||15
6639928|NCT02330588|7568075|FG003|NOT COMPLETED|Overall Study||22
6639929|NCT02330588|7568076|FG004|NOT COMPLETED|Overall Study||19
6639930|NCT02330627|7568098|FG000|STARTED|Overall Study||16
6639931|NCT02330627|7568099|FG001|STARTED|Overall Study||13
6639932|NCT02330627|7568098|FG000|COMPLETED|Overall Study||15
6639933|NCT02330627|7568099|FG001|COMPLETED|Overall Study||12
6419362|NCT00986258|7333592|FG000|STARTED|Titration and Optimal Dose Period||125
6419363|NCT00986258|7333592|FG000|COMPLETED|Titration and Optimal Dose Period||102
6419364|NCT00986258|7333592|FG000|NOT COMPLETED|Titration and Optimal Dose Period||23
6419365|NCT00986258|7333592|FG000|STARTED|Maintenance Period||102
6419366|NCT00986258|7333592|FG000|COMPLETED|Maintenance Period||93
6639934|NCT02330627|7568098|FG000|NOT COMPLETED|Overall Study||1
6639935|NCT02330627|7568099|FG001|NOT COMPLETED|Overall Study||1
6639936|NCT02330978|7568105|FG000|STARTED|The First Patient Included at Study||1
6639937|NCT02330978|7568105|FG000|COMPLETED|The First Patient Included at Study||1
6639938|NCT02330978|7568105|FG000|NOT COMPLETED|The First Patient Included at Study||0
6639939|NCT02330978|7568105|FG000|STARTED|The Second Patient Included at Study||1
6639940|NCT02330978|7568105|FG000|COMPLETED|The Second Patient Included at Study||1
6639941|NCT02330978|7568105|FG000|NOT COMPLETED|The Second Patient Included at Study||0
6639942|NCT02331095|7568111|FG000|STARTED|Overall Study||11
6639943|NCT02331095|7568112|FG001|STARTED|Overall Study||10
6639944|NCT02331095|7568111|FG000|COMPLETED|Overall Study||7
6639945|NCT02331095|7568112|FG001|COMPLETED|Overall Study||9
6639946|NCT02331095|7568111|FG000|NOT COMPLETED|Overall Study||4
6639947|NCT02331095|7568112|FG001|NOT COMPLETED|Overall Study||1
6639948|NCT02331108|7568128|FG000|STARTED|Overall Study||51
6639949|NCT02331108|7568129|FG001|STARTED|Overall Study||52
6639950|NCT02331108|7568130|FG002|STARTED|Overall Study||51
6639951|NCT02331108|7568131|FG003|STARTED|Overall Study||51
6639952|NCT02331108|7568132|FG004|STARTED|Overall Study||52
6639953|NCT02331108|7568133|FG005|STARTED|Overall Study||52
6639954|NCT02331108|7568128|FG000|COMPLETED|Overall Study||50
6639955|NCT02331108|7568129|FG001|COMPLETED|Overall Study||50
6639956|NCT02331108|7568130|FG002|COMPLETED|Overall Study||50
6639957|NCT02331108|7568131|FG003|COMPLETED|Overall Study||50
6639958|NCT02331108|7568132|FG004|COMPLETED|Overall Study||50
6639959|NCT02331108|7568133|FG005|COMPLETED|Overall Study||50
6639960|NCT02331108|7568128|FG000|NOT COMPLETED|Overall Study||1
6639961|NCT02331108|7568129|FG001|NOT COMPLETED|Overall Study||2
6639962|NCT02331108|7568130|FG002|NOT COMPLETED|Overall Study||1
6639963|NCT02331108|7568131|FG003|NOT COMPLETED|Overall Study||1
6639964|NCT02331108|7568132|FG004|NOT COMPLETED|Overall Study||2
6639965|NCT02331108|7568133|FG005|NOT COMPLETED|Overall Study||2
6639966|NCT02331368|7568149|FG000|STARTED|Overall Study||32
6639967|NCT02331368|7568149|FG000|COMPLETED|Overall Study||29
6639968|NCT02331368|7568149|FG000|NOT COMPLETED|Overall Study||3
6655728|NCT02454972|7585873|FG005|NOT COMPLETED|Overall Study||15
6655729|NCT02454972|7585874|FG006|NOT COMPLETED|Overall Study||21
6655730|NCT02454972|7585875|FG007|NOT COMPLETED|Overall Study||32
6655731|NCT02454972|7585876|FG008|NOT COMPLETED|Overall Study||110
6655732|NCT02455050|7585892|FG000|STARTED|Treatment Period 1||20
6655733|NCT02455050|7585893|FG001|STARTED|Treatment Period 1||19
6655734|NCT02455050|7585894|FG002|STARTED|Treatment Period 1||20
6655735|NCT02455050|7585895|FG003|STARTED|Treatment Period 1||20
6655736|NCT02455050|7585892|FG000|COMPLETED|Treatment Period 1||19
6655737|NCT02455050|7585893|FG001|COMPLETED|Treatment Period 1||18
6655738|NCT02455050|7585894|FG002|COMPLETED|Treatment Period 1||19
6655739|NCT02455050|7585895|FG003|COMPLETED|Treatment Period 1||18
6655740|NCT02455050|7585892|FG000|NOT COMPLETED|Treatment Period 1||1
6655741|NCT02455050|7585893|FG001|NOT COMPLETED|Treatment Period 1||1
6655742|NCT02455050|7585894|FG002|NOT COMPLETED|Treatment Period 1||1
6655743|NCT02455050|7585895|FG003|NOT COMPLETED|Treatment Period 1||2
6655744|NCT02455050|7585892|FG000|STARTED|Treatment Period 2||19
6655745|NCT02455050|7585893|FG001|STARTED|Treatment Period 2||18
6655746|NCT02455050|7585894|FG002|STARTED|Treatment Period 2||19
6655747|NCT02455050|7585895|FG003|STARTED|Treatment Period 2||18
6655748|NCT02455050|7585892|FG000|COMPLETED|Treatment Period 2||18
6655749|NCT02455050|7585893|FG001|COMPLETED|Treatment Period 2||18
6655750|NCT02455050|7585894|FG002|COMPLETED|Treatment Period 2||17
6655751|NCT02455050|7585895|FG003|COMPLETED|Treatment Period 2||17
6655752|NCT02455050|7585892|FG000|NOT COMPLETED|Treatment Period 2||1
6655753|NCT02455050|7585893|FG001|NOT COMPLETED|Treatment Period 2||0
6655754|NCT02455050|7585894|FG002|NOT COMPLETED|Treatment Period 2||2
6655755|NCT02455050|7585895|FG003|NOT COMPLETED|Treatment Period 2||1
6655756|NCT02455076|7585920|FG000|STARTED|Inpatient||47
6655757|NCT02455076|7585921|FG001|STARTED|Inpatient||51
6655758|NCT02455076|7585922|FG002|STARTED|Inpatient||52
6655759|NCT02455076|7585923|FG003|STARTED|Inpatient||0
6655760|NCT02455076|7585924|FG004|STARTED|Inpatient||0
6655761|NCT02455076|7585920|FG000|COMPLETED|Inpatient||43
6655762|NCT02455076|7585921|FG001|COMPLETED|Inpatient||50
6655763|NCT02455076|7585922|FG002|COMPLETED|Inpatient||52
6655764|NCT02455076|7585923|FG003|COMPLETED|Inpatient||0
6655765|NCT02455076|7585924|FG004|COMPLETED|Inpatient||0
6419367|NCT00986258|7333592|FG000|NOT COMPLETED|Maintenance Period||9
6655766|NCT02455076|7585920|FG000|NOT COMPLETED|Inpatient||4
6655767|NCT02455076|7585921|FG001|NOT COMPLETED|Inpatient||1
6655768|NCT02455076|7585922|FG002|NOT COMPLETED|Inpatient||0
6655769|NCT02455076|7585923|FG003|NOT COMPLETED|Inpatient||0
6655770|NCT02455076|7585924|FG004|NOT COMPLETED|Inpatient||0
6655771|NCT02455076|7585920|FG000|STARTED|Outpatient||0
6655772|NCT02455076|7585921|FG001|STARTED|Outpatient||0
6655773|NCT02455076|7585922|FG002|STARTED|Outpatient||0
6655774|NCT02455076|7585923|FG003|STARTED|Outpatient||48
6655775|NCT02455076|7585924|FG004|STARTED|Outpatient||55
6655776|NCT02455076|7585920|FG000|COMPLETED|Outpatient||0
6419368|NCT00986349|7333606|FG000|STARTED|Overall Study|attempted implant procedures|23
6419369|NCT00986349|7333606|FG000|Successful Implant Procedure|Overall Study|successful device implant procedure|20
6419370|NCT00986349|7333606|FG000|Early Explant|Overall Study||4
6419371|NCT00986349|7333606|FG000|COMPLETED|Overall Study||16
6419372|NCT00986349|7333606|FG000|NOT COMPLETED|Overall Study||7
6419373|NCT00986362|7333621|FG000|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
6419374|NCT00986362|7333622|FG001|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
6419375|NCT00986362|7333621|FG000|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
6419376|NCT00986362|7333622|FG001|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
6419377|NCT00986362|7333621|FG000|NOT COMPLETED|Overall Study||2
6419378|NCT00986362|7333622|FG001|NOT COMPLETED|Overall Study||1
6419379|NCT00986401|7333630|FG000|STARTED|Period 1||22
6419380|NCT00986401|7333631|FG001|STARTED|Period 1||22
6419381|NCT00986401|7333630|FG000|COMPLETED|Period 1||22
6419382|NCT00986401|7333631|FG001|COMPLETED|Period 1||21
6419383|NCT00986401|7333630|FG000|NOT COMPLETED|Period 1||0
6419384|NCT00986401|7333631|FG001|NOT COMPLETED|Period 1||1
6419385|NCT00986401|7333630|FG000|STARTED|Period 2||22
6419386|NCT00986401|7333631|FG001|STARTED|Period 2||21
6419387|NCT00986401|7333630|FG000|COMPLETED|Period 2||22
6419388|NCT00986401|7333631|FG001|COMPLETED|Period 2||21
6419389|NCT00986401|7333630|FG000|NOT COMPLETED|Period 2||0
6419390|NCT00986401|7333631|FG001|NOT COMPLETED|Period 2||0
6419391|NCT00986427|7333642|FG000|STARTED|Overall Study||12
6419392|NCT00986427|7333643|FG001|STARTED|Overall Study||12
6419393|NCT00986427|7333642|FG000|COMPLETED|Overall Study||8
6419394|NCT00986427|7333643|FG001|COMPLETED|Overall Study||12
6419395|NCT00986427|7333642|FG000|NOT COMPLETED|Overall Study||4
6419396|NCT00986427|7333643|FG001|NOT COMPLETED|Overall Study||0
6419397|NCT00986440|7333655|FG000|STARTED|Overall Study||41
6419398|NCT00986440|7333656|FG001|STARTED|Overall Study||43
6419399|NCT00986440|7333655|FG000|Randomized, But Not Dosed|Overall Study||0
6419400|NCT00986440|7333656|FG001|Randomized, But Not Dosed|Overall Study||1
6419401|NCT00986440|7333655|FG000|COMPLETED|Overall Study||0
6419402|NCT00986440|7333656|FG001|COMPLETED|Overall Study||0
6419403|NCT00986440|7333655|FG000|NOT COMPLETED|Overall Study||41
6419404|NCT00986440|7333656|FG001|NOT COMPLETED|Overall Study||43
6419405|NCT00986453|7333662|FG000|STARTED|Overall Study||45
6419406|NCT00986453|7333662|FG000|COMPLETED|Overall Study||43
6419407|NCT00986453|7333662|FG000|NOT COMPLETED|Overall Study||2
6419408|NCT00986479|7333670|FG000|STARTED|Period 1||12
6419409|NCT00986479|7333671|FG001|STARTED|Period 1||10
6419410|NCT00986479|7333670|FG000|COMPLETED|Period 1||10
6419411|NCT00986479|7333671|FG001|COMPLETED|Period 1||10
6419412|NCT00986479|7333670|FG000|NOT COMPLETED|Period 1||2
6419413|NCT00986479|7333671|FG001|NOT COMPLETED|Period 1||0
6419414|NCT00986479|7333670|FG000|STARTED|Period 2||10
6419415|NCT00986479|7333671|FG001|STARTED|Period 2||10
6419416|NCT00986479|7333670|FG000|COMPLETED|Period 2||10
6419417|NCT00986479|7333671|FG001|COMPLETED|Period 2||10
6419418|NCT00986479|7333670|FG000|NOT COMPLETED|Period 2||0
6419419|NCT00986479|7333671|FG001|NOT COMPLETED|Period 2||0
6419420|NCT00986544|7333679|FG000|STARTED|Overall Study||53
6419421|NCT00986544|7333680|FG001|STARTED|Overall Study||53
6419422|NCT00986544|7333679|FG000|COMPLETED|Overall Study||53
6419423|NCT00986544|7333680|FG001|COMPLETED|Overall Study||53
6419424|NCT00986544|7333679|FG000|NOT COMPLETED|Overall Study||0
6419425|NCT00986544|7333680|FG001|NOT COMPLETED|Overall Study||0
6419426|NCT00986570|7333687|FG000|STARTED|Overall Study||121
6419427|NCT00986570|7333687|FG000|COMPLETED|Overall Study||114
6419428|NCT00986570|7333687|FG000|NOT COMPLETED|Overall Study||7
6419429|NCT00986583|7333693|FG000|STARTED|Overall Study||38
6419430|NCT00986583|7333694|FG001|STARTED|Overall Study||32
6419431|NCT00986583|7333693|FG000|COMPLETED|Overall Study||38
6419432|NCT00986583|7333694|FG001|COMPLETED|Overall Study||32
6419433|NCT00986583|7333693|FG000|NOT COMPLETED|Overall Study||0
6419434|NCT00986583|7333694|FG001|NOT COMPLETED|Overall Study||0
6419435|NCT00986674|7333704|FG000|STARTED|Overall Study||47
6419436|NCT00986674|7333705|FG001|STARTED|Overall Study||45
6419437|NCT00986674|7333706|FG002|STARTED|Overall Study||48
6419438|NCT00986674|7333704|FG000|Treated|Overall Study||43
6419439|NCT00986674|7333705|FG001|Treated|Overall Study||42
6419440|NCT00986674|7333706|FG002|Treated|Overall Study||47
6419441|NCT00986674|7333704|FG000|Eligible and Treated|Overall Study||39
6419442|NCT00986674|7333705|FG001|Eligible and Treated|Overall Study||41
6419443|NCT00986674|7333706|FG002|Eligible and Treated|Overall Study||47
6419444|NCT00986674|7333704|FG000|COMPLETED|Overall Study||0
6419445|NCT00986674|7333705|FG001|COMPLETED|Overall Study||0
6419446|NCT00986674|7333706|FG002|COMPLETED|Overall Study||0
6419447|NCT00986674|7333704|FG000|NOT COMPLETED|Overall Study||47
6419448|NCT00986674|7333705|FG001|NOT COMPLETED|Overall Study||45
6419449|NCT00986674|7333706|FG002|NOT COMPLETED|Overall Study||48
6419450|NCT00986830|7333714|FG000|STARTED|Overall Study||74
6419451|NCT00986830|7333714|FG000|Treated|Overall Study||69
6419452|NCT00986830|7333714|FG000|COMPLETED|Overall Study||66
6419453|NCT00986830|7333714|FG000|NOT COMPLETED|Overall Study||8
6419454|NCT00986856|7333720|FG000|STARTED|Overall Study||42
6419455|NCT00986856|7333721|FG001|STARTED|Overall Study||16
6419456|NCT00986856|7333720|FG000|COMPLETED|Overall Study||42
6419457|NCT00986856|7333721|FG001|COMPLETED|Overall Study||16
6419458|NCT00986856|7333720|FG000|NOT COMPLETED|Overall Study||0
6419459|NCT00986856|7333721|FG001|NOT COMPLETED|Overall Study||0
6419460|NCT00986921|7333729|FG000|STARTED|Overall Study||25
6419461|NCT00986921|7333730|FG001|STARTED|Overall Study||25
6419462|NCT00986921|7333729|FG000|COMPLETED|Overall Study||24
6419463|NCT00986921|7333730|FG001|COMPLETED|Overall Study||25
6419464|NCT00986921|7333729|FG000|NOT COMPLETED|Overall Study||1
6419465|NCT00986921|7333730|FG001|NOT COMPLETED|Overall Study||0
6419466|NCT00986973|7333739|FG000|STARTED|Overall Study||6
6419467|NCT00986973|7333739|FG000|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
6419468|NCT00986973|7333739|FG000|NOT COMPLETED|Overall Study||1
6419469|NCT00986986|7333746|FG000|STARTED|Overall Study||10
6419470|NCT00986986|7333747|FG001|STARTED|Overall Study||10
6419471|NCT00986986|7333746|FG000|COMPLETED|Overall Study||10
6419472|NCT00986986|7333747|FG001|COMPLETED|Overall Study||9
6419473|NCT00986986|7333746|FG000|NOT COMPLETED|Overall Study||0
6419474|NCT00986986|7333747|FG001|NOT COMPLETED|Overall Study||1
6419475|NCT00987337|7333757|FG000|STARTED|Overall Study||96
6419476|NCT00987337|7333758|FG001|STARTED|Overall Study||96
6419477|NCT00987337|7333759|FG002|STARTED|Overall Study||96
6419478|NCT00987337|7333757|FG000|COMPLETED|Overall Study||39
6419479|NCT00987337|7333758|FG001|COMPLETED|Overall Study||41
6419480|NCT00987337|7333759|FG002|COMPLETED|Overall Study||45
6419481|NCT00987337|7333757|FG000|NOT COMPLETED|Overall Study||57
6419482|NCT00987337|7333758|FG001|NOT COMPLETED|Overall Study||55
6419483|NCT00987337|7333759|FG002|NOT COMPLETED|Overall Study||51
6419484|NCT00987389|7333771|FG000|STARTED|Overall Study||176
6419485|NCT00987389|7333772|FG001|STARTED|Overall Study||176
6419486|NCT00987389|7333773|FG002|STARTED|Overall Study||175
6419487|NCT00987389|7333774|FG003|STARTED|Overall Study||177
6419488|NCT00987389|7333771|FG000|COMPLETED|Overall Study||167
6419489|NCT00987389|7333772|FG001|COMPLETED|Overall Study||168
6419490|NCT00987389|7333773|FG002|COMPLETED|Overall Study||167
6419491|NCT00987389|7333774|FG003|COMPLETED|Overall Study||174
6419492|NCT00987389|7333771|FG000|NOT COMPLETED|Overall Study||9
6419493|NCT00987389|7333772|FG001|NOT COMPLETED|Overall Study||8
6419494|NCT00987389|7333773|FG002|NOT COMPLETED|Overall Study||8
6419495|NCT00987389|7333774|FG003|NOT COMPLETED|Overall Study||3
6419496|NCT00987402|7333784|FG000|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
6419497|NCT00987402|7333785|FG001|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
6419498|NCT00987402|7333784|FG000|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
6419499|NCT00987402|7333785|FG001|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
6419500|NCT00987402|7333784|FG000|NOT COMPLETED|Overall Study||86
6419501|NCT00987402|7333785|FG001|NOT COMPLETED|Overall Study||98
6419502|NCT00987415|7333793|FG000|STARTED|Overall Study||128
6419503|NCT00987415|7333794|FG001|STARTED|Overall Study||125
6419504|NCT00987415|7333793|FG000|COMPLETED|Overall Study||119
6419505|NCT00987415|7333794|FG001|COMPLETED|Overall Study||116
6419506|NCT00987415|7333793|FG000|NOT COMPLETED|Overall Study||9
6419507|NCT00987415|7333794|FG001|NOT COMPLETED|Overall Study||9
6419508|NCT00987467|7333800|FG000|STARTED|Overall Study||12
6419509|NCT00987467|7333800|FG000|COMPLETED|Overall Study||10
6419510|NCT00987467|7333800|FG000|NOT COMPLETED|Overall Study||2
6419511|NCT00987480|7333805|FG000|STARTED|Overall Study||45
6419512|NCT00987480|7333805|FG000|COMPLETED|Overall Study||45
6419513|NCT00987480|7333805|FG000|NOT COMPLETED|Overall Study||0
6419514|NCT00987558|7333809|FG000|STARTED|Overall Study||13
6419515|NCT00987558|7333810|FG001|STARTED|Overall Study||17
6419516|NCT00987558|7333809|FG000|Simvastatin|Overall Study||13
6419517|NCT00987558|7333810|FG001|Simvastatin|Overall Study||12
6419518|NCT00987558|7333809|FG000|Washout|Overall Study||13
6419519|NCT00987558|7333810|FG001|Washout|Overall Study||12
6419520|NCT00987558|7333809|FG000|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
6419521|NCT00987558|7333810|FG001|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
6419522|NCT00987558|7333809|FG000|COMPLETED|Overall Study||12
6419523|NCT00987558|7333810|FG001|COMPLETED|Overall Study||12
6419524|NCT00987558|7333809|FG000|NOT COMPLETED|Overall Study||1
6419525|NCT00987558|7333810|FG001|NOT COMPLETED|Overall Study||5
6419526|NCT00987623|7333819|FG000|STARTED|Overall Study||145
6419527|NCT00987623|7333820|FG001|STARTED|Overall Study||154
6419528|NCT00987623|7333819|FG000|COMPLETED|Overall Study||140
6419529|NCT00987623|7333820|FG001|COMPLETED|Overall Study||151
6419530|NCT00987623|7333819|FG000|NOT COMPLETED|Overall Study||5
6419531|NCT00987623|7333820|FG001|NOT COMPLETED|Overall Study||3
6419532|NCT00987727|7333828|FG000|STARTED|Overall Study||41
6419533|NCT00987727|7333829|FG001|STARTED|Overall Study||41
6419534|NCT00987727|7333828|FG000|COMPLETED|Overall Study||36
6419535|NCT00987727|7333829|FG001|COMPLETED|Overall Study||34
6419536|NCT00987727|7333828|FG000|NOT COMPLETED|Overall Study||5
6419537|NCT00987727|7333829|FG001|NOT COMPLETED|Overall Study||7
6499328|NCT01416610|7417992|FG000|Safety Population|Overall Study||86
6499329|NCT01416610|7417992|FG000|Per Protocol|Overall Study||83
6499330|NCT01416610|7417992|FG000|Completed Treatment|Overall Study||47
6499331|NCT01416610|7417992|FG000|Completed Follow-up|Overall Study||45
6499332|NCT01416610|7417992|FG000|COMPLETED|Overall Study||45
6499333|NCT01416610|7417992|FG000|NOT COMPLETED|Overall Study||43
6499334|NCT01416636|7418002|FG000|STARTED|Overall Study||53
6499335|NCT01416636|7418003|FG001|STARTED|Overall Study||52
6499336|NCT01416636|7418002|FG000|COMPLETED|Overall Study||45
6499337|NCT01416636|7418003|FG001|COMPLETED|Overall Study||46
6499338|NCT01416636|7418002|FG000|NOT COMPLETED|Overall Study||8
6419538|NCT00987831|7333838|FG000|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
6419539|NCT00987831|7333839|FG001|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
6419540|NCT00987831|7333840|FG002|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
6419541|NCT00987831|7333838|FG000|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
6419542|NCT00987831|7333839|FG001|COMPLETED|Overall Study|all controls returned for two visits|52
6419543|NCT00987831|7333840|FG002|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
6419544|NCT00987831|7333838|FG000|NOT COMPLETED|Overall Study||1
6419545|NCT00987831|7333839|FG001|NOT COMPLETED|Overall Study||3
6419546|NCT00987831|7333840|FG002|NOT COMPLETED|Overall Study||0
6419547|NCT00987935|7333858|FG000|STARTED|Overall Study||4
6419548|NCT00987935|7333859|FG001|STARTED|Overall Study||3
6419549|NCT00987935|7333860|FG002|STARTED|Overall Study||3
6419550|NCT00987935|7333861|FG003|STARTED|Overall Study||3
6419551|NCT00987935|7333862|FG004|STARTED|Overall Study||7
6419552|NCT00987935|7333863|FG005|STARTED|Overall Study||3
6419553|NCT00987935|7333864|FG006|STARTED|Overall Study||16
6419554|NCT00987935|7333865|FG007|STARTED|Overall Study||63
6419555|NCT00987935|7333866|FG008|STARTED|Overall Study||32
6419556|NCT00987935|7333858|FG000|COMPLETED|Overall Study||0
6419557|NCT00987935|7333859|FG001|COMPLETED|Overall Study||0
6419558|NCT00987935|7333860|FG002|COMPLETED|Overall Study||0
6419559|NCT00987935|7333861|FG003|COMPLETED|Overall Study||0
6419560|NCT00987935|7333862|FG004|COMPLETED|Overall Study||0
6419561|NCT00987935|7333863|FG005|COMPLETED|Overall Study||0
6419562|NCT00987935|7333864|FG006|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
6419563|NCT00987935|7333865|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
6419564|NCT00987935|7333866|FG008|COMPLETED|Overall Study||0
6419565|NCT00987935|7333858|FG000|NOT COMPLETED|Overall Study||4
6419566|NCT00987935|7333859|FG001|NOT COMPLETED|Overall Study||3
6419567|NCT00987935|7333860|FG002|NOT COMPLETED|Overall Study||3
6419568|NCT00987935|7333861|FG003|NOT COMPLETED|Overall Study||3
6419569|NCT00987935|7333862|FG004|NOT COMPLETED|Overall Study||7
6419570|NCT00987935|7333863|FG005|NOT COMPLETED|Overall Study||3
6419571|NCT00987935|7333864|FG006|NOT COMPLETED|Overall Study||15
6419572|NCT00987935|7333865|FG007|NOT COMPLETED|Overall Study||62
6419573|NCT00987935|7333866|FG008|NOT COMPLETED|Overall Study||32
6419574|NCT00987948|7333892|FG000|STARTED|Overall Study||15
6419575|NCT00987948|7333892|FG000|COMPLETED|Overall Study||12
6419576|NCT00987948|7333892|FG000|NOT COMPLETED|Overall Study||3
6419577|NCT00988000|7333899|FG000|STARTED|Overall Study||49
6419578|NCT00988000|7333900|FG001|STARTED|Overall Study||51
6419579|NCT00988000|7333901|FG002|STARTED|Overall Study||57
6419580|NCT00988000|7333899|FG000|COMPLETED|Overall Study||49
6419581|NCT00988000|7333900|FG001|COMPLETED|Overall Study||51
6419582|NCT00988000|7333901|FG002|COMPLETED|Overall Study||57
6419583|NCT00988000|7333899|FG000|NOT COMPLETED|Overall Study||0
6419584|NCT00988000|7333900|FG001|NOT COMPLETED|Overall Study||0
6419585|NCT00988000|7333901|FG002|NOT COMPLETED|Overall Study||0
6419586|NCT00988013|7333915|FG000|STARTED|Overall Study||3
6419587|NCT00988013|7333916|FG001|STARTED|Overall Study||3
6419588|NCT00988013|7333917|FG002|STARTED|Overall Study||6
6419589|NCT00988013|7333918|FG003|STARTED|Overall Study||2
6419590|NCT00988013|7333915|FG000|COMPLETED|Overall Study||3
6419591|NCT00988013|7333916|FG001|COMPLETED|Overall Study||3
6419592|NCT00988013|7333917|FG002|COMPLETED|Overall Study||6
6419593|NCT00988013|7333918|FG003|COMPLETED|Overall Study||2
6419594|NCT00988013|7333915|FG000|NOT COMPLETED|Overall Study||0
6419595|NCT00988013|7333916|FG001|NOT COMPLETED|Overall Study||0
6419596|NCT00988013|7333917|FG002|NOT COMPLETED|Overall Study||0
6419597|NCT00988013|7333918|FG003|NOT COMPLETED|Overall Study||0
6419598|NCT00988065|7333933|FG000|STARTED|Overall Study|Randomized to double-blind treatment|148
6419599|NCT00988065|7333934|FG001|STARTED|Overall Study|Randomized to double-blind treatment|150
6419600|NCT00988065|7333935|FG002|STARTED|Overall Study|Randomized to double-blind treatment|150
6419601|NCT00988065|7333933|FG000|Received First Randomized Dose|Overall Study||148
6419602|NCT00988065|7333934|FG001|Received First Randomized Dose|Overall Study||150
6419603|NCT00988065|7333935|FG002|Received First Randomized Dose|Overall Study||150
6419604|NCT00988065|7333933|FG000|Received Second Randomized Dose|Overall Study||139
6419605|NCT00988065|7333934|FG001|Received Second Randomized Dose|Overall Study||135
6419606|NCT00988065|7333935|FG002|Received Second Randomized Dose|Overall Study||145
6419607|NCT00988065|7333933|FG000|Received Third Randomized Dose|Overall Study||135
6419608|NCT00988065|7333934|FG001|Received Third Randomized Dose|Overall Study||127
6419609|NCT00988065|7333935|FG002|Received Third Randomized Dose|Overall Study||135
6419610|NCT00988065|7333933|FG000|COMPLETED|Overall Study||135
6419611|NCT00988065|7333934|FG001|COMPLETED|Overall Study||127
6419612|NCT00988065|7333935|FG002|COMPLETED|Overall Study||135
6419613|NCT00988065|7333933|FG000|NOT COMPLETED|Overall Study||13
6419614|NCT00988065|7333934|FG001|NOT COMPLETED|Overall Study||23
6419615|NCT00988065|7333935|FG002|NOT COMPLETED|Overall Study||15
6419616|NCT00988091|7333945|FG000|STARTED|Double-blind Period||298
6419617|NCT00988091|7333946|FG001|STARTED|Double-blind Period||298
6419618|NCT00988091|7333945|FG000|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
6499339|NCT01416636|7418003|FG001|NOT COMPLETED|Overall Study||6
6419619|NCT00988091|7333946|FG001|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
6419620|NCT00988091|7333945|FG000|COMPLETED|Double-blind Period||255
6419621|NCT00988091|7333946|FG001|COMPLETED|Double-blind Period||251
6419622|NCT00988091|7333945|FG000|NOT COMPLETED|Double-blind Period||43
6419623|NCT00988091|7333946|FG001|NOT COMPLETED|Double-blind Period||47
6419624|NCT00988091|7333945|FG000|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
6419625|NCT00988091|7333946|FG001|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
6419626|NCT00988091|7333945|FG000|COMPLETED|Open-label Period||208
6419627|NCT00988091|7333946|FG001|COMPLETED|Open-label Period||192
6419628|NCT00988091|7333945|FG000|NOT COMPLETED|Open-label Period||21
6419629|NCT00988091|7333946|FG001|NOT COMPLETED|Open-label Period||33
6419630|NCT00988117|7333953|FG000|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
6419631|NCT00988117|7333953|FG000|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
6419632|NCT00988117|7333953|FG000|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
6419633|NCT00988117|7333953|FG000|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
6419634|NCT00988117|7333953|FG000|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
6419635|NCT00988117|7333953|FG000|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
6419636|NCT00988143|7333961|FG000|STARTED|Overall Study||220
6419637|NCT00988143|7333962|FG001|STARTED|Overall Study||190
6419638|NCT00988143|7333963|FG002|STARTED|Overall Study||190
6419639|NCT00988143|7333961|FG000|COMPLETED|Overall Study||220
6419640|NCT00988143|7333962|FG001|COMPLETED|Overall Study||190
6419641|NCT00988143|7333963|FG002|COMPLETED|Overall Study||190
6419642|NCT00988143|7333961|FG000|NOT COMPLETED|Overall Study||0
6419643|NCT00988143|7333962|FG001|NOT COMPLETED|Overall Study||0
6419644|NCT00988143|7333963|FG002|NOT COMPLETED|Overall Study||0
6419645|NCT00988156|7333973|FG000|STARTED|Overall Study||149
6419646|NCT00988156|7333974|FG001|STARTED|Overall Study||155
6419647|NCT00988156|7333973|FG000|Intention-to-Treat Set (ITT)|Overall Study||129
6419648|NCT00988156|7333974|FG001|Intention-to-Treat Set (ITT)|Overall Study||134
6419649|NCT00988156|7333973|FG000|Per Protocol Set (PP)|Overall Study||101
6419650|NCT00988156|7333974|FG001|Per Protocol Set (PP)|Overall Study||97
6419651|NCT00988156|7333973|FG000|Safety Set|Overall Study||129
6419652|NCT00988156|7333974|FG001|Safety Set|Overall Study||134
6419653|NCT00988156|7333973|FG000|COMPLETED|Overall Study||132
6419654|NCT00988156|7333974|FG001|COMPLETED|Overall Study||135
6419655|NCT00988156|7333973|FG000|NOT COMPLETED|Overall Study||17
6419656|NCT00988156|7333974|FG001|NOT COMPLETED|Overall Study||20
6419657|NCT00988169|7333980|FG000|STARTED|Overall Study||6
6419658|NCT00988169|7333980|FG000|COMPLETED|Overall Study||5
6419659|NCT00988169|7333980|FG000|NOT COMPLETED|Overall Study||1
6419660|NCT00988208|7333986|FG000|STARTED|Overall Study||526
6419661|NCT00988208|7333987|FG001|STARTED|Overall Study||533
6419662|NCT00988208|7333986|FG000|Treated|Overall Study||521
6419663|NCT00988208|7333987|FG001|Treated|Overall Study||525
6419664|NCT00988208|7333986|FG000|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
6419665|NCT00988208|7333987|FG001|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
6419666|NCT00988208|7333986|FG000|NOT COMPLETED|Overall Study||431
6419667|NCT00988208|7333987|FG001|NOT COMPLETED|Overall Study||438
6419668|NCT00988221|7333996|FG000|STARTED|Part I||35
6419669|NCT00988221|7333997|FG001|STARTED|Part I||34
6419670|NCT00988221|7333998|FG002|STARTED|Part I||119
6419671|NCT00988221|7333999|FG003|STARTED|Part I|No patients received placebo in Part I of this study.|0
6419672|NCT00988221|7333996|FG000|COMPLETED|Part I||31
6419673|NCT00988221|7333997|FG001|COMPLETED|Part I||24
6419674|NCT00988221|7333998|FG002|COMPLETED|Part I||111
6419675|NCT00988221|7333999|FG003|COMPLETED|Part I||0
6419676|NCT00988221|7333996|FG000|NOT COMPLETED|Part I||4
6419677|NCT00988221|7333997|FG001|NOT COMPLETED|Part I||10
6419678|NCT00988221|7333998|FG002|NOT COMPLETED|Part I||8
6419679|NCT00988221|7333999|FG003|NOT COMPLETED|Part I||0
6419680|NCT00988221|7333996|FG000|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
6419681|NCT00988221|7333997|FG001|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
6419682|NCT00988221|7333998|FG002|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
6419683|NCT00988221|7333999|FG003|STARTED|Part II||84
6419684|NCT00988221|7333996|FG000|COMPLETED|Part II||15
6639969|NCT02331394|7568153|FG000|STARTED|Overall Study||15
6639970|NCT02331394|7568153|FG000|COMPLETED|Overall Study|14 patients, 1 dropped out|14
6639971|NCT02331394|7568153|FG000|NOT COMPLETED|Overall Study||1
6639972|NCT02331407|7568164|FG000|STARTED|Overall Study||9
6639973|NCT02331407|7568164|FG000|COMPLETED|Overall Study||9
6639974|NCT02331407|7568164|FG000|NOT COMPLETED|Overall Study||0
6639975|NCT02331446|7568172|FG000|STARTED|Overall Study||9
6639976|NCT02331446|7568173|FG001|STARTED|Overall Study||11
6639977|NCT02331446|7568174|FG002|STARTED|Overall Study||11
6639978|NCT02331446|7568175|FG003|STARTED|Overall Study||11
6639979|NCT02331446|7568172|FG000|COMPLETED|Overall Study||5
6419685|NCT00988221|7333997|FG001|COMPLETED|Part II||11
6419686|NCT00988221|7333998|FG002|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
6419687|NCT00988221|7333999|FG003|COMPLETED|Part II||81
6419688|NCT00988221|7333996|FG000|NOT COMPLETED|Part II||1
6419689|NCT00988221|7333997|FG001|NOT COMPLETED|Part II||0
6639980|NCT02331446|7568173|FG001|COMPLETED|Overall Study||6
6419690|NCT00988221|7333998|FG002|NOT COMPLETED|Part II||3
6419691|NCT00988221|7333999|FG003|NOT COMPLETED|Part II||3
6419692|NCT00988221|7333996|FG000|STARTED|Part III||30
6419693|NCT00988221|7333997|FG001|STARTED|Part III||24
6419694|NCT00988221|7333998|FG002|STARTED|Part III||106
6419695|NCT00988221|7333999|FG003|STARTED|Part III|No patients received placebo in Part III of this study.|0
6419696|NCT00988221|7333996|FG000|COMPLETED|Part III||29
6419697|NCT00988221|7333997|FG001|COMPLETED|Part III||23
6419698|NCT00988221|7333998|FG002|COMPLETED|Part III||103
6419699|NCT00988221|7333999|FG003|COMPLETED|Part III||0
6419700|NCT00988221|7333996|FG000|NOT COMPLETED|Part III||1
6419701|NCT00988221|7333997|FG001|NOT COMPLETED|Part III||1
6419702|NCT00988221|7333998|FG002|NOT COMPLETED|Part III||3
6419703|NCT00988221|7333999|FG003|NOT COMPLETED|Part III||0
6419704|NCT00988325|7334021|FG000|STARTED|Overall Study||40
6419705|NCT00988325|7334022|FG001|STARTED|Overall Study||20
6419706|NCT00988325|7334023|FG002|STARTED|Overall Study||5
6419707|NCT00988325|7334021|FG000|COMPLETED|Overall Study||40
6419708|NCT00988325|7334022|FG001|COMPLETED|Overall Study||20
6419709|NCT00988325|7334023|FG002|COMPLETED|Overall Study||5
6419710|NCT00988325|7334021|FG000|NOT COMPLETED|Overall Study||0
6419711|NCT00988325|7334022|FG001|NOT COMPLETED|Overall Study||0
6419712|NCT00988325|7334023|FG002|NOT COMPLETED|Overall Study||0
6639981|NCT02331446|7568174|FG002|COMPLETED|Overall Study||8
6639982|NCT02331446|7568175|FG003|COMPLETED|Overall Study||8
6639983|NCT02331446|7568172|FG000|NOT COMPLETED|Overall Study||4
6419713|NCT00988351|7334037|FG000|STARTED|Overall Study||78
6419714|NCT00988351|7334038|FG001|STARTED|Overall Study||78
6419715|NCT00988351|7334037|FG000|CPAP Titration|Overall Study|8 declined CPAP treatment|78
6419716|NCT00988351|7334038|FG001|CPAP Titration|Overall Study|no titration needed|78
6419717|NCT00988351|7334037|FG000|PAP Setup|Overall Study|CPAP treatment started|70
6419718|NCT00988351|7334038|FG001|PAP Setup|Overall Study|APAP treatment started|78
6419719|NCT00988351|7334037|FG000|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
6419720|NCT00988351|7334038|FG001|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
6419721|NCT00988351|7334037|FG000|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
6419722|NCT00988351|7334038|FG001|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
6419723|NCT00988351|7334037|FG000|COMPLETED|Overall Study||59
6419724|NCT00988351|7334038|FG001|COMPLETED|Overall Study||66
6419725|NCT00988351|7334037|FG000|NOT COMPLETED|Overall Study||19
6419726|NCT00988351|7334038|FG001|NOT COMPLETED|Overall Study||12
6419727|NCT00988429|7334047|FG000|STARTED|Overall Study||226
6419728|NCT00988429|7334048|FG001|STARTED|Overall Study||216
6419729|NCT00988429|7334049|FG002|STARTED|Overall Study||211
6419730|NCT00988429|7334047|FG000|Safety Population|Overall Study||224
6419731|NCT00988429|7334048|FG001|Safety Population|Overall Study||216
6419732|NCT00988429|7334049|FG002|Safety Population|Overall Study||210
6419733|NCT00988429|7334047|FG000|Intention-to-treat (ITT) Population|Overall Study||220
6419734|NCT00988429|7334048|FG001|Intention-to-treat (ITT) Population|Overall Study||215
6419735|NCT00988429|7334049|FG002|Intention-to-treat (ITT) Population|Overall Study||205
6419736|NCT00988429|7334047|FG000|COMPLETED|Overall Study||189
6419737|NCT00988429|7334048|FG001|COMPLETED|Overall Study||173
6419738|NCT00988429|7334049|FG002|COMPLETED|Overall Study||142
6419739|NCT00988429|7334047|FG000|NOT COMPLETED|Overall Study||37
6419740|NCT00988429|7334048|FG001|NOT COMPLETED|Overall Study||43
6419741|NCT00988429|7334049|FG002|NOT COMPLETED|Overall Study||69
6419742|NCT00988442|7334060|FG000|STARTED|Overall Study||30
6419743|NCT00988442|7334061|FG001|STARTED|Overall Study||29
6419744|NCT00988442|7334060|FG000|COMPLETED|Overall Study||0
6419745|NCT00988442|7334061|FG001|COMPLETED|Overall Study||1
6639984|NCT02331446|7568173|FG001|NOT COMPLETED|Overall Study||5
6639985|NCT02331446|7568174|FG002|NOT COMPLETED|Overall Study||3
6639986|NCT02331446|7568175|FG003|NOT COMPLETED|Overall Study||3
6639987|NCT02331589|7568187|FG000|STARTED|Overall Study||39
6419746|NCT00988442|7334060|FG000|NOT COMPLETED|Overall Study||30
6419747|NCT00988442|7334061|FG001|NOT COMPLETED|Overall Study||28
6419748|NCT00988533|7334070|FG000|STARTED|Overall Study||30
6419749|NCT00988533|7334070|FG000|COMPLETED|Overall Study||27
6419750|NCT00988533|7334070|FG000|NOT COMPLETED|Overall Study||3
6419751|NCT00988559|7334078|FG000|STARTED|Overall Study||10
6419752|NCT00988559|7334079|FG001|STARTED|Overall Study||11
6419753|NCT00988559|7334080|FG002|STARTED|Overall Study||11
6419754|NCT00988559|7334081|FG003|STARTED|Overall Study||7
6419755|NCT00988559|7334078|FG000|COMPLETED|Overall Study||9
6419756|NCT00988559|7334079|FG001|COMPLETED|Overall Study||9
6419757|NCT00988559|7334080|FG002|COMPLETED|Overall Study||9
6419758|NCT00988559|7334081|FG003|COMPLETED|Overall Study||6
6419759|NCT00988559|7334078|FG000|NOT COMPLETED|Overall Study||1
6419760|NCT00988559|7334079|FG001|NOT COMPLETED|Overall Study||2
6419761|NCT00988559|7334080|FG002|NOT COMPLETED|Overall Study||2
6419762|NCT00988559|7334081|FG003|NOT COMPLETED|Overall Study||1
6419763|NCT00988598|7334093|FG000|STARTED|Overall Study||10
6419764|NCT00988598|7334094|FG001|STARTED|Overall Study||5
6419765|NCT00988598|7334093|FG000|COMPLETED|Overall Study||8
6419766|NCT00988598|7334094|FG001|COMPLETED|Overall Study||5
6419767|NCT00988598|7334093|FG000|NOT COMPLETED|Overall Study||2
6419768|NCT00988598|7334094|FG001|NOT COMPLETED|Overall Study||0
6419769|NCT00988637|7334102|FG000|STARTED|Overall Study||70
6419770|NCT00988637|7334103|FG001|STARTED|Overall Study||68
6639988|NCT02331589|7568188|FG001|STARTED|Overall Study||36
6419771|NCT00988637|7334102|FG000|COMPLETED|Overall Study||67
6419772|NCT00988637|7334103|FG001|COMPLETED|Overall Study||65
6419773|NCT00988637|7334102|FG000|NOT COMPLETED|Overall Study||3
6419774|NCT00988637|7334103|FG001|NOT COMPLETED|Overall Study||3
6419775|NCT00988832|7334109|FG000|STARTED|Overall Study||380
6419776|NCT00988832|7334109|FG000|COMPLETED|Overall Study||380
6419777|NCT00988832|7334109|FG000|NOT COMPLETED|Overall Study||0
6419778|NCT00988858|7334116|FG000|STARTED|Overall Study||55
6419779|NCT00988858|7334116|FG000|COMPLETED|Overall Study||45
6419780|NCT00988858|7334116|FG000|NOT COMPLETED|Overall Study||10
6419781|NCT00988884|7334122|FG000|STARTED|Overall Study||621
6419782|NCT00988884|7334123|FG001|STARTED|Overall Study||620
6419783|NCT00988884|7334122|FG000|COMPLETED|Overall Study||586
6419784|NCT00988884|7334123|FG001|COMPLETED|Overall Study||584
6419785|NCT00988884|7334122|FG000|NOT COMPLETED|Overall Study||35
6419786|NCT00988884|7334123|FG001|NOT COMPLETED|Overall Study||36
6419787|NCT00989014|7334133|FG000|STARTED|Overall Study||31
6419788|NCT00989014|7334134|FG001|STARTED|Overall Study||31
6419789|NCT00989014|7334135|FG002|STARTED|Overall Study||28
6419790|NCT00989014|7334136|FG003|STARTED|Overall Study||32
6419791|NCT00989014|7334133|FG000|COMPLETED|Overall Study||31
6419792|NCT00989014|7334134|FG001|COMPLETED|Overall Study||31
6419793|NCT00989014|7334135|FG002|COMPLETED|Overall Study||28
6419794|NCT00989014|7334136|FG003|COMPLETED|Overall Study||32
6419795|NCT00989014|7334133|FG000|NOT COMPLETED|Overall Study||0
6419796|NCT00989014|7334134|FG001|NOT COMPLETED|Overall Study||0
6419797|NCT00989014|7334135|FG002|NOT COMPLETED|Overall Study||0
6419798|NCT00989014|7334136|FG003|NOT COMPLETED|Overall Study||0
6419799|NCT00989092|7334148|FG000|STARTED|Overall Study||228
6419800|NCT00989092|7334149|FG001|STARTED|Overall Study||59
6419801|NCT00989092|7334148|FG000|Treated With Darbepoetin Alfa|Overall Study||226
6419802|NCT00989092|7334149|FG001|Treated With Darbepoetin Alfa|Overall Study||33
6419803|NCT00989092|7334148|FG000|COMPLETED|Overall Study||138
6419804|NCT00989092|7334149|FG001|COMPLETED|Overall Study||31
6419805|NCT00989092|7334148|FG000|NOT COMPLETED|Overall Study||90
6419806|NCT00989092|7334149|FG001|NOT COMPLETED|Overall Study||28
6419807|NCT00989157|7334158|FG000|STARTED|Overall Study||10
6419808|NCT00989157|7334159|FG001|STARTED|Overall Study||10
6419809|NCT00989157|7334158|FG000|COMPLETED|Overall Study||10
6419810|NCT00989157|7334159|FG001|COMPLETED|Overall Study||10
6419811|NCT00989157|7334158|FG000|NOT COMPLETED|Overall Study||0
6419812|NCT00989157|7334159|FG001|NOT COMPLETED|Overall Study||0
6419813|NCT00989196|7334167|FG000|STARTED|PK Crossover Period||10
6419814|NCT00989196|7334168|FG001|STARTED|PK Crossover Period||12
6419815|NCT00989196|7334167|FG000|COMPLETED|PK Crossover Period||10
6419816|NCT00989196|7334168|FG001|COMPLETED|PK Crossover Period||12
6419817|NCT00989196|7334167|FG000|NOT COMPLETED|PK Crossover Period||0
6419818|NCT00989196|7334168|FG001|NOT COMPLETED|PK Crossover Period||0
6419819|NCT00989196|7334167|FG000|STARTED|Treatment Period||10
6419820|NCT00989196|7334168|FG001|STARTED|Treatment Period||12
6419821|NCT00989196|7334167|FG000|COMPLETED|Treatment Period||9
6419822|NCT00989196|7334168|FG001|COMPLETED|Treatment Period||12
6419823|NCT00989196|7334167|FG000|NOT COMPLETED|Treatment Period||1
6419824|NCT00989196|7334168|FG001|NOT COMPLETED|Treatment Period||0
6419825|NCT00989235|7334176|FG000|STARTED|Overall Study||58
6419826|NCT00989235|7334177|FG001|STARTED|Overall Study||50
6419827|NCT00989235|7334176|FG000|Number Rescued to Open-Label Treatment|Overall Study||4
6419828|NCT00989235|7334177|FG001|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
6419829|NCT00989235|7334176|FG000|Number Completing Double-Blind Treatment|Overall Study||51
6419830|NCT00989235|7334177|FG001|Number Completing Double-Blind Treatment|Overall Study||41
6419831|NCT00989235|7334176|FG000|COMPLETED|Overall Study||55
6419832|NCT00989235|7334177|FG001|COMPLETED|Overall Study||44
6419833|NCT00989235|7334176|FG000|NOT COMPLETED|Overall Study||3
6419834|NCT00989235|7334177|FG001|NOT COMPLETED|Overall Study||6
6419835|NCT00989261|7334188|FG000|STARTED|Overall Study||157
6419836|NCT00989261|7334189|FG001|STARTED|Overall Study||176
6419837|NCT00989261|7334188|FG000|COMPLETED|Overall Study||142
6419838|NCT00989261|7334189|FG001|COMPLETED|Overall Study||154
6419839|NCT00989261|7334188|FG000|NOT COMPLETED|Overall Study||15
6419840|NCT00989261|7334189|FG001|NOT COMPLETED|Overall Study||22
6419841|NCT00989287|7334197|FG000|STARTED|Overall Study||65
6419842|NCT00989287|7334198|FG001|STARTED|Overall Study||66
6419843|NCT00989287|7334197|FG000|COMPLETED|Overall Study||64
6419844|NCT00989287|7334198|FG001|COMPLETED|Overall Study||65
6419845|NCT00989287|7334197|FG000|NOT COMPLETED|Overall Study||1
6419846|NCT00989287|7334198|FG001|NOT COMPLETED|Overall Study||1
6419847|NCT00989573|7334220|FG000|STARTED|Overall Study||65
6419848|NCT00989573|7334221|FG001|STARTED|Overall Study||63
6419849|NCT00989573|7334222|FG002|STARTED|Overall Study||63
6419850|NCT00989573|7334220|FG000|COMPLETED|Overall Study||52
6419851|NCT00989573|7334221|FG001|COMPLETED|Overall Study||41
6419852|NCT00989573|7334222|FG002|COMPLETED|Overall Study||55
6419853|NCT00989573|7334220|FG000|NOT COMPLETED|Overall Study||13
6419854|NCT00989573|7334221|FG001|NOT COMPLETED|Overall Study||22
6419855|NCT00989573|7334222|FG002|NOT COMPLETED|Overall Study||8
6419856|NCT00989586|7334232|FG000|STARTED|Overall Study||18
6419857|NCT00989586|7334233|FG001|STARTED|Overall Study||17
6419858|NCT00989586|7334232|FG000|COMPLETED|Overall Study||18
6419859|NCT00989586|7334233|FG001|COMPLETED|Overall Study||17
6419860|NCT00989586|7334232|FG000|NOT COMPLETED|Overall Study||0
6419861|NCT00989586|7334233|FG001|NOT COMPLETED|Overall Study||0
6419862|NCT00989612|7334240|FG000|STARTED|Overall Study||100
6419863|NCT00989612|7334240|FG000|COMPLETED|Overall Study||100
6419864|NCT00989612|7334240|FG000|NOT COMPLETED|Overall Study||0
6419865|NCT00989664|7334246|FG000|STARTED|Dosimetric and Therapeutic Treatment||61
6419866|NCT00989664|7334246|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
6419867|NCT00989664|7334246|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
6419868|NCT00989664|7334246|FG000|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
6419869|NCT00989664|7334246|FG000|COMPLETED|Long-Term Follow-Up||11
6419870|NCT00989664|7334246|FG000|NOT COMPLETED|Long-Term Follow-Up||3
6419871|NCT00989768|7334252|FG000|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
6419872|NCT00989768|7334252|FG000|COMPLETED|Overall Study||28
6419873|NCT00989768|7334252|FG000|NOT COMPLETED|Overall Study||1
6419874|NCT00989781|7334262|FG000|STARTED|Ovarian Response to hCG||21
6419875|NCT00989781|7334263|FG001|STARTED|Ovarian Response to hCG||20
6419876|NCT00989781|7334262|FG000|COMPLETED|Ovarian Response to hCG||18
6419877|NCT00989781|7334263|FG001|COMPLETED|Ovarian Response to hCG||18
6419878|NCT00989781|7334262|FG000|NOT COMPLETED|Ovarian Response to hCG||3
6419879|NCT00989781|7334263|FG001|NOT COMPLETED|Ovarian Response to hCG||2
6419880|NCT00989781|7334262|FG000|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
6419881|NCT00989781|7334263|FG001|STARTED|Adrenal Response ot ACTH|15 subjects that completed part 1 elected to participate in Part 2|18
6419882|NCT00989781|7334262|FG000|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented. 2 dropped out and 13 completed study|13
6419883|NCT00989781|7334263|FG001|COMPLETED|Adrenal Response ot ACTH|Of 18 eligible, 15 consented and completed study|15
6419884|NCT00989781|7334262|FG000|NOT COMPLETED|Adrenal Response ot ACTH||5
6419885|NCT00989781|7334263|FG001|NOT COMPLETED|Adrenal Response ot ACTH||3
6419886|NCT00989833|7334273|FG000|STARTED|Overall Study||21
6419887|NCT00989833|7334274|FG001|STARTED|Overall Study||22
6419888|NCT00989833|7334275|FG002|STARTED|Overall Study||23
6419889|NCT00989833|7334273|FG000|COMPLETED|Overall Study||19
6419890|NCT00989833|7334274|FG001|COMPLETED|Overall Study||19
6419891|NCT00989833|7334275|FG002|COMPLETED|Overall Study||21
6419892|NCT00989833|7334273|FG000|NOT COMPLETED|Overall Study||2
6419893|NCT00989833|7334274|FG001|NOT COMPLETED|Overall Study||3
6419894|NCT00989833|7334275|FG002|NOT COMPLETED|Overall Study||2
6419895|NCT00989911|7334283|FG000|STARTED|Overall Study||10
6419896|NCT00989911|7334283|FG000|COMPLETED|Overall Study||7
6419897|NCT00989911|7334283|FG000|NOT COMPLETED|Overall Study||3
6419898|NCT00989950|7334291|FG000|STARTED|Open Label Dose Optimization||6
6419899|NCT00989950|7334292|FG001|STARTED|Open Label Dose Optimization||9
6419900|NCT00989950|7334293|FG002|STARTED|Open Label Dose Optimization||4
6419901|NCT00989950|7334294|FG003|STARTED|Open Label Dose Optimization||7
6419902|NCT00989950|7334291|FG000|COMPLETED|Open Label Dose Optimization||6
6419903|NCT00989950|7334292|FG001|COMPLETED|Open Label Dose Optimization||9
6419904|NCT00989950|7334293|FG002|COMPLETED|Open Label Dose Optimization||4
6419905|NCT00989950|7334294|FG003|COMPLETED|Open Label Dose Optimization||7
6419906|NCT00989950|7334291|FG000|NOT COMPLETED|Open Label Dose Optimization||0
6419907|NCT00989950|7334292|FG001|NOT COMPLETED|Open Label Dose Optimization||0
6419908|NCT00989950|7334293|FG002|NOT COMPLETED|Open Label Dose Optimization||0
6419909|NCT00989950|7334294|FG003|NOT COMPLETED|Open Label Dose Optimization||0
6419910|NCT00989950|7334291|FG000|STARTED|Randomized Phase||6
6419911|NCT00989950|7334292|FG001|STARTED|Randomized Phase||9
6419912|NCT00989950|7334293|FG002|STARTED|Randomized Phase||4
6419913|NCT00989950|7334294|FG003|STARTED|Randomized Phase||7
6419914|NCT00989950|7334291|FG000|COMPLETED|Randomized Phase||5
6419915|NCT00989950|7334292|FG001|COMPLETED|Randomized Phase||8
6419916|NCT00989950|7334293|FG002|COMPLETED|Randomized Phase||4
6419917|NCT00989950|7334294|FG003|COMPLETED|Randomized Phase||7
6419918|NCT00989950|7334291|FG000|NOT COMPLETED|Randomized Phase||1
6419919|NCT00989950|7334292|FG001|NOT COMPLETED|Randomized Phase||1
6419920|NCT00989950|7334293|FG002|NOT COMPLETED|Randomized Phase||0
6419921|NCT00989950|7334294|FG003|NOT COMPLETED|Randomized Phase||0
6419922|NCT00989963|7334307|FG000|STARTED|Overall Study||12
6419923|NCT00989963|7334308|FG001|STARTED|Overall Study||12
6419924|NCT00989963|7334309|FG002|STARTED|Overall Study||12
6419925|NCT00989963|7334307|FG000|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|13
6419926|NCT00989963|7334308|FG001|Safety Population|Overall Study||12
6419927|NCT00989963|7334309|FG002|Safety Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|11
6419928|NCT00989963|7334307|FG000|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|12
6419929|NCT00989963|7334308|FG001|Per-Protocol Population|Overall Study||11
6419930|NCT00989963|7334309|FG002|Per-Protocol Population|Overall Study|1 participant randomized to MTD received FD 60 ug; was included in FD 60 ug arm for this population|10
6419931|NCT00989963|7334307|FG000|COMPLETED|Overall Study||11
6419932|NCT00989963|7334308|FG001|COMPLETED|Overall Study||11
6419933|NCT00989963|7334309|FG002|COMPLETED|Overall Study||11
6419934|NCT00989963|7334307|FG000|NOT COMPLETED|Overall Study||1
6419935|NCT00989963|7334308|FG001|NOT COMPLETED|Overall Study||1
6419936|NCT00989963|7334309|FG002|NOT COMPLETED|Overall Study||1
6419937|NCT00989989|7334320|FG000|STARTED|Overall Study||132
6419938|NCT00989989|7334321|FG001|STARTED|Overall Study||133
6419939|NCT00989989|7334322|FG002|STARTED|Overall Study||131
6419940|NCT00989989|7334320|FG000|COMPLETED|Overall Study||114
6419941|NCT00989989|7334321|FG001|COMPLETED|Overall Study||123
6419942|NCT00989989|7334322|FG002|COMPLETED|Overall Study||108
6419943|NCT00989989|7334320|FG000|NOT COMPLETED|Overall Study||18
6419944|NCT00989989|7334321|FG001|NOT COMPLETED|Overall Study||10
6419945|NCT00989989|7334322|FG002|NOT COMPLETED|Overall Study||23
6499340|NCT01416805|7418011|FG000|STARTED|Overall Study||49
6499341|NCT01416805|7418012|FG001|STARTED|Overall Study||51
6499342|NCT01416805|7418011|FG000|COMPLETED|Overall Study||45
6499343|NCT01416805|7418012|FG001|COMPLETED|Overall Study||47
6499344|NCT01416805|7418011|FG000|NOT COMPLETED|Overall Study||4
6499345|NCT01416805|7418012|FG001|NOT COMPLETED|Overall Study||4
6499346|NCT01416987|7418018|FG000|STARTED|Overall Study||600
6499347|NCT01416987|7418018|FG000|COMPLETED|Overall Study||600
6499348|NCT01416987|7418018|FG000|NOT COMPLETED|Overall Study||0
6499349|NCT01417000|7418024|FG000|STARTED|Overall Study|62 subjects randomized into Cy/GVAX + CRS-207 arm; 61 subjects received ≥ 1 protocol-specified drug.|61
6499350|NCT01417000|7418025|FG001|STARTED|Overall Study|31 subjects randomized into Cy/GVAX arm; 29 subjects received ≥ 1 protocol-specified drug.|29
6499351|NCT01417000|7418024|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
6499352|NCT01417000|7418025|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/death/study close, so no subjects completed study."|0
6499353|NCT01417000|7418024|FG000|NOT COMPLETED|Overall Study||61
6499354|NCT01417000|7418025|FG001|NOT COMPLETED|Overall Study||29
6499355|NCT01417026|7418033|FG000|STARTED|Overall Study||16
6499356|NCT01417026|7418034|FG001|STARTED|Overall Study||13
6499357|NCT01417026|7418033|FG000|COMPLETED|Overall Study||14
6499358|NCT01417026|7418034|FG001|COMPLETED|Overall Study||13
6499359|NCT01417026|7418033|FG000|NOT COMPLETED|Overall Study||2
6499360|NCT01417026|7418034|FG001|NOT COMPLETED|Overall Study||0
6499361|NCT01417078|7418040|FG000|STARTED|Overall Study||31
6499362|NCT01417078|7418040|FG000|COMPLETED|Overall Study||30
6499363|NCT01417078|7418040|FG000|NOT COMPLETED|Overall Study||1
6499364|NCT01417104|7418048|FG000|STARTED|Overall Study||34
6499365|NCT01417104|7418049|FG001|STARTED|Overall Study||37
6499366|NCT01417104|7418048|FG000|COMPLETED|Overall Study||28
6499367|NCT01417104|7418049|FG001|COMPLETED|Overall Study||35
6499368|NCT01417104|7418048|FG000|NOT COMPLETED|Overall Study||6
6499369|NCT01417104|7418049|FG001|NOT COMPLETED|Overall Study||2
6499370|NCT01417156|7418055|FG000|STARTED|Overall Study||20
6499371|NCT01417156|7418055|FG000|COMPLETED|Overall Study||6
6499372|NCT01417156|7418055|FG000|NOT COMPLETED|Overall Study||14
6499373|NCT01417195|7418061|FG000|STARTED|Overall Study||60
6499374|NCT01417195|7418062|FG001|STARTED|Overall Study||62
6499375|NCT01417195|7418061|FG000|COMPLETED|Overall Study||57
6499376|NCT01417195|7418062|FG001|COMPLETED|Overall Study||61
6499377|NCT01417195|7418061|FG000|NOT COMPLETED|Overall Study||3
6499378|NCT01417195|7418062|FG001|NOT COMPLETED|Overall Study||1
6499379|NCT01417234|7418069|FG000|STARTED|Overall Study||30
6499380|NCT01417234|7418069|FG000|COMPLETED|Overall Study||27
6499381|NCT01417234|7418069|FG000|NOT COMPLETED|Overall Study||3
6499382|NCT01417455|7418081|FG000|STARTED|Overall Study||16
6499383|NCT01417455|7418082|FG001|STARTED|Overall Study||16
6499384|NCT01417455|7418083|FG002|STARTED|Overall Study||17
6499385|NCT01417455|7418084|FG003|STARTED|Overall Study||17
6499386|NCT01417455|7418085|FG004|STARTED|Overall Study||30
6499387|NCT01417455|7418086|FG005|STARTED|Overall Study||13
6499388|NCT01417455|7418087|FG006|STARTED|Overall Study||13
6499389|NCT01417455|7418088|FG007|STARTED|Overall Study||25
6499390|NCT01417455|7418081|FG000|COMPLETED|Overall Study||16
6499391|NCT01417455|7418082|FG001|COMPLETED|Overall Study||16
6499392|NCT01417455|7418083|FG002|COMPLETED|Overall Study||17
6499393|NCT01417455|7418084|FG003|COMPLETED|Overall Study||17
6499394|NCT01417455|7418085|FG004|COMPLETED|Overall Study||30
6499395|NCT01417455|7418086|FG005|COMPLETED|Overall Study||13
6499396|NCT01417455|7418087|FG006|COMPLETED|Overall Study||13
6499397|NCT01417455|7418088|FG007|COMPLETED|Overall Study||25
6499398|NCT01417455|7418081|FG000|NOT COMPLETED|Overall Study||0
6499399|NCT01417455|7418082|FG001|NOT COMPLETED|Overall Study||0
6499400|NCT01417455|7418083|FG002|NOT COMPLETED|Overall Study||0
6499401|NCT01417455|7418084|FG003|NOT COMPLETED|Overall Study||0
6499402|NCT01417455|7418085|FG004|NOT COMPLETED|Overall Study||0
6499403|NCT01417455|7418086|FG005|NOT COMPLETED|Overall Study||0
6499404|NCT01417455|7418087|FG006|NOT COMPLETED|Overall Study||0
6499405|NCT01417455|7418088|FG007|NOT COMPLETED|Overall Study||0
6499406|NCT01417481|7418108|FG000|STARTED|First Intervention (8 Weeks)||8
6499407|NCT01417481|7418109|FG001|STARTED|First Intervention (8 Weeks)||7
6499408|NCT01417481|7418108|FG000|COMPLETED|First Intervention (8 Weeks)||8
6499409|NCT01417481|7418109|FG001|COMPLETED|First Intervention (8 Weeks)||5
6499410|NCT01417481|7418108|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
6499411|NCT01417481|7418109|FG001|NOT COMPLETED|First Intervention (8 Weeks)||2
6499412|NCT01417481|7418108|FG000|STARTED|Washout (2 Weeks)||8
6499413|NCT01417481|7418109|FG001|STARTED|Washout (2 Weeks)||5
6499414|NCT01417481|7418108|FG000|COMPLETED|Washout (2 Weeks)||8
6499415|NCT01417481|7418109|FG001|COMPLETED|Washout (2 Weeks)||5
6499416|NCT01417481|7418108|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6499417|NCT01417481|7418109|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6499418|NCT01417481|7418108|FG000|STARTED|Second Period (8 Weeks)||8
6499419|NCT01417481|7418109|FG001|STARTED|Second Period (8 Weeks)||5
6419946|NCT00990093|7334330|FG000|STARTED|Test Period 1 (1-14 Days)||19
6419947|NCT00990093|7334331|FG001|STARTED|Test Period 1 (1-14 Days)||17
6419948|NCT00990093|7334330|FG000|COMPLETED|Test Period 1 (1-14 Days)||15
6419949|NCT00990093|7334331|FG001|COMPLETED|Test Period 1 (1-14 Days)||15
6419950|NCT00990093|7334330|FG000|NOT COMPLETED|Test Period 1 (1-14 Days)||4
6419951|NCT00990093|7334331|FG001|NOT COMPLETED|Test Period 1 (1-14 Days)||2
6419952|NCT00990093|7334330|FG000|STARTED|Test Period 2 (15-28 Days)||15
6419953|NCT00990093|7334331|FG001|STARTED|Test Period 2 (15-28 Days)||15
6419954|NCT00990093|7334330|FG000|COMPLETED|Test Period 2 (15-28 Days)||13
6419955|NCT00990093|7334331|FG001|COMPLETED|Test Period 2 (15-28 Days)||14
6419956|NCT00990093|7334330|FG000|NOT COMPLETED|Test Period 2 (15-28 Days)||2
6419957|NCT00990093|7334331|FG001|NOT COMPLETED|Test Period 2 (15-28 Days)||1
6419958|NCT00990106|7334339|FG000|STARTED|Overall Study||32
6419959|NCT00990106|7334340|FG001|STARTED|Overall Study||35
6419960|NCT00990106|7334339|FG000|COMPLETED|Overall Study||23
6419961|NCT00990106|7334340|FG001|COMPLETED|Overall Study||23
6419962|NCT00990106|7334339|FG000|NOT COMPLETED|Overall Study||9
6419963|NCT00990106|7334340|FG001|NOT COMPLETED|Overall Study||12
6419964|NCT00990184|7334346|FG000|STARTED|Overall Study||21
6419965|NCT00990184|7334346|FG000|COMPLETED|Overall Study||20
6419966|NCT00990184|7334346|FG000|NOT COMPLETED|Overall Study||1
6419967|NCT00990236|7334354|FG000|STARTED|Overall Study||89
6419968|NCT00990236|7334355|FG001|STARTED|Overall Study||96
6419969|NCT00990236|7334354|FG000|COMPLETED|Overall Study||89
6419970|NCT00990236|7334355|FG001|COMPLETED|Overall Study||96
6419971|NCT00990236|7334354|FG000|NOT COMPLETED|Overall Study||0
6419972|NCT00990236|7334355|FG001|NOT COMPLETED|Overall Study||0
6419973|NCT00990249|7334361|FG000|STARTED|Overall Study||120
6419974|NCT00990249|7334361|FG000|COMPLETED|Overall Study||107
6419975|NCT00990249|7334361|FG000|NOT COMPLETED|Overall Study||13
6419976|NCT00990288|7334367|FG000|STARTED|Overall Study||97
6419977|NCT00990288|7334368|FG001|STARTED|Overall Study||99
6419978|NCT00990288|7334367|FG000|COMPLETED|Overall Study||97
6419979|NCT00990288|7334368|FG001|COMPLETED|Overall Study||99
6419980|NCT00990288|7334367|FG000|NOT COMPLETED|Overall Study||0
6419981|NCT00990288|7334368|FG001|NOT COMPLETED|Overall Study||0
6419982|NCT00990314|7334374|FG000|STARTED|Overall Study||31
6419983|NCT00990314|7334374|FG000|COMPLETED|Overall Study||19
6419984|NCT00990314|7334374|FG000|NOT COMPLETED|Overall Study||12
6419985|NCT00990340|7334380|FG000|STARTED|First 14-day Treatment||27
6419986|NCT00990340|7334381|FG001|STARTED|First 14-day Treatment||25
6419987|NCT00990340|7334380|FG000|COMPLETED|First 14-day Treatment||21
6419988|NCT00990340|7334381|FG001|COMPLETED|First 14-day Treatment||21
6419989|NCT00990340|7334380|FG000|NOT COMPLETED|First 14-day Treatment||6
6419990|NCT00990340|7334381|FG001|NOT COMPLETED|First 14-day Treatment||4
6419991|NCT00990340|7334380|FG000|STARTED|Second 14-day Treatment||21
6419992|NCT00990340|7334381|FG001|STARTED|Second 14-day Treatment||21
6419993|NCT00990340|7334380|FG000|COMPLETED|Second 14-day Treatment||21
6419994|NCT00990340|7334381|FG001|COMPLETED|Second 14-day Treatment||21
6419995|NCT00990340|7334380|FG000|NOT COMPLETED|Second 14-day Treatment||0
6419996|NCT00990340|7334381|FG001|NOT COMPLETED|Second 14-day Treatment||0
6419997|NCT00990509|7334391|FG000|STARTED|Overall Study||5
6419998|NCT00990509|7334392|FG001|STARTED|Overall Study||9
6419999|NCT00990509|7334391|FG000|COMPLETED|Overall Study||5
6420000|NCT00990509|7334392|FG001|COMPLETED|Overall Study||8
6420001|NCT00990509|7334391|FG000|NOT COMPLETED|Overall Study||0
6420002|NCT00990509|7334392|FG001|NOT COMPLETED|Overall Study||1
6420003|NCT00990561|7334400|FG000|STARTED|Period 1||20
6420004|NCT00990561|7334401|FG001|STARTED|Period 1||20
6420005|NCT00990561|7334402|FG002|STARTED|Period 1||0
6420006|NCT00990561|7334403|FG003|STARTED|Period 1||0
6420007|NCT00990561|7334400|FG000|COMPLETED|Period 1||20
6420008|NCT00990561|7334401|FG001|COMPLETED|Period 1||19
6420009|NCT00990561|7334402|FG002|COMPLETED|Period 1||0
6420010|NCT00990561|7334403|FG003|COMPLETED|Period 1||0
6420011|NCT00990561|7334400|FG000|NOT COMPLETED|Period 1||0
6420012|NCT00990561|7334401|FG001|NOT COMPLETED|Period 1||1
6420013|NCT00990561|7334402|FG002|NOT COMPLETED|Period 1||0
6420014|NCT00990561|7334403|FG003|NOT COMPLETED|Period 1||0
6420015|NCT00990561|7334400|FG000|STARTED|Period 2||0
6420016|NCT00990561|7334401|FG001|STARTED|Period 2||0
6420017|NCT00990561|7334402|FG002|STARTED|Period 2||20
6420018|NCT00990561|7334403|FG003|STARTED|Period 2||19
6420019|NCT00990561|7334400|FG000|COMPLETED|Period 2||0
6420020|NCT00990561|7334401|FG001|COMPLETED|Period 2||0
6420021|NCT00990561|7334402|FG002|COMPLETED|Period 2||20
6420022|NCT00990561|7334403|FG003|COMPLETED|Period 2||17
6420023|NCT00990561|7334400|FG000|NOT COMPLETED|Period 2||0
6420024|NCT00990561|7334401|FG001|NOT COMPLETED|Period 2||0
6420025|NCT00990561|7334402|FG002|NOT COMPLETED|Period 2||0
6420026|NCT00990561|7334403|FG003|NOT COMPLETED|Period 2||2
6420027|NCT00990652|7334409|FG000|STARTED|Pre-surgical Bortezomib||10
6420028|NCT00990652|7334409|FG000|COMPLETED|Pre-surgical Bortezomib||9
6420029|NCT00990652|7334409|FG000|NOT COMPLETED|Pre-surgical Bortezomib||1
6420030|NCT00990652|7334409|FG000|STARTED|Surgical Resection||9
6420031|NCT00990652|7334409|FG000|COMPLETED|Surgical Resection||9
6420032|NCT00990652|7334409|FG000|NOT COMPLETED|Surgical Resection||0
6420033|NCT00990652|7334409|FG000|STARTED|Post-sugery Bortezomib + Temozolomide||9
6420034|NCT00990652|7334409|FG000|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
6420035|NCT00990652|7334409|FG000|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
6420036|NCT00990665|7334414|FG000|STARTED|Overall Study||178
6420037|NCT00990665|7334414|FG000|COMPLETED|Overall Study||130
6420038|NCT00990665|7334414|FG000|NOT COMPLETED|Overall Study||48
6420039|NCT00990704|7334422|FG000|STARTED|Overall Study||14
6420040|NCT00990704|7334423|FG001|STARTED|Overall Study||33
6420041|NCT00990704|7334422|FG000|COMPLETED|Overall Study||13
6420042|NCT00990704|7334423|FG001|COMPLETED|Overall Study||31
6420043|NCT00990704|7334422|FG000|NOT COMPLETED|Overall Study||1
6420044|NCT00990704|7334423|FG001|NOT COMPLETED|Overall Study||2
6420045|NCT00990769|7334431|FG000|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
6420046|NCT00990769|7334432|FG001|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
6304172|NCT00364793|7207488|FG003|NOT COMPLETED|Overall Study||3
6304173|NCT00364819|7207501|FG000|STARTED|Overall Study||6
6304174|NCT00364819|7207501|FG000|COMPLETED|Overall Study||6
6304175|NCT00364819|7207501|FG000|NOT COMPLETED|Overall Study||0
6304176|NCT00364832|7207514|FG000|STARTED|Core Period||16
6304177|NCT00364832|7207515|FG001|STARTED|Core Period||15
6420047|NCT00990769|7334431|FG000|COMPLETED|Overall Study||22
6420048|NCT00990769|7334432|FG001|COMPLETED|Overall Study||18
6420049|NCT00990769|7334431|FG000|NOT COMPLETED|Overall Study||0
6420050|NCT00990769|7334432|FG001|NOT COMPLETED|Overall Study||0
6420051|NCT00990782|7334438|FG000|STARTED|Overall Study||93
6420052|NCT00990782|7334438|FG000|COMPLETED|Overall Study||88
6420053|NCT00990782|7334438|FG000|NOT COMPLETED|Overall Study||5
6420054|NCT00990821|7334456|FG000|STARTED|Overall Study||14
6420055|NCT00990821|7334457|FG001|STARTED|Overall Study||16
6420056|NCT00990821|7334458|FG002|STARTED|Overall Study||14
6420057|NCT00990821|7334459|FG003|STARTED|Overall Study||8
6420058|NCT00990821|7334460|FG004|STARTED|Overall Study||17
6420059|NCT00990821|7334461|FG005|STARTED|Overall Study||17
6420060|NCT00990821|7334462|FG006|STARTED|Overall Study||12
6420061|NCT00990821|7334463|FG007|STARTED|Overall Study||14
6420062|NCT00990821|7334464|FG008|STARTED|Overall Study||12
6420063|NCT00990821|7334465|FG009|STARTED|Overall Study||14
6420064|NCT00990821|7334466|FG010|STARTED|Overall Study||12
6420065|NCT00990821|7334467|FG011|STARTED|Overall Study||14
6420066|NCT00990821|7334468|FG012|STARTED|Overall Study||12
6420067|NCT00990821|7334469|FG013|STARTED|Overall Study||12
6420068|NCT00990821|7334456|FG000|COMPLETED|Overall Study||14
6420069|NCT00990821|7334457|FG001|COMPLETED|Overall Study||14
6420070|NCT00990821|7334458|FG002|COMPLETED|Overall Study||14
6420071|NCT00990821|7334459|FG003|COMPLETED|Overall Study||8
6420072|NCT00990821|7334460|FG004|COMPLETED|Overall Study||14
6420073|NCT00990821|7334461|FG005|COMPLETED|Overall Study||14
6420074|NCT00990821|7334462|FG006|COMPLETED|Overall Study||11
6420075|NCT00990821|7334463|FG007|COMPLETED|Overall Study||14
6420076|NCT00990821|7334464|FG008|COMPLETED|Overall Study||12
6420077|NCT00990821|7334465|FG009|COMPLETED|Overall Study||13
6420078|NCT00990821|7334466|FG010|COMPLETED|Overall Study||9
6420079|NCT00990821|7334467|FG011|COMPLETED|Overall Study||9
6420080|NCT00990821|7334468|FG012|COMPLETED|Overall Study||10
6420081|NCT00990821|7334469|FG013|COMPLETED|Overall Study||11
6420082|NCT00990821|7334456|FG000|NOT COMPLETED|Overall Study||0
6420083|NCT00990821|7334457|FG001|NOT COMPLETED|Overall Study||2
6420084|NCT00990821|7334458|FG002|NOT COMPLETED|Overall Study||0
6420085|NCT00990821|7334459|FG003|NOT COMPLETED|Overall Study||0
6420086|NCT00990821|7334460|FG004|NOT COMPLETED|Overall Study||3
6420087|NCT00990821|7334461|FG005|NOT COMPLETED|Overall Study||3
6510793|NCT01484197|7430380|FG000|NOT COMPLETED|Treatment Period 2||0
6510794|NCT01484197|7430381|FG001|NOT COMPLETED|Treatment Period 2||0
6510795|NCT01484197|7430382|FG002|NOT COMPLETED|Treatment Period 2||0
6510796|NCT01484197|7430383|FG003|NOT COMPLETED|Treatment Period 2||1
6510797|NCT01484197|7430380|FG000|STARTED|Treatment Period 3||7
6510798|NCT01484197|7430381|FG001|STARTED|Treatment Period 3||8
6510799|NCT01484197|7430382|FG002|STARTED|Treatment Period 3||9
6510800|NCT01484197|7430383|FG003|STARTED|Treatment Period 3||8
6510801|NCT01484197|7430380|FG000|COMPLETED|Treatment Period 3||7
6510802|NCT01484197|7430381|FG001|COMPLETED|Treatment Period 3||8
6510803|NCT01484197|7430382|FG002|COMPLETED|Treatment Period 3||9
6510804|NCT01484197|7430383|FG003|COMPLETED|Treatment Period 3||8
6510805|NCT01484197|7430380|FG000|NOT COMPLETED|Treatment Period 3||0
6510806|NCT01484197|7430381|FG001|NOT COMPLETED|Treatment Period 3||0
6510807|NCT01484197|7430382|FG002|NOT COMPLETED|Treatment Period 3||0
6510808|NCT01484197|7430383|FG003|NOT COMPLETED|Treatment Period 3||0
6510809|NCT01484197|7430380|FG000|STARTED|Treatment Period 4||7
6510810|NCT01484197|7430381|FG001|STARTED|Treatment Period 4||8
6510811|NCT01484197|7430382|FG002|STARTED|Treatment Period 4||9
6510812|NCT01484197|7430383|FG003|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
6510813|NCT01484197|7430380|FG000|COMPLETED|Treatment Period 4||7
6510814|NCT01484197|7430381|FG001|COMPLETED|Treatment Period 4||8
6510815|NCT01484197|7430382|FG002|COMPLETED|Treatment Period 4||9
6510816|NCT01484197|7430383|FG003|COMPLETED|Treatment Period 4||6
6510817|NCT01484197|7430380|FG000|NOT COMPLETED|Treatment Period 4||0
6510818|NCT01484197|7430381|FG001|NOT COMPLETED|Treatment Period 4||0
6510819|NCT01484197|7430382|FG002|NOT COMPLETED|Treatment Period 4||0
6510820|NCT01484197|7430383|FG003|NOT COMPLETED|Treatment Period 4||0
6420088|NCT00990821|7334462|FG006|NOT COMPLETED|Overall Study||1
6420089|NCT00990821|7334463|FG007|NOT COMPLETED|Overall Study||0
6420090|NCT00990821|7334464|FG008|NOT COMPLETED|Overall Study||0
6420091|NCT00990821|7334465|FG009|NOT COMPLETED|Overall Study||1
6420092|NCT00990821|7334466|FG010|NOT COMPLETED|Overall Study||3
6420093|NCT00990821|7334467|FG011|NOT COMPLETED|Overall Study||5
6420094|NCT00990821|7334468|FG012|NOT COMPLETED|Overall Study||2
6420095|NCT00990821|7334469|FG013|NOT COMPLETED|Overall Study||1
6420096|NCT00990938|7334492|FG000|STARTED|Overall Study||3
6420097|NCT00990938|7334493|FG001|STARTED|Overall Study||12
6420098|NCT00990938|7334494|FG002|STARTED|Overall Study||12
6420099|NCT00990938|7334495|FG003|STARTED|Overall Study||12
6420100|NCT00990938|7334496|FG004|STARTED|Overall Study||12
6420101|NCT00990938|7334497|FG005|STARTED|Overall Study||12
6420102|NCT00990938|7334492|FG000|COMPLETED|Overall Study||3
6420103|NCT00990938|7334493|FG001|COMPLETED|Overall Study||12
6420104|NCT00990938|7334494|FG002|COMPLETED|Overall Study||12
6420105|NCT00990938|7334495|FG003|COMPLETED|Overall Study||12
6420106|NCT00990938|7334496|FG004|COMPLETED|Overall Study||12
6420107|NCT00990938|7334497|FG005|COMPLETED|Overall Study||12
6420108|NCT00990938|7334492|FG000|NOT COMPLETED|Overall Study||0
6420109|NCT00990938|7334493|FG001|NOT COMPLETED|Overall Study||0
6420110|NCT00990938|7334494|FG002|NOT COMPLETED|Overall Study||0
6420111|NCT00990938|7334495|FG003|NOT COMPLETED|Overall Study||0
6420112|NCT00990938|7334496|FG004|NOT COMPLETED|Overall Study||0
6420113|NCT00990938|7334497|FG005|NOT COMPLETED|Overall Study||0
6420114|NCT00990964|7334511|FG000|STARTED|Overall Study|Total number of subjects enrolled|2014
6420115|NCT00990964|7334511|FG000|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
6420116|NCT00990964|7334511|FG000|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
6420117|NCT00990964|7334511|FG000|NOT COMPLETED|Overall Study||212
6420118|NCT00991029|7334518|FG000|STARTED|Overall Study||2432
6420119|NCT00991029|7334519|FG001|STARTED|Overall Study||2449
6420120|NCT00991029|7334518|FG000|COMPLETED|Overall Study||2276
6420121|NCT00991029|7334519|FG001|COMPLETED|Overall Study||2281
6420122|NCT00991029|7334518|FG000|NOT COMPLETED|Overall Study||156
6420123|NCT00991029|7334519|FG001|NOT COMPLETED|Overall Study||168
6420124|NCT00991081|7334527|FG000|STARTED|Phase I, Formative Research||20
6420125|NCT00991081|7334528|FG001|STARTED|Phase I, Formative Research||0
6420126|NCT00991081|7334529|FG002|STARTED|Phase I, Formative Research||0
6420127|NCT00991081|7334527|FG000|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
6420128|NCT00991081|7334528|FG001|COMPLETED|Phase I, Formative Research||0
6420129|NCT00991081|7334529|FG002|COMPLETED|Phase I, Formative Research||0
6420130|NCT00991081|7334527|FG000|NOT COMPLETED|Phase I, Formative Research||0
6420131|NCT00991081|7334528|FG001|NOT COMPLETED|Phase I, Formative Research||0
6420132|NCT00991081|7334529|FG002|NOT COMPLETED|Phase I, Formative Research||0
6420133|NCT00991081|7334527|FG000|STARTED|Phase II, Randomized Control Trial||0
6420134|NCT00991081|7334528|FG001|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
6420135|NCT00991081|7334529|FG002|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
6420136|NCT00991081|7334527|FG000|Received First Clinical Call|Phase II, Randomized Control Trial||0
6420137|NCT00991081|7334528|FG001|Received First Clinical Call|Phase II, Randomized Control Trial||16
6420138|NCT00991081|7334529|FG002|Received First Clinical Call|Phase II, Randomized Control Trial||17
6420139|NCT00991081|7334527|FG000|COMPLETED|Phase II, Randomized Control Trial||0
6420140|NCT00991081|7334528|FG001|COMPLETED|Phase II, Randomized Control Trial||15
6420141|NCT00991081|7334529|FG002|COMPLETED|Phase II, Randomized Control Trial||15
6420142|NCT00991081|7334527|FG000|NOT COMPLETED|Phase II, Randomized Control Trial||0
6420143|NCT00991081|7334528|FG001|NOT COMPLETED|Phase II, Randomized Control Trial||2
6420144|NCT00991081|7334529|FG002|NOT COMPLETED|Phase II, Randomized Control Trial||4
6420145|NCT00991185|7334535|FG000|STARTED|Overall Study||8
6420146|NCT00991185|7334535|FG000|COMPLETED|Overall Study||8
6420147|NCT00991185|7334535|FG000|NOT COMPLETED|Overall Study||0
6420148|NCT00991276|7334545|FG000|STARTED|First Intervention Period||15
6420149|NCT00991276|7334546|FG001|STARTED|First Intervention Period||13
6420150|NCT00991276|7334547|FG002|STARTED|First Intervention Period||14
6420151|NCT00991276|7334548|FG003|STARTED|First Intervention Period||15
6420152|NCT00991276|7334549|FG004|STARTED|First Intervention Period||15
6420153|NCT00991276|7334550|FG005|STARTED|First Intervention Period||13
6420154|NCT00991276|7334545|FG000|COMPLETED|First Intervention Period||15
6420155|NCT00991276|7334546|FG001|COMPLETED|First Intervention Period||10
6420156|NCT00991276|7334547|FG002|COMPLETED|First Intervention Period||14
6420157|NCT00991276|7334548|FG003|COMPLETED|First Intervention Period||11
6420158|NCT00991276|7334549|FG004|COMPLETED|First Intervention Period||11
6420159|NCT00991276|7334550|FG005|COMPLETED|First Intervention Period||12
6420160|NCT00991276|7334545|FG000|NOT COMPLETED|First Intervention Period||0
6420161|NCT00991276|7334546|FG001|NOT COMPLETED|First Intervention Period||3
6420162|NCT00991276|7334547|FG002|NOT COMPLETED|First Intervention Period||0
6420163|NCT00991276|7334548|FG003|NOT COMPLETED|First Intervention Period||4
6420164|NCT00991276|7334549|FG004|NOT COMPLETED|First Intervention Period||4
6420165|NCT00991276|7334550|FG005|NOT COMPLETED|First Intervention Period||1
6420166|NCT00991276|7334545|FG000|STARTED|Placebo Wash-out Period (7 Days)||15
6420167|NCT00991276|7334546|FG001|STARTED|Placebo Wash-out Period (7 Days)||10
6420168|NCT00991276|7334547|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
6420169|NCT00991276|7334548|FG003|STARTED|Placebo Wash-out Period (7 Days)||11
6420170|NCT00991276|7334549|FG004|STARTED|Placebo Wash-out Period (7 Days)||11
6420171|NCT00991276|7334550|FG005|STARTED|Placebo Wash-out Period (7 Days)||12
6499420|NCT01417481|7418108|FG000|COMPLETED|Second Period (8 Weeks)||8
6420172|NCT00991276|7334545|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||15
6420173|NCT00991276|7334546|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||10
6420174|NCT00991276|7334547|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
6420175|NCT00991276|7334548|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||11
6420176|NCT00991276|7334549|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||11
6420177|NCT00991276|7334550|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||12
6420178|NCT00991276|7334545|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420179|NCT00991276|7334546|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420180|NCT00991276|7334547|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420181|NCT00991276|7334548|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420182|NCT00991276|7334549|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420183|NCT00991276|7334550|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420184|NCT00991276|7334545|FG000|STARTED|Second Intervention Period||15
6420185|NCT00991276|7334546|FG001|STARTED|Second Intervention Period||10
6420186|NCT00991276|7334547|FG002|STARTED|Second Intervention Period||14
6420187|NCT00991276|7334548|FG003|STARTED|Second Intervention Period||11
6420188|NCT00991276|7334549|FG004|STARTED|Second Intervention Period||11
6420189|NCT00991276|7334550|FG005|STARTED|Second Intervention Period||12
6420190|NCT00991276|7334545|FG000|COMPLETED|Second Intervention Period||14
6420191|NCT00991276|7334546|FG001|COMPLETED|Second Intervention Period||8
6420192|NCT00991276|7334547|FG002|COMPLETED|Second Intervention Period||14
6420193|NCT00991276|7334548|FG003|COMPLETED|Second Intervention Period||9
6420194|NCT00991276|7334549|FG004|COMPLETED|Second Intervention Period||10
6420195|NCT00991276|7334550|FG005|COMPLETED|Second Intervention Period||11
6420196|NCT00991276|7334545|FG000|NOT COMPLETED|Second Intervention Period||1
6420197|NCT00991276|7334546|FG001|NOT COMPLETED|Second Intervention Period||2
6420198|NCT00991276|7334547|FG002|NOT COMPLETED|Second Intervention Period||0
6420199|NCT00991276|7334548|FG003|NOT COMPLETED|Second Intervention Period||2
6420200|NCT00991276|7334549|FG004|NOT COMPLETED|Second Intervention Period||1
6420201|NCT00991276|7334550|FG005|NOT COMPLETED|Second Intervention Period||1
6420202|NCT00991276|7334545|FG000|STARTED|Placebo Wash-out Period (7 Days)||14
6420203|NCT00991276|7334546|FG001|STARTED|Placebo Wash-out Period (7 Days)||8
6420204|NCT00991276|7334547|FG002|STARTED|Placebo Wash-out Period (7 Days)||14
6420205|NCT00991276|7334548|FG003|STARTED|Placebo Wash-out Period (7 Days)||9
6420206|NCT00991276|7334549|FG004|STARTED|Placebo Wash-out Period (7 Days)||10
6420207|NCT00991276|7334550|FG005|STARTED|Placebo Wash-out Period (7 Days)||11
6420208|NCT00991276|7334545|FG000|COMPLETED|Placebo Wash-out Period (7 Days)||14
6420209|NCT00991276|7334546|FG001|COMPLETED|Placebo Wash-out Period (7 Days)||8
6420210|NCT00991276|7334547|FG002|COMPLETED|Placebo Wash-out Period (7 Days)||14
6420211|NCT00991276|7334548|FG003|COMPLETED|Placebo Wash-out Period (7 Days)||9
6420212|NCT00991276|7334549|FG004|COMPLETED|Placebo Wash-out Period (7 Days)||10
6420213|NCT00991276|7334550|FG005|COMPLETED|Placebo Wash-out Period (7 Days)||11
6420214|NCT00991276|7334545|FG000|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420215|NCT00991276|7334546|FG001|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420216|NCT00991276|7334547|FG002|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420217|NCT00991276|7334548|FG003|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420218|NCT00991276|7334549|FG004|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420219|NCT00991276|7334550|FG005|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
6420220|NCT00991276|7334545|FG000|STARTED|Third Intervention Period||14
6420221|NCT00991276|7334546|FG001|STARTED|Third Intervention Period||8
6420222|NCT00991276|7334547|FG002|STARTED|Third Intervention Period||14
6420223|NCT00991276|7334548|FG003|STARTED|Third Intervention Period||9
6420224|NCT00991276|7334549|FG004|STARTED|Third Intervention Period||10
6420225|NCT00991276|7334550|FG005|STARTED|Third Intervention Period||11
6420226|NCT00991276|7334545|FG000|COMPLETED|Third Intervention Period||13
6420227|NCT00991276|7334546|FG001|COMPLETED|Third Intervention Period||8
6420228|NCT00991276|7334547|FG002|COMPLETED|Third Intervention Period||13
6420229|NCT00991276|7334548|FG003|COMPLETED|Third Intervention Period||8
6420230|NCT00991276|7334549|FG004|COMPLETED|Third Intervention Period||10
6420231|NCT00991276|7334550|FG005|COMPLETED|Third Intervention Period||10
6420232|NCT00991276|7334545|FG000|NOT COMPLETED|Third Intervention Period||1
6420233|NCT00991276|7334546|FG001|NOT COMPLETED|Third Intervention Period||0
6420234|NCT00991276|7334547|FG002|NOT COMPLETED|Third Intervention Period||1
6420235|NCT00991276|7334548|FG003|NOT COMPLETED|Third Intervention Period||1
6420236|NCT00991276|7334549|FG004|NOT COMPLETED|Third Intervention Period||0
6420237|NCT00991276|7334550|FG005|NOT COMPLETED|Third Intervention Period||1
6420238|NCT00991289|7334559|FG000|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
6420239|NCT00991289|7334559|FG000|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
6420240|NCT00991289|7334559|FG000|COMPLETED|Overall Study|Completed study.|55
6420241|NCT00991289|7334559|FG000|NOT COMPLETED|Overall Study||12
6420242|NCT00991302|7334565|FG000|STARTED|Overall Study||86
6420243|NCT00991302|7334566|FG001|STARTED|Overall Study||86
6420244|NCT00991302|7334565|FG000|COMPLETED|Overall Study||72
6420245|NCT00991302|7334566|FG001|COMPLETED|Overall Study||73
6420246|NCT00991302|7334565|FG000|NOT COMPLETED|Overall Study||14
6420247|NCT00991302|7334566|FG001|NOT COMPLETED|Overall Study||13
6420248|NCT00991341|7334574|FG000|STARTED|Overall Study||742
6420249|NCT00991341|7334575|FG001|STARTED|Overall Study||739
6420250|NCT00991341|7334574|FG000|COMPLETED|Overall Study||538
6420251|NCT00991341|7334575|FG001|COMPLETED|Overall Study||560
6420252|NCT00991341|7334574|FG000|NOT COMPLETED|Overall Study||204
6420253|NCT00991341|7334575|FG001|NOT COMPLETED|Overall Study||179
6420254|NCT00991406|7334581|FG000|STARTED|Overall Study||9
6420255|NCT00991406|7334581|FG000|COMPLETED|Overall Study|One participant did not respond to FES due to tone.|8
6420256|NCT00991406|7334581|FG000|NOT COMPLETED|Overall Study||1
6420257|NCT00991458|7334588|FG000|STARTED|Overall Study||207
6420258|NCT00991458|7334589|FG001|STARTED|Overall Study||209
6420259|NCT00991458|7334590|FG002|STARTED|Overall Study||205
6420260|NCT00991458|7334588|FG000|COMPLETED|Overall Study||187
6420261|NCT00991458|7334589|FG001|COMPLETED|Overall Study||181
6420262|NCT00991458|7334590|FG002|COMPLETED|Overall Study||180
6420263|NCT00991458|7334588|FG000|NOT COMPLETED|Overall Study||20
6420264|NCT00991458|7334589|FG001|NOT COMPLETED|Overall Study||28
6420265|NCT00991458|7334590|FG002|NOT COMPLETED|Overall Study||25
6420266|NCT00991510|7334600|FG000|STARTED|Period I (Days 1-14)||22
6420267|NCT00991510|7334601|FG001|STARTED|Period I (Days 1-14)||21
6420268|NCT00991510|7334600|FG000|COMPLETED|Period I (Days 1-14)||21
6420269|NCT00991510|7334601|FG001|COMPLETED|Period I (Days 1-14)||21
6420270|NCT00991510|7334600|FG000|NOT COMPLETED|Period I (Days 1-14)||1
6420271|NCT00991510|7334601|FG001|NOT COMPLETED|Period I (Days 1-14)||0
6420272|NCT00991510|7334600|FG000|STARTED|Period II (Days 15-28)||21
6420273|NCT00991510|7334601|FG001|STARTED|Period II (Days 15-28)||21
6420274|NCT00991510|7334600|FG000|COMPLETED|Period II (Days 15-28)||21
6420275|NCT00991510|7334601|FG001|COMPLETED|Period II (Days 15-28)||21
6420276|NCT00991510|7334600|FG000|NOT COMPLETED|Period II (Days 15-28)||0
6420277|NCT00991510|7334601|FG001|NOT COMPLETED|Period II (Days 15-28)||0
6420278|NCT00991510|7334600|FG000|STARTED|Period III (Days 29-112)||21
6420279|NCT00991510|7334601|FG001|STARTED|Period III (Days 29-112)||21
6420280|NCT00991510|7334600|FG000|COMPLETED|Period III (Days 29-112)||20
6420281|NCT00991510|7334601|FG001|COMPLETED|Period III (Days 29-112)||20
6420282|NCT00991510|7334600|FG000|NOT COMPLETED|Period III (Days 29-112)||1
6420283|NCT00991510|7334601|FG001|NOT COMPLETED|Period III (Days 29-112)||1
6420284|NCT00991809|7334613|FG000|STARTED|Overall Study||12
6420285|NCT00991809|7334614|FG001|STARTED|Overall Study||10
6420286|NCT00991809|7334613|FG000|COMPLETED|Overall Study||8
6420287|NCT00991809|7334614|FG001|COMPLETED|Overall Study||4
6420288|NCT00991809|7334613|FG000|NOT COMPLETED|Overall Study||4
6420289|NCT00991809|7334614|FG001|NOT COMPLETED|Overall Study||6
6420290|NCT00991939|7334624|FG000|STARTED|Overall Study||5
6420291|NCT00991939|7334625|FG001|STARTED|Overall Study||3
6420292|NCT00991939|7334624|FG000|COMPLETED|Overall Study||0
6420293|NCT00991939|7334625|FG001|COMPLETED|Overall Study||1
6420294|NCT00991939|7334624|FG000|NOT COMPLETED|Overall Study||5
6420295|NCT00991939|7334625|FG001|NOT COMPLETED|Overall Study||2
6420296|NCT00991952|7334635|FG000|STARTED|Overall Study||13
6420297|NCT00991952|7334636|FG001|STARTED|Overall Study||6
6420298|NCT00991952|7334635|FG000|COMPLETED|Overall Study||13
6420299|NCT00991952|7334636|FG001|COMPLETED|Overall Study||5
6420300|NCT00991952|7334635|FG000|NOT COMPLETED|Overall Study||0
6420301|NCT00991952|7334636|FG001|NOT COMPLETED|Overall Study||1
6420302|NCT00992017|7334642|FG000|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
6420303|NCT00992017|7334642|FG000|Received Both Study Vaccinations|Overall Study||124
6420304|NCT00992017|7334642|FG000|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
6420305|NCT00992017|7334642|FG000|COMPLETED|Overall Study||118
6420306|NCT00992017|7334642|FG000|NOT COMPLETED|Overall Study||10
6420307|NCT00992056|7334653|FG000|STARTED|Treatment Period 1 (6 Weeks)||12
6420308|NCT00992056|7334654|FG001|STARTED|Treatment Period 1 (6 Weeks)||12
6420309|NCT00992056|7334653|FG000|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
6420310|NCT00992056|7334654|FG001|COMPLETED|Treatment Period 1 (6 Weeks)||10
6420311|NCT00992056|7334653|FG000|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
6420312|NCT00992056|7334654|FG001|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
6420313|NCT00992056|7334653|FG000|STARTED|Washout Period (2 Weeks)||11
6420314|NCT00992056|7334654|FG001|STARTED|Washout Period (2 Weeks)||10
6420315|NCT00992056|7334653|FG000|COMPLETED|Washout Period (2 Weeks)||10
6420316|NCT00992056|7334654|FG001|COMPLETED|Washout Period (2 Weeks)||10
6420317|NCT00992056|7334653|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
6420318|NCT00992056|7334654|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
6420319|NCT00992056|7334653|FG000|STARTED|Treatment Period 2 (6 Weeks)||10
6420320|NCT00992056|7334654|FG001|STARTED|Treatment Period 2 (6 Weeks)||10
6420321|NCT00992056|7334653|FG000|COMPLETED|Treatment Period 2 (6 Weeks)||10
6420322|NCT00992056|7334654|FG001|COMPLETED|Treatment Period 2 (6 Weeks)||10
6420323|NCT00992056|7334653|FG000|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
6420324|NCT00992056|7334654|FG001|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
6420325|NCT00992108|7334662|FG000|STARTED|Overall Study||7
6420326|NCT00992108|7334663|FG001|STARTED|Overall Study||10
6420327|NCT00992108|7334662|FG000|COMPLETED|Overall Study||7
6420328|NCT00992108|7334663|FG001|COMPLETED|Overall Study||9
6420329|NCT00992108|7334662|FG000|NOT COMPLETED|Overall Study||0
6420330|NCT00992108|7334663|FG001|NOT COMPLETED|Overall Study||1
6420331|NCT00992186|7334669|FG000|STARTED|Overall Study||46
6420332|NCT00992186|7334669|FG000|COMPLETED|Overall Study||0
6420333|NCT00992186|7334669|FG000|NOT COMPLETED|Overall Study||46
6420334|NCT00992225|7334674|FG000|STARTED|Overall Study||43
6420335|NCT00992225|7334674|FG000|Received at Least One Dose of Study Drug|Overall Study||33
6420336|NCT00992225|7334674|FG000|COMPLETED|Overall Study||33
6420337|NCT00992225|7334674|FG000|NOT COMPLETED|Overall Study||10
6420338|NCT00992264|7334694|FG000|STARTED|Overall Study||116
6420339|NCT00992264|7334695|FG001|STARTED|Overall Study||116
6420340|NCT00992264|7334696|FG002|STARTED|Overall Study||117
6420341|NCT00992264|7334697|FG003|STARTED|Overall Study||117
6420342|NCT00992264|7334698|FG004|STARTED|Overall Study||117
6420343|NCT00992264|7334699|FG005|STARTED|Overall Study||117
6420344|NCT00992264|7334700|FG006|STARTED|Overall Study||116
6420345|NCT00992264|7334701|FG007|STARTED|Overall Study||117
6420346|NCT00992264|7334702|FG008|STARTED|Overall Study||116
6420347|NCT00992264|7334703|FG009|STARTED|Overall Study||116
6420348|NCT00992264|7334704|FG010|STARTED|Overall Study||117
6420349|NCT00992264|7334705|FG011|STARTED|Overall Study||117
6420350|NCT00992264|7334706|FG012|STARTED|Overall Study||116
6420351|NCT00992264|7334707|FG013|STARTED|Overall Study||117
6420352|NCT00992264|7334708|FG014|STARTED|Overall Study||117
6420353|NCT00992264|7334709|FG015|STARTED|Overall Study||116
6420354|NCT00992264|7334694|FG000|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6420355|NCT00992264|7334695|FG001|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6420356|NCT00992264|7334696|FG002|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420357|NCT00992264|7334697|FG003|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420358|NCT00992264|7334698|FG004|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420359|NCT00992264|7334699|FG005|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420360|NCT00992264|7334700|FG006|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6420361|NCT00992264|7334701|FG007|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420362|NCT00992264|7334702|FG008|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6420363|NCT00992264|7334703|FG009|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6420364|NCT00992264|7334704|FG010|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420365|NCT00992264|7334705|FG011|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420366|NCT00992264|7334706|FG012|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6420367|NCT00992264|7334707|FG013|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420368|NCT00992264|7334708|FG014|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
6420369|NCT00992264|7334709|FG015|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
6420370|NCT00992264|7334694|FG000|NOT COMPLETED|Overall Study||0
6420371|NCT00992264|7334695|FG001|NOT COMPLETED|Overall Study||0
6420372|NCT00992264|7334696|FG002|NOT COMPLETED|Overall Study||0
6420373|NCT00992264|7334697|FG003|NOT COMPLETED|Overall Study||0
6420374|NCT00992264|7334698|FG004|NOT COMPLETED|Overall Study||0
6420375|NCT00992264|7334699|FG005|NOT COMPLETED|Overall Study||0
6420376|NCT00992264|7334700|FG006|NOT COMPLETED|Overall Study||0
6420377|NCT00992264|7334701|FG007|NOT COMPLETED|Overall Study||0
6420378|NCT00992264|7334702|FG008|NOT COMPLETED|Overall Study||0
6420379|NCT00992264|7334703|FG009|NOT COMPLETED|Overall Study||0
6420380|NCT00992264|7334704|FG010|NOT COMPLETED|Overall Study||0
6420381|NCT00992264|7334705|FG011|NOT COMPLETED|Overall Study||0
6420382|NCT00992264|7334706|FG012|NOT COMPLETED|Overall Study||0
6420383|NCT00992264|7334707|FG013|NOT COMPLETED|Overall Study||0
6420384|NCT00992264|7334708|FG014|NOT COMPLETED|Overall Study||0
6639989|NCT02331589|7568187|FG000|COMPLETED|Overall Study||34
6639990|NCT02331589|7568188|FG001|COMPLETED|Overall Study||31
6639991|NCT02331589|7568187|FG000|NOT COMPLETED|Overall Study||5
6639992|NCT02331589|7568188|FG001|NOT COMPLETED|Overall Study||5
6639993|NCT02331680|7568197|FG000|STARTED|Overall Study||40
6639994|NCT02331680|7568198|FG001|STARTED|Overall Study||40
6639995|NCT02331680|7568199|FG002|STARTED|Overall Study||44
6639996|NCT02331680|7568197|FG000|COMPLETED|Overall Study||34
6639997|NCT02331680|7568198|FG001|COMPLETED|Overall Study||36
6420385|NCT00992264|7334709|FG015|NOT COMPLETED|Overall Study||0
6420386|NCT00992394|7334722|FG000|STARTED|Overall Study||88
6420387|NCT00992394|7334723|FG001|STARTED|Overall Study||86
6420388|NCT00992394|7334722|FG000|Safety Population|Overall Study||87
6420389|NCT00992394|7334723|FG001|Safety Population|Overall Study||84
6420390|NCT00992394|7334722|FG000|mITT Population|Overall Study||86
6420391|NCT00992394|7334723|FG001|mITT Population|Overall Study||84
6420392|NCT00992394|7334722|FG000|COMPLETED|Overall Study||64
6420393|NCT00992394|7334723|FG001|COMPLETED|Overall Study||72
6420394|NCT00992394|7334722|FG000|NOT COMPLETED|Overall Study||24
6420395|NCT00992394|7334723|FG001|NOT COMPLETED|Overall Study||14
6420396|NCT00992407|7334731|FG000|STARTED|Overall Study||37
6420397|NCT00992407|7334732|FG001|STARTED|Overall Study||38
6420398|NCT00992407|7334731|FG000|Treated|Overall Study||20
6420399|NCT00992407|7334732|FG001|Treated|Overall Study||25
6420400|NCT00992407|7334731|FG000|COMPLETED|Overall Study||6
6639998|NCT02331680|7568199|FG002|COMPLETED|Overall Study||29
6639999|NCT02331680|7568197|FG000|NOT COMPLETED|Overall Study||6
6640000|NCT02331680|7568198|FG001|NOT COMPLETED|Overall Study||4
6420401|NCT00992407|7334732|FG001|COMPLETED|Overall Study||14
6420402|NCT00992407|7334731|FG000|NOT COMPLETED|Overall Study||31
6420403|NCT00992407|7334732|FG001|NOT COMPLETED|Overall Study||24
6420404|NCT00992433|7334743|FG000|STARTED|Overall Study||95
6420405|NCT00992433|7334744|FG001|STARTED|Overall Study||97
6420406|NCT00992433|7334743|FG000|COMPLETED|Overall Study||91
6420407|NCT00992433|7334744|FG001|COMPLETED|Overall Study||90
6420408|NCT00992433|7334743|FG000|NOT COMPLETED|Overall Study||4
6420409|NCT00992433|7334744|FG001|NOT COMPLETED|Overall Study||7
6420410|NCT00992446|7334750|FG000|STARTED|Overall Study||27
6420411|NCT00992446|7334750|FG000|COMPLETED|Overall Study||19
6420412|NCT00992446|7334750|FG000|NOT COMPLETED|Overall Study||8
6420413|NCT00992459|7334756|FG000|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
6420414|NCT00992459|7334757|FG001|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
6420415|NCT00992459|7334756|FG000|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
6420416|NCT00992459|7334757|FG001|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
6420417|NCT00992459|7334756|FG000|NOT COMPLETED|Overall Study||1
6420418|NCT00992459|7334757|FG001|NOT COMPLETED|Overall Study||1
6420419|NCT00992511|7334767|FG000|STARTED|Overall Study||76
6420420|NCT00992511|7334768|FG001|STARTED|Overall Study||73
6420421|NCT00992511|7334769|FG002|STARTED|Overall Study||76
6420422|NCT00992511|7334770|FG003|STARTED|Overall Study||75
6420423|NCT00992511|7334767|FG000|COMPLETED|Overall Study||74
6420424|NCT00992511|7334768|FG001|COMPLETED|Overall Study||73
6420425|NCT00992511|7334769|FG002|COMPLETED|Overall Study||74
6420426|NCT00992511|7334770|FG003|COMPLETED|Overall Study||70
6420427|NCT00992511|7334767|FG000|NOT COMPLETED|Overall Study||2
6420428|NCT00992511|7334768|FG001|NOT COMPLETED|Overall Study||0
6420429|NCT00992511|7334769|FG002|NOT COMPLETED|Overall Study||2
6420430|NCT00992511|7334770|FG003|NOT COMPLETED|Overall Study||5
6420431|NCT00992589|7334780|FG000|STARTED|Open-Label Phase||344
6420432|NCT00992589|7334781|FG001|STARTED|Open-Label Phase||0
6420433|NCT00992589|7334782|FG002|STARTED|Open-Label Phase||0
6420434|NCT00992589|7334783|FG003|STARTED|Open-Label Phase||0
6420435|NCT00992589|7334780|FG000|COMPLETED|Open-Label Phase||267
6420436|NCT00992589|7334781|FG001|COMPLETED|Open-Label Phase||0
6420437|NCT00992589|7334782|FG002|COMPLETED|Open-Label Phase||0
6420438|NCT00992589|7334783|FG003|COMPLETED|Open-Label Phase||0
6420439|NCT00992589|7334780|FG000|NOT COMPLETED|Open-Label Phase||77
6420440|NCT00992589|7334781|FG001|NOT COMPLETED|Open-Label Phase||0
6420441|NCT00992589|7334782|FG002|NOT COMPLETED|Open-Label Phase||0
6420442|NCT00992589|7334783|FG003|NOT COMPLETED|Open-Label Phase||0
6420443|NCT00992589|7334780|FG000|STARTED|Double-Blind Phase||0
6420444|NCT00992589|7334781|FG001|STARTED|Double-Blind Phase||89
6420445|NCT00992589|7334782|FG002|STARTED|Double-Blind Phase||90
6420446|NCT00992589|7334783|FG003|STARTED|Double-Blind Phase||88
6420447|NCT00992589|7334780|FG000|COMPLETED|Double-Blind Phase||0
6420448|NCT00992589|7334781|FG001|COMPLETED|Double-Blind Phase||76
6420449|NCT00992589|7334782|FG002|COMPLETED|Double-Blind Phase||77
6420450|NCT00992589|7334783|FG003|COMPLETED|Double-Blind Phase||78
6420451|NCT00992589|7334780|FG000|NOT COMPLETED|Double-Blind Phase||0
6420452|NCT00992589|7334781|FG001|NOT COMPLETED|Double-Blind Phase||13
6420453|NCT00992589|7334782|FG002|NOT COMPLETED|Double-Blind Phase||13
6420454|NCT00992589|7334783|FG003|NOT COMPLETED|Double-Blind Phase||10
6420455|NCT00992602|7334801|FG000|STARTED|Overall Study||3
6420456|NCT00992602|7334801|FG000|COMPLETED|Overall Study||0
6640001|NCT02331680|7568199|FG002|NOT COMPLETED|Overall Study||15
6640002|NCT02331940|7568209|FG000|STARTED|Overall Study||100
6640003|NCT02331940|7568210|FG001|STARTED|Overall Study||100
6640004|NCT02331940|7568209|FG000|COMPLETED|Overall Study||93
6640005|NCT02331940|7568210|FG001|COMPLETED|Overall Study||95
6640006|NCT02331940|7568209|FG000|NOT COMPLETED|Overall Study||7
6640007|NCT02331940|7568210|FG001|NOT COMPLETED|Overall Study||5
6640008|NCT02331992|7568216|FG000|STARTED|Overall Study||34
6640009|NCT02331992|7568216|FG000|COMPLETED|Overall Study||34
6640010|NCT02331992|7568216|FG000|NOT COMPLETED|Overall Study||0
6640011|NCT02332239|7568222|FG000|STARTED|Overall Study||58
6640012|NCT02332239|7568223|FG001|STARTED|Overall Study||58
6640013|NCT02332239|7568222|FG000|COMPLETED|Overall Study||54
6640014|NCT02332239|7568223|FG001|COMPLETED|Overall Study||52
6640015|NCT02332239|7568222|FG000|NOT COMPLETED|Overall Study||4
6640016|NCT02332239|7568223|FG001|NOT COMPLETED|Overall Study||6
6640017|NCT02332291|7568233|FG000|STARTED|Phase 1: Blinded Escitalopram or Placebo||63
6640018|NCT02332291|7568234|FG001|STARTED|Phase 1: Blinded Escitalopram or Placebo||32
6640019|NCT02332291|7568233|FG000|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||59
6640020|NCT02332291|7568234|FG001|COMPLETED|Phase 1: Blinded Escitalopram or Placebo||23
6640021|NCT02332291|7568233|FG000|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||4
6640022|NCT02332291|7568234|FG001|NOT COMPLETED|Phase 1: Blinded Escitalopram or Placebo||9
6640023|NCT02332291|7568233|FG000|STARTED|Phase 2: Open-Label Bupropion||22
6420457|NCT00992602|7334801|FG000|NOT COMPLETED|Overall Study||3
6420458|NCT00992719|7334808|FG000|STARTED|Overall Study||28
6420459|NCT00992719|7334809|FG001|STARTED|Overall Study||28
6420460|NCT00992719|7334810|FG002|STARTED|Overall Study||28
6420461|NCT00992719|7334808|FG000|COMPLETED|Overall Study||27
6640024|NCT02332291|7568234|FG001|STARTED|Phase 2: Open-Label Bupropion||19
6640025|NCT02332291|7568233|FG000|COMPLETED|Phase 2: Open-Label Bupropion||19
6420462|NCT00992719|7334809|FG001|COMPLETED|Overall Study||27
6420463|NCT00992719|7334810|FG002|COMPLETED|Overall Study||28
6420464|NCT00992719|7334808|FG000|NOT COMPLETED|Overall Study||1
6420465|NCT00992719|7334809|FG001|NOT COMPLETED|Overall Study||1
6420466|NCT00992719|7334810|FG002|NOT COMPLETED|Overall Study||0
6420467|NCT00992784|7334821|FG000|STARTED|Overall Study||180
6420468|NCT00992784|7334822|FG001|STARTED|Overall Study||104
6420469|NCT00992784|7334823|FG002|STARTED|Overall Study||86
6420470|NCT00992784|7334821|FG000|COMPLETED|Overall Study||177
6420471|NCT00992784|7334822|FG001|COMPLETED|Overall Study||102
6420472|NCT00992784|7334823|FG002|COMPLETED|Overall Study||85
6420473|NCT00992784|7334821|FG000|NOT COMPLETED|Overall Study||3
6420474|NCT00992784|7334822|FG001|NOT COMPLETED|Overall Study||2
6420475|NCT00992784|7334823|FG002|NOT COMPLETED|Overall Study||1
6420476|NCT00992836|7334831|FG000|STARTED|Overall Study||155
6420477|NCT00992836|7334831|FG000|Received Both Study Vaccinations|Overall Study||150
6420478|NCT00992836|7334831|FG000|COMPLETED|Overall Study||150
6420479|NCT00992836|7334831|FG000|NOT COMPLETED|Overall Study||5
6420480|NCT00992927|7334843|FG000|STARTED|Overall Study||32
6420481|NCT00992927|7334844|FG001|STARTED|Overall Study||22
6420482|NCT00992927|7334843|FG000|COMPLETED|Overall Study||32
6420483|NCT00992927|7334844|FG001|COMPLETED|Overall Study||22
6420484|NCT00992927|7334843|FG000|NOT COMPLETED|Overall Study||0
6420485|NCT00992927|7334844|FG001|NOT COMPLETED|Overall Study||0
6420486|NCT00992992|7334850|FG000|STARTED|Overall Study||25
6420487|NCT00992992|7334850|FG000|COMPLETED|Overall Study||0
6420488|NCT00992992|7334850|FG000|NOT COMPLETED|Overall Study||25
6420489|NCT00993031|7334856|FG000|STARTED|Overall Study||195
6420490|NCT00993031|7334857|FG001|STARTED|Overall Study||194
6420491|NCT00993031|7334856|FG000|Delivered|Overall Study||187
6420492|NCT00993031|7334857|FG001|Delivered|Overall Study||190
6420493|NCT00993031|7334856|FG000|COMPLETED|Overall Study||173
6420494|NCT00993031|7334857|FG001|COMPLETED|Overall Study||175
6420495|NCT00993031|7334856|FG000|NOT COMPLETED|Overall Study||22
6420496|NCT00993031|7334857|FG001|NOT COMPLETED|Overall Study||19
6420497|NCT00993044|7334867|FG000|STARTED|Irinotecan 30 mg||6
6420498|NCT00993044|7334867|FG000|COMPLETED|Irinotecan 30 mg||6
6420499|NCT00993044|7334867|FG000|NOT COMPLETED|Irinotecan 30 mg||0
6420500|NCT00993044|7334867|FG000|STARTED|Irinotecan 50 mg||7
6420501|NCT00993044|7334867|FG000|COMPLETED|Irinotecan 50 mg||6
6420502|NCT00993044|7334867|FG000|NOT COMPLETED|Irinotecan 50 mg||1
6420503|NCT00993148|7334872|FG000|STARTED|Overall Study||25
6420504|NCT00993148|7334872|FG000|COMPLETED|Overall Study||22
6420505|NCT00993148|7334872|FG000|NOT COMPLETED|Overall Study||3
6420506|NCT00993187|7334878|FG000|STARTED|Overall Study||147
6420507|NCT00993187|7334879|FG001|STARTED|Overall Study||145
6420508|NCT00993187|7334878|FG000|Received at Least 1 Dose of Study Drug|Overall Study||146
6420509|NCT00993187|7334879|FG001|Received at Least 1 Dose of Study Drug|Overall Study||144
6420510|NCT00993187|7334878|FG000|COMPLETED|Overall Study||121
6420511|NCT00993187|7334879|FG001|COMPLETED|Overall Study||108
6420512|NCT00993187|7334878|FG000|NOT COMPLETED|Overall Study||26
6420513|NCT00993187|7334879|FG001|NOT COMPLETED|Overall Study||37
6420514|NCT00993200|7334887|FG000|STARTED|Overall Study||13
6420515|NCT00993200|7334888|FG001|STARTED|Overall Study||13
6420516|NCT00993200|7334887|FG000|COMPLETED|Overall Study||13
6420517|NCT00993200|7334888|FG001|COMPLETED|Overall Study||13
6420518|NCT00993200|7334887|FG000|NOT COMPLETED|Overall Study||0
6420519|NCT00993200|7334888|FG001|NOT COMPLETED|Overall Study||0
6420520|NCT00993226|7334899|FG000|STARTED|Overall Study||61
6420521|NCT00993226|7334900|FG001|STARTED|Overall Study||27
6420522|NCT00993226|7334901|FG002|STARTED|Overall Study||27
6420523|NCT00993226|7334899|FG000|COMPLETED|Overall Study||60
6420524|NCT00993226|7334900|FG001|COMPLETED|Overall Study||26
6420525|NCT00993226|7334901|FG002|COMPLETED|Overall Study||27
6420526|NCT00993226|7334899|FG000|NOT COMPLETED|Overall Study||1
6420527|NCT00993226|7334900|FG001|NOT COMPLETED|Overall Study||1
6420528|NCT00993226|7334901|FG002|NOT COMPLETED|Overall Study||0
6420529|NCT00993265|7334911|FG000|STARTED|Overall Study||20
6420530|NCT00993265|7334912|FG001|STARTED|Overall Study||19
6420531|NCT00993265|7334911|FG000|COMPLETED|Overall Study||16
6420532|NCT00993265|7334912|FG001|COMPLETED|Overall Study||19
6420533|NCT00993265|7334911|FG000|NOT COMPLETED|Overall Study||4
6420534|NCT00993265|7334912|FG001|NOT COMPLETED|Overall Study||0
6420535|NCT00993291|7334918|FG000|STARTED|Overall Study||20
6420536|NCT00993291|7334918|FG000|COMPLETED|Overall Study||19
6420537|NCT00993291|7334918|FG000|NOT COMPLETED|Overall Study||1
6420538|NCT00993317|7334924|FG000|STARTED|Overall Study||42
6420539|NCT00993317|7334925|FG001|STARTED|Overall Study||85
6420540|NCT00993317|7334924|FG000|COMPLETED|Overall Study||21
6420541|NCT00993317|7334925|FG001|COMPLETED|Overall Study||60
6420542|NCT00993317|7334924|FG000|NOT COMPLETED|Overall Study||21
6420543|NCT00993317|7334925|FG001|NOT COMPLETED|Overall Study||25
6420544|NCT00993421|7334938|FG000|STARTED|Overall Study||49
6420545|NCT00993421|7334939|FG001|STARTED|Overall Study||49
6420546|NCT00993421|7334940|FG002|STARTED|Overall Study||48
6420547|NCT00993421|7334941|FG003|STARTED|Overall Study||49
6420548|NCT00993421|7334942|FG004|STARTED|Overall Study||52
6420549|NCT00993421|7334943|FG005|STARTED|Overall Study||50
6420550|NCT00993421|7334944|FG006|STARTED|Overall Study||46
6420551|NCT00993421|7334938|FG000|COMPLETED|Overall Study||5
6420552|NCT00993421|7334939|FG001|COMPLETED|Overall Study||4
6420553|NCT00993421|7334940|FG002|COMPLETED|Overall Study||5
6420554|NCT00993421|7334941|FG003|COMPLETED|Overall Study||4
6420555|NCT00993421|7334942|FG004|COMPLETED|Overall Study||6
6420556|NCT00993421|7334943|FG005|COMPLETED|Overall Study||4
6420557|NCT00993421|7334944|FG006|COMPLETED|Overall Study||4
6420558|NCT00993421|7334938|FG000|NOT COMPLETED|Overall Study||44
6420559|NCT00993421|7334939|FG001|NOT COMPLETED|Overall Study||45
6420560|NCT00993421|7334940|FG002|NOT COMPLETED|Overall Study||43
6420561|NCT00993421|7334941|FG003|NOT COMPLETED|Overall Study||45
6420562|NCT00993421|7334942|FG004|NOT COMPLETED|Overall Study||46
6420563|NCT00993421|7334943|FG005|NOT COMPLETED|Overall Study||46
6420564|NCT00993421|7334944|FG006|NOT COMPLETED|Overall Study||42
6420565|NCT00993473|7334962|FG000|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
6420566|NCT00993473|7334963|FG001|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
6420567|NCT00993473|7334962|FG000|COMPLETED|Overall Study||57
6420568|NCT00993473|7334963|FG001|COMPLETED|Overall Study||54
6420569|NCT00993473|7334962|FG000|NOT COMPLETED|Overall Study||4
6420570|NCT00993473|7334963|FG001|NOT COMPLETED|Overall Study||10
6420571|NCT00993499|7334975|FG000|STARTED|Run-in Period (8 Days)||13
6420572|NCT00993499|7334976|FG001|STARTED|Run-in Period (8 Days)||12
6420573|NCT00993499|7334977|FG002|STARTED|Run-in Period (8 Days)||10
6420574|NCT00993499|7334978|FG003|STARTED|Run-in Period (8 Days)||3
6420575|NCT00993499|7334979|FG004|STARTED|Run-in Period (8 Days)||3
6420576|NCT00993499|7334980|FG005|STARTED|Run-in Period (8 Days)||3
6420577|NCT00993499|7334975|FG000|COMPLETED|Run-in Period (8 Days)||12
6420578|NCT00993499|7334976|FG001|COMPLETED|Run-in Period (8 Days)||9
6420579|NCT00993499|7334977|FG002|COMPLETED|Run-in Period (8 Days)||9
6420580|NCT00993499|7334978|FG003|COMPLETED|Run-in Period (8 Days)||3
6420581|NCT00993499|7334979|FG004|COMPLETED|Run-in Period (8 Days)||3
6420582|NCT00993499|7334980|FG005|COMPLETED|Run-in Period (8 Days)||3
6420583|NCT00993499|7334975|FG000|NOT COMPLETED|Run-in Period (8 Days)||1
6420584|NCT00993499|7334976|FG001|NOT COMPLETED|Run-in Period (8 Days)||3
6420585|NCT00993499|7334977|FG002|NOT COMPLETED|Run-in Period (8 Days)||1
6420586|NCT00993499|7334978|FG003|NOT COMPLETED|Run-in Period (8 Days)||0
6420587|NCT00993499|7334979|FG004|NOT COMPLETED|Run-in Period (8 Days)||0
6420588|NCT00993499|7334980|FG005|NOT COMPLETED|Run-in Period (8 Days)||0
6420589|NCT00993499|7334975|FG000|STARTED|Discontinued Before Starting Course 3||12
6420590|NCT00993499|7334976|FG001|STARTED|Discontinued Before Starting Course 3||9
6420591|NCT00993499|7334977|FG002|STARTED|Discontinued Before Starting Course 3||9
6420592|NCT00993499|7334978|FG003|STARTED|Discontinued Before Starting Course 3||3
6420593|NCT00993499|7334979|FG004|STARTED|Discontinued Before Starting Course 3||3
6420594|NCT00993499|7334980|FG005|STARTED|Discontinued Before Starting Course 3||3
6420595|NCT00993499|7334975|FG000|COMPLETED|Discontinued Before Starting Course 3||8
6420596|NCT00993499|7334976|FG001|COMPLETED|Discontinued Before Starting Course 3||5
6420597|NCT00993499|7334977|FG002|COMPLETED|Discontinued Before Starting Course 3||6
6420598|NCT00993499|7334978|FG003|COMPLETED|Discontinued Before Starting Course 3||2
6420599|NCT00993499|7334979|FG004|COMPLETED|Discontinued Before Starting Course 3||3
6420600|NCT00993499|7334980|FG005|COMPLETED|Discontinued Before Starting Course 3||3
6420601|NCT00993499|7334975|FG000|NOT COMPLETED|Discontinued Before Starting Course 3||4
6420602|NCT00993499|7334976|FG001|NOT COMPLETED|Discontinued Before Starting Course 3||4
6420603|NCT00993499|7334977|FG002|NOT COMPLETED|Discontinued Before Starting Course 3||3
6420604|NCT00993499|7334978|FG003|NOT COMPLETED|Discontinued Before Starting Course 3||1
6420605|NCT00993499|7334979|FG004|NOT COMPLETED|Discontinued Before Starting Course 3||0
6420606|NCT00993499|7334980|FG005|NOT COMPLETED|Discontinued Before Starting Course 3||0
6420607|NCT00993499|7334975|FG000|STARTED|Discontinued After Starting Course 3||12
6420608|NCT00993499|7334976|FG001|STARTED|Discontinued After Starting Course 3||9
6420609|NCT00993499|7334977|FG002|STARTED|Discontinued After Starting Course 3||9
6420610|NCT00993499|7334978|FG003|STARTED|Discontinued After Starting Course 3||3
6420611|NCT00993499|7334979|FG004|STARTED|Discontinued After Starting Course 3||3
6420612|NCT00993499|7334980|FG005|STARTED|Discontinued After Starting Course 3||3
6420613|NCT00993499|7334975|FG000|COMPLETED|Discontinued After Starting Course 3||4
6420614|NCT00993499|7334976|FG001|COMPLETED|Discontinued After Starting Course 3||4
6420615|NCT00993499|7334977|FG002|COMPLETED|Discontinued After Starting Course 3||3
6420616|NCT00993499|7334978|FG003|COMPLETED|Discontinued After Starting Course 3||1
6420617|NCT00993499|7334979|FG004|COMPLETED|Discontinued After Starting Course 3||0
6420618|NCT00993499|7334980|FG005|COMPLETED|Discontinued After Starting Course 3||0
6420619|NCT00993499|7334975|FG000|NOT COMPLETED|Discontinued After Starting Course 3||8
6420620|NCT00993499|7334976|FG001|NOT COMPLETED|Discontinued After Starting Course 3||5
6420621|NCT00993499|7334977|FG002|NOT COMPLETED|Discontinued After Starting Course 3||6
6420622|NCT00993499|7334978|FG003|NOT COMPLETED|Discontinued After Starting Course 3||2
6420623|NCT00993499|7334979|FG004|NOT COMPLETED|Discontinued After Starting Course 3||3
6420624|NCT00993499|7334980|FG005|NOT COMPLETED|Discontinued After Starting Course 3||3
6420625|NCT00993616|7334994|FG000|STARTED|Overall Study||29
6420626|NCT00993616|7334994|FG000|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
6420627|NCT00993616|7334994|FG000|NOT COMPLETED|Overall Study||2
6420628|NCT00993655|7335007|FG000|STARTED|Overall Study||101
6420629|NCT00993655|7335008|FG001|STARTED|Overall Study||72
6420630|NCT00993655|7335009|FG002|STARTED|Overall Study||102
6420631|NCT00993655|7335007|FG000|COMPLETED|Overall Study||101
6420632|NCT00993655|7335008|FG001|COMPLETED|Overall Study||72
6420633|NCT00993655|7335009|FG002|COMPLETED|Overall Study||102
6420634|NCT00993655|7335007|FG000|NOT COMPLETED|Overall Study||0
6420635|NCT00993655|7335008|FG001|NOT COMPLETED|Overall Study||0
6420636|NCT00993655|7335009|FG002|NOT COMPLETED|Overall Study||0
6420637|NCT00993668|7335022|FG000|STARTED|Single-Blind Period||114
6420638|NCT00993668|7335023|FG001|STARTED|Single-Blind Period||110
6420639|NCT00993668|7335022|FG000|COMPLETED|Single-Blind Period||110
6420640|NCT00993668|7335023|FG001|COMPLETED|Single-Blind Period||107
6420641|NCT00993668|7335022|FG000|NOT COMPLETED|Single-Blind Period||4
6420642|NCT00993668|7335023|FG001|NOT COMPLETED|Single-Blind Period||3
6420643|NCT00993668|7335022|FG000|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
6420644|NCT00993668|7335023|FG001|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
6420645|NCT00993668|7335022|FG000|COMPLETED|Open-Label Period||86
6420646|NCT00993668|7335023|FG001|COMPLETED|Open-Label Period||91
6420647|NCT00993668|7335022|FG000|NOT COMPLETED|Open-Label Period||23
6420648|NCT00993668|7335023|FG001|NOT COMPLETED|Open-Label Period||15
6420649|NCT00993798|7335033|FG000|STARTED|Overall Study||53
6420650|NCT00993798|7335034|FG001|STARTED|Overall Study||25
6420651|NCT00993798|7335035|FG002|STARTED|Overall Study||29
6420652|NCT00993798|7335036|FG003|STARTED|Overall Study||0
6420653|NCT00993798|7335037|FG004|STARTED|Overall Study||0
6420654|NCT00993798|7335033|FG000|COMPLETED|Overall Study||53
6420655|NCT00993798|7335034|FG001|COMPLETED|Overall Study||25
6420656|NCT00993798|7335035|FG002|COMPLETED|Overall Study||29
6420657|NCT00993798|7335036|FG003|COMPLETED|Overall Study||0
6420658|NCT00993798|7335037|FG004|COMPLETED|Overall Study||0
6420659|NCT00993798|7335033|FG000|NOT COMPLETED|Overall Study||0
6420660|NCT00993798|7335034|FG001|NOT COMPLETED|Overall Study||0
6420661|NCT00993798|7335035|FG002|NOT COMPLETED|Overall Study||0
6420662|NCT00993798|7335036|FG003|NOT COMPLETED|Overall Study||0
6420663|NCT00993798|7335037|FG004|NOT COMPLETED|Overall Study||0
6420664|NCT00993824|7335047|FG000|STARTED|Overall Study||11
6420665|NCT00993824|7335048|FG001|STARTED|Overall Study||10
6420666|NCT00993824|7335047|FG000|COMPLETED|Overall Study||11
6420667|NCT00993824|7335048|FG001|COMPLETED|Overall Study||10
6420668|NCT00993824|7335047|FG000|NOT COMPLETED|Overall Study||0
6420669|NCT00993824|7335048|FG001|NOT COMPLETED|Overall Study||0
6420670|NCT00993915|7335056|FG000|STARTED|Overall Study||687
6420671|NCT00993915|7335056|FG000|COMPLETED|Overall Study||678
6420672|NCT00993915|7335056|FG000|NOT COMPLETED|Overall Study||9
6420673|NCT00993928|7335062|FG000|STARTED|Overall Study||48
6420674|NCT00993928|7335063|FG001|STARTED|Overall Study||45
6420675|NCT00993928|7335062|FG000|COMPLETED|Overall Study||43
6420676|NCT00993928|7335063|FG001|COMPLETED|Overall Study||38
6420677|NCT00993928|7335062|FG000|NOT COMPLETED|Overall Study||5
6420678|NCT00993928|7335063|FG001|NOT COMPLETED|Overall Study||7
6420679|NCT00993954|7335075|FG000|STARTED|Overall Study||145
6420680|NCT00993954|7335076|FG001|STARTED|Overall Study||123
6420681|NCT00993954|7335075|FG000|COMPLETED|Overall Study||124
6420682|NCT00993954|7335076|FG001|COMPLETED|Overall Study||121
6420683|NCT00993954|7335075|FG000|NOT COMPLETED|Overall Study||21
6420684|NCT00993954|7335076|FG001|NOT COMPLETED|Overall Study||2
6420685|NCT00993967|7335082|FG000|STARTED|Overall Study||200
6420686|NCT00993967|7335082|FG000|COMPLETED|Overall Study||139
6420687|NCT00993967|7335082|FG000|NOT COMPLETED|Overall Study||61
6420688|NCT00994110|7335088|FG000|STARTED|Overall Study||217
6420689|NCT00994110|7335089|FG001|STARTED|Overall Study||222
6420690|NCT00994110|7335088|FG000|COMPLETED|Overall Study||152
6420691|NCT00994110|7335089|FG001|COMPLETED|Overall Study||148
6420692|NCT00994110|7335088|FG000|NOT COMPLETED|Overall Study||65
6420693|NCT00994110|7335089|FG001|NOT COMPLETED|Overall Study||74
6420694|NCT00994123|7335098|FG000|STARTED|Overall Study||33
6420695|NCT00994123|7335099|FG001|STARTED|Overall Study||85
6420696|NCT00994123|7335100|FG002|STARTED|Overall Study||44
6420697|NCT00994123|7335098|FG000|COMPLETED|Overall Study||33
6420698|NCT00994123|7335099|FG001|COMPLETED|Overall Study||85
6420699|NCT00994123|7335100|FG002|COMPLETED|Overall Study||44
6420700|NCT00994123|7335098|FG000|NOT COMPLETED|Overall Study||0
6420701|NCT00994123|7335099|FG001|NOT COMPLETED|Overall Study||0
6420702|NCT00994123|7335100|FG002|NOT COMPLETED|Overall Study||0
6420703|NCT00994175|7335119|FG000|STARTED|First Intervention||6
6420704|NCT00994175|7335120|FG001|STARTED|First Intervention||9
6420705|NCT00994175|7335119|FG000|COMPLETED|First Intervention||4
6420706|NCT00994175|7335120|FG001|COMPLETED|First Intervention||8
6420707|NCT00994175|7335119|FG000|NOT COMPLETED|First Intervention||2
6420708|NCT00994175|7335120|FG001|NOT COMPLETED|First Intervention||1
6420709|NCT00994175|7335119|FG000|STARTED|Second Intervention||4
6420710|NCT00994175|7335120|FG001|STARTED|Second Intervention||8
6420711|NCT00994175|7335119|FG000|COMPLETED|Second Intervention||4
6420712|NCT00994175|7335120|FG001|COMPLETED|Second Intervention||8
6420713|NCT00994175|7335119|FG000|NOT COMPLETED|Second Intervention||0
6420714|NCT00994175|7335120|FG001|NOT COMPLETED|Second Intervention||0
6420715|NCT00994214|7335130|FG000|STARTED|ITT (Intention-to-Treat) - Part A||19
6420716|NCT00994214|7335131|FG001|STARTED|ITT (Intention-to-Treat) - Part A||19
6420717|NCT00994214|7335132|FG002|STARTED|ITT (Intention-to-Treat) - Part A||18
6420718|NCT00994214|7335133|FG003|STARTED|ITT (Intention-to-Treat) - Part A||20
6420719|NCT00994214|7335130|FG000|COMPLETED|ITT (Intention-to-Treat) - Part A||5
6420720|NCT00994214|7335131|FG001|COMPLETED|ITT (Intention-to-Treat) - Part A||6
6420721|NCT00994214|7335132|FG002|COMPLETED|ITT (Intention-to-Treat) - Part A||5
6420722|NCT00994214|7335133|FG003|COMPLETED|ITT (Intention-to-Treat) - Part A||5
6420723|NCT00994214|7335130|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
6420724|NCT00994214|7335131|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
6420725|NCT00994214|7335132|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
6420726|NCT00994214|7335133|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
6420727|NCT00994214|7335130|FG000|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
6420728|NCT00994214|7335131|FG001|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
6420729|NCT00994214|7335132|FG002|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
6420730|NCT00994214|7335133|FG003|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
6420731|NCT00994214|7335130|FG000|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
6420732|NCT00994214|7335131|FG001|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
6420733|NCT00994214|7335132|FG002|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
6420734|NCT00994214|7335133|FG003|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
6420735|NCT00994214|7335130|FG000|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
6420736|NCT00994214|7335131|FG001|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
6420737|NCT00994214|7335132|FG002|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
6420738|NCT00994214|7335133|FG003|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
6420739|NCT00994214|7335130|FG000|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
6420740|NCT00994214|7335131|FG001|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
6420741|NCT00994214|7335132|FG002|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
6420742|NCT00994214|7335133|FG003|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
6420743|NCT00994214|7335130|FG000|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
6420744|NCT00994214|7335131|FG001|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
6420745|NCT00994214|7335132|FG002|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
6420746|NCT00994214|7335133|FG003|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
6420747|NCT00994214|7335130|FG000|COMPLETED|ITT (Intention-to-Treat) - Part B||0
6420748|NCT00994214|7335131|FG001|COMPLETED|ITT (Intention-to-Treat) - Part B||0
6420749|NCT00994214|7335132|FG002|COMPLETED|ITT (Intention-to-Treat) - Part B||0
6420750|NCT00994214|7335133|FG003|COMPLETED|ITT (Intention-to-Treat) - Part B||0
6420751|NCT00994214|7335130|FG000|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
6420752|NCT00994214|7335131|FG001|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
6420753|NCT00994214|7335132|FG002|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
6420754|NCT00994214|7335133|FG003|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
6420755|NCT00994240|7335163|FG000|STARTED|Overall Study||41
6420756|NCT00994240|7335164|FG001|STARTED|Overall Study||44
6420757|NCT00994240|7335163|FG000|COMPLETED|Overall Study||35
6420758|NCT00994240|7335164|FG001|COMPLETED|Overall Study||39
6420759|NCT00994240|7335163|FG000|NOT COMPLETED|Overall Study||6
6420760|NCT00994240|7335164|FG001|NOT COMPLETED|Overall Study||5
6420761|NCT00994279|7335172|FG000|STARTED|Overall Study||22
6420762|NCT00994279|7335173|FG001|STARTED|Overall Study||18
6420763|NCT00994279|7335172|FG000|COMPLETED|Overall Study||18
6420764|NCT00994279|7335173|FG001|COMPLETED|Overall Study||13
6420765|NCT00994279|7335172|FG000|NOT COMPLETED|Overall Study||4
6420766|NCT00994279|7335173|FG001|NOT COMPLETED|Overall Study||5
6420767|NCT00994318|7335182|FG000|STARTED|Overall Study||155
6420768|NCT00994318|7335183|FG001|STARTED|Overall Study||154
6420769|NCT00994318|7335184|FG002|STARTED|Overall Study||317
6420770|NCT00994318|7335182|FG000|COMPLETED|Overall Study||133
6420771|NCT00994318|7335183|FG001|COMPLETED|Overall Study||136
6420772|NCT00994318|7335184|FG002|COMPLETED|Overall Study||250
6420773|NCT00994318|7335182|FG000|NOT COMPLETED|Overall Study||22
6420774|NCT00994318|7335183|FG001|NOT COMPLETED|Overall Study||18
6420775|NCT00994318|7335184|FG002|NOT COMPLETED|Overall Study||67
6420776|NCT00994422|7335194|FG000|STARTED|Overall Study||192
6420777|NCT00994422|7335195|FG001|STARTED|Overall Study||55
6420778|NCT00994422|7335194|FG000|COMPLETED|Overall Study||185
6420779|NCT00994422|7335195|FG001|COMPLETED|Overall Study||54
6420780|NCT00994422|7335194|FG000|NOT COMPLETED|Overall Study||7
6420781|NCT00994422|7335195|FG001|NOT COMPLETED|Overall Study||1
6420782|NCT00994448|7335205|FG000|STARTED|Overall Study||12
6420783|NCT00994448|7335206|FG001|STARTED|Overall Study||7
6420784|NCT00994448|7335205|FG000|COMPLETED|Overall Study||4
6420785|NCT00994448|7335206|FG001|COMPLETED|Overall Study||5
6420786|NCT00994448|7335205|FG000|NOT COMPLETED|Overall Study||8
6420787|NCT00994448|7335206|FG001|NOT COMPLETED|Overall Study||2
6420788|NCT00994461|7335215|FG000|STARTED|Overall Study||76
6420789|NCT00994461|7335216|FG001|STARTED|Overall Study||76
6420790|NCT00994461|7335217|FG002|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
6420791|NCT00994461|7335215|FG000|COMPLETED|Overall Study||74
6420792|NCT00994461|7335216|FG001|COMPLETED|Overall Study||75
6420793|NCT00994461|7335217|FG002|COMPLETED|Overall Study||37
6420794|NCT00994461|7335215|FG000|NOT COMPLETED|Overall Study||2
6420795|NCT00994461|7335216|FG001|NOT COMPLETED|Overall Study||1
6420796|NCT00994461|7335217|FG002|NOT COMPLETED|Overall Study||0
6420797|NCT00994604|7335225|FG000|STARTED|Overall Study||51
6420798|NCT00994604|7335225|FG000|COMPLETED|Overall Study||45
6420799|NCT00994604|7335225|FG000|NOT COMPLETED|Overall Study||6
6420800|NCT00994643|7335232|FG000|STARTED|Overall Study||11
6420801|NCT00994643|7335232|FG000|COMPLETED|Overall Study||10
6420802|NCT00994643|7335232|FG000|NOT COMPLETED|Overall Study||1
6420803|NCT00994682|7335238|FG000|STARTED|Double Bilnd||51
6420804|NCT00994682|7335239|FG001|STARTED|Double Bilnd||50
6420805|NCT00994682|7335238|FG000|COMPLETED|Double Bilnd||42
6420806|NCT00994682|7335239|FG001|COMPLETED|Double Bilnd||41
6420807|NCT00994682|7335238|FG000|NOT COMPLETED|Double Bilnd||9
6420808|NCT00994682|7335239|FG001|NOT COMPLETED|Double Bilnd||9
6420809|NCT00994682|7335238|FG000|STARTED|Pioglitazone Open Label||42
6420810|NCT00994682|7335239|FG001|STARTED|Pioglitazone Open Label||41
6420811|NCT00994682|7335238|FG000|COMPLETED|Pioglitazone Open Label||29
6420812|NCT00994682|7335239|FG001|COMPLETED|Pioglitazone Open Label||34
6420813|NCT00994682|7335238|FG000|NOT COMPLETED|Pioglitazone Open Label||13
6420814|NCT00994682|7335239|FG001|NOT COMPLETED|Pioglitazone Open Label||7
6420815|NCT00994760|7335249|FG000|STARTED|Overall Study||131
6420816|NCT00994760|7335249|FG000|COMPLETED|Overall Study||107
6420817|NCT00994760|7335249|FG000|NOT COMPLETED|Overall Study||24
6420818|NCT00994890|7335270|FG000|STARTED|Overall Study||231
6420819|NCT00994890|7335271|FG001|STARTED|Overall Study||222
6420820|NCT00994890|7335272|FG002|STARTED|Overall Study||226
6420821|NCT00994890|7335270|FG000|Treated|Overall Study||230
6420822|NCT00994890|7335271|FG001|Treated|Overall Study||222
6420823|NCT00994890|7335272|FG002|Treated|Overall Study||226
6420824|NCT00994890|7335270|FG000|COMPLETED|Overall Study||0
6420825|NCT00994890|7335271|FG001|COMPLETED|Overall Study||0
6420826|NCT00994890|7335272|FG002|COMPLETED|Overall Study||0
6420827|NCT00994890|7335270|FG000|NOT COMPLETED|Overall Study||231
6420828|NCT00994890|7335271|FG001|NOT COMPLETED|Overall Study||222
6420829|NCT00994890|7335272|FG002|NOT COMPLETED|Overall Study||226
6420830|NCT00994929|7335280|FG000|STARTED|Overall Study||9
6420831|NCT00994929|7335280|FG000|COMPLETED|Overall Study||9
6420832|NCT00994929|7335280|FG000|NOT COMPLETED|Overall Study||0
6420833|NCT00995007|7335287|FG000|STARTED|Overall Study||56
6420834|NCT00995007|7335288|FG001|STARTED|Overall Study||56
6420835|NCT00995007|7335287|FG000|Crossover to Vandetanib|Overall Study||42
6420836|NCT00995007|7335288|FG001|Crossover to Vandetanib|Overall Study||0
6420837|NCT00995007|7335287|FG000|COMPLETED|Overall Study||39
6420838|NCT00995007|7335288|FG001|COMPLETED|Overall Study||54
6420839|NCT00995007|7335287|FG000|NOT COMPLETED|Overall Study||17
6420840|NCT00995007|7335288|FG001|NOT COMPLETED|Overall Study||2
6420841|NCT00995020|7335305|FG000|STARTED|Overall Study||51
6420842|NCT00995020|7335306|FG001|STARTED|Overall Study||52
6420843|NCT00995020|7335305|FG000|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|48
6420844|NCT00995020|7335306|FG001|COMPLETED|Overall Study|"Reasons for not completed:~margin analysis not performed specimen fragmentation thermal damage"|45
6420845|NCT00995020|7335305|FG000|NOT COMPLETED|Overall Study||3
6420846|NCT00995020|7335306|FG001|NOT COMPLETED|Overall Study||7
6420847|NCT00995072|7335316|FG000|STARTED|Overall Study||10
6420848|NCT00995072|7335317|FG001|STARTED|Overall Study||15
6420849|NCT00995072|7335316|FG000|COMPLETED|Overall Study||9
6420850|NCT00995072|7335317|FG001|COMPLETED|Overall Study||12
6420851|NCT00995072|7335316|FG000|NOT COMPLETED|Overall Study||1
6420852|NCT00995072|7335317|FG001|NOT COMPLETED|Overall Study||3
6420853|NCT00995085|7335323|FG000|STARTED|Overall Study||43
6420854|NCT00995085|7335323|FG000|COMPLETED|Overall Study||38
6420855|NCT00995085|7335323|FG000|NOT COMPLETED|Overall Study||5
6420856|NCT00995215|7335327|FG000|STARTED|Overall Study||6
6420857|NCT00995215|7335327|FG000|COMPLETED|Overall Study||6
6420858|NCT00995215|7335327|FG000|NOT COMPLETED|Overall Study||0
6420859|NCT00995345|7335337|FG000|STARTED|Overall Study||81
6420860|NCT00995345|7335338|FG001|STARTED|Overall Study||81
6420861|NCT00995345|7335339|FG002|STARTED|Overall Study||80
6420862|NCT00995345|7335340|FG003|STARTED|Overall Study||81
6420863|NCT00995345|7335341|FG004|STARTED|Overall Study||80
6420864|NCT00995345|7335337|FG000|COMPLETED|Overall Study||70
6420865|NCT00995345|7335338|FG001|COMPLETED|Overall Study||74
6420866|NCT00995345|7335339|FG002|COMPLETED|Overall Study||73
6420867|NCT00995345|7335340|FG003|COMPLETED|Overall Study||76
6420868|NCT00995345|7335341|FG004|COMPLETED|Overall Study||75
6420869|NCT00995345|7335337|FG000|NOT COMPLETED|Overall Study||11
6420870|NCT00995345|7335338|FG001|NOT COMPLETED|Overall Study||7
6420871|NCT00995345|7335339|FG002|NOT COMPLETED|Overall Study||7
6420872|NCT00995345|7335340|FG003|NOT COMPLETED|Overall Study||5
6420873|NCT00995345|7335341|FG004|NOT COMPLETED|Overall Study||5
6420874|NCT00995371|7335355|FG000|STARTED|Prior to ESI Cross-over, 6 Weeks||21
6420875|NCT00995371|7335356|FG001|STARTED|Prior to ESI Cross-over, 6 Weeks||17
6420876|NCT00995371|7335355|FG000|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
6420877|NCT00995371|7335356|FG001|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
6420878|NCT00995371|7335355|FG000|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
6420879|NCT00995371|7335356|FG001|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
6420880|NCT00995371|7335355|FG000|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
6420881|NCT00995371|7335356|FG001|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
6420882|NCT00995371|7335355|FG000|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
6420883|NCT00995371|7335356|FG001|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
6420884|NCT00995371|7335355|FG000|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
6420885|NCT00995371|7335356|FG001|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
6420886|NCT00995410|7335364|FG000|STARTED|Overall Study||380
6420887|NCT00995410|7335364|FG000|Treated|Overall Study||379
6420888|NCT00995410|7335364|FG000|COMPLETED|Overall Study||292
6420889|NCT00995410|7335364|FG000|NOT COMPLETED|Overall Study||88
6420890|NCT00995436|7335371|FG000|STARTED|Overall Study|25|25
6420891|NCT00995436|7335372|FG001|STARTED|Overall Study||27
6420892|NCT00995436|7335373|FG002|STARTED|Overall Study||26
6420893|NCT00995436|7335371|FG000|COMPLETED|Overall Study||23
6420894|NCT00995436|7335372|FG001|COMPLETED|Overall Study||22
6420895|NCT00995436|7335373|FG002|COMPLETED|Overall Study||26
6420896|NCT00995436|7335371|FG000|NOT COMPLETED|Overall Study||2
6420897|NCT00995436|7335372|FG001|NOT COMPLETED|Overall Study||5
6420898|NCT00995436|7335373|FG002|NOT COMPLETED|Overall Study||0
6420899|NCT00995449|7335385|FG000|STARTED|Overall Study||0
6420900|NCT00995449|7335386|FG001|STARTED|Overall Study||0
6420901|NCT00995449|7335387|FG002|STARTED|Overall Study||7
6420902|NCT00995449|7335388|FG003|STARTED|Overall Study||2
6420903|NCT00995449|7335385|FG000|COMPLETED|Overall Study||0
6420904|NCT00995449|7335386|FG001|COMPLETED|Overall Study||0
6420905|NCT00995449|7335387|FG002|COMPLETED|Overall Study||5
6420906|NCT00995449|7335388|FG003|COMPLETED|Overall Study||2
6420907|NCT00995449|7335385|FG000|NOT COMPLETED|Overall Study||0
6420908|NCT00995449|7335386|FG001|NOT COMPLETED|Overall Study||0
6420909|NCT00995449|7335387|FG002|NOT COMPLETED|Overall Study||2
6420910|NCT00995449|7335388|FG003|NOT COMPLETED|Overall Study||0
6420911|NCT00995475|7335396|FG000|STARTED|First Intervention||9
6420912|NCT00995475|7335397|FG001|STARTED|First Intervention||9
6420913|NCT00995475|7335396|FG000|COMPLETED|First Intervention||9
6420914|NCT00995475|7335397|FG001|COMPLETED|First Intervention||9
6420915|NCT00995475|7335396|FG000|NOT COMPLETED|First Intervention||0
6420916|NCT00995475|7335397|FG001|NOT COMPLETED|First Intervention||0
6420917|NCT00995475|7335396|FG000|STARTED|Wash-out Two Week||9
6420918|NCT00995475|7335397|FG001|STARTED|Wash-out Two Week||9
6420919|NCT00995475|7335396|FG000|COMPLETED|Wash-out Two Week||9
6420920|NCT00995475|7335397|FG001|COMPLETED|Wash-out Two Week||9
6420921|NCT00995475|7335396|FG000|NOT COMPLETED|Wash-out Two Week||0
6420922|NCT00995475|7335397|FG001|NOT COMPLETED|Wash-out Two Week||0
6420923|NCT00995475|7335396|FG000|STARTED|Second Intervention||9
6420924|NCT00995475|7335397|FG001|STARTED|Second Intervention||9
6420925|NCT00995475|7335396|FG000|COMPLETED|Second Intervention||9
6420926|NCT00995475|7335397|FG001|COMPLETED|Second Intervention||9
6420927|NCT00995475|7335396|FG000|NOT COMPLETED|Second Intervention||0
6420928|NCT00995475|7335397|FG001|NOT COMPLETED|Second Intervention||0
6420929|NCT00995488|7335403|FG000|STARTED|Overall Study||16
6420930|NCT00995488|7335403|FG000|COMPLETED|Overall Study||15
6420931|NCT00995488|7335403|FG000|NOT COMPLETED|Overall Study||1
6420932|NCT00995501|7335415|FG000|STARTED|Overall Study||52
6420933|NCT00995501|7335416|FG001|STARTED|Overall Study||51
6420934|NCT00995501|7335417|FG002|STARTED|Overall Study||47
6420935|NCT00995501|7335418|FG003|STARTED|Overall Study||46
6420936|NCT00995501|7335419|FG004|STARTED|Overall Study||46
6420937|NCT00995501|7335420|FG005|STARTED|Overall Study||44
6420938|NCT00995501|7335421|FG006|STARTED|Overall Study||49
6420939|NCT00995501|7335422|FG007|STARTED|Overall Study||46
6420940|NCT00995501|7335415|FG000|COMPLETED|Overall Study||52
6420941|NCT00995501|7335416|FG001|COMPLETED|Overall Study||51
6420942|NCT00995501|7335417|FG002|COMPLETED|Overall Study||47
6420943|NCT00995501|7335418|FG003|COMPLETED|Overall Study||46
6420944|NCT00995501|7335419|FG004|COMPLETED|Overall Study||46
6420945|NCT00995501|7335420|FG005|COMPLETED|Overall Study||44
6420946|NCT00995501|7335421|FG006|COMPLETED|Overall Study||49
6420947|NCT00995501|7335422|FG007|COMPLETED|Overall Study||46
6420948|NCT00995501|7335415|FG000|NOT COMPLETED|Overall Study||0
6420949|NCT00995501|7335416|FG001|NOT COMPLETED|Overall Study||0
6420950|NCT00995501|7335417|FG002|NOT COMPLETED|Overall Study||0
6420951|NCT00995501|7335418|FG003|NOT COMPLETED|Overall Study||0
6420952|NCT00995501|7335419|FG004|NOT COMPLETED|Overall Study||0
6420953|NCT00995501|7335420|FG005|NOT COMPLETED|Overall Study||0
6420954|NCT00995501|7335421|FG006|NOT COMPLETED|Overall Study||0
6420955|NCT00995501|7335422|FG007|NOT COMPLETED|Overall Study||0
6499421|NCT01417481|7418109|FG001|COMPLETED|Second Period (8 Weeks)||5
6499422|NCT01417481|7418108|FG000|NOT COMPLETED|Second Period (8 Weeks)||0
6499423|NCT01417481|7418109|FG001|NOT COMPLETED|Second Period (8 Weeks)||0
6499424|NCT01417741|7418117|FG000|STARTED|Overall Study||75
6499425|NCT01417741|7418118|FG001|STARTED|Overall Study||86
6640026|NCT02332291|7568234|FG001|COMPLETED|Phase 2: Open-Label Bupropion||11
6640027|NCT02332291|7568233|FG000|NOT COMPLETED|Phase 2: Open-Label Bupropion||3
6640028|NCT02332291|7568234|FG001|NOT COMPLETED|Phase 2: Open-Label Bupropion||8
6640029|NCT02332707|7568262|FG000|STARTED|Overall Study||23
6640030|NCT02332707|7568263|FG001|STARTED|Overall Study||24
6640031|NCT02332707|7568264|FG002|STARTED|Overall Study||16
6499426|NCT01417741|7418117|FG000|COMPLETED|Overall Study||75
6499427|NCT01417741|7418118|FG001|COMPLETED|Overall Study|only 73 received the post op day phone phone call|86
6499428|NCT01417741|7418117|FG000|NOT COMPLETED|Overall Study||0
6499429|NCT01417741|7418118|FG001|NOT COMPLETED|Overall Study||0
6499430|NCT01417780|7418127|FG000|STARTED|Overall Study||15
6640032|NCT02332707|7568265|FG003|STARTED|Overall Study||14
6640033|NCT02332707|7568266|FG004|STARTED|Overall Study||23
6499431|NCT01417780|7418128|FG001|STARTED|Overall Study||17
6499432|NCT01417780|7418129|FG002|STARTED|Overall Study||11
6499433|NCT01417780|7418127|FG000|COMPLETED|Overall Study||14
6499434|NCT01417780|7418128|FG001|COMPLETED|Overall Study||14
6420956|NCT00995553|7335442|FG000|STARTED|Overall Study||40
6420957|NCT00995553|7335443|FG001|STARTED|Overall Study||41
6420958|NCT00995553|7335442|FG000|COMPLETED|Overall Study||38
6420959|NCT00995553|7335443|FG001|COMPLETED|Overall Study||35
6420960|NCT00995553|7335442|FG000|NOT COMPLETED|Overall Study||2
6420961|NCT00995553|7335443|FG001|NOT COMPLETED|Overall Study||6
6420962|NCT00995566|7335449|FG000|STARTED|Overall Study||54
6420963|NCT00995566|7335449|FG000|COMPLETED|Overall Study||0
6420964|NCT00995566|7335449|FG000|NOT COMPLETED|Overall Study||54
6420965|NCT00995670|7335456|FG000|STARTED|Overall Study||26
6420966|NCT00995670|7335457|FG001|STARTED|Overall Study||16
6420967|NCT00995670|7335458|FG002|STARTED|Overall Study||17
6420968|NCT00995670|7335456|FG000|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
6420969|NCT00995670|7335457|FG001|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
6420970|NCT00995670|7335458|FG002|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
6420971|NCT00995670|7335456|FG000|NOT COMPLETED|Overall Study||1
6420972|NCT00995670|7335457|FG001|NOT COMPLETED|Overall Study||0
6420973|NCT00995670|7335458|FG002|NOT COMPLETED|Overall Study||3
6420974|NCT00995709|7335469|FG000|STARTED|Overall Study||39
6420975|NCT00995709|7335470|FG001|STARTED|Overall Study||40
6420976|NCT00995709|7335471|FG002|STARTED|Overall Study||39
6420977|NCT00995709|7335469|FG000|COMPLETED|Overall Study||32
6420978|NCT00995709|7335470|FG001|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
6420979|NCT00995709|7335471|FG002|COMPLETED|Overall Study||34
6420980|NCT00995709|7335469|FG000|NOT COMPLETED|Overall Study||7
6420981|NCT00995709|7335470|FG001|NOT COMPLETED|Overall Study||9
6420982|NCT00995709|7335471|FG002|NOT COMPLETED|Overall Study||5
6420983|NCT00995722|7335481|FG000|STARTED|Double Blinded: 16 Weeks||6
6420984|NCT00995722|7335482|FG001|STARTED|Double Blinded: 16 Weeks||5
6420985|NCT00995722|7335481|FG000|COMPLETED|Double Blinded: 16 Weeks||5
6420986|NCT00995722|7335482|FG001|COMPLETED|Double Blinded: 16 Weeks||4
6420987|NCT00995722|7335481|FG000|NOT COMPLETED|Double Blinded: 16 Weeks||1
6420988|NCT00995722|7335482|FG001|NOT COMPLETED|Double Blinded: 16 Weeks||1
6420989|NCT00995722|7335481|FG000|STARTED|Overall Study: 36 Weeks||5
6420990|NCT00995722|7335482|FG001|STARTED|Overall Study: 36 Weeks||4
6420991|NCT00995722|7335481|FG000|COMPLETED|Overall Study: 36 Weeks||3
6420992|NCT00995722|7335482|FG001|COMPLETED|Overall Study: 36 Weeks||2
6420993|NCT00995722|7335481|FG000|NOT COMPLETED|Overall Study: 36 Weeks||2
6420994|NCT00995722|7335482|FG001|NOT COMPLETED|Overall Study: 36 Weeks||2
6420995|NCT00995761|7335488|FG000|STARTED|Overall Study||48
6420996|NCT00995761|7335488|FG000|COMPLETED|Overall Study||48
6420997|NCT00995761|7335488|FG000|NOT COMPLETED|Overall Study||0
6420998|NCT00995774|7335494|FG000|STARTED|Training Period 1||7
6420999|NCT00995774|7335495|FG001|STARTED|Training Period 1||5
6421000|NCT00995774|7335494|FG000|COMPLETED|Training Period 1||7
6421001|NCT00995774|7335495|FG001|COMPLETED|Training Period 1||5
6421002|NCT00995774|7335494|FG000|NOT COMPLETED|Training Period 1||0
6421003|NCT00995774|7335495|FG001|NOT COMPLETED|Training Period 1||0
6421004|NCT00995774|7335494|FG000|STARTED|Washout Period||7
6421005|NCT00995774|7335495|FG001|STARTED|Washout Period||5
6421006|NCT00995774|7335494|FG000|COMPLETED|Washout Period||7
6421007|NCT00995774|7335495|FG001|COMPLETED|Washout Period||5
6421008|NCT00995774|7335494|FG000|NOT COMPLETED|Washout Period||0
6421009|NCT00995774|7335495|FG001|NOT COMPLETED|Washout Period||0
6421010|NCT00995774|7335494|FG000|STARTED|Training Period 2||7
6421011|NCT00995774|7335495|FG001|STARTED|Training Period 2||5
6421012|NCT00995774|7335494|FG000|COMPLETED|Training Period 2||5
6421013|NCT00995774|7335495|FG001|COMPLETED|Training Period 2||5
6421014|NCT00995774|7335494|FG000|NOT COMPLETED|Training Period 2||2
6421015|NCT00995774|7335495|FG001|NOT COMPLETED|Training Period 2||0
6421016|NCT00995865|7335504|FG000|STARTED|Overall Study||24
6421017|NCT00995865|7335505|FG001|STARTED|Overall Study||24
6421018|NCT00995865|7335506|FG002|STARTED|Overall Study||12
6421019|NCT00995865|7335504|FG000|COMPLETED|Overall Study||22
6421020|NCT00995865|7335505|FG001|COMPLETED|Overall Study||24
6421021|NCT00995865|7335506|FG002|COMPLETED|Overall Study||11
6421022|NCT00995865|7335504|FG000|NOT COMPLETED|Overall Study||2
6421023|NCT00995865|7335505|FG001|NOT COMPLETED|Overall Study||0
6421024|NCT00995865|7335506|FG002|NOT COMPLETED|Overall Study||1
6421025|NCT00995904|7335519|FG000|STARTED|Visit 2 (Randomization)||4
6421026|NCT00995904|7335520|FG001|STARTED|Visit 2 (Randomization)||3
6421027|NCT00995904|7335521|FG002|STARTED|Visit 2 (Randomization)||4
6421028|NCT00995904|7335522|FG003|STARTED|Visit 2 (Randomization)||5
6421029|NCT00995904|7335523|FG004|STARTED|Visit 2 (Randomization)||5
6421030|NCT00995904|7335524|FG005|STARTED|Visit 2 (Randomization)||4
6421031|NCT00995904|7335519|FG000|COMPLETED|Visit 2 (Randomization)||4
6421032|NCT00995904|7335520|FG001|COMPLETED|Visit 2 (Randomization)||3
6421033|NCT00995904|7335521|FG002|COMPLETED|Visit 2 (Randomization)||4
6421034|NCT00995904|7335522|FG003|COMPLETED|Visit 2 (Randomization)||5
6421035|NCT00995904|7335523|FG004|COMPLETED|Visit 2 (Randomization)||5
6421036|NCT00995904|7335524|FG005|COMPLETED|Visit 2 (Randomization)||4
6421037|NCT00995904|7335519|FG000|NOT COMPLETED|Visit 2 (Randomization)||0
6421038|NCT00995904|7335520|FG001|NOT COMPLETED|Visit 2 (Randomization)||0
6421039|NCT00995904|7335521|FG002|NOT COMPLETED|Visit 2 (Randomization)||0
6421040|NCT00995904|7335522|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
6421041|NCT00995904|7335523|FG004|NOT COMPLETED|Visit 2 (Randomization)||0
6421042|NCT00995904|7335524|FG005|NOT COMPLETED|Visit 2 (Randomization)||0
6421043|NCT00995904|7335519|FG000|STARTED|Visit 3||4
6421044|NCT00995904|7335520|FG001|STARTED|Visit 3||3
6421045|NCT00995904|7335521|FG002|STARTED|Visit 3||4
6421046|NCT00995904|7335522|FG003|STARTED|Visit 3||5
6421047|NCT00995904|7335523|FG004|STARTED|Visit 3||5
6421048|NCT00995904|7335524|FG005|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
6421049|NCT00995904|7335519|FG000|COMPLETED|Visit 3||4
6421050|NCT00995904|7335520|FG001|COMPLETED|Visit 3||3
6421051|NCT00995904|7335521|FG002|COMPLETED|Visit 3||4
6421052|NCT00995904|7335522|FG003|COMPLETED|Visit 3||5
6421053|NCT00995904|7335523|FG004|COMPLETED|Visit 3||5
6421054|NCT00995904|7335524|FG005|COMPLETED|Visit 3||3
6421055|NCT00995904|7335519|FG000|NOT COMPLETED|Visit 3||0
6421056|NCT00995904|7335520|FG001|NOT COMPLETED|Visit 3||0
6421057|NCT00995904|7335521|FG002|NOT COMPLETED|Visit 3||0
6421058|NCT00995904|7335522|FG003|NOT COMPLETED|Visit 3||0
6421059|NCT00995904|7335523|FG004|NOT COMPLETED|Visit 3||0
6421060|NCT00995904|7335524|FG005|NOT COMPLETED|Visit 3||0
6421061|NCT00995904|7335519|FG000|STARTED|Visit 4||4
6421062|NCT00995904|7335520|FG001|STARTED|Visit 4||3
6421063|NCT00995904|7335521|FG002|STARTED|Visit 4||4
6421064|NCT00995904|7335522|FG003|STARTED|Visit 4||5
6421065|NCT00995904|7335523|FG004|STARTED|Visit 4||5
6421066|NCT00995904|7335524|FG005|STARTED|Visit 4||3
6421067|NCT00995904|7335519|FG000|COMPLETED|Visit 4||4
6421068|NCT00995904|7335520|FG001|COMPLETED|Visit 4||3
6421069|NCT00995904|7335521|FG002|COMPLETED|Visit 4||4
6421070|NCT00995904|7335522|FG003|COMPLETED|Visit 4||5
6421071|NCT00995904|7335523|FG004|COMPLETED|Visit 4||5
6421072|NCT00995904|7335524|FG005|COMPLETED|Visit 4||3
6421073|NCT00995904|7335519|FG000|NOT COMPLETED|Visit 4||0
6421074|NCT00995904|7335520|FG001|NOT COMPLETED|Visit 4||0
6421075|NCT00995904|7335521|FG002|NOT COMPLETED|Visit 4||0
6421076|NCT00995904|7335522|FG003|NOT COMPLETED|Visit 4||0
6421077|NCT00995904|7335523|FG004|NOT COMPLETED|Visit 4||0
6421078|NCT00995904|7335524|FG005|NOT COMPLETED|Visit 4||0
6421079|NCT00995904|7335519|FG000|STARTED|Follow-up Visit (Final Visit)||4
6421080|NCT00995904|7335520|FG001|STARTED|Follow-up Visit (Final Visit)||3
6421081|NCT00995904|7335521|FG002|STARTED|Follow-up Visit (Final Visit)||4
6421082|NCT00995904|7335522|FG003|STARTED|Follow-up Visit (Final Visit)||5
6421083|NCT00995904|7335523|FG004|STARTED|Follow-up Visit (Final Visit)||5
6421084|NCT00995904|7335524|FG005|STARTED|Follow-up Visit (Final Visit)||3
6421085|NCT00995904|7335519|FG000|COMPLETED|Follow-up Visit (Final Visit)||4
6421086|NCT00995904|7335520|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
6421087|NCT00995904|7335521|FG002|COMPLETED|Follow-up Visit (Final Visit)||4
6421088|NCT00995904|7335522|FG003|COMPLETED|Follow-up Visit (Final Visit)||5
6421089|NCT00995904|7335523|FG004|COMPLETED|Follow-up Visit (Final Visit)||5
6421090|NCT00995904|7335524|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
6421091|NCT00995904|7335519|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6421092|NCT00995904|7335520|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6421093|NCT00995904|7335521|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6421094|NCT00995904|7335522|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6421095|NCT00995904|7335523|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6421096|NCT00995904|7335524|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6421097|NCT00995930|7335537|FG000|STARTED|Overall Study||94
6421098|NCT00995930|7335538|FG001|STARTED|Overall Study||95
6640034|NCT02332707|7568267|FG005|STARTED|Overall Study||23
6640035|NCT02332707|7568268|FG006|STARTED|Overall Study||15
6640036|NCT02332707|7568269|FG007|STARTED|Overall Study||16
6640037|NCT02332707|7568270|FG008|STARTED|Overall Study||48
6640038|NCT02332707|7568271|FG009|STARTED|Overall Study||31
6421099|NCT00995930|7335537|FG000|Safety Analysis Set|Overall Study||94
6421100|NCT00995930|7335538|FG001|Safety Analysis Set|Overall Study||95
6421101|NCT00995930|7335537|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6421102|NCT00995930|7335538|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||95
6421103|NCT00995930|7335537|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||92
6421104|NCT00995930|7335538|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||92
6421105|NCT00995930|7335537|FG000|Imaging Analysis Set|Overall Study||92
6421106|NCT00995930|7335538|FG001|Imaging Analysis Set|Overall Study||92
6421107|NCT00995930|7335537|FG000|COMPLETED|Overall Study||73
6421108|NCT00995930|7335538|FG001|COMPLETED|Overall Study||67
6510821|NCT01484275|7430395|FG000|STARTED|Overall Study||43
6510822|NCT01484275|7430396|FG001|STARTED|Overall Study||42
6510823|NCT01484275|7430395|FG000|COMPLETED|Overall Study||0
6510824|NCT01484275|7430396|FG001|COMPLETED|Overall Study||0
6510825|NCT01484275|7430395|FG000|NOT COMPLETED|Overall Study||43
6510826|NCT01484275|7430396|FG001|NOT COMPLETED|Overall Study||42
6510827|NCT01484288|7430402|FG000|STARTED|Overall Study||11
6510828|NCT01484288|7430402|FG000|COMPLETED|Overall Study||11
6510829|NCT01484288|7430402|FG000|NOT COMPLETED|Overall Study||0
6510830|NCT01484340|7430408|FG000|STARTED|Overall Study||281
6510831|NCT01484340|7430409|FG001|STARTED|Overall Study||279
6510832|NCT01484340|7430408|FG000|COMPLETED|Overall Study||281
6510833|NCT01484340|7430409|FG001|COMPLETED|Overall Study||279
6510834|NCT01484340|7430408|FG000|NOT COMPLETED|Overall Study||0
6510835|NCT01484340|7430409|FG001|NOT COMPLETED|Overall Study||0
6743575|NCT03335254|7671812|FG002|STARTED|Period 1||0
6421109|NCT00995930|7335537|FG000|NOT COMPLETED|Overall Study||21
6640039|NCT02332707|7568272|FG010|STARTED|Overall Study||31
6640040|NCT02332707|7568273|FG011|STARTED|Overall Study||35
6421110|NCT00995930|7335538|FG001|NOT COMPLETED|Overall Study||28
6421111|NCT00996034|7335545|FG000|STARTED|Overall Study||14
6421112|NCT00996034|7335545|FG000|COMPLETED|Overall Study||11
6421113|NCT00996034|7335545|FG000|NOT COMPLETED|Overall Study||3
6421114|NCT00996125|7335551|FG000|STARTED|Overall Study||374
6421115|NCT00996125|7335552|FG001|STARTED|Overall Study||376
6421116|NCT00996125|7335551|FG000|COMPLETED|Overall Study||369
6421117|NCT00996125|7335552|FG001|COMPLETED|Overall Study||365
6421118|NCT00996125|7335551|FG000|NOT COMPLETED|Overall Study||5
6421119|NCT00996125|7335552|FG001|NOT COMPLETED|Overall Study||11
6421120|NCT00996164|7335560|FG000|STARTED|Overall Study||543
6421121|NCT00996164|7335561|FG001|STARTED|Overall Study||547
6421122|NCT00996164|7335560|FG000|COMPLETED|Overall Study||408
6421123|NCT00996164|7335561|FG001|COMPLETED|Overall Study||446
6421124|NCT00996164|7335560|FG000|NOT COMPLETED|Overall Study||135
6421125|NCT00996164|7335561|FG001|NOT COMPLETED|Overall Study||101
6421126|NCT00996203|7335567|FG000|STARTED|Overall Study||201
6421127|NCT00996203|7335567|FG000|COMPLETED|Overall Study||194
6421128|NCT00996203|7335567|FG000|NOT COMPLETED|Overall Study||7
6421129|NCT00996216|7335572|FG000|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
6421130|NCT00996216|7335572|FG000|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
6421131|NCT00996216|7335572|FG000|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
6421132|NCT00996216|7335572|FG000|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn't qualify to begin antiviral treatment in Part 2.|25
6421133|NCT00996216|7335572|FG000|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
6421134|NCT00996216|7335572|FG000|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
6421135|NCT00996281|7335579|FG000|STARTED|Overall Study||418
6421136|NCT00996281|7335580|FG001|STARTED|Overall Study||419
6421137|NCT00996281|7335579|FG000|COMPLETED|Overall Study||287
6421138|NCT00996281|7335580|FG001|COMPLETED|Overall Study||330
6421139|NCT00996281|7335579|FG000|NOT COMPLETED|Overall Study||131
6421140|NCT00996281|7335580|FG001|NOT COMPLETED|Overall Study||89
6421141|NCT00996307|7335590|FG000|STARTED|Overall Study||164
6421142|NCT00996307|7335591|FG001|STARTED|Overall Study||165
6421143|NCT00996307|7335592|FG002|STARTED|Overall Study||160
6421144|NCT00996307|7335593|FG003|STARTED|Overall Study||165
6421145|NCT00996307|7335590|FG000|COMPLETED|Overall Study||144
6421146|NCT00996307|7335591|FG001|COMPLETED|Overall Study||148
6421147|NCT00996307|7335592|FG002|COMPLETED|Overall Study||146
6421148|NCT00996307|7335593|FG003|COMPLETED|Overall Study||144
6421149|NCT00996307|7335590|FG000|NOT COMPLETED|Overall Study||20
6421150|NCT00996307|7335591|FG001|NOT COMPLETED|Overall Study||17
6421151|NCT00996307|7335592|FG002|NOT COMPLETED|Overall Study||14
6421152|NCT00996307|7335593|FG003|NOT COMPLETED|Overall Study||21
6421153|NCT00996346|7335624|FG000|STARTED|Overall Study||6
6421154|NCT00996346|7335625|FG001|STARTED|Overall Study||8
6421155|NCT00996346|7335626|FG002|STARTED|Overall Study||3
6421156|NCT00996346|7335624|FG000|COMPLETED|Overall Study||6
6421157|NCT00996346|7335625|FG001|COMPLETED|Overall Study||8
6421158|NCT00996346|7335626|FG002|COMPLETED|Overall Study||3
6421159|NCT00996346|7335624|FG000|NOT COMPLETED|Overall Study||0
6421160|NCT00996346|7335625|FG001|NOT COMPLETED|Overall Study||0
6421161|NCT00996346|7335626|FG002|NOT COMPLETED|Overall Study||0
6421162|NCT00996372|7335634|FG000|STARTED|Overall Study||468
6421163|NCT00996372|7335635|FG001|STARTED|Overall Study||481
6421164|NCT00996372|7335634|FG000|COMPLETED|Overall Study||365
6421165|NCT00996372|7335635|FG001|COMPLETED|Overall Study||397
6421166|NCT00996372|7335634|FG000|NOT COMPLETED|Overall Study||103
6421167|NCT00996372|7335635|FG001|NOT COMPLETED|Overall Study||84
6421168|NCT00996437|7335645|FG000|STARTED|Overall Study||125
6421169|NCT00996437|7335646|FG001|STARTED|Overall Study||136
6421170|NCT00996437|7335645|FG000|COMPLETED|Overall Study||120
6421171|NCT00996437|7335646|FG001|COMPLETED|Overall Study||129
6421172|NCT00996437|7335645|FG000|NOT COMPLETED|Overall Study||5
6421173|NCT00996437|7335646|FG001|NOT COMPLETED|Overall Study||7
6421174|NCT00996476|7335657|FG000|STARTED|Overall Study||27
6421175|NCT00996476|7335658|FG001|STARTED|Overall Study||26
6421176|NCT00996476|7335659|FG002|STARTED|Overall Study||13
6421177|NCT00996476|7335660|FG003|STARTED|Overall Study||13
6421178|NCT00996476|7335661|FG004|STARTED|Overall Study||13
6421179|NCT00996476|7335657|FG000|COMPLETED|Overall Study||26
6421180|NCT00996476|7335658|FG001|COMPLETED|Overall Study||23
6421181|NCT00996476|7335659|FG002|COMPLETED|Overall Study||12
6421182|NCT00996476|7335660|FG003|COMPLETED|Overall Study||13
6421183|NCT00996476|7335661|FG004|COMPLETED|Overall Study||11
6421184|NCT00996476|7335657|FG000|NOT COMPLETED|Overall Study||1
6421185|NCT00996476|7335658|FG001|NOT COMPLETED|Overall Study||3
6421186|NCT00996476|7335659|FG002|NOT COMPLETED|Overall Study||1
6421187|NCT00996476|7335660|FG003|NOT COMPLETED|Overall Study||0
6421188|NCT00996476|7335661|FG004|NOT COMPLETED|Overall Study||2
6421189|NCT00996489|7335678|FG000|STARTED|Overall Study||459
6421190|NCT00996489|7335678|FG000|COMPLETED|Overall Study||298
6421191|NCT00996489|7335678|FG000|NOT COMPLETED|Overall Study||161
6421192|NCT00996580|7335682|FG000|STARTED|Overall Study||3597
6421193|NCT00996580|7335682|FG000|Pregnancy Intent-to-Treat Population|Overall Study||3019
6421194|NCT00996580|7335682|FG000|COMPLETED|Overall Study||2144
6421195|NCT00996580|7335682|FG000|NOT COMPLETED|Overall Study||1453
6421196|NCT00996593|7335689|FG000|STARTED|Dosimetric and Therapeutic Treatment||43
6421197|NCT00996593|7335689|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
6421198|NCT00996593|7335689|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
6499435|NCT01417780|7418129|FG002|COMPLETED|Overall Study||9
6421199|NCT00996593|7335689|FG000|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
6421200|NCT00996593|7335689|FG000|COMPLETED|Long-Term Follow-Up||6
6421201|NCT00996593|7335689|FG000|NOT COMPLETED|Long-Term Follow-Up||3
6421202|NCT00996606|7335693|FG000|STARTED|Overall Study||58
6421203|NCT00996606|7335693|FG000|COMPLETED|Overall Study||50
6421204|NCT00996606|7335693|FG000|NOT COMPLETED|Overall Study||8
6421205|NCT00996632|7335699|FG000|STARTED|Overall Study||38
6421206|NCT00996632|7335700|FG001|STARTED|Overall Study||56
6421207|NCT00996632|7335699|FG000|COMPLETED|Overall Study||38
6421208|NCT00996632|7335700|FG001|COMPLETED|Overall Study||56
6421209|NCT00996632|7335699|FG000|NOT COMPLETED|Overall Study||0
6421210|NCT00996632|7335700|FG001|NOT COMPLETED|Overall Study||0
6421211|NCT00996658|7335708|FG000|STARTED|Overall Study||92
6421212|NCT00996658|7335709|FG001|STARTED|Overall Study||186
6421213|NCT00996658|7335708|FG000|COMPLETED|Overall Study||76
6421214|NCT00996658|7335709|FG001|COMPLETED|Overall Study||165
6421215|NCT00996658|7335708|FG000|NOT COMPLETED|Overall Study||16
6421216|NCT00996658|7335709|FG001|NOT COMPLETED|Overall Study||21
6421217|NCT00996736|7335717|FG000|STARTED|Overall Study||162
6421218|NCT00996736|7335718|FG001|STARTED|Overall Study||161
6421219|NCT00996736|7335717|FG000|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
6421220|NCT00996736|7335718|FG001|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
6421221|NCT00996736|7335717|FG000|3-month Visit|Overall Study||146
6421222|NCT00996736|7335718|FG001|3-month Visit|Overall Study||146
6421223|NCT00996736|7335717|FG000|COMPLETED|Overall Study||141
6421224|NCT00996736|7335718|FG001|COMPLETED|Overall Study||143
6421225|NCT00996736|7335717|FG000|NOT COMPLETED|Overall Study||21
6421226|NCT00996736|7335718|FG001|NOT COMPLETED|Overall Study||18
6421227|NCT00996775|7335726|FG000|STARTED|Overall Study||78
6421228|NCT00996775|7335727|FG001|STARTED|Overall Study||89
6421229|NCT00996775|7335726|FG000|COMPLETED|Overall Study||67
6421230|NCT00996775|7335727|FG001|COMPLETED|Overall Study||75
6421231|NCT00996775|7335726|FG000|NOT COMPLETED|Overall Study||11
6421232|NCT00996775|7335727|FG001|NOT COMPLETED|Overall Study||14
6421233|NCT00996801|7335739|FG000|STARTED|Overall Study||88
6421234|NCT00996801|7335740|FG001|STARTED|Overall Study||88
6421235|NCT00996801|7335741|FG002|STARTED|Overall Study||88
6421236|NCT00996801|7335742|FG003|STARTED|Overall Study||87
6421237|NCT00996801|7335743|FG004|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
6421238|NCT00996801|7335744|FG005|STARTED|Overall Study||87
6421239|NCT00996801|7335739|FG000|COMPLETED|Overall Study||68
6421240|NCT00996801|7335740|FG001|COMPLETED|Overall Study||72
6421241|NCT00996801|7335741|FG002|COMPLETED|Overall Study||65
6421242|NCT00996801|7335742|FG003|COMPLETED|Overall Study||56
6421243|NCT00996801|7335743|FG004|COMPLETED|Overall Study||0
6421244|NCT00996801|7335744|FG005|COMPLETED|Overall Study||68
6421245|NCT00996801|7335739|FG000|NOT COMPLETED|Overall Study||20
6421246|NCT00996801|7335740|FG001|NOT COMPLETED|Overall Study||16
6640041|NCT02332707|7568274|FG012|STARTED|Overall Study||40
6640042|NCT02332707|7568275|FG013|STARTED|Overall Study||15
6640043|NCT02332707|7568276|FG014|STARTED|Overall Study||16
6640044|NCT02332707|7568277|FG015|STARTED|Overall Study||26
6640045|NCT02332707|7568278|FG016|STARTED|Overall Study||30
6640046|NCT02332707|7568279|FG017|STARTED|Overall Study||16
6640047|NCT02332707|7568262|FG000|COMPLETED|Overall Study||23
6640048|NCT02332707|7568263|FG001|COMPLETED|Overall Study||24
6640049|NCT02332707|7568264|FG002|COMPLETED|Overall Study||15
6640050|NCT02332707|7568265|FG003|COMPLETED|Overall Study||13
6640051|NCT02332707|7568266|FG004|COMPLETED|Overall Study||23
6640052|NCT02332707|7568267|FG005|COMPLETED|Overall Study||22
6640053|NCT02332707|7568268|FG006|COMPLETED|Overall Study||15
6640054|NCT02332707|7568269|FG007|COMPLETED|Overall Study||16
6640055|NCT02332707|7568270|FG008|COMPLETED|Overall Study||48
6640056|NCT02332707|7568271|FG009|COMPLETED|Overall Study||28
6640057|NCT02332707|7568272|FG010|COMPLETED|Overall Study||29
6640058|NCT02332707|7568273|FG011|COMPLETED|Overall Study||35
6640059|NCT02332707|7568274|FG012|COMPLETED|Overall Study||35
6640060|NCT02332707|7568275|FG013|COMPLETED|Overall Study||15
6640061|NCT02332707|7568276|FG014|COMPLETED|Overall Study||16
6640062|NCT02332707|7568277|FG015|COMPLETED|Overall Study||26
6640063|NCT02332707|7568278|FG016|COMPLETED|Overall Study||30
6640064|NCT02332707|7568279|FG017|COMPLETED|Overall Study||16
6640065|NCT02332707|7568262|FG000|NOT COMPLETED|Overall Study||0
6640066|NCT02332707|7568263|FG001|NOT COMPLETED|Overall Study||0
6640067|NCT02332707|7568264|FG002|NOT COMPLETED|Overall Study||1
6640068|NCT02332707|7568265|FG003|NOT COMPLETED|Overall Study||1
6640069|NCT02332707|7568266|FG004|NOT COMPLETED|Overall Study||0
6640070|NCT02332707|7568267|FG005|NOT COMPLETED|Overall Study||1
6640071|NCT02332707|7568268|FG006|NOT COMPLETED|Overall Study||0
6640072|NCT02332707|7568269|FG007|NOT COMPLETED|Overall Study||0
6640073|NCT02332707|7568270|FG008|NOT COMPLETED|Overall Study||0
6640074|NCT02332707|7568271|FG009|NOT COMPLETED|Overall Study||3
6640075|NCT02332707|7568272|FG010|NOT COMPLETED|Overall Study||2
6640076|NCT02332707|7568273|FG011|NOT COMPLETED|Overall Study||0
6640077|NCT02332707|7568274|FG012|NOT COMPLETED|Overall Study||5
6640078|NCT02332707|7568275|FG013|NOT COMPLETED|Overall Study||0
6421247|NCT00996801|7335741|FG002|NOT COMPLETED|Overall Study||23
6421248|NCT00996801|7335742|FG003|NOT COMPLETED|Overall Study||31
6640079|NCT02332707|7568276|FG014|NOT COMPLETED|Overall Study||0
6421249|NCT00996801|7335743|FG004|NOT COMPLETED|Overall Study||88
6421250|NCT00996801|7335744|FG005|NOT COMPLETED|Overall Study||19
6421251|NCT00996840|7335765|FG000|STARTED|Overall Study||20
6421252|NCT00996840|7335766|FG001|STARTED|Overall Study||9
6421253|NCT00996840|7335767|FG002|STARTED|Overall Study||12
6421254|NCT00996840|7335768|FG003|STARTED|Overall Study||18
6421255|NCT00996840|7335769|FG004|STARTED|Overall Study||18
6421256|NCT00996840|7335765|FG000|COMPLETED|Overall Study||19
6421257|NCT00996840|7335766|FG001|COMPLETED|Overall Study||7
6421258|NCT00996840|7335767|FG002|COMPLETED|Overall Study||11
6421259|NCT00996840|7335768|FG003|COMPLETED|Overall Study||17
6421260|NCT00996840|7335769|FG004|COMPLETED|Overall Study||16
6421261|NCT00996840|7335765|FG000|NOT COMPLETED|Overall Study||1
6421262|NCT00996840|7335766|FG001|NOT COMPLETED|Overall Study||2
6421263|NCT00996840|7335767|FG002|NOT COMPLETED|Overall Study||1
6421264|NCT00996840|7335768|FG003|NOT COMPLETED|Overall Study||1
6421265|NCT00996840|7335769|FG004|NOT COMPLETED|Overall Study||2
6421266|NCT00996892|7335785|FG000|STARTED|Dose-Escalation Stage 1||4
6421267|NCT00996892|7335786|FG001|STARTED|Dose-Escalation Stage 1||3
6421268|NCT00996892|7335787|FG002|STARTED|Dose-Escalation Stage 1||3
6421269|NCT00996892|7335788|FG003|STARTED|Dose-Escalation Stage 1||9
6421270|NCT00996892|7335789|FG004|STARTED|Dose-Escalation Stage 1||11
6421271|NCT00996892|7335790|FG005|STARTED|Dose-Escalation Stage 1||10
6421272|NCT00996892|7335791|FG006|STARTED|Dose-Escalation Stage 1||4
6421273|NCT00996892|7335792|FG007|STARTED|Dose-Escalation Stage 1||0
6421274|NCT00996892|7335793|FG008|STARTED|Dose-Escalation Stage 1||0
6421275|NCT00996892|7335794|FG009|STARTED|Dose-Escalation Stage 1||0
6421276|NCT00996892|7335795|FG010|STARTED|Dose-Escalation Stage 1||0
6421277|NCT00996892|7335796|FG011|STARTED|Dose-Escalation Stage 1||0
6421278|NCT00996892|7335797|FG012|STARTED|Dose-Escalation Stage 1||0
6421279|NCT00996892|7335798|FG013|STARTED|Dose-Escalation Stage 1||0
6421280|NCT00996892|7335799|FG014|STARTED|Dose-Escalation Stage 1||0
6421281|NCT00996892|7335800|FG015|STARTED|Dose-Escalation Stage 1||0
6421282|NCT00996892|7335801|FG016|STARTED|Dose-Escalation Stage 1||0
6421283|NCT00996892|7335802|FG017|STARTED|Dose-Escalation Stage 1||0
6421284|NCT00996892|7335803|FG018|STARTED|Dose-Escalation Stage 1||0
6421285|NCT00996892|7335804|FG019|STARTED|Dose-Escalation Stage 1||0
6421286|NCT00996892|7335785|FG000|COMPLETED|Dose-Escalation Stage 1||0
6421287|NCT00996892|7335786|FG001|COMPLETED|Dose-Escalation Stage 1||0
6421288|NCT00996892|7335787|FG002|COMPLETED|Dose-Escalation Stage 1||0
6421289|NCT00996892|7335788|FG003|COMPLETED|Dose-Escalation Stage 1||0
6421290|NCT00996892|7335789|FG004|COMPLETED|Dose-Escalation Stage 1||0
6421291|NCT00996892|7335790|FG005|COMPLETED|Dose-Escalation Stage 1||0
6421292|NCT00996892|7335791|FG006|COMPLETED|Dose-Escalation Stage 1||0
6421293|NCT00996892|7335792|FG007|COMPLETED|Dose-Escalation Stage 1||0
6421294|NCT00996892|7335793|FG008|COMPLETED|Dose-Escalation Stage 1||0
6421295|NCT00996892|7335794|FG009|COMPLETED|Dose-Escalation Stage 1||0
6421296|NCT00996892|7335795|FG010|COMPLETED|Dose-Escalation Stage 1||0
6421297|NCT00996892|7335796|FG011|COMPLETED|Dose-Escalation Stage 1||0
6421298|NCT00996892|7335797|FG012|COMPLETED|Dose-Escalation Stage 1||0
6421299|NCT00996892|7335798|FG013|COMPLETED|Dose-Escalation Stage 1||0
6421300|NCT00996892|7335799|FG014|COMPLETED|Dose-Escalation Stage 1||0
6421301|NCT00996892|7335800|FG015|COMPLETED|Dose-Escalation Stage 1||0
6421302|NCT00996892|7335801|FG016|COMPLETED|Dose-Escalation Stage 1||0
6421303|NCT00996892|7335802|FG017|COMPLETED|Dose-Escalation Stage 1||0
6421304|NCT00996892|7335803|FG018|COMPLETED|Dose-Escalation Stage 1||0
6421305|NCT00996892|7335804|FG019|COMPLETED|Dose-Escalation Stage 1||0
6421306|NCT00996892|7335785|FG000|NOT COMPLETED|Dose-Escalation Stage 1||4
6421307|NCT00996892|7335786|FG001|NOT COMPLETED|Dose-Escalation Stage 1||3
6421308|NCT00996892|7335787|FG002|NOT COMPLETED|Dose-Escalation Stage 1||3
6421309|NCT00996892|7335788|FG003|NOT COMPLETED|Dose-Escalation Stage 1||9
6421310|NCT00996892|7335789|FG004|NOT COMPLETED|Dose-Escalation Stage 1||11
6421311|NCT00996892|7335790|FG005|NOT COMPLETED|Dose-Escalation Stage 1||10
6421312|NCT00996892|7335791|FG006|NOT COMPLETED|Dose-Escalation Stage 1||4
6421313|NCT00996892|7335792|FG007|NOT COMPLETED|Dose-Escalation Stage 1||0
6421314|NCT00996892|7335793|FG008|NOT COMPLETED|Dose-Escalation Stage 1||0
6421315|NCT00996892|7335794|FG009|NOT COMPLETED|Dose-Escalation Stage 1||0
6421316|NCT00996892|7335795|FG010|NOT COMPLETED|Dose-Escalation Stage 1||0
6421317|NCT00996892|7335796|FG011|NOT COMPLETED|Dose-Escalation Stage 1||0
6421318|NCT00996892|7335797|FG012|NOT COMPLETED|Dose-Escalation Stage 1||0
6421319|NCT00996892|7335798|FG013|NOT COMPLETED|Dose-Escalation Stage 1||0
6421320|NCT00996892|7335799|FG014|NOT COMPLETED|Dose-Escalation Stage 1||0
6421321|NCT00996892|7335800|FG015|NOT COMPLETED|Dose-Escalation Stage 1||0
6421322|NCT00996892|7335801|FG016|NOT COMPLETED|Dose-Escalation Stage 1||0
6421323|NCT00996892|7335802|FG017|NOT COMPLETED|Dose-Escalation Stage 1||0
6421324|NCT00996892|7335803|FG018|NOT COMPLETED|Dose-Escalation Stage 1||0
6421325|NCT00996892|7335804|FG019|NOT COMPLETED|Dose-Escalation Stage 1||0
6421326|NCT00996892|7335785|FG000|STARTED|Dose-Escalation Stage 1A||0
6421327|NCT00996892|7335786|FG001|STARTED|Dose-Escalation Stage 1A||0
6421328|NCT00996892|7335787|FG002|STARTED|Dose-Escalation Stage 1A||0
6421329|NCT00996892|7335788|FG003|STARTED|Dose-Escalation Stage 1A||0
6421330|NCT00996892|7335789|FG004|STARTED|Dose-Escalation Stage 1A||0
6421331|NCT00996892|7335790|FG005|STARTED|Dose-Escalation Stage 1A||0
6421332|NCT00996892|7335791|FG006|STARTED|Dose-Escalation Stage 1A||0
6421333|NCT00996892|7335792|FG007|STARTED|Dose-Escalation Stage 1A||3
6421334|NCT00996892|7335793|FG008|STARTED|Dose-Escalation Stage 1A||3
6421335|NCT00996892|7335794|FG009|STARTED|Dose-Escalation Stage 1A||4
6421336|NCT00996892|7335795|FG010|STARTED|Dose-Escalation Stage 1A||7
6421337|NCT00996892|7335796|FG011|STARTED|Dose-Escalation Stage 1A||9
6421338|NCT00996892|7335797|FG012|STARTED|Dose-Escalation Stage 1A||8
6421339|NCT00996892|7335798|FG013|STARTED|Dose-Escalation Stage 1A||5
6421340|NCT00996892|7335799|FG014|STARTED|Dose-Escalation Stage 1A||0
6421341|NCT00996892|7335800|FG015|STARTED|Dose-Escalation Stage 1A||0
6421342|NCT00996892|7335801|FG016|STARTED|Dose-Escalation Stage 1A||0
6421343|NCT00996892|7335802|FG017|STARTED|Dose-Escalation Stage 1A||0
6421344|NCT00996892|7335803|FG018|STARTED|Dose-Escalation Stage 1A||0
6421345|NCT00996892|7335804|FG019|STARTED|Dose-Escalation Stage 1A||0
6421346|NCT00996892|7335785|FG000|COMPLETED|Dose-Escalation Stage 1A||0
6421347|NCT00996892|7335786|FG001|COMPLETED|Dose-Escalation Stage 1A||0
6421348|NCT00996892|7335787|FG002|COMPLETED|Dose-Escalation Stage 1A||0
6421349|NCT00996892|7335788|FG003|COMPLETED|Dose-Escalation Stage 1A||0
6421350|NCT00996892|7335789|FG004|COMPLETED|Dose-Escalation Stage 1A||0
6421351|NCT00996892|7335790|FG005|COMPLETED|Dose-Escalation Stage 1A||0
6421352|NCT00996892|7335791|FG006|COMPLETED|Dose-Escalation Stage 1A||0
6421353|NCT00996892|7335792|FG007|COMPLETED|Dose-Escalation Stage 1A||0
6421354|NCT00996892|7335793|FG008|COMPLETED|Dose-Escalation Stage 1A||0
6421355|NCT00996892|7335794|FG009|COMPLETED|Dose-Escalation Stage 1A||0
6421356|NCT00996892|7335795|FG010|COMPLETED|Dose-Escalation Stage 1A||0
6421357|NCT00996892|7335796|FG011|COMPLETED|Dose-Escalation Stage 1A||0
6421358|NCT00996892|7335797|FG012|COMPLETED|Dose-Escalation Stage 1A||0
6421359|NCT00996892|7335798|FG013|COMPLETED|Dose-Escalation Stage 1A||0
6421360|NCT00996892|7335799|FG014|COMPLETED|Dose-Escalation Stage 1A||0
6421361|NCT00996892|7335800|FG015|COMPLETED|Dose-Escalation Stage 1A||0
6421362|NCT00996892|7335801|FG016|COMPLETED|Dose-Escalation Stage 1A||0
6421363|NCT00996892|7335802|FG017|COMPLETED|Dose-Escalation Stage 1A||0
6421364|NCT00996892|7335803|FG018|COMPLETED|Dose-Escalation Stage 1A||0
6421365|NCT00996892|7335804|FG019|COMPLETED|Dose-Escalation Stage 1A||0
6421366|NCT00996892|7335785|FG000|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421367|NCT00996892|7335786|FG001|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421368|NCT00996892|7335787|FG002|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421369|NCT00996892|7335788|FG003|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421370|NCT00996892|7335789|FG004|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421371|NCT00996892|7335790|FG005|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421372|NCT00996892|7335791|FG006|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421373|NCT00996892|7335792|FG007|NOT COMPLETED|Dose-Escalation Stage 1A||3
6421374|NCT00996892|7335793|FG008|NOT COMPLETED|Dose-Escalation Stage 1A||3
6421375|NCT00996892|7335794|FG009|NOT COMPLETED|Dose-Escalation Stage 1A||4
6421376|NCT00996892|7335795|FG010|NOT COMPLETED|Dose-Escalation Stage 1A||7
6421377|NCT00996892|7335796|FG011|NOT COMPLETED|Dose-Escalation Stage 1A||9
6421378|NCT00996892|7335797|FG012|NOT COMPLETED|Dose-Escalation Stage 1A||8
6421379|NCT00996892|7335798|FG013|NOT COMPLETED|Dose-Escalation Stage 1A||5
6421380|NCT00996892|7335799|FG014|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421381|NCT00996892|7335800|FG015|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421382|NCT00996892|7335801|FG016|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421383|NCT00996892|7335802|FG017|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421384|NCT00996892|7335803|FG018|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421385|NCT00996892|7335804|FG019|NOT COMPLETED|Dose-Escalation Stage 1A||0
6421386|NCT00996892|7335785|FG000|STARTED|Dose-Escalation Stage 1B||0
6421387|NCT00996892|7335786|FG001|STARTED|Dose-Escalation Stage 1B||0
6421388|NCT00996892|7335787|FG002|STARTED|Dose-Escalation Stage 1B||0
6421389|NCT00996892|7335788|FG003|STARTED|Dose-Escalation Stage 1B||0
6421390|NCT00996892|7335789|FG004|STARTED|Dose-Escalation Stage 1B||0
6421391|NCT00996892|7335790|FG005|STARTED|Dose-Escalation Stage 1B||0
6421392|NCT00996892|7335791|FG006|STARTED|Dose-Escalation Stage 1B||0
6421393|NCT00996892|7335792|FG007|STARTED|Dose-Escalation Stage 1B||0
6421394|NCT00996892|7335793|FG008|STARTED|Dose-Escalation Stage 1B||0
6421395|NCT00996892|7335794|FG009|STARTED|Dose-Escalation Stage 1B||0
6421396|NCT00996892|7335795|FG010|STARTED|Dose-Escalation Stage 1B||0
6421397|NCT00996892|7335796|FG011|STARTED|Dose-Escalation Stage 1B||0
6421398|NCT00996892|7335797|FG012|STARTED|Dose-Escalation Stage 1B||0
6421399|NCT00996892|7335798|FG013|STARTED|Dose-Escalation Stage 1B||0
6421400|NCT00996892|7335799|FG014|STARTED|Dose-Escalation Stage 1B||4
6421401|NCT00996892|7335800|FG015|STARTED|Dose-Escalation Stage 1B||3
6421402|NCT00996892|7335801|FG016|STARTED|Dose-Escalation Stage 1B||3
6421403|NCT00996892|7335802|FG017|STARTED|Dose-Escalation Stage 1B||5
6421404|NCT00996892|7335803|FG018|STARTED|Dose-Escalation Stage 1B||0
6421405|NCT00996892|7335804|FG019|STARTED|Dose-Escalation Stage 1B||0
6421406|NCT00996892|7335785|FG000|COMPLETED|Dose-Escalation Stage 1B||0
6421407|NCT00996892|7335786|FG001|COMPLETED|Dose-Escalation Stage 1B||0
6421408|NCT00996892|7335787|FG002|COMPLETED|Dose-Escalation Stage 1B||0
6421409|NCT00996892|7335788|FG003|COMPLETED|Dose-Escalation Stage 1B||0
6421410|NCT00996892|7335789|FG004|COMPLETED|Dose-Escalation Stage 1B||0
6421411|NCT00996892|7335790|FG005|COMPLETED|Dose-Escalation Stage 1B||0
6421412|NCT00996892|7335791|FG006|COMPLETED|Dose-Escalation Stage 1B||0
6421413|NCT00996892|7335792|FG007|COMPLETED|Dose-Escalation Stage 1B||0
6421414|NCT00996892|7335793|FG008|COMPLETED|Dose-Escalation Stage 1B||0
6421415|NCT00996892|7335794|FG009|COMPLETED|Dose-Escalation Stage 1B||0
6421416|NCT00996892|7335795|FG010|COMPLETED|Dose-Escalation Stage 1B||0
6421417|NCT00996892|7335796|FG011|COMPLETED|Dose-Escalation Stage 1B||0
6421418|NCT00996892|7335797|FG012|COMPLETED|Dose-Escalation Stage 1B||0
6421419|NCT00996892|7335798|FG013|COMPLETED|Dose-Escalation Stage 1B||0
6421420|NCT00996892|7335799|FG014|COMPLETED|Dose-Escalation Stage 1B||0
6421421|NCT00996892|7335800|FG015|COMPLETED|Dose-Escalation Stage 1B||0
6421422|NCT00996892|7335801|FG016|COMPLETED|Dose-Escalation Stage 1B||0
6640080|NCT02332707|7568277|FG015|NOT COMPLETED|Overall Study||0
6640081|NCT02332707|7568278|FG016|NOT COMPLETED|Overall Study||0
6640082|NCT02332707|7568279|FG017|NOT COMPLETED|Overall Study||0
6640083|NCT02332720|7568340|FG000|STARTED|Part A and Part B||21
6640084|NCT02332720|7568341|FG001|STARTED|Part A and Part B||21
6640085|NCT02332720|7568342|FG002|STARTED|Part A and Part B||22
6640086|NCT02332720|7568343|FG003|STARTED|Part A and Part B||22
6421423|NCT00996892|7335802|FG017|COMPLETED|Dose-Escalation Stage 1B||0
6421424|NCT00996892|7335803|FG018|COMPLETED|Dose-Escalation Stage 1B||0
6421425|NCT00996892|7335804|FG019|COMPLETED|Dose-Escalation Stage 1B||0
6421426|NCT00996892|7335785|FG000|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421427|NCT00996892|7335786|FG001|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421428|NCT00996892|7335787|FG002|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421429|NCT00996892|7335788|FG003|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421430|NCT00996892|7335789|FG004|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421431|NCT00996892|7335790|FG005|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421432|NCT00996892|7335791|FG006|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421433|NCT00996892|7335792|FG007|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421434|NCT00996892|7335793|FG008|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421435|NCT00996892|7335794|FG009|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421436|NCT00996892|7335795|FG010|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421437|NCT00996892|7335796|FG011|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421438|NCT00996892|7335797|FG012|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421439|NCT00996892|7335798|FG013|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421440|NCT00996892|7335799|FG014|NOT COMPLETED|Dose-Escalation Stage 1B||4
6421441|NCT00996892|7335800|FG015|NOT COMPLETED|Dose-Escalation Stage 1B||3
6421442|NCT00996892|7335801|FG016|NOT COMPLETED|Dose-Escalation Stage 1B||3
6421443|NCT00996892|7335802|FG017|NOT COMPLETED|Dose-Escalation Stage 1B||5
6421444|NCT00996892|7335803|FG018|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421445|NCT00996892|7335804|FG019|NOT COMPLETED|Dose-Escalation Stage 1B||0
6421446|NCT00996892|7335785|FG000|STARTED|Expansion Stage 2||0
6421447|NCT00996892|7335786|FG001|STARTED|Expansion Stage 2||0
6421448|NCT00996892|7335787|FG002|STARTED|Expansion Stage 2||0
6421449|NCT00996892|7335788|FG003|STARTED|Expansion Stage 2||0
6421450|NCT00996892|7335789|FG004|STARTED|Expansion Stage 2||0
6421451|NCT00996892|7335790|FG005|STARTED|Expansion Stage 2||0
6421452|NCT00996892|7335791|FG006|STARTED|Expansion Stage 2||0
6421453|NCT00996892|7335792|FG007|STARTED|Expansion Stage 2||0
6421454|NCT00996892|7335793|FG008|STARTED|Expansion Stage 2||0
6421455|NCT00996892|7335794|FG009|STARTED|Expansion Stage 2||0
6421456|NCT00996892|7335795|FG010|STARTED|Expansion Stage 2||0
6421457|NCT00996892|7335796|FG011|STARTED|Expansion Stage 2||0
6421458|NCT00996892|7335797|FG012|STARTED|Expansion Stage 2||0
6421459|NCT00996892|7335798|FG013|STARTED|Expansion Stage 2||0
6421460|NCT00996892|7335799|FG014|STARTED|Expansion Stage 2||0
6421461|NCT00996892|7335800|FG015|STARTED|Expansion Stage 2||0
6421462|NCT00996892|7335801|FG016|STARTED|Expansion Stage 2||0
6421463|NCT00996892|7335802|FG017|STARTED|Expansion Stage 2||0
6421464|NCT00996892|7335803|FG018|STARTED|Expansion Stage 2||35
6421465|NCT00996892|7335804|FG019|STARTED|Expansion Stage 2||0
6421466|NCT00996892|7335785|FG000|COMPLETED|Expansion Stage 2||0
6421467|NCT00996892|7335786|FG001|COMPLETED|Expansion Stage 2||0
6421468|NCT00996892|7335787|FG002|COMPLETED|Expansion Stage 2||0
6421469|NCT00996892|7335788|FG003|COMPLETED|Expansion Stage 2||0
6421470|NCT00996892|7335789|FG004|COMPLETED|Expansion Stage 2||0
6421471|NCT00996892|7335790|FG005|COMPLETED|Expansion Stage 2||0
6421472|NCT00996892|7335791|FG006|COMPLETED|Expansion Stage 2||0
6421473|NCT00996892|7335792|FG007|COMPLETED|Expansion Stage 2||0
6421474|NCT00996892|7335793|FG008|COMPLETED|Expansion Stage 2||0
6421475|NCT00996892|7335794|FG009|COMPLETED|Expansion Stage 2||0
6421476|NCT00996892|7335795|FG010|COMPLETED|Expansion Stage 2||0
6421477|NCT00996892|7335796|FG011|COMPLETED|Expansion Stage 2||0
6421478|NCT00996892|7335797|FG012|COMPLETED|Expansion Stage 2||0
6421479|NCT00996892|7335798|FG013|COMPLETED|Expansion Stage 2||0
6421480|NCT00996892|7335799|FG014|COMPLETED|Expansion Stage 2||0
6421481|NCT00996892|7335800|FG015|COMPLETED|Expansion Stage 2||0
6421482|NCT00996892|7335801|FG016|COMPLETED|Expansion Stage 2||0
6421483|NCT00996892|7335802|FG017|COMPLETED|Expansion Stage 2||0
6421484|NCT00996892|7335803|FG018|COMPLETED|Expansion Stage 2||0
6421485|NCT00996892|7335804|FG019|COMPLETED|Expansion Stage 2||0
6421486|NCT00996892|7335785|FG000|NOT COMPLETED|Expansion Stage 2||0
6421487|NCT00996892|7335786|FG001|NOT COMPLETED|Expansion Stage 2||0
6421488|NCT00996892|7335787|FG002|NOT COMPLETED|Expansion Stage 2||0
6421489|NCT00996892|7335788|FG003|NOT COMPLETED|Expansion Stage 2||0
6421490|NCT00996892|7335789|FG004|NOT COMPLETED|Expansion Stage 2||0
6421491|NCT00996892|7335790|FG005|NOT COMPLETED|Expansion Stage 2||0
6421492|NCT00996892|7335791|FG006|NOT COMPLETED|Expansion Stage 2||0
6421493|NCT00996892|7335792|FG007|NOT COMPLETED|Expansion Stage 2||0
6421494|NCT00996892|7335793|FG008|NOT COMPLETED|Expansion Stage 2||0
6421495|NCT00996892|7335794|FG009|NOT COMPLETED|Expansion Stage 2||0
6640087|NCT02332720|7568344|FG004|STARTED|Part A and Part B||16
6640088|NCT02332720|7568345|FG005|STARTED|Part A and Part B||36
6640089|NCT02332720|7568346|FG006|STARTED|Part A and Part B||37
6640090|NCT02332720|7568347|FG007|STARTED|Part A and Part B||35
6421496|NCT00996892|7335795|FG010|NOT COMPLETED|Expansion Stage 2||0
6421497|NCT00996892|7335796|FG011|NOT COMPLETED|Expansion Stage 2||0
6421498|NCT00996892|7335797|FG012|NOT COMPLETED|Expansion Stage 2||0
6421499|NCT00996892|7335798|FG013|NOT COMPLETED|Expansion Stage 2||0
6421500|NCT00996892|7335799|FG014|NOT COMPLETED|Expansion Stage 2||0
6421501|NCT00996892|7335800|FG015|NOT COMPLETED|Expansion Stage 2||0
6421502|NCT00996892|7335801|FG016|NOT COMPLETED|Expansion Stage 2||0
6421503|NCT00996892|7335802|FG017|NOT COMPLETED|Expansion Stage 2||0
6421504|NCT00996892|7335803|FG018|NOT COMPLETED|Expansion Stage 2||35
6421505|NCT00996892|7335804|FG019|NOT COMPLETED|Expansion Stage 2||0
6421506|NCT00996892|7335785|FG000|STARTED|Expansion Stage 2A||0
6421507|NCT00996892|7335786|FG001|STARTED|Expansion Stage 2A||0
6421508|NCT00996892|7335787|FG002|STARTED|Expansion Stage 2A||0
6421509|NCT00996892|7335788|FG003|STARTED|Expansion Stage 2A||0
6421510|NCT00996892|7335789|FG004|STARTED|Expansion Stage 2A||0
6421511|NCT00996892|7335790|FG005|STARTED|Expansion Stage 2A||0
6421512|NCT00996892|7335791|FG006|STARTED|Expansion Stage 2A||0
6421513|NCT00996892|7335792|FG007|STARTED|Expansion Stage 2A||0
6421514|NCT00996892|7335793|FG008|STARTED|Expansion Stage 2A||0
6421515|NCT00996892|7335794|FG009|STARTED|Expansion Stage 2A||0
6421516|NCT00996892|7335795|FG010|STARTED|Expansion Stage 2A||0
6421517|NCT00996892|7335796|FG011|STARTED|Expansion Stage 2A||0
6421518|NCT00996892|7335797|FG012|STARTED|Expansion Stage 2A||0
6421519|NCT00996892|7335798|FG013|STARTED|Expansion Stage 2A||0
6421520|NCT00996892|7335799|FG014|STARTED|Expansion Stage 2A||0
6421521|NCT00996892|7335800|FG015|STARTED|Expansion Stage 2A||0
6421522|NCT00996892|7335801|FG016|STARTED|Expansion Stage 2A||0
6421523|NCT00996892|7335802|FG017|STARTED|Expansion Stage 2A||0
6421524|NCT00996892|7335803|FG018|STARTED|Expansion Stage 2A||0
6421525|NCT00996892|7335804|FG019|STARTED|Expansion Stage 2A||45
6421526|NCT00996892|7335785|FG000|COMPLETED|Expansion Stage 2A||0
6421527|NCT00996892|7335786|FG001|COMPLETED|Expansion Stage 2A||0
6421528|NCT00996892|7335787|FG002|COMPLETED|Expansion Stage 2A||0
6421529|NCT00996892|7335788|FG003|COMPLETED|Expansion Stage 2A||0
6421530|NCT00996892|7335789|FG004|COMPLETED|Expansion Stage 2A||0
6421531|NCT00996892|7335790|FG005|COMPLETED|Expansion Stage 2A||0
6421532|NCT00996892|7335791|FG006|COMPLETED|Expansion Stage 2A||0
6421533|NCT00996892|7335792|FG007|COMPLETED|Expansion Stage 2A||0
6421534|NCT00996892|7335793|FG008|COMPLETED|Expansion Stage 2A||0
6421535|NCT00996892|7335794|FG009|COMPLETED|Expansion Stage 2A||0
6421536|NCT00996892|7335795|FG010|COMPLETED|Expansion Stage 2A||0
6421537|NCT00996892|7335796|FG011|COMPLETED|Expansion Stage 2A||0
6421538|NCT00996892|7335797|FG012|COMPLETED|Expansion Stage 2A||0
6421539|NCT00996892|7335798|FG013|COMPLETED|Expansion Stage 2A||0
6421540|NCT00996892|7335799|FG014|COMPLETED|Expansion Stage 2A||0
6421541|NCT00996892|7335800|FG015|COMPLETED|Expansion Stage 2A||0
6421542|NCT00996892|7335801|FG016|COMPLETED|Expansion Stage 2A||0
6421543|NCT00996892|7335802|FG017|COMPLETED|Expansion Stage 2A||0
6421544|NCT00996892|7335803|FG018|COMPLETED|Expansion Stage 2A||0
6421545|NCT00996892|7335804|FG019|COMPLETED|Expansion Stage 2A||0
6421546|NCT00996892|7335785|FG000|NOT COMPLETED|Expansion Stage 2A||0
6421547|NCT00996892|7335786|FG001|NOT COMPLETED|Expansion Stage 2A||0
6421548|NCT00996892|7335787|FG002|NOT COMPLETED|Expansion Stage 2A||0
6421549|NCT00996892|7335788|FG003|NOT COMPLETED|Expansion Stage 2A||0
6421550|NCT00996892|7335789|FG004|NOT COMPLETED|Expansion Stage 2A||0
6421551|NCT00996892|7335790|FG005|NOT COMPLETED|Expansion Stage 2A||0
6421552|NCT00996892|7335791|FG006|NOT COMPLETED|Expansion Stage 2A||0
6421553|NCT00996892|7335792|FG007|NOT COMPLETED|Expansion Stage 2A||0
6421554|NCT00996892|7335793|FG008|NOT COMPLETED|Expansion Stage 2A||0
6421555|NCT00996892|7335794|FG009|NOT COMPLETED|Expansion Stage 2A||0
6421556|NCT00996892|7335795|FG010|NOT COMPLETED|Expansion Stage 2A||0
6421557|NCT00996892|7335796|FG011|NOT COMPLETED|Expansion Stage 2A||0
6421558|NCT00996892|7335797|FG012|NOT COMPLETED|Expansion Stage 2A||0
6421559|NCT00996892|7335798|FG013|NOT COMPLETED|Expansion Stage 2A||0
6421560|NCT00996892|7335799|FG014|NOT COMPLETED|Expansion Stage 2A||0
6421561|NCT00996892|7335800|FG015|NOT COMPLETED|Expansion Stage 2A||0
6421562|NCT00996892|7335801|FG016|NOT COMPLETED|Expansion Stage 2A||0
6421563|NCT00996892|7335802|FG017|NOT COMPLETED|Expansion Stage 2A||0
6421564|NCT00996892|7335803|FG018|NOT COMPLETED|Expansion Stage 2A||0
6421565|NCT00996892|7335804|FG019|NOT COMPLETED|Expansion Stage 2A||45
6421566|NCT00996918|7335870|FG000|STARTED|Overall Study||39
6421567|NCT00996918|7335871|FG001|STARTED|Overall Study||66
6421568|NCT00996918|7335872|FG002|STARTED|Overall Study||37
6421569|NCT00996918|7335873|FG003|STARTED|Overall Study||56
6421570|NCT00996918|7335874|FG004|STARTED|Overall Study||4
6421571|NCT00996918|7335870|FG000|Treated|Overall Study||39
6421572|NCT00996918|7335871|FG001|Treated|Overall Study||66
6421573|NCT00996918|7335872|FG002|Treated|Overall Study||37
6421574|NCT00996918|7335873|FG003|Treated|Overall Study||56
6421575|NCT00996918|7335874|FG004|Treated|Overall Study||4
6421576|NCT00996918|7335870|FG000|COMPLETED|Overall Study||0
6421577|NCT00996918|7335871|FG001|COMPLETED|Overall Study||0
6421578|NCT00996918|7335872|FG002|COMPLETED|Overall Study||0
6421579|NCT00996918|7335873|FG003|COMPLETED|Overall Study||0
6421580|NCT00996918|7335874|FG004|COMPLETED|Overall Study||0
6421581|NCT00996918|7335870|FG000|NOT COMPLETED|Overall Study||39
6421582|NCT00996918|7335871|FG001|NOT COMPLETED|Overall Study||66
6421583|NCT00996918|7335872|FG002|NOT COMPLETED|Overall Study||37
6421584|NCT00996918|7335873|FG003|NOT COMPLETED|Overall Study||56
6421585|NCT00996918|7335874|FG004|NOT COMPLETED|Overall Study||4
6421586|NCT00996931|7335886|FG000|STARTED|Overall Study||6
6421587|NCT00996931|7335886|FG000|COMPLETED|Overall Study||6
6421588|NCT00996931|7335886|FG000|NOT COMPLETED|Overall Study||0
6421589|NCT00996944|7335893|FG000|STARTED|Double-blind Treatment Period||22
6421590|NCT00996944|7335894|FG001|STARTED|Double-blind Treatment Period||12
6421591|NCT00996944|7335893|FG000|COMPLETED|Double-blind Treatment Period||12
6421592|NCT00996944|7335894|FG001|COMPLETED|Double-blind Treatment Period||5
6421593|NCT00996944|7335893|FG000|NOT COMPLETED|Double-blind Treatment Period||10
6421594|NCT00996944|7335894|FG001|NOT COMPLETED|Double-blind Treatment Period||7
6421595|NCT00996944|7335893|FG000|STARTED|Long-term Treatment Period||12
6421596|NCT00996944|7335894|FG001|STARTED|Long-term Treatment Period||5
6421597|NCT00996944|7335893|FG000|COMPLETED|Long-term Treatment Period||0
6421598|NCT00996944|7335894|FG001|COMPLETED|Long-term Treatment Period||0
6421599|NCT00996944|7335893|FG000|NOT COMPLETED|Long-term Treatment Period||12
6421600|NCT00996944|7335894|FG001|NOT COMPLETED|Long-term Treatment Period||5
6421601|NCT00996996|7335902|FG000|STARTED|Overall Study||77
6421602|NCT00996996|7335902|FG000|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
6421603|NCT00996996|7335902|FG000|NOT COMPLETED|Overall Study||33
6421604|NCT00997035|7335908|FG000|STARTED|3-week Followup Visit||121
6421605|NCT00997035|7335909|FG001|STARTED|3-week Followup Visit||119
6421606|NCT00997035|7335908|FG000|COMPLETED|3-week Followup Visit||112
6421607|NCT00997035|7335909|FG001|COMPLETED|3-week Followup Visit||113
6421608|NCT00997035|7335908|FG000|NOT COMPLETED|3-week Followup Visit||9
6421609|NCT00997035|7335909|FG001|NOT COMPLETED|3-week Followup Visit||6
6421610|NCT00997035|7335908|FG000|STARTED|3-month Follow-up Visit||112
6421611|NCT00997035|7335909|FG001|STARTED|3-month Follow-up Visit||113
6421612|NCT00997035|7335908|FG000|COMPLETED|3-month Follow-up Visit||100
6421613|NCT00997035|7335909|FG001|COMPLETED|3-month Follow-up Visit||107
6421614|NCT00997035|7335908|FG000|NOT COMPLETED|3-month Follow-up Visit||12
6421615|NCT00997035|7335909|FG001|NOT COMPLETED|3-month Follow-up Visit||6
6421616|NCT00997113|7335927|FG000|STARTED|Overall Study||10
6421617|NCT00997113|7335928|FG001|STARTED|Overall Study||10
6421618|NCT00997113|7335927|FG000|COMPLETED|Overall Study||10
6421619|NCT00997113|7335928|FG001|COMPLETED|Overall Study||10
6421620|NCT00997113|7335927|FG000|NOT COMPLETED|Overall Study||0
6421621|NCT00997113|7335928|FG001|NOT COMPLETED|Overall Study||0
6421622|NCT00997126|7335936|FG000|STARTED|Overall Study||63
6421623|NCT00997126|7335937|FG001|STARTED|Overall Study||63
6421624|NCT00997126|7335936|FG000|COMPLETED|Overall Study||56
6421625|NCT00997126|7335937|FG001|COMPLETED|Overall Study||52
6421626|NCT00997126|7335936|FG000|NOT COMPLETED|Overall Study||7
6421627|NCT00997126|7335937|FG001|NOT COMPLETED|Overall Study||11
6421628|NCT00997139|7335943|FG000|STARTED|Overall Study||216
6421629|NCT00997139|7335943|FG000|Treated for Positive Baseline Culture|Overall Study||30
6421630|NCT00997139|7335943|FG000|COMPLETED|Overall Study||30
6421631|NCT00997139|7335943|FG000|NOT COMPLETED|Overall Study||186
6421632|NCT00997204|7335951|FG000|STARTED|Naive Treatment Phase||25
6421633|NCT00997204|7335952|FG001|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
6421634|NCT00997204|7335951|FG000|COMPLETED|Naive Treatment Phase||19
6421635|NCT00997204|7335952|FG001|COMPLETED|Naive Treatment Phase||0
6421636|NCT00997204|7335951|FG000|NOT COMPLETED|Naive Treatment Phase||6
6421637|NCT00997204|7335952|FG001|NOT COMPLETED|Naive Treatment Phase||79
6421638|NCT00997204|7335951|FG000|STARTED|Self-administration Phase||19
6421639|NCT00997204|7335952|FG001|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
6421640|NCT00997204|7335951|FG000|COMPLETED|Self-administration Phase||19
6421641|NCT00997204|7335952|FG001|COMPLETED|Self-administration Phase||77
6421642|NCT00997204|7335951|FG000|NOT COMPLETED|Self-administration Phase||0
6421643|NCT00997204|7335952|FG001|NOT COMPLETED|Self-administration Phase||1
6421644|NCT00997243|7335962|FG000|STARTED|Overall Study||7
6421645|NCT00997243|7335962|FG000|COMPLETED|Overall Study||0
6421646|NCT00997243|7335962|FG000|NOT COMPLETED|Overall Study||7
6421647|NCT00997321|7335968|FG000|STARTED|Overall Study||50
6421648|NCT00997321|7335969|FG001|STARTED|Overall Study||50
6421649|NCT00997321|7335968|FG000|COMPLETED|Overall Study||50
6421650|NCT00997321|7335969|FG001|COMPLETED|Overall Study||47
6421651|NCT00997321|7335968|FG000|NOT COMPLETED|Overall Study||0
6640091|NCT02332720|7568348|FG008|STARTED|Part A and Part B||15
6640092|NCT02332720|7568349|FG009|STARTED|Part A and Part B||14
6421652|NCT00997321|7335969|FG001|NOT COMPLETED|Overall Study||3
6421653|NCT00997334|7335981|FG000|STARTED|Overall Study||60
6421654|NCT00997334|7335981|FG000|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
6421655|NCT00997334|7335981|FG000|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
6421656|NCT00997334|7335981|FG000|COMPLETED|Overall Study||35
6421657|NCT00997334|7335981|FG000|NOT COMPLETED|Overall Study||25
6421658|NCT00997373|7335987|FG000|STARTED|Overall Study||28
6421659|NCT00997373|7335988|FG001|STARTED|Overall Study||15
6421660|NCT00997373|7335987|FG000|Received Letrozole|Overall Study||23
6421661|NCT00997373|7335988|FG001|Received Letrozole|Overall Study||0
6421662|NCT00997373|7335987|FG000|Completed Hysterectomy|Overall Study||17
6421663|NCT00997373|7335988|FG001|Completed Hysterectomy|Overall Study||15
6640093|NCT02332720|7568350|FG010|STARTED|Part A and Part B||14
6640094|NCT02332720|7568351|FG011|STARTED|Part A and Part B||15
6421664|NCT00997373|7335987|FG000|COMPLETED|Overall Study||13
6421665|NCT00997373|7335988|FG001|COMPLETED|Overall Study||15
6421666|NCT00997373|7335987|FG000|NOT COMPLETED|Overall Study||15
6421667|NCT00997373|7335988|FG001|NOT COMPLETED|Overall Study||0
6421668|NCT00997425|7335994|FG000|STARTED|Overall Study||19
6421669|NCT00997425|7335994|FG000|COMPLETED|Overall Study||19
6421670|NCT00997425|7335994|FG000|NOT COMPLETED|Overall Study||0
6421671|NCT00997438|7336002|FG000|STARTED|Overall Study||21
6421672|NCT00997438|7336003|FG001|STARTED|Overall Study||24
6421673|NCT00997438|7336004|FG002|STARTED|Overall Study||24
6421674|NCT00997438|7336002|FG000|COMPLETED|Overall Study||16
6421675|NCT00997438|7336003|FG001|COMPLETED|Overall Study||21
6421676|NCT00997438|7336004|FG002|COMPLETED|Overall Study||20
6421677|NCT00997438|7336002|FG000|NOT COMPLETED|Overall Study||5
6421678|NCT00997438|7336003|FG001|NOT COMPLETED|Overall Study||3
6421679|NCT00997438|7336004|FG002|NOT COMPLETED|Overall Study||4
6421680|NCT00997503|7336013|FG000|STARTED|Overall Study||4199
6421681|NCT00997503|7336013|FG000|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
6421682|NCT00997503|7336013|FG000|COMPLETED|Overall Study||3926
6421683|NCT00997503|7336013|FG000|NOT COMPLETED|Overall Study||273
6421684|NCT00997516|7336022|FG000|STARTED|Short-term Follow-up (Post Operative)||37
6421685|NCT00997516|7336023|FG001|STARTED|Short-term Follow-up (Post Operative)||38
6421686|NCT00997516|7336022|FG000|COMPLETED|Short-term Follow-up (Post Operative)||37
6421687|NCT00997516|7336023|FG001|COMPLETED|Short-term Follow-up (Post Operative)||38
6421688|NCT00997516|7336022|FG000|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
6421689|NCT00997516|7336023|FG001|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
6421690|NCT00997516|7336022|FG000|STARTED|Long-term Follow-up (After 6 Months)||37
6421691|NCT00997516|7336023|FG001|STARTED|Long-term Follow-up (After 6 Months)||38
6421692|NCT00997516|7336022|FG000|COMPLETED|Long-term Follow-up (After 6 Months)||31
6421693|NCT00997516|7336023|FG001|COMPLETED|Long-term Follow-up (After 6 Months)||36
6421694|NCT00997516|7336022|FG000|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
6421695|NCT00997516|7336023|FG001|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
6421696|NCT00997555|7336031|FG000|STARTED|Overall Study||13
6421697|NCT00997555|7336032|FG001|STARTED|Overall Study||15
6421698|NCT00997555|7336031|FG000|COMPLETED|Overall Study||13
6421699|NCT00997555|7336032|FG001|COMPLETED|Overall Study||15
6421700|NCT00997555|7336031|FG000|NOT COMPLETED|Overall Study||0
6421701|NCT00997555|7336032|FG001|NOT COMPLETED|Overall Study||0
6421702|NCT00997594|7336040|FG000|STARTED|Overall Study||9
6421703|NCT00997594|7336041|FG001|STARTED|Overall Study||9
6421704|NCT00997594|7336040|FG000|Completion of Ablation Procedure|Overall Study||9
6421705|NCT00997594|7336041|FG001|Completion of Ablation Procedure|Overall Study||9
6421706|NCT00997594|7336040|FG000|COMPLETED|Overall Study||9
6421707|NCT00997594|7336041|FG001|COMPLETED|Overall Study||9
6421708|NCT00997594|7336040|FG000|NOT COMPLETED|Overall Study||0
6421709|NCT00997594|7336041|FG001|NOT COMPLETED|Overall Study||0
6421710|NCT00997620|7336049|FG000|STARTED|Overall Study||19
6421711|NCT00997620|7336050|FG001|STARTED|Overall Study||21
6421712|NCT00997620|7336049|FG000|COMPLETED|Overall Study||19
6421713|NCT00997620|7336050|FG001|COMPLETED|Overall Study||21
6421714|NCT00997620|7336049|FG000|NOT COMPLETED|Overall Study||0
6421715|NCT00997620|7336050|FG001|NOT COMPLETED|Overall Study||0
6421716|NCT00997672|7336061|FG000|STARTED|Overall Study||4
6421717|NCT00997672|7336062|FG001|STARTED|Overall Study||5
6421718|NCT00997672|7336061|FG000|COMPLETED|Overall Study||0
6421719|NCT00997672|7336062|FG001|COMPLETED|Overall Study||1
6421720|NCT00997672|7336061|FG000|NOT COMPLETED|Overall Study||4
6421721|NCT00997672|7336062|FG001|NOT COMPLETED|Overall Study||4
6421722|NCT00997893|7336071|FG000|STARTED|Overall Study||14
6421723|NCT00997893|7336072|FG001|STARTED|Overall Study||13
6421724|NCT00997893|7336073|FG002|STARTED|Overall Study||13
6421725|NCT00997893|7336071|FG000|COMPLETED|Overall Study||12
6421726|NCT00997893|7336072|FG001|COMPLETED|Overall Study||12
6421727|NCT00997893|7336073|FG002|COMPLETED|Overall Study||13
6421728|NCT00997893|7336071|FG000|NOT COMPLETED|Overall Study||2
6421729|NCT00997893|7336072|FG001|NOT COMPLETED|Overall Study||1
6421730|NCT00997893|7336073|FG002|NOT COMPLETED|Overall Study||0
6421731|NCT00997932|7336081|FG000|STARTED|Overall Study||29
6421732|NCT00997932|7336081|FG000|COMPLETED|Overall Study||27
6421733|NCT00997932|7336081|FG000|NOT COMPLETED|Overall Study||2
6421734|NCT00997984|7336089|FG000|STARTED|Overall Study||113
6421735|NCT00997984|7336090|FG001|STARTED|Overall Study||113
6421736|NCT00997984|7336091|FG002|STARTED|Overall Study||114
6421737|NCT00997984|7336089|FG000|COMPLETED|Overall Study||76
6510836|NCT01484431|7430418|FG000|STARTED|Period 1: Low Dose||6
6421738|NCT00997984|7336090|FG001|COMPLETED|Overall Study||79
6421739|NCT00997984|7336091|FG002|COMPLETED|Overall Study||88
6510837|NCT01484431|7430419|FG001|STARTED|Period 1: Low Dose||7
6421740|NCT00997984|7336089|FG000|NOT COMPLETED|Overall Study||37
6421741|NCT00997984|7336090|FG001|NOT COMPLETED|Overall Study||34
6421742|NCT00997984|7336091|FG002|NOT COMPLETED|Overall Study||26
6421743|NCT00998010|7336101|FG000|STARTED|Overall Study||24
6421744|NCT00998010|7336101|FG000|COMPLETED|Overall Study||24
6421745|NCT00998010|7336101|FG000|NOT COMPLETED|Overall Study||0
6421746|NCT00998023|7336107|FG000|STARTED|Overall Study||32
6421747|NCT00998023|7336108|FG001|STARTED|Overall Study||32
6421748|NCT00998023|7336107|FG000|COMPLETED|Overall Study||32
6421749|NCT00998023|7336108|FG001|COMPLETED|Overall Study||32
6421750|NCT00998023|7336107|FG000|NOT COMPLETED|Overall Study||0
6421751|NCT00998023|7336108|FG001|NOT COMPLETED|Overall Study||0
6421752|NCT00998049|7336114|FG000|STARTED|Overall Study||39
6421753|NCT00998049|7336114|FG000|COMPLETED|Overall Study||39
6421754|NCT00998049|7336114|FG000|NOT COMPLETED|Overall Study||0
6421755|NCT00998205|7336118|FG000|STARTED|Overall Study||16
6421756|NCT00998205|7336118|FG000|COMPLETED|Overall Study||16
6421757|NCT00998205|7336118|FG000|NOT COMPLETED|Overall Study||0
6421758|NCT00998296|7336134|FG000|STARTED|Overall Study||6
6421759|NCT00998296|7336135|FG001|STARTED|Overall Study||3
6421760|NCT00998296|7336136|FG002|STARTED|Overall Study||3
6421761|NCT00998296|7336137|FG003|STARTED|Overall Study||3
6421762|NCT00998296|7336138|FG004|STARTED|Overall Study||8
6421763|NCT00998296|7336139|FG005|STARTED|Overall Study||3
6421764|NCT00998296|7336140|FG006|STARTED|Overall Study||7
6421765|NCT00998296|7336141|FG007|STARTED|Overall Study||6
6421766|NCT00998296|7336142|FG008|STARTED|Overall Study||6
6421767|NCT00998296|7336143|FG009|STARTED|Overall Study||18
6421768|NCT00998296|7336144|FG010|STARTED|Overall Study||7
6421769|NCT00998296|7336134|FG000|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
6421770|NCT00998296|7336135|FG001|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
6421771|NCT00998296|7336136|FG002|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
6421772|NCT00998296|7336137|FG003|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
6421773|NCT00998296|7336138|FG004|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
6421774|NCT00998296|7336139|FG005|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
6421775|NCT00998296|7336140|FG006|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
6421776|NCT00998296|7336141|FG007|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
6421777|NCT00998296|7336142|FG008|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
6421778|NCT00998296|7336143|FG009|COMPLETED|Overall Study||0
6421779|NCT00998296|7336144|FG010|COMPLETED|Overall Study||0
6421780|NCT00998296|7336134|FG000|NOT COMPLETED|Overall Study||0
6421781|NCT00998296|7336135|FG001|NOT COMPLETED|Overall Study||1
6421782|NCT00998296|7336136|FG002|NOT COMPLETED|Overall Study||0
6421783|NCT00998296|7336137|FG003|NOT COMPLETED|Overall Study||0
6421784|NCT00998296|7336138|FG004|NOT COMPLETED|Overall Study||2
6421785|NCT00998296|7336139|FG005|NOT COMPLETED|Overall Study||0
6421786|NCT00998296|7336140|FG006|NOT COMPLETED|Overall Study||1
6421787|NCT00998296|7336141|FG007|NOT COMPLETED|Overall Study||2
6421788|NCT00998296|7336142|FG008|NOT COMPLETED|Overall Study||2
6421789|NCT00998296|7336143|FG009|NOT COMPLETED|Overall Study||18
6421790|NCT00998296|7336144|FG010|NOT COMPLETED|Overall Study||7
6421791|NCT00998309|7336173|FG000|STARTED|Overall Study||502
6421792|NCT00998309|7336173|FG000|COMPLETED|Overall Study||498
6421793|NCT00998309|7336173|FG000|NOT COMPLETED|Overall Study||4
6421794|NCT00998335|7336227|FG000|STARTED|Initial Treatment (Months 0 - 3)||30
6421795|NCT00998335|7336228|FG001|STARTED|Initial Treatment (Months 0 - 3)||0
6421796|NCT00998335|7336227|FG000|COMPLETED|Initial Treatment (Months 0 - 3)||30
6421797|NCT00998335|7336228|FG001|COMPLETED|Initial Treatment (Months 0 - 3)||0
6421798|NCT00998335|7336227|FG000|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
6421799|NCT00998335|7336228|FG001|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
6421800|NCT00998335|7336227|FG000|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
6421801|NCT00998335|7336228|FG001|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
6421802|NCT00998335|7336227|FG000|COMPLETED|Randomized Period (Months 3 to 6)||8
6421803|NCT00998335|7336228|FG001|COMPLETED|Randomized Period (Months 3 to 6)||20
6421804|NCT00998335|7336227|FG000|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
6421805|NCT00998335|7336228|FG001|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
6421806|NCT00998374|7336242|FG000|STARTED|Overall Study||39
6421807|NCT00998374|7336243|FG001|STARTED|Overall Study||23
6421808|NCT00998374|7336242|FG000|COMPLETED|Overall Study||27
6421809|NCT00998374|7336243|FG001|COMPLETED|Overall Study||12
6421810|NCT00998374|7336242|FG000|NOT COMPLETED|Overall Study||12
6421811|NCT00998374|7336243|FG001|NOT COMPLETED|Overall Study||11
6421812|NCT00998400|7336253|FG000|STARTED|Overall Study||50
6421813|NCT00998400|7336254|FG001|STARTED|Overall Study||50
6421814|NCT00998400|7336253|FG000|COMPLETED|Overall Study||48
6421815|NCT00998400|7336254|FG001|COMPLETED|Overall Study||48
6421816|NCT00998400|7336253|FG000|NOT COMPLETED|Overall Study||2
6421817|NCT00998400|7336254|FG001|NOT COMPLETED|Overall Study||2
6421818|NCT00998426|7336261|FG000|STARTED|Overall Study||5
6421819|NCT00998426|7336261|FG000|Blood Glucose Monitoring|Overall Study||5
6421820|NCT00998426|7336261|FG000|COMPLETED|Overall Study||5
6421821|NCT00998426|7336261|FG000|NOT COMPLETED|Overall Study||0
6421822|NCT00998517|7336269|FG000|STARTED|Overall Study||888
6421823|NCT00998517|7336270|FG001|STARTED|Overall Study||906
6421824|NCT00998517|7336271|FG002|STARTED|Overall Study||918
6421825|NCT00998517|7336269|FG000|COMPLETED|Overall Study||888
6421826|NCT00998517|7336270|FG001|COMPLETED|Overall Study||906
6421827|NCT00998517|7336271|FG002|COMPLETED|Overall Study||918
6421828|NCT00998517|7336269|FG000|NOT COMPLETED|Overall Study||0
6421829|NCT00998517|7336270|FG001|NOT COMPLETED|Overall Study||0
6421830|NCT00998517|7336271|FG002|NOT COMPLETED|Overall Study||0
6421831|NCT00998582|7336281|FG000|STARTED|Overall Study||13
6421832|NCT00998582|7336282|FG001|STARTED|Overall Study||14
6421833|NCT00998582|7336281|FG000|COMPLETED|Overall Study||13
6421834|NCT00998582|7336282|FG001|COMPLETED|Overall Study||14
6421835|NCT00998582|7336281|FG000|NOT COMPLETED|Overall Study||0
6421836|NCT00998582|7336282|FG001|NOT COMPLETED|Overall Study||0
6421837|NCT00998660|7336291|FG000|STARTED|Overall Study||100
6421838|NCT00998660|7336291|FG000|Implanted|Overall Study||93
6421839|NCT00998660|7336291|FG000|Month 3 Visit|Overall Study||87
6421840|NCT00998660|7336291|FG000|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
6421841|NCT00998660|7336291|FG000|NOT COMPLETED|Overall Study||13
6421842|NCT00998764|7336297|FG000|STARTED|Overall Study||216
6421843|NCT00998764|7336298|FG001|STARTED|Overall Study||276
6421844|NCT00998764|7336297|FG000|Treated|Overall Study||215
6421845|NCT00998764|7336298|FG001|Treated|Overall Study||275
6421846|NCT00998764|7336297|FG000|COMPLETED|Overall Study||0
6421847|NCT00998764|7336298|FG001|COMPLETED|Overall Study||2
6421848|NCT00998764|7336297|FG000|NOT COMPLETED|Overall Study||216
6421849|NCT00998764|7336298|FG001|NOT COMPLETED|Overall Study||274
6421850|NCT00998790|7336306|FG000|STARTED|Overall Study||114
6421851|NCT00998790|7336306|FG000|Participants Who Were Treated|Overall Study||113
6421852|NCT00998790|7336306|FG000|COMPLETED|Overall Study||93
6421853|NCT00998790|7336306|FG000|NOT COMPLETED|Overall Study||21
6421854|NCT00998868|7336310|FG000|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
6421855|NCT00998868|7336310|FG000|COMPLETED|Overall Study||51
6421856|NCT00998868|7336310|FG000|NOT COMPLETED|Overall Study||0
6421857|NCT00998881|7336316|FG000|STARTED|Overall Study||104
6421858|NCT00998881|7336317|FG001|STARTED|Overall Study||99
6421859|NCT00998881|7336316|FG000|COMPLETED|Overall Study||96
6421860|NCT00998881|7336317|FG001|COMPLETED|Overall Study||97
6421861|NCT00998881|7336316|FG000|NOT COMPLETED|Overall Study||8
6421862|NCT00998881|7336317|FG001|NOT COMPLETED|Overall Study||2
6421863|NCT00998946|7336323|FG000|STARTED|Overall Study||29
6421864|NCT00998946|7336323|FG000|Safety Population|Overall Study|Safety population included all participants who received at least 1 dose of the study drug.|27
6421865|NCT00998946|7336323|FG000|COMPLETED|Overall Study||20
6421866|NCT00998946|7336323|FG000|NOT COMPLETED|Overall Study||9
6421867|NCT00998985|7336341|FG000|STARTED|Overall Study||5
6421868|NCT00998985|7336342|FG001|STARTED|Overall Study||5
6421869|NCT00998985|7336343|FG002|STARTED|Overall Study||15
6421870|NCT00998985|7336344|FG003|STARTED|Overall Study||5
6421871|NCT00998985|7336345|FG004|STARTED|Overall Study||5
6421872|NCT00998985|7336346|FG005|STARTED|Overall Study||5
6421873|NCT00998985|7336347|FG006|STARTED|Overall Study||5
6421874|NCT00998985|7336348|FG007|STARTED|Overall Study||5
6421875|NCT00998985|7336349|FG008|STARTED|Overall Study||6
6421876|NCT00998985|7336350|FG009|STARTED|Overall Study||5
6421877|NCT00998985|7336351|FG010|STARTED|Overall Study||5
6421878|NCT00998985|7336352|FG011|STARTED|Overall Study||5
6421879|NCT00998985|7336353|FG012|STARTED|Overall Study||5
6421880|NCT00998985|7336354|FG013|STARTED|Overall Study||15
6421881|NCT00998985|7336341|FG000|COMPLETED|Overall Study||5
6421882|NCT00998985|7336342|FG001|COMPLETED|Overall Study||5
6421883|NCT00998985|7336343|FG002|COMPLETED|Overall Study||15
6421884|NCT00998985|7336344|FG003|COMPLETED|Overall Study||5
6421885|NCT00998985|7336345|FG004|COMPLETED|Overall Study||5
6421886|NCT00998985|7336346|FG005|COMPLETED|Overall Study||4
6421887|NCT00998985|7336347|FG006|COMPLETED|Overall Study||5
6421888|NCT00998985|7336348|FG007|COMPLETED|Overall Study||5
6421889|NCT00998985|7336349|FG008|COMPLETED|Overall Study||5
6421890|NCT00998985|7336350|FG009|COMPLETED|Overall Study||5
6421891|NCT00998985|7336351|FG010|COMPLETED|Overall Study||5
6421892|NCT00998985|7336352|FG011|COMPLETED|Overall Study||5
6421893|NCT00998985|7336353|FG012|COMPLETED|Overall Study||5
6421894|NCT00998985|7336354|FG013|COMPLETED|Overall Study||15
6421895|NCT00998985|7336341|FG000|NOT COMPLETED|Overall Study||0
6421896|NCT00998985|7336342|FG001|NOT COMPLETED|Overall Study||0
6421897|NCT00998985|7336343|FG002|NOT COMPLETED|Overall Study||0
6421898|NCT00998985|7336344|FG003|NOT COMPLETED|Overall Study||0
6421899|NCT00998985|7336345|FG004|NOT COMPLETED|Overall Study||0
6421900|NCT00998985|7336346|FG005|NOT COMPLETED|Overall Study||1
6421901|NCT00998985|7336347|FG006|NOT COMPLETED|Overall Study||0
6421902|NCT00998985|7336348|FG007|NOT COMPLETED|Overall Study||0
6421903|NCT00998985|7336349|FG008|NOT COMPLETED|Overall Study||1
6421904|NCT00998985|7336350|FG009|NOT COMPLETED|Overall Study||0
6421905|NCT00998985|7336351|FG010|NOT COMPLETED|Overall Study||0
6421906|NCT00998985|7336352|FG011|NOT COMPLETED|Overall Study||0
6421907|NCT00998985|7336353|FG012|NOT COMPLETED|Overall Study||0
6421908|NCT00998985|7336354|FG013|NOT COMPLETED|Overall Study||0
6421909|NCT00999037|7336401|FG000|STARTED|Overall Study||9
6421910|NCT00999037|7336402|FG001|STARTED|Overall Study|20|9
6421911|NCT00999037|7336401|FG000|COMPLETED|Overall Study||9
6421912|NCT00999037|7336402|FG001|COMPLETED|Overall Study||9
6421913|NCT00999037|7336401|FG000|NOT COMPLETED|Overall Study||0
6421914|NCT00999037|7336402|FG001|NOT COMPLETED|Overall Study||0
6421915|NCT00999102|7336410|FG000|STARTED|4 Weeks at Lower Dose of First Drug||16
6421916|NCT00999102|7336411|FG001|STARTED|4 Weeks at Lower Dose of First Drug||17
6421917|NCT00999102|7336410|FG000|COMPLETED|4 Weeks at Lower Dose of First Drug||15
6421918|NCT00999102|7336411|FG001|COMPLETED|4 Weeks at Lower Dose of First Drug||16
6421919|NCT00999102|7336410|FG000|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
6421920|NCT00999102|7336411|FG001|NOT COMPLETED|4 Weeks at Lower Dose of First Drug||1
6421921|NCT00999102|7336410|FG000|STARTED|4 Weeks at Higher Dose of First Drug||15
6421922|NCT00999102|7336411|FG001|STARTED|4 Weeks at Higher Dose of First Drug||16
6421923|NCT00999102|7336410|FG000|COMPLETED|4 Weeks at Higher Dose of First Drug||15
6421924|NCT00999102|7336411|FG001|COMPLETED|4 Weeks at Higher Dose of First Drug||16
6421925|NCT00999102|7336410|FG000|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
6421926|NCT00999102|7336411|FG001|NOT COMPLETED|4 Weeks at Higher Dose of First Drug||0
6421927|NCT00999102|7336410|FG000|STARTED|4 Weeks at Lower Dose of Second Drug||15
6421928|NCT00999102|7336411|FG001|STARTED|4 Weeks at Lower Dose of Second Drug||16
6421929|NCT00999102|7336410|FG000|COMPLETED|4 Weeks at Lower Dose of Second Drug||15
6421930|NCT00999102|7336411|FG001|COMPLETED|4 Weeks at Lower Dose of Second Drug||16
6421931|NCT00999102|7336410|FG000|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
6421932|NCT00999102|7336411|FG001|NOT COMPLETED|4 Weeks at Lower Dose of Second Drug||0
6421933|NCT00999102|7336410|FG000|STARTED|4 Weeks at Higher Dose of Second Drug||15
6421934|NCT00999102|7336411|FG001|STARTED|4 Weeks at Higher Dose of Second Drug||16
6421935|NCT00999102|7336410|FG000|COMPLETED|4 Weeks at Higher Dose of Second Drug||15
6421936|NCT00999102|7336411|FG001|COMPLETED|4 Weeks at Higher Dose of Second Drug||16
6421937|NCT00999102|7336410|FG000|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
6421938|NCT00999102|7336411|FG001|NOT COMPLETED|4 Weeks at Higher Dose of Second Drug||0
6421939|NCT00999141|7336421|FG000|STARTED|Overall Study|Randomized and treated|75
6421940|NCT00999141|7336421|FG000|COMPLETED|Overall Study||75
6421941|NCT00999141|7336421|FG000|NOT COMPLETED|Overall Study||0
6421942|NCT00999167|7336479|FG000|STARTED|Part A: Open Label Safety run-in||15
6421943|NCT00999167|7336480|FG001|STARTED|Part A: Open Label Safety run-in||0
6421944|NCT00999167|7336481|FG002|STARTED|Part A: Open Label Safety run-in||0
6421945|NCT00999167|7336479|FG000|Received 9 mL BID|Part A: Open Label Safety run-in||15
6421946|NCT00999167|7336480|FG001|Received 9 mL BID|Part A: Open Label Safety run-in||0
6421947|NCT00999167|7336481|FG002|Received 9 mL BID|Part A: Open Label Safety run-in||0
6421948|NCT00999167|7336479|FG000|COMPLETED|Part A: Open Label Safety run-in||8
6421949|NCT00999167|7336480|FG001|COMPLETED|Part A: Open Label Safety run-in||0
6421950|NCT00999167|7336481|FG002|COMPLETED|Part A: Open Label Safety run-in||0
6421951|NCT00999167|7336479|FG000|NOT COMPLETED|Part A: Open Label Safety run-in||7
6421952|NCT00999167|7336480|FG001|NOT COMPLETED|Part A: Open Label Safety run-in||0
6421953|NCT00999167|7336481|FG002|NOT COMPLETED|Part A: Open Label Safety run-in||0
6421954|NCT00999167|7336479|FG000|STARTED|Part B: Randomized, Placebo Controlled||0
6421955|NCT00999167|7336480|FG001|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
6421956|NCT00999167|7336481|FG002|STARTED|Part B: Randomized, Placebo Controlled||88
6421957|NCT00999167|7336479|FG000|COMPLETED|Part B: Randomized, Placebo Controlled||0
6421958|NCT00999167|7336480|FG001|COMPLETED|Part B: Randomized, Placebo Controlled||55
6421959|NCT00999167|7336481|FG002|COMPLETED|Part B: Randomized, Placebo Controlled||67
6421960|NCT00999167|7336479|FG000|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
6421961|NCT00999167|7336480|FG001|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
6421962|NCT00999167|7336481|FG002|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
6421963|NCT00999466|7336494|FG000|STARTED|Pilot Part||6
6421964|NCT00999466|7336495|FG001|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
6421965|NCT00999466|7336496|FG002|STARTED|Pilot Part||3
6421966|NCT00999466|7336494|FG000|COMPLETED|Pilot Part||6
6421967|NCT00999466|7336495|FG001|COMPLETED|Pilot Part||0
6421968|NCT00999466|7336496|FG002|COMPLETED|Pilot Part||3
6421969|NCT00999466|7336494|FG000|NOT COMPLETED|Pilot Part||0
6421970|NCT00999466|7336495|FG001|NOT COMPLETED|Pilot Part||0
6421971|NCT00999466|7336496|FG002|NOT COMPLETED|Pilot Part||0
6421972|NCT00999466|7336494|FG000|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
6421973|NCT00999466|7336495|FG001|STARTED|Main Part||26
6421974|NCT00999466|7336496|FG002|STARTED|Main Part||25
6421975|NCT00999466|7336494|FG000|COMPLETED|Main Part||0
6421976|NCT00999466|7336495|FG001|COMPLETED|Main Part||22
6421977|NCT00999466|7336496|FG002|COMPLETED|Main Part||21
6421978|NCT00999466|7336494|FG000|NOT COMPLETED|Main Part||0
6421979|NCT00999466|7336495|FG001|NOT COMPLETED|Main Part||4
6421980|NCT00999466|7336496|FG002|NOT COMPLETED|Main Part||4
6421981|NCT00999518|7336509|FG000|STARTED|Overall Study||43
6421982|NCT00999518|7336510|FG001|STARTED|Overall Study||42
6421983|NCT00999518|7336511|FG002|STARTED|Overall Study||39
6421984|NCT00999518|7336512|FG003|STARTED|Overall Study||40
6421985|NCT00999518|7336513|FG004|STARTED|Overall Study||41
6421986|NCT00999518|7336509|FG000|Treated|Overall Study||42
6421987|NCT00999518|7336510|FG001|Treated|Overall Study||41
6421988|NCT00999518|7336511|FG002|Treated|Overall Study||37
6421989|NCT00999518|7336512|FG003|Treated|Overall Study||40
6421990|NCT00999518|7336513|FG004|Treated|Overall Study||40
6421991|NCT00999518|7336509|FG000|COMPLETED|Overall Study||19
6421992|NCT00999518|7336510|FG001|COMPLETED|Overall Study||17
6421993|NCT00999518|7336511|FG002|COMPLETED|Overall Study||17
6421994|NCT00999518|7336512|FG003|COMPLETED|Overall Study||18
6421995|NCT00999518|7336513|FG004|COMPLETED|Overall Study||17
6421996|NCT00999518|7336509|FG000|NOT COMPLETED|Overall Study||24
6421997|NCT00999518|7336510|FG001|NOT COMPLETED|Overall Study||25
6421998|NCT00999518|7336511|FG002|NOT COMPLETED|Overall Study||22
6421999|NCT00999518|7336512|FG003|NOT COMPLETED|Overall Study||22
6422000|NCT00999518|7336513|FG004|NOT COMPLETED|Overall Study||24
6422001|NCT00999544|7336529|FG000|STARTED|Overall Study||9
6422002|NCT00999544|7336529|FG000|COMPLETED|Overall Study||8
6422003|NCT00999544|7336529|FG000|NOT COMPLETED|Overall Study||1
6422004|NCT00999596|7336562|FG000|STARTED|Overall Study||107
6422005|NCT00999596|7336562|FG000|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
6422006|NCT00999596|7336562|FG000|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
6422007|NCT00999596|7336562|FG000|NOT COMPLETED|Overall Study||101
6422008|NCT00999661|7336567|FG000|STARTED|Overall Study||231
6422009|NCT00999661|7336567|FG000|COMPLETED|Overall Study||161
6422010|NCT00999661|7336567|FG000|NOT COMPLETED|Overall Study||70
6422011|NCT00999687|7336571|FG000|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
6422012|NCT00999687|7336571|FG000|COMPLETED|First Intervention||30
6422013|NCT00999687|7336571|FG000|NOT COMPLETED|First Intervention||1
6422014|NCT00999687|7336571|FG000|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
6422015|NCT00999687|7336571|FG000|COMPLETED|Second Intervention||27
6422016|NCT00999687|7336571|FG000|NOT COMPLETED|Second Intervention||3
6422017|NCT00999713|7336579|FG000|STARTED|Overall Study||26
6422018|NCT00999713|7336580|FG001|STARTED|Overall Study||17
6422019|NCT00999713|7336579|FG000|COMPLETED|Overall Study||24
6422020|NCT00999713|7336580|FG001|COMPLETED|Overall Study||17
6422021|NCT00999713|7336579|FG000|NOT COMPLETED|Overall Study||2
6422022|NCT00999713|7336580|FG001|NOT COMPLETED|Overall Study||0
6422023|NCT00999804|7336588|FG000|STARTED|Overall Study||85
6422024|NCT00999804|7336589|FG001|STARTED|Overall Study||43
6422025|NCT00999804|7336588|FG000|COMPLETED|Overall Study||64
6422026|NCT00999804|7336589|FG001|COMPLETED|Overall Study||38
6422027|NCT00999804|7336588|FG000|NOT COMPLETED|Overall Study||21
6422028|NCT00999804|7336589|FG001|NOT COMPLETED|Overall Study||5
6422029|NCT00999830|7336597|FG000|STARTED|Overall Study||14
6422030|NCT00999830|7336598|FG001|STARTED|Overall Study||13
6422031|NCT00999830|7336597|FG000|COMPLETED|Overall Study||14
6422032|NCT00999830|7336598|FG001|COMPLETED|Overall Study||13
6422033|NCT00999830|7336597|FG000|NOT COMPLETED|Overall Study||0
6422034|NCT00999830|7336598|FG001|NOT COMPLETED|Overall Study||0
6422035|NCT00999908|7336604|FG000|STARTED|Treatment Period 1||19
6422036|NCT00999908|7336605|FG001|STARTED|Treatment Period 1||16
6422037|NCT00999908|7336606|FG002|STARTED|Treatment Period 1||19
6422038|NCT00999908|7336604|FG000|COMPLETED|Treatment Period 1||17
6422039|NCT00999908|7336605|FG001|COMPLETED|Treatment Period 1||16
6422040|NCT00999908|7336606|FG002|COMPLETED|Treatment Period 1||19
6422041|NCT00999908|7336604|FG000|NOT COMPLETED|Treatment Period 1||2
6422042|NCT00999908|7336605|FG001|NOT COMPLETED|Treatment Period 1||0
6422043|NCT00999908|7336606|FG002|NOT COMPLETED|Treatment Period 1||0
6422044|NCT00999908|7336604|FG000|STARTED|Treatment Period 2||17
6422045|NCT00999908|7336605|FG001|STARTED|Treatment Period 2||16
6422046|NCT00999908|7336606|FG002|STARTED|Treatment Period 2||19
6422047|NCT00999908|7336604|FG000|COMPLETED|Treatment Period 2||16
6422048|NCT00999908|7336605|FG001|COMPLETED|Treatment Period 2||16
6422049|NCT00999908|7336606|FG002|COMPLETED|Treatment Period 2||19
6422050|NCT00999908|7336604|FG000|NOT COMPLETED|Treatment Period 2||1
6422051|NCT00999908|7336605|FG001|NOT COMPLETED|Treatment Period 2||0
6422052|NCT00999908|7336606|FG002|NOT COMPLETED|Treatment Period 2||0
6422053|NCT00999908|7336604|FG000|STARTED|Treatment Period 3||16
6422054|NCT00999908|7336605|FG001|STARTED|Treatment Period 3||16
6422055|NCT00999908|7336606|FG002|STARTED|Treatment Period 3||19
6422056|NCT00999908|7336604|FG000|COMPLETED|Treatment Period 3||16
6422057|NCT00999908|7336605|FG001|COMPLETED|Treatment Period 3||16
6422058|NCT00999908|7336606|FG002|COMPLETED|Treatment Period 3||19
6422059|NCT00999908|7336604|FG000|NOT COMPLETED|Treatment Period 3||0
6422060|NCT00999908|7336605|FG001|NOT COMPLETED|Treatment Period 3||0
6422061|NCT00999908|7336606|FG002|NOT COMPLETED|Treatment Period 3||0
6422062|NCT00999921|7336616|FG000|STARTED|Overall Study||127
6422063|NCT00999921|7336617|FG001|STARTED|Overall Study||129
6422064|NCT00999921|7336616|FG000|COMPLETED|Overall Study||117
6422065|NCT00999921|7336617|FG001|COMPLETED|Overall Study||110
6422066|NCT00999921|7336616|FG000|NOT COMPLETED|Overall Study||10
6422067|NCT00999921|7336617|FG001|NOT COMPLETED|Overall Study||19
6422068|NCT01000025|7336628|FG000|STARTED|Overall Study||480
6422069|NCT01000025|7336629|FG001|STARTED|Overall Study||240
6422070|NCT01000025|7336628|FG000|COMPLETED|Overall Study||12
6422071|NCT01000025|7336629|FG001|COMPLETED|Overall Study||2
6422072|NCT01000025|7336628|FG000|NOT COMPLETED|Overall Study||468
6422073|NCT01000025|7336629|FG001|NOT COMPLETED|Overall Study||238
6422074|NCT01000051|7336637|FG000|STARTED|Overall Study||42
6422075|NCT01000051|7336638|FG001|STARTED|Overall Study||18
6422076|NCT01000051|7336637|FG000|COMPLETED|Overall Study||39
6422077|NCT01000051|7336638|FG001|COMPLETED|Overall Study||17
6422078|NCT01000051|7336637|FG000|NOT COMPLETED|Overall Study||3
6422079|NCT01000051|7336638|FG001|NOT COMPLETED|Overall Study||1
6422080|NCT01000064|7336644|FG000|STARTED|Overall Study||7
6422081|NCT01000064|7336645|FG001|STARTED|Overall Study||6
6422082|NCT01000064|7336644|FG000|COMPLETED|Overall Study||6
6422083|NCT01000064|7336645|FG001|COMPLETED|Overall Study||5
6422084|NCT01000064|7336644|FG000|NOT COMPLETED|Overall Study||1
6422085|NCT01000064|7336645|FG001|NOT COMPLETED|Overall Study||1
6422086|NCT01000155|7336654|FG000|STARTED|Overall Study||5
6422087|NCT01000155|7336654|FG000|COMPLETED|Overall Study||3
6422088|NCT01000155|7336654|FG000|NOT COMPLETED|Overall Study||2
6422089|NCT01000285|7336660|FG000|STARTED|Overall Study||18
6422090|NCT01000285|7336660|FG000|COMPLETED|Overall Study||18
6422091|NCT01000285|7336660|FG000|NOT COMPLETED|Overall Study||0
6422092|NCT01000311|7336676|FG000|STARTED|Overall Study||258
6422093|NCT01000311|7336677|FG001|STARTED|Overall Study||271
6422094|NCT01000311|7336676|FG000|COMPLETED|Overall Study||213
6422095|NCT01000311|7336677|FG001|COMPLETED|Overall Study||201
6422096|NCT01000311|7336676|FG000|NOT COMPLETED|Overall Study||45
6422097|NCT01000311|7336677|FG001|NOT COMPLETED|Overall Study||70
6422098|NCT01000324|7336683|FG000|STARTED|Year 16||40
6422099|NCT01000324|7336683|FG000|COMPLETED|Year 16||40
6422100|NCT01000324|7336683|FG000|NOT COMPLETED|Year 16||0
6422101|NCT01000324|7336683|FG000|STARTED|Year 17||32
6422102|NCT01000324|7336683|FG000|COMPLETED|Year 17||32
6422103|NCT01000324|7336683|FG000|NOT COMPLETED|Year 17||0
6422104|NCT01000324|7336683|FG000|STARTED|Year 18||29
6422105|NCT01000324|7336683|FG000|COMPLETED|Year 18||29
6422106|NCT01000324|7336683|FG000|NOT COMPLETED|Year 18||0
6422107|NCT01000324|7336683|FG000|STARTED|Year 19||28
6422108|NCT01000324|7336683|FG000|COMPLETED|Year 19||28
6422109|NCT01000324|7336683|FG000|NOT COMPLETED|Year 19||0
6422110|NCT01000324|7336683|FG000|STARTED|Year 20||28
6422111|NCT01000324|7336683|FG000|COMPLETED|Year 20||28
6422112|NCT01000324|7336683|FG000|NOT COMPLETED|Year 20||0
6422113|NCT01000337|7336690|FG000|STARTED|Overall Study||34
6422114|NCT01000337|7336691|FG001|STARTED|Overall Study||33
6422115|NCT01000337|7336690|FG000|COMPLETED|Overall Study||30
6422116|NCT01000337|7336691|FG001|COMPLETED|Overall Study||30
6422117|NCT01000337|7336690|FG000|NOT COMPLETED|Overall Study||4
6422118|NCT01000337|7336691|FG001|NOT COMPLETED|Overall Study||3
6422119|NCT01000376|7336699|FG000|STARTED|Cycle 1 Day 1||6
6422120|NCT01000376|7336700|FG001|STARTED|Cycle 1 Day 1||6
6422121|NCT01000376|7336699|FG000|COMPLETED|Cycle 1 Day 1||4
6422122|NCT01000376|7336700|FG001|COMPLETED|Cycle 1 Day 1||6
6422123|NCT01000376|7336699|FG000|NOT COMPLETED|Cycle 1 Day 1||2
6422124|NCT01000376|7336700|FG001|NOT COMPLETED|Cycle 1 Day 1||0
6422125|NCT01000376|7336699|FG000|STARTED|Cycle 1 Day 15||4
6422126|NCT01000376|7336700|FG001|STARTED|Cycle 1 Day 15||6
6422127|NCT01000376|7336699|FG000|COMPLETED|Cycle 1 Day 15||4
6422128|NCT01000376|7336700|FG001|COMPLETED|Cycle 1 Day 15||6
6422129|NCT01000376|7336699|FG000|NOT COMPLETED|Cycle 1 Day 15||0
6422130|NCT01000376|7336700|FG001|NOT COMPLETED|Cycle 1 Day 15||0
6422131|NCT01000480|7336706|FG000|STARTED|Induction Phase||90
6422132|NCT01000480|7336706|FG000|Received at Least 1 Dose of Either Drug|Induction Phase||90
6422133|NCT01000480|7336706|FG000|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
6422134|NCT01000480|7336706|FG000|COMPLETED|Induction Phase||83
6422135|NCT01000480|7336706|FG000|NOT COMPLETED|Induction Phase||7
6422136|NCT01000480|7336706|FG000|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
6422137|NCT01000480|7336706|FG000|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
6422138|NCT01000480|7336706|FG000|COMPLETED|Concurrent Therapy Phase||65
6640095|NCT02332720|7568352|FG012|STARTED|Part A and Part B||16
6640096|NCT02332720|7568353|FG013|STARTED|Part A and Part B||13
6640097|NCT02332720|7568354|FG014|STARTED|Part A and Part B||16
6640098|NCT02332720|7568355|FG015|STARTED|Part A and Part B||14
6640099|NCT02332720|7568356|FG016|STARTED|Part A and Part B||15
6640100|NCT02332720|7568357|FG017|STARTED|Part A and Part B||14
6640101|NCT02332720|7568358|FG018|STARTED|Part A and Part B||21
6640102|NCT02332720|7568359|FG019|STARTED|Part A and Part B||25
6640103|NCT02332720|7568360|FG020|STARTED|Part A and Part B||7
6640104|NCT02332720|7568361|FG021|STARTED|Part A and Part B||0
6640105|NCT02332720|7568362|FG022|STARTED|Part A and Part B||4
6640106|NCT02332720|7568340|FG000|Treated|Part A and Part B||21
6640107|NCT02332720|7568341|FG001|Treated|Part A and Part B||21
6640108|NCT02332720|7568342|FG002|Treated|Part A and Part B||22
6640109|NCT02332720|7568343|FG003|Treated|Part A and Part B||22
6640110|NCT02332720|7568344|FG004|Treated|Part A and Part B||16
6640111|NCT02332720|7568345|FG005|Treated|Part A and Part B||36
6640112|NCT02332720|7568346|FG006|Treated|Part A and Part B||37
6640113|NCT02332720|7568347|FG007|Treated|Part A and Part B||35
6640114|NCT02332720|7568348|FG008|Treated|Part A and Part B||15
6640115|NCT02332720|7568349|FG009|Treated|Part A and Part B||14
6640116|NCT02332720|7568350|FG010|Treated|Part A and Part B||14
6640117|NCT02332720|7568351|FG011|Treated|Part A and Part B||15
6640118|NCT02332720|7568352|FG012|Treated|Part A and Part B||16
6640119|NCT02332720|7568353|FG013|Treated|Part A and Part B||13
6640120|NCT02332720|7568354|FG014|Treated|Part A and Part B||16
6640121|NCT02332720|7568355|FG015|Treated|Part A and Part B||14
6640122|NCT02332720|7568356|FG016|Treated|Part A and Part B||15
6640123|NCT02332720|7568357|FG017|Treated|Part A and Part B||14
6640124|NCT02332720|7568358|FG018|Treated|Part A and Part B||20
6640125|NCT02332720|7568359|FG019|Treated|Part A and Part B||25
6640126|NCT02332720|7568360|FG020|Treated|Part A and Part B||7
6640127|NCT02332720|7568361|FG021|Treated|Part A and Part B||0
6640128|NCT02332720|7568362|FG022|Treated|Part A and Part B||4
6640129|NCT02332720|7568340|FG000|COMPLETED|Part A and Part B||20
6640130|NCT02332720|7568341|FG001|COMPLETED|Part A and Part B||21
6422139|NCT01000480|7336706|FG000|NOT COMPLETED|Concurrent Therapy Phase||10
6422140|NCT01000480|7336706|FG000|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
6422141|NCT01000480|7336706|FG000|COMPLETED|Follow-Up Period||88
6422142|NCT01000480|7336706|FG000|NOT COMPLETED|Follow-Up Period||0
6499436|NCT01417780|7418127|FG000|NOT COMPLETED|Overall Study||1
6422143|NCT01000493|7336712|FG000|STARTED|Overall Study||60
6422144|NCT01000493|7336713|FG001|STARTED|Overall Study||69
6422145|NCT01000493|7336712|FG000|COMPLETED|Overall Study||21
6422146|NCT01000493|7336713|FG001|COMPLETED|Overall Study||14
6422147|NCT01000493|7336712|FG000|NOT COMPLETED|Overall Study||39
6422148|NCT01000493|7336713|FG001|NOT COMPLETED|Overall Study||55
6422149|NCT01000506|7336723|FG000|STARTED|Overall Study||155
6422150|NCT01000506|7336724|FG001|STARTED|Overall Study||153
6422151|NCT01000506|7336725|FG002|STARTED|Overall Study||152
6422152|NCT01000506|7336726|FG003|STARTED|Overall Study||156
6422153|NCT01000506|7336723|FG000|COMPLETED|Overall Study||127
6422154|NCT01000506|7336724|FG001|COMPLETED|Overall Study||129
6422155|NCT01000506|7336725|FG002|COMPLETED|Overall Study||131
6422156|NCT01000506|7336726|FG003|COMPLETED|Overall Study||133
6422157|NCT01000506|7336723|FG000|NOT COMPLETED|Overall Study||28
6422158|NCT01000506|7336724|FG001|NOT COMPLETED|Overall Study||24
6422159|NCT01000506|7336725|FG002|NOT COMPLETED|Overall Study||21
6422160|NCT01000506|7336726|FG003|NOT COMPLETED|Overall Study||23
6422161|NCT01000610|7336736|FG000|STARTED|Overall Study||18
6422162|NCT01000610|7336736|FG000|COMPLETED|Overall Study||12
6422163|NCT01000610|7336736|FG000|NOT COMPLETED|Overall Study||6
6422164|NCT01000636|7336740|FG000|STARTED|Overall Study||9
6422165|NCT01000636|7336740|FG000|COMPLETED|Overall Study||7
6422166|NCT01000636|7336740|FG000|NOT COMPLETED|Overall Study||2
6422167|NCT01000649|7336748|FG000|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
6422168|NCT01000649|7336749|FG001|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
6422169|NCT01000649|7336750|FG002|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
6422170|NCT01000649|7336751|FG003|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
6422171|NCT01000649|7336748|FG000|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
6422172|NCT01000649|7336749|FG001|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
6422173|NCT01000649|7336750|FG002|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
6422174|NCT01000649|7336751|FG003|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
6422175|NCT01000649|7336748|FG000|COMPLETED|Overall Study||5
6422176|NCT01000649|7336749|FG001|COMPLETED|Overall Study||16
6422177|NCT01000649|7336750|FG002|COMPLETED|Overall Study||0
6422178|NCT01000649|7336751|FG003|COMPLETED|Overall Study||15
6422179|NCT01000649|7336748|FG000|NOT COMPLETED|Overall Study||5
6422180|NCT01000649|7336749|FG001|NOT COMPLETED|Overall Study||3
6422181|NCT01000649|7336750|FG002|NOT COMPLETED|Overall Study||2
6422182|NCT01000649|7336751|FG003|NOT COMPLETED|Overall Study||6
6422183|NCT01000662|7336762|FG000|STARTED|Overall Study||206
6422184|NCT01000662|7336763|FG001|STARTED|Overall Study||206
6422185|NCT01000662|7336762|FG000|COMPLETED|Overall Study||202
6422186|NCT01000662|7336763|FG001|COMPLETED|Overall Study||198
6422187|NCT01000662|7336762|FG000|NOT COMPLETED|Overall Study||4
6422188|NCT01000662|7336763|FG001|NOT COMPLETED|Overall Study||8
6422189|NCT01000727|7336773|FG000|STARTED|Overall Study||6522
6422190|NCT01000727|7336774|FG001|STARTED|Overall Study||6504
6422191|NCT01000727|7336773|FG000|COMPLETED|Overall Study||6347
6422192|NCT01000727|7336774|FG001|COMPLETED|Overall Study||6328
6422193|NCT01000727|7336773|FG000|NOT COMPLETED|Overall Study||175
6422194|NCT01000727|7336774|FG001|NOT COMPLETED|Overall Study||176
6422195|NCT01000805|7336784|FG000|STARTED|Overall Study||262
6422196|NCT01000805|7336785|FG001|STARTED|Overall Study||266
6422197|NCT01000805|7336784|FG000|COMPLETED|Overall Study||192
6422198|NCT01000805|7336785|FG001|COMPLETED|Overall Study||204
6422199|NCT01000805|7336784|FG000|NOT COMPLETED|Overall Study||70
6422200|NCT01000805|7336785|FG001|NOT COMPLETED|Overall Study||62
6422201|NCT01000818|7336792|FG000|STARTED|Raltegravir||18
6422202|NCT01000818|7336792|FG000|COMPLETED|Raltegravir||18
6422203|NCT01000818|7336792|FG000|NOT COMPLETED|Raltegravir||0
6422204|NCT01000818|7336792|FG000|STARTED|Famotidine + Raltegravir||18
6422205|NCT01000818|7336792|FG000|COMPLETED|Famotidine + Raltegravir||18
6422206|NCT01000818|7336792|FG000|NOT COMPLETED|Famotidine + Raltegravir||0
6640131|NCT02332720|7568342|FG002|COMPLETED|Part A and Part B||22
6640132|NCT02332720|7568343|FG003|COMPLETED|Part A and Part B||22
6640133|NCT02332720|7568344|FG004|COMPLETED|Part A and Part B||16
6640134|NCT02332720|7568345|FG005|COMPLETED|Part A and Part B||33
6640135|NCT02332720|7568346|FG006|COMPLETED|Part A and Part B||36
6640136|NCT02332720|7568347|FG007|COMPLETED|Part A and Part B||34
6640137|NCT02332720|7568348|FG008|COMPLETED|Part A and Part B||15
6640138|NCT02332720|7568349|FG009|COMPLETED|Part A and Part B||14
6640139|NCT02332720|7568350|FG010|COMPLETED|Part A and Part B||14
6640140|NCT02332720|7568351|FG011|COMPLETED|Part A and Part B||15
6640141|NCT02332720|7568352|FG012|COMPLETED|Part A and Part B||16
6640142|NCT02332720|7568353|FG013|COMPLETED|Part A and Part B||13
6640143|NCT02332720|7568354|FG014|COMPLETED|Part A and Part B||16
6640144|NCT02332720|7568355|FG015|COMPLETED|Part A and Part B||13
6640145|NCT02332720|7568356|FG016|COMPLETED|Part A and Part B||15
6640146|NCT02332720|7568357|FG017|COMPLETED|Part A and Part B||13
6640147|NCT02332720|7568358|FG018|COMPLETED|Part A and Part B||20
6640148|NCT02332720|7568359|FG019|COMPLETED|Part A and Part B||24
6640149|NCT02332720|7568360|FG020|COMPLETED|Part A and Part B||7
6640150|NCT02332720|7568361|FG021|COMPLETED|Part A and Part B||0
6422207|NCT01000818|7336792|FG000|STARTED|Omeprazole + Raltegravir||18
6422208|NCT01000818|7336792|FG000|COMPLETED|Omeprazole + Raltegravir||18
6422209|NCT01000818|7336792|FG000|NOT COMPLETED|Omeprazole + Raltegravir||0
6422210|NCT01000961|7336801|FG000|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
6422211|NCT01000961|7336802|FG001|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
6510838|NCT01484431|7430420|FG002|STARTED|Period 1: Low Dose||6
6510839|NCT01484431|7430418|FG000|Received 2 mg|Period 1: Low Dose||1
6510840|NCT01484431|7430419|FG001|Received 2 mg|Period 1: Low Dose||0
6510841|NCT01484431|7430420|FG002|Received 2 mg|Period 1: Low Dose||0
6510842|NCT01484431|7430418|FG000|Received 4 mg|Period 1: Low Dose||5
6510843|NCT01484431|7430419|FG001|Received 4 mg|Period 1: Low Dose||0
6510844|NCT01484431|7430420|FG002|Received 4 mg|Period 1: Low Dose||0
6510845|NCT01484431|7430418|FG000|Received 5 mg|Period 1: Low Dose||0
6510846|NCT01484431|7430419|FG001|Received 5 mg|Period 1: Low Dose||7
6510847|NCT01484431|7430420|FG002|Received 5 mg|Period 1: Low Dose||0
6510848|NCT01484431|7430418|FG000|Received 10 mg|Period 1: Low Dose||0
6510849|NCT01484431|7430419|FG001|Received 10 mg|Period 1: Low Dose||0
6510850|NCT01484431|7430420|FG002|Received 10 mg|Period 1: Low Dose||6
6510851|NCT01484431|7430418|FG000|COMPLETED|Period 1: Low Dose||6
6510852|NCT01484431|7430419|FG001|COMPLETED|Period 1: Low Dose||7
6510853|NCT01484431|7430420|FG002|COMPLETED|Period 1: Low Dose||6
6510854|NCT01484431|7430418|FG000|NOT COMPLETED|Period 1: Low Dose||0
6510855|NCT01484431|7430419|FG001|NOT COMPLETED|Period 1: Low Dose||0
6510856|NCT01484431|7430420|FG002|NOT COMPLETED|Period 1: Low Dose||0
6510857|NCT01484431|7430418|FG000|STARTED|Period 1: High Dose||6
6510858|NCT01484431|7430419|FG001|STARTED|Period 1: High Dose||7
6510859|NCT01484431|7430420|FG002|STARTED|Period 1: High Dose||6
6510860|NCT01484431|7430418|FG000|Received 8 mg|Period 1: High Dose||1
6510861|NCT01484431|7430419|FG001|Received 8 mg|Period 1: High Dose||0
6422212|NCT01000961|7336801|FG000|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
6422213|NCT01000961|7336802|FG001|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
6422214|NCT01000961|7336801|FG000|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
6422215|NCT01000961|7336802|FG001|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
6422216|NCT01000961|7336801|FG000|STARTED|First Intervention (3 Weeks)||21
6422217|NCT01000961|7336802|FG001|STARTED|First Intervention (3 Weeks)||22
6422218|NCT01000961|7336801|FG000|COMPLETED|First Intervention (3 Weeks)||21
6422219|NCT01000961|7336802|FG001|COMPLETED|First Intervention (3 Weeks)||20
6422220|NCT01000961|7336801|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
6422221|NCT01000961|7336802|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
6422222|NCT01000961|7336801|FG000|STARTED|Second Intervention (3 Weeks)||21
6422223|NCT01000961|7336802|FG001|STARTED|Second Intervention (3 Weeks)||20
6422224|NCT01000961|7336801|FG000|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
6422225|NCT01000961|7336802|FG001|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
6422226|NCT01000961|7336801|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6422227|NCT01000961|7336802|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6640151|NCT02332720|7568362|FG022|COMPLETED|Part A and Part B||4
6422228|NCT01000974|7336813|FG000|STARTED|Primary Vaccination Phase||2963
6422229|NCT01000974|7336814|FG001|STARTED|Primary Vaccination Phase||520
6422230|NCT01000974|7336815|FG002|STARTED|Primary Vaccination Phase||520
6422231|NCT01000974|7336813|FG000|COMPLETED|Primary Vaccination Phase||2625
6422232|NCT01000974|7336814|FG001|COMPLETED|Primary Vaccination Phase||470
6422233|NCT01000974|7336815|FG002|COMPLETED|Primary Vaccination Phase||457
6422234|NCT01000974|7336813|FG000|NOT COMPLETED|Primary Vaccination Phase||338
6422235|NCT01000974|7336814|FG001|NOT COMPLETED|Primary Vaccination Phase||50
6422236|NCT01000974|7336815|FG002|NOT COMPLETED|Primary Vaccination Phase||63
6422237|NCT01000974|7336813|FG000|STARTED|Booster Vaccination Phase||2337
6422238|NCT01000974|7336814|FG001|STARTED|Booster Vaccination Phase||435
6422239|NCT01000974|7336815|FG002|STARTED|Booster Vaccination Phase||400
6422240|NCT01000974|7336813|FG000|COMPLETED|Booster Vaccination Phase||2270
6422241|NCT01000974|7336814|FG001|COMPLETED|Booster Vaccination Phase||423
6422242|NCT01000974|7336815|FG002|COMPLETED|Booster Vaccination Phase||386
6422243|NCT01000974|7336813|FG000|NOT COMPLETED|Booster Vaccination Phase||67
6422244|NCT01000974|7336814|FG001|NOT COMPLETED|Booster Vaccination Phase||12
6422245|NCT01000974|7336815|FG002|NOT COMPLETED|Booster Vaccination Phase||14
6422246|NCT01000987|7336829|FG000|STARTED|Overall Study||12
6422247|NCT01000987|7336830|FG001|STARTED|Overall Study||15
6422248|NCT01000987|7336831|FG002|STARTED|Overall Study||17
6422249|NCT01000987|7336829|FG000|COMPLETED|Overall Study||12
6422250|NCT01000987|7336830|FG001|COMPLETED|Overall Study||15
6422251|NCT01000987|7336831|FG002|COMPLETED|Overall Study||17
6422252|NCT01000987|7336829|FG000|NOT COMPLETED|Overall Study||0
6422253|NCT01000987|7336830|FG001|NOT COMPLETED|Overall Study||0
6510862|NCT01484431|7430420|FG002|Received 8 mg|Period 1: High Dose||0
6510863|NCT01484431|7430418|FG000|Received 10 mg|Period 1: High Dose||1
6510864|NCT01484431|7430419|FG001|Received 10 mg|Period 1: High Dose||1
6510865|NCT01484431|7430420|FG002|Received 10 mg|Period 1: High Dose||0
6510866|NCT01484431|7430418|FG000|Received 15 mg|Period 1: High Dose||1
6510867|NCT01484431|7430419|FG001|Received 15 mg|Period 1: High Dose||1
6510868|NCT01484431|7430420|FG002|Received 15 mg|Period 1: High Dose||0
6510869|NCT01484431|7430418|FG000|Received 20 mg|Period 1: High Dose||3
6510870|NCT01484431|7430419|FG001|Received 20 mg|Period 1: High Dose||5
6510871|NCT01484431|7430420|FG002|Received 20 mg|Period 1: High Dose||1
6422254|NCT01000987|7336831|FG002|NOT COMPLETED|Overall Study||0
6422255|NCT01001052|7336839|FG000|STARTED|Overall Study||20
6422256|NCT01001052|7336840|FG001|STARTED|Overall Study||18
6422257|NCT01001052|7336839|FG000|COMPLETED|Overall Study||20
6422258|NCT01001052|7336840|FG001|COMPLETED|Overall Study||18
6422259|NCT01001052|7336839|FG000|NOT COMPLETED|Overall Study||0
6422260|NCT01001052|7336840|FG001|NOT COMPLETED|Overall Study||0
6422261|NCT01001078|7336848|FG000|STARTED|Overall Study||50
6422262|NCT01001078|7336849|FG001|STARTED|Overall Study||50
6422263|NCT01001078|7336848|FG000|Received Allocated Intervention|Overall Study||46
6422264|NCT01001078|7336849|FG001|Received Allocated Intervention|Overall Study||46
6422265|NCT01001078|7336848|FG000|Received Crossover|Overall Study||2
6510872|NCT01484431|7430418|FG000|Received 40 mg|Period 1: High Dose||0
6510873|NCT01484431|7430419|FG001|Received 40 mg|Period 1: High Dose||0
6510874|NCT01484431|7430420|FG002|Received 40 mg|Period 1: High Dose||5
6510875|NCT01484431|7430418|FG000|COMPLETED|Period 1: High Dose||6
6510876|NCT01484431|7430419|FG001|COMPLETED|Period 1: High Dose||6
6510877|NCT01484431|7430420|FG002|COMPLETED|Period 1: High Dose||6
6510878|NCT01484431|7430418|FG000|NOT COMPLETED|Period 1: High Dose||0
6510879|NCT01484431|7430419|FG001|NOT COMPLETED|Period 1: High Dose||1
6510880|NCT01484431|7430420|FG002|NOT COMPLETED|Period 1: High Dose||0
6510881|NCT01484431|7430418|FG000|STARTED|Period 2||6
6510882|NCT01484431|7430419|FG001|STARTED|Period 2||6
6510883|NCT01484431|7430420|FG002|STARTED|Period 2||6
6510884|NCT01484431|7430418|FG000|Received 7 mg|Period 2||1
6510885|NCT01484431|7430419|FG001|Received 7 mg|Period 2||0
6510886|NCT01484431|7430420|FG002|Received 7 mg|Period 2||0
6510887|NCT01484431|7430418|FG000|Received 7.5 mg|Period 2||0
6510888|NCT01484431|7430419|FG001|Received 7.5 mg|Period 2||2
6510889|NCT01484431|7430420|FG002|Received 7.5 mg|Period 2||0
6510890|NCT01484431|7430418|FG000|Received 8 mg|Period 2||1
6510891|NCT01484431|7430419|FG001|Received 8 mg|Period 2||0
6510892|NCT01484431|7430420|FG002|Received 8 mg|Period 2||0
6510893|NCT01484431|7430418|FG000|Received 10 mg|Period 2||0
6510894|NCT01484431|7430419|FG001|Received 10 mg|Period 2||1
6510895|NCT01484431|7430420|FG002|Received 10 mg|Period 2||0
6510896|NCT01484431|7430418|FG000|Received 15 mg|Period 2||1
6510897|NCT01484431|7430419|FG001|Received 15 mg|Period 2||2
6510898|NCT01484431|7430420|FG002|Received 15 mg|Period 2||1
6510899|NCT01484431|7430418|FG000|Received 20 mg|Period 2||3
6510900|NCT01484431|7430419|FG001|Received 20 mg|Period 2||1
6510901|NCT01484431|7430420|FG002|Received 20 mg|Period 2||4
6510902|NCT01484431|7430418|FG000|Received 40 mg|Period 2||0
6510903|NCT01484431|7430419|FG001|Received 40 mg|Period 2||0
6510904|NCT01484431|7430420|FG002|Received 40 mg|Period 2||1
6510905|NCT01484431|7430418|FG000|COMPLETED|Period 2||5
6510906|NCT01484431|7430419|FG001|COMPLETED|Period 2||5
6510907|NCT01484431|7430420|FG002|COMPLETED|Period 2||4
6510908|NCT01484431|7430418|FG000|NOT COMPLETED|Period 2||1
6510909|NCT01484431|7430419|FG001|NOT COMPLETED|Period 2||1
6510910|NCT01484431|7430420|FG002|NOT COMPLETED|Period 2||2
6510911|NCT01484496|7430435|FG000|STARTED|Period 1||280
6510912|NCT01484496|7430436|FG001|STARTED|Period 1||556
6510913|NCT01484496|7430437|FG002|STARTED|Period 1||0
6510914|NCT01484496|7430438|FG003|STARTED|Period 1||0
6510915|NCT01484496|7430435|FG000|COMPLETED|Period 1||214
6510916|NCT01484496|7430436|FG001|COMPLETED|Period 1||463
6510917|NCT01484496|7430437|FG002|COMPLETED|Period 1||0
6510918|NCT01484496|7430438|FG003|COMPLETED|Period 1||0
6510919|NCT01484496|7430435|FG000|NOT COMPLETED|Period 1||66
6510920|NCT01484496|7430436|FG001|NOT COMPLETED|Period 1||93
6510921|NCT01484496|7430437|FG002|NOT COMPLETED|Period 1||0
6510922|NCT01484496|7430438|FG003|NOT COMPLETED|Period 1||0
6510923|NCT01484496|7430435|FG000|STARTED|Period 2||0
6510924|NCT01484496|7430436|FG001|STARTED|Period 2||0
6510925|NCT01484496|7430437|FG002|STARTED|Period 2||206
6510926|NCT01484496|7430438|FG003|STARTED|Period 2||456
6510927|NCT01484496|7430435|FG000|COMPLETED|Period 2||0
6510928|NCT01484496|7430436|FG001|COMPLETED|Period 2||0
6640152|NCT02332720|7568340|FG000|NOT COMPLETED|Part A and Part B||1
6640153|NCT02332720|7568341|FG001|NOT COMPLETED|Part A and Part B||0
6510929|NCT01484496|7430437|FG002|COMPLETED|Period 2||191
6510930|NCT01484496|7430438|FG003|COMPLETED|Period 2||434
6510931|NCT01484496|7430435|FG000|NOT COMPLETED|Period 2||0
6510932|NCT01484496|7430436|FG001|NOT COMPLETED|Period 2||0
6510933|NCT01484496|7430437|FG002|NOT COMPLETED|Period 2||15
6510934|NCT01484496|7430438|FG003|NOT COMPLETED|Period 2||22
6510935|NCT01484561|7430448|FG000|STARTED|Overall Study||97
6510936|NCT01484561|7430449|FG001|STARTED|Overall Study||51
6510937|NCT01484561|7430448|FG000|COMPLETED|Overall Study||88
6510938|NCT01484561|7430449|FG001|COMPLETED|Overall Study||45
6510939|NCT01484561|7430448|FG000|NOT COMPLETED|Overall Study||9
6510940|NCT01484561|7430449|FG001|NOT COMPLETED|Overall Study||6
6510941|NCT01484626|7430455|FG000|STARTED|Overall Study||3
6510942|NCT01484626|7430455|FG000|COMPLETED|Overall Study||3
6640154|NCT02332720|7568342|FG002|NOT COMPLETED|Part A and Part B||0
6640155|NCT02332720|7568343|FG003|NOT COMPLETED|Part A and Part B||0
6510943|NCT01484626|7430455|FG000|NOT COMPLETED|Overall Study||0
6510944|NCT01484652|7430461|FG000|STARTED|Overall Study||166
6510945|NCT01484652|7430462|FG001|STARTED|Overall Study||163
6510946|NCT01484652|7430461|FG000|COMPLETED|Overall Study||151
6510947|NCT01484652|7430462|FG001|COMPLETED|Overall Study||142
6510948|NCT01484652|7430461|FG000|NOT COMPLETED|Overall Study||15
6510949|NCT01484652|7430462|FG001|NOT COMPLETED|Overall Study||21
6510950|NCT01484834|7430472|FG000|STARTED|Overall Study||65
6510951|NCT01484834|7430473|FG001|STARTED|Overall Study||62
6510952|NCT01484834|7430474|FG002|STARTED|Overall Study||39
6510953|NCT01484834|7430475|FG003|STARTED|Overall Study||24
6510954|NCT01484834|7430472|FG000|COMPLETED|Overall Study||60
6510955|NCT01484834|7430473|FG001|COMPLETED|Overall Study||54
6510956|NCT01484834|7430474|FG002|COMPLETED|Overall Study||38
6510957|NCT01484834|7430475|FG003|COMPLETED|Overall Study||20
6510958|NCT01484834|7430472|FG000|NOT COMPLETED|Overall Study||5
6510959|NCT01484834|7430473|FG001|NOT COMPLETED|Overall Study||8
6510960|NCT01484834|7430474|FG002|NOT COMPLETED|Overall Study||1
6510961|NCT01484834|7430475|FG003|NOT COMPLETED|Overall Study||4
6510962|NCT01484873|7430485|FG000|STARTED|Overall Study||10
6510963|NCT01484873|7430485|FG000|COMPLETED|Overall Study||8
6510964|NCT01484873|7430485|FG000|NOT COMPLETED|Overall Study||2
6510965|NCT01484912|7430492|FG000|STARTED|Overall Study||39
6510966|NCT01484912|7430493|FG001|STARTED|Overall Study||40
6510967|NCT01484912|7430492|FG000|COMPLETED|Overall Study||38
6510968|NCT01484912|7430493|FG001|COMPLETED|Overall Study||39
6510969|NCT01484912|7430492|FG000|NOT COMPLETED|Overall Study||1
6510970|NCT01484912|7430493|FG001|NOT COMPLETED|Overall Study||1
6510971|NCT01484938|7430499|FG000|STARTED|Overall Study||175
6510972|NCT01484938|7430499|FG000|COMPLETED|Overall Study||171
6510973|NCT01484938|7430499|FG000|NOT COMPLETED|Overall Study||4
6510974|NCT01484951|7430503|FG000|STARTED|Overall Study||74
6510975|NCT01484951|7430503|FG000|COMPLETED|Overall Study||69
6510976|NCT01484951|7430503|FG000|NOT COMPLETED|Overall Study||5
6510977|NCT01484977|7430507|FG000|STARTED|Overall Study||120
6510978|NCT01484977|7430507|FG000|COMPLETED|Overall Study||93
6510979|NCT01484977|7430507|FG000|NOT COMPLETED|Overall Study||27
6510980|NCT01485055|7430511|FG000|STARTED|Overall Study||11
6510981|NCT01485055|7430511|FG000|COMPLETED|Overall Study||11
6510982|NCT01485055|7430511|FG000|NOT COMPLETED|Overall Study||0
6510983|NCT01485094|7430518|FG000|STARTED|Overall Study||20
6510984|NCT01485094|7430519|FG001|STARTED|Overall Study||20
6510985|NCT01485094|7430520|FG002|STARTED|Overall Study||19
6510986|NCT01485094|7430518|FG000|COMPLETED|Overall Study||17
6510987|NCT01485094|7430519|FG001|COMPLETED|Overall Study||18
6510988|NCT01485094|7430520|FG002|COMPLETED|Overall Study||18
6510989|NCT01485094|7430518|FG000|NOT COMPLETED|Overall Study||3
6510990|NCT01485094|7430519|FG001|NOT COMPLETED|Overall Study||2
6510991|NCT01485094|7430520|FG002|NOT COMPLETED|Overall Study||1
6510992|NCT01485120|7430528|FG000|STARTED|Overall Study||34
6510993|NCT01485120|7430528|FG000|COMPLETED|Overall Study||32
6510994|NCT01485120|7430528|FG000|NOT COMPLETED|Overall Study||2
6510995|NCT01485172|7430539|FG000|STARTED|Overall Study||40
6510996|NCT01485172|7430540|FG001|STARTED|Overall Study||13
6510997|NCT01485172|7430541|FG002|STARTED|Overall Study||41
6510998|NCT01485172|7430542|FG003|STARTED|Overall Study||40
6510999|NCT01485172|7430543|FG004|STARTED|Overall Study||39
6511000|NCT01485172|7430544|FG005|STARTED|Overall Study||13
6511001|NCT01485172|7430539|FG000|COMPLETED|Overall Study||33
6511002|NCT01485172|7430540|FG001|COMPLETED|Overall Study||12
6511003|NCT01485172|7430541|FG002|COMPLETED|Overall Study||34
6511004|NCT01485172|7430542|FG003|COMPLETED|Overall Study||32
6511005|NCT01485172|7430543|FG004|COMPLETED|Overall Study||34
6511006|NCT01485172|7430544|FG005|COMPLETED|Overall Study||9
6511007|NCT01485172|7430539|FG000|NOT COMPLETED|Overall Study||7
6511008|NCT01485172|7430540|FG001|NOT COMPLETED|Overall Study||1
6511009|NCT01485172|7430541|FG002|NOT COMPLETED|Overall Study||7
6511010|NCT01485172|7430542|FG003|NOT COMPLETED|Overall Study||8
6511011|NCT01485172|7430543|FG004|NOT COMPLETED|Overall Study||5
6511012|NCT01485172|7430544|FG005|NOT COMPLETED|Overall Study||4
6511013|NCT01485354|7430558|FG000|STARTED|Overall Study||17
6511014|NCT01485354|7430558|FG000|COMPLETED|Overall Study||12
6511015|NCT01485354|7430558|FG000|NOT COMPLETED|Overall Study||5
6511016|NCT01485380|7430562|FG000|STARTED|Overall Study||20
6511017|NCT01485380|7430562|FG000|COMPLETED|Overall Study||17
6511018|NCT01485380|7430562|FG000|NOT COMPLETED|Overall Study||3
6511019|NCT01485393|7430566|FG000|STARTED|Overall Study||5
6511020|NCT01485393|7430567|FG001|STARTED|Overall Study||5
6511021|NCT01485393|7430566|FG000|COMPLETED|Overall Study||5
6511022|NCT01485393|7430567|FG001|COMPLETED|Overall Study||5
6511023|NCT01485393|7430566|FG000|NOT COMPLETED|Overall Study||0
6511024|NCT01485393|7430567|FG001|NOT COMPLETED|Overall Study||0
6511025|NCT01485536|7430574|FG000|STARTED|Overall Study||21
6511026|NCT01485536|7430574|FG000|COMPLETED|Overall Study||17
6511027|NCT01485536|7430574|FG000|NOT COMPLETED|Overall Study||4
6511028|NCT01485588|7430581|FG000|STARTED|Overall Study||6
6511029|NCT01485588|7430582|FG001|STARTED|Overall Study||6
6511030|NCT01485588|7430583|FG002|STARTED|Overall Study||6
6511031|NCT01485588|7430581|FG000|COMPLETED|Overall Study||6
6511032|NCT01485588|7430582|FG001|COMPLETED|Overall Study||6
6511033|NCT01485588|7430583|FG002|COMPLETED|Overall Study||6
6511034|NCT01485588|7430581|FG000|NOT COMPLETED|Overall Study||0
6511035|NCT01485588|7430582|FG001|NOT COMPLETED|Overall Study||0
6511036|NCT01485588|7430583|FG002|NOT COMPLETED|Overall Study||0
6511037|NCT01485614|7430597|FG000|STARTED|Randomization||96
6511038|NCT01485614|7430598|FG001|STARTED|Randomization||90
6511039|NCT01485614|7430599|FG002|STARTED|Randomization||9
6511040|NCT01485614|7430600|FG003|STARTED|Randomization||5
6511041|NCT01485614|7430597|FG000|COMPLETED|Randomization||95
6511042|NCT01485614|7430598|FG001|COMPLETED|Randomization||90
6511043|NCT01485614|7430599|FG002|COMPLETED|Randomization||9
6511044|NCT01485614|7430600|FG003|COMPLETED|Randomization||5
6511045|NCT01485614|7430597|FG000|NOT COMPLETED|Randomization||1
6511046|NCT01485614|7430598|FG001|NOT COMPLETED|Randomization||0
6511047|NCT01485614|7430599|FG002|NOT COMPLETED|Randomization||0
6511048|NCT01485614|7430600|FG003|NOT COMPLETED|Randomization||0
6511049|NCT01485614|7430597|FG000|STARTED|Weeks 0-20||95
6511050|NCT01485614|7430598|FG001|STARTED|Weeks 0-20||90
6511051|NCT01485614|7430599|FG002|STARTED|Weeks 0-20||9
6511052|NCT01485614|7430600|FG003|STARTED|Weeks 0-20||5
6511053|NCT01485614|7430597|FG000|Treated|Weeks 0-20||95
6511054|NCT01485614|7430598|FG001|Treated|Weeks 0-20||90
6511055|NCT01485614|7430599|FG002|Treated|Weeks 0-20||9
6511056|NCT01485614|7430600|FG003|Treated|Weeks 0-20||5
6511057|NCT01485614|7430597|FG000|COMPLETED|Weeks 0-20||85
6511058|NCT01485614|7430598|FG001|COMPLETED|Weeks 0-20||86
6511059|NCT01485614|7430599|FG002|COMPLETED|Weeks 0-20||8
6511060|NCT01485614|7430600|FG003|COMPLETED|Weeks 0-20||5
6511061|NCT01485614|7430597|FG000|NOT COMPLETED|Weeks 0-20||10
6511062|NCT01485614|7430598|FG001|NOT COMPLETED|Weeks 0-20||4
6511063|NCT01485614|7430599|FG002|NOT COMPLETED|Weeks 0-20||1
6511064|NCT01485614|7430600|FG003|NOT COMPLETED|Weeks 0-20||0
6511065|NCT01485614|7430597|FG000|STARTED|Weeks 20-54||85
6511066|NCT01485614|7430598|FG001|STARTED|Weeks 20-54||86
6511067|NCT01485614|7430599|FG002|STARTED|Weeks 20-54||8
6511068|NCT01485614|7430600|FG003|STARTED|Weeks 20-54||5
6511069|NCT01485614|7430597|FG000|COMPLETED|Weeks 20-54||74
6511070|NCT01485614|7430598|FG001|COMPLETED|Weeks 20-54||78
6511071|NCT01485614|7430599|FG002|COMPLETED|Weeks 20-54||6
6511072|NCT01485614|7430600|FG003|COMPLETED|Weeks 20-54||5
6511073|NCT01485614|7430597|FG000|NOT COMPLETED|Weeks 20-54||11
6511074|NCT01485614|7430598|FG001|NOT COMPLETED|Weeks 20-54||8
6511075|NCT01485614|7430599|FG002|NOT COMPLETED|Weeks 20-54||2
6511076|NCT01485614|7430600|FG003|NOT COMPLETED|Weeks 20-54||0
6511077|NCT01485627|7430618|FG000|STARTED|Overall Study|139 patients and 105 caregivers|244
6511078|NCT01485627|7430619|FG001|STARTED|Overall Study|142 patients and 99 caregivers|241
6511079|NCT01485627|7430618|FG000|Allocated Caregivers: Total|Overall Study||105
6511080|NCT01485627|7430619|FG001|Allocated Caregivers: Total|Overall Study||99
6511081|NCT01485627|7430618|FG000|Bereaved Caregivers: Total|Overall Study||63
6511082|NCT01485627|7430619|FG001|Bereaved Caregivers: Total|Overall Study||64
6511083|NCT01485627|7430618|FG000|Bereaved Caregivers: 1 Month|Overall Study||51
6511084|NCT01485627|7430619|FG001|Bereaved Caregivers: 1 Month|Overall Study||51
6511085|NCT01485627|7430618|FG000|Bereaved Caregivers: 2 Month Completed|Overall Study||49
6511086|NCT01485627|7430619|FG001|Bereaved Caregivers: 2 Month Completed|Overall Study||52
6511087|NCT01485627|7430618|FG000|Bereaved Caregivers: 7 Month Completed|Overall Study||48
6511088|NCT01485627|7430619|FG001|Bereaved Caregivers: 7 Month Completed|Overall Study||49
6511089|NCT01485627|7430618|FG000|COMPLETED|Overall Study|130 patients and 48 caregivers|178
6511090|NCT01485627|7430619|FG001|COMPLETED|Overall Study|135 patients and 49 caregivers|184
6511091|NCT01485627|7430618|FG000|NOT COMPLETED|Overall Study||66
6511092|NCT01485627|7430619|FG001|NOT COMPLETED|Overall Study||57
6511093|NCT01485640|7430629|FG000|STARTED|Overall Study||162
6511094|NCT01485640|7430629|FG000|COMPLETED|Overall Study||40
6511095|NCT01485640|7430629|FG000|NOT COMPLETED|Overall Study||122
6511096|NCT01485770|7430635|FG000|STARTED|First Intervention (2 Weeks)||17
6511097|NCT01485770|7430636|FG001|STARTED|First Intervention (2 Weeks)||16
6511098|NCT01485770|7430635|FG000|COMPLETED|First Intervention (2 Weeks)||17
6511099|NCT01485770|7430636|FG001|COMPLETED|First Intervention (2 Weeks)||16
6511100|NCT01485770|7430635|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6511101|NCT01485770|7430636|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
6511102|NCT01485770|7430635|FG000|STARTED|Second Intervention (2 Weeks)||17
6511103|NCT01485770|7430636|FG001|STARTED|Second Intervention (2 Weeks)||16
6511104|NCT01485770|7430635|FG000|COMPLETED|Second Intervention (2 Weeks)||17
6511105|NCT01485770|7430636|FG001|COMPLETED|Second Intervention (2 Weeks)||16
6511106|NCT01485770|7430635|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6511107|NCT01485770|7430636|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6511108|NCT01485796|7430644|FG000|STARTED|Period 1: Epoch 1 (Ramp-up)||37
6511109|NCT01485796|7430644|FG000|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
6511110|NCT01485796|7430644|FG000|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
6511111|NCT01485796|7430644|FG000|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
6511112|NCT01485796|7430644|FG000|STARTED|Period 2: Epoch 2||36
6511113|NCT01485796|7430644|FG000|Treated in Epoch 2|Period 2: Epoch 2||36
6511114|NCT01485796|7430644|FG000|COMPLETED|Period 2: Epoch 2||1
6511115|NCT01485796|7430644|FG000|NOT COMPLETED|Period 2: Epoch 2||35
6511116|NCT01485796|7430644|FG000|STARTED|Overall Trial (Incl. Safety Follow-up)||37
6511117|NCT01485796|7430644|FG000|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
6511118|NCT01485796|7430644|FG000|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
6511119|NCT01485796|7430644|FG000|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
6511120|NCT01485796|7430644|FG000|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
6511121|NCT01485796|7430644|FG000|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
6511122|NCT01485796|7430644|FG000|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
6511123|NCT01485796|7430644|FG000|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
6511124|NCT01485796|7430644|FG000|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
6511125|NCT01485796|7430644|FG000|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
6511126|NCT01485887|7430652|FG000|STARTED|Overall Study||50
6511127|NCT01485887|7430652|FG000|COMPLETED|Overall Study||38
6511128|NCT01485887|7430652|FG000|NOT COMPLETED|Overall Study||12
6511129|NCT01485991|7430658|FG000|STARTED|Overall Study||385
6511130|NCT01485991|7430659|FG001|STARTED|Overall Study||386
6511131|NCT01485991|7430658|FG000|Treated|Overall Study||379
6511132|NCT01485991|7430659|FG001|Treated|Overall Study||384
6511133|NCT01485991|7430658|FG000|COMPLETED|Overall Study||353
6511134|NCT01485991|7430659|FG001|COMPLETED|Overall Study||350
6511135|NCT01485991|7430658|FG000|NOT COMPLETED|Overall Study||32
6511136|NCT01485991|7430659|FG001|NOT COMPLETED|Overall Study||36
6511137|NCT01486043|7430665|FG000|STARTED|Overall Study||4
6511138|NCT01486043|7430665|FG000|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
6511139|NCT01486043|7430665|FG000|NOT COMPLETED|Overall Study||2
6511140|NCT01486199|7430671|FG000|STARTED|Baseline Study Day||10
6511141|NCT01486199|7430672|FG001|STARTED|Baseline Study Day||10
6511142|NCT01486199|7430671|FG000|COMPLETED|Baseline Study Day||10
6511143|NCT01486199|7430672|FG001|COMPLETED|Baseline Study Day||9
6511144|NCT01486199|7430671|FG000|NOT COMPLETED|Baseline Study Day||0
6511145|NCT01486199|7430672|FG001|NOT COMPLETED|Baseline Study Day||1
6511146|NCT01486199|7430671|FG000|STARTED|Two Year Period Between Study Days||10
6511147|NCT01486199|7430672|FG001|STARTED|Two Year Period Between Study Days||0
6511148|NCT01486199|7430671|FG000|COMPLETED|Two Year Period Between Study Days||9
6511149|NCT01486199|7430672|FG001|COMPLETED|Two Year Period Between Study Days||0
6511150|NCT01486199|7430671|FG000|NOT COMPLETED|Two Year Period Between Study Days||1
6511151|NCT01486199|7430672|FG001|NOT COMPLETED|Two Year Period Between Study Days||0
6511152|NCT01486199|7430671|FG000|STARTED|Study Day at t= 2 Years||9
6511153|NCT01486199|7430672|FG001|STARTED|Study Day at t= 2 Years||0
6511154|NCT01486199|7430671|FG000|COMPLETED|Study Day at t= 2 Years||9
6511155|NCT01486199|7430672|FG001|COMPLETED|Study Day at t= 2 Years||0
6511156|NCT01486199|7430671|FG000|NOT COMPLETED|Study Day at t= 2 Years||0
6511157|NCT01486199|7430672|FG001|NOT COMPLETED|Study Day at t= 2 Years||0
6511158|NCT01486238|7430680|FG000|STARTED|Overall Study||23
6511159|NCT01486238|7430681|FG001|STARTED|Overall Study||49
6511160|NCT01486238|7430680|FG000|COMPLETED|Overall Study||21
6511161|NCT01486238|7430681|FG001|COMPLETED|Overall Study||43
6511162|NCT01486238|7430680|FG000|NOT COMPLETED|Overall Study||2
6511163|NCT01486238|7430681|FG001|NOT COMPLETED|Overall Study||6
6511164|NCT01486264|7430689|FG000|STARTED|Overall Study||142
6511165|NCT01486264|7430690|FG001|STARTED|Overall Study||141
6511166|NCT01486264|7430689|FG000|Treated|Overall Study||142
6511167|NCT01486264|7430690|FG001|Treated|Overall Study||140
6511168|NCT01486264|7430689|FG000|COMPLETED|Overall Study||113
6511169|NCT01486264|7430690|FG001|COMPLETED|Overall Study||94
6511170|NCT01486264|7430689|FG000|NOT COMPLETED|Overall Study||29
6511171|NCT01486264|7430690|FG001|NOT COMPLETED|Overall Study||47
6511172|NCT01486316|7430699|FG000|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm|7
6511173|NCT01486316|7430700|FG001|STARTED|Overall Study|prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm|10
6511174|NCT01486316|7430701|FG002|STARTED|Overall Study|Exited prior to implant|5
6511175|NCT01486316|7430702|FG003|STARTED|Overall Study|Exited prior to 6 month visit|2
6511176|NCT01486316|7430699|FG000|COMPLETED|Overall Study||3
6511177|NCT01486316|7430700|FG001|COMPLETED|Overall Study||7
6511178|NCT01486316|7430701|FG002|COMPLETED|Overall Study||0
6511179|NCT01486316|7430702|FG003|COMPLETED|Overall Study||0
6511180|NCT01486316|7430699|FG000|NOT COMPLETED|Overall Study||4
6511181|NCT01486316|7430700|FG001|NOT COMPLETED|Overall Study||3
6511182|NCT01486316|7430701|FG002|NOT COMPLETED|Overall Study||5
6511183|NCT01486316|7430702|FG003|NOT COMPLETED|Overall Study||2
6511184|NCT01486446|7430713|FG000|STARTED|Overall Study||7
6511185|NCT01486446|7430714|FG001|STARTED|Overall Study||1
6511186|NCT01486446|7430713|FG000|COMPLETED|Overall Study||6
6511187|NCT01486446|7430714|FG001|COMPLETED|Overall Study||1
6511188|NCT01486446|7430713|FG000|NOT COMPLETED|Overall Study||1
6511189|NCT01486446|7430714|FG001|NOT COMPLETED|Overall Study||0
6511190|NCT01486615|7430724|FG000|STARTED|Overall Study||20
6511191|NCT01486615|7430725|FG001|STARTED|Overall Study||20
6511192|NCT01486615|7430726|FG002|STARTED|Overall Study||20
6511193|NCT01486615|7430727|FG003|STARTED|Overall Study||20
6511194|NCT01486615|7430724|FG000|COMPLETED|Overall Study||20
6511195|NCT01486615|7430725|FG001|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
6511196|NCT01486615|7430726|FG002|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
6511197|NCT01486615|7430727|FG003|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
6511198|NCT01486615|7430724|FG000|NOT COMPLETED|Overall Study||0
6511199|NCT01486615|7430725|FG001|NOT COMPLETED|Overall Study||1
6511200|NCT01486615|7430726|FG002|NOT COMPLETED|Overall Study||2
6511201|NCT01486615|7430727|FG003|NOT COMPLETED|Overall Study||2
6511202|NCT01486758|7430739|FG000|STARTED|Overall Study||20
6511203|NCT01486758|7430740|FG001|STARTED|Overall Study||20
6511204|NCT01486758|7430739|FG000|COMPLETED|Overall Study||20
6511205|NCT01486758|7430740|FG001|COMPLETED|Overall Study||19
6511206|NCT01486758|7430739|FG000|NOT COMPLETED|Overall Study||0
6511207|NCT01486758|7430740|FG001|NOT COMPLETED|Overall Study||1
6511208|NCT01486784|7430753|FG000|STARTED|Overall Study||3
6511209|NCT01486784|7430754|FG001|STARTED|Overall Study||7
6511210|NCT01486784|7430755|FG002|STARTED|Overall Study||6
6511211|NCT01486784|7430756|FG003|STARTED|Overall Study||1
6511212|NCT01486784|7430757|FG004|STARTED|Overall Study||5
6511213|NCT01486784|7430758|FG005|STARTED|Overall Study||5
6511214|NCT01486784|7430753|FG000|Completed Cycle 1|Overall Study||2
6511215|NCT01486784|7430754|FG001|Completed Cycle 1|Overall Study||6
6511216|NCT01486784|7430755|FG002|Completed Cycle 1|Overall Study||3
6511217|NCT01486784|7430756|FG003|Completed Cycle 1|Overall Study||1
6511218|NCT01486784|7430757|FG004|Completed Cycle 1|Overall Study||3
6511219|NCT01486784|7430758|FG005|Completed Cycle 1|Overall Study||2
6511220|NCT01486784|7430753|FG000|Received Treatment|Overall Study||3
6511221|NCT01486784|7430754|FG001|Received Treatment|Overall Study||7
6511222|NCT01486784|7430755|FG002|Received Treatment|Overall Study||5
6511223|NCT01486784|7430756|FG003|Received Treatment|Overall Study||1
6511224|NCT01486784|7430757|FG004|Received Treatment|Overall Study||3
6511225|NCT01486784|7430758|FG005|Received Treatment|Overall Study||2
6511226|NCT01486784|7430753|FG000|COMPLETED|Overall Study||3
6511227|NCT01486784|7430754|FG001|COMPLETED|Overall Study||7
6511228|NCT01486784|7430755|FG002|COMPLETED|Overall Study||5
6511229|NCT01486784|7430756|FG003|COMPLETED|Overall Study||1
6511230|NCT01486784|7430757|FG004|COMPLETED|Overall Study||3
6511231|NCT01486784|7430758|FG005|COMPLETED|Overall Study||2
6511232|NCT01486784|7430753|FG000|NOT COMPLETED|Overall Study||0
6511233|NCT01486784|7430754|FG001|NOT COMPLETED|Overall Study||0
6511234|NCT01486784|7430755|FG002|NOT COMPLETED|Overall Study||1
6511235|NCT01486784|7430756|FG003|NOT COMPLETED|Overall Study||0
6511236|NCT01486784|7430757|FG004|NOT COMPLETED|Overall Study||2
6511237|NCT01486784|7430758|FG005|NOT COMPLETED|Overall Study||3
6511238|NCT01486810|7430772|FG000|STARTED|Overall Study||17
6511239|NCT01486810|7430772|FG000|COMPLETED|Overall Study||9
6511240|NCT01486810|7430772|FG000|NOT COMPLETED|Overall Study||8
6511241|NCT01486927|7430776|FG000|STARTED|Overall Study||174
6511242|NCT01486927|7430776|FG000|COMPLETED|Overall Study||161
6511243|NCT01486927|7430776|FG000|NOT COMPLETED|Overall Study||13
6511244|NCT01486966|7430789|FG000|STARTED|Overall Study||29
6511245|NCT01486966|7430790|FG001|STARTED|Overall Study||29
6511246|NCT01486966|7430789|FG000|COMPLETED|Overall Study||29
6511247|NCT01486966|7430790|FG001|COMPLETED|Overall Study||27
6511248|NCT01486966|7430789|FG000|NOT COMPLETED|Overall Study||0
6743576|NCT03335254|7671813|FG003|STARTED|Period 1||0
6511249|NCT01486966|7430790|FG001|NOT COMPLETED|Overall Study||2
6511250|NCT01487161|7430800|FG000|STARTED|Overall Study||58
6511251|NCT01487161|7430801|FG001|STARTED|Overall Study||59
6511252|NCT01487161|7430802|FG002|STARTED|Overall Study||60
6511253|NCT01487161|7430803|FG003|STARTED|Overall Study||52
6511254|NCT01487161|7430800|FG000|COMPLETED|Overall Study||56
6511255|NCT01487161|7430801|FG001|COMPLETED|Overall Study||57
6511256|NCT01487161|7430802|FG002|COMPLETED|Overall Study||59
6511257|NCT01487161|7430803|FG003|COMPLETED|Overall Study||50
6511258|NCT01487161|7430800|FG000|NOT COMPLETED|Overall Study||2
6511259|NCT01487161|7430801|FG001|NOT COMPLETED|Overall Study||2
6511260|NCT01487161|7430802|FG002|NOT COMPLETED|Overall Study||1
6511261|NCT01487161|7430803|FG003|NOT COMPLETED|Overall Study||2
6511262|NCT01487200|7430822|FG000|STARTED|Overall Study||5
6511263|NCT01487200|7430823|FG001|STARTED|Overall Study||7
6511264|NCT01487200|7430824|FG002|STARTED|Overall Study||7
6511265|NCT01487200|7430825|FG003|STARTED|Overall Study||5
6511266|NCT01487200|7430822|FG000|COMPLETED|Overall Study||5
6511267|NCT01487200|7430823|FG001|COMPLETED|Overall Study||6
6511268|NCT01487200|7430824|FG002|COMPLETED|Overall Study||7
6511269|NCT01487200|7430825|FG003|COMPLETED|Overall Study||5
6640156|NCT02332720|7568344|FG004|NOT COMPLETED|Part A and Part B||0
6640157|NCT02332720|7568345|FG005|NOT COMPLETED|Part A and Part B||3
6640158|NCT02332720|7568346|FG006|NOT COMPLETED|Part A and Part B||1
6640159|NCT02332720|7568347|FG007|NOT COMPLETED|Part A and Part B||1
6511270|NCT01487200|7430822|FG000|NOT COMPLETED|Overall Study||0
6511271|NCT01487200|7430823|FG001|NOT COMPLETED|Overall Study||1
6511272|NCT01487200|7430824|FG002|NOT COMPLETED|Overall Study||0
6511273|NCT01487200|7430825|FG003|NOT COMPLETED|Overall Study||0
6511274|NCT01487265|7430836|FG000|STARTED|Overall Study||37
6511275|NCT01487265|7430836|FG000|COMPLETED|Overall Study||0
6511276|NCT01487265|7430836|FG000|NOT COMPLETED|Overall Study||37
6511277|NCT01487525|7430842|FG000|STARTED|Overall Study||22
6511278|NCT01487525|7430843|FG001|STARTED|Overall Study||20
6511279|NCT01487525|7430842|FG000|COMPLETED|Overall Study||22
6511280|NCT01487525|7430843|FG001|COMPLETED|Overall Study||19
6511281|NCT01487525|7430842|FG000|NOT COMPLETED|Overall Study||0
6640160|NCT02332720|7568348|FG008|NOT COMPLETED|Part A and Part B||0
6640161|NCT02332720|7568349|FG009|NOT COMPLETED|Part A and Part B||0
6640162|NCT02332720|7568350|FG010|NOT COMPLETED|Part A and Part B||0
6640163|NCT02332720|7568351|FG011|NOT COMPLETED|Part A and Part B||0
6640164|NCT02332720|7568352|FG012|NOT COMPLETED|Part A and Part B||0
6640165|NCT02332720|7568353|FG013|NOT COMPLETED|Part A and Part B||0
6640166|NCT02332720|7568354|FG014|NOT COMPLETED|Part A and Part B||0
6511282|NCT01487525|7430843|FG001|NOT COMPLETED|Overall Study||1
6511283|NCT01487577|7430849|FG000|STARTED|Overall Study||19
6511284|NCT01487577|7430849|FG000|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
6511285|NCT01487577|7430849|FG000|NOT COMPLETED|Overall Study||1
6511286|NCT01487668|7430855|FG000|STARTED|Overall Study||146
6511287|NCT01487668|7430856|FG001|STARTED|Overall Study||141
6511288|NCT01487668|7430855|FG000|COMPLETED|Overall Study||121
6511289|NCT01487668|7430856|FG001|COMPLETED|Overall Study||124
6511290|NCT01487668|7430855|FG000|NOT COMPLETED|Overall Study||25
6511291|NCT01487668|7430856|FG001|NOT COMPLETED|Overall Study||17
6561263|NCT01791725|7484073|FG000|STARTED|Overall Study||12
6561264|NCT01791725|7484074|FG001|STARTED|Overall Study||5
6561265|NCT01791725|7484075|FG002|STARTED|Overall Study||6
6561266|NCT01791725|7484073|FG000|COMPLETED|Overall Study||12
6561267|NCT01791725|7484074|FG001|COMPLETED|Overall Study||4
6561268|NCT01791725|7484075|FG002|COMPLETED|Overall Study||6
6561269|NCT01791725|7484073|FG000|NOT COMPLETED|Overall Study||0
6561270|NCT01791725|7484074|FG001|NOT COMPLETED|Overall Study||1
6561271|NCT01791725|7484075|FG002|NOT COMPLETED|Overall Study||0
6561272|NCT01791803|7484087|FG000|STARTED|Overall Study||41
6561273|NCT01791803|7484088|FG001|STARTED|Overall Study||41
6561274|NCT01791803|7484089|FG002|STARTED|Overall Study||40
6561275|NCT01791803|7484090|FG003|STARTED|Overall Study||42
6561276|NCT01791803|7484087|FG000|COMPLETED|Overall Study||41
6561277|NCT01791803|7484088|FG001|COMPLETED|Overall Study||39
6561278|NCT01791803|7484089|FG002|COMPLETED|Overall Study||38
6561279|NCT01791803|7484090|FG003|COMPLETED|Overall Study||37
6561280|NCT01791803|7484087|FG000|NOT COMPLETED|Overall Study||0
6561281|NCT01791803|7484088|FG001|NOT COMPLETED|Overall Study||2
6561282|NCT01791803|7484089|FG002|NOT COMPLETED|Overall Study||2
6561283|NCT01791803|7484090|FG003|NOT COMPLETED|Overall Study||5
6561284|NCT01791894|7484103|FG000|STARTED|Overall Study||5
6561285|NCT01791894|7484103|FG000|COMPLETED|Overall Study||4
6561286|NCT01791894|7484103|FG000|NOT COMPLETED|Overall Study||1
6561287|NCT01791972|7484110|FG000|STARTED|Overall Study||19
6561288|NCT01791972|7484111|FG001|STARTED|Overall Study||19
6561289|NCT01791972|7484110|FG000|COMPLETED|Overall Study||19
6561290|NCT01791972|7484111|FG001|COMPLETED|Overall Study||19
6561291|NCT01791972|7484110|FG000|NOT COMPLETED|Overall Study||0
6561292|NCT01791972|7484111|FG001|NOT COMPLETED|Overall Study||0
6561293|NCT01792024|7484117|FG000|STARTED|Overall Study||27
6561294|NCT01792024|7484117|FG000|COMPLETED|Overall Study||27
6561295|NCT01792024|7484117|FG000|NOT COMPLETED|Overall Study||0
6561296|NCT01792115|7484124|FG000|STARTED|Overall Study||7
6561297|NCT01792115|7484125|FG001|STARTED|Overall Study||7
6561298|NCT01792115|7484126|FG002|STARTED|Overall Study||8
6561299|NCT01792115|7484124|FG000|COMPLETED|Overall Study||7
6561300|NCT01792115|7484125|FG001|COMPLETED|Overall Study||6
6561301|NCT01792115|7484126|FG002|COMPLETED|Overall Study||8
6561302|NCT01792115|7484124|FG000|NOT COMPLETED|Overall Study||0
6640167|NCT02332720|7568355|FG015|NOT COMPLETED|Part A and Part B||1
6640168|NCT02332720|7568356|FG016|NOT COMPLETED|Part A and Part B||0
6640169|NCT02332720|7568357|FG017|NOT COMPLETED|Part A and Part B||1
6640170|NCT02332720|7568358|FG018|NOT COMPLETED|Part A and Part B||1
6640171|NCT02332720|7568359|FG019|NOT COMPLETED|Part A and Part B||1
6640172|NCT02332720|7568360|FG020|NOT COMPLETED|Part A and Part B||0
6561303|NCT01792115|7484125|FG001|NOT COMPLETED|Overall Study||1
6561304|NCT01792115|7484126|FG002|NOT COMPLETED|Overall Study||0
6561305|NCT01792284|7484134|FG000|STARTED|Lead-in Period||212
6561306|NCT01792284|7484135|FG001|STARTED|Lead-in Period||0
6561307|NCT01792284|7484136|FG002|STARTED|Lead-in Period||0
6561308|NCT01792284|7484134|FG000|COMPLETED|Lead-in Period|Participants that completed the Lead-in Period were randomized and entered Randomization Period 1.|182
6561309|NCT01792284|7484135|FG001|COMPLETED|Lead-in Period||0
6561310|NCT01792284|7484136|FG002|COMPLETED|Lead-in Period||0
6561311|NCT01792284|7484134|FG000|NOT COMPLETED|Lead-in Period||30
6561312|NCT01792284|7484135|FG001|NOT COMPLETED|Lead-in Period||0
6561313|NCT01792284|7484136|FG002|NOT COMPLETED|Lead-in Period||0
6561314|NCT01792284|7484134|FG000|STARTED|Randomization Period 1||0
6561315|NCT01792284|7484135|FG001|STARTED|Randomization Period 1||92
6561316|NCT01792284|7484136|FG002|STARTED|Randomization Period 1||90
6561317|NCT01792284|7484134|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 1||0
6561318|NCT01792284|7484135|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 1||92
6561319|NCT01792284|7484136|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 1||90
6561320|NCT01792284|7484134|FG000|COMPLETED|Randomization Period 1||0
6561321|NCT01792284|7484135|FG001|COMPLETED|Randomization Period 1||90
6561322|NCT01792284|7484136|FG002|COMPLETED|Randomization Period 1||85
6561323|NCT01792284|7484134|FG000|NOT COMPLETED|Randomization Period 1||0
6561324|NCT01792284|7484135|FG001|NOT COMPLETED|Randomization Period 1||2
6561325|NCT01792284|7484136|FG002|NOT COMPLETED|Randomization Period 1||5
6561326|NCT01792284|7484134|FG000|STARTED|Randomization Period 2||0
6561327|NCT01792284|7484135|FG001|STARTED|Randomization Period 2||90
6743577|NCT03335254|7671814|FG004|STARTED|Period 1||0
6743578|NCT03335254|7671815|FG005|STARTED|Period 1||0
6561328|NCT01792284|7484136|FG002|STARTED|Randomization Period 2||85
6561329|NCT01792284|7484134|FG000|Received at Least 1 Dose of Study Drug|Randomization Period 2||0
6561330|NCT01792284|7484135|FG001|Received at Least 1 Dose of Study Drug|Randomization Period 2||90
6561331|NCT01792284|7484136|FG002|Received at Least 1 Dose of Study Drug|Randomization Period 2||85
6640173|NCT02332720|7568361|FG021|NOT COMPLETED|Part A and Part B||0
6640174|NCT02332720|7568362|FG022|NOT COMPLETED|Part A and Part B||0
6640175|NCT02332720|7568340|FG000|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
6640176|NCT02332720|7568341|FG001|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|1
6743579|NCT03335254|7671816|FG006|STARTED|Period 1||0
6561332|NCT01792284|7484134|FG000|COMPLETED|Randomization Period 2||0
6561333|NCT01792284|7484135|FG001|COMPLETED|Randomization Period 2||87
6511292|NCT01487863|7430866|FG000|STARTED|Overall Study||35
6511293|NCT01487863|7430867|FG001|STARTED|Overall Study||34
6511294|NCT01487863|7430866|FG000|Subjects Randomized (Efficacy Analysis)|Overall Study||35
6511295|NCT01487863|7430867|FG001|Subjects Randomized (Efficacy Analysis)|Overall Study||34
6511296|NCT01487863|7430866|FG000|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
6511297|NCT01487863|7430867|FG001|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
6511298|NCT01487863|7430866|FG000|COMPLETED|Overall Study||16
6511299|NCT01487863|7430867|FG001|COMPLETED|Overall Study||15
6511300|NCT01487863|7430866|FG000|NOT COMPLETED|Overall Study||19
6511301|NCT01487863|7430867|FG001|NOT COMPLETED|Overall Study||19
6511302|NCT01487954|7430875|FG000|STARTED|Overall Study||29
6511303|NCT01487954|7430876|FG001|STARTED|Overall Study||16
6511304|NCT01487954|7430875|FG000|Safety lead-in|Overall Study||10
6511305|NCT01487954|7430876|FG001|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
6511306|NCT01487954|7430875|FG000|COMPLETED|Overall Study||29
6511307|NCT01487954|7430876|FG001|COMPLETED|Overall Study||16
6511308|NCT01487954|7430875|FG000|NOT COMPLETED|Overall Study||0
6511309|NCT01487954|7430876|FG001|NOT COMPLETED|Overall Study||0
6511310|NCT01488019|7430884|FG000|STARTED|Overall Study||541
6511311|NCT01488019|7430885|FG001|STARTED|Overall Study||530
6511312|NCT01488019|7430884|FG000|COMPLETED|Overall Study||294
6511313|NCT01488019|7430885|FG001|COMPLETED|Overall Study||226
6511314|NCT01488019|7430884|FG000|NOT COMPLETED|Overall Study||247
6511315|NCT01488019|7430885|FG001|NOT COMPLETED|Overall Study||304
6511316|NCT01488071|7430895|FG000|STARTED|Overall Study|all-patients-treated set (APTS)|253
6511317|NCT01488071|7430896|FG001|STARTED|Overall Study|APTS|242
6511318|NCT01488071|7430895|FG000|COMPLETED|Overall Study||200
6511319|NCT01488071|7430896|FG001|COMPLETED|Overall Study||179
6511320|NCT01488071|7430895|FG000|NOT COMPLETED|Overall Study||53
6511321|NCT01488071|7430896|FG001|NOT COMPLETED|Overall Study||63
6511322|NCT01488097|7430902|FG000|STARTED|Overall Study||8
6511323|NCT01488097|7430902|FG000|Received Study Drug in Extension Study|Overall Study||8
6511324|NCT01488097|7430902|FG000|COMPLETED|Overall Study||7
6511325|NCT01488097|7430902|FG000|NOT COMPLETED|Overall Study||1
6511326|NCT01488188|7430908|FG000|STARTED|Overall Study||20
6511327|NCT01488188|7430909|FG001|STARTED|Overall Study||20
6511328|NCT01488188|7430908|FG000|COMPLETED|Overall Study||20
6511329|NCT01488188|7430909|FG001|COMPLETED|Overall Study||20
6511330|NCT01488188|7430908|FG000|NOT COMPLETED|Overall Study||0
6511331|NCT01488188|7430909|FG001|NOT COMPLETED|Overall Study||0
6511332|NCT01488279|7430917|FG000|STARTED|Overall Study||5
6511333|NCT01488279|7430918|FG001|STARTED|Overall Study||5
6511334|NCT01488279|7430917|FG000|COMPLETED|Overall Study||5
6511335|NCT01488279|7430918|FG001|COMPLETED|Overall Study||5
6511336|NCT01488279|7430917|FG000|NOT COMPLETED|Overall Study||0
6511337|NCT01488279|7430918|FG001|NOT COMPLETED|Overall Study||0
6511338|NCT01488318|7430927|FG000|STARTED|Overall Study||14
6511339|NCT01488318|7430927|FG000|COMPLETED|Overall Study||14
6511340|NCT01488318|7430927|FG000|NOT COMPLETED|Overall Study||0
6511341|NCT01488370|7430934|FG000|STARTED|Overall Study||22
6511342|NCT01488370|7430935|FG001|STARTED|Overall Study||23
6511343|NCT01488370|7430936|FG002|STARTED|Overall Study||20
6511344|NCT01488370|7430934|FG000|COMPLETED|Overall Study||22
6511345|NCT01488370|7430935|FG001|COMPLETED|Overall Study||22
6511346|NCT01488370|7430936|FG002|COMPLETED|Overall Study||19
6511347|NCT01488370|7430934|FG000|NOT COMPLETED|Overall Study||0
6511348|NCT01488370|7430935|FG001|NOT COMPLETED|Overall Study||1
6511349|NCT01488370|7430936|FG002|NOT COMPLETED|Overall Study||1
6511350|NCT01488409|7430946|FG000|STARTED|Overall Study||20
6511351|NCT01488409|7430947|FG001|STARTED|Overall Study||19
6511352|NCT01488409|7430946|FG000|COMPLETED|Overall Study||16
6511353|NCT01488409|7430947|FG001|COMPLETED|Overall Study||15
6511354|NCT01488409|7430946|FG000|NOT COMPLETED|Overall Study||4
6511355|NCT01488409|7430947|FG001|NOT COMPLETED|Overall Study||4
6511356|NCT01488448|7430955|FG000|STARTED|Overall Study||113
6511357|NCT01488448|7430956|FG001|STARTED|Overall Study||114
6511358|NCT01488448|7430955|FG000|COMPLETED|Overall Study||93
6511359|NCT01488448|7430956|FG001|COMPLETED|Overall Study||97
6511360|NCT01488448|7430955|FG000|NOT COMPLETED|Overall Study||20
6511361|NCT01488448|7430956|FG001|NOT COMPLETED|Overall Study||17
6511362|NCT01488487|7430964|FG000|STARTED|Overall Study||24
6511363|NCT01488487|7430964|FG000|Received Treatment|Overall Study||24
6511364|NCT01488487|7430964|FG000|COMPLETED|Overall Study||15
6511365|NCT01488487|7430964|FG000|NOT COMPLETED|Overall Study||9
6511366|NCT01488578|7430968|FG000|STARTED|Overall Study||11157
6511367|NCT01488578|7430968|FG000|COMPLETED|Overall Study||9321
6511368|NCT01488578|7430968|FG000|NOT COMPLETED|Overall Study||1836
6511369|NCT01488708|7431000|FG000|STARTED|Overall Study||940
6511370|NCT01488708|7431001|FG001|STARTED|Overall Study||578
6511371|NCT01488708|7431000|FG000|Received at Least 1 Dose of Study Drug|Overall Study||937
6511372|NCT01488708|7431001|FG001|Received at Least 1 Dose of Study Drug|Overall Study||578
6511373|NCT01488708|7431000|FG000|Participated in Follow Up|Overall Study||810
6511374|NCT01488708|7431001|FG001|Participated in Follow Up|Overall Study||526
6511375|NCT01488708|7431000|FG000|COMPLETED|Overall Study||0
6511376|NCT01488708|7431001|FG001|COMPLETED|Overall Study||0
6511377|NCT01488708|7431000|FG000|NOT COMPLETED|Overall Study||940
6511378|NCT01488708|7431001|FG001|NOT COMPLETED|Overall Study||578
6511379|NCT01488877|7431009|FG000|STARTED|Initial Randomization||1
6511380|NCT01488877|7431010|FG001|STARTED|Initial Randomization||5
6511381|NCT01488877|7431011|FG002|STARTED|Initial Randomization||0
6511382|NCT01488877|7431009|FG000|COMPLETED|Initial Randomization||1
6511383|NCT01488877|7431010|FG001|COMPLETED|Initial Randomization||5
6511384|NCT01488877|7431011|FG002|COMPLETED|Initial Randomization||0
6511385|NCT01488877|7431009|FG000|NOT COMPLETED|Initial Randomization||0
6511386|NCT01488877|7431010|FG001|NOT COMPLETED|Initial Randomization||0
6511387|NCT01488877|7431011|FG002|NOT COMPLETED|Initial Randomization||0
6511388|NCT01488877|7431009|FG000|STARTED|Re-randomization||0
6511389|NCT01488877|7431010|FG001|STARTED|Re-randomization||0
6511390|NCT01488877|7431011|FG002|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
6511391|NCT01488877|7431009|FG000|COMPLETED|Re-randomization||0
6511392|NCT01488877|7431010|FG001|COMPLETED|Re-randomization||0
6511393|NCT01488877|7431011|FG002|COMPLETED|Re-randomization||3
6511394|NCT01488877|7431009|FG000|NOT COMPLETED|Re-randomization||0
6511395|NCT01488877|7431010|FG001|NOT COMPLETED|Re-randomization||0
6511396|NCT01488877|7431011|FG002|NOT COMPLETED|Re-randomization||0
6511397|NCT01488994|7431020|FG000|STARTED|Overall Study||11
6511398|NCT01488994|7431021|FG001|STARTED|Overall Study||12
6511399|NCT01488994|7431020|FG000|COMPLETED|Overall Study||11
6511400|NCT01488994|7431021|FG001|COMPLETED|Overall Study||11
6511401|NCT01488994|7431020|FG000|NOT COMPLETED|Overall Study||0
6511402|NCT01488994|7431021|FG001|NOT COMPLETED|Overall Study||1
6511403|NCT01489020|7431038|FG000|STARTED|Overall Study||12
6511404|NCT01489020|7431039|FG001|STARTED|Overall Study||4
6511405|NCT01489020|7431040|FG002|STARTED|Overall Study||12
6511406|NCT01489020|7431041|FG003|STARTED|Overall Study||4
6511407|NCT01489020|7431042|FG004|STARTED|Overall Study||12
6511408|NCT01489020|7431043|FG005|STARTED|Overall Study||4
6511409|NCT01489020|7431038|FG000|COMPLETED|Overall Study||11
6511410|NCT01489020|7431039|FG001|COMPLETED|Overall Study||4
6511411|NCT01489020|7431040|FG002|COMPLETED|Overall Study||9
6511412|NCT01489020|7431041|FG003|COMPLETED|Overall Study||4
6511413|NCT01489020|7431042|FG004|COMPLETED|Overall Study||6
6511414|NCT01489020|7431043|FG005|COMPLETED|Overall Study||4
6511415|NCT01489020|7431038|FG000|NOT COMPLETED|Overall Study||1
6511416|NCT01489020|7431039|FG001|NOT COMPLETED|Overall Study||0
6511417|NCT01489020|7431040|FG002|NOT COMPLETED|Overall Study||3
6511418|NCT01489020|7431041|FG003|NOT COMPLETED|Overall Study||0
6640177|NCT02332720|7568342|FG002|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|3
6640178|NCT02332720|7568343|FG003|STARTED|Part C|Part A participants who had relapsed were offered the option of retreatment in Part C.|2
6640179|NCT02332720|7568344|FG004|STARTED|Part C|Part B participants were not included in Part C.|0
6640180|NCT02332720|7568345|FG005|STARTED|Part C|Part B participants were not included in Part C.|0
6640181|NCT02332720|7568346|FG006|STARTED|Part C|Part B participants were not included in Part C.|0
6640182|NCT02332720|7568347|FG007|STARTED|Part C|Part B participants were not included in Part C.|0
6640183|NCT02332720|7568348|FG008|STARTED|Part C|Part B participants were not included in Part C.|0
6640184|NCT02332720|7568349|FG009|STARTED|Part C|Part B participants were not included in Part C.|0
6640185|NCT02332720|7568350|FG010|STARTED|Part C|Part B participants were not included in Part C.|0
6640186|NCT02332720|7568351|FG011|STARTED|Part C|Part B participants were not included in Part C.|0
6640187|NCT02332720|7568352|FG012|STARTED|Part C|Part B participants were not included in Part C.|0
6640188|NCT02332720|7568353|FG013|STARTED|Part C|Part B participants were not included in Part C.|0
6640189|NCT02332720|7568354|FG014|STARTED|Part C|Part B participants were not included in Part C.|0
6640190|NCT02332720|7568355|FG015|STARTED|Part C|Part B participants were not included in Part C.|0
6640191|NCT02332720|7568356|FG016|STARTED|Part C|Part B participants were not included in Part C.|0
6640192|NCT02332720|7568357|FG017|STARTED|Part C|Part B participants were not included in Part C.|0
6640193|NCT02332720|7568358|FG018|STARTED|Part C|Part B participants were not included in Part C.|0
6640194|NCT02332720|7568359|FG019|STARTED|Part C|Part B participants were not included in Part C.|0
6640195|NCT02332720|7568360|FG020|STARTED|Part C|Part B participants were not included in Part C.|0
6640196|NCT02332720|7568361|FG021|STARTED|Part C||0
6743580|NCT03335254|7671817|FG007|STARTED|Period 1||0
6743581|NCT03335254|7671818|FG008|STARTED|Period 1||0
6743582|NCT03335254|7671819|FG009|STARTED|Period 1||0
6743583|NCT03335254|7671820|FG010|STARTED|Period 1||0
6743584|NCT03335254|7671821|FG011|STARTED|Period 1||0
6743585|NCT03335254|7671822|FG012|STARTED|Period 1||0
6743586|NCT03335254|7671823|FG013|STARTED|Period 1||0
6743587|NCT03335254|7671824|FG014|STARTED|Period 1||0
6743588|NCT03335254|7671825|FG015|STARTED|Period 1||0
6743589|NCT03335254|7671826|FG016|STARTED|Period 1||0
6743590|NCT03335254|7671827|FG017|STARTED|Period 1||0
6743591|NCT03335254|7671828|FG018|STARTED|Period 1||0
6511419|NCT01489020|7431042|FG004|NOT COMPLETED|Overall Study||6
6511420|NCT01489020|7431043|FG005|NOT COMPLETED|Overall Study||0
6511421|NCT01489111|7431063|FG000|STARTED|Overall Study||36
6743592|NCT03335254|7671829|FG019|STARTED|Period 1||0
6511422|NCT01489111|7431063|FG000|COMPLETED|Overall Study||35
6511423|NCT01489111|7431063|FG000|NOT COMPLETED|Overall Study||1
6511424|NCT01489189|7431069|FG000|STARTED|Overall Study|Number of Eyes|191
6511425|NCT01489189|7431070|FG001|STARTED|Overall Study|Number of Eyes|203
6511426|NCT01489189|7431069|FG000|COMPLETED|Overall Study|Number of Eyes|160
6511427|NCT01489189|7431070|FG001|COMPLETED|Overall Study|Number of Eyes|168
6511428|NCT01489189|7431069|FG000|NOT COMPLETED|Overall Study||31
6511429|NCT01489189|7431070|FG001|NOT COMPLETED|Overall Study||35
6511430|NCT01489254|7431080|FG000|STARTED|Double-blind Part||355
6511431|NCT01489254|7431081|FG001|STARTED|Double-blind Part||357
6511432|NCT01489254|7431082|FG002|STARTED|Double-blind Part||84
6511433|NCT01489254|7431083|FG003|STARTED|Double-blind Part||0
6511434|NCT01489254|7431080|FG000|COMPLETED|Double-blind Part||330
6511435|NCT01489254|7431081|FG001|COMPLETED|Double-blind Part||324
6511436|NCT01489254|7431082|FG002|COMPLETED|Double-blind Part||81
6511437|NCT01489254|7431083|FG003|COMPLETED|Double-blind Part||0
6511438|NCT01489254|7431080|FG000|NOT COMPLETED|Double-blind Part||25
6511439|NCT01489254|7431081|FG001|NOT COMPLETED|Double-blind Part||33
6511440|NCT01489254|7431082|FG002|NOT COMPLETED|Double-blind Part||3
6511441|NCT01489254|7431083|FG003|NOT COMPLETED|Double-blind Part||0
6511442|NCT01489254|7431080|FG000|STARTED|Open-label Extension Part||0
6511443|NCT01489254|7431081|FG001|STARTED|Open-label Extension Part||0
6511444|NCT01489254|7431082|FG002|STARTED|Open-label Extension Part||0
6511445|NCT01489254|7431083|FG003|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
6511446|NCT01489254|7431080|FG000|COMPLETED|Open-label Extension Part||0
6511447|NCT01489254|7431081|FG001|COMPLETED|Open-label Extension Part||0
6511448|NCT01489254|7431082|FG002|COMPLETED|Open-label Extension Part||0
6511449|NCT01489254|7431083|FG003|COMPLETED|Open-label Extension Part||670
6511450|NCT01489254|7431080|FG000|NOT COMPLETED|Open-label Extension Part||0
6511451|NCT01489254|7431081|FG001|NOT COMPLETED|Open-label Extension Part||0
6511452|NCT01489254|7431082|FG002|NOT COMPLETED|Open-label Extension Part||0
6511453|NCT01489254|7431083|FG003|NOT COMPLETED|Open-label Extension Part||58
6511454|NCT01489358|7431095|FG000|STARTED|Overall Study||5
6511455|NCT01489358|7431096|FG001|STARTED|Overall Study||10
6511456|NCT01489358|7431097|FG002|STARTED|Overall Study||10
6511457|NCT01489358|7431095|FG000|COMPLETED|Overall Study||5
6511458|NCT01489358|7431096|FG001|COMPLETED|Overall Study||10
6511459|NCT01489358|7431097|FG002|COMPLETED|Overall Study||8
6511460|NCT01489358|7431095|FG000|NOT COMPLETED|Overall Study||0
6511461|NCT01489358|7431096|FG001|NOT COMPLETED|Overall Study||0
6511462|NCT01489358|7431097|FG002|NOT COMPLETED|Overall Study||2
6511463|NCT01489527|7431107|FG000|STARTED|Overall Study||205
6511464|NCT01489527|7431108|FG001|STARTED|Overall Study||201
6511465|NCT01489527|7431107|FG000|COMPLETED|Overall Study||183
6511466|NCT01489527|7431108|FG001|COMPLETED|Overall Study||175
6511467|NCT01489527|7431107|FG000|NOT COMPLETED|Overall Study||22
6511468|NCT01489527|7431108|FG001|NOT COMPLETED|Overall Study||26
6511469|NCT01489579|7431116|FG000|STARTED|Overall Study||56
6511470|NCT01489579|7431117|FG001|STARTED|Overall Study||64
6511471|NCT01489579|7431116|FG000|COMPLETED|Overall Study||47
6511472|NCT01489579|7431117|FG001|COMPLETED|Overall Study||57
6511473|NCT01489579|7431116|FG000|NOT COMPLETED|Overall Study||9
6511474|NCT01489579|7431117|FG001|NOT COMPLETED|Overall Study||7
6511475|NCT01489670|7431125|FG000|STARTED|Overall Study||387
6511476|NCT01489670|7431125|FG000|COMPLETED|Overall Study||334
6511477|NCT01489670|7431125|FG000|NOT COMPLETED|Overall Study||53
6511478|NCT01489826|7431138|FG000|STARTED|Overall Study||3
6511479|NCT01489826|7431139|FG001|STARTED|Overall Study||3
6511480|NCT01489826|7431140|FG002|STARTED|Overall Study||3
6511481|NCT01489826|7431141|FG003|STARTED|Overall Study||7
6511482|NCT01489826|7431142|FG004|STARTED|Overall Study||3
6511483|NCT01489826|7431143|FG005|STARTED|Overall Study||3
6511484|NCT01489826|7431144|FG006|STARTED|Overall Study||9
6511485|NCT01489826|7431145|FG007|STARTED|Overall Study||3
6511486|NCT01489826|7431146|FG008|STARTED|Overall Study||6
6511487|NCT01489826|7431138|FG000|COMPLETED|Overall Study||3
6511488|NCT01489826|7431139|FG001|COMPLETED|Overall Study||3
6511489|NCT01489826|7431140|FG002|COMPLETED|Overall Study||3
6511490|NCT01489826|7431141|FG003|COMPLETED|Overall Study||7
6511491|NCT01489826|7431142|FG004|COMPLETED|Overall Study||3
6511492|NCT01489826|7431143|FG005|COMPLETED|Overall Study||3
6511493|NCT01489826|7431144|FG006|COMPLETED|Overall Study||9
6511494|NCT01489826|7431145|FG007|COMPLETED|Overall Study||3
6511495|NCT01489826|7431146|FG008|COMPLETED|Overall Study||6
6511496|NCT01489826|7431138|FG000|NOT COMPLETED|Overall Study||0
6511497|NCT01489826|7431139|FG001|NOT COMPLETED|Overall Study||0
6511498|NCT01489826|7431140|FG002|NOT COMPLETED|Overall Study||0
6511499|NCT01489826|7431141|FG003|NOT COMPLETED|Overall Study||0
6511500|NCT01489826|7431142|FG004|NOT COMPLETED|Overall Study||0
6511501|NCT01489826|7431143|FG005|NOT COMPLETED|Overall Study||0
6511502|NCT01489826|7431144|FG006|NOT COMPLETED|Overall Study||0
6511503|NCT01489826|7431145|FG007|NOT COMPLETED|Overall Study||0
6511504|NCT01489826|7431146|FG008|NOT COMPLETED|Overall Study||0
6511505|NCT01489891|7431176|FG000|STARTED|Overall Study||60
6511506|NCT01489891|7431177|FG001|STARTED|Overall Study||60
6511507|NCT01489891|7431176|FG000|COMPLETED|Overall Study||59
6511508|NCT01489891|7431177|FG001|COMPLETED|Overall Study||60
6511509|NCT01489891|7431176|FG000|NOT COMPLETED|Overall Study||1
6511510|NCT01489891|7431177|FG001|NOT COMPLETED|Overall Study||0
6511511|NCT01489956|7431185|FG000|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
6511512|NCT01489956|7431186|FG001|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
6511513|NCT01489956|7431187|FG002|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
6511514|NCT01489956|7431185|FG000|COMPLETED|Overall Study||12
6511515|NCT01489956|7431186|FG001|COMPLETED|Overall Study||0
6511516|NCT01489956|7431187|FG002|COMPLETED|Overall Study||5
6511517|NCT01489956|7431185|FG000|NOT COMPLETED|Overall Study||1
6511518|NCT01489956|7431186|FG001|NOT COMPLETED|Overall Study||0
6511519|NCT01489956|7431187|FG002|NOT COMPLETED|Overall Study||1
6511520|NCT01489969|7431198|FG000|STARTED|Overall Study||45
6511521|NCT01489969|7431199|FG001|STARTED|Overall Study||47
6511522|NCT01489969|7431200|FG002|STARTED|Overall Study||45
6511523|NCT01489969|7431198|FG000|COMPLETED|Overall Study||40
6511524|NCT01489969|7431199|FG001|COMPLETED|Overall Study||43
6511525|NCT01489969|7431200|FG002|COMPLETED|Overall Study||44
6511526|NCT01489969|7431198|FG000|NOT COMPLETED|Overall Study||5
6511527|NCT01489969|7431199|FG001|NOT COMPLETED|Overall Study||4
6511528|NCT01489969|7431200|FG002|NOT COMPLETED|Overall Study||1
6511529|NCT01490060|7431210|FG000|STARTED|Cycle 1||11
6511530|NCT01490060|7431211|FG001|STARTED|Cycle 1||13
6511531|NCT01490060|7431212|FG002|STARTED|Cycle 1||12
6511532|NCT01490060|7431213|FG003|STARTED|Cycle 1||11
6511533|NCT01490060|7431210|FG000|COMPLETED|Cycle 1||11
6511534|NCT01490060|7431211|FG001|COMPLETED|Cycle 1||12
6511535|NCT01490060|7431212|FG002|COMPLETED|Cycle 1||9
6511536|NCT01490060|7431213|FG003|COMPLETED|Cycle 1||8
6511537|NCT01490060|7431210|FG000|NOT COMPLETED|Cycle 1||0
6511538|NCT01490060|7431211|FG001|NOT COMPLETED|Cycle 1||1
6511539|NCT01490060|7431212|FG002|NOT COMPLETED|Cycle 1||3
6511540|NCT01490060|7431213|FG003|NOT COMPLETED|Cycle 1||3
6511541|NCT01490060|7431210|FG000|STARTED|Cycle 2||11
6511542|NCT01490060|7431211|FG001|STARTED|Cycle 2||12
6511543|NCT01490060|7431212|FG002|STARTED|Cycle 2||9
6511544|NCT01490060|7431213|FG003|STARTED|Cycle 2||8
6511545|NCT01490060|7431210|FG000|COMPLETED|Cycle 2||9
6511546|NCT01490060|7431211|FG001|COMPLETED|Cycle 2||11
6511547|NCT01490060|7431212|FG002|COMPLETED|Cycle 2||8
6511548|NCT01490060|7431213|FG003|COMPLETED|Cycle 2||8
6511549|NCT01490060|7431210|FG000|NOT COMPLETED|Cycle 2||2
6511550|NCT01490060|7431211|FG001|NOT COMPLETED|Cycle 2||1
6511551|NCT01490060|7431212|FG002|NOT COMPLETED|Cycle 2||1
6511552|NCT01490060|7431213|FG003|NOT COMPLETED|Cycle 2||0
6511553|NCT01490073|7431223|FG000|STARTED|Overall Study||12
6511554|NCT01490073|7431224|FG001|STARTED|Overall Study||12
6511555|NCT01490073|7431223|FG000|COMPLETED|Overall Study||12
6511556|NCT01490073|7431224|FG001|COMPLETED|Overall Study||12
6511557|NCT01490073|7431223|FG000|NOT COMPLETED|Overall Study||0
6511558|NCT01490073|7431224|FG001|NOT COMPLETED|Overall Study||0
6511559|NCT01490086|7431235|FG000|STARTED|Overall Study||58
6511560|NCT01490086|7431236|FG001|STARTED|Overall Study||59
6511561|NCT01490086|7431237|FG002|STARTED|Overall Study||58
6640197|NCT02332720|7568362|FG022|STARTED|Part C|Part B participants were not included in Part C.|0
6640198|NCT02332720|7568340|FG000|COMPLETED|Part C||2
6640199|NCT02332720|7568341|FG001|COMPLETED|Part C||1
6640200|NCT02332720|7568342|FG002|COMPLETED|Part C||3
6640201|NCT02332720|7568343|FG003|COMPLETED|Part C||2
6640202|NCT02332720|7568344|FG004|COMPLETED|Part C||0
6511562|NCT01490086|7431238|FG003|STARTED|Overall Study||20
6511563|NCT01490086|7431239|FG004|STARTED|Overall Study||39
6511564|NCT01490086|7431235|FG000|COMPLETED|Overall Study||50
6511565|NCT01490086|7431236|FG001|COMPLETED|Overall Study||44
6511566|NCT01490086|7431237|FG002|COMPLETED|Overall Study||51
6511567|NCT01490086|7431238|FG003|COMPLETED|Overall Study||13
6511568|NCT01490086|7431239|FG004|COMPLETED|Overall Study||28
6511569|NCT01490086|7431235|FG000|NOT COMPLETED|Overall Study||8
6511570|NCT01490086|7431236|FG001|NOT COMPLETED|Overall Study||15
6511571|NCT01490086|7431237|FG002|NOT COMPLETED|Overall Study||7
6511572|NCT01490086|7431238|FG003|NOT COMPLETED|Overall Study||7
6511573|NCT01490086|7431239|FG004|NOT COMPLETED|Overall Study||11
6511574|NCT01490125|7431251|FG000|STARTED|Period I||43
6511575|NCT01490125|7431252|FG001|STARTED|Period I||42
6511576|NCT01490125|7431253|FG002|STARTED|Period I||41
6511577|NCT01490125|7431254|FG003|STARTED|Period I||38
6511578|NCT01490125|7431255|FG004|STARTED|Period I||40
6511579|NCT01490125|7431256|FG005|STARTED|Period I||42
6511580|NCT01490125|7431251|FG000|COMPLETED|Period I||37
6511581|NCT01490125|7431252|FG001|COMPLETED|Period I||37
6511582|NCT01490125|7431253|FG002|COMPLETED|Period I||37
6511583|NCT01490125|7431254|FG003|COMPLETED|Period I||33
6511584|NCT01490125|7431255|FG004|COMPLETED|Period I||36
6511585|NCT01490125|7431256|FG005|COMPLETED|Period I||37
6511586|NCT01490125|7431251|FG000|NOT COMPLETED|Period I||6
6511587|NCT01490125|7431252|FG001|NOT COMPLETED|Period I||5
6511588|NCT01490125|7431253|FG002|NOT COMPLETED|Period I||4
6511589|NCT01490125|7431254|FG003|NOT COMPLETED|Period I||5
6511590|NCT01490125|7431255|FG004|NOT COMPLETED|Period I||4
6511591|NCT01490125|7431256|FG005|NOT COMPLETED|Period I||5
6511592|NCT01490125|7431251|FG000|STARTED|Period II||37
6511593|NCT01490125|7431252|FG001|STARTED|Period II||37
6511594|NCT01490125|7431253|FG002|STARTED|Period II||37
6511595|NCT01490125|7431254|FG003|STARTED|Period II||33
6511596|NCT01490125|7431255|FG004|STARTED|Period II||36
6511597|NCT01490125|7431256|FG005|STARTED|Period II||37
6511598|NCT01490125|7431251|FG000|COMPLETED|Period II||34
6511599|NCT01490125|7431252|FG001|COMPLETED|Period II||33
6511600|NCT01490125|7431253|FG002|COMPLETED|Period II||34
6511601|NCT01490125|7431254|FG003|COMPLETED|Period II||30
6511602|NCT01490125|7431255|FG004|COMPLETED|Period II||32
6511603|NCT01490125|7431256|FG005|COMPLETED|Period II||35
6511604|NCT01490125|7431251|FG000|NOT COMPLETED|Period II||3
6511605|NCT01490125|7431252|FG001|NOT COMPLETED|Period II||4
6511606|NCT01490125|7431253|FG002|NOT COMPLETED|Period II||3
6511607|NCT01490125|7431254|FG003|NOT COMPLETED|Period II||3
6511608|NCT01490125|7431255|FG004|NOT COMPLETED|Period II||4
6511609|NCT01490125|7431256|FG005|NOT COMPLETED|Period II||2
6640203|NCT02332720|7568345|FG005|COMPLETED|Part C||0
6640204|NCT02332720|7568346|FG006|COMPLETED|Part C||0
6511610|NCT01490125|7431251|FG000|STARTED|Period III||34
6511611|NCT01490125|7431252|FG001|STARTED|Period III||33
6511612|NCT01490125|7431253|FG002|STARTED|Period III||34
6511613|NCT01490125|7431254|FG003|STARTED|Period III||30
6511614|NCT01490125|7431255|FG004|STARTED|Period III||32
6511615|NCT01490125|7431256|FG005|STARTED|Period III||35
6511616|NCT01490125|7431251|FG000|COMPLETED|Period III||31
6511617|NCT01490125|7431252|FG001|COMPLETED|Period III||32
6511618|NCT01490125|7431253|FG002|COMPLETED|Period III||34
6511619|NCT01490125|7431254|FG003|COMPLETED|Period III||28
6511620|NCT01490125|7431255|FG004|COMPLETED|Period III||31
6511621|NCT01490125|7431256|FG005|COMPLETED|Period III||35
6511622|NCT01490125|7431251|FG000|NOT COMPLETED|Period III||3
6511623|NCT01490125|7431252|FG001|NOT COMPLETED|Period III||1
6511624|NCT01490125|7431253|FG002|NOT COMPLETED|Period III||0
6511625|NCT01490125|7431254|FG003|NOT COMPLETED|Period III||2
6511626|NCT01490125|7431255|FG004|NOT COMPLETED|Period III||1
6511627|NCT01490125|7431256|FG005|NOT COMPLETED|Period III||0
6511628|NCT01490151|7431264|FG000|STARTED|Overall Study||22
6511629|NCT01490151|7431264|FG000|COMPLETED|Overall Study||22
6511630|NCT01490151|7431264|FG000|NOT COMPLETED|Overall Study||0
6511631|NCT01490294|7431274|FG000|STARTED|Overall Study||58
6511632|NCT01490294|7431275|FG001|STARTED|Overall Study||60
6511633|NCT01490294|7431276|FG002|STARTED|Overall Study||59
6511634|NCT01490294|7431277|FG003|STARTED|Overall Study||55
6511635|NCT01490294|7431274|FG000|Participant Received Treatment|Overall Study||54
6511636|NCT01490294|7431275|FG001|Participant Received Treatment|Overall Study||60
6511637|NCT01490294|7431276|FG002|Participant Received Treatment|Overall Study||58
6511638|NCT01490294|7431277|FG003|Participant Received Treatment|Overall Study||54
6511639|NCT01490294|7431274|FG000|COMPLETED|Overall Study||53
6511640|NCT01490294|7431275|FG001|COMPLETED|Overall Study||60
6511641|NCT01490294|7431276|FG002|COMPLETED|Overall Study||58
6511642|NCT01490294|7431277|FG003|COMPLETED|Overall Study||54
6511643|NCT01490294|7431274|FG000|NOT COMPLETED|Overall Study||5
6511644|NCT01490294|7431275|FG001|NOT COMPLETED|Overall Study||0
6511645|NCT01490294|7431276|FG002|NOT COMPLETED|Overall Study||1
6511646|NCT01490294|7431277|FG003|NOT COMPLETED|Overall Study||1
6511647|NCT01490359|7431289|FG000|STARTED|Overall Study||609
6511648|NCT01490359|7431290|FG001|STARTED|Overall Study||572
6511649|NCT01490359|7431289|FG000|Followed-up at 6 mo|Overall Study||558
6511650|NCT01490359|7431290|FG001|Followed-up at 6 mo|Overall Study||535
6511651|NCT01490359|7431289|FG000|Followed-up at 12 mo|Overall Study||569
6511652|NCT01490359|7431290|FG001|Followed-up at 12 mo|Overall Study||537
6511653|NCT01490359|7431289|FG000|COMPLETED|Overall Study||585
6511654|NCT01490359|7431290|FG001|COMPLETED|Overall Study||555
6511655|NCT01490359|7431289|FG000|NOT COMPLETED|Overall Study||24
6511656|NCT01490359|7431290|FG001|NOT COMPLETED|Overall Study||17
6511657|NCT01490450|7431301|FG000|STARTED|Period 1||41
6511658|NCT01490450|7431302|FG001|STARTED|Period 1||41
6511659|NCT01490450|7431303|FG002|STARTED|Period 1||42
6511660|NCT01490450|7431304|FG003|STARTED|Period 1||41
6511661|NCT01490450|7431301|FG000|COMPLETED|Period 1||38
6511662|NCT01490450|7431302|FG001|COMPLETED|Period 1||40
6511663|NCT01490450|7431303|FG002|COMPLETED|Period 1||38
6511664|NCT01490450|7431304|FG003|COMPLETED|Period 1||33
6511665|NCT01490450|7431301|FG000|NOT COMPLETED|Period 1||3
6511666|NCT01490450|7431302|FG001|NOT COMPLETED|Period 1||1
6511667|NCT01490450|7431303|FG002|NOT COMPLETED|Period 1||4
6511668|NCT01490450|7431304|FG003|NOT COMPLETED|Period 1||8
6511669|NCT01490450|7431301|FG000|STARTED|Period 2||38
6511670|NCT01490450|7431302|FG001|STARTED|Period 2||40
6511671|NCT01490450|7431303|FG002|STARTED|Period 2||37
6511672|NCT01490450|7431304|FG003|STARTED|Period 2||32
6511673|NCT01490450|7431301|FG000|COMPLETED|Period 2||36
6511674|NCT01490450|7431302|FG001|COMPLETED|Period 2||39
6511675|NCT01490450|7431303|FG002|COMPLETED|Period 2||37
6511676|NCT01490450|7431304|FG003|COMPLETED|Period 2||28
6511677|NCT01490450|7431301|FG000|NOT COMPLETED|Period 2||2
6511678|NCT01490450|7431302|FG001|NOT COMPLETED|Period 2||1
6511679|NCT01490450|7431303|FG002|NOT COMPLETED|Period 2||0
6511680|NCT01490450|7431304|FG003|NOT COMPLETED|Period 2||4
6511681|NCT01490580|7431319|FG000|STARTED|Overall Study||82
6511682|NCT01490580|7431320|FG001|STARTED|Overall Study||91
6511683|NCT01490580|7431319|FG000|COMPLETED|Overall Study||82
6511684|NCT01490580|7431320|FG001|COMPLETED|Overall Study||89
6511685|NCT01490580|7431319|FG000|NOT COMPLETED|Overall Study||0
6511686|NCT01490580|7431320|FG001|NOT COMPLETED|Overall Study||2
6511687|NCT01490632|7431335|FG000|STARTED|Part A: Initial Treatment Period||34
6511688|NCT01490632|7431336|FG001|STARTED|Part A: Initial Treatment Period||32
6511689|NCT01490632|7431337|FG002|STARTED|Part A: Initial Treatment Period||72
6511690|NCT01490632|7431338|FG003|STARTED|Part A: Initial Treatment Period||64
6511691|NCT01490632|7431339|FG004|STARTED|Part A: Initial Treatment Period||69
6511692|NCT01490632|7431340|FG005|STARTED|Part A: Initial Treatment Period||0
6511693|NCT01490632|7431341|FG006|STARTED|Part A: Initial Treatment Period||0
6511694|NCT01490632|7431342|FG007|STARTED|Part A: Initial Treatment Period||0
6511695|NCT01490632|7431343|FG008|STARTED|Part A: Initial Treatment Period||0
6511696|NCT01490632|7431344|FG009|STARTED|Part A: Initial Treatment Period||0
6511697|NCT01490632|7431345|FG010|STARTED|Part A: Initial Treatment Period||0
6511698|NCT01490632|7431346|FG011|STARTED|Part A: Initial Treatment Period||0
6511699|NCT01490632|7431347|FG012|STARTED|Part A: Initial Treatment Period||0
6511700|NCT01490632|7431348|FG013|STARTED|Part A: Initial Treatment Period||0
6511701|NCT01490632|7431349|FG014|STARTED|Part A: Initial Treatment Period||0
6511702|NCT01490632|7431350|FG015|STARTED|Part A: Initial Treatment Period||0
6511703|NCT01490632|7431351|FG016|STARTED|Part A: Initial Treatment Period||0
6511704|NCT01490632|7431352|FG017|STARTED|Part A: Initial Treatment Period||0
6511705|NCT01490632|7431353|FG018|STARTED|Part A: Initial Treatment Period||0
6511706|NCT01490632|7431354|FG019|STARTED|Part A: Initial Treatment Period||0
6511707|NCT01490632|7431335|FG000|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
6511708|NCT01490632|7431336|FG001|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
6511709|NCT01490632|7431337|FG002|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
6511710|NCT01490632|7431338|FG003|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
6511711|NCT01490632|7431339|FG004|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
6511712|NCT01490632|7431340|FG005|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511713|NCT01490632|7431341|FG006|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511714|NCT01490632|7431342|FG007|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511715|NCT01490632|7431343|FG008|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511716|NCT01490632|7431344|FG009|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511717|NCT01490632|7431345|FG010|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511718|NCT01490632|7431346|FG011|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511719|NCT01490632|7431347|FG012|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511720|NCT01490632|7431348|FG013|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511721|NCT01490632|7431349|FG014|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511722|NCT01490632|7431350|FG015|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511723|NCT01490632|7431351|FG016|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511724|NCT01490632|7431352|FG017|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511725|NCT01490632|7431353|FG018|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511726|NCT01490632|7431354|FG019|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
6511727|NCT01490632|7431335|FG000|COMPLETED|Part A: Initial Treatment Period||27
6511728|NCT01490632|7431336|FG001|COMPLETED|Part A: Initial Treatment Period||28
6511729|NCT01490632|7431337|FG002|COMPLETED|Part A: Initial Treatment Period||67
6511730|NCT01490632|7431338|FG003|COMPLETED|Part A: Initial Treatment Period||55
6511731|NCT01490632|7431339|FG004|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
6511732|NCT01490632|7431340|FG005|COMPLETED|Part A: Initial Treatment Period||0
6511733|NCT01490632|7431341|FG006|COMPLETED|Part A: Initial Treatment Period||0
6511734|NCT01490632|7431342|FG007|COMPLETED|Part A: Initial Treatment Period||0
6511735|NCT01490632|7431343|FG008|COMPLETED|Part A: Initial Treatment Period||0
6511736|NCT01490632|7431344|FG009|COMPLETED|Part A: Initial Treatment Period||0
6511737|NCT01490632|7431345|FG010|COMPLETED|Part A: Initial Treatment Period||0
6511738|NCT01490632|7431346|FG011|COMPLETED|Part A: Initial Treatment Period||0
6511739|NCT01490632|7431347|FG012|COMPLETED|Part A: Initial Treatment Period||0
6511740|NCT01490632|7431348|FG013|COMPLETED|Part A: Initial Treatment Period||0
6511741|NCT01490632|7431349|FG014|COMPLETED|Part A: Initial Treatment Period||0
6511742|NCT01490632|7431350|FG015|COMPLETED|Part A: Initial Treatment Period||0
6511743|NCT01490632|7431351|FG016|COMPLETED|Part A: Initial Treatment Period||0
6511744|NCT01490632|7431352|FG017|COMPLETED|Part A: Initial Treatment Period||0
6511745|NCT01490632|7431353|FG018|COMPLETED|Part A: Initial Treatment Period||0
6511746|NCT01490632|7431354|FG019|COMPLETED|Part A: Initial Treatment Period||0
6511747|NCT01490632|7431335|FG000|NOT COMPLETED|Part A: Initial Treatment Period||7
6511748|NCT01490632|7431336|FG001|NOT COMPLETED|Part A: Initial Treatment Period||4
6511749|NCT01490632|7431337|FG002|NOT COMPLETED|Part A: Initial Treatment Period||5
6511750|NCT01490632|7431338|FG003|NOT COMPLETED|Part A: Initial Treatment Period||9
6511751|NCT01490632|7431339|FG004|NOT COMPLETED|Part A: Initial Treatment Period||17
6511752|NCT01490632|7431340|FG005|NOT COMPLETED|Part A: Initial Treatment Period||0
6511753|NCT01490632|7431341|FG006|NOT COMPLETED|Part A: Initial Treatment Period||0
6511754|NCT01490632|7431342|FG007|NOT COMPLETED|Part A: Initial Treatment Period||0
6511755|NCT01490632|7431343|FG008|NOT COMPLETED|Part A: Initial Treatment Period||0
6511756|NCT01490632|7431344|FG009|NOT COMPLETED|Part A: Initial Treatment Period||0
6511757|NCT01490632|7431345|FG010|NOT COMPLETED|Part A: Initial Treatment Period||0
6511758|NCT01490632|7431346|FG011|NOT COMPLETED|Part A: Initial Treatment Period||0
6511759|NCT01490632|7431347|FG012|NOT COMPLETED|Part A: Initial Treatment Period||0
6511760|NCT01490632|7431348|FG013|NOT COMPLETED|Part A: Initial Treatment Period||0
6511761|NCT01490632|7431349|FG014|NOT COMPLETED|Part A: Initial Treatment Period||0
6511762|NCT01490632|7431350|FG015|NOT COMPLETED|Part A: Initial Treatment Period||0
6511763|NCT01490632|7431351|FG016|NOT COMPLETED|Part A: Initial Treatment Period||0
6511764|NCT01490632|7431352|FG017|NOT COMPLETED|Part A: Initial Treatment Period||0
6511765|NCT01490632|7431353|FG018|NOT COMPLETED|Part A: Initial Treatment Period||0
6511766|NCT01490632|7431354|FG019|NOT COMPLETED|Part A: Initial Treatment Period||0
6640205|NCT02332720|7568347|FG007|COMPLETED|Part C||0
6640206|NCT02332720|7568348|FG008|COMPLETED|Part C||0
6640207|NCT02332720|7568349|FG009|COMPLETED|Part C||0
6640208|NCT02332720|7568350|FG010|COMPLETED|Part C||0
6640209|NCT02332720|7568351|FG011|COMPLETED|Part C||0
6640210|NCT02332720|7568352|FG012|COMPLETED|Part C||0
6511767|NCT01490632|7431335|FG000|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6511768|NCT01490632|7431336|FG001|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6511769|NCT01490632|7431337|FG002|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6511770|NCT01490632|7431338|FG003|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6511771|NCT01490632|7431339|FG004|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
6511772|NCT01490632|7431340|FG005|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
6511773|NCT01490632|7431341|FG006|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
6511774|NCT01490632|7431342|FG007|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
6511775|NCT01490632|7431343|FG008|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
6511776|NCT01490632|7431344|FG009|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
6511777|NCT01490632|7431345|FG010|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
6511778|NCT01490632|7431346|FG011|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
6511779|NCT01490632|7431347|FG012|STARTED|Part B: Extension or Step-Up Period||0
6511780|NCT01490632|7431348|FG013|STARTED|Part B: Extension or Step-Up Period||0
6511781|NCT01490632|7431349|FG014|STARTED|Part B: Extension or Step-Up Period||0
6511782|NCT01490632|7431350|FG015|STARTED|Part B: Extension or Step-Up Period||0
6511783|NCT01490632|7431351|FG016|STARTED|Part B: Extension or Step-Up Period||0
6511784|NCT01490632|7431352|FG017|STARTED|Part B: Extension or Step-Up Period||0
6511785|NCT01490632|7431353|FG018|STARTED|Part B: Extension or Step-Up Period||0
6511786|NCT01490632|7431354|FG019|STARTED|Part B: Extension or Step-Up Period||0
6511787|NCT01490632|7431335|FG000|COMPLETED|Part B: Extension or Step-Up Period||0
6511788|NCT01490632|7431336|FG001|COMPLETED|Part B: Extension or Step-Up Period||0
6511789|NCT01490632|7431337|FG002|COMPLETED|Part B: Extension or Step-Up Period||0
6511790|NCT01490632|7431338|FG003|COMPLETED|Part B: Extension or Step-Up Period||0
6511791|NCT01490632|7431339|FG004|COMPLETED|Part B: Extension or Step-Up Period||0
6511792|NCT01490632|7431340|FG005|COMPLETED|Part B: Extension or Step-Up Period||25
6511793|NCT01490632|7431341|FG006|COMPLETED|Part B: Extension or Step-Up Period||51
6511794|NCT01490632|7431342|FG007|COMPLETED|Part B: Extension or Step-Up Period||13
6511795|NCT01490632|7431343|FG008|COMPLETED|Part B: Extension or Step-Up Period||6
6511796|NCT01490632|7431344|FG009|COMPLETED|Part B: Extension or Step-Up Period||25
6511797|NCT01490632|7431345|FG010|COMPLETED|Part B: Extension or Step-Up Period||22
6511798|NCT01490632|7431346|FG011|COMPLETED|Part B: Extension or Step-Up Period||0
6511799|NCT01490632|7431347|FG012|COMPLETED|Part B: Extension or Step-Up Period||0
6511800|NCT01490632|7431348|FG013|COMPLETED|Part B: Extension or Step-Up Period||0
6511801|NCT01490632|7431349|FG014|COMPLETED|Part B: Extension or Step-Up Period||0
6511802|NCT01490632|7431350|FG015|COMPLETED|Part B: Extension or Step-Up Period||0
6640211|NCT02332720|7568353|FG013|COMPLETED|Part C||0
6640212|NCT02332720|7568354|FG014|COMPLETED|Part C||0
6640213|NCT02332720|7568355|FG015|COMPLETED|Part C||0
6640214|NCT02332720|7568356|FG016|COMPLETED|Part C||0
6640215|NCT02332720|7568357|FG017|COMPLETED|Part C||0
6640216|NCT02332720|7568358|FG018|COMPLETED|Part C||0
6640217|NCT02332720|7568359|FG019|COMPLETED|Part C||0
6640218|NCT02332720|7568360|FG020|COMPLETED|Part C||0
6640219|NCT02332720|7568361|FG021|COMPLETED|Part C||0
6640220|NCT02332720|7568362|FG022|COMPLETED|Part C||0
6640221|NCT02332720|7568340|FG000|NOT COMPLETED|Part C||0
6640222|NCT02332720|7568341|FG001|NOT COMPLETED|Part C||0
6640223|NCT02332720|7568342|FG002|NOT COMPLETED|Part C||0
6640224|NCT02332720|7568343|FG003|NOT COMPLETED|Part C||0
6640225|NCT02332720|7568344|FG004|NOT COMPLETED|Part C||0
6640226|NCT02332720|7568345|FG005|NOT COMPLETED|Part C||0
6640227|NCT02332720|7568346|FG006|NOT COMPLETED|Part C||0
6640228|NCT02332720|7568347|FG007|NOT COMPLETED|Part C||0
6640229|NCT02332720|7568348|FG008|NOT COMPLETED|Part C||0
6640230|NCT02332720|7568349|FG009|NOT COMPLETED|Part C||0
6640231|NCT02332720|7568350|FG010|NOT COMPLETED|Part C||0
6640232|NCT02332720|7568351|FG011|NOT COMPLETED|Part C||0
6640233|NCT02332720|7568352|FG012|NOT COMPLETED|Part C||0
6640234|NCT02332720|7568353|FG013|NOT COMPLETED|Part C||0
6640235|NCT02332720|7568354|FG014|NOT COMPLETED|Part C||0
6640236|NCT02332720|7568355|FG015|NOT COMPLETED|Part C||0
6640237|NCT02332720|7568356|FG016|NOT COMPLETED|Part C||0
6640238|NCT02332720|7568357|FG017|NOT COMPLETED|Part C||0
6640239|NCT02332720|7568358|FG018|NOT COMPLETED|Part C||0
6640240|NCT02332720|7568359|FG019|NOT COMPLETED|Part C||0
6640241|NCT02332720|7568360|FG020|NOT COMPLETED|Part C||0
6640242|NCT02332720|7568361|FG021|NOT COMPLETED|Part C||0
6640243|NCT02332720|7568362|FG022|NOT COMPLETED|Part C||0
6640244|NCT02332798|7568427|FG000|STARTED|Overall Study||13
6640245|NCT02332798|7568428|FG001|STARTED|Overall Study||14
6640246|NCT02332798|7568429|FG002|STARTED|Overall Study||12
6640247|NCT02332798|7568427|FG000|COMPLETED|Overall Study||12
6640248|NCT02332798|7568428|FG001|COMPLETED|Overall Study||12
6640249|NCT02332798|7568429|FG002|COMPLETED|Overall Study||11
6511803|NCT01490632|7431351|FG016|COMPLETED|Part B: Extension or Step-Up Period||0
6511804|NCT01490632|7431352|FG017|COMPLETED|Part B: Extension or Step-Up Period||0
6511805|NCT01490632|7431353|FG018|COMPLETED|Part B: Extension or Step-Up Period||0
6511806|NCT01490632|7431354|FG019|COMPLETED|Part B: Extension or Step-Up Period||0
6511807|NCT01490632|7431335|FG000|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511808|NCT01490632|7431336|FG001|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511809|NCT01490632|7431337|FG002|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511810|NCT01490632|7431338|FG003|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511811|NCT01490632|7431339|FG004|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511812|NCT01490632|7431340|FG005|NOT COMPLETED|Part B: Extension or Step-Up Period||4
6511813|NCT01490632|7431341|FG006|NOT COMPLETED|Part B: Extension or Step-Up Period||13
6511814|NCT01490632|7431342|FG007|NOT COMPLETED|Part B: Extension or Step-Up Period||6
6511815|NCT01490632|7431343|FG008|NOT COMPLETED|Part B: Extension or Step-Up Period||10
6511816|NCT01490632|7431344|FG009|NOT COMPLETED|Part B: Extension or Step-Up Period||25
6511817|NCT01490632|7431345|FG010|NOT COMPLETED|Part B: Extension or Step-Up Period||21
6511818|NCT01490632|7431346|FG011|NOT COMPLETED|Part B: Extension or Step-Up Period||8
6511819|NCT01490632|7431347|FG012|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511820|NCT01490632|7431348|FG013|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511821|NCT01490632|7431349|FG014|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511822|NCT01490632|7431350|FG015|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511823|NCT01490632|7431351|FG016|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511824|NCT01490632|7431352|FG017|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511825|NCT01490632|7431353|FG018|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511826|NCT01490632|7431354|FG019|NOT COMPLETED|Part B: Extension or Step-Up Period||0
6511827|NCT01490632|7431335|FG000|STARTED|Part C: Washout or Step-Down Period||0
6511828|NCT01490632|7431336|FG001|STARTED|Part C: Washout or Step-Down Period||0
6511829|NCT01490632|7431337|FG002|STARTED|Part C: Washout or Step-Down Period||0
6511830|NCT01490632|7431338|FG003|STARTED|Part C: Washout or Step-Down Period||0
6511831|NCT01490632|7431339|FG004|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
6511832|NCT01490632|7431340|FG005|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
6511833|NCT01490632|7431341|FG006|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
6511834|NCT01490632|7431342|FG007|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
6511835|NCT01490632|7431343|FG008|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
6511836|NCT01490632|7431344|FG009|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
6511837|NCT01490632|7431345|FG010|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
6511838|NCT01490632|7431346|FG011|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
6511839|NCT01490632|7431347|FG012|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
6511840|NCT01490632|7431348|FG013|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
6511841|NCT01490632|7431349|FG014|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
6511842|NCT01490632|7431350|FG015|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
6511843|NCT01490632|7431351|FG016|STARTED|Part C: Washout or Step-Down Period||0
6511844|NCT01490632|7431352|FG017|STARTED|Part C: Washout or Step-Down Period||0
6511845|NCT01490632|7431353|FG018|STARTED|Part C: Washout or Step-Down Period||0
6511846|NCT01490632|7431354|FG019|STARTED|Part C: Washout or Step-Down Period||0
6511847|NCT01490632|7431335|FG000|COMPLETED|Part C: Washout or Step-Down Period||0
6511848|NCT01490632|7431336|FG001|COMPLETED|Part C: Washout or Step-Down Period||0
6511849|NCT01490632|7431337|FG002|COMPLETED|Part C: Washout or Step-Down Period||0
6511850|NCT01490632|7431338|FG003|COMPLETED|Part C: Washout or Step-Down Period||0
6511851|NCT01490632|7431339|FG004|COMPLETED|Part C: Washout or Step-Down Period||0
6511852|NCT01490632|7431340|FG005|COMPLETED|Part C: Washout or Step-Down Period||0
6511853|NCT01490632|7431341|FG006|COMPLETED|Part C: Washout or Step-Down Period||0
6511854|NCT01490632|7431342|FG007|COMPLETED|Part C: Washout or Step-Down Period||0
6511855|NCT01490632|7431343|FG008|COMPLETED|Part C: Washout or Step-Down Period||0
6511856|NCT01490632|7431344|FG009|COMPLETED|Part C: Washout or Step-Down Period||0
6511857|NCT01490632|7431345|FG010|COMPLETED|Part C: Washout or Step-Down Period||0
6511858|NCT01490632|7431346|FG011|COMPLETED|Part C: Washout or Step-Down Period||0
6511859|NCT01490632|7431347|FG012|COMPLETED|Part C: Washout or Step-Down Period||10
6511860|NCT01490632|7431348|FG013|COMPLETED|Part C: Washout or Step-Down Period||6
6511861|NCT01490632|7431349|FG014|COMPLETED|Part C: Washout or Step-Down Period||37
6511862|NCT01490632|7431350|FG015|COMPLETED|Part C: Washout or Step-Down Period||18
6511863|NCT01490632|7431351|FG016|COMPLETED|Part C: Washout or Step-Down Period||0
6511864|NCT01490632|7431352|FG017|COMPLETED|Part C: Washout or Step-Down Period||0
6511865|NCT01490632|7431353|FG018|COMPLETED|Part C: Washout or Step-Down Period||0
6511866|NCT01490632|7431354|FG019|COMPLETED|Part C: Washout or Step-Down Period||0
6511867|NCT01490632|7431335|FG000|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511868|NCT01490632|7431336|FG001|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511869|NCT01490632|7431337|FG002|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511870|NCT01490632|7431338|FG003|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511871|NCT01490632|7431339|FG004|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511872|NCT01490632|7431340|FG005|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511873|NCT01490632|7431341|FG006|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511874|NCT01490632|7431342|FG007|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511875|NCT01490632|7431343|FG008|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511876|NCT01490632|7431344|FG009|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511877|NCT01490632|7431345|FG010|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511878|NCT01490632|7431346|FG011|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511879|NCT01490632|7431347|FG012|NOT COMPLETED|Part C: Washout or Step-Down Period||5
6511880|NCT01490632|7431348|FG013|NOT COMPLETED|Part C: Washout or Step-Down Period||10
6511881|NCT01490632|7431349|FG014|NOT COMPLETED|Part C: Washout or Step-Down Period||18
6511882|NCT01490632|7431350|FG015|NOT COMPLETED|Part C: Washout or Step-Down Period||37
6511883|NCT01490632|7431351|FG016|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511884|NCT01490632|7431352|FG017|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511885|NCT01490632|7431353|FG018|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511886|NCT01490632|7431354|FG019|NOT COMPLETED|Part C: Washout or Step-Down Period||0
6511887|NCT01490632|7431335|FG000|STARTED|Part D: Re-Treatment Period||0
6511888|NCT01490632|7431336|FG001|STARTED|Part D: Re-Treatment Period||0
6511889|NCT01490632|7431337|FG002|STARTED|Part D: Re-Treatment Period||0
6511890|NCT01490632|7431338|FG003|STARTED|Part D: Re-Treatment Period||0
6511891|NCT01490632|7431339|FG004|STARTED|Part D: Re-Treatment Period||0
6511892|NCT01490632|7431340|FG005|STARTED|Part D: Re-Treatment Period||0
6511893|NCT01490632|7431341|FG006|STARTED|Part D: Re-Treatment Period||0
6511894|NCT01490632|7431342|FG007|STARTED|Part D: Re-Treatment Period||0
6511895|NCT01490632|7431343|FG008|STARTED|Part D: Re-Treatment Period||0
6511896|NCT01490632|7431344|FG009|STARTED|Part D: Re-Treatment Period||0
6511897|NCT01490632|7431345|FG010|STARTED|Part D: Re-Treatment Period||0
6511898|NCT01490632|7431346|FG011|STARTED|Part D: Re-Treatment Period||0
6511899|NCT01490632|7431347|FG012|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
6511900|NCT01490632|7431348|FG013|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
6511901|NCT01490632|7431349|FG014|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
6511902|NCT01490632|7431350|FG015|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
6511903|NCT01490632|7431351|FG016|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
6511904|NCT01490632|7431352|FG017|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
6511905|NCT01490632|7431353|FG018|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
6511906|NCT01490632|7431354|FG019|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
6511907|NCT01490632|7431335|FG000|COMPLETED|Part D: Re-Treatment Period||0
6511908|NCT01490632|7431336|FG001|COMPLETED|Part D: Re-Treatment Period||0
6511909|NCT01490632|7431337|FG002|COMPLETED|Part D: Re-Treatment Period||0
6511910|NCT01490632|7431338|FG003|COMPLETED|Part D: Re-Treatment Period||0
6511911|NCT01490632|7431339|FG004|COMPLETED|Part D: Re-Treatment Period||0
6511912|NCT01490632|7431340|FG005|COMPLETED|Part D: Re-Treatment Period||0
6511913|NCT01490632|7431341|FG006|COMPLETED|Part D: Re-Treatment Period||0
6511914|NCT01490632|7431342|FG007|COMPLETED|Part D: Re-Treatment Period||0
6511915|NCT01490632|7431343|FG008|COMPLETED|Part D: Re-Treatment Period||0
6511916|NCT01490632|7431344|FG009|COMPLETED|Part D: Re-Treatment Period||0
6511917|NCT01490632|7431345|FG010|COMPLETED|Part D: Re-Treatment Period||0
6511918|NCT01490632|7431346|FG011|COMPLETED|Part D: Re-Treatment Period||0
6511919|NCT01490632|7431347|FG012|COMPLETED|Part D: Re-Treatment Period||0
6511920|NCT01490632|7431348|FG013|COMPLETED|Part D: Re-Treatment Period||0
6511921|NCT01490632|7431349|FG014|COMPLETED|Part D: Re-Treatment Period||0
6511922|NCT01490632|7431350|FG015|COMPLETED|Part D: Re-Treatment Period||0
6511923|NCT01490632|7431351|FG016|COMPLETED|Part D: Re-Treatment Period||3
6511924|NCT01490632|7431352|FG017|COMPLETED|Part D: Re-Treatment Period||8
6511925|NCT01490632|7431353|FG018|COMPLETED|Part D: Re-Treatment Period||12
6511926|NCT01490632|7431354|FG019|COMPLETED|Part D: Re-Treatment Period||30
6511927|NCT01490632|7431335|FG000|NOT COMPLETED|Part D: Re-Treatment Period||0
6511928|NCT01490632|7431336|FG001|NOT COMPLETED|Part D: Re-Treatment Period||0
6511929|NCT01490632|7431337|FG002|NOT COMPLETED|Part D: Re-Treatment Period||0
6511930|NCT01490632|7431338|FG003|NOT COMPLETED|Part D: Re-Treatment Period||0
6511931|NCT01490632|7431339|FG004|NOT COMPLETED|Part D: Re-Treatment Period||0
6511932|NCT01490632|7431340|FG005|NOT COMPLETED|Part D: Re-Treatment Period||0
6511933|NCT01490632|7431341|FG006|NOT COMPLETED|Part D: Re-Treatment Period||0
6511934|NCT01490632|7431342|FG007|NOT COMPLETED|Part D: Re-Treatment Period||0
6511935|NCT01490632|7431343|FG008|NOT COMPLETED|Part D: Re-Treatment Period||0
6511936|NCT01490632|7431344|FG009|NOT COMPLETED|Part D: Re-Treatment Period||0
6511937|NCT01490632|7431345|FG010|NOT COMPLETED|Part D: Re-Treatment Period||0
6511938|NCT01490632|7431346|FG011|NOT COMPLETED|Part D: Re-Treatment Period||0
6511939|NCT01490632|7431347|FG012|NOT COMPLETED|Part D: Re-Treatment Period||0
6511940|NCT01490632|7431348|FG013|NOT COMPLETED|Part D: Re-Treatment Period||0
6511941|NCT01490632|7431349|FG014|NOT COMPLETED|Part D: Re-Treatment Period||0
6511942|NCT01490632|7431350|FG015|NOT COMPLETED|Part D: Re-Treatment Period||0
6511943|NCT01490632|7431351|FG016|NOT COMPLETED|Part D: Re-Treatment Period||0
6511944|NCT01490632|7431352|FG017|NOT COMPLETED|Part D: Re-Treatment Period||5
6511945|NCT01490632|7431353|FG018|NOT COMPLETED|Part D: Re-Treatment Period||7
6511946|NCT01490632|7431354|FG019|NOT COMPLETED|Part D: Re-Treatment Period||7
6511947|NCT01490684|7431397|FG000|STARTED|Overall Study||162
6511948|NCT01490684|7431397|FG000|COMPLETED|Overall Study||162
6511949|NCT01490684|7431397|FG000|NOT COMPLETED|Overall Study||0
6511950|NCT01490697|7431403|FG000|STARTED|Overall Study||16
6511951|NCT01490697|7431404|FG001|STARTED|Overall Study||18
6511952|NCT01490697|7431403|FG000|COMPLETED|Overall Study||15
6511953|NCT01490697|7431404|FG001|COMPLETED|Overall Study||16
6511954|NCT01490697|7431403|FG000|NOT COMPLETED|Overall Study||1
6511955|NCT01490697|7431404|FG001|NOT COMPLETED|Overall Study||2
6511956|NCT01490723|7431410|FG000|STARTED|Overall Study||20
6511957|NCT01490723|7431410|FG000|COMPLETED|Overall Study||20
6511958|NCT01490723|7431410|FG000|NOT COMPLETED|Overall Study||0
6511959|NCT01490788|7431414|FG000|STARTED|Overall Study||5
6511960|NCT01490788|7431415|FG001|STARTED|Overall Study||5
6511961|NCT01490788|7431416|FG002|STARTED|Overall Study||5
6511962|NCT01490788|7431417|FG003|STARTED|Overall Study||5
6511963|NCT01490788|7431418|FG004|STARTED|Overall Study||5
6511964|NCT01490788|7431419|FG005|STARTED|Overall Study||5
6511965|NCT01490788|7431414|FG000|COMPLETED|Overall Study||4
6511966|NCT01490788|7431415|FG001|COMPLETED|Overall Study||5
6511967|NCT01490788|7431416|FG002|COMPLETED|Overall Study||5
6511968|NCT01490788|7431417|FG003|COMPLETED|Overall Study||5
6511969|NCT01490788|7431418|FG004|COMPLETED|Overall Study||5
6511970|NCT01490788|7431419|FG005|COMPLETED|Overall Study||5
6511971|NCT01490788|7431414|FG000|NOT COMPLETED|Overall Study||1
6511972|NCT01490788|7431415|FG001|NOT COMPLETED|Overall Study||0
6511973|NCT01490788|7431416|FG002|NOT COMPLETED|Overall Study||0
6511974|NCT01490788|7431417|FG003|NOT COMPLETED|Overall Study||0
6511975|NCT01490788|7431418|FG004|NOT COMPLETED|Overall Study||0
6511976|NCT01490788|7431419|FG005|NOT COMPLETED|Overall Study||0
6511977|NCT01490814|7431429|FG000|STARTED|Overall Study|378 subjects randomized to Cryoballoon arm|378
6511978|NCT01490814|7431430|FG001|STARTED|Overall Study|384 subjects randomized to radiofrequency arm|384
6511979|NCT01490814|7431429|FG000|COMPLETED|Overall Study|374 received ablation|374
6511980|NCT01490814|7431430|FG001|COMPLETED|Overall Study|376 received ablation|376
6511981|NCT01490814|7431429|FG000|NOT COMPLETED|Overall Study||4
6511982|NCT01490814|7431430|FG001|NOT COMPLETED|Overall Study||8
6511983|NCT01490840|7431438|FG000|STARTED|Phase 1||94
6511984|NCT01490840|7431439|FG001|STARTED|Phase 1||84
6511985|NCT01490840|7431438|FG000|Modified Full Analysis Set|Phase 1||56
6511986|NCT01490840|7431439|FG001|Modified Full Analysis Set|Phase 1||83
6511987|NCT01490840|7431438|FG000|COMPLETED|Phase 1||84
6511988|NCT01490840|7431439|FG001|COMPLETED|Phase 1||78
6511989|NCT01490840|7431438|FG000|NOT COMPLETED|Phase 1||10
6511990|NCT01490840|7431439|FG001|NOT COMPLETED|Phase 1||6
6511991|NCT01490840|7431438|FG000|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
6511992|NCT01490840|7431439|FG001|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
6511993|NCT01490840|7431438|FG000|COMPLETED|Phase 2||75
6511994|NCT01490840|7431439|FG001|COMPLETED|Phase 2||68
6511995|NCT01490840|7431438|FG000|NOT COMPLETED|Phase 2||6
6511996|NCT01490840|7431439|FG001|NOT COMPLETED|Phase 2||6
6511997|NCT01490866|7431445|FG000|STARTED|FOLFOX/Bevacizumab Treatment||70
6511998|NCT01490866|7431445|FG000|COMPLETED|FOLFOX/Bevacizumab Treatment||49
6511999|NCT01490866|7431445|FG000|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
6512000|NCT01490866|7431445|FG000|STARTED|Axitinib Maintenance Therapy||49
6512001|NCT01490866|7431445|FG000|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
6512002|NCT01490866|7431445|FG000|NOT COMPLETED|Axitinib Maintenance Therapy||49
6512003|NCT01490892|7431452|FG000|STARTED|Overall Study||219
6512004|NCT01490892|7431452|FG000|COMPLETED|Overall Study||219
6512005|NCT01490892|7431452|FG000|NOT COMPLETED|Overall Study||0
6512006|NCT01490918|7431459|FG000|STARTED|Overall Study||65
6512007|NCT01490918|7431460|FG001|STARTED|Overall Study||66
6512008|NCT01490918|7431461|FG002|STARTED|Overall Study||34
6512009|NCT01490918|7431459|FG000|COMPLETED|Overall Study||52
6512010|NCT01490918|7431460|FG001|COMPLETED|Overall Study||52
6512011|NCT01490918|7431461|FG002|COMPLETED|Overall Study||22
6512012|NCT01490918|7431459|FG000|NOT COMPLETED|Overall Study||13
6512013|NCT01490918|7431460|FG001|NOT COMPLETED|Overall Study||14
6512014|NCT01490918|7431461|FG002|NOT COMPLETED|Overall Study||12
6512015|NCT01490931|7431473|FG000|STARTED|Overall Study||25
6512016|NCT01490931|7431473|FG000|COMPLETED|Overall Study||25
6512017|NCT01490931|7431473|FG000|NOT COMPLETED|Overall Study||0
6512018|NCT01491022|7431479|FG000|STARTED|Intervention 1||10
6512019|NCT01491022|7431480|FG001|STARTED|Intervention 1||12
6512020|NCT01491022|7431479|FG000|COMPLETED|Intervention 1||9
6512021|NCT01491022|7431480|FG001|COMPLETED|Intervention 1||11
6512022|NCT01491022|7431479|FG000|NOT COMPLETED|Intervention 1||1
6512023|NCT01491022|7431480|FG001|NOT COMPLETED|Intervention 1||1
6512024|NCT01491022|7431479|FG000|STARTED|2 Week Washout||9
6512025|NCT01491022|7431480|FG001|STARTED|2 Week Washout||11
6512026|NCT01491022|7431479|FG000|COMPLETED|2 Week Washout||9
6512027|NCT01491022|7431480|FG001|COMPLETED|2 Week Washout||11
6512028|NCT01491022|7431479|FG000|NOT COMPLETED|2 Week Washout||0
6512029|NCT01491022|7431480|FG001|NOT COMPLETED|2 Week Washout||0
6512030|NCT01491022|7431479|FG000|STARTED|Intervention 2||9
6512031|NCT01491022|7431480|FG001|STARTED|Intervention 2||11
6512032|NCT01491022|7431479|FG000|COMPLETED|Intervention 2||8
6512033|NCT01491022|7431480|FG001|COMPLETED|Intervention 2||11
6512034|NCT01491022|7431479|FG000|NOT COMPLETED|Intervention 2||1
6512035|NCT01491022|7431480|FG001|NOT COMPLETED|Intervention 2||0
6512036|NCT01491035|7431498|FG000|STARTED|Overall Study||6
6512037|NCT01491035|7431499|FG001|STARTED|Overall Study||6
6512038|NCT01491035|7431500|FG002|STARTED|Overall Study||6
6512039|NCT01491035|7431501|FG003|STARTED|Overall Study||6
6512040|NCT01491035|7431502|FG004|STARTED|Overall Study||6
6512041|NCT01491035|7431503|FG005|STARTED|Overall Study||6
6512042|NCT01491035|7431504|FG006|STARTED|Overall Study||6
6512043|NCT01491035|7431505|FG007|STARTED|Overall Study||6
6512044|NCT01491035|7431498|FG000|COMPLETED|Overall Study||6
6512045|NCT01491035|7431499|FG001|COMPLETED|Overall Study||6
6512046|NCT01491035|7431500|FG002|COMPLETED|Overall Study||6
6512047|NCT01491035|7431501|FG003|COMPLETED|Overall Study||6
6512048|NCT01491035|7431502|FG004|COMPLETED|Overall Study||5
6512049|NCT01491035|7431503|FG005|COMPLETED|Overall Study||6
6512050|NCT01491035|7431504|FG006|COMPLETED|Overall Study||6
6512051|NCT01491035|7431505|FG007|COMPLETED|Overall Study||6
6512052|NCT01491035|7431498|FG000|NOT COMPLETED|Overall Study||0
6512053|NCT01491035|7431499|FG001|NOT COMPLETED|Overall Study||0
6512054|NCT01491035|7431500|FG002|NOT COMPLETED|Overall Study||0
6512055|NCT01491035|7431501|FG003|NOT COMPLETED|Overall Study||0
6512056|NCT01491035|7431502|FG004|NOT COMPLETED|Overall Study||1
6512057|NCT01491035|7431503|FG005|NOT COMPLETED|Overall Study||0
6512058|NCT01491035|7431504|FG006|NOT COMPLETED|Overall Study||0
6512059|NCT01491035|7431505|FG007|NOT COMPLETED|Overall Study||0
6512060|NCT01491113|7431528|FG000|STARTED|Overall Study||6
6640250|NCT02332798|7568427|FG000|NOT COMPLETED|Overall Study||1
6640251|NCT02332798|7568428|FG001|NOT COMPLETED|Overall Study||2
6640252|NCT02332798|7568429|FG002|NOT COMPLETED|Overall Study||1
6640253|NCT02332824|7568443|FG000|STARTED|Overall Study||67
6640254|NCT02332824|7568444|FG001|STARTED|Overall Study||67
6640255|NCT02332824|7568445|FG002|STARTED|Overall Study||74
6640256|NCT02332824|7568446|FG003|STARTED|Overall Study||68
6640257|NCT02332824|7568447|FG004|STARTED|Overall Study||69
6640258|NCT02332824|7568448|FG005|STARTED|Overall Study||70
6640259|NCT02332824|7568443|FG000|COMPLETED|Overall Study||61
6512061|NCT01491113|7431529|FG001|STARTED|Overall Study||6
6512062|NCT01491113|7431530|FG002|STARTED|Overall Study||6
6512063|NCT01491113|7431531|FG003|STARTED|Overall Study||6
6512064|NCT01491113|7431532|FG004|STARTED|Overall Study||6
6512065|NCT01491113|7431528|FG000|COMPLETED|Overall Study||6
6512066|NCT01491113|7431529|FG001|COMPLETED|Overall Study||6
6512067|NCT01491113|7431530|FG002|COMPLETED|Overall Study||6
6512068|NCT01491113|7431531|FG003|COMPLETED|Overall Study||6
6512069|NCT01491113|7431532|FG004|COMPLETED|Overall Study||6
6512070|NCT01491113|7431528|FG000|NOT COMPLETED|Overall Study||0
6512071|NCT01491113|7431529|FG001|NOT COMPLETED|Overall Study||0
6512072|NCT01491113|7431530|FG002|NOT COMPLETED|Overall Study||0
6512073|NCT01491113|7431531|FG003|NOT COMPLETED|Overall Study||0
6512074|NCT01491113|7431532|FG004|NOT COMPLETED|Overall Study||0
6512075|NCT01491178|7431546|FG000|STARTED|Overall Study|Started are the enrolled subjects who followed registration rule and for who eCRF was collected.|6443
6512076|NCT01491178|7431546|FG000|COMPLETED|Overall Study|Completed is defined as 104 weeks follow-up after enrollment.|3649
6512077|NCT01491178|7431546|FG000|NOT COMPLETED|Overall Study||2794
6512078|NCT01491490|7431552|FG000|STARTED|Overall Study||1
6512079|NCT01491490|7431553|FG001|STARTED|Overall Study||1
6512080|NCT01491490|7431552|FG000|COMPLETED|Overall Study||1
6512081|NCT01491490|7431553|FG001|COMPLETED|Overall Study||1
6512082|NCT01491490|7431552|FG000|NOT COMPLETED|Overall Study||0
6512083|NCT01491490|7431553|FG001|NOT COMPLETED|Overall Study||0
6512084|NCT01491607|7431563|FG000|STARTED|Overall Study||200
6512085|NCT01491607|7431563|FG000|COMPLETED|Overall Study||190
6512086|NCT01491607|7431563|FG000|NOT COMPLETED|Overall Study||10
6512087|NCT01491633|7431629|FG000|STARTED|Overall Study||5
6512088|NCT01491633|7431629|FG000|COMPLETED|Overall Study||0
6512089|NCT01491633|7431629|FG000|NOT COMPLETED|Overall Study||5
6512090|NCT01491672|7431636|FG000|STARTED|Overall Study||58
6512091|NCT01491672|7431637|FG001|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
6512092|NCT01491672|7431638|FG002|STARTED|Overall Study||14
6512093|NCT01491672|7431636|FG000|Safety Set|Overall Study||58
6512094|NCT01491672|7431637|FG001|Safety Set|Overall Study||61
6512095|NCT01491672|7431638|FG002|Safety Set|Overall Study||14
6512096|NCT01491672|7431636|FG000|COMPLETED|Overall Study||2
6512097|NCT01491672|7431637|FG001|COMPLETED|Overall Study||2
6512098|NCT01491672|7431638|FG002|COMPLETED|Overall Study||3
6512099|NCT01491672|7431636|FG000|NOT COMPLETED|Overall Study||56
6512100|NCT01491672|7431637|FG001|NOT COMPLETED|Overall Study||60
6512101|NCT01491672|7431638|FG002|NOT COMPLETED|Overall Study||11
6512102|NCT01491737|7431650|FG000|STARTED|Overall Study||129
6512103|NCT01491737|7431651|FG001|STARTED|Overall Study||129
6512104|NCT01491737|7431650|FG000|Received at Least One Dose of Study Drug|Overall Study||127
6512105|NCT01491737|7431651|FG001|Received at Least One Dose of Study Drug|Overall Study||124
6512106|NCT01491737|7431650|FG000|Entered Follow-Up (Post-Treatment)|Overall Study||120
6512107|NCT01491737|7431651|FG001|Entered Follow-Up (Post-Treatment)|Overall Study||116
6512108|NCT01491737|7431650|FG000|COMPLETED|Overall Study||0
6512109|NCT01491737|7431651|FG001|COMPLETED|Overall Study||0
6512110|NCT01491737|7431650|FG000|NOT COMPLETED|Overall Study||129
6512111|NCT01491737|7431651|FG001|NOT COMPLETED|Overall Study||129
6512112|NCT01491802|7431657|FG000|STARTED|Overall Study||9
6512113|NCT01491802|7431658|FG001|STARTED|Overall Study||8
6512114|NCT01491802|7431657|FG000|COMPLETED|Overall Study||8
6512115|NCT01491802|7431658|FG001|COMPLETED|Overall Study||6
6512116|NCT01491802|7431657|FG000|NOT COMPLETED|Overall Study||1
6512117|NCT01491802|7431658|FG001|NOT COMPLETED|Overall Study||2
6512118|NCT01491841|7431665|FG000|STARTED|Overall Study||33
6512119|NCT01491841|7431665|FG000|COMPLETED|Overall Study||22
6512120|NCT01491841|7431665|FG000|NOT COMPLETED|Overall Study||11
6512121|NCT01491854|7431677|FG000|STARTED|Overall Study||130
6512122|NCT01491854|7431677|FG000|COMPLETED|Overall Study||0
6512123|NCT01491854|7431677|FG000|NOT COMPLETED|Overall Study||130
6512124|NCT01491919|7431684|FG000|STARTED|Overall Study||13
6512125|NCT01491919|7431685|FG001|STARTED|Overall Study||10
6512126|NCT01491919|7431686|FG002|STARTED|Overall Study||3
6512127|NCT01491919|7431684|FG000|COMPLETED|Overall Study||12
6512128|NCT01491919|7431685|FG001|COMPLETED|Overall Study||8
6512129|NCT01491919|7431686|FG002|COMPLETED|Overall Study||2
6512130|NCT01491919|7431684|FG000|NOT COMPLETED|Overall Study||1
6512131|NCT01491919|7431685|FG001|NOT COMPLETED|Overall Study||2
6512132|NCT01491919|7431686|FG002|NOT COMPLETED|Overall Study||1
6512133|NCT01491945|7431696|FG000|STARTED|Overall Study||76
6512134|NCT01491945|7431696|FG000|COMPLETED|Overall Study||25
6512135|NCT01491945|7431696|FG000|NOT COMPLETED|Overall Study||51
6512136|NCT01491958|7431703|FG000|STARTED|Overall Study||40
6512137|NCT01491958|7431704|FG001|STARTED|Overall Study||40
6512138|NCT01491958|7431703|FG000|COMPLETED|Overall Study||40
6512139|NCT01491958|7431704|FG001|COMPLETED|Overall Study||40
6512140|NCT01491958|7431703|FG000|NOT COMPLETED|Overall Study||0
6512141|NCT01491958|7431704|FG001|NOT COMPLETED|Overall Study||0
6512142|NCT01491984|7431711|FG000|STARTED|Overall Study||49
6512143|NCT01491984|7431712|FG001|STARTED|Overall Study||45
6512144|NCT01491984|7431711|FG000|COMPLETED|Overall Study||47
6512145|NCT01491984|7431712|FG001|COMPLETED|Overall Study||44
6512146|NCT01491984|7431711|FG000|NOT COMPLETED|Overall Study||2
6512147|NCT01491984|7431712|FG001|NOT COMPLETED|Overall Study||1
6512148|NCT01492088|7431721|FG000|STARTED|Overall Study||3
6512149|NCT01492088|7431722|FG001|STARTED|Overall Study||16
6512150|NCT01492088|7431723|FG002|STARTED|Overall Study||17
6512151|NCT01492088|7431721|FG000|COMPLETED|Overall Study||0
6512152|NCT01492088|7431722|FG001|COMPLETED|Overall Study||2
6512153|NCT01492088|7431723|FG002|COMPLETED|Overall Study||3
6512154|NCT01492088|7431721|FG000|NOT COMPLETED|Overall Study||3
6512155|NCT01492088|7431722|FG001|NOT COMPLETED|Overall Study||14
6512156|NCT01492088|7431723|FG002|NOT COMPLETED|Overall Study||14
6512157|NCT01492101|7431736|FG000|STARTED|Overall Study||429
6512158|NCT01492101|7431737|FG001|STARTED|Overall Study||423
6512159|NCT01492101|7431736|FG000|COMPLETED|Overall Study||92
6512160|NCT01492101|7431737|FG001|COMPLETED|Overall Study||81
6512161|NCT01492101|7431736|FG000|NOT COMPLETED|Overall Study||337
6512162|NCT01492101|7431737|FG001|NOT COMPLETED|Overall Study||342
6512163|NCT01492309|7431745|FG000|STARTED|Overall Study||11
6512164|NCT01492309|7431746|FG001|STARTED|Overall Study||11
6512165|NCT01492309|7431745|FG000|COMPLETED|Overall Study||11
6512166|NCT01492309|7431746|FG001|COMPLETED|Overall Study||11
6512167|NCT01492309|7431745|FG000|NOT COMPLETED|Overall Study||0
6512168|NCT01492309|7431746|FG001|NOT COMPLETED|Overall Study||0
6512169|NCT01492400|7431754|FG000|STARTED|Overall Study||181
6512170|NCT01492400|7431755|FG001|STARTED|Overall Study||182
6512171|NCT01492400|7431754|FG000|COMPLETED|Overall Study||165
6512172|NCT01492400|7431755|FG001|COMPLETED|Overall Study||166
6512173|NCT01492400|7431754|FG000|NOT COMPLETED|Overall Study||16
6512174|NCT01492400|7431755|FG001|NOT COMPLETED|Overall Study||16
6512175|NCT01492426|7431763|FG000|STARTED|Treatment||402
6512176|NCT01492426|7431764|FG001|STARTED|Treatment||200
6512177|NCT01492426|7431763|FG000|COMPLETED|Treatment||319
6512178|NCT01492426|7431764|FG001|COMPLETED|Treatment||160
6512179|NCT01492426|7431763|FG000|NOT COMPLETED|Treatment||83
6512180|NCT01492426|7431764|FG001|NOT COMPLETED|Treatment||40
6512181|NCT01492426|7431763|FG000|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
6512182|NCT01492426|7431764|FG001|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
6512183|NCT01492426|7431763|FG000|COMPLETED|Follow-Up||359
6512184|NCT01492426|7431764|FG001|COMPLETED|Follow-Up||181
6512185|NCT01492426|7431763|FG000|NOT COMPLETED|Follow-Up||25
6512186|NCT01492426|7431764|FG001|NOT COMPLETED|Follow-Up||10
6512187|NCT01492439|7431776|FG000|STARTED|Overall Study||19
6512188|NCT01492439|7431777|FG001|STARTED|Overall Study||18
6512189|NCT01492439|7431776|FG000|Post-intervention|Overall Study||18
6512190|NCT01492439|7431777|FG001|Post-intervention|Overall Study||13
6512191|NCT01492439|7431776|FG000|COMPLETED|Overall Study||15
6512192|NCT01492439|7431777|FG001|COMPLETED|Overall Study||9
6512193|NCT01492439|7431776|FG000|NOT COMPLETED|Overall Study||4
6512194|NCT01492439|7431777|FG001|NOT COMPLETED|Overall Study||9
6512195|NCT01492582|7431785|FG000|STARTED|Overall Study|Consented to the vaccine arm (265 quadrivalent vaccine; 188 nonavalent vaccine)|453
6512196|NCT01492582|7431786|FG001|STARTED|Overall Study|Consented to the survey arm of the study|1046
6512197|NCT01492582|7431785|FG000|Received First Quadrivalent Vaccine Dose|Overall Study||254
6512198|NCT01492582|7431786|FG001|Received First Quadrivalent Vaccine Dose|Overall Study|Does not apply|0
6512199|NCT01492582|7431785|FG000|Received First Nonavalent Vaccine Dose|Overall Study||182
6512200|NCT01492582|7431786|FG001|Received First Nonavalent Vaccine Dose|Overall Study||0
6512201|NCT01492582|7431785|FG000|COMPLETED|Overall Study|Received 3 vaccine doses and completed Month 7 blood draw (224 quadrivalent; 160 nonavalent)|384
6512202|NCT01492582|7431786|FG001|COMPLETED|Overall Study|Returned evaluable survey|982
6512203|NCT01492582|7431785|FG000|NOT COMPLETED|Overall Study||69
6512204|NCT01492582|7431786|FG001|NOT COMPLETED|Overall Study||64
6512205|NCT01492673|7431809|FG000|STARTED|Overall Study||9
6512206|NCT01492673|7431809|FG000|COMPLETED|Overall Study||9
6512207|NCT01492673|7431809|FG000|NOT COMPLETED|Overall Study||0
6512208|NCT01492686|7431815|FG000|STARTED|Double-blind Phase||69
6512209|NCT01492686|7431816|FG001|STARTED|Double-blind Phase||68
6512210|NCT01492686|7431815|FG000|COMPLETED|Double-blind Phase||67
6512211|NCT01492686|7431816|FG001|COMPLETED|Double-blind Phase||60
6512212|NCT01492686|7431815|FG000|NOT COMPLETED|Double-blind Phase||2
6512213|NCT01492686|7431816|FG001|NOT COMPLETED|Double-blind Phase||8
6512214|NCT01492686|7431815|FG000|STARTED|Open-label Phase||65
6512215|NCT01492686|7431816|FG001|STARTED|Open-label Phase||58
6512216|NCT01492686|7431815|FG000|COMPLETED|Open-label Phase||53
6512217|NCT01492686|7431816|FG001|COMPLETED|Open-label Phase||40
6512218|NCT01492686|7431815|FG000|NOT COMPLETED|Open-label Phase||12
6512219|NCT01492686|7431816|FG001|NOT COMPLETED|Open-label Phase||18
6512220|NCT01493024|7431828|FG000|STARTED|Overall Study||30
6512221|NCT01493024|7431829|FG001|STARTED|Overall Study||12
6512222|NCT01493024|7431830|FG002|STARTED|Overall Study||24
6512223|NCT01493024|7431831|FG003|STARTED|Overall Study||24
6512224|NCT01493024|7431828|FG000|COMPLETED|Overall Study||30
6512225|NCT01493024|7431829|FG001|COMPLETED|Overall Study||12
6512226|NCT01493024|7431830|FG002|COMPLETED|Overall Study||24
6512227|NCT01493024|7431831|FG003|COMPLETED|Overall Study||24
6512228|NCT01493024|7431828|FG000|NOT COMPLETED|Overall Study||0
6512229|NCT01493024|7431829|FG001|NOT COMPLETED|Overall Study||0
6512230|NCT01493024|7431830|FG002|NOT COMPLETED|Overall Study||0
6512231|NCT01493024|7431831|FG003|NOT COMPLETED|Overall Study||0
6512232|NCT01493089|7431844|FG000|STARTED|Overall Study||122
6512233|NCT01493089|7431845|FG001|STARTED|Overall Study||117
6512234|NCT01493089|7431844|FG000|COMPLETED|Overall Study||119
6512235|NCT01493089|7431845|FG001|COMPLETED|Overall Study||114
6512236|NCT01493089|7431844|FG000|NOT COMPLETED|Overall Study||3
6512237|NCT01493089|7431845|FG001|NOT COMPLETED|Overall Study||3
6512238|NCT01493167|7431853|FG000|STARTED|Overall Study||97
6512239|NCT01493167|7431853|FG000|COMPLETED|Overall Study||97
6512240|NCT01493167|7431853|FG000|NOT COMPLETED|Overall Study||0
6512241|NCT01493180|7431859|FG000|STARTED|Overall Study||51
6512242|NCT01493180|7431860|FG001|STARTED|Overall Study||51
6512243|NCT01493180|7431859|FG000|COMPLETED|Overall Study||48
6512244|NCT01493180|7431860|FG001|COMPLETED|Overall Study||49
6512245|NCT01493180|7431859|FG000|NOT COMPLETED|Overall Study||3
6512246|NCT01493180|7431860|FG001|NOT COMPLETED|Overall Study||2
6512247|NCT01493284|7431866|FG000|STARTED|Overall Study||222
6512248|NCT01493284|7431866|FG000|COMPLETED|Overall Study||161
6512249|NCT01493284|7431866|FG000|NOT COMPLETED|Overall Study||61
6512250|NCT01493414|7431870|FG000|STARTED|Overall Study||2233
6512251|NCT01493414|7431870|FG000|COMPLETED|Overall Study||1283
6512252|NCT01493414|7431870|FG000|NOT COMPLETED|Overall Study||950
6512253|NCT01493427|7431878|FG000|STARTED|Overall Study||199
6512254|NCT01493427|7431878|FG000|COMPLETED|Overall Study||179
6512255|NCT01493427|7431878|FG000|NOT COMPLETED|Overall Study||20
6640260|NCT02332824|7568444|FG001|COMPLETED|Overall Study||66
6640261|NCT02332824|7568445|FG002|COMPLETED|Overall Study||72
6640262|NCT02332824|7568446|FG003|COMPLETED|Overall Study||66
6640263|NCT02332824|7568447|FG004|COMPLETED|Overall Study||65
6640264|NCT02332824|7568448|FG005|COMPLETED|Overall Study||69
6640265|NCT02332824|7568443|FG000|NOT COMPLETED|Overall Study||6
6640266|NCT02332824|7568444|FG001|NOT COMPLETED|Overall Study||1
6640267|NCT02332824|7568445|FG002|NOT COMPLETED|Overall Study||2
6640268|NCT02332824|7568446|FG003|NOT COMPLETED|Overall Study||2
6640269|NCT02332824|7568447|FG004|NOT COMPLETED|Overall Study||4
6640270|NCT02332824|7568448|FG005|NOT COMPLETED|Overall Study||1
6640271|NCT02332863|7568464|FG000|STARTED|Overall Study||22
6640272|NCT02332863|7568465|FG001|STARTED|Overall Study||22
6640273|NCT02332863|7568464|FG000|COMPLETED|Overall Study||22
6640274|NCT02332863|7568465|FG001|COMPLETED|Overall Study||22
6640275|NCT02332863|7568464|FG000|NOT COMPLETED|Overall Study||0
6640276|NCT02332863|7568465|FG001|NOT COMPLETED|Overall Study||0
6640277|NCT02332876|7568473|FG000|STARTED|Overall Study||43
6640278|NCT02332876|7568474|FG001|STARTED|Overall Study||44
6640279|NCT02332876|7568473|FG000|COMPLETED|Overall Study||42
6640280|NCT02332876|7568474|FG001|COMPLETED|Overall Study||43
6512256|NCT01493531|7431885|FG000|STARTED|Overall Study||204
6640281|NCT02332876|7568473|FG000|NOT COMPLETED|Overall Study||1
6640282|NCT02332876|7568474|FG001|NOT COMPLETED|Overall Study||1
6640283|NCT02332889|7568480|FG000|STARTED|Overall Study||1
6640284|NCT02332889|7568480|FG000|COMPLETED|Overall Study||0
6640285|NCT02332889|7568480|FG000|NOT COMPLETED|Overall Study||1
6640286|NCT02332902|7568484|FG000|STARTED|Overall Study||24
6640287|NCT02332902|7568484|FG000|COMPLETED|Overall Study||17
6640288|NCT02332902|7568484|FG000|NOT COMPLETED|Overall Study||7
6512257|NCT01493531|7431886|FG001|STARTED|Overall Study||200
6512258|NCT01493531|7431887|FG002|STARTED|Overall Study||206
6512259|NCT01493531|7431885|FG000|COMPLETED|Overall Study||163
6512260|NCT01493531|7431886|FG001|COMPLETED|Overall Study||150
6512261|NCT01493531|7431887|FG002|COMPLETED|Overall Study||158
6512262|NCT01493531|7431885|FG000|NOT COMPLETED|Overall Study||41
6512263|NCT01493531|7431886|FG001|NOT COMPLETED|Overall Study||50
6512264|NCT01493531|7431887|FG002|NOT COMPLETED|Overall Study||48
6512265|NCT01493557|7431898|FG000|STARTED|Not Randomized to Management Strategies||0
6512266|NCT01493557|7431899|FG001|STARTED|Not Randomized to Management Strategies||0
6512267|NCT01493557|7431900|FG002|STARTED|Not Randomized to Management Strategies||950
6512268|NCT01493557|7431898|FG000|Without Experiencing GIS|Not Randomized to Management Strategies||0
6512269|NCT01493557|7431899|FG001|Without Experiencing GIS|Not Randomized to Management Strategies||0
6512270|NCT01493557|7431900|FG002|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
6512271|NCT01493557|7431898|FG000|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
6512272|NCT01493557|7431899|FG001|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
6512273|NCT01493557|7431900|FG002|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
6512274|NCT01493557|7431898|FG000|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
6512275|NCT01493557|7431899|FG001|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
6512276|NCT01493557|7431900|FG002|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
6512277|NCT01493557|7431898|FG000|COMPLETED|Not Randomized to Management Strategies||0
6512278|NCT01493557|7431899|FG001|COMPLETED|Not Randomized to Management Strategies||0
6512279|NCT01493557|7431900|FG002|COMPLETED|Not Randomized to Management Strategies||816
6512280|NCT01493557|7431898|FG000|NOT COMPLETED|Not Randomized to Management Strategies||0
6512281|NCT01493557|7431899|FG001|NOT COMPLETED|Not Randomized to Management Strategies||0
6512282|NCT01493557|7431900|FG002|NOT COMPLETED|Not Randomized to Management Strategies||134
6512283|NCT01493557|7431898|FG000|STARTED|Randomized to Management Strategies||59
6512284|NCT01493557|7431899|FG001|STARTED|Randomized to Management Strategies||58
6512285|NCT01493557|7431900|FG002|STARTED|Randomized to Management Strategies||0
6512286|NCT01493557|7431898|FG000|COMPLETED|Randomized to Management Strategies||44
6512287|NCT01493557|7431899|FG001|COMPLETED|Randomized to Management Strategies||47
6512288|NCT01493557|7431900|FG002|COMPLETED|Randomized to Management Strategies||0
6512289|NCT01493557|7431898|FG000|NOT COMPLETED|Randomized to Management Strategies||15
6512290|NCT01493557|7431899|FG001|NOT COMPLETED|Randomized to Management Strategies||11
6512291|NCT01493557|7431900|FG002|NOT COMPLETED|Randomized to Management Strategies||0
6512292|NCT01493557|7431898|FG000|STARTED|Adding the Second Strategy||14
6512293|NCT01493557|7431899|FG001|STARTED|Adding the Second Strategy||15
6512294|NCT01493557|7431900|FG002|STARTED|Adding the Second Strategy||0
6512295|NCT01493557|7431898|FG000|COMPLETED|Adding the Second Strategy||12
6512296|NCT01493557|7431899|FG001|COMPLETED|Adding the Second Strategy||11
6512297|NCT01493557|7431900|FG002|COMPLETED|Adding the Second Strategy||0
6512298|NCT01493557|7431898|FG000|NOT COMPLETED|Adding the Second Strategy||2
6512299|NCT01493557|7431899|FG001|NOT COMPLETED|Adding the Second Strategy||4
6512300|NCT01493557|7431900|FG002|NOT COMPLETED|Adding the Second Strategy||0
6512301|NCT01493596|7431914|FG000|STARTED|Overall Study||8
6512302|NCT01493596|7431915|FG001|STARTED|Overall Study||8
6512303|NCT01493596|7431916|FG002|STARTED|Overall Study|Repeat of dose cohort because of incidences of hyperkalemia observed in cohort 2(a).|7
6512304|NCT01493596|7431917|FG003|STARTED|Overall Study||8
6512305|NCT01493596|7431918|FG004|STARTED|Overall Study||8
6512306|NCT01493596|7431919|FG005|STARTED|Overall Study||8
6512307|NCT01493596|7431920|FG006|STARTED|Overall Study||8
6512308|NCT01493596|7431914|FG000|COMPLETED|Overall Study||8
6512309|NCT01493596|7431915|FG001|COMPLETED|Overall Study||8
6512310|NCT01493596|7431916|FG002|COMPLETED|Overall Study||7
6512311|NCT01493596|7431917|FG003|COMPLETED|Overall Study||8
6512312|NCT01493596|7431918|FG004|COMPLETED|Overall Study||8
6512313|NCT01493596|7431919|FG005|COMPLETED|Overall Study||8
6512314|NCT01493596|7431920|FG006|COMPLETED|Overall Study||8
6512315|NCT01493596|7431914|FG000|NOT COMPLETED|Overall Study||0
6512316|NCT01493596|7431915|FG001|NOT COMPLETED|Overall Study||0
6512317|NCT01493596|7431916|FG002|NOT COMPLETED|Overall Study||0
6512318|NCT01493596|7431917|FG003|NOT COMPLETED|Overall Study||0
6512319|NCT01493596|7431918|FG004|NOT COMPLETED|Overall Study||0
6512320|NCT01493596|7431919|FG005|NOT COMPLETED|Overall Study||0
6512321|NCT01493596|7431920|FG006|NOT COMPLETED|Overall Study||0
6512322|NCT01493687|7431936|FG000|STARTED|Part A Vehicle Control (12 Weeks)||451
6512323|NCT01493687|7431937|FG001|STARTED|Part A Vehicle Control (12 Weeks)||232
6640289|NCT02332915|7568490|FG000|STARTED|Overall Study||18
6640290|NCT02332915|7568491|FG001|STARTED|Overall Study||18
6640291|NCT02332915|7568490|FG000|COMPLETED|Overall Study||12
6640292|NCT02332915|7568491|FG001|COMPLETED|Overall Study||12
6640293|NCT02332915|7568490|FG000|NOT COMPLETED|Overall Study||6
6640294|NCT02332915|7568491|FG001|NOT COMPLETED|Overall Study||6
6640295|NCT02333045|7568501|FG000|STARTED|Overall Study||1
6640296|NCT02333045|7568502|FG001|STARTED|Overall Study||3
6640297|NCT02333045|7568501|FG000|COMPLETED|Overall Study||1
6640298|NCT02333045|7568502|FG001|COMPLETED|Overall Study||3
6640299|NCT02333045|7568501|FG000|NOT COMPLETED|Overall Study||0
6640300|NCT02333045|7568502|FG001|NOT COMPLETED|Overall Study||0
6640301|NCT02333071|7568510|FG000|STARTED|Core Study||326
6640302|NCT02333071|7568511|FG001|STARTED|Core Study||327
6640303|NCT02333071|7568510|FG000|Received Intervention|Core Study||319
6640304|NCT02333071|7568511|FG001|Received Intervention|Core Study||324
6512324|NCT01493687|7431936|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||414
6512325|NCT01493687|7431937|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||210
6512326|NCT01493687|7431936|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
6512327|NCT01493687|7431937|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
6512328|NCT01493687|7431936|FG000|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
6512329|NCT01493687|7431937|FG001|STARTED|Part B Long Term Active Control 40 Weeks||210
6512330|NCT01493687|7431936|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||351
6512331|NCT01493687|7431937|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||175
6512332|NCT01493687|7431936|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
6512333|NCT01493687|7431937|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
6512334|NCT01493687|7431936|FG000|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
6512335|NCT01493687|7431937|FG001|STARTED|Part C Safety Follow up (4 Weeks)||175
6512336|NCT01493687|7431936|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||350
6512337|NCT01493687|7431937|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||174
6512338|NCT01493687|7431936|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
6512339|NCT01493687|7431937|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
6512340|NCT01493778|7431949|FG000|STARTED|Overall Study||60
6512341|NCT01493778|7431949|FG000|COMPLETED|Overall Study||52
6512342|NCT01493778|7431949|FG000|NOT COMPLETED|Overall Study||8
6512343|NCT01493947|7431964|FG000|STARTED|Period A Efficacy and Safety Data||478
6512344|NCT01493947|7431965|FG001|STARTED|Period A Efficacy and Safety Data||484
6512345|NCT01493947|7431964|FG000|COMPLETED|Period A Efficacy and Safety Data||446
6512346|NCT01493947|7431965|FG001|COMPLETED|Period A Efficacy and Safety Data||456
6512347|NCT01493947|7431964|FG000|NOT COMPLETED|Period A Efficacy and Safety Data||32
6512348|NCT01493947|7431965|FG001|NOT COMPLETED|Period A Efficacy and Safety Data||28
6512349|NCT01493947|7431964|FG000|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
6512350|NCT01493947|7431965|FG001|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
6512351|NCT01493947|7431964|FG000|COMPLETED|Period B Extension Period||366
6512352|NCT01493947|7431965|FG001|COMPLETED|Period B Extension Period||326
6512353|NCT01493947|7431964|FG000|NOT COMPLETED|Period B Extension Period||33
6512354|NCT01493947|7431965|FG001|NOT COMPLETED|Period B Extension Period||32
6512355|NCT01493960|7431976|FG000|STARTED|Overall Study||87
6512356|NCT01493960|7431977|FG001|STARTED|Overall Study||44
6512357|NCT01493960|7431976|FG000|Received Study Drug|Overall Study||87
6512358|NCT01493960|7431977|FG001|Received Study Drug|Overall Study||43
6512359|NCT01493960|7431976|FG000|COMPLETED|Overall Study||55
6512360|NCT01493960|7431977|FG001|COMPLETED|Overall Study||26
6512361|NCT01493960|7431976|FG000|NOT COMPLETED|Overall Study||32
6512362|NCT01493960|7431977|FG001|NOT COMPLETED|Overall Study||18
6512363|NCT01494038|7431985|FG000|STARTED|Overall Study||477
6512364|NCT01494038|7431986|FG001|STARTED|Overall Study||479
6512365|NCT01494038|7431985|FG000|COMPLETED|Overall Study||389
6512366|NCT01494038|7431986|FG001|COMPLETED|Overall Study||396
6512367|NCT01494038|7431985|FG000|NOT COMPLETED|Overall Study||88
6512368|NCT01494038|7431986|FG001|NOT COMPLETED|Overall Study||83
6512369|NCT01494051|7432009|FG000|STARTED|Overall Study||6
6512370|NCT01494051|7432010|FG001|STARTED|Overall Study||7
6512371|NCT01494051|7432009|FG000|COMPLETED|Overall Study||6
6512372|NCT01494051|7432010|FG001|COMPLETED|Overall Study||7
6512373|NCT01494051|7432009|FG000|NOT COMPLETED|Overall Study||0
6512374|NCT01494051|7432010|FG001|NOT COMPLETED|Overall Study||0
6512375|NCT01494298|7432018|FG000|STARTED|Overall Study||56
6512376|NCT01494298|7432019|FG001|STARTED|Overall Study||55
6512377|NCT01494298|7432018|FG000|COMPLETED|Overall Study||54
6512378|NCT01494298|7432019|FG001|COMPLETED|Overall Study||47
6512379|NCT01494298|7432018|FG000|NOT COMPLETED|Overall Study||2
6512380|NCT01494298|7432019|FG001|NOT COMPLETED|Overall Study||8
6512381|NCT01494350|7432027|FG000|STARTED|Overall Study||50
6512382|NCT01494350|7432027|FG000|COMPLETED|Overall Study||49
6512383|NCT01494350|7432027|FG000|NOT COMPLETED|Overall Study||1
6512384|NCT01494467|7432033|FG000|STARTED|Part A Vehicle Control (12 Weeks)||459
6512385|NCT01494467|7432034|FG001|STARTED|Part A Vehicle Control (12 Weeks)||229
6512386|NCT01494467|7432033|FG000|COMPLETED|Part A Vehicle Control (12 Weeks)||429
6512387|NCT01494467|7432034|FG001|COMPLETED|Part A Vehicle Control (12 Weeks)||208
6512388|NCT01494467|7432033|FG000|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
6512389|NCT01494467|7432034|FG001|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
6512390|NCT01494467|7432033|FG000|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
6512391|NCT01494467|7432034|FG001|STARTED|Part B Long Term Active Control 40 Weeks||208
6512392|NCT01494467|7432033|FG000|COMPLETED|Part B Long Term Active Control 40 Weeks||353
6512393|NCT01494467|7432034|FG001|COMPLETED|Part B Long Term Active Control 40 Weeks||159
6512394|NCT01494467|7432033|FG000|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
6512395|NCT01494467|7432034|FG001|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
6512396|NCT01494467|7432033|FG000|STARTED|Part C Safety Follow up (4 Weeks)||353
6304178|NCT00364832|7207516|FG002|STARTED|Core Period||15
6304179|NCT00364832|7207517|FG003|STARTED|Core Period||16
6304180|NCT00364832|7207518|FG004|STARTED|Core Period||16
6304181|NCT00364832|7207519|FG005|STARTED|Core Period||12
6304182|NCT00364832|7207520|FG006|STARTED|Core Period||16
6512397|NCT01494467|7432034|FG001|STARTED|Part C Safety Follow up (4 Weeks)||159
6512398|NCT01494467|7432033|FG000|COMPLETED|Part C Safety Follow up (4 Weeks)||353
6512399|NCT01494467|7432034|FG001|COMPLETED|Part C Safety Follow up (4 Weeks)||159
6512400|NCT01494467|7432033|FG000|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
6512401|NCT01494467|7432034|FG001|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
6512402|NCT01494506|7432049|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
6512403|NCT01494506|7432050|FG001|STARTED|Overall Study||149
6512404|NCT01494506|7432051|FG002|STARTED|Overall Study||117
6512405|NCT01494506|7432049|FG000|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
6512406|NCT01494506|7432050|FG001|Treated Population|Overall Study||134
6512407|NCT01494506|7432051|FG002|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
6512408|NCT01494506|7432049|FG000|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
6512409|NCT01494506|7432050|FG001|COMPLETED|Overall Study||6
6512410|NCT01494506|7432051|FG002|COMPLETED|Overall Study||14
6512411|NCT01494506|7432049|FG000|NOT COMPLETED|Overall Study||148
6512412|NCT01494506|7432050|FG001|NOT COMPLETED|Overall Study||143
6512413|NCT01494506|7432051|FG002|NOT COMPLETED|Overall Study||103
6512414|NCT01494532|7432067|FG000|STARTED|Overall Study||75
6512415|NCT01494532|7432068|FG001|STARTED|Overall Study||25
6512416|NCT01494532|7432069|FG002|STARTED|Overall Study||76
6512417|NCT01494532|7432070|FG003|STARTED|Overall Study||75
6512418|NCT01494532|7432071|FG004|STARTED|Overall Study||76
6512419|NCT01494532|7432072|FG005|STARTED|Overall Study||25
6512420|NCT01494532|7432067|FG000|COMPLETED|Overall Study||65
6512421|NCT01494532|7432068|FG001|COMPLETED|Overall Study||21
6512422|NCT01494532|7432069|FG002|COMPLETED|Overall Study||59
6512423|NCT01494532|7432070|FG003|COMPLETED|Overall Study||60
6512424|NCT01494532|7432071|FG004|COMPLETED|Overall Study||64
6512425|NCT01494532|7432072|FG005|COMPLETED|Overall Study||25
6512426|NCT01494532|7432067|FG000|NOT COMPLETED|Overall Study||10
6512427|NCT01494532|7432068|FG001|NOT COMPLETED|Overall Study||4
6512428|NCT01494532|7432069|FG002|NOT COMPLETED|Overall Study||17
6512429|NCT01494532|7432070|FG003|NOT COMPLETED|Overall Study||15
6512430|NCT01494532|7432071|FG004|NOT COMPLETED|Overall Study||12
6512431|NCT01494532|7432072|FG005|NOT COMPLETED|Overall Study||0
6512432|NCT01494545|7432087|FG000|STARTED|Overall Study||102
6512433|NCT01494545|7432087|FG000|COMPLETED|Overall Study||92
6512434|NCT01494545|7432087|FG000|NOT COMPLETED|Overall Study||10
6512435|NCT01494584|7432094|FG000|STARTED|Overall Study||5
6512436|NCT01494584|7432094|FG000|COMPLETED|Overall Study||4
6512437|NCT01494584|7432094|FG000|NOT COMPLETED|Overall Study||1
6512438|NCT01494610|7432117|FG000|STARTED|Period 1||31
6512439|NCT01494610|7432118|FG001|STARTED|Period 1||29
6512440|NCT01494610|7432117|FG000|COMPLETED|Period 1||30
6512441|NCT01494610|7432118|FG001|COMPLETED|Period 1||28
6512442|NCT01494610|7432117|FG000|NOT COMPLETED|Period 1||1
6512443|NCT01494610|7432118|FG001|NOT COMPLETED|Period 1||1
6512444|NCT01494610|7432117|FG000|STARTED|Period 2||30
6512445|NCT01494610|7432118|FG001|STARTED|Period 2||28
6512446|NCT01494610|7432117|FG000|COMPLETED|Period 2||30
6512447|NCT01494610|7432118|FG001|COMPLETED|Period 2||28
6512448|NCT01494610|7432117|FG000|NOT COMPLETED|Period 2||0
6512449|NCT01494610|7432118|FG001|NOT COMPLETED|Period 2||0
6512450|NCT01494610|7432117|FG000|STARTED|Period 3||30
6512451|NCT01494610|7432118|FG001|STARTED|Period 3||28
6512452|NCT01494610|7432117|FG000|COMPLETED|Period 3||28
6512453|NCT01494610|7432118|FG001|COMPLETED|Period 3||28
6512454|NCT01494610|7432117|FG000|NOT COMPLETED|Period 3||2
6512455|NCT01494610|7432118|FG001|NOT COMPLETED|Period 3||0
6512456|NCT01494610|7432117|FG000|STARTED|Period 4||28
6512457|NCT01494610|7432118|FG001|STARTED|Period 4||28
6512458|NCT01494610|7432117|FG000|COMPLETED|Period 4||27
6512459|NCT01494610|7432118|FG001|COMPLETED|Period 4||28
6512460|NCT01494610|7432117|FG000|NOT COMPLETED|Period 4||1
6512461|NCT01494610|7432118|FG001|NOT COMPLETED|Period 4||0
6512462|NCT01494649|7432132|FG000|STARTED|Overall Study||59
6512463|NCT01494649|7432133|FG001|STARTED|Overall Study||59
6512464|NCT01494649|7432132|FG000|COMPLETED|Overall Study||59
6512465|NCT01494649|7432133|FG001|COMPLETED|Overall Study||58
6512466|NCT01494649|7432132|FG000|NOT COMPLETED|Overall Study||0
6512467|NCT01494649|7432133|FG001|NOT COMPLETED|Overall Study||1
6512468|NCT01494753|7432143|FG000|STARTED|Day0-Day42||15
6512469|NCT01494753|7432144|FG001|STARTED|Day0-Day42||15
6512470|NCT01494753|7432143|FG000|COMPLETED|Day0-Day42||15
6512471|NCT01494753|7432144|FG001|COMPLETED|Day0-Day42||15
6512472|NCT01494753|7432143|FG000|NOT COMPLETED|Day0-Day42||0
6512473|NCT01494753|7432144|FG001|NOT COMPLETED|Day0-Day42||0
6512474|NCT01494753|7432143|FG000|STARTED|Day42-Day84||15
6512475|NCT01494753|7432144|FG001|STARTED|Day42-Day84||15
6512476|NCT01494753|7432143|FG000|COMPLETED|Day42-Day84||15
6512477|NCT01494753|7432144|FG001|COMPLETED|Day42-Day84||15
6512478|NCT01494753|7432143|FG000|NOT COMPLETED|Day42-Day84||0
6512479|NCT01494753|7432144|FG001|NOT COMPLETED|Day42-Day84||0
6512480|NCT01494818|7432152|FG000|STARTED|Overall Study||39
6512481|NCT01494818|7432153|FG001|STARTED|Overall Study||39
6512482|NCT01494818|7432152|FG000|COMPLETED|Overall Study||37
6512483|NCT01494818|7432153|FG001|COMPLETED|Overall Study||37
6512484|NCT01494818|7432152|FG000|NOT COMPLETED|Overall Study||2
6512485|NCT01494818|7432153|FG001|NOT COMPLETED|Overall Study||2
6561334|NCT01792284|7484136|FG002|COMPLETED|Randomization Period 2||85
6512486|NCT01494922|7432159|FG000|STARTED|Overall Study||14
6512487|NCT01494922|7432159|FG000|COMPLETED|Overall Study||13
6512488|NCT01494922|7432159|FG000|NOT COMPLETED|Overall Study||1
6512489|NCT01494987|7432165|FG000|STARTED|Overall Study||216
6512490|NCT01494987|7432166|FG001|STARTED|Overall Study||215
6512491|NCT01494987|7432165|FG000|COMPLETED|Overall Study||188
6512492|NCT01494987|7432166|FG001|COMPLETED|Overall Study||187
6512493|NCT01494987|7432165|FG000|NOT COMPLETED|Overall Study||28
6512494|NCT01494987|7432166|FG001|NOT COMPLETED|Overall Study||28
6512495|NCT01495000|7432174|FG000|STARTED|Overall Study||124
6512496|NCT01495000|7432175|FG001|STARTED|Overall Study||126
6512497|NCT01495000|7432174|FG000|COMPLETED|Overall Study||111
6512498|NCT01495000|7432175|FG001|COMPLETED|Overall Study||114
6512499|NCT01495000|7432174|FG000|NOT COMPLETED|Overall Study||13
6512500|NCT01495000|7432175|FG001|NOT COMPLETED|Overall Study||12
6512501|NCT01495221|7432181|FG000|STARTED|Overall Study|First Patient enrolled December 2011.|9
6512502|NCT01495221|7432181|FG000|COMPLETED|Overall Study|Last patient enrolled May 2012.|9
6512503|NCT01495221|7432181|FG000|NOT COMPLETED|Overall Study||0
6512504|NCT01495286|7432185|FG000|STARTED|Overall Study||30
6512505|NCT01495286|7432185|FG000|COMPLETED|Overall Study||30
6512506|NCT01495286|7432185|FG000|NOT COMPLETED|Overall Study||0
6512507|NCT01495481|7432189|FG000|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
6512508|NCT01495481|7432189|FG000|COMPLETED|Adenosine||22
6512509|NCT01495481|7432189|FG000|NOT COMPLETED|Adenosine||0
6512510|NCT01495481|7432189|FG000|STARTED|Washout||22
6512511|NCT01495481|7432189|FG000|COMPLETED|Washout||22
6512512|NCT01495481|7432189|FG000|NOT COMPLETED|Washout||0
6512513|NCT01495481|7432189|FG000|STARTED|Dexmedetomidine||22
6512514|NCT01495481|7432189|FG000|COMPLETED|Dexmedetomidine||22
6512515|NCT01495481|7432189|FG000|NOT COMPLETED|Dexmedetomidine||0
6640305|NCT02333071|7568510|FG000|COMPLETED|Core Study||274
6640306|NCT02333071|7568511|FG001|COMPLETED|Core Study||190
6640307|NCT02333071|7568510|FG000|NOT COMPLETED|Core Study||52
6640308|NCT02333071|7568511|FG001|NOT COMPLETED|Core Study||137
6640309|NCT02333071|7568510|FG000|STARTED|Open Label Extension||239
6640310|NCT02333071|7568511|FG001|STARTED|Open Label Extension||124
6640311|NCT02333071|7568510|FG000|COMPLETED|Open Label Extension||95
6640312|NCT02333071|7568511|FG001|COMPLETED|Open Label Extension||49
6640313|NCT02333071|7568510|FG000|NOT COMPLETED|Open Label Extension||144
6640314|NCT02333071|7568511|FG001|NOT COMPLETED|Open Label Extension||75
6640315|NCT02333331|7568526|FG000|STARTED|Overall Study||19
6640316|NCT02333331|7568527|FG001|STARTED|Overall Study||18
6640317|NCT02333331|7568528|FG002|STARTED|Overall Study||113
6640318|NCT02333331|7568529|FG003|STARTED|Overall Study||67
6640319|NCT02333331|7568526|FG000|COMPLETED|Overall Study||17
6640320|NCT02333331|7568527|FG001|COMPLETED|Overall Study||12
6640321|NCT02333331|7568528|FG002|COMPLETED|Overall Study||95
6640322|NCT02333331|7568529|FG003|COMPLETED|Overall Study||64
6640323|NCT02333331|7568526|FG000|NOT COMPLETED|Overall Study||2
6640324|NCT02333331|7568527|FG001|NOT COMPLETED|Overall Study||6
6640325|NCT02333331|7568528|FG002|NOT COMPLETED|Overall Study||18
6640326|NCT02333331|7568529|FG003|NOT COMPLETED|Overall Study||3
6640327|NCT02333383|7568539|FG000|STARTED|Overall Study||201
6640328|NCT02333383|7568539|FG000|COMPLETED|Overall Study||160
6640329|NCT02333383|7568539|FG000|NOT COMPLETED|Overall Study||41
6640330|NCT02333487|7568546|FG000|STARTED|Overall Study||6
6640331|NCT02333487|7568547|FG001|STARTED|Overall Study||8
6640332|NCT02333487|7568548|FG002|STARTED|Overall Study||8
6640333|NCT02333487|7568546|FG000|COMPLETED|Overall Study||6
6640334|NCT02333487|7568547|FG001|COMPLETED|Overall Study||6
6640335|NCT02333487|7568548|FG002|COMPLETED|Overall Study||8
6640336|NCT02333487|7568546|FG000|NOT COMPLETED|Overall Study||0
6640337|NCT02333487|7568547|FG001|NOT COMPLETED|Overall Study||2
6640338|NCT02333487|7568548|FG002|NOT COMPLETED|Overall Study||0
6640339|NCT02333630|7568559|FG000|STARTED|Overall Study||100
6640340|NCT02333630|7568560|FG001|STARTED|Overall Study||100
6640341|NCT02333630|7568559|FG000|COMPLETED|Overall Study||95
6640342|NCT02333630|7568560|FG001|COMPLETED|Overall Study||98
6640343|NCT02333630|7568559|FG000|NOT COMPLETED|Overall Study||5
6640344|NCT02333630|7568560|FG001|NOT COMPLETED|Overall Study||2
6640345|NCT02334059|7568573|FG000|STARTED|Overall Study||37
6640346|NCT02334059|7568574|FG001|STARTED|Overall Study||34
6640347|NCT02334059|7568575|FG002|STARTED|Overall Study||37
6640348|NCT02334059|7568573|FG000|COMPLETED|Overall Study||37
6640349|NCT02334059|7568574|FG001|COMPLETED|Overall Study||34
6640350|NCT02334059|7568575|FG002|COMPLETED|Overall Study||37
6512516|NCT01495572|7432199|FG000|STARTED|Overall Study||0
6512517|NCT01495572|7432200|FG001|STARTED|Overall Study||5
6640351|NCT02334059|7568573|FG000|NOT COMPLETED|Overall Study||0
6640352|NCT02334059|7568574|FG001|NOT COMPLETED|Overall Study||0
6640353|NCT02334059|7568575|FG002|NOT COMPLETED|Overall Study||0
6640354|NCT02334215|7568586|FG000|STARTED|Overall Study||75
6640355|NCT02334215|7568587|FG001|STARTED|Overall Study||74
6640356|NCT02334215|7568588|FG002|STARTED|Overall Study||76
6640357|NCT02334215|7568586|FG000|COMPLETED|Overall Study||68
6512518|NCT01495572|7432199|FG000|COMPLETED|Overall Study||0
6512519|NCT01495572|7432200|FG001|COMPLETED|Overall Study||5
6512520|NCT01495572|7432199|FG000|NOT COMPLETED|Overall Study||0
6512521|NCT01495572|7432200|FG001|NOT COMPLETED|Overall Study||0
6640358|NCT02334215|7568587|FG001|COMPLETED|Overall Study||68
6640359|NCT02334215|7568588|FG002|COMPLETED|Overall Study||61
6640360|NCT02334215|7568586|FG000|NOT COMPLETED|Overall Study||7
6512522|NCT01495585|7432210|FG000|STARTED|Overall Study||4
6512523|NCT01495585|7432211|FG001|STARTED|Overall Study||6
6512524|NCT01495585|7432212|FG002|STARTED|Overall Study||4
6512525|NCT01495585|7432210|FG000|Open Label Lonafarnib 200 mg|Overall Study||2
6512526|NCT01495585|7432211|FG001|Open Label Lonafarnib 200 mg|Overall Study||0
6512527|NCT01495585|7432212|FG002|Open Label Lonafarnib 200 mg|Overall Study||0
6512528|NCT01495585|7432210|FG000|COMPLETED|Overall Study||4
6512529|NCT01495585|7432211|FG001|COMPLETED|Overall Study||6
6512530|NCT01495585|7432212|FG002|COMPLETED|Overall Study||4
6512531|NCT01495585|7432210|FG000|NOT COMPLETED|Overall Study||0
6512532|NCT01495585|7432211|FG001|NOT COMPLETED|Overall Study||0
6512533|NCT01495585|7432212|FG002|NOT COMPLETED|Overall Study||0
6512534|NCT01495689|7432222|FG000|STARTED|Overall Study||26
6512535|NCT01495689|7432223|FG001|STARTED|Overall Study||23
6512536|NCT01495689|7432222|FG000|COMPLETED|Overall Study||16
6512537|NCT01495689|7432223|FG001|COMPLETED|Overall Study||16
6512538|NCT01495689|7432222|FG000|NOT COMPLETED|Overall Study||10
6512539|NCT01495689|7432223|FG001|NOT COMPLETED|Overall Study||7
6512540|NCT01495702|7432231|FG000|STARTED|Randomized Phase||292
6512541|NCT01495702|7432232|FG001|STARTED|Randomized Phase||147
6512542|NCT01495702|7432231|FG000|COMPLETED|Randomized Phase||266
6512543|NCT01495702|7432232|FG001|COMPLETED|Randomized Phase||119
6512544|NCT01495702|7432231|FG000|NOT COMPLETED|Randomized Phase||26
6512545|NCT01495702|7432232|FG001|NOT COMPLETED|Randomized Phase||28
6512546|NCT01495702|7432231|FG000|STARTED|Extension Phase||26
6512547|NCT01495702|7432232|FG001|STARTED|Extension Phase||2
6512548|NCT01495702|7432231|FG000|COMPLETED|Extension Phase||26
6512549|NCT01495702|7432232|FG001|COMPLETED|Extension Phase||2
6512550|NCT01495702|7432231|FG000|NOT COMPLETED|Extension Phase||0
6512551|NCT01495702|7432232|FG001|NOT COMPLETED|Extension Phase||0
6512552|NCT01495793|7432239|FG000|STARTED|Overall Study||24
6512553|NCT01495793|7432239|FG000|COMPLETED|Overall Study||22
6512554|NCT01495793|7432239|FG000|NOT COMPLETED|Overall Study||2
6512555|NCT01495819|7432243|FG000|STARTED|Overall Study||34
6512556|NCT01495819|7432243|FG000|Nicotine 0.0125|Overall Study||31
6512557|NCT01495819|7432243|FG000|Nicotine 0.025|Overall Study||32
6512558|NCT01495819|7432243|FG000|Nicotine 0.05|Overall Study||33
6512559|NCT01495819|7432243|FG000|Nicotine 0.1|Overall Study||31
6512560|NCT01495819|7432243|FG000|NIcotine 0.2|Overall Study||33
6512561|NCT01495819|7432243|FG000|COMPLETED|Overall Study||30
6512562|NCT01495819|7432243|FG000|NOT COMPLETED|Overall Study||4
6512563|NCT01495858|7432255|FG000|STARTED|Overall Study||107
6512564|NCT01495858|7432256|FG001|STARTED|Overall Study||106
6512565|NCT01495858|7432257|FG002|STARTED|Overall Study||54
6512566|NCT01495858|7432255|FG000|COMPLETED|Overall Study||107
6512567|NCT01495858|7432256|FG001|COMPLETED|Overall Study||106
6512568|NCT01495858|7432257|FG002|COMPLETED|Overall Study||54
6512569|NCT01495858|7432255|FG000|NOT COMPLETED|Overall Study||0
6512570|NCT01495858|7432256|FG001|NOT COMPLETED|Overall Study||0
6512571|NCT01495858|7432257|FG002|NOT COMPLETED|Overall Study||0
6512572|NCT01495923|7432267|FG000|STARTED|Overall Study||73
6512573|NCT01495923|7432268|FG001|STARTED|Overall Study||72
6512574|NCT01495923|7432267|FG000|COMPLETED|Overall Study||73
6512575|NCT01495923|7432268|FG001|COMPLETED|Overall Study||72
6512576|NCT01495923|7432267|FG000|NOT COMPLETED|Overall Study||0
6512577|NCT01495923|7432268|FG001|NOT COMPLETED|Overall Study||0
6512578|NCT01495975|7432278|FG000|STARTED|Overall Study||15
6512579|NCT01495975|7432279|FG001|STARTED|Overall Study||14
6512580|NCT01495975|7432278|FG000|COMPLETED|Overall Study||14
6512581|NCT01495975|7432279|FG001|COMPLETED|Overall Study||14
6512582|NCT01495975|7432278|FG000|NOT COMPLETED|Overall Study||1
6512583|NCT01495975|7432279|FG001|NOT COMPLETED|Overall Study||0
6512584|NCT01496066|7432287|FG000|STARTED|Overall Study||403
6512585|NCT01496066|7432288|FG001|STARTED|Overall Study||197
6512586|NCT01496066|7432287|FG000|COMPLETED|Overall Study||391
6512587|NCT01496066|7432288|FG001|COMPLETED|Overall Study||188
6512588|NCT01496066|7432287|FG000|NOT COMPLETED|Overall Study||12
6512589|NCT01496066|7432288|FG001|NOT COMPLETED|Overall Study||9
6512590|NCT01496131|7432303|FG000|STARTED|Overall Study||14
6640361|NCT02334215|7568587|FG001|NOT COMPLETED|Overall Study||6
6640362|NCT02334215|7568588|FG002|NOT COMPLETED|Overall Study||15
6640363|NCT02334267|7568598|FG000|STARTED|Overall Study||6
6640364|NCT02334267|7568599|FG001|STARTED|Overall Study||5
6640365|NCT02334267|7568598|FG000|COMPLETED|Overall Study||5
6640366|NCT02334267|7568599|FG001|COMPLETED|Overall Study||5
6640367|NCT02334267|7568598|FG000|NOT COMPLETED|Overall Study||1
6640368|NCT02334267|7568599|FG001|NOT COMPLETED|Overall Study||0
6512591|NCT01496131|7432304|FG001|STARTED|Overall Study||14
6512592|NCT01496131|7432303|FG000|COMPLETED|Overall Study||14
6512593|NCT01496131|7432304|FG001|COMPLETED|Overall Study||14
6512594|NCT01496131|7432303|FG000|NOT COMPLETED|Overall Study||0
6640369|NCT02334306|7568613|FG000|STARTED|Double-blind Period||16
6640370|NCT02334306|7568614|FG001|STARTED|Double-blind Period||16
6640371|NCT02334306|7568613|FG000|COMPLETED|Double-blind Period||15
6512595|NCT01496131|7432304|FG001|NOT COMPLETED|Overall Study||0
6512596|NCT01496157|7432310|FG000|STARTED|Overall Study||13
6512597|NCT01496157|7432310|FG000|COMPLETED|Overall Study||13
6512598|NCT01496157|7432310|FG000|NOT COMPLETED|Overall Study||0
6512599|NCT01496183|7432316|FG000|STARTED|Overall Study||9
6512600|NCT01496183|7432317|FG001|STARTED|Overall Study||15
6512601|NCT01496183|7432316|FG000|COMPLETED|Overall Study||6
6640372|NCT02334306|7568614|FG001|COMPLETED|Double-blind Period||14
6512602|NCT01496183|7432317|FG001|COMPLETED|Overall Study||13
6512603|NCT01496183|7432316|FG000|NOT COMPLETED|Overall Study||3
6512604|NCT01496183|7432317|FG001|NOT COMPLETED|Overall Study||2
6512605|NCT01496248|7432324|FG000|STARTED|Overall Study||35
6512606|NCT01496248|7432324|FG000|COMPLETED|Overall Study||25
6512607|NCT01496248|7432324|FG000|NOT COMPLETED|Overall Study||10
6512608|NCT01496274|7432330|FG000|STARTED|Overall Study||40
6512609|NCT01496274|7432331|FG001|STARTED|Overall Study||23
6512610|NCT01496274|7432330|FG000|COMPLETED|Overall Study||37
6512611|NCT01496274|7432331|FG001|COMPLETED|Overall Study||18
6512612|NCT01496274|7432330|FG000|NOT COMPLETED|Overall Study||3
6512613|NCT01496274|7432331|FG001|NOT COMPLETED|Overall Study||5
6512614|NCT01496287|7432352|FG000|STARTED|Overall Study||70
6512615|NCT01496287|7432352|FG000|COMPLETED|Overall Study||64
6512616|NCT01496287|7432352|FG000|NOT COMPLETED|Overall Study||6
6512617|NCT01496313|7432359|FG000|STARTED|Overall Study||40
6512618|NCT01496313|7432360|FG001|STARTED|Overall Study||41
6512619|NCT01496313|7432359|FG000|COMPLETED|Overall Study||35
6512620|NCT01496313|7432360|FG001|COMPLETED|Overall Study||26
6512621|NCT01496313|7432359|FG000|NOT COMPLETED|Overall Study||5
6512622|NCT01496313|7432360|FG001|NOT COMPLETED|Overall Study||15
6512623|NCT01496352|7432368|FG000|STARTED|Overall Study||24
6512624|NCT01496352|7432369|FG001|STARTED|Overall Study||6
6512625|NCT01496352|7432368|FG000|COMPLETED|Overall Study||24
6512626|NCT01496352|7432369|FG001|COMPLETED|Overall Study||6
6512627|NCT01496352|7432368|FG000|NOT COMPLETED|Overall Study||0
6512628|NCT01496352|7432369|FG001|NOT COMPLETED|Overall Study||0
6512629|NCT01496365|7432391|FG000|STARTED|Overall Study||112
6512630|NCT01496365|7432392|FG001|STARTED|Overall Study||56
6512631|NCT01496365|7432393|FG002|STARTED|Overall Study||57
6512632|NCT01496365|7432394|FG003|STARTED|Overall Study||57
6512633|NCT01496365|7432395|FG004|STARTED|Overall Study||57
6512634|NCT01496365|7432396|FG005|STARTED|Overall Study||56
6512635|NCT01496365|7432397|FG006|STARTED|Overall Study||57
6512636|NCT01496365|7432391|FG000|COMPLETED|Overall Study||97
6512637|NCT01496365|7432392|FG001|COMPLETED|Overall Study||41
6512638|NCT01496365|7432393|FG002|COMPLETED|Overall Study||51
6512639|NCT01496365|7432394|FG003|COMPLETED|Overall Study||53
6512640|NCT01496365|7432395|FG004|COMPLETED|Overall Study||44
6512641|NCT01496365|7432396|FG005|COMPLETED|Overall Study||46
6512642|NCT01496365|7432397|FG006|COMPLETED|Overall Study||51
6512643|NCT01496365|7432391|FG000|NOT COMPLETED|Overall Study||15
6512644|NCT01496365|7432392|FG001|NOT COMPLETED|Overall Study||15
6512645|NCT01496365|7432393|FG002|NOT COMPLETED|Overall Study||6
6512646|NCT01496365|7432394|FG003|NOT COMPLETED|Overall Study||4
6512647|NCT01496365|7432395|FG004|NOT COMPLETED|Overall Study||13
6512648|NCT01496365|7432396|FG005|NOT COMPLETED|Overall Study||10
6512649|NCT01496365|7432397|FG006|NOT COMPLETED|Overall Study||6
6512650|NCT01496430|7432416|FG000|STARTED|Overall Study||35
6512651|NCT01496430|7432417|FG001|STARTED|Overall Study||35
6512652|NCT01496430|7432418|FG002|STARTED|Overall Study||35
6512653|NCT01496430|7432416|FG000|COMPLETED|Overall Study||29
6512654|NCT01496430|7432417|FG001|COMPLETED|Overall Study||30
6512655|NCT01496430|7432418|FG002|COMPLETED|Overall Study||25
6512656|NCT01496430|7432416|FG000|NOT COMPLETED|Overall Study||6
6512657|NCT01496430|7432417|FG001|NOT COMPLETED|Overall Study||5
6512658|NCT01496430|7432418|FG002|NOT COMPLETED|Overall Study||10
6512659|NCT01496456|7432426|FG000|STARTED|Overall Study||17
6512660|NCT01496456|7432426|FG000|Baseline|Overall Study|Baseline group started with 16 patients.|16
6512661|NCT01496456|7432426|FG000|1-yr Recall|Overall Study||12
6512662|NCT01496456|7432426|FG000|2-yr Recall|Overall Study||10
6512663|NCT01496456|7432426|FG000|3-yr Final Recall|Overall Study||9
6512664|NCT01496456|7432426|FG000|COMPLETED|Overall Study||9
6512665|NCT01496456|7432426|FG000|NOT COMPLETED|Overall Study||8
6512666|NCT01496469|7432435|FG000|STARTED|Overall Study||60
6512667|NCT01496469|7432436|FG001|STARTED|Overall Study||61
6512668|NCT01496469|7432435|FG000|COMPLETED|Overall Study||50
6512669|NCT01496469|7432436|FG001|COMPLETED|Overall Study||53
6512670|NCT01496469|7432435|FG000|NOT COMPLETED|Overall Study||10
6512671|NCT01496469|7432436|FG001|NOT COMPLETED|Overall Study||8
6512672|NCT01496612|7432442|FG000|STARTED|1st Intervention||3
6512673|NCT01496612|7432443|FG001|STARTED|1st Intervention||4
6512674|NCT01496612|7432442|FG000|COMPLETED|1st Intervention||1
6512675|NCT01496612|7432443|FG001|COMPLETED|1st Intervention||4
6512676|NCT01496612|7432442|FG000|NOT COMPLETED|1st Intervention||2
6512677|NCT01496612|7432443|FG001|NOT COMPLETED|1st Intervention||0
6512678|NCT01496612|7432442|FG000|STARTED|2nd Intervention||1
6512679|NCT01496612|7432443|FG001|STARTED|2nd Intervention||4
6512680|NCT01496612|7432442|FG000|COMPLETED|2nd Intervention||1
6512681|NCT01496612|7432443|FG001|COMPLETED|2nd Intervention||4
6512682|NCT01496612|7432442|FG000|NOT COMPLETED|2nd Intervention||0
6512683|NCT01496612|7432443|FG001|NOT COMPLETED|2nd Intervention||0
6512684|NCT01496807|7432451|FG000|STARTED|Overall Study||31
6512685|NCT01496807|7432451|FG000|COMPLETED|Overall Study||1
6512686|NCT01496807|7432451|FG000|NOT COMPLETED|Overall Study||30
6512687|NCT01496846|7432461|FG000|STARTED|IANB Articaine (All Participants)||28
6512688|NCT01496846|7432462|FG001|STARTED|IANB Articaine (All Participants)||24
6512689|NCT01496846|7432463|FG002|STARTED|IANB Articaine (All Participants)||36
6512690|NCT01496846|7432464|FG003|STARTED|IANB Articaine (All Participants)||40
6512691|NCT01496846|7432465|FG004|STARTED|IANB Articaine (All Participants)||35
6512692|NCT01496846|7432466|FG005|STARTED|IANB Articaine (All Participants)||38
6561335|NCT01792284|7484134|FG000|NOT COMPLETED|Randomization Period 2||0
6512693|NCT01496846|7432461|FG000|COMPLETED|IANB Articaine (All Participants)||27
6512694|NCT01496846|7432462|FG001|COMPLETED|IANB Articaine (All Participants)||23
6512695|NCT01496846|7432463|FG002|COMPLETED|IANB Articaine (All Participants)||36
6512696|NCT01496846|7432464|FG003|COMPLETED|IANB Articaine (All Participants)||40
6512697|NCT01496846|7432465|FG004|COMPLETED|IANB Articaine (All Participants)||35
6512698|NCT01496846|7432466|FG005|COMPLETED|IANB Articaine (All Participants)||38
6512699|NCT01496846|7432461|FG000|NOT COMPLETED|IANB Articaine (All Participants)||1
6512700|NCT01496846|7432462|FG001|NOT COMPLETED|IANB Articaine (All Participants)||1
6512701|NCT01496846|7432463|FG002|NOT COMPLETED|IANB Articaine (All Participants)||0
6512702|NCT01496846|7432464|FG003|NOT COMPLETED|IANB Articaine (All Participants)||0
6512703|NCT01496846|7432465|FG004|NOT COMPLETED|IANB Articaine (All Participants)||0
6512704|NCT01496846|7432466|FG005|NOT COMPLETED|IANB Articaine (All Participants)||0
6512705|NCT01496846|7432461|FG000|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
6512706|NCT01496846|7432462|FG001|STARTED|Supplemental Buccal Infiltration|No participants with successful IANB initially were brought forward to supplemental anesthetic|0
6512707|NCT01496846|7432463|FG002|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|36
6512708|NCT01496846|7432464|FG003|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|40
6512709|NCT01496846|7432465|FG004|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|35
6512710|NCT01496846|7432466|FG005|STARTED|Supplemental Buccal Infiltration|Only after unsuccessful IANB.|38
6512711|NCT01496846|7432461|FG000|COMPLETED|Supplemental Buccal Infiltration||0
6512712|NCT01496846|7432462|FG001|COMPLETED|Supplemental Buccal Infiltration||0
6512713|NCT01496846|7432463|FG002|COMPLETED|Supplemental Buccal Infiltration||36
6512714|NCT01496846|7432464|FG003|COMPLETED|Supplemental Buccal Infiltration||40
6512715|NCT01496846|7432465|FG004|COMPLETED|Supplemental Buccal Infiltration||35
6512716|NCT01496846|7432466|FG005|COMPLETED|Supplemental Buccal Infiltration||38
6512717|NCT01496846|7432461|FG000|NOT COMPLETED|Supplemental Buccal Infiltration||0
6512718|NCT01496846|7432462|FG001|NOT COMPLETED|Supplemental Buccal Infiltration||0
6512719|NCT01496846|7432463|FG002|NOT COMPLETED|Supplemental Buccal Infiltration||0
6512720|NCT01496846|7432464|FG003|NOT COMPLETED|Supplemental Buccal Infiltration||0
6512721|NCT01496846|7432465|FG004|NOT COMPLETED|Supplemental Buccal Infiltration||0
6512722|NCT01496846|7432466|FG005|NOT COMPLETED|Supplemental Buccal Infiltration||0
6512723|NCT01496885|7432477|FG000|STARTED|Overall Study||120
6512724|NCT01496885|7432477|FG000|COMPLETED|Overall Study||97
6512725|NCT01496885|7432477|FG000|NOT COMPLETED|Overall Study||23
6512726|NCT01497067|7432481|FG000|STARTED|Overall Study||657
6512727|NCT01497067|7432481|FG000|COMPLETED|Overall Study||575
6512728|NCT01497067|7432481|FG000|NOT COMPLETED|Overall Study||82
6512729|NCT01497197|7432488|FG000|STARTED|Overall Study||89
6512730|NCT01497197|7432489|FG001|STARTED|Overall Study||85
6512731|NCT01497197|7432488|FG000|COMPLETED|Overall Study||72
6512732|NCT01497197|7432489|FG001|COMPLETED|Overall Study||70
6512733|NCT01497197|7432488|FG000|NOT COMPLETED|Overall Study||17
6512734|NCT01497197|7432489|FG001|NOT COMPLETED|Overall Study||15
6512735|NCT01497262|7432495|FG000|STARTED|Overall Study||162
6512736|NCT01497262|7432495|FG000|COMPLETED|Overall Study||151
6512737|NCT01497262|7432495|FG000|NOT COMPLETED|Overall Study||11
6512738|NCT01497275|7432499|FG000|STARTED|Overall Study||5
6512739|NCT01497275|7432499|FG000|COMPLETED|Overall Study||3
6512740|NCT01497275|7432499|FG000|NOT COMPLETED|Overall Study||2
6512741|NCT01497366|7432505|FG000|STARTED|Overall Study||263
6512742|NCT01497366|7432506|FG001|STARTED|Overall Study||264
6512743|NCT01497366|7432505|FG000|Randomized But Not Treated|Overall Study||7
6512744|NCT01497366|7432506|FG001|Randomized But Not Treated|Overall Study||21
6512745|NCT01497366|7432505|FG000|COMPLETED|Overall Study||224
6512746|NCT01497366|7432506|FG001|COMPLETED|Overall Study||176
6512747|NCT01497366|7432505|FG000|NOT COMPLETED|Overall Study||39
6512748|NCT01497366|7432506|FG001|NOT COMPLETED|Overall Study||88
6512749|NCT01497496|7432513|FG000|STARTED|Overall Study||29
6512750|NCT01497496|7432513|FG000|COMPLETED|Overall Study||29
6512751|NCT01497496|7432513|FG000|NOT COMPLETED|Overall Study||0
6512752|NCT01497613|7432519|FG000|STARTED|Overall Study||150
6512753|NCT01497613|7432520|FG001|STARTED|Overall Study||150
6512754|NCT01497613|7432519|FG000|COMPLETED|Overall Study||113
6512755|NCT01497613|7432520|FG001|COMPLETED|Overall Study||131
6512756|NCT01497613|7432519|FG000|NOT COMPLETED|Overall Study||37
6512757|NCT01497613|7432520|FG001|NOT COMPLETED|Overall Study||19
6512758|NCT01497665|7432526|FG000|STARTED|Overall Study||16
6512759|NCT01497665|7432526|FG000|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
6512760|NCT01497665|7432526|FG000|COMPLETED|Overall Study||16
6512761|NCT01497665|7432526|FG000|NOT COMPLETED|Overall Study||0
6512762|NCT01497756|7432530|FG000|STARTED|Overall Study||10
6512763|NCT01497756|7432530|FG000|COMPLETED|Overall Study||10
6512764|NCT01497756|7432530|FG000|NOT COMPLETED|Overall Study||0
6512765|NCT01497808|7432538|FG000|STARTED|Overall Study||6
6512766|NCT01497808|7432539|FG001|STARTED|Overall Study||4
6512767|NCT01497808|7432540|FG002|STARTED|Overall Study||6
6512768|NCT01497808|7432541|FG003|STARTED|Overall Study||6
6512769|NCT01497808|7432538|FG000|COMPLETED|Overall Study||6
6512770|NCT01497808|7432539|FG001|COMPLETED|Overall Study||4
6512771|NCT01497808|7432540|FG002|COMPLETED|Overall Study||6
6512772|NCT01497808|7432541|FG003|COMPLETED|Overall Study||6
6512773|NCT01497808|7432538|FG000|NOT COMPLETED|Overall Study||0
6512774|NCT01497808|7432539|FG001|NOT COMPLETED|Overall Study||0
6512775|NCT01497808|7432540|FG002|NOT COMPLETED|Overall Study||0
6512776|NCT01497808|7432541|FG003|NOT COMPLETED|Overall Study||0
6512777|NCT01497860|7432551|FG000|STARTED|Overall Study||12
6512778|NCT01497860|7432551|FG000|COMPLETED|Overall Study||12
6512779|NCT01497860|7432551|FG000|NOT COMPLETED|Overall Study||0
6512780|NCT01497899|7432559|FG000|STARTED|Double-Blind Phase||113
6512781|NCT01497899|7432560|FG001|STARTED|Double-Blind Phase||58
6512782|NCT01497899|7432561|FG002|STARTED|Double-Blind Phase||0
6512783|NCT01497899|7432562|FG003|STARTED|Double-Blind Phase||0
6512784|NCT01497899|7432559|FG000|COMPLETED|Double-Blind Phase||107
6512785|NCT01497899|7432560|FG001|COMPLETED|Double-Blind Phase||53
6512786|NCT01497899|7432561|FG002|COMPLETED|Double-Blind Phase||0
6512787|NCT01497899|7432562|FG003|COMPLETED|Double-Blind Phase||0
6512788|NCT01497899|7432559|FG000|NOT COMPLETED|Double-Blind Phase||6
6512789|NCT01497899|7432560|FG001|NOT COMPLETED|Double-Blind Phase||5
6512790|NCT01497899|7432561|FG002|NOT COMPLETED|Double-Blind Phase||0
6512791|NCT01497899|7432562|FG003|NOT COMPLETED|Double-Blind Phase||0
6512792|NCT01497899|7432559|FG000|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
6512793|NCT01497899|7432560|FG001|STARTED|Open-Label Extension Phase||53
6512794|NCT01497899|7432561|FG002|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|70
6512795|NCT01497899|7432562|FG003|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored Study GS-US-299-0102.|38
6512796|NCT01497899|7432559|FG000|COMPLETED|Open-Label Extension Phase||86
6512797|NCT01497899|7432560|FG001|COMPLETED|Open-Label Extension Phase||46
6512798|NCT01497899|7432561|FG002|COMPLETED|Open-Label Extension Phase||61
6512799|NCT01497899|7432562|FG003|COMPLETED|Open-Label Extension Phase||33
6512800|NCT01497899|7432559|FG000|NOT COMPLETED|Open-Label Extension Phase||19
6512801|NCT01497899|7432560|FG001|NOT COMPLETED|Open-Label Extension Phase||7
6512802|NCT01497899|7432561|FG002|NOT COMPLETED|Open-Label Extension Phase||9
6512803|NCT01497899|7432562|FG003|NOT COMPLETED|Open-Label Extension Phase||5
6640373|NCT02334306|7568613|FG000|NOT COMPLETED|Double-blind Period||1
6640374|NCT02334306|7568614|FG001|NOT COMPLETED|Double-blind Period||2
6640375|NCT02334306|7568613|FG000|STARTED|Open-label Period||15
6640376|NCT02334306|7568614|FG001|STARTED|Open-label Period||14
6640377|NCT02334306|7568613|FG000|COMPLETED|Open-label Period||15
6640378|NCT02334306|7568614|FG001|COMPLETED|Open-label Period||14
6640379|NCT02334306|7568613|FG000|NOT COMPLETED|Open-label Period||0
6640380|NCT02334306|7568614|FG001|NOT COMPLETED|Open-label Period||0
6640381|NCT02334358|7568621|FG000|STARTED|Overall Study||503
6640382|NCT02334358|7568621|FG000|COMPLETED|Overall Study||494
6640383|NCT02334358|7568621|FG000|NOT COMPLETED|Overall Study||9
6640384|NCT02334384|7568627|FG000|STARTED|Overall Study||4
6640385|NCT02334384|7568628|FG001|STARTED|Overall Study||2
6640386|NCT02334384|7568627|FG000|COMPLETED|Overall Study||3
6640387|NCT02334384|7568628|FG001|COMPLETED|Overall Study||1
6640388|NCT02334384|7568627|FG000|NOT COMPLETED|Overall Study||1
6640389|NCT02334384|7568628|FG001|NOT COMPLETED|Overall Study||1
6640390|NCT02334423|7568636|FG000|STARTED|Overall Study||246
6640391|NCT02334423|7568637|FG001|STARTED|Overall Study||84
6640392|NCT02334423|7568636|FG000|COMPLETED|Overall Study||236
6640393|NCT02334423|7568637|FG001|COMPLETED|Overall Study||81
6640394|NCT02334423|7568636|FG000|NOT COMPLETED|Overall Study||10
6640395|NCT02334423|7568637|FG001|NOT COMPLETED|Overall Study||3
6640396|NCT02334436|7568645|FG000|STARTED|Overall Study||246
6640397|NCT02334436|7568646|FG001|STARTED|Overall Study||78
6640398|NCT02334436|7568645|FG000|COMPLETED|Overall Study||237
6640399|NCT02334436|7568646|FG001|COMPLETED|Overall Study||77
6640400|NCT02334436|7568645|FG000|NOT COMPLETED|Overall Study||9
6640401|NCT02334436|7568646|FG001|NOT COMPLETED|Overall Study||1
6640402|NCT02334527|7568652|FG000|STARTED|Overall Study||12
6640403|NCT02334527|7568652|FG000|COMPLETED|Overall Study||12
6640404|NCT02334527|7568652|FG000|NOT COMPLETED|Overall Study||0
6640405|NCT02334683|7568662|FG000|STARTED|First 12 Week Period||10
6640406|NCT02334683|7568663|FG001|STARTED|First 12 Week Period||10
6640407|NCT02334683|7568662|FG000|COMPLETED|First 12 Week Period||9
6640408|NCT02334683|7568663|FG001|COMPLETED|First 12 Week Period||10
6640409|NCT02334683|7568662|FG000|NOT COMPLETED|First 12 Week Period||1
6640410|NCT02334683|7568663|FG001|NOT COMPLETED|First 12 Week Period||0
6640411|NCT02334683|7568662|FG000|STARTED|Second 12 Week Period||9
6640412|NCT02334683|7568663|FG001|STARTED|Second 12 Week Period||10
6640413|NCT02334683|7568662|FG000|COMPLETED|Second 12 Week Period||9
6640414|NCT02334683|7568663|FG001|COMPLETED|Second 12 Week Period||9
6640415|NCT02334683|7568662|FG000|NOT COMPLETED|Second 12 Week Period||0
6640416|NCT02334683|7568663|FG001|NOT COMPLETED|Second 12 Week Period||1
6640417|NCT02334748|7568669|FG000|STARTED|Overall Study||31
6640418|NCT02334748|7568669|FG000|COMPLETED|Overall Study||23
6640419|NCT02334748|7568669|FG000|NOT COMPLETED|Overall Study||8
6640420|NCT02334787|7568677|FG000|STARTED|Overall Study||8
6640421|NCT02334787|7568678|FG001|STARTED|Overall Study||8
6640422|NCT02334787|7568679|FG002|STARTED|Overall Study||8
6640423|NCT02334787|7568680|FG003|STARTED|Overall Study||8
6640424|NCT02334787|7568677|FG000|COMPLETED|Overall Study||8
6512804|NCT01497938|7432571|FG000|STARTED|Overall Study||121
6512805|NCT01497938|7432572|FG001|STARTED|Overall Study||126
6512806|NCT01497938|7432571|FG000|COMPLETED|Overall Study||116
6640425|NCT02334787|7568678|FG001|COMPLETED|Overall Study||8
6640426|NCT02334787|7568679|FG002|COMPLETED|Overall Study||8
6512807|NCT01497938|7432572|FG001|COMPLETED|Overall Study||124
6512808|NCT01497938|7432571|FG000|NOT COMPLETED|Overall Study||5
6512809|NCT01497938|7432572|FG001|NOT COMPLETED|Overall Study||2
6512810|NCT01498068|7432580|FG000|STARTED|Overall Study||16
6512811|NCT01498068|7432581|FG001|STARTED|Overall Study||20
6512812|NCT01498068|7432580|FG000|COMPLETED|Overall Study||15
6512813|NCT01498068|7432581|FG001|COMPLETED|Overall Study||19
6512814|NCT01498068|7432580|FG000|NOT COMPLETED|Overall Study||1
6512815|NCT01498068|7432581|FG001|NOT COMPLETED|Overall Study||1
6512816|NCT01498120|7432587|FG000|STARTED|Overall Study||14
6512817|NCT01498120|7432587|FG000|COMPLETED|Overall Study||1
6512818|NCT01498120|7432587|FG000|NOT COMPLETED|Overall Study||13
6512819|NCT01498185|7432596|FG000|STARTED|Overall Study||13
6512820|NCT01498185|7432597|FG001|STARTED|Overall Study||13
6512821|NCT01498185|7432598|FG002|STARTED|Overall Study||15
6512822|NCT01498185|7432599|FG003|STARTED|Overall Study||14
6512823|NCT01498185|7432600|FG004|STARTED|Overall Study||15
6512824|NCT01498185|7432596|FG000|COMPLETED|Overall Study||12
6512825|NCT01498185|7432597|FG001|COMPLETED|Overall Study||12
6512826|NCT01498185|7432598|FG002|COMPLETED|Overall Study||15
6512827|NCT01498185|7432599|FG003|COMPLETED|Overall Study||11
6512828|NCT01498185|7432600|FG004|COMPLETED|Overall Study||12
6512829|NCT01498185|7432596|FG000|NOT COMPLETED|Overall Study||1
6512830|NCT01498185|7432597|FG001|NOT COMPLETED|Overall Study||1
6512831|NCT01498185|7432598|FG002|NOT COMPLETED|Overall Study||0
6512832|NCT01498185|7432599|FG003|NOT COMPLETED|Overall Study||3
6512833|NCT01498185|7432600|FG004|NOT COMPLETED|Overall Study||3
6512834|NCT01498289|7432618|FG000|STARTED|Overall Study||98
6512835|NCT01498289|7432619|FG001|STARTED|Overall Study||104
6512836|NCT01498289|7432618|FG000|Participants Assessed for AEs|Overall Study||91
6512837|NCT01498289|7432619|FG001|Participants Assessed for AEs|Overall Study||98
6512838|NCT01498289|7432618|FG000|COMPLETED|Overall Study||0
6512839|NCT01498289|7432619|FG001|COMPLETED|Overall Study||0
6512840|NCT01498289|7432618|FG000|NOT COMPLETED|Overall Study||98
6512841|NCT01498289|7432619|FG001|NOT COMPLETED|Overall Study||104
6512842|NCT01498419|7432633|FG000|STARTED|Overall Study||60
6512843|NCT01498419|7432634|FG001|STARTED|Overall Study||62
6640427|NCT02334787|7568680|FG003|COMPLETED|Overall Study||8
6640428|NCT02334787|7568677|FG000|NOT COMPLETED|Overall Study||0
6640429|NCT02334787|7568678|FG001|NOT COMPLETED|Overall Study||0
6640430|NCT02334787|7568679|FG002|NOT COMPLETED|Overall Study||0
6640431|NCT02334787|7568680|FG003|NOT COMPLETED|Overall Study||0
6640432|NCT02334800|7568700|FG000|STARTED|Overall Study||7
6640433|NCT02334800|7568701|FG001|STARTED|Overall Study||7
6512844|NCT01498419|7432635|FG002|STARTED|Overall Study||59
6512845|NCT01498419|7432636|FG003|STARTED|Overall Study||26
6512846|NCT01498419|7432633|FG000|COMPLETED|Overall Study||42
6512847|NCT01498419|7432634|FG001|COMPLETED|Overall Study||39
6512848|NCT01498419|7432635|FG002|COMPLETED|Overall Study||41
6512849|NCT01498419|7432636|FG003|COMPLETED|Overall Study||7
6512850|NCT01498419|7432633|FG000|NOT COMPLETED|Overall Study||18
6512851|NCT01498419|7432634|FG001|NOT COMPLETED|Overall Study||23
6512852|NCT01498419|7432635|FG002|NOT COMPLETED|Overall Study||18
6512853|NCT01498419|7432636|FG003|NOT COMPLETED|Overall Study||19
6512854|NCT01498445|7432652|FG000|STARTED|Overall Study||4
6512855|NCT01498445|7432653|FG001|STARTED|Overall Study||3
6512856|NCT01498445|7432654|FG002|STARTED|Overall Study||8
6512857|NCT01498445|7432655|FG003|STARTED|Overall Study||8
6512858|NCT01498445|7432656|FG004|STARTED|Overall Study||4
6512859|NCT01498445|7432657|FG005|STARTED|Overall Study||5
6512860|NCT01498445|7432652|FG000|COMPLETED|Overall Study||4
6512861|NCT01498445|7432653|FG001|COMPLETED|Overall Study||3
6512862|NCT01498445|7432654|FG002|COMPLETED|Overall Study||7
6512863|NCT01498445|7432655|FG003|COMPLETED|Overall Study||6
6512864|NCT01498445|7432656|FG004|COMPLETED|Overall Study||3
6512865|NCT01498445|7432657|FG005|COMPLETED|Overall Study||4
6512866|NCT01498445|7432652|FG000|NOT COMPLETED|Overall Study||0
6512867|NCT01498445|7432653|FG001|NOT COMPLETED|Overall Study||0
6512868|NCT01498445|7432654|FG002|NOT COMPLETED|Overall Study||1
6512869|NCT01498445|7432655|FG003|NOT COMPLETED|Overall Study||2
6512870|NCT01498445|7432656|FG004|NOT COMPLETED|Overall Study||1
6512871|NCT01498445|7432657|FG005|NOT COMPLETED|Overall Study||1
6512872|NCT01498458|7432671|FG000|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
6512873|NCT01498458|7432671|FG000|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
6512874|NCT01498458|7432671|FG000|NOT COMPLETED|Overall Study||7
6512875|NCT01498549|7432680|FG000|STARTED|Overall Study||39
6512876|NCT01498549|7432680|FG000|Atomoxetine 40 mg|Overall Study||39
6640434|NCT02334800|7568702|FG002|STARTED|Overall Study||7
6640435|NCT02334800|7568703|FG003|STARTED|Overall Study||7
6512877|NCT01498549|7432680|FG000|Atomoxetine 80 mg|Overall Study||37
6512878|NCT01498549|7432680|FG000|Sugar Pill 0 mg|Overall Study||36
6512879|NCT01498549|7432680|FG000|COMPLETED|Overall Study||35
6512880|NCT01498549|7432680|FG000|NOT COMPLETED|Overall Study||4
6512881|NCT01498575|7432691|FG000|STARTED|Overall Sample||610
6512882|NCT01498575|7432692|FG001|STARTED|Overall Sample||414
6512883|NCT01498575|7432691|FG000|COMPLETED|Overall Sample||550
6512884|NCT01498575|7432692|FG001|COMPLETED|Overall Sample||400
6512885|NCT01498575|7432691|FG000|NOT COMPLETED|Overall Sample||60
6512886|NCT01498575|7432692|FG001|NOT COMPLETED|Overall Sample||14
6512887|NCT01498575|7432691|FG000|STARTED|On the Road Driving Assessment (ODA)||128
6512888|NCT01498575|7432692|FG001|STARTED|On the Road Driving Assessment (ODA)||89
6512889|NCT01498575|7432691|FG000|COMPLETED|On the Road Driving Assessment (ODA)||86
6512890|NCT01498575|7432692|FG001|COMPLETED|On the Road Driving Assessment (ODA)||65
6512891|NCT01498575|7432691|FG000|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
6512892|NCT01498575|7432692|FG001|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
6512893|NCT01498588|7432698|FG000|STARTED|Overall Study||7
6512894|NCT01498588|7432698|FG000|COMPLETED|Overall Study||7
6512895|NCT01498588|7432698|FG000|NOT COMPLETED|Overall Study||0
6512896|NCT01498601|7432704|FG000|STARTED|Overall Study||51
6512897|NCT01498601|7432705|FG001|STARTED|Overall Study||32
6512898|NCT01498601|7432704|FG000|COMPLETED|Overall Study||51
6512899|NCT01498601|7432705|FG001|COMPLETED|Overall Study||32
6512900|NCT01498601|7432704|FG000|NOT COMPLETED|Overall Study||0
6512901|NCT01498601|7432705|FG001|NOT COMPLETED|Overall Study||0
6512902|NCT01498640|7432711|FG000|STARTED|Overall Study||52
6512903|NCT01498640|7432711|FG000|COMPLETED|Overall Study||47
6512904|NCT01498640|7432711|FG000|NOT COMPLETED|Overall Study||5
6512905|NCT01498653|7432721|FG000|STARTED|Overall Study||155
6512906|NCT01498653|7432722|FG001|STARTED|Overall Study||154
6512907|NCT01498653|7432721|FG000|COMPLETED|Overall Study||136
6512908|NCT01498653|7432722|FG001|COMPLETED|Overall Study||119
6512909|NCT01498653|7432721|FG000|NOT COMPLETED|Overall Study||19
6512910|NCT01498653|7432722|FG001|NOT COMPLETED|Overall Study||35
6512911|NCT01498679|7432730|FG000|STARTED|Overall Study||154
6512912|NCT01498679|7432731|FG001|STARTED|Overall Study||153
6512913|NCT01498679|7432730|FG000|COMPLETED|Overall Study||65
6512914|NCT01498679|7432731|FG001|COMPLETED|Overall Study||131
6512915|NCT01498679|7432730|FG000|NOT COMPLETED|Overall Study||89
6512916|NCT01498679|7432731|FG001|NOT COMPLETED|Overall Study||22
6512917|NCT01498692|7432737|FG000|STARTED|Overall Study||94
6512918|NCT01498692|7432737|FG000|COMPLETED|Overall Study||86
6512919|NCT01498692|7432737|FG000|NOT COMPLETED|Overall Study||8
6512920|NCT01498744|7432743|FG000|STARTED|Overall Study||22
6512921|NCT01498744|7432744|FG001|STARTED|Overall Study||31
6512922|NCT01498744|7432743|FG000|COMPLETED|Overall Study||22
6512923|NCT01498744|7432744|FG001|COMPLETED|Overall Study||31
6512924|NCT01498744|7432743|FG000|NOT COMPLETED|Overall Study||0
6512925|NCT01498744|7432744|FG001|NOT COMPLETED|Overall Study||0
6512926|NCT01498822|7432752|FG000|STARTED|Overall Study||175
6512927|NCT01498822|7432753|FG001|STARTED|Overall Study||178
6512928|NCT01498822|7432752|FG000|COMPLETED|Overall Study||121
6512929|NCT01498822|7432753|FG001|COMPLETED|Overall Study||122
6512930|NCT01498822|7432752|FG000|NOT COMPLETED|Overall Study||54
6512931|NCT01498822|7432753|FG001|NOT COMPLETED|Overall Study||56
6512932|NCT01498887|7432763|FG000|STARTED|Overall Study||200
6512933|NCT01498887|7432764|FG001|STARTED|Overall Study||147
6512934|NCT01498887|7432763|FG000|Safety Set|Overall Study||200
6512935|NCT01498887|7432764|FG001|Safety Set|Overall Study||147
6512936|NCT01498887|7432763|FG000|Intent-to-treat|Overall Study||185
6512937|NCT01498887|7432764|FG001|Intent-to-treat|Overall Study||135
6512938|NCT01498887|7432763|FG000|COMPLETED|Overall Study||184
6512939|NCT01498887|7432764|FG001|COMPLETED|Overall Study||136
6640436|NCT02334800|7568700|FG000|Received Treatment|Overall Study||7
6640437|NCT02334800|7568701|FG001|Received Treatment|Overall Study||7
6640438|NCT02334800|7568702|FG002|Received Treatment|Overall Study||7
6640439|NCT02334800|7568703|FG003|Received Treatment|Overall Study||7
6640440|NCT02334800|7568700|FG000|COMPLETED|Overall Study||7
6640441|NCT02334800|7568701|FG001|COMPLETED|Overall Study||7
6640442|NCT02334800|7568702|FG002|COMPLETED|Overall Study||7
6640443|NCT02334800|7568703|FG003|COMPLETED|Overall Study||7
6640444|NCT02334800|7568700|FG000|NOT COMPLETED|Overall Study||0
6640445|NCT02334800|7568701|FG001|NOT COMPLETED|Overall Study||0
6640446|NCT02334800|7568702|FG002|NOT COMPLETED|Overall Study||0
6640447|NCT02334800|7568703|FG003|NOT COMPLETED|Overall Study||0
6640448|NCT02334813|7568715|FG000|STARTED|Overall Study||12
6640449|NCT02334813|7568716|FG001|STARTED|Overall Study||14
6640450|NCT02334813|7568715|FG000|COMPLETED|Overall Study||9
6640451|NCT02334813|7568716|FG001|COMPLETED|Overall Study||13
6640452|NCT02334813|7568715|FG000|NOT COMPLETED|Overall Study||3
6640453|NCT02334813|7568716|FG001|NOT COMPLETED|Overall Study||1
6640454|NCT02334982|7568729|FG000|STARTED|Overall Study||6
6640455|NCT02334982|7568730|FG001|STARTED|Overall Study||5
6640456|NCT02334982|7568731|FG002|STARTED|Overall Study||6
6640457|NCT02334982|7568732|FG003|STARTED|Overall Study||6
6640458|NCT02334982|7568733|FG004|STARTED|Overall Study||6
6640459|NCT02334982|7568734|FG005|STARTED|Overall Study||6
6512940|NCT01498887|7432763|FG000|NOT COMPLETED|Overall Study||16
6512941|NCT01498887|7432764|FG001|NOT COMPLETED|Overall Study||11
6512942|NCT01498952|7432773|FG000|STARTED|Overall Study||3
6512943|NCT01498952|7432774|FG001|STARTED|Overall Study||3
6512944|NCT01498952|7432775|FG002|STARTED|Overall Study||0
6512945|NCT01498952|7432776|FG003|STARTED|Overall Study||0
6512946|NCT01498952|7432777|FG004|STARTED|Overall Study||0
6512947|NCT01498952|7432773|FG000|COMPLETED|Overall Study||1
6512948|NCT01498952|7432774|FG001|COMPLETED|Overall Study||1
6512949|NCT01498952|7432775|FG002|COMPLETED|Overall Study||0
6512950|NCT01498952|7432776|FG003|COMPLETED|Overall Study||0
6512951|NCT01498952|7432777|FG004|COMPLETED|Overall Study||0
6512952|NCT01498952|7432773|FG000|NOT COMPLETED|Overall Study||2
6512953|NCT01498952|7432774|FG001|NOT COMPLETED|Overall Study||2
6512954|NCT01498952|7432775|FG002|NOT COMPLETED|Overall Study||0
6640460|NCT02334982|7568735|FG006|STARTED|Overall Study||12
6512955|NCT01498952|7432776|FG003|NOT COMPLETED|Overall Study||0
6512956|NCT01498952|7432777|FG004|NOT COMPLETED|Overall Study||0
6512957|NCT01498978|7432790|FG000|STARTED|Overall Study||10
6512958|NCT01498978|7432790|FG000|COMPLETED|Overall Study||8
6512959|NCT01498978|7432790|FG000|NOT COMPLETED|Overall Study||2
6512960|NCT01499043|7432796|FG000|STARTED|Overall Study||6
6512961|NCT01499043|7432796|FG000|COMPLETED|Overall Study||0
6512962|NCT01499043|7432796|FG000|NOT COMPLETED|Overall Study||6
6512963|NCT01499134|7432807|FG000|STARTED|Overall Study||9
6512964|NCT01499134|7432808|FG001|STARTED|Overall Study||8
6512965|NCT01499134|7432807|FG000|COMPLETED|Overall Study||9
6512966|NCT01499134|7432808|FG001|COMPLETED|Overall Study||7
6512967|NCT01499134|7432807|FG000|NOT COMPLETED|Overall Study||0
6512968|NCT01499134|7432808|FG001|NOT COMPLETED|Overall Study||1
6512969|NCT01499147|7432816|FG000|STARTED|Overall Study||33
6512970|NCT01499147|7432817|FG001|STARTED|Overall Study||17
6512971|NCT01499147|7432816|FG000|COMPLETED|Overall Study||18
6512972|NCT01499147|7432817|FG001|COMPLETED|Overall Study||12
6512973|NCT01499147|7432816|FG000|NOT COMPLETED|Overall Study||15
6512974|NCT01499147|7432817|FG001|NOT COMPLETED|Overall Study||5
6512975|NCT01499173|7432827|FG000|STARTED|Overall Study||101
6512976|NCT01499173|7432827|FG000|COMPLETED|Overall Study||64
6512977|NCT01499173|7432827|FG000|NOT COMPLETED|Overall Study||37
6512978|NCT01499199|7432832|FG000|STARTED|Overall Study||13
6512979|NCT01499199|7432832|FG000|COMPLETED|Overall Study||11
6512980|NCT01499199|7432832|FG000|NOT COMPLETED|Overall Study||2
6512981|NCT01499277|7432838|FG000|STARTED|Overall Study||506
6512982|NCT01499277|7432839|FG001|STARTED|Overall Study||255
6512983|NCT01499277|7432838|FG000|COMPLETED|Overall Study||459
6512984|NCT01499277|7432839|FG001|COMPLETED|Overall Study||223
6512985|NCT01499277|7432838|FG000|NOT COMPLETED|Overall Study||47
6512986|NCT01499277|7432839|FG001|NOT COMPLETED|Overall Study||32
6512987|NCT01499290|7432847|FG000|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
6512988|NCT01499290|7432848|FG001|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
6512989|NCT01499290|7432847|FG000|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
6512990|NCT01499290|7432848|FG001|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
6512991|NCT01499290|7432847|FG000|NOT COMPLETED|Overall Study||55
6512992|NCT01499290|7432848|FG001|NOT COMPLETED|Overall Study||35
6512993|NCT01499303|7432875|FG000|STARTED|Overall Study||21
6512994|NCT01499303|7432876|FG001|STARTED|Overall Study||47
6512995|NCT01499303|7432875|FG000|COMPLETED|Overall Study||18
6512996|NCT01499303|7432876|FG001|COMPLETED|Overall Study||40
6512997|NCT01499303|7432875|FG000|NOT COMPLETED|Overall Study||3
6512998|NCT01499303|7432876|FG001|NOT COMPLETED|Overall Study||7
6512999|NCT01499355|7432882|FG000|STARTED|Run-In Period||276
6513000|NCT01499355|7432883|FG001|STARTED|Run-In Period||0
6513001|NCT01499355|7432884|FG002|STARTED|Run-In Period||0
6513002|NCT01499355|7432885|FG003|STARTED|Run-In Period||0
6513003|NCT01499355|7432882|FG000|COMPLETED|Run-In Period||245
6513004|NCT01499355|7432883|FG001|COMPLETED|Run-In Period||0
6513005|NCT01499355|7432884|FG002|COMPLETED|Run-In Period||0
6513006|NCT01499355|7432885|FG003|COMPLETED|Run-In Period||0
6513007|NCT01499355|7432882|FG000|NOT COMPLETED|Run-In Period||31
6513008|NCT01499355|7432883|FG001|NOT COMPLETED|Run-In Period||0
6513009|NCT01499355|7432884|FG002|NOT COMPLETED|Run-In Period||0
6513010|NCT01499355|7432885|FG003|NOT COMPLETED|Run-In Period||0
6513011|NCT01499355|7432882|FG000|STARTED|Double-Blind Period||0
6513012|NCT01499355|7432883|FG001|STARTED|Double-Blind Period||63
6513013|NCT01499355|7432884|FG002|STARTED|Double-Blind Period||63
6513014|NCT01499355|7432885|FG003|STARTED|Double-Blind Period||62
6513015|NCT01499355|7432882|FG000|COMPLETED|Double-Blind Period||0
6513016|NCT01499355|7432883|FG001|COMPLETED|Double-Blind Period||40
6513017|NCT01499355|7432884|FG002|COMPLETED|Double-Blind Period||38
6513018|NCT01499355|7432885|FG003|COMPLETED|Double-Blind Period||39
6513019|NCT01499355|7432882|FG000|NOT COMPLETED|Double-Blind Period||0
6513020|NCT01499355|7432883|FG001|NOT COMPLETED|Double-Blind Period||23
6513021|NCT01499355|7432884|FG002|NOT COMPLETED|Double-Blind Period||25
6513022|NCT01499355|7432885|FG003|NOT COMPLETED|Double-Blind Period||23
6513023|NCT01499368|7432898|FG000|STARTED|Overall Study||165
6513024|NCT01499368|7432899|FG001|STARTED|Overall Study||163
6640461|NCT02334982|7568729|FG000|COMPLETED|Overall Study||6
6640462|NCT02334982|7568730|FG001|COMPLETED|Overall Study||5
6640463|NCT02334982|7568731|FG002|COMPLETED|Overall Study||6
6640464|NCT02334982|7568732|FG003|COMPLETED|Overall Study||6
6640465|NCT02334982|7568733|FG004|COMPLETED|Overall Study||6
6640466|NCT02334982|7568734|FG005|COMPLETED|Overall Study||6
6640467|NCT02334982|7568735|FG006|COMPLETED|Overall Study||12
6640468|NCT02334982|7568729|FG000|NOT COMPLETED|Overall Study||0
6640469|NCT02334982|7568730|FG001|NOT COMPLETED|Overall Study||0
6640470|NCT02334982|7568731|FG002|NOT COMPLETED|Overall Study||0
6640471|NCT02334982|7568732|FG003|NOT COMPLETED|Overall Study||0
6640472|NCT02334982|7568733|FG004|NOT COMPLETED|Overall Study||0
6513025|NCT01499368|7432900|FG002|STARTED|Overall Study||167
6513026|NCT01499368|7432898|FG000|COMPLETED|Overall Study||138
6513027|NCT01499368|7432899|FG001|COMPLETED|Overall Study||145
6513028|NCT01499368|7432900|FG002|COMPLETED|Overall Study||146
6640473|NCT02334982|7568734|FG005|NOT COMPLETED|Overall Study||0
6640474|NCT02334982|7568735|FG006|NOT COMPLETED|Overall Study||0
6640475|NCT02335125|7568764|FG000|STARTED|Overall Study||20
6513029|NCT01499368|7432898|FG000|NOT COMPLETED|Overall Study||27
6513030|NCT01499368|7432899|FG001|NOT COMPLETED|Overall Study||18
6513031|NCT01499368|7432900|FG002|NOT COMPLETED|Overall Study||21
6513032|NCT01499498|7432908|FG000|STARTED|Overall Study||13
6513033|NCT01499498|7432908|FG000|COMPLETED|Overall Study||13
6513034|NCT01499498|7432908|FG000|NOT COMPLETED|Overall Study||0
6513035|NCT01499511|7432917|FG000|STARTED|Overall Study||885
6513036|NCT01499511|7432918|FG001|STARTED|Overall Study||833
6513037|NCT01499511|7432917|FG000|COMPLETED|Overall Study||884
6513038|NCT01499511|7432918|FG001|COMPLETED|Overall Study||833
6513039|NCT01499511|7432917|FG000|NOT COMPLETED|Overall Study||1
6513040|NCT01499511|7432918|FG001|NOT COMPLETED|Overall Study||0
6513041|NCT01499576|7432925|FG000|STARTED|Overall Study||126
6513042|NCT01499576|7432925|FG000|COMPLETED|Overall Study||105
6513043|NCT01499576|7432925|FG000|NOT COMPLETED|Overall Study||21
6513044|NCT01499654|7432930|FG000|STARTED|Overall Study||64
6513045|NCT01499654|7432930|FG000|COMPLETED|Overall Study||64
6513046|NCT01499654|7432930|FG000|NOT COMPLETED|Overall Study||0
6513047|NCT01499667|7432943|FG000|STARTED|Overall Study|"Started indicates randomized as well as safety population."|50
6513048|NCT01499667|7432944|FG001|STARTED|Overall Study||42
6513049|NCT01499667|7432945|FG002|STARTED|Overall Study||50
6513050|NCT01499667|7432943|FG000|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
6513051|NCT01499667|7432944|FG001|Full Analysis Set (FAS)|Overall Study||42
6513052|NCT01499667|7432945|FG002|Full Analysis Set (FAS)|Overall Study||50
6513053|NCT01499667|7432943|FG000|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
6513054|NCT01499667|7432944|FG001|Modified Full Analysis Set|Overall Study||29
6513055|NCT01499667|7432945|FG002|Modified Full Analysis Set|Overall Study||39
6513056|NCT01499667|7432943|FG000|COMPLETED|Overall Study||41
6513057|NCT01499667|7432944|FG001|COMPLETED|Overall Study||31
6513058|NCT01499667|7432945|FG002|COMPLETED|Overall Study||40
6513059|NCT01499667|7432943|FG000|NOT COMPLETED|Overall Study||9
6513060|NCT01499667|7432944|FG001|NOT COMPLETED|Overall Study||11
6513061|NCT01499667|7432945|FG002|NOT COMPLETED|Overall Study||10
6513062|NCT01499810|7432953|FG000|STARTED|Overall Study||53
6513063|NCT01499810|7432953|FG000|COMPLETED|Overall Study||41
6513064|NCT01499810|7432953|FG000|NOT COMPLETED|Overall Study||12
6513065|NCT01499849|7432960|FG000|STARTED|Overall Study|Number of randomized patients|266
6513066|NCT01499849|7432961|FG001|STARTED|Overall Study||266
6513067|NCT01499849|7432960|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
6513068|NCT01499849|7432961|FG001|COMPLETED|Overall Study||40
6513069|NCT01499849|7432960|FG000|NOT COMPLETED|Overall Study||224
6513070|NCT01499849|7432961|FG001|NOT COMPLETED|Overall Study||226
6513071|NCT01499862|7432967|FG000|STARTED|Overall Study||3
6513072|NCT01499862|7432967|FG000|COMPLETED|Overall Study||3
6513073|NCT01499862|7432967|FG000|NOT COMPLETED|Overall Study||0
6513074|NCT01499940|7432985|FG000|STARTED|Overall Study||9
6513075|NCT01499940|7432985|FG000|COMPLETED|Overall Study||0
6513076|NCT01499940|7432985|FG000|NOT COMPLETED|Overall Study||9
6513077|NCT01500031|7432989|FG000|STARTED|Overall Study||92
6513078|NCT01500031|7432989|FG000|COMPLETED|Overall Study||87
6513079|NCT01500031|7432989|FG000|NOT COMPLETED|Overall Study||5
6513080|NCT01500057|7432995|FG000|STARTED|Overall Study||31
6513081|NCT01500057|7432996|FG001|STARTED|Overall Study||35
6513082|NCT01500057|7432995|FG000|COMPLETED|Overall Study||25
6640476|NCT02335125|7568765|FG001|STARTED|Overall Study||20
6640477|NCT02335125|7568764|FG000|COMPLETED|Overall Study||20
6640478|NCT02335125|7568765|FG001|COMPLETED|Overall Study||20
6513083|NCT01500057|7432996|FG001|COMPLETED|Overall Study||31
6513084|NCT01500057|7432995|FG000|NOT COMPLETED|Overall Study||6
6513085|NCT01500057|7432996|FG001|NOT COMPLETED|Overall Study||4
6513086|NCT01500083|7433004|FG000|STARTED|Overall Study||16
6513087|NCT01500083|7433005|FG001|STARTED|Overall Study||74
6513088|NCT01500083|7433004|FG000|COMPLETED|Overall Study||4
6513089|NCT01500083|7433005|FG001|COMPLETED|Overall Study||31
6513090|NCT01500083|7433004|FG000|NOT COMPLETED|Overall Study||12
6513091|NCT01500083|7433005|FG001|NOT COMPLETED|Overall Study||43
6513092|NCT01500096|7433015|FG000|STARTED|Overall Study||32
6640479|NCT02335125|7568764|FG000|NOT COMPLETED|Overall Study||0
6640480|NCT02335125|7568765|FG001|NOT COMPLETED|Overall Study||0
6640481|NCT02335216|7568771|FG000|STARTED|Overall Study||22
6640482|NCT02335216|7568771|FG000|Received Trial System|Overall Study||16
6640483|NCT02335216|7568771|FG000|Received Permanent System|Overall Study||13
6640484|NCT02335216|7568771|FG000|COMPLETED|Overall Study||9
6640485|NCT02335216|7568771|FG000|NOT COMPLETED|Overall Study||13
6640486|NCT02335229|7568775|FG000|STARTED|Overall Study||30
6640487|NCT02335229|7568775|FG000|Received Trial System|Overall Study||10
6640488|NCT02335229|7568775|FG000|Received Permanent System|Overall Study||26
6640489|NCT02335229|7568775|FG000|COMPLETED|Overall Study||23
6640490|NCT02335229|7568775|FG000|NOT COMPLETED|Overall Study||7
6640491|NCT02335294|7568785|FG000|STARTED|Overall Study||39
6640492|NCT02335294|7568786|FG001|STARTED|Overall Study||42
6640493|NCT02335294|7568787|FG002|STARTED|Overall Study||19
6640494|NCT02335294|7568788|FG003|STARTED|Overall Study||39
6640495|NCT02335294|7568789|FG004|STARTED|Overall Study||41
6640496|NCT02335294|7568790|FG005|STARTED|Overall Study||20
6640497|NCT02335294|7568785|FG000|COMPLETED|Overall Study||36
6640498|NCT02335294|7568786|FG001|COMPLETED|Overall Study||38
6640499|NCT02335294|7568787|FG002|COMPLETED|Overall Study||18
6640500|NCT02335294|7568788|FG003|COMPLETED|Overall Study||36
6513093|NCT01500096|7433016|FG001|STARTED|Overall Study||17
6513094|NCT01500096|7433017|FG002|STARTED|Overall Study||31
6513095|NCT01500096|7433018|FG003|STARTED|Overall Study||16
6513096|NCT01500096|7433015|FG000|COMPLETED|Overall Study||31
6513097|NCT01500096|7433016|FG001|COMPLETED|Overall Study||17
6513098|NCT01500096|7433017|FG002|COMPLETED|Overall Study||31
6513099|NCT01500096|7433018|FG003|COMPLETED|Overall Study||14
6513100|NCT01500096|7433015|FG000|NOT COMPLETED|Overall Study||1
6513101|NCT01500096|7433016|FG001|NOT COMPLETED|Overall Study||0
6513102|NCT01500096|7433017|FG002|NOT COMPLETED|Overall Study||0
6513103|NCT01500096|7433018|FG003|NOT COMPLETED|Overall Study||2
6513104|NCT01500135|7433030|FG000|STARTED|Overall Study||100
6513105|NCT01500135|7433031|FG001|STARTED|Overall Study||50
6513106|NCT01500135|7433030|FG000|COMPLETED|Overall Study||83
6513107|NCT01500135|7433031|FG001|COMPLETED|Overall Study||39
6513108|NCT01500135|7433030|FG000|NOT COMPLETED|Overall Study||17
6513109|NCT01500135|7433031|FG001|NOT COMPLETED|Overall Study||11
6513110|NCT01500187|7433039|FG000|STARTED|Overall Study||23
6513111|NCT01500187|7433040|FG001|STARTED|Overall Study||15
6513112|NCT01500187|7433039|FG000|COMPLETED|Overall Study||17
6513113|NCT01500187|7433040|FG001|COMPLETED|Overall Study||15
6513114|NCT01500187|7433039|FG000|NOT COMPLETED|Overall Study||6
6513115|NCT01500187|7433040|FG001|NOT COMPLETED|Overall Study||0
6513116|NCT01500200|7433049|FG000|STARTED|Stage 1||98
6513117|NCT01500200|7433050|FG001|STARTED|Stage 1||24
6513118|NCT01500200|7433051|FG002|STARTED|Stage 1||19
6513119|NCT01500200|7433052|FG003|STARTED|Stage 1||0
6513120|NCT01500200|7433053|FG004|STARTED|Stage 1||0
6513121|NCT01500200|7433054|FG005|STARTED|Stage 1||0
6513122|NCT01500200|7433049|FG000|COMPLETED|Stage 1||90
6513123|NCT01500200|7433050|FG001|COMPLETED|Stage 1||18
6513124|NCT01500200|7433051|FG002|COMPLETED|Stage 1||13
6513125|NCT01500200|7433052|FG003|COMPLETED|Stage 1||0
6513126|NCT01500200|7433053|FG004|COMPLETED|Stage 1||0
6513127|NCT01500200|7433054|FG005|COMPLETED|Stage 1||0
6513128|NCT01500200|7433049|FG000|NOT COMPLETED|Stage 1||8
6513129|NCT01500200|7433050|FG001|NOT COMPLETED|Stage 1||6
6513130|NCT01500200|7433051|FG002|NOT COMPLETED|Stage 1||6
6513131|NCT01500200|7433052|FG003|NOT COMPLETED|Stage 1||0
6513132|NCT01500200|7433053|FG004|NOT COMPLETED|Stage 1||0
6513133|NCT01500200|7433054|FG005|NOT COMPLETED|Stage 1||0
6513134|NCT01500200|7433049|FG000|STARTED|Stage 2||0
6513135|NCT01500200|7433050|FG001|STARTED|Stage 2||0
6513136|NCT01500200|7433051|FG002|STARTED|Stage 2||0
6513137|NCT01500200|7433052|FG003|STARTED|Stage 2||20
6513138|NCT01500200|7433053|FG004|STARTED|Stage 2||23
6513139|NCT01500200|7433054|FG005|STARTED|Stage 2||22
6513140|NCT01500200|7433049|FG000|COMPLETED|Stage 2||0
6513141|NCT01500200|7433050|FG001|COMPLETED|Stage 2||0
6513142|NCT01500200|7433051|FG002|COMPLETED|Stage 2||0
6513143|NCT01500200|7433052|FG003|COMPLETED|Stage 2||20
6513144|NCT01500200|7433053|FG004|COMPLETED|Stage 2||18
6513145|NCT01500200|7433054|FG005|COMPLETED|Stage 2||18
6513146|NCT01500200|7433049|FG000|NOT COMPLETED|Stage 2||0
6513147|NCT01500200|7433050|FG001|NOT COMPLETED|Stage 2||0
6513148|NCT01500200|7433051|FG002|NOT COMPLETED|Stage 2||0
6513149|NCT01500200|7433052|FG003|NOT COMPLETED|Stage 2||0
6513150|NCT01500200|7433053|FG004|NOT COMPLETED|Stage 2||5
6513151|NCT01500200|7433054|FG005|NOT COMPLETED|Stage 2||4
6513152|NCT01500213|7433070|FG000|STARTED|Overall Study|Number of randomized patients|278
6513153|NCT01500213|7433071|FG001|STARTED|Overall Study||277
6513154|NCT01500213|7433070|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
6513155|NCT01500213|7433071|FG001|COMPLETED|Overall Study||53
6513156|NCT01500213|7433070|FG000|NOT COMPLETED|Overall Study||217
6513157|NCT01500213|7433071|FG001|NOT COMPLETED|Overall Study||224
6513158|NCT01500226|7433079|FG000|STARTED|Overall Study|Number of randomized patients|684
6513159|NCT01500226|7433080|FG001|STARTED|Overall Study||685
6513160|NCT01500226|7433079|FG000|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
6513161|NCT01500226|7433080|FG001|COMPLETED|Overall Study||191
6513162|NCT01500226|7433079|FG000|NOT COMPLETED|Overall Study||499
6513163|NCT01500226|7433080|FG001|NOT COMPLETED|Overall Study||494
6513164|NCT01500252|7433088|FG000|STARTED|Overall Study||21
6513165|NCT01500252|7433089|FG001|STARTED|Overall Study||17
6513166|NCT01500252|7433088|FG000|One Years|Overall Study||20
6513167|NCT01500252|7433089|FG001|One Years|Overall Study||16
6513168|NCT01500252|7433088|FG000|Five Years|Overall Study||17
6513169|NCT01500252|7433089|FG001|Five Years|Overall Study||13
6513170|NCT01500252|7433088|FG000|Ten Years|Overall Study||12
6513171|NCT01500252|7433089|FG001|Ten Years|Overall Study||11
6513172|NCT01500252|7433088|FG000|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
6513173|NCT01500252|7433089|FG001|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
6513174|NCT01500252|7433088|FG000|NOT COMPLETED|Overall Study||9
6513175|NCT01500252|7433089|FG001|NOT COMPLETED|Overall Study||6
6513176|NCT01500278|7433098|FG000|STARTED|Week 0 - Week 12||457
6513177|NCT01500278|7433099|FG001|STARTED|Week 0 - Week 12||458
6513178|NCT01500278|7433098|FG000|COMPLETED|Week 0 - Week 12||426
6513179|NCT01500278|7433099|FG001|COMPLETED|Week 0 - Week 12||428
6513180|NCT01500278|7433098|FG000|NOT COMPLETED|Week 0 - Week 12||31
6513181|NCT01500278|7433099|FG001|NOT COMPLETED|Week 0 - Week 12||30
6513182|NCT01500278|7433098|FG000|STARTED|Week 13 - Week 104||426
6513183|NCT01500278|7433099|FG001|STARTED|Week 13 - Week 104||428
6513184|NCT01500278|7433098|FG000|COMPLETED|Week 13 - Week 104||287
6513185|NCT01500278|7433099|FG001|COMPLETED|Week 13 - Week 104||302
6513186|NCT01500278|7433098|FG000|NOT COMPLETED|Week 13 - Week 104||139
6513187|NCT01500278|7433099|FG001|NOT COMPLETED|Week 13 - Week 104||126
6513188|NCT01500317|7433110|FG000|STARTED|Overall Study||13
6513189|NCT01500317|7433111|FG001|STARTED|Overall Study||12
6513190|NCT01500317|7433112|FG002|STARTED|Overall Study||13
6513191|NCT01500317|7433110|FG000|COMPLETED|Overall Study||10
6513192|NCT01500317|7433111|FG001|COMPLETED|Overall Study||10
6513193|NCT01500317|7433112|FG002|COMPLETED|Overall Study||13
6513194|NCT01500317|7433110|FG000|NOT COMPLETED|Overall Study||3
6513195|NCT01500317|7433111|FG001|NOT COMPLETED|Overall Study||2
6513196|NCT01500317|7433112|FG002|NOT COMPLETED|Overall Study||0
6513197|NCT01500382|7433124|FG000|STARTED|Treatment Period 1||1
6513198|NCT01500382|7433125|FG001|STARTED|Treatment Period 1||1
6513199|NCT01500382|7433126|FG002|STARTED|Treatment Period 1||1
6513200|NCT01500382|7433127|FG003|STARTED|Treatment Period 1||1
6513201|NCT01500382|7433124|FG000|COMPLETED|Treatment Period 1||1
6513202|NCT01500382|7433125|FG001|COMPLETED|Treatment Period 1||1
6513203|NCT01500382|7433126|FG002|COMPLETED|Treatment Period 1||1
6513204|NCT01500382|7433127|FG003|COMPLETED|Treatment Period 1||1
6513205|NCT01500382|7433124|FG000|NOT COMPLETED|Treatment Period 1||0
6513206|NCT01500382|7433125|FG001|NOT COMPLETED|Treatment Period 1||0
6513207|NCT01500382|7433126|FG002|NOT COMPLETED|Treatment Period 1||0
6513208|NCT01500382|7433127|FG003|NOT COMPLETED|Treatment Period 1||0
6513209|NCT01500382|7433124|FG000|STARTED|Washout Period||1
6513210|NCT01500382|7433125|FG001|STARTED|Washout Period||1
6513211|NCT01500382|7433126|FG002|STARTED|Washout Period||1
6513212|NCT01500382|7433127|FG003|STARTED|Washout Period||1
6513213|NCT01500382|7433124|FG000|COMPLETED|Washout Period||1
6513214|NCT01500382|7433125|FG001|COMPLETED|Washout Period||1
6513215|NCT01500382|7433126|FG002|COMPLETED|Washout Period||0
6513216|NCT01500382|7433127|FG003|COMPLETED|Washout Period||1
6513217|NCT01500382|7433124|FG000|NOT COMPLETED|Washout Period||0
6513218|NCT01500382|7433125|FG001|NOT COMPLETED|Washout Period||0
6513219|NCT01500382|7433126|FG002|NOT COMPLETED|Washout Period||1
6513220|NCT01500382|7433127|FG003|NOT COMPLETED|Washout Period||0
6513221|NCT01500382|7433124|FG000|STARTED|Treatment Period 2||1
6513222|NCT01500382|7433125|FG001|STARTED|Treatment Period 2||1
6513223|NCT01500382|7433126|FG002|STARTED|Treatment Period 2||0
6513224|NCT01500382|7433127|FG003|STARTED|Treatment Period 2||1
6513225|NCT01500382|7433124|FG000|COMPLETED|Treatment Period 2||1
6513226|NCT01500382|7433125|FG001|COMPLETED|Treatment Period 2||1
6513227|NCT01500382|7433126|FG002|COMPLETED|Treatment Period 2||0
6513228|NCT01500382|7433127|FG003|COMPLETED|Treatment Period 2||1
6513229|NCT01500382|7433124|FG000|NOT COMPLETED|Treatment Period 2||0
6513230|NCT01500382|7433125|FG001|NOT COMPLETED|Treatment Period 2||0
6513231|NCT01500382|7433126|FG002|NOT COMPLETED|Treatment Period 2||0
6513232|NCT01500382|7433127|FG003|NOT COMPLETED|Treatment Period 2||0
6513233|NCT01500434|7433137|FG000|STARTED|Overall Study||102
6513234|NCT01500434|7433137|FG000|COMPLETED|Overall Study||95
6513235|NCT01500434|7433137|FG000|NOT COMPLETED|Overall Study||7
6513236|NCT01500525|7433143|FG000|STARTED|Overall Study||286
6513237|NCT01500525|7433144|FG001|STARTED|Overall Study||301
6513238|NCT01500525|7433143|FG000|COMPLETED|Overall Study||286
6513239|NCT01500525|7433144|FG001|COMPLETED|Overall Study||301
6513240|NCT01500525|7433143|FG000|NOT COMPLETED|Overall Study||0
6513241|NCT01500525|7433144|FG001|NOT COMPLETED|Overall Study||0
6513242|NCT01500629|7433152|FG000|STARTED|Period 1 (Single Dose)||11
6513243|NCT01500629|7433153|FG001|STARTED|Period 1 (Single Dose)||10
6513244|NCT01500629|7433152|FG000|COMPLETED|Period 1 (Single Dose)||11
6513245|NCT01500629|7433153|FG001|COMPLETED|Period 1 (Single Dose)||10
6513246|NCT01500629|7433152|FG000|NOT COMPLETED|Period 1 (Single Dose)||0
6513247|NCT01500629|7433153|FG001|NOT COMPLETED|Period 1 (Single Dose)||0
6513248|NCT01500629|7433152|FG000|STARTED|Washout Period of 14 to 30 Days||11
6513249|NCT01500629|7433153|FG001|STARTED|Washout Period of 14 to 30 Days||10
6513250|NCT01500629|7433152|FG000|COMPLETED|Washout Period of 14 to 30 Days||10
6513251|NCT01500629|7433153|FG001|COMPLETED|Washout Period of 14 to 30 Days||10
6513252|NCT01500629|7433152|FG000|NOT COMPLETED|Washout Period of 14 to 30 Days||1
6513253|NCT01500629|7433153|FG001|NOT COMPLETED|Washout Period of 14 to 30 Days||0
6513254|NCT01500629|7433152|FG000|STARTED|Period 2 (Single Dose)||10
6513255|NCT01500629|7433153|FG001|STARTED|Period 2 (Single Dose)||10
6513256|NCT01500629|7433152|FG000|COMPLETED|Period 2 (Single Dose)||10
6513257|NCT01500629|7433153|FG001|COMPLETED|Period 2 (Single Dose)||10
6513258|NCT01500629|7433152|FG000|NOT COMPLETED|Period 2 (Single Dose)||0
6513259|NCT01500629|7433153|FG001|NOT COMPLETED|Period 2 (Single Dose)||0
6561336|NCT01792284|7484135|FG001|NOT COMPLETED|Randomization Period 2||3
6561337|NCT01792284|7484136|FG002|NOT COMPLETED|Randomization Period 2||0
6561338|NCT01792518|7484146|FG000|STARTED|Overall Study||178
6561339|NCT01792518|7484147|FG001|STARTED|Overall Study||182
6561340|NCT01792518|7484146|FG000|COMPLETED|Overall Study||170
6561341|NCT01792518|7484147|FG001|COMPLETED|Overall Study||175
6561342|NCT01792518|7484146|FG000|NOT COMPLETED|Overall Study||8
6561343|NCT01792518|7484147|FG001|NOT COMPLETED|Overall Study||7
6561344|NCT01792635|7484156|FG000|STARTED|Part A||6
6561345|NCT01792635|7484157|FG001|STARTED|Part A||0
6561346|NCT01792635|7484158|FG002|STARTED|Part A||0
6561347|NCT01792635|7484156|FG000|COMPLETED|Part A||6
6561348|NCT01792635|7484157|FG001|COMPLETED|Part A||0
6561349|NCT01792635|7484158|FG002|COMPLETED|Part A||0
6561350|NCT01792635|7484156|FG000|NOT COMPLETED|Part A||0
6304183|NCT00364832|7207521|FG007|STARTED|Core Period||15
6513260|NCT01500694|7433168|FG000|STARTED|Overall Study||131
6513261|NCT01500694|7433169|FG001|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
6513262|NCT01500694|7433168|FG000|COMPLETED|Overall Study||79
6513263|NCT01500694|7433169|FG001|COMPLETED|Overall Study||54
6513264|NCT01500694|7433168|FG000|NOT COMPLETED|Overall Study||52
6513265|NCT01500694|7433169|FG001|NOT COMPLETED|Overall Study||29
6513266|NCT01500720|7433177|FG000|STARTED|Overall Study|Randomized|90
6513267|NCT01500720|7433178|FG001|STARTED|Overall Study|Randomized|89
6513268|NCT01500720|7433177|FG000|Treated|Overall Study||89
6513269|NCT01500720|7433178|FG001|Treated|Overall Study||88
6513270|NCT01500720|7433177|FG000|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
6513271|NCT01500720|7433178|FG001|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
6513272|NCT01500720|7433177|FG000|NOT COMPLETED|Overall Study||5
6513273|NCT01500720|7433178|FG001|NOT COMPLETED|Overall Study||9
6513274|NCT01500746|7433186|FG000|STARTED|Overall Study||4
6513275|NCT01500746|7433187|FG001|STARTED|Overall Study||4
6513276|NCT01500746|7433186|FG000|COMPLETED|Overall Study||4
6513277|NCT01500746|7433187|FG001|COMPLETED|Overall Study||4
6513278|NCT01500746|7433186|FG000|NOT COMPLETED|Overall Study||0
6513279|NCT01500746|7433187|FG001|NOT COMPLETED|Overall Study||0
6513280|NCT01500759|7433195|FG000|STARTED|Overall Study||3686
6513281|NCT01500759|7433196|FG001|STARTED|Overall Study||3190
6513282|NCT01500759|7433195|FG000|COMPLETED|Overall Study||3686
6513283|NCT01500759|7433196|FG001|COMPLETED|Overall Study||3190
6513284|NCT01500759|7433195|FG000|NOT COMPLETED|Overall Study||0
6513285|NCT01500759|7433196|FG001|NOT COMPLETED|Overall Study||0
6513286|NCT01501110|7433213|FG000|STARTED|Overall Study||34
6513287|NCT01501110|7433214|FG001|STARTED|Overall Study||34
6513288|NCT01501110|7433213|FG000|COMPLETED|Overall Study||34
6513289|NCT01501110|7433214|FG001|COMPLETED|Overall Study||33
6513290|NCT01501110|7433213|FG000|NOT COMPLETED|Overall Study||0
6513291|NCT01501110|7433214|FG001|NOT COMPLETED|Overall Study||1
6640501|NCT02335294|7568789|FG004|COMPLETED|Overall Study||39
6640502|NCT02335294|7568790|FG005|COMPLETED|Overall Study||19
6640503|NCT02335294|7568785|FG000|NOT COMPLETED|Overall Study||3
6640504|NCT02335294|7568786|FG001|NOT COMPLETED|Overall Study||4
6640505|NCT02335294|7568787|FG002|NOT COMPLETED|Overall Study||1
6640506|NCT02335294|7568788|FG003|NOT COMPLETED|Overall Study||3
6640507|NCT02335294|7568789|FG004|NOT COMPLETED|Overall Study||2
6640508|NCT02335294|7568790|FG005|NOT COMPLETED|Overall Study||1
6640509|NCT02335346|7568804|FG000|STARTED|Overall Study||93
6640510|NCT02335346|7568804|FG000|Received At Least 1 Dose of Study Drug|Overall Study||93
6640511|NCT02335346|7568804|FG000|COMPLETED|Overall Study||81
6640512|NCT02335346|7568804|FG000|NOT COMPLETED|Overall Study||12
6640513|NCT02335450|7568808|FG000|STARTED|Overall Study||5
6640514|NCT02335450|7568808|FG000|COMPLETED|Overall Study||4
6640515|NCT02335450|7568808|FG000|NOT COMPLETED|Overall Study||1
6640516|NCT02335489|7568818|FG000|STARTED|Overall Study||10
6640517|NCT02335489|7568818|FG000|Received Trial System|Overall Study||9
6640518|NCT02335489|7568818|FG000|Receiving Permanent System|Overall Study||8
6640519|NCT02335489|7568818|FG000|COMPLETED|Overall Study||0
6640520|NCT02335489|7568818|FG000|NOT COMPLETED|Overall Study||10
6640521|NCT02335502|7568822|FG000|STARTED|Overall Study||66
6640522|NCT02335502|7568822|FG000|Received Trial System|Overall Study||65
6640523|NCT02335502|7568822|FG000|Receiving Permanent System|Overall Study||56
6640524|NCT02335502|7568822|FG000|COMPLETED|Overall Study||49
6640525|NCT02335502|7568822|FG000|NOT COMPLETED|Overall Study||17
6640526|NCT02335710|7568828|FG000|STARTED|Overall Study||40
6640527|NCT02335710|7568829|FG001|STARTED|Overall Study||10
6640528|NCT02335710|7568828|FG000|COMPLETED|Overall Study||40
6743593|NCT03335254|7671810|FG000|COMPLETED|Period 1||9
6743594|NCT03335254|7671811|FG001|COMPLETED|Period 1||0
6743595|NCT03335254|7671812|FG002|COMPLETED|Period 1||0
6743596|NCT03335254|7671813|FG003|COMPLETED|Period 1||0
6743597|NCT03335254|7671814|FG004|COMPLETED|Period 1||0
6743598|NCT03335254|7671815|FG005|COMPLETED|Period 1||0
6743599|NCT03335254|7671816|FG006|COMPLETED|Period 1||0
6743600|NCT03335254|7671817|FG007|COMPLETED|Period 1||0
6743601|NCT03335254|7671818|FG008|COMPLETED|Period 1||0
6743602|NCT03335254|7671819|FG009|COMPLETED|Period 1||0
6743603|NCT03335254|7671820|FG010|COMPLETED|Period 1||0
6743604|NCT03335254|7671821|FG011|COMPLETED|Period 1||0
6743605|NCT03335254|7671822|FG012|COMPLETED|Period 1||0
6743606|NCT03335254|7671823|FG013|COMPLETED|Period 1||0
6743607|NCT03335254|7671824|FG014|COMPLETED|Period 1||0
6743608|NCT03335254|7671825|FG015|COMPLETED|Period 1||0
6743609|NCT03335254|7671826|FG016|COMPLETED|Period 1||0
6743610|NCT03335254|7671827|FG017|COMPLETED|Period 1||0
6743611|NCT03335254|7671828|FG018|COMPLETED|Period 1||0
6743612|NCT03335254|7671829|FG019|COMPLETED|Period 1||0
6304184|NCT00364832|7207522|FG008|STARTED|Core Period||16
6513292|NCT01501162|7433222|FG000|STARTED|Overall Study||65
6513293|NCT01501162|7433223|FG001|STARTED|Overall Study||65
6743613|NCT03335254|7671810|FG000|NOT COMPLETED|Period 1||0
6304185|NCT00364832|7207523|FG009|STARTED|Core Period||0
6304186|NCT00364832|7207524|FG010|STARTED|Core Period||0
6304187|NCT00364832|7207525|FG011|STARTED|Core Period||0
6304188|NCT00364832|7207514|FG000|COMPLETED|Core Period||14
6743614|NCT03335254|7671811|FG001|NOT COMPLETED|Period 1||0
6743615|NCT03335254|7671812|FG002|NOT COMPLETED|Period 1||0
6513294|NCT01501162|7433222|FG000|COMPLETED|Overall Study||57
6513295|NCT01501162|7433223|FG001|COMPLETED|Overall Study||60
6513296|NCT01501162|7433222|FG000|NOT COMPLETED|Overall Study||8
6513297|NCT01501162|7433223|FG001|NOT COMPLETED|Overall Study||5
6513298|NCT01501929|7433229|FG000|STARTED|First Intervention||8
6513299|NCT01501929|7433230|FG001|STARTED|First Intervention||17
6513300|NCT01501929|7433229|FG000|COMPLETED|First Intervention||8
6513301|NCT01501929|7433230|FG001|COMPLETED|First Intervention||17
6513302|NCT01501929|7433229|FG000|NOT COMPLETED|First Intervention||0
6513303|NCT01501929|7433230|FG001|NOT COMPLETED|First Intervention||0
6513304|NCT01501929|7433229|FG000|STARTED|Second Intervention||8
6513305|NCT01501929|7433230|FG001|STARTED|Second Intervention||17
6513306|NCT01501929|7433229|FG000|COMPLETED|Second Intervention||8
6513307|NCT01501929|7433230|FG001|COMPLETED|Second Intervention||17
6513308|NCT01501929|7433229|FG000|NOT COMPLETED|Second Intervention||0
6513309|NCT01501929|7433230|FG001|NOT COMPLETED|Second Intervention||0
6513310|NCT01502033|7433236|FG000|STARTED|Overall Study|Milestone (10 participants) met.|10
6513311|NCT01502033|7433236|FG000|COMPLETED|Overall Study|Milestone (10 participants) met|7
6513312|NCT01502033|7433236|FG000|NOT COMPLETED|Overall Study||3
6513313|NCT01502072|7433245|FG000|STARTED|Overall Study||14
6513314|NCT01502072|7433246|FG001|STARTED|Overall Study||10
6513315|NCT01502072|7433247|FG002|STARTED|Overall Study||20
6513316|NCT01502072|7433245|FG000|COMPLETED|Overall Study||13
6513317|NCT01502072|7433246|FG001|COMPLETED|Overall Study||9
6513318|NCT01502072|7433247|FG002|COMPLETED|Overall Study||20
6513319|NCT01502072|7433245|FG000|NOT COMPLETED|Overall Study||1
6513320|NCT01502072|7433246|FG001|NOT COMPLETED|Overall Study||1
6513321|NCT01502072|7433247|FG002|NOT COMPLETED|Overall Study||0
6513322|NCT01502228|7433255|FG000|STARTED|Overall Study||14
6513323|NCT01502228|7433255|FG000|COMPLETED|Overall Study||13
6513324|NCT01502228|7433255|FG000|NOT COMPLETED|Overall Study||1
6513325|NCT01502293|7433262|FG000|STARTED|Overall Study||30
6513326|NCT01502293|7433263|FG001|STARTED|Overall Study||17
6513327|NCT01502293|7433264|FG002|STARTED|Overall Study||4
6513328|NCT01502293|7433262|FG000|COMPLETED|Overall Study||5
6513329|NCT01502293|7433263|FG001|COMPLETED|Overall Study||0
6513330|NCT01502293|7433264|FG002|COMPLETED|Overall Study||0
6513331|NCT01502293|7433262|FG000|NOT COMPLETED|Overall Study||25
6513332|NCT01502293|7433263|FG001|NOT COMPLETED|Overall Study||17
6513333|NCT01502293|7433264|FG002|NOT COMPLETED|Overall Study||4
6513334|NCT01502306|7433278|FG000|STARTED|Overall Study||1004
6513335|NCT01502306|7433279|FG001|STARTED|Overall Study||1405
6513336|NCT01502306|7433280|FG002|STARTED|Overall Study||1407
6513337|NCT01502306|7433278|FG000|COMPLETED|Overall Study||1004
6513338|NCT01502306|7433279|FG001|COMPLETED|Overall Study||1405
6513339|NCT01502306|7433280|FG002|COMPLETED|Overall Study||1407
6513340|NCT01502306|7433278|FG000|NOT COMPLETED|Overall Study||0
6513341|NCT01502306|7433279|FG001|NOT COMPLETED|Overall Study||0
6513342|NCT01502306|7433280|FG002|NOT COMPLETED|Overall Study||0
6513343|NCT01502332|7433290|FG000|STARTED|Overall Study||157
6513344|NCT01502332|7433291|FG001|STARTED|Overall Study||163
6513345|NCT01502332|7433290|FG000|COMPLETED|Overall Study||157
6513346|NCT01502332|7433291|FG001|COMPLETED|Overall Study||163
6513347|NCT01502332|7433290|FG000|NOT COMPLETED|Overall Study||0
6513348|NCT01502332|7433291|FG001|NOT COMPLETED|Overall Study||0
6513349|NCT01502410|7433301|FG000|STARTED|Overall Study||10
6513350|NCT01502410|7433302|FG001|STARTED|Overall Study||10
6513351|NCT01502410|7433303|FG002|STARTED|Overall Study||0
6513352|NCT01502410|7433304|FG003|STARTED|Overall Study||0
6513353|NCT01502410|7433301|FG000|COMPLETED|Overall Study||0
6513354|NCT01502410|7433302|FG001|COMPLETED|Overall Study||0
6513355|NCT01502410|7433303|FG002|COMPLETED|Overall Study||0
6513356|NCT01502410|7433304|FG003|COMPLETED|Overall Study||0
6513357|NCT01502410|7433301|FG000|NOT COMPLETED|Overall Study||10
6513358|NCT01502410|7433302|FG001|NOT COMPLETED|Overall Study||10
6513359|NCT01502410|7433303|FG002|NOT COMPLETED|Overall Study||0
6513360|NCT01502410|7433304|FG003|NOT COMPLETED|Overall Study||0
6513361|NCT01502423|7433315|FG000|STARTED|Overall Study||31
6513362|NCT01502423|7433316|FG001|STARTED|Overall Study||30
6513363|NCT01502423|7433315|FG000|COMPLETED|Overall Study||31
6513364|NCT01502423|7433316|FG001|COMPLETED|Overall Study||29
6513365|NCT01502423|7433315|FG000|NOT COMPLETED|Overall Study||0
6513366|NCT01502423|7433316|FG001|NOT COMPLETED|Overall Study||1
6513367|NCT01502631|7433324|FG000|STARTED|Overall Study||30
6513368|NCT01502631|7433325|FG001|STARTED|Overall Study||31
6513369|NCT01502631|7433324|FG000|COMPLETED|Overall Study||10
6513370|NCT01502631|7433325|FG001|COMPLETED|Overall Study||11
6513371|NCT01502631|7433324|FG000|NOT COMPLETED|Overall Study||20
6513372|NCT01502631|7433325|FG001|NOT COMPLETED|Overall Study||20
6513373|NCT01502644|7433334|FG000|STARTED|Enrolled at Visit 1 After Pre-screening||81
6513374|NCT01502644|7433335|FG001|STARTED|Enrolled at Visit 1 After Pre-screening||0
6513375|NCT01502644|7433336|FG002|STARTED|Enrolled at Visit 1 After Pre-screening||0
6513376|NCT01502644|7433337|FG003|STARTED|Enrolled at Visit 1 After Pre-screening||0
6513377|NCT01502644|7433334|FG000|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
6513378|NCT01502644|7433335|FG001|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6513379|NCT01502644|7433336|FG002|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6513380|NCT01502644|7433337|FG003|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6513381|NCT01502644|7433334|FG000|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
6513382|NCT01502644|7433335|FG001|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6513383|NCT01502644|7433336|FG002|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6513384|NCT01502644|7433337|FG003|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
6513385|NCT01502644|7433334|FG000|STARTED|Assigned to NA Groups||0
6513386|NCT01502644|7433335|FG001|STARTED|Assigned to NA Groups||30
6513387|NCT01502644|7433336|FG002|STARTED|Assigned to NA Groups||10
6513388|NCT01502644|7433337|FG003|STARTED|Assigned to NA Groups||32
6513389|NCT01502644|7433334|FG000|COMPLETED|Assigned to NA Groups||0
6513390|NCT01502644|7433335|FG001|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
6513391|NCT01502644|7433336|FG002|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
6513392|NCT01502644|7433337|FG003|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
6513393|NCT01502644|7433334|FG000|NOT COMPLETED|Assigned to NA Groups||0
6513394|NCT01502644|7433335|FG001|NOT COMPLETED|Assigned to NA Groups||6
6513395|NCT01502644|7433336|FG002|NOT COMPLETED|Assigned to NA Groups||3
6513396|NCT01502644|7433337|FG003|NOT COMPLETED|Assigned to NA Groups||8
6513397|NCT01502709|7433347|FG000|STARTED|Overall Study||5
6513398|NCT01502709|7433348|FG001|STARTED|Overall Study||0
6513399|NCT01502709|7433347|FG000|COMPLETED|Overall Study||1
6513400|NCT01502709|7433348|FG001|COMPLETED|Overall Study||0
6513401|NCT01502709|7433347|FG000|NOT COMPLETED|Overall Study||4
6513402|NCT01502709|7433348|FG001|NOT COMPLETED|Overall Study||0
6513403|NCT01502761|7433359|FG000|STARTED|Overall Study||4
6513404|NCT01502761|7433360|FG001|STARTED|Overall Study||0
6513405|NCT01502761|7433361|FG002|STARTED|Overall Study||0
6513406|NCT01502761|7433362|FG003|STARTED|Overall Study||0
6513407|NCT01502761|7433359|FG000|COMPLETED|Overall Study||4
6513408|NCT01502761|7433360|FG001|COMPLETED|Overall Study||0
6513409|NCT01502761|7433361|FG002|COMPLETED|Overall Study||0
6513410|NCT01502761|7433362|FG003|COMPLETED|Overall Study||0
6513411|NCT01502761|7433359|FG000|NOT COMPLETED|Overall Study||0
6513412|NCT01502761|7433360|FG001|NOT COMPLETED|Overall Study||0
6513413|NCT01502761|7433361|FG002|NOT COMPLETED|Overall Study||0
6513414|NCT01502761|7433362|FG003|NOT COMPLETED|Overall Study||0
6513415|NCT01502787|7433372|FG000|STARTED|Overall Study||11
6513416|NCT01502787|7433373|FG001|STARTED|Overall Study||10
6513417|NCT01502787|7433372|FG000|COMPLETED|Overall Study||11
6513418|NCT01502787|7433373|FG001|COMPLETED|Overall Study||10
6513419|NCT01502787|7433372|FG000|NOT COMPLETED|Overall Study||0
6640529|NCT02335710|7568829|FG001|COMPLETED|Overall Study||10
6640530|NCT02335710|7568828|FG000|NOT COMPLETED|Overall Study||0
6640531|NCT02335710|7568829|FG001|NOT COMPLETED|Overall Study||0
6640532|NCT02335905|7568835|FG000|STARTED|Overall Study||11
6640533|NCT02335905|7568835|FG000|COMPLETED|Overall Study||7
6640534|NCT02335905|7568835|FG000|NOT COMPLETED|Overall Study||4
6640535|NCT02335983|7568845|FG000|STARTED|Overall Study||10
6640536|NCT02335983|7568846|FG001|STARTED|Overall Study||12
6640537|NCT02335983|7568847|FG002|STARTED|Overall Study||34
6640538|NCT02335983|7568848|FG003|STARTED|Overall Study||9
6640539|NCT02335983|7568849|FG004|STARTED|Overall Study||9
6640540|NCT02335983|7568850|FG005|STARTED|Overall Study||33
6640541|NCT02335983|7568845|FG000|COMPLETED|Overall Study||2
6640542|NCT02335983|7568846|FG001|COMPLETED|Overall Study||3
6640543|NCT02335983|7568847|FG002|COMPLETED|Overall Study||2
6640544|NCT02335983|7568848|FG003|COMPLETED|Overall Study||0
6640545|NCT02335983|7568849|FG004|COMPLETED|Overall Study||1
6640546|NCT02335983|7568850|FG005|COMPLETED|Overall Study||1
6640547|NCT02335983|7568845|FG000|NOT COMPLETED|Overall Study||8
6640548|NCT02335983|7568846|FG001|NOT COMPLETED|Overall Study||9
6640549|NCT02335983|7568847|FG002|NOT COMPLETED|Overall Study||32
6640550|NCT02335983|7568848|FG003|NOT COMPLETED|Overall Study||9
6640551|NCT02335983|7568849|FG004|NOT COMPLETED|Overall Study||8
6640552|NCT02335983|7568850|FG005|NOT COMPLETED|Overall Study||32
6640553|NCT02336074|7568875|FG000|STARTED|Overall Study||30
6640554|NCT02336074|7568876|FG001|STARTED|Overall Study||30
6640555|NCT02336074|7568875|FG000|COMPLETED|Overall Study||30
6640556|NCT02336074|7568876|FG001|COMPLETED|Overall Study||28
6640557|NCT02336074|7568875|FG000|NOT COMPLETED|Overall Study||0
6640558|NCT02336074|7568876|FG001|NOT COMPLETED|Overall Study||2
6640559|NCT02336165|7568892|FG000|STARTED|Overall Study||40
6640560|NCT02336165|7568893|FG001|STARTED|Overall Study||31
6640561|NCT02336165|7568894|FG002|STARTED|Overall Study||33
6640562|NCT02336165|7568895|FG003|STARTED|Overall Study||33
6640563|NCT02336165|7568896|FG004|STARTED|Overall Study||22
6640564|NCT02336165|7568892|FG000|COMPLETED|Overall Study||6
6640565|NCT02336165|7568893|FG001|COMPLETED|Overall Study||6
6640566|NCT02336165|7568894|FG002|COMPLETED|Overall Study||2
6640567|NCT02336165|7568895|FG003|COMPLETED|Overall Study||2
6640568|NCT02336165|7568896|FG004|COMPLETED|Overall Study||0
6513420|NCT01502787|7433373|FG001|NOT COMPLETED|Overall Study||0
6513421|NCT01502813|7433383|FG000|STARTED|Overall Study||40
6640569|NCT02336165|7568892|FG000|NOT COMPLETED|Overall Study||34
6640570|NCT02336165|7568893|FG001|NOT COMPLETED|Overall Study||25
6640571|NCT02336165|7568894|FG002|NOT COMPLETED|Overall Study||31
6640572|NCT02336165|7568895|FG003|NOT COMPLETED|Overall Study||31
6640573|NCT02336165|7568896|FG004|NOT COMPLETED|Overall Study||22
6640574|NCT02336178|7568912|FG000|STARTED|Overall Study||70
6640575|NCT02336178|7568912|FG000|COMPLETED|Overall Study||66
6640576|NCT02336178|7568912|FG000|NOT COMPLETED|Overall Study||4
6513422|NCT01502813|7433383|FG000|COMPLETED|Overall Study||40
6513423|NCT01502813|7433383|FG000|NOT COMPLETED|Overall Study||0
6513424|NCT01502956|7433389|FG000|STARTED|Overall Study||192
6513425|NCT01502956|7433390|FG001|STARTED|Overall Study||194
6513426|NCT01502956|7433389|FG000|COMPLETED|Overall Study||168
6513427|NCT01502956|7433390|FG001|COMPLETED|Overall Study||168
6513428|NCT01502956|7433389|FG000|NOT COMPLETED|Overall Study||24
6513429|NCT01502956|7433390|FG001|NOT COMPLETED|Overall Study||26
6513430|NCT01503021|7433398|FG000|STARTED|Overall Study||360
6513431|NCT01503021|7433399|FG001|STARTED|Overall Study||358
6513432|NCT01503021|7433398|FG000|Dosed|Overall Study||351
6513433|NCT01503021|7433399|FG001|Dosed|Overall Study||352
6513434|NCT01503021|7433398|FG000|Completed Treatment|Overall Study||333
6513435|NCT01503021|7433399|FG001|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
6513436|NCT01503021|7433398|FG000|COMPLETED|Overall Study||333
6513437|NCT01503021|7433399|FG001|COMPLETED|Overall Study||332
6513438|NCT01503021|7433398|FG000|NOT COMPLETED|Overall Study||27
6513439|NCT01503021|7433399|FG001|NOT COMPLETED|Overall Study||26
6513440|NCT01503164|7433412|FG000|STARTED|Overall Study||55
6513441|NCT01503164|7433413|FG001|STARTED|Overall Study||56
6513442|NCT01503164|7433412|FG000|COMPLETED|Overall Study||53
6513443|NCT01503164|7433413|FG001|COMPLETED|Overall Study||55
6513444|NCT01503164|7433412|FG000|NOT COMPLETED|Overall Study||2
6513445|NCT01503164|7433413|FG001|NOT COMPLETED|Overall Study||1
6513446|NCT01503229|7433419|FG000|STARTED|Overall Study||30
6513447|NCT01503229|7433419|FG000|COMPLETED|Overall Study||29
6513448|NCT01503229|7433419|FG000|NOT COMPLETED|Overall Study||1
6513449|NCT01503333|7433425|FG000|STARTED|Overall Study||777
6513450|NCT01503333|7433426|FG001|STARTED|Overall Study||766
6513451|NCT01503333|7433425|FG000|Completed Baseline|Overall Study||766
6513452|NCT01503333|7433426|FG001|Completed Baseline|Overall Study||753
6513453|NCT01503333|7433425|FG000|Completed Post-intervention|Overall Study||680
6513454|NCT01503333|7433426|FG001|Completed Post-intervention|Overall Study||706
6513455|NCT01503333|7433425|FG000|COMPLETED|Overall Study||437
6513456|NCT01503333|7433426|FG001|COMPLETED|Overall Study||461
6513457|NCT01503333|7433425|FG000|NOT COMPLETED|Overall Study||340
6513458|NCT01503333|7433426|FG001|NOT COMPLETED|Overall Study||305
6513459|NCT01503749|7433443|FG000|STARTED|Overall Study||3
6513460|NCT01503749|7433444|FG001|STARTED|Overall Study||3
6513461|NCT01503749|7433445|FG002|STARTED|Overall Study||3
6513462|NCT01503749|7433443|FG000|COMPLETED|Overall Study||3
6513463|NCT01503749|7433444|FG001|COMPLETED|Overall Study||3
6513464|NCT01503749|7433445|FG002|COMPLETED|Overall Study||3
6513465|NCT01503749|7433443|FG000|NOT COMPLETED|Overall Study||0
6513466|NCT01503749|7433444|FG001|NOT COMPLETED|Overall Study||0
6513467|NCT01503749|7433445|FG002|NOT COMPLETED|Overall Study||0
6513468|NCT01504204|7433455|FG000|STARTED|Overall Study||10
6513469|NCT01504204|7433456|FG001|STARTED|Overall Study||10
6513470|NCT01504204|7433455|FG000|COMPLETED|Overall Study||9
6513471|NCT01504204|7433456|FG001|COMPLETED|Overall Study||9
6513472|NCT01504204|7433455|FG000|NOT COMPLETED|Overall Study||1
6513473|NCT01504204|7433456|FG001|NOT COMPLETED|Overall Study||1
6513474|NCT01504412|7433467|FG000|STARTED|Overall Study||89
6513475|NCT01504412|7433468|FG001|STARTED|Overall Study||87
6513476|NCT01504412|7433469|FG002|STARTED|Overall Study||90
6513477|NCT01504412|7433470|FG003|STARTED|Overall Study||94
6513478|NCT01504412|7433471|FG004|STARTED|Overall Study||90
6513479|NCT01504412|7433467|FG000|COMPLETED|Overall Study||84
6513480|NCT01504412|7433468|FG001|COMPLETED|Overall Study||75
6513481|NCT01504412|7433469|FG002|COMPLETED|Overall Study||86
6640577|NCT02336282|7568924|FG000|STARTED|Overall Study||33
6640578|NCT02336282|7568924|FG000|COMPLETED|Overall Study||28
6640579|NCT02336282|7568924|FG000|NOT COMPLETED|Overall Study||5
6640580|NCT02336360|7568936|FG000|STARTED|Overall Study||6
6640581|NCT02336360|7568936|FG000|COMPLETED|Overall Study||6
6513482|NCT01504412|7433470|FG003|COMPLETED|Overall Study||75
6513483|NCT01504412|7433471|FG004|COMPLETED|Overall Study||77
6513484|NCT01504412|7433467|FG000|NOT COMPLETED|Overall Study||5
6513485|NCT01504412|7433468|FG001|NOT COMPLETED|Overall Study||12
6513486|NCT01504412|7433469|FG002|NOT COMPLETED|Overall Study||4
6513487|NCT01504412|7433470|FG003|NOT COMPLETED|Overall Study||19
6513488|NCT01504412|7433471|FG004|NOT COMPLETED|Overall Study||13
6513489|NCT01504477|7433483|FG000|STARTED|Overall Study||6
6513490|NCT01504477|7433483|FG000|COMPLETED|Overall Study||6
6513491|NCT01504477|7433483|FG000|NOT COMPLETED|Overall Study||0
6513492|NCT01504672|7433489|FG000|STARTED|Overall Study||230
6513493|NCT01504672|7433490|FG001|STARTED|Overall Study||230
6513494|NCT01504672|7433489|FG000|COMPLETED|Overall Study||212
6513495|NCT01504672|7433490|FG001|COMPLETED|Overall Study||217
6513496|NCT01504672|7433489|FG000|NOT COMPLETED|Overall Study||18
6513497|NCT01504672|7433490|FG001|NOT COMPLETED|Overall Study||13
6513498|NCT01504711|7433498|FG000|STARTED|Overall Study||30
6513499|NCT01504711|7433498|FG000|COMPLETED|Overall Study||27
6513500|NCT01504711|7433498|FG000|NOT COMPLETED|Overall Study||3
6513501|NCT01504841|7433505|FG000|STARTED|Overall Study||20
6513502|NCT01504841|7433506|FG001|STARTED|Overall Study||6
6561351|NCT01792635|7484157|FG001|NOT COMPLETED|Part A||0
6561352|NCT01792635|7484158|FG002|NOT COMPLETED|Part A||0
6561353|NCT01792635|7484156|FG000|STARTED|Part B||0
6561354|NCT01792635|7484157|FG001|STARTED|Part B||6
6561355|NCT01792635|7484158|FG002|STARTED|Part B||7
6561356|NCT01792635|7484156|FG000|COMPLETED|Part B||0
6513503|NCT01504841|7433507|FG002|STARTED|Overall Study|No enrollments occurred into Cohort 3 during the study.|0
6513504|NCT01504841|7433505|FG000|COMPLETED|Overall Study||19
6513505|NCT01504841|7433506|FG001|COMPLETED|Overall Study||5
6513506|NCT01504841|7433507|FG002|COMPLETED|Overall Study||0
6513507|NCT01504841|7433505|FG000|NOT COMPLETED|Overall Study||1
6513508|NCT01504841|7433506|FG001|NOT COMPLETED|Overall Study||1
6513509|NCT01504841|7433507|FG002|NOT COMPLETED|Overall Study||0
6513510|NCT01504854|7433516|FG000|STARTED|Overall Study||64
6513511|NCT01504854|7433517|FG001|STARTED|Overall Study||55
6513512|NCT01504854|7433516|FG000|COMPLETED|Overall Study||56
6513513|NCT01504854|7433517|FG001|COMPLETED|Overall Study||48
6513514|NCT01504854|7433516|FG000|NOT COMPLETED|Overall Study||8
6640582|NCT02336360|7568936|FG000|NOT COMPLETED|Overall Study||0
6640583|NCT02336373|7568940|FG000|STARTED|Overall Study||32
6640584|NCT02336373|7568940|FG000|COMPLETED|Overall Study||14
6640585|NCT02336373|7568940|FG000|NOT COMPLETED|Overall Study||18
6640586|NCT02336438|7568946|FG000|STARTED|Overall Study||11
6640587|NCT02336438|7568946|FG000|COMPLETED|Overall Study||10
6640588|NCT02336438|7568946|FG000|NOT COMPLETED|Overall Study||1
6640589|NCT02336451|7568955|FG000|STARTED|Overall Study||42
6640590|NCT02336451|7568956|FG001|STARTED|Overall Study||40
6640591|NCT02336451|7568957|FG002|STARTED|Overall Study||12
6640592|NCT02336451|7568958|FG003|STARTED|Overall Study||44
6640593|NCT02336451|7568959|FG004|STARTED|Overall Study||18
6640594|NCT02336451|7568955|FG000|COMPLETED|Overall Study||0
6640595|NCT02336451|7568956|FG001|COMPLETED|Overall Study||0
6640596|NCT02336451|7568957|FG002|COMPLETED|Overall Study||0
6640597|NCT02336451|7568958|FG003|COMPLETED|Overall Study||0
6640598|NCT02336451|7568959|FG004|COMPLETED|Overall Study||0
6640599|NCT02336451|7568955|FG000|NOT COMPLETED|Overall Study||42
6640600|NCT02336451|7568956|FG001|NOT COMPLETED|Overall Study||40
6640601|NCT02336451|7568957|FG002|NOT COMPLETED|Overall Study||12
6640602|NCT02336451|7568958|FG003|NOT COMPLETED|Overall Study||44
6640603|NCT02336451|7568959|FG004|NOT COMPLETED|Overall Study||18
6640604|NCT02336555|7568975|FG000|STARTED|Treatment Period 1 (28 Days)||18
6640605|NCT02336555|7568976|FG001|STARTED|Treatment Period 1 (28 Days)||17
6640606|NCT02336555|7568975|FG000|COMPLETED|Treatment Period 1 (28 Days)||16
6640607|NCT02336555|7568976|FG001|COMPLETED|Treatment Period 1 (28 Days)||16
6640608|NCT02336555|7568975|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||2
6640609|NCT02336555|7568976|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6640610|NCT02336555|7568975|FG000|STARTED|Treatment Period 2 (28 Days)||16
6640611|NCT02336555|7568976|FG001|STARTED|Treatment Period 2 (28 Days)||16
6640612|NCT02336555|7568975|FG000|COMPLETED|Treatment Period 2 (28 Days)||16
6640613|NCT02336555|7568976|FG001|COMPLETED|Treatment Period 2 (28 Days)||15
6640614|NCT02336555|7568975|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6640615|NCT02336555|7568976|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6640616|NCT02336594|7568986|FG000|STARTED|Overall Study||3
6640617|NCT02336594|7568987|FG001|STARTED|Overall Study||4
6640618|NCT02336594|7568988|FG002|STARTED|Overall Study||4
6640619|NCT02336594|7568989|FG003|STARTED|Overall Study||4
6640620|NCT02336594|7568986|FG000|COMPLETED|Overall Study||3
6640621|NCT02336594|7568987|FG001|COMPLETED|Overall Study||4
6640622|NCT02336594|7568988|FG002|COMPLETED|Overall Study||4
6640623|NCT02336594|7568989|FG003|COMPLETED|Overall Study||4
6640624|NCT02336594|7568986|FG000|NOT COMPLETED|Overall Study||0
6640625|NCT02336594|7568987|FG001|NOT COMPLETED|Overall Study||0
6640626|NCT02336594|7568988|FG002|NOT COMPLETED|Overall Study||0
6640627|NCT02336594|7568989|FG003|NOT COMPLETED|Overall Study||0
6640628|NCT02336607|7569006|FG000|STARTED|Overall Study||85
6640629|NCT02336607|7569007|FG001|STARTED|Overall Study||85
6640630|NCT02336607|7569008|FG002|STARTED|Overall Study||92
6640631|NCT02336607|7569009|FG003|STARTED|Overall Study||267
6640632|NCT02336607|7569006|FG000|Patients Included in ITT Population|Overall Study||84
6640633|NCT02336607|7569007|FG001|Patients Included in ITT Population|Overall Study||84
6640634|NCT02336607|7569008|FG002|Patients Included in ITT Population|Overall Study||91
6640635|NCT02336607|7569009|FG003|Patients Included in ITT Population|Overall Study||222
6640636|NCT02336607|7569006|FG000|Patients Included in PP Population|Overall Study||78
6640637|NCT02336607|7569007|FG001|Patients Included in PP Population|Overall Study||75
6640638|NCT02336607|7569008|FG002|Patients Included in PP Population|Overall Study||75
6640639|NCT02336607|7569009|FG003|Patients Included in PP Population|Overall Study||162
6640640|NCT02336607|7569006|FG000|Patients Included in Safety Population|Overall Study||85
6640641|NCT02336607|7569007|FG001|Patients Included in Safety Population|Overall Study||85
6640642|NCT02336607|7569008|FG002|Patients Included in Safety Population|Overall Study||92
6640643|NCT02336607|7569009|FG003|Patients Included in Safety Population|Overall Study||260
6640644|NCT02336607|7569006|FG000|COMPLETED|Overall Study||81
6640645|NCT02336607|7569007|FG001|COMPLETED|Overall Study||75
6640646|NCT02336607|7569008|FG002|COMPLETED|Overall Study||86
6640647|NCT02336607|7569009|FG003|COMPLETED|Overall Study||180
6640648|NCT02336607|7569006|FG000|NOT COMPLETED|Overall Study||4
6640649|NCT02336607|7569007|FG001|NOT COMPLETED|Overall Study||10
6640650|NCT02336607|7569008|FG002|NOT COMPLETED|Overall Study||6
6640651|NCT02336607|7569009|FG003|NOT COMPLETED|Overall Study||87
6513515|NCT01504854|7433517|FG001|NOT COMPLETED|Overall Study||7
6640652|NCT02336737|7569019|FG000|STARTED|Overall Study||160
6640653|NCT02336737|7569019|FG000|COMPLETED|Overall Study||147
6640654|NCT02336737|7569019|FG000|NOT COMPLETED|Overall Study||13
6513516|NCT01504867|7433525|FG000|STARTED|Overall Study||202
6513517|NCT01504867|7433526|FG001|STARTED|Overall Study||198
6513518|NCT01504867|7433525|FG000|COMPLETED|Overall Study||195
6513519|NCT01504867|7433526|FG001|COMPLETED|Overall Study||195
6513520|NCT01504867|7433525|FG000|NOT COMPLETED|Overall Study||7
6513521|NCT01504867|7433526|FG001|NOT COMPLETED|Overall Study||3
6513522|NCT01504958|7433535|FG000|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
6513523|NCT01504958|7433536|FG001|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
6513524|NCT01504958|7433537|FG002|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
6513525|NCT01504958|7433535|FG000|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
6513526|NCT01504958|7433536|FG001|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
6513527|NCT01504958|7433537|FG002|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
6513528|NCT01504958|7433535|FG000|NOT COMPLETED|Overall Study||0
6513529|NCT01504958|7433536|FG001|NOT COMPLETED|Overall Study||0
6513530|NCT01504958|7433537|FG002|NOT COMPLETED|Overall Study||0
6513531|NCT01504971|7433545|FG000|STARTED|Overall Study||95
6513532|NCT01504971|7433545|FG000|COMPLETED|Overall Study||82
6513533|NCT01504971|7433545|FG000|NOT COMPLETED|Overall Study||13
6513534|NCT01504997|7433553|FG000|STARTED|Overall Study||18
6513535|NCT01504997|7433553|FG000|COMPLETED|Overall Study||18
6513536|NCT01504997|7433553|FG000|NOT COMPLETED|Overall Study||0
6513537|NCT01505010|7433559|FG000|STARTED|Overall Study||9
6513538|NCT01505010|7433560|FG001|STARTED|Overall Study||8
6513539|NCT01505010|7433559|FG000|COMPLETED|Overall Study||9
6513540|NCT01505010|7433560|FG001|COMPLETED|Overall Study||6
6640655|NCT02336815|7569026|FG000|STARTED|Overall Study||79
6640656|NCT02336815|7569027|FG001|STARTED|Overall Study||123
6640657|NCT02336815|7569026|FG000|COMPLETED|Overall Study||0
6640658|NCT02336815|7569027|FG001|COMPLETED|Overall Study||0
6640659|NCT02336815|7569026|FG000|NOT COMPLETED|Overall Study||79
6640660|NCT02336815|7569027|FG001|NOT COMPLETED|Overall Study||123
6640661|NCT02336958|7569037|FG000|STARTED|Overall Study||20
6640662|NCT02336958|7569038|FG001|STARTED|Overall Study||20
6640663|NCT02336958|7569037|FG000|COMPLETED|Overall Study||20
6640664|NCT02336958|7569038|FG001|COMPLETED|Overall Study||20
6640665|NCT02336958|7569037|FG000|NOT COMPLETED|Overall Study||0
6640666|NCT02336958|7569038|FG001|NOT COMPLETED|Overall Study||0
6640667|NCT02337062|7569046|FG000|STARTED|Overall Study||572
6640668|NCT02337062|7569047|FG001|STARTED|Overall Study||575
6640669|NCT02337062|7569046|FG000|COMPLETED|Overall Study||555
6640670|NCT02337062|7569047|FG001|COMPLETED|Overall Study||556
6640671|NCT02337062|7569046|FG000|NOT COMPLETED|Overall Study||17
6640672|NCT02337062|7569047|FG001|NOT COMPLETED|Overall Study||19
6640673|NCT02337218|7569057|FG000|STARTED|Overall Study||17
6640674|NCT02337218|7569058|FG001|STARTED|Overall Study||11
6640675|NCT02337218|7569057|FG000|COMPLETED|Overall Study||17
6640676|NCT02337218|7569058|FG001|COMPLETED|Overall Study||11
6640677|NCT02337218|7569057|FG000|NOT COMPLETED|Overall Study||0
6640678|NCT02337218|7569058|FG001|NOT COMPLETED|Overall Study||0
6640679|NCT02337361|7569066|FG000|STARTED|Baseline Assessment||99
6640680|NCT02337361|7569067|FG001|STARTED|Baseline Assessment||86
6640681|NCT02337361|7569066|FG000|COMPLETED|Baseline Assessment||99
6640682|NCT02337361|7569067|FG001|COMPLETED|Baseline Assessment||86
6640683|NCT02337361|7569066|FG000|NOT COMPLETED|Baseline Assessment||0
6640684|NCT02337361|7569067|FG001|NOT COMPLETED|Baseline Assessment||0
6640685|NCT02337361|7569066|FG000|STARTED|3-month Follow-up||99
6640686|NCT02337361|7569067|FG001|STARTED|3-month Follow-up||86
6640687|NCT02337361|7569066|FG000|COMPLETED|3-month Follow-up||80
6640688|NCT02337361|7569067|FG001|COMPLETED|3-month Follow-up||72
6640689|NCT02337361|7569066|FG000|NOT COMPLETED|3-month Follow-up||19
6640690|NCT02337361|7569067|FG001|NOT COMPLETED|3-month Follow-up||14
6640691|NCT02337361|7569066|FG000|STARTED|6-month Follow-up||80
6640692|NCT02337361|7569067|FG001|STARTED|6-month Follow-up||72
6640693|NCT02337361|7569066|FG000|COMPLETED|6-month Follow-up||78
6640694|NCT02337361|7569067|FG001|COMPLETED|6-month Follow-up||68
6640695|NCT02337361|7569066|FG000|NOT COMPLETED|6-month Follow-up||2
6640696|NCT02337361|7569067|FG001|NOT COMPLETED|6-month Follow-up||4
6640697|NCT02337387|7569078|FG000|STARTED|Overall Study||14
6640698|NCT02337387|7569079|FG001|STARTED|Overall Study||8
6640699|NCT02337387|7569080|FG002|STARTED|Overall Study||3
6640700|NCT02337387|7569081|FG003|STARTED|Overall Study||3
6640701|NCT02337387|7569078|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
6640702|NCT02337387|7569079|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
6640703|NCT02337387|7569080|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6640704|NCT02337387|7569081|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6640705|NCT02337387|7569078|FG000|COMPLETED|Overall Study||0
6640706|NCT02337387|7569079|FG001|COMPLETED|Overall Study||0
6640707|NCT02337387|7569080|FG002|COMPLETED|Overall Study||0
6640708|NCT02337387|7569081|FG003|COMPLETED|Overall Study||0
6513541|NCT01505010|7433559|FG000|NOT COMPLETED|Overall Study||0
6513542|NCT01505010|7433560|FG001|NOT COMPLETED|Overall Study||2
6640709|NCT02337387|7569078|FG000|NOT COMPLETED|Overall Study||14
6640710|NCT02337387|7569079|FG001|NOT COMPLETED|Overall Study||8
6640711|NCT02337387|7569080|FG002|NOT COMPLETED|Overall Study||3
6640712|NCT02337387|7569081|FG003|NOT COMPLETED|Overall Study||3
6640713|NCT02337465|7569091|FG000|STARTED|Overall Study||30
6640714|NCT02337465|7569091|FG000|COMPLETED|Overall Study||30
6513552|NCT01505114|7433583|FG000|STARTED|Overall Study||148
6513553|NCT01505114|7433584|FG001|STARTED|Overall Study||148
6513554|NCT01505114|7433585|FG002|STARTED|Overall Study||147
6513555|NCT01505114|7433586|FG003|STARTED|Overall Study||151
6513556|NCT01505114|7433583|FG000|COMPLETED|Overall Study||123
6513557|NCT01505114|7433584|FG001|COMPLETED|Overall Study||135
6513558|NCT01505114|7433585|FG002|COMPLETED|Overall Study||129
6513559|NCT01505114|7433586|FG003|COMPLETED|Overall Study||128
6513560|NCT01505114|7433583|FG000|NOT COMPLETED|Overall Study||25
6513561|NCT01505114|7433584|FG001|NOT COMPLETED|Overall Study||13
6513562|NCT01505114|7433585|FG002|NOT COMPLETED|Overall Study||18
6513563|NCT01505114|7433586|FG003|NOT COMPLETED|Overall Study||23
6513564|NCT01505166|7433599|FG000|STARTED|Overall Study||3
6640715|NCT02337465|7569091|FG000|NOT COMPLETED|Overall Study||0
6640716|NCT02337478|7569095|FG000|STARTED|Overall Study||5
6640717|NCT02337478|7569095|FG000|COMPLETED|Overall Study||0
6640718|NCT02337478|7569095|FG000|NOT COMPLETED|Overall Study||5
6640719|NCT02337491|7569101|FG000|STARTED|Overall Study||50
6640720|NCT02337491|7569102|FG001|STARTED|Overall Study||30
6640721|NCT02337491|7569101|FG000|COMPLETED|Overall Study||0
6640722|NCT02337491|7569102|FG001|COMPLETED|Overall Study||0
6640723|NCT02337491|7569101|FG000|NOT COMPLETED|Overall Study||50
6640724|NCT02337491|7569102|FG001|NOT COMPLETED|Overall Study||30
6640725|NCT02337517|7569109|FG000|STARTED|Overall Study||6
6640726|NCT02337517|7569109|FG000|COMPLETED|Overall Study||6
6640727|NCT02337517|7569109|FG000|NOT COMPLETED|Overall Study||0
6640728|NCT02337530|7569116|FG000|STARTED|Overall Study||20
6640729|NCT02337530|7569117|FG001|STARTED|Overall Study||21
6640730|NCT02337530|7569118|FG002|STARTED|Overall Study||21
6640731|NCT02337530|7569116|FG000|COMPLETED|Overall Study||20
6640732|NCT02337530|7569117|FG001|COMPLETED|Overall Study||21
6640733|NCT02337530|7569118|FG002|COMPLETED|Overall Study||21
6640734|NCT02337530|7569116|FG000|NOT COMPLETED|Overall Study||0
6640735|NCT02337530|7569117|FG001|NOT COMPLETED|Overall Study||0
6640736|NCT02337530|7569118|FG002|NOT COMPLETED|Overall Study||0
6640737|NCT02337907|7569132|FG000|STARTED|Overall Study||55
6640738|NCT02337907|7569133|FG001|STARTED|Overall Study||53
6640739|NCT02337907|7569134|FG002|STARTED|Overall Study||55
6640740|NCT02337907|7569135|FG003|STARTED|Overall Study||55
6640741|NCT02337907|7569136|FG004|STARTED|Overall Study||106
6640742|NCT02337907|7569137|FG005|STARTED|Overall Study||5
6513565|NCT01505166|7433600|FG001|STARTED|Overall Study||0
6640743|NCT02337907|7569132|FG000|COMPLETED|Overall Study||51
6640744|NCT02337907|7569133|FG001|COMPLETED|Overall Study||49
6640745|NCT02337907|7569134|FG002|COMPLETED|Overall Study||54
6640746|NCT02337907|7569135|FG003|COMPLETED|Overall Study||51
6640747|NCT02337907|7569136|FG004|COMPLETED|Overall Study||96
6640748|NCT02337907|7569137|FG005|COMPLETED|Overall Study||4
6640749|NCT02337907|7569132|FG000|NOT COMPLETED|Overall Study||4
6640750|NCT02337907|7569133|FG001|NOT COMPLETED|Overall Study||4
6640751|NCT02337907|7569134|FG002|NOT COMPLETED|Overall Study||1
6640752|NCT02337907|7569135|FG003|NOT COMPLETED|Overall Study||4
6640753|NCT02337907|7569136|FG004|NOT COMPLETED|Overall Study||10
6640754|NCT02337907|7569137|FG005|NOT COMPLETED|Overall Study||1
6640755|NCT02337933|7569154|FG000|STARTED|Overall Study||12
6640756|NCT02337933|7569155|FG001|STARTED|Overall Study||12
6640757|NCT02337933|7569154|FG000|COMPLETED|Overall Study||12
6640758|NCT02337933|7569155|FG001|COMPLETED|Overall Study||12
6640759|NCT02337933|7569154|FG000|NOT COMPLETED|Overall Study||0
6640760|NCT02337933|7569155|FG001|NOT COMPLETED|Overall Study||0
6640761|NCT02337946|7569161|FG000|STARTED|Protocol Treatment 1 Period||164
6640762|NCT02337946|7569162|FG001|STARTED|Protocol Treatment 1 Period||0
6640763|NCT02337946|7569163|FG002|STARTED|Protocol Treatment 1 Period||0
6640764|NCT02337946|7569161|FG000|COMPLETED|Protocol Treatment 1 Period||114
6640765|NCT02337946|7569162|FG001|COMPLETED|Protocol Treatment 1 Period||0
6640766|NCT02337946|7569163|FG002|COMPLETED|Protocol Treatment 1 Period||0
6640767|NCT02337946|7569161|FG000|NOT COMPLETED|Protocol Treatment 1 Period||50
6640768|NCT02337946|7569162|FG001|NOT COMPLETED|Protocol Treatment 1 Period||0
6640769|NCT02337946|7569163|FG002|NOT COMPLETED|Protocol Treatment 1 Period||0
6513566|NCT01505166|7433601|FG002|STARTED|Overall Study||0
6513567|NCT01505166|7433599|FG000|COMPLETED|Overall Study|"Completed means subject had successful Vigil manufacturing and had been given all the doses."|3
6513568|NCT01505166|7433600|FG001|COMPLETED|Overall Study||0
6513569|NCT01505166|7433601|FG002|COMPLETED|Overall Study||0
6640770|NCT02337946|7569161|FG000|STARTED|In-between Period||114
6640771|NCT02337946|7569162|FG001|STARTED|In-between Period||0
6640772|NCT02337946|7569163|FG002|STARTED|In-between Period||0
6640773|NCT02337946|7569161|FG000|COMPLETED|In-between Period||113
6640774|NCT02337946|7569162|FG001|COMPLETED|In-between Period||0
6640775|NCT02337946|7569163|FG002|COMPLETED|In-between Period||0
6640776|NCT02337946|7569161|FG000|NOT COMPLETED|In-between Period||1
6640777|NCT02337946|7569162|FG001|NOT COMPLETED|In-between Period||0
6640778|NCT02337946|7569163|FG002|NOT COMPLETED|In-between Period||0
6640779|NCT02337946|7569161|FG000|STARTED|Protocol Treatment 2 Period||0
6513570|NCT01505166|7433599|FG000|NOT COMPLETED|Overall Study||0
6513571|NCT01505166|7433600|FG001|NOT COMPLETED|Overall Study||0
6513572|NCT01505166|7433601|FG002|NOT COMPLETED|Overall Study||0
6513573|NCT01505179|7433613|FG000|STARTED|Overall Study||6
6640780|NCT02337946|7569162|FG001|STARTED|Protocol Treatment 2 Period||56
6640781|NCT02337946|7569163|FG002|STARTED|Protocol Treatment 2 Period||57
6640782|NCT02337946|7569161|FG000|Safety Population|Protocol Treatment 2 Period||0
6640783|NCT02337946|7569162|FG001|Safety Population|Protocol Treatment 2 Period||56
6640784|NCT02337946|7569163|FG002|Safety Population|Protocol Treatment 2 Period||54
6640785|NCT02337946|7569161|FG000|COMPLETED|Protocol Treatment 2 Period||0
6640786|NCT02337946|7569162|FG001|COMPLETED|Protocol Treatment 2 Period||5
6640787|NCT02337946|7569163|FG002|COMPLETED|Protocol Treatment 2 Period||7
6640788|NCT02337946|7569161|FG000|NOT COMPLETED|Protocol Treatment 2 Period||0
6640789|NCT02337946|7569162|FG001|NOT COMPLETED|Protocol Treatment 2 Period||51
6640790|NCT02337946|7569163|FG002|NOT COMPLETED|Protocol Treatment 2 Period||50
6640791|NCT02337959|7569172|FG000|STARTED|Overall Study||10
6640792|NCT02337959|7569173|FG001|STARTED|Overall Study||10
6640793|NCT02337959|7569174|FG002|STARTED|Overall Study||7
6640794|NCT02337959|7569172|FG000|COMPLETED|Overall Study||10
6640795|NCT02337959|7569173|FG001|COMPLETED|Overall Study||7
6640796|NCT02337959|7569174|FG002|COMPLETED|Overall Study||7
6640797|NCT02337959|7569172|FG000|NOT COMPLETED|Overall Study||0
6640798|NCT02337959|7569173|FG001|NOT COMPLETED|Overall Study||3
6640799|NCT02337959|7569174|FG002|NOT COMPLETED|Overall Study||0
6640800|NCT02338076|7569182|FG000|STARTED|Overall Study||20
6640801|NCT02338076|7569182|FG000|COMPLETED|Overall Study||20
6640802|NCT02338076|7569182|FG000|NOT COMPLETED|Overall Study||0
6640803|NCT02338154|7569188|FG000|STARTED|Overall Study||516
6640804|NCT02338154|7569188|FG000|Enrolled Cohort (Intent to Treat)|Overall Study||516
6640805|NCT02338154|7569188|FG000|INTUITY (Study Valve Cohort)|Overall Study||493
6640806|NCT02338154|7569188|FG000|COMPLETED|Overall Study||373
6640807|NCT02338154|7569188|FG000|NOT COMPLETED|Overall Study||143
6640808|NCT02338193|7569203|FG000|STARTED|Overall Study||20
6640809|NCT02338193|7569204|FG001|STARTED|Overall Study||21
6640810|NCT02338193|7569205|FG002|STARTED|Overall Study||25
6640811|NCT02338193|7569203|FG000|COMPLETED|Overall Study||17
6640812|NCT02338193|7569204|FG001|COMPLETED|Overall Study||17
6640813|NCT02338193|7569205|FG002|COMPLETED|Overall Study||15
6640814|NCT02338193|7569203|FG000|NOT COMPLETED|Overall Study||3
6640815|NCT02338193|7569204|FG001|NOT COMPLETED|Overall Study||4
6640816|NCT02338193|7569205|FG002|NOT COMPLETED|Overall Study||10
6640817|NCT02338336|7569215|FG000|STARTED|Overall Study||26
6640818|NCT02338336|7569216|FG001|STARTED|Overall Study||17
6640819|NCT02338336|7569217|FG002|STARTED|Overall Study||7
6640820|NCT02338336|7569218|FG003|STARTED|Overall Study||4
6640821|NCT02338336|7569215|FG000|COMPLETED|Overall Study||24
6640822|NCT02338336|7569216|FG001|COMPLETED|Overall Study||17
6640823|NCT02338336|7569217|FG002|COMPLETED|Overall Study||7
6640824|NCT02338336|7569218|FG003|COMPLETED|Overall Study||4
6640825|NCT02338336|7569215|FG000|NOT COMPLETED|Overall Study||2
6640826|NCT02338336|7569216|FG001|NOT COMPLETED|Overall Study||0
6640827|NCT02338336|7569217|FG002|NOT COMPLETED|Overall Study||0
6640828|NCT02338336|7569218|FG003|NOT COMPLETED|Overall Study||0
6640829|NCT02338362|7569226|FG000|STARTED|Overall Study||11
6640830|NCT02338362|7569227|FG001|STARTED|Overall Study||11
6640831|NCT02338362|7569226|FG000|COMPLETED|Overall Study||10
6640832|NCT02338362|7569227|FG001|COMPLETED|Overall Study||10
6640833|NCT02338362|7569226|FG000|NOT COMPLETED|Overall Study||1
6640834|NCT02338362|7569227|FG001|NOT COMPLETED|Overall Study||1
6640835|NCT02338492|7569233|FG000|STARTED|Overall Study||81
6640836|NCT02338492|7569233|FG000|Enrolled|Overall Study||81
6640837|NCT02338492|7569233|FG000|Device Implanted|Overall Study||79
6640838|NCT02338492|7569233|FG000|Treatment Failure|Overall Study||2
6640839|NCT02338492|7569233|FG000|COMPLETED|Overall Study||36
6640840|NCT02338492|7569233|FG000|NOT COMPLETED|Overall Study||45
6640841|NCT02338713|7569237|FG000|STARTED|Overall Study||27
6640842|NCT02338713|7569237|FG000|COMPLETED|Overall Study||27
6640843|NCT02338713|7569237|FG000|NOT COMPLETED|Overall Study||0
6640844|NCT02338843|7569245|FG000|STARTED|Overall Study||163
6640845|NCT02338843|7569246|FG001|STARTED|Overall Study||158
6640846|NCT02338843|7569245|FG000|COMPLETED|Overall Study||119
6640847|NCT02338843|7569246|FG001|COMPLETED|Overall Study||100
6640848|NCT02338843|7569245|FG000|NOT COMPLETED|Overall Study||44
6513574|NCT01505179|7433614|FG001|STARTED|Overall Study||4
6640849|NCT02338843|7569246|FG001|NOT COMPLETED|Overall Study||58
6640850|NCT02338882|7569254|FG000|STARTED|Overall Study||50
6640851|NCT02338882|7569255|FG001|STARTED|Overall Study||50
6640852|NCT02338882|7569254|FG000|COMPLETED|Overall Study||43
6640853|NCT02338882|7569255|FG001|COMPLETED|Overall Study||47
6640854|NCT02338882|7569254|FG000|NOT COMPLETED|Overall Study||7
6640855|NCT02338882|7569255|FG001|NOT COMPLETED|Overall Study||3
6640856|NCT02338960|7569266|FG000|STARTED|Core Study||306
6640857|NCT02338960|7569267|FG001|STARTED|Core Study||308
6640858|NCT02338960|7569266|FG000|Received Intervention|Core Study||303
6640859|NCT02338960|7569267|FG001|Received Intervention|Core Study||301
6640860|NCT02338960|7569266|FG000|COMPLETED|Core Study||219
6513575|NCT01505179|7433613|FG000|COMPLETED|Overall Study||6
6640861|NCT02338960|7569267|FG001|COMPLETED|Core Study||173
6640862|NCT02338960|7569266|FG000|NOT COMPLETED|Core Study||87
6640863|NCT02338960|7569267|FG001|NOT COMPLETED|Core Study||135
6640864|NCT02338960|7569266|FG000|STARTED|Open Label Extension||191
6513576|NCT01505179|7433614|FG001|COMPLETED|Overall Study||4
6513577|NCT01505179|7433613|FG000|NOT COMPLETED|Overall Study||0
6513578|NCT01505179|7433614|FG001|NOT COMPLETED|Overall Study||0
6513579|NCT01505374|7433620|FG000|STARTED|Overall Study||30
6513580|NCT01505374|7433621|FG001|STARTED|Overall Study||30
6513581|NCT01505374|7433620|FG000|COMPLETED|Overall Study||29
6513582|NCT01505374|7433621|FG001|COMPLETED|Overall Study||30
6513583|NCT01505374|7433620|FG000|NOT COMPLETED|Overall Study||1
6513584|NCT01505374|7433621|FG001|NOT COMPLETED|Overall Study||0
6513585|NCT01505387|7433630|FG000|STARTED|Overall Study||25
6513586|NCT01505387|7433631|FG001|STARTED|Overall Study||25
6513587|NCT01505387|7433630|FG000|Treated|Overall Study||24
6513588|NCT01505387|7433631|FG001|Treated|Overall Study||24
6513589|NCT01505387|7433630|FG000|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
6513590|NCT01505387|7433631|FG001|COMPLETED|Overall Study||24
6640865|NCT02338960|7569267|FG001|STARTED|Open Label Extension||130
6640866|NCT02338960|7569266|FG000|COMPLETED|Open Label Extension||77
6640867|NCT02338960|7569267|FG001|COMPLETED|Open Label Extension||51
6640868|NCT02338960|7569266|FG000|NOT COMPLETED|Open Label Extension||114
6640869|NCT02338960|7569267|FG001|NOT COMPLETED|Open Label Extension||79
6640870|NCT02338973|7569278|FG000|STARTED|Overall Study||4
6640871|NCT02338973|7569278|FG000|Rod-cone Dystrophy (RCD)|Overall Study||2
6640872|NCT02338973|7569278|FG000|Enhanced S-Cone Syndrome (ESCS)|Overall Study||2
6640873|NCT02338973|7569278|FG000|COMPLETED|Overall Study||4
6640874|NCT02338973|7569278|FG000|NOT COMPLETED|Overall Study||0
6640875|NCT02338999|7569361|FG000|STARTED|First Intervention||39
6640876|NCT02338999|7569362|FG001|STARTED|First Intervention||41
6640877|NCT02338999|7569361|FG000|COMPLETED|First Intervention||36
6640878|NCT02338999|7569362|FG001|COMPLETED|First Intervention||40
6640879|NCT02338999|7569361|FG000|NOT COMPLETED|First Intervention||3
6640880|NCT02338999|7569362|FG001|NOT COMPLETED|First Intervention||1
6640881|NCT02338999|7569361|FG000|STARTED|Washout Period||36
6640882|NCT02338999|7569362|FG001|STARTED|Washout Period||40
6640883|NCT02338999|7569361|FG000|COMPLETED|Washout Period||36
6640884|NCT02338999|7569362|FG001|COMPLETED|Washout Period||38
6640885|NCT02338999|7569361|FG000|NOT COMPLETED|Washout Period||0
6640886|NCT02338999|7569362|FG001|NOT COMPLETED|Washout Period||2
6640887|NCT02338999|7569361|FG000|STARTED|Second Intervention||36
6640888|NCT02338999|7569362|FG001|STARTED|Second Intervention||38
6640889|NCT02338999|7569361|FG000|COMPLETED|Second Intervention||36
6640890|NCT02338999|7569362|FG001|COMPLETED|Second Intervention||36
6640891|NCT02338999|7569361|FG000|NOT COMPLETED|Second Intervention||0
6640892|NCT02338999|7569362|FG001|NOT COMPLETED|Second Intervention||2
6640893|NCT02339038|7569368|FG000|STARTED|Overall Study||600
6640894|NCT02339038|7569368|FG000|COMPLETED|Overall Study||0
6640895|NCT02339038|7569368|FG000|NOT COMPLETED|Overall Study||600
6640896|NCT02339155|7569374|FG000|STARTED|Overall Study||287
6640897|NCT02339155|7569375|FG001|STARTED|Overall Study||286
6640898|NCT02339155|7569374|FG000|Received Study Treatment|Overall Study||286
6640899|NCT02339155|7569375|FG001|Received Study Treatment|Overall Study||280
6640900|NCT02339155|7569374|FG000|COMPLETED|Overall Study||272
6640901|NCT02339155|7569375|FG001|COMPLETED|Overall Study||265
6640902|NCT02339155|7569374|FG000|NOT COMPLETED|Overall Study||15
6640903|NCT02339155|7569375|FG001|NOT COMPLETED|Overall Study||21
6640904|NCT02339246|7569385|FG000|STARTED|First Intervention (7 Days)||0
6640905|NCT02339246|7569386|FG001|STARTED|First Intervention (7 Days)||0
6640906|NCT02339246|7569387|FG002|STARTED|First Intervention (7 Days)||31
6640907|NCT02339246|7569385|FG000|COMPLETED|First Intervention (7 Days)||0
6640908|NCT02339246|7569386|FG001|COMPLETED|First Intervention (7 Days)||0
6640909|NCT02339246|7569387|FG002|COMPLETED|First Intervention (7 Days)||31
6640910|NCT02339246|7569385|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6640911|NCT02339246|7569386|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6640912|NCT02339246|7569387|FG002|NOT COMPLETED|First Intervention (7 Days)||0
6640913|NCT02339246|7569385|FG000|STARTED|Second Intervention (7 Days)||16
6640914|NCT02339246|7569386|FG001|STARTED|Second Intervention (7 Days)||15
6513591|NCT01505387|7433630|FG000|NOT COMPLETED|Overall Study||2
6640915|NCT02339246|7569387|FG002|STARTED|Second Intervention (7 Days)||0
6640916|NCT02339246|7569385|FG000|COMPLETED|Second Intervention (7 Days)||16
6640917|NCT02339246|7569386|FG001|COMPLETED|Second Intervention (7 Days)||15
6640918|NCT02339246|7569387|FG002|COMPLETED|Second Intervention (7 Days)||0
6640919|NCT02339246|7569385|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6640920|NCT02339246|7569386|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6640921|NCT02339246|7569387|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
6640922|NCT02339246|7569385|FG000|STARTED|Third Period (7 Days)||15
6640923|NCT02339246|7569386|FG001|STARTED|Third Period (7 Days)||16
6640924|NCT02339246|7569387|FG002|STARTED|Third Period (7 Days)||0
6640925|NCT02339246|7569385|FG000|COMPLETED|Third Period (7 Days)||15
6640926|NCT02339246|7569386|FG001|COMPLETED|Third Period (7 Days)||16
6640927|NCT02339246|7569387|FG002|COMPLETED|Third Period (7 Days)||0
6640928|NCT02339246|7569385|FG000|NOT COMPLETED|Third Period (7 Days)||0
6640929|NCT02339246|7569386|FG001|NOT COMPLETED|Third Period (7 Days)||0
6640930|NCT02339246|7569387|FG002|NOT COMPLETED|Third Period (7 Days)||0
6640931|NCT02339285|7569398|FG000|STARTED|Overall Study||10
6640932|NCT02339285|7569399|FG001|STARTED|Overall Study||11
6640933|NCT02339285|7569400|FG002|STARTED|Overall Study||11
6513592|NCT01505387|7433631|FG001|NOT COMPLETED|Overall Study||1
6513593|NCT01505465|7433639|FG000|STARTED|Overall Study||25
6513594|NCT01505465|7433640|FG001|STARTED|Overall Study||25
6513595|NCT01505465|7433639|FG000|COMPLETED|Overall Study||19
6513596|NCT01505465|7433640|FG001|COMPLETED|Overall Study||18
6513597|NCT01505465|7433639|FG000|NOT COMPLETED|Overall Study||6
6513598|NCT01505465|7433640|FG001|NOT COMPLETED|Overall Study||7
6513599|NCT01505491|7433649|FG000|STARTED|Overall Study||67
6513600|NCT01505491|7433650|FG001|STARTED|Overall Study||62
6513601|NCT01505491|7433651|FG002|STARTED|Overall Study||64
6513602|NCT01505491|7433649|FG000|COMPLETED|Overall Study||65
6513603|NCT01505491|7433650|FG001|COMPLETED|Overall Study||61
6513604|NCT01505491|7433651|FG002|COMPLETED|Overall Study||59
6513605|NCT01505491|7433649|FG000|NOT COMPLETED|Overall Study||2
6513606|NCT01505491|7433650|FG001|NOT COMPLETED|Overall Study||1
6513607|NCT01505491|7433651|FG002|NOT COMPLETED|Overall Study||5
6513608|NCT01505530|7433662|FG000|STARTED|Overall Study||41
6513609|NCT01505530|7433663|FG001|STARTED|Overall Study||43
6513610|NCT01505530|7433664|FG002|STARTED|Overall Study||41
6513611|NCT01505530|7433662|FG000|Received At Least One Dose of Study Drug|Overall Study||41
6513612|NCT01505530|7433663|FG001|Received At Least One Dose of Study Drug|Overall Study||42
6513613|NCT01505530|7433664|FG002|Received At Least One Dose of Study Drug|Overall Study||41
6513614|NCT01505530|7433662|FG000|Completed One Cycle of Study Drug|Overall Study||29
6513615|NCT01505530|7433663|FG001|Completed One Cycle of Study Drug|Overall Study||27
6513616|NCT01505530|7433664|FG002|Completed One Cycle of Study Drug|Overall Study||31
6513617|NCT01505530|7433662|FG000|COMPLETED|Overall Study||0
6513618|NCT01505530|7433663|FG001|COMPLETED|Overall Study||0
6513619|NCT01505530|7433664|FG002|COMPLETED|Overall Study||0
6513620|NCT01505530|7433662|FG000|NOT COMPLETED|Overall Study||41
6640934|NCT02339285|7569398|FG000|Completed Intervention|Overall Study||10
6640935|NCT02339285|7569399|FG001|Completed Intervention|Overall Study||10
6640936|NCT02339285|7569400|FG002|Completed Intervention|Overall Study||10
6640937|NCT02339285|7569398|FG000|2 Week Follow-up|Overall Study||9
6640938|NCT02339285|7569399|FG001|2 Week Follow-up|Overall Study||10
6640939|NCT02339285|7569400|FG002|2 Week Follow-up|Overall Study||10
6640940|NCT02339285|7569398|FG000|4 Week Follow-up Visit|Overall Study||9
6640941|NCT02339285|7569399|FG001|4 Week Follow-up Visit|Overall Study||8
6640942|NCT02339285|7569400|FG002|4 Week Follow-up Visit|Overall Study||9
6640943|NCT02339285|7569398|FG000|COMPLETED|Overall Study||9
6640944|NCT02339285|7569399|FG001|COMPLETED|Overall Study||8
6640945|NCT02339285|7569400|FG002|COMPLETED|Overall Study||9
6640946|NCT02339285|7569398|FG000|NOT COMPLETED|Overall Study||1
6640947|NCT02339285|7569399|FG001|NOT COMPLETED|Overall Study||3
6640948|NCT02339285|7569400|FG002|NOT COMPLETED|Overall Study||2
6640949|NCT02339389|7569408|FG000|STARTED|Overall Study||57
6640950|NCT02339389|7569408|FG000|COMPLETED|Overall Study||41
6640951|NCT02339389|7569408|FG000|NOT COMPLETED|Overall Study||16
6640952|NCT02339415|7569415|FG000|STARTED|First Period||22
6640953|NCT02339415|7569416|FG001|STARTED|First Period||22
6640954|NCT02339415|7569415|FG000|Received at Least One Dose|First Period||21
6640955|NCT02339415|7569416|FG001|Received at Least One Dose|First Period||20
6640956|NCT02339415|7569415|FG000|COMPLETED|First Period||20
6640957|NCT02339415|7569416|FG001|COMPLETED|First Period||20
6640958|NCT02339415|7569415|FG000|NOT COMPLETED|First Period||2
6640959|NCT02339415|7569416|FG001|NOT COMPLETED|First Period||2
6640960|NCT02339415|7569415|FG000|STARTED|Washout||20
6513621|NCT01505530|7433663|FG001|NOT COMPLETED|Overall Study||43
6513622|NCT01505530|7433664|FG002|NOT COMPLETED|Overall Study||41
6640961|NCT02339415|7569416|FG001|STARTED|Washout||20
6640962|NCT02339415|7569415|FG000|COMPLETED|Washout||20
6640963|NCT02339415|7569416|FG001|COMPLETED|Washout||20
6640964|NCT02339415|7569415|FG000|NOT COMPLETED|Washout||0
6640965|NCT02339415|7569416|FG001|NOT COMPLETED|Washout||0
6640966|NCT02339415|7569415|FG000|STARTED|Second Period||20
6640967|NCT02339415|7569416|FG001|STARTED|Second Period||20
6640968|NCT02339415|7569415|FG000|COMPLETED|Second Period||19
6640969|NCT02339415|7569416|FG001|COMPLETED|Second Period||18
6640970|NCT02339415|7569415|FG000|NOT COMPLETED|Second Period||1
6640971|NCT02339415|7569416|FG001|NOT COMPLETED|Second Period||2
6640972|NCT02339506|7569424|FG000|STARTED|Period 1 (Placebo or Cosyntropin)||12
6640973|NCT02339506|7569425|FG001|STARTED|Period 1 (Placebo or Cosyntropin)||11
6640974|NCT02339506|7569424|FG000|COMPLETED|Period 1 (Placebo or Cosyntropin)||12
6640975|NCT02339506|7569425|FG001|COMPLETED|Period 1 (Placebo or Cosyntropin)||10
6640976|NCT02339506|7569424|FG000|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||0
6640977|NCT02339506|7569425|FG001|NOT COMPLETED|Period 1 (Placebo or Cosyntropin)||1
6640978|NCT02339506|7569424|FG000|STARTED|Washout (Period 2)||12
6640979|NCT02339506|7569425|FG001|STARTED|Washout (Period 2)||10
6640980|NCT02339506|7569424|FG000|COMPLETED|Washout (Period 2)||10
6640981|NCT02339506|7569425|FG001|COMPLETED|Washout (Period 2)||10
6640982|NCT02339506|7569424|FG000|NOT COMPLETED|Washout (Period 2)||2
6640983|NCT02339506|7569425|FG001|NOT COMPLETED|Washout (Period 2)||0
6640984|NCT02339506|7569424|FG000|STARTED|Period 3 (Placebo or Cosyntropin)||10
6640985|NCT02339506|7569425|FG001|STARTED|Period 3 (Placebo or Cosyntropin)||10
6640986|NCT02339506|7569424|FG000|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
6640987|NCT02339506|7569425|FG001|COMPLETED|Period 3 (Placebo or Cosyntropin)||10
6640988|NCT02339506|7569424|FG000|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
6640989|NCT02339506|7569425|FG001|NOT COMPLETED|Period 3 (Placebo or Cosyntropin)||0
6640990|NCT02339545|7569431|FG000|STARTED|Overall Study||15
6640991|NCT02339545|7569431|FG000|COMPLETED|Overall Study||15
6640992|NCT02339545|7569431|FG000|NOT COMPLETED|Overall Study||0
6513623|NCT01505634|7433675|FG000|STARTED|Overall Study||101
6513624|NCT01505634|7433676|FG001|STARTED|Overall Study||101
6513625|NCT01505634|7433677|FG002|STARTED|Overall Study||100
6513626|NCT01505634|7433675|FG000|Treated|Overall Study||99
6513627|NCT01505634|7433676|FG001|Treated|Overall Study||99
6513628|NCT01505634|7433677|FG002|Treated|Overall Study||100
6513629|NCT01505634|7433675|FG000|COMPLETED|Overall Study||92
6513630|NCT01505634|7433676|FG001|COMPLETED|Overall Study||91
6513631|NCT01505634|7433677|FG002|COMPLETED|Overall Study||94
6513632|NCT01505634|7433675|FG000|NOT COMPLETED|Overall Study||9
6513633|NCT01505634|7433676|FG001|NOT COMPLETED|Overall Study||10
6513634|NCT01505634|7433677|FG002|NOT COMPLETED|Overall Study||6
6513635|NCT01505647|7433687|FG000|STARTED|Day 1 Through Day 42 Follow-up||332
6513636|NCT01505647|7433688|FG001|STARTED|Day 1 Through Day 42 Follow-up||166
6513637|NCT01505647|7433687|FG000|Vaccinated|Day 1 Through Day 42 Follow-up||331
6640993|NCT02339558|7569436|FG000|STARTED|Overall Study||45
6640994|NCT02339558|7569436|FG000|COMPLETED|Overall Study||45
6640995|NCT02339558|7569436|FG000|NOT COMPLETED|Overall Study||0
6640996|NCT02339584|7569442|FG000|STARTED|Overall Study||188
6640997|NCT02339584|7569443|FG001|STARTED|Overall Study||191
6640998|NCT02339584|7569442|FG000|COMPLETED|Overall Study||173
6640999|NCT02339584|7569443|FG001|COMPLETED|Overall Study||176
6641000|NCT02339584|7569442|FG000|NOT COMPLETED|Overall Study||15
6641001|NCT02339584|7569443|FG001|NOT COMPLETED|Overall Study||15
6641002|NCT02339831|7569451|FG000|STARTED|Overall Study||58
6641003|NCT02339831|7569452|FG001|STARTED|Overall Study||52
6641004|NCT02339831|7569451|FG000|Lost to Follow Up|Overall Study||20
6641005|NCT02339831|7569452|FG001|Lost to Follow Up|Overall Study||7
6641006|NCT02339831|7569451|FG000|COMPLETED|Overall Study||38
6641007|NCT02339831|7569452|FG001|COMPLETED|Overall Study||45
6641008|NCT02339831|7569451|FG000|NOT COMPLETED|Overall Study||20
6641009|NCT02339831|7569452|FG001|NOT COMPLETED|Overall Study||7
6655777|NCT02455076|7585921|FG001|COMPLETED|Outpatient||0
6655778|NCT02455076|7585922|FG002|COMPLETED|Outpatient||0
6655779|NCT02455076|7585923|FG003|COMPLETED|Outpatient||42
6655780|NCT02455076|7585924|FG004|COMPLETED|Outpatient||43
6655781|NCT02455076|7585920|FG000|NOT COMPLETED|Outpatient||0
6655782|NCT02455076|7585921|FG001|NOT COMPLETED|Outpatient||0
6655783|NCT02455076|7585922|FG002|NOT COMPLETED|Outpatient||0
6655784|NCT02455076|7585923|FG003|NOT COMPLETED|Outpatient||6
6655785|NCT02455076|7585924|FG004|NOT COMPLETED|Outpatient||12
6655786|NCT02455167|7585936|FG000|STARTED|Overall Study||4
6655787|NCT02455167|7585936|FG000|COMPLETED|Overall Study||4
6655788|NCT02455167|7585936|FG000|NOT COMPLETED|Overall Study||0
6655789|NCT02455336|7585942|FG000|STARTED|Overall Study||15
6655790|NCT02455336|7585943|FG001|STARTED|Overall Study||8
6655791|NCT02455336|7585942|FG000|COMPLETED|Overall Study||10
6655792|NCT02455336|7585943|FG001|COMPLETED|Overall Study||6
6655793|NCT02455336|7585942|FG000|NOT COMPLETED|Overall Study||5
6655794|NCT02455336|7585943|FG001|NOT COMPLETED|Overall Study||2
6655795|NCT02455388|7585951|FG000|STARTED|Overall Study||18
6655796|NCT02455388|7585952|FG001|STARTED|Overall Study||15
6655797|NCT02455388|7585953|FG002|STARTED|Overall Study||337
6655798|NCT02455388|7585951|FG000|COMPLETED|Overall Study||17
6655799|NCT02455388|7585952|FG001|COMPLETED|Overall Study||15
6655800|NCT02455388|7585953|FG002|COMPLETED|Overall Study||326
6655801|NCT02455388|7585951|FG000|NOT COMPLETED|Overall Study||1
6655802|NCT02455388|7585952|FG001|NOT COMPLETED|Overall Study||0
6655803|NCT02455388|7585953|FG002|NOT COMPLETED|Overall Study||11
6655804|NCT02455453|7585961|FG000|STARTED|Overall Study||47
6655805|NCT02455453|7585961|FG000|COMPLETED|Overall Study||47
6655806|NCT02455453|7585961|FG000|NOT COMPLETED|Overall Study||0
6655807|NCT02455518|7585969|FG000|STARTED|Overall Study||104
6655808|NCT02455518|7585970|FG001|STARTED|Overall Study||104
6655809|NCT02455518|7585971|FG002|STARTED|Overall Study||104
6655810|NCT02455518|7585972|FG003|STARTED|Overall Study||104
6655811|NCT02455518|7585969|FG000|COMPLETED|Overall Study||104
6655812|NCT02455518|7585970|FG001|COMPLETED|Overall Study||103
6655813|NCT02455518|7585971|FG002|COMPLETED|Overall Study||103
6655814|NCT02455518|7585972|FG003|COMPLETED|Overall Study||101
6655815|NCT02455518|7585969|FG000|NOT COMPLETED|Overall Study||0
6655816|NCT02455518|7585970|FG001|NOT COMPLETED|Overall Study||1
6655817|NCT02455518|7585971|FG002|NOT COMPLETED|Overall Study||1
6655818|NCT02455518|7585972|FG003|NOT COMPLETED|Overall Study||3
6655819|NCT02456103|7585982|FG000|STARTED|Overall Study||246
6655820|NCT02456103|7585982|FG000|As-Treated Population|Overall Study||245
6655821|NCT02456103|7585982|FG000|Intent-to-treat (ITT) Population|Overall Study||244
6513638|NCT01505647|7433688|FG001|Vaccinated|Day 1 Through Day 42 Follow-up||166
6513639|NCT01505647|7433687|FG000|COMPLETED|Day 1 Through Day 42 Follow-up||329
6513640|NCT01505647|7433688|FG001|COMPLETED|Day 1 Through Day 42 Follow-up||166
6655822|NCT02456103|7585982|FG000|COMPLETED|Overall Study||0
6655823|NCT02456103|7585982|FG000|NOT COMPLETED|Overall Study||246
6655824|NCT02456636|7585989|FG000|STARTED|Overall Study||478
6655825|NCT02456636|7585990|FG001|STARTED|Overall Study||479
6655826|NCT02456636|7585991|FG002|STARTED|Overall Study||475
6655827|NCT02456636|7585989|FG000|6 Month|Overall Study||474
6655828|NCT02456636|7585990|FG001|6 Month|Overall Study||474
6655829|NCT02456636|7585991|FG002|6 Month|Overall Study||468
6655830|NCT02456636|7585989|FG000|18 Month|Overall Study||467
6655831|NCT02456636|7585990|FG001|18 Month|Overall Study||463
6655832|NCT02456636|7585991|FG002|18 Month|Overall Study||461
6655833|NCT02456636|7585989|FG000|COMPLETED|Overall Study||410
6655834|NCT02456636|7585990|FG001|COMPLETED|Overall Study||410
6513641|NCT01505647|7433687|FG000|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
6513642|NCT01505647|7433688|FG001|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
6513643|NCT01505647|7433687|FG000|STARTED|Day 43 Through Day 182 Follow-up||329
6513644|NCT01505647|7433688|FG001|STARTED|Day 43 Through Day 182 Follow-up||166
6513645|NCT01505647|7433687|FG000|COMPLETED|Day 43 Through Day 182 Follow-up||328
6513646|NCT01505647|7433688|FG001|COMPLETED|Day 43 Through Day 182 Follow-up||163
6513647|NCT01505647|7433687|FG000|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
6513648|NCT01505647|7433688|FG001|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
6513649|NCT01505673|7433696|FG000|STARTED|Overall Study||35
6513650|NCT01505673|7433697|FG001|STARTED|Overall Study||36
6513651|NCT01505673|7433696|FG000|COMPLETED|Overall Study||32
6513652|NCT01505673|7433697|FG001|COMPLETED|Overall Study||34
6513653|NCT01505673|7433696|FG000|NOT COMPLETED|Overall Study||3
6513654|NCT01505673|7433697|FG001|NOT COMPLETED|Overall Study||2
6513655|NCT01505764|7433705|FG000|STARTED|Overall Study||6
6513656|NCT01505764|7433706|FG001|STARTED|Overall Study||3
6513657|NCT01505764|7433705|FG000|COMPLETED|Overall Study||3
6513658|NCT01505764|7433706|FG001|COMPLETED|Overall Study||2
6513659|NCT01505764|7433705|FG000|NOT COMPLETED|Overall Study||3
6513660|NCT01505764|7433706|FG001|NOT COMPLETED|Overall Study||1
6513661|NCT01505868|7433718|FG000|STARTED|Overall Study||4
6513662|NCT01505868|7433719|FG001|STARTED|Overall Study||3
6513663|NCT01505868|7433720|FG002|STARTED|Overall Study||3
6513664|NCT01505868|7433721|FG003|STARTED|Overall Study||79
6513665|NCT01505868|7433722|FG004|STARTED|Overall Study||81
6513666|NCT01505868|7433718|FG000|COMPLETED|Overall Study||3
6513667|NCT01505868|7433719|FG001|COMPLETED|Overall Study||3
6513668|NCT01505868|7433720|FG002|COMPLETED|Overall Study||3
6513669|NCT01505868|7433721|FG003|COMPLETED|Overall Study||79
6513670|NCT01505868|7433722|FG004|COMPLETED|Overall Study||81
6513671|NCT01505868|7433718|FG000|NOT COMPLETED|Overall Study||1
6513672|NCT01505868|7433719|FG001|NOT COMPLETED|Overall Study||0
6513673|NCT01505868|7433720|FG002|NOT COMPLETED|Overall Study||0
6513674|NCT01505868|7433721|FG003|NOT COMPLETED|Overall Study||0
6513675|NCT01505868|7433722|FG004|NOT COMPLETED|Overall Study||0
6513676|NCT01505881|7433736|FG000|STARTED|Overall Study||99
6513677|NCT01505881|7433737|FG001|STARTED|Overall Study||59
6513678|NCT01505881|7433736|FG000|COMPLETED|Overall Study||95
6513679|NCT01505881|7433737|FG001|COMPLETED|Overall Study||58
6513680|NCT01505881|7433736|FG000|NOT COMPLETED|Overall Study||4
6513681|NCT01505881|7433737|FG001|NOT COMPLETED|Overall Study||1
6513682|NCT01505933|7433746|FG000|STARTED|Overall Study||10
6513683|NCT01505933|7433747|FG001|STARTED|Overall Study||14
6513684|NCT01505933|7433746|FG000|COMPLETED|Overall Study||10
6513685|NCT01505933|7433747|FG001|COMPLETED|Overall Study||14
6513686|NCT01505933|7433746|FG000|NOT COMPLETED|Overall Study||0
6513687|NCT01505933|7433747|FG001|NOT COMPLETED|Overall Study||0
6513688|NCT01506193|7433756|FG000|STARTED|Overall Study||351
6513689|NCT01506193|7433757|FG001|STARTED|Overall Study||183
6513690|NCT01506193|7433758|FG002|STARTED|Overall Study||182
6513691|NCT01506193|7433756|FG000|COMPLETED|Overall Study||337
6513692|NCT01506193|7433757|FG001|COMPLETED|Overall Study||179
6513693|NCT01506193|7433758|FG002|COMPLETED|Overall Study||168
6513694|NCT01506193|7433756|FG000|NOT COMPLETED|Overall Study||14
6513695|NCT01506193|7433757|FG001|NOT COMPLETED|Overall Study||4
6513696|NCT01506193|7433758|FG002|NOT COMPLETED|Overall Study||14
6513697|NCT01506271|7433770|FG000|STARTED|Overall Study||118
6513698|NCT01506271|7433771|FG001|STARTED|Overall Study||116
6513699|NCT01506271|7433772|FG002|STARTED|Overall Study||117
6513700|NCT01506271|7433770|FG000|Treated|Overall Study||117
6513701|NCT01506271|7433771|FG001|Treated|Overall Study||116
6513702|NCT01506271|7433772|FG002|Treated|Overall Study||114
6513703|NCT01506271|7433770|FG000|COMPLETED|Overall Study||114
6513704|NCT01506271|7433771|FG001|COMPLETED|Overall Study||109
6513705|NCT01506271|7433772|FG002|COMPLETED|Overall Study||114
6513706|NCT01506271|7433770|FG000|NOT COMPLETED|Overall Study||4
6513707|NCT01506271|7433771|FG001|NOT COMPLETED|Overall Study||7
6513708|NCT01506271|7433772|FG002|NOT COMPLETED|Overall Study||3
6513709|NCT01506323|7433782|FG000|STARTED|Overall Study||89
6513710|NCT01506323|7433783|FG001|STARTED|Overall Study||84
6513711|NCT01506323|7433782|FG000|Post-treatment Completers|Overall Study||69
6513712|NCT01506323|7433783|FG001|Post-treatment Completers|Overall Study||72
6513713|NCT01506323|7433782|FG000|Post-treatment Completed CAPS|Overall Study||68
6513714|NCT01506323|7433783|FG001|Post-treatment Completed CAPS|Overall Study||72
6513715|NCT01506323|7433782|FG000|COMPLETED|Overall Study||65
6513716|NCT01506323|7433783|FG001|COMPLETED|Overall Study||71
6513717|NCT01506323|7433782|FG000|NOT COMPLETED|Overall Study||24
6513718|NCT01506323|7433783|FG001|NOT COMPLETED|Overall Study||13
6513719|NCT01506362|7433794|FG000|STARTED|Overall Study||22
6513720|NCT01506362|7433794|FG000|COMPLETED|Overall Study||16
6513721|NCT01506362|7433794|FG000|NOT COMPLETED|Overall Study||6
6513722|NCT01506453|7433800|FG000|STARTED|Overall Study||25
6513723|NCT01506453|7433801|FG001|STARTED|Overall Study||26
6513724|NCT01506453|7433800|FG000|COMPLETED|Overall Study||25
6513725|NCT01506453|7433801|FG001|COMPLETED|Overall Study||24
6513726|NCT01506453|7433800|FG000|NOT COMPLETED|Overall Study||0
6513727|NCT01506453|7433801|FG001|NOT COMPLETED|Overall Study||2
6513728|NCT01506479|7433810|FG000|STARTED|Overall Study||40
6513729|NCT01506479|7433811|FG001|STARTED|Overall Study||43
6513730|NCT01506479|7433812|FG002|STARTED|Overall Study||45
6513731|NCT01506479|7433810|FG000|COMPLETED|Overall Study||37
6513732|NCT01506479|7433811|FG001|COMPLETED|Overall Study||38
6513733|NCT01506479|7433812|FG002|COMPLETED|Overall Study||42
6513734|NCT01506479|7433810|FG000|NOT COMPLETED|Overall Study||3
6513735|NCT01506479|7433811|FG001|NOT COMPLETED|Overall Study||5
6513736|NCT01506479|7433812|FG002|NOT COMPLETED|Overall Study||3
6513737|NCT01506596|7433822|FG000|STARTED|Overall Study||42
6513738|NCT01506596|7433822|FG000|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
6513739|NCT01506596|7433822|FG000|NOT COMPLETED|Overall Study||1
6513740|NCT01506609|7433832|FG000|STARTED|Overall Study||2
6513741|NCT01506609|7433833|FG001|STARTED|Overall Study||1
6513742|NCT01506609|7433834|FG002|STARTED|Overall Study||1
6513743|NCT01506609|7433835|FG003|STARTED|Overall Study||99
6513744|NCT01506609|7433836|FG004|STARTED|Overall Study||97
6513745|NCT01506609|7433837|FG005|STARTED|Overall Study||94
6513746|NCT01506609|7433832|FG000|COMPLETED|Overall Study||0
6513747|NCT01506609|7433833|FG001|COMPLETED|Overall Study||0
6513748|NCT01506609|7433834|FG002|COMPLETED|Overall Study||0
6513749|NCT01506609|7433835|FG003|COMPLETED|Overall Study||0
6513750|NCT01506609|7433836|FG004|COMPLETED|Overall Study||1
6513751|NCT01506609|7433837|FG005|COMPLETED|Overall Study||0
6513752|NCT01506609|7433832|FG000|NOT COMPLETED|Overall Study||2
6513753|NCT01506609|7433833|FG001|NOT COMPLETED|Overall Study||1
6513754|NCT01506609|7433834|FG002|NOT COMPLETED|Overall Study||1
6513755|NCT01506609|7433835|FG003|NOT COMPLETED|Overall Study||99
6513756|NCT01506609|7433836|FG004|NOT COMPLETED|Overall Study||96
6513757|NCT01506609|7433837|FG005|NOT COMPLETED|Overall Study||94
6513758|NCT01506726|7433850|FG000|STARTED|Overall Study||6
6513759|NCT01506726|7433851|FG001|STARTED|Overall Study||5
6513760|NCT01506726|7433850|FG000|COMPLETED|Overall Study||5
6513761|NCT01506726|7433851|FG001|COMPLETED|Overall Study||3
6513762|NCT01506726|7433850|FG000|NOT COMPLETED|Overall Study||1
6513763|NCT01506726|7433851|FG001|NOT COMPLETED|Overall Study||2
6513764|NCT01506882|7433859|FG000|STARTED|Overall Study||61
6513765|NCT01506882|7433860|FG001|STARTED|Overall Study||10
6513766|NCT01506882|7433859|FG000|COMPLETED|Overall Study||39
6513767|NCT01506882|7433860|FG001|COMPLETED|Overall Study||3
6513768|NCT01506882|7433859|FG000|NOT COMPLETED|Overall Study||22
6513769|NCT01506882|7433860|FG001|NOT COMPLETED|Overall Study||7
6513770|NCT01506908|7433870|FG000|STARTED|Overall Study||162
6513771|NCT01506908|7433871|FG001|STARTED|Overall Study||161
6513772|NCT01506908|7433870|FG000|COMPLETED|Overall Study||161
6513773|NCT01506908|7433871|FG001|COMPLETED|Overall Study||161
6513774|NCT01506908|7433870|FG000|NOT COMPLETED|Overall Study||1
6513775|NCT01506908|7433871|FG001|NOT COMPLETED|Overall Study||0
6513776|NCT01506947|7433879|FG000|STARTED|Overall Study||65
6513777|NCT01506947|7433879|FG000|COMPLETED|Overall Study||49
6513778|NCT01506947|7433879|FG000|NOT COMPLETED|Overall Study||16
6513779|NCT01506960|7433885|FG000|STARTED|Overall Study||64
6513780|NCT01506960|7433885|FG000|COMPLETED|Overall Study||17
6513781|NCT01506960|7433885|FG000|NOT COMPLETED|Overall Study||47
6513782|NCT01507051|7433895|FG000|STARTED|Overall Study||29
6513783|NCT01507051|7433896|FG001|STARTED|Overall Study||31
6513784|NCT01507051|7433897|FG002|STARTED|Overall Study||29
6513785|NCT01507051|7433898|FG003|STARTED|Overall Study||7
6513786|NCT01507051|7433895|FG000|Warfarin run-in Phase|Overall Study||28
6513787|NCT01507051|7433896|FG001|Warfarin run-in Phase|Overall Study||28
6513788|NCT01507051|7433897|FG002|Warfarin run-in Phase|Overall Study||0
6513789|NCT01507051|7433898|FG003|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
6513790|NCT01507051|7433895|FG000|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
6513791|NCT01507051|7433896|FG001|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
6513792|NCT01507051|7433897|FG002|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
6513793|NCT01507051|7433898|FG003|Received Placebo or Rivaroxaban|Overall Study||0
6513794|NCT01507051|7433895|FG000|COMPLETED|Overall Study||27
6513795|NCT01507051|7433896|FG001|COMPLETED|Overall Study||28
6513796|NCT01507051|7433897|FG002|COMPLETED|Overall Study||28
6513797|NCT01507051|7433898|FG003|COMPLETED|Overall Study||0
6513798|NCT01507051|7433895|FG000|NOT COMPLETED|Overall Study||2
6513799|NCT01507051|7433896|FG001|NOT COMPLETED|Overall Study||3
6513800|NCT01507051|7433897|FG002|NOT COMPLETED|Overall Study||1
6513801|NCT01507051|7433898|FG003|NOT COMPLETED|Overall Study||7
6513802|NCT01507090|7433908|FG000|STARTED|Overall Study||642
6513803|NCT01507090|7433908|FG000|COMPLETED|Overall Study||624
6513804|NCT01507090|7433908|FG000|NOT COMPLETED|Overall Study||18
6513805|NCT01507103|7433920|FG000|STARTED|Overall Study||41
6513806|NCT01507103|7433921|FG001|STARTED|Overall Study||41
6513807|NCT01507103|7433922|FG002|STARTED|Overall Study||42
6513808|NCT01507103|7433920|FG000|COMPLETED|Overall Study||41
6513809|NCT01507103|7433921|FG001|COMPLETED|Overall Study||41
6513810|NCT01507103|7433922|FG002|COMPLETED|Overall Study||42
6513811|NCT01507103|7433920|FG000|NOT COMPLETED|Overall Study||0
6513812|NCT01507103|7433921|FG001|NOT COMPLETED|Overall Study||0
6513813|NCT01507103|7433922|FG002|NOT COMPLETED|Overall Study||0
6513814|NCT01507155|7433930|FG000|STARTED|Overall Study||625
6513815|NCT01507155|7433931|FG001|STARTED|Overall Study||60
6513816|NCT01507155|7433930|FG000|COMPLETED|Overall Study||625
6513817|NCT01507155|7433931|FG001|COMPLETED|Overall Study||60
6513818|NCT01507155|7433930|FG000|NOT COMPLETED|Overall Study||0
6513819|NCT01507155|7433931|FG001|NOT COMPLETED|Overall Study||0
6513820|NCT01507181|7433938|FG000|STARTED|Overall Study||12
6513821|NCT01507181|7433939|FG001|STARTED|Overall Study||12
6513822|NCT01507181|7433938|FG000|COMPLETED|Overall Study||12
6513823|NCT01507181|7433939|FG001|COMPLETED|Overall Study||12
6513824|NCT01507181|7433938|FG000|NOT COMPLETED|Overall Study||0
6513825|NCT01507181|7433939|FG001|NOT COMPLETED|Overall Study||0
6513826|NCT01507220|7433947|FG000|STARTED|Overall Study||2
6513827|NCT01507220|7433948|FG001|STARTED|Overall Study||0
6513828|NCT01507220|7433947|FG000|COMPLETED|Overall Study||2
6513829|NCT01507220|7433948|FG001|COMPLETED|Overall Study||0
6513830|NCT01507220|7433947|FG000|NOT COMPLETED|Overall Study||0
6513831|NCT01507220|7433948|FG001|NOT COMPLETED|Overall Study||0
6513832|NCT01507246|7433956|FG000|STARTED|Overall Study||20
6513833|NCT01507246|7433957|FG001|STARTED|Overall Study||22
6513834|NCT01507246|7433956|FG000|COMPLETED|Overall Study||18
6513835|NCT01507246|7433957|FG001|COMPLETED|Overall Study||21
6513836|NCT01507246|7433956|FG000|NOT COMPLETED|Overall Study||2
6513837|NCT01507246|7433957|FG001|NOT COMPLETED|Overall Study||1
6513838|NCT01507298|7433968|FG000|STARTED|Overall Study||1
6513839|NCT01507298|7433969|FG001|STARTED|Overall Study||20
6513840|NCT01507298|7433968|FG000|COMPLETED|Overall Study||1
6513841|NCT01507298|7433969|FG001|COMPLETED|Overall Study||14
6513842|NCT01507298|7433968|FG000|NOT COMPLETED|Overall Study||0
6513843|NCT01507298|7433969|FG001|NOT COMPLETED|Overall Study||6
6513844|NCT01507350|7433976|FG000|STARTED|Overall Study||9
6513845|NCT01507350|7433976|FG000|COMPLETED|Overall Study||9
6513846|NCT01507350|7433976|FG000|NOT COMPLETED|Overall Study||0
6513847|NCT01507493|7433982|FG000|STARTED|Overall Study||22
6513848|NCT01507493|7433983|FG001|STARTED|Overall Study||178
6513849|NCT01507493|7433982|FG000|COMPLETED|Overall Study||22
6513850|NCT01507493|7433983|FG001|COMPLETED|Overall Study||178
6513851|NCT01507493|7433982|FG000|NOT COMPLETED|Overall Study||0
6513852|NCT01507493|7433983|FG001|NOT COMPLETED|Overall Study||0
6513853|NCT01507662|7433991|FG000|STARTED|Overall Study||3898
6513854|NCT01507662|7433992|FG001|STARTED|Overall Study||3851
6513855|NCT01507662|7433991|FG000|COMPLETED|Overall Study||3082
6513856|NCT01507662|7433992|FG001|COMPLETED|Overall Study||3020
6513857|NCT01507662|7433991|FG000|NOT COMPLETED|Overall Study||816
6513858|NCT01507662|7433992|FG001|NOT COMPLETED|Overall Study||831
6513859|NCT01507688|7434000|FG000|STARTED|Baseline to 6 Month Assessment||129
6513860|NCT01507688|7434001|FG001|STARTED|Baseline to 6 Month Assessment||129
6513861|NCT01507688|7434000|FG000|COMPLETED|Baseline to 6 Month Assessment||113
6513862|NCT01507688|7434001|FG001|COMPLETED|Baseline to 6 Month Assessment||119
6513863|NCT01507688|7434000|FG000|NOT COMPLETED|Baseline to 6 Month Assessment||16
6513864|NCT01507688|7434001|FG001|NOT COMPLETED|Baseline to 6 Month Assessment||10
6513865|NCT01507688|7434000|FG000|STARTED|6 Month to 12 Month Assessment||113
6513866|NCT01507688|7434001|FG001|STARTED|6 Month to 12 Month Assessment||119
6513867|NCT01507688|7434000|FG000|COMPLETED|6 Month to 12 Month Assessment||108
6513868|NCT01507688|7434001|FG001|COMPLETED|6 Month to 12 Month Assessment||116
6513869|NCT01507688|7434000|FG000|NOT COMPLETED|6 Month to 12 Month Assessment||5
6513870|NCT01507688|7434001|FG001|NOT COMPLETED|6 Month to 12 Month Assessment||3
6513871|NCT01507779|7434009|FG000|STARTED|Overall Study||23
6513872|NCT01507779|7434010|FG001|STARTED|Overall Study||25
6513873|NCT01507779|7434009|FG000|COMPLETED|Overall Study||23
6513874|NCT01507779|7434010|FG001|COMPLETED|Overall Study||25
6513875|NCT01507779|7434009|FG000|NOT COMPLETED|Overall Study||0
6513876|NCT01507779|7434010|FG001|NOT COMPLETED|Overall Study||0
6513877|NCT01507831|7434020|FG000|STARTED|Overall Study|Randomized|788
6513878|NCT01507831|7434021|FG001|STARTED|Overall Study|Randomized|1553
6513879|NCT01507831|7434020|FG000|Treated|Overall Study||788
6513880|NCT01507831|7434021|FG001|Treated|Overall Study||1550
6513881|NCT01507831|7434020|FG000|COMPLETED|Overall Study||595
6513882|NCT01507831|7434021|FG001|COMPLETED|Overall Study||1113
6513883|NCT01507831|7434020|FG000|NOT COMPLETED|Overall Study||193
6513884|NCT01507831|7434021|FG001|NOT COMPLETED|Overall Study||440
6513885|NCT01507896|7434027|FG000|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
6513886|NCT01507896|7434027|FG000|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
6513887|NCT01507896|7434027|FG000|NOT COMPLETED|Overall Study||2
6513888|NCT01507987|7434040|FG000|STARTED|Overall Study||982
6513889|NCT01507987|7434041|FG001|STARTED|Overall Study||670
6513890|NCT01507987|7434042|FG002|STARTED|Overall Study||458
6513891|NCT01507987|7434043|FG003|STARTED|Overall Study||737
6513892|NCT01507987|7434040|FG000|COMPLETED|Overall Study||618
6513893|NCT01507987|7434041|FG001|COMPLETED|Overall Study||335
6513894|NCT01507987|7434042|FG002|COMPLETED|Overall Study||252
6513895|NCT01507987|7434043|FG003|COMPLETED|Overall Study||480
6513896|NCT01507987|7434040|FG000|NOT COMPLETED|Overall Study||364
6513897|NCT01507987|7434041|FG001|NOT COMPLETED|Overall Study||335
6513898|NCT01507987|7434042|FG002|NOT COMPLETED|Overall Study||206
6513899|NCT01507987|7434043|FG003|NOT COMPLETED|Overall Study||257
6513900|NCT01508013|7434072|FG000|STARTED|Overall Study||214
6513901|NCT01508013|7434073|FG001|STARTED|Overall Study||229
6513902|NCT01508013|7434072|FG000|COMPLETED|Overall Study||182
6513903|NCT01508013|7434073|FG001|COMPLETED|Overall Study||206
6513904|NCT01508013|7434072|FG000|NOT COMPLETED|Overall Study||32
6513905|NCT01508013|7434073|FG001|NOT COMPLETED|Overall Study||23
6513906|NCT01508052|7434081|FG000|STARTED|Overall Study||20
6513907|NCT01508052|7434082|FG001|STARTED|Overall Study||20
6513908|NCT01508052|7434081|FG000|COMPLETED|Overall Study||20
6513909|NCT01508052|7434082|FG001|COMPLETED|Overall Study||20
6513910|NCT01508052|7434081|FG000|NOT COMPLETED|Overall Study||0
6513911|NCT01508052|7434082|FG001|NOT COMPLETED|Overall Study||0
6513912|NCT01508117|7434088|FG000|STARTED|Overall Study||1
6513913|NCT01508117|7434088|FG000|COMPLETED|Overall Study||1
6513914|NCT01508117|7434088|FG000|NOT COMPLETED|Overall Study||0
6513915|NCT01508130|7434094|FG000|STARTED|Overall Study||493
6513916|NCT01508130|7434095|FG001|STARTED|Overall Study||142
6513917|NCT01508130|7434094|FG000|mTRT|Overall Study||493
6513918|NCT01508130|7434095|FG001|mTRT|Overall Study||142
6513919|NCT01508130|7434094|FG000|COMPLETED|Overall Study||266
6513920|NCT01508130|7434095|FG001|COMPLETED|Overall Study||73
6513921|NCT01508130|7434094|FG000|NOT COMPLETED|Overall Study||227
6513922|NCT01508130|7434095|FG001|NOT COMPLETED|Overall Study||69
6513923|NCT01508169|7434105|FG000|STARTED|Overall Study||47
6513924|NCT01508169|7434106|FG001|STARTED|Overall Study||47
6513925|NCT01508169|7434105|FG000|COMPLETED|Overall Study||44
6513926|NCT01508169|7434106|FG001|COMPLETED|Overall Study||45
6513927|NCT01508169|7434105|FG000|NOT COMPLETED|Overall Study||3
6513928|NCT01508169|7434106|FG001|NOT COMPLETED|Overall Study||2
6513929|NCT01508325|7434120|FG000|STARTED|Overall Study||93
6513930|NCT01508325|7434121|FG001|STARTED|Overall Study||93
6513931|NCT01508325|7434120|FG000|COMPLETED|Overall Study||75
6513932|NCT01508325|7434121|FG001|COMPLETED|Overall Study||72
6513933|NCT01508325|7434120|FG000|NOT COMPLETED|Overall Study||18
6513934|NCT01508325|7434121|FG001|NOT COMPLETED|Overall Study||21
6513935|NCT01508455|7434127|FG000|STARTED|Overall Study||6
6641010|NCT02339909|7569461|FG000|STARTED|Overall Study||524
6641011|NCT02339909|7569462|FG001|STARTED|Overall Study||375
6513936|NCT01508455|7434127|FG000|COMPLETED|Overall Study||6
6513937|NCT01508455|7434127|FG000|NOT COMPLETED|Overall Study||0
6513938|NCT01508650|7434133|FG000|STARTED|Overall Study||12
6513939|NCT01508650|7434134|FG001|STARTED|Overall Study||15
6513940|NCT01508650|7434133|FG000|COMPLETED|Overall Study||12
6513941|NCT01508650|7434134|FG001|COMPLETED|Overall Study||12
6513942|NCT01508650|7434133|FG000|NOT COMPLETED|Overall Study||0
6513943|NCT01508650|7434134|FG001|NOT COMPLETED|Overall Study||3
6513944|NCT01508676|7434142|FG000|STARTED|Phase I (2 Weeks)||18
6513945|NCT01508676|7434143|FG001|STARTED|Phase I (2 Weeks)||17
6513946|NCT01508676|7434142|FG000|COMPLETED|Phase I (2 Weeks)||16
6513947|NCT01508676|7434143|FG001|COMPLETED|Phase I (2 Weeks)||14
6513948|NCT01508676|7434142|FG000|NOT COMPLETED|Phase I (2 Weeks)||2
6513949|NCT01508676|7434143|FG001|NOT COMPLETED|Phase I (2 Weeks)||3
6513950|NCT01508676|7434142|FG000|STARTED|Washout Period (1 Week)||16
6513951|NCT01508676|7434143|FG001|STARTED|Washout Period (1 Week)||14
6513952|NCT01508676|7434142|FG000|COMPLETED|Washout Period (1 Week)||16
6513953|NCT01508676|7434143|FG001|COMPLETED|Washout Period (1 Week)||14
6513954|NCT01508676|7434142|FG000|NOT COMPLETED|Washout Period (1 Week)||0
6513955|NCT01508676|7434143|FG001|NOT COMPLETED|Washout Period (1 Week)||0
6513956|NCT01508676|7434142|FG000|STARTED|Phase II (2 Weeks)||16
6513957|NCT01508676|7434143|FG001|STARTED|Phase II (2 Weeks)||14
6513958|NCT01508676|7434142|FG000|COMPLETED|Phase II (2 Weeks)||15
6513959|NCT01508676|7434143|FG001|COMPLETED|Phase II (2 Weeks)||13
6513960|NCT01508676|7434142|FG000|NOT COMPLETED|Phase II (2 Weeks)||1
6513961|NCT01508676|7434143|FG001|NOT COMPLETED|Phase II (2 Weeks)||1
6513962|NCT01508702|7434152|FG000|STARTED|Overall Study||107
6513963|NCT01508702|7434153|FG001|STARTED|Overall Study||107
6513964|NCT01508702|7434152|FG000|COMPLETED|Overall Study||84
6513965|NCT01508702|7434153|FG001|COMPLETED|Overall Study||94
6513966|NCT01508702|7434152|FG000|NOT COMPLETED|Overall Study||23
6513967|NCT01508702|7434153|FG001|NOT COMPLETED|Overall Study||13
6513968|NCT01508832|7434161|FG000|STARTED|Overall Study||6
6513969|NCT01508832|7434162|FG001|STARTED|Overall Study||6
6513970|NCT01508832|7434161|FG000|COMPLETED|Overall Study||6
6513971|NCT01508832|7434162|FG001|COMPLETED|Overall Study||6
6513972|NCT01508832|7434161|FG000|NOT COMPLETED|Overall Study||0
6513973|NCT01508832|7434162|FG001|NOT COMPLETED|Overall Study||0
6513974|NCT01508910|7434171|FG000|STARTED|Randomization||57
6513975|NCT01508910|7434172|FG001|STARTED|Randomization||27
6513976|NCT01508910|7434173|FG002|STARTED|Randomization||28
6513977|NCT01508910|7434174|FG003|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
6513978|NCT01508910|7434171|FG000|COMPLETED|Randomization||57
6513979|NCT01508910|7434172|FG001|COMPLETED|Randomization||27
6513980|NCT01508910|7434173|FG002|COMPLETED|Randomization||28
6513981|NCT01508910|7434174|FG003|COMPLETED|Randomization||0
6513982|NCT01508910|7434171|FG000|NOT COMPLETED|Randomization||0
6513983|NCT01508910|7434172|FG001|NOT COMPLETED|Randomization||0
6513984|NCT01508910|7434173|FG002|NOT COMPLETED|Randomization||0
6513985|NCT01508910|7434174|FG003|NOT COMPLETED|Randomization||0
6513986|NCT01508910|7434171|FG000|STARTED|Treatment||50
6641012|NCT02339909|7569463|FG002|STARTED|Overall Study||375
6513987|NCT01508910|7434172|FG001|STARTED|Treatment||28
6513988|NCT01508910|7434173|FG002|STARTED|Treatment||28
6513989|NCT01508910|7434174|FG003|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
6513990|NCT01508910|7434171|FG000|COMPLETED|Treatment||48
6513991|NCT01508910|7434172|FG001|COMPLETED|Treatment||24
6513992|NCT01508910|7434173|FG002|COMPLETED|Treatment||18
6513993|NCT01508910|7434174|FG003|COMPLETED|Treatment||3
6513994|NCT01508910|7434171|FG000|NOT COMPLETED|Treatment||2
6513995|NCT01508910|7434172|FG001|NOT COMPLETED|Treatment||4
6513996|NCT01508910|7434173|FG002|NOT COMPLETED|Treatment||10
6641013|NCT02339909|7569461|FG000|COMPLETED|Overall Study||435
6513997|NCT01508910|7434174|FG003|NOT COMPLETED|Treatment||3
6513998|NCT01508936|7434188|FG000|STARTED|Overall Study||102
6513999|NCT01508936|7434189|FG001|STARTED|Overall Study||409
6514000|NCT01508936|7434188|FG000|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
6514001|NCT01508936|7434189|FG001|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
6514002|NCT01508936|7434188|FG000|Randomized|Overall Study||98
6641014|NCT02339909|7569462|FG001|COMPLETED|Overall Study||312
6641015|NCT02339909|7569463|FG002|COMPLETED|Overall Study||304
6641016|NCT02339909|7569461|FG000|NOT COMPLETED|Overall Study||89
6641017|NCT02339909|7569462|FG001|NOT COMPLETED|Overall Study||63
6641018|NCT02339909|7569463|FG002|NOT COMPLETED|Overall Study||71
6641019|NCT02340000|7569473|FG000|STARTED|Time Period 1||90
6514003|NCT01508936|7434189|FG001|Randomized|Overall Study||398
6514004|NCT01508936|7434188|FG000|Randomized, Not Treated|Overall Study||1
6514005|NCT01508936|7434189|FG001|Randomized, Not Treated|Overall Study||3
6514006|NCT01508936|7434188|FG000|Safety Analysis Set|Overall Study||97
6514007|NCT01508936|7434189|FG001|Safety Analysis Set|Overall Study||395
6514008|NCT01508936|7434188|FG000|Full Analysis Set|Overall Study||97
6514009|NCT01508936|7434189|FG001|Full Analysis Set|Overall Study||395
6514010|NCT01508936|7434188|FG000|FEV1 Subpopulation Analysis Set|Overall Study||91
6514011|NCT01508936|7434189|FG001|FEV1 Subpopulation Analysis Set|Overall Study||346
6514012|NCT01508936|7434188|FG000|COMPLETED|Overall Study||79
6514013|NCT01508936|7434189|FG001|COMPLETED|Overall Study||330
6514014|NCT01508936|7434188|FG000|NOT COMPLETED|Overall Study||23
6514015|NCT01508936|7434189|FG001|NOT COMPLETED|Overall Study||79
6514016|NCT01509040|7434198|FG000|STARTED|Overall Study||0
6514017|NCT01509040|7434199|FG001|STARTED|Overall Study||2
6514018|NCT01509040|7434200|FG002|STARTED|Overall Study||0
6514019|NCT01509040|7434198|FG000|COMPLETED|Overall Study||0
6514020|NCT01509040|7434199|FG001|COMPLETED|Overall Study||1
6514021|NCT01509040|7434200|FG002|COMPLETED|Overall Study||0
6514022|NCT01509040|7434198|FG000|NOT COMPLETED|Overall Study||0
6514023|NCT01509040|7434199|FG001|NOT COMPLETED|Overall Study||1
6514024|NCT01509040|7434200|FG002|NOT COMPLETED|Overall Study||0
6514025|NCT01509079|7434217|FG000|STARTED|Overall Study||57
6514026|NCT01509079|7434218|FG001|STARTED|Overall Study||59
6514027|NCT01509079|7434217|FG000|COMPLETED|Overall Study||57
6514028|NCT01509079|7434218|FG001|COMPLETED|Overall Study||56
6514029|NCT01509079|7434217|FG000|NOT COMPLETED|Overall Study||0
6514030|NCT01509079|7434218|FG001|NOT COMPLETED|Overall Study||3
6514031|NCT01509105|7434224|FG000|STARTED|Overall Study||649
6514032|NCT01509105|7434224|FG000|COMPLETED|Overall Study||649
6514033|NCT01509105|7434224|FG000|NOT COMPLETED|Overall Study||0
6561357|NCT01792635|7484157|FG001|COMPLETED|Part B||2
6561358|NCT01792635|7484158|FG002|COMPLETED|Part B||3
6561359|NCT01792635|7484156|FG000|NOT COMPLETED|Part B||0
6561360|NCT01792635|7484157|FG001|NOT COMPLETED|Part B||4
6561361|NCT01792635|7484158|FG002|NOT COMPLETED|Part B||4
6561362|NCT01792817|7484169|FG000|STARTED|Phase 1 Double Blind Period||77
6561363|NCT01792817|7484170|FG001|STARTED|Phase 1 Double Blind Period||73
6561364|NCT01792817|7484171|FG002|STARTED|Phase 1 Double Blind Period||0
6561365|NCT01792817|7484169|FG000|COMPLETED|Phase 1 Double Blind Period||58
6561366|NCT01792817|7484170|FG001|COMPLETED|Phase 1 Double Blind Period||42
6561367|NCT01792817|7484171|FG002|COMPLETED|Phase 1 Double Blind Period||0
6561368|NCT01792817|7484169|FG000|NOT COMPLETED|Phase 1 Double Blind Period||19
6561369|NCT01792817|7484170|FG001|NOT COMPLETED|Phase 1 Double Blind Period||31
6561370|NCT01792817|7484171|FG002|NOT COMPLETED|Phase 1 Double Blind Period||0
6561371|NCT01792817|7484169|FG000|STARTED|Phase 2 Open Label||0
6561372|NCT01792817|7484170|FG001|STARTED|Phase 2 Open Label||0
6561373|NCT01792817|7484171|FG002|STARTED|Phase 2 Open Label||100
6561374|NCT01792817|7484169|FG000|COMPLETED|Phase 2 Open Label||0
6561375|NCT01792817|7484170|FG001|COMPLETED|Phase 2 Open Label||0
6561376|NCT01792817|7484171|FG002|COMPLETED|Phase 2 Open Label||74
6561377|NCT01792817|7484169|FG000|NOT COMPLETED|Phase 2 Open Label||0
6561378|NCT01792817|7484170|FG001|NOT COMPLETED|Phase 2 Open Label||0
6561379|NCT01792817|7484171|FG002|NOT COMPLETED|Phase 2 Open Label||26
6561380|NCT01792830|7484189|FG000|STARTED|Overall Study||84
6561381|NCT01792830|7484190|FG001|STARTED|Overall Study||3
6561382|NCT01792830|7484191|FG002|STARTED|Overall Study||4
6561383|NCT01792830|7484192|FG003|STARTED|Overall Study||21
6561384|NCT01792830|7484193|FG004|STARTED|Overall Study||2
6561385|NCT01792830|7484194|FG005|STARTED|Overall Study||4
6561386|NCT01792830|7484195|FG006|STARTED|Overall Study||14
6561387|NCT01792830|7484196|FG007|STARTED|Overall Study||7
6561388|NCT01792830|7484197|FG008|STARTED|Overall Study||20
6561389|NCT01792830|7484198|FG009|STARTED|Overall Study||4
6561390|NCT01792830|7484199|FG010|STARTED|Overall Study||12
6561391|NCT01792830|7484189|FG000|COMPLETED|Overall Study||59
6561392|NCT01792830|7484190|FG001|COMPLETED|Overall Study||3
6561393|NCT01792830|7484191|FG002|COMPLETED|Overall Study||4
6561394|NCT01792830|7484192|FG003|COMPLETED|Overall Study||18
6561395|NCT01792830|7484193|FG004|COMPLETED|Overall Study||1
6561396|NCT01792830|7484194|FG005|COMPLETED|Overall Study||3
6561397|NCT01792830|7484195|FG006|COMPLETED|Overall Study||12
6561398|NCT01792830|7484196|FG007|COMPLETED|Overall Study||6
6561399|NCT01792830|7484197|FG008|COMPLETED|Overall Study||11
6561400|NCT01792830|7484198|FG009|COMPLETED|Overall Study||4
6561401|NCT01792830|7484199|FG010|COMPLETED|Overall Study||9
6561402|NCT01792830|7484189|FG000|NOT COMPLETED|Overall Study||25
6641020|NCT02340000|7569474|FG001|STARTED|Time Period 1||89
6514034|NCT01509183|7434230|FG000|STARTED|Overall Study||250
6514035|NCT01509183|7434231|FG001|STARTED|Overall Study||245
6514036|NCT01509183|7434230|FG000|COMPLETED|Overall Study||141
6514037|NCT01509183|7434231|FG001|COMPLETED|Overall Study||134
6514038|NCT01509183|7434230|FG000|NOT COMPLETED|Overall Study||109
6514039|NCT01509183|7434231|FG001|NOT COMPLETED|Overall Study||111
6514040|NCT01509404|7434241|FG000|STARTED|Overall Study||20
6514041|NCT01509404|7434242|FG001|STARTED|Overall Study||20
6514042|NCT01509404|7434241|FG000|COMPLETED|Overall Study||20
6514043|NCT01509404|7434242|FG001|COMPLETED|Overall Study||20
6514044|NCT01509404|7434241|FG000|NOT COMPLETED|Overall Study||0
6514045|NCT01509404|7434242|FG001|NOT COMPLETED|Overall Study||0
6514046|NCT01509547|7434250|FG000|STARTED|Overall Study||77
6514047|NCT01509547|7434251|FG001|STARTED|Overall Study||80
6514048|NCT01509547|7434250|FG000|COMPLETED|Overall Study||42
6514049|NCT01509547|7434251|FG001|COMPLETED|Overall Study||41
6514050|NCT01509547|7434250|FG000|NOT COMPLETED|Overall Study||35
6514051|NCT01509547|7434251|FG001|NOT COMPLETED|Overall Study||39
6514052|NCT01509586|7434259|FG000|STARTED|Overall Study|Week 0|626
6514053|NCT01509586|7434260|FG001|STARTED|Overall Study|Week 0|610
6514054|NCT01509586|7434259|FG000|Week 3|Overall Study||574
6514055|NCT01509586|7434260|FG001|Week 3|Overall Study||585
6514056|NCT01509586|7434259|FG000|Week 6|Overall Study||551
6514057|NCT01509586|7434260|FG001|Week 6|Overall Study||585
6514058|NCT01509586|7434259|FG000|Week 10|Overall Study||537
6514059|NCT01509586|7434260|FG001|Week 10|Overall Study||574
6514060|NCT01509586|7434259|FG000|Week 14|Overall Study||528
6514061|NCT01509586|7434260|FG001|Week 14|Overall Study||566
6514062|NCT01509586|7434259|FG000|Week18|Overall Study||529
6514063|NCT01509586|7434260|FG001|Week18|Overall Study||555
6514064|NCT01509586|7434259|FG000|Week 32 (Month 6)|Overall Study||504
6514065|NCT01509586|7434260|FG001|Week 32 (Month 6)|Overall Study||523
6514066|NCT01509586|7434259|FG000|Week 46|Overall Study||483
6514067|NCT01509586|7434260|FG001|Week 46|Overall Study||494
6514068|NCT01509586|7434259|FG000|Week 58 (Month 12)|Overall Study||492
6514069|NCT01509586|7434260|FG001|Week 58 (Month 12)|Overall Study||499
6514070|NCT01509586|7434259|FG000|COMPLETED|Overall Study|final intent to treat sample|626
6514071|NCT01509586|7434260|FG001|COMPLETED|Overall Study|final intent to treat sample|610
6514072|NCT01509586|7434259|FG000|NOT COMPLETED|Overall Study||0
6514073|NCT01509586|7434260|FG001|NOT COMPLETED|Overall Study||0
6514074|NCT01509612|7434269|FG000|STARTED|Overall Study||47
6514075|NCT01509612|7434270|FG001|STARTED|Overall Study||51
6514076|NCT01509612|7434271|FG002|STARTED|Overall Study||52
6514077|NCT01509612|7434269|FG000|COMPLETED|Overall Study||47
6514078|NCT01509612|7434270|FG001|COMPLETED|Overall Study||51
6514079|NCT01509612|7434271|FG002|COMPLETED|Overall Study||52
6514080|NCT01509612|7434269|FG000|NOT COMPLETED|Overall Study||0
6514081|NCT01509612|7434270|FG001|NOT COMPLETED|Overall Study||0
6514082|NCT01509612|7434271|FG002|NOT COMPLETED|Overall Study||0
6514083|NCT01509625|7434282|FG000|STARTED|Overall Study||272
6514084|NCT01509625|7434282|FG000|COMPLETED|Overall Study||263
6514085|NCT01509625|7434282|FG000|NOT COMPLETED|Overall Study||9
6514086|NCT01509638|7434297|FG000|STARTED|Overall Study||23
6514087|NCT01509638|7434298|FG001|STARTED|Overall Study||26
6514088|NCT01509638|7434297|FG000|COMPLETED|Overall Study||20
6514089|NCT01509638|7434298|FG001|COMPLETED|Overall Study||24
6514090|NCT01509638|7434297|FG000|NOT COMPLETED|Overall Study||3
6514091|NCT01509638|7434298|FG001|NOT COMPLETED|Overall Study||2
6514092|NCT01509664|7434306|FG000|STARTED|Overall Study||49
6514093|NCT01509664|7434307|FG001|STARTED|Overall Study||49
6514094|NCT01509664|7434306|FG000|T2 Follow-up|Overall Study||45
6514095|NCT01509664|7434307|FG001|T2 Follow-up|Overall Study||38
6514096|NCT01509664|7434306|FG000|T3 Follow-up|Overall Study||40
6514097|NCT01509664|7434307|FG001|T3 Follow-up|Overall Study||33
6514098|NCT01509664|7434306|FG000|COMPLETED|Overall Study||34
6514099|NCT01509664|7434307|FG001|COMPLETED|Overall Study||28
6514100|NCT01509664|7434306|FG000|NOT COMPLETED|Overall Study||15
6514101|NCT01509664|7434307|FG001|NOT COMPLETED|Overall Study||21
6514102|NCT01509677|7434315|FG000|STARTED|Overall Study||79
6514103|NCT01509677|7434316|FG001|STARTED|Overall Study||79
6514104|NCT01509677|7434315|FG000|COMPLETED|Overall Study||76
6514105|NCT01509677|7434316|FG001|COMPLETED|Overall Study||73
6514106|NCT01509677|7434315|FG000|NOT COMPLETED|Overall Study||3
6514107|NCT01509677|7434316|FG001|NOT COMPLETED|Overall Study||6
6514108|NCT01509807|7434324|FG000|STARTED|Overall Study||16
6514109|NCT01509807|7434325|FG001|STARTED|Overall Study||17
6514110|NCT01509807|7434324|FG000|COMPLETED|Overall Study||15
6514111|NCT01509807|7434325|FG001|COMPLETED|Overall Study||16
6514112|NCT01509807|7434324|FG000|NOT COMPLETED|Overall Study||1
6514113|NCT01509807|7434325|FG001|NOT COMPLETED|Overall Study||1
6514114|NCT01509846|7434336|FG000|STARTED|Received Vaccination 1||5
6514115|NCT01509846|7434337|FG001|STARTED|Received Vaccination 1||20
6514116|NCT01509846|7434338|FG002|STARTED|Received Vaccination 1||20
6514117|NCT01509846|7434339|FG003|STARTED|Received Vaccination 1||20
6514118|NCT01509846|7434340|FG004|STARTED|Received Vaccination 1||17
6514119|NCT01509846|7434336|FG000|COMPLETED|Received Vaccination 1||5
6514120|NCT01509846|7434337|FG001|COMPLETED|Received Vaccination 1||20
6514121|NCT01509846|7434338|FG002|COMPLETED|Received Vaccination 1||20
6514122|NCT01509846|7434339|FG003|COMPLETED|Received Vaccination 1||20
6514123|NCT01509846|7434340|FG004|COMPLETED|Received Vaccination 1||17
6514124|NCT01509846|7434336|FG000|NOT COMPLETED|Received Vaccination 1||0
6514125|NCT01509846|7434337|FG001|NOT COMPLETED|Received Vaccination 1||0
6514126|NCT01509846|7434338|FG002|NOT COMPLETED|Received Vaccination 1||0
6514127|NCT01509846|7434339|FG003|NOT COMPLETED|Received Vaccination 1||0
6514128|NCT01509846|7434340|FG004|NOT COMPLETED|Received Vaccination 1||0
6514129|NCT01509846|7434336|FG000|STARTED|Received Vaccination 2||5
6514130|NCT01509846|7434337|FG001|STARTED|Received Vaccination 2||20
6514131|NCT01509846|7434338|FG002|STARTED|Received Vaccination 2||20
6514132|NCT01509846|7434339|FG003|STARTED|Received Vaccination 2||20
6514133|NCT01509846|7434340|FG004|STARTED|Received Vaccination 2||17
6514134|NCT01509846|7434336|FG000|COMPLETED|Received Vaccination 2||0
6514135|NCT01509846|7434337|FG001|COMPLETED|Received Vaccination 2||20
6514136|NCT01509846|7434338|FG002|COMPLETED|Received Vaccination 2||19
6514137|NCT01509846|7434339|FG003|COMPLETED|Received Vaccination 2||20
6514138|NCT01509846|7434340|FG004|COMPLETED|Received Vaccination 2||14
6514139|NCT01509846|7434336|FG000|NOT COMPLETED|Received Vaccination 2||5
6514140|NCT01509846|7434337|FG001|NOT COMPLETED|Received Vaccination 2||0
6514141|NCT01509846|7434338|FG002|NOT COMPLETED|Received Vaccination 2||1
6514142|NCT01509846|7434339|FG003|NOT COMPLETED|Received Vaccination 2||0
6514143|NCT01509846|7434340|FG004|NOT COMPLETED|Received Vaccination 2||3
6514144|NCT01509846|7434336|FG000|STARTED|Received Vaccination 3||0
6514145|NCT01509846|7434337|FG001|STARTED|Received Vaccination 3||20
6514146|NCT01509846|7434338|FG002|STARTED|Received Vaccination 3||19
6514147|NCT01509846|7434339|FG003|STARTED|Received Vaccination 3||20
6514148|NCT01509846|7434340|FG004|STARTED|Received Vaccination 3||14
6514149|NCT01509846|7434336|FG000|COMPLETED|Received Vaccination 3||0
6514150|NCT01509846|7434337|FG001|COMPLETED|Received Vaccination 3||19
6514151|NCT01509846|7434338|FG002|COMPLETED|Received Vaccination 3||18
6514152|NCT01509846|7434339|FG003|COMPLETED|Received Vaccination 3||19
6514153|NCT01509846|7434340|FG004|COMPLETED|Received Vaccination 3||14
6514154|NCT01509846|7434336|FG000|NOT COMPLETED|Received Vaccination 3||0
6514155|NCT01509846|7434337|FG001|NOT COMPLETED|Received Vaccination 3||1
6514156|NCT01509846|7434338|FG002|NOT COMPLETED|Received Vaccination 3||1
6514157|NCT01509846|7434339|FG003|NOT COMPLETED|Received Vaccination 3||1
6514158|NCT01509846|7434340|FG004|NOT COMPLETED|Received Vaccination 3||0
6514159|NCT01509872|7434361|FG000|STARTED|Overall Study||26
6514160|NCT01509872|7434362|FG001|STARTED|Overall Study||24
6514161|NCT01509872|7434361|FG000|Post-Intervention Assessment|Overall Study||26
6514162|NCT01509872|7434362|FG001|Post-Intervention Assessment|Overall Study||24
6514163|NCT01509872|7434361|FG000|COMPLETED|Overall Study||25
6514164|NCT01509872|7434362|FG001|COMPLETED|Overall Study||24
6514165|NCT01509872|7434361|FG000|NOT COMPLETED|Overall Study||1
6514166|NCT01509872|7434362|FG001|NOT COMPLETED|Overall Study||0
6514167|NCT01509950|7434372|FG000|STARTED|Overall Study||7
6514168|NCT01509950|7434373|FG001|STARTED|Overall Study||8
6514169|NCT01509950|7434374|FG002|STARTED|Overall Study||0
6514170|NCT01509950|7434372|FG000|COMPLETED|Overall Study||7
6514171|NCT01509950|7434373|FG001|COMPLETED|Overall Study||8
6514172|NCT01509950|7434374|FG002|COMPLETED|Overall Study||0
6514173|NCT01509950|7434372|FG000|NOT COMPLETED|Overall Study||0
6514174|NCT01509950|7434373|FG001|NOT COMPLETED|Overall Study||0
6514175|NCT01509950|7434374|FG002|NOT COMPLETED|Overall Study||0
6514176|NCT01510028|7434384|FG000|STARTED|Overall Study||6
6514177|NCT01510028|7434385|FG001|STARTED|Overall Study||6
6514178|NCT01510028|7434386|FG002|STARTED|Overall Study||6
6514179|NCT01510028|7434387|FG003|STARTED|Overall Study||6
6514180|NCT01510028|7434384|FG000|COMPLETED|Overall Study||5
6514181|NCT01510028|7434385|FG001|COMPLETED|Overall Study||6
6514182|NCT01510028|7434386|FG002|COMPLETED|Overall Study||6
6514183|NCT01510028|7434387|FG003|COMPLETED|Overall Study||6
6514184|NCT01510028|7434384|FG000|NOT COMPLETED|Overall Study||1
6514185|NCT01510028|7434385|FG001|NOT COMPLETED|Overall Study||0
6514186|NCT01510028|7434386|FG002|NOT COMPLETED|Overall Study||0
6514187|NCT01510028|7434387|FG003|NOT COMPLETED|Overall Study||0
6514188|NCT01510145|7434399|FG000|STARTED|Overall Study||191
6514189|NCT01510145|7434399|FG000|COMPLETED|Overall Study||173
6514190|NCT01510145|7434399|FG000|NOT COMPLETED|Overall Study||18
6641021|NCT02340000|7569473|FG000|COMPLETED|Time Period 1||78
6641022|NCT02340000|7569474|FG001|COMPLETED|Time Period 1||74
6641023|NCT02340000|7569473|FG000|NOT COMPLETED|Time Period 1||12
6641024|NCT02340000|7569474|FG001|NOT COMPLETED|Time Period 1||15
6641025|NCT02340000|7569473|FG000|STARTED|Time Period 2||69
6641026|NCT02340000|7569474|FG001|STARTED|Time Period 2||67
6641027|NCT02340000|7569473|FG000|COMPLETED|Time Period 2||50
6641028|NCT02340000|7569474|FG001|COMPLETED|Time Period 2||52
6641029|NCT02340000|7569473|FG000|NOT COMPLETED|Time Period 2||19
6641030|NCT02340000|7569474|FG001|NOT COMPLETED|Time Period 2||15
6641031|NCT02340078|7569487|FG000|STARTED|Overall Study||62
6514191|NCT01510158|7434406|FG000|STARTED|Overall Study||202
6514192|NCT01510158|7434407|FG001|STARTED|Overall Study||203
6514193|NCT01510158|7434408|FG002|STARTED|Overall Study||202
6641032|NCT02340078|7569487|FG000|COMPLETED|Overall Study||61
6641033|NCT02340078|7569487|FG000|NOT COMPLETED|Overall Study||1
6514194|NCT01510158|7434406|FG000|COMPLETED|Overall Study||151
6514195|NCT01510158|7434407|FG001|COMPLETED|Overall Study||150
6514196|NCT01510158|7434408|FG002|COMPLETED|Overall Study||152
6514197|NCT01510158|7434406|FG000|NOT COMPLETED|Overall Study||51
6514198|NCT01510158|7434407|FG001|NOT COMPLETED|Overall Study||53
6514199|NCT01510158|7434408|FG002|NOT COMPLETED|Overall Study||50
6514200|NCT01510327|7434416|FG000|STARTED|Overall Study||22
6514201|NCT01510327|7434416|FG000|COMPLETED|Overall Study||22
6514202|NCT01510327|7434416|FG000|NOT COMPLETED|Overall Study||0
6514203|NCT01510379|7434428|FG000|STARTED|Overall Study||49
6514204|NCT01510379|7434429|FG001|STARTED|Overall Study||51
6514205|NCT01510379|7434428|FG000|COMPLETED|Overall Study||49
6514206|NCT01510379|7434429|FG001|COMPLETED|Overall Study||51
6514207|NCT01510379|7434428|FG000|NOT COMPLETED|Overall Study||0
6514208|NCT01510379|7434429|FG001|NOT COMPLETED|Overall Study||0
6514209|NCT01510457|7434437|FG000|STARTED|Overall Study||17
6514210|NCT01510457|7434438|FG001|STARTED|Overall Study||29
6514211|NCT01510457|7434437|FG000|COMPLETED|Overall Study||12
6514212|NCT01510457|7434438|FG001|COMPLETED|Overall Study||26
6514213|NCT01510457|7434437|FG000|NOT COMPLETED|Overall Study||5
6514214|NCT01510457|7434438|FG001|NOT COMPLETED|Overall Study||3
6514215|NCT01510652|7434448|FG000|STARTED|Overall Study||719
6514216|NCT01510652|7434449|FG001|STARTED|Overall Study||355
6514217|NCT01510652|7434448|FG000|Baseline|Overall Study||718
6514218|NCT01510652|7434449|FG001|Baseline|Overall Study||348
6514219|NCT01510652|7434448|FG000|COMPLETED|Overall Study||627
6514220|NCT01510652|7434449|FG001|COMPLETED|Overall Study||288
6514221|NCT01510652|7434448|FG000|NOT COMPLETED|Overall Study||92
6514222|NCT01510652|7434449|FG001|NOT COMPLETED|Overall Study||67
6514223|NCT01510704|7434459|FG000|STARTED|Overall Study||54
6514224|NCT01510704|7434460|FG001|STARTED|Overall Study||58
6514225|NCT01510704|7434461|FG002|STARTED|Overall Study||50
6514226|NCT01510704|7434462|FG003|STARTED|Overall Study||53
6514227|NCT01510704|7434459|FG000|COMPLETED|Overall Study||54
6514228|NCT01510704|7434460|FG001|COMPLETED|Overall Study||58
6514229|NCT01510704|7434461|FG002|COMPLETED|Overall Study||50
6514230|NCT01510704|7434462|FG003|COMPLETED|Overall Study||53
6514231|NCT01510704|7434459|FG000|NOT COMPLETED|Overall Study||0
6514232|NCT01510704|7434460|FG001|NOT COMPLETED|Overall Study||0
6514233|NCT01510704|7434461|FG002|NOT COMPLETED|Overall Study||0
6514234|NCT01510704|7434462|FG003|NOT COMPLETED|Overall Study||0
6514235|NCT01510717|7434474|FG000|STARTED|Overall Study||155
6514236|NCT01510717|7434475|FG001|STARTED|Overall Study||165
6514237|NCT01510717|7434474|FG000|COMPLETED|Overall Study||153
6514238|NCT01510717|7434475|FG001|COMPLETED|Overall Study||160
6514239|NCT01510717|7434474|FG000|NOT COMPLETED|Overall Study||2
6514240|NCT01510717|7434475|FG001|NOT COMPLETED|Overall Study||5
6514241|NCT01510769|7434485|FG000|STARTED|Overall Study||106
6514242|NCT01510769|7434486|FG001|STARTED|Overall Study||109
6514243|NCT01510769|7434487|FG002|STARTED|Overall Study||109
6514244|NCT01510769|7434485|FG000|COMPLETED|Overall Study||79
6514245|NCT01510769|7434486|FG001|COMPLETED|Overall Study||84
6514246|NCT01510769|7434487|FG002|COMPLETED|Overall Study||87
6514247|NCT01510769|7434485|FG000|NOT COMPLETED|Overall Study||27
6514248|NCT01510769|7434486|FG001|NOT COMPLETED|Overall Study||25
6514249|NCT01510769|7434487|FG002|NOT COMPLETED|Overall Study||22
6514250|NCT01510834|7434495|FG000|STARTED|Overall Study||90
6514251|NCT01510834|7434495|FG000|COMPLETED|Overall Study||57
6514252|NCT01510834|7434495|FG000|NOT COMPLETED|Overall Study||33
6514253|NCT01510912|7434502|FG000|STARTED|Overall Study||602
6514254|NCT01510912|7434502|FG000|COMPLETED|Overall Study||360
6514255|NCT01510912|7434502|FG000|NOT COMPLETED|Overall Study||242
6514256|NCT01511016|7434508|FG000|STARTED|Overall Study||8
6514257|NCT01511016|7434509|FG001|STARTED|Overall Study||9
6514258|NCT01511016|7434508|FG000|COMPLETED|Overall Study||6
6514259|NCT01511016|7434509|FG001|COMPLETED|Overall Study||7
6514260|NCT01511016|7434508|FG000|NOT COMPLETED|Overall Study||2
6514261|NCT01511016|7434509|FG001|NOT COMPLETED|Overall Study||2
6514262|NCT01511055|7434516|FG000|STARTED|Overall Study||27
6514263|NCT01511055|7434516|FG000|COMPLETED|Overall Study||21
6514264|NCT01511055|7434516|FG000|NOT COMPLETED|Overall Study||6
6514265|NCT01511068|7434520|FG000|STARTED|Overall Study||2
6514266|NCT01511068|7434520|FG000|COMPLETED|Overall Study||2
6514267|NCT01511068|7434520|FG000|NOT COMPLETED|Overall Study||0
6514268|NCT01511107|7434526|FG000|STARTED|Overall Study|Randomized to the treatment group.|260
6514269|NCT01511107|7434527|FG001|STARTED|Overall Study|Randomized to the treatment group.|260
6514270|NCT01511107|7434526|FG000|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
6514271|NCT01511107|7434527|FG001|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
6514272|NCT01511107|7434526|FG000|NOT COMPLETED|Overall Study||22
6514273|NCT01511107|7434527|FG001|NOT COMPLETED|Overall Study||41
6514274|NCT01511250|7434543|FG000|STARTED|Overall Study||24
6514275|NCT01511250|7434544|FG001|STARTED|Overall Study||14
6514276|NCT01511250|7434545|FG002|STARTED|Overall Study||22
6514277|NCT01511250|7434546|FG003|STARTED|Overall Study||14
6514278|NCT01511250|7434547|FG004|STARTED|Overall Study||21
6514279|NCT01511250|7434548|FG005|STARTED|Overall Study||17
6514280|NCT01511250|7434549|FG006|STARTED|Overall Study||23
6514281|NCT01511250|7434550|FG007|STARTED|Overall Study||13
6514282|NCT01511250|7434551|FG008|STARTED|Overall Study||159
6514283|NCT01511250|7434552|FG009|STARTED|Overall Study||53
6514284|NCT01511250|7434543|FG000|COMPLETED|Overall Study||15
6514285|NCT01511250|7434544|FG001|COMPLETED|Overall Study||9
6514286|NCT01511250|7434545|FG002|COMPLETED|Overall Study||18
6514287|NCT01511250|7434546|FG003|COMPLETED|Overall Study||11
6514288|NCT01511250|7434547|FG004|COMPLETED|Overall Study||21
6514289|NCT01511250|7434548|FG005|COMPLETED|Overall Study||17
6514290|NCT01511250|7434549|FG006|COMPLETED|Overall Study||21
6514291|NCT01511250|7434550|FG007|COMPLETED|Overall Study||9
6514292|NCT01511250|7434551|FG008|COMPLETED|Overall Study||145
6514293|NCT01511250|7434552|FG009|COMPLETED|Overall Study||48
6514294|NCT01511250|7434543|FG000|NOT COMPLETED|Overall Study||9
6514295|NCT01511250|7434544|FG001|NOT COMPLETED|Overall Study||5
6514296|NCT01511250|7434545|FG002|NOT COMPLETED|Overall Study||4
6514297|NCT01511250|7434546|FG003|NOT COMPLETED|Overall Study||3
6514298|NCT01511250|7434547|FG004|NOT COMPLETED|Overall Study||0
6514299|NCT01511250|7434548|FG005|NOT COMPLETED|Overall Study||0
6514300|NCT01511250|7434549|FG006|NOT COMPLETED|Overall Study||2
6514301|NCT01511250|7434550|FG007|NOT COMPLETED|Overall Study||4
6514302|NCT01511250|7434551|FG008|NOT COMPLETED|Overall Study||14
6514303|NCT01511250|7434552|FG009|NOT COMPLETED|Overall Study||5
6514304|NCT01511315|7434574|FG000|STARTED|Overall Study||36
6514305|NCT01511315|7434574|FG000|COMPLETED|Overall Study||32
6514306|NCT01511315|7434574|FG000|NOT COMPLETED|Overall Study||4
6514307|NCT01511419|7434580|FG000|STARTED|Dose 1||30
6514308|NCT01511419|7434581|FG001|STARTED|Dose 1||10
6514309|NCT01511419|7434580|FG000|COMPLETED|Dose 1||30
6514310|NCT01511419|7434581|FG001|COMPLETED|Dose 1||10
6514311|NCT01511419|7434580|FG000|NOT COMPLETED|Dose 1||0
6514312|NCT01511419|7434581|FG001|NOT COMPLETED|Dose 1||0
6514313|NCT01511419|7434580|FG000|STARTED|Dose 2||30
6514314|NCT01511419|7434581|FG001|STARTED|Dose 2||10
6514315|NCT01511419|7434580|FG000|COMPLETED|Dose 2||29
6514316|NCT01511419|7434581|FG001|COMPLETED|Dose 2||10
6514317|NCT01511419|7434580|FG000|NOT COMPLETED|Dose 2||1
6514318|NCT01511419|7434581|FG001|NOT COMPLETED|Dose 2||0
6514319|NCT01511445|7434613|FG000|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
6514320|NCT01511445|7434614|FG001|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
6514321|NCT01511445|7434613|FG000|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
6514322|NCT01511445|7434614|FG001|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
6514323|NCT01511445|7434613|FG000|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
6514324|NCT01511445|7434614|FG001|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
6514325|NCT01511445|7434613|FG000|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
6514326|NCT01511445|7434614|FG001|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
6514327|NCT01511445|7434613|FG000|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
6514328|NCT01511445|7434614|FG001|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
6514329|NCT01511445|7434613|FG000|NOT COMPLETED|Overall Study||5
6514330|NCT01511445|7434614|FG001|NOT COMPLETED|Overall Study||4
6514331|NCT01511536|7434623|FG000|STARTED|Phase 1||3
6514332|NCT01511536|7434624|FG001|STARTED|Phase 1||7
6514333|NCT01511536|7434625|FG002|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
6514334|NCT01511536|7434623|FG000|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
6514335|NCT01511536|7434624|FG001|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
6514336|NCT01511536|7434625|FG002|COMPLETED|Phase 1||0
6514337|NCT01511536|7434623|FG000|NOT COMPLETED|Phase 1||0
6514338|NCT01511536|7434624|FG001|NOT COMPLETED|Phase 1||1
6514339|NCT01511536|7434625|FG002|NOT COMPLETED|Phase 1||0
6514340|NCT01511536|7434623|FG000|STARTED|Phase 2||0
6514341|NCT01511536|7434624|FG001|STARTED|Phase 2||0
6514342|NCT01511536|7434625|FG002|STARTED|Phase 2||27
6514343|NCT01511536|7434623|FG000|COMPLETED|Phase 2||0
6514344|NCT01511536|7434624|FG001|COMPLETED|Phase 2||0
6514345|NCT01511536|7434625|FG002|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
6514346|NCT01511536|7434623|FG000|NOT COMPLETED|Phase 2||0
6514347|NCT01511536|7434624|FG001|NOT COMPLETED|Phase 2||0
6514348|NCT01511536|7434625|FG002|NOT COMPLETED|Phase 2||9
6514349|NCT01511640|7434637|FG000|STARTED|First Intervention (11-15 Days)||7
6514350|NCT01511640|7434638|FG001|STARTED|First Intervention (11-15 Days)||8
6514351|NCT01511640|7434639|FG002|STARTED|First Intervention (11-15 Days)||7
6514352|NCT01511640|7434640|FG003|STARTED|First Intervention (11-15 Days)||8
6514353|NCT01511640|7434637|FG000|COMPLETED|First Intervention (11-15 Days)||5
6514354|NCT01511640|7434638|FG001|COMPLETED|First Intervention (11-15 Days)||8
6514355|NCT01511640|7434639|FG002|COMPLETED|First Intervention (11-15 Days)||7
6514356|NCT01511640|7434640|FG003|COMPLETED|First Intervention (11-15 Days)||7
6514357|NCT01511640|7434637|FG000|NOT COMPLETED|First Intervention (11-15 Days)||2
6514358|NCT01511640|7434638|FG001|NOT COMPLETED|First Intervention (11-15 Days)||0
6514359|NCT01511640|7434639|FG002|NOT COMPLETED|First Intervention (11-15 Days)||0
6514360|NCT01511640|7434640|FG003|NOT COMPLETED|First Intervention (11-15 Days)||1
6514361|NCT01511640|7434637|FG000|STARTED|Washout (6-10 Days)||5
6514362|NCT01511640|7434638|FG001|STARTED|Washout (6-10 Days)||8
6514363|NCT01511640|7434639|FG002|STARTED|Washout (6-10 Days)||7
6514364|NCT01511640|7434640|FG003|STARTED|Washout (6-10 Days)||7
6514365|NCT01511640|7434637|FG000|COMPLETED|Washout (6-10 Days)||5
6514366|NCT01511640|7434638|FG001|COMPLETED|Washout (6-10 Days)||8
6514367|NCT01511640|7434639|FG002|COMPLETED|Washout (6-10 Days)||7
6514368|NCT01511640|7434640|FG003|COMPLETED|Washout (6-10 Days)||6
6514369|NCT01511640|7434637|FG000|NOT COMPLETED|Washout (6-10 Days)||0
6514370|NCT01511640|7434638|FG001|NOT COMPLETED|Washout (6-10 Days)||0
6514371|NCT01511640|7434639|FG002|NOT COMPLETED|Washout (6-10 Days)||0
6514372|NCT01511640|7434640|FG003|NOT COMPLETED|Washout (6-10 Days)||1
6514373|NCT01511640|7434637|FG000|STARTED|Third Intervention (11-15 Days)||5
6514374|NCT01511640|7434638|FG001|STARTED|Third Intervention (11-15 Days)||8
6514375|NCT01511640|7434639|FG002|STARTED|Third Intervention (11-15 Days)||7
6514376|NCT01511640|7434640|FG003|STARTED|Third Intervention (11-15 Days)||6
6514377|NCT01511640|7434637|FG000|COMPLETED|Third Intervention (11-15 Days)||4
6514378|NCT01511640|7434638|FG001|COMPLETED|Third Intervention (11-15 Days)||7
6514379|NCT01511640|7434639|FG002|COMPLETED|Third Intervention (11-15 Days)||7
6514380|NCT01511640|7434640|FG003|COMPLETED|Third Intervention (11-15 Days)||6
6514381|NCT01511640|7434637|FG000|NOT COMPLETED|Third Intervention (11-15 Days)||1
6514382|NCT01511640|7434638|FG001|NOT COMPLETED|Third Intervention (11-15 Days)||1
6514383|NCT01511640|7434639|FG002|NOT COMPLETED|Third Intervention (11-15 Days)||0
6514384|NCT01511640|7434640|FG003|NOT COMPLETED|Third Intervention (11-15 Days)||0
6514385|NCT01511809|7434652|FG000|STARTED|Overall Study||58
6514386|NCT01511809|7434653|FG001|STARTED|Overall Study||59
6514387|NCT01511809|7434652|FG000|COMPLETED|Overall Study||51
6514388|NCT01511809|7434653|FG001|COMPLETED|Overall Study||52
6514389|NCT01511809|7434652|FG000|NOT COMPLETED|Overall Study||7
6514390|NCT01511809|7434653|FG001|NOT COMPLETED|Overall Study||7
6514391|NCT01511939|7434662|FG000|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
6514392|NCT01511939|7434663|FG001|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
6514393|NCT01511939|7434664|FG002|STARTED|Overall Study||8
6514394|NCT01511939|7434662|FG000|COMPLETED|Overall Study||7
6514395|NCT01511939|7434663|FG001|COMPLETED|Overall Study||4
6514396|NCT01511939|7434664|FG002|COMPLETED|Overall Study||8
6514397|NCT01511939|7434662|FG000|NOT COMPLETED|Overall Study||2
6514398|NCT01511939|7434663|FG001|NOT COMPLETED|Overall Study||1
6514399|NCT01511939|7434664|FG002|NOT COMPLETED|Overall Study||0
6514400|NCT01511978|7434674|FG000|STARTED|Overall Study||14
6514401|NCT01511978|7434675|FG001|STARTED|Overall Study||18
6514402|NCT01511978|7434674|FG000|COMPLETED|Overall Study||14
6514403|NCT01511978|7434675|FG001|COMPLETED|Overall Study||18
6514404|NCT01511978|7434674|FG000|NOT COMPLETED|Overall Study||0
6514405|NCT01511978|7434675|FG001|NOT COMPLETED|Overall Study||0
6514406|NCT01512108|7434685|FG000|STARTED|Overall Study||243
6514407|NCT01512108|7434686|FG001|STARTED|Overall Study||120
6514408|NCT01512108|7434685|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
6514409|NCT01512108|7434686|FG001|Exposed|Overall Study||120
6514410|NCT01512108|7434685|FG000|COMPLETED|Overall Study||221
6514411|NCT01512108|7434686|FG001|COMPLETED|Overall Study||111
6514412|NCT01512108|7434685|FG000|NOT COMPLETED|Overall Study||22
6514413|NCT01512108|7434686|FG001|NOT COMPLETED|Overall Study||9
6514414|NCT01512160|7434696|FG000|STARTED|Overall Study||22
6514415|NCT01512160|7434697|FG001|STARTED|Overall Study||23
6514416|NCT01512160|7434698|FG002|STARTED|Overall Study||22
6514417|NCT01512160|7434699|FG003|STARTED|Overall Study||23
6514418|NCT01512160|7434696|FG000|COMPLETED|Overall Study||20
6514419|NCT01512160|7434697|FG001|COMPLETED|Overall Study||23
6514420|NCT01512160|7434698|FG002|COMPLETED|Overall Study||22
6514421|NCT01512160|7434699|FG003|COMPLETED|Overall Study||22
6514422|NCT01512160|7434696|FG000|NOT COMPLETED|Overall Study||2
6514423|NCT01512160|7434697|FG001|NOT COMPLETED|Overall Study||0
6514424|NCT01512160|7434698|FG002|NOT COMPLETED|Overall Study||0
6514425|NCT01512160|7434699|FG003|NOT COMPLETED|Overall Study||1
6514426|NCT01512225|7434712|FG000|STARTED|Overall Study||45
6514427|NCT01512225|7434713|FG001|STARTED|Overall Study||45
6514428|NCT01512225|7434712|FG000|Provided Day 14 Volume|Overall Study||45
6514429|NCT01512225|7434713|FG001|Provided Day 14 Volume|Overall Study||40
6514430|NCT01512225|7434712|FG000|COMPLETED|Overall Study||45
6514431|NCT01512225|7434713|FG001|COMPLETED|Overall Study||45
6514432|NCT01512225|7434712|FG000|NOT COMPLETED|Overall Study||0
6514433|NCT01512225|7434713|FG001|NOT COMPLETED|Overall Study||0
6514434|NCT01512251|7434723|FG000|STARTED|Dose Level -1||3
6514435|NCT01512251|7434724|FG001|STARTED|Dose Level -1||5
6514436|NCT01512251|7434723|FG000|COMPLETED|Dose Level -1||3
6514437|NCT01512251|7434724|FG001|COMPLETED|Dose Level -1||5
6514438|NCT01512251|7434723|FG000|NOT COMPLETED|Dose Level -1||0
6514439|NCT01512251|7434724|FG001|NOT COMPLETED|Dose Level -1||0
6514440|NCT01512251|7434723|FG000|STARTED|Phase I, Dose 1||3
6514441|NCT01512251|7434724|FG001|STARTED|Phase I, Dose 1||5
6514442|NCT01512251|7434723|FG000|COMPLETED|Phase I, Dose 1||0
6514443|NCT01512251|7434724|FG001|COMPLETED|Phase I, Dose 1||0
6514444|NCT01512251|7434723|FG000|NOT COMPLETED|Phase I, Dose 1||3
6514445|NCT01512251|7434724|FG001|NOT COMPLETED|Phase I, Dose 1||5
6514446|NCT01512251|7434723|FG000|STARTED|Phase I, Dose 2||0
6514447|NCT01512251|7434724|FG001|STARTED|Phase I, Dose 2||0
6514448|NCT01512251|7434723|FG000|COMPLETED|Phase I, Dose 2||0
6514449|NCT01512251|7434724|FG001|COMPLETED|Phase I, Dose 2||0
6514450|NCT01512251|7434723|FG000|NOT COMPLETED|Phase I, Dose 2||0
6514451|NCT01512251|7434724|FG001|NOT COMPLETED|Phase I, Dose 2||0
6514452|NCT01512251|7434723|FG000|STARTED|Phase I, Dose 3||0
6514453|NCT01512251|7434724|FG001|STARTED|Phase I, Dose 3||0
6514454|NCT01512251|7434723|FG000|COMPLETED|Phase I, Dose 3||0
6514455|NCT01512251|7434724|FG001|COMPLETED|Phase I, Dose 3||0
6514456|NCT01512251|7434723|FG000|NOT COMPLETED|Phase I, Dose 3||0
6514457|NCT01512251|7434724|FG001|NOT COMPLETED|Phase I, Dose 3||0
6514458|NCT01512251|7434723|FG000|STARTED|Phase I, Dose 4||0
6514459|NCT01512251|7434724|FG001|STARTED|Phase I, Dose 4||0
6514460|NCT01512251|7434723|FG000|COMPLETED|Phase I, Dose 4||0
6514461|NCT01512251|7434724|FG001|COMPLETED|Phase I, Dose 4||0
6514462|NCT01512251|7434723|FG000|NOT COMPLETED|Phase I, Dose 4||0
6514463|NCT01512251|7434724|FG001|NOT COMPLETED|Phase I, Dose 4||0
6514464|NCT01512251|7434723|FG000|STARTED|Phase II||0
6514465|NCT01512251|7434724|FG001|STARTED|Phase II||0
6514466|NCT01512251|7434723|FG000|COMPLETED|Phase II||0
6514467|NCT01512251|7434724|FG001|COMPLETED|Phase II||0
6514468|NCT01512251|7434723|FG000|NOT COMPLETED|Phase II||0
6514469|NCT01512251|7434724|FG001|NOT COMPLETED|Phase II||0
6514470|NCT01512264|7434735|FG000|STARTED|Overall Study||7
6514471|NCT01512264|7434736|FG001|STARTED|Overall Study||7
6514472|NCT01512264|7434737|FG002|STARTED|Overall Study||7
6514473|NCT01512264|7434738|FG003|STARTED|Overall Study||7
6514474|NCT01512264|7434735|FG000|COMPLETED|Overall Study||7
6514475|NCT01512264|7434736|FG001|COMPLETED|Overall Study||7
6514476|NCT01512264|7434737|FG002|COMPLETED|Overall Study||7
6514477|NCT01512264|7434738|FG003|COMPLETED|Overall Study||6
6514478|NCT01512264|7434735|FG000|NOT COMPLETED|Overall Study||0
6514479|NCT01512264|7434736|FG001|NOT COMPLETED|Overall Study||0
6514480|NCT01512264|7434737|FG002|NOT COMPLETED|Overall Study||0
6514481|NCT01512264|7434738|FG003|NOT COMPLETED|Overall Study||1
6514482|NCT01512368|7434748|FG000|STARTED|Overall Study||63
6514483|NCT01512368|7434748|FG000|COMPLETED|Overall Study||60
6514484|NCT01512368|7434748|FG000|NOT COMPLETED|Overall Study||3
6514485|NCT01512446|7434754|FG000|STARTED|Overall Study||221
6514486|NCT01512446|7434755|FG001|STARTED|Overall Study||215
6514487|NCT01512446|7434754|FG000|Safety Analysis Set|Overall Study||197
6514488|NCT01512446|7434755|FG001|Safety Analysis Set|Overall Study||188
6514489|NCT01512446|7434754|FG000|COMPLETED|Overall Study||0
6514490|NCT01512446|7434755|FG001|COMPLETED|Overall Study||0
6514491|NCT01512446|7434754|FG000|NOT COMPLETED|Overall Study||221
6514492|NCT01512446|7434755|FG001|NOT COMPLETED|Overall Study||215
6514493|NCT01512667|7434763|FG000|STARTED|Overall Study||13
6514494|NCT01512667|7434764|FG001|STARTED|Overall Study||12
6514495|NCT01512667|7434763|FG000|Matched Participants|Overall Study||12
6514496|NCT01512667|7434764|FG001|Matched Participants|Overall Study||12
6514497|NCT01512667|7434763|FG000|Unmatched Participants|Overall Study|Participant was not matched to a healthy control participant.|1
6514498|NCT01512667|7434764|FG001|Unmatched Participants|Overall Study||0
6514499|NCT01512667|7434763|FG000|COMPLETED|Overall Study||13
6514500|NCT01512667|7434764|FG001|COMPLETED|Overall Study||12
6514501|NCT01512667|7434763|FG000|NOT COMPLETED|Overall Study||0
6514502|NCT01512667|7434764|FG001|NOT COMPLETED|Overall Study||0
6514503|NCT01512693|7434772|FG000|STARTED|Overall Study||8
6514504|NCT01512693|7434773|FG001|STARTED|Overall Study||9
6514505|NCT01512693|7434772|FG000|COMPLETED|Overall Study||8
6514506|NCT01512693|7434773|FG001|COMPLETED|Overall Study||8
6514507|NCT01512693|7434772|FG000|NOT COMPLETED|Overall Study||0
6514508|NCT01512693|7434773|FG001|NOT COMPLETED|Overall Study||1
6514509|NCT01512745|7434781|FG000|STARTED|Overall Study||176
6514510|NCT01512745|7434782|FG001|STARTED|Overall Study||91
6514511|NCT01512745|7434781|FG000|COMPLETED|Overall Study||136
6514512|NCT01512745|7434782|FG001|COMPLETED|Overall Study||71
6514513|NCT01512745|7434781|FG000|NOT COMPLETED|Overall Study||40
6514514|NCT01512745|7434782|FG001|NOT COMPLETED|Overall Study||20
6514515|NCT01512758|7434790|FG000|STARTED|Overall Study||30
6514516|NCT01512758|7434791|FG001|STARTED|Overall Study||6
6514517|NCT01512758|7434790|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK assessment.|30
6514518|NCT01512758|7434791|FG001|COMPLETED|Overall Study||6
6514519|NCT01512758|7434790|FG000|NOT COMPLETED|Overall Study||0
6514520|NCT01512758|7434791|FG001|NOT COMPLETED|Overall Study||0
6514521|NCT01512797|7434800|FG000|STARTED|Overall Study||16
6514522|NCT01512797|7434801|FG001|STARTED|Overall Study||16
6514523|NCT01512797|7434800|FG000|COMPLETED|Overall Study||16
6514524|NCT01512797|7434801|FG001|COMPLETED|Overall Study||16
6514525|NCT01512797|7434800|FG000|NOT COMPLETED|Overall Study||0
6514526|NCT01512797|7434801|FG001|NOT COMPLETED|Overall Study||0
6514527|NCT01512849|7434809|FG000|STARTED|Crossover Period 1||6
6514528|NCT01512849|7434810|FG001|STARTED|Crossover Period 1||6
6514529|NCT01512849|7434811|FG002|STARTED|Crossover Period 1||6
6514530|NCT01512849|7434812|FG003|STARTED|Crossover Period 1||6
6514531|NCT01512849|7434809|FG000|COMPLETED|Crossover Period 1||6
6514532|NCT01512849|7434810|FG001|COMPLETED|Crossover Period 1||6
6514533|NCT01512849|7434811|FG002|COMPLETED|Crossover Period 1||6
6514534|NCT01512849|7434812|FG003|COMPLETED|Crossover Period 1||6
6514535|NCT01512849|7434809|FG000|NOT COMPLETED|Crossover Period 1||0
6514536|NCT01512849|7434810|FG001|NOT COMPLETED|Crossover Period 1||0
6514537|NCT01512849|7434811|FG002|NOT COMPLETED|Crossover Period 1||0
6514538|NCT01512849|7434812|FG003|NOT COMPLETED|Crossover Period 1||0
6514539|NCT01512849|7434809|FG000|STARTED|Crossover Period 2||6
6514540|NCT01512849|7434810|FG001|STARTED|Crossover Period 2||6
6514541|NCT01512849|7434811|FG002|STARTED|Crossover Period 2||6
6514542|NCT01512849|7434812|FG003|STARTED|Crossover Period 2||6
6514543|NCT01512849|7434809|FG000|COMPLETED|Crossover Period 2||6
6514544|NCT01512849|7434810|FG001|COMPLETED|Crossover Period 2||6
6514545|NCT01512849|7434811|FG002|COMPLETED|Crossover Period 2||6
6514546|NCT01512849|7434812|FG003|COMPLETED|Crossover Period 2||6
6514547|NCT01512849|7434809|FG000|NOT COMPLETED|Crossover Period 2||0
6514548|NCT01512849|7434810|FG001|NOT COMPLETED|Crossover Period 2||0
6514549|NCT01512849|7434811|FG002|NOT COMPLETED|Crossover Period 2||0
6514550|NCT01512849|7434812|FG003|NOT COMPLETED|Crossover Period 2||0
6514551|NCT01512979|7434824|FG000|STARTED|Overall Study|Randomised and treated|159
6514552|NCT01512979|7434825|FG001|STARTED|Overall Study|Randomised and treated|157
6514553|NCT01512979|7434824|FG000|COMPLETED|Overall Study||140
6514554|NCT01512979|7434825|FG001|COMPLETED|Overall Study||135
6514555|NCT01512979|7434824|FG000|NOT COMPLETED|Overall Study||19
6514556|NCT01512979|7434825|FG001|NOT COMPLETED|Overall Study||22
6514557|NCT01513122|7434833|FG000|STARTED|Overall Study||102
6514558|NCT01513122|7434834|FG001|STARTED|Overall Study||108
6514559|NCT01513122|7434833|FG000|COMPLETED|Overall Study||91
6514560|NCT01513122|7434834|FG001|COMPLETED|Overall Study||105
6514561|NCT01513122|7434833|FG000|NOT COMPLETED|Overall Study||11
6514562|NCT01513122|7434834|FG001|NOT COMPLETED|Overall Study||3
6514563|NCT01513148|7434842|FG000|STARTED|Overall Study||16
6514564|NCT01513148|7434843|FG001|STARTED|Overall Study||16
6514565|NCT01513148|7434842|FG000|COMPLETED|Overall Study||14
6514566|NCT01513148|7434843|FG001|COMPLETED|Overall Study||14
6514567|NCT01513148|7434842|FG000|NOT COMPLETED|Overall Study||2
6514568|NCT01513148|7434843|FG001|NOT COMPLETED|Overall Study||2
6514569|NCT01513239|7434892|FG000|STARTED|Period 1: Main Phase|Randomized participants|397
6514570|NCT01513239|7434893|FG001|STARTED|Period 1: Main Phase|Randomized participants|407
6514571|NCT01513239|7434894|FG002|STARTED|Period 1: Main Phase|Randomized participants|399
6514572|NCT01513239|7434895|FG003|STARTED|Period 1: Main Phase||0
6514573|NCT01513239|7434896|FG004|STARTED|Period 1: Main Phase||0
6514574|NCT01513239|7434897|FG005|STARTED|Period 1: Main Phase||0
6514575|NCT01513239|7434892|FG000|Treated|Period 1: Main Phase|Treated participants|391
6514576|NCT01513239|7434893|FG001|Treated|Period 1: Main Phase|Treated participants|396
6514577|NCT01513239|7434894|FG002|Treated|Period 1: Main Phase|Treated participants|381
6514578|NCT01513239|7434895|FG003|Treated|Period 1: Main Phase||0
6514579|NCT01513239|7434896|FG004|Treated|Period 1: Main Phase||0
6514580|NCT01513239|7434897|FG005|Treated|Period 1: Main Phase||0
6514581|NCT01513239|7434892|FG000|All Participants as Treated|Period 1: Main Phase|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
6514582|NCT01513239|7434893|FG001|All Participants as Treated|Period 1: Main Phase|Treatment actually received|396
6514583|NCT01513239|7434894|FG002|All Participants as Treated|Period 1: Main Phase|Treatment actually received|381
6514584|NCT01513239|7434895|FG003|All Participants as Treated|Period 1: Main Phase||0
6514585|NCT01513239|7434896|FG004|All Participants as Treated|Period 1: Main Phase||0
6514586|NCT01513239|7434897|FG005|All Participants as Treated|Period 1: Main Phase||0
6514587|NCT01513239|7434892|FG000|COMPLETED|Period 1: Main Phase||322
6514588|NCT01513239|7434893|FG001|COMPLETED|Period 1: Main Phase||337
6514589|NCT01513239|7434894|FG002|COMPLETED|Period 1: Main Phase||311
6514590|NCT01513239|7434895|FG003|COMPLETED|Period 1: Main Phase||0
6514591|NCT01513239|7434896|FG004|COMPLETED|Period 1: Main Phase||0
6514592|NCT01513239|7434897|FG005|COMPLETED|Period 1: Main Phase||0
6514593|NCT01513239|7434892|FG000|NOT COMPLETED|Period 1: Main Phase||75
6514594|NCT01513239|7434893|FG001|NOT COMPLETED|Period 1: Main Phase||70
6514595|NCT01513239|7434894|FG002|NOT COMPLETED|Period 1: Main Phase||88
6514596|NCT01513239|7434895|FG003|NOT COMPLETED|Period 1: Main Phase||0
6514597|NCT01513239|7434896|FG004|NOT COMPLETED|Period 1: Main Phase||0
6514598|NCT01513239|7434897|FG005|NOT COMPLETED|Period 1: Main Phase||0
6514599|NCT01513239|7434892|FG000|STARTED|Period 2: 9 Month Extension Phase||0
6514600|NCT01513239|7434893|FG001|STARTED|Period 2: 9 Month Extension Phase||0
6514601|NCT01513239|7434894|FG002|STARTED|Period 2: 9 Month Extension Phase||0
6514602|NCT01513239|7434895|FG003|STARTED|Period 2: 9 Month Extension Phase||112
6514603|NCT01513239|7434896|FG004|STARTED|Period 2: 9 Month Extension Phase||100
6514604|NCT01513239|7434897|FG005|STARTED|Period 2: 9 Month Extension Phase||83
6514605|NCT01513239|7434892|FG000|COMPLETED|Period 2: 9 Month Extension Phase||0
6514606|NCT01513239|7434893|FG001|COMPLETED|Period 2: 9 Month Extension Phase||0
6514607|NCT01513239|7434894|FG002|COMPLETED|Period 2: 9 Month Extension Phase||0
6514608|NCT01513239|7434895|FG003|COMPLETED|Period 2: 9 Month Extension Phase||102
6514609|NCT01513239|7434896|FG004|COMPLETED|Period 2: 9 Month Extension Phase||90
6514610|NCT01513239|7434897|FG005|COMPLETED|Period 2: 9 Month Extension Phase||78
6514611|NCT01513239|7434892|FG000|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
6641034|NCT02340091|7569492|FG000|STARTED|Overall Study|All Study Participants|62
6641035|NCT02340091|7569492|FG000|COMPLETED|Overall Study||60
6641036|NCT02340091|7569492|FG000|NOT COMPLETED|Overall Study||2
6514612|NCT01513239|7434893|FG001|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
6514613|NCT01513239|7434894|FG002|NOT COMPLETED|Period 2: 9 Month Extension Phase||0
6514614|NCT01513239|7434895|FG003|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
6514615|NCT01513239|7434896|FG004|NOT COMPLETED|Period 2: 9 Month Extension Phase||10
6514616|NCT01513239|7434897|FG005|NOT COMPLETED|Period 2: 9 Month Extension Phase||5
6514617|NCT01513291|7434911|FG000|STARTED|Treatment Period||120
6514618|NCT01513291|7434912|FG001|STARTED|Treatment Period||117
6514619|NCT01513291|7434913|FG002|STARTED|Treatment Period||0
6514620|NCT01513291|7434914|FG003|STARTED|Treatment Period||0
6514621|NCT01513291|7434915|FG004|STARTED|Treatment Period||0
6514622|NCT01513291|7434911|FG000|Treated|Treatment Period||120
6514623|NCT01513291|7434912|FG001|Treated|Treatment Period||115
6641037|NCT02340104|7569497|FG000|STARTED|Overall Study||8
6514624|NCT01513291|7434913|FG002|Treated|Treatment Period||0
6514625|NCT01513291|7434914|FG003|Treated|Treatment Period||0
6514626|NCT01513291|7434915|FG004|Treated|Treatment Period||0
6514627|NCT01513291|7434911|FG000|COMPLETED|Treatment Period||97
6514628|NCT01513291|7434912|FG001|COMPLETED|Treatment Period||101
6514629|NCT01513291|7434913|FG002|COMPLETED|Treatment Period||0
6514630|NCT01513291|7434914|FG003|COMPLETED|Treatment Period||0
6514631|NCT01513291|7434915|FG004|COMPLETED|Treatment Period||0
6514632|NCT01513291|7434911|FG000|NOT COMPLETED|Treatment Period||23
6514633|NCT01513291|7434912|FG001|NOT COMPLETED|Treatment Period||16
6514634|NCT01513291|7434913|FG002|NOT COMPLETED|Treatment Period||0
6514635|NCT01513291|7434914|FG003|NOT COMPLETED|Treatment Period||0
6514636|NCT01513291|7434915|FG004|NOT COMPLETED|Treatment Period||0
6514637|NCT01513291|7434911|FG000|STARTED|Run-out Period||0
6514638|NCT01513291|7434912|FG001|STARTED|Run-out Period||0
6514639|NCT01513291|7434913|FG002|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
6514640|NCT01513291|7434914|FG003|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
6514641|NCT01513291|7434915|FG004|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
6514642|NCT01513291|7434911|FG000|COMPLETED|Run-out Period||0
6514643|NCT01513291|7434912|FG001|COMPLETED|Run-out Period||0
6514644|NCT01513291|7434913|FG002|COMPLETED|Run-out Period||50
6514645|NCT01513291|7434914|FG003|COMPLETED|Run-out Period||45
6514646|NCT01513291|7434915|FG004|COMPLETED|Run-out Period||101
6514647|NCT01513291|7434911|FG000|NOT COMPLETED|Run-out Period||0
6514648|NCT01513291|7434912|FG001|NOT COMPLETED|Run-out Period||0
6514649|NCT01513291|7434913|FG002|NOT COMPLETED|Run-out Period||0
6514650|NCT01513291|7434914|FG003|NOT COMPLETED|Run-out Period||2
6514651|NCT01513291|7434915|FG004|NOT COMPLETED|Run-out Period||0
6514652|NCT01513317|7434929|FG000|STARTED|Overall Study||50
6514653|NCT01513317|7434930|FG001|STARTED|Overall Study||26
6514654|NCT01513317|7434929|FG000|COMPLETED|Overall Study||16
6514655|NCT01513317|7434930|FG001|COMPLETED|Overall Study||2
6514656|NCT01513317|7434929|FG000|NOT COMPLETED|Overall Study||34
6514657|NCT01513317|7434930|FG001|NOT COMPLETED|Overall Study||24
6514658|NCT01513330|7434936|FG000|STARTED|SenSura Mio First,||64
6514659|NCT01513330|7434937|FG001|STARTED|SenSura Mio First,||58
6514660|NCT01513330|7434936|FG000|COMPLETED|SenSura Mio First,||60
6514661|NCT01513330|7434937|FG001|COMPLETED|SenSura Mio First,||56
6514662|NCT01513330|7434936|FG000|NOT COMPLETED|SenSura Mio First,||4
6514663|NCT01513330|7434937|FG001|NOT COMPLETED|SenSura Mio First,||2
6514664|NCT01513330|7434936|FG000|STARTED|Standard Care First,||60
6514665|NCT01513330|7434937|FG001|STARTED|Standard Care First,||56
6514666|NCT01513330|7434936|FG000|COMPLETED|Standard Care First,||56
6514667|NCT01513330|7434937|FG001|COMPLETED|Standard Care First,||52
6514668|NCT01513330|7434936|FG000|NOT COMPLETED|Standard Care First,||4
6514669|NCT01513330|7434937|FG001|NOT COMPLETED|Standard Care First,||4
6514670|NCT01513447|7434945|FG000|STARTED|Overall Study||3
6514671|NCT01513447|7434946|FG001|STARTED|Overall Study||5
6514672|NCT01513447|7434945|FG000|COMPLETED|Overall Study||3
6514673|NCT01513447|7434946|FG001|COMPLETED|Overall Study||5
6514674|NCT01513447|7434945|FG000|NOT COMPLETED|Overall Study||0
6514675|NCT01513447|7434946|FG001|NOT COMPLETED|Overall Study||0
6514676|NCT01513460|7434955|FG000|STARTED|Overall Study||258
6514677|NCT01513460|7434956|FG001|STARTED|Overall Study||258
6514678|NCT01513460|7434957|FG002|STARTED|Overall Study||257
6514679|NCT01513460|7434955|FG000|Full Analysis Set|Overall Study||257
6514680|NCT01513460|7434956|FG001|Full Analysis Set|Overall Study||258
6514681|NCT01513460|7434957|FG002|Full Analysis Set|Overall Study||257
6514682|NCT01513460|7434955|FG000|Per-protocol Set|Overall Study||196
6514683|NCT01513460|7434956|FG001|Per-protocol Set|Overall Study||186
6514684|NCT01513460|7434957|FG002|Per-protocol Set|Overall Study||166
6514685|NCT01513460|7434955|FG000|COMPLETED|Overall Study||229
6514686|NCT01513460|7434956|FG001|COMPLETED|Overall Study||226
6514687|NCT01513460|7434957|FG002|COMPLETED|Overall Study||201
6514688|NCT01513460|7434955|FG000|NOT COMPLETED|Overall Study||29
6514689|NCT01513460|7434956|FG001|NOT COMPLETED|Overall Study||32
6514690|NCT01513460|7434957|FG002|NOT COMPLETED|Overall Study||56
6514691|NCT01513473|7434969|FG000|STARTED|Main Trial (26 Weeks)||174
6514692|NCT01513473|7434970|FG001|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
6514693|NCT01513473|7434969|FG000|Exposed|Main Trial (26 Weeks)||174
6514694|NCT01513473|7434970|FG001|Exposed|Main Trial (26 Weeks)||175
6514695|NCT01513473|7434969|FG000|COMPLETED|Main Trial (26 Weeks)||170
6514696|NCT01513473|7434970|FG001|COMPLETED|Main Trial (26 Weeks)||165
6514697|NCT01513473|7434969|FG000|NOT COMPLETED|Main Trial (26 Weeks)||4
6514698|NCT01513473|7434970|FG001|NOT COMPLETED|Main Trial (26 Weeks)||11
6514699|NCT01513473|7434969|FG000|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
6514700|NCT01513473|7434970|FG001|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
6514701|NCT01513473|7434969|FG000|COMPLETED|Extension Trial (26 Weeks)||151
6514702|NCT01513473|7434970|FG001|COMPLETED|Extension Trial (26 Weeks)||122
6514703|NCT01513473|7434969|FG000|NOT COMPLETED|Extension Trial (26 Weeks)||1
6514704|NCT01513473|7434970|FG001|NOT COMPLETED|Extension Trial (26 Weeks)||6
6514705|NCT01513538|7434976|FG000|STARTED|Overall Study||578
6514706|NCT01513538|7434976|FG000|COMPLETED|Overall Study||573
6514707|NCT01513538|7434976|FG000|NOT COMPLETED|Overall Study||5
6514708|NCT01513551|7434983|FG000|STARTED|Overall Study||230
6514709|NCT01513551|7434984|FG001|STARTED|Overall Study||231
6514710|NCT01513551|7434985|FG002|STARTED|Overall Study||231
6514711|NCT01513551|7434983|FG000|Vaccinated|Overall Study||230
6514712|NCT01513551|7434984|FG001|Vaccinated|Overall Study||231
6514713|NCT01513551|7434985|FG002|Vaccinated|Overall Study||230
6514714|NCT01513551|7434983|FG000|COMPLETED|Overall Study||226
6514715|NCT01513551|7434984|FG001|COMPLETED|Overall Study||225
6514716|NCT01513551|7434985|FG002|COMPLETED|Overall Study||226
6514717|NCT01513551|7434983|FG000|NOT COMPLETED|Overall Study||4
6514718|NCT01513551|7434984|FG001|NOT COMPLETED|Overall Study||6
6514719|NCT01513551|7434985|FG002|NOT COMPLETED|Overall Study||5
6514720|NCT01513590|7434995|FG000|STARTED|Overall Study||197
6514721|NCT01513590|7434996|FG001|STARTED|Overall Study||197
6514722|NCT01513590|7434995|FG000|Exposed|Overall Study|"One (1) subject was withdrawn prior to exposure due to non fulfilment of inclusion criteria"|196
6514723|NCT01513590|7434996|FG001|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
6514724|NCT01513590|7434995|FG000|COMPLETED|Overall Study||187
6514725|NCT01513590|7434996|FG001|COMPLETED|Overall Study||184
6514726|NCT01513590|7434995|FG000|NOT COMPLETED|Overall Study||10
6514727|NCT01513590|7434996|FG001|NOT COMPLETED|Overall Study||13
6514728|NCT01513759|7435002|FG000|STARTED|Overall Study||150
6514729|NCT01513759|7435002|FG000|At Least One Device Successfully Placed|Overall Study||149
6514730|NCT01513759|7435002|FG000|COMPLETED|Overall Study||145
6514731|NCT01513759|7435002|FG000|NOT COMPLETED|Overall Study||5
6514732|NCT01513902|7435009|FG000|STARTED|Overall Study||8
6514733|NCT01513902|7435010|FG001|STARTED|Overall Study||9
6514734|NCT01513902|7435011|FG002|STARTED|Overall Study||9
6514735|NCT01513902|7435009|FG000|COMPLETED|Overall Study||8
6514736|NCT01513902|7435010|FG001|COMPLETED|Overall Study||9
6514737|NCT01513902|7435011|FG002|COMPLETED|Overall Study||9
6514738|NCT01513902|7435009|FG000|NOT COMPLETED|Overall Study||0
6514739|NCT01513902|7435010|FG001|NOT COMPLETED|Overall Study||0
6514740|NCT01513902|7435011|FG002|NOT COMPLETED|Overall Study||0
6514741|NCT01513967|7435027|FG000|STARTED|Overall Study||4
6514742|NCT01513967|7435028|FG001|STARTED|Overall Study||4
6514743|NCT01513967|7435029|FG002|STARTED|Overall Study||4
6514744|NCT01513967|7435030|FG003|STARTED|Overall Study||6
6514745|NCT01513967|7435031|FG004|STARTED|Overall Study||4
6514746|NCT01513967|7435032|FG005|STARTED|Overall Study||4
6514747|NCT01513967|7435033|FG006|STARTED|Overall Study||5
6514748|NCT01513967|7435034|FG007|STARTED|Overall Study||8
6514749|NCT01513967|7435027|FG000|COMPLETED|Overall Study||4
6514750|NCT01513967|7435028|FG001|COMPLETED|Overall Study||4
6514751|NCT01513967|7435029|FG002|COMPLETED|Overall Study||4
6514752|NCT01513967|7435030|FG003|COMPLETED|Overall Study||6
6514753|NCT01513967|7435031|FG004|COMPLETED|Overall Study||4
6514754|NCT01513967|7435032|FG005|COMPLETED|Overall Study||3
6514755|NCT01513967|7435033|FG006|COMPLETED|Overall Study||3
6514756|NCT01513967|7435034|FG007|COMPLETED|Overall Study||6
6514757|NCT01513967|7435027|FG000|NOT COMPLETED|Overall Study||0
6514758|NCT01513967|7435028|FG001|NOT COMPLETED|Overall Study||0
6514759|NCT01513967|7435029|FG002|NOT COMPLETED|Overall Study||0
6514760|NCT01513967|7435030|FG003|NOT COMPLETED|Overall Study||0
6514761|NCT01513967|7435031|FG004|NOT COMPLETED|Overall Study||0
6514762|NCT01513967|7435032|FG005|NOT COMPLETED|Overall Study||1
6514763|NCT01513967|7435033|FG006|NOT COMPLETED|Overall Study||2
6514764|NCT01513967|7435034|FG007|NOT COMPLETED|Overall Study||2
6514765|NCT01514136|7435054|FG000|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
6514766|NCT01514136|7435055|FG001|STARTED|Test Period 1; Test A||0
6514767|NCT01514136|7435056|FG002|STARTED|Test Period 1; Test A||0
6514768|NCT01514136|7435057|FG003|STARTED|Test Period 1; Test A||0
6514769|NCT01514136|7435058|FG004|STARTED|Test Period 1; Test A||0
6514770|NCT01514136|7435059|FG005|STARTED|Test Period 1; Test A||0
6514771|NCT01514136|7435060|FG006|STARTED|Test Period 1; Test A||0
6514772|NCT01514136|7435061|FG007|STARTED|Test Period 1; Test A||0
6514773|NCT01514136|7435054|FG000|COMPLETED|Test Period 1; Test A||22
6514774|NCT01514136|7435055|FG001|COMPLETED|Test Period 1; Test A||0
6514775|NCT01514136|7435056|FG002|COMPLETED|Test Period 1; Test A||0
6514776|NCT01514136|7435057|FG003|COMPLETED|Test Period 1; Test A||0
6514777|NCT01514136|7435058|FG004|COMPLETED|Test Period 1; Test A||0
6514778|NCT01514136|7435059|FG005|COMPLETED|Test Period 1; Test A||0
6514779|NCT01514136|7435060|FG006|COMPLETED|Test Period 1; Test A||0
6514780|NCT01514136|7435061|FG007|COMPLETED|Test Period 1; Test A||0
6514781|NCT01514136|7435054|FG000|NOT COMPLETED|Test Period 1; Test A||3
6514782|NCT01514136|7435055|FG001|NOT COMPLETED|Test Period 1; Test A||0
6514783|NCT01514136|7435056|FG002|NOT COMPLETED|Test Period 1; Test A||0
6514784|NCT01514136|7435057|FG003|NOT COMPLETED|Test Period 1; Test A||0
6514785|NCT01514136|7435058|FG004|NOT COMPLETED|Test Period 1; Test A||0
6514786|NCT01514136|7435059|FG005|NOT COMPLETED|Test Period 1; Test A||0
6514787|NCT01514136|7435060|FG006|NOT COMPLETED|Test Period 1; Test A||0
6514788|NCT01514136|7435061|FG007|NOT COMPLETED|Test Period 1; Test A||0
6514789|NCT01514136|7435054|FG000|STARTED|Test Period 1; Test B||0
6514790|NCT01514136|7435055|FG001|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
6514791|NCT01514136|7435056|FG002|STARTED|Test Period 1; Test B||0
6514792|NCT01514136|7435057|FG003|STARTED|Test Period 1; Test B||0
6514793|NCT01514136|7435058|FG004|STARTED|Test Period 1; Test B||0
6514794|NCT01514136|7435059|FG005|STARTED|Test Period 1; Test B||0
6514795|NCT01514136|7435060|FG006|STARTED|Test Period 1; Test B||0
6514796|NCT01514136|7435061|FG007|STARTED|Test Period 1; Test B||0
6514797|NCT01514136|7435054|FG000|COMPLETED|Test Period 1; Test B||0
6514798|NCT01514136|7435055|FG001|COMPLETED|Test Period 1; Test B||23
6514799|NCT01514136|7435056|FG002|COMPLETED|Test Period 1; Test B||0
6514800|NCT01514136|7435057|FG003|COMPLETED|Test Period 1; Test B||0
6514801|NCT01514136|7435058|FG004|COMPLETED|Test Period 1; Test B||0
6514802|NCT01514136|7435059|FG005|COMPLETED|Test Period 1; Test B||0
6514803|NCT01514136|7435060|FG006|COMPLETED|Test Period 1; Test B||0
6514804|NCT01514136|7435061|FG007|COMPLETED|Test Period 1; Test B||0
6514805|NCT01514136|7435054|FG000|NOT COMPLETED|Test Period 1; Test B||0
6514806|NCT01514136|7435055|FG001|NOT COMPLETED|Test Period 1; Test B||1
6514807|NCT01514136|7435056|FG002|NOT COMPLETED|Test Period 1; Test B||0
6514808|NCT01514136|7435057|FG003|NOT COMPLETED|Test Period 1; Test B||0
6514809|NCT01514136|7435058|FG004|NOT COMPLETED|Test Period 1; Test B||0
6514810|NCT01514136|7435059|FG005|NOT COMPLETED|Test Period 1; Test B||0
6514811|NCT01514136|7435060|FG006|NOT COMPLETED|Test Period 1; Test B||0
6514812|NCT01514136|7435061|FG007|NOT COMPLETED|Test Period 1; Test B||0
6514813|NCT01514136|7435054|FG000|STARTED|Test Period 1; Test C||0
6514814|NCT01514136|7435055|FG001|STARTED|Test Period 1; Test C||0
6514815|NCT01514136|7435056|FG002|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
6514816|NCT01514136|7435057|FG003|STARTED|Test Period 1; Test C||0
6514817|NCT01514136|7435058|FG004|STARTED|Test Period 1; Test C||0
6514818|NCT01514136|7435059|FG005|STARTED|Test Period 1; Test C||0
6514819|NCT01514136|7435060|FG006|STARTED|Test Period 1; Test C||0
6514820|NCT01514136|7435061|FG007|STARTED|Test Period 1; Test C||0
6514821|NCT01514136|7435054|FG000|COMPLETED|Test Period 1; Test C||0
6514822|NCT01514136|7435055|FG001|COMPLETED|Test Period 1; Test C||0
6514823|NCT01514136|7435056|FG002|COMPLETED|Test Period 1; Test C||24
6514824|NCT01514136|7435057|FG003|COMPLETED|Test Period 1; Test C||0
6514825|NCT01514136|7435058|FG004|COMPLETED|Test Period 1; Test C||0
6514826|NCT01514136|7435059|FG005|COMPLETED|Test Period 1; Test C||0
6514827|NCT01514136|7435060|FG006|COMPLETED|Test Period 1; Test C||0
6514828|NCT01514136|7435061|FG007|COMPLETED|Test Period 1; Test C||0
6514829|NCT01514136|7435054|FG000|NOT COMPLETED|Test Period 1; Test C||0
6514830|NCT01514136|7435055|FG001|NOT COMPLETED|Test Period 1; Test C||0
6514831|NCT01514136|7435056|FG002|NOT COMPLETED|Test Period 1; Test C||0
6514832|NCT01514136|7435057|FG003|NOT COMPLETED|Test Period 1; Test C||0
6514833|NCT01514136|7435058|FG004|NOT COMPLETED|Test Period 1; Test C||0
6514834|NCT01514136|7435059|FG005|NOT COMPLETED|Test Period 1; Test C||0
6514835|NCT01514136|7435060|FG006|NOT COMPLETED|Test Period 1; Test C||0
6514836|NCT01514136|7435061|FG007|NOT COMPLETED|Test Period 1; Test C||0
6514837|NCT01514136|7435054|FG000|STARTED|Test Period 1; Test D||0
6514838|NCT01514136|7435055|FG001|STARTED|Test Period 1; Test D||0
6514839|NCT01514136|7435056|FG002|STARTED|Test Period 1; Test D||0
6514840|NCT01514136|7435057|FG003|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
6514841|NCT01514136|7435058|FG004|STARTED|Test Period 1; Test D||0
6514842|NCT01514136|7435059|FG005|STARTED|Test Period 1; Test D||0
6514843|NCT01514136|7435060|FG006|STARTED|Test Period 1; Test D||0
6514844|NCT01514136|7435061|FG007|STARTED|Test Period 1; Test D||0
6514845|NCT01514136|7435054|FG000|COMPLETED|Test Period 1; Test D||0
6514846|NCT01514136|7435055|FG001|COMPLETED|Test Period 1; Test D||0
6514847|NCT01514136|7435056|FG002|COMPLETED|Test Period 1; Test D||0
6514848|NCT01514136|7435057|FG003|COMPLETED|Test Period 1; Test D||24
6514849|NCT01514136|7435058|FG004|COMPLETED|Test Period 1; Test D||0
6514850|NCT01514136|7435059|FG005|COMPLETED|Test Period 1; Test D||0
6514851|NCT01514136|7435060|FG006|COMPLETED|Test Period 1; Test D||0
6514852|NCT01514136|7435061|FG007|COMPLETED|Test Period 1; Test D||0
6514853|NCT01514136|7435054|FG000|NOT COMPLETED|Test Period 1; Test D||0
6514854|NCT01514136|7435055|FG001|NOT COMPLETED|Test Period 1; Test D||0
6514855|NCT01514136|7435056|FG002|NOT COMPLETED|Test Period 1; Test D||0
6514856|NCT01514136|7435057|FG003|NOT COMPLETED|Test Period 1; Test D||2
6514857|NCT01514136|7435058|FG004|NOT COMPLETED|Test Period 1; Test D||0
6514858|NCT01514136|7435059|FG005|NOT COMPLETED|Test Period 1; Test D||0
6514859|NCT01514136|7435060|FG006|NOT COMPLETED|Test Period 1; Test D||0
6514860|NCT01514136|7435061|FG007|NOT COMPLETED|Test Period 1; Test D||0
6514861|NCT01514136|7435054|FG000|STARTED|Test Period 2; Test A*||0
6514862|NCT01514136|7435055|FG001|STARTED|Test Period 2; Test A*||0
6514863|NCT01514136|7435056|FG002|STARTED|Test Period 2; Test A*||0
6514864|NCT01514136|7435057|FG003|STARTED|Test Period 2; Test A*||0
6514865|NCT01514136|7435058|FG004|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
6514866|NCT01514136|7435059|FG005|STARTED|Test Period 2; Test A*||0
6514867|NCT01514136|7435060|FG006|STARTED|Test Period 2; Test A*||0
6514868|NCT01514136|7435061|FG007|STARTED|Test Period 2; Test A*||0
6514869|NCT01514136|7435054|FG000|COMPLETED|Test Period 2; Test A*||0
6514870|NCT01514136|7435055|FG001|COMPLETED|Test Period 2; Test A*||0
6514871|NCT01514136|7435056|FG002|COMPLETED|Test Period 2; Test A*||0
6514872|NCT01514136|7435057|FG003|COMPLETED|Test Period 2; Test A*||0
6514873|NCT01514136|7435058|FG004|COMPLETED|Test Period 2; Test A*||26
6514874|NCT01514136|7435059|FG005|COMPLETED|Test Period 2; Test A*||0
6514875|NCT01514136|7435060|FG006|COMPLETED|Test Period 2; Test A*||0
6514876|NCT01514136|7435061|FG007|COMPLETED|Test Period 2; Test A*||0
6514877|NCT01514136|7435054|FG000|NOT COMPLETED|Test Period 2; Test A*||0
6514878|NCT01514136|7435055|FG001|NOT COMPLETED|Test Period 2; Test A*||0
6514879|NCT01514136|7435056|FG002|NOT COMPLETED|Test Period 2; Test A*||0
6514880|NCT01514136|7435057|FG003|NOT COMPLETED|Test Period 2; Test A*||0
6514881|NCT01514136|7435058|FG004|NOT COMPLETED|Test Period 2; Test A*||2
6514882|NCT01514136|7435059|FG005|NOT COMPLETED|Test Period 2; Test A*||0
6514883|NCT01514136|7435060|FG006|NOT COMPLETED|Test Period 2; Test A*||0
6514884|NCT01514136|7435061|FG007|NOT COMPLETED|Test Period 2; Test A*||0
6514885|NCT01514136|7435054|FG000|STARTED|Test Period 2; Test B*||0
6514886|NCT01514136|7435055|FG001|STARTED|Test Period 2; Test B*||0
6514887|NCT01514136|7435056|FG002|STARTED|Test Period 2; Test B*||0
6514888|NCT01514136|7435057|FG003|STARTED|Test Period 2; Test B*||0
6514889|NCT01514136|7435058|FG004|STARTED|Test Period 2; Test B*||0
6514890|NCT01514136|7435059|FG005|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
6514891|NCT01514136|7435060|FG006|STARTED|Test Period 2; Test B*||0
6514892|NCT01514136|7435061|FG007|STARTED|Test Period 2; Test B*||0
6514893|NCT01514136|7435054|FG000|COMPLETED|Test Period 2; Test B*||0
6514894|NCT01514136|7435055|FG001|COMPLETED|Test Period 2; Test B*||0
6514895|NCT01514136|7435056|FG002|COMPLETED|Test Period 2; Test B*||0
6514896|NCT01514136|7435057|FG003|COMPLETED|Test Period 2; Test B*||0
6514897|NCT01514136|7435058|FG004|COMPLETED|Test Period 2; Test B*||0
6514898|NCT01514136|7435059|FG005|COMPLETED|Test Period 2; Test B*||26
6514899|NCT01514136|7435060|FG006|COMPLETED|Test Period 2; Test B*||0
6514900|NCT01514136|7435061|FG007|COMPLETED|Test Period 2; Test B*||0
6514901|NCT01514136|7435054|FG000|NOT COMPLETED|Test Period 2; Test B*||0
6514902|NCT01514136|7435055|FG001|NOT COMPLETED|Test Period 2; Test B*||0
6514903|NCT01514136|7435056|FG002|NOT COMPLETED|Test Period 2; Test B*||0
6514904|NCT01514136|7435057|FG003|NOT COMPLETED|Test Period 2; Test B*||0
6514905|NCT01514136|7435058|FG004|NOT COMPLETED|Test Period 2; Test B*||0
6514906|NCT01514136|7435059|FG005|NOT COMPLETED|Test Period 2; Test B*||2
6514907|NCT01514136|7435060|FG006|NOT COMPLETED|Test Period 2; Test B*||0
6514908|NCT01514136|7435061|FG007|NOT COMPLETED|Test Period 2; Test B*||0
6514909|NCT01514136|7435054|FG000|STARTED|Test Period 2; Test C*||0
6514910|NCT01514136|7435055|FG001|STARTED|Test Period 2; Test C*||0
6514911|NCT01514136|7435056|FG002|STARTED|Test Period 2; Test C*||0
6514912|NCT01514136|7435057|FG003|STARTED|Test Period 2; Test C*||0
6514913|NCT01514136|7435058|FG004|STARTED|Test Period 2; Test C*||0
6514914|NCT01514136|7435059|FG005|STARTED|Test Period 2; Test C*||0
6514915|NCT01514136|7435060|FG006|STARTED|Test Period 2; Test C*||26
6514916|NCT01514136|7435061|FG007|STARTED|Test Period 2; Test C*||0
6514917|NCT01514136|7435054|FG000|COMPLETED|Test Period 2; Test C*||0
6514918|NCT01514136|7435055|FG001|COMPLETED|Test Period 2; Test C*||0
6514919|NCT01514136|7435056|FG002|COMPLETED|Test Period 2; Test C*||0
6514920|NCT01514136|7435057|FG003|COMPLETED|Test Period 2; Test C*||0
6514921|NCT01514136|7435058|FG004|COMPLETED|Test Period 2; Test C*||0
6514922|NCT01514136|7435059|FG005|COMPLETED|Test Period 2; Test C*||0
6514923|NCT01514136|7435060|FG006|COMPLETED|Test Period 2; Test C*||23
6514924|NCT01514136|7435061|FG007|COMPLETED|Test Period 2; Test C*||0
6514925|NCT01514136|7435054|FG000|NOT COMPLETED|Test Period 2; Test C*||0
6514926|NCT01514136|7435055|FG001|NOT COMPLETED|Test Period 2; Test C*||0
6514927|NCT01514136|7435056|FG002|NOT COMPLETED|Test Period 2; Test C*||0
6514928|NCT01514136|7435057|FG003|NOT COMPLETED|Test Period 2; Test C*||0
6514929|NCT01514136|7435058|FG004|NOT COMPLETED|Test Period 2; Test C*||0
6514930|NCT01514136|7435059|FG005|NOT COMPLETED|Test Period 2; Test C*||0
6514931|NCT01514136|7435060|FG006|NOT COMPLETED|Test Period 2; Test C*||3
6514932|NCT01514136|7435061|FG007|NOT COMPLETED|Test Period 2; Test C*||0
6514933|NCT01514136|7435054|FG000|STARTED|Test Period; Test D*||0
6514934|NCT01514136|7435055|FG001|STARTED|Test Period; Test D*||0
6514935|NCT01514136|7435056|FG002|STARTED|Test Period; Test D*||0
6514936|NCT01514136|7435057|FG003|STARTED|Test Period; Test D*||0
6514937|NCT01514136|7435058|FG004|STARTED|Test Period; Test D*||0
6514938|NCT01514136|7435059|FG005|STARTED|Test Period; Test D*||0
6514939|NCT01514136|7435060|FG006|STARTED|Test Period; Test D*||0
6514940|NCT01514136|7435061|FG007|STARTED|Test Period; Test D*||23
6514941|NCT01514136|7435054|FG000|COMPLETED|Test Period; Test D*||0
6514942|NCT01514136|7435055|FG001|COMPLETED|Test Period; Test D*||0
6514943|NCT01514136|7435056|FG002|COMPLETED|Test Period; Test D*||0
6514944|NCT01514136|7435057|FG003|COMPLETED|Test Period; Test D*||0
6514945|NCT01514136|7435058|FG004|COMPLETED|Test Period; Test D*||0
6514946|NCT01514136|7435059|FG005|COMPLETED|Test Period; Test D*||0
6514947|NCT01514136|7435060|FG006|COMPLETED|Test Period; Test D*||0
6514948|NCT01514136|7435061|FG007|COMPLETED|Test Period; Test D*||23
6514949|NCT01514136|7435054|FG000|NOT COMPLETED|Test Period; Test D*||0
6514950|NCT01514136|7435055|FG001|NOT COMPLETED|Test Period; Test D*||0
6514951|NCT01514136|7435056|FG002|NOT COMPLETED|Test Period; Test D*||0
6514952|NCT01514136|7435057|FG003|NOT COMPLETED|Test Period; Test D*||0
6514953|NCT01514136|7435058|FG004|NOT COMPLETED|Test Period; Test D*||0
6514954|NCT01514136|7435059|FG005|NOT COMPLETED|Test Period; Test D*||0
6514955|NCT01514136|7435060|FG006|NOT COMPLETED|Test Period; Test D*||0
6514956|NCT01514136|7435061|FG007|NOT COMPLETED|Test Period; Test D*||0
6514957|NCT01514149|7435092|FG000|STARTED|Overall Study||15
6514958|NCT01514149|7435093|FG001|STARTED|Overall Study||15
6514959|NCT01514149|7435094|FG002|STARTED|Overall Study||14
6514960|NCT01514149|7435095|FG003|STARTED|Overall Study||14
6514961|NCT01514149|7435096|FG004|STARTED|Overall Study||15
6514962|NCT01514149|7435092|FG000|COMPLETED|Overall Study||12
6514963|NCT01514149|7435093|FG001|COMPLETED|Overall Study||14
6514964|NCT01514149|7435094|FG002|COMPLETED|Overall Study||11
6514965|NCT01514149|7435095|FG003|COMPLETED|Overall Study||13
6514966|NCT01514149|7435096|FG004|COMPLETED|Overall Study||14
6514967|NCT01514149|7435092|FG000|NOT COMPLETED|Overall Study||3
6514968|NCT01514149|7435093|FG001|NOT COMPLETED|Overall Study||1
6514969|NCT01514149|7435094|FG002|NOT COMPLETED|Overall Study||3
6514970|NCT01514149|7435095|FG003|NOT COMPLETED|Overall Study||1
6514971|NCT01514149|7435096|FG004|NOT COMPLETED|Overall Study||1
6514972|NCT01514162|7435108|FG000|STARTED|Overall Study||245
6514973|NCT01514162|7435108|FG000|COMPLETED|Overall Study||160
6514974|NCT01514162|7435108|FG000|NOT COMPLETED|Overall Study||85
6514975|NCT01514201|7435116|FG000|STARTED|PHASE I: Veliparib + Radiation Therapy||6
6514976|NCT01514201|7435117|FG001|STARTED|PHASE I: Veliparib + Radiation Therapy||6
6514977|NCT01514201|7435118|FG002|STARTED|PHASE I: Veliparib + Radiation Therapy||6
6514978|NCT01514201|7435119|FG003|STARTED|PHASE I: Veliparib + Radiation Therapy||0
6514979|NCT01514201|7435116|FG000|COMPLETED|PHASE I: Veliparib + Radiation Therapy||5
6514980|NCT01514201|7435117|FG001|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
6514981|NCT01514201|7435118|FG002|COMPLETED|PHASE I: Veliparib + Radiation Therapy||6
6514982|NCT01514201|7435119|FG003|COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
6514983|NCT01514201|7435116|FG000|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||1
6514984|NCT01514201|7435117|FG001|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
6514985|NCT01514201|7435118|FG002|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
6514986|NCT01514201|7435119|FG003|NOT COMPLETED|PHASE I: Veliparib + Radiation Therapy||0
6514987|NCT01514201|7435116|FG000|STARTED|PHASE I: Maintenance With Veliparib/TMZ||5
6514988|NCT01514201|7435117|FG001|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
6514989|NCT01514201|7435118|FG002|STARTED|PHASE I: Maintenance With Veliparib/TMZ||6
6514990|NCT01514201|7435119|FG003|STARTED|PHASE I: Maintenance With Veliparib/TMZ||0
6514991|NCT01514201|7435116|FG000|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6514992|NCT01514201|7435117|FG001|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6514993|NCT01514201|7435118|FG002|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6514994|NCT01514201|7435119|FG003|COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6514995|NCT01514201|7435116|FG000|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||5
6514996|NCT01514201|7435117|FG001|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
6514997|NCT01514201|7435118|FG002|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||6
6514998|NCT01514201|7435119|FG003|NOT COMPLETED|PHASE I: Maintenance With Veliparib/TMZ||0
6514999|NCT01514201|7435116|FG000|STARTED|PHASE II: Veliparib + Radiation Therapy||0
6515000|NCT01514201|7435117|FG001|STARTED|PHASE II: Veliparib + Radiation Therapy||0
6515001|NCT01514201|7435118|FG002|STARTED|PHASE II: Veliparib + Radiation Therapy||0
6515002|NCT01514201|7435119|FG003|STARTED|PHASE II: Veliparib + Radiation Therapy||47
6515003|NCT01514201|7435116|FG000|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6515004|NCT01514201|7435117|FG001|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6515005|NCT01514201|7435118|FG002|COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6515006|NCT01514201|7435119|FG003|COMPLETED|PHASE II: Veliparib + Radiation Therapy||35
6515007|NCT01514201|7435116|FG000|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6515008|NCT01514201|7435117|FG001|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6515009|NCT01514201|7435118|FG002|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||0
6515010|NCT01514201|7435119|FG003|NOT COMPLETED|PHASE II: Veliparib + Radiation Therapy||12
6515011|NCT01514201|7435116|FG000|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
6515012|NCT01514201|7435117|FG001|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
6515013|NCT01514201|7435118|FG002|STARTED|PHASE II: Maintenance With Veliparib/TMZ||0
6515014|NCT01514201|7435119|FG003|STARTED|PHASE II: Maintenance With Veliparib/TMZ||35
6515015|NCT01514201|7435116|FG000|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6515016|NCT01514201|7435117|FG001|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6515017|NCT01514201|7435118|FG002|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6515018|NCT01514201|7435119|FG003|COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||2
6515019|NCT01514201|7435116|FG000|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6515020|NCT01514201|7435117|FG001|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6515021|NCT01514201|7435118|FG002|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||0
6515022|NCT01514201|7435119|FG003|NOT COMPLETED|PHASE II: Maintenance With Veliparib/TMZ||33
6515023|NCT01514240|7435141|FG000|STARTED|Overall Study||56
6515024|NCT01514240|7435142|FG001|STARTED|Overall Study||56
6515025|NCT01514240|7435141|FG000|COMPLETED|Overall Study||50
6515026|NCT01514240|7435142|FG001|COMPLETED|Overall Study||45
6515027|NCT01514240|7435141|FG000|NOT COMPLETED|Overall Study||6
6515028|NCT01514240|7435142|FG001|NOT COMPLETED|Overall Study||11
6515029|NCT01514279|7435151|FG000|STARTED|Overall Study||118
6515030|NCT01514279|7435152|FG001|STARTED|Overall Study||123
6515031|NCT01514279|7435153|FG002|STARTED|Overall Study||119
6515032|NCT01514279|7435151|FG000|COMPLETED|Overall Study||107
6515033|NCT01514279|7435152|FG001|COMPLETED|Overall Study||110
6515034|NCT01514279|7435153|FG002|COMPLETED|Overall Study||114
6515035|NCT01514279|7435151|FG000|NOT COMPLETED|Overall Study||11
6515036|NCT01514279|7435152|FG001|NOT COMPLETED|Overall Study||13
6515037|NCT01514279|7435153|FG002|NOT COMPLETED|Overall Study||5
6515038|NCT01514292|7435161|FG000|STARTED|Overall Study||72
6515039|NCT01514292|7435161|FG000|COMPLETED|Overall Study||72
6515040|NCT01514292|7435161|FG000|NOT COMPLETED|Overall Study||0
6515041|NCT01514318|7435165|FG000|STARTED|Overall Study||8
6515042|NCT01514318|7435165|FG000|COMPLETED|Overall Study||8
6515043|NCT01514318|7435165|FG000|NOT COMPLETED|Overall Study||0
6515044|NCT01514357|7435171|FG000|STARTED|Overall Study||12
6515045|NCT01514357|7435172|FG001|STARTED|Overall Study||0
6515046|NCT01514357|7435171|FG000|COMPLETED|Overall Study||8
6515047|NCT01514357|7435172|FG001|COMPLETED|Overall Study||0
6515048|NCT01514357|7435171|FG000|NOT COMPLETED|Overall Study||4
6515049|NCT01514357|7435172|FG001|NOT COMPLETED|Overall Study||0
6515050|NCT01514370|7435180|FG000|STARTED|Overall Study||40
6515051|NCT01514370|7435181|FG001|STARTED|Overall Study||40
6515052|NCT01514370|7435180|FG000|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|38
6515053|NCT01514370|7435181|FG001|Safety Population|Overall Study|The Safety population consisted all randomized subjects who received at least 1 dose of study drug.|40
6515054|NCT01514370|7435180|FG000|COMPLETED|Overall Study||29
6515055|NCT01514370|7435181|FG001|COMPLETED|Overall Study||24
6515056|NCT01514370|7435180|FG000|NOT COMPLETED|Overall Study||11
6515057|NCT01514370|7435181|FG001|NOT COMPLETED|Overall Study||16
6515058|NCT01514383|7435188|FG000|STARTED|Overall Study||34
6515059|NCT01514383|7435188|FG000|COMPLETED|Overall Study||34
6515060|NCT01514383|7435188|FG000|NOT COMPLETED|Overall Study||0
6515061|NCT01514396|7435193|FG000|STARTED|Overall Study||8
6515062|NCT01514396|7435193|FG000|COMPLETED|Overall Study||8
6515063|NCT01514396|7435193|FG000|NOT COMPLETED|Overall Study||0
6515064|NCT01514422|7435198|FG000|STARTED|Overall Study||20
6515065|NCT01514422|7435198|FG000|COMPLETED|Overall Study||19
6515066|NCT01514422|7435198|FG000|NOT COMPLETED|Overall Study||1
6515067|NCT01514448|7435204|FG000|STARTED|Overall Study||16
6515068|NCT01514448|7435205|FG001|STARTED|Overall Study||13
6515069|NCT01514448|7435204|FG000|Full Analysis Set (FAS)|Overall Study||12
6515070|NCT01514448|7435205|FG001|Full Analysis Set (FAS)|Overall Study||13
6515071|NCT01514448|7435204|FG000|COMPLETED|Overall Study||4
6515072|NCT01514448|7435205|FG001|COMPLETED|Overall Study||5
6515073|NCT01514448|7435204|FG000|NOT COMPLETED|Overall Study||12
6515074|NCT01514448|7435205|FG001|NOT COMPLETED|Overall Study||8
6515075|NCT01514461|7435215|FG000|STARTED|Overall Study||15
6515076|NCT01514461|7435216|FG001|STARTED|Overall Study||15
6515077|NCT01514461|7435217|FG002|STARTED|Overall Study||15
6515078|NCT01514461|7435215|FG000|COMPLETED|Overall Study||10
6515079|NCT01514461|7435216|FG001|COMPLETED|Overall Study||12
6515080|NCT01514461|7435217|FG002|COMPLETED|Overall Study||11
6515081|NCT01514461|7435215|FG000|NOT COMPLETED|Overall Study||5
6515082|NCT01514461|7435216|FG001|NOT COMPLETED|Overall Study||3
6515083|NCT01514461|7435217|FG002|NOT COMPLETED|Overall Study||4
6515084|NCT01514513|7435230|FG000|STARTED|Overall Study||21
6515085|NCT01514513|7435231|FG001|STARTED|Overall Study||21
6515086|NCT01514513|7435230|FG000|COMPLETED|Overall Study||20
6515087|NCT01514513|7435231|FG001|COMPLETED|Overall Study||20
6515088|NCT01514513|7435230|FG000|NOT COMPLETED|Overall Study||1
6515089|NCT01514513|7435231|FG001|NOT COMPLETED|Overall Study||1
6515090|NCT01514630|7435237|FG000|STARTED|Overall Study||14
6515091|NCT01514630|7435237|FG000|COMPLETED|Overall Study||11
6515092|NCT01514630|7435237|FG000|NOT COMPLETED|Overall Study||3
6515093|NCT01514734|7435241|FG000|STARTED|Overall Study||9
6515094|NCT01514734|7435241|FG000|COMPLETED|Overall Study||9
6515095|NCT01514734|7435241|FG000|NOT COMPLETED|Overall Study||0
6515096|NCT01514760|7435245|FG000|STARTED|Overall Study||22
6515097|NCT01514760|7435245|FG000|COMPLETED|Overall Study||20
6515098|NCT01514760|7435245|FG000|NOT COMPLETED|Overall Study||2
6515099|NCT01514786|7435251|FG000|STARTED|Overall Study||286
6515100|NCT01514786|7435252|FG001|STARTED|Overall Study||284
6515101|NCT01514786|7435251|FG000|COMPLETED|Overall Study||286
6515102|NCT01514786|7435252|FG001|COMPLETED|Overall Study||284
6515103|NCT01514786|7435251|FG000|NOT COMPLETED|Overall Study||0
6515104|NCT01514786|7435252|FG001|NOT COMPLETED|Overall Study||0
6515105|NCT01514864|7435260|FG000|STARTED|Overall Study||9
6515106|NCT01514864|7435261|FG001|STARTED|Overall Study||5
6515107|NCT01514864|7435260|FG000|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
6515108|NCT01514864|7435261|FG001|COMPLETED|Overall Study||0
6515109|NCT01514864|7435260|FG000|NOT COMPLETED|Overall Study||9
6515110|NCT01514864|7435261|FG001|NOT COMPLETED|Overall Study||5
6515111|NCT01515046|7435268|FG000|STARTED|Overall Study||1
6515112|NCT01515046|7435268|FG000|COMPLETED|Overall Study||1
6515113|NCT01515046|7435268|FG000|NOT COMPLETED|Overall Study||0
6515114|NCT01515072|7435274|FG000|STARTED|Overall Study||166
6515115|NCT01515072|7435275|FG001|STARTED|Overall Study||155
6515116|NCT01515072|7435274|FG000|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
6515117|NCT01515072|7435275|FG001|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
6515118|NCT01515072|7435274|FG000|NOT COMPLETED|Overall Study||0
6515119|NCT01515072|7435275|FG001|NOT COMPLETED|Overall Study||0
6515120|NCT01515176|7435297|FG000|STARTED|Overall Study||4
6515121|NCT01515176|7435298|FG001|STARTED|Overall Study||32
6515122|NCT01515176|7435297|FG000|COMPLETED|Overall Study||4
6515123|NCT01515176|7435298|FG001|COMPLETED|Overall Study||32
6515124|NCT01515176|7435297|FG000|NOT COMPLETED|Overall Study||0
6515125|NCT01515176|7435298|FG001|NOT COMPLETED|Overall Study||0
6515126|NCT01515189|7435308|FG000|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
6515127|NCT01515189|7435309|FG001|STARTED|Induction||362
6515128|NCT01515189|7435308|FG000|COMPLETED|Induction||128
6515129|NCT01515189|7435309|FG001|COMPLETED|Induction||130
6515130|NCT01515189|7435308|FG000|NOT COMPLETED|Induction||237
6515131|NCT01515189|7435309|FG001|NOT COMPLETED|Induction||232
6515132|NCT01515189|7435308|FG000|STARTED|First Re-Induction Phase||23
6515133|NCT01515189|7435309|FG001|STARTED|First Re-Induction Phase||32
6515134|NCT01515189|7435308|FG000|COMPLETED|First Re-Induction Phase||9
6515135|NCT01515189|7435309|FG001|COMPLETED|First Re-Induction Phase||17
6515136|NCT01515189|7435308|FG000|NOT COMPLETED|First Re-Induction Phase||14
6515137|NCT01515189|7435309|FG001|NOT COMPLETED|First Re-Induction Phase||15
6515138|NCT01515319|7435325|FG000|STARTED|Overall Study||3
6515139|NCT01515319|7435326|FG001|STARTED|Overall Study||3
6515140|NCT01515319|7435327|FG002|STARTED|Overall Study||6
6515141|NCT01515319|7435328|FG003|STARTED|Overall Study||6
6515142|NCT01515319|7435329|FG004|STARTED|Overall Study||6
6515143|NCT01515319|7435330|FG005|STARTED|Overall Study||6
6515144|NCT01515319|7435331|FG006|STARTED|Overall Study||10
6515145|NCT01515319|7435332|FG007|STARTED|Overall Study||6
6515146|NCT01515319|7435333|FG008|STARTED|Overall Study||14
6515147|NCT01515319|7435334|FG009|STARTED|Overall Study||8
6515148|NCT01515319|7435325|FG000|COMPLETED|Overall Study||3
6515149|NCT01515319|7435326|FG001|COMPLETED|Overall Study||3
6515150|NCT01515319|7435327|FG002|COMPLETED|Overall Study||6
6515151|NCT01515319|7435328|FG003|COMPLETED|Overall Study||6
6515152|NCT01515319|7435329|FG004|COMPLETED|Overall Study||6
6515153|NCT01515319|7435330|FG005|COMPLETED|Overall Study||6
6515154|NCT01515319|7435331|FG006|COMPLETED|Overall Study||9
6515155|NCT01515319|7435332|FG007|COMPLETED|Overall Study||6
6515156|NCT01515319|7435333|FG008|COMPLETED|Overall Study||9
6515157|NCT01515319|7435334|FG009|COMPLETED|Overall Study||8
6515158|NCT01515319|7435325|FG000|NOT COMPLETED|Overall Study||0
6515159|NCT01515319|7435326|FG001|NOT COMPLETED|Overall Study||0
6515160|NCT01515319|7435327|FG002|NOT COMPLETED|Overall Study||0
6515161|NCT01515319|7435328|FG003|NOT COMPLETED|Overall Study||0
6515162|NCT01515319|7435329|FG004|NOT COMPLETED|Overall Study||0
6515163|NCT01515319|7435330|FG005|NOT COMPLETED|Overall Study||0
6515164|NCT01515319|7435331|FG006|NOT COMPLETED|Overall Study||1
6515165|NCT01515319|7435332|FG007|NOT COMPLETED|Overall Study||0
6515166|NCT01515319|7435333|FG008|NOT COMPLETED|Overall Study||5
6515167|NCT01515319|7435334|FG009|NOT COMPLETED|Overall Study||0
6641038|NCT02340104|7569497|FG000|COMPLETED|Overall Study||8
6641039|NCT02340104|7569497|FG000|NOT COMPLETED|Overall Study||0
6641040|NCT02340156|7569502|FG000|STARTED|Overall Study||1
6641041|NCT02340156|7569502|FG000|COMPLETED|Overall Study||1
6515168|NCT01515345|7435358|FG000|STARTED|Overall Study||665
6515169|NCT01515345|7435359|FG001|STARTED|Overall Study||343
6515170|NCT01515345|7435358|FG000|COMPLETED|Overall Study||664
6515171|NCT01515345|7435359|FG001|COMPLETED|Overall Study||343
6515172|NCT01515345|7435358|FG000|NOT COMPLETED|Overall Study||1
6515173|NCT01515345|7435359|FG001|NOT COMPLETED|Overall Study||0
6515174|NCT01515410|7435365|FG000|STARTED|Overall Study||19
6515175|NCT01515410|7435366|FG001|STARTED|Overall Study||15
6515176|NCT01515410|7435365|FG000|COMPLETED|Overall Study||19
6515177|NCT01515410|7435366|FG001|COMPLETED|Overall Study||15
6515178|NCT01515410|7435365|FG000|NOT COMPLETED|Overall Study||0
6515179|NCT01515410|7435366|FG001|NOT COMPLETED|Overall Study||0
6515180|NCT01515423|7435374|FG000|STARTED|Open Label Phase||1429
6515181|NCT01515423|7435375|FG001|STARTED|Open Label Phase||0
6515182|NCT01515423|7435376|FG002|STARTED|Open Label Phase||0
6515183|NCT01515423|7435374|FG000|COMPLETED|Open Label Phase||1016
6515184|NCT01515423|7435375|FG001|COMPLETED|Open Label Phase||0
6515185|NCT01515423|7435376|FG002|COMPLETED|Open Label Phase||0
6515186|NCT01515423|7435374|FG000|NOT COMPLETED|Open Label Phase||413
6515187|NCT01515423|7435375|FG001|NOT COMPLETED|Open Label Phase||0
6515188|NCT01515423|7435376|FG002|NOT COMPLETED|Open Label Phase||0
6515189|NCT01515423|7435374|FG000|STARTED|DOUBLE BLIND||0
6515190|NCT01515423|7435375|FG001|STARTED|DOUBLE BLIND||504
6515191|NCT01515423|7435376|FG002|STARTED|DOUBLE BLIND||512
6515192|NCT01515423|7435374|FG000|COMPLETED|DOUBLE BLIND||0
6515193|NCT01515423|7435375|FG001|COMPLETED|DOUBLE BLIND||422
6515194|NCT01515423|7435376|FG002|COMPLETED|DOUBLE BLIND||420
6515195|NCT01515423|7435374|FG000|NOT COMPLETED|DOUBLE BLIND||0
6515196|NCT01515423|7435375|FG001|NOT COMPLETED|DOUBLE BLIND||82
6515197|NCT01515423|7435376|FG002|NOT COMPLETED|DOUBLE BLIND||92
6515198|NCT01515475|7435387|FG000|STARTED|Overall Study||61
6515199|NCT01515475|7435388|FG001|STARTED|Overall Study||58
6515200|NCT01515475|7435389|FG002|STARTED|Overall Study||65
6515201|NCT01515475|7435390|FG003|STARTED|Overall Study||65
6515202|NCT01515475|7435387|FG000|COMPLETED|Overall Study||41
6515203|NCT01515475|7435388|FG001|COMPLETED|Overall Study||43
6515204|NCT01515475|7435389|FG002|COMPLETED|Overall Study||53
6515205|NCT01515475|7435390|FG003|COMPLETED|Overall Study||53
6515206|NCT01515475|7435387|FG000|NOT COMPLETED|Overall Study||20
6515207|NCT01515475|7435388|FG001|NOT COMPLETED|Overall Study||15
6515208|NCT01515475|7435389|FG002|NOT COMPLETED|Overall Study||12
6515209|NCT01515475|7435390|FG003|NOT COMPLETED|Overall Study||12
6515210|NCT01515488|7435402|FG000|STARTED|Overall Study||200
6515211|NCT01515488|7435403|FG001|STARTED|Overall Study||200
6515212|NCT01515488|7435402|FG000|COMPLETED|Overall Study||200
6515213|NCT01515488|7435403|FG001|COMPLETED|Overall Study||200
6515214|NCT01515488|7435402|FG000|NOT COMPLETED|Overall Study||0
6515215|NCT01515488|7435403|FG001|NOT COMPLETED|Overall Study||0
6515216|NCT01515540|7435411|FG000|STARTED|Overall Study||20
6515217|NCT01515540|7435412|FG001|STARTED|Overall Study||18
6641042|NCT02340156|7569502|FG000|NOT COMPLETED|Overall Study||0
6515218|NCT01515540|7435411|FG000|COMPLETED|Overall Study||15
6515219|NCT01515540|7435412|FG001|COMPLETED|Overall Study||15
6515220|NCT01515540|7435411|FG000|NOT COMPLETED|Overall Study||5
6515221|NCT01515540|7435412|FG001|NOT COMPLETED|Overall Study||3
6515222|NCT01515566|7435420|FG000|STARTED|Overall Study||10
6515223|NCT01515566|7435421|FG001|STARTED|Overall Study||10
6515224|NCT01515566|7435420|FG000|COMPLETED|Overall Study||10
6515225|NCT01515566|7435421|FG001|COMPLETED|Overall Study||10
6515226|NCT01515566|7435420|FG000|NOT COMPLETED|Overall Study||0
6515227|NCT01515566|7435421|FG001|NOT COMPLETED|Overall Study||0
6561403|NCT01792830|7484190|FG001|NOT COMPLETED|Overall Study||0
6561404|NCT01792830|7484191|FG002|NOT COMPLETED|Overall Study||0
6561405|NCT01792830|7484192|FG003|NOT COMPLETED|Overall Study||3
6561406|NCT01792830|7484193|FG004|NOT COMPLETED|Overall Study||1
6561407|NCT01792830|7484194|FG005|NOT COMPLETED|Overall Study||1
6561408|NCT01792830|7484195|FG006|NOT COMPLETED|Overall Study||2
6561409|NCT01792830|7484196|FG007|NOT COMPLETED|Overall Study||1
6561410|NCT01792830|7484197|FG008|NOT COMPLETED|Overall Study||9
6561411|NCT01792830|7484198|FG009|NOT COMPLETED|Overall Study||0
6561412|NCT01792830|7484199|FG010|NOT COMPLETED|Overall Study||3
6561413|NCT01792986|7484229|FG000|STARTED|Overall Study||12
6561414|NCT01792986|7484229|FG000|COMPLETED|Overall Study||12
6561415|NCT01792986|7484229|FG000|NOT COMPLETED|Overall Study||0
6561416|NCT01793051|7484235|FG000|STARTED|Overall Study||43
6561417|NCT01793051|7484236|FG001|STARTED|Overall Study||44
6561418|NCT01793051|7484235|FG000|COMPLETED|Overall Study||33
6561419|NCT01793051|7484236|FG001|COMPLETED|Overall Study||36
6561420|NCT01793051|7484235|FG000|NOT COMPLETED|Overall Study||10
6561421|NCT01793051|7484236|FG001|NOT COMPLETED|Overall Study||8
6561422|NCT01793142|7484242|FG000|STARTED|Overall Study||3430
6561423|NCT01793142|7484242|FG000|Treated|Overall Study||3423
6561424|NCT01793142|7484242|FG000|COMPLETED|Overall Study||3423
6561425|NCT01793142|7484242|FG000|NOT COMPLETED|Overall Study||7
6561426|NCT01793285|7484246|FG000|STARTED|Overall Study||85
6561427|NCT01793285|7484246|FG000|COMPLETED|Overall Study||85
6561428|NCT01793285|7484246|FG000|NOT COMPLETED|Overall Study||0
6561429|NCT01793688|7484250|FG000|STARTED|Overall Study||982
6561430|NCT01793688|7484250|FG000|COMPLETED|Overall Study||980
6561431|NCT01793688|7484250|FG000|NOT COMPLETED|Overall Study||2
6561432|NCT01793792|7484254|FG000|STARTED|Overall Study|153 treated: 1 attempted no device implanted, 152 device implanted.|153
6561433|NCT01793792|7484254|FG000|Treated|Overall Study|153 Treated, 152 implanted with device, 1 attempted no device implanted|153
6561434|NCT01793792|7484254|FG000|COMPLETED|Overall Study||141
6561435|NCT01793792|7484254|FG000|NOT COMPLETED|Overall Study||12
6561436|NCT01793883|7484261|FG000|STARTED|Overall Study||213
6561437|NCT01793883|7484262|FG001|STARTED|Overall Study||214
6561438|NCT01793883|7484263|FG002|STARTED|Overall Study||212
6561439|NCT01793883|7484261|FG000|COMPLETED|Overall Study||201
6561440|NCT01793883|7484262|FG001|COMPLETED|Overall Study||204
6561441|NCT01793883|7484263|FG002|COMPLETED|Overall Study||204
6561442|NCT01793883|7484261|FG000|NOT COMPLETED|Overall Study||12
6561443|NCT01793883|7484262|FG001|NOT COMPLETED|Overall Study||10
6561444|NCT01793883|7484263|FG002|NOT COMPLETED|Overall Study||8
6561445|NCT01793909|7484273|FG000|STARTED|Overall Study||30
6561446|NCT01793909|7484274|FG001|STARTED|Overall Study||25
6561447|NCT01793909|7484273|FG000|COMPLETED|Overall Study||20
6561448|NCT01793909|7484274|FG001|COMPLETED|Overall Study||20
6561449|NCT01793909|7484273|FG000|NOT COMPLETED|Overall Study||10
6561450|NCT01793909|7484274|FG001|NOT COMPLETED|Overall Study||5
6561451|NCT01793935|7484282|FG000|STARTED|Overall Study||34
6561452|NCT01793935|7484283|FG001|STARTED|Overall Study||34
6561453|NCT01793935|7484282|FG000|COMPLETED|Overall Study||28
6561454|NCT01793935|7484283|FG001|COMPLETED|Overall Study||31
6561455|NCT01793935|7484282|FG000|NOT COMPLETED|Overall Study||6
6561456|NCT01793935|7484283|FG001|NOT COMPLETED|Overall Study||3
6561457|NCT01794000|7484291|FG000|STARTED|Double-Blind Phase (DBP)||171
6561458|NCT01794000|7484292|FG001|STARTED|Double-Blind Phase (DBP)||170
6561459|NCT01794000|7484291|FG000|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
6561460|NCT01794000|7484292|FG001|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
6561461|NCT01794000|7484291|FG000|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
6561462|NCT01794000|7484292|FG001|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
6561463|NCT01794000|7484291|FG000|COMPLETED|Double-Blind Phase (DBP)||2
6561464|NCT01794000|7484292|FG001|COMPLETED|Double-Blind Phase (DBP)||4
6561465|NCT01794000|7484291|FG000|NOT COMPLETED|Double-Blind Phase (DBP)||169
6641043|NCT02340299|7569508|FG000|STARTED|Overall Study||4
6641044|NCT02340299|7569509|FG001|STARTED|Overall Study||2
6641045|NCT02340299|7569508|FG000|COMPLETED|Overall Study||4
6641046|NCT02340299|7569509|FG001|COMPLETED|Overall Study||2
6641047|NCT02340299|7569508|FG000|NOT COMPLETED|Overall Study||0
6641048|NCT02340299|7569509|FG001|NOT COMPLETED|Overall Study||0
6641049|NCT02340338|7569522|FG000|STARTED|Overall Study|2 vaccine + 1 placebo|2
6641050|NCT02340338|7569523|FG001|STARTED|Overall Study|2 vaccine + 1 placebo|2
6655835|NCT02456636|7585991|FG002|COMPLETED|Overall Study||400
6561466|NCT01794000|7484292|FG001|NOT COMPLETED|Double-Blind Phase (DBP)||166
6561467|NCT01794000|7484291|FG000|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
6561468|NCT01794000|7484292|FG001|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
6561469|NCT01794000|7484291|FG000|COMPLETED|Open-Label Extension Phase (OLE)||0
6515228|NCT01515657|7435427|FG000|STARTED|First Intervention||14
6515229|NCT01515657|7435428|FG001|STARTED|First Intervention||13
6515230|NCT01515657|7435429|FG002|STARTED|First Intervention||13
6515231|NCT01515657|7435427|FG000|COMPLETED|First Intervention||14
6515232|NCT01515657|7435428|FG001|COMPLETED|First Intervention||12
6515233|NCT01515657|7435429|FG002|COMPLETED|First Intervention||13
6515234|NCT01515657|7435427|FG000|NOT COMPLETED|First Intervention||0
6515235|NCT01515657|7435428|FG001|NOT COMPLETED|First Intervention||1
6515236|NCT01515657|7435429|FG002|NOT COMPLETED|First Intervention||0
6515237|NCT01515657|7435427|FG000|STARTED|Second Intervention||14
6515238|NCT01515657|7435428|FG001|STARTED|Second Intervention||12
6515239|NCT01515657|7435429|FG002|STARTED|Second Intervention||13
6515240|NCT01515657|7435427|FG000|COMPLETED|Second Intervention||14
6515241|NCT01515657|7435428|FG001|COMPLETED|Second Intervention||11
6515242|NCT01515657|7435429|FG002|COMPLETED|Second Intervention||13
6515243|NCT01515657|7435427|FG000|NOT COMPLETED|Second Intervention||0
6515244|NCT01515657|7435428|FG001|NOT COMPLETED|Second Intervention||1
6515245|NCT01515657|7435429|FG002|NOT COMPLETED|Second Intervention||0
6515246|NCT01515657|7435427|FG000|STARTED|Third Intervention||14
6515247|NCT01515657|7435428|FG001|STARTED|Third Intervention||11
6515248|NCT01515657|7435429|FG002|STARTED|Third Intervention||13
6515249|NCT01515657|7435427|FG000|COMPLETED|Third Intervention||13
6515250|NCT01515657|7435428|FG001|COMPLETED|Third Intervention||11
6515251|NCT01515657|7435429|FG002|COMPLETED|Third Intervention||13
6515252|NCT01515657|7435427|FG000|NOT COMPLETED|Third Intervention||1
6515253|NCT01515657|7435428|FG001|NOT COMPLETED|Third Intervention||0
6515254|NCT01515657|7435429|FG002|NOT COMPLETED|Third Intervention||0
6515255|NCT01515696|7435439|FG000|STARTED|Overall Study||47
6515256|NCT01515696|7435440|FG001|STARTED|Overall Study||49
6515257|NCT01515696|7435439|FG000|COMPLETED|Overall Study||39
6515258|NCT01515696|7435440|FG001|COMPLETED|Overall Study||39
6515259|NCT01515696|7435439|FG000|NOT COMPLETED|Overall Study||8
6515260|NCT01515696|7435440|FG001|NOT COMPLETED|Overall Study||10
6515261|NCT01515865|7435446|FG000|STARTED|Part A (Open-label)||98
6515262|NCT01515865|7435447|FG001|STARTED|Part A (Open-label)||0
6515263|NCT01515865|7435448|FG002|STARTED|Part A (Open-label)||0
6515264|NCT01515865|7435446|FG000|COMPLETED|Part A (Open-label)||95
6515265|NCT01515865|7435447|FG001|COMPLETED|Part A (Open-label)||0
6515266|NCT01515865|7435448|FG002|COMPLETED|Part A (Open-label)||0
6515267|NCT01515865|7435446|FG000|NOT COMPLETED|Part A (Open-label)||3
6515268|NCT01515865|7435447|FG001|NOT COMPLETED|Part A (Open-label)||0
6515269|NCT01515865|7435448|FG002|NOT COMPLETED|Part A (Open-label)||0
6515270|NCT01515865|7435446|FG000|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
6515271|NCT01515865|7435447|FG001|STARTED|Part B (Open-label)||0
6515272|NCT01515865|7435448|FG002|STARTED|Part B (Open-label)||0
6515273|NCT01515865|7435446|FG000|COMPLETED|Part B (Open-label)||69
6641051|NCT02340338|7569524|FG002|STARTED|Overall Study|3 vaccine + 1 placebo|3
6641052|NCT02340338|7569525|FG003|STARTED|Overall Study|9 vaccine + 3 placebo|9
6641053|NCT02340338|7569526|FG004|STARTED|Overall Study|9 vaccine + 3 placebo|9
6641054|NCT02340338|7569527|FG005|STARTED|Overall Study|9 vaccine + 3 placebo|9
6641055|NCT02340338|7569528|FG006|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
6641056|NCT02340338|7569522|FG000|COMPLETED|Overall Study||2
6641057|NCT02340338|7569523|FG001|COMPLETED|Overall Study||2
6641058|NCT02340338|7569524|FG002|COMPLETED|Overall Study||3
6641059|NCT02340338|7569525|FG003|COMPLETED|Overall Study||9
6641060|NCT02340338|7569526|FG004|COMPLETED|Overall Study||9
6641061|NCT02340338|7569527|FG005|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
6641062|NCT02340338|7569528|FG006|COMPLETED|Overall Study||12
6641063|NCT02340338|7569522|FG000|NOT COMPLETED|Overall Study||0
6641064|NCT02340338|7569523|FG001|NOT COMPLETED|Overall Study||0
6641065|NCT02340338|7569524|FG002|NOT COMPLETED|Overall Study||0
6641066|NCT02340338|7569525|FG003|NOT COMPLETED|Overall Study||0
6641067|NCT02340338|7569526|FG004|NOT COMPLETED|Overall Study||0
6515274|NCT01515865|7435447|FG001|COMPLETED|Part B (Open-label)||0
6515275|NCT01515865|7435448|FG002|COMPLETED|Part B (Open-label)||0
6515276|NCT01515865|7435446|FG000|NOT COMPLETED|Part B (Open-label)||2
6515277|NCT01515865|7435447|FG001|NOT COMPLETED|Part B (Open-label)||0
6515278|NCT01515865|7435448|FG002|NOT COMPLETED|Part B (Open-label)||0
6515279|NCT01515865|7435446|FG000|STARTED|Part C (Randomized)||0
6515280|NCT01515865|7435447|FG001|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
6515281|NCT01515865|7435448|FG002|STARTED|Part C (Randomized)||34
6515282|NCT01515865|7435446|FG000|COMPLETED|Part C (Randomized)||0
6641068|NCT02340338|7569527|FG005|NOT COMPLETED|Overall Study||0
6641069|NCT02340338|7569528|FG006|NOT COMPLETED|Overall Study||0
6641070|NCT02340520|7569544|FG000|STARTED|Overall Study||11
6515283|NCT01515865|7435447|FG001|COMPLETED|Part C (Randomized)||33
6515284|NCT01515865|7435448|FG002|COMPLETED|Part C (Randomized)||34
6515285|NCT01515865|7435446|FG000|NOT COMPLETED|Part C (Randomized)||0
6515286|NCT01515865|7435447|FG001|NOT COMPLETED|Part C (Randomized)||0
6515287|NCT01515865|7435448|FG002|NOT COMPLETED|Part C (Randomized)||0
6515288|NCT01515891|7435456|FG000|STARTED|Overall Study||4
6515289|NCT01515891|7435456|FG000|COMPLETED|Overall Study||4
6515290|NCT01515891|7435456|FG000|NOT COMPLETED|Overall Study||0
6515291|NCT01515943|7435463|FG000|STARTED|Overall Study||75
6515292|NCT01515943|7435464|FG001|STARTED|Overall Study||85
6515293|NCT01515943|7435465|FG002|STARTED|Overall Study||44
6515294|NCT01515943|7435463|FG000|COMPLETED|Overall Study||69
6515295|NCT01515943|7435464|FG001|COMPLETED|Overall Study||69
6515296|NCT01515943|7435465|FG002|COMPLETED|Overall Study||31
6515297|NCT01515943|7435463|FG000|NOT COMPLETED|Overall Study||6
6515298|NCT01515943|7435464|FG001|NOT COMPLETED|Overall Study||16
6515299|NCT01515943|7435465|FG002|NOT COMPLETED|Overall Study||13
6515300|NCT01515956|7435475|FG000|STARTED|Overall Study||15
6515301|NCT01515956|7435475|FG000|COMPLETED|Overall Study||15
6515302|NCT01515956|7435475|FG000|NOT COMPLETED|Overall Study||0
6515303|NCT01515995|7435482|FG000|STARTED|Overall Study||25
6515304|NCT01515995|7435483|FG001|STARTED|Overall Study||25
6515305|NCT01515995|7435482|FG000|COMPLETED|Overall Study||22
6515306|NCT01515995|7435483|FG001|COMPLETED|Overall Study||21
6515307|NCT01515995|7435482|FG000|NOT COMPLETED|Overall Study||3
6515308|NCT01515995|7435483|FG001|NOT COMPLETED|Overall Study||4
6515309|NCT01516008|7435492|FG000|STARTED|Overall Study||114
6515310|NCT01516008|7435493|FG001|STARTED|Overall Study||121
6515311|NCT01516008|7435494|FG002|STARTED|Overall Study||117
6515312|NCT01516008|7435492|FG000|COMPLETED|Overall Study||69
6515313|NCT01516008|7435493|FG001|COMPLETED|Overall Study||105
6515314|NCT01516008|7435494|FG002|COMPLETED|Overall Study||99
6515315|NCT01516008|7435492|FG000|NOT COMPLETED|Overall Study||45
6515316|NCT01516008|7435493|FG001|NOT COMPLETED|Overall Study||16
6515317|NCT01516008|7435494|FG002|NOT COMPLETED|Overall Study||18
6515318|NCT01516268|7435504|FG000|STARTED|Overall Study||25
6515319|NCT01516268|7435505|FG001|STARTED|Overall Study||25
6515320|NCT01516268|7435504|FG000|COMPLETED|Overall Study||25
6515321|NCT01516268|7435505|FG001|COMPLETED|Overall Study||25
6515322|NCT01516268|7435504|FG000|NOT COMPLETED|Overall Study||0
6515323|NCT01516268|7435505|FG001|NOT COMPLETED|Overall Study||0
6515324|NCT01516424|7435513|FG000|STARTED|Overall Study|the patient number of randomization for Blonanserin Group|131
6515325|NCT01516424|7435514|FG001|STARTED|Overall Study|the patient number of randomization for Risperidone Group|136
6515326|NCT01516424|7435513|FG000|COMPLETED|Overall Study||96
6515327|NCT01516424|7435514|FG001|COMPLETED|Overall Study||114
6515328|NCT01516424|7435513|FG000|NOT COMPLETED|Overall Study||35
6515329|NCT01516424|7435514|FG001|NOT COMPLETED|Overall Study||22
6515330|NCT01516437|7435524|FG000|STARTED|Overall Study||24
6515331|NCT01516437|7435525|FG001|STARTED|Overall Study||24
6515332|NCT01516437|7435526|FG002|STARTED|Overall Study||15
6515333|NCT01516437|7435527|FG003|STARTED|Overall Study||7
6515334|NCT01516437|7435524|FG000|COMPLETED|Overall Study||24
6515335|NCT01516437|7435525|FG001|COMPLETED|Overall Study||24
6515336|NCT01516437|7435526|FG002|COMPLETED|Overall Study||14
6515337|NCT01516437|7435527|FG003|COMPLETED|Overall Study||6
6515338|NCT01516437|7435524|FG000|NOT COMPLETED|Overall Study||0
6515339|NCT01516437|7435525|FG001|NOT COMPLETED|Overall Study||0
6515340|NCT01516437|7435526|FG002|NOT COMPLETED|Overall Study||1
6515341|NCT01516437|7435527|FG003|NOT COMPLETED|Overall Study||1
6515342|NCT01516632|7435541|FG000|STARTED|Overall Study||101
6515343|NCT01516632|7435542|FG001|STARTED|Overall Study||63
6515344|NCT01516632|7435541|FG000|COMPLETED|Overall Study||77
6515345|NCT01516632|7435542|FG001|COMPLETED|Overall Study||48
6515346|NCT01516632|7435541|FG000|NOT COMPLETED|Overall Study||24
6515347|NCT01516632|7435542|FG001|NOT COMPLETED|Overall Study||15
6515348|NCT01516684|7435552|FG000|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
6515349|NCT01516684|7435553|FG001|STARTED|Overall Study|"Overall number of units (trials) was used for measuring results with 170 trials.~Trials were randomized for each arm, not participants"|
6515350|NCT01516684|7435552|FG000|COMPLETED|Overall Study|Trials were randomized for each arm, not participants|
6515351|NCT01516684|7435553|FG001|COMPLETED|Overall Study|"Overall number of units (trials) completed was 152~Trials were randomized for each arm, not participants"|
6515352|NCT01516684|7435552|FG000|NOT COMPLETED|Overall Study||
6515353|NCT01516684|7435553|FG001|NOT COMPLETED|Overall Study||
6515354|NCT01516736|7435563|FG000|STARTED|Overall Study||155
6515355|NCT01516736|7435564|FG001|STARTED|Overall Study||153
6515356|NCT01516736|7435563|FG000|COMPLETED|Overall Study||135
6515357|NCT01516736|7435564|FG001|COMPLETED|Overall Study||140
6515358|NCT01516736|7435563|FG000|NOT COMPLETED|Overall Study||20
6515359|NCT01516736|7435564|FG001|NOT COMPLETED|Overall Study||13
6515360|NCT01516749|7435570|FG000|STARTED|Active Therapy||6
6515361|NCT01516749|7435570|FG000|COMPLETED|Active Therapy||5
6515362|NCT01516749|7435570|FG000|NOT COMPLETED|Active Therapy||1
6515363|NCT01516749|7435570|FG000|STARTED|Follow-up Off Therapy||5
6515364|NCT01516749|7435570|FG000|COMPLETED|Follow-up Off Therapy||4
6515365|NCT01516749|7435570|FG000|NOT COMPLETED|Follow-up Off Therapy||1
6515366|NCT01516879|7435576|FG000|STARTED|Overall Study||303
6515367|NCT01516879|7435577|FG001|STARTED|Overall Study||602
6515368|NCT01516879|7435576|FG000|Received Treatment|Overall Study||302
6515369|NCT01516879|7435577|FG001|Received Treatment|Overall Study||599
6515370|NCT01516879|7435576|FG000|COMPLETED|Overall Study||287
6515371|NCT01516879|7435577|FG001|COMPLETED|Overall Study||568
6515372|NCT01516879|7435576|FG000|NOT COMPLETED|Overall Study||16
6515373|NCT01516879|7435577|FG001|NOT COMPLETED|Overall Study||34
6515374|NCT01516892|7435583|FG000|STARTED|Overall Study||716
6515375|NCT01516892|7435583|FG000|COMPLETED|Overall Study||373
6515376|NCT01516892|7435583|FG000|NOT COMPLETED|Overall Study||343
6515377|NCT01516957|7435590|FG000|STARTED|Placebo-controlled Phase||55
6515378|NCT01516957|7435591|FG001|STARTED|Placebo-controlled Phase||57
6515379|NCT01516957|7435592|FG002|STARTED|Placebo-controlled Phase||56
6515380|NCT01516957|7435593|FG003|STARTED|Placebo-controlled Phase||0
6515381|NCT01516957|7435590|FG000|COMPLETED|Placebo-controlled Phase||52
6515382|NCT01516957|7435591|FG001|COMPLETED|Placebo-controlled Phase||53
6515383|NCT01516957|7435592|FG002|COMPLETED|Placebo-controlled Phase||51
6515384|NCT01516957|7435593|FG003|COMPLETED|Placebo-controlled Phase||0
6515385|NCT01516957|7435590|FG000|NOT COMPLETED|Placebo-controlled Phase||3
6515386|NCT01516957|7435591|FG001|NOT COMPLETED|Placebo-controlled Phase||4
6515387|NCT01516957|7435592|FG002|NOT COMPLETED|Placebo-controlled Phase||5
6515388|NCT01516957|7435593|FG003|NOT COMPLETED|Placebo-controlled Phase||0
6515389|NCT01516957|7435590|FG000|STARTED|Open-label Phase||0
6515390|NCT01516957|7435591|FG001|STARTED|Open-label Phase||0
6515391|NCT01516957|7435592|FG002|STARTED|Open-label Phase||0
6515392|NCT01516957|7435593|FG003|STARTED|Open-label Phase||156
6515393|NCT01516957|7435590|FG000|COMPLETED|Open-label Phase||0
6515394|NCT01516957|7435591|FG001|COMPLETED|Open-label Phase||0
6515395|NCT01516957|7435592|FG002|COMPLETED|Open-label Phase||0
6515396|NCT01516957|7435593|FG003|COMPLETED|Open-label Phase||0
6515397|NCT01516957|7435590|FG000|NOT COMPLETED|Open-label Phase||0
6515398|NCT01516957|7435591|FG001|NOT COMPLETED|Open-label Phase||0
6515399|NCT01516957|7435592|FG002|NOT COMPLETED|Open-label Phase||0
6515400|NCT01516957|7435593|FG003|NOT COMPLETED|Open-label Phase||156
6515401|NCT01516970|7435604|FG000|STARTED|Overall Study||159
6515402|NCT01516970|7435605|FG001|STARTED|Overall Study||153
6515403|NCT01516970|7435604|FG000|COMPLETED|Overall Study||141
6515404|NCT01516970|7435605|FG001|COMPLETED|Overall Study||132
6515405|NCT01516970|7435604|FG000|NOT COMPLETED|Overall Study||18
6515406|NCT01516970|7435605|FG001|NOT COMPLETED|Overall Study||21
6515407|NCT01517074|7435611|FG000|STARTED|Overall Study||5
6515408|NCT01517074|7435611|FG000|COMPLETED|Overall Study||5
6515409|NCT01517074|7435611|FG000|NOT COMPLETED|Overall Study||0
6515410|NCT01517178|7435620|FG000|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
6515411|NCT01517178|7435621|FG001|STARTED|Period 1||11
6515412|NCT01517178|7435620|FG000|COMPLETED|Period 1||12
6515413|NCT01517178|7435621|FG001|COMPLETED|Period 1||6
6515414|NCT01517178|7435620|FG000|NOT COMPLETED|Period 1||4
6515415|NCT01517178|7435621|FG001|NOT COMPLETED|Period 1||5
6515416|NCT01517178|7435620|FG000|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
6515417|NCT01517178|7435621|FG001|STARTED|Period 2||6
6515418|NCT01517178|7435620|FG000|COMPLETED|Period 2||5
6515419|NCT01517178|7435621|FG001|COMPLETED|Period 2||4
6515420|NCT01517178|7435620|FG000|NOT COMPLETED|Period 2||6
6515421|NCT01517178|7435621|FG001|NOT COMPLETED|Period 2||2
6515422|NCT01517282|7435631|FG000|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
6515423|NCT01517282|7435632|FG001|STARTED|Overall Study||8
6515424|NCT01517282|7435633|FG002|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
6515425|NCT01517282|7435634|FG003|STARTED|Overall Study||6
6515426|NCT01517282|7435631|FG000|COMPLETED|Overall Study||8
6515427|NCT01517282|7435632|FG001|COMPLETED|Overall Study||7
6515428|NCT01517282|7435633|FG002|COMPLETED|Overall Study||8
6515429|NCT01517282|7435634|FG003|COMPLETED|Overall Study||5
6515430|NCT01517282|7435631|FG000|NOT COMPLETED|Overall Study||1
6515431|NCT01517282|7435632|FG001|NOT COMPLETED|Overall Study||1
6515432|NCT01517282|7435633|FG002|NOT COMPLETED|Overall Study||1
6515433|NCT01517282|7435634|FG003|NOT COMPLETED|Overall Study||1
6515434|NCT01517295|7435646|FG000|STARTED|Overall Study||16
6515435|NCT01517295|7435647|FG001|STARTED|Overall Study||14
6515436|NCT01517295|7435646|FG000|COMPLETED|Overall Study||15
6515437|NCT01517295|7435647|FG001|COMPLETED|Overall Study||14
6515438|NCT01517295|7435646|FG000|NOT COMPLETED|Overall Study||1
6515439|NCT01517295|7435647|FG001|NOT COMPLETED|Overall Study||0
6515440|NCT01517373|7435658|FG000|STARTED|Run-in Period||361
6515441|NCT01517373|7435659|FG001|STARTED|Run-in Period||0
6515442|NCT01517373|7435660|FG002|STARTED|Run-in Period||0
6515443|NCT01517373|7435661|FG003|STARTED|Run-in Period||0
6515444|NCT01517373|7435662|FG004|STARTED|Run-in Period||0
6515445|NCT01517373|7435663|FG005|STARTED|Run-in Period||0
6515446|NCT01517373|7435658|FG000|COMPLETED|Run-in Period||304
6515447|NCT01517373|7435659|FG001|COMPLETED|Run-in Period||0
6515448|NCT01517373|7435660|FG002|COMPLETED|Run-in Period||0
6515449|NCT01517373|7435661|FG003|COMPLETED|Run-in Period||0
6515450|NCT01517373|7435662|FG004|COMPLETED|Run-in Period||0
6515451|NCT01517373|7435663|FG005|COMPLETED|Run-in Period||0
6515452|NCT01517373|7435658|FG000|NOT COMPLETED|Run-in Period||57
6515453|NCT01517373|7435659|FG001|NOT COMPLETED|Run-in Period||0
6515454|NCT01517373|7435660|FG002|NOT COMPLETED|Run-in Period||0
6515455|NCT01517373|7435661|FG003|NOT COMPLETED|Run-in Period||0
6515456|NCT01517373|7435662|FG004|NOT COMPLETED|Run-in Period||0
6515457|NCT01517373|7435663|FG005|NOT COMPLETED|Run-in Period||0
6515458|NCT01517373|7435658|FG000|STARTED|Treatment Period||0
6515459|NCT01517373|7435659|FG001|STARTED|Treatment Period||61
6515460|NCT01517373|7435660|FG002|STARTED|Treatment Period||60
6515461|NCT01517373|7435661|FG003|STARTED|Treatment Period||61
6515462|NCT01517373|7435662|FG004|STARTED|Treatment Period||61
6515463|NCT01517373|7435663|FG005|STARTED|Treatment Period||61
6515464|NCT01517373|7435658|FG000|COMPLETED|Treatment Period||0
6515465|NCT01517373|7435659|FG001|COMPLETED|Treatment Period||57
6515466|NCT01517373|7435660|FG002|COMPLETED|Treatment Period||54
6515467|NCT01517373|7435661|FG003|COMPLETED|Treatment Period||54
6515468|NCT01517373|7435662|FG004|COMPLETED|Treatment Period||55
6515469|NCT01517373|7435663|FG005|COMPLETED|Treatment Period||54
6515470|NCT01517373|7435658|FG000|NOT COMPLETED|Treatment Period||0
6515471|NCT01517373|7435659|FG001|NOT COMPLETED|Treatment Period||4
6515472|NCT01517373|7435660|FG002|NOT COMPLETED|Treatment Period||6
6515473|NCT01517373|7435661|FG003|NOT COMPLETED|Treatment Period||7
6641071|NCT02340520|7569544|FG000|COMPLETED|Overall Study||8
6641072|NCT02340520|7569544|FG000|NOT COMPLETED|Overall Study||3
6641073|NCT02340663|7569550|FG000|STARTED|Overall Study||35
6641074|NCT02340663|7569551|FG001|STARTED|Overall Study||32
6641075|NCT02340663|7569550|FG000|Clinical Exam, Impressions|Overall Study||35
6515474|NCT01517373|7435662|FG004|NOT COMPLETED|Treatment Period||6
6515475|NCT01517373|7435663|FG005|NOT COMPLETED|Treatment Period||7
6515476|NCT01517412|7435678|FG000|STARTED|Overall Study||225
6515477|NCT01517412|7435679|FG001|STARTED|Overall Study||226
6515478|NCT01517412|7435678|FG000|COMPLETED|Overall Study||189
6515479|NCT01517412|7435679|FG001|COMPLETED|Overall Study||202
6515480|NCT01517412|7435678|FG000|NOT COMPLETED|Overall Study||36
6515481|NCT01517412|7435679|FG001|NOT COMPLETED|Overall Study||24
6515482|NCT01517529|7435685|FG000|STARTED|Overall Study||10
6515483|NCT01517529|7435685|FG000|COMPLETED|Overall Study||10
6515484|NCT01517529|7435685|FG000|NOT COMPLETED|Overall Study||0
6515485|NCT01517750|7435693|FG000|STARTED|Overall Study||21
6515486|NCT01517750|7435694|FG001|STARTED|Overall Study||19
6515487|NCT01517750|7435695|FG002|STARTED|Overall Study||21
6515488|NCT01517750|7435696|FG003|STARTED|Overall Study||19
6515489|NCT01517750|7435693|FG000|COMPLETED|Overall Study||20
6515490|NCT01517750|7435694|FG001|COMPLETED|Overall Study||17
6515491|NCT01517750|7435695|FG002|COMPLETED|Overall Study||17
6515492|NCT01517750|7435696|FG003|COMPLETED|Overall Study||18
6515493|NCT01517750|7435693|FG000|NOT COMPLETED|Overall Study||1
6515494|NCT01517750|7435694|FG001|NOT COMPLETED|Overall Study||2
6515495|NCT01517750|7435695|FG002|NOT COMPLETED|Overall Study||4
6515496|NCT01517750|7435696|FG003|NOT COMPLETED|Overall Study||1
6515497|NCT01517867|7435712|FG000|STARTED|Overall Study||81
6515498|NCT01517867|7435713|FG001|STARTED|Overall Study||80
6515499|NCT01517867|7435712|FG000|COMPLETED|Overall Study||18
6515500|NCT01517867|7435713|FG001|COMPLETED|Overall Study||15
6515501|NCT01517867|7435712|FG000|NOT COMPLETED|Overall Study||63
6515502|NCT01517867|7435713|FG001|NOT COMPLETED|Overall Study||65
6515503|NCT01517893|7435721|FG000|STARTED|Overall Study||8
6515504|NCT01517893|7435722|FG001|STARTED|Overall Study||7
6515505|NCT01517893|7435721|FG000|COMPLETED|Overall Study||5
6515506|NCT01517893|7435722|FG001|COMPLETED|Overall Study||7
6515507|NCT01517893|7435721|FG000|NOT COMPLETED|Overall Study||3
6515508|NCT01517893|7435722|FG001|NOT COMPLETED|Overall Study||0
6515509|NCT01517984|7435731|FG000|STARTED|Overall Study||5
6515510|NCT01517984|7435732|FG001|STARTED|Overall Study||26
6515511|NCT01517984|7435733|FG002|STARTED|Overall Study||14
6515512|NCT01517984|7435734|FG003|STARTED|Overall Study||7
6515513|NCT01517984|7435731|FG000|COMPLETED|Overall Study||0
6515514|NCT01517984|7435732|FG001|COMPLETED|Overall Study||3
6515515|NCT01517984|7435733|FG002|COMPLETED|Overall Study||10
6515516|NCT01517984|7435734|FG003|COMPLETED|Overall Study||6
6515517|NCT01517984|7435731|FG000|NOT COMPLETED|Overall Study||5
6515518|NCT01517984|7435732|FG001|NOT COMPLETED|Overall Study||23
6515519|NCT01517984|7435733|FG002|NOT COMPLETED|Overall Study||4
6515520|NCT01517984|7435734|FG003|NOT COMPLETED|Overall Study||1
6515521|NCT01518153|7435741|FG000|STARTED|Stem Cell Transplant||16
6515522|NCT01518153|7435742|FG001|STARTED|Stem Cell Transplant||0
6515523|NCT01518153|7435743|FG002|STARTED|Stem Cell Transplant||0
6515524|NCT01518153|7435741|FG000|COMPLETED|Stem Cell Transplant||7
6515525|NCT01518153|7435742|FG001|COMPLETED|Stem Cell Transplant||0
6515526|NCT01518153|7435743|FG002|COMPLETED|Stem Cell Transplant||0
6515527|NCT01518153|7435741|FG000|NOT COMPLETED|Stem Cell Transplant||9
6515528|NCT01518153|7435742|FG001|NOT COMPLETED|Stem Cell Transplant||0
6515529|NCT01518153|7435743|FG002|NOT COMPLETED|Stem Cell Transplant||0
6515530|NCT01518153|7435741|FG000|STARTED|Donor Lymphocyte Infusion||0
6515531|NCT01518153|7435742|FG001|STARTED|Donor Lymphocyte Infusion||3
6515532|NCT01518153|7435743|FG002|STARTED|Donor Lymphocyte Infusion||4
6515533|NCT01518153|7435741|FG000|COMPLETED|Donor Lymphocyte Infusion||0
6515534|NCT01518153|7435742|FG001|COMPLETED|Donor Lymphocyte Infusion||1
6515535|NCT01518153|7435743|FG002|COMPLETED|Donor Lymphocyte Infusion||3
6515536|NCT01518153|7435741|FG000|NOT COMPLETED|Donor Lymphocyte Infusion||0
6515537|NCT01518153|7435742|FG001|NOT COMPLETED|Donor Lymphocyte Infusion||2
6515538|NCT01518153|7435743|FG002|NOT COMPLETED|Donor Lymphocyte Infusion||1
6515539|NCT01518192|7435754|FG000|STARTED|Overall Study||145
6515540|NCT01518192|7435755|FG001|STARTED|Overall Study||140
6515541|NCT01518192|7435756|FG002|STARTED|Overall Study||259
6515542|NCT01518192|7435754|FG000|COMPLETED|Overall Study||116
6515543|NCT01518192|7435755|FG001|COMPLETED|Overall Study||114
6515544|NCT01518192|7435756|FG002|COMPLETED|Overall Study||224
6515545|NCT01518192|7435754|FG000|NOT COMPLETED|Overall Study||29
6515546|NCT01518192|7435755|FG001|NOT COMPLETED|Overall Study||26
6515547|NCT01518192|7435756|FG002|NOT COMPLETED|Overall Study||35
6515548|NCT01518244|7435770|FG000|STARTED|Overall Study||50
6641076|NCT02340663|7569551|FG001|Clinical Exam, Impressions|Overall Study||32
6515549|NCT01518244|7435770|FG000|COMPLETED|Overall Study||47
6515550|NCT01518244|7435770|FG000|NOT COMPLETED|Overall Study||3
6515551|NCT01518257|7435776|FG000|STARTED|Overall Study||61
6655836|NCT02456636|7585989|FG000|NOT COMPLETED|Overall Study||68
6515552|NCT01518257|7435777|FG001|STARTED|Overall Study||60
6515553|NCT01518257|7435776|FG000|COMPLETED|Overall Study||59
6515554|NCT01518257|7435777|FG001|COMPLETED|Overall Study||60
6515555|NCT01518257|7435776|FG000|NOT COMPLETED|Overall Study||2
6515556|NCT01518257|7435777|FG001|NOT COMPLETED|Overall Study||0
6515557|NCT01518270|7435783|FG000|STARTED|Overall Study||179
6515558|NCT01518270|7435783|FG000|COMPLETED|Overall Study||179
6515559|NCT01518270|7435783|FG000|NOT COMPLETED|Overall Study||0
6515560|NCT01518309|7435787|FG000|STARTED|Overall Study||39
6515561|NCT01518309|7435787|FG000|COMPLETED|Overall Study||0
6515562|NCT01518309|7435787|FG000|NOT COMPLETED|Overall Study||39
6515563|NCT01518322|7435791|FG000|STARTED|Overall Study||235
6515564|NCT01518322|7435791|FG000|COMPLETED|Overall Study||222
6515565|NCT01518322|7435791|FG000|NOT COMPLETED|Overall Study||13
6515566|NCT01518374|7435800|FG000|STARTED|Overall Study||1768
6515567|NCT01518374|7435800|FG000|COMPLETED|Overall Study||1761
6515568|NCT01518374|7435800|FG000|NOT COMPLETED|Overall Study||7
6515569|NCT01518530|7435804|FG000|STARTED|Active Treatment Period||10
6515570|NCT01518530|7435804|FG000|COMPLETED|Active Treatment Period||9
6515571|NCT01518530|7435804|FG000|NOT COMPLETED|Active Treatment Period||1
6515572|NCT01518530|7435804|FG000|STARTED|Post-Treatment Follow-up||9
6515573|NCT01518530|7435804|FG000|COMPLETED|Post-Treatment Follow-up||9
6515574|NCT01518530|7435804|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
6515575|NCT01518699|7435814|FG000|STARTED|Period 1||10
6515576|NCT01518699|7435815|FG001|STARTED|Period 1||9
6515577|NCT01518699|7435816|FG002|STARTED|Period 1||9
6515578|NCT01518699|7435817|FG003|STARTED|Period 1||10
6515579|NCT01518699|7435818|FG004|STARTED|Period 1||10
6515580|NCT01518699|7435819|FG005|STARTED|Period 1||9
6515581|NCT01518699|7435814|FG000|COMPLETED|Period 1||10
6515582|NCT01518699|7435815|FG001|COMPLETED|Period 1||9
6515583|NCT01518699|7435816|FG002|COMPLETED|Period 1||9
6515584|NCT01518699|7435817|FG003|COMPLETED|Period 1||10
6515585|NCT01518699|7435818|FG004|COMPLETED|Period 1||10
6515586|NCT01518699|7435819|FG005|COMPLETED|Period 1||9
6515587|NCT01518699|7435814|FG000|NOT COMPLETED|Period 1||0
6515588|NCT01518699|7435815|FG001|NOT COMPLETED|Period 1||0
6515589|NCT01518699|7435816|FG002|NOT COMPLETED|Period 1||0
6515590|NCT01518699|7435817|FG003|NOT COMPLETED|Period 1||0
6515591|NCT01518699|7435818|FG004|NOT COMPLETED|Period 1||0
6515592|NCT01518699|7435819|FG005|NOT COMPLETED|Period 1||0
6515593|NCT01518699|7435814|FG000|STARTED|Period 2||10
6515594|NCT01518699|7435815|FG001|STARTED|Period 2||9
6515595|NCT01518699|7435816|FG002|STARTED|Period 2||9
6515596|NCT01518699|7435817|FG003|STARTED|Period 2||10
6515597|NCT01518699|7435818|FG004|STARTED|Period 2||10
6515598|NCT01518699|7435819|FG005|STARTED|Period 2||9
6515599|NCT01518699|7435814|FG000|COMPLETED|Period 2||8
6515600|NCT01518699|7435815|FG001|COMPLETED|Period 2||7
6515601|NCT01518699|7435816|FG002|COMPLETED|Period 2||9
6515602|NCT01518699|7435817|FG003|COMPLETED|Period 2||10
6515603|NCT01518699|7435818|FG004|COMPLETED|Period 2||10
6515604|NCT01518699|7435819|FG005|COMPLETED|Period 2||9
6515605|NCT01518699|7435814|FG000|NOT COMPLETED|Period 2||2
6515606|NCT01518699|7435815|FG001|NOT COMPLETED|Period 2||2
6515607|NCT01518699|7435816|FG002|NOT COMPLETED|Period 2||0
6515608|NCT01518699|7435817|FG003|NOT COMPLETED|Period 2||0
6515609|NCT01518699|7435818|FG004|NOT COMPLETED|Period 2||0
6515610|NCT01518699|7435819|FG005|NOT COMPLETED|Period 2||0
6515611|NCT01518699|7435814|FG000|STARTED|Period 3||8
6515612|NCT01518699|7435815|FG001|STARTED|Period 3||7
6515613|NCT01518699|7435816|FG002|STARTED|Period 3||9
6515614|NCT01518699|7435817|FG003|STARTED|Period 3||10
6515615|NCT01518699|7435818|FG004|STARTED|Period 3||10
6515616|NCT01518699|7435819|FG005|STARTED|Period 3||9
6515617|NCT01518699|7435814|FG000|COMPLETED|Period 3||8
6515618|NCT01518699|7435815|FG001|COMPLETED|Period 3||7
6515619|NCT01518699|7435816|FG002|COMPLETED|Period 3||9
6515620|NCT01518699|7435817|FG003|COMPLETED|Period 3||10
6515621|NCT01518699|7435818|FG004|COMPLETED|Period 3||10
6515622|NCT01518699|7435819|FG005|COMPLETED|Period 3||9
6515623|NCT01518699|7435814|FG000|NOT COMPLETED|Period 3||0
6515624|NCT01518699|7435815|FG001|NOT COMPLETED|Period 3||0
6515625|NCT01518699|7435816|FG002|NOT COMPLETED|Period 3||0
6515626|NCT01518699|7435817|FG003|NOT COMPLETED|Period 3||0
6515627|NCT01518699|7435818|FG004|NOT COMPLETED|Period 3||0
6515628|NCT01518699|7435819|FG005|NOT COMPLETED|Period 3||0
6515629|NCT01518868|7435827|FG000|STARTED|Overall Study||63
6515630|NCT01518868|7435828|FG001|STARTED|Overall Study||63
6515631|NCT01518868|7435827|FG000|COMPLETED|Overall Study||59
6515632|NCT01518868|7435828|FG001|COMPLETED|Overall Study||59
6515633|NCT01518868|7435827|FG000|NOT COMPLETED|Overall Study||4
6515634|NCT01518868|7435828|FG001|NOT COMPLETED|Overall Study||4
6515635|NCT01518946|7435836|FG000|STARTED|Open-label Phase||24
6515636|NCT01518946|7435837|FG001|STARTED|Open-label Phase||0
6515637|NCT01518946|7435838|FG002|STARTED|Open-label Phase||0
6515638|NCT01518946|7435836|FG000|COMPLETED|Open-label Phase||20
6515639|NCT01518946|7435837|FG001|COMPLETED|Open-label Phase||0
6515640|NCT01518946|7435838|FG002|COMPLETED|Open-label Phase||0
6515641|NCT01518946|7435836|FG000|NOT COMPLETED|Open-label Phase||4
6515642|NCT01518946|7435837|FG001|NOT COMPLETED|Open-label Phase||0
6515643|NCT01518946|7435838|FG002|NOT COMPLETED|Open-label Phase||0
6515644|NCT01518946|7435836|FG000|STARTED|Randomized Phase (First Intervention)||0
6515645|NCT01518946|7435837|FG001|STARTED|Randomized Phase (First Intervention)||10
6515646|NCT01518946|7435838|FG002|STARTED|Randomized Phase (First Intervention)||10
6515647|NCT01518946|7435836|FG000|COMPLETED|Randomized Phase (First Intervention)||0
6515648|NCT01518946|7435837|FG001|COMPLETED|Randomized Phase (First Intervention)||9
6515649|NCT01518946|7435838|FG002|COMPLETED|Randomized Phase (First Intervention)||10
6515650|NCT01518946|7435836|FG000|NOT COMPLETED|Randomized Phase (First Intervention)||0
6515651|NCT01518946|7435837|FG001|NOT COMPLETED|Randomized Phase (First Intervention)||1
6515652|NCT01518946|7435838|FG002|NOT COMPLETED|Randomized Phase (First Intervention)||0
6515653|NCT01518946|7435836|FG000|STARTED|Randomized Phase (Second Intervention)||0
6515654|NCT01518946|7435837|FG001|STARTED|Randomized Phase (Second Intervention)||9
6515655|NCT01518946|7435838|FG002|STARTED|Randomized Phase (Second Intervention)||10
6515656|NCT01518946|7435836|FG000|COMPLETED|Randomized Phase (Second Intervention)||0
6515657|NCT01518946|7435837|FG001|COMPLETED|Randomized Phase (Second Intervention)||9
6515658|NCT01518946|7435838|FG002|COMPLETED|Randomized Phase (Second Intervention)||10
6515659|NCT01518946|7435836|FG000|NOT COMPLETED|Randomized Phase (Second Intervention)||0
6515660|NCT01518946|7435837|FG001|NOT COMPLETED|Randomized Phase (Second Intervention)||0
6515661|NCT01518946|7435838|FG002|NOT COMPLETED|Randomized Phase (Second Intervention)||0
6515662|NCT01518972|7435847|FG000|STARTED|Overall Study||15
6515663|NCT01518972|7435848|FG001|STARTED|Overall Study||15
6515664|NCT01518972|7435847|FG000|COMPLETED|Overall Study||9
6515665|NCT01518972|7435848|FG001|COMPLETED|Overall Study||11
6515666|NCT01518972|7435847|FG000|NOT COMPLETED|Overall Study||6
6515667|NCT01518972|7435848|FG001|NOT COMPLETED|Overall Study||4
6515668|NCT01519063|7435856|FG000|STARTED|Overall Study||26
6515669|NCT01519063|7435857|FG001|STARTED|Overall Study||30
6515670|NCT01519063|7435856|FG000|COMPLETED|Overall Study||19
6515671|NCT01519063|7435857|FG001|COMPLETED|Overall Study||25
6515672|NCT01519063|7435856|FG000|NOT COMPLETED|Overall Study||7
6515673|NCT01519063|7435857|FG001|NOT COMPLETED|Overall Study||5
6515674|NCT01519089|7435865|FG000|STARTED|Overall Study||47
6515675|NCT01519089|7435866|FG001|STARTED|Overall Study||48
6515676|NCT01519089|7435865|FG000|Received Treatment|Overall Study||47
6515677|NCT01519089|7435866|FG001|Received Treatment|Overall Study||47
6515678|NCT01519089|7435865|FG000|COMPLETED|Overall Study||40
6515679|NCT01519089|7435866|FG001|COMPLETED|Overall Study||33
6515680|NCT01519089|7435865|FG000|NOT COMPLETED|Overall Study||7
6515681|NCT01519089|7435866|FG001|NOT COMPLETED|Overall Study||15
6515682|NCT01519167|7435876|FG000|STARTED|Overall Study||1
6515683|NCT01519167|7435877|FG001|STARTED|Overall Study||89
6515684|NCT01519167|7435876|FG000|COMPLETED|Overall Study||1
6515685|NCT01519167|7435877|FG001|COMPLETED|Overall Study||81
6515686|NCT01519167|7435876|FG000|NOT COMPLETED|Overall Study||0
6515687|NCT01519167|7435877|FG001|NOT COMPLETED|Overall Study||8
6515688|NCT01519206|7435883|FG000|STARTED|Overall Study||32
6515689|NCT01519206|7435883|FG000|COMPLETED|Overall Study||27
6515690|NCT01519206|7435883|FG000|NOT COMPLETED|Overall Study||5
6515691|NCT01519245|7435896|FG000|STARTED|Overall Study||24
6515692|NCT01519245|7435897|FG001|STARTED|Overall Study||20
6515693|NCT01519245|7435896|FG000|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
6515694|NCT01519245|7435897|FG001|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
6515695|NCT01519245|7435896|FG000|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
6515696|NCT01519245|7435897|FG001|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
6515697|NCT01519245|7435896|FG000|COMPLETED|Overall Study||23
6515698|NCT01519245|7435897|FG001|COMPLETED|Overall Study||18
6515699|NCT01519245|7435896|FG000|NOT COMPLETED|Overall Study||1
6515700|NCT01519245|7435897|FG001|NOT COMPLETED|Overall Study||2
6515701|NCT01519271|7435907|FG000|STARTED|Phase 1||14
6515702|NCT01519271|7435908|FG001|STARTED|Phase 1||14
6515703|NCT01519271|7435907|FG000|COMPLETED|Phase 1||14
6515704|NCT01519271|7435908|FG001|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
6515705|NCT01519271|7435907|FG000|NOT COMPLETED|Phase 1||0
6515706|NCT01519271|7435908|FG001|NOT COMPLETED|Phase 1||1
6641077|NCT02340663|7569550|FG000|Splint Delivery, Assessments|Overall Study||33
6641078|NCT02340663|7569551|FG001|Splint Delivery, Assessments|Overall Study||31
6641079|NCT02340663|7569550|FG000|1 Week Follow-up, Assessments|Overall Study||33
6641080|NCT02340663|7569551|FG001|1 Week Follow-up, Assessments|Overall Study||31
6641081|NCT02340663|7569550|FG000|4 Month Follow-up, Assessments|Overall Study||30
6641082|NCT02340663|7569551|FG001|4 Month Follow-up, Assessments|Overall Study||31
6641083|NCT02340663|7569550|FG000|COMPLETED|Overall Study||30
6641084|NCT02340663|7569551|FG001|COMPLETED|Overall Study||31
6641085|NCT02340663|7569550|FG000|NOT COMPLETED|Overall Study||5
6515707|NCT01519271|7435907|FG000|STARTED|Phase 2|2 participants discontinued after Phase 1|12
6515708|NCT01519271|7435908|FG001|STARTED|Phase 2||14
6515709|NCT01519271|7435907|FG000|COMPLETED|Phase 2||12
6515710|NCT01519271|7435908|FG001|COMPLETED|Phase 2||14
6515711|NCT01519271|7435907|FG000|NOT COMPLETED|Phase 2||0
6515712|NCT01519271|7435908|FG001|NOT COMPLETED|Phase 2||0
6515713|NCT01519284|7435921|FG000|STARTED|Overall Study||16
6515714|NCT01519284|7435922|FG001|STARTED|Overall Study||16
6515715|NCT01519284|7435923|FG002|STARTED|Overall Study||18
6515716|NCT01519284|7435924|FG003|STARTED|Overall Study||16
6515717|NCT01519284|7435925|FG004|STARTED|Overall Study||16
6515718|NCT01519284|7435921|FG000|COMPLETED|Overall Study||16
6515719|NCT01519284|7435922|FG001|COMPLETED|Overall Study||16
6641086|NCT02340663|7569551|FG001|NOT COMPLETED|Overall Study||1
6515720|NCT01519284|7435923|FG002|COMPLETED|Overall Study||16
6515721|NCT01519284|7435924|FG003|COMPLETED|Overall Study||16
6515722|NCT01519284|7435925|FG004|COMPLETED|Overall Study||16
6515723|NCT01519284|7435921|FG000|NOT COMPLETED|Overall Study||0
6515724|NCT01519284|7435922|FG001|NOT COMPLETED|Overall Study||0
6515725|NCT01519284|7435923|FG002|NOT COMPLETED|Overall Study||2
6515726|NCT01519284|7435924|FG003|NOT COMPLETED|Overall Study||0
6515727|NCT01519284|7435925|FG004|NOT COMPLETED|Overall Study||0
6515728|NCT01519323|7435937|FG000|STARTED|Overall Study||3
6515729|NCT01519323|7435938|FG001|STARTED|Overall Study||3
6515730|NCT01519323|7435937|FG000|COMPLETED|Overall Study||0
6515731|NCT01519323|7435938|FG001|COMPLETED|Overall Study||0
6641087|NCT02340715|7569557|FG000|STARTED|Overall Study|158|158
6641088|NCT02340715|7569557|FG000|COMPLETED|Overall Study|158|158
6641089|NCT02340715|7569557|FG000|NOT COMPLETED|Overall Study||0
6641090|NCT02340767|7569570|FG000|STARTED|Overall Study||28
6515732|NCT01519323|7435937|FG000|NOT COMPLETED|Overall Study||3
6515733|NCT01519323|7435938|FG001|NOT COMPLETED|Overall Study||3
6515734|NCT01519414|7435946|FG000|STARTED|Pre Cross-over||52
6515735|NCT01519414|7435947|FG001|STARTED|Pre Cross-over||26
6515736|NCT01519414|7435948|FG002|STARTED|Pre Cross-over||0
6515737|NCT01519414|7435946|FG000|COMPLETED|Pre Cross-over||52
6515738|NCT01519414|7435947|FG001|COMPLETED|Pre Cross-over||26
6515739|NCT01519414|7435948|FG002|COMPLETED|Pre Cross-over||0
6515740|NCT01519414|7435946|FG000|NOT COMPLETED|Pre Cross-over||0
6515741|NCT01519414|7435947|FG001|NOT COMPLETED|Pre Cross-over||0
6515742|NCT01519414|7435948|FG002|NOT COMPLETED|Pre Cross-over||0
6515743|NCT01519414|7435946|FG000|STARTED|Post Cross-over||52
6515744|NCT01519414|7435947|FG001|STARTED|Post Cross-over||14
6515745|NCT01519414|7435948|FG002|STARTED|Post Cross-over||12
6515746|NCT01519414|7435946|FG000|COMPLETED|Post Cross-over||52
6515747|NCT01519414|7435947|FG001|COMPLETED|Post Cross-over||14
6515748|NCT01519414|7435948|FG002|COMPLETED|Post Cross-over||12
6515749|NCT01519414|7435946|FG000|NOT COMPLETED|Post Cross-over||0
6515750|NCT01519414|7435947|FG001|NOT COMPLETED|Post Cross-over||0
6515751|NCT01519414|7435948|FG002|NOT COMPLETED|Post Cross-over||0
6515752|NCT01519427|7435959|FG000|STARTED|Overall Study||2
6515753|NCT01519427|7435959|FG000|COMPLETED|Overall Study||0
6515754|NCT01519427|7435959|FG000|NOT COMPLETED|Overall Study||2
6515755|NCT01519453|7435965|FG000|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
6515756|NCT01519453|7435966|FG001|STARTED|Overall Study|Number of dyads (caregiver-child pairs) or 398 individuals|199
6515757|NCT01519453|7435965|FG000|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 320 individuals|160
6515758|NCT01519453|7435966|FG001|3 Month|Overall Study|Number of dyads (caregiver-child pairs) or 362 individuals|181
6515759|NCT01519453|7435965|FG000|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 306 individuals|153
6515760|NCT01519453|7435966|FG001|6 Month|Overall Study|Number of dyads (caregiver-child pairs) or 350 individuals|175
6515761|NCT01519453|7435965|FG000|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 318 individuals|159
6515762|NCT01519453|7435966|FG001|9 Month|Overall Study|Number of dyads (caregiver-child pairs) or 332 individuals|166
6515763|NCT01519453|7435965|FG000|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 294 individuals|147
6515764|NCT01519453|7435966|FG001|COMPLETED|Overall Study|Number of dyads (caregiver-child pairs) or 326 individuals|163
6515765|NCT01519453|7435965|FG000|NOT COMPLETED|Overall Study||52
6515766|NCT01519453|7435966|FG001|NOT COMPLETED|Overall Study||36
6515767|NCT01519466|7435974|FG000|STARTED|Overall Study||33
6515768|NCT01519466|7435975|FG001|STARTED|Overall Study||16
6515769|NCT01519466|7435974|FG000|COMPLETED|Overall Study||33
6515770|NCT01519466|7435975|FG001|COMPLETED|Overall Study||16
6515771|NCT01519466|7435974|FG000|NOT COMPLETED|Overall Study||0
6515772|NCT01519466|7435975|FG001|NOT COMPLETED|Overall Study||0
6515773|NCT01519518|7435983|FG000|STARTED|Overall Study||914
6515774|NCT01519518|7435984|FG001|STARTED|Overall Study||915
6515775|NCT01519518|7435983|FG000|COMPLETED|Overall Study||907
6515776|NCT01519518|7435984|FG001|COMPLETED|Overall Study||905
6515777|NCT01519518|7435983|FG000|NOT COMPLETED|Overall Study||7
6515778|NCT01519518|7435984|FG001|NOT COMPLETED|Overall Study||10
6515779|NCT01519570|7435992|FG000|STARTED|Overall Study||500
6515780|NCT01519570|7435993|FG001|STARTED|Overall Study||2089
6515781|NCT01519570|7435992|FG000|COMPLETED|Overall Study||500
6515782|NCT01519570|7435993|FG001|COMPLETED|Overall Study||2089
6515783|NCT01519570|7435992|FG000|NOT COMPLETED|Overall Study||0
6515784|NCT01519570|7435993|FG001|NOT COMPLETED|Overall Study||0
6515785|NCT01519635|7436001|FG000|STARTED|Overall Study||12
6515786|NCT01519635|7436002|FG001|STARTED|Overall Study||12
6515787|NCT01519635|7436001|FG000|COMPLETED|Overall Study||11
6515788|NCT01519635|7436002|FG001|COMPLETED|Overall Study||9
6515789|NCT01519635|7436001|FG000|NOT COMPLETED|Overall Study||1
6515790|NCT01519635|7436002|FG001|NOT COMPLETED|Overall Study||3
6515791|NCT01519648|7436010|FG000|STARTED|Overall Study||502
6515792|NCT01519648|7436011|FG001|STARTED|Overall Study||306
6515793|NCT01519648|7436010|FG000|COMPLETED|Overall Study||502
6515794|NCT01519648|7436011|FG001|COMPLETED|Overall Study||306
6515795|NCT01519648|7436010|FG000|NOT COMPLETED|Overall Study||0
6515796|NCT01519648|7436011|FG001|NOT COMPLETED|Overall Study||0
6515797|NCT01519661|7436017|FG000|STARTED|Overall Study||157
6515798|NCT01519661|7436017|FG000|COMPLETED|Overall Study||96
6515799|NCT01519661|7436017|FG000|NOT COMPLETED|Overall Study||61
6515800|NCT01519674|7436025|FG000|STARTED|Overall Study||194
6515801|NCT01519674|7436026|FG001|STARTED|Overall Study||195
6641091|NCT02340767|7569571|FG001|STARTED|Overall Study||28
6515802|NCT01519674|7436027|FG002|STARTED|Overall Study||193
6515803|NCT01519674|7436025|FG000|Exposed|Overall Study||192
6515804|NCT01519674|7436026|FG001|Exposed|Overall Study||193
6515805|NCT01519674|7436027|FG002|Exposed|Overall Study||190
6515806|NCT01519674|7436025|FG000|COMPLETED|Overall Study||173
6515807|NCT01519674|7436026|FG001|COMPLETED|Overall Study||182
6515808|NCT01519674|7436027|FG002|COMPLETED|Overall Study||181
6515809|NCT01519674|7436025|FG000|NOT COMPLETED|Overall Study||21
6515810|NCT01519674|7436026|FG001|NOT COMPLETED|Overall Study||13
6515811|NCT01519674|7436027|FG002|NOT COMPLETED|Overall Study||12
6515812|NCT01519700|7436039|FG000|STARTED|Overall Study||54
6515813|NCT01519700|7436040|FG001|STARTED|Overall Study||55
6515814|NCT01519700|7436041|FG002|STARTED|Overall Study||55
6515815|NCT01519700|7436042|FG003|STARTED|Overall Study||54
6515816|NCT01519700|7436039|FG000|Treated Cycle 1 EP2006|Overall Study||53
6515817|NCT01519700|7436040|FG001|Treated Cycle 1 EP2006|Overall Study||54
6515818|NCT01519700|7436041|FG002|Treated Cycle 1 EP2006|Overall Study||0
6515819|NCT01519700|7436042|FG003|Treated Cycle 1 EP2006|Overall Study||0
6515820|NCT01519700|7436039|FG000|Treated Cycle 1 Neupogen|Overall Study||0
6515821|NCT01519700|7436040|FG001|Treated Cycle 1 Neupogen|Overall Study||0
6515822|NCT01519700|7436041|FG002|Treated Cycle 1 Neupogen|Overall Study||55
6515823|NCT01519700|7436042|FG003|Treated Cycle 1 Neupogen|Overall Study||52
6515824|NCT01519700|7436039|FG000|Treated Cycle 2 EP2006|Overall Study||52
6515825|NCT01519700|7436040|FG001|Treated Cycle 2 EP2006|Overall Study||0
6515826|NCT01519700|7436041|FG002|Treated Cycle 2 EP2006|Overall Study||55
6515827|NCT01519700|7436042|FG003|Treated Cycle 2 EP2006|Overall Study||0
6515828|NCT01519700|7436039|FG000|Treated Cycle 2 Neupogen|Overall Study||0
6515829|NCT01519700|7436040|FG001|Treated Cycle 2 Neupogen|Overall Study||52
6515830|NCT01519700|7436041|FG002|Treated Cycle 2 Neupogen|Overall Study||0
6515831|NCT01519700|7436042|FG003|Treated Cycle 2 Neupogen|Overall Study||51
6515832|NCT01519700|7436039|FG000|Treated Cycle 3 EP2006|Overall Study||51
6515833|NCT01519700|7436040|FG001|Treated Cycle 3 EP2006|Overall Study||51
6515834|NCT01519700|7436041|FG002|Treated Cycle 3 EP2006|Overall Study||0
6515835|NCT01519700|7436042|FG003|Treated Cycle 3 EP2006|Overall Study||0
6515836|NCT01519700|7436039|FG000|Treated Cycle 3 Neupogen|Overall Study||0
6515837|NCT01519700|7436040|FG001|Treated Cycle 3 Neupogen|Overall Study||0
6515838|NCT01519700|7436041|FG002|Treated Cycle 3 Neupogen|Overall Study||54
6641092|NCT02340767|7569572|FG002|STARTED|Overall Study||29
6641093|NCT02340767|7569573|FG003|STARTED|Overall Study||500
6641094|NCT02340767|7569574|FG004|STARTED|Overall Study||474
6641095|NCT02340767|7569575|FG005|STARTED|Overall Study||526
6641096|NCT02340767|7569576|FG006|STARTED|Overall Study||525
6641097|NCT02340767|7569577|FG007|STARTED|Overall Study||444
6641098|NCT02340767|7569578|FG008|STARTED|Overall Study||531
6641099|NCT02340767|7569570|FG000|COMPLETED|Overall Study||28
6515839|NCT01519700|7436042|FG003|Treated Cycle 3 Neupogen|Overall Study||51
6515840|NCT01519700|7436039|FG000|Treated Cycle 4 EP2006|Overall Study||51
6515841|NCT01519700|7436040|FG001|Treated Cycle 4 EP2006|Overall Study||0
6515842|NCT01519700|7436041|FG002|Treated Cycle 4 EP2006|Overall Study||50
6515843|NCT01519700|7436042|FG003|Treated Cycle 4 EP2006|Overall Study||0
6515844|NCT01519700|7436039|FG000|Treated Cycle 4 Neupogen|Overall Study||0
6515845|NCT01519700|7436040|FG001|Treated Cycle 4 Neupogen|Overall Study||51
6515846|NCT01519700|7436041|FG002|Treated Cycle 4 Neupogen|Overall Study||0
6515847|NCT01519700|7436042|FG003|Treated Cycle 4 Neupogen|Overall Study||50
6515848|NCT01519700|7436039|FG000|Treated Cycle 5 EP2006|Overall Study||46
6515849|NCT01519700|7436040|FG001|Treated Cycle 5 EP2006|Overall Study||49
6515850|NCT01519700|7436041|FG002|Treated Cycle 5 EP2006|Overall Study||0
6515851|NCT01519700|7436042|FG003|Treated Cycle 5 EP2006|Overall Study||0
6515852|NCT01519700|7436039|FG000|Treated Cycle 5 Neupogen|Overall Study||0
6515853|NCT01519700|7436040|FG001|Treated Cycle 5 Neupogen|Overall Study||0
6515854|NCT01519700|7436041|FG002|Treated Cycle 5 Neupogen|Overall Study||48
6515855|NCT01519700|7436042|FG003|Treated Cycle 5 Neupogen|Overall Study||50
6515856|NCT01519700|7436039|FG000|Treated Cycle 6 EP2006|Overall Study||45
6515857|NCT01519700|7436040|FG001|Treated Cycle 6 EP2006|Overall Study||0
6515858|NCT01519700|7436041|FG002|Treated Cycle 6 EP2006|Overall Study||48
6515859|NCT01519700|7436042|FG003|Treated Cycle 6 EP2006|Overall Study||0
6515860|NCT01519700|7436039|FG000|Treated Cycle 6 Neupogen|Overall Study||0
6515861|NCT01519700|7436040|FG001|Treated Cycle 6 Neupogen|Overall Study||49
6515862|NCT01519700|7436041|FG002|Treated Cycle 6 Neupogen|Overall Study||0
6515863|NCT01519700|7436042|FG003|Treated Cycle 6 Neupogen|Overall Study||49
6515864|NCT01519700|7436039|FG000|COMPLETED|Overall Study||45
6515865|NCT01519700|7436040|FG001|COMPLETED|Overall Study||49
6515866|NCT01519700|7436041|FG002|COMPLETED|Overall Study||48
6515867|NCT01519700|7436042|FG003|COMPLETED|Overall Study||47
6515868|NCT01519700|7436039|FG000|NOT COMPLETED|Overall Study||9
6515869|NCT01519700|7436040|FG001|NOT COMPLETED|Overall Study||6
6515870|NCT01519700|7436041|FG002|NOT COMPLETED|Overall Study||7
6515871|NCT01519700|7436042|FG003|NOT COMPLETED|Overall Study||7
6515872|NCT01519713|7436061|FG000|STARTED|Overall Study||194
6515873|NCT01519713|7436062|FG001|STARTED|Overall Study||2
6515874|NCT01519713|7436063|FG002|STARTED|Overall Study||4
6515875|NCT01519713|7436061|FG000|COMPLETED|Overall Study||194
6515876|NCT01519713|7436062|FG001|COMPLETED|Overall Study||2
6515877|NCT01519713|7436063|FG002|COMPLETED|Overall Study||4
6641100|NCT02340767|7569571|FG001|COMPLETED|Overall Study||28
6641101|NCT02340767|7569572|FG002|COMPLETED|Overall Study||29
6641102|NCT02340767|7569573|FG003|COMPLETED|Overall Study||500
6515878|NCT01519713|7436061|FG000|NOT COMPLETED|Overall Study||0
6515879|NCT01519713|7436062|FG001|NOT COMPLETED|Overall Study||0
6515880|NCT01519713|7436063|FG002|NOT COMPLETED|Overall Study||0
6515881|NCT01519765|7436073|FG000|STARTED|Overall Study||37
6515882|NCT01519765|7436074|FG001|STARTED|Overall Study||36
6515883|NCT01519765|7436073|FG000|COMPLETED|Overall Study||34
6515884|NCT01519765|7436074|FG001|COMPLETED|Overall Study||34
6515885|NCT01519765|7436073|FG000|NOT COMPLETED|Overall Study||3
6515886|NCT01519765|7436074|FG001|NOT COMPLETED|Overall Study||2
6515887|NCT01519778|7436081|FG000|STARTED|Overall Study||200
6515888|NCT01519778|7436081|FG000|COMPLETED|Overall Study||186
6515889|NCT01519778|7436081|FG000|NOT COMPLETED|Overall Study||14
6515890|NCT01519791|7436087|FG000|STARTED|Overall Study||219
6515891|NCT01519791|7436088|FG001|STARTED|Overall Study||660
6515892|NCT01519791|7436087|FG000|Completed Week 52|Overall Study||143
6515893|NCT01519791|7436088|FG001|Completed Week 52|Overall Study||500
6515894|NCT01519791|7436087|FG000|COMPLETED|Overall Study||67
6515895|NCT01519791|7436088|FG001|COMPLETED|Overall Study||292
6515896|NCT01519791|7436087|FG000|NOT COMPLETED|Overall Study||152
6515897|NCT01519791|7436088|FG001|NOT COMPLETED|Overall Study||368
6515898|NCT01519817|7436096|FG000|STARTED|Overall Study||4
6515899|NCT01519817|7436097|FG001|STARTED|Overall Study||3
6515900|NCT01519817|7436098|FG002|STARTED|Overall Study||16
6515901|NCT01519817|7436099|FG003|STARTED|Overall Study||11
6515902|NCT01519817|7436096|FG000|COMPLETED|Overall Study||3
6515903|NCT01519817|7436097|FG001|COMPLETED|Overall Study||3
6515904|NCT01519817|7436098|FG002|COMPLETED|Overall Study||16
6515905|NCT01519817|7436099|FG003|COMPLETED|Overall Study||10
6515906|NCT01519817|7436096|FG000|NOT COMPLETED|Overall Study||1
6515907|NCT01519817|7436097|FG001|NOT COMPLETED|Overall Study||0
6515908|NCT01519817|7436098|FG002|NOT COMPLETED|Overall Study||0
6515909|NCT01519817|7436099|FG003|NOT COMPLETED|Overall Study||1
6515910|NCT01519869|7436109|FG000|STARTED|Overall Study||28
6515911|NCT01519869|7436109|FG000|COMPLETED|Overall Study||27
6515912|NCT01519869|7436109|FG000|NOT COMPLETED|Overall Study||1
6515913|NCT01519882|7436115|FG000|STARTED|Overall Study||1
6515914|NCT01519882|7436116|FG001|STARTED|Overall Study||0
6515915|NCT01519882|7436115|FG000|COMPLETED|Overall Study||1
6515916|NCT01519882|7436116|FG001|COMPLETED|Overall Study||0
6515917|NCT01519882|7436115|FG000|NOT COMPLETED|Overall Study||0
6515918|NCT01519882|7436116|FG001|NOT COMPLETED|Overall Study||0
6515919|NCT01519921|7436124|FG000|STARTED|Overall Study||86
6515920|NCT01519921|7436125|FG001|STARTED|Overall Study||64
6515921|NCT01519921|7436124|FG000|COMPLETED|Overall Study||65
6515922|NCT01519921|7436125|FG001|COMPLETED|Overall Study||49
6515923|NCT01519921|7436124|FG000|NOT COMPLETED|Overall Study||21
6515924|NCT01519921|7436125|FG001|NOT COMPLETED|Overall Study||15
6515925|NCT01519934|7436131|FG000|STARTED|Overall Study||48
6515926|NCT01519934|7436131|FG000|COMPLETED|Overall Study||45
6515927|NCT01519934|7436131|FG000|NOT COMPLETED|Overall Study||3
6515928|NCT01519947|7436139|FG000|STARTED|Overall Study||19
6515929|NCT01519947|7436140|FG001|STARTED|Overall Study||11
6515930|NCT01519947|7436141|FG002|STARTED|Overall Study||15
6515931|NCT01519947|7436142|FG003|STARTED|Overall Study||42
6515932|NCT01519947|7436139|FG000|COMPLETED|Overall Study||17
6515933|NCT01519947|7436140|FG001|COMPLETED|Overall Study||7
6515934|NCT01519947|7436141|FG002|COMPLETED|Overall Study||8
6515935|NCT01519947|7436142|FG003|COMPLETED|Overall Study||34
6515936|NCT01519947|7436139|FG000|NOT COMPLETED|Overall Study||2
6515937|NCT01519947|7436140|FG001|NOT COMPLETED|Overall Study||4
6515938|NCT01519947|7436141|FG002|NOT COMPLETED|Overall Study||7
6515939|NCT01519947|7436142|FG003|NOT COMPLETED|Overall Study||8
6515940|NCT01520038|7436152|FG000|STARTED|Overall Study||2
6515941|NCT01520038|7436152|FG000|COMPLETED|Overall Study||1
6515942|NCT01520038|7436152|FG000|NOT COMPLETED|Overall Study||1
6515943|NCT01520207|7436158|FG000|STARTED|Overall Study||27
6515944|NCT01520207|7436159|FG001|STARTED|Overall Study||25
6515945|NCT01520207|7436158|FG000|COMPLETED|Overall Study||25
6515946|NCT01520207|7436159|FG001|COMPLETED|Overall Study||25
6515947|NCT01520207|7436158|FG000|NOT COMPLETED|Overall Study||2
6515948|NCT01520207|7436159|FG001|NOT COMPLETED|Overall Study||0
6515949|NCT01520324|7436165|FG000|STARTED|Overall Study||53
6515950|NCT01520324|7436165|FG000|COMPLETED|Overall Study||52
6515951|NCT01520324|7436165|FG000|NOT COMPLETED|Overall Study||1
6515952|NCT01520363|7436171|FG000|STARTED|Overall Study||26
6515953|NCT01520363|7436172|FG001|STARTED|Overall Study||26
6515954|NCT01520363|7436171|FG000|COMPLETED|Overall Study||24
6515955|NCT01520363|7436172|FG001|COMPLETED|Overall Study||26
6515956|NCT01520363|7436171|FG000|NOT COMPLETED|Overall Study||2
6515957|NCT01520363|7436172|FG001|NOT COMPLETED|Overall Study||0
6515958|NCT01520402|7436202|FG000|STARTED|Overall Study||35
6515959|NCT01520402|7436202|FG000|COMPLETED|Overall Study||30
6515960|NCT01520402|7436202|FG000|NOT COMPLETED|Overall Study||5
6515961|NCT01520454|7436217|FG000|STARTED|Overall Study||9
6515962|NCT01520454|7436218|FG001|STARTED|Overall Study||6
6515963|NCT01520454|7436219|FG002|STARTED|Overall Study||5
6515964|NCT01520454|7436220|FG003|STARTED|Overall Study||6
6515965|NCT01520454|7436217|FG000|COMPLETED|Overall Study||9
6515966|NCT01520454|7436218|FG001|COMPLETED|Overall Study||6
6515967|NCT01520454|7436219|FG002|COMPLETED|Overall Study||5
6515968|NCT01520454|7436220|FG003|COMPLETED|Overall Study||6
6515969|NCT01520454|7436217|FG000|NOT COMPLETED|Overall Study||0
6515970|NCT01520454|7436218|FG001|NOT COMPLETED|Overall Study||0
6515971|NCT01520454|7436219|FG002|NOT COMPLETED|Overall Study||0
6515972|NCT01520454|7436220|FG003|NOT COMPLETED|Overall Study||0
6515973|NCT01520506|7436233|FG000|STARTED|Overall Study||50
6515974|NCT01520506|7436233|FG000|COMPLETED|Overall Study||44
6515975|NCT01520506|7436233|FG000|NOT COMPLETED|Overall Study||6
6515976|NCT01520519|7436237|FG000|STARTED|Overall Study||40
6515977|NCT01520519|7436237|FG000|COMPLETED|Overall Study||40
6515978|NCT01520519|7436237|FG000|NOT COMPLETED|Overall Study||0
6515979|NCT01520532|7436241|FG000|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
6515980|NCT01520532|7436241|FG000|COMPLETED|Overall Study||60
6515981|NCT01520532|7436241|FG000|NOT COMPLETED|Overall Study||0
6515982|NCT01520558|7436248|FG000|STARTED|Overall Study||3
6515983|NCT01520558|7436249|FG001|STARTED|Overall Study||3
6515984|NCT01520558|7436250|FG002|STARTED|Overall Study||6
6515985|NCT01520558|7436248|FG000|COMPLETED|Overall Study||1
6515986|NCT01520558|7436249|FG001|COMPLETED|Overall Study||1
6515987|NCT01520558|7436250|FG002|COMPLETED|Overall Study||3
6515988|NCT01520558|7436248|FG000|NOT COMPLETED|Overall Study||2
6515989|NCT01520558|7436249|FG001|NOT COMPLETED|Overall Study||2
6515990|NCT01520558|7436250|FG002|NOT COMPLETED|Overall Study||3
6515991|NCT01520688|7436258|FG000|STARTED|Overall Study||4
6515992|NCT01520688|7436259|FG001|STARTED|Overall Study||4
6515993|NCT01520688|7436260|FG002|STARTED|Overall Study||4
6515994|NCT01520688|7436261|FG003|STARTED|Overall Study||5
6515995|NCT01520688|7436262|FG004|STARTED|Overall Study||5
6515996|NCT01520688|7436263|FG005|STARTED|Overall Study||5
6515997|NCT01520688|7436264|FG006|STARTED|Overall Study||5
6515998|NCT01520688|7436258|FG000|COMPLETED|Overall Study||4
6515999|NCT01520688|7436259|FG001|COMPLETED|Overall Study||2
6516000|NCT01520688|7436260|FG002|COMPLETED|Overall Study||4
6516001|NCT01520688|7436261|FG003|COMPLETED|Overall Study||4
6516002|NCT01520688|7436262|FG004|COMPLETED|Overall Study||4
6516003|NCT01520688|7436263|FG005|COMPLETED|Overall Study||5
6516004|NCT01520688|7436264|FG006|COMPLETED|Overall Study||0
6516005|NCT01520688|7436258|FG000|NOT COMPLETED|Overall Study||0
6516006|NCT01520688|7436259|FG001|NOT COMPLETED|Overall Study||2
6516007|NCT01520688|7436260|FG002|NOT COMPLETED|Overall Study||0
6516008|NCT01520688|7436261|FG003|NOT COMPLETED|Overall Study||1
6516009|NCT01520688|7436262|FG004|NOT COMPLETED|Overall Study||1
6516010|NCT01520688|7436263|FG005|NOT COMPLETED|Overall Study||0
6516011|NCT01520688|7436264|FG006|NOT COMPLETED|Overall Study||5
6516012|NCT01520727|7436281|FG000|STARTED|Overall Study||6
6516013|NCT01520727|7436282|FG001|STARTED|Overall Study||6
6516014|NCT01520727|7436283|FG002|STARTED|Overall Study||6
6516015|NCT01520727|7436284|FG003|STARTED|Overall Study||6
6516016|NCT01520727|7436285|FG004|STARTED|Overall Study||6
6516017|NCT01520727|7436286|FG005|STARTED|Overall Study||6
6516018|NCT01520727|7436287|FG006|STARTED|Overall Study||6
6516019|NCT01520727|7436288|FG007|STARTED|Overall Study||6
6516020|NCT01520727|7436289|FG008|STARTED|Overall Study||16
6516021|NCT01520727|7436281|FG000|COMPLETED|Overall Study||6
6516022|NCT01520727|7436282|FG001|COMPLETED|Overall Study||6
6516023|NCT01520727|7436283|FG002|COMPLETED|Overall Study||6
6516024|NCT01520727|7436284|FG003|COMPLETED|Overall Study||6
6516025|NCT01520727|7436285|FG004|COMPLETED|Overall Study||6
6516026|NCT01520727|7436286|FG005|COMPLETED|Overall Study||6
6516027|NCT01520727|7436287|FG006|COMPLETED|Overall Study||6
6516028|NCT01520727|7436288|FG007|COMPLETED|Overall Study||6
6516029|NCT01520727|7436289|FG008|COMPLETED|Overall Study||16
6516030|NCT01520727|7436281|FG000|NOT COMPLETED|Overall Study||0
6516031|NCT01520727|7436282|FG001|NOT COMPLETED|Overall Study||0
6516032|NCT01520727|7436283|FG002|NOT COMPLETED|Overall Study||0
6516033|NCT01520727|7436284|FG003|NOT COMPLETED|Overall Study||0
6516034|NCT01520727|7436285|FG004|NOT COMPLETED|Overall Study||0
6516035|NCT01520727|7436286|FG005|NOT COMPLETED|Overall Study||0
6516036|NCT01520727|7436287|FG006|NOT COMPLETED|Overall Study||0
6516037|NCT01520727|7436288|FG007|NOT COMPLETED|Overall Study||0
6516038|NCT01520727|7436289|FG008|NOT COMPLETED|Overall Study||0
6516039|NCT01520870|7436309|FG000|STARTED|Overall Study||49
6516040|NCT01520870|7436309|FG000|COMPLETED|Overall Study||47
6516041|NCT01520870|7436309|FG000|NOT COMPLETED|Overall Study||2
6516042|NCT01520909|7436315|FG000|STARTED|Part 1 (Randomized Period)||29
6516043|NCT01520909|7436316|FG001|STARTED|Part 1 (Randomized Period)||63
6516044|NCT01520909|7436317|FG002|STARTED|Part 1 (Randomized Period)||0
6516045|NCT01520909|7436315|FG000|COMPLETED|Part 1 (Randomized Period)||28
6516046|NCT01520909|7436316|FG001|COMPLETED|Part 1 (Randomized Period)||61
6516047|NCT01520909|7436317|FG002|COMPLETED|Part 1 (Randomized Period)||0
6516048|NCT01520909|7436315|FG000|NOT COMPLETED|Part 1 (Randomized Period)||1
6516049|NCT01520909|7436316|FG001|NOT COMPLETED|Part 1 (Randomized Period)||2
6516050|NCT01520909|7436317|FG002|NOT COMPLETED|Part 1 (Randomized Period)||0
6516051|NCT01520909|7436315|FG000|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
6516052|NCT01520909|7436316|FG001|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
6516053|NCT01520909|7436317|FG002|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
6516054|NCT01520909|7436315|FG000|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
6516055|NCT01520909|7436316|FG001|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
6516056|NCT01520909|7436317|FG002|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
6516057|NCT01520909|7436315|FG000|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
6516058|NCT01520909|7436316|FG001|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
6516059|NCT01520909|7436317|FG002|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
6516060|NCT01520922|7436339|FG000|STARTED|Treatment Phase||44
6516061|NCT01520922|7436340|FG001|STARTED|Treatment Phase||53
6516062|NCT01520922|7436339|FG000|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
6516063|NCT01520922|7436340|FG001|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
6516064|NCT01520922|7436339|FG000|NOT COMPLETED|Treatment Phase||5
6516065|NCT01520922|7436340|FG001|NOT COMPLETED|Treatment Phase||8
6516066|NCT01520922|7436339|FG000|STARTED|Follow up||44
6516067|NCT01520922|7436340|FG001|STARTED|Follow up||45
6516068|NCT01520922|7436339|FG000|COMPLETED|Follow up||44
6516069|NCT01520922|7436340|FG001|COMPLETED|Follow up||44
6516070|NCT01520922|7436339|FG000|NOT COMPLETED|Follow up||0
6516071|NCT01520922|7436340|FG001|NOT COMPLETED|Follow up||1
6516072|NCT01520922|7436339|FG000|STARTED|Survival Follow-up||21
6516073|NCT01520922|7436340|FG001|STARTED|Survival Follow-up||40
6516074|NCT01520922|7436339|FG000|COMPLETED|Survival Follow-up||20
6516075|NCT01520922|7436340|FG001|COMPLETED|Survival Follow-up||40
6516076|NCT01520922|7436339|FG000|NOT COMPLETED|Survival Follow-up||1
6516077|NCT01520922|7436340|FG001|NOT COMPLETED|Survival Follow-up||0
6516078|NCT01520987|7436354|FG000|STARTED|Overall Study||13
6516079|NCT01520987|7436355|FG001|STARTED|Overall Study||12
6516080|NCT01520987|7436356|FG002|STARTED|Overall Study||11
6516081|NCT01520987|7436357|FG003|STARTED|Overall Study||15
6516082|NCT01520987|7436358|FG004|STARTED|Overall Study||14
6516083|NCT01520987|7436359|FG005|STARTED|Overall Study||14
6516084|NCT01520987|7436360|FG006|STARTED|Overall Study||12
6516085|NCT01520987|7436361|FG007|STARTED|Overall Study||14
6516086|NCT01520987|7436354|FG000|Dosed|Overall Study||13
6516087|NCT01520987|7436355|FG001|Dosed|Overall Study||12
6516088|NCT01520987|7436356|FG002|Dosed|Overall Study||11
6516089|NCT01520987|7436357|FG003|Dosed|Overall Study||15
6516090|NCT01520987|7436358|FG004|Dosed|Overall Study||14
6516091|NCT01520987|7436359|FG005|Dosed|Overall Study||14
6516092|NCT01520987|7436360|FG006|Dosed|Overall Study||12
6516093|NCT01520987|7436361|FG007|Dosed|Overall Study||14
6516094|NCT01520987|7436354|FG000|COMPLETED|Overall Study||12
6516095|NCT01520987|7436355|FG001|COMPLETED|Overall Study||12
6516096|NCT01520987|7436356|FG002|COMPLETED|Overall Study||11
6516097|NCT01520987|7436357|FG003|COMPLETED|Overall Study||15
6516098|NCT01520987|7436358|FG004|COMPLETED|Overall Study||14
6516099|NCT01520987|7436359|FG005|COMPLETED|Overall Study||13
6516100|NCT01520987|7436360|FG006|COMPLETED|Overall Study||12
6516101|NCT01520987|7436361|FG007|COMPLETED|Overall Study||14
6516102|NCT01520987|7436354|FG000|NOT COMPLETED|Overall Study||1
6516103|NCT01520987|7436355|FG001|NOT COMPLETED|Overall Study||0
6516104|NCT01520987|7436356|FG002|NOT COMPLETED|Overall Study||0
6516105|NCT01520987|7436357|FG003|NOT COMPLETED|Overall Study||0
6516106|NCT01520987|7436358|FG004|NOT COMPLETED|Overall Study||0
6516107|NCT01520987|7436359|FG005|NOT COMPLETED|Overall Study||1
6516108|NCT01520987|7436360|FG006|NOT COMPLETED|Overall Study||0
6516109|NCT01520987|7436361|FG007|NOT COMPLETED|Overall Study||0
6516110|NCT01521026|7436379|FG000|STARTED|Overall Study||38
6516111|NCT01521026|7436380|FG001|STARTED|Overall Study||31
6516112|NCT01521026|7436379|FG000|COMPLETED|Overall Study||23
6516113|NCT01521026|7436380|FG001|COMPLETED|Overall Study||28
6516114|NCT01521026|7436379|FG000|NOT COMPLETED|Overall Study||15
6516115|NCT01521026|7436380|FG001|NOT COMPLETED|Overall Study||3
6516116|NCT01521117|7436386|FG000|STARTED|First Intervention (6 Weeks)||10
6516117|NCT01521117|7436387|FG001|STARTED|First Intervention (6 Weeks)||11
6516118|NCT01521117|7436386|FG000|COMPLETED|First Intervention (6 Weeks)||5
6516119|NCT01521117|7436387|FG001|COMPLETED|First Intervention (6 Weeks)||8
6516120|NCT01521117|7436386|FG000|NOT COMPLETED|First Intervention (6 Weeks)||5
6516121|NCT01521117|7436387|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
6516122|NCT01521117|7436386|FG000|STARTED|Washout (4 Weeks)||5
6516123|NCT01521117|7436387|FG001|STARTED|Washout (4 Weeks)||8
6516124|NCT01521117|7436386|FG000|COMPLETED|Washout (4 Weeks)||5
6516125|NCT01521117|7436387|FG001|COMPLETED|Washout (4 Weeks)||8
6516126|NCT01521117|7436386|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6516127|NCT01521117|7436387|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6516128|NCT01521117|7436386|FG000|STARTED|Second Intervention (6 Weeks)||5
6516129|NCT01521117|7436387|FG001|STARTED|Second Intervention (6 Weeks)||8
6516130|NCT01521117|7436386|FG000|COMPLETED|Second Intervention (6 Weeks)||5
6516131|NCT01521117|7436387|FG001|COMPLETED|Second Intervention (6 Weeks)||5
6516132|NCT01521117|7436386|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6516133|NCT01521117|7436387|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
6516134|NCT01521260|7436395|FG000|STARTED|Overall Study||15
6516135|NCT01521260|7436396|FG001|STARTED|Overall Study||15
6516136|NCT01521260|7436395|FG000|COMPLETED|Overall Study||15
6641103|NCT02340767|7569574|FG004|COMPLETED|Overall Study||474
6641104|NCT02340767|7569575|FG005|COMPLETED|Overall Study||526
6641105|NCT02340767|7569576|FG006|COMPLETED|Overall Study||525
6641106|NCT02340767|7569577|FG007|COMPLETED|Overall Study||444
6516137|NCT01521260|7436396|FG001|COMPLETED|Overall Study||15
6516138|NCT01521260|7436395|FG000|NOT COMPLETED|Overall Study||0
6516139|NCT01521260|7436396|FG001|NOT COMPLETED|Overall Study||0
6516140|NCT01521364|7436402|FG000|STARTED|Linezolid Without Clarithromycin (1 wk)||7
6641107|NCT02340767|7569578|FG008|COMPLETED|Overall Study||531
6641108|NCT02340767|7569570|FG000|NOT COMPLETED|Overall Study||0
6641109|NCT02340767|7569571|FG001|NOT COMPLETED|Overall Study||0
6641110|NCT02340767|7569572|FG002|NOT COMPLETED|Overall Study||0
6516141|NCT01521364|7436402|FG000|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
6516142|NCT01521364|7436402|FG000|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
6516143|NCT01521364|7436402|FG000|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
6516144|NCT01521364|7436402|FG000|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
6516145|NCT01521364|7436402|FG000|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
6516146|NCT01521364|7436402|FG000|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
6516147|NCT01521364|7436402|FG000|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
6516148|NCT01521364|7436402|FG000|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
6516149|NCT01521494|7436418|FG000|STARTED|Overall Study||39
6516150|NCT01521494|7436419|FG001|STARTED|Overall Study||36
6516151|NCT01521494|7436420|FG002|STARTED|Overall Study||35
6516152|NCT01521494|7436421|FG003|STARTED|Overall Study||36
6516153|NCT01521494|7436422|FG004|STARTED|Overall Study||37
6516154|NCT01521494|7436418|FG000|COMPLETED|Overall Study||37
6516155|NCT01521494|7436419|FG001|COMPLETED|Overall Study||31
6516156|NCT01521494|7436420|FG002|COMPLETED|Overall Study||23
6516157|NCT01521494|7436421|FG003|COMPLETED|Overall Study||15
6516158|NCT01521494|7436422|FG004|COMPLETED|Overall Study||30
6516159|NCT01521494|7436418|FG000|NOT COMPLETED|Overall Study||2
6516160|NCT01521494|7436419|FG001|NOT COMPLETED|Overall Study||5
6516161|NCT01521494|7436420|FG002|NOT COMPLETED|Overall Study||12
6516162|NCT01521494|7436421|FG003|NOT COMPLETED|Overall Study||21
6516163|NCT01521494|7436422|FG004|NOT COMPLETED|Overall Study||7
6516164|NCT01521507|7436436|FG000|STARTED|Stage 1: Randomized Design||101
6516165|NCT01521507|7436437|FG001|STARTED|Stage 1: Randomized Design||99
6516166|NCT01521507|7436436|FG000|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
6516167|NCT01521507|7436437|FG001|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
6516168|NCT01521507|7436436|FG000|COMPLETED|Stage 1: Randomized Design||98
6516169|NCT01521507|7436437|FG001|COMPLETED|Stage 1: Randomized Design||94
6516170|NCT01521507|7436436|FG000|NOT COMPLETED|Stage 1: Randomized Design||3
6516171|NCT01521507|7436437|FG001|NOT COMPLETED|Stage 1: Randomized Design||5
6516172|NCT01521507|7436436|FG000|STARTED|Stage 2: Observational Design||98
6516173|NCT01521507|7436437|FG001|STARTED|Stage 2: Observational Design||94
6516174|NCT01521507|7436436|FG000|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
6516175|NCT01521507|7436437|FG001|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
6516176|NCT01521507|7436436|FG000|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
6516177|NCT01521507|7436437|FG001|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
6516178|NCT01521507|7436436|FG000|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
6516179|NCT01521507|7436437|FG001|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
6516180|NCT01521507|7436436|FG000|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
6516181|NCT01521507|7436437|FG001|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
6516182|NCT01521507|7436436|FG000|COMPLETED|Stage 2: Observational Design||94
6516183|NCT01521507|7436437|FG001|COMPLETED|Stage 2: Observational Design||92
6516184|NCT01521507|7436436|FG000|NOT COMPLETED|Stage 2: Observational Design||4
6516185|NCT01521507|7436437|FG001|NOT COMPLETED|Stage 2: Observational Design||2
6516186|NCT01521546|7436452|FG000|STARTED|Overall Study||22
6516187|NCT01521546|7436453|FG001|STARTED|Overall Study||20
6516188|NCT01521546|7436452|FG000|COMPLETED|Overall Study||20
6516189|NCT01521546|7436453|FG001|COMPLETED|Overall Study||20
6516190|NCT01521546|7436452|FG000|NOT COMPLETED|Overall Study||2
6516191|NCT01521546|7436453|FG001|NOT COMPLETED|Overall Study||0
6516192|NCT01521559|7436461|FG000|STARTED|Overall Study||92
6516193|NCT01521559|7436462|FG001|STARTED|Overall Study||91
6516194|NCT01521559|7436461|FG000|Completed Week 24|Overall Study||83
6516195|NCT01521559|7436462|FG001|Completed Week 24|Overall Study||85
6516196|NCT01521559|7436461|FG000|Completed Week 52|Overall Study||77
6516197|NCT01521559|7436462|FG001|Completed Week 52|Overall Study||73
6516198|NCT01521559|7436461|FG000|COMPLETED|Overall Study||77
6516199|NCT01521559|7436462|FG001|COMPLETED|Overall Study||73
6516200|NCT01521559|7436461|FG000|NOT COMPLETED|Overall Study||15
6516201|NCT01521559|7436462|FG001|NOT COMPLETED|Overall Study||18
6516202|NCT01521780|7436469|FG000|STARTED|Overall Study||9
6516203|NCT01521780|7436470|FG001|STARTED|Overall Study||1
6516204|NCT01521780|7436471|FG002|STARTED|Overall Study||2
6516205|NCT01521780|7436469|FG000|COMPLETED|Overall Study||9
6516206|NCT01521780|7436470|FG001|COMPLETED|Overall Study||1
6516207|NCT01521780|7436471|FG002|COMPLETED|Overall Study||2
6516208|NCT01521780|7436469|FG000|NOT COMPLETED|Overall Study||0
6516209|NCT01521780|7436470|FG001|NOT COMPLETED|Overall Study||0
6516210|NCT01521780|7436471|FG002|NOT COMPLETED|Overall Study||0
6516211|NCT01521845|7436482|FG000|STARTED|Overall Study||52
6516212|NCT01521845|7436483|FG001|STARTED|Overall Study||52
6516213|NCT01521845|7436482|FG000|COMPLETED|Overall Study||43
6516214|NCT01521845|7436483|FG001|COMPLETED|Overall Study||47
6516215|NCT01521845|7436482|FG000|NOT COMPLETED|Overall Study||9
6516216|NCT01521845|7436483|FG001|NOT COMPLETED|Overall Study||5
6516217|NCT01521871|7436491|FG000|STARTED|Overall Study||32
6516218|NCT01521871|7436492|FG001|STARTED|Overall Study||32
6516219|NCT01521871|7436491|FG000|COMPLETED|Overall Study||32
6516220|NCT01521871|7436492|FG001|COMPLETED|Overall Study||32
6516221|NCT01521871|7436491|FG000|NOT COMPLETED|Overall Study||0
6516222|NCT01521871|7436492|FG001|NOT COMPLETED|Overall Study||0
6516223|NCT01521884|7436498|FG000|STARTED|Overall Study||62
6516224|NCT01521884|7436498|FG000|COMPLETED|Overall Study||35
6516225|NCT01521884|7436498|FG000|NOT COMPLETED|Overall Study||27
6516226|NCT01521897|7436502|FG000|STARTED|Overall Study||1143
6516227|NCT01521897|7436502|FG000|COMPLETED|Overall Study||1120
6516228|NCT01521897|7436502|FG000|NOT COMPLETED|Overall Study||23
6516229|NCT01521923|7436510|FG000|STARTED|Overall Study||66
6516230|NCT01521923|7436511|FG001|STARTED|Overall Study||81
6516231|NCT01521923|7436512|FG002|STARTED|Overall Study||127
6516232|NCT01521923|7436513|FG003|STARTED|Overall Study||83
6516233|NCT01521923|7436510|FG000|COMPLETED|Overall Study||59
6516234|NCT01521923|7436511|FG001|COMPLETED|Overall Study||72
6516235|NCT01521923|7436512|FG002|COMPLETED|Overall Study||112
6516236|NCT01521923|7436513|FG003|COMPLETED|Overall Study||70
6516237|NCT01521923|7436510|FG000|NOT COMPLETED|Overall Study||7
6516238|NCT01521923|7436511|FG001|NOT COMPLETED|Overall Study||9
6516239|NCT01521923|7436512|FG002|NOT COMPLETED|Overall Study||15
6516240|NCT01521923|7436513|FG003|NOT COMPLETED|Overall Study||13
6516241|NCT01521949|7436526|FG000|STARTED|Overall Study||21
6516242|NCT01521949|7436526|FG000|COMPLETED|Overall Study||21
6516243|NCT01521949|7436526|FG000|NOT COMPLETED|Overall Study||0
6516244|NCT01522131|7436532|FG000|STARTED|Overall Study||16
6516245|NCT01522131|7436533|FG001|STARTED|Overall Study||17
6516246|NCT01522131|7436532|FG000|COMPLETED|Overall Study||14
6516247|NCT01522131|7436533|FG001|COMPLETED|Overall Study||17
6516248|NCT01522131|7436532|FG000|NOT COMPLETED|Overall Study||2
6516249|NCT01522131|7436533|FG001|NOT COMPLETED|Overall Study||0
6516250|NCT01522235|7436541|FG000|STARTED|Overall Study||3
6516251|NCT01522235|7436542|FG001|STARTED|Overall Study||3
6516252|NCT01522235|7436541|FG000|Randomized|Overall Study||2
6516253|NCT01522235|7436542|FG001|Randomized|Overall Study||3
6516254|NCT01522235|7436541|FG000|COMPLETED|Overall Study||2
6516255|NCT01522235|7436542|FG001|COMPLETED|Overall Study||2
6516256|NCT01522235|7436541|FG000|NOT COMPLETED|Overall Study||1
6516257|NCT01522235|7436542|FG001|NOT COMPLETED|Overall Study||1
6516258|NCT01522248|7436554|FG000|STARTED|Overall Study||10
6516259|NCT01522248|7436555|FG001|STARTED|Overall Study||10
6516260|NCT01522248|7436554|FG000|COMPLETED|Overall Study||9
6516261|NCT01522248|7436555|FG001|COMPLETED|Overall Study||10
6516262|NCT01522248|7436554|FG000|NOT COMPLETED|Overall Study||1
6516263|NCT01522248|7436555|FG001|NOT COMPLETED|Overall Study||0
6516264|NCT01522339|7436566|FG000|STARTED|Overall Study||15
6516265|NCT01522339|7436566|FG000|COMPLETED|Overall Study||15
6516266|NCT01522339|7436566|FG000|NOT COMPLETED|Overall Study||0
6516267|NCT01522391|7436573|FG000|STARTED|Overall Study||20
6516268|NCT01522391|7436574|FG001|STARTED|Overall Study||21
6516269|NCT01522391|7436573|FG000|COMPLETED|Overall Study||19
6516270|NCT01522391|7436574|FG001|COMPLETED|Overall Study||20
6516271|NCT01522391|7436573|FG000|NOT COMPLETED|Overall Study||1
6516272|NCT01522391|7436574|FG001|NOT COMPLETED|Overall Study||1
6516273|NCT01522404|7436582|FG000|STARTED|First Intervention (up to Week 29)||20
6516274|NCT01522404|7436583|FG001|STARTED|First Intervention (up to Week 29)||19
6516275|NCT01522404|7436582|FG000|COMPLETED|First Intervention (up to Week 29)||18
6516276|NCT01522404|7436583|FG001|COMPLETED|First Intervention (up to Week 29)||19
6516277|NCT01522404|7436582|FG000|NOT COMPLETED|First Intervention (up to Week 29)||2
6516278|NCT01522404|7436583|FG001|NOT COMPLETED|First Intervention (up to Week 29)||0
6516279|NCT01522404|7436582|FG000|STARTED|Second Intervention (up to Week 58)||18
6516280|NCT01522404|7436583|FG001|STARTED|Second Intervention (up to Week 58)||19
6516281|NCT01522404|7436582|FG000|COMPLETED|Second Intervention (up to Week 58)||17
6516282|NCT01522404|7436583|FG001|COMPLETED|Second Intervention (up to Week 58)||19
6516283|NCT01522404|7436582|FG000|NOT COMPLETED|Second Intervention (up to Week 58)||1
6516284|NCT01522404|7436583|FG001|NOT COMPLETED|Second Intervention (up to Week 58)||0
6516285|NCT01522417|7436600|FG000|STARTED|Overall Study||209
6516286|NCT01522417|7436601|FG001|STARTED|Overall Study||202
6516287|NCT01522417|7436602|FG002|STARTED|Overall Study|Randomization into the long tirofiban arm was initiated on 14 June 2013.|124
6516288|NCT01522417|7436600|FG000|COMPLETED|Overall Study||209
6516289|NCT01522417|7436601|FG001|COMPLETED|Overall Study||202
6516290|NCT01522417|7436602|FG002|COMPLETED|Overall Study|Randomization into the long tirofiban arm was completed on 1 February 2018.|124
6516291|NCT01522417|7436600|FG000|NOT COMPLETED|Overall Study||0
6516292|NCT01522417|7436601|FG001|NOT COMPLETED|Overall Study||0
6516293|NCT01522417|7436602|FG002|NOT COMPLETED|Overall Study||0
6516294|NCT01522443|7436612|FG000|STARTED|Overall Study||61
6516295|NCT01522443|7436613|FG001|STARTED|Overall Study||58
6516296|NCT01522443|7436612|FG000|COMPLETED|Overall Study||8
6516297|NCT01522443|7436613|FG001|COMPLETED|Overall Study||3
6516298|NCT01522443|7436612|FG000|NOT COMPLETED|Overall Study||53
6516299|NCT01522443|7436613|FG001|NOT COMPLETED|Overall Study||55
6516300|NCT01522456|7436619|FG000|STARTED|Overall Study||73
6516301|NCT01522456|7436619|FG000|COMPLETED|Overall Study||65
6516302|NCT01522456|7436619|FG000|NOT COMPLETED|Overall Study||8
6516303|NCT01522651|7436635|FG000|STARTED|Overall Study||26
6516304|NCT01522651|7436636|FG001|STARTED|Overall Study||27
6516305|NCT01522651|7436637|FG002|STARTED|Overall Study||26
6516306|NCT01522651|7436638|FG003|STARTED|Overall Study||28
6516307|NCT01522651|7436639|FG004|STARTED|Overall Study||27
6516308|NCT01522651|7436635|FG000|COMPLETED|Overall Study||17
6516309|NCT01522651|7436636|FG001|COMPLETED|Overall Study||19
6516310|NCT01522651|7436637|FG002|COMPLETED|Overall Study||22
6516311|NCT01522651|7436638|FG003|COMPLETED|Overall Study||20
6516312|NCT01522651|7436639|FG004|COMPLETED|Overall Study||21
6516313|NCT01522651|7436635|FG000|NOT COMPLETED|Overall Study||9
6516314|NCT01522651|7436636|FG001|NOT COMPLETED|Overall Study||8
6516315|NCT01522651|7436637|FG002|NOT COMPLETED|Overall Study||4
6516316|NCT01522651|7436638|FG003|NOT COMPLETED|Overall Study||8
6516317|NCT01522651|7436639|FG004|NOT COMPLETED|Overall Study||6
6516318|NCT01522703|7436653|FG000|STARTED|Overall Study||25
6516319|NCT01522703|7436654|FG001|STARTED|Overall Study||26
6516320|NCT01522703|7436653|FG000|COMPLETED|Overall Study||20
6516321|NCT01522703|7436654|FG001|COMPLETED|Overall Study||20
6516322|NCT01522703|7436653|FG000|NOT COMPLETED|Overall Study||5
6516323|NCT01522703|7436654|FG001|NOT COMPLETED|Overall Study||6
6516324|NCT01522755|7436660|FG000|STARTED|Overall Study||409
6516325|NCT01522755|7436660|FG000|COMPLETED|Overall Study||409
6516326|NCT01522755|7436660|FG000|NOT COMPLETED|Overall Study||0
6516327|NCT01522924|7436667|FG000|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
6516328|NCT01522924|7436668|FG001|STARTED|Overall Study|There were 52 dental students in the control group.|52
6516329|NCT01522924|7436667|FG000|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
6516330|NCT01522924|7436668|FG001|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
6516331|NCT01522924|7436667|FG000|NOT COMPLETED|Overall Study||0
6516332|NCT01522924|7436668|FG001|NOT COMPLETED|Overall Study||0
6516333|NCT01522937|7436674|FG000|STARTED|Overall Study||146
6516334|NCT01522937|7436674|FG000|COMPLETED|Overall Study||146
6516335|NCT01522937|7436674|FG000|NOT COMPLETED|Overall Study||0
6516336|NCT01522950|7436681|FG000|STARTED|Overall Study||26
6516337|NCT01522950|7436682|FG001|STARTED|Overall Study||23
6516338|NCT01522950|7436683|FG002|STARTED|Overall Study||27
6516339|NCT01522950|7436681|FG000|COMPLETED|Overall Study||20
6516340|NCT01522950|7436682|FG001|COMPLETED|Overall Study||18
6516341|NCT01522950|7436683|FG002|COMPLETED|Overall Study||22
6516342|NCT01522950|7436681|FG000|NOT COMPLETED|Overall Study||6
6516343|NCT01522950|7436682|FG001|NOT COMPLETED|Overall Study||5
6516344|NCT01522950|7436683|FG002|NOT COMPLETED|Overall Study||5
6516345|NCT01522963|7436695|FG000|STARTED|Overall Study||24
6516346|NCT01522963|7436696|FG001|STARTED|Overall Study||25
6516347|NCT01522963|7436697|FG002|STARTED|Overall Study||25
6516348|NCT01522963|7436698|FG003|STARTED|Overall Study||24
6516349|NCT01522963|7436695|FG000|COMPLETED|Overall Study||22
6516350|NCT01522963|7436696|FG001|COMPLETED|Overall Study||22
6516351|NCT01522963|7436697|FG002|COMPLETED|Overall Study||22
6516352|NCT01522963|7436698|FG003|COMPLETED|Overall Study||18
6516353|NCT01522963|7436695|FG000|NOT COMPLETED|Overall Study||2
6516354|NCT01522963|7436696|FG001|NOT COMPLETED|Overall Study||3
6516355|NCT01522963|7436697|FG002|NOT COMPLETED|Overall Study||3
6516356|NCT01522963|7436698|FG003|NOT COMPLETED|Overall Study||6
6516357|NCT01523275|7436708|FG000|STARTED|Overall Study||6
6516358|NCT01523275|7436709|FG001|STARTED|Overall Study||9
6516359|NCT01523275|7436708|FG000|COMPLETED|Overall Study||4
6516360|NCT01523275|7436709|FG001|COMPLETED|Overall Study||7
6516361|NCT01523275|7436708|FG000|NOT COMPLETED|Overall Study||2
6516362|NCT01523275|7436709|FG001|NOT COMPLETED|Overall Study||2
6516363|NCT01523301|7436717|FG000|STARTED|Overall Study||184
6516364|NCT01523301|7436718|FG001|STARTED|Overall Study||196
6516365|NCT01523301|7436717|FG000|COMPLETED|Overall Study||149
6516366|NCT01523301|7436718|FG001|COMPLETED|Overall Study||164
6516367|NCT01523301|7436717|FG000|NOT COMPLETED|Overall Study||35
6516368|NCT01523301|7436718|FG001|NOT COMPLETED|Overall Study||32
6516369|NCT01523366|7436726|FG000|STARTED|Treatment Period 1||20
6516370|NCT01523366|7436727|FG001|STARTED|Treatment Period 1||20
6516371|NCT01523366|7436726|FG000|COMPLETED|Treatment Period 1||19
6516372|NCT01523366|7436727|FG001|COMPLETED|Treatment Period 1||20
6516373|NCT01523366|7436726|FG000|NOT COMPLETED|Treatment Period 1||1
6516374|NCT01523366|7436727|FG001|NOT COMPLETED|Treatment Period 1||0
6516375|NCT01523366|7436726|FG000|STARTED|Washout Period - 10-14 Days||19
6516376|NCT01523366|7436727|FG001|STARTED|Washout Period - 10-14 Days||20
6516377|NCT01523366|7436726|FG000|COMPLETED|Washout Period - 10-14 Days||19
6516378|NCT01523366|7436727|FG001|COMPLETED|Washout Period - 10-14 Days||20
6516379|NCT01523366|7436726|FG000|NOT COMPLETED|Washout Period - 10-14 Days||0
6516380|NCT01523366|7436727|FG001|NOT COMPLETED|Washout Period - 10-14 Days||0
6516381|NCT01523366|7436726|FG000|STARTED|Treatment Period 2||19
6516382|NCT01523366|7436727|FG001|STARTED|Treatment Period 2||20
6516383|NCT01523366|7436726|FG000|COMPLETED|Treatment Period 2||18
6516384|NCT01523366|7436727|FG001|COMPLETED|Treatment Period 2||20
6516385|NCT01523366|7436726|FG000|NOT COMPLETED|Treatment Period 2||1
6516386|NCT01523366|7436727|FG001|NOT COMPLETED|Treatment Period 2||0
6516387|NCT01523392|7436737|FG000|STARTED|Treatment Period 1||20
6516388|NCT01523392|7436738|FG001|STARTED|Treatment Period 1||14
6516389|NCT01523392|7436737|FG000|COMPLETED|Treatment Period 1||17
6516390|NCT01523392|7436738|FG001|COMPLETED|Treatment Period 1||14
6516391|NCT01523392|7436737|FG000|NOT COMPLETED|Treatment Period 1||3
6516392|NCT01523392|7436738|FG001|NOT COMPLETED|Treatment Period 1||0
6516393|NCT01523392|7436737|FG000|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
6516394|NCT01523392|7436738|FG001|STARTED|Washout Period - 10 to 14 Days||14
6516395|NCT01523392|7436737|FG000|COMPLETED|Washout Period - 10 to 14 Days||17
6516396|NCT01523392|7436738|FG001|COMPLETED|Washout Period - 10 to 14 Days||14
6516397|NCT01523392|7436737|FG000|NOT COMPLETED|Washout Period - 10 to 14 Days||1
6516398|NCT01523392|7436738|FG001|NOT COMPLETED|Washout Period - 10 to 14 Days||0
6516399|NCT01523392|7436737|FG000|STARTED|Treatment Period 2||17
6516400|NCT01523392|7436738|FG001|STARTED|Treatment Period 2||14
6516401|NCT01523392|7436737|FG000|COMPLETED|Treatment Period 2||17
6516402|NCT01523392|7436738|FG001|COMPLETED|Treatment Period 2||14
6516403|NCT01523392|7436737|FG000|NOT COMPLETED|Treatment Period 2||0
6516404|NCT01523392|7436738|FG001|NOT COMPLETED|Treatment Period 2||0
6516405|NCT01523457|7436748|FG000|STARTED|Overall Study||44
6516406|NCT01523457|7436749|FG001|STARTED|Overall Study||31
6516407|NCT01523457|7436748|FG000|COMPLETED|Overall Study||37
6516408|NCT01523457|7436749|FG001|COMPLETED|Overall Study||29
6516409|NCT01523457|7436748|FG000|NOT COMPLETED|Overall Study||7
6516410|NCT01523457|7436749|FG001|NOT COMPLETED|Overall Study||2
6516411|NCT01523496|7436759|FG000|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|66
6516412|NCT01523496|7436760|FG001|STARTED|Overall Study||36
6516413|NCT01523496|7436761|FG002|STARTED|Overall Study|The supplementation group includes medium and high dose vitamin D supplementation|58
6516414|NCT01523496|7436762|FG003|STARTED|Overall Study||30
6516415|NCT01523496|7436759|FG000|COMPLETED|Overall Study||56
6516416|NCT01523496|7436760|FG001|COMPLETED|Overall Study||32
6516417|NCT01523496|7436761|FG002|COMPLETED|Overall Study||46
6516418|NCT01523496|7436762|FG003|COMPLETED|Overall Study||27
6516419|NCT01523496|7436759|FG000|NOT COMPLETED|Overall Study||10
6516420|NCT01523496|7436760|FG001|NOT COMPLETED|Overall Study||4
6516421|NCT01523496|7436761|FG002|NOT COMPLETED|Overall Study||12
6516422|NCT01523496|7436762|FG003|NOT COMPLETED|Overall Study||3
6516423|NCT01523587|7436778|FG000|STARTED|Overall Study||398
6516424|NCT01523587|7436779|FG001|STARTED|Overall Study||397
6516425|NCT01523587|7436778|FG000|Treated|Overall Study||392
6516426|NCT01523587|7436779|FG001|Treated|Overall Study||395
6516427|NCT01523587|7436778|FG000|COMPLETED|Overall Study||0
6516428|NCT01523587|7436779|FG001|COMPLETED|Overall Study||0
6516429|NCT01523587|7436778|FG000|NOT COMPLETED|Overall Study||398
6516430|NCT01523587|7436779|FG001|NOT COMPLETED|Overall Study||397
6516431|NCT01523613|7436788|FG000|STARTED|Overall Study|- 30 single restorations (30 R)|30
6516432|NCT01523613|7436789|FG001|STARTED|Overall Study|- 30 single restorations (30 F)|30
6516433|NCT01523613|7436790|FG002|STARTED|Overall Study|- 66 paired restorations (33R + 33F)|33
6516434|NCT01523613|7436788|FG000|COMPLETED|Overall Study|- 23 single restorations (23R)|23
6516435|NCT01523613|7436789|FG001|COMPLETED|Overall Study|- 25 single restorations (25F)|25
6516436|NCT01523613|7436790|FG002|COMPLETED|Overall Study|- 42 paired restorations (21R and 21F)|21
6516437|NCT01523613|7436788|FG000|NOT COMPLETED|Overall Study||7
6516438|NCT01523613|7436789|FG001|NOT COMPLETED|Overall Study||5
6516439|NCT01523613|7436790|FG002|NOT COMPLETED|Overall Study||12
6516440|NCT01523704|7436800|FG000|STARTED|Overall Study|January 2012|636
6516441|NCT01523704|7436801|FG001|STARTED|Overall Study|January 2012|638
6516442|NCT01523704|7436800|FG000|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|558
6516443|NCT01523704|7436801|FG001|COMPLETED|Overall Study|February 2016 (Enrollment: as of October 2013)|550
6516444|NCT01523704|7436800|FG000|NOT COMPLETED|Overall Study||78
6516445|NCT01523704|7436801|FG001|NOT COMPLETED|Overall Study||88
6516446|NCT01523743|7436808|FG000|STARTED|Period 1||63
6516447|NCT01523743|7436809|FG001|STARTED|Period 1||62
6516448|NCT01523743|7436808|FG000|COMPLETED|Period 1||53
6516449|NCT01523743|7436809|FG001|COMPLETED|Period 1||60
6516450|NCT01523743|7436808|FG000|NOT COMPLETED|Period 1||10
6516451|NCT01523743|7436809|FG001|NOT COMPLETED|Period 1||2
6516452|NCT01523743|7436808|FG000|STARTED|Period 2||53
6516453|NCT01523743|7436809|FG001|STARTED|Period 2||60
6516454|NCT01523743|7436808|FG000|COMPLETED|Period 2||52
6516455|NCT01523743|7436809|FG001|COMPLETED|Period 2||58
6516456|NCT01523743|7436808|FG000|NOT COMPLETED|Period 2||1
6516457|NCT01523743|7436809|FG001|NOT COMPLETED|Period 2||2
6516458|NCT01523756|7436815|FG000|STARTED|Baseline Period||11
6516459|NCT01523756|7436816|FG001|STARTED|Baseline Period||9
6516460|NCT01523756|7436815|FG000|COMPLETED|Baseline Period||11
6516461|NCT01523756|7436816|FG001|COMPLETED|Baseline Period||8
6516462|NCT01523756|7436815|FG000|NOT COMPLETED|Baseline Period||0
6516463|NCT01523756|7436816|FG001|NOT COMPLETED|Baseline Period||1
6516464|NCT01523756|7436815|FG000|STARTED|Test Period 1||11
6516465|NCT01523756|7436816|FG001|STARTED|Test Period 1||8
6516466|NCT01523756|7436815|FG000|COMPLETED|Test Period 1||10
6516467|NCT01523756|7436816|FG001|COMPLETED|Test Period 1||8
6516468|NCT01523756|7436815|FG000|NOT COMPLETED|Test Period 1||1
6516469|NCT01523756|7436816|FG001|NOT COMPLETED|Test Period 1||0
6516470|NCT01523756|7436815|FG000|STARTED|Test Period 2||10
6516471|NCT01523756|7436816|FG001|STARTED|Test Period 2||8
6516472|NCT01523756|7436815|FG000|COMPLETED|Test Period 2||10
6516473|NCT01523756|7436816|FG001|COMPLETED|Test Period 2||7
6516474|NCT01523756|7436815|FG000|NOT COMPLETED|Test Period 2||0
6516475|NCT01523756|7436816|FG001|NOT COMPLETED|Test Period 2||1
6516476|NCT01523782|7436827|FG000|STARTED|Overall Study||3
6516477|NCT01523782|7436828|FG001|STARTED|Overall Study||13
6516478|NCT01523782|7436829|FG002|STARTED|Overall Study||14
6516479|NCT01523782|7436827|FG000|COMPLETED|Overall Study||2
6516480|NCT01523782|7436828|FG001|COMPLETED|Overall Study||13
6516481|NCT01523782|7436829|FG002|COMPLETED|Overall Study||9
6516482|NCT01523782|7436827|FG000|NOT COMPLETED|Overall Study||1
6516483|NCT01523782|7436828|FG001|NOT COMPLETED|Overall Study||0
6516484|NCT01523782|7436829|FG002|NOT COMPLETED|Overall Study||5
6516485|NCT01523808|7436841|FG000|STARTED|Overall Study||3
6516486|NCT01523808|7436842|FG001|STARTED|Overall Study||3
6516487|NCT01523808|7436843|FG002|STARTED|Overall Study||3
6516488|NCT01523808|7436844|FG003|STARTED|Overall Study||3
6516489|NCT01523808|7436841|FG000|COMPLETED|Overall Study||0
6516490|NCT01523808|7436842|FG001|COMPLETED|Overall Study||3
6516491|NCT01523808|7436843|FG002|COMPLETED|Overall Study||1
6516492|NCT01523808|7436844|FG003|COMPLETED|Overall Study||0
6516493|NCT01523808|7436841|FG000|NOT COMPLETED|Overall Study||3
6516494|NCT01523808|7436842|FG001|NOT COMPLETED|Overall Study||0
6516495|NCT01523808|7436843|FG002|NOT COMPLETED|Overall Study||2
6516496|NCT01523808|7436844|FG003|NOT COMPLETED|Overall Study||3
6516497|NCT01523821|7436866|FG000|STARTED|Overall Study||8
6516498|NCT01523821|7436867|FG001|STARTED|Overall Study||6
6516499|NCT01523821|7436868|FG002|STARTED|Overall Study||6
6516500|NCT01523821|7436866|FG000|COMPLETED|Overall Study||8
6516501|NCT01523821|7436867|FG001|COMPLETED|Overall Study||6
6516502|NCT01523821|7436868|FG002|COMPLETED|Overall Study||6
6516503|NCT01523821|7436866|FG000|NOT COMPLETED|Overall Study||0
6516504|NCT01523821|7436867|FG001|NOT COMPLETED|Overall Study||0
6516505|NCT01523821|7436868|FG002|NOT COMPLETED|Overall Study||0
6516506|NCT01523834|7436876|FG000|STARTED|Overall Study|Started Induction Phase|35
6516507|NCT01523834|7436876|FG000|Consolidation Phase|Overall Study|Started Consolidation Phase|7
6516508|NCT01523834|7436876|FG000|Maintenance Phase|Overall Study|Started Maintenance Phase|6
6516509|NCT01523834|7436876|FG000|COMPLETED|Overall Study||4
6516510|NCT01523834|7436876|FG000|NOT COMPLETED|Overall Study||31
6516511|NCT01523873|7436881|FG000|STARTED|Overall Study||35921
6516512|NCT01523873|7436881|FG000|Administered With Dotarem|Overall Study||35474
6516513|NCT01523873|7436881|FG000|COMPLETED|Overall Study||35499
6516514|NCT01523873|7436881|FG000|NOT COMPLETED|Overall Study||422
6516515|NCT01523886|7436889|FG000|STARTED|Overall Study||25
6516516|NCT01523886|7436890|FG001|STARTED|Overall Study||24
6516517|NCT01523886|7436889|FG000|COMPLETED|Overall Study||25
6516518|NCT01523886|7436890|FG001|COMPLETED|Overall Study||23
6516519|NCT01523886|7436889|FG000|NOT COMPLETED|Overall Study||0
6516520|NCT01523886|7436890|FG001|NOT COMPLETED|Overall Study||1
6516521|NCT01523899|7436898|FG000|STARTED|Overall Study||126
6516522|NCT01523899|7436899|FG001|STARTED|Overall Study||126
6516523|NCT01523899|7436898|FG000|COMPLETED|Overall Study||126
6516524|NCT01523899|7436899|FG001|COMPLETED|Overall Study||126
6516525|NCT01523899|7436898|FG000|NOT COMPLETED|Overall Study||0
6516526|NCT01523899|7436899|FG001|NOT COMPLETED|Overall Study||0
6516527|NCT01523964|7436910|FG000|STARTED|Overall Study||31
6516528|NCT01523964|7436911|FG001|STARTED|Overall Study||30
6516529|NCT01523964|7436912|FG002|STARTED|Overall Study||16
6516530|NCT01523964|7436913|FG003|STARTED|Overall Study||15
6516531|NCT01523964|7436910|FG000|COMPLETED|Overall Study||31
6516532|NCT01523964|7436911|FG001|COMPLETED|Overall Study||30
6516533|NCT01523964|7436912|FG002|COMPLETED|Overall Study||16
6516534|NCT01523964|7436913|FG003|COMPLETED|Overall Study||15
6516535|NCT01523964|7436910|FG000|NOT COMPLETED|Overall Study||0
6516536|NCT01523964|7436911|FG001|NOT COMPLETED|Overall Study||0
6516537|NCT01523964|7436912|FG002|NOT COMPLETED|Overall Study||0
6516538|NCT01523964|7436913|FG003|NOT COMPLETED|Overall Study||0
6516539|NCT01524133|7436926|FG000|STARTED|Treatment Phase||71
6516540|NCT01524133|7436927|FG001|STARTED|Treatment Phase||69
6516541|NCT01524133|7436928|FG002|STARTED|Treatment Phase||67
6516542|NCT01524133|7436926|FG000|COMPLETED|Treatment Phase|Completed Both Assigned treatment|52
6516543|NCT01524133|7436927|FG001|COMPLETED|Treatment Phase|Completed Both Assigned Treatments|37
6516544|NCT01524133|7436928|FG002|COMPLETED|Treatment Phase|Completed both assigned treatments|31
6516545|NCT01524133|7436926|FG000|NOT COMPLETED|Treatment Phase||19
6516546|NCT01524133|7436927|FG001|NOT COMPLETED|Treatment Phase||32
6516547|NCT01524133|7436928|FG002|NOT COMPLETED|Treatment Phase||36
6516548|NCT01524133|7436926|FG000|STARTED|Overall Study 52 Weeks||71
6516549|NCT01524133|7436927|FG001|STARTED|Overall Study 52 Weeks||69
6516550|NCT01524133|7436928|FG002|STARTED|Overall Study 52 Weeks||67
6516551|NCT01524133|7436926|FG000|COMPLETED|Overall Study 52 Weeks||50
6516552|NCT01524133|7436927|FG001|COMPLETED|Overall Study 52 Weeks||49
6516553|NCT01524133|7436928|FG002|COMPLETED|Overall Study 52 Weeks||40
6516554|NCT01524133|7436926|FG000|NOT COMPLETED|Overall Study 52 Weeks||21
6516555|NCT01524133|7436927|FG001|NOT COMPLETED|Overall Study 52 Weeks||20
6516556|NCT01524133|7436928|FG002|NOT COMPLETED|Overall Study 52 Weeks||27
6516557|NCT01524198|7436938|FG000|STARTED|Overall Study||471
6516558|NCT01524198|7436939|FG001|STARTED|Overall Study||474
6516559|NCT01524198|7436938|FG000|COMPLETED|Overall Study||448
6516560|NCT01524198|7436939|FG001|COMPLETED|Overall Study||458
6516561|NCT01524198|7436938|FG000|NOT COMPLETED|Overall Study||23
6516562|NCT01524198|7436939|FG001|NOT COMPLETED|Overall Study||16
6516563|NCT01524224|7436953|FG000|STARTED|Overall Study||4
6516564|NCT01524224|7436954|FG001|STARTED|Overall Study||3
6516565|NCT01524224|7436955|FG002|STARTED|Overall Study||3
6516566|NCT01524224|7436956|FG003|STARTED|Overall Study||3
6516567|NCT01524224|7436957|FG004|STARTED|Overall Study||4
6516568|NCT01524224|7436958|FG005|STARTED|Overall Study||3
6516569|NCT01524224|7436959|FG006|STARTED|Overall Study||3
6516570|NCT01524224|7436960|FG007|STARTED|Overall Study||6
6516571|NCT01524224|7436953|FG000|Received at Least One Dose of Study Drug|Overall Study||4
6516572|NCT01524224|7436954|FG001|Received at Least One Dose of Study Drug|Overall Study||3
6516573|NCT01524224|7436955|FG002|Received at Least One Dose of Study Drug|Overall Study||3
6516574|NCT01524224|7436956|FG003|Received at Least One Dose of Study Drug|Overall Study||3
6516575|NCT01524224|7436957|FG004|Received at Least One Dose of Study Drug|Overall Study||4
6562891|NCT01803282|7485793|FG008|COMPLETED|Overall Study||0
6516576|NCT01524224|7436958|FG005|Received at Least One Dose of Study Drug|Overall Study||3
6516577|NCT01524224|7436959|FG006|Received at Least One Dose of Study Drug|Overall Study||3
6516578|NCT01524224|7436960|FG007|Received at Least One Dose of Study Drug|Overall Study||6
6516579|NCT01524224|7436953|FG000|COMPLETED|Overall Study||1
6516580|NCT01524224|7436954|FG001|COMPLETED|Overall Study||2
6516581|NCT01524224|7436955|FG002|COMPLETED|Overall Study||1
6516582|NCT01524224|7436956|FG003|COMPLETED|Overall Study||1
6516583|NCT01524224|7436957|FG004|COMPLETED|Overall Study||0
6516584|NCT01524224|7436958|FG005|COMPLETED|Overall Study||1
6516585|NCT01524224|7436959|FG006|COMPLETED|Overall Study||0
6516586|NCT01524224|7436960|FG007|COMPLETED|Overall Study||0
6516587|NCT01524224|7436953|FG000|NOT COMPLETED|Overall Study||3
6516588|NCT01524224|7436954|FG001|NOT COMPLETED|Overall Study||1
6516589|NCT01524224|7436955|FG002|NOT COMPLETED|Overall Study||2
6516590|NCT01524224|7436956|FG003|NOT COMPLETED|Overall Study||2
6516591|NCT01524224|7436957|FG004|NOT COMPLETED|Overall Study||4
6516592|NCT01524224|7436958|FG005|NOT COMPLETED|Overall Study||2
6516593|NCT01524224|7436959|FG006|NOT COMPLETED|Overall Study||3
6516594|NCT01524224|7436960|FG007|NOT COMPLETED|Overall Study||6
6516595|NCT01524289|7436980|FG000|STARTED|Overall Study||204
6516596|NCT01524289|7436981|FG001|STARTED|Overall Study||102
6516597|NCT01524289|7436980|FG000|Treated|Overall Study||203
6516598|NCT01524289|7436981|FG001|Treated|Overall Study||102
6516599|NCT01524289|7436980|FG000|COMPLETED|Overall Study||174
6516600|NCT01524289|7436981|FG001|COMPLETED|Overall Study||88
6516601|NCT01524289|7436980|FG000|NOT COMPLETED|Overall Study||30
6516602|NCT01524289|7436981|FG001|NOT COMPLETED|Overall Study||14
6516603|NCT01524302|7436991|FG000|STARTED|Overall Study||6
6516604|NCT01524302|7436992|FG001|STARTED|Overall Study||6
6516605|NCT01524302|7436991|FG000|COMPLETED|Overall Study||6
6516606|NCT01524302|7436992|FG001|COMPLETED|Overall Study||6
6516607|NCT01524302|7436991|FG000|NOT COMPLETED|Overall Study||0
6516608|NCT01524302|7436992|FG001|NOT COMPLETED|Overall Study||0
6516609|NCT01524627|7437004|FG000|STARTED|Overall Study||22
6516610|NCT01524627|7437005|FG001|STARTED|Overall Study||21
6516611|NCT01524627|7437004|FG000|COMPLETED|Overall Study||21
6516612|NCT01524627|7437005|FG001|COMPLETED|Overall Study||19
6516613|NCT01524627|7437004|FG000|NOT COMPLETED|Overall Study||1
6516614|NCT01524627|7437005|FG001|NOT COMPLETED|Overall Study||2
6516615|NCT01524679|7437013|FG000|STARTED|Overall Study||112
6516616|NCT01524679|7437014|FG001|STARTED|Overall Study||58
6516617|NCT01524679|7437013|FG000|COMPLETED|Overall Study||89
6516618|NCT01524679|7437014|FG001|COMPLETED|Overall Study||49
6516619|NCT01524679|7437013|FG000|NOT COMPLETED|Overall Study||23
6516620|NCT01524679|7437014|FG001|NOT COMPLETED|Overall Study||9
6516621|NCT01524692|7437020|FG000|STARTED|Overall Study||35
6516622|NCT01524692|7437020|FG000|COMPLETED|Overall Study||32
6516623|NCT01524692|7437020|FG000|NOT COMPLETED|Overall Study||3
6516624|NCT01524770|7437025|FG000|STARTED|First Intervention||26
6516625|NCT01524770|7437026|FG001|STARTED|First Intervention||24
6516626|NCT01524770|7437025|FG000|Received at Least 1 Dose of Study Drug|First Intervention||26
6516627|NCT01524770|7437026|FG001|Received at Least 1 Dose of Study Drug|First Intervention||24
6516628|NCT01524770|7437025|FG000|COMPLETED|First Intervention||23
6516629|NCT01524770|7437026|FG001|COMPLETED|First Intervention||23
6516630|NCT01524770|7437025|FG000|NOT COMPLETED|First Intervention||3
6516631|NCT01524770|7437026|FG001|NOT COMPLETED|First Intervention||1
6516632|NCT01524770|7437025|FG000|STARTED|Washout Period of at Least 28 Days||23
6516633|NCT01524770|7437026|FG001|STARTED|Washout Period of at Least 28 Days||23
6516634|NCT01524770|7437025|FG000|COMPLETED|Washout Period of at Least 28 Days||23
6516635|NCT01524770|7437026|FG001|COMPLETED|Washout Period of at Least 28 Days||23
6516636|NCT01524770|7437025|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
6516637|NCT01524770|7437026|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
6516638|NCT01524770|7437025|FG000|STARTED|Second Intervention||23
6516639|NCT01524770|7437026|FG001|STARTED|Second Intervention||23
6516640|NCT01524770|7437025|FG000|COMPLETED|Second Intervention||23
6516641|NCT01524770|7437026|FG001|COMPLETED|Second Intervention||23
6516642|NCT01524770|7437025|FG000|NOT COMPLETED|Second Intervention||0
6516643|NCT01524770|7437026|FG001|NOT COMPLETED|Second Intervention||0
6516644|NCT01524783|7437034|FG000|STARTED|Blinded Period||205
6516645|NCT01524783|7437035|FG001|STARTED|Blinded Period||97
6516646|NCT01524783|7437036|FG002|STARTED|Blinded Period||0
6516647|NCT01524783|7437034|FG000|COMPLETED|Blinded Period||26
6516648|NCT01524783|7437035|FG001|COMPLETED|Blinded Period||6
6516649|NCT01524783|7437036|FG002|COMPLETED|Blinded Period||0
6516650|NCT01524783|7437034|FG000|NOT COMPLETED|Blinded Period||179
6516651|NCT01524783|7437035|FG001|NOT COMPLETED|Blinded Period||91
6516652|NCT01524783|7437036|FG002|NOT COMPLETED|Blinded Period||0
6516653|NCT01524783|7437034|FG000|STARTED|Open-label Period||26
6516654|NCT01524783|7437035|FG001|STARTED|Open-label Period||0
6516655|NCT01524783|7437036|FG002|STARTED|Open-label Period||6
6516656|NCT01524783|7437034|FG000|COMPLETED|Open-label Period||0
6516657|NCT01524783|7437035|FG001|COMPLETED|Open-label Period||0
6516658|NCT01524783|7437036|FG002|COMPLETED|Open-label Period||0
6516659|NCT01524783|7437034|FG000|NOT COMPLETED|Open-label Period||26
6516660|NCT01524783|7437035|FG001|NOT COMPLETED|Open-label Period||0
6516661|NCT01524783|7437036|FG002|NOT COMPLETED|Open-label Period||6
6516662|NCT01524796|7437048|FG000|STARTED|Overall Study||128
6516663|NCT01524796|7437048|FG000|COMPLETED|Overall Study||100
6516664|NCT01524796|7437048|FG000|NOT COMPLETED|Overall Study||28
6516665|NCT01524887|7437055|FG000|STARTED|Overall Study||85
6516666|NCT01524887|7437056|FG001|STARTED|Overall Study||90
6516667|NCT01524887|7437057|FG002|STARTED|Overall Study||86
6516668|NCT01524887|7437055|FG000|Received Treatment|Overall Study||83
6516669|NCT01524887|7437056|FG001|Received Treatment|Overall Study||85
6516670|NCT01524887|7437057|FG002|Received Treatment|Overall Study||83
6516671|NCT01524887|7437055|FG000|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
6516672|NCT01524887|7437056|FG001|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
6516673|NCT01524887|7437057|FG002|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
6516674|NCT01524887|7437055|FG000|NOT COMPLETED|Overall Study||85
6516675|NCT01524887|7437056|FG001|NOT COMPLETED|Overall Study||90
6516676|NCT01524887|7437057|FG002|NOT COMPLETED|Overall Study||86
6516677|NCT01524900|7437070|FG000|STARTED|Overall Study||49
6516678|NCT01524900|7437071|FG001|STARTED|Overall Study||246
6516679|NCT01524900|7437072|FG002|STARTED|Overall Study||30
6516680|NCT01524900|7437073|FG003|STARTED|Overall Study||22
6516681|NCT01524900|7437074|FG004|STARTED|Overall Study||40
6516682|NCT01524900|7437070|FG000|COMPLETED|Overall Study||43
6516683|NCT01524900|7437071|FG001|COMPLETED|Overall Study||232
6516684|NCT01524900|7437072|FG002|COMPLETED|Overall Study||29
6516685|NCT01524900|7437073|FG003|COMPLETED|Overall Study||21
6516686|NCT01524900|7437074|FG004|COMPLETED|Overall Study||40
6516687|NCT01524900|7437070|FG000|NOT COMPLETED|Overall Study||6
6516688|NCT01524900|7437071|FG001|NOT COMPLETED|Overall Study||14
6516689|NCT01524900|7437072|FG002|NOT COMPLETED|Overall Study||1
6516690|NCT01524900|7437073|FG003|NOT COMPLETED|Overall Study||1
6516691|NCT01524900|7437074|FG004|NOT COMPLETED|Overall Study||0
6516692|NCT01524913|7437090|FG000|STARTED|Overall Study||35
6516693|NCT01524913|7437091|FG001|STARTED|Overall Study||36
6516694|NCT01524913|7437092|FG002|STARTED|Overall Study||31
6516695|NCT01524913|7437090|FG000|COMPLETED|Overall Study||31
6516696|NCT01524913|7437091|FG001|COMPLETED|Overall Study||36
6516697|NCT01524913|7437092|FG002|COMPLETED|Overall Study||31
6516698|NCT01524913|7437090|FG000|NOT COMPLETED|Overall Study||4
6516699|NCT01524913|7437091|FG001|NOT COMPLETED|Overall Study||0
6516700|NCT01524913|7437092|FG002|NOT COMPLETED|Overall Study||0
6516701|NCT01524978|7437111|FG000|STARTED|Overall Study||62
6516702|NCT01524978|7437112|FG001|STARTED|Overall Study||4
6516703|NCT01524978|7437113|FG002|STARTED|Overall Study||10
6516704|NCT01524978|7437114|FG003|STARTED|Overall Study||27
6516705|NCT01524978|7437115|FG004|STARTED|Overall Study||9
6516706|NCT01524978|7437116|FG005|STARTED|Overall Study||9
6516707|NCT01524978|7437117|FG006|STARTED|Overall Study||26
6516708|NCT01524978|7437118|FG007|STARTED|Overall Study||12
6516709|NCT01524978|7437119|FG008|STARTED|Overall Study||12
6516710|NCT01524978|7437120|FG009|STARTED|Overall Study||9
6516711|NCT01524978|7437121|FG010|STARTED|Overall Study||28
6516712|NCT01524978|7437111|FG000|COMPLETED|Overall Study||0
6516713|NCT01524978|7437112|FG001|COMPLETED|Overall Study||0
6516714|NCT01524978|7437113|FG002|COMPLETED|Overall Study||0
6516715|NCT01524978|7437114|FG003|COMPLETED|Overall Study||0
6516716|NCT01524978|7437115|FG004|COMPLETED|Overall Study||0
6516717|NCT01524978|7437116|FG005|COMPLETED|Overall Study||0
6516718|NCT01524978|7437117|FG006|COMPLETED|Overall Study||0
6516719|NCT01524978|7437118|FG007|COMPLETED|Overall Study||0
6516720|NCT01524978|7437119|FG008|COMPLETED|Overall Study||0
6516721|NCT01524978|7437120|FG009|COMPLETED|Overall Study||0
6516722|NCT01524978|7437121|FG010|COMPLETED|Overall Study||0
6516723|NCT01524978|7437111|FG000|NOT COMPLETED|Overall Study||62
6516724|NCT01524978|7437112|FG001|NOT COMPLETED|Overall Study||4
6516725|NCT01524978|7437113|FG002|NOT COMPLETED|Overall Study||10
6516726|NCT01524978|7437114|FG003|NOT COMPLETED|Overall Study||27
6516727|NCT01524978|7437115|FG004|NOT COMPLETED|Overall Study||9
6516728|NCT01524978|7437116|FG005|NOT COMPLETED|Overall Study||9
6516729|NCT01524978|7437117|FG006|NOT COMPLETED|Overall Study||26
6516730|NCT01524978|7437118|FG007|NOT COMPLETED|Overall Study||12
6516731|NCT01524978|7437119|FG008|NOT COMPLETED|Overall Study||12
6516732|NCT01524978|7437120|FG009|NOT COMPLETED|Overall Study||9
6516733|NCT01524978|7437121|FG010|NOT COMPLETED|Overall Study||28
6516734|NCT01524991|7437136|FG000|STARTED|Overall Study||36
6516735|NCT01524991|7437136|FG000|COMPLETED|Overall Study||2
6516736|NCT01524991|7437136|FG000|NOT COMPLETED|Overall Study||34
6516737|NCT01525082|7437140|FG000|STARTED|Overall Study||20
6516738|NCT01525082|7437140|FG000|COMPLETED|Overall Study||19
6516739|NCT01525082|7437140|FG000|NOT COMPLETED|Overall Study||1
6516740|NCT01525173|7437149|FG000|STARTED|Overall Study||70
6516741|NCT01525173|7437150|FG001|STARTED|Overall Study||67
6516742|NCT01525173|7437149|FG000|COMPLETED|Overall Study||63
6516743|NCT01525173|7437150|FG001|COMPLETED|Overall Study||62
6516744|NCT01525173|7437149|FG000|NOT COMPLETED|Overall Study||7
6516745|NCT01525173|7437150|FG001|NOT COMPLETED|Overall Study||5
6516746|NCT01525225|7437156|FG000|STARTED|Enrollment||4
6516747|NCT01525225|7437156|FG000|COMPLETED|Enrollment||2
6516748|NCT01525225|7437156|FG000|NOT COMPLETED|Enrollment||2
6516749|NCT01525225|7437156|FG000|STARTED|Treated||2
6516750|NCT01525225|7437156|FG000|COMPLETED|Treated||2
6516751|NCT01525225|7437156|FG000|NOT COMPLETED|Treated||0
6516752|NCT01525238|7437163|FG000|STARTED|Overall Study||8
6516753|NCT01525238|7437164|FG001|STARTED|Overall Study||8
6516754|NCT01525238|7437165|FG002|STARTED|Overall Study||8
6516755|NCT01525238|7437163|FG000|COMPLETED|Overall Study||7
6516756|NCT01525238|7437164|FG001|COMPLETED|Overall Study||8
6516757|NCT01525238|7437165|FG002|COMPLETED|Overall Study||8
6516758|NCT01525238|7437163|FG000|NOT COMPLETED|Overall Study||1
6516759|NCT01525238|7437164|FG001|NOT COMPLETED|Overall Study||0
6516760|NCT01525238|7437165|FG002|NOT COMPLETED|Overall Study||0
6516761|NCT01525407|7437175|FG000|STARTED|Overall Study||41
6516762|NCT01525407|7437176|FG001|STARTED|Overall Study||42
6516763|NCT01525407|7437175|FG000|COMPLETED|Overall Study||38
6516764|NCT01525407|7437176|FG001|COMPLETED|Overall Study||38
6516765|NCT01525407|7437175|FG000|NOT COMPLETED|Overall Study||3
6516766|NCT01525407|7437176|FG001|NOT COMPLETED|Overall Study||4
6516767|NCT01525420|7437184|FG000|STARTED|Overall Study||59
6516768|NCT01525420|7437185|FG001|STARTED|Overall Study||62
6516769|NCT01525420|7437184|FG000|COMPLETED|Overall Study||43
6516770|NCT01525420|7437185|FG001|COMPLETED|Overall Study||38
6516771|NCT01525420|7437184|FG000|NOT COMPLETED|Overall Study||16
6516772|NCT01525420|7437185|FG001|NOT COMPLETED|Overall Study||24
6516773|NCT01525550|7437193|FG000|STARTED|Overall Study||61
6516774|NCT01525550|7437194|FG001|STARTED|Overall Study||45
6516775|NCT01525550|7437193|FG000|COMPLETED|Overall Study||0
6516776|NCT01525550|7437194|FG001|COMPLETED|Overall Study||0
6516777|NCT01525550|7437193|FG000|NOT COMPLETED|Overall Study||61
6516778|NCT01525550|7437194|FG001|NOT COMPLETED|Overall Study||45
6516779|NCT01525563|7437200|FG000|STARTED|Overall Study||1000
6516780|NCT01525563|7437200|FG000|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
6516781|NCT01525563|7437200|FG000|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
6516782|NCT01525563|7437200|FG000|COMPLETED|Overall Study|6 Months Follow-up|788
6516783|NCT01525563|7437200|FG000|NOT COMPLETED|Overall Study||212
6516784|NCT01525589|7437207|FG000|STARTED|Overall Study||56
6516785|NCT01525589|7437208|FG001|STARTED|Overall Study||20
6516786|NCT01525589|7437209|FG002|STARTED|Overall Study||35
6516787|NCT01525589|7437207|FG000|COMPLETED|Overall Study||0
6516788|NCT01525589|7437208|FG001|COMPLETED|Overall Study||0
6516789|NCT01525589|7437209|FG002|COMPLETED|Overall Study||0
6516790|NCT01525589|7437207|FG000|NOT COMPLETED|Overall Study||56
6516791|NCT01525589|7437208|FG001|NOT COMPLETED|Overall Study||20
6516792|NCT01525589|7437209|FG002|NOT COMPLETED|Overall Study||35
6516793|NCT01525602|7437225|FG000|STARTED|Overall Study||9
6516794|NCT01525602|7437226|FG001|STARTED|Overall Study||3
6516795|NCT01525602|7437227|FG002|STARTED|Overall Study||3
6516796|NCT01525602|7437228|FG003|STARTED|Overall Study||6
6516797|NCT01525602|7437229|FG004|STARTED|Overall Study||33
6516798|NCT01525602|7437230|FG005|STARTED|Overall Study||7
6516799|NCT01525602|7437231|FG006|STARTED|Overall Study||6
6516800|NCT01525602|7437232|FG007|STARTED|Overall Study||7
6516801|NCT01525602|7437225|FG000|COMPLETED|Overall Study||0
6516802|NCT01525602|7437226|FG001|COMPLETED|Overall Study||0
6516803|NCT01525602|7437227|FG002|COMPLETED|Overall Study||0
6516804|NCT01525602|7437228|FG003|COMPLETED|Overall Study||0
6516805|NCT01525602|7437229|FG004|COMPLETED|Overall Study||0
6516806|NCT01525602|7437230|FG005|COMPLETED|Overall Study||0
6516807|NCT01525602|7437231|FG006|COMPLETED|Overall Study||0
6516808|NCT01525602|7437232|FG007|COMPLETED|Overall Study||0
6516809|NCT01525602|7437225|FG000|NOT COMPLETED|Overall Study||9
6516810|NCT01525602|7437226|FG001|NOT COMPLETED|Overall Study||3
6516811|NCT01525602|7437227|FG002|NOT COMPLETED|Overall Study||3
6641111|NCT02340767|7569573|FG003|NOT COMPLETED|Overall Study||0
6641112|NCT02340767|7569574|FG004|NOT COMPLETED|Overall Study||0
6641113|NCT02340767|7569575|FG005|NOT COMPLETED|Overall Study||0
6641114|NCT02340767|7569576|FG006|NOT COMPLETED|Overall Study||0
6641115|NCT02340767|7569577|FG007|NOT COMPLETED|Overall Study||0
6641116|NCT02340767|7569578|FG008|NOT COMPLETED|Overall Study||0
6641117|NCT02340780|7569593|FG000|STARTED|Overall Study|A total of 14 patients enrolled, one patient was found ineligible after the enrollment.|14
6641118|NCT02340780|7569593|FG000|COMPLETED|Overall Study||13
6641119|NCT02340780|7569593|FG000|NOT COMPLETED|Overall Study||1
6641120|NCT02340806|7569599|FG000|STARTED|Overall Study||108
6641121|NCT02340806|7569600|FG001|STARTED|Overall Study||112
6641122|NCT02340806|7569599|FG000|COMPLETED|Overall Study||102
6641123|NCT02340806|7569600|FG001|COMPLETED|Overall Study||108
6641124|NCT02340806|7569599|FG000|NOT COMPLETED|Overall Study||6
6641125|NCT02340806|7569600|FG001|NOT COMPLETED|Overall Study||4
6641126|NCT02340819|7569606|FG000|STARTED|Overall Study||11
6641127|NCT02340819|7569606|FG000|Started Stage 2|Overall Study||11
6641128|NCT02340819|7569606|FG000|Completed Stage 2|Overall Study||9
6641129|NCT02340819|7569606|FG000|Started Stage 3|Overall Study||8
6641130|NCT02340819|7569606|FG000|Completed Stage 3|Overall Study||7
6641131|NCT02340819|7569606|FG000|Started Stage 4|Overall Study||7
6641132|NCT02340819|7569606|FG000|Completed Stage 4|Overall Study||7
6516812|NCT01525602|7437228|FG003|NOT COMPLETED|Overall Study||6
6516813|NCT01525602|7437229|FG004|NOT COMPLETED|Overall Study||33
6516814|NCT01525602|7437230|FG005|NOT COMPLETED|Overall Study||7
6516815|NCT01525602|7437231|FG006|NOT COMPLETED|Overall Study||6
6516816|NCT01525602|7437232|FG007|NOT COMPLETED|Overall Study||7
6516817|NCT01525615|7437260|FG000|STARTED|Overall Study||132
6516818|NCT01525615|7437261|FG001|STARTED|Overall Study||133
6641133|NCT02340819|7569606|FG000|COMPLETED|Overall Study||7
6516819|NCT01525615|7437262|FG002|STARTED|Overall Study||139
6516820|NCT01525615|7437260|FG000|COMPLETED|Overall Study||118
6516821|NCT01525615|7437261|FG001|COMPLETED|Overall Study||126
6516822|NCT01525615|7437262|FG002|COMPLETED|Overall Study||133
6516823|NCT01525615|7437260|FG000|NOT COMPLETED|Overall Study||14
6516824|NCT01525615|7437261|FG001|NOT COMPLETED|Overall Study||7
6516825|NCT01525615|7437262|FG002|NOT COMPLETED|Overall Study||6
6516826|NCT01525628|7437275|FG000|STARTED|Overall Study||16
6516827|NCT01525628|7437276|FG001|STARTED|Overall Study||19
6516828|NCT01525628|7437277|FG002|STARTED|Overall Study||16
6516829|NCT01525628|7437278|FG003|STARTED|Overall Study||14
6516830|NCT01525628|7437279|FG004|STARTED|Overall Study||7
6516831|NCT01525628|7437275|FG000|COMPLETED|Overall Study||14
6516832|NCT01525628|7437276|FG001|COMPLETED|Overall Study||14
6516833|NCT01525628|7437277|FG002|COMPLETED|Overall Study||11
6516834|NCT01525628|7437278|FG003|COMPLETED|Overall Study||10
6516835|NCT01525628|7437279|FG004|COMPLETED|Overall Study||4
6516836|NCT01525628|7437275|FG000|NOT COMPLETED|Overall Study||2
6516837|NCT01525628|7437276|FG001|NOT COMPLETED|Overall Study||5
6516838|NCT01525628|7437277|FG002|NOT COMPLETED|Overall Study||5
6516839|NCT01525628|7437278|FG003|NOT COMPLETED|Overall Study||4
6516840|NCT01525628|7437279|FG004|NOT COMPLETED|Overall Study||3
6516841|NCT01525641|7437293|FG000|STARTED|Overall Study||615
6516842|NCT01525641|7437293|FG000|COMPLETED|Overall Study||435
6516843|NCT01525641|7437293|FG000|NOT COMPLETED|Overall Study||180
6516844|NCT01525667|7437300|FG000|STARTED|Overall Study||7
6516845|NCT01525667|7437301|FG001|STARTED|Overall Study||6
6516846|NCT01525667|7437302|FG002|STARTED|Overall Study||7
6516847|NCT01525667|7437300|FG000|COMPLETED|Overall Study||7
6516848|NCT01525667|7437301|FG001|COMPLETED|Overall Study||6
6516849|NCT01525667|7437302|FG002|COMPLETED|Overall Study||7
6516850|NCT01525667|7437300|FG000|NOT COMPLETED|Overall Study||0
6516851|NCT01525667|7437301|FG001|NOT COMPLETED|Overall Study||0
6516852|NCT01525667|7437302|FG002|NOT COMPLETED|Overall Study||0
6516853|NCT01525849|7437314|FG000|STARTED|Overall Study||76
6516854|NCT01525849|7437315|FG001|STARTED|Overall Study||75
6516855|NCT01525849|7437314|FG000|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
6516856|NCT01525849|7437315|FG001|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
6516857|NCT01525849|7437314|FG000|6-Months|Overall Study||73
6516858|NCT01525849|7437315|FG001|6-Months|Overall Study||60
6516859|NCT01525849|7437314|FG000|COMPLETED|Overall Study||71
6516860|NCT01525849|7437315|FG001|COMPLETED|Overall Study||59
6516861|NCT01525849|7437314|FG000|NOT COMPLETED|Overall Study||5
6516862|NCT01525849|7437315|FG001|NOT COMPLETED|Overall Study||16
6516863|NCT01525862|7437321|FG000|STARTED|Overall Study||21
6516864|NCT01525862|7437321|FG000|COMPLETED|Overall Study||21
6516865|NCT01525862|7437321|FG000|NOT COMPLETED|Overall Study||0
6516866|NCT01525875|7437327|FG000|STARTED|Placebo-controlled Period||22
6516867|NCT01525875|7437328|FG001|STARTED|Placebo-controlled Period||22
6516868|NCT01525875|7437327|FG000|COMPLETED|Placebo-controlled Period||21
6516869|NCT01525875|7437328|FG001|COMPLETED|Placebo-controlled Period||20
6516870|NCT01525875|7437327|FG000|NOT COMPLETED|Placebo-controlled Period||1
6516871|NCT01525875|7437328|FG001|NOT COMPLETED|Placebo-controlled Period||2
6516872|NCT01525875|7437327|FG000|STARTED|Open-label Period||21
6516873|NCT01525875|7437328|FG001|STARTED|Open-label Period||20
6516874|NCT01525875|7437327|FG000|COMPLETED|Open-label Period||21
6516875|NCT01525875|7437328|FG001|COMPLETED|Open-label Period||18
6516876|NCT01525875|7437327|FG000|NOT COMPLETED|Open-label Period||0
6516877|NCT01525875|7437328|FG001|NOT COMPLETED|Open-label Period||2
6516878|NCT01526057|7437337|FG000|STARTED|Overall Study||73
6516879|NCT01526057|7437338|FG001|STARTED|Overall Study||74
6516880|NCT01526057|7437339|FG002|STARTED|Overall Study||73
6516881|NCT01526057|7437337|FG000|COMPLETED|Overall Study||64
6516882|NCT01526057|7437338|FG001|COMPLETED|Overall Study||71
6516883|NCT01526057|7437339|FG002|COMPLETED|Overall Study||67
6516884|NCT01526057|7437337|FG000|NOT COMPLETED|Overall Study||9
6516885|NCT01526057|7437338|FG001|NOT COMPLETED|Overall Study||3
6516886|NCT01526057|7437339|FG002|NOT COMPLETED|Overall Study||6
6516887|NCT01526148|7437349|FG000|STARTED|Overall Study||18
6516888|NCT01526148|7437350|FG001|STARTED|Overall Study||24
6516889|NCT01526148|7437349|FG000|COMPLETED|Overall Study||4
6516890|NCT01526148|7437350|FG001|COMPLETED|Overall Study||11
6516891|NCT01526148|7437349|FG000|NOT COMPLETED|Overall Study||14
6516892|NCT01526148|7437350|FG001|NOT COMPLETED|Overall Study||13
6516893|NCT01526213|7437362|FG000|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516894|NCT01526213|7437363|FG001|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516895|NCT01526213|7437364|FG002|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516896|NCT01526213|7437365|FG003|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516897|NCT01526213|7437366|FG004|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516898|NCT01526213|7437367|FG005|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
6516899|NCT01526213|7437362|FG000|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516900|NCT01526213|7437363|FG001|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516901|NCT01526213|7437364|FG002|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516902|NCT01526213|7437365|FG003|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516903|NCT01526213|7437366|FG004|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516904|NCT01526213|7437367|FG005|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516905|NCT01526213|7437362|FG000|NOT COMPLETED|Period 1 (5 Days)||0
6516906|NCT01526213|7437363|FG001|NOT COMPLETED|Period 1 (5 Days)||0
6516907|NCT01526213|7437364|FG002|NOT COMPLETED|Period 1 (5 Days)||0
6516908|NCT01526213|7437365|FG003|NOT COMPLETED|Period 1 (5 Days)||0
6516909|NCT01526213|7437366|FG004|NOT COMPLETED|Period 1 (5 Days)||0
6516910|NCT01526213|7437367|FG005|NOT COMPLETED|Period 1 (5 Days)||0
6516911|NCT01526213|7437362|FG000|STARTED|Washout 1 (10 Days)||3
6516912|NCT01526213|7437363|FG001|STARTED|Washout 1 (10 Days)||3
6516913|NCT01526213|7437364|FG002|STARTED|Washout 1 (10 Days)||3
6516914|NCT01526213|7437365|FG003|STARTED|Washout 1 (10 Days)||3
6516915|NCT01526213|7437366|FG004|STARTED|Washout 1 (10 Days)||3
6516916|NCT01526213|7437367|FG005|STARTED|Washout 1 (10 Days)||3
6516917|NCT01526213|7437362|FG000|COMPLETED|Washout 1 (10 Days)||3
6516918|NCT01526213|7437363|FG001|COMPLETED|Washout 1 (10 Days)||3
6516919|NCT01526213|7437364|FG002|COMPLETED|Washout 1 (10 Days)||3
6516920|NCT01526213|7437365|FG003|COMPLETED|Washout 1 (10 Days)||3
6516921|NCT01526213|7437366|FG004|COMPLETED|Washout 1 (10 Days)||3
6516922|NCT01526213|7437367|FG005|COMPLETED|Washout 1 (10 Days)||3
6516923|NCT01526213|7437362|FG000|NOT COMPLETED|Washout 1 (10 Days)||0
6516924|NCT01526213|7437363|FG001|NOT COMPLETED|Washout 1 (10 Days)||0
6516925|NCT01526213|7437364|FG002|NOT COMPLETED|Washout 1 (10 Days)||0
6516926|NCT01526213|7437365|FG003|NOT COMPLETED|Washout 1 (10 Days)||0
6516927|NCT01526213|7437366|FG004|NOT COMPLETED|Washout 1 (10 Days)||0
6516928|NCT01526213|7437367|FG005|NOT COMPLETED|Washout 1 (10 Days)||0
6516929|NCT01526213|7437362|FG000|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516930|NCT01526213|7437363|FG001|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516931|NCT01526213|7437364|FG002|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516932|NCT01526213|7437365|FG003|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6641134|NCT02340819|7569606|FG000|NOT COMPLETED|Overall Study||4
6641135|NCT02340949|7569612|FG000|STARTED|Overall Study||115
6641136|NCT02340949|7569613|FG001|STARTED|Overall Study||65
6641137|NCT02340949|7569612|FG000|COMPLETED|Overall Study||99
6641138|NCT02340949|7569613|FG001|COMPLETED|Overall Study||61
6641139|NCT02340949|7569612|FG000|NOT COMPLETED|Overall Study||16
6516933|NCT01526213|7437366|FG004|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516934|NCT01526213|7437367|FG005|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516935|NCT01526213|7437362|FG000|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516936|NCT01526213|7437363|FG001|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516937|NCT01526213|7437364|FG002|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
6516938|NCT01526213|7437365|FG003|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
6516939|NCT01526213|7437366|FG004|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
6516940|NCT01526213|7437367|FG005|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
6516941|NCT01526213|7437362|FG000|NOT COMPLETED|Period 2 (5 Days)||0
6516942|NCT01526213|7437363|FG001|NOT COMPLETED|Period 2 (5 Days)||0
6516943|NCT01526213|7437364|FG002|NOT COMPLETED|Period 2 (5 Days)||0
6516944|NCT01526213|7437365|FG003|NOT COMPLETED|Period 2 (5 Days)||0
6516945|NCT01526213|7437366|FG004|NOT COMPLETED|Period 2 (5 Days)||0
6516946|NCT01526213|7437367|FG005|NOT COMPLETED|Period 2 (5 Days)||0
6516947|NCT01526213|7437362|FG000|STARTED|Washout 2 (10 Days)||3
6516948|NCT01526213|7437363|FG001|STARTED|Washout 2 (10 Days)||3
6516949|NCT01526213|7437364|FG002|STARTED|Washout 2 (10 Days)||3
6516950|NCT01526213|7437365|FG003|STARTED|Washout 2 (10 Days)||3
6516951|NCT01526213|7437366|FG004|STARTED|Washout 2 (10 Days)||3
6516952|NCT01526213|7437367|FG005|STARTED|Washout 2 (10 Days)||3
6516953|NCT01526213|7437362|FG000|COMPLETED|Washout 2 (10 Days)||3
6516954|NCT01526213|7437363|FG001|COMPLETED|Washout 2 (10 Days)||3
6516955|NCT01526213|7437364|FG002|COMPLETED|Washout 2 (10 Days)||3
6516956|NCT01526213|7437365|FG003|COMPLETED|Washout 2 (10 Days)||3
6641140|NCT02340949|7569613|FG001|NOT COMPLETED|Overall Study||4
6641141|NCT02340962|7569621|FG000|STARTED|Overall Study||13
6641142|NCT02340962|7569622|FG001|STARTED|Overall Study||12
6641143|NCT02340962|7569621|FG000|COMPLETED|Overall Study||12
6641144|NCT02340962|7569622|FG001|COMPLETED|Overall Study||12
6641145|NCT02340962|7569621|FG000|NOT COMPLETED|Overall Study||1
6641146|NCT02340962|7569622|FG001|NOT COMPLETED|Overall Study||0
6516957|NCT01526213|7437366|FG004|COMPLETED|Washout 2 (10 Days)||3
6516958|NCT01526213|7437367|FG005|COMPLETED|Washout 2 (10 Days)||3
6641147|NCT02340975|7569634|FG000|STARTED|Overall Study||6
6641148|NCT02340975|7569635|FG001|STARTED|Overall Study||27
6641149|NCT02340975|7569636|FG002|STARTED|Overall Study||24
6641150|NCT02340975|7569637|FG003|STARTED|Overall Study||12
6641151|NCT02340975|7569638|FG004|STARTED|Overall Study||25
6641152|NCT02340975|7569639|FG005|STARTED|Overall Study||19
6641153|NCT02340975|7569634|FG000|COMPLETED|Overall Study||0
6641154|NCT02340975|7569635|FG001|COMPLETED|Overall Study||0
6516959|NCT01526213|7437362|FG000|NOT COMPLETED|Washout 2 (10 Days)||0
6516960|NCT01526213|7437363|FG001|NOT COMPLETED|Washout 2 (10 Days)||0
6516961|NCT01526213|7437364|FG002|NOT COMPLETED|Washout 2 (10 Days)||0
6516962|NCT01526213|7437365|FG003|NOT COMPLETED|Washout 2 (10 Days)||0
6516963|NCT01526213|7437366|FG004|NOT COMPLETED|Washout 2 (10 Days)||0
6516964|NCT01526213|7437367|FG005|NOT COMPLETED|Washout 2 (10 Days)||0
6516965|NCT01526213|7437362|FG000|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516966|NCT01526213|7437363|FG001|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516967|NCT01526213|7437364|FG002|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516968|NCT01526213|7437365|FG003|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516969|NCT01526213|7437366|FG004|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516970|NCT01526213|7437367|FG005|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
6516971|NCT01526213|7437362|FG000|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516972|NCT01526213|7437363|FG001|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516973|NCT01526213|7437364|FG002|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516974|NCT01526213|7437365|FG003|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516975|NCT01526213|7437366|FG004|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516976|NCT01526213|7437367|FG005|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
6516977|NCT01526213|7437362|FG000|NOT COMPLETED|Period 3 (5 Days)||0
6516978|NCT01526213|7437363|FG001|NOT COMPLETED|Period 3 (5 Days)||0
6516979|NCT01526213|7437364|FG002|NOT COMPLETED|Period 3 (5 Days)||0
6516980|NCT01526213|7437365|FG003|NOT COMPLETED|Period 3 (5 Days)||0
6516981|NCT01526213|7437366|FG004|NOT COMPLETED|Period 3 (5 Days)||0
6516982|NCT01526213|7437367|FG005|NOT COMPLETED|Period 3 (5 Days)||0
6516983|NCT01526343|7437378|FG000|STARTED|Overall Study||47
6516984|NCT01526343|7437378|FG000|COMPLETED|Overall Study||47
6516985|NCT01526343|7437378|FG000|NOT COMPLETED|Overall Study||0
6516986|NCT01526356|7437385|FG000|STARTED|Overall Study||59
6516987|NCT01526356|7437386|FG001|STARTED|Overall Study||63
6516988|NCT01526356|7437387|FG002|STARTED|Overall Study||57
6516989|NCT01526356|7437385|FG000|COMPLETED|Overall Study||51
6516990|NCT01526356|7437386|FG001|COMPLETED|Overall Study||53
6516991|NCT01526356|7437387|FG002|COMPLETED|Overall Study||45
6516992|NCT01526356|7437385|FG000|NOT COMPLETED|Overall Study||8
6516993|NCT01526356|7437386|FG001|NOT COMPLETED|Overall Study||10
6516994|NCT01526356|7437387|FG002|NOT COMPLETED|Overall Study||12
6516995|NCT01526538|7437399|FG000|STARTED|Overall Study||30
6516996|NCT01526538|7437400|FG001|STARTED|Overall Study||22
6516997|NCT01526538|7437399|FG000|COMPLETED|Overall Study||21
6516998|NCT01526538|7437400|FG001|COMPLETED|Overall Study||18
6516999|NCT01526538|7437399|FG000|NOT COMPLETED|Overall Study||9
6517000|NCT01526538|7437400|FG001|NOT COMPLETED|Overall Study||4
6517001|NCT01526551|7437408|FG000|STARTED|Overall Study||935
6517002|NCT01526551|7437408|FG000|COMPLETED|Overall Study||511
6517003|NCT01526551|7437408|FG000|NOT COMPLETED|Overall Study||424
6517004|NCT01526577|7437417|FG000|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|49
6517005|NCT01526577|7437418|FG001|STARTED|Overall Study||12
6517006|NCT01526577|7437419|FG002|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|33
6641155|NCT02340975|7569636|FG002|COMPLETED|Overall Study||0
6641156|NCT02340975|7569637|FG003|COMPLETED|Overall Study||0
6641157|NCT02340975|7569638|FG004|COMPLETED|Overall Study||0
6641158|NCT02340975|7569639|FG005|COMPLETED|Overall Study||0
6641159|NCT02340975|7569634|FG000|NOT COMPLETED|Overall Study||6
6641160|NCT02340975|7569635|FG001|NOT COMPLETED|Overall Study||27
6641161|NCT02340975|7569636|FG002|NOT COMPLETED|Overall Study||24
6641162|NCT02340975|7569637|FG003|NOT COMPLETED|Overall Study||12
6641163|NCT02340975|7569638|FG004|NOT COMPLETED|Overall Study||25
6641164|NCT02340975|7569639|FG005|NOT COMPLETED|Overall Study||19
6641165|NCT02341144|7569656|FG000|STARTED|Overall Study||30
6641166|NCT02341144|7569657|FG001|STARTED|Overall Study||31
6641167|NCT02341144|7569656|FG000|COMPLETED|Overall Study||28
6641168|NCT02341144|7569657|FG001|COMPLETED|Overall Study||30
6641169|NCT02341144|7569656|FG000|NOT COMPLETED|Overall Study||2
6641170|NCT02341144|7569657|FG001|NOT COMPLETED|Overall Study||1
6641171|NCT02341417|7569666|FG000|STARTED|Overall Study||13
6641172|NCT02341417|7569667|FG001|STARTED|Overall Study||14
6641173|NCT02341417|7569668|FG002|STARTED|Overall Study||1
6641174|NCT02341417|7569666|FG000|COMPLETED|Overall Study||11
6641175|NCT02341417|7569667|FG001|COMPLETED|Overall Study||12
6641176|NCT02341417|7569668|FG002|COMPLETED|Overall Study||0
6641177|NCT02341417|7569666|FG000|NOT COMPLETED|Overall Study||2
6641178|NCT02341417|7569667|FG001|NOT COMPLETED|Overall Study||2
6641179|NCT02341417|7569668|FG002|NOT COMPLETED|Overall Study||1
6641180|NCT02341456|7569680|FG000|STARTED|Overall Study||7
6641181|NCT02341456|7569681|FG001|STARTED|Overall Study||6
6517007|NCT01526577|7437420|FG003|STARTED|Overall Study|1 more subject enrolled as a substitute for 1 withdrawn subject before the administration.|9
6561470|NCT01794000|7484292|FG001|COMPLETED|Open-Label Extension Phase (OLE)||0
6641182|NCT02341456|7569682|FG002|STARTED|Overall Study||6
6517008|NCT01526577|7437421|FG004|STARTED|Overall Study|2 more subjects were enrolled as the substitutes for 2 withdrawn subjects before the administration.|10
6517009|NCT01526577|7437417|FG000|COMPLETED|Overall Study||48
6517010|NCT01526577|7437418|FG001|COMPLETED|Overall Study||12
6517011|NCT01526577|7437419|FG002|COMPLETED|Overall Study||32
6517012|NCT01526577|7437420|FG003|COMPLETED|Overall Study||8
6517013|NCT01526577|7437421|FG004|COMPLETED|Overall Study||8
6517014|NCT01526577|7437417|FG000|NOT COMPLETED|Overall Study||1
6517015|NCT01526577|7437418|FG001|NOT COMPLETED|Overall Study||0
6517016|NCT01526577|7437419|FG002|NOT COMPLETED|Overall Study||1
6517017|NCT01526577|7437420|FG003|NOT COMPLETED|Overall Study||1
6517018|NCT01526577|7437421|FG004|NOT COMPLETED|Overall Study||2
6517019|NCT01526629|7437429|FG000|STARTED|Overall Study||354
6517020|NCT01526629|7437429|FG000|COMPLETED|Overall Study||308
6517021|NCT01526629|7437429|FG000|NOT COMPLETED|Overall Study||46
6517022|NCT01526733|7437433|FG000|STARTED|Phase 1||12
6517023|NCT01526733|7437434|FG001|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
6517024|NCT01526733|7437433|FG000|Received at Least 1 Dose of Study Drug|Phase 1||12
6517025|NCT01526733|7437434|FG001|Received at Least 1 Dose of Study Drug|Phase 1||13
6517026|NCT01526733|7437433|FG000|COMPLETED|Phase 1||10
6517027|NCT01526733|7437434|FG001|COMPLETED|Phase 1||12
6517028|NCT01526733|7437433|FG000|NOT COMPLETED|Phase 1||2
6517029|NCT01526733|7437434|FG001|NOT COMPLETED|Phase 1||1
6517030|NCT01526733|7437433|FG000|STARTED|Washout Period of 5 to 21 Days||10
6517031|NCT01526733|7437434|FG001|STARTED|Washout Period of 5 to 21 Days||12
6517032|NCT01526733|7437433|FG000|COMPLETED|Washout Period of 5 to 21 Days||10
6517033|NCT01526733|7437434|FG001|COMPLETED|Washout Period of 5 to 21 Days||12
6517034|NCT01526733|7437433|FG000|NOT COMPLETED|Washout Period of 5 to 21 Days||0
6517035|NCT01526733|7437434|FG001|NOT COMPLETED|Washout Period of 5 to 21 Days||0
6517036|NCT01526733|7437433|FG000|STARTED|Phase 2||10
6517037|NCT01526733|7437434|FG001|STARTED|Phase 2||12
6517038|NCT01526733|7437433|FG000|COMPLETED|Phase 2||10
6517039|NCT01526733|7437434|FG001|COMPLETED|Phase 2||12
6517040|NCT01526733|7437433|FG000|NOT COMPLETED|Phase 2||0
6517041|NCT01526733|7437434|FG001|NOT COMPLETED|Phase 2||0
6517042|NCT01526785|7437441|FG000|STARTED|Overall Study||113
6517043|NCT01526785|7437441|FG000|COMPLETED|Overall Study||100
6517044|NCT01526785|7437441|FG000|NOT COMPLETED|Overall Study||13
6517045|NCT01526889|7437447|FG000|STARTED|Treatment Period||18
6517046|NCT01526889|7437448|FG001|STARTED|Treatment Period||7
6517047|NCT01526889|7437447|FG000|COMPLETED|Treatment Period||16
6517048|NCT01526889|7437448|FG001|COMPLETED|Treatment Period||7
6517049|NCT01526889|7437447|FG000|NOT COMPLETED|Treatment Period||2
6517050|NCT01526889|7437448|FG001|NOT COMPLETED|Treatment Period||0
6641183|NCT02341456|7569680|FG000|COMPLETED|Overall Study||3
6641184|NCT02341456|7569681|FG001|COMPLETED|Overall Study||0
6641185|NCT02341456|7569682|FG002|COMPLETED|Overall Study||2
6641186|NCT02341456|7569680|FG000|NOT COMPLETED|Overall Study||4
6641187|NCT02341456|7569681|FG001|NOT COMPLETED|Overall Study||6
6641188|NCT02341456|7569682|FG002|NOT COMPLETED|Overall Study||4
6641189|NCT02341482|7569690|FG000|STARTED|Overall Study||13
6641190|NCT02341482|7569690|FG000|COMPLETED|Overall Study||12
6641191|NCT02341482|7569690|FG000|NOT COMPLETED|Overall Study||1
6517051|NCT01526889|7437447|FG000|STARTED|Treatment Extension Period||5
6517052|NCT01526889|7437448|FG001|STARTED|Treatment Extension Period||0
6517053|NCT01526889|7437447|FG000|COMPLETED|Treatment Extension Period||4
6517054|NCT01526889|7437448|FG001|COMPLETED|Treatment Extension Period||0
6517055|NCT01526889|7437447|FG000|NOT COMPLETED|Treatment Extension Period||1
6517056|NCT01526889|7437448|FG001|NOT COMPLETED|Treatment Extension Period||0
6517057|NCT01526902|7437454|FG000|STARTED|Overall Study||25
6517058|NCT01526902|7437455|FG001|STARTED|Overall Study||24
6517059|NCT01526902|7437454|FG000|COMPLETED|Overall Study||25
6517060|NCT01526902|7437455|FG001|COMPLETED|Overall Study||24
6517061|NCT01526902|7437454|FG000|NOT COMPLETED|Overall Study||0
6517062|NCT01526902|7437455|FG001|NOT COMPLETED|Overall Study||0
6517063|NCT01526928|7437467|FG000|STARTED|Overall Study||38
6517064|NCT01526928|7437468|FG001|STARTED|Overall Study||19
6517065|NCT01526928|7437469|FG002|STARTED|Overall Study||209
6517066|NCT01526928|7437470|FG003|STARTED|Overall Study||245
6517067|NCT01526928|7437471|FG004|STARTED|Overall Study||95
6517068|NCT01526928|7437472|FG005|STARTED|Overall Study||6
6517069|NCT01526928|7437467|FG000|Started Phase 1|Overall Study||38
6517070|NCT01526928|7437468|FG001|Started Phase 1|Overall Study||19
6517071|NCT01526928|7437469|FG002|Started Phase 1|Overall Study||18
6517072|NCT01526928|7437470|FG003|Started Phase 1|Overall Study||17
6517073|NCT01526928|7437471|FG004|Started Phase 1|Overall Study||13
6517074|NCT01526928|7437472|FG005|Started Phase 1|Overall Study||6
6517075|NCT01526928|7437467|FG000|Started Phase 2|Overall Study||0
6517076|NCT01526928|7437468|FG001|Started Phase 2|Overall Study||0
6517077|NCT01526928|7437469|FG002|Started Phase 2|Overall Study||191
6641192|NCT02341599|7569704|FG000|STARTED|Overall Study||8
6641193|NCT02341599|7569705|FG001|STARTED|Overall Study||8
6641194|NCT02341599|7569706|FG002|STARTED|Overall Study||8
6517078|NCT01526928|7437470|FG003|Started Phase 2|Overall Study||228
6517079|NCT01526928|7437471|FG004|Started Phase 2|Overall Study||82
6517080|NCT01526928|7437472|FG005|Started Phase 2|Overall Study||0
6517081|NCT01526928|7437467|FG000|COMPLETED|Overall Study||0
6517082|NCT01526928|7437468|FG001|COMPLETED|Overall Study||0
6517083|NCT01526928|7437469|FG002|COMPLETED|Overall Study||0
6517084|NCT01526928|7437470|FG003|COMPLETED|Overall Study||0
6517085|NCT01526928|7437471|FG004|COMPLETED|Overall Study||0
6517086|NCT01526928|7437472|FG005|COMPLETED|Overall Study||0
6517087|NCT01526928|7437467|FG000|NOT COMPLETED|Overall Study||38
6517088|NCT01526928|7437468|FG001|NOT COMPLETED|Overall Study||19
6517089|NCT01526928|7437469|FG002|NOT COMPLETED|Overall Study||209
6517090|NCT01526928|7437470|FG003|NOT COMPLETED|Overall Study||245
6517091|NCT01526928|7437471|FG004|NOT COMPLETED|Overall Study||95
6517092|NCT01526928|7437472|FG005|NOT COMPLETED|Overall Study||6
6517093|NCT01527006|7437530|FG000|STARTED|Core Study||22
6517094|NCT01527006|7437531|FG001|STARTED|Core Study||28
6517095|NCT01527006|7437530|FG000|COMPLETED|Core Study||20
6517096|NCT01527006|7437531|FG001|COMPLETED|Core Study||22
6517097|NCT01527006|7437530|FG000|NOT COMPLETED|Core Study||2
6517098|NCT01527006|7437531|FG001|NOT COMPLETED|Core Study||6
6517099|NCT01527006|7437530|FG000|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
6517100|NCT01527006|7437531|FG001|STARTED|Extension Phase||22
6517101|NCT01527006|7437530|FG000|COMPLETED|Extension Phase||13
6517102|NCT01527006|7437531|FG001|COMPLETED|Extension Phase||14
6517103|NCT01527006|7437530|FG000|NOT COMPLETED|Extension Phase||6
6517104|NCT01527006|7437531|FG001|NOT COMPLETED|Extension Phase||8
6517105|NCT01527045|7437546|FG000|STARTED|Overall Study||30
6517106|NCT01527045|7437547|FG001|STARTED|Overall Study||5
6517107|NCT01527045|7437548|FG002|STARTED|Overall Study||12
6517108|NCT01527045|7437546|FG000|COMPLETED|Overall Study||29
6517109|NCT01527045|7437547|FG001|COMPLETED|Overall Study||5
6517110|NCT01527045|7437548|FG002|COMPLETED|Overall Study||12
6517111|NCT01527045|7437546|FG000|NOT COMPLETED|Overall Study||1
6517112|NCT01527045|7437547|FG001|NOT COMPLETED|Overall Study||0
6517113|NCT01527045|7437548|FG002|NOT COMPLETED|Overall Study||0
6517114|NCT01527110|7437556|FG000|STARTED|Overall Study||21
6517115|NCT01527110|7437556|FG000|COMPLETED|Overall Study||20
6517116|NCT01527110|7437556|FG000|NOT COMPLETED|Overall Study||1
6517117|NCT01527162|7437560|FG000|STARTED|Overall Study||6
6517118|NCT01527162|7437561|FG001|STARTED|Overall Study||5
6517119|NCT01527162|7437560|FG000|COMPLETED|Overall Study||6
6517120|NCT01527162|7437561|FG001|COMPLETED|Overall Study||5
6517121|NCT01527162|7437560|FG000|NOT COMPLETED|Overall Study||0
6517122|NCT01527162|7437561|FG001|NOT COMPLETED|Overall Study||0
6517123|NCT01527357|7437571|FG000|STARTED|Overall Study||482
6517124|NCT01527357|7437572|FG001|STARTED|Overall Study||239
6517125|NCT01527357|7437571|FG000|Efficacy Population|Overall Study|Two participants did not receive study treatment.|480
6517126|NCT01527357|7437572|FG001|Efficacy Population|Overall Study||239
6517127|NCT01527357|7437571|FG000|COMPLETED|Overall Study||465
6517128|NCT01527357|7437572|FG001|COMPLETED|Overall Study||230
6517129|NCT01527357|7437571|FG000|NOT COMPLETED|Overall Study||17
6517130|NCT01527357|7437572|FG001|NOT COMPLETED|Overall Study||9
6517131|NCT01527370|7437578|FG000|STARTED|Overall Study||250
6517132|NCT01527370|7437578|FG000|COMPLETED|Overall Study||244
6517133|NCT01527370|7437578|FG000|NOT COMPLETED|Overall Study||6
6517134|NCT01527383|7437584|FG000|STARTED|Overall Study||292
6517135|NCT01527383|7437585|FG001|STARTED|Overall Study||62
6517136|NCT01527383|7437584|FG000|Vaccination 1 (Day 1)|Overall Study||291
6517137|NCT01527383|7437585|FG001|Vaccination 1 (Day 1)|Overall Study||62
6517138|NCT01527383|7437584|FG000|Vaccination 2 (~Day 30)|Overall Study||283
6517139|NCT01527383|7437585|FG001|Vaccination 2 (~Day 30)|Overall Study||61
6517140|NCT01527383|7437584|FG000|Vaccination 3 (~Day 60)|Overall Study||278
6517141|NCT01527383|7437585|FG001|Vaccination 3 (~Day 60)|Overall Study||58
6517142|NCT01527383|7437584|FG000|Vaccination 4 (~Day 90)|Overall Study||277
6517143|NCT01527383|7437585|FG001|Vaccination 4 (~Day 90)|Overall Study||58
6517144|NCT01527383|7437584|FG000|COMPLETED|Overall Study||277
6517145|NCT01527383|7437585|FG001|COMPLETED|Overall Study||58
6517146|NCT01527383|7437584|FG000|NOT COMPLETED|Overall Study||15
6517147|NCT01527383|7437585|FG001|NOT COMPLETED|Overall Study||4
6517148|NCT01527487|7437593|FG000|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
6517149|NCT01527487|7437594|FG001|STARTED|Overall Study||22
6517150|NCT01527487|7437593|FG000|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
6517151|NCT01527487|7437594|FG001|COMPLETED|Overall Study||15
6517152|NCT01527487|7437593|FG000|NOT COMPLETED|Overall Study||8
6517153|NCT01527487|7437594|FG001|NOT COMPLETED|Overall Study||7
6517154|NCT01527500|7437609|FG000|STARTED|Part A||99
6517155|NCT01527500|7437610|FG001|STARTED|Part A||51
6517156|NCT01527500|7437609|FG000|COMPLETED|Part A||69
6517157|NCT01527500|7437610|FG001|COMPLETED|Part A||38
6517158|NCT01527500|7437609|FG000|NOT COMPLETED|Part A||30
6517159|NCT01527500|7437610|FG001|NOT COMPLETED|Part A||13
6517160|NCT01527500|7437609|FG000|STARTED|Part B||7
6517161|NCT01527500|7437610|FG001|STARTED|Part B||1
6517162|NCT01527500|7437609|FG000|COMPLETED|Part B||6
6517163|NCT01527500|7437610|FG001|COMPLETED|Part B||1
6517164|NCT01527500|7437609|FG000|NOT COMPLETED|Part B||1
6517165|NCT01527500|7437610|FG001|NOT COMPLETED|Part B||0
6517166|NCT01527513|7437628|FG000|STARTED|Double Blind Period (DB) - Part I||40
6517167|NCT01527513|7437629|FG001|STARTED|Double Blind Period (DB) - Part I||83
6517168|NCT01527513|7437628|FG000|Randomized|Double Blind Period (DB) - Part I||40
6517169|NCT01527513|7437629|FG001|Randomized|Double Blind Period (DB) - Part I||83
6517170|NCT01527513|7437628|FG000|Safety Population|Double Blind Period (DB) - Part I||40
6517171|NCT01527513|7437629|FG001|Safety Population|Double Blind Period (DB) - Part I||83
6517172|NCT01527513|7437628|FG000|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
6517173|NCT01527513|7437629|FG001|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
6517174|NCT01527513|7437628|FG000|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
6517175|NCT01527513|7437629|FG001|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
6517176|NCT01527513|7437628|FG000|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
6517177|NCT01527513|7437629|FG001|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
6517178|NCT01527513|7437628|FG000|Efficacy PP Population|Double Blind Period (DB) - Part I||37
6517179|NCT01527513|7437629|FG001|Efficacy PP Population|Double Blind Period (DB) - Part I||67
6517180|NCT01527513|7437628|FG000|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
6517181|NCT01527513|7437629|FG001|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
6517182|NCT01527513|7437628|FG000|COMPLETED|Double Blind Period (DB) - Part I||37
6517183|NCT01527513|7437629|FG001|COMPLETED|Double Blind Period (DB) - Part I||75
6517184|NCT01527513|7437628|FG000|NOT COMPLETED|Double Blind Period (DB) - Part I||3
6517185|NCT01527513|7437629|FG001|NOT COMPLETED|Double Blind Period (DB) - Part I||8
6641195|NCT02341599|7569707|FG003|STARTED|Overall Study||8
6641196|NCT02341599|7569708|FG004|STARTED|Overall Study||8
6641197|NCT02341599|7569704|FG000|COMPLETED|Overall Study||8
6641198|NCT02341599|7569705|FG001|COMPLETED|Overall Study||8
6641199|NCT02341599|7569706|FG002|COMPLETED|Overall Study||8
6641200|NCT02341599|7569707|FG003|COMPLETED|Overall Study||8
6641201|NCT02341599|7569708|FG004|COMPLETED|Overall Study||8
6641202|NCT02341599|7569704|FG000|NOT COMPLETED|Overall Study||0
6641203|NCT02341599|7569705|FG001|NOT COMPLETED|Overall Study||0
6641204|NCT02341599|7569706|FG002|NOT COMPLETED|Overall Study||0
6641205|NCT02341599|7569707|FG003|NOT COMPLETED|Overall Study||0
6641206|NCT02341599|7569708|FG004|NOT COMPLETED|Overall Study||0
6641207|NCT02341859|7569723|FG000|STARTED|First Intervention (1 Day)||10
6641208|NCT02341859|7569724|FG001|STARTED|First Intervention (1 Day)||9
6641209|NCT02341859|7569723|FG000|COMPLETED|First Intervention (1 Day)||10
6641210|NCT02341859|7569724|FG001|COMPLETED|First Intervention (1 Day)||9
6641211|NCT02341859|7569723|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6641212|NCT02341859|7569724|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6641213|NCT02341859|7569723|FG000|STARTED|Second Intervention (1 Day)||10
6641214|NCT02341859|7569724|FG001|STARTED|Second Intervention (1 Day)||9
6641215|NCT02341859|7569723|FG000|COMPLETED|Second Intervention (1 Day)||10
6641216|NCT02341859|7569724|FG001|COMPLETED|Second Intervention (1 Day)||9
6641217|NCT02341859|7569723|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6641218|NCT02341859|7569724|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6641219|NCT02342015|7569737|FG000|STARTED|Overall Study||20
6641220|NCT02342015|7569737|FG000|COMPLETED|Overall Study||20
6641221|NCT02342015|7569737|FG000|NOT COMPLETED|Overall Study||0
6641222|NCT02342171|7569743|FG000|STARTED|Overall Study||99
6641223|NCT02342171|7569744|FG001|STARTED|Overall Study||507
6641224|NCT02342171|7569743|FG000|COMPLETED|Overall Study||84
6641225|NCT02342171|7569744|FG001|COMPLETED|Overall Study||418
6641226|NCT02342171|7569743|FG000|NOT COMPLETED|Overall Study||15
6641227|NCT02342171|7569744|FG001|NOT COMPLETED|Overall Study||89
6641228|NCT02342197|7569751|FG000|STARTED|Overall Study||30
6641229|NCT02342197|7569752|FG001|STARTED|Overall Study||30
6641230|NCT02342197|7569751|FG000|COMPLETED|Overall Study||27
6641231|NCT02342197|7569752|FG001|COMPLETED|Overall Study||28
6641232|NCT02342197|7569751|FG000|NOT COMPLETED|Overall Study||3
6641233|NCT02342197|7569752|FG001|NOT COMPLETED|Overall Study||2
6641234|NCT02342223|7569758|FG000|STARTED|Overall Study||20
6641235|NCT02342223|7569758|FG000|COMPLETED|Overall Study||19
6641236|NCT02342223|7569758|FG000|NOT COMPLETED|Overall Study||1
6641237|NCT02342288|7569764|FG000|STARTED|Overall Study|16 patients were not randomized to either arm.|30
6641238|NCT02342288|7569765|FG001|STARTED|Overall Study|various issues listed below caused removal of subjects|33
6641239|NCT02342288|7569764|FG000|COMPLETED|Overall Study||25
6641240|NCT02342288|7569765|FG001|COMPLETED|Overall Study||27
6641241|NCT02342288|7569764|FG000|NOT COMPLETED|Overall Study||5
6641242|NCT02342288|7569765|FG001|NOT COMPLETED|Overall Study||6
6743616|NCT03335254|7671813|FG003|NOT COMPLETED|Period 1||0
6743617|NCT03335254|7671814|FG004|NOT COMPLETED|Period 1||0
6641243|NCT02342314|7569773|FG000|STARTED|Part A||6
6641244|NCT02342314|7569774|FG001|STARTED|Part A||3
6641245|NCT02342314|7569775|FG002|STARTED|Part A||3
6641246|NCT02342314|7569776|FG003|STARTED|Part A||3
6641247|NCT02342314|7569777|FG004|STARTED|Part A||6
6641248|NCT02342314|7569778|FG005|STARTED|Part A||3
6641249|NCT02342314|7569779|FG006|STARTED|Part A||0
6641250|NCT02342314|7569780|FG007|STARTED|Part A||0
6641251|NCT02342314|7569781|FG008|STARTED|Part A||0
6641252|NCT02342314|7569782|FG009|STARTED|Part A||0
6641253|NCT02342314|7569783|FG010|STARTED|Part A||0
6641254|NCT02342314|7569784|FG011|STARTED|Part A||0
6641255|NCT02342314|7569785|FG012|STARTED|Part A||0
6641256|NCT02342314|7569786|FG013|STARTED|Part A||0
6641257|NCT02342314|7569787|FG014|STARTED|Part A||0
6641258|NCT02342314|7569788|FG015|STARTED|Part A||0
6641259|NCT02342314|7569789|FG016|STARTED|Part A||0
6641260|NCT02342314|7569773|FG000|COMPLETED|Part A||6
6641261|NCT02342314|7569774|FG001|COMPLETED|Part A||3
6641262|NCT02342314|7569775|FG002|COMPLETED|Part A||3
6641263|NCT02342314|7569776|FG003|COMPLETED|Part A||3
6743618|NCT03335254|7671815|FG005|NOT COMPLETED|Period 1||0
6743619|NCT03335254|7671816|FG006|NOT COMPLETED|Period 1||0
6641264|NCT02342314|7569777|FG004|COMPLETED|Part A||6
6641265|NCT02342314|7569778|FG005|COMPLETED|Part A||3
6641266|NCT02342314|7569779|FG006|COMPLETED|Part A||0
6517186|NCT01527513|7437628|FG000|STARTED|Eligible for 1-Year Open Label Period||0
6517187|NCT01527513|7437629|FG001|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
6517188|NCT01527513|7437628|FG000|COMPLETED|Eligible for 1-Year Open Label Period||0
6517189|NCT01527513|7437629|FG001|COMPLETED|Eligible for 1-Year Open Label Period||95
6517190|NCT01527513|7437628|FG000|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
6517191|NCT01527513|7437629|FG001|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
6517192|NCT01527682|7437637|FG000|STARTED|Overall Study||37
6517193|NCT01527682|7437637|FG000|COMPLETED|Overall Study||29
6517194|NCT01527682|7437637|FG000|NOT COMPLETED|Overall Study||8
6517195|NCT01528033|7437643|FG000|STARTED|Primary Endpoint Assessment ITT||273
6517196|NCT01528033|7437644|FG001|STARTED|Primary Endpoint Assessment ITT||266
6517197|NCT01528033|7437643|FG000|COMPLETED|Primary Endpoint Assessment ITT||256
6517198|NCT01528033|7437644|FG001|COMPLETED|Primary Endpoint Assessment ITT||251
6517199|NCT01528033|7437643|FG000|NOT COMPLETED|Primary Endpoint Assessment ITT||17
6517200|NCT01528033|7437644|FG001|NOT COMPLETED|Primary Endpoint Assessment ITT||15
6517201|NCT01528033|7437643|FG000|STARTED|Follow Up||256
6517202|NCT01528033|7437644|FG001|STARTED|Follow Up||251
6517203|NCT01528033|7437643|FG000|COMPLETED|Follow Up||210
6517204|NCT01528033|7437644|FG001|COMPLETED|Follow Up||207
6517205|NCT01528033|7437643|FG000|NOT COMPLETED|Follow Up||46
6517206|NCT01528033|7437644|FG001|NOT COMPLETED|Follow Up||44
6517207|NCT01528072|7437650|FG000|STARTED|Overall Study||140
6517208|NCT01528072|7437650|FG000|COMPLETED|Overall Study||66
6517209|NCT01528072|7437650|FG000|NOT COMPLETED|Overall Study||74
6517210|NCT01528124|7437661|FG000|STARTED|Overall Study||6
6517211|NCT01528124|7437662|FG001|STARTED|Overall Study||6
6517212|NCT01528124|7437663|FG002|STARTED|Overall Study||6
6517213|NCT01528124|7437664|FG003|STARTED|Overall Study||6
6517214|NCT01528124|7437665|FG004|STARTED|Overall Study||5
6517215|NCT01528124|7437666|FG005|STARTED|Overall Study||6
6517216|NCT01528124|7437667|FG006|STARTED|Overall Study||6
6517217|NCT01528124|7437661|FG000|Received Study Drug|Overall Study||6
6517218|NCT01528124|7437662|FG001|Received Study Drug|Overall Study||6
6517219|NCT01528124|7437663|FG002|Received Study Drug|Overall Study||6
6517220|NCT01528124|7437664|FG003|Received Study Drug|Overall Study||6
6517221|NCT01528124|7437665|FG004|Received Study Drug|Overall Study||5
6517222|NCT01528124|7437666|FG005|Received Study Drug|Overall Study||6
6517223|NCT01528124|7437667|FG006|Received Study Drug|Overall Study||6
6517224|NCT01528124|7437661|FG000|COMPLETED|Overall Study||6
6517225|NCT01528124|7437662|FG001|COMPLETED|Overall Study||6
6517226|NCT01528124|7437663|FG002|COMPLETED|Overall Study||6
6517227|NCT01528124|7437664|FG003|COMPLETED|Overall Study||6
6641267|NCT02342314|7569780|FG007|COMPLETED|Part A||0
6641268|NCT02342314|7569781|FG008|COMPLETED|Part A||0
6641269|NCT02342314|7569782|FG009|COMPLETED|Part A||0
6641270|NCT02342314|7569783|FG010|COMPLETED|Part A||0
6517228|NCT01528124|7437665|FG004|COMPLETED|Overall Study||5
6517229|NCT01528124|7437666|FG005|COMPLETED|Overall Study||6
6517230|NCT01528124|7437667|FG006|COMPLETED|Overall Study||6
6517231|NCT01528124|7437661|FG000|NOT COMPLETED|Overall Study||0
6517232|NCT01528124|7437662|FG001|NOT COMPLETED|Overall Study||0
6517233|NCT01528124|7437663|FG002|NOT COMPLETED|Overall Study||0
6517234|NCT01528124|7437664|FG003|NOT COMPLETED|Overall Study||0
6517235|NCT01528124|7437665|FG004|NOT COMPLETED|Overall Study||0
6517236|NCT01528124|7437666|FG005|NOT COMPLETED|Overall Study||0
6517237|NCT01528124|7437667|FG006|NOT COMPLETED|Overall Study||0
6517238|NCT01528150|7437689|FG000|STARTED|Overall Study||466
6517239|NCT01528150|7437689|FG000|COMPLETED|Overall Study||422
6517240|NCT01528150|7437689|FG000|NOT COMPLETED|Overall Study||44
6561471|NCT01794000|7484291|FG000|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
6561472|NCT01794000|7484292|FG001|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
6561473|NCT01794039|7484301|FG000|STARTED|Overall Study||5
6561474|NCT01794039|7484302|FG001|STARTED|Overall Study||4
6561475|NCT01794039|7484301|FG000|COMPLETED|Overall Study||5
6561476|NCT01794039|7484302|FG001|COMPLETED|Overall Study||4
6561477|NCT01794039|7484301|FG000|NOT COMPLETED|Overall Study||0
6561478|NCT01794039|7484302|FG001|NOT COMPLETED|Overall Study||0
6561479|NCT01794117|7484314|FG000|STARTED|Overall Study||1
6561480|NCT01794117|7484315|FG001|STARTED|Overall Study||3
6561481|NCT01794117|7484316|FG002|STARTED|Overall Study||2
6561482|NCT01794117|7484317|FG003|STARTED|Overall Study||12
6561483|NCT01794117|7484314|FG000|COMPLETED|Overall Study||0
6561484|NCT01794117|7484315|FG001|COMPLETED|Overall Study||0
6561485|NCT01794117|7484316|FG002|COMPLETED|Overall Study||2
6561486|NCT01794117|7484317|FG003|COMPLETED|Overall Study||12
6561487|NCT01794117|7484314|FG000|NOT COMPLETED|Overall Study||1
6561488|NCT01794117|7484315|FG001|NOT COMPLETED|Overall Study||3
6561489|NCT01794117|7484316|FG002|NOT COMPLETED|Overall Study||0
6561490|NCT01794117|7484317|FG003|NOT COMPLETED|Overall Study||0
6561491|NCT01794299|7484328|FG000|STARTED|Overall Study||31
6561492|NCT01794299|7484328|FG000|COMPLETED|Overall Study||9
6561493|NCT01794299|7484328|FG000|NOT COMPLETED|Overall Study||22
6561494|NCT01794312|7484334|FG000|STARTED|Overall Study||74
6561495|NCT01794312|7484335|FG001|STARTED|Overall Study||78
6561496|NCT01794312|7484334|FG000|COMPLETED|Overall Study||68
6561497|NCT01794312|7484335|FG001|COMPLETED|Overall Study||67
6561498|NCT01794312|7484334|FG000|NOT COMPLETED|Overall Study||6
6561499|NCT01794312|7484335|FG001|NOT COMPLETED|Overall Study||11
6641271|NCT02342314|7569784|FG011|COMPLETED|Part A||0
6517241|NCT01528215|7437695|FG000|STARTED|Enrollment to 1 Year Follow-up||59
6517242|NCT01528215|7437696|FG001|STARTED|Enrollment to 1 Year Follow-up||61
6517243|NCT01528215|7437695|FG000|COMPLETED|Enrollment to 1 Year Follow-up||55
6517244|NCT01528215|7437696|FG001|COMPLETED|Enrollment to 1 Year Follow-up||60
6517245|NCT01528215|7437695|FG000|NOT COMPLETED|Enrollment to 1 Year Follow-up||4
6517246|NCT01528215|7437696|FG001|NOT COMPLETED|Enrollment to 1 Year Follow-up||1
6517247|NCT01528215|7437695|FG000|STARTED|1 Year Follow-up to 5 Year Follow-up||55
6517248|NCT01528215|7437696|FG001|STARTED|1 Year Follow-up to 5 Year Follow-up||60
6517249|NCT01528215|7437695|FG000|COMPLETED|1 Year Follow-up to 5 Year Follow-up||40
6517250|NCT01528215|7437696|FG001|COMPLETED|1 Year Follow-up to 5 Year Follow-up||45
6517251|NCT01528215|7437695|FG000|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
6517252|NCT01528215|7437696|FG001|NOT COMPLETED|1 Year Follow-up to 5 Year Follow-up||15
6517253|NCT01528228|7437704|FG000|STARTED|Overall Study||10
6517254|NCT01528228|7437705|FG001|STARTED|Overall Study||10
6517255|NCT01528228|7437704|FG000|COMPLETED|Overall Study||9
6517256|NCT01528228|7437705|FG001|COMPLETED|Overall Study||9
6517257|NCT01528228|7437704|FG000|NOT COMPLETED|Overall Study||1
6517258|NCT01528228|7437705|FG001|NOT COMPLETED|Overall Study||1
6517259|NCT01528254|7437713|FG000|STARTED|Overall Study||998
6517260|NCT01528254|7437714|FG001|STARTED|Overall Study||1003
6517261|NCT01528254|7437713|FG000|Safety Set|Overall Study||998
6517262|NCT01528254|7437714|FG001|Safety Set|Overall Study||1001
6517263|NCT01528254|7437713|FG000|Full Analysis Set (FAS)|Overall Study||983
6517264|NCT01528254|7437714|FG001|Full Analysis Set (FAS)|Overall Study||989
6517265|NCT01528254|7437713|FG000|Completed Treatment Period 1|Overall Study||458
6517266|NCT01528254|7437714|FG001|Completed Treatment Period 1|Overall Study||273
6517267|NCT01528254|7437713|FG000|Completed Treatment Period 2|Overall Study||244
6517268|NCT01528254|7437714|FG001|Completed Treatment Period 2|Overall Study||399
6517269|NCT01528254|7437713|FG000|Completed Treatment Period 3|Overall Study||109
6517270|NCT01528254|7437714|FG001|Completed Treatment Period 3|Overall Study||115
6517271|NCT01528254|7437713|FG000|COMPLETED|Overall Study||811
6517272|NCT01528254|7437714|FG001|COMPLETED|Overall Study||787
6517273|NCT01528254|7437713|FG000|NOT COMPLETED|Overall Study||187
6517274|NCT01528254|7437714|FG001|NOT COMPLETED|Overall Study||216
6517275|NCT01528319|7437721|FG000|STARTED|Overall Study||24
6517276|NCT01528319|7437721|FG000|12 Weeks After Surgery|Overall Study||24
6517277|NCT01528319|7437721|FG000|COMPLETED|Overall Study||23
6517278|NCT01528319|7437721|FG000|NOT COMPLETED|Overall Study||1
6517279|NCT01528332|7437727|FG000|STARTED|Overall Study||85
6517280|NCT01528332|7437728|FG001|STARTED|Overall Study||86
6517281|NCT01528332|7437727|FG000|COMPLETED|Overall Study||81
6517282|NCT01528332|7437728|FG001|COMPLETED|Overall Study||84
6517283|NCT01528332|7437727|FG000|NOT COMPLETED|Overall Study||4
6517284|NCT01528332|7437728|FG001|NOT COMPLETED|Overall Study||2
6517285|NCT01528345|7437736|FG000|STARTED|Overall Study||47
6517286|NCT01528345|7437737|FG001|STARTED|Overall Study||50
6517287|NCT01528345|7437736|FG000|COMPLETED|Overall Study||0
6517288|NCT01528345|7437737|FG001|COMPLETED|Overall Study||0
6517289|NCT01528345|7437736|FG000|NOT COMPLETED|Overall Study||47
6517290|NCT01528345|7437737|FG001|NOT COMPLETED|Overall Study||50
6517291|NCT01528592|7437743|FG000|STARTED|Overall Study||18
6517292|NCT01528592|7437743|FG000|COMPLETED|Overall Study||18
6517293|NCT01528592|7437743|FG000|NOT COMPLETED|Overall Study||0
6517294|NCT01528605|7437753|FG000|STARTED|Overall Study||28
6517295|NCT01528605|7437754|FG001|STARTED|Overall Study||28
6517296|NCT01528605|7437755|FG002|STARTED|Overall Study||28
6517297|NCT01528605|7437756|FG003|STARTED|Overall Study||28
6517298|NCT01528605|7437757|FG004|STARTED|Overall Study||28
6517299|NCT01528605|7437758|FG005|STARTED|Overall Study||28
6517300|NCT01528605|7437753|FG000|COMPLETED|Overall Study||26
6517301|NCT01528605|7437754|FG001|COMPLETED|Overall Study||28
6517302|NCT01528605|7437755|FG002|COMPLETED|Overall Study||27
6517303|NCT01528605|7437756|FG003|COMPLETED|Overall Study||27
6517304|NCT01528605|7437757|FG004|COMPLETED|Overall Study||28
6517305|NCT01528605|7437758|FG005|COMPLETED|Overall Study||28
6517306|NCT01528605|7437753|FG000|NOT COMPLETED|Overall Study||2
6517307|NCT01528605|7437754|FG001|NOT COMPLETED|Overall Study||0
6517308|NCT01528605|7437755|FG002|NOT COMPLETED|Overall Study||1
6517309|NCT01528605|7437756|FG003|NOT COMPLETED|Overall Study||1
6517310|NCT01528605|7437757|FG004|NOT COMPLETED|Overall Study||0
6517311|NCT01528605|7437758|FG005|NOT COMPLETED|Overall Study||0
6517312|NCT01528709|7437774|FG000|STARTED|Overall Study||86
6517313|NCT01528709|7437775|FG001|STARTED|Overall Study||87
6517314|NCT01528709|7437774|FG000|COMPLETED|Overall Study||73
6517315|NCT01528709|7437775|FG001|COMPLETED|Overall Study||72
6517316|NCT01528709|7437774|FG000|NOT COMPLETED|Overall Study||13
6517317|NCT01528709|7437775|FG001|NOT COMPLETED|Overall Study||15
6517318|NCT01528735|7437783|FG000|STARTED|Treatment Period 1: Faldap/Del/RBV||12
6517319|NCT01528735|7437784|FG001|STARTED|Treatment Period 1: Faldap/Del/RBV||13
6517320|NCT01528735|7437783|FG000|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
6517321|NCT01528735|7437784|FG001|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
6517322|NCT01528735|7437783|FG000|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
6517323|NCT01528735|7437784|FG001|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
6517324|NCT01528735|7437783|FG000|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
6517325|NCT01528735|7437784|FG001|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
6517326|NCT01528735|7437783|FG000|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
6517327|NCT01528735|7437784|FG001|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
6517328|NCT01528735|7437783|FG000|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
6517329|NCT01528735|7437784|FG001|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
6517330|NCT01528787|7437796|FG000|STARTED|Overall Study||22
6517331|NCT01528787|7437797|FG001|STARTED|Overall Study||21
6517332|NCT01528787|7437798|FG002|STARTED|Overall Study||19
6517333|NCT01528787|7437799|FG003|STARTED|Overall Study||23
6517334|NCT01528787|7437796|FG000|COMPLETED|Overall Study||22
6641272|NCT02342314|7569785|FG012|COMPLETED|Part A||0
6641273|NCT02342314|7569786|FG013|COMPLETED|Part A||0
6641274|NCT02342314|7569787|FG014|COMPLETED|Part A||0
6641275|NCT02342314|7569788|FG015|COMPLETED|Part A||0
6641276|NCT02342314|7569789|FG016|COMPLETED|Part A||0
6641277|NCT02342314|7569773|FG000|NOT COMPLETED|Part A||0
6641278|NCT02342314|7569774|FG001|NOT COMPLETED|Part A||0
6641279|NCT02342314|7569775|FG002|NOT COMPLETED|Part A||0
6641280|NCT02342314|7569776|FG003|NOT COMPLETED|Part A||0
6641281|NCT02342314|7569777|FG004|NOT COMPLETED|Part A||0
6641282|NCT02342314|7569778|FG005|NOT COMPLETED|Part A||0
6641283|NCT02342314|7569779|FG006|NOT COMPLETED|Part A||0
6641284|NCT02342314|7569780|FG007|NOT COMPLETED|Part A||0
6641285|NCT02342314|7569781|FG008|NOT COMPLETED|Part A||0
6641286|NCT02342314|7569782|FG009|NOT COMPLETED|Part A||0
6641287|NCT02342314|7569783|FG010|NOT COMPLETED|Part A||0
6517335|NCT01528787|7437797|FG001|COMPLETED|Overall Study||21
6517336|NCT01528787|7437798|FG002|COMPLETED|Overall Study||18
6517337|NCT01528787|7437799|FG003|COMPLETED|Overall Study||22
6517338|NCT01528787|7437796|FG000|NOT COMPLETED|Overall Study||0
6517339|NCT01528787|7437797|FG001|NOT COMPLETED|Overall Study||0
6517340|NCT01528787|7437798|FG002|NOT COMPLETED|Overall Study||1
6517341|NCT01528787|7437799|FG003|NOT COMPLETED|Overall Study||1
6517342|NCT01528878|7437809|FG000|STARTED|Overall Study||30
6517343|NCT01528878|7437809|FG000|COMPLETED|Overall Study||30
6517344|NCT01528878|7437809|FG000|NOT COMPLETED|Overall Study||0
6517345|NCT01528891|7437817|FG000|STARTED|Overall Study||200
6517346|NCT01528891|7437818|FG001|STARTED|Overall Study||200
6517347|NCT01528891|7437817|FG000|COMPLETED|Overall Study||200
6517348|NCT01528891|7437818|FG001|COMPLETED|Overall Study||200
6517349|NCT01528891|7437817|FG000|NOT COMPLETED|Overall Study||0
6517350|NCT01528891|7437818|FG001|NOT COMPLETED|Overall Study||0
6517351|NCT01528969|7437828|FG000|STARTED|Overall Study||37
6517352|NCT01528969|7437829|FG001|STARTED|Overall Study||38
6517353|NCT01528969|7437828|FG000|COMPLETED|Overall Study||35
6517354|NCT01528969|7437829|FG001|COMPLETED|Overall Study||38
6517355|NCT01528969|7437828|FG000|NOT COMPLETED|Overall Study||2
6517356|NCT01528969|7437829|FG001|NOT COMPLETED|Overall Study||0
6517357|NCT01529034|7437835|FG000|STARTED|Overall Study|Completed Study P261-401 and rolled over to Study P261-402|175
6517358|NCT01529034|7437835|FG000|Exposed|Overall Study|Treated at least 1 seizure cluster with USL261|161
6517359|NCT01529034|7437835|FG000|COMPLETED|Overall Study|Completed under initial protocol duration of 2 years; amended protocol open-ended duration|1
6517360|NCT01529034|7437835|FG000|NOT COMPLETED|Overall Study||174
6517361|NCT01529060|7437842|FG000|STARTED|Overall Study||10
6517362|NCT01529060|7437843|FG001|STARTED|Overall Study||10
6517363|NCT01529060|7437842|FG000|COMPLETED|Overall Study||10
6517364|NCT01529060|7437843|FG001|COMPLETED|Overall Study||10
6517365|NCT01529060|7437842|FG000|NOT COMPLETED|Overall Study||0
6517366|NCT01529060|7437843|FG001|NOT COMPLETED|Overall Study||0
6517367|NCT01529112|7437852|FG000|STARTED|Overall Study||89
6517368|NCT01529112|7437853|FG001|STARTED|Overall Study||46
6517369|NCT01529112|7437852|FG000|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
6517370|NCT01529112|7437853|FG001|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
6517371|NCT01529112|7437852|FG000|NOT COMPLETED|Overall Study||69
6517372|NCT01529112|7437853|FG001|NOT COMPLETED|Overall Study||41
6517373|NCT01529203|7437859|FG000|STARTED|Overall Study||60
6517374|NCT01529203|7437859|FG000|COMPLETED|Overall Study||57
6517375|NCT01529203|7437859|FG000|NOT COMPLETED|Overall Study||3
6517376|NCT01529268|7437865|FG000|STARTED|Overall Study||88
6517377|NCT01529268|7437866|FG001|STARTED|Overall Study||81
6517378|NCT01529268|7437865|FG000|Completed 52-week Biopsy|Overall Study||71
6517379|NCT01529268|7437866|FG001|Completed 52-week Biopsy|Overall Study||75
6517380|NCT01529268|7437865|FG000|COMPLETED|Overall Study||76
6517381|NCT01529268|7437866|FG001|COMPLETED|Overall Study||78
6517382|NCT01529268|7437865|FG000|NOT COMPLETED|Overall Study||12
6517383|NCT01529268|7437866|FG001|NOT COMPLETED|Overall Study||3
6517384|NCT01529346|7437877|FG000|STARTED|Overall Study||55
6517385|NCT01529346|7437878|FG001|STARTED|Overall Study||54
6517386|NCT01529346|7437879|FG002|STARTED|Overall Study||54
6517387|NCT01529346|7437880|FG003|STARTED|Overall Study||36
6517388|NCT01529346|7437881|FG004|STARTED|Overall Study||36
6517389|NCT01529346|7437877|FG000|COMPLETED|Overall Study||53
6517390|NCT01529346|7437878|FG001|COMPLETED|Overall Study||53
6517391|NCT01529346|7437879|FG002|COMPLETED|Overall Study||52
6517392|NCT01529346|7437880|FG003|COMPLETED|Overall Study||36
6517393|NCT01529346|7437881|FG004|COMPLETED|Overall Study||36
6517394|NCT01529346|7437877|FG000|NOT COMPLETED|Overall Study||2
6517395|NCT01529346|7437878|FG001|NOT COMPLETED|Overall Study||1
6517396|NCT01529346|7437879|FG002|NOT COMPLETED|Overall Study||2
6641288|NCT02342314|7569784|FG011|NOT COMPLETED|Part A||0
6641289|NCT02342314|7569785|FG012|NOT COMPLETED|Part A||0
6517397|NCT01529346|7437880|FG003|NOT COMPLETED|Overall Study||0
6517398|NCT01529346|7437881|FG004|NOT COMPLETED|Overall Study||0
6517399|NCT01529385|7437896|FG000|STARTED|Overall Study||40
6517400|NCT01529385|7437897|FG001|STARTED|Overall Study||40
6517401|NCT01529385|7437896|FG000|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
6517402|NCT01529385|7437897|FG001|Received Intervention|Overall Study||40
6517403|NCT01529385|7437896|FG000|COMPLETED|Overall Study||38
6517404|NCT01529385|7437897|FG001|COMPLETED|Overall Study||39
6517405|NCT01529385|7437896|FG000|NOT COMPLETED|Overall Study||2
6517406|NCT01529385|7437897|FG001|NOT COMPLETED|Overall Study||1
6517407|NCT01529450|7437905|FG000|STARTED|Overall Study||3
6517408|NCT01529450|7437906|FG001|STARTED|Overall Study||8
6517409|NCT01529450|7437905|FG000|COMPLETED|Overall Study||3
6517410|NCT01529450|7437906|FG001|COMPLETED|Overall Study||6
6517411|NCT01529450|7437905|FG000|NOT COMPLETED|Overall Study||0
6517412|NCT01529450|7437906|FG001|NOT COMPLETED|Overall Study||2
6517413|NCT01529502|7437919|FG000|STARTED|Overall Study||2
6517414|NCT01529502|7437920|FG001|STARTED|Overall Study||3
6517415|NCT01529502|7437921|FG002|STARTED|Overall Study||2
6517416|NCT01529502|7437922|FG003|STARTED|Overall Study||3
6517417|NCT01529502|7437923|FG004|STARTED|Overall Study||2
6517418|NCT01529502|7437924|FG005|STARTED|Overall Study||2
6517419|NCT01529502|7437919|FG000|COMPLETED|Overall Study||2
6517420|NCT01529502|7437920|FG001|COMPLETED|Overall Study||3
6517421|NCT01529502|7437921|FG002|COMPLETED|Overall Study||2
6517422|NCT01529502|7437922|FG003|COMPLETED|Overall Study||1
6517423|NCT01529502|7437923|FG004|COMPLETED|Overall Study||2
6517424|NCT01529502|7437924|FG005|COMPLETED|Overall Study||2
6517425|NCT01529502|7437919|FG000|NOT COMPLETED|Overall Study||0
6517426|NCT01529502|7437920|FG001|NOT COMPLETED|Overall Study||0
6517427|NCT01529502|7437921|FG002|NOT COMPLETED|Overall Study||0
6517428|NCT01529502|7437922|FG003|NOT COMPLETED|Overall Study||2
6517429|NCT01529502|7437923|FG004|NOT COMPLETED|Overall Study||0
6517430|NCT01529502|7437924|FG005|NOT COMPLETED|Overall Study||0
6517431|NCT01529515|7437934|FG000|STARTED|TRANSITION PHASE||506
6517432|NCT01529515|7437935|FG001|STARTED|TRANSITION PHASE||0
6517433|NCT01529515|7437936|FG002|STARTED|TRANSITION PHASE||0
6517434|NCT01529515|7437937|FG003|STARTED|TRANSITION PHASE||0
6517435|NCT01529515|7437934|FG000|COMPLETED|TRANSITION PHASE||379
6517436|NCT01529515|7437935|FG001|COMPLETED|TRANSITION PHASE||0
6517437|NCT01529515|7437936|FG002|COMPLETED|TRANSITION PHASE||0
6517438|NCT01529515|7437937|FG003|COMPLETED|TRANSITION PHASE||0
6517439|NCT01529515|7437934|FG000|NOT COMPLETED|TRANSITION PHASE||127
6517440|NCT01529515|7437935|FG001|NOT COMPLETED|TRANSITION PHASE||0
6517441|NCT01529515|7437936|FG002|NOT COMPLETED|TRANSITION PHASE||0
6517442|NCT01529515|7437937|FG003|NOT COMPLETED|TRANSITION PHASE||0
6517443|NCT01529515|7437934|FG000|STARTED|MAINTENANCE PHASE||0
6517444|NCT01529515|7437935|FG001|STARTED|MAINTENANCE PHASE||379
6517445|NCT01529515|7437936|FG002|STARTED|MAINTENANCE PHASE||0
6517446|NCT01529515|7437937|FG003|STARTED|MAINTENANCE PHASE||0
6517447|NCT01529515|7437934|FG000|COMPLETED|MAINTENANCE PHASE||0
6517448|NCT01529515|7437935|FG001|COMPLETED|MAINTENANCE PHASE||305
6517449|NCT01529515|7437936|FG002|COMPLETED|MAINTENANCE PHASE||0
6517450|NCT01529515|7437937|FG003|COMPLETED|MAINTENANCE PHASE||0
6517451|NCT01529515|7437934|FG000|NOT COMPLETED|MAINTENANCE PHASE||0
6517452|NCT01529515|7437935|FG001|NOT COMPLETED|MAINTENANCE PHASE||74
6517453|NCT01529515|7437936|FG002|NOT COMPLETED|MAINTENANCE PHASE||0
6517454|NCT01529515|7437937|FG003|NOT COMPLETED|MAINTENANCE PHASE||0
6517455|NCT01529515|7437934|FG000|STARTED|DOUBLE BLIND PHASE||0
6517456|NCT01529515|7437935|FG001|STARTED|DOUBLE BLIND PHASE||0
6517457|NCT01529515|7437936|FG002|STARTED|DOUBLE BLIND PHASE||145
6517458|NCT01529515|7437937|FG003|STARTED|DOUBLE BLIND PHASE||160
6517459|NCT01529515|7437934|FG000|COMPLETED|DOUBLE BLIND PHASE||0
6517460|NCT01529515|7437935|FG001|COMPLETED|DOUBLE BLIND PHASE||0
6517461|NCT01529515|7437936|FG002|COMPLETED|DOUBLE BLIND PHASE||122
6517462|NCT01529515|7437937|FG003|COMPLETED|DOUBLE BLIND PHASE||148
6517463|NCT01529515|7437934|FG000|NOT COMPLETED|DOUBLE BLIND PHASE||0
6517464|NCT01529515|7437935|FG001|NOT COMPLETED|DOUBLE BLIND PHASE||0
6517465|NCT01529515|7437936|FG002|NOT COMPLETED|DOUBLE BLIND PHASE||23
6517466|NCT01529515|7437937|FG003|NOT COMPLETED|DOUBLE BLIND PHASE||12
6517467|NCT01529606|7437946|FG000|STARTED|Overall Study||55
6517468|NCT01529606|7437947|FG001|STARTED|Overall Study||47
6517469|NCT01529606|7437946|FG000|COMPLETED|Overall Study||34
6517470|NCT01529606|7437947|FG001|COMPLETED|Overall Study||29
6517471|NCT01529606|7437946|FG000|NOT COMPLETED|Overall Study||21
6517472|NCT01529606|7437947|FG001|NOT COMPLETED|Overall Study||18
6517473|NCT01529632|7437955|FG000|STARTED|Overall Study||90
6517474|NCT01529632|7437956|FG001|STARTED|Overall Study||103
6517475|NCT01529632|7437955|FG000|COMPLETED|Overall Study||87
6517476|NCT01529632|7437956|FG001|COMPLETED|Overall Study||100
6517477|NCT01529632|7437955|FG000|NOT COMPLETED|Overall Study||3
6517478|NCT01529632|7437956|FG001|NOT COMPLETED|Overall Study||3
6517479|NCT01529645|7437972|FG000|STARTED|Overall Study||42
6517480|NCT01529645|7437973|FG001|STARTED|Overall Study||42
6517481|NCT01529645|7437974|FG002|STARTED|Overall Study||42
6517482|NCT01529645|7437975|FG003|STARTED|Overall Study||42
6517483|NCT01529645|7437976|FG004|STARTED|Overall Study||42
6517484|NCT01529645|7437977|FG005|STARTED|Overall Study||42
6517485|NCT01529645|7437978|FG006|STARTED|Overall Study||42
6517486|NCT01529645|7437979|FG007|STARTED|Overall Study||42
6517487|NCT01529645|7437980|FG008|STARTED|Overall Study||42
6517488|NCT01529645|7437981|FG009|STARTED|Overall Study||42
6517489|NCT01529645|7437972|FG000|COMPLETED|Overall Study||40
6517490|NCT01529645|7437973|FG001|COMPLETED|Overall Study||41
6517491|NCT01529645|7437974|FG002|COMPLETED|Overall Study||40
6517492|NCT01529645|7437975|FG003|COMPLETED|Overall Study||40
6517493|NCT01529645|7437976|FG004|COMPLETED|Overall Study||40
6517494|NCT01529645|7437977|FG005|COMPLETED|Overall Study||41
6517495|NCT01529645|7437978|FG006|COMPLETED|Overall Study||40
6517496|NCT01529645|7437979|FG007|COMPLETED|Overall Study||42
6517497|NCT01529645|7437980|FG008|COMPLETED|Overall Study||41
6517498|NCT01529645|7437981|FG009|COMPLETED|Overall Study||42
6517499|NCT01529645|7437972|FG000|NOT COMPLETED|Overall Study||2
6517500|NCT01529645|7437973|FG001|NOT COMPLETED|Overall Study||1
6517501|NCT01529645|7437974|FG002|NOT COMPLETED|Overall Study||2
6517502|NCT01529645|7437975|FG003|NOT COMPLETED|Overall Study||2
6517503|NCT01529645|7437976|FG004|NOT COMPLETED|Overall Study||2
6517504|NCT01529645|7437977|FG005|NOT COMPLETED|Overall Study||1
6517505|NCT01529645|7437978|FG006|NOT COMPLETED|Overall Study||2
6517506|NCT01529645|7437979|FG007|NOT COMPLETED|Overall Study||0
6517507|NCT01529645|7437980|FG008|NOT COMPLETED|Overall Study||1
6517508|NCT01529645|7437981|FG009|NOT COMPLETED|Overall Study||0
6517509|NCT01529749|7438015|FG000|STARTED|Overall Study||12
6517510|NCT01529749|7438016|FG001|STARTED|Overall Study||12
6517511|NCT01529749|7438017|FG002|STARTED|Overall Study||12
6517512|NCT01529749|7438018|FG003|STARTED|Overall Study||12
6517513|NCT01529749|7438015|FG000|COMPLETED|Overall Study||12
6517514|NCT01529749|7438016|FG001|COMPLETED|Overall Study||10
6517515|NCT01529749|7438017|FG002|COMPLETED|Overall Study||10
6517516|NCT01529749|7438018|FG003|COMPLETED|Overall Study||10
6517517|NCT01529749|7438015|FG000|NOT COMPLETED|Overall Study||0
6517518|NCT01529749|7438016|FG001|NOT COMPLETED|Overall Study||2
6517519|NCT01529749|7438017|FG002|NOT COMPLETED|Overall Study||2
6517520|NCT01529749|7438018|FG003|NOT COMPLETED|Overall Study||2
6517521|NCT01529827|7438028|FG000|STARTED|Overall Study||94
6517522|NCT01529827|7438028|FG000|COMPLETED|Overall Study||94
6517523|NCT01529827|7438028|FG000|NOT COMPLETED|Overall Study||0
6517524|NCT01530178|7438034|FG000|STARTED|Overall Study||2
6517525|NCT01530178|7438035|FG001|STARTED|Overall Study||6
6517526|NCT01530178|7438034|FG000|COMPLETED|Overall Study||2
6517527|NCT01530178|7438035|FG001|COMPLETED|Overall Study||6
6517528|NCT01530178|7438034|FG000|NOT COMPLETED|Overall Study||0
6517529|NCT01530178|7438035|FG001|NOT COMPLETED|Overall Study||0
6517530|NCT01530243|7438049|FG000|STARTED|Overall Study||26
6517531|NCT01530243|7438050|FG001|STARTED|Overall Study||26
6517532|NCT01530243|7438051|FG002|STARTED|Overall Study||26
6517533|NCT01530243|7438052|FG003|STARTED|Overall Study||26
6517534|NCT01530243|7438049|FG000|COMPLETED|Overall Study||24
6517535|NCT01530243|7438050|FG001|COMPLETED|Overall Study||23
6517536|NCT01530243|7438051|FG002|COMPLETED|Overall Study||23
6517537|NCT01530243|7438052|FG003|COMPLETED|Overall Study||24
6517538|NCT01530243|7438049|FG000|NOT COMPLETED|Overall Study||2
6517539|NCT01530243|7438050|FG001|NOT COMPLETED|Overall Study||3
6517540|NCT01530243|7438051|FG002|NOT COMPLETED|Overall Study||3
6517541|NCT01530243|7438052|FG003|NOT COMPLETED|Overall Study||2
6517542|NCT01530256|7438063|FG000|STARTED|Overall Study||3
6517543|NCT01530256|7438063|FG000|COMPLETED|Overall Study||1
6517544|NCT01530256|7438063|FG000|NOT COMPLETED|Overall Study||2
6517545|NCT01530334|7438067|FG000|STARTED|Overall Study||61
6517546|NCT01530334|7438067|FG000|COMPLETED|Overall Study||10
6517547|NCT01530334|7438067|FG000|NOT COMPLETED|Overall Study||51
6517548|NCT01530399|7438077|FG000|STARTED|Overall Study||8
6517549|NCT01530399|7438078|FG001|STARTED|Overall Study||10
6517550|NCT01530399|7438079|FG002|STARTED|Overall Study||8
6517551|NCT01530399|7438080|FG003|STARTED|Overall Study||10
6517552|NCT01530399|7438081|FG004|STARTED|Overall Study||6
6517553|NCT01530399|7438082|FG005|STARTED|Overall Study||7
6517554|NCT01530399|7438077|FG000|COMPLETED|Overall Study||7
6517555|NCT01530399|7438078|FG001|COMPLETED|Overall Study||8
6517556|NCT01530399|7438079|FG002|COMPLETED|Overall Study||7
6517557|NCT01530399|7438080|FG003|COMPLETED|Overall Study||10
6517558|NCT01530399|7438081|FG004|COMPLETED|Overall Study||6
6517559|NCT01530399|7438082|FG005|COMPLETED|Overall Study||6
6517560|NCT01530399|7438077|FG000|NOT COMPLETED|Overall Study||1
6517561|NCT01530399|7438078|FG001|NOT COMPLETED|Overall Study||2
6517562|NCT01530399|7438079|FG002|NOT COMPLETED|Overall Study||1
6517563|NCT01530399|7438080|FG003|NOT COMPLETED|Overall Study||0
6517564|NCT01530399|7438081|FG004|NOT COMPLETED|Overall Study||0
6517565|NCT01530399|7438082|FG005|NOT COMPLETED|Overall Study||1
6517566|NCT01530464|7438098|FG000|STARTED|First Intervention (24h)||10
6517567|NCT01530464|7438099|FG001|STARTED|First Intervention (24h)||8
6517568|NCT01530464|7438098|FG000|COMPLETED|First Intervention (24h)||10
6517569|NCT01530464|7438099|FG001|COMPLETED|First Intervention (24h)||8
6517570|NCT01530464|7438098|FG000|NOT COMPLETED|First Intervention (24h)||0
6517571|NCT01530464|7438099|FG001|NOT COMPLETED|First Intervention (24h)||0
6517572|NCT01530464|7438098|FG000|STARTED|Washout (24h)||10
6517573|NCT01530464|7438099|FG001|STARTED|Washout (24h)||8
6517574|NCT01530464|7438098|FG000|COMPLETED|Washout (24h)||10
6517575|NCT01530464|7438099|FG001|COMPLETED|Washout (24h)||8
6517576|NCT01530464|7438098|FG000|NOT COMPLETED|Washout (24h)||0
6517577|NCT01530464|7438099|FG001|NOT COMPLETED|Washout (24h)||0
6517578|NCT01530464|7438098|FG000|STARTED|Second Intervention (24h)||10
6517579|NCT01530464|7438099|FG001|STARTED|Second Intervention (24h)||8
6517580|NCT01530464|7438098|FG000|COMPLETED|Second Intervention (24h)||10
6517581|NCT01530464|7438099|FG001|COMPLETED|Second Intervention (24h)||8
6517582|NCT01530464|7438098|FG000|NOT COMPLETED|Second Intervention (24h)||0
6517583|NCT01530464|7438099|FG001|NOT COMPLETED|Second Intervention (24h)||0
6517584|NCT01530464|7438098|FG000|STARTED|Washout (24h)||10
6517585|NCT01530464|7438099|FG001|STARTED|Washout (24h)||8
6517586|NCT01530464|7438098|FG000|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
6517587|NCT01530464|7438099|FG001|COMPLETED|Washout (24h)||8
6517588|NCT01530464|7438098|FG000|NOT COMPLETED|Washout (24h)||1
6517589|NCT01530464|7438099|FG001|NOT COMPLETED|Washout (24h)||0
6517590|NCT01530464|7438098|FG000|STARTED|Third Intervention (24h)||9
6517591|NCT01530464|7438099|FG001|STARTED|Third Intervention (24h)||8
6517592|NCT01530464|7438098|FG000|COMPLETED|Third Intervention (24h)||9
6517593|NCT01530464|7438099|FG001|COMPLETED|Third Intervention (24h)||8
6517594|NCT01530464|7438098|FG000|NOT COMPLETED|Third Intervention (24h)||0
6517595|NCT01530464|7438099|FG001|NOT COMPLETED|Third Intervention (24h)||0
6517596|NCT01530464|7438098|FG000|STARTED|Washout (24h)||9
6517597|NCT01530464|7438099|FG001|STARTED|Washout (24h)||8
6517598|NCT01530464|7438098|FG000|COMPLETED|Washout (24h)||9
6517599|NCT01530464|7438099|FG001|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
6517600|NCT01530464|7438098|FG000|NOT COMPLETED|Washout (24h)||0
6517601|NCT01530464|7438099|FG001|NOT COMPLETED|Washout (24h)||1
6517602|NCT01530477|7438113|FG000|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
6517603|NCT01530477|7438114|FG001|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
6517604|NCT01530477|7438115|FG002|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
6517605|NCT01530477|7438113|FG000|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
6517606|NCT01530477|7438114|FG001|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
6517607|NCT01530477|7438115|FG002|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
6517608|NCT01530477|7438113|FG000|NOT COMPLETED|Overall Study||0
6517609|NCT01530477|7438114|FG001|NOT COMPLETED|Overall Study||0
6517610|NCT01530477|7438115|FG002|NOT COMPLETED|Overall Study||0
6517611|NCT01531153|7438124|FG000|STARTED|Overall Study||32
6517612|NCT01531153|7438125|FG001|STARTED|Overall Study||31
6517613|NCT01531153|7438126|FG002|STARTED|Overall Study||30
6517614|NCT01531153|7438124|FG000|COMPLETED|Overall Study||22
6517615|NCT01531153|7438125|FG001|COMPLETED|Overall Study||22
6517616|NCT01531153|7438126|FG002|COMPLETED|Overall Study||15
6517617|NCT01531153|7438124|FG000|NOT COMPLETED|Overall Study||10
6517618|NCT01531153|7438125|FG001|NOT COMPLETED|Overall Study||9
6517619|NCT01531153|7438126|FG002|NOT COMPLETED|Overall Study||15
6517620|NCT01531205|7438137|FG000|STARTED|Overall Study||2
6517621|NCT01531205|7438137|FG000|COMPLETED|Overall Study||1
6517622|NCT01531205|7438137|FG000|NOT COMPLETED|Overall Study||1
6517623|NCT01531335|7438145|FG000|STARTED|Overall Study||40
6517624|NCT01531335|7438146|FG001|STARTED|Overall Study||40
6517625|NCT01531335|7438145|FG000|COMPLETED|Overall Study||40
6517626|NCT01531335|7438146|FG001|COMPLETED|Overall Study||40
6517627|NCT01531335|7438145|FG000|NOT COMPLETED|Overall Study||0
6517628|NCT01531335|7438146|FG001|NOT COMPLETED|Overall Study||0
6517638|NCT01531439|7438169|FG000|STARTED|Overall Study||41
6641290|NCT02342314|7569786|FG013|NOT COMPLETED|Part A||0
6641291|NCT02342314|7569787|FG014|NOT COMPLETED|Part A||0
6641292|NCT02342314|7569788|FG015|NOT COMPLETED|Part A||0
6641293|NCT02342314|7569789|FG016|NOT COMPLETED|Part A||0
6641294|NCT02342314|7569773|FG000|STARTED|Part B|Participants received placebo in Part A.|0
6641295|NCT02342314|7569774|FG001|STARTED|Part B|Participants received LY3143753 in Part A.|0
6641296|NCT02342314|7569775|FG002|STARTED|Part B|Participants received LY3143753 in Part A.|0
6641297|NCT02342314|7569776|FG003|STARTED|Part B|Participants received LY3143753 in Part A.|0
6641298|NCT02342314|7569777|FG004|STARTED|Part B|Participants received LY3143753 in Part A.|0
6517639|NCT01531439|7438170|FG001|STARTED|Overall Study||43
6517640|NCT01531439|7438169|FG000|COMPLETED|Overall Study||37
6517641|NCT01531439|7438170|FG001|COMPLETED|Overall Study||42
6517642|NCT01531439|7438169|FG000|NOT COMPLETED|Overall Study||4
6517643|NCT01531439|7438170|FG001|NOT COMPLETED|Overall Study||1
6517644|NCT01531673|7438189|FG000|STARTED|Overall Study||33
6517645|NCT01531673|7438190|FG001|STARTED|Overall Study||8
6517646|NCT01531673|7438191|FG002|STARTED|Overall Study||8
6517647|NCT01531673|7438192|FG003|STARTED|Overall Study||18
6517648|NCT01531673|7438193|FG004|STARTED|Overall Study||8
6517649|NCT01531673|7438194|FG005|STARTED|Overall Study||19
6517650|NCT01531673|7438195|FG006|STARTED|Overall Study||17
6517651|NCT01531673|7438196|FG007|STARTED|Overall Study||9
6517652|NCT01531673|7438197|FG008|STARTED|Overall Study||17
6517653|NCT01531673|7438198|FG009|STARTED|Overall Study||19
6517654|NCT01531673|7438199|FG010|STARTED|Overall Study||16
6517655|NCT01531673|7438200|FG011|STARTED|Overall Study||4
6517656|NCT01531673|7438201|FG012|STARTED|Overall Study||14
6517657|NCT01531673|7438189|FG000|COMPLETED|Overall Study||33
6517658|NCT01531673|7438190|FG001|COMPLETED|Overall Study||7
6517659|NCT01531673|7438191|FG002|COMPLETED|Overall Study||8
6517660|NCT01531673|7438192|FG003|COMPLETED|Overall Study||17
6517661|NCT01531673|7438193|FG004|COMPLETED|Overall Study||7
6517662|NCT01531673|7438194|FG005|COMPLETED|Overall Study||18
6517663|NCT01531673|7438195|FG006|COMPLETED|Overall Study||17
6517664|NCT01531673|7438196|FG007|COMPLETED|Overall Study||9
6517665|NCT01531673|7438197|FG008|COMPLETED|Overall Study||17
6517666|NCT01531673|7438198|FG009|COMPLETED|Overall Study||18
6517667|NCT01531673|7438199|FG010|COMPLETED|Overall Study||16
6517668|NCT01531673|7438200|FG011|COMPLETED|Overall Study||4
6517669|NCT01531673|7438201|FG012|COMPLETED|Overall Study||14
6517670|NCT01531673|7438189|FG000|NOT COMPLETED|Overall Study||0
6517671|NCT01531673|7438190|FG001|NOT COMPLETED|Overall Study||1
6517672|NCT01531673|7438191|FG002|NOT COMPLETED|Overall Study||0
6641299|NCT02342314|7569778|FG005|STARTED|Part B|Participants received LY3143753 in Part A.|0
6641300|NCT02342314|7569779|FG006|STARTED|Part B|Participants received placebo in Part B.|11
6641301|NCT02342314|7569780|FG007|STARTED|Part B|Participants received LY3185643 in Part B.|3
6641302|NCT02342314|7569781|FG008|STARTED|Part B|Participants received LY3185643 in Part B.|3
6641303|NCT02342314|7569782|FG009|STARTED|Part B|Participants received LY3185643 in Part B.|3
6641304|NCT02342314|7569783|FG010|STARTED|Part B|Participants received LY3185643 in Part B.|3
6517673|NCT01531673|7438192|FG003|NOT COMPLETED|Overall Study||1
6517674|NCT01531673|7438193|FG004|NOT COMPLETED|Overall Study||1
6517675|NCT01531673|7438194|FG005|NOT COMPLETED|Overall Study||1
6517676|NCT01531673|7438195|FG006|NOT COMPLETED|Overall Study||0
6517677|NCT01531673|7438196|FG007|NOT COMPLETED|Overall Study||0
6517678|NCT01531673|7438197|FG008|NOT COMPLETED|Overall Study||0
6517679|NCT01531673|7438198|FG009|NOT COMPLETED|Overall Study||1
6517680|NCT01531673|7438199|FG010|NOT COMPLETED|Overall Study||0
6517681|NCT01531673|7438200|FG011|NOT COMPLETED|Overall Study||0
6517682|NCT01531673|7438201|FG012|NOT COMPLETED|Overall Study||0
6517683|NCT01531725|7438253|FG000|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
6517684|NCT01531725|7438253|FG000|COMPLETED|Overall Study||197
6517685|NCT01531725|7438253|FG000|NOT COMPLETED|Overall Study||5
6517686|NCT01531738|7438259|FG000|STARTED|Overall Study||11
6517687|NCT01531738|7438260|FG001|STARTED|Overall Study||11
6517688|NCT01531738|7438259|FG000|COMPLETED|Overall Study||11
6517689|NCT01531738|7438260|FG001|COMPLETED|Overall Study||11
6517690|NCT01531738|7438259|FG000|NOT COMPLETED|Overall Study||0
6517691|NCT01531738|7438260|FG001|NOT COMPLETED|Overall Study||0
6517692|NCT01531803|7438268|FG000|STARTED|Overall Study||1
6517693|NCT01531803|7438269|FG001|STARTED|Overall Study||2
6517694|NCT01531803|7438268|FG000|COMPLETED|Overall Study||1
6517695|NCT01531803|7438269|FG001|COMPLETED|Overall Study||2
6517696|NCT01531803|7438268|FG000|NOT COMPLETED|Overall Study||0
6517697|NCT01531803|7438269|FG001|NOT COMPLETED|Overall Study||0
6517698|NCT01531894|7438275|FG000|STARTED|Overall Study||11
6517699|NCT01531894|7438275|FG000|COMPLETED|Overall Study||2
6517700|NCT01531894|7438275|FG000|NOT COMPLETED|Overall Study||9
6517701|NCT01531959|7438281|FG000|STARTED|Overall Study||68
6517702|NCT01531959|7438282|FG001|STARTED|Overall Study||68
6517703|NCT01531959|7438281|FG000|COMPLETED|Overall Study||66
6517704|NCT01531959|7438282|FG001|COMPLETED|Overall Study||66
6517705|NCT01531959|7438281|FG000|NOT COMPLETED|Overall Study||2
6517706|NCT01531959|7438282|FG001|NOT COMPLETED|Overall Study||2
6517707|NCT01531998|7438288|FG000|STARTED|Overall Study||11
6517708|NCT01531998|7438288|FG000|COMPLETED|Overall Study||8
6517709|NCT01531998|7438288|FG000|NOT COMPLETED|Overall Study||3
6517710|NCT01532089|7438294|FG000|STARTED|Overall Study||45
6517711|NCT01532089|7438295|FG001|STARTED|Overall Study||43
6517712|NCT01532089|7438294|FG000|COMPLETED|Overall Study||45
6517713|NCT01532089|7438295|FG001|COMPLETED|Overall Study||43
6517714|NCT01532089|7438294|FG000|NOT COMPLETED|Overall Study||0
6517715|NCT01532089|7438295|FG001|NOT COMPLETED|Overall Study||0
6641305|NCT02342314|7569784|FG011|STARTED|Part B|Participants received LY3185643 in Part B.|3
6641306|NCT02342314|7569785|FG012|STARTED|Part B|Participants received LY3185643 in Part B.|3
6517716|NCT01532128|7438306|FG000|STARTED|Overall Study||8
6517717|NCT01532128|7438307|FG001|STARTED|Overall Study||8
6517718|NCT01532128|7438308|FG002|STARTED|Overall Study||8
6517719|NCT01532128|7438306|FG000|COMPLETED|Overall Study||8
6517720|NCT01532128|7438307|FG001|COMPLETED|Overall Study||8
6517721|NCT01532128|7438308|FG002|COMPLETED|Overall Study||8
6517722|NCT01532128|7438306|FG000|NOT COMPLETED|Overall Study||0
6517723|NCT01532128|7438307|FG001|NOT COMPLETED|Overall Study||0
6517724|NCT01532128|7438308|FG002|NOT COMPLETED|Overall Study||0
6517725|NCT01532141|7438320|FG000|STARTED|Overall Study||9
6517726|NCT01532141|7438321|FG001|STARTED|Overall Study||8
6517727|NCT01532141|7438322|FG002|STARTED|Overall Study||8
6517728|NCT01532141|7438320|FG000|Period 1|Overall Study||9
6517729|NCT01532141|7438321|FG001|Period 1|Overall Study||8
6517730|NCT01532141|7438322|FG002|Period 1|Overall Study||8
6517731|NCT01532141|7438320|FG000|Period 2|Overall Study||8
6517732|NCT01532141|7438321|FG001|Period 2|Overall Study||8
6517733|NCT01532141|7438322|FG002|Period 2|Overall Study||8
6517734|NCT01532141|7438320|FG000|Period 3|Overall Study||8
6517735|NCT01532141|7438321|FG001|Period 3|Overall Study||8
6517736|NCT01532141|7438322|FG002|Period 3|Overall Study||8
6517737|NCT01532141|7438320|FG000|COMPLETED|Overall Study||8
6517738|NCT01532141|7438321|FG001|COMPLETED|Overall Study||8
6517739|NCT01532141|7438322|FG002|COMPLETED|Overall Study||8
6517740|NCT01532141|7438320|FG000|NOT COMPLETED|Overall Study||1
6517741|NCT01532141|7438321|FG001|NOT COMPLETED|Overall Study||0
6517742|NCT01532141|7438322|FG002|NOT COMPLETED|Overall Study||0
6517743|NCT01532349|7438333|FG000|STARTED|Overall Study||17
6517744|NCT01532349|7438334|FG001|STARTED|Overall Study||17
6517745|NCT01532349|7438333|FG000|COMPLETED|Overall Study||15
6517746|NCT01532349|7438334|FG001|COMPLETED|Overall Study||12
6517747|NCT01532349|7438333|FG000|NOT COMPLETED|Overall Study||2
6517748|NCT01532349|7438334|FG001|NOT COMPLETED|Overall Study||5
6517749|NCT01532388|7438342|FG000|STARTED|3-month Follow-up||101
6517750|NCT01532388|7438343|FG001|STARTED|3-month Follow-up||101
6517751|NCT01532388|7438342|FG000|COMPLETED|3-month Follow-up||33
6517752|NCT01532388|7438343|FG001|COMPLETED|3-month Follow-up||33
6517753|NCT01532388|7438342|FG000|NOT COMPLETED|3-month Follow-up||68
6517754|NCT01532388|7438343|FG001|NOT COMPLETED|3-month Follow-up||68
6517755|NCT01532388|7438342|FG000|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
6517756|NCT01532388|7438343|FG001|STARTED|6-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
6517757|NCT01532388|7438342|FG000|COMPLETED|6-month Follow-up||27
6517758|NCT01532388|7438343|FG001|COMPLETED|6-month Follow-up||35
6517759|NCT01532388|7438342|FG000|NOT COMPLETED|6-month Follow-up||74
6517760|NCT01532388|7438343|FG001|NOT COMPLETED|6-month Follow-up||66
6517761|NCT01532388|7438342|FG000|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
6517762|NCT01532388|7438343|FG001|STARTED|12-month Follow-up|All participants registered in the trial were contacted for follow-ups at 3, 6 and 12 months.|101
6517763|NCT01532388|7438342|FG000|COMPLETED|12-month Follow-up||32
6517764|NCT01532388|7438343|FG001|COMPLETED|12-month Follow-up||34
6517765|NCT01532388|7438342|FG000|NOT COMPLETED|12-month Follow-up||69
6517766|NCT01532388|7438343|FG001|NOT COMPLETED|12-month Follow-up||67
6517767|NCT01532414|7438352|FG000|STARTED|Overall Study||92
6517768|NCT01532414|7438353|FG001|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
6517769|NCT01532414|7438354|FG002|STARTED|Overall Study||38
6517770|NCT01532414|7438352|FG000|COMPLETED|Overall Study||85
6517771|NCT01532414|7438353|FG001|COMPLETED|Overall Study||19
6517772|NCT01532414|7438354|FG002|COMPLETED|Overall Study||35
6517773|NCT01532414|7438352|FG000|NOT COMPLETED|Overall Study||7
6517774|NCT01532414|7438353|FG001|NOT COMPLETED|Overall Study||2
6517775|NCT01532414|7438354|FG002|NOT COMPLETED|Overall Study||3
6517776|NCT01532453|7438364|FG000|STARTED|Overall Study||81
6517777|NCT01532453|7438365|FG001|STARTED|Overall Study||160
6517778|NCT01532453|7438364|FG000|COMPLETED|Overall Study||54
6517779|NCT01532453|7438365|FG001|COMPLETED|Overall Study||90
6517780|NCT01532453|7438364|FG000|NOT COMPLETED|Overall Study||27
6517781|NCT01532453|7438365|FG001|NOT COMPLETED|Overall Study||70
6517782|NCT01532570|7438375|FG000|STARTED|Overall Study||11
6517783|NCT01532570|7438376|FG001|STARTED|Overall Study||2
6517784|NCT01532570|7438377|FG002|STARTED|Overall Study||1
6517785|NCT01532570|7438378|FG003|STARTED|Overall Study||4
6517786|NCT01532570|7438375|FG000|COMPLETED|Overall Study||10
6517787|NCT01532570|7438376|FG001|COMPLETED|Overall Study||1
6517788|NCT01532570|7438377|FG002|COMPLETED|Overall Study||1
6517789|NCT01532570|7438378|FG003|COMPLETED|Overall Study||4
6517790|NCT01532570|7438375|FG000|NOT COMPLETED|Overall Study||1
6517791|NCT01532570|7438376|FG001|NOT COMPLETED|Overall Study||1
6517792|NCT01532570|7438377|FG002|NOT COMPLETED|Overall Study||0
6517793|NCT01532570|7438378|FG003|NOT COMPLETED|Overall Study||0
6517794|NCT01532648|7438397|FG000|STARTED|Overall Study||255
6517795|NCT01532648|7438398|FG001|STARTED|Overall Study||255
6517796|NCT01532648|7438397|FG000|Safety Population|Overall Study||255
6517797|NCT01532648|7438398|FG001|Safety Population|Overall Study||255
6517798|NCT01532648|7438397|FG000|Intent-To-Treat Population|Overall Study||230
6517799|NCT01532648|7438398|FG001|Intent-To-Treat Population|Overall Study||228
6517800|NCT01532648|7438397|FG000|COMPLETED|Overall Study||219
6517801|NCT01532648|7438398|FG001|COMPLETED|Overall Study||238
6517802|NCT01532648|7438397|FG000|NOT COMPLETED|Overall Study||36
6517803|NCT01532648|7438398|FG001|NOT COMPLETED|Overall Study||17
6517804|NCT01532687|7438406|FG000|STARTED|Overall Study||29
6517805|NCT01532687|7438407|FG001|STARTED|Overall Study||25
6517806|NCT01532687|7438406|FG000|Crossover to Open-label Pazopanib|Overall Study||0
6517807|NCT01532687|7438407|FG001|Crossover to Open-label Pazopanib|Overall Study||14
6517808|NCT01532687|7438406|FG000|COMPLETED|Overall Study|Participants remain on treatment until time of progression and through the AE assessment period|15
6517809|NCT01532687|7438407|FG001|COMPLETED|Overall Study|Participants remain on treatment until time of progression|23
6517810|NCT01532687|7438406|FG000|NOT COMPLETED|Overall Study||14
6517811|NCT01532687|7438407|FG001|NOT COMPLETED|Overall Study||2
6517812|NCT01532700|7438415|FG000|STARTED|Overall Study||28
6517813|NCT01532700|7438415|FG000|COMPLETED|Overall Study||28
6517814|NCT01532700|7438415|FG000|NOT COMPLETED|Overall Study||0
6517815|NCT01532817|7438419|FG000|STARTED|Overall Study||30
6517816|NCT01532817|7438419|FG000|COMPLETED|Overall Study||30
6517817|NCT01532817|7438419|FG000|NOT COMPLETED|Overall Study||0
6517818|NCT01532830|7438423|FG000|STARTED|Overall Study||30
6517819|NCT01532830|7438423|FG000|COMPLETED|Overall Study||26
6517820|NCT01532830|7438423|FG000|NOT COMPLETED|Overall Study||4
6517821|NCT01532869|7438429|FG000|STARTED|Blinded-Treatment Period (Up to Week 24)||44
6517822|NCT01532869|7438430|FG001|STARTED|Blinded-Treatment Period (Up to Week 24)||43
6517823|NCT01532869|7438429|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
6517824|NCT01532869|7438430|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
6517825|NCT01532869|7438429|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
6517826|NCT01532869|7438430|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
6517827|NCT01532869|7438429|FG000|STARTED|Blinded-Treatment Period (Up to Week 48)||44
6517828|NCT01532869|7438430|FG001|STARTED|Blinded-Treatment Period (Up to Week 48)||43
6517829|NCT01532869|7438429|FG000|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
6517830|NCT01532869|7438430|FG001|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
6517831|NCT01532869|7438429|FG000|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
6517832|NCT01532869|7438430|FG001|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
6517833|NCT01532869|7438429|FG000|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
6517834|NCT01532869|7438430|FG001|STARTED|Open-label Period (Week 48 to Week 96)||30
6517835|NCT01532869|7438429|FG000|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
6517836|NCT01532869|7438430|FG001|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
6517837|NCT01532869|7438429|FG000|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
6517838|NCT01532869|7438430|FG001|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
6517839|NCT01532908|7438443|FG000|STARTED|Overall Study||9
6517840|NCT01532908|7438444|FG001|STARTED|Overall Study||2
6517841|NCT01532908|7438443|FG000|Infused|Overall Study||9
6517842|NCT01532908|7438444|FG001|Infused|Overall Study||2
6517843|NCT01532908|7438443|FG000|Transplanted|Overall Study||8
6517844|NCT01532908|7438444|FG001|Transplanted|Overall Study||2
6517845|NCT01532908|7438443|FG000|COMPLETED|Overall Study||8
6517846|NCT01532908|7438444|FG001|COMPLETED|Overall Study||2
6517847|NCT01532908|7438443|FG000|NOT COMPLETED|Overall Study||1
6517848|NCT01532908|7438444|FG001|NOT COMPLETED|Overall Study||0
6517849|NCT01532921|7438450|FG000|STARTED|Overall Study||85
6517850|NCT01532921|7438450|FG000|Implantation Procedure|Overall Study||76
6517851|NCT01532921|7438450|FG000|Discharge|Overall Study||75
6517852|NCT01532921|7438450|FG000|6 Months Follow Up|Overall Study||68
6517853|NCT01532921|7438450|FG000|COMPLETED|Overall Study||69
6517854|NCT01532921|7438450|FG000|NOT COMPLETED|Overall Study||16
6517855|NCT01532934|7438460|FG000|STARTED|Overall Study||53
6517856|NCT01532934|7438461|FG001|STARTED|Overall Study||52
6517857|NCT01532934|7438460|FG000|COMPLETED|Overall Study||39
6517858|NCT01532934|7438461|FG001|COMPLETED|Overall Study||39
6517859|NCT01532934|7438460|FG000|NOT COMPLETED|Overall Study||14
6517860|NCT01532934|7438461|FG001|NOT COMPLETED|Overall Study||13
6517861|NCT01532973|7438478|FG000|STARTED|Part 1||6
6517862|NCT01532973|7438479|FG001|STARTED|Part 1||6
6517863|NCT01532973|7438480|FG002|STARTED|Part 1||6
6517864|NCT01532973|7438481|FG003|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
6517865|NCT01532973|7438482|FG004|STARTED|Part 1||0
6517866|NCT01532973|7438483|FG005|STARTED|Part 1||0
6641307|NCT02342314|7569786|FG013|STARTED|Part B|Participants received LY3185643 in Part B.|3
6641308|NCT02342314|7569787|FG014|STARTED|Part B|Participants received LY3185643 in Part B.|3
6641309|NCT02342314|7569788|FG015|STARTED|Part B|Participants received LY3185643 in Part B.|3
6641310|NCT02342314|7569789|FG016|STARTED|Part B|Participants received rGlucagon in Part B.|6
6641311|NCT02342314|7569773|FG000|COMPLETED|Part B||0
6517867|NCT01532973|7438484|FG006|STARTED|Part 1||0
6517868|NCT01532973|7438485|FG007|STARTED|Part 1||0
6517869|NCT01532973|7438486|FG008|STARTED|Part 1||0
6517870|NCT01532973|7438487|FG009|STARTED|Part 1||0
6517871|NCT01532973|7438478|FG000|COMPLETED|Part 1||6
6517872|NCT01532973|7438479|FG001|COMPLETED|Part 1||6
6517873|NCT01532973|7438480|FG002|COMPLETED|Part 1||6
6517874|NCT01532973|7438481|FG003|COMPLETED|Part 1||0
6517875|NCT01532973|7438482|FG004|COMPLETED|Part 1||0
6517876|NCT01532973|7438483|FG005|COMPLETED|Part 1||0
6517877|NCT01532973|7438484|FG006|COMPLETED|Part 1||0
6517878|NCT01532973|7438485|FG007|COMPLETED|Part 1||0
6517879|NCT01532973|7438486|FG008|COMPLETED|Part 1||0
6517880|NCT01532973|7438487|FG009|COMPLETED|Part 1||0
6517881|NCT01532973|7438478|FG000|NOT COMPLETED|Part 1||0
6517882|NCT01532973|7438479|FG001|NOT COMPLETED|Part 1||0
6517883|NCT01532973|7438480|FG002|NOT COMPLETED|Part 1||0
6517884|NCT01532973|7438481|FG003|NOT COMPLETED|Part 1||0
6517885|NCT01532973|7438482|FG004|NOT COMPLETED|Part 1||0
6517886|NCT01532973|7438483|FG005|NOT COMPLETED|Part 1||0
6517887|NCT01532973|7438484|FG006|NOT COMPLETED|Part 1||0
6517888|NCT01532973|7438485|FG007|NOT COMPLETED|Part 1||0
6517889|NCT01532973|7438486|FG008|NOT COMPLETED|Part 1||0
6517890|NCT01532973|7438487|FG009|NOT COMPLETED|Part 1||0
6517891|NCT01532973|7438478|FG000|STARTED|Part 2||0
6517892|NCT01532973|7438479|FG001|STARTED|Part 2||0
6517893|NCT01532973|7438480|FG002|STARTED|Part 2||0
6517894|NCT01532973|7438481|FG003|STARTED|Part 2||0
6517895|NCT01532973|7438482|FG004|STARTED|Part 2||6
6517896|NCT01532973|7438483|FG005|STARTED|Part 2||6
6517897|NCT01532973|7438484|FG006|STARTED|Part 2||6
6517898|NCT01532973|7438485|FG007|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
6517899|NCT01532973|7438486|FG008|STARTED|Part 2||0
6517900|NCT01532973|7438487|FG009|STARTED|Part 2||0
6517901|NCT01532973|7438478|FG000|COMPLETED|Part 2||0
6517902|NCT01532973|7438479|FG001|COMPLETED|Part 2||0
6517903|NCT01532973|7438480|FG002|COMPLETED|Part 2||0
6517904|NCT01532973|7438481|FG003|COMPLETED|Part 2||0
6517905|NCT01532973|7438482|FG004|COMPLETED|Part 2||6
6517906|NCT01532973|7438483|FG005|COMPLETED|Part 2||6
6517907|NCT01532973|7438484|FG006|COMPLETED|Part 2||6
6517908|NCT01532973|7438485|FG007|COMPLETED|Part 2||0
6517909|NCT01532973|7438486|FG008|COMPLETED|Part 2||0
6517910|NCT01532973|7438487|FG009|COMPLETED|Part 2||0
6517911|NCT01532973|7438478|FG000|NOT COMPLETED|Part 2||0
6517912|NCT01532973|7438479|FG001|NOT COMPLETED|Part 2||0
6517913|NCT01532973|7438480|FG002|NOT COMPLETED|Part 2||0
6517914|NCT01532973|7438481|FG003|NOT COMPLETED|Part 2||0
6517915|NCT01532973|7438482|FG004|NOT COMPLETED|Part 2||0
6517916|NCT01532973|7438483|FG005|NOT COMPLETED|Part 2||0
6517917|NCT01532973|7438484|FG006|NOT COMPLETED|Part 2||0
6517918|NCT01532973|7438485|FG007|NOT COMPLETED|Part 2||0
6517919|NCT01532973|7438486|FG008|NOT COMPLETED|Part 2||0
6517920|NCT01532973|7438487|FG009|NOT COMPLETED|Part 2||0
6517921|NCT01532973|7438478|FG000|STARTED|Part 3||0
6517922|NCT01532973|7438479|FG001|STARTED|Part 3||0
6517923|NCT01532973|7438480|FG002|STARTED|Part 3||0
6517924|NCT01532973|7438481|FG003|STARTED|Part 3||0
6517925|NCT01532973|7438482|FG004|STARTED|Part 3||0
6517926|NCT01532973|7438483|FG005|STARTED|Part 3||0
6517927|NCT01532973|7438484|FG006|STARTED|Part 3||0
6517928|NCT01532973|7438485|FG007|STARTED|Part 3||0
6517929|NCT01532973|7438486|FG008|STARTED|Part 3||6
6517930|NCT01532973|7438487|FG009|STARTED|Part 3||6
6517931|NCT01532973|7438478|FG000|COMPLETED|Part 3||0
6517932|NCT01532973|7438479|FG001|COMPLETED|Part 3||0
6517933|NCT01532973|7438480|FG002|COMPLETED|Part 3||0
6517934|NCT01532973|7438481|FG003|COMPLETED|Part 3||0
6517935|NCT01532973|7438482|FG004|COMPLETED|Part 3||0
6517936|NCT01532973|7438483|FG005|COMPLETED|Part 3||0
6517937|NCT01532973|7438484|FG006|COMPLETED|Part 3||0
6517938|NCT01532973|7438485|FG007|COMPLETED|Part 3||0
6517939|NCT01532973|7438486|FG008|COMPLETED|Part 3||6
6517940|NCT01532973|7438487|FG009|COMPLETED|Part 3||6
6517941|NCT01532973|7438478|FG000|NOT COMPLETED|Part 3||0
6517942|NCT01532973|7438479|FG001|NOT COMPLETED|Part 3||0
6517943|NCT01532973|7438480|FG002|NOT COMPLETED|Part 3||0
6517944|NCT01532973|7438481|FG003|NOT COMPLETED|Part 3||0
6517945|NCT01532973|7438482|FG004|NOT COMPLETED|Part 3||0
6517946|NCT01532973|7438483|FG005|NOT COMPLETED|Part 3||0
6517947|NCT01532973|7438484|FG006|NOT COMPLETED|Part 3||0
6517948|NCT01532973|7438485|FG007|NOT COMPLETED|Part 3||0
6517949|NCT01532973|7438486|FG008|NOT COMPLETED|Part 3||0
6517950|NCT01532973|7438487|FG009|NOT COMPLETED|Part 3||0
6517951|NCT01532986|7438513|FG000|STARTED|Overall Study||166
6517952|NCT01532986|7438514|FG001|STARTED|Overall Study||162
6517953|NCT01532986|7438513|FG000|COMPLETED|Overall Study||143
6517954|NCT01532986|7438514|FG001|COMPLETED|Overall Study||138
6517955|NCT01532986|7438513|FG000|NOT COMPLETED|Overall Study||23
6517956|NCT01532986|7438514|FG001|NOT COMPLETED|Overall Study||24
6517957|NCT01532999|7438523|FG000|STARTED|Overall Study||96
6641312|NCT02342314|7569774|FG001|COMPLETED|Part B||0
6641313|NCT02342314|7569775|FG002|COMPLETED|Part B||0
6641314|NCT02342314|7569776|FG003|COMPLETED|Part B||0
6641315|NCT02342314|7569777|FG004|COMPLETED|Part B||0
6641316|NCT02342314|7569778|FG005|COMPLETED|Part B||0
6641317|NCT02342314|7569779|FG006|COMPLETED|Part B||11
6641318|NCT02342314|7569780|FG007|COMPLETED|Part B||3
6641319|NCT02342314|7569781|FG008|COMPLETED|Part B||3
6641320|NCT02342314|7569782|FG009|COMPLETED|Part B||3
6641321|NCT02342314|7569783|FG010|COMPLETED|Part B||3
6517958|NCT01532999|7438524|FG001|STARTED|Overall Study||95
6517959|NCT01532999|7438523|FG000|COMPLETED|Overall Study||65
6517960|NCT01532999|7438524|FG001|COMPLETED|Overall Study||77
6517961|NCT01532999|7438523|FG000|NOT COMPLETED|Overall Study||31
6517962|NCT01532999|7438524|FG001|NOT COMPLETED|Overall Study||18
6517963|NCT01533038|7438532|FG000|STARTED|Overall Study||45
6517964|NCT01533038|7438533|FG001|STARTED|Overall Study||35
6517965|NCT01533038|7438532|FG000|COMPLETED|Overall Study||45
6517966|NCT01533038|7438533|FG001|COMPLETED|Overall Study||34
6517967|NCT01533038|7438532|FG000|NOT COMPLETED|Overall Study||0
6641322|NCT02342314|7569784|FG011|COMPLETED|Part B||3
6641323|NCT02342314|7569785|FG012|COMPLETED|Part B||3
6641324|NCT02342314|7569786|FG013|COMPLETED|Part B||3
6517968|NCT01533038|7438533|FG001|NOT COMPLETED|Overall Study||1
6517969|NCT01533077|7438543|FG000|STARTED|Overall Study||5
6517970|NCT01533077|7438544|FG001|STARTED|Overall Study||5
6517971|NCT01533077|7438545|FG002|STARTED|Overall Study||4
6517972|NCT01533077|7438546|FG003|STARTED|Overall Study||4
6517973|NCT01533077|7438543|FG000|BIA 9-1067 50 mg|Overall Study||5
6517974|NCT01533077|7438544|FG001|BIA 9-1067 50 mg|Overall Study||5
6517975|NCT01533077|7438545|FG002|BIA 9-1067 50 mg|Overall Study||4
6517976|NCT01533077|7438546|FG003|BIA 9-1067 50 mg|Overall Study||4
6517977|NCT01533077|7438543|FG000|Sinemet® 100/25|Overall Study||4
6517978|NCT01533077|7438544|FG001|Sinemet® 100/25|Overall Study||5
6517979|NCT01533077|7438545|FG002|Sinemet® 100/25|Overall Study||4
6517980|NCT01533077|7438546|FG003|Sinemet® 100/25|Overall Study||4
6517981|NCT01533077|7438543|FG000|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
6641325|NCT02342314|7569787|FG014|COMPLETED|Part B||3
6641326|NCT02342314|7569788|FG015|COMPLETED|Part B||3
6641327|NCT02342314|7569789|FG016|COMPLETED|Part B||6
6641328|NCT02342314|7569773|FG000|NOT COMPLETED|Part B||0
6517982|NCT01533077|7438544|FG001|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
6517983|NCT01533077|7438545|FG002|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
6517984|NCT01533077|7438546|FG003|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
6517985|NCT01533077|7438543|FG000|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
6517986|NCT01533077|7438544|FG001|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
6517987|NCT01533077|7438545|FG002|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
6517988|NCT01533077|7438546|FG003|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
6517989|NCT01533077|7438543|FG000|COMPLETED|Overall Study||4
6517990|NCT01533077|7438544|FG001|COMPLETED|Overall Study||4
6517991|NCT01533077|7438545|FG002|COMPLETED|Overall Study||4
6517992|NCT01533077|7438546|FG003|COMPLETED|Overall Study||4
6517993|NCT01533077|7438543|FG000|NOT COMPLETED|Overall Study||1
6517994|NCT01533077|7438544|FG001|NOT COMPLETED|Overall Study||1
6517995|NCT01533077|7438545|FG002|NOT COMPLETED|Overall Study||0
6517996|NCT01533077|7438546|FG003|NOT COMPLETED|Overall Study||0
6517997|NCT01533116|7438560|FG000|STARTED|Overall Study||14
6517998|NCT01533116|7438561|FG001|STARTED|Overall Study||13
6517999|NCT01533116|7438562|FG002|STARTED|Overall Study||13
6518000|NCT01533116|7438563|FG003|STARTED|Overall Study||12
6518001|NCT01533116|7438560|FG000|COMPLETED|Overall Study||12
6518002|NCT01533116|7438561|FG001|COMPLETED|Overall Study||12
6518003|NCT01533116|7438562|FG002|COMPLETED|Overall Study||12
6518004|NCT01533116|7438563|FG003|COMPLETED|Overall Study||12
6518005|NCT01533116|7438560|FG000|NOT COMPLETED|Overall Study||2
6518006|NCT01533116|7438561|FG001|NOT COMPLETED|Overall Study||1
6518007|NCT01533116|7438562|FG002|NOT COMPLETED|Overall Study||1
6518008|NCT01533116|7438563|FG003|NOT COMPLETED|Overall Study||0
6518009|NCT01533181|7438575|FG000|STARTED|Overall Study||15
6518010|NCT01533181|7438576|FG001|STARTED|Overall Study||29
6518011|NCT01533181|7438575|FG000|COMPLETED|Overall Study||14
6518012|NCT01533181|7438576|FG001|COMPLETED|Overall Study||28
6518013|NCT01533181|7438575|FG000|NOT COMPLETED|Overall Study||1
6518014|NCT01533181|7438576|FG001|NOT COMPLETED|Overall Study||1
6518015|NCT01533207|7438584|FG000|STARTED|Overall Study||20
6518016|NCT01533207|7438585|FG001|STARTED|Overall Study||18
6518017|NCT01533207|7438584|FG000|COMPLETED|Overall Study||20
6518018|NCT01533207|7438585|FG001|COMPLETED|Overall Study||18
6641329|NCT02342314|7569774|FG001|NOT COMPLETED|Part B||0
6641330|NCT02342314|7569775|FG002|NOT COMPLETED|Part B||0
6641331|NCT02342314|7569776|FG003|NOT COMPLETED|Part B||0
6641332|NCT02342314|7569777|FG004|NOT COMPLETED|Part B||0
6641333|NCT02342314|7569778|FG005|NOT COMPLETED|Part B||0
6641334|NCT02342314|7569779|FG006|NOT COMPLETED|Part B||0
6518019|NCT01533207|7438584|FG000|NOT COMPLETED|Overall Study||0
6518020|NCT01533207|7438585|FG001|NOT COMPLETED|Overall Study||0
6518021|NCT01533246|7438591|FG000|STARTED|Overall Study||17
6518022|NCT01533246|7438591|FG000|COMPLETED|Overall Study||15
6518023|NCT01533246|7438591|FG000|NOT COMPLETED|Overall Study||2
6518024|NCT01533259|7438595|FG000|STARTED|Overall Study||48
6518025|NCT01533259|7438595|FG000|COMPLETED|Overall Study||48
6518026|NCT01533259|7438595|FG000|NOT COMPLETED|Overall Study||0
6518027|NCT01533428|7438601|FG000|STARTED|Overall Study||186
6518028|NCT01533428|7438602|FG001|STARTED|Overall Study||183
6518029|NCT01533428|7438601|FG000|COMPLETED|Overall Study||177
6518030|NCT01533428|7438602|FG001|COMPLETED|Overall Study||175
6518031|NCT01533428|7438601|FG000|NOT COMPLETED|Overall Study||9
6518032|NCT01533428|7438602|FG001|NOT COMPLETED|Overall Study||8
6518033|NCT01533493|7438610|FG000|STARTED|Overall Study||12
6518034|NCT01533493|7438611|FG001|STARTED|Overall Study||14
6641335|NCT02342314|7569780|FG007|NOT COMPLETED|Part B||0
6641336|NCT02342314|7569781|FG008|NOT COMPLETED|Part B||0
6641337|NCT02342314|7569782|FG009|NOT COMPLETED|Part B||0
6641338|NCT02342314|7569783|FG010|NOT COMPLETED|Part B||0
6743620|NCT03335254|7671817|FG007|NOT COMPLETED|Period 1||0
6743621|NCT03335254|7671818|FG008|NOT COMPLETED|Period 1||0
6743622|NCT03335254|7671819|FG009|NOT COMPLETED|Period 1||0
6743623|NCT03335254|7671820|FG010|NOT COMPLETED|Period 1||0
6743624|NCT03335254|7671821|FG011|NOT COMPLETED|Period 1||0
6743625|NCT03335254|7671822|FG012|NOT COMPLETED|Period 1||0
6743626|NCT03335254|7671823|FG013|NOT COMPLETED|Period 1||0
6743627|NCT03335254|7671824|FG014|NOT COMPLETED|Period 1||0
6743628|NCT03335254|7671825|FG015|NOT COMPLETED|Period 1||0
6518035|NCT01533493|7438610|FG000|COMPLETED|Overall Study||7
6518036|NCT01533493|7438611|FG001|COMPLETED|Overall Study||11
6518037|NCT01533493|7438610|FG000|NOT COMPLETED|Overall Study||5
6518038|NCT01533493|7438611|FG001|NOT COMPLETED|Overall Study||3
6518039|NCT01533597|7438619|FG000|STARTED|Overall Study||35
6518040|NCT01533597|7438620|FG001|STARTED|Overall Study||35
6518041|NCT01533597|7438619|FG000|COMPLETED|Overall Study||29
6518042|NCT01533597|7438620|FG001|COMPLETED|Overall Study||25
6518043|NCT01533597|7438619|FG000|NOT COMPLETED|Overall Study||6
6518044|NCT01533597|7438620|FG001|NOT COMPLETED|Overall Study||10
6518045|NCT01533688|7438629|FG000|STARTED|Overall Study||71
6518046|NCT01533688|7438630|FG001|STARTED|Overall Study||70
6518047|NCT01533688|7438631|FG002|STARTED|Overall Study||71
6518048|NCT01533688|7438629|FG000|COMPLETED|Overall Study||63
6518049|NCT01533688|7438630|FG001|COMPLETED|Overall Study||60
6641339|NCT02342314|7569784|FG011|NOT COMPLETED|Part B||0
6641340|NCT02342314|7569785|FG012|NOT COMPLETED|Part B||0
6743629|NCT03335254|7671826|FG016|NOT COMPLETED|Period 1||0
6743630|NCT03335254|7671827|FG017|NOT COMPLETED|Period 1||0
6743631|NCT03335254|7671828|FG018|NOT COMPLETED|Period 1||0
6518050|NCT01533688|7438631|FG002|COMPLETED|Overall Study||63
6518051|NCT01533688|7438629|FG000|NOT COMPLETED|Overall Study||8
6518052|NCT01533688|7438630|FG001|NOT COMPLETED|Overall Study||10
6518053|NCT01533688|7438631|FG002|NOT COMPLETED|Overall Study||8
6518054|NCT01533922|7438641|FG000|STARTED|Overall Study||59
6518055|NCT01533922|7438642|FG001|STARTED|Overall Study||59
6518056|NCT01533922|7438643|FG002|STARTED|Overall Study||60
6518057|NCT01533922|7438644|FG003|STARTED|Overall Study||58
6518058|NCT01533922|7438645|FG004|STARTED|Overall Study||59
6518059|NCT01533922|7438641|FG000|Received Placebo|Overall Study||0
6518060|NCT01533922|7438642|FG001|Received Placebo|Overall Study||49
6518061|NCT01533922|7438643|FG002|Received Placebo|Overall Study||57
6518062|NCT01533922|7438644|FG003|Received Placebo|Overall Study||57
6518063|NCT01533922|7438645|FG004|Received Placebo|Overall Study||59
6518064|NCT01533922|7438641|FG000|Received Olo 5|Overall Study||51
6518065|NCT01533922|7438642|FG001|Received Olo 5|Overall Study||52
6518066|NCT01533922|7438643|FG002|Received Olo 5|Overall Study||57
6518067|NCT01533922|7438644|FG003|Received Olo 5|Overall Study||57
6518068|NCT01533922|7438645|FG004|Received Olo 5|Overall Study||0
6518069|NCT01533922|7438641|FG000|Received Tio 5|Overall Study||54
6518070|NCT01533922|7438642|FG001|Received Tio 5|Overall Study||58
6518071|NCT01533922|7438643|FG002|Received Tio 5|Overall Study||59
6518072|NCT01533922|7438644|FG003|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
6518073|NCT01533922|7438645|FG004|Received Tio 5|Overall Study||54
6518074|NCT01533922|7438641|FG000|Received Tio+Olo 2.5/5|Overall Study||59
6518075|NCT01533922|7438642|FG001|Received Tio+Olo 2.5/5|Overall Study||0
6518076|NCT01533922|7438643|FG002|Received Tio+Olo 2.5/5|Overall Study||52
6518077|NCT01533922|7438644|FG003|Received Tio+Olo 2.5/5|Overall Study||55
6518078|NCT01533922|7438645|FG004|Received Tio+Olo 2.5/5|Overall Study||56
6518079|NCT01533922|7438641|FG000|Received Tio+Olo 5/5|Overall Study||58
6518080|NCT01533922|7438642|FG001|Received Tio+Olo 5/5|Overall Study||59
6518081|NCT01533922|7438643|FG002|Received Tio+Olo 5/5|Overall Study||0
6518082|NCT01533922|7438644|FG003|Received Tio+Olo 5/5|Overall Study||53
6518083|NCT01533922|7438645|FG004|Received Tio+Olo 5/5|Overall Study||56
6518084|NCT01533922|7438641|FG000|COMPLETED|Overall Study|Completed all treatment arms|49
6518085|NCT01533922|7438642|FG001|COMPLETED|Overall Study|Completed all treatment arms|47
6518086|NCT01533922|7438643|FG002|COMPLETED|Overall Study|Completed all treatment arms|50
6518087|NCT01533922|7438644|FG003|COMPLETED|Overall Study|Completed all treatment arms|53
6518088|NCT01533922|7438645|FG004|COMPLETED|Overall Study|Completed all treatment arms|53
6518089|NCT01533922|7438641|FG000|NOT COMPLETED|Overall Study||10
6518090|NCT01533922|7438642|FG001|NOT COMPLETED|Overall Study||12
6518091|NCT01533922|7438643|FG002|NOT COMPLETED|Overall Study||10
6518092|NCT01533922|7438644|FG003|NOT COMPLETED|Overall Study||5
6518093|NCT01533922|7438645|FG004|NOT COMPLETED|Overall Study||6
6518094|NCT01533935|7438657|FG000|STARTED|Overall Study||58
6518095|NCT01533935|7438658|FG001|STARTED|Overall Study||58
6518096|NCT01533935|7438659|FG002|STARTED|Overall Study||58
6518097|NCT01533935|7438660|FG003|STARTED|Overall Study||59
6518098|NCT01533935|7438661|FG004|STARTED|Overall Study||58
6518099|NCT01533935|7438657|FG000|Received Placebo|Overall Study||0
6518100|NCT01533935|7438658|FG001|Received Placebo|Overall Study||47
6518101|NCT01533935|7438659|FG002|Received Placebo|Overall Study||52
6518102|NCT01533935|7438660|FG003|Received Placebo|Overall Study||57
6518103|NCT01533935|7438661|FG004|Received Placebo|Overall Study||58
6518104|NCT01533935|7438657|FG000|Received Olo 5|Overall Study||52
6518105|NCT01533935|7438658|FG001|Received Olo 5|Overall Study||52
6518106|NCT01533935|7438659|FG002|Received Olo 5|Overall Study||55
6518107|NCT01533935|7438660|FG003|Received Olo 5|Overall Study||59
6518108|NCT01533935|7438661|FG004|Received Olo 5|Overall Study||0
6518109|NCT01533935|7438657|FG000|Received Tio 5|Overall Study||54
6518110|NCT01533935|7438658|FG001|Received Tio 5|Overall Study||54
6518111|NCT01533935|7438659|FG002|Received Tio 5|Overall Study||58
6518112|NCT01533935|7438660|FG003|Received Tio 5|Overall Study||0
6518113|NCT01533935|7438661|FG004|Received Tio 5|Overall Study||52
6518114|NCT01533935|7438657|FG000|Received Tio+Olo 2.5/5|Overall Study||58
6518115|NCT01533935|7438658|FG001|Received Tio+Olo 2.5/5|Overall Study||0
6518116|NCT01533935|7438659|FG002|Received Tio+Olo 2.5/5|Overall Study||49
6518117|NCT01533935|7438660|FG003|Received Tio+Olo 2.5/5|Overall Study||56
6518118|NCT01533935|7438661|FG004|Received Tio+Olo 2.5/5|Overall Study||56
6518119|NCT01533935|7438657|FG000|Received Tio+Olo 5/5|Overall Study||56
6518120|NCT01533935|7438658|FG001|Received Tio+Olo 5/5|Overall Study||58
6518121|NCT01533935|7438659|FG002|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
6518122|NCT01533935|7438660|FG003|Received Tio+Olo 5/5|Overall Study||54
6518123|NCT01533935|7438661|FG004|Received Tio+Olo 5/5|Overall Study||55
6518124|NCT01533935|7438657|FG000|COMPLETED|Overall Study|All treatment periods|52
6518125|NCT01533935|7438658|FG001|COMPLETED|Overall Study|All treatment periods|45
6518126|NCT01533935|7438659|FG002|COMPLETED|Overall Study|All treatment periods|50
6518127|NCT01533935|7438660|FG003|COMPLETED|Overall Study|All treatment periods|52
6518128|NCT01533935|7438661|FG004|COMPLETED|Overall Study|All treatment periods|50
6518129|NCT01533935|7438657|FG000|NOT COMPLETED|Overall Study||6
6518130|NCT01533935|7438658|FG001|NOT COMPLETED|Overall Study||13
6518131|NCT01533935|7438659|FG002|NOT COMPLETED|Overall Study||8
6518132|NCT01533935|7438660|FG003|NOT COMPLETED|Overall Study||7
6518133|NCT01533935|7438661|FG004|NOT COMPLETED|Overall Study||8
6518134|NCT01533948|7438673|FG000|STARTED|Overall Study||25
6518135|NCT01533948|7438673|FG000|COMPLETED|Overall Study||25
6518136|NCT01533948|7438673|FG000|NOT COMPLETED|Overall Study||0
6518137|NCT01533974|7438679|FG000|STARTED|Overall Study||224
6518138|NCT01533974|7438680|FG001|STARTED|Overall Study||226
6518139|NCT01533974|7438679|FG000|COMPLETED|Overall Study||173
6518140|NCT01533974|7438680|FG001|COMPLETED|Overall Study||176
6518141|NCT01533974|7438679|FG000|NOT COMPLETED|Overall Study||51
6518142|NCT01533974|7438680|FG001|NOT COMPLETED|Overall Study||50
6518143|NCT01534013|7438688|FG000|STARTED|Overall Study||8
6518144|NCT01534013|7438689|FG001|STARTED|Overall Study||6
6518145|NCT01534013|7438688|FG000|COMPLETED|Overall Study||6
6518146|NCT01534013|7438689|FG001|COMPLETED|Overall Study||6
6518147|NCT01534013|7438688|FG000|NOT COMPLETED|Overall Study||2
6518148|NCT01534013|7438689|FG001|NOT COMPLETED|Overall Study||0
6518149|NCT01534052|7438695|FG000|STARTED|Overall Study||52
6518150|NCT01534052|7438695|FG000|Treatment Received|Overall Study||52
6518151|NCT01534052|7438695|FG000|COMPLETED|Overall Study||52
6518152|NCT01534052|7438695|FG000|NOT COMPLETED|Overall Study||0
6518153|NCT01534078|7438699|FG000|STARTED|Overall Study||34
6518154|NCT01534078|7438699|FG000|COMPLETED|Overall Study||32
6518155|NCT01534078|7438699|FG000|NOT COMPLETED|Overall Study||2
6518156|NCT01534182|7438705|FG000|STARTED|Overall Study||230
6518157|NCT01534182|7438706|FG001|STARTED|Overall Study||68
6518158|NCT01534182|7438705|FG000|Safety Set|Overall Study||230
6518159|NCT01534182|7438706|FG001|Safety Set|Overall Study||64
6518160|NCT01534182|7438705|FG000|Full Analysis Set|Overall Study||229
6518161|NCT01534182|7438706|FG001|Full Analysis Set|Overall Study||62
6518162|NCT01534182|7438705|FG000|COMPLETED|Overall Study||218
6518163|NCT01534182|7438706|FG001|COMPLETED|Overall Study||58
6518164|NCT01534182|7438705|FG000|NOT COMPLETED|Overall Study||12
6518165|NCT01534182|7438706|FG001|NOT COMPLETED|Overall Study||10
6518166|NCT01534195|7438715|FG000|STARTED|Overall Study||5
6518167|NCT01534195|7438716|FG001|STARTED|Overall Study||6
6518168|NCT01534195|7438715|FG000|COMPLETED|Overall Study||4
6518169|NCT01534195|7438716|FG001|COMPLETED|Overall Study||5
6518170|NCT01534195|7438715|FG000|NOT COMPLETED|Overall Study||1
6518171|NCT01534195|7438716|FG001|NOT COMPLETED|Overall Study||1
6518172|NCT01534208|7438724|FG000|STARTED|Overall Study||216
6518173|NCT01534208|7438725|FG001|STARTED|Overall Study||283
6518174|NCT01534208|7438724|FG000|COMPLETED|Overall Study||159
6518175|NCT01534208|7438725|FG001|COMPLETED|Overall Study||234
6518176|NCT01534208|7438724|FG000|NOT COMPLETED|Overall Study||57
6518177|NCT01534208|7438725|FG001|NOT COMPLETED|Overall Study||49
6518178|NCT01534260|7438733|FG000|STARTED|Overall Study||17
6518179|NCT01534260|7438734|FG001|STARTED|Overall Study||20
6518180|NCT01534260|7438733|FG000|COMPLETED|Overall Study||1
6518181|NCT01534260|7438734|FG001|COMPLETED|Overall Study||0
6518182|NCT01534260|7438733|FG000|NOT COMPLETED|Overall Study||16
6518183|NCT01534260|7438734|FG001|NOT COMPLETED|Overall Study||20
6518184|NCT01534273|7438744|FG000|STARTED|Period 1||3
6518185|NCT01534273|7438745|FG001|STARTED|Period 1||6
6518186|NCT01534273|7438746|FG002|STARTED|Period 1||2
6518187|NCT01534273|7438747|FG003|STARTED|Period 1||7
6518188|NCT01534273|7438748|FG004|STARTED|Period 1||3
6518189|NCT01534273|7438749|FG005|STARTED|Period 1||3
6518190|NCT01534273|7438750|FG006|STARTED|Period 1||6
6518191|NCT01534273|7438744|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
6518192|NCT01534273|7438745|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
6518193|NCT01534273|7438746|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
6518194|NCT01534273|7438747|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
6518195|NCT01534273|7438748|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
6641341|NCT02342314|7569786|FG013|NOT COMPLETED|Part B||0
6641342|NCT02342314|7569787|FG014|NOT COMPLETED|Part B||0
6641343|NCT02342314|7569788|FG015|NOT COMPLETED|Part B||0
6641344|NCT02342314|7569789|FG016|NOT COMPLETED|Part B||0
6641345|NCT02342327|7569862|FG000|STARTED|Overall Study||60
6641346|NCT02342327|7569863|FG001|STARTED|Overall Study||62
6641347|NCT02342327|7569862|FG000|Completed Quit Day Visit|Overall Study||54
6641348|NCT02342327|7569863|FG001|Completed Quit Day Visit|Overall Study||53
6518196|NCT01534273|7438749|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
6518197|NCT01534273|7438750|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
6518198|NCT01534273|7438744|FG000|COMPLETED|Period 1||3
6518199|NCT01534273|7438745|FG001|COMPLETED|Period 1||6
6518200|NCT01534273|7438746|FG002|COMPLETED|Period 1||2
6518201|NCT01534273|7438747|FG003|COMPLETED|Period 1||6
6518202|NCT01534273|7438748|FG004|COMPLETED|Period 1||3
6518203|NCT01534273|7438749|FG005|COMPLETED|Period 1||3
6518204|NCT01534273|7438750|FG006|COMPLETED|Period 1||6
6518205|NCT01534273|7438744|FG000|NOT COMPLETED|Period 1||0
6518206|NCT01534273|7438745|FG001|NOT COMPLETED|Period 1||0
6518207|NCT01534273|7438746|FG002|NOT COMPLETED|Period 1||0
6518208|NCT01534273|7438747|FG003|NOT COMPLETED|Period 1||1
6518209|NCT01534273|7438748|FG004|NOT COMPLETED|Period 1||0
6518210|NCT01534273|7438749|FG005|NOT COMPLETED|Period 1||0
6518211|NCT01534273|7438750|FG006|NOT COMPLETED|Period 1||0
6518212|NCT01534273|7438744|FG000|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
6518213|NCT01534273|7438745|FG001|STARTED|Period 2|Participants in Cohort A participated in only 1 treatment period.|0
6518214|NCT01534273|7438746|FG002|STARTED|Period 2||2
6518215|NCT01534273|7438747|FG003|STARTED|Period 2||6
6641349|NCT02342327|7569862|FG000|COMPLETED|Overall Study||39
6641350|NCT02342327|7569863|FG001|COMPLETED|Overall Study||40
6518216|NCT01534273|7438748|FG004|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
6518217|NCT01534273|7438749|FG005|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
6518218|NCT01534273|7438750|FG006|STARTED|Period 2|Participants in Cohort C participated in only 1 treatment period.|0
6518219|NCT01534273|7438744|FG000|COMPLETED|Period 2||0
6518220|NCT01534273|7438745|FG001|COMPLETED|Period 2||0
6518221|NCT01534273|7438746|FG002|COMPLETED|Period 2||2
6518222|NCT01534273|7438747|FG003|COMPLETED|Period 2||6
6518223|NCT01534273|7438748|FG004|COMPLETED|Period 2||0
6518224|NCT01534273|7438749|FG005|COMPLETED|Period 2||0
6518225|NCT01534273|7438750|FG006|COMPLETED|Period 2||0
6518226|NCT01534273|7438744|FG000|NOT COMPLETED|Period 2||0
6641351|NCT02342327|7569862|FG000|NOT COMPLETED|Overall Study||21
6641352|NCT02342327|7569863|FG001|NOT COMPLETED|Overall Study||22
6641353|NCT02342379|7569869|FG000|STARTED|Overall Study||35
6641354|NCT02342379|7569869|FG000|COMPLETED|Overall Study||35
6641355|NCT02342379|7569869|FG000|NOT COMPLETED|Overall Study||0
6641356|NCT02342418|7569875|FG000|STARTED|Overall Study||9
6641357|NCT02342418|7569876|FG001|STARTED|Overall Study||10
6641358|NCT02342418|7569875|FG000|COMPLETED|Overall Study||9
6641359|NCT02342418|7569876|FG001|COMPLETED|Overall Study||9
6641360|NCT02342418|7569875|FG000|NOT COMPLETED|Overall Study||0
6641361|NCT02342418|7569876|FG001|NOT COMPLETED|Overall Study||1
6641362|NCT02342535|7569882|FG000|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
6641363|NCT02342535|7569882|FG000|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
6641364|NCT02342535|7569882|FG000|NOT COMPLETED|Overall Study||0
6641365|NCT02342548|7569889|FG000|STARTED|Overall Study||51
6641366|NCT02342548|7569890|FG001|STARTED|Overall Study||71
6641367|NCT02342548|7569891|FG002|STARTED|Overall Study||66
6641368|NCT02342548|7569889|FG000|COMPLETED|Overall Study||17
6641369|NCT02342548|7569890|FG001|COMPLETED|Overall Study||9
6641370|NCT02342548|7569891|FG002|COMPLETED|Overall Study||23
6641371|NCT02342548|7569889|FG000|NOT COMPLETED|Overall Study||34
6641372|NCT02342548|7569890|FG001|NOT COMPLETED|Overall Study||62
6641373|NCT02342548|7569891|FG002|NOT COMPLETED|Overall Study||43
6641374|NCT02342561|7569899|FG000|STARTED|Overall Study||20
6641375|NCT02342561|7569899|FG000|COMPLETED|Overall Study||20
6641376|NCT02342561|7569899|FG000|NOT COMPLETED|Overall Study||0
6641377|NCT02342639|7569909|FG000|STARTED|Overall Study||19
6641378|NCT02342639|7569910|FG001|STARTED|Overall Study||19
6641379|NCT02342639|7569909|FG000|COMPLETED|Overall Study||17
6641380|NCT02342639|7569910|FG001|COMPLETED|Overall Study||14
6641381|NCT02342639|7569909|FG000|NOT COMPLETED|Overall Study||2
6641382|NCT02342639|7569910|FG001|NOT COMPLETED|Overall Study||5
6641383|NCT02342678|7569920|FG000|STARTED|Overall Study||28
6641384|NCT02342678|7569921|FG001|STARTED|Overall Study||28
6641385|NCT02342678|7569920|FG000|COMPLETED|Overall Study||27
6641386|NCT02342678|7569921|FG001|COMPLETED|Overall Study||23
6641387|NCT02342678|7569920|FG000|NOT COMPLETED|Overall Study||1
6641388|NCT02342678|7569921|FG001|NOT COMPLETED|Overall Study||5
6641389|NCT02342704|7569929|FG000|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
6641390|NCT02342704|7569930|FG001|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
6641391|NCT02342704|7569929|FG000|COMPLETED|Overall Study||1
6641392|NCT02342704|7569930|FG001|COMPLETED|Overall Study||3
6641393|NCT02342704|7569929|FG000|NOT COMPLETED|Overall Study||53
6641394|NCT02342704|7569930|FG001|NOT COMPLETED|Overall Study||51
6641395|NCT02342743|7569936|FG000|STARTED|Baseline Period||73
6641396|NCT02342743|7569936|FG000|COMPLETED|Baseline Period||58
6641397|NCT02342743|7569936|FG000|NOT COMPLETED|Baseline Period||15
6641398|NCT02342743|7569936|FG000|STARTED|Treatment Period|7 patients didn't meet inclusion criteria for treatment period, evaluated at the end of the baseline|58
6641399|NCT02342743|7569936|FG000|COMPLETED|Treatment Period||47
6641400|NCT02342743|7569936|FG000|NOT COMPLETED|Treatment Period||11
6641401|NCT02342886|7569945|FG000|STARTED|Overall Study||65
6641402|NCT02342886|7569946|FG001|STARTED|Overall Study||71
6641403|NCT02342886|7569947|FG002|STARTED|Overall Study||67
6641404|NCT02342886|7569948|FG003|STARTED|Overall Study||68
6641405|NCT02342886|7569949|FG004|STARTED|Overall Study||13
6641406|NCT02342886|7569945|FG000|Completed Month 12 Follow-Up|Overall Study||43
6518227|NCT01534273|7438745|FG001|NOT COMPLETED|Period 2||0
6518228|NCT01534273|7438746|FG002|NOT COMPLETED|Period 2||0
6518229|NCT01534273|7438747|FG003|NOT COMPLETED|Period 2||0
6641407|NCT02342886|7569946|FG001|Completed Month 12 Follow-Up|Overall Study||52
6641408|NCT02342886|7569947|FG002|Completed Month 12 Follow-Up|Overall Study||49
6641409|NCT02342886|7569948|FG003|Completed Month 12 Follow-Up|Overall Study||57
6641410|NCT02342886|7569949|FG004|Completed Month 12 Follow-Up|Overall Study||10
6641411|NCT02342886|7569945|FG000|Completed Month 24 Follow-Up|Overall Study||40
6641412|NCT02342886|7569946|FG001|Completed Month 24 Follow-Up|Overall Study||47
6641413|NCT02342886|7569947|FG002|Completed Month 24 Follow-Up|Overall Study||46
6641414|NCT02342886|7569948|FG003|Completed Month 24 Follow-Up|Overall Study||53
6641415|NCT02342886|7569949|FG004|Completed Month 24 Follow-Up|Overall Study||10
6641416|NCT02342886|7569945|FG000|COMPLETED|Overall Study||57
6641417|NCT02342886|7569946|FG001|COMPLETED|Overall Study||63
6641418|NCT02342886|7569947|FG002|COMPLETED|Overall Study||52
6641419|NCT02342886|7569948|FG003|COMPLETED|Overall Study||59
6641420|NCT02342886|7569949|FG004|COMPLETED|Overall Study||10
6518230|NCT01534273|7438748|FG004|NOT COMPLETED|Period 2||0
6518231|NCT01534273|7438749|FG005|NOT COMPLETED|Period 2||0
6518232|NCT01534273|7438750|FG006|NOT COMPLETED|Period 2||0
6518233|NCT01534351|7438774|FG000|STARTED|Overall Study||1
6518234|NCT01534351|7438775|FG001|STARTED|Overall Study||0
6518235|NCT01534351|7438776|FG002|STARTED|Overall Study||0
6518236|NCT01534351|7438774|FG000|COMPLETED|Overall Study||0
6518237|NCT01534351|7438775|FG001|COMPLETED|Overall Study||0
6518238|NCT01534351|7438776|FG002|COMPLETED|Overall Study||0
6518239|NCT01534351|7438774|FG000|NOT COMPLETED|Overall Study||1
6518240|NCT01534351|7438775|FG001|NOT COMPLETED|Overall Study||0
6518241|NCT01534351|7438776|FG002|NOT COMPLETED|Overall Study||0
6518242|NCT01534416|7438786|FG000|STARTED|Overall Study||68
6518243|NCT01534416|7438787|FG001|STARTED|Overall Study||64
6518244|NCT01534416|7438786|FG000|COMPLETED|Overall Study||68
6518245|NCT01534416|7438787|FG001|COMPLETED|Overall Study||64
6518246|NCT01534416|7438786|FG000|NOT COMPLETED|Overall Study||0
6518247|NCT01534416|7438787|FG001|NOT COMPLETED|Overall Study||0
6518248|NCT01534520|7438805|FG000|STARTED|Overall Study||30
6518249|NCT01534520|7438806|FG001|STARTED|Overall Study||29
6518250|NCT01534520|7438805|FG000|COMPLETED|Overall Study||30
6518251|NCT01534520|7438806|FG001|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
6518252|NCT01534520|7438805|FG000|NOT COMPLETED|Overall Study||0
6518253|NCT01534520|7438806|FG001|NOT COMPLETED|Overall Study||1
6518254|NCT01534533|7438820|FG000|STARTED|Overall Study||48
6518255|NCT01534533|7438821|FG001|STARTED|Overall Study||48
6518256|NCT01534533|7438822|FG002|STARTED|Overall Study||48
6518257|NCT01534533|7438823|FG003|STARTED|Overall Study||48
6518258|NCT01534533|7438820|FG000|COMPLETED|Overall Study||40
6518259|NCT01534533|7438821|FG001|COMPLETED|Overall Study||45
6518260|NCT01534533|7438822|FG002|COMPLETED|Overall Study||40
6518261|NCT01534533|7438823|FG003|COMPLETED|Overall Study||44
6518262|NCT01534533|7438820|FG000|NOT COMPLETED|Overall Study||8
6518263|NCT01534533|7438821|FG001|NOT COMPLETED|Overall Study||3
6518264|NCT01534533|7438822|FG002|NOT COMPLETED|Overall Study||8
6518265|NCT01534533|7438823|FG003|NOT COMPLETED|Overall Study||4
6518266|NCT01534637|7438835|FG000|STARTED|Overall Study||22
6518267|NCT01534637|7438835|FG000|COMPLETED|Overall Study||13
6518268|NCT01534637|7438835|FG000|NOT COMPLETED|Overall Study||9
6518269|NCT01534663|7438841|FG000|STARTED|Overall Study||14
6518270|NCT01534663|7438842|FG001|STARTED|Overall Study||17
6518271|NCT01534663|7438841|FG000|COMPLETED|Overall Study||12
6518272|NCT01534663|7438842|FG001|COMPLETED|Overall Study||14
6518273|NCT01534663|7438841|FG000|NOT COMPLETED|Overall Study||2
6518274|NCT01534663|7438842|FG001|NOT COMPLETED|Overall Study||3
6518275|NCT01534689|7438848|FG000|STARTED|Overall Study||105
6518276|NCT01534689|7438848|FG000|COMPLETED|Overall Study||105
6518277|NCT01534689|7438848|FG000|NOT COMPLETED|Overall Study||0
6518278|NCT01534897|7438852|FG000|STARTED|Overall Study||10
6518279|NCT01534897|7438852|FG000|Day 25 Iodine-131 Scan|Overall Study||10
6518280|NCT01534897|7438852|FG000|Day 37 Iodine-131 Treatment|Overall Study||6
6518281|NCT01534897|7438852|FG000|COMPLETED|Overall Study||10
6518282|NCT01534897|7438852|FG000|NOT COMPLETED|Overall Study||0
6518283|NCT01534910|7438859|FG000|STARTED|Overall Study||33
6518284|NCT01534910|7438860|FG001|STARTED|Overall Study||32
6518285|NCT01534910|7438859|FG000|COMPLETED|Overall Study||29
6518286|NCT01534910|7438860|FG001|COMPLETED|Overall Study||28
6518287|NCT01534910|7438859|FG000|NOT COMPLETED|Overall Study||4
6518288|NCT01534910|7438860|FG001|NOT COMPLETED|Overall Study||4
6561500|NCT01794455|7484343|FG000|STARTED|Overall Study||0
6561501|NCT01794455|7484344|FG001|STARTED|Overall Study||1
6561502|NCT01794455|7484343|FG000|COMPLETED|Overall Study||0
6561503|NCT01794455|7484344|FG001|COMPLETED|Overall Study||1
6561504|NCT01794455|7484343|FG000|NOT COMPLETED|Overall Study||0
6561505|NCT01794455|7484344|FG001|NOT COMPLETED|Overall Study||0
6561506|NCT01794689|7484354|FG000|STARTED|Intervention 1 (2 Nights)||25
6561507|NCT01794689|7484355|FG001|STARTED|Intervention 1 (2 Nights)||29
6561508|NCT01794689|7484356|FG002|STARTED|Intervention 1 (2 Nights)||24
6561509|NCT01794689|7484357|FG003|STARTED|Intervention 1 (2 Nights)||22
6561510|NCT01794689|7484354|FG000|COMPLETED|Intervention 1 (2 Nights)||20
6561511|NCT01794689|7484355|FG001|COMPLETED|Intervention 1 (2 Nights)||27
6561512|NCT01794689|7484356|FG002|COMPLETED|Intervention 1 (2 Nights)||21
6561513|NCT01794689|7484357|FG003|COMPLETED|Intervention 1 (2 Nights)||18
6561514|NCT01794689|7484354|FG000|NOT COMPLETED|Intervention 1 (2 Nights)||5
6561515|NCT01794689|7484355|FG001|NOT COMPLETED|Intervention 1 (2 Nights)||2
6561516|NCT01794689|7484356|FG002|NOT COMPLETED|Intervention 1 (2 Nights)||3
6561517|NCT01794689|7484357|FG003|NOT COMPLETED|Intervention 1 (2 Nights)||4
6561518|NCT01794689|7484354|FG000|STARTED|Washout (2 Weeks)||20
6561519|NCT01794689|7484355|FG001|STARTED|Washout (2 Weeks)||27
6561520|NCT01794689|7484356|FG002|STARTED|Washout (2 Weeks)||21
6561521|NCT01794689|7484357|FG003|STARTED|Washout (2 Weeks)||18
6561522|NCT01794689|7484354|FG000|COMPLETED|Washout (2 Weeks)||20
6561523|NCT01794689|7484355|FG001|COMPLETED|Washout (2 Weeks)||27
6561524|NCT01794689|7484356|FG002|COMPLETED|Washout (2 Weeks)||21
6561525|NCT01794689|7484357|FG003|COMPLETED|Washout (2 Weeks)||18
6561526|NCT01794689|7484354|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6561527|NCT01794689|7484355|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6561528|NCT01794689|7484356|FG002|NOT COMPLETED|Washout (2 Weeks)||0
6561529|NCT01794689|7484357|FG003|NOT COMPLETED|Washout (2 Weeks)||0
6561530|NCT01794689|7484354|FG000|STARTED|Intervention 2 (2 Nights)||20
6518289|NCT01534962|7438872|FG000|STARTED|Overall Study||67
6518290|NCT01534962|7438873|FG001|STARTED|Overall Study||60
6518291|NCT01534962|7438874|FG002|STARTED|Overall Study||58
6518292|NCT01534962|7438875|FG003|STARTED|Overall Study||56
6518293|NCT01534962|7438872|FG000|COMPLETED|Overall Study||30
6518294|NCT01534962|7438873|FG001|COMPLETED|Overall Study||34
6518295|NCT01534962|7438874|FG002|COMPLETED|Overall Study||34
6518296|NCT01534962|7438875|FG003|COMPLETED|Overall Study||24
6518297|NCT01534962|7438872|FG000|NOT COMPLETED|Overall Study||37
6518298|NCT01534962|7438873|FG001|NOT COMPLETED|Overall Study||26
6518299|NCT01534962|7438874|FG002|NOT COMPLETED|Overall Study||24
6518300|NCT01534962|7438875|FG003|NOT COMPLETED|Overall Study||32
6518301|NCT01534975|7438889|FG000|STARTED|Overall Study||136
6518302|NCT01534975|7438890|FG001|STARTED|Overall Study||133
6518303|NCT01534975|7438891|FG002|STARTED|Overall Study||160
6518304|NCT01534975|7438892|FG003|STARTED|Overall Study||84
6518305|NCT01534975|7438889|FG000|COMPLETED|Overall Study||136
6518306|NCT01534975|7438890|FG001|COMPLETED|Overall Study||133
6518307|NCT01534975|7438891|FG002|COMPLETED|Overall Study||160
6518308|NCT01534975|7438892|FG003|COMPLETED|Overall Study||84
6518309|NCT01534975|7438889|FG000|NOT COMPLETED|Overall Study||0
6518310|NCT01534975|7438890|FG001|NOT COMPLETED|Overall Study||0
6518311|NCT01534975|7438891|FG002|NOT COMPLETED|Overall Study||0
6518312|NCT01534975|7438892|FG003|NOT COMPLETED|Overall Study||0
6518313|NCT01535001|7438904|FG000|STARTED|Overall Study||50
6518314|NCT01535001|7438905|FG001|STARTED|Overall Study||50
6518315|NCT01535001|7438904|FG000|COMPLETED|Overall Study||47
6518316|NCT01535001|7438905|FG001|COMPLETED|Overall Study||44
6518317|NCT01535001|7438904|FG000|NOT COMPLETED|Overall Study||3
6518318|NCT01535001|7438905|FG001|NOT COMPLETED|Overall Study||6
6518319|NCT01535014|7438915|FG000|STARTED|Overall Study||210
6518320|NCT01535014|7438916|FG001|STARTED|Overall Study||200
6518321|NCT01535014|7438917|FG002|STARTED|Overall Study||50
6518322|NCT01535014|7438918|FG003|STARTED|Overall Study||33
6518323|NCT01535014|7438915|FG000|COMPLETED|Overall Study||208
6518324|NCT01535014|7438916|FG001|COMPLETED|Overall Study||194
6518325|NCT01535014|7438917|FG002|COMPLETED|Overall Study||49
6518326|NCT01535014|7438918|FG003|COMPLETED|Overall Study||33
6518327|NCT01535014|7438915|FG000|NOT COMPLETED|Overall Study||2
6518328|NCT01535014|7438916|FG001|NOT COMPLETED|Overall Study||6
6518329|NCT01535014|7438917|FG002|NOT COMPLETED|Overall Study||1
6518330|NCT01535014|7438918|FG003|NOT COMPLETED|Overall Study||0
6518331|NCT01535040|7438928|FG000|STARTED|Overall Study||65
6518332|NCT01535040|7438929|FG001|STARTED|Overall Study||65
6518333|NCT01535040|7438928|FG000|COMPLETED|Overall Study||35
6518334|NCT01535040|7438929|FG001|COMPLETED|Overall Study||44
6518335|NCT01535040|7438928|FG000|NOT COMPLETED|Overall Study||30
6518336|NCT01535040|7438929|FG001|NOT COMPLETED|Overall Study||21
6518337|NCT01535053|7438937|FG000|STARTED|Overall Study||29
6518338|NCT01535053|7438938|FG001|STARTED|Overall Study||28
6518339|NCT01535053|7438937|FG000|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|28
6518340|NCT01535053|7438938|FG001|COMPLETED|Overall Study|treated for 3 cycles after hCG <5mIU/ml or until biologic,disease progression, unacceptable toxicity|26
6518341|NCT01535053|7438937|FG000|NOT COMPLETED|Overall Study||1
6518342|NCT01535053|7438938|FG001|NOT COMPLETED|Overall Study||2
6518343|NCT01535118|7438944|FG000|STARTED|Overall Study||2765
6518344|NCT01535118|7438944|FG000|COMPLETED|Overall Study||2765
6518345|NCT01535118|7438944|FG000|NOT COMPLETED|Overall Study||0
6518346|NCT01535222|7438954|FG000|STARTED|Overall Study||3
6518347|NCT01535222|7438955|FG001|STARTED|Overall Study||3
6518348|NCT01535222|7438956|FG002|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
6518349|NCT01535222|7438957|FG003|STARTED|Overall Study||6
6518350|NCT01535222|7438958|FG004|STARTED|Overall Study||6
6518351|NCT01535222|7438959|FG005|STARTED|Overall Study||8
6518352|NCT01535222|7438954|FG000|COMPLETED|Overall Study||3
6518353|NCT01535222|7438955|FG001|COMPLETED|Overall Study||3
6518354|NCT01535222|7438956|FG002|COMPLETED|Overall Study||6
6518355|NCT01535222|7438957|FG003|COMPLETED|Overall Study||6
6518356|NCT01535222|7438958|FG004|COMPLETED|Overall Study||6
6518357|NCT01535222|7438959|FG005|COMPLETED|Overall Study||8
6518358|NCT01535222|7438954|FG000|NOT COMPLETED|Overall Study||0
6518359|NCT01535222|7438955|FG001|NOT COMPLETED|Overall Study||0
6518360|NCT01535222|7438956|FG002|NOT COMPLETED|Overall Study||1
6518361|NCT01535222|7438957|FG003|NOT COMPLETED|Overall Study||0
6518362|NCT01535222|7438958|FG004|NOT COMPLETED|Overall Study||0
6518363|NCT01535222|7438959|FG005|NOT COMPLETED|Overall Study||0
6518364|NCT01535235|7438975|FG000|STARTED|Overall Study||16
6518365|NCT01535235|7438976|FG001|STARTED|Overall Study||15
6518366|NCT01535235|7438975|FG000|COMPLETED|Overall Study||15
6518367|NCT01535235|7438976|FG001|COMPLETED|Overall Study||15
6518368|NCT01535235|7438975|FG000|NOT COMPLETED|Overall Study||1
6518369|NCT01535235|7438976|FG001|NOT COMPLETED|Overall Study||0
6518370|NCT01535261|7438982|FG000|STARTED|Overall Study||357
6518371|NCT01535261|7438982|FG000|COMPLETED|Overall Study||307
6518372|NCT01535261|7438982|FG000|NOT COMPLETED|Overall Study||50
6518373|NCT01535287|7438988|FG000|STARTED|Overall Study||70
6518374|NCT01535287|7438989|FG001|STARTED|Overall Study||70
6518375|NCT01535287|7438988|FG000|COMPLETED|Overall Study||65
6518376|NCT01535287|7438989|FG001|COMPLETED|Overall Study||64
6518377|NCT01535287|7438988|FG000|NOT COMPLETED|Overall Study||5
6518378|NCT01535287|7438989|FG001|NOT COMPLETED|Overall Study||6
6518379|NCT01535326|7438998|FG000|STARTED|Overall Study||90
6518380|NCT01535326|7438999|FG001|STARTED|Overall Study||90
6518381|NCT01535326|7439000|FG002|STARTED|Overall Study||90
6518382|NCT01535326|7438998|FG000|COMPLETED|Overall Study||90
6518383|NCT01535326|7438999|FG001|COMPLETED|Overall Study||90
6518384|NCT01535326|7439000|FG002|COMPLETED|Overall Study||90
6518385|NCT01535326|7438998|FG000|NOT COMPLETED|Overall Study||0
6518386|NCT01535326|7438999|FG001|NOT COMPLETED|Overall Study||0
6518387|NCT01535326|7439000|FG002|NOT COMPLETED|Overall Study||0
6518388|NCT01535365|7439013|FG000|STARTED|Overall Study||31
6518389|NCT01535365|7439014|FG001|STARTED|Overall Study||29
6518390|NCT01535365|7439013|FG000|COMPLETED|Overall Study||31
6518391|NCT01535365|7439014|FG001|COMPLETED|Overall Study||29
6518392|NCT01535365|7439013|FG000|NOT COMPLETED|Overall Study||0
6518393|NCT01535365|7439014|FG001|NOT COMPLETED|Overall Study||0
6518394|NCT01535443|7439022|FG000|STARTED|Overall Study||35
6518395|NCT01535443|7439022|FG000|COMPLETED|Overall Study||32
6518396|NCT01535443|7439022|FG000|NOT COMPLETED|Overall Study||3
6518397|NCT01535560|7439029|FG000|STARTED|Overall Study||274
6518398|NCT01535560|7439030|FG001|STARTED|Overall Study||275
6518399|NCT01535560|7439029|FG000|COMPLETED|Overall Study||237
6518400|NCT01535560|7439030|FG001|COMPLETED|Overall Study||179
6518401|NCT01535560|7439029|FG000|NOT COMPLETED|Overall Study||37
6518402|NCT01535560|7439030|FG001|NOT COMPLETED|Overall Study||96
6518403|NCT01535573|7439039|FG000|STARTED|Overall Study||21
6518404|NCT01535573|7439040|FG001|STARTED|Overall Study||44
6518405|NCT01535573|7439041|FG002|STARTED|Overall Study||43
6518406|NCT01535573|7439039|FG000|COMPLETED|Overall Study||13
6518407|NCT01535573|7439040|FG001|COMPLETED|Overall Study||23
6518408|NCT01535573|7439041|FG002|COMPLETED|Overall Study||24
6518409|NCT01535573|7439039|FG000|NOT COMPLETED|Overall Study||8
6518410|NCT01535573|7439040|FG001|NOT COMPLETED|Overall Study||21
6518411|NCT01535573|7439041|FG002|NOT COMPLETED|Overall Study||19
6518412|NCT01535599|7439051|FG000|STARTED|Overall Study||347
6518413|NCT01535599|7439052|FG001|STARTED|Overall Study||346
6518414|NCT01535599|7439051|FG000|COMPLETED|Overall Study||297
6518415|NCT01535599|7439052|FG001|COMPLETED|Overall Study||250
6518416|NCT01535599|7439051|FG000|NOT COMPLETED|Overall Study||50
6518417|NCT01535599|7439052|FG001|NOT COMPLETED|Overall Study||96
6518418|NCT01535638|7439058|FG000|STARTED|Treatment 1 (Single Dose)||3
6518419|NCT01535638|7439059|FG001|STARTED|Treatment 1 (Single Dose)||3
6518420|NCT01535638|7439060|FG002|STARTED|Treatment 1 (Single Dose)||3
6518421|NCT01535638|7439061|FG003|STARTED|Treatment 1 (Single Dose)||3
6518422|NCT01535638|7439062|FG004|STARTED|Treatment 1 (Single Dose)||3
6518423|NCT01535638|7439063|FG005|STARTED|Treatment 1 (Single Dose)||3
6518424|NCT01535638|7439058|FG000|COMPLETED|Treatment 1 (Single Dose)||3
6518425|NCT01535638|7439059|FG001|COMPLETED|Treatment 1 (Single Dose)||3
6518426|NCT01535638|7439060|FG002|COMPLETED|Treatment 1 (Single Dose)||3
6518427|NCT01535638|7439061|FG003|COMPLETED|Treatment 1 (Single Dose)||3
6518428|NCT01535638|7439062|FG004|COMPLETED|Treatment 1 (Single Dose)||3
6518429|NCT01535638|7439063|FG005|COMPLETED|Treatment 1 (Single Dose)||2
6518430|NCT01535638|7439058|FG000|NOT COMPLETED|Treatment 1 (Single Dose)||0
6518431|NCT01535638|7439059|FG001|NOT COMPLETED|Treatment 1 (Single Dose)||0
6518432|NCT01535638|7439060|FG002|NOT COMPLETED|Treatment 1 (Single Dose)||0
6518433|NCT01535638|7439061|FG003|NOT COMPLETED|Treatment 1 (Single Dose)||0
6518434|NCT01535638|7439062|FG004|NOT COMPLETED|Treatment 1 (Single Dose)||0
6518435|NCT01535638|7439063|FG005|NOT COMPLETED|Treatment 1 (Single Dose)||1
6518436|NCT01535638|7439058|FG000|STARTED|Treatment 2 (Single Dose)||3
6518437|NCT01535638|7439059|FG001|STARTED|Treatment 2 (Single Dose)||3
6518438|NCT01535638|7439060|FG002|STARTED|Treatment 2 (Single Dose)||3
6518439|NCT01535638|7439061|FG003|STARTED|Treatment 2 (Single Dose)||3
6518440|NCT01535638|7439062|FG004|STARTED|Treatment 2 (Single Dose)||3
6518441|NCT01535638|7439063|FG005|STARTED|Treatment 2 (Single Dose)||2
6518442|NCT01535638|7439058|FG000|COMPLETED|Treatment 2 (Single Dose)||3
6518443|NCT01535638|7439059|FG001|COMPLETED|Treatment 2 (Single Dose)||3
6518444|NCT01535638|7439060|FG002|COMPLETED|Treatment 2 (Single Dose)||3
6518445|NCT01535638|7439061|FG003|COMPLETED|Treatment 2 (Single Dose)||3
6518446|NCT01535638|7439062|FG004|COMPLETED|Treatment 2 (Single Dose)||3
6518447|NCT01535638|7439063|FG005|COMPLETED|Treatment 2 (Single Dose)||2
6518448|NCT01535638|7439058|FG000|NOT COMPLETED|Treatment 2 (Single Dose)||0
6518449|NCT01535638|7439059|FG001|NOT COMPLETED|Treatment 2 (Single Dose)||0
6518450|NCT01535638|7439060|FG002|NOT COMPLETED|Treatment 2 (Single Dose)||0
6518451|NCT01535638|7439061|FG003|NOT COMPLETED|Treatment 2 (Single Dose)||0
6518452|NCT01535638|7439062|FG004|NOT COMPLETED|Treatment 2 (Single Dose)||0
6518453|NCT01535638|7439063|FG005|NOT COMPLETED|Treatment 2 (Single Dose)||0
6518454|NCT01535638|7439058|FG000|STARTED|Treatment 3 (Single Dose)||3
6518455|NCT01535638|7439059|FG001|STARTED|Treatment 3 (Single Dose)||3
6518456|NCT01535638|7439060|FG002|STARTED|Treatment 3 (Single Dose)||3
6518457|NCT01535638|7439061|FG003|STARTED|Treatment 3 (Single Dose)||3
6518458|NCT01535638|7439062|FG004|STARTED|Treatment 3 (Single Dose)||3
6518459|NCT01535638|7439063|FG005|STARTED|Treatment 3 (Single Dose)||2
6518460|NCT01535638|7439058|FG000|COMPLETED|Treatment 3 (Single Dose)||3
6518461|NCT01535638|7439059|FG001|COMPLETED|Treatment 3 (Single Dose)||3
6518462|NCT01535638|7439060|FG002|COMPLETED|Treatment 3 (Single Dose)||3
6518463|NCT01535638|7439061|FG003|COMPLETED|Treatment 3 (Single Dose)||2
6518464|NCT01535638|7439062|FG004|COMPLETED|Treatment 3 (Single Dose)||3
6518465|NCT01535638|7439063|FG005|COMPLETED|Treatment 3 (Single Dose)||2
6518466|NCT01535638|7439058|FG000|NOT COMPLETED|Treatment 3 (Single Dose)||0
6518467|NCT01535638|7439059|FG001|NOT COMPLETED|Treatment 3 (Single Dose)||0
6518468|NCT01535638|7439060|FG002|NOT COMPLETED|Treatment 3 (Single Dose)||0
6518469|NCT01535638|7439061|FG003|NOT COMPLETED|Treatment 3 (Single Dose)||1
6518470|NCT01535638|7439062|FG004|NOT COMPLETED|Treatment 3 (Single Dose)||0
6518471|NCT01535638|7439063|FG005|NOT COMPLETED|Treatment 3 (Single Dose)||0
6518472|NCT01535664|7439072|FG000|STARTED|Overall Study||20
6518473|NCT01535664|7439072|FG000|COMPLETED|Overall Study||20
6518474|NCT01535664|7439072|FG000|NOT COMPLETED|Overall Study||0
6518475|NCT01535729|7439080|FG000|STARTED|Overall Study||465
6518476|NCT01535729|7439080|FG000|Treated|Overall Study||385
6518477|NCT01535729|7439080|FG000|COMPLETED|Overall Study||49
6518478|NCT01535729|7439080|FG000|NOT COMPLETED|Overall Study||416
6518479|NCT01535924|7439090|FG000|STARTED|Overall Study||3
6518480|NCT01535924|7439091|FG001|STARTED|Overall Study||3
6518481|NCT01535924|7439092|FG002|STARTED|Overall Study||3
6518482|NCT01535924|7439093|FG003|STARTED|Overall Study||4
6518483|NCT01535924|7439094|FG004|STARTED|Overall Study||6
6518484|NCT01535924|7439095|FG005|STARTED|Overall Study||7
6518485|NCT01535924|7439090|FG000|COMPLETED|Overall Study||3
6518486|NCT01535924|7439091|FG001|COMPLETED|Overall Study||3
6518487|NCT01535924|7439092|FG002|COMPLETED|Overall Study||3
6518488|NCT01535924|7439093|FG003|COMPLETED|Overall Study||4
6518489|NCT01535924|7439094|FG004|COMPLETED|Overall Study||6
6518490|NCT01535924|7439095|FG005|COMPLETED|Overall Study||7
6518491|NCT01535924|7439090|FG000|NOT COMPLETED|Overall Study||0
6518492|NCT01535924|7439091|FG001|NOT COMPLETED|Overall Study||0
6641421|NCT02342886|7569945|FG000|NOT COMPLETED|Overall Study||8
6641422|NCT02342886|7569946|FG001|NOT COMPLETED|Overall Study||8
6641423|NCT02342886|7569947|FG002|NOT COMPLETED|Overall Study||15
6641424|NCT02342886|7569948|FG003|NOT COMPLETED|Overall Study||9
6641425|NCT02342886|7569949|FG004|NOT COMPLETED|Overall Study||3
6641426|NCT02343003|7569963|FG000|STARTED|Overall Study||76
6641427|NCT02343003|7569964|FG001|STARTED|Overall Study||75
6641428|NCT02343003|7569963|FG000|COMPLETED|Overall Study||58
6641429|NCT02343003|7569964|FG001|COMPLETED|Overall Study||68
6641430|NCT02343003|7569963|FG000|NOT COMPLETED|Overall Study||18
6641431|NCT02343003|7569964|FG001|NOT COMPLETED|Overall Study||7
6641432|NCT02343081|7569972|FG000|STARTED|First Intervention (Day 3)||8
6641433|NCT02343081|7569973|FG001|STARTED|First Intervention (Day 3)||8
6641434|NCT02343081|7569972|FG000|Received Intervention|First Intervention (Day 3)||8
6641435|NCT02343081|7569973|FG001|Received Intervention|First Intervention (Day 3)||8
6641436|NCT02343081|7569972|FG000|COMPLETED|First Intervention (Day 3)||8
6641437|NCT02343081|7569973|FG001|COMPLETED|First Intervention (Day 3)||8
6641438|NCT02343081|7569972|FG000|NOT COMPLETED|First Intervention (Day 3)||0
6641439|NCT02343081|7569973|FG001|NOT COMPLETED|First Intervention (Day 3)||0
6641440|NCT02343081|7569972|FG000|STARTED|Washout (10 Hours)||8
6641441|NCT02343081|7569973|FG001|STARTED|Washout (10 Hours)||8
6641442|NCT02343081|7569972|FG000|COMPLETED|Washout (10 Hours)||8
6641443|NCT02343081|7569973|FG001|COMPLETED|Washout (10 Hours)||8
6641444|NCT02343081|7569972|FG000|NOT COMPLETED|Washout (10 Hours)||0
6641445|NCT02343081|7569973|FG001|NOT COMPLETED|Washout (10 Hours)||0
6641446|NCT02343081|7569972|FG000|STARTED|Second Intervention (Day 4)||8
6641447|NCT02343081|7569973|FG001|STARTED|Second Intervention (Day 4)||8
6641448|NCT02343081|7569972|FG000|Received Intervention|Second Intervention (Day 4)||8
6641449|NCT02343081|7569973|FG001|Received Intervention|Second Intervention (Day 4)||8
6641450|NCT02343081|7569972|FG000|COMPLETED|Second Intervention (Day 4)||8
6641451|NCT02343081|7569973|FG001|COMPLETED|Second Intervention (Day 4)||8
6641452|NCT02343081|7569972|FG000|NOT COMPLETED|Second Intervention (Day 4)||0
6641453|NCT02343081|7569973|FG001|NOT COMPLETED|Second Intervention (Day 4)||0
6641454|NCT02343276|7569981|FG000|STARTED|Overall Study||164
6641455|NCT02343276|7569982|FG001|STARTED|Overall Study||164
6641456|NCT02343276|7569981|FG000|COMPLETED|Overall Study||164
6641457|NCT02343276|7569982|FG001|COMPLETED|Overall Study||164
6641458|NCT02343276|7569981|FG000|NOT COMPLETED|Overall Study||0
6641459|NCT02343276|7569982|FG001|NOT COMPLETED|Overall Study||0
6641460|NCT02343380|7569990|FG000|STARTED|Overall Study|Morning test (first week)|10
6641461|NCT02343380|7569991|FG001|STARTED|Overall Study|Evening test (first week)|10
6641462|NCT02343380|7569990|FG000|COMPLETED|Overall Study|Evening test (second week)|10
6641463|NCT02343380|7569991|FG001|COMPLETED|Overall Study|Morning test (second week)|10
6641464|NCT02343380|7569990|FG000|NOT COMPLETED|Overall Study||0
6641465|NCT02343380|7569991|FG001|NOT COMPLETED|Overall Study||0
6641466|NCT02343406|7570012|FG000|STARTED|Overall Study||88
6641467|NCT02343406|7570013|FG001|STARTED|Overall Study||86
6641468|NCT02343406|7570014|FG002|STARTED|Overall Study||60
6641469|NCT02343406|7570015|FG003|STARTED|Overall Study||26
6641470|NCT02343406|7570016|FG004|STARTED|Overall Study||6
6641471|NCT02343406|7570012|FG000|COMPLETED|Overall Study||0
6518493|NCT01535924|7439092|FG002|NOT COMPLETED|Overall Study||0
6518494|NCT01535924|7439093|FG003|NOT COMPLETED|Overall Study||0
6518495|NCT01535924|7439094|FG004|NOT COMPLETED|Overall Study||0
6641472|NCT02343406|7570013|FG001|COMPLETED|Overall Study||0
6641473|NCT02343406|7570014|FG002|COMPLETED|Overall Study||2
6641474|NCT02343406|7570015|FG003|COMPLETED|Overall Study||0
6641475|NCT02343406|7570016|FG004|COMPLETED|Overall Study||1
6641476|NCT02343406|7570012|FG000|NOT COMPLETED|Overall Study||88
6641477|NCT02343406|7570013|FG001|NOT COMPLETED|Overall Study||86
6641478|NCT02343406|7570014|FG002|NOT COMPLETED|Overall Study||58
6641479|NCT02343406|7570015|FG003|NOT COMPLETED|Overall Study||26
6518496|NCT01535924|7439095|FG005|NOT COMPLETED|Overall Study||0
6518497|NCT01535937|7439112|FG000|STARTED|Overall Study||27
6518498|NCT01535937|7439113|FG001|STARTED|Overall Study||28
6518499|NCT01535937|7439112|FG000|COMPLETED|Overall Study||27
6518500|NCT01535937|7439113|FG001|COMPLETED|Overall Study||28
6518501|NCT01535937|7439112|FG000|NOT COMPLETED|Overall Study||0
6518502|NCT01535937|7439113|FG001|NOT COMPLETED|Overall Study||0
6518503|NCT01535976|7439121|FG000|STARTED|Overall Study||27
6518504|NCT01535976|7439122|FG001|STARTED|Overall Study||27
6518505|NCT01535976|7439121|FG000|COMPLETED|Overall Study||26
6518506|NCT01535976|7439122|FG001|COMPLETED|Overall Study||26
6518507|NCT01535976|7439121|FG000|NOT COMPLETED|Overall Study||1
6518508|NCT01535976|7439122|FG001|NOT COMPLETED|Overall Study||1
6518509|NCT01536067|7439128|FG000|STARTED|Overall Study||3
6518510|NCT01536067|7439128|FG000|COMPLETED|Overall Study||2
6518511|NCT01536067|7439128|FG000|NOT COMPLETED|Overall Study||1
6518512|NCT01536093|7439134|FG000|STARTED|Overall Study||24
6518513|NCT01536093|7439135|FG001|STARTED|Overall Study||24
6518514|NCT01536093|7439134|FG000|COMPLETED|Overall Study||21
6518515|NCT01536093|7439135|FG001|COMPLETED|Overall Study||21
6518516|NCT01536093|7439134|FG000|NOT COMPLETED|Overall Study||3
6518517|NCT01536093|7439135|FG001|NOT COMPLETED|Overall Study||3
6518518|NCT01536119|7439143|FG000|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
6518519|NCT01536119|7439144|FG001|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
6518520|NCT01536119|7439143|FG000|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
6518521|NCT01536119|7439144|FG001|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
6518522|NCT01536119|7439143|FG000|NOT COMPLETED|Overall Study||17
6518523|NCT01536119|7439144|FG001|NOT COMPLETED|Overall Study||14
6518524|NCT01536145|7439150|FG000|STARTED|Overall Study||3
6518525|NCT01536145|7439151|FG001|STARTED|Overall Study||4
6518526|NCT01536145|7439152|FG002|STARTED|Overall Study||3
6518527|NCT01536145|7439153|FG003|STARTED|Overall Study||3
6518528|NCT01536145|7439154|FG004|STARTED|Overall Study||4
6518529|NCT01536145|7439155|FG005|STARTED|Overall Study||3
6518530|NCT01536145|7439156|FG006|STARTED|Overall Study||3
6518531|NCT01536145|7439157|FG007|STARTED|Overall Study||4
6518532|NCT01536145|7439158|FG008|STARTED|Overall Study||3
6518533|NCT01536145|7439159|FG009|STARTED|Overall Study||7
6518534|NCT01536145|7439160|FG010|STARTED|Overall Study||10
6518535|NCT01536145|7439150|FG000|COMPLETED|Overall Study||0
6518536|NCT01536145|7439151|FG001|COMPLETED|Overall Study||0
6518537|NCT01536145|7439152|FG002|COMPLETED|Overall Study||1
6518538|NCT01536145|7439153|FG003|COMPLETED|Overall Study||1
6518539|NCT01536145|7439154|FG004|COMPLETED|Overall Study||2
6518540|NCT01536145|7439155|FG005|COMPLETED|Overall Study||0
6518541|NCT01536145|7439156|FG006|COMPLETED|Overall Study||1
6518542|NCT01536145|7439157|FG007|COMPLETED|Overall Study||0
6518543|NCT01536145|7439158|FG008|COMPLETED|Overall Study||0
6518544|NCT01536145|7439159|FG009|COMPLETED|Overall Study||1
6518545|NCT01536145|7439160|FG010|COMPLETED|Overall Study||0
6518546|NCT01536145|7439150|FG000|NOT COMPLETED|Overall Study||3
6518547|NCT01536145|7439151|FG001|NOT COMPLETED|Overall Study||4
6518548|NCT01536145|7439152|FG002|NOT COMPLETED|Overall Study||2
6518549|NCT01536145|7439153|FG003|NOT COMPLETED|Overall Study||2
6518550|NCT01536145|7439154|FG004|NOT COMPLETED|Overall Study||2
6518551|NCT01536145|7439155|FG005|NOT COMPLETED|Overall Study||3
6518552|NCT01536145|7439156|FG006|NOT COMPLETED|Overall Study||2
6518553|NCT01536145|7439157|FG007|NOT COMPLETED|Overall Study||4
6518554|NCT01536145|7439158|FG008|NOT COMPLETED|Overall Study||3
6518555|NCT01536145|7439159|FG009|NOT COMPLETED|Overall Study||6
6518556|NCT01536145|7439160|FG010|NOT COMPLETED|Overall Study||10
6518557|NCT01536171|7439191|FG000|STARTED|Overall Study||22
6518558|NCT01536171|7439191|FG000|COMPLETED|Overall Study||21
6518559|NCT01536171|7439191|FG000|NOT COMPLETED|Overall Study||1
6518560|NCT01536184|7439198|FG000|STARTED|Overall Study||8
6518561|NCT01536184|7439199|FG001|STARTED|Overall Study||4
6518562|NCT01536184|7439198|FG000|COMPLETED|Overall Study||8
6518563|NCT01536184|7439199|FG001|COMPLETED|Overall Study||4
6518564|NCT01536184|7439198|FG000|NOT COMPLETED|Overall Study||0
6518565|NCT01536184|7439199|FG001|NOT COMPLETED|Overall Study||0
6518566|NCT01536197|7439207|FG000|STARTED|Overall Study||23
6518567|NCT01536197|7439208|FG001|STARTED|Overall Study||10
6518568|NCT01536197|7439207|FG000|COMPLETED|Overall Study||23
6518569|NCT01536197|7439208|FG001|COMPLETED|Overall Study||10
6518570|NCT01536197|7439207|FG000|NOT COMPLETED|Overall Study||0
6518571|NCT01536197|7439208|FG001|NOT COMPLETED|Overall Study||0
6518572|NCT01536262|7439217|FG000|STARTED|Overall Study||41
6518573|NCT01536262|7439218|FG001|STARTED|Overall Study||40
6518574|NCT01536262|7439219|FG002|STARTED|Overall Study||41
6518575|NCT01536262|7439217|FG000|COMPLETED|Overall Study||33
6518576|NCT01536262|7439218|FG001|COMPLETED|Overall Study||38
6518577|NCT01536262|7439219|FG002|COMPLETED|Overall Study||39
6518578|NCT01536262|7439217|FG000|NOT COMPLETED|Overall Study||8
6518579|NCT01536262|7439218|FG001|NOT COMPLETED|Overall Study||2
6518580|NCT01536262|7439219|FG002|NOT COMPLETED|Overall Study||2
6518581|NCT01536366|7439230|FG000|STARTED|Overall Study||14
6518582|NCT01536366|7439231|FG001|STARTED|Overall Study||13
6518583|NCT01536366|7439230|FG000|BIA 9-1067 + Repaglinide|Overall Study||14
6518584|NCT01536366|7439231|FG001|BIA 9-1067 + Repaglinide|Overall Study||10
6518585|NCT01536366|7439230|FG000|Repaglinide|Overall Study||14
6518586|NCT01536366|7439231|FG001|Repaglinide|Overall Study||13
6518587|NCT01536366|7439230|FG000|Follow-up|Overall Study||13
6518588|NCT01536366|7439231|FG001|Follow-up|Overall Study||9
6518589|NCT01536366|7439230|FG000|COMPLETED|Overall Study||1
6518590|NCT01536366|7439231|FG001|COMPLETED|Overall Study||9
6518591|NCT01536366|7439230|FG000|NOT COMPLETED|Overall Study||13
6518592|NCT01536366|7439231|FG001|NOT COMPLETED|Overall Study||4
6518593|NCT01536379|7439239|FG000|STARTED|Overall Study||13
6518594|NCT01536379|7439240|FG001|STARTED|Overall Study||12
6518595|NCT01536379|7439239|FG000|COMPLETED|Overall Study||11
6518596|NCT01536379|7439240|FG001|COMPLETED|Overall Study||9
6518597|NCT01536379|7439239|FG000|NOT COMPLETED|Overall Study||2
6518598|NCT01536379|7439240|FG001|NOT COMPLETED|Overall Study||3
6518599|NCT01536392|7439248|FG000|STARTED|Overall Study||41
6518600|NCT01536392|7439249|FG001|STARTED|Overall Study||34
6518601|NCT01536392|7439248|FG000|COMPLETED|Overall Study||28
6518602|NCT01536392|7439249|FG001|COMPLETED|Overall Study||19
6518603|NCT01536392|7439248|FG000|NOT COMPLETED|Overall Study||13
6518604|NCT01536392|7439249|FG001|NOT COMPLETED|Overall Study||15
6518605|NCT01536405|7439257|FG000|STARTED|Randomization to Visit 1 (Vaccination 1)||706
6518606|NCT01536405|7439258|FG001|STARTED|Randomization to Visit 1 (Vaccination 1)||706
6518607|NCT01536405|7439257|FG000|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
6518608|NCT01536405|7439258|FG001|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
6641480|NCT02343406|7570016|FG004|NOT COMPLETED|Overall Study||5
6641481|NCT02343458|7570031|FG000|STARTED|Overall Study||555
6641482|NCT02343458|7570032|FG001|STARTED|Overall Study||483
6641483|NCT02343458|7570033|FG002|STARTED|Overall Study||480
6641484|NCT02343458|7570034|FG003|STARTED|Overall Study||238
6641485|NCT02343458|7570031|FG000|COMPLETED|Overall Study||494
6641486|NCT02343458|7570032|FG001|COMPLETED|Overall Study||417
6641487|NCT02343458|7570033|FG002|COMPLETED|Overall Study||417
6641488|NCT02343458|7570034|FG003|COMPLETED|Overall Study||200
6641489|NCT02343458|7570031|FG000|NOT COMPLETED|Overall Study||61
6641490|NCT02343458|7570032|FG001|NOT COMPLETED|Overall Study||66
6641491|NCT02343458|7570033|FG002|NOT COMPLETED|Overall Study||63
6641492|NCT02343458|7570034|FG003|NOT COMPLETED|Overall Study||38
6641493|NCT02343575|7570046|FG000|STARTED|Overall Study||1
6641494|NCT02343575|7570047|FG001|STARTED|Overall Study||2
6641495|NCT02343575|7570046|FG000|COMPLETED|Overall Study||1
6641496|NCT02343575|7570047|FG001|COMPLETED|Overall Study||2
6641497|NCT02343575|7570046|FG000|NOT COMPLETED|Overall Study||0
6641498|NCT02343575|7570047|FG001|NOT COMPLETED|Overall Study||0
6641499|NCT02343627|7570055|FG000|STARTED|Overall Study||35
6641500|NCT02343627|7570056|FG001|STARTED|Overall Study||12
6641501|NCT02343627|7570055|FG000|COMPLETED|Overall Study||23
6641502|NCT02343627|7570056|FG001|COMPLETED|Overall Study||11
6641503|NCT02343627|7570055|FG000|NOT COMPLETED|Overall Study||12
6641504|NCT02343627|7570056|FG001|NOT COMPLETED|Overall Study||1
6641505|NCT02343939|7570071|FG000|STARTED|Overall Study||3
6641506|NCT02343939|7570072|FG001|STARTED|Overall Study||50
6641507|NCT02343939|7570073|FG002|STARTED|Overall Study||5
6641508|NCT02343939|7570074|FG003|STARTED|Overall Study||6
6641509|NCT02343939|7570075|FG004|STARTED|Overall Study||8
6641510|NCT02343939|7570076|FG005|STARTED|Overall Study||17
6641511|NCT02343939|7570077|FG006|STARTED|Overall Study||15
6641512|NCT02343939|7570078|FG007|STARTED|Overall Study||37
6641513|NCT02343939|7570079|FG008|STARTED|Overall Study||7
6641514|NCT02343939|7570071|FG000|COMPLETED|Overall Study||0
6641515|NCT02343939|7570072|FG001|COMPLETED|Overall Study||2
6641516|NCT02343939|7570073|FG002|COMPLETED|Overall Study||0
6641517|NCT02343939|7570074|FG003|COMPLETED|Overall Study||0
6641518|NCT02343939|7570075|FG004|COMPLETED|Overall Study||0
6641519|NCT02343939|7570076|FG005|COMPLETED|Overall Study||0
6641520|NCT02343939|7570077|FG006|COMPLETED|Overall Study||0
6641521|NCT02343939|7570078|FG007|COMPLETED|Overall Study||0
6641522|NCT02343939|7570079|FG008|COMPLETED|Overall Study||0
6641523|NCT02343939|7570071|FG000|NOT COMPLETED|Overall Study||3
6641524|NCT02343939|7570072|FG001|NOT COMPLETED|Overall Study||48
6641525|NCT02343939|7570073|FG002|NOT COMPLETED|Overall Study||5
6641526|NCT02343939|7570074|FG003|NOT COMPLETED|Overall Study||6
6641527|NCT02343939|7570075|FG004|NOT COMPLETED|Overall Study||8
6641528|NCT02343939|7570076|FG005|NOT COMPLETED|Overall Study||17
6641529|NCT02343939|7570077|FG006|NOT COMPLETED|Overall Study||15
6641530|NCT02343939|7570078|FG007|NOT COMPLETED|Overall Study||37
6641531|NCT02343939|7570079|FG008|NOT COMPLETED|Overall Study||7
6641532|NCT02344004|7570115|FG000|STARTED|Overall Study||224
6641533|NCT02344004|7570116|FG001|STARTED|Overall Study||112
6641534|NCT02344004|7570115|FG000|COMPLETED|Overall Study||163
6641535|NCT02344004|7570116|FG001|COMPLETED|Overall Study||98
6641536|NCT02344004|7570115|FG000|NOT COMPLETED|Overall Study||61
6641537|NCT02344004|7570116|FG001|NOT COMPLETED|Overall Study||14
6518609|NCT01536405|7439257|FG000|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
6518610|NCT01536405|7439258|FG001|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
6518611|NCT01536405|7439257|FG000|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
6641538|NCT02344173|7570123|FG000|STARTED|Enrollment||2035
6641539|NCT02344173|7570123|FG000|COMPLETED|Enrollment||2035
6641540|NCT02344173|7570123|FG000|NOT COMPLETED|Enrollment||0
6641541|NCT02344173|7570123|FG000|STARTED|Procedure||2035
6641542|NCT02344173|7570123|FG000|COMPLETED|Procedure||2028
6641543|NCT02344173|7570123|FG000|NOT COMPLETED|Procedure||7
6641544|NCT02344173|7570123|FG000|STARTED|12-month Visit||2028
6641545|NCT02344173|7570123|FG000|COMPLETED|12-month Visit||1932
6518612|NCT01536405|7439258|FG001|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
6518613|NCT01536405|7439257|FG000|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
6518614|NCT01536405|7439258|FG001|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
6518615|NCT01536405|7439257|FG000|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
6641546|NCT02344173|7570123|FG000|NOT COMPLETED|12-month Visit||96
6641547|NCT02344225|7570132|FG000|STARTED|Overall Study||6
6641548|NCT02344225|7570133|FG001|STARTED|Overall Study||3
6641549|NCT02344225|7570134|FG002|STARTED|Overall Study||5
6641550|NCT02344225|7570132|FG000|COMPLETED|Overall Study||6
6641551|NCT02344225|7570133|FG001|COMPLETED|Overall Study||3
6641552|NCT02344225|7570134|FG002|COMPLETED|Overall Study||5
6641553|NCT02344225|7570132|FG000|NOT COMPLETED|Overall Study||0
6518616|NCT01536405|7439258|FG001|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
6518617|NCT01536405|7439257|FG000|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
6518618|NCT01536405|7439258|FG001|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
6518619|NCT01536405|7439257|FG000|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
6518620|NCT01536405|7439258|FG001|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
6518621|NCT01536405|7439257|FG000|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
6518622|NCT01536405|7439258|FG001|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
6518623|NCT01536405|7439257|FG000|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
6518624|NCT01536405|7439258|FG001|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
6518625|NCT01536405|7439257|FG000|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
6518626|NCT01536405|7439258|FG001|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
6518627|NCT01536405|7439257|FG000|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
6518628|NCT01536405|7439258|FG001|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
6518629|NCT01536405|7439257|FG000|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
6518630|NCT01536405|7439258|FG001|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
6518631|NCT01536405|7439257|FG000|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
6518632|NCT01536405|7439258|FG001|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
6641554|NCT02344225|7570133|FG001|NOT COMPLETED|Overall Study||0
6641555|NCT02344225|7570134|FG002|NOT COMPLETED|Overall Study||0
6641556|NCT02344238|7570145|FG000|STARTED|Overall Study||20
6641557|NCT02344238|7570146|FG001|STARTED|Overall Study||20
6641558|NCT02344238|7570147|FG002|STARTED|Overall Study||20
6641559|NCT02344238|7570145|FG000|COMPLETED|Overall Study||20
6641560|NCT02344238|7570146|FG001|COMPLETED|Overall Study||20
6641561|NCT02344238|7570147|FG002|COMPLETED|Overall Study||20
6641562|NCT02344238|7570145|FG000|NOT COMPLETED|Overall Study||0
6641563|NCT02344238|7570146|FG001|NOT COMPLETED|Overall Study||0
6641564|NCT02344238|7570147|FG002|NOT COMPLETED|Overall Study||0
6641565|NCT02344251|7570158|FG000|STARTED|Overall Study||20
6641566|NCT02344251|7570159|FG001|STARTED|Overall Study||20
6641567|NCT02344251|7570158|FG000|COMPLETED|Overall Study||20
6641568|NCT02344251|7570159|FG001|COMPLETED|Overall Study||20
6641569|NCT02344251|7570158|FG000|NOT COMPLETED|Overall Study||0
6641570|NCT02344251|7570159|FG001|NOT COMPLETED|Overall Study||0
6641571|NCT02344316|7570169|FG000|STARTED|Overall Study||13
6641572|NCT02344316|7570170|FG001|STARTED|Overall Study||13
6641573|NCT02344316|7570169|FG000|COMPLETED|Overall Study||12
6641574|NCT02344316|7570170|FG001|COMPLETED|Overall Study||11
6641575|NCT02344316|7570169|FG000|NOT COMPLETED|Overall Study||1
6641576|NCT02344316|7570170|FG001|NOT COMPLETED|Overall Study||2
6641577|NCT02344342|7570183|FG000|STARTED|Overall Study||13
6641578|NCT02344342|7570184|FG001|STARTED|Overall Study||11
6641579|NCT02344342|7570185|FG002|STARTED|Overall Study||14
6641580|NCT02344342|7570186|FG003|STARTED|Overall Study||13
6641581|NCT02344342|7570183|FG000|COMPLETED|Overall Study||2
6641582|NCT02344342|7570184|FG001|COMPLETED|Overall Study||2
6641583|NCT02344342|7570185|FG002|COMPLETED|Overall Study||0
6641584|NCT02344342|7570186|FG003|COMPLETED|Overall Study||3
6641585|NCT02344342|7570183|FG000|NOT COMPLETED|Overall Study||11
6641586|NCT02344342|7570184|FG001|NOT COMPLETED|Overall Study||9
6641587|NCT02344342|7570185|FG002|NOT COMPLETED|Overall Study||14
6641588|NCT02344342|7570186|FG003|NOT COMPLETED|Overall Study||10
6641589|NCT02344407|7570203|FG000|STARTED|Overall Study||500
6641590|NCT02344407|7570204|FG001|STARTED|Overall Study||500
6641591|NCT02344407|7570205|FG002|STARTED|Overall Study||500
6641592|NCT02344407|7570203|FG000|COMPLETED|Overall Study||492
6641593|NCT02344407|7570204|FG001|COMPLETED|Overall Study||491
6641594|NCT02344407|7570205|FG002|COMPLETED|Overall Study||494
6641595|NCT02344407|7570203|FG000|NOT COMPLETED|Overall Study||8
6641596|NCT02344407|7570204|FG001|NOT COMPLETED|Overall Study||9
6641597|NCT02344407|7570205|FG002|NOT COMPLETED|Overall Study||6
6641598|NCT02344576|7570217|FG000|STARTED|Enrollment|Includes 7 patients who agreed to medical record review only and were excluded from further analysis|142
6641599|NCT02344576|7570218|FG001|STARTED|Enrollment|Includes 8 patients who agreed to medical record review only and were excluded from further analysis|121
6641600|NCT02344576|7570219|FG002|STARTED|Enrollment||111
6641601|NCT02344576|7570220|FG003|STARTED|Enrollment||71
6641602|NCT02344576|7570217|FG000|Agreed to Survey Data Collection|Enrollment||135
6641603|NCT02344576|7570218|FG001|Agreed to Survey Data Collection|Enrollment||113
6641604|NCT02344576|7570219|FG002|Agreed to Survey Data Collection|Enrollment||111
6641605|NCT02344576|7570220|FG003|Agreed to Survey Data Collection|Enrollment||71
6641606|NCT02344576|7570217|FG000|COMPLETED|Enrollment||135
6518633|NCT01536405|7439257|FG000|STARTED|Visit 4 to Extended Study Follow-up||615
6518634|NCT01536405|7439258|FG001|STARTED|Visit 4 to Extended Study Follow-up||618
6518635|NCT01536405|7439257|FG000|COMPLETED|Visit 4 to Extended Study Follow-up||595
6518636|NCT01536405|7439258|FG001|COMPLETED|Visit 4 to Extended Study Follow-up||595
6518637|NCT01536405|7439257|FG000|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
6518638|NCT01536405|7439258|FG001|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
6518639|NCT01536418|7439266|FG000|STARTED|Overall Study||127
6518640|NCT01536418|7439267|FG001|STARTED|Overall Study||126
6518641|NCT01536418|7439266|FG000|COMPLETED|Overall Study||58
6518642|NCT01536418|7439267|FG001|COMPLETED|Overall Study||60
6518643|NCT01536418|7439266|FG000|NOT COMPLETED|Overall Study||69
6518644|NCT01536418|7439267|FG001|NOT COMPLETED|Overall Study||66
6518645|NCT01536496|7439276|FG000|STARTED|Overall Study||57
6518646|NCT01536496|7439277|FG001|STARTED|Overall Study||57
6518647|NCT01536496|7439276|FG000|COMPLETED|Overall Study||55
6518648|NCT01536496|7439277|FG001|COMPLETED|Overall Study||56
6518649|NCT01536496|7439276|FG000|NOT COMPLETED|Overall Study||2
6518650|NCT01536496|7439277|FG001|NOT COMPLETED|Overall Study||1
6518651|NCT01536535|7439287|FG000|STARTED|Overall Study||178
6518652|NCT01536535|7439288|FG001|STARTED|Overall Study||250
6518653|NCT01536535|7439287|FG000|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|163
6518654|NCT01536535|7439288|FG001|COMPLETED|Overall Study|Patients either completed week 52 visit or had early colectomy or had additional therapy.|237
6518655|NCT01536535|7439287|FG000|NOT COMPLETED|Overall Study||15
6518656|NCT01536535|7439288|FG001|NOT COMPLETED|Overall Study||13
6518657|NCT01536561|7439295|FG000|STARTED|Dosimetric and Therapeutic Treatment||59
6518658|NCT01536561|7439295|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
6518659|NCT01536561|7439295|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
6518660|NCT01536561|7439295|FG000|STARTED|Long-Term Follow-Up||13
6518661|NCT01536561|7439295|FG000|COMPLETED|Long-Term Follow-Up||13
6518662|NCT01536561|7439295|FG000|NOT COMPLETED|Long-Term Follow-Up||0
6518663|NCT01536574|7439304|FG000|STARTED|Overall Study||162
6518664|NCT01536574|7439305|FG001|STARTED|Overall Study||133
6518665|NCT01536574|7439304|FG000|COMPLETED|Overall Study||156
6518666|NCT01536574|7439305|FG001|COMPLETED|Overall Study||126
6518667|NCT01536574|7439304|FG000|NOT COMPLETED|Overall Study||6
6518668|NCT01536574|7439305|FG001|NOT COMPLETED|Overall Study||7
6518669|NCT01536587|7439311|FG000|STARTED|Overall Study||32
6518670|NCT01536587|7439311|FG000|COMPLETED|Overall Study||30
6518671|NCT01536587|7439311|FG000|NOT COMPLETED|Overall Study||2
6518672|NCT01536704|7439315|FG000|STARTED|Period 1||12
6518673|NCT01536704|7439316|FG001|STARTED|Period 1||12
6518674|NCT01536704|7439317|FG002|STARTED|Period 1||13
6518675|NCT01536704|7439318|FG003|STARTED|Period 1||13
6518676|NCT01536704|7439315|FG000|COMPLETED|Period 1||12
6518677|NCT01536704|7439316|FG001|COMPLETED|Period 1||12
6518678|NCT01536704|7439317|FG002|COMPLETED|Period 1||13
6518679|NCT01536704|7439318|FG003|COMPLETED|Period 1||13
6518680|NCT01536704|7439315|FG000|NOT COMPLETED|Period 1||0
6641607|NCT02344576|7570218|FG001|COMPLETED|Enrollment||113
6641608|NCT02344576|7570219|FG002|COMPLETED|Enrollment||111
6641609|NCT02344576|7570220|FG003|COMPLETED|Enrollment||71
6641610|NCT02344576|7570217|FG000|NOT COMPLETED|Enrollment||7
6641611|NCT02344576|7570218|FG001|NOT COMPLETED|Enrollment||8
6641612|NCT02344576|7570219|FG002|NOT COMPLETED|Enrollment||0
6641613|NCT02344576|7570220|FG003|NOT COMPLETED|Enrollment||0
6641614|NCT02344576|7570217|FG000|STARTED|1-Month Follow-Up||135
6641615|NCT02344576|7570218|FG001|STARTED|1-Month Follow-Up||113
6641616|NCT02344576|7570219|FG002|STARTED|1-Month Follow-Up||111
6641617|NCT02344576|7570220|FG003|STARTED|1-Month Follow-Up||71
6641618|NCT02344576|7570217|FG000|Completed 1-Month Survey|1-Month Follow-Up||104
6641619|NCT02344576|7570218|FG001|Completed 1-Month Survey|1-Month Follow-Up||79
6641620|NCT02344576|7570219|FG002|Completed 1-Month Survey|1-Month Follow-Up||89
6518681|NCT01536704|7439316|FG001|NOT COMPLETED|Period 1||0
6518682|NCT01536704|7439317|FG002|NOT COMPLETED|Period 1||0
6518683|NCT01536704|7439318|FG003|NOT COMPLETED|Period 1||0
6518684|NCT01536704|7439315|FG000|STARTED|Washout Period 1||12
6518685|NCT01536704|7439316|FG001|STARTED|Washout Period 1||12
6518686|NCT01536704|7439317|FG002|STARTED|Washout Period 1||13
6518687|NCT01536704|7439318|FG003|STARTED|Washout Period 1||13
6518688|NCT01536704|7439315|FG000|COMPLETED|Washout Period 1||11
6518689|NCT01536704|7439316|FG001|COMPLETED|Washout Period 1||10
6518690|NCT01536704|7439317|FG002|COMPLETED|Washout Period 1||13
6518691|NCT01536704|7439318|FG003|COMPLETED|Washout Period 1||13
6518692|NCT01536704|7439315|FG000|NOT COMPLETED|Washout Period 1||1
6518693|NCT01536704|7439316|FG001|NOT COMPLETED|Washout Period 1||2
6518694|NCT01536704|7439317|FG002|NOT COMPLETED|Washout Period 1||0
6518695|NCT01536704|7439318|FG003|NOT COMPLETED|Washout Period 1||0
6518696|NCT01536704|7439315|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
6518697|NCT01536704|7439316|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
6561531|NCT01794689|7484355|FG001|STARTED|Intervention 2 (2 Nights)||27
6561532|NCT01794689|7484356|FG002|STARTED|Intervention 2 (2 Nights)||21
6561533|NCT01794689|7484357|FG003|STARTED|Intervention 2 (2 Nights)||18
6561534|NCT01794689|7484354|FG000|COMPLETED|Intervention 2 (2 Nights)||20
6561535|NCT01794689|7484355|FG001|COMPLETED|Intervention 2 (2 Nights)||27
6561536|NCT01794689|7484356|FG002|COMPLETED|Intervention 2 (2 Nights)||21
6561537|NCT01794689|7484357|FG003|COMPLETED|Intervention 2 (2 Nights)||18
6561538|NCT01794689|7484354|FG000|NOT COMPLETED|Intervention 2 (2 Nights)||0
6561539|NCT01794689|7484355|FG001|NOT COMPLETED|Intervention 2 (2 Nights)||0
6518698|NCT01536704|7439317|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
6518699|NCT01536704|7439318|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
6518700|NCT01536704|7439315|FG000|COMPLETED|Period 2||13
6518701|NCT01536704|7439316|FG001|COMPLETED|Period 2||11
6518702|NCT01536704|7439317|FG002|COMPLETED|Period 2||10
6518703|NCT01536704|7439318|FG003|COMPLETED|Period 2||13
6518704|NCT01536704|7439315|FG000|NOT COMPLETED|Period 2||0
6518705|NCT01536704|7439316|FG001|NOT COMPLETED|Period 2||0
6518706|NCT01536704|7439317|FG002|NOT COMPLETED|Period 2||0
6518707|NCT01536704|7439318|FG003|NOT COMPLETED|Period 2||0
6518708|NCT01536704|7439315|FG000|STARTED|Washout Period 2||13
6518709|NCT01536704|7439316|FG001|STARTED|Washout Period 2||11
6518710|NCT01536704|7439317|FG002|STARTED|Washout Period 2||10
6518711|NCT01536704|7439318|FG003|STARTED|Washout Period 2||13
6518712|NCT01536704|7439315|FG000|COMPLETED|Washout Period 2||12
6518713|NCT01536704|7439316|FG001|COMPLETED|Washout Period 2||11
6518714|NCT01536704|7439317|FG002|COMPLETED|Washout Period 2||10
6518715|NCT01536704|7439318|FG003|COMPLETED|Washout Period 2||12
6518716|NCT01536704|7439315|FG000|NOT COMPLETED|Washout Period 2||1
6518717|NCT01536704|7439316|FG001|NOT COMPLETED|Washout Period 2||0
6518718|NCT01536704|7439317|FG002|NOT COMPLETED|Washout Period 2||0
6518719|NCT01536704|7439318|FG003|NOT COMPLETED|Washout Period 2||1
6518720|NCT01536704|7439315|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
6518721|NCT01536704|7439316|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6518722|NCT01536704|7439317|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6518723|NCT01536704|7439318|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
6518724|NCT01536704|7439315|FG000|COMPLETED|Period 3||10
6518725|NCT01536704|7439316|FG001|COMPLETED|Period 3||12
6518726|NCT01536704|7439317|FG002|COMPLETED|Period 3||12
6518727|NCT01536704|7439318|FG003|COMPLETED|Period 3||10
6518728|NCT01536704|7439315|FG000|NOT COMPLETED|Period 3||0
6518729|NCT01536704|7439316|FG001|NOT COMPLETED|Period 3||0
6518730|NCT01536704|7439317|FG002|NOT COMPLETED|Period 3||0
6518731|NCT01536704|7439318|FG003|NOT COMPLETED|Period 3||1
6518732|NCT01536704|7439315|FG000|STARTED|Washout Period 3||10
6518733|NCT01536704|7439316|FG001|STARTED|Washout Period 3||12
6518734|NCT01536704|7439317|FG002|STARTED|Washout Period 3||12
6518735|NCT01536704|7439318|FG003|STARTED|Washout Period 3||10
6518736|NCT01536704|7439315|FG000|COMPLETED|Washout Period 3||10
6518737|NCT01536704|7439316|FG001|COMPLETED|Washout Period 3||12
6518738|NCT01536704|7439317|FG002|COMPLETED|Washout Period 3||11
6518739|NCT01536704|7439318|FG003|COMPLETED|Washout Period 3||10
6518740|NCT01536704|7439315|FG000|NOT COMPLETED|Washout Period 3||0
6518741|NCT01536704|7439316|FG001|NOT COMPLETED|Washout Period 3||0
6518742|NCT01536704|7439317|FG002|NOT COMPLETED|Washout Period 3||1
6518743|NCT01536704|7439318|FG003|NOT COMPLETED|Washout Period 3||0
6518744|NCT01536704|7439315|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
6518745|NCT01536704|7439316|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
6518746|NCT01536704|7439317|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
6518747|NCT01536704|7439318|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
6518748|NCT01536704|7439315|FG000|COMPLETED|Period 4||12
6641621|NCT02344576|7570220|FG003|Completed 1-Month Survey|1-Month Follow-Up||53
6641622|NCT02344576|7570217|FG000|COMPLETED|1-Month Follow-Up|Includes 13 patients who were still enrolled at 1-month but did not complete the 1-month survey.|117
6641623|NCT02344576|7570218|FG001|COMPLETED|1-Month Follow-Up|Includes 7 patients who were still enrolled at 1-month but did not complete the 1-month survey.|86
6641624|NCT02344576|7570219|FG002|COMPLETED|1-Month Follow-Up|Includes 3 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|92
6641625|NCT02344576|7570220|FG003|COMPLETED|1-Month Follow-Up|Includes 5 caregivers who were still enrolled at 1-month but did not complete the 1-month survey.|58
6641626|NCT02344576|7570217|FG000|NOT COMPLETED|1-Month Follow-Up||18
6641627|NCT02344576|7570218|FG001|NOT COMPLETED|1-Month Follow-Up||27
6641628|NCT02344576|7570219|FG002|NOT COMPLETED|1-Month Follow-Up||19
6641629|NCT02344576|7570220|FG003|NOT COMPLETED|1-Month Follow-Up||13
6641630|NCT02344576|7570217|FG000|STARTED|6-Month Follow-Up||117
6641631|NCT02344576|7570218|FG001|STARTED|6-Month Follow-Up||86
6641632|NCT02344576|7570219|FG002|STARTED|6-Month Follow-Up||92
6641633|NCT02344576|7570220|FG003|STARTED|6-Month Follow-Up||58
6641634|NCT02344576|7570217|FG000|Completed 6-Month Survey|6-Month Follow-Up||98
6641635|NCT02344576|7570218|FG001|Completed 6-Month Survey|6-Month Follow-Up||67
6641636|NCT02344576|7570219|FG002|Completed 6-Month Survey|6-Month Follow-Up||78
6641637|NCT02344576|7570220|FG003|Completed 6-Month Survey|6-Month Follow-Up||50
6641638|NCT02344576|7570217|FG000|COMPLETED|6-Month Follow-Up||98
6641639|NCT02344576|7570218|FG001|COMPLETED|6-Month Follow-Up||67
6641640|NCT02344576|7570219|FG002|COMPLETED|6-Month Follow-Up||78
6641641|NCT02344576|7570220|FG003|COMPLETED|6-Month Follow-Up||50
6518749|NCT01536704|7439316|FG001|COMPLETED|Period 4||11
6518750|NCT01536704|7439317|FG002|COMPLETED|Period 4||10
6518751|NCT01536704|7439318|FG003|COMPLETED|Period 4||10
6518752|NCT01536704|7439315|FG000|NOT COMPLETED|Period 4||0
6518753|NCT01536704|7439316|FG001|NOT COMPLETED|Period 4||0
6518754|NCT01536704|7439317|FG002|NOT COMPLETED|Period 4||0
6518755|NCT01536704|7439318|FG003|NOT COMPLETED|Period 4||0
6518756|NCT01536795|7439334|FG000|STARTED|Overall Study||24
6518757|NCT01536795|7439335|FG001|STARTED|Overall Study||24
6518758|NCT01536795|7439334|FG000|COMPLETED|Overall Study||23
6518759|NCT01536795|7439335|FG001|COMPLETED|Overall Study||22
6518760|NCT01536795|7439334|FG000|NOT COMPLETED|Overall Study||1
6518761|NCT01536795|7439335|FG001|NOT COMPLETED|Overall Study||2
6518762|NCT01536860|7439341|FG000|STARTED|First Intervention (1 Day)||4
6518763|NCT01536860|7439342|FG001|STARTED|First Intervention (1 Day)||4
6518764|NCT01536860|7439343|FG002|STARTED|First Intervention (1 Day)||4
6518765|NCT01536860|7439341|FG000|COMPLETED|First Intervention (1 Day)||4
6518766|NCT01536860|7439342|FG001|COMPLETED|First Intervention (1 Day)||4
6518767|NCT01536860|7439343|FG002|COMPLETED|First Intervention (1 Day)||4
6518768|NCT01536860|7439341|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6518769|NCT01536860|7439342|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6518770|NCT01536860|7439343|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6518771|NCT01536860|7439341|FG000|STARTED|Washout Period (3 Days)||4
6518772|NCT01536860|7439342|FG001|STARTED|Washout Period (3 Days)||4
6518773|NCT01536860|7439343|FG002|STARTED|Washout Period (3 Days)||4
6518774|NCT01536860|7439341|FG000|COMPLETED|Washout Period (3 Days)||4
6518775|NCT01536860|7439342|FG001|COMPLETED|Washout Period (3 Days)||4
6518776|NCT01536860|7439343|FG002|COMPLETED|Washout Period (3 Days)||4
6518777|NCT01536860|7439341|FG000|NOT COMPLETED|Washout Period (3 Days)||0
6518778|NCT01536860|7439342|FG001|NOT COMPLETED|Washout Period (3 Days)||0
6518779|NCT01536860|7439343|FG002|NOT COMPLETED|Washout Period (3 Days)||0
6518780|NCT01536860|7439341|FG000|STARTED|Second Intervention (1 Day)||4
6518781|NCT01536860|7439342|FG001|STARTED|Second Intervention (1 Day)||4
6518782|NCT01536860|7439343|FG002|STARTED|Second Intervention (1 Day)||4
6518783|NCT01536860|7439341|FG000|COMPLETED|Second Intervention (1 Day)||4
6518784|NCT01536860|7439342|FG001|COMPLETED|Second Intervention (1 Day)||4
6518785|NCT01536860|7439343|FG002|COMPLETED|Second Intervention (1 Day)||4
6518786|NCT01536860|7439341|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6518787|NCT01536860|7439342|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6518788|NCT01536860|7439343|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6518789|NCT01536860|7439341|FG000|STARTED|Washout Period (3 Days)||4
6518790|NCT01536860|7439342|FG001|STARTED|Washout Period (3 Days)||4
6518791|NCT01536860|7439343|FG002|STARTED|Washout Period (3 Days)||4
6518792|NCT01536860|7439341|FG000|COMPLETED|Washout Period (3 Days)||3
6518793|NCT01536860|7439342|FG001|COMPLETED|Washout Period (3 Days)||4
6518794|NCT01536860|7439343|FG002|COMPLETED|Washout Period (3 Days)||4
6518795|NCT01536860|7439341|FG000|NOT COMPLETED|Washout Period (3 Days)||1
6518796|NCT01536860|7439342|FG001|NOT COMPLETED|Washout Period (3 Days)||0
6518797|NCT01536860|7439343|FG002|NOT COMPLETED|Washout Period (3 Days)||0
6518798|NCT01536860|7439341|FG000|STARTED|Third Intervention (1 Day)||3
6518799|NCT01536860|7439342|FG001|STARTED|Third Intervention (1 Day)||4
6518800|NCT01536860|7439343|FG002|STARTED|Third Intervention (1 Day)||4
6518801|NCT01536860|7439341|FG000|COMPLETED|Third Intervention (1 Day)||3
6518802|NCT01536860|7439342|FG001|COMPLETED|Third Intervention (1 Day)||4
6518803|NCT01536860|7439343|FG002|COMPLETED|Third Intervention (1 Day)||4
6518804|NCT01536860|7439341|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6518805|NCT01536860|7439342|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6518806|NCT01536860|7439343|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6518807|NCT01536886|7439355|FG000|STARTED|Overall Study||141
6518808|NCT01536886|7439356|FG001|STARTED|Overall Study||135
6518809|NCT01536886|7439357|FG002|STARTED|Overall Study||49
6518810|NCT01536886|7439358|FG003|STARTED|Overall Study||51
6518811|NCT01536886|7439355|FG000|COMPLETED|Overall Study||136
6518812|NCT01536886|7439356|FG001|COMPLETED|Overall Study||127
6518813|NCT01536886|7439357|FG002|COMPLETED|Overall Study||47
6518814|NCT01536886|7439358|FG003|COMPLETED|Overall Study||48
6518815|NCT01536886|7439355|FG000|NOT COMPLETED|Overall Study||5
6518816|NCT01536886|7439356|FG001|NOT COMPLETED|Overall Study||8
6518817|NCT01536886|7439357|FG002|NOT COMPLETED|Overall Study||2
6518818|NCT01536886|7439358|FG003|NOT COMPLETED|Overall Study||3
6518819|NCT01536938|7439371|FG000|STARTED|Overall Study||100
6518820|NCT01536938|7439372|FG001|STARTED|Overall Study||101
6518821|NCT01536938|7439373|FG002|STARTED|Overall Study||101
6518822|NCT01536938|7439371|FG000|COMPLETED|Overall Study||94
6518823|NCT01536938|7439372|FG001|COMPLETED|Overall Study||94
6518824|NCT01536938|7439373|FG002|COMPLETED|Overall Study||93
6518825|NCT01536938|7439371|FG000|NOT COMPLETED|Overall Study||6
6518826|NCT01536938|7439372|FG001|NOT COMPLETED|Overall Study||7
6518827|NCT01536938|7439373|FG002|NOT COMPLETED|Overall Study||8
6518828|NCT01536951|7439383|FG000|STARTED|First Intervention and Washout Period 1||3
6518829|NCT01536951|7439384|FG001|STARTED|First Intervention and Washout Period 1||3
6518830|NCT01536951|7439385|FG002|STARTED|First Intervention and Washout Period 1||3
6518831|NCT01536951|7439386|FG003|STARTED|First Intervention and Washout Period 1||8
6518832|NCT01536951|7439387|FG004|STARTED|First Intervention and Washout Period 1||9
6518833|NCT01536951|7439388|FG005|STARTED|First Intervention and Washout Period 1||9
6518834|NCT01536951|7439389|FG006|STARTED|First Intervention and Washout Period 1||9
6518835|NCT01536951|7439390|FG007|STARTED|First Intervention and Washout Period 1||9
6518836|NCT01536951|7439391|FG008|STARTED|First Intervention and Washout Period 1||9
6561540|NCT01794689|7484356|FG002|NOT COMPLETED|Intervention 2 (2 Nights)||0
6518837|NCT01536951|7439383|FG000|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
6518838|NCT01536951|7439384|FG001|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
6518839|NCT01536951|7439385|FG002|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
6518840|NCT01536951|7439386|FG003|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
6518841|NCT01536951|7439387|FG004|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6518842|NCT01536951|7439388|FG005|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6518843|NCT01536951|7439389|FG006|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6518844|NCT01536951|7439390|FG007|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6518845|NCT01536951|7439391|FG008|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
6518846|NCT01536951|7439383|FG000|COMPLETED|First Intervention and Washout Period 1||3
6518847|NCT01536951|7439384|FG001|COMPLETED|First Intervention and Washout Period 1||3
6518848|NCT01536951|7439385|FG002|COMPLETED|First Intervention and Washout Period 1||2
6518849|NCT01536951|7439386|FG003|COMPLETED|First Intervention and Washout Period 1||8
6518850|NCT01536951|7439387|FG004|COMPLETED|First Intervention and Washout Period 1||9
6518851|NCT01536951|7439388|FG005|COMPLETED|First Intervention and Washout Period 1||9
6518852|NCT01536951|7439389|FG006|COMPLETED|First Intervention and Washout Period 1||9
6518853|NCT01536951|7439390|FG007|COMPLETED|First Intervention and Washout Period 1||9
6518854|NCT01536951|7439391|FG008|COMPLETED|First Intervention and Washout Period 1||9
6518855|NCT01536951|7439383|FG000|NOT COMPLETED|First Intervention and Washout Period 1||0
6518856|NCT01536951|7439384|FG001|NOT COMPLETED|First Intervention and Washout Period 1||0
6518857|NCT01536951|7439385|FG002|NOT COMPLETED|First Intervention and Washout Period 1||1
6518858|NCT01536951|7439386|FG003|NOT COMPLETED|First Intervention and Washout Period 1||0
6518859|NCT01536951|7439387|FG004|NOT COMPLETED|First Intervention and Washout Period 1||0
6518860|NCT01536951|7439388|FG005|NOT COMPLETED|First Intervention and Washout Period 1||0
6518861|NCT01536951|7439389|FG006|NOT COMPLETED|First Intervention and Washout Period 1||0
6518862|NCT01536951|7439390|FG007|NOT COMPLETED|First Intervention and Washout Period 1||0
6641642|NCT02344576|7570217|FG000|NOT COMPLETED|6-Month Follow-Up||19
6641643|NCT02344576|7570218|FG001|NOT COMPLETED|6-Month Follow-Up||19
6641644|NCT02344576|7570219|FG002|NOT COMPLETED|6-Month Follow-Up||14
6641645|NCT02344576|7570220|FG003|NOT COMPLETED|6-Month Follow-Up||8
6641646|NCT02344576|7570217|FG000|STARTED|12-Month Medical Record Follow-Up||98
6641647|NCT02344576|7570218|FG001|STARTED|12-Month Medical Record Follow-Up||67
6641648|NCT02344576|7570219|FG002|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
6641649|NCT02344576|7570220|FG003|STARTED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
6641650|NCT02344576|7570217|FG000|COMPLETED|12-Month Medical Record Follow-Up||98
6641651|NCT02344576|7570218|FG001|COMPLETED|12-Month Medical Record Follow-Up||67
6641652|NCT02344576|7570219|FG002|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|78
6641653|NCT02344576|7570220|FG003|COMPLETED|12-Month Medical Record Follow-Up|This period not applicable to caregivers, as medical record review was completed for patients only.|50
6641654|NCT02344576|7570217|FG000|NOT COMPLETED|12-Month Medical Record Follow-Up||0
6641655|NCT02344576|7570218|FG001|NOT COMPLETED|12-Month Medical Record Follow-Up||0
6641656|NCT02344576|7570219|FG002|NOT COMPLETED|12-Month Medical Record Follow-Up||0
6641657|NCT02344576|7570220|FG003|NOT COMPLETED|12-Month Medical Record Follow-Up||0
6641658|NCT02344628|7570234|FG000|STARTED|Overall Study||291
6641659|NCT02344628|7570235|FG001|STARTED|Overall Study||292
6641660|NCT02344628|7570234|FG000|COMPLETED|Overall Study|4/52 clinical data was available for 283. Serological data 6/12 for 212. Both were available for 200|200
6641661|NCT02344628|7570235|FG001|COMPLETED|Overall Study|4/52 clinical data was available for 286. Serological data 6/12 for 218. Both were available for 206|206
6641662|NCT02344628|7570234|FG000|NOT COMPLETED|Overall Study||91
6641663|NCT02344628|7570235|FG001|NOT COMPLETED|Overall Study||86
6641664|NCT02344745|7570243|FG000|STARTED|Overall Study||40
6641665|NCT02344745|7570244|FG001|STARTED|Overall Study||40
6641666|NCT02344745|7570243|FG000|COMPLETED|Overall Study||38
6641667|NCT02344745|7570244|FG001|COMPLETED|Overall Study||40
6641668|NCT02344745|7570243|FG000|NOT COMPLETED|Overall Study||2
6641669|NCT02344745|7570244|FG001|NOT COMPLETED|Overall Study||0
6641670|NCT02345031|7570252|FG000|STARTED|Overall Study||38
6641671|NCT02345031|7570253|FG001|STARTED|Overall Study||40
6641672|NCT02345031|7570252|FG000|COMPLETED|Overall Study||37
6641673|NCT02345031|7570253|FG001|COMPLETED|Overall Study||39
6641674|NCT02345031|7570252|FG000|NOT COMPLETED|Overall Study||1
6641675|NCT02345031|7570253|FG001|NOT COMPLETED|Overall Study||1
6641676|NCT02345161|7570263|FG000|STARTED|Overall Study||911
6641677|NCT02345161|7570264|FG001|STARTED|Overall Study||899
6641678|NCT02345161|7570263|FG000|COMPLETED|Overall Study||866
6641679|NCT02345161|7570264|FG001|COMPLETED|Overall Study||842
6641680|NCT02345161|7570263|FG000|NOT COMPLETED|Overall Study||45
6641681|NCT02345161|7570264|FG001|NOT COMPLETED|Overall Study||57
6641682|NCT02345226|7570277|FG000|STARTED|Double-Blind Phase||440
6641683|NCT02345226|7570278|FG001|STARTED|Double-Blind Phase||441
6641684|NCT02345226|7570277|FG000|COMPLETED|Double-Blind Phase||371
6641685|NCT02345226|7570278|FG001|COMPLETED|Double-Blind Phase||370
6641686|NCT02345226|7570277|FG000|NOT COMPLETED|Double-Blind Phase||69
6518863|NCT01536951|7439391|FG008|NOT COMPLETED|First Intervention and Washout Period 1||0
6518864|NCT01536951|7439383|FG000|STARTED|Second Intervention and Washout Period 2||3
6518865|NCT01536951|7439384|FG001|STARTED|Second Intervention and Washout Period 2||3
6518866|NCT01536951|7439385|FG002|STARTED|Second Intervention and Washout Period 2||2
6518867|NCT01536951|7439386|FG003|STARTED|Second Intervention and Washout Period 2||8
6518868|NCT01536951|7439387|FG004|STARTED|Second Intervention and Washout Period 2||9
6518869|NCT01536951|7439388|FG005|STARTED|Second Intervention and Washout Period 2||9
6518870|NCT01536951|7439389|FG006|STARTED|Second Intervention and Washout Period 2||9
6518871|NCT01536951|7439390|FG007|STARTED|Second Intervention and Washout Period 2||9
6518872|NCT01536951|7439391|FG008|STARTED|Second Intervention and Washout Period 2||9
6518873|NCT01536951|7439383|FG000|COMPLETED|Second Intervention and Washout Period 2||3
6518874|NCT01536951|7439384|FG001|COMPLETED|Second Intervention and Washout Period 2||3
6518875|NCT01536951|7439385|FG002|COMPLETED|Second Intervention and Washout Period 2||2
6518876|NCT01536951|7439386|FG003|COMPLETED|Second Intervention and Washout Period 2||8
6518877|NCT01536951|7439387|FG004|COMPLETED|Second Intervention and Washout Period 2||9
6518878|NCT01536951|7439388|FG005|COMPLETED|Second Intervention and Washout Period 2||9
6518879|NCT01536951|7439389|FG006|COMPLETED|Second Intervention and Washout Period 2||9
6518880|NCT01536951|7439390|FG007|COMPLETED|Second Intervention and Washout Period 2||8
6518881|NCT01536951|7439391|FG008|COMPLETED|Second Intervention and Washout Period 2||9
6518882|NCT01536951|7439383|FG000|NOT COMPLETED|Second Intervention and Washout Period 2||0
6518883|NCT01536951|7439384|FG001|NOT COMPLETED|Second Intervention and Washout Period 2||0
6518884|NCT01536951|7439385|FG002|NOT COMPLETED|Second Intervention and Washout Period 2||0
6518885|NCT01536951|7439386|FG003|NOT COMPLETED|Second Intervention and Washout Period 2||0
6518886|NCT01536951|7439387|FG004|NOT COMPLETED|Second Intervention and Washout Period 2||0
6518887|NCT01536951|7439388|FG005|NOT COMPLETED|Second Intervention and Washout Period 2||0
6518888|NCT01536951|7439389|FG006|NOT COMPLETED|Second Intervention and Washout Period 2||0
6518889|NCT01536951|7439390|FG007|NOT COMPLETED|Second Intervention and Washout Period 2||1
6518890|NCT01536951|7439391|FG008|NOT COMPLETED|Second Intervention and Washout Period 2||0
6518891|NCT01536951|7439383|FG000|STARTED|Third Intervention||3
6518892|NCT01536951|7439384|FG001|STARTED|Third Intervention||3
6518893|NCT01536951|7439385|FG002|STARTED|Third Intervention||2
6518894|NCT01536951|7439386|FG003|STARTED|Third Intervention||8
6518895|NCT01536951|7439387|FG004|STARTED|Third Intervention||9
6518896|NCT01536951|7439388|FG005|STARTED|Third Intervention||9
6518897|NCT01536951|7439389|FG006|STARTED|Third Intervention||9
6518898|NCT01536951|7439390|FG007|STARTED|Third Intervention||8
6518899|NCT01536951|7439391|FG008|STARTED|Third Intervention||9
6518900|NCT01536951|7439383|FG000|COMPLETED|Third Intervention||3
6518901|NCT01536951|7439384|FG001|COMPLETED|Third Intervention||3
6518902|NCT01536951|7439385|FG002|COMPLETED|Third Intervention||2
6518903|NCT01536951|7439386|FG003|COMPLETED|Third Intervention||8
6518904|NCT01536951|7439387|FG004|COMPLETED|Third Intervention||9
6518905|NCT01536951|7439388|FG005|COMPLETED|Third Intervention||9
6518906|NCT01536951|7439389|FG006|COMPLETED|Third Intervention||9
6518907|NCT01536951|7439390|FG007|COMPLETED|Third Intervention||8
6518908|NCT01536951|7439391|FG008|COMPLETED|Third Intervention||9
6518909|NCT01536951|7439383|FG000|NOT COMPLETED|Third Intervention||0
6518910|NCT01536951|7439384|FG001|NOT COMPLETED|Third Intervention||0
6518911|NCT01536951|7439385|FG002|NOT COMPLETED|Third Intervention||0
6518912|NCT01536951|7439386|FG003|NOT COMPLETED|Third Intervention||0
6518913|NCT01536951|7439387|FG004|NOT COMPLETED|Third Intervention||0
6518914|NCT01536951|7439388|FG005|NOT COMPLETED|Third Intervention||0
6518915|NCT01536951|7439389|FG006|NOT COMPLETED|Third Intervention||0
6518916|NCT01536951|7439390|FG007|NOT COMPLETED|Third Intervention||0
6518917|NCT01536951|7439391|FG008|NOT COMPLETED|Third Intervention||0
6518918|NCT01537029|7439414|FG000|STARTED|Overall Study||15
6518919|NCT01537029|7439414|FG000|COMPLETED|Overall Study||15
6518920|NCT01537029|7439414|FG000|NOT COMPLETED|Overall Study||0
6518921|NCT01537042|7439420|FG000|STARTED|Overall Study||10
6518922|NCT01537042|7439421|FG001|STARTED|Overall Study||20
6518923|NCT01537042|7439420|FG000|COMPLETED|Overall Study||10
6518924|NCT01537042|7439421|FG001|COMPLETED|Overall Study||15
6518925|NCT01537042|7439420|FG000|NOT COMPLETED|Overall Study||0
6518926|NCT01537042|7439421|FG001|NOT COMPLETED|Overall Study||5
6518927|NCT01537068|7439433|FG000|STARTED|Overall Study||30
6518928|NCT01537068|7439434|FG001|STARTED|Overall Study||29
6518929|NCT01537068|7439433|FG000|COMPLETED|Overall Study||26
6518930|NCT01537068|7439434|FG001|COMPLETED|Overall Study||26
6518931|NCT01537068|7439433|FG000|NOT COMPLETED|Overall Study||4
6518932|NCT01537068|7439434|FG001|NOT COMPLETED|Overall Study||3
6518933|NCT01537081|7439443|FG000|STARTED|Overall Study||1123
6518934|NCT01537081|7439444|FG001|STARTED|Overall Study||1124
6518935|NCT01537081|7439445|FG002|STARTED|Overall Study||563
6518936|NCT01537081|7439443|FG000|Safety Population|Overall Study||1122
6518937|NCT01537081|7439444|FG001|Safety Population|Overall Study||1122
6518938|NCT01537081|7439445|FG002|Safety Population|Overall Study||561
6518939|NCT01537081|7439443|FG000|Modified Intent to Treat Population|Overall Study||1106
6518940|NCT01537081|7439444|FG001|Modified Intent to Treat Population|Overall Study||1109
6518941|NCT01537081|7439445|FG002|Modified Intent to Treat Population|Overall Study||556
6518942|NCT01537081|7439443|FG000|COMPLETED|Overall Study||1084
6518943|NCT01537081|7439444|FG001|COMPLETED|Overall Study||1086
6518944|NCT01537081|7439445|FG002|COMPLETED|Overall Study||547
6518945|NCT01537081|7439443|FG000|NOT COMPLETED|Overall Study||39
6518946|NCT01537081|7439444|FG001|NOT COMPLETED|Overall Study||38
6518947|NCT01537081|7439445|FG002|NOT COMPLETED|Overall Study||16
6518948|NCT01537120|7439454|FG000|STARTED|Enrolled||25
6518949|NCT01537120|7439454|FG000|COMPLETED|Enrolled||25
6518950|NCT01537120|7439454|FG000|NOT COMPLETED|Enrolled||0
6518951|NCT01537120|7439454|FG000|STARTED|8 Weeks Washout||25
6518952|NCT01537120|7439454|FG000|COMPLETED|8 Weeks Washout||24
6518953|NCT01537120|7439454|FG000|NOT COMPLETED|8 Weeks Washout||1
6518954|NCT01537120|7439454|FG000|STARTED|3 Weeks Placebo||24
6518955|NCT01537120|7439454|FG000|COMPLETED|3 Weeks Placebo||23
6518956|NCT01537120|7439454|FG000|NOT COMPLETED|3 Weeks Placebo||1
6518957|NCT01537120|7439454|FG000|STARTED|12 Weeks Vildagliptin||23
6518958|NCT01537120|7439454|FG000|COMPLETED|12 Weeks Vildagliptin||23
6518959|NCT01537120|7439454|FG000|NOT COMPLETED|12 Weeks Vildagliptin||0
6518960|NCT01537133|7439464|FG000|STARTED|Overall Study||28
6518961|NCT01537133|7439465|FG001|STARTED|Overall Study||14
6518962|NCT01537133|7439466|FG002|STARTED|Overall Study||21
6518963|NCT01537133|7439467|FG003|STARTED|Overall Study||21
6518964|NCT01537133|7439464|FG000|COMPLETED|Overall Study||25
6518965|NCT01537133|7439465|FG001|COMPLETED|Overall Study||14
6518966|NCT01537133|7439466|FG002|COMPLETED|Overall Study||21
6518967|NCT01537133|7439467|FG003|COMPLETED|Overall Study||21
6518968|NCT01537133|7439464|FG000|NOT COMPLETED|Overall Study||3
6518969|NCT01537133|7439465|FG001|NOT COMPLETED|Overall Study||0
6518970|NCT01537133|7439466|FG002|NOT COMPLETED|Overall Study||0
6518971|NCT01537133|7439467|FG003|NOT COMPLETED|Overall Study||0
6641687|NCT02345226|7570278|FG001|NOT COMPLETED|Double-Blind Phase||71
6641688|NCT02345226|7570277|FG000|STARTED|Open-Label Extension Phase|346 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|25
6641689|NCT02345226|7570278|FG001|STARTED|Open-Label Extension Phase|349 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|21
6641690|NCT02345226|7570277|FG000|COMPLETED|Open-Label Extension Phase||25
6641691|NCT02345226|7570278|FG001|COMPLETED|Open-Label Extension Phase||20
6641692|NCT02345226|7570277|FG000|NOT COMPLETED|Open-Label Extension Phase||0
6641693|NCT02345226|7570278|FG001|NOT COMPLETED|Open-Label Extension Phase||1
6641694|NCT02345252|7570288|FG000|STARTED|Double-Blind Phase||316
6641695|NCT02345252|7570289|FG001|STARTED|Double-Blind Phase||316
6641696|NCT02345252|7570288|FG000|COMPLETED|Double-Blind Phase||276
6641697|NCT02345252|7570289|FG001|COMPLETED|Double-Blind Phase||267
6641698|NCT02345252|7570288|FG000|NOT COMPLETED|Double-Blind Phase||40
6641699|NCT02345252|7570289|FG001|NOT COMPLETED|Double-Blind Phase||49
6641700|NCT02345252|7570288|FG000|STARTED|Open-Label Extension Phase|257 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|19
6641701|NCT02345252|7570289|FG001|STARTED|Open-Label Extension Phase|250 participants completed the Double-Blind Phase, but did not enter Open-Label Extension Phase.|17
6641702|NCT02345252|7570288|FG000|COMPLETED|Open-Label Extension Phase||19
6641703|NCT02345252|7570289|FG001|COMPLETED|Open-Label Extension Phase||17
6641704|NCT02345252|7570288|FG000|NOT COMPLETED|Open-Label Extension Phase||0
6641705|NCT02345252|7570289|FG001|NOT COMPLETED|Open-Label Extension Phase||0
6641706|NCT02345330|7570297|FG000|STARTED|Overall Study||4
6641707|NCT02345330|7570297|FG000|COMPLETED|Overall Study||1
6641708|NCT02345330|7570297|FG000|NOT COMPLETED|Overall Study||3
6641709|NCT02345434|7570303|FG000|STARTED|Overall Study||763
6641710|NCT02345434|7570304|FG001|STARTED|Overall Study||762
6641711|NCT02345434|7570303|FG000|COMPLETED|Overall Study||758
6641712|NCT02345434|7570304|FG001|COMPLETED|Overall Study||760
6641713|NCT02345434|7570303|FG000|NOT COMPLETED|Overall Study||5
6641714|NCT02345434|7570304|FG001|NOT COMPLETED|Overall Study||2
6641715|NCT02345486|7570312|FG000|STARTED|Overall Study||454
6641716|NCT02345486|7570313|FG001|STARTED|Overall Study||520
6641717|NCT02345486|7570312|FG000|COMPLETED|Overall Study||454
6641718|NCT02345486|7570313|FG001|COMPLETED|Overall Study||520
6641719|NCT02345486|7570312|FG000|NOT COMPLETED|Overall Study||0
6641720|NCT02345486|7570313|FG001|NOT COMPLETED|Overall Study||0
6641721|NCT02345512|7570319|FG000|STARTED|Overall Study||11
6641722|NCT02345512|7570319|FG000|COMPLETED|Overall Study||9
6641723|NCT02345512|7570319|FG000|NOT COMPLETED|Overall Study||2
6641724|NCT02345642|7570330|FG000|STARTED|Overall Study||10
6641725|NCT02345642|7570331|FG001|STARTED|Overall Study||10
6641726|NCT02345642|7570330|FG000|COMPLETED|Overall Study||10
6641727|NCT02345642|7570331|FG001|COMPLETED|Overall Study||10
6641728|NCT02345642|7570330|FG000|NOT COMPLETED|Overall Study||0
6641729|NCT02345642|7570331|FG001|NOT COMPLETED|Overall Study||0
6641730|NCT02345720|7570337|FG000|STARTED|Overall Study||20
6641731|NCT02345720|7570337|FG000|COMPLETED|Overall Study||20
6641732|NCT02345720|7570337|FG000|NOT COMPLETED|Overall Study||0
6641733|NCT02345811|7570341|FG000|STARTED|First Intervention||17
6641734|NCT02345811|7570342|FG001|STARTED|First Intervention||17
6641735|NCT02345811|7570341|FG000|COMPLETED|First Intervention||16
6641736|NCT02345811|7570342|FG001|COMPLETED|First Intervention||16
6641737|NCT02345811|7570341|FG000|NOT COMPLETED|First Intervention||1
6518972|NCT01537185|7439479|FG000|STARTED|Overall Study||10
6518973|NCT01537185|7439480|FG001|STARTED|Overall Study||12
6518974|NCT01537185|7439481|FG002|STARTED|Overall Study||10
6518975|NCT01537185|7439482|FG003|STARTED|Overall Study||10
6518976|NCT01537185|7439479|FG000|COMPLETED|Overall Study||7
6518977|NCT01537185|7439480|FG001|COMPLETED|Overall Study||6
6518978|NCT01537185|7439481|FG002|COMPLETED|Overall Study||4
6518979|NCT01537185|7439482|FG003|COMPLETED|Overall Study||8
6518980|NCT01537185|7439479|FG000|NOT COMPLETED|Overall Study||3
6518981|NCT01537185|7439480|FG001|NOT COMPLETED|Overall Study||6
6518982|NCT01537185|7439481|FG002|NOT COMPLETED|Overall Study||6
6518983|NCT01537185|7439482|FG003|NOT COMPLETED|Overall Study||2
6518984|NCT01537198|7439494|FG000|STARTED|Overall Study||617
6518985|NCT01537198|7439494|FG000|COMPLETED|Overall Study||463
6518986|NCT01537198|7439494|FG000|NOT COMPLETED|Overall Study||154
6518987|NCT01537211|7439500|FG000|STARTED|Overall Study||4
6518988|NCT01537211|7439501|FG001|STARTED|Overall Study||6
6518989|NCT01537211|7439500|FG000|COMPLETED|Overall Study||4
6518990|NCT01537211|7439501|FG001|COMPLETED|Overall Study||5
6518991|NCT01537211|7439500|FG000|NOT COMPLETED|Overall Study||0
6518992|NCT01537211|7439501|FG001|NOT COMPLETED|Overall Study||1
6518993|NCT01537302|7439511|FG000|STARTED|Overall Study||100
6518994|NCT01537302|7439511|FG000|COMPLETED|Overall Study||100
6518995|NCT01537302|7439511|FG000|NOT COMPLETED|Overall Study||0
6518996|NCT01537315|7439517|FG000|STARTED|Overall Study||1
6518997|NCT01537315|7439518|FG001|STARTED|Overall Study||7
6518998|NCT01537315|7439517|FG000|COMPLETED|Overall Study||1
6518999|NCT01537315|7439518|FG001|COMPLETED|Overall Study||7
6519000|NCT01537315|7439517|FG000|NOT COMPLETED|Overall Study||0
6519001|NCT01537315|7439518|FG001|NOT COMPLETED|Overall Study||0
6519002|NCT01537367|7439527|FG000|STARTED|Overall Study||615
6519003|NCT01537367|7439528|FG001|STARTED|Overall Study||610
6519004|NCT01537367|7439529|FG002|STARTED|Overall Study||613
6519005|NCT01537367|7439527|FG000|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
6519006|NCT01537367|7439528|FG001|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
6519007|NCT01537367|7439529|FG002|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
6519008|NCT01537367|7439527|FG000|NOT COMPLETED|Overall Study||0
6519009|NCT01537367|7439528|FG001|NOT COMPLETED|Overall Study||0
6519010|NCT01537367|7439529|FG002|NOT COMPLETED|Overall Study||0
6519011|NCT01537393|7439539|FG000|STARTED|Overall Study||707
6519012|NCT01537393|7439540|FG001|STARTED|Overall Study||698
6519013|NCT01537393|7439539|FG000|COMPLETED|Overall Study||553
6519014|NCT01537393|7439540|FG001|COMPLETED|Overall Study||507
6519015|NCT01537393|7439539|FG000|NOT COMPLETED|Overall Study||154
6519016|NCT01537393|7439540|FG001|NOT COMPLETED|Overall Study||191
6519017|NCT01537419|7439548|FG000|STARTED|Overall Study||63
6519018|NCT01537419|7439549|FG001|STARTED|Overall Study||66
6519019|NCT01537419|7439548|FG000|COMPLETED|Overall Study||52
6519020|NCT01537419|7439549|FG001|COMPLETED|Overall Study||54
6519021|NCT01537419|7439548|FG000|NOT COMPLETED|Overall Study||11
6519022|NCT01537419|7439549|FG001|NOT COMPLETED|Overall Study||12
6519023|NCT01537432|7439557|FG000|STARTED|Overall Study||24
6519024|NCT01537432|7439558|FG001|STARTED|Overall Study||12
6519025|NCT01537432|7439557|FG000|COMPLETED|Overall Study||18
6519026|NCT01537432|7439558|FG001|COMPLETED|Overall Study||10
6519027|NCT01537432|7439557|FG000|NOT COMPLETED|Overall Study||6
6519028|NCT01537432|7439558|FG001|NOT COMPLETED|Overall Study||2
6519029|NCT01537549|7439564|FG000|STARTED|Overall Study||11
6519030|NCT01537549|7439564|FG000|COMPLETED|Overall Study||8
6519031|NCT01537549|7439564|FG000|NOT COMPLETED|Overall Study||3
6519032|NCT01537666|7439574|FG000|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
6519033|NCT01537666|7439575|FG001|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
6519034|NCT01537666|7439576|FG002|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
6519035|NCT01537666|7439577|FG003|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
6519036|NCT01537666|7439574|FG000|COMPLETED|Overall Study||6
6519037|NCT01537666|7439575|FG001|COMPLETED|Overall Study||6
6519038|NCT01537666|7439576|FG002|COMPLETED|Overall Study||6
6519039|NCT01537666|7439577|FG003|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
6519040|NCT01537666|7439574|FG000|NOT COMPLETED|Overall Study||0
6519041|NCT01537666|7439575|FG001|NOT COMPLETED|Overall Study||0
6519042|NCT01537666|7439576|FG002|NOT COMPLETED|Overall Study||0
6519043|NCT01537666|7439577|FG003|NOT COMPLETED|Overall Study||0
6519044|NCT01537783|7439599|FG000|STARTED|Overall Study||25
6519045|NCT01537783|7439600|FG001|STARTED|Overall Study||25
6519046|NCT01537783|7439599|FG000|COMPLETED|Overall Study||14
6519047|NCT01537783|7439600|FG001|COMPLETED|Overall Study||23
6519048|NCT01537783|7439599|FG000|NOT COMPLETED|Overall Study||11
6519049|NCT01537783|7439600|FG001|NOT COMPLETED|Overall Study||2
6519050|NCT01537835|7439609|FG000|STARTED|Overall Study||37
6519051|NCT01537835|7439610|FG001|STARTED|Overall Study||37
6519052|NCT01537835|7439611|FG002|STARTED|Overall Study||35
6519053|NCT01537835|7439609|FG000|COMPLETED|Overall Study||37
6519054|NCT01537835|7439610|FG001|COMPLETED|Overall Study||37
6519055|NCT01537835|7439611|FG002|COMPLETED|Overall Study||35
6519056|NCT01537835|7439609|FG000|NOT COMPLETED|Overall Study||0
6519057|NCT01537835|7439610|FG001|NOT COMPLETED|Overall Study||0
6519058|NCT01537835|7439611|FG002|NOT COMPLETED|Overall Study||0
6519059|NCT01537887|7439619|FG000|STARTED|Period 1||12
6519060|NCT01537887|7439620|FG001|STARTED|Period 1||12
6519061|NCT01537887|7439621|FG002|STARTED|Period 1||12
6519062|NCT01537887|7439622|FG003|STARTED|Period 1||12
6519063|NCT01537887|7439623|FG004|STARTED|Period 1||12
6519064|NCT01537887|7439624|FG005|STARTED|Period 1||12
6519065|NCT01537887|7439619|FG000|Received at Least 1 Dose of Study Drug|Period 1||12
6519066|NCT01537887|7439620|FG001|Received at Least 1 Dose of Study Drug|Period 1||12
6519067|NCT01537887|7439621|FG002|Received at Least 1 Dose of Study Drug|Period 1||11
6519068|NCT01537887|7439622|FG003|Received at Least 1 Dose of Study Drug|Period 1||12
6519069|NCT01537887|7439623|FG004|Received at Least 1 Dose of Study Drug|Period 1||12
6519070|NCT01537887|7439624|FG005|Received at Least 1 Dose of Study Drug|Period 1||12
6519071|NCT01537887|7439619|FG000|COMPLETED|Period 1||12
6519072|NCT01537887|7439620|FG001|COMPLETED|Period 1||12
6519073|NCT01537887|7439621|FG002|COMPLETED|Period 1||11
6519074|NCT01537887|7439622|FG003|COMPLETED|Period 1||12
6519075|NCT01537887|7439623|FG004|COMPLETED|Period 1||11
6519076|NCT01537887|7439624|FG005|COMPLETED|Period 1||11
6519077|NCT01537887|7439619|FG000|NOT COMPLETED|Period 1||0
6519078|NCT01537887|7439620|FG001|NOT COMPLETED|Period 1||0
6519079|NCT01537887|7439621|FG002|NOT COMPLETED|Period 1||1
6519080|NCT01537887|7439622|FG003|NOT COMPLETED|Period 1||0
6519081|NCT01537887|7439623|FG004|NOT COMPLETED|Period 1||1
6519082|NCT01537887|7439624|FG005|NOT COMPLETED|Period 1||1
6519083|NCT01537887|7439619|FG000|STARTED|Period 2||12
6519084|NCT01537887|7439620|FG001|STARTED|Period 2||12
6519085|NCT01537887|7439621|FG002|STARTED|Period 2||11
6519086|NCT01537887|7439622|FG003|STARTED|Period 2||12
6519087|NCT01537887|7439623|FG004|STARTED|Period 2||11
6519088|NCT01537887|7439624|FG005|STARTED|Period 2||11
6519089|NCT01537887|7439619|FG000|COMPLETED|Period 2||12
6519090|NCT01537887|7439620|FG001|COMPLETED|Period 2||11
6519091|NCT01537887|7439621|FG002|COMPLETED|Period 2||11
6519092|NCT01537887|7439622|FG003|COMPLETED|Period 2||12
6519093|NCT01537887|7439623|FG004|COMPLETED|Period 2||11
6519094|NCT01537887|7439624|FG005|COMPLETED|Period 2||11
6519095|NCT01537887|7439619|FG000|NOT COMPLETED|Period 2||0
6519096|NCT01537887|7439620|FG001|NOT COMPLETED|Period 2||1
6519097|NCT01537887|7439621|FG002|NOT COMPLETED|Period 2||0
6519098|NCT01537887|7439622|FG003|NOT COMPLETED|Period 2||0
6519099|NCT01537887|7439623|FG004|NOT COMPLETED|Period 2||0
6519100|NCT01537887|7439624|FG005|NOT COMPLETED|Period 2||0
6519101|NCT01537887|7439619|FG000|STARTED|Period 3||12
6519102|NCT01537887|7439620|FG001|STARTED|Period 3||11
6519103|NCT01537887|7439621|FG002|STARTED|Period 3||11
6519104|NCT01537887|7439622|FG003|STARTED|Period 3||12
6519105|NCT01537887|7439623|FG004|STARTED|Period 3||11
6519106|NCT01537887|7439624|FG005|STARTED|Period 3||11
6519107|NCT01537887|7439619|FG000|COMPLETED|Period 3||12
6519108|NCT01537887|7439620|FG001|COMPLETED|Period 3||10
6519109|NCT01537887|7439621|FG002|COMPLETED|Period 3||10
6519110|NCT01537887|7439622|FG003|COMPLETED|Period 3||12
6519111|NCT01537887|7439623|FG004|COMPLETED|Period 3||11
6519112|NCT01537887|7439624|FG005|COMPLETED|Period 3||11
6519113|NCT01537887|7439619|FG000|NOT COMPLETED|Period 3||0
6519114|NCT01537887|7439620|FG001|NOT COMPLETED|Period 3||1
6519115|NCT01537887|7439621|FG002|NOT COMPLETED|Period 3||1
6519116|NCT01537887|7439622|FG003|NOT COMPLETED|Period 3||0
6519117|NCT01537887|7439623|FG004|NOT COMPLETED|Period 3||0
6519118|NCT01537887|7439624|FG005|NOT COMPLETED|Period 3||0
6519119|NCT01537900|7439632|FG000|STARTED|Overall Study||4
6519120|NCT01537900|7439632|FG000|COMPLETED|Overall Study||4
6519121|NCT01537900|7439632|FG000|NOT COMPLETED|Overall Study||0
6519122|NCT01537926|7439638|FG000|STARTED|Overall Study||29
6519123|NCT01537926|7439639|FG001|STARTED|Overall Study||13
6519124|NCT01537926|7439638|FG000|COMPLETED|Overall Study||24
6519125|NCT01537926|7439639|FG001|COMPLETED|Overall Study||11
6519126|NCT01537926|7439638|FG000|NOT COMPLETED|Overall Study||5
6519127|NCT01537926|7439639|FG001|NOT COMPLETED|Overall Study||2
6519128|NCT01538199|7439652|FG000|STARTED|Overall Study||10
6519129|NCT01538199|7439653|FG001|STARTED|Overall Study||11
6519130|NCT01538199|7439654|FG002|STARTED|Overall Study||4
6519131|NCT01538199|7439655|FG003|STARTED|Overall Study||3
6519132|NCT01538199|7439652|FG000|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
6519133|NCT01538199|7439653|FG001|COMPLETED|Overall Study|"1 completed study but was excluded as a completer from analyses because started a new treatment"|8
6641738|NCT02345811|7570342|FG001|NOT COMPLETED|First Intervention||1
6641739|NCT02345811|7570341|FG000|STARTED|Second Intervention||16
6641740|NCT02345811|7570342|FG001|STARTED|Second Intervention||16
6641741|NCT02345811|7570341|FG000|COMPLETED|Second Intervention||16
6519134|NCT01538199|7439654|FG002|COMPLETED|Overall Study|1 non-completer included in analyses because only missed follow up, completed all treatment visits.|3
6519135|NCT01538199|7439655|FG003|COMPLETED|Overall Study|Completer excluded from analyses because determined to be not eligible at end of study.|1
6519136|NCT01538199|7439652|FG000|NOT COMPLETED|Overall Study||2
6519137|NCT01538199|7439653|FG001|NOT COMPLETED|Overall Study||3
6519138|NCT01538199|7439654|FG002|NOT COMPLETED|Overall Study||1
6519139|NCT01538199|7439655|FG003|NOT COMPLETED|Overall Study||2
6519140|NCT01538472|7439672|FG000|STARTED|Overall Study||40
6519141|NCT01538472|7439672|FG000|COMPLETED|Overall Study||36
6641742|NCT02345811|7570342|FG001|COMPLETED|Second Intervention||16
6519142|NCT01538472|7439672|FG000|NOT COMPLETED|Overall Study||4
6519143|NCT01538615|7439678|FG000|STARTED|Overall Study||162
6519144|NCT01538615|7439679|FG001|STARTED|Overall Study||158
6519145|NCT01538615|7439678|FG000|COMPLETED|Overall Study||140
6519146|NCT01538615|7439679|FG001|COMPLETED|Overall Study||146
6519147|NCT01538615|7439678|FG000|NOT COMPLETED|Overall Study||22
6519148|NCT01538615|7439679|FG001|NOT COMPLETED|Overall Study||12
6519149|NCT01538628|7439687|FG000|STARTED|Overall Study||149
6641743|NCT02345811|7570341|FG000|NOT COMPLETED|Second Intervention||0
6519150|NCT01538628|7439688|FG001|STARTED|Overall Study||73
6519151|NCT01538628|7439687|FG000|COMPLETED|Overall Study||148
6519152|NCT01538628|7439688|FG001|COMPLETED|Overall Study||71
6519153|NCT01538628|7439687|FG000|NOT COMPLETED|Overall Study||1
6519154|NCT01538628|7439688|FG001|NOT COMPLETED|Overall Study||2
6519155|NCT01538719|7439697|FG000|STARTED|Overall Study||7
6519156|NCT01538719|7439698|FG001|STARTED|Overall Study||12
6519157|NCT01538719|7439697|FG000|COMPLETED|Overall Study||5
6519158|NCT01538719|7439698|FG001|COMPLETED|Overall Study||12
6519159|NCT01538719|7439697|FG000|NOT COMPLETED|Overall Study||2
6519160|NCT01538719|7439698|FG001|NOT COMPLETED|Overall Study||0
6519161|NCT01538745|7439706|FG000|STARTED|Overall Study||24
6519162|NCT01538745|7439707|FG001|STARTED|Overall Study||21
6519163|NCT01538745|7439706|FG000|COMPLETED|Overall Study||24
6519164|NCT01538745|7439707|FG001|COMPLETED|Overall Study||21
6519165|NCT01538745|7439706|FG000|NOT COMPLETED|Overall Study||0
6519166|NCT01538745|7439707|FG001|NOT COMPLETED|Overall Study||0
6519167|NCT01538862|7439713|FG000|STARTED|Overall Study||7
6641744|NCT02345811|7570342|FG001|NOT COMPLETED|Second Intervention||0
6641745|NCT02345889|7570354|FG000|STARTED|Overall Study||316
6641746|NCT02345889|7570355|FG001|STARTED|Overall Study||316
6641747|NCT02345889|7570356|FG002|STARTED|Overall Study||315
6641748|NCT02345889|7570357|FG003|STARTED|Overall Study||315
6641749|NCT02345889|7570354|FG000|COMPLETED|Overall Study||295
6641750|NCT02345889|7570355|FG001|COMPLETED|Overall Study||299
6641751|NCT02345889|7570356|FG002|COMPLETED|Overall Study||295
6641752|NCT02345889|7570357|FG003|COMPLETED|Overall Study||299
6641753|NCT02345889|7570354|FG000|NOT COMPLETED|Overall Study||21
6641754|NCT02345889|7570355|FG001|NOT COMPLETED|Overall Study||17
6641755|NCT02345889|7570356|FG002|NOT COMPLETED|Overall Study||20
6641756|NCT02345889|7570357|FG003|NOT COMPLETED|Overall Study||16
6641757|NCT02346136|7570369|FG000|STARTED|Overall Study||93
6641758|NCT02346136|7570370|FG001|STARTED|Overall Study||87
6641759|NCT02346136|7570369|FG000|COMPLETED|Overall Study||71
6641760|NCT02346136|7570370|FG001|COMPLETED|Overall Study||64
6641761|NCT02346136|7570369|FG000|NOT COMPLETED|Overall Study||22
6641762|NCT02346136|7570370|FG001|NOT COMPLETED|Overall Study||23
6641763|NCT02346240|7570380|FG000|STARTED|Initial Period (Baseline to Week 16)||57
6641764|NCT02346240|7570381|FG001|STARTED|Initial Period (Baseline to Week 16)||170
6641765|NCT02346240|7570382|FG002|STARTED|Initial Period (Baseline to Week 16)||165
6641766|NCT02346240|7570383|FG003|STARTED|Initial Period (Baseline to Week 16)||167
6641767|NCT02346240|7570384|FG004|STARTED|Initial Period (Baseline to Week 16)||0
6641768|NCT02346240|7570385|FG005|STARTED|Initial Period (Baseline to Week 16)||0
6641769|NCT02346240|7570386|FG006|STARTED|Initial Period (Baseline to Week 16)||0
6641770|NCT02346240|7570387|FG007|STARTED|Initial Period (Baseline to Week 16)||0
6641771|NCT02346240|7570388|FG008|STARTED|Initial Period (Baseline to Week 16)||0
6641772|NCT02346240|7570389|FG009|STARTED|Initial Period (Baseline to Week 16)||0
6641773|NCT02346240|7570390|FG010|STARTED|Initial Period (Baseline to Week 16)||0
6641774|NCT02346240|7570391|FG011|STARTED|Initial Period (Baseline to Week 16)||0
6641775|NCT02346240|7570392|FG012|STARTED|Initial Period (Baseline to Week 16)||0
6641776|NCT02346240|7570393|FG013|STARTED|Initial Period (Baseline to Week 16)||0
6641777|NCT02346240|7570394|FG014|STARTED|Initial Period (Baseline to Week 16)||0
6641778|NCT02346240|7570395|FG015|STARTED|Initial Period (Baseline to Week 16)||0
6641779|NCT02346240|7570396|FG016|STARTED|Initial Period (Baseline to Week 16)||0
6641780|NCT02346240|7570397|FG017|STARTED|Initial Period (Baseline to Week 16)||0
6641781|NCT02346240|7570398|FG018|STARTED|Initial Period (Baseline to Week 16)||0
6641782|NCT02346240|7570399|FG019|STARTED|Initial Period (Baseline to Week 16)||0
6641783|NCT02346240|7570400|FG020|STARTED|Initial Period (Baseline to Week 16)||0
6641784|NCT02346240|7570401|FG021|STARTED|Initial Period (Baseline to Week 16)||0
6641785|NCT02346240|7570402|FG022|STARTED|Initial Period (Baseline to Week 16)||0
6641786|NCT02346240|7570403|FG023|STARTED|Initial Period (Baseline to Week 16)||0
6641787|NCT02346240|7570380|FG000|Completed Week 16|Initial Period (Baseline to Week 16)||55
6641788|NCT02346240|7570381|FG001|Completed Week 16|Initial Period (Baseline to Week 16)||159
6641789|NCT02346240|7570382|FG002|Completed Week 16|Initial Period (Baseline to Week 16)||159
6641790|NCT02346240|7570383|FG003|Completed Week 16|Initial Period (Baseline to Week 16)||162
6641791|NCT02346240|7570384|FG004|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641792|NCT02346240|7570385|FG005|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641793|NCT02346240|7570386|FG006|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641794|NCT02346240|7570387|FG007|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641795|NCT02346240|7570388|FG008|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641796|NCT02346240|7570389|FG009|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641797|NCT02346240|7570390|FG010|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641798|NCT02346240|7570391|FG011|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641799|NCT02346240|7570392|FG012|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641800|NCT02346240|7570393|FG013|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641801|NCT02346240|7570394|FG014|Completed Week 16|Initial Period (Baseline to Week 16)||0
6519168|NCT01538862|7439713|FG000|COMPLETED|Overall Study||7
6519169|NCT01538862|7439713|FG000|NOT COMPLETED|Overall Study||0
6519170|NCT01539070|7439720|FG000|STARTED|Overall Study||168
6519171|NCT01539070|7439721|FG001|STARTED|Overall Study||138
6519172|NCT01539070|7439720|FG000|COMPLETED|Overall Study||109
6519173|NCT01539070|7439721|FG001|COMPLETED|Overall Study||99
6519174|NCT01539070|7439720|FG000|NOT COMPLETED|Overall Study||59
6519175|NCT01539070|7439721|FG001|NOT COMPLETED|Overall Study||39
6519176|NCT01539083|7439727|FG000|STARTED|Before Randomization (VCD Induction)||256
6519177|NCT01539083|7439728|FG001|STARTED|Before Randomization (VCD Induction)||0
6519178|NCT01539083|7439729|FG002|STARTED|Before Randomization (VCD Induction)||0
6519179|NCT01539083|7439727|FG000|Treated|Before Randomization (VCD Induction)||254
6519180|NCT01539083|7439728|FG001|Treated|Before Randomization (VCD Induction)||0
6519181|NCT01539083|7439729|FG002|Treated|Before Randomization (VCD Induction)||0
6519182|NCT01539083|7439727|FG000|COMPLETED|Before Randomization (VCD Induction)||203
6519183|NCT01539083|7439728|FG001|COMPLETED|Before Randomization (VCD Induction)||0
6519184|NCT01539083|7439729|FG002|COMPLETED|Before Randomization (VCD Induction)||0
6519185|NCT01539083|7439727|FG000|NOT COMPLETED|Before Randomization (VCD Induction)||53
6519186|NCT01539083|7439728|FG001|NOT COMPLETED|Before Randomization (VCD Induction)||0
6519187|NCT01539083|7439729|FG002|NOT COMPLETED|Before Randomization (VCD Induction)||0
6519188|NCT01539083|7439727|FG000|STARTED|After Randomization (TP and VTP)||0
6519189|NCT01539083|7439728|FG001|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
6519190|NCT01539083|7439729|FG002|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidation treatment phase.|103
6641802|NCT02346240|7570395|FG015|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641803|NCT02346240|7570396|FG016|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641804|NCT02346240|7570397|FG017|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641805|NCT02346240|7570398|FG018|Completed Week 16|Initial Period (Baseline to Week 16)||0
6519191|NCT01539083|7439727|FG000|Safety Population|After Randomization (TP and VTP)||0
6519192|NCT01539083|7439728|FG001|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
6519193|NCT01539083|7439729|FG002|Safety Population|After Randomization (TP and VTP)||103
6519194|NCT01539083|7439727|FG000|COMPLETED|After Randomization (TP and VTP)||0
6519195|NCT01539083|7439728|FG001|COMPLETED|After Randomization (TP and VTP)||79
6519196|NCT01539083|7439729|FG002|COMPLETED|After Randomization (TP and VTP)||80
6519197|NCT01539083|7439727|FG000|NOT COMPLETED|After Randomization (TP and VTP)||0
6519198|NCT01539083|7439728|FG001|NOT COMPLETED|After Randomization (TP and VTP)||21
6519199|NCT01539083|7439729|FG002|NOT COMPLETED|After Randomization (TP and VTP)||23
6519200|NCT01539135|7439738|FG000|STARTED|Overall Study||43
6519201|NCT01539135|7439739|FG001|STARTED|Overall Study||37
6519202|NCT01539135|7439738|FG000|COMPLETED|Overall Study||43
6519203|NCT01539135|7439739|FG001|COMPLETED|Overall Study||37
6519204|NCT01539135|7439738|FG000|NOT COMPLETED|Overall Study||0
6519205|NCT01539135|7439739|FG001|NOT COMPLETED|Overall Study||0
6519206|NCT01539239|7439747|FG000|STARTED|Overall Study||369
6519207|NCT01539239|7439748|FG001|STARTED|Overall Study||187
6519208|NCT01539239|7439747|FG000|COMPLETED|Overall Study||357
6519209|NCT01539239|7439748|FG001|COMPLETED|Overall Study||170
6519210|NCT01539239|7439747|FG000|NOT COMPLETED|Overall Study||12
6519211|NCT01539239|7439748|FG001|NOT COMPLETED|Overall Study||17
6519212|NCT01539291|7439757|FG000|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|106
6519213|NCT01539291|7439758|FG001|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|4
6519214|NCT01539291|7439759|FG002|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|42
6519215|NCT01539291|7439760|FG003|STARTED|Study GS-US-312-0116|Started = Randomized in Study GS-US-312-0116.|44
6519216|NCT01539291|7439757|FG000|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|81
6519217|NCT01539291|7439758|FG001|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|4
6519218|NCT01539291|7439759|FG002|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|42
6519219|NCT01539291|7439760|FG003|COMPLETED|Study GS-US-312-0116|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|44
6519220|NCT01539291|7439757|FG000|NOT COMPLETED|Study GS-US-312-0116||25
6519221|NCT01539291|7439758|FG001|NOT COMPLETED|Study GS-US-312-0116||0
6519222|NCT01539291|7439759|FG002|NOT COMPLETED|Study GS-US-312-0116||0
6519223|NCT01539291|7439760|FG003|NOT COMPLETED|Study GS-US-312-0116||0
6519224|NCT01539291|7439757|FG000|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|71
6519225|NCT01539291|7439758|FG001|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|4
6519226|NCT01539291|7439759|FG002|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|42
6519227|NCT01539291|7439760|FG003|STARTED|Study GS-US-312-0117|Started = Completed GS-US-312-0116 and Enrolled in GS-US-312-0117.|44
6519228|NCT01539291|7439757|FG000|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|30
6519229|NCT01539291|7439758|FG001|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|2
6519230|NCT01539291|7439759|FG002|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|20
6519231|NCT01539291|7439760|FG003|COMPLETED|Study GS-US-312-0117|Completed = Met Primary Endpoint (reason as determined by investigator) or finished study period.|18
6519232|NCT01539291|7439757|FG000|NOT COMPLETED|Study GS-US-312-0117||41
6519233|NCT01539291|7439758|FG001|NOT COMPLETED|Study GS-US-312-0117||2
6519234|NCT01539291|7439759|FG002|NOT COMPLETED|Study GS-US-312-0117||22
6519235|NCT01539291|7439760|FG003|NOT COMPLETED|Study GS-US-312-0117||26
6519236|NCT01539317|7439779|FG000|STARTED|Overall Study||25
6519237|NCT01539317|7439780|FG001|STARTED|Overall Study||25
6519238|NCT01539317|7439779|FG000|COMPLETED|Overall Study||24
6519239|NCT01539317|7439780|FG001|COMPLETED|Overall Study||25
6519240|NCT01539317|7439779|FG000|NOT COMPLETED|Overall Study||1
6519241|NCT01539317|7439780|FG001|NOT COMPLETED|Overall Study||0
6519242|NCT01539512|7439791|FG000|STARTED|Overall Study||110
6519243|NCT01539512|7439792|FG001|STARTED|Overall Study||110
6519244|NCT01539512|7439791|FG000|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
6519245|NCT01539512|7439792|FG001|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
6519246|NCT01539512|7439791|FG000|NOT COMPLETED|Overall Study||23
6519247|NCT01539512|7439792|FG001|NOT COMPLETED|Overall Study||13
6519248|NCT01539525|7439801|FG000|STARTED|Overall Study||145
6519249|NCT01539525|7439802|FG001|STARTED|Overall Study||143
6519250|NCT01539525|7439803|FG002|STARTED|Overall Study||151
6519251|NCT01539525|7439801|FG000|COMPLETED|Overall Study||125
6519252|NCT01539525|7439802|FG001|COMPLETED|Overall Study||127
6519253|NCT01539525|7439803|FG002|COMPLETED|Overall Study||134
6519254|NCT01539525|7439801|FG000|NOT COMPLETED|Overall Study||20
6519255|NCT01539525|7439802|FG001|NOT COMPLETED|Overall Study||16
6519256|NCT01539525|7439803|FG002|NOT COMPLETED|Overall Study||17
6519257|NCT01539538|7439816|FG000|STARTED|Overall Study||177
6519258|NCT01539538|7439817|FG001|STARTED|Overall Study||180
6519259|NCT01539538|7439816|FG000|COMPLETED|Overall Study||146
6519260|NCT01539538|7439817|FG001|COMPLETED|Overall Study||136
6519261|NCT01539538|7439816|FG000|NOT COMPLETED|Overall Study||31
6519262|NCT01539538|7439817|FG001|NOT COMPLETED|Overall Study||44
6519263|NCT01539642|7439825|FG000|STARTED|Overall Study||114
6519264|NCT01539642|7439826|FG001|STARTED|Overall Study||58
6519265|NCT01539642|7439825|FG000|COMPLETED|Overall Study||78
6519266|NCT01539642|7439826|FG001|COMPLETED|Overall Study||27
6519267|NCT01539642|7439825|FG000|NOT COMPLETED|Overall Study||36
6519268|NCT01539642|7439826|FG001|NOT COMPLETED|Overall Study||31
6519269|NCT01539694|7439832|FG000|STARTED|Overall Study||63
6519270|NCT01539694|7439833|FG001|STARTED|Overall Study||63
6519271|NCT01539694|7439832|FG000|COMPLETED|Overall Study||62
6519272|NCT01539694|7439833|FG001|COMPLETED|Overall Study||62
6519273|NCT01539694|7439832|FG000|NOT COMPLETED|Overall Study||1
6519274|NCT01539694|7439833|FG001|NOT COMPLETED|Overall Study||1
6519275|NCT01539759|7439841|FG000|STARTED|Overall Study||56
6519276|NCT01539759|7439842|FG001|STARTED|Overall Study||56
6519277|NCT01539759|7439841|FG000|Had Successful IUD Placement|Overall Study||34
6519278|NCT01539759|7439842|FG001|Had Successful IUD Placement|Overall Study||53
6519279|NCT01539759|7439841|FG000|IUD Expulsion|Overall Study||1
6519280|NCT01539759|7439842|FG001|IUD Expulsion|Overall Study||4
6519281|NCT01539759|7439841|FG000|IUD Removal|Overall Study||2
6519282|NCT01539759|7439842|FG001|IUD Removal|Overall Study||7
6519283|NCT01539759|7439841|FG000|IUD in Place at 6 Months Posptartum|Overall Study||32
6519284|NCT01539759|7439842|FG001|IUD in Place at 6 Months Posptartum|Overall Study||40
6519285|NCT01539759|7439841|FG000|COMPLETED|Overall Study||50
6519286|NCT01539759|7439842|FG001|COMPLETED|Overall Study||48
6519287|NCT01539759|7439841|FG000|NOT COMPLETED|Overall Study||6
6519288|NCT01539759|7439842|FG001|NOT COMPLETED|Overall Study||8
6519289|NCT01539837|7439851|FG000|STARTED|Overall Study||8
6519290|NCT01539837|7439852|FG001|STARTED|Overall Study||7
6519291|NCT01539837|7439853|FG002|STARTED|Overall Study||7
6519292|NCT01539837|7439851|FG000|COMPLETED|Overall Study||8
6519293|NCT01539837|7439852|FG001|COMPLETED|Overall Study||6
6519294|NCT01539837|7439853|FG002|COMPLETED|Overall Study||5
6519295|NCT01539837|7439851|FG000|NOT COMPLETED|Overall Study||0
6519296|NCT01539837|7439852|FG001|NOT COMPLETED|Overall Study||1
6519297|NCT01539837|7439853|FG002|NOT COMPLETED|Overall Study||2
6519304|NCT01539980|7439870|FG000|STARTED|Overall Study||30
6519305|NCT01539980|7439870|FG000|COMPLETED|Overall Study||30
6519306|NCT01539980|7439870|FG000|NOT COMPLETED|Overall Study||0
6519307|NCT01540045|7439874|FG000|STARTED|Overall Study||40
6519308|NCT01540045|7439874|FG000|COMPLETED|Overall Study||40
6519309|NCT01540045|7439874|FG000|NOT COMPLETED|Overall Study||0
6519310|NCT01540071|7439899|FG000|STARTED|Overall Study||38
6519311|NCT01540071|7439899|FG000|COMPLETED|Overall Study||38
6519312|NCT01540071|7439899|FG000|NOT COMPLETED|Overall Study||0
6519313|NCT01540162|7439906|FG000|STARTED|Overall Study||30
6519314|NCT01540162|7439907|FG001|STARTED|Overall Study||32
6519315|NCT01540162|7439906|FG000|COMPLETED|Overall Study||30
6519316|NCT01540162|7439907|FG001|COMPLETED|Overall Study||32
6519317|NCT01540162|7439906|FG000|NOT COMPLETED|Overall Study||0
6519318|NCT01540162|7439907|FG001|NOT COMPLETED|Overall Study||0
6519319|NCT01540266|7439919|FG000|STARTED|Overall Study||63
6519320|NCT01540266|7439920|FG001|STARTED|Overall Study||42
6519321|NCT01540266|7439921|FG002|STARTED|Overall Study||60
6519322|NCT01540266|7439922|FG003|STARTED|Overall Study||38
6519323|NCT01540266|7439923|FG004|STARTED|Overall Study||20
6519324|NCT01540266|7439924|FG005|STARTED|Overall Study||19
6519325|NCT01540266|7439919|FG000|COMPLETED|Overall Study||57
6519326|NCT01540266|7439920|FG001|COMPLETED|Overall Study||41
6519327|NCT01540266|7439921|FG002|COMPLETED|Overall Study||59
6519328|NCT01540266|7439922|FG003|COMPLETED|Overall Study||38
6519329|NCT01540266|7439923|FG004|COMPLETED|Overall Study||20
6519330|NCT01540266|7439924|FG005|COMPLETED|Overall Study||19
6519331|NCT01540266|7439919|FG000|NOT COMPLETED|Overall Study||6
6519332|NCT01540266|7439920|FG001|NOT COMPLETED|Overall Study||1
6519333|NCT01540266|7439921|FG002|NOT COMPLETED|Overall Study||1
6519334|NCT01540266|7439922|FG003|NOT COMPLETED|Overall Study||0
6519335|NCT01540266|7439923|FG004|NOT COMPLETED|Overall Study||0
6519336|NCT01540266|7439924|FG005|NOT COMPLETED|Overall Study||0
6519337|NCT01540370|7439938|FG000|STARTED|Overall Study||102
6519338|NCT01540370|7439938|FG000|COMPLETED|Overall Study||100
6519339|NCT01540370|7439938|FG000|NOT COMPLETED|Overall Study||2
6519340|NCT01540409|7439944|FG000|STARTED|Overall Study||6
6519341|NCT01540409|7439945|FG001|STARTED|Overall Study||6
6519342|NCT01540409|7439944|FG000|COMPLETED|Overall Study||6
6519343|NCT01540409|7439945|FG001|COMPLETED|Overall Study||6
6519344|NCT01540409|7439944|FG000|NOT COMPLETED|Overall Study||0
6519345|NCT01540409|7439945|FG001|NOT COMPLETED|Overall Study||0
6519346|NCT01540474|7439958|FG000|STARTED|Vaccination Period||10
6519347|NCT01540474|7439959|FG001|STARTED|Vaccination Period||10
6519348|NCT01540474|7439960|FG002|STARTED|Vaccination Period||10
6519349|NCT01540474|7439961|FG003|STARTED|Vaccination Period||0
6519350|NCT01540474|7439958|FG000|COMPLETED|Vaccination Period||10
6519351|NCT01540474|7439959|FG001|COMPLETED|Vaccination Period||9
6519352|NCT01540474|7439960|FG002|COMPLETED|Vaccination Period||10
6519353|NCT01540474|7439961|FG003|COMPLETED|Vaccination Period||0
6519354|NCT01540474|7439958|FG000|NOT COMPLETED|Vaccination Period||0
6519355|NCT01540474|7439959|FG001|NOT COMPLETED|Vaccination Period||1
6519356|NCT01540474|7439960|FG002|NOT COMPLETED|Vaccination Period||0
6519357|NCT01540474|7439961|FG003|NOT COMPLETED|Vaccination Period||0
6519358|NCT01540474|7439958|FG000|STARTED|Malaria Challenge||10
6519359|NCT01540474|7439959|FG001|STARTED|Malaria Challenge||9
6519360|NCT01540474|7439960|FG002|STARTED|Malaria Challenge||10
6519361|NCT01540474|7439961|FG003|STARTED|Malaria Challenge||6
6519362|NCT01540474|7439958|FG000|COMPLETED|Malaria Challenge||10
6519363|NCT01540474|7439959|FG001|COMPLETED|Malaria Challenge||9
6519364|NCT01540474|7439960|FG002|COMPLETED|Malaria Challenge||10
6519365|NCT01540474|7439961|FG003|COMPLETED|Malaria Challenge||5
6519366|NCT01540474|7439958|FG000|NOT COMPLETED|Malaria Challenge||0
6519367|NCT01540474|7439959|FG001|NOT COMPLETED|Malaria Challenge||0
6519368|NCT01540474|7439960|FG002|NOT COMPLETED|Malaria Challenge||0
6519369|NCT01540474|7439961|FG003|NOT COMPLETED|Malaria Challenge||1
6519370|NCT01540487|7439974|FG000|STARTED|Overall Study||24
6519371|NCT01540487|7439975|FG001|STARTED|Overall Study||24
6519372|NCT01540487|7439974|FG000|COMPLETED|Overall Study||23
6519373|NCT01540487|7439975|FG001|COMPLETED|Overall Study||24
6519374|NCT01540487|7439974|FG000|NOT COMPLETED|Overall Study||1
6519375|NCT01540487|7439975|FG001|NOT COMPLETED|Overall Study||0
6519376|NCT01540513|7439985|FG000|STARTED|Overall Study||12
6519377|NCT01540513|7439985|FG000|COMPLETED|Overall Study||12
6519378|NCT01540513|7439985|FG000|NOT COMPLETED|Overall Study||0
6561541|NCT01794689|7484357|FG003|NOT COMPLETED|Intervention 2 (2 Nights)||0
6561542|NCT01794702|7484376|FG000|STARTED|Overall Study||18
6561543|NCT01794702|7484377|FG001|STARTED|Overall Study||0
6561544|NCT01794702|7484378|FG002|STARTED|Overall Study||47
6561545|NCT01794702|7484376|FG000|COMPLETED|Overall Study||18
6561546|NCT01794702|7484377|FG001|COMPLETED|Overall Study||0
6561547|NCT01794702|7484378|FG002|COMPLETED|Overall Study||47
6561548|NCT01794702|7484376|FG000|NOT COMPLETED|Overall Study||0
6561549|NCT01794702|7484377|FG001|NOT COMPLETED|Overall Study||0
6561550|NCT01794702|7484378|FG002|NOT COMPLETED|Overall Study||0
6561551|NCT01794741|7484388|FG000|STARTED|Overall Study||304
6561552|NCT01794741|7484389|FG001|STARTED|Overall Study||101
6561553|NCT01794741|7484388|FG000|COMPLETED|Overall Study||285
6561554|NCT01794741|7484389|FG001|COMPLETED|Overall Study||92
6561555|NCT01794741|7484388|FG000|NOT COMPLETED|Overall Study||19
6561556|NCT01794741|7484389|FG001|NOT COMPLETED|Overall Study||9
6561557|NCT01794780|7484403|FG000|STARTED|Overall Study||32
6561558|NCT01794780|7484404|FG001|STARTED|Overall Study||276
6561559|NCT01794780|7484405|FG002|STARTED|Overall Study||813
6561560|NCT01794780|7484406|FG003|STARTED|Overall Study||283
6561561|NCT01794780|7484407|FG004|STARTED|Overall Study||9
6561562|NCT01794780|7484408|FG005|STARTED|Overall Study||632
6561563|NCT01794780|7484409|FG006|STARTED|Overall Study||154
6561564|NCT01794780|7484410|FG007|STARTED|Overall Study||30
6561565|NCT01794780|7484403|FG000|COMPLETED|Overall Study||15
6561566|NCT01794780|7484404|FG001|COMPLETED|Overall Study||180
6561567|NCT01794780|7484405|FG002|COMPLETED|Overall Study||571
6561568|NCT01794780|7484406|FG003|COMPLETED|Overall Study||200
6561569|NCT01794780|7484407|FG004|COMPLETED|Overall Study||6
6561570|NCT01794780|7484408|FG005|COMPLETED|Overall Study||452
6561571|NCT01794780|7484409|FG006|COMPLETED|Overall Study||112
6561572|NCT01794780|7484410|FG007|COMPLETED|Overall Study||21
6561573|NCT01794780|7484403|FG000|NOT COMPLETED|Overall Study||17
6561574|NCT01794780|7484404|FG001|NOT COMPLETED|Overall Study||96
6561575|NCT01794780|7484405|FG002|NOT COMPLETED|Overall Study||242
6561576|NCT01794780|7484406|FG003|NOT COMPLETED|Overall Study||83
6561577|NCT01794780|7484407|FG004|NOT COMPLETED|Overall Study||3
6519379|NCT01540565|7439989|FG000|STARTED|Overall Study||52
6519380|NCT01540565|7439989|FG000|COMPLETED|Overall Study||50
6519381|NCT01540565|7439989|FG000|NOT COMPLETED|Overall Study||2
6519382|NCT01540773|7439993|FG000|STARTED|First Intervention||8
6519383|NCT01540773|7439994|FG001|STARTED|First Intervention||8
6519384|NCT01540773|7439993|FG000|COMPLETED|First Intervention||8
6519385|NCT01540773|7439994|FG001|COMPLETED|First Intervention||8
6519386|NCT01540773|7439993|FG000|NOT COMPLETED|First Intervention||0
6519387|NCT01540773|7439994|FG001|NOT COMPLETED|First Intervention||0
6519388|NCT01540773|7439993|FG000|STARTED|Wash Out Period of 1 Week||8
6519389|NCT01540773|7439994|FG001|STARTED|Wash Out Period of 1 Week||8
6519390|NCT01540773|7439993|FG000|COMPLETED|Wash Out Period of 1 Week||8
6519391|NCT01540773|7439994|FG001|COMPLETED|Wash Out Period of 1 Week||8
6519392|NCT01540773|7439993|FG000|NOT COMPLETED|Wash Out Period of 1 Week||0
6519393|NCT01540773|7439994|FG001|NOT COMPLETED|Wash Out Period of 1 Week||0
6519394|NCT01540773|7439993|FG000|STARTED|Second Intervention||8
6519395|NCT01540773|7439994|FG001|STARTED|Second Intervention||8
6519396|NCT01540773|7439993|FG000|COMPLETED|Second Intervention||8
6519397|NCT01540773|7439994|FG001|COMPLETED|Second Intervention||8
6519398|NCT01540773|7439993|FG000|NOT COMPLETED|Second Intervention||0
6519399|NCT01540773|7439994|FG001|NOT COMPLETED|Second Intervention||0
6519400|NCT01540825|7440013|FG000|STARTED|Overall Study||20
6519401|NCT01540825|7440014|FG001|STARTED|Overall Study||6
6519402|NCT01540825|7440015|FG002|STARTED|Overall Study||6
6519403|NCT01540825|7440016|FG003|STARTED|Overall Study||6
6519404|NCT01540825|7440017|FG004|STARTED|Overall Study||6
6519405|NCT01540825|7440018|FG005|STARTED|Overall Study||6
6519406|NCT01540825|7440019|FG006|STARTED|Overall Study||6
6519407|NCT01540825|7440020|FG007|STARTED|Overall Study||6
6519408|NCT01540825|7440021|FG008|STARTED|Overall Study||6
6519409|NCT01540825|7440022|FG009|STARTED|Overall Study||6
6519410|NCT01540825|7440023|FG010|STARTED|Overall Study||6
6519411|NCT01540825|7440013|FG000|COMPLETED|Overall Study||20
6519412|NCT01540825|7440014|FG001|COMPLETED|Overall Study||6
6519413|NCT01540825|7440015|FG002|COMPLETED|Overall Study||6
6519414|NCT01540825|7440016|FG003|COMPLETED|Overall Study||6
6519415|NCT01540825|7440017|FG004|COMPLETED|Overall Study||6
6519416|NCT01540825|7440018|FG005|COMPLETED|Overall Study||6
6519417|NCT01540825|7440019|FG006|COMPLETED|Overall Study||6
6519418|NCT01540825|7440020|FG007|COMPLETED|Overall Study||6
6519419|NCT01540825|7440021|FG008|COMPLETED|Overall Study||6
6519420|NCT01540825|7440022|FG009|COMPLETED|Overall Study||6
6519421|NCT01540825|7440023|FG010|COMPLETED|Overall Study||6
6519422|NCT01540825|7440013|FG000|NOT COMPLETED|Overall Study||0
6519423|NCT01540825|7440014|FG001|NOT COMPLETED|Overall Study||0
6519424|NCT01540825|7440015|FG002|NOT COMPLETED|Overall Study||0
6519425|NCT01540825|7440016|FG003|NOT COMPLETED|Overall Study||0
6519426|NCT01540825|7440017|FG004|NOT COMPLETED|Overall Study||0
6519427|NCT01540825|7440018|FG005|NOT COMPLETED|Overall Study||0
6519428|NCT01540825|7440019|FG006|NOT COMPLETED|Overall Study||0
6519429|NCT01540825|7440020|FG007|NOT COMPLETED|Overall Study||0
6519430|NCT01540825|7440021|FG008|NOT COMPLETED|Overall Study||0
6519431|NCT01540825|7440022|FG009|NOT COMPLETED|Overall Study||0
6519432|NCT01540825|7440023|FG010|NOT COMPLETED|Overall Study||0
6519433|NCT01540838|7440059|FG000|STARTED|Overall Study||188
6519434|NCT01540838|7440060|FG001|STARTED|Overall Study||187
6519435|NCT01540838|7440059|FG000|COMPLETED|Overall Study||166
6519436|NCT01540838|7440060|FG001|COMPLETED|Overall Study||164
6519437|NCT01540838|7440059|FG000|NOT COMPLETED|Overall Study||22
6519438|NCT01540838|7440060|FG001|NOT COMPLETED|Overall Study||23
6519439|NCT01540851|7440068|FG000|STARTED|Overall Study||154
6519440|NCT01540851|7440069|FG001|STARTED|Overall Study||154
6519441|NCT01540851|7440068|FG000|COMPLETED|Overall Study||133
6519442|NCT01540851|7440069|FG001|COMPLETED|Overall Study||136
6519443|NCT01540851|7440068|FG000|NOT COMPLETED|Overall Study||21
6519444|NCT01540851|7440069|FG001|NOT COMPLETED|Overall Study||18
6519445|NCT01540981|7440079|FG000|STARTED|Overall Study||6
6519446|NCT01540981|7440080|FG001|STARTED|Overall Study||6
6519447|NCT01540981|7440079|FG000|COMPLETED|Overall Study||5
6519448|NCT01540981|7440080|FG001|COMPLETED|Overall Study||6
6519449|NCT01540981|7440079|FG000|NOT COMPLETED|Overall Study||1
6519450|NCT01540981|7440080|FG001|NOT COMPLETED|Overall Study||0
6519451|NCT01541215|7440088|FG000|STARTED|Treatment Period (52 Weeks)||66
6519452|NCT01541215|7440089|FG001|STARTED|Treatment Period (52 Weeks)||69
6519453|NCT01541215|7440088|FG000|Exposed|Treatment Period (52 Weeks)||66
6519454|NCT01541215|7440089|FG001|Exposed|Treatment Period (52 Weeks)||68
6519455|NCT01541215|7440088|FG000|COMPLETED|Treatment Period (52 Weeks)||56
6519456|NCT01541215|7440089|FG001|COMPLETED|Treatment Period (52 Weeks)||53
6519457|NCT01541215|7440088|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||10
6519458|NCT01541215|7440089|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||16
6519459|NCT01541215|7440088|FG000|STARTED|Follow up 1 (Weeks 53-104)|Subjects who attended safety follow up visit at week 104 were included.|52
6519460|NCT01541215|7440089|FG001|STARTED|Follow up 1 (Weeks 53-104)|Follow up was not planned for the subjects who received placebo.|0
6519461|NCT01541215|7440088|FG000|COMPLETED|Follow up 1 (Weeks 53-104)||50
6519462|NCT01541215|7440089|FG001|COMPLETED|Follow up 1 (Weeks 53-104)||0
6519463|NCT01541215|7440088|FG000|NOT COMPLETED|Follow up 1 (Weeks 53-104)||2
6519464|NCT01541215|7440089|FG001|NOT COMPLETED|Follow up 1 (Weeks 53-104)||0
6519465|NCT01541215|7440088|FG000|STARTED|Follow up 2 (Weeks 105-156)|Subjects who attended safety follow up visit at week 156 were included.|48
6519466|NCT01541215|7440089|FG001|STARTED|Follow up 2 (Weeks 105-156)||0
6519467|NCT01541215|7440088|FG000|COMPLETED|Follow up 2 (Weeks 105-156)||48
6519468|NCT01541215|7440089|FG001|COMPLETED|Follow up 2 (Weeks 105-156)||0
6519469|NCT01541215|7440088|FG000|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
6519470|NCT01541215|7440089|FG001|NOT COMPLETED|Follow up 2 (Weeks 105-156)||0
6519471|NCT01541254|7440099|FG000|STARTED|Overall Study||36
6519472|NCT01541254|7440099|FG000|COMPLETED|Overall Study||30
6519473|NCT01541254|7440099|FG000|NOT COMPLETED|Overall Study||6
6519474|NCT01541358|7440103|FG000|STARTED|Overall Study||2
6519475|NCT01541358|7440103|FG000|COMPLETED|Overall Study||2
6519476|NCT01541358|7440103|FG000|NOT COMPLETED|Overall Study||0
6519477|NCT01541371|7440108|FG000|STARTED|Overall Study||403
6519478|NCT01541371|7440108|FG000|Full Analysis Set|Overall Study||394
6519479|NCT01541371|7440108|FG000|COMPLETED|Overall Study||326
6519480|NCT01541371|7440108|FG000|NOT COMPLETED|Overall Study||77
6519481|NCT01541384|7440119|FG000|STARTED|Overall Study||40
6519482|NCT01541384|7440120|FG001|STARTED|Overall Study||40
6519483|NCT01541384|7440121|FG002|STARTED|Overall Study||40
6519484|NCT01541384|7440119|FG000|COMPLETED|Overall Study||40
6519485|NCT01541384|7440120|FG001|COMPLETED|Overall Study||39
6519486|NCT01541384|7440121|FG002|COMPLETED|Overall Study||38
6519487|NCT01541384|7440119|FG000|NOT COMPLETED|Overall Study||0
6519488|NCT01541384|7440120|FG001|NOT COMPLETED|Overall Study||1
6519489|NCT01541384|7440121|FG002|NOT COMPLETED|Overall Study||2
6519490|NCT01541553|7440131|FG000|STARTED|Overall Study||167
6519491|NCT01541553|7440132|FG001|STARTED|Overall Study||162
6519492|NCT01541553|7440131|FG000|COMPLETED|Overall Study||155
6519493|NCT01541553|7440132|FG001|COMPLETED|Overall Study||148
6519494|NCT01541553|7440131|FG000|NOT COMPLETED|Overall Study||12
6519495|NCT01541553|7440132|FG001|NOT COMPLETED|Overall Study||14
6519496|NCT01541644|7440138|FG000|STARTED|Overall Study||27
6519497|NCT01541644|7440138|FG000|COMPLETED|Overall Study||24
6519498|NCT01541644|7440138|FG000|NOT COMPLETED|Overall Study||3
6519499|NCT01541735|7440144|FG000|STARTED|Overall Study||7
6519500|NCT01541735|7440145|FG001|STARTED|Overall Study||7
6519501|NCT01541735|7440144|FG000|COMPLETED|Overall Study||7
6519502|NCT01541735|7440145|FG001|COMPLETED|Overall Study||7
6519503|NCT01541735|7440144|FG000|NOT COMPLETED|Overall Study||0
6519504|NCT01541735|7440145|FG001|NOT COMPLETED|Overall Study||0
6519505|NCT01541748|7440151|FG000|STARTED|Overall Study|74 subjects were consented; however, 5 were screen failures and 1 did not receive the study device.|74
6519506|NCT01541748|7440151|FG000|COMPLETED|Overall Study||43
6519507|NCT01541748|7440151|FG000|NOT COMPLETED|Overall Study||31
6519508|NCT01541826|7440167|FG000|STARTED|Overall Study||28
6519509|NCT01541826|7440168|FG001|STARTED|Overall Study||28
6519510|NCT01541826|7440169|FG002|STARTED|Overall Study||6
6519511|NCT01541826|7440167|FG000|COMPLETED|Overall Study||24
6519512|NCT01541826|7440168|FG001|COMPLETED|Overall Study||25
6519513|NCT01541826|7440169|FG002|COMPLETED|Overall Study||6
6519514|NCT01541826|7440167|FG000|NOT COMPLETED|Overall Study||4
6519515|NCT01541826|7440168|FG001|NOT COMPLETED|Overall Study||3
6519516|NCT01541826|7440169|FG002|NOT COMPLETED|Overall Study||0
6519517|NCT01541865|7440177|FG000|STARTED|Overall Study||146
6519518|NCT01541865|7440177|FG000|COMPLETED|Overall Study||124
6519519|NCT01541865|7440177|FG000|NOT COMPLETED|Overall Study||22
6519520|NCT01541891|7440183|FG000|STARTED|Overall Study||15
6519521|NCT01541891|7440184|FG001|STARTED|Overall Study||15
6519522|NCT01541891|7440183|FG000|COMPLETED|Overall Study||14
6519523|NCT01541891|7440184|FG001|COMPLETED|Overall Study||14
6519524|NCT01541891|7440183|FG000|NOT COMPLETED|Overall Study||1
6519525|NCT01541891|7440184|FG001|NOT COMPLETED|Overall Study||1
6519526|NCT01541917|7440195|FG000|STARTED|Overall Study||144
6519527|NCT01541917|7440196|FG001|STARTED|Overall Study||145
6519528|NCT01541917|7440195|FG000|COMPLETED|Overall Study||129
6519529|NCT01541917|7440196|FG001|COMPLETED|Overall Study||136
6519530|NCT01541917|7440195|FG000|NOT COMPLETED|Overall Study||15
6519531|NCT01541917|7440196|FG001|NOT COMPLETED|Overall Study||9
6519532|NCT01541930|7440205|FG000|STARTED|Overall Study||21
6519533|NCT01541930|7440205|FG000|COMPLETED|Overall Study||20
6519534|NCT01541930|7440205|FG000|NOT COMPLETED|Overall Study||1
6519535|NCT01541969|7440222|FG000|STARTED|Double-blind (0-12 Weeks)||50
6519536|NCT01541969|7440223|FG001|STARTED|Double-blind (0-12 Weeks)||50
6519537|NCT01541969|7440222|FG000|COMPLETED|Double-blind (0-12 Weeks)||44
6519538|NCT01541969|7440223|FG001|COMPLETED|Double-blind (0-12 Weeks)||48
6519539|NCT01541969|7440222|FG000|NOT COMPLETED|Double-blind (0-12 Weeks)||6
6519540|NCT01541969|7440223|FG001|NOT COMPLETED|Double-blind (0-12 Weeks)||2
6519541|NCT01541969|7440222|FG000|STARTED|Open Label Extension (12-36 Weeks)||44
6519542|NCT01541969|7440223|FG001|STARTED|Open Label Extension (12-36 Weeks)||48
6519543|NCT01541969|7440222|FG000|COMPLETED|Open Label Extension (12-36 Weeks)||33
6519544|NCT01541969|7440223|FG001|COMPLETED|Open Label Extension (12-36 Weeks)||35
6519545|NCT01541969|7440222|FG000|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
6519546|NCT01541969|7440223|FG001|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
6519547|NCT01542034|7440234|FG000|STARTED|Overall Study||256
6519548|NCT01542034|7440235|FG001|STARTED|Overall Study||250
6519549|NCT01542034|7440234|FG000|Received Treatment|Overall Study||256
6519550|NCT01542034|7440235|FG001|Received Treatment|Overall Study||249
6519551|NCT01542034|7440234|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
6519552|NCT01542034|7440235|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
6519553|NCT01542034|7440234|FG000|NOT COMPLETED|Overall Study||30
6519554|NCT01542034|7440235|FG001|NOT COMPLETED|Overall Study||23
6519555|NCT01542125|7440243|FG000|STARTED|Overall Study||140
6519556|NCT01542125|7440244|FG001|STARTED|Overall Study||141
6519557|NCT01542125|7440243|FG000|COMPLETED|Overall Study||140
6519558|NCT01542125|7440244|FG001|COMPLETED|Overall Study||141
6519559|NCT01542125|7440243|FG000|NOT COMPLETED|Overall Study||0
6519560|NCT01542125|7440244|FG001|NOT COMPLETED|Overall Study||0
6519561|NCT01542229|7440252|FG000|STARTED|Overall Study||68
6519562|NCT01542229|7440253|FG001|STARTED|Overall Study||66
6519563|NCT01542229|7440252|FG000|COMPLETED|Overall Study||45
6519564|NCT01542229|7440253|FG001|COMPLETED|Overall Study||30
6519565|NCT01542229|7440252|FG000|NOT COMPLETED|Overall Study||23
6519566|NCT01542229|7440253|FG001|NOT COMPLETED|Overall Study||36
6519567|NCT01542255|7440260|FG000|STARTED|Overall Study||7
6519568|NCT01542255|7440260|FG000|Analyzed for Time to Progression|Overall Study||7
6519569|NCT01542255|7440260|FG000|COMPLETED|Overall Study||7
6519570|NCT01542255|7440260|FG000|NOT COMPLETED|Overall Study||0
6519571|NCT01542307|7440265|FG000|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
6519572|NCT01542307|7440266|FG001|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
6519573|NCT01542307|7440265|FG000|COMPLETED|Overall Study||22
6519574|NCT01542307|7440266|FG001|COMPLETED|Overall Study||22
6519575|NCT01542307|7440265|FG000|NOT COMPLETED|Overall Study||0
6519576|NCT01542307|7440266|FG001|NOT COMPLETED|Overall Study||0
6519577|NCT01542372|7440272|FG000|STARTED|Overall Study||11
6519578|NCT01542372|7440273|FG001|STARTED|Overall Study||11
6519579|NCT01542372|7440272|FG000|COMPLETED|Overall Study||11
6519580|NCT01542372|7440273|FG001|COMPLETED|Overall Study||11
6519581|NCT01542372|7440272|FG000|NOT COMPLETED|Overall Study||0
6519582|NCT01542372|7440273|FG001|NOT COMPLETED|Overall Study||0
6519583|NCT01542398|7440280|FG000|STARTED|Overall Study||79
6519584|NCT01542398|7440281|FG001|STARTED|Overall Study||80
6519585|NCT01542398|7440280|FG000|Post-Intervention Assessment|Overall Study||78
6519586|NCT01542398|7440281|FG001|Post-Intervention Assessment|Overall Study||80
6519587|NCT01542398|7440280|FG000|COMPLETED|Overall Study||71
6519588|NCT01542398|7440281|FG001|COMPLETED|Overall Study||67
6519589|NCT01542398|7440280|FG000|NOT COMPLETED|Overall Study||8
6519590|NCT01542398|7440281|FG001|NOT COMPLETED|Overall Study||13
6519591|NCT01542502|7440289|FG000|STARTED|Overall Study||6
6519592|NCT01542502|7440290|FG001|STARTED|Overall Study||6
6519593|NCT01542502|7440289|FG000|COMPLETED|Overall Study||6
6519594|NCT01542502|7440290|FG001|COMPLETED|Overall Study||6
6519595|NCT01542502|7440289|FG000|NOT COMPLETED|Overall Study||0
6519596|NCT01542502|7440290|FG001|NOT COMPLETED|Overall Study||0
6519597|NCT01542528|7440299|FG000|STARTED|Overall Study||61
6519598|NCT01542528|7440300|FG001|STARTED|Overall Study||56
6519599|NCT01542528|7440299|FG000|COMPLETED|Overall Study||49
6519600|NCT01542528|7440300|FG001|COMPLETED|Overall Study||49
6519601|NCT01542528|7440299|FG000|NOT COMPLETED|Overall Study||12
6641806|NCT02346240|7570399|FG019|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641807|NCT02346240|7570400|FG020|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641808|NCT02346240|7570401|FG021|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641809|NCT02346240|7570402|FG022|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641810|NCT02346240|7570403|FG023|Completed Week 16|Initial Period (Baseline to Week 16)||0
6641811|NCT02346240|7570380|FG000|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||55
6641812|NCT02346240|7570381|FG001|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
6641813|NCT02346240|7570382|FG002|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||159
6641814|NCT02346240|7570383|FG003|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||160
6641815|NCT02346240|7570384|FG004|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641816|NCT02346240|7570385|FG005|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641817|NCT02346240|7570386|FG006|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641818|NCT02346240|7570387|FG007|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641819|NCT02346240|7570388|FG008|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641820|NCT02346240|7570389|FG009|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641821|NCT02346240|7570390|FG010|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641822|NCT02346240|7570391|FG011|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641823|NCT02346240|7570392|FG012|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6519602|NCT01542528|7440300|FG001|NOT COMPLETED|Overall Study||7
6519603|NCT01542541|7440308|FG000|STARTED|Overall Study||38
6519604|NCT01542541|7440309|FG001|STARTED|Overall Study||30
6519605|NCT01542541|7440308|FG000|COMPLETED|Overall Study||30
6519606|NCT01542541|7440309|FG001|COMPLETED|Overall Study||30
6519607|NCT01542541|7440308|FG000|NOT COMPLETED|Overall Study||8
6519608|NCT01542541|7440309|FG001|NOT COMPLETED|Overall Study||0
6519609|NCT01542632|7440321|FG000|STARTED|Overall Study||25
6519610|NCT01542632|7440322|FG001|STARTED|Overall Study||25
6519611|NCT01542632|7440323|FG002|STARTED|Overall Study||24
6519612|NCT01542632|7440324|FG003|STARTED|Overall Study||21
6519613|NCT01542632|7440325|FG004|STARTED|Overall Study||21
6519614|NCT01542632|7440326|FG005|STARTED|Overall Study||24
6519615|NCT01542632|7440321|FG000|COMPLETED|Overall Study||25
6519616|NCT01542632|7440322|FG001|COMPLETED|Overall Study||24
6519617|NCT01542632|7440323|FG002|COMPLETED|Overall Study||23
6519618|NCT01542632|7440324|FG003|COMPLETED|Overall Study||19
6519619|NCT01542632|7440325|FG004|COMPLETED|Overall Study||17
6519620|NCT01542632|7440326|FG005|COMPLETED|Overall Study||24
6519621|NCT01542632|7440321|FG000|NOT COMPLETED|Overall Study||0
6519622|NCT01542632|7440322|FG001|NOT COMPLETED|Overall Study||1
6519623|NCT01542632|7440323|FG002|NOT COMPLETED|Overall Study||1
6519624|NCT01542632|7440324|FG003|NOT COMPLETED|Overall Study||2
6519625|NCT01542632|7440325|FG004|NOT COMPLETED|Overall Study||4
6519626|NCT01542632|7440326|FG005|NOT COMPLETED|Overall Study||0
6519627|NCT01542645|7440347|FG000|STARTED|Overall Study||82
6519628|NCT01542645|7440348|FG001|STARTED|Overall Study||82
6519629|NCT01542645|7440347|FG000|COMPLETED|Overall Study||77
6519630|NCT01542645|7440348|FG001|COMPLETED|Overall Study||79
6519631|NCT01542645|7440347|FG000|NOT COMPLETED|Overall Study||5
6519632|NCT01542645|7440348|FG001|NOT COMPLETED|Overall Study||3
6519633|NCT01542684|7440358|FG000|STARTED|Overall Study||8
6519634|NCT01542684|7440358|FG000|COMPLETED|Overall Study||8
6519635|NCT01542684|7440358|FG000|NOT COMPLETED|Overall Study||0
6519636|NCT01542788|7440364|FG000|STARTED|Overall Study||209
6519637|NCT01542788|7440365|FG001|STARTED|Overall Study||71
6519638|NCT01542788|7440364|FG000|Randomized and Treated|Overall Study||207
6519639|NCT01542788|7440365|FG001|Randomized and Treated|Overall Study||71
6519640|NCT01542788|7440364|FG000|COMPLETED|Overall Study||154
6519641|NCT01542788|7440365|FG001|COMPLETED|Overall Study||0
6519642|NCT01542788|7440364|FG000|NOT COMPLETED|Overall Study||55
6519643|NCT01542788|7440365|FG001|NOT COMPLETED|Overall Study||71
6519644|NCT01542957|7440373|FG000|STARTED|End of Therapy||65
6519645|NCT01542957|7440374|FG001|STARTED|End of Therapy||63
6519646|NCT01542957|7440373|FG000|COMPLETED|End of Therapy||53
6519647|NCT01542957|7440374|FG001|COMPLETED|End of Therapy||53
6519648|NCT01542957|7440373|FG000|NOT COMPLETED|End of Therapy||12
6519649|NCT01542957|7440374|FG001|NOT COMPLETED|End of Therapy||10
6519650|NCT01542957|7440373|FG000|STARTED|3-month Follow-up||53
6519651|NCT01542957|7440374|FG001|STARTED|3-month Follow-up||53
6519652|NCT01542957|7440373|FG000|COMPLETED|3-month Follow-up||50
6519653|NCT01542957|7440374|FG001|COMPLETED|3-month Follow-up||45
6519654|NCT01542957|7440373|FG000|NOT COMPLETED|3-month Follow-up||3
6519655|NCT01542957|7440374|FG001|NOT COMPLETED|3-month Follow-up||8
6519656|NCT01542957|7440373|FG000|STARTED|12-month Follow-up||53
6519657|NCT01542957|7440374|FG001|STARTED|12-month Follow-up||53
6519658|NCT01542957|7440373|FG000|COMPLETED|12-month Follow-up||37
6519659|NCT01542957|7440374|FG001|COMPLETED|12-month Follow-up||40
6519660|NCT01542957|7440373|FG000|NOT COMPLETED|12-month Follow-up||16
6519661|NCT01542957|7440374|FG001|NOT COMPLETED|12-month Follow-up||13
6519662|NCT01543074|7440384|FG000|STARTED|Overall Study||5
6519663|NCT01543074|7440385|FG001|STARTED|Overall Study||7
6519664|NCT01543074|7440386|FG002|STARTED|Overall Study||5
6519665|NCT01543074|7440387|FG003|STARTED|Overall Study||6
6519666|NCT01543074|7440384|FG000|COMPLETED|Overall Study||5
6519667|NCT01543074|7440385|FG001|COMPLETED|Overall Study||7
6519668|NCT01543074|7440386|FG002|COMPLETED|Overall Study||5
6519669|NCT01543074|7440387|FG003|COMPLETED|Overall Study||6
6519670|NCT01543074|7440384|FG000|NOT COMPLETED|Overall Study||0
6519671|NCT01543074|7440385|FG001|NOT COMPLETED|Overall Study||0
6519672|NCT01543074|7440386|FG002|NOT COMPLETED|Overall Study||0
6519673|NCT01543074|7440387|FG003|NOT COMPLETED|Overall Study||0
6519674|NCT01543087|7440407|FG000|STARTED|Stage 1 (48 Months)||70
6519675|NCT01543087|7440408|FG001|STARTED|Stage 1 (48 Months)||103
6519676|NCT01543087|7440409|FG002|STARTED|Stage 1 (48 Months)||277
6519677|NCT01543087|7440410|FG003|STARTED|Stage 1 (48 Months)||116
6519678|NCT01543087|7440411|FG004|STARTED|Stage 1 (48 Months)||86
6519679|NCT01543087|7440412|FG005|STARTED|Stage 1 (48 Months)||46
6519680|NCT01543087|7440407|FG000|Safety Population|Stage 1 (48 Months)||70
6519681|NCT01543087|7440408|FG001|Safety Population|Stage 1 (48 Months)||101
6519682|NCT01543087|7440409|FG002|Safety Population|Stage 1 (48 Months)||277
6519683|NCT01543087|7440410|FG003|Safety Population|Stage 1 (48 Months)||116
6519684|NCT01543087|7440411|FG004|Safety Population|Stage 1 (48 Months)||86
6519685|NCT01543087|7440412|FG005|Safety Population|Stage 1 (48 Months)||46
6519686|NCT01543087|7440407|FG000|COMPLETED|Stage 1 (48 Months)||56
6519687|NCT01543087|7440408|FG001|COMPLETED|Stage 1 (48 Months)||93
6519688|NCT01543087|7440409|FG002|COMPLETED|Stage 1 (48 Months)||237
6519689|NCT01543087|7440410|FG003|COMPLETED|Stage 1 (48 Months)||108
6519690|NCT01543087|7440411|FG004|COMPLETED|Stage 1 (48 Months)||83
6519691|NCT01543087|7440412|FG005|COMPLETED|Stage 1 (48 Months)||46
6519692|NCT01543087|7440407|FG000|NOT COMPLETED|Stage 1 (48 Months)||14
6519693|NCT01543087|7440408|FG001|NOT COMPLETED|Stage 1 (48 Months)||10
6519694|NCT01543087|7440409|FG002|NOT COMPLETED|Stage 1 (48 Months)||40
6519695|NCT01543087|7440410|FG003|NOT COMPLETED|Stage 1 (48 Months)||8
6519696|NCT01543087|7440411|FG004|NOT COMPLETED|Stage 1 (48 Months)||3
6519697|NCT01543087|7440412|FG005|NOT COMPLETED|Stage 1 (48 Months)||0
6519698|NCT01543087|7440407|FG000|STARTED|Booster Stage (26 Months)|Group1 participants (primary study B1971015)were not invited to participate in Booster stage (BS).|0
6519699|NCT01543087|7440408|FG001|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|60
6519700|NCT01543087|7440409|FG002|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|92
6561578|NCT01794780|7484408|FG005|NOT COMPLETED|Overall Study||180
6519701|NCT01543087|7440410|FG003|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|64
6519702|NCT01543087|7440411|FG004|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|56
6519703|NCT01543087|7440412|FG005|STARTED|Booster Stage (26 Months)|BS was optional for eligible participants. Not all participants completing stage 1 continued to BS.|32
6519704|NCT01543087|7440407|FG000|Vaccinated|Booster Stage (26 Months)||0
6519705|NCT01543087|7440408|FG001|Vaccinated|Booster Stage (26 Months)||59
6519706|NCT01543087|7440409|FG002|Vaccinated|Booster Stage (26 Months)||92
6519707|NCT01543087|7440410|FG003|Vaccinated|Booster Stage (26 Months)||64
6519708|NCT01543087|7440411|FG004|Vaccinated|Booster Stage (26 Months)||54
6519709|NCT01543087|7440412|FG005|Vaccinated|Booster Stage (26 Months)||32
6519710|NCT01543087|7440407|FG000|COMPLETED|Booster Stage (26 Months)||0
6519711|NCT01543087|7440408|FG001|COMPLETED|Booster Stage (26 Months)||59
6519712|NCT01543087|7440409|FG002|COMPLETED|Booster Stage (26 Months)||91
6519713|NCT01543087|7440410|FG003|COMPLETED|Booster Stage (26 Months)||64
6519714|NCT01543087|7440411|FG004|COMPLETED|Booster Stage (26 Months)||54
6519715|NCT01543087|7440412|FG005|COMPLETED|Booster Stage (26 Months)||32
6519716|NCT01543087|7440407|FG000|NOT COMPLETED|Booster Stage (26 Months)||0
6519717|NCT01543087|7440408|FG001|NOT COMPLETED|Booster Stage (26 Months)||1
6519718|NCT01543087|7440409|FG002|NOT COMPLETED|Booster Stage (26 Months)||1
6519719|NCT01543087|7440410|FG003|NOT COMPLETED|Booster Stage (26 Months)||0
6519720|NCT01543087|7440411|FG004|NOT COMPLETED|Booster Stage (26 Months)||2
6519721|NCT01543087|7440412|FG005|NOT COMPLETED|Booster Stage (26 Months)||0
6519722|NCT01543152|7440453|FG000|STARTED|Overall Study||3
6519723|NCT01543152|7440454|FG001|STARTED|Overall Study||6
6519724|NCT01543152|7440455|FG002|STARTED|Overall Study||11
6519725|NCT01543152|7440456|FG003|STARTED|Overall Study||3
6519726|NCT01543152|7440457|FG004|STARTED|Overall Study||3
6519727|NCT01543152|7440453|FG000|COMPLETED|Overall Study||3
6519728|NCT01543152|7440454|FG001|COMPLETED|Overall Study||4
6519729|NCT01543152|7440455|FG002|COMPLETED|Overall Study||11
6519730|NCT01543152|7440456|FG003|COMPLETED|Overall Study||3
6519731|NCT01543152|7440457|FG004|COMPLETED|Overall Study||3
6519732|NCT01543152|7440453|FG000|NOT COMPLETED|Overall Study||0
6519733|NCT01543152|7440454|FG001|NOT COMPLETED|Overall Study||2
6519734|NCT01543152|7440455|FG002|NOT COMPLETED|Overall Study||0
6519735|NCT01543152|7440456|FG003|NOT COMPLETED|Overall Study||0
6519736|NCT01543152|7440457|FG004|NOT COMPLETED|Overall Study||0
6641824|NCT02346240|7570393|FG013|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641825|NCT02346240|7570394|FG014|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641826|NCT02346240|7570395|FG015|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641827|NCT02346240|7570396|FG016|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641828|NCT02346240|7570397|FG017|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641829|NCT02346240|7570398|FG018|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641830|NCT02346240|7570399|FG019|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641831|NCT02346240|7570400|FG020|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641832|NCT02346240|7570401|FG021|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641833|NCT02346240|7570402|FG022|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641834|NCT02346240|7570403|FG023|Finished Wk16 Started Maintenance Period|Initial Period (Baseline to Week 16)||0
6641835|NCT02346240|7570380|FG000|COMPLETED|Initial Period (Baseline to Week 16)||55
6641836|NCT02346240|7570381|FG001|COMPLETED|Initial Period (Baseline to Week 16)||159
6641837|NCT02346240|7570382|FG002|COMPLETED|Initial Period (Baseline to Week 16)||159
6641838|NCT02346240|7570383|FG003|COMPLETED|Initial Period (Baseline to Week 16)||160
6641839|NCT02346240|7570384|FG004|COMPLETED|Initial Period (Baseline to Week 16)||0
6641840|NCT02346240|7570385|FG005|COMPLETED|Initial Period (Baseline to Week 16)||0
6641841|NCT02346240|7570386|FG006|COMPLETED|Initial Period (Baseline to Week 16)||0
6641842|NCT02346240|7570387|FG007|COMPLETED|Initial Period (Baseline to Week 16)||0
6641843|NCT02346240|7570388|FG008|COMPLETED|Initial Period (Baseline to Week 16)||0
6641844|NCT02346240|7570389|FG009|COMPLETED|Initial Period (Baseline to Week 16)||0
6641845|NCT02346240|7570390|FG010|COMPLETED|Initial Period (Baseline to Week 16)||0
6641846|NCT02346240|7570391|FG011|COMPLETED|Initial Period (Baseline to Week 16)||0
6641847|NCT02346240|7570392|FG012|COMPLETED|Initial Period (Baseline to Week 16)||0
6641848|NCT02346240|7570393|FG013|COMPLETED|Initial Period (Baseline to Week 16)||0
6641849|NCT02346240|7570394|FG014|COMPLETED|Initial Period (Baseline to Week 16)||0
6641850|NCT02346240|7570395|FG015|COMPLETED|Initial Period (Baseline to Week 16)||0
6641851|NCT02346240|7570396|FG016|COMPLETED|Initial Period (Baseline to Week 16)||0
6641852|NCT02346240|7570397|FG017|COMPLETED|Initial Period (Baseline to Week 16)||0
6641853|NCT02346240|7570398|FG018|COMPLETED|Initial Period (Baseline to Week 16)||0
6641854|NCT02346240|7570399|FG019|COMPLETED|Initial Period (Baseline to Week 16)||0
6641855|NCT02346240|7570400|FG020|COMPLETED|Initial Period (Baseline to Week 16)||0
6641856|NCT02346240|7570401|FG021|COMPLETED|Initial Period (Baseline to Week 16)||0
6641857|NCT02346240|7570402|FG022|COMPLETED|Initial Period (Baseline to Week 16)||0
6519737|NCT01543178|7440472|FG000|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
6519738|NCT01543178|7440473|FG001|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
6519739|NCT01543178|7440474|FG002|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
6519740|NCT01543178|7440472|FG000|COMPLETED|Open-label Period||636
6519741|NCT01543178|7440473|FG001|COMPLETED|Open-label Period||0
6519742|NCT01543178|7440474|FG002|COMPLETED|Open-label Period||0
6519743|NCT01543178|7440472|FG000|NOT COMPLETED|Open-label Period||1947
6519744|NCT01543178|7440473|FG001|NOT COMPLETED|Open-label Period||0
6519745|NCT01543178|7440474|FG002|NOT COMPLETED|Open-label Period||0
6519746|NCT01543178|7440472|FG000|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
6519747|NCT01543178|7440473|FG001|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
6519748|NCT01543178|7440474|FG002|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
6519749|NCT01543178|7440472|FG000|COMPLETED|Double-blind Period||0
6519750|NCT01543178|7440473|FG001|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
6519751|NCT01543178|7440474|FG002|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
6519752|NCT01543178|7440472|FG000|NOT COMPLETED|Double-blind Period||0
6519753|NCT01543178|7440473|FG001|NOT COMPLETED|Double-blind Period||44
6519754|NCT01543178|7440474|FG002|NOT COMPLETED|Double-blind Period||37
6519755|NCT01543204|7440481|FG000|STARTED|Overall Study||64
6519756|NCT01543204|7440481|FG000|COMPLETED|Overall Study||56
6519757|NCT01543204|7440481|FG000|NOT COMPLETED|Overall Study||8
6519758|NCT01543490|7440491|FG000|STARTED|Overall Study||368
6519759|NCT01543490|7440492|FG001|STARTED|Overall Study||190
6519760|NCT01543490|7440491|FG000|COMPLETED|Overall Study||352
6519761|NCT01543490|7440492|FG001|COMPLETED|Overall Study||185
6519762|NCT01543490|7440491|FG000|NOT COMPLETED|Overall Study||16
6519763|NCT01543490|7440492|FG001|NOT COMPLETED|Overall Study||5
6519764|NCT01543503|7440500|FG000|STARTED|Overall Study||426
6519765|NCT01543503|7440501|FG001|STARTED|Overall Study||798
6519766|NCT01543503|7440500|FG000|COMPLETED|Overall Study||350
6519767|NCT01543503|7440501|FG001|COMPLETED|Overall Study||711
6519768|NCT01543503|7440500|FG000|NOT COMPLETED|Overall Study||76
6519769|NCT01543503|7440501|FG001|NOT COMPLETED|Overall Study||87
6519770|NCT01543568|7440507|FG000|STARTED|Overall Study||46
6519771|NCT01543568|7440507|FG000|COMPLETED|Overall Study||45
6519772|NCT01543568|7440507|FG000|NOT COMPLETED|Overall Study||1
6519773|NCT01543581|7440511|FG000|STARTED|Overall Study||1
6519774|NCT01543581|7440512|FG001|STARTED|Overall Study||0
6519775|NCT01543581|7440511|FG000|COMPLETED|Overall Study||1
6641858|NCT02346240|7570403|FG023|COMPLETED|Initial Period (Baseline to Week 16)||0
6641859|NCT02346240|7570380|FG000|NOT COMPLETED|Initial Period (Baseline to Week 16)||2
6641860|NCT02346240|7570381|FG001|NOT COMPLETED|Initial Period (Baseline to Week 16)||11
6641861|NCT02346240|7570382|FG002|NOT COMPLETED|Initial Period (Baseline to Week 16)||6
6641862|NCT02346240|7570383|FG003|NOT COMPLETED|Initial Period (Baseline to Week 16)||7
6641863|NCT02346240|7570384|FG004|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641864|NCT02346240|7570385|FG005|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641865|NCT02346240|7570386|FG006|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641866|NCT02346240|7570387|FG007|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641867|NCT02346240|7570388|FG008|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641868|NCT02346240|7570389|FG009|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641869|NCT02346240|7570390|FG010|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641870|NCT02346240|7570391|FG011|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641871|NCT02346240|7570392|FG012|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641872|NCT02346240|7570393|FG013|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641873|NCT02346240|7570394|FG014|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641874|NCT02346240|7570395|FG015|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641875|NCT02346240|7570396|FG016|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641876|NCT02346240|7570397|FG017|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641877|NCT02346240|7570398|FG018|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641878|NCT02346240|7570399|FG019|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641879|NCT02346240|7570400|FG020|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641880|NCT02346240|7570401|FG021|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641881|NCT02346240|7570402|FG022|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641882|NCT02346240|7570403|FG023|NOT COMPLETED|Initial Period (Baseline to Week 16)||0
6641883|NCT02346240|7570380|FG000|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641884|NCT02346240|7570381|FG001|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641885|NCT02346240|7570382|FG002|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641886|NCT02346240|7570383|FG003|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641887|NCT02346240|7570384|FG004|STARTED|Maintenance Period (Week 16 to Week 48)||2
6641888|NCT02346240|7570385|FG005|STARTED|Maintenance Period (Week 16 to Week 48)||24
6641889|NCT02346240|7570386|FG006|STARTED|Maintenance Period (Week 16 to Week 48)||50
6641890|NCT02346240|7570387|FG007|STARTED|Maintenance Period (Week 16 to Week 48)||22
6641891|NCT02346240|7570388|FG008|STARTED|Maintenance Period (Week 16 to Week 48)||44
6641892|NCT02346240|7570389|FG009|STARTED|Maintenance Period (Week 16 to Week 48)||44
6519776|NCT01543581|7440512|FG001|COMPLETED|Overall Study||0
6519777|NCT01543581|7440511|FG000|NOT COMPLETED|Overall Study||0
6519778|NCT01543581|7440512|FG001|NOT COMPLETED|Overall Study||0
6519779|NCT01543607|7440518|FG000|STARTED|Overall Study||1
6519780|NCT01543607|7440518|FG000|COMPLETED|Overall Study||1
6519781|NCT01543607|7440518|FG000|NOT COMPLETED|Overall Study||0
6519782|NCT01543685|7440527|FG000|STARTED|Overall Study||93
6519783|NCT01543685|7440528|FG001|STARTED|Overall Study||91
6519784|NCT01543685|7440529|FG002|STARTED|Overall Study||91
6519785|NCT01543685|7440530|FG003|STARTED|Overall Study||93
6519786|NCT01543685|7440531|FG004|STARTED|Overall Study||94
6519787|NCT01543685|7440527|FG000|COMPLETED|Overall Study||90
6519788|NCT01543685|7440528|FG001|COMPLETED|Overall Study||88
6519789|NCT01543685|7440529|FG002|COMPLETED|Overall Study||89
6519790|NCT01543685|7440530|FG003|COMPLETED|Overall Study||93
6519791|NCT01543685|7440531|FG004|COMPLETED|Overall Study||90
6519792|NCT01543685|7440527|FG000|NOT COMPLETED|Overall Study||3
6519793|NCT01543685|7440528|FG001|NOT COMPLETED|Overall Study||3
6519794|NCT01543685|7440529|FG002|NOT COMPLETED|Overall Study||2
6519795|NCT01543685|7440530|FG003|NOT COMPLETED|Overall Study||0
6519796|NCT01543685|7440531|FG004|NOT COMPLETED|Overall Study||4
6519797|NCT01543776|7440545|FG000|STARTED|Overall Study||36
6519798|NCT01543776|7440546|FG001|STARTED|Overall Study||36
6519799|NCT01543776|7440545|FG000|COMPLETED|Overall Study||34
6519800|NCT01543776|7440546|FG001|COMPLETED|Overall Study||34
6519801|NCT01543776|7440545|FG000|NOT COMPLETED|Overall Study||2
6519802|NCT01543776|7440546|FG001|NOT COMPLETED|Overall Study||2
6519803|NCT01543828|7440554|FG000|STARTED|Treatment 1||20
6519804|NCT01543828|7440555|FG001|STARTED|Treatment 1||20
6519805|NCT01543828|7440554|FG000|COMPLETED|Treatment 1||20
6519806|NCT01543828|7440555|FG001|COMPLETED|Treatment 1||20
6519807|NCT01543828|7440554|FG000|NOT COMPLETED|Treatment 1||0
6519808|NCT01543828|7440555|FG001|NOT COMPLETED|Treatment 1||0
6519809|NCT01543828|7440554|FG000|STARTED|Treatment 2||20
6519810|NCT01543828|7440555|FG001|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
6519811|NCT01543828|7440554|FG000|COMPLETED|Treatment 2||19
6519812|NCT01543828|7440555|FG001|COMPLETED|Treatment 2||19
6519813|NCT01543828|7440554|FG000|NOT COMPLETED|Treatment 2||1
6519814|NCT01543828|7440555|FG001|NOT COMPLETED|Treatment 2||0
6519815|NCT01543958|7440563|FG000|STARTED|Overall Study||40
6519816|NCT01543958|7440563|FG000|COMPLETED|Overall Study||36
6519817|NCT01543958|7440563|FG000|NOT COMPLETED|Overall Study||4
6519818|NCT01544023|7440567|FG000|STARTED|Overall Study|retrospective|207
6519819|NCT01544023|7440567|FG000|COMPLETED|Overall Study||207
6519820|NCT01544023|7440567|FG000|NOT COMPLETED|Overall Study||0
6519821|NCT01544062|7440573|FG000|STARTED|Overall Study||33
6519822|NCT01544062|7440574|FG001|STARTED|Overall Study||35
6519823|NCT01544062|7440573|FG000|COMPLETED|Overall Study||33
6519824|NCT01544062|7440574|FG001|COMPLETED|Overall Study||35
6519825|NCT01544062|7440573|FG000|NOT COMPLETED|Overall Study||0
6519826|NCT01544062|7440574|FG001|NOT COMPLETED|Overall Study||0
6519827|NCT01544088|7440583|FG000|STARTED|Overall Study||98
6519828|NCT01544088|7440584|FG001|STARTED|Overall Study||100
6519829|NCT01544088|7440583|FG000|COMPLETED|Overall Study||61
6519830|NCT01544088|7440584|FG001|COMPLETED|Overall Study||79
6519831|NCT01544088|7440583|FG000|NOT COMPLETED|Overall Study||37
6519832|NCT01544088|7440584|FG001|NOT COMPLETED|Overall Study||21
6519833|NCT01544114|7440593|FG000|STARTED|Overall Study||4
6519834|NCT01544114|7440594|FG001|STARTED|Overall Study||20
6519835|NCT01544114|7440595|FG002|STARTED|Overall Study||22
6519836|NCT01544114|7440593|FG000|COMPLETED|Overall Study|completed study and received 6 months of study drug|3
6519837|NCT01544114|7440594|FG001|COMPLETED|Overall Study|completed study and received 6 months of study drug|16
6519838|NCT01544114|7440595|FG002|COMPLETED|Overall Study|completed study and received 6 months of study drug|17
6519839|NCT01544114|7440593|FG000|NOT COMPLETED|Overall Study||1
6519840|NCT01544114|7440594|FG001|NOT COMPLETED|Overall Study||4
6519841|NCT01544114|7440595|FG002|NOT COMPLETED|Overall Study||5
6519842|NCT01544153|7440609|FG000|STARTED|Overall Study||1337
6519843|NCT01544153|7440610|FG001|STARTED|Overall Study||1324
6519844|NCT01544153|7440611|FG002|STARTED|Overall Study||1314
6519845|NCT01544153|7440612|FG003|STARTED|Overall Study||1317
6519846|NCT01544153|7440609|FG000|COMPLETED|Overall Study||1337
6519847|NCT01544153|7440610|FG001|COMPLETED|Overall Study||1323
6519848|NCT01544153|7440611|FG002|COMPLETED|Overall Study||1313
6641893|NCT02346240|7570390|FG010|STARTED|Maintenance Period (Week 16 to Week 48)||25
6641894|NCT02346240|7570391|FG011|STARTED|Maintenance Period (Week 16 to Week 48)||50
6641895|NCT02346240|7570392|FG012|STARTED|Maintenance Period (Week 16 to Week 48)||49
6641896|NCT02346240|7570393|FG013|STARTED|Maintenance Period (Week 16 to Week 48)||53
6641897|NCT02346240|7570394|FG014|STARTED|Maintenance Period (Week 16 to Week 48)||85
6641898|NCT02346240|7570395|FG015|STARTED|Maintenance Period (Week 16 to Week 48)||49
6641899|NCT02346240|7570396|FG016|STARTED|Maintenance Period (Week 16 to Week 48)||36
6519849|NCT01544153|7440612|FG003|COMPLETED|Overall Study||1317
6519850|NCT01544153|7440609|FG000|NOT COMPLETED|Overall Study||0
6519851|NCT01544153|7440610|FG001|NOT COMPLETED|Overall Study||1
6519852|NCT01544153|7440611|FG002|NOT COMPLETED|Overall Study||1
6519853|NCT01544153|7440612|FG003|NOT COMPLETED|Overall Study||0
6519854|NCT01544166|7440622|FG000|STARTED|Overall Study||44
6519855|NCT01544166|7440622|FG000|COMPLETED|Overall Study||44
6519856|NCT01544166|7440622|FG000|NOT COMPLETED|Overall Study||0
6519857|NCT01544179|7440631|FG000|STARTED|Overall Study||133
6519858|NCT01544179|7440632|FG001|STARTED|Overall Study||132
6519859|NCT01544179|7440631|FG000|Received Treatment|Overall Study||132
6519860|NCT01544179|7440632|FG001|Received Treatment|Overall Study||132
6519861|NCT01544179|7440631|FG000|Did Not Receive Treatment|Overall Study||1
6519862|NCT01544179|7440632|FG001|Did Not Receive Treatment|Overall Study||0
6519863|NCT01544179|7440631|FG000|COMPLETED|Overall Study|Patients are ongoing in the study|70
6519864|NCT01544179|7440632|FG001|COMPLETED|Overall Study|Patients are ongoing in the study|86
6519865|NCT01544179|7440631|FG000|NOT COMPLETED|Overall Study||63
6519866|NCT01544179|7440632|FG001|NOT COMPLETED|Overall Study||46
6519867|NCT01544309|7440640|FG000|STARTED|Overall Study||524
6519868|NCT01544309|7440641|FG001|STARTED|Overall Study||525
6519869|NCT01544309|7440640|FG000|COMPLETED|Overall Study||504
6519870|NCT01544309|7440641|FG001|COMPLETED|Overall Study||514
6519871|NCT01544309|7440640|FG000|NOT COMPLETED|Overall Study||20
6519872|NCT01544309|7440641|FG001|NOT COMPLETED|Overall Study||11
6519873|NCT01544335|7440649|FG000|STARTED|Overall Study||191
6519874|NCT01544335|7440649|FG000|COMPLETED|Overall Study||138
6519875|NCT01544335|7440649|FG000|NOT COMPLETED|Overall Study||53
6519876|NCT01544348|7440661|FG000|STARTED|Overall Study||17
6519877|NCT01544348|7440662|FG001|STARTED|Overall Study||6
6519878|NCT01544348|7440663|FG002|STARTED|Overall Study||3
6519879|NCT01544348|7440664|FG003|STARTED|Overall Study||3
6519880|NCT01544348|7440665|FG004|STARTED|Overall Study||16
6519881|NCT01544348|7440666|FG005|STARTED|Overall Study||19
6519882|NCT01544348|7440667|FG006|STARTED|Overall Study||14
6519883|NCT01544348|7440668|FG007|STARTED|Overall Study||8
6519884|NCT01544348|7440661|FG000|Treated|Overall Study||17
6519885|NCT01544348|7440662|FG001|Treated|Overall Study||6
6519886|NCT01544348|7440663|FG002|Treated|Overall Study||3
6519887|NCT01544348|7440664|FG003|Treated|Overall Study||3
6519888|NCT01544348|7440665|FG004|Treated|Overall Study||15
6519889|NCT01544348|7440666|FG005|Treated|Overall Study||18
6519890|NCT01544348|7440667|FG006|Treated|Overall Study||14
6519891|NCT01544348|7440668|FG007|Treated|Overall Study||8
6519892|NCT01544348|7440661|FG000|COMPLETED|Overall Study||15
6519893|NCT01544348|7440662|FG001|COMPLETED|Overall Study||6
6519894|NCT01544348|7440663|FG002|COMPLETED|Overall Study||3
6519895|NCT01544348|7440664|FG003|COMPLETED|Overall Study||3
6519896|NCT01544348|7440665|FG004|COMPLETED|Overall Study||15
6519897|NCT01544348|7440666|FG005|COMPLETED|Overall Study||16
6519898|NCT01544348|7440667|FG006|COMPLETED|Overall Study||12
6519899|NCT01544348|7440668|FG007|COMPLETED|Overall Study||8
6519900|NCT01544348|7440661|FG000|NOT COMPLETED|Overall Study||2
6519901|NCT01544348|7440662|FG001|NOT COMPLETED|Overall Study||0
6519902|NCT01544348|7440663|FG002|NOT COMPLETED|Overall Study||0
6641900|NCT02346240|7570397|FG017|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641901|NCT02346240|7570398|FG018|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641902|NCT02346240|7570399|FG019|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641903|NCT02346240|7570400|FG020|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641904|NCT02346240|7570401|FG021|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641905|NCT02346240|7570402|FG022|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641906|NCT02346240|7570403|FG023|STARTED|Maintenance Period (Week 16 to Week 48)||0
6641907|NCT02346240|7570380|FG000|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641908|NCT02346240|7570381|FG001|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641909|NCT02346240|7570382|FG002|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641910|NCT02346240|7570383|FG003|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641911|NCT02346240|7570384|FG004|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||2
6641912|NCT02346240|7570385|FG005|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
6641913|NCT02346240|7570386|FG006|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||48
6641914|NCT02346240|7570387|FG007|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||20
6641915|NCT02346240|7570388|FG008|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||40
6641916|NCT02346240|7570389|FG009|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||43
6641917|NCT02346240|7570390|FG010|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||23
6641918|NCT02346240|7570391|FG011|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||47
6641919|NCT02346240|7570392|FG012|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||49
6641920|NCT02346240|7570393|FG013|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||46
6655837|NCT02456636|7585990|FG001|NOT COMPLETED|Overall Study||69
6304189|NCT00364832|7207515|FG001|COMPLETED|Core Period||13
6304190|NCT00364832|7207516|FG002|COMPLETED|Core Period||14
6304191|NCT00364832|7207517|FG003|COMPLETED|Core Period||15
6304192|NCT00364832|7207518|FG004|COMPLETED|Core Period||16
6304193|NCT00364832|7207519|FG005|COMPLETED|Core Period||12
6304194|NCT00364832|7207520|FG006|COMPLETED|Core Period||12
6304195|NCT00364832|7207521|FG007|COMPLETED|Core Period||14
6304196|NCT00364832|7207522|FG008|COMPLETED|Core Period||16
6304197|NCT00364832|7207523|FG009|COMPLETED|Core Period||0
6519903|NCT01544348|7440664|FG003|NOT COMPLETED|Overall Study||0
6519904|NCT01544348|7440665|FG004|NOT COMPLETED|Overall Study||1
6519905|NCT01544348|7440666|FG005|NOT COMPLETED|Overall Study||3
6304198|NCT00364832|7207524|FG010|COMPLETED|Core Period||0
6304199|NCT00364832|7207525|FG011|COMPLETED|Core Period||0
6304200|NCT00364832|7207514|FG000|NOT COMPLETED|Core Period||2
6519906|NCT01544348|7440667|FG006|NOT COMPLETED|Overall Study||2
6519907|NCT01544348|7440668|FG007|NOT COMPLETED|Overall Study||0
6519908|NCT01544361|7440698|FG000|STARTED|Overall Study||8
6519909|NCT01544361|7440699|FG001|STARTED|Overall Study||6
6519910|NCT01544361|7440700|FG002|STARTED|Overall Study||6
6519911|NCT01544361|7440701|FG003|STARTED|Overall Study||6
6519912|NCT01544361|7440702|FG004|STARTED|Overall Study||6
6519913|NCT01544361|7440698|FG000|COMPLETED|Overall Study||8
6519914|NCT01544361|7440699|FG001|COMPLETED|Overall Study||6
6519915|NCT01544361|7440700|FG002|COMPLETED|Overall Study||6
6519916|NCT01544361|7440701|FG003|COMPLETED|Overall Study||6
6519917|NCT01544361|7440702|FG004|COMPLETED|Overall Study||6
6519918|NCT01544361|7440698|FG000|NOT COMPLETED|Overall Study||0
6519919|NCT01544361|7440699|FG001|NOT COMPLETED|Overall Study||0
6519920|NCT01544361|7440700|FG002|NOT COMPLETED|Overall Study||0
6519921|NCT01544361|7440701|FG003|NOT COMPLETED|Overall Study||0
6519922|NCT01544361|7440702|FG004|NOT COMPLETED|Overall Study||0
6519923|NCT01544478|7440714|FG000|STARTED|Overall Study||1030
6519924|NCT01544478|7440714|FG000|Vaccination 1|Overall Study||1030
6519925|NCT01544478|7440714|FG000|Vaccination 2|Overall Study||1026
6519926|NCT01544478|7440714|FG000|Vaccination 3|Overall Study||1019
6519927|NCT01544478|7440714|FG000|COMPLETED|Overall Study||912
6519928|NCT01544478|7440714|FG000|NOT COMPLETED|Overall Study||118
6519929|NCT01544491|7440720|FG000|STARTED|Overall Study||52
6519930|NCT01544491|7440721|FG001|STARTED|Overall Study||54
6641921|NCT02346240|7570394|FG014|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||71
6641922|NCT02346240|7570395|FG015|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||36
6641923|NCT02346240|7570396|FG016|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||30
6641924|NCT02346240|7570397|FG017|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641925|NCT02346240|7570398|FG018|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641926|NCT02346240|7570399|FG019|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641927|NCT02346240|7570400|FG020|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641928|NCT02346240|7570401|FG021|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641929|NCT02346240|7570402|FG022|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641930|NCT02346240|7570403|FG023|Completed Maintenance Period|Maintenance Period (Week 16 to Week 48)||0
6641931|NCT02346240|7570380|FG000|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641932|NCT02346240|7570381|FG001|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641933|NCT02346240|7570382|FG002|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641934|NCT02346240|7570383|FG003|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641935|NCT02346240|7570384|FG004|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||2
6641936|NCT02346240|7570385|FG005|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
6641937|NCT02346240|7570386|FG006|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||48
6641938|NCT02346240|7570387|FG007|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||20
6641939|NCT02346240|7570388|FG008|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||40
6641940|NCT02346240|7570389|FG009|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||43
6641941|NCT02346240|7570390|FG010|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||23
6641942|NCT02346240|7570391|FG011|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||47
6641943|NCT02346240|7570392|FG012|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||49
6641944|NCT02346240|7570393|FG013|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||45
6641945|NCT02346240|7570394|FG014|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||68
6641946|NCT02346240|7570395|FG015|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||35
6641947|NCT02346240|7570396|FG016|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||29
6641948|NCT02346240|7570397|FG017|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641949|NCT02346240|7570398|FG018|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641950|NCT02346240|7570399|FG019|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641951|NCT02346240|7570400|FG020|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641952|NCT02346240|7570401|FG021|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641953|NCT02346240|7570402|FG022|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6743632|NCT03335254|7671829|FG019|NOT COMPLETED|Period 1||0
6519931|NCT01544491|7440720|FG000|COMPLETED|Overall Study||47
6519932|NCT01544491|7440721|FG001|COMPLETED|Overall Study||51
6519933|NCT01544491|7440720|FG000|NOT COMPLETED|Overall Study||5
6519934|NCT01544491|7440721|FG001|NOT COMPLETED|Overall Study||3
6519935|NCT01544582|7440730|FG000|STARTED|Screening/Eligibility||713
6519936|NCT01544582|7440731|FG001|STARTED|Screening/Eligibility||0
6519937|NCT01544582|7440732|FG002|STARTED|Screening/Eligibility||0
6519938|NCT01544582|7440733|FG003|STARTED|Screening/Eligibility||0
6519939|NCT01544582|7440730|FG000|Analysis Population|Screening/Eligibility||679
6519940|NCT01544582|7440731|FG001|Analysis Population|Screening/Eligibility||0
6519941|NCT01544582|7440732|FG002|Analysis Population|Screening/Eligibility||0
6519942|NCT01544582|7440733|FG003|Analysis Population|Screening/Eligibility||0
6519943|NCT01544582|7440730|FG000|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
6519944|NCT01544582|7440731|FG001|COMPLETED|Screening/Eligibility||0
6519945|NCT01544582|7440732|FG002|COMPLETED|Screening/Eligibility||0
6519946|NCT01544582|7440733|FG003|COMPLETED|Screening/Eligibility||0
6519947|NCT01544582|7440730|FG000|NOT COMPLETED|Screening/Eligibility||34
6519948|NCT01544582|7440731|FG001|NOT COMPLETED|Screening/Eligibility||0
6519949|NCT01544582|7440732|FG002|NOT COMPLETED|Screening/Eligibility||0
6519950|NCT01544582|7440733|FG003|NOT COMPLETED|Screening/Eligibility||0
6519951|NCT01544582|7440730|FG000|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
6519952|NCT01544582|7440731|FG001|STARTED|Analysis Population||298
6519953|NCT01544582|7440732|FG002|STARTED|Analysis Population||307
6519954|NCT01544582|7440733|FG003|STARTED|Analysis Population||74
6519955|NCT01544582|7440730|FG000|COMPLETED|Analysis Population||0
6519956|NCT01544582|7440731|FG001|COMPLETED|Analysis Population||180
6519957|NCT01544582|7440732|FG002|COMPLETED|Analysis Population||205
6519958|NCT01544582|7440733|FG003|COMPLETED|Analysis Population||35
6519959|NCT01544582|7440730|FG000|NOT COMPLETED|Analysis Population||0
6519960|NCT01544582|7440731|FG001|NOT COMPLETED|Analysis Population||118
6519961|NCT01544582|7440732|FG002|NOT COMPLETED|Analysis Population||102
6519962|NCT01544582|7440733|FG003|NOT COMPLETED|Analysis Population||39
6519963|NCT01544595|7440752|FG000|STARTED|Status at Week 68||301
6519964|NCT01544595|7440753|FG001|STARTED|Status at Week 68||363
6519965|NCT01544595|7440754|FG002|STARTED|Status at Week 68||150
6519966|NCT01544595|7440755|FG003|STARTED|Status at Week 68||181
6519967|NCT01544595|7440756|FG004|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
6519968|NCT01544595|7440757|FG005|STARTED|Status at Week 68|These patients were not in the study arms at this time point.|0
6519969|NCT01544595|7440752|FG000|COMPLETED|Status at Week 68||262
6641954|NCT02346240|7570403|FG023|Finished Wk48 Entered Open-label Period|Maintenance Period (Week 16 to Week 48)||0
6641955|NCT02346240|7570380|FG000|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641956|NCT02346240|7570381|FG001|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641957|NCT02346240|7570382|FG002|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641958|NCT02346240|7570383|FG003|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641959|NCT02346240|7570384|FG004|COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6641960|NCT02346240|7570385|FG005|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
6641961|NCT02346240|7570386|FG006|COMPLETED|Maintenance Period (Week 16 to Week 48)||48
6641962|NCT02346240|7570387|FG007|COMPLETED|Maintenance Period (Week 16 to Week 48)||20
6641963|NCT02346240|7570388|FG008|COMPLETED|Maintenance Period (Week 16 to Week 48)||40
6641964|NCT02346240|7570389|FG009|COMPLETED|Maintenance Period (Week 16 to Week 48)||43
6641965|NCT02346240|7570390|FG010|COMPLETED|Maintenance Period (Week 16 to Week 48)||23
6641966|NCT02346240|7570391|FG011|COMPLETED|Maintenance Period (Week 16 to Week 48)||47
6641967|NCT02346240|7570392|FG012|COMPLETED|Maintenance Period (Week 16 to Week 48)||49
6641968|NCT02346240|7570393|FG013|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|45
6641969|NCT02346240|7570394|FG014|COMPLETED|Maintenance Period (Week 16 to Week 48)|3 subjects completed the Maintenance Period but did not enter the Open-Label Period.|68
6641970|NCT02346240|7570395|FG015|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|35
6641971|NCT02346240|7570396|FG016|COMPLETED|Maintenance Period (Week 16 to Week 48)|1 subject completed the Maintenance Period but did not enter the Open-Label Period.|29
6641972|NCT02346240|7570397|FG017|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641973|NCT02346240|7570398|FG018|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641974|NCT02346240|7570399|FG019|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641975|NCT02346240|7570400|FG020|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641976|NCT02346240|7570401|FG021|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641977|NCT02346240|7570402|FG022|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641978|NCT02346240|7570403|FG023|COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641979|NCT02346240|7570380|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641980|NCT02346240|7570381|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641981|NCT02346240|7570382|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641982|NCT02346240|7570383|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641983|NCT02346240|7570384|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641984|NCT02346240|7570385|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
6641985|NCT02346240|7570386|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6641986|NCT02346240|7570387|FG007|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6641987|NCT02346240|7570388|FG008|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||4
6641988|NCT02346240|7570389|FG009|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||1
6641989|NCT02346240|7570390|FG010|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||2
6641990|NCT02346240|7570391|FG011|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||3
6641991|NCT02346240|7570392|FG012|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641992|NCT02346240|7570393|FG013|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||8
6641993|NCT02346240|7570394|FG014|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||17
6641994|NCT02346240|7570395|FG015|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||14
6641995|NCT02346240|7570396|FG016|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||7
6641996|NCT02346240|7570397|FG017|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641997|NCT02346240|7570398|FG018|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641998|NCT02346240|7570399|FG019|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6641999|NCT02346240|7570400|FG020|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6642000|NCT02346240|7570401|FG021|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6642001|NCT02346240|7570402|FG022|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6519970|NCT01544595|7440753|FG001|COMPLETED|Status at Week 68||346
6519971|NCT01544595|7440754|FG002|COMPLETED|Status at Week 68||87
6519972|NCT01544595|7440755|FG003|COMPLETED|Status at Week 68||130
6519973|NCT01544595|7440756|FG004|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
6519974|NCT01544595|7440757|FG005|COMPLETED|Status at Week 68|These patients were not in the study arms at this time point.|0
6519975|NCT01544595|7440752|FG000|NOT COMPLETED|Status at Week 68||39
6519976|NCT01544595|7440753|FG001|NOT COMPLETED|Status at Week 68||17
6519977|NCT01544595|7440754|FG002|NOT COMPLETED|Status at Week 68||63
6519978|NCT01544595|7440755|FG003|NOT COMPLETED|Status at Week 68||51
6519979|NCT01544595|7440756|FG004|NOT COMPLETED|Status at Week 68||0
6519980|NCT01544595|7440757|FG005|NOT COMPLETED|Status at Week 68||0
6519981|NCT01544595|7440752|FG000|STARTED|Status at Week 156||301
6519982|NCT01544595|7440753|FG001|STARTED|Status at Week 156||363
6519983|NCT01544595|7440754|FG002|STARTED|Status at Week 156||150
6519984|NCT01544595|7440755|FG003|STARTED|Status at Week 156||181
6519985|NCT01544595|7440756|FG004|STARTED|Status at Week 156||98
6642002|NCT02346240|7570403|FG023|NOT COMPLETED|Maintenance Period (Week 16 to Week 48)||0
6642003|NCT02346240|7570380|FG000|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642004|NCT02346240|7570381|FG001|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642005|NCT02346240|7570382|FG002|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642006|NCT02346240|7570383|FG003|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642007|NCT02346240|7570384|FG004|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642008|NCT02346240|7570385|FG005|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642009|NCT02346240|7570386|FG006|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642010|NCT02346240|7570387|FG007|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642011|NCT02346240|7570388|FG008|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642012|NCT02346240|7570389|FG009|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642013|NCT02346240|7570390|FG010|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642014|NCT02346240|7570391|FG011|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642015|NCT02346240|7570392|FG012|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642016|NCT02346240|7570393|FG013|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642017|NCT02346240|7570394|FG014|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642018|NCT02346240|7570395|FG015|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642019|NCT02346240|7570396|FG016|STARTED|Open-Label Period (Week 48 to Week 144)||0
6642020|NCT02346240|7570397|FG017|STARTED|Open-Label Period (Week 48 to Week 144)||34
6642021|NCT02346240|7570398|FG018|STARTED|Open-Label Period (Week 48 to Week 144)||122
6642022|NCT02346240|7570399|FG019|STARTED|Open-Label Period (Week 48 to Week 144)||41
6642023|NCT02346240|7570400|FG020|STARTED|Open-Label Period (Week 48 to Week 144)||48
6642024|NCT02346240|7570401|FG021|STARTED|Open-Label Period (Week 48 to Week 144)||177
6642025|NCT02346240|7570402|FG022|STARTED|Open-Label Period (Week 48 to Week 144)||34
6642026|NCT02346240|7570403|FG023|STARTED|Open-Label Period (Week 48 to Week 144)||16
6642027|NCT02346240|7570380|FG000|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642028|NCT02346240|7570381|FG001|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642029|NCT02346240|7570382|FG002|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642030|NCT02346240|7570383|FG003|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642031|NCT02346240|7570384|FG004|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642032|NCT02346240|7570385|FG005|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642033|NCT02346240|7570386|FG006|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642034|NCT02346240|7570387|FG007|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642035|NCT02346240|7570388|FG008|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642036|NCT02346240|7570389|FG009|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642037|NCT02346240|7570390|FG010|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642038|NCT02346240|7570391|FG011|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642039|NCT02346240|7570392|FG012|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642040|NCT02346240|7570393|FG013|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642041|NCT02346240|7570394|FG014|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642042|NCT02346240|7570395|FG015|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642043|NCT02346240|7570396|FG016|COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642044|NCT02346240|7570397|FG017|COMPLETED|Open-Label Period (Week 48 to Week 144)||31
6642045|NCT02346240|7570398|FG018|COMPLETED|Open-Label Period (Week 48 to Week 144)||105
6642046|NCT02346240|7570399|FG019|COMPLETED|Open-Label Period (Week 48 to Week 144)||34
6642047|NCT02346240|7570400|FG020|COMPLETED|Open-Label Period (Week 48 to Week 144)||45
6642048|NCT02346240|7570401|FG021|COMPLETED|Open-Label Period (Week 48 to Week 144)||146
6642049|NCT02346240|7570402|FG022|COMPLETED|Open-Label Period (Week 48 to Week 144)||27
6642050|NCT02346240|7570403|FG023|COMPLETED|Open-Label Period (Week 48 to Week 144)||8
6642051|NCT02346240|7570380|FG000|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642052|NCT02346240|7570381|FG001|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642053|NCT02346240|7570382|FG002|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642054|NCT02346240|7570383|FG003|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6519986|NCT01544595|7440757|FG005|STARTED|Status at Week 156||53
6642055|NCT02346240|7570384|FG004|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642056|NCT02346240|7570385|FG005|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642057|NCT02346240|7570386|FG006|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642058|NCT02346240|7570387|FG007|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642059|NCT02346240|7570388|FG008|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642060|NCT02346240|7570389|FG009|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6519987|NCT01544595|7440752|FG000|COMPLETED|Status at Week 156||184
6519988|NCT01544595|7440753|FG001|COMPLETED|Status at Week 156||285
6519989|NCT01544595|7440754|FG002|COMPLETED|Status at Week 156||10
6519990|NCT01544595|7440755|FG003|COMPLETED|Status at Week 156||15
6519991|NCT01544595|7440756|FG004|COMPLETED|Status at Week 156||60
6519992|NCT01544595|7440757|FG005|COMPLETED|Status at Week 156||38
6519993|NCT01544595|7440752|FG000|NOT COMPLETED|Status at Week 156||117
6519994|NCT01544595|7440753|FG001|NOT COMPLETED|Status at Week 156||78
6519995|NCT01544595|7440754|FG002|NOT COMPLETED|Status at Week 156||140
6642061|NCT02346240|7570390|FG010|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642062|NCT02346240|7570391|FG011|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642063|NCT02346240|7570392|FG012|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642064|NCT02346240|7570393|FG013|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642065|NCT02346240|7570394|FG014|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642066|NCT02346240|7570395|FG015|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642067|NCT02346240|7570396|FG016|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||0
6642068|NCT02346240|7570397|FG017|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
6642069|NCT02346240|7570398|FG018|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||17
6642070|NCT02346240|7570399|FG019|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
6642071|NCT02346240|7570400|FG020|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||3
6642072|NCT02346240|7570401|FG021|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||31
6642073|NCT02346240|7570402|FG022|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||7
6642074|NCT02346240|7570403|FG023|NOT COMPLETED|Open-Label Period (Week 48 to Week 144)||8
6642075|NCT02346370|7570428|FG000|STARTED|Overall Study||8
6642076|NCT02346370|7570429|FG001|STARTED|Overall Study||4
6642077|NCT02346370|7570430|FG002|STARTED|Overall Study||4
6642078|NCT02346370|7570428|FG000|COMPLETED|Overall Study||0
6642079|NCT02346370|7570429|FG001|COMPLETED|Overall Study||0
6642080|NCT02346370|7570430|FG002|COMPLETED|Overall Study||0
6642081|NCT02346370|7570428|FG000|NOT COMPLETED|Overall Study||8
6642082|NCT02346370|7570429|FG001|NOT COMPLETED|Overall Study||4
6642083|NCT02346370|7570430|FG002|NOT COMPLETED|Overall Study||4
6642084|NCT02346383|7570440|FG000|STARTED|Overall Study||40
6642085|NCT02346383|7570440|FG000|COMPLETED|Overall Study||40
6642086|NCT02346383|7570440|FG000|NOT COMPLETED|Overall Study||0
6642087|NCT02346461|7570450|FG000|STARTED|Overall Study||6
6642088|NCT02346461|7570451|FG001|STARTED|Overall Study||6
6642089|NCT02346461|7570450|FG000|COMPLETED|Overall Study||6
6642090|NCT02346461|7570451|FG001|COMPLETED|Overall Study||6
6642091|NCT02346461|7570450|FG000|NOT COMPLETED|Overall Study||0
6642092|NCT02346461|7570451|FG001|NOT COMPLETED|Overall Study||0
6642093|NCT02346643|7570458|FG000|STARTED|Overall Study||41
6642094|NCT02346643|7570458|FG000|Received Trial System|Overall Study||29
6642095|NCT02346643|7570458|FG000|Received Permanent System|Overall Study||31
6642096|NCT02346643|7570458|FG000|COMPLETED|Overall Study||6
6642097|NCT02346643|7570458|FG000|NOT COMPLETED|Overall Study||35
6642098|NCT02346708|7570464|FG000|STARTED|Overall Study||24
6642099|NCT02346708|7570465|FG001|STARTED|Overall Study||25
6642100|NCT02346708|7570464|FG000|COMPLETED|Overall Study||22
6642101|NCT02346708|7570465|FG001|COMPLETED|Overall Study||24
6642102|NCT02346708|7570464|FG000|NOT COMPLETED|Overall Study||2
6642103|NCT02346708|7570465|FG001|NOT COMPLETED|Overall Study||1
6642104|NCT02346721|7570472|FG000|STARTED|Overall Study||111
6642105|NCT02346721|7570472|FG000|COMPLETED|Overall Study||107
6642106|NCT02346721|7570472|FG000|NOT COMPLETED|Overall Study||4
6642107|NCT02346903|7570478|FG000|STARTED|Overall Study||99
6642108|NCT02346903|7570478|FG000|COMPLETED|Overall Study||99
6642109|NCT02346903|7570478|FG000|NOT COMPLETED|Overall Study||0
6642110|NCT02346916|7570482|FG000|STARTED|Overall Study||20
6642111|NCT02346916|7570482|FG000|COMPLETED|Overall Study||20
6642112|NCT02346916|7570482|FG000|NOT COMPLETED|Overall Study||0
6642113|NCT02347072|7570486|FG000|STARTED|Overall Study||80
6642114|NCT02347072|7570486|FG000|GFF MDI 14.4/9.6 µg|Overall Study||75
6642115|NCT02347072|7570486|FG000|Placebo MDI|Overall Study||72
6642116|NCT02347072|7570486|FG000|Spiriva Respimat 5 µg|Overall Study||73
6642117|NCT02347072|7570486|FG000|COMPLETED|Overall Study||62
6642118|NCT02347072|7570486|FG000|NOT COMPLETED|Overall Study||18
6642119|NCT02347085|7570494|FG000|STARTED|Overall Study||43
6642120|NCT02347085|7570494|FG000|GFF MDI 14.4/9.6 µg|Overall Study||40
6642121|NCT02347085|7570494|FG000|Placebo MDI|Overall Study||40
6519996|NCT01544595|7440755|FG003|NOT COMPLETED|Status at Week 156||166
6519997|NCT01544595|7440756|FG004|NOT COMPLETED|Status at Week 156||38
6519998|NCT01544595|7440757|FG005|NOT COMPLETED|Status at Week 156||15
6519999|NCT01544920|7440777|FG000|STARTED|Overall Study||368
6642122|NCT02347085|7570494|FG000|COMPLETED|Overall Study||33
6642123|NCT02347085|7570494|FG000|NOT COMPLETED|Overall Study||10
6642124|NCT02347098|7570502|FG000|STARTED|Overall Study||63
6642125|NCT02347098|7570503|FG001|STARTED|Overall Study||66
6642126|NCT02347098|7570502|FG000|COMPLETED|Overall Study||56
6642127|NCT02347098|7570503|FG001|COMPLETED|Overall Study||58
6642128|NCT02347098|7570502|FG000|NOT COMPLETED|Overall Study||7
6642129|NCT02347098|7570503|FG001|NOT COMPLETED|Overall Study||8
6642130|NCT02347124|7570511|FG000|STARTED|Overall Study||360
6642131|NCT02347124|7570512|FG001|STARTED|Overall Study||358
6642132|NCT02347124|7570511|FG000|2 Month Follow-up|Overall Study||298
6642133|NCT02347124|7570512|FG001|2 Month Follow-up|Overall Study||275
6642134|NCT02347124|7570511|FG000|COMPLETED|Overall Study||267
6520000|NCT01544920|7440778|FG001|STARTED|Overall Study||369
6520001|NCT01544920|7440777|FG000|COMPLETED|Overall Study||349
6520002|NCT01544920|7440778|FG001|COMPLETED|Overall Study||346
6520003|NCT01544920|7440777|FG000|NOT COMPLETED|Overall Study||19
6520004|NCT01544920|7440778|FG001|NOT COMPLETED|Overall Study||23
6520005|NCT01544998|7440786|FG000|STARTED|First Intervention (3 Hours)||26
6520006|NCT01544998|7440787|FG001|STARTED|First Intervention (3 Hours)||15
6520007|NCT01544998|7440786|FG000|COMPLETED|First Intervention (3 Hours)||26
6520008|NCT01544998|7440787|FG001|COMPLETED|First Intervention (3 Hours)||15
6520009|NCT01544998|7440786|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
6520010|NCT01544998|7440787|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
6520011|NCT01544998|7440786|FG000|STARTED|Washout (1 Week)||26
6520012|NCT01544998|7440787|FG001|STARTED|Washout (1 Week)||15
6520013|NCT01544998|7440786|FG000|COMPLETED|Washout (1 Week)||26
6520014|NCT01544998|7440787|FG001|COMPLETED|Washout (1 Week)||15
6520015|NCT01544998|7440786|FG000|NOT COMPLETED|Washout (1 Week)||0
6520016|NCT01544998|7440787|FG001|NOT COMPLETED|Washout (1 Week)||0
6520017|NCT01544998|7440786|FG000|STARTED|Second Intervention (3 Hours)||26
6520018|NCT01544998|7440787|FG001|STARTED|Second Intervention (3 Hours)||15
6520019|NCT01544998|7440786|FG000|COMPLETED|Second Intervention (3 Hours)||26
6520020|NCT01544998|7440787|FG001|COMPLETED|Second Intervention (3 Hours)||15
6520021|NCT01544998|7440786|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
6520022|NCT01544998|7440787|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
6520023|NCT01545076|7440795|FG000|STARTED|IgPro10 Restabilization Period||208
6520024|NCT01545076|7440796|FG001|STARTED|IgPro10 Restabilization Period||0
6520025|NCT01545076|7440797|FG002|STARTED|IgPro10 Restabilization Period||0
6520026|NCT01545076|7440798|FG003|STARTED|IgPro10 Restabilization Period||0
6520027|NCT01545076|7440799|FG004|STARTED|IgPro10 Restabilization Period||0
6520028|NCT01545076|7440795|FG000|COMPLETED|IgPro10 Restabilization Period||172
6520029|NCT01545076|7440796|FG001|COMPLETED|IgPro10 Restabilization Period||0
6520030|NCT01545076|7440797|FG002|COMPLETED|IgPro10 Restabilization Period||0
6520031|NCT01545076|7440798|FG003|COMPLETED|IgPro10 Restabilization Period||0
6520032|NCT01545076|7440799|FG004|COMPLETED|IgPro10 Restabilization Period||0
6520033|NCT01545076|7440795|FG000|NOT COMPLETED|IgPro10 Restabilization Period||36
6520034|NCT01545076|7440796|FG001|NOT COMPLETED|IgPro10 Restabilization Period||0
6520035|NCT01545076|7440797|FG002|NOT COMPLETED|IgPro10 Restabilization Period||0
6520036|NCT01545076|7440798|FG003|NOT COMPLETED|IgPro10 Restabilization Period||0
6520037|NCT01545076|7440799|FG004|NOT COMPLETED|IgPro10 Restabilization Period||0
6520038|NCT01545076|7440795|FG000|STARTED|IgPro20 Subcutaneous Treatment Period||0
6520039|NCT01545076|7440796|FG001|STARTED|IgPro20 Subcutaneous Treatment Period||58
6520040|NCT01545076|7440797|FG002|STARTED|IgPro20 Subcutaneous Treatment Period||57
6520041|NCT01545076|7440798|FG003|STARTED|IgPro20 Subcutaneous Treatment Period||57
6642135|NCT02347124|7570512|FG001|COMPLETED|Overall Study||259
6642136|NCT02347124|7570511|FG000|NOT COMPLETED|Overall Study||93
6642137|NCT02347124|7570512|FG001|NOT COMPLETED|Overall Study||99
6642138|NCT02347176|7570522|FG000|STARTED|Overall Study||51
6642139|NCT02347176|7570523|FG001|STARTED|Overall Study||50
6642140|NCT02347176|7570524|FG002|STARTED|Overall Study||51
6642141|NCT02347176|7570525|FG003|STARTED|Overall Study||52
6642142|NCT02347176|7570522|FG000|COMPLETED|Overall Study||39
6642143|NCT02347176|7570523|FG001|COMPLETED|Overall Study||40
6642144|NCT02347176|7570524|FG002|COMPLETED|Overall Study||43
6642145|NCT02347176|7570525|FG003|COMPLETED|Overall Study||48
6642146|NCT02347176|7570522|FG000|NOT COMPLETED|Overall Study||12
6642147|NCT02347176|7570523|FG001|NOT COMPLETED|Overall Study||10
6642148|NCT02347176|7570524|FG002|NOT COMPLETED|Overall Study||8
6642149|NCT02347176|7570525|FG003|NOT COMPLETED|Overall Study||4
6642150|NCT02347189|7570535|FG000|STARTED|Overall Study||39
6642151|NCT02347189|7570535|FG000|Catheterized|Overall Study||39
6642152|NCT02347189|7570535|FG000|Implanted|Overall Study||30
6642153|NCT02347189|7570535|FG000|Implanted > 24 Hours|Overall Study||30
6642154|NCT02347189|7570535|FG000|COMPLETED|Overall Study||28
6642155|NCT02347189|7570535|FG000|NOT COMPLETED|Overall Study||11
6642156|NCT02347332|7570552|FG000|STARTED|Overall Study||230
6642157|NCT02347332|7570553|FG001|STARTED|Overall Study||229
6642158|NCT02347332|7570552|FG000|COMPLETED|Overall Study|6 patients: suicide(1), unknown cause(5 - 4 at home +1 in city hospital).|0
6642159|NCT02347332|7570553|FG001|COMPLETED|Overall Study|6 patients: unknown cause(2home), PDsuspect(1home+1hosp), sudden death(1home), hypercapnie(1hosp).|0
6642160|NCT02347332|7570552|FG000|NOT COMPLETED|Overall Study||230
6642161|NCT02347332|7570553|FG001|NOT COMPLETED|Overall Study||229
6642162|NCT02347345|7570562|FG000|STARTED|Overall Study||10
6642163|NCT02347345|7570563|FG001|STARTED|Overall Study||12
6642164|NCT02347345|7570564|FG002|STARTED|Overall Study||12
6642165|NCT02347345|7570562|FG000|COMPLETED|Overall Study||10
6642166|NCT02347345|7570563|FG001|COMPLETED|Overall Study||12
6743633|NCT03335254|7671810|FG000|STARTED|Period 2, Day 1-15||9
6520042|NCT01545076|7440799|FG004|STARTED|IgPro20 Subcutaneous Treatment Period||0
6520043|NCT01545076|7440795|FG000|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
6520044|NCT01545076|7440796|FG001|COMPLETED|IgPro20 Subcutaneous Treatment Period||39
6642167|NCT02347345|7570564|FG002|COMPLETED|Overall Study||12
6642168|NCT02347345|7570562|FG000|NOT COMPLETED|Overall Study||0
6642169|NCT02347345|7570563|FG001|NOT COMPLETED|Overall Study||0
6642170|NCT02347345|7570564|FG002|NOT COMPLETED|Overall Study||0
6642171|NCT02347410|7570575|FG000|STARTED|Overall Study||102
6642172|NCT02347410|7570575|FG000|COMPLETED|Overall Study||98
6520045|NCT01545076|7440797|FG002|COMPLETED|IgPro20 Subcutaneous Treatment Period||36
6520046|NCT01545076|7440798|FG003|COMPLETED|IgPro20 Subcutaneous Treatment Period||21
6520047|NCT01545076|7440799|FG004|COMPLETED|IgPro20 Subcutaneous Treatment Period||0
6520048|NCT01545076|7440795|FG000|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
6520049|NCT01545076|7440796|FG001|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||19
6520050|NCT01545076|7440797|FG002|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||21
6520051|NCT01545076|7440798|FG003|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||36
6520052|NCT01545076|7440799|FG004|NOT COMPLETED|IgPro20 Subcutaneous Treatment Period||0
6520053|NCT01545076|7440795|FG000|STARTED|IgPro10 Rescue Period||0
6520054|NCT01545076|7440796|FG001|STARTED|IgPro10 Rescue Period||0
6520055|NCT01545076|7440797|FG002|STARTED|IgPro10 Rescue Period||0
6520056|NCT01545076|7440798|FG003|STARTED|IgPro10 Rescue Period||0
6520057|NCT01545076|7440799|FG004|STARTED|IgPro10 Rescue Period||60
6520058|NCT01545076|7440795|FG000|COMPLETED|IgPro10 Rescue Period||0
6520059|NCT01545076|7440796|FG001|COMPLETED|IgPro10 Rescue Period||0
6520060|NCT01545076|7440797|FG002|COMPLETED|IgPro10 Rescue Period||0
6520061|NCT01545076|7440798|FG003|COMPLETED|IgPro10 Rescue Period||0
6520062|NCT01545076|7440799|FG004|COMPLETED|IgPro10 Rescue Period||60
6520063|NCT01545076|7440795|FG000|NOT COMPLETED|IgPro10 Rescue Period||0
6520064|NCT01545076|7440796|FG001|NOT COMPLETED|IgPro10 Rescue Period||0
6642173|NCT02347410|7570575|FG000|NOT COMPLETED|Overall Study||4
6642174|NCT02347488|7570585|FG000|STARTED|Overall Study||30
6642175|NCT02347488|7570585|FG000|COMPLETED|Overall Study||30
6642176|NCT02347488|7570585|FG000|NOT COMPLETED|Overall Study||0
6642177|NCT02347605|7570597|FG000|STARTED|Overall Study||10
6642178|NCT02347605|7570598|FG001|STARTED|Overall Study||10
6642179|NCT02347605|7570599|FG002|STARTED|Overall Study||8
6642180|NCT02347605|7570600|FG003|STARTED|Overall Study||10
6642181|NCT02347605|7570601|FG004|STARTED|Overall Study||9
6642182|NCT02347605|7570602|FG005|STARTED|Overall Study||9
6642183|NCT02347605|7570597|FG000|Completed Lab 1|Overall Study||10
6642184|NCT02347605|7570598|FG001|Completed Lab 1|Overall Study||10
6642185|NCT02347605|7570599|FG002|Completed Lab 1|Overall Study||8
6642186|NCT02347605|7570600|FG003|Completed Lab 1|Overall Study||10
6642187|NCT02347605|7570601|FG004|Completed Lab 1|Overall Study||8
6642188|NCT02347605|7570602|FG005|Completed Lab 1|Overall Study||9
6642189|NCT02347605|7570597|FG000|Completed Lab 2|Overall Study||7
6642190|NCT02347605|7570598|FG001|Completed Lab 2|Overall Study||7
6642191|NCT02347605|7570599|FG002|Completed Lab 2|Overall Study||7
6642192|NCT02347605|7570600|FG003|Completed Lab 2|Overall Study||7
6642193|NCT02347605|7570601|FG004|Completed Lab 2|Overall Study||6
6642194|NCT02347605|7570602|FG005|Completed Lab 2|Overall Study||8
6642195|NCT02347605|7570597|FG000|COMPLETED|Overall Study||7
6642196|NCT02347605|7570598|FG001|COMPLETED|Overall Study||7
6642197|NCT02347605|7570599|FG002|COMPLETED|Overall Study||7
6642198|NCT02347605|7570600|FG003|COMPLETED|Overall Study||6
6642199|NCT02347605|7570601|FG004|COMPLETED|Overall Study||6
6642200|NCT02347605|7570602|FG005|COMPLETED|Overall Study||7
6642201|NCT02347605|7570597|FG000|NOT COMPLETED|Overall Study||3
6642202|NCT02347605|7570598|FG001|NOT COMPLETED|Overall Study||3
6642203|NCT02347605|7570599|FG002|NOT COMPLETED|Overall Study||1
6642204|NCT02347605|7570600|FG003|NOT COMPLETED|Overall Study||4
6642205|NCT02347605|7570601|FG004|NOT COMPLETED|Overall Study||3
6642206|NCT02347605|7570602|FG005|NOT COMPLETED|Overall Study||2
6642207|NCT02347631|7570612|FG000|STARTED|Washout 1 (1 Month)||61
6642208|NCT02347631|7570613|FG001|STARTED|Washout 1 (1 Month)||57
6642209|NCT02347631|7570612|FG000|COMPLETED|Washout 1 (1 Month)||61
6642210|NCT02347631|7570613|FG001|COMPLETED|Washout 1 (1 Month)||57
6642211|NCT02347631|7570612|FG000|NOT COMPLETED|Washout 1 (1 Month)||0
6642212|NCT02347631|7570613|FG001|NOT COMPLETED|Washout 1 (1 Month)||0
6642213|NCT02347631|7570612|FG000|STARTED|First Intervention (2 Months)||61
6642214|NCT02347631|7570613|FG001|STARTED|First Intervention (2 Months)||57
6642215|NCT02347631|7570612|FG000|COMPLETED|First Intervention (2 Months)||54
6642216|NCT02347631|7570613|FG001|COMPLETED|First Intervention (2 Months)||51
6642217|NCT02347631|7570612|FG000|NOT COMPLETED|First Intervention (2 Months)||7
6642218|NCT02347631|7570613|FG001|NOT COMPLETED|First Intervention (2 Months)||6
6642219|NCT02347631|7570612|FG000|STARTED|Washout 2 (1 Month)||54
6520065|NCT01545076|7440797|FG002|NOT COMPLETED|IgPro10 Rescue Period||0
6520066|NCT01545076|7440798|FG003|NOT COMPLETED|IgPro10 Rescue Period||0
6520067|NCT01545076|7440799|FG004|NOT COMPLETED|IgPro10 Rescue Period||0
6520068|NCT01545141|7440816|FG000|STARTED|Overall Study||2
6520069|NCT01545141|7440817|FG001|STARTED|Overall Study||3
6520070|NCT01545141|7440818|FG002|STARTED|Overall Study||3
6520071|NCT01545141|7440819|FG003|STARTED|Overall Study||7
6520072|NCT01545141|7440816|FG000|COMPLETED|Overall Study||2
6520073|NCT01545141|7440817|FG001|COMPLETED|Overall Study||3
6520074|NCT01545141|7440818|FG002|COMPLETED|Overall Study||3
6642220|NCT02347631|7570613|FG001|STARTED|Washout 2 (1 Month)||51
6642221|NCT02347631|7570612|FG000|COMPLETED|Washout 2 (1 Month)||52
6642222|NCT02347631|7570613|FG001|COMPLETED|Washout 2 (1 Month)||48
6642223|NCT02347631|7570612|FG000|NOT COMPLETED|Washout 2 (1 Month)||2
6642224|NCT02347631|7570613|FG001|NOT COMPLETED|Washout 2 (1 Month)||3
6642225|NCT02347631|7570612|FG000|STARTED|Second Intervention (2 Months)||52
6642226|NCT02347631|7570613|FG001|STARTED|Second Intervention (2 Months)||48
6642227|NCT02347631|7570612|FG000|COMPLETED|Second Intervention (2 Months)||39
6642228|NCT02347631|7570613|FG001|COMPLETED|Second Intervention (2 Months)||44
6520075|NCT01545141|7440819|FG003|COMPLETED|Overall Study||7
6520076|NCT01545141|7440816|FG000|NOT COMPLETED|Overall Study||0
6520077|NCT01545141|7440817|FG001|NOT COMPLETED|Overall Study||0
6520078|NCT01545141|7440818|FG002|NOT COMPLETED|Overall Study||0
6520079|NCT01545141|7440819|FG003|NOT COMPLETED|Overall Study||0
6520080|NCT01545193|7440830|FG000|STARTED|Overall Study||150
6520081|NCT01545193|7440831|FG001|STARTED|Overall Study||150
6520082|NCT01545193|7440830|FG000|COMPLETED|Overall Study||150
6520083|NCT01545193|7440831|FG001|COMPLETED|Overall Study||149
6520084|NCT01545193|7440830|FG000|NOT COMPLETED|Overall Study||0
6520085|NCT01545193|7440831|FG001|NOT COMPLETED|Overall Study||1
6520086|NCT01545232|7440839|FG000|STARTED|Overall Study||338
6642229|NCT02347631|7570612|FG000|NOT COMPLETED|Second Intervention (2 Months)||13
6642230|NCT02347631|7570613|FG001|NOT COMPLETED|Second Intervention (2 Months)||4
6642231|NCT02347657|7570623|FG000|STARTED|Overall Study||259
6642232|NCT02347657|7570624|FG001|STARTED|Overall Study||251
6642233|NCT02347657|7570623|FG000|Treated|Overall Study||258
6642234|NCT02347657|7570624|FG001|Treated|Overall Study||251
6642235|NCT02347657|7570623|FG000|COMPLETED|Overall Study||241
6642236|NCT02347657|7570624|FG001|COMPLETED|Overall Study||236
6642237|NCT02347657|7570623|FG000|NOT COMPLETED|Overall Study||18
6642238|NCT02347657|7570624|FG001|NOT COMPLETED|Overall Study||15
6642239|NCT02347761|7570634|FG000|STARTED|All Collected||218
6642240|NCT02347761|7570635|FG001|STARTED|All Collected||217
6642241|NCT02347761|7570636|FG002|STARTED|All Collected||218
6642242|NCT02347761|7570634|FG000|COMPLETED|All Collected||201
6642243|NCT02347761|7570635|FG001|COMPLETED|All Collected||203
6642244|NCT02347761|7570636|FG002|COMPLETED|All Collected||191
6642245|NCT02347761|7570634|FG000|NOT COMPLETED|All Collected||17
6642246|NCT02347761|7570635|FG001|NOT COMPLETED|All Collected||14
6642247|NCT02347761|7570636|FG002|NOT COMPLETED|All Collected||27
6642248|NCT02347761|7570634|FG000|STARTED|On Study Treatment||218
6642249|NCT02347761|7570635|FG001|STARTED|On Study Treatment||217
6642250|NCT02347761|7570636|FG002|STARTED|On Study Treatment||218
6642251|NCT02347761|7570634|FG000|COMPLETED|On Study Treatment||191
6642252|NCT02347761|7570635|FG001|COMPLETED|On Study Treatment||194
6642253|NCT02347761|7570636|FG002|COMPLETED|On Study Treatment||176
6642254|NCT02347761|7570634|FG000|NOT COMPLETED|On Study Treatment||27
6642255|NCT02347761|7570635|FG001|NOT COMPLETED|On Study Treatment||23
6642256|NCT02347761|7570636|FG002|NOT COMPLETED|On Study Treatment||42
6642257|NCT02347774|7570647|FG000|STARTED|Study Participation||214
6642258|NCT02347774|7570648|FG001|STARTED|Study Participation||214
6642259|NCT02347774|7570649|FG002|STARTED|Study Participation|One subject randomized in error to the placebo arm was never dosed .|213
6642260|NCT02347774|7570647|FG000|COMPLETED|Study Participation||199
6642261|NCT02347774|7570648|FG001|COMPLETED|Study Participation||193
6642262|NCT02347774|7570649|FG002|COMPLETED|Study Participation||188
6642263|NCT02347774|7570647|FG000|NOT COMPLETED|Study Participation||15
6642264|NCT02347774|7570648|FG001|NOT COMPLETED|Study Participation||21
6642265|NCT02347774|7570649|FG002|NOT COMPLETED|Study Participation||25
6642266|NCT02347774|7570647|FG000|STARTED|On Study Treatment||214
6642267|NCT02347774|7570648|FG001|STARTED|On Study Treatment||214
6642268|NCT02347774|7570649|FG002|STARTED|On Study Treatment|One subject randomized in error to the placebo arm was never dosed .|213
6642269|NCT02347774|7570647|FG000|COMPLETED|On Study Treatment||190
6642270|NCT02347774|7570648|FG001|COMPLETED|On Study Treatment||183
6642271|NCT02347774|7570649|FG002|COMPLETED|On Study Treatment||177
6642272|NCT02347774|7570647|FG000|NOT COMPLETED|On Study Treatment||24
6642273|NCT02347774|7570648|FG001|NOT COMPLETED|On Study Treatment||31
6642274|NCT02347774|7570649|FG002|NOT COMPLETED|On Study Treatment||36
6642275|NCT02347787|7570659|FG000|STARTED|6 Month Follow-Up||288
6642276|NCT02347787|7570660|FG001|STARTED|6 Month Follow-Up||304
6642277|NCT02347787|7570659|FG000|COMPLETED|6 Month Follow-Up||222
6642278|NCT02347787|7570660|FG001|COMPLETED|6 Month Follow-Up||248
6642279|NCT02347787|7570659|FG000|NOT COMPLETED|6 Month Follow-Up||66
6642280|NCT02347787|7570660|FG001|NOT COMPLETED|6 Month Follow-Up||56
6642281|NCT02347787|7570659|FG000|STARTED|9 Month Follow-Up||288
6642282|NCT02347787|7570660|FG001|STARTED|9 Month Follow-Up||304
6642283|NCT02347787|7570659|FG000|COMPLETED|9 Month Follow-Up||227
6520087|NCT01545232|7440840|FG001|STARTED|Overall Study||342
6520088|NCT01545232|7440839|FG000|COMPLETED|Overall Study||338
6520089|NCT01545232|7440840|FG001|COMPLETED|Overall Study||342
6520090|NCT01545232|7440839|FG000|NOT COMPLETED|Overall Study||0
6520091|NCT01545232|7440840|FG001|NOT COMPLETED|Overall Study||0
6520092|NCT01545336|7440850|FG000|STARTED|Overall Study||12
6520093|NCT01545336|7440851|FG001|STARTED|Overall Study||6
6520094|NCT01545336|7440850|FG000|COMPLETED|Overall Study||12
6520095|NCT01545336|7440851|FG001|COMPLETED|Overall Study||6
6520096|NCT01545336|7440850|FG000|NOT COMPLETED|Overall Study||0
6642284|NCT02347787|7570660|FG001|COMPLETED|9 Month Follow-Up||233
6642285|NCT02347787|7570659|FG000|NOT COMPLETED|9 Month Follow-Up||61
6642286|NCT02347787|7570660|FG001|NOT COMPLETED|9 Month Follow-Up||71
6642287|NCT02347813|7570673|FG000|STARTED|First Intervention, 24 Weeks||6
6642288|NCT02347813|7570674|FG001|STARTED|First Intervention, 24 Weeks||6
6642289|NCT02347813|7570673|FG000|COMPLETED|First Intervention, 24 Weeks||4
6642290|NCT02347813|7570674|FG001|COMPLETED|First Intervention, 24 Weeks||4
6642291|NCT02347813|7570673|FG000|NOT COMPLETED|First Intervention, 24 Weeks||2
6642292|NCT02347813|7570674|FG001|NOT COMPLETED|First Intervention, 24 Weeks||2
6642293|NCT02347813|7570673|FG000|STARTED|Second Intervention, 24 Weeks||4
6642294|NCT02347813|7570674|FG001|STARTED|Second Intervention, 24 Weeks||4
6520097|NCT01545336|7440851|FG001|NOT COMPLETED|Overall Study||0
6520098|NCT01545375|7440861|FG000|STARTED|Overall Study||900
6520099|NCT01545375|7440862|FG001|STARTED|Overall Study||903
6520100|NCT01545375|7440861|FG000|COMPLETED|Overall Study||803
6520101|NCT01545375|7440862|FG001|COMPLETED|Overall Study||813
6520102|NCT01545375|7440861|FG000|NOT COMPLETED|Overall Study||97
6520103|NCT01545375|7440862|FG001|NOT COMPLETED|Overall Study||90
6520104|NCT01545388|7440871|FG000|STARTED|Overall Study||138
6520105|NCT01545388|7440872|FG001|STARTED|Overall Study||133
6520106|NCT01545388|7440873|FG002|STARTED|Overall Study||66
6520107|NCT01545388|7440871|FG000|COMPLETED|Overall Study||130
6520108|NCT01545388|7440872|FG001|COMPLETED|Overall Study||122
6520109|NCT01545388|7440873|FG002|COMPLETED|Overall Study||58
6520110|NCT01545388|7440871|FG000|NOT COMPLETED|Overall Study||8
6520111|NCT01545388|7440872|FG001|NOT COMPLETED|Overall Study||11
6520112|NCT01545388|7440873|FG002|NOT COMPLETED|Overall Study||8
6520113|NCT01545583|7440890|FG000|STARTED|Overall Study||12
6520114|NCT01545583|7440891|FG001|STARTED|Overall Study||2
6520115|NCT01545583|7440892|FG002|STARTED|Overall Study||6
6520116|NCT01545583|7440893|FG003|STARTED|Overall Study||6
6520117|NCT01545583|7440894|FG004|STARTED|Overall Study||6
6520118|NCT01545583|7440895|FG005|STARTED|Overall Study||6
6520119|NCT01545583|7440896|FG006|STARTED|Overall Study||6
6520120|NCT01545583|7440897|FG007|STARTED|Overall Study||6
6520121|NCT01545583|7440898|FG008|STARTED|Overall Study||6
6520122|NCT01545583|7440890|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
6520123|NCT01545583|7440891|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
6520124|NCT01545583|7440892|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6520125|NCT01545583|7440893|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6520126|NCT01545583|7440894|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
6520127|NCT01545583|7440895|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
6520128|NCT01545583|7440896|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
6520129|NCT01545583|7440897|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
6520130|NCT01545583|7440898|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
6520131|NCT01545583|7440890|FG000|COMPLETED|Overall Study||12
6520132|NCT01545583|7440891|FG001|COMPLETED|Overall Study||2
6520133|NCT01545583|7440892|FG002|COMPLETED|Overall Study||6
6520134|NCT01545583|7440893|FG003|COMPLETED|Overall Study||6
6520135|NCT01545583|7440894|FG004|COMPLETED|Overall Study||6
6520136|NCT01545583|7440895|FG005|COMPLETED|Overall Study||6
6520137|NCT01545583|7440896|FG006|COMPLETED|Overall Study||6
6520138|NCT01545583|7440897|FG007|COMPLETED|Overall Study||6
6520139|NCT01545583|7440898|FG008|COMPLETED|Overall Study||6
6520140|NCT01545583|7440890|FG000|NOT COMPLETED|Overall Study||0
6520141|NCT01545583|7440891|FG001|NOT COMPLETED|Overall Study||0
6520142|NCT01545583|7440892|FG002|NOT COMPLETED|Overall Study||0
6520143|NCT01545583|7440893|FG003|NOT COMPLETED|Overall Study||0
6520144|NCT01545583|7440894|FG004|NOT COMPLETED|Overall Study||0
6520145|NCT01545583|7440895|FG005|NOT COMPLETED|Overall Study||0
6520146|NCT01545583|7440896|FG006|NOT COMPLETED|Overall Study||0
6520147|NCT01545583|7440897|FG007|NOT COMPLETED|Overall Study||0
6520148|NCT01545583|7440898|FG008|NOT COMPLETED|Overall Study||0
6520149|NCT01545700|7440931|FG000|STARTED|Overall Study||34
6642295|NCT02347813|7570673|FG000|COMPLETED|Second Intervention, 24 Weeks||4
6642296|NCT02347813|7570674|FG001|COMPLETED|Second Intervention, 24 Weeks||4
6642297|NCT02347813|7570673|FG000|NOT COMPLETED|Second Intervention, 24 Weeks||0
6642298|NCT02347813|7570674|FG001|NOT COMPLETED|Second Intervention, 24 Weeks||0
6655838|NCT02456636|7585991|FG002|NOT COMPLETED|Overall Study||75
6655839|NCT02456662|7586001|FG000|STARTED|Overall Study||159
6655840|NCT02456662|7586002|FG001|STARTED|Overall Study||160
6655841|NCT02456662|7586001|FG000|COMPLETED|Overall Study||157
6655842|NCT02456662|7586002|FG001|COMPLETED|Overall Study||159
6520150|NCT01545700|7440932|FG001|STARTED|Overall Study||33
6520151|NCT01545700|7440933|FG002|STARTED|Overall Study||33
6520152|NCT01545700|7440934|FG003|STARTED|Overall Study||34
6520153|NCT01545700|7440935|FG004|STARTED|Overall Study||33
6520154|NCT01545700|7440936|FG005|STARTED|Overall Study||33
6520155|NCT01545700|7440931|FG000|COMPLETED|Overall Study||33
6520156|NCT01545700|7440932|FG001|COMPLETED|Overall Study||32
6520157|NCT01545700|7440933|FG002|COMPLETED|Overall Study||31
6520158|NCT01545700|7440934|FG003|COMPLETED|Overall Study||34
6520159|NCT01545700|7440935|FG004|COMPLETED|Overall Study||32
6520160|NCT01545700|7440936|FG005|COMPLETED|Overall Study||33
6520161|NCT01545700|7440931|FG000|NOT COMPLETED|Overall Study||1
6520162|NCT01545700|7440932|FG001|NOT COMPLETED|Overall Study||1
6520163|NCT01545700|7440933|FG002|NOT COMPLETED|Overall Study||2
6520164|NCT01545700|7440934|FG003|NOT COMPLETED|Overall Study||0
6520165|NCT01545700|7440935|FG004|NOT COMPLETED|Overall Study||1
6520166|NCT01545700|7440936|FG005|NOT COMPLETED|Overall Study||0
6520167|NCT01545765|7440970|FG000|STARTED|Overall Study||31
6520168|NCT01545765|7440970|FG000|COMPLETED|Overall Study||31
6520169|NCT01545765|7440970|FG000|NOT COMPLETED|Overall Study||0
6520170|NCT01545817|7440977|FG000|STARTED|Pazopanib||74
6520171|NCT01545817|7440978|FG001|STARTED|Pazopanib||0
6520172|NCT01545817|7440977|FG000|COMPLETED|Pazopanib||0
6520173|NCT01545817|7440978|FG001|COMPLETED|Pazopanib||0
6520174|NCT01545817|7440977|FG000|NOT COMPLETED|Pazopanib||74
6520175|NCT01545817|7440978|FG001|NOT COMPLETED|Pazopanib||0
6655843|NCT02456662|7586001|FG000|NOT COMPLETED|Overall Study||2
6655844|NCT02456662|7586002|FG001|NOT COMPLETED|Overall Study||1
6520176|NCT01545817|7440977|FG000|STARTED|Everolimus||0
6520177|NCT01545817|7440978|FG001|STARTED|Everolimus||38
6520178|NCT01545817|7440977|FG000|COMPLETED|Everolimus||0
6520179|NCT01545817|7440978|FG001|COMPLETED|Everolimus||0
6520180|NCT01545817|7440977|FG000|NOT COMPLETED|Everolimus||0
6520181|NCT01545817|7440978|FG001|NOT COMPLETED|Everolimus||38
6520182|NCT01545843|7440989|FG000|STARTED|Overall Study||19
6520183|NCT01545843|7440990|FG001|STARTED|Overall Study||24
6520184|NCT01545843|7440991|FG002|STARTED|Overall Study||25
6520185|NCT01545843|7440989|FG000|COMPLETED|Overall Study||16
6520186|NCT01545843|7440990|FG001|COMPLETED|Overall Study||17
6520187|NCT01545843|7440991|FG002|COMPLETED|Overall Study||21
6520188|NCT01545843|7440989|FG000|NOT COMPLETED|Overall Study||3
6520189|NCT01545843|7440990|FG001|NOT COMPLETED|Overall Study||7
6520190|NCT01545843|7440991|FG002|NOT COMPLETED|Overall Study||4
6520191|NCT01545934|7441004|FG000|STARTED|Overall Study||132
6520192|NCT01545934|7441005|FG001|STARTED|Overall Study||132
6520193|NCT01545934|7441004|FG000|COMPLETED|Overall Study||127
6520194|NCT01545934|7441005|FG001|COMPLETED|Overall Study||129
6520195|NCT01545934|7441004|FG000|NOT COMPLETED|Overall Study||5
6520196|NCT01545934|7441005|FG001|NOT COMPLETED|Overall Study||3
6520197|NCT01546038|7441018|FG000|STARTED|Overall Study||17
6520198|NCT01546038|7441019|FG001|STARTED|Overall Study||6
6520199|NCT01546038|7441020|FG002|STARTED|Overall Study||4
6520200|NCT01546038|7441021|FG003|STARTED|Overall Study||3
6520201|NCT01546038|7441022|FG004|STARTED|Overall Study||16
6520202|NCT01546038|7441023|FG005|STARTED|Overall Study||6
6520203|NCT01546038|7441024|FG006|STARTED|Overall Study||71
6520204|NCT01546038|7441025|FG007|STARTED|Overall Study||88
6520205|NCT01546038|7441026|FG008|STARTED|Overall Study||44
6520206|NCT01546038|7441018|FG000|Received Treatment|Overall Study||17
6520207|NCT01546038|7441019|FG001|Received Treatment|Overall Study||6
6520208|NCT01546038|7441020|FG002|Received Treatment|Overall Study||4
6520209|NCT01546038|7441021|FG003|Received Treatment|Overall Study||3
6520210|NCT01546038|7441022|FG004|Received Treatment|Overall Study||16
6520211|NCT01546038|7441023|FG005|Received Treatment|Overall Study||6
6642299|NCT02348008|7570682|FG000|STARTED|Overall Study||3
6642300|NCT02348008|7570683|FG001|STARTED|Overall Study||10
6642301|NCT02348008|7570684|FG002|STARTED|Overall Study||48
6642302|NCT02348008|7570682|FG000|COMPLETED|Overall Study||0
6642303|NCT02348008|7570683|FG001|COMPLETED|Overall Study||0
6642304|NCT02348008|7570684|FG002|COMPLETED|Overall Study||29
6520212|NCT01546038|7441024|FG006|Received Treatment|Overall Study||69
6520213|NCT01546038|7441025|FG007|Received Treatment|Overall Study||84
6520214|NCT01546038|7441026|FG008|Received Treatment|Overall Study||41
6520215|NCT01546038|7441018|FG000|COMPLETED|Overall Study||1
6520216|NCT01546038|7441019|FG001|COMPLETED|Overall Study||0
6520217|NCT01546038|7441020|FG002|COMPLETED|Overall Study||0
6520218|NCT01546038|7441021|FG003|COMPLETED|Overall Study||0
6520219|NCT01546038|7441022|FG004|COMPLETED|Overall Study||6
6520220|NCT01546038|7441023|FG005|COMPLETED|Overall Study||2
6520221|NCT01546038|7441024|FG006|COMPLETED|Overall Study||18
6520222|NCT01546038|7441025|FG007|COMPLETED|Overall Study||4
6520223|NCT01546038|7441026|FG008|COMPLETED|Overall Study||1
6520224|NCT01546038|7441018|FG000|NOT COMPLETED|Overall Study||16
6520225|NCT01546038|7441019|FG001|NOT COMPLETED|Overall Study||6
6520226|NCT01546038|7441020|FG002|NOT COMPLETED|Overall Study||4
6520227|NCT01546038|7441021|FG003|NOT COMPLETED|Overall Study||3
6520228|NCT01546038|7441022|FG004|NOT COMPLETED|Overall Study||10
6520229|NCT01546038|7441023|FG005|NOT COMPLETED|Overall Study||4
6520230|NCT01546038|7441024|FG006|NOT COMPLETED|Overall Study||53
6520231|NCT01546038|7441025|FG007|NOT COMPLETED|Overall Study||84
6520232|NCT01546038|7441026|FG008|NOT COMPLETED|Overall Study||43
6520233|NCT01546142|7441078|FG000|STARTED|Overall Study||258
6520234|NCT01546142|7441079|FG001|STARTED|Overall Study||258
6520235|NCT01546142|7441078|FG000|Received Treatment|Overall Study||257
6520236|NCT01546142|7441079|FG001|Received Treatment|Overall Study||257
6520237|NCT01546142|7441078|FG000|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
6520238|NCT01546142|7441079|FG001|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
6520239|NCT01546142|7441078|FG000|NOT COMPLETED|Overall Study||44
6520240|NCT01546142|7441079|FG001|NOT COMPLETED|Overall Study||34
6520241|NCT01546155|7441085|FG000|STARTED|Overall Study||11
6520242|NCT01546155|7441085|FG000|COMPLETED|Overall Study||8
6520243|NCT01546155|7441085|FG000|NOT COMPLETED|Overall Study||3
6520244|NCT01546168|7441091|FG000|STARTED|Overall Study||55
6520245|NCT01546168|7441092|FG001|STARTED|Overall Study||33
6520246|NCT01546168|7441091|FG000|COMPLETED|Overall Study||51
6520247|NCT01546168|7441092|FG001|COMPLETED|Overall Study||33
6520248|NCT01546168|7441091|FG000|NOT COMPLETED|Overall Study||4
6520249|NCT01546168|7441092|FG001|NOT COMPLETED|Overall Study||0
6520250|NCT01546194|7441100|FG000|STARTED|Overall Study||100
6520251|NCT01546194|7441101|FG001|STARTED|Overall Study||100
6520252|NCT01546194|7441100|FG000|COMPLETED|Overall Study||64
6520253|NCT01546194|7441101|FG001|COMPLETED|Overall Study||65
6520254|NCT01546194|7441100|FG000|NOT COMPLETED|Overall Study||36
6520255|NCT01546194|7441101|FG001|NOT COMPLETED|Overall Study||35
6520256|NCT01546285|7441107|FG000|STARTED|Overall Study||66
6520257|NCT01546285|7441107|FG000|COMPLETED|Overall Study||66
6642305|NCT02348008|7570682|FG000|NOT COMPLETED|Overall Study||3
6642306|NCT02348008|7570683|FG001|NOT COMPLETED|Overall Study||10
6520258|NCT01546285|7441107|FG000|NOT COMPLETED|Overall Study||0
6520259|NCT01546402|7441115|FG000|STARTED|Overall Study||10
6642307|NCT02348008|7570684|FG002|NOT COMPLETED|Overall Study||19
6642308|NCT02348203|7570692|FG000|STARTED|Overall Study||31
6642309|NCT02348203|7570693|FG001|STARTED|Overall Study||32
6642310|NCT02348203|7570692|FG000|COMPLETED|Overall Study||21
6642311|NCT02348203|7570693|FG001|COMPLETED|Overall Study||22
6642312|NCT02348203|7570692|FG000|NOT COMPLETED|Overall Study||10
6642313|NCT02348203|7570693|FG001|NOT COMPLETED|Overall Study||10
6642314|NCT02348216|7570706|FG000|STARTED|Overall Study||8
6642315|NCT02348216|7570707|FG001|STARTED|Overall Study||81
6642316|NCT02348216|7570708|FG002|STARTED|Overall Study||30
6642317|NCT02348216|7570709|FG003|STARTED|Overall Study||42
6642318|NCT02348216|7570710|FG004|STARTED|Overall Study||46
6642319|NCT02348216|7570711|FG005|STARTED|Overall Study||58
6642320|NCT02348216|7570712|FG006|STARTED|Overall Study||42
6642321|NCT02348216|7570706|FG000|COMPLETED|Overall Study||0
6642322|NCT02348216|7570707|FG001|COMPLETED|Overall Study||0
6642323|NCT02348216|7570708|FG002|COMPLETED|Overall Study||0
6642324|NCT02348216|7570709|FG003|COMPLETED|Overall Study||0
6642325|NCT02348216|7570710|FG004|COMPLETED|Overall Study||0
6642326|NCT02348216|7570711|FG005|COMPLETED|Overall Study||0
6642327|NCT02348216|7570712|FG006|COMPLETED|Overall Study||0
6642328|NCT02348216|7570706|FG000|NOT COMPLETED|Overall Study||8
6642329|NCT02348216|7570707|FG001|NOT COMPLETED|Overall Study||81
6642330|NCT02348216|7570708|FG002|NOT COMPLETED|Overall Study||30
6642331|NCT02348216|7570709|FG003|NOT COMPLETED|Overall Study||42
6642332|NCT02348216|7570710|FG004|NOT COMPLETED|Overall Study||46
6642333|NCT02348216|7570711|FG005|NOT COMPLETED|Overall Study||58
6642334|NCT02348216|7570712|FG006|NOT COMPLETED|Overall Study||42
6642335|NCT02348385|7570752|FG000|STARTED|Overall Study||24
6642336|NCT02348385|7570753|FG001|STARTED|Overall Study||25
6642337|NCT02348385|7570752|FG000|COMPLETED|Overall Study||24
6642338|NCT02348385|7570753|FG001|COMPLETED|Overall Study||25
6642339|NCT02348385|7570752|FG000|NOT COMPLETED|Overall Study||0
6642340|NCT02348385|7570753|FG001|NOT COMPLETED|Overall Study||0
6642341|NCT02348489|7570763|FG000|STARTED|Overall Study||408
6642342|NCT02348489|7570764|FG001|STARTED|Overall Study||407
6642343|NCT02348489|7570763|FG000|COMPLETED|Overall Study||55
6642344|NCT02348489|7570764|FG001|COMPLETED|Overall Study||40
6642345|NCT02348489|7570763|FG000|NOT COMPLETED|Overall Study||353
6642346|NCT02348489|7570764|FG001|NOT COMPLETED|Overall Study||367
6642347|NCT02348593|7570776|FG000|STARTED|Overall Study||59
6642348|NCT02348593|7570777|FG001|STARTED|Overall Study||59
6642349|NCT02348593|7570778|FG002|STARTED|Overall Study||59
6642350|NCT02348593|7570779|FG003|STARTED|Overall Study||59
6642351|NCT02348593|7570776|FG000|COMPLETED|Overall Study||49
6642352|NCT02348593|7570777|FG001|COMPLETED|Overall Study||51
6642353|NCT02348593|7570778|FG002|COMPLETED|Overall Study||43
6642354|NCT02348593|7570779|FG003|COMPLETED|Overall Study||52
6642355|NCT02348593|7570776|FG000|NOT COMPLETED|Overall Study||10
6642356|NCT02348593|7570777|FG001|NOT COMPLETED|Overall Study||8
6642357|NCT02348593|7570778|FG002|NOT COMPLETED|Overall Study||16
6642358|NCT02348593|7570779|FG003|NOT COMPLETED|Overall Study||7
6642359|NCT02348606|7570794|FG000|STARTED|Overall Study||58
6642360|NCT02348606|7570795|FG001|STARTED|Overall Study||62
6642361|NCT02348606|7570796|FG002|STARTED|Overall Study||117
6642362|NCT02348606|7570797|FG003|STARTED|Overall Study||118
6642363|NCT02348606|7570798|FG004|STARTED|Overall Study||119
6642364|NCT02348606|7570794|FG000|COMPLETED|Overall Study||49
6642365|NCT02348606|7570795|FG001|COMPLETED|Overall Study||54
6642366|NCT02348606|7570796|FG002|COMPLETED|Overall Study||106
6642367|NCT02348606|7570797|FG003|COMPLETED|Overall Study||94
6642368|NCT02348606|7570798|FG004|COMPLETED|Overall Study||101
6642369|NCT02348606|7570794|FG000|NOT COMPLETED|Overall Study||9
6520260|NCT01546402|7441116|FG001|STARTED|Overall Study||10
6520261|NCT01546402|7441115|FG000|COMPLETED|Overall Study||10
6520262|NCT01546402|7441116|FG001|COMPLETED|Overall Study||10
6520263|NCT01546402|7441115|FG000|NOT COMPLETED|Overall Study||0
6520264|NCT01546402|7441116|FG001|NOT COMPLETED|Overall Study||0
6520265|NCT01546454|7441122|FG000|STARTED|Natural Menstrual Cycle||4
6520266|NCT01546454|7441122|FG000|COMPLETED|Natural Menstrual Cycle||4
6520267|NCT01546454|7441122|FG000|NOT COMPLETED|Natural Menstrual Cycle||0
6520268|NCT01546454|7441122|FG000|STARTED|Oral Contraceptive Cycle||4
6520269|NCT01546454|7441122|FG000|COMPLETED|Oral Contraceptive Cycle||4
6520270|NCT01546454|7441122|FG000|NOT COMPLETED|Oral Contraceptive Cycle||0
6642370|NCT02348606|7570795|FG001|NOT COMPLETED|Overall Study||8
6642371|NCT02348606|7570796|FG002|NOT COMPLETED|Overall Study||11
6642372|NCT02348606|7570797|FG003|NOT COMPLETED|Overall Study||24
6642373|NCT02348606|7570798|FG004|NOT COMPLETED|Overall Study||18
6642374|NCT02348619|7570810|FG000|STARTED|Titration Phase||174
6642375|NCT02348619|7570811|FG001|STARTED|Titration Phase||0
6642376|NCT02348619|7570810|FG000|COMPLETED|Titration Phase||157
6642377|NCT02348619|7570811|FG001|COMPLETED|Titration Phase||0
6642378|NCT02348619|7570810|FG000|NOT COMPLETED|Titration Phase||17
6642379|NCT02348619|7570811|FG001|NOT COMPLETED|Titration Phase||0
6642380|NCT02348619|7570810|FG000|STARTED|Stable-Dose Phase||157
6642381|NCT02348619|7570811|FG001|STARTED|Stable-Dose Phase||0
6642382|NCT02348619|7570810|FG000|COMPLETED|Stable-Dose Phase||124
6642383|NCT02348619|7570811|FG001|COMPLETED|Stable-Dose Phase||0
6642384|NCT02348619|7570810|FG000|NOT COMPLETED|Stable-Dose Phase||33
6642385|NCT02348619|7570811|FG001|NOT COMPLETED|Stable-Dose Phase||0
6520271|NCT01546454|7441122|FG000|STARTED|Eligard Treatment||4
6520272|NCT01546454|7441122|FG000|COMPLETED|Eligard Treatment||4
6520273|NCT01546454|7441122|FG000|NOT COMPLETED|Eligard Treatment||0
6520274|NCT01546454|7441122|FG000|STARTED|Estrogen/Progesterone Replacement Cycle||4
6520275|NCT01546454|7441122|FG000|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
6520276|NCT01546454|7441122|FG000|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
6520277|NCT01546519|7441132|FG000|STARTED|Overall Study||9
6520278|NCT01546519|7441133|FG001|STARTED|Overall Study||8
6520279|NCT01546519|7441134|FG002|STARTED|Overall Study||8
6520280|NCT01546519|7441135|FG003|STARTED|Overall Study||6
6520281|NCT01546519|7441132|FG000|Safety-Evaluable Participants|Overall Study||9
6520282|NCT01546519|7441133|FG001|Safety-Evaluable Participants|Overall Study||8
6520283|NCT01546519|7441134|FG002|Safety-Evaluable Participants|Overall Study||8
6520284|NCT01546519|7441135|FG003|Safety-Evaluable Participants|Overall Study||6
6520285|NCT01546519|7441132|FG000|COMPLETED|Overall Study||0
6520286|NCT01546519|7441133|FG001|COMPLETED|Overall Study||0
6520287|NCT01546519|7441134|FG002|COMPLETED|Overall Study||0
6520288|NCT01546519|7441135|FG003|COMPLETED|Overall Study||0
6642386|NCT02348619|7570810|FG000|STARTED|Double-Blind Withdrawal Phase||62
6520289|NCT01546519|7441132|FG000|NOT COMPLETED|Overall Study||9
6642387|NCT02348619|7570811|FG001|STARTED|Double-Blind Withdrawal Phase||62
6642388|NCT02348619|7570810|FG000|COMPLETED|Double-Blind Withdrawal Phase||60
6642389|NCT02348619|7570811|FG001|COMPLETED|Double-Blind Withdrawal Phase||62
6642390|NCT02348619|7570810|FG000|NOT COMPLETED|Double-Blind Withdrawal Phase||2
6642391|NCT02348619|7570811|FG001|NOT COMPLETED|Double-Blind Withdrawal Phase||0
6642392|NCT02348632|7570817|FG000|STARTED|Open-label Period||643
6642393|NCT02348632|7570818|FG001|STARTED|Open-label Period||0
6642394|NCT02348632|7570817|FG000|COMPLETED|Open-label Period||458
6642395|NCT02348632|7570818|FG001|COMPLETED|Open-label Period||0
6642396|NCT02348632|7570817|FG000|NOT COMPLETED|Open-label Period||185
6642397|NCT02348632|7570818|FG001|NOT COMPLETED|Open-label Period||0
6642398|NCT02348632|7570817|FG000|STARTED|Randomized Withdrawal Period||140
6520290|NCT01546519|7441133|FG001|NOT COMPLETED|Overall Study||8
6520291|NCT01546519|7441134|FG002|NOT COMPLETED|Overall Study||8
6520292|NCT01546519|7441135|FG003|NOT COMPLETED|Overall Study||6
6520293|NCT01546623|7441151|FG000|STARTED|Overall Study||82
6520294|NCT01546623|7441152|FG001|STARTED|Overall Study||80
6520295|NCT01546623|7441151|FG000|Received Study Drug|Overall Study||81
6520296|NCT01546623|7441152|FG001|Received Study Drug|Overall Study||79
6520297|NCT01546623|7441151|FG000|COMPLETED|Overall Study||76
6520298|NCT01546623|7441152|FG001|COMPLETED|Overall Study||74
6520299|NCT01546623|7441151|FG000|NOT COMPLETED|Overall Study||6
6520300|NCT01546623|7441152|FG001|NOT COMPLETED|Overall Study||6
6520301|NCT01546636|7441160|FG000|STARTED|Overall Study||36
6520302|NCT01546636|7441161|FG001|STARTED|Overall Study||34
6520303|NCT01546636|7441160|FG000|COMPLETED|Overall Study||36
6520304|NCT01546636|7441161|FG001|COMPLETED|Overall Study||34
6520305|NCT01546636|7441160|FG000|NOT COMPLETED|Overall Study||0
6520306|NCT01546636|7441161|FG001|NOT COMPLETED|Overall Study||0
6520307|NCT01546649|7441169|FG000|STARTED|Overall Study||83
6520308|NCT01546649|7441170|FG001|STARTED|Overall Study||84
6520309|NCT01546649|7441169|FG000|COMPLETED|Overall Study||75
6520310|NCT01546649|7441170|FG001|COMPLETED|Overall Study||75
6520311|NCT01546649|7441169|FG000|NOT COMPLETED|Overall Study||8
6520312|NCT01546649|7441170|FG001|NOT COMPLETED|Overall Study||9
6520313|NCT01546675|7441178|FG000|STARTED|Overall Study||1
6520314|NCT01546675|7441179|FG001|STARTED|Overall Study||1
6520315|NCT01546675|7441178|FG000|COMPLETED|Overall Study||1
6520316|NCT01546675|7441179|FG001|COMPLETED|Overall Study||1
6520317|NCT01546675|7441178|FG000|NOT COMPLETED|Overall Study||0
6520318|NCT01546675|7441179|FG001|NOT COMPLETED|Overall Study||0
6520319|NCT01546688|7441187|FG000|STARTED|Overall Study||18
6520320|NCT01546688|7441188|FG001|STARTED|Overall Study||33
6520321|NCT01546688|7441187|FG000|COMPLETED|Overall Study||15
6520322|NCT01546688|7441188|FG001|COMPLETED|Overall Study||28
6520323|NCT01546688|7441187|FG000|NOT COMPLETED|Overall Study||3
6520324|NCT01546688|7441188|FG001|NOT COMPLETED|Overall Study||5
6520325|NCT01546857|7441196|FG000|STARTED|Overall Study||14
6520326|NCT01546857|7441197|FG001|STARTED|Overall Study||20
6520327|NCT01546857|7441196|FG000|COMPLETED|Overall Study||12
6520328|NCT01546857|7441197|FG001|COMPLETED|Overall Study||17
6520329|NCT01546857|7441196|FG000|NOT COMPLETED|Overall Study||2
6520330|NCT01546857|7441197|FG001|NOT COMPLETED|Overall Study||3
6520331|NCT01546922|7441204|FG000|STARTED|First Period of 10 Weeks||30
6520332|NCT01546922|7441205|FG001|STARTED|First Period of 10 Weeks||30
6520333|NCT01546922|7441204|FG000|COMPLETED|First Period of 10 Weeks||25
6520334|NCT01546922|7441205|FG001|COMPLETED|First Period of 10 Weeks||28
6520335|NCT01546922|7441204|FG000|NOT COMPLETED|First Period of 10 Weeks||5
6520336|NCT01546922|7441205|FG001|NOT COMPLETED|First Period of 10 Weeks||2
6520337|NCT01546922|7441204|FG000|STARTED|Second Period of 10 Weeks||25
6520338|NCT01546922|7441205|FG001|STARTED|Second Period of 10 Weeks||28
6520339|NCT01546922|7441204|FG000|COMPLETED|Second Period of 10 Weeks||22
6642399|NCT02348632|7570818|FG001|STARTED|Randomized Withdrawal Period||142
6642400|NCT02348632|7570817|FG000|COMPLETED|Randomized Withdrawal Period||137
6642401|NCT02348632|7570818|FG001|COMPLETED|Randomized Withdrawal Period||141
6520340|NCT01546922|7441205|FG001|COMPLETED|Second Period of 10 Weeks||25
6520341|NCT01546922|7441204|FG000|NOT COMPLETED|Second Period of 10 Weeks||3
6520342|NCT01546922|7441205|FG001|NOT COMPLETED|Second Period of 10 Weeks||3
6520343|NCT01547000|7441213|FG000|STARTED|Overall Study||18
6520344|NCT01547000|7441214|FG001|STARTED|Overall Study||16
6520345|NCT01547000|7441213|FG000|COMPLETED|Overall Study||18
6520346|NCT01547000|7441214|FG001|COMPLETED|Overall Study||16
6520347|NCT01547000|7441213|FG000|NOT COMPLETED|Overall Study||0
6520348|NCT01547000|7441214|FG001|NOT COMPLETED|Overall Study||0
6520349|NCT01547130|7441222|FG000|STARTED|Overall Study||74
6520350|NCT01547130|7441223|FG001|STARTED|Overall Study||73
6520351|NCT01547130|7441222|FG000|COMPLETED|Overall Study||65
6520352|NCT01547130|7441223|FG001|COMPLETED|Overall Study||68
6520353|NCT01547130|7441222|FG000|NOT COMPLETED|Overall Study||9
6520354|NCT01547130|7441223|FG001|NOT COMPLETED|Overall Study||5
6520355|NCT01547247|7441239|FG000|STARTED|Overall Study||104
6520356|NCT01547247|7441240|FG001|STARTED|Overall Study||104
6520357|NCT01547247|7441239|FG000|COMPLETED|Overall Study||98
6520358|NCT01547247|7441240|FG001|COMPLETED|Overall Study||98
6520359|NCT01547247|7441239|FG000|NOT COMPLETED|Overall Study||6
6520360|NCT01547247|7441240|FG001|NOT COMPLETED|Overall Study||6
6520361|NCT01547286|7441246|FG000|STARTED|Overall Study||7
6520362|NCT01547286|7441246|FG000|COMPLETED|Overall Study||5
6520363|NCT01547286|7441246|FG000|NOT COMPLETED|Overall Study||2
6561579|NCT01794780|7484409|FG006|NOT COMPLETED|Overall Study||42
6561580|NCT01794780|7484410|FG007|NOT COMPLETED|Overall Study||9
6561581|NCT01794806|7484437|FG000|STARTED|Overall Study||31
6561582|NCT01794806|7484438|FG001|STARTED|Overall Study||28
6561583|NCT01794806|7484437|FG000|1 Week|Overall Study||28
6561584|NCT01794806|7484438|FG001|1 Week|Overall Study||28
6561585|NCT01794806|7484437|FG000|4 Weeks|Overall Study||26
6561586|NCT01794806|7484438|FG001|4 Weeks|Overall Study||27
6561587|NCT01794806|7484437|FG000|COMPLETED|Overall Study||26
6561588|NCT01794806|7484438|FG001|COMPLETED|Overall Study||27
6561589|NCT01794806|7484437|FG000|NOT COMPLETED|Overall Study||5
6561590|NCT01794806|7484438|FG001|NOT COMPLETED|Overall Study||1
6561591|NCT01794845|7484444|FG000|STARTED|Overall Study||5
6561592|NCT01794845|7484444|FG000|COMPLETED|Overall Study||4
6561593|NCT01794845|7484444|FG000|NOT COMPLETED|Overall Study||1
6561594|NCT01794923|7484451|FG000|STARTED|Overall Study||83
6561595|NCT01794923|7484452|FG001|STARTED|Overall Study||60
6561596|NCT01794923|7484453|FG002|STARTED|Overall Study||62
6561597|NCT01794923|7484451|FG000|COMPLETED|Overall Study||83
6561598|NCT01794923|7484452|FG001|COMPLETED|Overall Study||60
6561599|NCT01794923|7484453|FG002|COMPLETED|Overall Study||61
6561600|NCT01794923|7484451|FG000|NOT COMPLETED|Overall Study||0
6561601|NCT01794923|7484452|FG001|NOT COMPLETED|Overall Study||0
6561602|NCT01794923|7484453|FG002|NOT COMPLETED|Overall Study||1
6561603|NCT01794949|7484463|FG000|STARTED|Overall Study||7
6561604|NCT01794949|7484464|FG001|STARTED|Overall Study||1
6561605|NCT01794949|7484463|FG000|6 Month Follow-up|Overall Study||6
6561606|NCT01794949|7484464|FG001|6 Month Follow-up|Overall Study||1
6561607|NCT01794949|7484463|FG000|COMPLETED|Overall Study||6
6561608|NCT01794949|7484464|FG001|COMPLETED|Overall Study||1
6561609|NCT01794949|7484463|FG000|NOT COMPLETED|Overall Study||1
6561610|NCT01794949|7484464|FG001|NOT COMPLETED|Overall Study||0
6561611|NCT01795079|7484472|FG000|STARTED|Overall Study||16
6561612|NCT01795079|7484473|FG001|STARTED|Overall Study||15
6561613|NCT01795079|7484472|FG000|COMPLETED|Overall Study||13
6561614|NCT01795079|7484473|FG001|COMPLETED|Overall Study||12
6561615|NCT01795079|7484472|FG000|NOT COMPLETED|Overall Study||3
6561616|NCT01795079|7484473|FG001|NOT COMPLETED|Overall Study||3
6561617|NCT01795105|7484479|FG000|STARTED|Overall Study||692
6561618|NCT01795105|7484479|FG000|COMPLETED|Overall Study||648
6561619|NCT01795105|7484479|FG000|NOT COMPLETED|Overall Study||44
6561620|NCT01795495|7484487|FG000|STARTED|Overall Study||20
6561621|NCT01795495|7484488|FG001|STARTED|Overall Study||22
6561622|NCT01795495|7484489|FG002|STARTED|Overall Study||21
6561623|NCT01795495|7484487|FG000|COMPLETED|Overall Study||19
6561624|NCT01795495|7484488|FG001|COMPLETED|Overall Study||22
6561625|NCT01795495|7484489|FG002|COMPLETED|Overall Study||19
6561626|NCT01795495|7484487|FG000|NOT COMPLETED|Overall Study||1
6561627|NCT01795495|7484488|FG001|NOT COMPLETED|Overall Study||0
6561628|NCT01795495|7484489|FG002|NOT COMPLETED|Overall Study||2
6561629|NCT01795534|7484497|FG000|STARTED|First Intervention (First Shot)||5
6561630|NCT01795534|7484498|FG001|STARTED|First Intervention (First Shot)||5
6561631|NCT01795534|7484497|FG000|COMPLETED|First Intervention (First Shot)||5
6561632|NCT01795534|7484498|FG001|COMPLETED|First Intervention (First Shot)||5
6561633|NCT01795534|7484497|FG000|NOT COMPLETED|First Intervention (First Shot)||0
6561634|NCT01795534|7484498|FG001|NOT COMPLETED|First Intervention (First Shot)||0
6561635|NCT01795534|7484497|FG000|STARTED|Wash Out Period (4 Days)||5
6561636|NCT01795534|7484498|FG001|STARTED|Wash Out Period (4 Days)||5
6561637|NCT01795534|7484497|FG000|COMPLETED|Wash Out Period (4 Days)||5
6561638|NCT01795534|7484498|FG001|COMPLETED|Wash Out Period (4 Days)||5
6561639|NCT01795534|7484497|FG000|NOT COMPLETED|Wash Out Period (4 Days)||0
6561640|NCT01795534|7484498|FG001|NOT COMPLETED|Wash Out Period (4 Days)||0
6561641|NCT01795534|7484497|FG000|STARTED|Second Intervention (Second Shot)||5
6561642|NCT01795534|7484498|FG001|STARTED|Second Intervention (Second Shot)||5
6561643|NCT01795534|7484497|FG000|COMPLETED|Second Intervention (Second Shot)||5
6561644|NCT01795534|7484498|FG001|COMPLETED|Second Intervention (Second Shot)||5
6561645|NCT01795534|7484497|FG000|NOT COMPLETED|Second Intervention (Second Shot)||0
6561646|NCT01795534|7484498|FG001|NOT COMPLETED|Second Intervention (Second Shot)||0
6561647|NCT01795547|7484506|FG000|STARTED|Overall Study||148
6520364|NCT01547299|7441253|FG000|STARTED|Overall Study||25
6520365|NCT01547299|7441254|FG001|STARTED|Overall Study||27
6520366|NCT01547299|7441253|FG000|COMPLETED|Overall Study||23
6520367|NCT01547299|7441254|FG001|COMPLETED|Overall Study||25
6520368|NCT01547299|7441253|FG000|NOT COMPLETED|Overall Study||2
6520369|NCT01547299|7441254|FG001|NOT COMPLETED|Overall Study||2
6520370|NCT01547390|7441262|FG000|STARTED|Overall Study||27
6520371|NCT01547390|7441263|FG001|STARTED|Overall Study||26
6520372|NCT01547390|7441262|FG000|COMPLETED|Overall Study||14
6520373|NCT01547390|7441263|FG001|COMPLETED|Overall Study||16
6520374|NCT01547390|7441262|FG000|NOT COMPLETED|Overall Study||13
6520375|NCT01547390|7441263|FG001|NOT COMPLETED|Overall Study||10
6520376|NCT01547598|7441271|FG000|STARTED|Overall Study||67
6520377|NCT01547598|7441272|FG001|STARTED|Overall Study||68
6520378|NCT01547598|7441271|FG000|COMPLETED|Overall Study||61
6520379|NCT01547598|7441272|FG001|COMPLETED|Overall Study||63
6520380|NCT01547598|7441271|FG000|NOT COMPLETED|Overall Study||6
6520381|NCT01547598|7441272|FG001|NOT COMPLETED|Overall Study||5
6520382|NCT01547715|7441282|FG000|STARTED|Overall Study||60
6520383|NCT01547715|7441283|FG001|STARTED|Overall Study||60
6520384|NCT01547715|7441284|FG002|STARTED|Overall Study||60
6520385|NCT01547715|7441282|FG000|COMPLETED|Overall Study||60
6520386|NCT01547715|7441283|FG001|COMPLETED|Overall Study||60
6520387|NCT01547715|7441284|FG002|COMPLETED|Overall Study||60
6520388|NCT01547715|7441282|FG000|NOT COMPLETED|Overall Study||0
6520389|NCT01547715|7441283|FG001|NOT COMPLETED|Overall Study||0
6520390|NCT01547715|7441284|FG002|NOT COMPLETED|Overall Study||0
6520391|NCT01547780|7441297|FG000|STARTED|Baseline PET Scan||12
6520392|NCT01547780|7441298|FG001|STARTED|Baseline PET Scan||0
6520393|NCT01547780|7441299|FG002|STARTED|Baseline PET Scan||19
6520394|NCT01547780|7441300|FG003|STARTED|Baseline PET Scan||19
6520395|NCT01547780|7441297|FG000|COMPLETED|Baseline PET Scan||9
6520396|NCT01547780|7441298|FG001|COMPLETED|Baseline PET Scan||0
6520397|NCT01547780|7441299|FG002|COMPLETED|Baseline PET Scan||17
6520398|NCT01547780|7441300|FG003|COMPLETED|Baseline PET Scan||19
6520399|NCT01547780|7441297|FG000|NOT COMPLETED|Baseline PET Scan||3
6520400|NCT01547780|7441298|FG001|NOT COMPLETED|Baseline PET Scan||0
6520401|NCT01547780|7441299|FG002|NOT COMPLETED|Baseline PET Scan||2
6520402|NCT01547780|7441300|FG003|NOT COMPLETED|Baseline PET Scan||0
6520403|NCT01547780|7441297|FG000|STARTED|Repeat PET Scan||0
6520404|NCT01547780|7441298|FG001|STARTED|Repeat PET Scan||4
6520405|NCT01547780|7441299|FG002|STARTED|Repeat PET Scan||0
6520406|NCT01547780|7441300|FG003|STARTED|Repeat PET Scan||0
6520407|NCT01547780|7441297|FG000|COMPLETED|Repeat PET Scan||0
6520408|NCT01547780|7441298|FG001|COMPLETED|Repeat PET Scan||4
6520409|NCT01547780|7441299|FG002|COMPLETED|Repeat PET Scan||0
6520410|NCT01547780|7441300|FG003|COMPLETED|Repeat PET Scan||0
6520411|NCT01547780|7441297|FG000|NOT COMPLETED|Repeat PET Scan||0
6520412|NCT01547780|7441298|FG001|NOT COMPLETED|Repeat PET Scan||0
6520413|NCT01547780|7441299|FG002|NOT COMPLETED|Repeat PET Scan||0
6520414|NCT01547780|7441300|FG003|NOT COMPLETED|Repeat PET Scan||0
6520415|NCT01547806|7441310|FG000|STARTED|Overall Study||49
6520416|NCT01547806|7441310|FG000|COMPLETED|Overall Study||49
6520417|NCT01547806|7441310|FG000|NOT COMPLETED|Overall Study||0
6520418|NCT01548040|7441317|FG000|STARTED|Overall Study||56
6520419|NCT01548040|7441318|FG001|STARTED|Overall Study||55
6520420|NCT01548040|7441317|FG000|COMPLETED|Overall Study||43
6520421|NCT01548040|7441318|FG001|COMPLETED|Overall Study||45
6520422|NCT01548040|7441317|FG000|NOT COMPLETED|Overall Study||13
6520423|NCT01548040|7441318|FG001|NOT COMPLETED|Overall Study||10
6520424|NCT01548287|7441328|FG000|STARTED|Screening||19
6520425|NCT01548287|7441329|FG001|STARTED|Screening||22
6520426|NCT01548287|7441330|FG002|STARTED|Screening||20
6520427|NCT01548287|7441331|FG003|STARTED|Screening||20
6520428|NCT01548287|7441332|FG004|STARTED|Screening||83
6520429|NCT01548287|7441328|FG000|COMPLETED|Screening||19
6520430|NCT01548287|7441329|FG001|COMPLETED|Screening||22
6520431|NCT01548287|7441330|FG002|COMPLETED|Screening||20
6520432|NCT01548287|7441331|FG003|COMPLETED|Screening||20
6520433|NCT01548287|7441332|FG004|COMPLETED|Screening||0
6520434|NCT01548287|7441328|FG000|NOT COMPLETED|Screening||0
6520435|NCT01548287|7441329|FG001|NOT COMPLETED|Screening||0
6520436|NCT01548287|7441330|FG002|NOT COMPLETED|Screening||0
6520437|NCT01548287|7441331|FG003|NOT COMPLETED|Screening||0
6520438|NCT01548287|7441332|FG004|NOT COMPLETED|Screening||83
6520439|NCT01548287|7441328|FG000|STARTED|Randomized Period||19
6520440|NCT01548287|7441329|FG001|STARTED|Randomized Period||22
6520441|NCT01548287|7441330|FG002|STARTED|Randomized Period||20
6520442|NCT01548287|7441331|FG003|STARTED|Randomized Period||20
6520443|NCT01548287|7441332|FG004|STARTED|Randomized Period||0
6520444|NCT01548287|7441328|FG000|COMPLETED|Randomized Period||19
6520445|NCT01548287|7441329|FG001|COMPLETED|Randomized Period||20
6520446|NCT01548287|7441330|FG002|COMPLETED|Randomized Period||13
6520447|NCT01548287|7441331|FG003|COMPLETED|Randomized Period||20
6520448|NCT01548287|7441332|FG004|COMPLETED|Randomized Period||0
6520449|NCT01548287|7441328|FG000|NOT COMPLETED|Randomized Period||0
6520450|NCT01548287|7441329|FG001|NOT COMPLETED|Randomized Period||2
6520451|NCT01548287|7441330|FG002|NOT COMPLETED|Randomized Period||7
6520452|NCT01548287|7441331|FG003|NOT COMPLETED|Randomized Period||0
6520453|NCT01548287|7441332|FG004|NOT COMPLETED|Randomized Period||0
6520454|NCT01548339|7441344|FG000|STARTED|Overall Study||44
6520455|NCT01548339|7441345|FG001|STARTED|Overall Study||42
6520456|NCT01548339|7441344|FG000|COMPLETED|Overall Study||38
6520457|NCT01548339|7441345|FG001|COMPLETED|Overall Study||41
6520458|NCT01548339|7441344|FG000|NOT COMPLETED|Overall Study||6
6520459|NCT01548339|7441345|FG001|NOT COMPLETED|Overall Study||1
6520460|NCT01548404|7441353|FG000|STARTED|Overall Study||54
6642402|NCT02348632|7570817|FG000|NOT COMPLETED|Randomized Withdrawal Period||3
6642403|NCT02348632|7570818|FG001|NOT COMPLETED|Randomized Withdrawal Period||1
6642404|NCT02348658|7570824|FG000|STARTED|Period 1 (7 Days)||6
6642405|NCT02348658|7570825|FG001|STARTED|Period 1 (7 Days)||6
6642406|NCT02348658|7570824|FG000|COMPLETED|Period 1 (7 Days)||6
6642407|NCT02348658|7570825|FG001|COMPLETED|Period 1 (7 Days)||6
6642408|NCT02348658|7570824|FG000|NOT COMPLETED|Period 1 (7 Days)||0
6642409|NCT02348658|7570825|FG001|NOT COMPLETED|Period 1 (7 Days)||0
6642410|NCT02348658|7570824|FG000|STARTED|Washout Period (22 Days)||6
6642411|NCT02348658|7570825|FG001|STARTED|Washout Period (22 Days)||6
6642412|NCT02348658|7570824|FG000|COMPLETED|Washout Period (22 Days)||6
6642413|NCT02348658|7570825|FG001|COMPLETED|Washout Period (22 Days)||6
6520461|NCT01548404|7441354|FG001|STARTED|Overall Study||55
6520462|NCT01548404|7441353|FG000|COMPLETED|Overall Study||24
6520463|NCT01548404|7441354|FG001|COMPLETED|Overall Study||41
6520464|NCT01548404|7441353|FG000|NOT COMPLETED|Overall Study||30
6520465|NCT01548404|7441354|FG001|NOT COMPLETED|Overall Study||14
6520466|NCT01548417|7441363|FG000|STARTED|Overall Study||28
6520467|NCT01548417|7441364|FG001|STARTED|Overall Study||28
6520468|NCT01548417|7441363|FG000|COMPLETED|Overall Study||28
6520469|NCT01548417|7441364|FG001|COMPLETED|Overall Study||26
6520470|NCT01548417|7441363|FG000|NOT COMPLETED|Overall Study||0
6520471|NCT01548417|7441364|FG001|NOT COMPLETED|Overall Study||2
6520472|NCT01548573|7441370|FG000|STARTED|Overall Study||19
6520473|NCT01548573|7441370|FG000|COMPLETED|Overall Study||14
6520474|NCT01548573|7441370|FG000|NOT COMPLETED|Overall Study||5
6520475|NCT01548599|7441377|FG000|STARTED|Overall Study||72
6520476|NCT01548599|7441378|FG001|STARTED|Overall Study||68
6520477|NCT01548599|7441377|FG000|COMPLETED|Overall Study||66
6520478|NCT01548599|7441378|FG001|COMPLETED|Overall Study||66
6520479|NCT01548599|7441377|FG000|NOT COMPLETED|Overall Study||6
6520480|NCT01548599|7441378|FG001|NOT COMPLETED|Overall Study||2
6520481|NCT01548638|7441387|FG000|STARTED|Overall Study||13
6520482|NCT01548638|7441387|FG000|COMPLETED|Overall Study||9
6520483|NCT01548638|7441387|FG000|NOT COMPLETED|Overall Study||4
6520484|NCT01548690|7441396|FG000|STARTED|Overall Study||9
6520485|NCT01548690|7441397|FG001|STARTED|Overall Study||10
6520486|NCT01548690|7441398|FG002|STARTED|Overall Study||13
6520487|NCT01548690|7441399|FG003|STARTED|Overall Study||15
6520488|NCT01548690|7441396|FG000|Evaluable (72 Hours on Infusion)|Overall Study||6
6520489|NCT01548690|7441397|FG001|Evaluable (72 Hours on Infusion)|Overall Study||6
6520490|NCT01548690|7441398|FG002|Evaluable (72 Hours on Infusion)|Overall Study||12
6520491|NCT01548690|7441399|FG003|Evaluable (72 Hours on Infusion)|Overall Study||12
6520492|NCT01548690|7441396|FG000|COMPLETED|Overall Study||9
6520493|NCT01548690|7441397|FG001|COMPLETED|Overall Study||7
6520494|NCT01548690|7441398|FG002|COMPLETED|Overall Study||8
6520495|NCT01548690|7441399|FG003|COMPLETED|Overall Study||10
6520496|NCT01548690|7441396|FG000|NOT COMPLETED|Overall Study||0
6520497|NCT01548690|7441397|FG001|NOT COMPLETED|Overall Study||3
6520498|NCT01548690|7441398|FG002|NOT COMPLETED|Overall Study||5
6520499|NCT01548690|7441399|FG003|NOT COMPLETED|Overall Study||5
6520500|NCT01548742|7441414|FG000|STARTED|Overall Study||58
6520501|NCT01548742|7441415|FG001|STARTED|Overall Study||58
6520502|NCT01548742|7441414|FG000|COMPLETED|Overall Study||45
6520503|NCT01548742|7441415|FG001|COMPLETED|Overall Study||54
6520504|NCT01548742|7441414|FG000|NOT COMPLETED|Overall Study||13
6520505|NCT01548742|7441415|FG001|NOT COMPLETED|Overall Study||4
6520506|NCT01548768|7441427|FG000|STARTED|Overall Study||8
6520507|NCT01548768|7441428|FG001|STARTED|Overall Study||4
6520508|NCT01548768|7441429|FG002|STARTED|Overall Study||16
6520509|NCT01548768|7441430|FG003|STARTED|Overall Study||121
6520510|NCT01548768|7441427|FG000|COMPLETED|Overall Study||7
6520511|NCT01548768|7441428|FG001|COMPLETED|Overall Study||2
6520512|NCT01548768|7441429|FG002|COMPLETED|Overall Study||15
6520513|NCT01548768|7441430|FG003|COMPLETED|Overall Study||117
6520514|NCT01548768|7441427|FG000|NOT COMPLETED|Overall Study||1
6520515|NCT01548768|7441428|FG001|NOT COMPLETED|Overall Study||2
6520516|NCT01548768|7441429|FG002|NOT COMPLETED|Overall Study||1
6520517|NCT01548768|7441430|FG003|NOT COMPLETED|Overall Study||4
6520518|NCT01548833|7441442|FG000|STARTED|Overall Study||39
6520519|NCT01548833|7441442|FG000|COMPLETED|Overall Study||39
6642414|NCT02348658|7570824|FG000|NOT COMPLETED|Washout Period (22 Days)||0
6520520|NCT01548833|7441442|FG000|NOT COMPLETED|Overall Study||0
6520521|NCT01548885|7441450|FG000|STARTED|Overall Study||146
6520522|NCT01548885|7441450|FG000|COMPLETED|Overall Study||146
6520523|NCT01548885|7441450|FG000|NOT COMPLETED|Overall Study||0
6520524|NCT01549002|7441456|FG000|STARTED|Overall Study||10
6520525|NCT01549002|7441457|FG001|STARTED|Overall Study||10
6520526|NCT01549002|7441456|FG000|COMPLETED|Overall Study||10
6520527|NCT01549002|7441457|FG001|COMPLETED|Overall Study||6
6520528|NCT01549002|7441456|FG000|NOT COMPLETED|Overall Study||0
6520529|NCT01549002|7441457|FG001|NOT COMPLETED|Overall Study||4
6520530|NCT01549041|7441465|FG000|STARTED|Overall Study||12
6520531|NCT01549041|7441466|FG001|STARTED|Overall Study||18
6520532|NCT01549041|7441465|FG000|COMPLETED|Overall Study||10
6520533|NCT01549041|7441466|FG001|COMPLETED|Overall Study||10
6520534|NCT01549041|7441465|FG000|NOT COMPLETED|Overall Study||2
6520535|NCT01549041|7441466|FG001|NOT COMPLETED|Overall Study||8
6520536|NCT01549223|7441474|FG000|STARTED|Overall Study||30
6520537|NCT01549223|7441475|FG001|STARTED|Overall Study||30
6520538|NCT01549223|7441474|FG000|COMPLETED|Overall Study||30
6520539|NCT01549223|7441475|FG001|COMPLETED|Overall Study||30
6520540|NCT01549223|7441474|FG000|NOT COMPLETED|Overall Study||0
6520541|NCT01549223|7441475|FG001|NOT COMPLETED|Overall Study||0
6520542|NCT01549275|7441483|FG000|STARTED|Overall Study||76
6520543|NCT01549275|7441484|FG001|STARTED|Overall Study||29
6520544|NCT01549275|7441483|FG000|COMPLETED|Overall Study||75
6520545|NCT01549275|7441484|FG001|COMPLETED|Overall Study||29
6520546|NCT01549275|7441483|FG000|NOT COMPLETED|Overall Study||1
6520547|NCT01549275|7441484|FG001|NOT COMPLETED|Overall Study||0
6520548|NCT01549314|7441497|FG000|STARTED|Overall Study|1 subject signed the consent form but dropped out prior to any study procedures or data collection.|27
6520549|NCT01549314|7441498|FG001|STARTED|Overall Study||26
6520550|NCT01549314|7441499|FG002|STARTED|Overall Study||26
6520551|NCT01549314|7441497|FG000|COMPLETED|Overall Study||23
6520552|NCT01549314|7441498|FG001|COMPLETED|Overall Study||21
6520553|NCT01549314|7441499|FG002|COMPLETED|Overall Study||24
6520554|NCT01549314|7441497|FG000|NOT COMPLETED|Overall Study||4
6520555|NCT01549314|7441498|FG001|NOT COMPLETED|Overall Study||5
6520556|NCT01549314|7441499|FG002|NOT COMPLETED|Overall Study||2
6520557|NCT01549340|7441507|FG000|STARTED|Overall Study|Advised to receive AIT|8790
6520558|NCT01549340|7441507|FG000|Started AIT|Overall Study||3182
6520559|NCT01549340|7441507|FG000|COMPLETED|Overall Study|Completed 5 years of AIT|385
6520560|NCT01549340|7441507|FG000|NOT COMPLETED|Overall Study||8405
6520561|NCT01549392|7441518|FG000|STARTED|Overall Study||3
6520562|NCT01549392|7441519|FG001|STARTED|Overall Study||0
6520563|NCT01549392|7441518|FG000|COMPLETED|Overall Study||2
6520564|NCT01549392|7441519|FG001|COMPLETED|Overall Study||0
6520565|NCT01549392|7441518|FG000|NOT COMPLETED|Overall Study||1
6520566|NCT01549392|7441519|FG001|NOT COMPLETED|Overall Study||0
6520567|NCT01549405|7441527|FG000|STARTED|Overall Study||20
6520568|NCT01549405|7441528|FG001|STARTED|Overall Study||20
6520569|NCT01549405|7441527|FG000|COMPLETED|Overall Study||20
6520570|NCT01549405|7441528|FG001|COMPLETED|Overall Study||20
6520571|NCT01549405|7441527|FG000|NOT COMPLETED|Overall Study||0
6520572|NCT01549405|7441528|FG001|NOT COMPLETED|Overall Study||0
6520573|NCT01549587|7441538|FG000|STARTED|Overall Study||373
6520574|NCT01549587|7441539|FG001|STARTED|Overall Study||373
6520575|NCT01549587|7441538|FG000|COMPLETED|Overall Study||334
6520576|NCT01549587|7441539|FG001|COMPLETED|Overall Study||336
6520577|NCT01549587|7441538|FG000|NOT COMPLETED|Overall Study||39
6520578|NCT01549587|7441539|FG001|NOT COMPLETED|Overall Study||37
6520579|NCT01549613|7441547|FG000|STARTED|Overall Study||50
6520580|NCT01549613|7441548|FG001|STARTED|Overall Study||50
6520581|NCT01549613|7441547|FG000|COMPLETED|Overall Study||39
6520582|NCT01549613|7441548|FG001|COMPLETED|Overall Study||39
6520583|NCT01549613|7441547|FG000|NOT COMPLETED|Overall Study||11
6520584|NCT01549613|7441548|FG001|NOT COMPLETED|Overall Study||11
6520585|NCT01549652|7441557|FG000|STARTED|Overall Study||27
6520586|NCT01549652|7441558|FG001|STARTED|Overall Study||30
6520587|NCT01549652|7441559|FG002|STARTED|Overall Study||40
6520588|NCT01549652|7441560|FG003|STARTED|Overall Study||36
6520589|NCT01549652|7441557|FG000|COMPLETED|Overall Study||15
6520590|NCT01549652|7441558|FG001|COMPLETED|Overall Study||18
6520591|NCT01549652|7441559|FG002|COMPLETED|Overall Study||23
6520592|NCT01549652|7441560|FG003|COMPLETED|Overall Study||25
6520593|NCT01549652|7441557|FG000|NOT COMPLETED|Overall Study||12
6520594|NCT01549652|7441558|FG001|NOT COMPLETED|Overall Study||12
6520595|NCT01549652|7441559|FG002|NOT COMPLETED|Overall Study||17
6520596|NCT01549652|7441560|FG003|NOT COMPLETED|Overall Study||11
6520597|NCT01549860|7441568|FG000|STARTED|Overall Study||40
6520598|NCT01549860|7441569|FG001|STARTED|Overall Study||41
6520599|NCT01549860|7441568|FG000|COMPLETED|Overall Study||38
6520600|NCT01549860|7441569|FG001|COMPLETED|Overall Study||40
6520601|NCT01549860|7441568|FG000|NOT COMPLETED|Overall Study||2
6520602|NCT01549860|7441569|FG001|NOT COMPLETED|Overall Study||1
6520603|NCT01549873|7441577|FG000|STARTED|Overall Study||15
6520604|NCT01549873|7441578|FG001|STARTED|Overall Study||15
6520605|NCT01549873|7441577|FG000|COMPLETED|Overall Study||15
6520606|NCT01549873|7441578|FG001|COMPLETED|Overall Study||14
6520607|NCT01549873|7441577|FG000|NOT COMPLETED|Overall Study||0
6520608|NCT01549873|7441578|FG001|NOT COMPLETED|Overall Study||1
6520609|NCT01549886|7441586|FG000|STARTED|Overall Study||2
6520610|NCT01549886|7441587|FG001|STARTED|Overall Study||3
6520611|NCT01549886|7441586|FG000|COMPLETED|Overall Study||0
6520612|NCT01549886|7441587|FG001|COMPLETED|Overall Study||0
6520613|NCT01549886|7441586|FG000|NOT COMPLETED|Overall Study||2
6520614|NCT01549886|7441587|FG001|NOT COMPLETED|Overall Study||3
6520615|NCT01549925|7441597|FG000|STARTED|Overall Study||25
6520616|NCT01549925|7441598|FG001|STARTED|Overall Study||25
6520617|NCT01549925|7441597|FG000|COMPLETED|Overall Study||25
6520618|NCT01549925|7441598|FG001|COMPLETED|Overall Study||25
6520619|NCT01549925|7441597|FG000|NOT COMPLETED|Overall Study||0
6520620|NCT01549925|7441598|FG001|NOT COMPLETED|Overall Study||0
6520621|NCT01549951|7441604|FG000|STARTED|Overall Study||50
6520622|NCT01549951|7441604|FG000|Primary Reason Off Study Treatment|Overall Study||50
6520623|NCT01549951|7441604|FG000|COMPLETED|Overall Study||0
6520624|NCT01549951|7441604|FG000|NOT COMPLETED|Overall Study||50
6520625|NCT01549964|7441612|FG000|STARTED|24-Week Treatment Period||132
6520626|NCT01549964|7441613|FG001|STARTED|24-Week Treatment Period||260
6520627|NCT01549964|7441614|FG002|STARTED|24-Week Treatment Period||263
6520628|NCT01549964|7441615|FG003|STARTED|24-Week Treatment Period||261
6520629|NCT01549964|7441612|FG000|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
6520630|NCT01549964|7441613|FG001|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
6520631|NCT01549964|7441614|FG002|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
6520632|NCT01549964|7441615|FG003|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
6520633|NCT01549964|7441612|FG000|COMPLETED|24-Week Treatment Period||71
6520634|NCT01549964|7441613|FG001|COMPLETED|24-Week Treatment Period||149
6520635|NCT01549964|7441614|FG002|COMPLETED|24-Week Treatment Period||147
6520636|NCT01549964|7441615|FG003|COMPLETED|24-Week Treatment Period||140
6520637|NCT01549964|7441612|FG000|NOT COMPLETED|24-Week Treatment Period||61
6520638|NCT01549964|7441613|FG001|NOT COMPLETED|24-Week Treatment Period||111
6520639|NCT01549964|7441614|FG002|NOT COMPLETED|24-Week Treatment Period||116
6520640|NCT01549964|7441615|FG003|NOT COMPLETED|24-Week Treatment Period||121
6520641|NCT01549964|7441612|FG000|STARTED|80-Week Extension Period||66
6520642|NCT01549964|7441613|FG001|STARTED|80-Week Extension Period||138
6520643|NCT01549964|7441614|FG002|STARTED|80-Week Extension Period||140
6520644|NCT01549964|7441615|FG003|STARTED|80-Week Extension Period||137
6520645|NCT01549964|7441612|FG000|COMPLETED|80-Week Extension Period||0
6520646|NCT01549964|7441613|FG001|COMPLETED|80-Week Extension Period||0
6520647|NCT01549964|7441614|FG002|COMPLETED|80-Week Extension Period||0
6520648|NCT01549964|7441615|FG003|COMPLETED|80-Week Extension Period||0
6520649|NCT01549964|7441612|FG000|NOT COMPLETED|80-Week Extension Period||66
6520650|NCT01549964|7441613|FG001|NOT COMPLETED|80-Week Extension Period||138
6520651|NCT01549964|7441614|FG002|NOT COMPLETED|80-Week Extension Period||140
6520652|NCT01549964|7441615|FG003|NOT COMPLETED|80-Week Extension Period||137
6520653|NCT01550224|7441627|FG000|STARTED|Overall Study||3
6520654|NCT01550224|7441628|FG001|STARTED|Overall Study||20
6520655|NCT01550224|7441627|FG000|COMPLETED|Overall Study||3
6520656|NCT01550224|7441628|FG001|COMPLETED|Overall Study||20
6520657|NCT01550224|7441627|FG000|NOT COMPLETED|Overall Study||0
6520658|NCT01550224|7441628|FG001|NOT COMPLETED|Overall Study||0
6520659|NCT01550341|7441636|FG000|STARTED|Overall Study||32
6520660|NCT01550341|7441637|FG001|STARTED|Overall Study||18
6520661|NCT01550341|7441636|FG000|COMPLETED|Overall Study||32
6520662|NCT01550341|7441637|FG001|COMPLETED|Overall Study||18
6520663|NCT01550341|7441636|FG000|NOT COMPLETED|Overall Study||0
6520664|NCT01550341|7441637|FG001|NOT COMPLETED|Overall Study||0
6520665|NCT01550367|7441643|FG000|STARTED|Overall Study||30
6520666|NCT01550367|7441643|FG000|1200 mg/d HCQ|Overall Study||13
6520667|NCT01550367|7441643|FG000|600 mg/d HCQ|Overall Study||17
6520668|NCT01550367|7441643|FG000|COMPLETED|Overall Study||30
6520669|NCT01550367|7441643|FG000|NOT COMPLETED|Overall Study||0
6520670|NCT01550471|7441652|FG000|STARTED|Run-In Period (3 Weeks)||3
6520671|NCT01550471|7441653|FG001|STARTED|Run-In Period (3 Weeks)||4
6520672|NCT01550471|7441654|FG002|STARTED|Run-In Period (3 Weeks)||3
6520673|NCT01550471|7441655|FG003|STARTED|Run-In Period (3 Weeks)||4
6520674|NCT01550471|7441656|FG004|STARTED|Run-In Period (3 Weeks)||4
6520675|NCT01550471|7441657|FG005|STARTED|Run-In Period (3 Weeks)||4
6520676|NCT01550471|7441652|FG000|COMPLETED|Run-In Period (3 Weeks)||3
6520677|NCT01550471|7441653|FG001|COMPLETED|Run-In Period (3 Weeks)||4
6520678|NCT01550471|7441654|FG002|COMPLETED|Run-In Period (3 Weeks)||3
6520679|NCT01550471|7441655|FG003|COMPLETED|Run-In Period (3 Weeks)||4
6520680|NCT01550471|7441656|FG004|COMPLETED|Run-In Period (3 Weeks)||4
6520681|NCT01550471|7441657|FG005|COMPLETED|Run-In Period (3 Weeks)||4
6520682|NCT01550471|7441652|FG000|NOT COMPLETED|Run-In Period (3 Weeks)||0
6520683|NCT01550471|7441653|FG001|NOT COMPLETED|Run-In Period (3 Weeks)||0
6520684|NCT01550471|7441654|FG002|NOT COMPLETED|Run-In Period (3 Weeks)||0
6520685|NCT01550471|7441655|FG003|NOT COMPLETED|Run-In Period (3 Weeks)||0
6520686|NCT01550471|7441656|FG004|NOT COMPLETED|Run-In Period (3 Weeks)||0
6520687|NCT01550471|7441657|FG005|NOT COMPLETED|Run-In Period (3 Weeks)||0
6520688|NCT01550471|7441652|FG000|STARTED|First Treatment Period (3 Weeks)||3
6520689|NCT01550471|7441653|FG001|STARTED|First Treatment Period (3 Weeks)||4
6520690|NCT01550471|7441654|FG002|STARTED|First Treatment Period (3 Weeks)||3
6520691|NCT01550471|7441655|FG003|STARTED|First Treatment Period (3 Weeks)||4
6520692|NCT01550471|7441656|FG004|STARTED|First Treatment Period (3 Weeks)||4
6520693|NCT01550471|7441657|FG005|STARTED|First Treatment Period (3 Weeks)||4
6520694|NCT01550471|7441652|FG000|COMPLETED|First Treatment Period (3 Weeks)||3
6520695|NCT01550471|7441653|FG001|COMPLETED|First Treatment Period (3 Weeks)||4
6520696|NCT01550471|7441654|FG002|COMPLETED|First Treatment Period (3 Weeks)||3
6520697|NCT01550471|7441655|FG003|COMPLETED|First Treatment Period (3 Weeks)||4
6520698|NCT01550471|7441656|FG004|COMPLETED|First Treatment Period (3 Weeks)||4
6520699|NCT01550471|7441657|FG005|COMPLETED|First Treatment Period (3 Weeks)||4
6520700|NCT01550471|7441652|FG000|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6520701|NCT01550471|7441653|FG001|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6520702|NCT01550471|7441654|FG002|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6520703|NCT01550471|7441655|FG003|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6520704|NCT01550471|7441656|FG004|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6520705|NCT01550471|7441657|FG005|NOT COMPLETED|First Treatment Period (3 Weeks)||0
6520706|NCT01550471|7441652|FG000|STARTED|First Wash Out Period (3 Weeks)||3
6520707|NCT01550471|7441653|FG001|STARTED|First Wash Out Period (3 Weeks)||4
6520708|NCT01550471|7441654|FG002|STARTED|First Wash Out Period (3 Weeks)||3
6520709|NCT01550471|7441655|FG003|STARTED|First Wash Out Period (3 Weeks)||4
6520710|NCT01550471|7441656|FG004|STARTED|First Wash Out Period (3 Weeks)||4
6520711|NCT01550471|7441657|FG005|STARTED|First Wash Out Period (3 Weeks)||4
6520712|NCT01550471|7441652|FG000|COMPLETED|First Wash Out Period (3 Weeks)||3
6520713|NCT01550471|7441653|FG001|COMPLETED|First Wash Out Period (3 Weeks)||4
6520714|NCT01550471|7441654|FG002|COMPLETED|First Wash Out Period (3 Weeks)||3
6520715|NCT01550471|7441655|FG003|COMPLETED|First Wash Out Period (3 Weeks)||4
6520716|NCT01550471|7441656|FG004|COMPLETED|First Wash Out Period (3 Weeks)||4
6520717|NCT01550471|7441657|FG005|COMPLETED|First Wash Out Period (3 Weeks)||4
6520718|NCT01550471|7441652|FG000|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6520719|NCT01550471|7441653|FG001|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6520720|NCT01550471|7441654|FG002|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6520721|NCT01550471|7441655|FG003|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6520722|NCT01550471|7441656|FG004|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6520723|NCT01550471|7441657|FG005|NOT COMPLETED|First Wash Out Period (3 Weeks)||0
6520724|NCT01550471|7441652|FG000|STARTED|Second Treatment Period (3 Weeks)||3
6520725|NCT01550471|7441653|FG001|STARTED|Second Treatment Period (3 Weeks)||4
6520726|NCT01550471|7441654|FG002|STARTED|Second Treatment Period (3 Weeks)||3
6520727|NCT01550471|7441655|FG003|STARTED|Second Treatment Period (3 Weeks)||4
6520728|NCT01550471|7441656|FG004|STARTED|Second Treatment Period (3 Weeks)||4
6520729|NCT01550471|7441657|FG005|STARTED|Second Treatment Period (3 Weeks)||4
6520730|NCT01550471|7441652|FG000|COMPLETED|Second Treatment Period (3 Weeks)||3
6520731|NCT01550471|7441653|FG001|COMPLETED|Second Treatment Period (3 Weeks)||4
6520732|NCT01550471|7441654|FG002|COMPLETED|Second Treatment Period (3 Weeks)||3
6520733|NCT01550471|7441655|FG003|COMPLETED|Second Treatment Period (3 Weeks)||4
6520734|NCT01550471|7441656|FG004|COMPLETED|Second Treatment Period (3 Weeks)||4
6520735|NCT01550471|7441657|FG005|COMPLETED|Second Treatment Period (3 Weeks)||4
6520736|NCT01550471|7441652|FG000|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6520737|NCT01550471|7441653|FG001|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6520738|NCT01550471|7441654|FG002|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6520739|NCT01550471|7441655|FG003|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6520740|NCT01550471|7441656|FG004|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6520741|NCT01550471|7441657|FG005|NOT COMPLETED|Second Treatment Period (3 Weeks)||0
6520742|NCT01550471|7441652|FG000|STARTED|Second Wash Out Period (3 Weeks)||3
6520743|NCT01550471|7441653|FG001|STARTED|Second Wash Out Period (3 Weeks)||4
6520744|NCT01550471|7441654|FG002|STARTED|Second Wash Out Period (3 Weeks)||3
6520745|NCT01550471|7441655|FG003|STARTED|Second Wash Out Period (3 Weeks)||4
6520746|NCT01550471|7441656|FG004|STARTED|Second Wash Out Period (3 Weeks)||4
6520747|NCT01550471|7441657|FG005|STARTED|Second Wash Out Period (3 Weeks)||4
6520748|NCT01550471|7441652|FG000|COMPLETED|Second Wash Out Period (3 Weeks)||3
6520749|NCT01550471|7441653|FG001|COMPLETED|Second Wash Out Period (3 Weeks)||4
6520750|NCT01550471|7441654|FG002|COMPLETED|Second Wash Out Period (3 Weeks)||3
6520751|NCT01550471|7441655|FG003|COMPLETED|Second Wash Out Period (3 Weeks)||4
6520752|NCT01550471|7441656|FG004|COMPLETED|Second Wash Out Period (3 Weeks)||4
6520753|NCT01550471|7441657|FG005|COMPLETED|Second Wash Out Period (3 Weeks)||3
6520754|NCT01550471|7441652|FG000|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6520755|NCT01550471|7441653|FG001|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6520756|NCT01550471|7441654|FG002|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6520757|NCT01550471|7441655|FG003|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6520758|NCT01550471|7441656|FG004|NOT COMPLETED|Second Wash Out Period (3 Weeks)||0
6520759|NCT01550471|7441657|FG005|NOT COMPLETED|Second Wash Out Period (3 Weeks)||1
6520760|NCT01550471|7441652|FG000|STARTED|Third Treatment Period (3 Weeks)||3
6520761|NCT01550471|7441653|FG001|STARTED|Third Treatment Period (3 Weeks)||4
6520762|NCT01550471|7441654|FG002|STARTED|Third Treatment Period (3 Weeks)||3
6520763|NCT01550471|7441655|FG003|STARTED|Third Treatment Period (3 Weeks)||4
6520764|NCT01550471|7441656|FG004|STARTED|Third Treatment Period (3 Weeks)||4
6520765|NCT01550471|7441657|FG005|STARTED|Third Treatment Period (3 Weeks)||3
6520766|NCT01550471|7441652|FG000|COMPLETED|Third Treatment Period (3 Weeks)||3
6520767|NCT01550471|7441653|FG001|COMPLETED|Third Treatment Period (3 Weeks)||4
6520768|NCT01550471|7441654|FG002|COMPLETED|Third Treatment Period (3 Weeks)||3
6520769|NCT01550471|7441655|FG003|COMPLETED|Third Treatment Period (3 Weeks)||4
6642415|NCT02348658|7570825|FG001|NOT COMPLETED|Washout Period (22 Days)||0
6642416|NCT02348658|7570824|FG000|STARTED|Period 2 (7 Days)||6
6642417|NCT02348658|7570825|FG001|STARTED|Period 2 (7 Days)||6
6642418|NCT02348658|7570824|FG000|COMPLETED|Period 2 (7 Days)||6
6642419|NCT02348658|7570825|FG001|COMPLETED|Period 2 (7 Days)||6
6642420|NCT02348658|7570824|FG000|NOT COMPLETED|Period 2 (7 Days)||0
6642421|NCT02348658|7570825|FG001|NOT COMPLETED|Period 2 (7 Days)||0
6520770|NCT01550471|7441656|FG004|COMPLETED|Third Treatment Period (3 Weeks)||4
6520771|NCT01550471|7441657|FG005|COMPLETED|Third Treatment Period (3 Weeks)||3
6520772|NCT01550471|7441652|FG000|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6520773|NCT01550471|7441653|FG001|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6520774|NCT01550471|7441654|FG002|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6520775|NCT01550471|7441655|FG003|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6520776|NCT01550471|7441656|FG004|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6520777|NCT01550471|7441657|FG005|NOT COMPLETED|Third Treatment Period (3 Weeks)||0
6520778|NCT01550471|7441652|FG000|STARTED|Third Wash Out Period (3 Weeks)||3
6642422|NCT02348684|7570831|FG000|STARTED|Overall Study||20
6520779|NCT01550471|7441653|FG001|STARTED|Third Wash Out Period (3 Weeks)||4
6520780|NCT01550471|7441654|FG002|STARTED|Third Wash Out Period (3 Weeks)||3
6520781|NCT01550471|7441655|FG003|STARTED|Third Wash Out Period (3 Weeks)||4
6520782|NCT01550471|7441656|FG004|STARTED|Third Wash Out Period (3 Weeks)||4
6520783|NCT01550471|7441657|FG005|STARTED|Third Wash Out Period (3 Weeks)||3
6520784|NCT01550471|7441652|FG000|COMPLETED|Third Wash Out Period (3 Weeks)||3
6520785|NCT01550471|7441653|FG001|COMPLETED|Third Wash Out Period (3 Weeks)||4
6520786|NCT01550471|7441654|FG002|COMPLETED|Third Wash Out Period (3 Weeks)||3
6520787|NCT01550471|7441655|FG003|COMPLETED|Third Wash Out Period (3 Weeks)||4
6520788|NCT01550471|7441656|FG004|COMPLETED|Third Wash Out Period (3 Weeks)||4
6520789|NCT01550471|7441657|FG005|COMPLETED|Third Wash Out Period (3 Weeks)||3
6520790|NCT01550471|7441652|FG000|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6520791|NCT01550471|7441653|FG001|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6520792|NCT01550471|7441654|FG002|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6520793|NCT01550471|7441655|FG003|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6520794|NCT01550471|7441656|FG004|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6520795|NCT01550471|7441657|FG005|NOT COMPLETED|Third Wash Out Period (3 Weeks)||0
6520796|NCT01550549|7441666|FG000|STARTED|Overall Study||151
6520797|NCT01550549|7441666|FG000|COMPLETED|Overall Study||151
6520798|NCT01550549|7441666|FG000|NOT COMPLETED|Overall Study||0
6520799|NCT01550705|7441676|FG000|STARTED|Overall Study||11
6520800|NCT01550705|7441676|FG000|COMPLETED|Overall Study||10
6520801|NCT01550705|7441676|FG000|NOT COMPLETED|Overall Study||1
6520802|NCT01550731|7441682|FG000|STARTED|Overall Study||205
6520803|NCT01550731|7441683|FG001|STARTED|Overall Study||209
6520804|NCT01550731|7441682|FG000|COMPLETED|Overall Study||205
6520805|NCT01550731|7441683|FG001|COMPLETED|Overall Study||209
6520806|NCT01550731|7441682|FG000|NOT COMPLETED|Overall Study||0
6520807|NCT01550731|7441683|FG001|NOT COMPLETED|Overall Study||0
6520808|NCT01550744|7441689|FG000|STARTED|Open-Label||478
6520809|NCT01550744|7441690|FG001|STARTED|Open-Label||0
6520810|NCT01550744|7441691|FG002|STARTED|Open-Label||0
6520811|NCT01550744|7441689|FG000|COMPLETED|Open-Label||378
6520812|NCT01550744|7441690|FG001|COMPLETED|Open-Label||0
6520813|NCT01550744|7441691|FG002|COMPLETED|Open-Label||0
6520814|NCT01550744|7441689|FG000|NOT COMPLETED|Open-Label||100
6520815|NCT01550744|7441690|FG001|NOT COMPLETED|Open-Label||0
6520816|NCT01550744|7441691|FG002|NOT COMPLETED|Open-Label||0
6520817|NCT01550744|7441689|FG000|STARTED|Double-Blind||0
6520818|NCT01550744|7441690|FG001|STARTED|Double-Blind||76
6520819|NCT01550744|7441691|FG002|STARTED|Double-Blind||302
6520820|NCT01550744|7441689|FG000|COMPLETED|Double-Blind||0
6520821|NCT01550744|7441690|FG001|COMPLETED|Double-Blind||59
6520822|NCT01550744|7441691|FG002|COMPLETED|Double-Blind||235
6520823|NCT01550744|7441689|FG000|NOT COMPLETED|Double-Blind||0
6520824|NCT01550744|7441690|FG001|NOT COMPLETED|Double-Blind||17
6520825|NCT01550744|7441691|FG002|NOT COMPLETED|Double-Blind||67
6520826|NCT01550757|7441702|FG000|STARTED|Overall Study||56
6520827|NCT01550757|7441703|FG001|STARTED|Overall Study||52
6520828|NCT01550757|7441704|FG002|STARTED|Overall Study||130
6520829|NCT01550757|7441705|FG003|STARTED|Overall Study||144
6520830|NCT01550757|7441702|FG000|COMPLETED|Overall Study||33
6520831|NCT01550757|7441703|FG001|COMPLETED|Overall Study||38
6520832|NCT01550757|7441704|FG002|COMPLETED|Overall Study||85
6520833|NCT01550757|7441705|FG003|COMPLETED|Overall Study||90
6520834|NCT01550757|7441702|FG000|NOT COMPLETED|Overall Study||23
6520835|NCT01550757|7441703|FG001|NOT COMPLETED|Overall Study||14
6520836|NCT01550757|7441704|FG002|NOT COMPLETED|Overall Study||45
6520837|NCT01550757|7441705|FG003|NOT COMPLETED|Overall Study||54
6520838|NCT01550809|7441717|FG000|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
6520839|NCT01550809|7441718|FG001|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
6520840|NCT01550809|7441717|FG000|COMPLETED|Overall Study||6
6520841|NCT01550809|7441718|FG001|COMPLETED|Overall Study||6
6520842|NCT01550809|7441717|FG000|NOT COMPLETED|Overall Study||0
6520843|NCT01550809|7441718|FG001|NOT COMPLETED|Overall Study||0
6520844|NCT01550952|7441724|FG000|STARTED|Overall Study||10
6520845|NCT01550952|7441724|FG000|COMPLETED|Overall Study||10
6520846|NCT01550952|7441724|FG000|NOT COMPLETED|Overall Study||0
6520847|NCT01550965|7441728|FG000|STARTED|Overall Study||463
6520848|NCT01550965|7441728|FG000|COMPLETED|Overall Study||353
6520849|NCT01550965|7441728|FG000|NOT COMPLETED|Overall Study||110
6520850|NCT01551030|7441733|FG000|STARTED|Overall Study||19
6520851|NCT01551030|7441733|FG000|COMPLETED|Overall Study||19
6520852|NCT01551030|7441733|FG000|NOT COMPLETED|Overall Study||0
6520853|NCT01551056|7441739|FG000|STARTED|Overall Study||46
6520854|NCT01551056|7441740|FG001|STARTED|Overall Study||45
6520855|NCT01551056|7441739|FG000|COMPLETED|Overall Study||44
6520856|NCT01551056|7441740|FG001|COMPLETED|Overall Study||45
6520857|NCT01551056|7441739|FG000|NOT COMPLETED|Overall Study||2
6520858|NCT01551056|7441740|FG001|NOT COMPLETED|Overall Study||0
6520859|NCT01551095|7441746|FG000|STARTED|Overall Study||7
6520860|NCT01551095|7441746|FG000|COMPLETED|Overall Study||7
6520861|NCT01551095|7441746|FG000|NOT COMPLETED|Overall Study||0
6520862|NCT01551173|7441752|FG000|STARTED|Overall Study|"Started indicates randomized"|218
6520863|NCT01551173|7441753|FG001|STARTED|Overall Study||218
6520864|NCT01551173|7441752|FG000|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
6520865|NCT01551173|7441753|FG001|Full Analysis Set (FAS)|Overall Study||214
6520866|NCT01551173|7441752|FG000|COMPLETED|Overall Study||190
6520867|NCT01551173|7441753|FG001|COMPLETED|Overall Study||186
6520868|NCT01551173|7441752|FG000|NOT COMPLETED|Overall Study||28
6520869|NCT01551173|7441753|FG001|NOT COMPLETED|Overall Study||32
6520870|NCT01551186|7441762|FG000|STARTED|Overall Study||50
6520871|NCT01551186|7441763|FG001|STARTED|Overall Study||53
6520872|NCT01551186|7441762|FG000|COMPLETED|Overall Study||30
6520873|NCT01551186|7441763|FG001|COMPLETED|Overall Study||40
6520874|NCT01551186|7441762|FG000|NOT COMPLETED|Overall Study||20
6520875|NCT01551186|7441763|FG001|NOT COMPLETED|Overall Study||13
6520876|NCT01551199|7441769|FG000|STARTED|Overall Study||7
6520877|NCT01551199|7441769|FG000|COMPLETED|Overall Study||2
6520878|NCT01551199|7441769|FG000|NOT COMPLETED|Overall Study||5
6520879|NCT01551212|7441775|FG000|STARTED|Overall Study||171
6520880|NCT01551212|7441776|FG001|STARTED|Overall Study||168
6520881|NCT01551212|7441775|FG000|Full Anylsis Set (FAS)|Overall Study||169
6520882|NCT01551212|7441776|FG001|Full Anylsis Set (FAS)|Overall Study||164
6520883|NCT01551212|7441775|FG000|Safety Set|Overall Study||169
6520884|NCT01551212|7441776|FG001|Safety Set|Overall Study||164
6520885|NCT01551212|7441775|FG000|Per Protocol Set (PP)|Overall Study||110
6520886|NCT01551212|7441776|FG001|Per Protocol Set (PP)|Overall Study||101
6520887|NCT01551212|7441775|FG000|COMPLETED|Overall Study||166
6520888|NCT01551212|7441776|FG001|COMPLETED|Overall Study||148
6520889|NCT01551212|7441775|FG000|NOT COMPLETED|Overall Study||5
6520890|NCT01551212|7441776|FG001|NOT COMPLETED|Overall Study||20
6520891|NCT01551264|7441784|FG000|STARTED|Overall Study||70
6520892|NCT01551264|7441785|FG001|STARTED|Overall Study||69
6520893|NCT01551264|7441784|FG000|Started Bracing|Overall Study||69
6520894|NCT01551264|7441785|FG001|Started Bracing|Overall Study||67
6520895|NCT01551264|7441784|FG000|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|44
6520896|NCT01551264|7441785|FG001|Data for at Least One Follow-up After Brace Discontinuation Ascertained|Overall Study|Attended at least one visit within one year after discontinuing bracing|55
6520897|NCT01551264|7441784|FG000|COMPLETED|Overall Study|Attended 60 month follow-up visit|38
6520898|NCT01551264|7441785|FG001|COMPLETED|Overall Study|Attended 36 month follow-up visit|41
6520899|NCT01551264|7441784|FG000|NOT COMPLETED|Overall Study||32
6520900|NCT01551264|7441785|FG001|NOT COMPLETED|Overall Study||28
6520901|NCT01551303|7441793|FG000|STARTED|Overall Study||25
6520902|NCT01551303|7441794|FG001|STARTED|Overall Study||22
6520903|NCT01551303|7441793|FG000|COMPLETED|Overall Study||21
6520904|NCT01551303|7441794|FG001|COMPLETED|Overall Study||15
6520905|NCT01551303|7441793|FG000|NOT COMPLETED|Overall Study||4
6520906|NCT01551303|7441794|FG001|NOT COMPLETED|Overall Study||7
6520907|NCT01551355|7441806|FG000|STARTED|Overall Study||622
6520908|NCT01551355|7441807|FG001|STARTED|Overall Study||594
6520909|NCT01551355|7441808|FG002|STARTED|Overall Study||493
6520910|NCT01551355|7441809|FG003|STARTED|Overall Study||435
6520911|NCT01551355|7441810|FG004|STARTED|Overall Study||64
6520912|NCT01551355|7441811|FG005|STARTED|Overall Study||71
6520913|NCT01551355|7441806|FG000|COMPLETED|Overall Study||571
6642423|NCT02348684|7570831|FG000|COMPLETED|Overall Study||20
6642424|NCT02348684|7570831|FG000|NOT COMPLETED|Overall Study||0
6642425|NCT02348723|7570837|FG000|STARTED|Overall Study||338
6642426|NCT02348723|7570838|FG001|STARTED|Overall Study||338
6642427|NCT02348723|7570837|FG000|COMPLETED|Overall Study||310
6642428|NCT02348723|7570838|FG001|COMPLETED|Overall Study||312
6642429|NCT02348723|7570837|FG000|NOT COMPLETED|Overall Study||28
6642430|NCT02348723|7570838|FG001|NOT COMPLETED|Overall Study||26
6642431|NCT02348775|7570846|FG000|STARTED|Overall Study||8
6520914|NCT01551355|7441807|FG001|COMPLETED|Overall Study||545
6520915|NCT01551355|7441808|FG002|COMPLETED|Overall Study||459
6520916|NCT01551355|7441809|FG003|COMPLETED|Overall Study||411
6520917|NCT01551355|7441810|FG004|COMPLETED|Overall Study||55
6520918|NCT01551355|7441811|FG005|COMPLETED|Overall Study||65
6520919|NCT01551355|7441806|FG000|NOT COMPLETED|Overall Study||51
6520920|NCT01551355|7441807|FG001|NOT COMPLETED|Overall Study||49
6520921|NCT01551355|7441808|FG002|NOT COMPLETED|Overall Study||34
6520922|NCT01551355|7441809|FG003|NOT COMPLETED|Overall Study||24
6520923|NCT01551355|7441810|FG004|NOT COMPLETED|Overall Study||9
6520924|NCT01551355|7441811|FG005|NOT COMPLETED|Overall Study||6
6520925|NCT01551420|7441821|FG000|STARTED|In-laboratory (Part A)||39
6520926|NCT01551420|7441822|FG001|STARTED|In-laboratory (Part A)||13
6520927|NCT01551420|7441821|FG000|COMPLETED|In-laboratory (Part A)||33
6520928|NCT01551420|7441822|FG001|COMPLETED|In-laboratory (Part A)||11
6520929|NCT01551420|7441821|FG000|NOT COMPLETED|In-laboratory (Part A)||6
6520930|NCT01551420|7441822|FG001|NOT COMPLETED|In-laboratory (Part A)||2
6520931|NCT01551420|7441821|FG000|STARTED|Screened for Part B Eligibility||33
6520932|NCT01551420|7441822|FG001|STARTED|Screened for Part B Eligibility||11
6520933|NCT01551420|7441821|FG000|COMPLETED|Screened for Part B Eligibility||24
6520934|NCT01551420|7441822|FG001|COMPLETED|Screened for Part B Eligibility||8
6520935|NCT01551420|7441821|FG000|NOT COMPLETED|Screened for Part B Eligibility||9
6520936|NCT01551420|7441822|FG001|NOT COMPLETED|Screened for Part B Eligibility||3
6520937|NCT01551420|7441821|FG000|STARTED|Home Use (Part B)||24
6520938|NCT01551420|7441822|FG001|STARTED|Home Use (Part B)||8
6520939|NCT01551420|7441821|FG000|COMPLETED|Home Use (Part B)||18
6642432|NCT02348775|7570847|FG001|STARTED|Overall Study||8
6520940|NCT01551420|7441822|FG001|COMPLETED|Home Use (Part B)||7
6642433|NCT02348775|7570846|FG000|COMPLETED|Overall Study||8
6520941|NCT01551420|7441821|FG000|NOT COMPLETED|Home Use (Part B)||6
6520942|NCT01551420|7441822|FG001|NOT COMPLETED|Home Use (Part B)||1
6520943|NCT01551550|7441830|FG000|STARTED|Overall Study||41
6520944|NCT01551550|7441831|FG001|STARTED|Overall Study||41
6520945|NCT01551550|7441830|FG000|COMPLETED|Overall Study||41
6520946|NCT01551550|7441831|FG001|COMPLETED|Overall Study||40
6520947|NCT01551550|7441830|FG000|NOT COMPLETED|Overall Study||0
6520948|NCT01551550|7441831|FG001|NOT COMPLETED|Overall Study||1
6520949|NCT01551693|7441839|FG000|STARTED|Overall Study||1
6520950|NCT01551693|7441840|FG001|STARTED|Overall Study||2
6520951|NCT01551693|7441839|FG000|COMPLETED|Overall Study||0
6520952|NCT01551693|7441840|FG001|COMPLETED|Overall Study||0
6520953|NCT01551693|7441839|FG000|NOT COMPLETED|Overall Study||1
6520954|NCT01551693|7441840|FG001|NOT COMPLETED|Overall Study||2
6520955|NCT01551745|7441846|FG000|STARTED|Overall Study||5
6520956|NCT01551745|7441846|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses"|2
6520957|NCT01551745|7441846|FG000|NOT COMPLETED|Overall Study||3
6520958|NCT01551758|7441852|FG000|STARTED|Overall Study||1403
6520959|NCT01551758|7441853|FG001|STARTED|Overall Study||1396
6520960|NCT01551758|7441852|FG000|COMPLETED|Overall Study||1309
6520961|NCT01551758|7441853|FG001|COMPLETED|Overall Study||1291
6520962|NCT01551758|7441852|FG000|NOT COMPLETED|Overall Study||94
6520963|NCT01551758|7441853|FG001|NOT COMPLETED|Overall Study||105
6520964|NCT01551888|7441863|FG000|STARTED|Period 1||12
6520965|NCT01551888|7441864|FG001|STARTED|Period 1||12
6520966|NCT01551888|7441863|FG000|COMPLETED|Period 1||12
6520967|NCT01551888|7441864|FG001|COMPLETED|Period 1||12
6520968|NCT01551888|7441863|FG000|NOT COMPLETED|Period 1||0
6520969|NCT01551888|7441864|FG001|NOT COMPLETED|Period 1||0
6520970|NCT01551888|7441863|FG000|STARTED|Period 2||12
6520971|NCT01551888|7441864|FG001|STARTED|Period 2||12
6520972|NCT01551888|7441863|FG000|COMPLETED|Period 2||12
6520973|NCT01551888|7441864|FG001|COMPLETED|Period 2||12
6520974|NCT01551888|7441863|FG000|NOT COMPLETED|Period 2||0
6520975|NCT01551888|7441864|FG001|NOT COMPLETED|Period 2||0
6520976|NCT01551979|7441872|FG000|STARTED|Overall Study||10
6520977|NCT01551979|7441873|FG001|STARTED|Overall Study||7
6520978|NCT01551979|7441872|FG000|Last Day of Treatment (After 5 Days)|Overall Study||10
6520979|NCT01551979|7441873|FG001|Last Day of Treatment (After 5 Days)|Overall Study||7
6520980|NCT01551979|7441872|FG000|1 Week Post Treatment|Overall Study||10
6520981|NCT01551979|7441873|FG001|1 Week Post Treatment|Overall Study||6
6520982|NCT01551979|7441872|FG000|COMPLETED|Overall Study||8
6520983|NCT01551979|7441873|FG001|COMPLETED|Overall Study||5
6520984|NCT01551979|7441872|FG000|NOT COMPLETED|Overall Study||2
6520985|NCT01551979|7441873|FG001|NOT COMPLETED|Overall Study||2
6520986|NCT01552057|7441881|FG000|STARTED|Overall Study||196
6520987|NCT01552057|7441882|FG001|STARTED|Overall Study||197
6520988|NCT01552057|7441881|FG000|Received at Least 1 Dose of Study Drug|Overall Study||194
6520989|NCT01552057|7441882|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
6520990|NCT01552057|7441881|FG000|COMPLETED|Overall Study||166
6520991|NCT01552057|7441882|FG001|COMPLETED|Overall Study||149
6520992|NCT01552057|7441881|FG000|NOT COMPLETED|Overall Study||30
6520993|NCT01552057|7441882|FG001|NOT COMPLETED|Overall Study||48
6520994|NCT01552213|7441890|FG000|STARTED|Overall Study||50
6520995|NCT01552213|7441891|FG001|STARTED|Overall Study||45
6520996|NCT01552213|7441890|FG000|Analyzed|Overall Study||42
6520997|NCT01552213|7441891|FG001|Analyzed|Overall Study||41
6520998|NCT01552213|7441890|FG000|COMPLETED|Overall Study||37
6520999|NCT01552213|7441891|FG001|COMPLETED|Overall Study||37
6521000|NCT01552213|7441890|FG000|NOT COMPLETED|Overall Study||13
6521001|NCT01552213|7441891|FG001|NOT COMPLETED|Overall Study||8
6521002|NCT01552343|7441899|FG000|STARTED|Overall Study||29
6521003|NCT01552343|7441900|FG001|STARTED|Overall Study||27
6521004|NCT01552343|7441899|FG000|COMPLETED|Overall Study||29
6521005|NCT01552343|7441900|FG001|COMPLETED|Overall Study||27
6521006|NCT01552343|7441899|FG000|NOT COMPLETED|Overall Study||0
6521007|NCT01552343|7441900|FG001|NOT COMPLETED|Overall Study||0
6521008|NCT01552369|7441917|FG000|STARTED|Overall Study||100
6521009|NCT01552369|7441918|FG001|STARTED|Overall Study||105
6521010|NCT01552369|7441917|FG000|One Year|Overall Study||100
6521011|NCT01552369|7441918|FG001|One Year|Overall Study||105
6521012|NCT01552369|7441917|FG000|Final Follow up|Overall Study||92
6521013|NCT01552369|7441918|FG001|Final Follow up|Overall Study||96
6521014|NCT01552369|7441917|FG000|COMPLETED|Overall Study||92
6521015|NCT01552369|7441918|FG001|COMPLETED|Overall Study||96
6521016|NCT01552369|7441917|FG000|NOT COMPLETED|Overall Study||8
6521017|NCT01552369|7441918|FG001|NOT COMPLETED|Overall Study||9
6521018|NCT01552408|7441928|FG000|STARTED|Overall Study||20
6521019|NCT01552408|7441929|FG001|STARTED|Overall Study||20
6521020|NCT01552408|7441928|FG000|COMPLETED|Overall Study||16
6521021|NCT01552408|7441929|FG001|COMPLETED|Overall Study||18
6521022|NCT01552408|7441928|FG000|NOT COMPLETED|Overall Study||4
6521023|NCT01552408|7441929|FG001|NOT COMPLETED|Overall Study||2
6521024|NCT01552603|7441936|FG000|STARTED|Overall Study||14
6521025|NCT01552603|7441936|FG000|COMPLETED|Overall Study||13
6521026|NCT01552603|7441936|FG000|NOT COMPLETED|Overall Study||1
6521027|NCT01552681|7441942|FG000|STARTED|Overall Study||33
6521028|NCT01552681|7441943|FG001|STARTED|Overall Study||19
6521029|NCT01552681|7441942|FG000|COMPLETED|Overall Study||28
6521030|NCT01552681|7441943|FG001|COMPLETED|Overall Study||18
6521031|NCT01552681|7441942|FG000|NOT COMPLETED|Overall Study||5
6521032|NCT01552681|7441943|FG001|NOT COMPLETED|Overall Study||1
6521033|NCT01552694|7441951|FG000|STARTED|Overall Study||18
6521034|NCT01552694|7441952|FG001|STARTED|Overall Study||20
6521035|NCT01552694|7441951|FG000|COMPLETED|Overall Study||18
6521036|NCT01552694|7441952|FG001|COMPLETED|Overall Study||18
6521037|NCT01552694|7441951|FG000|NOT COMPLETED|Overall Study||0
6521038|NCT01552694|7441952|FG001|NOT COMPLETED|Overall Study||2
6521039|NCT01552772|7441958|FG000|STARTED|Overall Study||60
6521040|NCT01552772|7441958|FG000|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
6521041|NCT01552772|7441958|FG000|NOT COMPLETED|Overall Study||4
6521042|NCT01552876|7441963|FG000|STARTED|Overall Study||20
6521043|NCT01552876|7441964|FG001|STARTED|Overall Study||20
6521044|NCT01552876|7441963|FG000|COMPLETED|Overall Study||20
6521045|NCT01552876|7441964|FG001|COMPLETED|Overall Study||20
6521046|NCT01552876|7441963|FG000|NOT COMPLETED|Overall Study||0
6521047|NCT01552876|7441964|FG001|NOT COMPLETED|Overall Study||0
6521048|NCT01552889|7441978|FG000|STARTED|Overall Study||101
6521049|NCT01552889|7441979|FG001|STARTED|Overall Study||100
6521050|NCT01552889|7441978|FG000|COMPLETED|Overall Study||90
6521051|NCT01552889|7441979|FG001|COMPLETED|Overall Study||95
6521052|NCT01552889|7441978|FG000|NOT COMPLETED|Overall Study||11
6521053|NCT01552889|7441979|FG001|NOT COMPLETED|Overall Study||5
6521054|NCT01552902|7441990|FG000|STARTED|Overall Study||110
6521055|NCT01552902|7441991|FG001|STARTED|Overall Study||218
6521056|NCT01552902|7441992|FG002|STARTED|Overall Study||219
6521057|NCT01552902|7441990|FG000|COMPLETED|Overall Study||97
6521058|NCT01552902|7441991|FG001|COMPLETED|Overall Study||181
6521059|NCT01552902|7441992|FG002|COMPLETED|Overall Study||186
6521060|NCT01552902|7441990|FG000|NOT COMPLETED|Overall Study||13
6521061|NCT01552902|7441991|FG001|NOT COMPLETED|Overall Study||37
6521062|NCT01552902|7441992|FG002|NOT COMPLETED|Overall Study||33
6521063|NCT01552915|7442003|FG000|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
6521064|NCT01552915|7442004|FG001|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
6521065|NCT01552915|7442005|FG002|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
6521066|NCT01552915|7442003|FG000|COMPLETED|Overall Study||68
6521067|NCT01552915|7442004|FG001|COMPLETED|Overall Study||155
6521068|NCT01552915|7442005|FG002|COMPLETED|Overall Study||157
6521069|NCT01552915|7442003|FG000|NOT COMPLETED|Overall Study||23
6521070|NCT01552915|7442004|FG001|NOT COMPLETED|Overall Study||29
6521071|NCT01552915|7442005|FG002|NOT COMPLETED|Overall Study||27
6521072|NCT01552928|7442017|FG000|STARTED|Period 1||14
6521073|NCT01552928|7442018|FG001|STARTED|Period 1||15
6521074|NCT01552928|7442019|FG002|STARTED|Period 1||15
6521075|NCT01552928|7442020|FG003|STARTED|Period 1||16
6521076|NCT01552928|7442017|FG000|COMPLETED|Period 1||14
6521077|NCT01552928|7442018|FG001|COMPLETED|Period 1||15
6521078|NCT01552928|7442019|FG002|COMPLETED|Period 1||15
6521079|NCT01552928|7442020|FG003|COMPLETED|Period 1||16
6521080|NCT01552928|7442017|FG000|NOT COMPLETED|Period 1||0
6521081|NCT01552928|7442018|FG001|NOT COMPLETED|Period 1||0
6521082|NCT01552928|7442019|FG002|NOT COMPLETED|Period 1||0
6521083|NCT01552928|7442020|FG003|NOT COMPLETED|Period 1||0
6521084|NCT01552928|7442017|FG000|STARTED|Period 2||14
6521085|NCT01552928|7442018|FG001|STARTED|Period 2||15
6521086|NCT01552928|7442019|FG002|STARTED|Period 2||15
6521087|NCT01552928|7442020|FG003|STARTED|Period 2||16
6521088|NCT01552928|7442017|FG000|COMPLETED|Period 2||14
6521089|NCT01552928|7442018|FG001|COMPLETED|Period 2||15
6521090|NCT01552928|7442019|FG002|COMPLETED|Period 2||15
6521091|NCT01552928|7442020|FG003|COMPLETED|Period 2||16
6521092|NCT01552928|7442017|FG000|NOT COMPLETED|Period 2||0
6521093|NCT01552928|7442018|FG001|NOT COMPLETED|Period 2||0
6642434|NCT02348775|7570847|FG001|COMPLETED|Overall Study||8
6642435|NCT02348775|7570846|FG000|NOT COMPLETED|Overall Study||0
6642436|NCT02348775|7570847|FG001|NOT COMPLETED|Overall Study||0
6642437|NCT02348840|7570857|FG000|STARTED|Overall Study||23
6642438|NCT02348840|7570858|FG001|STARTED|Overall Study||21
6642439|NCT02348840|7570859|FG002|STARTED|Overall Study||425
6642440|NCT02348840|7570860|FG003|STARTED|Overall Study||374
6642441|NCT02348840|7570857|FG000|COMPLETED|Overall Study||21
6642442|NCT02348840|7570858|FG001|COMPLETED|Overall Study||20
6642443|NCT02348840|7570859|FG002|COMPLETED|Overall Study||425
6642444|NCT02348840|7570860|FG003|COMPLETED|Overall Study||374
6642445|NCT02348840|7570857|FG000|NOT COMPLETED|Overall Study||2
6642446|NCT02348840|7570858|FG001|NOT COMPLETED|Overall Study||1
6642447|NCT02348840|7570859|FG002|NOT COMPLETED|Overall Study||0
6642448|NCT02348840|7570860|FG003|NOT COMPLETED|Overall Study||0
6642449|NCT02348918|7570879|FG000|STARTED|Overall Study||39
6642450|NCT02348918|7570880|FG001|STARTED|Overall Study||33
6642451|NCT02348918|7570881|FG002|STARTED|Overall Study||42
6521094|NCT01552928|7442019|FG002|NOT COMPLETED|Period 2||0
6521095|NCT01552928|7442020|FG003|NOT COMPLETED|Period 2||0
6521096|NCT01552928|7442017|FG000|STARTED|Period 3||14
6521097|NCT01552928|7442018|FG001|STARTED|Period 3||15
6521098|NCT01552928|7442019|FG002|STARTED|Period 3||15
6521099|NCT01552928|7442020|FG003|STARTED|Period 3||16
6521100|NCT01552928|7442017|FG000|COMPLETED|Period 3||14
6521101|NCT01552928|7442018|FG001|COMPLETED|Period 3||15
6521102|NCT01552928|7442019|FG002|COMPLETED|Period 3||14
6642452|NCT02348918|7570882|FG003|STARTED|Overall Study||24
6642453|NCT02348918|7570883|FG004|STARTED|Overall Study||19
6642454|NCT02348918|7570884|FG005|STARTED|Overall Study||17
6521103|NCT01552928|7442020|FG003|COMPLETED|Period 3||16
6521104|NCT01552928|7442017|FG000|NOT COMPLETED|Period 3||0
6521105|NCT01552928|7442018|FG001|NOT COMPLETED|Period 3||0
6521106|NCT01552928|7442019|FG002|NOT COMPLETED|Period 3||1
6521107|NCT01552928|7442020|FG003|NOT COMPLETED|Period 3||0
6521108|NCT01552928|7442017|FG000|STARTED|Period 4||14
6521109|NCT01552928|7442018|FG001|STARTED|Period 4||15
6521110|NCT01552928|7442019|FG002|STARTED|Period 4||14
6521111|NCT01552928|7442020|FG003|STARTED|Period 4||16
6521112|NCT01552928|7442017|FG000|COMPLETED|Period 4||14
6521113|NCT01552928|7442018|FG001|COMPLETED|Period 4||15
6521114|NCT01552928|7442019|FG002|COMPLETED|Period 4||14
6521115|NCT01552928|7442020|FG003|COMPLETED|Period 4||16
6521116|NCT01552928|7442017|FG000|NOT COMPLETED|Period 4||0
6521117|NCT01552928|7442018|FG001|NOT COMPLETED|Period 4||0
6521118|NCT01552928|7442019|FG002|NOT COMPLETED|Period 4||0
6521119|NCT01552928|7442020|FG003|NOT COMPLETED|Period 4||0
6521120|NCT01552954|7442039|FG000|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
6521121|NCT01552954|7442040|FG001|STARTED|Overall Study||125
6521122|NCT01552954|7442039|FG000|COMPLETED|Overall Study||126
6521123|NCT01552954|7442040|FG001|COMPLETED|Overall Study||119
6521124|NCT01552954|7442039|FG000|NOT COMPLETED|Overall Study||5
6521125|NCT01552954|7442040|FG001|NOT COMPLETED|Overall Study||6
6521126|NCT01553058|7442049|FG000|STARTED|Overall Study||33
6642455|NCT02348918|7570885|FG006|STARTED|Overall Study||13
6642456|NCT02348918|7570886|FG007|STARTED|Overall Study||16
6642457|NCT02348918|7570887|FG008|STARTED|Overall Study||15
6642458|NCT02348918|7570879|FG000|COMPLETED|Overall Study||39
6642459|NCT02348918|7570880|FG001|COMPLETED|Overall Study||33
6642460|NCT02348918|7570881|FG002|COMPLETED|Overall Study||42
6642461|NCT02348918|7570882|FG003|COMPLETED|Overall Study||24
6642462|NCT02348918|7570883|FG004|COMPLETED|Overall Study||19
6521127|NCT01553058|7442050|FG001|STARTED|Overall Study||31
6521128|NCT01553058|7442051|FG002|STARTED|Overall Study||33
6521129|NCT01553058|7442049|FG000|COMPLETED|Overall Study||32
6521130|NCT01553058|7442050|FG001|COMPLETED|Overall Study||30
6521131|NCT01553058|7442051|FG002|COMPLETED|Overall Study||30
6521132|NCT01553058|7442049|FG000|NOT COMPLETED|Overall Study||1
6521133|NCT01553058|7442050|FG001|NOT COMPLETED|Overall Study||1
6521134|NCT01553058|7442051|FG002|NOT COMPLETED|Overall Study||3
6521135|NCT01553084|7442066|FG000|STARTED|Overall Study||241
6521136|NCT01553084|7442067|FG001|STARTED|Overall Study||421
6521137|NCT01553084|7442068|FG002|STARTED|Overall Study||424
6521138|NCT01553084|7442066|FG000|COMPLETED|Overall Study||226
6521139|NCT01553084|7442067|FG001|COMPLETED|Overall Study||408
6521140|NCT01553084|7442068|FG002|COMPLETED|Overall Study||389
6521141|NCT01553084|7442066|FG000|NOT COMPLETED|Overall Study||15
6521142|NCT01553084|7442067|FG001|NOT COMPLETED|Overall Study||13
6521143|NCT01553084|7442068|FG002|NOT COMPLETED|Overall Study||35
6521144|NCT01553136|7442080|FG000|STARTED|Overall Study||64
6521145|NCT01553136|7442081|FG001|STARTED|Overall Study||67
6521146|NCT01553136|7442080|FG000|Completed Treatment|Overall Study||55
6521147|NCT01553136|7442081|FG001|Completed Treatment|Overall Study||52
6521148|NCT01553136|7442080|FG000|COMPLETED|Overall Study||48
6521149|NCT01553136|7442081|FG001|COMPLETED|Overall Study||45
6521150|NCT01553136|7442080|FG000|NOT COMPLETED|Overall Study||16
6521151|NCT01553136|7442081|FG001|NOT COMPLETED|Overall Study||22
6521152|NCT01553188|7442091|FG000|STARTED|Overall Study||3
6521153|NCT01553188|7442092|FG001|STARTED|Overall Study||6
6521154|NCT01553188|7442093|FG002|STARTED|Overall Study||16
6521155|NCT01553188|7442094|FG003|STARTED|Overall Study||11
6521156|NCT01553188|7442091|FG000|COMPLETED|Overall Study||2
6521157|NCT01553188|7442092|FG001|COMPLETED|Overall Study||5
6521158|NCT01553188|7442093|FG002|COMPLETED|Overall Study||14
6521159|NCT01553188|7442094|FG003|COMPLETED|Overall Study||11
6521160|NCT01553188|7442091|FG000|NOT COMPLETED|Overall Study||1
6521161|NCT01553188|7442092|FG001|NOT COMPLETED|Overall Study||1
6521162|NCT01553188|7442093|FG002|NOT COMPLETED|Overall Study||2
6521163|NCT01553188|7442094|FG003|NOT COMPLETED|Overall Study||0
6521164|NCT01553201|7442109|FG000|STARTED|Overall Study||15
6521165|NCT01553201|7442110|FG001|STARTED|Overall Study||15
6743634|NCT03335254|7671811|FG001|STARTED|Period 2, Day 1-15||0
6743635|NCT03335254|7671812|FG002|STARTED|Period 2, Day 1-15||0
6743636|NCT03335254|7671813|FG003|STARTED|Period 2, Day 1-15||0
6521166|NCT01553201|7442109|FG000|COMPLETED|Overall Study||15
6521167|NCT01553201|7442110|FG001|COMPLETED|Overall Study||15
6521168|NCT01553201|7442109|FG000|NOT COMPLETED|Overall Study||0
6521169|NCT01553201|7442110|FG001|NOT COMPLETED|Overall Study||0
6521170|NCT01553279|7442118|FG000|STARTED|Part 1 (Infant Vaccinations)||142
6521171|NCT01553279|7442119|FG001|STARTED|Part 1 (Infant Vaccinations)||142
6521172|NCT01553279|7442118|FG000|COMPLETED|Part 1 (Infant Vaccinations)||140
6521173|NCT01553279|7442119|FG001|COMPLETED|Part 1 (Infant Vaccinations)||141
6521174|NCT01553279|7442118|FG000|NOT COMPLETED|Part 1 (Infant Vaccinations)||2
6521175|NCT01553279|7442119|FG001|NOT COMPLETED|Part 1 (Infant Vaccinations)||1
6521176|NCT01553279|7442118|FG000|STARTED|Interim Period||140
6521177|NCT01553279|7442119|FG001|STARTED|Interim Period||141
6521178|NCT01553279|7442118|FG000|COMPLETED|Interim Period||137
6521179|NCT01553279|7442119|FG001|COMPLETED|Interim Period||139
6521180|NCT01553279|7442118|FG000|NOT COMPLETED|Interim Period||3
6521181|NCT01553279|7442119|FG001|NOT COMPLETED|Interim Period||2
6521182|NCT01553279|7442118|FG000|STARTED|Period 2: Toddler Vaccinations||137
6642463|NCT02348918|7570884|FG005|COMPLETED|Overall Study||17
6743637|NCT03335254|7671814|FG004|STARTED|Period 2, Day 1-15||0
6743638|NCT03335254|7671815|FG005|STARTED|Period 2, Day 1-15||0
6743639|NCT03335254|7671816|FG006|STARTED|Period 2, Day 1-15||0
6743640|NCT03335254|7671817|FG007|STARTED|Period 2, Day 1-15||0
6521183|NCT01553279|7442119|FG001|STARTED|Period 2: Toddler Vaccinations||139
6521184|NCT01553279|7442118|FG000|COMPLETED|Period 2: Toddler Vaccinations||134
6521185|NCT01553279|7442119|FG001|COMPLETED|Period 2: Toddler Vaccinations||132
6521186|NCT01553279|7442118|FG000|NOT COMPLETED|Period 2: Toddler Vaccinations||3
6521187|NCT01553279|7442119|FG001|NOT COMPLETED|Period 2: Toddler Vaccinations||7
6521188|NCT01553292|7442126|FG000|STARTED|Overall Study||21
6521189|NCT01553292|7442126|FG000|COMPLETED|Overall Study||21
6521190|NCT01553292|7442126|FG000|NOT COMPLETED|Overall Study||0
6521191|NCT01553318|7442134|FG000|STARTED|Overall Study||24
6521192|NCT01553318|7442135|FG001|STARTED|Overall Study||27
6521193|NCT01553318|7442134|FG000|COMPLETED|Overall Study||21
6521194|NCT01553318|7442135|FG001|COMPLETED|Overall Study||25
6521195|NCT01553318|7442134|FG000|NOT COMPLETED|Overall Study||3
6521196|NCT01553318|7442135|FG001|NOT COMPLETED|Overall Study||2
6521197|NCT01553539|7442143|FG000|STARTED|Overall Study||20
6521198|NCT01553539|7442143|FG000|COMPLETED|Overall Study||20
6521199|NCT01553539|7442143|FG000|NOT COMPLETED|Overall Study||0
6521200|NCT01553591|7442150|FG000|STARTED|Overall Study||429
6521201|NCT01553591|7442151|FG001|STARTED|Overall Study||426
6521202|NCT01553591|7442152|FG002|STARTED|Overall Study||427
6521203|NCT01553591|7442150|FG000|Attended Week 12 Visit|Overall Study||341
6521204|NCT01553591|7442151|FG001|Attended Week 12 Visit|Overall Study||330
6521205|NCT01553591|7442152|FG002|Attended Week 12 Visit|Overall Study||342
6521206|NCT01553591|7442150|FG000|Attended Week 26 Visit|Overall Study||289
6521207|NCT01553591|7442151|FG001|Attended Week 26 Visit|Overall Study||291
6521208|NCT01553591|7442152|FG002|Attended Week 26 Visit|Overall Study||290
6521209|NCT01553591|7442150|FG000|COMPLETED|Overall Study||257
6521210|NCT01553591|7442151|FG001|COMPLETED|Overall Study||257
6521211|NCT01553591|7442152|FG002|COMPLETED|Overall Study||269
6521212|NCT01553591|7442150|FG000|NOT COMPLETED|Overall Study||172
6521213|NCT01553591|7442151|FG001|NOT COMPLETED|Overall Study||169
6521214|NCT01553591|7442152|FG002|NOT COMPLETED|Overall Study||158
6521215|NCT01553708|7442162|FG000|STARTED|Overall Study||17
6521216|NCT01553708|7442163|FG001|STARTED|Overall Study||17
6521217|NCT01553708|7442162|FG000|COMPLETED|Overall Study||17
6521218|NCT01553708|7442163|FG001|COMPLETED|Overall Study||17
6521219|NCT01553708|7442162|FG000|NOT COMPLETED|Overall Study||0
6521220|NCT01553708|7442163|FG001|NOT COMPLETED|Overall Study||0
6521221|NCT01553747|7442172|FG000|STARTED|Overall Study||381
6521222|NCT01553747|7442173|FG001|STARTED|Overall Study||383
6521223|NCT01553747|7442174|FG002|STARTED|Overall Study||382
6521224|NCT01553747|7442172|FG000|Attended Week 12 Visit|Overall Study||296
6521225|NCT01553747|7442173|FG001|Attended Week 12 Visit|Overall Study||301
6521226|NCT01553747|7442174|FG002|Attended Week 12 Visit|Overall Study||312
6521227|NCT01553747|7442172|FG000|Attended Week 26 Visit|Overall Study||259
6521228|NCT01553747|7442173|FG001|Attended Week 26 Visit|Overall Study||271
6521229|NCT01553747|7442174|FG002|Attended Week 26 Visit|Overall Study||278
6521230|NCT01553747|7442172|FG000|Participated in Blinded-Placebo Period|Overall Study||246
6521231|NCT01553747|7442173|FG001|Participated in Blinded-Placebo Period|Overall Study||253
6521232|NCT01553747|7442174|FG002|Participated in Blinded-Placebo Period|Overall Study||272
6521233|NCT01553747|7442172|FG000|COMPLETED|Overall Study||250
6521234|NCT01553747|7442173|FG001|COMPLETED|Overall Study||264
6521235|NCT01553747|7442174|FG002|COMPLETED|Overall Study||273
6521236|NCT01553747|7442172|FG000|NOT COMPLETED|Overall Study||131
6521237|NCT01553747|7442173|FG001|NOT COMPLETED|Overall Study||119
6521238|NCT01553747|7442174|FG002|NOT COMPLETED|Overall Study||109
6521239|NCT01553851|7442185|FG000|STARTED|Overall Study||20
6521240|NCT01553851|7442185|FG000|COMPLETED|Overall Study||17
6521241|NCT01553851|7442185|FG000|NOT COMPLETED|Overall Study||3
6521242|NCT01553916|7442189|FG000|STARTED|Overall Study||19
6521243|NCT01553916|7442189|FG000|COMPLETED|Overall Study||16
6521244|NCT01553916|7442189|FG000|NOT COMPLETED|Overall Study||3
6521245|NCT01554176|7442195|FG000|STARTED|Treatment Phase||65
6521246|NCT01554176|7442196|FG001|STARTED|Treatment Phase||64
6521247|NCT01554176|7442197|FG002|STARTED|Treatment Phase||0
6521248|NCT01554176|7442198|FG003|STARTED|Treatment Phase||0
6521249|NCT01554176|7442199|FG004|STARTED|Treatment Phase||0
6521250|NCT01554176|7442195|FG000|Treated|Treatment Phase||64
6521251|NCT01554176|7442196|FG001|Treated|Treatment Phase||64
6521252|NCT01554176|7442197|FG002|Treated|Treatment Phase||0
6521253|NCT01554176|7442198|FG003|Treated|Treatment Phase||0
6521254|NCT01554176|7442199|FG004|Treated|Treatment Phase||0
6521255|NCT01554176|7442195|FG000|COMPLETED|Treatment Phase||57
6521256|NCT01554176|7442196|FG001|COMPLETED|Treatment Phase||59
6521257|NCT01554176|7442197|FG002|COMPLETED|Treatment Phase||0
6521258|NCT01554176|7442198|FG003|COMPLETED|Treatment Phase||0
6521259|NCT01554176|7442199|FG004|COMPLETED|Treatment Phase||0
6521260|NCT01554176|7442195|FG000|NOT COMPLETED|Treatment Phase||8
6521261|NCT01554176|7442196|FG001|NOT COMPLETED|Treatment Phase||5
6521262|NCT01554176|7442197|FG002|NOT COMPLETED|Treatment Phase||0
6521263|NCT01554176|7442198|FG003|NOT COMPLETED|Treatment Phase||0
6521264|NCT01554176|7442199|FG004|NOT COMPLETED|Treatment Phase||0
6521265|NCT01554176|7442195|FG000|STARTED|Run-out Phase||0
6743641|NCT03335254|7671818|FG008|STARTED|Period 2, Day 1-15||0
6521266|NCT01554176|7442196|FG001|STARTED|Run-out Phase||0
6743642|NCT03335254|7671819|FG009|STARTED|Period 2, Day 1-15||0
6521267|NCT01554176|7442197|FG002|STARTED|Run-out Phase||29
6521268|NCT01554176|7442198|FG003|STARTED|Run-out Phase||28
6521269|NCT01554176|7442199|FG004|STARTED|Run-out Phase||59
6521270|NCT01554176|7442195|FG000|Treated|Run-out Phase||0
6521271|NCT01554176|7442196|FG001|Treated|Run-out Phase||0
6521272|NCT01554176|7442197|FG002|Treated|Run-out Phase||29
6521273|NCT01554176|7442198|FG003|Treated|Run-out Phase||28
6521274|NCT01554176|7442199|FG004|Treated|Run-out Phase||59
6521275|NCT01554176|7442195|FG000|COMPLETED|Run-out Phase||0
6521276|NCT01554176|7442196|FG001|COMPLETED|Run-out Phase||0
6521277|NCT01554176|7442197|FG002|COMPLETED|Run-out Phase||29
6521278|NCT01554176|7442198|FG003|COMPLETED|Run-out Phase||27
6521279|NCT01554176|7442199|FG004|COMPLETED|Run-out Phase||59
6521280|NCT01554176|7442195|FG000|NOT COMPLETED|Run-out Phase||0
6521281|NCT01554176|7442196|FG001|NOT COMPLETED|Run-out Phase||0
6521282|NCT01554176|7442197|FG002|NOT COMPLETED|Run-out Phase||0
6521283|NCT01554176|7442198|FG003|NOT COMPLETED|Run-out Phase||1
6521284|NCT01554176|7442199|FG004|NOT COMPLETED|Run-out Phase||0
6521285|NCT01554241|7442215|FG000|STARTED|Overall Study||23
6521286|NCT01554241|7442216|FG001|STARTED|Overall Study||20
6521287|NCT01554241|7442217|FG002|STARTED|Overall Study||24
6521288|NCT01554241|7442218|FG003|STARTED|Overall Study||14
6521289|NCT01554241|7442215|FG000|COMPLETED|Overall Study||20
6521290|NCT01554241|7442216|FG001|COMPLETED|Overall Study||19
6521291|NCT01554241|7442217|FG002|COMPLETED|Overall Study||20
6521292|NCT01554241|7442218|FG003|COMPLETED|Overall Study||13
6521293|NCT01554241|7442215|FG000|NOT COMPLETED|Overall Study||3
6521294|NCT01554241|7442216|FG001|NOT COMPLETED|Overall Study||1
6521295|NCT01554241|7442217|FG002|NOT COMPLETED|Overall Study||4
6521296|NCT01554241|7442218|FG003|NOT COMPLETED|Overall Study||1
6521297|NCT01554371|7442231|FG000|STARTED|Overall Study||3
6521298|NCT01554371|7442232|FG001|STARTED|Overall Study||3
6521299|NCT01554371|7442233|FG002|STARTED|Overall Study||38
6521300|NCT01554371|7442231|FG000|COMPLETED|Overall Study||3
6521301|NCT01554371|7442232|FG001|COMPLETED|Overall Study||3
6521302|NCT01554371|7442233|FG002|COMPLETED|Overall Study||38
6521303|NCT01554371|7442231|FG000|NOT COMPLETED|Overall Study||0
6521304|NCT01554371|7442232|FG001|NOT COMPLETED|Overall Study||0
6521305|NCT01554371|7442233|FG002|NOT COMPLETED|Overall Study||0
6521306|NCT01554488|7442246|FG000|STARTED|Overall Study||13
6521307|NCT01554488|7442247|FG001|STARTED|Overall Study||12
6521308|NCT01554488|7442246|FG000|COMPLETED|Overall Study||12
6521309|NCT01554488|7442247|FG001|COMPLETED|Overall Study||9
6521310|NCT01554488|7442246|FG000|NOT COMPLETED|Overall Study||1
6521311|NCT01554488|7442247|FG001|NOT COMPLETED|Overall Study||3
6521312|NCT01554514|7442253|FG000|STARTED|Overall Study||19
6521313|NCT01554514|7442253|FG000|COMPLETED|Overall Study||17
6521314|NCT01554514|7442253|FG000|NOT COMPLETED|Overall Study||2
6521315|NCT01554527|7442260|FG000|STARTED|Overall Study||34
6521316|NCT01554527|7442261|FG001|STARTED|Overall Study||38
6521317|NCT01554527|7442262|FG002|STARTED|Overall Study||33
6521318|NCT01554527|7442260|FG000|Crossed Over to Control|Overall Study||0
6521319|NCT01554527|7442261|FG001|Crossed Over to Control|Overall Study||0
6521320|NCT01554527|7442262|FG002|Crossed Over to Control|Overall Study||2
6521321|NCT01554527|7442260|FG000|Had CPAP Titration|Overall Study|No control group members received CPAP (definitionally)|0
6521322|NCT01554527|7442261|FG001|Had CPAP Titration|Overall Study||38
6521323|NCT01554527|7442262|FG002|Had CPAP Titration|Overall Study||30
6521324|NCT01554527|7442260|FG000|Initiated CPAP Treatment at Home|Overall Study||0
6521325|NCT01554527|7442261|FG001|Initiated CPAP Treatment at Home|Overall Study||38
6521326|NCT01554527|7442262|FG002|Initiated CPAP Treatment at Home|Overall Study||28
6521327|NCT01554527|7442260|FG000|Completed as a Control|Overall Study||33
6521328|NCT01554527|7442261|FG001|Completed as a Control|Overall Study||0
6521329|NCT01554527|7442262|FG002|Completed as a Control|Overall Study||1
6521330|NCT01554527|7442260|FG000|COMPLETED|Overall Study||33
6521331|NCT01554527|7442261|FG001|COMPLETED|Overall Study||38
6521332|NCT01554527|7442262|FG002|COMPLETED|Overall Study||25
6521333|NCT01554527|7442260|FG000|NOT COMPLETED|Overall Study||1
6521334|NCT01554527|7442261|FG001|NOT COMPLETED|Overall Study||0
6521335|NCT01554527|7442262|FG002|NOT COMPLETED|Overall Study||8
6561648|NCT01795547|7484507|FG001|STARTED|Overall Study||147
6561649|NCT01795547|7484506|FG000|COMPLETED|Overall Study||100
6561650|NCT01795547|7484507|FG001|COMPLETED|Overall Study||83
6561651|NCT01795547|7484506|FG000|NOT COMPLETED|Overall Study||48
6561652|NCT01795547|7484507|FG001|NOT COMPLETED|Overall Study||64
6561653|NCT01795638|7484517|FG000|STARTED|Overall Study||27
6561654|NCT01795638|7484518|FG001|STARTED|Overall Study||26
6561655|NCT01795638|7484517|FG000|COMPLETED|Overall Study||14
6561656|NCT01795638|7484518|FG001|COMPLETED|Overall Study||15
6561657|NCT01795638|7484517|FG000|NOT COMPLETED|Overall Study||13
6561658|NCT01795638|7484518|FG001|NOT COMPLETED|Overall Study||11
6561659|NCT01795716|7484526|FG000|STARTED|First Intervention (13 Days)||10
6561660|NCT01795716|7484527|FG001|STARTED|First Intervention (13 Days)||11
6561661|NCT01795716|7484526|FG000|COMPLETED|First Intervention (13 Days)||10
6561662|NCT01795716|7484527|FG001|COMPLETED|First Intervention (13 Days)||11
6561663|NCT01795716|7484526|FG000|NOT COMPLETED|First Intervention (13 Days)||0
6561664|NCT01795716|7484527|FG001|NOT COMPLETED|First Intervention (13 Days)||0
6561665|NCT01795716|7484526|FG000|STARTED|Washout (10 Days)||10
6561666|NCT01795716|7484527|FG001|STARTED|Washout (10 Days)||11
6561667|NCT01795716|7484526|FG000|COMPLETED|Washout (10 Days)||10
6561668|NCT01795716|7484527|FG001|COMPLETED|Washout (10 Days)||11
6521336|NCT01554579|7442273|FG000|STARTED|Overall Study||86
6521337|NCT01554579|7442274|FG001|STARTED|Overall Study||85
6521338|NCT01554579|7442273|FG000|COMPLETED|Overall Study||76
6521339|NCT01554579|7442274|FG001|COMPLETED|Overall Study||58
6521340|NCT01554579|7442273|FG000|NOT COMPLETED|Overall Study||10
6521341|NCT01554579|7442274|FG001|NOT COMPLETED|Overall Study||27
6521342|NCT01554618|7442283|FG000|STARTED|Randomized Through Start of Treatment||59
6521343|NCT01554618|7442284|FG001|STARTED|Randomized Through Start of Treatment||24
6521344|NCT01554618|7442283|FG000|COMPLETED|Randomized Through Start of Treatment||58
6521345|NCT01554618|7442284|FG001|COMPLETED|Randomized Through Start of Treatment||24
6521346|NCT01554618|7442283|FG000|NOT COMPLETED|Randomized Through Start of Treatment||1
6521347|NCT01554618|7442284|FG001|NOT COMPLETED|Randomized Through Start of Treatment||0
6521348|NCT01554618|7442283|FG000|STARTED|Controlled Assessment Period||58
6521349|NCT01554618|7442284|FG001|STARTED|Controlled Assessment Period||24
6521350|NCT01554618|7442283|FG000|COMPLETED|Controlled Assessment Period||50
6521351|NCT01554618|7442284|FG001|COMPLETED|Controlled Assessment Period||23
6521352|NCT01554618|7442283|FG000|NOT COMPLETED|Controlled Assessment Period||8
6521353|NCT01554618|7442284|FG001|NOT COMPLETED|Controlled Assessment Period||1
6521354|NCT01554618|7442283|FG000|STARTED|Open-Label Extension Period|1 patient who was noncompliant with study medication did not enter the open-label extension period|49
6521355|NCT01554618|7442284|FG001|STARTED|Open-Label Extension Period||23
6521356|NCT01554618|7442283|FG000|COMPLETED|Open-Label Extension Period||46
6521357|NCT01554618|7442284|FG001|COMPLETED|Open-Label Extension Period||18
6521358|NCT01554618|7442283|FG000|NOT COMPLETED|Open-Label Extension Period||3
6521359|NCT01554618|7442284|FG001|NOT COMPLETED|Open-Label Extension Period||5
6521360|NCT01554683|7442294|FG000|STARTED|Overall Study||2
6521361|NCT01554683|7442295|FG001|STARTED|Overall Study||1
6521362|NCT01554683|7442296|FG002|STARTED|Overall Study||3
6521363|NCT01554683|7442297|FG003|STARTED|Overall Study||2
6521364|NCT01554683|7442298|FG004|STARTED|Overall Study||1
6521365|NCT01554683|7442299|FG005|STARTED|Overall Study||0
6521366|NCT01554683|7442294|FG000|COMPLETED|Overall Study||2
6521367|NCT01554683|7442295|FG001|COMPLETED|Overall Study||1
6521368|NCT01554683|7442296|FG002|COMPLETED|Overall Study||3
6521369|NCT01554683|7442297|FG003|COMPLETED|Overall Study||2
6521370|NCT01554683|7442298|FG004|COMPLETED|Overall Study||1
6521371|NCT01554683|7442299|FG005|COMPLETED|Overall Study||0
6521372|NCT01554683|7442294|FG000|NOT COMPLETED|Overall Study||0
6521373|NCT01554683|7442295|FG001|NOT COMPLETED|Overall Study||0
6521374|NCT01554683|7442296|FG002|NOT COMPLETED|Overall Study||0
6521375|NCT01554683|7442297|FG003|NOT COMPLETED|Overall Study||0
6521376|NCT01554683|7442298|FG004|NOT COMPLETED|Overall Study||0
6521377|NCT01554683|7442299|FG005|NOT COMPLETED|Overall Study||0
6521378|NCT01554891|7442310|FG000|STARTED|Overall Study||105
6521379|NCT01554891|7442311|FG001|STARTED|Overall Study||120
6521380|NCT01554891|7442312|FG002|STARTED|Overall Study||57
6521381|NCT01554891|7442310|FG000|COMPLETED|Overall Study||98
6521382|NCT01554891|7442311|FG001|COMPLETED|Overall Study||115
6521383|NCT01554891|7442312|FG002|COMPLETED|Overall Study||55
6521384|NCT01554891|7442310|FG000|NOT COMPLETED|Overall Study||7
6521385|NCT01554891|7442311|FG001|NOT COMPLETED|Overall Study||5
6521386|NCT01554891|7442312|FG002|NOT COMPLETED|Overall Study||2
6521387|NCT01554904|7442320|FG000|STARTED|Overall Study||18
6521388|NCT01554904|7442320|FG000|Home Sleep Study 1|Overall Study|After informed consent signed.|18
6521389|NCT01554904|7442320|FG000|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
6521390|NCT01554904|7442320|FG000|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
6521391|NCT01554904|7442320|FG000|Home Sleep Study 2|Overall Study||14
6521392|NCT01554904|7442320|FG000|COMPLETED|Overall Study||14
6521393|NCT01554904|7442320|FG000|NOT COMPLETED|Overall Study||4
6521394|NCT01554982|7442324|FG000|STARTED|Overall Study||168
6521395|NCT01554982|7442324|FG000|Received Drug|Overall Study||166
6521396|NCT01554982|7442324|FG000|COMPLETED|Overall Study||125
6521397|NCT01554982|7442324|FG000|NOT COMPLETED|Overall Study||43
6521398|NCT01555125|7442331|FG000|STARTED|Induction Period||59
6521399|NCT01555125|7442332|FG001|STARTED|Induction Period||59
6521400|NCT01555125|7442333|FG002|STARTED|Induction Period||0
6521401|NCT01555125|7442334|FG003|STARTED|Induction Period||0
6521402|NCT01555125|7442335|FG004|STARTED|Induction Period||59
6521403|NCT01555125|7442331|FG000|COMPLETED|Induction Period||58
6521404|NCT01555125|7442332|FG001|COMPLETED|Induction Period||56
6521405|NCT01555125|7442333|FG002|COMPLETED|Induction Period||0
6521406|NCT01555125|7442334|FG003|COMPLETED|Induction Period||0
6521407|NCT01555125|7442335|FG004|COMPLETED|Induction Period||56
6521408|NCT01555125|7442331|FG000|NOT COMPLETED|Induction Period||1
6521409|NCT01555125|7442332|FG001|NOT COMPLETED|Induction Period||3
6521410|NCT01555125|7442333|FG002|NOT COMPLETED|Induction Period||0
6521411|NCT01555125|7442334|FG003|NOT COMPLETED|Induction Period||0
6521412|NCT01555125|7442335|FG004|NOT COMPLETED|Induction Period||3
6521413|NCT01555125|7442331|FG000|STARTED|Maintenance Period||58
6521414|NCT01555125|7442332|FG001|STARTED|Maintenance Period||56
6521415|NCT01555125|7442333|FG002|STARTED|Maintenance Period||29
6521416|NCT01555125|7442334|FG003|STARTED|Maintenance Period||27
6521417|NCT01555125|7442335|FG004|STARTED|Maintenance Period||0
6521418|NCT01555125|7442331|FG000|COMPLETED|Maintenance Period||48
6521419|NCT01555125|7442332|FG001|COMPLETED|Maintenance Period||52
6521420|NCT01555125|7442333|FG002|COMPLETED|Maintenance Period||25
6521421|NCT01555125|7442334|FG003|COMPLETED|Maintenance Period||25
6521422|NCT01555125|7442335|FG004|COMPLETED|Maintenance Period||0
6521423|NCT01555125|7442331|FG000|NOT COMPLETED|Maintenance Period||10
6521424|NCT01555125|7442332|FG001|NOT COMPLETED|Maintenance Period||4
6521425|NCT01555125|7442333|FG002|NOT COMPLETED|Maintenance Period||4
6521426|NCT01555125|7442334|FG003|NOT COMPLETED|Maintenance Period||2
6521427|NCT01555125|7442335|FG004|NOT COMPLETED|Maintenance Period||0
6521428|NCT01555125|7442331|FG000|STARTED|Extension||46
6521429|NCT01555125|7442332|FG001|STARTED|Extension||51
6521430|NCT01555125|7442333|FG002|STARTED|Extension||23
6521431|NCT01555125|7442334|FG003|STARTED|Extension||23
6521432|NCT01555125|7442335|FG004|STARTED|Extension||0
6521433|NCT01555125|7442331|FG000|COMPLETED|Extension||1
6521434|NCT01555125|7442332|FG001|COMPLETED|Extension||0
6521435|NCT01555125|7442333|FG002|COMPLETED|Extension||0
6521436|NCT01555125|7442334|FG003|COMPLETED|Extension||1
6521437|NCT01555125|7442335|FG004|COMPLETED|Extension||0
6521438|NCT01555125|7442331|FG000|NOT COMPLETED|Extension||45
6642464|NCT02348918|7570885|FG006|COMPLETED|Overall Study||13
6642465|NCT02348918|7570886|FG007|COMPLETED|Overall Study||16
6642466|NCT02348918|7570887|FG008|COMPLETED|Overall Study||15
6521439|NCT01555125|7442332|FG001|NOT COMPLETED|Extension||51
6521440|NCT01555125|7442333|FG002|NOT COMPLETED|Extension||23
6521441|NCT01555125|7442334|FG003|NOT COMPLETED|Extension||22
6521442|NCT01555125|7442335|FG004|NOT COMPLETED|Extension||0
6521443|NCT01555125|7442331|FG000|STARTED|Follow-Up Period||36
6521444|NCT01555125|7442332|FG001|STARTED|Follow-Up Period||31
6521445|NCT01555125|7442333|FG002|STARTED|Follow-Up Period||19
6521446|NCT01555125|7442334|FG003|STARTED|Follow-Up Period||18
6521447|NCT01555125|7442335|FG004|STARTED|Follow-Up Period||0
6521448|NCT01555125|7442331|FG000|COMPLETED|Follow-Up Period||32
6521449|NCT01555125|7442332|FG001|COMPLETED|Follow-Up Period||30
6521450|NCT01555125|7442333|FG002|COMPLETED|Follow-Up Period||18
6521451|NCT01555125|7442334|FG003|COMPLETED|Follow-Up Period||17
6521452|NCT01555125|7442335|FG004|COMPLETED|Follow-Up Period||0
6521453|NCT01555125|7442331|FG000|NOT COMPLETED|Follow-Up Period||4
6521454|NCT01555125|7442332|FG001|NOT COMPLETED|Follow-Up Period||1
6521455|NCT01555125|7442333|FG002|NOT COMPLETED|Follow-Up Period||1
6521456|NCT01555125|7442334|FG003|NOT COMPLETED|Follow-Up Period||1
6521457|NCT01555125|7442335|FG004|NOT COMPLETED|Follow-Up Period||0
6521458|NCT01555138|7442352|FG000|STARTED|Overall Study||293
6521459|NCT01555138|7442353|FG001|STARTED|Overall Study||288
6521460|NCT01555138|7442352|FG000|COMPLETED|Overall Study||246
6521461|NCT01555138|7442353|FG001|COMPLETED|Overall Study||250
6521462|NCT01555138|7442352|FG000|NOT COMPLETED|Overall Study||47
6521463|NCT01555138|7442353|FG001|NOT COMPLETED|Overall Study||38
6521464|NCT01555151|7442363|FG000|STARTED|Overall Study||188
6521465|NCT01555151|7442364|FG001|STARTED|Overall Study||181
6521466|NCT01555151|7442365|FG002|STARTED|Overall Study||184
6521467|NCT01555151|7442366|FG003|STARTED|Overall Study||186
6521468|NCT01555151|7442363|FG000|Safety Set (SAF)|Overall Study||186
6521469|NCT01555151|7442364|FG001|Safety Set (SAF)|Overall Study||180
6521470|NCT01555151|7442365|FG002|Safety Set (SAF)|Overall Study||183
6521471|NCT01555151|7442366|FG003|Safety Set (SAF)|Overall Study||186
6521472|NCT01555151|7442363|FG000|COMPLETED|Overall Study||175
6521473|NCT01555151|7442364|FG001|COMPLETED|Overall Study||173
6521474|NCT01555151|7442365|FG002|COMPLETED|Overall Study||178
6521475|NCT01555151|7442366|FG003|COMPLETED|Overall Study||176
6521476|NCT01555151|7442363|FG000|NOT COMPLETED|Overall Study||13
6521477|NCT01555151|7442364|FG001|NOT COMPLETED|Overall Study||8
6521478|NCT01555151|7442365|FG002|NOT COMPLETED|Overall Study||6
6521479|NCT01555151|7442366|FG003|NOT COMPLETED|Overall Study||10
6521480|NCT01555164|7442379|FG000|STARTED|Overall Study||222
6521481|NCT01555164|7442380|FG001|STARTED|Overall Study||220
6521482|NCT01555164|7442379|FG000|COMPLETED|Overall Study||182
6521483|NCT01555164|7442380|FG001|COMPLETED|Overall Study||185
6521484|NCT01555164|7442379|FG000|NOT COMPLETED|Overall Study||40
6521485|NCT01555164|7442380|FG001|NOT COMPLETED|Overall Study||35
6521486|NCT01555463|7442388|FG000|STARTED|Treatment||483
6521487|NCT01555463|7442389|FG001|STARTED|Treatment||478
6521488|NCT01555463|7442388|FG000|COMPLETED|Treatment||419
6521489|NCT01555463|7442389|FG001|COMPLETED|Treatment||399
6521490|NCT01555463|7442388|FG000|NOT COMPLETED|Treatment||64
6521491|NCT01555463|7442389|FG001|NOT COMPLETED|Treatment||79
6521492|NCT01555463|7442388|FG000|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
6521493|NCT01555463|7442389|FG001|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
6521494|NCT01555463|7442388|FG000|COMPLETED|Follow up||409
6521495|NCT01555463|7442389|FG001|COMPLETED|Follow up||394
6521496|NCT01555463|7442388|FG000|NOT COMPLETED|Follow up||38
6642467|NCT02348918|7570879|FG000|NOT COMPLETED|Overall Study||0
6642468|NCT02348918|7570880|FG001|NOT COMPLETED|Overall Study||0
6521497|NCT01555463|7442389|FG001|NOT COMPLETED|Follow up||45
6521498|NCT01555541|7442395|FG000|STARTED|Salvage Response Assessment||19
6521499|NCT01555541|7442395|FG000|COMPLETED|Salvage Response Assessment||19
6521500|NCT01555541|7442395|FG000|NOT COMPLETED|Salvage Response Assessment||0
6521501|NCT01555541|7442395|FG000|STARTED|OVA Treatment||19
6521502|NCT01555541|7442395|FG000|COMPLETED|OVA Treatment||19
6521503|NCT01555541|7442395|FG000|NOT COMPLETED|OVA Treatment||0
6521504|NCT01555541|7442395|FG000|STARTED|Autologous Stem Cell Transplantation|7 patients didn't move forward due to non-response/progression on last line of therapy prior to ASCT|12
6642469|NCT02348918|7570881|FG002|NOT COMPLETED|Overall Study||0
6642470|NCT02348918|7570882|FG003|NOT COMPLETED|Overall Study||0
6642471|NCT02348918|7570883|FG004|NOT COMPLETED|Overall Study||0
6521505|NCT01555541|7442395|FG000|COMPLETED|Autologous Stem Cell Transplantation||12
6521506|NCT01555541|7442395|FG000|NOT COMPLETED|Autologous Stem Cell Transplantation||0
6521507|NCT01555567|7442404|FG000|STARTED|12 Week||12
6521508|NCT01555567|7442405|FG001|STARTED|12 Week||13
6521509|NCT01555567|7442406|FG002|STARTED|12 Week||9
6521510|NCT01555567|7442407|FG003|STARTED|12 Week||9
6521511|NCT01555567|7442404|FG000|COMPLETED|12 Week||11
6521512|NCT01555567|7442405|FG001|COMPLETED|12 Week||12
6521513|NCT01555567|7442406|FG002|COMPLETED|12 Week||8
6521514|NCT01555567|7442407|FG003|COMPLETED|12 Week||9
6521515|NCT01555567|7442404|FG000|NOT COMPLETED|12 Week||1
6521516|NCT01555567|7442405|FG001|NOT COMPLETED|12 Week||1
6521517|NCT01555567|7442406|FG002|NOT COMPLETED|12 Week||1
6521518|NCT01555567|7442407|FG003|NOT COMPLETED|12 Week||0
6521519|NCT01555567|7442404|FG000|STARTED|Return to Activity||11
6521520|NCT01555567|7442405|FG001|STARTED|Return to Activity||12
6521521|NCT01555567|7442406|FG002|STARTED|Return to Activity||8
6521522|NCT01555567|7442407|FG003|STARTED|Return to Activity||9
6521523|NCT01555567|7442404|FG000|COMPLETED|Return to Activity||10
6521524|NCT01555567|7442405|FG001|COMPLETED|Return to Activity||10
6521525|NCT01555567|7442406|FG002|COMPLETED|Return to Activity||8
6521526|NCT01555567|7442407|FG003|COMPLETED|Return to Activity||8
6521527|NCT01555567|7442404|FG000|NOT COMPLETED|Return to Activity||1
6521528|NCT01555567|7442405|FG001|NOT COMPLETED|Return to Activity||2
6521529|NCT01555567|7442406|FG002|NOT COMPLETED|Return to Activity||0
6521530|NCT01555567|7442407|FG003|NOT COMPLETED|Return to Activity||1
6521531|NCT01555671|7442419|FG000|STARTED|Overall Study||125
6521532|NCT01555671|7442420|FG001|STARTED|Overall Study||125
6521533|NCT01555671|7442419|FG000|COMPLETED|Overall Study||105
6521534|NCT01555671|7442420|FG001|COMPLETED|Overall Study||100
6521535|NCT01555671|7442419|FG000|NOT COMPLETED|Overall Study||20
6521536|NCT01555671|7442420|FG001|NOT COMPLETED|Overall Study||25
6521537|NCT01555697|7442436|FG000|STARTED|Overall Study||10
6521538|NCT01555697|7442437|FG001|STARTED|Overall Study||10
6521539|NCT01555697|7442438|FG002|STARTED|Overall Study||10
6521540|NCT01555697|7442439|FG003|STARTED|Overall Study||10
6521541|NCT01555697|7442440|FG004|STARTED|Overall Study||10
6521542|NCT01555697|7442441|FG005|STARTED|Overall Study||10
6521543|NCT01555697|7442442|FG006|STARTED|Overall Study||10
6521544|NCT01555697|7442443|FG007|STARTED|Overall Study||10
6521545|NCT01555697|7442436|FG000|6 Hours Lab Testing Day 1|Overall Study||10
6521546|NCT01555697|7442437|FG001|6 Hours Lab Testing Day 1|Overall Study||10
6521547|NCT01555697|7442438|FG002|6 Hours Lab Testing Day 1|Overall Study||10
6521548|NCT01555697|7442439|FG003|6 Hours Lab Testing Day 1|Overall Study||10
6521549|NCT01555697|7442440|FG004|6 Hours Lab Testing Day 1|Overall Study||10
6521550|NCT01555697|7442441|FG005|6 Hours Lab Testing Day 1|Overall Study||10
6521551|NCT01555697|7442442|FG006|6 Hours Lab Testing Day 1|Overall Study||10
6521552|NCT01555697|7442443|FG007|6 Hours Lab Testing Day 1|Overall Study||10
6521553|NCT01555697|7442436|FG000|Approx 7 Day Washout|Overall Study||10
6521554|NCT01555697|7442437|FG001|Approx 7 Day Washout|Overall Study||10
6521555|NCT01555697|7442438|FG002|Approx 7 Day Washout|Overall Study||10
6521556|NCT01555697|7442439|FG003|Approx 7 Day Washout|Overall Study||10
6521557|NCT01555697|7442440|FG004|Approx 7 Day Washout|Overall Study||10
6521558|NCT01555697|7442441|FG005|Approx 7 Day Washout|Overall Study||10
6521559|NCT01555697|7442442|FG006|Approx 7 Day Washout|Overall Study||10
6521560|NCT01555697|7442443|FG007|Approx 7 Day Washout|Overall Study||10
6521561|NCT01555697|7442436|FG000|6 Hours Lab Testing Day 2|Overall Study||10
6521562|NCT01555697|7442437|FG001|6 Hours Lab Testing Day 2|Overall Study||10
6521563|NCT01555697|7442438|FG002|6 Hours Lab Testing Day 2|Overall Study||10
6521564|NCT01555697|7442439|FG003|6 Hours Lab Testing Day 2|Overall Study||10
6521565|NCT01555697|7442440|FG004|6 Hours Lab Testing Day 2|Overall Study||10
6521566|NCT01555697|7442441|FG005|6 Hours Lab Testing Day 2|Overall Study||10
6521567|NCT01555697|7442442|FG006|6 Hours Lab Testing Day 2|Overall Study||10
6521568|NCT01555697|7442443|FG007|6 Hours Lab Testing Day 2|Overall Study||10
6521569|NCT01555697|7442436|FG000|COMPLETED|Overall Study||10
6521570|NCT01555697|7442437|FG001|COMPLETED|Overall Study||10
6521571|NCT01555697|7442438|FG002|COMPLETED|Overall Study||10
6521572|NCT01555697|7442439|FG003|COMPLETED|Overall Study||10
6521573|NCT01555697|7442440|FG004|COMPLETED|Overall Study||10
6521574|NCT01555697|7442441|FG005|COMPLETED|Overall Study||10
6521575|NCT01555697|7442442|FG006|COMPLETED|Overall Study||10
6521576|NCT01555697|7442443|FG007|COMPLETED|Overall Study||10
6521577|NCT01555697|7442436|FG000|NOT COMPLETED|Overall Study||0
6521578|NCT01555697|7442437|FG001|NOT COMPLETED|Overall Study||0
6521579|NCT01555697|7442438|FG002|NOT COMPLETED|Overall Study||0
6521580|NCT01555697|7442439|FG003|NOT COMPLETED|Overall Study||0
6521581|NCT01555697|7442440|FG004|NOT COMPLETED|Overall Study||0
6521582|NCT01555697|7442441|FG005|NOT COMPLETED|Overall Study||0
6521583|NCT01555697|7442442|FG006|NOT COMPLETED|Overall Study||0
6642472|NCT02348918|7570884|FG005|NOT COMPLETED|Overall Study||0
6521584|NCT01555697|7442443|FG007|NOT COMPLETED|Overall Study||0
6521585|NCT01555762|7442455|FG000|STARTED|Overall Study||402
6521586|NCT01555762|7442455|FG000|Safety Population|Overall Study||383
6521587|NCT01555762|7442455|FG000|Efficacy Population|Overall Study||358
6521588|NCT01555762|7442455|FG000|COMPLETED|Overall Study||128
6521589|NCT01555762|7442455|FG000|NOT COMPLETED|Overall Study||274
6521590|NCT01555931|7442461|FG000|STARTED|Overall Study||17
6521591|NCT01555931|7442462|FG001|STARTED|Overall Study||18
6521592|NCT01555931|7442461|FG000|COMPLETED|Overall Study||15
6521593|NCT01555931|7442462|FG001|COMPLETED|Overall Study||13
6521594|NCT01555931|7442461|FG000|NOT COMPLETED|Overall Study||2
6521595|NCT01555931|7442462|FG001|NOT COMPLETED|Overall Study||5
6521596|NCT01555957|7442470|FG000|STARTED|Overall Study||20
6521597|NCT01555957|7442471|FG001|STARTED|Overall Study||20
6521598|NCT01555957|7442470|FG000|COMPLETED|Overall Study||20
6521599|NCT01555957|7442471|FG001|COMPLETED|Overall Study||20
6521600|NCT01555957|7442470|FG000|NOT COMPLETED|Overall Study||0
6521601|NCT01555957|7442471|FG001|NOT COMPLETED|Overall Study||0
6521602|NCT01555983|7442477|FG000|STARTED|Overall Study||9
6521603|NCT01555983|7442478|FG001|STARTED|Overall Study||7
6521604|NCT01555983|7442479|FG002|STARTED|Overall Study||7
6521605|NCT01555983|7442480|FG003|STARTED|Overall Study||7
6521606|NCT01555983|7442481|FG004|STARTED|Overall Study||5
6521607|NCT01555983|7442482|FG005|STARTED|Overall Study||7
6521608|NCT01555983|7442477|FG000|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
6521609|NCT01555983|7442478|FG001|COMPLETED|Overall Study||7
6521610|NCT01555983|7442479|FG002|COMPLETED|Overall Study||7
6521611|NCT01555983|7442480|FG003|COMPLETED|Overall Study||7
6521612|NCT01555983|7442481|FG004|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
6521613|NCT01555983|7442482|FG005|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
6521614|NCT01555983|7442477|FG000|NOT COMPLETED|Overall Study||1
6521615|NCT01555983|7442478|FG001|NOT COMPLETED|Overall Study||0
6521616|NCT01555983|7442479|FG002|NOT COMPLETED|Overall Study||0
6521617|NCT01555983|7442480|FG003|NOT COMPLETED|Overall Study||0
6521618|NCT01555983|7442481|FG004|NOT COMPLETED|Overall Study||1
6521619|NCT01555983|7442482|FG005|NOT COMPLETED|Overall Study||1
6521620|NCT01556061|7442492|FG000|STARTED|Overall Study||25
6521621|NCT01556061|7442493|FG001|STARTED|Overall Study||25
6521622|NCT01556061|7442492|FG000|COMPLETED|Overall Study||25
6521623|NCT01556061|7442493|FG001|COMPLETED|Overall Study||25
6521624|NCT01556061|7442492|FG000|NOT COMPLETED|Overall Study||0
6521625|NCT01556061|7442493|FG001|NOT COMPLETED|Overall Study||0
6521626|NCT01556100|7442501|FG000|STARTED|Overall Study||40
6521627|NCT01556100|7442501|FG000|COMPLETED|Overall Study||34
6521628|NCT01556100|7442501|FG000|NOT COMPLETED|Overall Study||6
6521629|NCT01556165|7442507|FG000|STARTED|Overall Study||65
6521630|NCT01556165|7442508|FG001|STARTED|Overall Study||65
6521631|NCT01556165|7442507|FG000|COMPLETED|Overall Study||53
6521632|NCT01556165|7442508|FG001|COMPLETED|Overall Study||58
6521633|NCT01556165|7442507|FG000|NOT COMPLETED|Overall Study||12
6521634|NCT01556165|7442508|FG001|NOT COMPLETED|Overall Study||7
6521635|NCT01556204|7442516|FG000|STARTED|Overall Study||35
6521636|NCT01556204|7442517|FG001|STARTED|Overall Study||38
6521637|NCT01556204|7442516|FG000|COMPLETED|Overall Study||35
6521638|NCT01556204|7442517|FG001|COMPLETED|Overall Study||38
6521639|NCT01556204|7442516|FG000|NOT COMPLETED|Overall Study||0
6521640|NCT01556204|7442517|FG001|NOT COMPLETED|Overall Study||0
6521641|NCT01556347|7442523|FG000|STARTED|Induction Immunotherapy||2
6521642|NCT01556347|7442523|FG000|COMPLETED|Induction Immunotherapy||2
6521643|NCT01556347|7442523|FG000|NOT COMPLETED|Induction Immunotherapy||0
6521644|NCT01556347|7442523|FG000|STARTED|Bortezomib Treatment Phase||2
6521645|NCT01556347|7442523|FG000|COMPLETED|Bortezomib Treatment Phase||2
6521646|NCT01556347|7442523|FG000|NOT COMPLETED|Bortezomib Treatment Phase||0
6521647|NCT01556347|7442523|FG000|STARTED|Recovery Phase||2
6521648|NCT01556347|7442523|FG000|COMPLETED|Recovery Phase||2
6521649|NCT01556347|7442523|FG000|NOT COMPLETED|Recovery Phase||0
6521650|NCT01556425|7442555|FG000|STARTED|Overall Study||25
6521651|NCT01556425|7442556|FG001|STARTED|Overall Study||23
6521652|NCT01556425|7442557|FG002|STARTED|Overall Study||18
6521653|NCT01556425|7442558|FG003|STARTED|Overall Study||18
6521654|NCT01556425|7442555|FG000|COMPLETED|Overall Study||25
6521655|NCT01556425|7442556|FG001|COMPLETED|Overall Study||23
6521656|NCT01556425|7442557|FG002|COMPLETED|Overall Study||18
6521657|NCT01556425|7442558|FG003|COMPLETED|Overall Study||18
6521658|NCT01556425|7442555|FG000|NOT COMPLETED|Overall Study||0
6521659|NCT01556425|7442556|FG001|NOT COMPLETED|Overall Study||0
6521660|NCT01556425|7442557|FG002|NOT COMPLETED|Overall Study||0
6521661|NCT01556425|7442558|FG003|NOT COMPLETED|Overall Study||0
6521662|NCT01556438|7442570|FG000|STARTED|Overall Study||4
6521663|NCT01556438|7442571|FG001|STARTED|Overall Study||12
6521664|NCT01556438|7442570|FG000|Received at Least 1 Dose of Study Drug|Overall Study|100 mg tabalumab IV|4
6521665|NCT01556438|7442571|FG001|Received at Least 1 Dose of Study Drug|Overall Study|300 mg tabalumab IV|12
6521666|NCT01556438|7442570|FG000|Received BTZ IV|Overall Study||4
6521667|NCT01556438|7442571|FG001|Received BTZ IV|Overall Study||4
6521668|NCT01556438|7442570|FG000|Received BTZ SC|Overall Study||0
6521669|NCT01556438|7442571|FG001|Received BTZ SC|Overall Study||8
6521670|NCT01556438|7442570|FG000|COMPLETED|Overall Study||0
6521671|NCT01556438|7442571|FG001|COMPLETED|Overall Study||1
6521672|NCT01556438|7442570|FG000|NOT COMPLETED|Overall Study||4
6521673|NCT01556438|7442571|FG001|NOT COMPLETED|Overall Study||11
6521674|NCT01556451|7442585|FG000|STARTED|Overall Study||180
6521675|NCT01556451|7442585|FG000|COMPLETED|Overall Study||180
6521676|NCT01556451|7442585|FG000|NOT COMPLETED|Overall Study||0
6521677|NCT01556581|7442591|FG000|STARTED|Overall Study||61
6521678|NCT01556581|7442592|FG001|STARTED|Overall Study||58
6521679|NCT01556581|7442591|FG000|COMPLETED|Overall Study||61
6521680|NCT01556581|7442592|FG001|COMPLETED|Overall Study||58
6521681|NCT01556581|7442591|FG000|NOT COMPLETED|Overall Study||0
6521682|NCT01556581|7442592|FG001|NOT COMPLETED|Overall Study||0
6521683|NCT01556594|7442601|FG000|STARTED|Overall Study||10
6521684|NCT01556594|7442602|FG001|STARTED|Overall Study||2
6521685|NCT01556594|7442603|FG002|STARTED|Overall Study||6
6521686|NCT01556594|7442601|FG000|COMPLETED|Overall Study||10
6521687|NCT01556594|7442602|FG001|COMPLETED|Overall Study||2
6521688|NCT01556594|7442603|FG002|COMPLETED|Overall Study||6
6521689|NCT01556594|7442601|FG000|NOT COMPLETED|Overall Study||0
6521690|NCT01556594|7442602|FG001|NOT COMPLETED|Overall Study||0
6521691|NCT01556594|7442603|FG002|NOT COMPLETED|Overall Study||0
6521692|NCT01556633|7442615|FG000|STARTED|Overall Study||10
6521693|NCT01556633|7442616|FG001|STARTED|Overall Study||6
6521694|NCT01556633|7442615|FG000|COMPLETED|Overall Study||10
6521695|NCT01556633|7442616|FG001|COMPLETED|Overall Study||6
6521696|NCT01556633|7442615|FG000|NOT COMPLETED|Overall Study||0
6521697|NCT01556633|7442616|FG001|NOT COMPLETED|Overall Study||0
6521698|NCT01556724|7442627|FG000|STARTED|Overall Study||16
6521699|NCT01556724|7442628|FG001|STARTED|Overall Study||14
6521700|NCT01556724|7442627|FG000|COMPLETED|Overall Study||16
6521701|NCT01556724|7442628|FG001|COMPLETED|Overall Study||14
6521702|NCT01556724|7442627|FG000|NOT COMPLETED|Overall Study||0
6521703|NCT01556724|7442628|FG001|NOT COMPLETED|Overall Study||0
6521704|NCT01556763|7442640|FG000|STARTED|Overall Study||4
6521705|NCT01556763|7442641|FG001|STARTED|Overall Study||9
6521706|NCT01556763|7442642|FG002|STARTED|Overall Study||8
6521707|NCT01556763|7442640|FG000|COMPLETED|Overall Study||4
6521708|NCT01556763|7442641|FG001|COMPLETED|Overall Study||8
6521709|NCT01556763|7442642|FG002|COMPLETED|Overall Study||8
6521710|NCT01556763|7442640|FG000|NOT COMPLETED|Overall Study||0
6521711|NCT01556763|7442641|FG001|NOT COMPLETED|Overall Study||1
6521712|NCT01556763|7442642|FG002|NOT COMPLETED|Overall Study||0
6521713|NCT01556906|7442652|FG000|STARTED|Overall Study||6
6521714|NCT01556906|7442652|FG000|COMPLETED|Overall Study||6
6521715|NCT01556906|7442652|FG000|NOT COMPLETED|Overall Study||0
6521716|NCT01556932|7442656|FG000|STARTED|Baseline First Treatment||13
6521717|NCT01556932|7442657|FG001|STARTED|Baseline First Treatment||9
6521718|NCT01556932|7442656|FG000|Recieved|Baseline First Treatment||13
6521719|NCT01556932|7442657|FG001|Recieved|Baseline First Treatment||9
6521720|NCT01556932|7442656|FG000|COMPLETED|Baseline First Treatment||13
6521721|NCT01556932|7442657|FG001|COMPLETED|Baseline First Treatment||9
6521722|NCT01556932|7442656|FG000|NOT COMPLETED|Baseline First Treatment||0
6521723|NCT01556932|7442657|FG001|NOT COMPLETED|Baseline First Treatment||0
6521724|NCT01556932|7442656|FG000|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
6521725|NCT01556932|7442657|FG001|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
6521726|NCT01556932|7442656|FG000|Recieved|Time Point 60 Minutes||12
6521727|NCT01556932|7442657|FG001|Recieved|Time Point 60 Minutes||8
6521728|NCT01556932|7442656|FG000|COMPLETED|Time Point 60 Minutes||12
6521729|NCT01556932|7442657|FG001|COMPLETED|Time Point 60 Minutes||8
6521730|NCT01556932|7442656|FG000|NOT COMPLETED|Time Point 60 Minutes||1
6521731|NCT01556932|7442657|FG001|NOT COMPLETED|Time Point 60 Minutes||1
6521732|NCT01556932|7442656|FG000|STARTED|Second Treament||12
6521733|NCT01556932|7442657|FG001|STARTED|Second Treament||8
6521734|NCT01556932|7442656|FG000|Recieved|Second Treament||12
6521735|NCT01556932|7442657|FG001|Recieved|Second Treament||8
6521736|NCT01556932|7442656|FG000|COMPLETED|Second Treament||12
6521737|NCT01556932|7442657|FG001|COMPLETED|Second Treament||8
6521738|NCT01556932|7442656|FG000|NOT COMPLETED|Second Treament||0
6521739|NCT01556932|7442657|FG001|NOT COMPLETED|Second Treament||0
6521740|NCT01556997|7442665|FG000|STARTED|Overall Study||279
6521741|NCT01556997|7442666|FG001|STARTED|Overall Study||280
6521742|NCT01556997|7442667|FG002|STARTED|Overall Study||278
6521743|NCT01556997|7442665|FG000|COMPLETED|Overall Study||253
6521744|NCT01556997|7442666|FG001|COMPLETED|Overall Study||252
6521745|NCT01556997|7442667|FG002|COMPLETED|Overall Study||246
6521746|NCT01556997|7442665|FG000|NOT COMPLETED|Overall Study||26
6521747|NCT01556997|7442666|FG001|NOT COMPLETED|Overall Study||28
6521748|NCT01556997|7442667|FG002|NOT COMPLETED|Overall Study||32
6521749|NCT01557166|7442677|FG000|STARTED|Overall Study||180
6521750|NCT01557166|7442678|FG001|STARTED|Overall Study||179
6642473|NCT02348918|7570885|FG006|NOT COMPLETED|Overall Study||0
6642474|NCT02348918|7570886|FG007|NOT COMPLETED|Overall Study||0
6642475|NCT02348918|7570887|FG008|NOT COMPLETED|Overall Study||0
6642476|NCT02349048|7570909|FG000|STARTED|Overall Study||59
6642477|NCT02349048|7570910|FG001|STARTED|Overall Study||9
6642478|NCT02349048|7570909|FG000|COMPLETED|Overall Study||54
6642479|NCT02349048|7570910|FG001|COMPLETED|Overall Study||9
6642480|NCT02349048|7570909|FG000|NOT COMPLETED|Overall Study||5
6642481|NCT02349048|7570910|FG001|NOT COMPLETED|Overall Study||0
6642482|NCT02349061|7570918|FG000|STARTED|Main Study: PCP (Up to Week 24)||42
6642483|NCT02349061|7570919|FG001|STARTED|Main Study: PCP (Up to Week 24)||60
6521751|NCT01557166|7442677|FG000|Exposed|Overall Study||176
6521752|NCT01557166|7442678|FG001|Exposed|Overall Study||179
6521753|NCT01557166|7442677|FG000|COMPLETED|Overall Study||134
6521754|NCT01557166|7442678|FG001|COMPLETED|Overall Study||142
6521755|NCT01557166|7442677|FG000|NOT COMPLETED|Overall Study||46
6521756|NCT01557166|7442678|FG001|NOT COMPLETED|Overall Study||37
6642484|NCT02349061|7570920|FG002|STARTED|Main Study: PCP (Up to Week 24)||0
6642485|NCT02349061|7570918|FG000|COMPLETED|Main Study: PCP (Up to Week 24)||33
6521757|NCT01557244|7442689|FG000|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
6521758|NCT01557244|7442690|FG001|STARTED|Active Comparator/Efficacy Phase:12Weeks||42
6521759|NCT01557244|7442691|FG002|STARTED|Active Comparator/Efficacy Phase:12Weeks||40
6521760|NCT01557244|7442692|FG003|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
6521761|NCT01557244|7442693|FG004|STARTED|Active Comparator/Efficacy Phase:12Weeks||0
6521762|NCT01557244|7442694|FG005|STARTED|Active Comparator/Efficacy Phase:12Weeks||28
6521763|NCT01557244|7442695|FG006|STARTED|Active Comparator/Efficacy Phase:12Weeks||29
6521764|NCT01557244|7442689|FG000|Treated|Active Comparator/Efficacy Phase:12Weeks||42
6521765|NCT01557244|7442690|FG001|Treated|Active Comparator/Efficacy Phase:12Weeks||42
6521766|NCT01557244|7442691|FG002|Treated|Active Comparator/Efficacy Phase:12Weeks||40
6521767|NCT01557244|7442692|FG003|Treated|Active Comparator/Efficacy Phase:12Weeks||0
6521768|NCT01557244|7442693|FG004|Treated|Active Comparator/Efficacy Phase:12Weeks||0
6521769|NCT01557244|7442694|FG005|Treated|Active Comparator/Efficacy Phase:12Weeks||28
6521770|NCT01557244|7442695|FG006|Treated|Active Comparator/Efficacy Phase:12Weeks||29
6521771|NCT01557244|7442689|FG000|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||33
6521772|NCT01557244|7442690|FG001|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||40
6521773|NCT01557244|7442691|FG002|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||36
6521774|NCT01557244|7442692|FG003|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
6521775|NCT01557244|7442693|FG004|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
6521776|NCT01557244|7442694|FG005|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||21
6521777|NCT01557244|7442695|FG006|COMPLETED|Active Comparator/Efficacy Phase:12Weeks||28
6521778|NCT01557244|7442689|FG000|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||9
6521779|NCT01557244|7442690|FG001|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||2
6521780|NCT01557244|7442691|FG002|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||4
6521781|NCT01557244|7442692|FG003|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
6521782|NCT01557244|7442693|FG004|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||0
6521783|NCT01557244|7442694|FG005|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||7
6521784|NCT01557244|7442695|FG006|NOT COMPLETED|Active Comparator/Efficacy Phase:12Weeks||1
6521785|NCT01557244|7442689|FG000|STARTED|Safety Extension Phase: 12 Weeks||33
6521786|NCT01557244|7442690|FG001|STARTED|Safety Extension Phase: 12 Weeks||40
6521787|NCT01557244|7442691|FG002|STARTED|Safety Extension Phase: 12 Weeks|Did not receive oxybutynin in safety extension phase.|0
6521788|NCT01557244|7442692|FG003|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|16
6521789|NCT01557244|7442693|FG004|STARTED|Safety Extension Phase: 12 Weeks|Allocated from oxybutynin arm to this arm by investigator in safety extension phase.|20
6521790|NCT01557244|7442694|FG005|STARTED|Safety Extension Phase: 12 Weeks||21
6521791|NCT01557244|7442695|FG006|STARTED|Safety Extension Phase: 12 Weeks||28
6521792|NCT01557244|7442689|FG000|Treated|Safety Extension Phase: 12 Weeks||30
6521793|NCT01557244|7442690|FG001|Treated|Safety Extension Phase: 12 Weeks||37
6521794|NCT01557244|7442691|FG002|Treated|Safety Extension Phase: 12 Weeks||0
6521795|NCT01557244|7442692|FG003|Treated|Safety Extension Phase: 12 Weeks||16
6521796|NCT01557244|7442693|FG004|Treated|Safety Extension Phase: 12 Weeks||20
6521797|NCT01557244|7442694|FG005|Treated|Safety Extension Phase: 12 Weeks||20
6521798|NCT01557244|7442695|FG006|Treated|Safety Extension Phase: 12 Weeks||28
6521799|NCT01557244|7442689|FG000|COMPLETED|Safety Extension Phase: 12 Weeks||30
6521800|NCT01557244|7442690|FG001|COMPLETED|Safety Extension Phase: 12 Weeks||36
6521801|NCT01557244|7442691|FG002|COMPLETED|Safety Extension Phase: 12 Weeks||0
6521802|NCT01557244|7442692|FG003|COMPLETED|Safety Extension Phase: 12 Weeks||15
6521803|NCT01557244|7442693|FG004|COMPLETED|Safety Extension Phase: 12 Weeks||20
6521804|NCT01557244|7442694|FG005|COMPLETED|Safety Extension Phase: 12 Weeks||20
6521805|NCT01557244|7442695|FG006|COMPLETED|Safety Extension Phase: 12 Weeks||28
6521806|NCT01557244|7442689|FG000|NOT COMPLETED|Safety Extension Phase: 12 Weeks||3
6521807|NCT01557244|7442690|FG001|NOT COMPLETED|Safety Extension Phase: 12 Weeks||4
6521808|NCT01557244|7442691|FG002|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
6521809|NCT01557244|7442692|FG003|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
6521810|NCT01557244|7442693|FG004|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
6521811|NCT01557244|7442694|FG005|NOT COMPLETED|Safety Extension Phase: 12 Weeks||1
6521812|NCT01557244|7442695|FG006|NOT COMPLETED|Safety Extension Phase: 12 Weeks||0
6521813|NCT01557283|7442723|FG000|STARTED|Overall Study||140
6521814|NCT01557283|7442723|FG000|COMPLETED|Overall Study||96
6521815|NCT01557283|7442723|FG000|NOT COMPLETED|Overall Study||44
6521816|NCT01557322|7442729|FG000|STARTED|Overall Study||211
6521817|NCT01557322|7442730|FG001|STARTED|Overall Study||1543
6521818|NCT01557322|7442729|FG000|COMPLETED|Overall Study||211
6521819|NCT01557322|7442730|FG001|COMPLETED|Overall Study||1543
6521820|NCT01557322|7442729|FG000|NOT COMPLETED|Overall Study||0
6521821|NCT01557322|7442730|FG001|NOT COMPLETED|Overall Study||0
6521822|NCT01557348|7442738|FG000|STARTED|Overall Study||604
6521823|NCT01557348|7442739|FG001|STARTED|Overall Study||507
6521824|NCT01557348|7442738|FG000|Safety Population|Overall Study||604
6521825|NCT01557348|7442739|FG001|Safety Population|Overall Study||507
6521826|NCT01557348|7442738|FG000|COMPLETED|Overall Study||524
6521827|NCT01557348|7442739|FG001|COMPLETED|Overall Study||417
6521828|NCT01557348|7442738|FG000|NOT COMPLETED|Overall Study||80
6521829|NCT01557348|7442739|FG001|NOT COMPLETED|Overall Study||90
6521830|NCT01557400|7442746|FG000|STARTED|Overall Study||94
6521831|NCT01557400|7442746|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
6521832|NCT01557400|7442746|FG000|COMPLETED|Overall Study||37
6521833|NCT01557400|7442746|FG000|NOT COMPLETED|Overall Study||57
6521834|NCT01557452|7442750|FG000|STARTED|Overall Study||1
6521835|NCT01557452|7442750|FG000|COMPLETED|Overall Study||1
6521836|NCT01557452|7442750|FG000|NOT COMPLETED|Overall Study||0
6521837|NCT01557504|7442757|FG000|STARTED|Overall Study||13
6521838|NCT01557504|7442758|FG001|STARTED|Overall Study||12
6521839|NCT01557504|7442757|FG000|COMPLETED|Overall Study||12
6521840|NCT01557504|7442758|FG001|COMPLETED|Overall Study||12
6521841|NCT01557504|7442757|FG000|NOT COMPLETED|Overall Study||1
6521842|NCT01557504|7442758|FG001|NOT COMPLETED|Overall Study||0
6521843|NCT01557517|7442772|FG000|STARTED|Overall Study||19
6521844|NCT01557517|7442773|FG001|STARTED|Overall Study||21
6521845|NCT01557517|7442772|FG000|COMPLETED|Overall Study||17
6521846|NCT01557517|7442773|FG001|COMPLETED|Overall Study||17
6521847|NCT01557517|7442772|FG000|NOT COMPLETED|Overall Study||2
6521848|NCT01557517|7442773|FG001|NOT COMPLETED|Overall Study||4
6521849|NCT01557569|7442788|FG000|STARTED|Overall Study|Those who received at least one dose of medication|6
6521850|NCT01557569|7442789|FG001|STARTED|Overall Study|Those who received at least one dose of medication|7
6521851|NCT01557569|7442788|FG000|Completed 2-wk Residential Stay|Overall Study||3
6521852|NCT01557569|7442789|FG001|Completed 2-wk Residential Stay|Overall Study||1
6521853|NCT01557569|7442788|FG000|COMPLETED|Overall Study||1
6521854|NCT01557569|7442789|FG001|COMPLETED|Overall Study||0
6521855|NCT01557569|7442788|FG000|NOT COMPLETED|Overall Study||5
6521856|NCT01557569|7442789|FG001|NOT COMPLETED|Overall Study||7
6521857|NCT01557582|7442795|FG000|STARTED|Overall Study||103
6521858|NCT01557582|7442795|FG000|COMPLETED|Overall Study||97
6521859|NCT01557582|7442795|FG000|NOT COMPLETED|Overall Study||6
6521860|NCT01557595|7442799|FG000|STARTED|Overall Study||22
6521861|NCT01557595|7442799|FG000|COMPLETED|Overall Study||14
6521862|NCT01557595|7442799|FG000|NOT COMPLETED|Overall Study||8
6521863|NCT01557699|7442806|FG000|STARTED|Overall Study||20
6521864|NCT01557699|7442807|FG001|STARTED|Overall Study||20
6521865|NCT01557699|7442808|FG002|STARTED|Overall Study||20
6521866|NCT01557699|7442806|FG000|COMPLETED|Overall Study||20
6521867|NCT01557699|7442807|FG001|COMPLETED|Overall Study||20
6521868|NCT01557699|7442808|FG002|COMPLETED|Overall Study||20
6521869|NCT01557699|7442806|FG000|NOT COMPLETED|Overall Study||0
6521870|NCT01557699|7442807|FG001|NOT COMPLETED|Overall Study||0
6521871|NCT01557699|7442808|FG002|NOT COMPLETED|Overall Study||0
6521872|NCT01557790|7442819|FG000|STARTED|Overall Study||5
6521873|NCT01557790|7442819|FG000|COMPLETED|Overall Study||4
6521874|NCT01557790|7442819|FG000|NOT COMPLETED|Overall Study||1
6521875|NCT01557842|7442825|FG000|STARTED|Overall Study||9
6521876|NCT01557842|7442826|FG001|STARTED|Overall Study||6
6521877|NCT01557842|7442825|FG000|COMPLETED|Overall Study||0
6642486|NCT02349061|7570919|FG001|COMPLETED|Main Study: PCP (Up to Week 24)||56
6642487|NCT02349061|7570920|FG002|COMPLETED|Main Study: PCP (Up to Week 24)||0
6642488|NCT02349061|7570918|FG000|NOT COMPLETED|Main Study: PCP (Up to Week 24)||9
6642489|NCT02349061|7570919|FG001|NOT COMPLETED|Main Study: PCP (Up to Week 24)||4
6642490|NCT02349061|7570920|FG002|NOT COMPLETED|Main Study: PCP (Up to Week 24)||0
6642491|NCT02349061|7570918|FG000|STARTED|Main Study: Week 24 to 56||0
6521878|NCT01557842|7442826|FG001|COMPLETED|Overall Study||0
6521879|NCT01557842|7442825|FG000|NOT COMPLETED|Overall Study||9
6521880|NCT01557842|7442826|FG001|NOT COMPLETED|Overall Study||6
6521881|NCT01557868|7442834|FG000|STARTED|Overall Study||103
6521882|NCT01557868|7442835|FG001|STARTED|Overall Study||95
6521883|NCT01557868|7442834|FG000|COMPLETED|Overall Study||76
6521884|NCT01557868|7442835|FG001|COMPLETED|Overall Study||65
6521885|NCT01557868|7442834|FG000|NOT COMPLETED|Overall Study||27
6521886|NCT01557868|7442835|FG001|NOT COMPLETED|Overall Study||30
6521887|NCT01557894|7442843|FG000|STARTED|Overall Study||38
6521888|NCT01557894|7442844|FG001|STARTED|Overall Study||38
6521889|NCT01557894|7442843|FG000|COMPLETED|Overall Study||35
6521890|NCT01557894|7442844|FG001|COMPLETED|Overall Study||33
6521891|NCT01557894|7442843|FG000|NOT COMPLETED|Overall Study||3
6521892|NCT01557894|7442844|FG001|NOT COMPLETED|Overall Study||5
6521893|NCT01557920|7442851|FG000|STARTED|Overall Study||9
6521894|NCT01557920|7442852|FG001|STARTED|Overall Study||9
6521895|NCT01557920|7442851|FG000|COMPLETED|Overall Study||6
6521896|NCT01557920|7442852|FG001|COMPLETED|Overall Study||6
6521897|NCT01557920|7442851|FG000|NOT COMPLETED|Overall Study||3
6521898|NCT01557920|7442852|FG001|NOT COMPLETED|Overall Study||3
6521899|NCT01557946|7442887|FG000|STARTED|Overall Study||20
6521900|NCT01557946|7442888|FG001|STARTED|Overall Study||12
6521901|NCT01557946|7442887|FG000|COMPLETED|Overall Study|20 consented and scanned - 1 subject's data not used due to ongoing neurological condition.|17
6521902|NCT01557946|7442888|FG001|COMPLETED|Overall Study|2 subjects with unusable imaging data.|12
6521903|NCT01557946|7442887|FG000|NOT COMPLETED|Overall Study||3
6521904|NCT01557946|7442888|FG001|NOT COMPLETED|Overall Study||0
6521905|NCT01557959|7442893|FG000|STARTED|Overall Study||45
6521906|NCT01557959|7442893|FG000|COMPLETED|Overall Study||45
6521907|NCT01557959|7442893|FG000|NOT COMPLETED|Overall Study||0
6521908|NCT01558063|7442905|FG000|STARTED|Overall Study||5
6521909|NCT01558063|7442906|FG001|STARTED|Overall Study||6
6521910|NCT01558063|7442907|FG002|STARTED|Overall Study||8
6521911|NCT01558063|7442908|FG003|STARTED|Overall Study||5
6521912|NCT01558063|7442909|FG004|STARTED|Overall Study||9
6521913|NCT01558063|7442910|FG005|STARTED|Overall Study||5
6521914|NCT01558063|7442905|FG000|COMPLETED|Overall Study||5
6521915|NCT01558063|7442906|FG001|COMPLETED|Overall Study||6
6521916|NCT01558063|7442907|FG002|COMPLETED|Overall Study||8
6521917|NCT01558063|7442908|FG003|COMPLETED|Overall Study||5
6521918|NCT01558063|7442909|FG004|COMPLETED|Overall Study||9
6521919|NCT01558063|7442910|FG005|COMPLETED|Overall Study||5
6521920|NCT01558063|7442905|FG000|NOT COMPLETED|Overall Study||0
6521921|NCT01558063|7442906|FG001|NOT COMPLETED|Overall Study||0
6521922|NCT01558063|7442907|FG002|NOT COMPLETED|Overall Study||0
6521923|NCT01558063|7442908|FG003|NOT COMPLETED|Overall Study||0
6521924|NCT01558063|7442909|FG004|NOT COMPLETED|Overall Study||0
6521925|NCT01558063|7442910|FG005|NOT COMPLETED|Overall Study||0
6521926|NCT01558089|7442919|FG000|STARTED|Overall Study||76
6521927|NCT01558089|7442919|FG000|COMPLETED|Overall Study||63
6521928|NCT01558089|7442919|FG000|NOT COMPLETED|Overall Study||13
6521929|NCT01558128|7442923|FG000|STARTED|Overall Study||1
6521930|NCT01558128|7442923|FG000|COMPLETED|Overall Study||1
6521931|NCT01558128|7442923|FG000|NOT COMPLETED|Overall Study||0
6521932|NCT01558271|7442930|FG000|STARTED|Overall Study||281
6521933|NCT01558271|7442931|FG001|STARTED|Overall Study||70
6521934|NCT01558271|7442932|FG002|STARTED|Overall Study||141
6521935|NCT01558271|7442930|FG000|Received at Least 1 Dose of Study Drug|Overall Study||280
6521936|NCT01558271|7442931|FG001|Received at Least 1 Dose of Study Drug|Overall Study||70
6642492|NCT02349061|7570919|FG001|STARTED|Main Study: Week 24 to 56||56
6642493|NCT02349061|7570920|FG002|STARTED|Main Study: Week 24 to 56||33
6642494|NCT02349061|7570918|FG000|COMPLETED|Main Study: Week 24 to 56||0
6743643|NCT03335254|7671820|FG010|STARTED|Period 2, Day 1-15||0
6743644|NCT03335254|7671821|FG011|STARTED|Period 2, Day 1-15||0
6743645|NCT03335254|7671822|FG012|STARTED|Period 2, Day 1-15||0
6743646|NCT03335254|7671823|FG013|STARTED|Period 2, Day 1-15||0
6743647|NCT03335254|7671824|FG014|STARTED|Period 2, Day 1-15||0
6743648|NCT03335254|7671825|FG015|STARTED|Period 2, Day 1-15||0
6743649|NCT03335254|7671826|FG016|STARTED|Period 2, Day 1-15||0
6743650|NCT03335254|7671827|FG017|STARTED|Period 2, Day 1-15||0
6743651|NCT03335254|7671828|FG018|STARTED|Period 2, Day 1-15||0
6743652|NCT03335254|7671829|FG019|STARTED|Period 2, Day 1-15||0
6743653|NCT03335254|7671810|FG000|COMPLETED|Period 2, Day 1-15||9
6743654|NCT03335254|7671811|FG001|COMPLETED|Period 2, Day 1-15||0
6743655|NCT03335254|7671812|FG002|COMPLETED|Period 2, Day 1-15||0
6743656|NCT03335254|7671813|FG003|COMPLETED|Period 2, Day 1-15||0
6743657|NCT03335254|7671814|FG004|COMPLETED|Period 2, Day 1-15||0
6743658|NCT03335254|7671815|FG005|COMPLETED|Period 2, Day 1-15||0
6743659|NCT03335254|7671816|FG006|COMPLETED|Period 2, Day 1-15||0
6743660|NCT03335254|7671817|FG007|COMPLETED|Period 2, Day 1-15||0
6743661|NCT03335254|7671818|FG008|COMPLETED|Period 2, Day 1-15||0
6743662|NCT03335254|7671819|FG009|COMPLETED|Period 2, Day 1-15||0
6743663|NCT03335254|7671820|FG010|COMPLETED|Period 2, Day 1-15||0
6743664|NCT03335254|7671821|FG011|COMPLETED|Period 2, Day 1-15||0
6521937|NCT01558271|7442932|FG002|Received at Least 1 Dose of Study Drug|Overall Study||137
6521938|NCT01558271|7442930|FG000|Completed 26 Weeks|Overall Study||271
6521939|NCT01558271|7442931|FG001|Completed 26 Weeks|Overall Study||63
6521940|NCT01558271|7442932|FG002|Completed 26 Weeks|Overall Study||128
6521941|NCT01558271|7442930|FG000|COMPLETED|Overall Study||263
6521942|NCT01558271|7442931|FG001|COMPLETED|Overall Study||59
6521943|NCT01558271|7442932|FG002|COMPLETED|Overall Study||124
6521944|NCT01558271|7442930|FG000|NOT COMPLETED|Overall Study||18
6521945|NCT01558271|7442931|FG001|NOT COMPLETED|Overall Study||11
6521946|NCT01558271|7442932|FG002|NOT COMPLETED|Overall Study||17
6521947|NCT01558297|7442947|FG000|STARTED|Overall Study||30
6521948|NCT01558297|7442948|FG001|STARTED|Overall Study||29
6521949|NCT01558297|7442949|FG002|STARTED|Overall Study||30
6521950|NCT01558297|7442947|FG000|COMPLETED|Overall Study||28
6521951|NCT01558297|7442948|FG001|COMPLETED|Overall Study||27
6521952|NCT01558297|7442949|FG002|COMPLETED|Overall Study||29
6521953|NCT01558297|7442947|FG000|NOT COMPLETED|Overall Study||2
6521954|NCT01558297|7442948|FG001|NOT COMPLETED|Overall Study||2
6521955|NCT01558297|7442949|FG002|NOT COMPLETED|Overall Study||1
6521956|NCT01558596|7442959|FG000|STARTED|Overall Study||104
6521957|NCT01558596|7442960|FG001|STARTED|Overall Study||101
6521958|NCT01558596|7442959|FG000|COMPLETED|Overall Study||101
6521959|NCT01558596|7442960|FG001|COMPLETED|Overall Study||100
6521960|NCT01558596|7442959|FG000|NOT COMPLETED|Overall Study||3
6521961|NCT01558596|7442960|FG001|NOT COMPLETED|Overall Study||1
6521962|NCT01558635|7442966|FG000|STARTED|Overall Study||17
6521963|NCT01558635|7442966|FG000|Treated|Overall Study||17
6642495|NCT02349061|7570919|FG001|COMPLETED|Main Study: Week 24 to 56||53
6642496|NCT02349061|7570920|FG002|COMPLETED|Main Study: Week 24 to 56||30
6642497|NCT02349061|7570918|FG000|NOT COMPLETED|Main Study: Week 24 to 56||0
6642498|NCT02349061|7570919|FG001|NOT COMPLETED|Main Study: Week 24 to 56||3
6642499|NCT02349061|7570920|FG002|NOT COMPLETED|Main Study: Week 24 to 56||3
6642500|NCT02349061|7570918|FG000|STARTED|Study Extension (Week 56 to Week 120)||0
6743665|NCT03335254|7671822|FG012|COMPLETED|Period 2, Day 1-15||0
6743666|NCT03335254|7671823|FG013|COMPLETED|Period 2, Day 1-15||0
6743667|NCT03335254|7671824|FG014|COMPLETED|Period 2, Day 1-15||0
6743668|NCT03335254|7671825|FG015|COMPLETED|Period 2, Day 1-15||0
6521964|NCT01558635|7442966|FG000|Discharge /1 Month Post-procedure|Overall Study||15
6521965|NCT01558635|7442966|FG000|3 Months Post-procedure|Overall Study||14
6521966|NCT01558635|7442966|FG000|6 Months Post-procedure|Overall Study||14
6521967|NCT01558635|7442966|FG000|COMPLETED|Overall Study||11
6521968|NCT01558635|7442966|FG000|NOT COMPLETED|Overall Study||6
6521969|NCT01558661|7442977|FG000|STARTED|Overall Study||33
6521970|NCT01558661|7442977|FG000|First Stage|Overall Study||18
6521971|NCT01558661|7442977|FG000|Second Stage|Overall Study||15
6521972|NCT01558661|7442977|FG000|COMPLETED|Overall Study||33
6521973|NCT01558661|7442977|FG000|NOT COMPLETED|Overall Study||0
6521974|NCT01558674|7442983|FG000|STARTED|Part 1||11
6521975|NCT01558674|7442984|FG001|STARTED|Part 1||0
6521976|NCT01558674|7442983|FG000|COMPLETED|Part 1||0
6521977|NCT01558674|7442984|FG001|COMPLETED|Part 1||0
6521978|NCT01558674|7442983|FG000|NOT COMPLETED|Part 1||11
6521979|NCT01558674|7442984|FG001|NOT COMPLETED|Part 1||0
6521980|NCT01558674|7442983|FG000|STARTED|Part 2||0
6521981|NCT01558674|7442984|FG001|STARTED|Part 2||0
6521982|NCT01558674|7442983|FG000|COMPLETED|Part 2||0
6521983|NCT01558674|7442984|FG001|COMPLETED|Part 2||0
6521984|NCT01558674|7442983|FG000|NOT COMPLETED|Part 2||0
6521985|NCT01558674|7442984|FG001|NOT COMPLETED|Part 2||0
6521986|NCT01558700|7443005|FG000|STARTED|Overall Study||19
6521987|NCT01558700|7443006|FG001|STARTED|Overall Study||21
6521988|NCT01558700|7443005|FG000|COMPLETED|Overall Study||19
6521989|NCT01558700|7443006|FG001|COMPLETED|Overall Study||21
6521990|NCT01558700|7443005|FG000|NOT COMPLETED|Overall Study||0
6521991|NCT01558700|7443006|FG001|NOT COMPLETED|Overall Study||0
6521992|NCT01558739|7443012|FG000|STARTED|Overall Study||48
6521993|NCT01558739|7443012|FG000|COMPLETED|Overall Study||31
6521994|NCT01558739|7443012|FG000|NOT COMPLETED|Overall Study||17
6521995|NCT01558752|7443018|FG000|STARTED|Overall Study||42
6521996|NCT01558752|7443019|FG001|STARTED|Overall Study||46
6521997|NCT01558752|7443018|FG000|COMPLETED|Overall Study||40
6521998|NCT01558752|7443019|FG001|COMPLETED|Overall Study||46
6521999|NCT01558752|7443018|FG000|NOT COMPLETED|Overall Study||2
6522000|NCT01558752|7443019|FG001|NOT COMPLETED|Overall Study||0
6522001|NCT01558791|7443027|FG000|STARTED|Overall Study||607
6522002|NCT01558791|7443028|FG001|STARTED|Overall Study||629
6522003|NCT01558791|7443027|FG000|COMPLETED|Overall Study||607
6522004|NCT01558791|7443028|FG001|COMPLETED|Overall Study||629
6522005|NCT01558791|7443027|FG000|NOT COMPLETED|Overall Study||0
6522006|NCT01558791|7443028|FG001|NOT COMPLETED|Overall Study||0
6522007|NCT01559012|7443038|FG000|STARTED|Overall Study||6
6522008|NCT01559012|7443039|FG001|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
6522009|NCT01559012|7443038|FG000|COMPLETED|Overall Study||6
6522010|NCT01559012|7443039|FG001|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
6522011|NCT01559012|7443038|FG000|NOT COMPLETED|Overall Study||0
6522012|NCT01559012|7443039|FG001|NOT COMPLETED|Overall Study||1
6522013|NCT01559064|7443063|FG000|STARTED|Overall Study||16
6522014|NCT01559064|7443064|FG001|STARTED|Overall Study||40
6522015|NCT01559064|7443065|FG002|STARTED|Overall Study||59
6522016|NCT01559064|7443063|FG000|COMPLETED|Overall Study||15
6522017|NCT01559064|7443064|FG001|COMPLETED|Overall Study||39
6522018|NCT01559064|7443065|FG002|COMPLETED|Overall Study||57
6522019|NCT01559064|7443063|FG000|NOT COMPLETED|Overall Study||1
6522020|NCT01559064|7443064|FG001|NOT COMPLETED|Overall Study||1
6522021|NCT01559064|7443065|FG002|NOT COMPLETED|Overall Study||2
6522022|NCT01559090|7443076|FG000|STARTED|Stage I||6
6522023|NCT01559090|7443077|FG001|STARTED|Stage I||5
6522024|NCT01559090|7443078|FG002|STARTED|Stage I||6
6522025|NCT01559090|7443076|FG000|COMPLETED|Stage I||4
6522026|NCT01559090|7443077|FG001|COMPLETED|Stage I||3
6522027|NCT01559090|7443078|FG002|COMPLETED|Stage I||3
6522028|NCT01559090|7443076|FG000|NOT COMPLETED|Stage I||2
6522029|NCT01559090|7443077|FG001|NOT COMPLETED|Stage I||2
6522030|NCT01559090|7443078|FG002|NOT COMPLETED|Stage I||3
6522031|NCT01559090|7443076|FG000|STARTED|Stage II||4
6522032|NCT01559090|7443077|FG001|STARTED|Stage II||3
6522033|NCT01559090|7443078|FG002|STARTED|Stage II|One subject who completed Stage I did not agree to participate in Stage II|2
6522034|NCT01559090|7443076|FG000|COMPLETED|Stage II||3
6522035|NCT01559090|7443077|FG001|COMPLETED|Stage II||3
6522036|NCT01559090|7443078|FG002|COMPLETED|Stage II||2
6522037|NCT01559090|7443076|FG000|NOT COMPLETED|Stage II||1
6522038|NCT01559090|7443077|FG001|NOT COMPLETED|Stage II||0
6522039|NCT01559090|7443078|FG002|NOT COMPLETED|Stage II||0
6522040|NCT01559116|7443086|FG000|STARTED|Overall Study|Randomised|219
6522041|NCT01559116|7443086|FG000|COMPLETED|Overall Study|Completed all 4 treatment periods|193
6522042|NCT01559116|7443086|FG000|NOT COMPLETED|Overall Study||26
6522043|NCT01559129|7443105|FG000|STARTED|Treatment Phase||12
6522044|NCT01559129|7443106|FG001|STARTED|Treatment Phase||11
6522045|NCT01559129|7443105|FG000|Received Treatment|Treatment Phase||12
6522046|NCT01559129|7443106|FG001|Received Treatment|Treatment Phase||10
6522047|NCT01559129|7443105|FG000|COMPLETED|Treatment Phase||7
6522048|NCT01559129|7443106|FG001|COMPLETED|Treatment Phase||4
6522049|NCT01559129|7443105|FG000|NOT COMPLETED|Treatment Phase||5
6522050|NCT01559129|7443106|FG001|NOT COMPLETED|Treatment Phase||7
6522051|NCT01559129|7443105|FG000|STARTED|Open-label Extension Period|One participant elected not to enter the Extension Phase.|6
6522052|NCT01559129|7443106|FG001|STARTED|Open-label Extension Period|Two participants elected not to enter the Extension Phase.|2
6522053|NCT01559129|7443105|FG000|COMPLETED|Open-label Extension Period||0
6522054|NCT01559129|7443106|FG001|COMPLETED|Open-label Extension Period||0
6522055|NCT01559129|7443105|FG000|NOT COMPLETED|Open-label Extension Period||6
6522056|NCT01559129|7443106|FG001|NOT COMPLETED|Open-label Extension Period||2
6522057|NCT01559259|7443123|FG000|STARTED|Overall Study||30
6522058|NCT01559259|7443124|FG001|STARTED|Overall Study||90
6522059|NCT01559259|7443125|FG002|STARTED|Overall Study||93
6522060|NCT01559259|7443126|FG003|STARTED|Overall Study||89
6522061|NCT01559259|7443127|FG004|STARTED|Overall Study||92
6522062|NCT01559259|7443123|FG000|COMPLETED|Overall Study||30
6522063|NCT01559259|7443124|FG001|COMPLETED|Overall Study||89
6522064|NCT01559259|7443125|FG002|COMPLETED|Overall Study||92
6522065|NCT01559259|7443126|FG003|COMPLETED|Overall Study||88
6522066|NCT01559259|7443127|FG004|COMPLETED|Overall Study||92
6522067|NCT01559259|7443123|FG000|NOT COMPLETED|Overall Study||0
6522068|NCT01559259|7443124|FG001|NOT COMPLETED|Overall Study||1
6522069|NCT01559259|7443125|FG002|NOT COMPLETED|Overall Study||1
6522070|NCT01559259|7443126|FG003|NOT COMPLETED|Overall Study||1
6522071|NCT01559259|7443127|FG004|NOT COMPLETED|Overall Study||0
6522072|NCT01559311|7443142|FG000|STARTED|Overall Study|Enrollment & Baseline|30
6522073|NCT01559311|7443143|FG001|STARTED|Overall Study|Enrollment & Baseline|34
6522074|NCT01559311|7443144|FG002|STARTED|Overall Study|Enrollment & Baseline|34
6522075|NCT01559311|7443142|FG000|Implant|Overall Study||28
6522076|NCT01559311|7443143|FG001|Implant|Overall Study||34
6522077|NCT01559311|7443144|FG002|Implant|Overall Study||32
6522078|NCT01559311|7443142|FG000|1-Month|Overall Study||27
6522079|NCT01559311|7443143|FG001|1-Month|Overall Study||34
6522080|NCT01559311|7443144|FG002|1-Month|Overall Study||29
6522081|NCT01559311|7443142|FG000|3-Month|Overall Study||27
6522082|NCT01559311|7443143|FG001|3-Month|Overall Study||34
6522083|NCT01559311|7443144|FG002|3-Month|Overall Study||29
6522084|NCT01559311|7443142|FG000|6-Month|Overall Study||27
6522085|NCT01559311|7443143|FG001|6-Month|Overall Study||33
6522086|NCT01559311|7443144|FG002|6-Month|Overall Study||28
6522087|NCT01559311|7443142|FG000|COMPLETED|Overall Study|12-Month|27
6522088|NCT01559311|7443143|FG001|COMPLETED|Overall Study|12-Month|28
6522089|NCT01559311|7443144|FG002|COMPLETED|Overall Study|12-Month|26
6522090|NCT01559311|7443142|FG000|NOT COMPLETED|Overall Study||3
6522091|NCT01559311|7443143|FG001|NOT COMPLETED|Overall Study||6
6522092|NCT01559311|7443144|FG002|NOT COMPLETED|Overall Study||8
6522093|NCT01559389|7443154|FG000|STARTED|Overall Study||69
6522094|NCT01559389|7443155|FG001|STARTED|Overall Study||69
6522095|NCT01559389|7443154|FG000|COMPLETED|Overall Study||49
6522096|NCT01559389|7443155|FG001|COMPLETED|Overall Study||49
6522097|NCT01559389|7443154|FG000|NOT COMPLETED|Overall Study||20
6522098|NCT01559389|7443155|FG001|NOT COMPLETED|Overall Study||20
6522099|NCT01559454|7443167|FG000|STARTED|Overall Study||9
6522100|NCT01559454|7443168|FG001|STARTED|Overall Study||10
6522101|NCT01559454|7443167|FG000|COMPLETED|Overall Study||6
6522102|NCT01559454|7443168|FG001|COMPLETED|Overall Study||4
6522103|NCT01559454|7443167|FG000|NOT COMPLETED|Overall Study||3
6522104|NCT01559454|7443168|FG001|NOT COMPLETED|Overall Study||6
6522105|NCT01559506|7443176|FG000|STARTED|Overall Study||20
6522106|NCT01559506|7443177|FG001|STARTED|Overall Study||21
6522107|NCT01559506|7443176|FG000|COMPLETED|Overall Study||20
6522108|NCT01559506|7443177|FG001|COMPLETED|Overall Study||18
6522109|NCT01559506|7443176|FG000|NOT COMPLETED|Overall Study||0
6522110|NCT01559506|7443177|FG001|NOT COMPLETED|Overall Study||3
6522111|NCT01559649|7443185|FG000|STARTED|Overall Study||269
6522112|NCT01559649|7443186|FG001|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
6522113|NCT01559649|7443185|FG000|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
6522114|NCT01559649|7443186|FG001|COMPLETED|Overall Study||9
6522115|NCT01559649|7443185|FG000|NOT COMPLETED|Overall Study||19
6522116|NCT01559649|7443186|FG001|NOT COMPLETED|Overall Study||6
6522117|NCT01559675|7443195|FG000|STARTED|Overall Study||58
6522118|NCT01559675|7443196|FG001|STARTED|Overall Study||63
6522119|NCT01559675|7443195|FG000|COMPLETED|Overall Study||43
6522120|NCT01559675|7443196|FG001|COMPLETED|Overall Study||49
6522121|NCT01559675|7443195|FG000|NOT COMPLETED|Overall Study||15
6522122|NCT01559675|7443196|FG001|NOT COMPLETED|Overall Study||14
6522123|NCT01559844|7443202|FG000|STARTED|Overall Study||61
6522124|NCT01559844|7443202|FG000|COMPLETED|Overall Study||36
6522125|NCT01559844|7443202|FG000|NOT COMPLETED|Overall Study||25
6522126|NCT01559857|7443208|FG000|STARTED|Overall Study||19
6522127|NCT01559857|7443209|FG001|STARTED|Overall Study||18
6522128|NCT01559857|7443208|FG000|COMPLETED|Overall Study||19
6522129|NCT01559857|7443209|FG001|COMPLETED|Overall Study||18
6522130|NCT01559857|7443208|FG000|NOT COMPLETED|Overall Study||0
6522131|NCT01559857|7443209|FG001|NOT COMPLETED|Overall Study||0
6522132|NCT01559922|7443219|FG000|STARTED|Overall Study||50
6522133|NCT01559922|7443220|FG001|STARTED|Overall Study||97
6522134|NCT01559922|7443219|FG000|COMPLETED|Overall Study||46
6522135|NCT01559922|7443220|FG001|COMPLETED|Overall Study||87
6522136|NCT01559922|7443219|FG000|NOT COMPLETED|Overall Study||4
6522137|NCT01559922|7443220|FG001|NOT COMPLETED|Overall Study||10
6522138|NCT01559935|7443226|FG000|STARTED|Car Phase||72
6522139|NCT01559935|7443226|FG000|COMPLETED|Car Phase||58
6522140|NCT01559935|7443226|FG000|NOT COMPLETED|Car Phase||14
6522141|NCT01559935|7443226|FG000|STARTED|BiRD Phase||58
6522142|NCT01559935|7443226|FG000|COMPLETED|BiRD Phase||54
6522143|NCT01559935|7443226|FG000|NOT COMPLETED|BiRD Phase||4
6522144|NCT01559935|7443226|FG000|STARTED|Maintenance Phase||54
6522145|NCT01559935|7443226|FG000|COMPLETED|Maintenance Phase||0
6522146|NCT01559935|7443226|FG000|NOT COMPLETED|Maintenance Phase||54
6522147|NCT01559948|7443232|FG000|STARTED|Overall Study||15
6522148|NCT01559948|7443233|FG001|STARTED|Overall Study||15
6522149|NCT01559948|7443232|FG000|COMPLETED|Overall Study||15
6522150|NCT01559948|7443233|FG001|COMPLETED|Overall Study||15
6522151|NCT01559948|7443232|FG000|NOT COMPLETED|Overall Study||0
6522152|NCT01559948|7443233|FG001|NOT COMPLETED|Overall Study||0
6522153|NCT01560143|7443243|FG000|STARTED|Overall Study||12
6522154|NCT01560143|7443243|FG000|COMPLETED|Overall Study||12
6522155|NCT01560143|7443243|FG000|NOT COMPLETED|Overall Study||0
6522156|NCT01560234|7443255|FG000|STARTED|Overall Study||16
6522157|NCT01560234|7443256|FG001|STARTED|Overall Study||4
6522158|NCT01560234|7443257|FG002|STARTED|Overall Study||4
6522159|NCT01560234|7443258|FG003|STARTED|Overall Study||3
6522160|NCT01560234|7443259|FG004|STARTED|Overall Study||4
6522161|NCT01560234|7443260|FG005|STARTED|Overall Study||4
6522162|NCT01560234|7443261|FG006|STARTED|Overall Study||4
6522163|NCT01560234|7443262|FG007|STARTED|Overall Study||8
6522164|NCT01560234|7443255|FG000|COMPLETED|Overall Study||13
6522165|NCT01560234|7443256|FG001|COMPLETED|Overall Study||4
6522166|NCT01560234|7443257|FG002|COMPLETED|Overall Study||3
6522167|NCT01560234|7443258|FG003|COMPLETED|Overall Study||3
6522168|NCT01560234|7443259|FG004|COMPLETED|Overall Study||4
6522169|NCT01560234|7443260|FG005|COMPLETED|Overall Study||2
6522170|NCT01560234|7443261|FG006|COMPLETED|Overall Study||4
6522171|NCT01560234|7443262|FG007|COMPLETED|Overall Study||6
6522172|NCT01560234|7443255|FG000|NOT COMPLETED|Overall Study||3
6522173|NCT01560234|7443256|FG001|NOT COMPLETED|Overall Study||0
6522174|NCT01560234|7443257|FG002|NOT COMPLETED|Overall Study||1
6522175|NCT01560234|7443258|FG003|NOT COMPLETED|Overall Study||0
6522176|NCT01560234|7443259|FG004|NOT COMPLETED|Overall Study||0
6522177|NCT01560234|7443260|FG005|NOT COMPLETED|Overall Study||2
6522178|NCT01560234|7443261|FG006|NOT COMPLETED|Overall Study||0
6522179|NCT01560234|7443262|FG007|NOT COMPLETED|Overall Study||2
6522180|NCT01560260|7443280|FG000|STARTED|Overall Study||20
6522181|NCT01560260|7443280|FG000|COMPLETED|Overall Study||20
6522182|NCT01560260|7443280|FG000|NOT COMPLETED|Overall Study||0
6522183|NCT01560286|7443286|FG000|STARTED|Overall Study||24
6522184|NCT01560286|7443286|FG000|COMPLETED|Overall Study||24
6522185|NCT01560286|7443286|FG000|NOT COMPLETED|Overall Study||0
6522186|NCT01560377|7443290|FG000|STARTED|Overall Study||147
6522187|NCT01560377|7443290|FG000|Eligible for Analysis|Overall Study||139
6522188|NCT01560377|7443290|FG000|COMPLETED|Overall Study||147
6522189|NCT01560377|7443290|FG000|NOT COMPLETED|Overall Study||0
6522190|NCT01560403|7443296|FG000|STARTED|Overall Study||5
6522191|NCT01560403|7443297|FG001|STARTED|Overall Study||9
6522192|NCT01560403|7443296|FG000|COMPLETED|Overall Study||5
6522193|NCT01560403|7443297|FG001|COMPLETED|Overall Study||8
6522194|NCT01560403|7443296|FG000|NOT COMPLETED|Overall Study||0
6522195|NCT01560403|7443297|FG001|NOT COMPLETED|Overall Study||1
6522196|NCT01560416|7443305|FG000|STARTED|Randomized Phase||15
6522197|NCT01560416|7443306|FG001|STARTED|Randomized Phase||35
6522198|NCT01560416|7443305|FG000|COMPLETED|Randomized Phase||8
6522199|NCT01560416|7443306|FG001|COMPLETED|Randomized Phase||35
6522200|NCT01560416|7443305|FG000|NOT COMPLETED|Randomized Phase||7
6522201|NCT01560416|7443306|FG001|NOT COMPLETED|Randomized Phase||0
6522202|NCT01560416|7443305|FG000|STARTED|Crossover Phase||7
6522203|NCT01560416|7443306|FG001|STARTED|Crossover Phase||0
6522204|NCT01560416|7443305|FG000|COMPLETED|Crossover Phase||7
6522205|NCT01560416|7443306|FG001|COMPLETED|Crossover Phase||0
6522206|NCT01560416|7443305|FG000|NOT COMPLETED|Crossover Phase||0
6522207|NCT01560416|7443306|FG001|NOT COMPLETED|Crossover Phase||0
6522208|NCT01560429|7443316|FG000|STARTED|Overall Study||26
6522209|NCT01560429|7443317|FG001|STARTED|Overall Study||26
6522210|NCT01560429|7443316|FG000|COMPLETED|Overall Study||23
6522211|NCT01560429|7443317|FG001|COMPLETED|Overall Study||20
6522212|NCT01560429|7443316|FG000|NOT COMPLETED|Overall Study||3
6522213|NCT01560429|7443317|FG001|NOT COMPLETED|Overall Study||6
6522214|NCT01560624|7443327|FG000|STARTED|Overall Study||346
6522215|NCT01560624|7443328|FG001|STARTED|Overall Study||344
6522216|NCT01560624|7443327|FG000|Clinical Worsening Event|Overall Study||91
6522217|NCT01560624|7443328|FG001|Clinical Worsening Event|Overall Study||133
6522218|NCT01560624|7443327|FG000|Early Discontinuation From Treatment|Overall Study||107
6522219|NCT01560624|7443328|FG001|Early Discontinuation From Treatment|Overall Study||56
6522220|NCT01560624|7443327|FG000|COMPLETED|Overall Study||148
6522221|NCT01560624|7443328|FG001|COMPLETED|Overall Study||155
6522222|NCT01560624|7443327|FG000|NOT COMPLETED|Overall Study||198
6522223|NCT01560624|7443328|FG001|NOT COMPLETED|Overall Study||189
6522224|NCT01560780|7443336|FG000|STARTED|Overall Study||42
6522225|NCT01560780|7443337|FG001|STARTED|Overall Study||42
6522226|NCT01560780|7443336|FG000|Clinical Follow-Up at 12 Months|Overall Study||42
6522227|NCT01560780|7443337|FG001|Clinical Follow-Up at 12 Months|Overall Study||42
6522228|NCT01560780|7443336|FG000|Completed Study Drug for 12 Months|Overall Study||27
6522229|NCT01560780|7443337|FG001|Completed Study Drug for 12 Months|Overall Study||27
6522230|NCT01560780|7443336|FG000|COMPLETED|Overall Study||29
6522231|NCT01560780|7443337|FG001|COMPLETED|Overall Study||30
6522232|NCT01560780|7443336|FG000|NOT COMPLETED|Overall Study||13
6522233|NCT01560780|7443337|FG001|NOT COMPLETED|Overall Study||12
6522234|NCT01560819|7443345|FG000|STARTED|Overall Study||10
6522235|NCT01560819|7443346|FG001|STARTED|Overall Study||10
6522236|NCT01560819|7443345|FG000|COMPLETED|Overall Study||9
6522237|NCT01560819|7443346|FG001|COMPLETED|Overall Study||10
6522238|NCT01560819|7443345|FG000|NOT COMPLETED|Overall Study||1
6522239|NCT01560819|7443346|FG001|NOT COMPLETED|Overall Study||0
6522240|NCT01560871|7443352|FG000|STARTED|Overall Study||9
6522241|NCT01560871|7443353|FG001|STARTED|Overall Study||7
6522242|NCT01560871|7443352|FG000|COMPLETED|Overall Study||3
6522243|NCT01560871|7443353|FG001|COMPLETED|Overall Study||5
6522244|NCT01560871|7443352|FG000|NOT COMPLETED|Overall Study||6
6522245|NCT01560871|7443353|FG001|NOT COMPLETED|Overall Study||2
6522246|NCT01560923|7443362|FG000|STARTED|Overall Study||24
6522247|NCT01560923|7443363|FG001|STARTED|Overall Study||22
6522248|NCT01560923|7443362|FG000|COMPLETED|Overall Study||24
6522249|NCT01560923|7443363|FG001|COMPLETED|Overall Study||22
6522250|NCT01560923|7443362|FG000|NOT COMPLETED|Overall Study||0
6522251|NCT01560923|7443363|FG001|NOT COMPLETED|Overall Study||0
6522252|NCT01560949|7443369|FG000|STARTED|Systemic Phase: mFOLFIRINOX||33
6522253|NCT01560949|7443369|FG000|COMPLETED|Systemic Phase: mFOLFIRINOX||27
6522254|NCT01560949|7443369|FG000|NOT COMPLETED|Systemic Phase: mFOLFIRINOX||6
6522255|NCT01560949|7443369|FG000|STARTED|Chemoradiation Phase: With Gemcitabine||23
6522256|NCT01560949|7443369|FG000|COMPLETED|Chemoradiation Phase: With Gemcitabine||23
6522257|NCT01560949|7443369|FG000|NOT COMPLETED|Chemoradiation Phase: With Gemcitabine||0
6522258|NCT01560949|7443369|FG000|STARTED|Surgery Phase||18
6522259|NCT01560949|7443369|FG000|COMPLETED|Surgery Phase||15
6522260|NCT01560949|7443369|FG000|NOT COMPLETED|Surgery Phase||3
6522261|NCT01560975|7443377|FG000|STARTED|Overall Study||10
6522262|NCT01560975|7443377|FG000|COMPLETED|Overall Study||10
6522263|NCT01560975|7443377|FG000|NOT COMPLETED|Overall Study||0
6561669|NCT01795716|7484526|FG000|NOT COMPLETED|Washout (10 Days)||0
6561670|NCT01795716|7484527|FG001|NOT COMPLETED|Washout (10 Days)||0
6561671|NCT01795716|7484526|FG000|STARTED|Second Intervention (13 Days)||10
6561672|NCT01795716|7484527|FG001|STARTED|Second Intervention (13 Days)||11
6561673|NCT01795716|7484526|FG000|COMPLETED|Second Intervention (13 Days)||10
6561674|NCT01795716|7484527|FG001|COMPLETED|Second Intervention (13 Days)||11
6561675|NCT01795716|7484526|FG000|NOT COMPLETED|Second Intervention (13 Days)||0
6561676|NCT01795716|7484527|FG001|NOT COMPLETED|Second Intervention (13 Days)||0
6561677|NCT01795833|7484537|FG000|STARTED|Overall Study||1031
6561678|NCT01795833|7484538|FG001|STARTED|Overall Study||1031
6561679|NCT01795833|7484537|FG000|COMPLETED|Overall Study||881
6561680|NCT01795833|7484538|FG001|COMPLETED|Overall Study||882
6561681|NCT01795833|7484537|FG000|NOT COMPLETED|Overall Study||150
6561682|NCT01795833|7484538|FG001|NOT COMPLETED|Overall Study||149
6561683|NCT01795859|7484546|FG000|STARTED|Overall Study||45
6561684|NCT01795859|7484547|FG001|STARTED|Overall Study||45
6561685|NCT01795859|7484546|FG000|COMPLETED|Overall Study||44
6561686|NCT01795859|7484547|FG001|COMPLETED|Overall Study||43
6561687|NCT01795859|7484546|FG000|NOT COMPLETED|Overall Study||1
6561688|NCT01795859|7484547|FG001|NOT COMPLETED|Overall Study||2
6561689|NCT01795898|7484553|FG000|STARTED|Overall Study||237
6561690|NCT01795898|7484553|FG000|COMPLETED|Overall Study||177
6561691|NCT01795898|7484553|FG000|NOT COMPLETED|Overall Study||60
6561692|NCT01795937|7484560|FG000|STARTED|Overall Study||18
6561693|NCT01795937|7484561|FG001|STARTED|Overall Study||16
6561694|NCT01795937|7484562|FG002|STARTED|Overall Study||17
6561695|NCT01795937|7484560|FG000|COMPLETED|Overall Study||17
6561696|NCT01795937|7484561|FG001|COMPLETED|Overall Study||15
6561697|NCT01795937|7484562|FG002|COMPLETED|Overall Study||17
6561698|NCT01795937|7484560|FG000|NOT COMPLETED|Overall Study||1
6561699|NCT01795937|7484561|FG001|NOT COMPLETED|Overall Study||1
6561700|NCT01795937|7484562|FG002|NOT COMPLETED|Overall Study||0
6561701|NCT01796236|7484580|FG000|STARTED|Overall Study||51
6561702|NCT01796236|7484581|FG001|STARTED|Overall Study||52
6561703|NCT01796236|7484580|FG000|COMPLETED|Overall Study||49
6561704|NCT01796236|7484581|FG001|COMPLETED|Overall Study||50
6561705|NCT01796236|7484580|FG000|NOT COMPLETED|Overall Study||2
6561706|NCT01796236|7484581|FG001|NOT COMPLETED|Overall Study||2
6561707|NCT01796301|7484590|FG000|STARTED|Overall Study||218
6561708|NCT01796301|7484591|FG001|STARTED|Overall Study||218
6561709|NCT01796301|7484590|FG000|Received Treatment|Overall Study||214
6561710|NCT01796301|7484591|FG001|Received Treatment|Overall Study||218
6561711|NCT01796301|7484590|FG000|COMPLETED|Overall Study||200
6561712|NCT01796301|7484591|FG001|COMPLETED|Overall Study||198
6561713|NCT01796301|7484590|FG000|NOT COMPLETED|Overall Study||18
6561714|NCT01796301|7484591|FG001|NOT COMPLETED|Overall Study||20
6561715|NCT01796392|7484599|FG000|STARTED|Overall Study||128
6561716|NCT01796392|7484600|FG001|STARTED|Overall Study||62
6561717|NCT01796392|7484599|FG000|COMPLETED|Overall Study|119 active subjects at 12-months|119
6561718|NCT01796392|7484600|FG001|COMPLETED|Overall Study|59 active subjects at 12-months|59
6561719|NCT01796392|7484599|FG000|NOT COMPLETED|Overall Study||9
6561720|NCT01796392|7484600|FG001|NOT COMPLETED|Overall Study||3
6562892|NCT01803282|7485794|FG009|COMPLETED|Overall Study||0
6562893|NCT01803282|7485795|FG010|COMPLETED|Overall Study||0
6562894|NCT01803282|7485796|FG011|COMPLETED|Overall Study||0
6562895|NCT01803282|7485785|FG000|NOT COMPLETED|Overall Study||4
6562896|NCT01803282|7485786|FG001|NOT COMPLETED|Overall Study||3
6562897|NCT01803282|7485787|FG002|NOT COMPLETED|Overall Study||6
6562898|NCT01803282|7485788|FG003|NOT COMPLETED|Overall Study||36
6562899|NCT01803282|7485789|FG004|NOT COMPLETED|Overall Study||11
6562900|NCT01803282|7485790|FG005|NOT COMPLETED|Overall Study||10
6562901|NCT01803282|7485791|FG006|NOT COMPLETED|Overall Study||41
6562902|NCT01803282|7485792|FG007|NOT COMPLETED|Overall Study||46
6562903|NCT01803282|7485793|FG008|NOT COMPLETED|Overall Study||11
6562904|NCT01803282|7485794|FG009|NOT COMPLETED|Overall Study||45
6562905|NCT01803282|7485795|FG010|NOT COMPLETED|Overall Study||8
6562906|NCT01803282|7485796|FG011|NOT COMPLETED|Overall Study||15
6522264|NCT01560988|7443385|FG000|STARTED|First Intervention (Six Weeks)||32
6522265|NCT01560988|7443386|FG001|STARTED|First Intervention (Six Weeks)||30
6522266|NCT01560988|7443385|FG000|COMPLETED|First Intervention (Six Weeks)||22
6522267|NCT01560988|7443386|FG001|COMPLETED|First Intervention (Six Weeks)||26
6522268|NCT01560988|7443385|FG000|NOT COMPLETED|First Intervention (Six Weeks)||10
6522269|NCT01560988|7443386|FG001|NOT COMPLETED|First Intervention (Six Weeks)||4
6522270|NCT01560988|7443385|FG000|STARTED|Washout (Six Weeks)||22
6522271|NCT01560988|7443386|FG001|STARTED|Washout (Six Weeks)||26
6522272|NCT01560988|7443385|FG000|COMPLETED|Washout (Six Weeks)||20
6522273|NCT01560988|7443386|FG001|COMPLETED|Washout (Six Weeks)||24
6522274|NCT01560988|7443385|FG000|NOT COMPLETED|Washout (Six Weeks)||2
6522275|NCT01560988|7443386|FG001|NOT COMPLETED|Washout (Six Weeks)||2
6522276|NCT01560988|7443385|FG000|STARTED|Second Intervention (Six Weeks)||20
6522277|NCT01560988|7443386|FG001|STARTED|Second Intervention (Six Weeks)||24
6522278|NCT01560988|7443385|FG000|COMPLETED|Second Intervention (Six Weeks)||18
6522279|NCT01560988|7443386|FG001|COMPLETED|Second Intervention (Six Weeks)||22
6522280|NCT01560988|7443385|FG000|NOT COMPLETED|Second Intervention (Six Weeks)||2
6522281|NCT01560988|7443386|FG001|NOT COMPLETED|Second Intervention (Six Weeks)||2
6522282|NCT01561053|7443401|FG000|STARTED|Overall Study||86
6522283|NCT01561053|7443402|FG001|STARTED|Overall Study||92
6522284|NCT01561053|7443403|FG002|STARTED|Overall Study||82
6522285|NCT01561053|7443404|FG003|STARTED|Overall Study||87
6522286|NCT01561053|7443401|FG000|Patients With Baseline MMSE:18-21|Overall Study||47
6522287|NCT01561053|7443402|FG001|Patients With Baseline MMSE:18-21|Overall Study||40
6522288|NCT01561053|7443403|FG002|Patients With Baseline MMSE:18-21|Overall Study||47
6522289|NCT01561053|7443404|FG003|Patients With Baseline MMSE:18-21|Overall Study||42
6522290|NCT01561053|7443401|FG000|Patients With Baseline MMSE:22-26|Overall Study||39
6522291|NCT01561053|7443402|FG001|Patients With Baseline MMSE:22-26|Overall Study||52
6522292|NCT01561053|7443403|FG002|Patients With Baseline MMSE:22-26|Overall Study||35
6522293|NCT01561053|7443404|FG003|Patients With Baseline MMSE:22-26|Overall Study||45
6522294|NCT01561053|7443401|FG000|Randomized Not Treated|Overall Study||8
6522295|NCT01561053|7443402|FG001|Randomized Not Treated|Overall Study||6
6522296|NCT01561053|7443403|FG002|Randomized Not Treated|Overall Study||4
6522297|NCT01561053|7443404|FG003|Randomized Not Treated|Overall Study||7
6522298|NCT01561053|7443401|FG000|Evaluable Subjects|Overall Study||78
6522299|NCT01561053|7443402|FG001|Evaluable Subjects|Overall Study||86
6522300|NCT01561053|7443403|FG002|Evaluable Subjects|Overall Study||78
6522301|NCT01561053|7443404|FG003|Evaluable Subjects|Overall Study||80
6522302|NCT01561053|7443401|FG000|COMPLETED|Overall Study||51
6522303|NCT01561053|7443402|FG001|COMPLETED|Overall Study||56
6522304|NCT01561053|7443403|FG002|COMPLETED|Overall Study||61
6522305|NCT01561053|7443404|FG003|COMPLETED|Overall Study||64
6522306|NCT01561053|7443401|FG000|NOT COMPLETED|Overall Study||35
6522307|NCT01561053|7443402|FG001|NOT COMPLETED|Overall Study||36
6522308|NCT01561053|7443403|FG002|NOT COMPLETED|Overall Study||21
6522309|NCT01561053|7443404|FG003|NOT COMPLETED|Overall Study||23
6522310|NCT01561079|7443415|FG000|STARTED|Overall Study||127
6522311|NCT01561079|7443415|FG000|COMPLETED|Overall Study||49
6522312|NCT01561079|7443415|FG000|NOT COMPLETED|Overall Study||78
6522313|NCT01561300|7443458|FG000|STARTED|Run in on Placebo||15
6522314|NCT01561300|7443459|FG001|STARTED|Run in on Placebo||15
6522315|NCT01561300|7443458|FG000|COMPLETED|Run in on Placebo||14
6522316|NCT01561300|7443459|FG001|COMPLETED|Run in on Placebo||15
6522317|NCT01561300|7443458|FG000|NOT COMPLETED|Run in on Placebo||1
6522318|NCT01561300|7443459|FG001|NOT COMPLETED|Run in on Placebo||0
6522319|NCT01561300|7443458|FG000|STARTED|First Intervention||14
6522320|NCT01561300|7443459|FG001|STARTED|First Intervention||15
6522321|NCT01561300|7443458|FG000|COMPLETED|First Intervention||14
6522322|NCT01561300|7443459|FG001|COMPLETED|First Intervention||15
6522323|NCT01561300|7443458|FG000|NOT COMPLETED|First Intervention||0
6522324|NCT01561300|7443459|FG001|NOT COMPLETED|First Intervention||0
6522325|NCT01561300|7443458|FG000|STARTED|Washout on Placebo||14
6522326|NCT01561300|7443459|FG001|STARTED|Washout on Placebo||15
6522327|NCT01561300|7443458|FG000|COMPLETED|Washout on Placebo||14
6522328|NCT01561300|7443459|FG001|COMPLETED|Washout on Placebo||15
6522329|NCT01561300|7443458|FG000|NOT COMPLETED|Washout on Placebo||0
6522330|NCT01561300|7443459|FG001|NOT COMPLETED|Washout on Placebo||0
6522331|NCT01561300|7443458|FG000|STARTED|Second Intervention||14
6522332|NCT01561300|7443459|FG001|STARTED|Second Intervention||15
6522333|NCT01561300|7443458|FG000|COMPLETED|Second Intervention||14
6522334|NCT01561300|7443459|FG001|COMPLETED|Second Intervention||15
6522335|NCT01561300|7443458|FG000|NOT COMPLETED|Second Intervention||0
6522336|NCT01561300|7443459|FG001|NOT COMPLETED|Second Intervention||0
6522337|NCT01561313|7443468|FG000|STARTED|Overall Study||33
6522338|NCT01561313|7443469|FG001|STARTED|Overall Study||31
6522339|NCT01561313|7443468|FG000|COMPLETED|Overall Study||31
6522340|NCT01561313|7443469|FG001|COMPLETED|Overall Study||31
6522341|NCT01561313|7443468|FG000|NOT COMPLETED|Overall Study||2
6522342|NCT01561313|7443469|FG001|NOT COMPLETED|Overall Study||0
6522343|NCT01561469|7443477|FG000|STARTED|Overall Study||101
6522344|NCT01561469|7443478|FG001|STARTED|Overall Study||87
6522345|NCT01561469|7443477|FG000|COMPLETED|Overall Study||101
6522346|NCT01561469|7443478|FG001|COMPLETED|Overall Study||87
6522347|NCT01561469|7443477|FG000|NOT COMPLETED|Overall Study||0
6522348|NCT01561469|7443478|FG001|NOT COMPLETED|Overall Study||0
6522349|NCT01561560|7443484|FG000|STARTED|First Two Weeks of Wear||60
6522350|NCT01561560|7443485|FG001|STARTED|First Two Weeks of Wear||61
6522351|NCT01561560|7443484|FG000|COMPLETED|First Two Weeks of Wear||60
6522352|NCT01561560|7443485|FG001|COMPLETED|First Two Weeks of Wear||59
6522353|NCT01561560|7443484|FG000|NOT COMPLETED|First Two Weeks of Wear||0
6522354|NCT01561560|7443485|FG001|NOT COMPLETED|First Two Weeks of Wear||2
6522355|NCT01561560|7443484|FG000|STARTED|Second Two Weeks of Wear||60
6522356|NCT01561560|7443485|FG001|STARTED|Second Two Weeks of Wear||59
6522357|NCT01561560|7443484|FG000|COMPLETED|Second Two Weeks of Wear||60
6522358|NCT01561560|7443485|FG001|COMPLETED|Second Two Weeks of Wear||58
6522359|NCT01561560|7443484|FG000|NOT COMPLETED|Second Two Weeks of Wear||0
6522360|NCT01561560|7443485|FG001|NOT COMPLETED|Second Two Weeks of Wear||1
6522361|NCT01561703|7443493|FG000|STARTED|Overall Study||28
6522362|NCT01561703|7443494|FG001|STARTED|Overall Study||30
6522363|NCT01561703|7443493|FG000|COMPLETED|Overall Study||20
6522364|NCT01561703|7443494|FG001|COMPLETED|Overall Study||24
6522365|NCT01561703|7443493|FG000|NOT COMPLETED|Overall Study||8
6522366|NCT01561703|7443494|FG001|NOT COMPLETED|Overall Study||6
6522367|NCT01561716|7443506|FG000|STARTED|Overall Study||5
6522368|NCT01561716|7443507|FG001|STARTED|Overall Study||5
6522369|NCT01561716|7443508|FG002|STARTED|Overall Study||5
6522370|NCT01561716|7443509|FG003|STARTED|Overall Study||5
6522371|NCT01561716|7443510|FG004|STARTED|Overall Study||5
6522372|NCT01561716|7443511|FG005|STARTED|Overall Study||5
6522373|NCT01561716|7443506|FG000|COMPLETED|Overall Study||5
6522374|NCT01561716|7443507|FG001|COMPLETED|Overall Study||5
6522375|NCT01561716|7443508|FG002|COMPLETED|Overall Study||5
6522376|NCT01561716|7443509|FG003|COMPLETED|Overall Study||5
6522377|NCT01561716|7443510|FG004|COMPLETED|Overall Study||5
6522378|NCT01561716|7443511|FG005|COMPLETED|Overall Study||5
6522379|NCT01561716|7443506|FG000|NOT COMPLETED|Overall Study||0
6522380|NCT01561716|7443507|FG001|NOT COMPLETED|Overall Study||0
6522381|NCT01561716|7443508|FG002|NOT COMPLETED|Overall Study||0
6522382|NCT01561716|7443509|FG003|NOT COMPLETED|Overall Study||0
6522383|NCT01561716|7443510|FG004|NOT COMPLETED|Overall Study||0
6522384|NCT01561716|7443511|FG005|NOT COMPLETED|Overall Study||0
6522385|NCT01561755|7443527|FG000|STARTED|Overall Study||6
6522386|NCT01561755|7443528|FG001|STARTED|Overall Study||6
6522387|NCT01561755|7443527|FG000|COMPLETED|Overall Study||6
6522388|NCT01561755|7443528|FG001|COMPLETED|Overall Study||5
6522389|NCT01561755|7443527|FG000|NOT COMPLETED|Overall Study||0
6522390|NCT01561755|7443528|FG001|NOT COMPLETED|Overall Study||1
6522391|NCT01561833|7443534|FG000|STARTED|Overall Study||12
6522392|NCT01561833|7443534|FG000|COMPLETED|Overall Study||12
6522393|NCT01561833|7443534|FG000|NOT COMPLETED|Overall Study||0
6522394|NCT01561898|7443542|FG000|STARTED|Overall Study||7
6522395|NCT01561898|7443543|FG001|STARTED|Overall Study||92
6522396|NCT01561898|7443544|FG002|STARTED|Overall Study||97
6522397|NCT01561898|7443545|FG003|STARTED|Overall Study||32
6522398|NCT01561898|7443542|FG000|COMPLETED|Overall Study||5
6522399|NCT01561898|7443543|FG001|COMPLETED|Overall Study||51
6522400|NCT01561898|7443544|FG002|COMPLETED|Overall Study||53
6522401|NCT01561898|7443545|FG003|COMPLETED|Overall Study||12
6522402|NCT01561898|7443542|FG000|NOT COMPLETED|Overall Study||2
6522403|NCT01561898|7443543|FG001|NOT COMPLETED|Overall Study||41
6522404|NCT01561898|7443544|FG002|NOT COMPLETED|Overall Study||44
6522405|NCT01561898|7443545|FG003|NOT COMPLETED|Overall Study||20
6522406|NCT01561963|7443553|FG000|STARTED|Overall Study||21
6522407|NCT01561963|7443553|FG000|Received Period 1 Treatment|Overall Study||21
6522408|NCT01561963|7443553|FG000|Received Period 2 Treatment|Overall Study||20
6522409|NCT01561963|7443553|FG000|Received Period 3 Treatment|Overall Study||20
6522410|NCT01561963|7443553|FG000|COMPLETED|Overall Study||20
6522411|NCT01561963|7443553|FG000|NOT COMPLETED|Overall Study||1
6522412|NCT01561976|7443568|FG000|STARTED|Period 1||5
6522413|NCT01561976|7443569|FG001|STARTED|Period 1||5
6522414|NCT01561976|7443570|FG002|STARTED|Period 1||5
6522415|NCT01561976|7443571|FG003|STARTED|Period 1||5
6522416|NCT01561976|7443572|FG004|STARTED|Period 1||5
6522417|NCT01561976|7443573|FG005|STARTED|Period 1||5
6522418|NCT01561976|7443568|FG000|COMPLETED|Period 1||5
6522419|NCT01561976|7443569|FG001|COMPLETED|Period 1||5
6522420|NCT01561976|7443570|FG002|COMPLETED|Period 1||4
6522421|NCT01561976|7443571|FG003|COMPLETED|Period 1||5
6522422|NCT01561976|7443572|FG004|COMPLETED|Period 1||5
6522423|NCT01561976|7443573|FG005|COMPLETED|Period 1||5
6522424|NCT01561976|7443568|FG000|NOT COMPLETED|Period 1||0
6522425|NCT01561976|7443569|FG001|NOT COMPLETED|Period 1||0
6522426|NCT01561976|7443570|FG002|NOT COMPLETED|Period 1||1
6522427|NCT01561976|7443571|FG003|NOT COMPLETED|Period 1||0
6522428|NCT01561976|7443572|FG004|NOT COMPLETED|Period 1||0
6522429|NCT01561976|7443573|FG005|NOT COMPLETED|Period 1||0
6522430|NCT01561976|7443568|FG000|STARTED|Washout Period 1 (7 Days)||5
6522431|NCT01561976|7443569|FG001|STARTED|Washout Period 1 (7 Days)||5
6522432|NCT01561976|7443570|FG002|STARTED|Washout Period 1 (7 Days)||4
6522433|NCT01561976|7443571|FG003|STARTED|Washout Period 1 (7 Days)||5
6522434|NCT01561976|7443572|FG004|STARTED|Washout Period 1 (7 Days)||5
6522435|NCT01561976|7443573|FG005|STARTED|Washout Period 1 (7 Days)||5
6522436|NCT01561976|7443568|FG000|COMPLETED|Washout Period 1 (7 Days)||5
6522437|NCT01561976|7443569|FG001|COMPLETED|Washout Period 1 (7 Days)||5
6522438|NCT01561976|7443570|FG002|COMPLETED|Washout Period 1 (7 Days)||4
6522439|NCT01561976|7443571|FG003|COMPLETED|Washout Period 1 (7 Days)||4
6522440|NCT01561976|7443572|FG004|COMPLETED|Washout Period 1 (7 Days)||5
6522441|NCT01561976|7443573|FG005|COMPLETED|Washout Period 1 (7 Days)||4
6522442|NCT01561976|7443568|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6522443|NCT01561976|7443569|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6522444|NCT01561976|7443570|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6522445|NCT01561976|7443571|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
6522446|NCT01561976|7443572|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
6522447|NCT01561976|7443573|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
6522448|NCT01561976|7443568|FG000|STARTED|Period 2||5
6522449|NCT01561976|7443569|FG001|STARTED|Period 2||5
6522450|NCT01561976|7443570|FG002|STARTED|Period 2||4
6522451|NCT01561976|7443571|FG003|STARTED|Period 2||4
6522452|NCT01561976|7443572|FG004|STARTED|Period 2||5
6522453|NCT01561976|7443573|FG005|STARTED|Period 2||4
6522454|NCT01561976|7443568|FG000|COMPLETED|Period 2||5
6522455|NCT01561976|7443569|FG001|COMPLETED|Period 2||5
6522456|NCT01561976|7443570|FG002|COMPLETED|Period 2||4
6522457|NCT01561976|7443571|FG003|COMPLETED|Period 2||4
6522458|NCT01561976|7443572|FG004|COMPLETED|Period 2||5
6522459|NCT01561976|7443573|FG005|COMPLETED|Period 2||4
6522460|NCT01561976|7443568|FG000|NOT COMPLETED|Period 2||0
6522461|NCT01561976|7443569|FG001|NOT COMPLETED|Period 2||0
6522462|NCT01561976|7443570|FG002|NOT COMPLETED|Period 2||0
6522463|NCT01561976|7443571|FG003|NOT COMPLETED|Period 2||0
6522464|NCT01561976|7443572|FG004|NOT COMPLETED|Period 2||0
6522465|NCT01561976|7443573|FG005|NOT COMPLETED|Period 2||0
6522466|NCT01561976|7443568|FG000|STARTED|Washout Period 2 (7 Days)||5
6522467|NCT01561976|7443569|FG001|STARTED|Washout Period 2 (7 Days)||5
6522468|NCT01561976|7443570|FG002|STARTED|Washout Period 2 (7 Days)||4
6522469|NCT01561976|7443571|FG003|STARTED|Washout Period 2 (7 Days)||4
6522470|NCT01561976|7443572|FG004|STARTED|Washout Period 2 (7 Days)||5
6522471|NCT01561976|7443573|FG005|STARTED|Washout Period 2 (7 Days)||4
6522472|NCT01561976|7443568|FG000|COMPLETED|Washout Period 2 (7 Days)||4
6522473|NCT01561976|7443569|FG001|COMPLETED|Washout Period 2 (7 Days)||5
6522474|NCT01561976|7443570|FG002|COMPLETED|Washout Period 2 (7 Days)||3
6522475|NCT01561976|7443571|FG003|COMPLETED|Washout Period 2 (7 Days)||4
6522476|NCT01561976|7443572|FG004|COMPLETED|Washout Period 2 (7 Days)||5
6522477|NCT01561976|7443573|FG005|COMPLETED|Washout Period 2 (7 Days)||4
6522478|NCT01561976|7443568|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
6522479|NCT01561976|7443569|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6522480|NCT01561976|7443570|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||1
6522481|NCT01561976|7443571|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6522482|NCT01561976|7443572|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6522483|NCT01561976|7443573|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6522484|NCT01561976|7443568|FG000|STARTED|Period 3||4
6522485|NCT01561976|7443569|FG001|STARTED|Period 3||5
6522486|NCT01561976|7443570|FG002|STARTED|Period 3||3
6522487|NCT01561976|7443571|FG003|STARTED|Period 3||4
6522488|NCT01561976|7443572|FG004|STARTED|Period 3||5
6522489|NCT01561976|7443573|FG005|STARTED|Period 3||4
6522490|NCT01561976|7443568|FG000|COMPLETED|Period 3||4
6522491|NCT01561976|7443569|FG001|COMPLETED|Period 3||5
6522492|NCT01561976|7443570|FG002|COMPLETED|Period 3||3
6522493|NCT01561976|7443571|FG003|COMPLETED|Period 3||4
6522494|NCT01561976|7443572|FG004|COMPLETED|Period 3||5
6522495|NCT01561976|7443573|FG005|COMPLETED|Period 3||4
6522496|NCT01561976|7443568|FG000|NOT COMPLETED|Period 3||0
6522497|NCT01561976|7443569|FG001|NOT COMPLETED|Period 3||0
6522498|NCT01561976|7443570|FG002|NOT COMPLETED|Period 3||0
6522499|NCT01561976|7443571|FG003|NOT COMPLETED|Period 3||0
6522500|NCT01561976|7443572|FG004|NOT COMPLETED|Period 3||0
6522501|NCT01561976|7443573|FG005|NOT COMPLETED|Period 3||0
6522502|NCT01562028|7443583|FG000|STARTED|Overall Study||37
6522503|NCT01562028|7443584|FG001|STARTED|Overall Study||72
6522504|NCT01562028|7443583|FG000|COMPLETED|Overall Study||34
6522505|NCT01562028|7443584|FG001|COMPLETED|Overall Study||70
6522506|NCT01562028|7443583|FG000|NOT COMPLETED|Overall Study||3
6522507|NCT01562028|7443584|FG001|NOT COMPLETED|Overall Study||2
6522508|NCT01562041|7443590|FG000|STARTED|Overall Study||14
6522509|NCT01562041|7443590|FG000|COMPLETED|Overall Study||14
6522510|NCT01562041|7443590|FG000|NOT COMPLETED|Overall Study||0
6522511|NCT01562132|7443596|FG000|STARTED|Overall Study||3
6522512|NCT01562132|7443597|FG001|STARTED|Overall Study||3
6522513|NCT01562132|7443596|FG000|COMPLETED|Overall Study||3
6522514|NCT01562132|7443597|FG001|COMPLETED|Overall Study||3
6522515|NCT01562132|7443596|FG000|NOT COMPLETED|Overall Study||0
6522516|NCT01562132|7443597|FG001|NOT COMPLETED|Overall Study||0
6522517|NCT01562275|7443616|FG000|STARTED|Stage 1||3
6522518|NCT01562275|7443617|FG001|STARTED|Stage 1||7
6522519|NCT01562275|7443618|FG002|STARTED|Stage 1||3
6522520|NCT01562275|7443619|FG003|STARTED|Stage 1||4
6522521|NCT01562275|7443620|FG004|STARTED|Stage 1||4
6522522|NCT01562275|7443621|FG005|STARTED|Stage 1||4
6522523|NCT01562275|7443622|FG006|STARTED|Stage 1||3
6522524|NCT01562275|7443623|FG007|STARTED|Stage 1||7
6522525|NCT01562275|7443624|FG008|STARTED|Stage 1||3
6522526|NCT01562275|7443625|FG009|STARTED|Stage 1||7
6522527|NCT01562275|7443626|FG010|STARTED|Stage 1||3
6522528|NCT01562275|7443627|FG011|STARTED|Stage 1||0
6522529|NCT01562275|7443628|FG012|STARTED|Stage 1||0
6522530|NCT01562275|7443616|FG000|COMPLETED|Stage 1||0
6522531|NCT01562275|7443617|FG001|COMPLETED|Stage 1||0
6522532|NCT01562275|7443618|FG002|COMPLETED|Stage 1||0
6522533|NCT01562275|7443619|FG003|COMPLETED|Stage 1||0
6522534|NCT01562275|7443620|FG004|COMPLETED|Stage 1||0
6522535|NCT01562275|7443621|FG005|COMPLETED|Stage 1||0
6522536|NCT01562275|7443622|FG006|COMPLETED|Stage 1||0
6522537|NCT01562275|7443623|FG007|COMPLETED|Stage 1||0
6522538|NCT01562275|7443624|FG008|COMPLETED|Stage 1||0
6522539|NCT01562275|7443625|FG009|COMPLETED|Stage 1||0
6522540|NCT01562275|7443626|FG010|COMPLETED|Stage 1||0
6522541|NCT01562275|7443627|FG011|COMPLETED|Stage 1||0
6522542|NCT01562275|7443628|FG012|COMPLETED|Stage 1||0
6522543|NCT01562275|7443616|FG000|NOT COMPLETED|Stage 1||3
6522544|NCT01562275|7443617|FG001|NOT COMPLETED|Stage 1||7
6522545|NCT01562275|7443618|FG002|NOT COMPLETED|Stage 1||3
6522546|NCT01562275|7443619|FG003|NOT COMPLETED|Stage 1||4
6522547|NCT01562275|7443620|FG004|NOT COMPLETED|Stage 1||4
6522548|NCT01562275|7443621|FG005|NOT COMPLETED|Stage 1||4
6522549|NCT01562275|7443622|FG006|NOT COMPLETED|Stage 1||3
6522550|NCT01562275|7443623|FG007|NOT COMPLETED|Stage 1||7
6522551|NCT01562275|7443624|FG008|NOT COMPLETED|Stage 1||3
6522552|NCT01562275|7443625|FG009|NOT COMPLETED|Stage 1||7
6522553|NCT01562275|7443626|FG010|NOT COMPLETED|Stage 1||3
6522554|NCT01562275|7443627|FG011|NOT COMPLETED|Stage 1||0
6522555|NCT01562275|7443628|FG012|NOT COMPLETED|Stage 1||0
6522556|NCT01562275|7443616|FG000|STARTED|Stage 2||0
6522557|NCT01562275|7443617|FG001|STARTED|Stage 2||0
6522558|NCT01562275|7443618|FG002|STARTED|Stage 2||0
6522559|NCT01562275|7443619|FG003|STARTED|Stage 2||0
6522560|NCT01562275|7443620|FG004|STARTED|Stage 2||0
6522561|NCT01562275|7443621|FG005|STARTED|Stage 2||0
6522562|NCT01562275|7443622|FG006|STARTED|Stage 2||0
6522563|NCT01562275|7443623|FG007|STARTED|Stage 2||0
6522564|NCT01562275|7443624|FG008|STARTED|Stage 2||0
6522565|NCT01562275|7443625|FG009|STARTED|Stage 2||0
6522566|NCT01562275|7443626|FG010|STARTED|Stage 2||0
6522567|NCT01562275|7443627|FG011|STARTED|Stage 2||14
6522568|NCT01562275|7443628|FG012|STARTED|Stage 2||5
6522569|NCT01562275|7443616|FG000|COMPLETED|Stage 2||0
6522570|NCT01562275|7443617|FG001|COMPLETED|Stage 2||0
6522571|NCT01562275|7443618|FG002|COMPLETED|Stage 2||0
6522572|NCT01562275|7443619|FG003|COMPLETED|Stage 2||0
6522573|NCT01562275|7443620|FG004|COMPLETED|Stage 2||0
6522574|NCT01562275|7443621|FG005|COMPLETED|Stage 2||0
6522575|NCT01562275|7443622|FG006|COMPLETED|Stage 2||0
6522576|NCT01562275|7443623|FG007|COMPLETED|Stage 2||0
6522577|NCT01562275|7443624|FG008|COMPLETED|Stage 2||0
6522578|NCT01562275|7443625|FG009|COMPLETED|Stage 2||0
6522579|NCT01562275|7443626|FG010|COMPLETED|Stage 2||0
6522580|NCT01562275|7443627|FG011|COMPLETED|Stage 2||0
6522581|NCT01562275|7443628|FG012|COMPLETED|Stage 2||0
6522582|NCT01562275|7443616|FG000|NOT COMPLETED|Stage 2||0
6522583|NCT01562275|7443617|FG001|NOT COMPLETED|Stage 2||0
6522584|NCT01562275|7443618|FG002|NOT COMPLETED|Stage 2||0
6522585|NCT01562275|7443619|FG003|NOT COMPLETED|Stage 2||0
6522586|NCT01562275|7443620|FG004|NOT COMPLETED|Stage 2||0
6642501|NCT02349061|7570919|FG001|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|29
6642502|NCT02349061|7570920|FG002|STARTED|Study Extension (Week 56 to Week 120)|Who met study extension inclusion criteria received open-label ustekinumab SC through Week 104.|17
6642503|NCT02349061|7570918|FG000|COMPLETED|Study Extension (Week 56 to Week 120)||0
6642504|NCT02349061|7570919|FG001|COMPLETED|Study Extension (Week 56 to Week 120)||24
6642505|NCT02349061|7570920|FG002|COMPLETED|Study Extension (Week 56 to Week 120)||14
6642506|NCT02349061|7570918|FG000|NOT COMPLETED|Study Extension (Week 56 to Week 120)||0
6642507|NCT02349061|7570919|FG001|NOT COMPLETED|Study Extension (Week 56 to Week 120)||5
6642508|NCT02349061|7570920|FG002|NOT COMPLETED|Study Extension (Week 56 to Week 120)||3
6642509|NCT02349152|7570932|FG000|STARTED|Overall Study||60
6642510|NCT02349152|7570933|FG001|STARTED|Overall Study||56
6642511|NCT02349152|7570932|FG000|COMPLETED|Overall Study||54
6642512|NCT02349152|7570933|FG001|COMPLETED|Overall Study||52
6642513|NCT02349152|7570932|FG000|NOT COMPLETED|Overall Study||6
6642514|NCT02349152|7570933|FG001|NOT COMPLETED|Overall Study||4
6642515|NCT02349178|7570939|FG000|STARTED|Overall Study||6
6642516|NCT02349178|7570939|FG000|COMPLETED|Overall Study||6
6642517|NCT02349178|7570939|FG000|NOT COMPLETED|Overall Study||0
6642518|NCT02349295|7570946|FG000|STARTED|Double Blind Treatment (Week 0-24)||123
6642519|NCT02349295|7570947|FG001|STARTED|Double Blind Treatment (Week 0-24)||122
6642520|NCT02349295|7570948|FG002|STARTED|Double Blind Treatment (Week 0-24)||118
6642521|NCT02349295|7570949|FG003|STARTED|Double Blind Treatment (Week 0-24)||0
6642522|NCT02349295|7570950|FG004|STARTED|Double Blind Treatment (Week 0-24)||0
6642523|NCT02349295|7570951|FG005|STARTED|Double Blind Treatment (Week 0-24)||0
6642524|NCT02349295|7570952|FG006|STARTED|Double Blind Treatment (Week 0-24)||0
6642525|NCT02349295|7570953|FG007|STARTED|Double Blind Treatment (Week 0-24)||0
6642526|NCT02349295|7570954|FG008|STARTED|Double Blind Treatment (Week 0-24)||0
6522587|NCT01562275|7443621|FG005|NOT COMPLETED|Stage 2||0
6522588|NCT01562275|7443622|FG006|NOT COMPLETED|Stage 2||0
6522589|NCT01562275|7443623|FG007|NOT COMPLETED|Stage 2||0
6522590|NCT01562275|7443624|FG008|NOT COMPLETED|Stage 2||0
6522591|NCT01562275|7443625|FG009|NOT COMPLETED|Stage 2||0
6522592|NCT01562275|7443626|FG010|NOT COMPLETED|Stage 2||0
6522593|NCT01562275|7443627|FG011|NOT COMPLETED|Stage 2||14
6522594|NCT01562275|7443628|FG012|NOT COMPLETED|Stage 2||5
6522595|NCT01562314|7443660|FG000|STARTED|Overall Study||29
6522596|NCT01562314|7443661|FG001|STARTED|Overall Study||31
6522597|NCT01562314|7443660|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
6522598|NCT01562314|7443661|FG001|Received at Least 1 Dose of Study Drug|Overall Study||31
6522599|NCT01562314|7443660|FG000|Intent-to-Treat (ITT) Analysis Set|Overall Study||29
6522600|NCT01562314|7443661|FG001|Intent-to-Treat (ITT) Analysis Set|Overall Study||31
6522601|NCT01562314|7443660|FG000|Per Protocol (PP) Analysis Set|Overall Study||17
6522602|NCT01562314|7443661|FG001|Per Protocol (PP) Analysis Set|Overall Study||27
6522603|NCT01562314|7443660|FG000|COMPLETED|Overall Study||16
6522604|NCT01562314|7443661|FG001|COMPLETED|Overall Study||23
6522605|NCT01562314|7443660|FG000|NOT COMPLETED|Overall Study||13
6522606|NCT01562314|7443661|FG001|NOT COMPLETED|Overall Study||8
6522607|NCT01562327|7443667|FG000|STARTED|Overall Study||50
6522608|NCT01562327|7443667|FG000|COMPLETED|Overall Study||42
6522609|NCT01562327|7443667|FG000|NOT COMPLETED|Overall Study||8
6522610|NCT01562379|7443677|FG000|STARTED|Overall Study||1438
6522611|NCT01562379|7443678|FG001|STARTED|Overall Study||1492
6522612|NCT01562379|7443679|FG002|STARTED|Overall Study||851
6522613|NCT01562379|7443680|FG003|STARTED|Overall Study||843
6522614|NCT01562379|7443681|FG004|STARTED|Overall Study||825
6522615|NCT01562379|7443677|FG000|COMPLETED|Overall Study||1312
6522616|NCT01562379|7443678|FG001|COMPLETED|Overall Study||1395
6522617|NCT01562379|7443679|FG002|COMPLETED|Overall Study||789
6522618|NCT01562379|7443680|FG003|COMPLETED|Overall Study||786
6522619|NCT01562379|7443681|FG004|COMPLETED|Overall Study||785
6522620|NCT01562379|7443677|FG000|NOT COMPLETED|Overall Study||126
6522621|NCT01562379|7443678|FG001|NOT COMPLETED|Overall Study||97
6522622|NCT01562379|7443679|FG002|NOT COMPLETED|Overall Study||62
6522623|NCT01562379|7443680|FG003|NOT COMPLETED|Overall Study||57
6522624|NCT01562379|7443681|FG004|NOT COMPLETED|Overall Study||40
6522625|NCT01562444|7443696|FG000|STARTED|Overall Study||48
6522626|NCT01562444|7443697|FG001|STARTED|Overall Study||51
6522627|NCT01562444|7443698|FG002|STARTED|Overall Study||106
6522628|NCT01562444|7443696|FG000|COMPLETED|Overall Study||43
6522629|NCT01562444|7443697|FG001|COMPLETED|Overall Study||49
6522630|NCT01562444|7443698|FG002|COMPLETED|Overall Study||99
6522631|NCT01562444|7443696|FG000|NOT COMPLETED|Overall Study||5
6522632|NCT01562444|7443697|FG001|NOT COMPLETED|Overall Study||2
6522633|NCT01562444|7443698|FG002|NOT COMPLETED|Overall Study||7
6522634|NCT01562548|7443710|FG000|STARTED|Overall Study||25
6522635|NCT01562548|7443711|FG001|STARTED|Overall Study||15
6522636|NCT01562548|7443712|FG002|STARTED|Overall Study||25
6522637|NCT01562548|7443713|FG003|STARTED|Overall Study||14
6522638|NCT01562548|7443710|FG000|COMPLETED|Overall Study||25
6522639|NCT01562548|7443711|FG001|COMPLETED|Overall Study||15
6522640|NCT01562548|7443712|FG002|COMPLETED|Overall Study||24
6522641|NCT01562548|7443713|FG003|COMPLETED|Overall Study||14
6522642|NCT01562548|7443710|FG000|NOT COMPLETED|Overall Study||0
6522643|NCT01562548|7443711|FG001|NOT COMPLETED|Overall Study||0
6522644|NCT01562548|7443712|FG002|NOT COMPLETED|Overall Study||1
6522645|NCT01562548|7443713|FG003|NOT COMPLETED|Overall Study||0
6522646|NCT01562613|7443725|FG000|STARTED|Overall Study||533
6522647|NCT01562613|7443725|FG000|COMPLETED|Overall Study||529
6522648|NCT01562613|7443725|FG000|NOT COMPLETED|Overall Study||4
6522649|NCT01562678|7443731|FG000|STARTED|Overall Study||14
6522650|NCT01562678|7443732|FG001|STARTED|Overall Study||14
6522651|NCT01562678|7443731|FG000|COMPLETED|Overall Study||8
6522652|NCT01562678|7443732|FG001|COMPLETED|Overall Study||12
6522653|NCT01562678|7443731|FG000|NOT COMPLETED|Overall Study||6
6522654|NCT01562678|7443732|FG001|NOT COMPLETED|Overall Study||2
6522655|NCT01562743|7443738|FG000|STARTED|Overall Study||185
6522656|NCT01562743|7443738|FG000|COMPLETED|Overall Study||133
6522657|NCT01562743|7443738|FG000|NOT COMPLETED|Overall Study||52
6522658|NCT01562756|7443742|FG000|STARTED|Overall Study||6
6522659|NCT01562756|7443742|FG000|COMPLETED|Overall Study||6
6522660|NCT01562756|7443742|FG000|NOT COMPLETED|Overall Study||0
6522661|NCT01562782|7443748|FG000|STARTED|Overall Study||19
6522662|NCT01562782|7443749|FG001|STARTED|Overall Study||20
6522663|NCT01562782|7443748|FG000|COMPLETED|Overall Study||15
6522664|NCT01562782|7443749|FG001|COMPLETED|Overall Study||15
6522665|NCT01562782|7443748|FG000|NOT COMPLETED|Overall Study||4
6522666|NCT01562782|7443749|FG001|NOT COMPLETED|Overall Study||5
6522667|NCT01562873|7443755|FG000|STARTED|Overall Study||21
6522668|NCT01562873|7443756|FG001|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
6522669|NCT01562873|7443755|FG000|COMPLETED|Overall Study||0
6522670|NCT01562873|7443756|FG001|COMPLETED|Overall Study||0
6522671|NCT01562873|7443755|FG000|NOT COMPLETED|Overall Study||21
6522672|NCT01562873|7443756|FG001|NOT COMPLETED|Overall Study||0
6522673|NCT01562886|7443760|FG000|STARTED|Overall Study||14
6522674|NCT01562886|7443760|FG000|COMPLETED|Overall Study||13
6522675|NCT01562886|7443760|FG000|NOT COMPLETED|Overall Study||1
6522676|NCT01563003|7443766|FG000|STARTED|Overall Study||16
6522677|NCT01563003|7443767|FG001|STARTED|Overall Study||15
6522678|NCT01563003|7443766|FG000|COMPLETED|Overall Study||16
6522679|NCT01563003|7443767|FG001|COMPLETED|Overall Study||15
6522680|NCT01563003|7443766|FG000|NOT COMPLETED|Overall Study||0
6522681|NCT01563003|7443767|FG001|NOT COMPLETED|Overall Study||0
6522682|NCT01563029|7443778|FG000|STARTED|Overall Study||119
6522683|NCT01563029|7443779|FG001|STARTED|Overall Study||118
6522684|NCT01563029|7443780|FG002|STARTED|Overall Study||120
6522685|NCT01563029|7443781|FG003|STARTED|Overall Study||118
6522686|NCT01563029|7443782|FG004|STARTED|Overall Study||118
6522687|NCT01563029|7443778|FG000|COMPLETED|Overall Study||66
6522688|NCT01563029|7443779|FG001|COMPLETED|Overall Study||94
6522689|NCT01563029|7443780|FG002|COMPLETED|Overall Study||87
6522690|NCT01563029|7443781|FG003|COMPLETED|Overall Study||85
6522691|NCT01563029|7443782|FG004|COMPLETED|Overall Study||89
6522692|NCT01563029|7443778|FG000|NOT COMPLETED|Overall Study||53
6522693|NCT01563029|7443779|FG001|NOT COMPLETED|Overall Study||24
6522694|NCT01563029|7443780|FG002|NOT COMPLETED|Overall Study||33
6522695|NCT01563029|7443781|FG003|NOT COMPLETED|Overall Study||33
6522696|NCT01563029|7443782|FG004|NOT COMPLETED|Overall Study||29
6522697|NCT01563055|7443795|FG000|STARTED|Overall Study||10
6522698|NCT01563055|7443795|FG000|COMPLETED|Overall Study||10
6522699|NCT01563055|7443795|FG000|NOT COMPLETED|Overall Study||0
6522700|NCT01563081|7443804|FG000|STARTED|Overall Study||30
6522701|NCT01563081|7443805|FG001|STARTED|Overall Study||30
6522702|NCT01563081|7443804|FG000|COMPLETED|Overall Study||30
6522703|NCT01563081|7443805|FG001|COMPLETED|Overall Study||30
6522704|NCT01563081|7443804|FG000|NOT COMPLETED|Overall Study||0
6522705|NCT01563081|7443805|FG001|NOT COMPLETED|Overall Study||0
6522706|NCT01563172|7443815|FG000|STARTED|Overall Study||65
6522707|NCT01563172|7443815|FG000|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
6522708|NCT01563172|7443815|FG000|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
6522709|NCT01563172|7443815|FG000|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
6522710|NCT01563172|7443815|FG000|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
6522711|NCT01563172|7443815|FG000|Control Dentifrice|Overall Study||60
6522712|NCT01563172|7443815|FG000|COMPLETED|Overall Study||52
6522713|NCT01563172|7443815|FG000|NOT COMPLETED|Overall Study||13
6522714|NCT01563185|7443830|FG000|STARTED|Overall Study||12
6522715|NCT01563185|7443830|FG000|COMPLETED|Overall Study||10
6522716|NCT01563185|7443830|FG000|NOT COMPLETED|Overall Study||2
6522717|NCT01563198|7443834|FG000|STARTED|Baseline||49733
6522718|NCT01563198|7443834|FG000|COMPLETED|Baseline||49733
6522719|NCT01563198|7443834|FG000|NOT COMPLETED|Baseline||0
6522720|NCT01563198|7443834|FG000|STARTED|After Training||47979
6522721|NCT01563198|7443834|FG000|COMPLETED|After Training||47979
6522722|NCT01563198|7443834|FG000|NOT COMPLETED|After Training||0
6522723|NCT01563237|7443838|FG000|STARTED|Overall Study||64
6522724|NCT01563237|7443839|FG001|STARTED|Overall Study||5
6522725|NCT01563237|7443838|FG000|COMPLETED|Overall Study||54
6522726|NCT01563237|7443839|FG001|COMPLETED|Overall Study||5
6522727|NCT01563237|7443838|FG000|NOT COMPLETED|Overall Study||10
6522728|NCT01563237|7443839|FG001|NOT COMPLETED|Overall Study||0
6522729|NCT01563354|7443847|FG000|STARTED|Core Phase||41
6522730|NCT01563354|7443848|FG001|STARTED|Core Phase||42
6522731|NCT01563354|7443849|FG002|STARTED|Core Phase||41
6522732|NCT01563354|7443847|FG000|Entered Extension Phase|Core Phase||12
6522733|NCT01563354|7443848|FG001|Entered Extension Phase|Core Phase||14
6522734|NCT01563354|7443849|FG002|Entered Extension Phase|Core Phase||15
6522735|NCT01563354|7443847|FG000|COMPLETED|Core Phase||12
6522736|NCT01563354|7443848|FG001|COMPLETED|Core Phase||14
6522737|NCT01563354|7443849|FG002|COMPLETED|Core Phase||15
6522738|NCT01563354|7443847|FG000|NOT COMPLETED|Core Phase||29
6522739|NCT01563354|7443848|FG001|NOT COMPLETED|Core Phase||28
6522740|NCT01563354|7443849|FG002|NOT COMPLETED|Core Phase||26
6522741|NCT01563354|7443847|FG000|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|12
6522742|NCT01563354|7443848|FG001|STARTED|Extension Phase|Criteria to enter Extension: continued clinical benefit and no unacceptable toxicity|14
6522743|NCT01563354|7443849|FG002|STARTED|Extension Phase||15
6522744|NCT01563354|7443847|FG000|COMPLETED|Extension Phase||0
6522745|NCT01563354|7443848|FG001|COMPLETED|Extension Phase||0
6522746|NCT01563354|7443849|FG002|COMPLETED|Extension Phase||0
6522747|NCT01563354|7443847|FG000|NOT COMPLETED|Extension Phase||12
6522748|NCT01563354|7443848|FG001|NOT COMPLETED|Extension Phase||14
6522749|NCT01563354|7443849|FG002|NOT COMPLETED|Extension Phase||15
6522750|NCT01563406|7443861|FG000|STARTED|Overall Study|194 hubs|60
6522751|NCT01563406|7443862|FG001|STARTED|Overall Study|102 hubs|30
6522752|NCT01563406|7443863|FG002|STARTED|Overall Study|101 hubs|30
6522753|NCT01563406|7443864|FG003|STARTED|Overall Study|112 hubs|29
6522754|NCT01563406|7443861|FG000|COMPLETED|Overall Study|194 hubs|60
6522755|NCT01563406|7443862|FG001|COMPLETED|Overall Study|102 hubs|30
6522756|NCT01563406|7443863|FG002|COMPLETED|Overall Study|101 hubs|30
6522757|NCT01563406|7443864|FG003|COMPLETED|Overall Study|112 hubs|29
6522758|NCT01563406|7443861|FG000|NOT COMPLETED|Overall Study||0
6522759|NCT01563406|7443862|FG001|NOT COMPLETED|Overall Study||0
6522760|NCT01563406|7443863|FG002|NOT COMPLETED|Overall Study||0
6522761|NCT01563406|7443864|FG003|NOT COMPLETED|Overall Study||0
6522762|NCT01563536|7443880|FG000|STARTED|Overall Study||6
6522763|NCT01563536|7443881|FG001|STARTED|Overall Study||6
6522764|NCT01563536|7443880|FG000|COMPLETED|Overall Study||5
6522765|NCT01563536|7443881|FG001|COMPLETED|Overall Study||4
6522766|NCT01563536|7443880|FG000|NOT COMPLETED|Overall Study||1
6522767|NCT01563536|7443881|FG001|NOT COMPLETED|Overall Study||2
6522768|NCT01563913|7443889|FG000|STARTED|Overall Study||15
6522769|NCT01563913|7443890|FG001|STARTED|Overall Study||15
6522770|NCT01563913|7443889|FG000|COMPLETED|Overall Study||13
6522771|NCT01563913|7443890|FG001|COMPLETED|Overall Study||15
6522772|NCT01563913|7443889|FG000|NOT COMPLETED|Overall Study||2
6522773|NCT01563913|7443890|FG001|NOT COMPLETED|Overall Study||0
6522774|NCT01563978|7443898|FG000|STARTED|Overall Study|Patients who received treatment.|68
6522775|NCT01563978|7443899|FG001|STARTED|Overall Study|Patients who received treatment.|67
6522776|NCT01563978|7443898|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
6522777|NCT01563978|7443899|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
6522778|NCT01563978|7443898|FG000|COMPLETED|Overall Study||64
6522779|NCT01563978|7443899|FG001|COMPLETED|Overall Study||65
6522780|NCT01563978|7443898|FG000|NOT COMPLETED|Overall Study||4
6522781|NCT01563978|7443899|FG001|NOT COMPLETED|Overall Study||2
6522782|NCT01564277|7443907|FG000|STARTED|Overall Study||12
6522783|NCT01564277|7443908|FG001|STARTED|Overall Study||12
6522784|NCT01564277|7443907|FG000|COMPLETED|Overall Study||11
6522785|NCT01564277|7443908|FG001|COMPLETED|Overall Study||11
6522786|NCT01564277|7443907|FG000|NOT COMPLETED|Overall Study||1
6522787|NCT01564277|7443908|FG001|NOT COMPLETED|Overall Study||1
6522788|NCT01564394|7443916|FG000|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
6522789|NCT01564394|7443917|FG001|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
6522790|NCT01564394|7443916|FG000|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
6522791|NCT01564394|7443917|FG001|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
6522792|NCT01564394|7443916|FG000|NOT COMPLETED|Overall Study||6
6522793|NCT01564394|7443917|FG001|NOT COMPLETED|Overall Study||10
6522794|NCT01564407|7443928|FG000|STARTED|Overall Study||4
6522795|NCT01564407|7443929|FG001|STARTED|Overall Study||5
6522796|NCT01564407|7443930|FG002|STARTED|Overall Study||4
6522797|NCT01564407|7443931|FG003|STARTED|Overall Study||2
6522798|NCT01564407|7443932|FG004|STARTED|Overall Study||0
6522799|NCT01564407|7443928|FG000|COMPLETED|Overall Study||4
6522800|NCT01564407|7443929|FG001|COMPLETED|Overall Study||3
6522801|NCT01564407|7443930|FG002|COMPLETED|Overall Study||4
6522802|NCT01564407|7443931|FG003|COMPLETED|Overall Study||1
6522803|NCT01564407|7443932|FG004|COMPLETED|Overall Study||0
6522804|NCT01564407|7443928|FG000|NOT COMPLETED|Overall Study||0
6522805|NCT01564407|7443929|FG001|NOT COMPLETED|Overall Study||2
6522806|NCT01564407|7443930|FG002|NOT COMPLETED|Overall Study||0
6522807|NCT01564407|7443931|FG003|NOT COMPLETED|Overall Study||1
6522808|NCT01564407|7443932|FG004|NOT COMPLETED|Overall Study||0
6522809|NCT01564459|7443956|FG000|STARTED|Run-In||12
6522810|NCT01564459|7443957|FG001|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
6522811|NCT01564459|7443958|FG002|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
6522812|NCT01564459|7443956|FG000|COMPLETED|Run-In||0
6522813|NCT01564459|7443957|FG001|COMPLETED|Run-In||87
6522814|NCT01564459|7443958|FG002|COMPLETED|Run-In||83
6522815|NCT01564459|7443956|FG000|NOT COMPLETED|Run-In||12
6522816|NCT01564459|7443957|FG001|NOT COMPLETED|Run-In||0
6522817|NCT01564459|7443958|FG002|NOT COMPLETED|Run-In||0
6522818|NCT01564459|7443956|FG000|STARTED|Double-blind Treatment||0
6522819|NCT01564459|7443957|FG001|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
6522820|NCT01564459|7443958|FG002|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
6522821|NCT01564459|7443956|FG000|COMPLETED|Double-blind Treatment||0
6522822|NCT01564459|7443957|FG001|COMPLETED|Double-blind Treatment||87
6522823|NCT01564459|7443958|FG002|COMPLETED|Double-blind Treatment||82
6522824|NCT01564459|7443956|FG000|NOT COMPLETED|Double-blind Treatment||0
6522825|NCT01564459|7443957|FG001|NOT COMPLETED|Double-blind Treatment||0
6522826|NCT01564459|7443958|FG002|NOT COMPLETED|Double-blind Treatment||1
6522827|NCT01564485|7443971|FG000|STARTED|Overall Study||92
6522828|NCT01564485|7443972|FG001|STARTED|Overall Study||101
6522829|NCT01564485|7443971|FG000|COMPLETED|Overall Study||84
6522830|NCT01564485|7443972|FG001|COMPLETED|Overall Study||78
6522831|NCT01564485|7443971|FG000|NOT COMPLETED|Overall Study||8
6522832|NCT01564485|7443972|FG001|NOT COMPLETED|Overall Study||23
6522833|NCT01564628|7443978|FG000|STARTED|Overall Study||185
6522834|NCT01564628|7443979|FG001|STARTED|Overall Study||58
6522835|NCT01564628|7443980|FG002|STARTED|Overall Study||63
6522836|NCT01564628|7443978|FG000|COMPLETED|Overall Study||181
6522837|NCT01564628|7443979|FG001|COMPLETED|Overall Study||56
6522838|NCT01564628|7443980|FG002|COMPLETED|Overall Study||61
6522839|NCT01564628|7443978|FG000|NOT COMPLETED|Overall Study||4
6522840|NCT01564628|7443979|FG001|NOT COMPLETED|Overall Study||2
6522841|NCT01564628|7443980|FG002|NOT COMPLETED|Overall Study||2
6522842|NCT01564654|7443984|FG000|STARTED|Overall Study|106 knees (bilateral)|89
6522843|NCT01564654|7443984|FG000|COMPLETED|Overall Study|106 knees (bilateral)|89
6522844|NCT01564654|7443984|FG000|NOT COMPLETED|Overall Study||0
6522845|NCT01564693|7443991|FG000|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
6522846|NCT01564693|7443992|FG001|STARTED|Overall Study||4
6522847|NCT01564693|7443993|FG002|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
6522848|NCT01564693|7443991|FG000|COMPLETED|Overall Study||9
6522849|NCT01564693|7443992|FG001|COMPLETED|Overall Study||4
6522850|NCT01564693|7443993|FG002|COMPLETED|Overall Study||2
6522851|NCT01564693|7443991|FG000|NOT COMPLETED|Overall Study||0
6522852|NCT01564693|7443992|FG001|NOT COMPLETED|Overall Study||0
6522853|NCT01564693|7443993|FG002|NOT COMPLETED|Overall Study||0
6522854|NCT01564706|7444001|FG000|STARTED|Overall Study||9
6522855|NCT01564706|7444001|FG000|COMPLETED|Overall Study||9
6522856|NCT01564706|7444001|FG000|NOT COMPLETED|Overall Study||0
6522857|NCT01564758|7444005|FG000|STARTED|Overall Study||99
6522858|NCT01564758|7444005|FG000|COMPLETED|Overall Study||85
6522859|NCT01564758|7444005|FG000|NOT COMPLETED|Overall Study||14
6522860|NCT01564784|7444011|FG000|STARTED|Overall Study|Treated (164 randomized)|164
6522861|NCT01564784|7444012|FG001|STARTED|Overall Study|Treated (162 randomized)|143
6522862|NCT01564784|7444011|FG000|COMPLETED|Overall Study||30
6522863|NCT01564784|7444012|FG001|COMPLETED|Overall Study||10
6522864|NCT01564784|7444011|FG000|NOT COMPLETED|Overall Study||134
6522865|NCT01564784|7444012|FG001|NOT COMPLETED|Overall Study||133
6522866|NCT01564862|7444021|FG000|STARTED|Overall Study||198
6522867|NCT01564862|7444022|FG001|STARTED|Overall Study||210
6522868|NCT01564862|7444023|FG002|STARTED|Overall Study||194
6522869|NCT01564862|7444021|FG000|Received Treatment|Overall Study||196
6522870|NCT01564862|7444022|FG001|Received Treatment|Overall Study||207
6522871|NCT01564862|7444023|FG002|Received Treatment|Overall Study||191
6522872|NCT01564862|7444021|FG000|COMPLETED|Overall Study||168
6522873|NCT01564862|7444022|FG001|COMPLETED|Overall Study||176
6522874|NCT01564862|7444023|FG002|COMPLETED|Overall Study||164
6522875|NCT01564862|7444021|FG000|NOT COMPLETED|Overall Study||30
6522876|NCT01564862|7444022|FG001|NOT COMPLETED|Overall Study||34
6522877|NCT01564862|7444023|FG002|NOT COMPLETED|Overall Study||30
6522878|NCT01564914|7444033|FG000|STARTED|Overall Study||16
6522879|NCT01564914|7444034|FG001|STARTED|Overall Study||6
6522880|NCT01564914|7444033|FG000|COMPLETED|Overall Study||16
6522881|NCT01564914|7444034|FG001|COMPLETED|Overall Study||6
6522882|NCT01564914|7444033|FG000|NOT COMPLETED|Overall Study||0
6522883|NCT01564914|7444034|FG001|NOT COMPLETED|Overall Study||0
6522884|NCT01564953|7444043|FG000|STARTED|Overall Study||143
6522885|NCT01564953|7444043|FG000|COMPLETED|Overall Study||143
6522886|NCT01564953|7444043|FG000|NOT COMPLETED|Overall Study||0
6522887|NCT01565083|7444053|FG000|STARTED|Overall Study||106
6522888|NCT01565083|7444054|FG001|STARTED|Overall Study||107
6522889|NCT01565083|7444053|FG000|COMPLETED|Overall Study||73
6522890|NCT01565083|7444054|FG001|COMPLETED|Overall Study||68
6522891|NCT01565083|7444053|FG000|NOT COMPLETED|Overall Study||33
6522892|NCT01565083|7444054|FG001|NOT COMPLETED|Overall Study||39
6522893|NCT01565148|7444064|FG000|STARTED|Overall Study||47
6522894|NCT01565148|7444065|FG001|STARTED|Overall Study||46
6522895|NCT01565148|7444066|FG002|STARTED|Overall Study||47
6522896|NCT01565148|7444067|FG003|STARTED|Overall Study||45
6522897|NCT01565148|7444064|FG000|COMPLETED|Overall Study||32
6522898|NCT01565148|7444065|FG001|COMPLETED|Overall Study||31
6522899|NCT01565148|7444066|FG002|COMPLETED|Overall Study||40
6522900|NCT01565148|7444067|FG003|COMPLETED|Overall Study||32
6522901|NCT01565148|7444064|FG000|NOT COMPLETED|Overall Study||15
6522902|NCT01565148|7444065|FG001|NOT COMPLETED|Overall Study||15
6522903|NCT01565148|7444066|FG002|NOT COMPLETED|Overall Study||7
6522904|NCT01565148|7444067|FG003|NOT COMPLETED|Overall Study||13
6522905|NCT01565291|7444083|FG000|STARTED|Overall Study||16
6522906|NCT01565291|7444084|FG001|STARTED|Overall Study||16
6522907|NCT01565291|7444083|FG000|COMPLETED|Overall Study||15
6522908|NCT01565291|7444084|FG001|COMPLETED|Overall Study||16
6522909|NCT01565291|7444083|FG000|NOT COMPLETED|Overall Study||1
6522910|NCT01565291|7444084|FG001|NOT COMPLETED|Overall Study||0
6522911|NCT01565330|7444094|FG000|STARTED|Overall Study||5
6522912|NCT01565330|7444095|FG001|STARTED|Overall Study||4
6522913|NCT01565330|7444096|FG002|STARTED|Overall Study||4
6522914|NCT01565330|7444097|FG003|STARTED|Overall Study||7
6522915|NCT01565330|7444094|FG000|COMPLETED|Overall Study||5
6522916|NCT01565330|7444095|FG001|COMPLETED|Overall Study||4
6522917|NCT01565330|7444096|FG002|COMPLETED|Overall Study||4
6522918|NCT01565330|7444097|FG003|COMPLETED|Overall Study||7
6522919|NCT01565330|7444094|FG000|NOT COMPLETED|Overall Study||0
6522920|NCT01565330|7444095|FG001|NOT COMPLETED|Overall Study||0
6522921|NCT01565330|7444096|FG002|NOT COMPLETED|Overall Study||0
6522922|NCT01565330|7444097|FG003|NOT COMPLETED|Overall Study||0
6522923|NCT01565343|7444111|FG000|STARTED|Overall Study||11
6522924|NCT01565343|7444112|FG001|STARTED|Overall Study||4
6522925|NCT01565343|7444113|FG002|STARTED|Overall Study||10
6522926|NCT01565343|7444111|FG000|COMPLETED|Overall Study||10
6522927|NCT01565343|7444112|FG001|COMPLETED|Overall Study||4
6522928|NCT01565343|7444113|FG002|COMPLETED|Overall Study||10
6522929|NCT01565343|7444111|FG000|NOT COMPLETED|Overall Study||1
6522930|NCT01565343|7444112|FG001|NOT COMPLETED|Overall Study||0
6522931|NCT01565343|7444113|FG002|NOT COMPLETED|Overall Study||0
6522932|NCT01565356|7444120|FG000|STARTED|Overall Study||41
6522933|NCT01565356|7444120|FG000|COMPLETED|Overall Study||41
6522934|NCT01565356|7444120|FG000|NOT COMPLETED|Overall Study||0
6522935|NCT01565369|7444124|FG000|STARTED|Overall Study||35
6522936|NCT01565369|7444124|FG000|COMPLETED|Overall Study||35
6522937|NCT01565369|7444124|FG000|NOT COMPLETED|Overall Study||0
6522938|NCT01565382|7444129|FG000|STARTED|Overall Study||40
6522939|NCT01565382|7444130|FG001|STARTED|Overall Study||7
6522940|NCT01565382|7444129|FG000|COMPLETED|Overall Study||40
6522941|NCT01565382|7444130|FG001|COMPLETED|Overall Study||7
6522942|NCT01565382|7444129|FG000|NOT COMPLETED|Overall Study||0
6522943|NCT01565382|7444130|FG001|NOT COMPLETED|Overall Study||0
6522944|NCT01565499|7444135|FG000|STARTED|Overall Study||83
6522945|NCT01565499|7444135|FG000|COMPLETED|Overall Study||75
6522946|NCT01565499|7444135|FG000|NOT COMPLETED|Overall Study||8
6522947|NCT01565538|7444141|FG000|STARTED|Overall Study||61
6522948|NCT01565538|7444142|FG001|STARTED|Overall Study||62
6522949|NCT01565538|7444141|FG000|COMPLETED|Overall Study||61
6522950|NCT01565538|7444142|FG001|COMPLETED|Overall Study||62
6522951|NCT01565538|7444141|FG000|NOT COMPLETED|Overall Study||0
6522952|NCT01565538|7444142|FG001|NOT COMPLETED|Overall Study||0
6522953|NCT01565551|7444150|FG000|STARTED|Overall Study||586
6522954|NCT01565551|7444151|FG001|STARTED|Overall Study||51
6522955|NCT01565551|7444150|FG000|Clinical/Demographics|Overall Study||586
6522956|NCT01565551|7444151|FG001|Clinical/Demographics|Overall Study||51
6522957|NCT01565551|7444150|FG000|Biospecimens/Biomarkers|Overall Study||479
6522958|NCT01565551|7444151|FG001|Biospecimens/Biomarkers|Overall Study||22
6522959|NCT01565551|7444150|FG000|Neuroimaging|Overall Study||233
6522960|NCT01565551|7444151|FG001|Neuroimaging|Overall Study||25
6522961|NCT01565551|7444150|FG000|6-Month Outcomes|Overall Study||412
6522962|NCT01565551|7444151|FG001|6-Month Outcomes|Overall Study||30
6522963|NCT01565551|7444150|FG000|COMPLETED|Overall Study||586
6522964|NCT01565551|7444151|FG001|COMPLETED|Overall Study||51
6522965|NCT01565551|7444150|FG000|NOT COMPLETED|Overall Study||0
6522966|NCT01565551|7444151|FG001|NOT COMPLETED|Overall Study||0
6522967|NCT01565564|7444159|FG000|STARTED|Overall Study||344
6522968|NCT01565564|7444160|FG001|STARTED|Overall Study||362
6522969|NCT01565564|7444159|FG000|COMPLETED|Overall Study||339
6522970|NCT01565564|7444160|FG001|COMPLETED|Overall Study||361
6522971|NCT01565564|7444159|FG000|NOT COMPLETED|Overall Study||5
6522972|NCT01565564|7444160|FG001|NOT COMPLETED|Overall Study||1
6522973|NCT01565616|7444166|FG000|STARTED|Overall Study||22
6522974|NCT01565616|7444166|FG000|First Component: 5 Related Donors|Overall Study||5
6522975|NCT01565616|7444166|FG000|Second Component: Related or Unrelated|Overall Study||17
6522976|NCT01565616|7444166|FG000|COMPLETED|Overall Study||22
6522977|NCT01565616|7444166|FG000|NOT COMPLETED|Overall Study||0
6522978|NCT01565642|7444172|FG000|STARTED|Overall Study||151
6522979|NCT01565642|7444173|FG001|STARTED|Overall Study||151
6522980|NCT01565642|7444172|FG000|COMPLETED|Overall Study||149
6522981|NCT01565642|7444173|FG001|COMPLETED|Overall Study||150
6522982|NCT01565642|7444172|FG000|NOT COMPLETED|Overall Study||2
6522983|NCT01565642|7444173|FG001|NOT COMPLETED|Overall Study||1
6522984|NCT01565668|7444181|FG000|STARTED|Overall Study||38
6522985|NCT01565668|7444182|FG001|STARTED|Overall Study||38
6522986|NCT01565668|7444181|FG000|Completed Treatment Per Protocol|Overall Study||0
6522987|NCT01565668|7444182|FG001|Completed Treatment Per Protocol|Overall Study||0
6522988|NCT01565668|7444181|FG000|Started 30-day Follow-up|Overall Study||37
6522989|NCT01565668|7444182|FG001|Started 30-day Follow-up|Overall Study||37
6522990|NCT01565668|7444181|FG000|Completed 30-day Follow-up|Overall Study||11
6522991|NCT01565668|7444182|FG001|Completed 30-day Follow-up|Overall Study||5
6522992|NCT01565668|7444181|FG000|Started Long-term Follow-up|Overall Study||36
6522993|NCT01565668|7444182|FG001|Started Long-term Follow-up|Overall Study||33
6522994|NCT01565668|7444181|FG000|Completed Long-term Follow-up|Overall Study||0
6522995|NCT01565668|7444182|FG001|Completed Long-term Follow-up|Overall Study||0
6522996|NCT01565668|7444181|FG000|COMPLETED|Overall Study||0
6522997|NCT01565668|7444182|FG001|COMPLETED|Overall Study||0
6522998|NCT01565668|7444181|FG000|NOT COMPLETED|Overall Study||38
6522999|NCT01565668|7444182|FG001|NOT COMPLETED|Overall Study||38
6523000|NCT01565694|7444188|FG000|STARTED|Dose-Titration Period||76
6523001|NCT01565694|7444188|FG000|COMPLETED|Dose-Titration Period||62
6523002|NCT01565694|7444188|FG000|NOT COMPLETED|Dose-Titration Period||14
6523003|NCT01565694|7444188|FG000|STARTED|Fixed-Dose Assessment Period||62
6523004|NCT01565694|7444188|FG000|COMPLETED|Fixed-Dose Assessment Period||58
6523005|NCT01565694|7444188|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||4
6523006|NCT01565707|7444196|FG000|STARTED|Overall Study||75
6523007|NCT01565707|7444197|FG001|STARTED|Overall Study||73
6523008|NCT01565707|7444198|FG002|STARTED|Overall Study||19
6523009|NCT01565707|7444199|FG003|STARTED|Overall Study||22
6523010|NCT01565707|7444196|FG000|Treated|Overall Study||73
6523011|NCT01565707|7444197|FG001|Treated|Overall Study||73
6523012|NCT01565707|7444198|FG002|Treated|Overall Study||19
6523013|NCT01565707|7444199|FG003|Treated|Overall Study||22
6523014|NCT01565707|7444196|FG000|COMPLETED|Overall Study||66
6523015|NCT01565707|7444197|FG001|COMPLETED|Overall Study||65
6523016|NCT01565707|7444198|FG002|COMPLETED|Overall Study||16
6523017|NCT01565707|7444199|FG003|COMPLETED|Overall Study||17
6523018|NCT01565707|7444196|FG000|NOT COMPLETED|Overall Study||9
6523019|NCT01565707|7444197|FG001|NOT COMPLETED|Overall Study||8
6523020|NCT01565707|7444198|FG002|NOT COMPLETED|Overall Study||3
6523021|NCT01565707|7444199|FG003|NOT COMPLETED|Overall Study||5
6523022|NCT01565850|7444218|FG000|STARTED|Overall Study||103
6523023|NCT01565850|7444219|FG001|STARTED|Overall Study||50
6523024|NCT01565850|7444218|FG000|COMPLETED|Overall Study||83
6523025|NCT01565850|7444219|FG001|COMPLETED|Overall Study||42
6523026|NCT01565850|7444218|FG000|NOT COMPLETED|Overall Study||20
6523027|NCT01565850|7444219|FG001|NOT COMPLETED|Overall Study||8
6523028|NCT01565889|7444231|FG000|STARTED|Part A||12
6523029|NCT01565889|7444232|FG001|STARTED|Part A||4
6523030|NCT01565889|7444233|FG002|STARTED|Part A||8
6523031|NCT01565889|7444234|FG003|STARTED|Part A||7
6523032|NCT01565889|7444235|FG004|STARTED|Part A||7
6523033|NCT01565889|7444236|FG005|STARTED|Part A||0
6523034|NCT01565889|7444231|FG000|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
6523035|NCT01565889|7444232|FG001|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
6523036|NCT01565889|7444233|FG002|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
6523037|NCT01565889|7444234|FG003|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
6523038|NCT01565889|7444235|FG004|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
6523039|NCT01565889|7444236|FG005|COMPLETED|Part A||0
6523040|NCT01565889|7444231|FG000|NOT COMPLETED|Part A||1
6523041|NCT01565889|7444232|FG001|NOT COMPLETED|Part A||0
6523042|NCT01565889|7444233|FG002|NOT COMPLETED|Part A||0
6523043|NCT01565889|7444234|FG003|NOT COMPLETED|Part A||0
6523044|NCT01565889|7444235|FG004|NOT COMPLETED|Part A||0
6523045|NCT01565889|7444236|FG005|NOT COMPLETED|Part A||0
6523046|NCT01565889|7444231|FG000|STARTED|Part B||0
6523047|NCT01565889|7444232|FG001|STARTED|Part B||0
6523048|NCT01565889|7444233|FG002|STARTED|Part B||0
6523049|NCT01565889|7444234|FG003|STARTED|Part B||0
6523050|NCT01565889|7444235|FG004|STARTED|Part B||0
6523051|NCT01565889|7444236|FG005|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
6523052|NCT01565889|7444231|FG000|COMPLETED|Part B||0
6523053|NCT01565889|7444232|FG001|COMPLETED|Part B||0
6523054|NCT01565889|7444233|FG002|COMPLETED|Part B||0
6523055|NCT01565889|7444234|FG003|COMPLETED|Part B||0
6523056|NCT01565889|7444235|FG004|COMPLETED|Part B||0
6523057|NCT01565889|7444236|FG005|COMPLETED|Part B||19
6523058|NCT01565889|7444231|FG000|NOT COMPLETED|Part B||0
6523059|NCT01565889|7444232|FG001|NOT COMPLETED|Part B||0
6523060|NCT01565889|7444233|FG002|NOT COMPLETED|Part B||0
6523061|NCT01565889|7444234|FG003|NOT COMPLETED|Part B||0
6523062|NCT01565889|7444235|FG004|NOT COMPLETED|Part B||0
6523063|NCT01565889|7444236|FG005|NOT COMPLETED|Part B||4
6523064|NCT01565902|7444255|FG000|STARTED|Overall Study||8
6523065|NCT01565902|7444256|FG001|STARTED|Overall Study||8
6523066|NCT01565902|7444257|FG002|STARTED|Overall Study||8
6523067|NCT01565902|7444258|FG003|STARTED|Overall Study||16
6523068|NCT01565902|7444255|FG000|COMPLETED|Overall Study||8
6523069|NCT01565902|7444256|FG001|COMPLETED|Overall Study||8
6523070|NCT01565902|7444257|FG002|COMPLETED|Overall Study||8
6523071|NCT01565902|7444258|FG003|COMPLETED|Overall Study||16
6523072|NCT01565902|7444255|FG000|NOT COMPLETED|Overall Study||0
6523073|NCT01565902|7444256|FG001|NOT COMPLETED|Overall Study||0
6523074|NCT01565902|7444257|FG002|NOT COMPLETED|Overall Study||0
6523075|NCT01565902|7444258|FG003|NOT COMPLETED|Overall Study||0
6523076|NCT01565928|7444271|FG000|STARTED|Overall Study||22
6523077|NCT01565928|7444271|FG000|COMPLETED|Overall Study||0
6523078|NCT01565928|7444271|FG000|NOT COMPLETED|Overall Study||22
6523079|NCT01565941|7444280|FG000|STARTED|Overall Study||360
6523080|NCT01565941|7444281|FG001|STARTED|Overall Study||353
6523081|NCT01565941|7444280|FG000|COMPLETED|Overall Study||349
6523082|NCT01565941|7444281|FG001|COMPLETED|Overall Study||349
6523083|NCT01565941|7444280|FG000|NOT COMPLETED|Overall Study||11
6523084|NCT01565941|7444281|FG001|NOT COMPLETED|Overall Study||4
6523085|NCT01565980|7444291|FG000|STARTED|Overall Study||20
6523086|NCT01565980|7444292|FG001|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
6523087|NCT01565980|7444291|FG000|COMPLETED|Overall Study||16
6523088|NCT01565980|7444292|FG001|COMPLETED|Overall Study||16
6523089|NCT01565980|7444291|FG000|NOT COMPLETED|Overall Study||4
6523090|NCT01565980|7444292|FG001|NOT COMPLETED|Overall Study||4
6523091|NCT01565993|7444304|FG000|STARTED|Overall Study||66
6523092|NCT01565993|7444305|FG001|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
6523093|NCT01565993|7444304|FG000|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
6523094|NCT01565993|7444305|FG001|COMPLETED|Overall Study||39
6523095|NCT01565993|7444304|FG000|NOT COMPLETED|Overall Study||0
6523096|NCT01565993|7444305|FG001|NOT COMPLETED|Overall Study||3
6523097|NCT01566084|7444313|FG000|STARTED|Overall Study||7
6523098|NCT01566084|7444314|FG001|STARTED|Overall Study||10
6523099|NCT01566084|7444313|FG000|COMPLETED|Overall Study||7
6523100|NCT01566084|7444314|FG001|COMPLETED|Overall Study||10
6523101|NCT01566084|7444313|FG000|NOT COMPLETED|Overall Study||0
6523102|NCT01566084|7444314|FG001|NOT COMPLETED|Overall Study||0
6523103|NCT01566162|7444328|FG000|STARTED|Overall Study||191
6523104|NCT01566162|7444328|FG000|COMPLETED|Overall Study||155
6523105|NCT01566162|7444328|FG000|NOT COMPLETED|Overall Study||36
6523106|NCT01566214|7444334|FG000|STARTED|Overall Study||6
6523107|NCT01566214|7444335|FG001|STARTED|Overall Study||6
6523108|NCT01566214|7444334|FG000|COMPLETED|Overall Study||3
6523109|NCT01566214|7444335|FG001|COMPLETED|Overall Study||6
6523110|NCT01566214|7444334|FG000|NOT COMPLETED|Overall Study||3
6523111|NCT01566214|7444335|FG001|NOT COMPLETED|Overall Study||0
6523112|NCT01566331|7444343|FG000|STARTED|Overall Study||40
6523113|NCT01566331|7444344|FG001|STARTED|Overall Study||40
6523114|NCT01566331|7444343|FG000|COMPLETED|Overall Study||40
6523115|NCT01566331|7444344|FG001|COMPLETED|Overall Study||40
6523116|NCT01566331|7444343|FG000|NOT COMPLETED|Overall Study||0
6523117|NCT01566331|7444344|FG001|NOT COMPLETED|Overall Study||0
6523118|NCT01566409|7444352|FG000|STARTED|Overall Study||49
6523119|NCT01566409|7444353|FG001|STARTED|Overall Study||53
6523120|NCT01566409|7444352|FG000|COMPLETED|Overall Study||47
6523121|NCT01566409|7444353|FG001|COMPLETED|Overall Study||48
6523122|NCT01566409|7444352|FG000|NOT COMPLETED|Overall Study||2
6523123|NCT01566409|7444353|FG001|NOT COMPLETED|Overall Study||5
6523124|NCT01566435|7444359|FG000|STARTED|ACF Induction Therapy||30
6523125|NCT01566435|7444359|FG000|COMPLETED|ACF Induction Therapy||30
6523126|NCT01566435|7444359|FG000|NOT COMPLETED|ACF Induction Therapy||0
6523127|NCT01566435|7444359|FG000|STARTED|ACF Definitive Chemoradiation-cisplatin||28
6523128|NCT01566435|7444359|FG000|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
6523129|NCT01566435|7444359|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
6523130|NCT01566435|7444359|FG000|STARTED|ACF Definitive Chemoradiation-cetuximab||2
6523131|NCT01566435|7444359|FG000|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
6523132|NCT01566435|7444359|FG000|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
6523133|NCT01566448|7444367|FG000|STARTED|Overall Study||30
6523134|NCT01566448|7444367|FG000|COMPLETED|Overall Study||30
6523135|NCT01566448|7444367|FG000|NOT COMPLETED|Overall Study||0
6523136|NCT01566461|7444373|FG000|STARTED|IN.PACT SFA I Phase||99
6523137|NCT01566461|7444374|FG001|STARTED|IN.PACT SFA I Phase||51
6523138|NCT01566461|7444373|FG000|COMPLETED|IN.PACT SFA I Phase||88
6523139|NCT01566461|7444374|FG001|COMPLETED|IN.PACT SFA I Phase||49
6523140|NCT01566461|7444373|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
6523141|NCT01566461|7444374|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
6523142|NCT01566461|7444373|FG000|STARTED|IN.PACT SFA II Phase||121
6523143|NCT01566461|7444374|FG001|STARTED|IN.PACT SFA II Phase||60
6523144|NCT01566461|7444373|FG000|COMPLETED|IN.PACT SFA II Phase||109
6523145|NCT01566461|7444374|FG001|COMPLETED|IN.PACT SFA II Phase||55
6523146|NCT01566461|7444373|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
6523147|NCT01566461|7444374|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
6523148|NCT01566500|7444380|FG000|STARTED|Overall Study||140
6523149|NCT01566500|7444380|FG000|COMPLETED|Overall Study||140
6523150|NCT01566500|7444380|FG000|NOT COMPLETED|Overall Study||0
6523151|NCT01566526|7444384|FG000|STARTED|Overall Study||26
6523152|NCT01566526|7444384|FG000|COMPLETED|Overall Study||26
6523153|NCT01566526|7444384|FG000|NOT COMPLETED|Overall Study||0
6523154|NCT01566539|7444396|FG000|STARTED|Main Study Period||101
6523155|NCT01566539|7444397|FG001|STARTED|Main Study Period||100
6523156|NCT01566539|7444398|FG002|STARTED|Main Study Period||104
6523157|NCT01566539|7444399|FG003|STARTED|Main Study Period||0
6523158|NCT01566539|7444400|FG004|STARTED|Main Study Period||40
6523159|NCT01566539|7444401|FG005|STARTED|Main Study Period||43
6523160|NCT01566539|7444402|FG006|STARTED|Main Study Period||30
6523161|NCT01566539|7444403|FG007|STARTED|Main Study Period||30
6523162|NCT01566539|7444404|FG008|STARTED|Main Study Period||1
6523163|NCT01566539|7444396|FG000|COMPLETED|Main Study Period||100
6523164|NCT01566539|7444397|FG001|COMPLETED|Main Study Period||100
6523165|NCT01566539|7444398|FG002|COMPLETED|Main Study Period||104
6523166|NCT01566539|7444399|FG003|COMPLETED|Main Study Period||0
6523167|NCT01566539|7444400|FG004|COMPLETED|Main Study Period||40
6523168|NCT01566539|7444401|FG005|COMPLETED|Main Study Period||40
6523169|NCT01566539|7444402|FG006|COMPLETED|Main Study Period||30
6523170|NCT01566539|7444403|FG007|COMPLETED|Main Study Period||30
6523171|NCT01566539|7444404|FG008|COMPLETED|Main Study Period||1
6523172|NCT01566539|7444396|FG000|NOT COMPLETED|Main Study Period||1
6523173|NCT01566539|7444397|FG001|NOT COMPLETED|Main Study Period||0
6523174|NCT01566539|7444398|FG002|NOT COMPLETED|Main Study Period||0
6523175|NCT01566539|7444399|FG003|NOT COMPLETED|Main Study Period||0
6523176|NCT01566539|7444400|FG004|NOT COMPLETED|Main Study Period||0
6523177|NCT01566539|7444401|FG005|NOT COMPLETED|Main Study Period||3
6523178|NCT01566539|7444402|FG006|NOT COMPLETED|Main Study Period||0
6523179|NCT01566539|7444403|FG007|NOT COMPLETED|Main Study Period||0
6523180|NCT01566539|7444404|FG008|NOT COMPLETED|Main Study Period||0
6523181|NCT01566539|7444396|FG000|STARTED|Within Subject Group||0
6523182|NCT01566539|7444397|FG001|STARTED|Within Subject Group||0
6523183|NCT01566539|7444398|FG002|STARTED|Within Subject Group||0
6523184|NCT01566539|7444399|FG003|STARTED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|156
6523185|NCT01566539|7444400|FG004|STARTED|Within Subject Group||0
6523186|NCT01566539|7444401|FG005|STARTED|Within Subject Group||0
6523187|NCT01566539|7444402|FG006|STARTED|Within Subject Group||0
6523188|NCT01566539|7444403|FG007|STARTED|Within Subject Group||0
6523189|NCT01566539|7444404|FG008|STARTED|Within Subject Group||0
6523190|NCT01566539|7444396|FG000|COMPLETED|Within Subject Group||0
6523191|NCT01566539|7444397|FG001|COMPLETED|Within Subject Group||0
6523192|NCT01566539|7444398|FG002|COMPLETED|Within Subject Group||0
6523193|NCT01566539|7444399|FG003|COMPLETED|Within Subject Group|Participants can move from Healthy Volunteers-AVP, OT and Placebo groups to the within subject group|153
6523194|NCT01566539|7444400|FG004|COMPLETED|Within Subject Group||0
6523195|NCT01566539|7444401|FG005|COMPLETED|Within Subject Group||0
6523196|NCT01566539|7444402|FG006|COMPLETED|Within Subject Group||0
6523197|NCT01566539|7444403|FG007|COMPLETED|Within Subject Group||0
6523198|NCT01566539|7444404|FG008|COMPLETED|Within Subject Group||0
6523199|NCT01566539|7444396|FG000|NOT COMPLETED|Within Subject Group||0
6523200|NCT01566539|7444397|FG001|NOT COMPLETED|Within Subject Group||0
6523201|NCT01566539|7444398|FG002|NOT COMPLETED|Within Subject Group||0
6523202|NCT01566539|7444399|FG003|NOT COMPLETED|Within Subject Group||3
6523203|NCT01566539|7444400|FG004|NOT COMPLETED|Within Subject Group||0
6523204|NCT01566539|7444401|FG005|NOT COMPLETED|Within Subject Group||0
6523205|NCT01566539|7444402|FG006|NOT COMPLETED|Within Subject Group||0
6523206|NCT01566539|7444403|FG007|NOT COMPLETED|Within Subject Group||0
6523207|NCT01566539|7444404|FG008|NOT COMPLETED|Within Subject Group||0
6642527|NCT02349295|7570955|FG009|STARTED|Double Blind Treatment (Week 0-24)||0
6642528|NCT02349295|7570956|FG010|STARTED|Double Blind Treatment (Week 0-24)||0
6523208|NCT01566604|7444428|FG000|STARTED|Overall Study||306
6523209|NCT01566604|7444429|FG001|STARTED|Overall Study||154
6523210|NCT01566604|7444428|FG000|Safety Set|Overall Study||305
6523211|NCT01566604|7444429|FG001|Safety Set|Overall Study||154
6523212|NCT01566604|7444428|FG000|Full Analysis Set (FAS)|Overall Study||305
6523213|NCT01566604|7444429|FG001|Full Analysis Set (FAS)|Overall Study||154
6523214|NCT01566604|7444428|FG000|FAS, Serial Spirometry Subgroup|Overall Study||134
6523215|NCT01566604|7444429|FG001|FAS, Serial Spirometry Subgroup|Overall Study||58
6523216|NCT01566604|7444428|FG000|COMPLETED|Overall Study||282
6523217|NCT01566604|7444429|FG001|COMPLETED|Overall Study||143
6523218|NCT01566604|7444428|FG000|NOT COMPLETED|Overall Study||24
6642529|NCT02349295|7570957|FG011|STARTED|Double Blind Treatment (Week 0-24)||0
6642530|NCT02349295|7570958|FG012|STARTED|Double Blind Treatment (Week 0-24)||0
6642531|NCT02349295|7570959|FG013|STARTED|Double Blind Treatment (Week 0-24)||0
6642532|NCT02349295|7570946|FG000|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||123
6642533|NCT02349295|7570947|FG001|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||122
6642534|NCT02349295|7570948|FG002|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||118
6642535|NCT02349295|7570949|FG003|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642536|NCT02349295|7570950|FG004|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6655845|NCT02456727|7586010|FG000|STARTED|Overall Study||389
6523219|NCT01566604|7444429|FG001|NOT COMPLETED|Overall Study||11
6523220|NCT01566630|7444437|FG000|STARTED|Overall Study||2
6523221|NCT01566630|7444438|FG001|STARTED|Overall Study||1
6523222|NCT01566630|7444437|FG000|COMPLETED|Overall Study||2
6523223|NCT01566630|7444438|FG001|COMPLETED|Overall Study||1
6523224|NCT01566630|7444437|FG000|NOT COMPLETED|Overall Study||0
6523225|NCT01566630|7444438|FG001|NOT COMPLETED|Overall Study||0
6523226|NCT01566682|7444450|FG000|STARTED|Overall Study||420
6523227|NCT01566682|7444450|FG000|COMPLETED|Overall Study||374
6523228|NCT01566682|7444450|FG000|NOT COMPLETED|Overall Study||46
6523229|NCT01566721|7444456|FG000|STARTED|Treatment Period||1867
6523230|NCT01566721|7444457|FG001|STARTED|Treatment Period||710
6523231|NCT01566721|7444456|FG000|COMPLETED|Treatment Period||1670
6523232|NCT01566721|7444457|FG001|COMPLETED|Treatment Period||652
6523233|NCT01566721|7444456|FG000|NOT COMPLETED|Treatment Period||197
6523234|NCT01566721|7444457|FG001|NOT COMPLETED|Treatment Period||58
6523235|NCT01566721|7444456|FG000|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|1865
6523236|NCT01566721|7444457|FG001|STARTED|Safety Follow-up|Participants who discontinued treatment were allowed to join the SFU Period.|708
6523237|NCT01566721|7444456|FG000|COMPLETED|Safety Follow-up||1318
6523238|NCT01566721|7444457|FG001|COMPLETED|Safety Follow-up||501
6523239|NCT01566721|7444456|FG000|NOT COMPLETED|Safety Follow-up||547
6523240|NCT01566721|7444457|FG001|NOT COMPLETED|Safety Follow-up||207
6523241|NCT01566773|7444470|FG000|STARTED|Overall Study||140
6523242|NCT01566773|7444470|FG000|GP MDI 18 µg BID|Overall Study||64
6523243|NCT01566773|7444470|FG000|GP MDI 9 µg BID|Overall Study||64
6523244|NCT01566773|7444470|FG000|GP MDI 4.6 µg BID|Overall Study||62
6523245|NCT01566773|7444470|FG000|GP MDI 2.4 µg BID|Overall Study||64
6523246|NCT01566773|7444470|FG000|GP MDI 1.2 µg BID|Overall Study||57
6523247|NCT01566773|7444470|FG000|GP MDI 0.6 µg BID|Overall Study||59
6523248|NCT01566773|7444470|FG000|Placebo MDI|Overall Study||62
6523249|NCT01566773|7444470|FG000|Spiriva® Handihaler®|Overall Study||62
6523250|NCT01566773|7444470|FG000|COMPLETED|Overall Study||110
6523251|NCT01566773|7444470|FG000|NOT COMPLETED|Overall Study||30
6523252|NCT01566838|7444492|FG000|STARTED|Overall Study||41
6523253|NCT01566838|7444493|FG001|STARTED|Overall Study||42
6523254|NCT01566838|7444492|FG000|COMPLETED|Overall Study||38
6523255|NCT01566838|7444493|FG001|COMPLETED|Overall Study||42
6523256|NCT01566838|7444492|FG000|NOT COMPLETED|Overall Study||3
6523257|NCT01566838|7444493|FG001|NOT COMPLETED|Overall Study||0
6523258|NCT01566981|7444501|FG000|STARTED|Overall Study||58
6523259|NCT01566981|7444502|FG001|STARTED|Overall Study||62
6523260|NCT01566981|7444501|FG000|COMPLETED|Overall Study||53
6523261|NCT01566981|7444502|FG001|COMPLETED|Overall Study||54
6523262|NCT01566981|7444501|FG000|NOT COMPLETED|Overall Study||5
6523263|NCT01566981|7444502|FG001|NOT COMPLETED|Overall Study||8
6523264|NCT01567020|7444514|FG000|STARTED|Overall Study||28
6523265|NCT01567020|7444515|FG001|STARTED|Overall Study||46
6523266|NCT01567020|7444516|FG002|STARTED|Overall Study||20
6523267|NCT01567020|7444517|FG003|STARTED|Overall Study||11
6523268|NCT01567020|7444514|FG000|COMPLETED|Overall Study||21
6523269|NCT01567020|7444515|FG001|COMPLETED|Overall Study||41
6523270|NCT01567020|7444516|FG002|COMPLETED|Overall Study||18
6523271|NCT01567020|7444517|FG003|COMPLETED|Overall Study||10
6523272|NCT01567020|7444514|FG000|NOT COMPLETED|Overall Study||7
6523273|NCT01567020|7444515|FG001|NOT COMPLETED|Overall Study||5
6523274|NCT01567020|7444516|FG002|NOT COMPLETED|Overall Study||2
6523275|NCT01567020|7444517|FG003|NOT COMPLETED|Overall Study||1
6561721|NCT01796470|7484611|FG000|STARTED|Overall Study||35
6561722|NCT01796470|7484612|FG001|STARTED|Overall Study||14
6561723|NCT01796470|7484613|FG002|STARTED|Overall Study||6
6561724|NCT01796470|7484614|FG003|STARTED|Overall Study||3
6561725|NCT01796470|7484615|FG004|STARTED|Overall Study||8
6561726|NCT01796470|7484611|FG000|Entospletinib Monotherapy|Overall Study||4
6561727|NCT01796470|7484612|FG001|Entospletinib Monotherapy|Overall Study||4
6561728|NCT01796470|7484613|FG002|Entospletinib Monotherapy|Overall Study||0
6561729|NCT01796470|7484614|FG003|Entospletinib Monotherapy|Overall Study||0
6561730|NCT01796470|7484615|FG004|Entospletinib Monotherapy|Overall Study||0
6561731|NCT01796470|7484611|FG000|COMPLETED|Overall Study||0
6561732|NCT01796470|7484612|FG001|COMPLETED|Overall Study||0
6561733|NCT01796470|7484613|FG002|COMPLETED|Overall Study||0
6561734|NCT01796470|7484614|FG003|COMPLETED|Overall Study||0
6561735|NCT01796470|7484615|FG004|COMPLETED|Overall Study||0
6561736|NCT01796470|7484611|FG000|NOT COMPLETED|Overall Study||35
6561737|NCT01796470|7484612|FG001|NOT COMPLETED|Overall Study||14
6561738|NCT01796470|7484613|FG002|NOT COMPLETED|Overall Study||6
6561739|NCT01796470|7484614|FG003|NOT COMPLETED|Overall Study||3
6561740|NCT01796470|7484615|FG004|NOT COMPLETED|Overall Study||8
6523276|NCT01567085|7444527|FG000|STARTED|Overall Study||80
6523277|NCT01567085|7444527|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
6523278|NCT01567085|7444527|FG000|COMPLETED|Overall Study||60
6523279|NCT01567085|7444527|FG000|NOT COMPLETED|Overall Study||20
6523280|NCT01567150|7444533|FG000|STARTED|Overall Study||21
6523281|NCT01567150|7444534|FG001|STARTED|Overall Study||18
6523282|NCT01567150|7444533|FG000|COMPLETED|Overall Study||19
6523283|NCT01567150|7444534|FG001|COMPLETED|Overall Study||16
6523284|NCT01567150|7444533|FG000|NOT COMPLETED|Overall Study||2
6523285|NCT01567150|7444534|FG001|NOT COMPLETED|Overall Study||2
6523286|NCT01567163|7444540|FG000|STARTED|Overall Study||22
6523287|NCT01567163|7444540|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
6523288|NCT01567163|7444540|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
6523289|NCT01567163|7444540|FG000|COMPLETED|Overall Study||18
6523290|NCT01567163|7444540|FG000|NOT COMPLETED|Overall Study||4
6523291|NCT01567306|7444555|FG000|STARTED|Overall Study||27
6523292|NCT01567306|7444556|FG001|STARTED|Overall Study||25
6523293|NCT01567306|7444557|FG002|STARTED|Overall Study||24
6523294|NCT01567306|7444558|FG003|STARTED|Overall Study||24
6523295|NCT01567306|7444559|FG004|STARTED|Overall Study||25
6523296|NCT01567306|7444560|FG005|STARTED|Overall Study||26
6523297|NCT01567306|7444555|FG000|COMPLETED|Overall Study||24
6523298|NCT01567306|7444556|FG001|COMPLETED|Overall Study||23
6523299|NCT01567306|7444557|FG002|COMPLETED|Overall Study||24
6523300|NCT01567306|7444558|FG003|COMPLETED|Overall Study||19
6523301|NCT01567306|7444559|FG004|COMPLETED|Overall Study||18
6523302|NCT01567306|7444560|FG005|COMPLETED|Overall Study||23
6523303|NCT01567306|7444555|FG000|NOT COMPLETED|Overall Study||3
6523304|NCT01567306|7444556|FG001|NOT COMPLETED|Overall Study||2
6523305|NCT01567306|7444557|FG002|NOT COMPLETED|Overall Study||0
6523306|NCT01567306|7444558|FG003|NOT COMPLETED|Overall Study||5
6523307|NCT01567306|7444559|FG004|NOT COMPLETED|Overall Study||7
6523308|NCT01567306|7444560|FG005|NOT COMPLETED|Overall Study||3
6523309|NCT01567371|7444574|FG000|STARTED|Overall Study||30
6523310|NCT01567371|7444574|FG000|COMPLETED|Overall Study||30
6523311|NCT01567371|7444574|FG000|NOT COMPLETED|Overall Study||0
6523312|NCT01567462|7444580|FG000|STARTED|Overall Study||45
6523313|NCT01567462|7444581|FG001|STARTED|Overall Study||45
6523314|NCT01567462|7444580|FG000|COMPLETED|Overall Study||41
6523315|NCT01567462|7444581|FG001|COMPLETED|Overall Study||38
6523316|NCT01567462|7444580|FG000|NOT COMPLETED|Overall Study||4
6523317|NCT01567462|7444581|FG001|NOT COMPLETED|Overall Study||7
6523318|NCT01567527|7444589|FG000|STARTED|Conversion Phase.||466
6523319|NCT01567527|7444590|FG001|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
6523320|NCT01567527|7444591|FG002|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
6523321|NCT01567527|7444592|FG003|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
6523322|NCT01567527|7444593|FG004|STARTED|Conversion Phase.|There were no subjects in this reporting group in this phase of the study.|0
6523323|NCT01567527|7444589|FG000|COMPLETED|Conversion Phase.||367
6523324|NCT01567527|7444590|FG001|COMPLETED|Conversion Phase.||0
6523325|NCT01567527|7444591|FG002|COMPLETED|Conversion Phase.||0
6523326|NCT01567527|7444592|FG003|COMPLETED|Conversion Phase.||0
6523327|NCT01567527|7444593|FG004|COMPLETED|Conversion Phase.||0
6523328|NCT01567527|7444589|FG000|NOT COMPLETED|Conversion Phase.||99
6523329|NCT01567527|7444590|FG001|NOT COMPLETED|Conversion Phase.||0
6523330|NCT01567527|7444591|FG002|NOT COMPLETED|Conversion Phase.||0
6523331|NCT01567527|7444592|FG003|NOT COMPLETED|Conversion Phase.||0
6523332|NCT01567527|7444593|FG004|NOT COMPLETED|Conversion Phase.||0
6523333|NCT01567527|7444589|FG000|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
6523334|NCT01567527|7444590|FG001|STARTED|Oral Aripiprazole Stabilization Phase.|265 of the 632 subjects who started this phase entered the Oral Stabilization Phase directly.|632
6523335|NCT01567527|7444591|FG002|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
6523336|NCT01567527|7444592|FG003|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
6523337|NCT01567527|7444593|FG004|STARTED|Oral Aripiprazole Stabilization Phase.|There were no subjects in this reporting group in this phase of the study.|0
6523338|NCT01567527|7444589|FG000|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6523339|NCT01567527|7444590|FG001|COMPLETED|Oral Aripiprazole Stabilization Phase.||425
6523340|NCT01567527|7444591|FG002|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6523341|NCT01567527|7444592|FG003|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6523342|NCT01567527|7444593|FG004|COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6523343|NCT01567527|7444589|FG000|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6523344|NCT01567527|7444590|FG001|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||207
6523345|NCT01567527|7444591|FG002|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6523346|NCT01567527|7444592|FG003|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6523347|NCT01567527|7444593|FG004|NOT COMPLETED|Oral Aripiprazole Stabilization Phase.||0
6523348|NCT01567527|7444589|FG000|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
6523349|NCT01567527|7444590|FG001|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
6523350|NCT01567527|7444591|FG002|STARTED|IM Depot Stabilization.||425
6561741|NCT01796548|7484631|FG000|STARTED|Overall Study||17
6561742|NCT01796548|7484631|FG000|Treated|Overall Study||15
6523351|NCT01567527|7444592|FG003|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
6523352|NCT01567527|7444593|FG004|STARTED|IM Depot Stabilization.|There were no subjects in this reporting group in this phase of the study.|0
6523353|NCT01567527|7444589|FG000|COMPLETED|IM Depot Stabilization.||0
6523354|NCT01567527|7444590|FG001|COMPLETED|IM Depot Stabilization.||0
6523355|NCT01567527|7444591|FG002|COMPLETED|IM Depot Stabilization.||266
6523356|NCT01567527|7444592|FG003|COMPLETED|IM Depot Stabilization.||0
6523357|NCT01567527|7444593|FG004|COMPLETED|IM Depot Stabilization.||0
6523358|NCT01567527|7444589|FG000|NOT COMPLETED|IM Depot Stabilization.||0
6523359|NCT01567527|7444590|FG001|NOT COMPLETED|IM Depot Stabilization.||0
6523360|NCT01567527|7444591|FG002|NOT COMPLETED|IM Depot Stabilization.||159
6523361|NCT01567527|7444592|FG003|NOT COMPLETED|IM Depot Stabilization.||0
6523362|NCT01567527|7444593|FG004|NOT COMPLETED|IM Depot Stabilization.||0
6523363|NCT01567527|7444589|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
6523364|NCT01567527|7444590|FG001|STARTED|Double-blind, Placebo-controlled Phase||0
6523365|NCT01567527|7444591|FG002|STARTED|Double-blind, Placebo-controlled Phase|Subjects were randomized to Aripiprazole IM Depot and placebo groups in this phase of the study|0
6523366|NCT01567527|7444592|FG003|STARTED|Double-blind, Placebo-controlled Phase||133
6523367|NCT01567527|7444593|FG004|STARTED|Double-blind, Placebo-controlled Phase||133
6523368|NCT01567527|7444589|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
6523369|NCT01567527|7444590|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||0
6523370|NCT01567527|7444591|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||0
6523371|NCT01567527|7444592|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||64
6523372|NCT01567527|7444593|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||38
6523373|NCT01567527|7444589|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6523374|NCT01567527|7444590|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6523375|NCT01567527|7444591|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6523376|NCT01567527|7444592|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||69
6523377|NCT01567527|7444593|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||95
6523378|NCT01567826|7444604|FG000|STARTED|Overall Study||43
6523379|NCT01567826|7444605|FG001|STARTED|Overall Study||44
6523380|NCT01567826|7444604|FG000|COMPLETED|Overall Study||40
6523381|NCT01567826|7444605|FG001|COMPLETED|Overall Study||42
6523382|NCT01567826|7444604|FG000|NOT COMPLETED|Overall Study||3
6523383|NCT01567826|7444605|FG001|NOT COMPLETED|Overall Study||2
6523384|NCT01567839|7444613|FG000|STARTED|Overall Study||60
6523385|NCT01567839|7444613|FG000|COMPLETED|Overall Study||60
6523386|NCT01567839|7444613|FG000|NOT COMPLETED|Overall Study||0
6523387|NCT01567852|7444623|FG000|STARTED|Overall Study||8
6523388|NCT01567852|7444624|FG001|STARTED|Overall Study||12
6523389|NCT01567852|7444623|FG000|COMPLETED|Overall Study||4
6523390|NCT01567852|7444624|FG001|COMPLETED|Overall Study||5
6523391|NCT01567852|7444623|FG000|NOT COMPLETED|Overall Study||4
6523392|NCT01567852|7444624|FG001|NOT COMPLETED|Overall Study||7
6523393|NCT01567865|7444634|FG000|STARTED|Enrolled and Vaccinated (Day 0)||163
6523394|NCT01567865|7444635|FG001|STARTED|Enrolled and Vaccinated (Day 0)||220
6523395|NCT01567865|7444636|FG002|STARTED|Enrolled and Vaccinated (Day 0)||211
6523396|NCT01567865|7444637|FG003|STARTED|Enrolled and Vaccinated (Day 0)||224
6523397|NCT01567865|7444634|FG000|COMPLETED|Enrolled and Vaccinated (Day 0)||163
6523398|NCT01567865|7444635|FG001|COMPLETED|Enrolled and Vaccinated (Day 0)||220
6523399|NCT01567865|7444636|FG002|COMPLETED|Enrolled and Vaccinated (Day 0)||211
6523400|NCT01567865|7444637|FG003|COMPLETED|Enrolled and Vaccinated (Day 0)||224
6523401|NCT01567865|7444634|FG000|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
6523402|NCT01567865|7444635|FG001|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
6523403|NCT01567865|7444636|FG002|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
6523404|NCT01567865|7444637|FG003|NOT COMPLETED|Enrolled and Vaccinated (Day 0)||0
6523405|NCT01567865|7444634|FG000|STARTED|Evaluated for Immunogenicity||163
6523406|NCT01567865|7444635|FG001|STARTED|Evaluated for Immunogenicity||220
6523407|NCT01567865|7444636|FG002|STARTED|Evaluated for Immunogenicity||211
6523408|NCT01567865|7444637|FG003|STARTED|Evaluated for Immunogenicity||224
6523409|NCT01567865|7444634|FG000|COMPLETED|Evaluated for Immunogenicity||146
6523410|NCT01567865|7444635|FG001|COMPLETED|Evaluated for Immunogenicity||195
6523411|NCT01567865|7444636|FG002|COMPLETED|Evaluated for Immunogenicity||192
6523412|NCT01567865|7444637|FG003|COMPLETED|Evaluated for Immunogenicity||194
6523413|NCT01567865|7444634|FG000|NOT COMPLETED|Evaluated for Immunogenicity||17
6523414|NCT01567865|7444635|FG001|NOT COMPLETED|Evaluated for Immunogenicity||25
6523415|NCT01567865|7444636|FG002|NOT COMPLETED|Evaluated for Immunogenicity||19
6523416|NCT01567865|7444637|FG003|NOT COMPLETED|Evaluated for Immunogenicity||30
6523417|NCT01567891|7444648|FG000|STARTED|Overall Study||9
6523418|NCT01567891|7444648|FG000|Received T-cell|Overall Study||6
6523419|NCT01567891|7444648|FG000|COMPLETED|Overall Study||6
6523420|NCT01567891|7444648|FG000|NOT COMPLETED|Overall Study||3
6523421|NCT01567943|7444663|FG000|STARTED|Overall Study||40
6523422|NCT01567943|7444664|FG001|STARTED|Overall Study||39
6523423|NCT01567943|7444665|FG002|STARTED|Overall Study||44
6523424|NCT01567943|7444663|FG000|COMPLETED|Overall Study||26
6523425|NCT01567943|7444664|FG001|COMPLETED|Overall Study||29
6523426|NCT01567943|7444665|FG002|COMPLETED|Overall Study||44
6523427|NCT01567943|7444663|FG000|NOT COMPLETED|Overall Study||14
6523428|NCT01567943|7444664|FG001|NOT COMPLETED|Overall Study||10
6523429|NCT01567943|7444665|FG002|NOT COMPLETED|Overall Study||0
6523430|NCT01568008|7444671|FG000|STARTED|Overall Study||933
6523431|NCT01568008|7444671|FG000|COMPLETED|Overall Study||699
6523432|NCT01568008|7444671|FG000|NOT COMPLETED|Overall Study||234
6523433|NCT01568021|7444675|FG000|STARTED|Overall Study||99
6523434|NCT01568021|7444675|FG000|COMPLETED|Overall Study||83
6523435|NCT01568021|7444675|FG000|NOT COMPLETED|Overall Study||16
6523436|NCT01568034|7444679|FG000|STARTED|Overall Study||2
6523437|NCT01568034|7444680|FG001|STARTED|Overall Study||2
6523438|NCT01568034|7444681|FG002|STARTED|Overall Study||3
6523439|NCT01568034|7444682|FG003|STARTED|Overall Study||3
6523440|NCT01568034|7444679|FG000|25 mg BIA 9-1067|Overall Study||2
6523441|NCT01568034|7444680|FG001|25 mg BIA 9-1067|Overall Study||2
6523442|NCT01568034|7444681|FG002|25 mg BIA 9-1067|Overall Study||3
6523443|NCT01568034|7444682|FG003|25 mg BIA 9-1067|Overall Study||3
6523444|NCT01568034|7444679|FG000|50 mg BIA 9-1067|Overall Study||2
6523445|NCT01568034|7444680|FG001|50 mg BIA 9-1067|Overall Study||2
6523446|NCT01568034|7444681|FG002|50 mg BIA 9-1067|Overall Study||3
6523447|NCT01568034|7444682|FG003|50 mg BIA 9-1067|Overall Study||3
6523448|NCT01568034|7444679|FG000|100 mg BIA 9-1067|Overall Study||2
6523449|NCT01568034|7444680|FG001|100 mg BIA 9-1067|Overall Study||2
6523450|NCT01568034|7444681|FG002|100 mg BIA 9-1067|Overall Study||3
6523451|NCT01568034|7444682|FG003|100 mg BIA 9-1067|Overall Study||3
6523452|NCT01568034|7444679|FG000|Placebo|Overall Study||1
6523453|NCT01568034|7444680|FG001|Placebo|Overall Study||2
6523454|NCT01568034|7444681|FG002|Placebo|Overall Study||3
6523455|NCT01568034|7444682|FG003|Placebo|Overall Study||3
6523456|NCT01568034|7444679|FG000|COMPLETED|Overall Study||1
6523457|NCT01568034|7444680|FG001|COMPLETED|Overall Study||2
6523458|NCT01568034|7444681|FG002|COMPLETED|Overall Study||3
6523459|NCT01568034|7444682|FG003|COMPLETED|Overall Study||3
6523460|NCT01568034|7444679|FG000|NOT COMPLETED|Overall Study||1
6523461|NCT01568034|7444680|FG001|NOT COMPLETED|Overall Study||0
6523462|NCT01568034|7444681|FG002|NOT COMPLETED|Overall Study||0
6523463|NCT01568034|7444682|FG003|NOT COMPLETED|Overall Study||0
6523464|NCT01568047|7444696|FG000|STARTED|Overall Study||10
6523465|NCT01568047|7444697|FG001|STARTED|Overall Study||10
6523466|NCT01568047|7444698|FG002|STARTED|Overall Study||10
6523467|NCT01568047|7444699|FG003|STARTED|Overall Study||10
6523468|NCT01568047|7444696|FG000|COMPLETED|Overall Study||9
6523469|NCT01568047|7444697|FG001|COMPLETED|Overall Study||9
6523470|NCT01568047|7444698|FG002|COMPLETED|Overall Study||9
6523471|NCT01568047|7444699|FG003|COMPLETED|Overall Study||9
6523472|NCT01568047|7444696|FG000|NOT COMPLETED|Overall Study||1
6523473|NCT01568047|7444697|FG001|NOT COMPLETED|Overall Study||1
6523474|NCT01568047|7444698|FG002|NOT COMPLETED|Overall Study||1
6523475|NCT01568047|7444699|FG003|NOT COMPLETED|Overall Study||1
6523476|NCT01568073|7444714|FG000|STARTED|Overall Study||121
6523477|NCT01568073|7444715|FG001|STARTED|Overall Study||122
6523478|NCT01568073|7444716|FG002|STARTED|Overall Study||122
6523479|NCT01568073|7444717|FG003|STARTED|Overall Study||119
6523480|NCT01568073|7444718|FG004|STARTED|Overall Study||116
6523481|NCT01568073|7444714|FG000|COMPLETED|Overall Study||110
6523482|NCT01568073|7444715|FG001|COMPLETED|Overall Study||107
6523483|NCT01568073|7444716|FG002|COMPLETED|Overall Study||110
6523484|NCT01568073|7444717|FG003|COMPLETED|Overall Study||108
6523485|NCT01568073|7444718|FG004|COMPLETED|Overall Study||107
6523486|NCT01568073|7444714|FG000|NOT COMPLETED|Overall Study||11
6523487|NCT01568073|7444715|FG001|NOT COMPLETED|Overall Study||15
6523488|NCT01568073|7444716|FG002|NOT COMPLETED|Overall Study||12
6523489|NCT01568073|7444717|FG003|NOT COMPLETED|Overall Study||11
6523490|NCT01568073|7444718|FG004|NOT COMPLETED|Overall Study||9
6523491|NCT01568112|7444734|FG000|STARTED|Overall Study||44
6523492|NCT01568112|7444735|FG001|STARTED|Overall Study||44
6523493|NCT01568112|7444736|FG002|STARTED|Overall Study||43
6523494|NCT01568112|7444737|FG003|STARTED|Overall Study||42
6523495|NCT01568112|7444734|FG000|COMPLETED|Overall Study||39
6523496|NCT01568112|7444735|FG001|COMPLETED|Overall Study||36
6523497|NCT01568112|7444736|FG002|COMPLETED|Overall Study||36
6523498|NCT01568112|7444737|FG003|COMPLETED|Overall Study||30
6523499|NCT01568112|7444734|FG000|NOT COMPLETED|Overall Study||5
6523500|NCT01568112|7444735|FG001|NOT COMPLETED|Overall Study||8
6523501|NCT01568112|7444736|FG002|NOT COMPLETED|Overall Study||7
6523502|NCT01568112|7444737|FG003|NOT COMPLETED|Overall Study||12
6523503|NCT01568255|7444750|FG000|STARTED|Overall Study||5
6523504|NCT01568255|7444751|FG001|STARTED|Overall Study||6
6523505|NCT01568255|7444750|FG000|COMPLETED|Overall Study||5
6523506|NCT01568255|7444751|FG001|COMPLETED|Overall Study||6
6523507|NCT01568255|7444750|FG000|NOT COMPLETED|Overall Study||0
6523508|NCT01568255|7444751|FG001|NOT COMPLETED|Overall Study||0
6523509|NCT01568320|7444757|FG000|STARTED|Overall Study||73
6523510|NCT01568320|7444757|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|36
6523511|NCT01568320|7444757|FG000|COMPLETED|Overall Study||32
6523512|NCT01568320|7444757|FG000|NOT COMPLETED|Overall Study||41
6523513|NCT01568424|7444761|FG000|STARTED|Overall Study||25
6523514|NCT01568424|7444761|FG000|COMPLETED|Overall Study||25
6523515|NCT01568424|7444761|FG000|NOT COMPLETED|Overall Study||0
6523516|NCT01568528|7444768|FG000|STARTED|Overall Study||19
6523517|NCT01568528|7444769|FG001|STARTED|Overall Study||11
6523518|NCT01568528|7444770|FG002|STARTED|Overall Study||9
6523519|NCT01568528|7444768|FG000|COMPLETED|Overall Study||19
6523520|NCT01568528|7444769|FG001|COMPLETED|Overall Study||11
6523521|NCT01568528|7444770|FG002|COMPLETED|Overall Study||9
6523522|NCT01568528|7444768|FG000|NOT COMPLETED|Overall Study||0
6523523|NCT01568528|7444769|FG001|NOT COMPLETED|Overall Study||0
6523524|NCT01568528|7444770|FG002|NOT COMPLETED|Overall Study||0
6523525|NCT01568593|7444780|FG000|STARTED|Overall Study||48
6523526|NCT01568593|7444781|FG001|STARTED|Overall Study||45
6523527|NCT01568593|7444780|FG000|COMPLETED|Overall Study||41
6523528|NCT01568593|7444781|FG001|COMPLETED|Overall Study||42
6523529|NCT01568593|7444780|FG000|NOT COMPLETED|Overall Study||7
6523530|NCT01568593|7444781|FG001|NOT COMPLETED|Overall Study||3
6523531|NCT01568606|7444787|FG000|STARTED|Overall Study||20
6523532|NCT01568606|7444787|FG000|COMPLETED|Overall Study||20
6523533|NCT01568606|7444787|FG000|NOT COMPLETED|Overall Study||0
6523534|NCT01568827|7444793|FG000|STARTED|First Intervention (6 Days)||5
6523535|NCT01568827|7444794|FG001|STARTED|First Intervention (6 Days)||5
6523536|NCT01568827|7444793|FG000|COMPLETED|First Intervention (6 Days)||5
6523537|NCT01568827|7444794|FG001|COMPLETED|First Intervention (6 Days)||5
6523538|NCT01568827|7444793|FG000|NOT COMPLETED|First Intervention (6 Days)||0
6523539|NCT01568827|7444794|FG001|NOT COMPLETED|First Intervention (6 Days)||0
6523540|NCT01568827|7444793|FG000|STARTED|Washout (2 Days)||5
6523541|NCT01568827|7444794|FG001|STARTED|Washout (2 Days)||5
6523542|NCT01568827|7444793|FG000|COMPLETED|Washout (2 Days)||5
6523543|NCT01568827|7444794|FG001|COMPLETED|Washout (2 Days)||5
6523544|NCT01568827|7444793|FG000|NOT COMPLETED|Washout (2 Days)||0
6523545|NCT01568827|7444794|FG001|NOT COMPLETED|Washout (2 Days)||0
6523546|NCT01568827|7444793|FG000|STARTED|Intervention 2 (5 Days)||5
6523547|NCT01568827|7444794|FG001|STARTED|Intervention 2 (5 Days)||5
6523548|NCT01568827|7444793|FG000|COMPLETED|Intervention 2 (5 Days)||5
6523549|NCT01568827|7444794|FG001|COMPLETED|Intervention 2 (5 Days)||5
6523550|NCT01568827|7444793|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
6523551|NCT01568827|7444794|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
6523552|NCT01568866|7444802|FG000|STARTED|Overall Study||465
6523553|NCT01568866|7444803|FG001|STARTED|Overall Study||464
6523554|NCT01568866|7444802|FG000|Received Treatment|Overall Study||456
6523555|NCT01568866|7444803|FG001|Received Treatment|Overall Study||463
6523556|NCT01568866|7444802|FG000|COMPLETED|Overall Study|Indicates participants still receiving treatment|27
6523557|NCT01568866|7444803|FG001|COMPLETED|Overall Study|Indicates participants still receiving treatment|48
6523558|NCT01568866|7444802|FG000|NOT COMPLETED|Overall Study||438
6523559|NCT01568866|7444803|FG001|NOT COMPLETED|Overall Study||416
6523560|NCT01568892|7444811|FG000|STARTED|Double-blind Phase||14
6523561|NCT01568892|7444812|FG001|STARTED|Double-blind Phase||16
6523562|NCT01568892|7444811|FG000|COMPLETED|Double-blind Phase||14
6523563|NCT01568892|7444812|FG001|COMPLETED|Double-blind Phase||16
6523564|NCT01568892|7444811|FG000|NOT COMPLETED|Double-blind Phase||0
6523565|NCT01568892|7444812|FG001|NOT COMPLETED|Double-blind Phase||0
6523566|NCT01568892|7444811|FG000|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
6523567|NCT01568892|7444812|FG001|STARTED|Open-label Phase||16
6523568|NCT01568892|7444811|FG000|COMPLETED|Open-label Phase||7
6523569|NCT01568892|7444812|FG001|COMPLETED|Open-label Phase||13
6523570|NCT01568892|7444811|FG000|NOT COMPLETED|Open-label Phase||6
6523571|NCT01568892|7444812|FG001|NOT COMPLETED|Open-label Phase||3
6523572|NCT01568905|7444822|FG000|STARTED|Overall Study||13
6523573|NCT01568905|7444823|FG001|STARTED|Overall Study||11
6523574|NCT01568905|7444824|FG002|STARTED|Overall Study||12
6523575|NCT01568905|7444822|FG000|COMPLETED|Overall Study||12
6523576|NCT01568905|7444823|FG001|COMPLETED|Overall Study||11
6523577|NCT01568905|7444824|FG002|COMPLETED|Overall Study||12
6523578|NCT01568905|7444822|FG000|NOT COMPLETED|Overall Study||1
6523579|NCT01568905|7444823|FG001|NOT COMPLETED|Overall Study||0
6523580|NCT01568905|7444824|FG002|NOT COMPLETED|Overall Study||0
6523581|NCT01568944|7444834|FG000|STARTED|Overall Study||8
6523582|NCT01568944|7444835|FG001|STARTED|Overall Study||10
6523583|NCT01568944|7444834|FG000|COMPLETED|Overall Study||8
6523584|NCT01568944|7444835|FG001|COMPLETED|Overall Study||10
6523585|NCT01568944|7444834|FG000|NOT COMPLETED|Overall Study||0
6523586|NCT01568944|7444835|FG001|NOT COMPLETED|Overall Study||0
6523587|NCT01569022|7444841|FG000|STARTED|First Intervention||21
6523588|NCT01569022|7444842|FG001|STARTED|First Intervention||21
6523589|NCT01569022|7444841|FG000|COMPLETED|First Intervention||19
6523590|NCT01569022|7444842|FG001|COMPLETED|First Intervention||20
6523591|NCT01569022|7444841|FG000|NOT COMPLETED|First Intervention||2
6523592|NCT01569022|7444842|FG001|NOT COMPLETED|First Intervention||1
6523593|NCT01569022|7444841|FG000|STARTED|Second Intervention||19
6523594|NCT01569022|7444842|FG001|STARTED|Second Intervention||20
6523595|NCT01569022|7444841|FG000|COMPLETED|Second Intervention||17
6523596|NCT01569022|7444842|FG001|COMPLETED|Second Intervention||18
6523597|NCT01569022|7444841|FG000|NOT COMPLETED|Second Intervention||2
6523598|NCT01569022|7444842|FG001|NOT COMPLETED|Second Intervention||2
6523599|NCT01569074|7444855|FG000|STARTED|Overall Study|Patients who received treatment|31
6523600|NCT01569074|7444856|FG001|STARTED|Overall Study|Patients who received treatment|33
6523601|NCT01569074|7444857|FG002|STARTED|Overall Study|Patients who received treatment|33
6523602|NCT01569074|7444858|FG003|STARTED|Overall Study|Patients who received treatment|33
6523603|NCT01569074|7444859|FG004|STARTED|Overall Study|Patients who received treatment|33
6523604|NCT01569074|7444855|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
6523605|NCT01569074|7444856|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
6523606|NCT01569074|7444857|FG002|Randomised But Did Not Receive Treatment|Overall Study||0
6523607|NCT01569074|7444858|FG003|Randomised But Did Not Receive Treatment|Overall Study||0
6523608|NCT01569074|7444859|FG004|Randomised But Did Not Receive Treatment|Overall Study||0
6523609|NCT01569074|7444855|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
6523610|NCT01569074|7444856|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
6523611|NCT01569074|7444857|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
6523612|NCT01569074|7444858|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
6523613|NCT01569074|7444859|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
6523614|NCT01569074|7444855|FG000|NOT COMPLETED|Overall Study||7
6523615|NCT01569074|7444856|FG001|NOT COMPLETED|Overall Study||9
6523616|NCT01569074|7444857|FG002|NOT COMPLETED|Overall Study||12
6523617|NCT01569074|7444858|FG003|NOT COMPLETED|Overall Study||8
6523618|NCT01569074|7444859|FG004|NOT COMPLETED|Overall Study||8
6523619|NCT01569087|7444878|FG000|STARTED|Overall Study||21
6523620|NCT01569087|7444879|FG001|STARTED|Overall Study||20
6523621|NCT01569087|7444880|FG002|STARTED|Overall Study||19
6523622|NCT01569087|7444878|FG000|COMPLETED|Overall Study||20
6523623|NCT01569087|7444879|FG001|COMPLETED|Overall Study||20
6523624|NCT01569087|7444880|FG002|COMPLETED|Overall Study||18
6523625|NCT01569087|7444878|FG000|NOT COMPLETED|Overall Study||1
6523626|NCT01569087|7444879|FG001|NOT COMPLETED|Overall Study||0
6523627|NCT01569087|7444880|FG002|NOT COMPLETED|Overall Study||1
6523628|NCT01569126|7444894|FG000|STARTED|Overall Study||8
6523629|NCT01569126|7444895|FG001|STARTED|Overall Study||8
6523630|NCT01569126|7444896|FG002|STARTED|Overall Study||8
6523631|NCT01569126|7444897|FG003|STARTED|Overall Study||8
6523632|NCT01569126|7444898|FG004|STARTED|Overall Study||12
6523633|NCT01569126|7444899|FG005|STARTED|Overall Study||12
6523634|NCT01569126|7444894|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6523635|NCT01569126|7444895|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
6523636|NCT01569126|7444896|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
6523637|NCT01569126|7444897|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
6523638|NCT01569126|7444898|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
6523639|NCT01569126|7444899|FG005|Received at Least 1 Dose of Study Drug|Overall Study||12
6523640|NCT01569126|7444894|FG000|COMPLETED|Overall Study||8
6523641|NCT01569126|7444895|FG001|COMPLETED|Overall Study||8
6523642|NCT01569126|7444896|FG002|COMPLETED|Overall Study||8
6523643|NCT01569126|7444897|FG003|COMPLETED|Overall Study||8
6523644|NCT01569126|7444898|FG004|COMPLETED|Overall Study||12
6523645|NCT01569126|7444899|FG005|COMPLETED|Overall Study||12
6523646|NCT01569126|7444894|FG000|NOT COMPLETED|Overall Study||0
6523647|NCT01569126|7444895|FG001|NOT COMPLETED|Overall Study||0
6523648|NCT01569126|7444896|FG002|NOT COMPLETED|Overall Study||0
6523649|NCT01569126|7444897|FG003|NOT COMPLETED|Overall Study||0
6523650|NCT01569126|7444898|FG004|NOT COMPLETED|Overall Study||0
6523651|NCT01569126|7444899|FG005|NOT COMPLETED|Overall Study||0
6523652|NCT01569152|7444920|FG000|STARTED|Phase IIa, Period 1||41
6523653|NCT01569152|7444921|FG001|STARTED|Phase IIa, Period 1||41
6523654|NCT01569152|7444922|FG002|STARTED|Phase IIa, Period 1||0
6523655|NCT01569152|7444920|FG000|COMPLETED|Phase IIa, Period 1||20
6523656|NCT01569152|7444921|FG001|COMPLETED|Phase IIa, Period 1||9
6523657|NCT01569152|7444922|FG002|COMPLETED|Phase IIa, Period 1||0
6523658|NCT01569152|7444920|FG000|NOT COMPLETED|Phase IIa, Period 1||21
6523659|NCT01569152|7444921|FG001|NOT COMPLETED|Phase IIa, Period 1||32
6523660|NCT01569152|7444922|FG002|NOT COMPLETED|Phase IIa, Period 1||0
6523661|NCT01569152|7444920|FG000|STARTED|Safety Extension, Period 3||0
6523662|NCT01569152|7444921|FG001|STARTED|Safety Extension, Period 3||0
6523663|NCT01569152|7444922|FG002|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
6523664|NCT01569152|7444920|FG000|COMPLETED|Safety Extension, Period 3||0
6523665|NCT01569152|7444921|FG001|COMPLETED|Safety Extension, Period 3||0
6523666|NCT01569152|7444922|FG002|COMPLETED|Safety Extension, Period 3||0
6523667|NCT01569152|7444920|FG000|NOT COMPLETED|Safety Extension, Period 3||0
6523668|NCT01569152|7444921|FG001|NOT COMPLETED|Safety Extension, Period 3||0
6523669|NCT01569152|7444922|FG002|NOT COMPLETED|Safety Extension, Period 3||55
6523670|NCT01569191|7444931|FG000|STARTED|Overall Study||11
6523671|NCT01569191|7444932|FG001|STARTED|Overall Study||7
6523672|NCT01569191|7444931|FG000|COMPLETED|Overall Study||11
6523673|NCT01569191|7444932|FG001|COMPLETED|Overall Study||7
6523674|NCT01569191|7444931|FG000|NOT COMPLETED|Overall Study||0
6523675|NCT01569191|7444932|FG001|NOT COMPLETED|Overall Study||0
6523676|NCT01569295|7444944|FG000|STARTED|Overall Study||207
6523677|NCT01569295|7444945|FG001|STARTED|Overall Study||209
6523678|NCT01569295|7444944|FG000|Long-Term Follow-up|Overall Study||109
6523679|NCT01569295|7444945|FG001|Long-Term Follow-up|Overall Study||161
6523680|NCT01569295|7444944|FG000|COMPLETED|Overall Study||0
6523681|NCT01569295|7444945|FG001|COMPLETED|Overall Study||0
6642537|NCT02349295|7570951|FG005|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642538|NCT02349295|7570952|FG006|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642539|NCT02349295|7570953|FG007|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642540|NCT02349295|7570954|FG008|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6523682|NCT01569295|7444944|FG000|NOT COMPLETED|Overall Study||207
6523683|NCT01569295|7444945|FG001|NOT COMPLETED|Overall Study||209
6523684|NCT01569438|7444954|FG000|STARTED|Overall Study||52
6642541|NCT02349295|7570955|FG009|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642542|NCT02349295|7570956|FG010|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642543|NCT02349295|7570957|FG011|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642544|NCT02349295|7570958|FG012|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642545|NCT02349295|7570959|FG013|Received Atleast One Dose of Study Drug|Double Blind Treatment (Week 0-24)||0
6642546|NCT02349295|7570946|FG000|COMPLETED|Double Blind Treatment (Week 0-24)||109
6642547|NCT02349295|7570947|FG001|COMPLETED|Double Blind Treatment (Week 0-24)||111
6642548|NCT02349295|7570948|FG002|COMPLETED|Double Blind Treatment (Week 0-24)||94
6523685|NCT01569438|7444955|FG001|STARTED|Overall Study||55
6523686|NCT01569438|7444954|FG000|Treated|Overall Study||51
6523687|NCT01569438|7444955|FG001|Treated|Overall Study||54
6523688|NCT01569438|7444954|FG000|Titration Set|Overall Study||38
6523689|NCT01569438|7444955|FG001|Titration Set|Overall Study||36
6523690|NCT01569438|7444954|FG000|COMPLETED|Overall Study||45
6523691|NCT01569438|7444955|FG001|COMPLETED|Overall Study||33
6523692|NCT01569438|7444954|FG000|NOT COMPLETED|Overall Study||7
6523693|NCT01569438|7444955|FG001|NOT COMPLETED|Overall Study||22
6523694|NCT01569451|7444963|FG000|STARTED|Overall Study||26
6642549|NCT02349295|7570949|FG003|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642550|NCT02349295|7570950|FG004|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642551|NCT02349295|7570951|FG005|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642552|NCT02349295|7570952|FG006|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642553|NCT02349295|7570953|FG007|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642554|NCT02349295|7570954|FG008|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642555|NCT02349295|7570955|FG009|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642556|NCT02349295|7570956|FG010|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642557|NCT02349295|7570957|FG011|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642558|NCT02349295|7570958|FG012|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642559|NCT02349295|7570959|FG013|COMPLETED|Double Blind Treatment (Week 0-24)||0
6642560|NCT02349295|7570946|FG000|NOT COMPLETED|Double Blind Treatment (Week 0-24)||14
6642561|NCT02349295|7570947|FG001|NOT COMPLETED|Double Blind Treatment (Week 0-24)||11
6642562|NCT02349295|7570948|FG002|NOT COMPLETED|Double Blind Treatment (Week 0-24)||24
6642563|NCT02349295|7570949|FG003|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642564|NCT02349295|7570950|FG004|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642565|NCT02349295|7570951|FG005|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642566|NCT02349295|7570952|FG006|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642567|NCT02349295|7570953|FG007|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642568|NCT02349295|7570954|FG008|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642569|NCT02349295|7570955|FG009|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642570|NCT02349295|7570956|FG010|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642571|NCT02349295|7570957|FG011|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642572|NCT02349295|7570958|FG012|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642573|NCT02349295|7570959|FG013|NOT COMPLETED|Double Blind Treatment (Week 0-24)||0
6642574|NCT02349295|7570946|FG000|STARTED|IR (Week 16-24)|Only IR participants were included.|0
6642575|NCT02349295|7570947|FG001|STARTED|IR (Week 16-24)|Only IR participants were included.|0
6642576|NCT02349295|7570948|FG002|STARTED|IR (Week 16-24)|Only IR participants were included.|0
6642577|NCT02349295|7570949|FG003|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q2W only.|17
6642578|NCT02349295|7570950|FG004|STARTED|IR (Week 16-24)|IR from ixekizumab 80 mg Q4W only.|15
6642579|NCT02349295|7570951|FG005|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q2W.|16
6642580|NCT02349295|7570952|FG006|STARTED|IR (Week 16-24)|IR from placebo who re-randomized (1:1) to ixekizumab 80 mg Q4W.|16
6642581|NCT02349295|7570953|FG007|STARTED|IR (Week 16-24)||0
6642582|NCT02349295|7570954|FG008|STARTED|IR (Week 16-24)||0
6642583|NCT02349295|7570955|FG009|STARTED|IR (Week 16-24)||0
6642584|NCT02349295|7570956|FG010|STARTED|IR (Week 16-24)||0
6642585|NCT02349295|7570957|FG011|STARTED|IR (Week 16-24)||0
6642586|NCT02349295|7570958|FG012|STARTED|IR (Week 16-24)||0
6642587|NCT02349295|7570959|FG013|STARTED|IR (Week 16-24)||0
6642588|NCT02349295|7570946|FG000|COMPLETED|IR (Week 16-24)||0
6642589|NCT02349295|7570947|FG001|COMPLETED|IR (Week 16-24)||0
6642590|NCT02349295|7570948|FG002|COMPLETED|IR (Week 16-24)||0
6642591|NCT02349295|7570949|FG003|COMPLETED|IR (Week 16-24)||16
6642592|NCT02349295|7570950|FG004|COMPLETED|IR (Week 16-24)||15
6642593|NCT02349295|7570951|FG005|COMPLETED|IR (Week 16-24)||16
6642594|NCT02349295|7570952|FG006|COMPLETED|IR (Week 16-24)||16
6642595|NCT02349295|7570953|FG007|COMPLETED|IR (Week 16-24)||0
6642596|NCT02349295|7570954|FG008|COMPLETED|IR (Week 16-24)||0
6642597|NCT02349295|7570955|FG009|COMPLETED|IR (Week 16-24)||0
6642598|NCT02349295|7570956|FG010|COMPLETED|IR (Week 16-24)||0
6642599|NCT02349295|7570957|FG011|COMPLETED|IR (Week 16-24)||0
6642600|NCT02349295|7570958|FG012|COMPLETED|IR (Week 16-24)||0
6642601|NCT02349295|7570959|FG013|COMPLETED|IR (Week 16-24)||0
6642602|NCT02349295|7570946|FG000|NOT COMPLETED|IR (Week 16-24)||0
6642603|NCT02349295|7570947|FG001|NOT COMPLETED|IR (Week 16-24)||0
6642604|NCT02349295|7570948|FG002|NOT COMPLETED|IR (Week 16-24)||0
6642605|NCT02349295|7570949|FG003|NOT COMPLETED|IR (Week 16-24)||1
6642606|NCT02349295|7570950|FG004|NOT COMPLETED|IR (Week 16-24)||0
6642607|NCT02349295|7570951|FG005|NOT COMPLETED|IR (Week 16-24)||0
6642608|NCT02349295|7570952|FG006|NOT COMPLETED|IR (Week 16-24)||0
6523695|NCT01569451|7444964|FG001|STARTED|Overall Study||27
6523696|NCT01569451|7444963|FG000|COMPLETED|Overall Study||12
6523697|NCT01569451|7444964|FG001|COMPLETED|Overall Study||14
6523698|NCT01569451|7444963|FG000|NOT COMPLETED|Overall Study||14
6523699|NCT01569451|7444964|FG001|NOT COMPLETED|Overall Study||13
6523700|NCT01569464|7444974|FG000|STARTED|Overall Study||101
6523701|NCT01569464|7444975|FG001|STARTED|Overall Study||49
6523702|NCT01569464|7444974|FG000|COMPLETED|Overall Study||91
6523703|NCT01569464|7444975|FG001|COMPLETED|Overall Study||44
6523704|NCT01569464|7444974|FG000|NOT COMPLETED|Overall Study||10
6523705|NCT01569464|7444975|FG001|NOT COMPLETED|Overall Study||5
6523706|NCT01569529|7444985|FG000|STARTED|Overall Study||2676
6523707|NCT01569529|7444986|FG001|STARTED|Overall Study||394
6523708|NCT01569529|7444985|FG000|COMPLETED|Overall Study||2676
6523709|NCT01569529|7444986|FG001|COMPLETED|Overall Study||394
6523710|NCT01569529|7444985|FG000|NOT COMPLETED|Overall Study||0
6523711|NCT01569529|7444986|FG001|NOT COMPLETED|Overall Study||0
6523712|NCT01569568|7444994|FG000|STARTED|Overall Study||20
6523713|NCT01569568|7444995|FG001|STARTED|Overall Study||29
6523714|NCT01569568|7444994|FG000|COMPLETED|Overall Study||20
6523715|NCT01569568|7444995|FG001|COMPLETED|Overall Study||27
6523716|NCT01569568|7444994|FG000|NOT COMPLETED|Overall Study||0
6642609|NCT02349295|7570953|FG007|NOT COMPLETED|IR (Week 16-24)||0
6642610|NCT02349295|7570954|FG008|NOT COMPLETED|IR (Week 16-24)||0
6642611|NCT02349295|7570955|FG009|NOT COMPLETED|IR (Week 16-24)||0
6642612|NCT02349295|7570956|FG010|NOT COMPLETED|IR (Week 16-24)||0
6642613|NCT02349295|7570957|FG011|NOT COMPLETED|IR (Week 16-24)||0
6523717|NCT01569568|7444995|FG001|NOT COMPLETED|Overall Study||2
6523718|NCT01569594|7445001|FG000|STARTED|Overall Study||230
6523719|NCT01569594|7445001|FG000|COMPLETED|Overall Study||163
6523720|NCT01569594|7445001|FG000|NOT COMPLETED|Overall Study||67
6523721|NCT01569607|7445007|FG000|STARTED|Overall Study||11
6523722|NCT01569607|7445008|FG001|STARTED|Overall Study||11
6523723|NCT01569607|7445007|FG000|COMPLETED|Overall Study||10
6523724|NCT01569607|7445008|FG001|COMPLETED|Overall Study||10
6523725|NCT01569607|7445007|FG000|NOT COMPLETED|Overall Study||1
6523726|NCT01569607|7445008|FG001|NOT COMPLETED|Overall Study||1
6523727|NCT01569737|7445014|FG000|STARTED|Overall Study||98
6523728|NCT01569737|7445014|FG000|COMPLETED|Overall Study||95
6523729|NCT01569737|7445014|FG000|NOT COMPLETED|Overall Study||3
6523730|NCT01569763|7445020|FG000|STARTED|Overall Study||102
6523731|NCT01569763|7445021|FG001|STARTED|Overall Study||51
6523732|NCT01569763|7445020|FG000|Treated|Overall Study||102
6523733|NCT01569763|7445021|FG001|Treated|Overall Study||51
6523734|NCT01569763|7445020|FG000|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
6523735|NCT01569763|7445021|FG001|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
6523736|NCT01569763|7445020|FG000|NOT COMPLETED|Overall Study||3
6523737|NCT01569763|7445021|FG001|NOT COMPLETED|Overall Study||7
6523738|NCT01569815|7445031|FG000|STARTED|Overall Study||8
6523739|NCT01569815|7445032|FG001|STARTED|Overall Study||8
6523740|NCT01569815|7445033|FG002|STARTED|Overall Study||8
6523741|NCT01569815|7445034|FG003|STARTED|Overall Study||8
6523742|NCT01569815|7445031|FG000|COMPLETED|Overall Study||8
6523743|NCT01569815|7445032|FG001|COMPLETED|Overall Study||8
6523744|NCT01569815|7445033|FG002|COMPLETED|Overall Study||8
6523745|NCT01569815|7445034|FG003|COMPLETED|Overall Study||8
6523746|NCT01569815|7445031|FG000|NOT COMPLETED|Overall Study||0
6523747|NCT01569815|7445032|FG001|NOT COMPLETED|Overall Study||0
6523748|NCT01569815|7445033|FG002|NOT COMPLETED|Overall Study||0
6523749|NCT01569815|7445034|FG003|NOT COMPLETED|Overall Study||0
6523750|NCT01569828|7445047|FG000|STARTED|Overall Study||6
6523751|NCT01569828|7445048|FG001|STARTED|Overall Study||6
6523752|NCT01569828|7445047|FG000|COMPLETED|Overall Study||6
6523753|NCT01569828|7445048|FG001|COMPLETED|Overall Study||6
6523754|NCT01569828|7445047|FG000|NOT COMPLETED|Overall Study||0
6523755|NCT01569828|7445048|FG001|NOT COMPLETED|Overall Study||0
6523756|NCT01569841|7445055|FG000|STARTED|Period A (6 Weeks)||12
6523757|NCT01569841|7445056|FG001|STARTED|Period A (6 Weeks)||12
6523758|NCT01569841|7445055|FG000|Exposed|Period A (6 Weeks)||12
6523759|NCT01569841|7445056|FG001|Exposed|Period A (6 Weeks)||12
6523760|NCT01569841|7445055|FG000|COMPLETED|Period A (6 Weeks)||12
6523761|NCT01569841|7445056|FG001|COMPLETED|Period A (6 Weeks)||11
6523762|NCT01569841|7445055|FG000|NOT COMPLETED|Period A (6 Weeks)||0
6523763|NCT01569841|7445056|FG001|NOT COMPLETED|Period A (6 Weeks)||1
6523764|NCT01569841|7445055|FG000|STARTED|Period B (6 Weeks)||12
6523765|NCT01569841|7445056|FG001|STARTED|Period B (6 Weeks)||11
6523766|NCT01569841|7445055|FG000|Exposed|Period B (6 Weeks)||12
6523767|NCT01569841|7445056|FG001|Exposed|Period B (6 Weeks)||11
6523768|NCT01569841|7445055|FG000|COMPLETED|Period B (6 Weeks)||12
6523769|NCT01569841|7445056|FG001|COMPLETED|Period B (6 Weeks)||11
6523770|NCT01569841|7445055|FG000|NOT COMPLETED|Period B (6 Weeks)||0
6523771|NCT01569841|7445056|FG001|NOT COMPLETED|Period B (6 Weeks)||0
6523772|NCT01570036|7445066|FG000|STARTED|Overall Study||136
6523773|NCT01570036|7445067|FG001|STARTED|Overall Study||139
6523774|NCT01570036|7445066|FG000|Primary Vaccine Series Completed|Overall Study||121
6523775|NCT01570036|7445067|FG001|Primary Vaccine Series Completed|Overall Study||132
6523776|NCT01570036|7445066|FG000|Booster Series Completed|Overall Study||40
6523777|NCT01570036|7445067|FG001|Booster Series Completed|Overall Study||30
6523778|NCT01570036|7445066|FG000|COMPLETED|Overall Study||18
6523779|NCT01570036|7445067|FG001|COMPLETED|Overall Study||17
6523780|NCT01570036|7445066|FG000|NOT COMPLETED|Overall Study||118
6523781|NCT01570036|7445067|FG001|NOT COMPLETED|Overall Study||122
6523782|NCT01570192|7445075|FG000|STARTED|Overall Study||13
6523783|NCT01570192|7445076|FG001|STARTED|Overall Study||30
6523784|NCT01570192|7445075|FG000|COMPLETED|Overall Study||6
6523785|NCT01570192|7445076|FG001|COMPLETED|Overall Study||17
6523786|NCT01570192|7445075|FG000|NOT COMPLETED|Overall Study||7
6523787|NCT01570192|7445076|FG001|NOT COMPLETED|Overall Study||13
6523788|NCT01570244|7445087|FG000|STARTED|Microgynon||16
6523789|NCT01570244|7445087|FG000|COMPLETED|Microgynon||16
6523790|NCT01570244|7445087|FG000|NOT COMPLETED|Microgynon||0
6523791|NCT01570244|7445087|FG000|STARTED|Microgynon+Faldaprevir||16
6523792|NCT01570244|7445087|FG000|COMPLETED|Microgynon+Faldaprevir||15
6523793|NCT01570244|7445087|FG000|NOT COMPLETED|Microgynon+Faldaprevir||1
6523794|NCT01570283|7445096|FG000|STARTED|Cohort 1: Dose Level 1||1
6523795|NCT01570283|7445097|FG001|STARTED|Cohort 1: Dose Level 1||3
6523796|NCT01570283|7445098|FG002|STARTED|Cohort 1: Dose Level 1||0
6523797|NCT01570283|7445099|FG003|STARTED|Cohort 1: Dose Level 1||0
6523798|NCT01570283|7445100|FG004|STARTED|Cohort 1: Dose Level 1||0
6523799|NCT01570283|7445101|FG005|STARTED|Cohort 1: Dose Level 1||0
6523800|NCT01570283|7445096|FG000|COMPLETED|Cohort 1: Dose Level 1||1
6523801|NCT01570283|7445097|FG001|COMPLETED|Cohort 1: Dose Level 1||1
6523802|NCT01570283|7445098|FG002|COMPLETED|Cohort 1: Dose Level 1||0
6523803|NCT01570283|7445099|FG003|COMPLETED|Cohort 1: Dose Level 1||0
6523804|NCT01570283|7445100|FG004|COMPLETED|Cohort 1: Dose Level 1||0
6523805|NCT01570283|7445101|FG005|COMPLETED|Cohort 1: Dose Level 1||0
6523806|NCT01570283|7445096|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
6523807|NCT01570283|7445097|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||2
6523808|NCT01570283|7445098|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
6523809|NCT01570283|7445099|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
6523810|NCT01570283|7445100|FG004|NOT COMPLETED|Cohort 1: Dose Level 1||0
6523811|NCT01570283|7445101|FG005|NOT COMPLETED|Cohort 1: Dose Level 1||0
6523812|NCT01570283|7445096|FG000|STARTED|Cohort 2: Dose Level 2||0
6523813|NCT01570283|7445097|FG001|STARTED|Cohort 2: Dose Level 2||0
6523814|NCT01570283|7445098|FG002|STARTED|Cohort 2: Dose Level 2||2
6523815|NCT01570283|7445099|FG003|STARTED|Cohort 2: Dose Level 2||2
6523816|NCT01570283|7445100|FG004|STARTED|Cohort 2: Dose Level 2||0
6523817|NCT01570283|7445101|FG005|STARTED|Cohort 2: Dose Level 2||0
6523818|NCT01570283|7445096|FG000|COMPLETED|Cohort 2: Dose Level 2||0
6523819|NCT01570283|7445097|FG001|COMPLETED|Cohort 2: Dose Level 2||0
6523820|NCT01570283|7445098|FG002|COMPLETED|Cohort 2: Dose Level 2||1
6523821|NCT01570283|7445099|FG003|COMPLETED|Cohort 2: Dose Level 2||1
6523822|NCT01570283|7445100|FG004|COMPLETED|Cohort 2: Dose Level 2||0
6523823|NCT01570283|7445101|FG005|COMPLETED|Cohort 2: Dose Level 2||0
6523824|NCT01570283|7445096|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
6523825|NCT01570283|7445097|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
6523826|NCT01570283|7445098|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||1
6523827|NCT01570283|7445099|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||1
6523828|NCT01570283|7445100|FG004|NOT COMPLETED|Cohort 2: Dose Level 2||0
6523829|NCT01570283|7445101|FG005|NOT COMPLETED|Cohort 2: Dose Level 2||0
6523830|NCT01570283|7445096|FG000|STARTED|Cohort 3: Dose Level 3||0
6523831|NCT01570283|7445097|FG001|STARTED|Cohort 3: Dose Level 3||0
6523832|NCT01570283|7445098|FG002|STARTED|Cohort 3: Dose Level 3||0
6523833|NCT01570283|7445099|FG003|STARTED|Cohort 3: Dose Level 3||0
6523834|NCT01570283|7445100|FG004|STARTED|Cohort 3: Dose Level 3||1
6523835|NCT01570283|7445101|FG005|STARTED|Cohort 3: Dose Level 3||12
6523836|NCT01570283|7445096|FG000|COMPLETED|Cohort 3: Dose Level 3||0
6523837|NCT01570283|7445097|FG001|COMPLETED|Cohort 3: Dose Level 3||0
6523838|NCT01570283|7445098|FG002|COMPLETED|Cohort 3: Dose Level 3||0
6523839|NCT01570283|7445099|FG003|COMPLETED|Cohort 3: Dose Level 3||0
6523840|NCT01570283|7445100|FG004|COMPLETED|Cohort 3: Dose Level 3||1
6523841|NCT01570283|7445101|FG005|COMPLETED|Cohort 3: Dose Level 3||10
6523842|NCT01570283|7445096|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
6523843|NCT01570283|7445097|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
6523844|NCT01570283|7445098|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
6523845|NCT01570283|7445099|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
6523846|NCT01570283|7445100|FG004|NOT COMPLETED|Cohort 3: Dose Level 3||0
6523847|NCT01570283|7445101|FG005|NOT COMPLETED|Cohort 3: Dose Level 3||2
6523848|NCT01570309|7445117|FG000|STARTED|Overall Study||48
6523849|NCT01570309|7445118|FG001|STARTED|Overall Study||48
6523850|NCT01570309|7445117|FG000|COMPLETED|Overall Study||45
6523851|NCT01570309|7445118|FG001|COMPLETED|Overall Study||45
6523852|NCT01570309|7445117|FG000|NOT COMPLETED|Overall Study||3
6523853|NCT01570309|7445118|FG001|NOT COMPLETED|Overall Study||3
6523854|NCT01570348|7445128|FG000|STARTED|Overall Study||2
6523855|NCT01570348|7445128|FG000|COMPLETED|Overall Study||2
6523856|NCT01570348|7445128|FG000|NOT COMPLETED|Overall Study||0
6523857|NCT01570361|7445134|FG000|STARTED|Overall Study||128
6523858|NCT01570361|7445135|FG001|STARTED|Overall Study||127
6523859|NCT01570361|7445134|FG000|Received Study Treatment|Overall Study||102
6523860|NCT01570361|7445135|FG001|Received Study Treatment|Overall Study||123
6523861|NCT01570361|7445134|FG000|Cross-over (AAD Therapy to RF Ablation)|Overall Study||0
6523862|NCT01570361|7445135|FG001|Cross-over (AAD Therapy to RF Ablation)|Overall Study||15
6523863|NCT01570361|7445134|FG000|AAD Therapy Only|Overall Study||0
6523864|NCT01570361|7445135|FG001|AAD Therapy Only|Overall Study||108
6523865|NCT01570361|7445134|FG000|COMPLETED|Overall Study||46
6523866|NCT01570361|7445135|FG001|COMPLETED|Overall Study||52
6523867|NCT01570361|7445134|FG000|NOT COMPLETED|Overall Study||82
6523868|NCT01570361|7445135|FG001|NOT COMPLETED|Overall Study||75
6523869|NCT01570387|7445148|FG000|STARTED|Overall Study||6
6523870|NCT01570387|7445149|FG001|STARTED|Overall Study||3
6523871|NCT01570387|7445150|FG002|STARTED|Overall Study||6
6523872|NCT01570387|7445151|FG003|STARTED|Overall Study||12
6523873|NCT01570387|7445148|FG000|Dose Limiting Toxicity|Overall Study||0
6523874|NCT01570387|7445149|FG001|Dose Limiting Toxicity|Overall Study||0
6523875|NCT01570387|7445150|FG002|Dose Limiting Toxicity|Overall Study||6
6523876|NCT01570387|7445151|FG003|Dose Limiting Toxicity|Overall Study||12
6523877|NCT01570387|7445148|FG000|Response to Maximal Tolerated Dose|Overall Study||0
6523878|NCT01570387|7445149|FG001|Response to Maximal Tolerated Dose|Overall Study||0
6523879|NCT01570387|7445150|FG002|Response to Maximal Tolerated Dose|Overall Study||3
6523880|NCT01570387|7445151|FG003|Response to Maximal Tolerated Dose|Overall Study||6
6523881|NCT01570387|7445148|FG000|COMPLETED|Overall Study||5
6523882|NCT01570387|7445149|FG001|COMPLETED|Overall Study||3
6523883|NCT01570387|7445150|FG002|COMPLETED|Overall Study||6
6523884|NCT01570387|7445151|FG003|COMPLETED|Overall Study||10
6523885|NCT01570387|7445148|FG000|NOT COMPLETED|Overall Study||1
6523886|NCT01570387|7445149|FG001|NOT COMPLETED|Overall Study||0
6523887|NCT01570387|7445150|FG002|NOT COMPLETED|Overall Study||0
6523888|NCT01570387|7445151|FG003|NOT COMPLETED|Overall Study||2
6523889|NCT01570491|7445160|FG000|STARTED|Overall Study||19
6523890|NCT01570491|7445161|FG001|STARTED|Overall Study||19
6523891|NCT01570491|7445160|FG000|COMPLETED|Overall Study||14
6523892|NCT01570491|7445161|FG001|COMPLETED|Overall Study||18
6523893|NCT01570491|7445160|FG000|NOT COMPLETED|Overall Study||5
6523894|NCT01570491|7445161|FG001|NOT COMPLETED|Overall Study||1
6523895|NCT01570686|7445169|FG000|STARTED|Overall Study||296
6523896|NCT01570686|7445170|FG001|STARTED|Overall Study||294
6523897|NCT01570686|7445169|FG000|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
6523898|NCT01570686|7445170|FG001|Safety and Full Analysis Set (FAS)|Overall Study||294
6523899|NCT01570686|7445169|FG000|COMPLETED|Overall Study||274
6523900|NCT01570686|7445170|FG001|COMPLETED|Overall Study||278
6523901|NCT01570686|7445169|FG000|NOT COMPLETED|Overall Study||22
6523902|NCT01570686|7445170|FG001|NOT COMPLETED|Overall Study||16
6523903|NCT01570751|7445178|FG000|STARTED|Period A (16 Weeks)||73
6523904|NCT01570751|7445179|FG001|STARTED|Period A (16 Weeks)||72
6523905|NCT01570751|7445178|FG000|Exposed|Period A (16 Weeks)||73
6523906|NCT01570751|7445179|FG001|Exposed|Period A (16 Weeks)||72
6523907|NCT01570751|7445178|FG000|COMPLETED|Period A (16 Weeks)||70
6523908|NCT01570751|7445179|FG001|COMPLETED|Period A (16 Weeks)||67
6523909|NCT01570751|7445178|FG000|NOT COMPLETED|Period A (16 Weeks)||3
6523910|NCT01570751|7445179|FG001|NOT COMPLETED|Period A (16 Weeks)||5
6523911|NCT01570751|7445178|FG000|STARTED|Period B (16 Weeks)||70
6523912|NCT01570751|7445179|FG001|STARTED|Period B (16 Weeks)||67
6523913|NCT01570751|7445178|FG000|Exposed|Period B (16 Weeks)||70
6523914|NCT01570751|7445179|FG001|Exposed|Period B (16 Weeks)||67
6523915|NCT01570751|7445178|FG000|COMPLETED|Period B (16 Weeks)||69
6523916|NCT01570751|7445179|FG001|COMPLETED|Period B (16 Weeks)||66
6523917|NCT01570751|7445178|FG000|NOT COMPLETED|Period B (16 Weeks)||1
6523918|NCT01570751|7445179|FG001|NOT COMPLETED|Period B (16 Weeks)||1
6523919|NCT01570829|7445189|FG000|STARTED|Overall Study||164
6523920|NCT01570829|7445190|FG001|STARTED|Overall Study||167
6523921|NCT01570829|7445189|FG000|COMPLETED|Overall Study||164
6523922|NCT01570829|7445190|FG001|COMPLETED|Overall Study||167
6523923|NCT01570829|7445189|FG000|NOT COMPLETED|Overall Study||0
6523924|NCT01570829|7445190|FG001|NOT COMPLETED|Overall Study||0
6523925|NCT01570868|7445198|FG000|STARTED|Overall Study||43
6523926|NCT01570868|7445199|FG001|STARTED|Overall Study||8
6523927|NCT01570868|7445198|FG000|COMPLETED|Overall Study||0
6523928|NCT01570868|7445199|FG001|COMPLETED|Overall Study||0
6523929|NCT01570868|7445198|FG000|NOT COMPLETED|Overall Study||43
6523930|NCT01570868|7445199|FG001|NOT COMPLETED|Overall Study||8
6642614|NCT02349295|7570958|FG012|NOT COMPLETED|IR (Week 16-24)||0
6642615|NCT02349295|7570959|FG013|NOT COMPLETED|IR (Week 16-24)||0
6523931|NCT01571232|7445211|FG000|STARTED|Overall Study||10
6523932|NCT01571232|7445212|FG001|STARTED|Overall Study||10
6523933|NCT01571232|7445211|FG000|COMPLETED|Overall Study||9
6523934|NCT01571232|7445212|FG001|COMPLETED|Overall Study||9
6523935|NCT01571232|7445211|FG000|NOT COMPLETED|Overall Study||1
6523936|NCT01571232|7445212|FG001|NOT COMPLETED|Overall Study||1
6523937|NCT01571284|7445219|FG000|STARTED|Overall Study||781
6523938|NCT01571284|7445219|FG000|Safety Population|Overall Study||779
6523939|NCT01571284|7445219|FG000|COMPLETED|Overall Study|403 participants with DP and 209 with adverse events were considered as completed.|612
6523940|NCT01571284|7445219|FG000|NOT COMPLETED|Overall Study||169
6523941|NCT01571362|7445223|FG000|STARTED|Open-Label Conversion + Titration Period||410
6523942|NCT01571362|7445224|FG001|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
6561743|NCT01796548|7484631|FG000|COMPLETED|Overall Study||14
6561744|NCT01796548|7484631|FG000|NOT COMPLETED|Overall Study||3
6561745|NCT01796665|7484638|FG000|STARTED|Overall Study||474
6561746|NCT01796665|7484639|FG001|STARTED|Overall Study||469
6561747|NCT01796665|7484640|FG002|STARTED|Overall Study||237
6561748|NCT01796665|7484638|FG000|COMPLETED|Overall Study||416
6561749|NCT01796665|7484639|FG001|COMPLETED|Overall Study||396
6561750|NCT01796665|7484640|FG002|COMPLETED|Overall Study||195
6561751|NCT01796665|7484638|FG000|NOT COMPLETED|Overall Study||58
6561752|NCT01796665|7484639|FG001|NOT COMPLETED|Overall Study||73
6561753|NCT01796665|7484640|FG002|NOT COMPLETED|Overall Study||42
6523943|NCT01571362|7445225|FG002|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
6523944|NCT01571362|7445223|FG000|COMPLETED|Open-Label Conversion + Titration Period||281
6523945|NCT01571362|7445224|FG001|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
6523946|NCT01571362|7445225|FG002|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
6523947|NCT01571362|7445223|FG000|NOT COMPLETED|Open-Label Conversion + Titration Period||129
6642616|NCT02349295|7570946|FG000|STARTED|Long-Term Extension Period (Week 24-156)||0
6642617|NCT02349295|7570947|FG001|STARTED|Long-Term Extension Period (Week 24-156)||0
6642618|NCT02349295|7570948|FG002|STARTED|Long-Term Extension Period (Week 24-156)||0
6642619|NCT02349295|7570949|FG003|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
6642620|NCT02349295|7570950|FG004|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
6523948|NCT01571362|7445224|FG001|NOT COMPLETED|Open-Label Conversion + Titration Period||0
6523949|NCT01571362|7445225|FG002|NOT COMPLETED|Open-Label Conversion + Titration Period||0
6523950|NCT01571362|7445223|FG000|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
6523951|NCT01571362|7445224|FG001|STARTED|Double-Blind Treatment Period||134
6523952|NCT01571362|7445225|FG002|STARTED|Double-Blind Treatment Period||146
6523953|NCT01571362|7445223|FG000|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
6523954|NCT01571362|7445224|FG001|COMPLETED|Double-Blind Treatment Period||81
6523955|NCT01571362|7445225|FG002|COMPLETED|Double-Blind Treatment Period||107
6523956|NCT01571362|7445223|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6523957|NCT01571362|7445224|FG001|NOT COMPLETED|Double-Blind Treatment Period||53
6523958|NCT01571362|7445225|FG002|NOT COMPLETED|Double-Blind Treatment Period||39
6523959|NCT01571427|7445235|FG000|STARTED|Overall Study||41
6523960|NCT01571427|7445236|FG001|STARTED|Overall Study||42
6523961|NCT01571427|7445235|FG000|COMPLETED|Overall Study||41
6523962|NCT01571427|7445236|FG001|COMPLETED|Overall Study||42
6523963|NCT01571427|7445235|FG000|NOT COMPLETED|Overall Study||0
6523964|NCT01571427|7445236|FG001|NOT COMPLETED|Overall Study||0
6523965|NCT01571453|7445244|FG000|STARTED|Overall Study||211
6523966|NCT01571453|7445245|FG001|STARTED|Overall Study||226
6523967|NCT01571453|7445244|FG000|COMPLETED|Overall Study||173
6523968|NCT01571453|7445245|FG001|COMPLETED|Overall Study||164
6523969|NCT01571453|7445244|FG000|NOT COMPLETED|Overall Study||38
6523970|NCT01571453|7445245|FG001|NOT COMPLETED|Overall Study||62
6523971|NCT01571557|7445251|FG000|STARTED|Overall Study||573
6523972|NCT01571557|7445251|FG000|COMPLETED|Overall Study||573
6523973|NCT01571557|7445251|FG000|NOT COMPLETED|Overall Study||0
6523974|NCT01571596|7445258|FG000|STARTED|Overall Study||21
6642621|NCT02349295|7570951|FG005|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
6642622|NCT02349295|7570952|FG006|STARTED|Long-Term Extension Period (Week 24-156)|Only included combined extension participants.|0
6642623|NCT02349295|7570953|FG007|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ2W participants who entered the long-term extension period.|107
6642624|NCT02349295|7570954|FG008|STARTED|Long-Term Extension Period (Week 24-156)|IxeQ4W participants who entered the long-term extension period.|111
6642625|NCT02349295|7570955|FG009|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ2W participants who entered the long-term extension period.|46
6642626|NCT02349295|7570956|FG010|STARTED|Long-Term Extension Period (Week 24-156)|Placebo/IxeQ4W participants who entered the long-term extension period.|46
6642627|NCT02349295|7570957|FG011|STARTED|Long-Term Extension Period (Week 24-156)||0
6642628|NCT02349295|7570958|FG012|STARTED|Long-Term Extension Period (Week 24-156)||0
6642629|NCT02349295|7570959|FG013|STARTED|Long-Term Extension Period (Week 24-156)||0
6642630|NCT02349295|7570946|FG000|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642631|NCT02349295|7570947|FG001|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642632|NCT02349295|7570948|FG002|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642633|NCT02349295|7570949|FG003|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6523975|NCT01571596|7445259|FG001|STARTED|Overall Study||1
6523976|NCT01571596|7445260|FG002|STARTED|Overall Study||1
6523977|NCT01571596|7445258|FG000|COMPLETED|Overall Study||19
6523978|NCT01571596|7445259|FG001|COMPLETED|Overall Study||0
6523979|NCT01571596|7445260|FG002|COMPLETED|Overall Study||0
6523980|NCT01571596|7445258|FG000|NOT COMPLETED|Overall Study||2
6523981|NCT01571596|7445259|FG001|NOT COMPLETED|Overall Study||1
6523982|NCT01571596|7445260|FG002|NOT COMPLETED|Overall Study||1
6523983|NCT01572038|7445270|FG000|STARTED|Overall Study|All participants who were enrolled in the study.|1436
6523984|NCT01572038|7445270|FG000|Received at Least One Dose of Study Drug|Overall Study||1436
6523985|NCT01572038|7445270|FG000|COMPLETED|Overall Study||445
6523986|NCT01572038|7445270|FG000|NOT COMPLETED|Overall Study||991
6523987|NCT01572298|7445298|FG000|STARTED|Overall Study||14
6523988|NCT01572298|7445299|FG001|STARTED|Overall Study||13
6523989|NCT01572298|7445298|FG000|COMPLETED|Overall Study||12
6523990|NCT01572298|7445299|FG001|COMPLETED|Overall Study||12
6523991|NCT01572298|7445298|FG000|NOT COMPLETED|Overall Study||2
6523992|NCT01572298|7445299|FG001|NOT COMPLETED|Overall Study||1
6523993|NCT01572389|7445309|FG000|STARTED|Overall Study||136
6523994|NCT01572389|7445310|FG001|STARTED|Overall Study||89
6523995|NCT01572389|7445309|FG000|COMPLETED|Overall Study||90
6523996|NCT01572389|7445310|FG001|COMPLETED|Overall Study||68
6523997|NCT01572389|7445309|FG000|NOT COMPLETED|Overall Study||46
6523998|NCT01572389|7445310|FG001|NOT COMPLETED|Overall Study||21
6523999|NCT01572428|7445318|FG000|STARTED|Overall Study||402
6524000|NCT01572428|7445319|FG001|STARTED|Overall Study||402
6524001|NCT01572428|7445318|FG000|COMPLETED|Overall Study||399
6524002|NCT01572428|7445319|FG001|COMPLETED|Overall Study||401
6524003|NCT01572428|7445318|FG000|NOT COMPLETED|Overall Study||3
6524004|NCT01572428|7445319|FG001|NOT COMPLETED|Overall Study||1
6524005|NCT01572727|7445327|FG000|STARTED|Overall Study||207
6524006|NCT01572727|7445328|FG001|STARTED|Overall Study||209
6524007|NCT01572727|7445327|FG000|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
6524008|NCT01572727|7445328|FG001|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
6524009|NCT01572727|7445327|FG000|COMPLETED|Overall Study||0
6524010|NCT01572727|7445328|FG001|COMPLETED|Overall Study||0
6524011|NCT01572727|7445327|FG000|NOT COMPLETED|Overall Study||207
6524012|NCT01572727|7445328|FG001|NOT COMPLETED|Overall Study||209
6524013|NCT01572740|7445336|FG000|STARTED|Overall Study||127
6524014|NCT01572740|7445337|FG001|STARTED|Overall Study||130
6524015|NCT01572740|7445336|FG000|COMPLETED|Overall Study||121
6524016|NCT01572740|7445337|FG001|COMPLETED|Overall Study||125
6524017|NCT01572740|7445336|FG000|NOT COMPLETED|Overall Study||6
6524018|NCT01572740|7445337|FG001|NOT COMPLETED|Overall Study||5
6524019|NCT01572792|7445348|FG000|STARTED|Lead-in Study||337
6524020|NCT01572792|7445349|FG001|STARTED|Lead-in Study||338
6524021|NCT01572792|7445350|FG002|STARTED|Lead-in Study||338
6524022|NCT01572792|7445351|FG003|STARTED|Lead-in Study||340
6524023|NCT01572792|7445352|FG004|STARTED|Lead-in Study||339
6524024|NCT01572792|7445348|FG000|COMPLETED|Lead-in Study||236
6524025|NCT01572792|7445349|FG001|COMPLETED|Lead-in Study||272
6524026|NCT01572792|7445350|FG002|COMPLETED|Lead-in Study||276
6524027|NCT01572792|7445351|FG003|COMPLETED|Lead-in Study||268
6524028|NCT01572792|7445352|FG004|COMPLETED|Lead-in Study||270
6524029|NCT01572792|7445348|FG000|NOT COMPLETED|Lead-in Study||101
6524030|NCT01572792|7445349|FG001|NOT COMPLETED|Lead-in Study||66
6524031|NCT01572792|7445350|FG002|NOT COMPLETED|Lead-in Study||62
6524032|NCT01572792|7445351|FG003|NOT COMPLETED|Lead-in Study||72
6524033|NCT01572792|7445352|FG004|NOT COMPLETED|Lead-in Study||69
6524034|NCT01572792|7445348|FG000|STARTED|Extension Study||146
6524035|NCT01572792|7445349|FG001|STARTED|Extension Study||184
6524036|NCT01572792|7445350|FG002|STARTED|Extension Study||205
6524037|NCT01572792|7445351|FG003|STARTED|Extension Study||194
6524038|NCT01572792|7445352|FG004|STARTED|Extension Study||192
6524039|NCT01572792|7445348|FG000|COMPLETED|Extension Study||121
6524040|NCT01572792|7445349|FG001|COMPLETED|Extension Study||155
6524041|NCT01572792|7445350|FG002|COMPLETED|Extension Study||179
6524042|NCT01572792|7445351|FG003|COMPLETED|Extension Study||165
6524043|NCT01572792|7445352|FG004|COMPLETED|Extension Study||160
6524044|NCT01572792|7445348|FG000|NOT COMPLETED|Extension Study||25
6524045|NCT01572792|7445349|FG001|NOT COMPLETED|Extension Study||29
6524046|NCT01572792|7445350|FG002|NOT COMPLETED|Extension Study||26
6524047|NCT01572792|7445351|FG003|NOT COMPLETED|Extension Study||29
6524048|NCT01572792|7445352|FG004|NOT COMPLETED|Extension Study||32
6524049|NCT01572844|7445365|FG000|STARTED|Overall Study||3
6524050|NCT01572844|7445366|FG001|STARTED|Overall Study||3
6524051|NCT01572844|7445365|FG000|COMPLETED|Overall Study||2
6524052|NCT01572844|7445366|FG001|COMPLETED|Overall Study||2
6524053|NCT01572844|7445365|FG000|NOT COMPLETED|Overall Study||1
6524054|NCT01572844|7445366|FG001|NOT COMPLETED|Overall Study||1
6524055|NCT01572909|7445377|FG000|STARTED|Overall Study||152
6524056|NCT01572909|7445378|FG001|STARTED|Overall Study||148
6524057|NCT01572909|7445377|FG000|COMPLETED|Overall Study||120
6524058|NCT01572909|7445378|FG001|COMPLETED|Overall Study||123
6524059|NCT01572909|7445377|FG000|NOT COMPLETED|Overall Study||32
6524060|NCT01572909|7445378|FG001|NOT COMPLETED|Overall Study||25
6524061|NCT01572922|7445386|FG000|STARTED|Overall Study||142
6524062|NCT01572922|7445386|FG000|COMPLETED|Overall Study||139
6524063|NCT01572922|7445386|FG000|NOT COMPLETED|Overall Study||3
6524064|NCT01572948|7445397|FG000|STARTED|Overall Study||11
6524065|NCT01572948|7445398|FG001|STARTED|Overall Study||16
6524066|NCT01572948|7445397|FG000|COMPLETED|Overall Study||10
6524067|NCT01572948|7445398|FG001|COMPLETED|Overall Study||15
6524068|NCT01572948|7445397|FG000|NOT COMPLETED|Overall Study||1
6524069|NCT01572948|7445398|FG001|NOT COMPLETED|Overall Study||1
6524070|NCT01573000|7445410|FG000|STARTED|Dosimetric and Therapeutic Treatment||42
6524071|NCT01573000|7445411|FG001|STARTED|Dosimetric and Therapeutic Treatment||36
6524072|NCT01573000|7445410|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
6524073|NCT01573000|7445411|FG001|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
6524074|NCT01573000|7445410|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
6524075|NCT01573000|7445411|FG001|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
6524076|NCT01573000|7445410|FG000|STARTED|Crossover Phase||0
6524077|NCT01573000|7445411|FG001|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
6524078|NCT01573000|7445410|FG000|COMPLETED|Crossover Phase||0
6524079|NCT01573000|7445411|FG001|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
6524080|NCT01573000|7445410|FG000|NOT COMPLETED|Crossover Phase||0
6524081|NCT01573000|7445411|FG001|NOT COMPLETED|Crossover Phase||18
6524082|NCT01573000|7445410|FG000|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
6524083|NCT01573000|7445411|FG001|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
6524084|NCT01573000|7445410|FG000|COMPLETED|Long-Term Follow-Up||11
6524085|NCT01573000|7445411|FG001|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
6524086|NCT01573000|7445410|FG000|NOT COMPLETED|Long-Term Follow-Up||3
6524087|NCT01573000|7445411|FG001|NOT COMPLETED|Long-Term Follow-Up||1
6524088|NCT01573052|7445423|FG000|STARTED|Overall Study||9
6524089|NCT01573052|7445424|FG001|STARTED|Overall Study||17
6524090|NCT01573052|7445423|FG000|COMPLETED|Overall Study||6
6524091|NCT01573052|7445424|FG001|COMPLETED|Overall Study||11
6524092|NCT01573052|7445423|FG000|NOT COMPLETED|Overall Study||3
6524093|NCT01573052|7445424|FG001|NOT COMPLETED|Overall Study||6
6524094|NCT01573169|7445433|FG000|STARTED|Overall Study||38
6524095|NCT01573169|7445434|FG001|STARTED|Overall Study||35
6524096|NCT01573169|7445433|FG000|COMPLETED|Overall Study||38
6524097|NCT01573169|7445434|FG001|COMPLETED|Overall Study||35
6524098|NCT01573169|7445433|FG000|NOT COMPLETED|Overall Study||0
6524099|NCT01573169|7445434|FG001|NOT COMPLETED|Overall Study||0
6524100|NCT01573260|7445442|FG000|STARTED|Overall Study||18
6524101|NCT01573260|7445443|FG001|STARTED|Overall Study||15
6524102|NCT01573260|7445442|FG000|COMPLETED|Overall Study||18
6524103|NCT01573260|7445443|FG001|COMPLETED|Overall Study||15
6524104|NCT01573260|7445442|FG000|NOT COMPLETED|Overall Study||0
6524105|NCT01573260|7445443|FG001|NOT COMPLETED|Overall Study||0
6524106|NCT01573273|7445455|FG000|STARTED|TSST : Trier Social Stress Task||24
6524107|NCT01573273|7445456|FG001|STARTED|TSST : Trier Social Stress Task||25
6524108|NCT01573273|7445457|FG002|STARTED|TSST : Trier Social Stress Task||0
6524109|NCT01573273|7445458|FG003|STARTED|TSST : Trier Social Stress Task||0
6524110|NCT01573273|7445459|FG004|STARTED|TSST : Trier Social Stress Task||0
6524111|NCT01573273|7445460|FG005|STARTED|TSST : Trier Social Stress Task||0
6524112|NCT01573273|7445461|FG006|STARTED|TSST : Trier Social Stress Task||32
6524113|NCT01573273|7445462|FG007|STARTED|TSST : Trier Social Stress Task||31
6524114|NCT01573273|7445463|FG008|STARTED|TSST : Trier Social Stress Task||0
6524115|NCT01573273|7445464|FG009|STARTED|TSST : Trier Social Stress Task||0
6524116|NCT01573273|7445465|FG010|STARTED|TSST : Trier Social Stress Task||0
6524117|NCT01573273|7445466|FG011|STARTED|TSST : Trier Social Stress Task||0
6524118|NCT01573273|7445455|FG000|COMPLETED|TSST : Trier Social Stress Task||24
6524119|NCT01573273|7445456|FG001|COMPLETED|TSST : Trier Social Stress Task||25
6524120|NCT01573273|7445457|FG002|COMPLETED|TSST : Trier Social Stress Task||0
6524121|NCT01573273|7445458|FG003|COMPLETED|TSST : Trier Social Stress Task||0
6524122|NCT01573273|7445459|FG004|COMPLETED|TSST : Trier Social Stress Task||0
6524123|NCT01573273|7445460|FG005|COMPLETED|TSST : Trier Social Stress Task||0
6524124|NCT01573273|7445461|FG006|COMPLETED|TSST : Trier Social Stress Task||32
6524125|NCT01573273|7445462|FG007|COMPLETED|TSST : Trier Social Stress Task||31
6524126|NCT01573273|7445463|FG008|COMPLETED|TSST : Trier Social Stress Task||0
6524127|NCT01573273|7445464|FG009|COMPLETED|TSST : Trier Social Stress Task||0
6524128|NCT01573273|7445465|FG010|COMPLETED|TSST : Trier Social Stress Task||0
6524129|NCT01573273|7445466|FG011|COMPLETED|TSST : Trier Social Stress Task||0
6524130|NCT01573273|7445455|FG000|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524131|NCT01573273|7445456|FG001|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524132|NCT01573273|7445457|FG002|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524133|NCT01573273|7445458|FG003|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524134|NCT01573273|7445459|FG004|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524135|NCT01573273|7445460|FG005|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524136|NCT01573273|7445461|FG006|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524137|NCT01573273|7445462|FG007|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524138|NCT01573273|7445463|FG008|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524139|NCT01573273|7445464|FG009|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524140|NCT01573273|7445465|FG010|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524141|NCT01573273|7445466|FG011|NOT COMPLETED|TSST : Trier Social Stress Task||0
6524142|NCT01573273|7445455|FG000|STARTED|MRI 1||0
6524143|NCT01573273|7445456|FG001|STARTED|MRI 1||0
6524144|NCT01573273|7445457|FG002|STARTED|MRI 1||19
6524145|NCT01573273|7445458|FG003|STARTED|MRI 1||23
6524146|NCT01573273|7445459|FG004|STARTED|MRI 1||0
6524147|NCT01573273|7445460|FG005|STARTED|MRI 1||0
6524148|NCT01573273|7445461|FG006|STARTED|MRI 1||0
6524149|NCT01573273|7445462|FG007|STARTED|MRI 1||0
6524150|NCT01573273|7445463|FG008|STARTED|MRI 1||28
6524151|NCT01573273|7445464|FG009|STARTED|MRI 1||29
6524152|NCT01573273|7445465|FG010|STARTED|MRI 1||0
6524153|NCT01573273|7445466|FG011|STARTED|MRI 1||0
6524154|NCT01573273|7445455|FG000|COMPLETED|MRI 1||0
6524155|NCT01573273|7445456|FG001|COMPLETED|MRI 1||0
6524156|NCT01573273|7445457|FG002|COMPLETED|MRI 1||19
6524157|NCT01573273|7445458|FG003|COMPLETED|MRI 1||23
6524158|NCT01573273|7445459|FG004|COMPLETED|MRI 1||0
6524159|NCT01573273|7445460|FG005|COMPLETED|MRI 1||0
6524160|NCT01573273|7445461|FG006|COMPLETED|MRI 1||0
6524161|NCT01573273|7445462|FG007|COMPLETED|MRI 1||0
6524162|NCT01573273|7445463|FG008|COMPLETED|MRI 1||28
6524163|NCT01573273|7445464|FG009|COMPLETED|MRI 1||29
6524164|NCT01573273|7445465|FG010|COMPLETED|MRI 1||0
6524165|NCT01573273|7445466|FG011|COMPLETED|MRI 1||0
6524166|NCT01573273|7445455|FG000|NOT COMPLETED|MRI 1||0
6524167|NCT01573273|7445456|FG001|NOT COMPLETED|MRI 1||0
6524168|NCT01573273|7445457|FG002|NOT COMPLETED|MRI 1||0
6524169|NCT01573273|7445458|FG003|NOT COMPLETED|MRI 1||0
6524170|NCT01573273|7445459|FG004|NOT COMPLETED|MRI 1||0
6524171|NCT01573273|7445460|FG005|NOT COMPLETED|MRI 1||0
6524172|NCT01573273|7445461|FG006|NOT COMPLETED|MRI 1||0
6524173|NCT01573273|7445462|FG007|NOT COMPLETED|MRI 1||0
6524174|NCT01573273|7445463|FG008|NOT COMPLETED|MRI 1||0
6524175|NCT01573273|7445464|FG009|NOT COMPLETED|MRI 1||0
6524176|NCT01573273|7445465|FG010|NOT COMPLETED|MRI 1||0
6524177|NCT01573273|7445466|FG011|NOT COMPLETED|MRI 1||0
6524178|NCT01573273|7445455|FG000|STARTED|MRI 2||0
6524179|NCT01573273|7445456|FG001|STARTED|MRI 2||0
6524180|NCT01573273|7445457|FG002|STARTED|MRI 2||0
6524181|NCT01573273|7445458|FG003|STARTED|MRI 2||0
6524182|NCT01573273|7445459|FG004|STARTED|MRI 2||23
6524183|NCT01573273|7445460|FG005|STARTED|MRI 2||18
6524184|NCT01573273|7445461|FG006|STARTED|MRI 2||0
6524185|NCT01573273|7445462|FG007|STARTED|MRI 2||0
6524186|NCT01573273|7445463|FG008|STARTED|MRI 2||0
6524187|NCT01573273|7445464|FG009|STARTED|MRI 2||0
6524188|NCT01573273|7445465|FG010|STARTED|MRI 2||27
6524189|NCT01573273|7445466|FG011|STARTED|MRI 2||28
6524190|NCT01573273|7445455|FG000|COMPLETED|MRI 2||0
6524191|NCT01573273|7445456|FG001|COMPLETED|MRI 2||0
6524192|NCT01573273|7445457|FG002|COMPLETED|MRI 2||0
6524193|NCT01573273|7445458|FG003|COMPLETED|MRI 2||0
6524194|NCT01573273|7445459|FG004|COMPLETED|MRI 2||23
6524195|NCT01573273|7445460|FG005|COMPLETED|MRI 2||18
6524196|NCT01573273|7445461|FG006|COMPLETED|MRI 2||0
6524197|NCT01573273|7445462|FG007|COMPLETED|MRI 2||0
6524198|NCT01573273|7445463|FG008|COMPLETED|MRI 2||0
6524199|NCT01573273|7445464|FG009|COMPLETED|MRI 2||0
6524200|NCT01573273|7445465|FG010|COMPLETED|MRI 2||27
6524201|NCT01573273|7445466|FG011|COMPLETED|MRI 2||28
6524202|NCT01573273|7445455|FG000|NOT COMPLETED|MRI 2||0
6524203|NCT01573273|7445456|FG001|NOT COMPLETED|MRI 2||0
6524204|NCT01573273|7445457|FG002|NOT COMPLETED|MRI 2||0
6524205|NCT01573273|7445458|FG003|NOT COMPLETED|MRI 2||0
6524206|NCT01573273|7445459|FG004|NOT COMPLETED|MRI 2||0
6524207|NCT01573273|7445460|FG005|NOT COMPLETED|MRI 2||0
6524208|NCT01573273|7445461|FG006|NOT COMPLETED|MRI 2||0
6524209|NCT01573273|7445462|FG007|NOT COMPLETED|MRI 2||0
6524210|NCT01573273|7445463|FG008|NOT COMPLETED|MRI 2||0
6524211|NCT01573273|7445464|FG009|NOT COMPLETED|MRI 2||0
6524212|NCT01573273|7445465|FG010|NOT COMPLETED|MRI 2||0
6524213|NCT01573273|7445466|FG011|NOT COMPLETED|MRI 2||0
6524214|NCT01573325|7445492|FG000|STARTED|Overall Study||50
6524215|NCT01573325|7445492|FG000|COMPLETED|Overall Study||50
6524216|NCT01573325|7445492|FG000|NOT COMPLETED|Overall Study||0
6524217|NCT01573442|7445499|FG000|STARTED|Overall Study||113
6524218|NCT01573442|7445500|FG001|STARTED|Overall Study||114
6524219|NCT01573442|7445499|FG000|COMPLETED|Overall Study||104
6524220|NCT01573442|7445500|FG001|COMPLETED|Overall Study||104
6524221|NCT01573442|7445499|FG000|NOT COMPLETED|Overall Study||9
6524222|NCT01573442|7445500|FG001|NOT COMPLETED|Overall Study||10
6524223|NCT01573533|7445506|FG000|STARTED|Overall Study||9
6524224|NCT01573533|7445506|FG000|COMPLETED|Overall Study||9
6524225|NCT01573533|7445506|FG000|NOT COMPLETED|Overall Study||0
6524226|NCT01573572|7445510|FG000|STARTED|Overall Study||131
6524227|NCT01573572|7445510|FG000|COMPLETED|Overall Study||103
6524228|NCT01573572|7445510|FG000|NOT COMPLETED|Overall Study||28
6524229|NCT01573624|7445514|FG000|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
6524230|NCT01573624|7445515|FG001|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
6524231|NCT01573624|7445516|FG002|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
6524232|NCT01573624|7445517|FG003|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
6524233|NCT01573624|7445518|FG004|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
6524234|NCT01573624|7445519|FG005|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
6524235|NCT01573624|7445520|FG006|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
6524236|NCT01573624|7445514|FG000|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
6524237|NCT01573624|7445515|FG001|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
6524238|NCT01573624|7445516|FG002|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
6524239|NCT01573624|7445517|FG003|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
6524240|NCT01573624|7445518|FG004|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
6524241|NCT01573624|7445519|FG005|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
6524242|NCT01573624|7445520|FG006|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
6524243|NCT01573624|7445514|FG000|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
6524244|NCT01573624|7445515|FG001|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
6524245|NCT01573624|7445516|FG002|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
6524246|NCT01573624|7445517|FG003|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
6524247|NCT01573624|7445518|FG004|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
6524248|NCT01573624|7445519|FG005|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
6524249|NCT01573624|7445520|FG006|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
6524250|NCT01573624|7445514|FG000|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
6524251|NCT01573624|7445515|FG001|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
6524252|NCT01573624|7445516|FG002|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
6524253|NCT01573624|7445517|FG003|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
6524254|NCT01573624|7445518|FG004|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
6524255|NCT01573624|7445519|FG005|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
6524256|NCT01573624|7445520|FG006|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
6524257|NCT01573624|7445514|FG000|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
6524258|NCT01573624|7445515|FG001|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
6524259|NCT01573624|7445516|FG002|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
6524260|NCT01573624|7445517|FG003|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
6524261|NCT01573624|7445518|FG004|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
6524262|NCT01573624|7445519|FG005|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
6524263|NCT01573624|7445520|FG006|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
6524264|NCT01573624|7445514|FG000|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
6524265|NCT01573624|7445515|FG001|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
6524266|NCT01573624|7445516|FG002|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
6524267|NCT01573624|7445517|FG003|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
6524268|NCT01573624|7445518|FG004|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
6524269|NCT01573624|7445519|FG005|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
6524270|NCT01573624|7445520|FG006|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
6524271|NCT01573624|7445514|FG000|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
6524272|NCT01573624|7445515|FG001|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
6524273|NCT01573624|7445516|FG002|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
6524274|NCT01573624|7445517|FG003|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
6524275|NCT01573624|7445518|FG004|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
6524276|NCT01573624|7445519|FG005|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
6524277|NCT01573624|7445520|FG006|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
6524278|NCT01573624|7445514|FG000|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
6524279|NCT01573624|7445515|FG001|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
6524280|NCT01573624|7445516|FG002|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
6524281|NCT01573624|7445517|FG003|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
6524282|NCT01573624|7445518|FG004|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
6524283|NCT01573624|7445519|FG005|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
6524284|NCT01573624|7445520|FG006|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
6524285|NCT01573624|7445514|FG000|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
6524286|NCT01573624|7445515|FG001|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
6524287|NCT01573624|7445516|FG002|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
6524288|NCT01573624|7445517|FG003|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
6524289|NCT01573624|7445518|FG004|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
6524290|NCT01573624|7445519|FG005|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
6524291|NCT01573624|7445520|FG006|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
6524292|NCT01573624|7445514|FG000|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
6524293|NCT01573624|7445515|FG001|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
6524294|NCT01573624|7445516|FG002|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
6524295|NCT01573624|7445517|FG003|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
6524296|NCT01573624|7445518|FG004|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
6524297|NCT01573624|7445519|FG005|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
6524298|NCT01573624|7445520|FG006|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
6524299|NCT01573624|7445514|FG000|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
6524300|NCT01573624|7445515|FG001|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
6524301|NCT01573624|7445516|FG002|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
6524302|NCT01573624|7445517|FG003|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
6524303|NCT01573624|7445518|FG004|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
6524304|NCT01573624|7445519|FG005|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
6524305|NCT01573624|7445520|FG006|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
6524306|NCT01573624|7445514|FG000|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
6524307|NCT01573624|7445515|FG001|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
6524308|NCT01573624|7445516|FG002|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
6524309|NCT01573624|7445517|FG003|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
6524310|NCT01573624|7445518|FG004|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
6524311|NCT01573624|7445519|FG005|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
6524312|NCT01573624|7445520|FG006|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
6524313|NCT01573624|7445514|FG000|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
6524314|NCT01573624|7445515|FG001|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
6524315|NCT01573624|7445516|FG002|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
6524316|NCT01573624|7445517|FG003|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
6524317|NCT01573624|7445518|FG004|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
6524318|NCT01573624|7445519|FG005|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
6524319|NCT01573624|7445520|FG006|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
6524320|NCT01573624|7445514|FG000|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
6524321|NCT01573624|7445515|FG001|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
6524322|NCT01573624|7445516|FG002|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
6524323|NCT01573624|7445517|FG003|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
6524324|NCT01573624|7445518|FG004|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
6524325|NCT01573624|7445519|FG005|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
6524326|NCT01573624|7445520|FG006|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
6524327|NCT01573624|7445514|FG000|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
6524328|NCT01573624|7445515|FG001|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
6524329|NCT01573624|7445516|FG002|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
6524330|NCT01573624|7445517|FG003|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
6524331|NCT01573624|7445518|FG004|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
6524332|NCT01573624|7445519|FG005|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
6524333|NCT01573624|7445520|FG006|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
6524334|NCT01573624|7445514|FG000|STARTED|Period 6 : Follow-up Period (7 Days)||46
6524335|NCT01573624|7445515|FG001|STARTED|Period 6 : Follow-up Period (7 Days)||47
6524336|NCT01573624|7445516|FG002|STARTED|Period 6 : Follow-up Period (7 Days)||43
6524337|NCT01573624|7445517|FG003|STARTED|Period 6 : Follow-up Period (7 Days)||53
6524338|NCT01573624|7445518|FG004|STARTED|Period 6 : Follow-up Period (7 Days)||51
6524339|NCT01573624|7445519|FG005|STARTED|Period 6 : Follow-up Period (7 Days)||39
6524340|NCT01573624|7445520|FG006|STARTED|Period 6 : Follow-up Period (7 Days)||48
6524341|NCT01573624|7445514|FG000|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
6524342|NCT01573624|7445515|FG001|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
6524343|NCT01573624|7445516|FG002|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
6524344|NCT01573624|7445517|FG003|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
6524345|NCT01573624|7445518|FG004|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
6524346|NCT01573624|7445519|FG005|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
6524347|NCT01573624|7445520|FG006|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
6524348|NCT01573624|7445514|FG000|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
6524349|NCT01573624|7445515|FG001|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
6524350|NCT01573624|7445516|FG002|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
6524351|NCT01573624|7445517|FG003|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
6524352|NCT01573624|7445518|FG004|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
6524353|NCT01573624|7445519|FG005|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
6524354|NCT01573624|7445520|FG006|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
6524355|NCT01573702|7445542|FG000|STARTED|Overall Study||25
6524356|NCT01573702|7445542|FG000|COMPLETED|Overall Study||25
6524357|NCT01573702|7445542|FG000|NOT COMPLETED|Overall Study||0
6524358|NCT01573767|7445551|FG000|STARTED|Overall Study||115
6524359|NCT01573767|7445552|FG001|STARTED|Overall Study||114
6524360|NCT01573767|7445553|FG002|STARTED|Overall Study||113
6524361|NCT01573767|7445554|FG003|STARTED|Overall Study||114
6524362|NCT01573767|7445551|FG000|COMPLETED|Overall Study||93
6524363|NCT01573767|7445552|FG001|COMPLETED|Overall Study||93
6524364|NCT01573767|7445553|FG002|COMPLETED|Overall Study||99
6524365|NCT01573767|7445554|FG003|COMPLETED|Overall Study||90
6524366|NCT01573767|7445551|FG000|NOT COMPLETED|Overall Study||22
6524367|NCT01573767|7445552|FG001|NOT COMPLETED|Overall Study||21
6524368|NCT01573767|7445553|FG002|NOT COMPLETED|Overall Study||14
6524369|NCT01573767|7445554|FG003|NOT COMPLETED|Overall Study||24
6524370|NCT01573910|7445566|FG000|STARTED|Overall Study||489
6524371|NCT01573910|7445567|FG001|STARTED|Overall Study||493
6524372|NCT01573910|7445566|FG000|COMPLETED|Overall Study||469
6524373|NCT01573910|7445567|FG001|COMPLETED|Overall Study||476
6524374|NCT01573910|7445566|FG000|NOT COMPLETED|Overall Study||20
6524375|NCT01573910|7445567|FG001|NOT COMPLETED|Overall Study||17
6524376|NCT01573949|7445573|FG000|STARTED|Overall Study||7
6524377|NCT01573949|7445573|FG000|COMPLETED|Overall Study||7
6524378|NCT01573949|7445573|FG000|NOT COMPLETED|Overall Study||0
6524379|NCT01574079|7445579|FG000|STARTED|Overall Study||18
6524380|NCT01574079|7445580|FG001|STARTED|Overall Study||15
6524381|NCT01574079|7445579|FG000|COMPLETED|Overall Study||17
6524382|NCT01574079|7445580|FG001|COMPLETED|Overall Study||13
6524383|NCT01574079|7445579|FG000|NOT COMPLETED|Overall Study||1
6524384|NCT01574079|7445580|FG001|NOT COMPLETED|Overall Study||2
6524385|NCT01574105|7445588|FG000|STARTED|Overall Study||29
6524386|NCT01574105|7445589|FG001|STARTED|Overall Study||37
6524387|NCT01574105|7445588|FG000|COMPLETED|Overall Study||29
6524388|NCT01574105|7445589|FG001|COMPLETED|Overall Study||37
6524389|NCT01574105|7445588|FG000|NOT COMPLETED|Overall Study||0
6524390|NCT01574105|7445589|FG001|NOT COMPLETED|Overall Study||0
6524391|NCT01574144|7445595|FG000|STARTED|Overall Study||70
6524392|NCT01574144|7445595|FG000|COMPLETED|Overall Study||70
6524393|NCT01574144|7445595|FG000|NOT COMPLETED|Overall Study||0
6524394|NCT01574157|7445602|FG000|STARTED|Overall Study||35
6524395|NCT01574157|7445603|FG001|STARTED|Overall Study||39
6524396|NCT01574157|7445602|FG000|Month 3|Overall Study||31
6524397|NCT01574157|7445603|FG001|Month 3|Overall Study||33
6524398|NCT01574157|7445602|FG000|COMPLETED|Overall Study||31
6524399|NCT01574157|7445603|FG001|COMPLETED|Overall Study||31
6524400|NCT01574157|7445602|FG000|NOT COMPLETED|Overall Study||4
6524401|NCT01574157|7445603|FG001|NOT COMPLETED|Overall Study||8
6524402|NCT01574183|7445615|FG000|STARTED|Overall Study||41
6524403|NCT01574183|7445616|FG001|STARTED|Overall Study||35
6524404|NCT01574183|7445615|FG000|COMPLETED|Overall Study||14
6524405|NCT01574183|7445616|FG001|COMPLETED|Overall Study||17
6524406|NCT01574183|7445615|FG000|NOT COMPLETED|Overall Study||27
6524407|NCT01574183|7445616|FG001|NOT COMPLETED|Overall Study||18
6524408|NCT01574248|7445626|FG000|STARTED|Overall Study||15
6524409|NCT01574248|7445627|FG001|STARTED|Overall Study||18
6524410|NCT01574248|7445626|FG000|COMPLETED|Overall Study||12
6524411|NCT01574248|7445627|FG001|COMPLETED|Overall Study||18
6524412|NCT01574248|7445626|FG000|NOT COMPLETED|Overall Study||3
6524413|NCT01574248|7445627|FG001|NOT COMPLETED|Overall Study||0
6561754|NCT01796860|7484648|FG000|STARTED|Overall Study||10
6561755|NCT01796860|7484648|FG000|COMPLETED|Overall Study||7
6561756|NCT01796860|7484648|FG000|NOT COMPLETED|Overall Study||3
6561757|NCT01796912|7484652|FG000|STARTED|First Intervention||10
6561758|NCT01796912|7484653|FG001|STARTED|First Intervention||10
6524414|NCT01574287|7445633|FG000|STARTED|Overall Study||4
6524415|NCT01574287|7445633|FG000|COMPLETED|Overall Study||4
6524416|NCT01574287|7445633|FG000|NOT COMPLETED|Overall Study||0
6524417|NCT01574326|7445639|FG000|STARTED|Overall Study||51
6524418|NCT01574326|7445640|FG001|STARTED|Overall Study||50
6524419|NCT01574326|7445639|FG000|Treated|Overall Study||51
6524420|NCT01574326|7445640|FG001|Treated|Overall Study||49
6524421|NCT01574326|7445639|FG000|COMPLETED|Overall Study||35
6524422|NCT01574326|7445640|FG001|COMPLETED|Overall Study||31
6524423|NCT01574326|7445639|FG000|NOT COMPLETED|Overall Study||16
6524424|NCT01574326|7445640|FG001|NOT COMPLETED|Overall Study||19
6524425|NCT01574352|7445653|FG000|STARTED|Overall Study|59 participants where randomized, but 4 dropped out prior to baseline measurements.|55
6524426|NCT01574352|7445654|FG001|STARTED|Overall Study|56 participants where randomized, but 5 dropped out prior to baseline measurements.|51
6524427|NCT01574352|7445653|FG000|COMPLETED|Overall Study|Participated in the last follow up measurement.|48
6524428|NCT01574352|7445654|FG001|COMPLETED|Overall Study|Participated in the last follow up measurement.|38
6524429|NCT01574352|7445653|FG000|NOT COMPLETED|Overall Study||7
6524430|NCT01574352|7445654|FG001|NOT COMPLETED|Overall Study||13
6524431|NCT01574612|7445660|FG000|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
6524432|NCT01574612|7445660|FG000|COMPLETED|Overall Study||46
6524433|NCT01574612|7445660|FG000|NOT COMPLETED|Overall Study||8
6524434|NCT01574651|7445666|FG000|STARTED|Overall Study||476
6524435|NCT01574651|7445667|FG001|STARTED|Overall Study||458
6524436|NCT01574651|7445666|FG000|Full Analysis Set (FAS)|Overall Study||476
6524437|NCT01574651|7445667|FG001|Full Analysis Set (FAS)|Overall Study||458
6524438|NCT01574651|7445666|FG000|Per Protocol Set (PPS)|Overall Study||373
6524439|NCT01574651|7445667|FG001|Per Protocol Set (PPS)|Overall Study||374
6524440|NCT01574651|7445666|FG000|COMPLETED|Overall Study||415
6524441|NCT01574651|7445667|FG001|COMPLETED|Overall Study||406
6524442|NCT01574651|7445666|FG000|NOT COMPLETED|Overall Study||61
6524443|NCT01574651|7445667|FG001|NOT COMPLETED|Overall Study||52
6524444|NCT01574703|7445677|FG000|STARTED|Overall Study||1192
6524445|NCT01574703|7445678|FG001|STARTED|Overall Study||1166
6524446|NCT01574703|7445679|FG002|STARTED|Overall Study||1116
6524447|NCT01574703|7445680|FG003|STARTED|Overall Study||1121
6524448|NCT01574703|7445677|FG000|COMPLETED|Overall Study||1067
6524449|NCT01574703|7445678|FG001|COMPLETED|Overall Study||1054
6524450|NCT01574703|7445679|FG002|COMPLETED|Overall Study||1011
6524451|NCT01574703|7445680|FG003|COMPLETED|Overall Study||1007
6524452|NCT01574703|7445677|FG000|NOT COMPLETED|Overall Study||125
6524453|NCT01574703|7445678|FG001|NOT COMPLETED|Overall Study||112
6524454|NCT01574703|7445679|FG002|NOT COMPLETED|Overall Study||105
6524455|NCT01574703|7445680|FG003|NOT COMPLETED|Overall Study||114
6524456|NCT01574716|7445695|FG000|STARTED|Part 1||3
6524457|NCT01574716|7445696|FG001|STARTED|Part 1||4
6524458|NCT01574716|7445697|FG002|STARTED|Part 1||9
6524459|NCT01574716|7445698|FG003|STARTED|Part 1||0
6524460|NCT01574716|7445699|FG004|STARTED|Part 1||0
6524461|NCT01574716|7445695|FG000|COMPLETED|Part 1||0
6524462|NCT01574716|7445696|FG001|COMPLETED|Part 1||0
6524463|NCT01574716|7445697|FG002|COMPLETED|Part 1||0
6524464|NCT01574716|7445698|FG003|COMPLETED|Part 1||0
6524465|NCT01574716|7445699|FG004|COMPLETED|Part 1||0
6524466|NCT01574716|7445695|FG000|NOT COMPLETED|Part 1||3
6642634|NCT02349295|7570950|FG004|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642635|NCT02349295|7570951|FG005|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642636|NCT02349295|7570952|FG006|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642637|NCT02349295|7570953|FG007|COMPLETED|Long-Term Extension Period (Week 24-156)||55
6642638|NCT02349295|7570954|FG008|COMPLETED|Long-Term Extension Period (Week 24-156)||70
6642639|NCT02349295|7570955|FG009|COMPLETED|Long-Term Extension Period (Week 24-156)||20
6642640|NCT02349295|7570956|FG010|COMPLETED|Long-Term Extension Period (Week 24-156)||23
6642641|NCT02349295|7570957|FG011|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642642|NCT02349295|7570958|FG012|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642643|NCT02349295|7570959|FG013|COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642644|NCT02349295|7570946|FG000|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642645|NCT02349295|7570947|FG001|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642646|NCT02349295|7570948|FG002|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642647|NCT02349295|7570949|FG003|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642648|NCT02349295|7570950|FG004|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642649|NCT02349295|7570951|FG005|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642650|NCT02349295|7570952|FG006|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642651|NCT02349295|7570953|FG007|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||52
6642652|NCT02349295|7570954|FG008|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||41
6524467|NCT01574716|7445696|FG001|NOT COMPLETED|Part 1||4
6524468|NCT01574716|7445697|FG002|NOT COMPLETED|Part 1||9
6524469|NCT01574716|7445698|FG003|NOT COMPLETED|Part 1||0
6524470|NCT01574716|7445699|FG004|NOT COMPLETED|Part 1||0
6524471|NCT01574716|7445695|FG000|STARTED|Part 2||0
6524472|NCT01574716|7445696|FG001|STARTED|Part 2||0
6524473|NCT01574716|7445697|FG002|STARTED|Part 2||0
6524474|NCT01574716|7445698|FG003|STARTED|Part 2||139
6524475|NCT01574716|7445699|FG004|STARTED|Part 2||70
6524476|NCT01574716|7445695|FG000|Treated Participants|Part 2||0
6524477|NCT01574716|7445696|FG001|Treated Participants|Part 2||0
6524478|NCT01574716|7445697|FG002|Treated Participants|Part 2||0
6524479|NCT01574716|7445698|FG003|Treated Participants|Part 2||140
6524480|NCT01574716|7445699|FG004|Treated Participants|Part 2||67
6524481|NCT01574716|7445695|FG000|COMPLETED|Part 2||0
6524482|NCT01574716|7445696|FG001|COMPLETED|Part 2||0
6524483|NCT01574716|7445697|FG002|COMPLETED|Part 2||0
6524484|NCT01574716|7445698|FG003|COMPLETED|Part 2||2
6524485|NCT01574716|7445699|FG004|COMPLETED|Part 2||0
6524486|NCT01574716|7445695|FG000|NOT COMPLETED|Part 2||0
6524487|NCT01574716|7445696|FG001|NOT COMPLETED|Part 2||0
6524488|NCT01574716|7445697|FG002|NOT COMPLETED|Part 2||0
6524489|NCT01574716|7445698|FG003|NOT COMPLETED|Part 2||137
6524490|NCT01574716|7445699|FG004|NOT COMPLETED|Part 2||70
6524491|NCT01574807|7445708|FG000|STARTED|First Appointment||50
6524492|NCT01574807|7445709|FG001|STARTED|First Appointment||50
6524493|NCT01574807|7445708|FG000|COMPLETED|First Appointment||50
6524494|NCT01574807|7445709|FG001|COMPLETED|First Appointment||50
6524495|NCT01574807|7445708|FG000|NOT COMPLETED|First Appointment||0
6524496|NCT01574807|7445709|FG001|NOT COMPLETED|First Appointment||0
6524497|NCT01574807|7445708|FG000|STARTED|Wash Out Period 2 Weeks||50
6524498|NCT01574807|7445709|FG001|STARTED|Wash Out Period 2 Weeks||50
6524499|NCT01574807|7445708|FG000|COMPLETED|Wash Out Period 2 Weeks||50
6524500|NCT01574807|7445709|FG001|COMPLETED|Wash Out Period 2 Weeks||50
6524501|NCT01574807|7445708|FG000|NOT COMPLETED|Wash Out Period 2 Weeks||0
6524502|NCT01574807|7445709|FG001|NOT COMPLETED|Wash Out Period 2 Weeks||0
6524503|NCT01574807|7445708|FG000|STARTED|Second Appointment||50
6524504|NCT01574807|7445709|FG001|STARTED|Second Appointment||50
6524505|NCT01574807|7445708|FG000|COMPLETED|Second Appointment||50
6524506|NCT01574807|7445709|FG001|COMPLETED|Second Appointment||50
6524507|NCT01574807|7445708|FG000|NOT COMPLETED|Second Appointment||0
6524508|NCT01574807|7445709|FG001|NOT COMPLETED|Second Appointment||0
6524509|NCT01575054|7445716|FG000|STARTED|Overall Study||233
6524510|NCT01575054|7445717|FG001|STARTED|Overall Study||235
6524511|NCT01575054|7445716|FG000|COMPLETED|Overall Study||204
6524512|NCT01575054|7445717|FG001|COMPLETED|Overall Study||209
6524513|NCT01575054|7445716|FG000|NOT COMPLETED|Overall Study||29
6524514|NCT01575054|7445717|FG001|NOT COMPLETED|Overall Study||26
6524515|NCT01575080|7445723|FG000|STARTED|Overall Study||102
6524516|NCT01575080|7445723|FG000|COMPLETED|Overall Study||102
6524517|NCT01575080|7445723|FG000|NOT COMPLETED|Overall Study||0
6524518|NCT01575106|7445727|FG000|STARTED|Overall Study||38
6524519|NCT01575106|7445727|FG000|COMPLETED|Overall Study||24
6524520|NCT01575106|7445727|FG000|NOT COMPLETED|Overall Study||14
6524521|NCT01575197|7445735|FG000|STARTED|Overall Study||152
6524522|NCT01575197|7445736|FG001|STARTED|Overall Study||152
6524523|NCT01575197|7445737|FG002|STARTED|Overall Study||152
6524524|NCT01575197|7445735|FG000|COMPLETED|Overall Study||149
6524525|NCT01575197|7445736|FG001|COMPLETED|Overall Study||143
6524526|NCT01575197|7445737|FG002|COMPLETED|Overall Study||146
6524527|NCT01575197|7445735|FG000|NOT COMPLETED|Overall Study||3
6524528|NCT01575197|7445736|FG001|NOT COMPLETED|Overall Study||9
6524529|NCT01575197|7445737|FG002|NOT COMPLETED|Overall Study||6
6524530|NCT01575275|7445745|FG000|STARTED|Overall Study||8
6524531|NCT01575275|7445745|FG000|COMPLETED|Overall Study||8
6524532|NCT01575275|7445745|FG000|NOT COMPLETED|Overall Study||0
6524533|NCT01575522|7445749|FG000|STARTED|Overall Study||22
6524534|NCT01575522|7445749|FG000|COMPLETED|Overall Study||22
6524535|NCT01575522|7445749|FG000|NOT COMPLETED|Overall Study||0
6524536|NCT01575561|7445756|FG000|STARTED|Overall Study||377
6524537|NCT01575561|7445756|FG000|COMPLETED|Overall Study||338
6524538|NCT01575561|7445756|FG000|NOT COMPLETED|Overall Study||39
6524539|NCT01575756|7445760|FG000|STARTED|Treatment Period 1||11
6524540|NCT01575756|7445761|FG001|STARTED|Treatment Period 1||11
6524541|NCT01575756|7445760|FG000|COMPLETED|Treatment Period 1||11
6524542|NCT01575756|7445761|FG001|COMPLETED|Treatment Period 1||11
6524543|NCT01575756|7445760|FG000|NOT COMPLETED|Treatment Period 1||0
6524544|NCT01575756|7445761|FG001|NOT COMPLETED|Treatment Period 1||0
6524545|NCT01575756|7445760|FG000|STARTED|Treatment Period 2||11
6524546|NCT01575756|7445761|FG001|STARTED|Treatment Period 2||11
6524547|NCT01575756|7445760|FG000|COMPLETED|Treatment Period 2||11
6524548|NCT01575756|7445761|FG001|COMPLETED|Treatment Period 2||11
6524549|NCT01575756|7445760|FG000|NOT COMPLETED|Treatment Period 2||0
6524550|NCT01575756|7445761|FG001|NOT COMPLETED|Treatment Period 2||0
6524551|NCT01575769|7445768|FG000|STARTED|Overall Study||41
6524552|NCT01575769|7445768|FG000|COMPLETED|Overall Study||0
6524553|NCT01575769|7445768|FG000|NOT COMPLETED|Overall Study||41
6524554|NCT01575808|7445776|FG000|STARTED|Overall Study||103
6524555|NCT01575808|7445777|FG001|STARTED|Overall Study||68
6524556|NCT01575808|7445776|FG000|COMPLETED|Overall Study|Study ongoing. All 103 assessed for primary invasiveness endpoints,100 for primary efficacy endpoint|100
6524557|NCT01575808|7445777|FG001|COMPLETED|Overall Study||68
6524558|NCT01575808|7445776|FG000|NOT COMPLETED|Overall Study||3
6524559|NCT01575808|7445777|FG001|NOT COMPLETED|Overall Study||0
6524560|NCT01575834|7445787|FG000|STARTED|Overall Study||3591
6524561|NCT01575834|7445788|FG001|STARTED|Overall Study||3589
6524562|NCT01575834|7445787|FG000|Received Double-blind Treatment|Overall Study|Six participants received a dose of romosozumab in error during the double-blind period.|3582
6524563|NCT01575834|7445788|FG001|Received Double-blind Treatment|Overall Study||3575
6524564|NCT01575834|7445787|FG000|Completed Double-blind Period|Overall Study||3205
6524565|NCT01575834|7445788|FG001|Completed Double-blind Period|Overall Study||3185
6524566|NCT01575834|7445787|FG000|Completed 24-month Study Period|Overall Study||3032
6524567|NCT01575834|7445788|FG001|Completed 24-month Study Period|Overall Study||2994
6524568|NCT01575834|7445787|FG000|COMPLETED|Overall Study|Completed 36-month study period|2892
6524569|NCT01575834|7445788|FG001|COMPLETED|Overall Study|Completed 36-month study period|2851
6524570|NCT01575834|7445787|FG000|NOT COMPLETED|Overall Study||699
6524571|NCT01575834|7445788|FG001|NOT COMPLETED|Overall Study||738
6524572|NCT01575860|7445798|FG000|STARTED|Overall Study||8
6524573|NCT01575860|7445798|FG000|COMPLETED|Overall Study||6
6524574|NCT01575860|7445798|FG000|NOT COMPLETED|Overall Study||2
6524575|NCT01575873|7445807|FG000|STARTED|Overall Study||145
6524576|NCT01575873|7445808|FG001|STARTED|Overall Study||145
6524577|NCT01575873|7445809|FG002|STARTED|Overall Study||252
6524578|NCT01575873|7445810|FG003|STARTED|Overall Study||253
6524579|NCT01575873|7445807|FG000|Received Study Drug|Overall Study|Participants who received oral risedronate|140
6524580|NCT01575873|7445808|FG001|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|142
6524581|NCT01575873|7445809|FG002|Received Study Drug|Overall Study|Participants who received oral risedronate|246
6524582|NCT01575873|7445810|FG003|Received Study Drug|Overall Study|Participants who received subcutaneous denosumab|251
6524583|NCT01575873|7445807|FG000|COMPLETED|Overall Study||117
6524584|NCT01575873|7445808|FG001|COMPLETED|Overall Study||109
6524585|NCT01575873|7445809|FG002|COMPLETED|Overall Study||178
6642653|NCT02349295|7570955|FG009|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||26
6642654|NCT02349295|7570956|FG010|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||23
6642655|NCT02349295|7570957|FG011|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642656|NCT02349295|7570958|FG012|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642657|NCT02349295|7570959|FG013|NOT COMPLETED|Long-Term Extension Period (Week 24-156)||0
6642658|NCT02349295|7570946|FG000|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6642659|NCT02349295|7570947|FG001|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6642660|NCT02349295|7570948|FG002|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6642661|NCT02349295|7570949|FG003|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6642662|NCT02349295|7570950|FG004|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6642663|NCT02349295|7570951|FG005|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6642664|NCT02349295|7570952|FG006|STARTED|Follow-Up Period (Up to 12-24 Weeks)||0
6642665|NCT02349295|7570953|FG007|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
6642666|NCT02349295|7570954|FG008|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
6642667|NCT02349295|7570955|FG009|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
6642668|NCT02349295|7570956|FG010|STARTED|Follow-Up Period (Up to 12-24 Weeks)|Only included post-treatment follow-up participants.|0
6743669|NCT03335254|7671826|FG016|COMPLETED|Period 2, Day 1-15||0
6524586|NCT01575873|7445810|FG003|COMPLETED|Overall Study||186
6524587|NCT01575873|7445807|FG000|NOT COMPLETED|Overall Study||28
6524588|NCT01575873|7445808|FG001|NOT COMPLETED|Overall Study||36
6524589|NCT01575873|7445809|FG002|NOT COMPLETED|Overall Study||74
6524590|NCT01575873|7445810|FG003|NOT COMPLETED|Overall Study||67
6524591|NCT01575899|7445821|FG000|STARTED|Overall Study||73
6524592|NCT01575899|7445822|FG001|STARTED|Overall Study||73
6524593|NCT01575899|7445823|FG002|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
6524594|NCT01575899|7445821|FG000|COMPLETED|Overall Study||68
6524595|NCT01575899|7445822|FG001|COMPLETED|Overall Study||68
6524596|NCT01575899|7445823|FG002|COMPLETED|Overall Study||60
6524597|NCT01575899|7445821|FG000|NOT COMPLETED|Overall Study||5
6524598|NCT01575899|7445822|FG001|NOT COMPLETED|Overall Study||5
6524599|NCT01575899|7445823|FG002|NOT COMPLETED|Overall Study||2
6524600|NCT01575912|7445836|FG000|STARTED|Overall Study||30
6524601|NCT01575912|7445837|FG001|STARTED|Overall Study||32
6524602|NCT01575912|7445838|FG002|STARTED|Overall Study||30
6524603|NCT01575912|7445836|FG000|COMPLETED|Overall Study||30
6524604|NCT01575912|7445837|FG001|COMPLETED|Overall Study||32
6524605|NCT01575912|7445838|FG002|COMPLETED|Overall Study||30
6524606|NCT01575912|7445836|FG000|NOT COMPLETED|Overall Study||0
6524607|NCT01575912|7445837|FG001|NOT COMPLETED|Overall Study||0
6524608|NCT01575912|7445838|FG002|NOT COMPLETED|Overall Study||0
6524609|NCT01576003|7445849|FG000|STARTED|Overall Study||2
6524610|NCT01576003|7445850|FG001|STARTED|Overall Study||3
6524611|NCT01576003|7445851|FG002|STARTED|Overall Study||4
6524612|NCT01576003|7445849|FG000|COMPLETED|Overall Study||1
6524613|NCT01576003|7445850|FG001|COMPLETED|Overall Study||1
6524614|NCT01576003|7445851|FG002|COMPLETED|Overall Study||4
6524615|NCT01576003|7445849|FG000|NOT COMPLETED|Overall Study||1
6524616|NCT01576003|7445850|FG001|NOT COMPLETED|Overall Study||2
6524617|NCT01576003|7445851|FG002|NOT COMPLETED|Overall Study||0
6524618|NCT01576016|7445861|FG000|STARTED|Lead Safety||920
6524619|NCT01576016|7445862|FG001|STARTED|Lead Safety||0
6524620|NCT01576016|7445861|FG000|COMPLETED|Lead Safety||647
6524621|NCT01576016|7445862|FG001|COMPLETED|Lead Safety||0
6524622|NCT01576016|7445861|FG000|NOT COMPLETED|Lead Safety||273
6524623|NCT01576016|7445862|FG001|NOT COMPLETED|Lead Safety||0
6524624|NCT01576016|7445861|FG000|STARTED|MRI Safety||0
6524625|NCT01576016|7445862|FG001|STARTED|MRI Safety|255 enrollments includes 30 supplemental scans performed in Australia using the same scan protocol.|255
6524626|NCT01576016|7445861|FG000|COMPLETED|MRI Safety||0
6524627|NCT01576016|7445862|FG001|COMPLETED|MRI Safety||181
6524628|NCT01576016|7445861|FG000|NOT COMPLETED|MRI Safety||0
6524629|NCT01576016|7445862|FG001|NOT COMPLETED|MRI Safety||74
6524630|NCT01576042|7445872|FG000|STARTED|Overall Study||13
6524631|NCT01576042|7445873|FG001|STARTED|Overall Study||14
6524632|NCT01576042|7445872|FG000|Switched to the Other Arm|Overall Study||5
6524633|NCT01576042|7445873|FG001|Switched to the Other Arm|Overall Study||1
6524634|NCT01576042|7445872|FG000|COMPLETED|Overall Study||11
6524635|NCT01576042|7445873|FG001|COMPLETED|Overall Study||14
6524636|NCT01576042|7445872|FG000|NOT COMPLETED|Overall Study||2
6524637|NCT01576042|7445873|FG001|NOT COMPLETED|Overall Study||0
6524638|NCT01576055|7445881|FG000|STARTED|Overall Study||197
6524639|NCT01576055|7445882|FG001|STARTED|Overall Study||70
6524640|NCT01576055|7445881|FG000|COMPLETED|Overall Study||178
6524641|NCT01576055|7445882|FG001|COMPLETED|Overall Study||64
6524642|NCT01576055|7445881|FG000|NOT COMPLETED|Overall Study||19
6524643|NCT01576055|7445882|FG001|NOT COMPLETED|Overall Study||6
6524644|NCT01576120|7445890|FG000|STARTED|Overall Study||21
6524645|NCT01576120|7445891|FG001|STARTED|Overall Study||19
6524646|NCT01576120|7445890|FG000|COMPLETED|Overall Study||21
6524647|NCT01576120|7445891|FG001|COMPLETED|Overall Study||19
6524648|NCT01576120|7445890|FG000|NOT COMPLETED|Overall Study||0
6524649|NCT01576120|7445891|FG001|NOT COMPLETED|Overall Study||0
6524650|NCT01576146|7445897|FG000|STARTED|Extension Period 1||30
6524651|NCT01576146|7445897|FG000|COMPLETED|Extension Period 1||20
6524652|NCT01576146|7445897|FG000|NOT COMPLETED|Extension Period 1||10
6524653|NCT01576146|7445897|FG000|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
6524654|NCT01576146|7445897|FG000|COMPLETED|Extension Period 2||0
6524655|NCT01576146|7445897|FG000|NOT COMPLETED|Extension Period 2||17
6524656|NCT01576159|7445905|FG000|STARTED|Overall Study||12
6524657|NCT01576159|7445906|FG001|STARTED|Overall Study||12
6524658|NCT01576159|7445907|FG002|STARTED|Overall Study||12
6524659|NCT01576159|7445908|FG003|STARTED|Overall Study||12
6524660|NCT01576159|7445905|FG000|COMPLETED|Overall Study||11
6524661|NCT01576159|7445906|FG001|COMPLETED|Overall Study||11
6524662|NCT01576159|7445907|FG002|COMPLETED|Overall Study||11
6524663|NCT01576159|7445908|FG003|COMPLETED|Overall Study||11
6524664|NCT01576159|7445905|FG000|NOT COMPLETED|Overall Study||1
6524665|NCT01576159|7445906|FG001|NOT COMPLETED|Overall Study||1
6524666|NCT01576159|7445907|FG002|NOT COMPLETED|Overall Study||1
6524667|NCT01576159|7445908|FG003|NOT COMPLETED|Overall Study||1
6524668|NCT01576172|7445927|FG000|STARTED|Overall Study||79
6524669|NCT01576172|7445928|FG001|STARTED|Overall Study||80
6524670|NCT01576172|7445927|FG000|COMPLETED|Overall Study||74
6524671|NCT01576172|7445928|FG001|COMPLETED|Overall Study||79
6524672|NCT01576172|7445927|FG000|NOT COMPLETED|Overall Study||5
6524673|NCT01576172|7445928|FG001|NOT COMPLETED|Overall Study||1
6524674|NCT01576276|7445938|FG000|STARTED|Overall Study||22
6524675|NCT01576276|7445939|FG001|STARTED|Overall Study||29
6524676|NCT01576276|7445938|FG000|COMPLETED|Overall Study||14
6524677|NCT01576276|7445939|FG001|COMPLETED|Overall Study||18
6524678|NCT01576276|7445938|FG000|NOT COMPLETED|Overall Study||8
6524679|NCT01576276|7445939|FG001|NOT COMPLETED|Overall Study||11
6524680|NCT01576341|7445946|FG000|STARTED|Overall Study||417
6524681|NCT01576341|7445946|FG000|COMPLETED|Overall Study||324
6524682|NCT01576341|7445946|FG000|NOT COMPLETED|Overall Study||93
6524683|NCT01576367|7445953|FG000|STARTED|Overall Study||17
6524684|NCT01576367|7445953|FG000|COMPLETED|Overall Study||14
6524685|NCT01576367|7445953|FG000|NOT COMPLETED|Overall Study||3
6524686|NCT01576406|7445963|FG000|STARTED|Overall Study||11
6524687|NCT01576406|7445964|FG001|STARTED|Overall Study||15
6524688|NCT01576406|7445965|FG002|STARTED|Overall Study||20
6524689|NCT01576406|7445966|FG003|STARTED|Overall Study||10
6524690|NCT01576406|7445967|FG004|STARTED|Overall Study||16
6524691|NCT01576406|7445968|FG005|STARTED|Overall Study||16
6524692|NCT01576406|7445963|FG000|COMPLETED|Overall Study||5
6524693|NCT01576406|7445964|FG001|COMPLETED|Overall Study||7
6524694|NCT01576406|7445965|FG002|COMPLETED|Overall Study||4
6524695|NCT01576406|7445966|FG003|COMPLETED|Overall Study||1
6524696|NCT01576406|7445967|FG004|COMPLETED|Overall Study||8
6524697|NCT01576406|7445968|FG005|COMPLETED|Overall Study||4
6524698|NCT01576406|7445963|FG000|NOT COMPLETED|Overall Study||6
6524699|NCT01576406|7445964|FG001|NOT COMPLETED|Overall Study||8
6524700|NCT01576406|7445965|FG002|NOT COMPLETED|Overall Study||16
6524701|NCT01576406|7445966|FG003|NOT COMPLETED|Overall Study||9
6524702|NCT01576406|7445967|FG004|NOT COMPLETED|Overall Study||8
6524703|NCT01576406|7445968|FG005|NOT COMPLETED|Overall Study||12
6524704|NCT01576471|7445984|FG000|STARTED|Overall Study||125
6524705|NCT01576471|7445985|FG001|STARTED|Overall Study||125
6524706|NCT01576471|7445984|FG000|COMPLETED|Overall Study||117
6524707|NCT01576471|7445985|FG001|COMPLETED|Overall Study||116
6524708|NCT01576471|7445984|FG000|NOT COMPLETED|Overall Study||8
6524709|NCT01576471|7445985|FG001|NOT COMPLETED|Overall Study||9
6524710|NCT01576484|7445993|FG000|STARTED|Overall Study||12
6524711|NCT01576484|7445994|FG001|STARTED|Overall Study||46
6524712|NCT01576484|7445993|FG000|COMPLETED|Overall Study||7
6524713|NCT01576484|7445994|FG001|COMPLETED|Overall Study||27
6524714|NCT01576484|7445993|FG000|NOT COMPLETED|Overall Study||5
6524715|NCT01576484|7445994|FG001|NOT COMPLETED|Overall Study||19
6524716|NCT01576523|7446008|FG000|STARTED|Dosing Period 1||3
6524717|NCT01576523|7446009|FG001|STARTED|Dosing Period 1||3
6524718|NCT01576523|7446010|FG002|STARTED|Dosing Period 1||3
6524719|NCT01576523|7446011|FG003|STARTED|Dosing Period 1||3
6524720|NCT01576523|7446012|FG004|STARTED|Dosing Period 1||3
6524721|NCT01576523|7446013|FG005|STARTED|Dosing Period 1||3
6524722|NCT01576523|7446008|FG000|COMPLETED|Dosing Period 1||3
6524723|NCT01576523|7446009|FG001|COMPLETED|Dosing Period 1||3
6524724|NCT01576523|7446010|FG002|COMPLETED|Dosing Period 1||3
6524725|NCT01576523|7446011|FG003|COMPLETED|Dosing Period 1||3
6524726|NCT01576523|7446012|FG004|COMPLETED|Dosing Period 1||3
6524727|NCT01576523|7446013|FG005|COMPLETED|Dosing Period 1||3
6524728|NCT01576523|7446008|FG000|NOT COMPLETED|Dosing Period 1||0
6524729|NCT01576523|7446009|FG001|NOT COMPLETED|Dosing Period 1||0
6524730|NCT01576523|7446010|FG002|NOT COMPLETED|Dosing Period 1||0
6524731|NCT01576523|7446011|FG003|NOT COMPLETED|Dosing Period 1||0
6524732|NCT01576523|7446012|FG004|NOT COMPLETED|Dosing Period 1||0
6524733|NCT01576523|7446013|FG005|NOT COMPLETED|Dosing Period 1||0
6524734|NCT01576523|7446008|FG000|STARTED|Dosing Period 2||3
6524735|NCT01576523|7446009|FG001|STARTED|Dosing Period 2||3
6524736|NCT01576523|7446010|FG002|STARTED|Dosing Period 2||3
6524737|NCT01576523|7446011|FG003|STARTED|Dosing Period 2||3
6524738|NCT01576523|7446012|FG004|STARTED|Dosing Period 2||3
6524739|NCT01576523|7446013|FG005|STARTED|Dosing Period 2||3
6524740|NCT01576523|7446008|FG000|COMPLETED|Dosing Period 2||3
6524741|NCT01576523|7446009|FG001|COMPLETED|Dosing Period 2||3
6524742|NCT01576523|7446010|FG002|COMPLETED|Dosing Period 2||3
6524743|NCT01576523|7446011|FG003|COMPLETED|Dosing Period 2||3
6524744|NCT01576523|7446012|FG004|COMPLETED|Dosing Period 2||3
6524745|NCT01576523|7446013|FG005|COMPLETED|Dosing Period 2||3
6524746|NCT01576523|7446008|FG000|NOT COMPLETED|Dosing Period 2||0
6524747|NCT01576523|7446009|FG001|NOT COMPLETED|Dosing Period 2||0
6524748|NCT01576523|7446010|FG002|NOT COMPLETED|Dosing Period 2||0
6524749|NCT01576523|7446011|FG003|NOT COMPLETED|Dosing Period 2||0
6524750|NCT01576523|7446012|FG004|NOT COMPLETED|Dosing Period 2||0
6524751|NCT01576523|7446013|FG005|NOT COMPLETED|Dosing Period 2||0
6524752|NCT01576536|7446022|FG000|STARTED|Overall Study||117
6524753|NCT01576536|7446022|FG000|COMPLETED|Overall Study||117
6524754|NCT01576536|7446022|FG000|NOT COMPLETED|Overall Study||0
6524755|NCT01576588|7446026|FG000|STARTED|Overall Study||25
6524756|NCT01576588|7446026|FG000|COMPLETED|Overall Study||23
6524757|NCT01576588|7446026|FG000|NOT COMPLETED|Overall Study||2
6524758|NCT01576705|7446035|FG000|STARTED|Overall Study||43
6524759|NCT01576705|7446036|FG001|STARTED|Overall Study||45
6524760|NCT01576705|7446037|FG002|STARTED|Overall Study||43
6524761|NCT01576705|7446038|FG003|STARTED|Overall Study||44
6524762|NCT01576705|7446035|FG000|COMPLETED|Overall Study||40
6524763|NCT01576705|7446036|FG001|COMPLETED|Overall Study||37
6524764|NCT01576705|7446037|FG002|COMPLETED|Overall Study||38
6524765|NCT01576705|7446038|FG003|COMPLETED|Overall Study||41
6524766|NCT01576705|7446035|FG000|NOT COMPLETED|Overall Study||3
6524767|NCT01576705|7446036|FG001|NOT COMPLETED|Overall Study||8
6524768|NCT01576705|7446037|FG002|NOT COMPLETED|Overall Study||5
6524769|NCT01576705|7446038|FG003|NOT COMPLETED|Overall Study||3
6524770|NCT01576718|7446054|FG000|STARTED|Pre-Assignment Period (Run-In Placebo)||889
6524771|NCT01576718|7446055|FG001|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6524772|NCT01576718|7446056|FG002|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6524773|NCT01576718|7446057|FG003|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6524774|NCT01576718|7446058|FG004|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6524775|NCT01576718|7446059|FG005|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6524776|NCT01576718|7446060|FG006|STARTED|Pre-Assignment Period (Run-In Placebo)||0
6524777|NCT01576718|7446054|FG000|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
6524778|NCT01576718|7446055|FG001|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524779|NCT01576718|7446056|FG002|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524780|NCT01576718|7446057|FG003|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524781|NCT01576718|7446058|FG004|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524782|NCT01576718|7446059|FG005|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524783|NCT01576718|7446060|FG006|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524784|NCT01576718|7446054|FG000|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
6524785|NCT01576718|7446055|FG001|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524786|NCT01576718|7446056|FG002|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524787|NCT01576718|7446057|FG003|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524788|NCT01576718|7446058|FG004|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524789|NCT01576718|7446059|FG005|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524790|NCT01576718|7446060|FG006|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
6524791|NCT01576718|7446054|FG000|STARTED|Treatment Period||0
6524792|NCT01576718|7446055|FG001|STARTED|Treatment Period||107
6524793|NCT01576718|7446056|FG002|STARTED|Treatment Period||107
6524794|NCT01576718|7446057|FG003|STARTED|Treatment Period||106
6524795|NCT01576718|7446058|FG004|STARTED|Treatment Period||107
6524796|NCT01576718|7446059|FG005|STARTED|Treatment Period||106
6524797|NCT01576718|7446060|FG006|STARTED|Treatment Period||107
6524798|NCT01576718|7446054|FG000|Safety Population|Treatment Period||0
6524799|NCT01576718|7446055|FG001|Safety Population|Treatment Period||107
6524800|NCT01576718|7446056|FG002|Safety Population|Treatment Period||107
6524801|NCT01576718|7446057|FG003|Safety Population|Treatment Period||106
6524802|NCT01576718|7446058|FG004|Safety Population|Treatment Period||107
6524803|NCT01576718|7446059|FG005|Safety Population|Treatment Period||106
6524804|NCT01576718|7446060|FG006|Safety Population|Treatment Period||106
6524805|NCT01576718|7446054|FG000|Efficacy Population (Full Analysis Set)|Treatment Period||0
6524806|NCT01576718|7446055|FG001|Efficacy Population (Full Analysis Set)|Treatment Period||107
6524807|NCT01576718|7446056|FG002|Efficacy Population (Full Analysis Set)|Treatment Period||106
6524808|NCT01576718|7446057|FG003|Efficacy Population (Full Analysis Set)|Treatment Period||102
6524809|NCT01576718|7446058|FG004|Efficacy Population (Full Analysis Set)|Treatment Period||107
6524810|NCT01576718|7446059|FG005|Efficacy Population (Full Analysis Set)|Treatment Period||105
6524811|NCT01576718|7446060|FG006|Efficacy Population (Full Analysis Set)|Treatment Period||103
6524812|NCT01576718|7446054|FG000|COMPLETED|Treatment Period||0
6524813|NCT01576718|7446055|FG001|COMPLETED|Treatment Period||82
6524814|NCT01576718|7446056|FG002|COMPLETED|Treatment Period||87
6524815|NCT01576718|7446057|FG003|COMPLETED|Treatment Period||75
6524816|NCT01576718|7446058|FG004|COMPLETED|Treatment Period||80
6524817|NCT01576718|7446059|FG005|COMPLETED|Treatment Period||58
6524818|NCT01576718|7446060|FG006|COMPLETED|Treatment Period||77
6524819|NCT01576718|7446054|FG000|NOT COMPLETED|Treatment Period||0
6524820|NCT01576718|7446055|FG001|NOT COMPLETED|Treatment Period||25
6524821|NCT01576718|7446056|FG002|NOT COMPLETED|Treatment Period||20
6524822|NCT01576718|7446057|FG003|NOT COMPLETED|Treatment Period||31
6524823|NCT01576718|7446058|FG004|NOT COMPLETED|Treatment Period||27
6524824|NCT01576718|7446059|FG005|NOT COMPLETED|Treatment Period||48
6524825|NCT01576718|7446060|FG006|NOT COMPLETED|Treatment Period||30
6524826|NCT01576783|7446076|FG000|STARTED|Overall Study||189
6524827|NCT01576783|7446077|FG001|STARTED|Overall Study||188
6524828|NCT01576783|7446076|FG000|COMPLETED|Overall Study||169
6524829|NCT01576783|7446077|FG001|COMPLETED|Overall Study||171
6524830|NCT01576783|7446076|FG000|NOT COMPLETED|Overall Study||20
6524831|NCT01576783|7446077|FG001|NOT COMPLETED|Overall Study||17
6524832|NCT01576809|7446083|FG000|STARTED|Overall Study||51
6524833|NCT01576809|7446083|FG000|COMPLETED|Overall Study||51
6524834|NCT01576809|7446083|FG000|NOT COMPLETED|Overall Study||0
6524835|NCT01576874|7446089|FG000|STARTED|Overall Study||72
6524836|NCT01576874|7446090|FG001|STARTED|Overall Study||72
6524837|NCT01576874|7446089|FG000|COMPLETED|Overall Study||72
6524838|NCT01576874|7446090|FG001|COMPLETED|Overall Study||72
6524839|NCT01576874|7446089|FG000|NOT COMPLETED|Overall Study||0
6524840|NCT01576874|7446090|FG001|NOT COMPLETED|Overall Study||0
6524841|NCT01576939|7446096|FG000|STARTED|Overall Study||30
6524842|NCT01576939|7446096|FG000|COMPLETED|Overall Study||30
6524843|NCT01576939|7446096|FG000|NOT COMPLETED|Overall Study||0
6524844|NCT01576952|7446102|FG000|STARTED|Overall Study||180
6524845|NCT01576952|7446103|FG001|STARTED|Overall Study||88
6524846|NCT01576952|7446102|FG000|Safety Population|Overall Study||169
6524847|NCT01576952|7446103|FG001|Safety Population|Overall Study||85
6524848|NCT01576952|7446102|FG000|mITT Population|Overall Study||168
6524849|NCT01576952|7446103|FG001|mITT Population|Overall Study||85
6524850|NCT01576952|7446102|FG000|COMPLETED|Overall Study||139
6524851|NCT01576952|7446103|FG001|COMPLETED|Overall Study||33
6524852|NCT01576952|7446102|FG000|NOT COMPLETED|Overall Study||41
6524853|NCT01576952|7446103|FG001|NOT COMPLETED|Overall Study||55
6524854|NCT01577108|7446111|FG000|STARTED|Overall Study||54
6524855|NCT01577108|7446112|FG001|STARTED|Overall Study||56
6524856|NCT01577108|7446111|FG000|COMPLETED|Overall Study||49
6524857|NCT01577108|7446112|FG001|COMPLETED|Overall Study||50
6524858|NCT01577108|7446111|FG000|NOT COMPLETED|Overall Study||5
6524859|NCT01577108|7446112|FG001|NOT COMPLETED|Overall Study||6
6524860|NCT01577160|7446118|FG000|STARTED|Overall Study||353
6524861|NCT01577160|7446118|FG000|COMPLETED|Overall Study||255
6524862|NCT01577160|7446118|FG000|NOT COMPLETED|Overall Study||98
6524863|NCT01577186|7446122|FG000|STARTED|Overall Study||480
6524864|NCT01577186|7446122|FG000|COMPLETED|Overall Study||350
6524865|NCT01577186|7446122|FG000|NOT COMPLETED|Overall Study||130
6524866|NCT01577238|7446128|FG000|STARTED|Overall Study||127
6524867|NCT01577238|7446129|FG001|STARTED|Overall Study||123
6524868|NCT01577238|7446128|FG000|COMPLETED|Overall Study||117
6524869|NCT01577238|7446129|FG001|COMPLETED|Overall Study||111
6524870|NCT01577238|7446128|FG000|NOT COMPLETED|Overall Study||10
6524871|NCT01577238|7446129|FG001|NOT COMPLETED|Overall Study||12
6524872|NCT01577329|7446137|FG000|STARTED|Overall Study||19
6524873|NCT01577329|7446138|FG001|STARTED|Overall Study||22
6524874|NCT01577329|7446137|FG000|COMPLETED|Overall Study||16
6524875|NCT01577329|7446138|FG001|COMPLETED|Overall Study||22
6524876|NCT01577329|7446137|FG000|NOT COMPLETED|Overall Study||3
6524877|NCT01577329|7446138|FG001|NOT COMPLETED|Overall Study||0
6524878|NCT01577381|7446148|FG000|STARTED|Overall Study||2
6524879|NCT01577381|7446149|FG001|STARTED|Overall Study||3
6524880|NCT01577381|7446150|FG002|STARTED|Overall Study||3
6524881|NCT01577381|7446151|FG003|STARTED|Overall Study||2
6524882|NCT01577381|7446148|FG000|COMPLETED|Overall Study||0
6524883|NCT01577381|7446149|FG001|COMPLETED|Overall Study||0
6524884|NCT01577381|7446150|FG002|COMPLETED|Overall Study||0
6524885|NCT01577381|7446151|FG003|COMPLETED|Overall Study||0
6524886|NCT01577381|7446148|FG000|NOT COMPLETED|Overall Study||2
6524887|NCT01577381|7446149|FG001|NOT COMPLETED|Overall Study||3
6524888|NCT01577381|7446150|FG002|NOT COMPLETED|Overall Study||3
6524889|NCT01577381|7446151|FG003|NOT COMPLETED|Overall Study||2
6524890|NCT01577537|7446163|FG000|STARTED|Overall Study||128
6524891|NCT01577537|7446164|FG001|STARTED|Overall Study||123
6524892|NCT01577537|7446163|FG000|COMPLETED|Overall Study||120
6524893|NCT01577537|7446164|FG001|COMPLETED|Overall Study||116
6524894|NCT01577537|7446163|FG000|NOT COMPLETED|Overall Study||8
6524895|NCT01577537|7446164|FG001|NOT COMPLETED|Overall Study||7
6524896|NCT01577706|7446170|FG000|STARTED|First Intervention (1 Day)||3
6524897|NCT01577706|7446171|FG001|STARTED|First Intervention (1 Day)||1
6524898|NCT01577706|7446172|FG002|STARTED|First Intervention (1 Day)||3
6524899|NCT01577706|7446170|FG000|COMPLETED|First Intervention (1 Day)||3
6524900|NCT01577706|7446171|FG001|COMPLETED|First Intervention (1 Day)||1
6524901|NCT01577706|7446172|FG002|COMPLETED|First Intervention (1 Day)||3
6524902|NCT01577706|7446170|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6524903|NCT01577706|7446171|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6524904|NCT01577706|7446172|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6524905|NCT01577706|7446170|FG000|STARTED|Washout (at Least 1 Week)||3
6524906|NCT01577706|7446171|FG001|STARTED|Washout (at Least 1 Week)||1
6524907|NCT01577706|7446172|FG002|STARTED|Washout (at Least 1 Week)||3
6524908|NCT01577706|7446170|FG000|COMPLETED|Washout (at Least 1 Week)||3
6524909|NCT01577706|7446171|FG001|COMPLETED|Washout (at Least 1 Week)||1
6524910|NCT01577706|7446172|FG002|COMPLETED|Washout (at Least 1 Week)||3
6524911|NCT01577706|7446170|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
6524912|NCT01577706|7446171|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
6524913|NCT01577706|7446172|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
6524914|NCT01577706|7446170|FG000|STARTED|Second Intervention (1 Day)||3
6524915|NCT01577706|7446171|FG001|STARTED|Second Intervention (1 Day)||1
6524916|NCT01577706|7446172|FG002|STARTED|Second Intervention (1 Day)||3
6524917|NCT01577706|7446170|FG000|COMPLETED|Second Intervention (1 Day)||3
6524918|NCT01577706|7446171|FG001|COMPLETED|Second Intervention (1 Day)||1
6524919|NCT01577706|7446172|FG002|COMPLETED|Second Intervention (1 Day)||3
6524920|NCT01577706|7446170|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6524921|NCT01577706|7446171|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6524922|NCT01577706|7446172|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6524923|NCT01577706|7446170|FG000|STARTED|Washout (at Least 1 Week)||3
6524924|NCT01577706|7446171|FG001|STARTED|Washout (at Least 1 Week)||1
6524925|NCT01577706|7446172|FG002|STARTED|Washout (at Least 1 Week)||3
6524926|NCT01577706|7446170|FG000|COMPLETED|Washout (at Least 1 Week)||3
6524927|NCT01577706|7446171|FG001|COMPLETED|Washout (at Least 1 Week)||1
6524928|NCT01577706|7446172|FG002|COMPLETED|Washout (at Least 1 Week)||3
6524929|NCT01577706|7446170|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
6524930|NCT01577706|7446171|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
6524931|NCT01577706|7446172|FG002|NOT COMPLETED|Washout (at Least 1 Week)||0
6524932|NCT01577706|7446170|FG000|STARTED|Third Intervention (1 Day)||3
6524933|NCT01577706|7446171|FG001|STARTED|Third Intervention (1 Day)||1
6524934|NCT01577706|7446172|FG002|STARTED|Third Intervention (1 Day)||3
6524935|NCT01577706|7446170|FG000|COMPLETED|Third Intervention (1 Day)||3
6524936|NCT01577706|7446171|FG001|COMPLETED|Third Intervention (1 Day)||1
6524937|NCT01577706|7446172|FG002|COMPLETED|Third Intervention (1 Day)||3
6524938|NCT01577706|7446170|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6524939|NCT01577706|7446171|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6524940|NCT01577706|7446172|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6524941|NCT01577732|7446180|FG000|STARTED|Overall Study||300
6524942|NCT01577732|7446180|FG000|COMPLETED|Overall Study||300
6524943|NCT01577732|7446180|FG000|NOT COMPLETED|Overall Study||0
6524944|NCT01577745|7446190|FG000|STARTED|Overall Study||3
6524945|NCT01577745|7446191|FG001|STARTED|Overall Study||3
6524946|NCT01577745|7446192|FG002|STARTED|Overall Study||3
6524947|NCT01577745|7446193|FG003|STARTED|Overall Study||6
6524948|NCT01577745|7446194|FG004|STARTED|Overall Study||5
6524949|NCT01577745|7446195|FG005|STARTED|Overall Study||5
6524950|NCT01577745|7446190|FG000|COMPLETED|Overall Study||0
6524951|NCT01577745|7446191|FG001|COMPLETED|Overall Study||0
6524952|NCT01577745|7446192|FG002|COMPLETED|Overall Study||1
6524953|NCT01577745|7446193|FG003|COMPLETED|Overall Study||0
6524954|NCT01577745|7446194|FG004|COMPLETED|Overall Study||0
6524955|NCT01577745|7446195|FG005|COMPLETED|Overall Study||1
6524956|NCT01577745|7446190|FG000|NOT COMPLETED|Overall Study||3
6524957|NCT01577745|7446191|FG001|NOT COMPLETED|Overall Study||3
6524958|NCT01577745|7446192|FG002|NOT COMPLETED|Overall Study||2
6524959|NCT01577745|7446193|FG003|NOT COMPLETED|Overall Study||6
6524960|NCT01577745|7446194|FG004|NOT COMPLETED|Overall Study||5
6524961|NCT01577745|7446195|FG005|NOT COMPLETED|Overall Study||4
6524962|NCT01577758|7446214|FG000|STARTED|Dose Escalation Phase||2
6524963|NCT01577758|7446215|FG001|STARTED|Dose Escalation Phase||2
6524964|NCT01577758|7446216|FG002|STARTED|Dose Escalation Phase||2
6524965|NCT01577758|7446217|FG003|STARTED|Dose Escalation Phase||2
6524966|NCT01577758|7446218|FG004|STARTED|Dose Escalation Phase||6
6524967|NCT01577758|7446219|FG005|STARTED|Dose Escalation Phase||4
6524968|NCT01577758|7446220|FG006|STARTED|Dose Escalation Phase||1
6524969|NCT01577758|7446221|FG007|STARTED|Dose Escalation Phase||0
6524970|NCT01577758|7446214|FG000|COMPLETED|Dose Escalation Phase||0
6524971|NCT01577758|7446215|FG001|COMPLETED|Dose Escalation Phase||0
6524972|NCT01577758|7446216|FG002|COMPLETED|Dose Escalation Phase||0
6524973|NCT01577758|7446217|FG003|COMPLETED|Dose Escalation Phase||0
6524974|NCT01577758|7446218|FG004|COMPLETED|Dose Escalation Phase||0
6524975|NCT01577758|7446219|FG005|COMPLETED|Dose Escalation Phase||0
6524976|NCT01577758|7446220|FG006|COMPLETED|Dose Escalation Phase||0
6524977|NCT01577758|7446221|FG007|COMPLETED|Dose Escalation Phase||0
6524978|NCT01577758|7446214|FG000|NOT COMPLETED|Dose Escalation Phase||2
6524979|NCT01577758|7446215|FG001|NOT COMPLETED|Dose Escalation Phase||2
6524980|NCT01577758|7446216|FG002|NOT COMPLETED|Dose Escalation Phase||2
6524981|NCT01577758|7446217|FG003|NOT COMPLETED|Dose Escalation Phase||2
6524982|NCT01577758|7446218|FG004|NOT COMPLETED|Dose Escalation Phase||6
6524983|NCT01577758|7446219|FG005|NOT COMPLETED|Dose Escalation Phase||4
6524984|NCT01577758|7446220|FG006|NOT COMPLETED|Dose Escalation Phase||1
6524985|NCT01577758|7446221|FG007|NOT COMPLETED|Dose Escalation Phase||0
6524986|NCT01577758|7446214|FG000|STARTED|mCRC Expansion Phase||0
6524987|NCT01577758|7446215|FG001|STARTED|mCRC Expansion Phase||0
6524988|NCT01577758|7446216|FG002|STARTED|mCRC Expansion Phase||0
6524989|NCT01577758|7446217|FG003|STARTED|mCRC Expansion Phase||0
6524990|NCT01577758|7446218|FG004|STARTED|mCRC Expansion Phase||0
6524991|NCT01577758|7446219|FG005|STARTED|mCRC Expansion Phase||0
6524992|NCT01577758|7446220|FG006|STARTED|mCRC Expansion Phase||0
6524993|NCT01577758|7446221|FG007|STARTED|mCRC Expansion Phase||25
6524994|NCT01577758|7446214|FG000|COMPLETED|mCRC Expansion Phase||0
6524995|NCT01577758|7446215|FG001|COMPLETED|mCRC Expansion Phase||0
6524996|NCT01577758|7446216|FG002|COMPLETED|mCRC Expansion Phase||0
6524997|NCT01577758|7446217|FG003|COMPLETED|mCRC Expansion Phase||0
6524998|NCT01577758|7446218|FG004|COMPLETED|mCRC Expansion Phase||0
6524999|NCT01577758|7446219|FG005|COMPLETED|mCRC Expansion Phase||0
6525000|NCT01577758|7446220|FG006|COMPLETED|mCRC Expansion Phase||0
6525001|NCT01577758|7446221|FG007|COMPLETED|mCRC Expansion Phase||0
6525002|NCT01577758|7446214|FG000|NOT COMPLETED|mCRC Expansion Phase||0
6525003|NCT01577758|7446215|FG001|NOT COMPLETED|mCRC Expansion Phase||0
6525004|NCT01577758|7446216|FG002|NOT COMPLETED|mCRC Expansion Phase||0
6525005|NCT01577758|7446217|FG003|NOT COMPLETED|mCRC Expansion Phase||0
6525006|NCT01577758|7446218|FG004|NOT COMPLETED|mCRC Expansion Phase||0
6525007|NCT01577758|7446219|FG005|NOT COMPLETED|mCRC Expansion Phase||0
6525008|NCT01577758|7446220|FG006|NOT COMPLETED|mCRC Expansion Phase||0
6525009|NCT01577758|7446221|FG007|NOT COMPLETED|mCRC Expansion Phase||25
6525010|NCT01577966|7446241|FG000|STARTED|Overall Study||9
6525011|NCT01577966|7446241|FG000|COMPLETED|Overall Study||9
6525012|NCT01577966|7446241|FG000|NOT COMPLETED|Overall Study||0
6525013|NCT01578031|7446249|FG000|STARTED|Overall Study||129
6525014|NCT01578031|7446250|FG001|STARTED|Overall Study||69
6525015|NCT01578031|7446251|FG002|STARTED|Overall Study||12
6525016|NCT01578031|7446252|FG003|STARTED|Overall Study||30
6525017|NCT01578031|7446249|FG000|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
6525018|NCT01578031|7446250|FG001|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
6525019|NCT01578031|7446251|FG002|COMPLETED|Overall Study|Only baseline data collected|12
6525020|NCT01578031|7446252|FG003|COMPLETED|Overall Study|Only baseline data collected|30
6525021|NCT01578031|7446249|FG000|NOT COMPLETED|Overall Study||62
6525022|NCT01578031|7446250|FG001|NOT COMPLETED|Overall Study||34
6525023|NCT01578031|7446251|FG002|NOT COMPLETED|Overall Study||0
6525024|NCT01578031|7446252|FG003|NOT COMPLETED|Overall Study||0
6525025|NCT01578044|7446262|FG000|STARTED|Overall Study||6
6525026|NCT01578044|7446263|FG001|STARTED|Overall Study||6
6525027|NCT01578044|7446262|FG000|COMPLETED|Overall Study||6
6525028|NCT01578044|7446263|FG001|COMPLETED|Overall Study||6
6525029|NCT01578044|7446262|FG000|NOT COMPLETED|Overall Study||0
6525030|NCT01578044|7446263|FG001|NOT COMPLETED|Overall Study||0
6525031|NCT01578187|7446269|FG000|STARTED|Label Comprehension Phase||63
6525032|NCT01578187|7446269|FG000|COMPLETED|Label Comprehension Phase||63
6525033|NCT01578187|7446269|FG000|NOT COMPLETED|Label Comprehension Phase||0
6525034|NCT01578187|7446269|FG000|STARTED|Usability Phase||48
6525035|NCT01578187|7446269|FG000|COMPLETED|Usability Phase||47
6525036|NCT01578187|7446269|FG000|NOT COMPLETED|Usability Phase||1
6525037|NCT01578278|7446279|FG000|STARTED|Overall Study||152
6525038|NCT01578278|7446280|FG001|STARTED|Overall Study||152
6525039|NCT01578278|7446281|FG002|STARTED|Overall Study||154
6525040|NCT01578278|7446282|FG003|STARTED|Overall Study||148
6525041|NCT01578278|7446279|FG000|COMPLETED|Overall Study||148
6525042|NCT01578278|7446280|FG001|COMPLETED|Overall Study||150
6525043|NCT01578278|7446281|FG002|COMPLETED|Overall Study||150
6525044|NCT01578278|7446282|FG003|COMPLETED|Overall Study||139
6525045|NCT01578278|7446279|FG000|NOT COMPLETED|Overall Study||4
6525046|NCT01578278|7446280|FG001|NOT COMPLETED|Overall Study||2
6525047|NCT01578278|7446281|FG002|NOT COMPLETED|Overall Study||4
6525048|NCT01578278|7446282|FG003|NOT COMPLETED|Overall Study||9
6525049|NCT01578317|7446294|FG000|STARTED|Overall Study||22
6525050|NCT01578317|7446295|FG001|STARTED|Overall Study||21
6525051|NCT01578317|7446294|FG000|Analysis Population|Overall Study||22
6525052|NCT01578317|7446295|FG001|Analysis Population|Overall Study||20
6525053|NCT01578317|7446294|FG000|COMPLETED|Overall Study||22
6525054|NCT01578317|7446295|FG001|COMPLETED|Overall Study||20
6525055|NCT01578317|7446294|FG000|NOT COMPLETED|Overall Study||0
6525056|NCT01578317|7446295|FG001|NOT COMPLETED|Overall Study||1
6525057|NCT01578330|7446301|FG000|STARTED|Overall Study||42
6525058|NCT01578330|7446301|FG000|Per Protocol Population|Overall Study||35
6525059|NCT01578330|7446301|FG000|COMPLETED|Overall Study||35
6525060|NCT01578330|7446301|FG000|NOT COMPLETED|Overall Study||7
6525061|NCT01578486|7446305|FG000|STARTED|Overall Study||13
6525062|NCT01578486|7446305|FG000|COMPLETED|Overall Study||8
6525063|NCT01578486|7446305|FG000|NOT COMPLETED|Overall Study||5
6525064|NCT01578499|7446311|FG000|STARTED|Overall Study||66
6525065|NCT01578499|7446312|FG001|STARTED|Overall Study||65
6525066|NCT01578499|7446311|FG000|Safety Population: Treated|Overall Study||66
6525067|NCT01578499|7446312|FG001|Safety Population: Treated|Overall Study||62
6525068|NCT01578499|7446311|FG000|Intent to Treat Population: CD30+|Overall Study||64
6525069|NCT01578499|7446312|FG001|Intent to Treat Population: CD30+|Overall Study||64
6525070|NCT01578499|7446311|FG000|COMPLETED|Overall Study||32
6525071|NCT01578499|7446312|FG001|COMPLETED|Overall Study||22
6525072|NCT01578499|7446311|FG000|NOT COMPLETED|Overall Study||34
6525073|NCT01578499|7446312|FG001|NOT COMPLETED|Overall Study||43
6525074|NCT01578551|7446324|FG000|STARTED|Overall Study||19
6525075|NCT01578551|7446325|FG001|STARTED|Overall Study||6
6525076|NCT01578551|7446324|FG000|COMPLETED|Overall Study||18
6525077|NCT01578551|7446325|FG001|COMPLETED|Overall Study||6
6525078|NCT01578551|7446324|FG000|NOT COMPLETED|Overall Study||1
6525079|NCT01578551|7446325|FG001|NOT COMPLETED|Overall Study||0
6525080|NCT01578577|7446335|FG000|STARTED|Overall Study||305
6525081|NCT01578577|7446336|FG001|STARTED|Overall Study||302
6525082|NCT01578577|7446337|FG002|STARTED|Overall Study||313
6525083|NCT01578577|7446335|FG000|COMPLETED|Overall Study||254
6525084|NCT01578577|7446336|FG001|COMPLETED|Overall Study||262
6525085|NCT01578577|7446337|FG002|COMPLETED|Overall Study||278
6525086|NCT01578577|7446335|FG000|NOT COMPLETED|Overall Study||51
6525087|NCT01578577|7446336|FG001|NOT COMPLETED|Overall Study||40
6525088|NCT01578577|7446337|FG002|NOT COMPLETED|Overall Study||35
6525089|NCT01578707|7446357|FG000|STARTED|Overall Study||196
6525090|NCT01578707|7446358|FG001|STARTED|Overall Study||195
6525091|NCT01578707|7446357|FG000|COMPLETED|Overall Study||196
6525092|NCT01578707|7446358|FG001|COMPLETED|Overall Study||195
6525093|NCT01578707|7446357|FG000|NOT COMPLETED|Overall Study||0
6525094|NCT01578707|7446358|FG001|NOT COMPLETED|Overall Study||0
6525095|NCT01578772|7446364|FG000|STARTED|Overall Study||17
6525096|NCT01578772|7446364|FG000|COMPLETED|Overall Study||17
6525097|NCT01578772|7446364|FG000|NOT COMPLETED|Overall Study||0
6525098|NCT01578850|7446371|FG000|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
6525099|NCT01578850|7446372|FG001|STARTED|Period 1||0
6525100|NCT01578850|7446373|FG002|STARTED|Period 1||0
6525101|NCT01578850|7446371|FG000|COMPLETED|Period 1||452
6525102|NCT01578850|7446372|FG001|COMPLETED|Period 1||0
6525103|NCT01578850|7446373|FG002|COMPLETED|Period 1||0
6525104|NCT01578850|7446371|FG000|NOT COMPLETED|Period 1||37
6525105|NCT01578850|7446372|FG001|NOT COMPLETED|Period 1||0
6525106|NCT01578850|7446373|FG002|NOT COMPLETED|Period 1||0
6525107|NCT01578850|7446371|FG000|STARTED|Period 2||0
6525108|NCT01578850|7446372|FG001|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
6525109|NCT01578850|7446373|FG002|STARTED|Period 2|One participants in PBO did not receive treatment.|176
6525110|NCT01578850|7446371|FG000|COMPLETED|Period 2||0
6525111|NCT01578850|7446372|FG001|COMPLETED|Period 2||154
6525112|NCT01578850|7446373|FG002|COMPLETED|Period 2||162
6525113|NCT01578850|7446371|FG000|NOT COMPLETED|Period 2||0
6525114|NCT01578850|7446372|FG001|NOT COMPLETED|Period 2||13
6525115|NCT01578850|7446373|FG002|NOT COMPLETED|Period 2||14
6525116|NCT01578902|7446381|FG000|STARTED|Overall Study||84
6525117|NCT01578902|7446381|FG000|COMPLETED|Overall Study||84
6525118|NCT01578902|7446381|FG000|NOT COMPLETED|Overall Study||0
6525119|NCT01578980|7446388|FG000|STARTED|Overall Study||20
6525120|NCT01578980|7446388|FG000|COMPLETED|Overall Study||20
6525121|NCT01578980|7446388|FG000|NOT COMPLETED|Overall Study||0
6525122|NCT01578993|7446392|FG000|STARTED|Overall Study||101
6525123|NCT01578993|7446392|FG000|COMPLETED|Overall Study||101
6525124|NCT01578993|7446392|FG000|NOT COMPLETED|Overall Study||0
6525125|NCT01579006|7446396|FG000|STARTED|Overall Study||184
6525126|NCT01579006|7446396|FG000|COMPLETED|Overall Study||151
6525127|NCT01579006|7446396|FG000|NOT COMPLETED|Overall Study||33
6525128|NCT01579045|7446400|FG000|STARTED|Overall Study||24
6525129|NCT01579045|7446400|FG000|COMPLETED|Overall Study||24
6525130|NCT01579045|7446400|FG000|NOT COMPLETED|Overall Study||0
6525131|NCT01579084|7446422|FG000|STARTED|Overall Study||8
6525132|NCT01579084|7446423|FG001|STARTED|Overall Study||8
6525133|NCT01579084|7446424|FG002|STARTED|Overall Study||8
6525134|NCT01579084|7446425|FG003|STARTED|Overall Study||8
6525135|NCT01579084|7446426|FG004|STARTED|Overall Study||8
6525136|NCT01579084|7446427|FG005|STARTED|Overall Study||8
6525137|NCT01579084|7446428|FG006|STARTED|Overall Study||4
6525138|NCT01579084|7446429|FG007|STARTED|Overall Study||4
6525139|NCT01579084|7446430|FG008|STARTED|Overall Study||4
6525140|NCT01579084|7446431|FG009|STARTED|Overall Study||4
6525141|NCT01579084|7446422|FG000|COMPLETED|Overall Study||8
6525142|NCT01579084|7446423|FG001|COMPLETED|Overall Study||8
6525143|NCT01579084|7446424|FG002|COMPLETED|Overall Study||8
6525144|NCT01579084|7446425|FG003|COMPLETED|Overall Study||8
6525145|NCT01579084|7446426|FG004|COMPLETED|Overall Study||8
6525146|NCT01579084|7446427|FG005|COMPLETED|Overall Study||8
6525147|NCT01579084|7446428|FG006|COMPLETED|Overall Study||4
6525148|NCT01579084|7446429|FG007|COMPLETED|Overall Study||4
6525149|NCT01579084|7446430|FG008|COMPLETED|Overall Study||4
6525150|NCT01579084|7446431|FG009|COMPLETED|Overall Study||4
6525151|NCT01579084|7446422|FG000|NOT COMPLETED|Overall Study||0
6525152|NCT01579084|7446423|FG001|NOT COMPLETED|Overall Study||0
6525153|NCT01579084|7446424|FG002|NOT COMPLETED|Overall Study||0
6525154|NCT01579084|7446425|FG003|NOT COMPLETED|Overall Study||0
6525155|NCT01579084|7446426|FG004|NOT COMPLETED|Overall Study||0
6525156|NCT01579084|7446427|FG005|NOT COMPLETED|Overall Study||0
6525157|NCT01579084|7446428|FG006|NOT COMPLETED|Overall Study||0
6525158|NCT01579084|7446429|FG007|NOT COMPLETED|Overall Study||0
6525159|NCT01579084|7446430|FG008|NOT COMPLETED|Overall Study||0
6525160|NCT01579084|7446431|FG009|NOT COMPLETED|Overall Study||0
6525161|NCT01579162|7446452|FG000|STARTED|Overall Study||16
6525162|NCT01579162|7446453|FG001|STARTED|Overall Study||8
6525163|NCT01579162|7446454|FG002|STARTED|Overall Study||8
6525164|NCT01579162|7446455|FG003|STARTED|Overall Study||8
6525165|NCT01579162|7446456|FG004|STARTED|Overall Study||8
6525166|NCT01579162|7446452|FG000|COMPLETED|Overall Study||16
6525167|NCT01579162|7446453|FG001|COMPLETED|Overall Study||8
6525168|NCT01579162|7446454|FG002|COMPLETED|Overall Study||8
6525169|NCT01579162|7446455|FG003|COMPLETED|Overall Study||8
6525170|NCT01579162|7446456|FG004|COMPLETED|Overall Study||8
6525171|NCT01579162|7446452|FG000|NOT COMPLETED|Overall Study||0
6525172|NCT01579162|7446453|FG001|NOT COMPLETED|Overall Study||0
6525173|NCT01579162|7446454|FG002|NOT COMPLETED|Overall Study||0
6525174|NCT01579162|7446455|FG003|NOT COMPLETED|Overall Study||0
6525175|NCT01579162|7446456|FG004|NOT COMPLETED|Overall Study||0
6525176|NCT01579214|7446471|FG000|STARTED|Overall Study||45
6525177|NCT01579214|7446472|FG001|STARTED|Overall Study||138
6525178|NCT01579214|7446471|FG000|COMPLETED|Overall Study||45
6525179|NCT01579214|7446472|FG001|COMPLETED|Overall Study||138
6525180|NCT01579214|7446471|FG000|NOT COMPLETED|Overall Study||0
6525181|NCT01579214|7446472|FG001|NOT COMPLETED|Overall Study||0
6525182|NCT01579305|7446480|FG000|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
6525183|NCT01579305|7446481|FG001|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
6525184|NCT01579305|7446480|FG000|Discontinued Before Treatment|Overall Study||0
6525185|NCT01579305|7446481|FG001|Discontinued Before Treatment|Overall Study||1
6525186|NCT01579305|7446480|FG000|Continued After Treatment|Overall Study||139
6525187|NCT01579305|7446481|FG001|Continued After Treatment|Overall Study||141
6525188|NCT01579305|7446480|FG000|COMPLETED|Overall Study||118
6525189|NCT01579305|7446481|FG001|COMPLETED|Overall Study||115
6525190|NCT01579305|7446480|FG000|NOT COMPLETED|Overall Study||21
6525191|NCT01579305|7446481|FG001|NOT COMPLETED|Overall Study||27
6525192|NCT01579318|7446487|FG000|STARTED|Overall Study||2
6525193|NCT01579318|7446487|FG000|COMPLETED|Overall Study||1
6525194|NCT01579318|7446487|FG000|NOT COMPLETED|Overall Study||1
6525195|NCT01579474|7446497|FG000|STARTED|Overall Study||44
6525196|NCT01579474|7446498|FG001|STARTED|Overall Study||43
6525197|NCT01579474|7446499|FG002|STARTED|Overall Study||29
6525198|NCT01579474|7446500|FG003|STARTED|Overall Study||3
6525199|NCT01579474|7446501|FG004|STARTED|Overall Study||10
6525200|NCT01579474|7446502|FG005|STARTED|Overall Study||2
6525201|NCT01579474|7446497|FG000|COMPLETED|Overall Study||41
6525202|NCT01579474|7446498|FG001|COMPLETED|Overall Study||30
6525203|NCT01579474|7446499|FG002|COMPLETED|Overall Study||27
6525204|NCT01579474|7446500|FG003|COMPLETED|Overall Study||3
6525205|NCT01579474|7446501|FG004|COMPLETED|Overall Study||9
6525206|NCT01579474|7446502|FG005|COMPLETED|Overall Study||1
6525207|NCT01579474|7446497|FG000|NOT COMPLETED|Overall Study||3
6525208|NCT01579474|7446498|FG001|NOT COMPLETED|Overall Study||13
6525209|NCT01579474|7446499|FG002|NOT COMPLETED|Overall Study||2
6525210|NCT01579474|7446500|FG003|NOT COMPLETED|Overall Study||0
6525211|NCT01579474|7446501|FG004|NOT COMPLETED|Overall Study||1
6525212|NCT01579474|7446502|FG005|NOT COMPLETED|Overall Study||1
6525213|NCT01579513|7446517|FG000|STARTED|Primary Hospitalization||91
6525214|NCT01579513|7446518|FG001|STARTED|Primary Hospitalization||99
6525215|NCT01579513|7446517|FG000|COMPLETED|Primary Hospitalization||81
6525216|NCT01579513|7446518|FG001|COMPLETED|Primary Hospitalization||95
6525217|NCT01579513|7446517|FG000|NOT COMPLETED|Primary Hospitalization||10
6525218|NCT01579513|7446518|FG001|NOT COMPLETED|Primary Hospitalization||4
6525219|NCT01579513|7446517|FG000|STARTED|1 Year Neurodevelopmental Follow up||81
6525220|NCT01579513|7446518|FG001|STARTED|1 Year Neurodevelopmental Follow up||95
6525221|NCT01579513|7446517|FG000|COMPLETED|1 Year Neurodevelopmental Follow up||61
6525222|NCT01579513|7446518|FG001|COMPLETED|1 Year Neurodevelopmental Follow up||68
6525223|NCT01579513|7446517|FG000|NOT COMPLETED|1 Year Neurodevelopmental Follow up||20
6525224|NCT01579513|7446518|FG001|NOT COMPLETED|1 Year Neurodevelopmental Follow up||27
6525225|NCT01579565|7446526|FG000|STARTED|Randomized||207
6525226|NCT01579565|7446527|FG001|STARTED|Randomized||209
6525227|NCT01579565|7446526|FG000|COMPLETED|Randomized||202
6525228|NCT01579565|7446527|FG001|COMPLETED|Randomized||204
6525229|NCT01579565|7446526|FG000|NOT COMPLETED|Randomized||5
6525230|NCT01579565|7446527|FG001|NOT COMPLETED|Randomized||5
6525231|NCT01579565|7446526|FG000|STARTED|Treated||202
6525232|NCT01579565|7446527|FG001|STARTED|Treated||204
6525233|NCT01579565|7446526|FG000|COMPLETED|Treated||200
6525234|NCT01579565|7446527|FG001|COMPLETED|Treated||201
6525235|NCT01579565|7446526|FG000|NOT COMPLETED|Treated||2
6525236|NCT01579565|7446527|FG001|NOT COMPLETED|Treated||3
6525237|NCT01579578|7446537|FG000|STARTED|Overall Study||13
6525238|NCT01579578|7446538|FG001|STARTED|Overall Study||12
6525239|NCT01579578|7446537|FG000|Ongoing|Overall Study||3
6525240|NCT01579578|7446538|FG001|Ongoing|Overall Study||0
6525241|NCT01579578|7446537|FG000|COMPLETED|Overall Study||0
6525242|NCT01579578|7446538|FG001|COMPLETED|Overall Study||0
6525243|NCT01579578|7446537|FG000|NOT COMPLETED|Overall Study||13
6525244|NCT01579578|7446538|FG001|NOT COMPLETED|Overall Study||12
6525245|NCT01579669|7446546|FG000|STARTED|Overall Study||170
6525246|NCT01579669|7446547|FG001|STARTED|Overall Study||41
6525247|NCT01579669|7446546|FG000|COMPLETED|Overall Study||134
6525248|NCT01579669|7446547|FG001|COMPLETED|Overall Study||41
6525249|NCT01579669|7446546|FG000|NOT COMPLETED|Overall Study||36
6525250|NCT01579669|7446547|FG001|NOT COMPLETED|Overall Study||0
6525251|NCT01579747|7446555|FG000|STARTED|Overall Study||12
6525252|NCT01579747|7446556|FG001|STARTED|Overall Study||12
6525253|NCT01579747|7446555|FG000|COMPLETED|Overall Study||12
6525254|NCT01579747|7446556|FG001|COMPLETED|Overall Study||12
6525255|NCT01579747|7446555|FG000|NOT COMPLETED|Overall Study||0
6525256|NCT01579747|7446556|FG001|NOT COMPLETED|Overall Study||0
6525257|NCT01579812|7446562|FG000|STARTED|Overall Study||90
6525258|NCT01579812|7446562|FG000|COMPLETED|Overall Study||38
6525259|NCT01579812|7446562|FG000|NOT COMPLETED|Overall Study||52
6525260|NCT01579916|7446571|FG000|STARTED|Overall Study||242
6525261|NCT01579916|7446572|FG001|STARTED|Overall Study||61
6525262|NCT01579916|7446571|FG000|COMPLETED|Overall Study||234
6525263|NCT01579916|7446572|FG001|COMPLETED|Overall Study||59
6525264|NCT01579916|7446571|FG000|NOT COMPLETED|Overall Study||8
6525265|NCT01579916|7446572|FG001|NOT COMPLETED|Overall Study||2
6525266|NCT01580020|7446580|FG000|STARTED|Overall Study||52
6525267|NCT01580020|7446581|FG001|STARTED|Overall Study||40
6525268|NCT01580020|7446582|FG002|STARTED|Overall Study||61
6525269|NCT01580020|7446583|FG003|STARTED|Overall Study||22
6525270|NCT01580020|7446580|FG000|COMPLETED|Overall Study||51
6525271|NCT01580020|7446581|FG001|COMPLETED|Overall Study||33
6525272|NCT01580020|7446582|FG002|COMPLETED|Overall Study||57
6525273|NCT01580020|7446583|FG003|COMPLETED|Overall Study||20
6525274|NCT01580020|7446580|FG000|NOT COMPLETED|Overall Study||1
6525275|NCT01580020|7446581|FG001|NOT COMPLETED|Overall Study||7
6525276|NCT01580020|7446582|FG002|NOT COMPLETED|Overall Study||4
6525277|NCT01580020|7446583|FG003|NOT COMPLETED|Overall Study||2
6525278|NCT01580072|7446596|FG000|STARTED|Overall Study||28
6525279|NCT01580072|7446597|FG001|STARTED|Overall Study||37
6525280|NCT01580072|7446598|FG002|STARTED|Overall Study||0
6525281|NCT01580072|7446596|FG000|COMPLETED|Overall Study||16
6525282|NCT01580072|7446597|FG001|COMPLETED|Overall Study||28
6525283|NCT01580072|7446598|FG002|COMPLETED|Overall Study||0
6525284|NCT01580072|7446596|FG000|NOT COMPLETED|Overall Study||12
6525285|NCT01580072|7446597|FG001|NOT COMPLETED|Overall Study||9
6525286|NCT01580072|7446598|FG002|NOT COMPLETED|Overall Study||0
6525287|NCT01580098|7446608|FG000|STARTED|Overall Study||76
6525288|NCT01580098|7446609|FG001|STARTED|Overall Study||114
6525289|NCT01580098|7446610|FG002|STARTED|Overall Study||3
6525290|NCT01580098|7446608|FG000|COMPLETED|Overall Study||61
6525291|NCT01580098|7446609|FG001|COMPLETED|Overall Study||101
6525292|NCT01580098|7446610|FG002|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
6525293|NCT01580098|7446608|FG000|NOT COMPLETED|Overall Study||15
6525294|NCT01580098|7446609|FG001|NOT COMPLETED|Overall Study||13
6525295|NCT01580098|7446610|FG002|NOT COMPLETED|Overall Study||3
6525296|NCT01580293|7446624|FG000|STARTED|Part A_Main Trial||20
6525297|NCT01580293|7446625|FG001|STARTED|Part A_Main Trial||114
6525298|NCT01580293|7446626|FG002|STARTED|Part A_Main Trial|Participants in Part B were not counted for Part A|0
6525299|NCT01580293|7446624|FG000|COMPLETED|Part A_Main Trial||18
6525300|NCT01580293|7446625|FG001|COMPLETED|Part A_Main Trial||108
6525301|NCT01580293|7446626|FG002|COMPLETED|Part A_Main Trial||0
6525302|NCT01580293|7446624|FG000|NOT COMPLETED|Part A_Main Trial||2
6525303|NCT01580293|7446625|FG001|NOT COMPLETED|Part A_Main Trial||6
6525304|NCT01580293|7446626|FG002|NOT COMPLETED|Part A_Main Trial||0
6525305|NCT01580293|7446624|FG000|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|14
6525306|NCT01580293|7446625|FG001|STARTED|Part A_Extension|Not all participants from main trial entered extension or remained in the same arm.|107
6525307|NCT01580293|7446626|FG002|STARTED|Part A_Extension|Participants in Part B were not counted for part A|0
6525308|NCT01580293|7446624|FG000|COMPLETED|Part A_Extension||14
6525309|NCT01580293|7446625|FG001|COMPLETED|Part A_Extension||95
6525310|NCT01580293|7446626|FG002|COMPLETED|Part A_Extension||0
6525311|NCT01580293|7446624|FG000|NOT COMPLETED|Part A_Extension||0
6525312|NCT01580293|7446625|FG001|NOT COMPLETED|Part A_Extension||12
6525313|NCT01580293|7446626|FG002|NOT COMPLETED|Part A_Extension||0
6525314|NCT01580293|7446624|FG000|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
6525315|NCT01580293|7446625|FG001|STARTED|Part B|Time in Part A for 8 participants coming from Part A was not counted in part B.|0
6525316|NCT01580293|7446626|FG002|STARTED|Part B|11 participants were enrolled in Part B only, 8 participants switched from Part A to Part B.|19
6525317|NCT01580293|7446624|FG000|COMPLETED|Part B||0
6525318|NCT01580293|7446625|FG001|COMPLETED|Part B||0
6525319|NCT01580293|7446626|FG002|COMPLETED|Part B||17
6525320|NCT01580293|7446624|FG000|NOT COMPLETED|Part B||0
6525321|NCT01580293|7446625|FG001|NOT COMPLETED|Part B||0
6525322|NCT01580293|7446626|FG002|NOT COMPLETED|Part B||2
6525323|NCT01580306|7446657|FG000|STARTED|Overall Study||8
6525324|NCT01580306|7446658|FG001|STARTED|Overall Study||8
6525325|NCT01580306|7446659|FG002|STARTED|Overall Study||8
6525326|NCT01580306|7446660|FG003|STARTED|Overall Study||8
6525327|NCT01580306|7446657|FG000|COMPLETED|Overall Study||8
6525328|NCT01580306|7446658|FG001|COMPLETED|Overall Study||8
6525329|NCT01580306|7446659|FG002|COMPLETED|Overall Study||8
6525330|NCT01580306|7446660|FG003|COMPLETED|Overall Study||8
6525331|NCT01580306|7446657|FG000|NOT COMPLETED|Overall Study||0
6525332|NCT01580306|7446658|FG001|NOT COMPLETED|Overall Study||0
6525333|NCT01580306|7446659|FG002|NOT COMPLETED|Overall Study||0
6525334|NCT01580306|7446660|FG003|NOT COMPLETED|Overall Study||0
6525335|NCT01580410|7446672|FG000|STARTED|Overall Study||68
6525336|NCT01580410|7446673|FG001|STARTED|Overall Study||68
6525337|NCT01580410|7446672|FG000|COMPLETED|Overall Study||57
6525338|NCT01580410|7446673|FG001|COMPLETED|Overall Study||60
6525339|NCT01580410|7446672|FG000|NOT COMPLETED|Overall Study||11
6525340|NCT01580410|7446673|FG001|NOT COMPLETED|Overall Study||8
6525341|NCT01580423|7446679|FG000|STARTED|First Intervention||8
6525342|NCT01580423|7446680|FG001|STARTED|First Intervention||8
6525343|NCT01580423|7446679|FG000|COMPLETED|First Intervention||8
6525344|NCT01580423|7446680|FG001|COMPLETED|First Intervention||8
6525345|NCT01580423|7446679|FG000|NOT COMPLETED|First Intervention||0
6525346|NCT01580423|7446680|FG001|NOT COMPLETED|First Intervention||0
6525347|NCT01580423|7446679|FG000|STARTED|Second Intervention||8
6525348|NCT01580423|7446680|FG001|STARTED|Second Intervention||8
6525349|NCT01580423|7446679|FG000|COMPLETED|Second Intervention||8
6525350|NCT01580423|7446680|FG001|COMPLETED|Second Intervention||8
6525351|NCT01580423|7446679|FG000|NOT COMPLETED|Second Intervention||0
6525352|NCT01580423|7446680|FG001|NOT COMPLETED|Second Intervention||0
6525353|NCT01580488|7446687|FG000|STARTED|Overall Study||24
6525354|NCT01580488|7446687|FG000|COMPLETED|Overall Study||23
6525355|NCT01580488|7446687|FG000|NOT COMPLETED|Overall Study||1
6525356|NCT01580592|7446704|FG000|STARTED|Overall Study||10
6525357|NCT01580592|7446705|FG001|STARTED|Overall Study||9
6525358|NCT01580592|7446706|FG002|STARTED|Overall Study||12
6525359|NCT01580592|7446704|FG000|COMPLETED|Overall Study||10
6525360|NCT01580592|7446705|FG001|COMPLETED|Overall Study||9
6525361|NCT01580592|7446706|FG002|COMPLETED|Overall Study||12
6525362|NCT01580592|7446704|FG000|NOT COMPLETED|Overall Study||0
6525363|NCT01580592|7446705|FG001|NOT COMPLETED|Overall Study||0
6525364|NCT01580592|7446706|FG002|NOT COMPLETED|Overall Study||0
6525365|NCT01580618|7446716|FG000|STARTED|Overall Study||8
6525366|NCT01580618|7446717|FG001|STARTED|Overall Study||12
6525367|NCT01580618|7446716|FG000|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
6525368|NCT01580618|7446717|FG001|COMPLETED|Overall Study||12
6525369|NCT01580618|7446716|FG000|NOT COMPLETED|Overall Study||1
6525370|NCT01580618|7446717|FG001|NOT COMPLETED|Overall Study||0
6561759|NCT01796912|7484652|FG000|COMPLETED|First Intervention||10
6561760|NCT01796912|7484653|FG001|COMPLETED|First Intervention||10
6561761|NCT01796912|7484652|FG000|NOT COMPLETED|First Intervention||0
6561762|NCT01796912|7484653|FG001|NOT COMPLETED|First Intervention||0
6561763|NCT01796912|7484652|FG000|STARTED|Washout||10
6561764|NCT01796912|7484653|FG001|STARTED|Washout||10
6561765|NCT01796912|7484652|FG000|COMPLETED|Washout||10
6561766|NCT01796912|7484653|FG001|COMPLETED|Washout||10
6561767|NCT01796912|7484652|FG000|NOT COMPLETED|Washout||0
6561768|NCT01796912|7484653|FG001|NOT COMPLETED|Washout||0
6561769|NCT01796912|7484652|FG000|STARTED|Second Intervention||10
6561770|NCT01796912|7484653|FG001|STARTED|Second Intervention||10
6561771|NCT01796912|7484652|FG000|COMPLETED|Second Intervention||10
6561772|NCT01796912|7484653|FG001|COMPLETED|Second Intervention||10
6561773|NCT01796912|7484652|FG000|NOT COMPLETED|Second Intervention||0
6561774|NCT01796912|7484653|FG001|NOT COMPLETED|Second Intervention||0
6561775|NCT01796964|7484663|FG000|STARTED|Overall Study||44
6561776|NCT01796964|7484664|FG001|STARTED|Overall Study||45
6561777|NCT01796964|7484663|FG000|COMPLETED|Overall Study||41
6561778|NCT01796964|7484664|FG001|COMPLETED|Overall Study||42
6561779|NCT01796964|7484663|FG000|NOT COMPLETED|Overall Study||3
6561780|NCT01796964|7484664|FG001|NOT COMPLETED|Overall Study||3
6561781|NCT01796977|7484671|FG000|STARTED|Overall Study||27
6561782|NCT01796977|7484671|FG000|COMPLETED|Overall Study||27
6561783|NCT01796977|7484671|FG000|NOT COMPLETED|Overall Study||0
6561784|NCT01797029|7484682|FG000|STARTED|Overall Study||1174
6561785|NCT01797029|7484683|FG001|STARTED|Overall Study||587
6561786|NCT01797029|7484682|FG000|COMPLETED|Overall Study||1015
6561787|NCT01797029|7484683|FG001|COMPLETED|Overall Study||526
6561788|NCT01797029|7484682|FG000|NOT COMPLETED|Overall Study||159
6561789|NCT01797029|7484683|FG001|NOT COMPLETED|Overall Study||61
6561790|NCT01797081|7484693|FG000|STARTED|Overall Study||104
6561791|NCT01797081|7484694|FG001|STARTED|Overall Study||99
6561792|NCT01797081|7484695|FG002|STARTED|Overall Study||48
6561793|NCT01797081|7484696|FG003|STARTED|Overall Study||49
6561794|NCT01797081|7484693|FG000|COMPLETED|Overall Study||90
6561795|NCT01797081|7484694|FG001|COMPLETED|Overall Study||95
6561796|NCT01797081|7484695|FG002|COMPLETED|Overall Study||43
6561797|NCT01797081|7484696|FG003|COMPLETED|Overall Study||40
6561798|NCT01797081|7484693|FG000|NOT COMPLETED|Overall Study||14
6561799|NCT01797081|7484694|FG001|NOT COMPLETED|Overall Study||4
6561800|NCT01797081|7484695|FG002|NOT COMPLETED|Overall Study||5
6561801|NCT01797081|7484696|FG003|NOT COMPLETED|Overall Study||9
6561802|NCT01797094|7484706|FG000|STARTED|Overall Study||48
6561803|NCT01797094|7484707|FG001|STARTED|Overall Study||53
6561804|NCT01797094|7484706|FG000|COMPLETED|Overall Study||42
6561805|NCT01797094|7484707|FG001|COMPLETED|Overall Study||51
6561806|NCT01797094|7484706|FG000|NOT COMPLETED|Overall Study||6
6561807|NCT01797094|7484707|FG001|NOT COMPLETED|Overall Study||2
6561808|NCT01797120|7484715|FG000|STARTED|Overall Study||66
6561809|NCT01797120|7484716|FG001|STARTED|Overall Study||65
6561810|NCT01797120|7484715|FG000|COMPLETED|Overall Study||0
6561811|NCT01797120|7484716|FG001|COMPLETED|Overall Study||0
6561812|NCT01797120|7484715|FG000|NOT COMPLETED|Overall Study||66
6561813|NCT01797120|7484716|FG001|NOT COMPLETED|Overall Study||65
6561814|NCT01797159|7484722|FG000|STARTED|Overall Study||20
6561815|NCT01797159|7484722|FG000|COMPLETED|Overall Study||20
6561816|NCT01797159|7484722|FG000|NOT COMPLETED|Overall Study||0
6561817|NCT01797185|7484730|FG000|STARTED|Overall Study||162
6561818|NCT01797185|7484731|FG001|STARTED|Overall Study||163
6525371|NCT01580670|7446723|FG000|STARTED|Induction Period (Week 0 to 14)||14
6525372|NCT01580670|7446723|FG000|COMPLETED|Induction Period (Week 0 to 14)||14
6525373|NCT01580670|7446723|FG000|NOT COMPLETED|Induction Period (Week 0 to 14)||0
6525374|NCT01580670|7446723|FG000|STARTED|Maintenance Period (Week 14 to 54)||14
6525375|NCT01580670|7446723|FG000|COMPLETED|Maintenance Period (Week 14 to 54)||12
6525376|NCT01580670|7446723|FG000|NOT COMPLETED|Maintenance Period (Week 14 to 54)||2
6525377|NCT01580904|7446729|FG000|STARTED|Overall Study||51
6525378|NCT01580904|7446730|FG001|STARTED|Overall Study||49
6525379|NCT01580904|7446729|FG000|COMPLETED|Overall Study||47
6525380|NCT01580904|7446730|FG001|COMPLETED|Overall Study||42
6525381|NCT01580904|7446729|FG000|NOT COMPLETED|Overall Study||4
6525382|NCT01580904|7446730|FG001|NOT COMPLETED|Overall Study||7
6525383|NCT01580969|7446740|FG000|STARTED|Overall Study||6
6525384|NCT01580969|7446741|FG001|STARTED|Overall Study||3
6525385|NCT01580969|7446742|FG002|STARTED|Overall Study||13
6525386|NCT01580969|7446740|FG000|COMPLETED|Overall Study||3
6525387|NCT01580969|7446741|FG001|COMPLETED|Overall Study||3
6525388|NCT01580969|7446742|FG002|COMPLETED|Overall Study||13
6525389|NCT01580969|7446740|FG000|NOT COMPLETED|Overall Study||3
6525390|NCT01580969|7446741|FG001|NOT COMPLETED|Overall Study||0
6525391|NCT01580969|7446742|FG002|NOT COMPLETED|Overall Study||0
6525392|NCT01580995|7446752|FG000|STARTED|Overall Study||10
6525393|NCT01580995|7446753|FG001|STARTED|Overall Study||9
6525394|NCT01580995|7446752|FG000|COMPLETED|Overall Study||8
6525395|NCT01580995|7446753|FG001|COMPLETED|Overall Study||7
6525396|NCT01580995|7446752|FG000|NOT COMPLETED|Overall Study||2
6525397|NCT01580995|7446753|FG001|NOT COMPLETED|Overall Study||2
6525398|NCT01581008|7446761|FG000|STARTED|Overall Study||17
6525399|NCT01581008|7446762|FG001|STARTED|Overall Study||13
6525400|NCT01581008|7446761|FG000|COMPLETED|Overall Study||16
6525401|NCT01581008|7446762|FG001|COMPLETED|Overall Study||7
6525402|NCT01581008|7446761|FG000|NOT COMPLETED|Overall Study||1
6525403|NCT01581008|7446762|FG001|NOT COMPLETED|Overall Study||6
6525404|NCT01581021|7446771|FG000|STARTED|Overall Study||29
6525405|NCT01581021|7446772|FG001|STARTED|Overall Study||29
6525406|NCT01581021|7446771|FG000|COMPLETED|Overall Study||19
6525407|NCT01581021|7446772|FG001|COMPLETED|Overall Study||18
6525408|NCT01581021|7446771|FG000|NOT COMPLETED|Overall Study||10
6525409|NCT01581021|7446772|FG001|NOT COMPLETED|Overall Study||11
6525410|NCT01581281|7446781|FG000|STARTED|Overall Study||145
6525411|NCT01581281|7446782|FG001|STARTED|Overall Study||72
6525412|NCT01581281|7446783|FG002|STARTED|Overall Study||144
6525413|NCT01581281|7446781|FG000|COMPLETED|Overall Study||130
6525414|NCT01581281|7446782|FG001|COMPLETED|Overall Study||66
6525415|NCT01581281|7446783|FG002|COMPLETED|Overall Study||132
6525416|NCT01581281|7446781|FG000|NOT COMPLETED|Overall Study||15
6525417|NCT01581281|7446782|FG001|NOT COMPLETED|Overall Study||6
6525418|NCT01581281|7446783|FG002|NOT COMPLETED|Overall Study||12
6525419|NCT01581307|7446792|FG000|STARTED|Overall Study||9
6525420|NCT01581307|7446792|FG000|COMPLETED|Overall Study||8
6525421|NCT01581307|7446792|FG000|NOT COMPLETED|Overall Study||1
6525422|NCT01581437|7446796|FG000|STARTED|Overall Study||78
6525423|NCT01581437|7446796|FG000|COMPLETED|Overall Study||78
6525424|NCT01581437|7446796|FG000|NOT COMPLETED|Overall Study||0
6525425|NCT01581541|7446804|FG000|STARTED|Overall Study||1
6525426|NCT01581541|7446805|FG001|STARTED|Overall Study||1
6525427|NCT01581541|7446806|FG002|STARTED|Overall Study||1
6525428|NCT01581541|7446807|FG003|STARTED|Overall Study||1
6525429|NCT01581541|7446808|FG004|STARTED|Overall Study||2
6525430|NCT01581541|7446809|FG005|STARTED|Overall Study||3
6525431|NCT01581541|7446810|FG006|STARTED|Overall Study||1
6525432|NCT01581541|7446811|FG007|STARTED|Overall Study||2
6525433|NCT01581541|7446812|FG008|STARTED|Overall Study||1
6525434|NCT01581541|7446813|FG009|STARTED|Overall Study||3
6525435|NCT01581541|7446814|FG010|STARTED|Overall Study||1
6525436|NCT01581541|7446804|FG000|COMPLETED|Overall Study||1
6525437|NCT01581541|7446805|FG001|COMPLETED|Overall Study||1
6525438|NCT01581541|7446806|FG002|COMPLETED|Overall Study||1
6525439|NCT01581541|7446807|FG003|COMPLETED|Overall Study||1
6525440|NCT01581541|7446808|FG004|COMPLETED|Overall Study||2
6525441|NCT01581541|7446809|FG005|COMPLETED|Overall Study||3
6525442|NCT01581541|7446810|FG006|COMPLETED|Overall Study||1
6525443|NCT01581541|7446811|FG007|COMPLETED|Overall Study||2
6525444|NCT01581541|7446812|FG008|COMPLETED|Overall Study||1
6525445|NCT01581541|7446813|FG009|COMPLETED|Overall Study||3
6525446|NCT01581541|7446814|FG010|COMPLETED|Overall Study||1
6525447|NCT01581541|7446804|FG000|NOT COMPLETED|Overall Study||0
6525448|NCT01581541|7446805|FG001|NOT COMPLETED|Overall Study||0
6525449|NCT01581541|7446806|FG002|NOT COMPLETED|Overall Study||0
6525450|NCT01581541|7446807|FG003|NOT COMPLETED|Overall Study||0
6525451|NCT01581541|7446808|FG004|NOT COMPLETED|Overall Study||0
6525452|NCT01581541|7446809|FG005|NOT COMPLETED|Overall Study||0
6525453|NCT01581541|7446810|FG006|NOT COMPLETED|Overall Study||0
6525454|NCT01581541|7446811|FG007|NOT COMPLETED|Overall Study||0
6525455|NCT01581541|7446812|FG008|NOT COMPLETED|Overall Study||0
6525456|NCT01581541|7446813|FG009|NOT COMPLETED|Overall Study||0
6525457|NCT01581541|7446814|FG010|NOT COMPLETED|Overall Study||0
6525458|NCT01581593|7446839|FG000|STARTED|Overall Study||45
6525459|NCT01581593|7446839|FG000|COMPLETED|Overall Study||44
6525460|NCT01581593|7446839|FG000|NOT COMPLETED|Overall Study||1
6525461|NCT01581619|7446847|FG000|STARTED|Overall Study||54
6525462|NCT01581619|7446847|FG000|COMPLETED|Overall Study||52
6525463|NCT01581619|7446847|FG000|NOT COMPLETED|Overall Study||2
6525464|NCT01581658|7446857|FG000|STARTED|Overall Study||8
6525465|NCT01581658|7446858|FG001|STARTED|Overall Study||8
6525466|NCT01581658|7446859|FG002|STARTED|Overall Study||8
6525467|NCT01581658|7446860|FG003|STARTED|Overall Study||8
6525468|NCT01581658|7446857|FG000|COMPLETED|Overall Study||8
6525469|NCT01581658|7446858|FG001|COMPLETED|Overall Study||8
6525470|NCT01581658|7446859|FG002|COMPLETED|Overall Study||8
6525471|NCT01581658|7446860|FG003|COMPLETED|Overall Study||8
6525472|NCT01581658|7446857|FG000|NOT COMPLETED|Overall Study||0
6525473|NCT01581658|7446858|FG001|NOT COMPLETED|Overall Study||0
6525474|NCT01581658|7446859|FG002|NOT COMPLETED|Overall Study||0
6525475|NCT01581658|7446860|FG003|NOT COMPLETED|Overall Study||0
6525476|NCT01581684|7446880|FG000|STARTED|Overall Study||14
6525477|NCT01581684|7446881|FG001|STARTED|Overall Study||6
6525478|NCT01581684|7446882|FG002|STARTED|Overall Study||6
6525479|NCT01581684|7446883|FG003|STARTED|Overall Study||6
6525480|NCT01581684|7446884|FG004|STARTED|Overall Study||6
6525481|NCT01581684|7446885|FG005|STARTED|Overall Study||6
6525482|NCT01581684|7446886|FG006|STARTED|Overall Study||6
6525483|NCT01581684|7446887|FG007|STARTED|Overall Study||6
6525484|NCT01581684|7446888|FG008|STARTED|Overall Study||1
6525485|NCT01581684|7446889|FG009|STARTED|Overall Study||5
6525486|NCT01581684|7446880|FG000|COMPLETED|Overall Study||14
6525487|NCT01581684|7446881|FG001|COMPLETED|Overall Study||6
6525488|NCT01581684|7446882|FG002|COMPLETED|Overall Study||6
6525489|NCT01581684|7446883|FG003|COMPLETED|Overall Study||6
6525490|NCT01581684|7446884|FG004|COMPLETED|Overall Study||6
6525491|NCT01581684|7446885|FG005|COMPLETED|Overall Study||6
6525492|NCT01581684|7446886|FG006|COMPLETED|Overall Study||6
6525493|NCT01581684|7446887|FG007|COMPLETED|Overall Study||6
6525494|NCT01581684|7446888|FG008|COMPLETED|Overall Study||0
6525495|NCT01581684|7446889|FG009|COMPLETED|Overall Study||5
6525496|NCT01581684|7446880|FG000|NOT COMPLETED|Overall Study||0
6525497|NCT01581684|7446881|FG001|NOT COMPLETED|Overall Study||0
6525498|NCT01581684|7446882|FG002|NOT COMPLETED|Overall Study||0
6525499|NCT01581684|7446883|FG003|NOT COMPLETED|Overall Study||0
6525500|NCT01581684|7446884|FG004|NOT COMPLETED|Overall Study||0
6525501|NCT01581684|7446885|FG005|NOT COMPLETED|Overall Study||0
6525502|NCT01581684|7446886|FG006|NOT COMPLETED|Overall Study||0
6525503|NCT01581684|7446887|FG007|NOT COMPLETED|Overall Study||0
6525504|NCT01581684|7446888|FG008|NOT COMPLETED|Overall Study||1
6525505|NCT01581684|7446889|FG009|NOT COMPLETED|Overall Study||0
6525506|NCT01581710|7446922|FG000|STARTED|First Intervention (14days)||18
6525507|NCT01581710|7446923|FG001|STARTED|First Intervention (14days)||14
6525508|NCT01581710|7446922|FG000|COMPLETED|First Intervention (14days)||18
6525509|NCT01581710|7446923|FG001|COMPLETED|First Intervention (14days)||14
6525510|NCT01581710|7446922|FG000|NOT COMPLETED|First Intervention (14days)||0
6525511|NCT01581710|7446923|FG001|NOT COMPLETED|First Intervention (14days)||0
6525512|NCT01581710|7446922|FG000|STARTED|Washout Period (14days)||18
6525513|NCT01581710|7446923|FG001|STARTED|Washout Period (14days)||14
6525514|NCT01581710|7446922|FG000|COMPLETED|Washout Period (14days)||18
6525515|NCT01581710|7446923|FG001|COMPLETED|Washout Period (14days)||14
6525516|NCT01581710|7446922|FG000|NOT COMPLETED|Washout Period (14days)||0
6525517|NCT01581710|7446923|FG001|NOT COMPLETED|Washout Period (14days)||0
6525518|NCT01581710|7446922|FG000|STARTED|Second Intervention (14days)||18
6525519|NCT01581710|7446923|FG001|STARTED|Second Intervention (14days)||14
6525520|NCT01581710|7446922|FG000|COMPLETED|Second Intervention (14days)||18
6525521|NCT01581710|7446923|FG001|COMPLETED|Second Intervention (14days)||12
6525522|NCT01581710|7446922|FG000|NOT COMPLETED|Second Intervention (14days)||0
6525523|NCT01581710|7446923|FG001|NOT COMPLETED|Second Intervention (14days)||2
6525524|NCT01581931|7446933|FG000|STARTED|First Period||16
6525525|NCT01581931|7446934|FG001|STARTED|First Period||16
6525526|NCT01581931|7446933|FG000|COMPLETED|First Period||16
6525527|NCT01581931|7446934|FG001|COMPLETED|First Period||16
6525528|NCT01581931|7446933|FG000|NOT COMPLETED|First Period||0
6525529|NCT01581931|7446934|FG001|NOT COMPLETED|First Period||0
6525530|NCT01581931|7446933|FG000|STARTED|Washout||16
6525531|NCT01581931|7446934|FG001|STARTED|Washout||16
6525532|NCT01581931|7446933|FG000|COMPLETED|Washout||16
6525533|NCT01581931|7446934|FG001|COMPLETED|Washout||15
6525534|NCT01581931|7446933|FG000|NOT COMPLETED|Washout||0
6525535|NCT01581931|7446934|FG001|NOT COMPLETED|Washout||1
6525536|NCT01581931|7446933|FG000|STARTED|Second Period||16
6525537|NCT01581931|7446934|FG001|STARTED|Second Period||15
6525538|NCT01581931|7446933|FG000|COMPLETED|Second Period||16
6525539|NCT01581931|7446934|FG001|COMPLETED|Second Period||15
6525540|NCT01581931|7446933|FG000|NOT COMPLETED|Second Period||0
6525541|NCT01581931|7446934|FG001|NOT COMPLETED|Second Period||0
6525542|NCT01581970|7446940|FG000|STARTED|Overall Study||7
6525543|NCT01581970|7446940|FG000|COMPLETED|Overall Study||7
6525544|NCT01581970|7446940|FG000|NOT COMPLETED|Overall Study||0
6525545|NCT01582009|7446944|FG000|STARTED|Overall Study||26
6525546|NCT01582009|7446944|FG000|COMPLETED|Overall Study||24
6525547|NCT01582009|7446944|FG000|NOT COMPLETED|Overall Study||2
6525548|NCT01582061|7446950|FG000|STARTED|Overall Study||49
6525549|NCT01582061|7446951|FG001|STARTED|Overall Study||55
6525550|NCT01582061|7446950|FG000|COMPLETED|Overall Study||21
6525551|NCT01582061|7446951|FG001|COMPLETED|Overall Study||19
6525552|NCT01582061|7446950|FG000|NOT COMPLETED|Overall Study||28
6525553|NCT01582061|7446951|FG001|NOT COMPLETED|Overall Study||36
6525554|NCT01582139|7446969|FG000|STARTED|Overall Study||6
6525555|NCT01582139|7446970|FG001|STARTED|Overall Study||6
6525556|NCT01582139|7446969|FG000|COMPLETED|Overall Study||6
6525557|NCT01582139|7446970|FG001|COMPLETED|Overall Study||6
6525558|NCT01582139|7446969|FG000|NOT COMPLETED|Overall Study||0
6525559|NCT01582139|7446970|FG001|NOT COMPLETED|Overall Study||0
6525560|NCT01582152|7446978|FG000|STARTED|Overall Study||6
6525561|NCT01582152|7446979|FG001|STARTED|Overall Study||6
6525562|NCT01582152|7446978|FG000|COMPLETED|Overall Study||0
6525563|NCT01582152|7446979|FG001|COMPLETED|Overall Study||0
6525564|NCT01582152|7446978|FG000|NOT COMPLETED|Overall Study||6
6525565|NCT01582152|7446979|FG001|NOT COMPLETED|Overall Study||6
6525566|NCT01582178|7446987|FG000|STARTED|Overall Study||106
6525567|NCT01582178|7446988|FG001|STARTED|Overall Study||106
6525568|NCT01582178|7446987|FG000|COMPLETED|Overall Study||100
6525569|NCT01582178|7446988|FG001|COMPLETED|Overall Study||101
6525570|NCT01582178|7446987|FG000|NOT COMPLETED|Overall Study||6
6525571|NCT01582178|7446988|FG001|NOT COMPLETED|Overall Study||5
6525572|NCT01582243|7446994|FG000|STARTED|Overall Study||40
6525573|NCT01582243|7446994|FG000|COMPLETED|Overall Study||37
6525574|NCT01582243|7446994|FG000|NOT COMPLETED|Overall Study||3
6525575|NCT01582282|7447001|FG000|STARTED|Overall Study||15
6525576|NCT01582282|7447002|FG001|STARTED|Overall Study||14
6525577|NCT01582282|7447003|FG002|STARTED|Overall Study||8
6525578|NCT01582282|7447001|FG000|COMPLETED|Overall Study||13
6525579|NCT01582282|7447002|FG001|COMPLETED|Overall Study||12
6525580|NCT01582282|7447003|FG002|COMPLETED|Overall Study||8
6525581|NCT01582282|7447001|FG000|NOT COMPLETED|Overall Study||2
6525582|NCT01582282|7447002|FG001|NOT COMPLETED|Overall Study||2
6525583|NCT01582282|7447003|FG002|NOT COMPLETED|Overall Study||0
6525584|NCT01582308|7447011|FG000|STARTED|Period 1||2
6525585|NCT01582308|7447012|FG001|STARTED|Period 1||2
6525586|NCT01582308|7447013|FG002|STARTED|Period 1||2
6525587|NCT01582308|7447014|FG003|STARTED|Period 1||2
6525588|NCT01582308|7447015|FG004|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
6525589|NCT01582308|7447016|FG005|STARTED|Period 1||2
6525590|NCT01582308|7447017|FG006|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
6525591|NCT01582308|7447018|FG007|STARTED|Period 1||2
6525592|NCT01582308|7447019|FG008|STARTED|Period 1||2
6525593|NCT01582308|7447020|FG009|STARTED|Period 1||2
6525594|NCT01582308|7447011|FG000|COMPLETED|Period 1||2
6525595|NCT01582308|7447012|FG001|COMPLETED|Period 1||2
6525596|NCT01582308|7447013|FG002|COMPLETED|Period 1||2
6525597|NCT01582308|7447014|FG003|COMPLETED|Period 1||2
6525598|NCT01582308|7447015|FG004|COMPLETED|Period 1||3
6525599|NCT01582308|7447016|FG005|COMPLETED|Period 1||2
6642669|NCT02349295|7570957|FG011|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ2W participants who entered post-treatment follow-up.|142
6525600|NCT01582308|7447017|FG006|COMPLETED|Period 1||2
6525601|NCT01582308|7447018|FG007|COMPLETED|Period 1||2
6525602|NCT01582308|7447019|FG008|COMPLETED|Period 1||2
6525603|NCT01582308|7447020|FG009|COMPLETED|Period 1||2
6525604|NCT01582308|7447011|FG000|NOT COMPLETED|Period 1||0
6525605|NCT01582308|7447012|FG001|NOT COMPLETED|Period 1||0
6525606|NCT01582308|7447013|FG002|NOT COMPLETED|Period 1||0
6525607|NCT01582308|7447014|FG003|NOT COMPLETED|Period 1||0
6525608|NCT01582308|7447015|FG004|NOT COMPLETED|Period 1||0
6525609|NCT01582308|7447016|FG005|NOT COMPLETED|Period 1||0
6525610|NCT01582308|7447017|FG006|NOT COMPLETED|Period 1||1
6525611|NCT01582308|7447018|FG007|NOT COMPLETED|Period 1||0
6525612|NCT01582308|7447019|FG008|NOT COMPLETED|Period 1||0
6525613|NCT01582308|7447020|FG009|NOT COMPLETED|Period 1||0
6525614|NCT01582308|7447011|FG000|STARTED|10-day Washout Following Period 1||2
6525615|NCT01582308|7447012|FG001|STARTED|10-day Washout Following Period 1||2
6525616|NCT01582308|7447013|FG002|STARTED|10-day Washout Following Period 1||2
6525617|NCT01582308|7447014|FG003|STARTED|10-day Washout Following Period 1||2
6525618|NCT01582308|7447015|FG004|STARTED|10-day Washout Following Period 1||3
6525619|NCT01582308|7447016|FG005|STARTED|10-day Washout Following Period 1||2
6525620|NCT01582308|7447017|FG006|STARTED|10-day Washout Following Period 1||2
6525621|NCT01582308|7447018|FG007|STARTED|10-day Washout Following Period 1||2
6525622|NCT01582308|7447019|FG008|STARTED|10-day Washout Following Period 1||2
6525623|NCT01582308|7447020|FG009|STARTED|10-day Washout Following Period 1||2
6525624|NCT01582308|7447011|FG000|COMPLETED|10-day Washout Following Period 1||2
6525625|NCT01582308|7447012|FG001|COMPLETED|10-day Washout Following Period 1||2
6525626|NCT01582308|7447013|FG002|COMPLETED|10-day Washout Following Period 1||2
6525627|NCT01582308|7447014|FG003|COMPLETED|10-day Washout Following Period 1||2
6525628|NCT01582308|7447015|FG004|COMPLETED|10-day Washout Following Period 1||2
6525629|NCT01582308|7447016|FG005|COMPLETED|10-day Washout Following Period 1||2
6525630|NCT01582308|7447017|FG006|COMPLETED|10-day Washout Following Period 1||2
6525631|NCT01582308|7447018|FG007|COMPLETED|10-day Washout Following Period 1||2
6525632|NCT01582308|7447019|FG008|COMPLETED|10-day Washout Following Period 1||2
6525633|NCT01582308|7447020|FG009|COMPLETED|10-day Washout Following Period 1||2
6525634|NCT01582308|7447011|FG000|NOT COMPLETED|10-day Washout Following Period 1||0
6525635|NCT01582308|7447012|FG001|NOT COMPLETED|10-day Washout Following Period 1||0
6525636|NCT01582308|7447013|FG002|NOT COMPLETED|10-day Washout Following Period 1||0
6525637|NCT01582308|7447014|FG003|NOT COMPLETED|10-day Washout Following Period 1||0
6525638|NCT01582308|7447015|FG004|NOT COMPLETED|10-day Washout Following Period 1||1
6525639|NCT01582308|7447016|FG005|NOT COMPLETED|10-day Washout Following Period 1||0
6525640|NCT01582308|7447017|FG006|NOT COMPLETED|10-day Washout Following Period 1||0
6525641|NCT01582308|7447018|FG007|NOT COMPLETED|10-day Washout Following Period 1||0
6525642|NCT01582308|7447019|FG008|NOT COMPLETED|10-day Washout Following Period 1||0
6525643|NCT01582308|7447020|FG009|NOT COMPLETED|10-day Washout Following Period 1||0
6525644|NCT01582308|7447011|FG000|STARTED|Period 2||2
6525645|NCT01582308|7447012|FG001|STARTED|Period 2||2
6525646|NCT01582308|7447013|FG002|STARTED|Period 2||2
6525647|NCT01582308|7447014|FG003|STARTED|Period 2||2
6525648|NCT01582308|7447015|FG004|STARTED|Period 2||2
6525649|NCT01582308|7447016|FG005|STARTED|Period 2||2
6525650|NCT01582308|7447017|FG006|STARTED|Period 2||2
6525651|NCT01582308|7447018|FG007|STARTED|Period 2||2
6525652|NCT01582308|7447019|FG008|STARTED|Period 2||2
6525653|NCT01582308|7447020|FG009|STARTED|Period 2||2
6525654|NCT01582308|7447011|FG000|COMPLETED|Period 2||2
6525655|NCT01582308|7447012|FG001|COMPLETED|Period 2||2
6525656|NCT01582308|7447013|FG002|COMPLETED|Period 2||2
6525657|NCT01582308|7447014|FG003|COMPLETED|Period 2||2
6525658|NCT01582308|7447015|FG004|COMPLETED|Period 2||2
6525659|NCT01582308|7447016|FG005|COMPLETED|Period 2||2
6525660|NCT01582308|7447017|FG006|COMPLETED|Period 2||2
6525661|NCT01582308|7447018|FG007|COMPLETED|Period 2||2
6525662|NCT01582308|7447019|FG008|COMPLETED|Period 2||2
6525663|NCT01582308|7447020|FG009|COMPLETED|Period 2||2
6525664|NCT01582308|7447011|FG000|NOT COMPLETED|Period 2||0
6525665|NCT01582308|7447012|FG001|NOT COMPLETED|Period 2||0
6525666|NCT01582308|7447013|FG002|NOT COMPLETED|Period 2||0
6525667|NCT01582308|7447014|FG003|NOT COMPLETED|Period 2||0
6525668|NCT01582308|7447015|FG004|NOT COMPLETED|Period 2||0
6525669|NCT01582308|7447016|FG005|NOT COMPLETED|Period 2||0
6525670|NCT01582308|7447017|FG006|NOT COMPLETED|Period 2||0
6525671|NCT01582308|7447018|FG007|NOT COMPLETED|Period 2||0
6525672|NCT01582308|7447019|FG008|NOT COMPLETED|Period 2||0
6525673|NCT01582308|7447020|FG009|NOT COMPLETED|Period 2||0
6525674|NCT01582308|7447011|FG000|STARTED|10-day Washout Following Period 2||2
6525675|NCT01582308|7447012|FG001|STARTED|10-day Washout Following Period 2||2
6525676|NCT01582308|7447013|FG002|STARTED|10-day Washout Following Period 2||2
6525677|NCT01582308|7447014|FG003|STARTED|10-day Washout Following Period 2||2
6525678|NCT01582308|7447015|FG004|STARTED|10-day Washout Following Period 2||2
6525679|NCT01582308|7447016|FG005|STARTED|10-day Washout Following Period 2||2
6525680|NCT01582308|7447017|FG006|STARTED|10-day Washout Following Period 2||2
6525681|NCT01582308|7447018|FG007|STARTED|10-day Washout Following Period 2||2
6525682|NCT01582308|7447019|FG008|STARTED|10-day Washout Following Period 2||2
6525683|NCT01582308|7447020|FG009|STARTED|10-day Washout Following Period 2||2
6525684|NCT01582308|7447011|FG000|COMPLETED|10-day Washout Following Period 2||2
6525685|NCT01582308|7447012|FG001|COMPLETED|10-day Washout Following Period 2||2
6525686|NCT01582308|7447013|FG002|COMPLETED|10-day Washout Following Period 2||2
6525687|NCT01582308|7447014|FG003|COMPLETED|10-day Washout Following Period 2||2
6525688|NCT01582308|7447015|FG004|COMPLETED|10-day Washout Following Period 2||2
6525689|NCT01582308|7447016|FG005|COMPLETED|10-day Washout Following Period 2||2
6525690|NCT01582308|7447017|FG006|COMPLETED|10-day Washout Following Period 2||2
6525691|NCT01582308|7447018|FG007|COMPLETED|10-day Washout Following Period 2||2
6525692|NCT01582308|7447019|FG008|COMPLETED|10-day Washout Following Period 2||2
6525693|NCT01582308|7447020|FG009|COMPLETED|10-day Washout Following Period 2||2
6525694|NCT01582308|7447011|FG000|NOT COMPLETED|10-day Washout Following Period 2||0
6525695|NCT01582308|7447012|FG001|NOT COMPLETED|10-day Washout Following Period 2||0
6525696|NCT01582308|7447013|FG002|NOT COMPLETED|10-day Washout Following Period 2||0
6525697|NCT01582308|7447014|FG003|NOT COMPLETED|10-day Washout Following Period 2||0
6525698|NCT01582308|7447015|FG004|NOT COMPLETED|10-day Washout Following Period 2||0
6525699|NCT01582308|7447016|FG005|NOT COMPLETED|10-day Washout Following Period 2||0
6525700|NCT01582308|7447017|FG006|NOT COMPLETED|10-day Washout Following Period 2||0
6525701|NCT01582308|7447018|FG007|NOT COMPLETED|10-day Washout Following Period 2||0
6525702|NCT01582308|7447019|FG008|NOT COMPLETED|10-day Washout Following Period 2||0
6525703|NCT01582308|7447020|FG009|NOT COMPLETED|10-day Washout Following Period 2||0
6525704|NCT01582308|7447011|FG000|STARTED|Period 3||2
6525705|NCT01582308|7447012|FG001|STARTED|Period 3||2
6525706|NCT01582308|7447013|FG002|STARTED|Period 3||2
6525707|NCT01582308|7447014|FG003|STARTED|Period 3||2
6525708|NCT01582308|7447015|FG004|STARTED|Period 3||2
6525709|NCT01582308|7447016|FG005|STARTED|Period 3||2
6525710|NCT01582308|7447017|FG006|STARTED|Period 3||2
6525711|NCT01582308|7447018|FG007|STARTED|Period 3||2
6525712|NCT01582308|7447019|FG008|STARTED|Period 3||2
6525713|NCT01582308|7447020|FG009|STARTED|Period 3||2
6525714|NCT01582308|7447011|FG000|COMPLETED|Period 3||2
6525715|NCT01582308|7447012|FG001|COMPLETED|Period 3||2
6525716|NCT01582308|7447013|FG002|COMPLETED|Period 3||2
6525717|NCT01582308|7447014|FG003|COMPLETED|Period 3||2
6525718|NCT01582308|7447015|FG004|COMPLETED|Period 3||2
6525719|NCT01582308|7447016|FG005|COMPLETED|Period 3||2
6525720|NCT01582308|7447017|FG006|COMPLETED|Period 3||2
6525721|NCT01582308|7447018|FG007|COMPLETED|Period 3||2
6525722|NCT01582308|7447019|FG008|COMPLETED|Period 3||2
6525723|NCT01582308|7447020|FG009|COMPLETED|Period 3||2
6525724|NCT01582308|7447011|FG000|NOT COMPLETED|Period 3||0
6525725|NCT01582308|7447012|FG001|NOT COMPLETED|Period 3||0
6525726|NCT01582308|7447013|FG002|NOT COMPLETED|Period 3||0
6525727|NCT01582308|7447014|FG003|NOT COMPLETED|Period 3||0
6525728|NCT01582308|7447015|FG004|NOT COMPLETED|Period 3||0
6525729|NCT01582308|7447016|FG005|NOT COMPLETED|Period 3||0
6525730|NCT01582308|7447017|FG006|NOT COMPLETED|Period 3||0
6525731|NCT01582308|7447018|FG007|NOT COMPLETED|Period 3||0
6525732|NCT01582308|7447019|FG008|NOT COMPLETED|Period 3||0
6525733|NCT01582308|7447020|FG009|NOT COMPLETED|Period 3||0
6525734|NCT01582308|7447011|FG000|STARTED|10-day Washout Following Period 3||2
6525735|NCT01582308|7447012|FG001|STARTED|10-day Washout Following Period 3||2
6525736|NCT01582308|7447013|FG002|STARTED|10-day Washout Following Period 3||2
6525737|NCT01582308|7447014|FG003|STARTED|10-day Washout Following Period 3||2
6525738|NCT01582308|7447015|FG004|STARTED|10-day Washout Following Period 3||2
6525739|NCT01582308|7447016|FG005|STARTED|10-day Washout Following Period 3||2
6525740|NCT01582308|7447017|FG006|STARTED|10-day Washout Following Period 3||2
6525741|NCT01582308|7447018|FG007|STARTED|10-day Washout Following Period 3||2
6525742|NCT01582308|7447019|FG008|STARTED|10-day Washout Following Period 3||2
6525743|NCT01582308|7447020|FG009|STARTED|10-day Washout Following Period 3||2
6525744|NCT01582308|7447011|FG000|COMPLETED|10-day Washout Following Period 3||2
6525745|NCT01582308|7447012|FG001|COMPLETED|10-day Washout Following Period 3||2
6525746|NCT01582308|7447013|FG002|COMPLETED|10-day Washout Following Period 3||2
6525747|NCT01582308|7447014|FG003|COMPLETED|10-day Washout Following Period 3||2
6525748|NCT01582308|7447015|FG004|COMPLETED|10-day Washout Following Period 3||2
6525749|NCT01582308|7447016|FG005|COMPLETED|10-day Washout Following Period 3||2
6525750|NCT01582308|7447017|FG006|COMPLETED|10-day Washout Following Period 3||2
6525751|NCT01582308|7447018|FG007|COMPLETED|10-day Washout Following Period 3||2
6525752|NCT01582308|7447019|FG008|COMPLETED|10-day Washout Following Period 3||2
6525753|NCT01582308|7447020|FG009|COMPLETED|10-day Washout Following Period 3||2
6525754|NCT01582308|7447011|FG000|NOT COMPLETED|10-day Washout Following Period 3||0
6525755|NCT01582308|7447012|FG001|NOT COMPLETED|10-day Washout Following Period 3||0
6525756|NCT01582308|7447013|FG002|NOT COMPLETED|10-day Washout Following Period 3||0
6525757|NCT01582308|7447014|FG003|NOT COMPLETED|10-day Washout Following Period 3||0
6525758|NCT01582308|7447015|FG004|NOT COMPLETED|10-day Washout Following Period 3||0
6525759|NCT01582308|7447016|FG005|NOT COMPLETED|10-day Washout Following Period 3||0
6525760|NCT01582308|7447017|FG006|NOT COMPLETED|10-day Washout Following Period 3||0
6525761|NCT01582308|7447018|FG007|NOT COMPLETED|10-day Washout Following Period 3||0
6525762|NCT01582308|7447019|FG008|NOT COMPLETED|10-day Washout Following Period 3||0
6525763|NCT01582308|7447020|FG009|NOT COMPLETED|10-day Washout Following Period 3||0
6525764|NCT01582308|7447011|FG000|STARTED|Period 4||2
6525765|NCT01582308|7447012|FG001|STARTED|Period 4||2
6525766|NCT01582308|7447013|FG002|STARTED|Period 4||2
6525767|NCT01582308|7447014|FG003|STARTED|Period 4||2
6525768|NCT01582308|7447015|FG004|STARTED|Period 4||2
6525769|NCT01582308|7447016|FG005|STARTED|Period 4||2
6525770|NCT01582308|7447017|FG006|STARTED|Period 4||2
6525771|NCT01582308|7447018|FG007|STARTED|Period 4||2
6525772|NCT01582308|7447019|FG008|STARTED|Period 4||2
6525773|NCT01582308|7447020|FG009|STARTED|Period 4||2
6525774|NCT01582308|7447011|FG000|COMPLETED|Period 4||1
6525775|NCT01582308|7447012|FG001|COMPLETED|Period 4||2
6525776|NCT01582308|7447013|FG002|COMPLETED|Period 4||2
6525777|NCT01582308|7447014|FG003|COMPLETED|Period 4||2
6525778|NCT01582308|7447015|FG004|COMPLETED|Period 4||2
6525779|NCT01582308|7447016|FG005|COMPLETED|Period 4||1
6525780|NCT01582308|7447017|FG006|COMPLETED|Period 4||2
6525781|NCT01582308|7447018|FG007|COMPLETED|Period 4||2
6525782|NCT01582308|7447019|FG008|COMPLETED|Period 4||2
6525783|NCT01582308|7447020|FG009|COMPLETED|Period 4||1
6525784|NCT01582308|7447011|FG000|NOT COMPLETED|Period 4||1
6525785|NCT01582308|7447012|FG001|NOT COMPLETED|Period 4||0
6525786|NCT01582308|7447013|FG002|NOT COMPLETED|Period 4||0
6525787|NCT01582308|7447014|FG003|NOT COMPLETED|Period 4||0
6525788|NCT01582308|7447015|FG004|NOT COMPLETED|Period 4||0
6525789|NCT01582308|7447016|FG005|NOT COMPLETED|Period 4||1
6525790|NCT01582308|7447017|FG006|NOT COMPLETED|Period 4||0
6525791|NCT01582308|7447018|FG007|NOT COMPLETED|Period 4||0
6525792|NCT01582308|7447019|FG008|NOT COMPLETED|Period 4||0
6525793|NCT01582308|7447020|FG009|NOT COMPLETED|Period 4||1
6525794|NCT01582308|7447011|FG000|STARTED|10-day Washout Following Period 4||1
6525795|NCT01582308|7447012|FG001|STARTED|10-day Washout Following Period 4||2
6525796|NCT01582308|7447013|FG002|STARTED|10-day Washout Following Period 4||2
6525797|NCT01582308|7447014|FG003|STARTED|10-day Washout Following Period 4||2
6525798|NCT01582308|7447015|FG004|STARTED|10-day Washout Following Period 4||2
6525799|NCT01582308|7447016|FG005|STARTED|10-day Washout Following Period 4||1
6525800|NCT01582308|7447017|FG006|STARTED|10-day Washout Following Period 4||2
6525801|NCT01582308|7447018|FG007|STARTED|10-day Washout Following Period 4||2
6525802|NCT01582308|7447019|FG008|STARTED|10-day Washout Following Period 4||2
6525803|NCT01582308|7447020|FG009|STARTED|10-day Washout Following Period 4||1
6525804|NCT01582308|7447011|FG000|COMPLETED|10-day Washout Following Period 4||1
6525805|NCT01582308|7447012|FG001|COMPLETED|10-day Washout Following Period 4||2
6525806|NCT01582308|7447013|FG002|COMPLETED|10-day Washout Following Period 4||2
6525807|NCT01582308|7447014|FG003|COMPLETED|10-day Washout Following Period 4||2
6525808|NCT01582308|7447015|FG004|COMPLETED|10-day Washout Following Period 4||2
6525809|NCT01582308|7447016|FG005|COMPLETED|10-day Washout Following Period 4||1
6525810|NCT01582308|7447017|FG006|COMPLETED|10-day Washout Following Period 4||2
6525811|NCT01582308|7447018|FG007|COMPLETED|10-day Washout Following Period 4||2
6525812|NCT01582308|7447019|FG008|COMPLETED|10-day Washout Following Period 4||2
6525813|NCT01582308|7447020|FG009|COMPLETED|10-day Washout Following Period 4||1
6525814|NCT01582308|7447011|FG000|NOT COMPLETED|10-day Washout Following Period 4||0
6525815|NCT01582308|7447012|FG001|NOT COMPLETED|10-day Washout Following Period 4||0
6525816|NCT01582308|7447013|FG002|NOT COMPLETED|10-day Washout Following Period 4||0
6525817|NCT01582308|7447014|FG003|NOT COMPLETED|10-day Washout Following Period 4||0
6525818|NCT01582308|7447015|FG004|NOT COMPLETED|10-day Washout Following Period 4||0
6525819|NCT01582308|7447016|FG005|NOT COMPLETED|10-day Washout Following Period 4||0
6525820|NCT01582308|7447017|FG006|NOT COMPLETED|10-day Washout Following Period 4||0
6525821|NCT01582308|7447018|FG007|NOT COMPLETED|10-day Washout Following Period 4||0
6525822|NCT01582308|7447019|FG008|NOT COMPLETED|10-day Washout Following Period 4||0
6525823|NCT01582308|7447020|FG009|NOT COMPLETED|10-day Washout Following Period 4||0
6525824|NCT01582308|7447011|FG000|STARTED|Period 5||1
6525825|NCT01582308|7447012|FG001|STARTED|Period 5||2
6525826|NCT01582308|7447013|FG002|STARTED|Period 5||2
6525827|NCT01582308|7447014|FG003|STARTED|Period 5||2
6525828|NCT01582308|7447015|FG004|STARTED|Period 5||2
6525829|NCT01582308|7447016|FG005|STARTED|Period 5||1
6525830|NCT01582308|7447017|FG006|STARTED|Period 5||2
6525831|NCT01582308|7447018|FG007|STARTED|Period 5||2
6525832|NCT01582308|7447019|FG008|STARTED|Period 5||2
6525833|NCT01582308|7447020|FG009|STARTED|Period 5||1
6525834|NCT01582308|7447011|FG000|COMPLETED|Period 5||1
6525835|NCT01582308|7447012|FG001|COMPLETED|Period 5||2
6525836|NCT01582308|7447013|FG002|COMPLETED|Period 5||2
6525837|NCT01582308|7447014|FG003|COMPLETED|Period 5||2
6525838|NCT01582308|7447015|FG004|COMPLETED|Period 5||2
6525839|NCT01582308|7447016|FG005|COMPLETED|Period 5||1
6525840|NCT01582308|7447017|FG006|COMPLETED|Period 5||2
6525841|NCT01582308|7447018|FG007|COMPLETED|Period 5||2
6525842|NCT01582308|7447019|FG008|COMPLETED|Period 5||2
6525843|NCT01582308|7447020|FG009|COMPLETED|Period 5||1
6525844|NCT01582308|7447011|FG000|NOT COMPLETED|Period 5||0
6525845|NCT01582308|7447012|FG001|NOT COMPLETED|Period 5||0
6525846|NCT01582308|7447013|FG002|NOT COMPLETED|Period 5||0
6525847|NCT01582308|7447014|FG003|NOT COMPLETED|Period 5||0
6525848|NCT01582308|7447015|FG004|NOT COMPLETED|Period 5||0
6525849|NCT01582308|7447016|FG005|NOT COMPLETED|Period 5||0
6525850|NCT01582308|7447017|FG006|NOT COMPLETED|Period 5||0
6525851|NCT01582308|7447018|FG007|NOT COMPLETED|Period 5||0
6525852|NCT01582308|7447019|FG008|NOT COMPLETED|Period 5||0
6525853|NCT01582308|7447020|FG009|NOT COMPLETED|Period 5||0
6525854|NCT01582451|7447035|FG000|STARTED|Overall Study||307
6525855|NCT01582451|7447036|FG001|STARTED|Overall Study||159
6525856|NCT01582451|7447035|FG000|Received at Least 1 Dose of Study Drug|Overall Study||305
6525857|NCT01582451|7447036|FG001|Received at Least 1 Dose of Study Drug|Overall Study||159
6525858|NCT01582451|7447035|FG000|COMPLETED|Overall Study||275
6525859|NCT01582451|7447036|FG001|COMPLETED|Overall Study||139
6525860|NCT01582451|7447035|FG000|NOT COMPLETED|Overall Study||32
6525861|NCT01582451|7447036|FG001|NOT COMPLETED|Overall Study||20
6525862|NCT01582477|7447044|FG000|STARTED|Overall Study||12
6525863|NCT01582477|7447045|FG001|STARTED|Overall Study||12
6525864|NCT01582477|7447044|FG000|COMPLETED|Overall Study||12
6525865|NCT01582477|7447045|FG001|COMPLETED|Overall Study||12
6525866|NCT01582477|7447044|FG000|NOT COMPLETED|Overall Study||0
6525867|NCT01582477|7447045|FG001|NOT COMPLETED|Overall Study||0
6525868|NCT01582490|7447053|FG000|STARTED|Overall Study||9
6525869|NCT01582490|7447054|FG001|STARTED|Overall Study||10
6525870|NCT01582490|7447053|FG000|COMPLETED|Overall Study||8
6525871|NCT01582490|7447054|FG001|COMPLETED|Overall Study||9
6525872|NCT01582490|7447053|FG000|NOT COMPLETED|Overall Study||1
6525873|NCT01582490|7447054|FG001|NOT COMPLETED|Overall Study||1
6525874|NCT01582789|7447062|FG000|STARTED|First Intervention (14 Days)||34
6525875|NCT01582789|7447063|FG001|STARTED|First Intervention (14 Days)||27
6525876|NCT01582789|7447062|FG000|COMPLETED|First Intervention (14 Days)||34
6525877|NCT01582789|7447063|FG001|COMPLETED|First Intervention (14 Days)||27
6525878|NCT01582789|7447062|FG000|NOT COMPLETED|First Intervention (14 Days)||0
6525879|NCT01582789|7447063|FG001|NOT COMPLETED|First Intervention (14 Days)||0
6525880|NCT01582789|7447062|FG000|STARTED|Second Intervention (14 Days)||34
6525881|NCT01582789|7447063|FG001|STARTED|Second Intervention (14 Days)||27
6525882|NCT01582789|7447062|FG000|COMPLETED|Second Intervention (14 Days)||33
6525883|NCT01582789|7447063|FG001|COMPLETED|Second Intervention (14 Days)||27
6525884|NCT01582789|7447062|FG000|NOT COMPLETED|Second Intervention (14 Days)||1
6525885|NCT01582789|7447063|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
6525886|NCT01582854|7447073|FG000|STARTED|Overall Study||248
6525887|NCT01582854|7447074|FG001|STARTED|Overall Study||255
6525888|NCT01582854|7447073|FG000|COMPLETED|Overall Study||212
6525889|NCT01582854|7447074|FG001|COMPLETED|Overall Study||221
6525890|NCT01582854|7447073|FG000|NOT COMPLETED|Overall Study||36
6525891|NCT01582854|7447074|FG001|NOT COMPLETED|Overall Study||34
6525892|NCT01582880|7447080|FG000|STARTED|Overall Study||1
6525893|NCT01582880|7447080|FG000|COMPLETED|Overall Study||1
6525894|NCT01582880|7447080|FG000|NOT COMPLETED|Overall Study||0
6525895|NCT01582945|7447084|FG000|STARTED|Overall Study||14
6525896|NCT01582945|7447084|FG000|COMPLETED|Overall Study||12
6525897|NCT01582945|7447084|FG000|NOT COMPLETED|Overall Study||2
6525898|NCT01582971|7447090|FG000|STARTED|Overall Study||128
6525899|NCT01582971|7447091|FG001|STARTED|Overall Study||128
6525900|NCT01582971|7447090|FG000|COMPLETED|Overall Study||89
6525901|NCT01582971|7447091|FG001|COMPLETED|Overall Study||91
6525902|NCT01582971|7447090|FG000|NOT COMPLETED|Overall Study||39
6525903|NCT01582971|7447091|FG001|NOT COMPLETED|Overall Study||37
6525904|NCT01583101|7447105|FG000|STARTED|Overall Study||1076
6525905|NCT01583101|7447106|FG001|STARTED|Overall Study||1161
6525906|NCT01583101|7447105|FG000|COMPLETED|Overall Study||1076
6525907|NCT01583101|7447106|FG001|COMPLETED|Overall Study||1161
6525908|NCT01583101|7447105|FG000|NOT COMPLETED|Overall Study||0
6525909|NCT01583101|7447106|FG001|NOT COMPLETED|Overall Study||0
6525910|NCT01583166|7447114|FG000|STARTED|Overall Study||45
6525911|NCT01583166|7447115|FG001|STARTED|Overall Study||45
6525912|NCT01583166|7447114|FG000|COMPLETED|Overall Study||41
6525913|NCT01583166|7447115|FG001|COMPLETED|Overall Study||39
6525914|NCT01583166|7447114|FG000|NOT COMPLETED|Overall Study||4
6525915|NCT01583166|7447115|FG001|NOT COMPLETED|Overall Study||6
6525916|NCT01583179|7447123|FG000|STARTED|Overall Study||14
6525917|NCT01583179|7447124|FG001|STARTED|Overall Study||12
6525918|NCT01583179|7447123|FG000|COMPLETED|Overall Study||13
6525919|NCT01583179|7447124|FG001|COMPLETED|Overall Study||10
6525920|NCT01583179|7447123|FG000|NOT COMPLETED|Overall Study||1
6525921|NCT01583179|7447124|FG001|NOT COMPLETED|Overall Study||2
6525922|NCT01583218|7447132|FG000|STARTED|Overall Study||3759
6525923|NCT01583218|7447133|FG001|STARTED|Overall Study||3754
6525924|NCT01583218|7447132|FG000|COMPLETED|Overall Study||3470
6525925|NCT01583218|7447133|FG001|COMPLETED|Overall Study||3471
6525926|NCT01583218|7447132|FG000|NOT COMPLETED|Overall Study||289
6525927|NCT01583218|7447133|FG001|NOT COMPLETED|Overall Study||283
6525928|NCT01583296|7447141|FG000|STARTED|Overall Study||27
6525929|NCT01583296|7447142|FG001|STARTED|Overall Study||26
6525930|NCT01583296|7447141|FG000|COMPLETED|Overall Study||16
6525931|NCT01583296|7447142|FG001|COMPLETED|Overall Study||16
6525932|NCT01583296|7447141|FG000|NOT COMPLETED|Overall Study||11
6525933|NCT01583296|7447142|FG001|NOT COMPLETED|Overall Study||10
6525934|NCT01583374|7447151|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||164
6525935|NCT01583374|7447152|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||163
6525936|NCT01583374|7447153|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||163
6525937|NCT01583374|7447154|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
6525938|NCT01583374|7447155|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
6525939|NCT01583374|7447156|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
6525940|NCT01583374|7447157|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
6525941|NCT01583374|7447158|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
6525942|NCT01583374|7447159|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
6525943|NCT01583374|7447151|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||164
6525944|NCT01583374|7447152|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
6525945|NCT01583374|7447153|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||163
6525946|NCT01583374|7447154|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6525947|NCT01583374|7447155|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6525948|NCT01583374|7447156|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6525949|NCT01583374|7447157|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6525950|NCT01583374|7447158|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6525951|NCT01583374|7447159|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6525952|NCT01583374|7447151|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||150
6525953|NCT01583374|7447152|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||151
6525954|NCT01583374|7447153|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||144
6525955|NCT01583374|7447154|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6525956|NCT01583374|7447155|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6525957|NCT01583374|7447156|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6525958|NCT01583374|7447157|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6525959|NCT01583374|7447158|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6525960|NCT01583374|7447159|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6525961|NCT01583374|7447151|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|51
6525962|NCT01583374|7447152|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||49
6525963|NCT01583374|7447153|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|One participant who escaped early did not complete Week 24|49
6525964|NCT01583374|7447154|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6525965|NCT01583374|7447155|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6525966|NCT01583374|7447156|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6525967|NCT01583374|7447157|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6525968|NCT01583374|7447158|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6525969|NCT01583374|7447159|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6525970|NCT01583374|7447151|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|145
6525971|NCT01583374|7447152|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|147
6525972|NCT01583374|7447153|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)|Completed = participants who completed the Placebo-controlled Phase|138
6525973|NCT01583374|7447154|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525974|NCT01583374|7447155|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525975|NCT01583374|7447156|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525976|NCT01583374|7447157|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525977|NCT01583374|7447158|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525978|NCT01583374|7447159|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6561819|NCT01797185|7484732|FG002|STARTED|Overall Study||50
6525979|NCT01583374|7447151|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||19
6525980|NCT01583374|7447152|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||16
6525981|NCT01583374|7447153|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||25
6525982|NCT01583374|7447154|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525983|NCT01583374|7447155|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525984|NCT01583374|7447156|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525985|NCT01583374|7447157|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525986|NCT01583374|7447158|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525987|NCT01583374|7447159|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6525988|NCT01583374|7447151|FG000|STARTED|Extension Phase (Weeks 24 to 52)||0
6525989|NCT01583374|7447152|FG001|STARTED|Extension Phase (Weeks 24 to 52)||74
6525990|NCT01583374|7447153|FG002|STARTED|Extension Phase (Weeks 24 to 52)||65
6525991|NCT01583374|7447154|FG003|STARTED|Extension Phase (Weeks 24 to 52)||47
6525992|NCT01583374|7447155|FG004|STARTED|Extension Phase (Weeks 24 to 52)||91
6525993|NCT01583374|7447156|FG005|STARTED|Extension Phase (Weeks 24 to 52)||48
6525994|NCT01583374|7447157|FG006|STARTED|Extension Phase (Weeks 24 to 52)||48
6525995|NCT01583374|7447158|FG007|STARTED|Extension Phase (Weeks 24 to 52)||25
6525996|NCT01583374|7447159|FG008|STARTED|Extension Phase (Weeks 24 to 52)||23
6525997|NCT01583374|7447151|FG000|COMPLETED|Extension Phase (Weeks 24 to 52)||0
6525998|NCT01583374|7447152|FG001|COMPLETED|Extension Phase (Weeks 24 to 52)||69
6525999|NCT01583374|7447153|FG002|COMPLETED|Extension Phase (Weeks 24 to 52)||61
6526000|NCT01583374|7447154|FG003|COMPLETED|Extension Phase (Weeks 24 to 52)||41
6526001|NCT01583374|7447155|FG004|COMPLETED|Extension Phase (Weeks 24 to 52)||85
6526002|NCT01583374|7447156|FG005|COMPLETED|Extension Phase (Weeks 24 to 52)||43
6526003|NCT01583374|7447157|FG006|COMPLETED|Extension Phase (Weeks 24 to 52)||43
6526004|NCT01583374|7447158|FG007|COMPLETED|Extension Phase (Weeks 24 to 52)||22
6526005|NCT01583374|7447159|FG008|COMPLETED|Extension Phase (Weeks 24 to 52)||21
6526006|NCT01583374|7447151|FG000|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||0
6526007|NCT01583374|7447152|FG001|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
6526008|NCT01583374|7447153|FG002|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||4
6526009|NCT01583374|7447154|FG003|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
6526010|NCT01583374|7447155|FG004|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||6
6526011|NCT01583374|7447156|FG005|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
6526012|NCT01583374|7447157|FG006|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
6526013|NCT01583374|7447158|FG007|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||3
6526014|NCT01583374|7447159|FG008|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||2
6526015|NCT01583374|7447151|FG000|STARTED|Long-Term Extension Phase Weeks 52-260||0
6526016|NCT01583374|7447152|FG001|STARTED|Long-Term Extension Phase Weeks 52-260||66
6526017|NCT01583374|7447153|FG002|STARTED|Long-Term Extension Phase Weeks 52-260||61
6526018|NCT01583374|7447154|FG003|STARTED|Long-Term Extension Phase Weeks 52-260||35
6526019|NCT01583374|7447155|FG004|STARTED|Long-Term Extension Phase Weeks 52-260||81
6526020|NCT01583374|7447156|FG005|STARTED|Long-Term Extension Phase Weeks 52-260||39
6526021|NCT01583374|7447157|FG006|STARTED|Long-Term Extension Phase Weeks 52-260||38
6526022|NCT01583374|7447158|FG007|STARTED|Long-Term Extension Phase Weeks 52-260||21
6526023|NCT01583374|7447159|FG008|STARTED|Long-Term Extension Phase Weeks 52-260||20
6526024|NCT01583374|7447151|FG000|COMPLETED|Long-Term Extension Phase Weeks 52-260||0
6526025|NCT01583374|7447152|FG001|COMPLETED|Long-Term Extension Phase Weeks 52-260||40
6526026|NCT01583374|7447153|FG002|COMPLETED|Long-Term Extension Phase Weeks 52-260||41
6526027|NCT01583374|7447154|FG003|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
6526028|NCT01583374|7447155|FG004|COMPLETED|Long-Term Extension Phase Weeks 52-260||50
6526029|NCT01583374|7447156|FG005|COMPLETED|Long-Term Extension Phase Weeks 52-260||22
6526030|NCT01583374|7447157|FG006|COMPLETED|Long-Term Extension Phase Weeks 52-260||20
6526031|NCT01583374|7447158|FG007|COMPLETED|Long-Term Extension Phase Weeks 52-260||12
6642670|NCT02349295|7570958|FG012|STARTED|Follow-Up Period (Up to 12-24 Weeks)|IxeQ4W participants who entered post-treatment follow-up.|145
6526032|NCT01583374|7447159|FG008|COMPLETED|Long-Term Extension Phase Weeks 52-260||10
6526033|NCT01583374|7447151|FG000|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||0
6526034|NCT01583374|7447152|FG001|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||26
6526035|NCT01583374|7447153|FG002|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||20
6526036|NCT01583374|7447154|FG003|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||13
6526037|NCT01583374|7447155|FG004|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||31
6526038|NCT01583374|7447156|FG005|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||17
6526039|NCT01583374|7447157|FG006|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||18
6526040|NCT01583374|7447158|FG007|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||9
6526041|NCT01583374|7447159|FG008|NOT COMPLETED|Long-Term Extension Phase Weeks 52-260||10
6526042|NCT01583452|7447180|FG000|STARTED|Overall Study||21
6526043|NCT01583452|7447181|FG001|STARTED|Overall Study||20
6526044|NCT01583452|7447180|FG000|COMPLETED|Overall Study||21
6526045|NCT01583452|7447181|FG001|COMPLETED|Overall Study||20
6526046|NCT01583452|7447180|FG000|NOT COMPLETED|Overall Study||0
6526047|NCT01583452|7447181|FG001|NOT COMPLETED|Overall Study||0
6526048|NCT01583530|7447196|FG000|STARTED|Overall Study||19
6526049|NCT01583530|7447197|FG001|STARTED|Overall Study||20
6526050|NCT01583530|7447198|FG002|STARTED|Overall Study||20
6526051|NCT01583530|7447199|FG003|STARTED|Overall Study||19
6526052|NCT01583530|7447200|FG004|STARTED|Overall Study||20
6526053|NCT01583530|7447201|FG005|STARTED|Overall Study||20
6526054|NCT01583530|7447196|FG000|COMPLETED|Overall Study||19
6526055|NCT01583530|7447197|FG001|COMPLETED|Overall Study||17
6526056|NCT01583530|7447198|FG002|COMPLETED|Overall Study||20
6526057|NCT01583530|7447199|FG003|COMPLETED|Overall Study||18
6526058|NCT01583530|7447200|FG004|COMPLETED|Overall Study||15
6526059|NCT01583530|7447201|FG005|COMPLETED|Overall Study||17
6526060|NCT01583530|7447196|FG000|NOT COMPLETED|Overall Study||0
6526061|NCT01583530|7447197|FG001|NOT COMPLETED|Overall Study||3
6526062|NCT01583530|7447198|FG002|NOT COMPLETED|Overall Study||0
6526063|NCT01583530|7447199|FG003|NOT COMPLETED|Overall Study||1
6526064|NCT01583530|7447200|FG004|NOT COMPLETED|Overall Study||5
6526065|NCT01583530|7447201|FG005|NOT COMPLETED|Overall Study||3
6526066|NCT01583543|7447218|FG000|STARTED|Overall Study||12
6526067|NCT01583543|7447218|FG000|COMPLETED|Overall Study||12
6526068|NCT01583543|7447218|FG000|NOT COMPLETED|Overall Study||0
6526069|NCT01583686|7447230|FG000|STARTED|Overall Study||3
6526070|NCT01583686|7447231|FG001|STARTED|Overall Study||3
6526071|NCT01583686|7447232|FG002|STARTED|Overall Study||3
6526072|NCT01583686|7447233|FG003|STARTED|Overall Study||3
6526073|NCT01583686|7447234|FG004|STARTED|Overall Study||3
6526074|NCT01583686|7447230|FG000|COMPLETED|Overall Study||3
6526075|NCT01583686|7447231|FG001|COMPLETED|Overall Study||3
6526076|NCT01583686|7447232|FG002|COMPLETED|Overall Study||3
6526077|NCT01583686|7447233|FG003|COMPLETED|Overall Study||3
6526078|NCT01583686|7447234|FG004|COMPLETED|Overall Study||3
6526079|NCT01583686|7447230|FG000|NOT COMPLETED|Overall Study||0
6526080|NCT01583686|7447231|FG001|NOT COMPLETED|Overall Study||0
6526081|NCT01583686|7447232|FG002|NOT COMPLETED|Overall Study||0
6526082|NCT01583686|7447233|FG003|NOT COMPLETED|Overall Study||0
6526083|NCT01583686|7447234|FG004|NOT COMPLETED|Overall Study||0
6526084|NCT01583868|7447251|FG000|STARTED|Overall Study||108
6526085|NCT01583868|7447252|FG001|STARTED|Overall Study||108
6526086|NCT01583868|7447251|FG000|COMPLETED|Overall Study||104
6526087|NCT01583868|7447252|FG001|COMPLETED|Overall Study||104
6526088|NCT01583868|7447251|FG000|NOT COMPLETED|Overall Study||4
6526089|NCT01583868|7447252|FG001|NOT COMPLETED|Overall Study||4
6526090|NCT01583894|7447262|FG000|STARTED|Overall Study||828
6526091|NCT01583894|7447262|FG000|COMPLETED|Overall Study||813
6526092|NCT01583894|7447262|FG000|NOT COMPLETED|Overall Study||15
6526093|NCT01583985|7447268|FG000|STARTED|Overall Study||120
6526094|NCT01583985|7447269|FG001|STARTED|Overall Study||120
6526095|NCT01583985|7447268|FG000|Included in Primary Analysis|Overall Study||119
6526096|NCT01583985|7447269|FG001|Included in Primary Analysis|Overall Study||119
6526097|NCT01583985|7447268|FG000|COMPLETED|Overall Study||117
6526098|NCT01583985|7447269|FG001|COMPLETED|Overall Study||117
6526099|NCT01583985|7447268|FG000|NOT COMPLETED|Overall Study||3
6526100|NCT01583985|7447269|FG001|NOT COMPLETED|Overall Study||3
6526101|NCT01584024|7447275|FG000|STARTED|Overall Study||42
6526102|NCT01584024|7447275|FG000|COMPLETED|Overall Study||29
6526103|NCT01584024|7447275|FG000|NOT COMPLETED|Overall Study||13
6526104|NCT01584232|7447282|FG000|STARTED|Overall Study||181
6526105|NCT01584232|7447283|FG001|STARTED|Overall Study||180
6526106|NCT01584232|7447282|FG000|Received at Least 1 Dose of Study Drug|Overall Study||181
6526107|NCT01584232|7447283|FG001|Received at Least 1 Dose of Study Drug|Overall Study||180
6526108|NCT01584232|7447282|FG000|COMPLETED|Overall Study||173
6526109|NCT01584232|7447283|FG001|COMPLETED|Overall Study||177
6526110|NCT01584232|7447282|FG000|NOT COMPLETED|Overall Study||8
6526111|NCT01584232|7447283|FG001|NOT COMPLETED|Overall Study||3
6526112|NCT01584388|7447289|FG000|STARTED|Overall Study||30
6526113|NCT01584388|7447289|FG000|COMPLETED|Overall Study||30
6526114|NCT01584388|7447289|FG000|NOT COMPLETED|Overall Study||0
6526115|NCT01584440|7447309|FG000|STARTED|Stage 1 (5 Weeks)||93
6526116|NCT01584440|7447310|FG001|STARTED|Stage 1 (5 Weeks)||127
6526117|NCT01584440|7447311|FG002|STARTED|Stage 1 (5 Weeks)||0
6526118|NCT01584440|7447312|FG003|STARTED|Stage 1 (5 Weeks)||0
6526119|NCT01584440|7447313|FG004|STARTED|Stage 1 (5 Weeks)||0
6526120|NCT01584440|7447309|FG000|COMPLETED|Stage 1 (5 Weeks)||83
6526121|NCT01584440|7447310|FG001|COMPLETED|Stage 1 (5 Weeks)||119
6526122|NCT01584440|7447311|FG002|COMPLETED|Stage 1 (5 Weeks)||0
6526123|NCT01584440|7447312|FG003|COMPLETED|Stage 1 (5 Weeks)||0
6526124|NCT01584440|7447313|FG004|COMPLETED|Stage 1 (5 Weeks)||0
6526125|NCT01584440|7447309|FG000|NOT COMPLETED|Stage 1 (5 Weeks)||10
6526126|NCT01584440|7447310|FG001|NOT COMPLETED|Stage 1 (5 Weeks)||8
6526127|NCT01584440|7447311|FG002|NOT COMPLETED|Stage 1 (5 Weeks)||0
6526128|NCT01584440|7447312|FG003|NOT COMPLETED|Stage 1 (5 Weeks)||0
6526129|NCT01584440|7447313|FG004|NOT COMPLETED|Stage 1 (5 Weeks)||0
6526130|NCT01584440|7447309|FG000|STARTED|Stage 2 (5 Weeks)||0
6526131|NCT01584440|7447310|FG001|STARTED|Stage 2 (5 Weeks)||0
6526132|NCT01584440|7447311|FG002|STARTED|Stage 2 (5 Weeks)||83
6526133|NCT01584440|7447312|FG003|STARTED|Stage 2 (5 Weeks)||59
6526134|NCT01584440|7447313|FG004|STARTED|Stage 2 (5 Weeks)||60
6526135|NCT01584440|7447309|FG000|COMPLETED|Stage 2 (5 Weeks)||0
6526136|NCT01584440|7447310|FG001|COMPLETED|Stage 2 (5 Weeks)||0
6526137|NCT01584440|7447311|FG002|COMPLETED|Stage 2 (5 Weeks)||80
6526138|NCT01584440|7447312|FG003|COMPLETED|Stage 2 (5 Weeks)||55
6526139|NCT01584440|7447313|FG004|COMPLETED|Stage 2 (5 Weeks)||59
6526140|NCT01584440|7447309|FG000|NOT COMPLETED|Stage 2 (5 Weeks)||0
6526141|NCT01584440|7447310|FG001|NOT COMPLETED|Stage 2 (5 Weeks)||0
6526142|NCT01584440|7447311|FG002|NOT COMPLETED|Stage 2 (5 Weeks)||3
6526143|NCT01584440|7447312|FG003|NOT COMPLETED|Stage 2 (5 Weeks)||4
6526144|NCT01584440|7447313|FG004|NOT COMPLETED|Stage 2 (5 Weeks)||1
6526145|NCT01584479|7447330|FG000|STARTED|Overall Study||732
6526146|NCT01584479|7447331|FG001|STARTED|Overall Study||1686
6526147|NCT01584479|7447332|FG002|STARTED|Overall Study||852
6526148|NCT01584479|7447333|FG003|STARTED|Overall Study||1847
6526149|NCT01584479|7447330|FG000|COMPLETED|Overall Study||732
6526150|NCT01584479|7447331|FG001|COMPLETED|Overall Study||1686
6526151|NCT01584479|7447332|FG002|COMPLETED|Overall Study||852
6526152|NCT01584479|7447333|FG003|COMPLETED|Overall Study||1847
6526153|NCT01584479|7447330|FG000|NOT COMPLETED|Overall Study||0
6526154|NCT01584479|7447331|FG001|NOT COMPLETED|Overall Study||0
6526155|NCT01584479|7447332|FG002|NOT COMPLETED|Overall Study||0
6526156|NCT01584479|7447333|FG003|NOT COMPLETED|Overall Study||0
6526157|NCT01584518|7447345|FG000|STARTED|Overall Study||25
6526158|NCT01584518|7447346|FG001|STARTED|Overall Study||25
6526159|NCT01584518|7447345|FG000|COMPLETED|Overall Study||25
6526160|NCT01584518|7447346|FG001|COMPLETED|Overall Study||25
6526161|NCT01584518|7447345|FG000|NOT COMPLETED|Overall Study||0
6526162|NCT01584518|7447346|FG001|NOT COMPLETED|Overall Study||0
6526163|NCT01584544|7447357|FG000|STARTED|Overall Study||3
6526164|NCT01584544|7447358|FG001|STARTED|Overall Study||6
6526165|NCT01584544|7447359|FG002|STARTED|Overall Study||6
6526166|NCT01584544|7447360|FG003|STARTED|Overall Study||3
6526167|NCT01584544|7447361|FG004|STARTED|Overall Study||6
6526168|NCT01584544|7447357|FG000|COMPLETED|Overall Study||3
6526169|NCT01584544|7447358|FG001|COMPLETED|Overall Study||6
6526170|NCT01584544|7447359|FG002|COMPLETED|Overall Study||6
6526171|NCT01584544|7447360|FG003|COMPLETED|Overall Study||3
6526172|NCT01584544|7447361|FG004|COMPLETED|Overall Study||6
6526173|NCT01584544|7447357|FG000|NOT COMPLETED|Overall Study||0
6526174|NCT01584544|7447358|FG001|NOT COMPLETED|Overall Study||0
6526175|NCT01584544|7447359|FG002|NOT COMPLETED|Overall Study||0
6526176|NCT01584544|7447360|FG003|NOT COMPLETED|Overall Study||0
6526177|NCT01584544|7447361|FG004|NOT COMPLETED|Overall Study||0
6526178|NCT01584609|7447375|FG000|STARTED|Overall Study||98
6526179|NCT01584609|7447376|FG001|STARTED|Overall Study||100
6526180|NCT01584609|7447375|FG000|COMPLETED|Overall Study||86
6526181|NCT01584609|7447376|FG001|COMPLETED|Overall Study||96
6526182|NCT01584609|7447375|FG000|NOT COMPLETED|Overall Study||12
6526183|NCT01584609|7447376|FG001|NOT COMPLETED|Overall Study||4
6526184|NCT01584648|7447384|FG000|STARTED|Overall Study||211
6526185|NCT01584648|7447385|FG001|STARTED|Overall Study||212
6526186|NCT01584648|7447384|FG000|Safety Set|Overall Study||209
6526187|NCT01584648|7447385|FG001|Safety Set|Overall Study||211
6526188|NCT01584648|7447384|FG000|Crossover Population|Overall Study||0
6526189|NCT01584648|7447385|FG001|Crossover Population|Overall Study||28
6526190|NCT01584648|7447384|FG000|COMPLETED|Overall Study||0
6526191|NCT01584648|7447385|FG001|COMPLETED|Overall Study||0
6526192|NCT01584648|7447384|FG000|NOT COMPLETED|Overall Study||211
6526193|NCT01584648|7447385|FG001|NOT COMPLETED|Overall Study||212
6526194|NCT01584843|7447398|FG000|STARTED|First Treatment Period||3
6526195|NCT01584843|7447399|FG001|STARTED|First Treatment Period||4
6526196|NCT01584843|7447400|FG002|STARTED|First Treatment Period||3
6526197|NCT01584843|7447401|FG003|STARTED|First Treatment Period||10
6526198|NCT01584843|7447402|FG004|STARTED|First Treatment Period||10
6526199|NCT01584843|7447403|FG005|STARTED|First Treatment Period||11
6526200|NCT01584843|7447398|FG000|COMPLETED|First Treatment Period||3
6526201|NCT01584843|7447399|FG001|COMPLETED|First Treatment Period||4
6526202|NCT01584843|7447400|FG002|COMPLETED|First Treatment Period||2
6526203|NCT01584843|7447401|FG003|COMPLETED|First Treatment Period||10
6526204|NCT01584843|7447402|FG004|COMPLETED|First Treatment Period||10
6526205|NCT01584843|7447403|FG005|COMPLETED|First Treatment Period||9
6526206|NCT01584843|7447398|FG000|NOT COMPLETED|First Treatment Period||0
6526207|NCT01584843|7447399|FG001|NOT COMPLETED|First Treatment Period||0
6526208|NCT01584843|7447400|FG002|NOT COMPLETED|First Treatment Period||1
6526209|NCT01584843|7447401|FG003|NOT COMPLETED|First Treatment Period||0
6526210|NCT01584843|7447402|FG004|NOT COMPLETED|First Treatment Period||0
6526211|NCT01584843|7447403|FG005|NOT COMPLETED|First Treatment Period||2
6526212|NCT01584843|7447398|FG000|STARTED|Second Treatment Period||2
6526213|NCT01584843|7447399|FG001|STARTED|Second Treatment Period||1
6526214|NCT01584843|7447400|FG002|STARTED|Second Treatment Period||2
6526215|NCT01584843|7447401|FG003|STARTED|Second Treatment Period||6
6526216|NCT01584843|7447402|FG004|STARTED|Second Treatment Period||3
6526217|NCT01584843|7447403|FG005|STARTED|Second Treatment Period||1
6526218|NCT01584843|7447398|FG000|COMPLETED|Second Treatment Period||2
6526219|NCT01584843|7447399|FG001|COMPLETED|Second Treatment Period||1
6526220|NCT01584843|7447400|FG002|COMPLETED|Second Treatment Period||2
6526221|NCT01584843|7447401|FG003|COMPLETED|Second Treatment Period||6
6526222|NCT01584843|7447402|FG004|COMPLETED|Second Treatment Period||3
6526223|NCT01584843|7447403|FG005|COMPLETED|Second Treatment Period||0
6526224|NCT01584843|7447398|FG000|NOT COMPLETED|Second Treatment Period||0
6526225|NCT01584843|7447399|FG001|NOT COMPLETED|Second Treatment Period||0
6526226|NCT01584843|7447400|FG002|NOT COMPLETED|Second Treatment Period||0
6526227|NCT01584843|7447401|FG003|NOT COMPLETED|Second Treatment Period||0
6526228|NCT01584843|7447402|FG004|NOT COMPLETED|Second Treatment Period||0
6526229|NCT01584843|7447403|FG005|NOT COMPLETED|Second Treatment Period||1
6526230|NCT01585025|7447422|FG000|STARTED|Overall Study||10
6526231|NCT01585025|7447423|FG001|STARTED|Overall Study||13
6526232|NCT01585025|7447424|FG002|STARTED|Overall Study||12
6526233|NCT01585025|7447422|FG000|COMPLETED|Overall Study||10
6526234|NCT01585025|7447423|FG001|COMPLETED|Overall Study||10
6526235|NCT01585025|7447424|FG002|COMPLETED|Overall Study||8
6526236|NCT01585025|7447422|FG000|NOT COMPLETED|Overall Study||0
6526237|NCT01585025|7447423|FG001|NOT COMPLETED|Overall Study||3
6526238|NCT01585025|7447424|FG002|NOT COMPLETED|Overall Study||4
6526239|NCT01585038|7447434|FG000|STARTED|Overall Study||20
6526240|NCT01585038|7447435|FG001|STARTED|Overall Study||20
6526241|NCT01585038|7447434|FG000|COMPLETED|Overall Study||18
6526242|NCT01585038|7447435|FG001|COMPLETED|Overall Study||18
6526243|NCT01585038|7447434|FG000|NOT COMPLETED|Overall Study||2
6526244|NCT01585038|7447435|FG001|NOT COMPLETED|Overall Study||2
6526245|NCT01585129|7447443|FG000|STARTED|Overall Study||41
6526246|NCT01585129|7447444|FG001|STARTED|Overall Study||39
6526247|NCT01585129|7447443|FG000|COMPLETED|Overall Study||41
6526248|NCT01585129|7447444|FG001|COMPLETED|Overall Study||39
6526249|NCT01585129|7447443|FG000|NOT COMPLETED|Overall Study||0
6526250|NCT01585129|7447444|FG001|NOT COMPLETED|Overall Study||0
6526251|NCT01585155|7447450|FG000|STARTED|Overall Study||21
6526252|NCT01585155|7447450|FG000|COMPLETED|Overall Study||16
6526253|NCT01585155|7447450|FG000|NOT COMPLETED|Overall Study||5
6526254|NCT01585168|7447456|FG000|STARTED|Overall Study||18
6526255|NCT01585168|7447457|FG001|STARTED|Overall Study||18
6526256|NCT01585168|7447458|FG002|STARTED|Overall Study||16
6526257|NCT01585168|7447459|FG003|STARTED|Overall Study||19
6526258|NCT01585168|7447456|FG000|COMPLETED|Overall Study||15
6526259|NCT01585168|7447457|FG001|COMPLETED|Overall Study||17
6526260|NCT01585168|7447458|FG002|COMPLETED|Overall Study||15
6526261|NCT01585168|7447459|FG003|COMPLETED|Overall Study||18
6526262|NCT01585168|7447456|FG000|NOT COMPLETED|Overall Study||3
6526263|NCT01585168|7447457|FG001|NOT COMPLETED|Overall Study||1
6526264|NCT01585168|7447458|FG002|NOT COMPLETED|Overall Study||1
6526265|NCT01585168|7447459|FG003|NOT COMPLETED|Overall Study||1
6526266|NCT01585194|7447467|FG000|STARTED|Overall Study||39
6526267|NCT01585194|7447467|FG000|COMPLETED|Overall Study||35
6642671|NCT02349295|7570959|FG013|STARTED|Follow-Up Period (Up to 12-24 Weeks)|PBO participants who entered post-treatment follow-up.|17
6642672|NCT02349295|7570946|FG000|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642673|NCT02349295|7570947|FG001|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642674|NCT02349295|7570948|FG002|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642675|NCT02349295|7570949|FG003|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642676|NCT02349295|7570950|FG004|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6526268|NCT01585194|7447467|FG000|NOT COMPLETED|Overall Study||4
6526269|NCT01585207|7447471|FG000|STARTED|Overall Study||4
6642677|NCT02349295|7570951|FG005|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642678|NCT02349295|7570952|FG006|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642679|NCT02349295|7570953|FG007|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642680|NCT02349295|7570954|FG008|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642681|NCT02349295|7570955|FG009|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642682|NCT02349295|7570956|FG010|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642683|NCT02349295|7570957|FG011|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||133
6642684|NCT02349295|7570958|FG012|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||137
6642685|NCT02349295|7570959|FG013|COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||16
6642686|NCT02349295|7570946|FG000|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642687|NCT02349295|7570947|FG001|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642688|NCT02349295|7570948|FG002|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642689|NCT02349295|7570949|FG003|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642690|NCT02349295|7570950|FG004|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642691|NCT02349295|7570951|FG005|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642692|NCT02349295|7570952|FG006|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642693|NCT02349295|7570953|FG007|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642694|NCT02349295|7570954|FG008|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642695|NCT02349295|7570955|FG009|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642696|NCT02349295|7570956|FG010|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||0
6642697|NCT02349295|7570957|FG011|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||9
6642698|NCT02349295|7570958|FG012|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||8
6642699|NCT02349295|7570959|FG013|NOT COMPLETED|Follow-Up Period (Up to 12-24 Weeks)||1
6642700|NCT02349360|7570986|FG000|STARTED|Overall Study||21
6642701|NCT02349360|7570987|FG001|STARTED|Overall Study||21
6642702|NCT02349360|7570986|FG000|COMPLETED|Overall Study||21
6642703|NCT02349360|7570987|FG001|COMPLETED|Overall Study||20
6642704|NCT02349360|7570986|FG000|NOT COMPLETED|Overall Study||0
6642705|NCT02349360|7570987|FG001|NOT COMPLETED|Overall Study||1
6642706|NCT02349412|7570995|FG000|STARTED|Overall Study||202
6642707|NCT02349412|7570996|FG001|STARTED|Overall Study||203
6642708|NCT02349412|7570995|FG000|Completed Week-12 QOL Assessment Measure|Overall Study||92
6642709|NCT02349412|7570996|FG001|Completed Week-12 QOL Assessment Measure|Overall Study||101
6655846|NCT02456727|7586011|FG001|STARTED|Overall Study||390
6526270|NCT01585207|7447471|FG000|COMPLETED|Overall Study||4
6526271|NCT01585207|7447471|FG000|NOT COMPLETED|Overall Study||0
6526272|NCT01585246|7447480|FG000|STARTED|Overall Study||3
6526273|NCT01585246|7447481|FG001|STARTED|Overall Study||4
6526274|NCT01585246|7447482|FG002|STARTED|Overall Study||20
6526275|NCT01585246|7447483|FG003|STARTED|Overall Study||10
6526276|NCT01585246|7447484|FG004|STARTED|Overall Study||11
6526277|NCT01585246|7447480|FG000|COMPLETED|Overall Study||3
6526278|NCT01585246|7447481|FG001|COMPLETED|Overall Study||3
6526279|NCT01585246|7447482|FG002|COMPLETED|Overall Study||16
6526280|NCT01585246|7447483|FG003|COMPLETED|Overall Study||6
6526281|NCT01585246|7447484|FG004|COMPLETED|Overall Study||9
6526282|NCT01585246|7447480|FG000|NOT COMPLETED|Overall Study||0
6526283|NCT01585246|7447481|FG001|NOT COMPLETED|Overall Study||1
6526284|NCT01585246|7447482|FG002|NOT COMPLETED|Overall Study||4
6526285|NCT01585246|7447483|FG003|NOT COMPLETED|Overall Study||4
6526286|NCT01585246|7447484|FG004|NOT COMPLETED|Overall Study||2
6526287|NCT01585272|7447499|FG000|STARTED|Overall Study||121
6526288|NCT01585272|7447499|FG000|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
6526289|NCT01585272|7447499|FG000|Exelon Patch 5 cm2|Overall Study||114
6526290|NCT01585272|7447499|FG000|Exelon Patch 10 cm2|Overall Study||96
6526291|NCT01585272|7447499|FG000|COMPLETED|Overall Study||82
6526292|NCT01585272|7447499|FG000|NOT COMPLETED|Overall Study||39
6526293|NCT01585298|7447503|FG000|STARTED|Overall Study||6998
6526294|NCT01585298|7447503|FG000|COMPLETED|Overall Study||6961
6526295|NCT01585298|7447503|FG000|NOT COMPLETED|Overall Study||37
6526296|NCT01585324|7447507|FG000|STARTED|Overall Study||30
6526297|NCT01585324|7447507|FG000|COMPLETED|Overall Study||30
6526298|NCT01585324|7447507|FG000|NOT COMPLETED|Overall Study||0
6526299|NCT01585428|7447515|FG000|STARTED|Overall Study||18
6526300|NCT01585428|7447516|FG001|STARTED|Overall Study||11
6526301|NCT01585428|7447515|FG000|COMPLETED|Overall Study||17
6526302|NCT01585428|7447516|FG001|COMPLETED|Overall Study||11
6526303|NCT01585428|7447515|FG000|NOT COMPLETED|Overall Study||1
6526304|NCT01585428|7447516|FG001|NOT COMPLETED|Overall Study||0
6526305|NCT01585441|7447525|FG000|STARTED|Overall Study||3
6526306|NCT01585441|7447526|FG001|STARTED|Overall Study||3
6526307|NCT01585441|7447525|FG000|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
6526308|NCT01585441|7447526|FG001|Month 3|Overall Study||3
6526309|NCT01585441|7447525|FG000|Received Finasteride at Month 3|Overall Study||2
6526310|NCT01585441|7447526|FG001|Received Finasteride at Month 3|Overall Study||2
6526311|NCT01585441|7447525|FG000|Final Study Safety Visit|Overall Study||3
6526312|NCT01585441|7447526|FG001|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
6526313|NCT01585441|7447525|FG000|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
6526314|NCT01585441|7447526|FG001|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
6526315|NCT01585441|7447525|FG000|NOT COMPLETED|Overall Study||0
6526316|NCT01585441|7447526|FG001|NOT COMPLETED|Overall Study||0
6526317|NCT01585558|7447535|FG000|STARTED|Overall Study||62
6526318|NCT01585558|7447536|FG001|STARTED|Overall Study||69
6526319|NCT01585558|7447537|FG002|STARTED|Overall Study||49
6526320|NCT01585558|7447535|FG000|COMPLETED|Overall Study||49
6526321|NCT01585558|7447536|FG001|COMPLETED|Overall Study||57
6526322|NCT01585558|7447537|FG002|COMPLETED|Overall Study||34
6526323|NCT01585558|7447535|FG000|NOT COMPLETED|Overall Study||13
6526324|NCT01585558|7447536|FG001|NOT COMPLETED|Overall Study||12
6526325|NCT01585558|7447537|FG002|NOT COMPLETED|Overall Study||15
6526326|NCT01585584|7447545|FG000|STARTED|Overall Study||10
6526327|NCT01585584|7447545|FG000|COMPLETED|Overall Study||6
6526328|NCT01585584|7447545|FG000|NOT COMPLETED|Overall Study||4
6526329|NCT01585597|7447549|FG000|STARTED|Overall Study||20
6526330|NCT01585597|7447549|FG000|COMPLETED|Overall Study||20
6526331|NCT01585597|7447549|FG000|NOT COMPLETED|Overall Study||0
6526332|NCT01585766|7447559|FG000|STARTED|Overall Study||7
6526333|NCT01585766|7447560|FG001|STARTED|Overall Study||5
6526334|NCT01585766|7447561|FG002|STARTED|Overall Study||3
6526335|NCT01585766|7447562|FG003|STARTED|Overall Study||4
6526336|NCT01585766|7447563|FG004|STARTED|Overall Study||3
6526337|NCT01585766|7447564|FG005|STARTED|Overall Study||6
6526338|NCT01585766|7447559|FG000|COMPLETED|Overall Study||7
6526339|NCT01585766|7447560|FG001|COMPLETED|Overall Study||3
6526340|NCT01585766|7447561|FG002|COMPLETED|Overall Study||1
6526341|NCT01585766|7447562|FG003|COMPLETED|Overall Study||4
6526342|NCT01585766|7447563|FG004|COMPLETED|Overall Study||3
6526343|NCT01585766|7447564|FG005|COMPLETED|Overall Study||6
6526344|NCT01585766|7447559|FG000|NOT COMPLETED|Overall Study||0
6526345|NCT01585766|7447560|FG001|NOT COMPLETED|Overall Study||2
6526346|NCT01585766|7447561|FG002|NOT COMPLETED|Overall Study||2
6526347|NCT01585766|7447562|FG003|NOT COMPLETED|Overall Study||0
6526348|NCT01585766|7447563|FG004|NOT COMPLETED|Overall Study||0
6526349|NCT01585766|7447564|FG005|NOT COMPLETED|Overall Study||0
6526350|NCT01585779|7447587|FG000|STARTED|Overall Study||36
6526351|NCT01585779|7447588|FG001|STARTED|Overall Study||28
6526352|NCT01585779|7447587|FG000|COMPLETED|Overall Study||26
6526353|NCT01585779|7447588|FG001|COMPLETED|Overall Study||21
6526354|NCT01585779|7447587|FG000|NOT COMPLETED|Overall Study||10
6526355|NCT01585779|7447588|FG001|NOT COMPLETED|Overall Study||7
6526356|NCT01585831|7447597|FG000|STARTED|Overall Study||28
6526357|NCT01585831|7447598|FG001|STARTED|Overall Study||20
6526358|NCT01585831|7447597|FG000|COMPLETED|Overall Study||26
6526359|NCT01585831|7447598|FG001|COMPLETED|Overall Study||18
6526360|NCT01585831|7447597|FG000|NOT COMPLETED|Overall Study||2
6526361|NCT01585831|7447598|FG001|NOT COMPLETED|Overall Study||2
6526362|NCT01585961|7447604|FG000|STARTED|Overall Study||511
6526363|NCT01585961|7447604|FG000|Safety|Overall Study|Patients ablated with study catheter|508
6526364|NCT01585961|7447604|FG000|COMPLETED|Overall Study||478
6526365|NCT01585961|7447604|FG000|NOT COMPLETED|Overall Study||33
6526366|NCT01585987|7447610|FG000|STARTED|Randomized||57
6526367|NCT01585987|7447611|FG001|STARTED|Randomized||57
6526368|NCT01585987|7447610|FG000|COMPLETED|Randomized||57
6526369|NCT01585987|7447611|FG001|COMPLETED|Randomized||51
6526370|NCT01585987|7447610|FG000|NOT COMPLETED|Randomized||0
6526371|NCT01585987|7447611|FG001|NOT COMPLETED|Randomized||6
6526372|NCT01585987|7447610|FG000|STARTED|Treated||57
6526373|NCT01585987|7447611|FG001|STARTED|Treated||51
6526374|NCT01585987|7447610|FG000|COMPLETED|Treated||3
6526375|NCT01585987|7447611|FG001|COMPLETED|Treated||2
6526376|NCT01585987|7447610|FG000|NOT COMPLETED|Treated||54
6526377|NCT01585987|7447611|FG001|NOT COMPLETED|Treated||49
6526378|NCT01586026|7447618|FG000|STARTED|Overall Study||350
6526379|NCT01586026|7447619|FG001|STARTED|Overall Study||414
6526380|NCT01586026|7447620|FG002|STARTED|Overall Study||271
6526381|NCT01586026|7447618|FG000|COMPLETED|Overall Study||350
6526382|NCT01586026|7447619|FG001|COMPLETED|Overall Study||414
6642710|NCT02349412|7570995|FG000|Completed Week-24 QOL Assessment Measure|Overall Study||68
6642711|NCT02349412|7570996|FG001|Completed Week-24 QOL Assessment Measure|Overall Study||80
6642712|NCT02349412|7570995|FG000|COMPLETED|Overall Study||195
6642713|NCT02349412|7570996|FG001|COMPLETED|Overall Study||196
6642714|NCT02349412|7570995|FG000|NOT COMPLETED|Overall Study||7
6642715|NCT02349412|7570996|FG001|NOT COMPLETED|Overall Study||7
6642716|NCT02349425|7571006|FG000|STARTED|Period 1||15
6642717|NCT02349425|7571007|FG001|STARTED|Period 1||14
6642718|NCT02349425|7571008|FG002|STARTED|Period 1||15
6642719|NCT02349425|7571009|FG003|STARTED|Period 1||15
6642720|NCT02349425|7571006|FG000|COMPLETED|Period 1||14
6642721|NCT02349425|7571007|FG001|COMPLETED|Period 1||13
6642722|NCT02349425|7571008|FG002|COMPLETED|Period 1||15
6642723|NCT02349425|7571009|FG003|COMPLETED|Period 1||15
6642724|NCT02349425|7571006|FG000|NOT COMPLETED|Period 1||1
6642725|NCT02349425|7571007|FG001|NOT COMPLETED|Period 1||1
6642726|NCT02349425|7571008|FG002|NOT COMPLETED|Period 1||0
6642727|NCT02349425|7571009|FG003|NOT COMPLETED|Period 1||0
6642728|NCT02349425|7571006|FG000|STARTED|Period 2||14
6642729|NCT02349425|7571007|FG001|STARTED|Period 2||13
6642730|NCT02349425|7571008|FG002|STARTED|Period 2||15
6642731|NCT02349425|7571009|FG003|STARTED|Period 2||15
6642732|NCT02349425|7571006|FG000|COMPLETED|Period 2||14
6642733|NCT02349425|7571007|FG001|COMPLETED|Period 2||12
6642734|NCT02349425|7571008|FG002|COMPLETED|Period 2||14
6642735|NCT02349425|7571009|FG003|COMPLETED|Period 2||15
6642736|NCT02349425|7571006|FG000|NOT COMPLETED|Period 2||0
6642737|NCT02349425|7571007|FG001|NOT COMPLETED|Period 2||1
6642738|NCT02349425|7571008|FG002|NOT COMPLETED|Period 2||1
6642739|NCT02349425|7571009|FG003|NOT COMPLETED|Period 2||0
6642740|NCT02349438|7571047|FG000|STARTED|Period 1||11
6642741|NCT02349438|7571048|FG001|STARTED|Period 1||10
6642742|NCT02349438|7571047|FG000|COMPLETED|Period 1||11
6642743|NCT02349438|7571048|FG001|COMPLETED|Period 1||10
6642744|NCT02349438|7571047|FG000|NOT COMPLETED|Period 1||0
6642745|NCT02349438|7571048|FG001|NOT COMPLETED|Period 1||0
6642746|NCT02349438|7571047|FG000|STARTED|Period 2||11
6642747|NCT02349438|7571048|FG001|STARTED|Period 2||10
6642748|NCT02349438|7571047|FG000|COMPLETED|Period 2||11
6642749|NCT02349438|7571048|FG001|COMPLETED|Period 2||10
6642750|NCT02349438|7571047|FG000|NOT COMPLETED|Period 2||0
6642751|NCT02349438|7571048|FG001|NOT COMPLETED|Period 2||0
6642752|NCT02349451|7571058|FG000|STARTED|Overall Study||24
6642753|NCT02349451|7571059|FG001|STARTED|Overall Study||72
6642754|NCT02349451|7571060|FG002|STARTED|Overall Study||71
6642755|NCT02349451|7571061|FG003|STARTED|Overall Study||73
6642756|NCT02349451|7571058|FG000|COMPLETED|Overall Study||24
6642757|NCT02349451|7571059|FG001|COMPLETED|Overall Study||71
6642758|NCT02349451|7571060|FG002|COMPLETED|Overall Study||69
6642759|NCT02349451|7571061|FG003|COMPLETED|Overall Study||72
6642760|NCT02349451|7571058|FG000|NOT COMPLETED|Overall Study||0
6642761|NCT02349451|7571059|FG001|NOT COMPLETED|Overall Study||1
6642762|NCT02349451|7571060|FG002|NOT COMPLETED|Overall Study||2
6642763|NCT02349451|7571061|FG003|NOT COMPLETED|Overall Study||1
6642764|NCT02349477|7571076|FG000|STARTED|Overall Study||44
6642765|NCT02349477|7571077|FG001|STARTED|Overall Study||46
6642766|NCT02349477|7571076|FG000|COMPLETED|Overall Study||31
6642767|NCT02349477|7571077|FG001|COMPLETED|Overall Study||28
6642768|NCT02349477|7571076|FG000|NOT COMPLETED|Overall Study||13
6642769|NCT02349477|7571077|FG001|NOT COMPLETED|Overall Study||18
6642770|NCT02349542|7571087|FG000|STARTED|Overall Study||20
6526383|NCT01586026|7447620|FG002|COMPLETED|Overall Study||271
6526384|NCT01586026|7447618|FG000|NOT COMPLETED|Overall Study||0
6526385|NCT01586026|7447619|FG001|NOT COMPLETED|Overall Study||0
6526386|NCT01586026|7447620|FG002|NOT COMPLETED|Overall Study||0
6526387|NCT01586039|7447632|FG000|STARTED|Overall Study||8
6526388|NCT01586039|7447633|FG001|STARTED|Overall Study||9
6526389|NCT01586039|7447634|FG002|STARTED|Overall Study||8
6526390|NCT01586039|7447635|FG003|STARTED|Overall Study||8
6642771|NCT02349542|7571087|FG000|COMPLETED|Overall Study||15
6642772|NCT02349542|7571087|FG000|NOT COMPLETED|Overall Study||5
6642773|NCT02349633|7571105|FG000|STARTED|Overall Study||4
6642774|NCT02349633|7571106|FG001|STARTED|Overall Study||3
6642775|NCT02349633|7571107|FG002|STARTED|Overall Study||4
6642776|NCT02349633|7571108|FG003|STARTED|Overall Study||4
6642777|NCT02349633|7571109|FG004|STARTED|Overall Study||3
6642778|NCT02349633|7571110|FG005|STARTED|Overall Study||4
6642779|NCT02349633|7571111|FG006|STARTED|Overall Study||4
6642780|NCT02349633|7571112|FG007|STARTED|Overall Study||29
6526391|NCT01586039|7447632|FG000|COMPLETED|Overall Study||8
6526392|NCT01586039|7447633|FG001|COMPLETED|Overall Study||8
6526393|NCT01586039|7447634|FG002|COMPLETED|Overall Study||8
6526394|NCT01586039|7447635|FG003|COMPLETED|Overall Study||8
6526395|NCT01586039|7447632|FG000|NOT COMPLETED|Overall Study||0
6526396|NCT01586039|7447633|FG001|NOT COMPLETED|Overall Study||1
6526397|NCT01586039|7447634|FG002|NOT COMPLETED|Overall Study||0
6526398|NCT01586039|7447635|FG003|NOT COMPLETED|Overall Study||0
6526399|NCT01586091|7447648|FG000|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
6526400|NCT01586091|7447649|FG001|STARTED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
6526401|NCT01586091|7447650|FG002|STARTED|Overall Study||6
6526402|NCT01586091|7447648|FG000|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
6526403|NCT01586091|7447649|FG001|COMPLETED|Overall Study|9 Caucasian and 9 Asian participants, each received Levocetiricine, fexofenadine and Placebo.|6
6526404|NCT01586091|7447650|FG002|COMPLETED|Overall Study||6
6526405|NCT01586091|7447648|FG000|NOT COMPLETED|Overall Study||0
6526406|NCT01586091|7447649|FG001|NOT COMPLETED|Overall Study||0
6526407|NCT01586091|7447650|FG002|NOT COMPLETED|Overall Study||0
6526408|NCT01586156|7447664|FG000|STARTED|Overall Study||10
6526409|NCT01586156|7447665|FG001|STARTED|Overall Study||10
6526410|NCT01586156|7447666|FG002|STARTED|Overall Study||10
6526411|NCT01586156|7447664|FG000|COMPLETED|Overall Study||10
6526412|NCT01586156|7447665|FG001|COMPLETED|Overall Study||9
6526413|NCT01586156|7447666|FG002|COMPLETED|Overall Study||10
6526414|NCT01586156|7447664|FG000|NOT COMPLETED|Overall Study||0
6526415|NCT01586156|7447665|FG001|NOT COMPLETED|Overall Study||1
6526416|NCT01586156|7447666|FG002|NOT COMPLETED|Overall Study||0
6526417|NCT01586195|7447674|FG000|STARTED|Overall Study||31
6642781|NCT02349633|7571113|FG008|STARTED|Overall Study||5
6642782|NCT02349633|7571114|FG009|STARTED|Overall Study||5
6642783|NCT02349633|7571115|FG010|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
6642784|NCT02349633|7571116|FG011|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
6642785|NCT02349633|7571117|FG012|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
6642786|NCT02349633|7571118|FG013|STARTED|Overall Study|No participants were enrolled in this cohort/arm prior to study termination.|0
6642787|NCT02349633|7571105|FG000|COMPLETED|Overall Study||4
6642788|NCT02349633|7571106|FG001|COMPLETED|Overall Study||2
6642789|NCT02349633|7571107|FG002|COMPLETED|Overall Study||4
6642790|NCT02349633|7571108|FG003|COMPLETED|Overall Study||2
6642791|NCT02349633|7571109|FG004|COMPLETED|Overall Study||1
6642792|NCT02349633|7571110|FG005|COMPLETED|Overall Study||3
6642793|NCT02349633|7571111|FG006|COMPLETED|Overall Study||3
6642794|NCT02349633|7571112|FG007|COMPLETED|Overall Study||13
6642795|NCT02349633|7571113|FG008|COMPLETED|Overall Study||3
6642796|NCT02349633|7571114|FG009|COMPLETED|Overall Study||0
6642797|NCT02349633|7571115|FG010|COMPLETED|Overall Study||0
6642798|NCT02349633|7571116|FG011|COMPLETED|Overall Study||0
6642799|NCT02349633|7571117|FG012|COMPLETED|Overall Study||0
6642800|NCT02349633|7571118|FG013|COMPLETED|Overall Study||0
6642801|NCT02349633|7571105|FG000|NOT COMPLETED|Overall Study||0
6642802|NCT02349633|7571106|FG001|NOT COMPLETED|Overall Study||1
6642803|NCT02349633|7571107|FG002|NOT COMPLETED|Overall Study||0
6642804|NCT02349633|7571108|FG003|NOT COMPLETED|Overall Study||2
6642805|NCT02349633|7571109|FG004|NOT COMPLETED|Overall Study||2
6642806|NCT02349633|7571110|FG005|NOT COMPLETED|Overall Study||1
6642807|NCT02349633|7571111|FG006|NOT COMPLETED|Overall Study||1
6642808|NCT02349633|7571112|FG007|NOT COMPLETED|Overall Study||16
6642809|NCT02349633|7571113|FG008|NOT COMPLETED|Overall Study||2
6642810|NCT02349633|7571114|FG009|NOT COMPLETED|Overall Study||5
6642811|NCT02349633|7571115|FG010|NOT COMPLETED|Overall Study||0
6642812|NCT02349633|7571116|FG011|NOT COMPLETED|Overall Study||0
6642813|NCT02349633|7571117|FG012|NOT COMPLETED|Overall Study||0
6642814|NCT02349633|7571118|FG013|NOT COMPLETED|Overall Study||0
6642815|NCT02349646|7571179|FG000|STARTED|Overall Study||33
6642816|NCT02349646|7571179|FG000|Received Trial System|Overall Study||24
6642817|NCT02349646|7571179|FG000|Receive Permanent System|Overall Study||27
6642818|NCT02349646|7571179|FG000|COMPLETED|Overall Study||16
6642819|NCT02349646|7571179|FG000|NOT COMPLETED|Overall Study||17
6642820|NCT02349685|7571186|FG000|STARTED|Overall Study||89
6642821|NCT02349685|7571187|FG001|STARTED|Overall Study||89
6642822|NCT02349685|7571188|FG002|STARTED|Overall Study||41
6642823|NCT02349685|7571186|FG000|COMPLETED|Overall Study||84
6642824|NCT02349685|7571187|FG001|COMPLETED|Overall Study||87
6642825|NCT02349685|7571188|FG002|COMPLETED|Overall Study||37
6642826|NCT02349685|7571186|FG000|NOT COMPLETED|Overall Study||5
6642827|NCT02349685|7571187|FG001|NOT COMPLETED|Overall Study||2
6642828|NCT02349685|7571188|FG002|NOT COMPLETED|Overall Study||4
6642829|NCT02349711|7571198|FG000|STARTED|Overall Study||87
6642830|NCT02349711|7571199|FG001|STARTED|Overall Study||86
6642831|NCT02349711|7571198|FG000|COMPLETED|Overall Study||84
6642832|NCT02349711|7571199|FG001|COMPLETED|Overall Study||84
6642833|NCT02349711|7571198|FG000|NOT COMPLETED|Overall Study||3
6642834|NCT02349711|7571199|FG001|NOT COMPLETED|Overall Study||2
6642835|NCT02349789|7571205|FG000|STARTED|Overall Study||11
6642836|NCT02349789|7571205|FG000|COMPLETED|Overall Study||9
6526418|NCT01586195|7447674|FG000|COMPLETED|Overall Study||5
6526419|NCT01586195|7447674|FG000|NOT COMPLETED|Overall Study||26
6526420|NCT01586312|7447680|FG000|STARTED|Overall Study||15
6526421|NCT01586312|7447681|FG001|STARTED|Overall Study||15
6526422|NCT01586312|7447680|FG000|COMPLETED|Overall Study||15
6526423|NCT01586312|7447681|FG001|COMPLETED|Overall Study||15
6526424|NCT01586312|7447680|FG000|NOT COMPLETED|Overall Study||0
6526425|NCT01586312|7447681|FG001|NOT COMPLETED|Overall Study||0
6526426|NCT01586338|7447687|FG000|STARTED|Overall Study||237
6526427|NCT01586338|7447687|FG000|COMPLETED|Overall Study||229
6526428|NCT01586338|7447687|FG000|NOT COMPLETED|Overall Study||8
6642837|NCT02349789|7571205|FG000|NOT COMPLETED|Overall Study||2
6642838|NCT02350127|7571211|FG000|STARTED|4-Month Assessment||44
6642839|NCT02350127|7571212|FG001|STARTED|4-Month Assessment||44
6642840|NCT02350127|7571211|FG000|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to time constraints (n=1) and lack of interest (n=1)|42
6642841|NCT02350127|7571212|FG001|Completed Baseline|4-Month Assessment|Withdrew prior to baseline due to health issue (n=1)|43
6642842|NCT02350127|7571211|FG000|COMPLETED|4-Month Assessment||33
6642843|NCT02350127|7571212|FG001|COMPLETED|4-Month Assessment||35
6642844|NCT02350127|7571211|FG000|NOT COMPLETED|4-Month Assessment||11
6642845|NCT02350127|7571212|FG001|NOT COMPLETED|4-Month Assessment||9
6642846|NCT02350127|7571211|FG000|STARTED|8-Month Assessment||33
6642847|NCT02350127|7571212|FG001|STARTED|8-Month Assessment||35
6642848|NCT02350127|7571211|FG000|COMPLETED|8-Month Assessment||27
6642849|NCT02350127|7571212|FG001|COMPLETED|8-Month Assessment||26
6642850|NCT02350127|7571211|FG000|NOT COMPLETED|8-Month Assessment||6
6642851|NCT02350127|7571212|FG001|NOT COMPLETED|8-Month Assessment||9
6642852|NCT02350309|7571225|FG000|STARTED|Treatment Period 1 (2 Days)||12
6642853|NCT02350309|7571226|FG001|STARTED|Treatment Period 1 (2 Days)||11
6642854|NCT02350309|7571227|FG002|STARTED|Treatment Period 1 (2 Days)||11
6642855|NCT02350309|7571228|FG003|STARTED|Treatment Period 1 (2 Days)||11
6642856|NCT02350309|7571229|FG004|STARTED|Treatment Period 1 (2 Days)||12
6642857|NCT02350309|7571230|FG005|STARTED|Treatment Period 1 (2 Days)||12
6642858|NCT02350309|7571225|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
6642859|NCT02350309|7571226|FG001|COMPLETED|Treatment Period 1 (2 Days)||11
6642860|NCT02350309|7571227|FG002|COMPLETED|Treatment Period 1 (2 Days)||10
6642861|NCT02350309|7571228|FG003|COMPLETED|Treatment Period 1 (2 Days)||11
6642862|NCT02350309|7571229|FG004|COMPLETED|Treatment Period 1 (2 Days)||12
6642863|NCT02350309|7571230|FG005|COMPLETED|Treatment Period 1 (2 Days)||12
6642864|NCT02350309|7571225|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6642865|NCT02350309|7571226|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6642866|NCT02350309|7571227|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||1
6642867|NCT02350309|7571228|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6642868|NCT02350309|7571229|FG004|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6642869|NCT02350309|7571230|FG005|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6642870|NCT02350309|7571225|FG000|STARTED|Washout Period 1 (12-16 Days)||12
6642871|NCT02350309|7571226|FG001|STARTED|Washout Period 1 (12-16 Days)||11
6642872|NCT02350309|7571227|FG002|STARTED|Washout Period 1 (12-16 Days)||10
6642873|NCT02350309|7571228|FG003|STARTED|Washout Period 1 (12-16 Days)||11
6642874|NCT02350309|7571229|FG004|STARTED|Washout Period 1 (12-16 Days)||12
6642875|NCT02350309|7571230|FG005|STARTED|Washout Period 1 (12-16 Days)||12
6642876|NCT02350309|7571225|FG000|COMPLETED|Washout Period 1 (12-16 Days)||12
6642877|NCT02350309|7571226|FG001|COMPLETED|Washout Period 1 (12-16 Days)||11
6642878|NCT02350309|7571227|FG002|COMPLETED|Washout Period 1 (12-16 Days)||10
6642879|NCT02350309|7571228|FG003|COMPLETED|Washout Period 1 (12-16 Days)||11
6642880|NCT02350309|7571229|FG004|COMPLETED|Washout Period 1 (12-16 Days)||12
6642881|NCT02350309|7571230|FG005|COMPLETED|Washout Period 1 (12-16 Days)||12
6642882|NCT02350309|7571225|FG000|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6642883|NCT02350309|7571226|FG001|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6642884|NCT02350309|7571227|FG002|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6642885|NCT02350309|7571228|FG003|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6642886|NCT02350309|7571229|FG004|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6642887|NCT02350309|7571230|FG005|NOT COMPLETED|Washout Period 1 (12-16 Days)||0
6642888|NCT02350309|7571225|FG000|STARTED|Treatment Period 2 (2 Days)||12
6642889|NCT02350309|7571226|FG001|STARTED|Treatment Period 2 (2 Days)||11
6642890|NCT02350309|7571227|FG002|STARTED|Treatment Period 2 (2 Days)||10
6642891|NCT02350309|7571228|FG003|STARTED|Treatment Period 2 (2 Days)||11
6642892|NCT02350309|7571229|FG004|STARTED|Treatment Period 2 (2 Days)||12
6642893|NCT02350309|7571230|FG005|STARTED|Treatment Period 2 (2 Days)||12
6642894|NCT02350309|7571225|FG000|COMPLETED|Treatment Period 2 (2 Days)||12
6642895|NCT02350309|7571226|FG001|COMPLETED|Treatment Period 2 (2 Days)||11
6642896|NCT02350309|7571227|FG002|COMPLETED|Treatment Period 2 (2 Days)||10
6642897|NCT02350309|7571228|FG003|COMPLETED|Treatment Period 2 (2 Days)||11
6642898|NCT02350309|7571229|FG004|COMPLETED|Treatment Period 2 (2 Days)||12
6642899|NCT02350309|7571230|FG005|COMPLETED|Treatment Period 2 (2 Days)||12
6642900|NCT02350309|7571225|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6642901|NCT02350309|7571226|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6642902|NCT02350309|7571227|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6642903|NCT02350309|7571228|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6642904|NCT02350309|7571229|FG004|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6642905|NCT02350309|7571230|FG005|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6526429|NCT01586364|7447691|FG000|STARTED|Overall Study||301
6526430|NCT01586364|7447691|FG000|COMPLETED|Overall Study||184
6526431|NCT01586364|7447691|FG000|NOT COMPLETED|Overall Study||117
6526432|NCT01586624|7447703|FG000|STARTED|Overall Study||6
6526433|NCT01586624|7447704|FG001|STARTED|Overall Study||6
6526434|NCT01586624|7447705|FG002|STARTED|Overall Study||6
6526435|NCT01586624|7447706|FG003|STARTED|Overall Study||7
6526436|NCT01586624|7447707|FG004|STARTED|Overall Study||9
6526437|NCT01586624|7447708|FG005|STARTED|Overall Study||8
6526438|NCT01586624|7447709|FG006|STARTED|Overall Study||8
6526439|NCT01586624|7447710|FG007|STARTED|Overall Study||11
6526440|NCT01586624|7447703|FG000|COMPLETED|Overall Study||2
6526441|NCT01586624|7447704|FG001|COMPLETED|Overall Study||2
6526442|NCT01586624|7447705|FG002|COMPLETED|Overall Study||1
6526443|NCT01586624|7447706|FG003|COMPLETED|Overall Study||0
6526444|NCT01586624|7447707|FG004|COMPLETED|Overall Study||1
6526445|NCT01586624|7447708|FG005|COMPLETED|Overall Study||0
6526446|NCT01586624|7447709|FG006|COMPLETED|Overall Study||0
6526447|NCT01586624|7447710|FG007|COMPLETED|Overall Study||1
6526448|NCT01586624|7447703|FG000|NOT COMPLETED|Overall Study||4
6526449|NCT01586624|7447704|FG001|NOT COMPLETED|Overall Study||4
6526450|NCT01586624|7447705|FG002|NOT COMPLETED|Overall Study||5
6526451|NCT01586624|7447706|FG003|NOT COMPLETED|Overall Study||7
6526452|NCT01586624|7447707|FG004|NOT COMPLETED|Overall Study||8
6526453|NCT01586624|7447708|FG005|NOT COMPLETED|Overall Study||8
6526454|NCT01586624|7447709|FG006|NOT COMPLETED|Overall Study||8
6526455|NCT01586624|7447710|FG007|NOT COMPLETED|Overall Study||10
6526456|NCT01586741|7447732|FG000|STARTED|Overall Study||28
6526457|NCT01586741|7447733|FG001|STARTED|Overall Study||29
6526458|NCT01586741|7447734|FG002|STARTED|Overall Study||32
6526459|NCT01586741|7447732|FG000|COMPLETED|Overall Study||27
6526460|NCT01586741|7447733|FG001|COMPLETED|Overall Study||29
6526461|NCT01586741|7447734|FG002|COMPLETED|Overall Study||30
6526462|NCT01586741|7447732|FG000|NOT COMPLETED|Overall Study||1
6526463|NCT01586741|7447733|FG001|NOT COMPLETED|Overall Study||0
6526464|NCT01586741|7447734|FG002|NOT COMPLETED|Overall Study||2
6526465|NCT01586806|7447745|FG000|STARTED|Overall Study||65
6526466|NCT01586806|7447746|FG001|STARTED|Overall Study||65
6526467|NCT01586806|7447747|FG002|STARTED|Overall Study||65
6526468|NCT01586806|7447745|FG000|COMPLETED|Overall Study||62
6526469|NCT01586806|7447746|FG001|COMPLETED|Overall Study||61
6526470|NCT01586806|7447747|FG002|COMPLETED|Overall Study||63
6526471|NCT01586806|7447745|FG000|NOT COMPLETED|Overall Study||3
6526472|NCT01586806|7447746|FG001|NOT COMPLETED|Overall Study||4
6526473|NCT01586806|7447747|FG002|NOT COMPLETED|Overall Study||2
6526474|NCT01586819|7447757|FG000|STARTED|Overall Study||12
6526475|NCT01586819|7447758|FG001|STARTED|Overall Study||14
6526476|NCT01586819|7447757|FG000|COMPLETED|Overall Study||11
6526477|NCT01586819|7447758|FG001|COMPLETED|Overall Study||14
6526478|NCT01586819|7447757|FG000|NOT COMPLETED|Overall Study||1
6526479|NCT01586819|7447758|FG001|NOT COMPLETED|Overall Study||0
6526480|NCT01586871|7447767|FG000|STARTED|Overall Study||560
6526481|NCT01586871|7447768|FG001|STARTED|Overall Study||554
6526482|NCT01586871|7447769|FG002|STARTED|Overall Study||33
6526483|NCT01586871|7447767|FG000|COMPLETED|Overall Study||560
6526484|NCT01586871|7447768|FG001|COMPLETED|Overall Study||554
6526485|NCT01586871|7447769|FG002|COMPLETED|Overall Study||33
6526486|NCT01586871|7447767|FG000|NOT COMPLETED|Overall Study||0
6526487|NCT01586871|7447768|FG001|NOT COMPLETED|Overall Study||0
6526488|NCT01586871|7447769|FG002|NOT COMPLETED|Overall Study||0
6526489|NCT01586897|7447779|FG000|STARTED|Overall Study||26
6526490|NCT01586897|7447780|FG001|STARTED|Overall Study||26
6526491|NCT01586897|7447779|FG000|COMPLETED|Overall Study||26
6526492|NCT01586897|7447780|FG001|COMPLETED|Overall Study||26
6526493|NCT01586897|7447779|FG000|NOT COMPLETED|Overall Study||0
6526494|NCT01586897|7447780|FG001|NOT COMPLETED|Overall Study||0
6642906|NCT02350309|7571225|FG000|STARTED|Washout Period 2 (12-16 Days)||12
6642907|NCT02350309|7571226|FG001|STARTED|Washout Period 2 (12-16 Days)||11
6642908|NCT02350309|7571227|FG002|STARTED|Washout Period 2 (12-16 Days)||10
6642909|NCT02350309|7571228|FG003|STARTED|Washout Period 2 (12-16 Days)||11
6642910|NCT02350309|7571229|FG004|STARTED|Washout Period 2 (12-16 Days)||12
6642911|NCT02350309|7571230|FG005|STARTED|Washout Period 2 (12-16 Days)||12
6642912|NCT02350309|7571225|FG000|COMPLETED|Washout Period 2 (12-16 Days)||12
6642913|NCT02350309|7571226|FG001|COMPLETED|Washout Period 2 (12-16 Days)||11
6642914|NCT02350309|7571227|FG002|COMPLETED|Washout Period 2 (12-16 Days)||10
6642915|NCT02350309|7571228|FG003|COMPLETED|Washout Period 2 (12-16 Days)||11
6642916|NCT02350309|7571229|FG004|COMPLETED|Washout Period 2 (12-16 Days)||12
6642917|NCT02350309|7571230|FG005|COMPLETED|Washout Period 2 (12-16 Days)||12
6642918|NCT02350309|7571225|FG000|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6642919|NCT02350309|7571226|FG001|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6642920|NCT02350309|7571227|FG002|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6642921|NCT02350309|7571228|FG003|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6642922|NCT02350309|7571229|FG004|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6526501|NCT01586962|7447799|FG000|STARTED|Overall Study||56
6526502|NCT01586962|7447799|FG000|COMPLETED|Overall Study||56
6526503|NCT01586962|7447799|FG000|NOT COMPLETED|Overall Study||0
6526504|NCT01586975|7447806|FG000|STARTED|Overall Study||15
6526505|NCT01586975|7447807|FG001|STARTED|Overall Study||32
6526506|NCT01586975|7447808|FG002|STARTED|Overall Study||46
6526507|NCT01586975|7447806|FG000|COMPLETED|Overall Study||15
6526508|NCT01586975|7447807|FG001|COMPLETED|Overall Study||32
6526509|NCT01586975|7447808|FG002|COMPLETED|Overall Study||46
6526510|NCT01586975|7447806|FG000|NOT COMPLETED|Overall Study||0
6526511|NCT01586975|7447807|FG001|NOT COMPLETED|Overall Study||0
6526512|NCT01586975|7447808|FG002|NOT COMPLETED|Overall Study||0
6526513|NCT01587001|7447818|FG000|STARTED|Overall Study||14
6526514|NCT01587001|7447819|FG001|STARTED|Overall Study||3
6526515|NCT01587001|7447818|FG000|COMPLETED|Overall Study||8
6526516|NCT01587001|7447819|FG001|COMPLETED|Overall Study||2
6526517|NCT01587001|7447818|FG000|NOT COMPLETED|Overall Study||6
6526518|NCT01587001|7447819|FG001|NOT COMPLETED|Overall Study||1
6526519|NCT01587014|7447826|FG000|STARTED|Overall Study||26
6526520|NCT01587014|7447826|FG000|COMPLETED|Overall Study||24
6526521|NCT01587014|7447826|FG000|NOT COMPLETED|Overall Study||2
6526522|NCT01587027|7447832|FG000|STARTED|First Intervention (1 Day)||8
6526523|NCT01587027|7447833|FG001|STARTED|First Intervention (1 Day)||8
6526524|NCT01587027|7447832|FG000|COMPLETED|First Intervention (1 Day)||8
6526525|NCT01587027|7447833|FG001|COMPLETED|First Intervention (1 Day)||8
6526526|NCT01587027|7447832|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6526527|NCT01587027|7447833|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6526528|NCT01587027|7447832|FG000|STARTED|Washout (1 Day)||8
6526529|NCT01587027|7447833|FG001|STARTED|Washout (1 Day)||8
6526530|NCT01587027|7447832|FG000|COMPLETED|Washout (1 Day)||8
6526531|NCT01587027|7447833|FG001|COMPLETED|Washout (1 Day)||8
6526532|NCT01587027|7447832|FG000|NOT COMPLETED|Washout (1 Day)||0
6526533|NCT01587027|7447833|FG001|NOT COMPLETED|Washout (1 Day)||0
6642923|NCT02350309|7571230|FG005|NOT COMPLETED|Washout Period 2 (12-16 Days)||0
6642924|NCT02350309|7571225|FG000|STARTED|Treatment Period 3 (2 Days)||12
6642925|NCT02350309|7571226|FG001|STARTED|Treatment Period 3 (2 Days)||11
6642926|NCT02350309|7571227|FG002|STARTED|Treatment Period 3 (2 Days)||10
6642927|NCT02350309|7571228|FG003|STARTED|Treatment Period 3 (2 Days)||11
6642928|NCT02350309|7571229|FG004|STARTED|Treatment Period 3 (2 Days)||12
6642929|NCT02350309|7571230|FG005|STARTED|Treatment Period 3 (2 Days)||12
6642930|NCT02350309|7571225|FG000|COMPLETED|Treatment Period 3 (2 Days)||12
6642931|NCT02350309|7571226|FG001|COMPLETED|Treatment Period 3 (2 Days)||11
6642932|NCT02350309|7571227|FG002|COMPLETED|Treatment Period 3 (2 Days)||10
6642933|NCT02350309|7571228|FG003|COMPLETED|Treatment Period 3 (2 Days)||11
6642934|NCT02350309|7571229|FG004|COMPLETED|Treatment Period 3 (2 Days)||12
6642935|NCT02350309|7571230|FG005|COMPLETED|Treatment Period 3 (2 Days)||12
6642936|NCT02350309|7571225|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6642937|NCT02350309|7571226|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6642938|NCT02350309|7571227|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6642939|NCT02350309|7571228|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6642940|NCT02350309|7571229|FG004|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6642941|NCT02350309|7571230|FG005|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6642942|NCT02350309|7571225|FG000|STARTED|Washout Period 3 (12-16 Days)||12
6642943|NCT02350309|7571226|FG001|STARTED|Washout Period 3 (12-16 Days)||11
6642944|NCT02350309|7571227|FG002|STARTED|Washout Period 3 (12-16 Days)||10
6642945|NCT02350309|7571228|FG003|STARTED|Washout Period 3 (12-16 Days)||11
6642946|NCT02350309|7571229|FG004|STARTED|Washout Period 3 (12-16 Days)||12
6642947|NCT02350309|7571230|FG005|STARTED|Washout Period 3 (12-16 Days)||12
6642948|NCT02350309|7571225|FG000|COMPLETED|Washout Period 3 (12-16 Days)||12
6642949|NCT02350309|7571226|FG001|COMPLETED|Washout Period 3 (12-16 Days)||11
6642950|NCT02350309|7571227|FG002|COMPLETED|Washout Period 3 (12-16 Days)||10
6642951|NCT02350309|7571228|FG003|COMPLETED|Washout Period 3 (12-16 Days)||11
6642952|NCT02350309|7571229|FG004|COMPLETED|Washout Period 3 (12-16 Days)||12
6642953|NCT02350309|7571230|FG005|COMPLETED|Washout Period 3 (12-16 Days)||12
6642954|NCT02350309|7571225|FG000|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6642955|NCT02350309|7571226|FG001|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6642956|NCT02350309|7571227|FG002|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6642957|NCT02350309|7571228|FG003|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6642958|NCT02350309|7571229|FG004|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6642959|NCT02350309|7571230|FG005|NOT COMPLETED|Washout Period 3 (12-16 Days)||0
6642960|NCT02350309|7571225|FG000|STARTED|Treatment Period 4 (2 Days)||12
6642961|NCT02350309|7571226|FG001|STARTED|Treatment Period 4 (2 Days)||11
6642962|NCT02350309|7571227|FG002|STARTED|Treatment Period 4 (2 Days)||10
6642963|NCT02350309|7571228|FG003|STARTED|Treatment Period 4 (2 Days)||11
6642964|NCT02350309|7571229|FG004|STARTED|Treatment Period 4 (2 Days)||12
6642965|NCT02350309|7571230|FG005|STARTED|Treatment Period 4 (2 Days)||12
6642966|NCT02350309|7571225|FG000|COMPLETED|Treatment Period 4 (2 Days)||12
6642967|NCT02350309|7571226|FG001|COMPLETED|Treatment Period 4 (2 Days)||11
6642968|NCT02350309|7571227|FG002|COMPLETED|Treatment Period 4 (2 Days)||10
6642969|NCT02350309|7571228|FG003|COMPLETED|Treatment Period 4 (2 Days)||11
6526534|NCT01587027|7447832|FG000|STARTED|Second Intervention (1 Day)||8
6526535|NCT01587027|7447833|FG001|STARTED|Second Intervention (1 Day)||8
6526536|NCT01587027|7447832|FG000|COMPLETED|Second Intervention (1 Day)||8
6526537|NCT01587027|7447833|FG001|COMPLETED|Second Intervention (1 Day)||8
6526538|NCT01587027|7447832|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6526539|NCT01587027|7447833|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6526540|NCT01587027|7447832|FG000|STARTED|Washout (1 Day)||8
6526541|NCT01587027|7447833|FG001|STARTED|Washout (1 Day)||8
6526542|NCT01587027|7447832|FG000|COMPLETED|Washout (1 Day)||8
6526543|NCT01587027|7447833|FG001|COMPLETED|Washout (1 Day)||8
6526544|NCT01587027|7447832|FG000|NOT COMPLETED|Washout (1 Day)||0
6526545|NCT01587027|7447833|FG001|NOT COMPLETED|Washout (1 Day)||0
6526546|NCT01587027|7447832|FG000|STARTED|Third Intervention (1 Day)||8
6526547|NCT01587027|7447833|FG001|STARTED|Third Intervention (1 Day)||8
6526548|NCT01587027|7447832|FG000|COMPLETED|Third Intervention (1 Day)||8
6526549|NCT01587027|7447833|FG001|COMPLETED|Third Intervention (1 Day)||8
6526550|NCT01587027|7447832|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6526551|NCT01587027|7447833|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6526552|NCT01587027|7447832|FG000|STARTED|Discharge (1 Day)||8
6526553|NCT01587027|7447833|FG001|STARTED|Discharge (1 Day)||8
6526554|NCT01587027|7447832|FG000|COMPLETED|Discharge (1 Day)||8
6526555|NCT01587027|7447833|FG001|COMPLETED|Discharge (1 Day)||8
6526556|NCT01587027|7447832|FG000|NOT COMPLETED|Discharge (1 Day)||0
6526557|NCT01587027|7447833|FG001|NOT COMPLETED|Discharge (1 Day)||0
6526558|NCT01587079|7447839|FG000|STARTED|Overall Study||159
6526559|NCT01587079|7447839|FG000|COMPLETED|Overall Study||120
6526560|NCT01587079|7447839|FG000|NOT COMPLETED|Overall Study||39
6526561|NCT01587105|7447875|FG000|STARTED|Overall Study||150
6526562|NCT01587105|7447876|FG001|STARTED|Overall Study||181
6526563|NCT01587105|7447875|FG000|COMPLETED|Overall Study||144
6526564|NCT01587105|7447876|FG001|COMPLETED|Overall Study||138
6526565|NCT01587105|7447875|FG000|NOT COMPLETED|Overall Study||6
6526566|NCT01587105|7447876|FG001|NOT COMPLETED|Overall Study||43
6526567|NCT01587118|7447882|FG000|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
6526568|NCT01587118|7447882|FG000|COMPLETED|Overall Study||11
6526569|NCT01587118|7447882|FG000|NOT COMPLETED|Overall Study||7
6561820|NCT01797185|7484730|FG000|COMPLETED|Overall Study||134
6561821|NCT01797185|7484731|FG001|COMPLETED|Overall Study||125
6561822|NCT01797185|7484732|FG002|COMPLETED|Overall Study||38
6561823|NCT01797185|7484730|FG000|NOT COMPLETED|Overall Study||28
6561824|NCT01797185|7484731|FG001|NOT COMPLETED|Overall Study||38
6561825|NCT01797185|7484732|FG002|NOT COMPLETED|Overall Study||12
6561826|NCT01797263|7484742|FG000|STARTED|Overall Study||129
6561827|NCT01797263|7484743|FG001|STARTED|Overall Study||127
6561828|NCT01797263|7484742|FG000|1 Month|Overall Study||96
6561829|NCT01797263|7484743|FG001|1 Month|Overall Study||87
6561830|NCT01797263|7484742|FG000|3 Month|Overall Study||87
6561831|NCT01797263|7484743|FG001|3 Month|Overall Study||84
6561832|NCT01797263|7484742|FG000|6 Month|Overall Study||90
6561833|NCT01797263|7484743|FG001|6 Month|Overall Study||85
6561834|NCT01797263|7484742|FG000|9 Month|Overall Study||92
6561835|NCT01797263|7484743|FG001|9 Month|Overall Study||87
6561836|NCT01797263|7484742|FG000|COMPLETED|Overall Study||92
6642970|NCT02350309|7571229|FG004|COMPLETED|Treatment Period 4 (2 Days)||12
6642971|NCT02350309|7571230|FG005|COMPLETED|Treatment Period 4 (2 Days)||11
6642972|NCT02350309|7571225|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6642973|NCT02350309|7571226|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6642974|NCT02350309|7571227|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6642975|NCT02350309|7571228|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6642976|NCT02350309|7571229|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6642977|NCT02350309|7571230|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||1
6642978|NCT02350478|7571247|FG000|STARTED|Overall Study||25
6642979|NCT02350478|7571248|FG001|STARTED|Overall Study||24
6642980|NCT02350478|7571247|FG000|COMPLETED|Overall Study||20
6642981|NCT02350478|7571248|FG001|COMPLETED|Overall Study||23
6642982|NCT02350478|7571247|FG000|NOT COMPLETED|Overall Study||5
6642983|NCT02350478|7571248|FG001|NOT COMPLETED|Overall Study||1
6642984|NCT02350569|7571254|FG000|STARTED|Main Study (LDV/SOF 4 Weeks)||16
6642985|NCT02350569|7571254|FG000|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
6642986|NCT02350569|7571254|FG000|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
6642987|NCT02350569|7571254|FG000|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
6642988|NCT02350569|7571254|FG000|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
6642989|NCT02350569|7571254|FG000|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
6642990|NCT02350647|7571262|FG000|STARTED|Overall Study||32
6642991|NCT02350647|7571263|FG001|STARTED|Overall Study||32
6642992|NCT02350647|7571262|FG000|COMPLETED|Overall Study||26
6642993|NCT02350647|7571263|FG001|COMPLETED|Overall Study||26
6642994|NCT02350647|7571262|FG000|NOT COMPLETED|Overall Study||6
6642995|NCT02350647|7571263|FG001|NOT COMPLETED|Overall Study||6
6642996|NCT02350660|7571271|FG000|STARTED|Overall Study||7
6642997|NCT02350660|7571272|FG001|STARTED|Overall Study||17
6642998|NCT02350660|7571271|FG000|COMPLETED|Overall Study||7
6642999|NCT02350660|7571272|FG001|COMPLETED|Overall Study||17
6643000|NCT02350660|7571271|FG000|NOT COMPLETED|Overall Study||0
6643001|NCT02350660|7571272|FG001|NOT COMPLETED|Overall Study||0
6643002|NCT02350816|7571282|FG000|STARTED|Overall Study||7
6561837|NCT01797263|7484743|FG001|COMPLETED|Overall Study||87
6561838|NCT01797263|7484742|FG000|NOT COMPLETED|Overall Study||37
6643003|NCT02350816|7571283|FG001|STARTED|Overall Study||6
6643004|NCT02350816|7571284|FG002|STARTED|Overall Study||2
6643005|NCT02350816|7571285|FG003|STARTED|Overall Study||2
6643006|NCT02350816|7571282|FG000|COMPLETED|Overall Study||7
6561839|NCT01797263|7484743|FG001|NOT COMPLETED|Overall Study||40
6561840|NCT01797302|7484752|FG000|STARTED|Overall Study||75
6561841|NCT01797302|7484753|FG001|STARTED|Overall Study||74
6526570|NCT01587274|7447889|FG000|STARTED|Overall Study||108
6526571|NCT01587274|7447890|FG001|STARTED|Overall Study||108
6526572|NCT01587274|7447891|FG002|STARTED|Overall Study||107
6526573|NCT01587274|7447889|FG000|COMPLETED|Overall Study||104
6526574|NCT01587274|7447890|FG001|COMPLETED|Overall Study||103
6526575|NCT01587274|7447891|FG002|COMPLETED|Overall Study||104
6526576|NCT01587274|7447889|FG000|NOT COMPLETED|Overall Study||4
6526577|NCT01587274|7447890|FG001|NOT COMPLETED|Overall Study||5
6526578|NCT01587274|7447891|FG002|NOT COMPLETED|Overall Study||3
6526579|NCT01587651|7447902|FG000|STARTED|Overall Study||34
6526580|NCT01587651|7447903|FG001|STARTED|Overall Study||41
6526581|NCT01587651|7447904|FG002|STARTED|Overall Study||35
6526582|NCT01587651|7447902|FG000|COMPLETED|Overall Study||34
6526583|NCT01587651|7447903|FG001|COMPLETED|Overall Study||38
6526584|NCT01587651|7447904|FG002|COMPLETED|Overall Study||34
6526585|NCT01587651|7447902|FG000|NOT COMPLETED|Overall Study||0
6526586|NCT01587651|7447903|FG001|NOT COMPLETED|Overall Study||3
6526587|NCT01587651|7447904|FG002|NOT COMPLETED|Overall Study||1
6526588|NCT01587703|7447931|FG000|STARTED|Part1 QD(Median Exposure of 1.38months)||3
6526589|NCT01587703|7447932|FG001|STARTED|Part1 QD(Median Exposure of 1.38months)||4
6526590|NCT01587703|7447933|FG002|STARTED|Part1 QD(Median Exposure of 1.38months)||1
6526591|NCT01587703|7447934|FG003|STARTED|Part1 QD(Median Exposure of 1.38months)||3
6526592|NCT01587703|7447935|FG004|STARTED|Part1 QD(Median Exposure of 1.38months)||4
6526593|NCT01587703|7447936|FG005|STARTED|Part1 QD(Median Exposure of 1.38months)||9
6526594|NCT01587703|7447937|FG006|STARTED|Part1 QD(Median Exposure of 1.38months)||32
6526595|NCT01587703|7447938|FG007|STARTED|Part1 QD(Median Exposure of 1.38months)||9
6526596|NCT01587703|7447939|FG008|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526597|NCT01587703|7447940|FG009|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6643007|NCT02350816|7571283|FG001|COMPLETED|Overall Study||6
6643008|NCT02350816|7571284|FG002|COMPLETED|Overall Study||2
6643009|NCT02350816|7571285|FG003|COMPLETED|Overall Study||2
6643010|NCT02350816|7571282|FG000|NOT COMPLETED|Overall Study||0
6643011|NCT02350816|7571283|FG001|NOT COMPLETED|Overall Study||0
6643012|NCT02350816|7571284|FG002|NOT COMPLETED|Overall Study||0
6643013|NCT02350816|7571285|FG003|NOT COMPLETED|Overall Study||0
6643014|NCT02350881|7571295|FG000|STARTED|Overall Study|64 patients were included (6 bilateral)|64
6643015|NCT02350881|7571295|FG000|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
6643016|NCT02350881|7571295|FG000|NOT COMPLETED|Overall Study||0
6643017|NCT02350998|7571320|FG000|STARTED|Overall Study||33
6643018|NCT02350998|7571320|FG000|COMPLETED|Overall Study||33
6643019|NCT02350998|7571320|FG000|NOT COMPLETED|Overall Study||0
6643020|NCT02351037|7571329|FG000|STARTED|Overall Study||7
6643021|NCT02351037|7571330|FG001|STARTED|Overall Study||21
6643022|NCT02351037|7571331|FG002|STARTED|Overall Study||8
6643023|NCT02351037|7571329|FG000|COMPLETED|Overall Study||7
6643024|NCT02351037|7571330|FG001|COMPLETED|Overall Study||21
6643025|NCT02351037|7571331|FG002|COMPLETED|Overall Study||8
6643026|NCT02351037|7571329|FG000|NOT COMPLETED|Overall Study||0
6643027|NCT02351037|7571330|FG001|NOT COMPLETED|Overall Study||0
6643028|NCT02351037|7571331|FG002|NOT COMPLETED|Overall Study||0
6643029|NCT02351115|7571344|FG000|STARTED|Overall Study||1
6643030|NCT02351115|7571345|FG001|STARTED|Overall Study||1
6643031|NCT02351115|7571346|FG002|STARTED|Overall Study||1
6643032|NCT02351115|7571347|FG003|STARTED|Overall Study||1
6643033|NCT02351115|7571348|FG004|STARTED|Overall Study||1
6643034|NCT02351115|7571344|FG000|COMPLETED|Overall Study||1
6643035|NCT02351115|7571345|FG001|COMPLETED|Overall Study||1
6643036|NCT02351115|7571346|FG002|COMPLETED|Overall Study||1
6643037|NCT02351115|7571347|FG003|COMPLETED|Overall Study||1
6643038|NCT02351115|7571348|FG004|COMPLETED|Overall Study||1
6643039|NCT02351115|7571344|FG000|NOT COMPLETED|Overall Study||0
6643040|NCT02351115|7571345|FG001|NOT COMPLETED|Overall Study||0
6643041|NCT02351115|7571346|FG002|NOT COMPLETED|Overall Study||0
6643042|NCT02351115|7571347|FG003|NOT COMPLETED|Overall Study||0
6643043|NCT02351115|7571348|FG004|NOT COMPLETED|Overall Study||0
6643044|NCT02351167|7571364|FG000|STARTED|Overall Study||275
6643045|NCT02351167|7571365|FG001|STARTED|Overall Study||274
6643046|NCT02351167|7571366|FG002|STARTED|Overall Study||273
6643047|NCT02351167|7571364|FG000|COMPLETED|Overall Study||256
6643048|NCT02351167|7571365|FG001|COMPLETED|Overall Study||256
6643049|NCT02351167|7571366|FG002|COMPLETED|Overall Study||252
6643050|NCT02351167|7571364|FG000|NOT COMPLETED|Overall Study||19
6643051|NCT02351167|7571365|FG001|NOT COMPLETED|Overall Study||18
6643052|NCT02351167|7571366|FG002|NOT COMPLETED|Overall Study||21
6526598|NCT01587703|7447941|FG010|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526599|NCT01587703|7447942|FG011|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526600|NCT01587703|7447943|FG012|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526601|NCT01587703|7447944|FG013|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526602|NCT01587703|7447945|FG014|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526603|NCT01587703|7447946|FG015|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526604|NCT01587703|7447947|FG016|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526605|NCT01587703|7447948|FG017|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6643053|NCT02351258|7571375|FG000|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643054|NCT02351258|7571376|FG001|STARTED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6655847|NCT02456727|7586010|FG000|Initiated Treatment|Overall Study||346
6655848|NCT02456727|7586011|FG001|Initiated Treatment|Overall Study||360
6526606|NCT01587703|7447949|FG018|STARTED|Part1 QD(Median Exposure of 1.38months)||0
6526607|NCT01587703|7447931|FG000|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526608|NCT01587703|7447932|FG001|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526609|NCT01587703|7447933|FG002|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526610|NCT01587703|7447934|FG003|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526611|NCT01587703|7447935|FG004|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526612|NCT01587703|7447936|FG005|COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
6526613|NCT01587703|7447937|FG006|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526614|NCT01587703|7447938|FG007|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526615|NCT01587703|7447939|FG008|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526616|NCT01587703|7447940|FG009|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526617|NCT01587703|7447941|FG010|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526618|NCT01587703|7447942|FG011|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526619|NCT01587703|7447943|FG012|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526620|NCT01587703|7447944|FG013|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526621|NCT01587703|7447945|FG014|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526622|NCT01587703|7447946|FG015|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526623|NCT01587703|7447947|FG016|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526624|NCT01587703|7447948|FG017|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526625|NCT01587703|7447949|FG018|COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526626|NCT01587703|7447931|FG000|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
6526627|NCT01587703|7447932|FG001|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
6526628|NCT01587703|7447933|FG002|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||1
6526629|NCT01587703|7447934|FG003|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||3
6526630|NCT01587703|7447935|FG004|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||4
6526631|NCT01587703|7447936|FG005|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||8
6526632|NCT01587703|7447937|FG006|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||32
6526633|NCT01587703|7447938|FG007|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||9
6526634|NCT01587703|7447939|FG008|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526635|NCT01587703|7447940|FG009|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526636|NCT01587703|7447941|FG010|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526637|NCT01587703|7447942|FG011|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526638|NCT01587703|7447943|FG012|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526639|NCT01587703|7447944|FG013|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526640|NCT01587703|7447945|FG014|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526641|NCT01587703|7447946|FG015|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526642|NCT01587703|7447947|FG016|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526643|NCT01587703|7447948|FG017|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526644|NCT01587703|7447949|FG018|NOT COMPLETED|Part1 QD(Median Exposure of 1.38months)||0
6526645|NCT01587703|7447931|FG000|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526646|NCT01587703|7447932|FG001|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526647|NCT01587703|7447933|FG002|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526648|NCT01587703|7447934|FG003|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526649|NCT01587703|7447935|FG004|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526650|NCT01587703|7447936|FG005|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526651|NCT01587703|7447937|FG006|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526652|NCT01587703|7447938|FG007|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526653|NCT01587703|7447939|FG008|STARTED|Part1 BID(Median Exposure of 1.41months)||4
6526654|NCT01587703|7447940|FG009|STARTED|Part1 BID(Median Exposure of 1.41months)||10
6526655|NCT01587703|7447941|FG010|STARTED|Part1 BID(Median Exposure of 1.41months)||5
6526656|NCT01587703|7447942|FG011|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526657|NCT01587703|7447943|FG012|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526658|NCT01587703|7447944|FG013|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526659|NCT01587703|7447945|FG014|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526660|NCT01587703|7447946|FG015|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526661|NCT01587703|7447947|FG016|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526662|NCT01587703|7447948|FG017|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526663|NCT01587703|7447949|FG018|STARTED|Part1 BID(Median Exposure of 1.41months)||0
6526664|NCT01587703|7447931|FG000|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526665|NCT01587703|7447932|FG001|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526666|NCT01587703|7447933|FG002|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526667|NCT01587703|7447934|FG003|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526668|NCT01587703|7447935|FG004|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526669|NCT01587703|7447936|FG005|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526670|NCT01587703|7447937|FG006|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526671|NCT01587703|7447938|FG007|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526672|NCT01587703|7447939|FG008|COMPLETED|Part1 BID(Median Exposure of 1.41months)||1
6526673|NCT01587703|7447940|FG009|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6643055|NCT02351258|7571375|FG000|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643056|NCT02351258|7571376|FG001|COMPLETED|Intervention 1 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643057|NCT02351258|7571375|FG000|NOT COMPLETED|Intervention 1 (12 Months)||
6643058|NCT02351258|7571376|FG001|NOT COMPLETED|Intervention 1 (12 Months)||
6643059|NCT02351258|7571375|FG000|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643060|NCT02351258|7571376|FG001|STARTED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643061|NCT02351258|7571375|FG000|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643062|NCT02351258|7571376|FG001|COMPLETED|Washout (2-3 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643063|NCT02351258|7571375|FG000|NOT COMPLETED|Washout (2-3 Months)||
6643064|NCT02351258|7571376|FG001|NOT COMPLETED|Washout (2-3 Months)||
6643065|NCT02351258|7571375|FG000|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643066|NCT02351258|7571376|FG001|STARTED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643067|NCT02351258|7571375|FG000|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643068|NCT02351258|7571376|FG001|COMPLETED|Intervention 2 (12 Months)|Number of participants is not available for this study, only clinic-level data collected.|
6643069|NCT02351258|7571375|FG000|NOT COMPLETED|Intervention 2 (12 Months)||
6526674|NCT01587703|7447941|FG010|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526675|NCT01587703|7447942|FG011|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526676|NCT01587703|7447943|FG012|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526677|NCT01587703|7447944|FG013|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526678|NCT01587703|7447945|FG014|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526679|NCT01587703|7447946|FG015|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526680|NCT01587703|7447947|FG016|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526681|NCT01587703|7447948|FG017|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526682|NCT01587703|7447949|FG018|COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526683|NCT01587703|7447931|FG000|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526684|NCT01587703|7447932|FG001|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526685|NCT01587703|7447933|FG002|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526686|NCT01587703|7447934|FG003|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526687|NCT01587703|7447935|FG004|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526688|NCT01587703|7447936|FG005|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526689|NCT01587703|7447937|FG006|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526690|NCT01587703|7447938|FG007|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526691|NCT01587703|7447939|FG008|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||3
6526692|NCT01587703|7447940|FG009|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||10
6526693|NCT01587703|7447941|FG010|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||5
6526694|NCT01587703|7447942|FG011|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526695|NCT01587703|7447943|FG012|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526696|NCT01587703|7447944|FG013|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526697|NCT01587703|7447945|FG014|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526698|NCT01587703|7447946|FG015|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526699|NCT01587703|7447947|FG016|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526700|NCT01587703|7447948|FG017|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526701|NCT01587703|7447949|FG018|NOT COMPLETED|Part1 BID(Median Exposure of 1.41months)||0
6526702|NCT01587703|7447931|FG000|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526703|NCT01587703|7447932|FG001|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6643070|NCT02351258|7571376|FG001|NOT COMPLETED|Intervention 2 (12 Months)||
6643071|NCT02351271|7571383|FG000|STARTED|Overall Study||68
6643072|NCT02351271|7571384|FG001|STARTED|Overall Study||62
6643073|NCT02351271|7571383|FG000|COMPLETED|Overall Study||68
6643074|NCT02351271|7571384|FG001|COMPLETED|Overall Study||62
6643075|NCT02351271|7571383|FG000|NOT COMPLETED|Overall Study||0
6643076|NCT02351271|7571384|FG001|NOT COMPLETED|Overall Study||0
6643077|NCT02351349|7571394|FG000|STARTED|Overall Study||6
6643078|NCT02351349|7571395|FG001|STARTED|Overall Study||8
6643079|NCT02351349|7571394|FG000|COMPLETED|Overall Study||4
6643080|NCT02351349|7571395|FG001|COMPLETED|Overall Study||5
6643081|NCT02351349|7571394|FG000|NOT COMPLETED|Overall Study||2
6643082|NCT02351349|7571395|FG001|NOT COMPLETED|Overall Study||3
6643083|NCT02351505|7571406|FG000|STARTED|Overall Study||1
6643084|NCT02351505|7571406|FG000|COMPLETED|Overall Study||1
6643085|NCT02351505|7571406|FG000|NOT COMPLETED|Overall Study||0
6643086|NCT02351700|7571413|FG000|STARTED|Overall Study||28
6643087|NCT02351700|7571414|FG001|STARTED|Overall Study||34
6643088|NCT02351700|7571413|FG000|COMPLETED|Overall Study||28
6643089|NCT02351700|7571414|FG001|COMPLETED|Overall Study||34
6643090|NCT02351700|7571413|FG000|NOT COMPLETED|Overall Study||0
6643091|NCT02351700|7571414|FG001|NOT COMPLETED|Overall Study||0
6643092|NCT02351739|7571424|FG000|STARTED|Overall Study||38
6643093|NCT02351739|7571425|FG001|STARTED|Overall Study||40
6643094|NCT02351739|7571424|FG000|Enrolled|Overall Study||38
6643095|NCT02351739|7571425|FG001|Enrolled|Overall Study||40
6643096|NCT02351739|7571424|FG000|Received Study Medication|Overall Study||35
6643097|NCT02351739|7571425|FG001|Received Study Medication|Overall Study||40
6643098|NCT02351739|7571424|FG000|Discontinued Study|Overall Study||38
6643099|NCT02351739|7571425|FG001|Discontinued Study|Overall Study||40
6643100|NCT02351739|7571424|FG000|COMPLETED|Overall Study||0
6526704|NCT01587703|7447933|FG002|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526705|NCT01587703|7447934|FG003|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526706|NCT01587703|7447935|FG004|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526707|NCT01587703|7447936|FG005|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526708|NCT01587703|7447937|FG006|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526709|NCT01587703|7447938|FG007|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526710|NCT01587703|7447939|FG008|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526711|NCT01587703|7447940|FG009|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526712|NCT01587703|7447941|FG010|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526713|NCT01587703|7447942|FG011|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526714|NCT01587703|7447943|FG012|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526715|NCT01587703|7447944|FG013|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526716|NCT01587703|7447945|FG014|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526717|NCT01587703|7447946|FG015|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526718|NCT01587703|7447947|FG016|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526719|NCT01587703|7447948|FG017|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
6526720|NCT01587703|7447949|FG018|STARTED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
6526721|NCT01587703|7447931|FG000|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526722|NCT01587703|7447932|FG001|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526723|NCT01587703|7447933|FG002|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526724|NCT01587703|7447934|FG003|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526725|NCT01587703|7447935|FG004|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526726|NCT01587703|7447936|FG005|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526727|NCT01587703|7447937|FG006|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526728|NCT01587703|7447938|FG007|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526729|NCT01587703|7447939|FG008|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526730|NCT01587703|7447940|FG009|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526731|NCT01587703|7447941|FG010|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526732|NCT01587703|7447942|FG011|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526733|NCT01587703|7447943|FG012|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526734|NCT01587703|7447944|FG013|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526735|NCT01587703|7447945|FG014|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526736|NCT01587703|7447946|FG015|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526737|NCT01587703|7447947|FG016|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526738|NCT01587703|7447948|FG017|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
6526739|NCT01587703|7447949|FG018|COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||5
6526740|NCT01587703|7447931|FG000|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526741|NCT01587703|7447932|FG001|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526742|NCT01587703|7447933|FG002|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526743|NCT01587703|7447934|FG003|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526744|NCT01587703|7447935|FG004|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526745|NCT01587703|7447936|FG005|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526746|NCT01587703|7447937|FG006|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526747|NCT01587703|7447938|FG007|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526748|NCT01587703|7447939|FG008|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6643101|NCT02351739|7571425|FG001|COMPLETED|Overall Study||0
6643102|NCT02351739|7571424|FG000|NOT COMPLETED|Overall Study||38
6643103|NCT02351739|7571425|FG001|NOT COMPLETED|Overall Study||40
6643104|NCT02351817|7571431|FG000|STARTED|Baseline Period||5
6643105|NCT02351817|7571432|FG001|STARTED|Baseline Period||5
6643106|NCT02351817|7571431|FG000|COMPLETED|Baseline Period||5
6643107|NCT02351817|7571432|FG001|COMPLETED|Baseline Period||5
6643108|NCT02351817|7571431|FG000|NOT COMPLETED|Baseline Period||0
6643109|NCT02351817|7571432|FG001|NOT COMPLETED|Baseline Period||0
6643110|NCT02351817|7571431|FG000|STARTED|Period 1||5
6643111|NCT02351817|7571432|FG001|STARTED|Period 1||5
6643112|NCT02351817|7571431|FG000|COMPLETED|Period 1||4
6643113|NCT02351817|7571432|FG001|COMPLETED|Period 1||2
6643114|NCT02351817|7571431|FG000|NOT COMPLETED|Period 1||1
6643115|NCT02351817|7571432|FG001|NOT COMPLETED|Period 1||3
6643116|NCT02351817|7571431|FG000|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
6643117|NCT02351817|7571432|FG001|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
6643118|NCT02351817|7571431|FG000|COMPLETED|Period 2||4
6643119|NCT02351817|7571432|FG001|COMPLETED|Period 2||3
6643120|NCT02351817|7571431|FG000|NOT COMPLETED|Period 2||1
6643121|NCT02351817|7571432|FG001|NOT COMPLETED|Period 2||2
6643122|NCT02351934|7571441|FG000|STARTED|Allocation||62
6643123|NCT02351934|7571442|FG001|STARTED|Allocation||61
6643124|NCT02351934|7571441|FG000|Received Allocation|Allocation||56
6643125|NCT02351934|7571442|FG001|Received Allocation|Allocation||61
6643126|NCT02351934|7571441|FG000|COMPLETED|Allocation||56
6643127|NCT02351934|7571442|FG001|COMPLETED|Allocation||61
6643128|NCT02351934|7571441|FG000|NOT COMPLETED|Allocation||6
6643129|NCT02351934|7571442|FG001|NOT COMPLETED|Allocation||0
6643130|NCT02351934|7571441|FG000|STARTED|Follow-Up||56
6643131|NCT02351934|7571442|FG001|STARTED|Follow-Up||61
6643132|NCT02351934|7571441|FG000|COMPLETED|Follow-Up||44
6643133|NCT02351934|7571442|FG001|COMPLETED|Follow-Up||51
6526749|NCT01587703|7447940|FG009|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526750|NCT01587703|7447941|FG010|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526751|NCT01587703|7447942|FG011|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526752|NCT01587703|7447943|FG012|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6643134|NCT02351934|7571441|FG000|NOT COMPLETED|Follow-Up||12
6643135|NCT02351934|7571442|FG001|NOT COMPLETED|Follow-Up||10
6643136|NCT02351960|7571450|FG000|STARTED|Overall Study||208
6643137|NCT02351960|7571451|FG001|STARTED|Overall Study||88
6643138|NCT02351960|7571450|FG000|COMPLETED|Overall Study||197
6643139|NCT02351960|7571451|FG001|COMPLETED|Overall Study||76
6643140|NCT02351960|7571450|FG000|NOT COMPLETED|Overall Study||11
6643141|NCT02351960|7571451|FG001|NOT COMPLETED|Overall Study||12
6643142|NCT02352259|7571458|FG000|STARTED|Overall Study||23
6643143|NCT02352259|7571458|FG000|COMPLETED|Overall Study||23
6643144|NCT02352259|7571458|FG000|NOT COMPLETED|Overall Study||0
6643145|NCT02352298|7571462|FG000|STARTED|Overall Study||52
6643146|NCT02352298|7571462|FG000|COMPLETED|Overall Study||52
6643147|NCT02352298|7571462|FG000|NOT COMPLETED|Overall Study||0
6643148|NCT02352363|7571469|FG000|STARTED|Overall Study||278
6643149|NCT02352363|7571470|FG001|STARTED|Overall Study||130
6643150|NCT02352363|7571469|FG000|COMPLETED|Overall Study||271
6643151|NCT02352363|7571470|FG001|COMPLETED|Overall Study||127
6643152|NCT02352363|7571469|FG000|NOT COMPLETED|Overall Study||7
6643153|NCT02352363|7571470|FG001|NOT COMPLETED|Overall Study||3
6643154|NCT02352493|7571494|FG000|STARTED|Overall Study||8
6643155|NCT02352493|7571495|FG001|STARTED|Overall Study||3
6643156|NCT02352493|7571496|FG002|STARTED|Overall Study||3
6643157|NCT02352493|7571497|FG003|STARTED|Overall Study||3
6643158|NCT02352493|7571498|FG004|STARTED|Overall Study||3
6643159|NCT02352493|7571499|FG005|STARTED|Overall Study||3
6643160|NCT02352493|7571500|FG006|STARTED|Overall Study||3
6643161|NCT02352493|7571501|FG007|STARTED|Overall Study||3
6643162|NCT02352493|7571502|FG008|STARTED|Overall Study||3
6643163|NCT02352493|7571503|FG009|STARTED|Overall Study||6
6643164|NCT02352493|7571504|FG010|STARTED|Overall Study||3
6643165|NCT02352493|7571505|FG011|STARTED|Overall Study||3
6643166|NCT02352493|7571506|FG012|STARTED|Overall Study||3
6643167|NCT02352493|7571507|FG013|STARTED|Overall Study||3
6643168|NCT02352493|7571508|FG014|STARTED|Overall Study||3
6643169|NCT02352493|7571509|FG015|STARTED|Overall Study||3
6643170|NCT02352493|7571510|FG016|STARTED|Overall Study||3
6643171|NCT02352493|7571511|FG017|STARTED|Overall Study||3
6643172|NCT02352493|7571494|FG000|COMPLETED|Overall Study||8
6643173|NCT02352493|7571495|FG001|COMPLETED|Overall Study||3
6643174|NCT02352493|7571496|FG002|COMPLETED|Overall Study||3
6643175|NCT02352493|7571497|FG003|COMPLETED|Overall Study||3
6643176|NCT02352493|7571498|FG004|COMPLETED|Overall Study||3
6643177|NCT02352493|7571499|FG005|COMPLETED|Overall Study||3
6643178|NCT02352493|7571500|FG006|COMPLETED|Overall Study||2
6643179|NCT02352493|7571501|FG007|COMPLETED|Overall Study||3
6643180|NCT02352493|7571502|FG008|COMPLETED|Overall Study||1
6643181|NCT02352493|7571503|FG009|COMPLETED|Overall Study||5
6643182|NCT02352493|7571504|FG010|COMPLETED|Overall Study||3
6643183|NCT02352493|7571505|FG011|COMPLETED|Overall Study||3
6643184|NCT02352493|7571506|FG012|COMPLETED|Overall Study||2
6643185|NCT02352493|7571507|FG013|COMPLETED|Overall Study||1
6643186|NCT02352493|7571508|FG014|COMPLETED|Overall Study||2
6643187|NCT02352493|7571509|FG015|COMPLETED|Overall Study||3
6643188|NCT02352493|7571510|FG016|COMPLETED|Overall Study||3
6643189|NCT02352493|7571511|FG017|COMPLETED|Overall Study||3
6643190|NCT02352493|7571494|FG000|NOT COMPLETED|Overall Study||0
6643191|NCT02352493|7571495|FG001|NOT COMPLETED|Overall Study||0
6643192|NCT02352493|7571496|FG002|NOT COMPLETED|Overall Study||0
6643193|NCT02352493|7571497|FG003|NOT COMPLETED|Overall Study||0
6643194|NCT02352493|7571498|FG004|NOT COMPLETED|Overall Study||0
6643195|NCT02352493|7571499|FG005|NOT COMPLETED|Overall Study||0
6643196|NCT02352493|7571500|FG006|NOT COMPLETED|Overall Study||1
6643197|NCT02352493|7571501|FG007|NOT COMPLETED|Overall Study||0
6643198|NCT02352493|7571502|FG008|NOT COMPLETED|Overall Study||2
6643199|NCT02352493|7571503|FG009|NOT COMPLETED|Overall Study||1
6643200|NCT02352493|7571504|FG010|NOT COMPLETED|Overall Study||0
6643201|NCT02352493|7571505|FG011|NOT COMPLETED|Overall Study||0
6643202|NCT02352493|7571506|FG012|NOT COMPLETED|Overall Study||1
6643203|NCT02352493|7571507|FG013|NOT COMPLETED|Overall Study||2
6643204|NCT02352493|7571508|FG014|NOT COMPLETED|Overall Study||1
6643205|NCT02352493|7571509|FG015|NOT COMPLETED|Overall Study||0
6643206|NCT02352493|7571510|FG016|NOT COMPLETED|Overall Study||0
6643207|NCT02352493|7571511|FG017|NOT COMPLETED|Overall Study||0
6643208|NCT02352779|7571569|FG000|STARTED|Overall Study||37
6643209|NCT02352779|7571570|FG001|STARTED|Overall Study||36
6643210|NCT02352779|7571571|FG002|STARTED|Overall Study||35
6643211|NCT02352779|7571569|FG000|COMPLETED|Overall Study||29
6643212|NCT02352779|7571570|FG001|COMPLETED|Overall Study||35
6643213|NCT02352779|7571571|FG002|COMPLETED|Overall Study||33
6643214|NCT02352779|7571569|FG000|NOT COMPLETED|Overall Study||8
6643215|NCT02352779|7571570|FG001|NOT COMPLETED|Overall Study||1
6643216|NCT02352779|7571571|FG002|NOT COMPLETED|Overall Study||2
6643217|NCT02352831|7571581|FG000|STARTED|Overall Study||6
6643218|NCT02352831|7571582|FG001|STARTED|Overall Study||10
6643219|NCT02352831|7571581|FG000|COMPLETED|Overall Study||6
6643220|NCT02352831|7571582|FG001|COMPLETED|Overall Study||10
6643221|NCT02352831|7571581|FG000|NOT COMPLETED|Overall Study||0
6526753|NCT01587703|7447944|FG013|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526754|NCT01587703|7447945|FG014|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526755|NCT01587703|7447946|FG015|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526756|NCT01587703|7447947|FG016|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526757|NCT01587703|7447948|FG017|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526758|NCT01587703|7447949|FG018|NOT COMPLETED|Substudy-Period(P)1, Week1(Day1 to Day3)||0
6526759|NCT01587703|7447931|FG000|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526760|NCT01587703|7447932|FG001|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526761|NCT01587703|7447933|FG002|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526762|NCT01587703|7447934|FG003|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526763|NCT01587703|7447935|FG004|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526764|NCT01587703|7447936|FG005|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526765|NCT01587703|7447937|FG006|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526766|NCT01587703|7447938|FG007|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526767|NCT01587703|7447939|FG008|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526768|NCT01587703|7447940|FG009|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526769|NCT01587703|7447941|FG010|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526770|NCT01587703|7447942|FG011|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526771|NCT01587703|7447943|FG012|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526772|NCT01587703|7447944|FG013|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526773|NCT01587703|7447945|FG014|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526774|NCT01587703|7447946|FG015|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526775|NCT01587703|7447947|FG016|STARTED|Substudy-P2, Week1Day3 to Week2Day1||0
6526776|NCT01587703|7447948|FG017|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
6526777|NCT01587703|7447949|FG018|STARTED|Substudy-P2, Week1Day3 to Week2Day1||5
6526778|NCT01587703|7447931|FG000|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526779|NCT01587703|7447932|FG001|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526780|NCT01587703|7447933|FG002|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526781|NCT01587703|7447934|FG003|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526782|NCT01587703|7447935|FG004|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526783|NCT01587703|7447936|FG005|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526784|NCT01587703|7447937|FG006|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526785|NCT01587703|7447938|FG007|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526786|NCT01587703|7447939|FG008|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526787|NCT01587703|7447940|FG009|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526788|NCT01587703|7447941|FG010|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526789|NCT01587703|7447942|FG011|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526790|NCT01587703|7447943|FG012|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526791|NCT01587703|7447944|FG013|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526792|NCT01587703|7447945|FG014|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526793|NCT01587703|7447946|FG015|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526794|NCT01587703|7447947|FG016|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526795|NCT01587703|7447948|FG017|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
6526796|NCT01587703|7447949|FG018|COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||5
6526797|NCT01587703|7447931|FG000|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526798|NCT01587703|7447932|FG001|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526799|NCT01587703|7447933|FG002|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6643222|NCT02352831|7571582|FG001|NOT COMPLETED|Overall Study||0
6643223|NCT02352844|7571590|FG000|STARTED|Overall Study||12
6643224|NCT02352844|7571590|FG000|COMPLETED|Overall Study||12
6643225|NCT02352844|7571590|FG000|NOT COMPLETED|Overall Study||0
6643226|NCT02352922|7571596|FG000|STARTED|Overall Study||32
6643227|NCT02352922|7571597|FG001|STARTED|Overall Study||32
6643228|NCT02352922|7571596|FG000|COMPLETED|Overall Study|completed POD14 Survey|28
6643229|NCT02352922|7571597|FG001|COMPLETED|Overall Study|Completed POD14 survey|28
6643230|NCT02352922|7571596|FG000|NOT COMPLETED|Overall Study||4
6643231|NCT02352922|7571597|FG001|NOT COMPLETED|Overall Study||4
6643232|NCT02352974|7571603|FG000|STARTED|Main Study||12
6643233|NCT02352974|7571603|FG000|COMPLETED|Main Study||12
6643234|NCT02352974|7571603|FG000|NOT COMPLETED|Main Study||0
6643235|NCT02352974|7571603|FG000|STARTED|Extension|Only 3 out of the 12 patients who completed the main study continued in to the extension period.|3
6643236|NCT02352974|7571603|FG000|COMPLETED|Extension||3
6643237|NCT02352974|7571603|FG000|NOT COMPLETED|Extension||0
6643238|NCT02353091|7571609|FG000|STARTED|Overall Study||13
6643239|NCT02353091|7571610|FG001|STARTED|Overall Study||13
6643240|NCT02353091|7571609|FG000|COMPLETED|Overall Study||13
6643241|NCT02353091|7571610|FG001|COMPLETED|Overall Study||13
6643242|NCT02353091|7571609|FG000|NOT COMPLETED|Overall Study||0
6643243|NCT02353091|7571610|FG001|NOT COMPLETED|Overall Study||0
6643244|NCT02353169|7571629|FG000|STARTED|Overall Study||15
6643245|NCT02353169|7571630|FG001|STARTED|Overall Study||18
6643246|NCT02353169|7571631|FG002|STARTED|Overall Study||16
6643247|NCT02353169|7571632|FG003|STARTED|Overall Study||15
6643248|NCT02353169|7571629|FG000|COMPLETED|Overall Study||12
6643249|NCT02353169|7571630|FG001|COMPLETED|Overall Study||12
6643250|NCT02353169|7571631|FG002|COMPLETED|Overall Study||12
6643251|NCT02353169|7571632|FG003|COMPLETED|Overall Study||12
6643252|NCT02353169|7571629|FG000|NOT COMPLETED|Overall Study||3
6643253|NCT02353169|7571630|FG001|NOT COMPLETED|Overall Study||6
6526800|NCT01587703|7447934|FG003|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526801|NCT01587703|7447935|FG004|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526802|NCT01587703|7447936|FG005|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526803|NCT01587703|7447937|FG006|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526804|NCT01587703|7447938|FG007|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526805|NCT01587703|7447939|FG008|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526806|NCT01587703|7447940|FG009|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526807|NCT01587703|7447941|FG010|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526808|NCT01587703|7447942|FG011|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526809|NCT01587703|7447943|FG012|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526810|NCT01587703|7447944|FG013|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526811|NCT01587703|7447945|FG014|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526812|NCT01587703|7447946|FG015|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526813|NCT01587703|7447947|FG016|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526814|NCT01587703|7447948|FG017|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526815|NCT01587703|7447949|FG018|NOT COMPLETED|Substudy-P2, Week1Day3 to Week2Day1||0
6526816|NCT01587703|7447931|FG000|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526817|NCT01587703|7447932|FG001|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526818|NCT01587703|7447933|FG002|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526819|NCT01587703|7447934|FG003|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526820|NCT01587703|7447935|FG004|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526821|NCT01587703|7447936|FG005|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526822|NCT01587703|7447937|FG006|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526823|NCT01587703|7447938|FG007|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526824|NCT01587703|7447939|FG008|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526825|NCT01587703|7447940|FG009|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526826|NCT01587703|7447941|FG010|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526827|NCT01587703|7447942|FG011|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526828|NCT01587703|7447943|FG012|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526829|NCT01587703|7447944|FG013|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526830|NCT01587703|7447945|FG014|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526831|NCT01587703|7447946|FG015|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526832|NCT01587703|7447947|FG016|STARTED|Substudy-P3, Week2Day1 to Week2Day3||0
6526833|NCT01587703|7447948|FG017|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
6526834|NCT01587703|7447949|FG018|STARTED|Substudy-P3, Week2Day1 to Week2Day3||5
6526835|NCT01587703|7447931|FG000|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526836|NCT01587703|7447932|FG001|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526837|NCT01587703|7447933|FG002|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526838|NCT01587703|7447934|FG003|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526839|NCT01587703|7447935|FG004|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526840|NCT01587703|7447936|FG005|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526841|NCT01587703|7447937|FG006|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526842|NCT01587703|7447938|FG007|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526843|NCT01587703|7447939|FG008|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526844|NCT01587703|7447940|FG009|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526845|NCT01587703|7447941|FG010|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526846|NCT01587703|7447942|FG011|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526847|NCT01587703|7447943|FG012|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526848|NCT01587703|7447944|FG013|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526849|NCT01587703|7447945|FG014|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526850|NCT01587703|7447946|FG015|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526851|NCT01587703|7447947|FG016|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526852|NCT01587703|7447948|FG017|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
6526853|NCT01587703|7447949|FG018|COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||5
6526854|NCT01587703|7447931|FG000|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526855|NCT01587703|7447932|FG001|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526856|NCT01587703|7447933|FG002|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526857|NCT01587703|7447934|FG003|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526858|NCT01587703|7447935|FG004|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526859|NCT01587703|7447936|FG005|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526860|NCT01587703|7447937|FG006|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526861|NCT01587703|7447938|FG007|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526862|NCT01587703|7447939|FG008|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526863|NCT01587703|7447940|FG009|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526864|NCT01587703|7447941|FG010|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526865|NCT01587703|7447942|FG011|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526866|NCT01587703|7447943|FG012|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526867|NCT01587703|7447944|FG013|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526868|NCT01587703|7447945|FG014|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526869|NCT01587703|7447946|FG015|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526870|NCT01587703|7447947|FG016|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526871|NCT01587703|7447948|FG017|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526872|NCT01587703|7447949|FG018|NOT COMPLETED|Substudy-P3, Week2Day1 to Week2Day3||0
6526873|NCT01587703|7447931|FG000|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6561842|NCT01797302|7484754|FG002|STARTED|Overall Study||76
6526874|NCT01587703|7447932|FG001|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526875|NCT01587703|7447933|FG002|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526876|NCT01587703|7447934|FG003|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526877|NCT01587703|7447935|FG004|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526878|NCT01587703|7447936|FG005|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526879|NCT01587703|7447937|FG006|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526880|NCT01587703|7447938|FG007|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526881|NCT01587703|7447939|FG008|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526882|NCT01587703|7447940|FG009|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526883|NCT01587703|7447941|FG010|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526884|NCT01587703|7447942|FG011|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526885|NCT01587703|7447943|FG012|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526886|NCT01587703|7447944|FG013|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526887|NCT01587703|7447945|FG014|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526888|NCT01587703|7447946|FG015|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526889|NCT01587703|7447947|FG016|STARTED|Substudy-P4,Maximum Exposure of 5.5month||0
6526890|NCT01587703|7447948|FG017|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
6526891|NCT01587703|7447949|FG018|STARTED|Substudy-P4,Maximum Exposure of 5.5month||5
6526892|NCT01587703|7447931|FG000|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526893|NCT01587703|7447932|FG001|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526894|NCT01587703|7447933|FG002|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526895|NCT01587703|7447934|FG003|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526896|NCT01587703|7447935|FG004|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526897|NCT01587703|7447936|FG005|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526898|NCT01587703|7447937|FG006|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526899|NCT01587703|7447938|FG007|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526900|NCT01587703|7447939|FG008|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526901|NCT01587703|7447940|FG009|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526902|NCT01587703|7447941|FG010|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526903|NCT01587703|7447942|FG011|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526904|NCT01587703|7447943|FG012|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6643254|NCT02353169|7571631|FG002|NOT COMPLETED|Overall Study||4
6643255|NCT02353169|7571632|FG003|NOT COMPLETED|Overall Study||3
6643256|NCT02353299|7571642|FG000|STARTED|First Intervention (1 Night)||13
6643257|NCT02353299|7571643|FG001|STARTED|First Intervention (1 Night)||13
6643258|NCT02353299|7571644|FG002|STARTED|First Intervention (1 Night)||13
6643259|NCT02353299|7571645|FG003|STARTED|First Intervention (1 Night)||13
6643260|NCT02353299|7571642|FG000|COMPLETED|First Intervention (1 Night)||13
6643261|NCT02353299|7571643|FG001|COMPLETED|First Intervention (1 Night)||13
6643262|NCT02353299|7571644|FG002|COMPLETED|First Intervention (1 Night)||13
6643263|NCT02353299|7571645|FG003|COMPLETED|First Intervention (1 Night)||13
6643264|NCT02353299|7571642|FG000|NOT COMPLETED|First Intervention (1 Night)||0
6643265|NCT02353299|7571643|FG001|NOT COMPLETED|First Intervention (1 Night)||0
6643266|NCT02353299|7571644|FG002|NOT COMPLETED|First Intervention (1 Night)||0
6643267|NCT02353299|7571645|FG003|NOT COMPLETED|First Intervention (1 Night)||0
6643268|NCT02353299|7571642|FG000|STARTED|Second Intervention (1 Night)||13
6643269|NCT02353299|7571643|FG001|STARTED|Second Intervention (1 Night)||13
6643270|NCT02353299|7571644|FG002|STARTED|Second Intervention (1 Night)||13
6643271|NCT02353299|7571645|FG003|STARTED|Second Intervention (1 Night)||13
6643272|NCT02353299|7571642|FG000|COMPLETED|Second Intervention (1 Night)||13
6643273|NCT02353299|7571643|FG001|COMPLETED|Second Intervention (1 Night)||13
6643274|NCT02353299|7571644|FG002|COMPLETED|Second Intervention (1 Night)||13
6643275|NCT02353299|7571645|FG003|COMPLETED|Second Intervention (1 Night)||13
6643276|NCT02353299|7571642|FG000|NOT COMPLETED|Second Intervention (1 Night)||0
6643277|NCT02353299|7571643|FG001|NOT COMPLETED|Second Intervention (1 Night)||0
6643278|NCT02353299|7571644|FG002|NOT COMPLETED|Second Intervention (1 Night)||0
6643279|NCT02353299|7571645|FG003|NOT COMPLETED|Second Intervention (1 Night)||0
6643280|NCT02353299|7571642|FG000|STARTED|Third Intervention (1 Night)||13
6643281|NCT02353299|7571643|FG001|STARTED|Third Intervention (1 Night)||13
6643282|NCT02353299|7571644|FG002|STARTED|Third Intervention (1 Night)||13
6643283|NCT02353299|7571645|FG003|STARTED|Third Intervention (1 Night)||13
6643284|NCT02353299|7571642|FG000|COMPLETED|Third Intervention (1 Night)||13
6643285|NCT02353299|7571643|FG001|COMPLETED|Third Intervention (1 Night)||13
6643286|NCT02353299|7571644|FG002|COMPLETED|Third Intervention (1 Night)||13
6643287|NCT02353299|7571645|FG003|COMPLETED|Third Intervention (1 Night)||13
6643288|NCT02353299|7571642|FG000|NOT COMPLETED|Third Intervention (1 Night)||0
6643289|NCT02353299|7571643|FG001|NOT COMPLETED|Third Intervention (1 Night)||0
6643290|NCT02353299|7571644|FG002|NOT COMPLETED|Third Intervention (1 Night)||0
6643291|NCT02353299|7571645|FG003|NOT COMPLETED|Third Intervention (1 Night)||0
6643292|NCT02353299|7571642|FG000|STARTED|Fourth Intervention (1 Night)||13
6643293|NCT02353299|7571643|FG001|STARTED|Fourth Intervention (1 Night)|One patient withdrawn from study prior to start of fourth intervention.|12
6643294|NCT02353299|7571644|FG002|STARTED|Fourth Intervention (1 Night)||13
6643295|NCT02353299|7571645|FG003|STARTED|Fourth Intervention (1 Night)||13
6643296|NCT02353299|7571642|FG000|COMPLETED|Fourth Intervention (1 Night)||13
6643297|NCT02353299|7571643|FG001|COMPLETED|Fourth Intervention (1 Night)||12
6526905|NCT01587703|7447944|FG013|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526906|NCT01587703|7447945|FG014|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526907|NCT01587703|7447946|FG015|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526908|NCT01587703|7447947|FG016|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526909|NCT01587703|7447948|FG017|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526910|NCT01587703|7447949|FG018|COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526911|NCT01587703|7447931|FG000|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526912|NCT01587703|7447932|FG001|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526913|NCT01587703|7447933|FG002|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526914|NCT01587703|7447934|FG003|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526915|NCT01587703|7447935|FG004|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526916|NCT01587703|7447936|FG005|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526917|NCT01587703|7447937|FG006|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526918|NCT01587703|7447938|FG007|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526919|NCT01587703|7447939|FG008|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6643298|NCT02353299|7571644|FG002|COMPLETED|Fourth Intervention (1 Night)||13
6643299|NCT02353299|7571645|FG003|COMPLETED|Fourth Intervention (1 Night)||13
6643300|NCT02353299|7571642|FG000|NOT COMPLETED|Fourth Intervention (1 Night)||0
6643301|NCT02353299|7571643|FG001|NOT COMPLETED|Fourth Intervention (1 Night)||0
6643302|NCT02353299|7571644|FG002|NOT COMPLETED|Fourth Intervention (1 Night)||0
6643303|NCT02353299|7571645|FG003|NOT COMPLETED|Fourth Intervention (1 Night)||0
6643304|NCT02353442|7571665|FG000|STARTED|Overall Study||28
6643305|NCT02353442|7571666|FG001|STARTED|Overall Study||31
6643306|NCT02353442|7571665|FG000|COMPLETED|Overall Study||25
6643307|NCT02353442|7571666|FG001|COMPLETED|Overall Study||27
6643308|NCT02353442|7571665|FG000|NOT COMPLETED|Overall Study||3
6643309|NCT02353442|7571666|FG001|NOT COMPLETED|Overall Study||4
6643310|NCT02353754|7571674|FG000|STARTED|Overall Study||12
6643311|NCT02353754|7571675|FG001|STARTED|Overall Study||0
6643312|NCT02353754|7571674|FG000|COMPLETED|Overall Study||10
6643313|NCT02353754|7571675|FG001|COMPLETED|Overall Study||0
6643314|NCT02353754|7571674|FG000|NOT COMPLETED|Overall Study||2
6643315|NCT02353754|7571675|FG001|NOT COMPLETED|Overall Study||0
6643316|NCT02353780|7571684|FG000|STARTED|Overall Study||3
6643317|NCT02353780|7571685|FG001|STARTED|Overall Study||3
6643318|NCT02353780|7571686|FG002|STARTED|Overall Study||3
6643319|NCT02353780|7571684|FG000|COMPLETED|Overall Study||3
6643320|NCT02353780|7571685|FG001|COMPLETED|Overall Study||3
6643321|NCT02353780|7571686|FG002|COMPLETED|Overall Study||3
6643322|NCT02353780|7571684|FG000|NOT COMPLETED|Overall Study||0
6643323|NCT02353780|7571685|FG001|NOT COMPLETED|Overall Study||0
6643324|NCT02353780|7571686|FG002|NOT COMPLETED|Overall Study||0
6643325|NCT02353806|7571694|FG000|STARTED|Overall Study||16
6643326|NCT02353806|7571694|FG000|COMPLETED|Overall Study||6
6643327|NCT02353806|7571694|FG000|NOT COMPLETED|Overall Study||10
6643328|NCT02353871|7571702|FG000|STARTED|Overall Study|Randomised.|125
6643329|NCT02353871|7571703|FG001|STARTED|Overall Study|Randomised. Included a subject who was randomised by mistake (excluded from mITT population).|60
6643330|NCT02353871|7571702|FG000|COMPLETED|Overall Study||122
6643331|NCT02353871|7571703|FG001|COMPLETED|Overall Study||51
6643332|NCT02353871|7571702|FG000|NOT COMPLETED|Overall Study||3
6643333|NCT02353871|7571703|FG001|NOT COMPLETED|Overall Study||9
6643334|NCT02354092|7571711|FG000|STARTED|Overall Study||7
6643335|NCT02354092|7571712|FG001|STARTED|Overall Study||7
6643336|NCT02354092|7571711|FG000|COMPLETED|Overall Study||7
6643337|NCT02354092|7571712|FG001|COMPLETED|Overall Study||7
6643338|NCT02354092|7571711|FG000|NOT COMPLETED|Overall Study||0
6643339|NCT02354092|7571712|FG001|NOT COMPLETED|Overall Study||0
6643340|NCT02354144|7571720|FG000|STARTED|Overall Study||127
6643341|NCT02354144|7571721|FG001|STARTED|Overall Study||128
6643342|NCT02354144|7571720|FG000|COMPLETED|Overall Study|Participants completed all 7 study visits.|48
6643343|NCT02354144|7571721|FG001|COMPLETED|Overall Study|Participants completed all 7 study visits.|51
6643344|NCT02354144|7571720|FG000|NOT COMPLETED|Overall Study||79
6643345|NCT02354144|7571721|FG001|NOT COMPLETED|Overall Study||77
6643346|NCT02354222|7571729|FG000|STARTED|Overall Study||77
6643347|NCT02354222|7571730|FG001|STARTED|Overall Study||77
6643348|NCT02354222|7571729|FG000|COMPLETED|Overall Study||73
6643349|NCT02354222|7571730|FG001|COMPLETED|Overall Study||66
6643350|NCT02354222|7571729|FG000|NOT COMPLETED|Overall Study||4
6643351|NCT02354222|7571730|FG001|NOT COMPLETED|Overall Study||11
6643352|NCT02354235|7571738|FG000|STARTED|Overall Study||70
6643353|NCT02354235|7571739|FG001|STARTED|Overall Study||68
6643354|NCT02354235|7571738|FG000|COMPLETED|Overall Study||67
6643355|NCT02354235|7571739|FG001|COMPLETED|Overall Study||61
6643356|NCT02354235|7571738|FG000|NOT COMPLETED|Overall Study||3
6643357|NCT02354235|7571739|FG001|NOT COMPLETED|Overall Study||7
6643358|NCT02354339|7571747|FG000|STARTED|Overall Study||12
6643359|NCT02354339|7571748|FG001|STARTED|Overall Study||12
6643360|NCT02354339|7571747|FG000|COMPLETED|Overall Study||12
6643361|NCT02354339|7571748|FG001|COMPLETED|Overall Study||12
6643362|NCT02354339|7571747|FG000|NOT COMPLETED|Overall Study||0
6643363|NCT02354339|7571748|FG001|NOT COMPLETED|Overall Study||0
6643364|NCT02354352|7571756|FG000|STARTED|Overall Study||26
6643365|NCT02354352|7571757|FG001|STARTED|Overall Study||26
6643366|NCT02354352|7571756|FG000|2 Weeks|Overall Study||26
6643367|NCT02354352|7571757|FG001|2 Weeks|Overall Study||25
6526920|NCT01587703|7447940|FG009|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526921|NCT01587703|7447941|FG010|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526922|NCT01587703|7447942|FG011|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526923|NCT01587703|7447943|FG012|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526924|NCT01587703|7447944|FG013|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526925|NCT01587703|7447945|FG014|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526926|NCT01587703|7447946|FG015|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526927|NCT01587703|7447947|FG016|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||0
6526928|NCT01587703|7447948|FG017|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
6526929|NCT01587703|7447949|FG018|NOT COMPLETED|Substudy-P4,Maximum Exposure of 5.5month||5
6526930|NCT01587703|7447931|FG000|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526931|NCT01587703|7447932|FG001|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526932|NCT01587703|7447933|FG002|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526933|NCT01587703|7447934|FG003|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526934|NCT01587703|7447935|FG004|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526935|NCT01587703|7447936|FG005|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526936|NCT01587703|7447937|FG006|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526937|NCT01587703|7447938|FG007|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526938|NCT01587703|7447939|FG008|STARTED|Part2(Median Exposure of 1.41 Months)||0
6643368|NCT02354352|7571756|FG000|1 Month|Overall Study||24
6643369|NCT02354352|7571757|FG001|1 Month|Overall Study||23
6643370|NCT02354352|7571756|FG000|2 Months|Overall Study||24
6643371|NCT02354352|7571757|FG001|2 Months|Overall Study||22
6643372|NCT02354352|7571756|FG000|3 Months|Overall Study||25
6643373|NCT02354352|7571757|FG001|3 Months|Overall Study||23
6643374|NCT02354352|7571756|FG000|6 Months|Overall Study||25
6643375|NCT02354352|7571757|FG001|6 Months|Overall Study||23
6643376|NCT02354352|7571756|FG000|9 Months|Overall Study||25
6643377|NCT02354352|7571757|FG001|9 Months|Overall Study||23
6643378|NCT02354352|7571756|FG000|COMPLETED|Overall Study||23
6643379|NCT02354352|7571757|FG001|COMPLETED|Overall Study||23
6643380|NCT02354352|7571756|FG000|NOT COMPLETED|Overall Study||3
6643381|NCT02354352|7571757|FG001|NOT COMPLETED|Overall Study||3
6643382|NCT02354378|7571765|FG000|STARTED|Overall Study||64
6643383|NCT02354378|7571766|FG001|STARTED|Overall Study||20
6643384|NCT02354378|7571765|FG000|COMPLETED|Overall Study||30
6643385|NCT02354378|7571766|FG001|COMPLETED|Overall Study||16
6643386|NCT02354378|7571765|FG000|NOT COMPLETED|Overall Study||34
6643387|NCT02354378|7571766|FG001|NOT COMPLETED|Overall Study||4
6643388|NCT02354417|7571772|FG000|STARTED|Overall Study||3
6643389|NCT02354417|7571772|FG000|COMPLETED|Overall Study||2
6643390|NCT02354417|7571772|FG000|NOT COMPLETED|Overall Study||1
6643391|NCT02354443|7571776|FG000|STARTED|Overall Study||1
6643392|NCT02354443|7571776|FG000|COMPLETED|Overall Study||1
6643393|NCT02354443|7571776|FG000|NOT COMPLETED|Overall Study||0
6643394|NCT02354482|7571780|FG000|STARTED|Patient Communication and Care||2158
6643395|NCT02354482|7571780|FG000|COMPLETED|Patient Communication and Care||2158
6643396|NCT02354482|7571780|FG000|NOT COMPLETED|Patient Communication and Care||0
6643397|NCT02354482|7571780|FG000|STARTED|Home-Based Trust and Plain Language||1979
6643398|NCT02354482|7571780|FG000|COMPLETED|Home-Based Trust and Plain Language||1979
6643399|NCT02354482|7571780|FG000|NOT COMPLETED|Home-Based Trust and Plain Language||0
6643400|NCT02354482|7571780|FG000|STARTED|Hospital-Based Trust and Plain Language||2090
6643401|NCT02354482|7571780|FG000|COMPLETED|Hospital-Based Trust and Plain Language||2090
6643402|NCT02354482|7571780|FG000|NOT COMPLETED|Hospital-Based Trust and Plain Language||0
6643403|NCT02354482|7571780|FG000|STARTED|Patient/Family Caregiver Assessment||3093
6643404|NCT02354482|7571780|FG000|COMPLETED|Patient/Family Caregiver Assessment||3093
6643405|NCT02354482|7571780|FG000|NOT COMPLETED|Patient/Family Caregiver Assessment||0
6643406|NCT02354482|7571780|FG000|STARTED|Assessment and Teach Back||508
6643407|NCT02354482|7571780|FG000|COMPLETED|Assessment and Teach Back||508
6643408|NCT02354482|7571780|FG000|NOT COMPLETED|Assessment and Teach Back||0
6643409|NCT02354482|7571780|FG000|STARTED|Reference||2042
6643410|NCT02354482|7571780|FG000|COMPLETED|Reference||2042
6643411|NCT02354482|7571780|FG000|NOT COMPLETED|Reference||0
6643412|NCT02354508|7571797|FG000|STARTED|Period 1: Core Phase||41
6643413|NCT02354508|7571798|FG001|STARTED|Period 1: Core Phase||29
6643414|NCT02354508|7571799|FG002|STARTED|Period 1: Core Phase||53
6643415|NCT02354508|7571797|FG000|COMPLETED|Period 1: Core Phase||39
6643416|NCT02354508|7571798|FG001|COMPLETED|Period 1: Core Phase||27
6643417|NCT02354508|7571799|FG002|COMPLETED|Period 1: Core Phase||47
6643418|NCT02354508|7571797|FG000|NOT COMPLETED|Period 1: Core Phase||2
6643419|NCT02354508|7571798|FG001|NOT COMPLETED|Period 1: Core Phase||2
6643420|NCT02354508|7571799|FG002|NOT COMPLETED|Period 1: Core Phase||6
6643421|NCT02354508|7571797|FG000|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|26
6643422|NCT02354508|7571798|FG001|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|23
6643423|NCT02354508|7571799|FG002|STARTED|Period 2: Extension Phase|not all patients who completed the Core phase went into the Extension phase|39
6643424|NCT02354508|7571797|FG000|COMPLETED|Period 2: Extension Phase||20
6643425|NCT02354508|7571798|FG001|COMPLETED|Period 2: Extension Phase||19
6643426|NCT02354508|7571799|FG002|COMPLETED|Period 2: Extension Phase||36
6643427|NCT02354508|7571797|FG000|NOT COMPLETED|Period 2: Extension Phase||6
6643428|NCT02354508|7571798|FG001|NOT COMPLETED|Period 2: Extension Phase||4
6526939|NCT01587703|7447940|FG009|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526940|NCT01587703|7447941|FG010|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526941|NCT01587703|7447942|FG011|STARTED|Part2(Median Exposure of 1.41 Months)||12
6526942|NCT01587703|7447943|FG012|STARTED|Part2(Median Exposure of 1.41 Months)||14
6526943|NCT01587703|7447944|FG013|STARTED|Part2(Median Exposure of 1.41 Months)||23
6526944|NCT01587703|7447945|FG014|STARTED|Part2(Median Exposure of 1.41 Months)||19
6526945|NCT01587703|7447946|FG015|STARTED|Part2(Median Exposure of 1.41 Months)||21
6526946|NCT01587703|7447947|FG016|STARTED|Part2(Median Exposure of 1.41 Months)||13
6526947|NCT01587703|7447948|FG017|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526948|NCT01587703|7447949|FG018|STARTED|Part2(Median Exposure of 1.41 Months)||0
6526949|NCT01587703|7447931|FG000|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526950|NCT01587703|7447932|FG001|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526951|NCT01587703|7447933|FG002|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526952|NCT01587703|7447934|FG003|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526953|NCT01587703|7447935|FG004|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6643429|NCT02354508|7571799|FG002|NOT COMPLETED|Period 2: Extension Phase||3
6643430|NCT02354508|7571797|FG000|STARTED|Period 3: Post-treatment Follow up Phase||26
6643431|NCT02354508|7571798|FG001|STARTED|Period 3: Post-treatment Follow up Phase||23
6643432|NCT02354508|7571799|FG002|STARTED|Period 3: Post-treatment Follow up Phase||39
6643433|NCT02354508|7571797|FG000|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|4
6643434|NCT02354508|7571798|FG001|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
6643435|NCT02354508|7571799|FG002|Entered Post-treatment f/up Discontinued|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, discontinued|3
6643436|NCT02354508|7571797|FG000|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|22
6643437|NCT02354508|7571798|FG001|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|20
6643438|NCT02354508|7571799|FG002|COMPLETED|Period 3: Post-treatment Follow up Phase|Entered post-treatment follow-up, completed|36
6643439|NCT02354508|7571797|FG000|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||4
6643440|NCT02354508|7571798|FG001|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
6643441|NCT02354508|7571799|FG002|NOT COMPLETED|Period 3: Post-treatment Follow up Phase||3
6643442|NCT02354534|7571852|FG000|STARTED|Overall Study||3
6643443|NCT02354534|7571853|FG001|STARTED|Overall Study||9
6643444|NCT02354534|7571854|FG002|STARTED|Overall Study||10
6643445|NCT02354534|7571855|FG003|STARTED|Overall Study||8
6643446|NCT02354534|7571852|FG000|COMPLETED|Overall Study||3
6643447|NCT02354534|7571853|FG001|COMPLETED|Overall Study||9
6643448|NCT02354534|7571854|FG002|COMPLETED|Overall Study||9
6643449|NCT02354534|7571855|FG003|COMPLETED|Overall Study||8
6643450|NCT02354534|7571852|FG000|NOT COMPLETED|Overall Study||0
6643451|NCT02354534|7571853|FG001|NOT COMPLETED|Overall Study||0
6643452|NCT02354534|7571854|FG002|NOT COMPLETED|Overall Study||1
6643453|NCT02354534|7571855|FG003|NOT COMPLETED|Overall Study||0
6643454|NCT02354586|7571865|FG000|STARTED|Overall Study||463
6643455|NCT02354586|7571865|FG000|Ongoing in Study|Overall Study||21
6643456|NCT02354586|7571865|FG000|COMPLETED|Overall Study||122
6643457|NCT02354586|7571865|FG000|NOT COMPLETED|Overall Study||341
6643458|NCT02354599|7571875|FG000|STARTED|Overall Study||6
6643459|NCT02354599|7571876|FG001|STARTED|Overall Study||6
6643460|NCT02354599|7571877|FG002|STARTED|Overall Study||6
6643461|NCT02354599|7571878|FG003|STARTED|Overall Study||6
6643462|NCT02354599|7571879|FG004|STARTED|Overall Study||2
6643463|NCT02354599|7571880|FG005|STARTED|Overall Study||6
6643464|NCT02354599|7571875|FG000|COMPLETED|Overall Study||5
6643465|NCT02354599|7571876|FG001|COMPLETED|Overall Study||5
6643466|NCT02354599|7571877|FG002|COMPLETED|Overall Study||6
6643467|NCT02354599|7571878|FG003|COMPLETED|Overall Study||6
6643468|NCT02354599|7571879|FG004|COMPLETED|Overall Study||2
6643469|NCT02354599|7571880|FG005|COMPLETED|Overall Study||5
6643470|NCT02354599|7571875|FG000|NOT COMPLETED|Overall Study||1
6643471|NCT02354599|7571876|FG001|NOT COMPLETED|Overall Study||1
6643472|NCT02354599|7571877|FG002|NOT COMPLETED|Overall Study||0
6643473|NCT02354599|7571878|FG003|NOT COMPLETED|Overall Study||0
6643474|NCT02354599|7571879|FG004|NOT COMPLETED|Overall Study||0
6643475|NCT02354599|7571880|FG005|NOT COMPLETED|Overall Study||1
6643476|NCT02354690|7571900|FG000|STARTED|Overall Study||13
6643477|NCT02354690|7571900|FG000|COMPLETED|Overall Study||12
6643478|NCT02354690|7571900|FG000|NOT COMPLETED|Overall Study||1
6643479|NCT02354781|7571904|FG000|STARTED|Overall Study||3
6643480|NCT02354781|7571904|FG000|COMPLETED|Overall Study||3
6643481|NCT02354781|7571904|FG000|NOT COMPLETED|Overall Study||0
6643482|NCT02354833|7571911|FG000|STARTED|Overall Study||38
6643483|NCT02354833|7571912|FG001|STARTED|Overall Study||43
6643484|NCT02354833|7571911|FG000|COMPLETED|Overall Study||38
6643485|NCT02354833|7571912|FG001|COMPLETED|Overall Study||43
6643486|NCT02354833|7571911|FG000|NOT COMPLETED|Overall Study||0
6643487|NCT02354833|7571912|FG001|NOT COMPLETED|Overall Study||0
6643488|NCT02354859|7571922|FG000|STARTED|Overall Study||60
6643489|NCT02354859|7571923|FG001|STARTED|Overall Study||59
6643490|NCT02354859|7571922|FG000|COMPLETED|Overall Study||60
6643491|NCT02354859|7571923|FG001|COMPLETED|Overall Study||57
6643492|NCT02354859|7571922|FG000|NOT COMPLETED|Overall Study||0
6643493|NCT02354859|7571923|FG001|NOT COMPLETED|Overall Study||2
6643494|NCT02354924|7571931|FG000|STARTED|Overall Study||40
6643495|NCT02354924|7571932|FG001|STARTED|Overall Study||20
6526954|NCT01587703|7447936|FG005|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526955|NCT01587703|7447937|FG006|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526956|NCT01587703|7447938|FG007|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526957|NCT01587703|7447939|FG008|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526958|NCT01587703|7447940|FG009|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526959|NCT01587703|7447941|FG010|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526960|NCT01587703|7447942|FG011|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526961|NCT01587703|7447943|FG012|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526962|NCT01587703|7447944|FG013|COMPLETED|Part2(Median Exposure of 1.41 Months)||1
6526963|NCT01587703|7447945|FG014|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526964|NCT01587703|7447946|FG015|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526965|NCT01587703|7447947|FG016|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526966|NCT01587703|7447948|FG017|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6643496|NCT02354924|7571931|FG000|COMPLETED|Overall Study||40
6643497|NCT02354924|7571932|FG001|COMPLETED|Overall Study||20
6643498|NCT02354924|7571931|FG000|NOT COMPLETED|Overall Study||0
6643499|NCT02354924|7571932|FG001|NOT COMPLETED|Overall Study||0
6643500|NCT02354976|7571943|FG000|STARTED|Overall Study||25
6643501|NCT02354976|7571944|FG001|STARTED|Overall Study||27
6643502|NCT02354976|7571945|FG002|STARTED|Overall Study||26
6643503|NCT02354976|7571943|FG000|COMPLETED|Overall Study||23
6643504|NCT02354976|7571944|FG001|COMPLETED|Overall Study||26
6643505|NCT02354976|7571945|FG002|COMPLETED|Overall Study||23
6643506|NCT02354976|7571943|FG000|NOT COMPLETED|Overall Study||2
6643507|NCT02354976|7571944|FG001|NOT COMPLETED|Overall Study||1
6643508|NCT02354976|7571945|FG002|NOT COMPLETED|Overall Study||3
6643509|NCT02355028|7571955|FG000|STARTED|Overall Study||47
6643510|NCT02355028|7571956|FG001|STARTED|Overall Study||46
6643511|NCT02355028|7571955|FG000|Treated|Overall Study||46
6643512|NCT02355028|7571956|FG001|Treated|Overall Study||45
6643513|NCT02355028|7571955|FG000|COMPLETED|Overall Study||36
6643514|NCT02355028|7571956|FG001|COMPLETED|Overall Study||41
6643515|NCT02355028|7571955|FG000|NOT COMPLETED|Overall Study||11
6643516|NCT02355028|7571956|FG001|NOT COMPLETED|Overall Study||5
6643517|NCT02355067|7571969|FG000|STARTED|Overall Study||20
6643518|NCT02355067|7571970|FG001|STARTED|Overall Study||20
6643519|NCT02355067|7571969|FG000|COMPLETED|Overall Study||12
6643520|NCT02355067|7571970|FG001|COMPLETED|Overall Study||12
6643521|NCT02355067|7571969|FG000|NOT COMPLETED|Overall Study||8
6643522|NCT02355067|7571970|FG001|NOT COMPLETED|Overall Study||8
6643523|NCT02355158|7571976|FG000|STARTED|Overall Study||197
6643524|NCT02355158|7571976|FG000|COMPLETED|Overall Study||47
6643525|NCT02355158|7571976|FG000|NOT COMPLETED|Overall Study||150
6643526|NCT02355210|7571986|FG000|STARTED|Overall Study||19
6643527|NCT02355210|7571987|FG001|STARTED|Overall Study||18
6643528|NCT02355210|7571988|FG002|STARTED|Overall Study||16
6643529|NCT02355210|7571989|FG003|STARTED|Overall Study||17
6643530|NCT02355210|7571990|FG004|STARTED|Overall Study||19
6643531|NCT02355210|7571991|FG005|STARTED|Overall Study||18
6643532|NCT02355210|7571986|FG000|COMPLETED|Overall Study||19
6643533|NCT02355210|7571987|FG001|COMPLETED|Overall Study||18
6643534|NCT02355210|7571988|FG002|COMPLETED|Overall Study||16
6643535|NCT02355210|7571989|FG003|COMPLETED|Overall Study||17
6643536|NCT02355210|7571990|FG004|COMPLETED|Overall Study||19
6643537|NCT02355210|7571991|FG005|COMPLETED|Overall Study||18
6643538|NCT02355210|7571986|FG000|NOT COMPLETED|Overall Study||0
6643539|NCT02355210|7571987|FG001|NOT COMPLETED|Overall Study||0
6643540|NCT02355210|7571988|FG002|NOT COMPLETED|Overall Study||0
6643541|NCT02355210|7571989|FG003|NOT COMPLETED|Overall Study||0
6643542|NCT02355210|7571990|FG004|NOT COMPLETED|Overall Study||0
6643543|NCT02355210|7571991|FG005|NOT COMPLETED|Overall Study||0
6643544|NCT02355275|7572005|FG000|STARTED|Overall Study||22
6643545|NCT02355275|7572005|FG000|COMPLETED|Overall Study||14
6526967|NCT01587703|7447949|FG018|COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526968|NCT01587703|7447931|FG000|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526969|NCT01587703|7447932|FG001|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526970|NCT01587703|7447933|FG002|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526971|NCT01587703|7447934|FG003|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6643546|NCT02355275|7572005|FG000|NOT COMPLETED|Overall Study||8
6643547|NCT02355665|7572011|FG000|STARTED|Overall Study||601
6643548|NCT02355665|7572012|FG001|STARTED|Overall Study||597
6643549|NCT02355665|7572011|FG000|COMPLETED|Overall Study||352
6643550|NCT02355665|7572012|FG001|COMPLETED|Overall Study||365
6643551|NCT02355665|7572011|FG000|NOT COMPLETED|Overall Study||249
6643552|NCT02355665|7572012|FG001|NOT COMPLETED|Overall Study||232
6643553|NCT02355691|7572020|FG000|STARTED|Overall Study||7
6643554|NCT02355691|7572021|FG001|STARTED|Overall Study||9
6643555|NCT02355691|7572020|FG000|1st Postop Visit|Overall Study||7
6643556|NCT02355691|7572021|FG001|1st Postop Visit|Overall Study||9
6643557|NCT02355691|7572020|FG000|2nd Postop Visit|Overall Study||7
6643558|NCT02355691|7572021|FG001|2nd Postop Visit|Overall Study||9
6643559|NCT02355691|7572020|FG000|COMPLETED|Overall Study||0
6643560|NCT02355691|7572021|FG001|COMPLETED|Overall Study||0
6643561|NCT02355691|7572020|FG000|NOT COMPLETED|Overall Study||7
6643562|NCT02355691|7572021|FG001|NOT COMPLETED|Overall Study||9
6643563|NCT02355743|7572027|FG000|STARTED|Overall Study||8
6643564|NCT02355743|7572027|FG000|COMPLETED|Overall Study||6
6643565|NCT02355743|7572027|FG000|NOT COMPLETED|Overall Study||2
6526972|NCT01587703|7447935|FG004|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526973|NCT01587703|7447936|FG005|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526974|NCT01587703|7447937|FG006|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526975|NCT01587703|7447938|FG007|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526976|NCT01587703|7447939|FG008|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526977|NCT01587703|7447940|FG009|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526978|NCT01587703|7447941|FG010|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526979|NCT01587703|7447942|FG011|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||12
6526980|NCT01587703|7447943|FG012|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||14
6526981|NCT01587703|7447944|FG013|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||22
6526982|NCT01587703|7447945|FG014|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||19
6526983|NCT01587703|7447946|FG015|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||21
6526984|NCT01587703|7447947|FG016|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||13
6526985|NCT01587703|7447948|FG017|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526986|NCT01587703|7447949|FG018|NOT COMPLETED|Part2(Median Exposure of 1.41 Months)||0
6526987|NCT01587885|7448008|FG000|STARTED|Treatment Period 1||26
6526988|NCT01587885|7448009|FG001|STARTED|Treatment Period 1||22
6526989|NCT01587885|7448008|FG000|COMPLETED|Treatment Period 1||26
6526990|NCT01587885|7448009|FG001|COMPLETED|Treatment Period 1||19
6526991|NCT01587885|7448008|FG000|NOT COMPLETED|Treatment Period 1||0
6526992|NCT01587885|7448009|FG001|NOT COMPLETED|Treatment Period 1||3
6526993|NCT01587885|7448008|FG000|STARTED|Treatment Period 2||26
6526994|NCT01587885|7448009|FG001|STARTED|Treatment Period 2||19
6526995|NCT01587885|7448008|FG000|COMPLETED|Treatment Period 2||26
6526996|NCT01587885|7448009|FG001|COMPLETED|Treatment Period 2||19
6526997|NCT01587885|7448008|FG000|NOT COMPLETED|Treatment Period 2||0
6526998|NCT01587885|7448009|FG001|NOT COMPLETED|Treatment Period 2||0
6526999|NCT01587898|7448020|FG000|STARTED|Overall Study||18
6527000|NCT01587898|7448021|FG001|STARTED|Overall Study||17
6527001|NCT01587898|7448022|FG002|STARTED|Overall Study||18
6527002|NCT01587898|7448023|FG003|STARTED|Overall Study||19
6527003|NCT01587898|7448020|FG000|COMPLETED|Overall Study||14
6527004|NCT01587898|7448021|FG001|COMPLETED|Overall Study||12
6527005|NCT01587898|7448022|FG002|COMPLETED|Overall Study||16
6527006|NCT01587898|7448023|FG003|COMPLETED|Overall Study||17
6527007|NCT01587898|7448020|FG000|NOT COMPLETED|Overall Study||4
6643566|NCT02355821|7572033|FG000|STARTED|Overall Study||57
6643567|NCT02355821|7572034|FG001|STARTED|Overall Study||57
6643568|NCT02355821|7572033|FG000|COMPLETED|Overall Study||57
6643569|NCT02355821|7572034|FG001|COMPLETED|Overall Study||57
6643570|NCT02355821|7572033|FG000|NOT COMPLETED|Overall Study||0
6643571|NCT02355821|7572034|FG001|NOT COMPLETED|Overall Study||0
6643572|NCT02355886|7572042|FG000|STARTED|Overall Study||13
6643573|NCT02355886|7572043|FG001|STARTED|Overall Study||12
6643574|NCT02355886|7572042|FG000|COMPLETED|Overall Study||13
6643575|NCT02355886|7572043|FG001|COMPLETED|Overall Study||12
6643576|NCT02355886|7572042|FG000|NOT COMPLETED|Overall Study||0
6643577|NCT02355886|7572043|FG001|NOT COMPLETED|Overall Study||0
6655849|NCT02456727|7586010|FG000|6 Week|Overall Study||298
6655850|NCT02456727|7586011|FG001|6 Week|Overall Study||320
6655851|NCT02456727|7586010|FG000|12 Week|Overall Study||295
6655852|NCT02456727|7586011|FG001|12 Week|Overall Study||310
6655853|NCT02456727|7586010|FG000|24 Week|Overall Study||280
6655854|NCT02456727|7586011|FG001|24 Week|Overall Study||284
6655855|NCT02456727|7586010|FG000|COMPLETED|Overall Study||280
6655856|NCT02456727|7586011|FG001|COMPLETED|Overall Study||284
6655857|NCT02456727|7586010|FG000|NOT COMPLETED|Overall Study||109
6655858|NCT02456727|7586011|FG001|NOT COMPLETED|Overall Study||106
6655859|NCT02456740|7586036|FG000|STARTED|Double-blind Treatment Phase (24 Weeks)||319
6655860|NCT02456740|7586037|FG001|STARTED|Double-blind Treatment Phase (24 Weeks)||317
6655861|NCT02456740|7586038|FG002|STARTED|Double-blind Treatment Phase (24 Weeks)||319
6655862|NCT02456740|7586039|FG003|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6655863|NCT02456740|7586040|FG004|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6655864|NCT02456740|7586041|FG005|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6655865|NCT02456740|7586042|FG006|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6655866|NCT02456740|7586043|FG007|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6655867|NCT02456740|7586044|FG008|STARTED|Double-blind Treatment Phase (24 Weeks)||0
6655868|NCT02456740|7586036|FG000|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
6655869|NCT02456740|7586037|FG001|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||314
6743670|NCT03335254|7671827|FG017|COMPLETED|Period 2, Day 1-15||0
6527008|NCT01587898|7448021|FG001|NOT COMPLETED|Overall Study||5
6527009|NCT01587898|7448022|FG002|NOT COMPLETED|Overall Study||2
6527010|NCT01587898|7448023|FG003|NOT COMPLETED|Overall Study||2
6527011|NCT01587924|7448040|FG000|STARTED|Overall Study||21
6527012|NCT01587924|7448041|FG001|STARTED|Overall Study||21
6527013|NCT01587924|7448042|FG002|STARTED|Overall Study||21
6527014|NCT01587924|7448043|FG003|STARTED|Overall Study||20
6527015|NCT01587924|7448040|FG000|COMPLETED|Overall Study||17
6655870|NCT02456740|7586038|FG002|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||319
6655871|NCT02456740|7586039|FG003|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6655872|NCT02456740|7586040|FG004|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6655873|NCT02456740|7586041|FG005|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6656238|NCT02459262|7586359|FG001|NOT COMPLETED|Overall Study||0
6527016|NCT01587924|7448041|FG001|COMPLETED|Overall Study||17
6527017|NCT01587924|7448042|FG002|COMPLETED|Overall Study||17
6527018|NCT01587924|7448043|FG003|COMPLETED|Overall Study||19
6527019|NCT01587924|7448040|FG000|NOT COMPLETED|Overall Study||4
6527020|NCT01587924|7448041|FG001|NOT COMPLETED|Overall Study||4
6527021|NCT01587924|7448042|FG002|NOT COMPLETED|Overall Study||4
6527022|NCT01587924|7448043|FG003|NOT COMPLETED|Overall Study||1
6527023|NCT01587950|7448053|FG000|STARTED|Period 1||12
6527024|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
6527025|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
6643578|NCT02355977|7572052|FG000|STARTED|Overall Study||21
6643579|NCT02355977|7572053|FG001|STARTED|Overall Study||26
6643580|NCT02355977|7572054|FG002|STARTED|Overall Study||23
6643581|NCT02355977|7572052|FG000|COMPLETED|Overall Study||21
6643582|NCT02355977|7572053|FG001|COMPLETED|Overall Study||26
6643583|NCT02355977|7572054|FG002|COMPLETED|Overall Study||23
6643584|NCT02355977|7572052|FG000|NOT COMPLETED|Overall Study||0
6643585|NCT02355977|7572053|FG001|NOT COMPLETED|Overall Study||0
6643586|NCT02355977|7572054|FG002|NOT COMPLETED|Overall Study||0
6643587|NCT02356003|7572062|FG000|STARTED|Overall Study||10
6643588|NCT02356003|7572062|FG000|COMPLETED|Overall Study||10
6643589|NCT02356003|7572062|FG000|NOT COMPLETED|Overall Study||0
6643590|NCT02356107|7572067|FG000|STARTED|Overall Study||15
6643591|NCT02356107|7572067|FG000|COMPLETED|Overall Study||12
6643592|NCT02356107|7572067|FG000|NOT COMPLETED|Overall Study||3
6643593|NCT02356198|7572073|FG000|STARTED|Overall Study||104
6643594|NCT02356198|7572074|FG001|STARTED|Overall Study||105
6643595|NCT02356198|7572073|FG000|COMPLETED|Overall Study||102
6643596|NCT02356198|7572074|FG001|COMPLETED|Overall Study||98
6643597|NCT02356198|7572073|FG000|NOT COMPLETED|Overall Study||2
6643598|NCT02356198|7572074|FG001|NOT COMPLETED|Overall Study||7
6643599|NCT02356211|7572082|FG000|STARTED|Overall Study||57
6643600|NCT02356211|7572083|FG001|STARTED|Overall Study||52
6643601|NCT02356211|7572082|FG000|COMPLETED|Overall Study||54
6643602|NCT02356211|7572083|FG001|COMPLETED|Overall Study||42
6643603|NCT02356211|7572082|FG000|NOT COMPLETED|Overall Study||3
6643604|NCT02356211|7572083|FG001|NOT COMPLETED|Overall Study||10
6643605|NCT02356471|7572089|FG000|STARTED|Overall Study||34
6643606|NCT02356471|7572089|FG000|COMPLETED|Overall Study||28
6643607|NCT02356471|7572089|FG000|NOT COMPLETED|Overall Study||6
6643608|NCT02356484|7572093|FG000|STARTED|Overall Study||138
6643609|NCT02356484|7572093|FG000|COMPLETED|Overall Study||138
6643610|NCT02356484|7572093|FG000|NOT COMPLETED|Overall Study||0
6643611|NCT02356562|7572099|FG000|STARTED|Overall Study||22
6643612|NCT02356562|7572100|FG001|STARTED|Overall Study||7
6643613|NCT02356562|7572099|FG000|COMPLETED|Overall Study||20
6643614|NCT02356562|7572100|FG001|COMPLETED|Overall Study||6
6643615|NCT02356562|7572099|FG000|NOT COMPLETED|Overall Study||2
6643616|NCT02356562|7572100|FG001|NOT COMPLETED|Overall Study||1
6643617|NCT02356575|7572109|FG000|STARTED|Overall Study||80
6643618|NCT02356575|7572110|FG001|STARTED|Overall Study||80
6643619|NCT02356575|7572109|FG000|COMPLETED|Overall Study||80
6643620|NCT02356575|7572110|FG001|COMPLETED|Overall Study||80
6643621|NCT02356575|7572109|FG000|NOT COMPLETED|Overall Study||0
6643622|NCT02356575|7572110|FG001|NOT COMPLETED|Overall Study||0
6643623|NCT02356588|7572118|FG000|STARTED|Overall Study||107
6643624|NCT02356588|7572119|FG001|STARTED|Overall Study||54
6643625|NCT02356588|7572118|FG000|COMPLETED|Overall Study||102
6643626|NCT02356588|7572119|FG001|COMPLETED|Overall Study||41
6643627|NCT02356588|7572118|FG000|NOT COMPLETED|Overall Study||5
6643628|NCT02356588|7572119|FG001|NOT COMPLETED|Overall Study||13
6643629|NCT02356692|7572125|FG000|STARTED|Overall Study||60
6643630|NCT02356692|7572126|FG001|STARTED|Overall Study||60
6643631|NCT02356692|7572125|FG000|COMPLETED|Overall Study||60
6643632|NCT02356692|7572126|FG001|COMPLETED|Overall Study||60
6643633|NCT02356692|7572125|FG000|NOT COMPLETED|Overall Study||0
6643634|NCT02356692|7572126|FG001|NOT COMPLETED|Overall Study||0
6643635|NCT02356783|7572136|FG000|STARTED|Overall Study||16
6643636|NCT02356783|7572137|FG001|STARTED|Overall Study||17
6643637|NCT02356783|7572136|FG000|COMPLETED|Overall Study||15
6643638|NCT02356783|7572137|FG001|COMPLETED|Overall Study||14
6643639|NCT02356783|7572136|FG000|NOT COMPLETED|Overall Study||1
6643640|NCT02356783|7572137|FG001|NOT COMPLETED|Overall Study||3
6643641|NCT02356887|7572143|FG000|STARTED|Overall Study||12
6643642|NCT02356887|7572143|FG000|COMPLETED|Overall Study||10
6643643|NCT02356887|7572143|FG000|NOT COMPLETED|Overall Study||2
6643644|NCT02356900|7572155|FG000|STARTED|Overall Study||11
6643645|NCT02356900|7572156|FG001|STARTED|Overall Study||10
6643646|NCT02356900|7572155|FG000|COMPLETED|Overall Study||11
6643647|NCT02356900|7572156|FG001|COMPLETED|Overall Study||10
6643648|NCT02356900|7572155|FG000|NOT COMPLETED|Overall Study||0
6643649|NCT02356900|7572156|FG001|NOT COMPLETED|Overall Study||0
6527026|NCT01587950|7448053|FG000|Received Sterile Water (2 Minutes)|Period 1||2
6527027|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
6527028|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
6527029|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
6527030|NCT01587950|7448053|FG000|Received Sterile Water (10 Minutes)|Period 1||5
6643650|NCT02357043|7572162|FG000|STARTED|Overall Study||368
6643651|NCT02357043|7572162|FG000|COMPLETED|Overall Study||368
6643652|NCT02357043|7572162|FG000|NOT COMPLETED|Overall Study||0
6643653|NCT02357134|7572170|FG000|STARTED|Overall Study||11
6643654|NCT02357134|7572171|FG001|STARTED|Overall Study||11
6527031|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
6527032|NCT01587950|7448053|FG000|Received Sterile Water (5 Minutes)|Period 1||5
6527033|NCT01587950|7448053|FG000|COMPLETED|Period 1||12
6527034|NCT01587950|7448053|FG000|NOT COMPLETED|Period 1||0
6527035|NCT01587950|7448053|FG000|STARTED|Washout 1||12
6527036|NCT01587950|7448053|FG000|COMPLETED|Washout 1||12
6527037|NCT01587950|7448053|FG000|NOT COMPLETED|Washout 1||0
6527038|NCT01587950|7448053|FG000|STARTED|Period 2||12
6527039|NCT01587950|7448053|FG000|Received Sterile Water (2 Minutes)|Period 2||8
6527040|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
6527041|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
6527042|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
6527043|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
6527044|NCT01587950|7448053|FG000|Received Sterile Water (5 Minutes)|Period 2||2
6527045|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
6527046|NCT01587950|7448053|FG000|Received Sterile Water (10 Minutes)|Period 2||2
6527047|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
6527048|NCT01587950|7448053|FG000|COMPLETED|Period 2||12
6527049|NCT01587950|7448053|FG000|NOT COMPLETED|Period 2||0
6527050|NCT01587950|7448053|FG000|STARTED|Washout 2||12
6527051|NCT01587950|7448053|FG000|COMPLETED|Washout 2||12
6527052|NCT01587950|7448053|FG000|NOT COMPLETED|Washout 2||0
6527053|NCT01587950|7448053|FG000|STARTED|Period 3||12
6527054|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
6527055|NCT01587950|7448053|FG000|Received Sterile Water (10 Minutes)|Period 3||5
6527056|NCT01587950|7448053|FG000|Received Sterile Water (2 Minutes)|Period 3||2
6527057|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
6527058|NCT01587950|7448053|FG000|Received Sterile Water (5 Minutes)|Period 3||5
6643655|NCT02357134|7572172|FG002|STARTED|Overall Study||12
6643656|NCT02357134|7572173|FG003|STARTED|Overall Study||11
6643657|NCT02357134|7572170|FG000|COMPLETED|Overall Study||10
6643658|NCT02357134|7572171|FG001|COMPLETED|Overall Study||11
6643659|NCT02357134|7572172|FG002|COMPLETED|Overall Study||12
6643660|NCT02357134|7572173|FG003|COMPLETED|Overall Study||11
6643661|NCT02357134|7572170|FG000|NOT COMPLETED|Overall Study||1
6643662|NCT02357134|7572171|FG001|NOT COMPLETED|Overall Study||0
6643663|NCT02357134|7572172|FG002|NOT COMPLETED|Overall Study||0
6643664|NCT02357134|7572173|FG003|NOT COMPLETED|Overall Study||0
6643665|NCT02357147|7572185|FG000|STARTED|Combination Treatment Phase||52
6643666|NCT02357147|7572186|FG001|STARTED|Combination Treatment Phase||56
6643667|NCT02357147|7572185|FG000|Treated|Combination Treatment Phase||52
6643668|NCT02357147|7572186|FG001|Treated|Combination Treatment Phase||54
6643669|NCT02357147|7572185|FG000|COMPLETED|Combination Treatment Phase||26
6643670|NCT02357147|7572186|FG001|COMPLETED|Combination Treatment Phase||29
6643671|NCT02357147|7572185|FG000|NOT COMPLETED|Combination Treatment Phase||26
6643672|NCT02357147|7572186|FG001|NOT COMPLETED|Combination Treatment Phase||27
6643673|NCT02357147|7572185|FG000|STARTED|Maintenance Treatment Phase||26
6643674|NCT02357147|7572186|FG001|STARTED|Maintenance Treatment Phase||29
6643675|NCT02357147|7572185|FG000|Treated|Maintenance Treatment Phase||25
6643676|NCT02357147|7572186|FG001|Treated|Maintenance Treatment Phase||29
6643677|NCT02357147|7572185|FG000|COMPLETED|Maintenance Treatment Phase||0
6643678|NCT02357147|7572186|FG001|COMPLETED|Maintenance Treatment Phase||0
6643679|NCT02357147|7572185|FG000|NOT COMPLETED|Maintenance Treatment Phase||26
6643680|NCT02357147|7572186|FG001|NOT COMPLETED|Maintenance Treatment Phase||29
6643681|NCT02357173|7572199|FG000|STARTED|Overall Study||25
6643682|NCT02357173|7572200|FG001|STARTED|Overall Study||21
6643683|NCT02357173|7572201|FG002|STARTED|Overall Study||22
6643684|NCT02357173|7572199|FG000|COMPLETED|Overall Study||19
6643685|NCT02357173|7572200|FG001|COMPLETED|Overall Study||15
6643686|NCT02357173|7572201|FG002|COMPLETED|Overall Study||16
6643687|NCT02357173|7572199|FG000|NOT COMPLETED|Overall Study||6
6643688|NCT02357173|7572200|FG001|NOT COMPLETED|Overall Study||6
6643689|NCT02357173|7572201|FG002|NOT COMPLETED|Overall Study||6
6643690|NCT02357264|7572211|FG000|STARTED|Overall Study||56
6643691|NCT02357264|7572212|FG001|STARTED|Overall Study||130
6643692|NCT02357264|7572211|FG000|COMPLETED|Overall Study||56
6643693|NCT02357264|7572212|FG001|COMPLETED|Overall Study||130
6643694|NCT02357264|7572211|FG000|NOT COMPLETED|Overall Study||0
6643695|NCT02357264|7572212|FG001|NOT COMPLETED|Overall Study||0
6643696|NCT02357290|7572218|FG000|STARTED|Overall Study||40
6643697|NCT02357290|7572218|FG000|Exposed|Overall Study||26
6643698|NCT02357290|7572218|FG000|COMPLETED|Overall Study||14
6643699|NCT02357290|7572218|FG000|NOT COMPLETED|Overall Study||26
6643700|NCT02357342|7572224|FG000|STARTED|First 6 Months||20
6643701|NCT02357342|7572225|FG001|STARTED|First 6 Months||20
6643702|NCT02357342|7572224|FG000|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
6643703|NCT02357342|7572225|FG001|COMPLETED|First 6 Months||20
6643704|NCT02357342|7572224|FG000|NOT COMPLETED|First 6 Months||2
6643705|NCT02357342|7572225|FG001|NOT COMPLETED|First 6 Months||0
6743671|NCT03335254|7671828|FG018|COMPLETED|Period 2, Day 1-15||0
6527059|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
6527060|NCT01587950|7448053|FG000|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
6527061|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
6561843|NCT01797302|7484752|FG000|3 Month Visit|Overall Study||60
6643706|NCT02357342|7572224|FG000|STARTED|Extension Study||4
6643707|NCT02357342|7572225|FG001|STARTED|Extension Study||9
6527062|NCT01587950|7448053|FG000|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
6527063|NCT01587950|7448053|FG000|COMPLETED|Period 3||12
6527064|NCT01587950|7448053|FG000|NOT COMPLETED|Period 3||0
6527065|NCT01587989|7448068|FG000|STARTED|12-Week Open-Label Run-In Period||77
6527066|NCT01587989|7448069|FG001|STARTED|12-Week Open-Label Run-In Period||0
6527067|NCT01587989|7448070|FG002|STARTED|12-Week Open-Label Run-In Period||0
6527068|NCT01587989|7448068|FG000|COMPLETED|12-Week Open-Label Run-In Period||65
6527069|NCT01587989|7448069|FG001|COMPLETED|12-Week Open-Label Run-In Period||0
6527070|NCT01587989|7448070|FG002|COMPLETED|12-Week Open-Label Run-In Period||0
6527071|NCT01587989|7448068|FG000|NOT COMPLETED|12-Week Open-Label Run-In Period||12
6527072|NCT01587989|7448069|FG001|NOT COMPLETED|12-Week Open-Label Run-In Period||0
6527073|NCT01587989|7448070|FG002|NOT COMPLETED|12-Week Open-Label Run-In Period||0
6527074|NCT01587989|7448068|FG000|STARTED|Randomized Study Treatment||0
6643708|NCT02357342|7572224|FG000|COMPLETED|Extension Study||4
6643709|NCT02357342|7572225|FG001|COMPLETED|Extension Study||9
6743672|NCT03335254|7671829|FG019|COMPLETED|Period 2, Day 1-15||0
6743673|NCT03335254|7671810|FG000|NOT COMPLETED|Period 2, Day 1-15||0
6743674|NCT03335254|7671811|FG001|NOT COMPLETED|Period 2, Day 1-15||0
6743675|NCT03335254|7671812|FG002|NOT COMPLETED|Period 2, Day 1-15||0
6743676|NCT03335254|7671813|FG003|NOT COMPLETED|Period 2, Day 1-15||0
6743677|NCT03335254|7671814|FG004|NOT COMPLETED|Period 2, Day 1-15||0
6743678|NCT03335254|7671815|FG005|NOT COMPLETED|Period 2, Day 1-15||0
6743679|NCT03335254|7671816|FG006|NOT COMPLETED|Period 2, Day 1-15||0
6743680|NCT03335254|7671817|FG007|NOT COMPLETED|Period 2, Day 1-15||0
6743681|NCT03335254|7671818|FG008|NOT COMPLETED|Period 2, Day 1-15||0
6743682|NCT03335254|7671819|FG009|NOT COMPLETED|Period 2, Day 1-15||0
6743683|NCT03335254|7671820|FG010|NOT COMPLETED|Period 2, Day 1-15||0
6743684|NCT03335254|7671821|FG011|NOT COMPLETED|Period 2, Day 1-15||0
6743685|NCT03335254|7671822|FG012|NOT COMPLETED|Period 2, Day 1-15||0
6743686|NCT03335254|7671823|FG013|NOT COMPLETED|Period 2, Day 1-15||0
6743687|NCT03335254|7671824|FG014|NOT COMPLETED|Period 2, Day 1-15||0
6743688|NCT03335254|7671825|FG015|NOT COMPLETED|Period 2, Day 1-15||0
6743689|NCT03335254|7671826|FG016|NOT COMPLETED|Period 2, Day 1-15||0
6743690|NCT03335254|7671827|FG017|NOT COMPLETED|Period 2, Day 1-15||0
6743691|NCT03335254|7671828|FG018|NOT COMPLETED|Period 2, Day 1-15||0
6743692|NCT03335254|7671829|FG019|NOT COMPLETED|Period 2, Day 1-15||0
6743693|NCT03335254|7671810|FG000|STARTED|Period 3, Day 16-25||9
6743694|NCT03335254|7671811|FG001|STARTED|Period 3, Day 16-25||0
6743695|NCT03335254|7671812|FG002|STARTED|Period 3, Day 16-25||0
6743696|NCT03335254|7671813|FG003|STARTED|Period 3, Day 16-25||0
6743697|NCT03335254|7671814|FG004|STARTED|Period 3, Day 16-25||0
6743698|NCT03335254|7671815|FG005|STARTED|Period 3, Day 16-25||0
6743699|NCT03335254|7671816|FG006|STARTED|Period 3, Day 16-25||0
6743700|NCT03335254|7671817|FG007|STARTED|Period 3, Day 16-25||0
6743701|NCT03335254|7671818|FG008|STARTED|Period 3, Day 16-25||0
6743702|NCT03335254|7671819|FG009|STARTED|Period 3, Day 16-25||0
6743703|NCT03335254|7671820|FG010|STARTED|Period 3, Day 16-25||0
6743704|NCT03335254|7671821|FG011|STARTED|Period 3, Day 16-25||0
6743705|NCT03335254|7671822|FG012|STARTED|Period 3, Day 16-25||0
6743706|NCT03335254|7671823|FG013|STARTED|Period 3, Day 16-25||0
6743707|NCT03335254|7671824|FG014|STARTED|Period 3, Day 16-25||0
6743708|NCT03335254|7671825|FG015|STARTED|Period 3, Day 16-25||0
6743709|NCT03335254|7671826|FG016|STARTED|Period 3, Day 16-25||0
6743710|NCT03335254|7671827|FG017|STARTED|Period 3, Day 16-25||0
6743711|NCT03335254|7671828|FG018|STARTED|Period 3, Day 16-25||0
6743712|NCT03335254|7671829|FG019|STARTED|Period 3, Day 16-25||0
6743713|NCT03335254|7671810|FG000|COMPLETED|Period 3, Day 16-25||9
6743714|NCT03335254|7671811|FG001|COMPLETED|Period 3, Day 16-25||0
6743715|NCT03335254|7671812|FG002|COMPLETED|Period 3, Day 16-25||0
6743716|NCT03335254|7671813|FG003|COMPLETED|Period 3, Day 16-25||0
6743717|NCT03335254|7671814|FG004|COMPLETED|Period 3, Day 16-25||0
6743718|NCT03335254|7671815|FG005|COMPLETED|Period 3, Day 16-25||0
6743719|NCT03335254|7671816|FG006|COMPLETED|Period 3, Day 16-25||0
6743720|NCT03335254|7671817|FG007|COMPLETED|Period 3, Day 16-25||0
6527075|NCT01587989|7448069|FG001|STARTED|Randomized Study Treatment||32
6527076|NCT01587989|7448070|FG002|STARTED|Randomized Study Treatment||33
6527077|NCT01587989|7448068|FG000|COMPLETED|Randomized Study Treatment||0
6643710|NCT02357342|7572224|FG000|NOT COMPLETED|Extension Study||0
6643711|NCT02357342|7572225|FG001|NOT COMPLETED|Extension Study||0
6643712|NCT02357368|7572235|FG000|STARTED|Overall Study||19
6643713|NCT02357368|7572236|FG001|STARTED|Overall Study||18
6643714|NCT02357368|7572237|FG002|STARTED|Overall Study||14
6643715|NCT02357368|7572238|FG003|STARTED|Overall Study||8
6643716|NCT02357368|7572235|FG000|COMPLETED|Overall Study||13
6643717|NCT02357368|7572236|FG001|COMPLETED|Overall Study||15
6643718|NCT02357368|7572237|FG002|COMPLETED|Overall Study||13
6643719|NCT02357368|7572238|FG003|COMPLETED|Overall Study||5
6643720|NCT02357368|7572235|FG000|NOT COMPLETED|Overall Study||6
6643721|NCT02357368|7572236|FG001|NOT COMPLETED|Overall Study||3
6643722|NCT02357368|7572237|FG002|NOT COMPLETED|Overall Study||1
6643723|NCT02357368|7572238|FG003|NOT COMPLETED|Overall Study||3
6643724|NCT02357394|7572250|FG000|STARTED|Overall Study||4
6643725|NCT02357394|7572251|FG001|STARTED|Overall Study||3
6743721|NCT03335254|7671818|FG008|COMPLETED|Period 3, Day 16-25||0
6743722|NCT03335254|7671819|FG009|COMPLETED|Period 3, Day 16-25||0
6743723|NCT03335254|7671820|FG010|COMPLETED|Period 3, Day 16-25||0
6743724|NCT03335254|7671821|FG011|COMPLETED|Period 3, Day 16-25||0
6643726|NCT02357394|7572250|FG000|COMPLETED|Overall Study||4
6643727|NCT02357394|7572251|FG001|COMPLETED|Overall Study||3
6643728|NCT02357394|7572250|FG000|NOT COMPLETED|Overall Study||0
6527078|NCT01587989|7448069|FG001|COMPLETED|Randomized Study Treatment||30
6527079|NCT01587989|7448070|FG002|COMPLETED|Randomized Study Treatment||32
6527080|NCT01587989|7448068|FG000|NOT COMPLETED|Randomized Study Treatment||0
6527081|NCT01587989|7448069|FG001|NOT COMPLETED|Randomized Study Treatment||2
6527082|NCT01587989|7448070|FG002|NOT COMPLETED|Randomized Study Treatment||1
6527083|NCT01588106|7448078|FG000|STARTED|Overall Study||78
6527084|NCT01588106|7448079|FG001|STARTED|Overall Study||76
6643729|NCT02357394|7572251|FG001|NOT COMPLETED|Overall Study||0
6643730|NCT02357420|7572261|FG000|STARTED|Overall Study||104
6643731|NCT02357420|7572262|FG001|STARTED|Overall Study||98
6643732|NCT02357420|7572263|FG002|STARTED|Overall Study||109
6643733|NCT02357420|7572264|FG003|STARTED|Overall Study||82
6643734|NCT02357420|7572261|FG000|Full Analysis Set (FAS)|Overall Study||104
6643735|NCT02357420|7572262|FG001|Full Analysis Set (FAS)|Overall Study||98
6643736|NCT02357420|7572263|FG002|Full Analysis Set (FAS)|Overall Study||109
6643737|NCT02357420|7572264|FG003|Full Analysis Set (FAS)|Overall Study|1 participant from safety set did not enter FAS.|81
6643738|NCT02357420|7572261|FG000|COMPLETED|Overall Study|3 participants who discontinued prematurely were included in completed as they fulfilled Visit 8.|92
6643739|NCT02357420|7572262|FG001|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|86
6643740|NCT02357420|7572263|FG002|COMPLETED|Overall Study|1 participant who discontinued prematurely was included in completed as he/she fulfilled Visit 8.|93
6643741|NCT02357420|7572264|FG003|COMPLETED|Overall Study||63
6643742|NCT02357420|7572261|FG000|NOT COMPLETED|Overall Study||12
6643743|NCT02357420|7572262|FG001|NOT COMPLETED|Overall Study||12
6643744|NCT02357420|7572263|FG002|NOT COMPLETED|Overall Study||16
6643745|NCT02357420|7572264|FG003|NOT COMPLETED|Overall Study||19
6643746|NCT02357459|7572277|FG000|STARTED|Overall Study||161
6643747|NCT02357459|7572278|FG001|STARTED|Overall Study||163
6643748|NCT02357459|7572279|FG002|STARTED|Overall Study||162
6643749|NCT02357459|7572277|FG000|COMPLETED|Overall Study||144
6643750|NCT02357459|7572278|FG001|COMPLETED|Overall Study||149
6643751|NCT02357459|7572279|FG002|COMPLETED|Overall Study||150
6643752|NCT02357459|7572277|FG000|NOT COMPLETED|Overall Study||17
6643753|NCT02357459|7572278|FG001|NOT COMPLETED|Overall Study||14
6643754|NCT02357459|7572279|FG002|NOT COMPLETED|Overall Study||12
6643755|NCT02357485|7572290|FG000|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
6643756|NCT02357485|7572290|FG000|COMPLETED|Overall Study||6
6643757|NCT02357485|7572290|FG000|NOT COMPLETED|Overall Study||0
6643758|NCT02357576|7572297|FG000|STARTED|Treatment Period||12
6643759|NCT02357576|7572298|FG001|STARTED|Treatment Period||9
6643760|NCT02357576|7572297|FG000|COMPLETED|Treatment Period||12
6643761|NCT02357576|7572298|FG001|COMPLETED|Treatment Period||7
6643762|NCT02357576|7572297|FG000|NOT COMPLETED|Treatment Period||0
6643763|NCT02357576|7572298|FG001|NOT COMPLETED|Treatment Period||2
6643764|NCT02357576|7572297|FG000|STARTED|Neurodevelopmental Outcome Follow Up|1 patient exited the study after treatment completion and before returning for follow up visits.|11
6643765|NCT02357576|7572298|FG001|STARTED|Neurodevelopmental Outcome Follow Up||7
6643766|NCT02357576|7572297|FG000|COMPLETED|Neurodevelopmental Outcome Follow Up||6
6643767|NCT02357576|7572298|FG001|COMPLETED|Neurodevelopmental Outcome Follow Up||2
6643768|NCT02357576|7572297|FG000|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
6643769|NCT02357576|7572298|FG001|NOT COMPLETED|Neurodevelopmental Outcome Follow Up||5
6643770|NCT02357706|7572304|FG000|STARTED|Overall Study||10
6643771|NCT02357706|7572305|FG001|STARTED|Overall Study||10
6643772|NCT02357706|7572304|FG000|COMPLETED|Overall Study||10
6643773|NCT02357706|7572305|FG001|COMPLETED|Overall Study||10
6643774|NCT02357706|7572304|FG000|NOT COMPLETED|Overall Study||0
6643775|NCT02357706|7572305|FG001|NOT COMPLETED|Overall Study||0
6643776|NCT02357758|7572317|FG000|STARTED|Overall Study||25
6643777|NCT02357758|7572318|FG001|STARTED|Overall Study||20
6643778|NCT02357758|7572319|FG002|STARTED|Overall Study||12
6643779|NCT02357758|7572317|FG000|COMPLETED|Overall Study||9
6643780|NCT02357758|7572318|FG001|COMPLETED|Overall Study||20
6643781|NCT02357758|7572319|FG002|COMPLETED|Overall Study||5
6643782|NCT02357758|7572317|FG000|NOT COMPLETED|Overall Study||16
6643783|NCT02357758|7572318|FG001|NOT COMPLETED|Overall Study||0
6643784|NCT02357758|7572319|FG002|NOT COMPLETED|Overall Study||7
6527085|NCT01588106|7448078|FG000|COMPLETED|Overall Study||73
6643785|NCT02357836|7572327|FG000|STARTED|Overall Study||13
6643786|NCT02357836|7572327|FG000|COMPLETED|Overall Study||13
6643787|NCT02357836|7572327|FG000|NOT COMPLETED|Overall Study||0
6643788|NCT02357901|7572335|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Received at least one dose of SUBOXONE sublingual film.|665
6643789|NCT02357901|7572336|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
6643790|NCT02357901|7572337|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
6643791|NCT02357901|7572338|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
6643792|NCT02357901|7572335|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||504
6643793|NCT02357901|7572336|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6643794|NCT02357901|7572337|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6643795|NCT02357901|7572338|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6643796|NCT02357901|7572335|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||161
6643797|NCT02357901|7572336|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6643798|NCT02357901|7572337|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6527086|NCT01588106|7448079|FG001|COMPLETED|Overall Study||72
6527087|NCT01588106|7448078|FG000|NOT COMPLETED|Overall Study||5
6527088|NCT01588106|7448079|FG001|NOT COMPLETED|Overall Study||4
6527089|NCT01588158|7448087|FG000|STARTED|Overall Study||4
6527090|NCT01588158|7448088|FG001|STARTED|Overall Study||3
6527091|NCT01588158|7448087|FG000|COMPLETED|Overall Study||4
6527092|NCT01588158|7448088|FG001|COMPLETED|Overall Study||3
6527093|NCT01588158|7448087|FG000|NOT COMPLETED|Overall Study||0
6527094|NCT01588158|7448088|FG001|NOT COMPLETED|Overall Study||0
6527095|NCT01588184|7448100|FG000|STARTED|Overall Study||11
6527096|NCT01588184|7448101|FG001|STARTED|Overall Study||41
6527097|NCT01588184|7448102|FG002|STARTED|Overall Study||7
6527098|NCT01588184|7448103|FG003|STARTED|Overall Study||6
6527099|NCT01588184|7448104|FG004|STARTED|Overall Study||16
6643799|NCT02357901|7572338|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6643800|NCT02357901|7572335|FG000|STARTED|Treatment Period (Day 1 to Week 24)||0
6643801|NCT02357901|7572336|FG001|STARTED|Treatment Period (Day 1 to Week 24)||203
6643802|NCT02357901|7572337|FG002|STARTED|Treatment Period (Day 1 to Week 24)||201
6643803|NCT02357901|7572338|FG003|STARTED|Treatment Period (Day 1 to Week 24)||100
6643804|NCT02357901|7572335|FG000|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||0
6643805|NCT02357901|7572336|FG001|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||203
6643806|NCT02357901|7572337|FG002|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||201
6643807|NCT02357901|7572338|FG003|Safety Analysis Set|Treatment Period (Day 1 to Week 24)||100
6643808|NCT02357901|7572335|FG000|Full Analysis Set|Treatment Period (Day 1 to Week 24)||0
6643809|NCT02357901|7572336|FG001|Full Analysis Set|Treatment Period (Day 1 to Week 24)||194
6643810|NCT02357901|7572337|FG002|Full Analysis Set|Treatment Period (Day 1 to Week 24)||196
6643811|NCT02357901|7572338|FG003|Full Analysis Set|Treatment Period (Day 1 to Week 24)||99
6643812|NCT02357901|7572335|FG000|COMPLETED|Treatment Period (Day 1 to Week 24)||0
6643813|NCT02357901|7572336|FG001|COMPLETED|Treatment Period (Day 1 to Week 24)||125
6643814|NCT02357901|7572337|FG002|COMPLETED|Treatment Period (Day 1 to Week 24)||129
6643815|NCT02357901|7572338|FG003|COMPLETED|Treatment Period (Day 1 to Week 24)||34
6643816|NCT02357901|7572335|FG000|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||0
6656239|NCT02459262|7586360|FG002|NOT COMPLETED|Overall Study||0
6527100|NCT01588184|7448105|FG005|STARTED|Overall Study||14
6527101|NCT01588184|7448100|FG000|COMPLETED|Overall Study||8
6527102|NCT01588184|7448101|FG001|COMPLETED|Overall Study||28
6527103|NCT01588184|7448102|FG002|COMPLETED|Overall Study||5
6527104|NCT01588184|7448103|FG003|COMPLETED|Overall Study||3
6527105|NCT01588184|7448104|FG004|COMPLETED|Overall Study||14
6527106|NCT01588184|7448105|FG005|COMPLETED|Overall Study||10
6527107|NCT01588184|7448100|FG000|NOT COMPLETED|Overall Study||3
6527108|NCT01588184|7448101|FG001|NOT COMPLETED|Overall Study||13
6527109|NCT01588184|7448102|FG002|NOT COMPLETED|Overall Study||2
6527110|NCT01588184|7448103|FG003|NOT COMPLETED|Overall Study||3
6527111|NCT01588184|7448104|FG004|NOT COMPLETED|Overall Study||2
6527112|NCT01588184|7448105|FG005|NOT COMPLETED|Overall Study||4
6527113|NCT01588197|7448121|FG000|STARTED|Overall Study||10
6527114|NCT01588197|7448122|FG001|STARTED|Overall Study||10
6527115|NCT01588197|7448121|FG000|COMPLETED|Overall Study||9
6527116|NCT01588197|7448122|FG001|COMPLETED|Overall Study||9
6527117|NCT01588197|7448121|FG000|NOT COMPLETED|Overall Study||1
6527118|NCT01588197|7448122|FG001|NOT COMPLETED|Overall Study||1
6527119|NCT01588236|7448131|FG000|STARTED|Overall Study||92
6527120|NCT01588236|7448132|FG001|STARTED|Overall Study||94
6527121|NCT01588236|7448133|FG002|STARTED|Overall Study||94
6527122|NCT01588236|7448131|FG000|COMPLETED|Overall Study||76
6527123|NCT01588236|7448132|FG001|COMPLETED|Overall Study||66
6527124|NCT01588236|7448133|FG002|COMPLETED|Overall Study||69
6527125|NCT01588236|7448131|FG000|NOT COMPLETED|Overall Study||16
6527126|NCT01588236|7448132|FG001|NOT COMPLETED|Overall Study||28
6527127|NCT01588236|7448133|FG002|NOT COMPLETED|Overall Study||25
6527128|NCT01588353|7448144|FG000|STARTED|Step1||6
6527129|NCT01588353|7448145|FG001|STARTED|Step1||0
6527130|NCT01588353|7448146|FG002|STARTED|Step1||0
6527131|NCT01588353|7448144|FG000|COMPLETED|Step1||6
6527132|NCT01588353|7448145|FG001|COMPLETED|Step1||0
6527133|NCT01588353|7448146|FG002|COMPLETED|Step1||0
6527134|NCT01588353|7448144|FG000|NOT COMPLETED|Step1||0
6527135|NCT01588353|7448145|FG001|NOT COMPLETED|Step1||0
6527136|NCT01588353|7448146|FG002|NOT COMPLETED|Step1||0
6527137|NCT01588353|7448144|FG000|STARTED|Step2||0
6527138|NCT01588353|7448145|FG001|STARTED|Step2||71
6527139|NCT01588353|7448146|FG002|STARTED|Step2||0
6527140|NCT01588353|7448144|FG000|COMPLETED|Step2||0
6527141|NCT01588353|7448145|FG001|COMPLETED|Step2||70
6527142|NCT01588353|7448146|FG002|COMPLETED|Step2||0
6527143|NCT01588353|7448144|FG000|NOT COMPLETED|Step2||0
6527144|NCT01588353|7448145|FG001|NOT COMPLETED|Step2||1
6527145|NCT01588353|7448146|FG002|NOT COMPLETED|Step2||0
6527146|NCT01588353|7448144|FG000|STARTED|Step3||0
6527147|NCT01588353|7448145|FG001|STARTED|Step3||0
6527148|NCT01588353|7448146|FG002|STARTED|Step3||25
6527149|NCT01588353|7448144|FG000|COMPLETED|Step3||0
6527150|NCT01588353|7448145|FG001|COMPLETED|Step3||0
6527151|NCT01588353|7448146|FG002|COMPLETED|Step3||23
6527152|NCT01588353|7448144|FG000|NOT COMPLETED|Step3||0
6527153|NCT01588353|7448145|FG001|NOT COMPLETED|Step3||0
6527154|NCT01588353|7448146|FG002|NOT COMPLETED|Step3||2
6527155|NCT01588366|7448158|FG000|STARTED|Overall Study||2
6527156|NCT01588366|7448159|FG001|STARTED|Overall Study||7
6527157|NCT01588366|7448160|FG002|STARTED|Overall Study||2
6527158|NCT01588366|7448161|FG003|STARTED|Overall Study||7
6527159|NCT01588366|7448162|FG004|STARTED|Overall Study||3
6527160|NCT01588366|7448163|FG005|STARTED|Overall Study||9
6527161|NCT01588366|7448158|FG000|Received at Least One Dose of Study Drug|Overall Study||2
6527162|NCT01588366|7448159|FG001|Received at Least One Dose of Study Drug|Overall Study||7
6527163|NCT01588366|7448160|FG002|Received at Least One Dose of Study Drug|Overall Study||2
6643817|NCT02357901|7572336|FG001|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||78
6643818|NCT02357901|7572337|FG002|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||72
6643819|NCT02357901|7572338|FG003|NOT COMPLETED|Treatment Period (Day 1 to Week 24)||66
6643820|NCT02357940|7572348|FG000|STARTED|Overall Study||9
6643821|NCT02357940|7572349|FG001|STARTED|Overall Study||32
6643822|NCT02357940|7572348|FG000|COMPLETED|Overall Study||9
6643823|NCT02357940|7572349|FG001|COMPLETED|Overall Study||30
6643824|NCT02357940|7572348|FG000|NOT COMPLETED|Overall Study||0
6643825|NCT02357940|7572349|FG001|NOT COMPLETED|Overall Study||2
6643826|NCT02357979|7572357|FG000|STARTED|Overall Study||60
6643827|NCT02357979|7572358|FG001|STARTED|Overall Study||60
6643828|NCT02357979|7572357|FG000|COMPLETED|Overall Study||55
6643829|NCT02357979|7572358|FG001|COMPLETED|Overall Study||55
6643830|NCT02357979|7572357|FG000|NOT COMPLETED|Overall Study||5
6643831|NCT02357979|7572358|FG001|NOT COMPLETED|Overall Study||5
6643832|NCT02358044|7572366|FG000|STARTED|Overall Study||129
6643833|NCT02358044|7572367|FG001|STARTED|Overall Study||128
6643834|NCT02358044|7572366|FG000|Treated|Overall Study||129
6643835|NCT02358044|7572367|FG001|Treated|Overall Study||126
6643836|NCT02358044|7572366|FG000|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
6643837|NCT02358044|7572367|FG001|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
6643838|NCT02358044|7572366|FG000|NOT COMPLETED|Overall Study||2
6643839|NCT02358044|7572367|FG001|NOT COMPLETED|Overall Study||7
6643840|NCT02358135|7572375|FG000|STARTED|Overall Study||150
6643841|NCT02358135|7572376|FG001|STARTED|Overall Study||150
6643842|NCT02358135|7572375|FG000|Randomized|Overall Study||148
6643843|NCT02358135|7572376|FG001|Randomized|Overall Study||148
6643844|NCT02358135|7572375|FG000|COMPLETED|Overall Study||135
6643845|NCT02358135|7572376|FG001|COMPLETED|Overall Study||131
6643846|NCT02358135|7572375|FG000|NOT COMPLETED|Overall Study||15
6643847|NCT02358135|7572376|FG001|NOT COMPLETED|Overall Study||19
6643848|NCT02358343|7572387|FG000|STARTED|Screening Intervention|90 completed engagement interview|92
6643849|NCT02358343|7572388|FG001|STARTED|Screening Intervention|89 completed control visit|92
6643850|NCT02358343|7572389|FG002|STARTED|Screening Intervention||0
6643851|NCT02358343|7572390|FG003|STARTED|Screening Intervention||0
6643852|NCT02358343|7572391|FG004|STARTED|Screening Intervention||0
6643853|NCT02358343|7572387|FG000|COMPLETED|Screening Intervention||86
6643854|NCT02358343|7572388|FG001|COMPLETED|Screening Intervention||84
6643855|NCT02358343|7572389|FG002|COMPLETED|Screening Intervention||0
6643856|NCT02358343|7572390|FG003|COMPLETED|Screening Intervention||0
6643857|NCT02358343|7572391|FG004|COMPLETED|Screening Intervention||0
6643858|NCT02358343|7572387|FG000|NOT COMPLETED|Screening Intervention||6
6643859|NCT02358343|7572388|FG001|NOT COMPLETED|Screening Intervention||8
6643860|NCT02358343|7572389|FG002|NOT COMPLETED|Screening Intervention||0
6643861|NCT02358343|7572390|FG003|NOT COMPLETED|Screening Intervention||0
6643862|NCT02358343|7572391|FG004|NOT COMPLETED|Screening Intervention||0
6643863|NCT02358343|7572387|FG000|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
6643864|NCT02358343|7572388|FG001|STARTED|Comparative Efficacy Trial / Observation|Participants enrolled in screening intervention enrolled in comparative efficacy trial|0
6643865|NCT02358343|7572389|FG002|STARTED|Comparative Efficacy Trial / Observation|44 completed treatment|60
6527164|NCT01588366|7448161|FG003|Received at Least One Dose of Study Drug|Overall Study||7
6527165|NCT01588366|7448162|FG004|Received at Least One Dose of Study Drug|Overall Study||3
6643866|NCT02358343|7572390|FG003|STARTED|Comparative Efficacy Trial / Observation|47 completed treatment|60
6643867|NCT02358343|7572391|FG004|STARTED|Comparative Efficacy Trial / Observation||20
6643868|NCT02358343|7572387|FG000|COMPLETED|Comparative Efficacy Trial / Observation||0
6643869|NCT02358343|7572388|FG001|COMPLETED|Comparative Efficacy Trial / Observation||0
6643870|NCT02358343|7572389|FG002|COMPLETED|Comparative Efficacy Trial / Observation||55
6643871|NCT02358343|7572390|FG003|COMPLETED|Comparative Efficacy Trial / Observation||58
6643872|NCT02358343|7572391|FG004|COMPLETED|Comparative Efficacy Trial / Observation||18
6643873|NCT02358343|7572387|FG000|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
6643874|NCT02358343|7572388|FG001|NOT COMPLETED|Comparative Efficacy Trial / Observation||0
6643875|NCT02358343|7572389|FG002|NOT COMPLETED|Comparative Efficacy Trial / Observation||5
6643876|NCT02358343|7572390|FG003|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
6643877|NCT02358343|7572391|FG004|NOT COMPLETED|Comparative Efficacy Trial / Observation||2
6643878|NCT02358369|7572405|FG000|STARTED|Pre-Randomization Washout Period||156
6643879|NCT02358369|7572406|FG001|STARTED|Pre-Randomization Washout Period||0
6643880|NCT02358369|7572407|FG002|STARTED|Pre-Randomization Washout Period||0
6643881|NCT02358369|7572408|FG003|STARTED|Pre-Randomization Washout Period||0
6643882|NCT02358369|7572409|FG004|STARTED|Pre-Randomization Washout Period||0
6643883|NCT02358369|7572405|FG000|COMPLETED|Pre-Randomization Washout Period||121
6643884|NCT02358369|7572406|FG001|COMPLETED|Pre-Randomization Washout Period||0
6643885|NCT02358369|7572407|FG002|COMPLETED|Pre-Randomization Washout Period||0
6527166|NCT01588366|7448163|FG005|Received at Least One Dose of Study Drug|Overall Study||9
6527167|NCT01588366|7448158|FG000|COMPLETED|Overall Study||2
6527168|NCT01588366|7448159|FG001|COMPLETED|Overall Study||6
6527169|NCT01588366|7448160|FG002|COMPLETED|Overall Study||2
6527170|NCT01588366|7448161|FG003|COMPLETED|Overall Study||6
6527171|NCT01588366|7448162|FG004|COMPLETED|Overall Study||3
6527172|NCT01588366|7448163|FG005|COMPLETED|Overall Study||7
6527173|NCT01588366|7448158|FG000|NOT COMPLETED|Overall Study||0
6527174|NCT01588366|7448159|FG001|NOT COMPLETED|Overall Study||1
6527175|NCT01588366|7448160|FG002|NOT COMPLETED|Overall Study||0
6527176|NCT01588366|7448161|FG003|NOT COMPLETED|Overall Study||1
6527177|NCT01588366|7448162|FG004|NOT COMPLETED|Overall Study||0
6527178|NCT01588366|7448163|FG005|NOT COMPLETED|Overall Study||2
6527179|NCT01588405|7448179|FG000|STARTED|Overall Study||33
6527180|NCT01588405|7448179|FG000|COMPLETED|Overall Study||31
6527181|NCT01588405|7448179|FG000|NOT COMPLETED|Overall Study||2
6527182|NCT01588418|7448186|FG000|STARTED|Overall Study||11
6527183|NCT01588418|7448187|FG001|STARTED|Overall Study||4
6527184|NCT01588418|7448186|FG000|COMPLETED|Overall Study||11
6527185|NCT01588418|7448187|FG001|COMPLETED|Overall Study||4
6527186|NCT01588418|7448186|FG000|NOT COMPLETED|Overall Study||0
6527187|NCT01588418|7448187|FG001|NOT COMPLETED|Overall Study||0
6527188|NCT01588444|7448195|FG000|STARTED|Overall Study||20
6527189|NCT01588444|7448196|FG001|STARTED|Overall Study||20
6527190|NCT01588444|7448195|FG000|COMPLETED|Overall Study||20
6527191|NCT01588444|7448196|FG001|COMPLETED|Overall Study||20
6527192|NCT01588444|7448195|FG000|NOT COMPLETED|Overall Study||0
6527193|NCT01588444|7448196|FG001|NOT COMPLETED|Overall Study||0
6527194|NCT01588457|7448204|FG000|STARTED|Randomization 1||53
6527195|NCT01588457|7448205|FG001|STARTED|Randomization 1||59
6527196|NCT01588457|7448206|FG002|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
6643886|NCT02358369|7572408|FG003|COMPLETED|Pre-Randomization Washout Period||0
6643887|NCT02358369|7572409|FG004|COMPLETED|Pre-Randomization Washout Period||0
6643888|NCT02358369|7572405|FG000|NOT COMPLETED|Pre-Randomization Washout Period||35
6643889|NCT02358369|7572406|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
6643890|NCT02358369|7572407|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
6643891|NCT02358369|7572408|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
6643892|NCT02358369|7572409|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
6643893|NCT02358369|7572405|FG000|STARTED|Treatment Period A/B||0
6643894|NCT02358369|7572406|FG001|STARTED|Treatment Period A/B||40
6643895|NCT02358369|7572407|FG002|STARTED|Treatment Period A/B||40
6643896|NCT02358369|7572408|FG003|STARTED|Treatment Period A/B||41
6643897|NCT02358369|7572409|FG004|STARTED|Treatment Period A/B||0
6643898|NCT02358369|7572405|FG000|COMPLETED|Treatment Period A/B||0
6643899|NCT02358369|7572406|FG001|COMPLETED|Treatment Period A/B||38
6643900|NCT02358369|7572407|FG002|COMPLETED|Treatment Period A/B||38
6643901|NCT02358369|7572408|FG003|COMPLETED|Treatment Period A/B||37
6643902|NCT02358369|7572409|FG004|COMPLETED|Treatment Period A/B||0
6643903|NCT02358369|7572405|FG000|NOT COMPLETED|Treatment Period A/B||0
6643904|NCT02358369|7572406|FG001|NOT COMPLETED|Treatment Period A/B||2
6643905|NCT02358369|7572407|FG002|NOT COMPLETED|Treatment Period A/B||2
6643906|NCT02358369|7572408|FG003|NOT COMPLETED|Treatment Period A/B||4
6643907|NCT02358369|7572409|FG004|NOT COMPLETED|Treatment Period A/B||0
6643908|NCT02358369|7572405|FG000|STARTED|Treatment Period C||0
6643909|NCT02358369|7572406|FG001|STARTED|Treatment Period C||0
6643910|NCT02358369|7572407|FG002|STARTED|Treatment Period C||0
6643911|NCT02358369|7572408|FG003|STARTED|Treatment Period C||0
6643912|NCT02358369|7572409|FG004|STARTED|Treatment Period C||113
6643913|NCT02358369|7572405|FG000|COMPLETED|Treatment Period C||0
6643914|NCT02358369|7572406|FG001|COMPLETED|Treatment Period C||0
6643915|NCT02358369|7572407|FG002|COMPLETED|Treatment Period C||0
6643916|NCT02358369|7572408|FG003|COMPLETED|Treatment Period C||0
6643917|NCT02358369|7572409|FG004|COMPLETED|Treatment Period C||106
6643918|NCT02358369|7572405|FG000|NOT COMPLETED|Treatment Period C||0
6643919|NCT02358369|7572406|FG001|NOT COMPLETED|Treatment Period C||0
6643920|NCT02358369|7572407|FG002|NOT COMPLETED|Treatment Period C||0
6643921|NCT02358369|7572408|FG003|NOT COMPLETED|Treatment Period C||0
6643922|NCT02358369|7572409|FG004|NOT COMPLETED|Treatment Period C||7
6643923|NCT02358473|7572419|FG000|STARTED|Overall Study||13
6643924|NCT02358473|7572419|FG000|COMPLETED|Overall Study||0
6643925|NCT02358473|7572419|FG000|NOT COMPLETED|Overall Study||13
6527197|NCT01588457|7448207|FG003|STARTED|Randomization 1|No subject assigned during first randomization to monotherapy|0
6527198|NCT01588457|7448204|FG000|COMPLETED|Randomization 1||30
6527199|NCT01588457|7448205|FG001|COMPLETED|Randomization 1||43
6527200|NCT01588457|7448206|FG002|COMPLETED|Randomization 1||0
6527201|NCT01588457|7448207|FG003|COMPLETED|Randomization 1||0
6527202|NCT01588457|7448204|FG000|NOT COMPLETED|Randomization 1||23
6527203|NCT01588457|7448205|FG001|NOT COMPLETED|Randomization 1||16
6527204|NCT01588457|7448206|FG002|NOT COMPLETED|Randomization 1||0
6643926|NCT02358603|7572425|FG000|STARTED|Overall Study||40
6643927|NCT02358603|7572426|FG001|STARTED|Overall Study||8
6643928|NCT02358603|7572425|FG000|COMPLETED|Overall Study||40
6643929|NCT02358603|7572426|FG001|COMPLETED|Overall Study||8
6643930|NCT02358603|7572425|FG000|NOT COMPLETED|Overall Study||0
6643931|NCT02358603|7572426|FG001|NOT COMPLETED|Overall Study||0
6643932|NCT02358668|7572435|FG000|STARTED|Overall Study||24
6643933|NCT02358668|7572436|FG001|STARTED|Overall Study||24
6527205|NCT01588457|7448207|FG003|NOT COMPLETED|Randomization 1||0
6527206|NCT01588457|7448204|FG000|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|21
6527207|NCT01588457|7448205|FG001|STARTED|Randomization 2|Some subjects who completed the first randomization had QTP or LTG added to regimen|31
6527208|NCT01588457|7448206|FG002|STARTED|Randomization 2|Assignment of Quetiapine plus monotherapy for symptoms of depression|17
6527209|NCT01588457|7448207|FG003|STARTED|Randomization 2|Assignment of Lamotrigine plus monotherapy for symptoms of depression|18
6527210|NCT01588457|7448204|FG000|COMPLETED|Randomization 2||1
6527211|NCT01588457|7448205|FG001|COMPLETED|Randomization 2||3
6527212|NCT01588457|7448206|FG002|COMPLETED|Randomization 2||12
6527213|NCT01588457|7448207|FG003|COMPLETED|Randomization 2||13
6527214|NCT01588457|7448204|FG000|NOT COMPLETED|Randomization 2||20
6527215|NCT01588457|7448205|FG001|NOT COMPLETED|Randomization 2||28
6527216|NCT01588457|7448206|FG002|NOT COMPLETED|Randomization 2||5
6527217|NCT01588457|7448207|FG003|NOT COMPLETED|Randomization 2||5
6527218|NCT01588470|7448227|FG000|STARTED|Overall Study|First enrolled April 2007|130
6527219|NCT01588470|7448227|FG000|COMPLETED|Overall Study|Completed Dec. 2011|50
6527220|NCT01588470|7448227|FG000|NOT COMPLETED|Overall Study||80
6527221|NCT01588496|7448239|FG000|STARTED|Overall Study||8
6527222|NCT01588496|7448240|FG001|STARTED|Overall Study||17
6527223|NCT01588496|7448241|FG002|STARTED|Overall Study||33
6527224|NCT01588496|7448239|FG000|Received Treatment|Overall Study||8
6527225|NCT01588496|7448240|FG001|Received Treatment|Overall Study||16
6527226|NCT01588496|7448241|FG002|Received Treatment|Overall Study||33
6527227|NCT01588496|7448239|FG000|COMPLETED|Overall Study||8
6527228|NCT01588496|7448240|FG001|COMPLETED|Overall Study||16
6527229|NCT01588496|7448241|FG002|COMPLETED|Overall Study||33
6527230|NCT01588496|7448239|FG000|NOT COMPLETED|Overall Study||0
6643934|NCT02358668|7572437|FG002|STARTED|Overall Study||12
6643935|NCT02358668|7572435|FG000|COMPLETED|Overall Study||22
6643936|NCT02358668|7572436|FG001|COMPLETED|Overall Study||23
6643937|NCT02358668|7572437|FG002|COMPLETED|Overall Study||12
6643938|NCT02358668|7572435|FG000|NOT COMPLETED|Overall Study||2
6643939|NCT02358668|7572436|FG001|NOT COMPLETED|Overall Study||1
6643940|NCT02358668|7572437|FG002|NOT COMPLETED|Overall Study||0
6643941|NCT02358863|7572445|FG000|STARTED|Overall Study||13
6643942|NCT02358863|7572445|FG000|COMPLETED|Overall Study||10
6643943|NCT02358863|7572445|FG000|NOT COMPLETED|Overall Study||3
6643944|NCT02358876|7572449|FG000|STARTED|Overall Study||32
6643945|NCT02358876|7572449|FG000|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
6643946|NCT02358876|7572449|FG000|NOT COMPLETED|Overall Study||2
6643947|NCT02358889|7572456|FG000|STARTED|Overall Study||30
6643948|NCT02358889|7572457|FG001|STARTED|Overall Study||30
6643949|NCT02358889|7572458|FG002|STARTED|Overall Study||28
6643950|NCT02358889|7572456|FG000|COMPLETED|Overall Study||30
6643951|NCT02358889|7572457|FG001|COMPLETED|Overall Study||28
6643952|NCT02358889|7572458|FG002|COMPLETED|Overall Study||27
6643953|NCT02358889|7572456|FG000|NOT COMPLETED|Overall Study||0
6643954|NCT02358889|7572457|FG001|NOT COMPLETED|Overall Study||2
6643955|NCT02358889|7572458|FG002|NOT COMPLETED|Overall Study||1
6643956|NCT02359006|7572468|FG000|STARTED|Overall Study||14
6643957|NCT02359006|7572469|FG001|STARTED|Overall Study||13
6643958|NCT02359006|7572468|FG000|COMPLETED|Overall Study||10
6743725|NCT03335254|7671822|FG012|COMPLETED|Period 3, Day 16-25||0
6743726|NCT03335254|7671823|FG013|COMPLETED|Period 3, Day 16-25||0
6743727|NCT03335254|7671824|FG014|COMPLETED|Period 3, Day 16-25||0
6743728|NCT03335254|7671825|FG015|COMPLETED|Period 3, Day 16-25||0
6527231|NCT01588496|7448240|FG001|NOT COMPLETED|Overall Study||1
6643959|NCT02359006|7572469|FG001|COMPLETED|Overall Study||10
6643960|NCT02359006|7572468|FG000|NOT COMPLETED|Overall Study||4
6643961|NCT02359006|7572469|FG001|NOT COMPLETED|Overall Study||3
6643962|NCT02359019|7572477|FG000|STARTED|Overall Study||45
6643963|NCT02359019|7572477|FG000|COMPLETED|Overall Study||45
6643964|NCT02359019|7572477|FG000|NOT COMPLETED|Overall Study||0
6643965|NCT02359045|7572483|FG000|STARTED|Overall Study||40
6643966|NCT02359045|7572484|FG001|STARTED|Overall Study||42
6643967|NCT02359045|7572483|FG000|COMPLETED|Overall Study||36
6643968|NCT02359045|7572484|FG001|COMPLETED|Overall Study||39
6643969|NCT02359045|7572483|FG000|NOT COMPLETED|Overall Study||4
6643970|NCT02359045|7572484|FG001|NOT COMPLETED|Overall Study||3
6643971|NCT02359058|7572503|FG000|STARTED|Overall Study||6
6643972|NCT02359058|7572504|FG001|STARTED|Overall Study||6
6643973|NCT02359058|7572505|FG002|STARTED|Overall Study||6
6643974|NCT02359058|7572503|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6643975|NCT02359058|7572504|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6643976|NCT02359058|7572505|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6643977|NCT02359058|7572503|FG000|COMPLETED|Overall Study||6
6643978|NCT02359058|7572504|FG001|COMPLETED|Overall Study||6
6643979|NCT02359058|7572505|FG002|COMPLETED|Overall Study||6
6643980|NCT02359058|7572503|FG000|NOT COMPLETED|Overall Study||0
6643981|NCT02359058|7572504|FG001|NOT COMPLETED|Overall Study||0
6643982|NCT02359058|7572505|FG002|NOT COMPLETED|Overall Study||0
6643983|NCT02359110|7572516|FG000|STARTED|Overall Study||55
6643984|NCT02359110|7572517|FG001|STARTED|Overall Study||54
6643985|NCT02359110|7572516|FG000|COMPLETED|Overall Study||55
6643986|NCT02359110|7572517|FG001|COMPLETED|Overall Study||54
6643987|NCT02359110|7572516|FG000|NOT COMPLETED|Overall Study||0
6643988|NCT02359110|7572517|FG001|NOT COMPLETED|Overall Study||0
6527232|NCT01588496|7448241|FG002|NOT COMPLETED|Overall Study||0
6527233|NCT01588509|7448251|FG000|STARTED|Overall Study||30
6527234|NCT01588509|7448252|FG001|STARTED|Overall Study||30
6527235|NCT01588509|7448251|FG000|Received Treatment|Overall Study||30
6527236|NCT01588509|7448252|FG001|Received Treatment|Overall Study||30
6527237|NCT01588509|7448251|FG000|COMPLETED|Overall Study||29
6527238|NCT01588509|7448252|FG001|COMPLETED|Overall Study||30
6527239|NCT01588509|7448251|FG000|NOT COMPLETED|Overall Study||1
6527240|NCT01588509|7448252|FG001|NOT COMPLETED|Overall Study||0
6527241|NCT01588548|7448264|FG000|STARTED|Overall Study||3
6527242|NCT01588548|7448265|FG001|STARTED|Overall Study||7
6527243|NCT01588548|7448266|FG002|STARTED|Overall Study||6
6643989|NCT02359305|7572525|FG000|STARTED|Overall Study||34
6643990|NCT02359305|7572526|FG001|STARTED|Overall Study||34
6643991|NCT02359305|7572525|FG000|COMPLETED|Overall Study||34
6643992|NCT02359305|7572526|FG001|COMPLETED|Overall Study||34
6643993|NCT02359305|7572525|FG000|NOT COMPLETED|Overall Study||0
6643994|NCT02359305|7572526|FG001|NOT COMPLETED|Overall Study||0
6643995|NCT02359435|7572534|FG000|STARTED|Overall Study||220
6643996|NCT02359435|7572535|FG001|STARTED|Overall Study||220
6643997|NCT02359435|7572534|FG000|COMPLETED|Overall Study||216
6643998|NCT02359435|7572535|FG001|COMPLETED|Overall Study||216
6643999|NCT02359435|7572534|FG000|NOT COMPLETED|Overall Study||4
6644000|NCT02359435|7572535|FG001|NOT COMPLETED|Overall Study||4
6644001|NCT02359552|7572543|FG000|STARTED|Overall Study||25
6644002|NCT02359552|7572544|FG001|STARTED|Overall Study||25
6644003|NCT02359552|7572543|FG000|COMPLETED|Overall Study||22
6644004|NCT02359552|7572544|FG001|COMPLETED|Overall Study||21
6644005|NCT02359552|7572543|FG000|NOT COMPLETED|Overall Study||3
6644006|NCT02359552|7572544|FG001|NOT COMPLETED|Overall Study||4
6644007|NCT02359851|7572550|FG000|STARTED|Overall Study||5
6644008|NCT02359851|7572550|FG000|COMPLETED|Overall Study||3
6644009|NCT02359851|7572550|FG000|NOT COMPLETED|Overall Study||2
6644010|NCT02359877|7572558|FG000|STARTED|Overall Study||34
6644011|NCT02359877|7572559|FG001|STARTED|Overall Study||6
6644012|NCT02359877|7572560|FG002|STARTED|Overall Study||6
6644013|NCT02359877|7572561|FG003|STARTED|Overall Study||14
6644014|NCT02359877|7572558|FG000|COMPLETED|Overall Study||33
6644015|NCT02359877|7572559|FG001|COMPLETED|Overall Study||6
6644016|NCT02359877|7572560|FG002|COMPLETED|Overall Study||6
6644017|NCT02359877|7572561|FG003|COMPLETED|Overall Study||11
6644018|NCT02359877|7572558|FG000|NOT COMPLETED|Overall Study||1
6644019|NCT02359877|7572559|FG001|NOT COMPLETED|Overall Study||0
6644020|NCT02359877|7572560|FG002|NOT COMPLETED|Overall Study||0
6644021|NCT02359877|7572561|FG003|NOT COMPLETED|Overall Study||3
6644022|NCT02359890|7572589|FG000|STARTED|Overall Study|Patients who enrolled in the study are those who signed informed consent forms.|165
6644023|NCT02359890|7572589|FG000|Safety Population|Overall Study|Enrolled subjects who had the study catheter inserted|159
6644024|NCT02359890|7572589|FG000|mITT Population|Overall Study|Enrolled subjects who met the inclusion/exclusion criteria and had the study catheter inserted|155
6644025|NCT02359890|7572589|FG000|Per-Protocol (PP) Population|Overall Study|Subjects part of mITT population who had undergone RF ablation.|155
6644026|NCT02359890|7572589|FG000|COMPLETED|Overall Study||155
6644027|NCT02359890|7572589|FG000|NOT COMPLETED|Overall Study||10
6644028|NCT02359903|7572595|FG000|STARTED|Overall Study||45
6644029|NCT02359903|7572596|FG001|STARTED|Overall Study||45
6644030|NCT02359903|7572595|FG000|COMPLETED|Overall Study||45
6644031|NCT02359903|7572596|FG001|COMPLETED|Overall Study||43
6644032|NCT02359903|7572595|FG000|NOT COMPLETED|Overall Study||0
6644033|NCT02359903|7572596|FG001|NOT COMPLETED|Overall Study||2
6644034|NCT02359916|7572609|FG000|STARTED|Overall Study|The number of unique individuals in this study is unknown|
6644035|NCT02359916|7572610|FG001|STARTED|Overall Study|The number of unique individuals in this study is unknown|
6644036|NCT02359916|7572611|FG002|STARTED|Overall Study|The number of unique individuals in this study is unknown|
6644037|NCT02359916|7572612|FG003|STARTED|Overall Study|The number of unique individuals in this study is unknown|
6644038|NCT02359916|7572613|FG004|STARTED|Overall Study|The number of unique individuals in this study is unknown|
6644039|NCT02359916|7572614|FG005|STARTED|Overall Study|The number of unique individuals in this study is unknown|
6644040|NCT02359916|7572615|FG006|STARTED|Overall Study|The number of unique individuals in this study is unknown|
6644041|NCT02359916|7572609|FG000|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
6644042|NCT02359916|7572610|FG001|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
6527244|NCT01588548|7448267|FG003|STARTED|Overall Study||7
6527245|NCT01588548|7448268|FG004|STARTED|Overall Study||6
6644043|NCT02359916|7572611|FG002|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
6644044|NCT02359916|7572612|FG003|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
6644045|NCT02359916|7572613|FG004|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
6644046|NCT02359916|7572614|FG005|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
6644047|NCT02359916|7572615|FG006|COMPLETED|Overall Study|The number of unique individuals in this study is unknown|
6644048|NCT02359916|7572609|FG000|NOT COMPLETED|Overall Study||
6644049|NCT02359916|7572610|FG001|NOT COMPLETED|Overall Study||
6644050|NCT02359916|7572611|FG002|NOT COMPLETED|Overall Study||
6644051|NCT02359916|7572612|FG003|NOT COMPLETED|Overall Study||
6644052|NCT02359916|7572613|FG004|NOT COMPLETED|Overall Study||
6644053|NCT02359916|7572614|FG005|NOT COMPLETED|Overall Study||
6644054|NCT02359916|7572615|FG006|NOT COMPLETED|Overall Study||
6644055|NCT02359955|7572632|FG000|STARTED|Overall Study||10
6527246|NCT01588548|7448269|FG005|STARTED|Overall Study||6
6527247|NCT01588548|7448264|FG000|Cycle 1 Day 21|Overall Study||3
6527248|NCT01588548|7448265|FG001|Cycle 1 Day 21|Overall Study||5
6527249|NCT01588548|7448266|FG002|Cycle 1 Day 21|Overall Study||2
6527250|NCT01588548|7448267|FG003|Cycle 1 Day 21|Overall Study||5
6527251|NCT01588548|7448268|FG004|Cycle 1 Day 21|Overall Study||3
6527252|NCT01588548|7448269|FG005|Cycle 1 Day 21|Overall Study||3
6527253|NCT01588548|7448264|FG000|COMPLETED|Overall Study||0
6527254|NCT01588548|7448265|FG001|COMPLETED|Overall Study||0
6527255|NCT01588548|7448266|FG002|COMPLETED|Overall Study||0
6527256|NCT01588548|7448267|FG003|COMPLETED|Overall Study||0
6527257|NCT01588548|7448268|FG004|COMPLETED|Overall Study||0
6527258|NCT01588548|7448269|FG005|COMPLETED|Overall Study||0
6527259|NCT01588548|7448264|FG000|NOT COMPLETED|Overall Study||3
6527260|NCT01588548|7448265|FG001|NOT COMPLETED|Overall Study||7
6527261|NCT01588548|7448266|FG002|NOT COMPLETED|Overall Study||6
6527262|NCT01588548|7448267|FG003|NOT COMPLETED|Overall Study||7
6527263|NCT01588548|7448268|FG004|NOT COMPLETED|Overall Study||6
6527264|NCT01588548|7448269|FG005|NOT COMPLETED|Overall Study||6
6527265|NCT01588561|7448283|FG000|STARTED|Overall Study||14
6527266|NCT01588561|7448284|FG001|STARTED|Overall Study||1
6527267|NCT01588561|7448283|FG000|First Injection (Visit 1)|Overall Study||14
6527268|NCT01588561|7448284|FG001|First Injection (Visit 1)|Overall Study||1
6527269|NCT01588561|7448283|FG000|Rest Period|Overall Study||14
6527270|NCT01588561|7448284|FG001|Rest Period|Overall Study||1
6527271|NCT01588561|7448283|FG000|Second Injection (Visit 2)|Overall Study||14
6527272|NCT01588561|7448284|FG001|Second Injection (Visit 2)|Overall Study||1
6527273|NCT01588561|7448283|FG000|COMPLETED|Overall Study||14
6527274|NCT01588561|7448284|FG001|COMPLETED|Overall Study||1
6527275|NCT01588561|7448283|FG000|NOT COMPLETED|Overall Study||0
6527276|NCT01588561|7448284|FG001|NOT COMPLETED|Overall Study||0
6527277|NCT01588821|7448290|FG000|STARTED|Overall Study||37
6527278|NCT01588821|7448290|FG000|COMPLETED|Overall Study||37
6527279|NCT01588821|7448290|FG000|NOT COMPLETED|Overall Study||0
6527280|NCT01588951|7448298|FG000|STARTED|Overall Study||2
6527281|NCT01588951|7448299|FG001|STARTED|Overall Study||2
6527282|NCT01588951|7448300|FG002|STARTED|Overall Study||6
6527283|NCT01588951|7448298|FG000|COMPLETED|Overall Study||2
6527284|NCT01588951|7448299|FG001|COMPLETED|Overall Study||2
6527285|NCT01588951|7448300|FG002|COMPLETED|Overall Study||5
6527286|NCT01588951|7448298|FG000|NOT COMPLETED|Overall Study||0
6527287|NCT01588951|7448299|FG001|NOT COMPLETED|Overall Study||0
6527288|NCT01588951|7448300|FG002|NOT COMPLETED|Overall Study||1
6527289|NCT01588990|7448308|FG000|STARTED|Phase A||128
6527290|NCT01588990|7448308|FG000|COMPLETED|Phase A|A total of 58 participants had disease progression in Phase A and ended Phase A.|58
6527291|NCT01588990|7448308|FG000|NOT COMPLETED|Phase A||70
6527292|NCT01588990|7448308|FG000|STARTED|Phase B|Of 58 participants who had documented disease progression in Phase A, 53 entered in Phase B.|53
6527293|NCT01588990|7448308|FG000|COMPLETED|Phase B|A total of 37 participants had disease progression in Phase B and ended Phase B.|37
6527294|NCT01588990|7448308|FG000|NOT COMPLETED|Phase B||16
6527295|NCT01589094|7448316|FG000|STARTED|Overall Study||51
6527296|NCT01589094|7448316|FG000|COMPLETED|Overall Study||49
6527297|NCT01589094|7448316|FG000|NOT COMPLETED|Overall Study||2
6527298|NCT01589185|7448325|FG000|STARTED|Overall Study||6
6527299|NCT01589185|7448326|FG001|STARTED|Overall Study||8
6527300|NCT01589185|7448327|FG002|STARTED|Overall Study||10
6527301|NCT01589185|7448328|FG003|STARTED|Overall Study||8
6527302|NCT01589185|7448329|FG004|STARTED|Overall Study||16
6527303|NCT01589185|7448325|FG000|COMPLETED|Overall Study||4
6527304|NCT01589185|7448326|FG001|COMPLETED|Overall Study||6
6527305|NCT01589185|7448327|FG002|COMPLETED|Overall Study||6
6527306|NCT01589185|7448328|FG003|COMPLETED|Overall Study||5
6527307|NCT01589185|7448329|FG004|COMPLETED|Overall Study||15
6527308|NCT01589185|7448325|FG000|NOT COMPLETED|Overall Study||2
6527309|NCT01589185|7448326|FG001|NOT COMPLETED|Overall Study||2
6527310|NCT01589185|7448327|FG002|NOT COMPLETED|Overall Study||4
6527311|NCT01589185|7448328|FG003|NOT COMPLETED|Overall Study||3
6527312|NCT01589185|7448329|FG004|NOT COMPLETED|Overall Study||1
6527313|NCT01589237|7448346|FG000|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
6527314|NCT01589237|7448347|FG001|STARTED|Part A (52 Weeks)||12
6527315|NCT01589237|7448348|FG002|STARTED|Part A (52 Weeks)||10
6527316|NCT01589237|7448349|FG003|STARTED|Part A (52 Weeks)||5
6527317|NCT01589237|7448346|FG000|COMPLETED|Part A (52 Weeks)||9
6527318|NCT01589237|7448347|FG001|COMPLETED|Part A (52 Weeks)||9
6527319|NCT01589237|7448348|FG002|COMPLETED|Part A (52 Weeks)||8
6527320|NCT01589237|7448349|FG003|COMPLETED|Part A (52 Weeks)||5
6527321|NCT01589237|7448346|FG000|NOT COMPLETED|Part A (52 Weeks)||2
6527322|NCT01589237|7448347|FG001|NOT COMPLETED|Part A (52 Weeks)||3
6527323|NCT01589237|7448348|FG002|NOT COMPLETED|Part A (52 Weeks)||2
6527324|NCT01589237|7448349|FG003|NOT COMPLETED|Part A (52 Weeks)||0
6527325|NCT01589237|7448346|FG000|STARTED|Part B (Planned for 78 Week-terminated)||5
6527326|NCT01589237|7448347|FG001|STARTED|Part B (Planned for 78 Week-terminated)||6
6527327|NCT01589237|7448348|FG002|STARTED|Part B (Planned for 78 Week-terminated)||4
6527328|NCT01589237|7448349|FG003|STARTED|Part B (Planned for 78 Week-terminated)||4
6527329|NCT01589237|7448346|FG000|COMPLETED|Part B (Planned for 78 Week-terminated)||0
6527330|NCT01589237|7448347|FG001|COMPLETED|Part B (Planned for 78 Week-terminated)||0
6527331|NCT01589237|7448348|FG002|COMPLETED|Part B (Planned for 78 Week-terminated)||0
6527332|NCT01589237|7448349|FG003|COMPLETED|Part B (Planned for 78 Week-terminated)||0
6527333|NCT01589237|7448346|FG000|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
6527334|NCT01589237|7448347|FG001|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
6527335|NCT01589237|7448348|FG002|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
6527336|NCT01589237|7448349|FG003|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
6527337|NCT01589263|7448365|FG000|STARTED|Overall Study||9
6527338|NCT01589263|7448366|FG001|STARTED|Overall Study||12
6527339|NCT01589263|7448365|FG000|COMPLETED|Overall Study||9
6527340|NCT01589263|7448366|FG001|COMPLETED|Overall Study||12
6527341|NCT01589263|7448365|FG000|NOT COMPLETED|Overall Study||0
6527342|NCT01589263|7448366|FG001|NOT COMPLETED|Overall Study||0
6527343|NCT01589302|7448372|FG000|STARTED|Overall Study||154
6527344|NCT01589302|7448372|FG000|Del17p Patients|Overall Study||76
6527345|NCT01589302|7448372|FG000|Non-Del17p Patients|Overall Study||76
6527346|NCT01589302|7448372|FG000|COMPLETED|Overall Study||152
6527347|NCT01589302|7448372|FG000|NOT COMPLETED|Overall Study||2
6527348|NCT01589315|7448377|FG000|STARTED|Overall Study||17
6527349|NCT01589315|7448377|FG000|COMPLETED|Overall Study||16
6527350|NCT01589315|7448377|FG000|NOT COMPLETED|Overall Study||1
6527351|NCT01589445|7448381|FG000|STARTED|001 (Pioglitazone) -3 Months||77
6527352|NCT01589445|7448381|FG000|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
6527353|NCT01589445|7448381|FG000|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
6527354|NCT01589445|7448381|FG000|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
6527355|NCT01589445|7448381|FG000|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
6527356|NCT01589445|7448381|FG000|NOT COMPLETED|002 (Metformin)-3 Months||9
6527357|NCT01589484|7448389|FG000|STARTED|Overall Study||104
6527358|NCT01589484|7448389|FG000|COMPLETED|Overall Study||100
6527359|NCT01589484|7448389|FG000|NOT COMPLETED|Overall Study||4
6527360|NCT01589497|7448398|FG000|STARTED|Overall Study||18
6527361|NCT01589497|7448399|FG001|STARTED|Overall Study||17
6527362|NCT01589497|7448400|FG002|STARTED|Overall Study||16
6527363|NCT01589497|7448401|FG003|STARTED|Overall Study||18
6527364|NCT01589497|7448398|FG000|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
6644056|NCT02359955|7572633|FG001|STARTED|Overall Study||10
6644057|NCT02359955|7572632|FG000|COMPLETED|Overall Study||10
6644058|NCT02359955|7572633|FG001|COMPLETED|Overall Study||10
6644059|NCT02359955|7572632|FG000|NOT COMPLETED|Overall Study||0
6644060|NCT02359955|7572633|FG001|NOT COMPLETED|Overall Study||0
6644061|NCT02360085|7572649|FG000|STARTED|Overall Study||65
6644062|NCT02360085|7572649|FG000|COMPLETED|Overall Study||49
6644063|NCT02360085|7572649|FG000|NOT COMPLETED|Overall Study||16
6644064|NCT02360098|7572662|FG000|STARTED|Overall Study||36
6644065|NCT02360098|7572662|FG000|COMPLETED|Overall Study||29
6644066|NCT02360098|7572662|FG000|NOT COMPLETED|Overall Study||7
6644067|NCT02360124|7572670|FG000|STARTED|Overall Study||108
6644068|NCT02360124|7572671|FG001|STARTED|Overall Study||107
6644069|NCT02360124|7572672|FG002|STARTED|Overall Study||108
6644070|NCT02360124|7572670|FG000|COMPLETED|Overall Study||80
6644071|NCT02360124|7572671|FG001|COMPLETED|Overall Study||95
6644072|NCT02360124|7572672|FG002|COMPLETED|Overall Study||82
6644073|NCT02360124|7572670|FG000|NOT COMPLETED|Overall Study||28
6644074|NCT02360124|7572671|FG001|NOT COMPLETED|Overall Study||12
6644075|NCT02360124|7572672|FG002|NOT COMPLETED|Overall Study||26
6644076|NCT02360215|7572684|FG000|STARTED|Overall Study||257
6644077|NCT02360215|7572685|FG001|STARTED|Overall Study||261
6644078|NCT02360215|7572684|FG000|All Randomized Participants|Overall Study||257
6644079|NCT02360215|7572685|FG001|All Randomized Participants|Overall Study||261
6644080|NCT02360215|7572684|FG000|Started Protocol Treatment|Overall Study||232
6644081|NCT02360215|7572685|FG001|Started Protocol Treatment|Overall Study||223
6644082|NCT02360215|7572684|FG000|MDASI-BT Symptom Score|Overall Study||249
6644083|NCT02360215|7572685|FG001|MDASI-BT Symptom Score|Overall Study||251
6644084|NCT02360215|7572684|FG000|MDASI-BT Intererence Score|Overall Study||248
6644085|NCT02360215|7572685|FG001|MDASI-BT Intererence Score|Overall Study||251
6644086|NCT02360215|7572684|FG000|MDASI-BT Cognitive Factor Score|Overall Study||249
6644087|NCT02360215|7572685|FG001|MDASI-BT Cognitive Factor Score|Overall Study||251
6644088|NCT02360215|7572684|FG000|MDASI-BT Neurologic Factor Score|Overall Study||249
6644089|NCT02360215|7572685|FG001|MDASI-BT Neurologic Factor Score|Overall Study||251
6644090|NCT02360215|7572684|FG000|HVLT-R Total Recall|Overall Study||256
6644091|NCT02360215|7572685|FG001|HVLT-R Total Recall|Overall Study||259
6644092|NCT02360215|7572684|FG000|HVLT-R Delayed Recall|Overall Study||256
6644093|NCT02360215|7572685|FG001|HVLT-R Delayed Recall|Overall Study||259
6644094|NCT02360215|7572684|FG000|HVLT-R Recognition|Overall Study||255
6644095|NCT02360215|7572685|FG001|HVLT-R Recognition|Overall Study||259
6527365|NCT01589497|7448399|FG001|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
6644096|NCT02360215|7572684|FG000|Trail Making Test (TMT) Part A|Overall Study||256
6644097|NCT02360215|7572685|FG001|Trail Making Test (TMT) Part A|Overall Study||260
6644098|NCT02360215|7572684|FG000|TMT Part B|Overall Study||250
6644099|NCT02360215|7572685|FG001|TMT Part B|Overall Study||257
6644100|NCT02360215|7572684|FG000|Controlled Oral Word Association (COWA)|Overall Study||257
6644101|NCT02360215|7572685|FG001|Controlled Oral Word Association (COWA)|Overall Study||261
6644102|NCT02360215|7572684|FG000|Clinical Trial Battery Composite Score|Overall Study||255
6644103|NCT02360215|7572685|FG001|Clinical Trial Battery Composite Score|Overall Study||259
6644104|NCT02360215|7572684|FG000|EQ-5D-5L Index at 2 Months|Overall Study||142
6527366|NCT01589497|7448400|FG002|COMPLETED|Overall Study||15
6527367|NCT01589497|7448401|FG003|COMPLETED|Overall Study||17
6527368|NCT01589497|7448398|FG000|NOT COMPLETED|Overall Study||1
6527369|NCT01589497|7448399|FG001|NOT COMPLETED|Overall Study||1
6527370|NCT01589497|7448400|FG002|NOT COMPLETED|Overall Study||1
6527371|NCT01589497|7448401|FG003|NOT COMPLETED|Overall Study||1
6527372|NCT01589510|7448416|FG000|STARTED|Overall Study||419
6527373|NCT01589510|7448416|FG000|COMPLETED|Overall Study||386
6527374|NCT01589510|7448416|FG000|NOT COMPLETED|Overall Study||33
6527375|NCT01589601|7448422|FG000|STARTED|Overall Study||75
6527376|NCT01589601|7448423|FG001|STARTED|Overall Study||75
6527377|NCT01589601|7448422|FG000|COMPLETED|Overall Study||28
6527378|NCT01589601|7448423|FG001|COMPLETED|Overall Study||26
6527379|NCT01589601|7448422|FG000|NOT COMPLETED|Overall Study||47
6527380|NCT01589601|7448423|FG001|NOT COMPLETED|Overall Study||49
6527381|NCT01589653|7448431|FG000|STARTED|Overall Study||76
6527382|NCT01589653|7448432|FG001|STARTED|Overall Study||79
6527383|NCT01589653|7448431|FG000|Exposed|Overall Study||76
6527384|NCT01589653|7448432|FG001|Exposed|Overall Study||78
6527385|NCT01589653|7448431|FG000|COMPLETED|Overall Study||69
6527386|NCT01589653|7448432|FG001|COMPLETED|Overall Study||68
6527387|NCT01589653|7448431|FG000|NOT COMPLETED|Overall Study||7
6527388|NCT01589653|7448432|FG001|NOT COMPLETED|Overall Study||11
6527389|NCT01589770|7448440|FG000|STARTED|Overall Study||67
6527390|NCT01589770|7448441|FG001|STARTED|Overall Study||61
6527391|NCT01589770|7448440|FG000|COMPLETED|Overall Study||59
6527392|NCT01589770|7448441|FG001|COMPLETED|Overall Study||56
6527393|NCT01589770|7448440|FG000|NOT COMPLETED|Overall Study||8
6527394|NCT01589770|7448441|FG001|NOT COMPLETED|Overall Study||5
6527395|NCT01589822|7448450|FG000|STARTED|Overall Study||84
6527396|NCT01589822|7448451|FG001|STARTED|Overall Study||89
6527397|NCT01589822|7448452|FG002|STARTED|Overall Study||41
6527398|NCT01589822|7448450|FG000|COMPLETED|Overall Study||80
6527399|NCT01589822|7448451|FG001|COMPLETED|Overall Study||86
6527400|NCT01589822|7448452|FG002|COMPLETED|Overall Study||40
6527401|NCT01589822|7448450|FG000|NOT COMPLETED|Overall Study||4
6527402|NCT01589822|7448451|FG001|NOT COMPLETED|Overall Study||3
6527403|NCT01589822|7448452|FG002|NOT COMPLETED|Overall Study||1
6527404|NCT01589978|7448462|FG000|STARTED|Overall Study||2681
6527405|NCT01589978|7448462|FG000|COMPLETED|Overall Study||2681
6527406|NCT01589978|7448462|FG000|NOT COMPLETED|Overall Study||0
6527407|NCT01590017|7448467|FG000|STARTED|Overall Study||41
6527408|NCT01590017|7448467|FG000|COMPLETED|Overall Study||37
6527409|NCT01590017|7448467|FG000|NOT COMPLETED|Overall Study||4
6527410|NCT01590082|7448473|FG000|STARTED|Overall Study||11
6527411|NCT01590082|7448474|FG001|STARTED|Overall Study||1
6527412|NCT01590082|7448473|FG000|COMPLETED|Overall Study||9
6527413|NCT01590082|7448474|FG001|COMPLETED|Overall Study||1
6527414|NCT01590082|7448473|FG000|NOT COMPLETED|Overall Study||2
6527415|NCT01590082|7448474|FG001|NOT COMPLETED|Overall Study||0
6527416|NCT01590212|7448483|FG000|STARTED|Overall Study||12
6527417|NCT01590212|7448484|FG001|STARTED|Overall Study||9
6527418|NCT01590212|7448485|FG002|STARTED|Overall Study||14
6527419|NCT01590212|7448483|FG000|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
6527420|NCT01590212|7448484|FG001|Baseline (Pre-intervention)|Overall Study||9
6644105|NCT02360215|7572685|FG001|EQ-5D-5L Index at 2 Months|Overall Study||125
6644106|NCT02360215|7572684|FG000|EQ-5D-5L Index at 4 Months|Overall Study||110
6644107|NCT02360215|7572685|FG001|EQ-5D-5L Index at 4 Months|Overall Study||96
6644108|NCT02360215|7572684|FG000|EQ-5D-5L Index at 6 Months|Overall Study||79
6644109|NCT02360215|7572685|FG001|EQ-5D-5L Index at 6 Months|Overall Study||70
6644110|NCT02360215|7572684|FG000|EQ-5D-5L Index at 12 Months|Overall Study||56
6644111|NCT02360215|7572685|FG001|EQ-5D-5L Index at 12 Months|Overall Study||45
6644112|NCT02360215|7572684|FG000|EQ-5D-5L VAS at 2 Months|Overall Study||139
6644113|NCT02360215|7572685|FG001|EQ-5D-5L VAS at 2 Months|Overall Study||123
6644114|NCT02360215|7572684|FG000|EQ-5D-5L VAS at 4 Months|Overall Study||104
6644115|NCT02360215|7572685|FG001|EQ-5D-5L VAS at 4 Months|Overall Study||193
6644116|NCT02360215|7572684|FG000|EQ-5D-5L VAS at 6 Months|Overall Study||76
6644117|NCT02360215|7572685|FG001|EQ-5D-5L VAS at 6 Months|Overall Study||69
6644118|NCT02360215|7572684|FG000|EQ-5D-5L VAS at 12 Months|Overall Study||57
6644119|NCT02360215|7572685|FG001|EQ-5D-5L VAS at 12 Months|Overall Study||48
6644120|NCT02360215|7572684|FG000|COMPLETED|Overall Study||257
6644121|NCT02360215|7572685|FG001|COMPLETED|Overall Study||261
6644122|NCT02360215|7572684|FG000|NOT COMPLETED|Overall Study||0
6644123|NCT02360215|7572685|FG001|NOT COMPLETED|Overall Study||0
6644124|NCT02360228|7572695|FG000|STARTED|Overall Study||9
6644125|NCT02360228|7572696|FG001|STARTED|Overall Study||8
6527421|NCT01590212|7448485|FG002|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
6527422|NCT01590212|7448483|FG000|Post-intervention|Overall Study|failed contact=3|7
6527423|NCT01590212|7448484|FG001|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
6527424|NCT01590212|7448485|FG002|Post-intervention|Overall Study|failed contact=1|10
6527425|NCT01590212|7448483|FG000|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
6527426|NCT01590212|7448484|FG001|COMPLETED|Overall Study||5
6527427|NCT01590212|7448485|FG002|COMPLETED|Overall Study||9
6527428|NCT01590212|7448483|FG000|NOT COMPLETED|Overall Study||3
6527429|NCT01590212|7448484|FG001|NOT COMPLETED|Overall Study||4
6527430|NCT01590212|7448485|FG002|NOT COMPLETED|Overall Study||5
6527431|NCT01590238|7448494|FG000|STARTED|Overall Study||15
6527432|NCT01590238|7448494|FG000|COMPLETED|Overall Study||13
6527433|NCT01590238|7448494|FG000|NOT COMPLETED|Overall Study||2
6527434|NCT01590264|7448498|FG000|STARTED|Overall Study||5
6527435|NCT01590264|7448498|FG000|COMPLETED|Overall Study||5
6527436|NCT01590264|7448498|FG000|NOT COMPLETED|Overall Study||0
6527437|NCT01590433|7448504|FG000|STARTED|Overall Study||127
6527438|NCT01590433|7448505|FG001|STARTED|Overall Study||55
6527439|NCT01590433|7448504|FG000|COMPLETED|Overall Study||75
6527440|NCT01590433|7448505|FG001|COMPLETED|Overall Study||33
6527441|NCT01590433|7448504|FG000|NOT COMPLETED|Overall Study||52
6527442|NCT01590433|7448505|FG001|NOT COMPLETED|Overall Study||22
6527443|NCT01590550|7448511|FG000|STARTED|Overall Study||18
6527444|NCT01590550|7448511|FG000|COMPLETED|Overall Study||18
6527445|NCT01590550|7448511|FG000|NOT COMPLETED|Overall Study||0
6527446|NCT01590563|7448516|FG000|STARTED|Overall Study||15
6527447|NCT01590563|7448516|FG000|COMPLETED|Overall Study||14
6527448|NCT01590563|7448516|FG000|NOT COMPLETED|Overall Study||1
6527449|NCT01590758|7448523|FG000|STARTED|Overall Study||85
6527450|NCT01590758|7448524|FG001|STARTED|Overall Study||104
6527451|NCT01590758|7448523|FG000|COMPLETED|Overall Study||80
6527452|NCT01590758|7448524|FG001|COMPLETED|Overall Study||97
6527453|NCT01590758|7448523|FG000|NOT COMPLETED|Overall Study||5
6527454|NCT01590758|7448524|FG001|NOT COMPLETED|Overall Study||7
6527455|NCT01590771|7448532|FG000|STARTED|Overall Study||249
6527456|NCT01590771|7448533|FG001|STARTED|Overall Study||249
6527457|NCT01590771|7448532|FG000|COMPLETED|Overall Study||230
6527458|NCT01590771|7448533|FG001|COMPLETED|Overall Study||210
6527459|NCT01590771|7448532|FG000|NOT COMPLETED|Overall Study||19
6527460|NCT01590771|7448533|FG001|NOT COMPLETED|Overall Study||39
6527461|NCT01590797|7448541|FG000|STARTED|Overall Study||234
6527462|NCT01590797|7448542|FG001|STARTED|Overall Study||233
6527463|NCT01590797|7448541|FG000|COMPLETED|Overall Study||217
6527464|NCT01590797|7448542|FG001|COMPLETED|Overall Study||217
6527465|NCT01590797|7448541|FG000|NOT COMPLETED|Overall Study||17
6527466|NCT01590797|7448542|FG001|NOT COMPLETED|Overall Study||16
6527467|NCT01590810|7448553|FG000|STARTED|Overall Study||8
6527468|NCT01590810|7448554|FG001|STARTED|Overall Study||8
6527469|NCT01590810|7448555|FG002|STARTED|Overall Study||8
6527470|NCT01590810|7448556|FG003|STARTED|Overall Study||8
6527471|NCT01590810|7448557|FG004|STARTED|Overall Study||2
6527472|NCT01590810|7448553|FG000|COMPLETED|Overall Study||8
6527473|NCT01590810|7448554|FG001|COMPLETED|Overall Study||7
6527474|NCT01590810|7448555|FG002|COMPLETED|Overall Study||7
6527475|NCT01590810|7448556|FG003|COMPLETED|Overall Study||8
6527476|NCT01590810|7448557|FG004|COMPLETED|Overall Study||2
6527477|NCT01590810|7448553|FG000|NOT COMPLETED|Overall Study||0
6527478|NCT01590810|7448554|FG001|NOT COMPLETED|Overall Study||1
6527479|NCT01590810|7448555|FG002|NOT COMPLETED|Overall Study||1
6527480|NCT01590810|7448556|FG003|NOT COMPLETED|Overall Study||0
6527481|NCT01590810|7448557|FG004|NOT COMPLETED|Overall Study||0
6527482|NCT01590875|7448592|FG000|STARTED|Overall Study||10
6527483|NCT01590875|7448593|FG001|STARTED|Overall Study||10
6527484|NCT01590875|7448592|FG000|COMPLETED|Overall Study||10
6527485|NCT01590875|7448593|FG001|COMPLETED|Overall Study||10
6527486|NCT01590875|7448592|FG000|NOT COMPLETED|Overall Study||0
6527487|NCT01590875|7448593|FG001|NOT COMPLETED|Overall Study||0
6527488|NCT01590888|7448604|FG000|STARTED|Overall Study||36
6527489|NCT01590888|7448605|FG001|STARTED|Overall Study||38
6527490|NCT01590888|7448606|FG002|STARTED|Overall Study||35
6527491|NCT01590888|7448604|FG000|COMPLETED|Overall Study||32
6527492|NCT01590888|7448605|FG001|COMPLETED|Overall Study||38
6527493|NCT01590888|7448606|FG002|COMPLETED|Overall Study||34
6527494|NCT01590888|7448604|FG000|NOT COMPLETED|Overall Study||4
6527495|NCT01590888|7448605|FG001|NOT COMPLETED|Overall Study||0
6527496|NCT01590888|7448606|FG002|NOT COMPLETED|Overall Study||1
6527497|NCT01590979|7448616|FG000|STARTED|Overall Study||27
6527498|NCT01590979|7448617|FG001|STARTED|Overall Study||27
6527499|NCT01590979|7448616|FG000|COMPLETED|Overall Study||27
6527500|NCT01590979|7448617|FG001|COMPLETED|Overall Study||27
6527501|NCT01590979|7448616|FG000|NOT COMPLETED|Overall Study||0
6527502|NCT01590979|7448617|FG001|NOT COMPLETED|Overall Study||0
6527503|NCT01591005|7448627|FG000|STARTED|Overall Study||53
6527504|NCT01591005|7448628|FG001|STARTED|Overall Study||53
6527505|NCT01591005|7448629|FG002|STARTED|Overall Study||68
6527506|NCT01591005|7448630|FG003|STARTED|Overall Study||68
6527507|NCT01591005|7448627|FG000|COMPLETED|Overall Study||53
6527508|NCT01591005|7448628|FG001|COMPLETED|Overall Study||53
6527509|NCT01591005|7448629|FG002|COMPLETED|Overall Study||68
6527510|NCT01591005|7448630|FG003|COMPLETED|Overall Study||68
6527511|NCT01591005|7448627|FG000|NOT COMPLETED|Overall Study||0
6527512|NCT01591005|7448628|FG001|NOT COMPLETED|Overall Study||0
6527513|NCT01591005|7448629|FG002|NOT COMPLETED|Overall Study||0
6527514|NCT01591005|7448630|FG003|NOT COMPLETED|Overall Study||0
6527515|NCT01591018|7448642|FG000|STARTED|Overall Study||60
6527516|NCT01591018|7448643|FG001|STARTED|Overall Study||60
6527517|NCT01591018|7448642|FG000|COMPLETED|Overall Study||60
6527518|NCT01591018|7448643|FG001|COMPLETED|Overall Study||60
6527519|NCT01591018|7448642|FG000|NOT COMPLETED|Overall Study||0
6527520|NCT01591018|7448643|FG001|NOT COMPLETED|Overall Study||0
6527521|NCT01591044|7448652|FG000|STARTED|Overall Study||101
6527522|NCT01591044|7448653|FG001|STARTED|Overall Study||100
6527523|NCT01591044|7448654|FG002|STARTED|Overall Study||100
6527524|NCT01591044|7448652|FG000|COMPLETED|Overall Study||94
6527525|NCT01591044|7448653|FG001|COMPLETED|Overall Study||91
6527526|NCT01591044|7448654|FG002|COMPLETED|Overall Study||96
6644126|NCT02360228|7572697|FG002|STARTED|Overall Study||8
6644127|NCT02360228|7572695|FG000|COMPLETED|Overall Study||8
6644128|NCT02360228|7572696|FG001|COMPLETED|Overall Study||7
6644129|NCT02360228|7572697|FG002|COMPLETED|Overall Study||7
6644130|NCT02360228|7572695|FG000|NOT COMPLETED|Overall Study||1
6644131|NCT02360228|7572696|FG001|NOT COMPLETED|Overall Study||1
6527527|NCT01591044|7448652|FG000|NOT COMPLETED|Overall Study||7
6527528|NCT01591044|7448653|FG001|NOT COMPLETED|Overall Study||9
6527529|NCT01591044|7448654|FG002|NOT COMPLETED|Overall Study||4
6527530|NCT01591161|7448664|FG000|STARTED|Overall Study||245
6527531|NCT01591161|7448665|FG001|STARTED|Overall Study||124
6527532|NCT01591161|7448664|FG000|COMPLETED|Overall Study||174
6527533|NCT01591161|7448665|FG001|COMPLETED|Overall Study||68
6527534|NCT01591161|7448664|FG000|NOT COMPLETED|Overall Study||71
6527535|NCT01591161|7448665|FG001|NOT COMPLETED|Overall Study||56
6527536|NCT01591317|7448674|FG000|STARTED|Overall Study||10
6527537|NCT01591317|7448675|FG001|STARTED|Overall Study||10
6527538|NCT01591317|7448676|FG002|STARTED|Overall Study||10
6527539|NCT01591317|7448674|FG000|COMPLETED|Overall Study||10
6527540|NCT01591317|7448675|FG001|COMPLETED|Overall Study||10
6527541|NCT01591317|7448676|FG002|COMPLETED|Overall Study||10
6527542|NCT01591317|7448674|FG000|NOT COMPLETED|Overall Study||0
6527543|NCT01591317|7448675|FG001|NOT COMPLETED|Overall Study||0
6527544|NCT01591317|7448676|FG002|NOT COMPLETED|Overall Study||0
6527545|NCT01591330|7448689|FG000|STARTED|Period 1||8
6527546|NCT01591330|7448690|FG001|STARTED|Period 1||9
6527547|NCT01591330|7448691|FG002|STARTED|Period 1||9
6527548|NCT01591330|7448692|FG003|STARTED|Period 1||9
6527549|NCT01591330|7448689|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
6527550|NCT01591330|7448690|FG001|Received at Least 1 Dose of Study Drug|Period 1||9
6527551|NCT01591330|7448691|FG002|Received at Least 1 Dose of Study Drug|Period 1||9
6527552|NCT01591330|7448692|FG003|Received at Least 1 Dose of Study Drug|Period 1||9
6527553|NCT01591330|7448689|FG000|COMPLETED|Period 1||7
6527554|NCT01591330|7448690|FG001|COMPLETED|Period 1||9
6527555|NCT01591330|7448691|FG002|COMPLETED|Period 1||9
6527556|NCT01591330|7448692|FG003|COMPLETED|Period 1||9
6527557|NCT01591330|7448689|FG000|NOT COMPLETED|Period 1||1
6527558|NCT01591330|7448690|FG001|NOT COMPLETED|Period 1||0
6527559|NCT01591330|7448691|FG002|NOT COMPLETED|Period 1||0
6527560|NCT01591330|7448692|FG003|NOT COMPLETED|Period 1||0
6527561|NCT01591330|7448689|FG000|STARTED|Washout of at Least 3 Days||7
6527562|NCT01591330|7448690|FG001|STARTED|Washout of at Least 3 Days||9
6527563|NCT01591330|7448691|FG002|STARTED|Washout of at Least 3 Days||9
6527564|NCT01591330|7448692|FG003|STARTED|Washout of at Least 3 Days||9
6527565|NCT01591330|7448689|FG000|COMPLETED|Washout of at Least 3 Days||6
6527566|NCT01591330|7448690|FG001|COMPLETED|Washout of at Least 3 Days||9
6527567|NCT01591330|7448691|FG002|COMPLETED|Washout of at Least 3 Days||9
6527568|NCT01591330|7448692|FG003|COMPLETED|Washout of at Least 3 Days||9
6527569|NCT01591330|7448689|FG000|NOT COMPLETED|Washout of at Least 3 Days||1
6527570|NCT01591330|7448690|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
6527571|NCT01591330|7448691|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
6527572|NCT01591330|7448692|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
6527573|NCT01591330|7448689|FG000|STARTED|Period 2||6
6527574|NCT01591330|7448690|FG001|STARTED|Period 2||9
6527575|NCT01591330|7448691|FG002|STARTED|Period 2||9
6527576|NCT01591330|7448692|FG003|STARTED|Period 2||9
6527577|NCT01591330|7448689|FG000|COMPLETED|Period 2||5
6527578|NCT01591330|7448690|FG001|COMPLETED|Period 2||9
6527579|NCT01591330|7448691|FG002|COMPLETED|Period 2||9
6527580|NCT01591330|7448692|FG003|COMPLETED|Period 2||9
6527581|NCT01591330|7448689|FG000|NOT COMPLETED|Period 2||1
6527582|NCT01591330|7448690|FG001|NOT COMPLETED|Period 2||0
6527583|NCT01591330|7448691|FG002|NOT COMPLETED|Period 2||0
6527584|NCT01591330|7448692|FG003|NOT COMPLETED|Period 2||0
6527585|NCT01591330|7448689|FG000|STARTED|Washout of at Least 3 Days||5
6527586|NCT01591330|7448690|FG001|STARTED|Washout of at Least 3 Days||9
6644132|NCT02360228|7572697|FG002|NOT COMPLETED|Overall Study||1
6644133|NCT02360280|7572707|FG000|STARTED|Overall Study||28
6644134|NCT02360280|7572708|FG001|STARTED|Overall Study||30
6644135|NCT02360280|7572707|FG000|COMPLETED|Overall Study||25
6644136|NCT02360280|7572708|FG001|COMPLETED|Overall Study||29
6644137|NCT02360280|7572707|FG000|NOT COMPLETED|Overall Study||3
6644138|NCT02360280|7572708|FG001|NOT COMPLETED|Overall Study||1
6644139|NCT02360293|7572716|FG000|STARTED|Overall Study||178
6644140|NCT02360293|7572717|FG001|STARTED|Overall Study||179
6527587|NCT01591330|7448691|FG002|STARTED|Washout of at Least 3 Days||9
6527588|NCT01591330|7448692|FG003|STARTED|Washout of at Least 3 Days||9
6527589|NCT01591330|7448689|FG000|COMPLETED|Washout of at Least 3 Days||5
6527590|NCT01591330|7448690|FG001|COMPLETED|Washout of at Least 3 Days||9
6527591|NCT01591330|7448691|FG002|COMPLETED|Washout of at Least 3 Days||9
6527592|NCT01591330|7448692|FG003|COMPLETED|Washout of at Least 3 Days||9
6527593|NCT01591330|7448689|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
6527594|NCT01591330|7448690|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
6527595|NCT01591330|7448691|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
6527596|NCT01591330|7448692|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
6527597|NCT01591330|7448689|FG000|STARTED|Period 3||5
6527598|NCT01591330|7448690|FG001|STARTED|Period 3||9
6527599|NCT01591330|7448691|FG002|STARTED|Period 3||9
6644141|NCT02360293|7572716|FG000|6month f/u Survey|Overall Study||110
6527600|NCT01591330|7448692|FG003|STARTED|Period 3||9
6527601|NCT01591330|7448689|FG000|COMPLETED|Period 3||5
6527602|NCT01591330|7448690|FG001|COMPLETED|Period 3||9
6527603|NCT01591330|7448691|FG002|COMPLETED|Period 3||9
6527604|NCT01591330|7448692|FG003|COMPLETED|Period 3||9
6527605|NCT01591330|7448689|FG000|NOT COMPLETED|Period 3||0
6527606|NCT01591330|7448690|FG001|NOT COMPLETED|Period 3||0
6527607|NCT01591330|7448691|FG002|NOT COMPLETED|Period 3||0
6527608|NCT01591330|7448692|FG003|NOT COMPLETED|Period 3||0
6527609|NCT01591330|7448689|FG000|STARTED|Washout of at Least 3 Days||5
6527610|NCT01591330|7448690|FG001|STARTED|Washout of at Least 3 Days||9
6527611|NCT01591330|7448691|FG002|STARTED|Washout of at Least 3 Days||9
6527612|NCT01591330|7448692|FG003|STARTED|Washout of at Least 3 Days||9
6527613|NCT01591330|7448689|FG000|COMPLETED|Washout of at Least 3 Days||5
6527614|NCT01591330|7448690|FG001|COMPLETED|Washout of at Least 3 Days||9
6527615|NCT01591330|7448691|FG002|COMPLETED|Washout of at Least 3 Days||9
6527616|NCT01591330|7448692|FG003|COMPLETED|Washout of at Least 3 Days||9
6527617|NCT01591330|7448689|FG000|NOT COMPLETED|Washout of at Least 3 Days||0
6527618|NCT01591330|7448690|FG001|NOT COMPLETED|Washout of at Least 3 Days||0
6527619|NCT01591330|7448691|FG002|NOT COMPLETED|Washout of at Least 3 Days||0
6527620|NCT01591330|7448692|FG003|NOT COMPLETED|Washout of at Least 3 Days||0
6527621|NCT01591330|7448689|FG000|STARTED|Period 4||5
6527622|NCT01591330|7448690|FG001|STARTED|Period 4||9
6527623|NCT01591330|7448691|FG002|STARTED|Period 4||9
6527624|NCT01591330|7448692|FG003|STARTED|Period 4||9
6527625|NCT01591330|7448689|FG000|COMPLETED|Period 4||5
6527626|NCT01591330|7448690|FG001|COMPLETED|Period 4||9
6527627|NCT01591330|7448691|FG002|COMPLETED|Period 4||9
6527628|NCT01591330|7448692|FG003|COMPLETED|Period 4||9
6527629|NCT01591330|7448689|FG000|NOT COMPLETED|Period 4||0
6527630|NCT01591330|7448690|FG001|NOT COMPLETED|Period 4||0
6527631|NCT01591330|7448691|FG002|NOT COMPLETED|Period 4||0
6527632|NCT01591330|7448692|FG003|NOT COMPLETED|Period 4||0
6527633|NCT01591382|7448704|FG000|STARTED|Overall Study||32
6527634|NCT01591382|7448705|FG001|STARTED|Overall Study||32
6527635|NCT01591382|7448704|FG000|COMPLETED|Overall Study||29
6527636|NCT01591382|7448705|FG001|COMPLETED|Overall Study||30
6527637|NCT01591382|7448704|FG000|NOT COMPLETED|Overall Study||3
6527638|NCT01591382|7448705|FG001|NOT COMPLETED|Overall Study||2
6527639|NCT01591408|7448713|FG000|STARTED|Overall Study||36
6527640|NCT01591408|7448714|FG001|STARTED|Overall Study||32
6527641|NCT01591408|7448713|FG000|COMPLETED|Overall Study||24
6527642|NCT01591408|7448714|FG001|COMPLETED|Overall Study||24
6527643|NCT01591408|7448713|FG000|NOT COMPLETED|Overall Study||12
6527644|NCT01591408|7448714|FG001|NOT COMPLETED|Overall Study||8
6527645|NCT01591460|7448720|FG000|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
6527646|NCT01591460|7448720|FG000|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
6527647|NCT01591460|7448720|FG000|NOT COMPLETED|Overall Study||26
6527648|NCT01591499|7448732|FG000|STARTED|Baseline Visit||33
6527649|NCT01591499|7448733|FG001|STARTED|Baseline Visit||39
6527650|NCT01591499|7448734|FG002|STARTED|Baseline Visit||31
6527651|NCT01591499|7448735|FG003|STARTED|Baseline Visit||39
6644142|NCT02360293|7572717|FG001|6month f/u Survey|Overall Study||105
6644143|NCT02360293|7572716|FG000|6month Physical Activity|Overall Study||122
6644144|NCT02360293|7572717|FG001|6month Physical Activity|Overall Study||108
6644145|NCT02360293|7572716|FG000|12month f/u Survey|Overall Study||102
6644146|NCT02360293|7572717|FG001|12month f/u Survey|Overall Study||83
6644147|NCT02360293|7572716|FG000|12month Physical Activity|Overall Study||68
6527652|NCT01591499|7448732|FG000|COMPLETED|Baseline Visit||33
6527653|NCT01591499|7448733|FG001|COMPLETED|Baseline Visit||37
6527654|NCT01591499|7448734|FG002|COMPLETED|Baseline Visit||31
6527655|NCT01591499|7448735|FG003|COMPLETED|Baseline Visit||37
6527656|NCT01591499|7448732|FG000|NOT COMPLETED|Baseline Visit||0
6527657|NCT01591499|7448733|FG001|NOT COMPLETED|Baseline Visit||2
6527658|NCT01591499|7448734|FG002|NOT COMPLETED|Baseline Visit||0
6527659|NCT01591499|7448735|FG003|NOT COMPLETED|Baseline Visit||2
6527660|NCT01591499|7448732|FG000|STARTED|First Intervention (up to 24 Days)||33
6527661|NCT01591499|7448733|FG001|STARTED|First Intervention (up to 24 Days)||37
6527662|NCT01591499|7448734|FG002|STARTED|First Intervention (up to 24 Days)||31
6527663|NCT01591499|7448735|FG003|STARTED|First Intervention (up to 24 Days)||37
6644148|NCT02360293|7572717|FG001|12month Physical Activity|Overall Study||59
6644149|NCT02360293|7572716|FG000|COMPLETED|Overall Study||102
6644150|NCT02360293|7572717|FG001|COMPLETED|Overall Study||83
6644151|NCT02360293|7572716|FG000|NOT COMPLETED|Overall Study||76
6644152|NCT02360293|7572717|FG001|NOT COMPLETED|Overall Study||96
6527664|NCT01591499|7448732|FG000|COMPLETED|First Intervention (up to 24 Days)||33
6527665|NCT01591499|7448733|FG001|COMPLETED|First Intervention (up to 24 Days)||37
6527666|NCT01591499|7448734|FG002|COMPLETED|First Intervention (up to 24 Days)||31
6527667|NCT01591499|7448735|FG003|COMPLETED|First Intervention (up to 24 Days)||37
6527668|NCT01591499|7448732|FG000|NOT COMPLETED|First Intervention (up to 24 Days)||0
6527669|NCT01591499|7448733|FG001|NOT COMPLETED|First Intervention (up to 24 Days)||0
6527670|NCT01591499|7448734|FG002|NOT COMPLETED|First Intervention (up to 24 Days)||0
6527671|NCT01591499|7448735|FG003|NOT COMPLETED|First Intervention (up to 24 Days)||0
6527672|NCT01591499|7448732|FG000|STARTED|Second Intervention (up to 24 Days)||33
6527673|NCT01591499|7448733|FG001|STARTED|Second Intervention (up to 24 Days)||37
6644153|NCT02360319|7572725|FG000|STARTED|Overall Study||255
6644154|NCT02360319|7572726|FG001|STARTED|Overall Study||234
6527674|NCT01591499|7448734|FG002|STARTED|Second Intervention (up to 24 Days)||31
6527675|NCT01591499|7448735|FG003|STARTED|Second Intervention (up to 24 Days)||37
6527676|NCT01591499|7448732|FG000|COMPLETED|Second Intervention (up to 24 Days)||27
6527677|NCT01591499|7448733|FG001|COMPLETED|Second Intervention (up to 24 Days)||34
6527678|NCT01591499|7448734|FG002|COMPLETED|Second Intervention (up to 24 Days)||28
6527679|NCT01591499|7448735|FG003|COMPLETED|Second Intervention (up to 24 Days)||34
6527680|NCT01591499|7448732|FG000|NOT COMPLETED|Second Intervention (up to 24 Days)||6
6527681|NCT01591499|7448733|FG001|NOT COMPLETED|Second Intervention (up to 24 Days)||3
6527682|NCT01591499|7448734|FG002|NOT COMPLETED|Second Intervention (up to 24 Days)||3
6527683|NCT01591499|7448735|FG003|NOT COMPLETED|Second Intervention (up to 24 Days)||3
6527684|NCT01591616|7448759|FG000|STARTED|Overall Study||16
6527685|NCT01591616|7448759|FG000|COMPLETED|Overall Study||15
6527686|NCT01591616|7448759|FG000|NOT COMPLETED|Overall Study||1
6527687|NCT01591655|7448900|FG000|STARTED|Overall Study||240
6527688|NCT01591655|7448901|FG001|STARTED|Overall Study||120
6527689|NCT01591655|7448900|FG000|COMPLETED|Overall Study||168
6527690|NCT01591655|7448901|FG001|COMPLETED|Overall Study||57
6527691|NCT01591655|7448900|FG000|NOT COMPLETED|Overall Study||72
6527692|NCT01591655|7448901|FG001|NOT COMPLETED|Overall Study||63
6527693|NCT01591681|7448907|FG000|STARTED|Overall Study||49
6527694|NCT01591681|7448907|FG000|COMPLETED|Overall Study||45
6527695|NCT01591681|7448907|FG000|NOT COMPLETED|Overall Study||4
6527696|NCT01591733|7448913|FG000|STARTED|Overall Study||48
6527697|NCT01591733|7448913|FG000|COMPLETED|Overall Study||48
6527698|NCT01591733|7448913|FG000|NOT COMPLETED|Overall Study||0
6527699|NCT01591746|7448921|FG000|STARTED|Overall Study||68
6527700|NCT01591746|7448922|FG001|STARTED|Overall Study||63
6527701|NCT01591746|7448921|FG000|COMPLETED|Overall Study||68
6527702|NCT01591746|7448922|FG001|COMPLETED|Overall Study||63
6527703|NCT01591746|7448921|FG000|NOT COMPLETED|Overall Study||0
6527704|NCT01591746|7448922|FG001|NOT COMPLETED|Overall Study||0
6527705|NCT01591785|7448930|FG000|STARTED|Overall Study||30
6527706|NCT01591785|7448931|FG001|STARTED|Overall Study||30
6527707|NCT01591785|7448930|FG000|COMPLETED|Overall Study||26
6527708|NCT01591785|7448931|FG001|COMPLETED|Overall Study||28
6527709|NCT01591785|7448930|FG000|NOT COMPLETED|Overall Study||4
6527710|NCT01591785|7448931|FG001|NOT COMPLETED|Overall Study||2
6527711|NCT01591837|7448939|FG000|STARTED|Overall Study||60
6527712|NCT01591837|7448940|FG001|STARTED|Overall Study||60
6527713|NCT01591837|7448939|FG000|COMPLETED|Overall Study||60
6527714|NCT01591837|7448940|FG001|COMPLETED|Overall Study||60
6527715|NCT01591837|7448939|FG000|NOT COMPLETED|Overall Study||0
6527716|NCT01591837|7448940|FG001|NOT COMPLETED|Overall Study||0
6527717|NCT01591863|7448946|FG000|STARTED|Overall Study||38
6527718|NCT01591863|7448946|FG000|COMPLETED|Overall Study||24
6527719|NCT01591863|7448946|FG000|NOT COMPLETED|Overall Study||14
6527720|NCT01592006|7448950|FG000|STARTED|Overall Study||3
6527721|NCT01592006|7448950|FG000|COMPLETED|Overall Study||3
6527722|NCT01592006|7448950|FG000|NOT COMPLETED|Overall Study||0
6527723|NCT01592045|7448956|FG000|STARTED|Overall Study||14
6527724|NCT01592045|7448957|FG001|STARTED|Overall Study||14
6527725|NCT01592045|7448956|FG000|Completed Course 1|Overall Study||13
6527726|NCT01592045|7448957|FG001|Completed Course 1|Overall Study||14
6527727|NCT01592045|7448956|FG000|Completed Course 2|Overall Study||13
6527728|NCT01592045|7448957|FG001|Completed Course 2|Overall Study||13
6527729|NCT01592045|7448956|FG000|Completed Course 3|Overall Study||11
6527730|NCT01592045|7448957|FG001|Completed Course 3|Overall Study||13
6527731|NCT01592045|7448956|FG000|Completed Course 4|Overall Study||11
6527732|NCT01592045|7448957|FG001|Completed Course 4|Overall Study||12
6527733|NCT01592045|7448956|FG000|Completed Course 5|Overall Study||9
6527734|NCT01592045|7448957|FG001|Completed Course 5|Overall Study||12
6527735|NCT01592045|7448956|FG000|COMPLETED|Overall Study||9
6527736|NCT01592045|7448957|FG001|COMPLETED|Overall Study||12
6527737|NCT01592045|7448956|FG000|NOT COMPLETED|Overall Study||5
6527738|NCT01592045|7448957|FG001|NOT COMPLETED|Overall Study||2
6527739|NCT01592071|7448963|FG000|STARTED|Overall Study||120
6527740|NCT01592071|7448963|FG000|COMPLETED|Overall Study||120
6527741|NCT01592071|7448963|FG000|NOT COMPLETED|Overall Study||0
6527742|NCT01592240|7448974|FG000|STARTED|Overall Study||50
6527743|NCT01592240|7448975|FG001|STARTED|Overall Study||50
6527744|NCT01592240|7448976|FG002|STARTED|Overall Study||52
6527745|NCT01592240|7448977|FG003|STARTED|Overall Study||50
6527746|NCT01592240|7448978|FG004|STARTED|Overall Study||51
6527747|NCT01592240|7448979|FG005|STARTED|Overall Study||50
6527748|NCT01592240|7448980|FG006|STARTED|Overall Study||51
6527749|NCT01592240|7448974|FG000|COMPLETED|Overall Study||47
6527750|NCT01592240|7448975|FG001|COMPLETED|Overall Study||39
6527751|NCT01592240|7448976|FG002|COMPLETED|Overall Study||45
6527752|NCT01592240|7448977|FG003|COMPLETED|Overall Study||47
6527753|NCT01592240|7448978|FG004|COMPLETED|Overall Study||44
6527754|NCT01592240|7448979|FG005|COMPLETED|Overall Study||47
6527755|NCT01592240|7448980|FG006|COMPLETED|Overall Study||48
6527756|NCT01592240|7448974|FG000|NOT COMPLETED|Overall Study||3
6527757|NCT01592240|7448975|FG001|NOT COMPLETED|Overall Study||11
6527758|NCT01592240|7448976|FG002|NOT COMPLETED|Overall Study||7
6527759|NCT01592240|7448977|FG003|NOT COMPLETED|Overall Study||3
6527760|NCT01592240|7448978|FG004|NOT COMPLETED|Overall Study||7
6527761|NCT01592240|7448979|FG005|NOT COMPLETED|Overall Study||3
6527762|NCT01592240|7448980|FG006|NOT COMPLETED|Overall Study||3
6527763|NCT01592292|7449003|FG000|STARTED|Overall Study||46
6527764|NCT01592292|7449004|FG001|STARTED|Overall Study||20
6527765|NCT01592292|7449005|FG002|STARTED|Overall Study||13
6527766|NCT01592292|7449006|FG003|STARTED|Overall Study||11
6527767|NCT01592292|7449003|FG000|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
6527768|NCT01592292|7449004|FG001|Intention to Treat (ITT) Set|Overall Study||13
6527769|NCT01592292|7449005|FG002|Intention to Treat (ITT) Set|Overall Study||10
6527770|NCT01592292|7449006|FG003|Intention to Treat (ITT) Set|Overall Study||8
6527771|NCT01592292|7449003|FG000|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
6527772|NCT01592292|7449004|FG001|Standard Population Set (SPS)|Overall Study||10
6527773|NCT01592292|7449005|FG002|Standard Population Set (SPS)|Overall Study||7
6527774|NCT01592292|7449006|FG003|Standard Population Set (SPS)|Overall Study||7
6527775|NCT01592292|7449003|FG000|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
6527776|NCT01592292|7449004|FG001|COMPLETED|Overall Study||15
6527777|NCT01592292|7449005|FG002|COMPLETED|Overall Study||10
6527778|NCT01592292|7449006|FG003|COMPLETED|Overall Study||10
6527779|NCT01592292|7449003|FG000|NOT COMPLETED|Overall Study||6
6527780|NCT01592292|7449004|FG001|NOT COMPLETED|Overall Study||5
6527781|NCT01592292|7449005|FG002|NOT COMPLETED|Overall Study||3
6527782|NCT01592292|7449006|FG003|NOT COMPLETED|Overall Study||1
6527783|NCT01592344|7449014|FG000|STARTED|Overall Study||45
6527784|NCT01592344|7449015|FG001|STARTED|Overall Study||49
6527785|NCT01592344|7449014|FG000|COMPLETED|Overall Study||41
6527786|NCT01592344|7449015|FG001|COMPLETED|Overall Study||44
6527787|NCT01592344|7449014|FG000|NOT COMPLETED|Overall Study||4
6527788|NCT01592344|7449015|FG001|NOT COMPLETED|Overall Study||5
6527789|NCT01592396|7449023|FG000|STARTED|Overall Study||10
6527790|NCT01592396|7449024|FG001|STARTED|Overall Study||10
6527791|NCT01592396|7449023|FG000|COMPLETED|Overall Study||10
6527792|NCT01592396|7449024|FG001|COMPLETED|Overall Study||10
6527793|NCT01592396|7449023|FG000|NOT COMPLETED|Overall Study||0
6527794|NCT01592396|7449024|FG001|NOT COMPLETED|Overall Study||0
6527795|NCT01592409|7449033|FG000|STARTED|Overall Study||67
6527796|NCT01592409|7449034|FG001|STARTED|Overall Study||32
6527797|NCT01592409|7449033|FG000|COMPLETED|Overall Study||67
6527798|NCT01592409|7449034|FG001|COMPLETED|Overall Study||31
6527799|NCT01592409|7449033|FG000|NOT COMPLETED|Overall Study||0
6527800|NCT01592409|7449034|FG001|NOT COMPLETED|Overall Study||1
6527801|NCT01592435|7449040|FG000|STARTED|Overall Study||76
6527802|NCT01592435|7449040|FG000|COMPLETED|Overall Study||76
6527803|NCT01592435|7449040|FG000|NOT COMPLETED|Overall Study||0
6527804|NCT01592500|7449050|FG000|STARTED|Overall Study|Randomized Participants|14
6527805|NCT01592500|7449051|FG001|STARTED|Overall Study||15
6527806|NCT01592500|7449052|FG002|STARTED|Overall Study||14
6527807|NCT01592500|7449053|FG003|STARTED|Overall Study|Randomized Participants|13
6527808|NCT01592500|7449050|FG000|COMPLETED|Overall Study||13
6527809|NCT01592500|7449051|FG001|COMPLETED|Overall Study||15
6527810|NCT01592500|7449052|FG002|COMPLETED|Overall Study||14
6527811|NCT01592500|7449053|FG003|COMPLETED|Overall Study||11
6527812|NCT01592500|7449050|FG000|NOT COMPLETED|Overall Study||1
6527813|NCT01592500|7449051|FG001|NOT COMPLETED|Overall Study||0
6527814|NCT01592500|7449052|FG002|NOT COMPLETED|Overall Study||0
6527815|NCT01592500|7449053|FG003|NOT COMPLETED|Overall Study||2
6527816|NCT01592695|7449065|FG000|STARTED|Overall Study||31
6527817|NCT01592695|7449066|FG001|STARTED|Overall Study||32
6527818|NCT01592695|7449065|FG000|COMPLETED|Overall Study||23
6527819|NCT01592695|7449066|FG001|COMPLETED|Overall Study||28
6527820|NCT01592695|7449065|FG000|NOT COMPLETED|Overall Study||8
6527821|NCT01592695|7449066|FG001|NOT COMPLETED|Overall Study||4
6527822|NCT01592708|7449074|FG000|STARTED|Overall Study||96
6527823|NCT01592708|7449075|FG001|STARTED|Overall Study||137
6527824|NCT01592708|7449074|FG000|COMPLETED|Overall Study||93
6527825|NCT01592708|7449075|FG001|COMPLETED|Overall Study||137
6527826|NCT01592708|7449074|FG000|NOT COMPLETED|Overall Study||3
6527827|NCT01592708|7449075|FG001|NOT COMPLETED|Overall Study||0
6527828|NCT01592747|7449087|FG000|STARTED|Overall Study|Based on Randomized Population|160
6527829|NCT01592747|7449088|FG001|STARTED|Overall Study|Based on Randomized Population|161
6527830|NCT01592747|7449089|FG002|STARTED|Overall Study|Based on Randomized Population|158
6527831|NCT01592747|7449087|FG000|COMPLETED|Overall Study||44
6527832|NCT01592747|7449088|FG001|COMPLETED|Overall Study||50
6527833|NCT01592747|7449089|FG002|COMPLETED|Overall Study||50
6527834|NCT01592747|7449087|FG000|NOT COMPLETED|Overall Study||116
6527835|NCT01592747|7449088|FG001|NOT COMPLETED|Overall Study||111
6527836|NCT01592747|7449089|FG002|NOT COMPLETED|Overall Study||108
6527837|NCT01592760|7449101|FG000|STARTED|Perioperative to Discharge||90
6527838|NCT01592760|7449102|FG001|STARTED|Perioperative to Discharge||90
6527839|NCT01592760|7449103|FG002|STARTED|Perioperative to Discharge||45
6527840|NCT01592760|7449101|FG000|COMPLETED|Perioperative to Discharge||90
6527841|NCT01592760|7449102|FG001|COMPLETED|Perioperative to Discharge||90
6527842|NCT01592760|7449103|FG002|COMPLETED|Perioperative to Discharge||45
6527843|NCT01592760|7449101|FG000|NOT COMPLETED|Perioperative to Discharge||0
6527844|NCT01592760|7449102|FG001|NOT COMPLETED|Perioperative to Discharge||0
6527845|NCT01592760|7449103|FG002|NOT COMPLETED|Perioperative to Discharge||0
6527846|NCT01592760|7449101|FG000|STARTED|24-hour Follow-Up||90
6527847|NCT01592760|7449102|FG001|STARTED|24-hour Follow-Up||90
6527848|NCT01592760|7449103|FG002|STARTED|24-hour Follow-Up||45
6527849|NCT01592760|7449101|FG000|COMPLETED|24-hour Follow-Up||86
6527850|NCT01592760|7449102|FG001|COMPLETED|24-hour Follow-Up||87
6527851|NCT01592760|7449103|FG002|COMPLETED|24-hour Follow-Up||43
6527852|NCT01592760|7449101|FG000|NOT COMPLETED|24-hour Follow-Up||4
6527853|NCT01592760|7449102|FG001|NOT COMPLETED|24-hour Follow-Up||3
6527854|NCT01592760|7449103|FG002|NOT COMPLETED|24-hour Follow-Up||2
6527855|NCT01592773|7449114|FG000|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
6527856|NCT01592773|7449114|FG000|COMPLETED|Overall Study||81
6527857|NCT01592773|7449114|FG000|NOT COMPLETED|Overall Study||666
6527858|NCT01592786|7449118|FG000|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
6527859|NCT01592786|7449118|FG000|COMPLETED|Overall Study||765
6527860|NCT01592786|7449118|FG000|NOT COMPLETED|Overall Study||138
6527861|NCT01592799|7449122|FG000|STARTED|Overall Study||501
6527862|NCT01592799|7449122|FG000|COMPLETED|Overall Study||501
6527863|NCT01592799|7449122|FG000|NOT COMPLETED|Overall Study||0
6527864|NCT01592851|7449130|FG000|STARTED|Overall Study||56
6527865|NCT01592851|7449131|FG001|STARTED|Overall Study||57
6527866|NCT01592851|7449130|FG000|COMPLETED|Overall Study||56
6527867|NCT01592851|7449131|FG001|COMPLETED|Overall Study||57
6527868|NCT01592851|7449130|FG000|NOT COMPLETED|Overall Study||0
6527869|NCT01592851|7449131|FG001|NOT COMPLETED|Overall Study||0
6527870|NCT01592864|7449139|FG000|STARTED|Overall Study||60
6527871|NCT01592864|7449140|FG001|STARTED|Overall Study||58
6527872|NCT01592864|7449139|FG000|COMPLETED|Overall Study||60
6527873|NCT01592864|7449140|FG001|COMPLETED|Overall Study||57
6527874|NCT01592864|7449139|FG000|NOT COMPLETED|Overall Study||0
6527875|NCT01592864|7449140|FG001|NOT COMPLETED|Overall Study||1
6527876|NCT01593020|7449148|FG000|STARTED|Overall Study||28
6527877|NCT01593020|7449149|FG001|STARTED|Overall Study||23
6527878|NCT01593020|7449148|FG000|COMPLETED|Overall Study||26
6527879|NCT01593020|7449149|FG001|COMPLETED|Overall Study||21
6527880|NCT01593020|7449148|FG000|NOT COMPLETED|Overall Study||2
6527881|NCT01593020|7449149|FG001|NOT COMPLETED|Overall Study||2
6527882|NCT01593215|7449157|FG000|STARTED|Overall Study||25
6527883|NCT01593215|7449158|FG001|STARTED|Overall Study||25
6527884|NCT01593215|7449157|FG000|COMPLETED|Overall Study||24
6527885|NCT01593215|7449158|FG001|COMPLETED|Overall Study||25
6527886|NCT01593215|7449157|FG000|NOT COMPLETED|Overall Study||1
6527887|NCT01593215|7449158|FG001|NOT COMPLETED|Overall Study||0
6527888|NCT01593592|7449166|FG000|STARTED|Overall Study||35
6527889|NCT01593592|7449167|FG001|STARTED|Overall Study||35
6527890|NCT01593592|7449166|FG000|COMPLETED|Overall Study||35
6527891|NCT01593592|7449167|FG001|COMPLETED|Overall Study||35
6527892|NCT01593592|7449166|FG000|NOT COMPLETED|Overall Study||0
6527893|NCT01593592|7449167|FG001|NOT COMPLETED|Overall Study||0
6527894|NCT01593670|7449173|FG000|STARTED|Overall Study||9
6527895|NCT01593670|7449173|FG000|COMPLETED|Overall Study||9
6527896|NCT01593670|7449173|FG000|NOT COMPLETED|Overall Study||0
6527897|NCT01593696|7449181|FG000|STARTED|Dose Escalation||16
6527898|NCT01593696|7449182|FG001|STARTED|Dose Escalation||5
6527899|NCT01593696|7449183|FG002|STARTED|Dose Escalation||0
6527900|NCT01593696|7449184|FG003|STARTED|Dose Escalation||0
6527901|NCT01593696|7449181|FG000|Prior Transplant|Dose Escalation||7
6527902|NCT01593696|7449182|FG001|Prior Transplant|Dose Escalation||1
6527903|NCT01593696|7449183|FG002|Prior Transplant|Dose Escalation||0
6527904|NCT01593696|7449184|FG003|Prior Transplant|Dose Escalation||0
6527905|NCT01593696|7449181|FG000|No Prior Transplant|Dose Escalation||9
6527906|NCT01593696|7449182|FG001|No Prior Transplant|Dose Escalation||4
6527907|NCT01593696|7449183|FG002|No Prior Transplant|Dose Escalation||0
6527908|NCT01593696|7449184|FG003|No Prior Transplant|Dose Escalation||0
6527909|NCT01593696|7449181|FG000|COMPLETED|Dose Escalation||14
6527910|NCT01593696|7449182|FG001|COMPLETED|Dose Escalation||5
6527911|NCT01593696|7449183|FG002|COMPLETED|Dose Escalation||0
6527912|NCT01593696|7449184|FG003|COMPLETED|Dose Escalation||0
6527913|NCT01593696|7449181|FG000|NOT COMPLETED|Dose Escalation||2
6527914|NCT01593696|7449182|FG001|NOT COMPLETED|Dose Escalation||0
6527915|NCT01593696|7449183|FG002|NOT COMPLETED|Dose Escalation||0
6527916|NCT01593696|7449184|FG003|NOT COMPLETED|Dose Escalation||0
6527917|NCT01593696|7449181|FG000|STARTED|Dose Expansion||0
6527918|NCT01593696|7449182|FG001|STARTED|Dose Expansion||0
6527919|NCT01593696|7449183|FG002|STARTED|Dose Expansion||16
6527920|NCT01593696|7449184|FG003|STARTED|Dose Expansion||16
6527921|NCT01593696|7449181|FG000|COMPLETED|Dose Expansion||0
6527922|NCT01593696|7449182|FG001|COMPLETED|Dose Expansion||0
6527923|NCT01593696|7449183|FG002|COMPLETED|Dose Expansion||15
6527924|NCT01593696|7449184|FG003|COMPLETED|Dose Expansion||16
6527925|NCT01593696|7449181|FG000|NOT COMPLETED|Dose Expansion||0
6527926|NCT01593696|7449182|FG001|NOT COMPLETED|Dose Expansion||0
6527927|NCT01593696|7449183|FG002|NOT COMPLETED|Dose Expansion||1
6527928|NCT01593696|7449184|FG003|NOT COMPLETED|Dose Expansion||0
6527929|NCT01593722|7449196|FG000|STARTED|Overall Study||6
6527930|NCT01593722|7449197|FG001|STARTED|Overall Study||6
6527931|NCT01593722|7449196|FG000|COMPLETED|Overall Study||6
6527932|NCT01593722|7449197|FG001|COMPLETED|Overall Study||6
6527933|NCT01593722|7449196|FG000|NOT COMPLETED|Overall Study||0
6527934|NCT01593722|7449197|FG001|NOT COMPLETED|Overall Study||0
6561844|NCT01797302|7484753|FG001|3 Month Visit|Overall Study||57
6561845|NCT01797302|7484754|FG002|3 Month Visit|Overall Study||57
6561846|NCT01797302|7484752|FG000|COMPLETED|Overall Study||58
6561847|NCT01797302|7484753|FG001|COMPLETED|Overall Study||48
6561848|NCT01797302|7484754|FG002|COMPLETED|Overall Study||50
6561849|NCT01797302|7484752|FG000|NOT COMPLETED|Overall Study||17
6527935|NCT01593748|7449207|FG000|STARTED|Overall Study||45
6527936|NCT01593748|7449208|FG001|STARTED|Overall Study||45
6527937|NCT01593748|7449207|FG000|COMPLETED|Overall Study||45
6527938|NCT01593748|7449208|FG001|COMPLETED|Overall Study||45
6527939|NCT01593748|7449207|FG000|NOT COMPLETED|Overall Study||0
6527940|NCT01593748|7449208|FG001|NOT COMPLETED|Overall Study||0
6527941|NCT01593787|7449217|FG000|STARTED|Overall Study||6
6527942|NCT01593787|7449218|FG001|STARTED|Overall Study||8
6527943|NCT01593787|7449219|FG002|STARTED|Overall Study||18
6527944|NCT01593787|7449217|FG000|COMPLETED|Overall Study||5
6527945|NCT01593787|7449218|FG001|COMPLETED|Overall Study||8
6527946|NCT01593787|7449219|FG002|COMPLETED|Overall Study||18
6527947|NCT01593787|7449217|FG000|NOT COMPLETED|Overall Study||1
6527948|NCT01593787|7449218|FG001|NOT COMPLETED|Overall Study||0
6527949|NCT01593787|7449219|FG002|NOT COMPLETED|Overall Study||0
6527950|NCT01593917|7449229|FG000|STARTED|Overall Study||329
6527951|NCT01593917|7449229|FG000|COMPLETED|Overall Study||159
6527952|NCT01593917|7449229|FG000|NOT COMPLETED|Overall Study||170
6527953|NCT01594125|7449238|FG000|STARTED|Overall Study||4
6527954|NCT01594125|7449239|FG001|STARTED|Overall Study||12
6527955|NCT01594125|7449240|FG002|STARTED|Overall Study||3
6527956|NCT01594125|7449241|FG003|STARTED|Overall Study||4
6527957|NCT01594125|7449242|FG004|STARTED|Overall Study||7
6527958|NCT01594125|7449238|FG000|COMPLETED|Overall Study||0
6527959|NCT01594125|7449239|FG001|COMPLETED|Overall Study||0
6527960|NCT01594125|7449240|FG002|COMPLETED|Overall Study||0
6527961|NCT01594125|7449241|FG003|COMPLETED|Overall Study||0
6527962|NCT01594125|7449242|FG004|COMPLETED|Overall Study||0
6527963|NCT01594125|7449238|FG000|NOT COMPLETED|Overall Study||4
6527964|NCT01594125|7449239|FG001|NOT COMPLETED|Overall Study||12
6527965|NCT01594125|7449240|FG002|NOT COMPLETED|Overall Study||3
6527966|NCT01594125|7449241|FG003|NOT COMPLETED|Overall Study||4
6527967|NCT01594125|7449242|FG004|NOT COMPLETED|Overall Study||7
6527968|NCT01594281|7449257|FG000|STARTED|Interventional Core Phase||36
6527969|NCT01594281|7449258|FG001|STARTED|Interventional Core Phase||36
6527970|NCT01594281|7449259|FG002|STARTED|Interventional Core Phase||36
6527971|NCT01594281|7449257|FG000|Full Analysis Set (FAS)|Interventional Core Phase||35
6527972|NCT01594281|7449258|FG001|Full Analysis Set (FAS)|Interventional Core Phase||35
6527973|NCT01594281|7449259|FG002|Full Analysis Set (FAS)|Interventional Core Phase||36
6527974|NCT01594281|7449257|FG000|COMPLETED|Interventional Core Phase||29
6527975|NCT01594281|7449258|FG001|COMPLETED|Interventional Core Phase||26
6527976|NCT01594281|7449259|FG002|COMPLETED|Interventional Core Phase||28
6527977|NCT01594281|7449257|FG000|NOT COMPLETED|Interventional Core Phase||7
6527978|NCT01594281|7449258|FG001|NOT COMPLETED|Interventional Core Phase||10
6527979|NCT01594281|7449259|FG002|NOT COMPLETED|Interventional Core Phase||8
6527980|NCT01594281|7449257|FG000|STARTED|Non-Interventional Follow Up Phase|1 patient exited after completing Core Phase and did not start the Follow-Up Phase|28
6527981|NCT01594281|7449258|FG001|STARTED|Non-Interventional Follow Up Phase|5 patients exited after completing Core Phase and did not start the Follow-Up Phase|21
6527982|NCT01594281|7449259|FG002|STARTED|Non-Interventional Follow Up Phase|3 patients exited after completing Core Phase and did not start the Follow-Up Phase|25
6527983|NCT01594281|7449257|FG000|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||28
6527984|NCT01594281|7449258|FG001|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||20
6527985|NCT01594281|7449259|FG002|Follow Up Set (FUS)|Non-Interventional Follow Up Phase||25
6527986|NCT01594281|7449257|FG000|COMPLETED|Non-Interventional Follow Up Phase||25
6527987|NCT01594281|7449258|FG001|COMPLETED|Non-Interventional Follow Up Phase||19
6527988|NCT01594281|7449259|FG002|COMPLETED|Non-Interventional Follow Up Phase||23
6527989|NCT01594281|7449257|FG000|NOT COMPLETED|Non-Interventional Follow Up Phase||3
6527990|NCT01594281|7449258|FG001|NOT COMPLETED|Non-Interventional Follow Up Phase||2
6527991|NCT01594281|7449259|FG002|NOT COMPLETED|Non-Interventional Follow Up Phase||2
6527992|NCT01594294|7449272|FG000|STARTED|Overall Study||39
6527993|NCT01594294|7449273|FG001|STARTED|Overall Study||40
6527994|NCT01594294|7449272|FG000|COMPLETED|Overall Study||36
6527995|NCT01594294|7449273|FG001|COMPLETED|Overall Study||36
6527996|NCT01594294|7449272|FG000|NOT COMPLETED|Overall Study||3
6527997|NCT01594294|7449273|FG001|NOT COMPLETED|Overall Study||4
6527998|NCT01594333|7449281|FG000|STARTED|Overall Study||2391
6527999|NCT01594333|7449282|FG001|STARTED|Overall Study||2395
6528000|NCT01594333|7449281|FG000|COMPLETED|Overall Study||2230
6528001|NCT01594333|7449282|FG001|COMPLETED|Overall Study||2244
6528002|NCT01594333|7449281|FG000|NOT COMPLETED|Overall Study||161
6528003|NCT01594333|7449282|FG001|NOT COMPLETED|Overall Study||151
6528004|NCT01594385|7449290|FG000|STARTED|Overall Study||17
6528005|NCT01594385|7449291|FG001|STARTED|Overall Study||13
6528006|NCT01594385|7449290|FG000|COMPLETED|Overall Study||17
6528007|NCT01594385|7449291|FG001|COMPLETED|Overall Study||13
6528008|NCT01594385|7449290|FG000|NOT COMPLETED|Overall Study||0
6528009|NCT01594385|7449291|FG001|NOT COMPLETED|Overall Study||0
6528010|NCT01594411|7449301|FG000|STARTED|Overall Study||251
6528011|NCT01594411|7449301|FG000|COMPLETED|Overall Study||249
6528012|NCT01594411|7449301|FG000|NOT COMPLETED|Overall Study||2
6528013|NCT01594424|7449308|FG000|STARTED|Overall Study||10
6528014|NCT01594424|7449308|FG000|COMPLETED|Overall Study||8
6528015|NCT01594424|7449308|FG000|NOT COMPLETED|Overall Study||2
6528016|NCT01594476|7449314|FG000|STARTED|Overall Study||101
6528017|NCT01594476|7449315|FG001|STARTED|Overall Study||100
6528018|NCT01594476|7449314|FG000|Received Intervention|Overall Study||66
6528019|NCT01594476|7449315|FG001|Received Intervention|Overall Study||73
6528020|NCT01594476|7449314|FG000|Excluded After Allocation|Overall Study||1
6528021|NCT01594476|7449315|FG001|Excluded After Allocation|Overall Study||3
6528022|NCT01594476|7449314|FG000|IUD Removal|Overall Study||3
6528023|NCT01594476|7449315|FG001|IUD Removal|Overall Study||5
6528024|NCT01594476|7449314|FG000|IUD Expulsion|Overall Study||2
6528025|NCT01594476|7449315|FG001|IUD Expulsion|Overall Study||0
6528026|NCT01594476|7449314|FG000|Pregnant|Overall Study||2
6528027|NCT01594476|7449315|FG001|Pregnant|Overall Study||5
6528028|NCT01594476|7449314|FG000|COMPLETED|Overall Study||100
6528029|NCT01594476|7449315|FG001|COMPLETED|Overall Study||97
6528030|NCT01594476|7449314|FG000|NOT COMPLETED|Overall Study||1
6528031|NCT01594476|7449315|FG001|NOT COMPLETED|Overall Study||3
6528032|NCT01594515|7449335|FG000|STARTED|Overall Study||6
6528033|NCT01594515|7449336|FG001|STARTED|Overall Study||6
6528034|NCT01594515|7449337|FG002|STARTED|Overall Study||6
6528035|NCT01594515|7449338|FG003|STARTED|Overall Study||6
6528036|NCT01594515|7449339|FG004|STARTED|Overall Study||6
6528037|NCT01594515|7449340|FG005|STARTED|Overall Study||6
6528038|NCT01594515|7449341|FG006|STARTED|Overall Study||6
6528039|NCT01594515|7449342|FG007|STARTED|Overall Study||6
6528040|NCT01594515|7449343|FG008|STARTED|Overall Study||6
6528041|NCT01594515|7449344|FG009|STARTED|Overall Study||16
6528042|NCT01594515|7449335|FG000|COMPLETED|Overall Study||6
6528043|NCT01594515|7449336|FG001|COMPLETED|Overall Study||6
6528044|NCT01594515|7449337|FG002|COMPLETED|Overall Study||6
6528045|NCT01594515|7449338|FG003|COMPLETED|Overall Study||6
6528046|NCT01594515|7449339|FG004|COMPLETED|Overall Study||6
6528047|NCT01594515|7449340|FG005|COMPLETED|Overall Study||6
6528048|NCT01594515|7449341|FG006|COMPLETED|Overall Study||6
6528049|NCT01594515|7449342|FG007|COMPLETED|Overall Study||6
6528050|NCT01594515|7449343|FG008|COMPLETED|Overall Study||6
6528051|NCT01594515|7449344|FG009|COMPLETED|Overall Study||16
6528052|NCT01594515|7449335|FG000|NOT COMPLETED|Overall Study||0
6528053|NCT01594515|7449336|FG001|NOT COMPLETED|Overall Study||0
6528054|NCT01594515|7449337|FG002|NOT COMPLETED|Overall Study||0
6528055|NCT01594515|7449338|FG003|NOT COMPLETED|Overall Study||0
6528056|NCT01594515|7449339|FG004|NOT COMPLETED|Overall Study||0
6528057|NCT01594515|7449340|FG005|NOT COMPLETED|Overall Study||0
6528058|NCT01594515|7449341|FG006|NOT COMPLETED|Overall Study||0
6528059|NCT01594515|7449342|FG007|NOT COMPLETED|Overall Study||0
6528060|NCT01594515|7449343|FG008|NOT COMPLETED|Overall Study||0
6528061|NCT01594515|7449344|FG009|NOT COMPLETED|Overall Study||0
6528062|NCT01594528|7449369|FG000|STARTED|Overall Study||16
6528063|NCT01594528|7449370|FG001|STARTED|Overall Study||17
6528064|NCT01594528|7449371|FG002|STARTED|Overall Study||16
6528065|NCT01594528|7449369|FG000|COMPLETED|Overall Study||16
6528066|NCT01594528|7449370|FG001|COMPLETED|Overall Study||17
6528067|NCT01594528|7449371|FG002|COMPLETED|Overall Study||16
6528068|NCT01594528|7449369|FG000|NOT COMPLETED|Overall Study||0
6528069|NCT01594528|7449370|FG001|NOT COMPLETED|Overall Study||0
6528070|NCT01594528|7449371|FG002|NOT COMPLETED|Overall Study||0
6528071|NCT01594749|7449379|FG000|STARTED|Overall Study||507
6528072|NCT01594749|7449380|FG001|STARTED|Overall Study||508
6528073|NCT01594749|7449379|FG000|Treated|Overall Study||503
6528074|NCT01594749|7449380|FG001|Treated|Overall Study||498
6528075|NCT01594749|7449379|FG000|COMPLETED|Overall Study||485
6528076|NCT01594749|7449380|FG001|COMPLETED|Overall Study||490
6528077|NCT01594749|7449379|FG000|NOT COMPLETED|Overall Study||22
6528078|NCT01594749|7449380|FG001|NOT COMPLETED|Overall Study||18
6528079|NCT01594762|7449388|FG000|STARTED|Overall Study||97
6528080|NCT01594762|7449389|FG001|STARTED|Overall Study||103
6528081|NCT01594762|7449388|FG000|COMPLETED|Overall Study||86
6528082|NCT01594762|7449389|FG001|COMPLETED|Overall Study||93
6528083|NCT01594762|7449388|FG000|NOT COMPLETED|Overall Study||11
6528084|NCT01594762|7449389|FG001|NOT COMPLETED|Overall Study||10
6528085|NCT01594827|7449397|FG000|STARTED|Overall Study||14
6528086|NCT01594827|7449398|FG001|STARTED|Overall Study||15
6528087|NCT01594827|7449397|FG000|COMPLETED|Overall Study||10
6528088|NCT01594827|7449398|FG001|COMPLETED|Overall Study||15
6528089|NCT01594827|7449397|FG000|NOT COMPLETED|Overall Study||4
6528090|NCT01594827|7449398|FG001|NOT COMPLETED|Overall Study||0
6528091|NCT01594853|7449408|FG000|STARTED|Overall Study||16
6528092|NCT01594853|7449409|FG001|STARTED|Overall Study||15
6528093|NCT01594853|7449408|FG000|COMPLETED|Overall Study||14
6528094|NCT01594853|7449409|FG001|COMPLETED|Overall Study||12
6528095|NCT01594853|7449408|FG000|NOT COMPLETED|Overall Study||2
6528096|NCT01594853|7449409|FG001|NOT COMPLETED|Overall Study||3
6528097|NCT01594931|7449418|FG000|STARTED|Overall Study||160
6528098|NCT01594931|7449419|FG001|STARTED|Overall Study||157
6528099|NCT01594931|7449420|FG002|STARTED|Overall Study|One randomized subject was not treated.|160
6528100|NCT01594931|7449418|FG000|COMPLETED|Overall Study||131
6528101|NCT01594931|7449419|FG001|COMPLETED|Overall Study||145
6528102|NCT01594931|7449420|FG002|COMPLETED|Overall Study||146
6528103|NCT01594931|7449418|FG000|NOT COMPLETED|Overall Study||29
6528104|NCT01594931|7449419|FG001|NOT COMPLETED|Overall Study||12
6528105|NCT01594931|7449420|FG002|NOT COMPLETED|Overall Study||14
6528106|NCT01594970|7449431|FG000|STARTED|Overall Study||295
6528107|NCT01594970|7449432|FG001|STARTED|Overall Study||248
6528108|NCT01594970|7449433|FG002|STARTED|Overall Study||257
6528109|NCT01594970|7449431|FG000|COMPLETED|Overall Study||220
6528110|NCT01594970|7449432|FG001|COMPLETED|Overall Study||166
6528111|NCT01594970|7449433|FG002|COMPLETED|Overall Study||191
6528112|NCT01594970|7449431|FG000|NOT COMPLETED|Overall Study||75
6528113|NCT01594970|7449432|FG001|NOT COMPLETED|Overall Study||82
6528114|NCT01594970|7449433|FG002|NOT COMPLETED|Overall Study||66
6528115|NCT01595282|7449443|FG000|STARTED|Overall Study||47
6528116|NCT01595282|7449444|FG001|STARTED|Overall Study||47
6528117|NCT01595282|7449443|FG000|COMPLETED|Overall Study||47
6528118|NCT01595282|7449444|FG001|COMPLETED|Overall Study||47
6528119|NCT01595282|7449443|FG000|NOT COMPLETED|Overall Study||0
6528120|NCT01595282|7449444|FG001|NOT COMPLETED|Overall Study||0
6528121|NCT01595386|7449452|FG000|STARTED|Overall Study||21
6528122|NCT01595386|7449453|FG001|STARTED|Overall Study||19
6528123|NCT01595386|7449452|FG000|COMPLETED|Overall Study||21
6528124|NCT01595386|7449453|FG001|COMPLETED|Overall Study||19
6528125|NCT01595386|7449452|FG000|NOT COMPLETED|Overall Study||0
6528126|NCT01595386|7449453|FG001|NOT COMPLETED|Overall Study||0
6528127|NCT01595438|7449461|FG000|STARTED|Overall Study||516
6644155|NCT02360319|7572725|FG000|COMPLETED|Overall Study||167
6644156|NCT02360319|7572726|FG001|COMPLETED|Overall Study||173
6644157|NCT02360319|7572725|FG000|NOT COMPLETED|Overall Study||88
6644158|NCT02360319|7572726|FG001|NOT COMPLETED|Overall Study||61
6528128|NCT01595438|7449462|FG001|STARTED|Overall Study||517
6528129|NCT01595438|7449461|FG000|COMPLETED|Overall Study||473
6528130|NCT01595438|7449462|FG001|COMPLETED|Overall Study||476
6528131|NCT01595438|7449461|FG000|NOT COMPLETED|Overall Study||43
6528132|NCT01595438|7449462|FG001|NOT COMPLETED|Overall Study||41
6528133|NCT01595516|7449471|FG000|STARTED|Overall Study||16
6528134|NCT01595516|7449472|FG001|STARTED|Overall Study||16
6528135|NCT01595516|7449473|FG002|STARTED|Overall Study||12
6528136|NCT01595516|7449471|FG000|COMPLETED|Overall Study||16
6528137|NCT01595516|7449472|FG001|COMPLETED|Overall Study||16
6528138|NCT01595516|7449473|FG002|COMPLETED|Overall Study||12
6528139|NCT01595516|7449471|FG000|NOT COMPLETED|Overall Study||0
6528140|NCT01595516|7449472|FG001|NOT COMPLETED|Overall Study||0
6528141|NCT01595516|7449473|FG002|NOT COMPLETED|Overall Study||0
6528142|NCT01595529|7449497|FG000|STARTED|Overall Study||348
6528143|NCT01595529|7449498|FG001|STARTED|Overall Study||345
6528144|NCT01595529|7449497|FG000|Treated|Overall Study||337
6528145|NCT01595529|7449498|FG001|Treated|Overall Study||340
6528146|NCT01595529|7449497|FG000|Evaluated for Primary Endpoint, ITT|Overall Study||328
6528147|NCT01595529|7449498|FG001|Evaluated for Primary Endpoint, ITT|Overall Study||336
6528148|NCT01595529|7449497|FG000|ITT Without Treatment Failure|Overall Study||326
6528149|NCT01595529|7449498|FG001|ITT Without Treatment Failure|Overall Study||322
6528150|NCT01595529|7449497|FG000|ITT With Stool Sample at TOC|Overall Study||298
6528151|NCT01595529|7449498|FG001|ITT With Stool Sample at TOC|Overall Study||310
6528152|NCT01595529|7449497|FG000|Per-protocol, Completed 80% of Dose|Overall Study||308
6528153|NCT01595529|7449498|FG001|Per-protocol, Completed 80% of Dose|Overall Study||314
6528154|NCT01595529|7449497|FG000|Per-protocol Without Treatment Failure|Overall Study||306
6528155|NCT01595529|7449498|FG001|Per-protocol Without Treatment Failure|Overall Study||305
6528156|NCT01595529|7449497|FG000|Per-protocol With Stool Sample at TOC|Overall Study||280
6528157|NCT01595529|7449498|FG001|Per-protocol With Stool Sample at TOC|Overall Study||289
6528158|NCT01595529|7449497|FG000|Completed All Milestones|Overall Study||318
6304201|NCT00364832|7207515|FG001|NOT COMPLETED|Core Period||2
6304202|NCT00364832|7207516|FG002|NOT COMPLETED|Core Period||1
6304203|NCT00364832|7207517|FG003|NOT COMPLETED|Core Period||1
6528159|NCT01595529|7449498|FG001|Completed All Milestones|Overall Study||318
6528160|NCT01595529|7449497|FG000|COMPLETED|Overall Study||324
6528161|NCT01595529|7449498|FG001|COMPLETED|Overall Study||325
6528162|NCT01595529|7449497|FG000|NOT COMPLETED|Overall Study||24
6528163|NCT01595529|7449498|FG001|NOT COMPLETED|Overall Study||20
6528164|NCT01595646|7449507|FG000|STARTED|Overall Study||13
6528165|NCT01595646|7449508|FG001|STARTED|Overall Study||12
6528166|NCT01595646|7449509|FG002|STARTED|Overall Study||12
6528167|NCT01595646|7449507|FG000|COMPLETED|Overall Study||12
6528168|NCT01595646|7449508|FG001|COMPLETED|Overall Study||12
6528169|NCT01595646|7449509|FG002|COMPLETED|Overall Study||12
6528170|NCT01595646|7449507|FG000|NOT COMPLETED|Overall Study||1
6528171|NCT01595646|7449508|FG001|NOT COMPLETED|Overall Study||0
6528172|NCT01595646|7449509|FG002|NOT COMPLETED|Overall Study||0
6528173|NCT01595854|7449525|FG000|STARTED|Overall Study||8
6528174|NCT01595854|7449526|FG001|STARTED|Overall Study||4
6528175|NCT01595854|7449527|FG002|STARTED|Overall Study||8
6528176|NCT01595854|7449528|FG003|STARTED|Overall Study||4
6528177|NCT01595854|7449529|FG004|STARTED|Overall Study||12
6528178|NCT01595854|7449525|FG000|COMPLETED|Overall Study||8
6528179|NCT01595854|7449526|FG001|COMPLETED|Overall Study||4
6528180|NCT01595854|7449527|FG002|COMPLETED|Overall Study||8
6528181|NCT01595854|7449528|FG003|COMPLETED|Overall Study||4
6528182|NCT01595854|7449529|FG004|COMPLETED|Overall Study||12
6644159|NCT02360371|7572734|FG000|STARTED|Overall Study||13
6528183|NCT01595854|7449525|FG000|NOT COMPLETED|Overall Study||0
6528184|NCT01595854|7449526|FG001|NOT COMPLETED|Overall Study||0
6528185|NCT01595854|7449527|FG002|NOT COMPLETED|Overall Study||0
6304204|NCT00364832|7207518|FG004|NOT COMPLETED|Core Period||0
6528186|NCT01595854|7449528|FG003|NOT COMPLETED|Overall Study||0
6528187|NCT01595854|7449529|FG004|NOT COMPLETED|Overall Study||0
6528188|NCT01596062|7449550|FG000|STARTED|Overall Study||3
6528189|NCT01596062|7449551|FG001|STARTED|Overall Study||6
6528190|NCT01596062|7449552|FG002|STARTED|Overall Study||7
6528191|NCT01596062|7449550|FG000|COMPLETED|Overall Study||2
6528192|NCT01596062|7449551|FG001|COMPLETED|Overall Study||6
6528193|NCT01596062|7449552|FG002|COMPLETED|Overall Study||4
6528194|NCT01596062|7449550|FG000|NOT COMPLETED|Overall Study||1
6528195|NCT01596062|7449551|FG001|NOT COMPLETED|Overall Study||0
6528196|NCT01596062|7449552|FG002|NOT COMPLETED|Overall Study||3
6528197|NCT01596088|7449560|FG000|STARTED|Overall Study||2
6528198|NCT01596088|7449560|FG000|COMPLETED|Overall Study||2
6528199|NCT01596088|7449560|FG000|NOT COMPLETED|Overall Study||0
6528200|NCT01596127|7449564|FG000|STARTED|Overall Study||4
6528201|NCT01596127|7449564|FG000|COMPLETED|Overall Study||3
6528202|NCT01596127|7449564|FG000|NOT COMPLETED|Overall Study||1
6528203|NCT01596231|7449570|FG000|STARTED|Overall Study||10
6528204|NCT01596231|7449571|FG001|STARTED|Overall Study||10
6528205|NCT01596231|7449570|FG000|COMPLETED|Overall Study||10
6528206|NCT01596231|7449571|FG001|COMPLETED|Overall Study||10
6528207|NCT01596231|7449570|FG000|NOT COMPLETED|Overall Study||0
6528208|NCT01596231|7449571|FG001|NOT COMPLETED|Overall Study||0
6528209|NCT01596283|7449579|FG000|STARTED|Overall Study||69
6528210|NCT01596283|7449580|FG001|STARTED|Overall Study||66
6528211|NCT01596283|7449579|FG000|COMPLETED|Overall Study||69
6528212|NCT01596283|7449580|FG001|COMPLETED|Overall Study||66
6528213|NCT01596283|7449579|FG000|NOT COMPLETED|Overall Study||0
6528214|NCT01596283|7449580|FG001|NOT COMPLETED|Overall Study||0
6528215|NCT01596335|7449590|FG000|STARTED|Overall Study||16
6528216|NCT01596335|7449591|FG001|STARTED|Overall Study||15
6528217|NCT01596335|7449590|FG000|COMPLETED|Overall Study||11
6528218|NCT01596335|7449591|FG001|COMPLETED|Overall Study||6
6528219|NCT01596335|7449590|FG000|NOT COMPLETED|Overall Study||5
6528220|NCT01596335|7449591|FG001|NOT COMPLETED|Overall Study||9
6528221|NCT01596504|7449600|FG000|STARTED|Overall Study||48
6528222|NCT01596504|7449601|FG001|STARTED|Overall Study||47
6528223|NCT01596504|7449602|FG002|STARTED|Overall Study||47
6528224|NCT01596504|7449600|FG000|COMPLETED|Overall Study||46
6528225|NCT01596504|7449601|FG001|COMPLETED|Overall Study||44
6528226|NCT01596504|7449602|FG002|COMPLETED|Overall Study||46
6528227|NCT01596504|7449600|FG000|NOT COMPLETED|Overall Study||2
6528228|NCT01596504|7449601|FG001|NOT COMPLETED|Overall Study||3
6528229|NCT01596504|7449602|FG002|NOT COMPLETED|Overall Study||1
6528230|NCT01596582|7449613|FG000|STARTED|Overall Study||172
6528231|NCT01596582|7449614|FG001|STARTED|Overall Study||180
6528232|NCT01596582|7449613|FG000|COMPLETED|Overall Study||168
6528233|NCT01596582|7449614|FG001|COMPLETED|Overall Study||173
6528234|NCT01596582|7449613|FG000|NOT COMPLETED|Overall Study||4
6528235|NCT01596582|7449614|FG001|NOT COMPLETED|Overall Study||7
6528236|NCT01596595|7449627|FG000|STARTED|Overall Study||1779
6528237|NCT01596595|7449627|FG000|COMPLETED|Overall Study||814
6528238|NCT01596595|7449627|FG000|NOT COMPLETED|Overall Study||965
6528239|NCT01596699|7449633|FG000|STARTED|Overall Study||10
6528240|NCT01596699|7449634|FG001|STARTED|Overall Study||6
6528241|NCT01596699|7449633|FG000|COMPLETED|Overall Study||10
6528242|NCT01596699|7449634|FG001|COMPLETED|Overall Study||6
6528243|NCT01596699|7449633|FG000|NOT COMPLETED|Overall Study||0
6528244|NCT01596699|7449634|FG001|NOT COMPLETED|Overall Study||0
6528245|NCT01596751|7449649|FG000|STARTED|Overall Study||5
6528246|NCT01596751|7449650|FG001|STARTED|Overall Study||4
6528247|NCT01596751|7449651|FG002|STARTED|Overall Study||3
6528248|NCT01596751|7449652|FG003|STARTED|Overall Study||6
6528249|NCT01596751|7449653|FG004|STARTED|Overall Study||4
6528250|NCT01596751|7449654|FG005|STARTED|Overall Study||6
6528251|NCT01596751|7449655|FG006|STARTED|Overall Study||17
6528252|NCT01596751|7449656|FG007|STARTED|Overall Study||22
6528253|NCT01596751|7449649|FG000|COMPLETED|Overall Study||5
6528254|NCT01596751|7449650|FG001|COMPLETED|Overall Study||4
6528255|NCT01596751|7449651|FG002|COMPLETED|Overall Study||3
6528256|NCT01596751|7449652|FG003|COMPLETED|Overall Study||6
6528257|NCT01596751|7449653|FG004|COMPLETED|Overall Study||4
6528258|NCT01596751|7449654|FG005|COMPLETED|Overall Study||6
6528259|NCT01596751|7449655|FG006|COMPLETED|Overall Study||17
6528260|NCT01596751|7449656|FG007|COMPLETED|Overall Study||22
6528261|NCT01596751|7449649|FG000|NOT COMPLETED|Overall Study||0
6528262|NCT01596751|7449650|FG001|NOT COMPLETED|Overall Study||0
6528263|NCT01596751|7449651|FG002|NOT COMPLETED|Overall Study||0
6528264|NCT01596751|7449652|FG003|NOT COMPLETED|Overall Study||0
6528265|NCT01596751|7449653|FG004|NOT COMPLETED|Overall Study||0
6528266|NCT01596751|7449654|FG005|NOT COMPLETED|Overall Study||0
6528267|NCT01596751|7449655|FG006|NOT COMPLETED|Overall Study||0
6528268|NCT01596751|7449656|FG007|NOT COMPLETED|Overall Study||0
6528269|NCT01596842|7449676|FG000|STARTED|Overall Study||10
6644160|NCT02360371|7572735|FG001|STARTED|Overall Study||84
6644161|NCT02360371|7572734|FG000|Placebo (Oral)|Overall Study||13
6644162|NCT02360371|7572735|FG001|Placebo (Oral)|Overall Study||69
6644163|NCT02360371|7572734|FG000|Hydromorphone (Oral) 2mg|Overall Study||13
6644164|NCT02360371|7572735|FG001|Hydromorphone (Oral) 2mg|Overall Study||69
6644165|NCT02360371|7572734|FG000|Hydromorphone (Oral) 4mg|Overall Study||13
6644166|NCT02360371|7572735|FG001|Hydromorphone (Oral) 4mg|Overall Study||69
6528270|NCT01596842|7449677|FG001|STARTED|Overall Study||7
6528271|NCT01596842|7449676|FG000|COMPLETED|Overall Study||8
6528272|NCT01596842|7449677|FG001|COMPLETED|Overall Study||7
6644167|NCT02360371|7572734|FG000|Hydromorphone (Oral) 8mg|Overall Study||13
6528273|NCT01596842|7449676|FG000|NOT COMPLETED|Overall Study||2
6528274|NCT01596842|7449677|FG001|NOT COMPLETED|Overall Study||0
6528275|NCT01596972|7449685|FG000|STARTED|Overall Study||25
6528276|NCT01596972|7449686|FG001|STARTED|Overall Study||26
6528277|NCT01596972|7449685|FG000|COMPLETED|Overall Study||24
6528278|NCT01596972|7449686|FG001|COMPLETED|Overall Study||12
6528279|NCT01596972|7449685|FG000|NOT COMPLETED|Overall Study||1
6528280|NCT01596972|7449686|FG001|NOT COMPLETED|Overall Study||14
6528281|NCT01597050|7449694|FG000|STARTED|Overall Study||36
6528282|NCT01597050|7449695|FG001|STARTED|Overall Study||18
6528283|NCT01597050|7449694|FG000|COMPLETED|Overall Study||35
6528284|NCT01597050|7449695|FG001|COMPLETED|Overall Study||18
6528285|NCT01597050|7449694|FG000|NOT COMPLETED|Overall Study||1
6528286|NCT01597050|7449695|FG001|NOT COMPLETED|Overall Study||0
6528287|NCT01597128|7449703|FG000|STARTED|Overall Study||18
6528288|NCT01597128|7449704|FG001|STARTED|Overall Study||17
6528289|NCT01597128|7449703|FG000|COMPLETED|Overall Study||18
6528290|NCT01597128|7449704|FG001|COMPLETED|Overall Study||17
6528291|NCT01597128|7449703|FG000|NOT COMPLETED|Overall Study||0
6528292|NCT01597128|7449704|FG001|NOT COMPLETED|Overall Study||0
6528293|NCT01597141|7449712|FG000|STARTED|Overall Study||50
6528294|NCT01597141|7449713|FG001|STARTED|Overall Study||50
6528295|NCT01597141|7449712|FG000|COMPLETED|Overall Study||50
6528296|NCT01597141|7449713|FG001|COMPLETED|Overall Study||50
6528297|NCT01597141|7449712|FG000|NOT COMPLETED|Overall Study||0
6528298|NCT01597141|7449713|FG001|NOT COMPLETED|Overall Study||0
6528299|NCT01597193|7449728|FG000|STARTED|Stage 1: Dose Escalation (141 Days)||7
6528300|NCT01597193|7449729|FG001|STARTED|Stage 1: Dose Escalation (141 Days)||8
6528301|NCT01597193|7449730|FG002|STARTED|Stage 1: Dose Escalation (141 Days)||0
6528302|NCT01597193|7449731|FG003|STARTED|Stage 1: Dose Escalation (141 Days)||0
6528303|NCT01597193|7449732|FG004|STARTED|Stage 1: Dose Escalation (141 Days)||0
6528304|NCT01597193|7449733|FG005|STARTED|Stage 1: Dose Escalation (141 Days)||0
6528305|NCT01597193|7449734|FG006|STARTED|Stage 1: Dose Escalation (141 Days)||0
6528306|NCT01597193|7449728|FG000|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528307|NCT01597193|7449729|FG001|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528308|NCT01597193|7449730|FG002|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528309|NCT01597193|7449731|FG003|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528310|NCT01597193|7449732|FG004|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528311|NCT01597193|7449733|FG005|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528312|NCT01597193|7449734|FG006|COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528313|NCT01597193|7449728|FG000|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||7
6528314|NCT01597193|7449729|FG001|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||8
6528315|NCT01597193|7449730|FG002|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528316|NCT01597193|7449731|FG003|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528317|NCT01597193|7449732|FG004|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528318|NCT01597193|7449733|FG005|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528319|NCT01597193|7449734|FG006|NOT COMPLETED|Stage 1: Dose Escalation (141 Days)||0
6528320|NCT01597193|7449728|FG000|STARTED|Stage 2: Dose Expansion (1067 Days)||0
6528321|NCT01597193|7449729|FG001|STARTED|Stage 2: Dose Expansion (1067 Days)||0
6528322|NCT01597193|7449730|FG002|STARTED|Stage 2: Dose Expansion (1067 Days)||14
6528323|NCT01597193|7449731|FG003|STARTED|Stage 2: Dose Expansion (1067 Days)||20
6528324|NCT01597193|7449732|FG004|STARTED|Stage 2: Dose Expansion (1067 Days)||16
6528325|NCT01597193|7449733|FG005|STARTED|Stage 2: Dose Expansion (1067 Days)||23
6528326|NCT01597193|7449734|FG006|STARTED|Stage 2: Dose Expansion (1067 Days)||11
6528327|NCT01597193|7449728|FG000|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528328|NCT01597193|7449729|FG001|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528329|NCT01597193|7449730|FG002|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528330|NCT01597193|7449731|FG003|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528331|NCT01597193|7449732|FG004|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528332|NCT01597193|7449733|FG005|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528333|NCT01597193|7449734|FG006|COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528334|NCT01597193|7449728|FG000|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528335|NCT01597193|7449729|FG001|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||0
6528336|NCT01597193|7449730|FG002|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||14
6528337|NCT01597193|7449731|FG003|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||20
6528338|NCT01597193|7449732|FG004|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||16
6528339|NCT01597193|7449733|FG005|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||23
6528340|NCT01597193|7449734|FG006|NOT COMPLETED|Stage 2: Dose Expansion (1067 Days)||11
6528341|NCT01597245|7449759|FG000|STARTED|Induction Period (Week 0 - Week 12)||168
6528342|NCT01597245|7449760|FG001|STARTED|Induction Period (Week 0 - Week 12)||358
6528343|NCT01597245|7449761|FG002|STARTED|Induction Period (Week 0 - Week 12)||347
6528344|NCT01597245|7449762|FG003|STARTED|Induction Period (Week 0 - Week 12)||351
6528345|NCT01597245|7449763|FG004|STARTED|Induction Period (Week 0 - Week 12)||0
6528346|NCT01597245|7449764|FG005|STARTED|Induction Period (Week 0 - Week 12)||0
6528347|NCT01597245|7449765|FG006|STARTED|Induction Period (Week 0 - Week 12)||0
6528348|NCT01597245|7449766|FG007|STARTED|Induction Period (Week 0 - Week 12)||0
6528349|NCT01597245|7449767|FG008|STARTED|Induction Period (Week 0 - Week 12)||0
6528350|NCT01597245|7449768|FG009|STARTED|Induction Period (Week 0 - Week 12)||0
6528351|NCT01597245|7449769|FG010|STARTED|Induction Period (Week 0 - Week 12)||0
6528352|NCT01597245|7449770|FG011|STARTED|Induction Period (Week 0 - Week 12)||0
6528353|NCT01597245|7449771|FG012|STARTED|Induction Period (Week 0 - Week 12)||0
6528354|NCT01597245|7449772|FG013|STARTED|Induction Period (Week 0 - Week 12)||0
6528355|NCT01597245|7449773|FG014|STARTED|Induction Period (Week 0 - Week 12)||0
6528356|NCT01597245|7449774|FG015|STARTED|Induction Period (Week 0 - Week 12)||0
6528357|NCT01597245|7449775|FG016|STARTED|Induction Period (Week 0 - Week 12)||0
6528358|NCT01597245|7449776|FG017|STARTED|Induction Period (Week 0 - Week 12)||0
6528359|NCT01597245|7449777|FG018|STARTED|Induction Period (Week 0 - Week 12)||0
6528360|NCT01597245|7449778|FG019|STARTED|Induction Period (Week 0 - Week 12)||0
6528361|NCT01597245|7449779|FG020|STARTED|Induction Period (Week 0 - Week 12)||0
6528362|NCT01597245|7449759|FG000|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
6528363|NCT01597245|7449760|FG001|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
6528364|NCT01597245|7449761|FG002|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
6528365|NCT01597245|7449762|FG003|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
6528366|NCT01597245|7449763|FG004|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528367|NCT01597245|7449764|FG005|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528368|NCT01597245|7449765|FG006|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528369|NCT01597245|7449766|FG007|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528370|NCT01597245|7449767|FG008|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528371|NCT01597245|7449768|FG009|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528372|NCT01597245|7449769|FG010|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528373|NCT01597245|7449770|FG011|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528374|NCT01597245|7449771|FG012|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528375|NCT01597245|7449772|FG013|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528376|NCT01597245|7449773|FG014|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528377|NCT01597245|7449774|FG015|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528378|NCT01597245|7449775|FG016|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528379|NCT01597245|7449776|FG017|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528380|NCT01597245|7449777|FG018|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528381|NCT01597245|7449778|FG019|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528382|NCT01597245|7449779|FG020|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
6528383|NCT01597245|7449759|FG000|COMPLETED|Induction Period (Week 0 - Week 12)||158
6528384|NCT01597245|7449760|FG001|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
6528385|NCT01597245|7449761|FG002|COMPLETED|Induction Period (Week 0 - Week 12)||328
6528386|NCT01597245|7449762|FG003|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
6528387|NCT01597245|7449763|FG004|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528388|NCT01597245|7449764|FG005|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528389|NCT01597245|7449765|FG006|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528390|NCT01597245|7449766|FG007|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528391|NCT01597245|7449767|FG008|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528392|NCT01597245|7449768|FG009|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528393|NCT01597245|7449769|FG010|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528394|NCT01597245|7449770|FG011|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528395|NCT01597245|7449771|FG012|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528396|NCT01597245|7449772|FG013|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528397|NCT01597245|7449773|FG014|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528398|NCT01597245|7449774|FG015|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528399|NCT01597245|7449775|FG016|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528400|NCT01597245|7449776|FG017|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528401|NCT01597245|7449777|FG018|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528402|NCT01597245|7449778|FG019|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528403|NCT01597245|7449779|FG020|COMPLETED|Induction Period (Week 0 - Week 12)||0
6528404|NCT01597245|7449759|FG000|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
6528405|NCT01597245|7449760|FG001|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
6528406|NCT01597245|7449761|FG002|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
6528407|NCT01597245|7449762|FG003|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
6528408|NCT01597245|7449763|FG004|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528409|NCT01597245|7449764|FG005|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528410|NCT01597245|7449765|FG006|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528411|NCT01597245|7449766|FG007|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528412|NCT01597245|7449767|FG008|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528413|NCT01597245|7449768|FG009|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528414|NCT01597245|7449769|FG010|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528415|NCT01597245|7449770|FG011|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528416|NCT01597245|7449771|FG012|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528417|NCT01597245|7449772|FG013|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528418|NCT01597245|7449773|FG014|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528419|NCT01597245|7449774|FG015|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528420|NCT01597245|7449775|FG016|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528421|NCT01597245|7449776|FG017|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528422|NCT01597245|7449777|FG018|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528423|NCT01597245|7449778|FG019|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528424|NCT01597245|7449779|FG020|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
6528425|NCT01597245|7449759|FG000|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
6528426|NCT01597245|7449760|FG001|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
6528427|NCT01597245|7449761|FG002|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
6528428|NCT01597245|7449762|FG003|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|0
6528429|NCT01597245|7449763|FG004|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|176
6528430|NCT01597245|7449764|FG005|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|187
6528431|NCT01597245|7449765|FG006|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|181
6528432|NCT01597245|7449766|FG007|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|3
6528433|NCT01597245|7449767|FG008|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|155
6528434|NCT01597245|7449768|FG009|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|132
6528435|NCT01597245|7449769|FG010|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|200
6528436|NCT01597245|7449770|FG011|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|75
6528437|NCT01597245|7449771|FG012|STARTED|Maintenance Period (Week 12 to Week 60)|Participants who completed the prior period and then randomized to the maintenance period.|49
6528438|NCT01597245|7449772|FG013|STARTED|Maintenance Period (Week 12 to Week 60)||0
6528439|NCT01597245|7449773|FG014|STARTED|Maintenance Period (Week 12 to Week 60)||0
6528440|NCT01597245|7449774|FG015|STARTED|Maintenance Period (Week 12 to Week 60)||0
6528441|NCT01597245|7449775|FG016|STARTED|Maintenance Period (Week 12 to Week 60)||0
6528442|NCT01597245|7449776|FG017|STARTED|Maintenance Period (Week 12 to Week 60)||0
6528443|NCT01597245|7449777|FG018|STARTED|Maintenance Period (Week 12 to Week 60)||0
6528444|NCT01597245|7449778|FG019|STARTED|Maintenance Period (Week 12 to Week 60)||0
6528445|NCT01597245|7449779|FG020|STARTED|Maintenance Period (Week 12 to Week 60)||0
6528446|NCT01597245|7449759|FG000|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528447|NCT01597245|7449760|FG001|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528448|NCT01597245|7449761|FG002|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528449|NCT01597245|7449762|FG003|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528450|NCT01597245|7449763|FG004|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
6528451|NCT01597245|7449764|FG005|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
6528452|NCT01597245|7449765|FG006|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
6528453|NCT01597245|7449766|FG007|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
6528454|NCT01597245|7449767|FG008|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
6528455|NCT01597245|7449768|FG009|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
6528456|NCT01597245|7449769|FG010|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
6528457|NCT01597245|7449770|FG011|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
6528458|NCT01597245|7449771|FG012|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
6528459|NCT01597245|7449772|FG013|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528460|NCT01597245|7449773|FG014|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528461|NCT01597245|7449774|FG015|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528462|NCT01597245|7449775|FG016|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528463|NCT01597245|7449776|FG017|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528464|NCT01597245|7449777|FG018|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528465|NCT01597245|7449778|FG019|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528466|NCT01597245|7449779|FG020|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
6528467|NCT01597245|7449759|FG000|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528468|NCT01597245|7449760|FG001|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528469|NCT01597245|7449761|FG002|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528470|NCT01597245|7449762|FG003|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528471|NCT01597245|7449763|FG004|COMPLETED|Maintenance Period (Week 12 to Week 60)||15
6528472|NCT01597245|7449764|FG005|COMPLETED|Maintenance Period (Week 12 to Week 60)||149
6528473|NCT01597245|7449765|FG006|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
6528474|NCT01597245|7449766|FG007|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528475|NCT01597245|7449767|FG008|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
6528476|NCT01597245|7449768|FG009|COMPLETED|Maintenance Period (Week 12 to Week 60)||11
6528477|NCT01597245|7449769|FG010|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
6528478|NCT01597245|7449770|FG011|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
6528479|NCT01597245|7449771|FG012|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
6528480|NCT01597245|7449772|FG013|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528481|NCT01597245|7449773|FG014|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528482|NCT01597245|7449774|FG015|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528483|NCT01597245|7449775|FG016|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528484|NCT01597245|7449776|FG017|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528485|NCT01597245|7449777|FG018|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528486|NCT01597245|7449778|FG019|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528487|NCT01597245|7449779|FG020|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528488|NCT01597245|7449759|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528489|NCT01597245|7449760|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528490|NCT01597245|7449761|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528491|NCT01597245|7449762|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528492|NCT01597245|7449763|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||161
6528493|NCT01597245|7449764|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||38
6528494|NCT01597245|7449765|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
6528495|NCT01597245|7449766|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
6528496|NCT01597245|7449767|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
6528497|NCT01597245|7449768|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||121
6528498|NCT01597245|7449769|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
6528499|NCT01597245|7449770|FG011|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
6528500|NCT01597245|7449771|FG012|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
6528501|NCT01597245|7449772|FG013|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528502|NCT01597245|7449773|FG014|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528503|NCT01597245|7449774|FG015|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528504|NCT01597245|7449775|FG016|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528505|NCT01597245|7449776|FG017|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528506|NCT01597245|7449777|FG018|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528507|NCT01597245|7449778|FG019|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528508|NCT01597245|7449779|FG020|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
6528509|NCT01597245|7449759|FG000|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528510|NCT01597245|7449760|FG001|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528511|NCT01597245|7449761|FG002|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528512|NCT01597245|7449762|FG003|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528513|NCT01597245|7449763|FG004|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6528514|NCT01597245|7449764|FG005|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6528515|NCT01597245|7449765|FG006|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6528516|NCT01597245|7449766|FG007|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528517|NCT01597245|7449767|FG008|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6528518|NCT01597245|7449768|FG009|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6528519|NCT01597245|7449769|FG010|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6528520|NCT01597245|7449770|FG011|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6528521|NCT01597245|7449771|FG012|STARTED|Long Term Extension (Week 60 - Week 264)|Includes participants who started the long-term extension period.|0
6528522|NCT01597245|7449772|FG013|STARTED|Long Term Extension (Week 60 - Week 264)|Participants who received placebo at the start of the long-term extension period.|26
6528523|NCT01597245|7449773|FG014|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe at the start of the long-term extension.|979
6528524|NCT01597245|7449774|FG015|STARTED|Long Term Extension (Week 60 - Week 264)|Participants received ixe in all dosing regimens, including participants who switched PBO to ixe.|1002
6528525|NCT01597245|7449775|FG016|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528526|NCT01597245|7449776|FG017|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528527|NCT01597245|7449777|FG018|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528528|NCT01597245|7449778|FG019|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528529|NCT01597245|7449779|FG020|STARTED|Long Term Extension (Week 60 - Week 264)||0
6528530|NCT01597245|7449759|FG000|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528531|NCT01597245|7449760|FG001|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528532|NCT01597245|7449761|FG002|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528533|NCT01597245|7449762|FG003|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528534|NCT01597245|7449763|FG004|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528535|NCT01597245|7449764|FG005|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528536|NCT01597245|7449765|FG006|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528537|NCT01597245|7449766|FG007|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528538|NCT01597245|7449767|FG008|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528539|NCT01597245|7449768|FG009|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528540|NCT01597245|7449769|FG010|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528541|NCT01597245|7449770|FG011|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528542|NCT01597245|7449771|FG012|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528543|NCT01597245|7449772|FG013|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528544|NCT01597245|7449773|FG014|COMPLETED|Long Term Extension (Week 60 - Week 264)||754
6528545|NCT01597245|7449774|FG015|COMPLETED|Long Term Extension (Week 60 - Week 264)||774
6528546|NCT01597245|7449775|FG016|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528547|NCT01597245|7449776|FG017|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528548|NCT01597245|7449777|FG018|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528549|NCT01597245|7449778|FG019|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528550|NCT01597245|7449779|FG020|COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528551|NCT01597245|7449759|FG000|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528552|NCT01597245|7449760|FG001|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528553|NCT01597245|7449761|FG002|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528554|NCT01597245|7449762|FG003|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528555|NCT01597245|7449763|FG004|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528556|NCT01597245|7449764|FG005|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528557|NCT01597245|7449765|FG006|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528558|NCT01597245|7449766|FG007|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528559|NCT01597245|7449767|FG008|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528560|NCT01597245|7449768|FG009|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528561|NCT01597245|7449769|FG010|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528562|NCT01597245|7449770|FG011|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6743729|NCT03335254|7671826|FG016|COMPLETED|Period 3, Day 16-25||0
6743730|NCT03335254|7671827|FG017|COMPLETED|Period 3, Day 16-25||0
6743731|NCT03335254|7671828|FG018|COMPLETED|Period 3, Day 16-25||0
6528563|NCT01597245|7449771|FG012|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528564|NCT01597245|7449772|FG013|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||26
6528565|NCT01597245|7449773|FG014|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||225
6528566|NCT01597245|7449774|FG015|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||228
6528567|NCT01597245|7449775|FG016|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528568|NCT01597245|7449776|FG017|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528569|NCT01597245|7449777|FG018|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528570|NCT01597245|7449778|FG019|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528571|NCT01597245|7449779|FG020|NOT COMPLETED|Long Term Extension (Week 60 - Week 264)||0
6528572|NCT01597245|7449759|FG000|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528573|NCT01597245|7449760|FG001|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528574|NCT01597245|7449761|FG002|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528575|NCT01597245|7449762|FG003|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528576|NCT01597245|7449763|FG004|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528577|NCT01597245|7449764|FG005|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528578|NCT01597245|7449765|FG006|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528579|NCT01597245|7449766|FG007|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528580|NCT01597245|7449767|FG008|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528581|NCT01597245|7449768|FG009|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528582|NCT01597245|7449769|FG010|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528583|NCT01597245|7449770|FG011|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528584|NCT01597245|7449771|FG012|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528585|NCT01597245|7449772|FG013|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528586|NCT01597245|7449773|FG014|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6528587|NCT01597245|7449774|FG015|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6528588|NCT01597245|7449775|FG016|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|16
6528589|NCT01597245|7449776|FG017|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|6
6528590|NCT01597245|7449777|FG018|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|24
6528591|NCT01597245|7449778|FG019|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|656
6528592|NCT01597245|7449779|FG020|STARTED|Post Treatment Follow-Up (12 - 24 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|248
6528593|NCT01597245|7449759|FG000|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528594|NCT01597245|7449760|FG001|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528595|NCT01597245|7449761|FG002|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528596|NCT01597245|7449762|FG003|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528597|NCT01597245|7449763|FG004|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528598|NCT01597245|7449764|FG005|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528599|NCT01597245|7449765|FG006|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528600|NCT01597245|7449766|FG007|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528601|NCT01597245|7449767|FG008|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528602|NCT01597245|7449768|FG009|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528603|NCT01597245|7449769|FG010|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6644168|NCT02360371|7572735|FG001|Hydromorphone (Oral) 8mg|Overall Study||69
6644169|NCT02360371|7572734|FG000|COMPLETED|Overall Study||13
6644170|NCT02360371|7572735|FG001|COMPLETED|Overall Study||69
6644171|NCT02360371|7572734|FG000|NOT COMPLETED|Overall Study||0
6528604|NCT01597245|7449770|FG011|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528605|NCT01597245|7449771|FG012|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528606|NCT01597245|7449772|FG013|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528607|NCT01597245|7449773|FG014|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528608|NCT01597245|7449774|FG015|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528609|NCT01597245|7449775|FG016|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528610|NCT01597245|7449776|FG017|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528611|NCT01597245|7449777|FG018|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||14
6528612|NCT01597245|7449778|FG019|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||489
6528613|NCT01597245|7449779|FG020|COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||212
6528614|NCT01597245|7449759|FG000|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528615|NCT01597245|7449760|FG001|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528616|NCT01597245|7449761|FG002|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528617|NCT01597245|7449762|FG003|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528618|NCT01597245|7449763|FG004|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528619|NCT01597245|7449764|FG005|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528620|NCT01597245|7449765|FG006|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528621|NCT01597245|7449766|FG007|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528622|NCT01597245|7449767|FG008|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528623|NCT01597245|7449768|FG009|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528624|NCT01597245|7449769|FG010|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528625|NCT01597245|7449770|FG011|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528626|NCT01597245|7449771|FG012|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528627|NCT01597245|7449772|FG013|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528628|NCT01597245|7449773|FG014|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528629|NCT01597245|7449774|FG015|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||0
6528630|NCT01597245|7449775|FG016|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||16
6528631|NCT01597245|7449776|FG017|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||6
6528632|NCT01597245|7449777|FG018|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||10
6528633|NCT01597245|7449778|FG019|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||167
6528634|NCT01597245|7449779|FG020|NOT COMPLETED|Post Treatment Follow-Up (12 - 24 Weeks)||36
6528635|NCT01597258|7449812|FG000|STARTED|Overall Study||2029
6528636|NCT01597258|7449812|FG000|COMPLETED|Overall Study||2028
6528637|NCT01597258|7449812|FG000|NOT COMPLETED|Overall Study||1
6528638|NCT01597375|7449816|FG000|STARTED|First Intervention (4 Weeks)||23
6528639|NCT01597375|7449817|FG001|STARTED|First Intervention (4 Weeks)||23
6528640|NCT01597375|7449816|FG000|COMPLETED|First Intervention (4 Weeks)||21
6528641|NCT01597375|7449817|FG001|COMPLETED|First Intervention (4 Weeks)||22
6528642|NCT01597375|7449816|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
6528643|NCT01597375|7449817|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
6528644|NCT01597375|7449816|FG000|STARTED|Washout (2 Weeks)||21
6528645|NCT01597375|7449817|FG001|STARTED|Washout (2 Weeks)||22
6528646|NCT01597375|7449816|FG000|COMPLETED|Washout (2 Weeks)||20
6528647|NCT01597375|7449817|FG001|COMPLETED|Washout (2 Weeks)||22
6528648|NCT01597375|7449816|FG000|NOT COMPLETED|Washout (2 Weeks)||1
6528649|NCT01597375|7449817|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6528650|NCT01597375|7449816|FG000|STARTED|Second Intervention||20
6528651|NCT01597375|7449817|FG001|STARTED|Second Intervention||22
6528652|NCT01597375|7449816|FG000|COMPLETED|Second Intervention||19
6528653|NCT01597375|7449817|FG001|COMPLETED|Second Intervention||21
6528654|NCT01597375|7449816|FG000|NOT COMPLETED|Second Intervention||1
6528655|NCT01597375|7449817|FG001|NOT COMPLETED|Second Intervention||1
6528656|NCT01597440|7449826|FG000|STARTED|Overall Study||1
6528657|NCT01597440|7449827|FG001|STARTED|Overall Study||0
6528658|NCT01597440|7449826|FG000|COMPLETED|Overall Study||1
6528659|NCT01597440|7449827|FG001|COMPLETED|Overall Study||0
6528660|NCT01597440|7449826|FG000|NOT COMPLETED|Overall Study||0
6528661|NCT01597440|7449827|FG001|NOT COMPLETED|Overall Study||0
6528662|NCT01597479|7449837|FG000|STARTED|Overall Study||26
6528663|NCT01597479|7449838|FG001|STARTED|Overall Study||26
6528664|NCT01597479|7449837|FG000|COMPLETED|Overall Study||24
6528665|NCT01597479|7449838|FG001|COMPLETED|Overall Study||26
6528666|NCT01597479|7449837|FG000|NOT COMPLETED|Overall Study||2
6528667|NCT01597479|7449838|FG001|NOT COMPLETED|Overall Study||0
6528668|NCT01597492|7449847|FG000|STARTED|Overall Study||34
6528669|NCT01597492|7449848|FG001|STARTED|Overall Study||45
6528670|NCT01597492|7449847|FG000|COMPLETED|Overall Study||28
6528671|NCT01597492|7449848|FG001|COMPLETED|Overall Study||41
6528672|NCT01597492|7449847|FG000|NOT COMPLETED|Overall Study||6
6528673|NCT01597492|7449848|FG001|NOT COMPLETED|Overall Study||4
6528674|NCT01597505|7449856|FG000|STARTED|Overall Study|Randomized participants|308
6528675|NCT01597505|7449857|FG001|STARTED|Overall Study|Randomized participants|298
6528676|NCT01597505|7449856|FG000|Treated|Overall Study|One participant was instead randomized to vancomycin|305
6528677|NCT01597505|7449857|FG001|Treated|Overall Study||286
6528678|NCT01597505|7449856|FG000|COMPLETED|Overall Study||264
6528679|NCT01597505|7449857|FG001|COMPLETED|Overall Study||265
6528680|NCT01597505|7449856|FG000|NOT COMPLETED|Overall Study||44
6528681|NCT01597505|7449857|FG001|NOT COMPLETED|Overall Study||33
6528682|NCT01597557|7449866|FG000|STARTED|Overall Study||132
6528683|NCT01597557|7449867|FG001|STARTED|Overall Study||129
6528684|NCT01597557|7449866|FG000|COMPLETED|Overall Study||128
6528685|NCT01597557|7449867|FG001|COMPLETED|Overall Study||126
6528686|NCT01597557|7449866|FG000|NOT COMPLETED|Overall Study||4
6528687|NCT01597557|7449867|FG001|NOT COMPLETED|Overall Study||3
6528688|NCT01597596|7449875|FG000|STARTED|Overall Study||1
6528689|NCT01597596|7449876|FG001|STARTED|Overall Study||3
6528690|NCT01597596|7449875|FG000|COMPLETED|Overall Study||0
6528691|NCT01597596|7449876|FG001|COMPLETED|Overall Study||2
6528692|NCT01597596|7449875|FG000|NOT COMPLETED|Overall Study||1
6528693|NCT01597596|7449876|FG001|NOT COMPLETED|Overall Study||1
6528694|NCT01597622|7449882|FG000|STARTED|Overall Study||142
6528695|NCT01597622|7449882|FG000|COMPLETED|Overall Study||104
6528696|NCT01597622|7449882|FG000|NOT COMPLETED|Overall Study||38
6528697|NCT01597635|7449889|FG000|STARTED|Part A||5
6528698|NCT01597635|7449890|FG001|STARTED|Part A||0
6528699|NCT01597635|7449891|FG002|STARTED|Part A||0
6528700|NCT01597635|7449889|FG000|COMPLETED|Part A||2
6528701|NCT01597635|7449890|FG001|COMPLETED|Part A||0
6528702|NCT01597635|7449891|FG002|COMPLETED|Part A||0
6528703|NCT01597635|7449889|FG000|NOT COMPLETED|Part A||3
6528704|NCT01597635|7449890|FG001|NOT COMPLETED|Part A||0
6528705|NCT01597635|7449891|FG002|NOT COMPLETED|Part A||0
6528706|NCT01597635|7449889|FG000|STARTED|Part B||0
6528707|NCT01597635|7449890|FG001|STARTED|Part B||20
6528708|NCT01597635|7449891|FG002|STARTED|Part B||19
6528709|NCT01597635|7449889|FG000|COMPLETED|Part B||0
6528710|NCT01597635|7449890|FG001|COMPLETED|Part B||14
6528711|NCT01597635|7449891|FG002|COMPLETED|Part B||15
6528712|NCT01597635|7449889|FG000|NOT COMPLETED|Part B||0
6528713|NCT01597635|7449890|FG001|NOT COMPLETED|Part B||6
6528714|NCT01597635|7449891|FG002|NOT COMPLETED|Part B||4
6528715|NCT01597687|7449903|FG000|STARTED|Overall Study||76
6528716|NCT01597687|7449904|FG001|STARTED|Overall Study||89
6528717|NCT01597687|7449905|FG002|STARTED|Overall Study||147
6528718|NCT01597687|7449903|FG000|COMPLETED|Overall Study||76
6528719|NCT01597687|7449904|FG001|COMPLETED|Overall Study||89
6528720|NCT01597687|7449905|FG002|COMPLETED|Overall Study||147
6528721|NCT01597687|7449903|FG000|NOT COMPLETED|Overall Study||0
6528722|NCT01597687|7449904|FG001|NOT COMPLETED|Overall Study||0
6528723|NCT01597687|7449905|FG002|NOT COMPLETED|Overall Study||0
6528724|NCT01597791|7449931|FG000|STARTED|Overall Study||28
6528725|NCT01597791|7449932|FG001|STARTED|Overall Study||28
6528726|NCT01597791|7449931|FG000|COMPLETED|Overall Study||20
6528727|NCT01597791|7449932|FG001|COMPLETED|Overall Study||18
6528728|NCT01597791|7449931|FG000|NOT COMPLETED|Overall Study||8
6528729|NCT01597791|7449932|FG001|NOT COMPLETED|Overall Study||10
6528730|NCT01597843|7449941|FG000|STARTED|Overall Study||79
6528731|NCT01597843|7449942|FG001|STARTED|Overall Study||122
6528732|NCT01597843|7449943|FG002|STARTED|Overall Study||81
6528733|NCT01597843|7449941|FG000|Survey 1 Responses|Overall Study||45
6528734|NCT01597843|7449942|FG001|Survey 1 Responses|Overall Study||71
6528735|NCT01597843|7449943|FG002|Survey 1 Responses|Overall Study||59
6528736|NCT01597843|7449941|FG000|Survey 2 Responses|Overall Study||52
6528737|NCT01597843|7449942|FG001|Survey 2 Responses|Overall Study||42
6528738|NCT01597843|7449943|FG002|Survey 2 Responses|Overall Study||58
6528739|NCT01597843|7449941|FG000|Survey 3 Responses|Overall Study||65
6528740|NCT01597843|7449942|FG001|Survey 3 Responses|Overall Study||56
6528741|NCT01597843|7449943|FG002|Survey 3 Responses|Overall Study||76
6528742|NCT01597843|7449941|FG000|COMPLETED|Overall Study||79
6528743|NCT01597843|7449942|FG001|COMPLETED|Overall Study||122
6528744|NCT01597843|7449943|FG002|COMPLETED|Overall Study||81
6528745|NCT01597843|7449941|FG000|NOT COMPLETED|Overall Study||0
6528746|NCT01597843|7449942|FG001|NOT COMPLETED|Overall Study||0
6528747|NCT01597843|7449943|FG002|NOT COMPLETED|Overall Study||0
6528748|NCT01597856|7449954|FG000|STARTED|Overall Study||85
6528749|NCT01597856|7449955|FG001|STARTED|Overall Study||87
6528750|NCT01597856|7449956|FG002|STARTED|Overall Study||174
6528751|NCT01597856|7449954|FG000|Week 4 Follow-up|Overall Study||62
6528752|NCT01597856|7449955|FG001|Week 4 Follow-up|Overall Study||67
6528753|NCT01597856|7449956|FG002|Week 4 Follow-up|Overall Study||129
6528754|NCT01597856|7449954|FG000|COMPLETED|Overall Study||63
6528755|NCT01597856|7449955|FG001|COMPLETED|Overall Study||61
6528756|NCT01597856|7449956|FG002|COMPLETED|Overall Study||120
6528757|NCT01597856|7449954|FG000|NOT COMPLETED|Overall Study||22
6528758|NCT01597856|7449955|FG001|NOT COMPLETED|Overall Study||26
6528759|NCT01597856|7449956|FG002|NOT COMPLETED|Overall Study||54
6528760|NCT01597908|7449967|FG000|STARTED|Randomized Phase||352
6528761|NCT01597908|7449968|FG001|STARTED|Randomized Phase||352
6528762|NCT01597908|7449969|FG002|STARTED|Randomized Phase||0
6528763|NCT01597908|7449967|FG000|Safety Set|Randomized Phase||350
6528764|NCT01597908|7449968|FG001|Safety Set|Randomized Phase||349
6528765|NCT01597908|7449969|FG002|Safety Set|Randomized Phase||0
6528766|NCT01597908|7449967|FG000|COMPLETED|Randomized Phase||1
6528767|NCT01597908|7449968|FG001|COMPLETED|Randomized Phase||0
6528768|NCT01597908|7449969|FG002|COMPLETED|Randomized Phase||0
6528769|NCT01597908|7449967|FG000|NOT COMPLETED|Randomized Phase||351
6528770|NCT01597908|7449968|FG001|NOT COMPLETED|Randomized Phase||352
6528771|NCT01597908|7449969|FG002|NOT COMPLETED|Randomized Phase||0
6528772|NCT01597908|7449967|FG000|STARTED|Crossover Phase||0
6528773|NCT01597908|7449968|FG001|STARTED|Crossover Phase||0
6528774|NCT01597908|7449969|FG002|STARTED|Crossover Phase||34
6528775|NCT01597908|7449967|FG000|COMPLETED|Crossover Phase||0
6528776|NCT01597908|7449968|FG001|COMPLETED|Crossover Phase||0
6528777|NCT01597908|7449969|FG002|COMPLETED|Crossover Phase||0
6528778|NCT01597908|7449967|FG000|NOT COMPLETED|Crossover Phase||0
6528779|NCT01597908|7449968|FG001|NOT COMPLETED|Crossover Phase||0
6528780|NCT01597908|7449969|FG002|NOT COMPLETED|Crossover Phase||34
6528781|NCT01597973|7449980|FG000|STARTED|Overall Study||234
6528782|NCT01597973|7449981|FG001|STARTED|Overall Study||230
6528783|NCT01597973|7449980|FG000|Began First Dose|Overall Study||230
6528784|NCT01597973|7449981|FG001|Began First Dose|Overall Study||228
6528785|NCT01597973|7449980|FG000|COMPLETED|Overall Study||214
6528786|NCT01597973|7449981|FG001|COMPLETED|Overall Study||211
6528787|NCT01597973|7449980|FG000|NOT COMPLETED|Overall Study||20
6528788|NCT01597973|7449981|FG001|NOT COMPLETED|Overall Study||19
6528789|NCT01598064|7449991|FG000|STARTED|Overall Study||25
6528790|NCT01598064|7449992|FG001|STARTED|Overall Study||24
6528791|NCT01598064|7449991|FG000|COMPLETED|Overall Study||25
6528792|NCT01598064|7449992|FG001|COMPLETED|Overall Study||24
6528793|NCT01598064|7449991|FG000|NOT COMPLETED|Overall Study||0
6528794|NCT01598064|7449992|FG001|NOT COMPLETED|Overall Study||0
6528795|NCT01598090|7450003|FG000|STARTED|Treatment Period||27
6528796|NCT01598090|7450004|FG001|STARTED|Treatment Period||411
6528797|NCT01598090|7450005|FG002|STARTED|Treatment Period||206
6528798|NCT01598090|7450003|FG000|COMPLETED|Treatment Period||16
6528799|NCT01598090|7450004|FG001|COMPLETED|Treatment Period||339
6528800|NCT01598090|7450005|FG002|COMPLETED|Treatment Period||171
6528801|NCT01598090|7450003|FG000|NOT COMPLETED|Treatment Period||11
6528802|NCT01598090|7450004|FG001|NOT COMPLETED|Treatment Period||72
6528803|NCT01598090|7450005|FG002|NOT COMPLETED|Treatment Period||35
6528804|NCT01598090|7450003|FG000|STARTED|Follow-up Period|Includes 10 participants who re-joined from treatment period to follow-up period.|26
6528805|NCT01598090|7450004|FG001|STARTED|Follow-up Period|Includes 60 participants who re-joined from treatment period to follow-up period.|399
6528806|NCT01598090|7450005|FG002|STARTED|Follow-up Period|Includes 28 participants who re-joined from treatment period to follow-up period.|199
6528807|NCT01598090|7450003|FG000|COMPLETED|Follow-up Period||21
6528808|NCT01598090|7450004|FG001|COMPLETED|Follow-up Period||364
6528809|NCT01598090|7450005|FG002|COMPLETED|Follow-up Period||171
6528810|NCT01598090|7450003|FG000|NOT COMPLETED|Follow-up Period||5
6528811|NCT01598090|7450004|FG001|NOT COMPLETED|Follow-up Period||35
6528812|NCT01598090|7450005|FG002|NOT COMPLETED|Follow-up Period||28
6528813|NCT01598129|7450016|FG000|STARTED|Overall Study||12
6528814|NCT01598129|7450016|FG000|COMPLETED|Overall Study||3
6528815|NCT01598129|7450016|FG000|NOT COMPLETED|Overall Study||9
6528816|NCT01598194|7450023|FG000|STARTED|Overall Study||30
6528817|NCT01598194|7450024|FG001|STARTED|Overall Study||30
6528818|NCT01598194|7450023|FG000|2 Passes With 25G for Cytology|Overall Study||30
6528819|NCT01598194|7450024|FG001|2 Passes With 25G for Cytology|Overall Study||30
6528820|NCT01598194|7450023|FG000|1 Pass With 22Gpc for Cytology|Overall Study|1 participant's pass could not be performed|29
6528821|NCT01598194|7450024|FG001|1 Pass With 22Gpc for Cytology|Overall Study||30
6528822|NCT01598194|7450023|FG000|1 Pass With 22Gpc for Histology|Overall Study|3 participants passes could not be performed|27
6528823|NCT01598194|7450024|FG001|1 Pass With 22Gpc for Histology|Overall Study|1 participant's pass could not be performed|29
6528824|NCT01598194|7450023|FG000|COMPLETED|Overall Study||30
6528825|NCT01598194|7450024|FG001|COMPLETED|Overall Study||30
6528826|NCT01598194|7450023|FG000|NOT COMPLETED|Overall Study||0
6528827|NCT01598194|7450024|FG001|NOT COMPLETED|Overall Study||0
6528828|NCT01598207|7450036|FG000|STARTED|Overall Study||7
6528829|NCT01598207|7450037|FG001|STARTED|Overall Study||6
6528830|NCT01598207|7450036|FG000|COMPLETED|Overall Study||6
6528831|NCT01598207|7450037|FG001|COMPLETED|Overall Study||6
6528832|NCT01598207|7450036|FG000|NOT COMPLETED|Overall Study||1
6528833|NCT01598207|7450037|FG001|NOT COMPLETED|Overall Study||0
6528834|NCT01598298|7450045|FG000|STARTED|Overall Study||150
6528835|NCT01598298|7450046|FG001|STARTED|Overall Study||149
6528836|NCT01598298|7450045|FG000|Patients Evaluable for Primary Endpoint|Overall Study||127
6528837|NCT01598298|7450046|FG001|Patients Evaluable for Primary Endpoint|Overall Study||128
6528838|NCT01598298|7450045|FG000|Patients Evaluable for Adverse Events|Overall Study||138
6528839|NCT01598298|7450046|FG001|Patients Evaluable for Adverse Events|Overall Study||141
6528840|NCT01598298|7450045|FG000|COMPLETED|Overall Study||110
6528841|NCT01598298|7450046|FG001|COMPLETED|Overall Study||108
6528842|NCT01598298|7450045|FG000|NOT COMPLETED|Overall Study||40
6528843|NCT01598298|7450046|FG001|NOT COMPLETED|Overall Study||41
6528844|NCT01598311|7450054|FG000|STARTED|Overall Study||303
6528845|NCT01598311|7450055|FG001|STARTED|Overall Study||305
6528846|NCT01598311|7450054|FG000|Treated|Overall Study||294
6528847|NCT01598311|7450055|FG001|Treated|Overall Study||301
6528848|NCT01598311|7450054|FG000|Treated and Confirmed CDAD|Overall Study||285
6528849|NCT01598311|7450055|FG001|Treated and Confirmed CDAD|Overall Study||292
6528850|NCT01598311|7450054|FG000|COMPLETED|Overall Study||256
6528851|NCT01598311|7450055|FG001|COMPLETED|Overall Study||244
6528852|NCT01598311|7450054|FG000|NOT COMPLETED|Overall Study||47
6528853|NCT01598311|7450055|FG001|NOT COMPLETED|Overall Study||61
6528854|NCT01598350|7450061|FG000|STARTED|Overall Study||6
6528855|NCT01598350|7450061|FG000|COMPLETED|Overall Study||6
6528856|NCT01598350|7450061|FG000|NOT COMPLETED|Overall Study||0
6528857|NCT01598428|7450065|FG000|STARTED|Overall Study||20
6528858|NCT01598428|7450065|FG000|COMPLETED|Overall Study||20
6528859|NCT01598428|7450065|FG000|NOT COMPLETED|Overall Study||0
6528860|NCT01598506|7450070|FG000|STARTED|Overall Study||22
6528861|NCT01598506|7450070|FG000|COMPLETED|Overall Study||20
6528862|NCT01598506|7450070|FG000|NOT COMPLETED|Overall Study||2
6528863|NCT01598532|7450075|FG000|STARTED|Overall Study||22
6528864|NCT01598532|7450075|FG000|COMPLETED|Overall Study||11
6528865|NCT01598532|7450075|FG000|NOT COMPLETED|Overall Study||11
6528866|NCT01598545|7450082|FG000|STARTED|Overall Study||20
6528867|NCT01598545|7450082|FG000|COMPLETED|Overall Study||20
6528868|NCT01598545|7450082|FG000|NOT COMPLETED|Overall Study||0
6528869|NCT01598610|7450086|FG000|STARTED|Overall Study||220
6528870|NCT01598610|7450086|FG000|COMPLETED|Overall Study||219
6528871|NCT01598610|7450086|FG000|NOT COMPLETED|Overall Study||1
6528872|NCT01598662|7450092|FG000|STARTED|Overall Study||11
6528873|NCT01598662|7450093|FG001|STARTED|Overall Study||21
6528874|NCT01598662|7450092|FG000|Patients Who Received IUD|Overall Study|Subjects did not return at 6 weeks for IUD insertion.|0
6528875|NCT01598662|7450093|FG001|Patients Who Received IUD|Overall Study||18
6528876|NCT01598662|7450092|FG000|Patients Returned for 6 wk Postpartum|Overall Study||0
6528877|NCT01598662|7450093|FG001|Patients Returned for 6 wk Postpartum|Overall Study||2
6528878|NCT01598662|7450092|FG000|COMPLETED|Overall Study||0
6528879|NCT01598662|7450093|FG001|COMPLETED|Overall Study||0
6528880|NCT01598662|7450092|FG000|NOT COMPLETED|Overall Study||11
6528881|NCT01598662|7450093|FG001|NOT COMPLETED|Overall Study||21
6528882|NCT01598701|7450101|FG000|STARTED|Overall Study||50
6528883|NCT01598701|7450102|FG001|STARTED|Overall Study||50
6528884|NCT01598701|7450101|FG000|COMPLETED|Overall Study||45
6528885|NCT01598701|7450102|FG001|COMPLETED|Overall Study||41
6528886|NCT01598701|7450101|FG000|NOT COMPLETED|Overall Study||5
6528887|NCT01598701|7450102|FG001|NOT COMPLETED|Overall Study||9
6528888|NCT01598740|7450110|FG000|STARTED|Period 1||9
6528889|NCT01598740|7450111|FG001|STARTED|Period 1||9
6528890|NCT01598740|7450110|FG000|COMPLETED|Period 1||9
6528891|NCT01598740|7450111|FG001|COMPLETED|Period 1||9
6528892|NCT01598740|7450110|FG000|NOT COMPLETED|Period 1||0
6528893|NCT01598740|7450111|FG001|NOT COMPLETED|Period 1||0
6528894|NCT01598740|7450110|FG000|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
6528895|NCT01598740|7450111|FG001|STARTED|Period 2||9
6528896|NCT01598740|7450110|FG000|COMPLETED|Period 2||7
6528897|NCT01598740|7450111|FG001|COMPLETED|Period 2||9
6528898|NCT01598740|7450110|FG000|NOT COMPLETED|Period 2||1
6528899|NCT01598740|7450111|FG001|NOT COMPLETED|Period 2||0
6528900|NCT01598753|7450122|FG000|STARTED|Overall Study||37
6528901|NCT01598753|7450123|FG001|STARTED|Overall Study||31
6528902|NCT01598753|7450124|FG002|STARTED|Overall Study||32
6528903|NCT01598753|7450125|FG003|STARTED|Overall Study||34
6528904|NCT01598753|7450122|FG000|COMPLETED|Overall Study||25
6528905|NCT01598753|7450123|FG001|COMPLETED|Overall Study||16
6528906|NCT01598753|7450124|FG002|COMPLETED|Overall Study||24
6528907|NCT01598753|7450125|FG003|COMPLETED|Overall Study||19
6528908|NCT01598753|7450122|FG000|NOT COMPLETED|Overall Study||12
6528909|NCT01598753|7450123|FG001|NOT COMPLETED|Overall Study||15
6528910|NCT01598753|7450124|FG002|NOT COMPLETED|Overall Study||8
6528911|NCT01598753|7450125|FG003|NOT COMPLETED|Overall Study||15
6528912|NCT01598779|7450135|FG000|STARTED|Overall Study||150
6528913|NCT01598779|7450135|FG000|COMPLETED|Overall Study||150
6528914|NCT01598779|7450135|FG000|NOT COMPLETED|Overall Study||0
6528915|NCT01598831|7450141|FG000|STARTED|Overall Study||402
6528916|NCT01598831|7450142|FG001|STARTED|Overall Study||414
6528917|NCT01598831|7450141|FG000|Received at Least 1 Dose Study Treatment|Overall Study||395
6528918|NCT01598831|7450142|FG001|Received at Least 1 Dose Study Treatment|Overall Study||405
6528919|NCT01598831|7450141|FG000|COMPLETED|Overall Study||283
6528920|NCT01598831|7450142|FG001|COMPLETED|Overall Study||278
6528921|NCT01598831|7450141|FG000|NOT COMPLETED|Overall Study||119
6528922|NCT01598831|7450142|FG001|NOT COMPLETED|Overall Study||136
6528923|NCT01598896|7450150|FG000|STARTED|Overall Study||3
6528924|NCT01598896|7450151|FG001|STARTED|Overall Study||4
6528925|NCT01598896|7450150|FG000|COMPLETED|Overall Study||3
6528926|NCT01598896|7450151|FG001|COMPLETED|Overall Study||2
6528927|NCT01598896|7450150|FG000|NOT COMPLETED|Overall Study||0
6528928|NCT01598896|7450151|FG001|NOT COMPLETED|Overall Study||2
6528929|NCT01598922|7450159|FG000|STARTED|Overall Study||37
6528930|NCT01598922|7450160|FG001|STARTED|Overall Study||40
6528931|NCT01598922|7450159|FG000|COMPLETED|Overall Study||34
6528932|NCT01598922|7450160|FG001|COMPLETED|Overall Study||30
6528933|NCT01598922|7450159|FG000|NOT COMPLETED|Overall Study||3
6528934|NCT01598922|7450160|FG001|NOT COMPLETED|Overall Study||10
6528935|NCT01598987|7450166|FG000|STARTED|Baseline to Month 12||56
6528936|NCT01598987|7450166|FG000|COMPLETED|Baseline to Month 12||50
6528937|NCT01598987|7450166|FG000|NOT COMPLETED|Baseline to Month 12||6
6528938|NCT01598987|7450166|FG000|STARTED|Baseline to 24 Month||56
6528939|NCT01598987|7450166|FG000|COMPLETED|Baseline to 24 Month||48
6528940|NCT01598987|7450166|FG000|NOT COMPLETED|Baseline to 24 Month||8
6528941|NCT01599104|7450180|FG000|STARTED|Overall Study||387
6528942|NCT01599104|7450181|FG001|STARTED|Overall Study||385
6528943|NCT01599104|7450182|FG002|STARTED|Overall Study||389
6528944|NCT01599104|7450180|FG000|COMPLETED|Overall Study||371
6528945|NCT01599104|7450181|FG001|COMPLETED|Overall Study||371
6528946|NCT01599104|7450182|FG002|COMPLETED|Overall Study||363
6528947|NCT01599104|7450180|FG000|NOT COMPLETED|Overall Study||16
6528948|NCT01599104|7450181|FG001|NOT COMPLETED|Overall Study||14
6528949|NCT01599104|7450182|FG002|NOT COMPLETED|Overall Study||26
6528950|NCT01599234|7450192|FG000|STARTED|Overall Study||167
6528951|NCT01599234|7450193|FG001|STARTED|Overall Study||170
6528952|NCT01599234|7450192|FG000|COMPLETED|Overall Study||150
6528953|NCT01599234|7450193|FG001|COMPLETED|Overall Study||155
6528954|NCT01599234|7450192|FG000|NOT COMPLETED|Overall Study||17
6528955|NCT01599234|7450193|FG001|NOT COMPLETED|Overall Study||15
6528956|NCT01599286|7450201|FG000|STARTED|Overall Study||24
6528957|NCT01599286|7450202|FG001|STARTED|Overall Study||23
6528958|NCT01599286|7450201|FG000|COMPLETED|Overall Study||24
6528959|NCT01599286|7450202|FG001|COMPLETED|Overall Study||23
6528960|NCT01599286|7450201|FG000|NOT COMPLETED|Overall Study||0
6528961|NCT01599286|7450202|FG001|NOT COMPLETED|Overall Study||0
6528962|NCT01599325|7450208|FG000|STARTED|Primary Parent Phase||72
6528963|NCT01599325|7450208|FG000|Intent to Treat (ITT) Population|Primary Parent Phase|Includes all participants who were enrolled into the study|72
6528964|NCT01599325|7450208|FG000|Pharmacokinetic (PK) Population|Primary Parent Phase|Includes all participants with evaluable azacitidine plasma PK profiles.|12
6528965|NCT01599325|7450208|FG000|COMPLETED|Primary Parent Phase|Participants still on study treatment at time of study closure|15
6528966|NCT01599325|7450208|FG000|NOT COMPLETED|Primary Parent Phase||57
6528967|NCT01599325|7450208|FG000|STARTED|Extension Phase||15
6528968|NCT01599325|7450208|FG000|COMPLETED|Extension Phase||0
6528969|NCT01599325|7450208|FG000|NOT COMPLETED|Extension Phase||15
6528970|NCT01599585|7450215|FG000|STARTED|Overall Study||62
6528971|NCT01599585|7450216|FG001|STARTED|Overall Study||59
6528972|NCT01599585|7450215|FG000|COMPLETED|Overall Study||40
6528973|NCT01599585|7450216|FG001|COMPLETED|Overall Study||42
6528974|NCT01599585|7450215|FG000|NOT COMPLETED|Overall Study||22
6528975|NCT01599585|7450216|FG001|NOT COMPLETED|Overall Study||17
6528976|NCT01599637|7450225|FG000|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
6528977|NCT01599637|7450226|FG001|STARTED|Overall Study||10
6528978|NCT01599637|7450227|FG002|STARTED|Overall Study||10
6528979|NCT01599637|7450225|FG000|COMPLETED|Overall Study||19
6528980|NCT01599637|7450226|FG001|COMPLETED|Overall Study||8
6528981|NCT01599637|7450227|FG002|COMPLETED|Overall Study||10
6528982|NCT01599637|7450225|FG000|NOT COMPLETED|Overall Study||1
6528983|NCT01599637|7450226|FG001|NOT COMPLETED|Overall Study||2
6528984|NCT01599637|7450227|FG002|NOT COMPLETED|Overall Study||0
6528985|NCT01599650|7450240|FG000|STARTED|Overall Study||183
6528986|NCT01599650|7450241|FG001|STARTED|Overall Study||180
6528987|NCT01599650|7450242|FG002|STARTED|Overall Study||92
6528988|NCT01599650|7450240|FG000|Completed 6 Mos|Overall Study||174
6528989|NCT01599650|7450241|FG001|Completed 6 Mos|Overall Study||170
6528990|NCT01599650|7450242|FG002|Completed 6 Mos|Overall Study||80
6528991|NCT01599650|7450240|FG000|COMPLETED|Overall Study||161
6528992|NCT01599650|7450241|FG001|COMPLETED|Overall Study||154
6528993|NCT01599650|7450242|FG002|COMPLETED|Overall Study||65
6528994|NCT01599650|7450240|FG000|NOT COMPLETED|Overall Study||22
6528995|NCT01599650|7450241|FG001|NOT COMPLETED|Overall Study||26
6528996|NCT01599650|7450242|FG002|NOT COMPLETED|Overall Study||27
6528997|NCT01599754|7450254|FG000|STARTED|Overall Study||363
6528998|NCT01599754|7450255|FG001|STARTED|Overall Study||361
6528999|NCT01599754|7450254|FG000|Treated|Overall Study||360
6529000|NCT01599754|7450255|FG001|Treated|Overall Study||360
6529001|NCT01599754|7450254|FG000|COMPLETED|Overall Study||0
6529002|NCT01599754|7450255|FG001|COMPLETED|Overall Study||1
6529003|NCT01599754|7450254|FG000|NOT COMPLETED|Overall Study||363
6529004|NCT01599754|7450255|FG001|NOT COMPLETED|Overall Study||360
6529005|NCT01599793|7450261|FG000|STARTED|Overall Study||19
6529006|NCT01599793|7450261|FG000|COMPLETED|Overall Study||17
6529007|NCT01599793|7450261|FG000|NOT COMPLETED|Overall Study||2
6529008|NCT01599806|7450267|FG000|STARTED|Overall Study||516
6529009|NCT01599806|7450268|FG001|STARTED|Overall Study||517
6529010|NCT01599806|7450267|FG000|COMPLETED|Overall Study||473
6529011|NCT01599806|7450268|FG001|COMPLETED|Overall Study||476
6529012|NCT01599806|7450267|FG000|NOT COMPLETED|Overall Study||43
6529013|NCT01599806|7450268|FG001|NOT COMPLETED|Overall Study||41
6529014|NCT01599832|7450274|FG000|STARTED|Overall Study||20
6529015|NCT01599832|7450274|FG000|COMPLETED|Overall Study||20
6529016|NCT01599832|7450274|FG000|NOT COMPLETED|Overall Study||0
6529017|NCT01600014|7450278|FG000|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
6529018|NCT01600014|7450279|FG001|STARTED|1. Cycle & Observation Period D1 to W52||0
6529019|NCT01600014|7450278|FG000|COMPLETED|1. Cycle & Observation Period D1 to W52||162
6529020|NCT01600014|7450279|FG001|COMPLETED|1. Cycle & Observation Period D1 to W52||0
6529021|NCT01600014|7450278|FG000|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
6529022|NCT01600014|7450279|FG001|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
6529023|NCT01600014|7450278|FG000|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
6529024|NCT01600014|7450279|FG001|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
6529025|NCT01600014|7450278|FG000|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
6529026|NCT01600014|7450279|FG001|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
6529027|NCT01600014|7450278|FG000|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
6529028|NCT01600014|7450279|FG001|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
6529029|NCT01600014|7450278|FG000|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
6529030|NCT01600014|7450279|FG001|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
6529031|NCT01600014|7450278|FG000|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
6529032|NCT01600014|7450279|FG001|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
6529033|NCT01600014|7450278|FG000|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
6529034|NCT01600014|7450279|FG001|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
6529035|NCT01600053|7450297|FG000|STARTED|Overall Study||11
6529036|NCT01600053|7450297|FG000|COMPLETED|Overall Study||0
6529037|NCT01600053|7450297|FG000|NOT COMPLETED|Overall Study||11
6529038|NCT01600092|7450303|FG000|STARTED|Overall Study||513
6529039|NCT01600092|7450304|FG001|STARTED|Overall Study||507
6644172|NCT02360371|7572735|FG001|NOT COMPLETED|Overall Study||15
6644173|NCT02360397|7572745|FG000|STARTED|Overall Study||6
6644174|NCT02360397|7572745|FG000|COMPLETED|Overall Study||2
6644175|NCT02360397|7572745|FG000|NOT COMPLETED|Overall Study||4
6644176|NCT02360475|7572754|FG000|STARTED|Overall Study||126
6644177|NCT02360475|7572755|FG001|STARTED|Overall Study||124
6644178|NCT02360475|7572756|FG002|STARTED|Overall Study||125
6644179|NCT02360475|7572757|FG003|STARTED|Overall Study||125
6644180|NCT02360475|7572754|FG000|COMPLETED|Overall Study||122
6644181|NCT02360475|7572755|FG001|COMPLETED|Overall Study||111
6644182|NCT02360475|7572756|FG002|COMPLETED|Overall Study||117
6644183|NCT02360475|7572757|FG003|COMPLETED|Overall Study||120
6644184|NCT02360475|7572754|FG000|NOT COMPLETED|Overall Study||4
6644185|NCT02360475|7572755|FG001|NOT COMPLETED|Overall Study||13
6644186|NCT02360475|7572756|FG002|NOT COMPLETED|Overall Study||8
6644187|NCT02360475|7572757|FG003|NOT COMPLETED|Overall Study||5
6644188|NCT02360488|7572769|FG000|STARTED|Overall Study||62
6644189|NCT02360488|7572770|FG001|STARTED|Overall Study||62
6529040|NCT01600092|7450303|FG000|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
6529041|NCT01600092|7450304|FG001|Received at Least 1 Vaccination|Overall Study||504
6529042|NCT01600092|7450303|FG000|Received All 3 Vaccinations|Overall Study||500
6529043|NCT01600092|7450304|FG001|Received All 3 Vaccinations|Overall Study||494
6529044|NCT01600092|7450303|FG000|COMPLETED|Overall Study||495
6529045|NCT01600092|7450304|FG001|COMPLETED|Overall Study||491
6529046|NCT01600092|7450303|FG000|NOT COMPLETED|Overall Study||18
6529047|NCT01600092|7450304|FG001|NOT COMPLETED|Overall Study||16
6529048|NCT01600105|7450312|FG000|STARTED|Total Participants||255
6529049|NCT01600105|7450313|FG001|STARTED|Total Participants||21
6529050|NCT01600105|7450312|FG000|COMPLETED|Total Participants||214
6529051|NCT01600105|7450313|FG001|COMPLETED|Total Participants||11
6529052|NCT01600105|7450312|FG000|NOT COMPLETED|Total Participants||41
6529053|NCT01600105|7450313|FG001|NOT COMPLETED|Total Participants||10
6529054|NCT01600105|7450312|FG000|STARTED|Sub Study I||19
6529055|NCT01600105|7450313|FG001|STARTED|Sub Study I||21
6529056|NCT01600105|7450312|FG000|COMPLETED|Sub Study I||19
6529057|NCT01600105|7450313|FG001|COMPLETED|Sub Study I||11
6529058|NCT01600105|7450312|FG000|NOT COMPLETED|Sub Study I||0
6529059|NCT01600105|7450313|FG001|NOT COMPLETED|Sub Study I||10
6529060|NCT01600105|7450312|FG000|STARTED|Sub Study II||65
6529061|NCT01600105|7450313|FG001|STARTED|Sub Study II||0
6529062|NCT01600105|7450312|FG000|COMPLETED|Sub Study II||60
6529063|NCT01600105|7450313|FG001|COMPLETED|Sub Study II||0
6529064|NCT01600105|7450312|FG000|NOT COMPLETED|Sub Study II||5
6529065|NCT01600105|7450313|FG001|NOT COMPLETED|Sub Study II||0
6529066|NCT01600105|7450312|FG000|STARTED|Sub Study III||39
6529067|NCT01600105|7450313|FG001|STARTED|Sub Study III||0
6529068|NCT01600105|7450312|FG000|COMPLETED|Sub Study III||34
6529069|NCT01600105|7450313|FG001|COMPLETED|Sub Study III||0
6529070|NCT01600105|7450312|FG000|NOT COMPLETED|Sub Study III||5
6529071|NCT01600105|7450313|FG001|NOT COMPLETED|Sub Study III||0
6529072|NCT01600105|7450312|FG000|STARTED|Sub Study IV||41
6529073|NCT01600105|7450313|FG001|STARTED|Sub Study IV||8
6529074|NCT01600105|7450312|FG000|COMPLETED|Sub Study IV||41
6529075|NCT01600105|7450313|FG001|COMPLETED|Sub Study IV||8
6529076|NCT01600105|7450312|FG000|NOT COMPLETED|Sub Study IV||0
6529077|NCT01600105|7450313|FG001|NOT COMPLETED|Sub Study IV||0
6529078|NCT01600105|7450312|FG000|STARTED|Sub Study V||52
6529079|NCT01600105|7450313|FG001|STARTED|Sub Study V||0
6529080|NCT01600105|7450312|FG000|COMPLETED|Sub Study V||50
6529081|NCT01600105|7450313|FG001|COMPLETED|Sub Study V||0
6529082|NCT01600105|7450312|FG000|NOT COMPLETED|Sub Study V||2
6529083|NCT01600105|7450313|FG001|NOT COMPLETED|Sub Study V||0
6529084|NCT01600170|7450325|FG000|STARTED|Period 1|Participants were assigned atorvastatin for 12 wks followed by a washout and then placebo.|6
6529085|NCT01600170|7450326|FG001|STARTED|Period 1|Participants were assigned placebo for 12 wks followed by a washout and then atorvastatin.|5
6529086|NCT01600170|7450325|FG000|COMPLETED|Period 1||6
6529087|NCT01600170|7450326|FG001|COMPLETED|Period 1||5
6529088|NCT01600170|7450325|FG000|NOT COMPLETED|Period 1||0
6644190|NCT02360488|7572769|FG000|COMPLETED|Overall Study||59
6529089|NCT01600170|7450326|FG001|NOT COMPLETED|Period 1||0
6529090|NCT01600170|7450325|FG000|STARTED|Period 2|These 6 were on atorvastatin in period 1 and on placebo in Period 2.|6
6529091|NCT01600170|7450326|FG001|STARTED|Period 2|These 5 were on placebo in Period 1 and on Atorvastatin in Period 2.|5
6529092|NCT01600170|7450325|FG000|COMPLETED|Period 2|One subject moved away from the area due to job responsibilities and dropped out of study.|5
6529093|NCT01600170|7450326|FG001|COMPLETED|Period 2||5
6529094|NCT01600170|7450325|FG000|NOT COMPLETED|Period 2||1
6529095|NCT01600170|7450326|FG001|NOT COMPLETED|Period 2||0
6529096|NCT01600222|7450334|FG000|STARTED|Overall Study||37
6529097|NCT01600222|7450334|FG000|COMPLETED|Overall Study||35
6529098|NCT01600222|7450334|FG000|NOT COMPLETED|Overall Study||2
6529099|NCT01600287|7450341|FG000|STARTED|Overall Study||20
6529100|NCT01600287|7450342|FG001|STARTED|Overall Study||20
6529101|NCT01600287|7450341|FG000|COMPLETED|Overall Study||20
6644191|NCT02360488|7572770|FG001|COMPLETED|Overall Study||55
6644192|NCT02360488|7572769|FG000|NOT COMPLETED|Overall Study||3
6529102|NCT01600287|7450342|FG001|COMPLETED|Overall Study||20
6529103|NCT01600287|7450341|FG000|NOT COMPLETED|Overall Study||0
6529104|NCT01600287|7450342|FG001|NOT COMPLETED|Overall Study||0
6561850|NCT01797302|7484753|FG001|NOT COMPLETED|Overall Study||26
6561851|NCT01797302|7484754|FG002|NOT COMPLETED|Overall Study||26
6561852|NCT01797328|7484764|FG000|STARTED|Overall Study||16
6561853|NCT01797328|7484765|FG001|STARTED|Overall Study||12
6561854|NCT01797328|7484764|FG000|COMPLETED|Overall Study||14
6561855|NCT01797328|7484765|FG001|COMPLETED|Overall Study||12
6561856|NCT01797328|7484764|FG000|NOT COMPLETED|Overall Study||2
6561857|NCT01797328|7484765|FG001|NOT COMPLETED|Overall Study||0
6561858|NCT01797432|7484771|FG000|STARTED|Overall Study||14
6561859|NCT01797432|7484771|FG000|COMPLETED|Overall Study||10
6561860|NCT01797432|7484771|FG000|NOT COMPLETED|Overall Study||4
6561861|NCT01797445|7484777|FG000|STARTED|Double-Blind Phase||435
6561862|NCT01797445|7484778|FG001|STARTED|Double-Blind Phase||437
6561863|NCT01797445|7484777|FG000|COMPLETED|Double-Blind Phase||348
6561864|NCT01797445|7484778|FG001|COMPLETED|Double-Blind Phase||348
6561865|NCT01797445|7484777|FG000|NOT COMPLETED|Double-Blind Phase||87
6561866|NCT01797445|7484778|FG001|NOT COMPLETED|Double-Blind Phase||89
6561867|NCT01797445|7484777|FG000|STARTED|Open-Label Extension Phase|207 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|141
6561868|NCT01797445|7484778|FG001|STARTED|Open-Label Extension Phase|229 participants completed the Double-Blind Phase, but did not enter the Open-Label Extension Phase.|119
6561869|NCT01797445|7484777|FG000|COMPLETED|Open-Label Extension Phase||140
6561870|NCT01797445|7484778|FG001|COMPLETED|Open-Label Extension Phase||119
6561871|NCT01797445|7484777|FG000|NOT COMPLETED|Open-Label Extension Phase||1
6561872|NCT01797445|7484778|FG001|NOT COMPLETED|Open-Label Extension Phase||0
6561873|NCT01797458|7484789|FG000|STARTED|Overall Study||52
6561874|NCT01797458|7484790|FG001|STARTED|Overall Study||52
6561875|NCT01797458|7484791|FG002|STARTED|Overall Study||65
6561876|NCT01797458|7484789|FG000|COMPLETED|Overall Study||40
6561877|NCT01797458|7484790|FG001|COMPLETED|Overall Study||43
6561878|NCT01797458|7484791|FG002|COMPLETED|Overall Study||58
6561879|NCT01797458|7484789|FG000|NOT COMPLETED|Overall Study||12
6561880|NCT01797458|7484790|FG001|NOT COMPLETED|Overall Study||9
6561881|NCT01797458|7484791|FG002|NOT COMPLETED|Overall Study||7
6561882|NCT01797471|7484808|FG000|STARTED|Overall Study||1
6561883|NCT01797471|7484808|FG000|COMPLETED|Overall Study||1
6561884|NCT01797471|7484808|FG000|NOT COMPLETED|Overall Study||0
6561885|NCT01797484|7484814|FG000|STARTED|Overall Study||10
6561886|NCT01797484|7484815|FG001|STARTED|Overall Study||10
6561887|NCT01797484|7484814|FG000|COMPLETED|Overall Study||10
6561888|NCT01797484|7484815|FG001|COMPLETED|Overall Study||10
6561889|NCT01797484|7484814|FG000|NOT COMPLETED|Overall Study||0
6561890|NCT01797484|7484815|FG001|NOT COMPLETED|Overall Study||0
6561891|NCT01797536|7484825|FG000|STARTED|Overall Study||8
6561892|NCT01797536|7484826|FG001|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
6561893|NCT01797536|7484827|FG002|STARTED|Overall Study||7
6561894|NCT01797536|7484828|FG003|STARTED|Overall Study||8
6561895|NCT01797536|7484825|FG000|COMPLETED|Overall Study||8
6561896|NCT01797536|7484826|FG001|COMPLETED|Overall Study||10
6561897|NCT01797536|7484827|FG002|COMPLETED|Overall Study||7
6561898|NCT01797536|7484828|FG003|COMPLETED|Overall Study||8
6561899|NCT01797536|7484825|FG000|NOT COMPLETED|Overall Study||0
6561900|NCT01797536|7484826|FG001|NOT COMPLETED|Overall Study||1
6561901|NCT01797536|7484827|FG002|NOT COMPLETED|Overall Study||0
6561902|NCT01797536|7484828|FG003|NOT COMPLETED|Overall Study||0
6561903|NCT01797562|7484838|FG000|STARTED|Overall Study||116
6561904|NCT01797562|7484838|FG000|COMPLETED|Overall Study||111
6561905|NCT01797562|7484838|FG000|NOT COMPLETED|Overall Study||5
6561906|NCT01797575|7484847|FG000|STARTED|Baseline Allocation||5
6561907|NCT01797575|7484848|FG001|STARTED|Baseline Allocation||9
6561908|NCT01797575|7484849|FG002|STARTED|Baseline Allocation||9
6561909|NCT01797575|7484850|FG003|STARTED|Baseline Allocation||15
6561910|NCT01797575|7484847|FG000|COMPLETED|Baseline Allocation||4
6561911|NCT01797575|7484848|FG001|COMPLETED|Baseline Allocation||8
6561912|NCT01797575|7484849|FG002|COMPLETED|Baseline Allocation||4
6561913|NCT01797575|7484850|FG003|COMPLETED|Baseline Allocation||8
6561914|NCT01797575|7484847|FG000|NOT COMPLETED|Baseline Allocation||1
6561915|NCT01797575|7484848|FG001|NOT COMPLETED|Baseline Allocation||1
6561916|NCT01797575|7484849|FG002|NOT COMPLETED|Baseline Allocation||5
6561917|NCT01797575|7484850|FG003|NOT COMPLETED|Baseline Allocation||7
6561918|NCT01797575|7484847|FG000|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|4
6561919|NCT01797575|7484848|FG001|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
6561920|NCT01797575|7484849|FG002|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|5
6561921|NCT01797575|7484850|FG003|STARTED|Week 8 Re-Randomization|Non-responders during Period 1 were re-randomized at week 8 into a new treatment arm.|10
6561922|NCT01797575|7484847|FG000|COMPLETED|Week 8 Re-Randomization||4
6561923|NCT01797575|7484848|FG001|COMPLETED|Week 8 Re-Randomization||5
6561924|NCT01797575|7484849|FG002|COMPLETED|Week 8 Re-Randomization||4
6561925|NCT01797575|7484850|FG003|COMPLETED|Week 8 Re-Randomization||7
6561926|NCT01797575|7484847|FG000|NOT COMPLETED|Week 8 Re-Randomization||0
6561927|NCT01797575|7484848|FG001|NOT COMPLETED|Week 8 Re-Randomization||0
6561928|NCT01797575|7484849|FG002|NOT COMPLETED|Week 8 Re-Randomization||1
6561929|NCT01797575|7484850|FG003|NOT COMPLETED|Week 8 Re-Randomization||3
6561930|NCT01797705|7484864|FG000|STARTED|Overall Study||33
6561931|NCT01797705|7484864|FG000|COMPLETED|Overall Study||28
6529105|NCT01600326|7450350|FG000|STARTED|Overall Study||15
6529106|NCT01600326|7450351|FG001|STARTED|Overall Study||15
6529107|NCT01600326|7450350|FG000|Primary Outcome Measure Data Collection|Overall Study||15
6529108|NCT01600326|7450351|FG001|Primary Outcome Measure Data Collection|Overall Study||15
6529109|NCT01600326|7450350|FG000|COMPLETED|Overall Study||14
6529110|NCT01600326|7450351|FG001|COMPLETED|Overall Study||14
6529111|NCT01600326|7450350|FG000|NOT COMPLETED|Overall Study||1
6529112|NCT01600326|7450351|FG001|NOT COMPLETED|Overall Study||1
6529113|NCT01600482|7450359|FG000|STARTED|Overall Study||148
6529114|NCT01600482|7450360|FG001|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
6529115|NCT01600482|7450359|FG000|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
6529116|NCT01600482|7450360|FG001|COMPLETED|Overall Study||59
6529117|NCT01600482|7450359|FG000|NOT COMPLETED|Overall Study||0
6529118|NCT01600482|7450360|FG001|NOT COMPLETED|Overall Study||0
6529119|NCT01600495|7450368|FG000|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
6529120|NCT01600495|7450369|FG001|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
6529121|NCT01600495|7450368|FG000|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
6529122|NCT01600495|7450369|FG001|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
6529123|NCT01600495|7450368|FG000|NOT COMPLETED|Overall Study||0
6529124|NCT01600495|7450369|FG001|NOT COMPLETED|Overall Study||0
6529125|NCT01600586|7450378|FG000|STARTED|Overall Study||49
6529126|NCT01600586|7450379|FG001|STARTED|Overall Study||51
6529127|NCT01600586|7450378|FG000|COMPLETED|Overall Study||46
6529128|NCT01600586|7450379|FG001|COMPLETED|Overall Study||48
6529129|NCT01600586|7450378|FG000|NOT COMPLETED|Overall Study||3
6529130|NCT01600586|7450379|FG001|NOT COMPLETED|Overall Study||3
6529131|NCT01600638|7450392|FG000|STARTED|Overall Study||25
6529132|NCT01600638|7450392|FG000|COMPLETED|Overall Study||25
6529133|NCT01600638|7450392|FG000|NOT COMPLETED|Overall Study||0
6529134|NCT01600677|7450398|FG000|STARTED|Overall Study||7
6529135|NCT01600677|7450399|FG001|STARTED|Overall Study||4
6529136|NCT01600677|7450398|FG000|COMPLETED|Overall Study||7
6529137|NCT01600677|7450399|FG001|COMPLETED|Overall Study||4
6529138|NCT01600677|7450398|FG000|NOT COMPLETED|Overall Study||0
6529139|NCT01600677|7450399|FG001|NOT COMPLETED|Overall Study||0
6529140|NCT01600703|7450405|FG000|STARTED|First Intervention||7
6529141|NCT01600703|7450406|FG001|STARTED|First Intervention||8
6529142|NCT01600703|7450405|FG000|COMPLETED|First Intervention||7
6529143|NCT01600703|7450406|FG001|COMPLETED|First Intervention||8
6529144|NCT01600703|7450405|FG000|NOT COMPLETED|First Intervention||0
6529145|NCT01600703|7450406|FG001|NOT COMPLETED|First Intervention||0
6529146|NCT01600703|7450405|FG000|STARTED|Second Intervention||7
6529147|NCT01600703|7450406|FG001|STARTED|Second Intervention||8
6529148|NCT01600703|7450405|FG000|COMPLETED|Second Intervention||7
6529149|NCT01600703|7450406|FG001|COMPLETED|Second Intervention||8
6529150|NCT01600703|7450405|FG000|NOT COMPLETED|Second Intervention||0
6529151|NCT01600703|7450406|FG001|NOT COMPLETED|Second Intervention||0
6529152|NCT01600716|7450414|FG000|STARTED|Overall Study||66
6529153|NCT01600716|7450415|FG001|STARTED|Overall Study||78
6529154|NCT01600716|7450414|FG000|COMPLETED|Overall Study||59
6529155|NCT01600716|7450415|FG001|COMPLETED|Overall Study||71
6529156|NCT01600716|7450414|FG000|NOT COMPLETED|Overall Study||7
6529157|NCT01600716|7450415|FG001|NOT COMPLETED|Overall Study||7
6529158|NCT01600729|7450423|FG000|STARTED|Overall Study||66
6529159|NCT01600729|7450423|FG000|COMPLETED|Overall Study||65
6529160|NCT01600729|7450423|FG000|NOT COMPLETED|Overall Study||1
6529161|NCT01600885|7450427|FG000|STARTED|First Period||10
6529162|NCT01600885|7450428|FG001|STARTED|First Period||9
6529163|NCT01600885|7450427|FG000|COMPLETED|First Period||8
6529164|NCT01600885|7450428|FG001|COMPLETED|First Period||8
6529165|NCT01600885|7450427|FG000|NOT COMPLETED|First Period||2
6529166|NCT01600885|7450428|FG001|NOT COMPLETED|First Period||1
6529167|NCT01600885|7450427|FG000|STARTED|Wash Out Period||8
6529168|NCT01600885|7450428|FG001|STARTED|Wash Out Period||8
6529169|NCT01600885|7450427|FG000|COMPLETED|Wash Out Period||8
6529170|NCT01600885|7450428|FG001|COMPLETED|Wash Out Period||8
6529171|NCT01600885|7450427|FG000|NOT COMPLETED|Wash Out Period||0
6529172|NCT01600885|7450428|FG001|NOT COMPLETED|Wash Out Period||0
6529173|NCT01600885|7450427|FG000|STARTED|Second Period||8
6529174|NCT01600885|7450428|FG001|STARTED|Second Period||8
6529175|NCT01600885|7450427|FG000|COMPLETED|Second Period||8
6529176|NCT01600885|7450428|FG001|COMPLETED|Second Period||8
6529177|NCT01600885|7450427|FG000|NOT COMPLETED|Second Period||0
6529178|NCT01600885|7450428|FG001|NOT COMPLETED|Second Period||0
6529179|NCT01600950|7450434|FG000|STARTED|Period 1||10
6529180|NCT01600950|7450435|FG001|STARTED|Period 1||10
6529181|NCT01600950|7450434|FG000|COMPLETED|Period 1||10
6529182|NCT01600950|7450435|FG001|COMPLETED|Period 1||10
6529183|NCT01600950|7450434|FG000|NOT COMPLETED|Period 1||0
6529184|NCT01600950|7450435|FG001|NOT COMPLETED|Period 1||0
6529185|NCT01600950|7450434|FG000|STARTED|Period 2||10
6529186|NCT01600950|7450435|FG001|STARTED|Period 2||10
6529187|NCT01600950|7450434|FG000|COMPLETED|Period 2||10
6529188|NCT01600950|7450435|FG001|COMPLETED|Period 2||10
6529189|NCT01600950|7450434|FG000|NOT COMPLETED|Period 2||0
6529190|NCT01600950|7450435|FG001|NOT COMPLETED|Period 2||0
6529191|NCT01601067|7450443|FG000|STARTED|Overall Study||63
6529192|NCT01601067|7450444|FG001|STARTED|Overall Study||56
6529193|NCT01601067|7450443|FG000|COMPLETED|Overall Study||30
6529194|NCT01601067|7450444|FG001|COMPLETED|Overall Study||34
6529195|NCT01601067|7450443|FG000|NOT COMPLETED|Overall Study||33
6529196|NCT01601067|7450444|FG001|NOT COMPLETED|Overall Study||22
6529197|NCT01601132|7450450|FG000|STARTED|Overall Study||30
6529198|NCT01601132|7450450|FG000|COMPLETED|Overall Study||28
6529199|NCT01601132|7450450|FG000|NOT COMPLETED|Overall Study||2
6529200|NCT01601236|7450463|FG000|STARTED|Overall Study||7
6529201|NCT01601236|7450464|FG001|STARTED|Overall Study||3
6529202|NCT01601236|7450465|FG002|STARTED|Overall Study||14
6529203|NCT01601236|7450466|FG003|STARTED|Overall Study||6
6529204|NCT01601236|7450467|FG004|STARTED|Overall Study||3
6529205|NCT01601236|7450468|FG005|STARTED|Overall Study||1
6529206|NCT01601236|7450463|FG000|COMPLETED|Overall Study||2
6529207|NCT01601236|7450464|FG001|COMPLETED|Overall Study||2
6529208|NCT01601236|7450465|FG002|COMPLETED|Overall Study||8
6529209|NCT01601236|7450466|FG003|COMPLETED|Overall Study||4
6529210|NCT01601236|7450467|FG004|COMPLETED|Overall Study||0
6529211|NCT01601236|7450468|FG005|COMPLETED|Overall Study||0
6529212|NCT01601236|7450463|FG000|NOT COMPLETED|Overall Study||5
6529213|NCT01601236|7450464|FG001|NOT COMPLETED|Overall Study||1
6529214|NCT01601236|7450465|FG002|NOT COMPLETED|Overall Study||6
6529215|NCT01601236|7450466|FG003|NOT COMPLETED|Overall Study||2
6529216|NCT01601236|7450467|FG004|NOT COMPLETED|Overall Study||3
6529217|NCT01601236|7450468|FG005|NOT COMPLETED|Overall Study||1
6529218|NCT01601431|7450479|FG000|STARTED|Overall Study||223
6529219|NCT01601431|7450480|FG001|STARTED|Overall Study||217
6529220|NCT01601431|7450479|FG000|COMPLETED|Overall Study||211
6529221|NCT01601431|7450480|FG001|COMPLETED|Overall Study||214
6529222|NCT01601431|7450479|FG000|NOT COMPLETED|Overall Study||12
6529223|NCT01601431|7450480|FG001|NOT COMPLETED|Overall Study||3
6529224|NCT01601470|7450486|FG000|STARTED|Period 1 - Sildenafil||28
6529225|NCT01601470|7450486|FG000|PK Analysis Set|Period 1 - Sildenafil||28
6529226|NCT01601470|7450486|FG000|Safety Set|Period 1 - Sildenafil||28
6529227|NCT01601470|7450486|FG000|COMPLETED|Period 1 - Sildenafil||28
6529228|NCT01601470|7450486|FG000|NOT COMPLETED|Period 1 - Sildenafil||0
6529229|NCT01601470|7450486|FG000|STARTED|Period 2 - LCZ696||28
6529230|NCT01601470|7450486|FG000|PK Analysis Set|Period 2 - LCZ696||27
6529231|NCT01601470|7450486|FG000|Safety Set|Period 2 - LCZ696||27
6529232|NCT01601470|7450486|FG000|COMPLETED|Period 2 - LCZ696||27
6529233|NCT01601470|7450486|FG000|NOT COMPLETED|Period 2 - LCZ696||1
6529234|NCT01601470|7450486|FG000|STARTED|Period 3 - LCZ696+Sildenafil||27
6529235|NCT01601470|7450486|FG000|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
6529236|NCT01601470|7450486|FG000|Safety Set|Period 3 - LCZ696+Sildenafil||27
6529237|NCT01601470|7450486|FG000|COMPLETED|Period 3 - LCZ696+Sildenafil||27
6529238|NCT01601470|7450486|FG000|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
6529239|NCT01601496|7450492|FG000|STARTED|Overall Study|Enrolled|117
6529240|NCT01601496|7450492|FG000|COMPLETED|Overall Study|Completed 12-M F/up|102
6529241|NCT01601496|7450492|FG000|NOT COMPLETED|Overall Study||15
6529242|NCT01601535|7450502|FG000|STARTED|Phase 1||6
6529243|NCT01601535|7450503|FG001|STARTED|Phase 1||6
6529244|NCT01601535|7450504|FG002|STARTED|Phase 1||6
6529245|NCT01601535|7450505|FG003|STARTED|Phase 1||4
6529246|NCT01601535|7450506|FG004|STARTED|Phase 1||0
6529247|NCT01601535|7450507|FG005|STARTED|Phase 1||0
6529248|NCT01601535|7450502|FG000|COMPLETED|Phase 1||0
6529249|NCT01601535|7450503|FG001|COMPLETED|Phase 1||0
6529250|NCT01601535|7450504|FG002|COMPLETED|Phase 1||1
6529251|NCT01601535|7450505|FG003|COMPLETED|Phase 1||0
6529252|NCT01601535|7450506|FG004|COMPLETED|Phase 1||0
6529253|NCT01601535|7450507|FG005|COMPLETED|Phase 1||0
6529254|NCT01601535|7450502|FG000|NOT COMPLETED|Phase 1||6
6529255|NCT01601535|7450503|FG001|NOT COMPLETED|Phase 1||6
6529256|NCT01601535|7450504|FG002|NOT COMPLETED|Phase 1||5
6529257|NCT01601535|7450505|FG003|NOT COMPLETED|Phase 1||4
6529258|NCT01601535|7450506|FG004|NOT COMPLETED|Phase 1||0
6529259|NCT01601535|7450507|FG005|NOT COMPLETED|Phase 1||0
6529260|NCT01601535|7450502|FG000|STARTED|Phase 2||0
6529261|NCT01601535|7450503|FG001|STARTED|Phase 2||0
6529262|NCT01601535|7450504|FG002|STARTED|Phase 2||0
6529263|NCT01601535|7450505|FG003|STARTED|Phase 2||0
6529264|NCT01601535|7450506|FG004|STARTED|Phase 2||20
6529265|NCT01601535|7450507|FG005|STARTED|Phase 2||12
6529266|NCT01601535|7450502|FG000|COMPLETED|Phase 2||0
6529267|NCT01601535|7450503|FG001|COMPLETED|Phase 2||0
6529268|NCT01601535|7450504|FG002|COMPLETED|Phase 2||0
6529269|NCT01601535|7450505|FG003|COMPLETED|Phase 2||0
6644193|NCT02360488|7572770|FG001|NOT COMPLETED|Overall Study||7
6644194|NCT02360605|7572778|FG000|STARTED|Overall Study||311
6644195|NCT02360605|7572779|FG001|STARTED|Overall Study||309
6529270|NCT01601535|7450506|FG004|COMPLETED|Phase 2||1
6529271|NCT01601535|7450507|FG005|COMPLETED|Phase 2||0
6529272|NCT01601535|7450502|FG000|NOT COMPLETED|Phase 2||0
6529273|NCT01601535|7450503|FG001|NOT COMPLETED|Phase 2||0
6529274|NCT01601535|7450504|FG002|NOT COMPLETED|Phase 2||0
6529275|NCT01601535|7450505|FG003|NOT COMPLETED|Phase 2||0
6529276|NCT01601535|7450506|FG004|NOT COMPLETED|Phase 2||19
6529277|NCT01601535|7450507|FG005|NOT COMPLETED|Phase 2||12
6529278|NCT01601626|7450533|FG000|STARTED|Overall Study||24
6529279|NCT01601626|7450534|FG001|STARTED|Overall Study||24
6529280|NCT01601626|7450535|FG002|STARTED|Overall Study||23
6529281|NCT01601626|7450533|FG000|COMPLETED|Overall Study||21
6529282|NCT01601626|7450534|FG001|COMPLETED|Overall Study||19
6529283|NCT01601626|7450535|FG002|COMPLETED|Overall Study||21
6529284|NCT01601626|7450533|FG000|NOT COMPLETED|Overall Study||3
6529285|NCT01601626|7450534|FG001|NOT COMPLETED|Overall Study||5
6529286|NCT01601626|7450535|FG002|NOT COMPLETED|Overall Study||2
6529287|NCT01601652|7450543|FG000|STARTED|Overall Study||12
6529288|NCT01601652|7450543|FG000|COMPLETED|Overall Study||11
6529289|NCT01601652|7450543|FG000|NOT COMPLETED|Overall Study||1
6529290|NCT01601691|7450547|FG000|STARTED|Overall Study||10
6529291|NCT01601691|7450547|FG000|COMPLETED|Overall Study||10
6529292|NCT01601691|7450547|FG000|NOT COMPLETED|Overall Study||0
6529293|NCT01601704|7450553|FG000|STARTED|Overall Study||4456
6529294|NCT01601704|7450554|FG001|STARTED|Overall Study||4454
6529295|NCT01601704|7450553|FG000|Treated|Overall Study||4455
6529296|NCT01601704|7450554|FG001|Treated|Overall Study||4450
6529297|NCT01601704|7450553|FG000|COMPLETED|Overall Study||4455
6529298|NCT01601704|7450554|FG001|COMPLETED|Overall Study||4450
6529299|NCT01601704|7450553|FG000|NOT COMPLETED|Overall Study||1
6529300|NCT01601704|7450554|FG001|NOT COMPLETED|Overall Study||4
6529301|NCT01601782|7450560|FG000|STARTED|Overall Study||16
6529302|NCT01601782|7450560|FG000|COMPLETED|Overall Study||16
6529303|NCT01601782|7450560|FG000|NOT COMPLETED|Overall Study||0
6529304|NCT01601821|7450566|FG000|STARTED|Overall Study||125
6529305|NCT01601821|7450567|FG001|STARTED|Overall Study||120
6529306|NCT01601821|7450566|FG000|COMPLETED|Overall Study||96
6529307|NCT01601821|7450567|FG001|COMPLETED|Overall Study||91
6529308|NCT01601821|7450566|FG000|NOT COMPLETED|Overall Study||29
6529309|NCT01601821|7450567|FG001|NOT COMPLETED|Overall Study||29
6529310|NCT01601847|7450575|FG000|STARTED|Overall Study||153
6529311|NCT01601847|7450576|FG001|STARTED|Overall Study||147
6529312|NCT01601847|7450575|FG000|COMPLETED|Overall Study||140
6529313|NCT01601847|7450576|FG001|COMPLETED|Overall Study||137
6529314|NCT01601847|7450575|FG000|NOT COMPLETED|Overall Study||13
6529315|NCT01601847|7450576|FG001|NOT COMPLETED|Overall Study||10
6529316|NCT01601860|7450584|FG000|STARTED|Overall Study||40
6529317|NCT01601860|7450585|FG001|STARTED|Overall Study||40
6529318|NCT01601860|7450584|FG000|COMPLETED|Overall Study||19
6529319|NCT01601860|7450585|FG001|COMPLETED|Overall Study||31
6529320|NCT01601860|7450584|FG000|NOT COMPLETED|Overall Study||21
6529321|NCT01601860|7450585|FG001|NOT COMPLETED|Overall Study||9
6529322|NCT01601873|7450594|FG000|STARTED|Overall Study||50
6529323|NCT01601873|7450595|FG001|STARTED|Overall Study||47
6529324|NCT01601873|7450594|FG000|COMPLETED|Overall Study||48
6529325|NCT01601873|7450595|FG001|COMPLETED|Overall Study||44
6529326|NCT01601873|7450594|FG000|NOT COMPLETED|Overall Study||2
6529327|NCT01601873|7450595|FG001|NOT COMPLETED|Overall Study||3
6529328|NCT01601977|7450601|FG000|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
6529329|NCT01601977|7450601|FG000|COMPLETED|Overall Study||10
6529330|NCT01601977|7450601|FG000|NOT COMPLETED|Overall Study||0
6529331|NCT01602068|7450609|FG000|STARTED|Overall Study|Day before surgery|23
6529332|NCT01602068|7450610|FG001|STARTED|Overall Study|Day before surgery|22
6529333|NCT01602068|7450609|FG000|COMPLETED|Overall Study||23
6529334|NCT01602068|7450610|FG001|COMPLETED|Overall Study||22
6529335|NCT01602068|7450609|FG000|NOT COMPLETED|Overall Study||0
6529336|NCT01602068|7450610|FG001|NOT COMPLETED|Overall Study||0
6529337|NCT01602120|7450620|FG000|STARTED|Overall Study||29
6529338|NCT01602120|7450621|FG001|STARTED|Overall Study||60
6529339|NCT01602120|7450622|FG002|STARTED|Overall Study||17
6529340|NCT01602120|7450623|FG003|STARTED|Overall Study||53
6529341|NCT01602120|7450620|FG000|COMPLETED|Overall Study||0
6529342|NCT01602120|7450621|FG001|COMPLETED|Overall Study||0
6529343|NCT01602120|7450622|FG002|COMPLETED|Overall Study||0
6529344|NCT01602120|7450623|FG003|COMPLETED|Overall Study||0
6529345|NCT01602120|7450620|FG000|NOT COMPLETED|Overall Study||29
6529346|NCT01602120|7450621|FG001|NOT COMPLETED|Overall Study||60
6529347|NCT01602120|7450622|FG002|NOT COMPLETED|Overall Study||17
6529348|NCT01602120|7450623|FG003|NOT COMPLETED|Overall Study||53
6529349|NCT01602172|7450638|FG000|STARTED|Overall Study||37
6529350|NCT01602172|7450639|FG001|STARTED|Overall Study||23
6529351|NCT01602172|7450640|FG002|STARTED|Overall Study||22
6529352|NCT01602172|7450638|FG000|COMPLETED|Overall Study||32
6529353|NCT01602172|7450639|FG001|COMPLETED|Overall Study||17
6529354|NCT01602172|7450640|FG002|COMPLETED|Overall Study||22
6529355|NCT01602172|7450638|FG000|NOT COMPLETED|Overall Study||5
6529356|NCT01602172|7450639|FG001|NOT COMPLETED|Overall Study||6
6529357|NCT01602172|7450640|FG002|NOT COMPLETED|Overall Study||0
6529358|NCT01602224|7450657|FG000|STARTED|Overall Study||74
6529359|NCT01602224|7450658|FG001|STARTED|Overall Study||74
6529360|NCT01602224|7450659|FG002|STARTED|Overall Study||72
6529361|NCT01602224|7450657|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
6529362|NCT01602224|7450658|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
6529363|NCT01602224|7450659|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
6529364|NCT01602224|7450657|FG000|COMPLETED|Overall Study||66
6529365|NCT01602224|7450658|FG001|COMPLETED|Overall Study||66
6529366|NCT01602224|7450659|FG002|COMPLETED|Overall Study||66
6529367|NCT01602224|7450657|FG000|NOT COMPLETED|Overall Study||8
6529368|NCT01602224|7450658|FG001|NOT COMPLETED|Overall Study||8
6529369|NCT01602224|7450659|FG002|NOT COMPLETED|Overall Study||6
6529370|NCT01602315|7450676|FG000|STARTED|Overall Study||16
6529371|NCT01602315|7450677|FG001|STARTED|Overall Study||5
6529372|NCT01602315|7450678|FG002|STARTED|Overall Study||18
6529373|NCT01602315|7450679|FG003|STARTED|Overall Study||6
6529374|NCT01602315|7450680|FG004|STARTED|Overall Study||71
6529375|NCT01602315|7450681|FG005|STARTED|Overall Study||35
6529376|NCT01602315|7450682|FG006|STARTED|Overall Study||29
6529377|NCT01602315|7450676|FG000|COMPLETED|Overall Study||0
6529378|NCT01602315|7450677|FG001|COMPLETED|Overall Study||0
6529379|NCT01602315|7450678|FG002|COMPLETED|Overall Study||0
6529380|NCT01602315|7450679|FG003|COMPLETED|Overall Study||0
6529381|NCT01602315|7450680|FG004|COMPLETED|Overall Study||0
6529382|NCT01602315|7450681|FG005|COMPLETED|Overall Study||0
6529383|NCT01602315|7450682|FG006|COMPLETED|Overall Study||0
6529384|NCT01602315|7450676|FG000|NOT COMPLETED|Overall Study||16
6529385|NCT01602315|7450677|FG001|NOT COMPLETED|Overall Study||5
6529386|NCT01602315|7450678|FG002|NOT COMPLETED|Overall Study||18
6529387|NCT01602315|7450679|FG003|NOT COMPLETED|Overall Study||6
6529388|NCT01602315|7450680|FG004|NOT COMPLETED|Overall Study||71
6529389|NCT01602315|7450681|FG005|NOT COMPLETED|Overall Study||35
6529390|NCT01602315|7450682|FG006|NOT COMPLETED|Overall Study||29
6529391|NCT01602341|7450720|FG000|STARTED|Overall Study||44
6529392|NCT01602341|7450721|FG001|STARTED|Overall Study||42
6529393|NCT01602341|7450720|FG000|COMPLETED|Overall Study||44
6529394|NCT01602341|7450721|FG001|COMPLETED|Overall Study||41
6529395|NCT01602341|7450720|FG000|NOT COMPLETED|Overall Study||0
6529396|NCT01602341|7450721|FG001|NOT COMPLETED|Overall Study||1
6529397|NCT01602419|7450731|FG000|STARTED|Overall Study||120
6529398|NCT01602419|7450731|FG000|SAF Population|Overall Study||111
6529399|NCT01602419|7450731|FG000|ITT Population|Overall Study||102
6529400|NCT01602419|7450731|FG000|EFF Population|Overall Study||91
6529401|NCT01602419|7450731|FG000|COMPLETED|Overall Study||91
6529402|NCT01602419|7450731|FG000|NOT COMPLETED|Overall Study||29
6529403|NCT01602484|7450778|FG000|STARTED|Overall Study||25
6529404|NCT01602484|7450779|FG001|STARTED|Overall Study||25
6529405|NCT01602484|7450778|FG000|COMPLETED|Overall Study||25
6529406|NCT01602484|7450779|FG001|COMPLETED|Overall Study||24
6529407|NCT01602484|7450778|FG000|NOT COMPLETED|Overall Study||0
6529408|NCT01602484|7450779|FG001|NOT COMPLETED|Overall Study||1
6529409|NCT01602510|7450785|FG000|STARTED|Open Label Phase||420
6529410|NCT01602510|7450786|FG001|STARTED|Open Label Phase||0
6529411|NCT01602510|7450787|FG002|STARTED|Open Label Phase||0
6529412|NCT01602510|7450785|FG000|COMPLETED|Open Label Phase||117
6529413|NCT01602510|7450786|FG001|COMPLETED|Open Label Phase||0
6529414|NCT01602510|7450787|FG002|COMPLETED|Open Label Phase||0
6529415|NCT01602510|7450785|FG000|NOT COMPLETED|Open Label Phase||303
6529416|NCT01602510|7450786|FG001|NOT COMPLETED|Open Label Phase||0
6529417|NCT01602510|7450787|FG002|NOT COMPLETED|Open Label Phase||0
6529418|NCT01602510|7450785|FG000|STARTED|Randomized Phase||0
6529419|NCT01602510|7450786|FG001|STARTED|Randomized Phase||133
6529420|NCT01602510|7450787|FG002|STARTED|Randomized Phase||131
6529421|NCT01602510|7450785|FG000|COMPLETED|Randomized Phase||0
6529422|NCT01602510|7450786|FG001|COMPLETED|Randomized Phase||59
6529423|NCT01602510|7450787|FG002|COMPLETED|Randomized Phase||58
6529424|NCT01602510|7450785|FG000|NOT COMPLETED|Randomized Phase||0
6529425|NCT01602510|7450786|FG001|NOT COMPLETED|Randomized Phase||74
6529426|NCT01602510|7450787|FG002|NOT COMPLETED|Randomized Phase||73
6529427|NCT01602549|7450795|FG000|STARTED|Overall Study||19
6529428|NCT01602549|7450796|FG001|STARTED|Overall Study||38
6529429|NCT01602549|7450795|FG000|COMPLETED|Overall Study||18
6529430|NCT01602549|7450796|FG001|COMPLETED|Overall Study||37
6529431|NCT01602549|7450795|FG000|NOT COMPLETED|Overall Study||1
6529432|NCT01602549|7450796|FG001|NOT COMPLETED|Overall Study||1
6529433|NCT01602562|7450806|FG000|STARTED|Overall Study||21
6529434|NCT01602562|7450807|FG001|STARTED|Overall Study||19
6529435|NCT01602562|7450806|FG000|COMPLETED|Overall Study||16
6529436|NCT01602562|7450807|FG001|COMPLETED|Overall Study||16
6529437|NCT01602562|7450806|FG000|NOT COMPLETED|Overall Study||5
6529438|NCT01602562|7450807|FG001|NOT COMPLETED|Overall Study||3
6529439|NCT01602614|7450818|FG000|STARTED|Overall Study||0
6529440|NCT01602614|7450819|FG001|STARTED|Overall Study||10
6529441|NCT01602614|7450820|FG002|STARTED|Overall Study||8
6529442|NCT01602614|7450821|FG003|STARTED|Overall Study||0
6529443|NCT01602614|7450818|FG000|COMPLETED|Overall Study||0
6529444|NCT01602614|7450819|FG001|COMPLETED|Overall Study||10
6529445|NCT01602614|7450820|FG002|COMPLETED|Overall Study||8
6529446|NCT01602614|7450821|FG003|COMPLETED|Overall Study||0
6529447|NCT01602614|7450818|FG000|NOT COMPLETED|Overall Study||0
6529448|NCT01602614|7450819|FG001|NOT COMPLETED|Overall Study||0
6529449|NCT01602614|7450820|FG002|NOT COMPLETED|Overall Study||0
6529450|NCT01602614|7450821|FG003|NOT COMPLETED|Overall Study||0
6529451|NCT01602679|7450837|FG000|STARTED|Overall Study||4
6529452|NCT01602679|7450838|FG001|STARTED|Overall Study||3
6529453|NCT01602679|7450837|FG000|COMPLETED|Overall Study||4
6529454|NCT01602679|7450838|FG001|COMPLETED|Overall Study||3
6529455|NCT01602679|7450837|FG000|NOT COMPLETED|Overall Study||0
6529456|NCT01602679|7450838|FG001|NOT COMPLETED|Overall Study||0
6529457|NCT01602692|7450846|FG000|STARTED|Overall Study||20
6529458|NCT01602692|7450847|FG001|STARTED|Overall Study||20
6529459|NCT01602692|7450846|FG000|COMPLETED|Overall Study||20
6529460|NCT01602692|7450847|FG001|COMPLETED|Overall Study||20
6529461|NCT01602692|7450846|FG000|NOT COMPLETED|Overall Study||0
6529462|NCT01602692|7450847|FG001|NOT COMPLETED|Overall Study||0
6529463|NCT01602731|7450857|FG000|STARTED|Overall Study||45
6529464|NCT01602731|7450857|FG000|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
6529465|NCT01602731|7450857|FG000|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
6529466|NCT01602731|7450857|FG000|COMPLETED|Overall Study||15
6529467|NCT01602731|7450857|FG000|NOT COMPLETED|Overall Study||30
6529468|NCT01602744|7450865|FG000|STARTED|Overall Study||176
6529469|NCT01602744|7450866|FG001|STARTED|Overall Study||183
6529470|NCT01602744|7450865|FG000|COMPLETED|Overall Study||146
6529471|NCT01602744|7450866|FG001|COMPLETED|Overall Study||160
6529472|NCT01602744|7450865|FG000|NOT COMPLETED|Overall Study||30
6529473|NCT01602744|7450866|FG001|NOT COMPLETED|Overall Study||23
6529474|NCT01602965|7450874|FG000|STARTED|Overall Study||20
6529475|NCT01602965|7450875|FG001|STARTED|Overall Study||20
6529476|NCT01602965|7450874|FG000|COMPLETED|Overall Study||16
6529477|NCT01602965|7450875|FG001|COMPLETED|Overall Study||18
6529478|NCT01602965|7450874|FG000|NOT COMPLETED|Overall Study||4
6529479|NCT01602965|7450875|FG001|NOT COMPLETED|Overall Study||2
6529480|NCT01603056|7450883|FG000|STARTED|Overall Study||413
6529481|NCT01603056|7450884|FG001|STARTED|Overall Study||204
6529482|NCT01603056|7450883|FG000|COMPLETED|Overall Study||379
6529483|NCT01603056|7450884|FG001|COMPLETED|Overall Study||190
6529484|NCT01603056|7450883|FG000|NOT COMPLETED|Overall Study||34
6529485|NCT01603056|7450884|FG001|NOT COMPLETED|Overall Study||14
6529486|NCT01603082|7450892|FG000|STARTED|Overall Study|Randomized|51
6529487|NCT01603082|7450893|FG001|STARTED|Overall Study|Randomized|49
6529488|NCT01603082|7450892|FG000|COMPLETED|Overall Study|Completed the study.|49
6529489|NCT01603082|7450893|FG001|COMPLETED|Overall Study|Completed the study|48
6529490|NCT01603082|7450892|FG000|NOT COMPLETED|Overall Study||2
6529491|NCT01603082|7450893|FG001|NOT COMPLETED|Overall Study||1
6529492|NCT01603277|7450901|FG000|STARTED|Overall Study||78
6529493|NCT01603277|7450902|FG001|STARTED|Overall Study||82
6529494|NCT01603277|7450901|FG000|COMPLETED|Overall Study||64
6529495|NCT01603277|7450902|FG001|COMPLETED|Overall Study||64
6529496|NCT01603277|7450901|FG000|NOT COMPLETED|Overall Study||14
6529497|NCT01603277|7450902|FG001|NOT COMPLETED|Overall Study||18
6529498|NCT01603355|7450908|FG000|STARTED|Overall Study||3
6529499|NCT01603355|7450908|FG000|COMPLETED|Overall Study||1
6529500|NCT01603355|7450908|FG000|NOT COMPLETED|Overall Study||2
6529501|NCT01603368|7450914|FG000|STARTED|Overall Study||68
6529502|NCT01603368|7450915|FG001|STARTED|Overall Study||66
6529503|NCT01603368|7450914|FG000|COMPLETED|Overall Study||68
6529504|NCT01603368|7450915|FG001|COMPLETED|Overall Study||66
6529505|NCT01603368|7450914|FG000|NOT COMPLETED|Overall Study||0
6529506|NCT01603368|7450915|FG001|NOT COMPLETED|Overall Study||0
6529507|NCT01603420|7450923|FG000|STARTED|Overall Study||1
6529508|NCT01603420|7450924|FG001|STARTED|Overall Study||1
6529509|NCT01603420|7450923|FG000|COMPLETED|Overall Study||1
6529510|NCT01603420|7450924|FG001|COMPLETED|Overall Study||1
6529511|NCT01603420|7450923|FG000|NOT COMPLETED|Overall Study||0
6529512|NCT01603420|7450924|FG001|NOT COMPLETED|Overall Study||0
6529513|NCT01603459|7450933|FG000|STARTED|Overall Study||155
6529514|NCT01603459|7450933|FG000|COMPLETED|Overall Study||137
6529515|NCT01603459|7450933|FG000|NOT COMPLETED|Overall Study||18
6529516|NCT01603602|7450958|FG000|STARTED|Overall Study||77
6529517|NCT01603602|7450959|FG001|STARTED|Overall Study||78
6529518|NCT01603602|7450960|FG002|STARTED|Overall Study||80
6529519|NCT01603602|7450958|FG000|COMPLETED|Overall Study||75
6529520|NCT01603602|7450959|FG001|COMPLETED|Overall Study||78
6529521|NCT01603602|7450960|FG002|COMPLETED|Overall Study||79
6529522|NCT01603602|7450958|FG000|NOT COMPLETED|Overall Study||2
6529523|NCT01603602|7450959|FG001|NOT COMPLETED|Overall Study||0
6529524|NCT01603602|7450960|FG002|NOT COMPLETED|Overall Study||1
6529525|NCT01603615|7450968|FG000|STARTED|Overall Study||220
6529526|NCT01603615|7450968|FG000|Safety Population (Treated)|Overall Study||213
6529527|NCT01603615|7450968|FG000|COMPLETED|Overall Study||186
6529528|NCT01603615|7450968|FG000|NOT COMPLETED|Overall Study||34
6529529|NCT01603628|7450975|FG000|STARTED|Overall Study||128
6529530|NCT01603628|7450976|FG001|STARTED|Overall Study||126
6529531|NCT01603628|7450977|FG002|STARTED|Overall Study||130
6529532|NCT01603628|7450975|FG000|Safety Population: Received Treatment|Overall Study||128
6529533|NCT01603628|7450976|FG001|Safety Population: Received Treatment|Overall Study||126
6529534|NCT01603628|7450977|FG002|Safety Population: Received Treatment|Overall Study||128
6529535|NCT01603628|7450975|FG000|COMPLETED|Overall Study||125
6529536|NCT01603628|7450976|FG001|COMPLETED|Overall Study||123
6529537|NCT01603628|7450977|FG002|COMPLETED|Overall Study||128
6529538|NCT01603628|7450975|FG000|NOT COMPLETED|Overall Study||3
6529539|NCT01603628|7450976|FG001|NOT COMPLETED|Overall Study||3
6529540|NCT01603628|7450977|FG002|NOT COMPLETED|Overall Study||2
6529541|NCT01603641|7450985|FG000|STARTED|Overall Study||370
6529542|NCT01603641|7450985|FG000|Safety Population (Treated)|Overall Study||367
6529543|NCT01603641|7450985|FG000|Modified Intent-to-treat Population|Overall Study||366
6529544|NCT01603641|7450985|FG000|COMPLETED|Overall Study||335
6529545|NCT01603641|7450985|FG000|NOT COMPLETED|Overall Study||35
6529546|NCT01603875|7450992|FG000|STARTED|Overall Study||35
6529547|NCT01603875|7450993|FG001|STARTED|Overall Study||35
6529548|NCT01603875|7450994|FG002|STARTED|Overall Study||35
6529549|NCT01603875|7450992|FG000|COMPLETED|Overall Study||28
6529550|NCT01603875|7450993|FG001|COMPLETED|Overall Study||27
6529551|NCT01603875|7450994|FG002|COMPLETED|Overall Study||26
6529552|NCT01603875|7450992|FG000|NOT COMPLETED|Overall Study||7
6529553|NCT01603875|7450993|FG001|NOT COMPLETED|Overall Study||8
6529554|NCT01603875|7450994|FG002|NOT COMPLETED|Overall Study||9
6529555|NCT01603940|7451004|FG000|STARTED|Overall Study||16
6529556|NCT01603940|7451005|FG001|STARTED|Overall Study||14
6529557|NCT01603940|7451004|FG000|COMPLETED|Overall Study||16
6529558|NCT01603940|7451005|FG001|COMPLETED|Overall Study||14
6529559|NCT01603940|7451004|FG000|NOT COMPLETED|Overall Study||0
6529560|NCT01603940|7451005|FG001|NOT COMPLETED|Overall Study||0
6529561|NCT01604109|7451013|FG000|STARTED|Overall Study||150
6529562|NCT01604109|7451014|FG001|STARTED|Overall Study||146
6529563|NCT01604109|7451013|FG000|COMPLETED|Overall Study||117
6529564|NCT01604109|7451014|FG001|COMPLETED|Overall Study||112
6529565|NCT01604109|7451013|FG000|NOT COMPLETED|Overall Study||33
6529566|NCT01604109|7451014|FG001|NOT COMPLETED|Overall Study||34
6529567|NCT01604122|7451022|FG000|STARTED|Overall Study||60
6529568|NCT01604122|7451023|FG001|STARTED|Overall Study||32
6529569|NCT01604122|7451022|FG000|COMPLETED|Overall Study||60
6529570|NCT01604122|7451023|FG001|COMPLETED|Overall Study||32
6529571|NCT01604122|7451022|FG000|NOT COMPLETED|Overall Study||0
6529572|NCT01604122|7451023|FG001|NOT COMPLETED|Overall Study||0
6529573|NCT01604265|7451032|FG000|STARTED|Overall Study||34
6529574|NCT01604265|7451033|FG001|STARTED|Overall Study||32
6529575|NCT01604265|7451032|FG000|COMPLETED|Overall Study||32
6529576|NCT01604265|7451033|FG001|COMPLETED|Overall Study||32
6529577|NCT01604265|7451032|FG000|NOT COMPLETED|Overall Study||2
6529578|NCT01604265|7451033|FG001|NOT COMPLETED|Overall Study||0
6529579|NCT01604278|7451041|FG000|STARTED|Overall Study||226
6529580|NCT01604278|7451042|FG001|STARTED|Overall Study||223
6529581|NCT01604278|7451041|FG000|Safety Set|Overall Study||226
6529582|NCT01604278|7451042|FG001|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
6529583|NCT01604278|7451041|FG000|Full Analysis Set|Overall Study||226
6529584|NCT01604278|7451042|FG001|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
6529585|NCT01604278|7451041|FG000|COMPLETED|Overall Study||212
6529586|NCT01604278|7451042|FG001|COMPLETED|Overall Study||210
6529587|NCT01604278|7451041|FG000|NOT COMPLETED|Overall Study||14
6529588|NCT01604278|7451042|FG001|NOT COMPLETED|Overall Study||13
6529589|NCT01604291|7451052|FG000|STARTED|Overall Study||311
6529590|NCT01604291|7451053|FG001|STARTED|Overall Study||443
6529591|NCT01604291|7451054|FG002|STARTED|Overall Study||193
6529592|NCT01604291|7451055|FG003|STARTED|Overall Study||44
6529593|NCT01604291|7451052|FG000|COMPLETED|Overall Study||311
6529594|NCT01604291|7451053|FG001|COMPLETED|Overall Study||443
6529595|NCT01604291|7451054|FG002|COMPLETED|Overall Study||193
6529596|NCT01604291|7451055|FG003|COMPLETED|Overall Study||44
6529597|NCT01604291|7451052|FG000|NOT COMPLETED|Overall Study||0
6529598|NCT01604291|7451053|FG001|NOT COMPLETED|Overall Study||0
6529599|NCT01604291|7451054|FG002|NOT COMPLETED|Overall Study||0
6529600|NCT01604291|7451055|FG003|NOT COMPLETED|Overall Study||0
6529601|NCT01604343|7451076|FG000|STARTED|Prior to W52 Administration(Through W52)||556
6529602|NCT01604343|7451077|FG001|STARTED|Prior to W52 Administration(Through W52)||0
6529603|NCT01604343|7451078|FG002|STARTED|Prior to W52 Administration(Through W52)||557
6529604|NCT01604343|7451079|FG003|STARTED|Prior to W52 Administration(Through W52)||0
6529605|NCT01604343|7451080|FG004|STARTED|Prior to W52 Administration(Through W52)||557
6529606|NCT01604343|7451076|FG000|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)|Out of 187, 95 were re-randomized to sirukumab 50 mg and 92 were re-randomized to 100 mg group.|187
6529607|NCT01604343|7451077|FG001|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
6529608|NCT01604343|7451078|FG002|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
6529609|NCT01604343|7451079|FG003|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
6529610|NCT01604343|7451080|FG004|Participants Re-randomized at Week 18|Prior to W52 Administration(Through W52)||0
6529611|NCT01604343|7451076|FG000|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)|Out of 24, 12 were re-randomized to sirukumab 50 mg and 12 were re-randomized to 100 mg group.|24
6529612|NCT01604343|7451077|FG001|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
6529613|NCT01604343|7451078|FG002|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
6529614|NCT01604343|7451079|FG003|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
6529615|NCT01604343|7451080|FG004|Participants Re-randomized at Week 40|Prior to W52 Administration(Through W52)||0
6529616|NCT01604343|7451076|FG000|COMPLETED|Prior to W52 Administration(Through W52)||458
6529617|NCT01604343|7451077|FG001|COMPLETED|Prior to W52 Administration(Through W52)||0
6529618|NCT01604343|7451078|FG002|COMPLETED|Prior to W52 Administration(Through W52)||481
6529619|NCT01604343|7451079|FG003|COMPLETED|Prior to W52 Administration(Through W52)||0
6529620|NCT01604343|7451080|FG004|COMPLETED|Prior to W52 Administration(Through W52)||470
6529621|NCT01604343|7451076|FG000|NOT COMPLETED|Prior to W52 Administration(Through W52)||98
6529622|NCT01604343|7451077|FG001|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
6529623|NCT01604343|7451078|FG002|NOT COMPLETED|Prior to W52 Administration(Through W52)||76
6529624|NCT01604343|7451079|FG003|NOT COMPLETED|Prior to W52 Administration(Through W52)||0
6529625|NCT01604343|7451080|FG004|NOT COMPLETED|Prior to W52 Administration(Through W52)||87
6529626|NCT01604343|7451076|FG000|STARTED|Week 52 to Week 104||0
6529627|NCT01604343|7451077|FG001|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (95), 40 (12) and 52 were included|243
6529628|NCT01604343|7451078|FG002|STARTED|Week 52 to Week 104||481
6529629|NCT01604343|7451079|FG003|STARTED|Week 52 to Week 104|Participants re-randomized at Week 18 (92), 40 (12) and 52 were included|241
6529630|NCT01604343|7451080|FG004|STARTED|Week 52 to Week 104||470
6529631|NCT01604343|7451076|FG000|Treated|Week 52 to Week 104||0
6529632|NCT01604343|7451077|FG001|Treated|Week 52 to Week 104||242
6529633|NCT01604343|7451078|FG002|Treated|Week 52 to Week 104||481
6529634|NCT01604343|7451079|FG003|Treated|Week 52 to Week 104||241
6529635|NCT01604343|7451080|FG004|Treated|Week 52 to Week 104||470
6529636|NCT01604343|7451076|FG000|COMPLETED|Week 52 to Week 104||0
6529637|NCT01604343|7451077|FG001|COMPLETED|Week 52 to Week 104||200
6529638|NCT01604343|7451078|FG002|COMPLETED|Week 52 to Week 104||414
6529639|NCT01604343|7451079|FG003|COMPLETED|Week 52 to Week 104||195
6529640|NCT01604343|7451080|FG004|COMPLETED|Week 52 to Week 104||429
6529641|NCT01604343|7451076|FG000|NOT COMPLETED|Week 52 to Week 104||0
6529642|NCT01604343|7451077|FG001|NOT COMPLETED|Week 52 to Week 104||43
6529643|NCT01604343|7451078|FG002|NOT COMPLETED|Week 52 to Week 104||67
6529644|NCT01604343|7451079|FG003|NOT COMPLETED|Week 52 to Week 104||46
6529645|NCT01604343|7451080|FG004|NOT COMPLETED|Week 52 to Week 104||41
6529646|NCT01604343|7451076|FG000|STARTED|Safety Follow-up Period (Week 104-120)||109
6529647|NCT01604343|7451077|FG001|STARTED|Safety Follow-up Period (Week 104-120)||27
6529648|NCT01604343|7451078|FG002|STARTED|Safety Follow-up Period (Week 104-120)||105
6529649|NCT01604343|7451079|FG003|STARTED|Safety Follow-up Period (Week 104-120)||36
6529650|NCT01604343|7451080|FG004|STARTED|Safety Follow-up Period (Week 104-120)||114
6529651|NCT01604343|7451076|FG000|Safety Population|Safety Follow-up Period (Week 104-120)||109
6529652|NCT01604343|7451077|FG001|Safety Population|Safety Follow-up Period (Week 104-120)||26
6529653|NCT01604343|7451078|FG002|Safety Population|Safety Follow-up Period (Week 104-120)||105
6529654|NCT01604343|7451079|FG003|Safety Population|Safety Follow-up Period (Week 104-120)||36
6529655|NCT01604343|7451080|FG004|Safety Population|Safety Follow-up Period (Week 104-120)||114
6529656|NCT01604343|7451076|FG000|COMPLETED|Safety Follow-up Period (Week 104-120)||79
6529657|NCT01604343|7451077|FG001|COMPLETED|Safety Follow-up Period (Week 104-120)||20
6529658|NCT01604343|7451078|FG002|COMPLETED|Safety Follow-up Period (Week 104-120)||72
6529659|NCT01604343|7451079|FG003|COMPLETED|Safety Follow-up Period (Week 104-120)||26
6529660|NCT01604343|7451080|FG004|COMPLETED|Safety Follow-up Period (Week 104-120)||85
6529661|NCT01604343|7451076|FG000|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||30
6529662|NCT01604343|7451077|FG001|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||7
6529663|NCT01604343|7451078|FG002|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||33
6529664|NCT01604343|7451079|FG003|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||10
6529665|NCT01604343|7451080|FG004|NOT COMPLETED|Safety Follow-up Period (Week 104-120)||29
6529666|NCT01604408|7451092|FG000|STARTED|Treatment Period 1||102
6529667|NCT01604408|7451093|FG001|STARTED|Treatment Period 1||99
6529668|NCT01604408|7451092|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||102
6529669|NCT01604408|7451093|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||99
6529670|NCT01604408|7451092|FG000|COMPLETED|Treatment Period 1||102
6529671|NCT01604408|7451093|FG001|COMPLETED|Treatment Period 1||98
6529672|NCT01604408|7451092|FG000|NOT COMPLETED|Treatment Period 1||0
6529673|NCT01604408|7451093|FG001|NOT COMPLETED|Treatment Period 1||1
6529674|NCT01604408|7451092|FG000|STARTED|Treatment Period 2||102
6529675|NCT01604408|7451093|FG001|STARTED|Treatment Period 2||98
6529676|NCT01604408|7451092|FG000|COMPLETED|Treatment Period 2||100
6529677|NCT01604408|7451093|FG001|COMPLETED|Treatment Period 2||96
6529678|NCT01604408|7451092|FG000|NOT COMPLETED|Treatment Period 2||2
6529679|NCT01604408|7451093|FG001|NOT COMPLETED|Treatment Period 2||2
6529680|NCT01604408|7451092|FG000|STARTED|Treatment Period 3||100
6529681|NCT01604408|7451093|FG001|STARTED|Treatment Period 3||96
6529682|NCT01604408|7451092|FG000|COMPLETED|Treatment Period 3||95
6529683|NCT01604408|7451093|FG001|COMPLETED|Treatment Period 3||91
6529684|NCT01604408|7451092|FG000|NOT COMPLETED|Treatment Period 3||5
6529685|NCT01604408|7451093|FG001|NOT COMPLETED|Treatment Period 3||5
6529686|NCT01604408|7451092|FG000|STARTED|Treatment Period 4||95
6529687|NCT01604408|7451093|FG001|STARTED|Treatment Period 4||91
6529688|NCT01604408|7451092|FG000|COMPLETED|Treatment Period 4||92
6529689|NCT01604408|7451093|FG001|COMPLETED|Treatment Period 4||89
6529690|NCT01604408|7451092|FG000|NOT COMPLETED|Treatment Period 4||3
6529691|NCT01604408|7451093|FG001|NOT COMPLETED|Treatment Period 4||2
6529692|NCT01604408|7451092|FG000|STARTED|Treatment Period 5||92
6529693|NCT01604408|7451093|FG001|STARTED|Treatment Period 5||89
6529694|NCT01604408|7451092|FG000|COMPLETED|Treatment Period 5||88
6529695|NCT01604408|7451093|FG001|COMPLETED|Treatment Period 5||89
6529696|NCT01604408|7451092|FG000|NOT COMPLETED|Treatment Period 5||4
6529697|NCT01604408|7451093|FG001|NOT COMPLETED|Treatment Period 5||0
6529698|NCT01604408|7451092|FG000|STARTED|Treatment Period 6||88
6529699|NCT01604408|7451093|FG001|STARTED|Treatment Period 6||89
6529700|NCT01604408|7451092|FG000|COMPLETED|Treatment Period 6||86
6529701|NCT01604408|7451093|FG001|COMPLETED|Treatment Period 6||87
6529702|NCT01604408|7451092|FG000|NOT COMPLETED|Treatment Period 6||2
6529703|NCT01604408|7451093|FG001|NOT COMPLETED|Treatment Period 6||2
6529704|NCT01604408|7451092|FG000|STARTED|Observation Period||86
6529705|NCT01604408|7451093|FG001|STARTED|Observation Period||87
6529706|NCT01604408|7451092|FG000|COMPLETED|Observation Period||85
6529707|NCT01604408|7451093|FG001|COMPLETED|Observation Period||84
6529708|NCT01604408|7451092|FG000|NOT COMPLETED|Observation Period||1
6529709|NCT01604408|7451093|FG001|NOT COMPLETED|Observation Period||3
6529710|NCT01604772|7451099|FG000|STARTED|Overall Study||16
6529711|NCT01604772|7451099|FG000|COMPLETED|Overall Study||16
6529712|NCT01604772|7451099|FG000|NOT COMPLETED|Overall Study||0
6529713|NCT01604785|7451106|FG000|STARTED|Overall Study||37
6529714|NCT01604785|7451107|FG001|STARTED|Overall Study||37
6529715|NCT01604785|7451106|FG000|COMPLETED|Overall Study||30
6529716|NCT01604785|7451107|FG001|COMPLETED|Overall Study||36
6529717|NCT01604785|7451106|FG000|NOT COMPLETED|Overall Study||7
6529718|NCT01604785|7451107|FG001|NOT COMPLETED|Overall Study||1
6529719|NCT01604824|7451117|FG000|STARTED|Double-blind (DB) Period||6
6529720|NCT01604824|7451118|FG001|STARTED|Double-blind (DB) Period||7
6529721|NCT01604824|7451119|FG002|STARTED|Double-blind (DB) Period||5
6529722|NCT01604824|7451120|FG003|STARTED|Double-blind (DB) Period||5
6529723|NCT01604824|7451121|FG004|STARTED|Double-blind (DB) Period||0
6529724|NCT01604824|7451122|FG005|STARTED|Double-blind (DB) Period||0
6529725|NCT01604824|7451117|FG000|Completed DB Period (Day 99)|Double-blind (DB) Period||6
6529726|NCT01604824|7451118|FG001|Completed DB Period (Day 99)|Double-blind (DB) Period||7
6529727|NCT01604824|7451119|FG002|Completed DB Period (Day 99)|Double-blind (DB) Period||5
6529728|NCT01604824|7451120|FG003|Completed DB Period (Day 99)|Double-blind (DB) Period||5
6529729|NCT01604824|7451121|FG004|Completed DB Period (Day 99)|Double-blind (DB) Period||0
6529730|NCT01604824|7451122|FG005|Completed DB Period (Day 99)|Double-blind (DB) Period||0
6529731|NCT01604824|7451117|FG000|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||6
6529732|NCT01604824|7451118|FG001|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||7
6529733|NCT01604824|7451119|FG002|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
6529734|NCT01604824|7451120|FG003|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||5
6529735|NCT01604824|7451121|FG004|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
6529736|NCT01604824|7451122|FG005|Completed DB Follow-up (Day 155)|Double-blind (DB) Period||0
6644196|NCT02360605|7572778|FG000|COMPLETED|Overall Study||300
6644197|NCT02360605|7572779|FG001|COMPLETED|Overall Study||291
6644198|NCT02360605|7572778|FG000|NOT COMPLETED|Overall Study||11
6644199|NCT02360605|7572779|FG001|NOT COMPLETED|Overall Study||18
6644200|NCT02360631|7572789|FG000|STARTED|Overall Study||300
6644201|NCT02360631|7572790|FG001|STARTED|Overall Study||200
6529737|NCT01604824|7451117|FG000|COMPLETED|Double-blind (DB) Period||6
6529738|NCT01604824|7451118|FG001|COMPLETED|Double-blind (DB) Period||7
6529739|NCT01604824|7451119|FG002|COMPLETED|Double-blind (DB) Period||5
6529740|NCT01604824|7451120|FG003|COMPLETED|Double-blind (DB) Period||5
6529741|NCT01604824|7451121|FG004|COMPLETED|Double-blind (DB) Period||0
6529742|NCT01604824|7451122|FG005|COMPLETED|Double-blind (DB) Period||0
6529743|NCT01604824|7451117|FG000|NOT COMPLETED|Double-blind (DB) Period||0
6529744|NCT01604824|7451118|FG001|NOT COMPLETED|Double-blind (DB) Period||0
6529745|NCT01604824|7451119|FG002|NOT COMPLETED|Double-blind (DB) Period||0
6529746|NCT01604824|7451120|FG003|NOT COMPLETED|Double-blind (DB) Period||0
6529747|NCT01604824|7451121|FG004|NOT COMPLETED|Double-blind (DB) Period||0
6529748|NCT01604824|7451122|FG005|NOT COMPLETED|Double-blind (DB) Period||0
6529749|NCT01604824|7451117|FG000|STARTED|Open-label Extension (OLE) Period||0
6529750|NCT01604824|7451118|FG001|STARTED|Open-label Extension (OLE) Period||0
6529751|NCT01604824|7451119|FG002|STARTED|Open-label Extension (OLE) Period||0
6529752|NCT01604824|7451120|FG003|STARTED|Open-label Extension (OLE) Period||0
6529753|NCT01604824|7451121|FG004|STARTED|Open-label Extension (OLE) Period|Completed DB Period (Day 99)|13
6529754|NCT01604824|7451122|FG005|STARTED|Open-label Extension (OLE) Period|Completed DB follow-up (Day 155)|10
6529755|NCT01604824|7451117|FG000|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
6529756|NCT01604824|7451118|FG001|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
6529757|NCT01604824|7451119|FG002|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
6529758|NCT01604824|7451120|FG003|Started Open-label Extension Period|Open-label Extension (OLE) Period||0
6529759|NCT01604824|7451121|FG004|Started Open-label Extension Period|Open-label Extension (OLE) Period|Two subjects chose not to enter OLE period|11
6529760|NCT01604824|7451122|FG005|Started Open-label Extension Period|Open-label Extension (OLE) Period||10
6529761|NCT01604824|7451117|FG000|Completed Study|Open-label Extension (OLE) Period||0
6529762|NCT01604824|7451118|FG001|Completed Study|Open-label Extension (OLE) Period||0
6529763|NCT01604824|7451119|FG002|Completed Study|Open-label Extension (OLE) Period||0
6529764|NCT01604824|7451120|FG003|Completed Study|Open-label Extension (OLE) Period||0
6529765|NCT01604824|7451121|FG004|Completed Study|Open-label Extension (OLE) Period||10
6529766|NCT01604824|7451122|FG005|Completed Study|Open-label Extension (OLE) Period||10
6529767|NCT01604824|7451117|FG000|COMPLETED|Open-label Extension (OLE) Period||0
6529768|NCT01604824|7451118|FG001|COMPLETED|Open-label Extension (OLE) Period||0
6529769|NCT01604824|7451119|FG002|COMPLETED|Open-label Extension (OLE) Period||0
6529770|NCT01604824|7451120|FG003|COMPLETED|Open-label Extension (OLE) Period||0
6529771|NCT01604824|7451121|FG004|COMPLETED|Open-label Extension (OLE) Period||10
6529772|NCT01604824|7451122|FG005|COMPLETED|Open-label Extension (OLE) Period||10
6644202|NCT02360631|7572789|FG000|Week 12|Overall Study||249
6644203|NCT02360631|7572790|FG001|Week 12|Overall Study||165
6644204|NCT02360631|7572789|FG000|COMPLETED|Overall Study||267
6644205|NCT02360631|7572790|FG001|COMPLETED|Overall Study||174
6529773|NCT01604824|7451117|FG000|NOT COMPLETED|Open-label Extension (OLE) Period||0
6529774|NCT01604824|7451118|FG001|NOT COMPLETED|Open-label Extension (OLE) Period||0
6529775|NCT01604824|7451119|FG002|NOT COMPLETED|Open-label Extension (OLE) Period||0
6529776|NCT01604824|7451120|FG003|NOT COMPLETED|Open-label Extension (OLE) Period||0
6529777|NCT01604824|7451121|FG004|NOT COMPLETED|Open-label Extension (OLE) Period||3
6529778|NCT01604824|7451122|FG005|NOT COMPLETED|Open-label Extension (OLE) Period||0
6529779|NCT01604850|7451136|FG000|STARTED|Overall Study||103
6529780|NCT01604850|7451137|FG001|STARTED|Overall Study||99
6529781|NCT01604850|7451136|FG000|Enrolled and Treated|Overall Study||103
6529782|NCT01604850|7451137|FG001|Enrolled and Treated|Overall Study||98
6529783|NCT01604850|7451136|FG000|COMPLETED|Overall Study||51
6529784|NCT01604850|7451137|FG001|COMPLETED|Overall Study||69
6529785|NCT01604850|7451136|FG000|NOT COMPLETED|Overall Study||52
6529786|NCT01604850|7451137|FG001|NOT COMPLETED|Overall Study||30
6529787|NCT01604941|7451145|FG000|STARTED|Overall Study||11
6529788|NCT01604941|7451146|FG001|STARTED|Overall Study||4
6529789|NCT01604941|7451147|FG002|STARTED|Overall Study||3
6529790|NCT01604941|7451148|FG003|STARTED|Overall Study||3
6529791|NCT01604941|7451149|FG004|STARTED|Overall Study||4
6529792|NCT01604941|7451150|FG005|STARTED|Overall Study||7
6529793|NCT01604941|7451145|FG000|COMPLETED|Overall Study||0
6529794|NCT01604941|7451146|FG001|COMPLETED|Overall Study||0
6529795|NCT01604941|7451147|FG002|COMPLETED|Overall Study||0
6529796|NCT01604941|7451148|FG003|COMPLETED|Overall Study||0
6529797|NCT01604941|7451149|FG004|COMPLETED|Overall Study||3
6529798|NCT01604941|7451150|FG005|COMPLETED|Overall Study||0
6529799|NCT01604941|7451145|FG000|NOT COMPLETED|Overall Study||11
6529800|NCT01604941|7451146|FG001|NOT COMPLETED|Overall Study||4
6529801|NCT01604941|7451147|FG002|NOT COMPLETED|Overall Study||3
6529802|NCT01604941|7451148|FG003|NOT COMPLETED|Overall Study||3
6529803|NCT01604941|7451149|FG004|NOT COMPLETED|Overall Study||1
6529804|NCT01604941|7451150|FG005|NOT COMPLETED|Overall Study||7
6529805|NCT01605032|7451156|FG000|STARTED|Overall Study||19
6529806|NCT01605032|7451156|FG000|COMPLETED|Overall Study||18
6529807|NCT01605032|7451156|FG000|NOT COMPLETED|Overall Study||1
6529808|NCT01605071|7451162|FG000|STARTED|Overall Study||27
6529809|NCT01605071|7451163|FG001|STARTED|Overall Study||26
6529810|NCT01605071|7451162|FG000|COMPLETED|Overall Study||24
6529811|NCT01605071|7451163|FG001|COMPLETED|Overall Study||24
6529812|NCT01605071|7451162|FG000|NOT COMPLETED|Overall Study||3
6529813|NCT01605071|7451163|FG001|NOT COMPLETED|Overall Study||2
6529814|NCT01605097|7451171|FG000|STARTED|Overall Study|One patient consented but was ineligible due to lack of lesion visible on mpMRI|26
6529815|NCT01605097|7451171|FG000|COMPLETED|Overall Study||25
6529816|NCT01605097|7451171|FG000|NOT COMPLETED|Overall Study||1
6529817|NCT01605136|7451178|FG000|STARTED|Study Period||48
6529818|NCT01605136|7451179|FG001|STARTED|Study Period||45
6529819|NCT01605136|7451178|FG000|COMPLETED|Study Period||45
6529820|NCT01605136|7451179|FG001|COMPLETED|Study Period||42
6529821|NCT01605136|7451178|FG000|NOT COMPLETED|Study Period||3
6529822|NCT01605136|7451179|FG001|NOT COMPLETED|Study Period||3
6529823|NCT01605136|7451178|FG000|STARTED|Safety Follow-Up Period||45
6529824|NCT01605136|7451179|FG001|STARTED|Safety Follow-Up Period||42
6529825|NCT01605136|7451178|FG000|COMPLETED|Safety Follow-Up Period||44
6529826|NCT01605136|7451179|FG001|COMPLETED|Safety Follow-Up Period||40
6529827|NCT01605136|7451178|FG000|NOT COMPLETED|Safety Follow-Up Period||1
6529828|NCT01605136|7451179|FG001|NOT COMPLETED|Safety Follow-Up Period||2
6529829|NCT01605227|7451187|FG000|STARTED|Overall Study||682
6529830|NCT01605227|7451188|FG001|STARTED|Overall Study||346
6529831|NCT01605227|7451187|FG000|COMPLETED|Overall Study||61
6529832|NCT01605227|7451188|FG001|COMPLETED|Overall Study||17
6529833|NCT01605227|7451187|FG000|NOT COMPLETED|Overall Study||621
6529834|NCT01605227|7451188|FG001|NOT COMPLETED|Overall Study||329
6529835|NCT01605292|7451196|FG000|STARTED|Overall Study||351
6529836|NCT01605292|7451197|FG001|STARTED|Overall Study||347
6529837|NCT01605292|7451196|FG000|COMPLETED|Overall Study||351
6529838|NCT01605292|7451197|FG001|COMPLETED|Overall Study||347
6529839|NCT01605292|7451196|FG000|NOT COMPLETED|Overall Study||0
6529840|NCT01605292|7451197|FG001|NOT COMPLETED|Overall Study||0
6529841|NCT01605396|7451205|FG000|STARTED|Overall Study||40
6529842|NCT01605396|7451206|FG001|STARTED|Overall Study||40
6529843|NCT01605396|7451205|FG000|Treated|Overall Study||39
6529844|NCT01605396|7451206|FG001|Treated|Overall Study||40
6529845|NCT01605396|7451205|FG000|COMPLETED|Overall Study||0
6529846|NCT01605396|7451206|FG001|COMPLETED|Overall Study||0
6529847|NCT01605396|7451205|FG000|NOT COMPLETED|Overall Study||40
6529848|NCT01605396|7451206|FG001|NOT COMPLETED|Overall Study||40
6529849|NCT01605435|7451212|FG000|STARTED|Overall Study||2
6529850|NCT01605435|7451213|FG001|STARTED|Overall Study||3
6529851|NCT01605435|7451212|FG000|COMPLETED|Overall Study||2
6529852|NCT01605435|7451213|FG001|COMPLETED|Overall Study||3
6529853|NCT01605435|7451212|FG000|NOT COMPLETED|Overall Study||0
6529854|NCT01605435|7451213|FG001|NOT COMPLETED|Overall Study||0
6529855|NCT01605461|7451230|FG000|STARTED|Overall Study||12
6529856|NCT01605461|7451230|FG000|COMPLETED|Overall Study||8
6529857|NCT01605461|7451230|FG000|NOT COMPLETED|Overall Study||4
6529858|NCT01605539|7451236|FG000|STARTED|Overall Study||3
6529859|NCT01605539|7451237|FG001|STARTED|Overall Study||3
6529860|NCT01605539|7451238|FG002|STARTED|Overall Study||4
6529861|NCT01605539|7451236|FG000|COMPLETED|Overall Study||3
6529862|NCT01605539|7451237|FG001|COMPLETED|Overall Study||2
6529863|NCT01605539|7451238|FG002|COMPLETED|Overall Study||4
6529864|NCT01605539|7451236|FG000|NOT COMPLETED|Overall Study||0
6529865|NCT01605539|7451237|FG001|NOT COMPLETED|Overall Study||1
6529866|NCT01605539|7451238|FG002|NOT COMPLETED|Overall Study||0
6529867|NCT01605552|7451249|FG000|STARTED|Overall Study||13
6529868|NCT01605552|7451250|FG001|STARTED|Overall Study||16
6529869|NCT01605552|7451249|FG000|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
6529870|NCT01605552|7451250|FG001|COMPLETED|Overall Study||14
6529871|NCT01605552|7451249|FG000|NOT COMPLETED|Overall Study||6
6529872|NCT01605552|7451250|FG001|NOT COMPLETED|Overall Study||2
6529873|NCT01605669|7451256|FG000|STARTED|Overall Study||50
6529874|NCT01605669|7451256|FG000|COMPLETED|Overall Study||50
6529875|NCT01605669|7451256|FG000|NOT COMPLETED|Overall Study||0
6529876|NCT01605799|7451263|FG000|STARTED|Overall Study||17
6529877|NCT01605799|7451264|FG001|STARTED|Overall Study||16
6529878|NCT01605799|7451263|FG000|COMPLETED|Overall Study||15
6529879|NCT01605799|7451264|FG001|COMPLETED|Overall Study||15
6529880|NCT01605799|7451263|FG000|NOT COMPLETED|Overall Study||2
6529881|NCT01605799|7451264|FG001|NOT COMPLETED|Overall Study||1
6529882|NCT01605825|7451272|FG000|STARTED|Overall Study||55
6529883|NCT01605825|7451273|FG001|STARTED|Overall Study||28
6529884|NCT01605825|7451272|FG000|COMPLETED|Overall Study||45
6529885|NCT01605825|7451273|FG001|COMPLETED|Overall Study||25
6529886|NCT01605825|7451272|FG000|NOT COMPLETED|Overall Study||10
6529887|NCT01605825|7451273|FG001|NOT COMPLETED|Overall Study||3
6529888|NCT01605877|7451279|FG000|STARTED|Overall Study||64
6529889|NCT01605877|7451279|FG000|COMPLETED|Overall Study||63
6529890|NCT01605877|7451279|FG000|NOT COMPLETED|Overall Study||1
6529891|NCT01605890|7451301|FG000|STARTED|Overall Study||30
6529892|NCT01605890|7451301|FG000|COMPLETED|Overall Study||28
6529893|NCT01605890|7451301|FG000|NOT COMPLETED|Overall Study||2
6529894|NCT01605903|7451307|FG000|STARTED|Overall Study||345
6529895|NCT01605903|7451308|FG001|STARTED|Overall Study||343
6529896|NCT01605903|7451307|FG000|COMPLETED|Overall Study||345
6529897|NCT01605903|7451308|FG001|COMPLETED|Overall Study||343
6529898|NCT01605903|7451307|FG000|NOT COMPLETED|Overall Study||0
6529899|NCT01605903|7451308|FG001|NOT COMPLETED|Overall Study||0
6529900|NCT01605916|7451319|FG000|STARTED|Overall Study||4
6529901|NCT01605916|7451320|FG001|STARTED|Overall Study||4
6529902|NCT01605916|7451321|FG002|STARTED|Overall Study||4
6529903|NCT01605916|7451322|FG003|STARTED|Overall Study||6
6529904|NCT01605916|7451323|FG004|STARTED|Overall Study||7
6529905|NCT01605916|7451319|FG000|COMPLETED|Overall Study||0
6529906|NCT01605916|7451320|FG001|COMPLETED|Overall Study||0
6529907|NCT01605916|7451321|FG002|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
6529908|NCT01605916|7451322|FG003|COMPLETED|Overall Study||0
6529909|NCT01605916|7451323|FG004|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
6529910|NCT01605916|7451319|FG000|NOT COMPLETED|Overall Study||4
6529911|NCT01605916|7451320|FG001|NOT COMPLETED|Overall Study||4
6529912|NCT01605916|7451321|FG002|NOT COMPLETED|Overall Study||3
6529913|NCT01605916|7451322|FG003|NOT COMPLETED|Overall Study||6
6529914|NCT01605916|7451323|FG004|NOT COMPLETED|Overall Study||6
6529915|NCT01605942|7451338|FG000|STARTED|Overall Study||6
6529916|NCT01605942|7451339|FG001|STARTED|Overall Study||2
6529917|NCT01605942|7451338|FG000|COMPLETED|Overall Study||6
6529918|NCT01605942|7451339|FG001|COMPLETED|Overall Study||2
6529919|NCT01605942|7451338|FG000|NOT COMPLETED|Overall Study||0
6529920|NCT01605942|7451339|FG001|NOT COMPLETED|Overall Study||0
6529921|NCT01606007|7451348|FG000|STARTED|Overall Study||176
6529922|NCT01606007|7451349|FG001|STARTED|Overall Study||179
6529923|NCT01606007|7451350|FG002|STARTED|Overall Study||179
6529924|NCT01606007|7451348|FG000|COMPLETED|Overall Study||161
6529925|NCT01606007|7451349|FG001|COMPLETED|Overall Study||160
6529926|NCT01606007|7451350|FG002|COMPLETED|Overall Study||169
6529927|NCT01606007|7451348|FG000|NOT COMPLETED|Overall Study||15
6529928|NCT01606007|7451349|FG001|NOT COMPLETED|Overall Study||19
6529929|NCT01606007|7451350|FG002|NOT COMPLETED|Overall Study||10
6529930|NCT01606124|7451360|FG000|STARTED|Overall Study||19
6529931|NCT01606124|7451361|FG001|STARTED|Overall Study||20
6529932|NCT01606124|7451360|FG000|COMPLETED|Overall Study||19
6529933|NCT01606124|7451361|FG001|COMPLETED|Overall Study||20
6529934|NCT01606124|7451360|FG000|NOT COMPLETED|Overall Study||0
6529935|NCT01606124|7451361|FG001|NOT COMPLETED|Overall Study||0
6529936|NCT01606137|7451367|FG000|STARTED|Overall Study||507
6529937|NCT01606137|7451367|FG000|COMPLETED|Overall Study||245
6529938|NCT01606137|7451367|FG000|NOT COMPLETED|Overall Study||262
6529939|NCT01606176|7451373|FG000|STARTED|Overall Study||36
6529940|NCT01606176|7451374|FG001|STARTED|Overall Study||34
6529941|NCT01606176|7451373|FG000|COMPLETED|Overall Study||32
6529942|NCT01606176|7451374|FG001|COMPLETED|Overall Study||31
6529943|NCT01606176|7451373|FG000|NOT COMPLETED|Overall Study||4
6529944|NCT01606176|7451374|FG001|NOT COMPLETED|Overall Study||3
6529945|NCT01606189|7451380|FG000|STARTED|First Intenvention (14-20 Days)||8
6529946|NCT01606189|7451381|FG001|STARTED|First Intenvention (14-20 Days)||8
6529947|NCT01606189|7451382|FG002|STARTED|First Intenvention (14-20 Days)||8
6529948|NCT01606189|7451383|FG003|STARTED|First Intenvention (14-20 Days)||8
6529949|NCT01606189|7451384|FG004|STARTED|First Intenvention (14-20 Days)||8
6529950|NCT01606189|7451385|FG005|STARTED|First Intenvention (14-20 Days)||8
6529951|NCT01606189|7451380|FG000|COMPLETED|First Intenvention (14-20 Days)||8
6529952|NCT01606189|7451381|FG001|COMPLETED|First Intenvention (14-20 Days)||8
6529953|NCT01606189|7451382|FG002|COMPLETED|First Intenvention (14-20 Days)||8
6529954|NCT01606189|7451383|FG003|COMPLETED|First Intenvention (14-20 Days)||8
6529955|NCT01606189|7451384|FG004|COMPLETED|First Intenvention (14-20 Days)||8
6529956|NCT01606189|7451385|FG005|COMPLETED|First Intenvention (14-20 Days)||8
6529957|NCT01606189|7451380|FG000|NOT COMPLETED|First Intenvention (14-20 Days)||0
6529958|NCT01606189|7451381|FG001|NOT COMPLETED|First Intenvention (14-20 Days)||0
6529959|NCT01606189|7451382|FG002|NOT COMPLETED|First Intenvention (14-20 Days)||0
6529960|NCT01606189|7451383|FG003|NOT COMPLETED|First Intenvention (14-20 Days)||0
6529961|NCT01606189|7451384|FG004|NOT COMPLETED|First Intenvention (14-20 Days)||0
6529962|NCT01606189|7451385|FG005|NOT COMPLETED|First Intenvention (14-20 Days)||0
6529963|NCT01606189|7451380|FG000|STARTED|Second Intenvention (14-20 Days)||8
6529964|NCT01606189|7451381|FG001|STARTED|Second Intenvention (14-20 Days)||8
6529965|NCT01606189|7451382|FG002|STARTED|Second Intenvention (14-20 Days)||8
6529966|NCT01606189|7451383|FG003|STARTED|Second Intenvention (14-20 Days)||8
6529967|NCT01606189|7451384|FG004|STARTED|Second Intenvention (14-20 Days)||8
6529968|NCT01606189|7451385|FG005|STARTED|Second Intenvention (14-20 Days)||8
6529969|NCT01606189|7451380|FG000|COMPLETED|Second Intenvention (14-20 Days)||8
6529970|NCT01606189|7451381|FG001|COMPLETED|Second Intenvention (14-20 Days)||8
6529971|NCT01606189|7451382|FG002|COMPLETED|Second Intenvention (14-20 Days)||8
6529972|NCT01606189|7451383|FG003|COMPLETED|Second Intenvention (14-20 Days)||8
6529973|NCT01606189|7451384|FG004|COMPLETED|Second Intenvention (14-20 Days)||8
6529974|NCT01606189|7451385|FG005|COMPLETED|Second Intenvention (14-20 Days)||7
6529975|NCT01606189|7451380|FG000|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6529976|NCT01606189|7451381|FG001|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6529977|NCT01606189|7451382|FG002|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6529978|NCT01606189|7451383|FG003|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6529979|NCT01606189|7451384|FG004|NOT COMPLETED|Second Intenvention (14-20 Days)||0
6529980|NCT01606189|7451385|FG005|NOT COMPLETED|Second Intenvention (14-20 Days)||1
6529981|NCT01606189|7451380|FG000|STARTED|Third Intenvention (14-20 Days)||8
6529982|NCT01606189|7451381|FG001|STARTED|Third Intenvention (14-20 Days)||8
6529983|NCT01606189|7451382|FG002|STARTED|Third Intenvention (14-20 Days)||8
6529984|NCT01606189|7451383|FG003|STARTED|Third Intenvention (14-20 Days)||8
6529985|NCT01606189|7451384|FG004|STARTED|Third Intenvention (14-20 Days)||8
6529986|NCT01606189|7451385|FG005|STARTED|Third Intenvention (14-20 Days)||7
6529987|NCT01606189|7451380|FG000|COMPLETED|Third Intenvention (14-20 Days)||8
6529988|NCT01606189|7451381|FG001|COMPLETED|Third Intenvention (14-20 Days)||8
6529989|NCT01606189|7451382|FG002|COMPLETED|Third Intenvention (14-20 Days)||8
6529990|NCT01606189|7451383|FG003|COMPLETED|Third Intenvention (14-20 Days)||8
6529991|NCT01606189|7451384|FG004|COMPLETED|Third Intenvention (14-20 Days)||8
6529992|NCT01606189|7451385|FG005|COMPLETED|Third Intenvention (14-20 Days)||6
6529993|NCT01606189|7451380|FG000|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6529994|NCT01606189|7451381|FG001|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6529995|NCT01606189|7451382|FG002|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6529996|NCT01606189|7451383|FG003|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6529997|NCT01606189|7451384|FG004|NOT COMPLETED|Third Intenvention (14-20 Days)||0
6529998|NCT01606189|7451385|FG005|NOT COMPLETED|Third Intenvention (14-20 Days)||1
6529999|NCT01606202|7451395|FG000|STARTED|Overall Study||56
6530000|NCT01606202|7451396|FG001|STARTED|Overall Study||60
6530001|NCT01606202|7451395|FG000|COMPLETED|Overall Study||49
6530002|NCT01606202|7451396|FG001|COMPLETED|Overall Study||57
6530003|NCT01606202|7451395|FG000|NOT COMPLETED|Overall Study||7
6530004|NCT01606202|7451396|FG001|NOT COMPLETED|Overall Study||3
6530005|NCT01606228|7451402|FG000|STARTED|Overall Study||188
6530006|NCT01606228|7451402|FG000|COMPLETED|Overall Study||159
6530007|NCT01606228|7451402|FG000|NOT COMPLETED|Overall Study||29
6530008|NCT01606254|7451410|FG000|STARTED|Overall Study||14
6530009|NCT01606254|7451411|FG001|STARTED|Overall Study||14
6530010|NCT01606254|7451412|FG002|STARTED|Overall Study||14
6530011|NCT01606254|7451413|FG003|STARTED|Overall Study||14
6530012|NCT01606254|7451410|FG000|COMPLETED|Overall Study||12
6530013|NCT01606254|7451411|FG001|COMPLETED|Overall Study||10
6530014|NCT01606254|7451412|FG002|COMPLETED|Overall Study||14
6530015|NCT01606254|7451413|FG003|COMPLETED|Overall Study||11
6530016|NCT01606254|7451410|FG000|NOT COMPLETED|Overall Study||2
6530017|NCT01606254|7451411|FG001|NOT COMPLETED|Overall Study||4
6530018|NCT01606254|7451412|FG002|NOT COMPLETED|Overall Study||0
6530019|NCT01606254|7451413|FG003|NOT COMPLETED|Overall Study||3
6530020|NCT01606306|7451429|FG000|STARTED|Overall Study||50
6530021|NCT01606306|7451430|FG001|STARTED|Overall Study||49
6530022|NCT01606306|7451431|FG002|STARTED|Overall Study||51
6530023|NCT01606306|7451432|FG003|STARTED|Overall Study||51
6530024|NCT01606306|7451433|FG004|STARTED|Overall Study||52
6530025|NCT01606306|7451434|FG005|STARTED|Overall Study||47
6530026|NCT01606306|7451429|FG000|Completed First Treatment Period|Overall Study||43
6530027|NCT01606306|7451430|FG001|Completed First Treatment Period|Overall Study||47
6530028|NCT01606306|7451431|FG002|Completed First Treatment Period|Overall Study||47
6530029|NCT01606306|7451432|FG003|Completed First Treatment Period|Overall Study||45
6530030|NCT01606306|7451433|FG004|Completed First Treatment Period|Overall Study||47
6530031|NCT01606306|7451434|FG005|Completed First Treatment Period|Overall Study||44
6530032|NCT01606306|7451429|FG000|Completed Second Treatment Period|Overall Study||41
6530033|NCT01606306|7451430|FG001|Completed Second Treatment Period|Overall Study||38
6530034|NCT01606306|7451431|FG002|Completed Second Treatment Period|Overall Study||43
6530035|NCT01606306|7451432|FG003|Completed Second Treatment Period|Overall Study||44
6530036|NCT01606306|7451433|FG004|Completed Second Treatment Period|Overall Study||46
6530037|NCT01606306|7451434|FG005|Completed Second Treatment Period|Overall Study||41
6530038|NCT01606306|7451429|FG000|Completed Third Treatment Period|Overall Study||35
6530039|NCT01606306|7451430|FG001|Completed Third Treatment Period|Overall Study||39
6644206|NCT02360631|7572789|FG000|NOT COMPLETED|Overall Study||33
6644207|NCT02360631|7572790|FG001|NOT COMPLETED|Overall Study||26
6644208|NCT02360774|7572798|FG000|STARTED|Overall Study||15
6644209|NCT02360774|7572799|FG001|STARTED|Overall Study||15
6644210|NCT02360774|7572798|FG000|COMPLETED|Overall Study||12
6644211|NCT02360774|7572799|FG001|COMPLETED|Overall Study||13
6644212|NCT02360774|7572798|FG000|NOT COMPLETED|Overall Study||3
6644213|NCT02360774|7572799|FG001|NOT COMPLETED|Overall Study||2
6644214|NCT02360995|7572810|FG000|STARTED|Overall Study||43
6644215|NCT02360995|7572811|FG001|STARTED|Overall Study||43
6644216|NCT02360995|7572812|FG002|STARTED|Overall Study||43
6644217|NCT02360995|7572810|FG000|COMPLETED|Overall Study||41
6644218|NCT02360995|7572811|FG001|COMPLETED|Overall Study||42
6644219|NCT02360995|7572812|FG002|COMPLETED|Overall Study||41
6530040|NCT01606306|7451431|FG002|Completed Third Treatment Period|Overall Study||37
6530041|NCT01606306|7451432|FG003|Completed Third Treatment Period|Overall Study||38
6530042|NCT01606306|7451433|FG004|Completed Third Treatment Period|Overall Study||41
6530043|NCT01606306|7451434|FG005|Completed Third Treatment Period|Overall Study||36
6530044|NCT01606306|7451429|FG000|COMPLETED|Overall Study||35
6530045|NCT01606306|7451430|FG001|COMPLETED|Overall Study||39
6530046|NCT01606306|7451431|FG002|COMPLETED|Overall Study||37
6530047|NCT01606306|7451432|FG003|COMPLETED|Overall Study||38
6530048|NCT01606306|7451433|FG004|COMPLETED|Overall Study||41
6530049|NCT01606306|7451434|FG005|COMPLETED|Overall Study||36
6530050|NCT01606306|7451429|FG000|NOT COMPLETED|Overall Study||15
6530051|NCT01606306|7451430|FG001|NOT COMPLETED|Overall Study||10
6530052|NCT01606306|7451431|FG002|NOT COMPLETED|Overall Study||14
6530053|NCT01606306|7451432|FG003|NOT COMPLETED|Overall Study||13
6530054|NCT01606306|7451433|FG004|NOT COMPLETED|Overall Study||11
6530055|NCT01606306|7451434|FG005|NOT COMPLETED|Overall Study||11
6530056|NCT01606319|7451442|FG000|STARTED|Overall Study||150
6530057|NCT01606319|7451443|FG001|STARTED|Overall Study||150
6530058|NCT01606319|7451442|FG000|COMPLETED|Overall Study||116
6530059|NCT01606319|7451443|FG001|COMPLETED|Overall Study||110
6530060|NCT01606319|7451442|FG000|NOT COMPLETED|Overall Study||34
6530061|NCT01606319|7451443|FG001|NOT COMPLETED|Overall Study||40
6530062|NCT01606670|7451449|FG000|STARTED|Overall Study||93
6530063|NCT01606670|7451449|FG000|Safety Set|Overall Study||93
6530064|NCT01606670|7451449|FG000|Full Analysis Set|Overall Study||70
6530065|NCT01606670|7451449|FG000|COMPLETED|Overall Study||77
6530066|NCT01606670|7451449|FG000|NOT COMPLETED|Overall Study||16
6561932|NCT01797705|7484864|FG000|NOT COMPLETED|Overall Study||5
6561933|NCT01797731|7484870|FG000|STARTED|Overall Study||50
6561934|NCT01797731|7484871|FG001|STARTED|Overall Study||50
6561935|NCT01797731|7484870|FG000|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
6561936|NCT01797731|7484871|FG001|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
6561937|NCT01797731|7484870|FG000|NOT COMPLETED|Overall Study||3
6561938|NCT01797731|7484871|FG001|NOT COMPLETED|Overall Study||3
6561939|NCT01797783|7484879|FG000|STARTED|Overall Study||52
6561940|NCT01797783|7484880|FG001|STARTED|Overall Study||27
6561941|NCT01797783|7484879|FG000|COMPLETED|Overall Study||50
6561942|NCT01797783|7484880|FG001|COMPLETED|Overall Study||26
6561943|NCT01797783|7484879|FG000|NOT COMPLETED|Overall Study||2
6561944|NCT01797783|7484880|FG001|NOT COMPLETED|Overall Study||1
6561945|NCT01797822|7484894|FG000|STARTED|Overall Study||20
6561946|NCT01797822|7484894|FG000|COMPLETED|Overall Study|The protocol is now closed.|20
6561947|NCT01797822|7484894|FG000|NOT COMPLETED|Overall Study||0
6561948|NCT01797835|7484902|FG000|STARTED|Overall Study||153
6561949|NCT01797835|7484903|FG001|STARTED|Overall Study||141
6561950|NCT01797835|7484902|FG000|COMPLETED|Overall Study||122
6561951|NCT01797835|7484903|FG001|COMPLETED|Overall Study||114
6561952|NCT01797835|7484902|FG000|NOT COMPLETED|Overall Study||31
6561953|NCT01797835|7484903|FG001|NOT COMPLETED|Overall Study||27
6561954|NCT01797965|7484913|FG000|STARTED|Overall Study||597
6561955|NCT01797965|7484914|FG001|STARTED|Overall Study||607
6561956|NCT01797965|7484915|FG002|STARTED|Overall Study||70
6561957|NCT01797965|7484916|FG003|STARTED|Overall Study||227
6561958|NCT01797965|7484913|FG000|COMPLETED|Overall Study||48
6561959|NCT01797965|7484914|FG001|COMPLETED|Overall Study||38
6561960|NCT01797965|7484915|FG002|COMPLETED|Overall Study||62
6561961|NCT01797965|7484916|FG003|COMPLETED|Overall Study||154
6561962|NCT01797965|7484913|FG000|NOT COMPLETED|Overall Study||549
6561963|NCT01797965|7484914|FG001|NOT COMPLETED|Overall Study||569
6561964|NCT01797965|7484915|FG002|NOT COMPLETED|Overall Study||8
6561965|NCT01797965|7484916|FG003|NOT COMPLETED|Overall Study||73
6561966|NCT01798056|7484929|FG000|STARTED|Overall Study||117
6561967|NCT01798056|7484930|FG001|STARTED|Overall Study||115
6561968|NCT01798056|7484929|FG000|COMPLETED|Overall Study||90
6561969|NCT01798056|7484930|FG001|COMPLETED|Overall Study||90
6561970|NCT01798056|7484929|FG000|NOT COMPLETED|Overall Study||27
6561971|NCT01798056|7484930|FG001|NOT COMPLETED|Overall Study||25
6561972|NCT01798134|7484938|FG000|STARTED|Overall Study||25
6561973|NCT01798134|7484938|FG000|COMPLETED|Overall Study||9
6561974|NCT01798134|7484938|FG000|NOT COMPLETED|Overall Study||16
6561975|NCT01798186|7484946|FG000|STARTED|Overall Study||6
6561976|NCT01798186|7484947|FG001|STARTED|Overall Study||6
6561977|NCT01798186|7484948|FG002|STARTED|Overall Study||6
6561978|NCT01798186|7484949|FG003|STARTED|Overall Study||8
6561979|NCT01798186|7484946|FG000|COMPLETED|Overall Study||6
6561980|NCT01798186|7484947|FG001|COMPLETED|Overall Study||6
6561981|NCT01798186|7484948|FG002|COMPLETED|Overall Study||6
6561982|NCT01798186|7484949|FG003|COMPLETED|Overall Study||8
6561983|NCT01798186|7484946|FG000|NOT COMPLETED|Overall Study||0
6561984|NCT01798186|7484947|FG001|NOT COMPLETED|Overall Study||0
6561985|NCT01798186|7484948|FG002|NOT COMPLETED|Overall Study||0
6644220|NCT02360995|7572810|FG000|NOT COMPLETED|Overall Study||2
6644221|NCT02360995|7572811|FG001|NOT COMPLETED|Overall Study||1
6644222|NCT02360995|7572812|FG002|NOT COMPLETED|Overall Study||2
6644223|NCT02361216|7572822|FG000|STARTED|3 Day Treatment and 8 Week Follow/up||552
6644224|NCT02361216|7572823|FG001|STARTED|3 Day Treatment and 8 Week Follow/up||177
6644225|NCT02361216|7572822|FG000|COMPLETED|3 Day Treatment and 8 Week Follow/up||541
6644226|NCT02361216|7572823|FG001|COMPLETED|3 Day Treatment and 8 Week Follow/up||158
6644227|NCT02361216|7572822|FG000|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||11
6644228|NCT02361216|7572823|FG001|NOT COMPLETED|3 Day Treatment and 8 Week Follow/up||19
6644229|NCT02361216|7572822|FG000|STARTED|12-month Follow-up||541
6644230|NCT02361216|7572823|FG001|STARTED|12-month Follow-up|1 of the 158 subjects did not receive treatment and was also excluded from the 12-month follow-up.|157
6644231|NCT02361216|7572822|FG000|COMPLETED|12-month Follow-up||489
6644232|NCT02361216|7572823|FG001|COMPLETED|12-month Follow-up||130
6644233|NCT02361216|7572822|FG000|NOT COMPLETED|12-month Follow-up||52
6644234|NCT02361216|7572823|FG001|NOT COMPLETED|12-month Follow-up||27
6644235|NCT02361307|7572834|FG000|STARTED|Overall Study||18
6644236|NCT02361307|7572835|FG001|STARTED|Overall Study||18
6644237|NCT02361307|7572834|FG000|COMPLETED|Overall Study||18
6644238|NCT02361307|7572835|FG001|COMPLETED|Overall Study||17
6644239|NCT02361307|7572834|FG000|NOT COMPLETED|Overall Study||0
6644240|NCT02361307|7572835|FG001|NOT COMPLETED|Overall Study||1
6644241|NCT02361476|7572843|FG000|STARTED|Overall Study||191
6644242|NCT02361476|7572844|FG001|STARTED|Overall Study||188
6644243|NCT02361476|7572843|FG000|COMPLETED|Overall Study||191
6644244|NCT02361476|7572844|FG001|COMPLETED|Overall Study||188
6644245|NCT02361476|7572843|FG000|NOT COMPLETED|Overall Study||0
6644246|NCT02361476|7572844|FG001|NOT COMPLETED|Overall Study||0
6644247|NCT02361736|7572852|FG000|STARTED|Overall Study||60
6644248|NCT02361736|7572853|FG001|STARTED|Overall Study||60
6644249|NCT02361736|7572852|FG000|COMPLETED|Overall Study||59
6644250|NCT02361736|7572853|FG001|COMPLETED|Overall Study||59
6644251|NCT02361736|7572852|FG000|NOT COMPLETED|Overall Study||1
6644252|NCT02361736|7572853|FG001|NOT COMPLETED|Overall Study||1
6644253|NCT02361762|7572861|FG000|STARTED|Overall Study||35
6644254|NCT02361762|7572862|FG001|STARTED|Overall Study||35
6644255|NCT02361762|7572861|FG000|COMPLETED|Overall Study||35
6644256|NCT02361762|7572862|FG001|COMPLETED|Overall Study||33
6644257|NCT02361762|7572861|FG000|NOT COMPLETED|Overall Study||0
6530067|NCT01606735|7451456|FG000|STARTED|Overall Study||58
6530068|NCT01606735|7451457|FG001|STARTED|Overall Study||56
6530069|NCT01606735|7451458|FG002|STARTED|Overall Study||58
6530070|NCT01606735|7451456|FG000|COMPLETED|Overall Study||58
6530071|NCT01606735|7451457|FG001|COMPLETED|Overall Study||56
6530072|NCT01606735|7451458|FG002|COMPLETED|Overall Study||58
6530073|NCT01606735|7451456|FG000|NOT COMPLETED|Overall Study||0
6530074|NCT01606735|7451457|FG001|NOT COMPLETED|Overall Study||0
6530075|NCT01606735|7451458|FG002|NOT COMPLETED|Overall Study||0
6530076|NCT01606748|7451468|FG000|STARTED|Overall Study||18
6530077|NCT01606748|7451469|FG001|STARTED|Overall Study||17
6530078|NCT01606748|7451468|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
6530079|NCT01606748|7451469|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
6530080|NCT01606748|7451468|FG000|COMPLETED|Overall Study||15
6530081|NCT01606748|7451469|FG001|COMPLETED|Overall Study||17
6530082|NCT01606748|7451468|FG000|NOT COMPLETED|Overall Study||3
6530083|NCT01606748|7451469|FG001|NOT COMPLETED|Overall Study||0
6530084|NCT01606761|7451490|FG000|STARTED|Prior to Week 24||294
6530085|NCT01606761|7451491|FG001|STARTED|Prior to Week 24||292
6530086|NCT01606761|7451492|FG002|STARTED|Prior to Week 24||292
6530087|NCT01606761|7451493|FG003|STARTED|Prior to Week 24||0
6530088|NCT01606761|7451494|FG004|STARTED|Prior to Week 24||0
6530089|NCT01606761|7451490|FG000|Participants Re-randomized at Week 18|Prior to Week 24|Out of 94, 46 were re-randomized to sirukumab 50 mg and 48 were re-randomized to 100 mg group.|94
6530090|NCT01606761|7451491|FG001|Participants Re-randomized at Week 18|Prior to Week 24||0
6530091|NCT01606761|7451492|FG002|Participants Re-randomized at Week 18|Prior to Week 24||0
6530092|NCT01606761|7451493|FG003|Participants Re-randomized at Week 18|Prior to Week 24||0
6530093|NCT01606761|7451494|FG004|Participants Re-randomized at Week 18|Prior to Week 24||0
6530094|NCT01606761|7451490|FG000|COMPLETED|Prior to Week 24||252
6530095|NCT01606761|7451491|FG001|COMPLETED|Prior to Week 24||237
6530096|NCT01606761|7451492|FG002|COMPLETED|Prior to Week 24||245
6530097|NCT01606761|7451493|FG003|COMPLETED|Prior to Week 24||0
6530098|NCT01606761|7451494|FG004|COMPLETED|Prior to Week 24||0
6530099|NCT01606761|7451490|FG000|NOT COMPLETED|Prior to Week 24||42
6530100|NCT01606761|7451491|FG001|NOT COMPLETED|Prior to Week 24||55
6530101|NCT01606761|7451492|FG002|NOT COMPLETED|Prior to Week 24||47
6530102|NCT01606761|7451493|FG003|NOT COMPLETED|Prior to Week 24||0
6530103|NCT01606761|7451494|FG004|NOT COMPLETED|Prior to Week 24||0
6530104|NCT01606761|7451490|FG000|STARTED|Week 24 to Week 52||0
6530105|NCT01606761|7451491|FG001|STARTED|Week 24 to Week 52||237
6530106|NCT01606761|7451492|FG002|STARTED|Week 24 to Week 52||245
6530107|NCT01606761|7451493|FG003|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (46) and Week 24 (80) were included.|126
6530108|NCT01606761|7451494|FG004|STARTED|Week 24 to Week 52|Participants re-randomized at Week 18 (48) and Week 24 (78) were included.|126
6530109|NCT01606761|7451490|FG000|Treated|Week 24 to Week 52||0
6644258|NCT02361762|7572862|FG001|NOT COMPLETED|Overall Study||2
6644259|NCT02362048|7572870|FG000|STARTED|Overall Study|37 enrolled but only 35 received study medication.|37
6644260|NCT02362048|7572871|FG001|STARTED|Overall Study|40 enrolled but only 38 received study medication.|40
6530110|NCT01606761|7451491|FG001|Treated|Week 24 to Week 52||237
6530111|NCT01606761|7451492|FG002|Treated|Week 24 to Week 52||245
6530112|NCT01606761|7451493|FG003|Treated|Week 24 to Week 52||124
6530113|NCT01606761|7451494|FG004|Treated|Week 24 to Week 52||126
6530114|NCT01606761|7451490|FG000|COMPLETED|Week 24 to Week 52||0
6530115|NCT01606761|7451491|FG001|COMPLETED|Week 24 to Week 52||204
6644261|NCT02362048|7572870|FG000|Enrolled|Overall Study||37
6644262|NCT02362048|7572871|FG001|Enrolled|Overall Study||40
6644263|NCT02362048|7572870|FG000|Received Study Medication|Overall Study||35
6644264|NCT02362048|7572871|FG001|Received Study Medication|Overall Study||38
6644265|NCT02362048|7572870|FG000|Discontinued Study|Overall Study||37
6644266|NCT02362048|7572871|FG001|Discontinued Study|Overall Study||40
6530116|NCT01606761|7451492|FG002|COMPLETED|Week 24 to Week 52||212
6530117|NCT01606761|7451493|FG003|COMPLETED|Week 24 to Week 52||109
6530118|NCT01606761|7451494|FG004|COMPLETED|Week 24 to Week 52||106
6530119|NCT01606761|7451490|FG000|NOT COMPLETED|Week 24 to Week 52||0
6530120|NCT01606761|7451491|FG001|NOT COMPLETED|Week 24 to Week 52||33
6530121|NCT01606761|7451492|FG002|NOT COMPLETED|Week 24 to Week 52||33
6530122|NCT01606761|7451493|FG003|NOT COMPLETED|Week 24 to Week 52||17
6530123|NCT01606761|7451494|FG004|NOT COMPLETED|Week 24 to Week 52||20
6530124|NCT01606761|7451490|FG000|STARTED|Safety Follow-up Period (Week 52-68)||28
6530125|NCT01606761|7451491|FG001|STARTED|Safety Follow-up Period (Week 52-68)||65
6530126|NCT01606761|7451492|FG002|STARTED|Safety Follow-up Period (Week 52-68)||62
6530127|NCT01606761|7451493|FG003|STARTED|Safety Follow-up Period (Week 52-68)||9
6530128|NCT01606761|7451494|FG004|STARTED|Safety Follow-up Period (Week 52-68)||19
6530129|NCT01606761|7451490|FG000|Safety Population|Safety Follow-up Period (Week 52-68)||28
6530130|NCT01606761|7451491|FG001|Safety Population|Safety Follow-up Period (Week 52-68)||65
6530131|NCT01606761|7451492|FG002|Safety Population|Safety Follow-up Period (Week 52-68)||62
6530132|NCT01606761|7451493|FG003|Safety Population|Safety Follow-up Period (Week 52-68)||7
6530133|NCT01606761|7451494|FG004|Safety Population|Safety Follow-up Period (Week 52-68)||19
6530134|NCT01606761|7451490|FG000|COMPLETED|Safety Follow-up Period (Week 52-68)||24
6530135|NCT01606761|7451491|FG001|COMPLETED|Safety Follow-up Period (Week 52-68)||55
6530136|NCT01606761|7451492|FG002|COMPLETED|Safety Follow-up Period (Week 52-68)||45
6530137|NCT01606761|7451493|FG003|COMPLETED|Safety Follow-up Period (Week 52-68)||7
6530138|NCT01606761|7451494|FG004|COMPLETED|Safety Follow-up Period (Week 52-68)||11
6530139|NCT01606761|7451490|FG000|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||4
6530140|NCT01606761|7451491|FG001|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||10
6530141|NCT01606761|7451492|FG002|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||17
6530142|NCT01606761|7451493|FG003|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||2
6530143|NCT01606761|7451494|FG004|NOT COMPLETED|Safety Follow-up Period (Week 52-68)||8
6530144|NCT01606787|7451511|FG000|STARTED|Overall Study||105
6530145|NCT01606787|7451512|FG001|STARTED|Overall Study||105
6530146|NCT01606787|7451511|FG000|COMPLETED|Overall Study||101
6530147|NCT01606787|7451512|FG001|COMPLETED|Overall Study||98
6530148|NCT01606787|7451511|FG000|NOT COMPLETED|Overall Study||4
6530149|NCT01606787|7451512|FG001|NOT COMPLETED|Overall Study||7
6530150|NCT01606800|7451520|FG000|STARTED|Overall Study||22
6530151|NCT01606800|7451521|FG001|STARTED|Overall Study||23
6530152|NCT01606800|7451520|FG000|Treated|Overall Study||22
6530153|NCT01606800|7451521|FG001|Treated|Overall Study||23
6530154|NCT01606800|7451520|FG000|COMPLETED|Overall Study||17
6530155|NCT01606800|7451521|FG001|COMPLETED|Overall Study||21
6530156|NCT01606800|7451520|FG000|NOT COMPLETED|Overall Study||5
6530157|NCT01606800|7451521|FG001|NOT COMPLETED|Overall Study||2
6530158|NCT01606852|7451529|FG000|STARTED|Overall Study||7
6530159|NCT01606852|7451530|FG001|STARTED|Overall Study||8
6530160|NCT01606852|7451529|FG000|COMPLETED|Overall Study||7
6530161|NCT01606852|7451530|FG001|COMPLETED|Overall Study||8
6530162|NCT01606852|7451529|FG000|NOT COMPLETED|Overall Study||0
6530163|NCT01606852|7451530|FG001|NOT COMPLETED|Overall Study||0
6530164|NCT01607073|7451536|FG000|STARTED|Overall Study||2
6530165|NCT01607073|7451536|FG000|COMPLETED|Overall Study||1
6530166|NCT01607073|7451536|FG000|NOT COMPLETED|Overall Study||1
6530167|NCT01607112|7451545|FG000|STARTED|Overall Study||60
6530168|NCT01607112|7451546|FG001|STARTED|Overall Study||59
6530169|NCT01607112|7451545|FG000|COMPLETED|Overall Study||60
6530170|NCT01607112|7451546|FG001|COMPLETED|Overall Study||59
6530171|NCT01607112|7451545|FG000|NOT COMPLETED|Overall Study||0
6530172|NCT01607112|7451546|FG001|NOT COMPLETED|Overall Study||0
6530173|NCT01607203|7451558|FG000|STARTED|Overall Study||59
6530174|NCT01607203|7451559|FG001|STARTED|Overall Study||61
6530175|NCT01607203|7451558|FG000|COMPLETED|Overall Study||59
6530176|NCT01607203|7451559|FG001|COMPLETED|Overall Study||61
6530177|NCT01607203|7451558|FG000|NOT COMPLETED|Overall Study||0
6644267|NCT02362048|7572870|FG000|COMPLETED|Overall Study||0
6644268|NCT02362048|7572871|FG001|COMPLETED|Overall Study||0
6644269|NCT02362048|7572870|FG000|NOT COMPLETED|Overall Study||37
6644270|NCT02362048|7572871|FG001|NOT COMPLETED|Overall Study||40
6530178|NCT01607203|7451559|FG001|NOT COMPLETED|Overall Study||0
6530179|NCT01607255|7451569|FG000|STARTED|Overall Study||161
6530180|NCT01607255|7451570|FG001|STARTED|Overall Study||160
6530181|NCT01607255|7451571|FG002|STARTED|Overall Study||159
6530182|NCT01607255|7451569|FG000|COMPLETED|Overall Study||161
6644271|NCT02362191|7572877|FG000|STARTED|Overall Study||5
6530183|NCT01607255|7451570|FG001|COMPLETED|Overall Study||160
6644272|NCT02362191|7572877|FG000|COMPLETED|Overall Study||3
6530184|NCT01607255|7451571|FG002|COMPLETED|Overall Study||159
6530185|NCT01607255|7451569|FG000|NOT COMPLETED|Overall Study||0
6530186|NCT01607255|7451570|FG001|NOT COMPLETED|Overall Study||0
6530187|NCT01607255|7451571|FG002|NOT COMPLETED|Overall Study||0
6530188|NCT01607346|7451579|FG000|STARTED|Overall Study||10
6530189|NCT01607346|7451579|FG000|COMPLETED|Overall Study||7
6530190|NCT01607346|7451579|FG000|NOT COMPLETED|Overall Study||3
6530191|NCT01607398|7451585|FG000|STARTED|Overall Study||28
6530192|NCT01607398|7451586|FG001|STARTED|Overall Study||28
6530193|NCT01607398|7451585|FG000|COMPLETED|Overall Study||26
6644273|NCT02362191|7572877|FG000|NOT COMPLETED|Overall Study||2
6644274|NCT02362269|7572883|FG000|STARTED|Overall Study||83
6530194|NCT01607398|7451586|FG001|COMPLETED|Overall Study||26
6530195|NCT01607398|7451585|FG000|NOT COMPLETED|Overall Study||2
6530196|NCT01607398|7451586|FG001|NOT COMPLETED|Overall Study||2
6530197|NCT01607411|7451592|FG000|STARTED|Period I||14
6530198|NCT01607411|7451593|FG001|STARTED|Period I||13
6530199|NCT01607411|7451594|FG002|STARTED|Period I||14
6530200|NCT01607411|7451595|FG003|STARTED|Period I||14
6530201|NCT01607411|7451592|FG000|COMPLETED|Period I||14
6530202|NCT01607411|7451593|FG001|COMPLETED|Period I||13
6530203|NCT01607411|7451594|FG002|COMPLETED|Period I||14
6530204|NCT01607411|7451595|FG003|COMPLETED|Period I||14
6530205|NCT01607411|7451592|FG000|NOT COMPLETED|Period I||0
6530206|NCT01607411|7451593|FG001|NOT COMPLETED|Period I||0
6530207|NCT01607411|7451594|FG002|NOT COMPLETED|Period I||0
6530208|NCT01607411|7451595|FG003|NOT COMPLETED|Period I||0
6530209|NCT01607411|7451592|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
6530210|NCT01607411|7451593|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
6530211|NCT01607411|7451594|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
6530212|NCT01607411|7451595|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
6530213|NCT01607411|7451592|FG000|COMPLETED|Period II||14
6530214|NCT01607411|7451593|FG001|COMPLETED|Period II||14
6530215|NCT01607411|7451594|FG002|COMPLETED|Period II||13
6530216|NCT01607411|7451595|FG003|COMPLETED|Period II||14
6530217|NCT01607411|7451592|FG000|NOT COMPLETED|Period II||0
6530218|NCT01607411|7451593|FG001|NOT COMPLETED|Period II||0
6530219|NCT01607411|7451594|FG002|NOT COMPLETED|Period II||0
6530220|NCT01607411|7451595|FG003|NOT COMPLETED|Period II||0
6530221|NCT01607411|7451592|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
6530222|NCT01607411|7451593|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
6530223|NCT01607411|7451594|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
6530224|NCT01607411|7451595|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
6530225|NCT01607411|7451592|FG000|COMPLETED|Period III||14
6530226|NCT01607411|7451593|FG001|COMPLETED|Period III||14
6530227|NCT01607411|7451594|FG002|COMPLETED|Period III||14
6530228|NCT01607411|7451595|FG003|COMPLETED|Period III||13
6530229|NCT01607411|7451592|FG000|NOT COMPLETED|Period III||0
6530230|NCT01607411|7451593|FG001|NOT COMPLETED|Period III||0
6530231|NCT01607411|7451594|FG002|NOT COMPLETED|Period III||0
6530232|NCT01607411|7451595|FG003|NOT COMPLETED|Period III||0
6530233|NCT01607411|7451592|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
6530234|NCT01607411|7451593|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
6530235|NCT01607411|7451594|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
6530236|NCT01607411|7451595|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
6530237|NCT01607411|7451592|FG000|COMPLETED|Period IV||13
6530238|NCT01607411|7451593|FG001|COMPLETED|Period IV||14
6530239|NCT01607411|7451594|FG002|COMPLETED|Period IV||14
6530240|NCT01607411|7451595|FG003|COMPLETED|Period IV||14
6530241|NCT01607411|7451592|FG000|NOT COMPLETED|Period IV||0
6530242|NCT01607411|7451593|FG001|NOT COMPLETED|Period IV||0
6530243|NCT01607411|7451594|FG002|NOT COMPLETED|Period IV||0
6530244|NCT01607411|7451595|FG003|NOT COMPLETED|Period IV||0
6530245|NCT01607450|7451612|FG000|STARTED|Overall Study||6
6530246|NCT01607450|7451613|FG001|STARTED|Overall Study||8
6530247|NCT01607450|7451614|FG002|STARTED|Overall Study||7
6530248|NCT01607450|7451615|FG003|STARTED|Overall Study||11
6530249|NCT01607450|7451616|FG004|STARTED|Overall Study||1
6530250|NCT01607450|7451617|FG005|STARTED|Overall Study||0
6530251|NCT01607450|7451618|FG006|STARTED|Overall Study||0
6530252|NCT01607450|7451612|FG000|COMPLETED|Overall Study||6
6530253|NCT01607450|7451613|FG001|COMPLETED|Overall Study||8
6530254|NCT01607450|7451614|FG002|COMPLETED|Overall Study||7
6530255|NCT01607450|7451615|FG003|COMPLETED|Overall Study||11
6530256|NCT01607450|7451616|FG004|COMPLETED|Overall Study||1
6530257|NCT01607450|7451617|FG005|COMPLETED|Overall Study||0
6530258|NCT01607450|7451618|FG006|COMPLETED|Overall Study||0
6530259|NCT01607450|7451612|FG000|NOT COMPLETED|Overall Study||0
6530260|NCT01607450|7451613|FG001|NOT COMPLETED|Overall Study||0
6530261|NCT01607450|7451614|FG002|NOT COMPLETED|Overall Study||0
6530262|NCT01607450|7451615|FG003|NOT COMPLETED|Overall Study||0
6530263|NCT01607450|7451616|FG004|NOT COMPLETED|Overall Study||0
6530264|NCT01607450|7451617|FG005|NOT COMPLETED|Overall Study||0
6530265|NCT01607450|7451618|FG006|NOT COMPLETED|Overall Study||0
6644275|NCT02362269|7572884|FG001|STARTED|Overall Study||86
6644276|NCT02362269|7572883|FG000|COMPLETED|Overall Study||82
6530266|NCT01607476|7451642|FG000|STARTED|Overall Study||25
6530267|NCT01607476|7451643|FG001|STARTED|Overall Study||30
6530268|NCT01607476|7451644|FG002|STARTED|Overall Study||33
6530269|NCT01607476|7451642|FG000|COMPLETED|Overall Study||24
6530270|NCT01607476|7451643|FG001|COMPLETED|Overall Study||30
6530271|NCT01607476|7451644|FG002|COMPLETED|Overall Study||30
6530272|NCT01607476|7451642|FG000|NOT COMPLETED|Overall Study||1
6530273|NCT01607476|7451643|FG001|NOT COMPLETED|Overall Study||0
6530274|NCT01607476|7451644|FG002|NOT COMPLETED|Overall Study||3
6530275|NCT01607554|7451652|FG000|STARTED|Overall Study||2
6530276|NCT01607554|7451652|FG000|COMPLETED|Overall Study||0
6530277|NCT01607554|7451652|FG000|NOT COMPLETED|Overall Study||2
6530278|NCT01607593|7451656|FG000|STARTED|Overall Study||122
6530279|NCT01607593|7451656|FG000|COMPLETED|Overall Study||29
6530280|NCT01607593|7451656|FG000|NOT COMPLETED|Overall Study||93
6530281|NCT01607645|7451662|FG000|STARTED|Overall Study||4
6530282|NCT01607645|7451663|FG001|STARTED|Overall Study||3
6530283|NCT01607645|7451662|FG000|COMPLETED|Overall Study||4
6530284|NCT01607645|7451663|FG001|COMPLETED|Overall Study||3
6530285|NCT01607645|7451662|FG000|NOT COMPLETED|Overall Study||0
6530286|NCT01607645|7451663|FG001|NOT COMPLETED|Overall Study||0
6530287|NCT01607658|7451673|FG000|STARTED|Overall Study||65
6530288|NCT01607658|7451674|FG001|STARTED|Overall Study||67
6530289|NCT01607658|7451675|FG002|STARTED|Overall Study||58
6530290|NCT01607658|7451676|FG003|STARTED|Overall Study||63
6530291|NCT01607658|7451673|FG000|COMPLETED|Overall Study||56
6530292|NCT01607658|7451674|FG001|COMPLETED|Overall Study||56
6530293|NCT01607658|7451675|FG002|COMPLETED|Overall Study||47
6530294|NCT01607658|7451676|FG003|COMPLETED|Overall Study||52
6530295|NCT01607658|7451673|FG000|NOT COMPLETED|Overall Study||9
6530296|NCT01607658|7451674|FG001|NOT COMPLETED|Overall Study||11
6530297|NCT01607658|7451675|FG002|NOT COMPLETED|Overall Study||11
6530298|NCT01607658|7451676|FG003|NOT COMPLETED|Overall Study||11
6530299|NCT01607853|7451686|FG000|STARTED|Overall Study||24
6530300|NCT01607853|7451686|FG000|COMPLETED|Overall Study||24
6530301|NCT01607853|7451686|FG000|NOT COMPLETED|Overall Study||0
6530302|NCT01607892|7451698|FG000|STARTED|Overall Study||58
6530303|NCT01607892|7451699|FG001|STARTED|Overall Study||27
6530304|NCT01607892|7451700|FG002|STARTED|Overall Study||81
6530305|NCT01607892|7451701|FG003|STARTED|Overall Study||95
6530306|NCT01607892|7451702|FG004|STARTED|Overall Study||24
6530307|NCT01607892|7451698|FG000|COMPLETED|Overall Study||0
6530308|NCT01607892|7451699|FG001|COMPLETED|Overall Study||0
6530309|NCT01607892|7451700|FG002|COMPLETED|Overall Study||0
6530310|NCT01607892|7451701|FG003|COMPLETED|Overall Study||0
6530311|NCT01607892|7451702|FG004|COMPLETED|Overall Study||0
6530312|NCT01607892|7451698|FG000|NOT COMPLETED|Overall Study||58
6530313|NCT01607892|7451699|FG001|NOT COMPLETED|Overall Study||27
6530314|NCT01607892|7451700|FG002|NOT COMPLETED|Overall Study||81
6530315|NCT01607892|7451701|FG003|NOT COMPLETED|Overall Study||95
6530316|NCT01607892|7451702|FG004|NOT COMPLETED|Overall Study||24
6530317|NCT01607905|7451735|FG000|STARTED|Overall Study||60
6530318|NCT01607905|7451736|FG001|STARTED|Overall Study||20
6530319|NCT01607905|7451737|FG002|STARTED|Overall Study||21
6530320|NCT01607905|7451738|FG003|STARTED|Overall Study||21
6530321|NCT01607905|7451739|FG004|STARTED|Overall Study||7
6530322|NCT01607905|7451740|FG005|STARTED|Overall Study||15
6530323|NCT01607905|7451741|FG006|STARTED|Overall Study||47
6530324|NCT01607905|7451735|FG000|Received Study Drug|Overall Study||59
6530325|NCT01607905|7451736|FG001|Received Study Drug|Overall Study||20
6530326|NCT01607905|7451737|FG002|Received Study Drug|Overall Study||21
6530327|NCT01607905|7451738|FG003|Received Study Drug|Overall Study||21
6530328|NCT01607905|7451739|FG004|Received Study Drug|Overall Study||6
6530329|NCT01607905|7451740|FG005|Received Study Drug|Overall Study||15
6530330|NCT01607905|7451741|FG006|Received Study Drug|Overall Study||47
6530331|NCT01607905|7451735|FG000|Low Dose (<30 mg/m^2)|Overall Study||16
6530332|NCT01607905|7451736|FG001|Low Dose (<30 mg/m^2)|Overall Study||5
6530333|NCT01607905|7451737|FG002|Low Dose (<30 mg/m^2)|Overall Study||3
6530334|NCT01607905|7451738|FG003|Low Dose (<30 mg/m^2)|Overall Study||0
6530335|NCT01607905|7451739|FG004|Low Dose (<30 mg/m^2)|Overall Study||0
6530336|NCT01607905|7451740|FG005|Low Dose (<30 mg/m^2)|Overall Study||2
6530337|NCT01607905|7451741|FG006|Low Dose (<30 mg/m^2)|Overall Study||8
6530338|NCT01607905|7451735|FG000|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||27
6530339|NCT01607905|7451736|FG001|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||11
6530340|NCT01607905|7451737|FG002|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||15
6530341|NCT01607905|7451738|FG003|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||8
6530342|NCT01607905|7451739|FG004|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||6
6530343|NCT01607905|7451740|FG005|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||3
6530344|NCT01607905|7451741|FG006|Medium Dose (>=30 mg/m^2 and <55 mg/m^2)|Overall Study||21
6530345|NCT01607905|7451735|FG000|High Dose (>= 55 mg/m^2)|Overall Study||16
6530346|NCT01607905|7451736|FG001|High Dose (>= 55 mg/m^2)|Overall Study||4
6530347|NCT01607905|7451737|FG002|High Dose (>= 55 mg/m^2)|Overall Study||3
6530348|NCT01607905|7451738|FG003|High Dose (>= 55 mg/m^2)|Overall Study||13
6530349|NCT01607905|7451739|FG004|High Dose (>= 55 mg/m^2)|Overall Study||0
6530350|NCT01607905|7451740|FG005|High Dose (>= 55 mg/m^2)|Overall Study||10
6530351|NCT01607905|7451741|FG006|High Dose (>= 55 mg/m^2)|Overall Study||18
6530352|NCT01607905|7451735|FG000|COMPLETED|Overall Study||0
6530353|NCT01607905|7451736|FG001|COMPLETED|Overall Study||0
6530354|NCT01607905|7451737|FG002|COMPLETED|Overall Study||0
6530355|NCT01607905|7451738|FG003|COMPLETED|Overall Study||0
6530356|NCT01607905|7451739|FG004|COMPLETED|Overall Study||0
6530357|NCT01607905|7451740|FG005|COMPLETED|Overall Study||0
6530358|NCT01607905|7451741|FG006|COMPLETED|Overall Study||0
6530359|NCT01607905|7451735|FG000|NOT COMPLETED|Overall Study||60
6530360|NCT01607905|7451736|FG001|NOT COMPLETED|Overall Study||20
6530361|NCT01607905|7451737|FG002|NOT COMPLETED|Overall Study||21
6530362|NCT01607905|7451738|FG003|NOT COMPLETED|Overall Study||21
6530363|NCT01607905|7451739|FG004|NOT COMPLETED|Overall Study||7
6530364|NCT01607905|7451740|FG005|NOT COMPLETED|Overall Study||15
6530365|NCT01607905|7451741|FG006|NOT COMPLETED|Overall Study||47
6530366|NCT01607957|7451801|FG000|STARTED|Overall Study||534
6530367|NCT01607957|7451802|FG001|STARTED|Overall Study||266
6530368|NCT01607957|7451801|FG000|Treated|Overall Study||533
6530369|NCT01607957|7451802|FG001|Treated|Overall Study||265
6530370|NCT01607957|7451801|FG000|COMPLETED|Overall Study||162
6530371|NCT01607957|7451802|FG001|COMPLETED|Overall Study||51
6530372|NCT01607957|7451801|FG000|NOT COMPLETED|Overall Study||372
6530373|NCT01607957|7451802|FG001|NOT COMPLETED|Overall Study||215
6530374|NCT01608061|7451810|FG000|STARTED|Blinded Period||21
6530375|NCT01608061|7451811|FG001|STARTED|Blinded Period||21
6530376|NCT01608061|7451810|FG000|COMPLETED|Blinded Period||21
6530377|NCT01608061|7451811|FG001|COMPLETED|Blinded Period||21
6530378|NCT01608061|7451810|FG000|NOT COMPLETED|Blinded Period||0
6530379|NCT01608061|7451811|FG001|NOT COMPLETED|Blinded Period||0
6530380|NCT01608061|7451810|FG000|STARTED|Long Term Follow-Up||21
6530381|NCT01608061|7451811|FG001|STARTED|Long Term Follow-Up||21
6530382|NCT01608061|7451810|FG000|COMPLETED|Long Term Follow-Up||14
6530383|NCT01608061|7451811|FG001|COMPLETED|Long Term Follow-Up||16
6530384|NCT01608061|7451810|FG000|NOT COMPLETED|Long Term Follow-Up||7
6530385|NCT01608061|7451811|FG001|NOT COMPLETED|Long Term Follow-Up||5
6530386|NCT01608061|7451810|FG000|STARTED|Extension Period||14
6530387|NCT01608061|7451811|FG001|STARTED|Extension Period||16
6530388|NCT01608061|7451810|FG000|COMPLETED|Extension Period||14
6530389|NCT01608061|7451811|FG001|COMPLETED|Extension Period||14
6530390|NCT01608061|7451810|FG000|NOT COMPLETED|Extension Period||0
6530391|NCT01608061|7451811|FG001|NOT COMPLETED|Extension Period||2
6530392|NCT01608087|7451821|FG000|STARTED|Overall Study||30
6530393|NCT01608087|7451822|FG001|STARTED|Overall Study||30
6530394|NCT01608087|7451823|FG002|STARTED|Overall Study||31
6530395|NCT01608087|7451821|FG000|COMPLETED|Overall Study||30
6530396|NCT01608087|7451822|FG001|COMPLETED|Overall Study||28
6530397|NCT01608087|7451823|FG002|COMPLETED|Overall Study||31
6530398|NCT01608087|7451821|FG000|NOT COMPLETED|Overall Study||0
6530399|NCT01608087|7451822|FG001|NOT COMPLETED|Overall Study||2
6530400|NCT01608087|7451823|FG002|NOT COMPLETED|Overall Study||0
6530401|NCT01608100|7451831|FG000|STARTED|Overall Study||1101
6530402|NCT01608100|7451831|FG000|COMPLETED|Overall Study||1101
6530403|NCT01608100|7451831|FG000|NOT COMPLETED|Overall Study||0
6530404|NCT01608295|7451857|FG000|STARTED|Overall Study||26
6530405|NCT01608295|7451858|FG001|STARTED|Overall Study||30
6530406|NCT01608295|7451857|FG000|COMPLETED|Overall Study||20
6530407|NCT01608295|7451858|FG001|COMPLETED|Overall Study||25
6530408|NCT01608295|7451857|FG000|NOT COMPLETED|Overall Study||6
6530409|NCT01608295|7451858|FG001|NOT COMPLETED|Overall Study||5
6530410|NCT01608308|7451869|FG000|STARTED|Overall Study||31
6530411|NCT01608308|7451870|FG001|STARTED|Overall Study||31
6530412|NCT01608308|7451869|FG000|COMPLETED|Overall Study||31
6530413|NCT01608308|7451870|FG001|COMPLETED|Overall Study||29
6530414|NCT01608308|7451869|FG000|NOT COMPLETED|Overall Study||0
6530415|NCT01608308|7451870|FG001|NOT COMPLETED|Overall Study||2
6530416|NCT01608321|7451878|FG000|STARTED|Overall Study||13
6530417|NCT01608321|7451879|FG001|STARTED|Overall Study||4
6530418|NCT01608321|7451878|FG000|COMPLETED|Overall Study||12
6530419|NCT01608321|7451879|FG001|COMPLETED|Overall Study||4
6530420|NCT01608321|7451878|FG000|NOT COMPLETED|Overall Study||1
6530421|NCT01608321|7451879|FG001|NOT COMPLETED|Overall Study||0
6530422|NCT01608490|7451887|FG000|STARTED|Overall Study||158
6530423|NCT01608490|7451888|FG001|STARTED|Overall Study||157
6530424|NCT01608490|7451887|FG000|COMPLETED|Overall Study||141
6530425|NCT01608490|7451888|FG001|COMPLETED|Overall Study||142
6530426|NCT01608490|7451887|FG000|NOT COMPLETED|Overall Study||17
6530427|NCT01608490|7451888|FG001|NOT COMPLETED|Overall Study||15
6530428|NCT01608659|7451894|FG000|STARTED|Overall Study||110
6530429|NCT01608659|7451894|FG000|COMPLETED|Overall Study||94
6530430|NCT01608659|7451894|FG000|NOT COMPLETED|Overall Study||16
6530431|NCT01608672|7451898|FG000|STARTED|Overall Study||207
6530432|NCT01608672|7451898|FG000|COMPLETED|Overall Study||207
6530433|NCT01608672|7451898|FG000|NOT COMPLETED|Overall Study||0
6530434|NCT01608724|7451902|FG000|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
6530435|NCT01608724|7451902|FG000|Treated|Overall Study||1361
6530436|NCT01608724|7451902|FG000|COMPLETED|Overall Study||1180
6530437|NCT01608724|7451902|FG000|NOT COMPLETED|Overall Study||243
6530438|NCT01608815|7451909|FG000|STARTED|Overall Study||188
6530439|NCT01608815|7451910|FG001|STARTED|Overall Study||7
6530440|NCT01608815|7451911|FG002|STARTED|Overall Study||5
6530441|NCT01608815|7451909|FG000|COMPLETED|Overall Study||188
6530442|NCT01608815|7451910|FG001|COMPLETED|Overall Study||7
6530443|NCT01608815|7451911|FG002|COMPLETED|Overall Study||5
6530444|NCT01608815|7451909|FG000|NOT COMPLETED|Overall Study||0
6530445|NCT01608815|7451910|FG001|NOT COMPLETED|Overall Study||0
6530446|NCT01608815|7451911|FG002|NOT COMPLETED|Overall Study||0
6530447|NCT01608971|7451922|FG000|STARTED|Overall Study||15
6530448|NCT01608971|7451923|FG001|STARTED|Overall Study||15
6530449|NCT01608971|7451922|FG000|COMPLETED|Overall Study||15
6530450|NCT01608971|7451923|FG001|COMPLETED|Overall Study||15
6530451|NCT01608971|7451922|FG000|NOT COMPLETED|Overall Study||0
6530452|NCT01608971|7451923|FG001|NOT COMPLETED|Overall Study||0
6530453|NCT01609010|7451933|FG000|STARTED|Overall Study||156
6530454|NCT01609010|7451934|FG001|STARTED|Overall Study||157
6530455|NCT01609010|7451933|FG000|Entering Cycle 2|Overall Study||120
6530456|NCT01609010|7451934|FG001|Entering Cycle 2|Overall Study||124
6530457|NCT01609010|7451933|FG000|COMPLETED|Overall Study||113
6530458|NCT01609010|7451934|FG001|COMPLETED|Overall Study||120
6530459|NCT01609010|7451933|FG000|NOT COMPLETED|Overall Study||43
6530460|NCT01609010|7451934|FG001|NOT COMPLETED|Overall Study||37
6530461|NCT01609023|7451940|FG000|STARTED|Overall Study||67
6530462|NCT01609023|7451940|FG000|COMPLETED|Overall Study||34
6530463|NCT01609023|7451940|FG000|NOT COMPLETED|Overall Study||33
6530464|NCT01609062|7451946|FG000|STARTED|Primary Phase||15
6530465|NCT01609062|7451947|FG001|STARTED|Primary Phase||10
6530466|NCT01609062|7451946|FG000|COMPLETED|Primary Phase||15
6530467|NCT01609062|7451947|FG001|COMPLETED|Primary Phase||10
6530468|NCT01609062|7451946|FG000|NOT COMPLETED|Primary Phase||0
6530469|NCT01609062|7451947|FG001|NOT COMPLETED|Primary Phase||0
6530470|NCT01609062|7451946|FG000|STARTED|Extension Phase||15
6530471|NCT01609062|7451947|FG001|STARTED|Extension Phase||10
6530472|NCT01609062|7451946|FG000|COMPLETED|Extension Phase||0
6530473|NCT01609062|7451947|FG001|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
6530474|NCT01609062|7451946|FG000|NOT COMPLETED|Extension Phase||15
6530475|NCT01609062|7451947|FG001|NOT COMPLETED|Extension Phase||10
6530476|NCT01609218|7451954|FG000|STARTED|Period 1||13
6530477|NCT01609218|7451955|FG001|STARTED|Period 1||14
6530478|NCT01609218|7451954|FG000|Received LY2140023|Period 1||13
6530479|NCT01609218|7451955|FG001|Received LY2140023|Period 1||14
6530480|NCT01609218|7451954|FG000|Received Activated Charcoal|Period 1|Participants in this treatment sequence did not receive activated charcoal during Period 1.|0
6530481|NCT01609218|7451955|FG001|Received Activated Charcoal|Period 1|Two participants discontinued after receiving LY2140023 but prior to receiving activated charcoal.|12
6530482|NCT01609218|7451954|FG000|COMPLETED|Period 1||10
6530483|NCT01609218|7451955|FG001|COMPLETED|Period 1||8
6530484|NCT01609218|7451954|FG000|NOT COMPLETED|Period 1||3
6530485|NCT01609218|7451955|FG001|NOT COMPLETED|Period 1||6
6530486|NCT01609218|7451954|FG000|STARTED|Period 2||10
6530487|NCT01609218|7451955|FG001|STARTED|Period 2|One participant did not complete Period 1 but did continue onto Period 2.|9
6530488|NCT01609218|7451954|FG000|Received LY2140023|Period 2||10
6530489|NCT01609218|7451955|FG001|Received LY2140023|Period 2||9
6530490|NCT01609218|7451954|FG000|Received Activated Charcoal|Period 2||9
6530491|NCT01609218|7451955|FG001|Received Activated Charcoal|Period 2|Participants in this treatment sequence did not receive activated charcoal during Period 2.|0
6530492|NCT01609218|7451954|FG000|COMPLETED|Period 2||9
6530493|NCT01609218|7451955|FG001|COMPLETED|Period 2||9
6530494|NCT01609218|7451954|FG000|NOT COMPLETED|Period 2||1
6530495|NCT01609218|7451955|FG001|NOT COMPLETED|Period 2||0
6530496|NCT01609257|7451963|FG000|STARTED|Overall Study||67
6530497|NCT01609257|7451964|FG001|STARTED|Overall Study||65
6530498|NCT01609257|7451963|FG000|Received 2 Doses|Overall Study||63
6530499|NCT01609257|7451964|FG001|Received 2 Doses|Overall Study||64
6530500|NCT01609257|7451963|FG000|Received Challenge Product|Overall Study||56
6530501|NCT01609257|7451964|FG001|Received Challenge Product|Overall Study||53
6530502|NCT01609257|7451963|FG000|COMPLETED|Overall Study||61
6530503|NCT01609257|7451964|FG001|COMPLETED|Overall Study||57
6530504|NCT01609257|7451963|FG000|NOT COMPLETED|Overall Study||6
6530505|NCT01609257|7451964|FG001|NOT COMPLETED|Overall Study||8
6530506|NCT01609296|7451973|FG000|STARTED|Overall Study||1406
6530507|NCT01609296|7451973|FG000|COMPLETED|Overall Study||918
6530508|NCT01609296|7451973|FG000|NOT COMPLETED|Overall Study||488
6530509|NCT01609348|7451983|FG000|STARTED|Overall Study||3
6530510|NCT01609348|7451984|FG001|STARTED|Overall Study||2
6530511|NCT01609348|7451983|FG000|COMPLETED|Overall Study||3
6530512|NCT01609348|7451984|FG001|COMPLETED|Overall Study||2
6530513|NCT01609348|7451983|FG000|NOT COMPLETED|Overall Study||0
6530514|NCT01609348|7451984|FG001|NOT COMPLETED|Overall Study||0
6530515|NCT01609478|7451993|FG000|STARTED|Overall Study||111
6530516|NCT01609478|7451994|FG001|STARTED|Overall Study||108
6530517|NCT01609478|7451995|FG002|STARTED|Overall Study||116
6530518|NCT01609478|7451993|FG000|Full Analysis Set (FAS)|Overall Study||110
6530519|NCT01609478|7451994|FG001|Full Analysis Set (FAS)|Overall Study||108
6530520|NCT01609478|7451995|FG002|Full Analysis Set (FAS)|Overall Study||115
6530521|NCT01609478|7451993|FG000|COMPLETED|Overall Study||104
6530522|NCT01609478|7451994|FG001|COMPLETED|Overall Study||106
6530523|NCT01609478|7451995|FG002|COMPLETED|Overall Study||107
6530524|NCT01609478|7451993|FG000|NOT COMPLETED|Overall Study||7
6530525|NCT01609478|7451994|FG001|NOT COMPLETED|Overall Study||2
6530526|NCT01609478|7451995|FG002|NOT COMPLETED|Overall Study||9
6530527|NCT01609543|7452003|FG000|STARTED|Overall Study||62
6530528|NCT01609543|7452003|FG000|COMPLETED|Overall Study||20
6530529|NCT01609543|7452003|FG000|NOT COMPLETED|Overall Study||42
6530530|NCT01609556|7452024|FG000|STARTED|Dose Escalation: Maximum 101.3 Weeks||2
6530531|NCT01609556|7452025|FG001|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
6530532|NCT01609556|7452026|FG002|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
6530533|NCT01609556|7452027|FG003|STARTED|Dose Escalation: Maximum 101.3 Weeks||1
6530534|NCT01609556|7452028|FG004|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
6530535|NCT01609556|7452029|FG005|STARTED|Dose Escalation: Maximum 101.3 Weeks||18
6530536|NCT01609556|7452030|FG006|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
6530537|NCT01609556|7452031|FG007|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
6530538|NCT01609556|7452032|FG008|STARTED|Dose Escalation: Maximum 101.3 Weeks||5
6530539|NCT01609556|7452033|FG009|STARTED|Dose Escalation: Maximum 101.3 Weeks||4
6530540|NCT01609556|7452034|FG010|STARTED|Dose Escalation: Maximum 101.3 Weeks||9
6530541|NCT01609556|7452035|FG011|STARTED|Dose Escalation: Maximum 101.3 Weeks||7
6530542|NCT01609556|7452036|FG012|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
6530543|NCT01609556|7452037|FG013|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
6530544|NCT01609556|7452038|FG014|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
6530545|NCT01609556|7452039|FG015|STARTED|Dose Escalation: Maximum 101.3 Weeks||0
6530546|NCT01609556|7452024|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||2
6530547|NCT01609556|7452025|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
6530548|NCT01609556|7452026|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
6530549|NCT01609556|7452027|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||1
6530550|NCT01609556|7452028|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
6530551|NCT01609556|7452029|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||18
6530552|NCT01609556|7452030|FG006|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
6530553|NCT01609556|7452031|FG007|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
6530554|NCT01609556|7452032|FG008|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||5
6530555|NCT01609556|7452033|FG009|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||4
6530556|NCT01609556|7452034|FG010|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||9
6530557|NCT01609556|7452035|FG011|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||7
6530558|NCT01609556|7452036|FG012|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
6530559|NCT01609556|7452037|FG013|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
6530560|NCT01609556|7452038|FG014|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
6530561|NCT01609556|7452039|FG015|Received at Least 1 Dose of Study Drug|Dose Escalation: Maximum 101.3 Weeks||0
6530562|NCT01609556|7452024|FG000|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530563|NCT01609556|7452025|FG001|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530564|NCT01609556|7452026|FG002|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530565|NCT01609556|7452027|FG003|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530566|NCT01609556|7452028|FG004|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530567|NCT01609556|7452029|FG005|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530568|NCT01609556|7452030|FG006|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530569|NCT01609556|7452031|FG007|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530570|NCT01609556|7452032|FG008|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530571|NCT01609556|7452033|FG009|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530572|NCT01609556|7452034|FG010|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530573|NCT01609556|7452035|FG011|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530574|NCT01609556|7452036|FG012|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530575|NCT01609556|7452037|FG013|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530576|NCT01609556|7452038|FG014|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530577|NCT01609556|7452039|FG015|COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530578|NCT01609556|7452024|FG000|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||2
6530579|NCT01609556|7452025|FG001|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
6530580|NCT01609556|7452026|FG002|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
6530581|NCT01609556|7452027|FG003|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||1
6530582|NCT01609556|7452028|FG004|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
6530583|NCT01609556|7452029|FG005|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||18
6530584|NCT01609556|7452030|FG006|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
6530585|NCT01609556|7452031|FG007|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
6530586|NCT01609556|7452032|FG008|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||5
6530587|NCT01609556|7452033|FG009|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||4
6530588|NCT01609556|7452034|FG010|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||9
6530589|NCT01609556|7452035|FG011|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||7
6530590|NCT01609556|7452036|FG012|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530591|NCT01609556|7452037|FG013|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530592|NCT01609556|7452038|FG014|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530593|NCT01609556|7452039|FG015|NOT COMPLETED|Dose Escalation: Maximum 101.3 Weeks||0
6530594|NCT01609556|7452024|FG000|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530595|NCT01609556|7452025|FG001|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530596|NCT01609556|7452026|FG002|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530597|NCT01609556|7452027|FG003|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530598|NCT01609556|7452028|FG004|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530599|NCT01609556|7452029|FG005|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530600|NCT01609556|7452030|FG006|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530601|NCT01609556|7452031|FG007|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530602|NCT01609556|7452032|FG008|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530603|NCT01609556|7452033|FG009|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530604|NCT01609556|7452034|FG010|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530605|NCT01609556|7452035|FG011|STARTED|Dose Expansion: Maximum 124 Weeks||0
6530606|NCT01609556|7452036|FG012|STARTED|Dose Expansion: Maximum 124 Weeks||46
6530607|NCT01609556|7452037|FG013|STARTED|Dose Expansion: Maximum 124 Weeks||24
6530608|NCT01609556|7452038|FG014|STARTED|Dose Expansion: Maximum 124 Weeks||27
6530609|NCT01609556|7452039|FG015|STARTED|Dose Expansion: Maximum 124 Weeks||40
6530610|NCT01609556|7452024|FG000|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530611|NCT01609556|7452025|FG001|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530612|NCT01609556|7452026|FG002|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530613|NCT01609556|7452027|FG003|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530614|NCT01609556|7452028|FG004|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530615|NCT01609556|7452029|FG005|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530616|NCT01609556|7452030|FG006|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530617|NCT01609556|7452031|FG007|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530618|NCT01609556|7452032|FG008|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530619|NCT01609556|7452033|FG009|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530620|NCT01609556|7452034|FG010|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530621|NCT01609556|7452035|FG011|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530622|NCT01609556|7452036|FG012|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530623|NCT01609556|7452037|FG013|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530624|NCT01609556|7452038|FG014|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530625|NCT01609556|7452039|FG015|COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530626|NCT01609556|7452024|FG000|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530627|NCT01609556|7452025|FG001|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6644277|NCT02362269|7572884|FG001|COMPLETED|Overall Study||80
6644278|NCT02362269|7572883|FG000|NOT COMPLETED|Overall Study||1
6530628|NCT01609556|7452026|FG002|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530629|NCT01609556|7452027|FG003|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530630|NCT01609556|7452028|FG004|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530631|NCT01609556|7452029|FG005|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530632|NCT01609556|7452030|FG006|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530633|NCT01609556|7452031|FG007|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530634|NCT01609556|7452032|FG008|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530635|NCT01609556|7452033|FG009|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530636|NCT01609556|7452034|FG010|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530637|NCT01609556|7452035|FG011|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||0
6530638|NCT01609556|7452036|FG012|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||46
6530639|NCT01609556|7452037|FG013|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||24
6530640|NCT01609556|7452038|FG014|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||27
6530641|NCT01609556|7452039|FG015|NOT COMPLETED|Dose Expansion: Maximum 124 Weeks||40
6530642|NCT01609582|7452082|FG000|STARTED|Overall Study||1603
6530643|NCT01609582|7452083|FG001|STARTED|Overall Study||1604
6530644|NCT01609582|7452082|FG000|Treated|Overall Study||1603
6530645|NCT01609582|7452083|FG001|Treated|Overall Study||1601
6530646|NCT01609582|7452082|FG000|COMPLETED|Overall Study||0
6530647|NCT01609582|7452083|FG001|COMPLETED|Overall Study||0
6530648|NCT01609582|7452082|FG000|NOT COMPLETED|Overall Study||1603
6530649|NCT01609582|7452083|FG001|NOT COMPLETED|Overall Study||1604
6530650|NCT01609933|7452089|FG000|STARTED|Overall Study||32
6644279|NCT02362269|7572884|FG001|NOT COMPLETED|Overall Study||6
6530651|NCT01609933|7452089|FG000|COMPLETED|Overall Study||28
6530652|NCT01609933|7452089|FG000|NOT COMPLETED|Overall Study||4
6644280|NCT02362282|7572892|FG000|STARTED|Overall Study||5
6530653|NCT01610011|7452097|FG000|STARTED|Overall Study||19
6530654|NCT01610011|7452098|FG001|STARTED|Overall Study||2
6530655|NCT01610011|7452097|FG000|COMPLETED|Overall Study||9
6530656|NCT01610011|7452098|FG001|COMPLETED|Overall Study||2
6530657|NCT01610011|7452097|FG000|NOT COMPLETED|Overall Study||10
6530658|NCT01610011|7452098|FG001|NOT COMPLETED|Overall Study||0
6530659|NCT01610037|7452107|FG000|STARTED|All Patients||407
6530660|NCT01610037|7452108|FG001|STARTED|All Patients||405
6530661|NCT01610037|7452109|FG002|STARTED|All Patients||404
6530662|NCT01610037|7452107|FG000|Randomized Set (RAN)|All Patients||407
6530663|NCT01610037|7452108|FG001|Randomized Set (RAN)|All Patients||405
6530664|NCT01610037|7452109|FG002|Randomized Set (RAN)|All Patients||404
6530665|NCT01610037|7452107|FG000|Full Analysis Set (FAS)|All Patients||407
6530666|NCT01610037|7452108|FG001|Full Analysis Set (FAS)|All Patients||405
6530667|NCT01610037|7452109|FG002|Full Analysis Set (FAS)|All Patients||403
6530668|NCT01610037|7452107|FG000|COMPLETED|All Patients||348
6530669|NCT01610037|7452108|FG001|COMPLETED|All Patients||354
6530670|NCT01610037|7452109|FG002|COMPLETED|All Patients||320
6530671|NCT01610037|7452107|FG000|NOT COMPLETED|All Patients||59
6530672|NCT01610037|7452108|FG001|NOT COMPLETED|All Patients||51
6530673|NCT01610037|7452109|FG002|NOT COMPLETED|All Patients||84
6530674|NCT01610037|7452107|FG000|STARTED|Treatment and Follow up Period||407
6530675|NCT01610037|7452108|FG001|STARTED|Treatment and Follow up Period||405
6530676|NCT01610037|7452109|FG002|STARTED|Treatment and Follow up Period||404
6530677|NCT01610037|7452107|FG000|COMPLETED|Treatment and Follow up Period||382
6530678|NCT01610037|7452108|FG001|COMPLETED|Treatment and Follow up Period||377
6530679|NCT01610037|7452109|FG002|COMPLETED|Treatment and Follow up Period||378
6530680|NCT01610037|7452107|FG000|NOT COMPLETED|Treatment and Follow up Period||25
6530681|NCT01610037|7452108|FG001|NOT COMPLETED|Treatment and Follow up Period||28
6530682|NCT01610037|7452109|FG002|NOT COMPLETED|Treatment and Follow up Period||26
6530683|NCT01610063|7452119|FG000|STARTED|Overall Study||114
6530684|NCT01610063|7452120|FG001|STARTED|Overall Study||113
6530685|NCT01610063|7452119|FG000|Baseline|Overall Study||114
6530686|NCT01610063|7452120|FG001|Baseline|Overall Study||113
6530687|NCT01610063|7452119|FG000|Completed 2-week|Overall Study||97
6530688|NCT01610063|7452120|FG001|Completed 2-week|Overall Study||105
6530689|NCT01610063|7452119|FG000|Completed 4-week|Overall Study||86
6530690|NCT01610063|7452120|FG001|Completed 4-week|Overall Study||98
6530691|NCT01610063|7452119|FG000|Completed 8-week|Overall Study||72
6530692|NCT01610063|7452120|FG001|Completed 8-week|Overall Study||93
6530693|NCT01610063|7452119|FG000|COMPLETED|Overall Study||72
6530694|NCT01610063|7452120|FG001|COMPLETED|Overall Study||93
6530695|NCT01610063|7452119|FG000|NOT COMPLETED|Overall Study||42
6530696|NCT01610063|7452120|FG001|NOT COMPLETED|Overall Study||20
6530697|NCT01610076|7452128|FG000|STARTED|Overall Study||103
6530698|NCT01610076|7452129|FG001|STARTED|Overall Study||105
6530699|NCT01610076|7452128|FG000|COMPLETED|Overall Study||100
6530700|NCT01610076|7452129|FG001|COMPLETED|Overall Study||100
6530701|NCT01610076|7452128|FG000|NOT COMPLETED|Overall Study||3
6530702|NCT01610076|7452129|FG001|NOT COMPLETED|Overall Study||5
6530703|NCT01610154|7452136|FG000|STARTED|Overall Study||85
6530704|NCT01610154|7452136|FG000|COMPLETED|Overall Study||84
6530705|NCT01610154|7452136|FG000|NOT COMPLETED|Overall Study||1
6530706|NCT01610167|7452145|FG000|STARTED|Overall Study||52
6530707|NCT01610167|7452146|FG001|STARTED|Overall Study||49
6530708|NCT01610167|7452147|FG002|STARTED|Overall Study||50
6530709|NCT01610167|7452145|FG000|COMPLETED|Overall Study||52
6530710|NCT01610167|7452146|FG001|COMPLETED|Overall Study||49
6530711|NCT01610167|7452147|FG002|COMPLETED|Overall Study||48
6530712|NCT01610167|7452145|FG000|NOT COMPLETED|Overall Study||0
6530713|NCT01610167|7452146|FG001|NOT COMPLETED|Overall Study||0
6530714|NCT01610167|7452147|FG002|NOT COMPLETED|Overall Study||2
6530715|NCT01610206|7452157|FG000|STARTED|Overall Study||73
6530716|NCT01610206|7452158|FG001|STARTED|Overall Study||75
6530717|NCT01610206|7452157|FG000|COMPLETED|Overall Study||63
6530718|NCT01610206|7452158|FG001|COMPLETED|Overall Study||45
6530719|NCT01610206|7452157|FG000|NOT COMPLETED|Overall Study||10
6530720|NCT01610206|7452158|FG001|NOT COMPLETED|Overall Study||30
6530721|NCT01610271|7452166|FG000|STARTED|Overall Study||150
6530722|NCT01610271|7452167|FG001|STARTED|Overall Study||150
6530723|NCT01610271|7452166|FG000|COMPLETED|Overall Study||148
6530724|NCT01610271|7452167|FG001|COMPLETED|Overall Study||146
6530725|NCT01610271|7452166|FG000|NOT COMPLETED|Overall Study||2
6530726|NCT01610271|7452167|FG001|NOT COMPLETED|Overall Study||4
6530727|NCT01610284|7452177|FG000|STARTED|Randomization Phase||576
6530728|NCT01610284|7452178|FG001|STARTED|Randomization Phase||571
6530729|NCT01610284|7452177|FG000|Safety Set (SS)|Randomization Phase||573
6530730|NCT01610284|7452178|FG001|Safety Set (SS)|Randomization Phase||570
6530731|NCT01610284|7452177|FG000|COMPLETED|Randomization Phase||574
6530732|NCT01610284|7452178|FG001|COMPLETED|Randomization Phase||569
6530733|NCT01610284|7452177|FG000|NOT COMPLETED|Randomization Phase||2
6530734|NCT01610284|7452178|FG001|NOT COMPLETED|Randomization Phase||2
6530735|NCT01610284|7452177|FG000|STARTED|Treatment Phase||574
6530736|NCT01610284|7452178|FG001|STARTED|Treatment Phase||569
6530737|NCT01610284|7452177|FG000|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||93
6530738|NCT01610284|7452178|FG001|BKM120 Pharmacokinetic Analysis Set|Treatment Phase||0
6530739|NCT01610284|7452177|FG000|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||35
6530740|NCT01610284|7452178|FG001|Full Pharmacokinetic Analysis Set (FPAS)|Treatment Phase||0
6530741|NCT01610284|7452177|FG000|COMPLETED|Treatment Phase||0
6530742|NCT01610284|7452178|FG001|COMPLETED|Treatment Phase||0
6530743|NCT01610284|7452177|FG000|NOT COMPLETED|Treatment Phase||574
6530744|NCT01610284|7452178|FG001|NOT COMPLETED|Treatment Phase||569
6530745|NCT01610284|7452177|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|89
6530746|NCT01610284|7452178|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|29
6530747|NCT01610284|7452177|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6530748|NCT01610284|7452178|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6530749|NCT01610284|7452177|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||89
6530750|NCT01610284|7452178|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||29
6530751|NCT01610297|7452184|FG000|STARTED|Overall Study||27
6530752|NCT01610297|7452184|FG000|COMPLETED|Overall Study||26
6530753|NCT01610297|7452184|FG000|NOT COMPLETED|Overall Study||1
6530754|NCT01610336|7452199|FG000|STARTED|Overall Study||5
6530755|NCT01610336|7452200|FG001|STARTED|Overall Study||7
6530756|NCT01610336|7452201|FG002|STARTED|Overall Study||6
6530757|NCT01610336|7452202|FG003|STARTED|Overall Study||7
6530758|NCT01610336|7452203|FG004|STARTED|Overall Study||4
6530759|NCT01610336|7452204|FG005|STARTED|Overall Study||12
6530760|NCT01610336|7452205|FG006|STARTED|Overall Study||5
6530761|NCT01610336|7452206|FG007|STARTED|Overall Study||7
6530762|NCT01610336|7452207|FG008|STARTED|Overall Study||8
6530763|NCT01610336|7452208|FG009|STARTED|Overall Study||53
6530764|NCT01610336|7452209|FG010|STARTED|Overall Study||47
6530765|NCT01610336|7452199|FG000|COMPLETED|Overall Study||0
6530766|NCT01610336|7452200|FG001|COMPLETED|Overall Study||0
6530767|NCT01610336|7452201|FG002|COMPLETED|Overall Study||0
6530768|NCT01610336|7452202|FG003|COMPLETED|Overall Study||0
6530769|NCT01610336|7452203|FG004|COMPLETED|Overall Study||0
6530770|NCT01610336|7452204|FG005|COMPLETED|Overall Study||0
6530771|NCT01610336|7452205|FG006|COMPLETED|Overall Study||0
6530772|NCT01610336|7452206|FG007|COMPLETED|Overall Study||0
6530773|NCT01610336|7452207|FG008|COMPLETED|Overall Study||0
6530774|NCT01610336|7452208|FG009|COMPLETED|Overall Study||0
6530775|NCT01610336|7452209|FG010|COMPLETED|Overall Study||0
6530776|NCT01610336|7452199|FG000|NOT COMPLETED|Overall Study||5
6530777|NCT01610336|7452200|FG001|NOT COMPLETED|Overall Study||7
6530778|NCT01610336|7452201|FG002|NOT COMPLETED|Overall Study||6
6530779|NCT01610336|7452202|FG003|NOT COMPLETED|Overall Study||7
6530780|NCT01610336|7452203|FG004|NOT COMPLETED|Overall Study||4
6530781|NCT01610336|7452204|FG005|NOT COMPLETED|Overall Study||12
6530782|NCT01610336|7452205|FG006|NOT COMPLETED|Overall Study||5
6530783|NCT01610336|7452206|FG007|NOT COMPLETED|Overall Study||7
6530784|NCT01610336|7452207|FG008|NOT COMPLETED|Overall Study||8
6530785|NCT01610336|7452208|FG009|NOT COMPLETED|Overall Study||53
6530786|NCT01610336|7452209|FG010|NOT COMPLETED|Overall Study||47
6530787|NCT01610414|7452239|FG000|STARTED|Study Start - Month 13||922
6530788|NCT01610414|7452240|FG001|STARTED|Study Start - Month 13||924
6530789|NCT01610414|7452239|FG000|COMPLETED|Study Start - Month 13||807
6530790|NCT01610414|7452240|FG001|COMPLETED|Study Start - Month 13||795
6530791|NCT01610414|7452239|FG000|NOT COMPLETED|Study Start - Month 13||115
6530792|NCT01610414|7452240|FG001|NOT COMPLETED|Study Start - Month 13||129
6530793|NCT01610414|7452239|FG000|STARTED|Month 13 - Month 25||922
6530794|NCT01610414|7452240|FG001|STARTED|Month 13 - Month 25||924
6530795|NCT01610414|7452239|FG000|COMPLETED|Month 13 - Month 25||857
6530796|NCT01610414|7452240|FG001|COMPLETED|Month 13 - Month 25||854
6530797|NCT01610414|7452239|FG000|NOT COMPLETED|Month 13 - Month 25||65
6530798|NCT01610414|7452240|FG001|NOT COMPLETED|Month 13 - Month 25||70
6530799|NCT01610414|7452239|FG000|STARTED|After Month 25||922
6530800|NCT01610414|7452240|FG001|STARTED|After Month 25||924
6530801|NCT01610414|7452239|FG000|COMPLETED|After Month 25||874
6530802|NCT01610414|7452240|FG001|COMPLETED|After Month 25||871
6530803|NCT01610414|7452239|FG000|NOT COMPLETED|After Month 25||48
6530804|NCT01610414|7452240|FG001|NOT COMPLETED|After Month 25||53
6530805|NCT01610427|7452247|FG000|STARTED|Overall Study||22
6530806|NCT01610427|7452247|FG000|COMPLETED|Overall Study||22
6530807|NCT01610427|7452247|FG000|NOT COMPLETED|Overall Study||0
6530808|NCT01610453|7452251|FG000|STARTED|Overall Study||150
6530809|NCT01610453|7452251|FG000|COMPLETED|Overall Study||150
6530810|NCT01610453|7452251|FG000|NOT COMPLETED|Overall Study||0
6530811|NCT01610492|7452256|FG000|STARTED|Overall Study||14
6530812|NCT01610492|7452256|FG000|COMPLETED|Overall Study||8
6530813|NCT01610492|7452256|FG000|NOT COMPLETED|Overall Study||6
6530814|NCT01610557|7452264|FG000|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
6530815|NCT01610557|7452265|FG001|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
6530816|NCT01610557|7452266|FG002|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
6530817|NCT01610557|7452267|FG003|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
6530818|NCT01610557|7452268|FG004|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
6530819|NCT01610557|7452264|FG000|COMPLETED|36-Week Randomized Crossover Phase||16
6530820|NCT01610557|7452265|FG001|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
6530821|NCT01610557|7452266|FG002|COMPLETED|36-Week Randomized Crossover Phase||14
6530822|NCT01610557|7452267|FG003|COMPLETED|36-Week Randomized Crossover Phase||13
6530823|NCT01610557|7452268|FG004|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
6530824|NCT01610557|7452264|FG000|NOT COMPLETED|36-Week Randomized Crossover Phase||0
6530825|NCT01610557|7452265|FG001|NOT COMPLETED|36-Week Randomized Crossover Phase||1
6530826|NCT01610557|7452266|FG002|NOT COMPLETED|36-Week Randomized Crossover Phase||0
6530827|NCT01610557|7452267|FG003|NOT COMPLETED|36-Week Randomized Crossover Phase||0
6530828|NCT01610557|7452268|FG004|NOT COMPLETED|36-Week Randomized Crossover Phase||0
6530829|NCT01610557|7452264|FG000|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6530830|NCT01610557|7452265|FG001|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6530831|NCT01610557|7452266|FG002|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6530832|NCT01610557|7452267|FG003|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6530833|NCT01610557|7452268|FG004|STARTED|Post-36-Week Extension Phase||55
6530834|NCT01610557|7452264|FG000|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6530835|NCT01610557|7452265|FG001|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6530836|NCT01610557|7452266|FG002|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6530837|NCT01610557|7452267|FG003|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
6530838|NCT01610557|7452268|FG004|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
6530839|NCT01610557|7452264|FG000|NOT COMPLETED|Post-36-Week Extension Phase||0
6530840|NCT01610557|7452265|FG001|NOT COMPLETED|Post-36-Week Extension Phase||0
6530841|NCT01610557|7452266|FG002|NOT COMPLETED|Post-36-Week Extension Phase||0
6530842|NCT01610557|7452267|FG003|NOT COMPLETED|Post-36-Week Extension Phase||0
6530843|NCT01610557|7452268|FG004|NOT COMPLETED|Post-36-Week Extension Phase||3
6530844|NCT01610570|7452283|FG000|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
6530845|NCT01610570|7452284|FG001|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
6530846|NCT01610570|7452285|FG002|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
6530847|NCT01610570|7452286|FG003|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
6530848|NCT01610570|7452283|FG000|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6530849|NCT01610570|7452284|FG001|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
6530850|NCT01610570|7452285|FG002|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6530851|NCT01610570|7452286|FG003|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6530852|NCT01610570|7452283|FG000|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6530853|NCT01610570|7452284|FG001|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6530854|NCT01610570|7452285|FG002|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6530855|NCT01610570|7452286|FG003|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
6530856|NCT01610570|7452283|FG000|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
6530857|NCT01610570|7452284|FG001|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
6530858|NCT01610570|7452285|FG002|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
6530859|NCT01610570|7452286|FG003|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
6530860|NCT01610570|7452283|FG000|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6530861|NCT01610570|7452284|FG001|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6530862|NCT01610570|7452285|FG002|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6530863|NCT01610570|7452286|FG003|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
6530864|NCT01610570|7452283|FG000|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6530865|NCT01610570|7452284|FG001|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6530866|NCT01610570|7452285|FG002|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6530867|NCT01610570|7452286|FG003|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
6530868|NCT01610570|7452283|FG000|STARTED|Ph II >/= 12 mo. & </=17yrs||0
6530869|NCT01610570|7452284|FG001|STARTED|Ph II >/= 12 mo. & </=17yrs||0
6530870|NCT01610570|7452285|FG002|STARTED|Ph II >/= 12 mo. & </=17yrs||0
6530871|NCT01610570|7452286|FG003|STARTED|Ph II >/= 12 mo. & </=17yrs||0
6530872|NCT01610570|7452283|FG000|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6530873|NCT01610570|7452284|FG001|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6530874|NCT01610570|7452285|FG002|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6530875|NCT01610570|7452286|FG003|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6530876|NCT01610570|7452283|FG000|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6530877|NCT01610570|7452284|FG001|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6530878|NCT01610570|7452285|FG002|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6530879|NCT01610570|7452286|FG003|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
6530880|NCT01610596|7452304|FG000|STARTED|Overall Study||36
6530881|NCT01610596|7452305|FG001|STARTED|Overall Study||36
6530882|NCT01610596|7452304|FG000|COMPLETED|Overall Study||36
6530883|NCT01610596|7452305|FG001|COMPLETED|Overall Study||35
6530884|NCT01610596|7452304|FG000|NOT COMPLETED|Overall Study||0
6530885|NCT01610596|7452305|FG001|NOT COMPLETED|Overall Study||1
6530886|NCT01610687|7452311|FG000|STARTED|Overall Study||137
6530887|NCT01610687|7452311|FG000|COMPLETED|Overall Study||70
6530888|NCT01610687|7452311|FG000|NOT COMPLETED|Overall Study||67
6530889|NCT01610700|7452317|FG000|STARTED|Overall Study||80
6530890|NCT01610700|7452318|FG001|STARTED|Overall Study||80
6530891|NCT01610700|7452317|FG000|COMPLETED|Overall Study||77
6530892|NCT01610700|7452318|FG001|COMPLETED|Overall Study||77
6530893|NCT01610700|7452317|FG000|NOT COMPLETED|Overall Study||3
6530894|NCT01610700|7452318|FG001|NOT COMPLETED|Overall Study||3
6530895|NCT01610713|7452327|FG000|STARTED|Overall Study||77
6530896|NCT01610713|7452328|FG001|STARTED|Overall Study||77
6530897|NCT01610713|7452327|FG000|COMPLETED|Overall Study||71
6530898|NCT01610713|7452328|FG001|COMPLETED|Overall Study||76
6530899|NCT01610713|7452327|FG000|NOT COMPLETED|Overall Study||6
6530900|NCT01610713|7452328|FG001|NOT COMPLETED|Overall Study||1
6530901|NCT01610752|7452337|FG000|STARTED|Overall Study||18
6530902|NCT01610752|7452338|FG001|STARTED|Overall Study||19
6530903|NCT01610752|7452339|FG002|STARTED|Overall Study||17
6530904|NCT01610752|7452337|FG000|COMPLETED|Overall Study||18
6530905|NCT01610752|7452338|FG001|COMPLETED|Overall Study||19
6530906|NCT01610752|7452339|FG002|COMPLETED|Overall Study||13
6530907|NCT01610752|7452337|FG000|NOT COMPLETED|Overall Study||0
6530908|NCT01610752|7452338|FG001|NOT COMPLETED|Overall Study||0
6530909|NCT01610752|7452339|FG002|NOT COMPLETED|Overall Study||4
6530910|NCT01610791|7452347|FG000|STARTED|Overall Study||121
6530911|NCT01610791|7452347|FG000|COMPLETED|Overall Study||100
6530912|NCT01610791|7452347|FG000|NOT COMPLETED|Overall Study||21
6644281|NCT02362282|7572893|FG001|STARTED|Overall Study||7
6644282|NCT02362282|7572892|FG000|COMPLETED|Overall Study||4
6644283|NCT02362282|7572893|FG001|COMPLETED|Overall Study||7
6644284|NCT02362282|7572892|FG000|NOT COMPLETED|Overall Study||1
6530913|NCT01611090|7452353|FG000|STARTED|Randomized Period||289
6530914|NCT01611090|7452354|FG001|STARTED|Randomized Period||289
6530915|NCT01611090|7452355|FG002|STARTED|Randomized Period||0
6530916|NCT01611090|7452353|FG000|Treated|Randomized Period||287
6530917|NCT01611090|7452354|FG001|Treated|Randomized Period||287
6530918|NCT01611090|7452355|FG002|Treated|Randomized Period||0
6530919|NCT01611090|7452353|FG000|COMPLETED|Randomized Period||259
6530920|NCT01611090|7452354|FG001|COMPLETED|Randomized Period||260
6530921|NCT01611090|7452355|FG002|COMPLETED|Randomized Period||0
6530922|NCT01611090|7452353|FG000|NOT COMPLETED|Randomized Period||30
6530923|NCT01611090|7452354|FG001|NOT COMPLETED|Randomized Period||29
6530924|NCT01611090|7452355|FG002|NOT COMPLETED|Randomized Period||0
6530925|NCT01611090|7452353|FG000|STARTED|Cross Over (Placebo to Ibrutinib)||0
6530926|NCT01611090|7452354|FG001|STARTED|Cross Over (Placebo to Ibrutinib)||0
6530927|NCT01611090|7452355|FG002|STARTED|Cross Over (Placebo to Ibrutinib)||183
6530928|NCT01611090|7452353|FG000|Treated|Cross Over (Placebo to Ibrutinib)||0
6530929|NCT01611090|7452354|FG001|Treated|Cross Over (Placebo to Ibrutinib)||0
6530930|NCT01611090|7452355|FG002|Treated|Cross Over (Placebo to Ibrutinib)||183
6530931|NCT01611090|7452353|FG000|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
6530932|NCT01611090|7452354|FG001|COMPLETED|Cross Over (Placebo to Ibrutinib)||0
6530933|NCT01611090|7452355|FG002|COMPLETED|Cross Over (Placebo to Ibrutinib)||178
6530934|NCT01611090|7452353|FG000|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
6644285|NCT02362282|7572893|FG001|NOT COMPLETED|Overall Study||0
6644286|NCT02362321|7572901|FG000|STARTED|Overall Study||10
6644287|NCT02362321|7572902|FG001|STARTED|Overall Study||10
6644288|NCT02362321|7572901|FG000|COMPLETED|Overall Study||6
6644289|NCT02362321|7572902|FG001|COMPLETED|Overall Study||10
6644290|NCT02362321|7572901|FG000|NOT COMPLETED|Overall Study||4
6644291|NCT02362321|7572902|FG001|NOT COMPLETED|Overall Study||0
6644292|NCT02362360|7572908|FG000|STARTED|Period 1||26
6644293|NCT02362360|7572909|FG001|STARTED|Period 1||26
6644294|NCT02362360|7572908|FG000|COMPLETED|Period 1||23
6644295|NCT02362360|7572909|FG001|COMPLETED|Period 1||25
6644296|NCT02362360|7572908|FG000|NOT COMPLETED|Period 1||3
6644297|NCT02362360|7572909|FG001|NOT COMPLETED|Period 1||1
6644298|NCT02362360|7572908|FG000|STARTED|Period 2||23
6644299|NCT02362360|7572909|FG001|STARTED|Period 2||25
6644300|NCT02362360|7572908|FG000|COMPLETED|Period 2||23
6644301|NCT02362360|7572909|FG001|COMPLETED|Period 2||25
6644302|NCT02362360|7572908|FG000|NOT COMPLETED|Period 2||0
6644303|NCT02362360|7572909|FG001|NOT COMPLETED|Period 2||0
6644304|NCT02362373|7572915|FG000|STARTED|Overall Study||20
6644305|NCT02362373|7572915|FG000|COMPLETED|Overall Study||20
6644306|NCT02362373|7572915|FG000|NOT COMPLETED|Overall Study||0
6644307|NCT02362412|7572919|FG000|STARTED|Treatment Period II||9
6644308|NCT02362412|7572920|FG001|STARTED|Treatment Period II||11
6644309|NCT02362412|7572919|FG000|TREATED|Treatment Period II||9
6644310|NCT02362412|7572920|FG001|TREATED|Treatment Period II||11
6644311|NCT02362412|7572919|FG000|COMPLETED|Treatment Period II||9
6644312|NCT02362412|7572920|FG001|COMPLETED|Treatment Period II||11
6644313|NCT02362412|7572919|FG000|NOT COMPLETED|Treatment Period II||0
6644314|NCT02362412|7572920|FG001|NOT COMPLETED|Treatment Period II||0
6644315|NCT02362412|7572919|FG000|STARTED|Treatment Period III||9
6644316|NCT02362412|7572920|FG001|STARTED|Treatment Period III||11
6644317|NCT02362412|7572919|FG000|TREATED|Treatment Period III||9
6644318|NCT02362412|7572920|FG001|TREATED|Treatment Period III||11
6644319|NCT02362412|7572919|FG000|COMPLETED|Treatment Period III||9
6644320|NCT02362412|7572920|FG001|COMPLETED|Treatment Period III||10
6644321|NCT02362412|7572919|FG000|NOT COMPLETED|Treatment Period III||0
6644322|NCT02362412|7572920|FG001|NOT COMPLETED|Treatment Period III||1
6644323|NCT02362425|7572936|FG000|STARTED|Phase 1 (up to 6 Months)||53
6644324|NCT02362425|7572937|FG001|STARTED|Phase 1 (up to 6 Months)||10
6644325|NCT02362425|7572938|FG002|STARTED|Phase 1 (up to 6 Months)||0
6530935|NCT01611090|7452354|FG001|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||0
6530936|NCT01611090|7452355|FG002|NOT COMPLETED|Cross Over (Placebo to Ibrutinib)||5
6644326|NCT02362425|7572939|FG003|STARTED|Phase 1 (up to 6 Months)||0
6644327|NCT02362425|7572936|FG000|COMPLETED|Phase 1 (up to 6 Months)||37
6644328|NCT02362425|7572937|FG001|COMPLETED|Phase 1 (up to 6 Months)||10
6644329|NCT02362425|7572938|FG002|COMPLETED|Phase 1 (up to 6 Months)||0
6530937|NCT01611155|7452364|FG000|STARTED|Overall Study||25
6530938|NCT01611155|7452365|FG001|STARTED|Overall Study||25
6530939|NCT01611155|7452364|FG000|Received Treatment|Overall Study||25
6530940|NCT01611155|7452365|FG001|Received Treatment|Overall Study||25
6530941|NCT01611155|7452364|FG000|COMPLETED|Overall Study||16
6530942|NCT01611155|7452365|FG001|COMPLETED|Overall Study||18
6530943|NCT01611155|7452364|FG000|NOT COMPLETED|Overall Study||9
6530944|NCT01611155|7452365|FG001|NOT COMPLETED|Overall Study||7
6530945|NCT01611194|7452373|FG000|STARTED|Overall Study||36
6530946|NCT01611194|7452374|FG001|STARTED|Overall Study||35
6530947|NCT01611194|7452373|FG000|COMPLETED|Overall Study||36
6530948|NCT01611194|7452374|FG001|COMPLETED|Overall Study||32
6530949|NCT01611194|7452373|FG000|NOT COMPLETED|Overall Study||0
6530950|NCT01611194|7452374|FG001|NOT COMPLETED|Overall Study||3
6530951|NCT01611259|7452380|FG000|STARTED|Overall Study||48
6530952|NCT01611259|7452380|FG000|COMPLETED|Overall Study||34
6530953|NCT01611259|7452380|FG000|NOT COMPLETED|Overall Study||14
6530954|NCT01611298|7452384|FG000|STARTED|Overall Study||7
6530955|NCT01611298|7452384|FG000|COMPLETED|Overall Study||5
6530956|NCT01611298|7452384|FG000|NOT COMPLETED|Overall Study||2
6530957|NCT01611454|7452390|FG000|STARTED|Overall Study||58
6530958|NCT01611454|7452391|FG001|STARTED|Overall Study||48
6530959|NCT01611454|7452390|FG000|COMPLETED|Overall Study||40
6530960|NCT01611454|7452391|FG001|COMPLETED|Overall Study||38
6530961|NCT01611454|7452390|FG000|NOT COMPLETED|Overall Study||18
6530962|NCT01611454|7452391|FG001|NOT COMPLETED|Overall Study||10
6530963|NCT01611558|7452401|FG000|STARTED|Induction Phase||40
6530964|NCT01611558|7452401|FG000|COMPLETED|Induction Phase||2
6530965|NCT01611558|7452401|FG000|NOT COMPLETED|Induction Phase||38
6530966|NCT01611558|7452401|FG000|STARTED|Maintenance Phase||2
6530967|NCT01611558|7452401|FG000|COMPLETED|Maintenance Phase||0
6530968|NCT01611558|7452401|FG000|NOT COMPLETED|Maintenance Phase||2
6530969|NCT01611571|7452409|FG000|STARTED|Overall Study||11
6530970|NCT01611571|7452410|FG001|STARTED|Overall Study||10
6530971|NCT01611571|7452411|FG002|STARTED|Overall Study||10
6530972|NCT01611571|7452409|FG000|COMPLETED|Overall Study||10
6530973|NCT01611571|7452410|FG001|COMPLETED|Overall Study||10
6530974|NCT01611571|7452411|FG002|COMPLETED|Overall Study||9
6530975|NCT01611571|7452409|FG000|NOT COMPLETED|Overall Study||1
6530976|NCT01611571|7452410|FG001|NOT COMPLETED|Overall Study||0
6530977|NCT01611571|7452411|FG002|NOT COMPLETED|Overall Study||1
6530978|NCT01611662|7452419|FG000|STARTED|Overall Study||32
6530979|NCT01611662|7452419|FG000|COMPLETED|Overall Study||31
6530980|NCT01611662|7452419|FG000|NOT COMPLETED|Overall Study||1
6644330|NCT02362425|7572939|FG003|COMPLETED|Phase 1 (up to 6 Months)||0
6644331|NCT02362425|7572936|FG000|NOT COMPLETED|Phase 1 (up to 6 Months)||16
6644332|NCT02362425|7572937|FG001|NOT COMPLETED|Phase 1 (up to 6 Months)||0
6644333|NCT02362425|7572938|FG002|NOT COMPLETED|Phase 1 (up to 6 Months)||0
6644334|NCT02362425|7572939|FG003|NOT COMPLETED|Phase 1 (up to 6 Months)||0
6644335|NCT02362425|7572936|FG000|STARTED|Phase 2 (up to 6 Months, Randomized)||0
6644336|NCT02362425|7572937|FG001|STARTED|Phase 2 (up to 6 Months, Randomized)||0
6644337|NCT02362425|7572938|FG002|STARTED|Phase 2 (up to 6 Months, Randomized)||16
6644338|NCT02362425|7572939|FG003|STARTED|Phase 2 (up to 6 Months, Randomized)||17
6644339|NCT02362425|7572936|FG000|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
6644340|NCT02362425|7572937|FG001|COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
6644341|NCT02362425|7572938|FG002|COMPLETED|Phase 2 (up to 6 Months, Randomized)||15
6644342|NCT02362425|7572939|FG003|COMPLETED|Phase 2 (up to 6 Months, Randomized)||14
6644343|NCT02362425|7572936|FG000|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
6644344|NCT02362425|7572937|FG001|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||0
6644345|NCT02362425|7572938|FG002|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||1
6644346|NCT02362425|7572939|FG003|NOT COMPLETED|Phase 2 (up to 6 Months, Randomized)||3
6644347|NCT02362594|7572952|FG000|STARTED|Overall Study||514
6644348|NCT02362594|7572953|FG001|STARTED|Overall Study||505
6644349|NCT02362594|7572952|FG000|Treated|Overall Study||509
6644350|NCT02362594|7572953|FG001|Treated|Overall Study||502
6644351|NCT02362594|7572952|FG000|Continuing Part 1 Adjuvant Therapy|Overall Study||41
6644352|NCT02362594|7572953|FG001|Continuing Part 1 Adjuvant Therapy|Overall Study||21
6530981|NCT01611779|7452423|FG000|STARTED|Overall Study||5
6530982|NCT01611779|7452423|FG000|COMPLETED|Overall Study||5
6530983|NCT01611779|7452423|FG000|NOT COMPLETED|Overall Study||0
6530984|NCT01611792|7452429|FG000|STARTED|Initial Period: Time 0||29
6530985|NCT01611792|7452430|FG001|STARTED|Initial Period: Time 0||29
6530986|NCT01611792|7452429|FG000|COMPLETED|Initial Period: Time 0||17
6530987|NCT01611792|7452430|FG001|COMPLETED|Initial Period: Time 0||20
6530988|NCT01611792|7452429|FG000|NOT COMPLETED|Initial Period: Time 0||12
6530989|NCT01611792|7452430|FG001|NOT COMPLETED|Initial Period: Time 0||9
6530990|NCT01611792|7452429|FG000|STARTED|Follow-up: at 11 Weeks||17
6644353|NCT02362594|7572952|FG000|COMPLETED|Overall Study||264
6644354|NCT02362594|7572953|FG001|COMPLETED|Overall Study||280
6644355|NCT02362594|7572952|FG000|NOT COMPLETED|Overall Study||250
6644356|NCT02362594|7572953|FG001|NOT COMPLETED|Overall Study||225
6644357|NCT02362646|7572961|FG000|STARTED|Overall Study||106
6644358|NCT02362646|7572962|FG001|STARTED|Overall Study||53
6644359|NCT02362646|7572961|FG000|COMPLETED|Overall Study||68
6644360|NCT02362646|7572962|FG001|COMPLETED|Overall Study||29
6644361|NCT02362646|7572961|FG000|NOT COMPLETED|Overall Study||38
6644362|NCT02362646|7572962|FG001|NOT COMPLETED|Overall Study||24
6644363|NCT02362672|7572972|FG000|STARTED|Titration Phase||1189
6530991|NCT01611792|7452430|FG001|STARTED|Follow-up: at 11 Weeks||20
6530992|NCT01611792|7452429|FG000|COMPLETED|Follow-up: at 11 Weeks||17
6530993|NCT01611792|7452430|FG001|COMPLETED|Follow-up: at 11 Weeks||20
6530994|NCT01611792|7452429|FG000|NOT COMPLETED|Follow-up: at 11 Weeks||0
6530995|NCT01611792|7452430|FG001|NOT COMPLETED|Follow-up: at 11 Weeks||0
6530996|NCT01611792|7452429|FG000|STARTED|Followup: at 6 Months||17
6530997|NCT01611792|7452430|FG001|STARTED|Followup: at 6 Months||20
6530998|NCT01611792|7452429|FG000|COMPLETED|Followup: at 6 Months||11
6530999|NCT01611792|7452430|FG001|COMPLETED|Followup: at 6 Months||7
6531000|NCT01611792|7452429|FG000|NOT COMPLETED|Followup: at 6 Months||6
6531001|NCT01611792|7452430|FG001|NOT COMPLETED|Followup: at 6 Months||13
6531002|NCT01611857|7452439|FG000|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
6531003|NCT01611857|7452440|FG001|STARTED|Overall Study||34
6531004|NCT01611857|7452439|FG000|Tivantinib 120 mg|Overall Study||5
6531005|NCT01611857|7452440|FG001|Tivantinib 120 mg|Overall Study||0
6531006|NCT01611857|7452439|FG000|Tivantinib 240 mg|Overall Study||3
6531007|NCT01611857|7452440|FG001|Tivantinib 240 mg|Overall Study||0
6531008|NCT01611857|7452439|FG000|Tivantinib 360 mg|Overall Study||7
6531009|NCT01611857|7452440|FG001|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
6531010|NCT01611857|7452439|FG000|COMPLETED|Overall Study||15
6531011|NCT01611857|7452440|FG001|COMPLETED|Overall Study||32
6531012|NCT01611857|7452439|FG000|NOT COMPLETED|Overall Study||0
6531013|NCT01611857|7452440|FG001|NOT COMPLETED|Overall Study||2
6531014|NCT01611935|7452450|FG000|STARTED|Overall Study||50
6531015|NCT01611935|7452451|FG001|STARTED|Overall Study||51
6531016|NCT01611935|7452450|FG000|COMPLETED|Overall Study||49
6531017|NCT01611935|7452451|FG001|COMPLETED|Overall Study||51
6531018|NCT01611935|7452450|FG000|NOT COMPLETED|Overall Study||1
6531019|NCT01611935|7452451|FG001|NOT COMPLETED|Overall Study||0
6531020|NCT01611948|7452459|FG000|STARTED|Overall Study||32
6531021|NCT01611948|7452460|FG001|STARTED|Overall Study||38
6531022|NCT01611948|7452459|FG000|COMPLETED|Overall Study||18
6531023|NCT01611948|7452460|FG001|COMPLETED|Overall Study||26
6531024|NCT01611948|7452459|FG000|NOT COMPLETED|Overall Study||14
6531025|NCT01611948|7452460|FG001|NOT COMPLETED|Overall Study||12
6531026|NCT01611974|7452469|FG000|STARTED|Overall Study||40
6531027|NCT01611974|7452470|FG001|STARTED|Overall Study||40
6531028|NCT01611974|7452471|FG002|STARTED|Overall Study||40
6531029|NCT01611974|7452469|FG000|COMPLETED|Overall Study||25
6531030|NCT01611974|7452470|FG001|COMPLETED|Overall Study||25
6531031|NCT01611974|7452471|FG002|COMPLETED|Overall Study||24
6531032|NCT01611974|7452469|FG000|NOT COMPLETED|Overall Study||15
6531033|NCT01611974|7452470|FG001|NOT COMPLETED|Overall Study||15
6531034|NCT01611974|7452471|FG002|NOT COMPLETED|Overall Study||16
6531035|NCT01612000|7452483|FG000|STARTED|Overall Study||84
6531036|NCT01612000|7452484|FG001|STARTED|Overall Study||86
6531037|NCT01612000|7452485|FG002|STARTED|Overall Study||85
6531038|NCT01612000|7452486|FG003|STARTED|Overall Study||86
6531039|NCT01612000|7452483|FG000|COMPLETED|Overall Study||75
6531040|NCT01612000|7452484|FG001|COMPLETED|Overall Study||81
6531041|NCT01612000|7452485|FG002|COMPLETED|Overall Study||78
6531042|NCT01612000|7452486|FG003|COMPLETED|Overall Study||76
6531043|NCT01612000|7452483|FG000|NOT COMPLETED|Overall Study||9
6531044|NCT01612000|7452484|FG001|NOT COMPLETED|Overall Study||5
6531045|NCT01612000|7452485|FG002|NOT COMPLETED|Overall Study||7
6531046|NCT01612000|7452486|FG003|NOT COMPLETED|Overall Study||10
6531047|NCT01612156|7452498|FG000|STARTED|Overall Study||42
6531048|NCT01612156|7452499|FG001|STARTED|Overall Study||48
6531049|NCT01612156|7452498|FG000|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
6531050|NCT01612156|7452499|FG001|COMPLETED|Overall Study||48
6531051|NCT01612156|7452498|FG000|NOT COMPLETED|Overall Study||2
6531052|NCT01612156|7452499|FG001|NOT COMPLETED|Overall Study||0
6531053|NCT01612221|7452507|FG000|STARTED|Overall Study||50
6531054|NCT01612221|7452508|FG001|STARTED|Overall Study||50
6531055|NCT01612221|7452507|FG000|COMPLETED|Overall Study||50
6531056|NCT01612221|7452508|FG001|COMPLETED|Overall Study||50
6531057|NCT01612221|7452507|FG000|NOT COMPLETED|Overall Study||0
6531058|NCT01612221|7452508|FG001|NOT COMPLETED|Overall Study||0
6531059|NCT01612494|7452516|FG000|STARTED|Overall Study||21
6531060|NCT01612494|7452517|FG001|STARTED|Overall Study||23
6531061|NCT01612494|7452516|FG000|COMPLETED|Overall Study||21
6531062|NCT01612494|7452517|FG001|COMPLETED|Overall Study||23
6531063|NCT01612494|7452516|FG000|NOT COMPLETED|Overall Study||0
6531064|NCT01612494|7452517|FG001|NOT COMPLETED|Overall Study||0
6531065|NCT01612546|7452523|FG000|STARTED|Overall Study||10
6531066|NCT01612546|7452523|FG000|COMPLETED|Overall Study||10
6531067|NCT01612546|7452523|FG000|NOT COMPLETED|Overall Study||0
6531068|NCT01612676|7452531|FG000|STARTED|Overall Study||6
6531069|NCT01612676|7452532|FG001|STARTED|Overall Study||7
6531070|NCT01612676|7452533|FG002|STARTED|Overall Study||5
6531071|NCT01612676|7452534|FG003|STARTED|Overall Study||13
6531072|NCT01612676|7452531|FG000|Dosed|Overall Study||5
6531073|NCT01612676|7452532|FG001|Dosed|Overall Study||7
6531074|NCT01612676|7452533|FG002|Dosed|Overall Study||5
6531075|NCT01612676|7452534|FG003|Dosed|Overall Study||13
6531076|NCT01612676|7452531|FG000|COMPLETED|Overall Study||4
6531077|NCT01612676|7452532|FG001|COMPLETED|Overall Study||3
6531078|NCT01612676|7452533|FG002|COMPLETED|Overall Study||4
6531079|NCT01612676|7452534|FG003|COMPLETED|Overall Study||10
6531080|NCT01612676|7452531|FG000|NOT COMPLETED|Overall Study||2
6531081|NCT01612676|7452532|FG001|NOT COMPLETED|Overall Study||4
6531082|NCT01612676|7452533|FG002|NOT COMPLETED|Overall Study||1
6531083|NCT01612676|7452534|FG003|NOT COMPLETED|Overall Study||3
6531084|NCT01612702|7452548|FG000|STARTED|Overall Study||146
6531085|NCT01612702|7452549|FG001|STARTED|Overall Study||145
6531086|NCT01612702|7452548|FG000|COMPLETED|Overall Study||135
6531087|NCT01612702|7452549|FG001|COMPLETED|Overall Study||134
6531088|NCT01612702|7452548|FG000|NOT COMPLETED|Overall Study||11
6531089|NCT01612702|7452549|FG001|NOT COMPLETED|Overall Study||11
6531090|NCT01612767|7452555|FG000|STARTED|Overall Study||329
6531091|NCT01612767|7452555|FG000|COMPLETED|Overall Study||287
6531092|NCT01612767|7452555|FG000|NOT COMPLETED|Overall Study||42
6531093|NCT01612780|7452580|FG000|STARTED|Overall Study||82
6531094|NCT01612780|7452580|FG000|COMPLETED|Overall Study||76
6531095|NCT01612780|7452580|FG000|NOT COMPLETED|Overall Study||6
6531096|NCT01612793|7452586|FG000|STARTED|Overall Study||2
6531097|NCT01612793|7452587|FG001|STARTED|Overall Study||2
6531098|NCT01612793|7452586|FG000|COMPLETED|Overall Study||2
6531099|NCT01612793|7452587|FG001|COMPLETED|Overall Study||2
6531100|NCT01612793|7452586|FG000|NOT COMPLETED|Overall Study||0
6531101|NCT01612793|7452587|FG001|NOT COMPLETED|Overall Study||0
6531102|NCT01612858|7452595|FG000|STARTED|Overall Study||16
6531103|NCT01612858|7452596|FG001|STARTED|Overall Study||4
6531104|NCT01612858|7452595|FG000|COMPLETED|Overall Study||11
6531105|NCT01612858|7452596|FG001|COMPLETED|Overall Study||3
6531106|NCT01612858|7452595|FG000|NOT COMPLETED|Overall Study||5
6531107|NCT01612858|7452596|FG001|NOT COMPLETED|Overall Study||1
6531108|NCT01612884|7452604|FG000|STARTED|Overall Study||19
6531109|NCT01612884|7452605|FG001|STARTED|Overall Study||18
6531110|NCT01612884|7452604|FG000|COMPLETED|Overall Study||19
6531111|NCT01612884|7452605|FG001|COMPLETED|Overall Study||18
6531112|NCT01612884|7452604|FG000|NOT COMPLETED|Overall Study||0
6531113|NCT01612884|7452605|FG001|NOT COMPLETED|Overall Study||0
6531114|NCT01613014|7452613|FG000|STARTED|Overall Study||75
6531115|NCT01613014|7452614|FG001|STARTED|Overall Study||75
6531116|NCT01613014|7452613|FG000|COMPLETED|Overall Study||57
6531117|NCT01613014|7452614|FG001|COMPLETED|Overall Study||63
6531118|NCT01613014|7452613|FG000|NOT COMPLETED|Overall Study||18
6531119|NCT01613014|7452614|FG001|NOT COMPLETED|Overall Study||12
6531120|NCT01613027|7452620|FG000|STARTED|Overall Study||135
6531121|NCT01613027|7452620|FG000|COMPLETED|Overall Study||127
6531122|NCT01613027|7452620|FG000|NOT COMPLETED|Overall Study||8
6531123|NCT01613118|7452628|FG000|STARTED|Double-blind||13
6531124|NCT01613118|7452629|FG001|STARTED|Double-blind||26
6531125|NCT01613118|7452630|FG002|STARTED|Double-blind||34
6531126|NCT01613118|7452631|FG003|STARTED|Double-blind||36
6531127|NCT01613118|7452628|FG000|COMPLETED|Double-blind||13
6531128|NCT01613118|7452629|FG001|COMPLETED|Double-blind||23
6531129|NCT01613118|7452630|FG002|COMPLETED|Double-blind||32
6531130|NCT01613118|7452631|FG003|COMPLETED|Double-blind||35
6531131|NCT01613118|7452628|FG000|NOT COMPLETED|Double-blind||0
6531132|NCT01613118|7452629|FG001|NOT COMPLETED|Double-blind||3
6531133|NCT01613118|7452630|FG002|NOT COMPLETED|Double-blind||2
6531134|NCT01613118|7452631|FG003|NOT COMPLETED|Double-blind||1
6531135|NCT01613118|7452628|FG000|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|21
6531136|NCT01613118|7452629|FG001|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|42
6531137|NCT01613118|7452630|FG002|STARTED|Open-label Extension|Arm includes subjects from the Irbesartan Arm in the Double-blind period.|40
6531138|NCT01613118|7452631|FG003|STARTED|Open-label Extension||0
6531139|NCT01613118|7452628|FG000|COMPLETED|Open-label Extension|OLE ongoing|0
6531140|NCT01613118|7452629|FG001|COMPLETED|Open-label Extension|OLE ongoing|0
6531141|NCT01613118|7452630|FG002|COMPLETED|Open-label Extension|OLE ongoing|0
6531142|NCT01613118|7452631|FG003|COMPLETED|Open-label Extension||0
6531143|NCT01613118|7452628|FG000|NOT COMPLETED|Open-label Extension||21
6531144|NCT01613118|7452629|FG001|NOT COMPLETED|Open-label Extension||42
6531145|NCT01613118|7452630|FG002|NOT COMPLETED|Open-label Extension||40
6531146|NCT01613118|7452631|FG003|NOT COMPLETED|Open-label Extension||0
6561986|NCT01798186|7484949|FG003|NOT COMPLETED|Overall Study||0
6561987|NCT01798225|7484964|FG000|STARTED|Overall Study||57
6561988|NCT01798225|7484965|FG001|STARTED|Overall Study||56
6561989|NCT01798225|7484964|FG000|COMPLETED|Overall Study||57
6561990|NCT01798225|7484965|FG001|COMPLETED|Overall Study||53
6561991|NCT01798225|7484964|FG000|NOT COMPLETED|Overall Study||0
6561992|NCT01798225|7484965|FG001|NOT COMPLETED|Overall Study||3
6561993|NCT01798264|7484975|FG000|STARTED|Overall Study||12
6561994|NCT01798264|7484976|FG001|STARTED|Overall Study||11
6561995|NCT01798264|7484977|FG002|STARTED|Overall Study||10
6561996|NCT01798264|7484978|FG003|STARTED|Overall Study||11
6561997|NCT01798264|7484975|FG000|COMPLETED|Overall Study||11
6561998|NCT01798264|7484976|FG001|COMPLETED|Overall Study||11
6561999|NCT01798264|7484977|FG002|COMPLETED|Overall Study||10
6562000|NCT01798264|7484978|FG003|COMPLETED|Overall Study||7
6562001|NCT01798264|7484975|FG000|NOT COMPLETED|Overall Study||1
6562002|NCT01798264|7484976|FG001|NOT COMPLETED|Overall Study||0
6562003|NCT01798264|7484977|FG002|NOT COMPLETED|Overall Study||0
6562004|NCT01798264|7484978|FG003|NOT COMPLETED|Overall Study||4
6562005|NCT01798316|7484990|FG000|STARTED|Overall Study||52
6562006|NCT01798316|7484991|FG001|STARTED|Overall Study||53
6562007|NCT01798316|7484990|FG000|COMPLETED|Overall Study||52
6562008|NCT01798316|7484991|FG001|COMPLETED|Overall Study||53
6531147|NCT01613131|7452644|FG000|STARTED|Overall Study||20
6531148|NCT01613131|7452645|FG001|STARTED|Overall Study||18
6531149|NCT01613131|7452644|FG000|COMPLETED|Overall Study||17
6531150|NCT01613131|7452645|FG001|COMPLETED|Overall Study||13
6531151|NCT01613131|7452644|FG000|NOT COMPLETED|Overall Study||3
6531152|NCT01613131|7452645|FG001|NOT COMPLETED|Overall Study||5
6531153|NCT01613222|7452651|FG000|STARTED|Overall Study||63
6531154|NCT01613222|7452651|FG000|COMPLETED|Overall Study||51
6531155|NCT01613222|7452651|FG000|NOT COMPLETED|Overall Study||12
6531156|NCT01613248|7452670|FG000|STARTED|Overall Study||139
6531157|NCT01613248|7452671|FG001|STARTED|Overall Study||138
6531158|NCT01613248|7452672|FG002|STARTED|Overall Study||139
6531159|NCT01613248|7452673|FG003|STARTED|Overall Study||139
6531160|NCT01613248|7452674|FG004|STARTED|Overall Study||139
6531161|NCT01613248|7452675|FG005|STARTED|Overall Study||140
6531162|NCT01613248|7452670|FG000|COMPLETED|Overall Study||110
6531163|NCT01613248|7452671|FG001|COMPLETED|Overall Study||104
6531164|NCT01613248|7452672|FG002|COMPLETED|Overall Study||106
6531165|NCT01613248|7452673|FG003|COMPLETED|Overall Study||101
6531166|NCT01613248|7452674|FG004|COMPLETED|Overall Study||104
6531167|NCT01613248|7452675|FG005|COMPLETED|Overall Study||102
6531168|NCT01613248|7452670|FG000|NOT COMPLETED|Overall Study||29
6531169|NCT01613248|7452671|FG001|NOT COMPLETED|Overall Study||34
6531170|NCT01613248|7452672|FG002|NOT COMPLETED|Overall Study||33
6531171|NCT01613248|7452673|FG003|NOT COMPLETED|Overall Study||38
6531172|NCT01613248|7452674|FG004|NOT COMPLETED|Overall Study||35
6531173|NCT01613248|7452675|FG005|NOT COMPLETED|Overall Study||38
6531174|NCT01613313|7452693|FG000|STARTED|Overall Study||2
6531175|NCT01613313|7452694|FG001|STARTED|Overall Study||4
6531176|NCT01613313|7452695|FG002|STARTED|Overall Study||4
6531177|NCT01613313|7452696|FG003|STARTED|Overall Study||4
6531178|NCT01613313|7452693|FG000|COMPLETED|Overall Study||2
6531179|NCT01613313|7452694|FG001|COMPLETED|Overall Study||4
6531180|NCT01613313|7452695|FG002|COMPLETED|Overall Study||4
6531181|NCT01613313|7452696|FG003|COMPLETED|Overall Study||4
6531182|NCT01613313|7452693|FG000|NOT COMPLETED|Overall Study||0
6531183|NCT01613313|7452694|FG001|NOT COMPLETED|Overall Study||0
6531184|NCT01613313|7452695|FG002|NOT COMPLETED|Overall Study||0
6531185|NCT01613313|7452696|FG003|NOT COMPLETED|Overall Study||0
6531186|NCT01613326|7452708|FG000|STARTED|Overall Study||327
6531187|NCT01613326|7452709|FG001|STARTED|Overall Study||330
6531188|NCT01613326|7452708|FG000|COMPLETED|Overall Study||314
6531189|NCT01613326|7452709|FG001|COMPLETED|Overall Study||316
6531190|NCT01613326|7452708|FG000|NOT COMPLETED|Overall Study||13
6531191|NCT01613326|7452709|FG001|NOT COMPLETED|Overall Study||14
6531192|NCT01613339|7452717|FG000|STARTED|Overall Study||24
6531193|NCT01613339|7452718|FG001|STARTED|Overall Study||22
6531194|NCT01613339|7452717|FG000|COMPLETED|Overall Study||21
6531195|NCT01613339|7452718|FG001|COMPLETED|Overall Study||21
6531196|NCT01613339|7452717|FG000|NOT COMPLETED|Overall Study||3
6531197|NCT01613339|7452718|FG001|NOT COMPLETED|Overall Study||1
6531198|NCT01613378|7452723|FG000|STARTED|Overall Study||200
6531199|NCT01613378|7452723|FG000|COMPLETED|Overall Study||161
6531200|NCT01613378|7452723|FG000|NOT COMPLETED|Overall Study||39
6531201|NCT01613417|7452729|FG000|STARTED|First Injection||113
6531202|NCT01613417|7452730|FG001|STARTED|First Injection||116
6531203|NCT01613417|7452729|FG000|COMPLETED|First Injection||113
6531204|NCT01613417|7452730|FG001|COMPLETED|First Injection||116
6531205|NCT01613417|7452729|FG000|NOT COMPLETED|First Injection||0
6531206|NCT01613417|7452730|FG001|NOT COMPLETED|First Injection||0
6531207|NCT01613417|7452729|FG000|STARTED|Washout (no Second Injection/MRI)||113
6531208|NCT01613417|7452730|FG001|STARTED|Washout (no Second Injection/MRI)||116
6531209|NCT01613417|7452729|FG000|COMPLETED|Washout (no Second Injection/MRI)||100
6644364|NCT02362672|7572973|FG001|STARTED|Titration Phase||0
6644365|NCT02362672|7572974|FG002|STARTED|Titration Phase||0
6644366|NCT02362672|7572972|FG000|COMPLETED|Titration Phase||610
6644367|NCT02362672|7572973|FG001|COMPLETED|Titration Phase||0
6644368|NCT02362672|7572974|FG002|COMPLETED|Titration Phase||0
6644369|NCT02362672|7572972|FG000|NOT COMPLETED|Titration Phase||579
6644370|NCT02362672|7572973|FG001|NOT COMPLETED|Titration Phase||0
6644371|NCT02362672|7572974|FG002|NOT COMPLETED|Titration Phase||0
6644372|NCT02362672|7572972|FG000|STARTED|Double-blind Maintenance Phase||0
6644373|NCT02362672|7572973|FG001|STARTED|Double-blind Maintenance Phase||309
6644374|NCT02362672|7572974|FG002|STARTED|Double-blind Maintenance Phase||301
6644375|NCT02362672|7572972|FG000|COMPLETED|Double-blind Maintenance Phase||0
6644376|NCT02362672|7572973|FG001|COMPLETED|Double-blind Maintenance Phase||249
6644377|NCT02362672|7572974|FG002|COMPLETED|Double-blind Maintenance Phase||242
6644378|NCT02362672|7572972|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
6644379|NCT02362672|7572973|FG001|NOT COMPLETED|Double-blind Maintenance Phase||60
6644380|NCT02362672|7572974|FG002|NOT COMPLETED|Double-blind Maintenance Phase||59
6644381|NCT02362724|7572985|FG000|STARTED|Overall Study||59
6644382|NCT02362724|7572986|FG001|STARTED|Overall Study||30
6644383|NCT02362724|7572985|FG000|COMPLETED|Overall Study||53
6644384|NCT02362724|7572986|FG001|COMPLETED|Overall Study||29
6531210|NCT01613417|7452730|FG001|COMPLETED|Washout (no Second Injection/MRI)||109
6531211|NCT01613417|7452729|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||13
6531212|NCT01613417|7452730|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||7
6531213|NCT01613417|7452729|FG000|STARTED|Second Injection||100
6531214|NCT01613417|7452730|FG001|STARTED|Second Injection||109
6531215|NCT01613417|7452729|FG000|COMPLETED|Second Injection||100
6531216|NCT01613417|7452730|FG001|COMPLETED|Second Injection||109
6531217|NCT01613417|7452729|FG000|NOT COMPLETED|Second Injection||0
6531218|NCT01613417|7452730|FG001|NOT COMPLETED|Second Injection||0
6531219|NCT01613599|7452746|FG000|STARTED|Overall Study||97
6531220|NCT01613599|7452746|FG000|COMPLETED|Overall Study||72
6531221|NCT01613599|7452746|FG000|NOT COMPLETED|Overall Study||25
6531222|NCT01613716|7452750|FG000|STARTED|Overall Study||30
6531223|NCT01613716|7452750|FG000|COMPLETED|Overall Study||23
6531224|NCT01613716|7452750|FG000|NOT COMPLETED|Overall Study||7
6531225|NCT01613768|7452754|FG000|STARTED|Overall Study||29
6531226|NCT01613768|7452754|FG000|COMPLETED|Overall Study||29
6531227|NCT01613768|7452754|FG000|NOT COMPLETED|Overall Study||0
6531228|NCT01614093|7452759|FG000|STARTED|Overall Study||17
6531229|NCT01614093|7452759|FG000|COMPLETED|Overall Study||16
6531230|NCT01614093|7452759|FG000|NOT COMPLETED|Overall Study||1
6531231|NCT01614210|7452764|FG000|STARTED|Overall Study||52
6531232|NCT01614210|7452764|FG000|COMPLETED|Overall Study||52
6531233|NCT01614210|7452764|FG000|NOT COMPLETED|Overall Study||0
6531234|NCT01614249|7452770|FG000|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
6531235|NCT01614249|7452771|FG001|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
6531236|NCT01614249|7452770|FG000|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
6531237|NCT01614249|7452771|FG001|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
6531238|NCT01614249|7452770|FG000|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
6531239|NCT01614249|7452771|FG001|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
6531240|NCT01614249|7452770|FG000|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
6531241|NCT01614249|7452771|FG001|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
6531242|NCT01614249|7452770|FG000|NOT COMPLETED|Overall Study||11
6531243|NCT01614249|7452771|FG001|NOT COMPLETED|Overall Study||23
6531244|NCT01614392|7452779|FG000|STARTED|Overall Study||25
6531245|NCT01614392|7452780|FG001|STARTED|Overall Study||27
6531246|NCT01614392|7452779|FG000|COMPLETED|Overall Study||24
6531247|NCT01614392|7452780|FG001|COMPLETED|Overall Study||24
6531248|NCT01614392|7452779|FG000|NOT COMPLETED|Overall Study||1
6531249|NCT01614392|7452780|FG001|NOT COMPLETED|Overall Study||3
6531250|NCT01614457|7452788|FG000|STARTED|Overall Study||34
6531251|NCT01614457|7452789|FG001|STARTED|Overall Study||35
6531252|NCT01614457|7452788|FG000|COMPLETED|Overall Study||32
6531253|NCT01614457|7452789|FG001|COMPLETED|Overall Study||35
6531254|NCT01614457|7452788|FG000|NOT COMPLETED|Overall Study||2
6531255|NCT01614457|7452789|FG001|NOT COMPLETED|Overall Study||0
6531256|NCT01614470|7452797|FG000|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
6531257|NCT01614470|7452798|FG001|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
6531258|NCT01614470|7452799|FG002|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
6531259|NCT01614470|7452797|FG000|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
6531260|NCT01614470|7452798|FG001|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
6531261|NCT01614470|7452799|FG002|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
6531262|NCT01614470|7452797|FG000|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
6531263|NCT01614470|7452798|FG001|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
6531264|NCT01614470|7452799|FG002|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
6531265|NCT01614470|7452797|FG000|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
6531266|NCT01614470|7452798|FG001|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
6531267|NCT01614470|7452799|FG002|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
6531268|NCT01614470|7452797|FG000|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
6531269|NCT01614470|7452798|FG001|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
6531270|NCT01614470|7452799|FG002|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
6531271|NCT01614470|7452797|FG000|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
6531272|NCT01614470|7452798|FG001|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
6531273|NCT01614470|7452799|FG002|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
6531274|NCT01614470|7452797|FG000|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
6531275|NCT01614470|7452798|FG001|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
6531276|NCT01614470|7452799|FG002|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
6531277|NCT01614470|7452797|FG000|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
6531278|NCT01614470|7452798|FG001|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
6531279|NCT01614470|7452799|FG002|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
6531280|NCT01614470|7452797|FG000|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
6531281|NCT01614470|7452798|FG001|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
6531282|NCT01614470|7452799|FG002|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
6531283|NCT01614470|7452797|FG000|STARTED|Part 2: Open-label Period (16 Weeks)||0
6531284|NCT01614470|7452798|FG001|STARTED|Part 2: Open-label Period (16 Weeks)||0
6531285|NCT01614470|7452799|FG002|STARTED|Part 2: Open-label Period (16 Weeks)||36
6531286|NCT01614470|7452797|FG000|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6531287|NCT01614470|7452798|FG001|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6531288|NCT01614470|7452799|FG002|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
6531289|NCT01614470|7452797|FG000|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6531290|NCT01614470|7452798|FG001|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6531291|NCT01614470|7452799|FG002|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
6531292|NCT01614509|7452810|FG000|STARTED|Overall Study||24
6531293|NCT01614509|7452811|FG001|STARTED|Overall Study||21
6531294|NCT01614509|7452810|FG000|COMPLETED|Overall Study||23
6531295|NCT01614509|7452811|FG001|COMPLETED|Overall Study||18
6531296|NCT01614509|7452810|FG000|NOT COMPLETED|Overall Study||1
6531297|NCT01614509|7452811|FG001|NOT COMPLETED|Overall Study||3
6531298|NCT01614574|7452817|FG000|STARTED|Overall Study||6
6531299|NCT01614574|7452817|FG000|COMPLETED|Overall Study||6
6531300|NCT01614574|7452817|FG000|NOT COMPLETED|Overall Study||0
6531301|NCT01614600|7452821|FG000|STARTED|Overall Study||88
6531302|NCT01614600|7452821|FG000|COMPLETED|Overall Study||84
6531303|NCT01614600|7452821|FG000|NOT COMPLETED|Overall Study||4
6531304|NCT01614613|7452825|FG000|STARTED|Overall Study||146
6531305|NCT01614613|7452825|FG000|COMPLETED|Overall Study||146
6531306|NCT01614613|7452825|FG000|NOT COMPLETED|Overall Study||0
6531307|NCT01614743|7452832|FG000|STARTED|Overall Study||4
6531308|NCT01614743|7452833|FG001|STARTED|Overall Study||5
6531309|NCT01614743|7452832|FG000|COMPLETED|Overall Study||3
6531310|NCT01614743|7452833|FG001|COMPLETED|Overall Study|Subject in the placebo group (5) also received the treatment (IncobotulinumtoxinA) at Visit 5.|5
6531311|NCT01614743|7452832|FG000|NOT COMPLETED|Overall Study||1
6531312|NCT01614743|7452833|FG001|NOT COMPLETED|Overall Study||0
6531313|NCT01614769|7452839|FG000|STARTED|Period 1||2
6531314|NCT01614769|7452840|FG001|STARTED|Period 1||1
6531315|NCT01614769|7452841|FG002|STARTED|Period 1||2
6531316|NCT01614769|7452842|FG003|STARTED|Period 1||2
6531317|NCT01614769|7452843|FG004|STARTED|Period 1||1
6531318|NCT01614769|7452844|FG005|STARTED|Period 1||2
6531319|NCT01614769|7452839|FG000|COMPLETED|Period 1||1
6531320|NCT01614769|7452840|FG001|COMPLETED|Period 1||1
6531321|NCT01614769|7452841|FG002|COMPLETED|Period 1||2
6531322|NCT01614769|7452842|FG003|COMPLETED|Period 1||0
6531323|NCT01614769|7452843|FG004|COMPLETED|Period 1||1
6531324|NCT01614769|7452844|FG005|COMPLETED|Period 1||1
6531325|NCT01614769|7452839|FG000|NOT COMPLETED|Period 1||1
6531326|NCT01614769|7452840|FG001|NOT COMPLETED|Period 1||0
6531327|NCT01614769|7452841|FG002|NOT COMPLETED|Period 1||0
6531328|NCT01614769|7452842|FG003|NOT COMPLETED|Period 1||2
6531329|NCT01614769|7452843|FG004|NOT COMPLETED|Period 1||0
6531330|NCT01614769|7452844|FG005|NOT COMPLETED|Period 1||1
6531331|NCT01614769|7452839|FG000|STARTED|7-Day Washout||1
6531332|NCT01614769|7452840|FG001|STARTED|7-Day Washout||1
6531333|NCT01614769|7452841|FG002|STARTED|7-Day Washout||2
6531334|NCT01614769|7452842|FG003|STARTED|7-Day Washout||0
6531335|NCT01614769|7452843|FG004|STARTED|7-Day Washout||1
6531336|NCT01614769|7452844|FG005|STARTED|7-Day Washout||1
6531337|NCT01614769|7452839|FG000|COMPLETED|7-Day Washout||1
6531338|NCT01614769|7452840|FG001|COMPLETED|7-Day Washout||1
6531339|NCT01614769|7452841|FG002|COMPLETED|7-Day Washout||2
6531340|NCT01614769|7452842|FG003|COMPLETED|7-Day Washout||0
6531341|NCT01614769|7452843|FG004|COMPLETED|7-Day Washout||1
6531342|NCT01614769|7452844|FG005|COMPLETED|7-Day Washout||1
6531343|NCT01614769|7452839|FG000|NOT COMPLETED|7-Day Washout||0
6531344|NCT01614769|7452840|FG001|NOT COMPLETED|7-Day Washout||0
6531345|NCT01614769|7452841|FG002|NOT COMPLETED|7-Day Washout||0
6531346|NCT01614769|7452842|FG003|NOT COMPLETED|7-Day Washout||0
6531347|NCT01614769|7452843|FG004|NOT COMPLETED|7-Day Washout||0
6531348|NCT01614769|7452844|FG005|NOT COMPLETED|7-Day Washout||0
6531349|NCT01614769|7452839|FG000|STARTED|Period 2||1
6531350|NCT01614769|7452840|FG001|STARTED|Period 2||1
6531351|NCT01614769|7452841|FG002|STARTED|Period 2||2
6531352|NCT01614769|7452842|FG003|STARTED|Period 2||0
6531353|NCT01614769|7452843|FG004|STARTED|Period 2||1
6531354|NCT01614769|7452844|FG005|STARTED|Period 2||1
6531355|NCT01614769|7452839|FG000|COMPLETED|Period 2||1
6531356|NCT01614769|7452840|FG001|COMPLETED|Period 2||1
6531357|NCT01614769|7452841|FG002|COMPLETED|Period 2||2
6531358|NCT01614769|7452842|FG003|COMPLETED|Period 2||0
6531359|NCT01614769|7452843|FG004|COMPLETED|Period 2||1
6531360|NCT01614769|7452844|FG005|COMPLETED|Period 2||1
6531361|NCT01614769|7452839|FG000|NOT COMPLETED|Period 2||0
6531362|NCT01614769|7452840|FG001|NOT COMPLETED|Period 2||0
6531363|NCT01614769|7452841|FG002|NOT COMPLETED|Period 2||0
6531364|NCT01614769|7452842|FG003|NOT COMPLETED|Period 2||0
6531365|NCT01614769|7452843|FG004|NOT COMPLETED|Period 2||0
6531366|NCT01614769|7452844|FG005|NOT COMPLETED|Period 2||0
6531367|NCT01614769|7452839|FG000|STARTED|7-Day Washout||1
6531368|NCT01614769|7452840|FG001|STARTED|7-Day Washout||1
6531369|NCT01614769|7452841|FG002|STARTED|7-Day Washout||2
6531370|NCT01614769|7452842|FG003|STARTED|7-Day Washout||0
6531371|NCT01614769|7452843|FG004|STARTED|7-Day Washout||1
6531372|NCT01614769|7452844|FG005|STARTED|7-Day Washout||1
6531373|NCT01614769|7452839|FG000|COMPLETED|7-Day Washout||1
6531374|NCT01614769|7452840|FG001|COMPLETED|7-Day Washout||1
6531375|NCT01614769|7452841|FG002|COMPLETED|7-Day Washout||2
6531376|NCT01614769|7452842|FG003|COMPLETED|7-Day Washout||0
6531377|NCT01614769|7452843|FG004|COMPLETED|7-Day Washout||1
6531378|NCT01614769|7452844|FG005|COMPLETED|7-Day Washout||1
6531379|NCT01614769|7452839|FG000|NOT COMPLETED|7-Day Washout||0
6531380|NCT01614769|7452840|FG001|NOT COMPLETED|7-Day Washout||0
6531381|NCT01614769|7452841|FG002|NOT COMPLETED|7-Day Washout||0
6531382|NCT01614769|7452842|FG003|NOT COMPLETED|7-Day Washout||0
6531383|NCT01614769|7452843|FG004|NOT COMPLETED|7-Day Washout||0
6531384|NCT01614769|7452844|FG005|NOT COMPLETED|7-Day Washout||0
6531385|NCT01614769|7452839|FG000|STARTED|Period 3||1
6531386|NCT01614769|7452840|FG001|STARTED|Period 3||1
6531387|NCT01614769|7452841|FG002|STARTED|Period 3||2
6531388|NCT01614769|7452842|FG003|STARTED|Period 3||0
6531389|NCT01614769|7452843|FG004|STARTED|Period 3||1
6531390|NCT01614769|7452844|FG005|STARTED|Period 3||1
6531391|NCT01614769|7452839|FG000|COMPLETED|Period 3||1
6531392|NCT01614769|7452840|FG001|COMPLETED|Period 3||1
6531393|NCT01614769|7452841|FG002|COMPLETED|Period 3||1
6531394|NCT01614769|7452842|FG003|COMPLETED|Period 3||0
6531395|NCT01614769|7452843|FG004|COMPLETED|Period 3||1
6531396|NCT01614769|7452844|FG005|COMPLETED|Period 3||1
6531397|NCT01614769|7452839|FG000|NOT COMPLETED|Period 3||0
6531398|NCT01614769|7452840|FG001|NOT COMPLETED|Period 3||0
6531399|NCT01614769|7452841|FG002|NOT COMPLETED|Period 3||1
6531400|NCT01614769|7452842|FG003|NOT COMPLETED|Period 3||0
6531401|NCT01614769|7452843|FG004|NOT COMPLETED|Period 3||0
6531402|NCT01614769|7452844|FG005|NOT COMPLETED|Period 3||0
6531403|NCT01614795|7452856|FG000|STARTED|Overall Study||11
6531404|NCT01614795|7452857|FG001|STARTED|Overall Study||12
6531405|NCT01614795|7452858|FG002|STARTED|Overall Study||11
6531406|NCT01614795|7452859|FG003|STARTED|Overall Study||12
6531407|NCT01614795|7452856|FG000|COMPLETED|Overall Study||0
6531408|NCT01614795|7452857|FG001|COMPLETED|Overall Study||0
6531409|NCT01614795|7452858|FG002|COMPLETED|Overall Study||0
6531410|NCT01614795|7452859|FG003|COMPLETED|Overall Study||0
6531411|NCT01614795|7452856|FG000|NOT COMPLETED|Overall Study||11
6531412|NCT01614795|7452857|FG001|NOT COMPLETED|Overall Study||12
6531413|NCT01614795|7452858|FG002|NOT COMPLETED|Overall Study||11
6531414|NCT01614795|7452859|FG003|NOT COMPLETED|Overall Study||12
6531415|NCT01614821|7452870|FG000|STARTED|Overall Study||63
6531416|NCT01614821|7452870|FG000|COMPLETED|Overall Study||63
6531417|NCT01614821|7452870|FG000|NOT COMPLETED|Overall Study||0
6531418|NCT01614847|7452876|FG000|STARTED|Day 1|Four subjects chosen at random received Drop A (hyaluronate) during Day 1.|4
6531419|NCT01614847|7452877|FG001|STARTED|Day 1|The other 4 subjects, not to Group 1, received Drop B (saline) on Day 1.|4
6531420|NCT01614847|7452876|FG000|COMPLETED|Day 1||4
6531421|NCT01614847|7452877|FG001|COMPLETED|Day 1|See Arm 1 comments.|4
6531422|NCT01614847|7452876|FG000|NOT COMPLETED|Day 1||0
6531423|NCT01614847|7452877|FG001|NOT COMPLETED|Day 1||0
6531424|NCT01614847|7452876|FG000|STARTED|Day 2 (24 Hours Later)|On Day 2, these subject will received Drop B (normal saline).|4
6531425|NCT01614847|7452877|FG001|STARTED|Day 2 (24 Hours Later)|On Day 2, these subjects received Drop A (hyaluronate).|4
6531426|NCT01614847|7452876|FG000|COMPLETED|Day 2 (24 Hours Later)||4
6531427|NCT01614847|7452877|FG001|COMPLETED|Day 2 (24 Hours Later)||4
6531428|NCT01614847|7452876|FG000|NOT COMPLETED|Day 2 (24 Hours Later)||0
6531429|NCT01614847|7452877|FG001|NOT COMPLETED|Day 2 (24 Hours Later)||0
6531430|NCT01614886|7452890|FG000|STARTED|Overall Study||107
6531431|NCT01614886|7452891|FG001|STARTED|Overall Study||109
6531432|NCT01614886|7452890|FG000|Safety Population (SAF)|Overall Study||107
6531433|NCT01614886|7452891|FG001|Safety Population (SAF)|Overall Study||108
6531434|NCT01614886|7452890|FG000|Full Analysis Set (FAS)|Overall Study||104
6531435|NCT01614886|7452891|FG001|Full Analysis Set (FAS)|Overall Study||105
6531436|NCT01614886|7452890|FG000|COMPLETED|Overall Study||87
6531437|NCT01614886|7452891|FG001|COMPLETED|Overall Study||83
6531438|NCT01614886|7452890|FG000|NOT COMPLETED|Overall Study||20
6531439|NCT01614886|7452891|FG001|NOT COMPLETED|Overall Study||26
6531440|NCT01614925|7452899|FG000|STARTED|Overall Study||18
6531441|NCT01614925|7452900|FG001|STARTED|Overall Study||17
6531442|NCT01614925|7452899|FG000|COMPLETED|Overall Study||14
6531443|NCT01614925|7452900|FG001|COMPLETED|Overall Study||15
6531444|NCT01614925|7452899|FG000|NOT COMPLETED|Overall Study||4
6531445|NCT01614925|7452900|FG001|NOT COMPLETED|Overall Study||2
6531446|NCT01615120|7452908|FG000|STARTED|Overall Study||38
6531447|NCT01615120|7452909|FG001|STARTED|Overall Study||39
6531448|NCT01615120|7452908|FG000|COMPLETED|Overall Study||23
6531449|NCT01615120|7452909|FG001|COMPLETED|Overall Study||19
6531450|NCT01615120|7452908|FG000|NOT COMPLETED|Overall Study||15
6531451|NCT01615120|7452909|FG001|NOT COMPLETED|Overall Study||20
6531452|NCT01615198|7452917|FG000|STARTED|Overall Study||296
6531453|NCT01615198|7452918|FG001|STARTED|Overall Study||292
6531454|NCT01615198|7452917|FG000|Full Analysis Set|Overall Study||296
6531455|NCT01615198|7452918|FG001|Full Analysis Set|Overall Study||292
6531456|NCT01615198|7452917|FG000|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
6531457|NCT01615198|7452918|FG001|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
6531458|NCT01615198|7452917|FG000|Safety Set|Overall Study||296
6531459|NCT01615198|7452918|FG001|Safety Set|Overall Study||292
6531460|NCT01615198|7452917|FG000|ABPM Dipper Status Subset|Overall Study||82
6531461|NCT01615198|7452918|FG001|ABPM Dipper Status Subset|Overall Study||84
6531462|NCT01615198|7452917|FG000|COMPLETED|Overall Study||272
6531463|NCT01615198|7452918|FG001|COMPLETED|Overall Study||273
6531464|NCT01615198|7452917|FG000|NOT COMPLETED|Overall Study||24
6531465|NCT01615198|7452918|FG001|NOT COMPLETED|Overall Study||19
6531466|NCT01615263|7452926|FG000|STARTED|Overall Study||20
6531467|NCT01615263|7452927|FG001|STARTED|Overall Study||20
6531468|NCT01615263|7452926|FG000|COMPLETED|Overall Study||20
6531469|NCT01615263|7452927|FG001|COMPLETED|Overall Study||18
6531470|NCT01615263|7452926|FG000|NOT COMPLETED|Overall Study||0
6531471|NCT01615263|7452927|FG001|NOT COMPLETED|Overall Study||2
6531472|NCT01615328|7452935|FG000|STARTED|Overall Study||42
6531473|NCT01615328|7452936|FG001|STARTED|Overall Study||43
6531474|NCT01615328|7452935|FG000|COMPLETED|Overall Study||39
6531475|NCT01615328|7452936|FG001|COMPLETED|Overall Study||38
6531476|NCT01615328|7452935|FG000|NOT COMPLETED|Overall Study||3
6531477|NCT01615328|7452936|FG001|NOT COMPLETED|Overall Study||5
6531478|NCT01615367|7452948|FG000|STARTED|Overall Study||19
6531479|NCT01615367|7452949|FG001|STARTED|Overall Study||19
6531480|NCT01615367|7452948|FG000|COMPLETED|Overall Study||14
6531481|NCT01615367|7452949|FG001|COMPLETED|Overall Study|11 TAU participants chose to participate in NEW Tx after the completion of the waitlist period.|13
6531482|NCT01615367|7452948|FG000|NOT COMPLETED|Overall Study||5
6531483|NCT01615367|7452949|FG001|NOT COMPLETED|Overall Study||6
6531484|NCT01615484|7452957|FG000|STARTED|Overall Study||0
6531485|NCT01615484|7452958|FG001|STARTED|Overall Study||24
6531486|NCT01615484|7452957|FG000|COMPLETED|Overall Study||0
6531487|NCT01615484|7452958|FG001|COMPLETED|Overall Study||24
6644385|NCT02362724|7572985|FG000|NOT COMPLETED|Overall Study||6
6531488|NCT01615484|7452957|FG000|NOT COMPLETED|Overall Study||0
6531489|NCT01615484|7452958|FG001|NOT COMPLETED|Overall Study||0
6531490|NCT01615731|7452966|FG000|STARTED|Overall Study||24
6531491|NCT01615731|7452967|FG001|STARTED|Overall Study||26
6531492|NCT01615731|7452966|FG000|COMPLETED|Overall Study||21
6531493|NCT01615731|7452967|FG001|COMPLETED|Overall Study||24
6531494|NCT01615731|7452966|FG000|NOT COMPLETED|Overall Study||3
6531495|NCT01615731|7452967|FG001|NOT COMPLETED|Overall Study||2
6531496|NCT01615809|7452973|FG000|STARTED|Overall Study|basal visit|32
6531497|NCT01615809|7452973|FG000|COMPLETED|Overall Study||22
6531498|NCT01615809|7452973|FG000|NOT COMPLETED|Overall Study||10
6531499|NCT01615822|7452980|FG000|STARTED|Period 1||8
6531500|NCT01615822|7452981|FG001|STARTED|Period 1||11
6531501|NCT01615822|7452982|FG002|STARTED|Period 1||6
6531502|NCT01615822|7452980|FG000|COMPLETED|Period 1||7
6531503|NCT01615822|7452981|FG001|COMPLETED|Period 1||9
6531504|NCT01615822|7452982|FG002|COMPLETED|Period 1||6
6531505|NCT01615822|7452980|FG000|NOT COMPLETED|Period 1||1
6531506|NCT01615822|7452981|FG001|NOT COMPLETED|Period 1||2
6531507|NCT01615822|7452982|FG002|NOT COMPLETED|Period 1||0
6531508|NCT01615822|7452980|FG000|STARTED|Period 2||7
6531509|NCT01615822|7452981|FG001|STARTED|Period 2||9
6531510|NCT01615822|7452982|FG002|STARTED|Period 2||6
6531511|NCT01615822|7452980|FG000|COMPLETED|Period 2||7
6531512|NCT01615822|7452981|FG001|COMPLETED|Period 2||8
6531513|NCT01615822|7452982|FG002|COMPLETED|Period 2||4
6531514|NCT01615822|7452980|FG000|NOT COMPLETED|Period 2||0
6531515|NCT01615822|7452981|FG001|NOT COMPLETED|Period 2||1
6531516|NCT01615822|7452982|FG002|NOT COMPLETED|Period 2||2
6531517|NCT01615939|7452995|FG000|STARTED|Overall Study||13
6531518|NCT01615939|7452996|FG001|STARTED|Overall Study||4
6531519|NCT01615939|7452995|FG000|COMPLETED|Overall Study||8
6531520|NCT01615939|7452996|FG001|COMPLETED|Overall Study||4
6531521|NCT01615939|7452995|FG000|NOT COMPLETED|Overall Study||5
6531522|NCT01615939|7452996|FG001|NOT COMPLETED|Overall Study||0
6531523|NCT01616056|7453002|FG000|STARTED|Overall Study||20
6531524|NCT01616056|7453002|FG000|COMPLETED|Overall Study||19
6531525|NCT01616056|7453002|FG000|NOT COMPLETED|Overall Study||1
6531526|NCT01616082|7453008|FG000|STARTED|Overall Study||19
6531527|NCT01616082|7453009|FG001|STARTED|Overall Study||20
6531528|NCT01616082|7453008|FG000|COMPLETED|Overall Study||19
6531529|NCT01616082|7453009|FG001|COMPLETED|Overall Study||18
6531530|NCT01616082|7453008|FG000|NOT COMPLETED|Overall Study||0
6531531|NCT01616082|7453009|FG001|NOT COMPLETED|Overall Study||2
6531532|NCT01616160|7453016|FG000|STARTED|Overall Study||11
6531533|NCT01616160|7453016|FG000|COMPLETED|Overall Study||9
6531534|NCT01616160|7453016|FG000|NOT COMPLETED|Overall Study||2
6531535|NCT01616173|7453023|FG000|STARTED|Overall Study||27
6531536|NCT01616173|7453024|FG001|STARTED|Overall Study||26
6531537|NCT01616173|7453025|FG002|STARTED|Overall Study||27
6531538|NCT01616173|7453023|FG000|COMPLETED|Overall Study||27
6531539|NCT01616173|7453024|FG001|COMPLETED|Overall Study||24
6531540|NCT01616173|7453025|FG002|COMPLETED|Overall Study||27
6531541|NCT01616173|7453023|FG000|NOT COMPLETED|Overall Study||0
6531542|NCT01616173|7453024|FG001|NOT COMPLETED|Overall Study||2
6531543|NCT01616173|7453025|FG002|NOT COMPLETED|Overall Study||0
6531544|NCT01616459|7453037|FG000|STARTED|Overall Study||240
6531545|NCT01616459|7453038|FG001|STARTED|Overall Study||240
6531546|NCT01616459|7453039|FG002|STARTED|Overall Study||230
6531547|NCT01616459|7453040|FG003|STARTED|Overall Study||241
6531548|NCT01616459|7453037|FG000|COMPLETED|Overall Study||236
6531549|NCT01616459|7453038|FG001|COMPLETED|Overall Study||223
6531550|NCT01616459|7453039|FG002|COMPLETED|Overall Study||220
6531551|NCT01616459|7453040|FG003|COMPLETED|Overall Study||233
6531552|NCT01616459|7453037|FG000|NOT COMPLETED|Overall Study||4
6531553|NCT01616459|7453038|FG001|NOT COMPLETED|Overall Study||17
6531554|NCT01616459|7453039|FG002|NOT COMPLETED|Overall Study||10
6531555|NCT01616459|7453040|FG003|NOT COMPLETED|Overall Study||8
6531556|NCT01616563|7453055|FG000|STARTED|Overall Study||293
6531557|NCT01616563|7453055|FG000|COMPLETED|Overall Study||253
6531558|NCT01616563|7453055|FG000|NOT COMPLETED|Overall Study||40
6531559|NCT01616576|7453062|FG000|STARTED|Overall Study||18
6531560|NCT01616576|7453063|FG001|STARTED|Overall Study||18
6531561|NCT01616576|7453062|FG000|COMPLETED|Overall Study||18
6531562|NCT01616576|7453063|FG001|COMPLETED|Overall Study||18
6531563|NCT01616576|7453062|FG000|NOT COMPLETED|Overall Study||0
6531564|NCT01616576|7453063|FG001|NOT COMPLETED|Overall Study||0
6531565|NCT01616654|7453077|FG000|STARTED|Overall Study||61
6531566|NCT01616654|7453078|FG001|STARTED|Overall Study||61
6531567|NCT01616654|7453079|FG002|STARTED|Overall Study||60
6531568|NCT01616654|7453080|FG003|STARTED|Overall Study||61
6531569|NCT01616654|7453081|FG004|STARTED|Overall Study||61
6531570|NCT01616654|7453077|FG000|COMPLETED|Overall Study||56
6531571|NCT01616654|7453078|FG001|COMPLETED|Overall Study||53
6531572|NCT01616654|7453079|FG002|COMPLETED|Overall Study||50
6531573|NCT01616654|7453080|FG003|COMPLETED|Overall Study||53
6531574|NCT01616654|7453081|FG004|COMPLETED|Overall Study||49
6531575|NCT01616654|7453077|FG000|NOT COMPLETED|Overall Study||5
6531576|NCT01616654|7453078|FG001|NOT COMPLETED|Overall Study||8
6531577|NCT01616654|7453079|FG002|NOT COMPLETED|Overall Study||10
6531578|NCT01616654|7453080|FG003|NOT COMPLETED|Overall Study||8
6531579|NCT01616654|7453081|FG004|NOT COMPLETED|Overall Study||12
6531580|NCT01616693|7453098|FG000|STARTED|Evaluated for Safety||155
6531581|NCT01616693|7453099|FG001|STARTED|Evaluated for Safety||155
6531582|NCT01616693|7453100|FG002|STARTED|Evaluated for Safety||155
6531583|NCT01616693|7453101|FG003|STARTED|Evaluated for Safety||155
6531584|NCT01616693|7453098|FG000|COMPLETED|Evaluated for Safety||154
6531585|NCT01616693|7453099|FG001|COMPLETED|Evaluated for Safety||155
6531586|NCT01616693|7453100|FG002|COMPLETED|Evaluated for Safety||154
6531587|NCT01616693|7453101|FG003|COMPLETED|Evaluated for Safety||155
6531588|NCT01616693|7453098|FG000|NOT COMPLETED|Evaluated for Safety||1
6531589|NCT01616693|7453099|FG001|NOT COMPLETED|Evaluated for Safety||0
6531590|NCT01616693|7453100|FG002|NOT COMPLETED|Evaluated for Safety||1
6531591|NCT01616693|7453101|FG003|NOT COMPLETED|Evaluated for Safety||0
6531592|NCT01616693|7453098|FG000|STARTED|Received Both Vaccines||154
6531593|NCT01616693|7453099|FG001|STARTED|Received Both Vaccines||155
6531594|NCT01616693|7453100|FG002|STARTED|Received Both Vaccines||154
6531595|NCT01616693|7453101|FG003|STARTED|Received Both Vaccines||155
6531596|NCT01616693|7453098|FG000|COMPLETED|Received Both Vaccines||141
6531597|NCT01616693|7453099|FG001|COMPLETED|Received Both Vaccines||145
6531598|NCT01616693|7453100|FG002|COMPLETED|Received Both Vaccines||142
6531599|NCT01616693|7453101|FG003|COMPLETED|Received Both Vaccines||136
6531600|NCT01616693|7453098|FG000|NOT COMPLETED|Received Both Vaccines||13
6531601|NCT01616693|7453099|FG001|NOT COMPLETED|Received Both Vaccines||10
6531602|NCT01616693|7453100|FG002|NOT COMPLETED|Received Both Vaccines||12
6531603|NCT01616693|7453101|FG003|NOT COMPLETED|Received Both Vaccines||19
6531604|NCT01616693|7453098|FG000|STARTED|Blood Analyzed for Immunogenicity||141
6531605|NCT01616693|7453099|FG001|STARTED|Blood Analyzed for Immunogenicity||145
6531606|NCT01616693|7453100|FG002|STARTED|Blood Analyzed for Immunogenicity||142
6531607|NCT01616693|7453101|FG003|STARTED|Blood Analyzed for Immunogenicity||136
6531608|NCT01616693|7453098|FG000|COMPLETED|Blood Analyzed for Immunogenicity||137
6531609|NCT01616693|7453099|FG001|COMPLETED|Blood Analyzed for Immunogenicity||143
6531610|NCT01616693|7453100|FG002|COMPLETED|Blood Analyzed for Immunogenicity||136
6531611|NCT01616693|7453101|FG003|COMPLETED|Blood Analyzed for Immunogenicity||135
6531612|NCT01616693|7453098|FG000|NOT COMPLETED|Blood Analyzed for Immunogenicity||4
6531613|NCT01616693|7453099|FG001|NOT COMPLETED|Blood Analyzed for Immunogenicity||2
6531614|NCT01616693|7453100|FG002|NOT COMPLETED|Blood Analyzed for Immunogenicity||6
6531615|NCT01616693|7453101|FG003|NOT COMPLETED|Blood Analyzed for Immunogenicity||1
6531616|NCT01616771|7453115|FG000|STARTED|Macintosh Laryngoscopy for 5 Sec||23
6531617|NCT01616771|7453115|FG000|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
6531618|NCT01616771|7453115|FG000|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
6531619|NCT01616771|7453115|FG000|STARTED|GVL Selected by Weight for 5 Sec||23
6531620|NCT01616771|7453115|FG000|COMPLETED|GVL Selected by Weight for 5 Sec||23
6531621|NCT01616771|7453115|FG000|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
6531622|NCT01616771|7453115|FG000|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
6531623|NCT01616771|7453115|FG000|COMPLETED|Smaller Sized GVL for 5 Sec||19
6531624|NCT01616771|7453115|FG000|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
6531625|NCT01616953|7453126|FG000|STARTED|Overall Study||10
6531626|NCT01616953|7453127|FG001|STARTED|Overall Study||8
6531627|NCT01616953|7453126|FG000|Implant Placement Surgery|Overall Study||9
6531628|NCT01616953|7453127|FG001|Implant Placement Surgery|Overall Study||8
6531629|NCT01616953|7453126|FG000|Implant Uncovery|Overall Study||8
6531630|NCT01616953|7453127|FG001|Implant Uncovery|Overall Study||8
6531631|NCT01616953|7453126|FG000|6 Months Post-loading|Overall Study||8
6531632|NCT01616953|7453127|FG001|6 Months Post-loading|Overall Study||8
6531633|NCT01616953|7453126|FG000|COMPLETED|Overall Study||8
6531634|NCT01616953|7453127|FG001|COMPLETED|Overall Study||8
6531635|NCT01616953|7453126|FG000|NOT COMPLETED|Overall Study||2
6531636|NCT01616953|7453127|FG001|NOT COMPLETED|Overall Study||0
6531637|NCT01617005|7453133|FG000|STARTED|Overall Study||50
6531638|NCT01617005|7453133|FG000|COMPLETED|Overall Study||48
6531639|NCT01617005|7453133|FG000|NOT COMPLETED|Overall Study||2
6531640|NCT01617070|7453137|FG000|STARTED|LNAA (4 Weeks)||10
6531641|NCT01617070|7453137|FG000|COMPLETED|LNAA (4 Weeks)||10
6531642|NCT01617070|7453137|FG000|NOT COMPLETED|LNAA (4 Weeks)||0
6531643|NCT01617070|7453137|FG000|STARTED|Washout (4 Weeks)||10
6531644|NCT01617070|7453137|FG000|COMPLETED|Washout (4 Weeks)||10
6531645|NCT01617070|7453137|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6531646|NCT01617070|7453137|FG000|STARTED|BH4 Therapy (4 Weeks)||10
6531647|NCT01617070|7453137|FG000|COMPLETED|BH4 Therapy (4 Weeks)||10
6531648|NCT01617070|7453137|FG000|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
6531649|NCT01617070|7453137|FG000|STARTED|BH4 and LNAA (4 Weeks)||10
6531650|NCT01617070|7453137|FG000|COMPLETED|BH4 and LNAA (4 Weeks)||9
6531651|NCT01617070|7453137|FG000|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
6531652|NCT01617083|7453150|FG000|STARTED|Overall Study||18
6531653|NCT01617083|7453151|FG001|STARTED|Overall Study||14
6531654|NCT01617083|7453152|FG002|STARTED|Overall Study||15
6531655|NCT01617083|7453150|FG000|COMPLETED|Overall Study||18
6531656|NCT01617083|7453151|FG001|COMPLETED|Overall Study||14
6531657|NCT01617083|7453152|FG002|COMPLETED|Overall Study||15
6531658|NCT01617083|7453150|FG000|NOT COMPLETED|Overall Study||0
6531659|NCT01617083|7453151|FG001|NOT COMPLETED|Overall Study||0
6531660|NCT01617083|7453152|FG002|NOT COMPLETED|Overall Study||0
6531661|NCT01617148|7453159|FG000|STARTED|Overall Study||26
6531662|NCT01617148|7453159|FG000|COMPLETED|Overall Study||26
6531663|NCT01617148|7453159|FG000|NOT COMPLETED|Overall Study||0
6531664|NCT01617369|7453164|FG000|STARTED|Overall Study||12
6531665|NCT01617369|7453164|FG000|COMPLETED|Overall Study||12
6531666|NCT01617369|7453164|FG000|NOT COMPLETED|Overall Study||0
6531667|NCT01617421|7453170|FG000|STARTED|Overall Study||18
6531668|NCT01617421|7453170|FG000|COMPLETED|Overall Study||12
6531669|NCT01617421|7453170|FG000|NOT COMPLETED|Overall Study||6
6531670|NCT01617434|7453176|FG000|STARTED|Overall Study||226
6531671|NCT01617434|7453177|FG001|STARTED|Overall Study||225
6531672|NCT01617434|7453176|FG000|Exposed|Overall Study||225
6531673|NCT01617434|7453177|FG001|Exposed|Overall Study||225
6531674|NCT01617434|7453176|FG000|COMPLETED|Overall Study||191
6531675|NCT01617434|7453177|FG001|COMPLETED|Overall Study||174
6531676|NCT01617434|7453176|FG000|NOT COMPLETED|Overall Study||35
6531677|NCT01617434|7453177|FG001|NOT COMPLETED|Overall Study||51
6531678|NCT01617447|7453185|FG000|STARTED|Overall Study||47
6531679|NCT01617447|7453186|FG001|STARTED|Overall Study||45
6531680|NCT01617447|7453185|FG000|COMPLETED|Overall Study||47
6531681|NCT01617447|7453186|FG001|COMPLETED|Overall Study||42
6531682|NCT01617447|7453185|FG000|NOT COMPLETED|Overall Study||0
6531683|NCT01617447|7453186|FG001|NOT COMPLETED|Overall Study||3
6531684|NCT01617460|7453192|FG000|STARTED|Overall Study||86
6531685|NCT01617460|7453192|FG000|COMPLETED|Overall Study||46
6531686|NCT01617460|7453192|FG000|NOT COMPLETED|Overall Study||40
6531687|NCT01617577|7453198|FG000|STARTED|Overall Study||5
6531688|NCT01617577|7453199|FG001|STARTED|Overall Study||3
6531689|NCT01617577|7453198|FG000|COMPLETED|Overall Study||5
6531690|NCT01617577|7453199|FG001|COMPLETED|Overall Study||3
6531691|NCT01617577|7453198|FG000|NOT COMPLETED|Overall Study||0
6531692|NCT01617577|7453199|FG001|NOT COMPLETED|Overall Study||0
6531693|NCT01617603|7453209|FG000|STARTED|Overall Study||20
6531694|NCT01617603|7453210|FG001|STARTED|Overall Study||21
6531695|NCT01617603|7453211|FG002|STARTED|Overall Study||21
6531696|NCT01617603|7453209|FG000|COMPLETED|Overall Study||17
6531697|NCT01617603|7453210|FG001|COMPLETED|Overall Study||19
6531698|NCT01617603|7453211|FG002|COMPLETED|Overall Study||20
6531699|NCT01617603|7453209|FG000|NOT COMPLETED|Overall Study||3
6531700|NCT01617603|7453210|FG001|NOT COMPLETED|Overall Study||2
6531701|NCT01617603|7453211|FG002|NOT COMPLETED|Overall Study||1
6531702|NCT01617629|7453219|FG000|STARTED|Overall Study||9
6531703|NCT01617629|7453219|FG000|COMPLETED|Overall Study||3
6531704|NCT01617629|7453219|FG000|NOT COMPLETED|Overall Study||6
6531705|NCT01617655|7453225|FG000|STARTED|Overall Study|Randomized|35
6644386|NCT02362724|7572986|FG001|NOT COMPLETED|Overall Study||1
6644387|NCT02362789|7572994|FG000|STARTED|Run-in Phase (Week 0 to 16)||130
6644388|NCT02362789|7572995|FG001|STARTED|Run-in Phase (Week 0 to 16)||0
6644389|NCT02362789|7572996|FG002|STARTED|Run-in Phase (Week 0 to 16)||0
6644390|NCT02362789|7572994|FG000|COMPLETED|Run-in Phase (Week 0 to 16)||128
6644391|NCT02362789|7572995|FG001|COMPLETED|Run-in Phase (Week 0 to 16)||0
6644392|NCT02362789|7572996|FG002|COMPLETED|Run-in Phase (Week 0 to 16)||0
6644393|NCT02362789|7572994|FG000|NOT COMPLETED|Run-in Phase (Week 0 to 16)||2
6644394|NCT02362789|7572995|FG001|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
6644395|NCT02362789|7572996|FG002|NOT COMPLETED|Run-in Phase (Week 0 to 16)||0
6644396|NCT02362789|7572994|FG000|STARTED|Randomized Withdrawal (Wk 16 to 32)|N/A. Run-in phase completed.|0
6644397|NCT02362789|7572995|FG001|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|42
6644398|NCT02362789|7572996|FG002|STARTED|Randomized Withdrawal (Wk 16 to 32)|Subjects achieving PASI reduction by 98-100% vs. baseline during Run-In|38
6644399|NCT02362789|7572994|FG000|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
6644400|NCT02362789|7572995|FG001|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||38
6644401|NCT02362789|7572996|FG002|COMPLETED|Randomized Withdrawal (Wk 16 to 32)||26
6644402|NCT02362789|7572994|FG000|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||0
6644403|NCT02362789|7572995|FG001|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||4
6644404|NCT02362789|7572996|FG002|NOT COMPLETED|Randomized Withdrawal (Wk 16 to 32)||12
6531706|NCT01617655|7453226|FG001|STARTED|Overall Study|Randomized|72
6531707|NCT01617655|7453225|FG000|Treated|Overall Study||35
6531708|NCT01617655|7453226|FG001|Treated|Overall Study||72
6531709|NCT01617655|7453225|FG000|COMPLETED|Overall Study||26
6531710|NCT01617655|7453226|FG001|COMPLETED|Overall Study||43
6531711|NCT01617655|7453225|FG000|NOT COMPLETED|Overall Study||9
6531712|NCT01617655|7453226|FG001|NOT COMPLETED|Overall Study||29
6531713|NCT01617668|7453236|FG000|STARTED|Overall Study||51
6531714|NCT01617668|7453237|FG001|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
6531715|NCT01617668|7453238|FG002|STARTED|Overall Study||55
6644405|NCT02363270|7573005|FG000|STARTED|Overall Study||24
6644406|NCT02363270|7573006|FG001|STARTED|Overall Study||24
6644407|NCT02363270|7573005|FG000|COMPLETED|Overall Study||24
6531716|NCT01617668|7453239|FG003|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
6531717|NCT01617668|7453236|FG000|Randomized Patients|Overall Study||51
6531718|NCT01617668|7453237|FG001|Randomized Patients|Overall Study||54
6531719|NCT01617668|7453238|FG002|Randomized Patients|Overall Study||55
6531720|NCT01617668|7453239|FG003|Randomized Patients|Overall Study||55
6531721|NCT01617668|7453236|FG000|COMPLETED|Overall Study||38
6531722|NCT01617668|7453237|FG001|COMPLETED|Overall Study||41
6531723|NCT01617668|7453238|FG002|COMPLETED|Overall Study||32
6531724|NCT01617668|7453239|FG003|COMPLETED|Overall Study||38
6531725|NCT01617668|7453236|FG000|NOT COMPLETED|Overall Study||13
6531726|NCT01617668|7453237|FG001|NOT COMPLETED|Overall Study||9
6531727|NCT01617668|7453238|FG002|NOT COMPLETED|Overall Study||23
6531728|NCT01617668|7453239|FG003|NOT COMPLETED|Overall Study||15
6531729|NCT01617681|7453257|FG000|STARTED|Period 1 Double Blind||32
6531730|NCT01617681|7453258|FG001|STARTED|Period 1 Double Blind||31
6531731|NCT01617681|7453259|FG002|STARTED|Period 1 Double Blind||33
6531732|NCT01617681|7453260|FG003|STARTED|Period 1 Double Blind||31
6531733|NCT01617681|7453261|FG004|STARTED|Period 1 Double Blind||0
6531734|NCT01617681|7453257|FG000|Full Analysis Set (FAS)|Period 1 Double Blind||31
6531735|NCT01617681|7453258|FG001|Full Analysis Set (FAS)|Period 1 Double Blind||31
6531736|NCT01617681|7453259|FG002|Full Analysis Set (FAS)|Period 1 Double Blind||33
6531737|NCT01617681|7453260|FG003|Full Analysis Set (FAS)|Period 1 Double Blind||31
6531738|NCT01617681|7453261|FG004|Full Analysis Set (FAS)|Period 1 Double Blind||0
6531739|NCT01617681|7453257|FG000|COMPLETED|Period 1 Double Blind||29
6531740|NCT01617681|7453258|FG001|COMPLETED|Period 1 Double Blind||30
6531741|NCT01617681|7453259|FG002|COMPLETED|Period 1 Double Blind||32
6531742|NCT01617681|7453260|FG003|COMPLETED|Period 1 Double Blind||29
6531743|NCT01617681|7453261|FG004|COMPLETED|Period 1 Double Blind||0
6531744|NCT01617681|7453257|FG000|NOT COMPLETED|Period 1 Double Blind||3
6531745|NCT01617681|7453258|FG001|NOT COMPLETED|Period 1 Double Blind||1
6531746|NCT01617681|7453259|FG002|NOT COMPLETED|Period 1 Double Blind||1
6531747|NCT01617681|7453260|FG003|NOT COMPLETED|Period 1 Double Blind||2
6531748|NCT01617681|7453261|FG004|NOT COMPLETED|Period 1 Double Blind||0
6531749|NCT01617681|7453257|FG000|STARTED|Period 2 Open Label||0
6531750|NCT01617681|7453258|FG001|STARTED|Period 2 Open Label||0
6531751|NCT01617681|7453259|FG002|STARTED|Period 2 Open Label||0
6531752|NCT01617681|7453260|FG003|STARTED|Period 2 Open Label||0
6531753|NCT01617681|7453261|FG004|STARTED|Period 2 Open Label||120
6531754|NCT01617681|7453257|FG000|COMPLETED|Period 2 Open Label||0
6531755|NCT01617681|7453258|FG001|COMPLETED|Period 2 Open Label||0
6531756|NCT01617681|7453259|FG002|COMPLETED|Period 2 Open Label||0
6531757|NCT01617681|7453260|FG003|COMPLETED|Period 2 Open Label||0
6531758|NCT01617681|7453261|FG004|COMPLETED|Period 2 Open Label||114
6531759|NCT01617681|7453257|FG000|NOT COMPLETED|Period 2 Open Label||0
6531760|NCT01617681|7453258|FG001|NOT COMPLETED|Period 2 Open Label||0
6531761|NCT01617681|7453259|FG002|NOT COMPLETED|Period 2 Open Label||0
6531762|NCT01617681|7453260|FG003|NOT COMPLETED|Period 2 Open Label||0
6531763|NCT01617681|7453261|FG004|NOT COMPLETED|Period 2 Open Label||6
6531764|NCT01617967|7453276|FG000|STARTED|Overall Study||4
6531765|NCT01617967|7453277|FG001|STARTED|Overall Study||3
6531766|NCT01617967|7453278|FG002|STARTED|Overall Study||3
6531767|NCT01617967|7453279|FG003|STARTED|Overall Study||7
6531768|NCT01617967|7453280|FG004|STARTED|Overall Study||3
6531769|NCT01617967|7453281|FG005|STARTED|Overall Study||9
6531770|NCT01617967|7453276|FG000|COMPLETED|Overall Study||3
6531771|NCT01617967|7453277|FG001|COMPLETED|Overall Study||3
6531772|NCT01617967|7453278|FG002|COMPLETED|Overall Study||3
6531773|NCT01617967|7453279|FG003|COMPLETED|Overall Study||6
6531774|NCT01617967|7453280|FG004|COMPLETED|Overall Study||3
6531775|NCT01617967|7453281|FG005|COMPLETED|Overall Study||8
6531776|NCT01617967|7453276|FG000|NOT COMPLETED|Overall Study||1
6531777|NCT01617967|7453277|FG001|NOT COMPLETED|Overall Study||0
6531778|NCT01617967|7453278|FG002|NOT COMPLETED|Overall Study||0
6531779|NCT01617967|7453279|FG003|NOT COMPLETED|Overall Study||1
6531780|NCT01617967|7453280|FG004|NOT COMPLETED|Overall Study||0
6531781|NCT01617967|7453281|FG005|NOT COMPLETED|Overall Study||1
6531782|NCT01618019|7453298|FG000|STARTED|Overall Study||55
6531783|NCT01618019|7453299|FG001|STARTED|Overall Study||54
6531784|NCT01618019|7453298|FG000|COMPLETED|Overall Study||41
6531785|NCT01618019|7453299|FG001|COMPLETED|Overall Study||40
6531786|NCT01618019|7453298|FG000|NOT COMPLETED|Overall Study||14
6531787|NCT01618019|7453299|FG001|NOT COMPLETED|Overall Study||14
6531788|NCT01618162|7453307|FG000|STARTED|Overall Study||289
6531789|NCT01618162|7453308|FG001|STARTED|Overall Study||146
6531790|NCT01618162|7453307|FG000|Exposed|Overall Study||288
6531791|NCT01618162|7453308|FG001|Exposed|Overall Study||146
6531792|NCT01618162|7453307|FG000|COMPLETED|Overall Study||251
6531793|NCT01618162|7453308|FG001|COMPLETED|Overall Study||111
6531794|NCT01618162|7453307|FG000|NOT COMPLETED|Overall Study||38
6531795|NCT01618162|7453308|FG001|NOT COMPLETED|Overall Study||35
6531796|NCT01618214|7453316|FG000|STARTED|Overall Study||172
6531797|NCT01618214|7453317|FG001|STARTED|Overall Study||172
6531798|NCT01618214|7453316|FG000|Exposed|Overall Study||172
6531799|NCT01618214|7453317|FG001|Exposed|Overall Study||172
6531800|NCT01618214|7453316|FG000|COMPLETED|Overall Study||162
6531801|NCT01618214|7453317|FG001|COMPLETED|Overall Study||159
6531802|NCT01618214|7453316|FG000|NOT COMPLETED|Overall Study||10
6531803|NCT01618214|7453317|FG001|NOT COMPLETED|Overall Study||13
6531804|NCT01618227|7453325|FG000|STARTED|Overall Study||2
6531805|NCT01618227|7453326|FG001|STARTED|Overall Study||2
6531806|NCT01618227|7453325|FG000|COMPLETED|Overall Study||2
6531807|NCT01618227|7453326|FG001|COMPLETED|Overall Study||0
6531808|NCT01618227|7453325|FG000|NOT COMPLETED|Overall Study||0
6531809|NCT01618227|7453326|FG001|NOT COMPLETED|Overall Study||2
6531810|NCT01618240|7453332|FG000|STARTED|Overall Study||30
6531811|NCT01618240|7453332|FG000|COMPLETED|Overall Study||30
6531812|NCT01618240|7453332|FG000|NOT COMPLETED|Overall Study||0
6531813|NCT01618266|7453336|FG000|STARTED|Overall Study||375
6531814|NCT01618266|7453336|FG000|COMPLETED|Overall Study||279
6531815|NCT01618266|7453336|FG000|NOT COMPLETED|Overall Study||96
6531816|NCT01618305|7453342|FG000|STARTED|Overall Study||202
6531817|NCT01618305|7453343|FG001|STARTED|Overall Study||206
6531818|NCT01618305|7453342|FG000|COMPLETED|Overall Study||187
6531819|NCT01618305|7453343|FG001|COMPLETED|Overall Study||196
6531820|NCT01618305|7453342|FG000|NOT COMPLETED|Overall Study||15
6531821|NCT01618305|7453343|FG001|NOT COMPLETED|Overall Study||10
6531822|NCT01618344|7453353|FG000|STARTED|Overall Study||32
6531823|NCT01618344|7453353|FG000|COMPLETED|Overall Study||23
6531824|NCT01618344|7453353|FG000|NOT COMPLETED|Overall Study||9
6531825|NCT01618422|7453359|FG000|STARTED|Overall Study||114
6531826|NCT01618422|7453360|FG001|STARTED|Overall Study||111
6531827|NCT01618422|7453359|FG000|COMPLETED|Overall Study||114
6531828|NCT01618422|7453360|FG001|COMPLETED|Overall Study||111
6531829|NCT01618422|7453359|FG000|NOT COMPLETED|Overall Study||0
6531830|NCT01618422|7453360|FG001|NOT COMPLETED|Overall Study||0
6531831|NCT01618669|7453368|FG000|STARTED|Overall Study||578
6531832|NCT01618669|7453369|FG001|STARTED|Overall Study||569
6531833|NCT01618669|7453368|FG000|Received Treatment|Overall Study||575
6531834|NCT01618669|7453369|FG001|Received Treatment|Overall Study||567
6531835|NCT01618669|7453368|FG000|COMPLETED|Overall Study||544
6531836|NCT01618669|7453369|FG001|COMPLETED|Overall Study||546
6531837|NCT01618669|7453368|FG000|NOT COMPLETED|Overall Study||34
6531838|NCT01618669|7453369|FG001|NOT COMPLETED|Overall Study||23
6531839|NCT01618695|7453391|FG000|STARTED|Core Phase||177
6531840|NCT01618695|7453392|FG001|STARTED|Core Phase||176
6531841|NCT01618695|7453393|FG002|STARTED|Core Phase||177
6531842|NCT01618695|7453394|FG003|STARTED|Core Phase||180
6531843|NCT01618695|7453391|FG000|Treated (Safety Analysis Set)|Core Phase||176
6531844|NCT01618695|7453392|FG001|Treated (Safety Analysis Set)|Core Phase||176
6531845|NCT01618695|7453393|FG002|Treated (Safety Analysis Set)|Core Phase||175
6531846|NCT01618695|7453394|FG003|Treated (Safety Analysis Set)|Core Phase||180
6531847|NCT01618695|7453391|FG000|COMPLETED|Core Phase||152
6531848|NCT01618695|7453392|FG001|COMPLETED|Core Phase||156
6531849|NCT01618695|7453393|FG002|COMPLETED|Core Phase||147
6531850|NCT01618695|7453394|FG003|COMPLETED|Core Phase||144
6531851|NCT01618695|7453391|FG000|NOT COMPLETED|Core Phase||25
6531852|NCT01618695|7453392|FG001|NOT COMPLETED|Core Phase||20
6531853|NCT01618695|7453393|FG002|NOT COMPLETED|Core Phase||30
6531854|NCT01618695|7453394|FG003|NOT COMPLETED|Core Phase||36
6531855|NCT01618695|7453391|FG000|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|151
6531856|NCT01618695|7453392|FG001|STARTED|Extension Phase||156
6531857|NCT01618695|7453393|FG002|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|146
6531858|NCT01618695|7453394|FG003|STARTED|Extension Phase|Participants who completed Core Phase and gave consent, entered the Extension Phase.|143
6531859|NCT01618695|7453391|FG000|COMPLETED|Extension Phase||56
6531860|NCT01618695|7453392|FG001|COMPLETED|Extension Phase||40
6531861|NCT01618695|7453393|FG002|COMPLETED|Extension Phase||54
6531862|NCT01618695|7453394|FG003|COMPLETED|Extension Phase||46
6531863|NCT01618695|7453391|FG000|NOT COMPLETED|Extension Phase||95
6531864|NCT01618695|7453392|FG001|NOT COMPLETED|Extension Phase||116
6531865|NCT01618695|7453393|FG002|NOT COMPLETED|Extension Phase||92
6531866|NCT01618695|7453394|FG003|NOT COMPLETED|Extension Phase||97
6531867|NCT01618708|7453407|FG000|STARTED|Overall Study||175
6531868|NCT01618708|7453408|FG001|STARTED|Overall Study||182
6531869|NCT01618708|7453407|FG000|Treated|Overall Study||172
6531870|NCT01618708|7453408|FG001|Treated|Overall Study||180
6531871|NCT01618708|7453407|FG000|COMPLETED|Overall Study||131
6531872|NCT01618708|7453408|FG001|COMPLETED|Overall Study||136
6531873|NCT01618708|7453407|FG000|NOT COMPLETED|Overall Study||44
6531874|NCT01618708|7453408|FG001|NOT COMPLETED|Overall Study||46
6531875|NCT01618838|7453415|FG000|STARTED|Overall Study||4
6531876|NCT01618838|7453415|FG000|COMPLETED|Overall Study||0
6531877|NCT01618838|7453415|FG000|NOT COMPLETED|Overall Study||4
6531878|NCT01618864|7453420|FG000|STARTED|Overall Study||23
6531879|NCT01618864|7453420|FG000|Completed 2 Weeks|Overall Study||19
6531880|NCT01618864|7453420|FG000|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
6531881|NCT01618864|7453420|FG000|NOT COMPLETED|Overall Study||4
6531882|NCT01618916|7453435|FG000|STARTED|Overall Study||12
6531883|NCT01618916|7453436|FG001|STARTED|Overall Study||10
6531884|NCT01618916|7453437|FG002|STARTED|Overall Study||11
6531885|NCT01618916|7453438|FG003|STARTED|Overall Study||9
6531886|NCT01618916|7453439|FG004|STARTED|Overall Study||5
6531887|NCT01618916|7453440|FG005|STARTED|Overall Study||4
6531888|NCT01618916|7453435|FG000|Received At Least 1 Dose of Study Drug|Overall Study||12
6531889|NCT01618916|7453436|FG001|Received At Least 1 Dose of Study Drug|Overall Study||10
6531890|NCT01618916|7453437|FG002|Received At Least 1 Dose of Study Drug|Overall Study||11
6531891|NCT01618916|7453438|FG003|Received At Least 1 Dose of Study Drug|Overall Study||9
6531892|NCT01618916|7453439|FG004|Received At Least 1 Dose of Study Drug|Overall Study||5
6531893|NCT01618916|7453440|FG005|Received At Least 1 Dose of Study Drug|Overall Study||4
6531894|NCT01618916|7453435|FG000|COMPLETED|Overall Study||10
6531895|NCT01618916|7453436|FG001|COMPLETED|Overall Study||9
6531896|NCT01618916|7453437|FG002|COMPLETED|Overall Study||10
6531897|NCT01618916|7453438|FG003|COMPLETED|Overall Study||7
6531898|NCT01618916|7453439|FG004|COMPLETED|Overall Study||4
6531899|NCT01618916|7453440|FG005|COMPLETED|Overall Study||4
6531900|NCT01618916|7453435|FG000|NOT COMPLETED|Overall Study||2
6531901|NCT01618916|7453436|FG001|NOT COMPLETED|Overall Study||1
6531902|NCT01618916|7453437|FG002|NOT COMPLETED|Overall Study||1
6531903|NCT01618916|7453438|FG003|NOT COMPLETED|Overall Study||2
6531904|NCT01618916|7453439|FG004|NOT COMPLETED|Overall Study||1
6531905|NCT01618916|7453440|FG005|NOT COMPLETED|Overall Study||0
6531906|NCT01618942|7453455|FG000|STARTED|Overall Study||50
6531907|NCT01618942|7453456|FG001|STARTED|Overall Study||50
6531908|NCT01618942|7453455|FG000|COMPLETED|Overall Study||50
6531909|NCT01618942|7453456|FG001|COMPLETED|Overall Study||50
6531910|NCT01618942|7453455|FG000|NOT COMPLETED|Overall Study||0
6531911|NCT01618942|7453456|FG001|NOT COMPLETED|Overall Study||0
6531912|NCT01618955|7453466|FG000|STARTED|Overall Study||20
6531913|NCT01618955|7453467|FG001|STARTED|Overall Study||30
6531914|NCT01618955|7453468|FG002|STARTED|Overall Study||31
6531915|NCT01618955|7453469|FG003|STARTED|Overall Study||20
6531916|NCT01618955|7453466|FG000|COMPLETED|Overall Study||20
6531917|NCT01618955|7453467|FG001|COMPLETED|Overall Study||30
6531918|NCT01618955|7453468|FG002|COMPLETED|Overall Study||31
6531919|NCT01618955|7453469|FG003|COMPLETED|Overall Study||20
6531920|NCT01618955|7453466|FG000|NOT COMPLETED|Overall Study||0
6531921|NCT01618955|7453467|FG001|NOT COMPLETED|Overall Study||0
6531922|NCT01618955|7453468|FG002|NOT COMPLETED|Overall Study||0
6644408|NCT02363270|7573006|FG001|COMPLETED|Overall Study||24
6644409|NCT02363270|7573005|FG000|NOT COMPLETED|Overall Study||0
6644410|NCT02363270|7573006|FG001|NOT COMPLETED|Overall Study||0
6644411|NCT02363283|7573012|FG000|STARTED|Overall Study||37
6644412|NCT02363283|7573012|FG000|COMPLETED|Overall Study||35
6644413|NCT02363283|7573012|FG000|NOT COMPLETED|Overall Study||2
6644414|NCT02363322|7573018|FG000|STARTED|Overall Study||36
6644415|NCT02363322|7573019|FG001|STARTED|Overall Study||36
6531923|NCT01618955|7453469|FG003|NOT COMPLETED|Overall Study||0
6531924|NCT01618968|7453483|FG000|STARTED|Overall Study||13
6531925|NCT01618968|7453484|FG001|STARTED|Overall Study||12
6531926|NCT01618968|7453485|FG002|STARTED|Overall Study||12
6531927|NCT01618968|7453486|FG003|STARTED|Overall Study||12
6531928|NCT01618968|7453483|FG000|Received Treatment A|Overall Study||12
6531929|NCT01618968|7453484|FG001|Received Treatment A|Overall Study||12
6531930|NCT01618968|7453485|FG002|Received Treatment A|Overall Study||12
6531931|NCT01618968|7453486|FG003|Received Treatment A|Overall Study||11
6531932|NCT01618968|7453483|FG000|Received Treatment B|Overall Study||13
6531933|NCT01618968|7453484|FG001|Received Treatment B|Overall Study||12
6531934|NCT01618968|7453485|FG002|Received Treatment B|Overall Study||12
6531935|NCT01618968|7453486|FG003|Received Treatment B|Overall Study||12
6531936|NCT01618968|7453483|FG000|Received Treatment C|Overall Study||12
6531937|NCT01618968|7453484|FG001|Received Treatment C|Overall Study||12
6531938|NCT01618968|7453485|FG002|Received Treatment C|Overall Study||12
6531939|NCT01618968|7453486|FG003|Received Treatment C|Overall Study||11
6531940|NCT01618968|7453483|FG000|COMPLETED|Overall Study||12
6531941|NCT01618968|7453484|FG001|COMPLETED|Overall Study||12
6531942|NCT01618968|7453485|FG002|COMPLETED|Overall Study||12
6531943|NCT01618968|7453486|FG003|COMPLETED|Overall Study||11
6531944|NCT01618968|7453483|FG000|NOT COMPLETED|Overall Study||1
6531945|NCT01618968|7453484|FG001|NOT COMPLETED|Overall Study||0
6531946|NCT01618968|7453485|FG002|NOT COMPLETED|Overall Study||0
6531947|NCT01618968|7453486|FG003|NOT COMPLETED|Overall Study||1
6531948|NCT01619059|7453497|FG000|STARTED|Short-Term (ST) Treatment Period||162
6531949|NCT01619059|7453498|FG001|STARTED|Short-Term (ST) Treatment Period||153
6531950|NCT01619059|7453497|FG000|COMPLETED|Short-Term (ST) Treatment Period||156
6531951|NCT01619059|7453498|FG001|COMPLETED|Short-Term (ST) Treatment Period||142
6531952|NCT01619059|7453497|FG000|NOT COMPLETED|Short-Term (ST) Treatment Period||6
6531953|NCT01619059|7453498|FG001|NOT COMPLETED|Short-Term (ST) Treatment Period||11
6531954|NCT01619059|7453497|FG000|STARTED|Long-Term (LT) Treatment Period||155
6531955|NCT01619059|7453498|FG001|STARTED|Long-Term (LT) Treatment Period||142
6531956|NCT01619059|7453497|FG000|COMPLETED|Long-Term (LT) Treatment Period||147
6531957|NCT01619059|7453498|FG001|COMPLETED|Long-Term (LT) Treatment Period||133
6531958|NCT01619059|7453497|FG000|NOT COMPLETED|Long-Term (LT) Treatment Period||8
6531959|NCT01619059|7453498|FG001|NOT COMPLETED|Long-Term (LT) Treatment Period||9
6531960|NCT01619410|7453506|FG000|STARTED|Overall Study||14
6531961|NCT01619410|7453507|FG001|STARTED|Overall Study||11
6531962|NCT01619410|7453506|FG000|COMPLETED|Overall Study||7
6531963|NCT01619410|7453507|FG001|COMPLETED|Overall Study||7
6531964|NCT01619410|7453506|FG000|NOT COMPLETED|Overall Study||7
6531965|NCT01619410|7453507|FG001|NOT COMPLETED|Overall Study||4
6531966|NCT01619423|7453517|FG000|STARTED|Part 1 (Dose Escalation)||0
6531967|NCT01619423|7453518|FG001|STARTED|Part 1 (Dose Escalation)||5
6531968|NCT01619423|7453519|FG002|STARTED|Part 1 (Dose Escalation)||3
6531969|NCT01619423|7453520|FG003|STARTED|Part 1 (Dose Escalation)||5
6644416|NCT02363322|7573018|FG000|COMPLETED|Overall Study||35
6531970|NCT01619423|7453517|FG000|COMPLETED|Part 1 (Dose Escalation)||0
6531971|NCT01619423|7453518|FG001|COMPLETED|Part 1 (Dose Escalation)||3
6531972|NCT01619423|7453519|FG002|COMPLETED|Part 1 (Dose Escalation)||3
6531973|NCT01619423|7453520|FG003|COMPLETED|Part 1 (Dose Escalation)||5
6531974|NCT01619423|7453517|FG000|NOT COMPLETED|Part 1 (Dose Escalation)||0
6531975|NCT01619423|7453518|FG001|NOT COMPLETED|Part 1 (Dose Escalation)||2
6531976|NCT01619423|7453519|FG002|NOT COMPLETED|Part 1 (Dose Escalation)||0
6531977|NCT01619423|7453520|FG003|NOT COMPLETED|Part 1 (Dose Escalation)||0
6531978|NCT01619423|7453517|FG000|STARTED|Part 2a||15
6531979|NCT01619423|7453518|FG001|STARTED|Part 2a||13
6531980|NCT01619423|7453519|FG002|STARTED|Part 2a||0
6531981|NCT01619423|7453520|FG003|STARTED|Part 2a||11
6531982|NCT01619423|7453517|FG000|COMPLETED|Part 2a||15
6531983|NCT01619423|7453518|FG001|COMPLETED|Part 2a||13
6531984|NCT01619423|7453519|FG002|COMPLETED|Part 2a||0
6531985|NCT01619423|7453520|FG003|COMPLETED|Part 2a||11
6531986|NCT01619423|7453517|FG000|NOT COMPLETED|Part 2a||0
6531987|NCT01619423|7453518|FG001|NOT COMPLETED|Part 2a||0
6531988|NCT01619423|7453519|FG002|NOT COMPLETED|Part 2a||0
6531989|NCT01619423|7453520|FG003|NOT COMPLETED|Part 2a||0
6531990|NCT01619423|7453517|FG000|STARTED|Part 2b||45
6531991|NCT01619423|7453518|FG001|STARTED|Part 2b||44
6531992|NCT01619423|7453519|FG002|STARTED|Part 2b||45
6531993|NCT01619423|7453520|FG003|STARTED|Part 2b||0
6531994|NCT01619423|7453517|FG000|COMPLETED|Part 2b||45
6531995|NCT01619423|7453518|FG001|COMPLETED|Part 2b||44
6531996|NCT01619423|7453519|FG002|COMPLETED|Part 2b||45
6531997|NCT01619423|7453520|FG003|COMPLETED|Part 2b||0
6531998|NCT01619423|7453517|FG000|NOT COMPLETED|Part 2b||0
6531999|NCT01619423|7453518|FG001|NOT COMPLETED|Part 2b||0
6532000|NCT01619423|7453519|FG002|NOT COMPLETED|Part 2b||0
6532001|NCT01619423|7453520|FG003|NOT COMPLETED|Part 2b||0
6532002|NCT01619579|7453533|FG000|STARTED|Overall Study||5
6532003|NCT01619579|7453534|FG001|STARTED|Overall Study||17
6532004|NCT01619579|7453533|FG000|COMPLETED|Overall Study||5
6532005|NCT01619579|7453534|FG001|COMPLETED|Overall Study||14
6532006|NCT01619579|7453533|FG000|NOT COMPLETED|Overall Study||0
6532007|NCT01619579|7453534|FG001|NOT COMPLETED|Overall Study||3
6532008|NCT01619774|7453540|FG000|STARTED|Overall Study||23
6532009|NCT01619774|7453540|FG000|COMPLETED|Overall Study||23
6532010|NCT01619774|7453540|FG000|NOT COMPLETED|Overall Study||0
6532011|NCT01619787|7453546|FG000|STARTED|Overall Study||217
6532012|NCT01619787|7453546|FG000|COMPLETED|Overall Study||212
6532013|NCT01619787|7453546|FG000|NOT COMPLETED|Overall Study||5
6532014|NCT01619839|7453557|FG000|STARTED|Overall Study||48
6532015|NCT01619839|7453558|FG001|STARTED|Overall Study||31
6532016|NCT01619839|7453559|FG002|STARTED|Overall Study||18
6532017|NCT01619839|7453560|FG003|STARTED|Overall Study||10
6532018|NCT01619839|7453561|FG004|STARTED|Overall Study||106
6532019|NCT01619839|7453557|FG000|COMPLETED|Overall Study||43
6532020|NCT01619839|7453558|FG001|COMPLETED|Overall Study||27
6532021|NCT01619839|7453559|FG002|COMPLETED|Overall Study||17
6532022|NCT01619839|7453560|FG003|COMPLETED|Overall Study||9
6532023|NCT01619839|7453561|FG004|COMPLETED|Overall Study||97
6532024|NCT01619839|7453557|FG000|NOT COMPLETED|Overall Study||5
6532025|NCT01619839|7453558|FG001|NOT COMPLETED|Overall Study||4
6532026|NCT01619839|7453559|FG002|NOT COMPLETED|Overall Study||1
6532027|NCT01619839|7453560|FG003|NOT COMPLETED|Overall Study||1
6532028|NCT01619839|7453561|FG004|NOT COMPLETED|Overall Study||9
6532029|NCT01619852|7453572|FG000|STARTED|24 Hour Assessment||75
6532030|NCT01619852|7453573|FG001|STARTED|24 Hour Assessment||75
6532031|NCT01619852|7453572|FG000|COMPLETED|24 Hour Assessment||74
6532032|NCT01619852|7453573|FG001|COMPLETED|24 Hour Assessment||74
6532033|NCT01619852|7453572|FG000|NOT COMPLETED|24 Hour Assessment||1
6532034|NCT01619852|7453573|FG001|NOT COMPLETED|24 Hour Assessment||1
6532035|NCT01619852|7453572|FG000|STARTED|3 Month Follow up||74
6532036|NCT01619852|7453573|FG001|STARTED|3 Month Follow up||74
6644417|NCT02363322|7573019|FG001|COMPLETED|Overall Study||36
6644418|NCT02363322|7573018|FG000|NOT COMPLETED|Overall Study||1
6644419|NCT02363322|7573019|FG001|NOT COMPLETED|Overall Study||0
6644420|NCT02363439|7573025|FG000|STARTED|Overall Study||5
6644421|NCT02363439|7573025|FG000|COMPLETED|Overall Study||1
6644422|NCT02363439|7573025|FG000|NOT COMPLETED|Overall Study||4
6644423|NCT02363478|7573029|FG000|STARTED|Overall Study||30
6644424|NCT02363478|7573029|FG000|COMPLETED|Overall Study||22
6644425|NCT02363478|7573029|FG000|NOT COMPLETED|Overall Study||8
6644426|NCT02363621|7573036|FG000|STARTED|Overall Study||51
6644427|NCT02363621|7573037|FG001|STARTED|Overall Study||50
6644428|NCT02363621|7573036|FG000|COMPLETED|Overall Study||50
6644429|NCT02363621|7573037|FG001|COMPLETED|Overall Study||50
6644430|NCT02363621|7573036|FG000|NOT COMPLETED|Overall Study||1
6644431|NCT02363621|7573037|FG001|NOT COMPLETED|Overall Study||0
6644432|NCT02363686|7573043|FG000|STARTED|Overall Study||248
6532037|NCT01619852|7453572|FG000|COMPLETED|3 Month Follow up||43
6532038|NCT01619852|7453573|FG001|COMPLETED|3 Month Follow up||40
6532039|NCT01619852|7453572|FG000|NOT COMPLETED|3 Month Follow up||31
6532040|NCT01619852|7453573|FG001|NOT COMPLETED|3 Month Follow up||34
6532041|NCT01619865|7453580|FG000|STARTED|Overall Study||223
6532042|NCT01619865|7453580|FG000|COMPLETED|Overall Study||219
6532043|NCT01619865|7453580|FG000|NOT COMPLETED|Overall Study||4
6532044|NCT01619878|7453585|FG000|STARTED|6 Week Follow-up Phase||20
6532045|NCT01619878|7453585|FG000|COMPLETED|6 Week Follow-up Phase||19
6532046|NCT01619878|7453585|FG000|NOT COMPLETED|6 Week Follow-up Phase||1
6644433|NCT02363686|7573043|FG000|COMPLETED|Overall Study||213
6644434|NCT02363686|7573043|FG000|NOT COMPLETED|Overall Study||35
6644435|NCT02363738|7573049|FG000|STARTED|Overall Study||29
6532047|NCT01619878|7453585|FG000|STARTED|Follow-up at 12 Months of Age||20
6532048|NCT01619878|7453585|FG000|COMPLETED|Follow-up at 12 Months of Age||17
6532049|NCT01619878|7453585|FG000|NOT COMPLETED|Follow-up at 12 Months of Age||3
6532050|NCT01619982|7453591|FG000|STARTED|Overall Study||20
6532051|NCT01619982|7453592|FG001|STARTED|Overall Study||12
6532052|NCT01619982|7453591|FG000|COMPLETED|Overall Study||20
6532053|NCT01619982|7453592|FG001|COMPLETED|Overall Study||12
6532054|NCT01619982|7453591|FG000|NOT COMPLETED|Overall Study||0
6532055|NCT01619982|7453592|FG001|NOT COMPLETED|Overall Study||0
6532056|NCT01620047|7453605|FG000|STARTED|Overall Study||20
6532057|NCT01620047|7453606|FG001|STARTED|Overall Study||20
6532058|NCT01620047|7453607|FG002|STARTED|Overall Study||20
6532059|NCT01620047|7453605|FG000|COMPLETED|Overall Study||20
6532060|NCT01620047|7453606|FG001|COMPLETED|Overall Study||20
6532061|NCT01620047|7453607|FG002|COMPLETED|Overall Study||20
6532062|NCT01620047|7453605|FG000|NOT COMPLETED|Overall Study||0
6532063|NCT01620047|7453606|FG001|NOT COMPLETED|Overall Study||0
6532064|NCT01620047|7453607|FG002|NOT COMPLETED|Overall Study||0
6532065|NCT01620060|7453615|FG000|STARTED|Overall Study||105
6532066|NCT01620060|7453615|FG000|COMPLETED|Overall Study||90
6532067|NCT01620060|7453615|FG000|NOT COMPLETED|Overall Study||15
6532068|NCT01620086|7453621|FG000|STARTED|Overall Study||13
6532069|NCT01620086|7453622|FG001|STARTED|Overall Study||11
6532070|NCT01620086|7453623|FG002|STARTED|Overall Study||2
6532071|NCT01620086|7453621|FG000|COMPLETED|Overall Study||8
6532072|NCT01620086|7453622|FG001|COMPLETED|Overall Study||4
6532073|NCT01620086|7453623|FG002|COMPLETED|Overall Study||2
6532074|NCT01620086|7453621|FG000|NOT COMPLETED|Overall Study||5
6532075|NCT01620086|7453622|FG001|NOT COMPLETED|Overall Study||7
6532076|NCT01620086|7453623|FG002|NOT COMPLETED|Overall Study||0
6532077|NCT01620138|7453634|FG000|STARTED|Overall Study||12
6532078|NCT01620138|7453635|FG001|STARTED|Overall Study||9
6532079|NCT01620138|7453634|FG000|COMPLETED|Overall Study||6
6532080|NCT01620138|7453635|FG001|COMPLETED|Overall Study||9
6532081|NCT01620138|7453634|FG000|NOT COMPLETED|Overall Study||6
6532082|NCT01620138|7453635|FG001|NOT COMPLETED|Overall Study||0
6532083|NCT01620177|7453641|FG000|STARTED|Overall Study||98
6532084|NCT01620177|7453641|FG000|COMPLETED|Overall Study||19
6532085|NCT01620177|7453641|FG000|NOT COMPLETED|Overall Study||79
6532086|NCT01620190|7453658|FG000|STARTED|Overall Study||26
6532087|NCT01620190|7453658|FG000|COMPLETED|Overall Study||26
6532088|NCT01620190|7453658|FG000|NOT COMPLETED|Overall Study||0
6562009|NCT01798316|7484990|FG000|NOT COMPLETED|Overall Study||0
6562010|NCT01798316|7484991|FG001|NOT COMPLETED|Overall Study||0
6562011|NCT01798394|7485001|FG000|STARTED|Overall Study||24
6562012|NCT01798394|7485002|FG001|STARTED|Overall Study||22
6562013|NCT01798394|7485001|FG000|COMPLETED|Overall Study||21
6562014|NCT01798394|7485002|FG001|COMPLETED|Overall Study||19
6562015|NCT01798394|7485001|FG000|NOT COMPLETED|Overall Study||3
6562016|NCT01798394|7485002|FG001|NOT COMPLETED|Overall Study||3
6562017|NCT01798485|7485010|FG000|STARTED|Overall Study||347
6562018|NCT01798485|7485011|FG001|STARTED|Overall Study||349
6562019|NCT01798485|7485010|FG000|Safety Population as of 23 Dec 2015|Overall Study||338
6562020|NCT01798485|7485011|FG001|Safety Population as of 23 Dec 2015|Overall Study||342
6562021|NCT01798485|7485010|FG000|Randomized as of 19 October 2015|Overall Study||335
6562022|NCT01798485|7485011|FG001|Randomized as of 19 October 2015|Overall Study||337
6562023|NCT01798485|7485010|FG000|COMPLETED|Overall Study||1
6562024|NCT01798485|7485011|FG001|COMPLETED|Overall Study||59
6562025|NCT01798485|7485010|FG000|NOT COMPLETED|Overall Study||346
6562026|NCT01798485|7485011|FG001|NOT COMPLETED|Overall Study||290
6562027|NCT01798550|7485019|FG000|STARTED|Overall Study||30
6562028|NCT01798550|7485020|FG001|STARTED|Overall Study||32
6562029|NCT01798550|7485019|FG000|COMPLETED|Overall Study||28
6562030|NCT01798550|7485020|FG001|COMPLETED|Overall Study||26
6562031|NCT01798550|7485019|FG000|NOT COMPLETED|Overall Study||2
6562032|NCT01798550|7485020|FG001|NOT COMPLETED|Overall Study||6
6562033|NCT01798589|7485026|FG000|STARTED|Overall Study||16
6562034|NCT01798589|7485026|FG000|COMPLETED|Overall Study||16
6562035|NCT01798589|7485026|FG000|NOT COMPLETED|Overall Study||0
6562036|NCT01798641|7485036|FG000|STARTED|First Intervention (6 Weeks)||19
6562037|NCT01798641|7485037|FG001|STARTED|First Intervention (6 Weeks)||19
6562038|NCT01798641|7485036|FG000|COMPLETED|First Intervention (6 Weeks)||19
6562039|NCT01798641|7485037|FG001|COMPLETED|First Intervention (6 Weeks)||19
6562040|NCT01798641|7485036|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
6562041|NCT01798641|7485037|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
6562042|NCT01798641|7485036|FG000|STARTED|Second Intervention (6 Weeks)||19
6562043|NCT01798641|7485037|FG001|STARTED|Second Intervention (6 Weeks)||19
6562044|NCT01798641|7485036|FG000|COMPLETED|Second Intervention (6 Weeks)||19
6562045|NCT01798641|7485037|FG001|COMPLETED|Second Intervention (6 Weeks)||19
6562046|NCT01798641|7485036|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6562047|NCT01798641|7485037|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6562048|NCT01798706|7485046|FG000|STARTED|Overall Study||176
6562049|NCT01798706|7485047|FG001|STARTED|Overall Study||174
6562050|NCT01798706|7485046|FG000|COMPLETED|Overall Study||155
6562051|NCT01798706|7485047|FG001|COMPLETED|Overall Study||153
6562052|NCT01798706|7485046|FG000|NOT COMPLETED|Overall Study||21
6562053|NCT01798706|7485047|FG001|NOT COMPLETED|Overall Study||21
6562054|NCT01798849|7485056|FG000|STARTED|Overall Study||8
6562055|NCT01798849|7485057|FG001|STARTED|Overall Study||8
6532089|NCT01620216|7453669|FG000|STARTED|Overall Study||4
6532090|NCT01620216|7453670|FG001|STARTED|Overall Study||2
6532091|NCT01620216|7453671|FG002|STARTED|Overall Study||6
6532092|NCT01620216|7453672|FG003|STARTED|Overall Study||0
6644436|NCT02363738|7573050|FG001|STARTED|Overall Study||31
6644437|NCT02363738|7573049|FG000|COMPLETED|Overall Study||21
6644438|NCT02363738|7573050|FG001|COMPLETED|Overall Study||26
6644439|NCT02363738|7573049|FG000|NOT COMPLETED|Overall Study||8
6644440|NCT02363738|7573050|FG001|NOT COMPLETED|Overall Study||5
6655874|NCT02456740|7586042|FG006|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6655875|NCT02456740|7586043|FG007|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6655876|NCT02456740|7586044|FG008|Received Study Drug|Double-blind Treatment Phase (24 Weeks)||0
6655877|NCT02456740|7586036|FG000|COMPLETED|Double-blind Treatment Phase (24 Weeks)||282
6532093|NCT01620216|7453673|FG004|STARTED|Overall Study||0
6532094|NCT01620216|7453674|FG005|STARTED|Overall Study||0
6532095|NCT01620216|7453675|FG006|STARTED|Overall Study||0
6532096|NCT01620216|7453669|FG000|COMPLETED|Overall Study||4
6532097|NCT01620216|7453670|FG001|COMPLETED|Overall Study||2
6532098|NCT01620216|7453671|FG002|COMPLETED|Overall Study||6
6532099|NCT01620216|7453672|FG003|COMPLETED|Overall Study||0
6532100|NCT01620216|7453673|FG004|COMPLETED|Overall Study||0
6532101|NCT01620216|7453674|FG005|COMPLETED|Overall Study||0
6532102|NCT01620216|7453675|FG006|COMPLETED|Overall Study||0
6532103|NCT01620216|7453669|FG000|NOT COMPLETED|Overall Study||0
6532104|NCT01620216|7453670|FG001|NOT COMPLETED|Overall Study||0
6532105|NCT01620216|7453671|FG002|NOT COMPLETED|Overall Study||0
6532106|NCT01620216|7453672|FG003|NOT COMPLETED|Overall Study||0
6532107|NCT01620216|7453673|FG004|NOT COMPLETED|Overall Study||0
6532108|NCT01620216|7453674|FG005|NOT COMPLETED|Overall Study||0
6532109|NCT01620216|7453675|FG006|NOT COMPLETED|Overall Study||0
6532110|NCT01620255|7453696|FG000|STARTED|Overall Study||73
6532111|NCT01620255|7453697|FG001|STARTED|Overall Study||71
6532112|NCT01620255|7453698|FG002|STARTED|Overall Study||70
6532113|NCT01620255|7453699|FG003|STARTED|Overall Study||73
6532114|NCT01620255|7453700|FG004|STARTED|Overall Study||70
6532115|NCT01620255|7453696|FG000|Treated|Overall Study||73
6532116|NCT01620255|7453697|FG001|Treated|Overall Study||71
6655878|NCT02456740|7586037|FG001|COMPLETED|Double-blind Treatment Phase (24 Weeks)||284
6655879|NCT02456740|7586038|FG002|COMPLETED|Double-blind Treatment Phase (24 Weeks)||292
6655880|NCT02456740|7586039|FG003|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655881|NCT02456740|7586040|FG004|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655882|NCT02456740|7586041|FG005|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655883|NCT02456740|7586042|FG006|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655884|NCT02456740|7586043|FG007|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655885|NCT02456740|7586044|FG008|COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655886|NCT02456740|7586036|FG000|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||37
6655887|NCT02456740|7586037|FG001|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||33
6655888|NCT02456740|7586038|FG002|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||27
6655889|NCT02456740|7586039|FG003|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655890|NCT02456740|7586040|FG004|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655891|NCT02456740|7586041|FG005|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655892|NCT02456740|7586042|FG006|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655893|NCT02456740|7586043|FG007|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655894|NCT02456740|7586044|FG008|NOT COMPLETED|Double-blind Treatment Phase (24 Weeks)||0
6655895|NCT02456740|7586036|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6655896|NCT02456740|7586037|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6655897|NCT02456740|7586038|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6655898|NCT02456740|7586039|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||138
6655899|NCT02456740|7586040|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
6655900|NCT02456740|7586041|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)||143
6655901|NCT02456740|7586042|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
6655902|NCT02456740|7586043|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||140
6655903|NCT02456740|7586044|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||144
6655904|NCT02456740|7586036|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6655905|NCT02456740|7586037|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6655906|NCT02456740|7586038|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6655907|NCT02456740|7586039|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||124
6655908|NCT02456740|7586040|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||123
6655909|NCT02456740|7586041|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||130
6655910|NCT02456740|7586042|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||131
6655911|NCT02456740|7586043|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||128
6655912|NCT02456740|7586044|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||126
6655913|NCT02456740|7586036|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6655914|NCT02456740|7586037|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6532117|NCT01620255|7453698|FG002|Treated|Overall Study||70
6532118|NCT01620255|7453699|FG003|Treated|Overall Study||73
6532119|NCT01620255|7453700|FG004|Treated|Overall Study||70
6532120|NCT01620255|7453696|FG000|COMPLETED|Overall Study||69
6532121|NCT01620255|7453697|FG001|COMPLETED|Overall Study||65
6532122|NCT01620255|7453698|FG002|COMPLETED|Overall Study||68
6532123|NCT01620255|7453699|FG003|COMPLETED|Overall Study||70
6532124|NCT01620255|7453700|FG004|COMPLETED|Overall Study||64
6532125|NCT01620255|7453696|FG000|NOT COMPLETED|Overall Study||4
6532126|NCT01620255|7453697|FG001|NOT COMPLETED|Overall Study||6
6532127|NCT01620255|7453698|FG002|NOT COMPLETED|Overall Study||2
6532128|NCT01620255|7453699|FG003|NOT COMPLETED|Overall Study||3
6532129|NCT01620255|7453700|FG004|NOT COMPLETED|Overall Study||6
6532130|NCT01620489|7453714|FG000|STARTED|Overall Study||140
6532131|NCT01620489|7453715|FG001|STARTED|Overall Study||139
6532132|NCT01620489|7453714|FG000|Exposed|Overall Study||140
6532133|NCT01620489|7453715|FG001|Exposed|Overall Study|2 subjects did not take trial product|137
6532134|NCT01620489|7453714|FG000|COMPLETED|Overall Study||105
6532135|NCT01620489|7453715|FG001|COMPLETED|Overall Study|2 subjects did not take trial product|105
6532136|NCT01620489|7453714|FG000|NOT COMPLETED|Overall Study||35
6532137|NCT01620489|7453715|FG001|NOT COMPLETED|Overall Study||34
6532138|NCT01620528|7453724|FG000|STARTED|Treatment Period||374
6532139|NCT01620528|7453725|FG001|STARTED|Treatment Period||249
6532140|NCT01620528|7453726|FG002|STARTED|Treatment Period|1 subject did not receive study drug|249
6532141|NCT01620528|7453724|FG000|COMPLETED|Treatment Period||274
6532142|NCT01620528|7453725|FG001|COMPLETED|Treatment Period||196
6532143|NCT01620528|7453726|FG002|COMPLETED|Treatment Period||183
6532144|NCT01620528|7453724|FG000|NOT COMPLETED|Treatment Period||100
6532145|NCT01620528|7453725|FG001|NOT COMPLETED|Treatment Period||53
6532146|NCT01620528|7453726|FG002|NOT COMPLETED|Treatment Period||66
6532147|NCT01620528|7453724|FG000|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|68
6532148|NCT01620528|7453725|FG001|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|48
6532149|NCT01620528|7453726|FG002|STARTED|Post-Treatment Follow-Up Period|elected to enter the PTFU Period|51
6532150|NCT01620528|7453724|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up Period||46
6532151|NCT01620528|7453725|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|26
6532152|NCT01620528|7453726|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up Period|Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).|18
6532153|NCT01620528|7453724|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up Period||2
6532154|NCT01620528|7453725|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up Period||5
6532155|NCT01620528|7453726|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up Period||19
6532156|NCT01620528|7453724|FG000|COMPLETED|Post-Treatment Follow-Up Period||48
6532157|NCT01620528|7453725|FG001|COMPLETED|Post-Treatment Follow-Up Period||31
6532158|NCT01620528|7453726|FG002|COMPLETED|Post-Treatment Follow-Up Period||37
6532159|NCT01620528|7453724|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||20
6532160|NCT01620528|7453725|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||17
6532161|NCT01620528|7453726|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||14
6532162|NCT01620567|7453736|FG000|STARTED|Overall Study||23
6532163|NCT01620567|7453737|FG001|STARTED|Overall Study||25
6532164|NCT01620567|7453736|FG000|COMPLETED|Overall Study||20
6532165|NCT01620567|7453737|FG001|COMPLETED|Overall Study||20
6532166|NCT01620567|7453736|FG000|NOT COMPLETED|Overall Study||3
6532167|NCT01620567|7453737|FG001|NOT COMPLETED|Overall Study||5
6532168|NCT01620593|7453748|FG000|STARTED|Overall Study||21
6532169|NCT01620593|7453749|FG001|STARTED|Overall Study||20
6532170|NCT01620593|7453748|FG000|COMPLETED|Overall Study||17
6532171|NCT01620593|7453749|FG001|COMPLETED|Overall Study||19
6532172|NCT01620593|7453748|FG000|NOT COMPLETED|Overall Study||4
6532173|NCT01620593|7453749|FG001|NOT COMPLETED|Overall Study||1
6532174|NCT01620762|7453758|FG000|STARTED|Overall Study||468
6532175|NCT01620762|7453759|FG001|STARTED|Overall Study||470
6532176|NCT01620762|7453760|FG002|STARTED|Overall Study||470
6532177|NCT01620762|7453758|FG000|COMPLETED|Overall Study||420
6532178|NCT01620762|7453759|FG001|COMPLETED|Overall Study||412
6532179|NCT01620762|7453760|FG002|COMPLETED|Overall Study||417
6532180|NCT01620762|7453758|FG000|NOT COMPLETED|Overall Study||48
6532181|NCT01620762|7453759|FG001|NOT COMPLETED|Overall Study||58
6532182|NCT01620762|7453760|FG002|NOT COMPLETED|Overall Study||53
6532183|NCT01620983|7453771|FG000|STARTED|Overall Study||130
6532184|NCT01620983|7453772|FG001|STARTED|Overall Study||135
6532185|NCT01620983|7453773|FG002|STARTED|Overall Study||137
6532186|NCT01620983|7453771|FG000|COMPLETED|Overall Study||111
6532187|NCT01620983|7453772|FG001|COMPLETED|Overall Study||113
6532188|NCT01620983|7453773|FG002|COMPLETED|Overall Study||122
6532189|NCT01620983|7453771|FG000|NOT COMPLETED|Overall Study||19
6532190|NCT01620983|7453772|FG001|NOT COMPLETED|Overall Study||22
6532191|NCT01620983|7453773|FG002|NOT COMPLETED|Overall Study||15
6532192|NCT01621009|7453785|FG000|STARTED|Overall Study||113
6532193|NCT01621009|7453786|FG001|STARTED|Overall Study||116
6532194|NCT01621009|7453787|FG002|STARTED|Overall Study||121
6532195|NCT01621009|7453788|FG003|STARTED|Overall Study||113
6532196|NCT01621009|7453785|FG000|COMPLETED|Overall Study||70
6532197|NCT01621009|7453786|FG001|COMPLETED|Overall Study||65
6532198|NCT01621009|7453787|FG002|COMPLETED|Overall Study||58
6532199|NCT01621009|7453788|FG003|COMPLETED|Overall Study||60
6532200|NCT01621009|7453785|FG000|NOT COMPLETED|Overall Study||43
6532201|NCT01621009|7453786|FG001|NOT COMPLETED|Overall Study||51
6532202|NCT01621009|7453787|FG002|NOT COMPLETED|Overall Study||63
6532203|NCT01621009|7453788|FG003|NOT COMPLETED|Overall Study||53
6532204|NCT01621126|7453796|FG000|STARTED|Overall Study||40
6532205|NCT01621126|7453796|FG000|COMPLETED|Overall Study||34
6532206|NCT01621126|7453796|FG000|NOT COMPLETED|Overall Study||6
6532207|NCT01621178|7453803|FG000|STARTED|Overall Study||194
6532208|NCT01621178|7453804|FG001|STARTED|Overall Study||190
6532209|NCT01621178|7453805|FG002|STARTED|Overall Study||193
6532210|NCT01621178|7453803|FG000|Received at Least One Dose of Study Drug|Overall Study||194
6532211|NCT01621178|7453804|FG001|Received at Least One Dose of Study Drug|Overall Study||190
6532212|NCT01621178|7453805|FG002|Received at Least One Dose of Study Drug|Overall Study||192
6532213|NCT01621178|7453803|FG000|Modified Intent to Treat Population|Overall Study||186
6532214|NCT01621178|7453804|FG001|Modified Intent to Treat Population|Overall Study||180
6532215|NCT01621178|7453805|FG002|Modified Intent to Treat Population|Overall Study||183
6532216|NCT01621178|7453803|FG000|COMPLETED|Overall Study||163
6532217|NCT01621178|7453804|FG001|COMPLETED|Overall Study||160
6532218|NCT01621178|7453805|FG002|COMPLETED|Overall Study||157
6532219|NCT01621178|7453803|FG000|NOT COMPLETED|Overall Study||31
6532220|NCT01621178|7453804|FG001|NOT COMPLETED|Overall Study||30
6532221|NCT01621178|7453805|FG002|NOT COMPLETED|Overall Study||36
6532222|NCT01621191|7453817|FG000|STARTED|Overall Study||149
6532223|NCT01621191|7453817|FG000|Received at Least 1 Dose of Study Drug|Overall Study||149
6532224|NCT01621191|7453817|FG000|Had at Least 1 Post-Baseline Observation|Overall Study||148
6532225|NCT01621191|7453817|FG000|COMPLETED|Overall Study||124
6532226|NCT01621191|7453817|FG000|NOT COMPLETED|Overall Study||25
6532227|NCT01621230|7453824|FG000|STARTED|Overall Study||154
6532228|NCT01621230|7453825|FG001|STARTED|Overall Study||156
6532229|NCT01621230|7453824|FG000|COMPLETED|Overall Study||154
6532230|NCT01621230|7453825|FG001|COMPLETED|Overall Study||156
6532231|NCT01621230|7453824|FG000|NOT COMPLETED|Overall Study||0
6532232|NCT01621230|7453825|FG001|NOT COMPLETED|Overall Study||0
6532233|NCT01621477|7453834|FG000|STARTED|Overall Study||17
6532234|NCT01621477|7453834|FG000|COMPLETED|Overall Study||17
6532235|NCT01621477|7453834|FG000|NOT COMPLETED|Overall Study||0
6532236|NCT01621490|7453847|FG000|STARTED|Overall Study||41
6532237|NCT01621490|7453848|FG001|STARTED|Overall Study||44
6532238|NCT01621490|7453849|FG002|STARTED|Overall Study||11
6532239|NCT01621490|7453850|FG003|STARTED|Overall Study||10
6532240|NCT01621490|7453851|FG004|STARTED|Overall Study||6
6532241|NCT01621490|7453852|FG005|STARTED|Overall Study||25
6532242|NCT01621490|7453853|FG006|STARTED|Overall Study||11
6532243|NCT01621490|7453854|FG007|STARTED|Overall Study||10
6532244|NCT01621490|7453855|FG008|STARTED|Overall Study||10
6532245|NCT01621490|7453847|FG000|COMPLETED|Overall Study||0
6532246|NCT01621490|7453848|FG001|COMPLETED|Overall Study||0
6532247|NCT01621490|7453849|FG002|COMPLETED|Overall Study||0
6532248|NCT01621490|7453850|FG003|COMPLETED|Overall Study||1
6532249|NCT01621490|7453851|FG004|COMPLETED|Overall Study||0
6532250|NCT01621490|7453852|FG005|COMPLETED|Overall Study||1
6532251|NCT01621490|7453853|FG006|COMPLETED|Overall Study||0
6532252|NCT01621490|7453854|FG007|COMPLETED|Overall Study||0
6532253|NCT01621490|7453855|FG008|COMPLETED|Overall Study||2
6532254|NCT01621490|7453847|FG000|NOT COMPLETED|Overall Study||41
6532255|NCT01621490|7453848|FG001|NOT COMPLETED|Overall Study||44
6532256|NCT01621490|7453849|FG002|NOT COMPLETED|Overall Study||11
6532257|NCT01621490|7453850|FG003|NOT COMPLETED|Overall Study||9
6532258|NCT01621490|7453851|FG004|NOT COMPLETED|Overall Study||6
6532259|NCT01621490|7453852|FG005|NOT COMPLETED|Overall Study||24
6532260|NCT01621490|7453853|FG006|NOT COMPLETED|Overall Study||11
6532261|NCT01621490|7453854|FG007|NOT COMPLETED|Overall Study||10
6532262|NCT01621490|7453855|FG008|NOT COMPLETED|Overall Study||8
6532263|NCT01621542|7453974|FG000|STARTED|Overall Study||5
6532264|NCT01621542|7453975|FG001|STARTED|Overall Study||5
6532265|NCT01621542|7453976|FG002|STARTED|Overall Study||6
6532266|NCT01621542|7453977|FG003|STARTED|Overall Study||28
6532267|NCT01621542|7453978|FG004|STARTED|Overall Study||9
6532268|NCT01621542|7453979|FG005|STARTED|Overall Study||9
6532269|NCT01621542|7453974|FG000|COMPLETED|Overall Study||0
6532270|NCT01621542|7453975|FG001|COMPLETED|Overall Study||0
6532271|NCT01621542|7453976|FG002|COMPLETED|Overall Study||0
6532272|NCT01621542|7453977|FG003|COMPLETED|Overall Study||0
6532273|NCT01621542|7453978|FG004|COMPLETED|Overall Study||0
6532274|NCT01621542|7453979|FG005|COMPLETED|Overall Study||0
6532275|NCT01621542|7453974|FG000|NOT COMPLETED|Overall Study||5
6532276|NCT01621542|7453975|FG001|NOT COMPLETED|Overall Study||5
6532277|NCT01621542|7453976|FG002|NOT COMPLETED|Overall Study||6
6532278|NCT01621542|7453977|FG003|NOT COMPLETED|Overall Study||28
6532279|NCT01621542|7453978|FG004|NOT COMPLETED|Overall Study||9
6532280|NCT01621542|7453979|FG005|NOT COMPLETED|Overall Study||9
6532281|NCT01621633|7453997|FG000|STARTED|Overall Study||8
6532282|NCT01621633|7453998|FG001|STARTED|Overall Study||8
6532283|NCT01621633|7453999|FG002|STARTED|Overall Study||8
6532284|NCT01621633|7454000|FG003|STARTED|Overall Study||8
6532285|NCT01621633|7453997|FG000|COMPLETED|Overall Study||8
6532286|NCT01621633|7453998|FG001|COMPLETED|Overall Study||8
6532287|NCT01621633|7453999|FG002|COMPLETED|Overall Study||8
6532288|NCT01621633|7454000|FG003|COMPLETED|Overall Study||8
6532289|NCT01621633|7453997|FG000|NOT COMPLETED|Overall Study||0
6532290|NCT01621633|7453998|FG001|NOT COMPLETED|Overall Study||0
6532291|NCT01621633|7453999|FG002|NOT COMPLETED|Overall Study||0
6532292|NCT01621633|7454000|FG003|NOT COMPLETED|Overall Study||0
6532293|NCT01621672|7454012|FG000|STARTED|Overall Study||25
6532294|NCT01621672|7454013|FG001|STARTED|Overall Study||17
6532295|NCT01621672|7454012|FG000|COMPLETED|Overall Study||25
6532296|NCT01621672|7454013|FG001|COMPLETED|Overall Study||17
6532297|NCT01621672|7454012|FG000|NOT COMPLETED|Overall Study||0
6532298|NCT01621672|7454013|FG001|NOT COMPLETED|Overall Study||0
6532299|NCT01621776|7454022|FG000|STARTED|Overall Study||41
6532300|NCT01621776|7454023|FG001|STARTED|Overall Study||40
6532301|NCT01621776|7454024|FG002|STARTED|Overall Study||18
6532302|NCT01621776|7454022|FG000|COMPLETED|Overall Study||41
6532303|NCT01621776|7454023|FG001|COMPLETED|Overall Study||40
6532304|NCT01621776|7454024|FG002|COMPLETED|Overall Study||18
6532305|NCT01621776|7454022|FG000|NOT COMPLETED|Overall Study||0
6532306|NCT01621776|7454023|FG001|NOT COMPLETED|Overall Study||0
6532307|NCT01621776|7454024|FG002|NOT COMPLETED|Overall Study||0
6532308|NCT01621802|7454038|FG000|STARTED|Overall Study||802
6532309|NCT01621802|7454039|FG001|STARTED|Overall Study||298
6532310|NCT01621802|7454040|FG002|STARTED|Overall Study||796
6532311|NCT01621802|7454041|FG003|STARTED|Overall Study||303
6532312|NCT01621802|7454042|FG004|STARTED|Overall Study||1319
6532313|NCT01621802|7454043|FG005|STARTED|Overall Study||489
6532314|NCT01621802|7454038|FG000|COMPLETED|Overall Study||755
6532315|NCT01621802|7454039|FG001|COMPLETED|Overall Study||275
6532316|NCT01621802|7454040|FG002|COMPLETED|Overall Study||763
6532317|NCT01621802|7454041|FG003|COMPLETED|Overall Study||292
6532318|NCT01621802|7454042|FG004|COMPLETED|Overall Study||1284
6532319|NCT01621802|7454043|FG005|COMPLETED|Overall Study||477
6532320|NCT01621802|7454038|FG000|NOT COMPLETED|Overall Study||47
6532321|NCT01621802|7454039|FG001|NOT COMPLETED|Overall Study||23
6532322|NCT01621802|7454040|FG002|NOT COMPLETED|Overall Study||33
6532323|NCT01621802|7454041|FG003|NOT COMPLETED|Overall Study||11
6532324|NCT01621802|7454042|FG004|NOT COMPLETED|Overall Study||35
6532325|NCT01621802|7454043|FG005|NOT COMPLETED|Overall Study||12
6532326|NCT01621880|7454062|FG000|STARTED|Overall Study||58
6532327|NCT01621880|7454063|FG001|STARTED|Overall Study||54
6532328|NCT01621880|7454062|FG000|COMPLETED|Overall Study||48
6532329|NCT01621880|7454063|FG001|COMPLETED|Overall Study||49
6532330|NCT01621880|7454062|FG000|NOT COMPLETED|Overall Study||10
6532331|NCT01621880|7454063|FG001|NOT COMPLETED|Overall Study||5
6532332|NCT01622010|7454072|FG000|STARTED|Overall Study||18
6532333|NCT01622010|7454073|FG001|STARTED|Overall Study||12
6532334|NCT01622010|7454072|FG000|COMPLETED|Overall Study||12
6532335|NCT01622010|7454073|FG001|COMPLETED|Overall Study||8
6532336|NCT01622010|7454072|FG000|NOT COMPLETED|Overall Study||6
6532337|NCT01622010|7454073|FG001|NOT COMPLETED|Overall Study||4
6532338|NCT01622231|7454081|FG000|STARTED|Overall Study||61
6532339|NCT01622231|7454081|FG000|COMPLETED|Overall Study||59
6532340|NCT01622231|7454081|FG000|NOT COMPLETED|Overall Study||2
6532341|NCT01622257|7454088|FG000|STARTED|Overall Study||66
6644441|NCT02363803|7573058|FG000|STARTED|Period 1||17
6644442|NCT02363803|7573059|FG001|STARTED|Period 1||17
6644443|NCT02363803|7573058|FG000|COMPLETED|Period 1||17
6644444|NCT02363803|7573059|FG001|COMPLETED|Period 1||17
6644445|NCT02363803|7573058|FG000|NOT COMPLETED|Period 1||0
6644446|NCT02363803|7573059|FG001|NOT COMPLETED|Period 1||0
6644447|NCT02363803|7573058|FG000|STARTED|Period 2||17
6644448|NCT02363803|7573059|FG001|STARTED|Period 2|One participant did not return for Period 2 treatment|16
6644449|NCT02363803|7573058|FG000|COMPLETED|Period 2||17
6644450|NCT02363803|7573059|FG001|COMPLETED|Period 2||16
6644451|NCT02363803|7573058|FG000|NOT COMPLETED|Period 2||0
6644452|NCT02363803|7573059|FG001|NOT COMPLETED|Period 2||0
6644453|NCT02363907|7573071|FG000|STARTED|Overall Study||30
6644454|NCT02363907|7573071|FG000|COMPLETED|Overall Study||30
6644455|NCT02363907|7573071|FG000|NOT COMPLETED|Overall Study||0
6644456|NCT02363933|7573075|FG000|STARTED|Overall Study||8
6644457|NCT02363933|7573075|FG000|COMPLETED|Overall Study||2
6644458|NCT02363933|7573075|FG000|NOT COMPLETED|Overall Study||6
6644459|NCT02363946|7573092|FG000|STARTED|Overall Study||4
6644460|NCT02363946|7573093|FG001|STARTED|Overall Study||4
6644461|NCT02363946|7573094|FG002|STARTED|Overall Study||4
6644462|NCT02363946|7573095|FG003|STARTED|Overall Study||4
6644463|NCT02363946|7573096|FG004|STARTED|Overall Study||4
6644464|NCT02363946|7573097|FG005|STARTED|Overall Study||4
6644465|NCT02363946|7573098|FG006|STARTED|Overall Study||4
6644466|NCT02363946|7573099|FG007|STARTED|Overall Study||4
6644467|NCT02363946|7573100|FG008|STARTED|Overall Study||4
6644468|NCT02363946|7573101|FG009|STARTED|Overall Study||18
6644469|NCT02363946|7573102|FG010|STARTED|Overall Study||4
6644470|NCT02363946|7573103|FG011|STARTED|Overall Study||3
6644471|NCT02363946|7573104|FG012|STARTED|Overall Study||4
6644472|NCT02363946|7573092|FG000|COMPLETED|Overall Study||4
6644473|NCT02363946|7573093|FG001|COMPLETED|Overall Study||4
6644474|NCT02363946|7573094|FG002|COMPLETED|Overall Study||4
6644475|NCT02363946|7573095|FG003|COMPLETED|Overall Study||4
6532342|NCT01622257|7454089|FG001|STARTED|Overall Study||66
6532343|NCT01622257|7454090|FG002|STARTED|Overall Study||66
6532344|NCT01622257|7454088|FG000|COMPLETED|Overall Study||66
6532345|NCT01622257|7454089|FG001|COMPLETED|Overall Study||66
6532346|NCT01622257|7454090|FG002|COMPLETED|Overall Study||66
6532347|NCT01622257|7454088|FG000|NOT COMPLETED|Overall Study||0
6532348|NCT01622257|7454089|FG001|NOT COMPLETED|Overall Study||0
6532349|NCT01622257|7454090|FG002|NOT COMPLETED|Overall Study||0
6644476|NCT02363946|7573096|FG004|COMPLETED|Overall Study||4
6532350|NCT01622296|7454098|FG000|STARTED|First Intervention||10
6532351|NCT01622296|7454099|FG001|STARTED|First Intervention||10
6644477|NCT02363946|7573097|FG005|COMPLETED|Overall Study||4
6644478|NCT02363946|7573098|FG006|COMPLETED|Overall Study||4
6644479|NCT02363946|7573099|FG007|COMPLETED|Overall Study||3
6644480|NCT02363946|7573100|FG008|COMPLETED|Overall Study||4
6644481|NCT02363946|7573101|FG009|COMPLETED|Overall Study||18
6644482|NCT02363946|7573102|FG010|COMPLETED|Overall Study||4
6532352|NCT01622296|7454098|FG000|COMPLETED|First Intervention||10
6532353|NCT01622296|7454099|FG001|COMPLETED|First Intervention||10
6532354|NCT01622296|7454098|FG000|NOT COMPLETED|First Intervention||0
6532355|NCT01622296|7454099|FG001|NOT COMPLETED|First Intervention||0
6532356|NCT01622296|7454098|FG000|STARTED|Washout Period of at Least 1 Week||10
6532357|NCT01622296|7454099|FG001|STARTED|Washout Period of at Least 1 Week||10
6532358|NCT01622296|7454098|FG000|COMPLETED|Washout Period of at Least 1 Week||10
6532359|NCT01622296|7454099|FG001|COMPLETED|Washout Period of at Least 1 Week||10
6532360|NCT01622296|7454098|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
6532361|NCT01622296|7454099|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
6532362|NCT01622296|7454098|FG000|STARTED|Second Intervention||10
6532363|NCT01622296|7454099|FG001|STARTED|Second Intervention||10
6532364|NCT01622296|7454098|FG000|COMPLETED|Second Intervention||10
6532365|NCT01622296|7454099|FG001|COMPLETED|Second Intervention||10
6532366|NCT01622296|7454098|FG000|NOT COMPLETED|Second Intervention||0
6532367|NCT01622296|7454099|FG001|NOT COMPLETED|Second Intervention||0
6532368|NCT01622348|7454107|FG000|STARTED|Overall Study||15
6532369|NCT01622348|7454108|FG001|STARTED|Overall Study||14
6532370|NCT01622348|7454109|FG002|STARTED|Overall Study||15
6532371|NCT01622348|7454107|FG000|COMPLETED|Overall Study||14
6532372|NCT01622348|7454108|FG001|COMPLETED|Overall Study||14
6532373|NCT01622348|7454109|FG002|COMPLETED|Overall Study||14
6532374|NCT01622348|7454107|FG000|NOT COMPLETED|Overall Study||1
6532375|NCT01622348|7454108|FG001|NOT COMPLETED|Overall Study||0
6532376|NCT01622348|7454109|FG002|NOT COMPLETED|Overall Study||1
6532377|NCT01622543|7454119|FG000|STARTED|Overall Study||51
6532378|NCT01622543|7454120|FG001|STARTED|Overall Study||52
6532379|NCT01622543|7454119|FG000|COMPLETED|Overall Study||51
6532380|NCT01622543|7454120|FG001|COMPLETED|Overall Study||52
6532381|NCT01622543|7454119|FG000|NOT COMPLETED|Overall Study||0
6532382|NCT01622543|7454120|FG001|NOT COMPLETED|Overall Study||0
6532383|NCT01622569|7454130|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
6532384|NCT01622569|7454131|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
6532385|NCT01622569|7454132|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
6532386|NCT01622569|7454133|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
6532387|NCT01622569|7454130|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
6532388|NCT01622569|7454131|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||75
6532389|NCT01622569|7454132|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||71
6532390|NCT01622569|7454133|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
6532391|NCT01622569|7454130|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||12
6532392|NCT01622569|7454131|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||6
6532393|NCT01622569|7454132|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||9
6532394|NCT01622569|7454133|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
6532395|NCT01622569|7454130|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||68
6532396|NCT01622569|7454131|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||72
6532397|NCT01622569|7454132|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||67
6532398|NCT01622569|7454133|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||75
6532399|NCT01622569|7454130|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||67
6532400|NCT01622569|7454131|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||70
6532401|NCT01622569|7454132|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||64
6532402|NCT01622569|7454133|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||73
6532403|NCT01622569|7454130|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
6532404|NCT01622569|7454131|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
6532405|NCT01622569|7454132|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||3
6532406|NCT01622569|7454133|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
6532407|NCT01622660|7454153|FG000|STARTED|Overall Study||2
6532408|NCT01622660|7454153|FG000|COMPLETED|Overall Study||1
6532409|NCT01622660|7454153|FG000|NOT COMPLETED|Overall Study||1
6532410|NCT01622673|7454163|FG000|STARTED|Treatment Period 1||4
6532411|NCT01622673|7454164|FG001|STARTED|Treatment Period 1||5
6532412|NCT01622673|7454165|FG002|STARTED|Treatment Period 1||4
6532413|NCT01622673|7454166|FG003|STARTED|Treatment Period 1||6
6532414|NCT01622673|7454167|FG004|STARTED|Treatment Period 1||4
6532415|NCT01622673|7454168|FG005|STARTED|Treatment Period 1||4
6532416|NCT01622673|7454163|FG000|COMPLETED|Treatment Period 1||4
6532417|NCT01622673|7454164|FG001|COMPLETED|Treatment Period 1||4
6532418|NCT01622673|7454165|FG002|COMPLETED|Treatment Period 1||4
6532419|NCT01622673|7454166|FG003|COMPLETED|Treatment Period 1||5
6532420|NCT01622673|7454167|FG004|COMPLETED|Treatment Period 1||4
6532421|NCT01622673|7454168|FG005|COMPLETED|Treatment Period 1||4
6532422|NCT01622673|7454163|FG000|NOT COMPLETED|Treatment Period 1||0
6532423|NCT01622673|7454164|FG001|NOT COMPLETED|Treatment Period 1||1
6532424|NCT01622673|7454165|FG002|NOT COMPLETED|Treatment Period 1||0
6532425|NCT01622673|7454166|FG003|NOT COMPLETED|Treatment Period 1||1
6532426|NCT01622673|7454167|FG004|NOT COMPLETED|Treatment Period 1||0
6532427|NCT01622673|7454168|FG005|NOT COMPLETED|Treatment Period 1||0
6532428|NCT01622673|7454163|FG000|STARTED|Treatment Period 2||4
6532429|NCT01622673|7454164|FG001|STARTED|Treatment Period 2||4
6532430|NCT01622673|7454165|FG002|STARTED|Treatment Period 2||4
6532431|NCT01622673|7454166|FG003|STARTED|Treatment Period 2||5
6532432|NCT01622673|7454167|FG004|STARTED|Treatment Period 2||4
6532433|NCT01622673|7454168|FG005|STARTED|Treatment Period 2||4
6532434|NCT01622673|7454163|FG000|COMPLETED|Treatment Period 2||4
6532435|NCT01622673|7454164|FG001|COMPLETED|Treatment Period 2||4
6532436|NCT01622673|7454165|FG002|COMPLETED|Treatment Period 2||4
6532437|NCT01622673|7454166|FG003|COMPLETED|Treatment Period 2||4
6532438|NCT01622673|7454167|FG004|COMPLETED|Treatment Period 2||4
6532439|NCT01622673|7454168|FG005|COMPLETED|Treatment Period 2||4
6532440|NCT01622673|7454163|FG000|NOT COMPLETED|Treatment Period 2||0
6532441|NCT01622673|7454164|FG001|NOT COMPLETED|Treatment Period 2||0
6532442|NCT01622673|7454165|FG002|NOT COMPLETED|Treatment Period 2||0
6532443|NCT01622673|7454166|FG003|NOT COMPLETED|Treatment Period 2||1
6532444|NCT01622673|7454167|FG004|NOT COMPLETED|Treatment Period 2||0
6532445|NCT01622673|7454168|FG005|NOT COMPLETED|Treatment Period 2||0
6532446|NCT01622673|7454163|FG000|STARTED|Treatment Period 3||4
6532447|NCT01622673|7454164|FG001|STARTED|Treatment Period 3||4
6532448|NCT01622673|7454165|FG002|STARTED|Treatment Period 3||4
6532449|NCT01622673|7454166|FG003|STARTED|Treatment Period 3||4
6532450|NCT01622673|7454167|FG004|STARTED|Treatment Period 3||4
6532451|NCT01622673|7454168|FG005|STARTED|Treatment Period 3||4
6532452|NCT01622673|7454163|FG000|COMPLETED|Treatment Period 3||4
6532453|NCT01622673|7454164|FG001|COMPLETED|Treatment Period 3||3
6532454|NCT01622673|7454165|FG002|COMPLETED|Treatment Period 3||4
6532455|NCT01622673|7454166|FG003|COMPLETED|Treatment Period 3||4
6532456|NCT01622673|7454167|FG004|COMPLETED|Treatment Period 3||4
6532457|NCT01622673|7454168|FG005|COMPLETED|Treatment Period 3||4
6532458|NCT01622673|7454163|FG000|NOT COMPLETED|Treatment Period 3||0
6532459|NCT01622673|7454164|FG001|NOT COMPLETED|Treatment Period 3||1
6532460|NCT01622673|7454165|FG002|NOT COMPLETED|Treatment Period 3||0
6532461|NCT01622673|7454166|FG003|NOT COMPLETED|Treatment Period 3||0
6532462|NCT01622673|7454167|FG004|NOT COMPLETED|Treatment Period 3||0
6532463|NCT01622673|7454168|FG005|NOT COMPLETED|Treatment Period 3||0
6532464|NCT01622673|7454163|FG000|STARTED|Treatment Period 4||4
6532465|NCT01622673|7454164|FG001|STARTED|Treatment Period 4||3
6532466|NCT01622673|7454165|FG002|STARTED|Treatment Period 4||4
6532467|NCT01622673|7454166|FG003|STARTED|Treatment Period 4||4
6532468|NCT01622673|7454167|FG004|STARTED|Treatment Period 4||4
6532469|NCT01622673|7454168|FG005|STARTED|Treatment Period 4||4
6532470|NCT01622673|7454163|FG000|COMPLETED|Treatment Period 4||4
6532471|NCT01622673|7454164|FG001|COMPLETED|Treatment Period 4||3
6532472|NCT01622673|7454165|FG002|COMPLETED|Treatment Period 4||4
6532473|NCT01622673|7454166|FG003|COMPLETED|Treatment Period 4||4
6532474|NCT01622673|7454167|FG004|COMPLETED|Treatment Period 4||4
6532475|NCT01622673|7454168|FG005|COMPLETED|Treatment Period 4||4
6532476|NCT01622673|7454163|FG000|NOT COMPLETED|Treatment Period 4||0
6532477|NCT01622673|7454164|FG001|NOT COMPLETED|Treatment Period 4||0
6532478|NCT01622673|7454165|FG002|NOT COMPLETED|Treatment Period 4||0
6532479|NCT01622673|7454166|FG003|NOT COMPLETED|Treatment Period 4||0
6532480|NCT01622673|7454167|FG004|NOT COMPLETED|Treatment Period 4||0
6532481|NCT01622673|7454168|FG005|NOT COMPLETED|Treatment Period 4||0
6532482|NCT01622673|7454163|FG000|STARTED|Treatment Period 5||4
6532483|NCT01622673|7454164|FG001|STARTED|Treatment Period 5||3
6532484|NCT01622673|7454165|FG002|STARTED|Treatment Period 5||4
6532485|NCT01622673|7454166|FG003|STARTED|Treatment Period 5||4
6532486|NCT01622673|7454167|FG004|STARTED|Treatment Period 5||4
6532487|NCT01622673|7454168|FG005|STARTED|Treatment Period 5||4
6532488|NCT01622673|7454163|FG000|COMPLETED|Treatment Period 5||4
6532489|NCT01622673|7454164|FG001|COMPLETED|Treatment Period 5||3
6532490|NCT01622673|7454165|FG002|COMPLETED|Treatment Period 5||4
6532491|NCT01622673|7454166|FG003|COMPLETED|Treatment Period 5||4
6532492|NCT01622673|7454167|FG004|COMPLETED|Treatment Period 5||4
6532493|NCT01622673|7454168|FG005|COMPLETED|Treatment Period 5||4
6532494|NCT01622673|7454163|FG000|NOT COMPLETED|Treatment Period 5||0
6532495|NCT01622673|7454164|FG001|NOT COMPLETED|Treatment Period 5||0
6532496|NCT01622673|7454165|FG002|NOT COMPLETED|Treatment Period 5||0
6532497|NCT01622673|7454166|FG003|NOT COMPLETED|Treatment Period 5||0
6532498|NCT01622673|7454167|FG004|NOT COMPLETED|Treatment Period 5||0
6532499|NCT01622673|7454168|FG005|NOT COMPLETED|Treatment Period 5||0
6532500|NCT01622699|7454189|FG000|STARTED|Overall Study||213
6532501|NCT01622699|7454190|FG001|STARTED|Overall Study||217
6532502|NCT01622699|7454189|FG000|COMPLETED|Overall Study||213
6532503|NCT01622699|7454190|FG001|COMPLETED|Overall Study||217
6532504|NCT01622699|7454189|FG000|NOT COMPLETED|Overall Study||0
6532505|NCT01622699|7454190|FG001|NOT COMPLETED|Overall Study||0
6532506|NCT01623037|7454196|FG000|STARTED|Overall Study||15
6532507|NCT01623037|7454196|FG000|COMPLETED|Overall Study||15
6532508|NCT01623037|7454196|FG000|NOT COMPLETED|Overall Study||0
6532509|NCT01623050|7454202|FG000|STARTED|Overall Study||36
6532510|NCT01623050|7454202|FG000|Treated|Overall Study||34
6532511|NCT01623050|7454202|FG000|COMPLETED|Overall Study||27
6532512|NCT01623050|7454202|FG000|NOT COMPLETED|Overall Study||9
6532513|NCT01623115|7454208|FG000|STARTED|Overall Study|Randomized|163
6532514|NCT01623115|7454209|FG001|STARTED|Overall Study|Randomized|323
6532515|NCT01623115|7454208|FG000|Treated|Overall Study||163
6532516|NCT01623115|7454209|FG001|Treated|Overall Study||322
6532517|NCT01623115|7454208|FG000|COMPLETED|Overall Study||130
6532518|NCT01623115|7454209|FG001|COMPLETED|Overall Study||246
6532519|NCT01623115|7454208|FG000|NOT COMPLETED|Overall Study||33
6532520|NCT01623115|7454209|FG001|NOT COMPLETED|Overall Study||77
6532521|NCT01623154|7454215|FG000|STARTED|Overall Study||99
6532522|NCT01623154|7454215|FG000|Available for Analysis|Overall Study||95
6532523|NCT01623154|7454215|FG000|COMPLETED|Overall Study||95
6532524|NCT01623154|7454215|FG000|NOT COMPLETED|Overall Study||4
6532525|NCT01623271|7454221|FG000|STARTED|Overall Study||5
6532526|NCT01623271|7454221|FG000|COMPLETED|Overall Study||3
6532527|NCT01623271|7454221|FG000|NOT COMPLETED|Overall Study||2
6532528|NCT01623310|7454225|FG000|STARTED|Overall Study||223
6532529|NCT01623310|7454225|FG000|COMPLETED|Overall Study||144
6532530|NCT01623310|7454225|FG000|NOT COMPLETED|Overall Study||79
6532531|NCT01623323|7454229|FG000|STARTED|Overall Study||705
6532532|NCT01623323|7454229|FG000|COMPLETED|Overall Study||601
6532533|NCT01623323|7454229|FG000|NOT COMPLETED|Overall Study||104
6532534|NCT01623466|7454235|FG000|STARTED|Overall Study||18
6532535|NCT01623466|7454236|FG001|STARTED|Overall Study||18
6532536|NCT01623466|7454235|FG000|COMPLETED|Overall Study||17
6532537|NCT01623466|7454236|FG001|COMPLETED|Overall Study||18
6532538|NCT01623466|7454235|FG000|NOT COMPLETED|Overall Study||1
6304205|NCT00364832|7207519|FG005|NOT COMPLETED|Core Period||0
6304206|NCT00364832|7207520|FG006|NOT COMPLETED|Core Period||4
6304207|NCT00364832|7207521|FG007|NOT COMPLETED|Core Period||1
6304208|NCT00364832|7207522|FG008|NOT COMPLETED|Core Period||0
6304209|NCT00364832|7207523|FG009|NOT COMPLETED|Core Period||0
6304210|NCT00364832|7207524|FG010|NOT COMPLETED|Core Period||0
6532539|NCT01623466|7454236|FG001|NOT COMPLETED|Overall Study||0
6532540|NCT01623479|7454242|FG000|STARTED|Overall Study||585
6532541|NCT01623479|7454242|FG000|COMPLETED|Overall Study||585
6532542|NCT01623479|7454242|FG000|NOT COMPLETED|Overall Study||0
6532543|NCT01623531|7454248|FG000|STARTED|Overall Study||31
6532544|NCT01623531|7454249|FG001|STARTED|Overall Study||31
6532545|NCT01623531|7454248|FG000|COMPLETED|Overall Study||27
6532546|NCT01623531|7454249|FG001|COMPLETED|Overall Study||29
6532547|NCT01623531|7454248|FG000|NOT COMPLETED|Overall Study||4
6532548|NCT01623531|7454249|FG001|NOT COMPLETED|Overall Study||2
6532549|NCT01623596|7454260|FG000|STARTED|Overall Study||436
6532550|NCT01623596|7454261|FG001|STARTED|Overall Study||439
6532551|NCT01623596|7454260|FG000|On Randomized Treatment|Overall Study||352
6532552|NCT01623596|7454261|FG001|On Randomized Treatment|Overall Study||125
6532553|NCT01623596|7454260|FG000|On Switched Treatment|Overall Study||22
6532554|NCT01623596|7454261|FG001|On Switched Treatment|Overall Study||214
6532555|NCT01623596|7454260|FG000|COMPLETED|Overall Study||374
6532556|NCT01623596|7454261|FG001|COMPLETED|Overall Study||339
6532557|NCT01623596|7454260|FG000|NOT COMPLETED|Overall Study||62
6532558|NCT01623596|7454261|FG001|NOT COMPLETED|Overall Study||100
6532559|NCT01623739|7454271|FG000|STARTED|Overall Study||19
6532560|NCT01623739|7454272|FG001|STARTED|Overall Study||19
6532561|NCT01623739|7454271|FG000|COMPLETED|Overall Study||17
6532562|NCT01623739|7454272|FG001|COMPLETED|Overall Study||15
6532563|NCT01623739|7454271|FG000|NOT COMPLETED|Overall Study||2
6532564|NCT01623739|7454272|FG001|NOT COMPLETED|Overall Study||4
6532565|NCT01623752|7454282|FG000|STARTED|Phase 1 (78 Weeks)||1378
6532566|NCT01623752|7454283|FG001|STARTED|Phase 1 (78 Weeks)||440
6532567|NCT01623752|7454284|FG002|STARTED|Phase 1 (78 Weeks)||3
6532568|NCT01623752|7454282|FG000|COMPLETED|Phase 1 (78 Weeks)||747
6532569|NCT01623752|7454283|FG001|COMPLETED|Phase 1 (78 Weeks)||233
6532570|NCT01623752|7454284|FG002|COMPLETED|Phase 1 (78 Weeks)||1
6532571|NCT01623752|7454282|FG000|NOT COMPLETED|Phase 1 (78 Weeks)||631
6532572|NCT01623752|7454283|FG001|NOT COMPLETED|Phase 1 (78 Weeks)||207
6532573|NCT01623752|7454284|FG002|NOT COMPLETED|Phase 1 (78 Weeks)||2
6532574|NCT01623752|7454282|FG000|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|291
6532575|NCT01623752|7454283|FG001|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|116
6532576|NCT01623752|7454284|FG002|STARTED|Phase 2 (78 Weeks)|Participants only who consented to continue in Period 2.|0
6532577|NCT01623752|7454282|FG000|COMPLETED|Phase 2 (78 Weeks)||225
6532578|NCT01623752|7454283|FG001|COMPLETED|Phase 2 (78 Weeks)||98
6532579|NCT01623752|7454284|FG002|COMPLETED|Phase 2 (78 Weeks)||0
6532580|NCT01623752|7454282|FG000|NOT COMPLETED|Phase 2 (78 Weeks)||66
6532581|NCT01623752|7454283|FG001|NOT COMPLETED|Phase 2 (78 Weeks)||18
6532582|NCT01623752|7454284|FG002|NOT COMPLETED|Phase 2 (78 Weeks)||0
6532583|NCT01623830|7454295|FG000|STARTED|Overall Study||45
6532584|NCT01623830|7454296|FG001|STARTED|Overall Study||44
6532585|NCT01623830|7454295|FG000|COMPLETED|Overall Study||38
6532586|NCT01623830|7454296|FG001|COMPLETED|Overall Study||35
6532587|NCT01623830|7454295|FG000|NOT COMPLETED|Overall Study||7
6532588|NCT01623830|7454296|FG001|NOT COMPLETED|Overall Study||9
6532589|NCT01623869|7454302|FG000|STARTED|Overall Study||16
6532590|NCT01623869|7454302|FG000|COMPLETED|Overall Study||16
6532591|NCT01623869|7454302|FG000|NOT COMPLETED|Overall Study||0
6532592|NCT01624090|7454310|FG000|STARTED|Overall Study||2
6532593|NCT01624090|7454311|FG001|STARTED|Overall Study||2
6532594|NCT01624090|7454312|FG002|STARTED|Overall Study||10
6532595|NCT01624090|7454313|FG003|STARTED|Overall Study||2
6532596|NCT01624090|7454310|FG000|COMPLETED|Overall Study||2
6532597|NCT01624090|7454311|FG001|COMPLETED|Overall Study||0
6532598|NCT01624090|7454312|FG002|COMPLETED|Overall Study||3
6532599|NCT01624090|7454313|FG003|COMPLETED|Overall Study||2
6532600|NCT01624090|7454310|FG000|NOT COMPLETED|Overall Study||0
6532601|NCT01624090|7454311|FG001|NOT COMPLETED|Overall Study||2
6532602|NCT01624090|7454312|FG002|NOT COMPLETED|Overall Study||7
6532603|NCT01624090|7454313|FG003|NOT COMPLETED|Overall Study||0
6532604|NCT01624142|7454325|FG000|STARTED|Overall Study||106
6532605|NCT01624142|7454326|FG001|STARTED|Overall Study||194
6532606|NCT01624142|7454325|FG000|COMPLETED|Overall Study||74
6532607|NCT01624142|7454326|FG001|COMPLETED|Overall Study||178
6532608|NCT01624142|7454325|FG000|NOT COMPLETED|Overall Study||32
6532609|NCT01624142|7454326|FG001|NOT COMPLETED|Overall Study||16
6532610|NCT01624168|7454336|FG000|STARTED|Overall Study||19
6532611|NCT01624168|7454337|FG001|STARTED|Overall Study||28
6532612|NCT01624168|7454338|FG002|STARTED|Overall Study||28
6532613|NCT01624168|7454336|FG000|COMPLETED|Overall Study||15
6532614|NCT01624168|7454337|FG001|COMPLETED|Overall Study||16
6532615|NCT01624168|7454338|FG002|COMPLETED|Overall Study||22
6532616|NCT01624168|7454336|FG000|NOT COMPLETED|Overall Study||4
6532617|NCT01624168|7454337|FG001|NOT COMPLETED|Overall Study||12
6532618|NCT01624168|7454338|FG002|NOT COMPLETED|Overall Study||6
6532619|NCT01624194|7454348|FG000|STARTED|Overall Study||16
6532620|NCT01624194|7454349|FG001|STARTED|Overall Study||18
6532621|NCT01624194|7454348|FG000|COMPLETED|Overall Study||14
6532622|NCT01624194|7454349|FG001|COMPLETED|Overall Study||18
6532623|NCT01624194|7454348|FG000|NOT COMPLETED|Overall Study||2
6532624|NCT01624194|7454349|FG001|NOT COMPLETED|Overall Study||0
6532625|NCT01624233|7454356|FG000|STARTED|Period 2 - Induction||91
6532626|NCT01624233|7454356|FG000|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
6532627|NCT01624233|7454356|FG000|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
6532628|NCT01624233|7454356|FG000|Pustular Ps|Period 2 - Induction||5
6532629|NCT01624233|7454356|FG000|Plaque Ps|Period 2 - Induction||78
6532630|NCT01624233|7454356|FG000|COMPLETED|Period 2 - Induction||90
6532631|NCT01624233|7454356|FG000|NOT COMPLETED|Period 2 - Induction||1
6532632|NCT01624233|7454356|FG000|STARTED|Period 3 - Maintenance||90
6532633|NCT01624233|7454356|FG000|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
6532634|NCT01624233|7454356|FG000|COMPLETED|Period 3 - Maintenance||83
6532635|NCT01624233|7454356|FG000|NOT COMPLETED|Period 3 - Maintenance||7
6532636|NCT01624233|7454356|FG000|STARTED|Period 4 - Drug Free Period|Only responders in participants with plaque Ps moved to the Drug Free Period 4.|70
6532637|NCT01624233|7454356|FG000|Adverse Event|Period 4 - Drug Free Period|1 participant who discontinued due to adverse event is included in the participants who relapsed.|1
6532638|NCT01624233|7454356|FG000|Physician Decision|Period 4 - Drug Free Period|1 participant who discontinued due to physician decision is included in the participants relapsed.|1
6532639|NCT01624233|7454356|FG000|COMPLETED|Period 4 - Drug Free Period||9
6532640|NCT01624233|7454356|FG000|NOT COMPLETED|Period 4 - Drug Free Period||61
6532641|NCT01624233|7454356|FG000|STARTED|Period 5 - Retreatment Period|Period 5 included (participants with erythrodermic Ps or pustular Ps) or Period 4 completers.|80
6532642|NCT01624233|7454356|FG000|COMPLETED|Period 5 - Retreatment Period||70
6532643|NCT01624233|7454356|FG000|NOT COMPLETED|Period 5 - Retreatment Period||10
6532644|NCT01624233|7454356|FG000|STARTED|Period 6: Follow-up|Period 6 included participants received a dose of drug and exhibited the required neutrophil count.|88
6532645|NCT01624233|7454356|FG000|COMPLETED|Period 6: Follow-up||79
6532646|NCT01624233|7454356|FG000|NOT COMPLETED|Period 6: Follow-up||9
6532647|NCT01624259|7454366|FG000|STARTED|Overall Study||299
6532648|NCT01624259|7454367|FG001|STARTED|Overall Study||300
6532649|NCT01624259|7454366|FG000|Received at Least One Dose of Study Drug|Overall Study||299
6532650|NCT01624259|7454367|FG001|Received at Least One Dose of Study Drug|Overall Study||300
6532651|NCT01624259|7454366|FG000|COMPLETED|Overall Study|Completed the study on study treatment|269
6532652|NCT01624259|7454367|FG001|COMPLETED|Overall Study|Completed the study on study treatment|269
6532653|NCT01624259|7454366|FG000|NOT COMPLETED|Overall Study||30
6532654|NCT01624259|7454367|FG001|NOT COMPLETED|Overall Study||31
6532655|NCT01624350|7454375|FG000|STARTED|Overall Study||100
6532656|NCT01624350|7454375|FG000|COMPLETED|Overall Study||75
6532657|NCT01624350|7454375|FG000|NOT COMPLETED|Overall Study||25
6532658|NCT01624363|7454395|FG000|STARTED|Overall Study||341
6532659|NCT01624363|7454395|FG000|COMPLETED|Overall Study||341
6532660|NCT01624363|7454395|FG000|NOT COMPLETED|Overall Study||0
6532661|NCT01624467|7454399|FG000|STARTED|Overall Study||75
6532662|NCT01624467|7454399|FG000|Received at Least One Dose of Study Drug|Overall Study||75
6532663|NCT01624467|7454399|FG000|COMPLETED|Overall Study||44
6532664|NCT01624467|7454399|FG000|NOT COMPLETED|Overall Study||31
6532665|NCT01624506|7454407|FG000|STARTED|Overall Study||530
6532666|NCT01624506|7454408|FG001|STARTED|Overall Study||230
6532667|NCT01624506|7454407|FG000|COMPLETED|Overall Study||465
6532668|NCT01624506|7454408|FG001|COMPLETED|Overall Study||213
6532669|NCT01624506|7454407|FG000|NOT COMPLETED|Overall Study||65
6532670|NCT01624506|7454408|FG001|NOT COMPLETED|Overall Study||17
6532671|NCT01624662|7454418|FG000|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
6532672|NCT01624662|7454419|FG001|STARTED|Double-Blind Treatment Phase (Wks 1-16)||81
6532673|NCT01624662|7454420|FG002|STARTED|Double-Blind Treatment Phase (Wks 1-16)||80
6532674|NCT01624662|7454421|FG003|STARTED|Double-Blind Treatment Phase (Wks 1-16)||82
6532675|NCT01624662|7454418|FG000|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||70
6532676|NCT01624662|7454419|FG001|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||78
6532677|NCT01624662|7454420|FG002|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||76
6532678|NCT01624662|7454421|FG003|COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||82
6532679|NCT01624662|7454418|FG000|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||10
6532680|NCT01624662|7454419|FG001|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||3
6532681|NCT01624662|7454420|FG002|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||4
6532682|NCT01624662|7454421|FG003|NOT COMPLETED|Double-Blind Treatment Phase (Wks 1-16)||0
6532683|NCT01624662|7454418|FG000|STARTED|Open-Label Extension Phase (Wks 17-24)||70
6532684|NCT01624662|7454419|FG001|STARTED|Open-Label Extension Phase (Wks 17-24)||78
6532685|NCT01624662|7454420|FG002|STARTED|Open-Label Extension Phase (Wks 17-24)||72
6532686|NCT01624662|7454421|FG003|STARTED|Open-Label Extension Phase (Wks 17-24)||79
6532687|NCT01624662|7454418|FG000|COMPLETED|Open-Label Extension Phase (Wks 17-24)||69
6532688|NCT01624662|7454419|FG001|COMPLETED|Open-Label Extension Phase (Wks 17-24)||76
6532689|NCT01624662|7454420|FG002|COMPLETED|Open-Label Extension Phase (Wks 17-24)||71
6532690|NCT01624662|7454421|FG003|COMPLETED|Open-Label Extension Phase (Wks 17-24)||78
6532691|NCT01624662|7454418|FG000|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
6532692|NCT01624662|7454419|FG001|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||2
6532693|NCT01624662|7454420|FG002|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
6532694|NCT01624662|7454421|FG003|NOT COMPLETED|Open-Label Extension Phase (Wks 17-24)||1
6532695|NCT01624870|7454442|FG000|STARTED|Overall Study|provided informed consent|200
6532696|NCT01624870|7454442|FG000|COMPLETED|Overall Study|Completed 6 month follow up|173
6532697|NCT01624870|7454442|FG000|NOT COMPLETED|Overall Study||27
6532698|NCT01624740|7454450|FG000|STARTED|First Intervention (3-4 Days)||9
6532699|NCT01624740|7454451|FG001|STARTED|First Intervention (3-4 Days)||9
6532700|NCT01624740|7454450|FG000|COMPLETED|First Intervention (3-4 Days)||9
6532701|NCT01624740|7454451|FG001|COMPLETED|First Intervention (3-4 Days)||9
6532702|NCT01624740|7454450|FG000|NOT COMPLETED|First Intervention (3-4 Days)||0
6532703|NCT01624740|7454451|FG001|NOT COMPLETED|First Intervention (3-4 Days)||0
6532704|NCT01624740|7454450|FG000|STARTED|Washout (1 Hour)||9
6532705|NCT01624740|7454451|FG001|STARTED|Washout (1 Hour)||9
6532706|NCT01624740|7454450|FG000|COMPLETED|Washout (1 Hour)||9
6532707|NCT01624740|7454451|FG001|COMPLETED|Washout (1 Hour)||9
6532708|NCT01624740|7454450|FG000|NOT COMPLETED|Washout (1 Hour)||0
6532709|NCT01624740|7454451|FG001|NOT COMPLETED|Washout (1 Hour)||0
6532710|NCT01624740|7454450|FG000|STARTED|Second Intervention (3-4 Days)||9
6532711|NCT01624740|7454451|FG001|STARTED|Second Intervention (3-4 Days)||9
6532712|NCT01624740|7454450|FG000|COMPLETED|Second Intervention (3-4 Days)||8
6532713|NCT01624740|7454451|FG001|COMPLETED|Second Intervention (3-4 Days)||9
6532714|NCT01624740|7454450|FG000|NOT COMPLETED|Second Intervention (3-4 Days)||1
6532715|NCT01624740|7454451|FG001|NOT COMPLETED|Second Intervention (3-4 Days)||0
6532716|NCT01624948|7454460|FG000|STARTED|Overall Study||20
6532717|NCT01624948|7454461|FG001|STARTED|Overall Study||20
6532718|NCT01624948|7454460|FG000|COMPLETED|Overall Study||20
6532719|NCT01624948|7454461|FG001|COMPLETED|Overall Study||20
6532720|NCT01624948|7454460|FG000|NOT COMPLETED|Overall Study||0
6532721|NCT01624948|7454461|FG001|NOT COMPLETED|Overall Study||0
6532722|NCT01624974|7454473|FG000|STARTED|Period III of Treatment (4 Weeks)||54
6532723|NCT01624974|7454474|FG001|STARTED|Period III of Treatment (4 Weeks)||53
6532724|NCT01624974|7454473|FG000|COMPLETED|Period III of Treatment (4 Weeks)||47
6532725|NCT01624974|7454474|FG001|COMPLETED|Period III of Treatment (4 Weeks)||45
6532726|NCT01624974|7454473|FG000|NOT COMPLETED|Period III of Treatment (4 Weeks)||7
6532727|NCT01624974|7454474|FG001|NOT COMPLETED|Period III of Treatment (4 Weeks)||8
6532728|NCT01624974|7454473|FG000|STARTED|Period IV Washout (4 Weeks)||47
6532729|NCT01624974|7454474|FG001|STARTED|Period IV Washout (4 Weeks)||45
6532730|NCT01624974|7454473|FG000|COMPLETED|Period IV Washout (4 Weeks)||44
6532731|NCT01624974|7454474|FG001|COMPLETED|Period IV Washout (4 Weeks)||42
6532732|NCT01624974|7454473|FG000|NOT COMPLETED|Period IV Washout (4 Weeks)||3
6532733|NCT01624974|7454474|FG001|NOT COMPLETED|Period IV Washout (4 Weeks)||3
6532734|NCT01624974|7454473|FG000|STARTED|Period V of Treatment (4 Weeks)||44
6532735|NCT01624974|7454474|FG001|STARTED|Period V of Treatment (4 Weeks)||42
6532736|NCT01624974|7454473|FG000|COMPLETED|Period V of Treatment (4 Weeks)||39
6532737|NCT01624974|7454474|FG001|COMPLETED|Period V of Treatment (4 Weeks)||42
6532738|NCT01624974|7454473|FG000|NOT COMPLETED|Period V of Treatment (4 Weeks)||5
6532739|NCT01624974|7454474|FG001|NOT COMPLETED|Period V of Treatment (4 Weeks)||0
6532740|NCT01625000|7454486|FG000|STARTED|Overall Study||126
6532741|NCT01625000|7454487|FG001|STARTED|Overall Study||133
6644483|NCT02363946|7573103|FG011|COMPLETED|Overall Study||3
6644484|NCT02363946|7573104|FG012|COMPLETED|Overall Study||4
6644485|NCT02363946|7573092|FG000|NOT COMPLETED|Overall Study||0
6644486|NCT02363946|7573093|FG001|NOT COMPLETED|Overall Study||0
6644487|NCT02363946|7573094|FG002|NOT COMPLETED|Overall Study||0
6644488|NCT02363946|7573095|FG003|NOT COMPLETED|Overall Study||0
6644489|NCT02363946|7573096|FG004|NOT COMPLETED|Overall Study||0
6644490|NCT02363946|7573097|FG005|NOT COMPLETED|Overall Study||0
6644491|NCT02363946|7573098|FG006|NOT COMPLETED|Overall Study||0
6644492|NCT02363946|7573099|FG007|NOT COMPLETED|Overall Study||1
6644493|NCT02363946|7573100|FG008|NOT COMPLETED|Overall Study||0
6644494|NCT02363946|7573101|FG009|NOT COMPLETED|Overall Study||0
6644495|NCT02363946|7573102|FG010|NOT COMPLETED|Overall Study||0
6644496|NCT02363946|7573103|FG011|NOT COMPLETED|Overall Study||0
6644497|NCT02363946|7573104|FG012|NOT COMPLETED|Overall Study||0
6644498|NCT02363959|7573134|FG000|STARTED|Overall Study||10
6644499|NCT02363959|7573135|FG001|STARTED|Overall Study||10
6644500|NCT02363959|7573134|FG000|COMPLETED|Overall Study||9
6644501|NCT02363959|7573135|FG001|COMPLETED|Overall Study||10
6644502|NCT02363959|7573134|FG000|NOT COMPLETED|Overall Study||1
6644503|NCT02363959|7573135|FG001|NOT COMPLETED|Overall Study||0
6644504|NCT02363972|7573141|FG000|STARTED|Overall Study||103
6532742|NCT01625000|7454488|FG002|STARTED|Overall Study||67
6532743|NCT01625000|7454489|FG003|STARTED|Overall Study||56
6532744|NCT01625000|7454490|FG004|STARTED|Overall Study||126
6644505|NCT02363972|7573141|FG000|COMPLETED|Overall Study||77
6644506|NCT02363972|7573141|FG000|NOT COMPLETED|Overall Study||26
6644507|NCT02364037|7573147|FG000|STARTED|Overall Study||502
6532745|NCT01625000|7454486|FG000|COMPLETED|Overall Study||74
6532746|NCT01625000|7454487|FG001|COMPLETED|Overall Study||81
6532747|NCT01625000|7454488|FG002|COMPLETED|Overall Study||34
6532748|NCT01625000|7454489|FG003|COMPLETED|Overall Study||37
6532749|NCT01625000|7454490|FG004|COMPLETED|Overall Study||71
6532750|NCT01625000|7454486|FG000|NOT COMPLETED|Overall Study||52
6532751|NCT01625000|7454487|FG001|NOT COMPLETED|Overall Study||52
6532752|NCT01625000|7454488|FG002|NOT COMPLETED|Overall Study||33
6532753|NCT01625000|7454489|FG003|NOT COMPLETED|Overall Study||19
6532754|NCT01625000|7454490|FG004|NOT COMPLETED|Overall Study||55
6532755|NCT01625013|7454502|FG000|STARTED|Overall Study||51
6532756|NCT01625013|7454502|FG000|COMPLETED|Overall Study||48
6532757|NCT01625013|7454502|FG000|NOT COMPLETED|Overall Study||3
6532758|NCT01625091|7454509|FG000|STARTED|Intervention||96
6532759|NCT01625091|7454510|FG001|STARTED|Intervention||98
6532760|NCT01625091|7454509|FG000|2 Months|Intervention||90
6532761|NCT01625091|7454510|FG001|2 Months|Intervention||93
6532762|NCT01625091|7454509|FG000|4 Months|Intervention||85
6532763|NCT01625091|7454510|FG001|4 Months|Intervention||87
6532764|NCT01625091|7454509|FG000|COMPLETED|Intervention||85
6532765|NCT01625091|7454510|FG001|COMPLETED|Intervention||87
6532766|NCT01625091|7454509|FG000|NOT COMPLETED|Intervention||11
6532767|NCT01625091|7454510|FG001|NOT COMPLETED|Intervention||11
6532768|NCT01625091|7454509|FG000|STARTED|Post-intervention||85
6532769|NCT01625091|7454510|FG001|STARTED|Post-intervention||87
6532770|NCT01625091|7454509|FG000|7 Months|Post-intervention||81
6532771|NCT01625091|7454510|FG001|7 Months|Post-intervention||85
6532772|NCT01625091|7454509|FG000|COMPLETED|Post-intervention||81
6532773|NCT01625091|7454510|FG001|COMPLETED|Post-intervention||85
6532774|NCT01625091|7454509|FG000|NOT COMPLETED|Post-intervention||4
6532775|NCT01625091|7454510|FG001|NOT COMPLETED|Post-intervention||2
6532776|NCT01625104|7454518|FG000|STARTED|Overall Study||448
6532777|NCT01625104|7454519|FG001|STARTED|Overall Study||434
6644508|NCT02364037|7573148|FG001|STARTED|Overall Study||506
6644509|NCT02364037|7573147|FG000|COMPLETED|Overall Study||458
6644510|NCT02364037|7573148|FG001|COMPLETED|Overall Study||453
6644511|NCT02364037|7573147|FG000|NOT COMPLETED|Overall Study||44
6532778|NCT01625104|7454518|FG000|COMPLETED|Overall Study||448
6532779|NCT01625104|7454519|FG001|COMPLETED|Overall Study||434
6532780|NCT01625104|7454518|FG000|NOT COMPLETED|Overall Study||0
6532781|NCT01625104|7454519|FG001|NOT COMPLETED|Overall Study||0
6532782|NCT01625169|7454525|FG000|STARTED|Overall Study||9
6532783|NCT01625169|7454525|FG000|COMPLETED|Overall Study||9
6532784|NCT01625169|7454525|FG000|NOT COMPLETED|Overall Study||0
6532785|NCT01625182|7454531|FG000|STARTED|Overall Study||54
6532786|NCT01625182|7454532|FG001|STARTED|Overall Study||52
6532787|NCT01625182|7454531|FG000|COMPLETED|Overall Study||34
6532788|NCT01625182|7454532|FG001|COMPLETED|Overall Study||41
6532789|NCT01625182|7454531|FG000|NOT COMPLETED|Overall Study||20
6532790|NCT01625182|7454532|FG001|NOT COMPLETED|Overall Study||11
6532791|NCT01625221|7454539|FG000|STARTED|Overall Study||35
6532792|NCT01625221|7454539|FG000|COMPLETED|Overall Study||28
6532793|NCT01625221|7454539|FG000|NOT COMPLETED|Overall Study||7
6532794|NCT01625338|7454546|FG000|STARTED|Overall Study||114
6532795|NCT01625338|7454547|FG001|STARTED|Overall Study||200
6532796|NCT01625338|7454548|FG002|STARTED|Overall Study||220
6532797|NCT01625338|7454546|FG000|COMPLETED|Overall Study||82
6532798|NCT01625338|7454547|FG001|COMPLETED|Overall Study||156
6532799|NCT01625338|7454548|FG002|COMPLETED|Overall Study||181
6532800|NCT01625338|7454546|FG000|NOT COMPLETED|Overall Study||32
6532801|NCT01625338|7454547|FG001|NOT COMPLETED|Overall Study||44
6532802|NCT01625338|7454548|FG002|NOT COMPLETED|Overall Study||39
6532803|NCT01625377|7454558|FG000|STARTED|Overall Study|"Started indicates randomized patients."|95
6532804|NCT01625377|7454559|FG001|STARTED|Overall Study||93
6532805|NCT01625377|7454558|FG000|Safety Set of Population|Overall Study||94
6532806|NCT01625377|7454559|FG001|Safety Set of Population|Overall Study||90
6532807|NCT01625377|7454558|FG000|Intent to Treat Population|Overall Study||93
6532808|NCT01625377|7454559|FG001|Intent to Treat Population|Overall Study||90
6532809|NCT01625377|7454558|FG000|COMPLETED|Overall Study||88
6532810|NCT01625377|7454559|FG001|COMPLETED|Overall Study||71
6532811|NCT01625377|7454558|FG000|NOT COMPLETED|Overall Study||7
6532812|NCT01625377|7454559|FG001|NOT COMPLETED|Overall Study||22
6532813|NCT01625416|7454567|FG000|STARTED|Overall Study||60
6532814|NCT01625416|7454568|FG001|STARTED|Overall Study||61
6532815|NCT01625416|7454567|FG000|COMPLETED|Overall Study||51
6532816|NCT01625416|7454568|FG001|COMPLETED|Overall Study||54
6532817|NCT01625416|7454567|FG000|NOT COMPLETED|Overall Study||9
6532818|NCT01625416|7454568|FG001|NOT COMPLETED|Overall Study||7
6532819|NCT01625455|7454577|FG000|STARTED|Overall Study||2
6532820|NCT01625455|7454578|FG001|STARTED|Overall Study||3
6532821|NCT01625455|7454577|FG000|COMPLETED|Overall Study||2
6532822|NCT01625455|7454578|FG001|COMPLETED|Overall Study||3
6532823|NCT01625455|7454577|FG000|NOT COMPLETED|Overall Study||0
6532824|NCT01625455|7454578|FG001|NOT COMPLETED|Overall Study||0
6532825|NCT01625507|7454584|FG000|STARTED|Overall Study||73
6532826|NCT01625507|7454584|FG000|COMPLETED|Overall Study||63
6532827|NCT01625507|7454584|FG000|NOT COMPLETED|Overall Study||10
6532828|NCT01625689|7454591|FG000|STARTED|Overall Study||150
6532829|NCT01625689|7454592|FG001|STARTED|Overall Study||150
6532830|NCT01625689|7454591|FG000|COMPLETED|Overall Study||148
6644512|NCT02364037|7573148|FG001|NOT COMPLETED|Overall Study||53
6644513|NCT02364076|7573154|FG000|STARTED|Overall Study||45
6532831|NCT01625689|7454592|FG001|COMPLETED|Overall Study||149
6532832|NCT01625689|7454591|FG000|NOT COMPLETED|Overall Study||2
6532833|NCT01625689|7454592|FG001|NOT COMPLETED|Overall Study||1
6532834|NCT01625845|7454600|FG000|STARTED|Overall Study||10
6532835|NCT01625845|7454601|FG001|STARTED|Overall Study||6
6532836|NCT01625845|7454600|FG000|COMPLETED|Overall Study||5
6532837|NCT01625845|7454601|FG001|COMPLETED|Overall Study||3
6532838|NCT01625845|7454600|FG000|NOT COMPLETED|Overall Study||5
6532839|NCT01625845|7454601|FG001|NOT COMPLETED|Overall Study||3
6532840|NCT01625897|7454609|FG000|STARTED|Overall Study||83
6532841|NCT01625897|7454610|FG001|STARTED|Overall Study||42
6532842|NCT01625897|7454609|FG000|COMPLETED|Overall Study||31
6532843|NCT01625897|7454610|FG001|COMPLETED|Overall Study||28
6532844|NCT01625897|7454609|FG000|NOT COMPLETED|Overall Study||52
6532845|NCT01625897|7454610|FG001|NOT COMPLETED|Overall Study||14
6532846|NCT01625910|7454618|FG000|STARTED|Overall Study||35
6532847|NCT01625910|7454619|FG001|STARTED|Overall Study||37
6532848|NCT01625910|7454618|FG000|COMPLETED|Overall Study||32
6532849|NCT01625910|7454619|FG001|COMPLETED|Overall Study||33
6532850|NCT01625910|7454618|FG000|NOT COMPLETED|Overall Study||3
6532851|NCT01625910|7454619|FG001|NOT COMPLETED|Overall Study||4
6532852|NCT01625923|7454627|FG000|STARTED|Overall Study||3
6532853|NCT01625923|7454627|FG000|COMPLETED|Overall Study||3
6532854|NCT01625923|7454627|FG000|NOT COMPLETED|Overall Study||0
6532855|NCT01625988|7454634|FG000|STARTED|Overall Study|One participant was randomized inappropriately and was discontinued before start of study treatment.|108
6532856|NCT01625988|7454635|FG001|STARTED|Overall Study||110
6532857|NCT01625988|7454634|FG000|Received at Least One Dose of Study Drug|Overall Study||107
6532858|NCT01625988|7454635|FG001|Received at Least One Dose of Study Drug|Overall Study||110
6532859|NCT01625988|7454634|FG000|COMPLETED|Overall Study||94
6532860|NCT01625988|7454635|FG001|COMPLETED|Overall Study||97
6532861|NCT01625988|7454634|FG000|NOT COMPLETED|Overall Study||14
6532862|NCT01625988|7454635|FG001|NOT COMPLETED|Overall Study||13
6532863|NCT01626079|7454646|FG000|STARTED|Overall Study||302
6532864|NCT01626079|7454647|FG001|STARTED|Overall Study||312
6532865|NCT01626079|7454646|FG000|COMPLETED|Overall Study||135
6532866|NCT01626079|7454647|FG001|COMPLETED|Overall Study||96
6532867|NCT01626079|7454646|FG000|NOT COMPLETED|Overall Study||167
6532868|NCT01626079|7454647|FG001|NOT COMPLETED|Overall Study||216
6532869|NCT01626092|7454654|FG000|STARTED|Overall Study||3
6532870|NCT01626092|7454654|FG000|COMPLETED|Overall Study||3
6532871|NCT01626092|7454654|FG000|NOT COMPLETED|Overall Study||0
6532872|NCT01626118|7454662|FG000|STARTED|Overall Study||94
6532873|NCT01626118|7454663|FG001|STARTED|Overall Study||93
6532874|NCT01626118|7454664|FG002|STARTED|Overall Study||92
6532875|NCT01626118|7454665|FG003|STARTED|Overall Study||94
6532876|NCT01626118|7454662|FG000|COMPLETED|Overall Study||92
6532877|NCT01626118|7454663|FG001|COMPLETED|Overall Study||91
6532878|NCT01626118|7454664|FG002|COMPLETED|Overall Study||90
6532879|NCT01626118|7454665|FG003|COMPLETED|Overall Study||91
6532880|NCT01626118|7454662|FG000|NOT COMPLETED|Overall Study||2
6532881|NCT01626118|7454663|FG001|NOT COMPLETED|Overall Study||2
6532882|NCT01626118|7454664|FG002|NOT COMPLETED|Overall Study||2
6532883|NCT01626118|7454665|FG003|NOT COMPLETED|Overall Study||3
6532884|NCT01626352|7454675|FG000|STARTED|Overall Study||22
6532885|NCT01626352|7454675|FG000|COMPLETED|Overall Study||12
6532886|NCT01626352|7454675|FG000|NOT COMPLETED|Overall Study||10
6532887|NCT01626391|7454684|FG000|STARTED|Overall Study||5
6532888|NCT01626391|7454685|FG001|STARTED|Overall Study||4
6532889|NCT01626391|7454684|FG000|COMPLETED|Overall Study||3
6532890|NCT01626391|7454685|FG001|COMPLETED|Overall Study||4
6532891|NCT01626391|7454684|FG000|NOT COMPLETED|Overall Study||2
6532892|NCT01626391|7454685|FG001|NOT COMPLETED|Overall Study||0
6532893|NCT01626456|7454693|FG000|STARTED|Overall Study||110
6532894|NCT01626456|7454694|FG001|STARTED|Overall Study||368
6532895|NCT01626456|7454693|FG000|COMPLETED|Overall Study||75
6532896|NCT01626456|7454694|FG001|COMPLETED|Overall Study||251
6532897|NCT01626456|7454693|FG000|NOT COMPLETED|Overall Study||35
6532898|NCT01626456|7454694|FG001|NOT COMPLETED|Overall Study||117
6532899|NCT01626495|7454709|FG000|STARTED|Overall Study|Number of enrolled subjects|73
6532900|NCT01626495|7454709|FG000|Intervention|Overall Study||62
6532901|NCT01626495|7454709|FG000|COMPLETED|Overall Study|Follow up phase completed as per protocol|21
6532902|NCT01626495|7454709|FG000|NOT COMPLETED|Overall Study||52
6532903|NCT01626664|7454715|FG000|STARTED|Randomization Period||47
6532904|NCT01626664|7454716|FG001|STARTED|Randomization Period||24
6532905|NCT01626664|7454717|FG002|STARTED|Randomization Period||0
6532906|NCT01626664|7454715|FG000|COMPLETED|Randomization Period||47
6532907|NCT01626664|7454716|FG001|COMPLETED|Randomization Period||24
6532908|NCT01626664|7454717|FG002|COMPLETED|Randomization Period||0
6532909|NCT01626664|7454715|FG000|NOT COMPLETED|Randomization Period||0
6532910|NCT01626664|7454716|FG001|NOT COMPLETED|Randomization Period||0
6532911|NCT01626664|7454717|FG002|NOT COMPLETED|Randomization Period||0
6532912|NCT01626664|7454715|FG000|STARTED|Crossover Period||0
6532913|NCT01626664|7454716|FG001|STARTED|Crossover Period||0
6532914|NCT01626664|7454717|FG002|STARTED|Crossover Period||18
6532915|NCT01626664|7454715|FG000|COMPLETED|Crossover Period||0
6532916|NCT01626664|7454716|FG001|COMPLETED|Crossover Period||0
6532917|NCT01626664|7454717|FG002|COMPLETED|Crossover Period||18
6532918|NCT01626664|7454715|FG000|NOT COMPLETED|Crossover Period||0
6532919|NCT01626664|7454716|FG001|NOT COMPLETED|Crossover Period||0
6532920|NCT01626664|7454717|FG002|NOT COMPLETED|Crossover Period||0
6532921|NCT01626690|7454726|FG000|STARTED|Overall Study||49
6532922|NCT01626690|7454727|FG001|STARTED|Overall Study||51
6532923|NCT01626690|7454726|FG000|COMPLETED|Overall Study||47
6532924|NCT01626690|7454727|FG001|COMPLETED|Overall Study||51
6532925|NCT01626690|7454726|FG000|NOT COMPLETED|Overall Study||2
6532926|NCT01626690|7454727|FG001|NOT COMPLETED|Overall Study||0
6532927|NCT01626820|7454737|FG000|STARTED|Overall Study||56
6532928|NCT01626820|7454738|FG001|STARTED|Overall Study||57
6532929|NCT01626820|7454737|FG000|COMPLETED|Overall Study||56
6532930|NCT01626820|7454738|FG001|COMPLETED|Overall Study||57
6532931|NCT01626820|7454737|FG000|NOT COMPLETED|Overall Study||0
6532932|NCT01626820|7454738|FG001|NOT COMPLETED|Overall Study||0
6532933|NCT01626859|7454748|FG000|STARTED|Overall Study||11
6532934|NCT01626859|7454749|FG001|STARTED|Overall Study||16
6532935|NCT01626859|7454750|FG002|STARTED|Overall Study||11
6532936|NCT01626859|7454748|FG000|COMPLETED|Overall Study||9
6532937|NCT01626859|7454749|FG001|COMPLETED|Overall Study||8
6532938|NCT01626859|7454750|FG002|COMPLETED|Overall Study||7
6532939|NCT01626859|7454748|FG000|NOT COMPLETED|Overall Study||2
6532940|NCT01626859|7454749|FG001|NOT COMPLETED|Overall Study||8
6532941|NCT01626859|7454750|FG002|NOT COMPLETED|Overall Study||4
6532942|NCT01626872|7454761|FG000|STARTED|Overall Study||81
6532943|NCT01626872|7454762|FG001|STARTED|Overall Study||109
6532944|NCT01626872|7454763|FG002|STARTED|Overall Study||58
6532945|NCT01626872|7454761|FG000|COMPLETED|Overall Study||29
6532946|NCT01626872|7454762|FG001|COMPLETED|Overall Study||43
6532947|NCT01626872|7454763|FG002|COMPLETED|Overall Study||34
6532948|NCT01626872|7454761|FG000|NOT COMPLETED|Overall Study||52
6532949|NCT01626872|7454762|FG001|NOT COMPLETED|Overall Study||66
6532950|NCT01626872|7454763|FG002|NOT COMPLETED|Overall Study||24
6532951|NCT01626885|7454771|FG000|STARTED|Overall Study||42
6644514|NCT02364076|7573154|FG000|COMPLETED|Overall Study||40
6644515|NCT02364076|7573154|FG000|NOT COMPLETED|Overall Study||5
6644516|NCT02364180|7573158|FG000|STARTED|Overall Study||11
6644517|NCT02364180|7573158|FG000|COMPLETED|Overall Study||10
6644518|NCT02364180|7573158|FG000|NOT COMPLETED|Overall Study||1
6644519|NCT02364271|7573164|FG000|STARTED|Overall Study||479
6644520|NCT02364271|7573165|FG001|STARTED|Overall Study||123
6644521|NCT02364271|7573164|FG000|COMPLETED|Overall Study||479
6644522|NCT02364271|7573165|FG001|COMPLETED|Overall Study||123
6644523|NCT02364271|7573164|FG000|NOT COMPLETED|Overall Study||0
6644524|NCT02364271|7573165|FG001|NOT COMPLETED|Overall Study||0
6644525|NCT02364336|7573174|FG000|STARTED|Overall Study||1
6644526|NCT02364336|7573175|FG001|STARTED|Overall Study||12
6644527|NCT02364336|7573174|FG000|6 Hours Post First Peginterferon Inject|Overall Study||1
6644528|NCT02364336|7573175|FG001|6 Hours Post First Peginterferon Inject|Overall Study||12
6644529|NCT02364336|7573174|FG000|End of Peginterferon Treatment|Overall Study||1
6644530|NCT02364336|7573175|FG001|End of Peginterferon Treatment|Overall Study||11
6644531|NCT02364336|7573174|FG000|24 Weeks After End of Peginterferon|Overall Study||1
6644532|NCT02364336|7573175|FG001|24 Weeks After End of Peginterferon|Overall Study||11
6644533|NCT02364336|7573174|FG000|48 Weeks After End of Peginterferon|Overall Study||1
6644534|NCT02364336|7573175|FG001|48 Weeks After End of Peginterferon|Overall Study||10
6644535|NCT02364336|7573174|FG000|COMPLETED|Overall Study||1
6644536|NCT02364336|7573175|FG001|COMPLETED|Overall Study||11
6644537|NCT02364336|7573174|FG000|NOT COMPLETED|Overall Study||0
6644538|NCT02364336|7573175|FG001|NOT COMPLETED|Overall Study||1
6644539|NCT02364388|7573182|FG000|STARTED|Overall Study||217
6644540|NCT02364388|7573182|FG000|Biopsied|Overall Study||209
6644541|NCT02364388|7573182|FG000|Excluded|Overall Study||8
6644542|NCT02364388|7573182|FG000|COMPLETED|Overall Study||209
6644543|NCT02364388|7573182|FG000|NOT COMPLETED|Overall Study||8
6644544|NCT02364570|7573186|FG000|STARTED|Overall Study||1
6644545|NCT02364570|7573187|FG001|STARTED|Overall Study||1
6644546|NCT02364570|7573188|FG002|STARTED|Overall Study||2
6644547|NCT02364570|7573189|FG003|STARTED|Overall Study||1
6644548|NCT02364570|7573190|FG004|STARTED|Overall Study||1
6644549|NCT02364570|7573191|FG005|STARTED|Overall Study||1
6644550|NCT02364570|7573192|FG006|STARTED|Overall Study||2
6644551|NCT02364570|7573193|FG007|STARTED|Overall Study||1
6532952|NCT01626885|7454771|FG000|COMPLETED|Overall Study||30
6532953|NCT01626885|7454771|FG000|NOT COMPLETED|Overall Study||12
6532954|NCT01626989|7454775|FG000|STARTED|Screening Period||44
6532955|NCT01626989|7454776|FG001|STARTED|Screening Period||0
6532956|NCT01626989|7454777|FG002|STARTED|Screening Period||0
6532957|NCT01626989|7454775|FG000|COMPLETED|Screening Period||27
6644552|NCT02364570|7573194|FG008|STARTED|Overall Study||2
6644553|NCT02364570|7573195|FG009|STARTED|Overall Study||1
6644554|NCT02364570|7573196|FG010|STARTED|Overall Study||1
6644555|NCT02364570|7573197|FG011|STARTED|Overall Study||1
6644556|NCT02364570|7573198|FG012|STARTED|Overall Study||1
6644557|NCT02364570|7573199|FG013|STARTED|Overall Study||2
6644558|NCT02364570|7573200|FG014|STARTED|Overall Study||1
6644559|NCT02364570|7573201|FG015|STARTED|Overall Study||1
6532958|NCT01626989|7454776|FG001|COMPLETED|Screening Period||0
6532959|NCT01626989|7454777|FG002|COMPLETED|Screening Period||0
6644560|NCT02364570|7573186|FG000|COMPLETED|Overall Study||1
6644561|NCT02364570|7573187|FG001|COMPLETED|Overall Study||1
6644562|NCT02364570|7573188|FG002|COMPLETED|Overall Study||2
6644563|NCT02364570|7573189|FG003|COMPLETED|Overall Study||1
6644564|NCT02364570|7573190|FG004|COMPLETED|Overall Study||1
6644565|NCT02364570|7573191|FG005|COMPLETED|Overall Study||1
6644566|NCT02364570|7573192|FG006|COMPLETED|Overall Study||2
6532960|NCT01626989|7454775|FG000|NOT COMPLETED|Screening Period||17
6532961|NCT01626989|7454776|FG001|NOT COMPLETED|Screening Period||0
6532962|NCT01626989|7454777|FG002|NOT COMPLETED|Screening Period||0
6532963|NCT01626989|7454775|FG000|STARTED|Fist Intervention (Night 1)||0
6532964|NCT01626989|7454776|FG001|STARTED|Fist Intervention (Night 1)||15
6532965|NCT01626989|7454777|FG002|STARTED|Fist Intervention (Night 1)||12
6532966|NCT01626989|7454775|FG000|COMPLETED|Fist Intervention (Night 1)||0
6532967|NCT01626989|7454776|FG001|COMPLETED|Fist Intervention (Night 1)||15
6532968|NCT01626989|7454777|FG002|COMPLETED|Fist Intervention (Night 1)||12
6532969|NCT01626989|7454775|FG000|NOT COMPLETED|Fist Intervention (Night 1)||0
6532970|NCT01626989|7454776|FG001|NOT COMPLETED|Fist Intervention (Night 1)||0
6532971|NCT01626989|7454777|FG002|NOT COMPLETED|Fist Intervention (Night 1)||0
6532972|NCT01626989|7454775|FG000|STARTED|Second Intervention (Night 2)||0
6532973|NCT01626989|7454776|FG001|STARTED|Second Intervention (Night 2)||15
6532974|NCT01626989|7454777|FG002|STARTED|Second Intervention (Night 2)||12
6532975|NCT01626989|7454775|FG000|COMPLETED|Second Intervention (Night 2)||0
6532976|NCT01626989|7454776|FG001|COMPLETED|Second Intervention (Night 2)||15
6532977|NCT01626989|7454777|FG002|COMPLETED|Second Intervention (Night 2)||12
6532978|NCT01626989|7454775|FG000|NOT COMPLETED|Second Intervention (Night 2)||0
6532979|NCT01626989|7454776|FG001|NOT COMPLETED|Second Intervention (Night 2)||0
6532980|NCT01626989|7454777|FG002|NOT COMPLETED|Second Intervention (Night 2)||0
6532981|NCT01627002|7454788|FG000|STARTED|Overall Study||4
6532982|NCT01627002|7454789|FG001|STARTED|Overall Study||4
6532983|NCT01627002|7454790|FG002|STARTED|Overall Study||4
6532984|NCT01627002|7454791|FG003|STARTED|Overall Study||4
6532985|NCT01627002|7454792|FG004|STARTED|Overall Study||2
6532986|NCT01627002|7454793|FG005|STARTED|Overall Study||9
6532987|NCT01627002|7454794|FG006|STARTED|Overall Study||10
6532988|NCT01627002|7454795|FG007|STARTED|Overall Study||5
6532989|NCT01627002|7454796|FG008|STARTED|Overall Study||7
6532990|NCT01627002|7454788|FG000|COMPLETED|Overall Study||4
6532991|NCT01627002|7454789|FG001|COMPLETED|Overall Study||4
6532992|NCT01627002|7454790|FG002|COMPLETED|Overall Study||4
6532993|NCT01627002|7454791|FG003|COMPLETED|Overall Study||4
6532994|NCT01627002|7454792|FG004|COMPLETED|Overall Study||2
6532995|NCT01627002|7454793|FG005|COMPLETED|Overall Study||9
6532996|NCT01627002|7454794|FG006|COMPLETED|Overall Study||10
6532997|NCT01627002|7454795|FG007|COMPLETED|Overall Study||5
6532998|NCT01627002|7454796|FG008|COMPLETED|Overall Study||7
6532999|NCT01627002|7454788|FG000|NOT COMPLETED|Overall Study||0
6533000|NCT01627002|7454789|FG001|NOT COMPLETED|Overall Study||0
6533001|NCT01627002|7454790|FG002|NOT COMPLETED|Overall Study||0
6533002|NCT01627002|7454791|FG003|NOT COMPLETED|Overall Study||0
6533003|NCT01627002|7454792|FG004|NOT COMPLETED|Overall Study||0
6533004|NCT01627002|7454793|FG005|NOT COMPLETED|Overall Study||0
6533005|NCT01627002|7454794|FG006|NOT COMPLETED|Overall Study||0
6533006|NCT01627002|7454795|FG007|NOT COMPLETED|Overall Study||0
6533007|NCT01627002|7454796|FG008|NOT COMPLETED|Overall Study||0
6533008|NCT01627067|7454823|FG000|STARTED|Overall Study||23
6533009|NCT01627067|7454823|FG000|COMPLETED|Overall Study||22
6533010|NCT01627067|7454823|FG000|NOT COMPLETED|Overall Study||1
6533011|NCT01627249|7454832|FG000|STARTED|Overall Study||224
6533012|NCT01627249|7454833|FG001|STARTED|Overall Study||218
6533013|NCT01627249|7454834|FG002|STARTED|Overall Study||218
6533014|NCT01627249|7454832|FG000|COMPLETED|Overall Study||208
6533015|NCT01627249|7454833|FG001|COMPLETED|Overall Study||206
6533016|NCT01627249|7454834|FG002|COMPLETED|Overall Study||206
6533017|NCT01627249|7454832|FG000|NOT COMPLETED|Overall Study||16
6533018|NCT01627249|7454833|FG001|NOT COMPLETED|Overall Study||12
6533019|NCT01627249|7454834|FG002|NOT COMPLETED|Overall Study||12
6533020|NCT01627288|7454846|FG000|STARTED|Overall Study||3
6533021|NCT01627288|7454847|FG001|STARTED|Overall Study||3
6533022|NCT01627288|7454848|FG002|STARTED|Overall Study||6
6533023|NCT01627288|7454849|FG003|STARTED|Overall Study||0
6533024|NCT01627288|7454846|FG000|COMPLETED|Overall Study||3
6533025|NCT01627288|7454847|FG001|COMPLETED|Overall Study||3
6533026|NCT01627288|7454848|FG002|COMPLETED|Overall Study||6
6533027|NCT01627288|7454849|FG003|COMPLETED|Overall Study||0
6533028|NCT01627288|7454846|FG000|NOT COMPLETED|Overall Study||0
6533029|NCT01627288|7454847|FG001|NOT COMPLETED|Overall Study||0
6533030|NCT01627288|7454848|FG002|NOT COMPLETED|Overall Study||0
6533031|NCT01627288|7454849|FG003|NOT COMPLETED|Overall Study||0
6533032|NCT01627327|7454863|FG000|STARTED|Overall Study||310
6533033|NCT01627327|7454864|FG001|STARTED|Overall Study||313
6533034|NCT01627327|7454863|FG000|COMPLETED|Overall Study||291
6533035|NCT01627327|7454864|FG001|COMPLETED|Overall Study||274
6533036|NCT01627327|7454863|FG000|NOT COMPLETED|Overall Study||19
6533037|NCT01627327|7454864|FG001|NOT COMPLETED|Overall Study||39
6533038|NCT01627340|7454872|FG000|STARTED|Overall Study||416
6533039|NCT01627340|7454873|FG001|STARTED|Overall Study||258
6533040|NCT01627340|7454872|FG000|COMPLETED|Overall Study||404
6533041|NCT01627340|7454873|FG001|COMPLETED|Overall Study||254
6533042|NCT01627340|7454872|FG000|NOT COMPLETED|Overall Study||12
6533043|NCT01627340|7454873|FG001|NOT COMPLETED|Overall Study||4
6533044|NCT01627574|7454883|FG000|STARTED|Overall Study||142
6533045|NCT01627574|7454884|FG001|STARTED|Overall Study||130
6533046|NCT01627574|7454883|FG000|COMPLETED|Overall Study||121
6533047|NCT01627574|7454884|FG001|COMPLETED|Overall Study||112
6533048|NCT01627574|7454883|FG000|NOT COMPLETED|Overall Study||21
6533049|NCT01627574|7454884|FG001|NOT COMPLETED|Overall Study||18
6533050|NCT01627691|7454890|FG000|STARTED|Overall Study||250
6533051|NCT01627691|7454890|FG000|Primary Endpoint (30days)|Overall Study||239
6533052|NCT01627691|7454890|FG000|COMPLETED|Overall Study||232
6533053|NCT01627691|7454890|FG000|NOT COMPLETED|Overall Study||18
6533054|NCT01627782|7454898|FG000|STARTED|Overall Study||17
6533055|NCT01627782|7454899|FG001|STARTED|Overall Study||18
6533056|NCT01627782|7454900|FG002|STARTED|Overall Study||16
6533057|NCT01627782|7454901|FG003|STARTED|Overall Study||17
6533058|NCT01627782|7454898|FG000|Treated|Overall Study||16
6533059|NCT01627782|7454899|FG001|Treated|Overall Study||18
6533060|NCT01627782|7454900|FG002|Treated|Overall Study||16
6533061|NCT01627782|7454901|FG003|Treated|Overall Study||17
6533062|NCT01627782|7454898|FG000|COMPLETED|Overall Study||1
6533063|NCT01627782|7454899|FG001|COMPLETED|Overall Study||12
6533064|NCT01627782|7454900|FG002|COMPLETED|Overall Study||1
6533065|NCT01627782|7454901|FG003|COMPLETED|Overall Study||11
6533066|NCT01627782|7454898|FG000|NOT COMPLETED|Overall Study||16
6533067|NCT01627782|7454899|FG001|NOT COMPLETED|Overall Study||6
6533068|NCT01627782|7454900|FG002|NOT COMPLETED|Overall Study||15
6533069|NCT01627782|7454901|FG003|NOT COMPLETED|Overall Study||6
6533070|NCT01627860|7454915|FG000|STARTED|Overall Study||35
6533071|NCT01627860|7454916|FG001|STARTED|Overall Study||20
6533072|NCT01627860|7454915|FG000|COMPLETED|Overall Study||23
6533073|NCT01627860|7454916|FG001|COMPLETED|Overall Study||14
6533074|NCT01627860|7454915|FG000|NOT COMPLETED|Overall Study||12
6533075|NCT01627860|7454916|FG001|NOT COMPLETED|Overall Study||6
6533076|NCT01628016|7454925|FG000|STARTED|Pretraining to Posttraining||27
6533077|NCT01628016|7454926|FG001|STARTED|Pretraining to Posttraining||27
6533078|NCT01628016|7454927|FG002|STARTED|Pretraining to Posttraining||23
6533079|NCT01628016|7454925|FG000|COMPLETED|Pretraining to Posttraining||27
6533080|NCT01628016|7454926|FG001|COMPLETED|Pretraining to Posttraining||27
6533081|NCT01628016|7454927|FG002|COMPLETED|Pretraining to Posttraining||23
6533082|NCT01628016|7454925|FG000|NOT COMPLETED|Pretraining to Posttraining||0
6533083|NCT01628016|7454926|FG001|NOT COMPLETED|Pretraining to Posttraining||0
6533084|NCT01628016|7454927|FG002|NOT COMPLETED|Pretraining to Posttraining||0
6533085|NCT01628016|7454925|FG000|STARTED|Posttraining to 5 Follow-ups||27
6533086|NCT01628016|7454926|FG001|STARTED|Posttraining to 5 Follow-ups||27
6533087|NCT01628016|7454927|FG002|STARTED|Posttraining to 5 Follow-ups||23
6533088|NCT01628016|7454925|FG000|COMPLETED|Posttraining to 5 Follow-ups||23
6533089|NCT01628016|7454926|FG001|COMPLETED|Posttraining to 5 Follow-ups||20
6533090|NCT01628016|7454927|FG002|COMPLETED|Posttraining to 5 Follow-ups||18
6533091|NCT01628016|7454925|FG000|NOT COMPLETED|Posttraining to 5 Follow-ups||4
6533092|NCT01628016|7454926|FG001|NOT COMPLETED|Posttraining to 5 Follow-ups||7
6533093|NCT01628016|7454927|FG002|NOT COMPLETED|Posttraining to 5 Follow-ups||5
6533094|NCT01628042|7454941|FG000|STARTED|Overall Study||8
6533095|NCT01628042|7454942|FG001|STARTED|Overall Study||8
6533096|NCT01628042|7454943|FG002|STARTED|Overall Study||8
6533097|NCT01628042|7454944|FG003|STARTED|Overall Study||8
6533098|NCT01628042|7454941|FG000|COMPLETED|Overall Study||8
6533099|NCT01628042|7454942|FG001|COMPLETED|Overall Study||8
6533100|NCT01628042|7454943|FG002|COMPLETED|Overall Study||8
6533101|NCT01628042|7454944|FG003|COMPLETED|Overall Study||8
6533102|NCT01628042|7454941|FG000|NOT COMPLETED|Overall Study||0
6533103|NCT01628042|7454942|FG001|NOT COMPLETED|Overall Study||0
6533104|NCT01628042|7454943|FG002|NOT COMPLETED|Overall Study||0
6533105|NCT01628042|7454944|FG003|NOT COMPLETED|Overall Study||0
6533106|NCT01628107|7454954|FG000|STARTED|Overall Study||414
6533107|NCT01628107|7454954|FG000|Treated|Overall Study||406
6533108|NCT01628107|7454954|FG000|COMPLETED|Overall Study||295
6533109|NCT01628107|7454954|FG000|NOT COMPLETED|Overall Study||119
6533110|NCT01628120|7454958|FG000|STARTED|Overall Study||173
6533111|NCT01628120|7454958|FG000|Treated|Overall Study||170
6533112|NCT01628120|7454958|FG000|COMPLETED|Overall Study||129
6533113|NCT01628120|7454958|FG000|NOT COMPLETED|Overall Study||44
6533114|NCT01628159|7454962|FG000|STARTED|Overall Study||657
6533115|NCT01628159|7454962|FG000|COMPLETED|Overall Study||493
6533116|NCT01628159|7454962|FG000|NOT COMPLETED|Overall Study||164
6533117|NCT01628198|7454966|FG000|STARTED|Overall Study||38
6533118|NCT01628198|7454966|FG000|COMPLETED|Overall Study||20
6533119|NCT01628198|7454966|FG000|NOT COMPLETED|Overall Study||18
6533120|NCT01628250|7454972|FG000|STARTED|Overall Study||49
6533121|NCT01628250|7454973|FG001|STARTED|Overall Study||50
6533122|NCT01628250|7454972|FG000|COMPLETED|Overall Study||49
6533123|NCT01628250|7454973|FG001|COMPLETED|Overall Study||50
6533124|NCT01628250|7454972|FG000|NOT COMPLETED|Overall Study||0
6533125|NCT01628250|7454973|FG001|NOT COMPLETED|Overall Study||0
6533126|NCT01628367|7454981|FG000|STARTED|Overall Study||16
6533127|NCT01628367|7454982|FG001|STARTED|Overall Study||16
6533128|NCT01628367|7454981|FG000|COMPLETED|Overall Study||15
6533129|NCT01628367|7454982|FG001|COMPLETED|Overall Study||16
6533130|NCT01628367|7454981|FG000|NOT COMPLETED|Overall Study||1
6533131|NCT01628367|7454982|FG001|NOT COMPLETED|Overall Study||0
6533132|NCT01628393|7454991|FG000|STARTED|Placebo-controlled Treatment Period||88
6533133|NCT01628393|7454992|FG001|STARTED|Placebo-controlled Treatment Period||87
6533134|NCT01628393|7454993|FG002|STARTED|Placebo-controlled Treatment Period||83
6533135|NCT01628393|7454994|FG003|STARTED|Placebo-controlled Treatment Period||0
6533136|NCT01628393|7454995|FG004|STARTED|Placebo-controlled Treatment Period||0
6533137|NCT01628393|7454991|FG000|COMPLETED|Placebo-controlled Treatment Period||85
6533138|NCT01628393|7454992|FG001|COMPLETED|Placebo-controlled Treatment Period||85
6533139|NCT01628393|7454993|FG002|COMPLETED|Placebo-controlled Treatment Period||82
6533140|NCT01628393|7454994|FG003|COMPLETED|Placebo-controlled Treatment Period||0
6533141|NCT01628393|7454995|FG004|COMPLETED|Placebo-controlled Treatment Period||0
6533142|NCT01628393|7454991|FG000|NOT COMPLETED|Placebo-controlled Treatment Period||3
6533143|NCT01628393|7454992|FG001|NOT COMPLETED|Placebo-controlled Treatment Period||2
6533144|NCT01628393|7454993|FG002|NOT COMPLETED|Placebo-controlled Treatment Period||1
6533145|NCT01628393|7454994|FG003|NOT COMPLETED|Placebo-controlled Treatment Period||0
6533146|NCT01628393|7454995|FG004|NOT COMPLETED|Placebo-controlled Treatment Period||0
6533147|NCT01628393|7454991|FG000|STARTED|Blinded Active Extension Period||0
6533148|NCT01628393|7454992|FG001|STARTED|Blinded Active Extension Period||85
6533149|NCT01628393|7454993|FG002|STARTED|Blinded Active Extension Period||81
6533150|NCT01628393|7454994|FG003|STARTED|Blinded Active Extension Period||41
6533151|NCT01628393|7454995|FG004|STARTED|Blinded Active Extension Period||42
6533152|NCT01628393|7454991|FG000|COMPLETED|Blinded Active Extension Period||0
6533153|NCT01628393|7454992|FG001|COMPLETED|Blinded Active Extension Period||75
6533154|NCT01628393|7454993|FG002|COMPLETED|Blinded Active Extension Period||75
6533155|NCT01628393|7454994|FG003|COMPLETED|Blinded Active Extension Period||37
6533156|NCT01628393|7454995|FG004|COMPLETED|Blinded Active Extension Period||36
6533157|NCT01628393|7454991|FG000|NOT COMPLETED|Blinded Active Extension Period||0
6533158|NCT01628393|7454992|FG001|NOT COMPLETED|Blinded Active Extension Period||10
6533159|NCT01628393|7454993|FG002|NOT COMPLETED|Blinded Active Extension Period||6
6533160|NCT01628393|7454994|FG003|NOT COMPLETED|Blinded Active Extension Period||4
6533161|NCT01628393|7454995|FG004|NOT COMPLETED|Blinded Active Extension Period||6
6533162|NCT01628510|7455011|FG000|STARTED|Overall Study||51
6533163|NCT01628510|7455012|FG001|STARTED|Overall Study||49
6533164|NCT01628510|7455011|FG000|COMPLETED|Overall Study||48
6533165|NCT01628510|7455012|FG001|COMPLETED|Overall Study||44
6533166|NCT01628510|7455011|FG000|NOT COMPLETED|Overall Study||3
6533167|NCT01628510|7455012|FG001|NOT COMPLETED|Overall Study||5
6533168|NCT01628523|7455020|FG000|STARTED|Overall Study||219
6533169|NCT01628523|7455020|FG000|COMPLETED|Overall Study||219
6533170|NCT01628523|7455020|FG000|NOT COMPLETED|Overall Study||0
6533171|NCT01628549|7455029|FG000|STARTED|Overall Study||73
6533172|NCT01628549|7455030|FG001|STARTED|Overall Study||76
6533173|NCT01628549|7455031|FG002|STARTED|Overall Study||70
6533174|NCT01628549|7455032|FG003|STARTED|Overall Study||66
6533175|NCT01628549|7455029|FG000|COMPLETED|Overall Study||64
6533176|NCT01628549|7455030|FG001|COMPLETED|Overall Study||64
6533177|NCT01628549|7455031|FG002|COMPLETED|Overall Study||60
6533178|NCT01628549|7455032|FG003|COMPLETED|Overall Study||57
6533179|NCT01628549|7455029|FG000|NOT COMPLETED|Overall Study||9
6533180|NCT01628549|7455030|FG001|NOT COMPLETED|Overall Study||12
6533181|NCT01628549|7455031|FG002|NOT COMPLETED|Overall Study||10
6533182|NCT01628549|7455032|FG003|NOT COMPLETED|Overall Study||9
6533183|NCT01628588|7455042|FG000|STARTED|Overall Study||854
6533184|NCT01628588|7455042|FG000|COMPLETED|Overall Study||838
6533185|NCT01628588|7455042|FG000|NOT COMPLETED|Overall Study||16
6533186|NCT01628601|7455046|FG000|STARTED|Overall Study||392
6533187|NCT01628601|7455046|FG000|COMPLETED|Overall Study||351
6533188|NCT01628601|7455046|FG000|NOT COMPLETED|Overall Study||41
6533189|NCT01628614|7455050|FG000|STARTED|Overall Study||4812
6533190|NCT01628614|7455050|FG000|COMPLETED|Overall Study||3037
6533191|NCT01628614|7455050|FG000|NOT COMPLETED|Overall Study||1775
6533192|NCT01628692|7455060|FG000|STARTED|Overall Study||53
6533193|NCT01628692|7455061|FG001|STARTED|Overall Study||23
6533194|NCT01628692|7455062|FG002|STARTED|Overall Study||51
6533195|NCT01628692|7455063|FG003|STARTED|Overall Study||20
6533196|NCT01628692|7455064|FG004|STARTED|Overall Study||12
6533197|NCT01628692|7455065|FG005|STARTED|Overall Study||9
6533198|NCT01628692|7455060|FG000|COMPLETED|Overall Study||46
6533199|NCT01628692|7455061|FG001|COMPLETED|Overall Study||17
6533200|NCT01628692|7455062|FG002|COMPLETED|Overall Study||43
6533201|NCT01628692|7455063|FG003|COMPLETED|Overall Study||19
6533202|NCT01628692|7455064|FG004|COMPLETED|Overall Study||8
6533203|NCT01628692|7455065|FG005|COMPLETED|Overall Study||0
6533204|NCT01628692|7455060|FG000|NOT COMPLETED|Overall Study||7
6533205|NCT01628692|7455061|FG001|NOT COMPLETED|Overall Study||6
6533206|NCT01628692|7455062|FG002|NOT COMPLETED|Overall Study||8
6533207|NCT01628692|7455063|FG003|NOT COMPLETED|Overall Study||1
6533208|NCT01628692|7455064|FG004|NOT COMPLETED|Overall Study||4
6533209|NCT01628692|7455065|FG005|NOT COMPLETED|Overall Study||9
6533210|NCT01628718|7455084|FG000|STARTED|Overall Study||60
6533211|NCT01628718|7455085|FG001|STARTED|Overall Study||62
6533212|NCT01628718|7455084|FG000|COMPLETED|Overall Study||33
6533213|NCT01628718|7455085|FG001|COMPLETED|Overall Study||37
6533214|NCT01628718|7455084|FG000|NOT COMPLETED|Overall Study||27
6533215|NCT01628718|7455085|FG001|NOT COMPLETED|Overall Study||25
6533216|NCT01628848|7455093|FG000|STARTED|Overall Study||87
6533217|NCT01628848|7455094|FG001|STARTED|Overall Study||87
6533218|NCT01628848|7455093|FG000|COMPLETED|Overall Study||75
6533219|NCT01628848|7455094|FG001|COMPLETED|Overall Study||73
6533220|NCT01628848|7455093|FG000|NOT COMPLETED|Overall Study||12
6533221|NCT01628848|7455094|FG001|NOT COMPLETED|Overall Study||14
6533222|NCT01628874|7455102|FG000|STARTED|Overall Study||34
6533223|NCT01628874|7455103|FG001|STARTED|Overall Study||32
6533224|NCT01628874|7455102|FG000|COMPLETED|Overall Study||29
6533225|NCT01628874|7455103|FG001|COMPLETED|Overall Study||29
6533226|NCT01628874|7455102|FG000|NOT COMPLETED|Overall Study||5
6533227|NCT01628874|7455103|FG001|NOT COMPLETED|Overall Study||3
6533228|NCT01628913|7455111|FG000|STARTED|Overall Study||31
6533229|NCT01628913|7455112|FG001|STARTED|Overall Study||31
6533230|NCT01628913|7455111|FG000|COMPLETED|Overall Study||0
6533231|NCT01628913|7455112|FG001|COMPLETED|Overall Study||0
6533232|NCT01628913|7455111|FG000|NOT COMPLETED|Overall Study||31
6533233|NCT01628913|7455112|FG001|NOT COMPLETED|Overall Study||31
6533234|NCT01628926|7455121|FG000|STARTED|Overall Study||168
6533235|NCT01628926|7455122|FG001|STARTED|Overall Study||167
6533236|NCT01628926|7455123|FG002|STARTED|Overall Study||85
6533237|NCT01628926|7455121|FG000|COMPLETED|Overall Study||142
6533238|NCT01628926|7455122|FG001|COMPLETED|Overall Study||144
6533239|NCT01628926|7455123|FG002|COMPLETED|Overall Study||68
6533240|NCT01628926|7455121|FG000|NOT COMPLETED|Overall Study||26
6533241|NCT01628926|7455122|FG001|NOT COMPLETED|Overall Study||23
6533242|NCT01628926|7455123|FG002|NOT COMPLETED|Overall Study||17
6533243|NCT01628965|7455132|FG000|STARTED|Overall Study||143
6533244|NCT01628965|7455132|FG000|COMPLETED|Overall Study||94
6533245|NCT01628965|7455132|FG000|NOT COMPLETED|Overall Study||49
6533246|NCT01629134|7455136|FG000|STARTED|Overall Study||62
6533247|NCT01629134|7455136|FG000|COMPLETED|Overall Study||62
6533248|NCT01629134|7455136|FG000|NOT COMPLETED|Overall Study||0
6533249|NCT01629290|7455140|FG000|STARTED|Overall Study||15
6533250|NCT01629290|7455140|FG000|COMPLETED|Overall Study||15
6533251|NCT01629290|7455140|FG000|NOT COMPLETED|Overall Study||0
6533252|NCT01629381|7455152|FG000|STARTED|Overall Study||122
6533253|NCT01629381|7455153|FG001|STARTED|Overall Study||119
6533254|NCT01629381|7455152|FG000|COMPLETED|Overall Study||120
6533255|NCT01629381|7455153|FG001|COMPLETED|Overall Study||114
6533256|NCT01629381|7455152|FG000|NOT COMPLETED|Overall Study||2
6533257|NCT01629381|7455153|FG001|NOT COMPLETED|Overall Study||5
6533258|NCT01629563|7455165|FG000|STARTED|Overall Study||228
6533259|NCT01629563|7455166|FG001|STARTED|Overall Study|2 subjects randomised to 10mg received 5mg treatment in error (FAS 1: 10mg, Safety Set: 5mg)|223
6533260|NCT01629563|7455165|FG000|Safety Population|Overall Study||230
6533261|NCT01629563|7455166|FG001|Safety Population|Overall Study||221
6533262|NCT01629563|7455165|FG000|Started Treatment Course 2|Overall Study||213
6533263|NCT01629563|7455166|FG001|Started Treatment Course 2|Overall Study||207
6533264|NCT01629563|7455165|FG000|Started Treatment Course 3|Overall Study||191
6533265|NCT01629563|7455166|FG001|Started Treatment Course 3|Overall Study||190
6533266|NCT01629563|7455165|FG000|Started Treatment Course 4|Overall Study||178
6533267|NCT01629563|7455166|FG001|Started Treatment Course 4|Overall Study||176
6533268|NCT01629563|7455165|FG000|COMPLETED|Overall Study||167
6533269|NCT01629563|7455166|FG001|COMPLETED|Overall Study||170
6533270|NCT01629563|7455165|FG000|NOT COMPLETED|Overall Study||61
6533271|NCT01629563|7455166|FG001|NOT COMPLETED|Overall Study||53
6533272|NCT01629589|7455174|FG000|STARTED|Overall Study||212
6533273|NCT01629589|7455175|FG001|STARTED|Overall Study||211
6533274|NCT01629589|7455174|FG000|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
6533275|NCT01629589|7455175|FG001|COMPLETED|Overall Study||204
6533276|NCT01629589|7455174|FG000|NOT COMPLETED|Overall Study||8
6533277|NCT01629589|7455175|FG001|NOT COMPLETED|Overall Study||7
6533278|NCT01629615|7455181|FG000|STARTED|Overall Study||50
6533279|NCT01629615|7455181|FG000|COMPLETED|Overall Study||50
6533280|NCT01629615|7455181|FG000|NOT COMPLETED|Overall Study||0
6533281|NCT01629667|7455188|FG000|STARTED|Overall Study||59
6533282|NCT01629667|7455189|FG001|STARTED|Overall Study||58
6533283|NCT01629667|7455190|FG002|STARTED|Overall Study||59
6533284|NCT01629667|7455188|FG000|Randomized and Treated|Overall Study||57
6533285|NCT01629667|7455189|FG001|Randomized and Treated|Overall Study||57
6533286|NCT01629667|7455190|FG002|Randomized and Treated|Overall Study||59
6533287|NCT01629667|7455188|FG000|COMPLETED|Overall Study||12
6533288|NCT01629667|7455189|FG001|COMPLETED|Overall Study||17
6533289|NCT01629667|7455190|FG002|COMPLETED|Overall Study||14
6533290|NCT01629667|7455188|FG000|NOT COMPLETED|Overall Study||47
6533291|NCT01629667|7455189|FG001|NOT COMPLETED|Overall Study||41
6533292|NCT01629667|7455190|FG002|NOT COMPLETED|Overall Study||45
6533293|NCT01629693|7455202|FG000|STARTED|Overall Study||193
6533294|NCT01629693|7455203|FG001|STARTED|Overall Study||188
6533295|NCT01629693|7455202|FG000|COMPLETED|Overall Study||188
6533296|NCT01629693|7455203|FG001|COMPLETED|Overall Study||178
6533297|NCT01629693|7455202|FG000|NOT COMPLETED|Overall Study||5
6533298|NCT01629693|7455203|FG001|NOT COMPLETED|Overall Study||10
6533299|NCT01629706|7455209|FG000|STARTED|Phase 1 PureVision||44
6533300|NCT01629706|7455209|FG000|COMPLETED|Phase 1 PureVision||35
6533301|NCT01629706|7455209|FG000|NOT COMPLETED|Phase 1 PureVision||9
6533302|NCT01629706|7455209|FG000|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
6533303|NCT01629706|7455209|FG000|COMPLETED|Phase 2 Habitual||48
6533304|NCT01629706|7455209|FG000|NOT COMPLETED|Phase 2 Habitual||10
6533305|NCT01629771|7455219|FG000|STARTED|Overall Study||36
6533306|NCT01629771|7455220|FG001|STARTED|Overall Study||36
6533307|NCT01629771|7455219|FG000|COMPLETED|Overall Study||36
6533308|NCT01629771|7455220|FG001|COMPLETED|Overall Study||36
6533309|NCT01629771|7455219|FG000|NOT COMPLETED|Overall Study||0
6533310|NCT01629771|7455220|FG001|NOT COMPLETED|Overall Study||0
6533311|NCT01629784|7455226|FG000|STARTED|Overall Study||31
6533312|NCT01629784|7455226|FG000|COMPLETED|Overall Study||25
6533313|NCT01629784|7455226|FG000|NOT COMPLETED|Overall Study||6
6533314|NCT01629797|7455233|FG000|STARTED|Overall Study||100
6533315|NCT01629797|7455233|FG000|COMPLETED|Overall Study||82
6533316|NCT01629797|7455233|FG000|NOT COMPLETED|Overall Study||18
6533317|NCT01629823|7455243|FG000|STARTED|Trial Period||66
6533318|NCT01629823|7455244|FG001|STARTED|Trial Period||69
6533319|NCT01629823|7455245|FG002|STARTED|Trial Period||59
6533320|NCT01629823|7455243|FG000|COMPLETED|Trial Period||53
6533321|NCT01629823|7455244|FG001|COMPLETED|Trial Period||56
6533322|NCT01629823|7455245|FG002|COMPLETED|Trial Period||49
6533323|NCT01629823|7455243|FG000|NOT COMPLETED|Trial Period||13
6533324|NCT01629823|7455244|FG001|NOT COMPLETED|Trial Period||13
6533325|NCT01629823|7455245|FG002|NOT COMPLETED|Trial Period||10
6533326|NCT01629823|7455243|FG000|STARTED|Washout Period||54
6533327|NCT01629823|7455244|FG001|STARTED|Washout Period||57
6533328|NCT01629823|7455245|FG002|STARTED|Washout Period||50
6533329|NCT01629823|7455243|FG000|COMPLETED|Washout Period||51
6533330|NCT01629823|7455244|FG001|COMPLETED|Washout Period||51
6533331|NCT01629823|7455245|FG002|COMPLETED|Washout Period||50
6533332|NCT01629823|7455243|FG000|NOT COMPLETED|Washout Period||3
6533333|NCT01629823|7455244|FG001|NOT COMPLETED|Washout Period||6
6533334|NCT01629823|7455245|FG002|NOT COMPLETED|Washout Period||0
6533335|NCT01629862|7455255|FG000|STARTED|Overall Study||28
6533336|NCT01629862|7455256|FG001|STARTED|Overall Study||25
6533337|NCT01629862|7455255|FG000|COMPLETED|Overall Study||26
6533338|NCT01629862|7455256|FG001|COMPLETED|Overall Study||23
6533339|NCT01629862|7455255|FG000|NOT COMPLETED|Overall Study||2
6533340|NCT01629862|7455256|FG001|NOT COMPLETED|Overall Study||2
6533341|NCT01629953|7455264|FG000|STARTED|Overall Study||65
6533342|NCT01629953|7455265|FG001|STARTED|Overall Study||75
6533343|NCT01629953|7455264|FG000|COMPLETED|Overall Study||52
6533344|NCT01629953|7455265|FG001|COMPLETED|Overall Study||60
6533345|NCT01629953|7455264|FG000|NOT COMPLETED|Overall Study||13
6533346|NCT01629953|7455265|FG001|NOT COMPLETED|Overall Study||15
6533347|NCT01629966|7455274|FG000|STARTED|Overall Study||221
6533348|NCT01629966|7455275|FG001|STARTED|Overall Study||227
6533349|NCT01629966|7455276|FG002|STARTED|Overall Study||225
6533350|NCT01629966|7455274|FG000|COMPLETED|Overall Study||180
6533351|NCT01629966|7455275|FG001|COMPLETED|Overall Study||175
6533352|NCT01629966|7455276|FG002|COMPLETED|Overall Study||159
6533353|NCT01629966|7455274|FG000|NOT COMPLETED|Overall Study||41
6533354|NCT01629966|7455275|FG001|NOT COMPLETED|Overall Study||52
6533355|NCT01629966|7455276|FG002|NOT COMPLETED|Overall Study||66
6533356|NCT01630109|7455287|FG000|STARTED|Overall Study||1
6533357|NCT01630109|7455288|FG001|STARTED|Overall Study||1
6533358|NCT01630109|7455289|FG002|STARTED|Overall Study||3
6533359|NCT01630109|7455287|FG000|COMPLETED|Overall Study||1
6533360|NCT01630109|7455288|FG001|COMPLETED|Overall Study||1
6533361|NCT01630109|7455289|FG002|COMPLETED|Overall Study||3
6533362|NCT01630109|7455287|FG000|NOT COMPLETED|Overall Study||0
6533363|NCT01630109|7455288|FG001|NOT COMPLETED|Overall Study||0
6533364|NCT01630109|7455289|FG002|NOT COMPLETED|Overall Study||0
6533365|NCT01630135|7455305|FG000|STARTED|Overall Study||131
6644567|NCT02364570|7573193|FG007|COMPLETED|Overall Study||1
6644568|NCT02364570|7573194|FG008|COMPLETED|Overall Study||2
6644569|NCT02364570|7573195|FG009|COMPLETED|Overall Study||1
6644570|NCT02364570|7573196|FG010|COMPLETED|Overall Study||1
6644571|NCT02364570|7573197|FG011|COMPLETED|Overall Study||1
6644572|NCT02364570|7573198|FG012|COMPLETED|Overall Study||1
6644573|NCT02364570|7573199|FG013|COMPLETED|Overall Study||2
6644574|NCT02364570|7573200|FG014|COMPLETED|Overall Study||1
6644575|NCT02364570|7573201|FG015|COMPLETED|Overall Study||1
6644576|NCT02364570|7573186|FG000|NOT COMPLETED|Overall Study||0
6644577|NCT02364570|7573187|FG001|NOT COMPLETED|Overall Study||0
6644578|NCT02364570|7573188|FG002|NOT COMPLETED|Overall Study||0
6533366|NCT01630135|7455306|FG001|STARTED|Overall Study||130
6533367|NCT01630135|7455305|FG000|COMPLETED|Overall Study||131
6533368|NCT01630135|7455306|FG001|COMPLETED|Overall Study||128
6644579|NCT02364570|7573189|FG003|NOT COMPLETED|Overall Study||0
6644580|NCT02364570|7573190|FG004|NOT COMPLETED|Overall Study||0
6644581|NCT02364570|7573191|FG005|NOT COMPLETED|Overall Study||0
6644582|NCT02364570|7573192|FG006|NOT COMPLETED|Overall Study||0
6644583|NCT02364570|7573193|FG007|NOT COMPLETED|Overall Study||0
6644584|NCT02364570|7573194|FG008|NOT COMPLETED|Overall Study||0
6644585|NCT02364570|7573195|FG009|NOT COMPLETED|Overall Study||0
6644586|NCT02364570|7573196|FG010|NOT COMPLETED|Overall Study||0
6533369|NCT01630135|7455305|FG000|NOT COMPLETED|Overall Study||0
6533370|NCT01630135|7455306|FG001|NOT COMPLETED|Overall Study||2
6533371|NCT01630200|7455314|FG000|STARTED|Overall Study||40
6533372|NCT01630200|7455315|FG001|STARTED|Overall Study||40
6533373|NCT01630200|7455314|FG000|COMPLETED|Overall Study||33
6533374|NCT01630200|7455315|FG001|COMPLETED|Overall Study||34
6533375|NCT01630200|7455314|FG000|NOT COMPLETED|Overall Study||7
6533376|NCT01630200|7455315|FG001|NOT COMPLETED|Overall Study||6
6533377|NCT01630616|7455327|FG000|STARTED|Overall Study||5
6533378|NCT01630616|7455328|FG001|STARTED|Overall Study||3
6533379|NCT01630616|7455329|FG002|STARTED|Overall Study||3
6533380|NCT01630616|7455330|FG003|STARTED|Overall Study||12
6533381|NCT01630616|7455331|FG004|STARTED|Overall Study||6
6533382|NCT01630616|7455332|FG005|STARTED|Overall Study||2
6533383|NCT01630616|7455327|FG000|COMPLETED|Overall Study||5
6533384|NCT01630616|7455328|FG001|COMPLETED|Overall Study||3
6644587|NCT02364570|7573197|FG011|NOT COMPLETED|Overall Study||0
6644588|NCT02364570|7573198|FG012|NOT COMPLETED|Overall Study||0
6644589|NCT02364570|7573199|FG013|NOT COMPLETED|Overall Study||0
6533385|NCT01630616|7455329|FG002|COMPLETED|Overall Study||3
6533386|NCT01630616|7455330|FG003|COMPLETED|Overall Study||9
6533387|NCT01630616|7455331|FG004|COMPLETED|Overall Study||6
6533388|NCT01630616|7455332|FG005|COMPLETED|Overall Study||2
6533389|NCT01630616|7455327|FG000|NOT COMPLETED|Overall Study||0
6533390|NCT01630616|7455328|FG001|NOT COMPLETED|Overall Study||0
6533391|NCT01630616|7455329|FG002|NOT COMPLETED|Overall Study||0
6533392|NCT01630616|7455330|FG003|NOT COMPLETED|Overall Study||3
6533393|NCT01630616|7455331|FG004|NOT COMPLETED|Overall Study||0
6533394|NCT01630616|7455332|FG005|NOT COMPLETED|Overall Study||0
6533395|NCT01630694|7455351|FG000|STARTED|Overall Study||12
6533396|NCT01630694|7455352|FG001|STARTED|Overall Study||16
6533397|NCT01630694|7455351|FG000|COMPLETED|Overall Study||12
6533398|NCT01630694|7455352|FG001|COMPLETED|Overall Study||16
6533399|NCT01630694|7455351|FG000|NOT COMPLETED|Overall Study||0
6533400|NCT01630694|7455352|FG001|NOT COMPLETED|Overall Study||0
6533401|NCT01630811|7455358|FG000|STARTED|First Intervention (8 Weeks)||7
6533402|NCT01630811|7455359|FG001|STARTED|First Intervention (8 Weeks)||6
6533403|NCT01630811|7455358|FG000|COMPLETED|First Intervention (8 Weeks)||7
6533404|NCT01630811|7455359|FG001|COMPLETED|First Intervention (8 Weeks)||6
6533405|NCT01630811|7455358|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
6533406|NCT01630811|7455359|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
6533407|NCT01630811|7455358|FG000|STARTED|Washout (4 Weeks)||7
6533408|NCT01630811|7455359|FG001|STARTED|Washout (4 Weeks)||6
6533409|NCT01630811|7455358|FG000|COMPLETED|Washout (4 Weeks)||7
6533410|NCT01630811|7455359|FG001|COMPLETED|Washout (4 Weeks)||6
6533411|NCT01630811|7455358|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6533412|NCT01630811|7455359|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6533413|NCT01630811|7455358|FG000|STARTED|Second Intervention (8 Weeks)||7
6533414|NCT01630811|7455359|FG001|STARTED|Second Intervention (8 Weeks)||6
6533415|NCT01630811|7455358|FG000|COMPLETED|Second Intervention (8 Weeks)||6
6533416|NCT01630811|7455359|FG001|COMPLETED|Second Intervention (8 Weeks)||6
6644590|NCT02364570|7573200|FG014|NOT COMPLETED|Overall Study||0
6644591|NCT02364570|7573201|FG015|NOT COMPLETED|Overall Study||0
6644592|NCT02364700|7573211|FG000|STARTED|Overall Study||12
6644593|NCT02364700|7573211|FG000|COMPLETED|Overall Study||12
6644594|NCT02364700|7573211|FG000|NOT COMPLETED|Overall Study||0
6644595|NCT02364778|7573217|FG000|STARTED|Overall Study||30
6644596|NCT02364778|7573217|FG000|COMPLETED|Overall Study||30
6644597|NCT02364778|7573217|FG000|NOT COMPLETED|Overall Study||0
6644598|NCT02364947|7573226|FG000|STARTED|Overall Study||248
6644599|NCT02364947|7573227|FG001|STARTED|Overall Study||184
6644600|NCT02364947|7573228|FG002|STARTED|Overall Study||245
6644601|NCT02364947|7573226|FG000|COMPLETED|Overall Study||189
6644602|NCT02364947|7573227|FG001|COMPLETED|Overall Study||139
6644603|NCT02364947|7573228|FG002|COMPLETED|Overall Study||219
6644604|NCT02364947|7573226|FG000|NOT COMPLETED|Overall Study||59
6644605|NCT02364947|7573227|FG001|NOT COMPLETED|Overall Study||45
6644606|NCT02364947|7573228|FG002|NOT COMPLETED|Overall Study||26
6644607|NCT02364999|7573238|FG000|STARTED|Overall Study||358
6644608|NCT02364999|7573239|FG001|STARTED|Overall Study||361
6644609|NCT02364999|7573238|FG000|Received Treatment|Overall Study||356
6644610|NCT02364999|7573239|FG001|Received Treatment|Overall Study||358
6644611|NCT02364999|7573238|FG000|COMPLETED|Overall Study||193
6644612|NCT02364999|7573239|FG001|COMPLETED|Overall Study||188
6644613|NCT02364999|7573238|FG000|NOT COMPLETED|Overall Study||165
6644614|NCT02364999|7573239|FG001|NOT COMPLETED|Overall Study||173
6644615|NCT02365064|7573248|FG000|STARTED|Overall Study||31
6644616|NCT02365064|7573249|FG001|STARTED|Overall Study||47
6644617|NCT02365064|7573248|FG000|Included in ITT Analysis|Overall Study||29
6644618|NCT02365064|7573249|FG001|Included in ITT Analysis|Overall Study||32
6644619|NCT02365064|7573248|FG000|COMPLETED|Overall Study||21
6644620|NCT02365064|7573249|FG001|COMPLETED|Overall Study||19
6644621|NCT02365064|7573248|FG000|NOT COMPLETED|Overall Study||10
6644622|NCT02365064|7573249|FG001|NOT COMPLETED|Overall Study||28
6644623|NCT02365285|7573259|FG000|STARTED|Overall Study||7
6644624|NCT02365285|7573260|FG001|STARTED|Overall Study||6
6644625|NCT02365285|7573261|FG002|STARTED|Overall Study||7
6644626|NCT02365285|7573262|FG003|STARTED|Overall Study||3
6644627|NCT02365285|7573259|FG000|COMPLETED|Overall Study||7
6644628|NCT02365285|7573260|FG001|COMPLETED|Overall Study||5
6644629|NCT02365285|7573261|FG002|COMPLETED|Overall Study||6
6644630|NCT02365285|7573262|FG003|COMPLETED|Overall Study||1
6533417|NCT01630811|7455358|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||1
6533418|NCT01630811|7455359|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
6533419|NCT01630811|7455358|FG000|STARTED|Second Washout (4 Weeks)||6
6533420|NCT01630811|7455359|FG001|STARTED|Second Washout (4 Weeks)||6
6533421|NCT01630811|7455358|FG000|COMPLETED|Second Washout (4 Weeks)||6
6533422|NCT01630811|7455359|FG001|COMPLETED|Second Washout (4 Weeks)||6
6533423|NCT01630811|7455358|FG000|NOT COMPLETED|Second Washout (4 Weeks)||0
6533424|NCT01630811|7455359|FG001|NOT COMPLETED|Second Washout (4 Weeks)||0
6533425|NCT01630889|7455367|FG000|STARTED|Overall Study||15
6533426|NCT01630889|7455367|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
6533427|NCT01630889|7455367|FG000|COMPLETED|Overall Study||5
6533428|NCT01630889|7455367|FG000|NOT COMPLETED|Overall Study||10
6533429|NCT01631071|7455373|FG000|STARTED|Overall Study||55
6644631|NCT02365285|7573259|FG000|NOT COMPLETED|Overall Study||0
6533430|NCT01631071|7455374|FG001|STARTED|Overall Study||55
6533431|NCT01631071|7455373|FG000|COMPLETED|Overall Study||55
6644632|NCT02365285|7573260|FG001|NOT COMPLETED|Overall Study||1
6644633|NCT02365285|7573261|FG002|NOT COMPLETED|Overall Study||1
6533432|NCT01631071|7455374|FG001|COMPLETED|Overall Study||55
6533433|NCT01631071|7455373|FG000|NOT COMPLETED|Overall Study||0
6533434|NCT01631071|7455374|FG001|NOT COMPLETED|Overall Study||0
6533435|NCT01631110|7455382|FG000|STARTED|Overall Study||55
6533436|NCT01631110|7455383|FG001|STARTED|Overall Study||55
6533437|NCT01631110|7455382|FG000|COMPLETED|Overall Study||55
6533438|NCT01631110|7455383|FG001|COMPLETED|Overall Study||55
6533439|NCT01631110|7455382|FG000|NOT COMPLETED|Overall Study||0
6533440|NCT01631110|7455383|FG001|NOT COMPLETED|Overall Study||0
6533441|NCT01631149|7455391|FG000|STARTED|Overall Study||12
6533442|NCT01631149|7455392|FG001|STARTED|Overall Study||12
6533443|NCT01631149|7455391|FG000|COMPLETED|Overall Study||12
6533444|NCT01631149|7455392|FG001|COMPLETED|Overall Study||12
6533445|NCT01631149|7455391|FG000|NOT COMPLETED|Overall Study||0
6533446|NCT01631149|7455392|FG001|NOT COMPLETED|Overall Study||0
6533447|NCT01631188|7455398|FG000|STARTED|Overall Study||100
6533448|NCT01631188|7455398|FG000|COMPLETED|Overall Study||25
6533449|NCT01631188|7455398|FG000|NOT COMPLETED|Overall Study||75
6533450|NCT01631214|7455404|FG000|STARTED|Overall Study||2047
6533451|NCT01631214|7455405|FG001|STARTED|Overall Study||2046
6533452|NCT01631214|7455404|FG000|Received Double-blind Treatment|Overall Study||2040
6533453|NCT01631214|7455405|FG001|Received Double-blind Treatment|Overall Study||2038
6533454|NCT01631214|7455404|FG000|Completed Double-blind Period|Overall Study||1823
6533455|NCT01631214|7455405|FG001|Completed Double-blind Period|Overall Study||1831
6533456|NCT01631214|7455404|FG000|Completed Primary Analysis Period|Overall Study||1576
6533457|NCT01631214|7455405|FG001|Completed Primary Analysis Period|Overall Study||1574
6533458|NCT01631214|7455404|FG000|COMPLETED|Overall Study||1503
6533459|NCT01631214|7455405|FG001|COMPLETED|Overall Study||1523
6533460|NCT01631214|7455404|FG000|NOT COMPLETED|Overall Study||544
6533461|NCT01631214|7455405|FG001|NOT COMPLETED|Overall Study||523
6533462|NCT01631227|7455415|FG000|STARTED|Overall Study||333
6533463|NCT01631227|7455416|FG001|STARTED|Overall Study||332
6533464|NCT01631227|7455415|FG000|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
6533465|NCT01631227|7455416|FG001|Safety Subject Sample|Overall Study||332
6533466|NCT01631227|7455415|FG000|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
6533467|NCT01631227|7455416|FG001|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
6533468|NCT01631227|7455415|FG000|COMPLETED|Overall Study||303
6533469|NCT01631227|7455416|FG001|COMPLETED|Overall Study||310
6533470|NCT01631227|7455415|FG000|NOT COMPLETED|Overall Study||30
6533471|NCT01631227|7455416|FG001|NOT COMPLETED|Overall Study||22
6533472|NCT01631331|7455422|FG000|STARTED|Overall Study||15
6533473|NCT01631331|7455422|FG000|COMPLETED|Overall Study||11
6533474|NCT01631331|7455422|FG000|NOT COMPLETED|Overall Study||4
6533475|NCT01631435|7455427|FG000|STARTED|Overall Study||75
6533476|NCT01631435|7455427|FG000|COMPLETED|Overall Study||66
6533477|NCT01631435|7455427|FG000|NOT COMPLETED|Overall Study||9
6533478|NCT01631474|7455437|FG000|STARTED|Overall Study||72
6644634|NCT02365285|7573262|FG003|NOT COMPLETED|Overall Study||2
6644635|NCT02365298|7573274|FG000|STARTED|Period 1||14
6644636|NCT02365298|7573275|FG001|STARTED|Period 1||14
6644637|NCT02365298|7573274|FG000|COMPLETED|Period 1||14
6644638|NCT02365298|7573275|FG001|COMPLETED|Period 1||14
6644639|NCT02365298|7573274|FG000|NOT COMPLETED|Period 1||0
6644640|NCT02365298|7573275|FG001|NOT COMPLETED|Period 1||0
6644641|NCT02365298|7573274|FG000|STARTED|Period 2||14
6644642|NCT02365298|7573275|FG001|STARTED|Period 2||14
6644643|NCT02365298|7573274|FG000|COMPLETED|Period 2||12
6644644|NCT02365298|7573275|FG001|COMPLETED|Period 2||12
6644645|NCT02365298|7573274|FG000|NOT COMPLETED|Period 2||2
6644646|NCT02365298|7573275|FG001|NOT COMPLETED|Period 2||2
6644647|NCT02365480|7573283|FG000|STARTED|Overall Study||14
6644648|NCT02365480|7573284|FG001|STARTED|Overall Study||4
6644649|NCT02365480|7573283|FG000|COMPLETED|Overall Study||12
6644650|NCT02365480|7573284|FG001|COMPLETED|Overall Study||4
6644651|NCT02365480|7573283|FG000|NOT COMPLETED|Overall Study||2
6644652|NCT02365480|7573284|FG001|NOT COMPLETED|Overall Study||0
6644653|NCT02365506|7573293|FG000|STARTED|Overall Study||4
6644654|NCT02365506|7573294|FG001|STARTED|Overall Study||4
6644655|NCT02365506|7573295|FG002|STARTED|Overall Study||5
6644656|NCT02365506|7573293|FG000|COMPLETED|Overall Study||4
6644657|NCT02365506|7573294|FG001|COMPLETED|Overall Study||4
6644658|NCT02365506|7573295|FG002|COMPLETED|Overall Study||4
6533479|NCT01631474|7455438|FG001|STARTED|Overall Study||76
6533480|NCT01631474|7455439|FG002|STARTED|Overall Study||70
6533481|NCT01631474|7455440|FG003|STARTED|Overall Study||70
6533482|NCT01631474|7455441|FG004|STARTED|Overall Study||75
6533483|NCT01631474|7455437|FG000|COMPLETED|Overall Study||58
6533484|NCT01631474|7455438|FG001|COMPLETED|Overall Study||64
6533485|NCT01631474|7455439|FG002|COMPLETED|Overall Study||61
6533486|NCT01631474|7455440|FG003|COMPLETED|Overall Study||59
6533487|NCT01631474|7455441|FG004|COMPLETED|Overall Study||62
6533488|NCT01631474|7455437|FG000|NOT COMPLETED|Overall Study||14
6644659|NCT02365506|7573293|FG000|NOT COMPLETED|Overall Study||0
6644660|NCT02365506|7573294|FG001|NOT COMPLETED|Overall Study||0
6533489|NCT01631474|7455438|FG001|NOT COMPLETED|Overall Study||12
6533490|NCT01631474|7455439|FG002|NOT COMPLETED|Overall Study||9
6533491|NCT01631474|7455440|FG003|NOT COMPLETED|Overall Study||11
6533492|NCT01631474|7455441|FG004|NOT COMPLETED|Overall Study||13
6533493|NCT01631552|7455457|FG000|STARTED|Overall Study||83
6644661|NCT02365506|7573295|FG002|NOT COMPLETED|Overall Study||1
6533494|NCT01631552|7455458|FG001|STARTED|Overall Study||420
6533495|NCT01631552|7455459|FG002|STARTED|Overall Study||9
6533496|NCT01631552|7455460|FG003|STARTED|Overall Study||3
6533497|NCT01631552|7455457|FG000|Enrolled and Treated|Overall Study||81
6533498|NCT01631552|7455458|FG001|Enrolled and Treated|Overall Study||402
6533499|NCT01631552|7455459|FG002|Enrolled and Treated|Overall Study||9
6533500|NCT01631552|7455460|FG003|Enrolled and Treated|Overall Study||3
6533501|NCT01631552|7455457|FG000|COMPLETED|Overall Study||81
6533502|NCT01631552|7455458|FG001|COMPLETED|Overall Study||400
6533503|NCT01631552|7455459|FG002|COMPLETED|Overall Study||9
6533504|NCT01631552|7455460|FG003|COMPLETED|Overall Study||3
6533505|NCT01631552|7455457|FG000|NOT COMPLETED|Overall Study||2
6533506|NCT01631552|7455458|FG001|NOT COMPLETED|Overall Study||20
6533507|NCT01631552|7455459|FG002|NOT COMPLETED|Overall Study||0
6533508|NCT01631552|7455460|FG003|NOT COMPLETED|Overall Study||0
6533509|NCT01631630|7455474|FG000|STARTED|Overall Study||8
6533510|NCT01631630|7455475|FG001|STARTED|Overall Study||8
6533511|NCT01631630|7455474|FG000|COMPLETED|Overall Study||5
6533512|NCT01631630|7455475|FG001|COMPLETED|Overall Study||8
6533513|NCT01631630|7455474|FG000|NOT COMPLETED|Overall Study||3
6533514|NCT01631630|7455475|FG001|NOT COMPLETED|Overall Study||0
6533515|NCT01631656|7455483|FG000|STARTED|Overall Study||5
6533516|NCT01631656|7455484|FG001|STARTED|Overall Study||5
6533517|NCT01631656|7455483|FG000|COMPLETED|Overall Study||5
6533518|NCT01631656|7455484|FG001|COMPLETED|Overall Study||5
6533519|NCT01631656|7455483|FG000|NOT COMPLETED|Overall Study||0
6533520|NCT01631656|7455484|FG001|NOT COMPLETED|Overall Study||0
6533521|NCT01631682|7455494|FG000|STARTED|Overall Study||55
6533522|NCT01631682|7455495|FG001|STARTED|Overall Study||66
6533523|NCT01631682|7455496|FG002|STARTED|Overall Study||44
6533524|NCT01631682|7455497|FG003|STARTED|Overall Study||7
6533525|NCT01631682|7455494|FG000|COMPLETED|Overall Study||24
6533526|NCT01631682|7455495|FG001|COMPLETED|Overall Study||21
6533527|NCT01631682|7455496|FG002|COMPLETED|Overall Study||13
6533528|NCT01631682|7455497|FG003|COMPLETED|Overall Study||5
6533529|NCT01631682|7455494|FG000|NOT COMPLETED|Overall Study||31
6533530|NCT01631682|7455495|FG001|NOT COMPLETED|Overall Study||45
6533531|NCT01631682|7455496|FG002|NOT COMPLETED|Overall Study||31
6533532|NCT01631682|7455497|FG003|NOT COMPLETED|Overall Study||2
6533533|NCT01631747|7455509|FG000|STARTED|Randomization Through End of Pregnancy||141
6533534|NCT01631747|7455510|FG001|STARTED|Randomization Through End of Pregnancy||140
6533535|NCT01631747|7455509|FG000|COMPLETED|Randomization Through End of Pregnancy||140
6533536|NCT01631747|7455510|FG001|COMPLETED|Randomization Through End of Pregnancy||140
6533537|NCT01631747|7455509|FG000|NOT COMPLETED|Randomization Through End of Pregnancy||1
6533538|NCT01631747|7455510|FG001|NOT COMPLETED|Randomization Through End of Pregnancy||0
6533539|NCT01631747|7455509|FG000|STARTED|Live Birth||140
6533540|NCT01631747|7455510|FG001|STARTED|Live Birth||140
6533541|NCT01631747|7455509|FG000|COMPLETED|Live Birth||136
6533542|NCT01631747|7455510|FG001|COMPLETED|Live Birth||139
6533543|NCT01631747|7455509|FG000|NOT COMPLETED|Live Birth||4
6533544|NCT01631747|7455510|FG001|NOT COMPLETED|Live Birth||1
6533545|NCT01631747|7455509|FG000|STARTED|One Year Infant Outcomes||136
6533546|NCT01631747|7455510|FG001|STARTED|One Year Infant Outcomes||139
6533547|NCT01631747|7455509|FG000|COMPLETED|One Year Infant Outcomes||123
6533548|NCT01631747|7455510|FG001|COMPLETED|One Year Infant Outcomes||130
6533549|NCT01631747|7455509|FG000|NOT COMPLETED|One Year Infant Outcomes||13
6533550|NCT01631747|7455510|FG001|NOT COMPLETED|One Year Infant Outcomes||9
6533551|NCT01631812|7455517|FG000|STARTED|Overall Study||130
6533552|NCT01631812|7455517|FG000|COMPLETED|Overall Study||93
6533553|NCT01631812|7455517|FG000|NOT COMPLETED|Overall Study||37
6533554|NCT01631825|7455521|FG000|STARTED|Overall Study||321
6533555|NCT01631825|7455521|FG000|COMPLETED|Overall Study||256
6533556|NCT01631825|7455521|FG000|NOT COMPLETED|Overall Study||65
6533557|NCT01631864|7455527|FG000|STARTED|Overall Study||50
6533558|NCT01631864|7455528|FG001|STARTED|Overall Study||48
6533559|NCT01631864|7455527|FG000|COMPLETED|Overall Study||48
6533560|NCT01631864|7455528|FG001|COMPLETED|Overall Study||44
6533561|NCT01631864|7455527|FG000|NOT COMPLETED|Overall Study||2
6533562|NCT01631864|7455528|FG001|NOT COMPLETED|Overall Study||4
6533563|NCT01631929|7455536|FG000|STARTED|Overall Study||6
6533564|NCT01631929|7455537|FG001|STARTED|Overall Study||6
6533565|NCT01631929|7455536|FG000|COMPLETED|Overall Study||6
6533566|NCT01631929|7455537|FG001|COMPLETED|Overall Study||6
6533567|NCT01631929|7455536|FG000|NOT COMPLETED|Overall Study||0
6533568|NCT01631929|7455537|FG001|NOT COMPLETED|Overall Study||0
6533569|NCT01632150|7455543|FG000|STARTED|Overall Study||40
6533570|NCT01632150|7455543|FG000|Received Cyclophosphamide|Overall Study||11
6533571|NCT01632150|7455543|FG000|COMPLETED|Overall Study|Completed=still receiving treatment|0
6533572|NCT01632150|7455543|FG000|NOT COMPLETED|Overall Study||40
6533573|NCT01632202|7455552|FG000|STARTED|Overall Study||1
6533574|NCT01632202|7455553|FG001|STARTED|Overall Study||7
6533575|NCT01632202|7455552|FG000|COMPLETED|Overall Study||1
6533576|NCT01632202|7455553|FG001|COMPLETED|Overall Study||7
6533577|NCT01632202|7455552|FG000|NOT COMPLETED|Overall Study||0
6533578|NCT01632202|7455553|FG001|NOT COMPLETED|Overall Study||0
6533579|NCT01632215|7455561|FG000|STARTED|Overall Study||20
6533580|NCT01632215|7455562|FG001|STARTED|Overall Study||20
6533581|NCT01632215|7455561|FG000|COMPLETED|Overall Study||18
6533582|NCT01632215|7455562|FG001|COMPLETED|Overall Study||19
6533583|NCT01632215|7455561|FG000|NOT COMPLETED|Overall Study||2
6533584|NCT01632215|7455562|FG001|NOT COMPLETED|Overall Study||1
6533585|NCT01632241|7455570|FG000|STARTED|Double-blinded (Up to Week 52)||165
6533586|NCT01632241|7455571|FG001|STARTED|Double-blinded (Up to Week 52)||331
6533587|NCT01632241|7455570|FG000|COMPLETED|Double-blinded (Up to Week 52)||121
6533588|NCT01632241|7455571|FG001|COMPLETED|Double-blinded (Up to Week 52)||252
6533589|NCT01632241|7455570|FG000|NOT COMPLETED|Double-blinded (Up to Week 52)||44
6533590|NCT01632241|7455571|FG001|NOT COMPLETED|Double-blinded (Up to Week 52)||79
6533591|NCT01632241|7455570|FG000|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|117
6533592|NCT01632241|7455571|FG001|STARTED|Open-label (Week 52 to Week 76)|As the OL phase was optional, participants did not choose to enter the OL Phase.|242
6533593|NCT01632241|7455570|FG000|COMPLETED|Open-label (Week 52 to Week 76)||107
6533594|NCT01632241|7455571|FG001|COMPLETED|Open-label (Week 52 to Week 76)||220
6533595|NCT01632241|7455570|FG000|NOT COMPLETED|Open-label (Week 52 to Week 76)||10
6533596|NCT01632241|7455571|FG001|NOT COMPLETED|Open-label (Week 52 to Week 76)||22
6533597|NCT01632267|7455583|FG000|STARTED|Overall Study||104
6533598|NCT01632267|7455583|FG000|COMPLETED|Overall Study||97
6533599|NCT01632267|7455583|FG000|NOT COMPLETED|Overall Study||7
6533600|NCT01632280|7455589|FG000|STARTED|Overall Study||6
6533601|NCT01632280|7455590|FG001|STARTED|Overall Study||6
6533602|NCT01632280|7455589|FG000|COMPLETED|Overall Study||5
6533603|NCT01632280|7455590|FG001|COMPLETED|Overall Study||6
6533604|NCT01632280|7455589|FG000|NOT COMPLETED|Overall Study||1
6533605|NCT01632280|7455590|FG001|NOT COMPLETED|Overall Study||0
6533606|NCT01632306|7455598|FG000|STARTED|Overall Study||3
6533607|NCT01632306|7455599|FG001|STARTED|Overall Study||10
6533608|NCT01632306|7455600|FG002|STARTED|Overall Study||0
6533609|NCT01632306|7455598|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6533610|NCT01632306|7455599|FG001|Received at Least One Dose of Study Drug|Overall Study||10
6533611|NCT01632306|7455600|FG002|Received at Least One Dose of Study Drug|Overall Study||0
6533612|NCT01632306|7455598|FG000|COMPLETED|Overall Study||2
6533613|NCT01632306|7455599|FG001|COMPLETED|Overall Study||10
6533614|NCT01632306|7455600|FG002|COMPLETED|Overall Study||0
6533615|NCT01632306|7455598|FG000|NOT COMPLETED|Overall Study||1
6533616|NCT01632306|7455599|FG001|NOT COMPLETED|Overall Study||0
6533617|NCT01632306|7455600|FG002|NOT COMPLETED|Overall Study||0
6533618|NCT01632345|7455611|FG000|STARTED|Randomized Participants||41
6533619|NCT01632345|7455612|FG001|STARTED|Randomized Participants||43
6533620|NCT01632345|7455613|FG002|STARTED|Randomized Participants||42
6533621|NCT01632345|7455614|FG003|STARTED|Randomized Participants||41
6533622|NCT01632345|7455615|FG004|STARTED|Randomized Participants||43
6533623|NCT01632345|7455616|FG005|STARTED|Randomized Participants||66
6533624|NCT01632345|7455617|FG006|STARTED|Randomized Participants||66
6533625|NCT01632345|7455611|FG000|COMPLETED|Randomized Participants||41
6533626|NCT01632345|7455612|FG001|COMPLETED|Randomized Participants||43
6533627|NCT01632345|7455613|FG002|COMPLETED|Randomized Participants||42
6533628|NCT01632345|7455614|FG003|COMPLETED|Randomized Participants||41
6533629|NCT01632345|7455615|FG004|COMPLETED|Randomized Participants||43
6533630|NCT01632345|7455616|FG005|COMPLETED|Randomized Participants||66
6533631|NCT01632345|7455617|FG006|COMPLETED|Randomized Participants||66
6533632|NCT01632345|7455611|FG000|NOT COMPLETED|Randomized Participants||0
6533633|NCT01632345|7455612|FG001|NOT COMPLETED|Randomized Participants||0
6644662|NCT02365519|7573305|FG000|STARTED|Vehicle Run-In||213
6644663|NCT02365519|7573306|FG001|STARTED|Vehicle Run-In||0
6644664|NCT02365519|7573307|FG002|STARTED|Vehicle Run-In||0
6644665|NCT02365519|7573305|FG000|COMPLETED|Vehicle Run-In||134
6644666|NCT02365519|7573306|FG001|COMPLETED|Vehicle Run-In||0
6644667|NCT02365519|7573307|FG002|COMPLETED|Vehicle Run-In||0
6644668|NCT02365519|7573305|FG000|NOT COMPLETED|Vehicle Run-In||79
6644669|NCT02365519|7573306|FG001|NOT COMPLETED|Vehicle Run-In||0
6644670|NCT02365519|7573307|FG002|NOT COMPLETED|Vehicle Run-In||0
6644671|NCT02365519|7573305|FG000|STARTED|Randomized and Treated||0
6644672|NCT02365519|7573306|FG001|STARTED|Randomized and Treated||69
6644673|NCT02365519|7573307|FG002|STARTED|Randomized and Treated||65
6644674|NCT02365519|7573305|FG000|COMPLETED|Randomized and Treated||0
6644675|NCT02365519|7573306|FG001|COMPLETED|Randomized and Treated||67
6644676|NCT02365519|7573307|FG002|COMPLETED|Randomized and Treated||64
6644677|NCT02365519|7573305|FG000|NOT COMPLETED|Randomized and Treated||0
6644678|NCT02365519|7573306|FG001|NOT COMPLETED|Randomized and Treated||2
6644679|NCT02365519|7573307|FG002|NOT COMPLETED|Randomized and Treated||1
6644680|NCT02365558|7573316|FG000|STARTED|Period 1 (Day 1 Through Day 7)||34
6644681|NCT02365558|7573317|FG001|STARTED|Period 1 (Day 1 Through Day 7)||0
6644682|NCT02365558|7573316|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||34
6644683|NCT02365558|7573317|FG001|Received at Least One Dose of Study Drug|Period 1 (Day 1 Through Day 7)||0
6644684|NCT02365558|7573316|FG000|COMPLETED|Period 1 (Day 1 Through Day 7)||33
6644685|NCT02365558|7573317|FG001|COMPLETED|Period 1 (Day 1 Through Day 7)||0
6644686|NCT02365558|7573316|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||1
6644687|NCT02365558|7573317|FG001|NOT COMPLETED|Period 1 (Day 1 Through Day 7)||0
6644688|NCT02365558|7573316|FG000|STARTED|Period 2 (Day 8 Through Day 20)|Participants move to Evacetrapib + Omeprazole for Period 2.|0
6644689|NCT02365558|7573317|FG001|STARTED|Period 2 (Day 8 Through Day 20)|Participants completed Period 1 and entered Evacetrapib + Omeprazole for Period 2.|33
6644690|NCT02365558|7573316|FG000|COMPLETED|Period 2 (Day 8 Through Day 20)||0
6533634|NCT01632345|7455613|FG002|NOT COMPLETED|Randomized Participants||0
6533635|NCT01632345|7455614|FG003|NOT COMPLETED|Randomized Participants||0
6533636|NCT01632345|7455615|FG004|NOT COMPLETED|Randomized Participants||0
6533637|NCT01632345|7455616|FG005|NOT COMPLETED|Randomized Participants||0
6533638|NCT01632345|7455617|FG006|NOT COMPLETED|Randomized Participants||0
6533639|NCT01632345|7455611|FG000|STARTED|Treatment: Part I||41
6533640|NCT01632345|7455612|FG001|STARTED|Treatment: Part I||43
6533641|NCT01632345|7455613|FG002|STARTED|Treatment: Part I||42
6533642|NCT01632345|7455614|FG003|STARTED|Treatment: Part I||41
6533643|NCT01632345|7455615|FG004|STARTED|Treatment: Part I||43
6533644|NCT01632345|7455616|FG005|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
6533645|NCT01632345|7455617|FG006|STARTED|Treatment: Part I|Participants in Part II did not participate in Part I.|0
6533646|NCT01632345|7455611|FG000|Treated|Treatment: Part I||40
6533647|NCT01632345|7455612|FG001|Treated|Treatment: Part I||43
6533648|NCT01632345|7455613|FG002|Treated|Treatment: Part I||42
6533649|NCT01632345|7455614|FG003|Treated|Treatment: Part I||41
6533650|NCT01632345|7455615|FG004|Treated|Treatment: Part I||43
6533651|NCT01632345|7455616|FG005|Treated|Treatment: Part I||0
6533652|NCT01632345|7455617|FG006|Treated|Treatment: Part I||0
6533653|NCT01632345|7455611|FG000|COMPLETED|Treatment: Part I||29
6533654|NCT01632345|7455612|FG001|COMPLETED|Treatment: Part I||28
6533655|NCT01632345|7455613|FG002|COMPLETED|Treatment: Part I||32
6533656|NCT01632345|7455614|FG003|COMPLETED|Treatment: Part I||33
6533657|NCT01632345|7455615|FG004|COMPLETED|Treatment: Part I||30
6533658|NCT01632345|7455616|FG005|COMPLETED|Treatment: Part I||0
6533659|NCT01632345|7455617|FG006|COMPLETED|Treatment: Part I||0
6533660|NCT01632345|7455611|FG000|NOT COMPLETED|Treatment: Part I||12
6533661|NCT01632345|7455612|FG001|NOT COMPLETED|Treatment: Part I||15
6533662|NCT01632345|7455613|FG002|NOT COMPLETED|Treatment: Part I||10
6533663|NCT01632345|7455614|FG003|NOT COMPLETED|Treatment: Part I||8
6533664|NCT01632345|7455615|FG004|NOT COMPLETED|Treatment: Part I||13
6533665|NCT01632345|7455616|FG005|NOT COMPLETED|Treatment: Part I||0
6533666|NCT01632345|7455617|FG006|NOT COMPLETED|Treatment: Part I||0
6533667|NCT01632345|7455611|FG000|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6533668|NCT01632345|7455612|FG001|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6533669|NCT01632345|7455613|FG002|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6533670|NCT01632345|7455614|FG003|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6533671|NCT01632345|7455615|FG004|STARTED|Treatment: Part II|Participants in Part I did not continue in Part II.|0
6533672|NCT01632345|7455616|FG005|STARTED|Treatment: Part II|66 new participants enrolled at 100 mg dose in Part II.|66
6533673|NCT01632345|7455617|FG006|STARTED|Treatment: Part II|66 new participants enrolled at efavirenz treatment in Part II.|66
6533674|NCT01632345|7455611|FG000|Treated|Treatment: Part II||0
6533675|NCT01632345|7455612|FG001|Treated|Treatment: Part II||0
6533676|NCT01632345|7455613|FG002|Treated|Treatment: Part II||0
6533677|NCT01632345|7455614|FG003|Treated|Treatment: Part II||0
6533678|NCT01632345|7455615|FG004|Treated|Treatment: Part II||0
6533679|NCT01632345|7455616|FG005|Treated|Treatment: Part II||66
6533680|NCT01632345|7455617|FG006|Treated|Treatment: Part II||66
6533681|NCT01632345|7455611|FG000|COMPLETED|Treatment: Part II||0
6533682|NCT01632345|7455612|FG001|COMPLETED|Treatment: Part II||0
6533683|NCT01632345|7455613|FG002|COMPLETED|Treatment: Part II||0
6533684|NCT01632345|7455614|FG003|COMPLETED|Treatment: Part II||0
6533685|NCT01632345|7455615|FG004|COMPLETED|Treatment: Part II||0
6533686|NCT01632345|7455616|FG005|COMPLETED|Treatment: Part II||55
6533687|NCT01632345|7455617|FG006|COMPLETED|Treatment: Part II||55
6533688|NCT01632345|7455611|FG000|NOT COMPLETED|Treatment: Part II||0
6533689|NCT01632345|7455612|FG001|NOT COMPLETED|Treatment: Part II||0
6533690|NCT01632345|7455613|FG002|NOT COMPLETED|Treatment: Part II||0
6533691|NCT01632345|7455614|FG003|NOT COMPLETED|Treatment: Part II||0
6533692|NCT01632345|7455615|FG004|NOT COMPLETED|Treatment: Part II||0
6533693|NCT01632345|7455616|FG005|NOT COMPLETED|Treatment: Part II||11
6533694|NCT01632345|7455617|FG006|NOT COMPLETED|Treatment: Part II||11
6533695|NCT01632423|7455632|FG000|STARTED|Overall Study||10337
6533696|NCT01632423|7455632|FG000|COMPLETED|Overall Study||10091
6533697|NCT01632423|7455632|FG000|NOT COMPLETED|Overall Study||246
6533698|NCT01632566|7455641|FG000|STARTED|Overall Study||8
6533699|NCT01632566|7455642|FG001|STARTED|Overall Study||10
6533700|NCT01632566|7455643|FG002|STARTED|Overall Study||9
6533701|NCT01632566|7455644|FG003|STARTED|Overall Study||6
6533702|NCT01632566|7455645|FG004|STARTED|Overall Study||6
6533703|NCT01632566|7455641|FG000|Received at Least One Dose LY3031207|Overall Study||8
6533704|NCT01632566|7455642|FG001|Received at Least One Dose LY3031207|Overall Study||10
6533705|NCT01632566|7455643|FG002|Received at Least One Dose LY3031207|Overall Study||9
6533706|NCT01632566|7455644|FG003|Received at Least One Dose LY3031207|Overall Study||0
6533707|NCT01632566|7455645|FG004|Received at Least One Dose LY3031207|Overall Study||0
6533708|NCT01632566|7455641|FG000|Received at Least One Dose Simvastatin|Overall Study||0
6533709|NCT01632566|7455642|FG001|Received at Least One Dose Simvastatin|Overall Study||10
6533710|NCT01632566|7455643|FG002|Received at Least One Dose Simvastatin|Overall Study||9
6533711|NCT01632566|7455644|FG003|Received at Least One Dose Simvastatin|Overall Study||4
6533712|NCT01632566|7455645|FG004|Received at Least One Dose Simvastatin|Overall Study||4
6533713|NCT01632566|7455641|FG000|COMPLETED|Overall Study||8
6533714|NCT01632566|7455642|FG001|COMPLETED|Overall Study||7
6533715|NCT01632566|7455643|FG002|COMPLETED|Overall Study||0
6533716|NCT01632566|7455644|FG003|COMPLETED|Overall Study||4
6533717|NCT01632566|7455645|FG004|COMPLETED|Overall Study||4
6533718|NCT01632566|7455641|FG000|NOT COMPLETED|Overall Study||0
6533719|NCT01632566|7455642|FG001|NOT COMPLETED|Overall Study||3
6533720|NCT01632566|7455643|FG002|NOT COMPLETED|Overall Study||9
6533721|NCT01632566|7455644|FG003|NOT COMPLETED|Overall Study||2
6533722|NCT01632566|7455645|FG004|NOT COMPLETED|Overall Study||2
6533723|NCT01632579|7455661|FG000|STARTED|Period 1 (First Intervention)||2
6533724|NCT01632579|7455662|FG001|STARTED|Period 1 (First Intervention)||6
6533725|NCT01632579|7455663|FG002|STARTED|Period 1 (First Intervention)||2
6533726|NCT01632579|7455664|FG003|STARTED|Period 1 (First Intervention)||2
6533727|NCT01632579|7455665|FG004|STARTED|Period 1 (First Intervention)||6
6533728|NCT01632579|7455666|FG005|STARTED|Period 1 (First Intervention)||2
6533729|NCT01632579|7455667|FG006|STARTED|Period 1 (First Intervention)||2
6533730|NCT01632579|7455668|FG007|STARTED|Period 1 (First Intervention)||6
6533731|NCT01632579|7455669|FG008|STARTED|Period 1 (First Intervention)||2
6533732|NCT01632579|7455661|FG000|Received at Least 1 Dose|Period 1 (First Intervention)||2
6533733|NCT01632579|7455662|FG001|Received at Least 1 Dose|Period 1 (First Intervention)||6
6533734|NCT01632579|7455663|FG002|Received at Least 1 Dose|Period 1 (First Intervention)||2
6533735|NCT01632579|7455664|FG003|Received at Least 1 Dose|Period 1 (First Intervention)||2
6533736|NCT01632579|7455665|FG004|Received at Least 1 Dose|Period 1 (First Intervention)||6
6533737|NCT01632579|7455666|FG005|Received at Least 1 Dose|Period 1 (First Intervention)||2
6533738|NCT01632579|7455667|FG006|Received at Least 1 Dose|Period 1 (First Intervention)||2
6533739|NCT01632579|7455668|FG007|Received at Least 1 Dose|Period 1 (First Intervention)||6
6533740|NCT01632579|7455669|FG008|Received at Least 1 Dose|Period 1 (First Intervention)||2
6533741|NCT01632579|7455661|FG000|COMPLETED|Period 1 (First Intervention)||2
6533742|NCT01632579|7455662|FG001|COMPLETED|Period 1 (First Intervention)||6
6533743|NCT01632579|7455663|FG002|COMPLETED|Period 1 (First Intervention)||2
6533744|NCT01632579|7455664|FG003|COMPLETED|Period 1 (First Intervention)||2
6533745|NCT01632579|7455665|FG004|COMPLETED|Period 1 (First Intervention)||6
6533746|NCT01632579|7455666|FG005|COMPLETED|Period 1 (First Intervention)||2
6533747|NCT01632579|7455667|FG006|COMPLETED|Period 1 (First Intervention)||2
6533748|NCT01632579|7455668|FG007|COMPLETED|Period 1 (First Intervention)||6
6533749|NCT01632579|7455669|FG008|COMPLETED|Period 1 (First Intervention)||2
6533750|NCT01632579|7455661|FG000|NOT COMPLETED|Period 1 (First Intervention)||0
6533751|NCT01632579|7455662|FG001|NOT COMPLETED|Period 1 (First Intervention)||0
6533752|NCT01632579|7455663|FG002|NOT COMPLETED|Period 1 (First Intervention)||0
6533753|NCT01632579|7455664|FG003|NOT COMPLETED|Period 1 (First Intervention)||0
6533754|NCT01632579|7455665|FG004|NOT COMPLETED|Period 1 (First Intervention)||0
6533755|NCT01632579|7455666|FG005|NOT COMPLETED|Period 1 (First Intervention)||0
6533756|NCT01632579|7455667|FG006|NOT COMPLETED|Period 1 (First Intervention)||0
6533757|NCT01632579|7455668|FG007|NOT COMPLETED|Period 1 (First Intervention)||0
6533758|NCT01632579|7455669|FG008|NOT COMPLETED|Period 1 (First Intervention)||0
6533759|NCT01632579|7455661|FG000|STARTED|Washout Period||2
6533760|NCT01632579|7455662|FG001|STARTED|Washout Period||6
6533761|NCT01632579|7455663|FG002|STARTED|Washout Period||2
6533762|NCT01632579|7455664|FG003|STARTED|Washout Period||2
6533763|NCT01632579|7455665|FG004|STARTED|Washout Period||6
6533764|NCT01632579|7455666|FG005|STARTED|Washout Period||2
6533765|NCT01632579|7455667|FG006|STARTED|Washout Period||2
6533766|NCT01632579|7455668|FG007|STARTED|Washout Period||6
6533767|NCT01632579|7455669|FG008|STARTED|Washout Period||2
6533768|NCT01632579|7455661|FG000|COMPLETED|Washout Period||1
6533769|NCT01632579|7455662|FG001|COMPLETED|Washout Period||6
6533770|NCT01632579|7455663|FG002|COMPLETED|Washout Period||2
6533771|NCT01632579|7455664|FG003|COMPLETED|Washout Period||2
6533772|NCT01632579|7455665|FG004|COMPLETED|Washout Period||6
6533773|NCT01632579|7455666|FG005|COMPLETED|Washout Period||2
6533774|NCT01632579|7455667|FG006|COMPLETED|Washout Period||2
6533775|NCT01632579|7455668|FG007|COMPLETED|Washout Period||6
6533776|NCT01632579|7455669|FG008|COMPLETED|Washout Period||2
6533777|NCT01632579|7455661|FG000|NOT COMPLETED|Washout Period||1
6533778|NCT01632579|7455662|FG001|NOT COMPLETED|Washout Period||0
6533779|NCT01632579|7455663|FG002|NOT COMPLETED|Washout Period||0
6533780|NCT01632579|7455664|FG003|NOT COMPLETED|Washout Period||0
6533781|NCT01632579|7455665|FG004|NOT COMPLETED|Washout Period||0
6533782|NCT01632579|7455666|FG005|NOT COMPLETED|Washout Period||0
6533783|NCT01632579|7455667|FG006|NOT COMPLETED|Washout Period||0
6533784|NCT01632579|7455668|FG007|NOT COMPLETED|Washout Period||0
6533785|NCT01632579|7455669|FG008|NOT COMPLETED|Washout Period||0
6533786|NCT01632579|7455661|FG000|STARTED|Period 2 (Second Intervention)||1
6533787|NCT01632579|7455662|FG001|STARTED|Period 2 (Second Intervention)||6
6533788|NCT01632579|7455663|FG002|STARTED|Period 2 (Second Intervention)||2
6533789|NCT01632579|7455664|FG003|STARTED|Period 2 (Second Intervention)||2
6533790|NCT01632579|7455665|FG004|STARTED|Period 2 (Second Intervention)||6
6533791|NCT01632579|7455666|FG005|STARTED|Period 2 (Second Intervention)||2
6533792|NCT01632579|7455667|FG006|STARTED|Period 2 (Second Intervention)||2
6533793|NCT01632579|7455668|FG007|STARTED|Period 2 (Second Intervention)||6
6533794|NCT01632579|7455669|FG008|STARTED|Period 2 (Second Intervention)||2
6533795|NCT01632579|7455661|FG000|Received at Least 1 Dose|Period 2 (Second Intervention)||1
6533796|NCT01632579|7455662|FG001|Received at Least 1 Dose|Period 2 (Second Intervention)||6
6533797|NCT01632579|7455663|FG002|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6533798|NCT01632579|7455664|FG003|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6533799|NCT01632579|7455665|FG004|Received at Least 1 Dose|Period 2 (Second Intervention)||6
6533800|NCT01632579|7455666|FG005|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6533801|NCT01632579|7455667|FG006|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6533802|NCT01632579|7455668|FG007|Received at Least 1 Dose|Period 2 (Second Intervention)||6
6533803|NCT01632579|7455669|FG008|Received at Least 1 Dose|Period 2 (Second Intervention)||2
6533804|NCT01632579|7455661|FG000|COMPLETED|Period 2 (Second Intervention)||0
6533805|NCT01632579|7455662|FG001|COMPLETED|Period 2 (Second Intervention)||6
6533806|NCT01632579|7455663|FG002|COMPLETED|Period 2 (Second Intervention)||2
6533807|NCT01632579|7455664|FG003|COMPLETED|Period 2 (Second Intervention)||2
6533808|NCT01632579|7455665|FG004|COMPLETED|Period 2 (Second Intervention)||6
6533809|NCT01632579|7455666|FG005|COMPLETED|Period 2 (Second Intervention)||2
6533810|NCT01632579|7455667|FG006|COMPLETED|Period 2 (Second Intervention)||2
6533811|NCT01632579|7455668|FG007|COMPLETED|Period 2 (Second Intervention)||6
6533812|NCT01632579|7455669|FG008|COMPLETED|Period 2 (Second Intervention)||2
6533813|NCT01632579|7455661|FG000|NOT COMPLETED|Period 2 (Second Intervention)||1
6533814|NCT01632579|7455662|FG001|NOT COMPLETED|Period 2 (Second Intervention)||0
6533815|NCT01632579|7455663|FG002|NOT COMPLETED|Period 2 (Second Intervention)||0
6533816|NCT01632579|7455664|FG003|NOT COMPLETED|Period 2 (Second Intervention)||0
6533817|NCT01632579|7455665|FG004|NOT COMPLETED|Period 2 (Second Intervention)||0
6533818|NCT01632579|7455666|FG005|NOT COMPLETED|Period 2 (Second Intervention)||0
6533819|NCT01632579|7455667|FG006|NOT COMPLETED|Period 2 (Second Intervention)||0
6533820|NCT01632579|7455668|FG007|NOT COMPLETED|Period 2 (Second Intervention)||0
6533821|NCT01632579|7455669|FG008|NOT COMPLETED|Period 2 (Second Intervention)||0
6533822|NCT01632579|7455661|FG000|STARTED|Washout Period||0
6533823|NCT01632579|7455662|FG001|STARTED|Washout Period||6
6533824|NCT01632579|7455663|FG002|STARTED|Washout Period||2
6533825|NCT01632579|7455664|FG003|STARTED|Washout Period||2
6533826|NCT01632579|7455665|FG004|STARTED|Washout Period||6
6533827|NCT01632579|7455666|FG005|STARTED|Washout Period||2
6533828|NCT01632579|7455667|FG006|STARTED|Washout Period||2
6533829|NCT01632579|7455668|FG007|STARTED|Washout Period||6
6533830|NCT01632579|7455669|FG008|STARTED|Washout Period||2
6533831|NCT01632579|7455661|FG000|COMPLETED|Washout Period||0
6533832|NCT01632579|7455662|FG001|COMPLETED|Washout Period||6
6533833|NCT01632579|7455663|FG002|COMPLETED|Washout Period||2
6533834|NCT01632579|7455664|FG003|COMPLETED|Washout Period||2
6533835|NCT01632579|7455665|FG004|COMPLETED|Washout Period||6
6533836|NCT01632579|7455666|FG005|COMPLETED|Washout Period||2
6533837|NCT01632579|7455667|FG006|COMPLETED|Washout Period||2
6533838|NCT01632579|7455668|FG007|COMPLETED|Washout Period||6
6533839|NCT01632579|7455669|FG008|COMPLETED|Washout Period||2
6533840|NCT01632579|7455661|FG000|NOT COMPLETED|Washout Period||0
6533841|NCT01632579|7455662|FG001|NOT COMPLETED|Washout Period||0
6533842|NCT01632579|7455663|FG002|NOT COMPLETED|Washout Period||0
6533843|NCT01632579|7455664|FG003|NOT COMPLETED|Washout Period||0
6533844|NCT01632579|7455665|FG004|NOT COMPLETED|Washout Period||0
6533845|NCT01632579|7455666|FG005|NOT COMPLETED|Washout Period||0
6533846|NCT01632579|7455667|FG006|NOT COMPLETED|Washout Period||0
6533847|NCT01632579|7455668|FG007|NOT COMPLETED|Washout Period||0
6533848|NCT01632579|7455669|FG008|NOT COMPLETED|Washout Period||0
6533849|NCT01632579|7455661|FG000|STARTED|Period 3 (Third Intervention)||0
6533850|NCT01632579|7455662|FG001|STARTED|Period 3 (Third Intervention)||6
6533851|NCT01632579|7455663|FG002|STARTED|Period 3 (Third Intervention)||2
6533852|NCT01632579|7455664|FG003|STARTED|Period 3 (Third Intervention)||2
6644691|NCT02365558|7573317|FG001|COMPLETED|Period 2 (Day 8 Through Day 20)||32
6644692|NCT02365558|7573316|FG000|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||0
6644693|NCT02365558|7573317|FG001|NOT COMPLETED|Period 2 (Day 8 Through Day 20)||1
6644694|NCT02365584|7573328|FG000|STARTED|Overall Study||21
6644695|NCT02365584|7573329|FG001|STARTED|Overall Study||22
6644696|NCT02365584|7573328|FG000|COMPLETED|Overall Study||9
6644697|NCT02365584|7573329|FG001|COMPLETED|Overall Study||8
6644698|NCT02365584|7573328|FG000|NOT COMPLETED|Overall Study||12
6644699|NCT02365584|7573329|FG001|NOT COMPLETED|Overall Study||14
6644700|NCT02365636|7573338|FG000|STARTED|Overall Study||100
6644701|NCT02365636|7573339|FG001|STARTED|Overall Study||100
6644702|NCT02365636|7573340|FG002|STARTED|Overall Study||100
6644703|NCT02365636|7573338|FG000|Safety Population|Overall Study||100
6644704|NCT02365636|7573339|FG001|Safety Population|Overall Study|2 terminated prior to treatment due to 1) prohibited concomitant medication 2) exclusion criteria|98
6644705|NCT02365636|7573340|FG002|Safety Population|Overall Study||100
6644706|NCT02365636|7573338|FG000|Full Analysis Set|Overall Study||100
6644707|NCT02365636|7573339|FG001|Full Analysis Set|Overall Study||98
6644708|NCT02365636|7573340|FG002|Full Analysis Set|Overall Study||100
6644709|NCT02365636|7573338|FG000|COMPLETED|Overall Study||94
6644710|NCT02365636|7573339|FG001|COMPLETED|Overall Study||93
6644711|NCT02365636|7573340|FG002|COMPLETED|Overall Study||97
6644712|NCT02365636|7573338|FG000|NOT COMPLETED|Overall Study||6
6644713|NCT02365636|7573339|FG001|NOT COMPLETED|Overall Study||7
6644714|NCT02365636|7573340|FG002|NOT COMPLETED|Overall Study||3
6644715|NCT02365714|7573348|FG000|STARTED|Overall Study||2
6644716|NCT02365714|7573348|FG000|COMPLETED|Overall Study||2
6644717|NCT02365714|7573348|FG000|NOT COMPLETED|Overall Study||0
6644718|NCT02365870|7573354|FG000|STARTED|Overall Study||1
6644719|NCT02365870|7573355|FG001|STARTED|Overall Study||3
6743732|NCT03335254|7671829|FG019|COMPLETED|Period 3, Day 16-25||0
6743733|NCT03335254|7671810|FG000|NOT COMPLETED|Period 3, Day 16-25||0
6533853|NCT01632579|7455665|FG004|STARTED|Period 3 (Third Intervention)||6
6533854|NCT01632579|7455666|FG005|STARTED|Period 3 (Third Intervention)||2
6533855|NCT01632579|7455667|FG006|STARTED|Period 3 (Third Intervention)||2
6533856|NCT01632579|7455668|FG007|STARTED|Period 3 (Third Intervention)||6
6533857|NCT01632579|7455669|FG008|STARTED|Period 3 (Third Intervention)||2
6533858|NCT01632579|7455661|FG000|Received at Least 1 Dose|Period 3 (Third Intervention)||0
6533859|NCT01632579|7455662|FG001|Received at Least 1 Dose|Period 3 (Third Intervention)||6
6533860|NCT01632579|7455663|FG002|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6533861|NCT01632579|7455664|FG003|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6533862|NCT01632579|7455665|FG004|Received at Least 1 Dose|Period 3 (Third Intervention)||6
6533863|NCT01632579|7455666|FG005|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6533864|NCT01632579|7455667|FG006|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6533865|NCT01632579|7455668|FG007|Received at Least 1 Dose|Period 3 (Third Intervention)||6
6533866|NCT01632579|7455669|FG008|Received at Least 1 Dose|Period 3 (Third Intervention)||2
6533867|NCT01632579|7455661|FG000|COMPLETED|Period 3 (Third Intervention)||0
6533868|NCT01632579|7455662|FG001|COMPLETED|Period 3 (Third Intervention)||6
6533869|NCT01632579|7455663|FG002|COMPLETED|Period 3 (Third Intervention)||2
6533870|NCT01632579|7455664|FG003|COMPLETED|Period 3 (Third Intervention)||2
6533871|NCT01632579|7455665|FG004|COMPLETED|Period 3 (Third Intervention)||6
6533872|NCT01632579|7455666|FG005|COMPLETED|Period 3 (Third Intervention)||2
6533873|NCT01632579|7455667|FG006|COMPLETED|Period 3 (Third Intervention)||2
6533874|NCT01632579|7455668|FG007|COMPLETED|Period 3 (Third Intervention)||6
6533875|NCT01632579|7455669|FG008|COMPLETED|Period 3 (Third Intervention)||2
6533876|NCT01632579|7455661|FG000|NOT COMPLETED|Period 3 (Third Intervention)||0
6533877|NCT01632579|7455662|FG001|NOT COMPLETED|Period 3 (Third Intervention)||0
6533878|NCT01632579|7455663|FG002|NOT COMPLETED|Period 3 (Third Intervention)||0
6533879|NCT01632579|7455664|FG003|NOT COMPLETED|Period 3 (Third Intervention)||0
6533880|NCT01632579|7455665|FG004|NOT COMPLETED|Period 3 (Third Intervention)||0
6533881|NCT01632579|7455666|FG005|NOT COMPLETED|Period 3 (Third Intervention)||0
6533882|NCT01632579|7455667|FG006|NOT COMPLETED|Period 3 (Third Intervention)||0
6533883|NCT01632579|7455668|FG007|NOT COMPLETED|Period 3 (Third Intervention)||0
6533884|NCT01632579|7455669|FG008|NOT COMPLETED|Period 3 (Third Intervention)||0
6533885|NCT01632683|7455695|FG000|STARTED|Overall Study||548
6533886|NCT01632683|7455696|FG001|STARTED|Overall Study||552
6533887|NCT01632683|7455695|FG000|COMPLETED|Overall Study||548
6533888|NCT01632683|7455696|FG001|COMPLETED|Overall Study||552
6533889|NCT01632683|7455695|FG000|NOT COMPLETED|Overall Study||0
6533890|NCT01632683|7455696|FG001|NOT COMPLETED|Overall Study||0
6533891|NCT01632709|7455706|FG000|STARTED|Overall Study||4
6533892|NCT01632709|7455707|FG001|STARTED|Overall Study||3
6533893|NCT01632709|7455708|FG002|STARTED|Overall Study||5
6533894|NCT01632709|7455709|FG003|STARTED|Overall Study||4
6533895|NCT01632709|7455706|FG000|Completed Visit 2 (Received Injection)|Overall Study||4
6533896|NCT01632709|7455707|FG001|Completed Visit 2 (Received Injection)|Overall Study||2
6533897|NCT01632709|7455708|FG002|Completed Visit 2 (Received Injection)|Overall Study||5
6533898|NCT01632709|7455709|FG003|Completed Visit 2 (Received Injection)|Overall Study||3
6533899|NCT01632709|7455706|FG000|COMPLETED|Overall Study||2
6533900|NCT01632709|7455707|FG001|COMPLETED|Overall Study||2
6533901|NCT01632709|7455708|FG002|COMPLETED|Overall Study||5
6533902|NCT01632709|7455709|FG003|COMPLETED|Overall Study||3
6533903|NCT01632709|7455706|FG000|NOT COMPLETED|Overall Study||2
6533904|NCT01632709|7455707|FG001|NOT COMPLETED|Overall Study||1
6533905|NCT01632709|7455708|FG002|NOT COMPLETED|Overall Study||0
6533906|NCT01632709|7455709|FG003|NOT COMPLETED|Overall Study||1
6533907|NCT01632735|7455719|FG000|STARTED|Overall Study||40
6533908|NCT01632735|7455720|FG001|STARTED|Overall Study||40
6533909|NCT01632735|7455719|FG000|COMPLETED|Overall Study||36
6533910|NCT01632735|7455720|FG001|COMPLETED|Overall Study||37
6533911|NCT01632735|7455719|FG000|NOT COMPLETED|Overall Study||4
6533912|NCT01632735|7455720|FG001|NOT COMPLETED|Overall Study||3
6533913|NCT01632800|7455726|FG000|STARTED|Overall Study||26
6533914|NCT01632800|7455726|FG000|COMPLETED|Overall Study||25
6533915|NCT01632800|7455726|FG000|NOT COMPLETED|Overall Study||1
6533916|NCT01632891|7455732|FG000|STARTED|Overall Study||26
6533917|NCT01632891|7455733|FG001|STARTED|Overall Study||26
6533918|NCT01632891|7455732|FG000|COMPLETED|Overall Study||25
6533919|NCT01632891|7455733|FG001|COMPLETED|Overall Study||25
6533920|NCT01632891|7455732|FG000|NOT COMPLETED|Overall Study||1
6533921|NCT01632891|7455733|FG001|NOT COMPLETED|Overall Study||1
6533922|NCT01632904|7455745|FG000|STARTED|Overall Study||54
6533923|NCT01632904|7455746|FG001|STARTED|Overall Study||56
6533924|NCT01632904|7455745|FG000|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
6533925|NCT01632904|7455746|FG001|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
6533926|NCT01632904|7455745|FG000|NOT COMPLETED|Overall Study||7
6533927|NCT01632904|7455746|FG001|NOT COMPLETED|Overall Study||6
6533928|NCT01632995|7455752|FG000|STARTED|Pre-screening to Enrollment Period||1069
6533929|NCT01632995|7455752|FG000|COMPLETED|Pre-screening to Enrollment Period||557
6533930|NCT01632995|7455752|FG000|NOT COMPLETED|Pre-screening to Enrollment Period||512
6533931|NCT01632995|7455752|FG000|STARTED|Main Study Follow-up Period||557
6533932|NCT01632995|7455752|FG000|COMPLETED|Main Study Follow-up Period||437
6533933|NCT01632995|7455752|FG000|NOT COMPLETED|Main Study Follow-up Period||120
6533934|NCT01633060|7455760|FG000|STARTED|Randomization Phase|All randomized patients|289
6533935|NCT01633060|7455761|FG001|STARTED|Randomization Phase|All randomized patients|143
6533936|NCT01633060|7455760|FG000|COMPLETED|Randomization Phase||288
6533937|NCT01633060|7455761|FG001|COMPLETED|Randomization Phase||140
6533938|NCT01633060|7455760|FG000|NOT COMPLETED|Randomization Phase||1
6533939|NCT01633060|7455761|FG001|NOT COMPLETED|Randomization Phase||3
6533940|NCT01633060|7455760|FG000|STARTED|Treatment Phase||288
6533941|NCT01633060|7455761|FG001|STARTED|Treatment Phase||140
6533942|NCT01633060|7455760|FG000|FAS - ctDNA PIK3CA Mutant|Treatment Phase||100
6533943|NCT01633060|7455761|FG001|FAS - ctDNA PIK3CA Mutant|Treatment Phase||35
6533944|NCT01633060|7455760|FG000|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||132
6533945|NCT01633060|7455761|FG001|FAS - ctDNA PIK3CA Non-mutant|Treatment Phase||81
6533946|NCT01633060|7455760|FG000|Safety Set (SS)|Treatment Phase||288
6533947|NCT01633060|7455761|FG001|Safety Set (SS)|Treatment Phase||140
6533948|NCT01633060|7455760|FG000|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||63
6533949|NCT01633060|7455761|FG001|Pharmacokinetic Analysis Set (PAS)|Treatment Phase||0
6533950|NCT01633060|7455760|FG000|COMPLETED|Treatment Phase||0
6533951|NCT01633060|7455761|FG001|COMPLETED|Treatment Phase||0
6533952|NCT01633060|7455760|FG000|NOT COMPLETED|Treatment Phase||288
6533953|NCT01633060|7455761|FG001|NOT COMPLETED|Treatment Phase||140
6533954|NCT01633060|7455760|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|16
6533955|NCT01633060|7455761|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
6533956|NCT01633060|7455760|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6533957|NCT01633060|7455761|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6644720|NCT02365870|7573354|FG000|COMPLETED|Overall Study||1
6644721|NCT02365870|7573355|FG001|COMPLETED|Overall Study||3
6644722|NCT02365870|7573354|FG000|NOT COMPLETED|Overall Study||0
6644723|NCT02365870|7573355|FG001|NOT COMPLETED|Overall Study||0
6644724|NCT02365961|7573363|FG000|STARTED|Overall Study||41
6644725|NCT02365961|7573364|FG001|STARTED|Overall Study||43
6644726|NCT02365961|7573363|FG000|COMPLETED|Overall Study||41
6644727|NCT02365961|7573364|FG001|COMPLETED|Overall Study||43
6644728|NCT02365961|7573363|FG000|NOT COMPLETED|Overall Study||0
6644729|NCT02365961|7573364|FG001|NOT COMPLETED|Overall Study||0
6644730|NCT02366091|7573374|FG000|STARTED|Overall Study||24
6644731|NCT02366091|7573375|FG001|STARTED|Overall Study||23
6644732|NCT02366091|7573376|FG002|STARTED|Overall Study||24
6644733|NCT02366091|7573377|FG003|STARTED|Overall Study||23
6644734|NCT02366091|7573374|FG000|COMPLETED|Overall Study||21
6644735|NCT02366091|7573375|FG001|COMPLETED|Overall Study||16
6644736|NCT02366091|7573376|FG002|COMPLETED|Overall Study||21
6644737|NCT02366091|7573377|FG003|COMPLETED|Overall Study||22
6644738|NCT02366091|7573374|FG000|NOT COMPLETED|Overall Study||3
6644739|NCT02366091|7573375|FG001|NOT COMPLETED|Overall Study||7
6644740|NCT02366091|7573376|FG002|NOT COMPLETED|Overall Study||3
6644741|NCT02366091|7573377|FG003|NOT COMPLETED|Overall Study||1
6644742|NCT02366130|7573387|FG000|STARTED|Overall Study||45
6644743|NCT02366130|7573387|FG000|COMPLETED|Overall Study||36
6644744|NCT02366130|7573387|FG000|NOT COMPLETED|Overall Study||9
6644745|NCT02366143|7573394|FG000|STARTED|Overall Study||400
6644746|NCT02366143|7573395|FG001|STARTED|Overall Study||400
6644747|NCT02366143|7573396|FG002|STARTED|Overall Study||402
6644748|NCT02366143|7573394|FG000|COMPLETED|Overall Study||0
6644749|NCT02366143|7573395|FG001|COMPLETED|Overall Study||0
6644750|NCT02366143|7573396|FG002|COMPLETED|Overall Study||0
6644751|NCT02366143|7573394|FG000|NOT COMPLETED|Overall Study||400
6644752|NCT02366143|7573395|FG001|NOT COMPLETED|Overall Study||400
6644753|NCT02366143|7573396|FG002|NOT COMPLETED|Overall Study||402
6644754|NCT02366195|7573408|FG000|STARTED|Overall Study||112
6644755|NCT02366195|7573408|FG000|Received Study Drug|Overall Study||111
6644756|NCT02366195|7573408|FG000|COMPLETED|Overall Study||58
6644757|NCT02366195|7573408|FG000|NOT COMPLETED|Overall Study||54
6644758|NCT02366312|7573414|FG000|STARTED|Overall Study||1
6644759|NCT02366312|7573415|FG001|STARTED|Overall Study||1
6644760|NCT02366312|7573414|FG000|COMPLETED|Overall Study||1
6644761|NCT02366312|7573415|FG001|COMPLETED|Overall Study|The subject did not attend the 2-year post-treatment visit (last visit).|0
6644762|NCT02366312|7573414|FG000|NOT COMPLETED|Overall Study||0
6644763|NCT02366312|7573415|FG001|NOT COMPLETED|Overall Study||1
6644764|NCT02366338|7573424|FG000|STARTED|Overall Study||73
6644765|NCT02366338|7573425|FG001|STARTED|Overall Study||39
6644766|NCT02366338|7573426|FG002|STARTED|Overall Study||36
6644767|NCT02366338|7573424|FG000|COMPLETED|Overall Study||73
6644768|NCT02366338|7573425|FG001|COMPLETED|Overall Study||39
6644769|NCT02366338|7573426|FG002|COMPLETED|Overall Study||36
6533958|NCT01633060|7455760|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||16
6533959|NCT01633060|7455761|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
6644770|NCT02366338|7573424|FG000|NOT COMPLETED|Overall Study||0
6644771|NCT02366338|7573425|FG001|NOT COMPLETED|Overall Study||0
6644772|NCT02366338|7573426|FG002|NOT COMPLETED|Overall Study||0
6644773|NCT02366403|7573436|FG000|STARTED|Overall Study||41
6644774|NCT02366403|7573437|FG001|STARTED|Overall Study||44
6644775|NCT02366403|7573436|FG000|COMPLETED|Overall Study||30
6644776|NCT02366403|7573437|FG001|COMPLETED|Overall Study||29
6644777|NCT02366403|7573436|FG000|NOT COMPLETED|Overall Study||11
6644778|NCT02366403|7573437|FG001|NOT COMPLETED|Overall Study||15
6644779|NCT02366468|7573445|FG000|STARTED|Overall Study||68
6644780|NCT02366468|7573446|FG001|STARTED|Overall Study||67
6644781|NCT02366468|7573445|FG000|Full Analysis Set (FAS)|Overall Study||67
6533960|NCT01633112|7455771|FG000|STARTED|Overall Study||352
6533961|NCT01633112|7455772|FG001|STARTED|Overall Study||370
6533962|NCT01633112|7455773|FG002|STARTED|Overall Study||342
6533963|NCT01633112|7455771|FG000|COMPLETED|Overall Study||299
6533964|NCT01633112|7455772|FG001|COMPLETED|Overall Study||310
6533965|NCT01633112|7455773|FG002|COMPLETED|Overall Study||250
6533966|NCT01633112|7455771|FG000|NOT COMPLETED|Overall Study||53
6533967|NCT01633112|7455772|FG001|NOT COMPLETED|Overall Study||60
6533968|NCT01633112|7455773|FG002|NOT COMPLETED|Overall Study||92
6533969|NCT01633320|7455784|FG000|STARTED|Overall Study||132
6533970|NCT01633320|7455785|FG001|STARTED|Overall Study||68
6533971|NCT01633320|7455784|FG000|COMPLETED|Overall Study||132
6533972|NCT01633320|7455785|FG001|COMPLETED|Overall Study||68
6533973|NCT01633320|7455784|FG000|NOT COMPLETED|Overall Study||0
6533974|NCT01633320|7455785|FG001|NOT COMPLETED|Overall Study||0
6533975|NCT01633398|7455793|FG000|STARTED|Overall Study||4779
6533976|NCT01633398|7455794|FG001|STARTED|Overall Study||1550
6533977|NCT01633398|7455793|FG000|COMPLETED|Overall Study||4779
6533978|NCT01633398|7455794|FG001|COMPLETED|Overall Study||1550
6533979|NCT01633398|7455793|FG000|NOT COMPLETED|Overall Study||0
6533980|NCT01633398|7455794|FG001|NOT COMPLETED|Overall Study||0
6533981|NCT01633788|7455804|FG000|STARTED|Overall Study||57
6533982|NCT01633788|7455805|FG001|STARTED|Overall Study||58
6533983|NCT01633788|7455806|FG002|STARTED|Overall Study||59
6533984|NCT01633788|7455807|FG003|STARTED|Overall Study||58
6533985|NCT01633788|7455804|FG000|COMPLETED|Overall Study||50
6533986|NCT01633788|7455805|FG001|COMPLETED|Overall Study||50
6533987|NCT01633788|7455806|FG002|COMPLETED|Overall Study||49
6533988|NCT01633788|7455807|FG003|COMPLETED|Overall Study||45
6533989|NCT01633788|7455804|FG000|NOT COMPLETED|Overall Study||7
6533990|NCT01633788|7455805|FG001|NOT COMPLETED|Overall Study||8
6533991|NCT01633788|7455806|FG002|NOT COMPLETED|Overall Study||10
6533992|NCT01633788|7455807|FG003|NOT COMPLETED|Overall Study||13
6533993|NCT01633827|7455817|FG000|STARTED|First Intervention||11
6533994|NCT01633827|7455818|FG001|STARTED|First Intervention||11
6533995|NCT01633827|7455817|FG000|COMPLETED|First Intervention||11
6533996|NCT01633827|7455818|FG001|COMPLETED|First Intervention||11
6533997|NCT01633827|7455817|FG000|NOT COMPLETED|First Intervention||0
6644782|NCT02366468|7573446|FG001|Full Analysis Set (FAS)|Overall Study||66
6644783|NCT02366468|7573445|FG000|Per Protocol Set (PPS)|Overall Study||62
6644784|NCT02366468|7573446|FG001|Per Protocol Set (PPS)|Overall Study||61
6644785|NCT02366468|7573445|FG000|COMPLETED|Overall Study||62
6644786|NCT02366468|7573446|FG001|COMPLETED|Overall Study||58
6644787|NCT02366468|7573445|FG000|NOT COMPLETED|Overall Study||6
6644788|NCT02366468|7573446|FG001|NOT COMPLETED|Overall Study||9
6644789|NCT02366611|7573454|FG000|STARTED|Overall Study||10
6743734|NCT03335254|7671811|FG001|NOT COMPLETED|Period 3, Day 16-25||0
6743735|NCT03335254|7671812|FG002|NOT COMPLETED|Period 3, Day 16-25||0
6743736|NCT03335254|7671813|FG003|NOT COMPLETED|Period 3, Day 16-25||0
6743737|NCT03335254|7671814|FG004|NOT COMPLETED|Period 3, Day 16-25||0
6743738|NCT03335254|7671815|FG005|NOT COMPLETED|Period 3, Day 16-25||0
6743739|NCT03335254|7671816|FG006|NOT COMPLETED|Period 3, Day 16-25||0
6743740|NCT03335254|7671817|FG007|NOT COMPLETED|Period 3, Day 16-25||0
6743741|NCT03335254|7671818|FG008|NOT COMPLETED|Period 3, Day 16-25||0
6743742|NCT03335254|7671819|FG009|NOT COMPLETED|Period 3, Day 16-25||0
6743743|NCT03335254|7671820|FG010|NOT COMPLETED|Period 3, Day 16-25||0
6743744|NCT03335254|7671821|FG011|NOT COMPLETED|Period 3, Day 16-25||0
6743745|NCT03335254|7671822|FG012|NOT COMPLETED|Period 3, Day 16-25||0
6743746|NCT03335254|7671823|FG013|NOT COMPLETED|Period 3, Day 16-25||0
6743747|NCT03335254|7671824|FG014|NOT COMPLETED|Period 3, Day 16-25||0
6743748|NCT03335254|7671825|FG015|NOT COMPLETED|Period 3, Day 16-25||0
6743749|NCT03335254|7671826|FG016|NOT COMPLETED|Period 3, Day 16-25||0
6533998|NCT01633827|7455818|FG001|NOT COMPLETED|First Intervention||0
6533999|NCT01633827|7455817|FG000|STARTED|Washout Period||11
6534000|NCT01633827|7455818|FG001|STARTED|Washout Period||11
6534001|NCT01633827|7455817|FG000|COMPLETED|Washout Period||11
6644790|NCT02366611|7573455|FG001|STARTED|Overall Study||1
6644791|NCT02366611|7573454|FG000|COMPLETED|Overall Study||8
6644792|NCT02366611|7573455|FG001|COMPLETED|Overall Study||1
6644793|NCT02366611|7573454|FG000|NOT COMPLETED|Overall Study||2
6644794|NCT02366611|7573455|FG001|NOT COMPLETED|Overall Study||0
6644795|NCT02366637|7573462|FG000|STARTED|First Intervention Period||7
6644796|NCT02366637|7573463|FG001|STARTED|First Intervention Period||6
6644797|NCT02366637|7573462|FG000|COMPLETED|First Intervention Period||1
6644798|NCT02366637|7573463|FG001|COMPLETED|First Intervention Period||1
6644799|NCT02366637|7573462|FG000|NOT COMPLETED|First Intervention Period||6
6644800|NCT02366637|7573463|FG001|NOT COMPLETED|First Intervention Period||5
6644801|NCT02366637|7573462|FG000|STARTED|Washout Period 28 to 49 Days||1
6644802|NCT02366637|7573463|FG001|STARTED|Washout Period 28 to 49 Days||1
6644803|NCT02366637|7573462|FG000|COMPLETED|Washout Period 28 to 49 Days||1
6644804|NCT02366637|7573463|FG001|COMPLETED|Washout Period 28 to 49 Days||1
6644805|NCT02366637|7573462|FG000|NOT COMPLETED|Washout Period 28 to 49 Days||0
6644806|NCT02366637|7573463|FG001|NOT COMPLETED|Washout Period 28 to 49 Days||0
6644807|NCT02366637|7573462|FG000|STARTED|Second Intervention Period||1
6644808|NCT02366637|7573463|FG001|STARTED|Second Intervention Period||1
6644809|NCT02366637|7573462|FG000|COMPLETED|Second Intervention Period||0
6743750|NCT03335254|7671827|FG017|NOT COMPLETED|Period 3, Day 16-25||0
6743751|NCT03335254|7671828|FG018|NOT COMPLETED|Period 3, Day 16-25||0
6743752|NCT03335254|7671829|FG019|NOT COMPLETED|Period 3, Day 16-25||0
6534002|NCT01633827|7455818|FG001|COMPLETED|Washout Period||11
6534003|NCT01633827|7455817|FG000|NOT COMPLETED|Washout Period||0
6534004|NCT01633827|7455818|FG001|NOT COMPLETED|Washout Period||0
6534005|NCT01633827|7455817|FG000|STARTED|Second Intervention||11
6534006|NCT01633827|7455818|FG001|STARTED|Second Intervention||11
6534007|NCT01633827|7455817|FG000|COMPLETED|Second Intervention||11
6534008|NCT01633827|7455818|FG001|COMPLETED|Second Intervention||11
6534009|NCT01633827|7455817|FG000|NOT COMPLETED|Second Intervention||0
6534010|NCT01633827|7455818|FG001|NOT COMPLETED|Second Intervention||0
6534011|NCT01633853|7455833|FG000|STARTED|Overall Study||104
6534012|NCT01633853|7455834|FG001|STARTED|Overall Study||100
6534013|NCT01633853|7455833|FG000|COMPLETED|Overall Study||104
6534014|NCT01633853|7455834|FG001|COMPLETED|Overall Study||100
6534015|NCT01633853|7455833|FG000|NOT COMPLETED|Overall Study||0
6534016|NCT01633853|7455834|FG001|NOT COMPLETED|Overall Study||0
6534017|NCT01633892|7455841|FG000|STARTED|Overall Study||5
6534018|NCT01633892|7455841|FG000|COMPLETED|Overall Study||5
6534019|NCT01633892|7455841|FG000|NOT COMPLETED|Overall Study||0
6534020|NCT01633944|7455847|FG000|STARTED|Open-label Titration Phase||752
6534021|NCT01633944|7455848|FG001|STARTED|Open-label Titration Phase||0
6534022|NCT01633944|7455849|FG002|STARTED|Open-label Titration Phase||0
6534023|NCT01633944|7455847|FG000|COMPLETED|Open-label Titration Phase||462
6534024|NCT01633944|7455848|FG001|COMPLETED|Open-label Titration Phase||0
6534025|NCT01633944|7455849|FG002|COMPLETED|Open-label Titration Phase||0
6534026|NCT01633944|7455847|FG000|NOT COMPLETED|Open-label Titration Phase||290
6534027|NCT01633944|7455848|FG001|NOT COMPLETED|Open-label Titration Phase||0
6534028|NCT01633944|7455849|FG002|NOT COMPLETED|Open-label Titration Phase||0
6534029|NCT01633944|7455847|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
6534030|NCT01633944|7455848|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
6534031|NCT01633944|7455849|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
6534032|NCT01633944|7455847|FG000|COMPLETED|Double-blind Treatment Phase||0
6534033|NCT01633944|7455848|FG001|COMPLETED|Double-blind Treatment Phase||176
6534034|NCT01633944|7455849|FG002|COMPLETED|Double-blind Treatment Phase||174
6534035|NCT01633944|7455847|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
6534036|NCT01633944|7455848|FG001|NOT COMPLETED|Double-blind Treatment Phase||54
6534037|NCT01633944|7455849|FG002|NOT COMPLETED|Double-blind Treatment Phase||58
6534044|NCT01634100|7455866|FG000|STARTED|Overall Study||3
6534045|NCT01634100|7455867|FG001|STARTED|Overall Study||3
6534046|NCT01634100|7455868|FG002|STARTED|Overall Study||3
6534047|NCT01634100|7455869|FG003|STARTED|Overall Study||3
6534048|NCT01634100|7455870|FG004|STARTED|Overall Study||3
6534049|NCT01634100|7455871|FG005|STARTED|Overall Study||3
6534050|NCT01634100|7455866|FG000|Received Empa Alone|Overall Study||3
6534051|NCT01634100|7455867|FG001|Received Empa Alone|Overall Study||3
6534052|NCT01634100|7455868|FG002|Received Empa Alone|Overall Study||3
6534053|NCT01634100|7455869|FG003|Received Empa Alone|Overall Study||3
6534054|NCT01634100|7455870|FG004|Received Empa Alone|Overall Study||3
6534055|NCT01634100|7455871|FG005|Received Empa Alone|Overall Study||3
6534056|NCT01634100|7455866|FG000|Received Empa + Rifampicin|Overall Study||3
6534057|NCT01634100|7455867|FG001|Received Empa + Rifampicin|Overall Study||3
6534058|NCT01634100|7455868|FG002|Received Empa + Rifampicin|Overall Study||3
6534059|NCT01634100|7455869|FG003|Received Empa + Rifampicin|Overall Study||3
6534060|NCT01634100|7455870|FG004|Received Empa + Rifampicin|Overall Study||3
6534061|NCT01634100|7455871|FG005|Received Empa + Rifampicin|Overall Study||3
6534062|NCT01634100|7455866|FG000|Received Empa + Probenecid|Overall Study||2
6534063|NCT01634100|7455867|FG001|Received Empa + Probenecid|Overall Study||3
6534064|NCT01634100|7455868|FG002|Received Empa + Probenecid|Overall Study||2
6534065|NCT01634100|7455869|FG003|Received Empa + Probenecid|Overall Study||3
6644810|NCT02366637|7573463|FG001|COMPLETED|Second Intervention Period||0
6644811|NCT02366637|7573462|FG000|NOT COMPLETED|Second Intervention Period||1
6644812|NCT02366637|7573463|FG001|NOT COMPLETED|Second Intervention Period||1
6644813|NCT02366663|7573471|FG000|STARTED|Overall Study||2
6644814|NCT02366663|7573472|FG001|STARTED|Overall Study||1
6644815|NCT02366663|7573471|FG000|COMPLETED|Overall Study||2
6644816|NCT02366663|7573472|FG001|COMPLETED|Overall Study||1
6644817|NCT02366663|7573471|FG000|NOT COMPLETED|Overall Study||0
6534066|NCT01634100|7455870|FG004|Received Empa + Probenecid|Overall Study||3
6534067|NCT01634100|7455871|FG005|Received Empa + Probenecid|Overall Study||3
6534068|NCT01634100|7455866|FG000|COMPLETED|Overall Study||2
6534069|NCT01634100|7455867|FG001|COMPLETED|Overall Study||3
6534070|NCT01634100|7455868|FG002|COMPLETED|Overall Study||2
6534071|NCT01634100|7455869|FG003|COMPLETED|Overall Study||3
6534072|NCT01634100|7455870|FG004|COMPLETED|Overall Study||3
6534073|NCT01634100|7455871|FG005|COMPLETED|Overall Study||3
6534074|NCT01634100|7455866|FG000|NOT COMPLETED|Overall Study||1
6534075|NCT01634100|7455867|FG001|NOT COMPLETED|Overall Study||0
6534076|NCT01634100|7455868|FG002|NOT COMPLETED|Overall Study||1
6534077|NCT01634100|7455869|FG003|NOT COMPLETED|Overall Study||0
6534078|NCT01634100|7455870|FG004|NOT COMPLETED|Overall Study||0
6534079|NCT01634100|7455871|FG005|NOT COMPLETED|Overall Study||0
6534080|NCT01634113|7455882|FG000|STARTED|Overall Study||34
6534081|NCT01634113|7455883|FG001|STARTED|Overall Study||36
6534082|NCT01634113|7455884|FG002|STARTED|Overall Study||32
6534083|NCT01634113|7455882|FG000|COMPLETED|Overall Study||34
6534084|NCT01634113|7455883|FG001|COMPLETED|Overall Study||36
6534085|NCT01634113|7455884|FG002|COMPLETED|Overall Study||31
6534086|NCT01634113|7455882|FG000|NOT COMPLETED|Overall Study||0
6534087|NCT01634113|7455883|FG001|NOT COMPLETED|Overall Study||0
6534088|NCT01634113|7455884|FG002|NOT COMPLETED|Overall Study||1
6534089|NCT01634139|7455895|FG000|STARTED|Overall Study||132
6534090|NCT01634139|7455896|FG001|STARTED|Overall Study||136
6534091|NCT01634139|7455897|FG002|STARTED|Overall Study||135
6534092|NCT01634139|7455895|FG000|COMPLETED|Overall Study||122
6534093|NCT01634139|7455896|FG001|COMPLETED|Overall Study||130
6534094|NCT01634139|7455897|FG002|COMPLETED|Overall Study||130
6534095|NCT01634139|7455895|FG000|NOT COMPLETED|Overall Study||10
6534096|NCT01634139|7455896|FG001|NOT COMPLETED|Overall Study||6
6534097|NCT01634139|7455897|FG002|NOT COMPLETED|Overall Study||5
6534098|NCT01634152|7455908|FG000|STARTED|Overall Study||134
6534099|NCT01634152|7455909|FG001|STARTED|Overall Study||137
6534100|NCT01634152|7455910|FG002|STARTED|Overall Study||130
6534101|NCT01634152|7455908|FG000|COMPLETED|Overall Study||130
6534102|NCT01634152|7455909|FG001|COMPLETED|Overall Study||136
6534103|NCT01634152|7455910|FG002|COMPLETED|Overall Study||126
6534104|NCT01634152|7455908|FG000|NOT COMPLETED|Overall Study||4
6534105|NCT01634152|7455909|FG001|NOT COMPLETED|Overall Study||1
6534106|NCT01634152|7455910|FG002|NOT COMPLETED|Overall Study||4
6534107|NCT01634165|7455918|FG000|STARTED|Period 1||6
6534108|NCT01634165|7455919|FG001|STARTED|Period 1||6
6534109|NCT01634165|7455920|FG002|STARTED|Period 1||6
6534110|NCT01634165|7455921|FG003|STARTED|Period 1||6
6534111|NCT01634165|7455918|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
6534112|NCT01634165|7455919|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
6534113|NCT01634165|7455920|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
6534114|NCT01634165|7455921|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
6534115|NCT01634165|7455918|FG000|COMPLETED|Period 1||6
6534116|NCT01634165|7455919|FG001|COMPLETED|Period 1||6
6534117|NCT01634165|7455920|FG002|COMPLETED|Period 1||6
6534118|NCT01634165|7455921|FG003|COMPLETED|Period 1||6
6534119|NCT01634165|7455918|FG000|NOT COMPLETED|Period 1||0
6534120|NCT01634165|7455919|FG001|NOT COMPLETED|Period 1||0
6534121|NCT01634165|7455920|FG002|NOT COMPLETED|Period 1||0
6534122|NCT01634165|7455921|FG003|NOT COMPLETED|Period 1||0
6534123|NCT01634165|7455918|FG000|STARTED|Period 2||6
6534124|NCT01634165|7455919|FG001|STARTED|Period 2||6
6534125|NCT01634165|7455920|FG002|STARTED|Period 2||6
6534126|NCT01634165|7455921|FG003|STARTED|Period 2||6
6534127|NCT01634165|7455918|FG000|COMPLETED|Period 2||6
6644818|NCT02366663|7573472|FG001|NOT COMPLETED|Overall Study||0
6644819|NCT02366689|7573481|FG000|STARTED|Overall Study||60
6644820|NCT02366689|7573482|FG001|STARTED|Overall Study||58
6644821|NCT02366689|7573483|FG002|STARTED|Overall Study||61
6644822|NCT02366689|7573481|FG000|COMPLETED|Overall Study||56
6304211|NCT00364832|7207525|FG011|NOT COMPLETED|Core Period||0
6304212|NCT00364832|7207514|FG000|STARTED|Extension Year 1||0
6304213|NCT00364832|7207515|FG001|STARTED|Extension Year 1||0
6304214|NCT00364832|7207516|FG002|STARTED|Extension Year 1||0
6304215|NCT00364832|7207517|FG003|STARTED|Extension Year 1||0
6304216|NCT00364832|7207518|FG004|STARTED|Extension Year 1||0
6644823|NCT02366689|7573482|FG001|COMPLETED|Overall Study||55
6644824|NCT02366689|7573483|FG002|COMPLETED|Overall Study||59
6644825|NCT02366689|7573481|FG000|NOT COMPLETED|Overall Study||4
6644826|NCT02366689|7573482|FG001|NOT COMPLETED|Overall Study||3
6644827|NCT02366689|7573483|FG002|NOT COMPLETED|Overall Study||2
6644828|NCT02366767|7573493|FG000|STARTED|Overall Study||11
6644829|NCT02366767|7573494|FG001|STARTED|Overall Study||10
6644830|NCT02366767|7573493|FG000|COMPLETED|Overall Study||10
6644831|NCT02366767|7573494|FG001|COMPLETED|Overall Study||10
6644832|NCT02366767|7573493|FG000|NOT COMPLETED|Overall Study||1
6644833|NCT02366767|7573494|FG001|NOT COMPLETED|Overall Study||0
6644834|NCT02366845|7573502|FG000|STARTED|Overall Study||25
6644835|NCT02366845|7573503|FG001|STARTED|Overall Study||25
6644836|NCT02366845|7573502|FG000|COMPLETED|Overall Study||25
6644837|NCT02366845|7573503|FG001|COMPLETED|Overall Study||25
6644838|NCT02366845|7573502|FG000|NOT COMPLETED|Overall Study||0
6644839|NCT02366845|7573503|FG001|NOT COMPLETED|Overall Study||0
6644840|NCT02366871|7573511|FG000|STARTED|Overall Study||204
6644841|NCT02366871|7573512|FG001|STARTED|Overall Study||196
6644842|NCT02366871|7573511|FG000|COMPLETED|Overall Study||204
6644843|NCT02366871|7573512|FG001|COMPLETED|Overall Study||196
6644844|NCT02366871|7573511|FG000|NOT COMPLETED|Overall Study||0
6644845|NCT02366871|7573512|FG001|NOT COMPLETED|Overall Study||0
6304217|NCT00364832|7207519|FG005|STARTED|Extension Year 1||0
6304218|NCT00364832|7207520|FG006|STARTED|Extension Year 1||0
6534128|NCT01634165|7455919|FG001|COMPLETED|Period 2||5
6534129|NCT01634165|7455920|FG002|COMPLETED|Period 2||6
6534130|NCT01634165|7455921|FG003|COMPLETED|Period 2||6
6534131|NCT01634165|7455918|FG000|NOT COMPLETED|Period 2||0
6534132|NCT01634165|7455919|FG001|NOT COMPLETED|Period 2||1
6534133|NCT01634165|7455920|FG002|NOT COMPLETED|Period 2||0
6534134|NCT01634165|7455921|FG003|NOT COMPLETED|Period 2||0
6534135|NCT01634165|7455918|FG000|STARTED|Period 3||6
6534136|NCT01634165|7455919|FG001|STARTED|Period 3||5
6534137|NCT01634165|7455920|FG002|STARTED|Period 3||6
6534138|NCT01634165|7455921|FG003|STARTED|Period 3||6
6534139|NCT01634165|7455918|FG000|COMPLETED|Period 3||6
6534140|NCT01634165|7455919|FG001|COMPLETED|Period 3||5
6534141|NCT01634165|7455920|FG002|COMPLETED|Period 3||6
6534142|NCT01634165|7455921|FG003|COMPLETED|Period 3||6
6534143|NCT01634165|7455918|FG000|NOT COMPLETED|Period 3||0
6534144|NCT01634165|7455919|FG001|NOT COMPLETED|Period 3||0
6534145|NCT01634165|7455920|FG002|NOT COMPLETED|Period 3||0
6534146|NCT01634165|7455921|FG003|NOT COMPLETED|Period 3||0
6534147|NCT01634165|7455918|FG000|STARTED|Period 4||6
6534148|NCT01634165|7455919|FG001|STARTED|Period 4||5
6534149|NCT01634165|7455920|FG002|STARTED|Period 4||6
6534150|NCT01634165|7455921|FG003|STARTED|Period 4||6
6534151|NCT01634165|7455918|FG000|COMPLETED|Period 4||6
6534152|NCT01634165|7455919|FG001|COMPLETED|Period 4||5
6534153|NCT01634165|7455920|FG002|COMPLETED|Period 4||6
6534154|NCT01634165|7455921|FG003|COMPLETED|Period 4||6
6534155|NCT01634165|7455918|FG000|NOT COMPLETED|Period 4||0
6534156|NCT01634165|7455919|FG001|NOT COMPLETED|Period 4||0
6534157|NCT01634165|7455920|FG002|NOT COMPLETED|Period 4||0
6534158|NCT01634165|7455921|FG003|NOT COMPLETED|Period 4||0
6534159|NCT01634178|7455931|FG000|STARTED|Treatment Period 1||23
6534160|NCT01634178|7455932|FG001|STARTED|Treatment Period 1||23
6534161|NCT01634178|7455931|FG000|COMPLETED|Treatment Period 1||23
6534162|NCT01634178|7455932|FG001|COMPLETED|Treatment Period 1||22
6534163|NCT01634178|7455931|FG000|NOT COMPLETED|Treatment Period 1||0
6534164|NCT01634178|7455932|FG001|NOT COMPLETED|Treatment Period 1||1
6534165|NCT01634178|7455931|FG000|STARTED|Treatment Period 2||23
6534166|NCT01634178|7455932|FG001|STARTED|Treatment Period 2||22
6534167|NCT01634178|7455931|FG000|COMPLETED|Treatment Period 2||22
6534168|NCT01634178|7455932|FG001|COMPLETED|Treatment Period 2||22
6534169|NCT01634178|7455931|FG000|NOT COMPLETED|Treatment Period 2||1
6534170|NCT01634178|7455932|FG001|NOT COMPLETED|Treatment Period 2||0
6562056|NCT01798849|7485058|FG002|STARTED|Overall Study|1 participant discontinued after Period 1 and was replaced for Periods 2-4|9
6644846|NCT02366910|7573518|FG000|STARTED|Overall Study||26
6644847|NCT02366910|7573518|FG000|COMPLETED|Overall Study||21
6644848|NCT02366910|7573518|FG000|NOT COMPLETED|Overall Study||5
6644849|NCT02366923|7573524|FG000|STARTED|Overall Study||28
6644850|NCT02366923|7573524|FG000|COMPLETED|Overall Study||22
6644851|NCT02366923|7573524|FG000|NOT COMPLETED|Overall Study||6
6644852|NCT02366936|7573529|FG000|STARTED|Overall Study||32
6644853|NCT02366936|7573529|FG000|COMPLETED|Overall Study||24
6644854|NCT02366936|7573529|FG000|NOT COMPLETED|Overall Study||8
6644855|NCT02367014|7573537|FG000|STARTED|Overall Study||9
6644856|NCT02367014|7573538|FG001|STARTED|Overall Study||9
6644857|NCT02367014|7573539|FG002|STARTED|Overall Study||9
6644858|NCT02367014|7573540|FG003|STARTED|Overall Study||9
6644859|NCT02367014|7573537|FG000|COMPLETED|Overall Study||9
6644860|NCT02367014|7573538|FG001|COMPLETED|Overall Study||9
6644861|NCT02367014|7573539|FG002|COMPLETED|Overall Study||9
6644862|NCT02367014|7573540|FG003|COMPLETED|Overall Study||9
6644863|NCT02367014|7573537|FG000|NOT COMPLETED|Overall Study||0
6644864|NCT02367014|7573538|FG001|NOT COMPLETED|Overall Study||0
6644865|NCT02367014|7573539|FG002|NOT COMPLETED|Overall Study||0
6644866|NCT02367014|7573540|FG003|NOT COMPLETED|Overall Study||0
6644867|NCT02367066|7573554|FG000|STARTED|Overall Study||10
6644868|NCT02367066|7573555|FG001|STARTED|Overall Study||10
6644869|NCT02367066|7573554|FG000|COMPLETED|Overall Study||10
6644870|NCT02367066|7573555|FG001|COMPLETED|Overall Study||10
6644871|NCT02367066|7573554|FG000|NOT COMPLETED|Overall Study||0
6644872|NCT02367066|7573555|FG001|NOT COMPLETED|Overall Study||0
6644873|NCT02367131|7573566|FG000|STARTED|Overall Study|Started are the treated patients|423
6644874|NCT02367131|7573566|FG000|COMPLETED|Overall Study||201
6644875|NCT02367131|7573566|FG000|NOT COMPLETED|Overall Study||222
6644876|NCT02367352|7573570|FG000|STARTED|Overall Study||9
6644877|NCT02367352|7573571|FG001|STARTED|Overall Study||0
6644878|NCT02367352|7573572|FG002|STARTED|Overall Study||0
6644879|NCT02367352|7573570|FG000|COMPLETED|Overall Study||0
6644880|NCT02367352|7573571|FG001|COMPLETED|Overall Study||0
6644881|NCT02367352|7573572|FG002|COMPLETED|Overall Study||0
6644882|NCT02367352|7573570|FG000|NOT COMPLETED|Overall Study||9
6562057|NCT01798849|7485056|FG000|COMPLETED|Overall Study||8
6562058|NCT01798849|7485057|FG001|COMPLETED|Overall Study||8
6562059|NCT01798849|7485058|FG002|COMPLETED|Overall Study||8
6562060|NCT01798849|7485056|FG000|NOT COMPLETED|Overall Study||0
6562061|NCT01798849|7485057|FG001|NOT COMPLETED|Overall Study||0
6562062|NCT01798849|7485058|FG002|NOT COMPLETED|Overall Study||1
6562063|NCT01798927|7485095|FG000|STARTED|Overall Study||4
6562064|NCT01798927|7485095|FG000|COMPLETED|Overall Study||3
6562065|NCT01798927|7485095|FG000|NOT COMPLETED|Overall Study||1
6562066|NCT01798966|7485099|FG000|STARTED|Overall Study||10
6562067|NCT01798966|7485099|FG000|COMPLETED|Overall Study||10
6562068|NCT01798966|7485099|FG000|NOT COMPLETED|Overall Study||0
6562069|NCT01798992|7485108|FG000|STARTED|Overall Study||4
6644883|NCT02367352|7573571|FG001|NOT COMPLETED|Overall Study||0
6644884|NCT02367352|7573572|FG002|NOT COMPLETED|Overall Study||0
6644885|NCT02367391|7573580|FG000|STARTED|Overall Study||76
6644886|NCT02367391|7573581|FG001|STARTED|Overall Study||76
6644887|NCT02367391|7573580|FG000|COMPLETED|Overall Study||74
6562070|NCT01798992|7485109|FG001|STARTED|Overall Study||19
6562071|NCT01798992|7485110|FG002|STARTED|Overall Study||16
6534171|NCT01634191|7455943|FG000|STARTED|Overall Study||18
6534172|NCT01634191|7455944|FG001|STARTED|Overall Study||18
6534173|NCT01634191|7455943|FG000|COMPLETED|Overall Study||18
6534174|NCT01634191|7455944|FG001|COMPLETED|Overall Study||18
6534175|NCT01634191|7455943|FG000|NOT COMPLETED|Overall Study||0
6534176|NCT01634191|7455944|FG001|NOT COMPLETED|Overall Study||0
6534177|NCT01634243|7455963|FG000|STARTED|Overall Study||21
6534178|NCT01634243|7455964|FG001|STARTED|Overall Study||43
6534179|NCT01634243|7455963|FG000|COMPLETED|Overall Study||15
6534180|NCT01634243|7455964|FG001|COMPLETED|Overall Study||38
6534181|NCT01634243|7455963|FG000|NOT COMPLETED|Overall Study||6
6534182|NCT01634243|7455964|FG001|NOT COMPLETED|Overall Study||5
6534183|NCT01634256|7455972|FG000|STARTED|Overall Study||30
6534184|NCT01634256|7455973|FG001|STARTED|Overall Study||30
6534185|NCT01634256|7455972|FG000|COMPLETED|Overall Study||26
6534186|NCT01634256|7455973|FG001|COMPLETED|Overall Study||22
6534187|NCT01634256|7455972|FG000|NOT COMPLETED|Overall Study||4
6534188|NCT01634256|7455973|FG001|NOT COMPLETED|Overall Study||8
6534189|NCT01634269|7455979|FG000|STARTED|Overall Study||20
6534190|NCT01634269|7455979|FG000|30 Days|Overall Study||20
6534191|NCT01634269|7455979|FG000|6 Month|Overall Study||20
6534192|NCT01634269|7455979|FG000|12 Month|Overall Study||20
6534193|NCT01634269|7455979|FG000|24 Month|Overall Study||18
6534194|NCT01634269|7455979|FG000|COMPLETED|Overall Study||18
6534195|NCT01634269|7455979|FG000|NOT COMPLETED|Overall Study||2
6534196|NCT01634360|7455991|FG000|STARTED|Overall Study||49
6534197|NCT01634360|7455992|FG001|STARTED|Overall Study||136
6534198|NCT01634360|7455991|FG000|COMPLETED|Overall Study||0
6534199|NCT01634360|7455992|FG001|COMPLETED|Overall Study||0
6534200|NCT01634360|7455991|FG000|NOT COMPLETED|Overall Study||49
6534201|NCT01634360|7455992|FG001|NOT COMPLETED|Overall Study||136
6534202|NCT01634555|7455998|FG000|STARTED|Overall Study||29
6534203|NCT01634555|7455998|FG000|Received at Least 1 Dose of Study Drug|Overall Study||29
6534204|NCT01634555|7455998|FG000|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
6534205|NCT01634555|7455998|FG000|COMPLETED|Overall Study|Completed the required treatment and assessment.|25
6534206|NCT01634555|7455998|FG000|NOT COMPLETED|Overall Study||4
6534207|NCT01634620|7456003|FG000|STARTED|Overall Study||200
6534208|NCT01634620|7456003|FG000|COMPLETED|Overall Study||200
6534209|NCT01634620|7456003|FG000|NOT COMPLETED|Overall Study||0
6534210|NCT01634659|7456014|FG000|STARTED|Period 1 - First 8 Days of Wear||155
6534211|NCT01634659|7456015|FG001|STARTED|Period 1 - First 8 Days of Wear||158
6534212|NCT01634659|7456014|FG000|COMPLETED|Period 1 - First 8 Days of Wear||155
6534213|NCT01634659|7456015|FG001|COMPLETED|Period 1 - First 8 Days of Wear||158
6534214|NCT01634659|7456014|FG000|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
6534215|NCT01634659|7456015|FG001|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
6534216|NCT01634659|7456014|FG000|STARTED|Period 2 - Second 8 Days of Wear||155
6534217|NCT01634659|7456015|FG001|STARTED|Period 2 - Second 8 Days of Wear||158
6534218|NCT01634659|7456014|FG000|COMPLETED|Period 2 - Second 8 Days of Wear||152
6534219|NCT01634659|7456015|FG001|COMPLETED|Period 2 - Second 8 Days of Wear||158
6534220|NCT01634659|7456014|FG000|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
6534221|NCT01634659|7456015|FG001|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
6534222|NCT01634854|7456023|FG000|STARTED|Overall Study||64
6534223|NCT01634854|7456024|FG001|STARTED|Overall Study||66
6534224|NCT01634854|7456023|FG000|COMPLETED|Overall Study||62
6534225|NCT01634854|7456024|FG001|COMPLETED|Overall Study||59
6534226|NCT01634854|7456023|FG000|NOT COMPLETED|Overall Study||2
6534227|NCT01634854|7456024|FG001|NOT COMPLETED|Overall Study||7
6534228|NCT01635062|7456032|FG000|STARTED|Overall Study||9
6534229|NCT01635062|7456033|FG001|STARTED|Overall Study||9
6534230|NCT01635062|7456032|FG000|Sodium Restriction Baseline Visit|Overall Study||9
6534231|NCT01635062|7456033|FG001|Sodium Restriction Baseline Visit|Overall Study||9
6534232|NCT01635062|7456032|FG000|Sodium Loading Baseline Visit|Overall Study||9
6534233|NCT01635062|7456033|FG001|Sodium Loading Baseline Visit|Overall Study||9
6534234|NCT01635062|7456032|FG000|Post-randomization Sodium Restriction|Overall Study||9
6534235|NCT01635062|7456033|FG001|Post-randomization Sodium Restriction|Overall Study||9
6644888|NCT02367391|7573581|FG001|COMPLETED|Overall Study||76
6644889|NCT02367391|7573580|FG000|NOT COMPLETED|Overall Study||2
6644890|NCT02367391|7573581|FG001|NOT COMPLETED|Overall Study||0
6644891|NCT02367430|7573587|FG000|STARTED|Overall Study||14
6644892|NCT02367430|7573587|FG000|COMPLETED|Overall Study||11
6534236|NCT01635062|7456032|FG000|Post-Randomization Sodium Loaded|Overall Study||9
6534237|NCT01635062|7456033|FG001|Post-Randomization Sodium Loaded|Overall Study||9
6534238|NCT01635062|7456032|FG000|COMPLETED|Overall Study||9
6534239|NCT01635062|7456033|FG001|COMPLETED|Overall Study||9
6534240|NCT01635062|7456032|FG000|NOT COMPLETED|Overall Study||0
6534241|NCT01635062|7456033|FG001|NOT COMPLETED|Overall Study||0
6534242|NCT01635101|7456046|FG000|STARTED|Overall Study||61
6534243|NCT01635101|7456047|FG001|STARTED|Overall Study||67
6534244|NCT01635101|7456048|FG002|STARTED|Overall Study||69
6534245|NCT01635101|7456046|FG000|Safety Population|Overall Study||61
6534246|NCT01635101|7456047|FG001|Safety Population|Overall Study||67
6534247|NCT01635101|7456048|FG002|Safety Population|Overall Study||69
6534248|NCT01635101|7456046|FG000|Modified Intent to Treat (mITT)|Overall Study||61
6534249|NCT01635101|7456047|FG001|Modified Intent to Treat (mITT)|Overall Study||67
6644893|NCT02367430|7573587|FG000|NOT COMPLETED|Overall Study||3
6644894|NCT02367521|7573593|FG000|STARTED|Overall Study||17
6534250|NCT01635101|7456048|FG002|Modified Intent to Treat (mITT)|Overall Study||69
6534251|NCT01635101|7456046|FG000|Pharmacokinetics Evaluable Population|Overall Study||50
6534252|NCT01635101|7456047|FG001|Pharmacokinetics Evaluable Population|Overall Study||59
6534253|NCT01635101|7456048|FG002|Pharmacokinetics Evaluable Population|Overall Study||58
6534254|NCT01635101|7456046|FG000|COMPLETED|Overall Study||52
6534255|NCT01635101|7456047|FG001|COMPLETED|Overall Study||55
6534256|NCT01635101|7456048|FG002|COMPLETED|Overall Study||52
6534257|NCT01635101|7456046|FG000|NOT COMPLETED|Overall Study||9
6534258|NCT01635101|7456047|FG001|NOT COMPLETED|Overall Study||12
6534259|NCT01635101|7456048|FG002|NOT COMPLETED|Overall Study||17
6534260|NCT01635153|7456061|FG000|STARTED|Overall Study||72
6534261|NCT01635153|7456062|FG001|STARTED|Overall Study||79
6534262|NCT01635153|7456061|FG000|COMPLETED|Overall Study||32
6534263|NCT01635153|7456062|FG001|COMPLETED|Overall Study||36
6644895|NCT02367521|7573594|FG001|STARTED|Overall Study||17
6644896|NCT02367521|7573593|FG000|COMPLETED|Overall Study||13
6644897|NCT02367521|7573594|FG001|COMPLETED|Overall Study||17
6644898|NCT02367521|7573593|FG000|NOT COMPLETED|Overall Study||4
6644899|NCT02367521|7573594|FG001|NOT COMPLETED|Overall Study||0
6644900|NCT02367599|7573602|FG000|STARTED|Overall Study||48
6644901|NCT02367599|7573603|FG001|STARTED|Overall Study||48
6644902|NCT02367599|7573602|FG000|COMPLETED|Overall Study||48
6644903|NCT02367599|7573603|FG001|COMPLETED|Overall Study||48
6644904|NCT02367599|7573602|FG000|NOT COMPLETED|Overall Study||0
6644905|NCT02367599|7573603|FG001|NOT COMPLETED|Overall Study||0
6644906|NCT02367716|7573609|FG000|STARTED|Overall Study||121
6644907|NCT02367716|7573609|FG000|COMPLETED|Overall Study||120
6644908|NCT02367716|7573609|FG000|NOT COMPLETED|Overall Study||1
6644909|NCT02367729|7573616|FG000|STARTED|Overall Study||60
6644910|NCT02367729|7573617|FG001|STARTED|Overall Study||55
6644911|NCT02367729|7573616|FG000|COMPLETED|Overall Study||57
6644912|NCT02367729|7573617|FG001|COMPLETED|Overall Study||47
6644913|NCT02367729|7573616|FG000|NOT COMPLETED|Overall Study||3
6644914|NCT02367729|7573617|FG001|NOT COMPLETED|Overall Study||8
6644915|NCT02367781|7573626|FG000|STARTED|Overall Study||483
6644916|NCT02367781|7573627|FG001|STARTED|Overall Study||240
6644917|NCT02367781|7573626|FG000|COMPLETED|Overall Study||0
6644918|NCT02367781|7573627|FG001|COMPLETED|Overall Study||0
6644919|NCT02367781|7573626|FG000|NOT COMPLETED|Overall Study||483
6644920|NCT02367781|7573627|FG001|NOT COMPLETED|Overall Study||240
6644921|NCT02367820|7573639|FG000|STARTED|Overall Study||638
6644922|NCT02367820|7573639|FG000|COMPLETED|Overall Study||402
6644923|NCT02367820|7573639|FG000|NOT COMPLETED|Overall Study||236
6644924|NCT02367833|7573652|FG000|STARTED|Overall Study||9
6644925|NCT02367833|7573653|FG001|STARTED|Overall Study||9
6644926|NCT02367833|7573654|FG002|STARTED|Overall Study||8
6644927|NCT02367833|7573652|FG000|COMPLETED|Overall Study||8
6644928|NCT02367833|7573653|FG001|COMPLETED|Overall Study||8
6644929|NCT02367833|7573654|FG002|COMPLETED|Overall Study||8
6644930|NCT02367833|7573652|FG000|NOT COMPLETED|Overall Study||1
6644931|NCT02367833|7573653|FG001|NOT COMPLETED|Overall Study||1
6644932|NCT02367833|7573654|FG002|NOT COMPLETED|Overall Study||0
6644933|NCT02367859|7573662|FG000|STARTED|Overall Study||1
6644934|NCT02367859|7573662|FG000|COMPLETED|Overall Study||1
6644935|NCT02367859|7573662|FG000|NOT COMPLETED|Overall Study||0
6644936|NCT02367872|7573674|FG000|STARTED|Overall Study||6
6644937|NCT02367872|7573675|FG001|STARTED|Overall Study||6
6644938|NCT02367872|7573676|FG002|STARTED|Overall Study||6
6644939|NCT02367872|7573677|FG003|STARTED|Overall Study||6
6644940|NCT02367872|7573678|FG004|STARTED|Overall Study||6
6644941|NCT02367872|7573679|FG005|STARTED|Overall Study||6
6644942|NCT02367872|7573680|FG006|STARTED|Overall Study||6
6644943|NCT02367872|7573681|FG007|STARTED|Overall Study||6
6644944|NCT02367872|7573674|FG000|COMPLETED|Overall Study||6
6644945|NCT02367872|7573675|FG001|COMPLETED|Overall Study||6
6644946|NCT02367872|7573676|FG002|COMPLETED|Overall Study||6
6644947|NCT02367872|7573677|FG003|COMPLETED|Overall Study||6
6644948|NCT02367872|7573678|FG004|COMPLETED|Overall Study||6
6644949|NCT02367872|7573679|FG005|COMPLETED|Overall Study||6
6644950|NCT02367872|7573680|FG006|COMPLETED|Overall Study||6
6644951|NCT02367872|7573681|FG007|COMPLETED|Overall Study||6
6644952|NCT02367872|7573674|FG000|NOT COMPLETED|Overall Study||0
6644953|NCT02367872|7573675|FG001|NOT COMPLETED|Overall Study||0
6644954|NCT02367872|7573676|FG002|NOT COMPLETED|Overall Study||0
6644955|NCT02367872|7573677|FG003|NOT COMPLETED|Overall Study||0
6644956|NCT02367872|7573678|FG004|NOT COMPLETED|Overall Study||0
6644957|NCT02367872|7573679|FG005|NOT COMPLETED|Overall Study||0
6644958|NCT02367872|7573680|FG006|NOT COMPLETED|Overall Study||0
6644959|NCT02367872|7573681|FG007|NOT COMPLETED|Overall Study||0
6644960|NCT02367885|7573711|FG000|STARTED|Overall Study||33
6644961|NCT02367885|7573712|FG001|STARTED|Overall Study||33
6644962|NCT02367885|7573713|FG002|STARTED|Overall Study||33
6534264|NCT01635153|7456061|FG000|NOT COMPLETED|Overall Study||40
6644963|NCT02367885|7573711|FG000|COMPLETED|Overall Study||31
6644964|NCT02367885|7573712|FG001|COMPLETED|Overall Study||33
6534265|NCT01635153|7456062|FG001|NOT COMPLETED|Overall Study||43
6644965|NCT02367885|7573713|FG002|COMPLETED|Overall Study||33
6644966|NCT02367885|7573711|FG000|NOT COMPLETED|Overall Study||2
6644967|NCT02367885|7573712|FG001|NOT COMPLETED|Overall Study||0
6644968|NCT02367885|7573713|FG002|NOT COMPLETED|Overall Study||0
6644969|NCT02367911|7573726|FG000|STARTED|Overall Study||71
6644970|NCT02367911|7573727|FG001|STARTED|Overall Study||73
6534266|NCT01635218|7456071|FG000|STARTED|Overall Study||44
6534267|NCT01635218|7456072|FG001|STARTED|Overall Study||46
6534268|NCT01635218|7456073|FG002|STARTED|Overall Study||43
6534269|NCT01635218|7456071|FG000|COMPLETED|Overall Study||41
6534270|NCT01635218|7456072|FG001|COMPLETED|Overall Study||39
6534271|NCT01635218|7456073|FG002|COMPLETED|Overall Study||37
6534272|NCT01635218|7456071|FG000|NOT COMPLETED|Overall Study||3
6534273|NCT01635218|7456072|FG001|NOT COMPLETED|Overall Study||7
6534274|NCT01635218|7456073|FG002|NOT COMPLETED|Overall Study||6
6534275|NCT01635244|7456084|FG000|STARTED|Overall Study||18
6534276|NCT01635244|7456085|FG001|STARTED|Overall Study||22
6534277|NCT01635244|7456086|FG002|STARTED|Overall Study||20
6534278|NCT01635244|7456084|FG000|COMPLETED|Overall Study||17
6534279|NCT01635244|7456085|FG001|COMPLETED|Overall Study||21
6534280|NCT01635244|7456086|FG002|COMPLETED|Overall Study||18
6534281|NCT01635244|7456084|FG000|NOT COMPLETED|Overall Study||1
6534282|NCT01635244|7456085|FG001|NOT COMPLETED|Overall Study||1
6534283|NCT01635244|7456086|FG002|NOT COMPLETED|Overall Study||2
6534284|NCT01635283|7456094|FG000|STARTED|Overall Study||5
6534285|NCT01635283|7456094|FG000|COMPLETED|Overall Study||1
6534286|NCT01635283|7456094|FG000|NOT COMPLETED|Overall Study||4
6534287|NCT01635439|7456103|FG000|STARTED|Overall Study||100
6534288|NCT01635439|7456104|FG001|STARTED|Overall Study||100
6534289|NCT01635439|7456103|FG000|COMPLETED|Overall Study||100
6534290|NCT01635439|7456104|FG001|COMPLETED|Overall Study||100
6534291|NCT01635439|7456103|FG000|NOT COMPLETED|Overall Study||0
6534292|NCT01635439|7456104|FG001|NOT COMPLETED|Overall Study||0
6534293|NCT01635504|7456110|FG000|STARTED|Overall Study||5
6534294|NCT01635504|7456110|FG000|COMPLETED|Overall Study||5
6534295|NCT01635504|7456110|FG000|NOT COMPLETED|Overall Study||0
6534296|NCT01635764|7456119|FG000|STARTED|Overall Study||508
6534297|NCT01635764|7456119|FG000|COMPLETED|Overall Study||235
6534298|NCT01635764|7456119|FG000|NOT COMPLETED|Overall Study||273
6534299|NCT01635855|7456130|FG000|STARTED|Overall Study||117
6534300|NCT01635855|7456130|FG000|COMPLETED|Overall Study||113
6534301|NCT01635855|7456130|FG000|NOT COMPLETED|Overall Study||4
6534302|NCT01635881|7456134|FG000|STARTED|Overall Study||60
6534303|NCT01635881|7456134|FG000|COMPLETED|Overall Study||60
6534304|NCT01635881|7456134|FG000|NOT COMPLETED|Overall Study||0
6534305|NCT01635920|7456140|FG000|STARTED|Overall Study||125
6534306|NCT01635920|7456141|FG001|STARTED|Overall Study||126
6644971|NCT02367911|7573726|FG000|COMPLETED|Overall Study||66
6644972|NCT02367911|7573727|FG001|COMPLETED|Overall Study||69
6644973|NCT02367911|7573726|FG000|NOT COMPLETED|Overall Study||5
6644974|NCT02367911|7573727|FG001|NOT COMPLETED|Overall Study||4
6644975|NCT02368093|7573735|FG000|STARTED|Overall Study||24
6644976|NCT02368093|7573736|FG001|STARTED|Overall Study||24
6644977|NCT02368093|7573735|FG000|COMPLETED|Overall Study||24
6644978|NCT02368093|7573736|FG001|COMPLETED|Overall Study||24
6644979|NCT02368093|7573735|FG000|NOT COMPLETED|Overall Study||0
6644980|NCT02368093|7573736|FG001|NOT COMPLETED|Overall Study||0
6644981|NCT02368210|7573744|FG000|STARTED|Overall Study||75
6644982|NCT02368210|7573745|FG001|STARTED|Overall Study||76
6644983|NCT02368210|7573744|FG000|COMPLETED|Overall Study||74
6644984|NCT02368210|7573745|FG001|COMPLETED|Overall Study||75
6644985|NCT02368210|7573744|FG000|NOT COMPLETED|Overall Study||1
6644986|NCT02368210|7573745|FG001|NOT COMPLETED|Overall Study||1
6644987|NCT02368314|7573753|FG000|STARTED|Overall Study||64
6644988|NCT02368314|7573754|FG001|STARTED|Overall Study||60
6644989|NCT02368314|7573753|FG000|COMPLETED|Overall Study||61
6644990|NCT02368314|7573754|FG001|COMPLETED|Overall Study||57
6644991|NCT02368314|7573753|FG000|NOT COMPLETED|Overall Study||3
6644992|NCT02368314|7573754|FG001|NOT COMPLETED|Overall Study||3
6644993|NCT02368431|7573762|FG000|STARTED|Overall Study||46
6644994|NCT02368431|7573763|FG001|STARTED|Overall Study||46
6644995|NCT02368431|7573762|FG000|COMPLETED|Overall Study||22
6644996|NCT02368431|7573763|FG001|COMPLETED|Overall Study||27
6644997|NCT02368431|7573762|FG000|NOT COMPLETED|Overall Study||24
6644998|NCT02368431|7573763|FG001|NOT COMPLETED|Overall Study||19
6644999|NCT02368457|7573771|FG000|STARTED|Overall Study||12
6645000|NCT02368457|7573772|FG001|STARTED|Overall Study||12
6645001|NCT02368457|7573771|FG000|COMPLETED|Overall Study||12
6645002|NCT02368457|7573772|FG001|COMPLETED|Overall Study||12
6645003|NCT02368457|7573771|FG000|NOT COMPLETED|Overall Study||0
6645004|NCT02368457|7573772|FG001|NOT COMPLETED|Overall Study||0
6645005|NCT02368691|7573779|FG000|STARTED|Overall Study|32 subjects were enrolled and received at least one dose of study drug|32
6645006|NCT02368691|7573779|FG000|COMPLETED|Overall Study||0
6645007|NCT02368691|7573779|FG000|NOT COMPLETED|Overall Study||32
6645008|NCT02369068|7573785|FG000|STARTED|1 Month||10
6645009|NCT02369068|7573786|FG001|STARTED|1 Month||11
6645010|NCT02369068|7573785|FG000|COMPLETED|1 Month||9
6645011|NCT02369068|7573786|FG001|COMPLETED|1 Month||10
6645012|NCT02369068|7573785|FG000|NOT COMPLETED|1 Month||1
6645013|NCT02369068|7573786|FG001|NOT COMPLETED|1 Month||1
6645014|NCT02369068|7573785|FG000|STARTED|3 Months||9
6645015|NCT02369068|7573786|FG001|STARTED|3 Months||10
6534307|NCT01635920|7456140|FG000|COMPLETED|Overall Study||122
6534308|NCT01635920|7456141|FG001|COMPLETED|Overall Study||125
6534309|NCT01635920|7456140|FG000|NOT COMPLETED|Overall Study||3
6534310|NCT01635920|7456141|FG001|NOT COMPLETED|Overall Study||1
6534311|NCT01635933|7456150|FG000|STARTED|Overall Study||178
6645016|NCT02369068|7573785|FG000|COMPLETED|3 Months||9
6645017|NCT02369068|7573786|FG001|COMPLETED|3 Months||8
6645018|NCT02369068|7573785|FG000|NOT COMPLETED|3 Months||0
6534312|NCT01635933|7456151|FG001|STARTED|Overall Study||185
6534313|NCT01635933|7456150|FG000|COMPLETED|Overall Study||176
6534314|NCT01635933|7456151|FG001|COMPLETED|Overall Study||177
6534315|NCT01635933|7456150|FG000|NOT COMPLETED|Overall Study||2
6534316|NCT01635933|7456151|FG001|NOT COMPLETED|Overall Study||8
6534317|NCT01635998|7456159|FG000|STARTED|Overall Study||28
6534318|NCT01635998|7456160|FG001|STARTED|Overall Study||22
6534319|NCT01635998|7456159|FG000|COMPLETED|Overall Study||24
6534320|NCT01635998|7456160|FG001|COMPLETED|Overall Study||15
6534321|NCT01635998|7456159|FG000|NOT COMPLETED|Overall Study||4
6534322|NCT01635998|7456160|FG001|NOT COMPLETED|Overall Study||7
6534323|NCT01636063|7456168|FG000|STARTED|Overall Study||21
6534324|NCT01636063|7456169|FG001|STARTED|Overall Study||21
6534325|NCT01636063|7456168|FG000|COMPLETED|Overall Study||21
6534326|NCT01636063|7456169|FG001|COMPLETED|Overall Study||21
6534327|NCT01636063|7456168|FG000|NOT COMPLETED|Overall Study||0
6534328|NCT01636063|7456169|FG001|NOT COMPLETED|Overall Study||0
6534329|NCT01636076|7456177|FG000|STARTED|Overall Study||316
6534330|NCT01636076|7456178|FG001|STARTED|Overall Study||313
6534331|NCT01636076|7456177|FG000|COMPLETED|Overall Study||299
6534332|NCT01636076|7456178|FG001|COMPLETED|Overall Study||288
6534333|NCT01636076|7456177|FG000|NOT COMPLETED|Overall Study||17
6534334|NCT01636076|7456178|FG001|NOT COMPLETED|Overall Study||25
6534335|NCT01636102|7456193|FG000|STARTED|Overall Study||63
6534336|NCT01636102|7456194|FG001|STARTED|Overall Study||63
6534337|NCT01636102|7456193|FG000|COMPLETED|Overall Study||63
6534338|NCT01636102|7456194|FG001|COMPLETED|Overall Study||63
6534339|NCT01636102|7456193|FG000|NOT COMPLETED|Overall Study||0
6534340|NCT01636102|7456194|FG001|NOT COMPLETED|Overall Study||0
6534341|NCT01636206|7456203|FG000|STARTED|Overall Study||111
6534342|NCT01636206|7456204|FG001|STARTED|Overall Study||221
6534343|NCT01636206|7456203|FG000|COMPLETED|Overall Study||92
6534344|NCT01636206|7456204|FG001|COMPLETED|Overall Study||170
6534345|NCT01636206|7456203|FG000|NOT COMPLETED|Overall Study||19
6534346|NCT01636206|7456204|FG001|NOT COMPLETED|Overall Study||51
6534347|NCT01636258|7456212|FG000|STARTED|Overall Study||13
6534348|NCT01636258|7456213|FG001|STARTED|Overall Study||14
6534349|NCT01636258|7456212|FG000|COMPLETED|Overall Study||12
6534350|NCT01636258|7456213|FG001|COMPLETED|Overall Study||14
6534351|NCT01636258|7456212|FG000|NOT COMPLETED|Overall Study||1
6534352|NCT01636258|7456213|FG001|NOT COMPLETED|Overall Study||0
6534353|NCT01636284|7456220|FG000|STARTED|Overall Study||16
6534354|NCT01636284|7456220|FG000|COMPLETED|Overall Study||16
6534355|NCT01636284|7456220|FG000|NOT COMPLETED|Overall Study||0
6534356|NCT01636297|7456227|FG000|STARTED|Overall Study||40
6534357|NCT01636297|7456228|FG001|STARTED|Overall Study||40
6534358|NCT01636297|7456229|FG002|STARTED|Overall Study||20
6534359|NCT01636297|7456227|FG000|COMPLETED|Overall Study||36
6534360|NCT01636297|7456228|FG001|COMPLETED|Overall Study||36
6534361|NCT01636297|7456229|FG002|COMPLETED|Overall Study||19
6534362|NCT01636297|7456227|FG000|NOT COMPLETED|Overall Study||4
6534363|NCT01636297|7456228|FG001|NOT COMPLETED|Overall Study||4
6534364|NCT01636297|7456229|FG002|NOT COMPLETED|Overall Study||1
6534365|NCT01636362|7456239|FG000|STARTED|Overall Study||45
6534366|NCT01636362|7456239|FG000|COMPLETED|Overall Study||37
6534367|NCT01636362|7456239|FG000|NOT COMPLETED|Overall Study||8
6534368|NCT01636414|7456246|FG000|STARTED|Overall Study||64
6534369|NCT01636414|7456247|FG001|STARTED|Overall Study||66
6534370|NCT01636414|7456248|FG002|STARTED|Overall Study||74
6534371|NCT01636414|7456246|FG000|COMPLETED|Overall Study||61
6534372|NCT01636414|7456247|FG001|COMPLETED|Overall Study||60
6534373|NCT01636414|7456248|FG002|COMPLETED|Overall Study||65
6534374|NCT01636414|7456246|FG000|NOT COMPLETED|Overall Study||3
6534375|NCT01636414|7456247|FG001|NOT COMPLETED|Overall Study||6
6534376|NCT01636414|7456248|FG002|NOT COMPLETED|Overall Study||9
6534377|NCT01636453|7456256|FG000|STARTED|Overall Study||120
6534378|NCT01636453|7456256|FG000|COMPLETED|Overall Study||112
6534379|NCT01636453|7456256|FG000|NOT COMPLETED|Overall Study||8
6534380|NCT01636661|7456262|FG000|STARTED|Overall Study||5
6534381|NCT01636661|7456263|FG001|STARTED|Overall Study||6
6534382|NCT01636661|7456262|FG000|COMPLETED|Overall Study||5
6534383|NCT01636661|7456263|FG001|COMPLETED|Overall Study||6
6534384|NCT01636661|7456262|FG000|NOT COMPLETED|Overall Study||0
6534385|NCT01636661|7456263|FG001|NOT COMPLETED|Overall Study||0
6534386|NCT01636687|7456272|FG000|STARTED|Induction Period||61
6534387|NCT01636687|7456273|FG001|STARTED|Induction Period||60
6534388|NCT01636687|7456274|FG002|STARTED|Induction Period||0
6534389|NCT01636687|7456275|FG003|STARTED|Induction Period||0
6534390|NCT01636687|7456276|FG004|STARTED|Induction Period||61
6534391|NCT01636687|7456272|FG000|COMPLETED|Induction Period||58
6534392|NCT01636687|7456273|FG001|COMPLETED|Induction Period||60
6534393|NCT01636687|7456274|FG002|COMPLETED|Induction Period||0
6534394|NCT01636687|7456275|FG003|COMPLETED|Induction Period||0
6534395|NCT01636687|7456276|FG004|COMPLETED|Induction Period||59
6534396|NCT01636687|7456272|FG000|NOT COMPLETED|Induction Period||3
6534397|NCT01636687|7456273|FG001|NOT COMPLETED|Induction Period||0
6534398|NCT01636687|7456274|FG002|NOT COMPLETED|Induction Period||0
6534399|NCT01636687|7456275|FG003|NOT COMPLETED|Induction Period||0
6534400|NCT01636687|7456276|FG004|NOT COMPLETED|Induction Period||2
6534401|NCT01636687|7456272|FG000|STARTED|Maintenance Period||58
6534402|NCT01636687|7456273|FG001|STARTED|Maintenance Period||60
6534403|NCT01636687|7456274|FG002|STARTED|Maintenance Period||28
6534404|NCT01636687|7456275|FG003|STARTED|Maintenance Period||28
6534405|NCT01636687|7456276|FG004|STARTED|Maintenance Period||3
6534406|NCT01636687|7456272|FG000|COMPLETED|Maintenance Period||50
6534407|NCT01636687|7456273|FG001|COMPLETED|Maintenance Period||58
6534408|NCT01636687|7456274|FG002|COMPLETED|Maintenance Period||26
6534409|NCT01636687|7456275|FG003|COMPLETED|Maintenance Period||28
6534410|NCT01636687|7456276|FG004|COMPLETED|Maintenance Period||1
6534411|NCT01636687|7456272|FG000|NOT COMPLETED|Maintenance Period||8
6534412|NCT01636687|7456273|FG001|NOT COMPLETED|Maintenance Period||2
6534413|NCT01636687|7456274|FG002|NOT COMPLETED|Maintenance Period||2
6534414|NCT01636687|7456275|FG003|NOT COMPLETED|Maintenance Period||0
6534415|NCT01636687|7456276|FG004|NOT COMPLETED|Maintenance Period||2
6534416|NCT01636687|7456272|FG000|STARTED|Extension Period||47
6534417|NCT01636687|7456273|FG001|STARTED|Extension Period||54
6534418|NCT01636687|7456274|FG002|STARTED|Extension Period||25
6534419|NCT01636687|7456275|FG003|STARTED|Extension Period||28
6534420|NCT01636687|7456276|FG004|STARTED|Extension Period||0
6534421|NCT01636687|7456272|FG000|COMPLETED|Extension Period||0
6534422|NCT01636687|7456273|FG001|COMPLETED|Extension Period||0
6534423|NCT01636687|7456274|FG002|COMPLETED|Extension Period||0
6534424|NCT01636687|7456275|FG003|COMPLETED|Extension Period||0
6534425|NCT01636687|7456276|FG004|COMPLETED|Extension Period||0
6534426|NCT01636687|7456272|FG000|NOT COMPLETED|Extension Period||47
6534427|NCT01636687|7456273|FG001|NOT COMPLETED|Extension Period||54
6534428|NCT01636687|7456274|FG002|NOT COMPLETED|Extension Period||25
6534429|NCT01636687|7456275|FG003|NOT COMPLETED|Extension Period||28
6534430|NCT01636687|7456276|FG004|NOT COMPLETED|Extension Period||0
6534431|NCT01636687|7456272|FG000|STARTED|Follow-up Period||38
6534432|NCT01636687|7456273|FG001|STARTED|Follow-up Period||45
6534433|NCT01636687|7456274|FG002|STARTED|Follow-up Period||21
6534434|NCT01636687|7456275|FG003|STARTED|Follow-up Period||20
6534435|NCT01636687|7456276|FG004|STARTED|Follow-up Period||2
6534436|NCT01636687|7456272|FG000|COMPLETED|Follow-up Period||37
6534437|NCT01636687|7456273|FG001|COMPLETED|Follow-up Period||45
6534438|NCT01636687|7456274|FG002|COMPLETED|Follow-up Period||21
6534439|NCT01636687|7456275|FG003|COMPLETED|Follow-up Period||20
6534440|NCT01636687|7456276|FG004|COMPLETED|Follow-up Period||1
6534441|NCT01636687|7456272|FG000|NOT COMPLETED|Follow-up Period||1
6534442|NCT01636687|7456273|FG001|NOT COMPLETED|Follow-up Period||0
6534443|NCT01636687|7456274|FG002|NOT COMPLETED|Follow-up Period||0
6534444|NCT01636687|7456275|FG003|NOT COMPLETED|Follow-up Period||0
6534445|NCT01636687|7456276|FG004|NOT COMPLETED|Follow-up Period||1
6534446|NCT01636713|7456297|FG000|STARTED|Overall Study||193
6534447|NCT01636713|7456298|FG001|STARTED|Overall Study||194
6534448|NCT01636713|7456299|FG002|STARTED|Overall Study||193
6534449|NCT01636713|7456297|FG000|COMPLETED|Overall Study||161
6534450|NCT01636713|7456298|FG001|COMPLETED|Overall Study||166
6534451|NCT01636713|7456299|FG002|COMPLETED|Overall Study||170
6534452|NCT01636713|7456297|FG000|NOT COMPLETED|Overall Study||32
6534453|NCT01636713|7456298|FG001|NOT COMPLETED|Overall Study||28
6534454|NCT01636713|7456299|FG002|NOT COMPLETED|Overall Study||23
6534455|NCT01636765|7456307|FG000|STARTED|Overall Study||104
6534456|NCT01636765|7456307|FG000|COMPLETED|Overall Study||104
6534457|NCT01636765|7456307|FG000|NOT COMPLETED|Overall Study||0
6534458|NCT01636778|7456311|FG000|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
6534459|NCT01636778|7456312|FG001|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
6534460|NCT01636778|7456313|FG002|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
6534461|NCT01636778|7456311|FG000|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
6534462|NCT01636778|7456312|FG001|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
6534463|NCT01636778|7456313|FG002|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
6534464|NCT01636778|7456311|FG000|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
6534465|NCT01636778|7456312|FG001|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
6534466|NCT01636778|7456313|FG002|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
6534467|NCT01636778|7456311|FG000|STARTED|Antiviral Treatment Period (Part 2)||0
6534468|NCT01636778|7456312|FG001|STARTED|Antiviral Treatment Period (Part 2)||41
6534469|NCT01636778|7456313|FG002|STARTED|Antiviral Treatment Period (Part 2)||0
6534470|NCT01636778|7456311|FG000|COMPLETED|Antiviral Treatment Period (Part 2)||0
6534471|NCT01636778|7456312|FG001|COMPLETED|Antiviral Treatment Period (Part 2)||31
6645019|NCT02369068|7573786|FG001|NOT COMPLETED|3 Months||2
6645020|NCT02369068|7573785|FG000|STARTED|6 Months||9
6645021|NCT02369068|7573786|FG001|STARTED|6 Months||8
6645022|NCT02369068|7573785|FG000|COMPLETED|6 Months||9
6645023|NCT02369068|7573786|FG001|COMPLETED|6 Months||7
6645024|NCT02369068|7573785|FG000|NOT COMPLETED|6 Months||0
6645025|NCT02369068|7573786|FG001|NOT COMPLETED|6 Months||1
6534472|NCT01636778|7456313|FG002|COMPLETED|Antiviral Treatment Period (Part 2)||0
6534473|NCT01636778|7456311|FG000|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
6534474|NCT01636778|7456312|FG001|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
6645026|NCT02369159|7573794|FG000|STARTED|Overall Study||114
6645027|NCT02369159|7573795|FG001|STARTED|Overall Study||23
6534475|NCT01636778|7456313|FG002|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
6534476|NCT01636778|7456311|FG000|STARTED|Follow-up Period After Part 2||0
6534477|NCT01636778|7456312|FG001|STARTED|Follow-up Period After Part 2||0
6534478|NCT01636778|7456313|FG002|STARTED|Follow-up Period After Part 2||41
6534479|NCT01636778|7456311|FG000|COMPLETED|Follow-up Period After Part 2||0
6534480|NCT01636778|7456312|FG001|COMPLETED|Follow-up Period After Part 2||0
6645028|NCT02369159|7573794|FG000|ITT Population|Overall Study||114
6645029|NCT02369159|7573795|FG001|ITT Population|Overall Study||23
6534481|NCT01636778|7456313|FG002|COMPLETED|Follow-up Period After Part 2||37
6534482|NCT01636778|7456311|FG000|NOT COMPLETED|Follow-up Period After Part 2||0
6534483|NCT01636778|7456312|FG001|NOT COMPLETED|Follow-up Period After Part 2||0
6534484|NCT01636778|7456313|FG002|NOT COMPLETED|Follow-up Period After Part 2||4
6534485|NCT01636882|7456321|FG000|STARTED|Overall Study||16
6534486|NCT01636882|7456321|FG000|COMPLETED|Overall Study||16
6645030|NCT02369159|7573794|FG000|Safety Population|Overall Study||107
6645031|NCT02369159|7573795|FG001|Safety Population|Overall Study||23
6645032|NCT02369159|7573794|FG000|ITTI Population|Overall Study||81
6534487|NCT01636882|7456321|FG000|NOT COMPLETED|Overall Study||0
6534488|NCT01636934|7456327|FG000|STARTED|Overall Study||25
6534489|NCT01636934|7456328|FG001|STARTED|Overall Study||24
6534490|NCT01636934|7456327|FG000|COMPLETED|Overall Study||19
6534491|NCT01636934|7456328|FG001|COMPLETED|Overall Study||21
6534492|NCT01636934|7456327|FG000|NOT COMPLETED|Overall Study||6
6534493|NCT01636934|7456328|FG001|NOT COMPLETED|Overall Study||3
6534494|NCT01636947|7456336|FG000|STARTED|Overall Study||244
6534495|NCT01636947|7456337|FG001|STARTED|Overall Study||250
6534496|NCT01636947|7456336|FG000|Treated|Overall Study||242
6534497|NCT01636947|7456337|FG001|Treated|Overall Study||248
6534498|NCT01636947|7456336|FG000|COMPLETED|Overall Study||232
6534499|NCT01636947|7456337|FG001|COMPLETED|Overall Study||239
6534500|NCT01636947|7456336|FG000|NOT COMPLETED|Overall Study||12
6534501|NCT01636947|7456337|FG001|NOT COMPLETED|Overall Study||11
6534502|NCT01636960|7456343|FG000|STARTED|Induction Phase||9
6534503|NCT01636960|7456343|FG000|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
6534504|NCT01636960|7456343|FG000|NOT COMPLETED|Induction Phase||2
6534505|NCT01636960|7456343|FG000|STARTED|Maintenance Phase||7
6534506|NCT01636960|7456343|FG000|COMPLETED|Maintenance Phase||0
6534507|NCT01636960|7456343|FG000|NOT COMPLETED|Maintenance Phase||7
6534508|NCT01636986|7456349|FG000|STARTED|Overall Study||30
6534509|NCT01636986|7456350|FG001|STARTED|Overall Study||32
6534510|NCT01636986|7456349|FG000|COMPLETED|Overall Study||30
6534511|NCT01636986|7456350|FG001|COMPLETED|Overall Study||30
6534512|NCT01636986|7456349|FG000|NOT COMPLETED|Overall Study||0
6534513|NCT01636986|7456350|FG001|NOT COMPLETED|Overall Study||2
6534514|NCT01637077|7456358|FG000|STARTED|Overall Study||23
6534515|NCT01637077|7456359|FG001|STARTED|Overall Study||23
6534516|NCT01637077|7456358|FG000|COMPLETED|Overall Study||19
6534517|NCT01637077|7456359|FG001|COMPLETED|Overall Study||22
6534518|NCT01637077|7456358|FG000|NOT COMPLETED|Overall Study||4
6534519|NCT01637077|7456359|FG001|NOT COMPLETED|Overall Study||1
6534520|NCT01637090|7456365|FG000|STARTED|Overall Study||3
6534521|NCT01637090|7456365|FG000|COMPLETED|Overall Study||0
6534522|NCT01637090|7456365|FG000|NOT COMPLETED|Overall Study||3
6534523|NCT01637142|7456369|FG000|STARTED|Treatment Period 1||18
6534524|NCT01637142|7456369|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||18
6534525|NCT01637142|7456369|FG000|COMPLETED|Treatment Period 1||18
6534526|NCT01637142|7456369|FG000|NOT COMPLETED|Treatment Period 1||0
6534527|NCT01637142|7456369|FG000|STARTED|Washout Period (at Least 3 Days)||18
6534528|NCT01637142|7456369|FG000|COMPLETED|Washout Period (at Least 3 Days)||17
6534529|NCT01637142|7456369|FG000|NOT COMPLETED|Washout Period (at Least 3 Days)||1
6534530|NCT01637142|7456369|FG000|STARTED|Treatment Period 2||17
6534531|NCT01637142|7456369|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||17
6534532|NCT01637142|7456369|FG000|COMPLETED|Treatment Period 2||17
6645033|NCT02369159|7573795|FG001|ITTI Population|Overall Study||16
6645034|NCT02369159|7573794|FG000|E-R Population|Overall Study||80
6645035|NCT02369159|7573795|FG001|E-R Population|Overall Study|Milestone only applied to Peramivir group|0
6645036|NCT02369159|7573794|FG000|COMPLETED|Overall Study||106
6645037|NCT02369159|7573795|FG001|COMPLETED|Overall Study||21
6645038|NCT02369159|7573794|FG000|NOT COMPLETED|Overall Study||8
6645039|NCT02369159|7573795|FG001|NOT COMPLETED|Overall Study||2
6645040|NCT02369172|7573812|FG000|STARTED|Overall Study||24
6645041|NCT02369172|7573812|FG000|COMPLETED|Overall Study||24
6645042|NCT02369172|7573812|FG000|NOT COMPLETED|Overall Study||0
6645043|NCT02369211|7573836|FG000|STARTED|Overall Study||43
6645044|NCT02369211|7573837|FG001|STARTED|Overall Study||43
6645045|NCT02369211|7573836|FG000|COMPLETED|Overall Study||43
6645046|NCT02369211|7573837|FG001|COMPLETED|Overall Study||41
6645047|NCT02369211|7573836|FG000|NOT COMPLETED|Overall Study||0
6645048|NCT02369211|7573837|FG001|NOT COMPLETED|Overall Study||2
6534533|NCT01637142|7456369|FG000|NOT COMPLETED|Treatment Period 2||0
6534534|NCT01637246|7456375|FG000|STARTED|Overall Study||4385
6534535|NCT01637246|7456375|FG000|COMPLETED|Overall Study||2246
6534536|NCT01637246|7456375|FG000|NOT COMPLETED|Overall Study||2139
6534537|NCT01637272|7456379|FG000|STARTED|Overall Study||43
6534538|NCT01637272|7456379|FG000|Completed sc Phase|Overall Study||33
6534539|NCT01637272|7456379|FG000|Completed Core Phase (sc + LAR)|Overall Study||31
6534540|NCT01637272|7456379|FG000|Entered Extension Phase|Overall Study||27
6645049|NCT02369341|7573845|FG000|STARTED|Overall Study||63
6645050|NCT02369341|7573846|FG001|STARTED|Overall Study||57
6645051|NCT02369341|7573845|FG000|COMPLETED|Overall Study||62
6645052|NCT02369341|7573846|FG001|COMPLETED|Overall Study||57
6645053|NCT02369341|7573845|FG000|NOT COMPLETED|Overall Study||1
6645054|NCT02369341|7573846|FG001|NOT COMPLETED|Overall Study||0
6645055|NCT02369484|7573856|FG000|STARTED|Overall Study||13
6645056|NCT02369484|7573856|FG000|COMPLETED|Overall Study||13
6645057|NCT02369484|7573856|FG000|NOT COMPLETED|Overall Study||0
6645058|NCT02369510|7573863|FG000|STARTED|Overall Study||23
6645059|NCT02369510|7573864|FG001|STARTED|Overall Study||22
6645060|NCT02369510|7573865|FG002|STARTED|Overall Study||23
6645061|NCT02369510|7573863|FG000|COMPLETED|Overall Study||21
6534541|NCT01637272|7456379|FG000|Completed Core But Did no Enter Ext..|Overall Study||4
6534542|NCT01637272|7456379|FG000|COMPLETED|Overall Study||23
6534543|NCT01637272|7456379|FG000|NOT COMPLETED|Overall Study||20
6534544|NCT01637402|7456398|FG000|STARTED|Standard Dose Regimen||41
6534545|NCT01637402|7456399|FG001|STARTED|Standard Dose Regimen|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
6534546|NCT01637402|7456398|FG000|COMPLETED|Standard Dose Regimen||38
6534547|NCT01637402|7456399|FG001|COMPLETED|Standard Dose Regimen||0
6534548|NCT01637402|7456398|FG000|NOT COMPLETED|Standard Dose Regimen||3
6534549|NCT01637402|7456399|FG001|NOT COMPLETED|Standard Dose Regimen||0
6534550|NCT01637402|7456398|FG000|STARTED|Week 12 Evaluation||38
6534551|NCT01637402|7456399|FG001|STARTED|Week 12 Evaluation|Escalated dose not introduced as treatment option until after Week 12 evaluation|0
6534552|NCT01637402|7456398|FG000|COMPLETED|Week 12 Evaluation||32
6534553|NCT01637402|7456399|FG001|COMPLETED|Week 12 Evaluation||0
6534554|NCT01637402|7456398|FG000|NOT COMPLETED|Week 12 Evaluation||6
6534555|NCT01637402|7456399|FG001|NOT COMPLETED|Week 12 Evaluation||0
6534556|NCT01637402|7456398|FG000|STARTED|Treatment Regiments Post Week 12|Patients continuing on standard dose|14
6534557|NCT01637402|7456399|FG001|STARTED|Treatment Regiments Post Week 12|Patients who progressed after decline on standard dose|18
6534558|NCT01637402|7456398|FG000|COMPLETED|Treatment Regiments Post Week 12||5
6534559|NCT01637402|7456399|FG001|COMPLETED|Treatment Regiments Post Week 12||14
6534560|NCT01637402|7456398|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||9
6534561|NCT01637402|7456399|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
6534562|NCT01637584|7456426|FG000|STARTED|Overall Study||20
6534563|NCT01637584|7456427|FG001|STARTED|Overall Study||20
6534564|NCT01637584|7456426|FG000|COMPLETED|Overall Study||19
6534565|NCT01637584|7456427|FG001|COMPLETED|Overall Study||17
6534566|NCT01637584|7456426|FG000|NOT COMPLETED|Overall Study||1
6534567|NCT01637584|7456427|FG001|NOT COMPLETED|Overall Study||3
6534568|NCT01637623|7456437|FG000|STARTED|Overall Study||29
6645062|NCT02369510|7573864|FG001|COMPLETED|Overall Study||19
6645063|NCT02369510|7573865|FG002|COMPLETED|Overall Study||17
6645064|NCT02369510|7573863|FG000|NOT COMPLETED|Overall Study||2
6645065|NCT02369510|7573864|FG001|NOT COMPLETED|Overall Study||3
6645066|NCT02369510|7573865|FG002|NOT COMPLETED|Overall Study||6
6645067|NCT02369796|7573878|FG000|STARTED|Overall Study||3
6645068|NCT02369796|7573879|FG001|STARTED|Overall Study||3
6645069|NCT02369796|7573880|FG002|STARTED|Overall Study||3
6645070|NCT02369796|7573881|FG003|STARTED|Overall Study||3
6645071|NCT02369796|7573882|FG004|STARTED|Overall Study||3
6645072|NCT02369796|7573878|FG000|COMPLETED|Overall Study||3
6645073|NCT02369796|7573879|FG001|COMPLETED|Overall Study||3
6645074|NCT02369796|7573880|FG002|COMPLETED|Overall Study||3
6645075|NCT02369796|7573881|FG003|COMPLETED|Overall Study||3
6645076|NCT02369796|7573882|FG004|COMPLETED|Overall Study||3
6645077|NCT02369796|7573878|FG000|NOT COMPLETED|Overall Study||0
6645078|NCT02369796|7573879|FG001|NOT COMPLETED|Overall Study||0
6645079|NCT02369796|7573880|FG002|NOT COMPLETED|Overall Study||0
6645080|NCT02369796|7573881|FG003|NOT COMPLETED|Overall Study||0
6645081|NCT02369796|7573882|FG004|NOT COMPLETED|Overall Study||0
6645082|NCT02369835|7573896|FG000|STARTED|Overall Study||64
6645083|NCT02369835|7573897|FG001|STARTED|Overall Study||68
6645084|NCT02369835|7573896|FG000|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|53
6645085|NCT02369835|7573897|FG001|COMPLETED|Overall Study|Reasons that participants did not complete for the Primary Outcome are not available.|55
6645086|NCT02369835|7573896|FG000|NOT COMPLETED|Overall Study||11
6645087|NCT02369835|7573897|FG001|NOT COMPLETED|Overall Study||13
6645088|NCT02369848|7573903|FG000|STARTED|Overall Study||60
6645089|NCT02369848|7573903|FG000|30 Day Primary Safety Endpoint|Overall Study||58
6645090|NCT02369848|7573903|FG000|12 Month Primary Endpoint|Overall Study||30
6645091|NCT02369848|7573903|FG000|COMPLETED|Overall Study||56
6645092|NCT02369848|7573903|FG000|NOT COMPLETED|Overall Study||4
6645093|NCT02369874|7573910|FG000|STARTED|Overall Study||247
6645094|NCT02369874|7573911|FG001|STARTED|Overall Study||240
6645095|NCT02369874|7573912|FG002|STARTED|Overall Study||249
6645096|NCT02369874|7573910|FG000|Received Treatment|Overall Study||246
6645097|NCT02369874|7573911|FG001|Received Treatment|Overall Study||237
6645098|NCT02369874|7573912|FG002|Received Treatment|Overall Study||240
6645099|NCT02369874|7573910|FG000|COMPLETED|Overall Study||203
6645100|NCT02369874|7573911|FG001|COMPLETED|Overall Study||183
6645101|NCT02369874|7573912|FG002|COMPLETED|Overall Study||188
6645102|NCT02369874|7573910|FG000|NOT COMPLETED|Overall Study||44
6645103|NCT02369874|7573911|FG001|NOT COMPLETED|Overall Study||57
6645104|NCT02369874|7573912|FG002|NOT COMPLETED|Overall Study||61
6645105|NCT02369900|7573922|FG000|STARTED|Overall Study||18
6534569|NCT01637623|7456438|FG001|STARTED|Overall Study||30
6645106|NCT02369900|7573923|FG001|STARTED|Overall Study||22
6645107|NCT02369900|7573922|FG000|COMPLETED|Overall Study||18
6645108|NCT02369900|7573923|FG001|COMPLETED|Overall Study||22
6645109|NCT02369900|7573922|FG000|NOT COMPLETED|Overall Study||0
6645110|NCT02369900|7573923|FG001|NOT COMPLETED|Overall Study||0
6645111|NCT02370004|7573929|FG000|STARTED|Overall Study||11
6645112|NCT02370004|7573929|FG000|COMPLETED|Overall Study||10
6645113|NCT02370004|7573929|FG000|NOT COMPLETED|Overall Study||1
6645114|NCT02370043|7573938|FG000|STARTED|Overall Study||3
6534570|NCT01637623|7456439|FG002|STARTED|Overall Study||28
6534571|NCT01637623|7456437|FG000|Received Intervention|Overall Study||28
6534572|NCT01637623|7456438|FG001|Received Intervention|Overall Study||30
6534573|NCT01637623|7456439|FG002|Received Intervention|Overall Study||27
6534574|NCT01637623|7456437|FG000|Did Not Receive Intervention|Overall Study||1
6534575|NCT01637623|7456438|FG001|Did Not Receive Intervention|Overall Study||0
6534576|NCT01637623|7456439|FG002|Did Not Receive Intervention|Overall Study||1
6534577|NCT01637623|7456437|FG000|Analyzed|Overall Study||28
6534578|NCT01637623|7456438|FG001|Analyzed|Overall Study||30
6534579|NCT01637623|7456439|FG002|Analyzed|Overall Study||28
6534580|NCT01637623|7456437|FG000|COMPLETED|Overall Study||28
6534581|NCT01637623|7456438|FG001|COMPLETED|Overall Study||30
6534582|NCT01637623|7456439|FG002|COMPLETED|Overall Study||25
6534583|NCT01637623|7456437|FG000|NOT COMPLETED|Overall Study||1
6534584|NCT01637623|7456438|FG001|NOT COMPLETED|Overall Study||0
6534585|NCT01637623|7456439|FG002|NOT COMPLETED|Overall Study||3
6534586|NCT01637870|7456447|FG000|STARTED|Overall Study||110
6534587|NCT01637870|7456447|FG000|COMPLETED|Overall Study||110
6534588|NCT01637870|7456447|FG000|NOT COMPLETED|Overall Study||0
6534589|NCT01637922|7456453|FG000|STARTED|Overall Study||15
6534590|NCT01637922|7456454|FG001|STARTED|Overall Study||19
6534591|NCT01637922|7456453|FG000|COMPLETED|Overall Study||13
6534592|NCT01637922|7456454|FG001|COMPLETED|Overall Study||14
6534593|NCT01637922|7456453|FG000|NOT COMPLETED|Overall Study||2
6534594|NCT01637922|7456454|FG001|NOT COMPLETED|Overall Study||5
6534595|NCT01637935|7456463|FG000|STARTED|Overall Study||34181
6534596|NCT01637935|7456464|FG001|STARTED|Overall Study||158918
6534597|NCT01637935|7456463|FG000|COMPLETED|Overall Study||34181
6534598|NCT01637935|7456464|FG001|COMPLETED|Overall Study||158918
6534599|NCT01637935|7456463|FG000|NOT COMPLETED|Overall Study||0
6534600|NCT01637935|7456464|FG001|NOT COMPLETED|Overall Study||0
6534601|NCT01637961|7456470|FG000|STARTED|Overall Study||23
6534602|NCT01637961|7456470|FG000|COMPLETED|Overall Study|Eligible and treated patients.|21
6534603|NCT01637961|7456470|FG000|NOT COMPLETED|Overall Study||2
6534604|NCT01638000|7456482|FG000|STARTED|Overall Study||943
6534605|NCT01638000|7456483|FG001|STARTED|Overall Study||944
6645115|NCT02370043|7573939|FG001|STARTED|Overall Study||3
6645116|NCT02370043|7573940|FG002|STARTED|Overall Study||3
6645117|NCT02370043|7573941|FG003|STARTED|Overall Study||3
6645118|NCT02370043|7573942|FG004|STARTED|Overall Study||3
6645119|NCT02370043|7573943|FG005|STARTED|Overall Study||4
6645120|NCT02370043|7573938|FG000|COMPLETED|Overall Study||3
6645121|NCT02370043|7573939|FG001|COMPLETED|Overall Study||3
6645122|NCT02370043|7573940|FG002|COMPLETED|Overall Study||3
6645123|NCT02370043|7573941|FG003|COMPLETED|Overall Study||3
6645124|NCT02370043|7573942|FG004|COMPLETED|Overall Study||2
6645125|NCT02370043|7573943|FG005|COMPLETED|Overall Study||3
6645126|NCT02370043|7573938|FG000|NOT COMPLETED|Overall Study||0
6645127|NCT02370043|7573939|FG001|NOT COMPLETED|Overall Study||0
6645128|NCT02370043|7573940|FG002|NOT COMPLETED|Overall Study||0
6645129|NCT02370043|7573941|FG003|NOT COMPLETED|Overall Study||0
6645130|NCT02370043|7573942|FG004|NOT COMPLETED|Overall Study||1
6645131|NCT02370043|7573943|FG005|NOT COMPLETED|Overall Study||1
6645132|NCT02370056|7573973|FG000|STARTED|Overall Study||27
6645133|NCT02370056|7573974|FG001|STARTED|Overall Study||26
6645134|NCT02370056|7573973|FG000|COMPLETED|Overall Study||27
6645135|NCT02370056|7573974|FG001|COMPLETED|Overall Study||26
6645136|NCT02370056|7573973|FG000|NOT COMPLETED|Overall Study||0
6645137|NCT02370056|7573974|FG001|NOT COMPLETED|Overall Study||0
6645138|NCT02370095|7573982|FG000|STARTED|Overall Study||10
6645139|NCT02370095|7573983|FG001|STARTED|Overall Study||4
6645140|NCT02370095|7573982|FG000|COMPLETED|Overall Study||10
6645141|NCT02370095|7573983|FG001|COMPLETED|Overall Study||3
6645142|NCT02370095|7573982|FG000|NOT COMPLETED|Overall Study||0
6645143|NCT02370095|7573983|FG001|NOT COMPLETED|Overall Study||1
6645144|NCT02370121|7573991|FG000|STARTED|Overall Study||12
6645145|NCT02370121|7573992|FG001|STARTED|Overall Study||12
6645146|NCT02370121|7573991|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
6645147|NCT02370121|7573992|FG001|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
6645148|NCT02370121|7573991|FG000|NOT COMPLETED|Overall Study||1
6645149|NCT02370121|7573992|FG001|NOT COMPLETED|Overall Study||1
6645150|NCT02370160|7573998|FG000|STARTED|Overall Study||9
6645151|NCT02370160|7573999|FG001|STARTED|Overall Study||6
6645152|NCT02370160|7574000|FG002|STARTED|Overall Study||3
6645153|NCT02370160|7573998|FG000|COMPLETED|Overall Study||6
6645154|NCT02370160|7573999|FG001|COMPLETED|Overall Study||2
6645155|NCT02370160|7574000|FG002|COMPLETED|Overall Study||2
6534606|NCT01638000|7456482|FG000|Received at Least 1 Double-Blind Dose|Overall Study||936
6534607|NCT01638000|7456483|FG001|Received at Least 1 Double-Blind Dose|Overall Study||934
6534608|NCT01638000|7456482|FG000|COMPLETED|Overall Study||883
6534609|NCT01638000|7456483|FG001|COMPLETED|Overall Study||873
6534610|NCT01638000|7456482|FG000|NOT COMPLETED|Overall Study||60
6534611|NCT01638000|7456483|FG001|NOT COMPLETED|Overall Study||71
6534612|NCT01638013|7456492|FG000|STARTED|Overall Study||201
6645156|NCT02370160|7573998|FG000|NOT COMPLETED|Overall Study||3
6534613|NCT01638013|7456493|FG001|STARTED|Overall Study||225
6534614|NCT01638013|7456494|FG002|STARTED|Overall Study||417
6645157|NCT02370160|7573999|FG001|NOT COMPLETED|Overall Study||4
6645158|NCT02370160|7574000|FG002|NOT COMPLETED|Overall Study||1
6645159|NCT02370238|7574015|FG000|STARTED|Overall Study||62
6534615|NCT01638013|7456492|FG000|COMPLETED|Overall Study||70
6534616|NCT01638013|7456493|FG001|COMPLETED|Overall Study||147
6534617|NCT01638013|7456494|FG002|COMPLETED|Overall Study||296
6534618|NCT01638013|7456492|FG000|NOT COMPLETED|Overall Study||131
6534619|NCT01638013|7456493|FG001|NOT COMPLETED|Overall Study||78
6534620|NCT01638013|7456494|FG002|NOT COMPLETED|Overall Study||121
6534621|NCT01638052|7456508|FG000|STARTED|Overall Study||28
6534622|NCT01638052|7456509|FG001|STARTED|Overall Study||28
6534623|NCT01638052|7456508|FG000|COMPLETED|Overall Study||28
6534624|NCT01638052|7456509|FG001|COMPLETED|Overall Study||28
6534625|NCT01638052|7456508|FG000|NOT COMPLETED|Overall Study||0
6534626|NCT01638052|7456509|FG001|NOT COMPLETED|Overall Study||0
6645160|NCT02370238|7574016|FG001|STARTED|Overall Study||61
6645161|NCT02370238|7574015|FG000|ITT Population|Overall Study||62
6645162|NCT02370238|7574016|FG001|ITT Population|Overall Study||61
6645163|NCT02370238|7574015|FG000|Safety Population|Overall Study||61
6645164|NCT02370238|7574016|FG001|Safety Population|Overall Study||60
6645165|NCT02370238|7574015|FG000|Responsable-evaluable Population|Overall Study||57
6645166|NCT02370238|7574016|FG001|Responsable-evaluable Population|Overall Study||54
6645167|NCT02370238|7574015|FG000|COMPLETED|Overall Study||15
6645168|NCT02370238|7574016|FG001|COMPLETED|Overall Study||16
6645169|NCT02370238|7574015|FG000|NOT COMPLETED|Overall Study||47
6645170|NCT02370238|7574016|FG001|NOT COMPLETED|Overall Study||45
6645171|NCT02370251|7574026|FG000|STARTED|Overall Study||63
6645172|NCT02370251|7574026|FG000|COMPLETED|Overall Study||52
6645173|NCT02370251|7574026|FG000|NOT COMPLETED|Overall Study||11
6645174|NCT02370368|7574032|FG000|STARTED|Overall Study||14
6645175|NCT02370368|7574033|FG001|STARTED|Overall Study||13
6645176|NCT02370368|7574032|FG000|COMPLETED|Overall Study||8
6645177|NCT02370368|7574033|FG001|COMPLETED|Overall Study||7
6645178|NCT02370368|7574032|FG000|NOT COMPLETED|Overall Study||6
6645179|NCT02370368|7574033|FG001|NOT COMPLETED|Overall Study||6
6645180|NCT02370394|7574041|FG000|STARTED|Overall Study||28
6645181|NCT02370394|7574042|FG001|STARTED|Overall Study||25
6645182|NCT02370394|7574041|FG000|COMPLETED|Overall Study||26
6645183|NCT02370394|7574042|FG001|COMPLETED|Overall Study||23
6645184|NCT02370394|7574041|FG000|NOT COMPLETED|Overall Study||2
6645185|NCT02370394|7574042|FG001|NOT COMPLETED|Overall Study||2
6645186|NCT02370407|7574051|FG000|STARTED|Overall Study||20
6645187|NCT02370407|7574052|FG001|STARTED|Overall Study||20
6645188|NCT02370407|7574051|FG000|COMPLETED|Overall Study||20
6645189|NCT02370407|7574052|FG001|COMPLETED|Overall Study||20
6645190|NCT02370407|7574051|FG000|NOT COMPLETED|Overall Study||0
6645191|NCT02370407|7574052|FG001|NOT COMPLETED|Overall Study||0
6645192|NCT02370420|7574064|FG000|STARTED|Overall Study||29
6645193|NCT02370420|7574065|FG001|STARTED|Overall Study||27
6645194|NCT02370420|7574064|FG000|COMPLETED|Overall Study||15
6645195|NCT02370420|7574065|FG001|COMPLETED|Overall Study||15
6645196|NCT02370420|7574064|FG000|NOT COMPLETED|Overall Study||14
6645197|NCT02370420|7574065|FG001|NOT COMPLETED|Overall Study||12
6645198|NCT02370498|7574073|FG000|STARTED|Overall Study||296
6645199|NCT02370498|7574074|FG001|STARTED|Overall Study||296
6645200|NCT02370498|7574073|FG000|Treated|Overall Study||294
6645201|NCT02370498|7574074|FG001|Treated|Overall Study||276
6645202|NCT02370498|7574073|FG000|PD-L1 Positive Participants|Overall Study||196
6645203|NCT02370498|7574074|FG001|PD-L1 Positive Participants|Overall Study||199
6645204|NCT02370498|7574073|FG000|COMPLETED|Overall Study||0
6645205|NCT02370498|7574074|FG001|COMPLETED|Overall Study||0
6645206|NCT02370498|7574073|FG000|NOT COMPLETED|Overall Study||296
6645207|NCT02370498|7574074|FG001|NOT COMPLETED|Overall Study||296
6645208|NCT02370511|7574083|FG000|STARTED|Overall Study||31
6645209|NCT02370511|7574084|FG001|STARTED|Overall Study||30
6645210|NCT02370511|7574085|FG002|STARTED|Overall Study||30
6645211|NCT02370511|7574083|FG000|COMPLETED|Overall Study||19
6645212|NCT02370511|7574084|FG001|COMPLETED|Overall Study||19
6645213|NCT02370511|7574085|FG002|COMPLETED|Overall Study||29
6645214|NCT02370511|7574083|FG000|NOT COMPLETED|Overall Study||12
6645215|NCT02370511|7574084|FG001|NOT COMPLETED|Overall Study||11
6645216|NCT02370511|7574085|FG002|NOT COMPLETED|Overall Study||1
6645217|NCT02370537|7574096|FG000|STARTED|Part A (Open-label Recruitment)||16
6645218|NCT02370537|7574097|FG001|STARTED|Part A (Open-label Recruitment)||16
6645219|NCT02370537|7574098|FG002|STARTED|Part A (Open-label Recruitment)||283
6645220|NCT02370537|7574096|FG000|COMPLETED|Part A (Open-label Recruitment)||16
6645221|NCT02370537|7574097|FG001|COMPLETED|Part A (Open-label Recruitment)||15
6534627|NCT01638312|7456517|FG000|STARTED|Overall Study||20
6534628|NCT01638312|7456518|FG001|STARTED|Overall Study||30
6534629|NCT01638312|7456517|FG000|COMPLETED|Overall Study||20
6534630|NCT01638312|7456518|FG001|COMPLETED|Overall Study||30
6534631|NCT01638312|7456517|FG000|NOT COMPLETED|Overall Study||0
6534632|NCT01638312|7456518|FG001|NOT COMPLETED|Overall Study||0
6645222|NCT02370537|7574098|FG002|COMPLETED|Part A (Open-label Recruitment)||282
6645223|NCT02370537|7574096|FG000|NOT COMPLETED|Part A (Open-label Recruitment)||0
6645224|NCT02370537|7574097|FG001|NOT COMPLETED|Part A (Open-label Recruitment)||1
6645225|NCT02370537|7574098|FG002|NOT COMPLETED|Part A (Open-label Recruitment)||1
6645226|NCT02370537|7574096|FG000|STARTED|Part B||16
6645227|NCT02370537|7574097|FG001|STARTED|Part B||15
6645228|NCT02370537|7574098|FG002|STARTED|Part B||282
6645229|NCT02370537|7574096|FG000|Eligible for Randomisation|Part B||15
6645230|NCT02370537|7574097|FG001|Eligible for Randomisation|Part B||13
6645231|NCT02370537|7574098|FG002|Eligible for Randomisation|Part B||23
6645232|NCT02370537|7574096|FG000|Period 1 Sequence AB|Part B||8
6534633|NCT01638390|7456524|FG000|STARTED|Overall Study|enrolled|357
6534634|NCT01638390|7456524|FG000|COMPLETED|Overall Study|treated eyes|336
6534635|NCT01638390|7456524|FG000|NOT COMPLETED|Overall Study||21
6562072|NCT01798992|7485111|FG003|STARTED|Overall Study||17
6562073|NCT01798992|7485108|FG000|COMPLETED|Overall Study||4
6645233|NCT02370537|7574097|FG001|Period 1 Sequence AB|Part B||6
6645234|NCT02370537|7574098|FG002|Period 1 Sequence AB|Part B||11
6645235|NCT02370537|7574096|FG000|Period 1 Sequence BA|Part B||7
6645236|NCT02370537|7574097|FG001|Period 1 Sequence BA|Part B||7
6645237|NCT02370537|7574098|FG002|Period 1 Sequence BA|Part B||12
6645238|NCT02370537|7574096|FG000|Period 2 Sequence AB|Part B||8
6645239|NCT02370537|7574097|FG001|Period 2 Sequence AB|Part B||5
6645240|NCT02370537|7574098|FG002|Period 2 Sequence AB|Part B||11
6645241|NCT02370537|7574096|FG000|Period 2 Sequence BA|Part B||7
6645242|NCT02370537|7574097|FG001|Period 2 Sequence BA|Part B||7
6645243|NCT02370537|7574098|FG002|Period 2 Sequence BA|Part B||12
6645244|NCT02370537|7574096|FG000|COMPLETED|Part B||15
6645245|NCT02370537|7574097|FG001|COMPLETED|Part B||12
6645246|NCT02370537|7574098|FG002|COMPLETED|Part B||23
6645247|NCT02370537|7574096|FG000|NOT COMPLETED|Part B||1
6645248|NCT02370537|7574097|FG001|NOT COMPLETED|Part B||3
6645249|NCT02370537|7574098|FG002|NOT COMPLETED|Part B||259
6645250|NCT02370602|7574121|FG000|STARTED|Overall Study||1
6645251|NCT02370602|7574122|FG001|STARTED|Overall Study||2
6645252|NCT02370602|7574123|FG002|STARTED|Overall Study||2
6645253|NCT02370602|7574124|FG003|STARTED|Overall Study||3
6645254|NCT02370602|7574125|FG004|STARTED|Overall Study||3
6645255|NCT02370602|7574126|FG005|STARTED|Overall Study||2
6645256|NCT02370602|7574121|FG000|COMPLETED|Overall Study||0
6645257|NCT02370602|7574122|FG001|COMPLETED|Overall Study||2
6645258|NCT02370602|7574123|FG002|COMPLETED|Overall Study||2
6645259|NCT02370602|7574124|FG003|COMPLETED|Overall Study||3
6645260|NCT02370602|7574125|FG004|COMPLETED|Overall Study||3
6645261|NCT02370602|7574126|FG005|COMPLETED|Overall Study||2
6645262|NCT02370602|7574121|FG000|NOT COMPLETED|Overall Study||1
6645263|NCT02370602|7574122|FG001|NOT COMPLETED|Overall Study||0
6645264|NCT02370602|7574123|FG002|NOT COMPLETED|Overall Study||0
6645265|NCT02370602|7574124|FG003|NOT COMPLETED|Overall Study||0
6645266|NCT02370602|7574125|FG004|NOT COMPLETED|Overall Study||0
6645267|NCT02370602|7574126|FG005|NOT COMPLETED|Overall Study||0
6645268|NCT02370615|7574145|FG000|STARTED|Overall Study||16
6645269|NCT02370615|7574146|FG001|STARTED|Overall Study||18
6645270|NCT02370615|7574145|FG000|COMPLETED|Overall Study||15
6645271|NCT02370615|7574146|FG001|COMPLETED|Overall Study||18
6645272|NCT02370615|7574145|FG000|NOT COMPLETED|Overall Study||1
6645273|NCT02370615|7574146|FG001|NOT COMPLETED|Overall Study||0
6645274|NCT02370641|7574161|FG000|STARTED|Overall Study||18
6645275|NCT02370641|7574162|FG001|STARTED|Overall Study||8
6645276|NCT02370641|7574161|FG000|COMPLETED|Overall Study||14
6645277|NCT02370641|7574162|FG001|COMPLETED|Overall Study||6
6645278|NCT02370641|7574161|FG000|NOT COMPLETED|Overall Study||4
6645279|NCT02370641|7574162|FG001|NOT COMPLETED|Overall Study||2
6655915|NCT02456740|7586038|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6655916|NCT02456740|7586039|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||14
6655917|NCT02456740|7586040|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||17
6655918|NCT02456740|7586041|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||13
6655919|NCT02456740|7586042|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||9
6655920|NCT02456740|7586043|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
6655921|NCT02456740|7586044|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||18
6655922|NCT02456896|7586056|FG000|STARTED|Overall Study||25
6655923|NCT02456896|7586057|FG001|STARTED|Overall Study||25
6655924|NCT02456896|7586056|FG000|COMPLETED|Overall Study||19
6655925|NCT02456896|7586057|FG001|COMPLETED|Overall Study||21
6655926|NCT02456896|7586056|FG000|NOT COMPLETED|Overall Study||6
6655927|NCT02456896|7586057|FG001|NOT COMPLETED|Overall Study||4
6655928|NCT02456909|7586065|FG000|STARTED|Overall Study||88
6655929|NCT02456909|7586066|FG001|STARTED|Overall Study||88
6655930|NCT02456909|7586065|FG000|COMPLETED|Overall Study||64
6655931|NCT02456909|7586066|FG001|COMPLETED|Overall Study||61
6655932|NCT02456909|7586065|FG000|NOT COMPLETED|Overall Study||24
6655933|NCT02456909|7586066|FG001|NOT COMPLETED|Overall Study||27
6655934|NCT02457065|7586074|FG000|STARTED|Overall Study||27
6655935|NCT02457065|7586075|FG001|STARTED|Overall Study||27
6655936|NCT02457065|7586074|FG000|COMPLETED|Overall Study||18
6655937|NCT02457065|7586075|FG001|COMPLETED|Overall Study||16
6655938|NCT02457065|7586074|FG000|NOT COMPLETED|Overall Study||9
6655939|NCT02457065|7586075|FG001|NOT COMPLETED|Overall Study||11
6655940|NCT02457182|7586083|FG000|STARTED|Overall Study||9
6655941|NCT02457182|7586084|FG001|STARTED|Overall Study||11
6655942|NCT02457182|7586083|FG000|COMPLETED|Overall Study||8
6655943|NCT02457182|7586084|FG001|COMPLETED|Overall Study||11
6562074|NCT01798992|7485109|FG001|COMPLETED|Overall Study||17
6562075|NCT01798992|7485110|FG002|COMPLETED|Overall Study||14
6655944|NCT02457182|7586083|FG000|NOT COMPLETED|Overall Study||1
6655945|NCT02457182|7586084|FG001|NOT COMPLETED|Overall Study||0
6655946|NCT02457195|7586090|FG000|STARTED|Overall Study||50
6655947|NCT02457195|7586090|FG000|COMPLETED|Overall Study||41
6655948|NCT02457195|7586090|FG000|NOT COMPLETED|Overall Study||9
6562076|NCT01798992|7485111|FG003|COMPLETED|Overall Study||16
6655949|NCT02457247|7586098|FG000|STARTED|Period 1||68
6655950|NCT02457247|7586099|FG001|STARTED|Period 1||70
6534636|NCT01638416|7456537|FG000|STARTED|Overall Study||2490
6534637|NCT01638416|7456538|FG001|STARTED|Overall Study||2504
6534638|NCT01638416|7456537|FG000|COMPLETED|Overall Study||2457
6534639|NCT01638416|7456538|FG001|COMPLETED|Overall Study||2462
6534640|NCT01638416|7456537|FG000|NOT COMPLETED|Overall Study||33
6534641|NCT01638416|7456538|FG001|NOT COMPLETED|Overall Study||42
6534642|NCT01638429|7456545|FG000|STARTED|Overall Study||12
6534643|NCT01638429|7456545|FG000|Pre-treatment Testing|Overall Study||11
6534644|NCT01638429|7456545|FG000|Antibiotic Treatment|Overall Study||11
6534645|NCT01638429|7456545|FG000|Post-treatment Testing|Overall Study||11
6534646|NCT01638429|7456545|FG000|COMPLETED|Overall Study||11
6534647|NCT01638429|7456545|FG000|NOT COMPLETED|Overall Study||1
6534648|NCT01638468|7456553|FG000|STARTED|Overall Study||7
6534649|NCT01638468|7456553|FG000|COMPLETED|Overall Study||7
6534650|NCT01638468|7456553|FG000|NOT COMPLETED|Overall Study||0
6534651|NCT01638507|7456557|FG000|STARTED|Overall Study||230
6534652|NCT01638507|7456557|FG000|COMPLETED|Overall Study||224
6534653|NCT01638507|7456557|FG000|NOT COMPLETED|Overall Study||6
6534654|NCT01638546|7456565|FG000|STARTED|Overall Study||52
6534655|NCT01638546|7456566|FG001|STARTED|Overall Study||45
6534656|NCT01638546|7456565|FG000|COMPLETED|Overall Study||51
6534657|NCT01638546|7456566|FG001|COMPLETED|Overall Study||42
6534658|NCT01638546|7456565|FG000|NOT COMPLETED|Overall Study||1
6534659|NCT01638546|7456566|FG001|NOT COMPLETED|Overall Study||3
6534660|NCT01638559|7456574|FG000|STARTED|Overall Study||88
6534661|NCT01638559|7456574|FG000|COMPLETED|Overall Study|Completion through the time of the primary endpoint (outcome).|85
6534662|NCT01638559|7456574|FG000|NOT COMPLETED|Overall Study||3
6534663|NCT01638819|7456591|FG000|STARTED|Overall Study||15
6534664|NCT01638819|7456592|FG001|STARTED|Overall Study||15
6534665|NCT01638819|7456591|FG000|First Intervention (8 Weeks)|Overall Study||15
6534666|NCT01638819|7456592|FG001|First Intervention (8 Weeks)|Overall Study||15
6534667|NCT01638819|7456591|FG000|Second Intervention (24 Weeks)|Overall Study||14
6534668|NCT01638819|7456592|FG001|Second Intervention (24 Weeks)|Overall Study||15
6534669|NCT01638819|7456591|FG000|COMPLETED|Overall Study||14
6534670|NCT01638819|7456592|FG001|COMPLETED|Overall Study||15
6534671|NCT01638819|7456591|FG000|NOT COMPLETED|Overall Study||1
6534672|NCT01638819|7456592|FG001|NOT COMPLETED|Overall Study||0
6534673|NCT01639001|7456599|FG000|STARTED|Overall Study||104
6534674|NCT01639001|7456600|FG001|STARTED|Overall Study||103
6645280|NCT02370667|7574171|FG000|STARTED|Overall Study||10
6645281|NCT02370667|7574172|FG001|STARTED|Overall Study||11
6645282|NCT02370667|7574173|FG002|STARTED|Overall Study||10
6645283|NCT02370667|7574171|FG000|COMPLETED|Overall Study||10
6645284|NCT02370667|7574172|FG001|COMPLETED|Overall Study||10
6645285|NCT02370667|7574173|FG002|COMPLETED|Overall Study||10
6645286|NCT02370667|7574171|FG000|NOT COMPLETED|Overall Study||0
6645287|NCT02370667|7574172|FG001|NOT COMPLETED|Overall Study||1
6645288|NCT02370667|7574173|FG002|NOT COMPLETED|Overall Study||0
6645289|NCT02370693|7574184|FG000|STARTED|Overall Study||3
6645290|NCT02370693|7574185|FG001|STARTED|Overall Study||4
6645291|NCT02370693|7574184|FG000|COMPLETED|Overall Study||2
6645292|NCT02370693|7574185|FG001|COMPLETED|Overall Study||3
6645293|NCT02370693|7574184|FG000|NOT COMPLETED|Overall Study||1
6645294|NCT02370693|7574185|FG001|NOT COMPLETED|Overall Study||1
6645295|NCT02370784|7574193|FG000|STARTED|Overall Study||10
6645296|NCT02370784|7574194|FG001|STARTED|Overall Study||14
6645297|NCT02370784|7574193|FG000|COMPLETED|Overall Study||10
6645298|NCT02370784|7574194|FG001|COMPLETED|Overall Study||13
6645299|NCT02370784|7574193|FG000|NOT COMPLETED|Overall Study||0
6645300|NCT02370784|7574194|FG001|NOT COMPLETED|Overall Study||1
6645301|NCT02370810|7574204|FG000|STARTED|Overall Study||73
6645302|NCT02370810|7574205|FG001|STARTED|Overall Study||73
6645303|NCT02370810|7574204|FG000|COMPLETED|Overall Study||50
6645304|NCT02370810|7574205|FG001|COMPLETED|Overall Study||54
6645305|NCT02370810|7574204|FG000|NOT COMPLETED|Overall Study||23
6645306|NCT02370810|7574205|FG001|NOT COMPLETED|Overall Study||19
6534675|NCT01639001|7456599|FG000|Treated|Overall Study||104
6534676|NCT01639001|7456600|FG001|Treated|Overall Study||101
6534677|NCT01639001|7456599|FG000|COMPLETED|Overall Study||29
6534678|NCT01639001|7456600|FG001|COMPLETED|Overall Study||26
6534679|NCT01639001|7456599|FG000|NOT COMPLETED|Overall Study||75
6534680|NCT01639001|7456600|FG001|NOT COMPLETED|Overall Study||77
6534681|NCT01639040|7456610|FG000|STARTED|Overall Study||10
6534682|NCT01639040|7456611|FG001|STARTED|Overall Study||21
6534683|NCT01639040|7456610|FG000|COMPLETED|Overall Study||9
6534684|NCT01639040|7456611|FG001|COMPLETED|Overall Study||21
6534685|NCT01639040|7456610|FG000|NOT COMPLETED|Overall Study||1
6534686|NCT01639040|7456611|FG001|NOT COMPLETED|Overall Study||0
6534687|NCT01639144|7456622|FG000|STARTED|Overall Study||260
6645307|NCT02370914|7574213|FG000|STARTED|Overall Study||84
6645308|NCT02370914|7574213|FG000|COMPLETED|Overall Study||82
6645309|NCT02370914|7574213|FG000|NOT COMPLETED|Overall Study||2
6645310|NCT02371187|7574219|FG000|STARTED|Overall Study||18
6645311|NCT02371187|7574220|FG001|STARTED|Overall Study||19
6645312|NCT02371187|7574219|FG000|COMPLETED|Overall Study||15
6645313|NCT02371187|7574220|FG001|COMPLETED|Overall Study||15
6645314|NCT02371187|7574219|FG000|NOT COMPLETED|Overall Study||3
6534688|NCT01639144|7456623|FG001|STARTED|Overall Study||255
6534689|NCT01639144|7456622|FG000|COMPLETED|Overall Study||250
6534690|NCT01639144|7456623|FG001|COMPLETED|Overall Study||250
6645315|NCT02371187|7574220|FG001|NOT COMPLETED|Overall Study||4
6645316|NCT02371252|7574228|FG000|STARTED|Overall Study||70
6645317|NCT02371252|7574229|FG001|STARTED|Overall Study||70
6645318|NCT02371252|7574228|FG000|COMPLETED|Overall Study||70
6645319|NCT02371252|7574229|FG001|COMPLETED|Overall Study||70
6645320|NCT02371252|7574228|FG000|NOT COMPLETED|Overall Study||0
6645321|NCT02371252|7574229|FG001|NOT COMPLETED|Overall Study||0
6645322|NCT02371356|7574240|FG000|STARTED|Overall Study||1320
6645323|NCT02371356|7574241|FG001|STARTED|Overall Study||7354
6645324|NCT02371356|7574242|FG002|STARTED|Overall Study||2804
6645325|NCT02371356|7574243|FG003|STARTED|Overall Study||7423
6645326|NCT02371356|7574244|FG004|STARTED|Overall Study||72183
6645327|NCT02371356|7574240|FG000|COMPLETED|Overall Study||1320
6645328|NCT02371356|7574241|FG001|COMPLETED|Overall Study||7354
6645329|NCT02371356|7574242|FG002|COMPLETED|Overall Study||2804
6645330|NCT02371356|7574243|FG003|COMPLETED|Overall Study||7423
6645331|NCT02371356|7574244|FG004|COMPLETED|Overall Study||72183
6645332|NCT02371356|7574240|FG000|NOT COMPLETED|Overall Study||0
6645333|NCT02371356|7574241|FG001|NOT COMPLETED|Overall Study||0
6645334|NCT02371356|7574242|FG002|NOT COMPLETED|Overall Study||0
6645335|NCT02371356|7574243|FG003|NOT COMPLETED|Overall Study||0
6645336|NCT02371356|7574244|FG004|NOT COMPLETED|Overall Study||0
6645337|NCT02371369|7574258|FG000|STARTED|Part 1||61
6645338|NCT02371369|7574259|FG001|STARTED|Part 1||59
6645339|NCT02371369|7574258|FG000|COMPLETED|Part 1||52
6645340|NCT02371369|7574259|FG001|COMPLETED|Part 1||48
6645341|NCT02371369|7574258|FG000|NOT COMPLETED|Part 1||9
6645342|NCT02371369|7574259|FG001|NOT COMPLETED|Part 1||11
6645343|NCT02371369|7574258|FG000|STARTED|Part 2|N=48; Only participants who were eligible to receive treatment in Part 2.|48
6645344|NCT02371369|7574259|FG001|STARTED|Part 2|N=30; Only participants who were eligible to receive treatment in Part 2.|30
6645345|NCT02371369|7574258|FG000|COMPLETED|Part 2||39
6645346|NCT02371369|7574259|FG001|COMPLETED|Part 2||26
6645347|NCT02371369|7574258|FG000|NOT COMPLETED|Part 2||9
6645348|NCT02371369|7574259|FG001|NOT COMPLETED|Part 2||4
6645349|NCT02371395|7574280|FG000|STARTED|Overall Study||1000
6645350|NCT02371395|7574280|FG000|COMPLETED|Overall Study||1000
6645351|NCT02371395|7574280|FG000|NOT COMPLETED|Overall Study||0
6645352|NCT02371616|7574286|FG000|STARTED|Overall Study||150
6645353|NCT02371616|7574287|FG001|STARTED|Overall Study||154
6645354|NCT02371616|7574286|FG000|COMPLETED|Overall Study||146
6645355|NCT02371616|7574287|FG001|COMPLETED|Overall Study||147
6645356|NCT02371616|7574286|FG000|NOT COMPLETED|Overall Study||4
6645357|NCT02371616|7574287|FG001|NOT COMPLETED|Overall Study||7
6645358|NCT02371629|7574295|FG000|STARTED|Overall Study||388
6645359|NCT02371629|7574296|FG001|STARTED|Overall Study||388
6645360|NCT02371629|7574295|FG000|COMPLETED|Overall Study||362
6645361|NCT02371629|7574296|FG001|COMPLETED|Overall Study||363
6645362|NCT02371629|7574295|FG000|NOT COMPLETED|Overall Study||26
6645363|NCT02371629|7574296|FG001|NOT COMPLETED|Overall Study||25
6645364|NCT02371668|7574304|FG000|STARTED|Overall Study||49
6645365|NCT02371668|7574305|FG001|STARTED|Overall Study||42
6645366|NCT02371668|7574304|FG000|COMPLETED|Overall Study||49
6645367|NCT02371668|7574305|FG001|COMPLETED|Overall Study||42
6645368|NCT02371668|7574304|FG000|NOT COMPLETED|Overall Study||0
6645369|NCT02371668|7574305|FG001|NOT COMPLETED|Overall Study||0
6645370|NCT02371746|7574318|FG000|STARTED|Overall Study||7
6645371|NCT02371746|7574319|FG001|STARTED|Overall Study||10
6645372|NCT02371746|7574320|FG002|STARTED|Overall Study||2
6645373|NCT02371746|7574321|FG003|STARTED|Overall Study||2
6645374|NCT02371746|7574322|FG004|STARTED|Overall Study||5
6645375|NCT02371746|7574323|FG005|STARTED|Overall Study||6
6645376|NCT02371746|7574324|FG006|STARTED|Overall Study||9
6645377|NCT02371746|7574318|FG000|COMPLETED|Overall Study||7
6645378|NCT02371746|7574319|FG001|COMPLETED|Overall Study||10
6645379|NCT02371746|7574320|FG002|COMPLETED|Overall Study||2
6645380|NCT02371746|7574321|FG003|COMPLETED|Overall Study||2
6645381|NCT02371746|7574322|FG004|COMPLETED|Overall Study||5
6645382|NCT02371746|7574323|FG005|COMPLETED|Overall Study||6
6645383|NCT02371746|7574324|FG006|COMPLETED|Overall Study||8
6645384|NCT02371746|7574318|FG000|NOT COMPLETED|Overall Study||0
6645385|NCT02371746|7574319|FG001|NOT COMPLETED|Overall Study||0
6645386|NCT02371746|7574320|FG002|NOT COMPLETED|Overall Study||0
6645387|NCT02371746|7574321|FG003|NOT COMPLETED|Overall Study||0
6645388|NCT02371746|7574322|FG004|NOT COMPLETED|Overall Study||0
6645389|NCT02371746|7574323|FG005|NOT COMPLETED|Overall Study||0
6645390|NCT02371746|7574324|FG006|NOT COMPLETED|Overall Study||1
6645391|NCT02371759|7574348|FG000|STARTED|Overall Study||32
6645392|NCT02371759|7574349|FG001|STARTED|Overall Study||31
6645393|NCT02371759|7574350|FG002|STARTED|Overall Study||33
6645394|NCT02371759|7574351|FG003|STARTED|Overall Study||31
6645395|NCT02371759|7574352|FG004|STARTED|Overall Study||27
6645396|NCT02371759|7574353|FG005|STARTED|Overall Study||26
6645397|NCT02371759|7574354|FG006|STARTED|Overall Study||25
6645398|NCT02371759|7574355|FG007|STARTED|Overall Study||28
6645399|NCT02371759|7574348|FG000|COMPLETED|Overall Study||29
6645400|NCT02371759|7574349|FG001|COMPLETED|Overall Study||30
6645401|NCT02371759|7574350|FG002|COMPLETED|Overall Study||32
6645402|NCT02371759|7574351|FG003|COMPLETED|Overall Study||31
6645403|NCT02371759|7574352|FG004|COMPLETED|Overall Study||24
6645404|NCT02371759|7574353|FG005|COMPLETED|Overall Study||25
6645405|NCT02371759|7574354|FG006|COMPLETED|Overall Study||25
6645406|NCT02371759|7574355|FG007|COMPLETED|Overall Study||24
6645407|NCT02371759|7574348|FG000|NOT COMPLETED|Overall Study||3
6645408|NCT02371759|7574349|FG001|NOT COMPLETED|Overall Study||1
6645409|NCT02371759|7574350|FG002|NOT COMPLETED|Overall Study||1
6534691|NCT01639144|7456622|FG000|NOT COMPLETED|Overall Study||10
6534692|NCT01639144|7456623|FG001|NOT COMPLETED|Overall Study||5
6534693|NCT01639157|7456629|FG000|STARTED|Overall Study||4
6534694|NCT01639157|7456630|FG001|STARTED|Overall Study||5
6534695|NCT01639157|7456629|FG000|COMPLETED|Overall Study||4
6534696|NCT01639157|7456630|FG001|COMPLETED|Overall Study||5
6534697|NCT01639157|7456629|FG000|NOT COMPLETED|Overall Study||0
6534698|NCT01639157|7456630|FG001|NOT COMPLETED|Overall Study||0
6534699|NCT01639222|7456636|FG000|STARTED|Overall Study||55
6534700|NCT01639222|7456636|FG000|COMPLETED|Overall Study||55
6534701|NCT01639222|7456636|FG000|NOT COMPLETED|Overall Study||0
6534702|NCT01639339|7456644|FG000|STARTED|Double-blind Period (Up to Week 104)||224
6534703|NCT01639339|7456645|FG001|STARTED|Double-blind Period (Up to Week 104)||224
6534704|NCT01639339|7456644|FG000|COMPLETED|Double-blind Period (Up to Week 104)||170
6534705|NCT01639339|7456645|FG001|COMPLETED|Double-blind Period (Up to Week 104)||186
6534706|NCT01639339|7456644|FG000|NOT COMPLETED|Double-blind Period (Up to Week 104)||54
6534707|NCT01639339|7456645|FG001|NOT COMPLETED|Double-blind Period (Up to Week 104)||38
6534708|NCT01639339|7456644|FG000|STARTED|Open-label Period (Up to Week 28)|Of the 356 participants who completed the double-blind period, 279 were eligible for open-label treatment. As enrolling into the open-label period was optional, only 257 participants enrolled, of whom 255 started open-label treatment.|123
6534709|NCT01639339|7456645|FG001|STARTED|Open-label Period (Up to Week 28)||132
6534710|NCT01639339|7456644|FG000|COMPLETED|Open-label Period (Up to Week 28)||122
6534711|NCT01639339|7456645|FG001|COMPLETED|Open-label Period (Up to Week 28)||124
6534712|NCT01639339|7456644|FG000|NOT COMPLETED|Open-label Period (Up to Week 28)||1
6534713|NCT01639339|7456645|FG001|NOT COMPLETED|Open-label Period (Up to Week 28)||8
6534714|NCT01639352|7456655|FG000|STARTED|Overall Study||20
6534715|NCT01639352|7456655|FG000|COMPLETED|Overall Study||20
6534716|NCT01639352|7456655|FG000|NOT COMPLETED|Overall Study||0
6645410|NCT02371759|7574351|FG003|NOT COMPLETED|Overall Study||0
6645411|NCT02371759|7574352|FG004|NOT COMPLETED|Overall Study||3
6645412|NCT02371759|7574353|FG005|NOT COMPLETED|Overall Study||1
6645413|NCT02371759|7574354|FG006|NOT COMPLETED|Overall Study||0
6645414|NCT02371759|7574355|FG007|NOT COMPLETED|Overall Study||4
6645415|NCT02371785|7574373|FG000|STARTED|Overall Study||20
6645416|NCT02371785|7574373|FG000|COMPLETED|Overall Study||20
6645417|NCT02371785|7574373|FG000|NOT COMPLETED|Overall Study||0
6645418|NCT02371850|7574383|FG000|STARTED|Overall Study||10
6645419|NCT02371850|7574383|FG000|COMPLETED|Overall Study||10
6645420|NCT02371850|7574383|FG000|NOT COMPLETED|Overall Study||0
6645421|NCT02371876|7574394|FG000|STARTED|Overall Study||134
6645422|NCT02371876|7574394|FG000|COMPLETED|Overall Study||134
6645423|NCT02371876|7574394|FG000|NOT COMPLETED|Overall Study||0
6645424|NCT02371980|7574402|FG000|STARTED|Open-label Period||1106
6645425|NCT02371980|7574403|FG001|STARTED|Open-label Period||0
6645426|NCT02371980|7574404|FG002|STARTED|Open-label Period||0
6645427|NCT02371980|7574405|FG003|STARTED|Open-label Period||0
6645428|NCT02371980|7574406|FG004|STARTED|Open-label Period||0
6645429|NCT02371980|7574402|FG000|COMPLETED|Open-label Period||580
6645430|NCT02371980|7574403|FG001|COMPLETED|Open-label Period||0
6645431|NCT02371980|7574404|FG002|COMPLETED|Open-label Period||0
6645432|NCT02371980|7574405|FG003|COMPLETED|Open-label Period||0
6645433|NCT02371980|7574406|FG004|COMPLETED|Open-label Period||0
6645434|NCT02371980|7574402|FG000|NOT COMPLETED|Open-label Period||526
6645435|NCT02371980|7574403|FG001|NOT COMPLETED|Open-label Period||0
6645436|NCT02371980|7574404|FG002|NOT COMPLETED|Open-label Period||0
6645437|NCT02371980|7574405|FG003|NOT COMPLETED|Open-label Period||0
6645438|NCT02371980|7574406|FG004|NOT COMPLETED|Open-label Period||0
6645439|NCT02371980|7574402|FG000|STARTED|Double-blind Period||0
6645440|NCT02371980|7574403|FG001|STARTED|Double-blind Period||151
6645441|NCT02371980|7574404|FG002|STARTED|Double-blind Period||140
6645442|NCT02371980|7574405|FG003|STARTED|Double-blind Period||145
6645443|NCT02371980|7574406|FG004|STARTED|Double-blind Period||144
6645444|NCT02371980|7574402|FG000|COMPLETED|Double-blind Period||0
6645445|NCT02371980|7574403|FG001|COMPLETED|Double-blind Period||70
6645446|NCT02371980|7574404|FG002|COMPLETED|Double-blind Period||84
6645447|NCT02371980|7574405|FG003|COMPLETED|Double-blind Period||96
6645448|NCT02371980|7574406|FG004|COMPLETED|Double-blind Period||86
6645449|NCT02371980|7574402|FG000|NOT COMPLETED|Double-blind Period||0
6645450|NCT02371980|7574403|FG001|NOT COMPLETED|Double-blind Period||81
6645451|NCT02371980|7574404|FG002|NOT COMPLETED|Double-blind Period||56
6645452|NCT02371980|7574405|FG003|NOT COMPLETED|Double-blind Period||49
6645453|NCT02371980|7574406|FG004|NOT COMPLETED|Double-blind Period||58
6534717|NCT01639443|7456661|FG000|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
6534718|NCT01639443|7456662|FG001|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
6534719|NCT01639443|7456661|FG000|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
6534720|NCT01639443|7456662|FG001|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
6645454|NCT02372006|7574420|FG000|STARTED|Overall Study||8
6645455|NCT02372006|7574421|FG001|STARTED|Overall Study||9
6645456|NCT02372006|7574422|FG002|STARTED|Overall Study||39
6645457|NCT02372006|7574420|FG000|COMPLETED|Overall Study||0
6645458|NCT02372006|7574421|FG001|COMPLETED|Overall Study||0
6645459|NCT02372006|7574422|FG002|COMPLETED|Overall Study||0
6645460|NCT02372006|7574420|FG000|NOT COMPLETED|Overall Study||8
6645461|NCT02372006|7574421|FG001|NOT COMPLETED|Overall Study||9
6645462|NCT02372006|7574422|FG002|NOT COMPLETED|Overall Study||39
6534721|NCT01639443|7456661|FG000|NOT COMPLETED|Overall Study||0
6534722|NCT01639443|7456662|FG001|NOT COMPLETED|Overall Study||0
6534723|NCT01639469|7456670|FG000|STARTED|Overall Study||89
6534724|NCT01639469|7456671|FG001|STARTED|Overall Study||80
6534725|NCT01639469|7456670|FG000|COMPLETED|Overall Study||84
6534726|NCT01639469|7456671|FG001|COMPLETED|Overall Study||77
6534727|NCT01639469|7456670|FG000|NOT COMPLETED|Overall Study||5
6534728|NCT01639469|7456671|FG001|NOT COMPLETED|Overall Study||3
6534729|NCT01639495|7456677|FG000|STARTED|Overall Study|Patients who signed the informed consent.|148
6534730|NCT01639495|7456677|FG000|Safety Cohort|Overall Study||144
6534731|NCT01639495|7456677|FG000|Primary Effectiveness Cohort|Overall Study||138
6534732|NCT01639495|7456677|FG000|COMPLETED|Overall Study||132
6534733|NCT01639495|7456677|FG000|NOT COMPLETED|Overall Study||16
6534734|NCT01639560|7456683|FG000|STARTED|Overall Study||45
6534735|NCT01639560|7456684|FG001|STARTED|Overall Study||48
6534736|NCT01639560|7456683|FG000|End of Treatment|Overall Study||28
6534737|NCT01639560|7456684|FG001|End of Treatment|Overall Study||20
6534738|NCT01639560|7456683|FG000|COMPLETED|Overall Study||26
6534739|NCT01639560|7456684|FG001|COMPLETED|Overall Study||19
6534740|NCT01639560|7456683|FG000|NOT COMPLETED|Overall Study||19
6534741|NCT01639560|7456684|FG001|NOT COMPLETED|Overall Study||29
6534742|NCT01639599|7456693|FG000|STARTED|Overall Study||50
6534743|NCT01639599|7456694|FG001|STARTED|Overall Study||50
6534744|NCT01639599|7456695|FG002|STARTED|Overall Study||50
6534745|NCT01639599|7456693|FG000|COMPLETED|Overall Study||50
6534746|NCT01639599|7456694|FG001|COMPLETED|Overall Study||49
6534747|NCT01639599|7456695|FG002|COMPLETED|Overall Study||50
6534748|NCT01639599|7456693|FG000|NOT COMPLETED|Overall Study||0
6534749|NCT01639599|7456694|FG001|NOT COMPLETED|Overall Study||1
6534750|NCT01639599|7456695|FG002|NOT COMPLETED|Overall Study||0
6534751|NCT01639664|7456705|FG000|STARTED|Overall Study||63
6534752|NCT01639664|7456706|FG001|STARTED|Overall Study||52
6534753|NCT01639664|7456705|FG000|COMPLETED|Overall Study||63
6534754|NCT01639664|7456706|FG001|COMPLETED|Overall Study||52
6534755|NCT01639664|7456705|FG000|NOT COMPLETED|Overall Study||0
6534756|NCT01639664|7456706|FG001|NOT COMPLETED|Overall Study||0
6534757|NCT01639703|7456713|FG000|STARTED|Overall Study||96
6534758|NCT01639703|7456713|FG000|COMPLETED|Overall Study||84
6534759|NCT01639703|7456713|FG000|NOT COMPLETED|Overall Study||12
6534760|NCT01639729|7456729|FG000|STARTED|Overall Study||4
6534761|NCT01639729|7456730|FG001|STARTED|Overall Study||4
6534762|NCT01639729|7456731|FG002|STARTED|Overall Study||4
6534763|NCT01639729|7456732|FG003|STARTED|Overall Study||5
6534764|NCT01639729|7456733|FG004|STARTED|Overall Study||4
6534765|NCT01639729|7456734|FG005|STARTED|Overall Study||4
6534766|NCT01639729|7456729|FG000|COMPLETED|Overall Study||3
6534767|NCT01639729|7456730|FG001|COMPLETED|Overall Study||4
6534768|NCT01639729|7456731|FG002|COMPLETED|Overall Study||3
6534769|NCT01639729|7456732|FG003|COMPLETED|Overall Study||4
6534770|NCT01639729|7456733|FG004|COMPLETED|Overall Study||4
6534771|NCT01639729|7456734|FG005|COMPLETED|Overall Study||4
6534772|NCT01639729|7456729|FG000|NOT COMPLETED|Overall Study||1
6534773|NCT01639729|7456730|FG001|NOT COMPLETED|Overall Study||0
6534774|NCT01639729|7456731|FG002|NOT COMPLETED|Overall Study||1
6534775|NCT01639729|7456732|FG003|NOT COMPLETED|Overall Study||1
6534776|NCT01639729|7456733|FG004|NOT COMPLETED|Overall Study||0
6534777|NCT01639729|7456734|FG005|NOT COMPLETED|Overall Study||0
6534778|NCT01639742|7456744|FG000|STARTED|Overall Study||18
6534779|NCT01639742|7456744|FG000|COMPLETED|Overall Study||0
6534780|NCT01639742|7456744|FG000|NOT COMPLETED|Overall Study||18
6534781|NCT01639755|7456748|FG000|STARTED|Overall Study||19
6534782|NCT01639755|7456748|FG000|COMPLETED|Overall Study||0
6534783|NCT01639755|7456748|FG000|NOT COMPLETED|Overall Study||19
6534784|NCT01639833|7456754|FG000|STARTED|Overall Study||45
6534785|NCT01639833|7456755|FG001|STARTED|Overall Study||45
6534786|NCT01639833|7456754|FG000|COMPLETED|Overall Study||39
6534787|NCT01639833|7456755|FG001|COMPLETED|Overall Study||41
6534788|NCT01639833|7456754|FG000|NOT COMPLETED|Overall Study||6
6534789|NCT01639833|7456755|FG001|NOT COMPLETED|Overall Study||4
6534790|NCT01639872|7456763|FG000|STARTED|Overall Study||24
6534791|NCT01639872|7456764|FG001|STARTED|Overall Study||25
6534792|NCT01639872|7456763|FG000|COMPLETED|Overall Study||14
6534793|NCT01639872|7456764|FG001|COMPLETED|Overall Study||20
6534794|NCT01639872|7456763|FG000|NOT COMPLETED|Overall Study||10
6534795|NCT01639872|7456764|FG001|NOT COMPLETED|Overall Study||5
6534796|NCT01640054|7456770|FG000|STARTED|Overall Study|Patients who received treatment|115
6534797|NCT01640054|7456770|FG000|Did Not Receive Treatment|Overall Study||0
6534798|NCT01640054|7456770|FG000|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
6534799|NCT01640054|7456770|FG000|NOT COMPLETED|Overall Study||6
6534800|NCT01640171|7456774|FG000|STARTED|Overall Study||57
6534801|NCT01640171|7456774|FG000|COMPLETED|Overall Study||57
6534802|NCT01640171|7456774|FG000|NOT COMPLETED|Overall Study||0
6534803|NCT01640184|7456782|FG000|STARTED|Overall Study||34
6534804|NCT01640184|7456783|FG001|STARTED|Overall Study||23
6534805|NCT01640184|7456784|FG002|STARTED|Overall Study||22
6534806|NCT01640184|7456782|FG000|COMPLETED|Overall Study||26
6534807|NCT01640184|7456783|FG001|COMPLETED|Overall Study||21
6534808|NCT01640184|7456784|FG002|COMPLETED|Overall Study||20
6534809|NCT01640184|7456782|FG000|NOT COMPLETED|Overall Study||8
6534810|NCT01640184|7456783|FG001|NOT COMPLETED|Overall Study||2
6534811|NCT01640184|7456784|FG002|NOT COMPLETED|Overall Study||2
6534812|NCT01640197|7456797|FG000|STARTED|Overall Study||30
6534813|NCT01640197|7456798|FG001|STARTED|Overall Study||30
6534814|NCT01640197|7456797|FG000|COMPLETED|Overall Study||30
6534815|NCT01640197|7456798|FG001|COMPLETED|Overall Study||30
6534816|NCT01640197|7456797|FG000|NOT COMPLETED|Overall Study||0
6534817|NCT01640197|7456798|FG001|NOT COMPLETED|Overall Study||0
6534818|NCT01640249|7456811|FG000|STARTED|Period 1||3
6534819|NCT01640249|7456812|FG001|STARTED|Period 1||2
6534820|NCT01640249|7456813|FG002|STARTED|Period 1||2
6534821|NCT01640249|7456814|FG003|STARTED|Period 1||2
6534822|NCT01640249|7456815|FG004|STARTED|Period 1||2
6534823|NCT01640249|7456816|FG005|STARTED|Period 1||5
6534824|NCT01640249|7456817|FG006|STARTED|Period 1||2
6534825|NCT01640249|7456811|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
6534826|NCT01640249|7456812|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
6534827|NCT01640249|7456813|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
6534828|NCT01640249|7456814|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
6534829|NCT01640249|7456815|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
6534830|NCT01640249|7456816|FG005|Received at Least 1 Dose of Study Drug|Period 1||5
6534831|NCT01640249|7456817|FG006|Received at Least 1 Dose of Study Drug|Period 1||2
6534832|NCT01640249|7456811|FG000|COMPLETED|Period 1||2
6534833|NCT01640249|7456812|FG001|COMPLETED|Period 1||2
6534834|NCT01640249|7456813|FG002|COMPLETED|Period 1||2
6534835|NCT01640249|7456814|FG003|COMPLETED|Period 1||2
6534836|NCT01640249|7456815|FG004|COMPLETED|Period 1||2
6534837|NCT01640249|7456816|FG005|COMPLETED|Period 1||4
6534838|NCT01640249|7456817|FG006|COMPLETED|Period 1||2
6534839|NCT01640249|7456811|FG000|NOT COMPLETED|Period 1||1
6534840|NCT01640249|7456812|FG001|NOT COMPLETED|Period 1||0
6534841|NCT01640249|7456813|FG002|NOT COMPLETED|Period 1||0
6534842|NCT01640249|7456814|FG003|NOT COMPLETED|Period 1||0
6534843|NCT01640249|7456815|FG004|NOT COMPLETED|Period 1||0
6534844|NCT01640249|7456816|FG005|NOT COMPLETED|Period 1||1
6534845|NCT01640249|7456817|FG006|NOT COMPLETED|Period 1||0
6534846|NCT01640249|7456811|FG000|STARTED|Period 2||2
6534847|NCT01640249|7456812|FG001|STARTED|Period 2||2
6534848|NCT01640249|7456813|FG002|STARTED|Period 2||2
6534849|NCT01640249|7456814|FG003|STARTED|Period 2||2
6534850|NCT01640249|7456815|FG004|STARTED|Period 2||2
6534851|NCT01640249|7456816|FG005|STARTED|Period 2||4
6534852|NCT01640249|7456817|FG006|STARTED|Period 2||2
6534853|NCT01640249|7456811|FG000|COMPLETED|Period 2||2
6534854|NCT01640249|7456812|FG001|COMPLETED|Period 2||2
6534855|NCT01640249|7456813|FG002|COMPLETED|Period 2||2
6534856|NCT01640249|7456814|FG003|COMPLETED|Period 2||2
6534857|NCT01640249|7456815|FG004|COMPLETED|Period 2||2
6534858|NCT01640249|7456816|FG005|COMPLETED|Period 2||4
6534859|NCT01640249|7456817|FG006|COMPLETED|Period 2||2
6534860|NCT01640249|7456811|FG000|NOT COMPLETED|Period 2||0
6534861|NCT01640249|7456812|FG001|NOT COMPLETED|Period 2||0
6534862|NCT01640249|7456813|FG002|NOT COMPLETED|Period 2||0
6534863|NCT01640249|7456814|FG003|NOT COMPLETED|Period 2||0
6534864|NCT01640249|7456815|FG004|NOT COMPLETED|Period 2||0
6534865|NCT01640249|7456816|FG005|NOT COMPLETED|Period 2||0
6534866|NCT01640249|7456817|FG006|NOT COMPLETED|Period 2||0
6534867|NCT01640249|7456811|FG000|STARTED|Period 3||2
6534868|NCT01640249|7456812|FG001|STARTED|Period 3||2
6534869|NCT01640249|7456813|FG002|STARTED|Period 3||2
6534870|NCT01640249|7456814|FG003|STARTED|Period 3||2
6534871|NCT01640249|7456815|FG004|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
6534872|NCT01640249|7456816|FG005|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
6534873|NCT01640249|7456817|FG006|STARTED|Period 3|Cohort 2 was planned for only 2 dosing periods.|0
6534874|NCT01640249|7456811|FG000|COMPLETED|Period 3||2
6534875|NCT01640249|7456812|FG001|COMPLETED|Period 3||2
6534876|NCT01640249|7456813|FG002|COMPLETED|Period 3||2
6534877|NCT01640249|7456814|FG003|COMPLETED|Period 3||1
6534878|NCT01640249|7456815|FG004|COMPLETED|Period 3||0
6534879|NCT01640249|7456816|FG005|COMPLETED|Period 3||0
6534880|NCT01640249|7456817|FG006|COMPLETED|Period 3||0
6534881|NCT01640249|7456811|FG000|NOT COMPLETED|Period 3||0
6534882|NCT01640249|7456812|FG001|NOT COMPLETED|Period 3||0
6534883|NCT01640249|7456813|FG002|NOT COMPLETED|Period 3||0
6534884|NCT01640249|7456814|FG003|NOT COMPLETED|Period 3||1
6534885|NCT01640249|7456815|FG004|NOT COMPLETED|Period 3||0
6534886|NCT01640249|7456816|FG005|NOT COMPLETED|Period 3||0
6534887|NCT01640249|7456817|FG006|NOT COMPLETED|Period 3||0
6534888|NCT01640288|7456838|FG000|STARTED|Overall Study||100
6534889|NCT01640288|7456839|FG001|STARTED|Overall Study||71
6534890|NCT01640288|7456838|FG000|Received Allocated Intervention|Overall Study|74 rec'd the gas (inc. 4 images were not obtained due to equipment failure = 70)|70
6534891|NCT01640288|7456839|FG001|Received Allocated Intervention|Overall Study|53 rec'd the gas (exc. 1 images not obtained due to equipment failure, 4 poor images = 48 )|48
6534892|NCT01640288|7456838|FG000|Did Not Receive Allocated Intervention|Overall Study||26
6534893|NCT01640288|7456839|FG001|Did Not Receive Allocated Intervention|Overall Study||18
6534894|NCT01640288|7456838|FG000|COMPLETED|Overall Study|One subject was lost to followup but rec'd the gas and images were obtained|70
6534895|NCT01640288|7456839|FG001|COMPLETED|Overall Study||48
6534896|NCT01640288|7456838|FG000|NOT COMPLETED|Overall Study||30
6534897|NCT01640288|7456839|FG001|NOT COMPLETED|Overall Study||23
6534898|NCT01640314|7456848|FG000|STARTED|Overall Study||63
6534899|NCT01640314|7456849|FG001|STARTED|Overall Study||63
6534900|NCT01640314|7456848|FG000|COMPLETED|Overall Study||63
6534901|NCT01640314|7456849|FG001|COMPLETED|Overall Study||62
6534902|NCT01640314|7456848|FG000|NOT COMPLETED|Overall Study||0
6534903|NCT01640314|7456849|FG001|NOT COMPLETED|Overall Study||1
6534904|NCT01640327|7456857|FG000|STARTED|Overall Study||63
6534905|NCT01640327|7456858|FG001|STARTED|Overall Study||63
6534906|NCT01640327|7456857|FG000|COMPLETED|Overall Study||63
6534907|NCT01640327|7456858|FG001|COMPLETED|Overall Study||63
6534908|NCT01640327|7456857|FG000|NOT COMPLETED|Overall Study||0
6534909|NCT01640327|7456858|FG001|NOT COMPLETED|Overall Study||0
6534910|NCT01640340|7456866|FG000|STARTED|Overall Study||20
6534911|NCT01640340|7456867|FG001|STARTED|Overall Study||20
6534912|NCT01640340|7456866|FG000|Overall Complete Response Rate|Overall Study||20
6534913|NCT01640340|7456867|FG001|Overall Complete Response Rate|Overall Study||20
6534914|NCT01640340|7456866|FG000|COMPLETED|Overall Study||20
6534915|NCT01640340|7456867|FG001|COMPLETED|Overall Study||20
6534916|NCT01640340|7456866|FG000|NOT COMPLETED|Overall Study||0
6534917|NCT01640340|7456867|FG001|NOT COMPLETED|Overall Study||0
6534918|NCT01640353|7456873|FG000|STARTED|Overall Study||194
6534919|NCT01640353|7456873|FG000|Treated|Overall Study||172
6534920|NCT01640353|7456873|FG000|Month 1|Overall Study||171
6534921|NCT01640353|7456873|FG000|Month 3|Overall Study||169
6534922|NCT01640353|7456873|FG000|Month 6|Overall Study||168
6534923|NCT01640353|7456873|FG000|Month 12|Overall Study||160
6534924|NCT01640353|7456873|FG000|Month 18|Overall Study||150
6534925|NCT01640353|7456873|FG000|COMPLETED|Overall Study||149
6534926|NCT01640353|7456873|FG000|NOT COMPLETED|Overall Study||45
6534927|NCT01640366|7456877|FG000|STARTED|Overall Study||200
6534928|NCT01640366|7456877|FG000|Day 21 Follow-up|Overall Study||185
6534929|NCT01640366|7456877|FG000|Day 42 Follow-up|Overall Study||177
6534930|NCT01640366|7456877|FG000|Day 90 Follow-up|Overall Study||178
6534931|NCT01640366|7456877|FG000|COMPLETED|Overall Study||178
6534932|NCT01640366|7456877|FG000|NOT COMPLETED|Overall Study||22
6534933|NCT01640379|7456885|FG000|STARTED|Overall Study||149
6534934|NCT01640379|7456886|FG001|STARTED|Overall Study||137
6534935|NCT01640379|7456885|FG000|COMPLETED|Overall Study||135
6534936|NCT01640379|7456886|FG001|COMPLETED|Overall Study||125
6534937|NCT01640379|7456885|FG000|NOT COMPLETED|Overall Study||14
6534938|NCT01640379|7456886|FG001|NOT COMPLETED|Overall Study||12
6534939|NCT01640548|7456893|FG000|STARTED|Overall Study||309
6534940|NCT01640548|7456893|FG000|COMPLETED|Overall Study||309
6534941|NCT01640548|7456893|FG000|NOT COMPLETED|Overall Study||0
6534942|NCT01640808|7456899|FG000|STARTED|Overall Study||309
6534943|NCT01640808|7456900|FG001|STARTED|Overall Study||307
6534944|NCT01640808|7456899|FG000|Subjects Received Treatment|Overall Study||305
6534945|NCT01640808|7456900|FG001|Subjects Received Treatment|Overall Study||305
6534946|NCT01640808|7456899|FG000|COMPLETED|Overall Study||251
6534947|NCT01640808|7456900|FG001|COMPLETED|Overall Study||291
6534948|NCT01640808|7456899|FG000|NOT COMPLETED|Overall Study||58
6534949|NCT01640808|7456900|FG001|NOT COMPLETED|Overall Study||16
6562077|NCT01798992|7485108|FG000|NOT COMPLETED|Overall Study||0
6562078|NCT01798992|7485109|FG001|NOT COMPLETED|Overall Study||2
6562079|NCT01798992|7485110|FG002|NOT COMPLETED|Overall Study||2
6562080|NCT01798992|7485111|FG003|NOT COMPLETED|Overall Study||1
6562081|NCT01799135|7485120|FG000|STARTED|Overall Study||6
6562082|NCT01799135|7485120|FG000|COMPLETED|Overall Study||6
6562083|NCT01799135|7485120|FG000|NOT COMPLETED|Overall Study||0
6562084|NCT01799213|7485126|FG000|STARTED|Overall Study||180
6562085|NCT01799213|7485127|FG001|STARTED|Overall Study||184
6562086|NCT01799213|7485126|FG000|COMPLETED|Overall Study||173
6562087|NCT01799213|7485127|FG001|COMPLETED|Overall Study||178
6562088|NCT01799213|7485126|FG000|NOT COMPLETED|Overall Study||7
6562089|NCT01799213|7485127|FG001|NOT COMPLETED|Overall Study||6
6562090|NCT01799226|7485141|FG000|STARTED|Overall Study||16
6562091|NCT01799226|7485142|FG001|STARTED|Overall Study||16
6562092|NCT01799226|7485141|FG000|Right Stent Side|Overall Study||8
6562093|NCT01799226|7485142|FG001|Right Stent Side|Overall Study||8
6562094|NCT01799226|7485141|FG000|Left Stent Side|Overall Study||8
6562095|NCT01799226|7485142|FG001|Left Stent Side|Overall Study||8
6562096|NCT01799226|7485141|FG000|COMPLETED|Overall Study||14
6562097|NCT01799226|7485142|FG001|COMPLETED|Overall Study||16
6562098|NCT01799226|7485141|FG000|NOT COMPLETED|Overall Study||2
6562099|NCT01799226|7485142|FG001|NOT COMPLETED|Overall Study||0
6562100|NCT01799239|7485148|FG000|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
6562101|NCT01799239|7485149|FG001|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
6562102|NCT01799239|7485148|FG000|COMPLETED|Period 1 (7 Days)||12
6562103|NCT01799239|7485149|FG001|COMPLETED|Period 1 (7 Days)||15
6562104|NCT01799239|7485148|FG000|NOT COMPLETED|Period 1 (7 Days)||3
6562105|NCT01799239|7485149|FG001|NOT COMPLETED|Period 1 (7 Days)||1
6562106|NCT01799239|7485148|FG000|STARTED|Period 2 (7 Days)||13
6562107|NCT01799239|7485149|FG001|STARTED|Period 2 (7 Days)||15
6562108|NCT01799239|7485148|FG000|COMPLETED|Period 2 (7 Days)||11
6562109|NCT01799239|7485149|FG001|COMPLETED|Period 2 (7 Days)||14
6562110|NCT01799239|7485148|FG000|NOT COMPLETED|Period 2 (7 Days)||2
6562111|NCT01799239|7485149|FG001|NOT COMPLETED|Period 2 (7 Days)||1
6562112|NCT01799278|7485155|FG000|STARTED|Overall Study||60
6562113|NCT01799278|7485155|FG000|COMPLETED|Overall Study||60
6562114|NCT01799278|7485155|FG000|NOT COMPLETED|Overall Study||0
6562115|NCT01799590|7485166|FG000|STARTED|Overall Study||111
6562116|NCT01799590|7485167|FG001|STARTED|Overall Study||94
6562117|NCT01799590|7485168|FG002|STARTED|Overall Study||91
6534950|NCT01640834|7456909|FG000|STARTED|Overall Study||8
6534951|NCT01640834|7456910|FG001|STARTED|Overall Study||8
6534952|NCT01640834|7456911|FG002|STARTED|Overall Study||4
6534953|NCT01640834|7456909|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6534954|NCT01640834|7456910|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
6534955|NCT01640834|7456911|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
6534956|NCT01640834|7456909|FG000|COMPLETED|Overall Study||8
6534957|NCT01640834|7456910|FG001|COMPLETED|Overall Study||8
6534958|NCT01640834|7456911|FG002|COMPLETED|Overall Study||4
6534959|NCT01640834|7456909|FG000|NOT COMPLETED|Overall Study||0
6534960|NCT01640834|7456910|FG001|NOT COMPLETED|Overall Study||0
6534961|NCT01640834|7456911|FG002|NOT COMPLETED|Overall Study||0
6534962|NCT01640873|7456923|FG000|STARTED|Overall Study||22
6534963|NCT01640873|7456924|FG001|STARTED|Overall Study||11
6534964|NCT01640873|7456923|FG000|COMPLETED|Overall Study||20
6534965|NCT01640873|7456924|FG001|COMPLETED|Overall Study||10
6534966|NCT01640873|7456923|FG000|NOT COMPLETED|Overall Study||2
6534967|NCT01640873|7456924|FG001|NOT COMPLETED|Overall Study||1
6534968|NCT01640925|7456932|FG000|STARTED|Overall Study||175
6534969|NCT01640925|7456933|FG001|STARTED|Overall Study||175
6534970|NCT01640925|7456932|FG000|COMPLETED|Overall Study||161
6534971|NCT01640925|7456933|FG001|COMPLETED|Overall Study||164
6534972|NCT01640925|7456932|FG000|NOT COMPLETED|Overall Study||14
6534973|NCT01640925|7456933|FG001|NOT COMPLETED|Overall Study||11
6534974|NCT01640951|7456947|FG000|STARTED|Overall Study||77
6534975|NCT01640951|7456948|FG001|STARTED|Overall Study||75
6534976|NCT01640951|7456949|FG002|STARTED|Overall Study||168
6534977|NCT01640951|7456950|FG003|STARTED|Overall Study||55
6534978|NCT01640951|7456951|FG004|STARTED|Overall Study||95
6534979|NCT01640951|7456952|FG005|STARTED|Overall Study||60
6534980|NCT01640951|7456953|FG006|STARTED|Overall Study||112
6534981|NCT01640951|7456954|FG007|STARTED|Overall Study||33
6534982|NCT01640951|7456947|FG000|COMPLETED|Overall Study||31
6534983|NCT01640951|7456948|FG001|COMPLETED|Overall Study||60
6534984|NCT01640951|7456949|FG002|COMPLETED|Overall Study||126
6534985|NCT01640951|7456950|FG003|COMPLETED|Overall Study||10
6534986|NCT01640951|7456951|FG004|COMPLETED|Overall Study||82
6534987|NCT01640951|7456952|FG005|COMPLETED|Overall Study||13
6534988|NCT01640951|7456953|FG006|COMPLETED|Overall Study||94
6534989|NCT01640951|7456954|FG007|COMPLETED|Overall Study||17
6534990|NCT01640951|7456947|FG000|NOT COMPLETED|Overall Study||46
6534991|NCT01640951|7456948|FG001|NOT COMPLETED|Overall Study||15
6534992|NCT01640951|7456949|FG002|NOT COMPLETED|Overall Study||42
6534993|NCT01640951|7456950|FG003|NOT COMPLETED|Overall Study||45
6534994|NCT01640951|7456951|FG004|NOT COMPLETED|Overall Study||13
6534995|NCT01640951|7456952|FG005|NOT COMPLETED|Overall Study||47
6534996|NCT01640951|7456953|FG006|NOT COMPLETED|Overall Study||18
6534997|NCT01640951|7456954|FG007|NOT COMPLETED|Overall Study||16
6534998|NCT01640964|7456977|FG000|STARTED|Overall Study||20
6534999|NCT01640964|7456978|FG001|STARTED|Overall Study||20
6535000|NCT01640964|7456979|FG002|STARTED|Overall Study||6
6535001|NCT01640964|7456977|FG000|COMPLETED|Overall Study||19
6535002|NCT01640964|7456978|FG001|COMPLETED|Overall Study||19
6535003|NCT01640964|7456979|FG002|COMPLETED|Overall Study||3
6535004|NCT01640964|7456977|FG000|NOT COMPLETED|Overall Study||1
6535005|NCT01640964|7456978|FG001|NOT COMPLETED|Overall Study||1
6535006|NCT01640964|7456979|FG002|NOT COMPLETED|Overall Study||3
6535007|NCT01641042|7456990|FG000|STARTED|Overall Study||43
6535008|NCT01641042|7456991|FG001|STARTED|Overall Study||43
6535009|NCT01641042|7456990|FG000|COMPLETED|Overall Study||43
6535010|NCT01641042|7456991|FG001|COMPLETED|Overall Study||43
6535011|NCT01641042|7456990|FG000|NOT COMPLETED|Overall Study||0
6535012|NCT01641042|7456991|FG001|NOT COMPLETED|Overall Study||0
6535013|NCT01641081|7456997|FG000|STARTED|Period 1||18
6535014|NCT01641081|7456998|FG001|STARTED|Period 1||18
6535015|NCT01641081|7456999|FG002|STARTED|Period 1||15
6535016|NCT01641081|7457000|FG003|STARTED|Period 1||22
6535017|NCT01641081|7457001|FG004|STARTED|Period 1||17
6535018|NCT01641081|7457002|FG005|STARTED|Period 1||19
6535019|NCT01641081|7457003|FG006|STARTED|Period 1||19
6535020|NCT01641081|7457004|FG007|STARTED|Period 1||17
6535021|NCT01641081|7457005|FG008|STARTED|Period 1||15
6535022|NCT01641081|7457006|FG009|STARTED|Period 1||14
6535023|NCT01641081|7456997|FG000|COMPLETED|Period 1||17
6535024|NCT01641081|7456998|FG001|COMPLETED|Period 1||18
6535025|NCT01641081|7456999|FG002|COMPLETED|Period 1||15
6535026|NCT01641081|7457000|FG003|COMPLETED|Period 1||22
6535027|NCT01641081|7457001|FG004|COMPLETED|Period 1||16
6535028|NCT01641081|7457002|FG005|COMPLETED|Period 1||19
6535029|NCT01641081|7457003|FG006|COMPLETED|Period 1||18
6535030|NCT01641081|7457004|FG007|COMPLETED|Period 1||14
6535031|NCT01641081|7457005|FG008|COMPLETED|Period 1||15
6535032|NCT01641081|7457006|FG009|COMPLETED|Period 1||14
6535033|NCT01641081|7456997|FG000|NOT COMPLETED|Period 1||1
6535034|NCT01641081|7456998|FG001|NOT COMPLETED|Period 1||0
6535035|NCT01641081|7456999|FG002|NOT COMPLETED|Period 1||0
6535036|NCT01641081|7457000|FG003|NOT COMPLETED|Period 1||0
6535037|NCT01641081|7457001|FG004|NOT COMPLETED|Period 1||1
6535038|NCT01641081|7457002|FG005|NOT COMPLETED|Period 1||0
6535039|NCT01641081|7457003|FG006|NOT COMPLETED|Period 1||1
6535040|NCT01641081|7457004|FG007|NOT COMPLETED|Period 1||3
6535041|NCT01641081|7457005|FG008|NOT COMPLETED|Period 1||0
6535042|NCT01641081|7457006|FG009|NOT COMPLETED|Period 1||0
6535043|NCT01641081|7456997|FG000|STARTED|Period 2||17
6535044|NCT01641081|7456998|FG001|STARTED|Period 2||18
6535045|NCT01641081|7456999|FG002|STARTED|Period 2||15
6535046|NCT01641081|7457000|FG003|STARTED|Period 2||22
6535047|NCT01641081|7457001|FG004|STARTED|Period 2||16
6535048|NCT01641081|7457002|FG005|STARTED|Period 2||19
6535049|NCT01641081|7457003|FG006|STARTED|Period 2||18
6535050|NCT01641081|7457004|FG007|STARTED|Period 2||14
6535051|NCT01641081|7457005|FG008|STARTED|Period 2||15
6535052|NCT01641081|7457006|FG009|STARTED|Period 2||14
6535053|NCT01641081|7456997|FG000|COMPLETED|Period 2||16
6535054|NCT01641081|7456998|FG001|COMPLETED|Period 2||18
6535055|NCT01641081|7456999|FG002|COMPLETED|Period 2||15
6535056|NCT01641081|7457000|FG003|COMPLETED|Period 2||21
6535057|NCT01641081|7457001|FG004|COMPLETED|Period 2||16
6535058|NCT01641081|7457002|FG005|COMPLETED|Period 2||18
6535059|NCT01641081|7457003|FG006|COMPLETED|Period 2||16
6535060|NCT01641081|7457004|FG007|COMPLETED|Period 2||14
6535061|NCT01641081|7457005|FG008|COMPLETED|Period 2||15
6535062|NCT01641081|7457006|FG009|COMPLETED|Period 2||14
6535063|NCT01641081|7456997|FG000|NOT COMPLETED|Period 2||1
6535064|NCT01641081|7456998|FG001|NOT COMPLETED|Period 2||0
6535065|NCT01641081|7456999|FG002|NOT COMPLETED|Period 2||0
6535066|NCT01641081|7457000|FG003|NOT COMPLETED|Period 2||1
6535067|NCT01641081|7457001|FG004|NOT COMPLETED|Period 2||0
6535068|NCT01641081|7457002|FG005|NOT COMPLETED|Period 2||1
6535069|NCT01641081|7457003|FG006|NOT COMPLETED|Period 2||2
6535070|NCT01641081|7457004|FG007|NOT COMPLETED|Period 2||0
6535071|NCT01641081|7457005|FG008|NOT COMPLETED|Period 2||0
6535072|NCT01641081|7457006|FG009|NOT COMPLETED|Period 2||0
6535073|NCT01641081|7456997|FG000|STARTED|Period 3||16
6535074|NCT01641081|7456998|FG001|STARTED|Period 3||18
6535075|NCT01641081|7456999|FG002|STARTED|Period 3||15
6535076|NCT01641081|7457000|FG003|STARTED|Period 3||21
6535077|NCT01641081|7457001|FG004|STARTED|Period 3||16
6535078|NCT01641081|7457002|FG005|STARTED|Period 3||18
6535079|NCT01641081|7457003|FG006|STARTED|Period 3||16
6535080|NCT01641081|7457004|FG007|STARTED|Period 3||14
6535081|NCT01641081|7457005|FG008|STARTED|Period 3||15
6535082|NCT01641081|7457006|FG009|STARTED|Period 3||14
6535083|NCT01641081|7456997|FG000|COMPLETED|Period 3||16
6535084|NCT01641081|7456998|FG001|COMPLETED|Period 3||18
6535085|NCT01641081|7456999|FG002|COMPLETED|Period 3||14
6535086|NCT01641081|7457000|FG003|COMPLETED|Period 3||21
6535087|NCT01641081|7457001|FG004|COMPLETED|Period 3||16
6535088|NCT01641081|7457002|FG005|COMPLETED|Period 3||18
6535089|NCT01641081|7457003|FG006|COMPLETED|Period 3||16
6535090|NCT01641081|7457004|FG007|COMPLETED|Period 3||14
6535091|NCT01641081|7457005|FG008|COMPLETED|Period 3||14
6535092|NCT01641081|7457006|FG009|COMPLETED|Period 3||14
6535093|NCT01641081|7456997|FG000|NOT COMPLETED|Period 3||0
6535094|NCT01641081|7456998|FG001|NOT COMPLETED|Period 3||0
6535095|NCT01641081|7456999|FG002|NOT COMPLETED|Period 3||1
6535096|NCT01641081|7457000|FG003|NOT COMPLETED|Period 3||0
6535097|NCT01641081|7457001|FG004|NOT COMPLETED|Period 3||0
6535098|NCT01641081|7457002|FG005|NOT COMPLETED|Period 3||0
6535099|NCT01641081|7457003|FG006|NOT COMPLETED|Period 3||0
6535100|NCT01641081|7457004|FG007|NOT COMPLETED|Period 3||0
6535101|NCT01641081|7457005|FG008|NOT COMPLETED|Period 3||1
6535102|NCT01641081|7457006|FG009|NOT COMPLETED|Period 3||0
6535103|NCT01641081|7456997|FG000|STARTED|Period 4||16
6535104|NCT01641081|7456998|FG001|STARTED|Period 4||18
6535105|NCT01641081|7456999|FG002|STARTED|Period 4||14
6535106|NCT01641081|7457000|FG003|STARTED|Period 4||21
6535107|NCT01641081|7457001|FG004|STARTED|Period 4||16
6535108|NCT01641081|7457002|FG005|STARTED|Period 4||18
6535109|NCT01641081|7457003|FG006|STARTED|Period 4||16
6535110|NCT01641081|7457004|FG007|STARTED|Period 4||14
6535111|NCT01641081|7457005|FG008|STARTED|Period 4||14
6535112|NCT01641081|7457006|FG009|STARTED|Period 4||14
6535113|NCT01641081|7456997|FG000|COMPLETED|Period 4||16
6535114|NCT01641081|7456998|FG001|COMPLETED|Period 4||17
6535115|NCT01641081|7456999|FG002|COMPLETED|Period 4||14
6535116|NCT01641081|7457000|FG003|COMPLETED|Period 4||20
6535117|NCT01641081|7457001|FG004|COMPLETED|Period 4||16
6535118|NCT01641081|7457002|FG005|COMPLETED|Period 4||18
6535119|NCT01641081|7457003|FG006|COMPLETED|Period 4||16
6535120|NCT01641081|7457004|FG007|COMPLETED|Period 4||14
6535121|NCT01641081|7457005|FG008|COMPLETED|Period 4||14
6535122|NCT01641081|7457006|FG009|COMPLETED|Period 4||14
6535123|NCT01641081|7456997|FG000|NOT COMPLETED|Period 4||0
6535124|NCT01641081|7456998|FG001|NOT COMPLETED|Period 4||1
6535125|NCT01641081|7456999|FG002|NOT COMPLETED|Period 4||0
6535126|NCT01641081|7457000|FG003|NOT COMPLETED|Period 4||1
6535127|NCT01641081|7457001|FG004|NOT COMPLETED|Period 4||0
6535128|NCT01641081|7457002|FG005|NOT COMPLETED|Period 4||0
6535129|NCT01641081|7457003|FG006|NOT COMPLETED|Period 4||0
6535130|NCT01641081|7457004|FG007|NOT COMPLETED|Period 4||0
6535131|NCT01641081|7457005|FG008|NOT COMPLETED|Period 4||0
6535132|NCT01641081|7457006|FG009|NOT COMPLETED|Period 4||0
6535133|NCT01641081|7456997|FG000|STARTED|Period 5||16
6535134|NCT01641081|7456998|FG001|STARTED|Period 5||17
6535135|NCT01641081|7456999|FG002|STARTED|Period 5||14
6535136|NCT01641081|7457000|FG003|STARTED|Period 5||20
6535137|NCT01641081|7457001|FG004|STARTED|Period 5||16
6535138|NCT01641081|7457002|FG005|STARTED|Period 5||18
6535139|NCT01641081|7457003|FG006|STARTED|Period 5||16
6535140|NCT01641081|7457004|FG007|STARTED|Period 5||14
6535141|NCT01641081|7457005|FG008|STARTED|Period 5||14
6535142|NCT01641081|7457006|FG009|STARTED|Period 5||14
6535143|NCT01641081|7456997|FG000|COMPLETED|Period 5||16
6535144|NCT01641081|7456998|FG001|COMPLETED|Period 5||17
6535145|NCT01641081|7456999|FG002|COMPLETED|Period 5||12
6535146|NCT01641081|7457000|FG003|COMPLETED|Period 5||20
6535147|NCT01641081|7457001|FG004|COMPLETED|Period 5||16
6535148|NCT01641081|7457002|FG005|COMPLETED|Period 5||18
6535149|NCT01641081|7457003|FG006|COMPLETED|Period 5||16
6535150|NCT01641081|7457004|FG007|COMPLETED|Period 5||14
6535151|NCT01641081|7457005|FG008|COMPLETED|Period 5||14
6535152|NCT01641081|7457006|FG009|COMPLETED|Period 5||14
6535153|NCT01641081|7456997|FG000|NOT COMPLETED|Period 5||0
6535154|NCT01641081|7456998|FG001|NOT COMPLETED|Period 5||0
6535155|NCT01641081|7456999|FG002|NOT COMPLETED|Period 5||2
6535156|NCT01641081|7457000|FG003|NOT COMPLETED|Period 5||0
6535157|NCT01641081|7457001|FG004|NOT COMPLETED|Period 5||0
6535158|NCT01641081|7457002|FG005|NOT COMPLETED|Period 5||0
6535159|NCT01641081|7457003|FG006|NOT COMPLETED|Period 5||0
6535160|NCT01641081|7457004|FG007|NOT COMPLETED|Period 5||0
6535161|NCT01641081|7457005|FG008|NOT COMPLETED|Period 5||0
6535162|NCT01641081|7457006|FG009|NOT COMPLETED|Period 5||0
6535163|NCT01641120|7457018|FG000|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
6535164|NCT01641120|7457018|FG000|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
6535165|NCT01641120|7457018|FG000|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
6535166|NCT01641120|7457018|FG000|STARTED|30 Gauge Needle Weeks 2 and 3||20
6535167|NCT01641120|7457018|FG000|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
6535168|NCT01641120|7457018|FG000|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
6535169|NCT01641133|7457028|FG000|STARTED|Overall Study||97
6535170|NCT01641133|7457029|FG001|STARTED|Overall Study||99
6535171|NCT01641133|7457030|FG002|STARTED|Overall Study||98
6535172|NCT01641133|7457028|FG000|COMPLETED|Overall Study||87
6535173|NCT01641133|7457029|FG001|COMPLETED|Overall Study||90
6535174|NCT01641133|7457030|FG002|COMPLETED|Overall Study||90
6535175|NCT01641133|7457028|FG000|NOT COMPLETED|Overall Study||10
6535176|NCT01641133|7457029|FG001|NOT COMPLETED|Overall Study||9
6535177|NCT01641133|7457030|FG002|NOT COMPLETED|Overall Study||8
6535178|NCT01641159|7457040|FG000|STARTED|Overall Study||35
6535179|NCT01641159|7457041|FG001|STARTED|Overall Study||27
6535180|NCT01641159|7457040|FG000|COMPLETED|Overall Study||33
6535181|NCT01641159|7457041|FG001|COMPLETED|Overall Study||25
6535182|NCT01641159|7457040|FG000|NOT COMPLETED|Overall Study||2
6535183|NCT01641159|7457041|FG001|NOT COMPLETED|Overall Study||2
6535184|NCT01641198|7457050|FG000|STARTED|After 12 Months of Function||20
6535185|NCT01641198|7457051|FG001|STARTED|After 12 Months of Function||19
6535186|NCT01641198|7457052|FG002|STARTED|After 12 Months of Function||19
6535187|NCT01641198|7457050|FG000|COMPLETED|After 12 Months of Function|Participants: 3 interval violation, 1 protocol violation. Implants: 13 bone loss not measurable|16
6535188|NCT01641198|7457051|FG001|COMPLETED|After 12 Months of Function|Participants: 2 interval violation, 1 adverse event. Implants: 3 bone loss not measurable|16
6535189|NCT01641198|7457052|FG002|COMPLETED|After 12 Months of Function|Participants: 2 interval violation. Implants: 3 bone loss not measurable|17
6535190|NCT01641198|7457050|FG000|NOT COMPLETED|After 12 Months of Function||4
6535191|NCT01641198|7457051|FG001|NOT COMPLETED|After 12 Months of Function||3
6535192|NCT01641198|7457052|FG002|NOT COMPLETED|After 12 Months of Function||2
6535193|NCT01641198|7457050|FG000|STARTED|After 24 Months of Function||16
6535194|NCT01641198|7457051|FG001|STARTED|After 24 Months of Function||16
6535195|NCT01641198|7457052|FG002|STARTED|After 24 Months of Function||17
6535196|NCT01641198|7457050|FG000|COMPLETED|After 24 Months of Function|Participants: 4 interval violation. Implants: 3 bone loss not measurable|12
6535197|NCT01641198|7457051|FG001|COMPLETED|After 24 Months of Function|Participants: 9 interval violation|7
6535198|NCT01641198|7457052|FG002|COMPLETED|After 24 Months of Function|Participants: 6 interval violation. Implants: 2 bone loss not measurable|11
6535199|NCT01641198|7457050|FG000|NOT COMPLETED|After 24 Months of Function||4
6535200|NCT01641198|7457051|FG001|NOT COMPLETED|After 24 Months of Function||9
6535201|NCT01641198|7457052|FG002|NOT COMPLETED|After 24 Months of Function||6
6535202|NCT01641198|7457050|FG000|STARTED|At 15-20 Years of Function||12
6535203|NCT01641198|7457051|FG001|STARTED|At 15-20 Years of Function||7
6535204|NCT01641198|7457052|FG002|STARTED|At 15-20 Years of Function||11
6535205|NCT01641198|7457050|FG000|COMPLETED|At 15-20 Years of Function|Participants: 5 interval violation, 1 death|6
6535206|NCT01641198|7457051|FG001|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation|6
6535207|NCT01641198|7457052|FG002|COMPLETED|At 15-20 Years of Function|Participants: 1 interval violation, 1 death|9
6535208|NCT01641198|7457050|FG000|NOT COMPLETED|At 15-20 Years of Function||6
6535209|NCT01641198|7457051|FG001|NOT COMPLETED|At 15-20 Years of Function||1
6535210|NCT01641198|7457052|FG002|NOT COMPLETED|At 15-20 Years of Function||2
6535211|NCT01641237|7457061|FG000|STARTED|Period I||16
6535212|NCT01641237|7457062|FG001|STARTED|Period I||16
6535213|NCT01641237|7457063|FG002|STARTED|Period I||15
6535214|NCT01641237|7457064|FG003|STARTED|Period I||15
6535215|NCT01641237|7457061|FG000|COMPLETED|Period I||16
6535216|NCT01641237|7457062|FG001|COMPLETED|Period I||16
6535217|NCT01641237|7457063|FG002|COMPLETED|Period I||15
6535218|NCT01641237|7457064|FG003|COMPLETED|Period I||15
6535219|NCT01641237|7457061|FG000|NOT COMPLETED|Period I||0
6535220|NCT01641237|7457062|FG001|NOT COMPLETED|Period I||0
6535221|NCT01641237|7457063|FG002|NOT COMPLETED|Period I||0
6535222|NCT01641237|7457064|FG003|NOT COMPLETED|Period I||0
6535223|NCT01641237|7457061|FG000|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
6535224|NCT01641237|7457062|FG001|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
6535225|NCT01641237|7457063|FG002|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
6645463|NCT02372058|7574431|FG000|STARTED|Overall Study||103
6645464|NCT02372058|7574431|FG000|COMPLETED|Overall Study||100
6645465|NCT02372058|7574431|FG000|NOT COMPLETED|Overall Study||3
6645466|NCT02372071|7574437|FG000|STARTED|Overall Study||111
6645467|NCT02372071|7574437|FG000|COMPLETED|Overall Study||93
6645468|NCT02372071|7574437|FG000|NOT COMPLETED|Overall Study||18
6645469|NCT02372097|7574444|FG000|STARTED|First Intervention Period (8 Days)||12
6645470|NCT02372097|7574445|FG001|STARTED|First Intervention Period (8 Days)||12
6535226|NCT01641237|7457064|FG003|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
6535227|NCT01641237|7457061|FG000|COMPLETED|Period II||14
6535228|NCT01641237|7457062|FG001|COMPLETED|Period II||16
6535229|NCT01641237|7457063|FG002|COMPLETED|Period II||16
6535230|NCT01641237|7457064|FG003|COMPLETED|Period II||15
6535231|NCT01641237|7457061|FG000|NOT COMPLETED|Period II||1
6535232|NCT01641237|7457062|FG001|NOT COMPLETED|Period II||0
6535233|NCT01641237|7457063|FG002|NOT COMPLETED|Period II||0
6535234|NCT01641237|7457064|FG003|NOT COMPLETED|Period II||0
6535235|NCT01641237|7457061|FG000|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
6535236|NCT01641237|7457062|FG001|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
6535237|NCT01641237|7457063|FG002|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
6535238|NCT01641237|7457064|FG003|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
6535239|NCT01641237|7457061|FG000|COMPLETED|Period III||15
6535240|NCT01641237|7457062|FG001|COMPLETED|Period III||14
6535241|NCT01641237|7457063|FG002|COMPLETED|Period III||15
6535242|NCT01641237|7457064|FG003|COMPLETED|Period III||16
6535243|NCT01641237|7457061|FG000|NOT COMPLETED|Period III||1
6743753|NCT03335254|7671810|FG000|STARTED|Period 3, Day 26-30||9
6743754|NCT03335254|7671811|FG001|STARTED|Period 3, Day 26-30||0
6743755|NCT03335254|7671812|FG002|STARTED|Period 3, Day 26-30||0
6743756|NCT03335254|7671813|FG003|STARTED|Period 3, Day 26-30||0
6743757|NCT03335254|7671814|FG004|STARTED|Period 3, Day 26-30||0
6743758|NCT03335254|7671815|FG005|STARTED|Period 3, Day 26-30||0
6743759|NCT03335254|7671816|FG006|STARTED|Period 3, Day 26-30||0
6535244|NCT01641237|7457062|FG001|NOT COMPLETED|Period III||0
6535245|NCT01641237|7457063|FG002|NOT COMPLETED|Period III||0
6535246|NCT01641237|7457064|FG003|NOT COMPLETED|Period III||0
6535247|NCT01641237|7457061|FG000|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
6535248|NCT01641237|7457062|FG001|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
6535249|NCT01641237|7457063|FG002|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
6535250|NCT01641237|7457064|FG003|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
6535251|NCT01641237|7457061|FG000|COMPLETED|Period IV||15
6535252|NCT01641237|7457062|FG001|COMPLETED|Period IV||15
6535253|NCT01641237|7457063|FG002|COMPLETED|Period IV||15
6535254|NCT01641237|7457064|FG003|COMPLETED|Period IV||15
6535255|NCT01641237|7457061|FG000|NOT COMPLETED|Period IV||0
6535256|NCT01641237|7457062|FG001|NOT COMPLETED|Period IV||0
6535257|NCT01641237|7457063|FG002|NOT COMPLETED|Period IV||0
6535258|NCT01641237|7457064|FG003|NOT COMPLETED|Period IV||0
6535259|NCT01641367|7457080|FG000|STARTED|Cohorts||287
6535260|NCT01641367|7457081|FG001|STARTED|Cohorts||74
6535261|NCT01641367|7457082|FG002|STARTED|Cohorts||72
6535262|NCT01641367|7457083|FG003|STARTED|Cohorts||8
6535263|NCT01641367|7457084|FG004|STARTED|Cohorts||70
6535264|NCT01641367|7457085|FG005|STARTED|Cohorts||34
6535265|NCT01641367|7457086|FG006|STARTED|Cohorts||0
6535266|NCT01641367|7457087|FG007|STARTED|Cohorts||0
6535267|NCT01641367|7457080|FG000|Followed 72 Weeks on Step 1/2|Cohorts||211
6535268|NCT01641367|7457081|FG001|Followed 72 Weeks on Step 1/2|Cohorts||60
6535269|NCT01641367|7457082|FG002|Followed 72 Weeks on Step 1/2|Cohorts||60
6535270|NCT01641367|7457083|FG003|Followed 72 Weeks on Step 1/2|Cohorts||6
6535271|NCT01641367|7457084|FG004|Followed 72 Weeks on Step 1/2|Cohorts||52
6535272|NCT01641367|7457085|FG005|Followed 72 Weeks on Step 1/2|Cohorts||30
6535273|NCT01641367|7457086|FG006|Followed 72 Weeks on Step 1/2|Cohorts||0
6535274|NCT01641367|7457087|FG007|Followed 72 Weeks on Step 1/2|Cohorts||0
6535275|NCT01641367|7457080|FG000|COMPLETED|Cohorts||253
6535276|NCT01641367|7457081|FG001|COMPLETED|Cohorts||73
6535277|NCT01641367|7457082|FG002|COMPLETED|Cohorts||68
6535278|NCT01641367|7457083|FG003|COMPLETED|Cohorts||8
6535279|NCT01641367|7457084|FG004|COMPLETED|Cohorts||67
6535280|NCT01641367|7457085|FG005|COMPLETED|Cohorts||33
6535281|NCT01641367|7457086|FG006|COMPLETED|Cohorts||0
6535282|NCT01641367|7457087|FG007|COMPLETED|Cohorts||0
6535283|NCT01641367|7457080|FG000|NOT COMPLETED|Cohorts||34
6535284|NCT01641367|7457081|FG001|NOT COMPLETED|Cohorts||1
6535285|NCT01641367|7457082|FG002|NOT COMPLETED|Cohorts||4
6535286|NCT01641367|7457083|FG003|NOT COMPLETED|Cohorts||0
6535287|NCT01641367|7457084|FG004|NOT COMPLETED|Cohorts||3
6535288|NCT01641367|7457085|FG005|NOT COMPLETED|Cohorts||1
6535289|NCT01641367|7457086|FG006|NOT COMPLETED|Cohorts||0
6535290|NCT01641367|7457087|FG007|NOT COMPLETED|Cohorts||0
6535291|NCT01641367|7457080|FG000|STARTED|Randomized Adherence Intervention||0
6535292|NCT01641367|7457081|FG001|STARTED|Randomized Adherence Intervention||0
6535293|NCT01641367|7457082|FG002|STARTED|Randomized Adherence Intervention||0
6645471|NCT02372097|7574444|FG000|COMPLETED|First Intervention Period (8 Days)||12
6645472|NCT02372097|7574445|FG001|COMPLETED|First Intervention Period (8 Days)||12
6743760|NCT03335254|7671817|FG007|STARTED|Period 3, Day 26-30||0
6535294|NCT01641367|7457083|FG003|STARTED|Randomized Adherence Intervention||0
6535295|NCT01641367|7457084|FG004|STARTED|Randomized Adherence Intervention||0
6535296|NCT01641367|7457085|FG005|STARTED|Randomized Adherence Intervention||0
6535297|NCT01641367|7457086|FG006|STARTED|Randomized Adherence Intervention||257
6535298|NCT01641367|7457087|FG007|STARTED|Randomized Adherence Intervention||264
6535299|NCT01641367|7457080|FG000|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6535300|NCT01641367|7457081|FG001|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6535301|NCT01641367|7457082|FG002|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6535302|NCT01641367|7457083|FG003|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6535303|NCT01641367|7457084|FG004|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6535304|NCT01641367|7457085|FG005|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||0
6535305|NCT01641367|7457086|FG006|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||196
6535306|NCT01641367|7457087|FG007|Followed 72 Weeks on Step 1/2|Randomized Adherence Intervention||202
6535307|NCT01641367|7457080|FG000|COMPLETED|Randomized Adherence Intervention||0
6535308|NCT01641367|7457081|FG001|COMPLETED|Randomized Adherence Intervention||0
6535309|NCT01641367|7457082|FG002|COMPLETED|Randomized Adherence Intervention||0
6535310|NCT01641367|7457083|FG003|COMPLETED|Randomized Adherence Intervention||0
6535311|NCT01641367|7457084|FG004|COMPLETED|Randomized Adherence Intervention||0
6535312|NCT01641367|7457085|FG005|COMPLETED|Randomized Adherence Intervention||0
6535313|NCT01641367|7457086|FG006|COMPLETED|Randomized Adherence Intervention||238
6535314|NCT01641367|7457087|FG007|COMPLETED|Randomized Adherence Intervention||240
6535315|NCT01641367|7457080|FG000|NOT COMPLETED|Randomized Adherence Intervention||0
6535316|NCT01641367|7457081|FG001|NOT COMPLETED|Randomized Adherence Intervention||0
6535317|NCT01641367|7457082|FG002|NOT COMPLETED|Randomized Adherence Intervention||0
6535318|NCT01641367|7457083|FG003|NOT COMPLETED|Randomized Adherence Intervention||0
6535319|NCT01641367|7457084|FG004|NOT COMPLETED|Randomized Adherence Intervention||0
6535320|NCT01641367|7457085|FG005|NOT COMPLETED|Randomized Adherence Intervention||0
6535321|NCT01641367|7457086|FG006|NOT COMPLETED|Randomized Adherence Intervention||19
6535322|NCT01641367|7457087|FG007|NOT COMPLETED|Randomized Adherence Intervention||24
6535323|NCT01641380|7457112|FG000|STARTED|First Injection Cycle||50
6535324|NCT01641380|7457113|FG001|STARTED|First Injection Cycle||50
6535325|NCT01641380|7457112|FG000|COMPLETED|First Injection Cycle||43
6535326|NCT01641380|7457113|FG001|COMPLETED|First Injection Cycle||44
6535327|NCT01641380|7457112|FG000|NOT COMPLETED|First Injection Cycle||7
6535328|NCT01641380|7457113|FG001|NOT COMPLETED|First Injection Cycle||6
6535329|NCT01641380|7457112|FG000|STARTED|Second Injection Cycle||43
6535330|NCT01641380|7457113|FG001|STARTED|Second Injection Cycle||44
6535331|NCT01641380|7457112|FG000|COMPLETED|Second Injection Cycle||39
6535332|NCT01641380|7457113|FG001|COMPLETED|Second Injection Cycle||38
6535333|NCT01641380|7457112|FG000|NOT COMPLETED|Second Injection Cycle||4
6535334|NCT01641380|7457113|FG001|NOT COMPLETED|Second Injection Cycle||6
6535335|NCT01641380|7457112|FG000|STARTED|Third Injection Cycle||39
6535336|NCT01641380|7457113|FG001|STARTED|Third Injection Cycle||38
6535337|NCT01641380|7457112|FG000|COMPLETED|Third Injection Cycle||36
6535338|NCT01641380|7457113|FG001|COMPLETED|Third Injection Cycle||33
6535339|NCT01641380|7457112|FG000|NOT COMPLETED|Third Injection Cycle||3
6535340|NCT01641380|7457113|FG001|NOT COMPLETED|Third Injection Cycle||5
6535341|NCT01641445|7457122|FG000|STARTED|Overall Study||41
6535342|NCT01641445|7457123|FG001|STARTED|Overall Study||41
6535343|NCT01641445|7457122|FG000|COMPLETED|Overall Study||31
6535344|NCT01641445|7457123|FG001|COMPLETED|Overall Study||36
6535345|NCT01641445|7457122|FG000|NOT COMPLETED|Overall Study||10
6535346|NCT01641445|7457123|FG001|NOT COMPLETED|Overall Study||5
6535347|NCT01641471|7457131|FG000|STARTED|Overall Study||58
6535348|NCT01641471|7457132|FG001|STARTED|Overall Study||58
6535349|NCT01641471|7457131|FG000|COMPLETED|Overall Study||35
6535350|NCT01641471|7457132|FG001|COMPLETED|Overall Study||31
6535351|NCT01641471|7457131|FG000|NOT COMPLETED|Overall Study||23
6535352|NCT01641471|7457132|FG001|NOT COMPLETED|Overall Study||27
6535353|NCT01641640|7457138|FG000|STARTED|Overall Study||328
6535354|NCT01641640|7457138|FG000|Enrolled and Treated|Overall Study||327
6535355|NCT01641640|7457138|FG000|COMPLETED|Overall Study||292
6535356|NCT01641640|7457138|FG000|NOT COMPLETED|Overall Study||36
6535357|NCT01641653|7457144|FG000|STARTED|Overall Study||30
6535358|NCT01641653|7457145|FG001|STARTED|Overall Study||30
6535359|NCT01641653|7457144|FG000|COMPLETED|Overall Study||30
6535360|NCT01641653|7457145|FG001|COMPLETED|Overall Study||30
6535361|NCT01641653|7457144|FG000|NOT COMPLETED|Overall Study||0
6535362|NCT01641653|7457145|FG001|NOT COMPLETED|Overall Study||0
6535363|NCT01641692|7457154|FG000|STARTED|Treatment Period 1||42
6535364|NCT01641692|7457155|FG001|STARTED|Treatment Period 1||45
6535365|NCT01641692|7457156|FG002|STARTED|Treatment Period 1||51
6535366|NCT01641692|7457157|FG003|STARTED|Treatment Period 1||41
6535367|NCT01641692|7457158|FG004|STARTED|Treatment Period 1||43
6535368|NCT01641692|7457159|FG005|STARTED|Treatment Period 1||39
6535369|NCT01641692|7457160|FG006|STARTED|Treatment Period 1||38
6535370|NCT01641692|7457161|FG007|STARTED|Treatment Period 1||51
6535371|NCT01641692|7457154|FG000|COMPLETED|Treatment Period 1||40
6535372|NCT01641692|7457155|FG001|COMPLETED|Treatment Period 1||45
6535373|NCT01641692|7457156|FG002|COMPLETED|Treatment Period 1||50
6535374|NCT01641692|7457157|FG003|COMPLETED|Treatment Period 1||41
6535375|NCT01641692|7457158|FG004|COMPLETED|Treatment Period 1||39
6535376|NCT01641692|7457159|FG005|COMPLETED|Treatment Period 1||37
6535377|NCT01641692|7457160|FG006|COMPLETED|Treatment Period 1||38
6535378|NCT01641692|7457161|FG007|COMPLETED|Treatment Period 1||48
6535379|NCT01641692|7457154|FG000|NOT COMPLETED|Treatment Period 1||2
6535380|NCT01641692|7457155|FG001|NOT COMPLETED|Treatment Period 1||0
6535381|NCT01641692|7457156|FG002|NOT COMPLETED|Treatment Period 1||1
6535382|NCT01641692|7457157|FG003|NOT COMPLETED|Treatment Period 1||0
6535383|NCT01641692|7457158|FG004|NOT COMPLETED|Treatment Period 1||4
6535384|NCT01641692|7457159|FG005|NOT COMPLETED|Treatment Period 1||2
6535385|NCT01641692|7457160|FG006|NOT COMPLETED|Treatment Period 1||0
6535386|NCT01641692|7457161|FG007|NOT COMPLETED|Treatment Period 1||3
6535387|NCT01641692|7457154|FG000|STARTED|Washout Period 1 (12-14 Days)||40
6535388|NCT01641692|7457155|FG001|STARTED|Washout Period 1 (12-14 Days)||45
6535389|NCT01641692|7457156|FG002|STARTED|Washout Period 1 (12-14 Days)||50
6535390|NCT01641692|7457157|FG003|STARTED|Washout Period 1 (12-14 Days)||41
6535391|NCT01641692|7457158|FG004|STARTED|Washout Period 1 (12-14 Days)||39
6535392|NCT01641692|7457159|FG005|STARTED|Washout Period 1 (12-14 Days)||37
6535393|NCT01641692|7457160|FG006|STARTED|Washout Period 1 (12-14 Days)||38
6535394|NCT01641692|7457161|FG007|STARTED|Washout Period 1 (12-14 Days)||48
6535395|NCT01641692|7457154|FG000|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
6535396|NCT01641692|7457155|FG001|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
6535397|NCT01641692|7457156|FG002|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
6535398|NCT01641692|7457157|FG003|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
6535399|NCT01641692|7457158|FG004|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
6535400|NCT01641692|7457159|FG005|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
6535401|NCT01641692|7457160|FG006|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
6535402|NCT01641692|7457161|FG007|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
6535403|NCT01641692|7457154|FG000|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
6535404|NCT01641692|7457155|FG001|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
6535405|NCT01641692|7457156|FG002|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
6535406|NCT01641692|7457157|FG003|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
6535407|NCT01641692|7457158|FG004|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
6535408|NCT01641692|7457159|FG005|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
6535409|NCT01641692|7457160|FG006|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
6535410|NCT01641692|7457161|FG007|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
6535411|NCT01641692|7457154|FG000|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
6535412|NCT01641692|7457155|FG001|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
6535413|NCT01641692|7457156|FG002|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
6535414|NCT01641692|7457157|FG003|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
6535415|NCT01641692|7457158|FG004|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
6535416|NCT01641692|7457159|FG005|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
6535417|NCT01641692|7457160|FG006|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
6535418|NCT01641692|7457161|FG007|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
6535419|NCT01641692|7457154|FG000|COMPLETED|Treatment Period 2||30
6535420|NCT01641692|7457155|FG001|COMPLETED|Treatment Period 2||46
6535421|NCT01641692|7457156|FG002|COMPLETED|Treatment Period 2||40
6535422|NCT01641692|7457157|FG003|COMPLETED|Treatment Period 2||41
6535423|NCT01641692|7457158|FG004|COMPLETED|Treatment Period 2||37
6535424|NCT01641692|7457159|FG005|COMPLETED|Treatment Period 2||43
6535425|NCT01641692|7457160|FG006|COMPLETED|Treatment Period 2||43
6535426|NCT01641692|7457161|FG007|COMPLETED|Treatment Period 2||35
6535427|NCT01641692|7457154|FG000|NOT COMPLETED|Treatment Period 2||3
6535428|NCT01641692|7457155|FG001|NOT COMPLETED|Treatment Period 2||0
6535429|NCT01641692|7457156|FG002|NOT COMPLETED|Treatment Period 2||0
6535430|NCT01641692|7457157|FG003|NOT COMPLETED|Treatment Period 2||0
6535431|NCT01641692|7457158|FG004|NOT COMPLETED|Treatment Period 2||0
6535432|NCT01641692|7457159|FG005|NOT COMPLETED|Treatment Period 2||2
6535433|NCT01641692|7457160|FG006|NOT COMPLETED|Treatment Period 2||0
6535434|NCT01641692|7457161|FG007|NOT COMPLETED|Treatment Period 2||1
6535435|NCT01641692|7457154|FG000|STARTED|Washout Period 2 (12-14 Days)||30
6535436|NCT01641692|7457155|FG001|STARTED|Washout Period 2 (12-14 Days)||46
6535437|NCT01641692|7457156|FG002|STARTED|Washout Period 2 (12-14 Days)||40
6535438|NCT01641692|7457157|FG003|STARTED|Washout Period 2 (12-14 Days)||41
6535439|NCT01641692|7457158|FG004|STARTED|Washout Period 2 (12-14 Days)||37
6535440|NCT01641692|7457159|FG005|STARTED|Washout Period 2 (12-14 Days)||43
6535441|NCT01641692|7457160|FG006|STARTED|Washout Period 2 (12-14 Days)||43
6535442|NCT01641692|7457161|FG007|STARTED|Washout Period 2 (12-14 Days)||35
6562118|NCT01799590|7485166|FG000|COMPLETED|Overall Study||85
6562119|NCT01799590|7485167|FG001|COMPLETED|Overall Study||78
6535443|NCT01641692|7457154|FG000|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
6535444|NCT01641692|7457155|FG001|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
6535445|NCT01641692|7457156|FG002|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
6535446|NCT01641692|7457157|FG003|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
6535447|NCT01641692|7457158|FG004|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
6535448|NCT01641692|7457159|FG005|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
6535449|NCT01641692|7457160|FG006|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
6535450|NCT01641692|7457161|FG007|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
6535451|NCT01641692|7457154|FG000|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
6535452|NCT01641692|7457155|FG001|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
6535453|NCT01641692|7457156|FG002|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
6535454|NCT01641692|7457157|FG003|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
6535455|NCT01641692|7457158|FG004|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
6535456|NCT01641692|7457159|FG005|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
6535457|NCT01641692|7457160|FG006|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
6535458|NCT01641692|7457161|FG007|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
6535459|NCT01641692|7457154|FG000|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
6535460|NCT01641692|7457155|FG001|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
6535461|NCT01641692|7457156|FG002|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
6535462|NCT01641692|7457157|FG003|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
6535463|NCT01641692|7457158|FG004|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
6535464|NCT01641692|7457159|FG005|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
6535465|NCT01641692|7457160|FG006|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
6535466|NCT01641692|7457161|FG007|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
6535467|NCT01641692|7457154|FG000|COMPLETED|Treatment Period 3||43
6535468|NCT01641692|7457155|FG001|COMPLETED|Treatment Period 3||32
6535469|NCT01641692|7457156|FG002|COMPLETED|Treatment Period 3||37
6535470|NCT01641692|7457157|FG003|COMPLETED|Treatment Period 3||42
6535471|NCT01641692|7457158|FG004|COMPLETED|Treatment Period 3||40
6535472|NCT01641692|7457159|FG005|COMPLETED|Treatment Period 3||39
6535473|NCT01641692|7457160|FG006|COMPLETED|Treatment Period 3||33
6535474|NCT01641692|7457161|FG007|COMPLETED|Treatment Period 3||38
6535475|NCT01641692|7457154|FG000|NOT COMPLETED|Treatment Period 3||0
6535476|NCT01641692|7457155|FG001|NOT COMPLETED|Treatment Period 3||1
6535477|NCT01641692|7457156|FG002|NOT COMPLETED|Treatment Period 3||1
6535478|NCT01641692|7457157|FG003|NOT COMPLETED|Treatment Period 3||0
6535479|NCT01641692|7457158|FG004|NOT COMPLETED|Treatment Period 3||0
6535480|NCT01641692|7457159|FG005|NOT COMPLETED|Treatment Period 3||0
6535481|NCT01641692|7457160|FG006|NOT COMPLETED|Treatment Period 3||2
6535482|NCT01641692|7457161|FG007|NOT COMPLETED|Treatment Period 3||0
6535483|NCT01641692|7457154|FG000|STARTED|Washout Period 3 or Follow-up||43
6535484|NCT01641692|7457155|FG001|STARTED|Washout Period 3 or Follow-up||32
6535485|NCT01641692|7457156|FG002|STARTED|Washout Period 3 or Follow-up||37
6535486|NCT01641692|7457157|FG003|STARTED|Washout Period 3 or Follow-up||42
6535487|NCT01641692|7457158|FG004|STARTED|Washout Period 3 or Follow-up||40
6535488|NCT01641692|7457159|FG005|STARTED|Washout Period 3 or Follow-up||39
6535489|NCT01641692|7457160|FG006|STARTED|Washout Period 3 or Follow-up||33
6535490|NCT01641692|7457161|FG007|STARTED|Washout Period 3 or Follow-up||38
6535491|NCT01641692|7457154|FG000|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
6535492|NCT01641692|7457155|FG001|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
6535493|NCT01641692|7457156|FG002|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
6535494|NCT01641692|7457157|FG003|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
6535495|NCT01641692|7457158|FG004|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
6535496|NCT01641692|7457159|FG005|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
6535497|NCT01641692|7457160|FG006|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
6535498|NCT01641692|7457161|FG007|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
6535499|NCT01641692|7457154|FG000|NOT COMPLETED|Washout Period 3 or Follow-up||1
6535500|NCT01641692|7457155|FG001|NOT COMPLETED|Washout Period 3 or Follow-up||0
6535501|NCT01641692|7457156|FG002|NOT COMPLETED|Washout Period 3 or Follow-up||1
6535502|NCT01641692|7457157|FG003|NOT COMPLETED|Washout Period 3 or Follow-up||1
6535503|NCT01641692|7457158|FG004|NOT COMPLETED|Washout Period 3 or Follow-up||0
6535504|NCT01641692|7457159|FG005|NOT COMPLETED|Washout Period 3 or Follow-up||2
6535505|NCT01641692|7457160|FG006|NOT COMPLETED|Washout Period 3 or Follow-up||1
6535506|NCT01641692|7457161|FG007|NOT COMPLETED|Washout Period 3 or Follow-up||0
6535507|NCT01641809|7457184|FG000|STARTED|Induction Phase (Day 1 to Week 24)||60
6535508|NCT01641809|7457185|FG001|STARTED|Induction Phase (Day 1 to Week 24)||60
6535509|NCT01641809|7457186|FG002|STARTED|Induction Phase (Day 1 to Week 24)||61
6535510|NCT01641809|7457187|FG003|STARTED|Induction Phase (Day 1 to Week 24)||62
6535511|NCT01641809|7457184|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)||52
6535512|NCT01641809|7457185|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)||53
6535513|NCT01641809|7457186|FG002|COMPLETED|Induction Phase (Day 1 to Week 24)||55
6535514|NCT01641809|7457187|FG003|COMPLETED|Induction Phase (Day 1 to Week 24)||47
6535515|NCT01641809|7457184|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||8
6535516|NCT01641809|7457185|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||7
6535517|NCT01641809|7457186|FG002|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||6
6535518|NCT01641809|7457187|FG003|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||15
6535519|NCT01641809|7457184|FG000|STARTED|Maintenance Phase (Week 24 to Week 96)||52
6535520|NCT01641809|7457185|FG001|STARTED|Maintenance Phase (Week 24 to Week 96)||53
6535521|NCT01641809|7457186|FG002|STARTED|Maintenance Phase (Week 24 to Week 96)||55
6535522|NCT01641809|7457187|FG003|STARTED|Maintenance Phase (Week 24 to Week 96)||47
6535523|NCT01641809|7457184|FG000|COMPLETED|Maintenance Phase (Week 24 to Week 96)||46
6535524|NCT01641809|7457185|FG001|COMPLETED|Maintenance Phase (Week 24 to Week 96)||48
6535525|NCT01641809|7457186|FG002|COMPLETED|Maintenance Phase (Week 24 to Week 96)||52
6535526|NCT01641809|7457187|FG003|COMPLETED|Maintenance Phase (Week 24 to Week 96)||41
6535527|NCT01641809|7457184|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
6535528|NCT01641809|7457185|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||5
6535529|NCT01641809|7457186|FG002|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||3
6535530|NCT01641809|7457187|FG003|NOT COMPLETED|Maintenance Phase (Week 24 to Week 96)||6
6535531|NCT01641809|7457184|FG000|STARTED|Open-label (Week 96 to Week 324)||46
6535532|NCT01641809|7457185|FG001|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|47
6535533|NCT01641809|7457186|FG002|STARTED|Open-label (Week 96 to Week 324)|1 participant completed study as per protocol at Week 96 and opted to not enter open-label phase|51
6535534|NCT01641809|7457187|FG003|STARTED|Open-label (Week 96 to Week 324)|Participants completed study at Week 96 and did not enter open-label phase|0
6535535|NCT01641809|7457184|FG000|COMPLETED|Open-label (Week 96 to Week 324)||30
6535536|NCT01641809|7457185|FG001|COMPLETED|Open-label (Week 96 to Week 324)||35
6535537|NCT01641809|7457186|FG002|COMPLETED|Open-label (Week 96 to Week 324)||43
6535538|NCT01641809|7457187|FG003|COMPLETED|Open-label (Week 96 to Week 324)||0
6535539|NCT01641809|7457184|FG000|NOT COMPLETED|Open-label (Week 96 to Week 324)||16
6535540|NCT01641809|7457185|FG001|NOT COMPLETED|Open-label (Week 96 to Week 324)||12
6535541|NCT01641809|7457186|FG002|NOT COMPLETED|Open-label (Week 96 to Week 324)||8
6535542|NCT01641809|7457187|FG003|NOT COMPLETED|Open-label (Week 96 to Week 324)||0
6535543|NCT01641822|7457207|FG000|STARTED|Run-in Phase||107
6535544|NCT01641822|7457208|FG001|STARTED|Run-in Phase||0
6535545|NCT01641822|7457209|FG002|STARTED|Run-in Phase||0
6535546|NCT01641822|7457207|FG000|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
6535547|NCT01641822|7457208|FG001|COMPLETED|Run-in Phase||0
6535548|NCT01641822|7457209|FG002|COMPLETED|Run-in Phase||0
6535549|NCT01641822|7457207|FG000|NOT COMPLETED|Run-in Phase||14
6535550|NCT01641822|7457208|FG001|NOT COMPLETED|Run-in Phase||0
6535551|NCT01641822|7457209|FG002|NOT COMPLETED|Run-in Phase||0
6535552|NCT01641822|7457207|FG000|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
6535553|NCT01641822|7457208|FG001|STARTED|Comparative Phase||43
6535554|NCT01641822|7457209|FG002|STARTED|Comparative Phase||47
6535555|NCT01641822|7457207|FG000|Received Randomized Study Drug Treatment|Comparative Phase||0
6535556|NCT01641822|7457208|FG001|Received Randomized Study Drug Treatment|Comparative Phase||42
6535557|NCT01641822|7457209|FG002|Received Randomized Study Drug Treatment|Comparative Phase||46
6535558|NCT01641822|7457207|FG000|COMPLETED|Comparative Phase||0
6535559|NCT01641822|7457208|FG001|COMPLETED|Comparative Phase||37
6535560|NCT01641822|7457209|FG002|COMPLETED|Comparative Phase||37
6535561|NCT01641822|7457207|FG000|NOT COMPLETED|Comparative Phase||0
6535562|NCT01641822|7457208|FG001|NOT COMPLETED|Comparative Phase||6
6535563|NCT01641822|7457209|FG002|NOT COMPLETED|Comparative Phase||10
6535564|NCT01641835|7457216|FG000|STARTED|Overall Study||303
6535565|NCT01641835|7457216|FG000|COMPLETED|Overall Study||303
6535566|NCT01641835|7457216|FG000|NOT COMPLETED|Overall Study||0
6535567|NCT01641861|7457222|FG000|STARTED|Overall Study||246
6535568|NCT01641861|7457223|FG001|STARTED|Overall Study||242
6535569|NCT01641861|7457222|FG000|COMPLETED|Overall Study||211
6535570|NCT01641861|7457223|FG001|COMPLETED|Overall Study||217
6535571|NCT01641861|7457222|FG000|NOT COMPLETED|Overall Study||35
6535572|NCT01641861|7457223|FG001|NOT COMPLETED|Overall Study||25
6535573|NCT01641900|7457231|FG000|STARTED|Overall Study||28
6535574|NCT01641900|7457232|FG001|STARTED|Overall Study||31
6535575|NCT01641900|7457231|FG000|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
6562120|NCT01799590|7485168|FG002|COMPLETED|Overall Study||77
6535576|NCT01641900|7457232|FG001|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
6535577|NCT01641900|7457231|FG000|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
6535578|NCT01641900|7457232|FG001|Completed Drug Intervention|Overall Study||29
6535579|NCT01641900|7457231|FG000|COMPLETED|Overall Study||26
6535580|NCT01641900|7457232|FG001|COMPLETED|Overall Study||29
6535581|NCT01641900|7457231|FG000|NOT COMPLETED|Overall Study||2
6535582|NCT01641900|7457232|FG001|NOT COMPLETED|Overall Study||2
6535583|NCT01641926|7457244|FG000|STARTED|Overall Study||143
6535584|NCT01641926|7457245|FG001|STARTED|Overall Study||145
6535585|NCT01641926|7457246|FG002|STARTED|Overall Study||57
6535586|NCT01641926|7457247|FG003|STARTED|Overall Study||57
6535587|NCT01641926|7457244|FG000|Treated (All Participants as Treated)|Overall Study||142
6535588|NCT01641926|7457245|FG001|Treated (All Participants as Treated)|Overall Study||144
6535589|NCT01641926|7457246|FG002|Treated (All Participants as Treated)|Overall Study||56
6535590|NCT01641926|7457247|FG003|Treated (All Participants as Treated)|Overall Study||57
6535591|NCT01641926|7457244|FG000|COMPLETED|Overall Study||115
6535592|NCT01641926|7457245|FG001|COMPLETED|Overall Study||130
6535593|NCT01641926|7457246|FG002|COMPLETED|Overall Study||46
6535594|NCT01641926|7457247|FG003|COMPLETED|Overall Study||53
6535595|NCT01641926|7457244|FG000|NOT COMPLETED|Overall Study||28
6535596|NCT01641926|7457245|FG001|NOT COMPLETED|Overall Study||15
6535597|NCT01641926|7457246|FG002|NOT COMPLETED|Overall Study||11
6535598|NCT01641926|7457247|FG003|NOT COMPLETED|Overall Study||4
6535599|NCT01641939|7457260|FG000|STARTED|Overall Study||117
6535600|NCT01641939|7457261|FG001|STARTED|Overall Study||228
6535601|NCT01641939|7457262|FG002|STARTED|Overall Study||70
6535602|NCT01641939|7457260|FG000|Stage 1|Overall Study||37
6535603|NCT01641939|7457261|FG001|Stage 1|Overall Study||75
6535604|NCT01641939|7457262|FG002|Stage 1|Overall Study||70
6535605|NCT01641939|7457260|FG000|Stage 2|Overall Study||80
6535606|NCT01641939|7457261|FG001|Stage 2|Overall Study||153
6535607|NCT01641939|7457262|FG002|Stage 2|Overall Study||0
6535608|NCT01641939|7457260|FG000|COMPLETED|Overall Study||0
6535609|NCT01641939|7457261|FG001|COMPLETED|Overall Study||0
6535610|NCT01641939|7457262|FG002|COMPLETED|Overall Study||0
6535611|NCT01641939|7457260|FG000|NOT COMPLETED|Overall Study||117
6535612|NCT01641939|7457261|FG001|NOT COMPLETED|Overall Study||228
6535613|NCT01641939|7457262|FG002|NOT COMPLETED|Overall Study||70
6535614|NCT01641952|7457272|FG000|STARTED|Overall Study||505
6535615|NCT01641952|7457272|FG000|Treated|Overall Study||504
6535616|NCT01641952|7457272|FG000|COMPLETED|Overall Study||471
6535617|NCT01641952|7457272|FG000|NOT COMPLETED|Overall Study||34
6535618|NCT01641978|7457276|FG000|STARTED|Overall Study||125
6535619|NCT01641978|7457276|FG000|COMPLETED|Overall Study||125
6535620|NCT01641978|7457276|FG000|NOT COMPLETED|Overall Study||0
6535621|NCT01641991|7457288|FG000|STARTED|Overall Study||82
6535622|NCT01641991|7457289|FG001|STARTED|Overall Study||82
6535623|NCT01641991|7457290|FG002|STARTED|Overall Study||82
6535624|NCT01641991|7457291|FG003|STARTED|Overall Study||82
6535625|NCT01641991|7457288|FG000|COMPLETED|Overall Study||73
6535626|NCT01641991|7457289|FG001|COMPLETED|Overall Study||74
6535627|NCT01641991|7457290|FG002|COMPLETED|Overall Study||65
6535628|NCT01641991|7457291|FG003|COMPLETED|Overall Study||66
6535629|NCT01641991|7457288|FG000|NOT COMPLETED|Overall Study||9
6535630|NCT01641991|7457289|FG001|NOT COMPLETED|Overall Study||8
6535631|NCT01641991|7457290|FG002|NOT COMPLETED|Overall Study||17
6535632|NCT01641991|7457291|FG003|NOT COMPLETED|Overall Study||16
6535633|NCT01642056|7457306|FG000|STARTED|First Intervention||10
6535634|NCT01642056|7457307|FG001|STARTED|First Intervention||10
6535635|NCT01642056|7457306|FG000|COMPLETED|First Intervention||9
6535636|NCT01642056|7457307|FG001|COMPLETED|First Intervention||10
6535637|NCT01642056|7457306|FG000|NOT COMPLETED|First Intervention||1
6535638|NCT01642056|7457307|FG001|NOT COMPLETED|First Intervention||0
6535639|NCT01642056|7457306|FG000|STARTED|Second Intervention||9
6535640|NCT01642056|7457307|FG001|STARTED|Second Intervention||10
6535641|NCT01642056|7457306|FG000|COMPLETED|Second Intervention||8
6535642|NCT01642056|7457307|FG001|COMPLETED|Second Intervention||8
6535643|NCT01642056|7457306|FG000|NOT COMPLETED|Second Intervention||1
6535644|NCT01642056|7457307|FG001|NOT COMPLETED|Second Intervention||2
6535645|NCT01642082|7457313|FG000|STARTED|Overall Study||28
6535646|NCT01642082|7457313|FG000|COMPLETED|Overall Study||28
6535647|NCT01642082|7457313|FG000|NOT COMPLETED|Overall Study||0
6535648|NCT01642147|7457326|FG000|STARTED|Overall Study||30
6535649|NCT01642147|7457327|FG001|STARTED|Overall Study||30
6535650|NCT01642147|7457326|FG000|COMPLETED|Overall Study||30
6535651|NCT01642147|7457327|FG001|COMPLETED|Overall Study||30
6535652|NCT01642147|7457326|FG000|NOT COMPLETED|Overall Study||0
6535653|NCT01642147|7457327|FG001|NOT COMPLETED|Overall Study||0
6535654|NCT01642212|7457335|FG000|STARTED|Single-blind Baseline||119
6535655|NCT01642212|7457336|FG001|STARTED|Single-blind Baseline||0
6535656|NCT01642212|7457337|FG002|STARTED|Single-blind Baseline||0
6535657|NCT01642212|7457338|FG003|STARTED|Single-blind Baseline||0
6535658|NCT01642212|7457339|FG004|STARTED|Single-blind Baseline||0
6535659|NCT01642212|7457335|FG000|COMPLETED|Single-blind Baseline||93
6535660|NCT01642212|7457336|FG001|COMPLETED|Single-blind Baseline||0
6535661|NCT01642212|7457337|FG002|COMPLETED|Single-blind Baseline||0
6535662|NCT01642212|7457338|FG003|COMPLETED|Single-blind Baseline||0
6535663|NCT01642212|7457339|FG004|COMPLETED|Single-blind Baseline||0
6535664|NCT01642212|7457335|FG000|NOT COMPLETED|Single-blind Baseline||26
6535665|NCT01642212|7457336|FG001|NOT COMPLETED|Single-blind Baseline||0
6535666|NCT01642212|7457337|FG002|NOT COMPLETED|Single-blind Baseline||0
6535667|NCT01642212|7457338|FG003|NOT COMPLETED|Single-blind Baseline||0
6535668|NCT01642212|7457339|FG004|NOT COMPLETED|Single-blind Baseline||0
6535669|NCT01642212|7457335|FG000|STARTED|Double-blind Treatment||0
6535670|NCT01642212|7457336|FG001|STARTED|Double-blind Treatment||42
6535671|NCT01642212|7457337|FG002|STARTED|Double-blind Treatment||51
6535672|NCT01642212|7457338|FG003|STARTED|Double-blind Treatment||0
6535673|NCT01642212|7457339|FG004|STARTED|Double-blind Treatment||0
6535674|NCT01642212|7457335|FG000|COMPLETED|Double-blind Treatment||0
6535675|NCT01642212|7457336|FG001|COMPLETED|Double-blind Treatment||39
6535676|NCT01642212|7457337|FG002|COMPLETED|Double-blind Treatment||49
6535677|NCT01642212|7457338|FG003|COMPLETED|Double-blind Treatment||0
6535678|NCT01642212|7457339|FG004|COMPLETED|Double-blind Treatment||0
6535679|NCT01642212|7457335|FG000|NOT COMPLETED|Double-blind Treatment||0
6535680|NCT01642212|7457336|FG001|NOT COMPLETED|Double-blind Treatment||3
6535681|NCT01642212|7457337|FG002|NOT COMPLETED|Double-blind Treatment||2
6535682|NCT01642212|7457338|FG003|NOT COMPLETED|Double-blind Treatment||0
6535683|NCT01642212|7457339|FG004|NOT COMPLETED|Double-blind Treatment||0
6535684|NCT01642212|7457335|FG000|STARTED|Open-label Extension||0
6535685|NCT01642212|7457336|FG001|STARTED|Open-label Extension||0
6535686|NCT01642212|7457337|FG002|STARTED|Open-label Extension||0
6535687|NCT01642212|7457338|FG003|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
6535688|NCT01642212|7457339|FG004|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
6535689|NCT01642212|7457335|FG000|COMPLETED|Open-label Extension||0
6535690|NCT01642212|7457336|FG001|COMPLETED|Open-label Extension||0
6535691|NCT01642212|7457337|FG002|COMPLETED|Open-label Extension||0
6535692|NCT01642212|7457338|FG003|COMPLETED|Open-label Extension||27
6535693|NCT01642212|7457339|FG004|COMPLETED|Open-label Extension||37
6535694|NCT01642212|7457335|FG000|NOT COMPLETED|Open-label Extension||0
6535695|NCT01642212|7457336|FG001|NOT COMPLETED|Open-label Extension||0
6535696|NCT01642212|7457337|FG002|NOT COMPLETED|Open-label Extension||0
6535697|NCT01642212|7457338|FG003|NOT COMPLETED|Open-label Extension||10
6535698|NCT01642212|7457339|FG004|NOT COMPLETED|Open-label Extension||8
6535699|NCT01642238|7457347|FG000|STARTED|First Intervention (1 Day)||7
6535700|NCT01642238|7457348|FG001|STARTED|First Intervention (1 Day)||8
6535701|NCT01642238|7457347|FG000|COMPLETED|First Intervention (1 Day)||7
6535702|NCT01642238|7457348|FG001|COMPLETED|First Intervention (1 Day)||8
6535703|NCT01642238|7457347|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6535704|NCT01642238|7457348|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6535705|NCT01642238|7457347|FG000|STARTED|Washout (1-2 Weeks)||7
6535706|NCT01642238|7457348|FG001|STARTED|Washout (1-2 Weeks)||8
6535707|NCT01642238|7457347|FG000|COMPLETED|Washout (1-2 Weeks)||7
6535708|NCT01642238|7457348|FG001|COMPLETED|Washout (1-2 Weeks)||8
6535709|NCT01642238|7457347|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
6535710|NCT01642238|7457348|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
6535711|NCT01642238|7457347|FG000|STARTED|Second Intervention (1 Day)||7
6535712|NCT01642238|7457348|FG001|STARTED|Second Intervention (1 Day)||8
6535713|NCT01642238|7457347|FG000|COMPLETED|Second Intervention (1 Day)||7
6535714|NCT01642238|7457348|FG001|COMPLETED|Second Intervention (1 Day)||8
6535715|NCT01642238|7457347|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6535716|NCT01642238|7457348|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6535717|NCT01642251|7457357|FG000|STARTED|Overall Study||3
6535718|NCT01642251|7457358|FG001|STARTED|Overall Study||6
6535719|NCT01642251|7457359|FG002|STARTED|Overall Study||75
6535720|NCT01642251|7457360|FG003|STARTED|Overall Study||72
6535721|NCT01642251|7457357|FG000|Started Protocol Therapy|Overall Study||3
6535722|NCT01642251|7457358|FG001|Started Protocol Therapy|Overall Study||6
6535723|NCT01642251|7457359|FG002|Started Protocol Therapy|Overall Study||66
6535724|NCT01642251|7457360|FG003|Started Protocol Therapy|Overall Study||66
6535725|NCT01642251|7457357|FG000|Eligible|Overall Study||3
6535726|NCT01642251|7457358|FG001|Eligible|Overall Study||6
6535727|NCT01642251|7457359|FG002|Eligible|Overall Study||72
6535728|NCT01642251|7457360|FG003|Eligible|Overall Study||69
6535729|NCT01642251|7457357|FG000|Eligible and Treated|Overall Study||3
6535730|NCT01642251|7457358|FG001|Eligible and Treated|Overall Study||6
6535731|NCT01642251|7457359|FG002|Eligible and Treated|Overall Study||64
6535732|NCT01642251|7457360|FG003|Eligible and Treated|Overall Study||64
6535733|NCT01642251|7457357|FG000|COMPLETED|Overall Study||3
6535734|NCT01642251|7457358|FG001|COMPLETED|Overall Study||6
6535735|NCT01642251|7457359|FG002|COMPLETED|Overall Study||53
6535736|NCT01642251|7457360|FG003|COMPLETED|Overall Study||49
6535737|NCT01642251|7457357|FG000|NOT COMPLETED|Overall Study||0
6535738|NCT01642251|7457358|FG001|NOT COMPLETED|Overall Study||0
6535739|NCT01642251|7457359|FG002|NOT COMPLETED|Overall Study||22
6535740|NCT01642251|7457360|FG003|NOT COMPLETED|Overall Study||23
6535741|NCT01642277|7457371|FG000|STARTED|Overall Study||74
6535742|NCT01642277|7457372|FG001|STARTED|Overall Study||60
6535743|NCT01642277|7457371|FG000|COMPLETED|Overall Study||50
6535744|NCT01642277|7457372|FG001|COMPLETED|Overall Study||60
6535745|NCT01642277|7457371|FG000|NOT COMPLETED|Overall Study||24
6535746|NCT01642277|7457372|FG001|NOT COMPLETED|Overall Study||0
6535747|NCT01642407|7457379|FG000|STARTED|Part 1 (Screening Till Week 16)||6
6535748|NCT01642407|7457379|FG000|COMPLETED|Part 1 (Screening Till Week 16)||3
6535749|NCT01642407|7457379|FG000|NOT COMPLETED|Part 1 (Screening Till Week 16)||3
6535750|NCT01642407|7457379|FG000|STARTED|Part 2(Week17 to Maximum of 119.6 Weeks)||3
6535751|NCT01642407|7457379|FG000|COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||1
6535752|NCT01642407|7457379|FG000|NOT COMPLETED|Part 2(Week17 to Maximum of 119.6 Weeks)||2
6535753|NCT01642485|7457383|FG000|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
6535754|NCT01642485|7457384|FG001|STARTED|Period 1, Day 1||4
6535755|NCT01642485|7457385|FG002|STARTED|Period 1, Day 1||4
6535756|NCT01642485|7457386|FG003|STARTED|Period 1, Day 1||4
6535757|NCT01642485|7457387|FG004|STARTED|Period 1, Day 1||4
6535758|NCT01642485|7457388|FG005|STARTED|Period 1, Day 1||4
6535759|NCT01642485|7457389|FG006|STARTED|Period 1, Day 1||4
6535760|NCT01642485|7457390|FG007|STARTED|Period 1, Day 1||4
6535761|NCT01642485|7457383|FG000|COMPLETED|Period 1, Day 1||4
6535762|NCT01642485|7457384|FG001|COMPLETED|Period 1, Day 1||4
6535763|NCT01642485|7457385|FG002|COMPLETED|Period 1, Day 1||4
6535764|NCT01642485|7457386|FG003|COMPLETED|Period 1, Day 1||4
6535765|NCT01642485|7457387|FG004|COMPLETED|Period 1, Day 1||4
6535766|NCT01642485|7457388|FG005|COMPLETED|Period 1, Day 1||4
6535767|NCT01642485|7457389|FG006|COMPLETED|Period 1, Day 1||4
6535768|NCT01642485|7457390|FG007|COMPLETED|Period 1, Day 1||4
6535769|NCT01642485|7457383|FG000|NOT COMPLETED|Period 1, Day 1||0
6535770|NCT01642485|7457384|FG001|NOT COMPLETED|Period 1, Day 1||0
6535771|NCT01642485|7457385|FG002|NOT COMPLETED|Period 1, Day 1||0
6535772|NCT01642485|7457386|FG003|NOT COMPLETED|Period 1, Day 1||0
6535773|NCT01642485|7457387|FG004|NOT COMPLETED|Period 1, Day 1||0
6535774|NCT01642485|7457388|FG005|NOT COMPLETED|Period 1, Day 1||0
6535775|NCT01642485|7457389|FG006|NOT COMPLETED|Period 1, Day 1||0
6535776|NCT01642485|7457390|FG007|NOT COMPLETED|Period 1, Day 1||0
6535777|NCT01642485|7457383|FG000|STARTED|Period 1, Day 2||4
6535778|NCT01642485|7457384|FG001|STARTED|Period 1, Day 2||4
6535779|NCT01642485|7457385|FG002|STARTED|Period 1, Day 2||4
6535780|NCT01642485|7457386|FG003|STARTED|Period 1, Day 2||4
6535781|NCT01642485|7457387|FG004|STARTED|Period 1, Day 2||4
6535782|NCT01642485|7457388|FG005|STARTED|Period 1, Day 2||4
6535783|NCT01642485|7457389|FG006|STARTED|Period 1, Day 2||4
6535784|NCT01642485|7457390|FG007|STARTED|Period 1, Day 2||4
6535785|NCT01642485|7457383|FG000|COMPLETED|Period 1, Day 2||4
6535786|NCT01642485|7457384|FG001|COMPLETED|Period 1, Day 2||4
6535787|NCT01642485|7457385|FG002|COMPLETED|Period 1, Day 2||4
6535788|NCT01642485|7457386|FG003|COMPLETED|Period 1, Day 2||4
6535789|NCT01642485|7457387|FG004|COMPLETED|Period 1, Day 2||4
6535790|NCT01642485|7457388|FG005|COMPLETED|Period 1, Day 2||4
6535791|NCT01642485|7457389|FG006|COMPLETED|Period 1, Day 2||4
6535792|NCT01642485|7457390|FG007|COMPLETED|Period 1, Day 2||4
6535793|NCT01642485|7457383|FG000|NOT COMPLETED|Period 1, Day 2||0
6535794|NCT01642485|7457384|FG001|NOT COMPLETED|Period 1, Day 2||0
6535795|NCT01642485|7457385|FG002|NOT COMPLETED|Period 1, Day 2||0
6535796|NCT01642485|7457386|FG003|NOT COMPLETED|Period 1, Day 2||0
6535797|NCT01642485|7457387|FG004|NOT COMPLETED|Period 1, Day 2||0
6535798|NCT01642485|7457388|FG005|NOT COMPLETED|Period 1, Day 2||0
6535799|NCT01642485|7457389|FG006|NOT COMPLETED|Period 1, Day 2||0
6535800|NCT01642485|7457390|FG007|NOT COMPLETED|Period 1, Day 2||0
6535801|NCT01642485|7457383|FG000|STARTED|Period 1, Day 3||4
6535802|NCT01642485|7457384|FG001|STARTED|Period 1, Day 3||4
6535803|NCT01642485|7457385|FG002|STARTED|Period 1, Day 3||4
6535804|NCT01642485|7457386|FG003|STARTED|Period 1, Day 3||4
6535805|NCT01642485|7457387|FG004|STARTED|Period 1, Day 3||4
6535806|NCT01642485|7457388|FG005|STARTED|Period 1, Day 3||4
6535807|NCT01642485|7457389|FG006|STARTED|Period 1, Day 3||4
6535808|NCT01642485|7457390|FG007|STARTED|Period 1, Day 3||4
6535809|NCT01642485|7457383|FG000|COMPLETED|Period 1, Day 3||4
6535810|NCT01642485|7457384|FG001|COMPLETED|Period 1, Day 3||4
6535811|NCT01642485|7457385|FG002|COMPLETED|Period 1, Day 3||4
6535812|NCT01642485|7457386|FG003|COMPLETED|Period 1, Day 3||4
6535813|NCT01642485|7457387|FG004|COMPLETED|Period 1, Day 3||4
6535814|NCT01642485|7457388|FG005|COMPLETED|Period 1, Day 3||4
6535815|NCT01642485|7457389|FG006|COMPLETED|Period 1, Day 3||4
6535816|NCT01642485|7457390|FG007|COMPLETED|Period 1, Day 3||4
6535817|NCT01642485|7457383|FG000|NOT COMPLETED|Period 1, Day 3||0
6535818|NCT01642485|7457384|FG001|NOT COMPLETED|Period 1, Day 3||0
6535819|NCT01642485|7457385|FG002|NOT COMPLETED|Period 1, Day 3||0
6535820|NCT01642485|7457386|FG003|NOT COMPLETED|Period 1, Day 3||0
6535821|NCT01642485|7457387|FG004|NOT COMPLETED|Period 1, Day 3||0
6535822|NCT01642485|7457388|FG005|NOT COMPLETED|Period 1, Day 3||0
6535823|NCT01642485|7457389|FG006|NOT COMPLETED|Period 1, Day 3||0
6535824|NCT01642485|7457390|FG007|NOT COMPLETED|Period 1, Day 3||0
6535825|NCT01642485|7457383|FG000|STARTED|Period 2, Day 1||4
6535826|NCT01642485|7457384|FG001|STARTED|Period 2, Day 1||4
6535827|NCT01642485|7457385|FG002|STARTED|Period 2, Day 1||4
6535828|NCT01642485|7457386|FG003|STARTED|Period 2, Day 1||4
6535829|NCT01642485|7457387|FG004|STARTED|Period 2, Day 1||4
6535830|NCT01642485|7457388|FG005|STARTED|Period 2, Day 1||4
6535831|NCT01642485|7457389|FG006|STARTED|Period 2, Day 1||4
6535832|NCT01642485|7457390|FG007|STARTED|Period 2, Day 1||4
6535833|NCT01642485|7457383|FG000|COMPLETED|Period 2, Day 1||4
6535834|NCT01642485|7457384|FG001|COMPLETED|Period 2, Day 1||4
6535835|NCT01642485|7457385|FG002|COMPLETED|Period 2, Day 1||4
6535836|NCT01642485|7457386|FG003|COMPLETED|Period 2, Day 1||4
6535837|NCT01642485|7457387|FG004|COMPLETED|Period 2, Day 1||4
6535838|NCT01642485|7457388|FG005|COMPLETED|Period 2, Day 1||4
6535839|NCT01642485|7457389|FG006|COMPLETED|Period 2, Day 1||4
6535840|NCT01642485|7457390|FG007|COMPLETED|Period 2, Day 1||4
6535841|NCT01642485|7457383|FG000|NOT COMPLETED|Period 2, Day 1||0
6535842|NCT01642485|7457384|FG001|NOT COMPLETED|Period 2, Day 1||0
6535843|NCT01642485|7457385|FG002|NOT COMPLETED|Period 2, Day 1||0
6535844|NCT01642485|7457386|FG003|NOT COMPLETED|Period 2, Day 1||0
6535845|NCT01642485|7457387|FG004|NOT COMPLETED|Period 2, Day 1||0
6535846|NCT01642485|7457388|FG005|NOT COMPLETED|Period 2, Day 1||0
6535847|NCT01642485|7457389|FG006|NOT COMPLETED|Period 2, Day 1||0
6535848|NCT01642485|7457390|FG007|NOT COMPLETED|Period 2, Day 1||0
6535849|NCT01642485|7457383|FG000|STARTED|Period 2, Day 2||4
6535850|NCT01642485|7457384|FG001|STARTED|Period 2, Day 2||4
6535851|NCT01642485|7457385|FG002|STARTED|Period 2, Day 2||4
6535852|NCT01642485|7457386|FG003|STARTED|Period 2, Day 2||4
6535853|NCT01642485|7457387|FG004|STARTED|Period 2, Day 2||4
6535854|NCT01642485|7457388|FG005|STARTED|Period 2, Day 2||4
6535855|NCT01642485|7457389|FG006|STARTED|Period 2, Day 2||4
6535856|NCT01642485|7457390|FG007|STARTED|Period 2, Day 2||4
6535857|NCT01642485|7457383|FG000|COMPLETED|Period 2, Day 2||4
6535858|NCT01642485|7457384|FG001|COMPLETED|Period 2, Day 2||4
6535859|NCT01642485|7457385|FG002|COMPLETED|Period 2, Day 2||4
6535860|NCT01642485|7457386|FG003|COMPLETED|Period 2, Day 2||4
6535861|NCT01642485|7457387|FG004|COMPLETED|Period 2, Day 2||4
6535862|NCT01642485|7457388|FG005|COMPLETED|Period 2, Day 2||4
6535863|NCT01642485|7457389|FG006|COMPLETED|Period 2, Day 2||4
6535864|NCT01642485|7457390|FG007|COMPLETED|Period 2, Day 2||4
6535865|NCT01642485|7457383|FG000|NOT COMPLETED|Period 2, Day 2||0
6535866|NCT01642485|7457384|FG001|NOT COMPLETED|Period 2, Day 2||0
6535867|NCT01642485|7457385|FG002|NOT COMPLETED|Period 2, Day 2||0
6535868|NCT01642485|7457386|FG003|NOT COMPLETED|Period 2, Day 2||0
6535869|NCT01642485|7457387|FG004|NOT COMPLETED|Period 2, Day 2||0
6535870|NCT01642485|7457388|FG005|NOT COMPLETED|Period 2, Day 2||0
6535871|NCT01642485|7457389|FG006|NOT COMPLETED|Period 2, Day 2||0
6535872|NCT01642485|7457390|FG007|NOT COMPLETED|Period 2, Day 2||0
6535873|NCT01642485|7457383|FG000|STARTED|Period 2, Day 3||4
6535874|NCT01642485|7457384|FG001|STARTED|Period 2, Day 3||4
6535875|NCT01642485|7457385|FG002|STARTED|Period 2, Day 3||4
6645473|NCT02372097|7574444|FG000|NOT COMPLETED|First Intervention Period (8 Days)||0
6645474|NCT02372097|7574445|FG001|NOT COMPLETED|First Intervention Period (8 Days)||0
6645475|NCT02372097|7574444|FG000|STARTED|Wash Out Period (13 Days)||12
6535876|NCT01642485|7457386|FG003|STARTED|Period 2, Day 3||4
6535877|NCT01642485|7457387|FG004|STARTED|Period 2, Day 3||4
6535878|NCT01642485|7457388|FG005|STARTED|Period 2, Day 3||4
6535879|NCT01642485|7457389|FG006|STARTED|Period 2, Day 3||4
6535880|NCT01642485|7457390|FG007|STARTED|Period 2, Day 3||4
6535881|NCT01642485|7457383|FG000|COMPLETED|Period 2, Day 3||4
6535882|NCT01642485|7457384|FG001|COMPLETED|Period 2, Day 3||4
6535883|NCT01642485|7457385|FG002|COMPLETED|Period 2, Day 3||4
6535884|NCT01642485|7457386|FG003|COMPLETED|Period 2, Day 3||4
6535885|NCT01642485|7457387|FG004|COMPLETED|Period 2, Day 3||4
6535886|NCT01642485|7457388|FG005|COMPLETED|Period 2, Day 3||4
6535887|NCT01642485|7457389|FG006|COMPLETED|Period 2, Day 3||4
6535888|NCT01642485|7457390|FG007|COMPLETED|Period 2, Day 3||4
6535889|NCT01642485|7457383|FG000|NOT COMPLETED|Period 2, Day 3||0
6535890|NCT01642485|7457384|FG001|NOT COMPLETED|Period 2, Day 3||0
6535891|NCT01642485|7457385|FG002|NOT COMPLETED|Period 2, Day 3||0
6535892|NCT01642485|7457386|FG003|NOT COMPLETED|Period 2, Day 3||0
6535893|NCT01642485|7457387|FG004|NOT COMPLETED|Period 2, Day 3||0
6535894|NCT01642485|7457388|FG005|NOT COMPLETED|Period 2, Day 3||0
6535895|NCT01642485|7457389|FG006|NOT COMPLETED|Period 2, Day 3||0
6535896|NCT01642485|7457390|FG007|NOT COMPLETED|Period 2, Day 3||0
6535897|NCT01642589|7457410|FG000|STARTED|Overall Study||200
6535898|NCT01642589|7457411|FG001|STARTED|Overall Study||100
6535899|NCT01642589|7457410|FG000|COMPLETED|Overall Study||199
6535900|NCT01642589|7457411|FG001|COMPLETED|Overall Study||99
6535901|NCT01642589|7457410|FG000|NOT COMPLETED|Overall Study||1
6535902|NCT01642589|7457411|FG001|NOT COMPLETED|Overall Study||1
6535903|NCT01642602|7457417|FG000|STARTED|Overall Study||104
6535904|NCT01642602|7457417|FG000|COMPLETED|Overall Study||102
6535905|NCT01642602|7457417|FG000|NOT COMPLETED|Overall Study||2
6535906|NCT01642615|7457421|FG000|STARTED|Open Label Maintenance Phase||63
6535907|NCT01642615|7457422|FG001|STARTED|Open Label Maintenance Phase||0
6535908|NCT01642615|7457423|FG002|STARTED|Open Label Maintenance Phase||0
6535909|NCT01642615|7457421|FG000|Safety Analysis Set|Open Label Maintenance Phase||62
6535910|NCT01642615|7457422|FG001|Safety Analysis Set|Open Label Maintenance Phase||0
6535911|NCT01642615|7457423|FG002|Safety Analysis Set|Open Label Maintenance Phase||0
6535912|NCT01642615|7457421|FG000|COMPLETED|Open Label Maintenance Phase||58
6535913|NCT01642615|7457422|FG001|COMPLETED|Open Label Maintenance Phase||0
6535914|NCT01642615|7457423|FG002|COMPLETED|Open Label Maintenance Phase||0
6535915|NCT01642615|7457421|FG000|NOT COMPLETED|Open Label Maintenance Phase||5
6535916|NCT01642615|7457422|FG001|NOT COMPLETED|Open Label Maintenance Phase||0
6535917|NCT01642615|7457423|FG002|NOT COMPLETED|Open Label Maintenance Phase||0
6535918|NCT01642615|7457421|FG000|STARTED|Double Blind Maintenance Phase||0
6535919|NCT01642615|7457422|FG001|STARTED|Double Blind Maintenance Phase||25
6535920|NCT01642615|7457423|FG002|STARTED|Double Blind Maintenance Phase||26
6535921|NCT01642615|7457421|FG000|COMPLETED|Double Blind Maintenance Phase||0
6535922|NCT01642615|7457422|FG001|COMPLETED|Double Blind Maintenance Phase||18
6535923|NCT01642615|7457423|FG002|COMPLETED|Double Blind Maintenance Phase||20
6535924|NCT01642615|7457421|FG000|NOT COMPLETED|Double Blind Maintenance Phase||0
6645476|NCT02372097|7574445|FG001|STARTED|Wash Out Period (13 Days)||12
6535925|NCT01642615|7457422|FG001|NOT COMPLETED|Double Blind Maintenance Phase||7
6535926|NCT01642615|7457423|FG002|NOT COMPLETED|Double Blind Maintenance Phase||6
6535927|NCT01642914|7457434|FG000|STARTED|Overall Study||173
6535928|NCT01642914|7457435|FG001|STARTED|Overall Study||154
6535929|NCT01642914|7457436|FG002|STARTED|Overall Study||160
6535930|NCT01642914|7457434|FG000|COMPLETED|Overall Study||127
6535931|NCT01642914|7457435|FG001|COMPLETED|Overall Study||122
6535932|NCT01642914|7457436|FG002|COMPLETED|Overall Study||120
6535933|NCT01642914|7457434|FG000|NOT COMPLETED|Overall Study||46
6535934|NCT01642914|7457435|FG001|NOT COMPLETED|Overall Study||32
6535935|NCT01642914|7457436|FG002|NOT COMPLETED|Overall Study||40
6535936|NCT01643044|7457448|FG000|STARTED|Overall Study||24
6535937|NCT01643044|7457449|FG001|STARTED|Overall Study||24
6535938|NCT01643044|7457448|FG000|COMPLETED|Overall Study||20
6535939|NCT01643044|7457449|FG001|COMPLETED|Overall Study||19
6535940|NCT01643044|7457448|FG000|NOT COMPLETED|Overall Study||4
6535941|NCT01643044|7457449|FG001|NOT COMPLETED|Overall Study||5
6535942|NCT01643213|7457457|FG000|STARTED|Overall Study||13
6535943|NCT01643213|7457458|FG001|STARTED|Overall Study||14
6535944|NCT01643213|7457457|FG000|COMPLETED|Overall Study||12
6535945|NCT01643213|7457458|FG001|COMPLETED|Overall Study||14
6535946|NCT01643213|7457457|FG000|NOT COMPLETED|Overall Study||1
6535947|NCT01643213|7457458|FG001|NOT COMPLETED|Overall Study||0
6535948|NCT01643382|7457466|FG000|STARTED|Overall Study||30
6535949|NCT01643382|7457467|FG001|STARTED|Overall Study||30
6535950|NCT01643382|7457466|FG000|COMPLETED|Overall Study||30
6535951|NCT01643382|7457467|FG001|COMPLETED|Overall Study||30
6535952|NCT01643382|7457466|FG000|NOT COMPLETED|Overall Study||0
6535953|NCT01643382|7457467|FG001|NOT COMPLETED|Overall Study||0
6535954|NCT01643408|7457473|FG000|STARTED|Overall Study||30
6535955|NCT01643408|7457473|FG000|COMPLETED|Overall Study||16
6535956|NCT01643408|7457473|FG000|NOT COMPLETED|Overall Study||14
6535957|NCT01643473|7457479|FG000|STARTED|Overall Study||21
6535958|NCT01643473|7457480|FG001|STARTED|Overall Study||21
6535959|NCT01643473|7457479|FG000|COMPLETED|Overall Study||20
6535960|NCT01643473|7457480|FG001|COMPLETED|Overall Study||21
6535961|NCT01643473|7457479|FG000|NOT COMPLETED|Overall Study||1
6535962|NCT01643473|7457480|FG001|NOT COMPLETED|Overall Study||0
6535963|NCT01643616|7457488|FG000|STARTED|Overall Study||125
6535964|NCT01643616|7457489|FG001|STARTED|Overall Study||125
6535965|NCT01643616|7457488|FG000|COMPLETED|Overall Study||125
6535966|NCT01643616|7457489|FG001|COMPLETED|Overall Study||125
6535967|NCT01643616|7457488|FG000|NOT COMPLETED|Overall Study||0
6535968|NCT01643616|7457489|FG001|NOT COMPLETED|Overall Study||0
6535969|NCT01643668|7457495|FG000|STARTED|Overall Study||34
6535970|NCT01643668|7457495|FG000|COMPLETED|Overall Study||33
6535971|NCT01643668|7457495|FG000|NOT COMPLETED|Overall Study||1
6535972|NCT01643707|7457501|FG000|STARTED|Overall Study||858
6535973|NCT01643707|7457502|FG001|STARTED|Overall Study||484
6535974|NCT01643707|7457501|FG000|COMPLETED|Overall Study||823
6535975|NCT01643707|7457502|FG001|COMPLETED|Overall Study||470
6535976|NCT01643707|7457501|FG000|NOT COMPLETED|Overall Study||35
6535977|NCT01643707|7457502|FG001|NOT COMPLETED|Overall Study||14
6535978|NCT01643772|7457515|FG000|STARTED|Overall Study||15
6535979|NCT01643772|7457516|FG001|STARTED|Overall Study||15
6535980|NCT01643772|7457517|FG002|STARTED|Overall Study||15
6535981|NCT01643772|7457518|FG003|STARTED|Overall Study||16
6535982|NCT01643772|7457515|FG000|COMPLETED|Overall Study||15
6535983|NCT01643772|7457516|FG001|COMPLETED|Overall Study||15
6535984|NCT01643772|7457517|FG002|COMPLETED|Overall Study||15
6535985|NCT01643772|7457518|FG003|COMPLETED|Overall Study||14
6535986|NCT01643772|7457515|FG000|NOT COMPLETED|Overall Study||0
6535987|NCT01643772|7457516|FG001|NOT COMPLETED|Overall Study||0
6535988|NCT01643772|7457517|FG002|NOT COMPLETED|Overall Study||0
6535989|NCT01643772|7457518|FG003|NOT COMPLETED|Overall Study||2
6535990|NCT01643798|7457530|FG000|STARTED|Pretreatment 1 and Stimulation||7
6535991|NCT01643798|7457531|FG001|STARTED|Pretreatment 1 and Stimulation||8
6535992|NCT01643798|7457530|FG000|COMPLETED|Pretreatment 1 and Stimulation||6
6535993|NCT01643798|7457531|FG001|COMPLETED|Pretreatment 1 and Stimulation||8
6535994|NCT01643798|7457530|FG000|NOT COMPLETED|Pretreatment 1 and Stimulation||1
6535995|NCT01643798|7457531|FG001|NOT COMPLETED|Pretreatment 1 and Stimulation||0
6535996|NCT01643798|7457530|FG000|STARTED|Pretreatment 2 and Stimulation||6
6535997|NCT01643798|7457531|FG001|STARTED|Pretreatment 2 and Stimulation||8
6535998|NCT01643798|7457530|FG000|COMPLETED|Pretreatment 2 and Stimulation||6
6535999|NCT01643798|7457531|FG001|COMPLETED|Pretreatment 2 and Stimulation||8
6536000|NCT01643798|7457530|FG000|NOT COMPLETED|Pretreatment 2 and Stimulation||0
6536001|NCT01643798|7457531|FG001|NOT COMPLETED|Pretreatment 2 and Stimulation||0
6536002|NCT01643850|7457551|FG000|STARTED|Overall Study||5
6536003|NCT01643850|7457552|FG001|STARTED|Overall Study||2
6536004|NCT01643850|7457553|FG002|STARTED|Overall Study||8
6536005|NCT01643850|7457554|FG003|STARTED|Overall Study||3
6536006|NCT01643850|7457555|FG004|STARTED|Overall Study||3
6536007|NCT01643850|7457556|FG005|STARTED|Overall Study||3
6536008|NCT01643850|7457557|FG006|STARTED|Overall Study||4
6536009|NCT01643850|7457558|FG007|STARTED|Overall Study||4
6536010|NCT01643850|7457559|FG008|STARTED|Overall Study||4
6536011|NCT01643850|7457551|FG000|COMPLETED|Overall Study||5
6536012|NCT01643850|7457552|FG001|COMPLETED|Overall Study||2
6536013|NCT01643850|7457553|FG002|COMPLETED|Overall Study||7
6536014|NCT01643850|7457554|FG003|COMPLETED|Overall Study||3
6536015|NCT01643850|7457555|FG004|COMPLETED|Overall Study||0
6536016|NCT01643850|7457556|FG005|COMPLETED|Overall Study||3
6536017|NCT01643850|7457557|FG006|COMPLETED|Overall Study||3
6536018|NCT01643850|7457558|FG007|COMPLETED|Overall Study||4
6536019|NCT01643850|7457559|FG008|COMPLETED|Overall Study||3
6536020|NCT01643850|7457551|FG000|NOT COMPLETED|Overall Study||0
6536021|NCT01643850|7457552|FG001|NOT COMPLETED|Overall Study||0
6536022|NCT01643850|7457553|FG002|NOT COMPLETED|Overall Study||1
6536023|NCT01643850|7457554|FG003|NOT COMPLETED|Overall Study||0
6536024|NCT01643850|7457555|FG004|NOT COMPLETED|Overall Study||3
6536025|NCT01643850|7457556|FG005|NOT COMPLETED|Overall Study||0
6536026|NCT01643850|7457557|FG006|NOT COMPLETED|Overall Study||1
6536027|NCT01643850|7457558|FG007|NOT COMPLETED|Overall Study||0
6536028|NCT01643850|7457559|FG008|NOT COMPLETED|Overall Study||1
6536029|NCT01643876|7457625|FG000|STARTED|Overall Study||48
6536030|NCT01643876|7457625|FG000|COMPLETED|Overall Study||48
6536031|NCT01643876|7457625|FG000|NOT COMPLETED|Overall Study||0
6536032|NCT01643902|7457629|FG000|STARTED|Overall Study||20
6536033|NCT01643902|7457629|FG000|COMPLETED|Overall Study||20
6536034|NCT01643902|7457629|FG000|NOT COMPLETED|Overall Study||0
6536035|NCT01643928|7457639|FG000|STARTED|Overall Study||58
6536036|NCT01643928|7457640|FG001|STARTED|Overall Study||32
6536037|NCT01643928|7457641|FG002|STARTED|Overall Study||33
6536038|NCT01643928|7457642|FG003|STARTED|Overall Study||30
6536039|NCT01643928|7457643|FG004|STARTED|Overall Study||30
6536040|NCT01643928|7457639|FG000|COMPLETED|Overall Study||48
6536041|NCT01643928|7457640|FG001|COMPLETED|Overall Study||30
6536042|NCT01643928|7457641|FG002|COMPLETED|Overall Study||30
6536043|NCT01643928|7457642|FG003|COMPLETED|Overall Study||27
6536044|NCT01643928|7457643|FG004|COMPLETED|Overall Study||28
6536045|NCT01643928|7457639|FG000|NOT COMPLETED|Overall Study||10
6536046|NCT01643928|7457640|FG001|NOT COMPLETED|Overall Study||2
6536047|NCT01643928|7457641|FG002|NOT COMPLETED|Overall Study||3
6536048|NCT01643928|7457642|FG003|NOT COMPLETED|Overall Study||3
6536049|NCT01643928|7457643|FG004|NOT COMPLETED|Overall Study||2
6536050|NCT01644058|7457684|FG000|STARTED|Overall Study||18
6536051|NCT01644058|7457684|FG000|COMPLETED|Overall Study||18
6536052|NCT01644058|7457684|FG000|NOT COMPLETED|Overall Study||0
6536053|NCT01644149|7457691|FG000|STARTED|Overall Study||43
6536054|NCT01644149|7457692|FG001|STARTED|Overall Study||40
6536055|NCT01644149|7457691|FG000|COMPLETED|Overall Study|One subject discontinued prior to vaccination. 28 day serum samples not obtained from 3 subjects.|39
6536056|NCT01644149|7457692|FG001|COMPLETED|Overall Study|28 day serum samples were not obtained from one NS subject.|39
6536057|NCT01644149|7457691|FG000|NOT COMPLETED|Overall Study||4
6536058|NCT01644149|7457692|FG001|NOT COMPLETED|Overall Study||1
6536059|NCT01644175|7457701|FG000|STARTED|Overall Study|Randomized|107
6536060|NCT01644175|7457702|FG001|STARTED|Overall Study|Randomized|209
6536061|NCT01644175|7457701|FG000|Treated|Overall Study||107
6536062|NCT01644175|7457702|FG001|Treated|Overall Study||207
6536063|NCT01644175|7457701|FG000|COMPLETED|Overall Study||75
6536064|NCT01644175|7457702|FG001|COMPLETED|Overall Study||156
6536065|NCT01644175|7457701|FG000|NOT COMPLETED|Overall Study||32
6536066|NCT01644175|7457702|FG001|NOT COMPLETED|Overall Study||53
6536067|NCT01644188|7457710|FG000|STARTED|Overall Study|Randomized|479
6536068|NCT01644188|7457711|FG001|STARTED|Overall Study|Randomized|241
6536069|NCT01644188|7457710|FG000|Treated|Overall Study||479
6536070|NCT01644188|7457711|FG001|Treated|Overall Study||241
6536071|NCT01644188|7457710|FG000|COMPLETED|Overall Study||357
6536072|NCT01644188|7457711|FG001|COMPLETED|Overall Study||166
6536073|NCT01644188|7457710|FG000|NOT COMPLETED|Overall Study||122
6536074|NCT01644188|7457711|FG001|NOT COMPLETED|Overall Study||75
6536075|NCT01644240|7457720|FG000|STARTED|Overall Study||6
6536076|NCT01644240|7457721|FG001|STARTED|Overall Study||4
6536077|NCT01644240|7457722|FG002|STARTED|Overall Study||6
6536078|NCT01644240|7457720|FG000|COMPLETED|Overall Study||6
6536079|NCT01644240|7457721|FG001|COMPLETED|Overall Study||4
6536080|NCT01644240|7457722|FG002|COMPLETED|Overall Study||6
6536081|NCT01644240|7457720|FG000|NOT COMPLETED|Overall Study||0
6536082|NCT01644240|7457721|FG001|NOT COMPLETED|Overall Study||0
6536083|NCT01644240|7457722|FG002|NOT COMPLETED|Overall Study||0
6536084|NCT01644292|7457730|FG000|STARTED|Overall Study||2
6536085|NCT01644292|7457730|FG000|COMPLETED|Overall Study||2
6536086|NCT01644292|7457730|FG000|NOT COMPLETED|Overall Study||0
6536087|NCT01644331|7457736|FG000|STARTED|Overall Study||129
6536088|NCT01644331|7457737|FG001|STARTED|Overall Study||128
6536089|NCT01644331|7457736|FG000|COMPLETED|Overall Study||118
6536090|NCT01644331|7457737|FG001|COMPLETED|Overall Study||118
6536091|NCT01644331|7457736|FG000|NOT COMPLETED|Overall Study||11
6536092|NCT01644331|7457737|FG001|NOT COMPLETED|Overall Study||10
6536093|NCT01644396|7457743|FG000|STARTED|Overall Study||50
6536094|NCT01644396|7457743|FG000|COMPLETED|Overall Study||50
6536095|NCT01644396|7457743|FG000|NOT COMPLETED|Overall Study||0
6536096|NCT01644474|7457750|FG000|STARTED|Overall Study|Randomized|51
6536097|NCT01644474|7457751|FG001|STARTED|Overall Study|Randomized|52
6536098|NCT01644474|7457750|FG000|Treated|Overall Study||51
6536099|NCT01644474|7457751|FG001|Treated|Overall Study||52
6536100|NCT01644474|7457750|FG000|COMPLETED|Overall Study||44
6536101|NCT01644474|7457751|FG001|COMPLETED|Overall Study||44
6536102|NCT01644474|7457750|FG000|NOT COMPLETED|Overall Study||7
6536103|NCT01644474|7457751|FG001|NOT COMPLETED|Overall Study||8
6536104|NCT01644500|7457760|FG000|STARTED|Overall Study||244
6536105|NCT01644500|7457761|FG001|STARTED|Overall Study||248
6536106|NCT01644500|7457762|FG002|STARTED|Overall Study||245
6536107|NCT01644500|7457760|FG000|Received at Least One Dose of Study Drug|Overall Study||244
6536108|NCT01644500|7457761|FG001|Received at Least One Dose of Study Drug|Overall Study||248
6536109|NCT01644500|7457762|FG002|Received at Least One Dose of Study Drug|Overall Study||243
6536110|NCT01644500|7457760|FG000|Modified Intent-to-treat Population|Overall Study||239
6536111|NCT01644500|7457761|FG001|Modified Intent-to-treat Population|Overall Study||239
6536112|NCT01644500|7457762|FG002|Modified Intent-to-treat Population|Overall Study||242
6536113|NCT01644500|7457760|FG000|COMPLETED|Overall Study||222
6536114|NCT01644500|7457761|FG001|COMPLETED|Overall Study||224
6536115|NCT01644500|7457762|FG002|COMPLETED|Overall Study||230
6536116|NCT01644500|7457760|FG000|NOT COMPLETED|Overall Study||22
6536117|NCT01644500|7457761|FG001|NOT COMPLETED|Overall Study||24
6536118|NCT01644500|7457762|FG002|NOT COMPLETED|Overall Study||15
6536119|NCT01644565|7457770|FG000|STARTED|Overall Study||5
6536120|NCT01644565|7457771|FG001|STARTED|Overall Study||5
6536121|NCT01644565|7457772|FG002|STARTED|Overall Study||5
6536122|NCT01644565|7457773|FG003|STARTED|Overall Study||5
6536123|NCT01644565|7457774|FG004|STARTED|Overall Study||5
6536124|NCT01644565|7457775|FG005|STARTED|Overall Study||7
6536125|NCT01644565|7457776|FG006|STARTED|Overall Study||7
6536126|NCT01644565|7457777|FG007|STARTED|Overall Study||10
6536127|NCT01644565|7457778|FG008|STARTED|Overall Study||8
6536128|NCT01644565|7457770|FG000|COMPLETED|Overall Study||4
6536129|NCT01644565|7457771|FG001|COMPLETED|Overall Study||5
6536130|NCT01644565|7457772|FG002|COMPLETED|Overall Study||5
6536131|NCT01644565|7457773|FG003|COMPLETED|Overall Study||4
6536132|NCT01644565|7457774|FG004|COMPLETED|Overall Study||4
6536133|NCT01644565|7457775|FG005|COMPLETED|Overall Study||7
6536134|NCT01644565|7457776|FG006|COMPLETED|Overall Study||7
6536135|NCT01644565|7457777|FG007|COMPLETED|Overall Study||8
6536136|NCT01644565|7457778|FG008|COMPLETED|Overall Study||7
6536137|NCT01644565|7457770|FG000|NOT COMPLETED|Overall Study||1
6536138|NCT01644565|7457771|FG001|NOT COMPLETED|Overall Study||0
6536139|NCT01644565|7457772|FG002|NOT COMPLETED|Overall Study||0
6536140|NCT01644565|7457773|FG003|NOT COMPLETED|Overall Study||1
6536141|NCT01644565|7457774|FG004|NOT COMPLETED|Overall Study||1
6536142|NCT01644565|7457775|FG005|NOT COMPLETED|Overall Study||0
6536143|NCT01644565|7457776|FG006|NOT COMPLETED|Overall Study||0
6536144|NCT01644565|7457777|FG007|NOT COMPLETED|Overall Study||2
6536145|NCT01644565|7457778|FG008|NOT COMPLETED|Overall Study||1
6536146|NCT01644617|7457801|FG000|STARTED|Overall Study||42
6536147|NCT01644617|7457802|FG001|STARTED|Overall Study||41
6536148|NCT01644617|7457803|FG002|STARTED|Overall Study||41
6536149|NCT01644617|7457801|FG000|COMPLETED|Overall Study||36
6536150|NCT01644617|7457802|FG001|COMPLETED|Overall Study||36
6536151|NCT01644617|7457803|FG002|COMPLETED|Overall Study||34
6536152|NCT01644617|7457801|FG000|NOT COMPLETED|Overall Study||6
6536153|NCT01644617|7457802|FG001|NOT COMPLETED|Overall Study||5
6536154|NCT01644617|7457803|FG002|NOT COMPLETED|Overall Study||7
6536155|NCT01644643|7457815|FG000|STARTED|Overall Study||15
6536156|NCT01644643|7457816|FG001|STARTED|Overall Study||12
6536157|NCT01644643|7457817|FG002|STARTED|Overall Study||153
6536158|NCT01644643|7457818|FG003|STARTED|Overall Study||153
6536159|NCT01644643|7457815|FG000|COMPLETED|Overall Study||13
6536160|NCT01644643|7457816|FG001|COMPLETED|Overall Study||12
6536161|NCT01644643|7457817|FG002|COMPLETED|Overall Study||148
6536162|NCT01644643|7457818|FG003|COMPLETED|Overall Study||143
6536163|NCT01644643|7457815|FG000|NOT COMPLETED|Overall Study||2
6536164|NCT01644643|7457816|FG001|NOT COMPLETED|Overall Study||0
6536165|NCT01644643|7457817|FG002|NOT COMPLETED|Overall Study||5
6536166|NCT01644643|7457818|FG003|NOT COMPLETED|Overall Study||10
6536167|NCT01644695|7457834|FG000|STARTED|Overall Study||85
6536168|NCT01644695|7457834|FG000|COMPLETED|Overall Study||85
6536169|NCT01644695|7457834|FG000|NOT COMPLETED|Overall Study||0
6536170|NCT01644734|7457838|FG000|STARTED|Overall Study|Patients with documentation of treatment.|1282
6536171|NCT01644734|7457838|FG000|COMPLETED|Overall Study||1016
6536172|NCT01644734|7457838|FG000|NOT COMPLETED|Overall Study||266
6536173|NCT01644890|7457844|FG000|STARTED|Overall Study||218
6536174|NCT01644890|7457845|FG001|STARTED|Overall Study||218
6536175|NCT01644890|7457844|FG000|COMPLETED|Overall Study||2
6536176|NCT01644890|7457845|FG001|COMPLETED|Overall Study||3
6536177|NCT01644890|7457844|FG000|NOT COMPLETED|Overall Study||216
6536178|NCT01644890|7457845|FG001|NOT COMPLETED|Overall Study||215
6536179|NCT01645059|7457851|FG000|STARTED|Overall Study||129
6536180|NCT01645059|7457851|FG000|COMPLETED|Overall Study||129
6536181|NCT01645059|7457851|FG000|NOT COMPLETED|Overall Study||0
6536182|NCT01645098|7457862|FG000|STARTED|Overall Study||24
6536183|NCT01645098|7457863|FG001|STARTED|Overall Study||29
6536184|NCT01645098|7457862|FG000|COMPLETED|Overall Study||24
6536185|NCT01645098|7457863|FG001|COMPLETED|Overall Study||29
6536186|NCT01645098|7457862|FG000|NOT COMPLETED|Overall Study||0
6536187|NCT01645098|7457863|FG001|NOT COMPLETED|Overall Study||0
6536188|NCT01645111|7457869|FG000|STARTED|Overall Study||50
6536189|NCT01645111|7457869|FG000|COMPLETED|Overall Study||35
6536190|NCT01645111|7457869|FG000|NOT COMPLETED|Overall Study||15
6536191|NCT01645176|7457873|FG000|STARTED|Overall Study||21
6536192|NCT01645176|7457873|FG000|COMPLETED|Overall Study||16
6536193|NCT01645176|7457873|FG000|NOT COMPLETED|Overall Study||5
6536194|NCT01645280|7457882|FG000|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
6536195|NCT01645280|7457883|FG001|STARTED|Overall Study||54
6536196|NCT01645280|7457884|FG002|STARTED|Overall Study||55
6536197|NCT01645280|7457885|FG003|STARTED|Overall Study||54
6536198|NCT01645280|7457886|FG004|STARTED|Overall Study||55
6536199|NCT01645280|7457882|FG000|COMPLETED|Overall Study||49
6536200|NCT01645280|7457883|FG001|COMPLETED|Overall Study||51
6536201|NCT01645280|7457884|FG002|COMPLETED|Overall Study||49
6536202|NCT01645280|7457885|FG003|COMPLETED|Overall Study||48
6536203|NCT01645280|7457886|FG004|COMPLETED|Overall Study||47
6536204|NCT01645280|7457882|FG000|NOT COMPLETED|Overall Study||6
6536205|NCT01645280|7457883|FG001|NOT COMPLETED|Overall Study||3
6536206|NCT01645280|7457884|FG002|NOT COMPLETED|Overall Study||6
6536207|NCT01645280|7457885|FG003|NOT COMPLETED|Overall Study||6
6536208|NCT01645280|7457886|FG004|NOT COMPLETED|Overall Study||8
6536209|NCT01645306|7457902|FG000|STARTED|Overall Study||51
6536210|NCT01645306|7457903|FG001|STARTED|Overall Study||54
6536211|NCT01645306|7457904|FG002|STARTED|Overall Study||53
6536212|NCT01645306|7457902|FG000|COMPLETED|Overall Study||49
6536213|NCT01645306|7457903|FG001|COMPLETED|Overall Study||50
6536214|NCT01645306|7457904|FG002|COMPLETED|Overall Study||48
6536215|NCT01645306|7457902|FG000|NOT COMPLETED|Overall Study||2
6536216|NCT01645306|7457903|FG001|NOT COMPLETED|Overall Study||4
6536217|NCT01645306|7457904|FG002|NOT COMPLETED|Overall Study||5
6536218|NCT01645735|7457914|FG000|STARTED|Overall Study||32
6536219|NCT01645735|7457915|FG001|STARTED|Overall Study||17
6536220|NCT01645735|7457914|FG000|COMPLETED|Overall Study||28
6536221|NCT01645735|7457915|FG001|COMPLETED|Overall Study||16
6536222|NCT01645735|7457914|FG000|NOT COMPLETED|Overall Study||4
6536223|NCT01645735|7457915|FG001|NOT COMPLETED|Overall Study||1
6536224|NCT01645930|7457922|FG000|STARTED|Overall Study||43
6536225|NCT01645930|7457922|FG000|COMPLETED|Overall Study||0
6536226|NCT01645930|7457922|FG000|NOT COMPLETED|Overall Study||43
6536227|NCT01646021|7457928|FG000|STARTED|Overall Study||139
6536228|NCT01646021|7457929|FG001|STARTED|Overall Study||141
6536229|NCT01646021|7457928|FG000|Treated|Overall Study||139
6536230|NCT01646021|7457929|FG001|Treated|Overall Study||139
6536231|NCT01646021|7457928|FG000|COMPLETED|Overall Study||0
6536232|NCT01646021|7457929|FG001|COMPLETED|Overall Study||0
6536233|NCT01646021|7457928|FG000|NOT COMPLETED|Overall Study||139
6536234|NCT01646021|7457929|FG001|NOT COMPLETED|Overall Study||141
6536235|NCT01646073|7457937|FG000|STARTED|Period A (12 Weeks)||87
6536236|NCT01646073|7457938|FG001|STARTED|Period A (12 Weeks)||338
6536237|NCT01646073|7457937|FG000|COMPLETED|Period A (12 Weeks)||85
6536238|NCT01646073|7457938|FG001|COMPLETED|Period A (12 Weeks)||333
6536239|NCT01646073|7457937|FG000|NOT COMPLETED|Period A (12 Weeks)||2
6536240|NCT01646073|7457938|FG001|NOT COMPLETED|Period A (12 Weeks)||5
6536241|NCT01646073|7457937|FG000|STARTED|Period B (12 Weeks)||85
6536242|NCT01646073|7457938|FG001|STARTED|Period B (12 Weeks)||333
6536243|NCT01646073|7457937|FG000|COMPLETED|Period B (12 Weeks)||84
6536244|NCT01646073|7457938|FG001|COMPLETED|Period B (12 Weeks)||320
6536245|NCT01646073|7457937|FG000|NOT COMPLETED|Period B (12 Weeks)||1
6536246|NCT01646073|7457938|FG001|NOT COMPLETED|Period B (12 Weeks)||13
6536247|NCT01646125|7457949|FG000|STARTED|Overall Study||31
6536248|NCT01646125|7457950|FG001|STARTED|Overall Study||28
6536249|NCT01646125|7457949|FG000|COMPLETED|Overall Study||0
6536250|NCT01646125|7457950|FG001|COMPLETED|Overall Study||0
6536251|NCT01646125|7457949|FG000|NOT COMPLETED|Overall Study||31
6536252|NCT01646125|7457950|FG001|NOT COMPLETED|Overall Study||28
6536253|NCT01646138|7457962|FG000|STARTED|Overall Study||5
6536254|NCT01646138|7457963|FG001|STARTED|Overall Study||4
6536255|NCT01646138|7457964|FG002|STARTED|Overall Study||5
6536256|NCT01646138|7457965|FG003|STARTED|Overall Study||19
6536257|NCT01646138|7457966|FG004|STARTED|Overall Study||15
6536258|NCT01646138|7457962|FG000|COMPLETED|Overall Study||5
6536259|NCT01646138|7457963|FG001|COMPLETED|Overall Study||4
6536260|NCT01646138|7457964|FG002|COMPLETED|Overall Study||5
6536261|NCT01646138|7457965|FG003|COMPLETED|Overall Study||19
6536262|NCT01646138|7457966|FG004|COMPLETED|Overall Study||13
6536263|NCT01646138|7457962|FG000|NOT COMPLETED|Overall Study||0
6536264|NCT01646138|7457963|FG001|NOT COMPLETED|Overall Study||0
6536265|NCT01646138|7457964|FG002|NOT COMPLETED|Overall Study||0
6536266|NCT01646138|7457965|FG003|NOT COMPLETED|Overall Study||0
6536267|NCT01646138|7457966|FG004|NOT COMPLETED|Overall Study||2
6536268|NCT01646151|7457978|FG000|STARTED|Overall Study||2580
6536269|NCT01646151|7457978|FG000|COMPLETED|Overall Study||2410
6536270|NCT01646151|7457978|FG000|NOT COMPLETED|Overall Study||170
6536271|NCT01646177|7457986|FG000|STARTED|Blinded Induction Dosing (Week 0-12)||193
6536272|NCT01646177|7457987|FG001|STARTED|Blinded Induction Dosing (Week 0-12)||382
6536273|NCT01646177|7457988|FG002|STARTED|Blinded Induction Dosing (Week 0-12)||386
6536274|NCT01646177|7457989|FG003|STARTED|Blinded Induction Dosing (Week 0-12)||385
6536275|NCT01646177|7457990|FG004|STARTED|Blinded Induction Dosing (Week 0-12)||0
6536276|NCT01646177|7457991|FG005|STARTED|Blinded Induction Dosing (Week 0-12)||0
6536277|NCT01646177|7457992|FG006|STARTED|Blinded Induction Dosing (Week 0-12)||0
6536278|NCT01646177|7457993|FG007|STARTED|Blinded Induction Dosing (Week 0-12)||0
6536279|NCT01646177|7457994|FG008|STARTED|Blinded Induction Dosing (Week 0-12)||0
6536280|NCT01646177|7457995|FG009|STARTED|Blinded Induction Dosing (Week 0-12)||0
6536281|NCT01646177|7457996|FG010|STARTED|Blinded Induction Dosing (Week 0-12)||0
6536282|NCT01646177|7457997|FG011|STARTED|Blinded Induction Dosing (Week 0-12)||0
6536283|NCT01646177|7457986|FG000|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||193
6536284|NCT01646177|7457987|FG001|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
6536285|NCT01646177|7457988|FG002|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||382
6536286|NCT01646177|7457989|FG003|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||384
6536287|NCT01646177|7457990|FG004|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6536288|NCT01646177|7457991|FG005|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6536289|NCT01646177|7457992|FG006|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6536290|NCT01646177|7457993|FG007|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6536291|NCT01646177|7457994|FG008|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6536292|NCT01646177|7457995|FG009|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6536293|NCT01646177|7457996|FG010|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6536294|NCT01646177|7457997|FG011|Received at Least One Dose of Study Drug|Blinded Induction Dosing (Week 0-12)||0
6536295|NCT01646177|7457986|FG000|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
6536296|NCT01646177|7457987|FG001|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
6536297|NCT01646177|7457988|FG002|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
6536298|NCT01646177|7457989|FG003|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
6536299|NCT01646177|7457990|FG004|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536300|NCT01646177|7457991|FG005|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536301|NCT01646177|7457992|FG006|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536302|NCT01646177|7457993|FG007|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536303|NCT01646177|7457994|FG008|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536304|NCT01646177|7457995|FG009|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536305|NCT01646177|7457996|FG010|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536306|NCT01646177|7457997|FG011|COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536307|NCT01646177|7457986|FG000|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
6536308|NCT01646177|7457987|FG001|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
6536309|NCT01646177|7457988|FG002|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
6536310|NCT01646177|7457989|FG003|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
6536311|NCT01646177|7457990|FG004|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536312|NCT01646177|7457991|FG005|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536313|NCT01646177|7457992|FG006|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536314|NCT01646177|7457993|FG007|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536315|NCT01646177|7457994|FG008|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536316|NCT01646177|7457995|FG009|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536317|NCT01646177|7457996|FG010|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536318|NCT01646177|7457997|FG011|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||0
6536319|NCT01646177|7457986|FG000|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
6536320|NCT01646177|7457987|FG001|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
6536321|NCT01646177|7457988|FG002|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
6536322|NCT01646177|7457989|FG003|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|0
6536323|NCT01646177|7457990|FG004|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|183
6536324|NCT01646177|7457991|FG005|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|369
6536325|NCT01646177|7457992|FG006|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|360
6536326|NCT01646177|7457993|FG007|STARTED|Long-Term Extension Period (Week 12-264)|Participants completed prior period then proceeded to IXE80Q4W long-term extension period.|362
6536327|NCT01646177|7457994|FG008|STARTED|Long-Term Extension Period (Week 12-264)||0
6536328|NCT01646177|7457995|FG009|STARTED|Long-Term Extension Period (Week 12-264)||0
6536329|NCT01646177|7457996|FG010|STARTED|Long-Term Extension Period (Week 12-264)||0
6536330|NCT01646177|7457997|FG011|STARTED|Long-Term Extension Period (Week 12-264)||0
6536331|NCT01646177|7457986|FG000|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6536332|NCT01646177|7457987|FG001|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6536333|NCT01646177|7457988|FG002|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6536334|NCT01646177|7457989|FG003|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6536335|NCT01646177|7457990|FG004|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||183
6536336|NCT01646177|7457991|FG005|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||369
6536337|NCT01646177|7457992|FG006|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||360
6536338|NCT01646177|7457993|FG007|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||362
6536339|NCT01646177|7457994|FG008|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6536340|NCT01646177|7457995|FG009|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6536341|NCT01646177|7457996|FG010|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6536342|NCT01646177|7457997|FG011|Received at Least One Dose of Study Drug|Long-Term Extension Period (Week 12-264)||0
6536343|NCT01646177|7457986|FG000|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536344|NCT01646177|7457987|FG001|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536345|NCT01646177|7457988|FG002|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536346|NCT01646177|7457989|FG003|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536347|NCT01646177|7457990|FG004|COMPLETED|Long-Term Extension Period (Week 12-264)||135
6536348|NCT01646177|7457991|FG005|COMPLETED|Long-Term Extension Period (Week 12-264)||256
6536349|NCT01646177|7457992|FG006|COMPLETED|Long-Term Extension Period (Week 12-264)||244
6536350|NCT01646177|7457993|FG007|COMPLETED|Long-Term Extension Period (Week 12-264)||255
6536351|NCT01646177|7457994|FG008|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536352|NCT01646177|7457995|FG009|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536353|NCT01646177|7457996|FG010|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536354|NCT01646177|7457997|FG011|COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536355|NCT01646177|7457986|FG000|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536356|NCT01646177|7457987|FG001|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536357|NCT01646177|7457988|FG002|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536358|NCT01646177|7457989|FG003|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536359|NCT01646177|7457990|FG004|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||48
6536360|NCT01646177|7457991|FG005|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||113
6536361|NCT01646177|7457992|FG006|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||116
6536362|NCT01646177|7457993|FG007|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||107
6536363|NCT01646177|7457994|FG008|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536364|NCT01646177|7457995|FG009|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536365|NCT01646177|7457996|FG010|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536366|NCT01646177|7457997|FG011|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
6536367|NCT01646177|7457986|FG000|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
6536368|NCT01646177|7457987|FG001|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
6536369|NCT01646177|7457988|FG002|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
6536370|NCT01646177|7457989|FG003|STARTED|Follow-Up Period (Minimum of 12 Weeks)||0
6536371|NCT01646177|7457990|FG004|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6536372|NCT01646177|7457991|FG005|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6536373|NCT01646177|7457992|FG006|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6536374|NCT01646177|7457993|FG007|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|0
6536375|NCT01646177|7457994|FG008|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|157
6536376|NCT01646177|7457995|FG009|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|309
6536377|NCT01646177|7457996|FG010|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|305
6536378|NCT01646177|7457997|FG011|STARTED|Follow-Up Period (Minimum of 12 Weeks)|Participants who completed or discontinued from study treatment and entered the follow-up period.|313
6536379|NCT01646177|7457986|FG000|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6536380|NCT01646177|7457987|FG001|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6536381|NCT01646177|7457988|FG002|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6536382|NCT01646177|7457989|FG003|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6536383|NCT01646177|7457990|FG004|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6536384|NCT01646177|7457991|FG005|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6536385|NCT01646177|7457992|FG006|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6536386|NCT01646177|7457993|FG007|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||0
6536387|NCT01646177|7457994|FG008|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||157
6536388|NCT01646177|7457995|FG009|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||309
6536389|NCT01646177|7457996|FG010|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||305
6536390|NCT01646177|7457997|FG011|Received at Least One Dose of Study Drug|Follow-Up Period (Minimum of 12 Weeks)||313
6536391|NCT01646177|7457986|FG000|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536392|NCT01646177|7457987|FG001|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536393|NCT01646177|7457988|FG002|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536394|NCT01646177|7457989|FG003|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536395|NCT01646177|7457990|FG004|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536396|NCT01646177|7457991|FG005|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536397|NCT01646177|7457992|FG006|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536398|NCT01646177|7457993|FG007|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536399|NCT01646177|7457994|FG008|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||126
6536400|NCT01646177|7457995|FG009|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||233
6645477|NCT02372097|7574444|FG000|COMPLETED|Wash Out Period (13 Days)||12
6645478|NCT02372097|7574445|FG001|COMPLETED|Wash Out Period (13 Days)||12
6645479|NCT02372097|7574444|FG000|NOT COMPLETED|Wash Out Period (13 Days)||0
6645480|NCT02372097|7574445|FG001|NOT COMPLETED|Wash Out Period (13 Days)||0
6645481|NCT02372097|7574444|FG000|STARTED|Second Intervention Period (8 Days)||12
6536401|NCT01646177|7457996|FG010|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||225
6536402|NCT01646177|7457997|FG011|COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||230
6536403|NCT01646177|7457986|FG000|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6645482|NCT02372097|7574445|FG001|STARTED|Second Intervention Period (8 Days)||12
6645483|NCT02372097|7574444|FG000|COMPLETED|Second Intervention Period (8 Days)||12
6536404|NCT01646177|7457987|FG001|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536405|NCT01646177|7457988|FG002|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536406|NCT01646177|7457989|FG003|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536407|NCT01646177|7457990|FG004|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536408|NCT01646177|7457991|FG005|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536409|NCT01646177|7457992|FG006|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536410|NCT01646177|7457993|FG007|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||0
6536411|NCT01646177|7457994|FG008|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||31
6536412|NCT01646177|7457995|FG009|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||76
6536413|NCT01646177|7457996|FG010|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||80
6536414|NCT01646177|7457997|FG011|NOT COMPLETED|Follow-Up Period (Minimum of 12 Weeks)||83
6536415|NCT01646203|7458020|FG000|STARTED|Overall Study||2
6536416|NCT01646203|7458021|FG001|STARTED|Overall Study||5
6536417|NCT01646203|7458022|FG002|STARTED|Overall Study||7
6536418|NCT01646203|7458020|FG000|Received at Least One Dose of Study Drug|Overall Study||2
6536419|NCT01646203|7458021|FG001|Received at Least One Dose of Study Drug|Overall Study||5
6536420|NCT01646203|7458022|FG002|Received at Least One Dose of Study Drug|Overall Study||7
6536421|NCT01646203|7458020|FG000|COMPLETED|Overall Study||0
6536422|NCT01646203|7458021|FG001|COMPLETED|Overall Study||3
6536423|NCT01646203|7458022|FG002|COMPLETED|Overall Study||6
6536424|NCT01646203|7458020|FG000|NOT COMPLETED|Overall Study||2
6536425|NCT01646203|7458021|FG001|NOT COMPLETED|Overall Study||2
6536426|NCT01646203|7458022|FG002|NOT COMPLETED|Overall Study||1
6536427|NCT01646216|7458037|FG000|STARTED|Overall Study||17
6536428|NCT01646216|7458038|FG001|STARTED|Overall Study||17
6536429|NCT01646216|7458037|FG000|COMPLETED|Overall Study||6
6536430|NCT01646216|7458038|FG001|COMPLETED|Overall Study||4
6536431|NCT01646216|7458037|FG000|NOT COMPLETED|Overall Study||11
6536432|NCT01646216|7458038|FG001|NOT COMPLETED|Overall Study||13
6536433|NCT01646255|7458050|FG000|STARTED|Overall Study||172
6536434|NCT01646255|7458051|FG001|STARTED|Overall Study||174
6536435|NCT01646255|7458050|FG000|COMPLETED|Overall Study||151
6536436|NCT01646255|7458051|FG001|COMPLETED|Overall Study||160
6536437|NCT01646255|7458050|FG000|NOT COMPLETED|Overall Study||21
6536438|NCT01646255|7458051|FG001|NOT COMPLETED|Overall Study||14
6536439|NCT01646268|7458060|FG000|STARTED|Overall Study||124
6536440|NCT01646268|7458061|FG001|STARTED|Overall Study||123
6536441|NCT01646268|7458060|FG000|COMPLETED|Overall Study||113
6536442|NCT01646268|7458061|FG001|COMPLETED|Overall Study||107
6536443|NCT01646268|7458060|FG000|NOT COMPLETED|Overall Study||11
6536444|NCT01646268|7458061|FG001|NOT COMPLETED|Overall Study||16
6536445|NCT01646320|7458069|FG000|STARTED|Short-term Period (Day 1 to Week 24)||160
6536446|NCT01646320|7458070|FG001|STARTED|Short-term Period (Day 1 to Week 24)||160
6536447|NCT01646320|7458069|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)||148
6536448|NCT01646320|7458070|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)||153
6536449|NCT01646320|7458069|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
6536450|NCT01646320|7458070|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
6536451|NCT01646320|7458069|FG000|STARTED|Long-term Period (Weeks 24 to 52)||147
6536452|NCT01646320|7458070|FG001|STARTED|Long-term Period (Weeks 24 to 52)||147
6536453|NCT01646320|7458069|FG000|COMPLETED|Long-term Period (Weeks 24 to 52)||141
6536454|NCT01646320|7458070|FG001|COMPLETED|Long-term Period (Weeks 24 to 52)||140
6536455|NCT01646320|7458069|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
6536456|NCT01646320|7458070|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
6536457|NCT01646346|7458076|FG000|STARTED|Overall Study||46
6536458|NCT01646346|7458076|FG000|COMPLETED|Overall Study||46
6536459|NCT01646346|7458076|FG000|NOT COMPLETED|Overall Study||0
6536460|NCT01646385|7458082|FG000|STARTED|Overall Study||3529
6536461|NCT01646385|7458083|FG001|STARTED|Overall Study||2864
6536462|NCT01646385|7458082|FG000|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
6536463|NCT01646385|7458083|FG001|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
6536464|NCT01646385|7458082|FG000|NOT COMPLETED|Overall Study||838
6536465|NCT01646385|7458083|FG001|NOT COMPLETED|Overall Study||871
6536466|NCT01646398|7458091|FG000|STARTED|Overall Study||382
6536467|NCT01646398|7458092|FG001|STARTED|Overall Study||382
6536468|NCT01646398|7458091|FG000|COMPLETED|Overall Study||381
6536469|NCT01646398|7458092|FG001|COMPLETED|Overall Study||382
6536470|NCT01646398|7458091|FG000|NOT COMPLETED|Overall Study||1
6536471|NCT01646398|7458092|FG001|NOT COMPLETED|Overall Study||0
6536472|NCT01646645|7458098|FG000|STARTED|Overall Study||58
6536473|NCT01646645|7458098|FG000|COMPLETED|Overall Study||28
6536474|NCT01646645|7458098|FG000|NOT COMPLETED|Overall Study||30
6536475|NCT01646671|7458105|FG000|STARTED|Overall Study||3
6536476|NCT01646671|7458106|FG001|STARTED|Overall Study||11
6536477|NCT01646671|7458107|FG002|STARTED|Overall Study||21
6645484|NCT02372097|7574445|FG001|COMPLETED|Second Intervention Period (8 Days)||12
6536478|NCT01646671|7458105|FG000|COMPLETED|Overall Study||3
6536479|NCT01646671|7458106|FG001|COMPLETED|Overall Study||11
6536480|NCT01646671|7458107|FG002|COMPLETED|Overall Study||21
6536481|NCT01646671|7458105|FG000|NOT COMPLETED|Overall Study||0
6536482|NCT01646671|7458106|FG001|NOT COMPLETED|Overall Study||0
6536483|NCT01646671|7458107|FG002|NOT COMPLETED|Overall Study||0
6536484|NCT01646762|7458117|FG000|STARTED|Overall Study||13
6536485|NCT01646762|7458117|FG000|COMPLETED|Overall Study||13
6536486|NCT01646762|7458117|FG000|NOT COMPLETED|Overall Study||0
6536487|NCT01646814|7458123|FG000|STARTED|Overall Study||121
6536488|NCT01646814|7458124|FG001|STARTED|Overall Study||126
6536489|NCT01646814|7458123|FG000|COMPLETED|Overall Study||110
6536490|NCT01646814|7458124|FG001|COMPLETED|Overall Study||120
6536491|NCT01646814|7458123|FG000|NOT COMPLETED|Overall Study||11
6536492|NCT01646814|7458124|FG001|NOT COMPLETED|Overall Study||6
6536493|NCT01646827|7458132|FG000|STARTED|Overall Study||18
6536494|NCT01646827|7458133|FG001|STARTED|Overall Study||19
6536495|NCT01646827|7458132|FG000|COMPLETED|Overall Study||16
6536496|NCT01646827|7458133|FG001|COMPLETED|Overall Study||14
6536497|NCT01646827|7458132|FG000|NOT COMPLETED|Overall Study||2
6536498|NCT01646827|7458133|FG001|NOT COMPLETED|Overall Study||5
6536499|NCT01647217|7458141|FG000|STARTED|Overall Study||8
6536500|NCT01647217|7458142|FG001|STARTED|Overall Study||9
6536501|NCT01647217|7458141|FG000|COMPLETED|Overall Study||7
6536502|NCT01647217|7458142|FG001|COMPLETED|Overall Study||8
6536503|NCT01647217|7458141|FG000|NOT COMPLETED|Overall Study||1
6536504|NCT01647217|7458142|FG001|NOT COMPLETED|Overall Study||1
6562121|NCT01799590|7485166|FG000|NOT COMPLETED|Overall Study||26
6562122|NCT01799590|7485167|FG001|NOT COMPLETED|Overall Study||16
6562123|NCT01799590|7485168|FG002|NOT COMPLETED|Overall Study||14
6562124|NCT01799720|7485179|FG000|STARTED|Overall Study||20
6562125|NCT01799720|7485180|FG001|STARTED|Overall Study||18
6562126|NCT01799720|7485181|FG002|STARTED|Overall Study||19
6562127|NCT01799720|7485179|FG000|Began the Treatment|Overall Study||20
6562128|NCT01799720|7485180|FG001|Began the Treatment|Overall Study||18
6562129|NCT01799720|7485181|FG002|Began the Treatment|Overall Study||19
6562130|NCT01799720|7485179|FG000|Began the Treatment and Finished it|Overall Study||17
6562131|NCT01799720|7485180|FG001|Began the Treatment and Finished it|Overall Study||17
6562132|NCT01799720|7485181|FG002|Began the Treatment and Finished it|Overall Study||18
6562133|NCT01799720|7485179|FG000|COMPLETED|Overall Study||17
6562134|NCT01799720|7485180|FG001|COMPLETED|Overall Study||17
6562135|NCT01799720|7485181|FG002|COMPLETED|Overall Study||18
6562136|NCT01799720|7485179|FG000|NOT COMPLETED|Overall Study||3
6562137|NCT01799720|7485180|FG001|NOT COMPLETED|Overall Study||1
6562138|NCT01799720|7485181|FG002|NOT COMPLETED|Overall Study||1
6562139|NCT01799889|7485201|FG000|STARTED|Overall Study||41
6562140|NCT01799889|7485202|FG001|STARTED|Overall Study||41
6562141|NCT01799889|7485203|FG002|STARTED|Overall Study||44
6562142|NCT01799889|7485204|FG003|STARTED|Overall Study||39
6562143|NCT01799889|7485205|FG004|STARTED|Overall Study||49
6562144|NCT01799889|7485206|FG005|STARTED|Overall Study||20
6562145|NCT01799889|7485207|FG006|STARTED|Overall Study||21
6562146|NCT01799889|7485208|FG007|STARTED|Overall Study||20
6562147|NCT01799889|7485209|FG008|STARTED|Overall Study||33
6562148|NCT01799889|7485210|FG009|STARTED|Overall Study||8
6562149|NCT01799889|7485211|FG010|STARTED|Overall Study||7
6562150|NCT01799889|7485212|FG011|STARTED|Overall Study||3
6562151|NCT01799889|7485201|FG000|COMPLETED|Overall Study||0
6562152|NCT01799889|7485202|FG001|COMPLETED|Overall Study||0
6562153|NCT01799889|7485203|FG002|COMPLETED|Overall Study||0
6562154|NCT01799889|7485204|FG003|COMPLETED|Overall Study||0
6562155|NCT01799889|7485205|FG004|COMPLETED|Overall Study||0
6562156|NCT01799889|7485206|FG005|COMPLETED|Overall Study||0
6562157|NCT01799889|7485207|FG006|COMPLETED|Overall Study||0
6562158|NCT01799889|7485208|FG007|COMPLETED|Overall Study||0
6562159|NCT01799889|7485209|FG008|COMPLETED|Overall Study||0
6562160|NCT01799889|7485210|FG009|COMPLETED|Overall Study||0
6562161|NCT01799889|7485211|FG010|COMPLETED|Overall Study||0
6562162|NCT01799889|7485212|FG011|COMPLETED|Overall Study||0
6562163|NCT01799889|7485201|FG000|NOT COMPLETED|Overall Study||41
6562164|NCT01799889|7485202|FG001|NOT COMPLETED|Overall Study||41
6562165|NCT01799889|7485203|FG002|NOT COMPLETED|Overall Study||44
6562166|NCT01799889|7485204|FG003|NOT COMPLETED|Overall Study||39
6562167|NCT01799889|7485205|FG004|NOT COMPLETED|Overall Study||49
6562168|NCT01799889|7485206|FG005|NOT COMPLETED|Overall Study||20
6562169|NCT01799889|7485207|FG006|NOT COMPLETED|Overall Study||21
6562170|NCT01799889|7485208|FG007|NOT COMPLETED|Overall Study||20
6655951|NCT02457247|7586100|FG002|STARTED|Period 1||68
6562171|NCT01799889|7485209|FG008|NOT COMPLETED|Overall Study||33
6562172|NCT01799889|7485210|FG009|NOT COMPLETED|Overall Study||8
6562173|NCT01799889|7485211|FG010|NOT COMPLETED|Overall Study||7
6562174|NCT01799889|7485212|FG011|NOT COMPLETED|Overall Study||3
6562175|NCT01799941|7485249|FG000|STARTED|Overall Study||367
6562176|NCT01799941|7485249|FG000|COMPLETED|Overall Study||271
6562177|NCT01799941|7485249|FG000|NOT COMPLETED|Overall Study||96
6562178|NCT01799993|7485261|FG000|STARTED|Overall Study||362
6562179|NCT01799993|7485262|FG001|STARTED|Overall Study||363
6562180|NCT01799993|7485261|FG000|ITT Population|Overall Study||354
6562181|NCT01799993|7485262|FG001|ITT Population|Overall Study||358
6562182|NCT01799993|7485261|FG000|mITT Population|Overall Study||255
6562183|NCT01799993|7485262|FG001|mITT Population|Overall Study||253
6562184|NCT01799993|7485261|FG000|COMPLETED|Overall Study||229
6562185|NCT01799993|7485262|FG001|COMPLETED|Overall Study||235
6562186|NCT01799993|7485261|FG000|NOT COMPLETED|Overall Study||133
6536505|NCT01647282|7458152|FG000|STARTED|Overall Study||30
6536506|NCT01647282|7458153|FG001|STARTED|Overall Study||30
6536507|NCT01647282|7458152|FG000|COMPLETED|Overall Study||23
6536508|NCT01647282|7458153|FG001|COMPLETED|Overall Study||25
6536509|NCT01647282|7458152|FG000|NOT COMPLETED|Overall Study||7
6536510|NCT01647282|7458153|FG001|NOT COMPLETED|Overall Study||5
6536511|NCT01647438|7458161|FG000|STARTED|Overall Study||32
6536512|NCT01647438|7458162|FG001|STARTED|Overall Study||31
6536513|NCT01647438|7458161|FG000|COMPLETED|Overall Study||32
6645485|NCT02372097|7574444|FG000|NOT COMPLETED|Second Intervention Period (8 Days)||0
6645486|NCT02372097|7574445|FG001|NOT COMPLETED|Second Intervention Period (8 Days)||0
6536514|NCT01647438|7458162|FG001|COMPLETED|Overall Study||31
6536515|NCT01647438|7458161|FG000|NOT COMPLETED|Overall Study||0
6536516|NCT01647438|7458162|FG001|NOT COMPLETED|Overall Study||0
6536517|NCT01647464|7458168|FG000|STARTED|Overall Study||10
6536518|NCT01647464|7458168|FG000|COMPLETED|Overall Study||10
6536519|NCT01647464|7458168|FG000|NOT COMPLETED|Overall Study||0
6536520|NCT01647516|7458175|FG000|STARTED|Induction Period (IP)||66
6536521|NCT01647516|7458176|FG001|STARTED|Induction Period (IP)||66
6536522|NCT01647516|7458177|FG002|STARTED|Induction Period (IP)||67
6536523|NCT01647516|7458178|FG003|STARTED|Induction Period (IP)||0
6536524|NCT01647516|7458179|FG004|STARTED|Induction Period (IP)||0
6536525|NCT01647516|7458180|FG005|STARTED|Induction Period (IP)||0
6536526|NCT01647516|7458175|FG000|Received Study Drug|Induction Period (IP)||65
6536527|NCT01647516|7458176|FG001|Received Study Drug|Induction Period (IP)||65
6536528|NCT01647516|7458177|FG002|Received Study Drug|Induction Period (IP)||67
6536529|NCT01647516|7458178|FG003|Received Study Drug|Induction Period (IP)||0
6536530|NCT01647516|7458179|FG004|Received Study Drug|Induction Period (IP)||0
6536531|NCT01647516|7458180|FG005|Received Study Drug|Induction Period (IP)||0
6536532|NCT01647516|7458175|FG000|COMPLETED|Induction Period (IP)||60
6536533|NCT01647516|7458176|FG001|COMPLETED|Induction Period (IP)||63
6536534|NCT01647516|7458177|FG002|COMPLETED|Induction Period (IP)||63
6536535|NCT01647516|7458178|FG003|COMPLETED|Induction Period (IP)||0
6536536|NCT01647516|7458179|FG004|COMPLETED|Induction Period (IP)||0
6536537|NCT01647516|7458180|FG005|COMPLETED|Induction Period (IP)||0
6536538|NCT01647516|7458175|FG000|NOT COMPLETED|Induction Period (IP)||6
6536539|NCT01647516|7458176|FG001|NOT COMPLETED|Induction Period (IP)||3
6536540|NCT01647516|7458177|FG002|NOT COMPLETED|Induction Period (IP)||4
6536541|NCT01647516|7458178|FG003|NOT COMPLETED|Induction Period (IP)||0
6536542|NCT01647516|7458179|FG004|NOT COMPLETED|Induction Period (IP)||0
6536543|NCT01647516|7458180|FG005|NOT COMPLETED|Induction Period (IP)||0
6536544|NCT01647516|7458175|FG000|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|25
6536545|NCT01647516|7458176|FG001|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|36
6536546|NCT01647516|7458177|FG002|STARTED|Maintenance Period (MP)|The MP includes participants who were responders at week 8.|42
6536547|NCT01647516|7458178|FG003|STARTED|Maintenance Period (MP)||0
6536548|NCT01647516|7458179|FG004|STARTED|Maintenance Period (MP)||0
6536549|NCT01647516|7458180|FG005|STARTED|Maintenance Period (MP)||0
6536550|NCT01647516|7458175|FG000|COMPLETED|Maintenance Period (MP)||21
6536551|NCT01647516|7458176|FG001|COMPLETED|Maintenance Period (MP)||30
6536552|NCT01647516|7458177|FG002|COMPLETED|Maintenance Period (MP)||40
6536553|NCT01647516|7458178|FG003|COMPLETED|Maintenance Period (MP)||0
6536554|NCT01647516|7458179|FG004|COMPLETED|Maintenance Period (MP)||0
6536555|NCT01647516|7458180|FG005|COMPLETED|Maintenance Period (MP)||0
6536556|NCT01647516|7458175|FG000|NOT COMPLETED|Maintenance Period (MP)||4
6536557|NCT01647516|7458176|FG001|NOT COMPLETED|Maintenance Period (MP)||6
6536558|NCT01647516|7458177|FG002|NOT COMPLETED|Maintenance Period (MP)||2
6536559|NCT01647516|7458178|FG003|NOT COMPLETED|Maintenance Period (MP)||0
6536560|NCT01647516|7458179|FG004|NOT COMPLETED|Maintenance Period (MP)||0
6536561|NCT01647516|7458180|FG005|NOT COMPLETED|Maintenance Period (MP)||0
6536562|NCT01647516|7458175|FG000|STARTED|Open-Label Period||0
6536563|NCT01647516|7458176|FG001|STARTED|Open-Label Period||0
6536564|NCT01647516|7458177|FG002|STARTED|Open-Label Period||0
6536565|NCT01647516|7458178|FG003|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|55
6536566|NCT01647516|7458179|FG004|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|56
6536567|NCT01647516|7458180|FG005|STARTED|Open-Label Period|"The participants were:~non-responders at Week 8,completed the MP or had disease relapse during MP"|59
6536568|NCT01647516|7458175|FG000|COMPLETED|Open-Label Period||0
6536569|NCT01647516|7458176|FG001|COMPLETED|Open-Label Period||0
6536570|NCT01647516|7458177|FG002|COMPLETED|Open-Label Period||0
6536571|NCT01647516|7458178|FG003|COMPLETED|Open-Label Period||6
6536572|NCT01647516|7458179|FG004|COMPLETED|Open-Label Period||5
6536573|NCT01647516|7458180|FG005|COMPLETED|Open-Label Period||3
6536574|NCT01647516|7458175|FG000|NOT COMPLETED|Open-Label Period||0
6536575|NCT01647516|7458176|FG001|NOT COMPLETED|Open-Label Period||0
6536576|NCT01647516|7458177|FG002|NOT COMPLETED|Open-Label Period||0
6536577|NCT01647516|7458178|FG003|NOT COMPLETED|Open-Label Period||49
6536578|NCT01647516|7458179|FG004|NOT COMPLETED|Open-Label Period||51
6536579|NCT01647516|7458180|FG005|NOT COMPLETED|Open-Label Period||56
6536580|NCT01647542|7458198|FG000|STARTED|Overall Study||131
6536581|NCT01647542|7458199|FG001|STARTED|Overall Study||131
6536582|NCT01647542|7458200|FG002|STARTED|Overall Study||131
6536583|NCT01647542|7458198|FG000|COMPLETED|Overall Study||55
6536584|NCT01647542|7458199|FG001|COMPLETED|Overall Study||58
6536585|NCT01647542|7458200|FG002|COMPLETED|Overall Study||59
6536586|NCT01647542|7458198|FG000|NOT COMPLETED|Overall Study||76
6536587|NCT01647542|7458199|FG001|NOT COMPLETED|Overall Study||73
6536588|NCT01647542|7458200|FG002|NOT COMPLETED|Overall Study||72
6536589|NCT01647581|7458210|FG000|STARTED|Overall Study||547
6536590|NCT01647581|7458211|FG001|STARTED|Overall Study||551
6536591|NCT01647581|7458210|FG000|COMPLETED|Overall Study||530
6536592|NCT01647581|7458211|FG001|COMPLETED|Overall Study||520
6536593|NCT01647581|7458210|FG000|NOT COMPLETED|Overall Study||17
6536594|NCT01647581|7458211|FG001|NOT COMPLETED|Overall Study||31
6536595|NCT01647711|7458222|FG000|STARTED|Overall Study||6
6536596|NCT01647711|7458223|FG001|STARTED|Overall Study||3
6536597|NCT01647711|7458224|FG002|STARTED|Overall Study||9
6536598|NCT01647711|7458225|FG003|STARTED|Overall Study||11
6536599|NCT01647711|7458226|FG004|STARTED|Overall Study||6
6536600|NCT01647711|7458222|FG000|COMPLETED|Overall Study||0
6536601|NCT01647711|7458223|FG001|COMPLETED|Overall Study||0
6645487|NCT02372136|7574453|FG000|STARTED|Overall Study||62
6645488|NCT02372136|7574454|FG001|STARTED|Overall Study||58
6645489|NCT02372136|7574453|FG000|COMPLETED|Overall Study||59
6645490|NCT02372136|7574454|FG001|COMPLETED|Overall Study||57
6645491|NCT02372136|7574453|FG000|NOT COMPLETED|Overall Study||3
6645492|NCT02372136|7574454|FG001|NOT COMPLETED|Overall Study||1
6645493|NCT02372253|7574464|FG000|STARTED|Overall Study||13
6645494|NCT02372253|7574465|FG001|STARTED|Overall Study||13
6645495|NCT02372253|7574464|FG000|COMPLETED|Overall Study||11
6536602|NCT01647711|7458224|FG002|COMPLETED|Overall Study||0
6536603|NCT01647711|7458225|FG003|COMPLETED|Overall Study||0
6536604|NCT01647711|7458226|FG004|COMPLETED|Overall Study||0
6536605|NCT01647711|7458222|FG000|NOT COMPLETED|Overall Study||6
6536606|NCT01647711|7458223|FG001|NOT COMPLETED|Overall Study||3
6536607|NCT01647711|7458224|FG002|NOT COMPLETED|Overall Study||9
6536608|NCT01647711|7458225|FG003|NOT COMPLETED|Overall Study||11
6536609|NCT01647711|7458226|FG004|NOT COMPLETED|Overall Study||6
6536610|NCT01647737|7458242|FG000|STARTED|Overall Study||30
6536611|NCT01647737|7458243|FG001|STARTED|Overall Study||30
6536612|NCT01647737|7458242|FG000|COMPLETED|Overall Study||26
6536613|NCT01647737|7458243|FG001|COMPLETED|Overall Study||25
6645496|NCT02372253|7574465|FG001|COMPLETED|Overall Study||13
6645497|NCT02372253|7574464|FG000|NOT COMPLETED|Overall Study||2
6645498|NCT02372253|7574465|FG001|NOT COMPLETED|Overall Study||0
6645499|NCT02372344|7574473|FG000|STARTED|Period 1 (Visit 2)||14
6645500|NCT02372344|7574474|FG001|STARTED|Period 1 (Visit 2)||14
6645501|NCT02372344|7574475|FG002|STARTED|Period 1 (Visit 2)||14
6645502|NCT02372344|7574473|FG000|COMPLETED|Period 1 (Visit 2)||14
6645503|NCT02372344|7574474|FG001|COMPLETED|Period 1 (Visit 2)||14
6645504|NCT02372344|7574475|FG002|COMPLETED|Period 1 (Visit 2)||14
6645505|NCT02372344|7574473|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
6536614|NCT01647737|7458242|FG000|NOT COMPLETED|Overall Study||4
6536615|NCT01647737|7458243|FG001|NOT COMPLETED|Overall Study||5
6536616|NCT01647945|7458253|FG000|STARTED|Overall Study||6
6536617|NCT01647945|7458254|FG001|STARTED|Overall Study||6
6536618|NCT01647945|7458255|FG002|STARTED|Overall Study||5
6536619|NCT01647945|7458256|FG003|STARTED|Overall Study||6
6536620|NCT01647945|7458253|FG000|COMPLETED|Overall Study||6
6536621|NCT01647945|7458254|FG001|COMPLETED|Overall Study||6
6536622|NCT01647945|7458255|FG002|COMPLETED|Overall Study||3
6536623|NCT01647945|7458256|FG003|COMPLETED|Overall Study||5
6536624|NCT01647945|7458253|FG000|NOT COMPLETED|Overall Study||0
6536625|NCT01647945|7458254|FG001|NOT COMPLETED|Overall Study||0
6536626|NCT01647945|7458255|FG002|NOT COMPLETED|Overall Study||2
6536627|NCT01647945|7458256|FG003|NOT COMPLETED|Overall Study||1
6536628|NCT01647958|7458268|FG000|STARTED|Initial Study||41
6536629|NCT01647958|7458269|FG001|STARTED|Initial Study||24
6536630|NCT01647958|7458268|FG000|COMPLETED|Initial Study||39
6536631|NCT01647958|7458269|FG001|COMPLETED|Initial Study||21
6536632|NCT01647958|7458268|FG000|NOT COMPLETED|Initial Study||2
6536633|NCT01647958|7458269|FG001|NOT COMPLETED|Initial Study||3
6536634|NCT01647958|7458268|FG000|STARTED|Continuation Phase||39
6536635|NCT01647958|7458269|FG001|STARTED|Continuation Phase||21
6536636|NCT01647958|7458268|FG000|COMPLETED|Continuation Phase|Treatment-arm patients received TIF procedure during Initial Study phase|0
6536637|NCT01647958|7458269|FG001|COMPLETED|Continuation Phase|21 Control patients received TIF crossover procedure following 6-month follow-up visit.|21
6536638|NCT01647958|7458268|FG000|NOT COMPLETED|Continuation Phase||39
6536639|NCT01647958|7458269|FG001|NOT COMPLETED|Continuation Phase||0
6536640|NCT01647958|7458268|FG000|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients were combined into 1 cohort for this follow up. 39+21=60|60
6536641|NCT01647958|7458269|FG001|STARTED|Extended Follow-up Phase|Treatment and Control/Crossover patients combined into 1 cohort for this period=60, 0 under Control|0
6536642|NCT01647958|7458268|FG000|COMPLETED|Extended Follow-up Phase|The 8 lost to follow up patients are of the combined Treatment and Control cohort of 52 patients|52
6536643|NCT01647958|7458269|FG001|COMPLETED|Extended Follow-up Phase||0
6536644|NCT01647958|7458268|FG000|NOT COMPLETED|Extended Follow-up Phase||8
6536645|NCT01647958|7458269|FG001|NOT COMPLETED|Extended Follow-up Phase||0
6536646|NCT01648101|7458287|FG000|STARTED|Titration Phase (4 Weeks)||25
6536647|NCT01648101|7458288|FG001|STARTED|Titration Phase (4 Weeks)||26
6536648|NCT01648101|7458289|FG002|STARTED|Titration Phase (4 Weeks)||24
6536649|NCT01648101|7458287|FG000|COMPLETED|Titration Phase (4 Weeks)||23
6536650|NCT01648101|7458288|FG001|COMPLETED|Titration Phase (4 Weeks)||23
6645506|NCT02372344|7574474|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
6536651|NCT01648101|7458289|FG002|COMPLETED|Titration Phase (4 Weeks)||18
6536652|NCT01648101|7458287|FG000|NOT COMPLETED|Titration Phase (4 Weeks)||2
6536653|NCT01648101|7458288|FG001|NOT COMPLETED|Titration Phase (4 Weeks)||3
6536654|NCT01648101|7458289|FG002|NOT COMPLETED|Titration Phase (4 Weeks)||6
6536655|NCT01648101|7458287|FG000|STARTED|Maintenance Phase (12 Weeks)||23
6536656|NCT01648101|7458288|FG001|STARTED|Maintenance Phase (12 Weeks)||23
6536657|NCT01648101|7458289|FG002|STARTED|Maintenance Phase (12 Weeks)||18
6536658|NCT01648101|7458287|FG000|COMPLETED|Maintenance Phase (12 Weeks)||20
6536659|NCT01648101|7458288|FG001|COMPLETED|Maintenance Phase (12 Weeks)||20
6536660|NCT01648101|7458289|FG002|COMPLETED|Maintenance Phase (12 Weeks)||12
6536661|NCT01648101|7458287|FG000|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
6536662|NCT01648101|7458288|FG001|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
6536663|NCT01648101|7458289|FG002|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
6536664|NCT01648101|7458287|FG000|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
6536665|NCT01648101|7458288|FG001|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
6536666|NCT01648101|7458289|FG002|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
6536667|NCT01648101|7458287|FG000|COMPLETED|Transition Phase (4 Weeks)||12
6536668|NCT01648101|7458288|FG001|COMPLETED|Transition Phase (4 Weeks)||13
6536669|NCT01648101|7458289|FG002|COMPLETED|Transition Phase (4 Weeks)||5
6536670|NCT01648101|7458287|FG000|NOT COMPLETED|Transition Phase (4 Weeks)||5
6536671|NCT01648101|7458288|FG001|NOT COMPLETED|Transition Phase (4 Weeks)||5
6536672|NCT01648101|7458289|FG002|NOT COMPLETED|Transition Phase (4 Weeks)||4
6536673|NCT01648101|7458287|FG000|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
6536674|NCT01648101|7458288|FG001|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
6536675|NCT01648101|7458289|FG002|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
6536676|NCT01648101|7458287|FG000|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
6536677|NCT01648101|7458288|FG001|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
6536678|NCT01648101|7458289|FG002|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
6536679|NCT01648101|7458287|FG000|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
6536680|NCT01648101|7458288|FG001|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
6536681|NCT01648101|7458289|FG002|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
6536682|NCT01648140|7458305|FG000|STARTED|Overall Study||41
6536683|NCT01648140|7458306|FG001|STARTED|Overall Study||40
6536684|NCT01648140|7458307|FG002|STARTED|Overall Study||17
6536685|NCT01648140|7458308|FG003|STARTED|Overall Study||13
6536686|NCT01648140|7458305|FG000|COMPLETED|Overall Study||29
6536687|NCT01648140|7458306|FG001|COMPLETED|Overall Study||28
6536688|NCT01648140|7458307|FG002|COMPLETED|Overall Study||9
6536689|NCT01648140|7458308|FG003|COMPLETED|Overall Study||11
6536690|NCT01648140|7458305|FG000|NOT COMPLETED|Overall Study||12
6536691|NCT01648140|7458306|FG001|NOT COMPLETED|Overall Study||12
6536692|NCT01648140|7458307|FG002|NOT COMPLETED|Overall Study||8
6536693|NCT01648140|7458308|FG003|NOT COMPLETED|Overall Study||2
6536694|NCT01648166|7458329|FG000|STARTED|Overall Study||153
6536695|NCT01648166|7458330|FG001|STARTED|Overall Study||367
6536696|NCT01648166|7458329|FG000|COMPLETED|Overall Study||100
6536697|NCT01648166|7458330|FG001|COMPLETED|Overall Study||267
6536698|NCT01648166|7458329|FG000|NOT COMPLETED|Overall Study||53
6536699|NCT01648166|7458330|FG001|NOT COMPLETED|Overall Study||100
6536700|NCT01648283|7458336|FG000|STARTED|Overall Study||78
6536701|NCT01648283|7458336|FG000|COMPLETED|Overall Study||64
6536702|NCT01648283|7458336|FG000|NOT COMPLETED|Overall Study||14
6536703|NCT01648322|7458346|FG000|STARTED|Overall Study||35
6536704|NCT01648322|7458347|FG001|STARTED|Overall Study||67
6536705|NCT01648322|7458348|FG002|STARTED|Overall Study||65
6536706|NCT01648322|7458349|FG003|STARTED|Overall Study||65
6536707|NCT01648322|7458346|FG000|COMPLETED|Overall Study||33
6536708|NCT01648322|7458347|FG001|COMPLETED|Overall Study||62
6536709|NCT01648322|7458348|FG002|COMPLETED|Overall Study||60
6536710|NCT01648322|7458349|FG003|COMPLETED|Overall Study||61
6536711|NCT01648322|7458346|FG000|NOT COMPLETED|Overall Study||2
6536712|NCT01648322|7458347|FG001|NOT COMPLETED|Overall Study||5
6536713|NCT01648322|7458348|FG002|NOT COMPLETED|Overall Study||5
6536714|NCT01648322|7458349|FG003|NOT COMPLETED|Overall Study||4
6536715|NCT01648348|7458378|FG000|STARTED|Overall Study||5
6536716|NCT01648348|7458379|FG001|STARTED|Overall Study||3
6536717|NCT01648348|7458380|FG002|STARTED|Overall Study||4
6536718|NCT01648348|7458381|FG003|STARTED|Overall Study||3
6536719|NCT01648348|7458382|FG004|STARTED|Overall Study||52
6536720|NCT01648348|7458383|FG005|STARTED|Overall Study||49
6536721|NCT01648348|7458378|FG000|COMPLETED|Overall Study||3
6536722|NCT01648348|7458379|FG001|COMPLETED|Overall Study||3
6536723|NCT01648348|7458380|FG002|COMPLETED|Overall Study||3
6536724|NCT01648348|7458381|FG003|COMPLETED|Overall Study||3
6536725|NCT01648348|7458382|FG004|COMPLETED|Overall Study||49
6536726|NCT01648348|7458383|FG005|COMPLETED|Overall Study||43
6536727|NCT01648348|7458378|FG000|NOT COMPLETED|Overall Study||2
6536728|NCT01648348|7458379|FG001|NOT COMPLETED|Overall Study||0
6536729|NCT01648348|7458380|FG002|NOT COMPLETED|Overall Study||1
6536730|NCT01648348|7458381|FG003|NOT COMPLETED|Overall Study||0
6536731|NCT01648348|7458382|FG004|NOT COMPLETED|Overall Study||3
6536732|NCT01648348|7458383|FG005|NOT COMPLETED|Overall Study||6
6536733|NCT01648452|7458396|FG000|STARTED|Overall Study||5
6536734|NCT01648452|7458396|FG000|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
6536735|NCT01648452|7458396|FG000|NOT COMPLETED|Overall Study||0
6536736|NCT01648491|7458402|FG000|STARTED|Overall Study||1
6536737|NCT01648491|7458402|FG000|COMPLETED|Overall Study||1
6536738|NCT01648491|7458402|FG000|NOT COMPLETED|Overall Study||0
6536739|NCT01648530|7458407|FG000|STARTED|Overall Study||16789
6536740|NCT01648530|7458407|FG000|COMPLETED|Overall Study||5915
6536741|NCT01648530|7458407|FG000|NOT COMPLETED|Overall Study||10874
6536742|NCT01648582|7458416|FG000|STARTED|Overall Study||258
6536743|NCT01648582|7458417|FG001|STARTED|Overall Study||257
6536744|NCT01648582|7458418|FG002|STARTED|Overall Study||259
6536745|NCT01648582|7458416|FG000|Received at Least One Dose of Study Drug|Overall Study||258
6536746|NCT01648582|7458417|FG001|Received at Least One Dose of Study Drug|Overall Study||257
6536747|NCT01648582|7458418|FG002|Received at Least One Dose of Study Drug|Overall Study||259
6536748|NCT01648582|7458416|FG000|Modified Intent-to-Treat Population|Overall Study||253
6536749|NCT01648582|7458417|FG001|Modified Intent-to-Treat Population|Overall Study||252
6536750|NCT01648582|7458418|FG002|Modified Intent-to-Treat Population|Overall Study||250
6536751|NCT01648582|7458416|FG000|COMPLETED|Overall Study||226
6536752|NCT01648582|7458417|FG001|COMPLETED|Overall Study||219
6536753|NCT01648582|7458418|FG002|COMPLETED|Overall Study||227
6536754|NCT01648582|7458416|FG000|NOT COMPLETED|Overall Study||32
6536755|NCT01648582|7458417|FG001|NOT COMPLETED|Overall Study||38
6536756|NCT01648582|7458418|FG002|NOT COMPLETED|Overall Study||32
6536757|NCT01648699|7458429|FG000|STARTED|Overall Study||20
6536758|NCT01648699|7458429|FG000|COMPLETED|Overall Study||15
6536759|NCT01648699|7458429|FG000|NOT COMPLETED|Overall Study||5
6536760|NCT01648764|7458456|FG000|STARTED|Overall Study||3
6536761|NCT01648764|7458457|FG001|STARTED|Overall Study||3
6536762|NCT01648764|7458458|FG002|STARTED|Overall Study||3
6536763|NCT01648764|7458459|FG003|STARTED|Overall Study||3
6536764|NCT01648764|7458460|FG004|STARTED|Overall Study||3
6536765|NCT01648764|7458461|FG005|STARTED|Overall Study||5
6536766|NCT01648764|7458462|FG006|STARTED|Overall Study||9
6536767|NCT01648764|7458463|FG007|STARTED|Overall Study||3
6536768|NCT01648764|7458464|FG008|STARTED|Overall Study||3
6536769|NCT01648764|7458465|FG009|STARTED|Overall Study||7
6536770|NCT01648764|7458466|FG010|STARTED|Overall Study||3
6536771|NCT01648764|7458467|FG011|STARTED|Overall Study||9
6536772|NCT01648764|7458468|FG012|STARTED|Overall Study||7
6536773|NCT01648764|7458469|FG013|STARTED|Overall Study||12
6536774|NCT01648764|7458456|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6536775|NCT01648764|7458457|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6536776|NCT01648764|7458458|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6536777|NCT01648764|7458459|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6536778|NCT01648764|7458460|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
6536779|NCT01648764|7458461|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
6536780|NCT01648764|7458462|FG006|Received at Least 1 Dose of Study Drug|Overall Study||9
6536781|NCT01648764|7458463|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
6536782|NCT01648764|7458464|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
6536783|NCT01648764|7458465|FG009|Received at Least 1 Dose of Study Drug|Overall Study||7
6536784|NCT01648764|7458466|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
6536785|NCT01648764|7458467|FG011|Received at Least 1 Dose of Study Drug|Overall Study||9
6536786|NCT01648764|7458468|FG012|Received at Least 1 Dose of Study Drug|Overall Study||7
6536787|NCT01648764|7458469|FG013|Received at Least 1 Dose of Study Drug|Overall Study||12
6536788|NCT01648764|7458456|FG000|COMPLETED|Overall Study||3
6536789|NCT01648764|7458457|FG001|COMPLETED|Overall Study||2
6536790|NCT01648764|7458458|FG002|COMPLETED|Overall Study||3
6536791|NCT01648764|7458459|FG003|COMPLETED|Overall Study||3
6536792|NCT01648764|7458460|FG004|COMPLETED|Overall Study||3
6536793|NCT01648764|7458461|FG005|COMPLETED|Overall Study||3
6536794|NCT01648764|7458462|FG006|COMPLETED|Overall Study||4
6536795|NCT01648764|7458463|FG007|COMPLETED|Overall Study||3
6536796|NCT01648764|7458464|FG008|COMPLETED|Overall Study||3
6536797|NCT01648764|7458465|FG009|COMPLETED|Overall Study||4
6536798|NCT01648764|7458466|FG010|COMPLETED|Overall Study||3
6536799|NCT01648764|7458467|FG011|COMPLETED|Overall Study||4
6536800|NCT01648764|7458468|FG012|COMPLETED|Overall Study||3
6536801|NCT01648764|7458469|FG013|COMPLETED|Overall Study||9
6536802|NCT01648764|7458456|FG000|NOT COMPLETED|Overall Study||0
6536803|NCT01648764|7458457|FG001|NOT COMPLETED|Overall Study||1
6536804|NCT01648764|7458458|FG002|NOT COMPLETED|Overall Study||0
6536805|NCT01648764|7458459|FG003|NOT COMPLETED|Overall Study||0
6536806|NCT01648764|7458460|FG004|NOT COMPLETED|Overall Study||0
6536807|NCT01648764|7458461|FG005|NOT COMPLETED|Overall Study||2
6536808|NCT01648764|7458462|FG006|NOT COMPLETED|Overall Study||5
6536809|NCT01648764|7458463|FG007|NOT COMPLETED|Overall Study||0
6536810|NCT01648764|7458464|FG008|NOT COMPLETED|Overall Study||0
6536811|NCT01648764|7458465|FG009|NOT COMPLETED|Overall Study||3
6536812|NCT01648764|7458466|FG010|NOT COMPLETED|Overall Study||0
6536813|NCT01648764|7458467|FG011|NOT COMPLETED|Overall Study||5
6536814|NCT01648764|7458468|FG012|NOT COMPLETED|Overall Study||4
6536815|NCT01648764|7458469|FG013|NOT COMPLETED|Overall Study||3
6536816|NCT01648790|7458503|FG000|STARTED|Treatment 1||4
6536817|NCT01648790|7458504|FG001|STARTED|Treatment 1||4
6536818|NCT01648790|7458505|FG002|STARTED|Treatment 1||4
6536819|NCT01648790|7458506|FG003|STARTED|Treatment 1||4
6536820|NCT01648790|7458507|FG004|STARTED|Treatment 1||4
6536821|NCT01648790|7458503|FG000|Received at Least 1 Dose of Study Drug|Treatment 1||4
6536822|NCT01648790|7458504|FG001|Received at Least 1 Dose of Study Drug|Treatment 1||4
6536823|NCT01648790|7458505|FG002|Received at Least 1 Dose of Study Drug|Treatment 1||4
6536824|NCT01648790|7458506|FG003|Received at Least 1 Dose of Study Drug|Treatment 1||4
6536825|NCT01648790|7458507|FG004|Received at Least 1 Dose of Study Drug|Treatment 1||4
6536826|NCT01648790|7458503|FG000|COMPLETED|Treatment 1||4
6536827|NCT01648790|7458504|FG001|COMPLETED|Treatment 1||4
6536828|NCT01648790|7458505|FG002|COMPLETED|Treatment 1||4
6536829|NCT01648790|7458506|FG003|COMPLETED|Treatment 1||4
6536830|NCT01648790|7458507|FG004|COMPLETED|Treatment 1||4
6536831|NCT01648790|7458503|FG000|NOT COMPLETED|Treatment 1||0
6536832|NCT01648790|7458504|FG001|NOT COMPLETED|Treatment 1||0
6536833|NCT01648790|7458505|FG002|NOT COMPLETED|Treatment 1||0
6536834|NCT01648790|7458506|FG003|NOT COMPLETED|Treatment 1||0
6536835|NCT01648790|7458507|FG004|NOT COMPLETED|Treatment 1||0
6536836|NCT01648790|7458503|FG000|STARTED|Treatment 2||4
6536837|NCT01648790|7458504|FG001|STARTED|Treatment 2||4
6536838|NCT01648790|7458505|FG002|STARTED|Treatment 2||4
6536839|NCT01648790|7458506|FG003|STARTED|Treatment 2||4
6536840|NCT01648790|7458507|FG004|STARTED|Treatment 2||4
6536841|NCT01648790|7458503|FG000|COMPLETED|Treatment 2||4
6536842|NCT01648790|7458504|FG001|COMPLETED|Treatment 2||4
6536843|NCT01648790|7458505|FG002|COMPLETED|Treatment 2||4
6536844|NCT01648790|7458506|FG003|COMPLETED|Treatment 2||4
6536845|NCT01648790|7458507|FG004|COMPLETED|Treatment 2||4
6536846|NCT01648790|7458503|FG000|NOT COMPLETED|Treatment 2||0
6536847|NCT01648790|7458504|FG001|NOT COMPLETED|Treatment 2||0
6536848|NCT01648790|7458505|FG002|NOT COMPLETED|Treatment 2||0
6536849|NCT01648790|7458506|FG003|NOT COMPLETED|Treatment 2||0
6536850|NCT01648790|7458507|FG004|NOT COMPLETED|Treatment 2||0
6536851|NCT01648790|7458503|FG000|STARTED|Treatment 3||4
6536852|NCT01648790|7458504|FG001|STARTED|Treatment 3||4
6536853|NCT01648790|7458505|FG002|STARTED|Treatment 3||4
6536854|NCT01648790|7458506|FG003|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
6536855|NCT01648790|7458507|FG004|STARTED|Treatment 3||4
6536856|NCT01648790|7458503|FG000|COMPLETED|Treatment 3||4
6536857|NCT01648790|7458504|FG001|COMPLETED|Treatment 3||4
6536858|NCT01648790|7458505|FG002|COMPLETED|Treatment 3||4
6536859|NCT01648790|7458506|FG003|COMPLETED|Treatment 3||3
6536860|NCT01648790|7458507|FG004|COMPLETED|Treatment 3||4
6536861|NCT01648790|7458503|FG000|NOT COMPLETED|Treatment 3||0
6536862|NCT01648790|7458504|FG001|NOT COMPLETED|Treatment 3||0
6536863|NCT01648790|7458505|FG002|NOT COMPLETED|Treatment 3||0
6536864|NCT01648790|7458506|FG003|NOT COMPLETED|Treatment 3||1
6536865|NCT01648790|7458507|FG004|NOT COMPLETED|Treatment 3||0
6536866|NCT01648790|7458503|FG000|STARTED|Treatment 4||4
6536867|NCT01648790|7458504|FG001|STARTED|Treatment 4||4
6536868|NCT01648790|7458505|FG002|STARTED|Treatment 4||4
6536869|NCT01648790|7458506|FG003|STARTED|Treatment 4||3
6536870|NCT01648790|7458507|FG004|STARTED|Treatment 4||4
6536871|NCT01648790|7458503|FG000|COMPLETED|Treatment 4||4
6536872|NCT01648790|7458504|FG001|COMPLETED|Treatment 4||4
6536873|NCT01648790|7458505|FG002|COMPLETED|Treatment 4||4
6536874|NCT01648790|7458506|FG003|COMPLETED|Treatment 4||3
6536875|NCT01648790|7458507|FG004|COMPLETED|Treatment 4||4
6536876|NCT01648790|7458503|FG000|NOT COMPLETED|Treatment 4||0
6536877|NCT01648790|7458504|FG001|NOT COMPLETED|Treatment 4||0
6536878|NCT01648790|7458505|FG002|NOT COMPLETED|Treatment 4||0
6536879|NCT01648790|7458506|FG003|NOT COMPLETED|Treatment 4||0
6536880|NCT01648790|7458507|FG004|NOT COMPLETED|Treatment 4||0
6536881|NCT01648790|7458503|FG000|STARTED|Treatment 5||4
6536882|NCT01648790|7458504|FG001|STARTED|Treatment 5||4
6536883|NCT01648790|7458505|FG002|STARTED|Treatment 5||4
6536884|NCT01648790|7458506|FG003|STARTED|Treatment 5||3
6536885|NCT01648790|7458507|FG004|STARTED|Treatment 5||4
6536886|NCT01648790|7458503|FG000|COMPLETED|Treatment 5||4
6536887|NCT01648790|7458504|FG001|COMPLETED|Treatment 5||4
6536888|NCT01648790|7458505|FG002|COMPLETED|Treatment 5||4
6536889|NCT01648790|7458506|FG003|COMPLETED|Treatment 5||3
6536890|NCT01648790|7458507|FG004|COMPLETED|Treatment 5||4
6536891|NCT01648790|7458503|FG000|NOT COMPLETED|Treatment 5||0
6536892|NCT01648790|7458504|FG001|NOT COMPLETED|Treatment 5||0
6536893|NCT01648790|7458505|FG002|NOT COMPLETED|Treatment 5||0
6536894|NCT01648790|7458506|FG003|NOT COMPLETED|Treatment 5||0
6536895|NCT01648790|7458507|FG004|NOT COMPLETED|Treatment 5||0
6536896|NCT01648920|7458519|FG000|STARTED|Overall Study||50
6536897|NCT01648920|7458519|FG000|COMPLETED|Overall Study||50
6536898|NCT01648920|7458519|FG000|NOT COMPLETED|Overall Study||0
6536899|NCT01648959|7458523|FG000|STARTED|Overall Study||5
6536900|NCT01648959|7458523|FG000|COMPLETED|Overall Study||5
6536901|NCT01648959|7458523|FG000|NOT COMPLETED|Overall Study||0
6536902|NCT01649180|7458527|FG000|STARTED|Overall Study||3
6536903|NCT01649180|7458527|FG000|COMPLETED|Overall Study||3
6536904|NCT01649180|7458527|FG000|NOT COMPLETED|Overall Study||0
6536905|NCT01649232|7458533|FG000|STARTED|Overall Study||30
6536906|NCT01649232|7458534|FG001|STARTED|Overall Study||30
6536907|NCT01649232|7458533|FG000|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
6536908|NCT01649232|7458534|FG001|COMPLETED|Overall Study||30
6536909|NCT01649232|7458533|FG000|NOT COMPLETED|Overall Study||2
6536910|NCT01649232|7458534|FG001|NOT COMPLETED|Overall Study||0
6536911|NCT01649271|7458548|FG000|STARTED|Overall Study||6
6536912|NCT01649271|7458549|FG001|STARTED|Overall Study||7
6536913|NCT01649271|7458548|FG000|COMPLETED|Overall Study||0
6536914|NCT01649271|7458549|FG001|COMPLETED|Overall Study||0
6536915|NCT01649271|7458548|FG000|NOT COMPLETED|Overall Study||6
6536916|NCT01649271|7458549|FG001|NOT COMPLETED|Overall Study||7
6536917|NCT01649297|7458561|FG000|STARTED|Overall Study|randomised|219
6536918|NCT01649297|7458562|FG001|STARTED|Overall Study|randomised|218
6536919|NCT01649297|7458563|FG002|STARTED|Overall Study|randomised|219
6536920|NCT01649297|7458564|FG003|STARTED|Overall Study|randomised|220
6536921|NCT01649297|7458565|FG004|STARTED|Overall Study|randomised|107
6536922|NCT01649297|7458561|FG000|COMPLETED|Overall Study||205
6536923|NCT01649297|7458562|FG001|COMPLETED|Overall Study||205
6536924|NCT01649297|7458563|FG002|COMPLETED|Overall Study||202
6536925|NCT01649297|7458564|FG003|COMPLETED|Overall Study||201
6536926|NCT01649297|7458565|FG004|COMPLETED|Overall Study||103
6536927|NCT01649297|7458561|FG000|NOT COMPLETED|Overall Study||14
6536928|NCT01649297|7458562|FG001|NOT COMPLETED|Overall Study||13
6536929|NCT01649297|7458563|FG002|NOT COMPLETED|Overall Study||17
6536930|NCT01649297|7458564|FG003|NOT COMPLETED|Overall Study||19
6536931|NCT01649297|7458565|FG004|NOT COMPLETED|Overall Study||4
6536932|NCT01649362|7458579|FG000|STARTED|Overall Study||47
6536933|NCT01649362|7458580|FG001|STARTED|Overall Study||54
6536934|NCT01649362|7458579|FG000|COMPLETED|Overall Study||46
6536935|NCT01649362|7458580|FG001|COMPLETED|Overall Study||40
6536936|NCT01649362|7458579|FG000|NOT COMPLETED|Overall Study||1
6536937|NCT01649362|7458580|FG001|NOT COMPLETED|Overall Study||14
6536938|NCT01649375|7458589|FG000|STARTED|Up to Week 16||73
6536939|NCT01649375|7458590|FG001|STARTED|Up to Week 16||72
6536940|NCT01649375|7458591|FG002|STARTED|Up to Week 16||74
6536941|NCT01649375|7458592|FG003|STARTED|Up to Week 16||0
6536942|NCT01649375|7458593|FG004|STARTED|Up to Week 16||0
6536943|NCT01649375|7458589|FG000|COMPLETED|Up to Week 16||68
6536944|NCT01649375|7458590|FG001|COMPLETED|Up to Week 16||66
6536945|NCT01649375|7458591|FG002|COMPLETED|Up to Week 16||66
6536946|NCT01649375|7458592|FG003|COMPLETED|Up to Week 16||0
6536947|NCT01649375|7458593|FG004|COMPLETED|Up to Week 16||0
6536948|NCT01649375|7458589|FG000|NOT COMPLETED|Up to Week 16||5
6536949|NCT01649375|7458590|FG001|NOT COMPLETED|Up to Week 16||6
6536950|NCT01649375|7458591|FG002|NOT COMPLETED|Up to Week 16||8
6536951|NCT01649375|7458592|FG003|NOT COMPLETED|Up to Week 16||0
6536952|NCT01649375|7458593|FG004|NOT COMPLETED|Up to Week 16||0
6536953|NCT01649375|7458589|FG000|STARTED|Week 16 up to Week 260||68
6536954|NCT01649375|7458590|FG001|STARTED|Week 16 up to Week 260||66
6536955|NCT01649375|7458591|FG002|STARTED|Week 16 up to Week 260||0
6536956|NCT01649375|7458592|FG003|STARTED|Week 16 up to Week 260||32
6536957|NCT01649375|7458593|FG004|STARTED|Week 16 up to Week 260||34
6536958|NCT01649375|7458589|FG000|COMPLETED|Week 16 up to Week 260||48
6536959|NCT01649375|7458590|FG001|COMPLETED|Week 16 up to Week 260||53
6536960|NCT01649375|7458591|FG002|COMPLETED|Week 16 up to Week 260||0
6536961|NCT01649375|7458592|FG003|COMPLETED|Week 16 up to Week 260||20
6536962|NCT01649375|7458593|FG004|COMPLETED|Week 16 up to Week 260||29
6536963|NCT01649375|7458589|FG000|NOT COMPLETED|Week 16 up to Week 260||20
6536964|NCT01649375|7458590|FG001|NOT COMPLETED|Week 16 up to Week 260||13
6536965|NCT01649375|7458591|FG002|NOT COMPLETED|Week 16 up to Week 260||0
6536966|NCT01649375|7458592|FG003|NOT COMPLETED|Week 16 up to Week 260||12
6536967|NCT01649375|7458593|FG004|NOT COMPLETED|Week 16 up to Week 260||5
6536968|NCT01649427|7458603|FG000|STARTED|Overall Study||35
6536969|NCT01649427|7458604|FG001|STARTED|Overall Study||38
6536970|NCT01649427|7458603|FG000|COMPLETED|Overall Study||24
6536971|NCT01649427|7458604|FG001|COMPLETED|Overall Study||26
6536972|NCT01649427|7458603|FG000|NOT COMPLETED|Overall Study||11
6536973|NCT01649427|7458604|FG001|NOT COMPLETED|Overall Study||12
6536974|NCT01649557|7458613|FG000|STARTED|Overall Study||179
6536975|NCT01649557|7458614|FG001|STARTED|Overall Study||41
6536976|NCT01649557|7458615|FG002|STARTED|Overall Study||24
6536977|NCT01649557|7458613|FG000|6-week Enrollers|Overall Study||159
6536978|NCT01649557|7458614|FG001|6-week Enrollers|Overall Study||35
6536979|NCT01649557|7458615|FG002|6-week Enrollers|Overall Study||22
6536980|NCT01649557|7458613|FG000|52-week Enrollers|Overall Study||20
6536981|NCT01649557|7458614|FG001|52-week Enrollers|Overall Study||6
6536982|NCT01649557|7458615|FG002|52-week Enrollers|Overall Study||2
6536983|NCT01649557|7458613|FG000|COMPLETED|Overall Study||135
6536984|NCT01649557|7458614|FG001|COMPLETED|Overall Study||27
6536985|NCT01649557|7458615|FG002|COMPLETED|Overall Study||15
6536986|NCT01649557|7458613|FG000|NOT COMPLETED|Overall Study||44
6536987|NCT01649557|7458614|FG001|NOT COMPLETED|Overall Study||14
6536988|NCT01649557|7458615|FG002|NOT COMPLETED|Overall Study||9
6536989|NCT01649596|7458625|FG000|STARTED|Overall Study||46
6536990|NCT01649596|7458626|FG001|STARTED|Overall Study||48
6536991|NCT01649596|7458625|FG000|COMPLETED|Overall Study||46
6536992|NCT01649596|7458626|FG001|COMPLETED|Overall Study||48
6536993|NCT01649596|7458625|FG000|NOT COMPLETED|Overall Study||0
6536994|NCT01649596|7458626|FG001|NOT COMPLETED|Overall Study||0
6536995|NCT01649609|7458634|FG000|STARTED|Overall Study||20
6536996|NCT01649609|7458635|FG001|STARTED|Overall Study||20
6536997|NCT01649609|7458634|FG000|COMPLETED|Overall Study||20
6536998|NCT01649609|7458635|FG001|COMPLETED|Overall Study||20
6536999|NCT01649609|7458634|FG000|NOT COMPLETED|Overall Study||0
6537000|NCT01649609|7458635|FG001|NOT COMPLETED|Overall Study||0
6537001|NCT01649765|7458643|FG000|STARTED|Overall Study||40
6537002|NCT01649765|7458644|FG001|STARTED|Overall Study||53
6537003|NCT01649765|7458643|FG000|COMPLETED|Overall Study||31
6537004|NCT01649765|7458644|FG001|COMPLETED|Overall Study||45
6537005|NCT01649765|7458643|FG000|NOT COMPLETED|Overall Study||9
6537006|NCT01649765|7458644|FG001|NOT COMPLETED|Overall Study||8
6537007|NCT01649791|7458651|FG000|STARTED|Overall Study||8
6537008|NCT01649791|7458651|FG000|COMPLETED|Overall Study||5
6537009|NCT01649791|7458651|FG000|NOT COMPLETED|Overall Study||3
6537010|NCT01649804|7458655|FG000|STARTED|Overall Study||12
6537011|NCT01649804|7458655|FG000|COMPLETED|Overall Study||4
6537012|NCT01649804|7458655|FG000|NOT COMPLETED|Overall Study||8
6537013|NCT01649856|7458661|FG000|STARTED|Overall Study||369
6537014|NCT01649856|7458662|FG001|STARTED|Overall Study||203
6537015|NCT01649856|7458661|FG000|COMPLETED|Overall Study||230
6537016|NCT01649856|7458662|FG001|COMPLETED|Overall Study||125
6537017|NCT01649856|7458661|FG000|NOT COMPLETED|Overall Study||139
6537018|NCT01649856|7458662|FG001|NOT COMPLETED|Overall Study||78
6537019|NCT01649869|7458670|FG000|STARTED|Overall Study||18
6537020|NCT01649869|7458671|FG001|STARTED|Overall Study||17
6537021|NCT01649869|7458670|FG000|COMPLETED|Overall Study||16
6537022|NCT01649869|7458671|FG001|COMPLETED|Overall Study||16
6537023|NCT01649869|7458670|FG000|NOT COMPLETED|Overall Study||2
6537024|NCT01649869|7458671|FG001|NOT COMPLETED|Overall Study||1
6537025|NCT01649947|7458681|FG000|STARTED|Overall Study||12
6537026|NCT01649947|7458682|FG001|STARTED|Overall Study||20
6537027|NCT01649947|7458681|FG000|COMPLETED|Overall Study||0
6537028|NCT01649947|7458682|FG001|COMPLETED|Overall Study||2
6537029|NCT01649947|7458681|FG000|NOT COMPLETED|Overall Study||12
6537030|NCT01649947|7458682|FG001|NOT COMPLETED|Overall Study||18
6537031|NCT01650194|7458689|FG000|STARTED|Overall Study||60
6537032|NCT01650194|7458689|FG000|Treated|Overall Study||60
6537033|NCT01650194|7458689|FG000|COMPLETED|Overall Study||13
6537034|NCT01650194|7458689|FG000|NOT COMPLETED|Overall Study||47
6537035|NCT01650246|7458694|FG000|STARTED|Overall Study||143
6537036|NCT01650246|7458694|FG000|COMPLETED|Overall Study||0
6537037|NCT01650246|7458694|FG000|NOT COMPLETED|Overall Study||143
6537038|NCT01650259|7458700|FG000|STARTED|Overall Study|Started are the registered patients|2513
6537039|NCT01650259|7458701|FG001|STARTED|Overall Study|Started are the registered patients|2363
6537040|NCT01650259|7458700|FG000|COMPLETED|Overall Study||1470
6537041|NCT01650259|7458701|FG001|COMPLETED|Overall Study||2128
6537042|NCT01650259|7458700|FG000|NOT COMPLETED|Overall Study||1043
6537043|NCT01650259|7458701|FG001|NOT COMPLETED|Overall Study||235
6537044|NCT01650298|7458707|FG000|STARTED|Overall Study||16
6537045|NCT01650298|7458708|FG001|STARTED|Overall Study||48
6537046|NCT01650298|7458707|FG000|COMPLETED|Overall Study||11
6537047|NCT01650298|7458708|FG001|COMPLETED|Overall Study||42
6537048|NCT01650298|7458707|FG000|NOT COMPLETED|Overall Study||5
6537049|NCT01650298|7458708|FG001|NOT COMPLETED|Overall Study||6
6537050|NCT01650324|7458719|FG000|STARTED|Overall Study||8
6537051|NCT01650324|7458720|FG001|STARTED|Overall Study||6
6537052|NCT01650324|7458721|FG002|STARTED|Overall Study||6
6537053|NCT01650324|7458722|FG003|STARTED|Overall Study||6
6537054|NCT01650324|7458723|FG004|STARTED|Overall Study||6
6537055|NCT01650324|7458719|FG000|COMPLETED|Overall Study||8
6537056|NCT01650324|7458720|FG001|COMPLETED|Overall Study||6
6537057|NCT01650324|7458721|FG002|COMPLETED|Overall Study||6
6537058|NCT01650324|7458722|FG003|COMPLETED|Overall Study||6
6537059|NCT01650324|7458723|FG004|COMPLETED|Overall Study||6
6537060|NCT01650324|7458719|FG000|NOT COMPLETED|Overall Study||0
6537061|NCT01650324|7458720|FG001|NOT COMPLETED|Overall Study||0
6537062|NCT01650324|7458721|FG002|NOT COMPLETED|Overall Study||0
6537063|NCT01650324|7458722|FG003|NOT COMPLETED|Overall Study||0
6537064|NCT01650324|7458723|FG004|NOT COMPLETED|Overall Study||0
6537065|NCT01650402|7458742|FG000|STARTED|Overall Study||99
6537066|NCT01650402|7458743|FG001|STARTED|Overall Study||100
6537067|NCT01650402|7458742|FG000|COMPLETED|Overall Study||79
6537068|NCT01650402|7458743|FG001|COMPLETED|Overall Study||86
6537069|NCT01650402|7458742|FG000|NOT COMPLETED|Overall Study||20
6537070|NCT01650402|7458743|FG001|NOT COMPLETED|Overall Study||14
6537071|NCT01650519|7458751|FG000|STARTED|Overall Study||20
6537072|NCT01650519|7458752|FG001|STARTED|Overall Study||31
6537073|NCT01650519|7458751|FG000|COMPLETED|Overall Study||19
6537074|NCT01650519|7458752|FG001|COMPLETED|Overall Study||31
6537075|NCT01650519|7458751|FG000|NOT COMPLETED|Overall Study||1
6537076|NCT01650519|7458752|FG001|NOT COMPLETED|Overall Study||0
6537077|NCT01650545|7458760|FG000|STARTED|Overall Study||11
6537078|NCT01650545|7458761|FG001|STARTED|Overall Study||10
6537079|NCT01650545|7458760|FG000|COMPLETED|Overall Study||11
6537080|NCT01650545|7458761|FG001|COMPLETED|Overall Study||10
6537081|NCT01650545|7458760|FG000|NOT COMPLETED|Overall Study||0
6537082|NCT01650545|7458761|FG001|NOT COMPLETED|Overall Study||0
6537083|NCT01650558|7458772|FG000|STARTED|Overall Study||500
6537084|NCT01650558|7458773|FG001|STARTED|Overall Study||500
6537085|NCT01650558|7458774|FG002|STARTED|Overall Study||499
6537086|NCT01650558|7458772|FG000|COMPLETED|Overall Study||417
6537087|NCT01650558|7458773|FG001|COMPLETED|Overall Study||408
6537088|NCT01650558|7458774|FG002|COMPLETED|Overall Study||424
6537089|NCT01650558|7458772|FG000|NOT COMPLETED|Overall Study||83
6537090|NCT01650558|7458773|FG001|NOT COMPLETED|Overall Study||92
6537091|NCT01650558|7458774|FG002|NOT COMPLETED|Overall Study||75
6537092|NCT01650584|7458785|FG000|STARTED|Overall Study|Each participant received one of 2 treatments in each eye.|35
6537093|NCT01650584|7458785|FG000|COMPLETED|Overall Study||35
6537094|NCT01650584|7458785|FG000|NOT COMPLETED|Overall Study||0
6537095|NCT01650636|7458792|FG000|STARTED|Intervention Phase||150
6537096|NCT01650636|7458793|FG001|STARTED|Intervention Phase||150
6537097|NCT01650636|7458792|FG000|COMPLETED|Intervention Phase||150
6537098|NCT01650636|7458793|FG001|COMPLETED|Intervention Phase||150
6537099|NCT01650636|7458792|FG000|NOT COMPLETED|Intervention Phase||0
6537100|NCT01650636|7458793|FG001|NOT COMPLETED|Intervention Phase||0
6537101|NCT01650636|7458792|FG000|STARTED|Washout up to 5 Months||150
6537102|NCT01650636|7458793|FG001|STARTED|Washout up to 5 Months||150
6537103|NCT01650636|7458792|FG000|COMPLETED|Washout up to 5 Months||141
6537104|NCT01650636|7458793|FG001|COMPLETED|Washout up to 5 Months||132
6537105|NCT01650636|7458792|FG000|NOT COMPLETED|Washout up to 5 Months||9
6537106|NCT01650636|7458793|FG001|NOT COMPLETED|Washout up to 5 Months||18
6537107|NCT01650636|7458792|FG000|STARTED|5 Month Visit||141
6537108|NCT01650636|7458793|FG001|STARTED|5 Month Visit||132
6537109|NCT01650636|7458792|FG000|COMPLETED|5 Month Visit||141
6537110|NCT01650636|7458793|FG001|COMPLETED|5 Month Visit||132
6537111|NCT01650636|7458792|FG000|NOT COMPLETED|5 Month Visit||0
6537112|NCT01650636|7458793|FG001|NOT COMPLETED|5 Month Visit||0
6537113|NCT01650636|7458792|FG000|STARTED|Washout up to 9 Months||141
6537114|NCT01650636|7458793|FG001|STARTED|Washout up to 9 Months||132
6537115|NCT01650636|7458792|FG000|COMPLETED|Washout up to 9 Months||135
6537116|NCT01650636|7458793|FG001|COMPLETED|Washout up to 9 Months||129
6537117|NCT01650636|7458792|FG000|NOT COMPLETED|Washout up to 9 Months||6
6537118|NCT01650636|7458793|FG001|NOT COMPLETED|Washout up to 9 Months||3
6537119|NCT01650636|7458792|FG000|STARTED|9 Month Visit||135
6537120|NCT01650636|7458793|FG001|STARTED|9 Month Visit||129
6537121|NCT01650636|7458792|FG000|COMPLETED|9 Month Visit||135
6537122|NCT01650636|7458793|FG001|COMPLETED|9 Month Visit||129
6537123|NCT01650636|7458792|FG000|NOT COMPLETED|9 Month Visit||0
6537124|NCT01650636|7458793|FG001|NOT COMPLETED|9 Month Visit||0
6537125|NCT01650779|7458799|FG000|STARTED|Overall Study||15
6537126|NCT01650779|7458799|FG000|COMPLETED|Overall Study||14
6537127|NCT01650779|7458799|FG000|NOT COMPLETED|Overall Study||1
6537128|NCT01650805|7458805|FG000|STARTED|Overall Study|Started means patient has been randomized.|155
6537129|NCT01650805|7458806|FG001|STARTED|Overall Study||152
6537130|NCT01650805|7458805|FG000|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
6537131|NCT01650805|7458806|FG001|COMPLETED|Overall Study||152
6537132|NCT01650805|7458805|FG000|NOT COMPLETED|Overall Study||1
6537133|NCT01650805|7458806|FG001|NOT COMPLETED|Overall Study||0
6537134|NCT01650831|7458812|FG000|STARTED|Overall Study||113
6537135|NCT01650831|7458812|FG000|COMPLETED|Overall Study||112
6537136|NCT01650831|7458812|FG000|NOT COMPLETED|Overall Study||1
6537137|NCT01650844|7458822|FG000|STARTED|Overall Study||200
6537138|NCT01650844|7458823|FG001|STARTED|Overall Study||200
6537139|NCT01650844|7458822|FG000|COMPLETED|Overall Study||199
6537140|NCT01650844|7458823|FG001|COMPLETED|Overall Study||196
6537141|NCT01650844|7458822|FG000|NOT COMPLETED|Overall Study||1
6537142|NCT01650844|7458823|FG001|NOT COMPLETED|Overall Study||4
6537143|NCT01651000|7458831|FG000|STARTED|Overall Study||72
6537144|NCT01651000|7458832|FG001|STARTED|Overall Study||141
6537145|NCT01651000|7458831|FG000|Entered Extension Study|Overall Study||50
6537146|NCT01651000|7458832|FG001|Entered Extension Study|Overall Study||93
6537147|NCT01651000|7458831|FG000|COMPLETED|Overall Study||62
6537148|NCT01651000|7458832|FG001|COMPLETED|Overall Study||113
6537149|NCT01651000|7458831|FG000|NOT COMPLETED|Overall Study||10
6537150|NCT01651000|7458832|FG001|NOT COMPLETED|Overall Study||28
6537151|NCT01651039|7458838|FG000|STARTED|Overall Study||32
6537152|NCT01651039|7458838|FG000|COMPLETED|Overall Study||2
6537153|NCT01651039|7458838|FG000|NOT COMPLETED|Overall Study||30
6537154|NCT01651052|7458842|FG000|STARTED|Overall Study||133
6537155|NCT01651052|7458842|FG000|Study Valve Group|Overall Study||133
6537156|NCT01651052|7458842|FG000|COMPLETED|Overall Study||107
6537157|NCT01651052|7458842|FG000|NOT COMPLETED|Overall Study||26
6537158|NCT01651078|7458846|FG000|STARTED|Overall Study|Two (2) out of 44 patients were enrolled but did not go on to have the NeuroBlate Procedure.|42
6537159|NCT01651078|7458846|FG000|COMPLETED|Overall Study||16
6537160|NCT01651078|7458846|FG000|NOT COMPLETED|Overall Study||26
6537161|NCT01651104|7458850|FG000|STARTED|Overall Study||63
6537162|NCT01651104|7458850|FG000|COMPLETED|Overall Study||63
6537163|NCT01651104|7458850|FG000|NOT COMPLETED|Overall Study||0
6537164|NCT01651117|7458858|FG000|STARTED|Overall Study||156
6537165|NCT01651117|7458859|FG001|STARTED|Overall Study||205
6537166|NCT01651117|7458860|FG002|STARTED|Overall Study||49
6537167|NCT01651117|7458861|FG003|STARTED|Overall Study||70
6537168|NCT01651117|7458858|FG000|COMPLETED|Overall Study||154
6537169|NCT01651117|7458859|FG001|COMPLETED|Overall Study||202
6537170|NCT01651117|7458860|FG002|COMPLETED|Overall Study||47
6537171|NCT01651117|7458861|FG003|COMPLETED|Overall Study||68
6537172|NCT01651117|7458858|FG000|NOT COMPLETED|Overall Study||2
6537173|NCT01651117|7458859|FG001|NOT COMPLETED|Overall Study||3
6537174|NCT01651117|7458860|FG002|NOT COMPLETED|Overall Study||2
6537175|NCT01651117|7458861|FG003|NOT COMPLETED|Overall Study||2
6537176|NCT01651195|7458878|FG000|STARTED|Overall Study||284
6537177|NCT01651195|7458879|FG001|STARTED|Overall Study||284
6537178|NCT01651195|7458880|FG002|STARTED|Overall Study||204
6537179|NCT01651195|7458881|FG003|STARTED|Overall Study||211
6537180|NCT01651195|7458878|FG000|COMPLETED|Overall Study||63
6537181|NCT01651195|7458879|FG001|COMPLETED|Overall Study||73
6537182|NCT01651195|7458880|FG002|COMPLETED|Overall Study||121
6537183|NCT01651195|7458881|FG003|COMPLETED|Overall Study||103
6537184|NCT01651195|7458878|FG000|NOT COMPLETED|Overall Study||221
6537185|NCT01651195|7458879|FG001|NOT COMPLETED|Overall Study||211
6537186|NCT01651195|7458880|FG002|NOT COMPLETED|Overall Study||83
6537187|NCT01651195|7458881|FG003|NOT COMPLETED|Overall Study||108
6537188|NCT01651208|7458897|FG000|STARTED|Overall Study||227
6537189|NCT01651208|7458898|FG001|STARTED|Overall Study||225
6537190|NCT01651208|7458897|FG000|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
6537191|NCT01651208|7458898|FG001|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
6537192|NCT01651208|7458897|FG000|NOT COMPLETED|Overall Study||14
6537193|NCT01651208|7458898|FG001|NOT COMPLETED|Overall Study||16
6537194|NCT01651260|7458905|FG000|STARTED|Overall Study||65
6537195|NCT01651260|7458905|FG000|COMPLETED|Overall Study||62
6537196|NCT01651260|7458905|FG000|NOT COMPLETED|Overall Study||3
6537197|NCT01651351|7458912|FG000|STARTED|Overall Study||15
6537198|NCT01651351|7458913|FG001|STARTED|Overall Study||15
6537199|NCT01651351|7458912|FG000|COMPLETED|Overall Study||15
6537200|NCT01651351|7458913|FG001|COMPLETED|Overall Study||15
6537201|NCT01651351|7458912|FG000|NOT COMPLETED|Overall Study||0
6537202|NCT01651351|7458913|FG001|NOT COMPLETED|Overall Study||0
6537203|NCT01651442|7458922|FG000|STARTED|Phase I Treatment||104
6537204|NCT01651442|7458923|FG001|STARTED|Phase I Treatment||107
6537205|NCT01651442|7458924|FG002|STARTED|Phase I Treatment||0
6537206|NCT01651442|7458925|FG003|STARTED|Phase I Treatment||0
6537207|NCT01651442|7458926|FG004|STARTED|Phase I Treatment||0
6537208|NCT01651442|7458927|FG005|STARTED|Phase I Treatment||0
6537209|NCT01651442|7458922|FG000|COMPLETED|Phase I Treatment||88
6537210|NCT01651442|7458923|FG001|COMPLETED|Phase I Treatment||80
6537211|NCT01651442|7458924|FG002|COMPLETED|Phase I Treatment||0
6537212|NCT01651442|7458925|FG003|COMPLETED|Phase I Treatment||0
6537213|NCT01651442|7458926|FG004|COMPLETED|Phase I Treatment||0
6537214|NCT01651442|7458927|FG005|COMPLETED|Phase I Treatment||0
6537215|NCT01651442|7458922|FG000|NOT COMPLETED|Phase I Treatment||16
6537216|NCT01651442|7458923|FG001|NOT COMPLETED|Phase I Treatment||27
6537217|NCT01651442|7458924|FG002|NOT COMPLETED|Phase I Treatment||0
6537218|NCT01651442|7458925|FG003|NOT COMPLETED|Phase I Treatment||0
6537219|NCT01651442|7458926|FG004|NOT COMPLETED|Phase I Treatment||0
6537220|NCT01651442|7458927|FG005|NOT COMPLETED|Phase I Treatment||0
6537221|NCT01651442|7458922|FG000|STARTED|Phase II Treatment||0
6537222|NCT01651442|7458923|FG001|STARTED|Phase II Treatment||0
6537223|NCT01651442|7458924|FG002|STARTED|Phase II Treatment||27
6537224|NCT01651442|7458925|FG003|STARTED|Phase II Treatment||27
6537225|NCT01651442|7458926|FG004|STARTED|Phase II Treatment||27
6537226|NCT01651442|7458927|FG005|STARTED|Phase II Treatment||27
6537227|NCT01651442|7458922|FG000|COMPLETED|Phase II Treatment||0
6537228|NCT01651442|7458923|FG001|COMPLETED|Phase II Treatment||0
6537229|NCT01651442|7458924|FG002|COMPLETED|Phase II Treatment||25
6537230|NCT01651442|7458925|FG003|COMPLETED|Phase II Treatment||15
6537231|NCT01651442|7458926|FG004|COMPLETED|Phase II Treatment||21
6537232|NCT01651442|7458927|FG005|COMPLETED|Phase II Treatment||17
6537233|NCT01651442|7458922|FG000|NOT COMPLETED|Phase II Treatment||0
6537234|NCT01651442|7458923|FG001|NOT COMPLETED|Phase II Treatment||0
6537235|NCT01651442|7458924|FG002|NOT COMPLETED|Phase II Treatment||2
6537236|NCT01651442|7458925|FG003|NOT COMPLETED|Phase II Treatment||12
6537237|NCT01651442|7458926|FG004|NOT COMPLETED|Phase II Treatment||6
6537238|NCT01651442|7458927|FG005|NOT COMPLETED|Phase II Treatment||10
6537239|NCT01651780|7458941|FG000|STARTED|Overall Study||405
6537240|NCT01651780|7458942|FG001|STARTED|Overall Study||398
6537241|NCT01651780|7458941|FG000|Intent-To-Treat (ITT) Population|Overall Study||404
6537242|NCT01651780|7458942|FG001|Intent-To-Treat (ITT) Population|Overall Study||398
6537243|NCT01651780|7458941|FG000|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
6537244|NCT01651780|7458942|FG001|Received at Least 1 Dose of Study Drug|Overall Study||394
6537245|NCT01651780|7458941|FG000|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
6537246|NCT01651780|7458942|FG001|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
6537247|NCT01651780|7458941|FG000|COMPLETED|Overall Study||394
6537248|NCT01651780|7458942|FG001|COMPLETED|Overall Study||388
6537249|NCT01651780|7458941|FG000|NOT COMPLETED|Overall Study||11
6537250|NCT01651780|7458942|FG001|NOT COMPLETED|Overall Study||10
6537251|NCT01651793|7458952|FG000|STARTED|Overall Study||6
6537252|NCT01651793|7458953|FG001|STARTED|Overall Study||6
6537253|NCT01651793|7458954|FG002|STARTED|Overall Study||6
6537254|NCT01651793|7458955|FG003|STARTED|Overall Study||6
6537255|NCT01651793|7458952|FG000|COMPLETED|Overall Study||6
6537256|NCT01651793|7458953|FG001|COMPLETED|Overall Study||6
6537257|NCT01651793|7458954|FG002|COMPLETED|Overall Study||6
6537258|NCT01651793|7458955|FG003|COMPLETED|Overall Study||5
6537259|NCT01651793|7458952|FG000|NOT COMPLETED|Overall Study||0
6537260|NCT01651793|7458953|FG001|NOT COMPLETED|Overall Study||0
6537261|NCT01651793|7458954|FG002|NOT COMPLETED|Overall Study||0
6537262|NCT01651793|7458955|FG003|NOT COMPLETED|Overall Study||1
6537263|NCT01651806|7458974|FG000|STARTED|Overall Study||13
6537264|NCT01651806|7458975|FG001|STARTED|Overall Study||12
6537265|NCT01651806|7458976|FG002|STARTED|Overall Study||25
6537266|NCT01651806|7458977|FG003|STARTED|Overall Study||7
6537267|NCT01651806|7458978|FG004|STARTED|Overall Study||8
6537268|NCT01651806|7458974|FG000|COMPLETED|Overall Study||13
6537269|NCT01651806|7458975|FG001|COMPLETED|Overall Study||12
6537270|NCT01651806|7458976|FG002|COMPLETED|Overall Study||25
6537271|NCT01651806|7458977|FG003|COMPLETED|Overall Study||7
6537272|NCT01651806|7458978|FG004|COMPLETED|Overall Study||8
6537273|NCT01651806|7458974|FG000|NOT COMPLETED|Overall Study||0
6537274|NCT01651806|7458975|FG001|NOT COMPLETED|Overall Study||0
6537275|NCT01651806|7458976|FG002|NOT COMPLETED|Overall Study||0
6537276|NCT01651806|7458977|FG003|NOT COMPLETED|Overall Study||0
6537277|NCT01651806|7458978|FG004|NOT COMPLETED|Overall Study||0
6537278|NCT01651936|7458993|FG000|STARTED|Base Study||30
6537279|NCT01651936|7458994|FG001|STARTED|Base Study||26
6537280|NCT01651936|7458995|FG002|STARTED|Base Study||0
6537281|NCT01651936|7458993|FG000|COMPLETED|Base Study||3
6537282|NCT01651936|7458994|FG001|COMPLETED|Base Study||1
6537283|NCT01651936|7458995|FG002|COMPLETED|Base Study||0
6537284|NCT01651936|7458993|FG000|NOT COMPLETED|Base Study||27
6537285|NCT01651936|7458994|FG001|NOT COMPLETED|Base Study||25
6537286|NCT01651936|7458995|FG002|NOT COMPLETED|Base Study||0
6537287|NCT01651936|7458993|FG000|STARTED|Extension Study||0
6537288|NCT01651936|7458994|FG001|STARTED|Extension Study||0
6537289|NCT01651936|7458995|FG002|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
6537290|NCT01651936|7458993|FG000|COMPLETED|Extension Study||0
6537291|NCT01651936|7458994|FG001|COMPLETED|Extension Study||0
6537292|NCT01651936|7458995|FG002|COMPLETED|Extension Study||0
6537293|NCT01651936|7458993|FG000|NOT COMPLETED|Extension Study||0
6537294|NCT01651936|7458994|FG001|NOT COMPLETED|Extension Study||0
6537295|NCT01651936|7458995|FG002|NOT COMPLETED|Extension Study||14
6645507|NCT02372344|7574475|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
6645508|NCT02372344|7574473|FG000|STARTED|Period 2 (Visit 3)||14
6645509|NCT02372344|7574474|FG001|STARTED|Period 2 (Visit 3)||14
6645510|NCT02372344|7574475|FG002|STARTED|Period 2 (Visit 3)||14
6645511|NCT02372344|7574473|FG000|COMPLETED|Period 2 (Visit 3)||14
6537296|NCT01651949|7459005|FG000|STARTED|Overall Study||1106
6537297|NCT01651949|7459006|FG001|STARTED|Overall Study||1101
6537298|NCT01651949|7459007|FG002|STARTED|Overall Study||313
6537299|NCT01651949|7459005|FG000|Vaccination 1|Overall Study||1103
6537300|NCT01651949|7459006|FG001|Vaccination 1|Overall Study||1099
6537301|NCT01651949|7459007|FG002|Vaccination 1|Overall Study||313
6537302|NCT01651949|7459005|FG000|Vaccination 2|Overall Study||1089
6537303|NCT01651949|7459006|FG001|Vaccination 2|Overall Study||1069
6537304|NCT01651949|7459007|FG002|Vaccination 2|Overall Study||298
6537305|NCT01651949|7459005|FG000|Vaccination 3|Overall Study||1067
6537306|NCT01651949|7459006|FG001|Vaccination 3|Overall Study||1037
6537307|NCT01651949|7459007|FG002|Vaccination 3|Overall Study||291
6537308|NCT01651949|7459005|FG000|COMPLETED|Overall Study||1053
6537309|NCT01651949|7459006|FG001|COMPLETED|Overall Study||1015
6537310|NCT01651949|7459007|FG002|COMPLETED|Overall Study||282
6537311|NCT01651949|7459005|FG000|NOT COMPLETED|Overall Study||53
6537312|NCT01651949|7459006|FG001|NOT COMPLETED|Overall Study||86
6537313|NCT01651949|7459007|FG002|NOT COMPLETED|Overall Study||31
6537314|NCT01652001|7459017|FG000|STARTED|Overall Study||100
6537315|NCT01652001|7459018|FG001|STARTED|Overall Study||85
6537316|NCT01652001|7459017|FG000|COMPLETED|Overall Study||91
6537317|NCT01652001|7459018|FG001|COMPLETED|Overall Study||79
6537318|NCT01652001|7459017|FG000|NOT COMPLETED|Overall Study||9
6537319|NCT01652001|7459018|FG001|NOT COMPLETED|Overall Study||6
6537320|NCT01652040|7459026|FG000|STARTED|Overall Study||13
6537321|NCT01652040|7459027|FG001|STARTED|Overall Study||13
6537322|NCT01652040|7459026|FG000|COMPLETED|Overall Study||11
6537323|NCT01652040|7459027|FG001|COMPLETED|Overall Study||11
6537324|NCT01652040|7459026|FG000|NOT COMPLETED|Overall Study||2
6537325|NCT01652040|7459027|FG001|NOT COMPLETED|Overall Study||2
6537326|NCT01652287|7459036|FG000|STARTED|Overall Study||31
6537327|NCT01652287|7459037|FG001|STARTED|Overall Study||31
6537328|NCT01652287|7459036|FG000|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
6537329|NCT01652287|7459037|FG001|COMPLETED|Overall Study||31
6537330|NCT01652287|7459036|FG000|NOT COMPLETED|Overall Study||2
6537331|NCT01652287|7459037|FG001|NOT COMPLETED|Overall Study||0
6537332|NCT01652469|7459045|FG000|STARTED|Overall Study||38
6537333|NCT01652469|7459046|FG001|STARTED|Overall Study||42
6537334|NCT01652469|7459045|FG000|COMPLETED|Overall Study||37
6537335|NCT01652469|7459046|FG001|COMPLETED|Overall Study||36
6537336|NCT01652469|7459045|FG000|NOT COMPLETED|Overall Study||1
6537337|NCT01652469|7459046|FG001|NOT COMPLETED|Overall Study||6
6537338|NCT01652495|7459054|FG000|STARTED|Overall Study||22
6537339|NCT01652495|7459055|FG001|STARTED|Overall Study||22
6537340|NCT01652495|7459054|FG000|COMPLETED|Overall Study||20
6537341|NCT01652495|7459055|FG001|COMPLETED|Overall Study||20
6537342|NCT01652495|7459054|FG000|NOT COMPLETED|Overall Study||2
6537343|NCT01652495|7459055|FG001|NOT COMPLETED|Overall Study||2
6537344|NCT01652573|7459065|FG000|STARTED|Overall Study||10
6537345|NCT01652573|7459066|FG001|STARTED|Overall Study||11
6537346|NCT01652573|7459065|FG000|COMPLETED|Overall Study||10
6537347|NCT01652573|7459066|FG001|COMPLETED|Overall Study||10
6537348|NCT01652573|7459065|FG000|NOT COMPLETED|Overall Study||0
6537349|NCT01652573|7459066|FG001|NOT COMPLETED|Overall Study||1
6537350|NCT01652664|7459074|FG000|STARTED|Overall Study||77
6537351|NCT01652664|7459075|FG001|STARTED|Overall Study||75
6537352|NCT01652664|7459074|FG000|COMPLETED|Overall Study||71
6537353|NCT01652664|7459075|FG001|COMPLETED|Overall Study||74
6537354|NCT01652664|7459074|FG000|NOT COMPLETED|Overall Study||6
6537355|NCT01652664|7459075|FG001|NOT COMPLETED|Overall Study||1
6537356|NCT01652690|7459084|FG000|STARTED|Overall Study||300
6537357|NCT01652690|7459085|FG001|STARTED|Overall Study||300
6537358|NCT01652690|7459084|FG000|COMPLETED|Overall Study||265
6537359|NCT01652690|7459085|FG001|COMPLETED|Overall Study||279
6537360|NCT01652690|7459084|FG000|NOT COMPLETED|Overall Study||35
6537361|NCT01652690|7459085|FG001|NOT COMPLETED|Overall Study||21
6537362|NCT01652703|7459097|FG000|STARTED|Overall Study||52
6537363|NCT01652703|7459098|FG001|STARTED|Overall Study||51
6537364|NCT01652703|7459099|FG002|STARTED|Overall Study||50
6537365|NCT01652703|7459100|FG003|STARTED|Overall Study||52
6537366|NCT01652703|7459101|FG004|STARTED|Overall Study||52
6537367|NCT01652703|7459102|FG005|STARTED|Overall Study||53
6537368|NCT01652703|7459097|FG000|Received Treatment|Overall Study||52
6537369|NCT01652703|7459098|FG001|Received Treatment|Overall Study||50
6537370|NCT01652703|7459099|FG002|Received Treatment|Overall Study||49
6537371|NCT01652703|7459100|FG003|Received Treatment|Overall Study||52
6537372|NCT01652703|7459101|FG004|Received Treatment|Overall Study||51
6537373|NCT01652703|7459102|FG005|Received Treatment|Overall Study||53
6537374|NCT01652703|7459097|FG000|COMPLETED|Overall Study||52
6537375|NCT01652703|7459098|FG001|COMPLETED|Overall Study||50
6537376|NCT01652703|7459099|FG002|COMPLETED|Overall Study||47
6537377|NCT01652703|7459100|FG003|COMPLETED|Overall Study||50
6537378|NCT01652703|7459101|FG004|COMPLETED|Overall Study||51
6537379|NCT01652703|7459102|FG005|COMPLETED|Overall Study||51
6537380|NCT01652703|7459097|FG000|NOT COMPLETED|Overall Study||0
6537381|NCT01652703|7459098|FG001|NOT COMPLETED|Overall Study||1
6537382|NCT01652703|7459099|FG002|NOT COMPLETED|Overall Study||3
6537383|NCT01652703|7459100|FG003|NOT COMPLETED|Overall Study||2
6537384|NCT01652703|7459101|FG004|NOT COMPLETED|Overall Study||1
6537385|NCT01652703|7459102|FG005|NOT COMPLETED|Overall Study||2
6537386|NCT01652716|7459118|FG000|STARTED|Overall Study||229
6537387|NCT01652716|7459119|FG001|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
6537388|NCT01652716|7459118|FG000|Completed 28-week|Overall Study||197
6537389|NCT01652716|7459119|FG001|Completed 28-week|Overall Study||118
6537390|NCT01652716|7459118|FG000|COMPLETED|Overall Study|* completed study|173
6537391|NCT01652716|7459119|FG001|COMPLETED|Overall Study|* completed study|102
6537392|NCT01652716|7459118|FG000|NOT COMPLETED|Overall Study||56
6537393|NCT01652716|7459119|FG001|NOT COMPLETED|Overall Study||46
6537394|NCT01652729|7459128|FG000|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
6537395|NCT01652729|7459129|FG001|STARTED|Overall Study||122
6537396|NCT01652729|7459130|FG002|STARTED|Overall Study||61
6537397|NCT01652729|7459128|FG000|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
6537398|NCT01652729|7459129|FG001|Modified Intent-to-Treat|Overall Study||122
6537399|NCT01652729|7459130|FG002|Modified Intent-to-Treat|Overall Study||61
6537400|NCT01652729|7459128|FG000|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
6537401|NCT01652729|7459129|FG001|Treated|Overall Study||122
6537402|NCT01652729|7459130|FG002|Treated|Overall Study||61
6537403|NCT01652729|7459128|FG000|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
6537404|NCT01652729|7459129|FG001|Evaluable|Overall Study||91
6537405|NCT01652729|7459130|FG002|Evaluable|Overall Study||43
6537406|NCT01652729|7459128|FG000|Meal Test Subjects|Overall Study||60
6537407|NCT01652729|7459129|FG001|Meal Test Subjects|Overall Study||41
6537408|NCT01652729|7459130|FG002|Meal Test Subjects|Overall Study||20
6537409|NCT01652729|7459128|FG000|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
6537410|NCT01652729|7459129|FG001|Meal Test Evaluable|Overall Study||31
6537411|NCT01652729|7459130|FG002|Meal Test Evaluable|Overall Study||15
6537412|NCT01652729|7459128|FG000|COMPLETED|Overall Study|The double-enrolled subject's reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
6537413|NCT01652729|7459129|FG001|COMPLETED|Overall Study||109
6537414|NCT01652729|7459130|FG002|COMPLETED|Overall Study||47
6537415|NCT01652729|7459128|FG000|NOT COMPLETED|Overall Study||27
6537416|NCT01652729|7459129|FG001|NOT COMPLETED|Overall Study||13
6537417|NCT01652729|7459130|FG002|NOT COMPLETED|Overall Study||14
6537418|NCT01652872|7459140|FG000|STARTED|Overall Study||377
6645512|NCT02372344|7574474|FG001|COMPLETED|Period 2 (Visit 3)||14
6645513|NCT02372344|7574475|FG002|COMPLETED|Period 2 (Visit 3)||14
6645514|NCT02372344|7574473|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
6645515|NCT02372344|7574474|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
6645516|NCT02372344|7574475|FG002|NOT COMPLETED|Period 2 (Visit 3)||0
6537419|NCT01652872|7459141|FG001|STARTED|Overall Study||379
6537420|NCT01652872|7459140|FG000|Received Investigational Product|Overall Study||377
6537421|NCT01652872|7459141|FG001|Received Investigational Product|Overall Study||377
6537422|NCT01652872|7459140|FG000|COMPLETED|Overall Study||232
6537423|NCT01652872|7459141|FG001|COMPLETED|Overall Study||226
6537424|NCT01652872|7459140|FG000|NOT COMPLETED|Overall Study||145
6537425|NCT01652872|7459141|FG001|NOT COMPLETED|Overall Study||153
6537426|NCT01652885|7459147|FG000|STARTED|Overall Study||23
6537427|NCT01652885|7459147|FG000|COMPLETED|Overall Study||22
6537428|NCT01652885|7459147|FG000|NOT COMPLETED|Overall Study||1
6537429|NCT01652976|7459151|FG000|STARTED|Overall Study||44
6537430|NCT01652976|7459151|FG000|COMPLETED|Overall Study||44
6537431|NCT01652976|7459151|FG000|NOT COMPLETED|Overall Study||0
6537432|NCT01653028|7459160|FG000|STARTED|Overall Study||12
6537433|NCT01653028|7459161|FG001|STARTED|Overall Study||10
6537434|NCT01653028|7459162|FG002|STARTED|Overall Study||11
6537435|NCT01653028|7459163|FG003|STARTED|Overall Study||10
6537436|NCT01653028|7459164|FG004|STARTED|Overall Study||29
6537437|NCT01653028|7459160|FG000|COMPLETED|Overall Study||12
6537438|NCT01653028|7459161|FG001|COMPLETED|Overall Study||10
6537439|NCT01653028|7459162|FG002|COMPLETED|Overall Study||11
6537440|NCT01653028|7459163|FG003|COMPLETED|Overall Study||10
6537441|NCT01653028|7459164|FG004|COMPLETED|Overall Study||29
6537442|NCT01653028|7459160|FG000|NOT COMPLETED|Overall Study||0
6537443|NCT01653028|7459161|FG001|NOT COMPLETED|Overall Study||0
6537444|NCT01653028|7459162|FG002|NOT COMPLETED|Overall Study||0
6537445|NCT01653028|7459163|FG003|NOT COMPLETED|Overall Study||0
6537446|NCT01653028|7459164|FG004|NOT COMPLETED|Overall Study||0
6537447|NCT01653132|7459176|FG000|STARTED|First Intervention||5
6537448|NCT01653132|7459177|FG001|STARTED|First Intervention||5
6537449|NCT01653132|7459176|FG000|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
6537450|NCT01653132|7459177|FG001|COMPLETED|First Intervention||5
6537451|NCT01653132|7459176|FG000|NOT COMPLETED|First Intervention||1
6537452|NCT01653132|7459177|FG001|NOT COMPLETED|First Intervention||0
6537453|NCT01653132|7459176|FG000|STARTED|Washout 1-2 Months||4
6537454|NCT01653132|7459177|FG001|STARTED|Washout 1-2 Months||5
6537455|NCT01653132|7459176|FG000|COMPLETED|Washout 1-2 Months||4
6537456|NCT01653132|7459177|FG001|COMPLETED|Washout 1-2 Months||5
6537457|NCT01653132|7459176|FG000|NOT COMPLETED|Washout 1-2 Months||0
6537458|NCT01653132|7459177|FG001|NOT COMPLETED|Washout 1-2 Months||0
6537459|NCT01653132|7459176|FG000|STARTED|Second Intervention||4
6537460|NCT01653132|7459177|FG001|STARTED|Second Intervention||5
6537461|NCT01653132|7459176|FG000|COMPLETED|Second Intervention||4
6537462|NCT01653132|7459177|FG001|COMPLETED|Second Intervention||5
6537463|NCT01653132|7459176|FG000|NOT COMPLETED|Second Intervention||0
6537464|NCT01653132|7459177|FG001|NOT COMPLETED|Second Intervention||0
6537465|NCT01653158|7459187|FG000|STARTED|Overall Study||3
6537466|NCT01653158|7459188|FG001|STARTED|Overall Study||3
6537467|NCT01653158|7459189|FG002|STARTED|Overall Study||3
6537468|NCT01653158|7459190|FG003|STARTED|Overall Study||3
6645517|NCT02372344|7574473|FG000|STARTED|Period 3 (Visit 4)||14
6645518|NCT02372344|7574474|FG001|STARTED|Period 3 (Visit 4)||14
6645519|NCT02372344|7574475|FG002|STARTED|Period 3 (Visit 4)||14
6645520|NCT02372344|7574473|FG000|COMPLETED|Period 3 (Visit 4)||14
6537469|NCT01653158|7459191|FG004|STARTED|Overall Study||3
6537470|NCT01653158|7459192|FG005|STARTED|Overall Study||3
6537471|NCT01653158|7459193|FG006|STARTED|Overall Study||9
6537472|NCT01653158|7459194|FG007|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
6537473|NCT01653158|7459187|FG000|COMPLETED|Overall Study||2
6537474|NCT01653158|7459188|FG001|COMPLETED|Overall Study||3
6537475|NCT01653158|7459189|FG002|COMPLETED|Overall Study||3
6537476|NCT01653158|7459190|FG003|COMPLETED|Overall Study||1
6537477|NCT01653158|7459191|FG004|COMPLETED|Overall Study||2
6537478|NCT01653158|7459192|FG005|COMPLETED|Overall Study||2
6537479|NCT01653158|7459193|FG006|COMPLETED|Overall Study||7
6537480|NCT01653158|7459194|FG007|COMPLETED|Overall Study||4
6537481|NCT01653158|7459187|FG000|NOT COMPLETED|Overall Study||1
6537482|NCT01653158|7459188|FG001|NOT COMPLETED|Overall Study||0
6537483|NCT01653158|7459189|FG002|NOT COMPLETED|Overall Study||0
6537484|NCT01653158|7459190|FG003|NOT COMPLETED|Overall Study||2
6537485|NCT01653158|7459191|FG004|NOT COMPLETED|Overall Study||1
6537486|NCT01653158|7459192|FG005|NOT COMPLETED|Overall Study||1
6537487|NCT01653158|7459193|FG006|NOT COMPLETED|Overall Study||2
6537488|NCT01653158|7459194|FG007|NOT COMPLETED|Overall Study||15
6537489|NCT01653210|7459217|FG000|STARTED|Overall Study||15
6537490|NCT01653210|7459217|FG000|COMPLETED|Overall Study||12
6537491|NCT01653210|7459217|FG000|NOT COMPLETED|Overall Study||3
6537492|NCT01653262|7459221|FG000|STARTED|Overall Study||29
6537493|NCT01653262|7459221|FG000|COMPLETED|Overall Study||26
6537494|NCT01653262|7459221|FG000|NOT COMPLETED|Overall Study||3
6537495|NCT01653288|7459227|FG000|STARTED|Overall Study||36
6537496|NCT01653288|7459228|FG001|STARTED|Overall Study||36
6537497|NCT01653288|7459227|FG000|COMPLETED|Overall Study||26
6537498|NCT01653288|7459228|FG001|COMPLETED|Overall Study||35
6537499|NCT01653288|7459227|FG000|NOT COMPLETED|Overall Study||10
6537500|NCT01653288|7459228|FG001|NOT COMPLETED|Overall Study||1
6537501|NCT01653327|7459236|FG000|STARTED|Overall Study||11
6645521|NCT02372344|7574474|FG001|COMPLETED|Period 3 (Visit 4)||14
6537502|NCT01653327|7459236|FG000|COMPLETED|Overall Study||10
6537503|NCT01653327|7459236|FG000|NOT COMPLETED|Overall Study||1
6537504|NCT01653405|7459244|FG000|STARTED|Overall Study||11794
6537505|NCT01653405|7459245|FG001|STARTED|Overall Study||1248782
6645522|NCT02372344|7574475|FG002|COMPLETED|Period 3 (Visit 4)||14
6537506|NCT01653405|7459244|FG000|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|8029
6537507|NCT01653405|7459245|FG001|COMPLETED|Overall Study|These patients had enough data to calculate TTR.|179979
6537508|NCT01653405|7459244|FG000|NOT COMPLETED|Overall Study||3765
6537509|NCT01653405|7459245|FG001|NOT COMPLETED|Overall Study||1068803
6537510|NCT01653418|7459251|FG000|STARTED|Overall Study||10
6537511|NCT01653418|7459251|FG000|COMPLETED|Overall Study||10
6537512|NCT01653418|7459251|FG000|NOT COMPLETED|Overall Study||0
6537513|NCT01653509|7459257|FG000|STARTED|Overall Study||12
6645523|NCT02372344|7574473|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
6537514|NCT01653509|7459258|FG001|STARTED|Overall Study||13
6537515|NCT01653509|7459257|FG000|COMPLETED|Overall Study||12
6537516|NCT01653509|7459258|FG001|COMPLETED|Overall Study||13
6537517|NCT01653509|7459257|FG000|NOT COMPLETED|Overall Study||0
6537518|NCT01653509|7459258|FG001|NOT COMPLETED|Overall Study||0
6537519|NCT01653587|7459268|FG000|STARTED|Overall Study||120
6537520|NCT01653587|7459269|FG001|STARTED|Overall Study||120
6537521|NCT01653587|7459268|FG000|COMPLETED|Overall Study||120
6537522|NCT01653587|7459269|FG001|COMPLETED|Overall Study||120
6537523|NCT01653587|7459268|FG000|NOT COMPLETED|Overall Study||0
6537524|NCT01653587|7459269|FG001|NOT COMPLETED|Overall Study||0
6537525|NCT01653704|7459277|FG000|STARTED|Overall Study||21
6537526|NCT01653704|7459278|FG001|STARTED|Overall Study||21
6537527|NCT01653704|7459277|FG000|COMPLETED|Overall Study||19
6537528|NCT01653704|7459278|FG001|COMPLETED|Overall Study||20
6537529|NCT01653704|7459277|FG000|NOT COMPLETED|Overall Study||2
6537530|NCT01653704|7459278|FG001|NOT COMPLETED|Overall Study||1
6537531|NCT01653743|7459286|FG000|STARTED|Overall Study||54
6537532|NCT01653743|7459287|FG001|STARTED|Overall Study||27
6537533|NCT01653743|7459286|FG000|COMPLETED|Overall Study||50
6537534|NCT01653743|7459287|FG001|COMPLETED|Overall Study||27
6537535|NCT01653743|7459286|FG000|NOT COMPLETED|Overall Study||4
6537536|NCT01653743|7459287|FG001|NOT COMPLETED|Overall Study||0
6537537|NCT01653782|7459296|FG000|STARTED|Overall Study||52
6537538|NCT01653782|7459297|FG001|STARTED|Overall Study||55
6537539|NCT01653782|7459298|FG002|STARTED|Overall Study||52
6537540|NCT01653782|7459296|FG000|COMPLETED|Overall Study||36
6537541|NCT01653782|7459297|FG001|COMPLETED|Overall Study||37
6537542|NCT01653782|7459298|FG002|COMPLETED|Overall Study||46
6537543|NCT01653782|7459296|FG000|NOT COMPLETED|Overall Study||16
6537544|NCT01653782|7459297|FG001|NOT COMPLETED|Overall Study||18
6537545|NCT01653782|7459298|FG002|NOT COMPLETED|Overall Study||6
6562187|NCT01799993|7485262|FG001|NOT COMPLETED|Overall Study||128
6562188|NCT01800058|7485268|FG000|STARTED|Overall Study||66
6562189|NCT01800058|7485268|FG000|COMPLETED|Overall Study||65
6562190|NCT01800058|7485268|FG000|NOT COMPLETED|Overall Study||1
6562191|NCT01800201|7485275|FG000|STARTED|Overall Study||506
6562192|NCT01800201|7485276|FG001|STARTED|Overall Study||1003
6562193|NCT01800201|7485275|FG000|COMPLETED|Overall Study||503
6562194|NCT01800201|7485276|FG001|COMPLETED|Overall Study||1000
6562195|NCT01800201|7485275|FG000|NOT COMPLETED|Overall Study||3
6562196|NCT01800201|7485276|FG001|NOT COMPLETED|Overall Study||3
6562197|NCT01800318|7485287|FG000|STARTED|Overall Study||39
6562198|NCT01800318|7485288|FG001|STARTED|Overall Study||42
6562199|NCT01800318|7485289|FG002|STARTED|Overall Study||41
6562200|NCT01800318|7485290|FG003|STARTED|Overall Study||40
6562201|NCT01800318|7485287|FG000|COMPLETED|Overall Study||37
6562202|NCT01800318|7485288|FG001|COMPLETED|Overall Study||37
6562203|NCT01800318|7485289|FG002|COMPLETED|Overall Study||40
6562204|NCT01800318|7485290|FG003|COMPLETED|Overall Study||39
6562205|NCT01800318|7485287|FG000|NOT COMPLETED|Overall Study||2
6562206|NCT01800318|7485288|FG001|NOT COMPLETED|Overall Study||5
6562207|NCT01800318|7485289|FG002|NOT COMPLETED|Overall Study||1
6562208|NCT01800318|7485290|FG003|NOT COMPLETED|Overall Study||1
6562209|NCT01800786|7485306|FG000|STARTED|Overall Study||17
6562210|NCT01800786|7485307|FG001|STARTED|Overall Study||16
6562211|NCT01800786|7485306|FG000|COMPLETED|Overall Study||15
6562212|NCT01800786|7485307|FG001|COMPLETED|Overall Study||15
6562213|NCT01800786|7485306|FG000|NOT COMPLETED|Overall Study||2
6562214|NCT01800786|7485307|FG001|NOT COMPLETED|Overall Study||1
6562215|NCT01800838|7485317|FG000|STARTED|Overall Study||1
6562216|NCT01800838|7485318|FG001|STARTED|Overall Study||1
6562217|NCT01800838|7485319|FG002|STARTED|Overall Study||7
6562218|NCT01800838|7485320|FG003|STARTED|Overall Study||2
6562219|NCT01800838|7485317|FG000|COMPLETED|Overall Study||1
6562220|NCT01800838|7485318|FG001|COMPLETED|Overall Study||1
6562221|NCT01800838|7485319|FG002|COMPLETED|Overall Study||7
6562222|NCT01800838|7485320|FG003|COMPLETED|Overall Study||2
6562223|NCT01800838|7485317|FG000|NOT COMPLETED|Overall Study||0
6562224|NCT01800838|7485318|FG001|NOT COMPLETED|Overall Study||0
6562225|NCT01800838|7485319|FG002|NOT COMPLETED|Overall Study||0
6562226|NCT01800838|7485320|FG003|NOT COMPLETED|Overall Study||0
6562227|NCT01800877|7485326|FG000|STARTED|Overall Study||60
6562228|NCT01800877|7485327|FG001|STARTED|Overall Study||60
6562229|NCT01800877|7485326|FG000|COMPLETED|Overall Study||58
6562230|NCT01800877|7485327|FG001|COMPLETED|Overall Study||60
6562231|NCT01800877|7485326|FG000|NOT COMPLETED|Overall Study||2
6562232|NCT01800877|7485327|FG001|NOT COMPLETED|Overall Study||0
6562233|NCT01800890|7485333|FG000|STARTED|Test Period 1||3
6562234|NCT01800890|7485334|FG001|STARTED|Test Period 1||3
6562235|NCT01800890|7485335|FG002|STARTED|Test Period 1||3
6562236|NCT01800890|7485336|FG003|STARTED|Test Period 1||3
6562237|NCT01800890|7485337|FG004|STARTED|Test Period 1||4
6562238|NCT01800890|7485338|FG005|STARTED|Test Period 1||4
6562239|NCT01800890|7485339|FG006|STARTED|Test Period 1||3
6562240|NCT01800890|7485340|FG007|STARTED|Test Period 1||3
6562241|NCT01800890|7485341|FG008|STARTED|Test Period 1||3
6562242|NCT01800890|7485333|FG000|COMPLETED|Test Period 1||3
6562243|NCT01800890|7485334|FG001|COMPLETED|Test Period 1||3
6562244|NCT01800890|7485335|FG002|COMPLETED|Test Period 1||3
6562245|NCT01800890|7485336|FG003|COMPLETED|Test Period 1||2
6562246|NCT01800890|7485337|FG004|COMPLETED|Test Period 1||4
6562247|NCT01800890|7485338|FG005|COMPLETED|Test Period 1||4
6562248|NCT01800890|7485339|FG006|COMPLETED|Test Period 1||3
6537546|NCT01653847|7459308|FG000|STARTED|Overall Study||20
6537547|NCT01653847|7459309|FG001|STARTED|Overall Study||20
6537548|NCT01653847|7459308|FG000|COMPLETED|Overall Study||19
6537549|NCT01653847|7459309|FG001|COMPLETED|Overall Study||20
6537550|NCT01653847|7459308|FG000|NOT COMPLETED|Overall Study||1
6537551|NCT01653847|7459309|FG001|NOT COMPLETED|Overall Study||0
6537552|NCT01653912|7459317|FG000|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||4
6537553|NCT01653912|7459318|FG001|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537554|NCT01653912|7459319|FG002|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537555|NCT01653912|7459320|FG003|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537556|NCT01653912|7459321|FG004|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537557|NCT01653912|7459322|FG005|STARTED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537558|NCT01653912|7459317|FG000|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||4
6537559|NCT01653912|7459318|FG001|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537560|NCT01653912|7459319|FG002|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537561|NCT01653912|7459320|FG003|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537562|NCT01653912|7459321|FG004|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537563|NCT01653912|7459322|FG005|COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537564|NCT01653912|7459317|FG000|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537565|NCT01653912|7459318|FG001|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537566|NCT01653912|7459319|FG002|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537567|NCT01653912|7459320|FG003|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537568|NCT01653912|7459321|FG004|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537569|NCT01653912|7459322|FG005|NOT COMPLETED|Phase 1-Cohort 1: GSK2110183 50 mg||0
6537570|NCT01653912|7459317|FG000|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537571|NCT01653912|7459318|FG001|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||4
6537572|NCT01653912|7459319|FG002|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537573|NCT01653912|7459320|FG003|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537574|NCT01653912|7459321|FG004|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537575|NCT01653912|7459322|FG005|STARTED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537576|NCT01653912|7459317|FG000|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537577|NCT01653912|7459318|FG001|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||3
6537578|NCT01653912|7459319|FG002|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537579|NCT01653912|7459320|FG003|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537580|NCT01653912|7459321|FG004|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537581|NCT01653912|7459322|FG005|COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537582|NCT01653912|7459317|FG000|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537583|NCT01653912|7459318|FG001|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||1
6537584|NCT01653912|7459319|FG002|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537585|NCT01653912|7459320|FG003|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537586|NCT01653912|7459321|FG004|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537587|NCT01653912|7459322|FG005|NOT COMPLETED|Phase 1-Cohort 1.5: GSK2110183 75 mg||0
6537588|NCT01653912|7459317|FG000|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537589|NCT01653912|7459318|FG001|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537590|NCT01653912|7459319|FG002|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||6
6537591|NCT01653912|7459320|FG003|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537592|NCT01653912|7459321|FG004|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537593|NCT01653912|7459322|FG005|STARTED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537594|NCT01653912|7459317|FG000|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537595|NCT01653912|7459318|FG001|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537596|NCT01653912|7459319|FG002|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||4
6537597|NCT01653912|7459320|FG003|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537598|NCT01653912|7459321|FG004|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537599|NCT01653912|7459322|FG005|COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537600|NCT01653912|7459317|FG000|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537601|NCT01653912|7459318|FG001|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537602|NCT01653912|7459319|FG002|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||2
6537603|NCT01653912|7459320|FG003|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537604|NCT01653912|7459321|FG004|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537605|NCT01653912|7459322|FG005|NOT COMPLETED|Phase 1-Cohort 2: GSK2110183 100 mg||0
6537606|NCT01653912|7459317|FG000|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537607|NCT01653912|7459318|FG001|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537608|NCT01653912|7459319|FG002|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537609|NCT01653912|7459320|FG003|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||12
6537610|NCT01653912|7459321|FG004|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537611|NCT01653912|7459322|FG005|STARTED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537612|NCT01653912|7459317|FG000|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537613|NCT01653912|7459318|FG001|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537614|NCT01653912|7459319|FG002|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537615|NCT01653912|7459320|FG003|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||10
6537616|NCT01653912|7459321|FG004|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537617|NCT01653912|7459322|FG005|COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537618|NCT01653912|7459317|FG000|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537619|NCT01653912|7459318|FG001|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537620|NCT01653912|7459319|FG002|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537621|NCT01653912|7459320|FG003|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||2
6537622|NCT01653912|7459321|FG004|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537623|NCT01653912|7459322|FG005|NOT COMPLETED|Phase 1-Cohort 3: GSK2110183 125 mg||0
6537624|NCT01653912|7459317|FG000|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537625|NCT01653912|7459318|FG001|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537626|NCT01653912|7459319|FG002|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6645524|NCT02372344|7574474|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
6645525|NCT02372344|7574475|FG002|NOT COMPLETED|Period 3 (Visit 4)||0
6645526|NCT02372383|7574485|FG000|STARTED|First Intervention (1 Day)||10
6645527|NCT02372383|7574486|FG001|STARTED|First Intervention (1 Day)||11
6645528|NCT02372383|7574487|FG002|STARTED|First Intervention (1 Day)||10
6537627|NCT01653912|7459320|FG003|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537628|NCT01653912|7459321|FG004|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||3
6537629|NCT01653912|7459322|FG005|STARTED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537630|NCT01653912|7459317|FG000|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537631|NCT01653912|7459318|FG001|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537632|NCT01653912|7459319|FG002|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537633|NCT01653912|7459320|FG003|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537634|NCT01653912|7459321|FG004|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||3
6537635|NCT01653912|7459322|FG005|COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537636|NCT01653912|7459317|FG000|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537637|NCT01653912|7459318|FG001|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537638|NCT01653912|7459319|FG002|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537639|NCT01653912|7459320|FG003|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537640|NCT01653912|7459321|FG004|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537641|NCT01653912|7459322|FG005|NOT COMPLETED|Phase 1-Cohort 4: GSK2110183 150 mg||0
6537642|NCT01653912|7459317|FG000|STARTED|Phase 2: GSK2110183 125 mg||0
6537643|NCT01653912|7459318|FG001|STARTED|Phase 2: GSK2110183 125 mg||0
6537644|NCT01653912|7459319|FG002|STARTED|Phase 2: GSK2110183 125 mg||0
6537645|NCT01653912|7459320|FG003|STARTED|Phase 2: GSK2110183 125 mg||0
6537646|NCT01653912|7459321|FG004|STARTED|Phase 2: GSK2110183 125 mg||0
6537647|NCT01653912|7459322|FG005|STARTED|Phase 2: GSK2110183 125 mg|Per SAP, Cohort B (n=2) data was summarized in phase 2 total column as cohort B had <10 subjects.|30
6537648|NCT01653912|7459317|FG000|COMPLETED|Phase 2: GSK2110183 125 mg||0
6537649|NCT01653912|7459318|FG001|COMPLETED|Phase 2: GSK2110183 125 mg||0
6537650|NCT01653912|7459319|FG002|COMPLETED|Phase 2: GSK2110183 125 mg||0
6537651|NCT01653912|7459320|FG003|COMPLETED|Phase 2: GSK2110183 125 mg||0
6537652|NCT01653912|7459321|FG004|COMPLETED|Phase 2: GSK2110183 125 mg||0
6537653|NCT01653912|7459322|FG005|COMPLETED|Phase 2: GSK2110183 125 mg||22
6537654|NCT01653912|7459317|FG000|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6537655|NCT01653912|7459318|FG001|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6537656|NCT01653912|7459319|FG002|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6537657|NCT01653912|7459320|FG003|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6537658|NCT01653912|7459321|FG004|NOT COMPLETED|Phase 2: GSK2110183 125 mg||0
6537659|NCT01653912|7459322|FG005|NOT COMPLETED|Phase 2: GSK2110183 125 mg||8
6537660|NCT01653964|7459328|FG000|STARTED|Overall Study||82
6537661|NCT01653964|7459328|FG000|COMPLETED|Overall Study||82
6537662|NCT01653964|7459328|FG000|NOT COMPLETED|Overall Study||0
6537663|NCT01654068|7459332|FG000|STARTED|Overall Study||14
6537664|NCT01654068|7459332|FG000|COMPLETED|Overall Study||14
6537665|NCT01654068|7459332|FG000|NOT COMPLETED|Overall Study||0
6537666|NCT01654107|7459338|FG000|STARTED|Overall Study||28
6537667|NCT01654107|7459339|FG001|STARTED|Overall Study||30
6537668|NCT01654107|7459338|FG000|COMPLETED|Overall Study||25
6537669|NCT01654107|7459339|FG001|COMPLETED|Overall Study||22
6537670|NCT01654107|7459338|FG000|NOT COMPLETED|Overall Study||3
6537671|NCT01654107|7459339|FG001|NOT COMPLETED|Overall Study||8
6537672|NCT01654224|7459347|FG000|STARTED|Overall Study||95
6537673|NCT01654224|7459348|FG001|STARTED|Overall Study||110
6537674|NCT01654224|7459347|FG000|COMPLETED|Overall Study||89
6537675|NCT01654224|7459348|FG001|COMPLETED|Overall Study||98
6537676|NCT01654224|7459347|FG000|NOT COMPLETED|Overall Study||6
6537677|NCT01654224|7459348|FG001|NOT COMPLETED|Overall Study||12
6537678|NCT01654250|7459356|FG000|STARTED|Overall Study||44
6537679|NCT01654250|7459357|FG001|STARTED|Overall Study||42
6537680|NCT01654250|7459356|FG000|COMPLETED|Overall Study||43
6537681|NCT01654250|7459357|FG001|COMPLETED|Overall Study||42
6537682|NCT01654250|7459356|FG000|NOT COMPLETED|Overall Study||1
6537683|NCT01654250|7459357|FG001|NOT COMPLETED|Overall Study||0
6537684|NCT01654263|7459370|FG000|STARTED|Overall Study||164
6537685|NCT01654263|7459371|FG001|STARTED|Overall Study||147
6537686|NCT01654263|7459372|FG002|STARTED|Overall Study||139
6537687|NCT01654263|7459373|FG003|STARTED|Overall Study||145
6537688|NCT01654263|7459374|FG004|STARTED|Overall Study||140
6537689|NCT01654263|7459375|FG005|STARTED|Overall Study||149
6537690|NCT01654263|7459370|FG000|COMPLETED|Overall Study||164
6537691|NCT01654263|7459371|FG001|COMPLETED|Overall Study||147
6537692|NCT01654263|7459372|FG002|COMPLETED|Overall Study||137
6537693|NCT01654263|7459373|FG003|COMPLETED|Overall Study||144
6537694|NCT01654263|7459374|FG004|COMPLETED|Overall Study||139
6537695|NCT01654263|7459375|FG005|COMPLETED|Overall Study||148
6537696|NCT01654263|7459370|FG000|NOT COMPLETED|Overall Study||0
6537697|NCT01654263|7459371|FG001|NOT COMPLETED|Overall Study||0
6537698|NCT01654263|7459372|FG002|NOT COMPLETED|Overall Study||2
6645529|NCT02372383|7574485|FG000|COMPLETED|First Intervention (1 Day)||10
6537699|NCT01654263|7459373|FG003|NOT COMPLETED|Overall Study||1
6537700|NCT01654263|7459374|FG004|NOT COMPLETED|Overall Study||1
6537701|NCT01654263|7459375|FG005|NOT COMPLETED|Overall Study||1
6537702|NCT01654276|7459386|FG000|STARTED|Overall Study||24
6537703|NCT01654276|7459386|FG000|Visit 2 (2 Months)|Overall Study||19
6537704|NCT01654276|7459386|FG000|Visit 3 (4 Months)|Overall Study||18
6537705|NCT01654276|7459386|FG000|Visit 4 (6months)|Overall Study||18
6537706|NCT01654276|7459386|FG000|COMPLETED|Overall Study||18
6537707|NCT01654276|7459386|FG000|NOT COMPLETED|Overall Study||6
6537708|NCT01654289|7459393|FG000|STARTED|Overall Study||138
6537709|NCT01654289|7459394|FG001|STARTED|Overall Study||137
6537710|NCT01654289|7459395|FG002|STARTED|Overall Study||138
6537711|NCT01654289|7459393|FG000|COMPLETED|Overall Study||111
6537712|NCT01654289|7459394|FG001|COMPLETED|Overall Study||109
6537713|NCT01654289|7459395|FG002|COMPLETED|Overall Study||133
6537714|NCT01654289|7459393|FG000|NOT COMPLETED|Overall Study||27
6537715|NCT01654289|7459394|FG001|NOT COMPLETED|Overall Study||28
6537716|NCT01654289|7459395|FG002|NOT COMPLETED|Overall Study||5
6537717|NCT01654302|7459405|FG000|STARTED|First Intervention (Day 1)||20
6537718|NCT01654302|7459406|FG001|STARTED|First Intervention (Day 1)||20
6537719|NCT01654302|7459405|FG000|COMPLETED|First Intervention (Day 1)||20
6537720|NCT01654302|7459406|FG001|COMPLETED|First Intervention (Day 1)||20
6537721|NCT01654302|7459405|FG000|NOT COMPLETED|First Intervention (Day 1)||0
6537722|NCT01654302|7459406|FG001|NOT COMPLETED|First Intervention (Day 1)||0
6537723|NCT01654302|7459405|FG000|STARTED|Second Intervention (Day 7)||20
6537724|NCT01654302|7459406|FG001|STARTED|Second Intervention (Day 7)||20
6537725|NCT01654302|7459405|FG000|COMPLETED|Second Intervention (Day 7)||19
6537726|NCT01654302|7459406|FG001|COMPLETED|Second Intervention (Day 7)||19
6537727|NCT01654302|7459405|FG000|NOT COMPLETED|Second Intervention (Day 7)||1
6537728|NCT01654302|7459406|FG001|NOT COMPLETED|Second Intervention (Day 7)||1
6537729|NCT01654380|7459414|FG000|STARTED|Part A, Period 1||4
6537730|NCT01654380|7459415|FG001|STARTED|Part A, Period 1||4
6537731|NCT01654380|7459416|FG002|STARTED|Part A, Period 1||0
6537732|NCT01654380|7459417|FG003|STARTED|Part A, Period 1||0
6537733|NCT01654380|7459414|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
6537734|NCT01654380|7459415|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||4
6537735|NCT01654380|7459416|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
6537736|NCT01654380|7459417|FG003|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
6537737|NCT01654380|7459414|FG000|COMPLETED|Part A, Period 1||4
6537738|NCT01654380|7459415|FG001|COMPLETED|Part A, Period 1||4
6537739|NCT01654380|7459416|FG002|COMPLETED|Part A, Period 1||0
6537740|NCT01654380|7459417|FG003|COMPLETED|Part A, Period 1||0
6537741|NCT01654380|7459414|FG000|NOT COMPLETED|Part A, Period 1||0
6537742|NCT01654380|7459415|FG001|NOT COMPLETED|Part A, Period 1||0
6537743|NCT01654380|7459416|FG002|NOT COMPLETED|Part A, Period 1||0
6537744|NCT01654380|7459417|FG003|NOT COMPLETED|Part A, Period 1||0
6537745|NCT01654380|7459414|FG000|STARTED|Part A, Washout of at Least 6 Days||4
6645530|NCT02372383|7574486|FG001|COMPLETED|First Intervention (1 Day)||10
6645531|NCT02372383|7574487|FG002|COMPLETED|First Intervention (1 Day)||10
6645532|NCT02372383|7574485|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6645533|NCT02372383|7574486|FG001|NOT COMPLETED|First Intervention (1 Day)||1
6645534|NCT02372383|7574487|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6645535|NCT02372383|7574485|FG000|STARTED|Washout (14 Days)||10
6537746|NCT01654380|7459415|FG001|STARTED|Part A, Washout of at Least 6 Days||4
6537747|NCT01654380|7459416|FG002|STARTED|Part A, Washout of at Least 6 Days||0
6537748|NCT01654380|7459417|FG003|STARTED|Part A, Washout of at Least 6 Days||0
6537749|NCT01654380|7459414|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
6537750|NCT01654380|7459415|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
6537751|NCT01654380|7459416|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
6537752|NCT01654380|7459417|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
6537753|NCT01654380|7459414|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537754|NCT01654380|7459415|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537755|NCT01654380|7459416|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537756|NCT01654380|7459417|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537757|NCT01654380|7459414|FG000|STARTED|Part A, Period 2||4
6537758|NCT01654380|7459415|FG001|STARTED|Part A, Period 2||4
6537759|NCT01654380|7459416|FG002|STARTED|Part A, Period 2||0
6537760|NCT01654380|7459417|FG003|STARTED|Part A, Period 2||0
6537761|NCT01654380|7459414|FG000|COMPLETED|Part A, Period 2||4
6537762|NCT01654380|7459415|FG001|COMPLETED|Part A, Period 2||4
6537763|NCT01654380|7459416|FG002|COMPLETED|Part A, Period 2||0
6537764|NCT01654380|7459417|FG003|COMPLETED|Part A, Period 2||0
6537765|NCT01654380|7459414|FG000|NOT COMPLETED|Part A, Period 2||0
6537766|NCT01654380|7459415|FG001|NOT COMPLETED|Part A, Period 2||0
6537767|NCT01654380|7459416|FG002|NOT COMPLETED|Part A, Period 2||0
6537768|NCT01654380|7459417|FG003|NOT COMPLETED|Part A, Period 2||0
6537769|NCT01654380|7459414|FG000|STARTED|Part A, Washout of at Least 6 Days||4
6537770|NCT01654380|7459415|FG001|STARTED|Part A, Washout of at Least 6 Days||4
6537771|NCT01654380|7459416|FG002|STARTED|Part A, Washout of at Least 6 Days||0
6537772|NCT01654380|7459417|FG003|STARTED|Part A, Washout of at Least 6 Days||0
6537773|NCT01654380|7459414|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
6537774|NCT01654380|7459415|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
6645536|NCT02372383|7574486|FG001|STARTED|Washout (14 Days)||10
6645537|NCT02372383|7574487|FG002|STARTED|Washout (14 Days)||10
6537775|NCT01654380|7459416|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
6537776|NCT01654380|7459417|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
6537777|NCT01654380|7459414|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537778|NCT01654380|7459415|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537779|NCT01654380|7459416|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537780|NCT01654380|7459417|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537781|NCT01654380|7459414|FG000|STARTED|Part A, Period 3||4
6537782|NCT01654380|7459415|FG001|STARTED|Part A, Period 3||4
6537783|NCT01654380|7459416|FG002|STARTED|Part A, Period 3||0
6537784|NCT01654380|7459417|FG003|STARTED|Part A, Period 3||0
6537785|NCT01654380|7459414|FG000|COMPLETED|Part A, Period 3||4
6537786|NCT01654380|7459415|FG001|COMPLETED|Part A, Period 3||4
6537787|NCT01654380|7459416|FG002|COMPLETED|Part A, Period 3||0
6537788|NCT01654380|7459417|FG003|COMPLETED|Part A, Period 3||0
6537789|NCT01654380|7459414|FG000|NOT COMPLETED|Part A, Period 3||0
6537790|NCT01654380|7459415|FG001|NOT COMPLETED|Part A, Period 3||0
6537791|NCT01654380|7459416|FG002|NOT COMPLETED|Part A, Period 3||0
6537792|NCT01654380|7459417|FG003|NOT COMPLETED|Part A, Period 3||0
6537793|NCT01654380|7459414|FG000|STARTED|Part A, Washout of at Least 6 Days||4
6537794|NCT01654380|7459415|FG001|STARTED|Part A, Washout of at Least 6 Days||4
6537795|NCT01654380|7459416|FG002|STARTED|Part A, Washout of at Least 6 Days||0
6537796|NCT01654380|7459417|FG003|STARTED|Part A, Washout of at Least 6 Days||0
6537797|NCT01654380|7459414|FG000|COMPLETED|Part A, Washout of at Least 6 Days||4
6537798|NCT01654380|7459415|FG001|COMPLETED|Part A, Washout of at Least 6 Days||4
6537799|NCT01654380|7459416|FG002|COMPLETED|Part A, Washout of at Least 6 Days||0
6537800|NCT01654380|7459417|FG003|COMPLETED|Part A, Washout of at Least 6 Days||0
6537801|NCT01654380|7459414|FG000|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537802|NCT01654380|7459415|FG001|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537803|NCT01654380|7459416|FG002|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537804|NCT01654380|7459417|FG003|NOT COMPLETED|Part A, Washout of at Least 6 Days||0
6537805|NCT01654380|7459414|FG000|STARTED|Part A, Period 4||4
6537806|NCT01654380|7459415|FG001|STARTED|Part A, Period 4||4
6537807|NCT01654380|7459416|FG002|STARTED|Part A, Period 4||0
6537808|NCT01654380|7459417|FG003|STARTED|Part A, Period 4||0
6537809|NCT01654380|7459414|FG000|COMPLETED|Part A, Period 4||4
6537810|NCT01654380|7459415|FG001|COMPLETED|Part A, Period 4||4
6537811|NCT01654380|7459416|FG002|COMPLETED|Part A, Period 4||0
6537812|NCT01654380|7459417|FG003|COMPLETED|Part A, Period 4||0
6537813|NCT01654380|7459414|FG000|NOT COMPLETED|Part A, Period 4||0
6537814|NCT01654380|7459415|FG001|NOT COMPLETED|Part A, Period 4||0
6537815|NCT01654380|7459416|FG002|NOT COMPLETED|Part A, Period 4||0
6537816|NCT01654380|7459417|FG003|NOT COMPLETED|Part A, Period 4||0
6537817|NCT01654380|7459414|FG000|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
6537818|NCT01654380|7459415|FG001|STARTED|Part B, Period 1|Participants in Part A were not included in Part B.|0
6537819|NCT01654380|7459416|FG002|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
6537820|NCT01654380|7459417|FG003|STARTED|Part B, Period 1|Participants in Part B were not included in Part A.|7
6537821|NCT01654380|7459414|FG000|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
6537822|NCT01654380|7459415|FG001|Received at Least 1 Dose of Study Drug|Part B, Period 1||0
6537823|NCT01654380|7459416|FG002|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
6537824|NCT01654380|7459417|FG003|Received at Least 1 Dose of Study Drug|Part B, Period 1||7
6537825|NCT01654380|7459414|FG000|COMPLETED|Part B, Period 1||0
6537826|NCT01654380|7459415|FG001|COMPLETED|Part B, Period 1||0
6537827|NCT01654380|7459416|FG002|COMPLETED|Part B, Period 1|Participant who did not complete received only 1 dose of LY2605541 74.1 mU/min IV for 8 hours|6
6537828|NCT01654380|7459417|FG003|COMPLETED|Part B, Period 1||7
6537829|NCT01654380|7459414|FG000|NOT COMPLETED|Part B, Period 1||0
6537830|NCT01654380|7459415|FG001|NOT COMPLETED|Part B, Period 1||0
6537831|NCT01654380|7459416|FG002|NOT COMPLETED|Part B, Period 1||1
6537832|NCT01654380|7459417|FG003|NOT COMPLETED|Part B, Period 1||0
6537833|NCT01654380|7459414|FG000|STARTED|Part B, Washout of at Least 6 Days||0
6537834|NCT01654380|7459415|FG001|STARTED|Part B, Washout of at Least 6 Days||0
6537835|NCT01654380|7459416|FG002|STARTED|Part B, Washout of at Least 6 Days||6
6537836|NCT01654380|7459417|FG003|STARTED|Part B, Washout of at Least 6 Days||7
6537837|NCT01654380|7459414|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
6537838|NCT01654380|7459415|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
6537839|NCT01654380|7459416|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
6537840|NCT01654380|7459417|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
6537841|NCT01654380|7459414|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537842|NCT01654380|7459415|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537843|NCT01654380|7459416|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537844|NCT01654380|7459417|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537845|NCT01654380|7459414|FG000|STARTED|Part B, Period 2||0
6537846|NCT01654380|7459415|FG001|STARTED|Part B, Period 2||0
6537847|NCT01654380|7459416|FG002|STARTED|Part B, Period 2||6
6537848|NCT01654380|7459417|FG003|STARTED|Part B, Period 2||7
6537849|NCT01654380|7459414|FG000|COMPLETED|Part B, Period 2||0
6537850|NCT01654380|7459415|FG001|COMPLETED|Part B, Period 2||0
6537851|NCT01654380|7459416|FG002|COMPLETED|Part B, Period 2||6
6537852|NCT01654380|7459417|FG003|COMPLETED|Part B, Period 2||7
6537853|NCT01654380|7459414|FG000|NOT COMPLETED|Part B, Period 2||0
6537854|NCT01654380|7459415|FG001|NOT COMPLETED|Part B, Period 2||0
6537855|NCT01654380|7459416|FG002|NOT COMPLETED|Part B, Period 2||0
6537856|NCT01654380|7459417|FG003|NOT COMPLETED|Part B, Period 2||0
6537857|NCT01654380|7459414|FG000|STARTED|Part B, Washout of at Least 6 Days||0
6537858|NCT01654380|7459415|FG001|STARTED|Part B, Washout of at Least 6 Days||0
6537859|NCT01654380|7459416|FG002|STARTED|Part B, Washout of at Least 6 Days||6
6537860|NCT01654380|7459417|FG003|STARTED|Part B, Washout of at Least 6 Days||7
6537861|NCT01654380|7459414|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
6537862|NCT01654380|7459415|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
6537863|NCT01654380|7459416|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
6537864|NCT01654380|7459417|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
6537865|NCT01654380|7459414|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537866|NCT01654380|7459415|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537867|NCT01654380|7459416|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537868|NCT01654380|7459417|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537869|NCT01654380|7459414|FG000|STARTED|Part B, Period 3||0
6537870|NCT01654380|7459415|FG001|STARTED|Part B, Period 3||0
6537871|NCT01654380|7459416|FG002|STARTED|Part B, Period 3||6
6537872|NCT01654380|7459417|FG003|STARTED|Part B, Period 3||7
6537873|NCT01654380|7459414|FG000|COMPLETED|Part B, Period 3||0
6537874|NCT01654380|7459415|FG001|COMPLETED|Part B, Period 3||0
6537875|NCT01654380|7459416|FG002|COMPLETED|Part B, Period 3||6
6537876|NCT01654380|7459417|FG003|COMPLETED|Part B, Period 3||7
6537877|NCT01654380|7459414|FG000|NOT COMPLETED|Part B, Period 3||0
6537878|NCT01654380|7459415|FG001|NOT COMPLETED|Part B, Period 3||0
6537879|NCT01654380|7459416|FG002|NOT COMPLETED|Part B, Period 3||0
6537880|NCT01654380|7459417|FG003|NOT COMPLETED|Part B, Period 3||0
6537881|NCT01654380|7459414|FG000|STARTED|Part B, Washout of at Least 6 Days||0
6537882|NCT01654380|7459415|FG001|STARTED|Part B, Washout of at Least 6 Days||0
6537883|NCT01654380|7459416|FG002|STARTED|Part B, Washout of at Least 6 Days||6
6537884|NCT01654380|7459417|FG003|STARTED|Part B, Washout of at Least 6 Days||7
6537885|NCT01654380|7459414|FG000|COMPLETED|Part B, Washout of at Least 6 Days||0
6537886|NCT01654380|7459415|FG001|COMPLETED|Part B, Washout of at Least 6 Days||0
6537887|NCT01654380|7459416|FG002|COMPLETED|Part B, Washout of at Least 6 Days||6
6537888|NCT01654380|7459417|FG003|COMPLETED|Part B, Washout of at Least 6 Days||7
6537889|NCT01654380|7459414|FG000|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537890|NCT01654380|7459415|FG001|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537891|NCT01654380|7459416|FG002|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537892|NCT01654380|7459417|FG003|NOT COMPLETED|Part B, Washout of at Least 6 Days||0
6537893|NCT01654380|7459414|FG000|STARTED|Part B, Period 4||0
6537894|NCT01654380|7459415|FG001|STARTED|Part B, Period 4||0
6537895|NCT01654380|7459416|FG002|STARTED|Part B, Period 4||6
6537896|NCT01654380|7459417|FG003|STARTED|Part B, Period 4||7
6537897|NCT01654380|7459414|FG000|COMPLETED|Part B, Period 4||0
6537898|NCT01654380|7459415|FG001|COMPLETED|Part B, Period 4||0
6537899|NCT01654380|7459416|FG002|COMPLETED|Part B, Period 4||6
6537900|NCT01654380|7459417|FG003|COMPLETED|Part B, Period 4||7
6537901|NCT01654380|7459414|FG000|NOT COMPLETED|Part B, Period 4||0
6537902|NCT01654380|7459415|FG001|NOT COMPLETED|Part B, Period 4||0
6537903|NCT01654380|7459416|FG002|NOT COMPLETED|Part B, Period 4||0
6537904|NCT01654380|7459417|FG003|NOT COMPLETED|Part B, Period 4||0
6537905|NCT01654445|7459436|FG000|STARTED|Overall Study||25
6537906|NCT01654445|7459437|FG001|STARTED|Overall Study||25
6537907|NCT01654445|7459436|FG000|COMPLETED|Overall Study||25
6537908|NCT01654445|7459437|FG001|COMPLETED|Overall Study||25
6537909|NCT01654445|7459436|FG000|NOT COMPLETED|Overall Study||0
6537910|NCT01654445|7459437|FG001|NOT COMPLETED|Overall Study||0
6537911|NCT01654523|7459443|FG000|STARTED|Overall Study||20
6537912|NCT01654523|7459443|FG000|COMPLETED|Overall Study||19
6537913|NCT01654523|7459443|FG000|NOT COMPLETED|Overall Study||1
6537914|NCT01654536|7459449|FG000|STARTED|Overall Study||368
6537915|NCT01654536|7459450|FG001|STARTED|Overall Study||369
6537916|NCT01654536|7459449|FG000|COMPLETED|Overall Study||324
6537917|NCT01654536|7459450|FG001|COMPLETED|Overall Study||331
6537918|NCT01654536|7459449|FG000|NOT COMPLETED|Overall Study||44
6537919|NCT01654536|7459450|FG001|NOT COMPLETED|Overall Study||38
6537920|NCT01654549|7459459|FG000|STARTED|Overall Study||20
6537921|NCT01654549|7459460|FG001|STARTED|Overall Study||20
6537922|NCT01654549|7459459|FG000|COMPLETED|Overall Study||20
6537923|NCT01654549|7459460|FG001|COMPLETED|Overall Study||19
6537924|NCT01654549|7459459|FG000|NOT COMPLETED|Overall Study||0
6537925|NCT01654549|7459460|FG001|NOT COMPLETED|Overall Study||1
6537926|NCT01654601|7459472|FG000|STARTED|1st Administration||14
6537927|NCT01654601|7459473|FG001|STARTED|1st Administration||14
6537928|NCT01654601|7459472|FG000|COMPLETED|1st Administration||12
6537929|NCT01654601|7459473|FG001|COMPLETED|1st Administration||12
6537930|NCT01654601|7459472|FG000|NOT COMPLETED|1st Administration||2
6537931|NCT01654601|7459473|FG001|NOT COMPLETED|1st Administration||2
6537932|NCT01654601|7459472|FG000|STARTED|2nd Administration||12
6537933|NCT01654601|7459473|FG001|STARTED|2nd Administration||12
6537934|NCT01654601|7459472|FG000|COMPLETED|2nd Administration||11
6537935|NCT01654601|7459473|FG001|COMPLETED|2nd Administration||11
6537936|NCT01654601|7459472|FG000|NOT COMPLETED|2nd Administration||1
6537937|NCT01654601|7459473|FG001|NOT COMPLETED|2nd Administration||1
6537938|NCT01654666|7459482|FG000|STARTED|Overall Study||63
6537939|NCT01654666|7459483|FG001|STARTED|Overall Study||63
6537940|NCT01654666|7459484|FG002|STARTED|Overall Study||63
6537941|NCT01654666|7459482|FG000|Primary Analysis|Overall Study||52
6537942|NCT01654666|7459483|FG001|Primary Analysis|Overall Study||56
6537943|NCT01654666|7459484|FG002|Primary Analysis|Overall Study||54
6537944|NCT01654666|7459482|FG000|COMPLETED|Overall Study||48
6537945|NCT01654666|7459483|FG001|COMPLETED|Overall Study||50
6537946|NCT01654666|7459484|FG002|COMPLETED|Overall Study||49
6537947|NCT01654666|7459482|FG000|NOT COMPLETED|Overall Study||15
6537948|NCT01654666|7459483|FG001|NOT COMPLETED|Overall Study||13
6537949|NCT01654666|7459484|FG002|NOT COMPLETED|Overall Study||14
6537950|NCT01654796|7459495|FG000|STARTED|Overall Study||26
6537951|NCT01654796|7459496|FG001|STARTED|Overall Study||29
6537952|NCT01654796|7459497|FG002|STARTED|Overall Study||29
6537953|NCT01654796|7459495|FG000|COMPLETED|Overall Study||25
6537954|NCT01654796|7459496|FG001|COMPLETED|Overall Study||26
6537955|NCT01654796|7459497|FG002|COMPLETED|Overall Study||28
6537956|NCT01654796|7459495|FG000|NOT COMPLETED|Overall Study||1
6537957|NCT01654796|7459496|FG001|NOT COMPLETED|Overall Study||3
6537958|NCT01654796|7459497|FG002|NOT COMPLETED|Overall Study||1
6537959|NCT01654861|7459506|FG000|STARTED|Overall Study||3
6537960|NCT01654861|7459506|FG000|COMPLETED|Overall Study||3
6537961|NCT01654861|7459506|FG000|NOT COMPLETED|Overall Study||0
6537962|NCT01654887|7459512|FG000|STARTED|Overall Study||103
6537963|NCT01654887|7459513|FG001|STARTED|Overall Study||88
6537964|NCT01654887|7459512|FG000|COMPLETED|Overall Study||103
6537965|NCT01654887|7459513|FG001|COMPLETED|Overall Study||88
6537966|NCT01654887|7459512|FG000|NOT COMPLETED|Overall Study||0
6537967|NCT01654887|7459513|FG001|NOT COMPLETED|Overall Study||0
6537968|NCT01655043|7459520|FG000|STARTED|Overall Study||20
6645538|NCT02372383|7574485|FG000|COMPLETED|Washout (14 Days)||10
6645539|NCT02372383|7574486|FG001|COMPLETED|Washout (14 Days)||10
6645540|NCT02372383|7574487|FG002|COMPLETED|Washout (14 Days)||10
6645541|NCT02372383|7574485|FG000|NOT COMPLETED|Washout (14 Days)||0
6645542|NCT02372383|7574486|FG001|NOT COMPLETED|Washout (14 Days)||0
6645543|NCT02372383|7574487|FG002|NOT COMPLETED|Washout (14 Days)||0
6645544|NCT02372383|7574485|FG000|STARTED|Second Intervention (1 Day)||10
6645545|NCT02372383|7574486|FG001|STARTED|Second Intervention (1 Day)||10
6645546|NCT02372383|7574487|FG002|STARTED|Second Intervention (1 Day)||10
6645547|NCT02372383|7574485|FG000|COMPLETED|Second Intervention (1 Day)||10
6645548|NCT02372383|7574486|FG001|COMPLETED|Second Intervention (1 Day)||10
6645549|NCT02372383|7574487|FG002|COMPLETED|Second Intervention (1 Day)||10
6537969|NCT01655043|7459520|FG000|COMPLETED|Overall Study||20
6537970|NCT01655043|7459520|FG000|NOT COMPLETED|Overall Study||0
6537971|NCT01655069|7459528|FG000|STARTED|Overall Study||61
6537972|NCT01655069|7459529|FG001|STARTED|Overall Study||58
6537973|NCT01655069|7459530|FG002|STARTED|Overall Study||14
6537974|NCT01655069|7459531|FG003|STARTED|Overall Study||15
6537975|NCT01655069|7459528|FG000|Safety Analysis Set (SAF)|Overall Study||61
6645550|NCT02372383|7574485|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6645551|NCT02372383|7574486|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6645552|NCT02372383|7574487|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6645553|NCT02372396|7574499|FG000|STARTED|Overall Study||17
6645554|NCT02372396|7574500|FG001|STARTED|Overall Study||20
6645555|NCT02372396|7574499|FG000|Began Intervention|Overall Study||14
6645556|NCT02372396|7574500|FG001|Began Intervention|Overall Study||14
6645557|NCT02372396|7574499|FG000|COMPLETED|Overall Study||10
6645558|NCT02372396|7574500|FG001|COMPLETED|Overall Study||11
6645559|NCT02372396|7574499|FG000|NOT COMPLETED|Overall Study||7
6645560|NCT02372396|7574500|FG001|NOT COMPLETED|Overall Study||9
6645561|NCT02372682|7574508|FG000|STARTED|Overall Study||78
6645562|NCT02372682|7574509|FG001|STARTED|Overall Study||93
6645563|NCT02372682|7574508|FG000|COMPLETED|Overall Study||70
6645564|NCT02372682|7574509|FG001|COMPLETED|Overall Study||79
6645565|NCT02372682|7574508|FG000|NOT COMPLETED|Overall Study||8
6645566|NCT02372682|7574509|FG001|NOT COMPLETED|Overall Study||14
6645567|NCT02372799|7574525|FG000|STARTED|Treatment Period||186
6645568|NCT02372799|7574526|FG001|STARTED|Treatment Period||187
6645569|NCT02372799|7574527|FG002|STARTED|Treatment Period||97
6645570|NCT02372799|7574525|FG000|COMPLETED|Treatment Period||152
6645571|NCT02372799|7574526|FG001|COMPLETED|Treatment Period||155
6645572|NCT02372799|7574527|FG002|COMPLETED|Treatment Period||82
6645573|NCT02372799|7574525|FG000|NOT COMPLETED|Treatment Period||34
6645574|NCT02372799|7574526|FG001|NOT COMPLETED|Treatment Period||32
6645575|NCT02372799|7574527|FG002|NOT COMPLETED|Treatment Period||15
6645576|NCT02372799|7574525|FG000|STARTED|Down-taper Period||152
6645577|NCT02372799|7574526|FG001|STARTED|Down-taper Period||159
6645578|NCT02372799|7574527|FG002|STARTED|Down-taper Period||82
6645579|NCT02372799|7574525|FG000|COMPLETED|Down-taper Period||151
6645580|NCT02372799|7574526|FG001|COMPLETED|Down-taper Period||157
6537976|NCT01655069|7459529|FG001|Safety Analysis Set (SAF)|Overall Study||57
6537977|NCT01655069|7459530|FG002|Safety Analysis Set (SAF)|Overall Study||14
6537978|NCT01655069|7459531|FG003|Safety Analysis Set (SAF)|Overall Study||15
6537979|NCT01655069|7459528|FG000|Full Analysis Set (FAS)|Overall Study||60
6537980|NCT01655069|7459529|FG001|Full Analysis Set (FAS)|Overall Study||57
6537981|NCT01655069|7459530|FG002|Full Analysis Set (FAS)|Overall Study||14
6645581|NCT02372799|7574527|FG002|COMPLETED|Down-taper Period||80
6645582|NCT02372799|7574525|FG000|NOT COMPLETED|Down-taper Period||1
6645583|NCT02372799|7574526|FG001|NOT COMPLETED|Down-taper Period||2
6645584|NCT02372799|7574527|FG002|NOT COMPLETED|Down-taper Period||2
6645585|NCT02373098|7574537|FG000|STARTED|Overall Study||66
6537982|NCT01655069|7459531|FG003|Full Analysis Set (FAS)|Overall Study||15
6537983|NCT01655069|7459528|FG000|COMPLETED|Overall Study||53
6537984|NCT01655069|7459529|FG001|COMPLETED|Overall Study||46
6537985|NCT01655069|7459530|FG002|COMPLETED|Overall Study||12
6537986|NCT01655069|7459531|FG003|COMPLETED|Overall Study||11
6537987|NCT01655069|7459528|FG000|NOT COMPLETED|Overall Study||8
6537988|NCT01655069|7459529|FG001|NOT COMPLETED|Overall Study||12
6537989|NCT01655069|7459530|FG002|NOT COMPLETED|Overall Study||2
6537990|NCT01655069|7459531|FG003|NOT COMPLETED|Overall Study||4
6537991|NCT01655329|7459539|FG000|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
6537992|NCT01655329|7459539|FG000|COMPLETED|Overall Study||10
6537993|NCT01655329|7459539|FG000|NOT COMPLETED|Overall Study||0
6537994|NCT01655381|7459553|FG000|STARTED|Overall Study||15
6537995|NCT01655381|7459553|FG000|COMPLETED|Overall Study||12
6537996|NCT01655381|7459553|FG000|NOT COMPLETED|Overall Study||3
6537997|NCT01655498|7459558|FG000|STARTED|Overall Study||61
6537998|NCT01655498|7459558|FG000|COMPLETED|Overall Study||56
6537999|NCT01655498|7459558|FG000|NOT COMPLETED|Overall Study||5
6538000|NCT01655563|7459567|FG000|STARTED|Overall Study||18
6538001|NCT01655563|7459568|FG001|STARTED|Overall Study||35
6538002|NCT01655563|7459567|FG000|COMPLETED|Overall Study||18
6538003|NCT01655563|7459568|FG001|COMPLETED|Overall Study||35
6538004|NCT01655563|7459567|FG000|NOT COMPLETED|Overall Study||0
6538005|NCT01655563|7459568|FG001|NOT COMPLETED|Overall Study||0
6538006|NCT01655693|7459577|FG000|STARTED|Overall Study||130
6538007|NCT01655693|7459578|FG001|STARTED|Overall Study||133
6538008|NCT01655693|7459579|FG002|STARTED|Overall Study||134
6538009|NCT01655693|7459577|FG000|COMPLETED|Overall Study||4
6538010|NCT01655693|7459578|FG001|COMPLETED|Overall Study||7
6538011|NCT01655693|7459579|FG002|COMPLETED|Overall Study||4
6538012|NCT01655693|7459577|FG000|NOT COMPLETED|Overall Study||126
6538013|NCT01655693|7459578|FG001|NOT COMPLETED|Overall Study||126
6538014|NCT01655693|7459579|FG002|NOT COMPLETED|Overall Study||130
6538015|NCT01655719|7459597|FG000|STARTED|Overall Study||1
6538016|NCT01655719|7459597|FG000|COMPLETED|Overall Study||1
6538017|NCT01655719|7459597|FG000|NOT COMPLETED|Overall Study||0
6538018|NCT01655823|7459606|FG000|STARTED|Overall Study||25
6538019|NCT01655823|7459607|FG001|STARTED|Overall Study||25
6538020|NCT01655823|7459608|FG002|STARTED|Overall Study||24
6538021|NCT01655823|7459609|FG003|STARTED|Overall Study||25
6538022|NCT01655823|7459610|FG004|STARTED|Overall Study||26
6538023|NCT01655823|7459606|FG000|COMPLETED|Overall Study||25
6538024|NCT01655823|7459607|FG001|COMPLETED|Overall Study||23
6538025|NCT01655823|7459608|FG002|COMPLETED|Overall Study||24
6538026|NCT01655823|7459609|FG003|COMPLETED|Overall Study||24
6538027|NCT01655823|7459610|FG004|COMPLETED|Overall Study||25
6538028|NCT01655823|7459606|FG000|NOT COMPLETED|Overall Study||0
6538029|NCT01655823|7459607|FG001|NOT COMPLETED|Overall Study||2
6538030|NCT01655823|7459608|FG002|NOT COMPLETED|Overall Study||0
6538031|NCT01655823|7459609|FG003|NOT COMPLETED|Overall Study||1
6538032|NCT01655823|7459610|FG004|NOT COMPLETED|Overall Study||1
6538033|NCT01655901|7459622|FG000|STARTED|First Intervention (Hour 1)||5
6538034|NCT01655901|7459623|FG001|STARTED|First Intervention (Hour 1)||5
6538035|NCT01655901|7459624|FG002|STARTED|First Intervention (Hour 1)||5
6538036|NCT01655901|7459625|FG003|STARTED|First Intervention (Hour 1)||5
6538037|NCT01655901|7459626|FG004|STARTED|First Intervention (Hour 1)||5
6538038|NCT01655901|7459627|FG005|STARTED|First Intervention (Hour 1)||5
6538039|NCT01655901|7459622|FG000|COMPLETED|First Intervention (Hour 1)||5
6538040|NCT01655901|7459623|FG001|COMPLETED|First Intervention (Hour 1)||5
6538041|NCT01655901|7459624|FG002|COMPLETED|First Intervention (Hour 1)||5
6538042|NCT01655901|7459625|FG003|COMPLETED|First Intervention (Hour 1)||5
6538043|NCT01655901|7459626|FG004|COMPLETED|First Intervention (Hour 1)||5
6538044|NCT01655901|7459627|FG005|COMPLETED|First Intervention (Hour 1)||5
6538045|NCT01655901|7459622|FG000|NOT COMPLETED|First Intervention (Hour 1)||0
6538046|NCT01655901|7459623|FG001|NOT COMPLETED|First Intervention (Hour 1)||0
6538047|NCT01655901|7459624|FG002|NOT COMPLETED|First Intervention (Hour 1)||0
6538048|NCT01655901|7459625|FG003|NOT COMPLETED|First Intervention (Hour 1)||0
6538049|NCT01655901|7459626|FG004|NOT COMPLETED|First Intervention (Hour 1)||0
6538050|NCT01655901|7459627|FG005|NOT COMPLETED|First Intervention (Hour 1)||0
6538051|NCT01655901|7459622|FG000|STARTED|Washout (1 Week)||5
6538052|NCT01655901|7459623|FG001|STARTED|Washout (1 Week)||5
6538053|NCT01655901|7459624|FG002|STARTED|Washout (1 Week)||5
6538054|NCT01655901|7459625|FG003|STARTED|Washout (1 Week)||5
6538055|NCT01655901|7459626|FG004|STARTED|Washout (1 Week)||5
6538056|NCT01655901|7459627|FG005|STARTED|Washout (1 Week)||5
6538057|NCT01655901|7459622|FG000|COMPLETED|Washout (1 Week)||5
6538058|NCT01655901|7459623|FG001|COMPLETED|Washout (1 Week)||5
6538059|NCT01655901|7459624|FG002|COMPLETED|Washout (1 Week)||5
6538060|NCT01655901|7459625|FG003|COMPLETED|Washout (1 Week)||5
6538061|NCT01655901|7459626|FG004|COMPLETED|Washout (1 Week)||5
6538062|NCT01655901|7459627|FG005|COMPLETED|Washout (1 Week)||5
6538063|NCT01655901|7459622|FG000|NOT COMPLETED|Washout (1 Week)||0
6538064|NCT01655901|7459623|FG001|NOT COMPLETED|Washout (1 Week)||0
6538065|NCT01655901|7459624|FG002|NOT COMPLETED|Washout (1 Week)||0
6538066|NCT01655901|7459625|FG003|NOT COMPLETED|Washout (1 Week)||0
6538067|NCT01655901|7459626|FG004|NOT COMPLETED|Washout (1 Week)||0
6538068|NCT01655901|7459627|FG005|NOT COMPLETED|Washout (1 Week)||0
6538069|NCT01655901|7459622|FG000|STARTED|Second Intervention (Hour 2)||5
6538070|NCT01655901|7459623|FG001|STARTED|Second Intervention (Hour 2)||5
6538071|NCT01655901|7459624|FG002|STARTED|Second Intervention (Hour 2)||5
6538072|NCT01655901|7459625|FG003|STARTED|Second Intervention (Hour 2)||5
6538073|NCT01655901|7459626|FG004|STARTED|Second Intervention (Hour 2)||5
6538074|NCT01655901|7459627|FG005|STARTED|Second Intervention (Hour 2)||5
6538075|NCT01655901|7459622|FG000|COMPLETED|Second Intervention (Hour 2)||5
6538076|NCT01655901|7459623|FG001|COMPLETED|Second Intervention (Hour 2)||5
6538077|NCT01655901|7459624|FG002|COMPLETED|Second Intervention (Hour 2)||5
6538078|NCT01655901|7459625|FG003|COMPLETED|Second Intervention (Hour 2)||5
6538079|NCT01655901|7459626|FG004|COMPLETED|Second Intervention (Hour 2)||5
6538080|NCT01655901|7459627|FG005|COMPLETED|Second Intervention (Hour 2)||5
6538081|NCT01655901|7459622|FG000|NOT COMPLETED|Second Intervention (Hour 2)||0
6538082|NCT01655901|7459623|FG001|NOT COMPLETED|Second Intervention (Hour 2)||0
6538083|NCT01655901|7459624|FG002|NOT COMPLETED|Second Intervention (Hour 2)||0
6538084|NCT01655901|7459625|FG003|NOT COMPLETED|Second Intervention (Hour 2)||0
6538085|NCT01655901|7459626|FG004|NOT COMPLETED|Second Intervention (Hour 2)||0
6538086|NCT01655901|7459627|FG005|NOT COMPLETED|Second Intervention (Hour 2)||0
6538087|NCT01655901|7459622|FG000|STARTED|Washout (1 Week)||5
6538088|NCT01655901|7459623|FG001|STARTED|Washout (1 Week)||5
6538089|NCT01655901|7459624|FG002|STARTED|Washout (1 Week)||5
6538090|NCT01655901|7459625|FG003|STARTED|Washout (1 Week)||5
6538091|NCT01655901|7459626|FG004|STARTED|Washout (1 Week)||5
6538092|NCT01655901|7459627|FG005|STARTED|Washout (1 Week)||5
6538093|NCT01655901|7459622|FG000|COMPLETED|Washout (1 Week)||5
6538094|NCT01655901|7459623|FG001|COMPLETED|Washout (1 Week)||5
6538095|NCT01655901|7459624|FG002|COMPLETED|Washout (1 Week)||5
6538096|NCT01655901|7459625|FG003|COMPLETED|Washout (1 Week)||5
6538097|NCT01655901|7459626|FG004|COMPLETED|Washout (1 Week)||5
6538098|NCT01655901|7459627|FG005|COMPLETED|Washout (1 Week)||5
6538099|NCT01655901|7459622|FG000|NOT COMPLETED|Washout (1 Week)||0
6538100|NCT01655901|7459623|FG001|NOT COMPLETED|Washout (1 Week)||0
6538101|NCT01655901|7459624|FG002|NOT COMPLETED|Washout (1 Week)||0
6538102|NCT01655901|7459625|FG003|NOT COMPLETED|Washout (1 Week)||0
6538103|NCT01655901|7459626|FG004|NOT COMPLETED|Washout (1 Week)||0
6538104|NCT01655901|7459627|FG005|NOT COMPLETED|Washout (1 Week)||0
6538105|NCT01655901|7459622|FG000|STARTED|Third Intervention (Hour 3)||5
6538106|NCT01655901|7459623|FG001|STARTED|Third Intervention (Hour 3)||5
6538107|NCT01655901|7459624|FG002|STARTED|Third Intervention (Hour 3)||5
6538108|NCT01655901|7459625|FG003|STARTED|Third Intervention (Hour 3)||5
6538109|NCT01655901|7459626|FG004|STARTED|Third Intervention (Hour 3)||5
6538110|NCT01655901|7459627|FG005|STARTED|Third Intervention (Hour 3)||5
6538111|NCT01655901|7459622|FG000|COMPLETED|Third Intervention (Hour 3)||4
6538112|NCT01655901|7459623|FG001|COMPLETED|Third Intervention (Hour 3)||4
6538113|NCT01655901|7459624|FG002|COMPLETED|Third Intervention (Hour 3)||4
6538114|NCT01655901|7459625|FG003|COMPLETED|Third Intervention (Hour 3)||5
6538115|NCT01655901|7459626|FG004|COMPLETED|Third Intervention (Hour 3)||4
6538116|NCT01655901|7459627|FG005|COMPLETED|Third Intervention (Hour 3)||5
6538117|NCT01655901|7459622|FG000|NOT COMPLETED|Third Intervention (Hour 3)||1
6538118|NCT01655901|7459623|FG001|NOT COMPLETED|Third Intervention (Hour 3)||1
6538119|NCT01655901|7459624|FG002|NOT COMPLETED|Third Intervention (Hour 3)||1
6538120|NCT01655901|7459625|FG003|NOT COMPLETED|Third Intervention (Hour 3)||0
6538121|NCT01655901|7459626|FG004|NOT COMPLETED|Third Intervention (Hour 3)||1
6538122|NCT01655901|7459627|FG005|NOT COMPLETED|Third Intervention (Hour 3)||0
6538123|NCT01656031|7459636|FG000|STARTED|Overall Study||39
6538124|NCT01656031|7459636|FG000|COMPLETED|Overall Study||39
6538125|NCT01656031|7459636|FG000|NOT COMPLETED|Overall Study||0
6538126|NCT01656161|7459640|FG000|STARTED|Overall Study|Intention to treat analysis set|120
6538127|NCT01656161|7459640|FG000|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
6538128|NCT01656161|7459640|FG000|Received Triptorelin at Day 169|Overall Study||115
6538129|NCT01656161|7459640|FG000|COMPLETED|Overall Study|Per protocol analysis set|113
6538130|NCT01656161|7459640|FG000|NOT COMPLETED|Overall Study||7
6538131|NCT01656187|7459649|FG000|STARTED|First Intervention (24 Weeks)||20
6538132|NCT01656187|7459650|FG001|STARTED|First Intervention (24 Weeks)||26
6538133|NCT01656187|7459649|FG000|COMPLETED|First Intervention (24 Weeks)||14
6538134|NCT01656187|7459650|FG001|COMPLETED|First Intervention (24 Weeks)||23
6538135|NCT01656187|7459649|FG000|NOT COMPLETED|First Intervention (24 Weeks)||6
6538136|NCT01656187|7459650|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
6538137|NCT01656187|7459649|FG000|STARTED|Washout (4 Weeks)||14
6538138|NCT01656187|7459650|FG001|STARTED|Washout (4 Weeks)||23
6538139|NCT01656187|7459649|FG000|COMPLETED|Washout (4 Weeks)||14
6538140|NCT01656187|7459650|FG001|COMPLETED|Washout (4 Weeks)||22
6538141|NCT01656187|7459649|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6538142|NCT01656187|7459650|FG001|NOT COMPLETED|Washout (4 Weeks)||1
6538143|NCT01656187|7459649|FG000|STARTED|Second Intervention (24 Weeks)||14
6538144|NCT01656187|7459650|FG001|STARTED|Second Intervention (24 Weeks)||22
6538145|NCT01656187|7459649|FG000|COMPLETED|Second Intervention (24 Weeks)||13
6538146|NCT01656187|7459650|FG001|COMPLETED|Second Intervention (24 Weeks)||19
6538147|NCT01656187|7459649|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||1
6538148|NCT01656187|7459650|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||3
6538149|NCT01656200|7459656|FG000|STARTED|Overall Study||17
6538150|NCT01656200|7459656|FG000|COMPLETED|Overall Study||16
6538151|NCT01656200|7459656|FG000|NOT COMPLETED|Overall Study||1
6538152|NCT01656252|7459660|FG000|STARTED|Phase I||14
6538153|NCT01656252|7459660|FG000|COMPLETED|Phase I||14
6538154|NCT01656252|7459660|FG000|NOT COMPLETED|Phase I||0
6538155|NCT01656252|7459660|FG000|STARTED|Phase II||0
6538156|NCT01656252|7459660|FG000|COMPLETED|Phase II||0
6538157|NCT01656252|7459660|FG000|NOT COMPLETED|Phase II||0
6538158|NCT01656304|7459666|FG000|STARTED|Overall Study||16
6538159|NCT01656304|7459666|FG000|COMPLETED|Overall Study||15
6538160|NCT01656304|7459666|FG000|NOT COMPLETED|Overall Study||1
6538161|NCT01656395|7459676|FG000|STARTED|Overall Study||60
6538162|NCT01656395|7459677|FG001|STARTED|Overall Study||127
6538163|NCT01656395|7459678|FG002|STARTED|Overall Study||142
6538164|NCT01656395|7459679|FG003|STARTED|Overall Study||53
6538165|NCT01656395|7459680|FG004|STARTED|Overall Study||60
6538166|NCT01656395|7459681|FG005|STARTED|Overall Study||134
6538167|NCT01656395|7459682|FG006|STARTED|Overall Study||0
6538168|NCT01656395|7459683|FG007|STARTED|Overall Study||0
6538169|NCT01656395|7459676|FG000|Treated Participants|Overall Study||58
6743761|NCT03335254|7671818|FG008|STARTED|Period 3, Day 26-30||0
6743762|NCT03335254|7671819|FG009|STARTED|Period 3, Day 26-30||0
6538170|NCT01656395|7459677|FG001|Treated Participants|Overall Study||126
6538171|NCT01656395|7459678|FG002|Treated Participants|Overall Study||135
6538172|NCT01656395|7459679|FG003|Treated Participants|Overall Study||52
6538173|NCT01656395|7459680|FG004|Treated Participants|Overall Study||60
6538174|NCT01656395|7459681|FG005|Treated Participants|Overall Study||126
6538175|NCT01656395|7459682|FG006|Treated Participants|Overall Study||0
6538176|NCT01656395|7459683|FG007|Treated Participants|Overall Study||0
6538177|NCT01656395|7459676|FG000|COMPLETED|Overall Study||43
6538178|NCT01656395|7459677|FG001|COMPLETED|Overall Study||93
6538179|NCT01656395|7459678|FG002|COMPLETED|Overall Study||106
6538180|NCT01656395|7459679|FG003|COMPLETED|Overall Study||41
6538181|NCT01656395|7459680|FG004|COMPLETED|Overall Study||46
6538182|NCT01656395|7459681|FG005|COMPLETED|Overall Study||94
6538183|NCT01656395|7459682|FG006|COMPLETED|Overall Study||0
6538184|NCT01656395|7459683|FG007|COMPLETED|Overall Study||0
6538185|NCT01656395|7459676|FG000|NOT COMPLETED|Overall Study||17
6538186|NCT01656395|7459677|FG001|NOT COMPLETED|Overall Study||34
6538187|NCT01656395|7459678|FG002|NOT COMPLETED|Overall Study||36
6538188|NCT01656395|7459679|FG003|NOT COMPLETED|Overall Study||12
6538189|NCT01656395|7459680|FG004|NOT COMPLETED|Overall Study||14
6538190|NCT01656395|7459681|FG005|NOT COMPLETED|Overall Study||40
6538191|NCT01656395|7459682|FG006|NOT COMPLETED|Overall Study||0
6538192|NCT01656395|7459683|FG007|NOT COMPLETED|Overall Study||0
6538193|NCT01656408|7459707|FG000|STARTED|Overall Study||8
6538194|NCT01656408|7459708|FG001|STARTED|Overall Study||8
6538195|NCT01656408|7459709|FG002|STARTED|Overall Study||8
6538196|NCT01656408|7459710|FG003|STARTED|Overall Study||7
6538197|NCT01656408|7459711|FG004|STARTED|Overall Study||9
6538198|NCT01656408|7459712|FG005|STARTED|Overall Study||9
6538199|NCT01656408|7459713|FG006|STARTED|Overall Study||10
6538200|NCT01656408|7459714|FG007|STARTED|Overall Study||8
6538201|NCT01656408|7459715|FG008|STARTED|Overall Study||18
6538202|NCT01656408|7459716|FG009|STARTED|Overall Study||18
6538203|NCT01656408|7459707|FG000|COMPLETED|Overall Study||7
6538204|NCT01656408|7459708|FG001|COMPLETED|Overall Study||8
6538205|NCT01656408|7459709|FG002|COMPLETED|Overall Study||6
6538206|NCT01656408|7459710|FG003|COMPLETED|Overall Study||7
6538207|NCT01656408|7459711|FG004|COMPLETED|Overall Study||8
6538208|NCT01656408|7459712|FG005|COMPLETED|Overall Study||7
6538209|NCT01656408|7459713|FG006|COMPLETED|Overall Study||9
6538210|NCT01656408|7459714|FG007|COMPLETED|Overall Study||7
6538211|NCT01656408|7459715|FG008|COMPLETED|Overall Study||16
6538212|NCT01656408|7459716|FG009|COMPLETED|Overall Study||15
6538213|NCT01656408|7459707|FG000|NOT COMPLETED|Overall Study||1
6538214|NCT01656408|7459708|FG001|NOT COMPLETED|Overall Study||0
6538215|NCT01656408|7459709|FG002|NOT COMPLETED|Overall Study||2
6538216|NCT01656408|7459710|FG003|NOT COMPLETED|Overall Study||0
6538217|NCT01656408|7459711|FG004|NOT COMPLETED|Overall Study||1
6538218|NCT01656408|7459712|FG005|NOT COMPLETED|Overall Study||2
6538219|NCT01656408|7459713|FG006|NOT COMPLETED|Overall Study||1
6538220|NCT01656408|7459714|FG007|NOT COMPLETED|Overall Study||1
6538221|NCT01656408|7459715|FG008|NOT COMPLETED|Overall Study||2
6538222|NCT01656408|7459716|FG009|NOT COMPLETED|Overall Study||3
6538223|NCT01656460|7459762|FG000|STARTED|Overall Study||3
6538224|NCT01656460|7459763|FG001|STARTED|Overall Study||3
6538225|NCT01656460|7459764|FG002|STARTED|Overall Study||3
6538226|NCT01656460|7459765|FG003|STARTED|Overall Study||3
6538227|NCT01656460|7459762|FG000|COMPLETED|Overall Study||3
6538228|NCT01656460|7459763|FG001|COMPLETED|Overall Study||3
6538229|NCT01656460|7459764|FG002|COMPLETED|Overall Study||3
6645586|NCT02373098|7574538|FG001|STARTED|Overall Study||60
6645587|NCT02373098|7574537|FG000|COMPLETED|Overall Study||54
6645588|NCT02373098|7574538|FG001|COMPLETED|Overall Study||60
6538230|NCT01656460|7459765|FG003|COMPLETED|Overall Study||3
6538231|NCT01656460|7459762|FG000|NOT COMPLETED|Overall Study||0
6538232|NCT01656460|7459763|FG001|NOT COMPLETED|Overall Study||0
6538233|NCT01656460|7459764|FG002|NOT COMPLETED|Overall Study||0
6538234|NCT01656460|7459765|FG003|NOT COMPLETED|Overall Study||0
6538235|NCT01656486|7459775|FG000|STARTED|Overall Study||1
6538236|NCT01656486|7459775|FG000|COMPLETED|Overall Study||1
6538237|NCT01656486|7459775|FG000|NOT COMPLETED|Overall Study||0
6538238|NCT01656629|7459782|FG000|STARTED|Overall Study||21
6538239|NCT01656629|7459783|FG001|STARTED|Overall Study||18
6538240|NCT01656629|7459784|FG002|STARTED|Overall Study||16
6645589|NCT02373098|7574537|FG000|NOT COMPLETED|Overall Study||12
6538241|NCT01656629|7459782|FG000|COMPLETED|Overall Study||16
6538242|NCT01656629|7459783|FG001|COMPLETED|Overall Study||16
6538243|NCT01656629|7459784|FG002|COMPLETED|Overall Study||14
6538244|NCT01656629|7459782|FG000|NOT COMPLETED|Overall Study||5
6538245|NCT01656629|7459783|FG001|NOT COMPLETED|Overall Study||2
6538246|NCT01656629|7459784|FG002|NOT COMPLETED|Overall Study||2
6538247|NCT01656733|7459794|FG000|STARTED|Overall Study|4 discontinued after BL visit (lost to follow up)|67
6538248|NCT01656733|7459795|FG001|STARTED|Overall Study|5 discontinued after BL visit ( lost to follow up)|70
6538249|NCT01656733|7459794|FG000|Visit 1 (1 Week After Quit Date)|Overall Study||45
6538250|NCT01656733|7459795|FG001|Visit 1 (1 Week After Quit Date)|Overall Study||42
6538251|NCT01656733|7459794|FG000|Visit 2 (2 Weeks After Quit Date)|Overall Study||32
6538252|NCT01656733|7459795|FG001|Visit 2 (2 Weeks After Quit Date)|Overall Study||44
6538253|NCT01656733|7459794|FG000|Visit 3 (3 Weeks After Quit Date)|Overall Study||33
6538254|NCT01656733|7459795|FG001|Visit 3 (3 Weeks After Quit Date)|Overall Study||34
6538255|NCT01656733|7459794|FG000|Visit 4 (4 Weeks After Quit Date)|Overall Study||32
6538256|NCT01656733|7459795|FG001|Visit 4 (4 Weeks After Quit Date)|Overall Study||30
6538257|NCT01656733|7459794|FG000|Visit 5 (6 Weeks After Quit Date)|Overall Study||37
6538258|NCT01656733|7459795|FG001|Visit 5 (6 Weeks After Quit Date)|Overall Study||36
6538259|NCT01656733|7459794|FG000|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||39
6538260|NCT01656733|7459795|FG001|Visit 6 ( 32-36 Weeks Gestation)|Overall Study||47
6538261|NCT01656733|7459794|FG000|Participants With Perinatal Outcomes|Overall Study||67
6538262|NCT01656733|7459795|FG001|Participants With Perinatal Outcomes|Overall Study||66
6538263|NCT01656733|7459794|FG000|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||47
6538264|NCT01656733|7459795|FG001|Visit 7 (1 Month Postpartum) Phone Call|Overall Study||50
6538265|NCT01656733|7459794|FG000|Visit 8 (6 Months Postpartum)|Overall Study||30
6538266|NCT01656733|7459795|FG001|Visit 8 (6 Months Postpartum)|Overall Study||28
6538267|NCT01656733|7459794|FG000|COMPLETED|Overall Study||67
6538268|NCT01656733|7459795|FG001|COMPLETED|Overall Study||66
6538269|NCT01656733|7459794|FG000|NOT COMPLETED|Overall Study||0
6538270|NCT01656733|7459795|FG001|NOT COMPLETED|Overall Study||4
6538271|NCT01656759|7459803|FG000|STARTED|Overall Study||27
6538272|NCT01656759|7459804|FG001|STARTED|Overall Study||25
6538273|NCT01656759|7459803|FG000|COMPLETED|Overall Study||25
6538274|NCT01656759|7459804|FG001|COMPLETED|Overall Study||22
6538275|NCT01656759|7459803|FG000|NOT COMPLETED|Overall Study||2
6538276|NCT01656759|7459804|FG001|NOT COMPLETED|Overall Study||3
6538277|NCT01656772|7459812|FG000|STARTED|Overall Study||43
6538278|NCT01656772|7459813|FG001|STARTED|Overall Study||77
6538279|NCT01656772|7459812|FG000|COMPLETED|Overall Study||43
6538280|NCT01656772|7459813|FG001|COMPLETED|Overall Study||77
6538281|NCT01656772|7459812|FG000|NOT COMPLETED|Overall Study||0
6538282|NCT01656772|7459813|FG001|NOT COMPLETED|Overall Study||0
6538283|NCT01656850|7459821|FG000|STARTED|First Intervention (3 Months)||20
6538284|NCT01656850|7459822|FG001|STARTED|First Intervention (3 Months)||20
6538285|NCT01656850|7459821|FG000|COMPLETED|First Intervention (3 Months)||17
6538286|NCT01656850|7459822|FG001|COMPLETED|First Intervention (3 Months)||16
6538287|NCT01656850|7459821|FG000|NOT COMPLETED|First Intervention (3 Months)||3
6538288|NCT01656850|7459822|FG001|NOT COMPLETED|First Intervention (3 Months)||4
6538289|NCT01656850|7459821|FG000|STARTED|Washout (2 Weeks)||17
6538290|NCT01656850|7459822|FG001|STARTED|Washout (2 Weeks)||16
6538291|NCT01656850|7459821|FG000|COMPLETED|Washout (2 Weeks)||17
6538292|NCT01656850|7459822|FG001|COMPLETED|Washout (2 Weeks)||16
6538293|NCT01656850|7459821|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6538294|NCT01656850|7459822|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6538295|NCT01656850|7459821|FG000|STARTED|Second Intervention (3 Months)||17
6538296|NCT01656850|7459822|FG001|STARTED|Second Intervention (3 Months)||16
6538297|NCT01656850|7459821|FG000|COMPLETED|Second Intervention (3 Months)||17
6538298|NCT01656850|7459822|FG001|COMPLETED|Second Intervention (3 Months)||16
6538299|NCT01656850|7459821|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
6538300|NCT01656850|7459822|FG001|NOT COMPLETED|Second Intervention (3 Months)||0
6538301|NCT01656889|7459834|FG000|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
6538302|NCT01656889|7459835|FG001|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
6538303|NCT01656889|7459834|FG000|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
6538304|NCT01656889|7459835|FG001|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
6538305|NCT01656889|7459834|FG000|NOT COMPLETED|Treatment Period, 12 Weeks||12
6538306|NCT01656889|7459835|FG001|NOT COMPLETED|Treatment Period, 12 Weeks||11
6538307|NCT01656889|7459834|FG000|STARTED|Post Treatment Follow-Up, 3 Months||210
6538308|NCT01656889|7459835|FG001|STARTED|Post Treatment Follow-Up, 3 Months||213
6538309|NCT01656889|7459834|FG000|COMPLETED|Post Treatment Follow-Up, 3 Months||206
6538310|NCT01656889|7459835|FG001|COMPLETED|Post Treatment Follow-Up, 3 Months||204
6538311|NCT01656889|7459834|FG000|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
6538312|NCT01656889|7459835|FG001|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
6538313|NCT01656967|7459843|FG000|STARTED|Overall Study||33
6538314|NCT01656967|7459844|FG001|STARTED|Overall Study||33
6538315|NCT01656967|7459843|FG000|SGA Placement|Overall Study||32
6538316|NCT01656967|7459844|FG001|SGA Placement|Overall Study||33
6538317|NCT01656967|7459843|FG000|ETT Insertion|Overall Study||29
6538318|NCT01656967|7459844|FG001|ETT Insertion|Overall Study||31
6538319|NCT01656967|7459843|FG000|COMPLETED|Overall Study||29
6538320|NCT01656967|7459844|FG001|COMPLETED|Overall Study||31
6538321|NCT01656967|7459843|FG000|NOT COMPLETED|Overall Study||4
6538322|NCT01656967|7459844|FG001|NOT COMPLETED|Overall Study||2
6538323|NCT01657019|7459854|FG000|STARTED|Overall Study||604
6538324|NCT01657019|7459854|FG000|COMPLETED|Overall Study||369
6538325|NCT01657019|7459854|FG000|NOT COMPLETED|Overall Study||235
6538326|NCT01657032|7459860|FG000|STARTED|Overall Study||44
6538327|NCT01657032|7459861|FG001|STARTED|Overall Study||44
6538328|NCT01657032|7459860|FG000|COMPLETED|Overall Study||44
6538329|NCT01657032|7459861|FG001|COMPLETED|Overall Study||37
6538330|NCT01657032|7459860|FG000|NOT COMPLETED|Overall Study||0
6538331|NCT01657032|7459861|FG001|NOT COMPLETED|Overall Study||7
6538332|NCT01657162|7459869|FG000|STARTED|Overall Study||558
6538333|NCT01657162|7459870|FG001|STARTED|Overall Study||581
6538334|NCT01657162|7459869|FG000|Study 003 ITT Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|824
6538335|NCT01657162|7459870|FG001|Study 003 ITT Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|821
6538336|NCT01657162|7459869|FG000|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|690
6538337|NCT01657162|7459870|FG001|Study 003 Modified ITT (mITT) Population|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|711
6538338|NCT01657162|7459869|FG000|Completed Study 003|Overall Study|Participants received 80 mcg abaloparatide SC during Study 003.|606
6538339|NCT01657162|7459870|FG001|Completed Study 003|Overall Study|Participants received abaloparatide-matching placebo during Study 003.|637
6538340|NCT01657162|7459869|FG000|Study 005 ITT Population|Overall Study||558
6538341|NCT01657162|7459870|FG001|Study 005 ITT Population|Overall Study||581
6538342|NCT01657162|7459869|FG000|Study 005 Safety Population|Overall Study||553
6538343|NCT01657162|7459870|FG001|Study 005 Safety Population|Overall Study||580
6538344|NCT01657162|7459869|FG000|Study 005 mITT Population|Overall Study||544
6538345|NCT01657162|7459870|FG001|Study 005 mITT Population|Overall Study||568
6538346|NCT01657162|7459869|FG000|COMPLETED|Overall Study||499
6538347|NCT01657162|7459870|FG001|COMPLETED|Overall Study||506
6538348|NCT01657162|7459869|FG000|NOT COMPLETED|Overall Study||59
6538349|NCT01657162|7459870|FG001|NOT COMPLETED|Overall Study||75
6538350|NCT01657253|7459878|FG000|STARTED|Overall Study||93
6538351|NCT01657253|7459879|FG001|STARTED|Overall Study||90
6538352|NCT01657253|7459878|FG000|COMPLETED|Overall Study||76
6538353|NCT01657253|7459879|FG001|COMPLETED|Overall Study||72
6538354|NCT01657253|7459878|FG000|NOT COMPLETED|Overall Study||17
6538355|NCT01657253|7459879|FG001|NOT COMPLETED|Overall Study||18
6538356|NCT01657266|7459887|FG000|STARTED|Overall Study||73
6538357|NCT01657266|7459888|FG001|STARTED|Overall Study||75
6538358|NCT01657266|7459887|FG000|COMPLETED|Overall Study||69
6538359|NCT01657266|7459888|FG001|COMPLETED|Overall Study||70
6538360|NCT01657266|7459887|FG000|NOT COMPLETED|Overall Study||4
6538361|NCT01657266|7459888|FG001|NOT COMPLETED|Overall Study||5
6538362|NCT01657292|7459894|FG000|STARTED|Overall Study||61
6538363|NCT01657292|7459894|FG000|COMPLETED|Overall Study||51
6538364|NCT01657292|7459894|FG000|NOT COMPLETED|Overall Study||10
6538365|NCT01657305|7459901|FG000|STARTED|Overall Study||107
6538366|NCT01657305|7459901|FG000|COMPLETED|Overall Study||82
6538367|NCT01657305|7459901|FG000|NOT COMPLETED|Overall Study||25
6538368|NCT01657344|7459941|FG000|STARTED|Overall Study||421622
6538369|NCT01657344|7459942|FG001|STARTED|Overall Study||409967
6538370|NCT01657344|7459943|FG002|STARTED|Overall Study||196300
6538371|NCT01657344|7459944|FG003|STARTED|Overall Study||376517
6538372|NCT01657344|7459945|FG004|STARTED|Overall Study||157802
6538373|NCT01657344|7459946|FG005|STARTED|Overall Study||316477
6538374|NCT01657344|7459947|FG006|STARTED|Overall Study||140776
6538375|NCT01657344|7459941|FG000|COMPLETED|Overall Study||421622
6538376|NCT01657344|7459942|FG001|COMPLETED|Overall Study||409967
6538377|NCT01657344|7459943|FG002|COMPLETED|Overall Study||196300
6538378|NCT01657344|7459944|FG003|COMPLETED|Overall Study||376517
6538379|NCT01657344|7459945|FG004|COMPLETED|Overall Study||157802
6538380|NCT01657344|7459946|FG005|COMPLETED|Overall Study||316477
6538381|NCT01657344|7459947|FG006|COMPLETED|Overall Study||140776
6538382|NCT01657344|7459941|FG000|NOT COMPLETED|Overall Study||0
6538383|NCT01657344|7459942|FG001|NOT COMPLETED|Overall Study||0
6538384|NCT01657344|7459943|FG002|NOT COMPLETED|Overall Study||0
6538385|NCT01657344|7459944|FG003|NOT COMPLETED|Overall Study||0
6538386|NCT01657344|7459945|FG004|NOT COMPLETED|Overall Study||0
6538387|NCT01657344|7459946|FG005|NOT COMPLETED|Overall Study||0
6538388|NCT01657344|7459947|FG006|NOT COMPLETED|Overall Study||0
6538389|NCT01657370|7459963|FG000|STARTED|Overall Study||33
6538390|NCT01657370|7459964|FG001|STARTED|Overall Study||32
6538391|NCT01657370|7459965|FG002|STARTED|Overall Study||32
6538392|NCT01657370|7459966|FG003|STARTED|Overall Study||33
6538393|NCT01657370|7459967|FG004|STARTED|Overall Study||34
6538394|NCT01657370|7459968|FG005|STARTED|Overall Study||31
6538395|NCT01657370|7459963|FG000|COMPLETED|Overall Study||27
6538396|NCT01657370|7459964|FG001|COMPLETED|Overall Study||28
6538397|NCT01657370|7459965|FG002|COMPLETED|Overall Study||25
6538398|NCT01657370|7459966|FG003|COMPLETED|Overall Study||28
6538399|NCT01657370|7459967|FG004|COMPLETED|Overall Study||27
6538400|NCT01657370|7459968|FG005|COMPLETED|Overall Study||27
6538401|NCT01657370|7459963|FG000|NOT COMPLETED|Overall Study||6
6538402|NCT01657370|7459964|FG001|NOT COMPLETED|Overall Study||4
6538403|NCT01657370|7459965|FG002|NOT COMPLETED|Overall Study||7
6538404|NCT01657370|7459966|FG003|NOT COMPLETED|Overall Study||5
6538405|NCT01657370|7459967|FG004|NOT COMPLETED|Overall Study||7
6538406|NCT01657370|7459968|FG005|NOT COMPLETED|Overall Study||4
6538407|NCT01657461|7459989|FG000|STARTED|Overall Study||98
6538408|NCT01657461|7459990|FG001|STARTED|Overall Study||98
6538409|NCT01657461|7459989|FG000|COMPLETED|Overall Study||88
6538410|NCT01657461|7459990|FG001|COMPLETED|Overall Study||78
6538411|NCT01657461|7459989|FG000|NOT COMPLETED|Overall Study||10
6538412|NCT01657461|7459990|FG001|NOT COMPLETED|Overall Study||20
6538413|NCT01657617|7459996|FG000|STARTED|Overall Study||35
6538414|NCT01657617|7459996|FG000|COMPLETED|Overall Study||35
6538415|NCT01657617|7459996|FG000|NOT COMPLETED|Overall Study||0
6538416|NCT01657760|7460002|FG000|STARTED|Overall Study||5
6538417|NCT01657760|7460003|FG001|STARTED|Overall Study||7
6538418|NCT01657760|7460004|FG002|STARTED|Overall Study||7
6538419|NCT01657760|7460005|FG003|STARTED|Overall Study||7
6538420|NCT01657760|7460002|FG000|COMPLETED|Overall Study||4
6538421|NCT01657760|7460003|FG001|COMPLETED|Overall Study||6
6538422|NCT01657760|7460004|FG002|COMPLETED|Overall Study||6
6538423|NCT01657760|7460005|FG003|COMPLETED|Overall Study||4
6538424|NCT01657760|7460002|FG000|NOT COMPLETED|Overall Study||1
6538425|NCT01657760|7460003|FG001|NOT COMPLETED|Overall Study||1
6538426|NCT01657760|7460004|FG002|NOT COMPLETED|Overall Study||1
6538427|NCT01657760|7460005|FG003|NOT COMPLETED|Overall Study||3
6538428|NCT01657799|7460020|FG000|STARTED|Overall Study||102
6538429|NCT01657799|7460021|FG001|STARTED|Overall Study||103
6538430|NCT01657799|7460022|FG002|STARTED|Overall Study||102
6538431|NCT01657799|7460020|FG000|Received Treatment|Overall Study||101
6538432|NCT01657799|7460021|FG001|Received Treatment|Overall Study||103
6538433|NCT01657799|7460022|FG002|Received Treatment|Overall Study||102
6538434|NCT01657799|7460020|FG000|COMPLETED|Overall Study||0
6538435|NCT01657799|7460021|FG001|COMPLETED|Overall Study||0
6538436|NCT01657799|7460022|FG002|COMPLETED|Overall Study||0
6538437|NCT01657799|7460020|FG000|NOT COMPLETED|Overall Study||102
6538438|NCT01657799|7460021|FG001|NOT COMPLETED|Overall Study||103
6538439|NCT01657799|7460022|FG002|NOT COMPLETED|Overall Study||102
6538440|NCT01657877|7460030|FG000|STARTED|Overall Study||79
6538441|NCT01657877|7460030|FG000|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
6538442|NCT01657877|7460030|FG000|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
6538443|NCT01657877|7460030|FG000|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
6538444|NCT01657877|7460030|FG000|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
6538445|NCT01657877|7460030|FG000|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
6538446|NCT01657877|7460030|FG000|COMPLETED|Overall Study||65
6538447|NCT01657877|7460030|FG000|NOT COMPLETED|Overall Study||14
6538448|NCT01657903|7460047|FG000|STARTED|Overall Study||56
6538449|NCT01657903|7460047|FG000|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
6538450|NCT01657903|7460047|FG000|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
6538451|NCT01657903|7460047|FG000|Received NaF/KNO3 Toothpaste 3|Overall Study||54
6538452|NCT01657903|7460047|FG000|Received NaF/KNO3 Toothpaste 2|Overall Study||55
6538453|NCT01657903|7460047|FG000|COMPLETED|Overall Study||54
6538454|NCT01657903|7460047|FG000|NOT COMPLETED|Overall Study||2
6538455|NCT01658020|7460060|FG000|STARTED|Overall Study||175
6538456|NCT01658020|7460061|FG001|STARTED|Overall Study||167
6538457|NCT01658020|7460060|FG000|COMPLETED|Overall Study||167
6538458|NCT01658020|7460061|FG001|COMPLETED|Overall Study||158
6538459|NCT01658020|7460060|FG000|NOT COMPLETED|Overall Study||8
6538460|NCT01658020|7460061|FG001|NOT COMPLETED|Overall Study||9
6538461|NCT01658059|7460068|FG000|STARTED|First Intervention- 2 Days||12
6538462|NCT01658059|7460069|FG001|STARTED|First Intervention- 2 Days||10
6538463|NCT01658059|7460068|FG000|COMPLETED|First Intervention- 2 Days||6
6538464|NCT01658059|7460069|FG001|COMPLETED|First Intervention- 2 Days||5
6538465|NCT01658059|7460068|FG000|NOT COMPLETED|First Intervention- 2 Days||6
6538466|NCT01658059|7460069|FG001|NOT COMPLETED|First Intervention- 2 Days||5
6538467|NCT01658059|7460068|FG000|STARTED|Washout Period- 14 Days||6
6538468|NCT01658059|7460069|FG001|STARTED|Washout Period- 14 Days||5
6538469|NCT01658059|7460068|FG000|COMPLETED|Washout Period- 14 Days||6
6538470|NCT01658059|7460069|FG001|COMPLETED|Washout Period- 14 Days||5
6538471|NCT01658059|7460068|FG000|NOT COMPLETED|Washout Period- 14 Days||0
6538472|NCT01658059|7460069|FG001|NOT COMPLETED|Washout Period- 14 Days||0
6538473|NCT01658059|7460068|FG000|STARTED|Second Intervention- 2 Days||6
6538474|NCT01658059|7460069|FG001|STARTED|Second Intervention- 2 Days||5
6538475|NCT01658059|7460068|FG000|COMPLETED|Second Intervention- 2 Days||6
6538476|NCT01658059|7460069|FG001|COMPLETED|Second Intervention- 2 Days||5
6538477|NCT01658059|7460068|FG000|NOT COMPLETED|Second Intervention- 2 Days||0
6538478|NCT01658059|7460069|FG001|NOT COMPLETED|Second Intervention- 2 Days||0
6538479|NCT01658072|7460077|FG000|STARTED|Overall Study||45
6538480|NCT01658072|7460078|FG001|STARTED|Overall Study||45
6538481|NCT01658072|7460077|FG000|COMPLETED|Overall Study||41
6538482|NCT01658072|7460078|FG001|COMPLETED|Overall Study||43
6538483|NCT01658072|7460077|FG000|NOT COMPLETED|Overall Study||4
6538484|NCT01658072|7460078|FG001|NOT COMPLETED|Overall Study||2
6538485|NCT01658150|7460084|FG000|STARTED|Overall Study||11
6538486|NCT01658150|7460084|FG000|COMPLETED|Overall Study||10
6538487|NCT01658150|7460084|FG000|NOT COMPLETED|Overall Study||1
6538488|NCT01658228|7460091|FG000|STARTED|Overall Study||30
6538489|NCT01658228|7460092|FG001|STARTED|Overall Study||31
6645590|NCT02373098|7574538|FG001|NOT COMPLETED|Overall Study||0
6645591|NCT02373124|7574550|FG000|STARTED|Overall Study||4
6645592|NCT02373124|7574550|FG000|COMPLETED|Overall Study||3
6538490|NCT01658228|7460091|FG000|COMPLETED|Overall Study||23
6538491|NCT01658228|7460092|FG001|COMPLETED|Overall Study||23
6538492|NCT01658228|7460091|FG000|NOT COMPLETED|Overall Study||7
6538493|NCT01658228|7460092|FG001|NOT COMPLETED|Overall Study||8
6538494|NCT01658436|7460098|FG000|STARTED|Overall Study||20
6538495|NCT01658436|7460099|FG001|STARTED|Overall Study||11
6538496|NCT01658436|7460098|FG000|COMPLETED|Overall Study||0
6538497|NCT01658436|7460099|FG001|COMPLETED|Overall Study||0
6538498|NCT01658436|7460098|FG000|NOT COMPLETED|Overall Study||20
6538499|NCT01658436|7460099|FG001|NOT COMPLETED|Overall Study||11
6538500|NCT01658514|7460108|FG000|STARTED|Overall Study||14
6538501|NCT01658514|7460109|FG001|STARTED|Overall Study||11
6538502|NCT01658514|7460110|FG002|STARTED|Overall Study||14
6538503|NCT01658514|7460108|FG000|Completed Treatment A|Overall Study||14
6538504|NCT01658514|7460109|FG001|Completed Treatment A|Overall Study||11
6538505|NCT01658514|7460110|FG002|Completed Treatment A|Overall Study||12
6538506|NCT01658514|7460108|FG000|Completed Treatment B|Overall Study||13
6538507|NCT01658514|7460109|FG001|Completed Treatment B|Overall Study||11
6538508|NCT01658514|7460110|FG002|Completed Treatment B|Overall Study||14
6538509|NCT01658514|7460108|FG000|Completed Treatment C|Overall Study||13
6538510|NCT01658514|7460109|FG001|Completed Treatment C|Overall Study||11
6538511|NCT01658514|7460110|FG002|Completed Treatment C|Overall Study||12
6538512|NCT01658514|7460108|FG000|Started - Normal RF Cohort Only|Overall Study||3
6538513|NCT01658514|7460109|FG001|Started - Normal RF Cohort Only|Overall Study||2
6538514|NCT01658514|7460110|FG002|Started - Normal RF Cohort Only|Overall Study||3
6538515|NCT01658514|7460108|FG000|Completed - Normal RF Cohort Only|Overall Study||3
6538516|NCT01658514|7460109|FG001|Completed - Normal RF Cohort Only|Overall Study||2
6538517|NCT01658514|7460110|FG002|Completed - Normal RF Cohort Only|Overall Study||3
6538518|NCT01658514|7460108|FG000|Started - Mild RI Cohort Only|Overall Study||4
6538519|NCT01658514|7460109|FG001|Started - Mild RI Cohort Only|Overall Study||3
6538520|NCT01658514|7460110|FG002|Started - Mild RI Cohort Only|Overall Study||4
6538521|NCT01658514|7460108|FG000|Completed - Mild RI Cohort Only|Overall Study||4
6538522|NCT01658514|7460109|FG001|Completed - Mild RI Cohort Only|Overall Study||3
6538523|NCT01658514|7460110|FG002|Completed - Mild RI Cohort Only|Overall Study||4
6538524|NCT01658514|7460108|FG000|Started - Moderate RI Cohort Only|Overall Study||4
6538525|NCT01658514|7460109|FG001|Started - Moderate RI Cohort Only|Overall Study||4
6538526|NCT01658514|7460110|FG002|Started - Moderate RI Cohort Only|Overall Study||4
6538527|NCT01658514|7460108|FG000|Completed - Moderate RI Cohort Only|Overall Study||3
6538528|NCT01658514|7460109|FG001|Completed - Moderate RI Cohort Only|Overall Study||4
6538529|NCT01658514|7460110|FG002|Completed - Moderate RI Cohort Only|Overall Study||2
6538530|NCT01658514|7460108|FG000|Started - Severe RI Cohort Only|Overall Study||3
6538531|NCT01658514|7460109|FG001|Started - Severe RI Cohort Only|Overall Study||2
6538532|NCT01658514|7460110|FG002|Started - Severe RI Cohort Only|Overall Study||3
6538533|NCT01658514|7460108|FG000|Completed - Severe RI Cohort Only|Overall Study||3
6538534|NCT01658514|7460109|FG001|Completed - Severe RI Cohort Only|Overall Study||2
6538535|NCT01658514|7460110|FG002|Completed - Severe RI Cohort Only|Overall Study||3
6538536|NCT01658514|7460108|FG000|COMPLETED|Overall Study||13
6538537|NCT01658514|7460109|FG001|COMPLETED|Overall Study||11
6538538|NCT01658514|7460110|FG002|COMPLETED|Overall Study||12
6538539|NCT01658514|7460108|FG000|NOT COMPLETED|Overall Study||1
6538540|NCT01658514|7460109|FG001|NOT COMPLETED|Overall Study||0
6538541|NCT01658514|7460110|FG002|NOT COMPLETED|Overall Study||2
6538542|NCT01658579|7460121|FG000|STARTED|Treatment Period A||15
6538543|NCT01658579|7460122|FG001|STARTED|Treatment Period A||15
6538544|NCT01658579|7460123|FG002|STARTED|Treatment Period A||15
6538545|NCT01658579|7460124|FG003|STARTED|Treatment Period A||14
6538546|NCT01658579|7460121|FG000|COMPLETED|Treatment Period A||14
6538547|NCT01658579|7460122|FG001|COMPLETED|Treatment Period A||15
6538548|NCT01658579|7460123|FG002|COMPLETED|Treatment Period A||14
6538549|NCT01658579|7460124|FG003|COMPLETED|Treatment Period A||13
6538550|NCT01658579|7460121|FG000|NOT COMPLETED|Treatment Period A||1
6538551|NCT01658579|7460122|FG001|NOT COMPLETED|Treatment Period A||0
6538552|NCT01658579|7460123|FG002|NOT COMPLETED|Treatment Period A||1
6538553|NCT01658579|7460124|FG003|NOT COMPLETED|Treatment Period A||1
6538554|NCT01658579|7460121|FG000|STARTED|Treatment Period B||14
6538555|NCT01658579|7460122|FG001|STARTED|Treatment Period B||15
6538556|NCT01658579|7460123|FG002|STARTED|Treatment Period B||14
6538557|NCT01658579|7460124|FG003|STARTED|Treatment Period B||13
6538558|NCT01658579|7460121|FG000|COMPLETED|Treatment Period B||14
6538559|NCT01658579|7460122|FG001|COMPLETED|Treatment Period B||15
6538560|NCT01658579|7460123|FG002|COMPLETED|Treatment Period B||14
6538561|NCT01658579|7460124|FG003|COMPLETED|Treatment Period B||12
6538562|NCT01658579|7460121|FG000|NOT COMPLETED|Treatment Period B||0
6538563|NCT01658579|7460122|FG001|NOT COMPLETED|Treatment Period B||0
6538564|NCT01658579|7460123|FG002|NOT COMPLETED|Treatment Period B||0
6538565|NCT01658579|7460124|FG003|NOT COMPLETED|Treatment Period B||1
6538566|NCT01658657|7460132|FG000|STARTED|Overall Study||7
6538567|NCT01658657|7460133|FG001|STARTED|Overall Study||10
6538568|NCT01658657|7460132|FG000|COMPLETED|Overall Study||4
6538569|NCT01658657|7460133|FG001|COMPLETED|Overall Study||7
6538570|NCT01658657|7460132|FG000|NOT COMPLETED|Overall Study||3
6538571|NCT01658657|7460133|FG001|NOT COMPLETED|Overall Study||3
6538572|NCT01658735|7460142|FG000|STARTED|Overall Study||39
6538573|NCT01658735|7460143|FG001|STARTED|Overall Study||36
6538574|NCT01658735|7460144|FG002|STARTED|Overall Study||38
6538575|NCT01658735|7460142|FG000|COMPLETED|Overall Study||34
6538576|NCT01658735|7460143|FG001|COMPLETED|Overall Study||29
6538577|NCT01658735|7460144|FG002|COMPLETED|Overall Study||34
6538578|NCT01658735|7460142|FG000|NOT COMPLETED|Overall Study||5
6538579|NCT01658735|7460143|FG001|NOT COMPLETED|Overall Study||7
6538580|NCT01658735|7460144|FG002|NOT COMPLETED|Overall Study||4
6538581|NCT01658839|7460152|FG000|STARTED|Overall Study||25
6538582|NCT01658839|7460152|FG000|COMPLETED|Overall Study||25
6538583|NCT01658839|7460152|FG000|NOT COMPLETED|Overall Study||0
6538584|NCT01658904|7460159|FG000|STARTED|Overall Study||3
6538585|NCT01658904|7460160|FG001|STARTED|Overall Study||0
6538586|NCT01658904|7460161|FG002|STARTED|Overall Study||0
6538587|NCT01658904|7460159|FG000|COMPLETED|Overall Study||1
6538588|NCT01658904|7460160|FG001|COMPLETED|Overall Study||0
6538589|NCT01658904|7460161|FG002|COMPLETED|Overall Study||0
6538590|NCT01658904|7460159|FG000|NOT COMPLETED|Overall Study||2
6538591|NCT01658904|7460160|FG001|NOT COMPLETED|Overall Study||0
6538592|NCT01658904|7460161|FG002|NOT COMPLETED|Overall Study||0
6538593|NCT01658943|7460174|FG000|STARTED|Overall Study||70
6538594|NCT01658943|7460175|FG001|STARTED|Overall Study||67
6538595|NCT01658943|7460174|FG000|Eligible|Overall Study||63
6538596|NCT01658943|7460175|FG001|Eligible|Overall Study||58
6538597|NCT01658943|7460174|FG000|Eligible and Began Protocol Therapy|Overall Study||62
6538598|NCT01658943|7460175|FG001|Eligible and Began Protocol Therapy|Overall Study||58
6538599|NCT01658943|7460174|FG000|COMPLETED|Overall Study||0
6538600|NCT01658943|7460175|FG001|COMPLETED|Overall Study||0
6538601|NCT01658943|7460174|FG000|NOT COMPLETED|Overall Study||70
6538602|NCT01658943|7460175|FG001|NOT COMPLETED|Overall Study||67
6538603|NCT01658995|7460183|FG000|STARTED|Overall Study||42
6538604|NCT01658995|7460184|FG001|STARTED|Overall Study||40
6538605|NCT01658995|7460183|FG000|COMPLETED|Overall Study||42
6538606|NCT01658995|7460184|FG001|COMPLETED|Overall Study||40
6538607|NCT01658995|7460183|FG000|NOT COMPLETED|Overall Study||0
6538608|NCT01658995|7460184|FG001|NOT COMPLETED|Overall Study||0
6538609|NCT01659021|7460192|FG000|STARTED|Main Study||174
6538610|NCT01659021|7460193|FG001|STARTED|Main Study||87
6538611|NCT01659021|7460192|FG000|Randomized and Treated|Main Study||173
6538612|NCT01659021|7460193|FG001|Randomized and Treated|Main Study||86
6538613|NCT01659021|7460192|FG000|COMPLETED|Main Study||100
6538614|NCT01659021|7460193|FG001|COMPLETED|Main Study||50
6538615|NCT01659021|7460192|FG000|NOT COMPLETED|Main Study||74
6538616|NCT01659021|7460193|FG001|NOT COMPLETED|Main Study||37
6538617|NCT01659021|7460192|FG000|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|138
6538618|NCT01659021|7460193|FG001|STARTED|Long-Term Follow Up|Participants did not have to complete the main study to enter the Long-Term Follow Up period.|69
6538619|NCT01659021|7460192|FG000|COMPLETED|Long-Term Follow Up||133
6538620|NCT01659021|7460193|FG001|COMPLETED|Long-Term Follow Up||65
6538621|NCT01659021|7460192|FG000|NOT COMPLETED|Long-Term Follow Up||5
6538622|NCT01659021|7460193|FG001|NOT COMPLETED|Long-Term Follow Up||4
6538623|NCT01659125|7460203|FG000|STARTED|Overall Study||26
6538624|NCT01659125|7460203|FG000|Initiated Treatment|Overall Study||24
6538625|NCT01659125|7460203|FG000|Completed the Posttreatment Assessment|Overall Study||17
6538626|NCT01659125|7460203|FG000|Completed 3-month Follow-up|Overall Study||16
6538627|NCT01659125|7460203|FG000|Completed 6-month Follow-up|Overall Study||12
6538628|NCT01659125|7460203|FG000|COMPLETED|Overall Study||12
6538629|NCT01659125|7460203|FG000|NOT COMPLETED|Overall Study||14
6538630|NCT01659255|7460224|FG000|STARTED|Overall Study||3
6538631|NCT01659255|7460225|FG001|STARTED|Overall Study||3
6538632|NCT01659255|7460226|FG002|STARTED|Overall Study||4
6538633|NCT01659255|7460227|FG003|STARTED|Overall Study||3
6538634|NCT01659255|7460228|FG004|STARTED|Overall Study||3
6538635|NCT01659255|7460229|FG005|STARTED|Overall Study||3
6538636|NCT01659255|7460230|FG006|STARTED|Overall Study||3
6538637|NCT01659255|7460231|FG007|STARTED|Overall Study||3
6538638|NCT01659255|7460232|FG008|STARTED|Overall Study||3
6538639|NCT01659255|7460233|FG009|STARTED|Overall Study||3
6538640|NCT01659255|7460234|FG010|STARTED|Overall Study||3
6538641|NCT01659255|7460235|FG011|STARTED|Overall Study||5
6538642|NCT01659255|7460236|FG012|STARTED|Overall Study||8
6538643|NCT01659255|7460237|FG013|STARTED|Overall Study||21
6538644|NCT01659255|7460238|FG014|STARTED|Overall Study||10
6538645|NCT01659255|7460239|FG015|STARTED|Overall Study||9
6538646|NCT01659255|7460240|FG016|STARTED|Overall Study||3
6538647|NCT01659255|7460224|FG000|COMPLETED|Overall Study||1
6538648|NCT01659255|7460225|FG001|COMPLETED|Overall Study||2
6538649|NCT01659255|7460226|FG002|COMPLETED|Overall Study||4
6538650|NCT01659255|7460227|FG003|COMPLETED|Overall Study||3
6538651|NCT01659255|7460228|FG004|COMPLETED|Overall Study||3
6538652|NCT01659255|7460229|FG005|COMPLETED|Overall Study||2
6538653|NCT01659255|7460230|FG006|COMPLETED|Overall Study||1
6538654|NCT01659255|7460231|FG007|COMPLETED|Overall Study||1
6538655|NCT01659255|7460232|FG008|COMPLETED|Overall Study||2
6538656|NCT01659255|7460233|FG009|COMPLETED|Overall Study||0
6538657|NCT01659255|7460234|FG010|COMPLETED|Overall Study||0
6538658|NCT01659255|7460235|FG011|COMPLETED|Overall Study||1
6538659|NCT01659255|7460236|FG012|COMPLETED|Overall Study||0
6538660|NCT01659255|7460237|FG013|COMPLETED|Overall Study||3
6538661|NCT01659255|7460238|FG014|COMPLETED|Overall Study||2
6538662|NCT01659255|7460239|FG015|COMPLETED|Overall Study||4
6538663|NCT01659255|7460240|FG016|COMPLETED|Overall Study||0
6538664|NCT01659255|7460224|FG000|NOT COMPLETED|Overall Study||2
6538665|NCT01659255|7460225|FG001|NOT COMPLETED|Overall Study||1
6538666|NCT01659255|7460226|FG002|NOT COMPLETED|Overall Study||0
6538667|NCT01659255|7460227|FG003|NOT COMPLETED|Overall Study||0
6538668|NCT01659255|7460228|FG004|NOT COMPLETED|Overall Study||0
6538669|NCT01659255|7460229|FG005|NOT COMPLETED|Overall Study||1
6538670|NCT01659255|7460230|FG006|NOT COMPLETED|Overall Study||2
6538671|NCT01659255|7460231|FG007|NOT COMPLETED|Overall Study||2
6538672|NCT01659255|7460232|FG008|NOT COMPLETED|Overall Study||1
6538673|NCT01659255|7460233|FG009|NOT COMPLETED|Overall Study||3
6538674|NCT01659255|7460234|FG010|NOT COMPLETED|Overall Study||3
6538675|NCT01659255|7460235|FG011|NOT COMPLETED|Overall Study||4
6538676|NCT01659255|7460236|FG012|NOT COMPLETED|Overall Study||8
6538677|NCT01659255|7460237|FG013|NOT COMPLETED|Overall Study||18
6538678|NCT01659255|7460238|FG014|NOT COMPLETED|Overall Study||8
6538679|NCT01659255|7460239|FG015|NOT COMPLETED|Overall Study||5
6538680|NCT01659255|7460240|FG016|NOT COMPLETED|Overall Study||3
6538681|NCT01659268|7460280|FG000|STARTED|Overall Study||9
6538682|NCT01659268|7460281|FG001|STARTED|Overall Study||8
6538683|NCT01659268|7460280|FG000|COMPLETED|Overall Study||9
6538684|NCT01659268|7460281|FG001|COMPLETED|Overall Study||8
6538685|NCT01659268|7460280|FG000|NOT COMPLETED|Overall Study||0
6538686|NCT01659268|7460281|FG001|NOT COMPLETED|Overall Study||0
6538687|NCT01659320|7460287|FG000|STARTED|Overall Study||16
6538688|NCT01659320|7460287|FG000|COMPLETED|Overall Study||13
6538689|NCT01659320|7460287|FG000|NOT COMPLETED|Overall Study||3
6538690|NCT01659567|7460291|FG000|STARTED|Overall Study||516
6538691|NCT01659567|7460291|FG000|COMPLETED|Overall Study||393
6538692|NCT01659567|7460291|FG000|NOT COMPLETED|Overall Study||123
6538693|NCT01659736|7460297|FG000|STARTED|Treatment Period||14
6538694|NCT01659736|7460298|FG001|STARTED|Treatment Period||12
6538695|NCT01659736|7460297|FG000|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
6538696|NCT01659736|7460298|FG001|COMPLETED|Treatment Period||10
6538697|NCT01659736|7460297|FG000|NOT COMPLETED|Treatment Period||5
6538698|NCT01659736|7460298|FG001|NOT COMPLETED|Treatment Period||2
6538699|NCT01659736|7460297|FG000|STARTED|3-month Follow-up||9
6538700|NCT01659736|7460298|FG001|STARTED|3-month Follow-up||10
6538701|NCT01659736|7460297|FG000|COMPLETED|3-month Follow-up||9
6538702|NCT01659736|7460298|FG001|COMPLETED|3-month Follow-up||9
6538703|NCT01659736|7460297|FG000|NOT COMPLETED|3-month Follow-up||0
6538704|NCT01659736|7460298|FG001|NOT COMPLETED|3-month Follow-up||1
6538705|NCT01659853|7460306|FG000|STARTED|Treatment Period 1||35
6538706|NCT01659853|7460307|FG001|STARTED|Treatment Period 1||35
6538707|NCT01659853|7460306|FG000|COMPLETED|Treatment Period 1||35
6538708|NCT01659853|7460307|FG001|COMPLETED|Treatment Period 1||35
6538709|NCT01659853|7460306|FG000|NOT COMPLETED|Treatment Period 1||0
6538710|NCT01659853|7460307|FG001|NOT COMPLETED|Treatment Period 1||0
6538711|NCT01659853|7460306|FG000|STARTED|Washout , 3 to 7 Days||35
6538712|NCT01659853|7460307|FG001|STARTED|Washout , 3 to 7 Days||35
6538713|NCT01659853|7460306|FG000|COMPLETED|Washout , 3 to 7 Days||33
6538714|NCT01659853|7460307|FG001|COMPLETED|Washout , 3 to 7 Days||35
6538715|NCT01659853|7460306|FG000|NOT COMPLETED|Washout , 3 to 7 Days||2
6538716|NCT01659853|7460307|FG001|NOT COMPLETED|Washout , 3 to 7 Days||0
6538717|NCT01659853|7460306|FG000|STARTED|Treatment Period 2||33
6538718|NCT01659853|7460307|FG001|STARTED|Treatment Period 2||35
6538719|NCT01659853|7460306|FG000|COMPLETED|Treatment Period 2||33
6538720|NCT01659853|7460307|FG001|COMPLETED|Treatment Period 2||35
6538721|NCT01659853|7460306|FG000|NOT COMPLETED|Treatment Period 2||0
6538722|NCT01659853|7460307|FG001|NOT COMPLETED|Treatment Period 2||0
6538723|NCT01659866|7460317|FG000|STARTED|Overall Study||430
6538724|NCT01659866|7460318|FG001|STARTED|Overall Study||80
6538725|NCT01659866|7460317|FG000|COMPLETED|Overall Study||430
6538726|NCT01659866|7460318|FG001|COMPLETED|Overall Study||80
6538727|NCT01659866|7460317|FG000|NOT COMPLETED|Overall Study||0
6538728|NCT01659866|7460318|FG001|NOT COMPLETED|Overall Study||0
6538729|NCT01659996|7460327|FG000|STARTED|Overall Study||421
6538730|NCT01659996|7460328|FG001|STARTED|Overall Study||395
6538731|NCT01659996|7460329|FG002|STARTED|Overall Study||472
6538732|NCT01659996|7460327|FG000|COMPLETED|Overall Study||413
6538733|NCT01659996|7460328|FG001|COMPLETED|Overall Study||388
6538734|NCT01659996|7460329|FG002|COMPLETED|Overall Study||461
6538735|NCT01659996|7460327|FG000|NOT COMPLETED|Overall Study||8
6538736|NCT01659996|7460328|FG001|NOT COMPLETED|Overall Study||7
6538737|NCT01659996|7460329|FG002|NOT COMPLETED|Overall Study||11
6538738|NCT01660022|7460345|FG000|STARTED|First Sequence (7 Days)||8
6538739|NCT01660022|7460346|FG001|STARTED|First Sequence (7 Days)||8
6538740|NCT01660022|7460347|FG002|STARTED|First Sequence (7 Days)||8
6538741|NCT01660022|7460348|FG003|STARTED|First Sequence (7 Days)||8
6538742|NCT01660022|7460349|FG004|STARTED|First Sequence (7 Days)||7
6538743|NCT01660022|7460350|FG005|STARTED|First Sequence (7 Days)||20
6538744|NCT01660022|7460345|FG000|COMPLETED|First Sequence (7 Days)||8
6538745|NCT01660022|7460346|FG001|COMPLETED|First Sequence (7 Days)||7
6538746|NCT01660022|7460347|FG002|COMPLETED|First Sequence (7 Days)||8
6538747|NCT01660022|7460348|FG003|COMPLETED|First Sequence (7 Days)||7
6538748|NCT01660022|7460349|FG004|COMPLETED|First Sequence (7 Days)||6
6538749|NCT01660022|7460350|FG005|COMPLETED|First Sequence (7 Days)||16
6538750|NCT01660022|7460345|FG000|NOT COMPLETED|First Sequence (7 Days)||0
6538751|NCT01660022|7460346|FG001|NOT COMPLETED|First Sequence (7 Days)||1
6538752|NCT01660022|7460347|FG002|NOT COMPLETED|First Sequence (7 Days)||0
6538753|NCT01660022|7460348|FG003|NOT COMPLETED|First Sequence (7 Days)||1
6538754|NCT01660022|7460349|FG004|NOT COMPLETED|First Sequence (7 Days)||1
6538755|NCT01660022|7460350|FG005|NOT COMPLETED|First Sequence (7 Days)||4
6538756|NCT01660022|7460345|FG000|STARTED|Second Sequence (42 Days)||8
6538757|NCT01660022|7460346|FG001|STARTED|Second Sequence (42 Days)||7
6538758|NCT01660022|7460347|FG002|STARTED|Second Sequence (42 Days)||8
6538759|NCT01660022|7460348|FG003|STARTED|Second Sequence (42 Days)||7
6538760|NCT01660022|7460349|FG004|STARTED|Second Sequence (42 Days)||6
6538761|NCT01660022|7460350|FG005|STARTED|Second Sequence (42 Days)||16
6538762|NCT01660022|7460345|FG000|COMPLETED|Second Sequence (42 Days)||8
6538763|NCT01660022|7460346|FG001|COMPLETED|Second Sequence (42 Days)||7
6538764|NCT01660022|7460347|FG002|COMPLETED|Second Sequence (42 Days)||8
6538765|NCT01660022|7460348|FG003|COMPLETED|Second Sequence (42 Days)||7
6538766|NCT01660022|7460349|FG004|COMPLETED|Second Sequence (42 Days)||6
6538767|NCT01660022|7460350|FG005|COMPLETED|Second Sequence (42 Days)||16
6538768|NCT01660022|7460345|FG000|NOT COMPLETED|Second Sequence (42 Days)||0
6538769|NCT01660022|7460346|FG001|NOT COMPLETED|Second Sequence (42 Days)||0
6538770|NCT01660022|7460347|FG002|NOT COMPLETED|Second Sequence (42 Days)||0
6538771|NCT01660022|7460348|FG003|NOT COMPLETED|Second Sequence (42 Days)||0
6538772|NCT01660022|7460349|FG004|NOT COMPLETED|Second Sequence (42 Days)||0
6538773|NCT01660022|7460350|FG005|NOT COMPLETED|Second Sequence (42 Days)||0
6538774|NCT01660191|7460379|FG000|STARTED|Enrollment and Washout||45
6538775|NCT01660191|7460380|FG001|STARTED|Enrollment and Washout||45
6538776|NCT01660191|7460381|FG002|STARTED|Enrollment and Washout||44
6538777|NCT01660191|7460379|FG000|COMPLETED|Enrollment and Washout||45
6538778|NCT01660191|7460380|FG001|COMPLETED|Enrollment and Washout||45
6538779|NCT01660191|7460381|FG002|COMPLETED|Enrollment and Washout||44
6538780|NCT01660191|7460379|FG000|NOT COMPLETED|Enrollment and Washout||0
6538781|NCT01660191|7460380|FG001|NOT COMPLETED|Enrollment and Washout||0
6538782|NCT01660191|7460381|FG002|NOT COMPLETED|Enrollment and Washout||0
6538783|NCT01660191|7460379|FG000|STARTED|Randomization||45
6538784|NCT01660191|7460380|FG001|STARTED|Randomization||45
6538785|NCT01660191|7460381|FG002|STARTED|Randomization||44
6538786|NCT01660191|7460379|FG000|COMPLETED|Randomization||45
6538787|NCT01660191|7460380|FG001|COMPLETED|Randomization||45
6538788|NCT01660191|7460381|FG002|COMPLETED|Randomization||44
6538789|NCT01660191|7460379|FG000|NOT COMPLETED|Randomization||0
6538790|NCT01660191|7460380|FG001|NOT COMPLETED|Randomization||0
6538791|NCT01660191|7460381|FG002|NOT COMPLETED|Randomization||0
6538792|NCT01660191|7460379|FG000|STARTED|End of Treatment||45
6538793|NCT01660191|7460380|FG001|STARTED|End of Treatment||45
6538794|NCT01660191|7460381|FG002|STARTED|End of Treatment||44
6538795|NCT01660191|7460379|FG000|COMPLETED|End of Treatment||44
6538796|NCT01660191|7460380|FG001|COMPLETED|End of Treatment||39
6538797|NCT01660191|7460381|FG002|COMPLETED|End of Treatment||43
6538798|NCT01660191|7460379|FG000|NOT COMPLETED|End of Treatment||1
6538799|NCT01660191|7460380|FG001|NOT COMPLETED|End of Treatment||6
6538800|NCT01660191|7460381|FG002|NOT COMPLETED|End of Treatment||1
6538801|NCT01660230|7460401|FG000|STARTED|Overall Study||4
6538802|NCT01660230|7460402|FG001|STARTED|Overall Study||4
6538803|NCT01660230|7460403|FG002|STARTED|Overall Study||4
6538804|NCT01660230|7460404|FG003|STARTED|Overall Study||4
6538805|NCT01660230|7460405|FG004|STARTED|Overall Study||4
6538806|NCT01660230|7460406|FG005|STARTED|Overall Study||2
6538807|NCT01660230|7460407|FG006|STARTED|Overall Study||4
6538808|NCT01660230|7460408|FG007|STARTED|Overall Study||6
6538809|NCT01660230|7460409|FG008|STARTED|Overall Study||6
6538810|NCT01660230|7460410|FG009|STARTED|Overall Study||6
6538811|NCT01660230|7460411|FG010|STARTED|Overall Study||6
6538812|NCT01660230|7460412|FG011|STARTED|Overall Study||14
6538813|NCT01660230|7460401|FG000|COMPLETED|Overall Study||4
6538814|NCT01660230|7460402|FG001|COMPLETED|Overall Study||4
6538815|NCT01660230|7460403|FG002|COMPLETED|Overall Study||4
6538816|NCT01660230|7460404|FG003|COMPLETED|Overall Study||4
6538817|NCT01660230|7460405|FG004|COMPLETED|Overall Study||4
6538818|NCT01660230|7460406|FG005|COMPLETED|Overall Study||2
6538819|NCT01660230|7460407|FG006|COMPLETED|Overall Study||4
6538820|NCT01660230|7460408|FG007|COMPLETED|Overall Study||6
6538821|NCT01660230|7460409|FG008|COMPLETED|Overall Study||6
6538822|NCT01660230|7460410|FG009|COMPLETED|Overall Study||6
6538823|NCT01660230|7460411|FG010|COMPLETED|Overall Study||6
6538824|NCT01660230|7460412|FG011|COMPLETED|Overall Study||14
6538825|NCT01660230|7460401|FG000|NOT COMPLETED|Overall Study||0
6538826|NCT01660230|7460402|FG001|NOT COMPLETED|Overall Study||0
6538827|NCT01660230|7460403|FG002|NOT COMPLETED|Overall Study||0
6538828|NCT01660230|7460404|FG003|NOT COMPLETED|Overall Study||0
6538829|NCT01660230|7460405|FG004|NOT COMPLETED|Overall Study||0
6538830|NCT01660230|7460406|FG005|NOT COMPLETED|Overall Study||0
6538831|NCT01660230|7460407|FG006|NOT COMPLETED|Overall Study||0
6538832|NCT01660230|7460408|FG007|NOT COMPLETED|Overall Study||0
6538833|NCT01660230|7460409|FG008|NOT COMPLETED|Overall Study||0
6538834|NCT01660230|7460410|FG009|NOT COMPLETED|Overall Study||0
6538835|NCT01660230|7460411|FG010|NOT COMPLETED|Overall Study||0
6538836|NCT01660230|7460412|FG011|NOT COMPLETED|Overall Study||0
6538837|NCT01660256|7460442|FG000|STARTED|Overall Study||84
6538838|NCT01660256|7460443|FG001|STARTED|Overall Study||83
6538839|NCT01660256|7460444|FG002|STARTED|Overall Study||42
6538840|NCT01660256|7460442|FG000|COMPLETED|Overall Study||79
6538841|NCT01660256|7460443|FG001|COMPLETED|Overall Study||83
6538842|NCT01660256|7460444|FG002|COMPLETED|Overall Study||38
6538843|NCT01660256|7460442|FG000|NOT COMPLETED|Overall Study||5
6538844|NCT01660256|7460443|FG001|NOT COMPLETED|Overall Study||0
6538845|NCT01660256|7460444|FG002|NOT COMPLETED|Overall Study||4
6538846|NCT01660321|7460452|FG000|STARTED|Overall Study||26
6538847|NCT01660321|7460452|FG000|COMPLETED|Overall Study||26
6538848|NCT01660321|7460452|FG000|NOT COMPLETED|Overall Study||0
6538849|NCT01660334|7460456|FG000|STARTED|Overall Study||13
6538850|NCT01660334|7460456|FG000|COMPLETED|Overall Study||12
6538851|NCT01660334|7460456|FG000|NOT COMPLETED|Overall Study||1
6538852|NCT01660412|7460460|FG000|STARTED|Overall Study||29
6538853|NCT01660412|7460461|FG001|STARTED|Overall Study||31
6538854|NCT01660412|7460460|FG000|Head|Overall Study||1
6538855|NCT01660412|7460461|FG001|Head|Overall Study||4
6538856|NCT01660412|7460460|FG000|Thorax|Overall Study||9
6538857|NCT01660412|7460461|FG001|Thorax|Overall Study||9
6538858|NCT01660412|7460460|FG000|Appendicular Structures|Overall Study||17
6538859|NCT01660412|7460461|FG001|Appendicular Structures|Overall Study||11
6538860|NCT01660412|7460460|FG000|Other|Overall Study||2
6538861|NCT01660412|7460461|FG001|Other|Overall Study||4
6538862|NCT01660412|7460460|FG000|Injection 1|Overall Study||29
6538863|NCT01660412|7460461|FG001|Injection 1|Overall Study||31
6538864|NCT01660412|7460460|FG000|Injection 2|Overall Study||29
6538865|NCT01660412|7460461|FG001|Injection 2|Overall Study||31
6538866|NCT01660412|7460460|FG000|Injection 3|Overall Study||29
6538867|NCT01660412|7460461|FG001|Injection 3|Overall Study||31
6538868|NCT01660412|7460460|FG000|Injection 4|Overall Study||29
6538869|NCT01660412|7460461|FG001|Injection 4|Overall Study||31
6538870|NCT01660412|7460460|FG000|COMPLETED|Overall Study||29
6538871|NCT01660412|7460461|FG001|COMPLETED|Overall Study||28
6538872|NCT01660412|7460460|FG000|NOT COMPLETED|Overall Study||0
6538873|NCT01660412|7460461|FG001|NOT COMPLETED|Overall Study||3
6538874|NCT01660672|7460467|FG000|STARTED|Overall Study||7
6538875|NCT01660672|7460467|FG000|COMPLETED|Overall Study||7
6538876|NCT01660672|7460467|FG000|NOT COMPLETED|Overall Study||0
6538877|NCT01660698|7460474|FG000|STARTED|Overall Study||10
6538878|NCT01660698|7460475|FG001|STARTED|Overall Study||10
6538879|NCT01660698|7460474|FG000|COMPLETED|Overall Study||10
6538880|NCT01660698|7460475|FG001|COMPLETED|Overall Study||10
6538881|NCT01660698|7460474|FG000|NOT COMPLETED|Overall Study||0
6538882|NCT01660698|7460475|FG001|NOT COMPLETED|Overall Study||0
6538883|NCT01660711|7460481|FG000|STARTED|Overall Study||22
6538884|NCT01660711|7460481|FG000|COMPLETED|Overall Study||14
6538885|NCT01660711|7460481|FG000|NOT COMPLETED|Overall Study||8
6538886|NCT01660737|7460485|FG000|STARTED|Overall Study||123
6538887|NCT01660737|7460485|FG000|COMPLETED|Overall Study||123
6538888|NCT01660737|7460485|FG000|NOT COMPLETED|Overall Study||0
6538889|NCT01660763|7460491|FG000|STARTED|Overall Study||315
6538890|NCT01660763|7460492|FG001|STARTED|Overall Study||104
6538891|NCT01660763|7460491|FG000|COMPLETED|Overall Study||215
6538892|NCT01660763|7460492|FG001|COMPLETED|Overall Study||43
6538893|NCT01660763|7460491|FG000|NOT COMPLETED|Overall Study||100
6538894|NCT01660763|7460492|FG001|NOT COMPLETED|Overall Study||61
6538895|NCT01660802|7460500|FG000|STARTED|Overall Study||130
6538896|NCT01660802|7460501|FG001|STARTED|Overall Study||132
6538897|NCT01660802|7460500|FG000|COMPLETED|Overall Study||126
6538898|NCT01660802|7460501|FG001|COMPLETED|Overall Study||121
6538899|NCT01660802|7460500|FG000|NOT COMPLETED|Overall Study||4
6538900|NCT01660802|7460501|FG001|NOT COMPLETED|Overall Study||11
6562249|NCT01800890|7485340|FG007|COMPLETED|Test Period 1||3
6562250|NCT01800890|7485341|FG008|COMPLETED|Test Period 1||3
6562251|NCT01800890|7485333|FG000|NOT COMPLETED|Test Period 1||0
6562252|NCT01800890|7485334|FG001|NOT COMPLETED|Test Period 1||0
6562253|NCT01800890|7485335|FG002|NOT COMPLETED|Test Period 1||0
6562254|NCT01800890|7485336|FG003|NOT COMPLETED|Test Period 1||1
6562255|NCT01800890|7485337|FG004|NOT COMPLETED|Test Period 1||0
6562256|NCT01800890|7485338|FG005|NOT COMPLETED|Test Period 1||0
6562257|NCT01800890|7485339|FG006|NOT COMPLETED|Test Period 1||0
6562258|NCT01800890|7485340|FG007|NOT COMPLETED|Test Period 1||0
6562259|NCT01800890|7485341|FG008|NOT COMPLETED|Test Period 1||0
6562260|NCT01800890|7485333|FG000|STARTED|Test Period 2||3
6562261|NCT01800890|7485334|FG001|STARTED|Test Period 2||3
6562262|NCT01800890|7485335|FG002|STARTED|Test Period 2||3
6562263|NCT01800890|7485336|FG003|STARTED|Test Period 2||2
6562264|NCT01800890|7485337|FG004|STARTED|Test Period 2||4
6562265|NCT01800890|7485338|FG005|STARTED|Test Period 2||4
6562266|NCT01800890|7485339|FG006|STARTED|Test Period 2||3
6562267|NCT01800890|7485340|FG007|STARTED|Test Period 2||3
6562268|NCT01800890|7485341|FG008|STARTED|Test Period 2||3
6562269|NCT01800890|7485333|FG000|COMPLETED|Test Period 2||3
6562270|NCT01800890|7485334|FG001|COMPLETED|Test Period 2||3
6562271|NCT01800890|7485335|FG002|COMPLETED|Test Period 2||3
6562272|NCT01800890|7485336|FG003|COMPLETED|Test Period 2||2
6562273|NCT01800890|7485337|FG004|COMPLETED|Test Period 2||4
6562274|NCT01800890|7485338|FG005|COMPLETED|Test Period 2||4
6562275|NCT01800890|7485339|FG006|COMPLETED|Test Period 2||3
6562276|NCT01800890|7485340|FG007|COMPLETED|Test Period 2||3
6562277|NCT01800890|7485341|FG008|COMPLETED|Test Period 2||3
6562278|NCT01800890|7485333|FG000|NOT COMPLETED|Test Period 2||0
6562279|NCT01800890|7485334|FG001|NOT COMPLETED|Test Period 2||0
6562280|NCT01800890|7485335|FG002|NOT COMPLETED|Test Period 2||0
6562281|NCT01800890|7485336|FG003|NOT COMPLETED|Test Period 2||0
6562282|NCT01800890|7485337|FG004|NOT COMPLETED|Test Period 2||0
6538901|NCT01660815|7460507|FG000|STARTED|Overall Study||7
6538902|NCT01660815|7460507|FG000|COMPLETED|Overall Study||7
6538903|NCT01660815|7460507|FG000|NOT COMPLETED|Overall Study||0
6538904|NCT01660893|7460515|FG000|STARTED|Overall Study||10
6538905|NCT01660893|7460516|FG001|STARTED|Overall Study||10
6538906|NCT01660893|7460517|FG002|STARTED|Overall Study||6
6538907|NCT01660893|7460515|FG000|COMPLETED|Overall Study||10
6538908|NCT01660893|7460516|FG001|COMPLETED|Overall Study||10
6538909|NCT01660893|7460517|FG002|COMPLETED|Overall Study||6
6538910|NCT01660893|7460515|FG000|NOT COMPLETED|Overall Study||0
6538911|NCT01660893|7460516|FG001|NOT COMPLETED|Overall Study||0
6538912|NCT01660893|7460517|FG002|NOT COMPLETED|Overall Study||0
6538913|NCT01660906|7460525|FG000|STARTED|Overall Study||39
6538914|NCT01660906|7460525|FG000|COMPLETED|Overall Study||36
6538915|NCT01660906|7460525|FG000|NOT COMPLETED|Overall Study||3
6538916|NCT01661062|7460529|FG000|STARTED|Overall Study||23
6538917|NCT01661062|7460529|FG000|COMPLETED|Overall Study||18
6538918|NCT01661062|7460529|FG000|NOT COMPLETED|Overall Study||5
6538919|NCT01661088|7460533|FG000|STARTED|FOLFIRINOX||25
6538920|NCT01661088|7460533|FG000|COMPLETED|FOLFIRINOX||21
6538921|NCT01661088|7460533|FG000|NOT COMPLETED|FOLFIRINOX||4
6538922|NCT01661088|7460533|FG000|STARTED|IMRT With FDR Gemcitabine||21
6538923|NCT01661088|7460533|FG000|COMPLETED|IMRT With FDR Gemcitabine||19
6538924|NCT01661088|7460533|FG000|NOT COMPLETED|IMRT With FDR Gemcitabine||2
6538925|NCT01661114|7460537|FG000|STARTED|Overall Study||39
6538926|NCT01661114|7460537|FG000|COMPLETED|Overall Study||39
6538927|NCT01661114|7460537|FG000|NOT COMPLETED|Overall Study||0
6538928|NCT01661140|7460541|FG000|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
6538929|NCT01661140|7460542|FG001|STARTED|Open-Label Period||0
6538930|NCT01661140|7460543|FG002|STARTED|Open-Label Period||0
6538931|NCT01661140|7460541|FG000|COMPLETED|Open-Label Period||351
6538932|NCT01661140|7460542|FG001|COMPLETED|Open-Label Period||0
6538933|NCT01661140|7460543|FG002|COMPLETED|Open-Label Period||0
6538934|NCT01661140|7460541|FG000|NOT COMPLETED|Open-Label Period||76
6538935|NCT01661140|7460542|FG001|NOT COMPLETED|Open-Label Period||0
6538936|NCT01661140|7460543|FG002|NOT COMPLETED|Open-Label Period||0
6538937|NCT01661140|7460541|FG000|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
6538938|NCT01661140|7460542|FG001|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
6538939|NCT01661140|7460543|FG002|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
6538940|NCT01661140|7460541|FG000|COMPLETED|Double-Blind Period||0
6538941|NCT01661140|7460542|FG001|COMPLETED|Double-Blind Period||95
6538942|NCT01661140|7460543|FG002|COMPLETED|Double-Blind Period||86
6538943|NCT01661140|7460541|FG000|NOT COMPLETED|Double-Blind Period||0
6538944|NCT01661140|7460542|FG001|NOT COMPLETED|Double-Blind Period||41
6538945|NCT01661140|7460543|FG002|NOT COMPLETED|Double-Blind Period||50
6538946|NCT01661179|7460551|FG000|STARTED|Overall Study||14
6538947|NCT01661179|7460551|FG000|COMPLETED|Overall Study||8
6538948|NCT01661179|7460551|FG000|NOT COMPLETED|Overall Study||6
6538949|NCT01661205|7460555|FG000|STARTED|Overall Study||26
6538950|NCT01661205|7460555|FG000|COMPLETED|Overall Study||24
6538951|NCT01661205|7460555|FG000|NOT COMPLETED|Overall Study||2
6538952|NCT01661270|7460561|FG000|STARTED|Overall Study||109
6538953|NCT01661270|7460562|FG001|STARTED|Overall Study||223
6538954|NCT01661270|7460561|FG000|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
6538955|NCT01661270|7460562|FG001|Adverse Event|Overall Study|Met EOT criteria|47
6538956|NCT01661270|7460561|FG000|Disease Progression|Overall Study|Met EOT criteria|67
6538957|NCT01661270|7460562|FG001|Disease Progression|Overall Study|Met EOT criteria|118
6538958|NCT01661270|7460561|FG000|Physician Decision|Overall Study|Met EOT criteria|1
6538959|NCT01661270|7460562|FG001|Physician Decision|Overall Study|Met EOT criteria|8
6538960|NCT01661270|7460561|FG000|Participant's Request|Overall Study|Met EOT criteria|15
6538961|NCT01661270|7460562|FG001|Participant's Request|Overall Study|Met EOT criteria|48
6538962|NCT01661270|7460561|FG000|Other Reasons|Overall Study||0
6538963|NCT01661270|7460562|FG001|Other Reasons|Overall Study||2
6538964|NCT01661270|7460561|FG000|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
6538965|NCT01661270|7460562|FG001|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
6538966|NCT01661270|7460561|FG000|NOT COMPLETED|Overall Study||0
6538967|NCT01661270|7460562|FG001|NOT COMPLETED|Overall Study||0
6538968|NCT01661283|7460569|FG000|STARTED|Overall Study|15 patients enrolled in the first stage; 10 patients enrolled in the second stage|25
6538969|NCT01661283|7460569|FG000|COMPLETED|Overall Study||25
6538970|NCT01661283|7460569|FG000|NOT COMPLETED|Overall Study||0
6538971|NCT01661595|7460577|FG000|STARTED|Phase 1: Week 0-4||5
6538972|NCT01661595|7460578|FG001|STARTED|Phase 1: Week 0-4||4
6538973|NCT01661595|7460579|FG002|STARTED|Phase 1: Week 0-4||5
6538974|NCT01661595|7460580|FG003|STARTED|Phase 1: Week 0-4||4
6538975|NCT01661595|7460577|FG000|COMPLETED|Phase 1: Week 0-4||4
6538976|NCT01661595|7460578|FG001|COMPLETED|Phase 1: Week 0-4||4
6538977|NCT01661595|7460579|FG002|COMPLETED|Phase 1: Week 0-4||5
6538978|NCT01661595|7460580|FG003|COMPLETED|Phase 1: Week 0-4||4
6538979|NCT01661595|7460577|FG000|NOT COMPLETED|Phase 1: Week 0-4||1
6538980|NCT01661595|7460578|FG001|NOT COMPLETED|Phase 1: Week 0-4||0
6538981|NCT01661595|7460579|FG002|NOT COMPLETED|Phase 1: Week 0-4||0
6538982|NCT01661595|7460580|FG003|NOT COMPLETED|Phase 1: Week 0-4||0
6538983|NCT01661595|7460577|FG000|STARTED|Phase 2: Week 5-8.||4
6538984|NCT01661595|7460578|FG001|STARTED|Phase 2: Week 5-8.||4
6538985|NCT01661595|7460579|FG002|STARTED|Phase 2: Week 5-8.||5
6538986|NCT01661595|7460580|FG003|STARTED|Phase 2: Week 5-8.||4
6538987|NCT01661595|7460577|FG000|COMPLETED|Phase 2: Week 5-8.||4
6538988|NCT01661595|7460578|FG001|COMPLETED|Phase 2: Week 5-8.||4
6538989|NCT01661595|7460579|FG002|COMPLETED|Phase 2: Week 5-8.||4
6538990|NCT01661595|7460580|FG003|COMPLETED|Phase 2: Week 5-8.||4
6538991|NCT01661595|7460577|FG000|NOT COMPLETED|Phase 2: Week 5-8.||0
6538992|NCT01661595|7460578|FG001|NOT COMPLETED|Phase 2: Week 5-8.||0
6538993|NCT01661595|7460579|FG002|NOT COMPLETED|Phase 2: Week 5-8.||1
6538994|NCT01661595|7460580|FG003|NOT COMPLETED|Phase 2: Week 5-8.||0
6538995|NCT01661621|7460599|FG000|STARTED|Overall Study||116
6538996|NCT01661621|7460600|FG001|STARTED|Overall Study||279
6538997|NCT01661621|7460599|FG000|COMPLETED|Overall Study||116
6538998|NCT01661621|7460600|FG001|COMPLETED|Overall Study||279
6538999|NCT01661621|7460599|FG000|NOT COMPLETED|Overall Study||0
6539000|NCT01661621|7460600|FG001|NOT COMPLETED|Overall Study||0
6539001|NCT01661686|7460608|FG000|STARTED|Overall Study||49
6539002|NCT01661686|7460609|FG001|STARTED|Overall Study||49
6539003|NCT01661686|7460608|FG000|COMPLETED|Overall Study||47
6539004|NCT01661686|7460609|FG001|COMPLETED|Overall Study||47
6539005|NCT01661686|7460608|FG000|NOT COMPLETED|Overall Study||2
6539006|NCT01661686|7460609|FG001|NOT COMPLETED|Overall Study||2
6539007|NCT01661712|7460617|FG000|STARTED|Overall Study|initial sham stimulation night|18
6539008|NCT01661712|7460618|FG001|STARTED|Overall Study|initial night on transcutaneous electrical stimulation|18
6539009|NCT01661712|7460617|FG000|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
6539010|NCT01661712|7460618|FG001|Washout Period|Overall Study|>Three nights of no stimulation/sham stimulation|18
6539011|NCT01661712|7460617|FG000|COMPLETED|Overall Study|night on transcutaneous electrical stimulation|18
6539012|NCT01661712|7460618|FG001|COMPLETED|Overall Study|sham stimulation night|18
6539013|NCT01661712|7460617|FG000|NOT COMPLETED|Overall Study||0
6539014|NCT01661712|7460618|FG001|NOT COMPLETED|Overall Study||0
6539015|NCT01661764|7460636|FG000|STARTED|Overall Study||26
6539016|NCT01661764|7460637|FG001|STARTED|Overall Study||25
6539017|NCT01661764|7460638|FG002|STARTED|Overall Study||25
6539018|NCT01661764|7460639|FG003|STARTED|Overall Study||26
6539019|NCT01661764|7460640|FG004|STARTED|Overall Study||19
6539020|NCT01661764|7460641|FG005|STARTED|Overall Study||20
6539021|NCT01661764|7460636|FG000|COMPLETED|Overall Study||24
6539022|NCT01661764|7460637|FG001|COMPLETED|Overall Study||20
6539023|NCT01661764|7460638|FG002|COMPLETED|Overall Study||22
6539024|NCT01661764|7460639|FG003|COMPLETED|Overall Study||24
6539025|NCT01661764|7460640|FG004|COMPLETED|Overall Study||16
6539026|NCT01661764|7460641|FG005|COMPLETED|Overall Study||18
6539027|NCT01661764|7460636|FG000|NOT COMPLETED|Overall Study||2
6539028|NCT01661764|7460637|FG001|NOT COMPLETED|Overall Study||5
6539029|NCT01661764|7460638|FG002|NOT COMPLETED|Overall Study||3
6539030|NCT01661764|7460639|FG003|NOT COMPLETED|Overall Study||2
6539031|NCT01661764|7460640|FG004|NOT COMPLETED|Overall Study||3
6539032|NCT01661764|7460641|FG005|NOT COMPLETED|Overall Study||2
6539033|NCT01661790|7460657|FG000|STARTED|Overall Study||36
6539034|NCT01661790|7460658|FG001|STARTED|Overall Study||36
6539035|NCT01661790|7460657|FG000|COMPLETED|Overall Study||36
6539036|NCT01661790|7460658|FG001|COMPLETED|Overall Study||34
6539037|NCT01661790|7460657|FG000|NOT COMPLETED|Overall Study||0
6539038|NCT01661790|7460658|FG001|NOT COMPLETED|Overall Study||2
6539039|NCT01661881|7460664|FG000|STARTED|Overall Study||23
6539040|NCT01661881|7460664|FG000|COMPLETED|Overall Study||22
6539041|NCT01661881|7460664|FG000|NOT COMPLETED|Overall Study||1
6539042|NCT01661933|7460668|FG000|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
6539043|NCT01661933|7460668|FG000|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
6539044|NCT01661933|7460668|FG000|NOT COMPLETED|Gluten Micro-challenge||0
6539045|NCT01661933|7460668|FG000|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
6539046|NCT01661933|7460668|FG000|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
6539047|NCT01661933|7460668|FG000|NOT COMPLETED|Low-dose Gluten Challenge||2
6539048|NCT01661933|7460668|FG000|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
6539049|NCT01661933|7460668|FG000|COMPLETED|High-dose Gluten Challenge||8
6539050|NCT01661933|7460668|FG000|NOT COMPLETED|High-dose Gluten Challenge||2
6539051|NCT01661946|7460676|FG000|STARTED|Overall Study||5
6539052|NCT01661946|7460677|FG001|STARTED|Overall Study||5
6539053|NCT01661946|7460676|FG000|COMPLETED|Overall Study||5
6539054|NCT01661946|7460677|FG001|COMPLETED|Overall Study||5
6539055|NCT01661946|7460676|FG000|NOT COMPLETED|Overall Study||0
6539056|NCT01661946|7460677|FG001|NOT COMPLETED|Overall Study||0
6539057|NCT01661972|7460685|FG000|STARTED|Overall Study||13
6539058|NCT01661972|7460686|FG001|STARTED|Overall Study||50
6539059|NCT01661972|7460685|FG000|COMPLETED|Overall Study||11
6539060|NCT01661972|7460686|FG001|COMPLETED|Overall Study||46
6539061|NCT01661972|7460685|FG000|NOT COMPLETED|Overall Study||2
6539062|NCT01661972|7460686|FG001|NOT COMPLETED|Overall Study||4
6539063|NCT01662024|7460694|FG000|STARTED|Overall Study||20
6539064|NCT01662024|7460694|FG000|COMPLETED|Overall Study||15
6539065|NCT01662024|7460694|FG000|NOT COMPLETED|Overall Study||5
6539066|NCT01662063|7460703|FG000|STARTED|Overall Study||44
6539067|NCT01662063|7460704|FG001|STARTED|Overall Study||173
6539068|NCT01662063|7460705|FG002|STARTED|Overall Study||1
6539069|NCT01662063|7460703|FG000|COMPLETED|Overall Study||39
6539070|NCT01662063|7460704|FG001|COMPLETED|Overall Study||144
6539071|NCT01662063|7460705|FG002|COMPLETED|Overall Study||0
6539072|NCT01662063|7460703|FG000|NOT COMPLETED|Overall Study||5
6539073|NCT01662063|7460704|FG001|NOT COMPLETED|Overall Study||29
6539074|NCT01662063|7460705|FG002|NOT COMPLETED|Overall Study||1
6539075|NCT01662115|7460716|FG000|STARTED|Overall Study||2
6539076|NCT01662115|7460717|FG001|STARTED|Overall Study||2
6539077|NCT01662115|7460718|FG002|STARTED|Overall Study||0
6539078|NCT01662115|7460716|FG000|COMPLETED|Overall Study||2
6539079|NCT01662115|7460717|FG001|COMPLETED|Overall Study||2
6539080|NCT01662115|7460718|FG002|COMPLETED|Overall Study||0
6539081|NCT01662115|7460716|FG000|NOT COMPLETED|Overall Study||0
6539082|NCT01662115|7460717|FG001|NOT COMPLETED|Overall Study||0
6539083|NCT01662115|7460718|FG002|NOT COMPLETED|Overall Study||0
6539084|NCT01662297|7460728|FG000|STARTED|Overall Study||0
6539085|NCT01662297|7460729|FG001|STARTED|Overall Study||1
6539086|NCT01662297|7460728|FG000|COMPLETED|Overall Study||0
6539087|NCT01662297|7460729|FG001|COMPLETED|Overall Study||1
6539088|NCT01662297|7460728|FG000|NOT COMPLETED|Overall Study||0
6539089|NCT01662297|7460729|FG001|NOT COMPLETED|Overall Study||0
6539090|NCT01662310|7460735|FG000|STARTED|Run-In or Stabilization Phase||201
6539091|NCT01662310|7460736|FG001|STARTED|Run-In or Stabilization Phase||0
6539092|NCT01662310|7460737|FG002|STARTED|Run-In or Stabilization Phase||0
6539093|NCT01662310|7460738|FG003|STARTED|Run-In or Stabilization Phase||0
6539094|NCT01662310|7460739|FG004|STARTED|Run-In or Stabilization Phase||0
6539095|NCT01662310|7460735|FG000|COMPLETED|Run-In or Stabilization Phase||136
6539096|NCT01662310|7460736|FG001|COMPLETED|Run-In or Stabilization Phase||0
6539097|NCT01662310|7460737|FG002|COMPLETED|Run-In or Stabilization Phase||0
6539098|NCT01662310|7460738|FG003|COMPLETED|Run-In or Stabilization Phase||0
6539099|NCT01662310|7460739|FG004|COMPLETED|Run-In or Stabilization Phase||0
6539100|NCT01662310|7460735|FG000|NOT COMPLETED|Run-In or Stabilization Phase||65
6539101|NCT01662310|7460736|FG001|NOT COMPLETED|Run-In or Stabilization Phase||0
6539102|NCT01662310|7460737|FG002|NOT COMPLETED|Run-In or Stabilization Phase||0
6539103|NCT01662310|7460738|FG003|NOT COMPLETED|Run-In or Stabilization Phase||0
6539104|NCT01662310|7460739|FG004|NOT COMPLETED|Run-In or Stabilization Phase||0
6539105|NCT01662310|7460735|FG000|STARTED|Double-Blind Phase||0
6539106|NCT01662310|7460736|FG001|STARTED|Double-Blind Phase||65
6539107|NCT01662310|7460737|FG002|STARTED|Double-Blind Phase||71
6539108|NCT01662310|7460738|FG003|STARTED|Double-Blind Phase||0
6539109|NCT01662310|7460739|FG004|STARTED|Double-Blind Phase||0
6539110|NCT01662310|7460735|FG000|Treated|Double-Blind Phase||0
6539111|NCT01662310|7460736|FG001|Treated|Double-Blind Phase||64
6539112|NCT01662310|7460737|FG002|Treated|Double-Blind Phase||71
6539113|NCT01662310|7460738|FG003|Treated|Double-Blind Phase||0
6539114|NCT01662310|7460739|FG004|Treated|Double-Blind Phase||0
6539115|NCT01662310|7460735|FG000|COMPLETED|Double-Blind Phase||0
6539116|NCT01662310|7460736|FG001|COMPLETED|Double-Blind Phase||50
6539117|NCT01662310|7460737|FG002|COMPLETED|Double-Blind Phase||66
6539118|NCT01662310|7460738|FG003|COMPLETED|Double-Blind Phase||0
6539119|NCT01662310|7460739|FG004|COMPLETED|Double-Blind Phase||0
6539120|NCT01662310|7460735|FG000|NOT COMPLETED|Double-Blind Phase||0
6539121|NCT01662310|7460736|FG001|NOT COMPLETED|Double-Blind Phase||15
6539122|NCT01662310|7460737|FG002|NOT COMPLETED|Double-Blind Phase||5
6539123|NCT01662310|7460738|FG003|NOT COMPLETED|Double-Blind Phase||0
6539124|NCT01662310|7460739|FG004|NOT COMPLETED|Double-Blind Phase||0
6539125|NCT01662310|7460735|FG000|STARTED|Open-Label Extension Phase||0
6539126|NCT01662310|7460736|FG001|STARTED|Open-Label Extension Phase||0
6539127|NCT01662310|7460737|FG002|STARTED|Open-Label Extension Phase||0
6539128|NCT01662310|7460738|FG003|STARTED|Open-Label Extension Phase||47
6539129|NCT01662310|7460739|FG004|STARTED|Open-Label Extension Phase||59
6539130|NCT01662310|7460735|FG000|COMPLETED|Open-Label Extension Phase||0
6539131|NCT01662310|7460736|FG001|COMPLETED|Open-Label Extension Phase||0
6539132|NCT01662310|7460737|FG002|COMPLETED|Open-Label Extension Phase||0
6539133|NCT01662310|7460738|FG003|COMPLETED|Open-Label Extension Phase||36
6539134|NCT01662310|7460739|FG004|COMPLETED|Open-Label Extension Phase||49
6539135|NCT01662310|7460735|FG000|NOT COMPLETED|Open-Label Extension Phase||0
6539136|NCT01662310|7460736|FG001|NOT COMPLETED|Open-Label Extension Phase||0
6539137|NCT01662310|7460737|FG002|NOT COMPLETED|Open-Label Extension Phase||0
6539138|NCT01662310|7460738|FG003|NOT COMPLETED|Open-Label Extension Phase||11
6539139|NCT01662310|7460739|FG004|NOT COMPLETED|Open-Label Extension Phase||10
6539140|NCT01662336|7460751|FG000|STARTED|Overall Study||173
6539141|NCT01662336|7460751|FG000|Completed Month 6 Visit|Overall Study||142
6539142|NCT01662336|7460751|FG000|Completed Month 12 Visit|Overall Study||109
6539143|NCT01662336|7460751|FG000|COMPLETED|Overall Study||107
6539144|NCT01662336|7460751|FG000|NOT COMPLETED|Overall Study||66
6539145|NCT01662362|7460760|FG000|STARTED|Overall Study||63
6539146|NCT01662362|7460760|FG000|COMPLETED|Overall Study||25
6539147|NCT01662362|7460760|FG000|NOT COMPLETED|Overall Study||38
6539148|NCT01662440|7460769|FG000|STARTED|Overall Study||167
6539149|NCT01662440|7460770|FG001|STARTED|Overall Study||217
6539150|NCT01662440|7460771|FG002|STARTED|Overall Study||221
6539151|NCT01662440|7460772|FG003|STARTED|Overall Study||56
6539152|NCT01662440|7460769|FG000|COMPLETED|Overall Study||158
6539153|NCT01662440|7460770|FG001|COMPLETED|Overall Study||211
6539154|NCT01662440|7460771|FG002|COMPLETED|Overall Study||215
6539155|NCT01662440|7460772|FG003|COMPLETED|Overall Study||52
6539156|NCT01662440|7460769|FG000|NOT COMPLETED|Overall Study||9
6539157|NCT01662440|7460770|FG001|NOT COMPLETED|Overall Study||6
6539158|NCT01662440|7460771|FG002|NOT COMPLETED|Overall Study||6
6539159|NCT01662440|7460772|FG003|NOT COMPLETED|Overall Study||4
6539160|NCT01662492|7460795|FG000|STARTED|Overall Study||45
6539161|NCT01662492|7460796|FG001|STARTED|Overall Study||43
6539162|NCT01662492|7460797|FG002|STARTED|Overall Study||37
6539163|NCT01662492|7460795|FG000|COMPLETED|Overall Study||42
6539164|NCT01662492|7460796|FG001|COMPLETED|Overall Study||42
6539165|NCT01662492|7460797|FG002|COMPLETED|Overall Study||31
6539166|NCT01662492|7460795|FG000|NOT COMPLETED|Overall Study||3
6539167|NCT01662492|7460796|FG001|NOT COMPLETED|Overall Study||1
6539168|NCT01662492|7460797|FG002|NOT COMPLETED|Overall Study||6
6539169|NCT01662505|7460808|FG000|STARTED|Overall Study||7
6539170|NCT01662505|7460809|FG001|STARTED|Overall Study||4
6539171|NCT01662505|7460810|FG002|STARTED|Overall Study||8
6539172|NCT01662505|7460808|FG000|COMPLETED|Overall Study||0
6539173|NCT01662505|7460809|FG001|COMPLETED|Overall Study||0
6539174|NCT01662505|7460810|FG002|COMPLETED|Overall Study||0
6539175|NCT01662505|7460808|FG000|NOT COMPLETED|Overall Study||7
6539176|NCT01662505|7460809|FG001|NOT COMPLETED|Overall Study||4
6539177|NCT01662505|7460810|FG002|NOT COMPLETED|Overall Study||8
6539178|NCT01662531|7460821|FG000|STARTED|Overall Study||27
6539179|NCT01662531|7460821|FG000|COMPLETED|Overall Study||27
6539180|NCT01662531|7460821|FG000|NOT COMPLETED|Overall Study||0
6539181|NCT01662583|7460830|FG000|STARTED|Overall Study||216
6539182|NCT01662583|7460831|FG001|STARTED|Overall Study||225
6539183|NCT01662583|7460832|FG002|STARTED|Overall Study||219
6539184|NCT01662583|7460830|FG000|COMPLETED|Overall Study||216
6539185|NCT01662583|7460831|FG001|COMPLETED|Overall Study||225
6539186|NCT01662583|7460832|FG002|COMPLETED|Overall Study||219
6539187|NCT01662583|7460830|FG000|NOT COMPLETED|Overall Study||0
6539188|NCT01662583|7460831|FG001|NOT COMPLETED|Overall Study||0
6539189|NCT01662583|7460832|FG002|NOT COMPLETED|Overall Study||0
6539190|NCT01662635|7460840|FG000|STARTED|Overall Study||230
6539191|NCT01662635|7460840|FG000|COMPLETED|Overall Study||200
6539192|NCT01662635|7460840|FG000|NOT COMPLETED|Overall Study||30
6539193|NCT01662648|7460848|FG000|STARTED|Overall Study||520
6539194|NCT01662648|7460849|FG001|STARTED|Overall Study||597
6539195|NCT01662648|7460848|FG000|COMPLETED|Overall Study||373
6539196|NCT01662648|7460849|FG001|COMPLETED|Overall Study||419
6539197|NCT01662648|7460848|FG000|NOT COMPLETED|Overall Study||147
6539198|NCT01662648|7460849|FG001|NOT COMPLETED|Overall Study||178
6539199|NCT01662752|7460855|FG000|STARTED|Overall Study||30
6539200|NCT01662752|7460855|FG000|COMPLETED|Overall Study||30
6539201|NCT01662752|7460855|FG000|NOT COMPLETED|Overall Study||0
6539202|NCT01662765|7460861|FG000|STARTED|Overall Study||42
6539203|NCT01662765|7460862|FG001|STARTED|Overall Study||42
6539204|NCT01662765|7460861|FG000|COMPLETED|Overall Study||41
6539205|NCT01662765|7460862|FG001|COMPLETED|Overall Study||40
6539206|NCT01662765|7460861|FG000|NOT COMPLETED|Overall Study||1
6539207|NCT01662765|7460862|FG001|NOT COMPLETED|Overall Study||2
6539208|NCT01662778|7460873|FG000|STARTED|Period 1||6
6539209|NCT01662778|7460874|FG001|STARTED|Period 1||5
6539210|NCT01662778|7460875|FG002|STARTED|Period 1||6
6539211|NCT01662778|7460876|FG003|STARTED|Period 1||4
6539212|NCT01662778|7460873|FG000|COMPLETED|Period 1||6
6539213|NCT01662778|7460874|FG001|COMPLETED|Period 1||5
6539214|NCT01662778|7460875|FG002|COMPLETED|Period 1||6
6539215|NCT01662778|7460876|FG003|COMPLETED|Period 1||4
6539216|NCT01662778|7460873|FG000|NOT COMPLETED|Period 1||0
6539217|NCT01662778|7460874|FG001|NOT COMPLETED|Period 1||0
6539218|NCT01662778|7460875|FG002|NOT COMPLETED|Period 1||0
6539219|NCT01662778|7460876|FG003|NOT COMPLETED|Period 1||0
6539220|NCT01662778|7460873|FG000|STARTED|Period 2||6
6539221|NCT01662778|7460874|FG001|STARTED|Period 2||5
6539222|NCT01662778|7460875|FG002|STARTED|Period 2||6
6539223|NCT01662778|7460876|FG003|STARTED|Period 2||4
6539224|NCT01662778|7460873|FG000|COMPLETED|Period 2||6
6539225|NCT01662778|7460874|FG001|COMPLETED|Period 2||5
6539226|NCT01662778|7460875|FG002|COMPLETED|Period 2||6
6539227|NCT01662778|7460876|FG003|COMPLETED|Period 2||4
6539228|NCT01662778|7460873|FG000|NOT COMPLETED|Period 2||0
6539229|NCT01662778|7460874|FG001|NOT COMPLETED|Period 2||0
6539230|NCT01662778|7460875|FG002|NOT COMPLETED|Period 2||0
6539231|NCT01662778|7460876|FG003|NOT COMPLETED|Period 2||0
6539232|NCT01662778|7460873|FG000|STARTED|Period 3||6
6539233|NCT01662778|7460874|FG001|STARTED|Period 3||5
6539234|NCT01662778|7460875|FG002|STARTED|Period 3||6
6539235|NCT01662778|7460876|FG003|STARTED|Period 3||4
6539236|NCT01662778|7460873|FG000|COMPLETED|Period 3||6
6539237|NCT01662778|7460874|FG001|COMPLETED|Period 3||5
6539238|NCT01662778|7460875|FG002|COMPLETED|Period 3||6
6539239|NCT01662778|7460876|FG003|COMPLETED|Period 3||4
6539240|NCT01662778|7460873|FG000|NOT COMPLETED|Period 3||0
6539241|NCT01662778|7460874|FG001|NOT COMPLETED|Period 3||0
6539242|NCT01662778|7460875|FG002|NOT COMPLETED|Period 3||0
6539243|NCT01662778|7460876|FG003|NOT COMPLETED|Period 3||0
6539244|NCT01662778|7460873|FG000|STARTED|Period 4||6
6539245|NCT01662778|7460874|FG001|STARTED|Period 4||5
6539246|NCT01662778|7460875|FG002|STARTED|Period 4||6
6539247|NCT01662778|7460876|FG003|STARTED|Period 4||4
6539248|NCT01662778|7460873|FG000|COMPLETED|Period 4||6
6539249|NCT01662778|7460874|FG001|COMPLETED|Period 4||5
6539250|NCT01662778|7460875|FG002|COMPLETED|Period 4||6
6539251|NCT01662778|7460876|FG003|COMPLETED|Period 4||4
6539252|NCT01662778|7460873|FG000|NOT COMPLETED|Period 4||0
6539253|NCT01662778|7460874|FG001|NOT COMPLETED|Period 4||0
6539254|NCT01662778|7460875|FG002|NOT COMPLETED|Period 4||0
6539255|NCT01662778|7460876|FG003|NOT COMPLETED|Period 4||0
6539256|NCT01662791|7460892|FG000|STARTED|Part 1 - Observational||8
6539257|NCT01662791|7460893|FG001|STARTED|Part 1 - Observational||41
6539258|NCT01662791|7460892|FG000|COMPLETED|Part 1 - Observational||8
6539259|NCT01662791|7460893|FG001|COMPLETED|Part 1 - Observational||41
6539260|NCT01662791|7460892|FG000|NOT COMPLETED|Part 1 - Observational||0
6539261|NCT01662791|7460893|FG001|NOT COMPLETED|Part 1 - Observational||0
6539262|NCT01662791|7460892|FG000|STARTED|Part 2 - Interventional||8
6539263|NCT01662791|7460893|FG001|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
6539264|NCT01662791|7460892|FG000|COMPLETED|Part 2 - Interventional||8
6539265|NCT01662791|7460893|FG001|COMPLETED|Part 2 - Interventional||0
6539266|NCT01662791|7460892|FG000|NOT COMPLETED|Part 2 - Interventional||0
6539267|NCT01662791|7460893|FG001|NOT COMPLETED|Part 2 - Interventional||0
6539268|NCT01662856|7460901|FG000|STARTED|Part I + Part II (Overall Study)||168
6539269|NCT01662856|7460902|FG001|STARTED|Part I + Part II (Overall Study)||57
6539270|NCT01662856|7460901|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
6539271|NCT01662856|7460902|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
6539272|NCT01662856|7460901|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
6539273|NCT01662856|7460902|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
6539274|NCT01662856|7460901|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||16
6539275|NCT01662856|7460902|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||2
6539276|NCT01662856|7460901|FG000|STARTED|Primary Part II||109
6539277|NCT01662856|7460902|FG001|STARTED|Primary Part II||57
6539278|NCT01662856|7460901|FG000|Completed Study up to Week 6|Primary Part II||106
6539279|NCT01662856|7460902|FG001|Completed Study up to Week 6|Primary Part II||56
6539280|NCT01662856|7460901|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
6539281|NCT01662856|7460902|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
6539282|NCT01662856|7460901|FG000|NOT COMPLETED|Primary Part II||10
6539283|NCT01662856|7460902|FG001|NOT COMPLETED|Primary Part II||2
6539284|NCT01662882|7460911|FG000|STARTED|Overall Study||15
6539285|NCT01662882|7460912|FG001|STARTED|Overall Study||18
6539286|NCT01662882|7460913|FG002|STARTED|Overall Study||15
6539287|NCT01662882|7460911|FG000|COMPLETED|Overall Study||15
6539288|NCT01662882|7460912|FG001|COMPLETED|Overall Study||18
6539289|NCT01662882|7460913|FG002|COMPLETED|Overall Study||15
6539290|NCT01662882|7460911|FG000|NOT COMPLETED|Overall Study||0
6539291|NCT01662882|7460912|FG001|NOT COMPLETED|Overall Study||0
6539292|NCT01662882|7460913|FG002|NOT COMPLETED|Overall Study||0
6539293|NCT01662895|7460923|FG000|STARTED|Overall Study||21
6539294|NCT01662895|7460924|FG001|STARTED|Overall Study||21
6539295|NCT01662895|7460923|FG000|Initiated Study Drug|Overall Study||21
6539296|NCT01662895|7460924|FG001|Initiated Study Drug|Overall Study||21
6539297|NCT01662895|7460923|FG000|COMPLETED|Overall Study||21
6539298|NCT01662895|7460924|FG001|COMPLETED|Overall Study||20
6539299|NCT01662895|7460923|FG000|NOT COMPLETED|Overall Study||0
6539300|NCT01662895|7460924|FG001|NOT COMPLETED|Overall Study||1
6539301|NCT01662908|7460932|FG000|STARTED|Overall Study||56
6539302|NCT01662908|7460933|FG001|STARTED|Overall Study||28
6539303|NCT01662908|7460932|FG000|COMPLETED|Overall Study||50
6539304|NCT01662908|7460933|FG001|COMPLETED|Overall Study||23
6539305|NCT01662908|7460932|FG000|NOT COMPLETED|Overall Study||6
6539306|NCT01662908|7460933|FG001|NOT COMPLETED|Overall Study||5
6539307|NCT01662960|7460943|FG000|STARTED|End of 4 Week Treatment Period||25
6539308|NCT01662960|7460944|FG001|STARTED|End of 4 Week Treatment Period||23
6539309|NCT01662960|7460945|FG002|STARTED|End of 4 Week Treatment Period||9
6539310|NCT01662960|7460946|FG003|STARTED|End of 4 Week Treatment Period||15
6539311|NCT01662960|7460943|FG000|COMPLETED|End of 4 Week Treatment Period||24
6539312|NCT01662960|7460944|FG001|COMPLETED|End of 4 Week Treatment Period||19
6539313|NCT01662960|7460945|FG002|COMPLETED|End of 4 Week Treatment Period||8
6539314|NCT01662960|7460946|FG003|COMPLETED|End of 4 Week Treatment Period||15
6539315|NCT01662960|7460943|FG000|NOT COMPLETED|End of 4 Week Treatment Period||1
6539316|NCT01662960|7460944|FG001|NOT COMPLETED|End of 4 Week Treatment Period||4
6539317|NCT01662960|7460945|FG002|NOT COMPLETED|End of 4 Week Treatment Period||1
6539318|NCT01662960|7460946|FG003|NOT COMPLETED|End of 4 Week Treatment Period||0
6539319|NCT01662960|7460943|FG000|STARTED|3 Month Follow-up||24
6539320|NCT01662960|7460944|FG001|STARTED|3 Month Follow-up||19
6539321|NCT01662960|7460945|FG002|STARTED|3 Month Follow-up||8
6539322|NCT01662960|7460946|FG003|STARTED|3 Month Follow-up||15
6539323|NCT01662960|7460943|FG000|COMPLETED|3 Month Follow-up||21
6539324|NCT01662960|7460944|FG001|COMPLETED|3 Month Follow-up||16
6539325|NCT01662960|7460945|FG002|COMPLETED|3 Month Follow-up||5
6539326|NCT01662960|7460946|FG003|COMPLETED|3 Month Follow-up||13
6539327|NCT01662960|7460943|FG000|NOT COMPLETED|3 Month Follow-up||3
6539328|NCT01662960|7460944|FG001|NOT COMPLETED|3 Month Follow-up||3
6539329|NCT01662960|7460945|FG002|NOT COMPLETED|3 Month Follow-up||3
6539330|NCT01662960|7460946|FG003|NOT COMPLETED|3 Month Follow-up||2
6539331|NCT01662986|7460958|FG000|STARTED|Overall Study||40
6539332|NCT01662986|7460959|FG001|STARTED|Overall Study||39
6539333|NCT01662986|7460958|FG000|COMPLETED|Overall Study||22
6539334|NCT01662986|7460959|FG001|COMPLETED|Overall Study||26
6539335|NCT01662986|7460958|FG000|NOT COMPLETED|Overall Study||18
6539336|NCT01662986|7460959|FG001|NOT COMPLETED|Overall Study||13
6539337|NCT01662999|7460971|FG000|STARTED|Period 1||7
6539338|NCT01662999|7460972|FG001|STARTED|Period 1||7
6539339|NCT01662999|7460973|FG002|STARTED|Period 1||7
6539340|NCT01662999|7460974|FG003|STARTED|Period 1||7
6539341|NCT01662999|7460975|FG004|STARTED|Period 1||7
6539342|NCT01662999|7460976|FG005|STARTED|Period 1||7
6539343|NCT01662999|7460971|FG000|COMPLETED|Period 1||7
6539344|NCT01662999|7460972|FG001|COMPLETED|Period 1||7
6539345|NCT01662999|7460973|FG002|COMPLETED|Period 1||7
6539346|NCT01662999|7460974|FG003|COMPLETED|Period 1||7
6539347|NCT01662999|7460975|FG004|COMPLETED|Period 1||7
6539348|NCT01662999|7460976|FG005|COMPLETED|Period 1||7
6539349|NCT01662999|7460971|FG000|NOT COMPLETED|Period 1||0
6539350|NCT01662999|7460972|FG001|NOT COMPLETED|Period 1||0
6539351|NCT01662999|7460973|FG002|NOT COMPLETED|Period 1||0
6539352|NCT01662999|7460974|FG003|NOT COMPLETED|Period 1||0
6539353|NCT01662999|7460975|FG004|NOT COMPLETED|Period 1||0
6539354|NCT01662999|7460976|FG005|NOT COMPLETED|Period 1||0
6539355|NCT01662999|7460971|FG000|STARTED|Period 2||7
6539356|NCT01662999|7460972|FG001|STARTED|Period 2||7
6539357|NCT01662999|7460973|FG002|STARTED|Period 2||7
6539358|NCT01662999|7460974|FG003|STARTED|Period 2||7
6539359|NCT01662999|7460975|FG004|STARTED|Period 2||7
6539360|NCT01662999|7460976|FG005|STARTED|Period 2||7
6539361|NCT01662999|7460971|FG000|COMPLETED|Period 2||7
6539362|NCT01662999|7460972|FG001|COMPLETED|Period 2||7
6539363|NCT01662999|7460973|FG002|COMPLETED|Period 2||7
6539364|NCT01662999|7460974|FG003|COMPLETED|Period 2||7
6539365|NCT01662999|7460975|FG004|COMPLETED|Period 2||7
6539366|NCT01662999|7460976|FG005|COMPLETED|Period 2||7
6539367|NCT01662999|7460971|FG000|NOT COMPLETED|Period 2||0
6539368|NCT01662999|7460972|FG001|NOT COMPLETED|Period 2||0
6539369|NCT01662999|7460973|FG002|NOT COMPLETED|Period 2||0
6539370|NCT01662999|7460974|FG003|NOT COMPLETED|Period 2||0
6539371|NCT01662999|7460975|FG004|NOT COMPLETED|Period 2||0
6539372|NCT01662999|7460976|FG005|NOT COMPLETED|Period 2||0
6539373|NCT01662999|7460971|FG000|STARTED|Period 3||7
6539374|NCT01662999|7460972|FG001|STARTED|Period 3||7
6539375|NCT01662999|7460973|FG002|STARTED|Period 3||7
6539376|NCT01662999|7460974|FG003|STARTED|Period 3||7
6539377|NCT01662999|7460975|FG004|STARTED|Period 3||7
6539378|NCT01662999|7460976|FG005|STARTED|Period 3||7
6539379|NCT01662999|7460971|FG000|COMPLETED|Period 3||7
6539380|NCT01662999|7460972|FG001|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
6539381|NCT01662999|7460973|FG002|COMPLETED|Period 3||7
6539382|NCT01662999|7460974|FG003|COMPLETED|Period 3||7
6539383|NCT01662999|7460975|FG004|COMPLETED|Period 3||7
6539384|NCT01662999|7460976|FG005|COMPLETED|Period 3||7
6539385|NCT01662999|7460971|FG000|NOT COMPLETED|Period 3||0
6539386|NCT01662999|7460972|FG001|NOT COMPLETED|Period 3||1
6539387|NCT01662999|7460973|FG002|NOT COMPLETED|Period 3||0
6539388|NCT01662999|7460974|FG003|NOT COMPLETED|Period 3||0
6539389|NCT01662999|7460975|FG004|NOT COMPLETED|Period 3||0
6539390|NCT01662999|7460976|FG005|NOT COMPLETED|Period 3||0
6539391|NCT01663012|7461006|FG000|STARTED|Overall Study||20
6539392|NCT01663012|7461006|FG000|COMPLETED|Overall Study||20
6539393|NCT01663012|7461006|FG000|NOT COMPLETED|Overall Study||0
6539394|NCT01663103|7461012|FG000|STARTED|Overall Study||21
6539395|NCT01663103|7461013|FG001|STARTED|Overall Study||21
6539396|NCT01663103|7461012|FG000|COMPLETED|Overall Study||18
6539397|NCT01663103|7461013|FG001|COMPLETED|Overall Study||19
6539398|NCT01663103|7461012|FG000|NOT COMPLETED|Overall Study||3
6645593|NCT02373124|7574550|FG000|NOT COMPLETED|Overall Study||1
6645594|NCT02373137|7574556|FG000|STARTED|Overall Study||19
6645595|NCT02373137|7574557|FG001|STARTED|Overall Study||19
6645596|NCT02373137|7574556|FG000|3-Month Follow-Up|Overall Study||19
6645597|NCT02373137|7574557|FG001|3-Month Follow-Up|Overall Study||19
6645598|NCT02373137|7574556|FG000|6-Month Follow-Up|Overall Study||19
6645599|NCT02373137|7574557|FG001|6-Month Follow-Up|Overall Study||18
6645600|NCT02373137|7574556|FG000|12-Month Follow-Up|Overall Study||19
6645601|NCT02373137|7574557|FG001|12-Month Follow-Up|Overall Study||19
6645602|NCT02373137|7574556|FG000|COMPLETED|Overall Study||18
6645603|NCT02373137|7574557|FG001|COMPLETED|Overall Study||18
6539399|NCT01663103|7461013|FG001|NOT COMPLETED|Overall Study||2
6539400|NCT01663233|7461025|FG000|STARTED|Overall Study||130
6539401|NCT01663233|7461026|FG001|STARTED|Overall Study||136
6539402|NCT01663233|7461025|FG000|COMPLETED|Overall Study||126
6539403|NCT01663233|7461026|FG001|COMPLETED|Overall Study||129
6539404|NCT01663233|7461025|FG000|NOT COMPLETED|Overall Study||4
6539405|NCT01663233|7461026|FG001|NOT COMPLETED|Overall Study||7
6539406|NCT01663259|7461032|FG000|STARTED|Overall Study||42
6539407|NCT01663259|7461032|FG000|COMPLETED|Overall Study||42
6539408|NCT01663259|7461032|FG000|NOT COMPLETED|Overall Study||0
6645604|NCT02373137|7574556|FG000|NOT COMPLETED|Overall Study||1
6539409|NCT01663272|7461036|FG000|STARTED|Overall Study||5
6539410|NCT01663272|7461037|FG001|STARTED|Overall Study||6
6539411|NCT01663272|7461038|FG002|STARTED|Overall Study||1
6539412|NCT01663272|7461036|FG000|COMPLETED|Overall Study||5
6539413|NCT01663272|7461037|FG001|COMPLETED|Overall Study||6
6539414|NCT01663272|7461038|FG002|COMPLETED|Overall Study||1
6645605|NCT02373137|7574557|FG001|NOT COMPLETED|Overall Study||1
6539415|NCT01663272|7461036|FG000|NOT COMPLETED|Overall Study||0
6539416|NCT01663272|7461037|FG001|NOT COMPLETED|Overall Study||0
6539417|NCT01663272|7461038|FG002|NOT COMPLETED|Overall Study||0
6539418|NCT01663363|7461042|FG000|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
6539419|NCT01663363|7461042|FG000|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
6539420|NCT01663363|7461042|FG000|NOT COMPLETED|Overall Study||0
6539421|NCT01663402|7461048|FG000|STARTED|Overall Study||9462
6539422|NCT01663402|7461049|FG001|STARTED|Overall Study||9462
6539423|NCT01663402|7461048|FG000|Treated|Overall Study||9443
6539424|NCT01663402|7461049|FG001|Treated|Overall Study||9451
6539425|NCT01663402|7461048|FG000|COMPLETED|Overall Study||7947
6539426|NCT01663402|7461049|FG001|COMPLETED|Overall Study||7378
6539427|NCT01663402|7461048|FG000|NOT COMPLETED|Overall Study||1515
6539428|NCT01663402|7461049|FG001|NOT COMPLETED|Overall Study||2084
6539429|NCT01663506|7461055|FG000|STARTED|Overall Study||23
6539430|NCT01663506|7461055|FG000|COMPLETED|Overall Study||15
6539431|NCT01663506|7461055|FG000|NOT COMPLETED|Overall Study||8
6539432|NCT01663532|7461061|FG000|STARTED|Overall Study||168
6539433|NCT01663532|7461062|FG001|STARTED|Overall Study||172
6539434|NCT01663532|7461061|FG000|COMPLETED|Overall Study||94
6539435|NCT01663532|7461062|FG001|COMPLETED|Overall Study||65
6539436|NCT01663532|7461061|FG000|NOT COMPLETED|Overall Study||74
6539437|NCT01663532|7461062|FG001|NOT COMPLETED|Overall Study||107
6539438|NCT01663623|7461070|FG000|STARTED|Overall Study||52
6539439|NCT01663623|7461071|FG001|STARTED|Overall Study||53
6539440|NCT01663623|7461070|FG000|COMPLETED|Overall Study||40
6539441|NCT01663623|7461071|FG001|COMPLETED|Overall Study||33
6539442|NCT01663623|7461070|FG000|NOT COMPLETED|Overall Study||12
6539443|NCT01663623|7461071|FG001|NOT COMPLETED|Overall Study||20
6539444|NCT01663636|7461079|FG000|STARTED|Infant SMS Reminder Feasibility Study||160
6539445|NCT01663636|7461080|FG001|STARTED|Infant SMS Reminder Feasibility Study||161
6539446|NCT01663636|7461079|FG000|COMPLETED|Infant SMS Reminder Feasibility Study||135
6539447|NCT01663636|7461080|FG001|COMPLETED|Infant SMS Reminder Feasibility Study||130
6539448|NCT01663636|7461079|FG000|NOT COMPLETED|Infant SMS Reminder Feasibility Study||25
6539449|NCT01663636|7461080|FG001|NOT COMPLETED|Infant SMS Reminder Feasibility Study||31
6539450|NCT01663636|7461079|FG000|STARTED|Parent SMS Acceptability Assessment||135
6539451|NCT01663636|7461080|FG001|STARTED|Parent SMS Acceptability Assessment||130
6539452|NCT01663636|7461079|FG000|COMPLETED|Parent SMS Acceptability Assessment||135
6539453|NCT01663636|7461080|FG001|COMPLETED|Parent SMS Acceptability Assessment||130
6539454|NCT01663636|7461079|FG000|NOT COMPLETED|Parent SMS Acceptability Assessment||0
6539455|NCT01663636|7461080|FG001|NOT COMPLETED|Parent SMS Acceptability Assessment||0
6539456|NCT01663714|7461086|FG000|STARTED|Dosimetric and Therapeutic Treatment||30
6539457|NCT01663714|7461086|FG000|COMPLETED|Dosimetric and Therapeutic Treatment||0
6539458|NCT01663714|7461086|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
6539459|NCT01663714|7461086|FG000|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
6539460|NCT01663714|7461086|FG000|COMPLETED|Long-Term Follow-Up||16
6539461|NCT01663714|7461086|FG000|NOT COMPLETED|Long-Term Follow-Up||6
6539462|NCT01663727|7461094|FG000|STARTED|Overall Study||242
6539463|NCT01663727|7461095|FG001|STARTED|Overall Study||239
6539464|NCT01663727|7461094|FG000|COMPLETED|Overall Study||0
6539465|NCT01663727|7461095|FG001|COMPLETED|Overall Study||1
6539466|NCT01663727|7461094|FG000|NOT COMPLETED|Overall Study||242
6539467|NCT01663727|7461095|FG001|NOT COMPLETED|Overall Study||238
6539468|NCT01663740|7461103|FG000|STARTED|Overall Study|Safety Population|38
6539469|NCT01663740|7461104|FG001|STARTED|Overall Study|Safety Population|21
6539470|NCT01663740|7461103|FG000|COMPLETED|Overall Study||22
6539471|NCT01663740|7461104|FG001|COMPLETED|Overall Study||13
6539472|NCT01663740|7461103|FG000|NOT COMPLETED|Overall Study||16
6539473|NCT01663740|7461104|FG001|NOT COMPLETED|Overall Study||8
6539474|NCT01663779|7461112|FG000|STARTED|Overall Study||27
6539475|NCT01663779|7461113|FG001|STARTED|Overall Study||23
6539476|NCT01663779|7461112|FG000|COMPLETED|Overall Study||27
6539477|NCT01663779|7461113|FG001|COMPLETED|Overall Study||23
6539478|NCT01663779|7461112|FG000|NOT COMPLETED|Overall Study||0
6539479|NCT01663779|7461113|FG001|NOT COMPLETED|Overall Study||0
6539480|NCT01663857|7461123|FG000|STARTED|Overall Study||6
6539481|NCT01663857|7461124|FG001|STARTED|Overall Study||2
6539482|NCT01663857|7461125|FG002|STARTED|Overall Study||58
6539483|NCT01663857|7461126|FG003|STARTED|Overall Study||52
6539484|NCT01663857|7461123|FG000|Received at Least One Dose of Study Drug|Overall Study||6
6539485|NCT01663857|7461124|FG001|Received at Least One Dose of Study Drug|Overall Study||2
6539486|NCT01663857|7461125|FG002|Received at Least One Dose of Study Drug|Overall Study||58
6539487|NCT01663857|7461126|FG003|Received at Least One Dose of Study Drug|Overall Study||52
6539488|NCT01663857|7461123|FG000|COMPLETED|Overall Study||6
6539489|NCT01663857|7461124|FG001|COMPLETED|Overall Study||1
6539490|NCT01663857|7461125|FG002|COMPLETED|Overall Study||48
6539491|NCT01663857|7461126|FG003|COMPLETED|Overall Study||48
6539492|NCT01663857|7461123|FG000|NOT COMPLETED|Overall Study||0
6539493|NCT01663857|7461124|FG001|NOT COMPLETED|Overall Study||1
6539494|NCT01663857|7461125|FG002|NOT COMPLETED|Overall Study||10
6539495|NCT01663857|7461126|FG003|NOT COMPLETED|Overall Study||4
6539496|NCT01663896|7461142|FG000|STARTED|Overall Study||418
6539497|NCT01663896|7461142|FG000|COMPLETED|Overall Study||375
6539498|NCT01663896|7461142|FG000|NOT COMPLETED|Overall Study||43
6539499|NCT01663922|7461147|FG000|STARTED|First Intervention (14 Days or 5 Days)||8
6539500|NCT01663922|7461148|FG001|STARTED|First Intervention (14 Days or 5 Days)||9
6539501|NCT01663922|7461147|FG000|COMPLETED|First Intervention (14 Days or 5 Days)||8
6539502|NCT01663922|7461148|FG001|COMPLETED|First Intervention (14 Days or 5 Days)||9
6539503|NCT01663922|7461147|FG000|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
6539504|NCT01663922|7461148|FG001|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
6645606|NCT02373202|7574568|FG000|STARTED|Overall Study||15
6645607|NCT02373202|7574569|FG001|STARTED|Overall Study||15
6645608|NCT02373202|7574570|FG002|STARTED|Overall Study||30
6645609|NCT02373202|7574571|FG003|STARTED|Overall Study||31
6645610|NCT02373202|7574568|FG000|COMPLETED|Overall Study||13
6645611|NCT02373202|7574569|FG001|COMPLETED|Overall Study||9
6645612|NCT02373202|7574570|FG002|COMPLETED|Overall Study||27
6645613|NCT02373202|7574571|FG003|COMPLETED|Overall Study||30
6645614|NCT02373202|7574568|FG000|NOT COMPLETED|Overall Study||2
6539505|NCT01663922|7461147|FG000|STARTED|Washout (7 Days)||8
6539506|NCT01663922|7461148|FG001|STARTED|Washout (7 Days)||9
6539507|NCT01663922|7461147|FG000|COMPLETED|Washout (7 Days)||8
6539508|NCT01663922|7461148|FG001|COMPLETED|Washout (7 Days)||9
6539509|NCT01663922|7461147|FG000|NOT COMPLETED|Washout (7 Days)||0
6539510|NCT01663922|7461148|FG001|NOT COMPLETED|Washout (7 Days)||0
6539511|NCT01663922|7461147|FG000|STARTED|Second Intervention (14 Days)||8
6539512|NCT01663922|7461148|FG001|STARTED|Second Intervention (14 Days)||9
6539513|NCT01663922|7461147|FG000|COMPLETED|Second Intervention (14 Days)||8
6539514|NCT01663922|7461148|FG001|COMPLETED|Second Intervention (14 Days)||9
6539515|NCT01663922|7461147|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
6539516|NCT01663922|7461148|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
6539517|NCT01663922|7461147|FG000|STARTED|Washout (7 Days)||8
6539518|NCT01663922|7461148|FG001|STARTED|Washout (7 Days)||9
6539519|NCT01663922|7461147|FG000|COMPLETED|Washout (7 Days)||8
6539520|NCT01663922|7461148|FG001|COMPLETED|Washout (7 Days)||9
6539521|NCT01663922|7461147|FG000|NOT COMPLETED|Washout (7 Days)||0
6539522|NCT01663922|7461148|FG001|NOT COMPLETED|Washout (7 Days)||0
6539523|NCT01663922|7461147|FG000|STARTED|Third Intervention (14 Days or 5 Days)||8
6539524|NCT01663922|7461148|FG001|STARTED|Third Intervention (14 Days or 5 Days)||9
6539525|NCT01663922|7461147|FG000|COMPLETED|Third Intervention (14 Days or 5 Days)||8
6539526|NCT01663922|7461148|FG001|COMPLETED|Third Intervention (14 Days or 5 Days)||9
6539527|NCT01663922|7461147|FG000|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
6539528|NCT01663922|7461148|FG001|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
6539529|NCT01663935|7461153|FG000|STARTED|Overall Study||20
6539530|NCT01663935|7461153|FG000|COMPLETED|Overall Study||20
6539531|NCT01663935|7461153|FG000|NOT COMPLETED|Overall Study||0
6539532|NCT01663987|7461159|FG000|STARTED|Overall Study||39
6539533|NCT01663987|7461160|FG001|STARTED|Overall Study||40
6539534|NCT01663987|7461159|FG000|COMPLETED|Overall Study||26
6539535|NCT01663987|7461160|FG001|COMPLETED|Overall Study||34
6539536|NCT01663987|7461159|FG000|NOT COMPLETED|Overall Study||13
6539537|NCT01663987|7461160|FG001|NOT COMPLETED|Overall Study||6
6539538|NCT01664039|7461168|FG000|STARTED|Overall Study||52
6539539|NCT01664039|7461169|FG001|STARTED|Overall Study||52
6539540|NCT01664039|7461168|FG000|COMPLETED|Overall Study||46
6539541|NCT01664039|7461169|FG001|COMPLETED|Overall Study||43
6539542|NCT01664039|7461168|FG000|NOT COMPLETED|Overall Study||6
6539543|NCT01664039|7461169|FG001|NOT COMPLETED|Overall Study||9
6539544|NCT01664052|7461177|FG000|STARTED|Phase 1|Screening and enrollment|31
6539545|NCT01664052|7461178|FG001|STARTED|Phase 1||0
6539546|NCT01664052|7461177|FG000|Insert Placed in at Least One Tube|Phase 1||25
6539547|NCT01664052|7461178|FG001|Insert Placed in at Least One Tube|Phase 1||0
6539548|NCT01664052|7461177|FG000|HSG 1 Hour Post Placement|Phase 1||24
6539549|NCT01664052|7461178|FG001|HSG 1 Hour Post Placement|Phase 1||0
6539550|NCT01664052|7461177|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
6539551|NCT01664052|7461178|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
6539552|NCT01664052|7461177|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
6539553|NCT01664052|7461178|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
6539554|NCT01664052|7461177|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
6539555|NCT01664052|7461178|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
6539556|NCT01664052|7461177|FG000|COMPLETED|Phase 1||24
6539557|NCT01664052|7461178|FG001|COMPLETED|Phase 1||0
6539558|NCT01664052|7461177|FG000|NOT COMPLETED|Phase 1||7
6539559|NCT01664052|7461178|FG001|NOT COMPLETED|Phase 1||0
6539560|NCT01664052|7461177|FG000|STARTED|Phase 2|Screened and enrolled|0
6539561|NCT01664052|7461178|FG001|STARTED|Phase 2||35
6539562|NCT01664052|7461177|FG000|Insert Placed|Phase 2||0
6539563|NCT01664052|7461178|FG001|Insert Placed|Phase 2||31
6539564|NCT01664052|7461177|FG000|HSG 1 Hour Post Placement|Phase 2||0
6645615|NCT02373202|7574569|FG001|NOT COMPLETED|Overall Study||6
6645616|NCT02373202|7574570|FG002|NOT COMPLETED|Overall Study||3
6645617|NCT02373202|7574571|FG003|NOT COMPLETED|Overall Study||1
6645618|NCT02373371|7574583|FG000|STARTED|Overall Study||13
6645619|NCT02373371|7574584|FG001|STARTED|Overall Study||13
6645620|NCT02373371|7574583|FG000|COMPLETED|Overall Study||13
6645621|NCT02373371|7574584|FG001|COMPLETED|Overall Study||13
6645622|NCT02373371|7574583|FG000|NOT COMPLETED|Overall Study||0
6645623|NCT02373371|7574584|FG001|NOT COMPLETED|Overall Study||0
6645624|NCT02373813|7574593|FG000|STARTED|Run-In Period||371
6645625|NCT02373813|7574594|FG001|STARTED|Run-In Period||0
6645626|NCT02373813|7574595|FG002|STARTED|Run-In Period||0
6645627|NCT02373813|7574596|FG003|STARTED|Run-In Period||0
6539565|NCT01664052|7461178|FG001|HSG 1 Hour Post Placement|Phase 2||31
6539566|NCT01664052|7461177|FG000|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
6539567|NCT01664052|7461178|FG001|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
6539568|NCT01664052|7461177|FG000|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
6539569|NCT01664052|7461178|FG001|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
6539570|NCT01664052|7461177|FG000|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
6539571|NCT01664052|7461178|FG001|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
6539572|NCT01664052|7461177|FG000|COMPLETED|Phase 2||0
6539573|NCT01664052|7461178|FG001|COMPLETED|Phase 2||31
6539574|NCT01664052|7461177|FG000|NOT COMPLETED|Phase 2||0
6539575|NCT01664052|7461178|FG001|NOT COMPLETED|Phase 2||4
6539576|NCT01664078|7461185|FG000|STARTED|Overall Study||190
6539577|NCT01664078|7461185|FG000|COMPLETED|Overall Study||121
6539578|NCT01664078|7461185|FG000|NOT COMPLETED|Overall Study||69
6539579|NCT01664091|7461235|FG000|STARTED|Overall Study||32
6539580|NCT01664091|7461235|FG000|COMPLETED|Overall Study||26
6539581|NCT01664091|7461235|FG000|NOT COMPLETED|Overall Study||6
6539582|NCT01664104|7461240|FG000|STARTED|Overall Study||136
6539583|NCT01664104|7461240|FG000|COMPLETED|Overall Study||120
6539584|NCT01664104|7461240|FG000|NOT COMPLETED|Overall Study||16
6539585|NCT01664117|7461246|FG000|STARTED|Overall Study||209
6539586|NCT01664117|7461246|FG000|COMPLETED|Overall Study||209
6539587|NCT01664117|7461246|FG000|NOT COMPLETED|Overall Study||0
6539588|NCT01664130|7461253|FG000|STARTED|Overall Study||35
6539589|NCT01664130|7461253|FG000|COMPLETED|Overall Study||33
6539590|NCT01664130|7461253|FG000|NOT COMPLETED|Overall Study||2
6539591|NCT01664247|7461262|FG000|STARTED|Overall Study||174
6539592|NCT01664247|7461263|FG001|STARTED|Overall Study||172
6539593|NCT01664247|7461262|FG000|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
6539594|NCT01664247|7461263|FG001|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
6539595|NCT01664247|7461262|FG000|COMPLETED|Overall Study||160
6539596|NCT01664247|7461263|FG001|COMPLETED|Overall Study||131
6539597|NCT01664247|7461262|FG000|NOT COMPLETED|Overall Study||14
6539598|NCT01664247|7461263|FG001|NOT COMPLETED|Overall Study||41
6539599|NCT01664494|7461269|FG000|STARTED|Overall Study||563
6539600|NCT01664494|7461269|FG000|COMPLETED|Overall Study||370
6539601|NCT01664494|7461269|FG000|NOT COMPLETED|Overall Study||193
6539602|NCT01664533|7461273|FG000|STARTED|Overall Study||57
6539603|NCT01664533|7461273|FG000|COMPLETED|Overall Study||0
6539604|NCT01664533|7461273|FG000|NOT COMPLETED|Overall Study||57
6539605|NCT01664559|7461280|FG000|STARTED|Overall Study||34
6539606|NCT01664559|7461281|FG001|STARTED|Overall Study||33
6539607|NCT01664559|7461280|FG000|COMPLETED|Overall Study||34
6539608|NCT01664559|7461281|FG001|COMPLETED|Overall Study||33
6539609|NCT01664559|7461280|FG000|NOT COMPLETED|Overall Study||0
6539610|NCT01664559|7461281|FG001|NOT COMPLETED|Overall Study||0
6539611|NCT01664624|7461291|FG000|STARTED|Overall Study||10
6539612|NCT01664624|7461292|FG001|STARTED|Overall Study||11
6539613|NCT01664624|7461293|FG002|STARTED|Overall Study||10
6539614|NCT01664624|7461294|FG003|STARTED|Overall Study||9
6539615|NCT01664624|7461291|FG000|COMPLETED|Overall Study||10
6539616|NCT01664624|7461292|FG001|COMPLETED|Overall Study||10
6539617|NCT01664624|7461293|FG002|COMPLETED|Overall Study||10
6539618|NCT01664624|7461294|FG003|COMPLETED|Overall Study||9
6539619|NCT01664624|7461291|FG000|NOT COMPLETED|Overall Study||0
6539620|NCT01664624|7461292|FG001|NOT COMPLETED|Overall Study||1
6539621|NCT01664624|7461293|FG002|NOT COMPLETED|Overall Study||0
6539622|NCT01664624|7461294|FG003|NOT COMPLETED|Overall Study||0
6539623|NCT01664741|7461307|FG000|STARTED|Overall Study||6
6539624|NCT01664741|7461308|FG001|STARTED|Overall Study||6
6539625|NCT01664741|7461309|FG002|STARTED|Overall Study||13
6539626|NCT01664741|7461307|FG000|COMPLETED|Overall Study||6
6539627|NCT01664741|7461308|FG001|COMPLETED|Overall Study||6
6539628|NCT01664741|7461309|FG002|COMPLETED|Overall Study||13
6539629|NCT01664741|7461307|FG000|NOT COMPLETED|Overall Study||0
6539630|NCT01664741|7461308|FG001|NOT COMPLETED|Overall Study||0
6539631|NCT01664741|7461309|FG002|NOT COMPLETED|Overall Study||0
6539632|NCT01664793|7461318|FG000|STARTED|Overall Study||49039
6539633|NCT01664793|7461319|FG001|STARTED|Overall Study||38626
6539634|NCT01664793|7461318|FG000|COMPLETED|Overall Study||49039
6539635|NCT01664793|7461319|FG001|COMPLETED|Overall Study||38626
6539636|NCT01664793|7461318|FG000|NOT COMPLETED|Overall Study||0
6539637|NCT01664793|7461319|FG001|NOT COMPLETED|Overall Study||0
6539638|NCT01664806|7461329|FG000|STARTED|Overall Study||20
6539639|NCT01664806|7461330|FG001|STARTED|Overall Study||20
6539640|NCT01664806|7461329|FG000|COMPLETED|Overall Study||20
6539641|NCT01664806|7461330|FG001|COMPLETED|Overall Study||20
6539642|NCT01664806|7461329|FG000|NOT COMPLETED|Overall Study||0
6539643|NCT01664806|7461330|FG001|NOT COMPLETED|Overall Study||0
6539644|NCT01664858|7461339|FG000|STARTED|Overall Study||481
6539645|NCT01664858|7461340|FG001|STARTED|Overall Study||481
6539646|NCT01664858|7461341|FG002|STARTED|Overall Study||240
6539647|NCT01664858|7461339|FG000|COMPLETED|Overall Study||467
6539648|NCT01664858|7461340|FG001|COMPLETED|Overall Study||468
6539649|NCT01664858|7461341|FG002|COMPLETED|Overall Study||234
6539650|NCT01664858|7461339|FG000|NOT COMPLETED|Overall Study||14
6539651|NCT01664858|7461340|FG001|NOT COMPLETED|Overall Study||13
6539652|NCT01664858|7461341|FG002|NOT COMPLETED|Overall Study||6
6539653|NCT01664897|7461352|FG000|STARTED|Overall Study||29
6539654|NCT01664897|7461352|FG000|COMPLETED|Overall Study||29
6539655|NCT01664897|7461352|FG000|NOT COMPLETED|Overall Study||0
6645628|NCT02373813|7574593|FG000|Treated|Run-In Period||368
6645629|NCT02373813|7574594|FG001|Treated|Run-In Period||0
6645630|NCT02373813|7574595|FG002|Treated|Run-In Period||0
6645631|NCT02373813|7574596|FG003|Treated|Run-In Period||0
6645632|NCT02373813|7574593|FG000|COMPLETED|Run-In Period|1 participant who completed the run-in period had no end of study case report form.|255
6645633|NCT02373813|7574594|FG001|COMPLETED|Run-In Period||0
6645634|NCT02373813|7574595|FG002|COMPLETED|Run-In Period||0
6645635|NCT02373813|7574596|FG003|COMPLETED|Run-In Period||0
6645636|NCT02373813|7574593|FG000|NOT COMPLETED|Run-In Period||116
6645637|NCT02373813|7574594|FG001|NOT COMPLETED|Run-In Period||0
6645638|NCT02373813|7574595|FG002|NOT COMPLETED|Run-In Period||0
6645639|NCT02373813|7574596|FG003|NOT COMPLETED|Run-In Period||0
6539656|NCT01664923|7461358|FG000|STARTED|Period1:Double Blind Phase-29 Months||198
6539657|NCT01664923|7461359|FG001|STARTED|Period1:Double Blind Phase-29 Months||198
6539658|NCT01664923|7461358|FG000|Received Study Treatment|Period1:Double Blind Phase-29 Months||197
6539659|NCT01664923|7461359|FG001|Received Study Treatment|Period1:Double Blind Phase-29 Months||198
6539660|NCT01664923|7461358|FG000|COMPLETED|Period1:Double Blind Phase-29 Months||93
6539661|NCT01664923|7461359|FG001|COMPLETED|Period1:Double Blind Phase-29 Months||38
6539662|NCT01664923|7461358|FG000|NOT COMPLETED|Period1:Double Blind Phase-29 Months||105
6539663|NCT01664923|7461359|FG001|NOT COMPLETED|Period1:Double Blind Phase-29 Months||160
6539664|NCT01664923|7461358|FG000|STARTED|Period 2: Open-label Phase-36 Months||93
6539665|NCT01664923|7461359|FG001|STARTED|Period 2: Open-label Phase-36 Months||38
6539666|NCT01664923|7461358|FG000|Treated|Period 2: Open-label Phase-36 Months||93
6539667|NCT01664923|7461359|FG001|Treated|Period 2: Open-label Phase-36 Months||37
6539668|NCT01664923|7461358|FG000|COMPLETED|Period 2: Open-label Phase-36 Months||52
6539669|NCT01664923|7461359|FG001|COMPLETED|Period 2: Open-label Phase-36 Months||15
6539670|NCT01664923|7461358|FG000|NOT COMPLETED|Period 2: Open-label Phase-36 Months||41
6539671|NCT01664923|7461359|FG001|NOT COMPLETED|Period 2: Open-label Phase-36 Months||23
6539672|NCT01664949|7461371|FG000|STARTED|Overall Study||224
6539673|NCT01664949|7461372|FG001|STARTED|Overall Study||236
6539674|NCT01664949|7461371|FG000|COMPLETED|Overall Study||200
6539675|NCT01664949|7461372|FG001|COMPLETED|Overall Study||211
6539676|NCT01664949|7461371|FG000|NOT COMPLETED|Overall Study||24
6539677|NCT01664949|7461372|FG001|NOT COMPLETED|Overall Study||25
6539678|NCT01664975|7461380|FG000|STARTED|Overall Study||57
6539679|NCT01664975|7461381|FG001|STARTED|Overall Study||54
6539680|NCT01664975|7461380|FG000|COMPLETED|Overall Study||52
6539681|NCT01664975|7461381|FG001|COMPLETED|Overall Study||51
6539682|NCT01664975|7461380|FG000|NOT COMPLETED|Overall Study||5
6539683|NCT01664975|7461381|FG001|NOT COMPLETED|Overall Study||3
6539684|NCT01665040|7461387|FG000|STARTED|Overall Study||40
6539685|NCT01665040|7461387|FG000|COMPLETED|Overall Study||36
6539686|NCT01665040|7461387|FG000|NOT COMPLETED|Overall Study||4
6539687|NCT01665053|7461393|FG000|STARTED|Overall Study||838
6539688|NCT01665053|7461394|FG001|STARTED|Overall Study||846
6539689|NCT01665053|7461393|FG000|Completed 12-Month Clinical F/U|Overall Study||797
6539690|NCT01665053|7461394|FG001|Completed 12-Month Clinical F/U|Overall Study||822
6539691|NCT01665053|7461393|FG000|No 12-Month F/U|Overall Study||32
6539692|NCT01665053|7461394|FG001|No 12-Month F/U|Overall Study||15
6645640|NCT02373813|7574593|FG000|STARTED|Double-Blind Treatment Period||0
6645641|NCT02373813|7574594|FG001|STARTED|Double-Blind Treatment Period||101
6645642|NCT02373813|7574595|FG002|STARTED|Double-Blind Treatment Period||101
6645643|NCT02373813|7574596|FG003|STARTED|Double-Blind Treatment Period||51
6645644|NCT02373813|7574593|FG000|Received Investigational Product (IP)|Double-Blind Treatment Period||0
6645645|NCT02373813|7574594|FG001|Received Investigational Product (IP)|Double-Blind Treatment Period||101
6645646|NCT02373813|7574595|FG002|Received Investigational Product (IP)|Double-Blind Treatment Period||100
6645647|NCT02373813|7574596|FG003|Received Investigational Product (IP)|Double-Blind Treatment Period||51
6645648|NCT02373813|7574593|FG000|Received Rescue Treatment|Double-Blind Treatment Period||0
6645649|NCT02373813|7574594|FG001|Received Rescue Treatment|Double-Blind Treatment Period||52
6645650|NCT02373813|7574595|FG002|Received Rescue Treatment|Double-Blind Treatment Period||36
6645651|NCT02373813|7574596|FG003|Received Rescue Treatment|Double-Blind Treatment Period||15
6645652|NCT02373813|7574593|FG000|COMPLETED|Double-Blind Treatment Period||0
6645653|NCT02373813|7574594|FG001|COMPLETED|Double-Blind Treatment Period||88
6645654|NCT02373813|7574595|FG002|COMPLETED|Double-Blind Treatment Period||92
6645655|NCT02373813|7574596|FG003|COMPLETED|Double-Blind Treatment Period||47
6539693|NCT01665053|7461393|FG000|Death With No 12-month Clinical FU|Overall Study||9
6539694|NCT01665053|7461394|FG001|Death With No 12-month Clinical FU|Overall Study||9
6539695|NCT01665053|7461393|FG000|COMPLETED|Overall Study||806
6539696|NCT01665053|7461394|FG001|COMPLETED|Overall Study||831
6539697|NCT01665053|7461393|FG000|NOT COMPLETED|Overall Study||32
6539698|NCT01665053|7461394|FG001|NOT COMPLETED|Overall Study||15
6539699|NCT01665092|7461404|FG000|STARTED|Overall Study||75
6539700|NCT01665092|7461405|FG001|STARTED|Overall Study||35
6539701|NCT01665092|7461406|FG002|STARTED|Overall Study||34
6539702|NCT01665092|7461407|FG003|STARTED|Overall Study||106
6539703|NCT01665092|7461404|FG000|COMPLETED|Overall Study||75
6539704|NCT01665092|7461405|FG001|COMPLETED|Overall Study||35
6539705|NCT01665092|7461406|FG002|COMPLETED|Overall Study||32
6539706|NCT01665092|7461407|FG003|COMPLETED|Overall Study||105
6539707|NCT01665092|7461404|FG000|NOT COMPLETED|Overall Study||0
6539708|NCT01665092|7461405|FG001|NOT COMPLETED|Overall Study||0
6539709|NCT01665092|7461406|FG002|NOT COMPLETED|Overall Study||2
6539710|NCT01665092|7461407|FG003|NOT COMPLETED|Overall Study||1
6539711|NCT01665157|7461420|FG000|STARTED|Overall Study||60
6539712|NCT01665157|7461421|FG001|STARTED|Overall Study||60
6539713|NCT01665157|7461422|FG002|STARTED|Overall Study||60
6539714|NCT01665157|7461420|FG000|COMPLETED|Overall Study||60
6539715|NCT01665157|7461421|FG001|COMPLETED|Overall Study||60
6539716|NCT01665157|7461422|FG002|COMPLETED|Overall Study||60
6539717|NCT01665157|7461420|FG000|NOT COMPLETED|Overall Study||0
6539718|NCT01665157|7461421|FG001|NOT COMPLETED|Overall Study||0
6539719|NCT01665157|7461422|FG002|NOT COMPLETED|Overall Study||0
6539720|NCT01665170|7461437|FG000|STARTED|Overall Study|First patient in|30
6539721|NCT01665170|7461438|FG001|STARTED|Overall Study||30
6539722|NCT01665170|7461437|FG000|Bevore TSST|Overall Study||30
6539723|NCT01665170|7461438|FG001|Bevore TSST|Overall Study||30
6539724|NCT01665170|7461437|FG000|During TSST|Overall Study||30
6539725|NCT01665170|7461438|FG001|During TSST|Overall Study||30
6539726|NCT01665170|7461437|FG000|After TSST|Overall Study||30
6539727|NCT01665170|7461438|FG001|After TSST|Overall Study||30
6539728|NCT01665170|7461437|FG000|COMPLETED|Overall Study|Last TSST/ last patient out|30
6539729|NCT01665170|7461438|FG001|COMPLETED|Overall Study||30
6539730|NCT01665170|7461437|FG000|NOT COMPLETED|Overall Study||0
6539731|NCT01665170|7461438|FG001|NOT COMPLETED|Overall Study||0
6539732|NCT01665430|7461446|FG000|STARTED|Overall Study||38
6539733|NCT01665430|7461446|FG000|COMPLETED|Overall Study||29
6539734|NCT01665430|7461446|FG000|NOT COMPLETED|Overall Study||9
6539735|NCT01665508|7461450|FG000|STARTED|Overall Study||12
6539736|NCT01665508|7461450|FG000|COMPLETED|Overall Study||7
6539737|NCT01665508|7461450|FG000|NOT COMPLETED|Overall Study||5
6539738|NCT01665599|7461459|FG000|STARTED|Overall Study||180
6539739|NCT01665599|7461459|FG000|COMPLETED|Overall Study||172
6539740|NCT01665599|7461459|FG000|NOT COMPLETED|Overall Study||8
6539741|NCT01665768|7461463|FG000|STARTED|Overall Study||49
6539742|NCT01665768|7461463|FG000|COMPLETED|Overall Study||26
6539743|NCT01665768|7461463|FG000|NOT COMPLETED|Overall Study||23
6539744|NCT01665807|7461470|FG000|STARTED|Overall Study||411
6539745|NCT01665807|7461471|FG001|STARTED|Overall Study||58
6539746|NCT01665807|7461472|FG002|STARTED|Overall Study||402
6539747|NCT01665807|7461470|FG000|COMPLETED|Overall Study||409
6539748|NCT01665807|7461471|FG001|COMPLETED|Overall Study||58
6539749|NCT01665807|7461472|FG002|COMPLETED|Overall Study||401
6539750|NCT01665807|7461470|FG000|NOT COMPLETED|Overall Study||2
6539751|NCT01665807|7461471|FG001|NOT COMPLETED|Overall Study||0
6539752|NCT01665807|7461472|FG002|NOT COMPLETED|Overall Study||1
6539753|NCT01665872|7461482|FG000|STARTED|Screening||172
6539754|NCT01665872|7461483|FG001|STARTED|Screening||172
6539755|NCT01665872|7461482|FG000|COMPLETED|Screening||172
6539756|NCT01665872|7461483|FG001|COMPLETED|Screening||172
6539757|NCT01665872|7461482|FG000|NOT COMPLETED|Screening||0
6539758|NCT01665872|7461483|FG001|NOT COMPLETED|Screening||0
6539759|NCT01665872|7461482|FG000|STARTED|Treatment||87
6539760|NCT01665872|7461483|FG001|STARTED|Treatment||67
6539761|NCT01665872|7461482|FG000|COMPLETED|Treatment||72
6539762|NCT01665872|7461483|FG001|COMPLETED|Treatment||50
6539763|NCT01665872|7461482|FG000|NOT COMPLETED|Treatment||15
6645656|NCT02373813|7574593|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6645657|NCT02373813|7574594|FG001|NOT COMPLETED|Double-Blind Treatment Period||13
6645658|NCT02373813|7574595|FG002|NOT COMPLETED|Double-Blind Treatment Period||9
6645659|NCT02373813|7574596|FG003|NOT COMPLETED|Double-Blind Treatment Period||4
6645660|NCT02373852|7574607|FG000|STARTED|Overall Study|Includes patients from a previous retrospective study NCT01042444|12
6645661|NCT02373852|7574607|FG000|COMPLETED|Overall Study||11
6645662|NCT02373852|7574607|FG000|NOT COMPLETED|Overall Study||1
6645663|NCT02374060|7574614|FG000|STARTED|Overall Study||65
6645664|NCT02374060|7574615|FG001|STARTED|Overall Study||63
6645665|NCT02374060|7574616|FG002|STARTED|Overall Study||64
6645666|NCT02374060|7574614|FG000|COMPLETED|Overall Study||63
6645667|NCT02374060|7574615|FG001|COMPLETED|Overall Study||62
6645668|NCT02374060|7574616|FG002|COMPLETED|Overall Study||61
6645669|NCT02374060|7574614|FG000|NOT COMPLETED|Overall Study||2
6539764|NCT01665872|7461483|FG001|NOT COMPLETED|Treatment||17
6539765|NCT01665872|7461482|FG000|STARTED|6 Month Follow-up||72
6539766|NCT01665872|7461483|FG001|STARTED|6 Month Follow-up||50
6539767|NCT01665872|7461482|FG000|COMPLETED|6 Month Follow-up||66
6539768|NCT01665872|7461483|FG001|COMPLETED|6 Month Follow-up||49
6539769|NCT01665872|7461482|FG000|NOT COMPLETED|6 Month Follow-up||6
6539770|NCT01665872|7461483|FG001|NOT COMPLETED|6 Month Follow-up||1
6539771|NCT01665872|7461482|FG000|STARTED|12 Month Follow-up||72
6539772|NCT01665872|7461483|FG001|STARTED|12 Month Follow-up||50
6539773|NCT01665872|7461482|FG000|COMPLETED|12 Month Follow-up||58
6539774|NCT01665872|7461483|FG001|COMPLETED|12 Month Follow-up||47
6539775|NCT01665872|7461482|FG000|NOT COMPLETED|12 Month Follow-up||14
6539776|NCT01665872|7461483|FG001|NOT COMPLETED|12 Month Follow-up||3
6539777|NCT01665911|7461489|FG000|STARTED|Overall Study||28
6539778|NCT01665911|7461489|FG000|0 mg Fluoride in 200 ml Milk|Overall Study||22
6539779|NCT01665911|7461489|FG000|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
6539780|NCT01665911|7461489|FG000|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
6539781|NCT01665911|7461489|FG000|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
6645670|NCT02374060|7574615|FG001|NOT COMPLETED|Overall Study||1
6645671|NCT02374060|7574616|FG002|NOT COMPLETED|Overall Study||3
6539782|NCT01665911|7461489|FG000|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
6539783|NCT01665911|7461489|FG000|COMPLETED|Overall Study||22
6539784|NCT01665911|7461489|FG000|NOT COMPLETED|Overall Study||6
6539785|NCT01665950|7461497|FG000|STARTED|Overall Study||2
6539786|NCT01665950|7461498|FG001|STARTED|Overall Study||0
6539787|NCT01665950|7461499|FG002|STARTED|Overall Study||2
6539788|NCT01665950|7461497|FG000|COMPLETED|Overall Study||1
6539789|NCT01665950|7461498|FG001|COMPLETED|Overall Study||0
6539790|NCT01665950|7461499|FG002|COMPLETED|Overall Study||1
6539791|NCT01665950|7461497|FG000|NOT COMPLETED|Overall Study||1
6539792|NCT01665950|7461498|FG001|NOT COMPLETED|Overall Study||0
6539793|NCT01665950|7461499|FG002|NOT COMPLETED|Overall Study||1
6539794|NCT01666002|7461509|FG000|STARTED|Overall Study||17
6539795|NCT01666002|7461510|FG001|STARTED|Overall Study||10
6539796|NCT01666002|7461509|FG000|COMPLETED|Overall Study||12
6539797|NCT01666002|7461510|FG001|COMPLETED|Overall Study||10
6539798|NCT01666002|7461509|FG000|NOT COMPLETED|Overall Study||5
6539799|NCT01666002|7461510|FG001|NOT COMPLETED|Overall Study||0
6562283|NCT01800890|7485338|FG005|NOT COMPLETED|Test Period 2||0
6562284|NCT01800890|7485339|FG006|NOT COMPLETED|Test Period 2||0
6562285|NCT01800890|7485340|FG007|NOT COMPLETED|Test Period 2||0
6562286|NCT01800890|7485341|FG008|NOT COMPLETED|Test Period 2||0
6562287|NCT01800890|7485333|FG000|STARTED|Test Period 3||3
6562288|NCT01800890|7485334|FG001|STARTED|Test Period 3||3
6562289|NCT01800890|7485335|FG002|STARTED|Test Period 3||3
6562290|NCT01800890|7485336|FG003|STARTED|Test Period 3||2
6562291|NCT01800890|7485337|FG004|STARTED|Test Period 3||4
6562292|NCT01800890|7485338|FG005|STARTED|Test Period 3||4
6562293|NCT01800890|7485339|FG006|STARTED|Test Period 3||3
6562294|NCT01800890|7485340|FG007|STARTED|Test Period 3||3
6562295|NCT01800890|7485341|FG008|STARTED|Test Period 3||3
6562296|NCT01800890|7485333|FG000|COMPLETED|Test Period 3||3
6562297|NCT01800890|7485334|FG001|COMPLETED|Test Period 3||3
6562298|NCT01800890|7485335|FG002|COMPLETED|Test Period 3||3
6562299|NCT01800890|7485336|FG003|COMPLETED|Test Period 3||2
6562300|NCT01800890|7485337|FG004|COMPLETED|Test Period 3||4
6562301|NCT01800890|7485338|FG005|COMPLETED|Test Period 3||4
6562302|NCT01800890|7485339|FG006|COMPLETED|Test Period 3||3
6562303|NCT01800890|7485340|FG007|COMPLETED|Test Period 3||3
6562304|NCT01800890|7485341|FG008|COMPLETED|Test Period 3||3
6562305|NCT01800890|7485333|FG000|NOT COMPLETED|Test Period 3||0
6562306|NCT01800890|7485334|FG001|NOT COMPLETED|Test Period 3||0
6562307|NCT01800890|7485335|FG002|NOT COMPLETED|Test Period 3||0
6562308|NCT01800890|7485336|FG003|NOT COMPLETED|Test Period 3||0
6562309|NCT01800890|7485337|FG004|NOT COMPLETED|Test Period 3||0
6562310|NCT01800890|7485338|FG005|NOT COMPLETED|Test Period 3||0
6562311|NCT01800890|7485339|FG006|NOT COMPLETED|Test Period 3||0
6562312|NCT01800890|7485340|FG007|NOT COMPLETED|Test Period 3||0
6562313|NCT01800890|7485341|FG008|NOT COMPLETED|Test Period 3||0
6562314|NCT01800903|7485351|FG000|STARTED|First Test Period||7
6562315|NCT01800903|7485352|FG001|STARTED|First Test Period||6
6562316|NCT01800903|7485353|FG002|STARTED|First Test Period||4
6562317|NCT01800903|7485354|FG003|STARTED|First Test Period||7
6562318|NCT01800903|7485355|FG004|STARTED|First Test Period||6
6562319|NCT01800903|7485356|FG005|STARTED|First Test Period||6
6562320|NCT01800903|7485351|FG000|COMPLETED|First Test Period||7
6562321|NCT01800903|7485352|FG001|COMPLETED|First Test Period||6
6562322|NCT01800903|7485353|FG002|COMPLETED|First Test Period||4
6562323|NCT01800903|7485354|FG003|COMPLETED|First Test Period||7
6562324|NCT01800903|7485355|FG004|COMPLETED|First Test Period||6
6562325|NCT01800903|7485356|FG005|COMPLETED|First Test Period||6
6562326|NCT01800903|7485351|FG000|NOT COMPLETED|First Test Period||0
6562327|NCT01800903|7485352|FG001|NOT COMPLETED|First Test Period||0
6562328|NCT01800903|7485353|FG002|NOT COMPLETED|First Test Period||0
6562329|NCT01800903|7485354|FG003|NOT COMPLETED|First Test Period||0
6562330|NCT01800903|7485355|FG004|NOT COMPLETED|First Test Period||0
6562331|NCT01800903|7485356|FG005|NOT COMPLETED|First Test Period||0
6562332|NCT01800903|7485351|FG000|STARTED|Second Test Period||7
6562333|NCT01800903|7485352|FG001|STARTED|Second Test Period||6
6562334|NCT01800903|7485353|FG002|STARTED|Second Test Period||4
6562335|NCT01800903|7485354|FG003|STARTED|Second Test Period||7
6562336|NCT01800903|7485355|FG004|STARTED|Second Test Period||6
6562337|NCT01800903|7485356|FG005|STARTED|Second Test Period||6
6562338|NCT01800903|7485351|FG000|COMPLETED|Second Test Period||6
6562339|NCT01800903|7485352|FG001|COMPLETED|Second Test Period||6
6562340|NCT01800903|7485353|FG002|COMPLETED|Second Test Period||4
6562341|NCT01800903|7485354|FG003|COMPLETED|Second Test Period||7
6562342|NCT01800903|7485355|FG004|COMPLETED|Second Test Period||6
6562343|NCT01800903|7485356|FG005|COMPLETED|Second Test Period||6
6562344|NCT01800903|7485351|FG000|NOT COMPLETED|Second Test Period||1
6562345|NCT01800903|7485352|FG001|NOT COMPLETED|Second Test Period||0
6562346|NCT01800903|7485353|FG002|NOT COMPLETED|Second Test Period||0
6562347|NCT01800903|7485354|FG003|NOT COMPLETED|Second Test Period||0
6562348|NCT01800903|7485355|FG004|NOT COMPLETED|Second Test Period||0
6562349|NCT01800903|7485356|FG005|NOT COMPLETED|Second Test Period||0
6562350|NCT01800903|7485351|FG000|STARTED|Third Test Period||6
6562351|NCT01800903|7485352|FG001|STARTED|Third Test Period||6
6562352|NCT01800903|7485353|FG002|STARTED|Third Test Period||4
6562353|NCT01800903|7485354|FG003|STARTED|Third Test Period||7
6562354|NCT01800903|7485355|FG004|STARTED|Third Test Period||6
6562355|NCT01800903|7485356|FG005|STARTED|Third Test Period||6
6562356|NCT01800903|7485351|FG000|COMPLETED|Third Test Period||6
6539800|NCT01666119|7461517|FG000|STARTED|Overall Study||249
6539801|NCT01666119|7461517|FG000|COMPLETED|Overall Study||197
6539802|NCT01666119|7461517|FG000|NOT COMPLETED|Overall Study||52
6539803|NCT01666197|7461523|FG000|STARTED|Overall Study||50
6539804|NCT01666197|7461524|FG001|STARTED|Overall Study||50
6539805|NCT01666197|7461523|FG000|COMPLETED|Overall Study||50
6539806|NCT01666197|7461524|FG001|COMPLETED|Overall Study||50
6539807|NCT01666197|7461523|FG000|NOT COMPLETED|Overall Study||0
6539808|NCT01666197|7461524|FG001|NOT COMPLETED|Overall Study||0
6539809|NCT01666210|7461532|FG000|STARTED|Overall Study||30
6539810|NCT01666210|7461533|FG001|STARTED|Overall Study||30
6539811|NCT01666210|7461532|FG000|COMPLETED|Overall Study||28
6539812|NCT01666210|7461533|FG001|COMPLETED|Overall Study||29
6539813|NCT01666210|7461532|FG000|NOT COMPLETED|Overall Study||2
6539814|NCT01666210|7461533|FG001|NOT COMPLETED|Overall Study||1
6539815|NCT01666314|7461547|FG000|STARTED|Overall Study||33
6539816|NCT01666314|7461548|FG001|STARTED|Overall Study||32
6539817|NCT01666314|7461549|FG002|STARTED|Overall Study||36
6539818|NCT01666314|7461550|FG003|STARTED|Overall Study||36
6539819|NCT01666314|7461547|FG000|COMPLETED|Overall Study||0
6539820|NCT01666314|7461548|FG001|COMPLETED|Overall Study||0
6539821|NCT01666314|7461549|FG002|COMPLETED|Overall Study||0
6539822|NCT01666314|7461550|FG003|COMPLETED|Overall Study||0
6539823|NCT01666314|7461547|FG000|NOT COMPLETED|Overall Study||33
6539824|NCT01666314|7461548|FG001|NOT COMPLETED|Overall Study||32
6539825|NCT01666314|7461549|FG002|NOT COMPLETED|Overall Study||36
6539826|NCT01666314|7461550|FG003|NOT COMPLETED|Overall Study||36
6539827|NCT01666444|7461573|FG000|STARTED|Overall Study||149
6539828|NCT01666444|7461574|FG001|STARTED|Overall Study||148
6539829|NCT01666444|7461573|FG000|COMPLETED|Overall Study||147
6539830|NCT01666444|7461574|FG001|COMPLETED|Overall Study||147
6539831|NCT01666444|7461573|FG000|NOT COMPLETED|Overall Study||2
6539832|NCT01666444|7461574|FG001|NOT COMPLETED|Overall Study||1
6539833|NCT01666652|7461585|FG000|STARTED|Overall Study||20
6539834|NCT01666652|7461586|FG001|STARTED|Overall Study||20
6539835|NCT01666652|7461587|FG002|STARTED|Overall Study||20
6539836|NCT01666652|7461588|FG003|STARTED|Overall Study||20
6539837|NCT01666652|7461589|FG004|STARTED|Overall Study||20
6539838|NCT01666652|7461585|FG000|COMPLETED|Overall Study||18
6539839|NCT01666652|7461586|FG001|COMPLETED|Overall Study||19
6539840|NCT01666652|7461587|FG002|COMPLETED|Overall Study||19
6539841|NCT01666652|7461588|FG003|COMPLETED|Overall Study||16
6539842|NCT01666652|7461589|FG004|COMPLETED|Overall Study||19
6539843|NCT01666652|7461585|FG000|NOT COMPLETED|Overall Study||2
6539844|NCT01666652|7461586|FG001|NOT COMPLETED|Overall Study||1
6539845|NCT01666652|7461587|FG002|NOT COMPLETED|Overall Study||1
6539846|NCT01666652|7461588|FG003|NOT COMPLETED|Overall Study||4
6539847|NCT01666652|7461589|FG004|NOT COMPLETED|Overall Study||1
6539848|NCT01666730|7461601|FG000|STARTED|Overall Study||50
6539849|NCT01666730|7461601|FG000|COMPLETED|Overall Study||0
6539850|NCT01666730|7461601|FG000|NOT COMPLETED|Overall Study||50
6539851|NCT01666782|7461607|FG000|STARTED|Overall Study||54
6539852|NCT01666782|7461608|FG001|STARTED|Overall Study||51
6539853|NCT01666782|7461607|FG000|COMPLETED|Overall Study||50
6539854|NCT01666782|7461608|FG001|COMPLETED|Overall Study||50
6539855|NCT01666782|7461607|FG000|NOT COMPLETED|Overall Study||4
6539856|NCT01666782|7461608|FG001|NOT COMPLETED|Overall Study||1
6539857|NCT01666912|7461616|FG000|STARTED|Overall Study||48
6539858|NCT01666912|7461617|FG001|STARTED|Overall Study||48
6539859|NCT01666912|7461616|FG000|COMPLETED|Overall Study||27
6539860|NCT01666912|7461617|FG001|COMPLETED|Overall Study||37
6539861|NCT01666912|7461616|FG000|NOT COMPLETED|Overall Study||21
6539862|NCT01666912|7461617|FG001|NOT COMPLETED|Overall Study||11
6539863|NCT01666951|7461625|FG000|STARTED|Overall Study||18
6539864|NCT01666951|7461626|FG001|STARTED|Overall Study||18
6539865|NCT01666951|7461625|FG000|COMPLETED|Overall Study||17
6539866|NCT01666951|7461626|FG001|COMPLETED|Overall Study||17
6539867|NCT01666951|7461625|FG000|NOT COMPLETED|Overall Study||1
6539868|NCT01666951|7461626|FG001|NOT COMPLETED|Overall Study||1
6539869|NCT01667029|7461632|FG000|STARTED|Overall Study||4
6539870|NCT01667029|7461633|FG001|STARTED|Overall Study||4
6539871|NCT01667029|7461632|FG000|COMPLETED|Overall Study||3
6539872|NCT01667029|7461633|FG001|COMPLETED|Overall Study||3
6539873|NCT01667029|7461632|FG000|NOT COMPLETED|Overall Study||1
6539874|NCT01667029|7461633|FG001|NOT COMPLETED|Overall Study||1
6539875|NCT01667107|7461641|FG000|STARTED|Overall Study||8
6539876|NCT01667107|7461642|FG001|STARTED|Overall Study||18
6539877|NCT01667107|7461641|FG000|COMPLETED|Overall Study||4
6539878|NCT01667107|7461642|FG001|COMPLETED|Overall Study||11
6539879|NCT01667107|7461641|FG000|NOT COMPLETED|Overall Study||4
6539880|NCT01667107|7461642|FG001|NOT COMPLETED|Overall Study||7
6539881|NCT01667224|7461650|FG000|STARTED|Overall Study||40
6539882|NCT01667224|7461651|FG001|STARTED|Overall Study||40
6539883|NCT01667224|7461650|FG000|COMPLETED|Overall Study||36
6539884|NCT01667224|7461651|FG001|COMPLETED|Overall Study||38
6539885|NCT01667224|7461650|FG000|NOT COMPLETED|Overall Study||4
6539886|NCT01667224|7461651|FG001|NOT COMPLETED|Overall Study||2
6539887|NCT01667250|7461661|FG000|STARTED|Run-in (no Treatment)||0
6539888|NCT01667250|7461662|FG001|STARTED|Run-in (no Treatment)||0
6539889|NCT01667250|7461663|FG002|STARTED|Run-in (no Treatment)||73
6539890|NCT01667250|7461661|FG000|COMPLETED|Run-in (no Treatment)||0
6539891|NCT01667250|7461662|FG001|COMPLETED|Run-in (no Treatment)||0
6539892|NCT01667250|7461663|FG002|COMPLETED|Run-in (no Treatment)||59
6539893|NCT01667250|7461661|FG000|NOT COMPLETED|Run-in (no Treatment)||0
6539894|NCT01667250|7461662|FG001|NOT COMPLETED|Run-in (no Treatment)||0
6539895|NCT01667250|7461663|FG002|NOT COMPLETED|Run-in (no Treatment)||14
6539896|NCT01667250|7461661|FG000|STARTED|Randomised Period||30
6539897|NCT01667250|7461662|FG001|STARTED|Randomised Period||29
6539898|NCT01667250|7461663|FG002|STARTED|Randomised Period||0
6539899|NCT01667250|7461661|FG000|COMPLETED|Randomised Period||29
6539900|NCT01667250|7461662|FG001|COMPLETED|Randomised Period||28
6539901|NCT01667250|7461663|FG002|COMPLETED|Randomised Period||0
6539902|NCT01667250|7461661|FG000|NOT COMPLETED|Randomised Period||1
6539903|NCT01667250|7461662|FG001|NOT COMPLETED|Randomised Period||1
6539904|NCT01667250|7461663|FG002|NOT COMPLETED|Randomised Period||0
6539905|NCT01667406|7461680|FG000|STARTED|Overall Study||2
6539906|NCT01667406|7461681|FG001|STARTED|Overall Study||3
6539907|NCT01667406|7461682|FG002|STARTED|Overall Study||24
6539908|NCT01667406|7461683|FG003|STARTED|Overall Study||24
6539909|NCT01667406|7461684|FG004|STARTED|Overall Study||5
6539910|NCT01667406|7461685|FG005|STARTED|Overall Study||20
6539911|NCT01667406|7461686|FG006|STARTED|Overall Study||15
6539912|NCT01667406|7461687|FG007|STARTED|Overall Study||20
6539913|NCT01667406|7461688|FG008|STARTED|Overall Study||31
6539914|NCT01667406|7461689|FG009|STARTED|Overall Study||31
6539915|NCT01667406|7461680|FG000|COMPLETED|Overall Study||2
6539916|NCT01667406|7461681|FG001|COMPLETED|Overall Study||3
6539917|NCT01667406|7461682|FG002|COMPLETED|Overall Study||24
6539918|NCT01667406|7461683|FG003|COMPLETED|Overall Study||24
6539919|NCT01667406|7461684|FG004|COMPLETED|Overall Study||5
6539920|NCT01667406|7461685|FG005|COMPLETED|Overall Study||20
6539921|NCT01667406|7461686|FG006|COMPLETED|Overall Study||15
6539922|NCT01667406|7461687|FG007|COMPLETED|Overall Study||20
6539923|NCT01667406|7461688|FG008|COMPLETED|Overall Study||31
6539924|NCT01667406|7461689|FG009|COMPLETED|Overall Study||31
6539925|NCT01667406|7461680|FG000|NOT COMPLETED|Overall Study||0
6539926|NCT01667406|7461681|FG001|NOT COMPLETED|Overall Study||0
6539927|NCT01667406|7461682|FG002|NOT COMPLETED|Overall Study||0
6539928|NCT01667406|7461683|FG003|NOT COMPLETED|Overall Study||0
6539929|NCT01667406|7461684|FG004|NOT COMPLETED|Overall Study||0
6539930|NCT01667406|7461685|FG005|NOT COMPLETED|Overall Study||0
6539931|NCT01667406|7461686|FG006|NOT COMPLETED|Overall Study||0
6539932|NCT01667406|7461687|FG007|NOT COMPLETED|Overall Study||0
6539933|NCT01667406|7461688|FG008|NOT COMPLETED|Overall Study||0
6539934|NCT01667406|7461689|FG009|NOT COMPLETED|Overall Study||0
6539935|NCT01667419|7461745|FG000|STARTED|Overall Study||157
6539936|NCT01667419|7461746|FG001|STARTED|Overall Study||157
6539937|NCT01667419|7461747|FG002|STARTED|Overall Study||93
6539938|NCT01667419|7461748|FG003|STARTED|Overall Study||91
6539939|NCT01667419|7461745|FG000|COMPLETED|Overall Study||114
6539940|NCT01667419|7461746|FG001|COMPLETED|Overall Study||110
6539941|NCT01667419|7461747|FG002|COMPLETED|Overall Study||57
6539942|NCT01667419|7461748|FG003|COMPLETED|Overall Study||52
6539943|NCT01667419|7461745|FG000|NOT COMPLETED|Overall Study||43
6539944|NCT01667419|7461746|FG001|NOT COMPLETED|Overall Study||47
6539945|NCT01667419|7461747|FG002|NOT COMPLETED|Overall Study||36
6539946|NCT01667419|7461748|FG003|NOT COMPLETED|Overall Study||39
6539947|NCT01667432|7461759|FG000|STARTED|Overall Study||141
6539948|NCT01667432|7461759|FG000|COMPLETED|Overall Study||84
6539949|NCT01667432|7461759|FG000|NOT COMPLETED|Overall Study||57
6539950|NCT01667471|7461763|FG000|STARTED|Overall Study||7
6539951|NCT01667471|7461763|FG000|COMPLETED|Overall Study||7
6539952|NCT01667471|7461763|FG000|NOT COMPLETED|Overall Study||0
6539953|NCT01667536|7461768|FG000|STARTED|Overall Study||105
6539954|NCT01667536|7461768|FG000|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
6539955|NCT01667536|7461768|FG000|NOT COMPLETED|Overall Study||0
6539956|NCT01667549|7461780|FG000|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
6539957|NCT01667549|7461781|FG001|STARTED|Overall Study|20 dyads=20 infants, 20 mothers|20
6539958|NCT01667549|7461782|FG002|STARTED|Overall Study|21 dyads=21 infants, 21 mothers|21
6539959|NCT01667549|7461783|FG003|STARTED|Overall Study|20 dyads= 20 infants, 20 mothers|20
6539960|NCT01667549|7461784|FG004|STARTED|Overall Study|16 dyads=16 infants, 16 mothers|16
6539961|NCT01667549|7461780|FG000|COMPLETED|Overall Study|17 dyads=17 infants, 17 mothers|17
6539962|NCT01667549|7461781|FG001|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
6539963|NCT01667549|7461782|FG002|COMPLETED|Overall Study|14 dyads=14 infants, 14 mothers|14
6539964|NCT01667549|7461783|FG003|COMPLETED|Overall Study|14 dyads= 14 infants, 14 mothers|14
6539965|NCT01667549|7461784|FG004|COMPLETED|Overall Study|15 dyads=15 infants, 15 mothers|15
6539966|NCT01667549|7461780|FG000|NOT COMPLETED|Overall Study||3
6539967|NCT01667549|7461781|FG001|NOT COMPLETED|Overall Study||5
6539968|NCT01667549|7461782|FG002|NOT COMPLETED|Overall Study||7
6539969|NCT01667549|7461783|FG003|NOT COMPLETED|Overall Study||6
6539970|NCT01667549|7461784|FG004|NOT COMPLETED|Overall Study||1
6539971|NCT01667562|7461801|FG000|STARTED|Diagnostic Phase||375
6539972|NCT01667562|7461802|FG001|STARTED|Diagnostic Phase||0
6539973|NCT01667562|7461801|FG000|COMPLETED|Diagnostic Phase||345
6539974|NCT01667562|7461802|FG001|COMPLETED|Diagnostic Phase||0
6539975|NCT01667562|7461801|FG000|NOT COMPLETED|Diagnostic Phase||30
6539976|NCT01667562|7461802|FG001|NOT COMPLETED|Diagnostic Phase||0
6539977|NCT01667562|7461801|FG000|STARTED|Erlotinib Phase||0
6539978|NCT01667562|7461802|FG001|STARTED|Erlotinib Phase||30
6539979|NCT01667562|7461801|FG000|COMPLETED|Erlotinib Phase||0
6539980|NCT01667562|7461802|FG001|COMPLETED|Erlotinib Phase||27
6539981|NCT01667562|7461801|FG000|NOT COMPLETED|Erlotinib Phase||0
6539982|NCT01667562|7461802|FG001|NOT COMPLETED|Erlotinib Phase||3
6539983|NCT01667679|7461809|FG000|STARTED|Treatment Period 1 (<=12 Weeks)||138
6539984|NCT01667679|7461810|FG001|STARTED|Treatment Period 1 (<=12 Weeks)||137
6539985|NCT01667679|7461809|FG000|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
6539986|NCT01667679|7461810|FG001|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
6539987|NCT01667679|7461809|FG000|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
6539988|NCT01667679|7461810|FG001|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
6539989|NCT01667679|7461809|FG000|STARTED|Treatment Period 2 (<=12 Weeks)||122
6539990|NCT01667679|7461810|FG001|STARTED|Treatment Period 2 (<=12 Weeks)||107
6539991|NCT01667679|7461809|FG000|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
6539992|NCT01667679|7461810|FG001|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
6539993|NCT01667679|7461809|FG000|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
6539994|NCT01667679|7461810|FG001|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
6539995|NCT01667731|7461823|FG000|STARTED|Overall Study||26
6539996|NCT01667731|7461824|FG001|STARTED|Overall Study||42
6539997|NCT01667731|7461825|FG002|STARTED|Overall Study||24
6539998|NCT01667731|7461826|FG003|STARTED|Overall Study||17
6539999|NCT01667731|7461827|FG004|STARTED|Overall Study||115
6540000|NCT01667731|7461823|FG000|COMPLETED|Overall Study||21
6540001|NCT01667731|7461824|FG001|COMPLETED|Overall Study||26
6540002|NCT01667731|7461825|FG002|COMPLETED|Overall Study||22
6540003|NCT01667731|7461826|FG003|COMPLETED|Overall Study||15
6540004|NCT01667731|7461827|FG004|COMPLETED|Overall Study||87
6540005|NCT01667731|7461823|FG000|NOT COMPLETED|Overall Study||5
6540006|NCT01667731|7461824|FG001|NOT COMPLETED|Overall Study||16
6540007|NCT01667731|7461825|FG002|NOT COMPLETED|Overall Study||2
6540008|NCT01667731|7461826|FG003|NOT COMPLETED|Overall Study||2
6540009|NCT01667731|7461827|FG004|NOT COMPLETED|Overall Study||28
6540010|NCT01667796|7461842|FG000|STARTED|Overall Study||27
6540011|NCT01667796|7461843|FG001|STARTED|Overall Study||30
6540012|NCT01667796|7461842|FG000|COMPLETED|Overall Study||24
6540013|NCT01667796|7461843|FG001|COMPLETED|Overall Study||29
6540014|NCT01667796|7461842|FG000|NOT COMPLETED|Overall Study||3
6540015|NCT01667796|7461843|FG001|NOT COMPLETED|Overall Study||1
6540016|NCT01667848|7461855|FG000|STARTED|Overall Study||67
6540017|NCT01667848|7461856|FG001|STARTED|Overall Study||81
6540018|NCT01667848|7461855|FG000|COMPLETED|Overall Study||67
6540019|NCT01667848|7461856|FG001|COMPLETED|Overall Study||81
6540020|NCT01667848|7461855|FG000|NOT COMPLETED|Overall Study||0
6540021|NCT01667848|7461856|FG001|NOT COMPLETED|Overall Study||0
6540022|NCT01667900|7461867|FG000|STARTED|Part A, Period 1||1
6540023|NCT01667900|7461868|FG001|STARTED|Part A, Period 1||1
6540024|NCT01667900|7461869|FG002|STARTED|Part A, Period 1||1
6540025|NCT01667900|7461870|FG003|STARTED|Part A, Period 1||1
6540026|NCT01667900|7461871|FG004|STARTED|Part A, Period 1||1
6540027|NCT01667900|7461872|FG005|STARTED|Part A, Period 1||1
6540028|NCT01667900|7461873|FG006|STARTED|Part A, Period 1||1
6540029|NCT01667900|7461874|FG007|STARTED|Part A, Period 1||1
6540030|NCT01667900|7461875|FG008|STARTED|Part A, Period 1||1
6540031|NCT01667900|7461876|FG009|STARTED|Part A, Period 1||1
6540032|NCT01667900|7461877|FG010|STARTED|Part A, Period 1||1
6540033|NCT01667900|7461878|FG011|STARTED|Part A, Period 1||1
6540034|NCT01667900|7461879|FG012|STARTED|Part A, Period 1||1
6540035|NCT01667900|7461880|FG013|STARTED|Part A, Period 1||1
6540036|NCT01667900|7461881|FG014|STARTED|Part A, Period 1||1
6540037|NCT01667900|7461882|FG015|STARTED|Part A, Period 1||1
6540038|NCT01667900|7461883|FG016|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
6540039|NCT01667900|7461884|FG017|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
6540040|NCT01667900|7461885|FG018|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
6540041|NCT01667900|7461886|FG019|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
6540042|NCT01667900|7461867|FG000|COMPLETED|Part A, Period 1||1
6540043|NCT01667900|7461868|FG001|COMPLETED|Part A, Period 1||1
6540044|NCT01667900|7461869|FG002|COMPLETED|Part A, Period 1||1
6540045|NCT01667900|7461870|FG003|COMPLETED|Part A, Period 1||1
6540046|NCT01667900|7461871|FG004|COMPLETED|Part A, Period 1||1
6540047|NCT01667900|7461872|FG005|COMPLETED|Part A, Period 1||1
6540048|NCT01667900|7461873|FG006|COMPLETED|Part A, Period 1||1
6540049|NCT01667900|7461874|FG007|COMPLETED|Part A, Period 1||1
6540050|NCT01667900|7461875|FG008|COMPLETED|Part A, Period 1||1
6540051|NCT01667900|7461876|FG009|COMPLETED|Part A, Period 1||1
6540052|NCT01667900|7461877|FG010|COMPLETED|Part A, Period 1||1
6540053|NCT01667900|7461878|FG011|COMPLETED|Part A, Period 1||1
6540054|NCT01667900|7461879|FG012|COMPLETED|Part A, Period 1||1
6540055|NCT01667900|7461880|FG013|COMPLETED|Part A, Period 1||1
6540056|NCT01667900|7461881|FG014|COMPLETED|Part A, Period 1||1
6540057|NCT01667900|7461882|FG015|COMPLETED|Part A, Period 1||1
6540058|NCT01667900|7461883|FG016|COMPLETED|Part A, Period 1||0
6540059|NCT01667900|7461884|FG017|COMPLETED|Part A, Period 1||0
6540060|NCT01667900|7461885|FG018|COMPLETED|Part A, Period 1||0
6540061|NCT01667900|7461886|FG019|COMPLETED|Part A, Period 1||0
6540062|NCT01667900|7461867|FG000|NOT COMPLETED|Part A, Period 1||0
6540063|NCT01667900|7461868|FG001|NOT COMPLETED|Part A, Period 1||0
6540064|NCT01667900|7461869|FG002|NOT COMPLETED|Part A, Period 1||0
6540065|NCT01667900|7461870|FG003|NOT COMPLETED|Part A, Period 1||0
6540066|NCT01667900|7461871|FG004|NOT COMPLETED|Part A, Period 1||0
6540067|NCT01667900|7461872|FG005|NOT COMPLETED|Part A, Period 1||0
6540068|NCT01667900|7461873|FG006|NOT COMPLETED|Part A, Period 1||0
6540069|NCT01667900|7461874|FG007|NOT COMPLETED|Part A, Period 1||0
6540070|NCT01667900|7461875|FG008|NOT COMPLETED|Part A, Period 1||0
6540071|NCT01667900|7461876|FG009|NOT COMPLETED|Part A, Period 1||0
6540072|NCT01667900|7461877|FG010|NOT COMPLETED|Part A, Period 1||0
6540073|NCT01667900|7461878|FG011|NOT COMPLETED|Part A, Period 1||0
6540074|NCT01667900|7461879|FG012|NOT COMPLETED|Part A, Period 1||0
6540075|NCT01667900|7461880|FG013|NOT COMPLETED|Part A, Period 1||0
6540076|NCT01667900|7461881|FG014|NOT COMPLETED|Part A, Period 1||0
6540077|NCT01667900|7461882|FG015|NOT COMPLETED|Part A, Period 1||0
6540078|NCT01667900|7461883|FG016|NOT COMPLETED|Part A, Period 1||0
6540079|NCT01667900|7461884|FG017|NOT COMPLETED|Part A, Period 1||0
6540080|NCT01667900|7461885|FG018|NOT COMPLETED|Part A, Period 1||0
6540081|NCT01667900|7461886|FG019|NOT COMPLETED|Part A, Period 1||0
6540082|NCT01667900|7461867|FG000|STARTED|Part A, Washout 1||1
6540083|NCT01667900|7461868|FG001|STARTED|Part A, Washout 1||1
6540084|NCT01667900|7461869|FG002|STARTED|Part A, Washout 1||1
6540085|NCT01667900|7461870|FG003|STARTED|Part A, Washout 1||1
6540086|NCT01667900|7461871|FG004|STARTED|Part A, Washout 1||1
6540087|NCT01667900|7461872|FG005|STARTED|Part A, Washout 1||1
6540088|NCT01667900|7461873|FG006|STARTED|Part A, Washout 1||1
6540089|NCT01667900|7461874|FG007|STARTED|Part A, Washout 1||1
6540090|NCT01667900|7461875|FG008|STARTED|Part A, Washout 1||1
6540091|NCT01667900|7461876|FG009|STARTED|Part A, Washout 1||1
6540092|NCT01667900|7461877|FG010|STARTED|Part A, Washout 1||1
6304219|NCT00364832|7207521|FG007|STARTED|Extension Year 1||0
6304220|NCT00364832|7207522|FG008|STARTED|Extension Year 1||0
6304221|NCT00364832|7207523|FG009|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
6304222|NCT00364832|7207524|FG010|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
6304223|NCT00364832|7207525|FG011|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
6304224|NCT00364832|7207514|FG000|COMPLETED|Extension Year 1||0
6304225|NCT00364832|7207515|FG001|COMPLETED|Extension Year 1||0
6304226|NCT00364832|7207516|FG002|COMPLETED|Extension Year 1||0
6304227|NCT00364832|7207517|FG003|COMPLETED|Extension Year 1||0
6304228|NCT00364832|7207518|FG004|COMPLETED|Extension Year 1||0
6304229|NCT00364832|7207519|FG005|COMPLETED|Extension Year 1||0
6304230|NCT00364832|7207520|FG006|COMPLETED|Extension Year 1||0
6304231|NCT00364832|7207521|FG007|COMPLETED|Extension Year 1||0
6304232|NCT00364832|7207522|FG008|COMPLETED|Extension Year 1||0
6304233|NCT00364832|7207523|FG009|COMPLETED|Extension Year 1||14
6304234|NCT00364832|7207524|FG010|COMPLETED|Extension Year 1||15
6540093|NCT01667900|7461878|FG011|STARTED|Part A, Washout 1||1
6540094|NCT01667900|7461879|FG012|STARTED|Part A, Washout 1||1
6540095|NCT01667900|7461880|FG013|STARTED|Part A, Washout 1||1
6540096|NCT01667900|7461881|FG014|STARTED|Part A, Washout 1||1
6540097|NCT01667900|7461882|FG015|STARTED|Part A, Washout 1||1
6540098|NCT01667900|7461883|FG016|STARTED|Part A, Washout 1||0
6540099|NCT01667900|7461884|FG017|STARTED|Part A, Washout 1||0
6540100|NCT01667900|7461885|FG018|STARTED|Part A, Washout 1||0
6540101|NCT01667900|7461886|FG019|STARTED|Part A, Washout 1||0
6540102|NCT01667900|7461867|FG000|COMPLETED|Part A, Washout 1||1
6540103|NCT01667900|7461868|FG001|COMPLETED|Part A, Washout 1||1
6540104|NCT01667900|7461869|FG002|COMPLETED|Part A, Washout 1||1
6540105|NCT01667900|7461870|FG003|COMPLETED|Part A, Washout 1||1
6540106|NCT01667900|7461871|FG004|COMPLETED|Part A, Washout 1||1
6540107|NCT01667900|7461872|FG005|COMPLETED|Part A, Washout 1||1
6540108|NCT01667900|7461873|FG006|COMPLETED|Part A, Washout 1||1
6540109|NCT01667900|7461874|FG007|COMPLETED|Part A, Washout 1||1
6540110|NCT01667900|7461875|FG008|COMPLETED|Part A, Washout 1||1
6540111|NCT01667900|7461876|FG009|COMPLETED|Part A, Washout 1||1
6540112|NCT01667900|7461877|FG010|COMPLETED|Part A, Washout 1||1
6540113|NCT01667900|7461878|FG011|COMPLETED|Part A, Washout 1||1
6540114|NCT01667900|7461879|FG012|COMPLETED|Part A, Washout 1||1
6540115|NCT01667900|7461880|FG013|COMPLETED|Part A, Washout 1||1
6540116|NCT01667900|7461881|FG014|COMPLETED|Part A, Washout 1||1
6540117|NCT01667900|7461882|FG015|COMPLETED|Part A, Washout 1||1
6540118|NCT01667900|7461883|FG016|COMPLETED|Part A, Washout 1||0
6540119|NCT01667900|7461884|FG017|COMPLETED|Part A, Washout 1||0
6540120|NCT01667900|7461885|FG018|COMPLETED|Part A, Washout 1||0
6540121|NCT01667900|7461886|FG019|COMPLETED|Part A, Washout 1||0
6540122|NCT01667900|7461867|FG000|NOT COMPLETED|Part A, Washout 1||0
6540123|NCT01667900|7461868|FG001|NOT COMPLETED|Part A, Washout 1||0
6540124|NCT01667900|7461869|FG002|NOT COMPLETED|Part A, Washout 1||0
6540125|NCT01667900|7461870|FG003|NOT COMPLETED|Part A, Washout 1||0
6540126|NCT01667900|7461871|FG004|NOT COMPLETED|Part A, Washout 1||0
6540127|NCT01667900|7461872|FG005|NOT COMPLETED|Part A, Washout 1||0
6540128|NCT01667900|7461873|FG006|NOT COMPLETED|Part A, Washout 1||0
6540129|NCT01667900|7461874|FG007|NOT COMPLETED|Part A, Washout 1||0
6540130|NCT01667900|7461875|FG008|NOT COMPLETED|Part A, Washout 1||0
6540131|NCT01667900|7461876|FG009|NOT COMPLETED|Part A, Washout 1||0
6540132|NCT01667900|7461877|FG010|NOT COMPLETED|Part A, Washout 1||0
6540133|NCT01667900|7461878|FG011|NOT COMPLETED|Part A, Washout 1||0
6540134|NCT01667900|7461879|FG012|NOT COMPLETED|Part A, Washout 1||0
6540135|NCT01667900|7461880|FG013|NOT COMPLETED|Part A, Washout 1||0
6540136|NCT01667900|7461881|FG014|NOT COMPLETED|Part A, Washout 1||0
6540137|NCT01667900|7461882|FG015|NOT COMPLETED|Part A, Washout 1||0
6540138|NCT01667900|7461883|FG016|NOT COMPLETED|Part A, Washout 1||0
6540139|NCT01667900|7461884|FG017|NOT COMPLETED|Part A, Washout 1||0
6540140|NCT01667900|7461885|FG018|NOT COMPLETED|Part A, Washout 1||0
6540141|NCT01667900|7461886|FG019|NOT COMPLETED|Part A, Washout 1||0
6540142|NCT01667900|7461867|FG000|STARTED|Part A, Period 2||1
6540143|NCT01667900|7461868|FG001|STARTED|Part A, Period 2||1
6540144|NCT01667900|7461869|FG002|STARTED|Part A, Period 2||1
6540145|NCT01667900|7461870|FG003|STARTED|Part A, Period 2||1
6540146|NCT01667900|7461871|FG004|STARTED|Part A, Period 2||1
6540147|NCT01667900|7461872|FG005|STARTED|Part A, Period 2||1
6540148|NCT01667900|7461873|FG006|STARTED|Part A, Period 2||1
6540149|NCT01667900|7461874|FG007|STARTED|Part A, Period 2||1
6540150|NCT01667900|7461875|FG008|STARTED|Part A, Period 2||1
6540151|NCT01667900|7461876|FG009|STARTED|Part A, Period 2||1
6540152|NCT01667900|7461877|FG010|STARTED|Part A, Period 2||1
6540153|NCT01667900|7461878|FG011|STARTED|Part A, Period 2||1
6540154|NCT01667900|7461879|FG012|STARTED|Part A, Period 2||1
6540155|NCT01667900|7461880|FG013|STARTED|Part A, Period 2||1
6540156|NCT01667900|7461881|FG014|STARTED|Part A, Period 2||1
6540157|NCT01667900|7461882|FG015|STARTED|Part A, Period 2||1
6540158|NCT01667900|7461883|FG016|STARTED|Part A, Period 2||0
6540159|NCT01667900|7461884|FG017|STARTED|Part A, Period 2||0
6540160|NCT01667900|7461885|FG018|STARTED|Part A, Period 2||0
6540161|NCT01667900|7461886|FG019|STARTED|Part A, Period 2||0
6540162|NCT01667900|7461867|FG000|COMPLETED|Part A, Period 2||1
6540163|NCT01667900|7461868|FG001|COMPLETED|Part A, Period 2||1
6540164|NCT01667900|7461869|FG002|COMPLETED|Part A, Period 2||1
6540165|NCT01667900|7461870|FG003|COMPLETED|Part A, Period 2||1
6540166|NCT01667900|7461871|FG004|COMPLETED|Part A, Period 2||1
6645672|NCT02374099|7574626|FG000|STARTED|Overall Study||48
6645673|NCT02374099|7574627|FG001|STARTED|Overall Study||49
6645674|NCT02374099|7574626|FG000|Participants Treated|Overall Study|2 participants randomized, but not treated|46
6645675|NCT02374099|7574627|FG001|Participants Treated|Overall Study|1 participant randomized, but not treated|48
6645676|NCT02374099|7574626|FG000|COMPLETED|Overall Study||0
6645677|NCT02374099|7574627|FG001|COMPLETED|Overall Study||0
6645678|NCT02374099|7574626|FG000|NOT COMPLETED|Overall Study||48
6645679|NCT02374099|7574627|FG001|NOT COMPLETED|Overall Study||49
6645680|NCT02374138|7574635|FG000|STARTED|Six Month Follow Up||110
6645681|NCT02374138|7574636|FG001|STARTED|Six Month Follow Up||107
6645682|NCT02374138|7574635|FG000|COMPLETED|Six Month Follow Up|6 Month Follow Up|102
6645683|NCT02374138|7574636|FG001|COMPLETED|Six Month Follow Up|6 Month Follow Up|93
6645684|NCT02374138|7574635|FG000|NOT COMPLETED|Six Month Follow Up||8
6645685|NCT02374138|7574636|FG001|NOT COMPLETED|Six Month Follow Up||14
6645686|NCT02374138|7574635|FG000|STARTED|Twelve Month FollowUp||110
6645687|NCT02374138|7574636|FG001|STARTED|Twelve Month FollowUp||107
6645688|NCT02374138|7574635|FG000|COMPLETED|Twelve Month FollowUp||101
6645689|NCT02374138|7574636|FG001|COMPLETED|Twelve Month FollowUp||95
6645690|NCT02374138|7574635|FG000|NOT COMPLETED|Twelve Month FollowUp||9
6645691|NCT02374138|7574636|FG001|NOT COMPLETED|Twelve Month FollowUp||12
6645692|NCT02374164|7574646|FG000|STARTED|Treatment Period 1||12
6645693|NCT02374164|7574647|FG001|STARTED|Treatment Period 1||12
6645694|NCT02374164|7574648|FG002|STARTED|Treatment Period 1||12
6645695|NCT02374164|7574646|FG000|COMPLETED|Treatment Period 1||12
6645696|NCT02374164|7574647|FG001|COMPLETED|Treatment Period 1||12
6645697|NCT02374164|7574648|FG002|COMPLETED|Treatment Period 1||12
6645698|NCT02374164|7574646|FG000|NOT COMPLETED|Treatment Period 1||0
6645699|NCT02374164|7574647|FG001|NOT COMPLETED|Treatment Period 1||0
6645700|NCT02374164|7574648|FG002|NOT COMPLETED|Treatment Period 1||0
6645701|NCT02374164|7574646|FG000|STARTED|Treatment Period 2||12
6645702|NCT02374164|7574647|FG001|STARTED|Treatment Period 2||12
6645703|NCT02374164|7574648|FG002|STARTED|Treatment Period 2||12
6645704|NCT02374164|7574646|FG000|COMPLETED|Treatment Period 2||12
6645705|NCT02374164|7574647|FG001|COMPLETED|Treatment Period 2||12
6645706|NCT02374164|7574648|FG002|COMPLETED|Treatment Period 2||12
6645707|NCT02374164|7574646|FG000|NOT COMPLETED|Treatment Period 2||0
6645708|NCT02374164|7574647|FG001|NOT COMPLETED|Treatment Period 2||0
6645709|NCT02374164|7574648|FG002|NOT COMPLETED|Treatment Period 2||0
6645710|NCT02374164|7574646|FG000|STARTED|Treatment Period 3||12
6645711|NCT02374164|7574647|FG001|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
6645712|NCT02374164|7574648|FG002|STARTED|Treatment Period 3||12
6645713|NCT02374164|7574646|FG000|COMPLETED|Treatment Period 3||12
6645714|NCT02374164|7574647|FG001|COMPLETED|Treatment Period 3||11
6645715|NCT02374164|7574648|FG002|COMPLETED|Treatment Period 3||12
6645716|NCT02374164|7574646|FG000|NOT COMPLETED|Treatment Period 3||0
6645717|NCT02374164|7574647|FG001|NOT COMPLETED|Treatment Period 3||0
6645718|NCT02374164|7574648|FG002|NOT COMPLETED|Treatment Period 3||0
6645719|NCT02374255|7574660|FG000|STARTED|Overall Study||155
6645720|NCT02374255|7574661|FG001|STARTED|Overall Study||110
6645721|NCT02374255|7574662|FG002|STARTED|Overall Study||11
6540167|NCT01667900|7461872|FG005|COMPLETED|Part A, Period 2||1
6645722|NCT02374255|7574663|FG003|STARTED|Overall Study||11
6645723|NCT02374255|7574660|FG000|COMPLETED|Overall Study||153
6645724|NCT02374255|7574661|FG001|COMPLETED|Overall Study||110
6645725|NCT02374255|7574662|FG002|COMPLETED|Overall Study||11
6645726|NCT02374255|7574663|FG003|COMPLETED|Overall Study||11
6645727|NCT02374255|7574660|FG000|NOT COMPLETED|Overall Study||2
6540168|NCT01667900|7461873|FG006|COMPLETED|Part A, Period 2||1
6645728|NCT02374255|7574661|FG001|NOT COMPLETED|Overall Study||0
6645729|NCT02374255|7574662|FG002|NOT COMPLETED|Overall Study||0
6540169|NCT01667900|7461874|FG007|COMPLETED|Part A, Period 2||1
6540170|NCT01667900|7461875|FG008|COMPLETED|Part A, Period 2||1
6645730|NCT02374255|7574663|FG003|NOT COMPLETED|Overall Study||0
6540171|NCT01667900|7461876|FG009|COMPLETED|Part A, Period 2||1
6540172|NCT01667900|7461877|FG010|COMPLETED|Part A, Period 2||1
6540173|NCT01667900|7461878|FG011|COMPLETED|Part A, Period 2||1
6540174|NCT01667900|7461879|FG012|COMPLETED|Part A, Period 2||1
6540175|NCT01667900|7461880|FG013|COMPLETED|Part A, Period 2||1
6540176|NCT01667900|7461881|FG014|COMPLETED|Part A, Period 2||1
6540177|NCT01667900|7461882|FG015|COMPLETED|Part A, Period 2||1
6540178|NCT01667900|7461883|FG016|COMPLETED|Part A, Period 2||0
6540179|NCT01667900|7461884|FG017|COMPLETED|Part A, Period 2||0
6540180|NCT01667900|7461885|FG018|COMPLETED|Part A, Period 2||0
6540181|NCT01667900|7461886|FG019|COMPLETED|Part A, Period 2||0
6540182|NCT01667900|7461867|FG000|NOT COMPLETED|Part A, Period 2||0
6540183|NCT01667900|7461868|FG001|NOT COMPLETED|Part A, Period 2||0
6540184|NCT01667900|7461869|FG002|NOT COMPLETED|Part A, Period 2||0
6540185|NCT01667900|7461870|FG003|NOT COMPLETED|Part A, Period 2||0
6540186|NCT01667900|7461871|FG004|NOT COMPLETED|Part A, Period 2||0
6540187|NCT01667900|7461872|FG005|NOT COMPLETED|Part A, Period 2||0
6540188|NCT01667900|7461873|FG006|NOT COMPLETED|Part A, Period 2||0
6540189|NCT01667900|7461874|FG007|NOT COMPLETED|Part A, Period 2||0
6540190|NCT01667900|7461875|FG008|NOT COMPLETED|Part A, Period 2||0
6540191|NCT01667900|7461876|FG009|NOT COMPLETED|Part A, Period 2||0
6540192|NCT01667900|7461877|FG010|NOT COMPLETED|Part A, Period 2||0
6540193|NCT01667900|7461878|FG011|NOT COMPLETED|Part A, Period 2||0
6540194|NCT01667900|7461879|FG012|NOT COMPLETED|Part A, Period 2||0
6540195|NCT01667900|7461880|FG013|NOT COMPLETED|Part A, Period 2||0
6540196|NCT01667900|7461881|FG014|NOT COMPLETED|Part A, Period 2||0
6540197|NCT01667900|7461882|FG015|NOT COMPLETED|Part A, Period 2||0
6540198|NCT01667900|7461883|FG016|NOT COMPLETED|Part A, Period 2||0
6540199|NCT01667900|7461884|FG017|NOT COMPLETED|Part A, Period 2||0
6540200|NCT01667900|7461885|FG018|NOT COMPLETED|Part A, Period 2||0
6540201|NCT01667900|7461886|FG019|NOT COMPLETED|Part A, Period 2||0
6540202|NCT01667900|7461867|FG000|STARTED|Part A, Washout 2||1
6540203|NCT01667900|7461868|FG001|STARTED|Part A, Washout 2||1
6540204|NCT01667900|7461869|FG002|STARTED|Part A, Washout 2||1
6540205|NCT01667900|7461870|FG003|STARTED|Part A, Washout 2||1
6540206|NCT01667900|7461871|FG004|STARTED|Part A, Washout 2||1
6540207|NCT01667900|7461872|FG005|STARTED|Part A, Washout 2||1
6540208|NCT01667900|7461873|FG006|STARTED|Part A, Washout 2||1
6540209|NCT01667900|7461874|FG007|STARTED|Part A, Washout 2||1
6540210|NCT01667900|7461875|FG008|STARTED|Part A, Washout 2||1
6540211|NCT01667900|7461876|FG009|STARTED|Part A, Washout 2||1
6540212|NCT01667900|7461877|FG010|STARTED|Part A, Washout 2||1
6540213|NCT01667900|7461878|FG011|STARTED|Part A, Washout 2||1
6540214|NCT01667900|7461879|FG012|STARTED|Part A, Washout 2||1
6540215|NCT01667900|7461880|FG013|STARTED|Part A, Washout 2||1
6540216|NCT01667900|7461881|FG014|STARTED|Part A, Washout 2||1
6540217|NCT01667900|7461882|FG015|STARTED|Part A, Washout 2||1
6540218|NCT01667900|7461883|FG016|STARTED|Part A, Washout 2||0
6540219|NCT01667900|7461884|FG017|STARTED|Part A, Washout 2||0
6540220|NCT01667900|7461885|FG018|STARTED|Part A, Washout 2||0
6540221|NCT01667900|7461886|FG019|STARTED|Part A, Washout 2||0
6540222|NCT01667900|7461867|FG000|COMPLETED|Part A, Washout 2||1
6540223|NCT01667900|7461868|FG001|COMPLETED|Part A, Washout 2||1
6540224|NCT01667900|7461869|FG002|COMPLETED|Part A, Washout 2||1
6540225|NCT01667900|7461870|FG003|COMPLETED|Part A, Washout 2||1
6540226|NCT01667900|7461871|FG004|COMPLETED|Part A, Washout 2||1
6540227|NCT01667900|7461872|FG005|COMPLETED|Part A, Washout 2||1
6540228|NCT01667900|7461873|FG006|COMPLETED|Part A, Washout 2||1
6540229|NCT01667900|7461874|FG007|COMPLETED|Part A, Washout 2||1
6540230|NCT01667900|7461875|FG008|COMPLETED|Part A, Washout 2||1
6540231|NCT01667900|7461876|FG009|COMPLETED|Part A, Washout 2||1
6540232|NCT01667900|7461877|FG010|COMPLETED|Part A, Washout 2||1
6540233|NCT01667900|7461878|FG011|COMPLETED|Part A, Washout 2||1
6540234|NCT01667900|7461879|FG012|COMPLETED|Part A, Washout 2||1
6540235|NCT01667900|7461880|FG013|COMPLETED|Part A, Washout 2||1
6540236|NCT01667900|7461881|FG014|COMPLETED|Part A, Washout 2||1
6540237|NCT01667900|7461882|FG015|COMPLETED|Part A, Washout 2||1
6540238|NCT01667900|7461883|FG016|COMPLETED|Part A, Washout 2||0
6540239|NCT01667900|7461884|FG017|COMPLETED|Part A, Washout 2||0
6540240|NCT01667900|7461885|FG018|COMPLETED|Part A, Washout 2||0
6540241|NCT01667900|7461886|FG019|COMPLETED|Part A, Washout 2||0
6645731|NCT02374307|7574681|FG000|STARTED|3-months Follow-up||77
6645732|NCT02374307|7574682|FG001|STARTED|3-months Follow-up||78
6645733|NCT02374307|7574681|FG000|COMPLETED|3-months Follow-up||69
6645734|NCT02374307|7574682|FG001|COMPLETED|3-months Follow-up||69
6645735|NCT02374307|7574681|FG000|NOT COMPLETED|3-months Follow-up||8
6645736|NCT02374307|7574682|FG001|NOT COMPLETED|3-months Follow-up||9
6645737|NCT02374307|7574681|FG000|STARTED|6-months Follow-up|5 subjects missed the first follow-up, but continued the study and were assessed at 6 months.|74
6645738|NCT02374307|7574682|FG001|STARTED|6-months Follow-up|1 subject missed the first follow-up, but continued the study and was assessed at 6 months.|70
6645739|NCT02374307|7574681|FG000|COMPLETED|6-months Follow-up||71
6540242|NCT01667900|7461867|FG000|NOT COMPLETED|Part A, Washout 2||0
6540243|NCT01667900|7461868|FG001|NOT COMPLETED|Part A, Washout 2||0
6540244|NCT01667900|7461869|FG002|NOT COMPLETED|Part A, Washout 2||0
6540245|NCT01667900|7461870|FG003|NOT COMPLETED|Part A, Washout 2||0
6540246|NCT01667900|7461871|FG004|NOT COMPLETED|Part A, Washout 2||0
6540247|NCT01667900|7461872|FG005|NOT COMPLETED|Part A, Washout 2||0
6540248|NCT01667900|7461873|FG006|NOT COMPLETED|Part A, Washout 2||0
6540249|NCT01667900|7461874|FG007|NOT COMPLETED|Part A, Washout 2||0
6540250|NCT01667900|7461875|FG008|NOT COMPLETED|Part A, Washout 2||0
6540251|NCT01667900|7461876|FG009|NOT COMPLETED|Part A, Washout 2||0
6540252|NCT01667900|7461877|FG010|NOT COMPLETED|Part A, Washout 2||0
6540253|NCT01667900|7461878|FG011|NOT COMPLETED|Part A, Washout 2||0
6540254|NCT01667900|7461879|FG012|NOT COMPLETED|Part A, Washout 2||0
6540255|NCT01667900|7461880|FG013|NOT COMPLETED|Part A, Washout 2||0
6540256|NCT01667900|7461881|FG014|NOT COMPLETED|Part A, Washout 2||0
6540257|NCT01667900|7461882|FG015|NOT COMPLETED|Part A, Washout 2||0
6540258|NCT01667900|7461883|FG016|NOT COMPLETED|Part A, Washout 2||0
6540259|NCT01667900|7461884|FG017|NOT COMPLETED|Part A, Washout 2||0
6540260|NCT01667900|7461885|FG018|NOT COMPLETED|Part A, Washout 2||0
6540261|NCT01667900|7461886|FG019|NOT COMPLETED|Part A, Washout 2||0
6540262|NCT01667900|7461867|FG000|STARTED|Part A, Period 3||1
6540263|NCT01667900|7461868|FG001|STARTED|Part A, Period 3||1
6540264|NCT01667900|7461869|FG002|STARTED|Part A, Period 3||1
6540265|NCT01667900|7461870|FG003|STARTED|Part A, Period 3||1
6540266|NCT01667900|7461871|FG004|STARTED|Part A, Period 3||1
6540267|NCT01667900|7461872|FG005|STARTED|Part A, Period 3||1
6540268|NCT01667900|7461873|FG006|STARTED|Part A, Period 3||1
6540269|NCT01667900|7461874|FG007|STARTED|Part A, Period 3||1
6540270|NCT01667900|7461875|FG008|STARTED|Part A, Period 3||1
6540271|NCT01667900|7461876|FG009|STARTED|Part A, Period 3||1
6540272|NCT01667900|7461877|FG010|STARTED|Part A, Period 3||1
6540273|NCT01667900|7461878|FG011|STARTED|Part A, Period 3||1
6540274|NCT01667900|7461879|FG012|STARTED|Part A, Period 3||1
6540275|NCT01667900|7461880|FG013|STARTED|Part A, Period 3||1
6540276|NCT01667900|7461881|FG014|STARTED|Part A, Period 3||1
6540277|NCT01667900|7461882|FG015|STARTED|Part A, Period 3||1
6540278|NCT01667900|7461883|FG016|STARTED|Part A, Period 3||0
6540279|NCT01667900|7461884|FG017|STARTED|Part A, Period 3||0
6540280|NCT01667900|7461885|FG018|STARTED|Part A, Period 3||0
6540281|NCT01667900|7461886|FG019|STARTED|Part A, Period 3||0
6540282|NCT01667900|7461867|FG000|COMPLETED|Part A, Period 3||1
6540283|NCT01667900|7461868|FG001|COMPLETED|Part A, Period 3||1
6540284|NCT01667900|7461869|FG002|COMPLETED|Part A, Period 3||1
6540285|NCT01667900|7461870|FG003|COMPLETED|Part A, Period 3||1
6540286|NCT01667900|7461871|FG004|COMPLETED|Part A, Period 3||1
6540287|NCT01667900|7461872|FG005|COMPLETED|Part A, Period 3||1
6540288|NCT01667900|7461873|FG006|COMPLETED|Part A, Period 3||1
6540289|NCT01667900|7461874|FG007|COMPLETED|Part A, Period 3||1
6540290|NCT01667900|7461875|FG008|COMPLETED|Part A, Period 3||1
6540291|NCT01667900|7461876|FG009|COMPLETED|Part A, Period 3||1
6540292|NCT01667900|7461877|FG010|COMPLETED|Part A, Period 3||1
6540293|NCT01667900|7461878|FG011|COMPLETED|Part A, Period 3||1
6540294|NCT01667900|7461879|FG012|COMPLETED|Part A, Period 3||1
6540295|NCT01667900|7461880|FG013|COMPLETED|Part A, Period 3||1
6540296|NCT01667900|7461881|FG014|COMPLETED|Part A, Period 3||1
6540297|NCT01667900|7461882|FG015|COMPLETED|Part A, Period 3||1
6540298|NCT01667900|7461883|FG016|COMPLETED|Part A, Period 3||0
6540299|NCT01667900|7461884|FG017|COMPLETED|Part A, Period 3||0
6540300|NCT01667900|7461885|FG018|COMPLETED|Part A, Period 3||0
6540301|NCT01667900|7461886|FG019|COMPLETED|Part A, Period 3||0
6540302|NCT01667900|7461867|FG000|NOT COMPLETED|Part A, Period 3||0
6540303|NCT01667900|7461868|FG001|NOT COMPLETED|Part A, Period 3||0
6540304|NCT01667900|7461869|FG002|NOT COMPLETED|Part A, Period 3||0
6645740|NCT02374307|7574682|FG001|COMPLETED|6-months Follow-up||64
6645741|NCT02374307|7574681|FG000|NOT COMPLETED|6-months Follow-up||3
6645742|NCT02374307|7574682|FG001|NOT COMPLETED|6-months Follow-up||6
6645743|NCT02374346|7574688|FG000|STARTED|Overall Study||494
6645744|NCT02374346|7574688|FG000|COMPLETED|Overall Study||446
6645745|NCT02374346|7574688|FG000|NOT COMPLETED|Overall Study||48
6645746|NCT02374398|7574698|FG000|STARTED|Overall Study||31
6645747|NCT02374398|7574699|FG001|STARTED|Overall Study||32
6645748|NCT02374398|7574700|FG002|STARTED|Overall Study||32
6645749|NCT02374398|7574701|FG003|STARTED|Overall Study||32
6645750|NCT02374398|7574698|FG000|COMPLETED|Overall Study||29
6645751|NCT02374398|7574699|FG001|COMPLETED|Overall Study||31
6645752|NCT02374398|7574700|FG002|COMPLETED|Overall Study||29
6645753|NCT02374398|7574701|FG003|COMPLETED|Overall Study||32
6645754|NCT02374398|7574698|FG000|NOT COMPLETED|Overall Study||2
6645755|NCT02374398|7574699|FG001|NOT COMPLETED|Overall Study||1
6645756|NCT02374398|7574700|FG002|NOT COMPLETED|Overall Study||3
6645757|NCT02374398|7574701|FG003|NOT COMPLETED|Overall Study||0
6645758|NCT02374463|7574714|FG000|STARTED|Overall Study||15
6645759|NCT02374463|7574715|FG001|STARTED|Overall Study||12
6645760|NCT02374463|7574714|FG000|COMPLETED|Overall Study||12
6645761|NCT02374463|7574715|FG001|COMPLETED|Overall Study||9
6540305|NCT01667900|7461870|FG003|NOT COMPLETED|Part A, Period 3||0
6540306|NCT01667900|7461871|FG004|NOT COMPLETED|Part A, Period 3||0
6645762|NCT02374463|7574714|FG000|NOT COMPLETED|Overall Study||3
6645763|NCT02374463|7574715|FG001|NOT COMPLETED|Overall Study||3
6645764|NCT02374593|7574724|FG000|STARTED|Overall Study||24
6540307|NCT01667900|7461872|FG005|NOT COMPLETED|Part A, Period 3||0
6540308|NCT01667900|7461873|FG006|NOT COMPLETED|Part A, Period 3||0
6540309|NCT01667900|7461874|FG007|NOT COMPLETED|Part A, Period 3||0
6540310|NCT01667900|7461875|FG008|NOT COMPLETED|Part A, Period 3||0
6645765|NCT02374593|7574725|FG001|STARTED|Overall Study||44
6645766|NCT02374593|7574724|FG000|COMPLETED|Overall Study||22
6645767|NCT02374593|7574725|FG001|COMPLETED|Overall Study||44
6645768|NCT02374593|7574724|FG000|NOT COMPLETED|Overall Study||2
6645769|NCT02374593|7574725|FG001|NOT COMPLETED|Overall Study||0
6540311|NCT01667900|7461876|FG009|NOT COMPLETED|Part A, Period 3||0
6540312|NCT01667900|7461877|FG010|NOT COMPLETED|Part A, Period 3||0
6540313|NCT01667900|7461878|FG011|NOT COMPLETED|Part A, Period 3||0
6540314|NCT01667900|7461879|FG012|NOT COMPLETED|Part A, Period 3||0
6540315|NCT01667900|7461880|FG013|NOT COMPLETED|Part A, Period 3||0
6540316|NCT01667900|7461881|FG014|NOT COMPLETED|Part A, Period 3||0
6540317|NCT01667900|7461882|FG015|NOT COMPLETED|Part A, Period 3||0
6540318|NCT01667900|7461883|FG016|NOT COMPLETED|Part A, Period 3||0
6540319|NCT01667900|7461884|FG017|NOT COMPLETED|Part A, Period 3||0
6540320|NCT01667900|7461885|FG018|NOT COMPLETED|Part A, Period 3||0
6540321|NCT01667900|7461886|FG019|NOT COMPLETED|Part A, Period 3||0
6645770|NCT02374671|7574738|FG000|STARTED|Observation (Deferred Implantation)||0
6645771|NCT02374671|7574739|FG001|STARTED|Observation (Deferred Implantation)||0
6645772|NCT02374671|7574740|FG002|STARTED|Observation (Deferred Implantation)||31
6645773|NCT02374671|7574738|FG000|COMPLETED|Observation (Deferred Implantation)||0
6655952|NCT02457247|7586101|FG003|STARTED|Period 1||70
6540322|NCT01667900|7461867|FG000|STARTED|Part B|Part A participants did not participate in Part B.|0
6540323|NCT01667900|7461868|FG001|STARTED|Part B|Part A participants did not participate in Part B.|0
6540324|NCT01667900|7461869|FG002|STARTED|Part B|Part A participants did not participate in Part B.|0
6540325|NCT01667900|7461870|FG003|STARTED|Part B|Part A participants did not participate in Part B.|0
6540326|NCT01667900|7461871|FG004|STARTED|Part B|Part A participants did not participate in Part B.|0
6540327|NCT01667900|7461872|FG005|STARTED|Part B|Part A participants did not participate in Part B.|0
6540328|NCT01667900|7461873|FG006|STARTED|Part B|Part A participants did not participate in Part B.|0
6540329|NCT01667900|7461874|FG007|STARTED|Part B|Part A participants did not participate in Part B.|0
6540330|NCT01667900|7461875|FG008|STARTED|Part B|Part A participants did not participate in Part B.|0
6540331|NCT01667900|7461876|FG009|STARTED|Part B|Part A participants did not participate in Part B.|0
6540332|NCT01667900|7461877|FG010|STARTED|Part B|Part A participants did not participate in Part B.|0
6540333|NCT01667900|7461878|FG011|STARTED|Part B|Part A participants did not participate in Part B.|0
6540334|NCT01667900|7461879|FG012|STARTED|Part B|Part A participants did not participate in Part B.|0
6540335|NCT01667900|7461880|FG013|STARTED|Part B|Part A participants did not participate in Part B.|0
6540336|NCT01667900|7461881|FG014|STARTED|Part B|Part A participants did not participate in Part B.|0
6540337|NCT01667900|7461882|FG015|STARTED|Part B|Part A participants did not participate in Part B.|0
6540338|NCT01667900|7461883|FG016|STARTED|Part B||11
6540339|NCT01667900|7461884|FG017|STARTED|Part B||11
6540340|NCT01667900|7461885|FG018|STARTED|Part B||10
6540341|NCT01667900|7461886|FG019|STARTED|Part B||10
6540342|NCT01667900|7461867|FG000|COMPLETED|Part B||0
6540343|NCT01667900|7461868|FG001|COMPLETED|Part B||0
6540344|NCT01667900|7461869|FG002|COMPLETED|Part B||0
6540345|NCT01667900|7461870|FG003|COMPLETED|Part B||0
6540346|NCT01667900|7461871|FG004|COMPLETED|Part B||0
6540347|NCT01667900|7461872|FG005|COMPLETED|Part B||0
6540348|NCT01667900|7461873|FG006|COMPLETED|Part B||0
6540349|NCT01667900|7461874|FG007|COMPLETED|Part B||0
6540350|NCT01667900|7461875|FG008|COMPLETED|Part B||0
6540351|NCT01667900|7461876|FG009|COMPLETED|Part B||0
6540352|NCT01667900|7461877|FG010|COMPLETED|Part B||0
6540353|NCT01667900|7461878|FG011|COMPLETED|Part B||0
6540354|NCT01667900|7461879|FG012|COMPLETED|Part B||0
6540355|NCT01667900|7461880|FG013|COMPLETED|Part B||0
6540356|NCT01667900|7461881|FG014|COMPLETED|Part B||0
6540357|NCT01667900|7461882|FG015|COMPLETED|Part B||0
6540358|NCT01667900|7461883|FG016|COMPLETED|Part B||10
6540359|NCT01667900|7461884|FG017|COMPLETED|Part B||11
6540360|NCT01667900|7461885|FG018|COMPLETED|Part B||10
6540361|NCT01667900|7461886|FG019|COMPLETED|Part B||10
6540362|NCT01667900|7461867|FG000|NOT COMPLETED|Part B||0
6540363|NCT01667900|7461868|FG001|NOT COMPLETED|Part B||0
6540364|NCT01667900|7461869|FG002|NOT COMPLETED|Part B||0
6540365|NCT01667900|7461870|FG003|NOT COMPLETED|Part B||0
6540366|NCT01667900|7461871|FG004|NOT COMPLETED|Part B||0
6540367|NCT01667900|7461872|FG005|NOT COMPLETED|Part B||0
6540368|NCT01667900|7461873|FG006|NOT COMPLETED|Part B||0
6540369|NCT01667900|7461874|FG007|NOT COMPLETED|Part B||0
6540370|NCT01667900|7461875|FG008|NOT COMPLETED|Part B||0
6540371|NCT01667900|7461876|FG009|NOT COMPLETED|Part B||0
6540372|NCT01667900|7461877|FG010|NOT COMPLETED|Part B||0
6540373|NCT01667900|7461878|FG011|NOT COMPLETED|Part B||0
6540374|NCT01667900|7461879|FG012|NOT COMPLETED|Part B||0
6540375|NCT01667900|7461880|FG013|NOT COMPLETED|Part B||0
6540376|NCT01667900|7461881|FG014|NOT COMPLETED|Part B||0
6540377|NCT01667900|7461882|FG015|NOT COMPLETED|Part B||0
6540378|NCT01667900|7461883|FG016|NOT COMPLETED|Part B||1
6540379|NCT01667900|7461884|FG017|NOT COMPLETED|Part B||0
6540380|NCT01667900|7461885|FG018|NOT COMPLETED|Part B||0
6540381|NCT01667900|7461886|FG019|NOT COMPLETED|Part B||0
6540382|NCT01667926|7461908|FG000|STARTED|Overall Study||13
6540383|NCT01667926|7461909|FG001|STARTED|Overall Study||13
6540384|NCT01667926|7461910|FG002|STARTED|Overall Study||11
6540385|NCT01667926|7461908|FG000|COMPLETED|Overall Study||8
6540386|NCT01667926|7461909|FG001|COMPLETED|Overall Study||9
6540387|NCT01667926|7461910|FG002|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
6540388|NCT01667926|7461908|FG000|NOT COMPLETED|Overall Study||5
6540389|NCT01667926|7461909|FG001|NOT COMPLETED|Overall Study||4
6540390|NCT01667926|7461910|FG002|NOT COMPLETED|Overall Study||11
6540391|NCT01667978|7461918|FG000|STARTED|Overall Study||18
6540392|NCT01667978|7461919|FG001|STARTED|Overall Study||17
6540393|NCT01667978|7461918|FG000|COMPLETED|Overall Study||16
6540394|NCT01667978|7461919|FG001|COMPLETED|Overall Study||17
6540395|NCT01667978|7461918|FG000|NOT COMPLETED|Overall Study||2
6540396|NCT01667978|7461919|FG001|NOT COMPLETED|Overall Study||0
6540397|NCT01668004|7461925|FG000|STARTED|Overall Study||101
6540398|NCT01668004|7461925|FG000|Treated|Overall Study||101
6540399|NCT01668004|7461925|FG000|COMPLETED|Overall Study||76
6540400|NCT01668004|7461925|FG000|NOT COMPLETED|Overall Study||25
6540401|NCT01668017|7461936|FG000|STARTED|Overall Study||4
6540402|NCT01668017|7461937|FG001|STARTED|Overall Study||9
6540403|NCT01668017|7461938|FG002|STARTED|Overall Study||6
6540404|NCT01668017|7461939|FG003|STARTED|Overall Study||5
6540405|NCT01668017|7461940|FG004|STARTED|Overall Study||2
6540406|NCT01668017|7461936|FG000|COMPLETED|Overall Study||4
6540407|NCT01668017|7461937|FG001|COMPLETED|Overall Study||9
6540408|NCT01668017|7461938|FG002|COMPLETED|Overall Study||6
6540409|NCT01668017|7461939|FG003|COMPLETED|Overall Study||5
6540410|NCT01668017|7461940|FG004|COMPLETED|Overall Study||2
6540411|NCT01668017|7461936|FG000|NOT COMPLETED|Overall Study||0
6540412|NCT01668017|7461937|FG001|NOT COMPLETED|Overall Study||0
6540413|NCT01668017|7461938|FG002|NOT COMPLETED|Overall Study||0
6540414|NCT01668017|7461939|FG003|NOT COMPLETED|Overall Study||0
6540415|NCT01668017|7461940|FG004|NOT COMPLETED|Overall Study||0
6540416|NCT01668030|7461967|FG000|STARTED|Overall Study||10
6540417|NCT01668030|7461968|FG001|STARTED|Overall Study||10
6540418|NCT01668030|7461967|FG000|COMPLETED|Overall Study||10
6645774|NCT02374671|7574739|FG001|COMPLETED|Observation (Deferred Implantation)||0
6645775|NCT02374671|7574740|FG002|COMPLETED|Observation (Deferred Implantation)||26
6645776|NCT02374671|7574738|FG000|NOT COMPLETED|Observation (Deferred Implantation)||0
6645777|NCT02374671|7574739|FG001|NOT COMPLETED|Observation (Deferred Implantation)||0
6645778|NCT02374671|7574740|FG002|NOT COMPLETED|Observation (Deferred Implantation)||5
6655953|NCT02457247|7586098|FG000|COMPLETED|Period 1||66
6540419|NCT01668030|7461968|FG001|COMPLETED|Overall Study||10
6540420|NCT01668030|7461967|FG000|NOT COMPLETED|Overall Study||0
6540421|NCT01668030|7461968|FG001|NOT COMPLETED|Overall Study||0
6540422|NCT01668173|7461973|FG000|STARTED|Overall Study||7
6540423|NCT01668173|7461973|FG000|COMPLETED|Overall Study||0
6540424|NCT01668173|7461973|FG000|NOT COMPLETED|Overall Study||7
6540425|NCT01668355|7461979|FG000|STARTED|Overall Study||164
6540426|NCT01668355|7461980|FG001|STARTED|Overall Study||167
6540427|NCT01668355|7461979|FG000|COMPLETED|Overall Study||155
6540428|NCT01668355|7461980|FG001|COMPLETED|Overall Study||165
6540429|NCT01668355|7461979|FG000|NOT COMPLETED|Overall Study||9
6540430|NCT01668355|7461980|FG001|NOT COMPLETED|Overall Study||2
6540431|NCT01668537|7461989|FG000|STARTED|Overall Study||327
6540432|NCT01668537|7461990|FG001|STARTED|Overall Study||324
6540433|NCT01668537|7461989|FG000|COMPLETED|Overall Study||305
6540434|NCT01668537|7461990|FG001|COMPLETED|Overall Study||314
6540435|NCT01668537|7461989|FG000|NOT COMPLETED|Overall Study||22
6540436|NCT01668537|7461990|FG001|NOT COMPLETED|Overall Study||10
6540437|NCT01668589|7462000|FG000|STARTED|Overall Study||600
6540438|NCT01668589|7462001|FG001|STARTED|Overall Study||300
6540439|NCT01668589|7462002|FG002|STARTED|Overall Study||300
6540440|NCT01668589|7462003|FG003|STARTED|Overall Study||301
6540441|NCT01668589|7462000|FG000|Received Denosumab|Overall Study||599
6540442|NCT01668589|7462001|FG001|Received Denosumab|Overall Study||300
6540443|NCT01668589|7462002|FG002|Received Denosumab|Overall Study||300
6540444|NCT01668589|7462003|FG003|Received Denosumab|Overall Study||301
6540445|NCT01668589|7462000|FG000|COMPLETED|Overall Study||461
6540446|NCT01668589|7462001|FG001|COMPLETED|Overall Study||242
6540447|NCT01668589|7462002|FG002|COMPLETED|Overall Study||265
6540448|NCT01668589|7462003|FG003|COMPLETED|Overall Study||266
6540449|NCT01668589|7462000|FG000|NOT COMPLETED|Overall Study||139
6540450|NCT01668589|7462001|FG001|NOT COMPLETED|Overall Study||58
6540451|NCT01668589|7462002|FG002|NOT COMPLETED|Overall Study||35
6540452|NCT01668589|7462003|FG003|NOT COMPLETED|Overall Study||35
6540453|NCT01668602|7462015|FG000|STARTED|Overall Study||2
6540454|NCT01668602|7462016|FG001|STARTED|Overall Study||22
6540455|NCT01668602|7462015|FG000|Cohort 2 - Began FastFES Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
6540456|NCT01668602|7462016|FG001|Cohort 2 - Began FastFES Sessions|Overall Study||20
6540457|NCT01668602|7462015|FG000|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study|This milestone does not apply to Cohort 1.|0
6540458|NCT01668602|7462016|FG001|Cohort 2 - Completed 3 Sessions of FastFES|Overall Study||19
6540459|NCT01668602|7462015|FG000|Cohort 2 - Began Fast Walking Sessions|Overall Study|This milestone does not apply to Cohort 1.|0
6540460|NCT01668602|7462016|FG001|Cohort 2 - Began Fast Walking Sessions|Overall Study||20
6540461|NCT01668602|7462015|FG000|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study|This milestone does not apply to Cohort 1.|0
6540462|NCT01668602|7462016|FG001|Cohort 2 - Completed 3 Sessions of Fast Walking|Overall Study||18
6540463|NCT01668602|7462015|FG000|COMPLETED|Overall Study||2
6540464|NCT01668602|7462016|FG001|COMPLETED|Overall Study||18
6540465|NCT01668602|7462015|FG000|NOT COMPLETED|Overall Study||0
6540466|NCT01668602|7462016|FG001|NOT COMPLETED|Overall Study||4
6540467|NCT01668628|7462027|FG000|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
6540468|NCT01668628|7462028|FG001|STARTED|Overall Study||359
6540469|NCT01668628|7462029|FG002|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
6540470|NCT01668628|7462027|FG000|COMPLETED|Overall Study||347
6540471|NCT01668628|7462028|FG001|COMPLETED|Overall Study||359
6540472|NCT01668628|7462029|FG002|COMPLETED|Overall Study||367
6540473|NCT01668628|7462027|FG000|NOT COMPLETED|Overall Study||2
6540474|NCT01668628|7462028|FG001|NOT COMPLETED|Overall Study||0
6540475|NCT01668628|7462029|FG002|NOT COMPLETED|Overall Study||0
6540476|NCT01668654|7462041|FG000|STARTED|Overall Study||4
6540477|NCT01668654|7462041|FG000|COMPLETED|Overall Study||0
6540478|NCT01668654|7462041|FG000|NOT COMPLETED|Overall Study||4
6540479|NCT01668667|7462049|FG000|STARTED|Overall Study||126
6540480|NCT01668667|7462050|FG001|STARTED|Overall Study||125
6540481|NCT01668667|7462051|FG002|STARTED|Overall Study||125
6540482|NCT01668667|7462052|FG003|STARTED|Overall Study||125
6540483|NCT01668667|7462049|FG000|COMPLETED|Overall Study||95
6540484|NCT01668667|7462050|FG001|COMPLETED|Overall Study||99
6540485|NCT01668667|7462051|FG002|COMPLETED|Overall Study||94
6540486|NCT01668667|7462052|FG003|COMPLETED|Overall Study||102
6540487|NCT01668667|7462049|FG000|NOT COMPLETED|Overall Study||31
6540488|NCT01668667|7462050|FG001|NOT COMPLETED|Overall Study||26
6540489|NCT01668667|7462051|FG002|NOT COMPLETED|Overall Study||31
6540490|NCT01668667|7462052|FG003|NOT COMPLETED|Overall Study||23
6540491|NCT01668719|7462065|FG000|STARTED|Phase I||6
6540492|NCT01668719|7462066|FG001|STARTED|Phase I||0
6540493|NCT01668719|7462067|FG002|STARTED|Phase I||0
6540494|NCT01668719|7462065|FG000|COMPLETED|Phase I||0
6540495|NCT01668719|7462066|FG001|COMPLETED|Phase I||0
6540496|NCT01668719|7462067|FG002|COMPLETED|Phase I||0
6540497|NCT01668719|7462065|FG000|NOT COMPLETED|Phase I||6
6540498|NCT01668719|7462066|FG001|NOT COMPLETED|Phase I||0
6540499|NCT01668719|7462067|FG002|NOT COMPLETED|Phase I||0
6540500|NCT01668719|7462065|FG000|STARTED|Phase II||0
6540501|NCT01668719|7462066|FG001|STARTED|Phase II||52
6540502|NCT01668719|7462067|FG002|STARTED|Phase II||48
6540503|NCT01668719|7462065|FG000|COMPLETED|Phase II||0
6540504|NCT01668719|7462066|FG001|COMPLETED|Phase II||0
6540505|NCT01668719|7462067|FG002|COMPLETED|Phase II||0
6540506|NCT01668719|7462065|FG000|NOT COMPLETED|Phase II||0
6540507|NCT01668719|7462066|FG001|NOT COMPLETED|Phase II||52
6540508|NCT01668719|7462067|FG002|NOT COMPLETED|Phase II||48
6540509|NCT01668797|7462079|FG000|STARTED|Phase A (Conversion Phase)||406
6540510|NCT01668797|7462080|FG001|STARTED|Phase A (Conversion Phase)||0
6540511|NCT01668797|7462081|FG002|STARTED|Phase A (Conversion Phase)||0
6540512|NCT01668797|7462082|FG003|STARTED|Phase A (Conversion Phase)||0
6540513|NCT01668797|7462079|FG000|COMPLETED|Phase A (Conversion Phase)||346
6540514|NCT01668797|7462080|FG001|COMPLETED|Phase A (Conversion Phase)||0
6540515|NCT01668797|7462081|FG002|COMPLETED|Phase A (Conversion Phase)||0
6540516|NCT01668797|7462082|FG003|COMPLETED|Phase A (Conversion Phase)||0
6540517|NCT01668797|7462079|FG000|NOT COMPLETED|Phase A (Conversion Phase)||60
6540518|NCT01668797|7462080|FG001|NOT COMPLETED|Phase A (Conversion Phase)||0
6540519|NCT01668797|7462081|FG002|NOT COMPLETED|Phase A (Conversion Phase)||0
6540520|NCT01668797|7462082|FG003|NOT COMPLETED|Phase A (Conversion Phase)||0
6540521|NCT01668797|7462079|FG000|STARTED|Phase B (Stabilization Phase)||0
6540522|NCT01668797|7462080|FG001|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
6540523|NCT01668797|7462081|FG002|STARTED|Phase B (Stabilization Phase)||0
6540524|NCT01668797|7462082|FG003|STARTED|Phase B (Stabilization Phase)||0
6540525|NCT01668797|7462079|FG000|COMPLETED|Phase B (Stabilization Phase)||0
6540526|NCT01668797|7462080|FG001|COMPLETED|Phase B (Stabilization Phase)||202
6540527|NCT01668797|7462081|FG002|COMPLETED|Phase B (Stabilization Phase)||0
6540528|NCT01668797|7462082|FG003|COMPLETED|Phase B (Stabilization Phase)||0
6540529|NCT01668797|7462079|FG000|NOT COMPLETED|Phase B (Stabilization Phase)||0
6540530|NCT01668797|7462080|FG001|NOT COMPLETED|Phase B (Stabilization Phase)||262
6540531|NCT01668797|7462081|FG002|NOT COMPLETED|Phase B (Stabilization Phase)||0
6540532|NCT01668797|7462082|FG003|NOT COMPLETED|Phase B (Stabilization Phase)||0
6540533|NCT01668797|7462079|FG000|STARTED|Phase C (Double-Blind Maintenance Phase)||0
6540534|NCT01668797|7462080|FG001|STARTED|Phase C (Double-Blind Maintenance Phase)||0
6540535|NCT01668797|7462081|FG002|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
6540536|NCT01668797|7462082|FG003|STARTED|Phase C (Double-Blind Maintenance Phase)||105
6540537|NCT01668797|7462079|FG000|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
6540538|NCT01668797|7462080|FG001|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
6540539|NCT01668797|7462081|FG002|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
6540540|NCT01668797|7462082|FG003|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
6540541|NCT01668797|7462079|FG000|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
6540542|NCT01668797|7462080|FG001|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
6540543|NCT01668797|7462081|FG002|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
6540544|NCT01668797|7462082|FG003|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
6540545|NCT01668836|7462093|FG000|STARTED|Overall Study||12
6540546|NCT01668836|7462094|FG001|STARTED|Overall Study||12
6540547|NCT01668836|7462095|FG002|STARTED|Overall Study||12
6540548|NCT01668836|7462096|FG003|STARTED|Overall Study||12
6540549|NCT01668836|7462093|FG000|COMPLETED|Overall Study||12
6540550|NCT01668836|7462094|FG001|COMPLETED|Overall Study||12
6540551|NCT01668836|7462095|FG002|COMPLETED|Overall Study||12
6540552|NCT01668836|7462096|FG003|COMPLETED|Overall Study||12
6540553|NCT01668836|7462093|FG000|NOT COMPLETED|Overall Study||0
6540554|NCT01668836|7462094|FG001|NOT COMPLETED|Overall Study||0
6540555|NCT01668836|7462095|FG002|NOT COMPLETED|Overall Study||0
6540556|NCT01668836|7462096|FG003|NOT COMPLETED|Overall Study||0
6540557|NCT01668966|7462112|FG000|STARTED|Overall Study||23
6540558|NCT01668966|7462112|FG000|Treated|Overall Study||21
6540559|NCT01668966|7462112|FG000|COMPLETED|Overall Study||19
6540560|NCT01668966|7462112|FG000|NOT COMPLETED|Overall Study||4
6540561|NCT01669096|7462116|FG000|STARTED|Overall Study||20
6540562|NCT01669096|7462116|FG000|COMPLETED|Overall Study||20
6540563|NCT01669096|7462116|FG000|NOT COMPLETED|Overall Study||0
6540564|NCT01669122|7462120|FG000|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
6540565|NCT01669122|7462120|FG000|Safety Population|Period I||39
6540566|NCT01669122|7462120|FG000|COMPLETED|Period I||39
6540567|NCT01669122|7462120|FG000|NOT COMPLETED|Period I||1
6540568|NCT01669122|7462120|FG000|STARTED|Washout Period I||39
6540569|NCT01669122|7462120|FG000|COMPLETED|Washout Period I||39
6540570|NCT01669122|7462120|FG000|NOT COMPLETED|Washout Period I||0
6540571|NCT01669122|7462120|FG000|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
6540572|NCT01669122|7462120|FG000|COMPLETED|Period II||39
6540573|NCT01669122|7462120|FG000|NOT COMPLETED|Period II||0
6540574|NCT01669122|7462120|FG000|STARTED|Washout Period II||39
6540575|NCT01669122|7462120|FG000|COMPLETED|Washout Period II||37
6540576|NCT01669122|7462120|FG000|NOT COMPLETED|Washout Period II||2
6540577|NCT01669122|7462120|FG000|STARTED|Washout Period III||37
6540578|NCT01669122|7462120|FG000|COMPLETED|Washout Period III||37
6540579|NCT01669122|7462120|FG000|NOT COMPLETED|Washout Period III||0
6540580|NCT01669122|7462120|FG000|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
6540581|NCT01669122|7462120|FG000|COMPLETED|Period III||37
6540582|NCT01669122|7462120|FG000|NOT COMPLETED|Period III||0
6540583|NCT01669122|7462120|FG000|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
6540584|NCT01669122|7462120|FG000|COMPLETED|Period IV||37
6540585|NCT01669122|7462120|FG000|NOT COMPLETED|Period IV||0
6540586|NCT01669174|7462133|FG000|STARTED|Overall Study||33
6540587|NCT01669174|7462134|FG001|STARTED|Overall Study||34
6540588|NCT01669174|7462133|FG000|COMPLETED|Overall Study||27
6540589|NCT01669174|7462134|FG001|COMPLETED|Overall Study||28
6540590|NCT01669174|7462133|FG000|NOT COMPLETED|Overall Study||6
6540591|NCT01669174|7462134|FG001|NOT COMPLETED|Overall Study||6
6540592|NCT01669343|7462140|FG000|STARTED|Part A: All Patients||121
6540593|NCT01669343|7462140|FG000|COMPLETED|Part A: All Patients||112
6540594|NCT01669343|7462140|FG000|NOT COMPLETED|Part A: All Patients||9
6540595|NCT01669343|7462140|FG000|STARTED|Part B: Patients With BMI>=25||48
6540596|NCT01669343|7462140|FG000|COMPLETED|Part B: Patients With BMI>=25||31
6540597|NCT01669343|7462140|FG000|NOT COMPLETED|Part B: Patients With BMI>=25||17
6540598|NCT01669421|7462147|FG000|STARTED|Phase 1: Standard Dose Therapy||10
6540599|NCT01669421|7462147|FG000|COMPLETED|Phase 1: Standard Dose Therapy||8
6540600|NCT01669421|7462147|FG000|NOT COMPLETED|Phase 1: Standard Dose Therapy||2
6540601|NCT01669421|7462147|FG000|STARTED|Phase 2: Double Dose Therapy||8
6540602|NCT01669421|7462147|FG000|COMPLETED|Phase 2: Double Dose Therapy||8
6540603|NCT01669421|7462147|FG000|NOT COMPLETED|Phase 2: Double Dose Therapy||0
6540604|NCT01669421|7462147|FG000|STARTED|Phase 3: Standard Dose Therapy||8
6540605|NCT01669421|7462147|FG000|COMPLETED|Phase 3: Standard Dose Therapy||8
6540606|NCT01669421|7462147|FG000|NOT COMPLETED|Phase 3: Standard Dose Therapy||0
6540607|NCT01669434|7462163|FG000|STARTED|Overall Study||146
6540608|NCT01669434|7462164|FG001|STARTED|Overall Study||145
6540609|NCT01669434|7462163|FG000|COMPLETED|Overall Study||137
6540610|NCT01669434|7462164|FG001|COMPLETED|Overall Study||138
6540611|NCT01669434|7462163|FG000|NOT COMPLETED|Overall Study||9
6540612|NCT01669434|7462164|FG001|NOT COMPLETED|Overall Study||7
6540613|NCT01669538|7462172|FG000|STARTED|Overall Study||40
6540614|NCT01669538|7462173|FG001|STARTED|Overall Study||42
6540615|NCT01669538|7462172|FG000|COMPLETED|Overall Study||28
6540616|NCT01669538|7462173|FG001|COMPLETED|Overall Study||33
6540617|NCT01669538|7462172|FG000|NOT COMPLETED|Overall Study||12
6540618|NCT01669538|7462173|FG001|NOT COMPLETED|Overall Study||9
6540619|NCT01669577|7462179|FG000|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
6540620|NCT01669577|7462179|FG000|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
6540621|NCT01669577|7462179|FG000|NOT COMPLETED|Overall Study||134
6540622|NCT01669603|7462185|FG000|STARTED|Overall Study||95
6540623|NCT01669603|7462186|FG001|STARTED|Overall Study||95
6540624|NCT01669603|7462185|FG000|COMPLETED|Overall Study||58
6540625|NCT01669603|7462186|FG001|COMPLETED|Overall Study||57
6540626|NCT01669603|7462185|FG000|NOT COMPLETED|Overall Study||37
6540627|NCT01669603|7462186|FG001|NOT COMPLETED|Overall Study||38
6540628|NCT01669629|7462192|FG000|STARTED|Period 1||92
6540629|NCT01669629|7462193|FG001|STARTED|Period 1||91
6540630|NCT01669629|7462192|FG000|COMPLETED|Period 1||91
6540631|NCT01669629|7462193|FG001|COMPLETED|Period 1||89
6540632|NCT01669629|7462192|FG000|NOT COMPLETED|Period 1||1
6540633|NCT01669629|7462193|FG001|NOT COMPLETED|Period 1||2
6540634|NCT01669629|7462192|FG000|STARTED|Period 2||91
6540635|NCT01669629|7462193|FG001|STARTED|Period 2||89
6540636|NCT01669629|7462192|FG000|COMPLETED|Period 2||91
6540637|NCT01669629|7462193|FG001|COMPLETED|Period 2||89
6540638|NCT01669629|7462192|FG000|NOT COMPLETED|Period 2||0
6540639|NCT01669629|7462193|FG001|NOT COMPLETED|Period 2||0
6540640|NCT01669642|7462204|FG000|STARTED|Overall Study||20
6540641|NCT01669642|7462205|FG001|STARTED|Overall Study||20
6540642|NCT01669642|7462206|FG002|STARTED|Overall Study||20
6540643|NCT01669642|7462207|FG003|STARTED|Overall Study||21
6540644|NCT01669642|7462208|FG004|STARTED|Overall Study||20
6540645|NCT01669642|7462209|FG005|STARTED|Overall Study||10
6540646|NCT01669642|7462204|FG000|COMPLETED|Overall Study||20
6540647|NCT01669642|7462205|FG001|COMPLETED|Overall Study||20
6540648|NCT01669642|7462206|FG002|COMPLETED|Overall Study||20
6540649|NCT01669642|7462207|FG003|COMPLETED|Overall Study||20
6540650|NCT01669642|7462208|FG004|COMPLETED|Overall Study||20
6540651|NCT01669642|7462209|FG005|COMPLETED|Overall Study||0
6540652|NCT01669642|7462204|FG000|NOT COMPLETED|Overall Study||0
6540653|NCT01669642|7462205|FG001|NOT COMPLETED|Overall Study||0
6540654|NCT01669642|7462206|FG002|NOT COMPLETED|Overall Study||0
6540655|NCT01669642|7462207|FG003|NOT COMPLETED|Overall Study||1
6540656|NCT01669642|7462208|FG004|NOT COMPLETED|Overall Study||0
6540657|NCT01669642|7462209|FG005|NOT COMPLETED|Overall Study||10
6540658|NCT01669720|7462228|FG000|STARTED|Overall Study||7
6540659|NCT01669720|7462229|FG001|STARTED|Overall Study||3
6540660|NCT01669720|7462228|FG000|COMPLETED|Overall Study||7
6540661|NCT01669720|7462229|FG001|COMPLETED|Overall Study||3
6540662|NCT01669720|7462228|FG000|NOT COMPLETED|Overall Study||0
6540663|NCT01669720|7462229|FG001|NOT COMPLETED|Overall Study||0
6540664|NCT01669785|7462238|FG000|STARTED|Overall Study||45
6540665|NCT01669785|7462239|FG001|STARTED|Overall Study||48
6540666|NCT01669785|7462240|FG002|STARTED|Overall Study||46
6540667|NCT01669785|7462238|FG000|COMPLETED|Overall Study||45
6540668|NCT01669785|7462239|FG001|COMPLETED|Overall Study||48
6540669|NCT01669785|7462240|FG002|COMPLETED|Overall Study||46
6540670|NCT01669785|7462238|FG000|NOT COMPLETED|Overall Study||0
6540671|NCT01669785|7462239|FG001|NOT COMPLETED|Overall Study||0
6540672|NCT01669785|7462240|FG002|NOT COMPLETED|Overall Study||0
6540673|NCT01669798|7462249|FG000|STARTED|Overall Study||32
6540674|NCT01669798|7462249|FG000|COMPLETED|Overall Study||27
6540675|NCT01669798|7462249|FG000|NOT COMPLETED|Overall Study||5
6540676|NCT01669811|7462255|FG000|STARTED|Overall Study||145
6540677|NCT01669811|7462256|FG001|STARTED|Overall Study||142
6540678|NCT01669811|7462255|FG000|COMPLETED|Overall Study||142
6540679|NCT01669811|7462256|FG001|COMPLETED|Overall Study||131
6540680|NCT01669811|7462255|FG000|NOT COMPLETED|Overall Study||3
6540681|NCT01669811|7462256|FG001|NOT COMPLETED|Overall Study||11
6540682|NCT01669863|7462262|FG000|STARTED|Overall Study||6
6540683|NCT01669863|7462262|FG000|COMPLETED|Overall Study||6
6540684|NCT01669863|7462262|FG000|NOT COMPLETED|Overall Study||0
6540685|NCT01669902|7462267|FG000|STARTED|Overall Study||107
6540686|NCT01669902|7462267|FG000|COMPLETED|Overall Study||78
6540687|NCT01669902|7462267|FG000|NOT COMPLETED|Overall Study||29
6540688|NCT01669928|7462273|FG000|STARTED|First Intervention||51
6540689|NCT01669928|7462274|FG001|STARTED|First Intervention||52
6540690|NCT01669928|7462273|FG000|COMPLETED|First Intervention||48
6540691|NCT01669928|7462274|FG001|COMPLETED|First Intervention||47
6540692|NCT01669928|7462273|FG000|NOT COMPLETED|First Intervention||3
6540693|NCT01669928|7462274|FG001|NOT COMPLETED|First Intervention||5
6540694|NCT01669928|7462273|FG000|STARTED|Second Intervention||48
6540695|NCT01669928|7462274|FG001|STARTED|Second Intervention||47
6540696|NCT01669928|7462273|FG000|COMPLETED|Second Intervention||48
6540697|NCT01669928|7462274|FG001|COMPLETED|Second Intervention||47
6540698|NCT01669928|7462273|FG000|NOT COMPLETED|Second Intervention||0
6540699|NCT01669928|7462274|FG001|NOT COMPLETED|Second Intervention||0
6540700|NCT01670019|7462284|FG000|STARTED|Overall Study||23
6540701|NCT01670019|7462285|FG001|STARTED|Overall Study||23
6540702|NCT01670019|7462284|FG000|COMPLETED|Overall Study||14
6540703|NCT01670019|7462285|FG001|COMPLETED|Overall Study||23
6540704|NCT01670019|7462284|FG000|NOT COMPLETED|Overall Study||9
6540705|NCT01670019|7462285|FG001|NOT COMPLETED|Overall Study||0
6540706|NCT01670045|7462291|FG000|STARTED|Overall Study||43
6540707|NCT01670045|7462291|FG000|COMPLETED|Overall Study||27
6540708|NCT01670045|7462291|FG000|NOT COMPLETED|Overall Study||16
6540709|NCT01670097|7462297|FG000|STARTED|Overall Study||20
6540710|NCT01670097|7462298|FG001|STARTED|Overall Study||21
6540711|NCT01670097|7462297|FG000|Completed Week 1 Intervention|Overall Study||18
6540712|NCT01670097|7462298|FG001|Completed Week 1 Intervention|Overall Study||17
6540713|NCT01670097|7462297|FG000|Completed Week 2 Intervention|Overall Study||13
6540714|NCT01670097|7462298|FG001|Completed Week 2 Intervention|Overall Study||15
6540715|NCT01670097|7462297|FG000|COMPLETED|Overall Study||18
6540716|NCT01670097|7462298|FG001|COMPLETED|Overall Study||17
6540717|NCT01670097|7462297|FG000|NOT COMPLETED|Overall Study||2
6540718|NCT01670097|7462298|FG001|NOT COMPLETED|Overall Study||4
6540719|NCT01670110|7462306|FG000|STARTED|Overall Study||33
6540720|NCT01670110|7462307|FG001|STARTED|Overall Study||15
6540721|NCT01670110|7462306|FG000|COMPLETED|Overall Study||29
6540722|NCT01670110|7462307|FG001|COMPLETED|Overall Study||12
6540723|NCT01670110|7462306|FG000|NOT COMPLETED|Overall Study||4
6540724|NCT01670110|7462307|FG001|NOT COMPLETED|Overall Study||3
6540725|NCT01670188|7462315|FG000|STARTED|Overall Study||38
6540726|NCT01670188|7462316|FG001|STARTED|Overall Study||40
6540727|NCT01670188|7462315|FG000|COMPLETED|Overall Study||38
6540728|NCT01670188|7462316|FG001|COMPLETED|Overall Study||39
6540729|NCT01670188|7462315|FG000|NOT COMPLETED|Overall Study||0
6540730|NCT01670188|7462316|FG001|NOT COMPLETED|Overall Study||1
6540731|NCT01670201|7462322|FG000|STARTED|Overall Study||8
6540732|NCT01670201|7462322|FG000|COMPLETED|Overall Study||8
6540733|NCT01670201|7462322|FG000|NOT COMPLETED|Overall Study||0
6540734|NCT01670279|7462329|FG000|STARTED|Overall Study||6
6540735|NCT01670279|7462330|FG001|STARTED|Overall Study||7
6540736|NCT01670279|7462331|FG002|STARTED|Overall Study||0
6540737|NCT01670279|7462332|FG003|STARTED|Overall Study||5
6540738|NCT01670279|7462329|FG000|COMPLETED|Overall Study||6
6540739|NCT01670279|7462330|FG001|COMPLETED|Overall Study||5
6540740|NCT01670279|7462331|FG002|COMPLETED|Overall Study||0
6540741|NCT01670279|7462332|FG003|COMPLETED|Overall Study||4
6540742|NCT01670279|7462329|FG000|NOT COMPLETED|Overall Study||0
6540743|NCT01670279|7462330|FG001|NOT COMPLETED|Overall Study||2
6540744|NCT01670279|7462331|FG002|NOT COMPLETED|Overall Study||0
6540745|NCT01670279|7462332|FG003|NOT COMPLETED|Overall Study||1
6540746|NCT01670292|7462340|FG000|STARTED|Overall Study||82
6540747|NCT01670292|7462340|FG000|COMPLETED|Overall Study||68
6540748|NCT01670292|7462340|FG000|NOT COMPLETED|Overall Study||14
6540749|NCT01670487|7462354|FG000|STARTED|Overall Study||150
6540750|NCT01670487|7462355|FG001|STARTED|Overall Study||150
6540751|NCT01670487|7462354|FG000|COMPLETED|Overall Study||150
6540752|NCT01670487|7462355|FG001|COMPLETED|Overall Study||150
6540753|NCT01670487|7462354|FG000|NOT COMPLETED|Overall Study||0
6540754|NCT01670487|7462355|FG001|NOT COMPLETED|Overall Study||0
6540755|NCT01670526|7462363|FG000|STARTED|Overall Study||49
6540756|NCT01670526|7462364|FG001|STARTED|Overall Study||45
6540757|NCT01670526|7462363|FG000|COMPLETED|Overall Study||37
6540758|NCT01670526|7462364|FG001|COMPLETED|Overall Study||39
6540759|NCT01670526|7462363|FG000|NOT COMPLETED|Overall Study||12
6540760|NCT01670526|7462364|FG001|NOT COMPLETED|Overall Study||6
6540761|NCT01670721|7462370|FG000|STARTED|Overall Study||175
6540762|NCT01670721|7462370|FG000|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
6540763|NCT01670721|7462370|FG000|NOT COMPLETED|Overall Study||53
6540764|NCT01670760|7462374|FG000|STARTED|Overall Study||20
6540765|NCT01670760|7462374|FG000|COMPLETED|Overall Study||20
6540766|NCT01670760|7462374|FG000|NOT COMPLETED|Overall Study||0
6540767|NCT01670825|7462380|FG000|STARTED|Overall Study||42
6540768|NCT01670825|7462381|FG001|STARTED|Overall Study||39
6540769|NCT01670825|7462380|FG000|COMPLETED|Overall Study||42
6540770|NCT01670825|7462381|FG001|COMPLETED|Overall Study||39
6540771|NCT01670825|7462380|FG000|NOT COMPLETED|Overall Study||0
6540772|NCT01670825|7462381|FG001|NOT COMPLETED|Overall Study||0
6540773|NCT01671007|7462398|FG000|STARTED|Overall Study||2089
6540774|NCT01671007|7462399|FG001|STARTED|Overall Study||2834
6540775|NCT01671007|7462400|FG002|STARTED|Overall Study||2033
6540776|NCT01671007|7462401|FG003|STARTED|Overall Study||2214
6540777|NCT01671007|7462402|FG004|STARTED|Overall Study||180
6540778|NCT01671007|7462403|FG005|STARTED|Overall Study||513
6540779|NCT01671007|7462404|FG006|STARTED|Overall Study||80
6540780|NCT01671007|7462405|FG007|STARTED|Overall Study||526
6540781|NCT01671007|7462406|FG008|STARTED|Overall Study||2
6540782|NCT01671007|7462398|FG000|All Eligible|Overall Study||2066
6540783|NCT01671007|7462399|FG001|All Eligible|Overall Study||2758
6540784|NCT01671007|7462400|FG002|All Eligible|Overall Study||2008
6540785|NCT01671007|7462401|FG003|All Eligible|Overall Study||2197
6540786|NCT01671007|7462402|FG004|All Eligible|Overall Study||180
6540787|NCT01671007|7462403|FG005|All Eligible|Overall Study||507
6540788|NCT01671007|7462404|FG006|All Eligible|Overall Study||79
6540789|NCT01671007|7462405|FG007|All Eligible|Overall Study||507
6540790|NCT01671007|7462406|FG008|All Eligible|Overall Study||2
6540791|NCT01671007|7462398|FG000|COMPLETED|Overall Study||1768
6540792|NCT01671007|7462399|FG001|COMPLETED|Overall Study||2183
6540793|NCT01671007|7462400|FG002|COMPLETED|Overall Study||1667
6540794|NCT01671007|7462401|FG003|COMPLETED|Overall Study||1846
6540795|NCT01671007|7462402|FG004|COMPLETED|Overall Study||155
6540796|NCT01671007|7462403|FG005|COMPLETED|Overall Study||401
6540797|NCT01671007|7462404|FG006|COMPLETED|Overall Study||59
6540798|NCT01671007|7462405|FG007|COMPLETED|Overall Study||394
6540799|NCT01671007|7462406|FG008|COMPLETED|Overall Study||2
6540800|NCT01671007|7462398|FG000|NOT COMPLETED|Overall Study||321
6540801|NCT01671007|7462399|FG001|NOT COMPLETED|Overall Study||651
6540802|NCT01671007|7462400|FG002|NOT COMPLETED|Overall Study||366
6540803|NCT01671007|7462401|FG003|NOT COMPLETED|Overall Study||368
6540804|NCT01671007|7462402|FG004|NOT COMPLETED|Overall Study||25
6540805|NCT01671007|7462403|FG005|NOT COMPLETED|Overall Study||112
6540806|NCT01671007|7462404|FG006|NOT COMPLETED|Overall Study||21
6540807|NCT01671007|7462405|FG007|NOT COMPLETED|Overall Study||132
6540808|NCT01671007|7462406|FG008|NOT COMPLETED|Overall Study||0
6540809|NCT01671059|7462417|FG000|STARTED|Overall Study||80
6540810|NCT01671059|7462417|FG000|COMPLETED|Overall Study||75
6540811|NCT01671059|7462417|FG000|NOT COMPLETED|Overall Study||5
6540812|NCT01671085|7462424|FG000|STARTED|Overall Study|1 participant who dropped out was replaced.|11
6540813|NCT01671085|7462425|FG001|STARTED|Overall Study||2
6540814|NCT01671085|7462424|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
6540815|NCT01671085|7462425|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
6540816|NCT01671085|7462424|FG000|COMPLETED|Overall Study||10
6540817|NCT01671085|7462425|FG001|COMPLETED|Overall Study||2
6540818|NCT01671085|7462424|FG000|NOT COMPLETED|Overall Study||1
6540819|NCT01671085|7462425|FG001|NOT COMPLETED|Overall Study||0
6540820|NCT01671111|7462432|FG000|STARTED|Overall Study||30
6540821|NCT01671111|7462432|FG000|COMPLETED|Overall Study||0
6540822|NCT01671111|7462432|FG000|NOT COMPLETED|Overall Study||30
6540823|NCT01671176|7462436|FG000|STARTED|Overall Study||30
6540824|NCT01671176|7462436|FG000|COMPLETED|Overall Study||30
6540825|NCT01671176|7462436|FG000|NOT COMPLETED|Overall Study||0
6540826|NCT01671280|7462440|FG000|STARTED|Overall Study|The number is enrollment.|403
6540827|NCT01671280|7462440|FG000|COMPLETED|Overall Study||401
6540828|NCT01671280|7462440|FG000|NOT COMPLETED|Overall Study||2
6540829|NCT01671293|7462446|FG000|STARTED|Overall Study||36
6540830|NCT01671293|7462447|FG001|STARTED|Overall Study||34
6540831|NCT01671293|7462446|FG000|COMPLETED|Overall Study||33
6540832|NCT01671293|7462447|FG001|COMPLETED|Overall Study||32
6540833|NCT01671293|7462446|FG000|NOT COMPLETED|Overall Study||3
6540834|NCT01671293|7462447|FG001|NOT COMPLETED|Overall Study||2
6540835|NCT01671319|7462453|FG000|STARTED|Overall Study||42
6540836|NCT01671319|7462453|FG000|COMPLETED|Overall Study||41
6540837|NCT01671319|7462453|FG000|NOT COMPLETED|Overall Study||1
6540838|NCT01671332|7462459|FG000|STARTED|Overall Study||40
6540839|NCT01671332|7462460|FG001|STARTED|Overall Study||40
6540840|NCT01671332|7462459|FG000|Crossed Over to Docetaxel Plus Suramin|Overall Study||0
6540841|NCT01671332|7462460|FG001|Crossed Over to Docetaxel Plus Suramin|Overall Study|Participants with disease progression on Docetaxel Arm were allowed to crossover to Suramin.|13
6540842|NCT01671332|7462459|FG000|COMPLETED|Overall Study||39
6540843|NCT01671332|7462460|FG001|COMPLETED|Overall Study||39
6540844|NCT01671332|7462459|FG000|NOT COMPLETED|Overall Study||1
6540845|NCT01671332|7462460|FG001|NOT COMPLETED|Overall Study||1
6540846|NCT01671345|7462468|FG000|STARTED|Overall Study||77
6540847|NCT01671345|7462469|FG001|STARTED|Overall Study||92
6540848|NCT01671345|7462468|FG000|COMPLETED|Overall Study||64
6540849|NCT01671345|7462469|FG001|COMPLETED|Overall Study||83
6540850|NCT01671345|7462468|FG000|NOT COMPLETED|Overall Study||13
6540851|NCT01671345|7462469|FG001|NOT COMPLETED|Overall Study||9
6540852|NCT01671423|7462480|FG000|STARTED|Overall Study||20
6540853|NCT01671423|7462481|FG001|STARTED|Overall Study||20
6540854|NCT01671423|7462480|FG000|COMPLETED|Overall Study||14
6540855|NCT01671423|7462481|FG001|COMPLETED|Overall Study||9
6540856|NCT01671423|7462480|FG000|NOT COMPLETED|Overall Study||6
6540857|NCT01671423|7462481|FG001|NOT COMPLETED|Overall Study||11
6540858|NCT01671488|7462487|FG000|STARTED|Overall Study||11
6540859|NCT01671488|7462487|FG000|COMPLETED|Overall Study||10
6540860|NCT01671488|7462487|FG000|NOT COMPLETED|Overall Study||1
6540861|NCT01671605|7462493|FG000|STARTED|Overall Study||72
6540862|NCT01671605|7462494|FG001|STARTED|Overall Study||31
6540863|NCT01671605|7462493|FG000|COMPLETED|Overall Study||72
6540864|NCT01671605|7462494|FG001|COMPLETED|Overall Study||31
6540865|NCT01671605|7462493|FG000|NOT COMPLETED|Overall Study||0
6540866|NCT01671605|7462494|FG001|NOT COMPLETED|Overall Study||0
6540867|NCT01671748|7462502|FG000|STARTED|4 Week run-in Phase||47
6540868|NCT01671748|7462503|FG001|STARTED|4 Week run-in Phase||0
6540869|NCT01671748|7462502|FG000|COMPLETED|4 Week run-in Phase||36
6540870|NCT01671748|7462503|FG001|COMPLETED|4 Week run-in Phase||0
6540871|NCT01671748|7462502|FG000|NOT COMPLETED|4 Week run-in Phase||11
6540872|NCT01671748|7462503|FG001|NOT COMPLETED|4 Week run-in Phase||0
6540873|NCT01671748|7462502|FG000|STARTED|12 Week Treatment Phase||19
6540874|NCT01671748|7462503|FG001|STARTED|12 Week Treatment Phase||17
6540875|NCT01671748|7462502|FG000|COMPLETED|12 Week Treatment Phase||19
6540876|NCT01671748|7462503|FG001|COMPLETED|12 Week Treatment Phase||17
6540877|NCT01671748|7462502|FG000|NOT COMPLETED|12 Week Treatment Phase||0
6540878|NCT01671748|7462503|FG001|NOT COMPLETED|12 Week Treatment Phase||0
6540879|NCT01671839|7462509|FG000|STARTED|Overall Study||55
6540880|NCT01671839|7462509|FG000|3-year Follow-up|Overall Study||45
6540881|NCT01671839|7462509|FG000|5-year Follow-up|Overall Study||37
6540882|NCT01671839|7462509|FG000|COMPLETED|Overall Study||37
6540883|NCT01671839|7462509|FG000|NOT COMPLETED|Overall Study||18
6540884|NCT01672294|7462520|FG000|STARTED|Overall Study||71
6540885|NCT01672294|7462521|FG001|STARTED|Overall Study||71
6540886|NCT01672294|7462522|FG002|STARTED|Overall Study||72
6540887|NCT01672294|7462523|FG003|STARTED|Overall Study||72
6540888|NCT01672294|7462520|FG000|COMPLETED|Overall Study||65
6540889|NCT01672294|7462521|FG001|COMPLETED|Overall Study||50
6540890|NCT01672294|7462522|FG002|COMPLETED|Overall Study||61
6540891|NCT01672294|7462523|FG003|COMPLETED|Overall Study||59
6540892|NCT01672294|7462520|FG000|NOT COMPLETED|Overall Study||6
6540893|NCT01672294|7462521|FG001|NOT COMPLETED|Overall Study||21
6540894|NCT01672294|7462522|FG002|NOT COMPLETED|Overall Study||11
6540895|NCT01672294|7462523|FG003|NOT COMPLETED|Overall Study||13
6540896|NCT01672658|7462535|FG000|STARTED|Overall Study||16
6540897|NCT01672658|7462536|FG001|STARTED|Overall Study||15
6540898|NCT01672658|7462535|FG000|COMPLETED|Overall Study||16
6540899|NCT01672658|7462536|FG001|COMPLETED|Overall Study||14
6540900|NCT01672658|7462535|FG000|NOT COMPLETED|Overall Study||0
6540901|NCT01672658|7462536|FG001|NOT COMPLETED|Overall Study||1
6540902|NCT01672710|7462544|FG000|STARTED|Controlled Comparison 5 Week Follow-up||22
6540903|NCT01672710|7462545|FG001|STARTED|Controlled Comparison 5 Week Follow-up||10
6540904|NCT01672710|7462544|FG000|COMPLETED|Controlled Comparison 5 Week Follow-up|sauna intervention group repeat all assessments 7 days after complete the regimen|22
6540905|NCT01672710|7462545|FG001|COMPLETED|Controlled Comparison 5 Week Follow-up|waitlist group repeat baseline assessments after 4 week time period then begin sauna|10
6540906|NCT01672710|7462544|FG000|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
6540907|NCT01672710|7462545|FG001|NOT COMPLETED|Controlled Comparison 5 Week Follow-up||0
6540908|NCT01672710|7462544|FG000|STARTED|Waitlist Assessed After Sauna Regimen|immediate start group no further assessments until 3 month follow up|22
6540909|NCT01672710|7462545|FG001|STARTED|Waitlist Assessed After Sauna Regimen|waitlisted group receive the 4 week intervention and complete 7 day assessments|10
6540910|NCT01672710|7462544|FG000|COMPLETED|Waitlist Assessed After Sauna Regimen|non applicable, cannot compare the immediate start and waitlist in this period|22
6540911|NCT01672710|7462545|FG001|COMPLETED|Waitlist Assessed After Sauna Regimen||9
6540912|NCT01672710|7462544|FG000|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||0
6540913|NCT01672710|7462545|FG001|NOT COMPLETED|Waitlist Assessed After Sauna Regimen||1
6540914|NCT01672710|7462544|FG000|STARTED|3 Month Follow up||22
6540915|NCT01672710|7462545|FG001|STARTED|3 Month Follow up||9
6540916|NCT01672710|7462544|FG000|COMPLETED|3 Month Follow up||16
6540917|NCT01672710|7462545|FG001|COMPLETED|3 Month Follow up||5
6540918|NCT01672710|7462544|FG000|NOT COMPLETED|3 Month Follow up||6
6540919|NCT01672710|7462545|FG001|NOT COMPLETED|3 Month Follow up||4
6540920|NCT01672723|7462551|FG000|STARTED|First Intervention||19
6540921|NCT01672723|7462552|FG001|STARTED|First Intervention||15
6540922|NCT01672723|7462551|FG000|COMPLETED|First Intervention||16
6540923|NCT01672723|7462552|FG001|COMPLETED|First Intervention||15
6540924|NCT01672723|7462551|FG000|NOT COMPLETED|First Intervention||3
6540925|NCT01672723|7462552|FG001|NOT COMPLETED|First Intervention||0
6540926|NCT01672723|7462551|FG000|STARTED|Washout Period of 10 Days||16
6540927|NCT01672723|7462552|FG001|STARTED|Washout Period of 10 Days||15
6540928|NCT01672723|7462551|FG000|COMPLETED|Washout Period of 10 Days||16
6540929|NCT01672723|7462552|FG001|COMPLETED|Washout Period of 10 Days||15
6540930|NCT01672723|7462551|FG000|NOT COMPLETED|Washout Period of 10 Days||0
6540931|NCT01672723|7462552|FG001|NOT COMPLETED|Washout Period of 10 Days||0
6540932|NCT01672723|7462551|FG000|STARTED|Second Intervention||16
6540933|NCT01672723|7462552|FG001|STARTED|Second Intervention||15
6540934|NCT01672723|7462551|FG000|COMPLETED|Second Intervention||16
6540935|NCT01672723|7462552|FG001|COMPLETED|Second Intervention||15
6540936|NCT01672723|7462551|FG000|NOT COMPLETED|Second Intervention||0
6540937|NCT01672723|7462552|FG001|NOT COMPLETED|Second Intervention||0
6540938|NCT01672736|7462558|FG000|STARTED|Overall Study|Phase I study part stopped early due to manufacturer's decision to stop further drug development.|19
6540939|NCT01672736|7462558|FG000|COMPLETED|Overall Study|3 patients taken off study due to non-availability of further study (Linsitinib) drug supply.|16
6540940|NCT01672736|7462558|FG000|NOT COMPLETED|Overall Study||3
6540941|NCT01672788|7462562|FG000|STARTED|Treatment Period 1 (3 Days)||9
6540942|NCT01672788|7462563|FG001|STARTED|Treatment Period 1 (3 Days)||9
6540943|NCT01672788|7462564|FG002|STARTED|Treatment Period 1 (3 Days)||9
6540944|NCT01672788|7462565|FG003|STARTED|Treatment Period 1 (3 Days)||9
6540945|NCT01672788|7462562|FG000|COMPLETED|Treatment Period 1 (3 Days)||9
6540946|NCT01672788|7462563|FG001|COMPLETED|Treatment Period 1 (3 Days)||9
6540947|NCT01672788|7462564|FG002|COMPLETED|Treatment Period 1 (3 Days)||9
6540948|NCT01672788|7462565|FG003|COMPLETED|Treatment Period 1 (3 Days)||9
6540949|NCT01672788|7462562|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6540950|NCT01672788|7462563|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6540951|NCT01672788|7462564|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6540952|NCT01672788|7462565|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6540953|NCT01672788|7462562|FG000|STARTED|Washout Period 1 (7 Days)||9
6540954|NCT01672788|7462563|FG001|STARTED|Washout Period 1 (7 Days)||9
6540955|NCT01672788|7462564|FG002|STARTED|Washout Period 1 (7 Days)||9
6540956|NCT01672788|7462565|FG003|STARTED|Washout Period 1 (7 Days)||9
6540957|NCT01672788|7462562|FG000|COMPLETED|Washout Period 1 (7 Days)||9
6540958|NCT01672788|7462563|FG001|COMPLETED|Washout Period 1 (7 Days)||9
6540959|NCT01672788|7462564|FG002|COMPLETED|Washout Period 1 (7 Days)||9
6540960|NCT01672788|7462565|FG003|COMPLETED|Washout Period 1 (7 Days)||9
6540961|NCT01672788|7462562|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6540962|NCT01672788|7462563|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6540963|NCT01672788|7462564|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6540964|NCT01672788|7462565|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6540965|NCT01672788|7462562|FG000|STARTED|Treatment Period 2 (3 Days)||9
6540966|NCT01672788|7462563|FG001|STARTED|Treatment Period 2 (3 Days)||9
6540967|NCT01672788|7462564|FG002|STARTED|Treatment Period 2 (3 Days)||9
6540968|NCT01672788|7462565|FG003|STARTED|Treatment Period 2 (3 Days)||9
6540969|NCT01672788|7462562|FG000|COMPLETED|Treatment Period 2 (3 Days)||9
6540970|NCT01672788|7462563|FG001|COMPLETED|Treatment Period 2 (3 Days)||9
6540971|NCT01672788|7462564|FG002|COMPLETED|Treatment Period 2 (3 Days)||9
6540972|NCT01672788|7462565|FG003|COMPLETED|Treatment Period 2 (3 Days)||9
6540973|NCT01672788|7462562|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6540974|NCT01672788|7462563|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6540975|NCT01672788|7462564|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6540976|NCT01672788|7462565|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6540977|NCT01672788|7462562|FG000|STARTED|Washout Period 2 (7 Days)||9
6540978|NCT01672788|7462563|FG001|STARTED|Washout Period 2 (7 Days)||9
6540979|NCT01672788|7462564|FG002|STARTED|Washout Period 2 (7 Days)||9
6540980|NCT01672788|7462565|FG003|STARTED|Washout Period 2 (7 Days)||9
6540981|NCT01672788|7462562|FG000|COMPLETED|Washout Period 2 (7 Days)||9
6540982|NCT01672788|7462563|FG001|COMPLETED|Washout Period 2 (7 Days)||9
6540983|NCT01672788|7462564|FG002|COMPLETED|Washout Period 2 (7 Days)||9
6540984|NCT01672788|7462565|FG003|COMPLETED|Washout Period 2 (7 Days)||8
6540985|NCT01672788|7462562|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6540986|NCT01672788|7462563|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6540987|NCT01672788|7462564|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6540988|NCT01672788|7462565|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
6540989|NCT01672788|7462562|FG000|STARTED|Treatment Period 3 (3 Days)||9
6540990|NCT01672788|7462563|FG001|STARTED|Treatment Period 3 (3 Days)||9
6540991|NCT01672788|7462564|FG002|STARTED|Treatment Period 3 (3 Days)||9
6540992|NCT01672788|7462565|FG003|STARTED|Treatment Period 3 (3 Days)||8
6540993|NCT01672788|7462562|FG000|COMPLETED|Treatment Period 3 (3 Days)||9
6540994|NCT01672788|7462563|FG001|COMPLETED|Treatment Period 3 (3 Days)||9
6540995|NCT01672788|7462564|FG002|COMPLETED|Treatment Period 3 (3 Days)||9
6540996|NCT01672788|7462565|FG003|COMPLETED|Treatment Period 3 (3 Days)||8
6540997|NCT01672788|7462562|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6540998|NCT01672788|7462563|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6540999|NCT01672788|7462564|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6541000|NCT01672788|7462565|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6541001|NCT01672788|7462562|FG000|STARTED|Washout Period 3 (7 Days)||9
6541002|NCT01672788|7462563|FG001|STARTED|Washout Period 3 (7 Days)||9
6541003|NCT01672788|7462564|FG002|STARTED|Washout Period 3 (7 Days)||9
6541004|NCT01672788|7462565|FG003|STARTED|Washout Period 3 (7 Days)||8
6541005|NCT01672788|7462562|FG000|COMPLETED|Washout Period 3 (7 Days)||9
6541006|NCT01672788|7462563|FG001|COMPLETED|Washout Period 3 (7 Days)||9
6541007|NCT01672788|7462564|FG002|COMPLETED|Washout Period 3 (7 Days)||9
6541008|NCT01672788|7462565|FG003|COMPLETED|Washout Period 3 (7 Days)||8
6541009|NCT01672788|7462562|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
6541010|NCT01672788|7462563|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
6541011|NCT01672788|7462564|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
6541012|NCT01672788|7462565|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
6541013|NCT01672788|7462562|FG000|STARTED|Treatment Period 4 (3 Days)||9
6541014|NCT01672788|7462563|FG001|STARTED|Treatment Period 4 (3 Days)||9
6541015|NCT01672788|7462564|FG002|STARTED|Treatment Period 4 (3 Days)||9
6541016|NCT01672788|7462565|FG003|STARTED|Treatment Period 4 (3 Days)||8
6541017|NCT01672788|7462562|FG000|COMPLETED|Treatment Period 4 (3 Days)||9
6541018|NCT01672788|7462563|FG001|COMPLETED|Treatment Period 4 (3 Days)||9
6541019|NCT01672788|7462564|FG002|COMPLETED|Treatment Period 4 (3 Days)||9
6541020|NCT01672788|7462565|FG003|COMPLETED|Treatment Period 4 (3 Days)||8
6541021|NCT01672788|7462562|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6541022|NCT01672788|7462563|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6541023|NCT01672788|7462564|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6541024|NCT01672788|7462565|FG003|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6541025|NCT01672801|7462577|FG000|STARTED|Overall Study||9
6541026|NCT01672801|7462578|FG001|STARTED|Overall Study||9
6541027|NCT01672801|7462577|FG000|COMPLETED|Overall Study||9
6541028|NCT01672801|7462578|FG001|COMPLETED|Overall Study||8
6541029|NCT01672801|7462577|FG000|NOT COMPLETED|Overall Study||0
6541030|NCT01672801|7462578|FG001|NOT COMPLETED|Overall Study||1
6541031|NCT01672827|7462584|FG000|STARTED|Overall Study||276
6541032|NCT01672827|7462584|FG000|COMPLETED|Overall Study||276
6541033|NCT01672827|7462584|FG000|NOT COMPLETED|Overall Study||0
6541034|NCT01672853|7462593|FG000|STARTED|Overall Study||79
6541035|NCT01672853|7462594|FG001|STARTED|Overall Study||77
6541036|NCT01672853|7462595|FG002|STARTED|Overall Study||79
6541037|NCT01672853|7462593|FG000|COMPLETED|Overall Study||69
6541038|NCT01672853|7462594|FG001|COMPLETED|Overall Study||60
6541039|NCT01672853|7462595|FG002|COMPLETED|Overall Study||65
6541040|NCT01672853|7462593|FG000|NOT COMPLETED|Overall Study||10
6541041|NCT01672853|7462594|FG001|NOT COMPLETED|Overall Study||17
6541042|NCT01672853|7462595|FG002|NOT COMPLETED|Overall Study||14
6541043|NCT01672866|7462606|FG000|STARTED|Blinded Phase (up to 240 Weeks)||74
6541044|NCT01672866|7462607|FG001|STARTED|Blinded Phase (up to 240 Weeks)||74
6541045|NCT01672866|7462608|FG002|STARTED|Blinded Phase (up to 240 Weeks)||74
6541046|NCT01672866|7462606|FG000|COMPLETED|Blinded Phase (up to 240 Weeks)||0
6541047|NCT01672866|7462607|FG001|COMPLETED|Blinded Phase (up to 240 Weeks)||0
6541048|NCT01672866|7462608|FG002|COMPLETED|Blinded Phase (up to 240 Weeks)||0
6541049|NCT01672866|7462606|FG000|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
6541050|NCT01672866|7462607|FG001|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
6541051|NCT01672866|7462608|FG002|NOT COMPLETED|Blinded Phase (up to 240 Weeks)||74
6541052|NCT01672866|7462606|FG000|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|11
6541053|NCT01672866|7462607|FG001|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
6541054|NCT01672866|7462608|FG002|STARTED|Open-Label Phase (up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|16
6541055|NCT01672866|7462606|FG000|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
6541056|NCT01672866|7462607|FG001|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
6541057|NCT01672866|7462608|FG002|COMPLETED|Open-Label Phase (up to 240 Weeks)||0
6541058|NCT01672866|7462606|FG000|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||11
6541059|NCT01672866|7462607|FG001|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||15
6541060|NCT01672866|7462608|FG002|NOT COMPLETED|Open-Label Phase (up to 240 Weeks)||16
6541061|NCT01672879|7462621|FG000|STARTED|Blinded Phase (Up to 240 Weeks)||87
6541062|NCT01672879|7462622|FG001|STARTED|Blinded Phase (Up to 240 Weeks)||86
6541063|NCT01672879|7462623|FG002|STARTED|Blinded Phase (Up to 240 Weeks)||86
6541064|NCT01672879|7462621|FG000|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
6541065|NCT01672879|7462622|FG001|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
6541066|NCT01672879|7462623|FG002|COMPLETED|Blinded Phase (Up to 240 Weeks)||0
6541067|NCT01672879|7462621|FG000|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||87
6541068|NCT01672879|7462622|FG001|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
6541069|NCT01672879|7462623|FG002|NOT COMPLETED|Blinded Phase (Up to 240 Weeks)||86
6562357|NCT01800903|7485352|FG001|COMPLETED|Third Test Period||6
6541070|NCT01672879|7462621|FG000|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|15
6541071|NCT01672879|7462622|FG001|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|17
6541072|NCT01672879|7462623|FG002|STARTED|Open-Label Phase (Up to 240 Weeks)|Met protocol-specified reason(s) for study discontinuation during Blinded Phase & entered Open-Label|8
6541073|NCT01672879|7462621|FG000|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
6541074|NCT01672879|7462622|FG001|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
6541075|NCT01672879|7462623|FG002|COMPLETED|Open-Label Phase (Up to 240 Weeks)||0
6541076|NCT01672879|7462621|FG000|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||15
6541077|NCT01672879|7462622|FG001|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||17
6541078|NCT01672879|7462623|FG002|NOT COMPLETED|Open-Label Phase (Up to 240 Weeks)||8
6562358|NCT01800903|7485353|FG002|COMPLETED|Third Test Period||4
6562359|NCT01800903|7485354|FG003|COMPLETED|Third Test Period||7
6562360|NCT01800903|7485355|FG004|COMPLETED|Third Test Period||6
6645779|NCT02374671|7574738|FG000|STARTED|Implantation- Nonrandomized & Randomized|(8) subjects were unilaterally implanted|306
6645780|NCT02374671|7574739|FG001|STARTED|Implantation- Nonrandomized & Randomized|(1) subject was unilaterally implanted|28
6645781|NCT02374671|7574740|FG002|STARTED|Implantation- Nonrandomized & Randomized|(3) subjects were unilaterally implanted|26
6645782|NCT02374671|7574738|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||281
6645783|NCT02374671|7574739|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||27
6645784|NCT02374671|7574740|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) unilaterally implanted subject discontinued (1 eye)|23
6645785|NCT02374671|7574738|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||25
6645786|NCT02374671|7574739|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
6645787|NCT02374671|7574740|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||3
6645788|NCT02374918|7574750|FG000|STARTED|Overall Study||17
6645789|NCT02374918|7574751|FG001|STARTED|Overall Study||18
6645790|NCT02374918|7574752|FG002|STARTED|Overall Study||22
6645791|NCT02374918|7574753|FG003|STARTED|Overall Study||20
6645792|NCT02374918|7574750|FG000|COMPLETED|Overall Study||14
6645793|NCT02374918|7574751|FG001|COMPLETED|Overall Study||17
6645794|NCT02374918|7574752|FG002|COMPLETED|Overall Study||18
6645795|NCT02374918|7574753|FG003|COMPLETED|Overall Study||18
6645796|NCT02374918|7574750|FG000|NOT COMPLETED|Overall Study||3
6645797|NCT02374918|7574751|FG001|NOT COMPLETED|Overall Study||1
6645798|NCT02374918|7574752|FG002|NOT COMPLETED|Overall Study||4
6645799|NCT02374918|7574753|FG003|NOT COMPLETED|Overall Study||2
6645800|NCT02374957|7574763|FG000|STARTED|Overall Study||11
6645801|NCT02374957|7574764|FG001|STARTED|Overall Study||9
6645802|NCT02374957|7574763|FG000|COMPLETED|Overall Study||10
6645803|NCT02374957|7574764|FG001|COMPLETED|Overall Study||9
6645804|NCT02374957|7574763|FG000|NOT COMPLETED|Overall Study||1
6645805|NCT02374957|7574764|FG001|NOT COMPLETED|Overall Study||0
6645806|NCT02375347|7574770|FG000|STARTED|Overall Study||13
6645807|NCT02375347|7574770|FG000|COMPLETED|Overall Study||12
6645808|NCT02375347|7574770|FG000|NOT COMPLETED|Overall Study||1
6645809|NCT02375373|7574774|FG000|STARTED|Overall Study||12
6645810|NCT02375373|7574774|FG000|COMPLETED|Overall Study||1
6645811|NCT02375373|7574774|FG000|NOT COMPLETED|Overall Study||11
6645812|NCT02375698|7574780|FG000|STARTED|Overall Study||16
6645813|NCT02375698|7574781|FG001|STARTED|Overall Study||6
6645814|NCT02375698|7574780|FG000|COMPLETED|Overall Study||14
6645815|NCT02375698|7574781|FG001|COMPLETED|Overall Study||4
6645816|NCT02375698|7574780|FG000|NOT COMPLETED|Overall Study||2
6645817|NCT02375698|7574781|FG001|NOT COMPLETED|Overall Study||2
6645818|NCT02375724|7574789|FG000|STARTED|Overall Study||135
6645819|NCT02375724|7574790|FG001|STARTED|Overall Study||134
6645820|NCT02375724|7574789|FG000|COMPLETED|Overall Study||129
6645821|NCT02375724|7574790|FG001|COMPLETED|Overall Study||128
6645822|NCT02375724|7574789|FG000|NOT COMPLETED|Overall Study||6
6645823|NCT02375724|7574790|FG001|NOT COMPLETED|Overall Study||6
6645824|NCT02375971|7574799|FG000|STARTED|Treatment (Day 1 - Baseline)||74
6645825|NCT02375971|7574800|FG001|STARTED|Treatment (Day 1 - Baseline)||77
6645826|NCT02375971|7574801|FG002|STARTED|Treatment (Day 1 - Baseline)||74
6645827|NCT02375971|7574799|FG000|Safety Set|Treatment (Day 1 - Baseline)||73
6645828|NCT02375971|7574800|FG001|Safety Set|Treatment (Day 1 - Baseline)||76
6645829|NCT02375971|7574801|FG002|Safety Set|Treatment (Day 1 - Baseline)||69
6645830|NCT02375971|7574799|FG000|VEGF Set|Treatment (Day 1 - Baseline)||19
6645831|NCT02375971|7574800|FG001|VEGF Set|Treatment (Day 1 - Baseline)||26
6645832|NCT02375971|7574801|FG002|VEGF Set|Treatment (Day 1 - Baseline)||51
6645833|NCT02375971|7574799|FG000|PK Set|Treatment (Day 1 - Baseline)||49
6645834|NCT02375971|7574800|FG001|PK Set|Treatment (Day 1 - Baseline)||46
6645835|NCT02375971|7574801|FG002|PK Set|Treatment (Day 1 - Baseline)||0
6645836|NCT02375971|7574799|FG000|COMPLETED|Treatment (Day 1 - Baseline)||73
6645837|NCT02375971|7574800|FG001|COMPLETED|Treatment (Day 1 - Baseline)||76
6645838|NCT02375971|7574801|FG002|COMPLETED|Treatment (Day 1 - Baseline)||69
6562361|NCT01800903|7485356|FG005|COMPLETED|Third Test Period||6
6562362|NCT01800903|7485351|FG000|NOT COMPLETED|Third Test Period||0
6562363|NCT01800903|7485352|FG001|NOT COMPLETED|Third Test Period||0
6562364|NCT01800903|7485353|FG002|NOT COMPLETED|Third Test Period||0
6562365|NCT01800903|7485354|FG003|NOT COMPLETED|Third Test Period||0
6562366|NCT01800903|7485355|FG004|NOT COMPLETED|Third Test Period||0
6562367|NCT01800903|7485356|FG005|NOT COMPLETED|Third Test Period||0
6645839|NCT02375971|7574799|FG000|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
6541079|NCT01672892|7462634|FG000|STARTED|Overall Study||137
6541080|NCT01672892|7462635|FG001|STARTED|Overall Study||152
6541081|NCT01672892|7462634|FG000|Eligible Population|Overall Study||130
6541082|NCT01672892|7462635|FG001|Eligible Population|Overall Study||149
6541083|NCT01672892|7462634|FG000|Adverse Event Population|Overall Study||125
6541084|NCT01672892|7462635|FG001|Adverse Event Population|Overall Study||144
6541085|NCT01672892|7462634|FG000|COMPLETED|Overall Study||130
6541086|NCT01672892|7462635|FG001|COMPLETED|Overall Study||149
6541087|NCT01672892|7462634|FG000|NOT COMPLETED|Overall Study||7
6541088|NCT01672892|7462635|FG001|NOT COMPLETED|Overall Study||3
6541089|NCT01672957|7462644|FG000|STARTED|Overall Study||128
6541090|NCT01672957|7462644|FG000|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
6541091|NCT01672957|7462644|FG000|COMPLETED|Overall Study||73
6541092|NCT01672957|7462644|FG000|NOT COMPLETED|Overall Study||55
6541093|NCT01672970|7462648|FG000|STARTED|Overall Study||291
6541094|NCT01672970|7462648|FG000|Treated|Overall Study||290
6541095|NCT01672970|7462648|FG000|COMPLETED|Overall Study||244
6541096|NCT01672970|7462648|FG000|NOT COMPLETED|Overall Study||47
6541097|NCT01672983|7462658|FG000|STARTED|Overall Study||18
6541098|NCT01672983|7462659|FG001|STARTED|Overall Study||18
6541099|NCT01672983|7462660|FG002|STARTED|Overall Study||19
6541100|NCT01672983|7462661|FG003|STARTED|Overall Study||18
6645840|NCT02375971|7574800|FG001|NOT COMPLETED|Treatment (Day 1 - Baseline)||1
6645841|NCT02375971|7574801|FG002|NOT COMPLETED|Treatment (Day 1 - Baseline)||5
6645842|NCT02375971|7574799|FG000|STARTED|Follow-Up Phase (up to Day 169)||73
6645843|NCT02375971|7574800|FG001|STARTED|Follow-Up Phase (up to Day 169)||76
6645844|NCT02375971|7574801|FG002|STARTED|Follow-Up Phase (up to Day 169)||69
6645845|NCT02375971|7574799|FG000|COMPLETED|Follow-Up Phase (up to Day 169)||66
6541101|NCT01672983|7462662|FG004|STARTED|Overall Study||19
6541102|NCT01672983|7462663|FG005|STARTED|Overall Study||18
6541103|NCT01672983|7462658|FG000|Completed Study Drug|Overall Study||18
6645846|NCT02375971|7574800|FG001|COMPLETED|Follow-Up Phase (up to Day 169)||71
6645847|NCT02375971|7574801|FG002|COMPLETED|Follow-Up Phase (up to Day 169)||64
6645848|NCT02375971|7574799|FG000|NOT COMPLETED|Follow-Up Phase (up to Day 169)||7
6645849|NCT02375971|7574800|FG001|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
6645850|NCT02375971|7574801|FG002|NOT COMPLETED|Follow-Up Phase (up to Day 169)||5
6645851|NCT02375984|7574809|FG000|STARTED|Overall Study||1
6645852|NCT02375984|7574809|FG000|COMPLETED|Overall Study||1
6645853|NCT02375984|7574809|FG000|NOT COMPLETED|Overall Study||0
6645854|NCT02376010|7574815|FG000|STARTED|Overall Study||55
6645855|NCT02376010|7574816|FG001|STARTED|Overall Study||55
6645856|NCT02376010|7574815|FG000|COMPLETED|Overall Study||46
6645857|NCT02376010|7574816|FG001|COMPLETED|Overall Study||51
6645858|NCT02376010|7574815|FG000|NOT COMPLETED|Overall Study||9
6645859|NCT02376010|7574816|FG001|NOT COMPLETED|Overall Study||4
6645860|NCT02376166|7574822|FG000|STARTED|Overall Study||15
6645861|NCT02376166|7574822|FG000|COMPLETED|Overall Study||12
6645862|NCT02376166|7574822|FG000|NOT COMPLETED|Overall Study||3
6645863|NCT02376179|7574826|FG000|STARTED|Overall Study||84
6645864|NCT02376179|7574826|FG000|COMPLETED|Overall Study||84
6645865|NCT02376179|7574826|FG000|NOT COMPLETED|Overall Study||0
6645866|NCT02376257|7574833|FG000|STARTED|Overall Study||13
6645867|NCT02376257|7574834|FG001|STARTED|Overall Study||12
6645868|NCT02376257|7574835|FG002|STARTED|Overall Study||11
6645869|NCT02376257|7574833|FG000|COMPLETED|Overall Study||13
6645870|NCT02376257|7574834|FG001|COMPLETED|Overall Study||12
6645871|NCT02376257|7574835|FG002|COMPLETED|Overall Study||11
6645872|NCT02376257|7574833|FG000|NOT COMPLETED|Overall Study||0
6645873|NCT02376257|7574834|FG001|NOT COMPLETED|Overall Study||0
6645874|NCT02376257|7574835|FG002|NOT COMPLETED|Overall Study||0
6645875|NCT02376283|7574846|FG000|STARTED|Overall Study||27
6645876|NCT02376283|7574847|FG001|STARTED|Overall Study||30
6645877|NCT02376283|7574848|FG002|STARTED|Overall Study||30
6645878|NCT02376283|7574846|FG000|COMPLETED|Overall Study||27
6645879|NCT02376283|7574847|FG001|COMPLETED|Overall Study||30
6541104|NCT01672983|7462659|FG001|Completed Study Drug|Overall Study||17
6541105|NCT01672983|7462660|FG002|Completed Study Drug|Overall Study||18
6541106|NCT01672983|7462661|FG003|Completed Study Drug|Overall Study||18
6541107|NCT01672983|7462662|FG004|Completed Study Drug|Overall Study||12
6541108|NCT01672983|7462663|FG005|Completed Study Drug|Overall Study||17
6541109|NCT01672983|7462658|FG000|COMPLETED|Overall Study||18
6541110|NCT01672983|7462659|FG001|COMPLETED|Overall Study||18
6645880|NCT02376283|7574848|FG002|COMPLETED|Overall Study||30
6645881|NCT02376283|7574846|FG000|NOT COMPLETED|Overall Study||0
6645882|NCT02376283|7574847|FG001|NOT COMPLETED|Overall Study||0
6645883|NCT02376283|7574848|FG002|NOT COMPLETED|Overall Study||0
6645884|NCT02376361|7574859|FG000|STARTED|Overall Study||229
6645885|NCT02376361|7574860|FG001|STARTED|Overall Study||207
6645886|NCT02376361|7574859|FG000|COMPLETED|Overall Study||58
6645887|NCT02376361|7574860|FG001|COMPLETED|Overall Study||90
6645888|NCT02376361|7574859|FG000|NOT COMPLETED|Overall Study||171
6645889|NCT02376361|7574860|FG001|NOT COMPLETED|Overall Study||117
6645890|NCT02376530|7574870|FG000|STARTED|Overall Study||196
6645891|NCT02376530|7574871|FG001|STARTED|Overall Study||198
6645892|NCT02376530|7574872|FG002|STARTED|Overall Study||197
6645893|NCT02376530|7574873|FG003|STARTED|Overall Study||197
6541111|NCT01672983|7462660|FG002|COMPLETED|Overall Study||19
6541112|NCT01672983|7462661|FG003|COMPLETED|Overall Study||18
6541113|NCT01672983|7462662|FG004|COMPLETED|Overall Study||19
6541114|NCT01672983|7462663|FG005|COMPLETED|Overall Study||18
6645894|NCT02376530|7574870|FG000|COMPLETED|Overall Study||196
6645895|NCT02376530|7574871|FG001|COMPLETED|Overall Study||198
6541115|NCT01672983|7462658|FG000|NOT COMPLETED|Overall Study||0
6541116|NCT01672983|7462659|FG001|NOT COMPLETED|Overall Study||0
6541117|NCT01672983|7462660|FG002|NOT COMPLETED|Overall Study||0
6541118|NCT01672983|7462661|FG003|NOT COMPLETED|Overall Study||0
6541119|NCT01672983|7462662|FG004|NOT COMPLETED|Overall Study||0
6541120|NCT01672983|7462663|FG005|NOT COMPLETED|Overall Study||0
6541121|NCT01672996|7462692|FG000|STARTED|Overall Study||30
6541122|NCT01672996|7462693|FG001|STARTED|Overall Study||30
6541123|NCT01672996|7462694|FG002|STARTED|Overall Study||6
6541124|NCT01672996|7462692|FG000|COMPLETED|Overall Study||30
6541125|NCT01672996|7462693|FG001|COMPLETED|Overall Study||30
6541126|NCT01672996|7462694|FG002|COMPLETED|Overall Study||6
6541127|NCT01672996|7462692|FG000|NOT COMPLETED|Overall Study||0
6541128|NCT01672996|7462693|FG001|NOT COMPLETED|Overall Study||0
6541129|NCT01672996|7462694|FG002|NOT COMPLETED|Overall Study||0
6541130|NCT01673009|7462710|FG000|STARTED|Overall Study||36
6541131|NCT01673009|7462710|FG000|COMPLETED|Overall Study||23
6541132|NCT01673009|7462710|FG000|NOT COMPLETED|Overall Study||13
6541133|NCT01673022|7462714|FG000|STARTED|Overall Study||430
6541134|NCT01673022|7462714|FG000|COMPLETED|Overall Study||422
6541135|NCT01673022|7462714|FG000|NOT COMPLETED|Overall Study||8
6541136|NCT01673113|7462720|FG000|STARTED|Overall Study||11
6541137|NCT01673113|7462721|FG001|STARTED|Overall Study||11
6541138|NCT01673113|7462720|FG000|COMPLETED|Overall Study||11
6541139|NCT01673113|7462721|FG001|COMPLETED|Overall Study||11
6541140|NCT01673113|7462720|FG000|NOT COMPLETED|Overall Study||0
6541141|NCT01673113|7462721|FG001|NOT COMPLETED|Overall Study||0
6541142|NCT01673126|7462730|FG000|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
6541143|NCT01673126|7462731|FG001|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
6541144|NCT01673126|7462730|FG000|COMPLETED|Overall Study||32
6541145|NCT01673126|7462731|FG001|COMPLETED|Overall Study||23
6541146|NCT01673126|7462730|FG000|NOT COMPLETED|Overall Study||4
6541147|NCT01673126|7462731|FG001|NOT COMPLETED|Overall Study||3
6541148|NCT01673178|7462742|FG000|STARTED|Overall Study||22
6541149|NCT01673178|7462743|FG001|STARTED|Overall Study||21
6541150|NCT01673178|7462744|FG002|STARTED|Overall Study||21
6541151|NCT01673178|7462745|FG003|STARTED|Overall Study||22
6645896|NCT02376530|7574872|FG002|COMPLETED|Overall Study||197
6645897|NCT02376530|7574873|FG003|COMPLETED|Overall Study||197
6645898|NCT02376530|7574870|FG000|NOT COMPLETED|Overall Study||0
6645899|NCT02376530|7574871|FG001|NOT COMPLETED|Overall Study||0
6645900|NCT02376530|7574872|FG002|NOT COMPLETED|Overall Study||0
6645901|NCT02376530|7574873|FG003|NOT COMPLETED|Overall Study||0
6645902|NCT02376790|7574886|FG000|STARTED|Overall Study||284
6645903|NCT02376790|7574887|FG001|STARTED|Overall Study||284
6645904|NCT02376790|7574888|FG002|STARTED|Overall Study||283
6645905|NCT02376790|7574886|FG000|Received Treatment|Overall Study||282
6645906|NCT02376790|7574887|FG001|Received Treatment|Overall Study||284
6645907|NCT02376790|7574888|FG002|Received Treatment|Overall Study||282
6645908|NCT02376790|7574886|FG000|COMPLETED|Overall Study||224
6645909|NCT02376790|7574887|FG001|COMPLETED|Overall Study||237
6645910|NCT02376790|7574888|FG002|COMPLETED|Overall Study||230
6645911|NCT02376790|7574886|FG000|NOT COMPLETED|Overall Study||60
6645912|NCT02376790|7574887|FG001|NOT COMPLETED|Overall Study||47
6645913|NCT02376790|7574888|FG002|NOT COMPLETED|Overall Study||53
6645914|NCT02376998|7574896|FG000|STARTED|Overall Study||20
6645915|NCT02376998|7574896|FG000|COMPLETED|Overall Study||11
6645916|NCT02376998|7574896|FG000|NOT COMPLETED|Overall Study||9
6645917|NCT02377063|7574900|FG000|STARTED|Overall Study||25
6645918|NCT02377063|7574900|FG000|COMPLETED|Overall Study||20
6645919|NCT02377063|7574900|FG000|NOT COMPLETED|Overall Study||5
6645920|NCT02377349|7574906|FG000|STARTED|Overall Study||341
6645921|NCT02377349|7574907|FG001|STARTED|Overall Study||346
6645922|NCT02377349|7574906|FG000|COMPLETED|Overall Study||325
6645923|NCT02377349|7574907|FG001|COMPLETED|Overall Study||335
6645924|NCT02377349|7574906|FG000|NOT COMPLETED|Overall Study||16
6645925|NCT02377349|7574907|FG001|NOT COMPLETED|Overall Study||11
6645926|NCT02377362|7574935|FG000|STARTED|Part A First Treatment||4
6645927|NCT02377362|7574936|FG001|STARTED|Part A First Treatment||4
6645928|NCT02377362|7574937|FG002|STARTED|Part A First Treatment||4
6645929|NCT02377362|7574938|FG003|STARTED|Part A First Treatment||4
6645930|NCT02377362|7574939|FG004|STARTED|Part A First Treatment||4
6645931|NCT02377362|7574940|FG005|STARTED|Part A First Treatment||4
6645932|NCT02377362|7574941|FG006|STARTED|Part A First Treatment||0
6645933|NCT02377362|7574942|FG007|STARTED|Part A First Treatment||0
6645934|NCT02377362|7574943|FG008|STARTED|Part A First Treatment||0
6645935|NCT02377362|7574944|FG009|STARTED|Part A First Treatment||0
6645936|NCT02377362|7574945|FG010|STARTED|Part A First Treatment||0
6645937|NCT02377362|7574946|FG011|STARTED|Part A First Treatment||0
6645938|NCT02377362|7574947|FG012|STARTED|Part A First Treatment||0
6541152|NCT01673178|7462746|FG004|STARTED|Overall Study||21
6541153|NCT01673178|7462742|FG000|COMPLETED|Overall Study||19
6541154|NCT01673178|7462743|FG001|COMPLETED|Overall Study||19
6541155|NCT01673178|7462744|FG002|COMPLETED|Overall Study||18
6541156|NCT01673178|7462745|FG003|COMPLETED|Overall Study||14
6541157|NCT01673178|7462746|FG004|COMPLETED|Overall Study||19
6541158|NCT01673178|7462742|FG000|NOT COMPLETED|Overall Study||3
6645939|NCT02377362|7574935|FG000|COMPLETED|Part A First Treatment||4
6541159|NCT01673178|7462743|FG001|NOT COMPLETED|Overall Study||2
6541160|NCT01673178|7462744|FG002|NOT COMPLETED|Overall Study||3
6541161|NCT01673178|7462745|FG003|NOT COMPLETED|Overall Study||8
6541162|NCT01673178|7462746|FG004|NOT COMPLETED|Overall Study||2
6541163|NCT01673191|7462764|FG000|STARTED|Overall Study||26
6541164|NCT01673191|7462765|FG001|STARTED|Overall Study||11
6541165|NCT01673191|7462764|FG000|COMPLETED|Overall Study||26
6541166|NCT01673191|7462765|FG001|COMPLETED|Overall Study||11
6541167|NCT01673191|7462764|FG000|NOT COMPLETED|Overall Study||0
6541168|NCT01673191|7462765|FG001|NOT COMPLETED|Overall Study||0
6541169|NCT01673256|7462771|FG000|STARTED|Overall Study||90
6541170|NCT01673256|7462771|FG000|COMPLETED|Overall Study||90
6541171|NCT01673256|7462771|FG000|NOT COMPLETED|Overall Study||0
6541172|NCT01673282|7462777|FG000|STARTED|Overall Study||153
6541173|NCT01673282|7462778|FG001|STARTED|Overall Study||158
6541174|NCT01673282|7462777|FG000|COMPLETED|Overall Study||120
6541175|NCT01673282|7462778|FG001|COMPLETED|Overall Study||132
6541176|NCT01673282|7462777|FG000|NOT COMPLETED|Overall Study||33
6541177|NCT01673282|7462778|FG001|NOT COMPLETED|Overall Study||26
6541178|NCT01673347|7462784|FG000|STARTED|Overall Study||24
6541179|NCT01673347|7462784|FG000|COMPLETED|Overall Study||17
6541180|NCT01673347|7462784|FG000|NOT COMPLETED|Overall Study||7
6541181|NCT01673373|7462788|FG000|STARTED|Overall Study||68
6541182|NCT01673373|7462788|FG000|COMPLETED|Overall Study|Completed primary endpoint follow up.|66
6541183|NCT01673373|7462788|FG000|NOT COMPLETED|Overall Study||2
6541184|NCT01673386|7462792|FG000|STARTED|Overall Study||27
6541185|NCT01673386|7462793|FG001|STARTED|Overall Study||31
6541186|NCT01673386|7462792|FG000|COMPLETED|Overall Study|Of 2 subjects, 1 subject discontinued tivozanib early, completed planned treatment with sunitinib.|2
6541187|NCT01673386|7462793|FG001|COMPLETED|Overall Study|Of 4 subjects, 3 subjects discontinued sunitinib early, completed planned treatment with tivozanib.|4
6541188|NCT01673386|7462792|FG000|NOT COMPLETED|Overall Study||25
6541189|NCT01673386|7462793|FG001|NOT COMPLETED|Overall Study||27
6541190|NCT01673490|7462799|FG000|STARTED|Overall Study||59
6645940|NCT02377362|7574936|FG001|COMPLETED|Part A First Treatment||4
6645941|NCT02377362|7574937|FG002|COMPLETED|Part A First Treatment||4
6645942|NCT02377362|7574938|FG003|COMPLETED|Part A First Treatment||4
6645943|NCT02377362|7574939|FG004|COMPLETED|Part A First Treatment||4
6645944|NCT02377362|7574940|FG005|COMPLETED|Part A First Treatment||4
6645945|NCT02377362|7574941|FG006|COMPLETED|Part A First Treatment||0
6645946|NCT02377362|7574942|FG007|COMPLETED|Part A First Treatment||0
6645947|NCT02377362|7574943|FG008|COMPLETED|Part A First Treatment||0
6645948|NCT02377362|7574944|FG009|COMPLETED|Part A First Treatment||0
6645949|NCT02377362|7574945|FG010|COMPLETED|Part A First Treatment||0
6645950|NCT02377362|7574946|FG011|COMPLETED|Part A First Treatment||0
6645951|NCT02377362|7574947|FG012|COMPLETED|Part A First Treatment||0
6645952|NCT02377362|7574935|FG000|NOT COMPLETED|Part A First Treatment||0
6645953|NCT02377362|7574936|FG001|NOT COMPLETED|Part A First Treatment||0
6645954|NCT02377362|7574937|FG002|NOT COMPLETED|Part A First Treatment||0
6645955|NCT02377362|7574938|FG003|NOT COMPLETED|Part A First Treatment||0
6645956|NCT02377362|7574939|FG004|NOT COMPLETED|Part A First Treatment||0
6645957|NCT02377362|7574940|FG005|NOT COMPLETED|Part A First Treatment||0
6645958|NCT02377362|7574941|FG006|NOT COMPLETED|Part A First Treatment||0
6645959|NCT02377362|7574942|FG007|NOT COMPLETED|Part A First Treatment||0
6645960|NCT02377362|7574943|FG008|NOT COMPLETED|Part A First Treatment||0
6645961|NCT02377362|7574944|FG009|NOT COMPLETED|Part A First Treatment||0
6645962|NCT02377362|7574945|FG010|NOT COMPLETED|Part A First Treatment||0
6645963|NCT02377362|7574946|FG011|NOT COMPLETED|Part A First Treatment||0
6645964|NCT02377362|7574947|FG012|NOT COMPLETED|Part A First Treatment||0
6645965|NCT02377362|7574935|FG000|STARTED|Part A Second Treatment||4
6645966|NCT02377362|7574936|FG001|STARTED|Part A Second Treatment||4
6645967|NCT02377362|7574937|FG002|STARTED|Part A Second Treatment||4
6645968|NCT02377362|7574938|FG003|STARTED|Part A Second Treatment||4
6645969|NCT02377362|7574939|FG004|STARTED|Part A Second Treatment||4
6645970|NCT02377362|7574940|FG005|STARTED|Part A Second Treatment||4
6645971|NCT02377362|7574941|FG006|STARTED|Part A Second Treatment||0
6645972|NCT02377362|7574942|FG007|STARTED|Part A Second Treatment||0
6645973|NCT02377362|7574943|FG008|STARTED|Part A Second Treatment||0
6645974|NCT02377362|7574944|FG009|STARTED|Part A Second Treatment||0
6645975|NCT02377362|7574945|FG010|STARTED|Part A Second Treatment||0
6645976|NCT02377362|7574946|FG011|STARTED|Part A Second Treatment||0
6645977|NCT02377362|7574947|FG012|STARTED|Part A Second Treatment||0
6645978|NCT02377362|7574935|FG000|COMPLETED|Part A Second Treatment||4
6645979|NCT02377362|7574936|FG001|COMPLETED|Part A Second Treatment||4
6645980|NCT02377362|7574937|FG002|COMPLETED|Part A Second Treatment||4
6645981|NCT02377362|7574938|FG003|COMPLETED|Part A Second Treatment||4
6645982|NCT02377362|7574939|FG004|COMPLETED|Part A Second Treatment||3
6645983|NCT02377362|7574940|FG005|COMPLETED|Part A Second Treatment||4
6645984|NCT02377362|7574941|FG006|COMPLETED|Part A Second Treatment||0
6645985|NCT02377362|7574942|FG007|COMPLETED|Part A Second Treatment||0
6645986|NCT02377362|7574943|FG008|COMPLETED|Part A Second Treatment||0
6645987|NCT02377362|7574944|FG009|COMPLETED|Part A Second Treatment||0
6645988|NCT02377362|7574945|FG010|COMPLETED|Part A Second Treatment||0
6645989|NCT02377362|7574946|FG011|COMPLETED|Part A Second Treatment||0
6541191|NCT01673490|7462799|FG000|COMPLETED|Overall Study||52
6541192|NCT01673490|7462799|FG000|NOT COMPLETED|Overall Study||7
6541193|NCT01673568|7462805|FG000|STARTED|Overall Study||28
6645990|NCT02377362|7574947|FG012|COMPLETED|Part A Second Treatment||0
6541194|NCT01673568|7462806|FG001|STARTED|Overall Study||28
6541195|NCT01673568|7462805|FG000|COMPLETED|Overall Study||28
6541196|NCT01673568|7462806|FG001|COMPLETED|Overall Study||28
6541197|NCT01673568|7462805|FG000|NOT COMPLETED|Overall Study||0
6541198|NCT01673568|7462806|FG001|NOT COMPLETED|Overall Study||0
6541199|NCT01673594|7462814|FG000|STARTED|Overall Study||18
6541200|NCT01673594|7462815|FG001|STARTED|Overall Study||19
6541201|NCT01673594|7462814|FG000|COMPLETED|Overall Study||12
6541202|NCT01673594|7462815|FG001|COMPLETED|Overall Study||13
6541203|NCT01673594|7462814|FG000|NOT COMPLETED|Overall Study||6
6541204|NCT01673594|7462815|FG001|NOT COMPLETED|Overall Study||6
6541205|NCT01673646|7462824|FG000|STARTED|Overall Study||11
6541206|NCT01673646|7462825|FG001|STARTED|Overall Study||11
6541207|NCT01673646|7462826|FG002|STARTED|Overall Study||11
6541208|NCT01673646|7462824|FG000|Entered/Treated in Core Phase|Overall Study||11
6541209|NCT01673646|7462825|FG001|Entered/Treated in Core Phase|Overall Study||11
6541210|NCT01673646|7462826|FG002|Entered/Treated in Core Phase|Overall Study||11
6541211|NCT01673646|7462824|FG000|Completed Core Phase|Overall Study||9
6541212|NCT01673646|7462825|FG001|Completed Core Phase|Overall Study||10
6541213|NCT01673646|7462826|FG002|Completed Core Phase|Overall Study||10
6541214|NCT01673646|7462824|FG000|Entered Ext. Phase|Overall Study||7
6541215|NCT01673646|7462825|FG001|Entered Ext. Phase|Overall Study||9
6541216|NCT01673646|7462826|FG002|Entered Ext. Phase|Overall Study||9
6541217|NCT01673646|7462824|FG000|Did Not Enter Ext. Phase|Overall Study||2
6541218|NCT01673646|7462825|FG001|Did Not Enter Ext. Phase|Overall Study||1
6541219|NCT01673646|7462826|FG002|Did Not Enter Ext. Phase|Overall Study||1
6541220|NCT01673646|7462824|FG000|Treated Beyond 24 Months|Overall Study||7
6541221|NCT01673646|7462825|FG001|Treated Beyond 24 Months|Overall Study||8
6541222|NCT01673646|7462826|FG002|Treated Beyond 24 Months|Overall Study||8
6541223|NCT01673646|7462824|FG000|Discontinued Beyond 24 Months|Overall Study||0
6541224|NCT01673646|7462825|FG001|Discontinued Beyond 24 Months|Overall Study||4
6541225|NCT01673646|7462826|FG002|Discontinued Beyond 24 Months|Overall Study||1
6541226|NCT01673646|7462824|FG000|COMPLETED|Overall Study||7
6541227|NCT01673646|7462825|FG001|COMPLETED|Overall Study||4
6541228|NCT01673646|7462826|FG002|COMPLETED|Overall Study||7
6541229|NCT01673646|7462824|FG000|NOT COMPLETED|Overall Study||4
6541230|NCT01673646|7462825|FG001|NOT COMPLETED|Overall Study||7
6541231|NCT01673646|7462826|FG002|NOT COMPLETED|Overall Study||4
6541232|NCT01673698|7462840|FG000|STARTED|Overall Study||187
6541233|NCT01673698|7462841|FG001|STARTED|Overall Study||139
6541234|NCT01673698|7462840|FG000|COMPLETED|Overall Study||136
6541235|NCT01673698|7462841|FG001|COMPLETED|Overall Study||126
6541236|NCT01673698|7462840|FG000|NOT COMPLETED|Overall Study||51
6541237|NCT01673698|7462841|FG001|NOT COMPLETED|Overall Study||13
6541238|NCT01673802|7462848|FG000|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
6541239|NCT01673802|7462848|FG000|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
6541240|NCT01673802|7462848|FG000|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
6541241|NCT01673802|7462848|FG000|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
6541242|NCT01673802|7462848|FG000|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
6541243|NCT01673802|7462848|FG000|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
6541244|NCT01673828|7462854|FG000|STARTED|Overall Study||7
6541245|NCT01673828|7462855|FG001|STARTED|Overall Study||6
6541246|NCT01673828|7462854|FG000|COMPLETED|Overall Study||7
6541247|NCT01673828|7462855|FG001|COMPLETED|Overall Study||6
6541248|NCT01673828|7462854|FG000|NOT COMPLETED|Overall Study||0
6541249|NCT01673828|7462855|FG001|NOT COMPLETED|Overall Study||0
6541250|NCT01673854|7462861|FG000|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
6541251|NCT01673854|7462861|FG000|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
6541252|NCT01673854|7462861|FG000|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
6645991|NCT02377362|7574935|FG000|NOT COMPLETED|Part A Second Treatment||0
6645992|NCT02377362|7574936|FG001|NOT COMPLETED|Part A Second Treatment||0
6645993|NCT02377362|7574937|FG002|NOT COMPLETED|Part A Second Treatment||0
6645994|NCT02377362|7574938|FG003|NOT COMPLETED|Part A Second Treatment||0
6645995|NCT02377362|7574939|FG004|NOT COMPLETED|Part A Second Treatment||1
6645996|NCT02377362|7574940|FG005|NOT COMPLETED|Part A Second Treatment||0
6645997|NCT02377362|7574941|FG006|NOT COMPLETED|Part A Second Treatment||0
6645998|NCT02377362|7574942|FG007|NOT COMPLETED|Part A Second Treatment||0
6645999|NCT02377362|7574943|FG008|NOT COMPLETED|Part A Second Treatment||0
6646000|NCT02377362|7574944|FG009|NOT COMPLETED|Part A Second Treatment||0
6646001|NCT02377362|7574945|FG010|NOT COMPLETED|Part A Second Treatment||0
6646002|NCT02377362|7574946|FG011|NOT COMPLETED|Part A Second Treatment||0
6646003|NCT02377362|7574947|FG012|NOT COMPLETED|Part A Second Treatment||0
6646004|NCT02377362|7574935|FG000|STARTED|Part A Third Treatment||4
6646005|NCT02377362|7574936|FG001|STARTED|Part A Third Treatment||4
6541253|NCT01673854|7462861|FG000|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
6541254|NCT01673854|7462861|FG000|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
6541255|NCT01673854|7462861|FG000|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
6541256|NCT01673854|7462861|FG000|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
6541257|NCT01673854|7462861|FG000|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
6541258|NCT01673854|7462861|FG000|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
6541259|NCT01673893|7462867|FG000|STARTED|Overall Study||59
6646006|NCT02377362|7574937|FG002|STARTED|Part A Third Treatment||4
6646007|NCT02377362|7574938|FG003|STARTED|Part A Third Treatment||4
6646008|NCT02377362|7574939|FG004|STARTED|Part A Third Treatment||3
6541260|NCT01673893|7462867|FG000|COMPLETED|Overall Study||59
6541261|NCT01673893|7462867|FG000|NOT COMPLETED|Overall Study||0
6541262|NCT01673919|7462873|FG000|STARTED|Overall Study||7
6541263|NCT01673919|7462873|FG000|COMPLETED|Overall Study||7
6541264|NCT01673919|7462873|FG000|NOT COMPLETED|Overall Study||0
6541265|NCT01673984|7462879|FG000|STARTED|Overall Study||14
6541266|NCT01673984|7462880|FG001|STARTED|Overall Study||7
6541267|NCT01673984|7462879|FG000|COMPLETED|Overall Study||4
6541268|NCT01673984|7462880|FG001|COMPLETED|Overall Study||1
6541269|NCT01673984|7462879|FG000|NOT COMPLETED|Overall Study||10
6541270|NCT01673984|7462880|FG001|NOT COMPLETED|Overall Study||6
6541271|NCT01674010|7462886|FG000|STARTED|Open Treatment Phase 1||309
6541272|NCT01674010|7462887|FG001|STARTED|Open Treatment Phase 1||0
6541273|NCT01674010|7462888|FG002|STARTED|Open Treatment Phase 1||0
6541274|NCT01674010|7462886|FG000|COMPLETED|Open Treatment Phase 1||129
6541275|NCT01674010|7462887|FG001|COMPLETED|Open Treatment Phase 1||0
6541276|NCT01674010|7462888|FG002|COMPLETED|Open Treatment Phase 1||0
6541277|NCT01674010|7462886|FG000|NOT COMPLETED|Open Treatment Phase 1||180
6541278|NCT01674010|7462887|FG001|NOT COMPLETED|Open Treatment Phase 1||0
6541279|NCT01674010|7462888|FG002|NOT COMPLETED|Open Treatment Phase 1||0
6541280|NCT01674010|7462886|FG000|STARTED|Randomization Phase 2||0
6541281|NCT01674010|7462887|FG001|STARTED|Randomization Phase 2||65
6541282|NCT01674010|7462888|FG002|STARTED|Randomization Phase 2||64
6541283|NCT01674010|7462886|FG000|COMPLETED|Randomization Phase 2||0
6541284|NCT01674010|7462887|FG001|COMPLETED|Randomization Phase 2||3
6541285|NCT01674010|7462888|FG002|COMPLETED|Randomization Phase 2||3
6541286|NCT01674010|7462886|FG000|NOT COMPLETED|Randomization Phase 2||0
6541287|NCT01674010|7462887|FG001|NOT COMPLETED|Randomization Phase 2||62
6541288|NCT01674010|7462888|FG002|NOT COMPLETED|Randomization Phase 2||61
6541289|NCT01674062|7462898|FG000|STARTED|Overall Study||66
6541290|NCT01674062|7462899|FG001|STARTED|Overall Study||29
6541291|NCT01674062|7462898|FG000|COMPLETED|Overall Study||0
6541292|NCT01674062|7462899|FG001|COMPLETED|Overall Study||0
6541293|NCT01674062|7462898|FG000|NOT COMPLETED|Overall Study||66
6541294|NCT01674062|7462899|FG001|NOT COMPLETED|Overall Study||29
6541295|NCT01674478|7462907|FG000|STARTED|Overall Study||9
6541296|NCT01674478|7462908|FG001|STARTED|Overall Study||9
6541297|NCT01674478|7462907|FG000|COMPLETED|Overall Study||9
6541298|NCT01674478|7462908|FG001|COMPLETED|Overall Study||9
6541299|NCT01674478|7462907|FG000|NOT COMPLETED|Overall Study||0
6541300|NCT01674478|7462908|FG001|NOT COMPLETED|Overall Study||0
6541301|NCT01674569|7462914|FG000|STARTED|Overall Study||3
6541302|NCT01674569|7462915|FG001|STARTED|Overall Study||8
6541303|NCT01674569|7462916|FG002|STARTED|Overall Study||4
6541304|NCT01674569|7462917|FG003|STARTED|Overall Study||10
6541305|NCT01674569|7462918|FG004|STARTED|Overall Study||7
6541306|NCT01674569|7462919|FG005|STARTED|Overall Study||3
6541307|NCT01674569|7462914|FG000|COMPLETED|Overall Study||3
6541308|NCT01674569|7462915|FG001|COMPLETED|Overall Study||5
6541309|NCT01674569|7462916|FG002|COMPLETED|Overall Study||2
6541310|NCT01674569|7462917|FG003|COMPLETED|Overall Study||9
6541311|NCT01674569|7462918|FG004|COMPLETED|Overall Study||5
6541312|NCT01674569|7462919|FG005|COMPLETED|Overall Study||1
6541313|NCT01674569|7462914|FG000|NOT COMPLETED|Overall Study||0
6541314|NCT01674569|7462915|FG001|NOT COMPLETED|Overall Study||3
6541315|NCT01674569|7462916|FG002|NOT COMPLETED|Overall Study||2
6541316|NCT01674569|7462917|FG003|NOT COMPLETED|Overall Study||1
6541317|NCT01674569|7462918|FG004|NOT COMPLETED|Overall Study||2
6541318|NCT01674569|7462919|FG005|NOT COMPLETED|Overall Study||2
6541319|NCT01674621|7462928|FG000|STARTED|Overall Study||50
6541320|NCT01674621|7462929|FG001|STARTED|Overall Study||51
6541321|NCT01674621|7462930|FG002|STARTED|Overall Study||48
6541322|NCT01674621|7462931|FG003|STARTED|Overall Study||51
6541323|NCT01674621|7462932|FG004|STARTED|Overall Study||50
6541324|NCT01674621|7462928|FG000|Modified Intent-to-Treat Population|Overall Study||47
6541325|NCT01674621|7462929|FG001|Modified Intent-to-Treat Population|Overall Study||46
6541326|NCT01674621|7462930|FG002|Modified Intent-to-Treat Population|Overall Study||43
6541327|NCT01674621|7462931|FG003|Modified Intent-to-Treat Population|Overall Study||49
6541328|NCT01674621|7462932|FG004|Modified Intent-to-Treat Population|Overall Study||46
6541329|NCT01674621|7462928|FG000|Safety Population|Overall Study||50
6541330|NCT01674621|7462929|FG001|Safety Population|Overall Study||51
6541331|NCT01674621|7462930|FG002|Safety Population|Overall Study||47
6541332|NCT01674621|7462931|FG003|Safety Population|Overall Study||51
6541333|NCT01674621|7462932|FG004|Safety Population|Overall Study||50
6541334|NCT01674621|7462928|FG000|COMPLETED|Overall Study||45
6541335|NCT01674621|7462929|FG001|COMPLETED|Overall Study||43
6541336|NCT01674621|7462930|FG002|COMPLETED|Overall Study||41
6541337|NCT01674621|7462931|FG003|COMPLETED|Overall Study||45
6541338|NCT01674621|7462932|FG004|COMPLETED|Overall Study||44
6541339|NCT01674621|7462928|FG000|NOT COMPLETED|Overall Study||5
6541340|NCT01674621|7462929|FG001|NOT COMPLETED|Overall Study||8
6541341|NCT01674621|7462930|FG002|NOT COMPLETED|Overall Study||7
6541342|NCT01674621|7462931|FG003|NOT COMPLETED|Overall Study||6
6541343|NCT01674621|7462932|FG004|NOT COMPLETED|Overall Study||6
6541344|NCT01674634|7462945|FG000|STARTED|Overall Study||715
6541345|NCT01674634|7462945|FG000|COMPLETED|Overall Study||709
6541346|NCT01674634|7462945|FG000|NOT COMPLETED|Overall Study||6
6541347|NCT01674647|7462955|FG000|STARTED|Treatment Period||1002
6541348|NCT01674647|7462956|FG001|STARTED|Treatment Period||502
6541349|NCT01674647|7462955|FG000|Subjects Received Treatment|Treatment Period||988
6541350|NCT01674647|7462956|FG001|Subjects Received Treatment|Treatment Period||499
6541351|NCT01674647|7462955|FG000|COMPLETED|Treatment Period||846
6541352|NCT01674647|7462956|FG001|COMPLETED|Treatment Period||400
6541353|NCT01674647|7462955|FG000|NOT COMPLETED|Treatment Period||156
6541354|NCT01674647|7462956|FG001|NOT COMPLETED|Treatment Period||102
6541355|NCT01674647|7462955|FG000|STARTED|30-day Safety Follow-up Period||982
6541356|NCT01674647|7462956|FG001|STARTED|30-day Safety Follow-up Period||487
6541357|NCT01674647|7462955|FG000|COMPLETED|30-day Safety Follow-up Period||924
6541358|NCT01674647|7462956|FG001|COMPLETED|30-day Safety Follow-up Period||446
6541359|NCT01674647|7462955|FG000|NOT COMPLETED|30-day Safety Follow-up Period||58
6541360|NCT01674647|7462956|FG001|NOT COMPLETED|30-day Safety Follow-up Period||41
6541361|NCT01674712|7462967|FG000|STARTED|Overall Study||114
6541362|NCT01674712|7462968|FG001|STARTED|Overall Study||117
6541363|NCT01674712|7462969|FG002|STARTED|Overall Study||115
6541364|NCT01674712|7462970|FG003|STARTED|Overall Study||116
6541365|NCT01674712|7462971|FG004|STARTED|Overall Study||113
6541366|NCT01674712|7462967|FG000|Full Analysis Subject Sample|Overall Study||109
6541367|NCT01674712|7462968|FG001|Full Analysis Subject Sample|Overall Study||114
6541368|NCT01674712|7462969|FG002|Full Analysis Subject Sample|Overall Study||110
6541369|NCT01674712|7462970|FG003|Full Analysis Subject Sample|Overall Study||112
6541370|NCT01674712|7462971|FG004|Full Analysis Subject Sample|Overall Study||111
6541371|NCT01674712|7462967|FG000|Safety Subject Sample|Overall Study||111
6541372|NCT01674712|7462968|FG001|Safety Subject Sample|Overall Study||117
6541373|NCT01674712|7462969|FG002|Safety Subject Sample|Overall Study||113
6541374|NCT01674712|7462970|FG003|Safety Subject Sample|Overall Study||115
6541375|NCT01674712|7462971|FG004|Safety Subject Sample|Overall Study||112
6541376|NCT01674712|7462967|FG000|COMPLETED|Overall Study||104
6541377|NCT01674712|7462968|FG001|COMPLETED|Overall Study||108
6541378|NCT01674712|7462969|FG002|COMPLETED|Overall Study||106
6541379|NCT01674712|7462970|FG003|COMPLETED|Overall Study||108
6541380|NCT01674712|7462971|FG004|COMPLETED|Overall Study||102
6541381|NCT01674712|7462967|FG000|NOT COMPLETED|Overall Study||10
6541382|NCT01674712|7462968|FG001|NOT COMPLETED|Overall Study||9
6541383|NCT01674712|7462969|FG002|NOT COMPLETED|Overall Study||9
6541384|NCT01674712|7462970|FG003|NOT COMPLETED|Overall Study||8
6541385|NCT01674712|7462971|FG004|NOT COMPLETED|Overall Study||11
6541386|NCT01674725|7462985|FG000|STARTED|Overall Study||92
6646009|NCT02377362|7574940|FG005|STARTED|Part A Third Treatment||4
6646010|NCT02377362|7574941|FG006|STARTED|Part A Third Treatment||0
6646011|NCT02377362|7574942|FG007|STARTED|Part A Third Treatment||0
6646012|NCT02377362|7574943|FG008|STARTED|Part A Third Treatment||0
6646013|NCT02377362|7574944|FG009|STARTED|Part A Third Treatment||0
6646014|NCT02377362|7574945|FG010|STARTED|Part A Third Treatment||0
6646015|NCT02377362|7574946|FG011|STARTED|Part A Third Treatment||0
6646016|NCT02377362|7574947|FG012|STARTED|Part A Third Treatment||0
6541387|NCT01674725|7462986|FG001|STARTED|Overall Study||95
6541388|NCT01674725|7462985|FG000|COMPLETED|Overall Study||89
6541389|NCT01674725|7462986|FG001|COMPLETED|Overall Study||94
6541390|NCT01674725|7462985|FG000|NOT COMPLETED|Overall Study||3
6541391|NCT01674725|7462986|FG001|NOT COMPLETED|Overall Study||1
6541392|NCT01675050|7462994|FG000|STARTED|Period One Treatment||2
6541393|NCT01675050|7462995|FG001|STARTED|Period One Treatment||2
6541394|NCT01675050|7462994|FG000|COMPLETED|Period One Treatment||1
6541395|NCT01675050|7462995|FG001|COMPLETED|Period One Treatment||2
6541396|NCT01675050|7462994|FG000|NOT COMPLETED|Period One Treatment||1
6541397|NCT01675050|7462995|FG001|NOT COMPLETED|Period One Treatment||0
6541398|NCT01675050|7462994|FG000|STARTED|Wash Out Period||1
6646017|NCT02377362|7574935|FG000|COMPLETED|Part A Third Treatment||4
6646018|NCT02377362|7574936|FG001|COMPLETED|Part A Third Treatment||4
6646019|NCT02377362|7574937|FG002|COMPLETED|Part A Third Treatment||4
6646020|NCT02377362|7574938|FG003|COMPLETED|Part A Third Treatment||0
6646021|NCT02377362|7574939|FG004|COMPLETED|Part A Third Treatment||0
6646022|NCT02377362|7574940|FG005|COMPLETED|Part A Third Treatment||0
6646023|NCT02377362|7574941|FG006|COMPLETED|Part A Third Treatment||0
6646024|NCT02377362|7574942|FG007|COMPLETED|Part A Third Treatment||0
6646025|NCT02377362|7574943|FG008|COMPLETED|Part A Third Treatment||0
6646026|NCT02377362|7574944|FG009|COMPLETED|Part A Third Treatment||0
6646027|NCT02377362|7574945|FG010|COMPLETED|Part A Third Treatment||0
6646028|NCT02377362|7574946|FG011|COMPLETED|Part A Third Treatment||0
6646029|NCT02377362|7574947|FG012|COMPLETED|Part A Third Treatment||0
6646030|NCT02377362|7574935|FG000|NOT COMPLETED|Part A Third Treatment||0
6541399|NCT01675050|7462995|FG001|STARTED|Wash Out Period||2
6541400|NCT01675050|7462994|FG000|COMPLETED|Wash Out Period||1
6541401|NCT01675050|7462995|FG001|COMPLETED|Wash Out Period||2
6541402|NCT01675050|7462994|FG000|NOT COMPLETED|Wash Out Period||0
6541403|NCT01675050|7462995|FG001|NOT COMPLETED|Wash Out Period||0
6541404|NCT01675050|7462994|FG000|STARTED|Second Period Treatment||1
6541405|NCT01675050|7462995|FG001|STARTED|Second Period Treatment||2
6541406|NCT01675050|7462994|FG000|COMPLETED|Second Period Treatment||1
6646031|NCT02377362|7574936|FG001|NOT COMPLETED|Part A Third Treatment||0
6646032|NCT02377362|7574937|FG002|NOT COMPLETED|Part A Third Treatment||0
6646033|NCT02377362|7574938|FG003|NOT COMPLETED|Part A Third Treatment||4
6646034|NCT02377362|7574939|FG004|NOT COMPLETED|Part A Third Treatment||3
6646035|NCT02377362|7574940|FG005|NOT COMPLETED|Part A Third Treatment||4
6646036|NCT02377362|7574941|FG006|NOT COMPLETED|Part A Third Treatment||0
6646037|NCT02377362|7574942|FG007|NOT COMPLETED|Part A Third Treatment||0
6541407|NCT01675050|7462995|FG001|COMPLETED|Second Period Treatment||2
6541408|NCT01675050|7462994|FG000|NOT COMPLETED|Second Period Treatment||0
6541409|NCT01675050|7462995|FG001|NOT COMPLETED|Second Period Treatment||0
6541410|NCT01675063|7463001|FG000|STARTED|Overall Study||77
6541411|NCT01675063|7463001|FG000|COMPLETED|Overall Study||77
6541412|NCT01675063|7463001|FG000|NOT COMPLETED|Overall Study||0
6541413|NCT01675128|7463008|FG000|STARTED|Overall Study||4
6541414|NCT01675128|7463009|FG001|STARTED|Overall Study||10
6541415|NCT01675128|7463010|FG002|STARTED|Overall Study||10
6541416|NCT01675128|7463008|FG000|COMPLETED|Overall Study||2
6541417|NCT01675128|7463009|FG001|COMPLETED|Overall Study||8
6541418|NCT01675128|7463010|FG002|COMPLETED|Overall Study||9
6541419|NCT01675128|7463008|FG000|NOT COMPLETED|Overall Study||2
6541420|NCT01675128|7463009|FG001|NOT COMPLETED|Overall Study||2
6541421|NCT01675128|7463010|FG002|NOT COMPLETED|Overall Study||1
6541422|NCT01675141|7463025|FG000|STARTED|Overall Study||11
6541423|NCT01675141|7463025|FG000|COMPLETED|Overall Study||0
6541424|NCT01675141|7463025|FG000|NOT COMPLETED|Overall Study||11
6541425|NCT01675154|7463033|FG000|STARTED|First Intervention Period (4 Weeks)||2
6541426|NCT01675154|7463034|FG001|STARTED|First Intervention Period (4 Weeks)||1
6541427|NCT01675154|7463035|FG002|STARTED|First Intervention Period (4 Weeks)||1
6541428|NCT01675154|7463036|FG003|STARTED|First Intervention Period (4 Weeks)||1
6541429|NCT01675154|7463033|FG000|COMPLETED|First Intervention Period (4 Weeks)||2
6541430|NCT01675154|7463034|FG001|COMPLETED|First Intervention Period (4 Weeks)||1
6541431|NCT01675154|7463035|FG002|COMPLETED|First Intervention Period (4 Weeks)||1
6541432|NCT01675154|7463036|FG003|COMPLETED|First Intervention Period (4 Weeks)||1
6541433|NCT01675154|7463033|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||0
6541434|NCT01675154|7463034|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||0
6541435|NCT01675154|7463035|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||0
6541436|NCT01675154|7463036|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||0
6541437|NCT01675154|7463033|FG000|STARTED|First Washout Period (1 Week)|Subjects were enrolled Regimen 1|2
6541438|NCT01675154|7463034|FG001|STARTED|First Washout Period (1 Week)||1
6541439|NCT01675154|7463035|FG002|STARTED|First Washout Period (1 Week)||1
6541440|NCT01675154|7463036|FG003|STARTED|First Washout Period (1 Week)||1
6541441|NCT01675154|7463033|FG000|COMPLETED|First Washout Period (1 Week)||2
6541442|NCT01675154|7463034|FG001|COMPLETED|First Washout Period (1 Week)||1
6541443|NCT01675154|7463035|FG002|COMPLETED|First Washout Period (1 Week)||1
6541444|NCT01675154|7463036|FG003|COMPLETED|First Washout Period (1 Week)||1
6541445|NCT01675154|7463033|FG000|NOT COMPLETED|First Washout Period (1 Week)||0
6541446|NCT01675154|7463034|FG001|NOT COMPLETED|First Washout Period (1 Week)||0
6541447|NCT01675154|7463035|FG002|NOT COMPLETED|First Washout Period (1 Week)||0
6541448|NCT01675154|7463036|FG003|NOT COMPLETED|First Washout Period (1 Week)||0
6541449|NCT01675154|7463033|FG000|STARTED|Second Intervention Period (4 Weeks)||1
6541450|NCT01675154|7463034|FG001|STARTED|Second Intervention Period (4 Weeks)|Subjects were enrolled in Regimen 2|1
6541451|NCT01675154|7463035|FG002|STARTED|Second Intervention Period (4 Weeks)||1
6541452|NCT01675154|7463036|FG003|STARTED|Second Intervention Period (4 Weeks)||2
6541453|NCT01675154|7463033|FG000|COMPLETED|Second Intervention Period (4 Weeks)||0
6541454|NCT01675154|7463034|FG001|COMPLETED|Second Intervention Period (4 Weeks)||1
6541455|NCT01675154|7463035|FG002|COMPLETED|Second Intervention Period (4 Weeks)||1
6541456|NCT01675154|7463036|FG003|COMPLETED|Second Intervention Period (4 Weeks)||1
6541457|NCT01675154|7463033|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
6541458|NCT01675154|7463034|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
6541459|NCT01675154|7463035|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
6541460|NCT01675154|7463036|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
6541461|NCT01675154|7463033|FG000|STARTED|Second Washout Period (1 Week)||1
6541462|NCT01675154|7463034|FG001|STARTED|Second Washout Period (1 Week)||1
6541463|NCT01675154|7463035|FG002|STARTED|Second Washout Period (1 Week)||1
6541464|NCT01675154|7463036|FG003|STARTED|Second Washout Period (1 Week)||2
6541465|NCT01675154|7463033|FG000|COMPLETED|Second Washout Period (1 Week)||1
6541466|NCT01675154|7463034|FG001|COMPLETED|Second Washout Period (1 Week)||1
6541467|NCT01675154|7463035|FG002|COMPLETED|Second Washout Period (1 Week)||1
6541468|NCT01675154|7463036|FG003|COMPLETED|Second Washout Period (1 Week)||2
6541469|NCT01675154|7463033|FG000|NOT COMPLETED|Second Washout Period (1 Week)||0
6541470|NCT01675154|7463034|FG001|NOT COMPLETED|Second Washout Period (1 Week)||0
6541471|NCT01675154|7463035|FG002|NOT COMPLETED|Second Washout Period (1 Week)||0
6541472|NCT01675154|7463036|FG003|NOT COMPLETED|Second Washout Period (1 Week)||0
6541473|NCT01675154|7463033|FG000|STARTED|Third Intervention Period (4 Weeks)||1
6541474|NCT01675154|7463034|FG001|STARTED|Third Intervention Period (4 Weeks)||1
6541475|NCT01675154|7463035|FG002|STARTED|Third Intervention Period (4 Weeks)||1
6541476|NCT01675154|7463036|FG003|STARTED|Third Intervention Period (4 Weeks)||0
6541477|NCT01675154|7463033|FG000|COMPLETED|Third Intervention Period (4 Weeks)||1
6541478|NCT01675154|7463034|FG001|COMPLETED|Third Intervention Period (4 Weeks)||0
6541479|NCT01675154|7463035|FG002|COMPLETED|Third Intervention Period (4 Weeks)||1
6541480|NCT01675154|7463036|FG003|COMPLETED|Third Intervention Period (4 Weeks)||0
6541481|NCT01675154|7463033|FG000|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
6541482|NCT01675154|7463034|FG001|NOT COMPLETED|Third Intervention Period (4 Weeks)||1
6541483|NCT01675154|7463035|FG002|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
6541484|NCT01675154|7463036|FG003|NOT COMPLETED|Third Intervention Period (4 Weeks)||0
6541485|NCT01675154|7463033|FG000|STARTED|Third Washout Period (1 Week)||1
6541486|NCT01675154|7463034|FG001|STARTED|Third Washout Period (1 Week)||0
6541487|NCT01675154|7463035|FG002|STARTED|Third Washout Period (1 Week)||1
6541488|NCT01675154|7463036|FG003|STARTED|Third Washout Period (1 Week)||0
6541489|NCT01675154|7463033|FG000|COMPLETED|Third Washout Period (1 Week)||1
6541490|NCT01675154|7463034|FG001|COMPLETED|Third Washout Period (1 Week)||0
6541491|NCT01675154|7463035|FG002|COMPLETED|Third Washout Period (1 Week)||1
6541492|NCT01675154|7463036|FG003|COMPLETED|Third Washout Period (1 Week)||0
6541493|NCT01675154|7463033|FG000|NOT COMPLETED|Third Washout Period (1 Week)||0
6541494|NCT01675154|7463034|FG001|NOT COMPLETED|Third Washout Period (1 Week)||0
6541495|NCT01675154|7463035|FG002|NOT COMPLETED|Third Washout Period (1 Week)||0
6541496|NCT01675154|7463036|FG003|NOT COMPLETED|Third Washout Period (1 Week)||0
6541497|NCT01675154|7463033|FG000|STARTED|Fourth Intervention Period (4 Weeks)||1
6541498|NCT01675154|7463034|FG001|STARTED|Fourth Intervention Period (4 Weeks)||0
6541499|NCT01675154|7463035|FG002|STARTED|Fourth Intervention Period (4 Weeks)||1
6541500|NCT01675154|7463036|FG003|STARTED|Fourth Intervention Period (4 Weeks)||0
6541501|NCT01675154|7463033|FG000|COMPLETED|Fourth Intervention Period (4 Weeks)||1
6541502|NCT01675154|7463034|FG001|COMPLETED|Fourth Intervention Period (4 Weeks)||0
6541503|NCT01675154|7463035|FG002|COMPLETED|Fourth Intervention Period (4 Weeks)||1
6541504|NCT01675154|7463036|FG003|COMPLETED|Fourth Intervention Period (4 Weeks)||0
6541505|NCT01675154|7463033|FG000|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
6541506|NCT01675154|7463034|FG001|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
6541507|NCT01675154|7463035|FG002|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
6541508|NCT01675154|7463036|FG003|NOT COMPLETED|Fourth Intervention Period (4 Weeks)||0
6541509|NCT01675167|7463060|FG000|STARTED|Open-label Titration Phase||815
6541510|NCT01675167|7463061|FG001|STARTED|Open-label Titration Phase||0
6541511|NCT01675167|7463062|FG002|STARTED|Open-label Titration Phase||0
6646038|NCT02377362|7574943|FG008|NOT COMPLETED|Part A Third Treatment||0
6646039|NCT02377362|7574944|FG009|NOT COMPLETED|Part A Third Treatment||0
6646040|NCT02377362|7574945|FG010|NOT COMPLETED|Part A Third Treatment||0
6646041|NCT02377362|7574946|FG011|NOT COMPLETED|Part A Third Treatment||0
6646042|NCT02377362|7574947|FG012|NOT COMPLETED|Part A Third Treatment||0
6646043|NCT02377362|7574935|FG000|STARTED|Part B Overall||0
6646044|NCT02377362|7574936|FG001|STARTED|Part B Overall||0
6646045|NCT02377362|7574937|FG002|STARTED|Part B Overall||0
6646046|NCT02377362|7574938|FG003|STARTED|Part B Overall||0
6646047|NCT02377362|7574939|FG004|STARTED|Part B Overall||0
6646048|NCT02377362|7574940|FG005|STARTED|Part B Overall||0
6646049|NCT02377362|7574941|FG006|STARTED|Part B Overall||6
6646050|NCT02377362|7574942|FG007|STARTED|Part B Overall||6
6646051|NCT02377362|7574943|FG008|STARTED|Part B Overall||6
6743763|NCT03335254|7671820|FG010|STARTED|Period 3, Day 26-30||0
6743764|NCT03335254|7671821|FG011|STARTED|Period 3, Day 26-30||0
6743765|NCT03335254|7671822|FG012|STARTED|Period 3, Day 26-30||0
6743766|NCT03335254|7671823|FG013|STARTED|Period 3, Day 26-30||0
6743767|NCT03335254|7671824|FG014|STARTED|Period 3, Day 26-30||0
6743768|NCT03335254|7671825|FG015|STARTED|Period 3, Day 26-30||0
6743769|NCT03335254|7671826|FG016|STARTED|Period 3, Day 26-30||0
6743770|NCT03335254|7671827|FG017|STARTED|Period 3, Day 26-30||0
6743771|NCT03335254|7671828|FG018|STARTED|Period 3, Day 26-30||0
6743772|NCT03335254|7671829|FG019|STARTED|Period 3, Day 26-30||0
6646052|NCT02377362|7574944|FG009|STARTED|Part B Overall||7
6646053|NCT02377362|7574945|FG010|STARTED|Part B Overall||6
6646054|NCT02377362|7574946|FG011|STARTED|Part B Overall||7
6646055|NCT02377362|7574947|FG012|STARTED|Part B Overall||12
6646056|NCT02377362|7574935|FG000|COMPLETED|Part B Overall||0
6646057|NCT02377362|7574936|FG001|COMPLETED|Part B Overall||0
6646058|NCT02377362|7574937|FG002|COMPLETED|Part B Overall||0
6646059|NCT02377362|7574938|FG003|COMPLETED|Part B Overall||0
6646060|NCT02377362|7574939|FG004|COMPLETED|Part B Overall||0
6646061|NCT02377362|7574940|FG005|COMPLETED|Part B Overall||0
6646062|NCT02377362|7574941|FG006|COMPLETED|Part B Overall||4
6646063|NCT02377362|7574942|FG007|COMPLETED|Part B Overall||5
6646064|NCT02377362|7574943|FG008|COMPLETED|Part B Overall||6
6646065|NCT02377362|7574944|FG009|COMPLETED|Part B Overall||6
6646066|NCT02377362|7574945|FG010|COMPLETED|Part B Overall||6
6646067|NCT02377362|7574946|FG011|COMPLETED|Part B Overall||6
6646068|NCT02377362|7574947|FG012|COMPLETED|Part B Overall||12
6646069|NCT02377362|7574935|FG000|NOT COMPLETED|Part B Overall||0
6646070|NCT02377362|7574936|FG001|NOT COMPLETED|Part B Overall||0
6646071|NCT02377362|7574937|FG002|NOT COMPLETED|Part B Overall||0
6646072|NCT02377362|7574938|FG003|NOT COMPLETED|Part B Overall||0
6646073|NCT02377362|7574939|FG004|NOT COMPLETED|Part B Overall||0
6646074|NCT02377362|7574940|FG005|NOT COMPLETED|Part B Overall||0
6646075|NCT02377362|7574941|FG006|NOT COMPLETED|Part B Overall||2
6646076|NCT02377362|7574942|FG007|NOT COMPLETED|Part B Overall||1
6646077|NCT02377362|7574943|FG008|NOT COMPLETED|Part B Overall||0
6646078|NCT02377362|7574944|FG009|NOT COMPLETED|Part B Overall||1
6646079|NCT02377362|7574945|FG010|NOT COMPLETED|Part B Overall||0
6646080|NCT02377362|7574946|FG011|NOT COMPLETED|Part B Overall||1
6646081|NCT02377362|7574947|FG012|NOT COMPLETED|Part B Overall||0
6646082|NCT02377427|7574987|FG000|STARTED|Part A (Up to Week 20)||26
6646083|NCT02377427|7574988|FG001|STARTED|Part A (Up to Week 20)||10
6646084|NCT02377427|7574989|FG002|STARTED|Part A (Up to Week 20)||0
6743773|NCT03335254|7671810|FG000|COMPLETED|Period 3, Day 26-30||9
6743774|NCT03335254|7671811|FG001|COMPLETED|Period 3, Day 26-30||0
6541512|NCT01675167|7463060|FG000|COMPLETED|Open-label Titration Phase||511
6541513|NCT01675167|7463061|FG001|COMPLETED|Open-label Titration Phase||0
6541514|NCT01675167|7463062|FG002|COMPLETED|Open-label Titration Phase||0
6541515|NCT01675167|7463060|FG000|NOT COMPLETED|Open-label Titration Phase||304
6541516|NCT01675167|7463061|FG001|NOT COMPLETED|Open-label Titration Phase||0
6541517|NCT01675167|7463062|FG002|NOT COMPLETED|Open-label Titration Phase||0
6541518|NCT01675167|7463060|FG000|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
6541519|NCT01675167|7463061|FG001|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
6541520|NCT01675167|7463062|FG002|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
6541521|NCT01675167|7463060|FG000|COMPLETED|Double-blind Treatment Phase||0
6541522|NCT01675167|7463061|FG001|COMPLETED|Double-blind Treatment Phase||206
6541523|NCT01675167|7463062|FG002|COMPLETED|Double-blind Treatment Phase||147
6541524|NCT01675167|7463060|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
6541525|NCT01675167|7463061|FG001|NOT COMPLETED|Double-blind Treatment Phase||48
6541526|NCT01675167|7463062|FG002|NOT COMPLETED|Double-blind Treatment Phase||110
6541527|NCT01675297|7463072|FG000|STARTED|Overall Study||806
6541528|NCT01675297|7463073|FG001|STARTED|Overall Study||247
6541529|NCT01675297|7463072|FG000|COMPLETED|Overall Study||642
6541530|NCT01675297|7463073|FG001|COMPLETED|Overall Study||199
6541531|NCT01675297|7463072|FG000|NOT COMPLETED|Overall Study||164
6541532|NCT01675297|7463073|FG001|NOT COMPLETED|Overall Study||48
6541533|NCT01675427|7463079|FG000|STARTED|Overall Study||4766
6541534|NCT01675427|7463079|FG000|COMPLETED|Overall Study||4732
6541535|NCT01675427|7463079|FG000|NOT COMPLETED|Overall Study||34
6541536|NCT01675453|7463115|FG000|STARTED|Overall Study||20
6541537|NCT01675453|7463116|FG001|STARTED|Overall Study||20
6541538|NCT01675453|7463115|FG000|COMPLETED|Overall Study||20
6541539|NCT01675453|7463116|FG001|COMPLETED|Overall Study||20
6541540|NCT01675453|7463115|FG000|NOT COMPLETED|Overall Study||0
6541541|NCT01675453|7463116|FG001|NOT COMPLETED|Overall Study||0
6541542|NCT01675492|7463122|FG000|STARTED|Overall Study||84
6541543|NCT01675492|7463122|FG000|COMPLETED|Overall Study||42
6541544|NCT01675492|7463122|FG000|NOT COMPLETED|Overall Study||42
6541545|NCT01675531|7463127|FG000|STARTED|Overall Study||66
6541546|NCT01675531|7463127|FG000|COMPLETED|Overall Study||41
6541547|NCT01675531|7463127|FG000|NOT COMPLETED|Overall Study||25
6541548|NCT01675544|7463132|FG000|STARTED|Overall Study||46
6541549|NCT01675544|7463132|FG000|COMPLETED|Overall Study||44
6541550|NCT01675544|7463132|FG000|NOT COMPLETED|Overall Study||2
6541551|NCT01675596|7463136|FG000|STARTED|Overall Study|One patient did not receive the study device.|199
6541552|NCT01675596|7463136|FG000|COMPLETED|Overall Study||191
6541553|NCT01675596|7463136|FG000|NOT COMPLETED|Overall Study||8
6541554|NCT01675622|7463142|FG000|STARTED|Overall Study||122
6541555|NCT01675622|7463143|FG001|STARTED|Overall Study||120
6541556|NCT01675622|7463142|FG000|COMPLETED|Overall Study||96
6541557|NCT01675622|7463143|FG001|COMPLETED|Overall Study||96
6541558|NCT01675622|7463142|FG000|NOT COMPLETED|Overall Study||26
6541559|NCT01675622|7463143|FG001|NOT COMPLETED|Overall Study||24
6541560|NCT01675635|7463151|FG000|STARTED|Overall Study||117
6541561|NCT01675635|7463152|FG001|STARTED|Overall Study||117
6541562|NCT01675635|7463151|FG000|COMPLETED|Overall Study||117
6541563|NCT01675635|7463152|FG001|COMPLETED|Overall Study||117
6541564|NCT01675635|7463151|FG000|NOT COMPLETED|Overall Study||0
6541565|NCT01675635|7463152|FG001|NOT COMPLETED|Overall Study||0
6541566|NCT01675661|7463165|FG000|STARTED|Overall Study||153
6541567|NCT01675661|7463166|FG001|STARTED|Overall Study||149
6541568|NCT01675661|7463165|FG000|COMPLETED|Overall Study||113
6541569|NCT01675661|7463166|FG001|COMPLETED|Overall Study||103
6541570|NCT01675661|7463165|FG000|NOT COMPLETED|Overall Study||40
6541571|NCT01675661|7463166|FG001|NOT COMPLETED|Overall Study||46
6541572|NCT01675765|7463174|FG000|STARTED|Overall Study||38
6541573|NCT01675765|7463175|FG001|STARTED|Overall Study||22
6541574|NCT01675765|7463174|FG000|COMPLETED|Overall Study||27
6541575|NCT01675765|7463175|FG001|COMPLETED|Overall Study||14
6541576|NCT01675765|7463174|FG000|NOT COMPLETED|Overall Study||11
6541577|NCT01675765|7463175|FG001|NOT COMPLETED|Overall Study||8
6541578|NCT01675778|7463181|FG000|STARTED|Overall Study||174
6541579|NCT01675778|7463181|FG000|COMPLETED|Overall Study||174
6541580|NCT01675778|7463181|FG000|NOT COMPLETED|Overall Study||0
6541581|NCT01675830|7463186|FG000|STARTED|Overall Study||10
6541582|NCT01675830|7463186|FG000|COMPLETED|Overall Study||10
6541583|NCT01675830|7463186|FG000|NOT COMPLETED|Overall Study||0
6541584|NCT01675882|7463194|FG000|STARTED|Overall Study||53
6541585|NCT01675882|7463195|FG001|STARTED|Overall Study||56
6541586|NCT01675882|7463196|FG002|STARTED|Overall Study||56
6541587|NCT01675882|7463197|FG003|STARTED|Overall Study||56
6541588|NCT01675882|7463194|FG000|COMPLETED|Overall Study||51
6541589|NCT01675882|7463195|FG001|COMPLETED|Overall Study||49
6541590|NCT01675882|7463196|FG002|COMPLETED|Overall Study||53
6541591|NCT01675882|7463197|FG003|COMPLETED|Overall Study||54
6541592|NCT01675882|7463194|FG000|NOT COMPLETED|Overall Study||2
6541593|NCT01675882|7463195|FG001|NOT COMPLETED|Overall Study||7
6541594|NCT01675882|7463196|FG002|NOT COMPLETED|Overall Study||3
6541595|NCT01675882|7463197|FG003|NOT COMPLETED|Overall Study||2
6541596|NCT01676012|7463207|FG000|STARTED|Overall Study||32
6541597|NCT01676012|7463207|FG000|COMPLETED|Overall Study||29
6541598|NCT01676012|7463207|FG000|NOT COMPLETED|Overall Study||3
6541599|NCT01676116|7463213|FG000|STARTED|Overall Study||292
6541600|NCT01676116|7463214|FG001|STARTED|Overall Study||146
6541601|NCT01676116|7463213|FG000|COMPLETED|Overall Study||276
6541602|NCT01676116|7463214|FG001|COMPLETED|Overall Study||117
6541603|NCT01676116|7463213|FG000|NOT COMPLETED|Overall Study||16
6541604|NCT01676116|7463214|FG001|NOT COMPLETED|Overall Study||29
6541605|NCT01676220|7463222|FG000|STARTED|Overall Study||439
6541606|NCT01676220|7463223|FG001|STARTED|Overall Study||439
6541607|NCT01676220|7463222|FG000|Treated|Overall Study||435
6541608|NCT01676220|7463223|FG001|Treated|Overall Study||438
6541609|NCT01676220|7463222|FG000|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|432
6541610|NCT01676220|7463223|FG001|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|430
6541611|NCT01676220|7463222|FG000|COMPLETED|Overall Study||337
6541612|NCT01676220|7463223|FG001|COMPLETED|Overall Study||314
6541613|NCT01676220|7463222|FG000|NOT COMPLETED|Overall Study||102
6541614|NCT01676220|7463223|FG001|NOT COMPLETED|Overall Study||125
6541615|NCT01676298|7463239|FG000|STARTED|Overall Study||1
6541616|NCT01676298|7463240|FG001|STARTED|Overall Study||1
6541617|NCT01676298|7463241|FG002|STARTED|Overall Study||1
6541618|NCT01676298|7463242|FG003|STARTED|Overall Study||1
6541619|NCT01676298|7463243|FG004|STARTED|Overall Study||1
6541620|NCT01676298|7463244|FG005|STARTED|Overall Study||1
6541621|NCT01676298|7463245|FG006|STARTED|Overall Study||1
6541622|NCT01676298|7463246|FG007|STARTED|Overall Study||1
6541623|NCT01676298|7463239|FG000|All Genotypes Confirmed With Reference|Overall Study||1
6541624|NCT01676298|7463240|FG001|All Genotypes Confirmed With Reference|Overall Study||1
6541625|NCT01676298|7463241|FG002|All Genotypes Confirmed With Reference|Overall Study||1
6541626|NCT01676298|7463242|FG003|All Genotypes Confirmed With Reference|Overall Study||1
6541627|NCT01676298|7463243|FG004|All Genotypes Confirmed With Reference|Overall Study||1
6541628|NCT01676298|7463244|FG005|All Genotypes Confirmed With Reference|Overall Study||1
6541629|NCT01676298|7463245|FG006|All Genotypes Confirmed With Reference|Overall Study||1
6541630|NCT01676298|7463246|FG007|All Genotypes Confirmed With Reference|Overall Study||1
6541631|NCT01676298|7463239|FG000|Participated in All Tests|Overall Study||1
6541632|NCT01676298|7463240|FG001|Participated in All Tests|Overall Study||1
6541633|NCT01676298|7463241|FG002|Participated in All Tests|Overall Study||1
6541634|NCT01676298|7463242|FG003|Participated in All Tests|Overall Study||1
6541635|NCT01676298|7463243|FG004|Participated in All Tests|Overall Study||1
6541636|NCT01676298|7463244|FG005|Participated in All Tests|Overall Study||1
6541637|NCT01676298|7463245|FG006|Participated in All Tests|Overall Study||1
6541638|NCT01676298|7463246|FG007|Participated in All Tests|Overall Study||1
6541639|NCT01676298|7463239|FG000|COMPLETED|Overall Study||1
6541640|NCT01676298|7463240|FG001|COMPLETED|Overall Study||1
6541641|NCT01676298|7463241|FG002|COMPLETED|Overall Study||1
6541642|NCT01676298|7463242|FG003|COMPLETED|Overall Study||1
6541643|NCT01676298|7463243|FG004|COMPLETED|Overall Study||1
6541644|NCT01676298|7463244|FG005|COMPLETED|Overall Study||1
6541645|NCT01676298|7463245|FG006|COMPLETED|Overall Study||1
6541646|NCT01676298|7463246|FG007|COMPLETED|Overall Study||1
6541647|NCT01676298|7463239|FG000|NOT COMPLETED|Overall Study||0
6541648|NCT01676298|7463240|FG001|NOT COMPLETED|Overall Study||0
6541649|NCT01676298|7463241|FG002|NOT COMPLETED|Overall Study||0
6541650|NCT01676298|7463242|FG003|NOT COMPLETED|Overall Study||0
6541651|NCT01676298|7463243|FG004|NOT COMPLETED|Overall Study||0
6541652|NCT01676298|7463244|FG005|NOT COMPLETED|Overall Study||0
6541653|NCT01676298|7463245|FG006|NOT COMPLETED|Overall Study||0
6541654|NCT01676298|7463246|FG007|NOT COMPLETED|Overall Study||0
6541655|NCT01676311|7463266|FG000|STARTED|Overall Study||7
6541656|NCT01676311|7463267|FG001|STARTED|Overall Study||7
6541657|NCT01676311|7463266|FG000|COMPLETED|Overall Study||7
6541658|NCT01676311|7463267|FG001|COMPLETED|Overall Study||5
6541659|NCT01676311|7463266|FG000|NOT COMPLETED|Overall Study||0
6541660|NCT01676311|7463267|FG001|NOT COMPLETED|Overall Study||2
6541661|NCT01676415|7463275|FG000|STARTED|Overall Study||4
6541662|NCT01676415|7463276|FG001|STARTED|Overall Study||5
6541663|NCT01676415|7463275|FG000|COMPLETED|Overall Study||4
6541664|NCT01676415|7463276|FG001|COMPLETED|Overall Study||5
6541665|NCT01676415|7463275|FG000|NOT COMPLETED|Overall Study||0
6541666|NCT01676415|7463276|FG001|NOT COMPLETED|Overall Study||0
6541667|NCT01676532|7463282|FG000|STARTED|Overall Study||127
6541668|NCT01676532|7463282|FG000|COMPLETED|Overall Study||127
6541669|NCT01676532|7463282|FG000|NOT COMPLETED|Overall Study||0
6541670|NCT01676714|7463291|FG000|STARTED|Overall Study||10
6541671|NCT01676714|7463291|FG000|COMPLETED|Overall Study||10
6541672|NCT01676714|7463291|FG000|NOT COMPLETED|Overall Study||0
6541673|NCT01676727|7463296|FG000|STARTED|Overall Study||100
6541674|NCT01676727|7463296|FG000|Implanted|Overall Study||92
6541675|NCT01676727|7463296|FG000|COMPLETED|Overall Study||68
6541676|NCT01676727|7463296|FG000|NOT COMPLETED|Overall Study||32
6541677|NCT01676831|7463303|FG000|STARTED|Overall Study||8
6541678|NCT01676831|7463304|FG001|STARTED|Overall Study||5
6541679|NCT01676831|7463303|FG000|COMPLETED|Overall Study||8
6541680|NCT01676831|7463304|FG001|COMPLETED|Overall Study||4
6541681|NCT01676831|7463303|FG000|NOT COMPLETED|Overall Study||0
6541682|NCT01676831|7463304|FG001|NOT COMPLETED|Overall Study||1
6541683|NCT01676896|7463313|FG000|STARTED|Overall Study||96
6541684|NCT01676896|7463314|FG001|STARTED|Overall Study||96
6541685|NCT01676896|7463315|FG002|STARTED|Overall Study||100
6541686|NCT01676896|7463313|FG000|COMPLETED|Overall Study||84
6541687|NCT01676896|7463314|FG001|COMPLETED|Overall Study||89
6541688|NCT01676896|7463315|FG002|COMPLETED|Overall Study||81
6541689|NCT01676896|7463313|FG000|NOT COMPLETED|Overall Study||12
6541690|NCT01676896|7463314|FG001|NOT COMPLETED|Overall Study||7
6541691|NCT01676896|7463315|FG002|NOT COMPLETED|Overall Study||19
6541692|NCT01676909|7463325|FG000|STARTED|Overall Study||124
6541693|NCT01676909|7463326|FG001|STARTED|Overall Study||118
6541694|NCT01676909|7463325|FG000|Post-Treatment Assessment|Overall Study|19 not completed (3 withdrawn, 15 timed out, 1 declined)|105
6541695|NCT01676909|7463326|FG001|Post-Treatment Assessment|Overall Study|11 not completed (5 withdrawn, 6 timed out)|107
6541696|NCT01676909|7463325|FG000|COMPLETED|Overall Study|18 not completed (3 withdrawn, 15 timed out)|106
6541697|NCT01676909|7463326|FG001|COMPLETED|Overall Study|14 not completed (5 withdrawn, 9 timed out|104
6541698|NCT01676909|7463325|FG000|NOT COMPLETED|Overall Study||18
6541699|NCT01676909|7463326|FG001|NOT COMPLETED|Overall Study||14
6541700|NCT01677182|7463337|FG000|STARTED|Overall Study||184
6541701|NCT01677182|7463338|FG001|STARTED|Overall Study||169
6541702|NCT01677182|7463339|FG002|STARTED|Overall Study||182
6541703|NCT01677182|7463337|FG000|COMPLETED|Overall Study||150
6541704|NCT01677182|7463338|FG001|COMPLETED|Overall Study||141
6541705|NCT01677182|7463339|FG002|COMPLETED|Overall Study||143
6541706|NCT01677182|7463337|FG000|NOT COMPLETED|Overall Study||34
6541707|NCT01677182|7463338|FG001|NOT COMPLETED|Overall Study||28
6541708|NCT01677182|7463339|FG002|NOT COMPLETED|Overall Study||39
6541709|NCT01677195|7463350|FG000|STARTED|Overall Study||71
6541710|NCT01677195|7463351|FG001|STARTED|Overall Study||83
6541711|NCT01677195|7463352|FG002|STARTED|Overall Study||80
6541712|NCT01677195|7463350|FG000|COMPLETED|Overall Study||42
6541713|NCT01677195|7463351|FG001|COMPLETED|Overall Study||51
6541714|NCT01677195|7463352|FG002|COMPLETED|Overall Study||50
6541715|NCT01677195|7463350|FG000|NOT COMPLETED|Overall Study||29
6541716|NCT01677195|7463351|FG001|NOT COMPLETED|Overall Study||32
6541717|NCT01677195|7463352|FG002|NOT COMPLETED|Overall Study||30
6541718|NCT01677286|7463360|FG000|STARTED|Overall Study||25
6541719|NCT01677286|7463360|FG000|COMPLETED|Overall Study||14
6541720|NCT01677286|7463360|FG000|NOT COMPLETED|Overall Study||11
6541721|NCT01677299|7463370|FG000|STARTED|Overall Study||6
6541722|NCT01677299|7463371|FG001|STARTED|Overall Study||6
6541723|NCT01677299|7463372|FG002|STARTED|Overall Study||6
6541724|NCT01677299|7463373|FG003|STARTED|Overall Study||6
6541725|NCT01677299|7463370|FG000|COMPLETED|Overall Study||6
6541726|NCT01677299|7463371|FG001|COMPLETED|Overall Study||3
6541727|NCT01677299|7463372|FG002|COMPLETED|Overall Study||5
6541728|NCT01677299|7463373|FG003|COMPLETED|Overall Study||5
6541729|NCT01677299|7463370|FG000|NOT COMPLETED|Overall Study||0
6541730|NCT01677299|7463371|FG001|NOT COMPLETED|Overall Study||3
6541731|NCT01677299|7463372|FG002|NOT COMPLETED|Overall Study||1
6541732|NCT01677299|7463373|FG003|NOT COMPLETED|Overall Study||1
6541733|NCT01677312|7463389|FG000|STARTED|Overall Study||36
6541734|NCT01677312|7463390|FG001|STARTED|Overall Study||36
6541735|NCT01677312|7463389|FG000|COMPLETED|Overall Study||36
6541736|NCT01677312|7463390|FG001|COMPLETED|Overall Study||36
6541737|NCT01677312|7463389|FG000|NOT COMPLETED|Overall Study||0
6541738|NCT01677312|7463390|FG001|NOT COMPLETED|Overall Study||0
6541739|NCT01677377|7463399|FG000|STARTED|Overall Study||15
6541740|NCT01677377|7463400|FG001|STARTED|Overall Study||15
6541741|NCT01677377|7463401|FG002|STARTED|Overall Study||15
6541742|NCT01677377|7463399|FG000|COMPLETED|Overall Study||14
6541743|NCT01677377|7463400|FG001|COMPLETED|Overall Study||14
6541744|NCT01677377|7463401|FG002|COMPLETED|Overall Study||9
6541745|NCT01677377|7463399|FG000|NOT COMPLETED|Overall Study||1
6541746|NCT01677377|7463400|FG001|NOT COMPLETED|Overall Study||1
6541747|NCT01677377|7463401|FG002|NOT COMPLETED|Overall Study||6
6541748|NCT01677507|7463409|FG000|STARTED|Initial Assignment||63
6541749|NCT01677507|7463410|FG001|STARTED|Initial Assignment||58
6541750|NCT01677507|7463409|FG000|COMPLETED|Initial Assignment||63
6541751|NCT01677507|7463410|FG001|COMPLETED|Initial Assignment||56
6541752|NCT01677507|7463409|FG000|NOT COMPLETED|Initial Assignment||0
6541753|NCT01677507|7463410|FG001|NOT COMPLETED|Initial Assignment||2
6541754|NCT01677507|7463409|FG000|STARTED|Second Assigment||63
6541755|NCT01677507|7463410|FG001|STARTED|Second Assigment||56
6541756|NCT01677507|7463409|FG000|COMPLETED|Second Assigment||60
6541757|NCT01677507|7463410|FG001|COMPLETED|Second Assigment||51
6541758|NCT01677507|7463409|FG000|NOT COMPLETED|Second Assigment||3
6541759|NCT01677507|7463410|FG001|NOT COMPLETED|Second Assigment||5
6541760|NCT01677624|7463418|FG000|STARTED|Overall Study||28
6541761|NCT01677624|7463418|FG000|COMPLETED|Overall Study||27
6541762|NCT01677624|7463418|FG000|NOT COMPLETED|Overall Study||1
6541763|NCT01677741|7463430|FG000|STARTED|Overall Study||3
6541764|NCT01677741|7463431|FG001|STARTED|Overall Study||10
6541765|NCT01677741|7463432|FG002|STARTED|Overall Study||8
6541766|NCT01677741|7463433|FG003|STARTED|Overall Study||6
6541767|NCT01677741|7463434|FG004|STARTED|Overall Study||17
6541768|NCT01677741|7463435|FG005|STARTED|Overall Study||28
6541769|NCT01677741|7463436|FG006|STARTED|Overall Study||11
6541770|NCT01677741|7463437|FG007|STARTED|Overall Study||2
6541771|NCT01677741|7463430|FG000|DLT Evaluable Population|Overall Study||3
6541772|NCT01677741|7463431|FG001|DLT Evaluable Population|Overall Study||10
6541773|NCT01677741|7463432|FG002|DLT Evaluable Population|Overall Study||8
6541774|NCT01677741|7463433|FG003|DLT Evaluable Population|Overall Study||6
6541775|NCT01677741|7463434|FG004|DLT Evaluable Population|Overall Study||0
6541776|NCT01677741|7463435|FG005|DLT Evaluable Population|Overall Study||0
6541777|NCT01677741|7463436|FG006|DLT Evaluable Population|Overall Study||0
6541778|NCT01677741|7463437|FG007|DLT Evaluable Population|Overall Study||0
6541779|NCT01677741|7463430|FG000|PK Population|Overall Study||3
6541780|NCT01677741|7463431|FG001|PK Population|Overall Study||10
6541781|NCT01677741|7463432|FG002|PK Population|Overall Study||8
6541782|NCT01677741|7463433|FG003|PK Population|Overall Study||6
6541783|NCT01677741|7463434|FG004|PK Population|Overall Study||17
6541784|NCT01677741|7463435|FG005|PK Population|Overall Study||28
6541785|NCT01677741|7463436|FG006|PK Population|Overall Study||11
6541786|NCT01677741|7463437|FG007|PK Population|Overall Study||2
6541787|NCT01677741|7463430|FG000|COMPLETED|Overall Study||0
6541788|NCT01677741|7463431|FG001|COMPLETED|Overall Study||0
6541789|NCT01677741|7463432|FG002|COMPLETED|Overall Study||0
6541790|NCT01677741|7463433|FG003|COMPLETED|Overall Study||0
6541791|NCT01677741|7463434|FG004|COMPLETED|Overall Study||0
6541792|NCT01677741|7463435|FG005|COMPLETED|Overall Study||0
6541793|NCT01677741|7463436|FG006|COMPLETED|Overall Study||0
6541794|NCT01677741|7463437|FG007|COMPLETED|Overall Study||0
6541795|NCT01677741|7463430|FG000|NOT COMPLETED|Overall Study||3
6541796|NCT01677741|7463431|FG001|NOT COMPLETED|Overall Study||10
6541797|NCT01677741|7463432|FG002|NOT COMPLETED|Overall Study||8
6541798|NCT01677741|7463433|FG003|NOT COMPLETED|Overall Study||6
6541799|NCT01677741|7463434|FG004|NOT COMPLETED|Overall Study||17
6541800|NCT01677741|7463435|FG005|NOT COMPLETED|Overall Study||28
6541801|NCT01677741|7463436|FG006|NOT COMPLETED|Overall Study||11
6541802|NCT01677741|7463437|FG007|NOT COMPLETED|Overall Study||2
6541803|NCT01677767|7463471|FG000|STARTED|Overall Study||124
6541804|NCT01677767|7463471|FG000|COMPLETED|Overall Study||102
6541805|NCT01677767|7463471|FG000|NOT COMPLETED|Overall Study||22
6541806|NCT01677858|7463482|FG000|STARTED|Overall Study||3
6541807|NCT01677858|7463483|FG001|STARTED|Overall Study||3
6541808|NCT01677858|7463484|FG002|STARTED|Overall Study||15
6541809|NCT01677858|7463485|FG003|STARTED|Overall Study||6
6541810|NCT01677858|7463486|FG004|STARTED|Overall Study||89
6541811|NCT01677858|7463482|FG000|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
6541812|NCT01677858|7463483|FG001|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
6541813|NCT01677858|7463484|FG002|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
6541814|NCT01677858|7463485|FG003|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
6541815|NCT01677858|7463486|FG004|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
6541816|NCT01677858|7463482|FG000|NOT COMPLETED|Overall Study||3
6541817|NCT01677858|7463483|FG001|NOT COMPLETED|Overall Study||2
6541818|NCT01677858|7463484|FG002|NOT COMPLETED|Overall Study||14
6541819|NCT01677858|7463485|FG003|NOT COMPLETED|Overall Study||6
6646085|NCT02377427|7574990|FG003|STARTED|Part A (Up to Week 20)||0
6541820|NCT01677858|7463486|FG004|NOT COMPLETED|Overall Study||85
6541821|NCT01677910|7463506|FG000|STARTED|Double-Blind Treatment Period||45
6541822|NCT01677910|7463507|FG001|STARTED|Double-Blind Treatment Period||45
6541823|NCT01677910|7463508|FG002|STARTED|Double-Blind Treatment Period||45
6541824|NCT01677910|7463509|FG003|STARTED|Double-Blind Treatment Period||0
6541825|NCT01677910|7463506|FG000|COMPLETED|Double-Blind Treatment Period||38
6541826|NCT01677910|7463507|FG001|COMPLETED|Double-Blind Treatment Period||42
6541827|NCT01677910|7463508|FG002|COMPLETED|Double-Blind Treatment Period||38
6541828|NCT01677910|7463509|FG003|COMPLETED|Double-Blind Treatment Period||0
6541829|NCT01677910|7463506|FG000|NOT COMPLETED|Double-Blind Treatment Period||7
6541830|NCT01677910|7463507|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
6541831|NCT01677910|7463508|FG002|NOT COMPLETED|Double-Blind Treatment Period||7
6541832|NCT01677910|7463509|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
6541833|NCT01677910|7463506|FG000|STARTED|Open-Label Extension Period (OLE)||0
6541834|NCT01677910|7463507|FG001|STARTED|Open-Label Extension Period (OLE)||0
6541835|NCT01677910|7463508|FG002|STARTED|Open-Label Extension Period (OLE)||0
6541836|NCT01677910|7463509|FG003|STARTED|Open-Label Extension Period (OLE)||115
6541837|NCT01677910|7463506|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
6541838|NCT01677910|7463507|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
6541839|NCT01677910|7463508|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
6541840|NCT01677910|7463509|FG003|COMPLETED|Open-Label Extension Period (OLE)||79
6541841|NCT01677910|7463506|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6541842|NCT01677910|7463507|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6541843|NCT01677910|7463508|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6541844|NCT01677910|7463509|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||36
6541845|NCT01677936|7463521|FG000|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
6541846|NCT01677936|7463522|FG001|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
6541847|NCT01677936|7463521|FG000|COMPLETED|Overall Study|Full analysis dataset completers|22
6541848|NCT01677936|7463522|FG001|COMPLETED|Overall Study|Full analysis dataset completers|15
6541849|NCT01677936|7463521|FG000|NOT COMPLETED|Overall Study||9
6541850|NCT01677936|7463522|FG001|NOT COMPLETED|Overall Study||5
6541851|NCT01677988|7463528|FG000|STARTED|Overall Study||3
6541852|NCT01677988|7463528|FG000|COMPLETED|Overall Study||1
6646086|NCT02377427|7574991|FG004|STARTED|Part A (Up to Week 20)||0
6541853|NCT01677988|7463528|FG000|NOT COMPLETED|Overall Study||2
6541854|NCT01678131|7463536|FG000|STARTED|Overall Study||10
6541855|NCT01678131|7463537|FG001|STARTED|Overall Study||10
6541856|NCT01678131|7463538|FG002|STARTED|Overall Study||11
6541857|NCT01678131|7463536|FG000|COMPLETED|Overall Study||10
6541858|NCT01678131|7463537|FG001|COMPLETED|Overall Study||9
6541859|NCT01678131|7463538|FG002|COMPLETED|Overall Study||9
6541860|NCT01678131|7463536|FG000|NOT COMPLETED|Overall Study||0
6541861|NCT01678131|7463537|FG001|NOT COMPLETED|Overall Study||1
6541862|NCT01678131|7463538|FG002|NOT COMPLETED|Overall Study||2
6541863|NCT01678144|7463546|FG000|STARTED|Stage 1: MAR Classic||7
6541864|NCT01678144|7463546|FG000|COMPLETED|Stage 1: MAR Classic||6
6541865|NCT01678144|7463546|FG000|NOT COMPLETED|Stage 1: MAR Classic||1
6541866|NCT01678144|7463546|FG000|STARTED|Stage 2: MAR Regular and MAR Expanded||5
6541867|NCT01678144|7463546|FG000|COMPLETED|Stage 2: MAR Regular and MAR Expanded||5
6541868|NCT01678144|7463546|FG000|NOT COMPLETED|Stage 2: MAR Regular and MAR Expanded||0
6541869|NCT01678196|7463552|FG000|STARTED|Overall Study||34
6541870|NCT01678196|7463553|FG001|STARTED|Overall Study||32
6541871|NCT01678196|7463552|FG000|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
6541872|NCT01678196|7463553|FG001|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
6541873|NCT01678196|7463552|FG000|NOT COMPLETED|Overall Study||0
6541874|NCT01678196|7463553|FG001|NOT COMPLETED|Overall Study||0
6541875|NCT01678209|7463562|FG000|STARTED|Overall Study||47
6541876|NCT01678209|7463563|FG001|STARTED|Overall Study||40
6541877|NCT01678209|7463564|FG002|STARTED|Overall Study||40
6541878|NCT01678209|7463562|FG000|COMPLETED|Overall Study||30
6541879|NCT01678209|7463563|FG001|COMPLETED|Overall Study||22
6541880|NCT01678209|7463564|FG002|COMPLETED|Overall Study||22
6541881|NCT01678209|7463562|FG000|NOT COMPLETED|Overall Study||17
6541882|NCT01678209|7463563|FG001|NOT COMPLETED|Overall Study||18
6541883|NCT01678209|7463564|FG002|NOT COMPLETED|Overall Study||18
6541884|NCT01678313|7463574|FG000|STARTED|Completed the 3-month Therapy||70
6541885|NCT01678313|7463575|FG001|STARTED|Completed the 3-month Therapy||70
6541886|NCT01678313|7463574|FG000|COMPLETED|Completed the 3-month Therapy||64
6541887|NCT01678313|7463575|FG001|COMPLETED|Completed the 3-month Therapy||58
6541888|NCT01678313|7463574|FG000|NOT COMPLETED|Completed the 3-month Therapy||6
6541889|NCT01678313|7463575|FG001|NOT COMPLETED|Completed the 3-month Therapy||12
6541890|NCT01678313|7463574|FG000|STARTED|PSA >4 ng/dL at 3 Months||64
6541891|NCT01678313|7463575|FG001|STARTED|PSA >4 ng/dL at 3 Months||58
6541892|NCT01678313|7463574|FG000|COMPLETED|PSA >4 ng/dL at 3 Months||56
6541893|NCT01678313|7463575|FG001|COMPLETED|PSA >4 ng/dL at 3 Months||49
6541894|NCT01678313|7463574|FG000|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
6541895|NCT01678313|7463575|FG001|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
6541896|NCT01678313|7463574|FG000|STARTED|Prostate Biopsy at 3 Months||56
6541897|NCT01678313|7463575|FG001|STARTED|Prostate Biopsy at 3 Months||49
6541898|NCT01678313|7463574|FG000|COMPLETED|Prostate Biopsy at 3 Months||45
6541899|NCT01678313|7463575|FG001|COMPLETED|Prostate Biopsy at 3 Months||37
6541900|NCT01678313|7463574|FG000|NOT COMPLETED|Prostate Biopsy at 3 Months||11
6541901|NCT01678313|7463575|FG001|NOT COMPLETED|Prostate Biopsy at 3 Months||12
6541902|NCT01678443|7463581|FG000|STARTED|Overall Study||2
6541903|NCT01678443|7463581|FG000|COMPLETED|Overall Study||2
6541904|NCT01678443|7463581|FG000|NOT COMPLETED|Overall Study||0
6541905|NCT01678560|7463587|FG000|STARTED|Overall Study||26
6541906|NCT01678560|7463588|FG001|STARTED|Overall Study||26
6541907|NCT01678560|7463587|FG000|COMPLETED|Overall Study||22
6541908|NCT01678560|7463588|FG001|COMPLETED|Overall Study||20
6541909|NCT01678560|7463587|FG000|NOT COMPLETED|Overall Study||4
6541910|NCT01678560|7463588|FG001|NOT COMPLETED|Overall Study||6
6541911|NCT01678794|7463600|FG000|STARTED|Overall Study||16
6541912|NCT01678794|7463601|FG001|STARTED|Overall Study||17
6541913|NCT01678794|7463600|FG000|COMPLETED|Overall Study||16
6541914|NCT01678794|7463601|FG001|COMPLETED|Overall Study||17
6541915|NCT01678794|7463600|FG000|NOT COMPLETED|Overall Study||0
6541916|NCT01678794|7463601|FG001|NOT COMPLETED|Overall Study||0
6541917|NCT01678807|7463610|FG000|STARTED|Overall Study||65
6541918|NCT01678807|7463611|FG001|STARTED|Overall Study||65
6541919|NCT01678807|7463612|FG002|STARTED|Overall Study||65
6541920|NCT01678807|7463610|FG000|COMPLETED|Overall Study||61
6541921|NCT01678807|7463611|FG001|COMPLETED|Overall Study||60
6541922|NCT01678807|7463612|FG002|COMPLETED|Overall Study||65
6541923|NCT01678807|7463610|FG000|NOT COMPLETED|Overall Study||4
6541924|NCT01678807|7463611|FG001|NOT COMPLETED|Overall Study||5
6541925|NCT01678807|7463612|FG002|NOT COMPLETED|Overall Study||0
6541926|NCT01678820|7463623|FG000|STARTED|Overall Study||100
6541927|NCT01678820|7463624|FG001|STARTED|Overall Study||99
6541928|NCT01678820|7463625|FG002|STARTED|Overall Study||100
6541929|NCT01678820|7463623|FG000|Treated With Double-blind Study Drug|Overall Study||100
6541930|NCT01678820|7463624|FG001|Treated With Double-blind Study Drug|Overall Study||97
6541931|NCT01678820|7463625|FG002|Treated With Double-blind Study Drug|Overall Study||98
6541932|NCT01678820|7463623|FG000|COMPLETED|Overall Study||38
6541933|NCT01678820|7463624|FG001|COMPLETED|Overall Study||36
6541934|NCT01678820|7463625|FG002|COMPLETED|Overall Study||43
6541935|NCT01678820|7463623|FG000|NOT COMPLETED|Overall Study||62
6541936|NCT01678820|7463624|FG001|NOT COMPLETED|Overall Study||63
6541937|NCT01678820|7463625|FG002|NOT COMPLETED|Overall Study||57
6541938|NCT01678846|7463636|FG000|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
6541939|NCT01678846|7463637|FG001|STARTED|Overall Study||1899
6541940|NCT01678846|7463636|FG000|COMPLETED|Overall Study||1921
6541941|NCT01678846|7463637|FG001|COMPLETED|Overall Study||1899
6541942|NCT01678846|7463636|FG000|NOT COMPLETED|Overall Study||0
6541943|NCT01678846|7463637|FG001|NOT COMPLETED|Overall Study||0
6541944|NCT01678885|7463645|FG000|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
6541945|NCT01678885|7463646|FG001|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
6541946|NCT01678885|7463647|FG002|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
6541947|NCT01678885|7463648|FG003|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
6541948|NCT01678885|7463649|FG004|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
6541949|NCT01678885|7463645|FG000|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
6541950|NCT01678885|7463646|FG001|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
6541951|NCT01678885|7463647|FG002|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
6541952|NCT01678885|7463648|FG003|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
6541953|NCT01678885|7463649|FG004|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
6541954|NCT01678885|7463645|FG000|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
6541955|NCT01678885|7463646|FG001|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
6541956|NCT01678885|7463647|FG002|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
6541957|NCT01678885|7463648|FG003|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
6541958|NCT01678885|7463649|FG004|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
6541959|NCT01678885|7463645|FG000|STARTED|Phase II; 8 Week Low Calorie Diet||0
6541960|NCT01678885|7463646|FG001|STARTED|Phase II; 8 Week Low Calorie Diet||0
6541961|NCT01678885|7463647|FG002|STARTED|Phase II; 8 Week Low Calorie Diet||0
6541962|NCT01678885|7463648|FG003|STARTED|Phase II; 8 Week Low Calorie Diet||0
6541963|NCT01678885|7463649|FG004|STARTED|Phase II; 8 Week Low Calorie Diet||87
6541964|NCT01678885|7463645|FG000|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6541965|NCT01678885|7463646|FG001|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6541966|NCT01678885|7463647|FG002|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6541967|NCT01678885|7463648|FG003|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6541968|NCT01678885|7463649|FG004|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
6541969|NCT01678885|7463645|FG000|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6541970|NCT01678885|7463646|FG001|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6541971|NCT01678885|7463647|FG002|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6541972|NCT01678885|7463648|FG003|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
6541973|NCT01678885|7463649|FG004|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
6541974|NCT01678898|7463660|FG000|STARTED|PB-102-F01||6
6541975|NCT01678898|7463661|FG001|STARTED|PB-102-F01||8
6541976|NCT01678898|7463662|FG002|STARTED|PB-102-F01||4
6541977|NCT01678898|7463660|FG000|COMPLETED|PB-102-F01||6
6541978|NCT01678898|7463661|FG001|COMPLETED|PB-102-F01||6
6541979|NCT01678898|7463662|FG002|COMPLETED|PB-102-F01||4
6541980|NCT01678898|7463660|FG000|NOT COMPLETED|PB-102-F01||0
6541981|NCT01678898|7463661|FG001|NOT COMPLETED|PB-102-F01||2
6541982|NCT01678898|7463662|FG002|NOT COMPLETED|PB-102-F01||0
6541983|NCT01678898|7463660|FG000|STARTED|PB-102-F02||6
6541984|NCT01678898|7463661|FG001|STARTED|PB-102-F02||6
6541985|NCT01678898|7463662|FG002|STARTED|PB-102-F02||4
6541986|NCT01678898|7463660|FG000|COMPLETED|PB-102-F02||6
6541987|NCT01678898|7463661|FG001|COMPLETED|PB-102-F02||6
6646087|NCT02377427|7574987|FG000|COMPLETED|Part A (Up to Week 20)||22
6646088|NCT02377427|7574988|FG001|COMPLETED|Part A (Up to Week 20)||10
6646089|NCT02377427|7574989|FG002|COMPLETED|Part A (Up to Week 20)||0
6646090|NCT02377427|7574990|FG003|COMPLETED|Part A (Up to Week 20)||0
6646091|NCT02377427|7574991|FG004|COMPLETED|Part A (Up to Week 20)||0
6646092|NCT02377427|7574987|FG000|NOT COMPLETED|Part A (Up to Week 20)||4
6646093|NCT02377427|7574988|FG001|NOT COMPLETED|Part A (Up to Week 20)||0
6646094|NCT02377427|7574989|FG002|NOT COMPLETED|Part A (Up to Week 20)||0
6646095|NCT02377427|7574990|FG003|NOT COMPLETED|Part A (Up to Week 20)||0
6646096|NCT02377427|7574991|FG004|NOT COMPLETED|Part A (Up to Week 20)||0
6646097|NCT02377427|7574987|FG000|STARTED|Part B (From Week 20 and up to Week 80)||0
6646098|NCT02377427|7574988|FG001|STARTED|Part B (From Week 20 and up to Week 80)||0
6646099|NCT02377427|7574989|FG002|STARTED|Part B (From Week 20 and up to Week 80)|Two participants of PartA chose not to continue in PartB;4 shifted to PartB Mepolizumab 40/100mg arm|16
6646100|NCT02377427|7574990|FG003|STARTED|Part B (From Week 20 and up to Week 80)||10
6646101|NCT02377427|7574991|FG004|STARTED|Part B (From Week 20 and up to Week 80)||4
6646102|NCT02377427|7574987|FG000|COMPLETED|Part B (From Week 20 and up to Week 80)||0
6646103|NCT02377427|7574988|FG001|COMPLETED|Part B (From Week 20 and up to Week 80)||0
6646104|NCT02377427|7574989|FG002|COMPLETED|Part B (From Week 20 and up to Week 80)||15
6646105|NCT02377427|7574990|FG003|COMPLETED|Part B (From Week 20 and up to Week 80)||10
6646106|NCT02377427|7574991|FG004|COMPLETED|Part B (From Week 20 and up to Week 80)||4
6646107|NCT02377427|7574987|FG000|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
6646108|NCT02377427|7574988|FG001|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
6646109|NCT02377427|7574989|FG002|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||1
6646110|NCT02377427|7574990|FG003|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
6646111|NCT02377427|7574991|FG004|NOT COMPLETED|Part B (From Week 20 and up to Week 80)||0
6646112|NCT02377466|7575006|FG000|STARTED|Overall Study||13
6646113|NCT02377466|7575007|FG001|STARTED|Overall Study||12
6646114|NCT02377466|7575006|FG000|Treated|Overall Study||13
6646115|NCT02377466|7575007|FG001|Treated|Overall Study||10
6646116|NCT02377466|7575006|FG000|COMPLETED|Overall Study||13
6646117|NCT02377466|7575007|FG001|COMPLETED|Overall Study||10
6646118|NCT02377466|7575006|FG000|NOT COMPLETED|Overall Study||0
6541988|NCT01678898|7463662|FG002|COMPLETED|PB-102-F02||4
6541989|NCT01678898|7463660|FG000|NOT COMPLETED|PB-102-F02||0
6541990|NCT01678898|7463661|FG001|NOT COMPLETED|PB-102-F02||0
6541991|NCT01678898|7463662|FG002|NOT COMPLETED|PB-102-F02||0
6541992|NCT01678911|7463679|FG000|STARTED|First Intervention||4
6541993|NCT01678911|7463680|FG001|STARTED|First Intervention||1
6541994|NCT01678911|7463679|FG000|Cross Over|First Intervention||4
6541995|NCT01678911|7463680|FG001|Cross Over|First Intervention||1
6541996|NCT01678911|7463679|FG000|COMPLETED|First Intervention||4
6541997|NCT01678911|7463680|FG001|COMPLETED|First Intervention||1
6541998|NCT01678911|7463679|FG000|NOT COMPLETED|First Intervention||0
6541999|NCT01678911|7463680|FG001|NOT COMPLETED|First Intervention||0
6542000|NCT01678911|7463679|FG000|STARTED|Second Intervention||4
6542001|NCT01678911|7463680|FG001|STARTED|Second Intervention||1
6542002|NCT01678911|7463679|FG000|COMPLETED|Second Intervention||2
6542003|NCT01678911|7463680|FG001|COMPLETED|Second Intervention||1
6542004|NCT01678911|7463679|FG000|NOT COMPLETED|Second Intervention||2
6542005|NCT01678911|7463680|FG001|NOT COMPLETED|Second Intervention||0
6646119|NCT02377466|7575007|FG001|NOT COMPLETED|Overall Study||2
6646120|NCT02377674|7575020|FG000|STARTED|Overall Study||5
6646121|NCT02377674|7575020|FG000|COMPLETED|Overall Study||5
6646122|NCT02377674|7575020|FG000|NOT COMPLETED|Overall Study||0
6646123|NCT02377700|7575024|FG000|STARTED|Overall Study||5
6646124|NCT02377700|7575024|FG000|COMPLETED|Overall Study||5
6646125|NCT02377700|7575024|FG000|NOT COMPLETED|Overall Study||0
6646126|NCT02377752|7575032|FG000|STARTED|Overall Study||7
6542006|NCT01678924|7463690|FG000|STARTED|Overall Study||64
6542007|NCT01678924|7463691|FG001|STARTED|Overall Study||63
6542008|NCT01678924|7463692|FG002|STARTED|Overall Study||30
6542009|NCT01678924|7463693|FG003|STARTED|Overall Study||123
6542010|NCT01678924|7463690|FG000|COMPLETED|Overall Study||54
6542011|NCT01678924|7463691|FG001|COMPLETED|Overall Study||51
6542012|NCT01678924|7463692|FG002|COMPLETED|Overall Study||28
6542013|NCT01678924|7463693|FG003|COMPLETED|Overall Study||105
6542014|NCT01678924|7463690|FG000|NOT COMPLETED|Overall Study||10
6542015|NCT01678924|7463691|FG001|NOT COMPLETED|Overall Study||12
6542016|NCT01678924|7463692|FG002|NOT COMPLETED|Overall Study||2
6542017|NCT01678924|7463693|FG003|NOT COMPLETED|Overall Study||18
6542018|NCT01678976|7463706|FG000|STARTED|First Period||6
6542019|NCT01678976|7463707|FG001|STARTED|First Period||7
6542020|NCT01678976|7463706|FG000|COMPLETED|First Period||6
6542021|NCT01678976|7463707|FG001|COMPLETED|First Period||6
6542022|NCT01678976|7463706|FG000|NOT COMPLETED|First Period||0
6542023|NCT01678976|7463707|FG001|NOT COMPLETED|First Period||1
6646127|NCT02377752|7575033|FG001|STARTED|Overall Study||6
6646128|NCT02377752|7575034|FG002|STARTED|Overall Study||6
6646129|NCT02377752|7575035|FG003|STARTED|Overall Study||6
6646130|NCT02377752|7575032|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
6646131|NCT02377752|7575033|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6646132|NCT02377752|7575034|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6646133|NCT02377752|7575035|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6646134|NCT02377752|7575032|FG000|COMPLETED|Overall Study||7
6646135|NCT02377752|7575033|FG001|COMPLETED|Overall Study||6
6646136|NCT02377752|7575034|FG002|COMPLETED|Overall Study||6
6646137|NCT02377752|7575035|FG003|COMPLETED|Overall Study||6
6646138|NCT02377752|7575032|FG000|NOT COMPLETED|Overall Study||0
6646139|NCT02377752|7575033|FG001|NOT COMPLETED|Overall Study||0
6646140|NCT02377752|7575034|FG002|NOT COMPLETED|Overall Study||0
6646141|NCT02377752|7575035|FG003|NOT COMPLETED|Overall Study||0
6646142|NCT02377817|7575050|FG000|STARTED|Overall Study||13
6646143|NCT02377817|7575051|FG001|STARTED|Overall Study||10
6646144|NCT02377817|7575050|FG000|COMPLETED|Overall Study||10
6646145|NCT02377817|7575051|FG001|COMPLETED|Overall Study||10
6646146|NCT02377817|7575050|FG000|NOT COMPLETED|Overall Study||3
6646147|NCT02377817|7575051|FG001|NOT COMPLETED|Overall Study||0
6646148|NCT02377921|7575061|FG000|STARTED|Overall Study||45
6646149|NCT02377921|7575062|FG001|STARTED|Overall Study||44
6646150|NCT02377921|7575061|FG000|COMPLETED|Overall Study||44
6646151|NCT02377921|7575062|FG001|COMPLETED|Overall Study||43
6646152|NCT02377921|7575061|FG000|NOT COMPLETED|Overall Study||1
6646153|NCT02377921|7575062|FG001|NOT COMPLETED|Overall Study||1
6646154|NCT02377947|7575068|FG000|STARTED|Overall Study||50
6646155|NCT02377947|7575068|FG000|COMPLETED|Overall Study||50
6646156|NCT02377947|7575068|FG000|NOT COMPLETED|Overall Study||0
6646157|NCT02377986|7575072|FG000|STARTED|Overall Study||5
6646158|NCT02377986|7575072|FG000|COMPLETED|Overall Study||5
6646159|NCT02377986|7575072|FG000|NOT COMPLETED|Overall Study||0
6646160|NCT02378025|7575078|FG000|STARTED|Overall Study||39
6542024|NCT01678976|7463706|FG000|STARTED|Second Period||6
6542025|NCT01678976|7463707|FG001|STARTED|Second Period||6
6542026|NCT01678976|7463706|FG000|COMPLETED|Second Period||6
6542027|NCT01678976|7463707|FG001|COMPLETED|Second Period||6
6542028|NCT01678976|7463706|FG000|NOT COMPLETED|Second Period||0
6646161|NCT02378025|7575079|FG001|STARTED|Overall Study||36
6646162|NCT02378025|7575078|FG000|COMPLETED|Overall Study||26
6646163|NCT02378025|7575079|FG001|COMPLETED|Overall Study||15
6542029|NCT01678976|7463707|FG001|NOT COMPLETED|Second Period||0
6542030|NCT01679002|7463719|FG000|STARTED|Overall Study||4
6542031|NCT01679002|7463720|FG001|STARTED|Overall Study||4
6542032|NCT01679002|7463721|FG002|STARTED|Overall Study||4
6542033|NCT01679002|7463719|FG000|BIA 2-093 900 mg Once-daily Period|Overall Study||4
6646164|NCT02378025|7575078|FG000|NOT COMPLETED|Overall Study||13
6542034|NCT01679002|7463720|FG001|BIA 2-093 900 mg Once-daily Period|Overall Study||3
6542035|NCT01679002|7463721|FG002|BIA 2-093 900 mg Once-daily Period|Overall Study||4
6542036|NCT01679002|7463719|FG000|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
6542037|NCT01679002|7463720|FG001|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
6542038|NCT01679002|7463721|FG002|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
6542039|NCT01679002|7463719|FG000|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
6542040|NCT01679002|7463720|FG001|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
6542041|NCT01679002|7463721|FG002|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
6542042|NCT01679002|7463719|FG000|COMPLETED|Overall Study||3
6542043|NCT01679002|7463720|FG001|COMPLETED|Overall Study||3
6542044|NCT01679002|7463721|FG002|COMPLETED|Overall Study||4
6542045|NCT01679002|7463719|FG000|NOT COMPLETED|Overall Study||1
6542046|NCT01679002|7463720|FG001|NOT COMPLETED|Overall Study||1
6542047|NCT01679002|7463721|FG002|NOT COMPLETED|Overall Study||0
6542048|NCT01679028|7463735|FG000|STARTED|Overall Study||2
6542049|NCT01679028|7463736|FG001|STARTED|Overall Study||4
6542050|NCT01679028|7463737|FG002|STARTED|Overall Study||2
6542051|NCT01679028|7463738|FG003|STARTED|Overall Study||4
6542052|NCT01679028|7463739|FG004|STARTED|Overall Study||2
6542053|NCT01679028|7463740|FG005|STARTED|Overall Study||6
6542054|NCT01679028|7463735|FG000|COMPLETED|Overall Study||2
6542055|NCT01679028|7463736|FG001|COMPLETED|Overall Study||4
6542056|NCT01679028|7463737|FG002|COMPLETED|Overall Study||2
6542057|NCT01679028|7463738|FG003|COMPLETED|Overall Study||4
6542058|NCT01679028|7463739|FG004|COMPLETED|Overall Study||2
6542059|NCT01679028|7463740|FG005|COMPLETED|Overall Study||6
6542060|NCT01679028|7463735|FG000|NOT COMPLETED|Overall Study||0
6542061|NCT01679028|7463736|FG001|NOT COMPLETED|Overall Study||0
6542062|NCT01679028|7463737|FG002|NOT COMPLETED|Overall Study||0
6542063|NCT01679028|7463738|FG003|NOT COMPLETED|Overall Study||0
6542064|NCT01679028|7463739|FG004|NOT COMPLETED|Overall Study||0
6542065|NCT01679028|7463740|FG005|NOT COMPLETED|Overall Study||0
6646165|NCT02378025|7575079|FG001|NOT COMPLETED|Overall Study||21
6646166|NCT02378038|7575085|FG000|STARTED|Overall Study||5
6646167|NCT02378038|7575085|FG000|COMPLETED|Overall Study||0
6646168|NCT02378038|7575085|FG000|NOT COMPLETED|Overall Study||5
6646169|NCT02378207|7575093|FG000|STARTED|Overall Study||24
6646170|NCT02378207|7575094|FG001|STARTED|Overall Study||24
6646171|NCT02378207|7575095|FG002|STARTED|Overall Study||24
6646172|NCT02378207|7575096|FG003|STARTED|Overall Study||12
6646173|NCT02378207|7575093|FG000|COMPLETED|Overall Study||24
6743775|NCT03335254|7671812|FG002|COMPLETED|Period 3, Day 26-30||0
6743776|NCT03335254|7671813|FG003|COMPLETED|Period 3, Day 26-30||0
6743777|NCT03335254|7671814|FG004|COMPLETED|Period 3, Day 26-30||0
6743778|NCT03335254|7671815|FG005|COMPLETED|Period 3, Day 26-30||0
6743779|NCT03335254|7671816|FG006|COMPLETED|Period 3, Day 26-30||0
6743780|NCT03335254|7671817|FG007|COMPLETED|Period 3, Day 26-30||0
6743781|NCT03335254|7671818|FG008|COMPLETED|Period 3, Day 26-30||0
6743782|NCT03335254|7671819|FG009|COMPLETED|Period 3, Day 26-30||0
6743783|NCT03335254|7671820|FG010|COMPLETED|Period 3, Day 26-30||0
6743784|NCT03335254|7671821|FG011|COMPLETED|Period 3, Day 26-30||0
6743785|NCT03335254|7671822|FG012|COMPLETED|Period 3, Day 26-30||0
6743786|NCT03335254|7671823|FG013|COMPLETED|Period 3, Day 26-30||0
6743787|NCT03335254|7671824|FG014|COMPLETED|Period 3, Day 26-30||0
6743788|NCT03335254|7671825|FG015|COMPLETED|Period 3, Day 26-30||0
6743789|NCT03335254|7671826|FG016|COMPLETED|Period 3, Day 26-30||0
6743790|NCT03335254|7671827|FG017|COMPLETED|Period 3, Day 26-30||0
6743791|NCT03335254|7671828|FG018|COMPLETED|Period 3, Day 26-30||0
6743792|NCT03335254|7671829|FG019|COMPLETED|Period 3, Day 26-30||0
6743793|NCT03335254|7671810|FG000|NOT COMPLETED|Period 3, Day 26-30||0
6743794|NCT03335254|7671811|FG001|NOT COMPLETED|Period 3, Day 26-30||0
6743795|NCT03335254|7671812|FG002|NOT COMPLETED|Period 3, Day 26-30||0
6743796|NCT03335254|7671813|FG003|NOT COMPLETED|Period 3, Day 26-30||0
6743797|NCT03335254|7671814|FG004|NOT COMPLETED|Period 3, Day 26-30||0
6743798|NCT03335254|7671815|FG005|NOT COMPLETED|Period 3, Day 26-30||0
6743799|NCT03335254|7671816|FG006|NOT COMPLETED|Period 3, Day 26-30||0
6743800|NCT03335254|7671817|FG007|NOT COMPLETED|Period 3, Day 26-30||0
6743801|NCT03335254|7671818|FG008|NOT COMPLETED|Period 3, Day 26-30||0
6743802|NCT03335254|7671819|FG009|NOT COMPLETED|Period 3, Day 26-30||0
6743803|NCT03335254|7671820|FG010|NOT COMPLETED|Period 3, Day 26-30||0
6743804|NCT03335254|7671821|FG011|NOT COMPLETED|Period 3, Day 26-30||0
6743805|NCT03335254|7671822|FG012|NOT COMPLETED|Period 3, Day 26-30||0
6743806|NCT03335254|7671823|FG013|NOT COMPLETED|Period 3, Day 26-30||0
6743807|NCT03335254|7671824|FG014|NOT COMPLETED|Period 3, Day 26-30||0
6743808|NCT03335254|7671825|FG015|NOT COMPLETED|Period 3, Day 26-30||0
6562368|NCT01800916|7485362|FG000|STARTED|Test Period 1 (1 Week)||7
6562369|NCT01800916|7485363|FG001|STARTED|Test Period 1 (1 Week)||7
6562370|NCT01800916|7485364|FG002|STARTED|Test Period 1 (1 Week)||7
6646174|NCT02378207|7575094|FG001|COMPLETED|Overall Study||21
6646175|NCT02378207|7575095|FG002|COMPLETED|Overall Study||22
6646176|NCT02378207|7575096|FG003|COMPLETED|Overall Study||11
6646177|NCT02378207|7575093|FG000|NOT COMPLETED|Overall Study||0
6743809|NCT03335254|7671826|FG016|NOT COMPLETED|Period 3, Day 26-30||0
6743810|NCT03335254|7671827|FG017|NOT COMPLETED|Period 3, Day 26-30||0
6743811|NCT03335254|7671828|FG018|NOT COMPLETED|Period 3, Day 26-30||0
6743812|NCT03335254|7671829|FG019|NOT COMPLETED|Period 3, Day 26-30||0
6743813|NCT03335566|7671860|FG000|STARTED|Overall Study||218
6743814|NCT03335566|7671861|FG001|STARTED|Overall Study||206
6743815|NCT03335566|7671860|FG000|COMPLETED|Overall Study||214
6542066|NCT01679197|7463754|FG000|STARTED|Overall Study||23
6542067|NCT01679197|7463754|FG000|COMPLETED|Overall Study||19
6542068|NCT01679197|7463754|FG000|NOT COMPLETED|Overall Study||4
6542069|NCT01679236|7463766|FG000|STARTED|Overall Study||30
6542070|NCT01679236|7463767|FG001|STARTED|Overall Study||25
6542071|NCT01679236|7463766|FG000|COMPLETED|Overall Study||15
6542072|NCT01679236|7463767|FG001|COMPLETED|Overall Study||10
6542073|NCT01679236|7463766|FG000|NOT COMPLETED|Overall Study||15
6542074|NCT01679236|7463767|FG001|NOT COMPLETED|Overall Study||15
6542075|NCT01679301|7463773|FG000|STARTED|Screening Period||11
6542076|NCT01679301|7463774|FG001|STARTED|Screening Period||0
6542077|NCT01679301|7463775|FG002|STARTED|Screening Period||0
6542078|NCT01679301|7463773|FG000|COMPLETED|Screening Period||8
6542079|NCT01679301|7463774|FG001|COMPLETED|Screening Period||0
6542080|NCT01679301|7463775|FG002|COMPLETED|Screening Period||0
6542081|NCT01679301|7463773|FG000|NOT COMPLETED|Screening Period||3
6542082|NCT01679301|7463774|FG001|NOT COMPLETED|Screening Period||0
6542083|NCT01679301|7463775|FG002|NOT COMPLETED|Screening Period||0
6542084|NCT01679301|7463773|FG000|STARTED|Study Period||0
6542085|NCT01679301|7463774|FG001|STARTED|Study Period||4
6542086|NCT01679301|7463775|FG002|STARTED|Study Period||4
6542087|NCT01679301|7463773|FG000|COMPLETED|Study Period||0
6542088|NCT01679301|7463774|FG001|COMPLETED|Study Period||4
6542089|NCT01679301|7463775|FG002|COMPLETED|Study Period||4
6542090|NCT01679301|7463773|FG000|NOT COMPLETED|Study Period||0
6542091|NCT01679301|7463774|FG001|NOT COMPLETED|Study Period||0
6542092|NCT01679301|7463775|FG002|NOT COMPLETED|Study Period||0
6542093|NCT01679314|7463783|FG000|STARTED|Overall Study||26
6542094|NCT01679314|7463784|FG001|STARTED|Overall Study||28
6542095|NCT01679314|7463783|FG000|COMPLETED|Overall Study||24
6542096|NCT01679314|7463784|FG001|COMPLETED|Overall Study||28
6542097|NCT01679314|7463783|FG000|NOT COMPLETED|Overall Study||2
6542098|NCT01679314|7463784|FG001|NOT COMPLETED|Overall Study||0
6542099|NCT01679405|7463796|FG000|STARTED|Overall Study||3
6542100|NCT01679405|7463797|FG001|STARTED|Overall Study||6
6542101|NCT01679405|7463796|FG000|COMPLETED|Overall Study||1
6542102|NCT01679405|7463797|FG001|COMPLETED|Overall Study||1
6542103|NCT01679405|7463796|FG000|NOT COMPLETED|Overall Study||2
6542104|NCT01679405|7463797|FG001|NOT COMPLETED|Overall Study||5
6542105|NCT01679600|7463805|FG000|STARTED|Overall Study||7
6542106|NCT01679600|7463806|FG001|STARTED|Overall Study||7
6542107|NCT01679600|7463805|FG000|COMPLETED|Overall Study||7
6542108|NCT01679600|7463806|FG001|COMPLETED|Overall Study||7
6542109|NCT01679600|7463805|FG000|NOT COMPLETED|Overall Study||0
6542110|NCT01679600|7463806|FG001|NOT COMPLETED|Overall Study||0
6542111|NCT01679613|7463812|FG000|STARTED|Overall Study||4
6542112|NCT01679613|7463813|FG001|STARTED|Overall Study||4
6542113|NCT01679613|7463814|FG002|STARTED|Overall Study||13
6542114|NCT01679613|7463815|FG003|STARTED|Overall Study||13
6542115|NCT01679613|7463812|FG000|Received Nintedanib (Pilot)|Overall Study||4
6542116|NCT01679613|7463813|FG001|Received Nintedanib (Pilot)|Overall Study||3
6542117|NCT01679613|7463814|FG002|Received Nintedanib (Pilot)|Overall Study||0
6542118|NCT01679613|7463815|FG003|Received Nintedanib (Pilot)|Overall Study||0
6542119|NCT01679613|7463812|FG000|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
6542120|NCT01679613|7463813|FG001|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
6542121|NCT01679613|7463814|FG002|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
6542122|NCT01679613|7463815|FG003|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
6542123|NCT01679613|7463812|FG000|Received Nintedanib (Main)|Overall Study||0
6542124|NCT01679613|7463813|FG001|Received Nintedanib (Main)|Overall Study||0
6542125|NCT01679613|7463814|FG002|Received Nintedanib (Main)|Overall Study||13
6542126|NCT01679613|7463815|FG003|Received Nintedanib (Main)|Overall Study||11
6542127|NCT01679613|7463812|FG000|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
6542128|NCT01679613|7463813|FG001|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
6542129|NCT01679613|7463814|FG002|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
6542130|NCT01679613|7463815|FG003|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
6542131|NCT01679613|7463812|FG000|COMPLETED|Overall Study||4
6542132|NCT01679613|7463813|FG001|COMPLETED|Overall Study||3
6542133|NCT01679613|7463814|FG002|COMPLETED|Overall Study||11
6542134|NCT01679613|7463815|FG003|COMPLETED|Overall Study||11
6542135|NCT01679613|7463812|FG000|NOT COMPLETED|Overall Study||0
6542136|NCT01679613|7463813|FG001|NOT COMPLETED|Overall Study||1
6542137|NCT01679613|7463814|FG002|NOT COMPLETED|Overall Study||2
6542138|NCT01679613|7463815|FG003|NOT COMPLETED|Overall Study||2
6542139|NCT01680016|7463824|FG000|STARTED|Overall Study||121
6542140|NCT01680016|7463825|FG001|STARTED|Overall Study||122
6542141|NCT01680016|7463826|FG002|STARTED|Overall Study||201
6542142|NCT01680016|7463827|FG003|STARTED|Overall Study||200
6542143|NCT01680016|7463824|FG000|COMPLETED|Overall Study||115
6542144|NCT01680016|7463825|FG001|COMPLETED|Overall Study||114
6542145|NCT01680016|7463826|FG002|COMPLETED|Overall Study||196
6542146|NCT01680016|7463827|FG003|COMPLETED|Overall Study||195
6542147|NCT01680016|7463824|FG000|NOT COMPLETED|Overall Study||6
6542148|NCT01680016|7463825|FG001|NOT COMPLETED|Overall Study||8
6542149|NCT01680016|7463826|FG002|NOT COMPLETED|Overall Study||5
6542150|NCT01680016|7463827|FG003|NOT COMPLETED|Overall Study||5
6542151|NCT01680159|7463853|FG000|STARTED|Screening Period||46
6542152|NCT01680159|7463853|FG000|COMPLETED|Screening Period||39
6542153|NCT01680159|7463853|FG000|NOT COMPLETED|Screening Period||7
6542154|NCT01680159|7463853|FG000|STARTED|Increased Dose Period||51
6542155|NCT01680159|7463853|FG000|COMPLETED|Increased Dose Period||43
6542156|NCT01680159|7463853|FG000|NOT COMPLETED|Increased Dose Period||8
6542157|NCT01680172|7463875|FG000|STARTED|Overall Study||3
6542158|NCT01680172|7463876|FG001|STARTED|Overall Study||2
6542159|NCT01680172|7463875|FG000|COMPLETED|Overall Study||3
6542160|NCT01680172|7463876|FG001|COMPLETED|Overall Study||2
6542161|NCT01680172|7463875|FG000|NOT COMPLETED|Overall Study||0
6542162|NCT01680172|7463876|FG001|NOT COMPLETED|Overall Study||0
6542163|NCT01680328|7463882|FG000|STARTED|Overall Study||82
6542164|NCT01680328|7463882|FG000|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
6542165|NCT01680328|7463882|FG000|COMPLETED|Overall Study||80
6542166|NCT01680328|7463882|FG000|NOT COMPLETED|Overall Study||2
6542167|NCT01680341|7463919|FG000|STARTED|Overall Study||136
6542168|NCT01680341|7463920|FG001|STARTED|Overall Study||136
6542169|NCT01680341|7463919|FG000|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
6542170|NCT01680341|7463920|FG001|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
6542171|NCT01680341|7463919|FG000|COMPLETED|Overall Study||115
6542172|NCT01680341|7463920|FG001|COMPLETED|Overall Study||119
6542173|NCT01680341|7463919|FG000|NOT COMPLETED|Overall Study||21
6542174|NCT01680341|7463920|FG001|NOT COMPLETED|Overall Study||17
6542175|NCT01680458|7463926|FG000|STARTED|Overall Study||30
6542176|NCT01680458|7463926|FG000|COMPLETED|Overall Study||27
6542177|NCT01680458|7463926|FG000|NOT COMPLETED|Overall Study||3
6542178|NCT01680497|7463930|FG000|STARTED|Overall Study||70
6542179|NCT01680497|7463930|FG000|COMPLETED|Overall Study||68
6542180|NCT01680497|7463930|FG000|NOT COMPLETED|Overall Study||2
6542181|NCT01680549|7463936|FG000|STARTED|Overall Study||25
6542182|NCT01680549|7463937|FG001|STARTED|Overall Study||25
6542183|NCT01680549|7463936|FG000|COMPLETED|Overall Study||20
6542184|NCT01680549|7463937|FG001|COMPLETED|Overall Study||17
6542185|NCT01680549|7463936|FG000|NOT COMPLETED|Overall Study||5
6542186|NCT01680549|7463937|FG001|NOT COMPLETED|Overall Study||8
6542187|NCT01680640|7463951|FG000|STARTED|Overall Study||55
6542188|NCT01680640|7463952|FG001|STARTED|Overall Study||49
6542189|NCT01680640|7463951|FG000|COMPLETED|Overall Study||45
6542190|NCT01680640|7463952|FG001|COMPLETED|Overall Study||44
6542191|NCT01680640|7463951|FG000|NOT COMPLETED|Overall Study||10
6542192|NCT01680640|7463952|FG001|NOT COMPLETED|Overall Study||5
6542193|NCT01680653|7463958|FG000|STARTED|Overall Study||57
6542194|NCT01680653|7463958|FG000|COMPLETED|Overall Study||57
6542195|NCT01680653|7463958|FG000|NOT COMPLETED|Overall Study||0
6542196|NCT01680666|7463970|FG000|STARTED|Overall Study||84
6542197|NCT01680666|7463971|FG001|STARTED|Overall Study||66
6542198|NCT01680666|7463970|FG000|COMPLETED|Overall Study||84
6542199|NCT01680666|7463971|FG001|COMPLETED|Overall Study||66
6542200|NCT01680666|7463970|FG000|NOT COMPLETED|Overall Study||0
6542201|NCT01680666|7463971|FG001|NOT COMPLETED|Overall Study||0
6542202|NCT01680783|7463980|FG000|STARTED|Overall Study||39
6542203|NCT01680783|7463981|FG001|STARTED|Overall Study||44
6542204|NCT01680783|7463980|FG000|COMPLETED|Overall Study||39
6542205|NCT01680783|7463981|FG001|COMPLETED|Overall Study||44
6542206|NCT01680783|7463980|FG000|NOT COMPLETED|Overall Study||0
6542207|NCT01680783|7463981|FG001|NOT COMPLETED|Overall Study||0
6542208|NCT01680835|7463987|FG000|STARTED|Overall Study||108
6542209|NCT01680835|7463987|FG000|COMPLETED|Overall Study||83
6542210|NCT01680835|7463987|FG000|NOT COMPLETED|Overall Study||25
6542211|NCT01680848|7463991|FG000|STARTED|Overall Study||282
6542212|NCT01680848|7463991|FG000|COMPLETED|Overall Study||189
6542213|NCT01680848|7463991|FG000|NOT COMPLETED|Overall Study||93
6542214|NCT01680861|7463997|FG000|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
6542215|NCT01680861|7463998|FG001|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
6542216|NCT01680861|7463997|FG000|COMPLETED|Early Post-transplant Period||15
6542217|NCT01680861|7463998|FG001|COMPLETED|Early Post-transplant Period||15
6542218|NCT01680861|7463997|FG000|NOT COMPLETED|Early Post-transplant Period||1
6542219|NCT01680861|7463998|FG001|NOT COMPLETED|Early Post-transplant Period||1
6542220|NCT01680861|7463997|FG000|STARTED|First 12 Months Post-transplant||15
6542221|NCT01680861|7463998|FG001|STARTED|First 12 Months Post-transplant||15
6542222|NCT01680861|7463997|FG000|COMPLETED|First 12 Months Post-transplant||15
6542223|NCT01680861|7463998|FG001|COMPLETED|First 12 Months Post-transplant||15
6542224|NCT01680861|7463997|FG000|NOT COMPLETED|First 12 Months Post-transplant||0
6542225|NCT01680861|7463998|FG001|NOT COMPLETED|First 12 Months Post-transplant||0
6542226|NCT01680887|7464008|FG000|STARTED|Overall Study||80
6542227|NCT01680887|7464009|FG001|STARTED|Overall Study||76
6542228|NCT01680887|7464008|FG000|COMPLETED|Overall Study||51
6542229|NCT01680887|7464009|FG001|COMPLETED|Overall Study||52
6542230|NCT01680887|7464008|FG000|NOT COMPLETED|Overall Study||29
6542231|NCT01680887|7464009|FG001|NOT COMPLETED|Overall Study||24
6542232|NCT01680900|7464017|FG000|STARTED|Overall Study||24
6542233|NCT01680900|7464018|FG001|STARTED|Overall Study||12
6542234|NCT01680900|7464017|FG000|COMPLETED|Overall Study||20
6542235|NCT01680900|7464018|FG001|COMPLETED|Overall Study||11
6542236|NCT01680900|7464017|FG000|NOT COMPLETED|Overall Study||4
6542237|NCT01680900|7464018|FG001|NOT COMPLETED|Overall Study||1
6542238|NCT01680991|7464027|FG000|STARTED|Overall Study||12
6542239|NCT01680991|7464028|FG001|STARTED|Overall Study||23
6542240|NCT01680991|7464029|FG002|STARTED|Overall Study||13
6542241|NCT01680991|7464027|FG000|COMPLETED|Overall Study||4
6542242|NCT01680991|7464028|FG001|COMPLETED|Overall Study||4
6542243|NCT01680991|7464029|FG002|COMPLETED|Overall Study||9
6542244|NCT01680991|7464027|FG000|NOT COMPLETED|Overall Study||8
6542245|NCT01680991|7464028|FG001|NOT COMPLETED|Overall Study||19
6542246|NCT01680991|7464029|FG002|NOT COMPLETED|Overall Study||4
6542247|NCT01681004|7464041|FG000|STARTED|Primary Endpoint: 6 Months||102
6542248|NCT01681004|7464042|FG001|STARTED|Primary Endpoint: 6 Months||46
6542249|NCT01681004|7464041|FG000|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
6542250|NCT01681004|7464042|FG001|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
6542251|NCT01681004|7464041|FG000|COMPLETED|Primary Endpoint: 6 Months||101
6542252|NCT01681004|7464042|FG001|COMPLETED|Primary Endpoint: 6 Months||44
6542253|NCT01681004|7464041|FG000|NOT COMPLETED|Primary Endpoint: 6 Months||1
6542254|NCT01681004|7464042|FG001|NOT COMPLETED|Primary Endpoint: 6 Months||2
6542255|NCT01681004|7464041|FG000|STARTED|Study Completion||101
6542256|NCT01681004|7464042|FG001|STARTED|Study Completion||44
6542257|NCT01681004|7464041|FG000|COMPLETED|Study Completion||89
6542258|NCT01681004|7464042|FG001|COMPLETED|Study Completion||36
6542259|NCT01681004|7464041|FG000|NOT COMPLETED|Study Completion||12
6542260|NCT01681004|7464042|FG001|NOT COMPLETED|Study Completion||8
6542261|NCT01681030|7464055|FG000|STARTED|Overall Study||13
6542262|NCT01681030|7464056|FG001|STARTED|Overall Study||18
6542263|NCT01681030|7464057|FG002|STARTED|Overall Study||11
6542264|NCT01681030|7464055|FG000|COMPLETED|Overall Study||13
6542265|NCT01681030|7464056|FG001|COMPLETED|Overall Study||18
6542266|NCT01681030|7464057|FG002|COMPLETED|Overall Study||11
6542267|NCT01681030|7464055|FG000|NOT COMPLETED|Overall Study||0
6542268|NCT01681030|7464056|FG001|NOT COMPLETED|Overall Study||0
6542269|NCT01681030|7464057|FG002|NOT COMPLETED|Overall Study||0
6542270|NCT01681069|7464067|FG000|STARTED|Overall Study||60
6542271|NCT01681069|7464068|FG001|STARTED|Overall Study||60
6542272|NCT01681069|7464067|FG000|Full Analysis Set (FAS)|Overall Study||57
6542273|NCT01681069|7464068|FG001|Full Analysis Set (FAS)|Overall Study||60
6542274|NCT01681069|7464067|FG000|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
6542275|NCT01681069|7464068|FG001|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
6542276|NCT01681069|7464067|FG000|NOT COMPLETED|Overall Study||5
6542277|NCT01681069|7464068|FG001|NOT COMPLETED|Overall Study||7
6542278|NCT01681095|7464076|FG000|STARTED|Overall Study||55
6542279|NCT01681095|7464077|FG001|STARTED|Overall Study||55
6542280|NCT01681095|7464076|FG000|COMPLETED|Overall Study||55
6542281|NCT01681095|7464077|FG001|COMPLETED|Overall Study||55
6646178|NCT02378207|7575094|FG001|NOT COMPLETED|Overall Study||3
6646179|NCT02378207|7575095|FG002|NOT COMPLETED|Overall Study||2
6646180|NCT02378207|7575096|FG003|NOT COMPLETED|Overall Study||1
6646181|NCT02378220|7575108|FG000|STARTED|Overall Study||53
6646182|NCT02378220|7575109|FG001|STARTED|Overall Study||57
6542282|NCT01681095|7464076|FG000|NOT COMPLETED|Overall Study||0
6542283|NCT01681095|7464077|FG001|NOT COMPLETED|Overall Study||0
6542284|NCT01681121|7464085|FG000|STARTED|Overall Study||44
6542285|NCT01681121|7464086|FG001|STARTED|Overall Study||49
6542286|NCT01681121|7464085|FG000|COMPLETED|Overall Study||36
6542287|NCT01681121|7464086|FG001|COMPLETED|Overall Study||38
6542288|NCT01681121|7464085|FG000|NOT COMPLETED|Overall Study||8
6542289|NCT01681121|7464086|FG001|NOT COMPLETED|Overall Study||11
6542290|NCT01681186|7464102|FG000|STARTED|First Intervention||4
6542291|NCT01681186|7464103|FG001|STARTED|First Intervention||2
6542292|NCT01681186|7464104|FG002|STARTED|First Intervention||2
6542293|NCT01681186|7464105|FG003|STARTED|First Intervention||3
6542294|NCT01681186|7464106|FG004|STARTED|First Intervention||3
6542295|NCT01681186|7464107|FG005|STARTED|First Intervention||2
6542296|NCT01681186|7464108|FG006|STARTED|First Intervention||7
6542297|NCT01681186|7464109|FG007|STARTED|First Intervention||7
6542298|NCT01681186|7464102|FG000|COMPLETED|First Intervention||4
6542299|NCT01681186|7464103|FG001|COMPLETED|First Intervention||2
6542300|NCT01681186|7464104|FG002|COMPLETED|First Intervention||2
6542301|NCT01681186|7464105|FG003|COMPLETED|First Intervention||3
6542302|NCT01681186|7464106|FG004|COMPLETED|First Intervention||3
6542303|NCT01681186|7464107|FG005|COMPLETED|First Intervention||2
6542304|NCT01681186|7464108|FG006|COMPLETED|First Intervention||7
6542305|NCT01681186|7464109|FG007|COMPLETED|First Intervention||7
6542306|NCT01681186|7464102|FG000|NOT COMPLETED|First Intervention||0
6542307|NCT01681186|7464103|FG001|NOT COMPLETED|First Intervention||0
6542308|NCT01681186|7464104|FG002|NOT COMPLETED|First Intervention||0
6542309|NCT01681186|7464105|FG003|NOT COMPLETED|First Intervention||0
6646183|NCT02378220|7575108|FG000|COMPLETED|Overall Study||47
6646184|NCT02378220|7575109|FG001|COMPLETED|Overall Study||56
6646185|NCT02378220|7575108|FG000|NOT COMPLETED|Overall Study||6
6646186|NCT02378220|7575109|FG001|NOT COMPLETED|Overall Study||1
6646187|NCT02378402|7575119|FG000|STARTED|Overall Study||25
6646188|NCT02378402|7575120|FG001|STARTED|Overall Study||25
6646189|NCT02378402|7575121|FG002|STARTED|Overall Study||21
6542310|NCT01681186|7464106|FG004|NOT COMPLETED|First Intervention||0
6542311|NCT01681186|7464107|FG005|NOT COMPLETED|First Intervention||0
6542312|NCT01681186|7464108|FG006|NOT COMPLETED|First Intervention||0
6542313|NCT01681186|7464109|FG007|NOT COMPLETED|First Intervention||0
6646190|NCT02378402|7575119|FG000|COMPLETED|Overall Study||25
6542314|NCT01681186|7464102|FG000|STARTED|Washout Period From First Intervention||4
6542315|NCT01681186|7464103|FG001|STARTED|Washout Period From First Intervention||2
6542316|NCT01681186|7464104|FG002|STARTED|Washout Period From First Intervention||2
6542317|NCT01681186|7464105|FG003|STARTED|Washout Period From First Intervention||3
6542318|NCT01681186|7464106|FG004|STARTED|Washout Period From First Intervention||3
6542319|NCT01681186|7464107|FG005|STARTED|Washout Period From First Intervention||2
6542320|NCT01681186|7464108|FG006|STARTED|Washout Period From First Intervention||7
6542321|NCT01681186|7464109|FG007|STARTED|Washout Period From First Intervention||7
6542322|NCT01681186|7464102|FG000|COMPLETED|Washout Period From First Intervention||4
6542323|NCT01681186|7464103|FG001|COMPLETED|Washout Period From First Intervention||2
6542324|NCT01681186|7464104|FG002|COMPLETED|Washout Period From First Intervention||2
6542325|NCT01681186|7464105|FG003|COMPLETED|Washout Period From First Intervention||3
6542326|NCT01681186|7464106|FG004|COMPLETED|Washout Period From First Intervention||3
6542327|NCT01681186|7464107|FG005|COMPLETED|Washout Period From First Intervention||2
6542328|NCT01681186|7464108|FG006|COMPLETED|Washout Period From First Intervention||7
6542329|NCT01681186|7464109|FG007|COMPLETED|Washout Period From First Intervention||7
6542330|NCT01681186|7464102|FG000|NOT COMPLETED|Washout Period From First Intervention||0
6542331|NCT01681186|7464103|FG001|NOT COMPLETED|Washout Period From First Intervention||0
6542332|NCT01681186|7464104|FG002|NOT COMPLETED|Washout Period From First Intervention||0
6542333|NCT01681186|7464105|FG003|NOT COMPLETED|Washout Period From First Intervention||0
6542334|NCT01681186|7464106|FG004|NOT COMPLETED|Washout Period From First Intervention||0
6542335|NCT01681186|7464107|FG005|NOT COMPLETED|Washout Period From First Intervention||0
6542336|NCT01681186|7464108|FG006|NOT COMPLETED|Washout Period From First Intervention||0
6542337|NCT01681186|7464109|FG007|NOT COMPLETED|Washout Period From First Intervention||0
6542338|NCT01681186|7464102|FG000|STARTED|Second Intervention||4
6542339|NCT01681186|7464103|FG001|STARTED|Second Intervention||2
6542340|NCT01681186|7464104|FG002|STARTED|Second Intervention||2
6542341|NCT01681186|7464105|FG003|STARTED|Second Intervention||3
6542342|NCT01681186|7464106|FG004|STARTED|Second Intervention||3
6542343|NCT01681186|7464107|FG005|STARTED|Second Intervention||2
6542344|NCT01681186|7464108|FG006|STARTED|Second Intervention||7
6542345|NCT01681186|7464109|FG007|STARTED|Second Intervention||7
6542346|NCT01681186|7464102|FG000|COMPLETED|Second Intervention||4
6542347|NCT01681186|7464103|FG001|COMPLETED|Second Intervention||2
6542348|NCT01681186|7464104|FG002|COMPLETED|Second Intervention||2
6542349|NCT01681186|7464105|FG003|COMPLETED|Second Intervention||3
6542350|NCT01681186|7464106|FG004|COMPLETED|Second Intervention||3
6542351|NCT01681186|7464107|FG005|COMPLETED|Second Intervention||2
6542352|NCT01681186|7464108|FG006|COMPLETED|Second Intervention||7
6542353|NCT01681186|7464109|FG007|COMPLETED|Second Intervention||7
6542354|NCT01681186|7464102|FG000|NOT COMPLETED|Second Intervention||0
6542355|NCT01681186|7464103|FG001|NOT COMPLETED|Second Intervention||0
6542356|NCT01681186|7464104|FG002|NOT COMPLETED|Second Intervention||0
6542357|NCT01681186|7464105|FG003|NOT COMPLETED|Second Intervention||0
6542358|NCT01681186|7464106|FG004|NOT COMPLETED|Second Intervention||0
6542359|NCT01681186|7464107|FG005|NOT COMPLETED|Second Intervention||0
6542360|NCT01681186|7464108|FG006|NOT COMPLETED|Second Intervention||0
6542361|NCT01681186|7464109|FG007|NOT COMPLETED|Second Intervention||0
6542362|NCT01681186|7464102|FG000|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6542363|NCT01681186|7464103|FG001|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6542364|NCT01681186|7464104|FG002|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6542365|NCT01681186|7464105|FG003|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6542366|NCT01681186|7464106|FG004|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6542367|NCT01681186|7464107|FG005|STARTED|Washout Period From Second Intervention|Part A participants received only First Intervention and Second Intervention.|0
6542368|NCT01681186|7464108|FG006|STARTED|Washout Period From Second Intervention||7
6542369|NCT01681186|7464109|FG007|STARTED|Washout Period From Second Intervention||7
6542370|NCT01681186|7464102|FG000|COMPLETED|Washout Period From Second Intervention||0
6542371|NCT01681186|7464103|FG001|COMPLETED|Washout Period From Second Intervention||0
6542372|NCT01681186|7464104|FG002|COMPLETED|Washout Period From Second Intervention||0
6542373|NCT01681186|7464105|FG003|COMPLETED|Washout Period From Second Intervention||0
6542374|NCT01681186|7464106|FG004|COMPLETED|Washout Period From Second Intervention||0
6542375|NCT01681186|7464107|FG005|COMPLETED|Washout Period From Second Intervention||0
6542376|NCT01681186|7464108|FG006|COMPLETED|Washout Period From Second Intervention||6
6542377|NCT01681186|7464109|FG007|COMPLETED|Washout Period From Second Intervention||6
6542378|NCT01681186|7464102|FG000|NOT COMPLETED|Washout Period From Second Intervention||0
6542379|NCT01681186|7464103|FG001|NOT COMPLETED|Washout Period From Second Intervention||0
6542380|NCT01681186|7464104|FG002|NOT COMPLETED|Washout Period From Second Intervention||0
6542381|NCT01681186|7464105|FG003|NOT COMPLETED|Washout Period From Second Intervention||0
6542382|NCT01681186|7464106|FG004|NOT COMPLETED|Washout Period From Second Intervention||0
6542383|NCT01681186|7464107|FG005|NOT COMPLETED|Washout Period From Second Intervention||0
6542384|NCT01681186|7464108|FG006|NOT COMPLETED|Washout Period From Second Intervention||1
6542385|NCT01681186|7464109|FG007|NOT COMPLETED|Washout Period From Second Intervention||1
6542386|NCT01681186|7464102|FG000|STARTED|Third Intervention||0
6542387|NCT01681186|7464103|FG001|STARTED|Third Intervention||0
6542388|NCT01681186|7464104|FG002|STARTED|Third Intervention||0
6542389|NCT01681186|7464105|FG003|STARTED|Third Intervention||0
6542390|NCT01681186|7464106|FG004|STARTED|Third Intervention||0
6542391|NCT01681186|7464107|FG005|STARTED|Third Intervention||0
6542392|NCT01681186|7464108|FG006|STARTED|Third Intervention||6
6542393|NCT01681186|7464109|FG007|STARTED|Third Intervention||6
6542394|NCT01681186|7464102|FG000|COMPLETED|Third Intervention||0
6542395|NCT01681186|7464103|FG001|COMPLETED|Third Intervention||0
6542396|NCT01681186|7464104|FG002|COMPLETED|Third Intervention||0
6542397|NCT01681186|7464105|FG003|COMPLETED|Third Intervention||0
6542398|NCT01681186|7464106|FG004|COMPLETED|Third Intervention||0
6542399|NCT01681186|7464107|FG005|COMPLETED|Third Intervention||0
6542400|NCT01681186|7464108|FG006|COMPLETED|Third Intervention||6
6542401|NCT01681186|7464109|FG007|COMPLETED|Third Intervention||6
6542402|NCT01681186|7464102|FG000|NOT COMPLETED|Third Intervention||0
6542403|NCT01681186|7464103|FG001|NOT COMPLETED|Third Intervention||0
6542404|NCT01681186|7464104|FG002|NOT COMPLETED|Third Intervention||0
6542405|NCT01681186|7464105|FG003|NOT COMPLETED|Third Intervention||0
6542406|NCT01681186|7464106|FG004|NOT COMPLETED|Third Intervention||0
6542407|NCT01681186|7464107|FG005|NOT COMPLETED|Third Intervention||0
6542408|NCT01681186|7464108|FG006|NOT COMPLETED|Third Intervention||0
6542409|NCT01681186|7464109|FG007|NOT COMPLETED|Third Intervention||0
6542410|NCT01681186|7464102|FG000|STARTED|Washout Period From Third Intervention||0
6542411|NCT01681186|7464103|FG001|STARTED|Washout Period From Third Intervention||0
6542412|NCT01681186|7464104|FG002|STARTED|Washout Period From Third Intervention||0
6542413|NCT01681186|7464105|FG003|STARTED|Washout Period From Third Intervention||0
6542414|NCT01681186|7464106|FG004|STARTED|Washout Period From Third Intervention||0
6542415|NCT01681186|7464107|FG005|STARTED|Washout Period From Third Intervention||0
6542416|NCT01681186|7464108|FG006|STARTED|Washout Period From Third Intervention||6
6542417|NCT01681186|7464109|FG007|STARTED|Washout Period From Third Intervention||6
6542418|NCT01681186|7464102|FG000|COMPLETED|Washout Period From Third Intervention||0
6542419|NCT01681186|7464103|FG001|COMPLETED|Washout Period From Third Intervention||0
6542420|NCT01681186|7464104|FG002|COMPLETED|Washout Period From Third Intervention||0
6542421|NCT01681186|7464105|FG003|COMPLETED|Washout Period From Third Intervention||0
6542422|NCT01681186|7464106|FG004|COMPLETED|Washout Period From Third Intervention||0
6542423|NCT01681186|7464107|FG005|COMPLETED|Washout Period From Third Intervention||0
6542424|NCT01681186|7464108|FG006|COMPLETED|Washout Period From Third Intervention||5
6542425|NCT01681186|7464109|FG007|COMPLETED|Washout Period From Third Intervention||6
6542426|NCT01681186|7464102|FG000|NOT COMPLETED|Washout Period From Third Intervention||0
6542427|NCT01681186|7464103|FG001|NOT COMPLETED|Washout Period From Third Intervention||0
6542428|NCT01681186|7464104|FG002|NOT COMPLETED|Washout Period From Third Intervention||0
6542429|NCT01681186|7464105|FG003|NOT COMPLETED|Washout Period From Third Intervention||0
6542430|NCT01681186|7464106|FG004|NOT COMPLETED|Washout Period From Third Intervention||0
6542431|NCT01681186|7464107|FG005|NOT COMPLETED|Washout Period From Third Intervention||0
6542432|NCT01681186|7464108|FG006|NOT COMPLETED|Washout Period From Third Intervention||1
6542433|NCT01681186|7464109|FG007|NOT COMPLETED|Washout Period From Third Intervention||0
6542434|NCT01681186|7464102|FG000|STARTED|Fourth Intervention||0
6542435|NCT01681186|7464103|FG001|STARTED|Fourth Intervention||0
6542436|NCT01681186|7464104|FG002|STARTED|Fourth Intervention||0
6542437|NCT01681186|7464105|FG003|STARTED|Fourth Intervention||0
6542438|NCT01681186|7464106|FG004|STARTED|Fourth Intervention||0
6542439|NCT01681186|7464107|FG005|STARTED|Fourth Intervention||0
6542440|NCT01681186|7464108|FG006|STARTED|Fourth Intervention||5
6542441|NCT01681186|7464109|FG007|STARTED|Fourth Intervention||6
6542442|NCT01681186|7464102|FG000|COMPLETED|Fourth Intervention||0
6542443|NCT01681186|7464103|FG001|COMPLETED|Fourth Intervention||0
6542444|NCT01681186|7464104|FG002|COMPLETED|Fourth Intervention||0
6542445|NCT01681186|7464105|FG003|COMPLETED|Fourth Intervention||0
6542446|NCT01681186|7464106|FG004|COMPLETED|Fourth Intervention||0
6542447|NCT01681186|7464107|FG005|COMPLETED|Fourth Intervention||0
6542448|NCT01681186|7464108|FG006|COMPLETED|Fourth Intervention||5
6542449|NCT01681186|7464109|FG007|COMPLETED|Fourth Intervention||5
6542450|NCT01681186|7464102|FG000|NOT COMPLETED|Fourth Intervention||0
6542451|NCT01681186|7464103|FG001|NOT COMPLETED|Fourth Intervention||0
6542452|NCT01681186|7464104|FG002|NOT COMPLETED|Fourth Intervention||0
6542453|NCT01681186|7464105|FG003|NOT COMPLETED|Fourth Intervention||0
6542454|NCT01681186|7464106|FG004|NOT COMPLETED|Fourth Intervention||0
6542455|NCT01681186|7464107|FG005|NOT COMPLETED|Fourth Intervention||0
6542456|NCT01681186|7464108|FG006|NOT COMPLETED|Fourth Intervention||0
6542457|NCT01681186|7464109|FG007|NOT COMPLETED|Fourth Intervention||1
6542458|NCT01681212|7464139|FG000|STARTED|Overall Study|Enrolled|21
6542459|NCT01681212|7464139|FG000|Received Treatment|Overall Study||15
6542460|NCT01681212|7464139|FG000|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
6542461|NCT01681212|7464139|FG000|NOT COMPLETED|Overall Study||6
6542462|NCT01681277|7464148|FG000|STARTED|Overall Study||12
6542463|NCT01681277|7464149|FG001|STARTED|Overall Study||9
6542464|NCT01681277|7464150|FG002|STARTED|Overall Study||9
6542465|NCT01681277|7464151|FG003|STARTED|Overall Study||9
6542466|NCT01681277|7464152|FG004|STARTED|Overall Study||9
6542467|NCT01681277|7464148|FG000|COMPLETED|Overall Study||11
6542468|NCT01681277|7464149|FG001|COMPLETED|Overall Study||9
6542469|NCT01681277|7464150|FG002|COMPLETED|Overall Study||9
6646191|NCT02378402|7575120|FG001|COMPLETED|Overall Study||23
6646192|NCT02378402|7575121|FG002|COMPLETED|Overall Study||21
6646193|NCT02378402|7575119|FG000|NOT COMPLETED|Overall Study||0
6646194|NCT02378402|7575120|FG001|NOT COMPLETED|Overall Study||2
6542470|NCT01681277|7464151|FG003|COMPLETED|Overall Study||9
6542471|NCT01681277|7464152|FG004|COMPLETED|Overall Study||9
6542472|NCT01681277|7464148|FG000|NOT COMPLETED|Overall Study||1
6542473|NCT01681277|7464149|FG001|NOT COMPLETED|Overall Study||0
6542474|NCT01681277|7464150|FG002|NOT COMPLETED|Overall Study||0
6542475|NCT01681277|7464151|FG003|NOT COMPLETED|Overall Study||0
6542476|NCT01681277|7464152|FG004|NOT COMPLETED|Overall Study||0
6542477|NCT01681368|7464168|FG000|STARTED|Overall Study||11
6542478|NCT01681368|7464168|FG000|COMPLETED|Overall Study||9
6542479|NCT01681368|7464168|FG000|NOT COMPLETED|Overall Study||2
6542480|NCT01681433|7464174|FG000|STARTED|Overall Study||36
6542481|NCT01681433|7464175|FG001|STARTED|Overall Study||36
6542482|NCT01681433|7464174|FG000|COMPLETED|Overall Study||4
6542483|NCT01681433|7464175|FG001|COMPLETED|Overall Study||3
6542484|NCT01681433|7464174|FG000|NOT COMPLETED|Overall Study||32
6542485|NCT01681433|7464175|FG001|NOT COMPLETED|Overall Study||33
6542486|NCT01681472|7464185|FG000|STARTED|Overall Study||8
6542487|NCT01681472|7464186|FG001|STARTED|Overall Study||8
6542488|NCT01681472|7464187|FG002|STARTED|Overall Study||8
6542489|NCT01681472|7464188|FG003|STARTED|Overall Study||8
6542490|NCT01681472|7464185|FG000|COMPLETED|Overall Study||8
6542491|NCT01681472|7464186|FG001|COMPLETED|Overall Study||7
6542492|NCT01681472|7464187|FG002|COMPLETED|Overall Study||8
6542493|NCT01681472|7464188|FG003|COMPLETED|Overall Study||8
6542494|NCT01681472|7464185|FG000|NOT COMPLETED|Overall Study||0
6542495|NCT01681472|7464186|FG001|NOT COMPLETED|Overall Study||1
6542496|NCT01681472|7464187|FG002|NOT COMPLETED|Overall Study||0
6542497|NCT01681472|7464188|FG003|NOT COMPLETED|Overall Study||0
6542498|NCT01681511|7464209|FG000|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
6542499|NCT01681511|7464210|FG001|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
6542500|NCT01681511|7464209|FG000|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
6542501|NCT01681511|7464210|FG001|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
6542502|NCT01681511|7464209|FG000|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
6542503|NCT01681511|7464210|FG001|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
6542504|NCT01681511|7464209|FG000|COMPLETED|Overall Study||28
6542505|NCT01681511|7464210|FG001|COMPLETED|Overall Study||35
6542506|NCT01681511|7464209|FG000|NOT COMPLETED|Overall Study||18
6542507|NCT01681511|7464210|FG001|NOT COMPLETED|Overall Study||14
6542508|NCT01681576|7464218|FG000|STARTED|Period 1||36
6542509|NCT01681576|7464219|FG001|STARTED|Period 1||36
6542510|NCT01681576|7464218|FG000|COMPLETED|Period 1||34
6542511|NCT01681576|7464219|FG001|COMPLETED|Period 1||36
6542512|NCT01681576|7464218|FG000|NOT COMPLETED|Period 1||2
6542513|NCT01681576|7464219|FG001|NOT COMPLETED|Period 1||0
6542514|NCT01681576|7464218|FG000|STARTED|Period 2|Period 2: Valsartan 320mg|34
6542515|NCT01681576|7464219|FG001|STARTED|Period 2|Period 2: LCZ696 400mg|36
6542516|NCT01681576|7464218|FG000|COMPLETED|Period 2||30
6542517|NCT01681576|7464219|FG001|COMPLETED|Period 2||35
6542518|NCT01681576|7464218|FG000|NOT COMPLETED|Period 2||4
6542519|NCT01681576|7464219|FG001|NOT COMPLETED|Period 2||1
6542520|NCT01681628|7464229|FG000|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
6542521|NCT01681628|7464230|FG001|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
6646195|NCT02378402|7575121|FG002|NOT COMPLETED|Overall Study||0
6646196|NCT02378480|7575131|FG000|STARTED|Overall Study||329
6646197|NCT02378480|7575132|FG001|STARTED|Overall Study||326
6646198|NCT02378480|7575131|FG000|COMPLETED|Overall Study||301
6646199|NCT02378480|7575132|FG001|COMPLETED|Overall Study||294
6646200|NCT02378480|7575131|FG000|NOT COMPLETED|Overall Study||28
6646201|NCT02378480|7575132|FG001|NOT COMPLETED|Overall Study||32
6646202|NCT02378506|7575138|FG000|STARTED|Overall Study||188
6646203|NCT02378506|7575138|FG000|Treated|Overall Study||187
6646204|NCT02378506|7575138|FG000|COMPLETED|Overall Study||163
6646205|NCT02378506|7575138|FG000|NOT COMPLETED|Overall Study||25
6646206|NCT02378662|7575144|FG000|STARTED|Overall Study||2
6646207|NCT02378662|7575145|FG001|STARTED|Overall Study||0
6646208|NCT02378662|7575144|FG000|Harvesting|Overall Study||2
6646209|NCT02378662|7575145|FG001|Harvesting|Overall Study||0
6646210|NCT02378662|7575144|FG000|Implantation|Overall Study||2
6646211|NCT02378662|7575145|FG001|Implantation|Overall Study||0
6646212|NCT02378662|7575144|FG000|COMPLETED|Overall Study||0
6646213|NCT02378662|7575145|FG001|COMPLETED|Overall Study||0
6646214|NCT02378662|7575144|FG000|NOT COMPLETED|Overall Study||2
6646215|NCT02378662|7575145|FG001|NOT COMPLETED|Overall Study||0
6646216|NCT02378714|7575155|FG000|STARTED|Overall Study||68
6646217|NCT02378714|7575156|FG001|STARTED|Overall Study||68
6646218|NCT02378714|7575157|FG002|STARTED|Overall Study||81
6646219|NCT02378714|7575158|FG003|STARTED|Overall Study||83
6646220|NCT02378714|7575155|FG000|COMPLETED|Overall Study||39
6646221|NCT02378714|7575156|FG001|COMPLETED|Overall Study||29
6646222|NCT02378714|7575157|FG002|COMPLETED|Overall Study||51
6646223|NCT02378714|7575158|FG003|COMPLETED|Overall Study||51
6646224|NCT02378714|7575155|FG000|NOT COMPLETED|Overall Study||29
6542522|NCT01681628|7464229|FG000|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
6542523|NCT01681628|7464230|FG001|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
6542524|NCT01681628|7464229|FG000|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
6542525|NCT01681628|7464230|FG001|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
6542526|NCT01681628|7464229|FG000|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
6542527|NCT01681628|7464230|FG001|STARTED|Time 2 to Time 3 (One Week Later).||122
6646225|NCT02378714|7575156|FG001|NOT COMPLETED|Overall Study||39
6646226|NCT02378714|7575157|FG002|NOT COMPLETED|Overall Study||30
6646227|NCT02378714|7575158|FG003|NOT COMPLETED|Overall Study||32
6646228|NCT02378753|7575192|FG000|STARTED|Overall Study||4319
6646229|NCT02378753|7575193|FG001|STARTED|Overall Study||4332
6646230|NCT02378753|7575192|FG000|COMPLETED|Overall Study||4101
6646231|NCT02378753|7575193|FG001|COMPLETED|Overall Study||3637
6646232|NCT02378753|7575192|FG000|NOT COMPLETED|Overall Study||218
6646233|NCT02378753|7575193|FG001|NOT COMPLETED|Overall Study||695
6646234|NCT02378844|7575201|FG000|STARTED|Run-in Period||169
6542528|NCT01681628|7464229|FG000|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
6542529|NCT01681628|7464230|FG001|COMPLETED|Time 2 to Time 3 (One Week Later).||107
6542530|NCT01681628|7464229|FG000|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
6542531|NCT01681628|7464230|FG001|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
6542532|NCT01681628|7464229|FG000|STARTED|19 Months Follow-up||114
6542533|NCT01681628|7464230|FG001|STARTED|19 Months Follow-up||107
6542534|NCT01681628|7464229|FG000|COMPLETED|19 Months Follow-up||52
6542535|NCT01681628|7464230|FG001|COMPLETED|19 Months Follow-up||64
6542536|NCT01681628|7464229|FG000|NOT COMPLETED|19 Months Follow-up||62
6542537|NCT01681628|7464230|FG001|NOT COMPLETED|19 Months Follow-up||43
6542538|NCT01681771|7464241|FG000|STARTED|Overall Study||25
6542539|NCT01681771|7464242|FG001|STARTED|Overall Study||25
6542540|NCT01681771|7464241|FG000|COMPLETED|Overall Study||21
6542541|NCT01681771|7464242|FG001|COMPLETED|Overall Study||23
6542542|NCT01681771|7464241|FG000|NOT COMPLETED|Overall Study||4
6542543|NCT01681771|7464242|FG001|NOT COMPLETED|Overall Study||2
6542544|NCT01681810|7464248|FG000|STARTED|Overall Study||20
6542545|NCT01681810|7464248|FG000|COMPLETED|Overall Study||20
6542546|NCT01681810|7464248|FG000|NOT COMPLETED|Overall Study||0
6542547|NCT01681836|7464252|FG000|STARTED|First Intervention||6
6542548|NCT01681836|7464253|FG001|STARTED|First Intervention||5
6542549|NCT01681836|7464252|FG000|COMPLETED|First Intervention||6
6542550|NCT01681836|7464253|FG001|COMPLETED|First Intervention||5
6542551|NCT01681836|7464252|FG000|NOT COMPLETED|First Intervention||0
6542552|NCT01681836|7464253|FG001|NOT COMPLETED|First Intervention||0
6542553|NCT01681836|7464252|FG000|STARTED|Washout Period of 3-7 Days||6
6542554|NCT01681836|7464253|FG001|STARTED|Washout Period of 3-7 Days||5
6542555|NCT01681836|7464252|FG000|COMPLETED|Washout Period of 3-7 Days||6
6542556|NCT01681836|7464253|FG001|COMPLETED|Washout Period of 3-7 Days||5
6542557|NCT01681836|7464252|FG000|NOT COMPLETED|Washout Period of 3-7 Days||0
6542558|NCT01681836|7464253|FG001|NOT COMPLETED|Washout Period of 3-7 Days||0
6542559|NCT01681836|7464252|FG000|STARTED|Second Intervention||6
6542560|NCT01681836|7464253|FG001|STARTED|Second Intervention||5
6542561|NCT01681836|7464252|FG000|COMPLETED|Second Intervention||6
6646235|NCT02378844|7575202|FG001|STARTED|Run-in Period||172
6646236|NCT02378844|7575203|FG002|STARTED|Run-in Period||136
6646237|NCT02378844|7575201|FG000|COMPLETED|Run-in Period||165
6646238|NCT02378844|7575202|FG001|COMPLETED|Run-in Period||167
6646239|NCT02378844|7575203|FG002|COMPLETED|Run-in Period||0
6646240|NCT02378844|7575201|FG000|NOT COMPLETED|Run-in Period||4
6646241|NCT02378844|7575202|FG001|NOT COMPLETED|Run-in Period||5
6646242|NCT02378844|7575203|FG002|NOT COMPLETED|Run-in Period||136
6646243|NCT02378844|7575201|FG000|STARTED|Randomized Period (Double Blind)||165
6646244|NCT02378844|7575202|FG001|STARTED|Randomized Period (Double Blind)||167
6646245|NCT02378844|7575203|FG002|STARTED|Randomized Period (Double Blind)||0
6646246|NCT02378844|7575201|FG000|COMPLETED|Randomized Period (Double Blind)||142
6646247|NCT02378844|7575202|FG001|COMPLETED|Randomized Period (Double Blind)||135
6646248|NCT02378844|7575203|FG002|COMPLETED|Randomized Period (Double Blind)||0
6646249|NCT02378844|7575201|FG000|NOT COMPLETED|Randomized Period (Double Blind)||23
6646250|NCT02378844|7575202|FG001|NOT COMPLETED|Randomized Period (Double Blind)||32
6646251|NCT02378844|7575203|FG002|NOT COMPLETED|Randomized Period (Double Blind)||0
6646252|NCT02378844|7575201|FG000|STARTED|Open Label Period||142
6646253|NCT02378844|7575202|FG001|STARTED|Open Label Period||135
6646254|NCT02378844|7575203|FG002|STARTED|Open Label Period||0
6646255|NCT02378844|7575201|FG000|COMPLETED|Open Label Period||99
6646256|NCT02378844|7575202|FG001|COMPLETED|Open Label Period||87
6646257|NCT02378844|7575203|FG002|COMPLETED|Open Label Period||0
6646258|NCT02378844|7575201|FG000|NOT COMPLETED|Open Label Period||43
6646259|NCT02378844|7575202|FG001|NOT COMPLETED|Open Label Period||48
6646260|NCT02378844|7575203|FG002|NOT COMPLETED|Open Label Period||0
6646261|NCT02378883|7575213|FG000|STARTED|Enrollment|Participants consented and assessed for eligibility|121
6646262|NCT02378883|7575213|FG000|COMPLETED|Enrollment|Attempted with study device - intent to treat population|112
6646263|NCT02378883|7575213|FG000|NOT COMPLETED|Enrollment||9
6646264|NCT02378883|7575213|FG000|STARTED|Discharge||112
6646265|NCT02378883|7575213|FG000|COMPLETED|Discharge||112
6542562|NCT01681836|7464253|FG001|COMPLETED|Second Intervention||4
6646266|NCT02378883|7575213|FG000|NOT COMPLETED|Discharge||0
6646267|NCT02378883|7575213|FG000|STARTED|30 Day Follow-Up||112
6542563|NCT01681836|7464252|FG000|NOT COMPLETED|Second Intervention||0
6542564|NCT01681836|7464253|FG001|NOT COMPLETED|Second Intervention||1
6542565|NCT01681849|7464262|FG000|STARTED|Overall Study||15
6542566|NCT01681849|7464263|FG001|STARTED|Overall Study||13
6542567|NCT01681849|7464264|FG002|STARTED|Overall Study||56
6542568|NCT01681849|7464262|FG000|COMPLETED|Overall Study||7
6542569|NCT01681849|7464263|FG001|COMPLETED|Overall Study||6
6542570|NCT01681849|7464264|FG002|COMPLETED|Overall Study||17
6542571|NCT01681849|7464262|FG000|NOT COMPLETED|Overall Study||8
6542572|NCT01681849|7464263|FG001|NOT COMPLETED|Overall Study||7
6542573|NCT01681849|7464264|FG002|NOT COMPLETED|Overall Study||39
6542574|NCT01681992|7464274|FG000|STARTED|Overall Study||1493
6542575|NCT01681992|7464275|FG001|STARTED|Overall Study||1497
6542576|NCT01681992|7464276|FG002|STARTED|Overall Study||1526
6542577|NCT01681992|7464274|FG000|COMPLETED|Overall Study||1427
6542578|NCT01681992|7464275|FG001|COMPLETED|Overall Study||1427
6542579|NCT01681992|7464276|FG002|COMPLETED|Overall Study||1443
6542580|NCT01681992|7464274|FG000|NOT COMPLETED|Overall Study||66
6542581|NCT01681992|7464275|FG001|NOT COMPLETED|Overall Study||70
6542582|NCT01681992|7464276|FG002|NOT COMPLETED|Overall Study||83
6542583|NCT01682031|7464286|FG000|STARTED|Overall Study||8
6542584|NCT01682031|7464287|FG001|STARTED|Overall Study||10
6542585|NCT01682031|7464286|FG000|COMPLETED|Overall Study||7
6542586|NCT01682031|7464287|FG001|COMPLETED|Overall Study||5
6542587|NCT01682031|7464286|FG000|NOT COMPLETED|Overall Study||1
6542588|NCT01682031|7464287|FG001|NOT COMPLETED|Overall Study||5
6542589|NCT01682044|7464293|FG000|STARTED|Overall Study||20
6542590|NCT01682044|7464293|FG000|COMPLETED|Overall Study||16
6542591|NCT01682044|7464293|FG000|NOT COMPLETED|Overall Study||4
6542592|NCT01682083|7464299|FG000|STARTED|Overall Study||438
6542593|NCT01682083|7464300|FG001|STARTED|Overall Study||432
6542594|NCT01682083|7464299|FG000|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off. 3 patients were untreated|331
6542595|NCT01682083|7464300|FG001|COMPLETED|Overall Study|Ongoing patients at the time of data cut-off.|277
6542596|NCT01682083|7464299|FG000|NOT COMPLETED|Overall Study||107
6542597|NCT01682083|7464300|FG001|NOT COMPLETED|Overall Study||155
6542598|NCT01682135|7464309|FG000|STARTED|Overall Study||6
6542599|NCT01682135|7464310|FG001|STARTED|Overall Study||10
6646268|NCT02378883|7575213|FG000|COMPLETED|30 Day Follow-Up||106
6646269|NCT02378883|7575213|FG000|NOT COMPLETED|30 Day Follow-Up||6
6646270|NCT02378883|7575213|FG000|STARTED|12 Months Follow-Up|Two deaths occurred between 30 day FU and prior to 12 month FU.|46
6646271|NCT02378883|7575213|FG000|COMPLETED|12 Months Follow-Up||41
6646272|NCT02378883|7575213|FG000|NOT COMPLETED|12 Months Follow-Up||5
6646273|NCT02378935|7575225|FG000|STARTED|Overall Study||34
6646274|NCT02378935|7575226|FG001|STARTED|Overall Study||36
6646275|NCT02378935|7575227|FG002|STARTED|Overall Study||33
6646276|NCT02378935|7575228|FG003|STARTED|Overall Study||31
6646277|NCT02378935|7575229|FG004|STARTED|Overall Study||31
6646278|NCT02378935|7575230|FG005|STARTED|Overall Study||32
6646279|NCT02378935|7575231|FG006|STARTED|Overall Study||8
6646280|NCT02378935|7575225|FG000|COMPLETED|Overall Study||24
6646281|NCT02378935|7575226|FG001|COMPLETED|Overall Study||36
6646282|NCT02378935|7575227|FG002|COMPLETED|Overall Study||30
6646283|NCT02378935|7575228|FG003|COMPLETED|Overall Study||25
6646284|NCT02378935|7575229|FG004|COMPLETED|Overall Study||31
6646285|NCT02378935|7575230|FG005|COMPLETED|Overall Study||32
6646286|NCT02378935|7575231|FG006|COMPLETED|Overall Study||8
6646287|NCT02378935|7575225|FG000|NOT COMPLETED|Overall Study||10
6646288|NCT02378935|7575226|FG001|NOT COMPLETED|Overall Study||0
6646289|NCT02378935|7575227|FG002|NOT COMPLETED|Overall Study||3
6646290|NCT02378935|7575228|FG003|NOT COMPLETED|Overall Study||6
6646291|NCT02378935|7575229|FG004|NOT COMPLETED|Overall Study||0
6646292|NCT02378935|7575230|FG005|NOT COMPLETED|Overall Study||0
6646293|NCT02378935|7575231|FG006|NOT COMPLETED|Overall Study||0
6646294|NCT02378961|7575251|FG000|STARTED|Overall Study||33
6646295|NCT02378961|7575252|FG001|STARTED|Overall Study||30
6646296|NCT02378961|7575253|FG002|STARTED|Overall Study||36
6646297|NCT02378961|7575254|FG003|STARTED|Overall Study||29
6646298|NCT02378961|7575251|FG000|COMPLETED|Overall Study||29
6646299|NCT02378961|7575252|FG001|COMPLETED|Overall Study||28
6646300|NCT02378961|7575253|FG002|COMPLETED|Overall Study||35
6542600|NCT01682135|7464311|FG002|STARTED|Overall Study||12
6542601|NCT01682135|7464309|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6542602|NCT01682135|7464310|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
6542603|NCT01682135|7464311|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
6542604|NCT01682135|7464309|FG000|COMPLETED|Overall Study||6
6542605|NCT01682135|7464310|FG001|COMPLETED|Overall Study||10
6542606|NCT01682135|7464311|FG002|COMPLETED|Overall Study||12
6542607|NCT01682135|7464309|FG000|NOT COMPLETED|Overall Study||0
6542608|NCT01682135|7464310|FG001|NOT COMPLETED|Overall Study||0
6542609|NCT01682135|7464311|FG002|NOT COMPLETED|Overall Study||0
6542610|NCT01682148|7464323|FG000|STARTED|Overall Study||44
6542611|NCT01682148|7464324|FG001|STARTED|Overall Study||44
6646301|NCT02378961|7575254|FG003|COMPLETED|Overall Study||28
6646302|NCT02378961|7575251|FG000|NOT COMPLETED|Overall Study||4
6646303|NCT02378961|7575252|FG001|NOT COMPLETED|Overall Study||2
6646304|NCT02378961|7575253|FG002|NOT COMPLETED|Overall Study||1
6646305|NCT02378961|7575254|FG003|NOT COMPLETED|Overall Study||1
6646306|NCT02379052|7575266|FG000|STARTED|Overall Study||24
6646307|NCT02379052|7575267|FG001|STARTED|Overall Study||23
6646308|NCT02379052|7575266|FG000|COMPLETED|Overall Study||18
6542612|NCT01682148|7464323|FG000|COMPLETED|Overall Study||40
6542613|NCT01682148|7464324|FG001|COMPLETED|Overall Study||41
6542614|NCT01682148|7464323|FG000|NOT COMPLETED|Overall Study||4
6542615|NCT01682148|7464324|FG001|NOT COMPLETED|Overall Study||3
6542616|NCT01682213|7464335|FG000|STARTED|Overall Study||23
6542617|NCT01682213|7464335|FG000|COMPLETED|Overall Study||21
6542618|NCT01682213|7464335|FG000|NOT COMPLETED|Overall Study||2
6542619|NCT01682460|7464340|FG000|STARTED|Overall Study||15
6542620|NCT01682460|7464340|FG000|COMPLETED|Overall Study||11
6542621|NCT01682460|7464340|FG000|NOT COMPLETED|Overall Study||4
6542622|NCT01682512|7464347|FG000|STARTED|Overall Study||116
6542623|NCT01682512|7464348|FG001|STARTED|Overall Study||111
6542624|NCT01682512|7464349|FG002|STARTED|Overall Study||66
6542625|NCT01682512|7464347|FG000|Randomized in Part-I|Overall Study||66
6542626|NCT01682512|7464348|FG001|Randomized in Part-I|Overall Study||65
6542627|NCT01682512|7464349|FG002|Randomized in Part-I|Overall Study||66
6542628|NCT01682512|7464347|FG000|Randomized in Part-II|Overall Study||50
6542629|NCT01682512|7464348|FG001|Randomized in Part-II|Overall Study||46
6542630|NCT01682512|7464349|FG002|Randomized in Part-II|Overall Study||0
6542631|NCT01682512|7464347|FG000|COMPLETED|Overall Study||44
6646309|NCT02379052|7575267|FG001|COMPLETED|Overall Study||18
6646310|NCT02379052|7575266|FG000|NOT COMPLETED|Overall Study||6
6646311|NCT02379052|7575267|FG001|NOT COMPLETED|Overall Study||5
6646312|NCT02379078|7575275|FG000|STARTED|Overall Study||111
6646313|NCT02379078|7575276|FG001|STARTED|Overall Study||114
6646314|NCT02379078|7575275|FG000|COMPLETED|Overall Study||72
6646315|NCT02379078|7575276|FG001|COMPLETED|Overall Study||79
6646316|NCT02379078|7575275|FG000|NOT COMPLETED|Overall Study||39
6646317|NCT02379078|7575276|FG001|NOT COMPLETED|Overall Study||35
6646318|NCT02379091|7575286|FG000|STARTED|Overall Study||27
6646319|NCT02379091|7575287|FG001|STARTED|Overall Study||28
6646320|NCT02379091|7575288|FG002|STARTED|Overall Study||25
6646321|NCT02379091|7575289|FG003|STARTED|Overall Study||28
6646322|NCT02379091|7575286|FG000|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|26
6646323|NCT02379091|7575287|FG001|Full Analysis Set|Overall Study||28
6646324|NCT02379091|7575288|FG002|Full Analysis Set|Overall Study|One participant was excluded because of data collection issues.|24
6646325|NCT02379091|7575289|FG003|Full Analysis Set|Overall Study||28
6646326|NCT02379091|7575286|FG000|COMPLETED|Overall Study||15
6646327|NCT02379091|7575287|FG001|COMPLETED|Overall Study||18
6646328|NCT02379091|7575288|FG002|COMPLETED|Overall Study||18
6542632|NCT01682512|7464348|FG001|COMPLETED|Overall Study||40
6542633|NCT01682512|7464349|FG002|COMPLETED|Overall Study||48
6542634|NCT01682512|7464347|FG000|NOT COMPLETED|Overall Study||72
6542635|NCT01682512|7464348|FG001|NOT COMPLETED|Overall Study||71
6542636|NCT01682512|7464349|FG002|NOT COMPLETED|Overall Study||18
6542637|NCT01682538|7464357|FG000|STARTED|Overall Study||12
6542638|NCT01682538|7464357|FG000|COMPLETED|Overall Study||12
6542639|NCT01682538|7464357|FG000|NOT COMPLETED|Overall Study||0
6542640|NCT01682603|7464372|FG000|STARTED|Overall Study||37
6542641|NCT01682603|7464372|FG000|COMPLETED|Overall Study||34
6542642|NCT01682603|7464372|FG000|NOT COMPLETED|Overall Study||3
6542643|NCT01682642|7464380|FG000|STARTED|Overall Study||61
6542644|NCT01682642|7464381|FG001|STARTED|Overall Study||59
6542645|NCT01682642|7464380|FG000|COMPLETED|Overall Study||61
6542646|NCT01682642|7464381|FG001|COMPLETED|Overall Study||58
6542647|NCT01682642|7464380|FG000|NOT COMPLETED|Overall Study||0
6542648|NCT01682642|7464381|FG001|NOT COMPLETED|Overall Study||1
6542649|NCT01682681|7464393|FG000|STARTED|Overall Study||1234
6646329|NCT02379091|7575289|FG003|COMPLETED|Overall Study||14
6646330|NCT02379091|7575286|FG000|NOT COMPLETED|Overall Study||12
6646331|NCT02379091|7575287|FG001|NOT COMPLETED|Overall Study||10
6646332|NCT02379091|7575288|FG002|NOT COMPLETED|Overall Study||7
6542650|NCT01682681|7464393|FG000|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
6542651|NCT01682681|7464393|FG000|COMPLETED|Overall Study||902
6542652|NCT01682681|7464393|FG000|NOT COMPLETED|Overall Study||332
6542653|NCT01682720|7464401|FG000|STARTED|Overall Study||85
6542654|NCT01682720|7464402|FG001|STARTED|Overall Study||74
6542655|NCT01682720|7464403|FG002|STARTED|Overall Study||12
6542656|NCT01682720|7464404|FG003|STARTED|Overall Study||250
6542657|NCT01682720|7464401|FG000|Included in Full Analysis Set|Overall Study||0
6542658|NCT01682720|7464402|FG001|Included in Full Analysis Set|Overall Study||73
6542659|NCT01682720|7464403|FG002|Included in Full Analysis Set|Overall Study||11
6542660|NCT01682720|7464404|FG003|Included in Full Analysis Set|Overall Study||250
6542661|NCT01682720|7464401|FG000|COMPLETED|Overall Study||0
6542662|NCT01682720|7464402|FG001|COMPLETED|Overall Study||69
6542663|NCT01682720|7464403|FG002|COMPLETED|Overall Study||5
6542664|NCT01682720|7464404|FG003|COMPLETED|Overall Study||211
6542665|NCT01682720|7464401|FG000|NOT COMPLETED|Overall Study||85
6542666|NCT01682720|7464402|FG001|NOT COMPLETED|Overall Study||5
6646333|NCT02379091|7575289|FG003|NOT COMPLETED|Overall Study||14
6646334|NCT02379117|7575303|FG000|STARTED|Overall Study||30
6646335|NCT02379117|7575304|FG001|STARTED|Overall Study||31
6646336|NCT02379117|7575303|FG000|COMPLETED|Overall Study||30
6646337|NCT02379117|7575304|FG001|COMPLETED|Overall Study||31
6646338|NCT02379117|7575303|FG000|NOT COMPLETED|Overall Study||0
6646339|NCT02379117|7575304|FG001|NOT COMPLETED|Overall Study||0
6646340|NCT02379195|7575310|FG000|STARTED|Overall Study||12
6646341|NCT02379195|7575310|FG000|COMPLETED|Overall Study||12
6646342|NCT02379195|7575310|FG000|NOT COMPLETED|Overall Study||0
6542667|NCT01682720|7464403|FG002|NOT COMPLETED|Overall Study||7
6542668|NCT01682720|7464404|FG003|NOT COMPLETED|Overall Study||39
6542669|NCT01682759|7464416|FG000|STARTED|Overall Study||376
6542670|NCT01682759|7464417|FG001|STARTED|Overall Study||375
6542671|NCT01682759|7464416|FG000|Treated|Overall Study||375
6542672|NCT01682759|7464417|FG001|Treated|Overall Study||375
6542673|NCT01682759|7464416|FG000|COMPLETED|Overall Study||307
6542674|NCT01682759|7464417|FG001|COMPLETED|Overall Study||305
6542675|NCT01682759|7464416|FG000|NOT COMPLETED|Overall Study||69
6542676|NCT01682759|7464417|FG001|NOT COMPLETED|Overall Study||70
6542677|NCT01682811|7464430|FG000|STARTED|Part 1 Levulan Injection||1
6542678|NCT01682811|7464431|FG001|STARTED|Part 1 Levulan Injection||0
6542679|NCT01682811|7464432|FG002|STARTED|Part 1 Levulan Injection||0
6542680|NCT01682811|7464433|FG003|STARTED|Part 1 Levulan Injection||0
6542681|NCT01682811|7464434|FG004|STARTED|Part 1 Levulan Injection||0
6542682|NCT01682811|7464435|FG005|STARTED|Part 1 Levulan Injection||0
6542683|NCT01682811|7464436|FG006|STARTED|Part 1 Levulan Injection||0
6542684|NCT01682811|7464430|FG000|Control|Part 1 Levulan Injection||1
6542685|NCT01682811|7464431|FG001|Control|Part 1 Levulan Injection||0
6542686|NCT01682811|7464432|FG002|Control|Part 1 Levulan Injection||0
6542687|NCT01682811|7464433|FG003|Control|Part 1 Levulan Injection||0
6542688|NCT01682811|7464434|FG004|Control|Part 1 Levulan Injection||0
6542689|NCT01682811|7464435|FG005|Control|Part 1 Levulan Injection||0
6542690|NCT01682811|7464436|FG006|Control|Part 1 Levulan Injection||0
6542691|NCT01682811|7464430|FG000|Treated 3 Hours|Part 1 Levulan Injection||1
6542692|NCT01682811|7464431|FG001|Treated 3 Hours|Part 1 Levulan Injection||0
6542693|NCT01682811|7464432|FG002|Treated 3 Hours|Part 1 Levulan Injection||0
6542694|NCT01682811|7464433|FG003|Treated 3 Hours|Part 1 Levulan Injection||0
6542695|NCT01682811|7464434|FG004|Treated 3 Hours|Part 1 Levulan Injection||0
6542696|NCT01682811|7464435|FG005|Treated 3 Hours|Part 1 Levulan Injection||0
6542697|NCT01682811|7464436|FG006|Treated 3 Hours|Part 1 Levulan Injection||0
6542698|NCT01682811|7464430|FG000|Treated 24 Hours|Part 1 Levulan Injection||1
6542699|NCT01682811|7464431|FG001|Treated 24 Hours|Part 1 Levulan Injection||0
6542700|NCT01682811|7464432|FG002|Treated 24 Hours|Part 1 Levulan Injection||0
6542701|NCT01682811|7464433|FG003|Treated 24 Hours|Part 1 Levulan Injection||0
6542702|NCT01682811|7464434|FG004|Treated 24 Hours|Part 1 Levulan Injection||0
6542703|NCT01682811|7464435|FG005|Treated 24 Hours|Part 1 Levulan Injection||0
6542704|NCT01682811|7464436|FG006|Treated 24 Hours|Part 1 Levulan Injection||0
6542705|NCT01682811|7464430|FG000|COMPLETED|Part 1 Levulan Injection||1
6542706|NCT01682811|7464431|FG001|COMPLETED|Part 1 Levulan Injection||0
6542707|NCT01682811|7464432|FG002|COMPLETED|Part 1 Levulan Injection||0
6542708|NCT01682811|7464433|FG003|COMPLETED|Part 1 Levulan Injection||0
6646343|NCT02379221|7575314|FG000|STARTED|Overall Study||49
6646344|NCT02379221|7575314|FG000|COMPLETED|Overall Study||48
6646345|NCT02379221|7575314|FG000|NOT COMPLETED|Overall Study||1
6646346|NCT02379247|7575327|FG000|STARTED|Overall Study||3
6646347|NCT02379247|7575328|FG001|STARTED|Overall Study||3
6646348|NCT02379247|7575329|FG002|STARTED|Overall Study||7
6646349|NCT02379247|7575330|FG003|STARTED|Overall Study||30
6646350|NCT02379247|7575327|FG000|COMPLETED|Overall Study||3
6646351|NCT02379247|7575328|FG001|COMPLETED|Overall Study||3
6646352|NCT02379247|7575329|FG002|COMPLETED|Overall Study||7
6646353|NCT02379247|7575330|FG003|COMPLETED|Overall Study||30
6646354|NCT02379247|7575327|FG000|NOT COMPLETED|Overall Study||0
6646355|NCT02379247|7575328|FG001|NOT COMPLETED|Overall Study||0
6646356|NCT02379247|7575329|FG002|NOT COMPLETED|Overall Study||0
6646357|NCT02379247|7575330|FG003|NOT COMPLETED|Overall Study||0
6646358|NCT02379273|7575343|FG000|STARTED|Overall Study||35
6646359|NCT02379273|7575343|FG000|COMPLETED|Overall Study|Completed 5 years postactivation.|35
6646360|NCT02379273|7575343|FG000|NOT COMPLETED|Overall Study||0
6646361|NCT02379442|7575347|FG000|STARTED|Overall Study||1
6646362|NCT02379442|7575347|FG000|COMPLETED|Overall Study||1
6646363|NCT02379442|7575347|FG000|NOT COMPLETED|Overall Study||0
6655954|NCT02457247|7586099|FG001|COMPLETED|Period 1||68
6655955|NCT02457247|7586100|FG002|COMPLETED|Period 1||68
6542709|NCT01682811|7464434|FG004|COMPLETED|Part 1 Levulan Injection||0
6542710|NCT01682811|7464435|FG005|COMPLETED|Part 1 Levulan Injection||0
6542711|NCT01682811|7464436|FG006|COMPLETED|Part 1 Levulan Injection||0
6542712|NCT01682811|7464430|FG000|NOT COMPLETED|Part 1 Levulan Injection||0
6542713|NCT01682811|7464431|FG001|NOT COMPLETED|Part 1 Levulan Injection||0
6542714|NCT01682811|7464432|FG002|NOT COMPLETED|Part 1 Levulan Injection||0
6542715|NCT01682811|7464433|FG003|NOT COMPLETED|Part 1 Levulan Injection||0
6542716|NCT01682811|7464434|FG004|NOT COMPLETED|Part 1 Levulan Injection||0
6542717|NCT01682811|7464435|FG005|NOT COMPLETED|Part 1 Levulan Injection||0
6542718|NCT01682811|7464436|FG006|NOT COMPLETED|Part 1 Levulan Injection||0
6542719|NCT01682811|7464430|FG000|STARTED|Part 1 Levulan Painting||0
6542720|NCT01682811|7464431|FG001|STARTED|Part 1 Levulan Painting||1
6542721|NCT01682811|7464432|FG002|STARTED|Part 1 Levulan Painting||0
6542722|NCT01682811|7464433|FG003|STARTED|Part 1 Levulan Painting||0
6542723|NCT01682811|7464434|FG004|STARTED|Part 1 Levulan Painting||0
6542724|NCT01682811|7464435|FG005|STARTED|Part 1 Levulan Painting||0
6542725|NCT01682811|7464436|FG006|STARTED|Part 1 Levulan Painting||0
6655956|NCT02457247|7586101|FG003|COMPLETED|Period 1||70
6655957|NCT02457247|7586098|FG000|NOT COMPLETED|Period 1||2
6655958|NCT02457247|7586099|FG001|NOT COMPLETED|Period 1||2
6655959|NCT02457247|7586100|FG002|NOT COMPLETED|Period 1||0
6655960|NCT02457247|7586101|FG003|NOT COMPLETED|Period 1||0
6655961|NCT02457247|7586098|FG000|STARTED|Period 2||66
6542726|NCT01682811|7464430|FG000|Control|Part 1 Levulan Painting||0
6542727|NCT01682811|7464431|FG001|Control|Part 1 Levulan Painting||1
6542728|NCT01682811|7464432|FG002|Control|Part 1 Levulan Painting||0
6542729|NCT01682811|7464433|FG003|Control|Part 1 Levulan Painting||0
6542730|NCT01682811|7464434|FG004|Control|Part 1 Levulan Painting||0
6542731|NCT01682811|7464435|FG005|Control|Part 1 Levulan Painting||0
6542732|NCT01682811|7464436|FG006|Control|Part 1 Levulan Painting||0
6542733|NCT01682811|7464430|FG000|Treated 3 Hours|Part 1 Levulan Painting||0
6542734|NCT01682811|7464431|FG001|Treated 3 Hours|Part 1 Levulan Painting||1
6646364|NCT02379637|7575353|FG000|STARTED|Overall Study||35
6646365|NCT02379637|7575354|FG001|STARTED|Overall Study||35
6646366|NCT02379637|7575353|FG000|COMPLETED|Overall Study||33
6646367|NCT02379637|7575354|FG001|COMPLETED|Overall Study||34
6646368|NCT02379637|7575353|FG000|NOT COMPLETED|Overall Study||2
6646369|NCT02379637|7575354|FG001|NOT COMPLETED|Overall Study||1
6646370|NCT02379728|7575362|FG000|STARTED|Overall Study||84
6646371|NCT02379728|7575363|FG001|STARTED|Overall Study||16
6646372|NCT02379728|7575364|FG002|STARTED|Overall Study||84
6646373|NCT02379728|7575365|FG003|STARTED|Overall Study||16
6646374|NCT02379728|7575362|FG000|COMPLETED|Overall Study||78
6646375|NCT02379728|7575363|FG001|COMPLETED|Overall Study||16
6646376|NCT02379728|7575364|FG002|COMPLETED|Overall Study||74
6646377|NCT02379728|7575365|FG003|COMPLETED|Overall Study||13
6646378|NCT02379728|7575362|FG000|NOT COMPLETED|Overall Study||6
6646379|NCT02379728|7575363|FG001|NOT COMPLETED|Overall Study||0
6646380|NCT02379728|7575364|FG002|NOT COMPLETED|Overall Study||10
6646381|NCT02379728|7575365|FG003|NOT COMPLETED|Overall Study||3
6646382|NCT02379858|7575376|FG000|STARTED|Overall Study||6
6646383|NCT02379858|7575377|FG001|STARTED|Overall Study||4
6646384|NCT02379858|7575376|FG000|COMPLETED|Overall Study||6
6646385|NCT02379858|7575377|FG001|COMPLETED|Overall Study||4
6646386|NCT02379858|7575376|FG000|NOT COMPLETED|Overall Study||0
6646387|NCT02379858|7575377|FG001|NOT COMPLETED|Overall Study||0
6646388|NCT02379923|7575383|FG000|STARTED|Overall Study||163
6646389|NCT02379923|7575383|FG000|COMPLETED|Overall Study||158
6646390|NCT02379923|7575383|FG000|NOT COMPLETED|Overall Study||5
6646391|NCT02380183|7575392|FG000|STARTED|Overall Study||36
6646392|NCT02380183|7575393|FG001|STARTED|Overall Study||34
6646393|NCT02380183|7575392|FG000|COMPLETED|Overall Study||36
6646394|NCT02380183|7575393|FG001|COMPLETED|Overall Study||34
6646395|NCT02380183|7575392|FG000|NOT COMPLETED|Overall Study||0
6646396|NCT02380183|7575393|FG001|NOT COMPLETED|Overall Study||0
6646397|NCT02380248|7575399|FG000|STARTED|Overall Study||200
6646398|NCT02380248|7575399|FG000|COMPLETED|Overall Study||186
6646399|NCT02380248|7575399|FG000|NOT COMPLETED|Overall Study||14
6646400|NCT02380261|7575404|FG000|STARTED|Overall Study||35
6646401|NCT02380261|7575404|FG000|COMPLETED|Overall Study||35
6646402|NCT02380261|7575404|FG000|NOT COMPLETED|Overall Study||0
6646403|NCT02380287|7575416|FG000|STARTED|Overall Study||1
6646404|NCT02380287|7575417|FG001|STARTED|Overall Study||3
6646405|NCT02380287|7575418|FG002|STARTED|Overall Study||3
6646406|NCT02380287|7575419|FG003|STARTED|Overall Study||3
6646407|NCT02380287|7575420|FG004|STARTED|Overall Study||3
6646408|NCT02380287|7575421|FG005|STARTED|Overall Study||3
6646409|NCT02380287|7575422|FG006|STARTED|Overall Study||3
6646410|NCT02380287|7575423|FG007|STARTED|Overall Study||3
6646411|NCT02380287|7575416|FG000|COMPLETED|Overall Study||1
6646412|NCT02380287|7575417|FG001|COMPLETED|Overall Study||3
6646413|NCT02380287|7575418|FG002|COMPLETED|Overall Study||2
6646414|NCT02380287|7575419|FG003|COMPLETED|Overall Study||3
6646415|NCT02380287|7575420|FG004|COMPLETED|Overall Study||3
6646416|NCT02380287|7575421|FG005|COMPLETED|Overall Study||3
6646417|NCT02380287|7575422|FG006|COMPLETED|Overall Study||3
6646418|NCT02380287|7575423|FG007|COMPLETED|Overall Study||3
6646419|NCT02380287|7575416|FG000|NOT COMPLETED|Overall Study||0
6646420|NCT02380287|7575417|FG001|NOT COMPLETED|Overall Study||0
6646421|NCT02380287|7575418|FG002|NOT COMPLETED|Overall Study||1
6646422|NCT02380287|7575419|FG003|NOT COMPLETED|Overall Study||0
6646423|NCT02380287|7575420|FG004|NOT COMPLETED|Overall Study||0
6542735|NCT01682811|7464432|FG002|Treated 3 Hours|Part 1 Levulan Painting||0
6542736|NCT01682811|7464433|FG003|Treated 3 Hours|Part 1 Levulan Painting||0
6542737|NCT01682811|7464434|FG004|Treated 3 Hours|Part 1 Levulan Painting||0
6542738|NCT01682811|7464435|FG005|Treated 3 Hours|Part 1 Levulan Painting||0
6542739|NCT01682811|7464436|FG006|Treated 3 Hours|Part 1 Levulan Painting||0
6542740|NCT01682811|7464430|FG000|Treated 24 Hours|Part 1 Levulan Painting||0
6542741|NCT01682811|7464431|FG001|Treated 24 Hours|Part 1 Levulan Painting||1
6646424|NCT02380287|7575421|FG005|NOT COMPLETED|Overall Study||0
6646425|NCT02380287|7575422|FG006|NOT COMPLETED|Overall Study||0
6646426|NCT02380287|7575423|FG007|NOT COMPLETED|Overall Study||0
6646427|NCT02380612|7575448|FG000|STARTED|Overall Study||30
6646428|NCT02380612|7575448|FG000|COMPLETED|Overall Study||27
6646429|NCT02380612|7575448|FG000|NOT COMPLETED|Overall Study||3
6646430|NCT02380677|7575467|FG000|STARTED|Overall Study||1
6646431|NCT02380677|7575468|FG001|STARTED|Overall Study||1
6646432|NCT02380677|7575469|FG002|STARTED|Overall Study||3
6646433|NCT02380677|7575470|FG003|STARTED|Overall Study||3
6646434|NCT02380677|7575471|FG004|STARTED|Overall Study||6
6646435|NCT02380677|7575472|FG005|STARTED|Overall Study||6
6646436|NCT02380677|7575473|FG006|STARTED|Overall Study||3
6646437|NCT02380677|7575474|FG007|STARTED|Overall Study||4
6646438|NCT02380677|7575475|FG008|STARTED|Overall Study||4
6646439|NCT02380677|7575476|FG009|STARTED|Overall Study||2
6542742|NCT01682811|7464432|FG002|Treated 24 Hours|Part 1 Levulan Painting||0
6542743|NCT01682811|7464433|FG003|Treated 24 Hours|Part 1 Levulan Painting||0
6542744|NCT01682811|7464434|FG004|Treated 24 Hours|Part 1 Levulan Painting||0
6542745|NCT01682811|7464435|FG005|Treated 24 Hours|Part 1 Levulan Painting||0
6542746|NCT01682811|7464436|FG006|Treated 24 Hours|Part 1 Levulan Painting||0
6542747|NCT01682811|7464430|FG000|COMPLETED|Part 1 Levulan Painting||0
6542748|NCT01682811|7464431|FG001|COMPLETED|Part 1 Levulan Painting||1
6542749|NCT01682811|7464432|FG002|COMPLETED|Part 1 Levulan Painting||0
6542750|NCT01682811|7464433|FG003|COMPLETED|Part 1 Levulan Painting||0
6542751|NCT01682811|7464434|FG004|COMPLETED|Part 1 Levulan Painting||0
6542752|NCT01682811|7464435|FG005|COMPLETED|Part 1 Levulan Painting||0
6542753|NCT01682811|7464436|FG006|COMPLETED|Part 1 Levulan Painting||0
6542754|NCT01682811|7464430|FG000|NOT COMPLETED|Part 1 Levulan Painting||0
6542755|NCT01682811|7464431|FG001|NOT COMPLETED|Part 1 Levulan Painting||0
6542756|NCT01682811|7464432|FG002|NOT COMPLETED|Part 1 Levulan Painting||0
6542757|NCT01682811|7464433|FG003|NOT COMPLETED|Part 1 Levulan Painting||0
6542758|NCT01682811|7464434|FG004|NOT COMPLETED|Part 1 Levulan Painting||0
6542759|NCT01682811|7464435|FG005|NOT COMPLETED|Part 1 Levulan Painting||0
6542760|NCT01682811|7464436|FG006|NOT COMPLETED|Part 1 Levulan Painting||0
6646440|NCT02380677|7575477|FG010|STARTED|Overall Study||4
6646441|NCT02380677|7575478|FG011|STARTED|Overall Study||5
6646442|NCT02380677|7575467|FG000|COMPLETED|Overall Study||0
6646443|NCT02380677|7575468|FG001|COMPLETED|Overall Study||0
6646444|NCT02380677|7575469|FG002|COMPLETED|Overall Study||0
6646445|NCT02380677|7575470|FG003|COMPLETED|Overall Study||0
6646446|NCT02380677|7575471|FG004|COMPLETED|Overall Study||0
6646447|NCT02380677|7575472|FG005|COMPLETED|Overall Study||0
6646448|NCT02380677|7575473|FG006|COMPLETED|Overall Study||0
6646449|NCT02380677|7575474|FG007|COMPLETED|Overall Study||0
6646450|NCT02380677|7575475|FG008|COMPLETED|Overall Study||0
6646451|NCT02380677|7575476|FG009|COMPLETED|Overall Study||0
6646452|NCT02380677|7575477|FG010|COMPLETED|Overall Study||0
6646453|NCT02380677|7575478|FG011|COMPLETED|Overall Study||0
6646454|NCT02380677|7575467|FG000|NOT COMPLETED|Overall Study||1
6646455|NCT02380677|7575468|FG001|NOT COMPLETED|Overall Study||1
6646456|NCT02380677|7575469|FG002|NOT COMPLETED|Overall Study||3
6646457|NCT02380677|7575470|FG003|NOT COMPLETED|Overall Study||3
6646458|NCT02380677|7575471|FG004|NOT COMPLETED|Overall Study||6
6646459|NCT02380677|7575472|FG005|NOT COMPLETED|Overall Study||6
6646460|NCT02380677|7575473|FG006|NOT COMPLETED|Overall Study||3
6646461|NCT02380677|7575474|FG007|NOT COMPLETED|Overall Study||4
6646462|NCT02380677|7575475|FG008|NOT COMPLETED|Overall Study||4
6646463|NCT02380677|7575476|FG009|NOT COMPLETED|Overall Study||2
6646464|NCT02380677|7575477|FG010|NOT COMPLETED|Overall Study||4
6646465|NCT02380677|7575478|FG011|NOT COMPLETED|Overall Study||5
6646466|NCT02380690|7575508|FG000|STARTED|Overall Study||119
6646467|NCT02380690|7575509|FG001|STARTED|Overall Study||94
6646468|NCT02380690|7575508|FG000|COMPLETED|Overall Study||85
6646469|NCT02380690|7575509|FG001|COMPLETED|Overall Study||82
6646470|NCT02380690|7575508|FG000|NOT COMPLETED|Overall Study||34
6646471|NCT02380690|7575509|FG001|NOT COMPLETED|Overall Study||12
6646472|NCT02380703|7575517|FG000|STARTED|Overall Study||114
6646473|NCT02380703|7575518|FG001|STARTED|Overall Study||114
6646474|NCT02380703|7575517|FG000|Month 3|Overall Study||104
6646475|NCT02380703|7575518|FG001|Month 3|Overall Study||109
6646476|NCT02380703|7575517|FG000|Month 6|Overall Study||102
6646477|NCT02380703|7575518|FG001|Month 6|Overall Study||107
6646478|NCT02380703|7575517|FG000|Month 12|Overall Study||99
6646479|NCT02380703|7575518|FG001|Month 12|Overall Study||100
6646480|NCT02380703|7575517|FG000|COMPLETED|Overall Study||78
6646481|NCT02380703|7575518|FG001|COMPLETED|Overall Study||78
6646482|NCT02380703|7575517|FG000|NOT COMPLETED|Overall Study||36
6646483|NCT02380703|7575518|FG001|NOT COMPLETED|Overall Study||36
6646484|NCT02380742|7575526|FG000|STARTED|Overall Study||28
6646485|NCT02380742|7575527|FG001|STARTED|Overall Study||26
6646486|NCT02380742|7575526|FG000|COMPLETED|Overall Study||27
6646487|NCT02380742|7575527|FG001|COMPLETED|Overall Study||26
6646488|NCT02380742|7575526|FG000|NOT COMPLETED|Overall Study||1
6646489|NCT02380742|7575527|FG001|NOT COMPLETED|Overall Study||0
6646490|NCT02380859|7575535|FG000|STARTED|Overall Study||19
6646491|NCT02380859|7575536|FG001|STARTED|Overall Study||13
6646492|NCT02380859|7575535|FG000|COMPLETED|Overall Study||17
6646493|NCT02380859|7575536|FG001|COMPLETED|Overall Study||13
6646494|NCT02380859|7575535|FG000|NOT COMPLETED|Overall Study||2
6646495|NCT02380859|7575536|FG001|NOT COMPLETED|Overall Study||0
6646496|NCT02381015|7575546|FG000|STARTED|Visit 1 - Enrollment||175
6646497|NCT02381015|7575547|FG001|STARTED|Visit 1 - Enrollment||175
6646498|NCT02381015|7575548|FG002|STARTED|Visit 1 - Enrollment||175
6542761|NCT01682811|7464430|FG000|STARTED|Part 1 Levulan Painted Twice||0
6542762|NCT01682811|7464431|FG001|STARTED|Part 1 Levulan Painted Twice||0
6646499|NCT02381015|7575549|FG003|STARTED|Visit 1 - Enrollment||175
6646500|NCT02381015|7575546|FG000|COMPLETED|Visit 1 - Enrollment||175
6646501|NCT02381015|7575547|FG001|COMPLETED|Visit 1 - Enrollment||173
6646502|NCT02381015|7575548|FG002|COMPLETED|Visit 1 - Enrollment||175
6646503|NCT02381015|7575549|FG003|COMPLETED|Visit 1 - Enrollment||172
6646504|NCT02381015|7575546|FG000|NOT COMPLETED|Visit 1 - Enrollment||0
6542763|NCT01682811|7464432|FG002|STARTED|Part 1 Levulan Painted Twice||2
6542764|NCT01682811|7464433|FG003|STARTED|Part 1 Levulan Painted Twice||0
6542765|NCT01682811|7464434|FG004|STARTED|Part 1 Levulan Painted Twice||0
6646505|NCT02381015|7575547|FG001|NOT COMPLETED|Visit 1 - Enrollment||2
6542766|NCT01682811|7464435|FG005|STARTED|Part 1 Levulan Painted Twice||0
6542767|NCT01682811|7464436|FG006|STARTED|Part 1 Levulan Painted Twice||0
6542768|NCT01682811|7464430|FG000|Control|Part 1 Levulan Painted Twice||0
6542769|NCT01682811|7464431|FG001|Control|Part 1 Levulan Painted Twice||0
6542770|NCT01682811|7464432|FG002|Control|Part 1 Levulan Painted Twice||2
6542771|NCT01682811|7464433|FG003|Control|Part 1 Levulan Painted Twice||0
6542772|NCT01682811|7464434|FG004|Control|Part 1 Levulan Painted Twice||0
6542773|NCT01682811|7464435|FG005|Control|Part 1 Levulan Painted Twice||0
6542774|NCT01682811|7464436|FG006|Control|Part 1 Levulan Painted Twice||0
6542775|NCT01682811|7464430|FG000|Treated 24 Hours|Part 1 Levulan Painted Twice||0
6542776|NCT01682811|7464431|FG001|Treated 24 Hours|Part 1 Levulan Painted Twice||0
6542777|NCT01682811|7464432|FG002|Treated 24 Hours|Part 1 Levulan Painted Twice||2
6542778|NCT01682811|7464433|FG003|Treated 24 Hours|Part 1 Levulan Painted Twice||0
6542779|NCT01682811|7464434|FG004|Treated 24 Hours|Part 1 Levulan Painted Twice||0
6646506|NCT02381015|7575548|FG002|NOT COMPLETED|Visit 1 - Enrollment||0
6646507|NCT02381015|7575549|FG003|NOT COMPLETED|Visit 1 - Enrollment||3
6646508|NCT02381015|7575546|FG000|STARTED|Visit 2 - Results DIsclosure||175
6646509|NCT02381015|7575547|FG001|STARTED|Visit 2 - Results DIsclosure||173
6646510|NCT02381015|7575548|FG002|STARTED|Visit 2 - Results DIsclosure||175
6646511|NCT02381015|7575549|FG003|STARTED|Visit 2 - Results DIsclosure||172
6646512|NCT02381015|7575546|FG000|COMPLETED|Visit 2 - Results DIsclosure||172
6646513|NCT02381015|7575547|FG001|COMPLETED|Visit 2 - Results DIsclosure||168
6646514|NCT02381015|7575548|FG002|COMPLETED|Visit 2 - Results DIsclosure||173
6646515|NCT02381015|7575549|FG003|COMPLETED|Visit 2 - Results DIsclosure||169
6646516|NCT02381015|7575546|FG000|NOT COMPLETED|Visit 2 - Results DIsclosure||3
6646517|NCT02381015|7575547|FG001|NOT COMPLETED|Visit 2 - Results DIsclosure||5
6646518|NCT02381015|7575548|FG002|NOT COMPLETED|Visit 2 - Results DIsclosure||2
6646519|NCT02381015|7575549|FG003|NOT COMPLETED|Visit 2 - Results DIsclosure||3
6646520|NCT02381015|7575546|FG000|STARTED|Visit 3 - 3 Months Followup||172
6646521|NCT02381015|7575547|FG001|STARTED|Visit 3 - 3 Months Followup||168
6646522|NCT02381015|7575548|FG002|STARTED|Visit 3 - 3 Months Followup||173
6646523|NCT02381015|7575549|FG003|STARTED|Visit 3 - 3 Months Followup||169
6646524|NCT02381015|7575546|FG000|COMPLETED|Visit 3 - 3 Months Followup||172
6646525|NCT02381015|7575547|FG001|COMPLETED|Visit 3 - 3 Months Followup||168
6646526|NCT02381015|7575548|FG002|COMPLETED|Visit 3 - 3 Months Followup||173
6646527|NCT02381015|7575549|FG003|COMPLETED|Visit 3 - 3 Months Followup||169
6646528|NCT02381015|7575546|FG000|NOT COMPLETED|Visit 3 - 3 Months Followup||0
6646529|NCT02381015|7575547|FG001|NOT COMPLETED|Visit 3 - 3 Months Followup||0
6646530|NCT02381015|7575548|FG002|NOT COMPLETED|Visit 3 - 3 Months Followup||0
6646531|NCT02381015|7575549|FG003|NOT COMPLETED|Visit 3 - 3 Months Followup||0
6646532|NCT02381015|7575546|FG000|STARTED|Year 3 Chart Review||172
6646533|NCT02381015|7575547|FG001|STARTED|Year 3 Chart Review||168
6646534|NCT02381015|7575548|FG002|STARTED|Year 3 Chart Review||173
6646535|NCT02381015|7575549|FG003|STARTED|Year 3 Chart Review||169
6646536|NCT02381015|7575546|FG000|COMPLETED|Year 3 Chart Review||125
6646537|NCT02381015|7575547|FG001|COMPLETED|Year 3 Chart Review||134
6646538|NCT02381015|7575548|FG002|COMPLETED|Year 3 Chart Review||115
6646539|NCT02381015|7575549|FG003|COMPLETED|Year 3 Chart Review||118
6646540|NCT02381015|7575546|FG000|NOT COMPLETED|Year 3 Chart Review||47
6646541|NCT02381015|7575547|FG001|NOT COMPLETED|Year 3 Chart Review||34
6646542|NCT02381015|7575548|FG002|NOT COMPLETED|Year 3 Chart Review||58
6646543|NCT02381015|7575549|FG003|NOT COMPLETED|Year 3 Chart Review||51
6646544|NCT02381288|7575568|FG000|STARTED|Overall Study||5
6646545|NCT02381288|7575569|FG001|STARTED|Overall Study||2
6646546|NCT02381288|7575570|FG002|STARTED|Overall Study||5
6646547|NCT02381288|7575571|FG003|STARTED|Overall Study||5
6646548|NCT02381288|7575568|FG000|COMPLETED|Overall Study||5
6646549|NCT02381288|7575569|FG001|COMPLETED|Overall Study||2
6646550|NCT02381288|7575570|FG002|COMPLETED|Overall Study||5
6646551|NCT02381288|7575571|FG003|COMPLETED|Overall Study||5
6646552|NCT02381288|7575568|FG000|NOT COMPLETED|Overall Study||0
6646553|NCT02381288|7575569|FG001|NOT COMPLETED|Overall Study||0
6646554|NCT02381288|7575570|FG002|NOT COMPLETED|Overall Study||0
6646555|NCT02381288|7575571|FG003|NOT COMPLETED|Overall Study||0
6646556|NCT02381392|7575586|FG000|STARTED|Overall Study||11
6646557|NCT02381392|7575587|FG001|STARTED|Overall Study||12
6646558|NCT02381392|7575586|FG000|COMPLETED|Overall Study||11
6646559|NCT02381392|7575587|FG001|COMPLETED|Overall Study||12
6646560|NCT02381392|7575586|FG000|NOT COMPLETED|Overall Study||0
6646561|NCT02381392|7575587|FG001|NOT COMPLETED|Overall Study||0
6646562|NCT02381418|7575593|FG000|STARTED|Overall Study||120
6646563|NCT02381418|7575593|FG000|COMPLETED|Overall Study||120
6646564|NCT02381418|7575593|FG000|NOT COMPLETED|Overall Study||0
6646565|NCT02381678|7575598|FG000|STARTED|Overall Study||54
6646566|NCT02381678|7575599|FG001|STARTED|Overall Study||139
6646567|NCT02381678|7575600|FG002|STARTED|Overall Study||32
6542780|NCT01682811|7464435|FG005|Treated 24 Hours|Part 1 Levulan Painted Twice||0
6542781|NCT01682811|7464436|FG006|Treated 24 Hours|Part 1 Levulan Painted Twice||0
6542782|NCT01682811|7464430|FG000|COMPLETED|Part 1 Levulan Painted Twice||0
6542783|NCT01682811|7464431|FG001|COMPLETED|Part 1 Levulan Painted Twice||0
6646568|NCT02381678|7575598|FG000|COMPLETED|Overall Study||54
6646569|NCT02381678|7575599|FG001|COMPLETED|Overall Study||139
6646570|NCT02381678|7575600|FG002|COMPLETED|Overall Study||32
6646571|NCT02381678|7575598|FG000|NOT COMPLETED|Overall Study||0
6646572|NCT02381678|7575599|FG001|NOT COMPLETED|Overall Study||0
6542784|NCT01682811|7464432|FG002|COMPLETED|Part 1 Levulan Painted Twice||2
6542785|NCT01682811|7464433|FG003|COMPLETED|Part 1 Levulan Painted Twice||0
6542786|NCT01682811|7464434|FG004|COMPLETED|Part 1 Levulan Painted Twice||0
6542787|NCT01682811|7464435|FG005|COMPLETED|Part 1 Levulan Painted Twice||0
6542788|NCT01682811|7464436|FG006|COMPLETED|Part 1 Levulan Painted Twice||0
6542789|NCT01682811|7464430|FG000|NOT COMPLETED|Part 1 Levulan Painted Twice||0
6542790|NCT01682811|7464431|FG001|NOT COMPLETED|Part 1 Levulan Painted Twice||0
6542791|NCT01682811|7464432|FG002|NOT COMPLETED|Part 1 Levulan Painted Twice||0
6542792|NCT01682811|7464433|FG003|NOT COMPLETED|Part 1 Levulan Painted Twice||0
6542793|NCT01682811|7464434|FG004|NOT COMPLETED|Part 1 Levulan Painted Twice||0
6542794|NCT01682811|7464435|FG005|NOT COMPLETED|Part 1 Levulan Painted Twice||0
6542795|NCT01682811|7464436|FG006|NOT COMPLETED|Part 1 Levulan Painted Twice||0
6542796|NCT01682811|7464430|FG000|STARTED|Part 1 Levulan Paint Twice Microneedling||0
6542797|NCT01682811|7464431|FG001|STARTED|Part 1 Levulan Paint Twice Microneedling||0
6542798|NCT01682811|7464432|FG002|STARTED|Part 1 Levulan Paint Twice Microneedling||0
6542799|NCT01682811|7464433|FG003|STARTED|Part 1 Levulan Paint Twice Microneedling||2
6542800|NCT01682811|7464434|FG004|STARTED|Part 1 Levulan Paint Twice Microneedling||0
6542801|NCT01682811|7464435|FG005|STARTED|Part 1 Levulan Paint Twice Microneedling||0
6542802|NCT01682811|7464436|FG006|STARTED|Part 1 Levulan Paint Twice Microneedling||0
6646573|NCT02381678|7575600|FG002|NOT COMPLETED|Overall Study||0
6646574|NCT02381795|7575606|FG000|STARTED|Overall Study||10
6646575|NCT02381795|7575606|FG000|COMPLETED|Overall Study||7
6646576|NCT02381795|7575606|FG000|NOT COMPLETED|Overall Study||3
6646577|NCT02382016|7575612|FG000|STARTED|Double-blind (DB) Treatment Period||43
6646578|NCT02382016|7575613|FG001|STARTED|Double-blind (DB) Treatment Period||42
6646579|NCT02382016|7575612|FG000|COMPLETED|Double-blind (DB) Treatment Period||39
6646580|NCT02382016|7575613|FG001|COMPLETED|Double-blind (DB) Treatment Period||41
6646581|NCT02382016|7575612|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||4
6646582|NCT02382016|7575613|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||1
6646583|NCT02382016|7575612|FG000|STARTED|Open-label (OL) Treatment Period||80
6646584|NCT02382016|7575613|FG001|STARTED|Open-label (OL) Treatment Period||0
6646585|NCT02382016|7575612|FG000|COMPLETED|Open-label (OL) Treatment Period||71
6646586|NCT02382016|7575613|FG001|COMPLETED|Open-label (OL) Treatment Period||0
6646587|NCT02382016|7575612|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||9
6646588|NCT02382016|7575613|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||0
6646589|NCT02382016|7575612|FG000|STARTED|OL Extension Period|Participants(French site) who completed DB,OL periods, consented receiving macitentan in OLE period.|33
6646590|NCT02382016|7575613|FG001|STARTED|OL Extension Period||0
6646591|NCT02382016|7575612|FG000|COMPLETED|OL Extension Period||27
6646592|NCT02382016|7575613|FG001|COMPLETED|OL Extension Period||0
6646593|NCT02382016|7575612|FG000|NOT COMPLETED|OL Extension Period||6
6646594|NCT02382016|7575613|FG001|NOT COMPLETED|OL Extension Period||0
6646595|NCT02382133|7575621|FG000|STARTED|Overall Study||43
6646596|NCT02382133|7575621|FG000|COMPLETED|Overall Study||10
6646597|NCT02382133|7575621|FG000|NOT COMPLETED|Overall Study||33
6646598|NCT02382276|7575628|FG000|STARTED|Overall Study||137
6646599|NCT02382276|7575629|FG001|STARTED|Overall Study||94
6646600|NCT02382276|7575630|FG002|STARTED|Overall Study||172
6646601|NCT02382276|7575628|FG000|COMPLETED|Overall Study||126
6646602|NCT02382276|7575629|FG001|COMPLETED|Overall Study||84
6646603|NCT02382276|7575630|FG002|COMPLETED|Overall Study||133
6646604|NCT02382276|7575628|FG000|NOT COMPLETED|Overall Study||11
6646605|NCT02382276|7575629|FG001|NOT COMPLETED|Overall Study||10
6646606|NCT02382276|7575630|FG002|NOT COMPLETED|Overall Study||39
6646607|NCT02382640|7575640|FG000|STARTED|Intervention Period 1 (3 Days)||9
6646608|NCT02382640|7575641|FG001|STARTED|Intervention Period 1 (3 Days)||9
6646609|NCT02382640|7575642|FG002|STARTED|Intervention Period 1 (3 Days)||9
6646610|NCT02382640|7575643|FG003|STARTED|Intervention Period 1 (3 Days)||9
6646611|NCT02382640|7575640|FG000|COMPLETED|Intervention Period 1 (3 Days)||9
6646612|NCT02382640|7575641|FG001|COMPLETED|Intervention Period 1 (3 Days)||9
6646613|NCT02382640|7575642|FG002|COMPLETED|Intervention Period 1 (3 Days)||9
6646614|NCT02382640|7575643|FG003|COMPLETED|Intervention Period 1 (3 Days)||9
6646615|NCT02382640|7575640|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6646616|NCT02382640|7575641|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6646617|NCT02382640|7575642|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6646618|NCT02382640|7575643|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6646619|NCT02382640|7575640|FG000|STARTED|Washout Period 1 (7 Days)||9
6646620|NCT02382640|7575641|FG001|STARTED|Washout Period 1 (7 Days)||9
6646621|NCT02382640|7575642|FG002|STARTED|Washout Period 1 (7 Days)||9
6646622|NCT02382640|7575643|FG003|STARTED|Washout Period 1 (7 Days)||9
6646623|NCT02382640|7575640|FG000|COMPLETED|Washout Period 1 (7 Days)||9
6646624|NCT02382640|7575641|FG001|COMPLETED|Washout Period 1 (7 Days)||9
6646625|NCT02382640|7575642|FG002|COMPLETED|Washout Period 1 (7 Days)||9
6646626|NCT02382640|7575643|FG003|COMPLETED|Washout Period 1 (7 Days)||9
6646627|NCT02382640|7575640|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6646628|NCT02382640|7575641|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6646629|NCT02382640|7575642|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6646630|NCT02382640|7575643|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6542803|NCT01682811|7464430|FG000|Control|Part 1 Levulan Paint Twice Microneedling||0
6542804|NCT01682811|7464431|FG001|Control|Part 1 Levulan Paint Twice Microneedling||0
6542805|NCT01682811|7464432|FG002|Control|Part 1 Levulan Paint Twice Microneedling||0
6542806|NCT01682811|7464433|FG003|Control|Part 1 Levulan Paint Twice Microneedling||2
6542807|NCT01682811|7464434|FG004|Control|Part 1 Levulan Paint Twice Microneedling||0
6542808|NCT01682811|7464435|FG005|Control|Part 1 Levulan Paint Twice Microneedling||0
6542809|NCT01682811|7464436|FG006|Control|Part 1 Levulan Paint Twice Microneedling||0
6542810|NCT01682811|7464430|FG000|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
6542811|NCT01682811|7464431|FG001|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
6542812|NCT01682811|7464432|FG002|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
6542813|NCT01682811|7464433|FG003|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||2
6542814|NCT01682811|7464434|FG004|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
6542815|NCT01682811|7464435|FG005|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
6542816|NCT01682811|7464436|FG006|Treated 24 Hours|Part 1 Levulan Paint Twice Microneedling||0
6542817|NCT01682811|7464430|FG000|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542818|NCT01682811|7464431|FG001|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542819|NCT01682811|7464432|FG002|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542820|NCT01682811|7464433|FG003|COMPLETED|Part 1 Levulan Paint Twice Microneedling||2
6542821|NCT01682811|7464434|FG004|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542822|NCT01682811|7464435|FG005|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542823|NCT01682811|7464436|FG006|COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542824|NCT01682811|7464430|FG000|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542825|NCT01682811|7464431|FG001|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6646631|NCT02382640|7575640|FG000|STARTED|Intervention Period 2 (3 Days)||9
6646632|NCT02382640|7575641|FG001|STARTED|Intervention Period 2 (3 Days)||9
6646633|NCT02382640|7575642|FG002|STARTED|Intervention Period 2 (3 Days)||9
6646634|NCT02382640|7575643|FG003|STARTED|Intervention Period 2 (3 Days)||9
6646635|NCT02382640|7575640|FG000|COMPLETED|Intervention Period 2 (3 Days)||9
6646636|NCT02382640|7575641|FG001|COMPLETED|Intervention Period 2 (3 Days)||9
6646637|NCT02382640|7575642|FG002|COMPLETED|Intervention Period 2 (3 Days)||9
6646638|NCT02382640|7575643|FG003|COMPLETED|Intervention Period 2 (3 Days)||9
6646639|NCT02382640|7575640|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6646640|NCT02382640|7575641|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6646641|NCT02382640|7575642|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6646642|NCT02382640|7575643|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6646643|NCT02382640|7575640|FG000|STARTED|Washout Period 2 (7 Days)||9
6646644|NCT02382640|7575641|FG001|STARTED|Washout Period 2 (7 Days)||9
6646645|NCT02382640|7575642|FG002|STARTED|Washout Period 2 (7 Days)||9
6646646|NCT02382640|7575643|FG003|STARTED|Washout Period 2 (7 Days)||9
6646647|NCT02382640|7575640|FG000|COMPLETED|Washout Period 2 (7 Days)||9
6646648|NCT02382640|7575641|FG001|COMPLETED|Washout Period 2 (7 Days)||9
6646649|NCT02382640|7575642|FG002|COMPLETED|Washout Period 2 (7 Days)||9
6646650|NCT02382640|7575643|FG003|COMPLETED|Washout Period 2 (7 Days)||9
6646651|NCT02382640|7575640|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6646652|NCT02382640|7575641|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6646653|NCT02382640|7575642|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6646654|NCT02382640|7575643|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6646655|NCT02382640|7575640|FG000|STARTED|Intervention Period 3 (3 Days)||9
6646656|NCT02382640|7575641|FG001|STARTED|Intervention Period 3 (3 Days)||9
6646657|NCT02382640|7575642|FG002|STARTED|Intervention Period 3 (3 Days)||9
6646658|NCT02382640|7575643|FG003|STARTED|Intervention Period 3 (3 Days)||9
6646659|NCT02382640|7575640|FG000|COMPLETED|Intervention Period 3 (3 Days)||9
6646660|NCT02382640|7575641|FG001|COMPLETED|Intervention Period 3 (3 Days)||9
6646661|NCT02382640|7575642|FG002|COMPLETED|Intervention Period 3 (3 Days)||9
6646662|NCT02382640|7575643|FG003|COMPLETED|Intervention Period 3 (3 Days)||9
6646663|NCT02382640|7575640|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6646664|NCT02382640|7575641|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6646665|NCT02382640|7575642|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6646666|NCT02382640|7575643|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6646667|NCT02382640|7575640|FG000|STARTED|Washout Period 3 (7 Days)||9
6646668|NCT02382640|7575641|FG001|STARTED|Washout Period 3 (7 Days)||9
6646669|NCT02382640|7575642|FG002|STARTED|Washout Period 3 (7 Days)||9
6646670|NCT02382640|7575643|FG003|STARTED|Washout Period 3 (7 Days)||9
6646671|NCT02382640|7575640|FG000|COMPLETED|Washout Period 3 (7 Days)||9
6646672|NCT02382640|7575641|FG001|COMPLETED|Washout Period 3 (7 Days)||9
6646673|NCT02382640|7575642|FG002|COMPLETED|Washout Period 3 (7 Days)||9
6646674|NCT02382640|7575643|FG003|COMPLETED|Washout Period 3 (7 Days)||9
6646675|NCT02382640|7575640|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
6646676|NCT02382640|7575641|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
6646677|NCT02382640|7575642|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
6646678|NCT02382640|7575643|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
6646679|NCT02382640|7575640|FG000|STARTED|Intervention Period 4 (3 Days)||9
6646680|NCT02382640|7575641|FG001|STARTED|Intervention Period 4 (3 Days)||9
6646681|NCT02382640|7575642|FG002|STARTED|Intervention Period 4 (3 Days)||9
6646682|NCT02382640|7575643|FG003|STARTED|Intervention Period 4 (3 Days)||9
6646683|NCT02382640|7575640|FG000|COMPLETED|Intervention Period 4 (3 Days)||8
6646684|NCT02382640|7575641|FG001|COMPLETED|Intervention Period 4 (3 Days)||9
6646685|NCT02382640|7575642|FG002|COMPLETED|Intervention Period 4 (3 Days)||9
6646686|NCT02382640|7575643|FG003|COMPLETED|Intervention Period 4 (3 Days)||9
6646687|NCT02382640|7575640|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||1
6655962|NCT02457247|7586099|FG001|STARTED|Period 2||68
6646688|NCT02382640|7575641|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6646689|NCT02382640|7575642|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6646690|NCT02382640|7575643|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6646691|NCT02382705|7575653|FG000|STARTED|Overall Study||57
6646692|NCT02382705|7575653|FG000|COMPLETED|Overall Study||33
6646693|NCT02382705|7575653|FG000|NOT COMPLETED|Overall Study||24
6646694|NCT02382744|7575659|FG000|STARTED|Overall Study||40
6646695|NCT02382744|7575660|FG001|STARTED|Overall Study||40
6646696|NCT02382744|7575659|FG000|Allocated|Overall Study||40
6646697|NCT02382744|7575660|FG001|Allocated|Overall Study||40
6646698|NCT02382744|7575659|FG000|Analyzed|Overall Study||40
6646699|NCT02382744|7575660|FG001|Analyzed|Overall Study||40
6646700|NCT02382744|7575659|FG000|COMPLETED|Overall Study||40
6646701|NCT02382744|7575660|FG001|COMPLETED|Overall Study||40
6646702|NCT02382744|7575659|FG000|NOT COMPLETED|Overall Study||0
6646703|NCT02382744|7575660|FG001|NOT COMPLETED|Overall Study||0
6646704|NCT02382796|7575670|FG000|STARTED|Overall Study||7
6646705|NCT02382796|7575670|FG000|COMPLETED|Overall Study||0
6646706|NCT02382796|7575670|FG000|NOT COMPLETED|Overall Study||7
6646707|NCT02382848|7575674|FG000|STARTED|First Intervention (3 Weeks)||3
6646708|NCT02382848|7575675|FG001|STARTED|First Intervention (3 Weeks)||5
6646709|NCT02382848|7575674|FG000|COMPLETED|First Intervention (3 Weeks)||3
6646710|NCT02382848|7575675|FG001|COMPLETED|First Intervention (3 Weeks)||5
6646711|NCT02382848|7575674|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
6646712|NCT02382848|7575675|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
6646713|NCT02382848|7575674|FG000|STARTED|Washout (1 Week)||3
6646714|NCT02382848|7575675|FG001|STARTED|Washout (1 Week)||5
6646715|NCT02382848|7575674|FG000|COMPLETED|Washout (1 Week)||3
6646716|NCT02382848|7575675|FG001|COMPLETED|Washout (1 Week)||5
6646717|NCT02382848|7575674|FG000|NOT COMPLETED|Washout (1 Week)||0
6646718|NCT02382848|7575675|FG001|NOT COMPLETED|Washout (1 Week)||0
6646719|NCT02382848|7575674|FG000|STARTED|Second Intervention (3 Weeks)||3
6646720|NCT02382848|7575675|FG001|STARTED|Second Intervention (3 Weeks)||5
6646721|NCT02382848|7575674|FG000|COMPLETED|Second Intervention (3 Weeks)||3
6646722|NCT02382848|7575675|FG001|COMPLETED|Second Intervention (3 Weeks)||5
6646723|NCT02382848|7575674|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6646724|NCT02382848|7575675|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6646725|NCT02382913|7575691|FG000|STARTED|Overall Study||27
6646726|NCT02382913|7575692|FG001|STARTED|Overall Study||36
6646727|NCT02382913|7575693|FG002|STARTED|Overall Study||32
6646728|NCT02382913|7575694|FG003|STARTED|Overall Study||27
6646729|NCT02382913|7575695|FG004|STARTED|Overall Study||33
6646730|NCT02382913|7575696|FG005|STARTED|Overall Study||30
6646731|NCT02382913|7575697|FG006|STARTED|Overall Study||37
6646732|NCT02382913|7575698|FG007|STARTED|Overall Study||30
6646733|NCT02382913|7575699|FG008|STARTED|Overall Study||30
6646734|NCT02382913|7575700|FG009|STARTED|Overall Study||33
6646735|NCT02382913|7575691|FG000|COMPLETED|Overall Study||27
6646736|NCT02382913|7575692|FG001|COMPLETED|Overall Study||36
6646737|NCT02382913|7575693|FG002|COMPLETED|Overall Study||32
6646738|NCT02382913|7575694|FG003|COMPLETED|Overall Study||27
6646739|NCT02382913|7575695|FG004|COMPLETED|Overall Study||33
6646740|NCT02382913|7575696|FG005|COMPLETED|Overall Study||30
6646741|NCT02382913|7575697|FG006|COMPLETED|Overall Study||37
6646742|NCT02382913|7575698|FG007|COMPLETED|Overall Study||30
6646743|NCT02382913|7575699|FG008|COMPLETED|Overall Study||30
6646744|NCT02382913|7575700|FG009|COMPLETED|Overall Study||33
6646745|NCT02382913|7575691|FG000|NOT COMPLETED|Overall Study||0
6646746|NCT02382913|7575692|FG001|NOT COMPLETED|Overall Study||0
6646747|NCT02382913|7575693|FG002|NOT COMPLETED|Overall Study||0
6646748|NCT02382913|7575694|FG003|NOT COMPLETED|Overall Study||0
6646749|NCT02382913|7575695|FG004|NOT COMPLETED|Overall Study||0
6646750|NCT02382913|7575696|FG005|NOT COMPLETED|Overall Study||0
6646751|NCT02382913|7575697|FG006|NOT COMPLETED|Overall Study||0
6646752|NCT02382913|7575698|FG007|NOT COMPLETED|Overall Study||0
6646753|NCT02382913|7575699|FG008|NOT COMPLETED|Overall Study||0
6646754|NCT02382913|7575700|FG009|NOT COMPLETED|Overall Study||0
6646755|NCT02382939|7575724|FG000|STARTED|Overall Study||31
6646756|NCT02382939|7575725|FG001|STARTED|Overall Study||61
6646757|NCT02382939|7575724|FG000|Exposed|Overall Study||31
6646758|NCT02382939|7575725|FG001|Exposed|Overall Study||61
6646759|NCT02382939|7575724|FG000|COMPLETED|Overall Study||28
6646760|NCT02382939|7575725|FG001|COMPLETED|Overall Study||58
6646761|NCT02382939|7575724|FG000|NOT COMPLETED|Overall Study||3
6646762|NCT02382939|7575725|FG001|NOT COMPLETED|Overall Study||3
6646763|NCT02382991|7575734|FG000|STARTED|Overall Study||17
6646764|NCT02382991|7575735|FG001|STARTED|Overall Study||18
6646765|NCT02382991|7575734|FG000|COMPLETED|Overall Study||15
6646766|NCT02382991|7575735|FG001|COMPLETED|Overall Study||15
6646767|NCT02382991|7575734|FG000|NOT COMPLETED|Overall Study||2
6646768|NCT02382991|7575735|FG001|NOT COMPLETED|Overall Study||3
6646769|NCT02383017|7575742|FG000|STARTED|Overall Study||15
6646770|NCT02383017|7575743|FG001|STARTED|Overall Study||13
6646771|NCT02383017|7575742|FG000|COMPLETED|Overall Study||10
6646772|NCT02383017|7575743|FG001|COMPLETED|Overall Study||11
6646773|NCT02383017|7575742|FG000|NOT COMPLETED|Overall Study||5
6646774|NCT02383017|7575743|FG001|NOT COMPLETED|Overall Study||2
6646775|NCT02383043|7575752|FG000|STARTED|Overall Study||9
6646776|NCT02383043|7575753|FG001|STARTED|Overall Study||5
6646777|NCT02383043|7575754|FG002|STARTED|Overall Study||4
6646778|NCT02383043|7575752|FG000|COMPLETED|Overall Study||7
6542826|NCT01682811|7464432|FG002|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542827|NCT01682811|7464433|FG003|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542828|NCT01682811|7464434|FG004|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542829|NCT01682811|7464435|FG005|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542830|NCT01682811|7464436|FG006|NOT COMPLETED|Part 1 Levulan Paint Twice Microneedling||0
6542831|NCT01682811|7464430|FG000|STARTED|Part 2 Dose Level 1||0
6542832|NCT01682811|7464431|FG001|STARTED|Part 2 Dose Level 1||0
6542833|NCT01682811|7464432|FG002|STARTED|Part 2 Dose Level 1||0
6646779|NCT02383043|7575753|FG001|COMPLETED|Overall Study||5
6646780|NCT02383043|7575754|FG002|COMPLETED|Overall Study||4
6646781|NCT02383043|7575752|FG000|NOT COMPLETED|Overall Study||2
6646782|NCT02383043|7575753|FG001|NOT COMPLETED|Overall Study||0
6646783|NCT02383043|7575754|FG002|NOT COMPLETED|Overall Study||0
6646784|NCT02383056|7575765|FG000|STARTED|Overall Study||7
6646785|NCT02383056|7575766|FG001|STARTED|Overall Study||7
6646786|NCT02383056|7575765|FG000|COMPLETED|Overall Study||6
6646787|NCT02383056|7575766|FG001|COMPLETED|Overall Study||5
6646788|NCT02383056|7575765|FG000|NOT COMPLETED|Overall Study||1
6646789|NCT02383056|7575766|FG001|NOT COMPLETED|Overall Study||2
6646790|NCT02383173|7575774|FG000|STARTED|Overall Study||88
6646791|NCT02383173|7575775|FG001|STARTED|Overall Study||46
6646792|NCT02383173|7575774|FG000|COMPLETED|Overall Study||88
6646793|NCT02383173|7575775|FG001|COMPLETED|Overall Study||44
6646794|NCT02383173|7575774|FG000|NOT COMPLETED|Overall Study||0
6646795|NCT02383173|7575775|FG001|NOT COMPLETED|Overall Study||2
6646796|NCT02383355|7575783|FG000|STARTED|Overall Study||19
6646797|NCT02383355|7575784|FG001|STARTED|Overall Study||21
6646798|NCT02383355|7575783|FG000|COMPLETED|Overall Study||17
6646799|NCT02383355|7575784|FG001|COMPLETED|Overall Study||21
6646800|NCT02383355|7575783|FG000|NOT COMPLETED|Overall Study||2
6646801|NCT02383355|7575784|FG001|NOT COMPLETED|Overall Study||0
6646802|NCT02383420|7575793|FG000|STARTED|Overall Study||10
6646803|NCT02383420|7575794|FG001|STARTED|Overall Study||10
6646804|NCT02383420|7575795|FG002|STARTED|Overall Study||3
6646805|NCT02383420|7575793|FG000|COMPLETED|Overall Study||8
6646806|NCT02383420|7575794|FG001|COMPLETED|Overall Study||10
6646807|NCT02383420|7575795|FG002|COMPLETED|Overall Study||3
6646808|NCT02383420|7575793|FG000|NOT COMPLETED|Overall Study||2
6646809|NCT02383420|7575794|FG001|NOT COMPLETED|Overall Study||0
6646810|NCT02383420|7575795|FG002|NOT COMPLETED|Overall Study||0
6646811|NCT02383472|7575805|FG000|STARTED|Overall Study||23
6646812|NCT02383472|7575806|FG001|STARTED|Overall Study||30
6646813|NCT02383472|7575805|FG000|COMPLETED|Overall Study||22
6646814|NCT02383472|7575806|FG001|COMPLETED|Overall Study||29
6646815|NCT02383472|7575805|FG000|NOT COMPLETED|Overall Study||1
6646816|NCT02383472|7575806|FG001|NOT COMPLETED|Overall Study||1
6646817|NCT02383576|7575816|FG000|STARTED|Overall Study||94
6646818|NCT02383576|7575817|FG001|STARTED|Overall Study||91
6646819|NCT02383576|7575816|FG000|COMPLETED|Overall Study||31
6646820|NCT02383576|7575817|FG001|COMPLETED|Overall Study||46
6646821|NCT02383576|7575816|FG000|NOT COMPLETED|Overall Study||63
6646822|NCT02383576|7575817|FG001|NOT COMPLETED|Overall Study||45
6646823|NCT02383589|7575825|FG000|STARTED|Treatment Period||67
6646824|NCT02383589|7575826|FG001|STARTED|Treatment Period||68
6646825|NCT02383589|7575825|FG000|COMPLETED|Treatment Period||66
6646826|NCT02383589|7575826|FG001|COMPLETED|Treatment Period||58
6646827|NCT02383589|7575825|FG000|NOT COMPLETED|Treatment Period||1
6646828|NCT02383589|7575826|FG001|NOT COMPLETED|Treatment Period||10
6646829|NCT02383589|7575825|FG000|STARTED|Safety Follow-up (SFU)||66
6646830|NCT02383589|7575826|FG001|STARTED|Safety Follow-up (SFU)||58
6646831|NCT02383589|7575825|FG000|COMPLETED|Safety Follow-up (SFU)||59
6646832|NCT02383589|7575826|FG001|COMPLETED|Safety Follow-up (SFU)||53
6646833|NCT02383589|7575825|FG000|NOT COMPLETED|Safety Follow-up (SFU)||7
6646834|NCT02383589|7575826|FG001|NOT COMPLETED|Safety Follow-up (SFU)||5
6646835|NCT02383667|7575834|FG000|STARTED|Overall Study||20
6646836|NCT02383667|7575834|FG000|COMPLETED|Overall Study||20
6646837|NCT02383667|7575834|FG000|NOT COMPLETED|Overall Study||0
6646838|NCT02383706|7575838|FG000|STARTED|Overall Study||108
6646839|NCT02383706|7575838|FG000|COMPLETED|Overall Study||80
6646840|NCT02383706|7575838|FG000|NOT COMPLETED|Overall Study||28
6646841|NCT02383719|7575843|FG000|STARTED|Overall Study||18
6646842|NCT02383719|7575843|FG000|COMPLETED|Overall Study||18
6646843|NCT02383719|7575843|FG000|NOT COMPLETED|Overall Study||0
6646844|NCT02383758|7575849|FG000|STARTED|Overall Study||10
6646845|NCT02383758|7575850|FG001|STARTED|Overall Study||10
6646846|NCT02383758|7575849|FG000|COMPLETED|Overall Study||10
6646847|NCT02383758|7575850|FG001|COMPLETED|Overall Study||8
6646848|NCT02383758|7575849|FG000|NOT COMPLETED|Overall Study||0
6646849|NCT02383758|7575850|FG001|NOT COMPLETED|Overall Study||2
6646850|NCT02383862|7575858|FG000|STARTED|Baseline||151
6646851|NCT02383862|7575859|FG001|STARTED|Baseline||149
6646852|NCT02383862|7575858|FG000|COMPLETED|Baseline||151
6646853|NCT02383862|7575859|FG001|COMPLETED|Baseline||149
6646854|NCT02383862|7575858|FG000|NOT COMPLETED|Baseline||0
6646855|NCT02383862|7575859|FG001|NOT COMPLETED|Baseline||0
6646856|NCT02383862|7575858|FG000|STARTED|3 Month Follow up||151
6646857|NCT02383862|7575859|FG001|STARTED|3 Month Follow up||149
6646858|NCT02383862|7575858|FG000|COMPLETED|3 Month Follow up||128
6646859|NCT02383862|7575859|FG001|COMPLETED|3 Month Follow up||128
6646860|NCT02383862|7575858|FG000|NOT COMPLETED|3 Month Follow up||23
6646861|NCT02383862|7575859|FG001|NOT COMPLETED|3 Month Follow up||21
6542834|NCT01682811|7464433|FG003|STARTED|Part 2 Dose Level 1||0
6542835|NCT01682811|7464434|FG004|STARTED|Part 2 Dose Level 1||11
6542836|NCT01682811|7464435|FG005|STARTED|Part 2 Dose Level 1||0
6542837|NCT01682811|7464436|FG006|STARTED|Part 2 Dose Level 1||0
6542838|NCT01682811|7464430|FG000|Control|Part 2 Dose Level 1||0
6542839|NCT01682811|7464431|FG001|Control|Part 2 Dose Level 1||0
6542840|NCT01682811|7464432|FG002|Control|Part 2 Dose Level 1||0
6542841|NCT01682811|7464433|FG003|Control|Part 2 Dose Level 1||0
6542842|NCT01682811|7464434|FG004|Control|Part 2 Dose Level 1||10
6542843|NCT01682811|7464435|FG005|Control|Part 2 Dose Level 1||0
6542844|NCT01682811|7464436|FG006|Control|Part 2 Dose Level 1||0
6542845|NCT01682811|7464430|FG000|Treated|Part 2 Dose Level 1||0
6542846|NCT01682811|7464431|FG001|Treated|Part 2 Dose Level 1||0
6542847|NCT01682811|7464432|FG002|Treated|Part 2 Dose Level 1||0
6542848|NCT01682811|7464433|FG003|Treated|Part 2 Dose Level 1||0
6542849|NCT01682811|7464434|FG004|Treated|Part 2 Dose Level 1||10
6542850|NCT01682811|7464435|FG005|Treated|Part 2 Dose Level 1||0
6542851|NCT01682811|7464436|FG006|Treated|Part 2 Dose Level 1||0
6542852|NCT01682811|7464430|FG000|COMPLETED|Part 2 Dose Level 1||0
6542853|NCT01682811|7464431|FG001|COMPLETED|Part 2 Dose Level 1||0
6542854|NCT01682811|7464432|FG002|COMPLETED|Part 2 Dose Level 1||0
6542855|NCT01682811|7464433|FG003|COMPLETED|Part 2 Dose Level 1||0
6542856|NCT01682811|7464434|FG004|COMPLETED|Part 2 Dose Level 1||0
6542857|NCT01682811|7464435|FG005|COMPLETED|Part 2 Dose Level 1||0
6542858|NCT01682811|7464436|FG006|COMPLETED|Part 2 Dose Level 1||0
6542859|NCT01682811|7464430|FG000|NOT COMPLETED|Part 2 Dose Level 1||0
6542860|NCT01682811|7464431|FG001|NOT COMPLETED|Part 2 Dose Level 1||0
6542861|NCT01682811|7464432|FG002|NOT COMPLETED|Part 2 Dose Level 1||0
6542862|NCT01682811|7464433|FG003|NOT COMPLETED|Part 2 Dose Level 1||0
6542863|NCT01682811|7464434|FG004|NOT COMPLETED|Part 2 Dose Level 1||11
6542864|NCT01682811|7464435|FG005|NOT COMPLETED|Part 2 Dose Level 1||0
6542865|NCT01682811|7464436|FG006|NOT COMPLETED|Part 2 Dose Level 1||0
6542866|NCT01682811|7464430|FG000|STARTED|Part 2 Dose Level 2||0
6542867|NCT01682811|7464431|FG001|STARTED|Part 2 Dose Level 2||0
6542868|NCT01682811|7464432|FG002|STARTED|Part 2 Dose Level 2||0
6542869|NCT01682811|7464433|FG003|STARTED|Part 2 Dose Level 2||0
6542870|NCT01682811|7464434|FG004|STARTED|Part 2 Dose Level 2||0
6542871|NCT01682811|7464435|FG005|STARTED|Part 2 Dose Level 2||3
6542872|NCT01682811|7464436|FG006|STARTED|Part 2 Dose Level 2||0
6542873|NCT01682811|7464430|FG000|Control|Part 2 Dose Level 2||0
6542874|NCT01682811|7464431|FG001|Control|Part 2 Dose Level 2||0
6542875|NCT01682811|7464432|FG002|Control|Part 2 Dose Level 2||0
6542876|NCT01682811|7464433|FG003|Control|Part 2 Dose Level 2||0
6542877|NCT01682811|7464434|FG004|Control|Part 2 Dose Level 2||0
6542878|NCT01682811|7464435|FG005|Control|Part 2 Dose Level 2||3
6542879|NCT01682811|7464436|FG006|Control|Part 2 Dose Level 2||0
6542880|NCT01682811|7464430|FG000|Treated|Part 2 Dose Level 2||0
6542881|NCT01682811|7464431|FG001|Treated|Part 2 Dose Level 2||0
6542882|NCT01682811|7464432|FG002|Treated|Part 2 Dose Level 2||0
6542883|NCT01682811|7464433|FG003|Treated|Part 2 Dose Level 2||0
6542884|NCT01682811|7464434|FG004|Treated|Part 2 Dose Level 2||0
6542885|NCT01682811|7464435|FG005|Treated|Part 2 Dose Level 2||3
6542886|NCT01682811|7464436|FG006|Treated|Part 2 Dose Level 2||0
6542887|NCT01682811|7464430|FG000|COMPLETED|Part 2 Dose Level 2||0
6542888|NCT01682811|7464431|FG001|COMPLETED|Part 2 Dose Level 2||0
6542889|NCT01682811|7464432|FG002|COMPLETED|Part 2 Dose Level 2||0
6542890|NCT01682811|7464433|FG003|COMPLETED|Part 2 Dose Level 2||0
6542891|NCT01682811|7464434|FG004|COMPLETED|Part 2 Dose Level 2||0
6542892|NCT01682811|7464435|FG005|COMPLETED|Part 2 Dose Level 2||0
6542893|NCT01682811|7464436|FG006|COMPLETED|Part 2 Dose Level 2||0
6542894|NCT01682811|7464430|FG000|NOT COMPLETED|Part 2 Dose Level 2||0
6542895|NCT01682811|7464431|FG001|NOT COMPLETED|Part 2 Dose Level 2||0
6542896|NCT01682811|7464432|FG002|NOT COMPLETED|Part 2 Dose Level 2||0
6542897|NCT01682811|7464433|FG003|NOT COMPLETED|Part 2 Dose Level 2||0
6542898|NCT01682811|7464434|FG004|NOT COMPLETED|Part 2 Dose Level 2||0
6542899|NCT01682811|7464435|FG005|NOT COMPLETED|Part 2 Dose Level 2||3
6542900|NCT01682811|7464436|FG006|NOT COMPLETED|Part 2 Dose Level 2||0
6646862|NCT02383940|7575874|FG000|STARTED|Overall Study||44
6646863|NCT02383940|7575875|FG001|STARTED|Overall Study||43
6646864|NCT02383940|7575874|FG000|Treated|Overall Study||42
6646865|NCT02383940|7575875|FG001|Treated|Overall Study||43
6646866|NCT02383940|7575874|FG000|COMPLETED|Overall Study||35
6646867|NCT02383940|7575875|FG001|COMPLETED|Overall Study||40
6646868|NCT02383940|7575874|FG000|NOT COMPLETED|Overall Study||9
6646869|NCT02383940|7575875|FG001|NOT COMPLETED|Overall Study||3
6646870|NCT02383966|7575883|FG000|STARTED|Overall Study||164
6646871|NCT02383966|7575884|FG001|STARTED|Overall Study||79
6646872|NCT02383966|7575883|FG000|COMPLETED|Overall Study||138
6646873|NCT02383966|7575884|FG001|COMPLETED|Overall Study||72
6646874|NCT02383966|7575883|FG000|NOT COMPLETED|Overall Study||26
6542901|NCT01682811|7464430|FG000|STARTED|Part 2 Dose Level 3||0
6542902|NCT01682811|7464431|FG001|STARTED|Part 2 Dose Level 3||0
6542903|NCT01682811|7464432|FG002|STARTED|Part 2 Dose Level 3||0
6542904|NCT01682811|7464433|FG003|STARTED|Part 2 Dose Level 3||0
6542905|NCT01682811|7464434|FG004|STARTED|Part 2 Dose Level 3||0
6542906|NCT01682811|7464435|FG005|STARTED|Part 2 Dose Level 3||0
6542907|NCT01682811|7464436|FG006|STARTED|Part 2 Dose Level 3||0
6542908|NCT01682811|7464430|FG000|Control|Part 2 Dose Level 3||0
6542909|NCT01682811|7464431|FG001|Control|Part 2 Dose Level 3||0
6542910|NCT01682811|7464432|FG002|Control|Part 2 Dose Level 3||0
6542911|NCT01682811|7464433|FG003|Control|Part 2 Dose Level 3||0
6542912|NCT01682811|7464434|FG004|Control|Part 2 Dose Level 3||0
6542913|NCT01682811|7464435|FG005|Control|Part 2 Dose Level 3||0
6542914|NCT01682811|7464436|FG006|Control|Part 2 Dose Level 3||0
6542915|NCT01682811|7464430|FG000|Treated|Part 2 Dose Level 3||0
6542916|NCT01682811|7464431|FG001|Treated|Part 2 Dose Level 3||0
6542917|NCT01682811|7464432|FG002|Treated|Part 2 Dose Level 3||0
6542918|NCT01682811|7464433|FG003|Treated|Part 2 Dose Level 3||0
6542919|NCT01682811|7464434|FG004|Treated|Part 2 Dose Level 3||0
6542920|NCT01682811|7464435|FG005|Treated|Part 2 Dose Level 3||0
6542921|NCT01682811|7464436|FG006|Treated|Part 2 Dose Level 3||0
6542922|NCT01682811|7464430|FG000|COMPLETED|Part 2 Dose Level 3||0
6542923|NCT01682811|7464431|FG001|COMPLETED|Part 2 Dose Level 3||0
6542924|NCT01682811|7464432|FG002|COMPLETED|Part 2 Dose Level 3||0
6542925|NCT01682811|7464433|FG003|COMPLETED|Part 2 Dose Level 3||0
6542926|NCT01682811|7464434|FG004|COMPLETED|Part 2 Dose Level 3||0
6542927|NCT01682811|7464435|FG005|COMPLETED|Part 2 Dose Level 3||0
6542928|NCT01682811|7464436|FG006|COMPLETED|Part 2 Dose Level 3||0
6542929|NCT01682811|7464430|FG000|NOT COMPLETED|Part 2 Dose Level 3||0
6542930|NCT01682811|7464431|FG001|NOT COMPLETED|Part 2 Dose Level 3||0
6542931|NCT01682811|7464432|FG002|NOT COMPLETED|Part 2 Dose Level 3||0
6542932|NCT01682811|7464433|FG003|NOT COMPLETED|Part 2 Dose Level 3||0
6542933|NCT01682811|7464434|FG004|NOT COMPLETED|Part 2 Dose Level 3||0
6542934|NCT01682811|7464435|FG005|NOT COMPLETED|Part 2 Dose Level 3||0
6542935|NCT01682811|7464436|FG006|NOT COMPLETED|Part 2 Dose Level 3||0
6542936|NCT01682837|7464455|FG000|STARTED|Baseline||35
6542937|NCT01682837|7464455|FG000|COMPLETED|Baseline||30
6542938|NCT01682837|7464455|FG000|NOT COMPLETED|Baseline||5
6542939|NCT01682837|7464455|FG000|STARTED|First Intervention (4 Weeks)||30
6542940|NCT01682837|7464455|FG000|Received KMgCit|First Intervention (4 Weeks)||8
6542941|NCT01682837|7464455|FG000|Received KCit|First Intervention (4 Weeks)||8
6542942|NCT01682837|7464455|FG000|Received KCl|First Intervention (4 Weeks)||7
6542943|NCT01682837|7464455|FG000|Received Placebo|First Intervention (4 Weeks)||7
6542944|NCT01682837|7464455|FG000|COMPLETED|First Intervention (4 Weeks)||30
6542945|NCT01682837|7464455|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6542946|NCT01682837|7464455|FG000|STARTED|Second Intervention (4 Weeks)||30
6542947|NCT01682837|7464455|FG000|Received KMgCit|Second Intervention (4 Weeks)||7
6542948|NCT01682837|7464455|FG000|Received KCit|Second Intervention (4 Weeks)||6
6542949|NCT01682837|7464455|FG000|Received KCl|Second Intervention (4 Weeks)||8
6542950|NCT01682837|7464455|FG000|Received Placebo|Second Intervention (4 Weeks)||9
6542951|NCT01682837|7464455|FG000|COMPLETED|Second Intervention (4 Weeks)||30
6542952|NCT01682837|7464455|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6542953|NCT01682837|7464455|FG000|STARTED|Third Intervention (4 Weeks)||30
6542954|NCT01682837|7464455|FG000|Received KMgCit|Third Intervention (4 Weeks)||9
6542955|NCT01682837|7464455|FG000|Received KCit|Third Intervention (4 Weeks)||7
6542956|NCT01682837|7464455|FG000|Received KCl|Third Intervention (4 Weeks)||7
6542957|NCT01682837|7464455|FG000|Received Placebo|Third Intervention (4 Weeks)||7
6542958|NCT01682837|7464455|FG000|COMPLETED|Third Intervention (4 Weeks)||30
6542959|NCT01682837|7464455|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
6542960|NCT01682837|7464455|FG000|STARTED|Fourth Intervention (4 Weeks)||30
6542961|NCT01682837|7464455|FG000|Received KMgCit|Fourth Intervention (4 Weeks)||6
6542962|NCT01682837|7464455|FG000|Received KCit|Fourth Intervention (4 Weeks)||9
6542963|NCT01682837|7464455|FG000|Received KCl|Fourth Intervention (4 Weeks)||8
6542964|NCT01682837|7464455|FG000|Received Placebo|Fourth Intervention (4 Weeks)||7
6542965|NCT01682837|7464455|FG000|COMPLETED|Fourth Intervention (4 Weeks)||30
6542966|NCT01682837|7464455|FG000|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
6542967|NCT01682863|7464468|FG000|STARTED|Overall Study||204
6542968|NCT01682863|7464469|FG001|STARTED|Overall Study||204
6542969|NCT01682863|7464470|FG002|STARTED|Overall Study||207
6542970|NCT01682863|7464468|FG000|Safety Set|Overall Study||204
6542971|NCT01682863|7464469|FG001|Safety Set|Overall Study||204
6542972|NCT01682863|7464470|FG002|Safety Set|Overall Study||206
6542973|NCT01682863|7464468|FG000|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
6542974|NCT01682863|7464469|FG001|Full Analysis Set (FAS)|Overall Study||204
6542975|NCT01682863|7464470|FG002|Full Analysis Set (FAS)|Overall Study||206
6542976|NCT01682863|7464468|FG000|Randomized Set|Overall Study||204
6542977|NCT01682863|7464469|FG001|Randomized Set|Overall Study||204
6542978|NCT01682863|7464470|FG002|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
6542979|NCT01682863|7464468|FG000|COMPLETED|Overall Study||177
6542980|NCT01682863|7464469|FG001|COMPLETED|Overall Study||187
6542981|NCT01682863|7464470|FG002|COMPLETED|Overall Study||183
6542982|NCT01682863|7464468|FG000|NOT COMPLETED|Overall Study||27
6542983|NCT01682863|7464469|FG001|NOT COMPLETED|Overall Study||17
6542984|NCT01682863|7464470|FG002|NOT COMPLETED|Overall Study||24
6542985|NCT01682876|7464482|FG000|STARTED|Overall Study||176
6542986|NCT01682876|7464483|FG001|STARTED|Overall Study||183
6542987|NCT01682876|7464484|FG002|STARTED|Overall Study||180
6542988|NCT01682876|7464485|FG003|STARTED|Overall Study||176
6542989|NCT01682876|7464482|FG000|COMPLETED|Overall Study||155
6542990|NCT01682876|7464483|FG001|COMPLETED|Overall Study||163
6542991|NCT01682876|7464484|FG002|COMPLETED|Overall Study||169
6542992|NCT01682876|7464485|FG003|COMPLETED|Overall Study||157
6542993|NCT01682876|7464482|FG000|NOT COMPLETED|Overall Study||21
6542994|NCT01682876|7464483|FG001|NOT COMPLETED|Overall Study||20
6542995|NCT01682876|7464484|FG002|NOT COMPLETED|Overall Study||11
6542996|NCT01682876|7464485|FG003|NOT COMPLETED|Overall Study||19
6542997|NCT01682954|7464500|FG000|STARTED|Overall Study||40
6542998|NCT01682954|7464501|FG001|STARTED|Overall Study||38
6542999|NCT01682954|7464500|FG000|COMPLETED|Overall Study||35
6543000|NCT01682954|7464501|FG001|COMPLETED|Overall Study||33
6543001|NCT01682954|7464500|FG000|NOT COMPLETED|Overall Study||5
6543002|NCT01682954|7464501|FG001|NOT COMPLETED|Overall Study||5
6543003|NCT01683019|7464510|FG000|STARTED|Overall Study||18
6543004|NCT01683019|7464511|FG001|STARTED|Overall Study||15
6543005|NCT01683019|7464512|FG002|STARTED|Overall Study||19
6543006|NCT01683019|7464510|FG000|COMPLETED|Overall Study||16
6543007|NCT01683019|7464511|FG001|COMPLETED|Overall Study||14
6543008|NCT01683019|7464512|FG002|COMPLETED|Overall Study||15
6543009|NCT01683019|7464510|FG000|NOT COMPLETED|Overall Study||2
6543010|NCT01683019|7464511|FG001|NOT COMPLETED|Overall Study||1
6543011|NCT01683019|7464512|FG002|NOT COMPLETED|Overall Study||4
6543012|NCT01683058|7464520|FG000|STARTED|Overall Study||74
6543013|NCT01683058|7464520|FG000|COMPLETED|Overall Study||45
6543014|NCT01683058|7464520|FG000|NOT COMPLETED|Overall Study||29
6543015|NCT01683071|7464531|FG000|STARTED|Part 1||25
6543016|NCT01683071|7464532|FG001|STARTED|Part 1||26
6543017|NCT01683071|7464533|FG002|STARTED|Part 1||25
6543018|NCT01683071|7464534|FG003|STARTED|Part 1||25
6543019|NCT01683071|7464535|FG004|STARTED|Part 1||0
6543020|NCT01683071|7464536|FG005|STARTED|Part 1||0
6543021|NCT01683071|7464531|FG000|COMPLETED|Part 1||21
6543022|NCT01683071|7464532|FG001|COMPLETED|Part 1||22
6543023|NCT01683071|7464533|FG002|COMPLETED|Part 1||22
6543024|NCT01683071|7464534|FG003|COMPLETED|Part 1||20
6543025|NCT01683071|7464535|FG004|COMPLETED|Part 1||0
6543026|NCT01683071|7464536|FG005|COMPLETED|Part 1||0
6543027|NCT01683071|7464531|FG000|NOT COMPLETED|Part 1||4
6543028|NCT01683071|7464532|FG001|NOT COMPLETED|Part 1||4
6543029|NCT01683071|7464533|FG002|NOT COMPLETED|Part 1||3
6543030|NCT01683071|7464534|FG003|NOT COMPLETED|Part 1||5
6543031|NCT01683071|7464535|FG004|NOT COMPLETED|Part 1||0
6543032|NCT01683071|7464536|FG005|NOT COMPLETED|Part 1||0
6543033|NCT01683071|7464531|FG000|STARTED|Part 2||0
6543034|NCT01683071|7464532|FG001|STARTED|Part 2||0
6543035|NCT01683071|7464533|FG002|STARTED|Part 2||0
6543036|NCT01683071|7464534|FG003|STARTED|Part 2||0
6543037|NCT01683071|7464535|FG004|STARTED|Part 2||99
6543038|NCT01683071|7464536|FG005|STARTED|Part 2||97
6543039|NCT01683071|7464531|FG000|COMPLETED|Part 2||0
6543040|NCT01683071|7464532|FG001|COMPLETED|Part 2||0
6543041|NCT01683071|7464533|FG002|COMPLETED|Part 2||0
6543042|NCT01683071|7464534|FG003|COMPLETED|Part 2||0
6543043|NCT01683071|7464535|FG004|COMPLETED|Part 2||82
6543044|NCT01683071|7464536|FG005|COMPLETED|Part 2||82
6543045|NCT01683071|7464531|FG000|NOT COMPLETED|Part 2||0
6543046|NCT01683071|7464532|FG001|NOT COMPLETED|Part 2||0
6543047|NCT01683071|7464533|FG002|NOT COMPLETED|Part 2||0
6543048|NCT01683071|7464534|FG003|NOT COMPLETED|Part 2||0
6543049|NCT01683071|7464535|FG004|NOT COMPLETED|Part 2||17
6543050|NCT01683071|7464536|FG005|NOT COMPLETED|Part 2||15
6543051|NCT01683266|7464558|FG000|STARTED|Overall Study||274
6543052|NCT01683266|7464559|FG001|STARTED|Overall Study||275
6543053|NCT01683266|7464558|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
6543054|NCT01683266|7464559|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
6543055|NCT01683266|7464558|FG000|COMPLETED|Overall Study||219
6543056|NCT01683266|7464559|FG001|COMPLETED|Overall Study||225
6543057|NCT01683266|7464558|FG000|NOT COMPLETED|Overall Study||55
6543058|NCT01683266|7464559|FG001|NOT COMPLETED|Overall Study||50
6543059|NCT01683331|7464567|FG000|STARTED|Overall Study||18
6543060|NCT01683331|7464568|FG001|STARTED|Overall Study||18
6543061|NCT01683331|7464567|FG000|Began Dosage|Overall Study||18
6543062|NCT01683331|7464568|FG001|Began Dosage|Overall Study||18
6543063|NCT01683331|7464567|FG000|12 Months|Overall Study||18
6543064|NCT01683331|7464568|FG001|12 Months|Overall Study||18
6543065|NCT01683331|7464567|FG000|24 Months|Overall Study||18
6543066|NCT01683331|7464568|FG001|24 Months|Overall Study||18
6543067|NCT01683331|7464567|FG000|COMPLETED|Overall Study||18
6543068|NCT01683331|7464568|FG001|COMPLETED|Overall Study||18
6543069|NCT01683331|7464567|FG000|NOT COMPLETED|Overall Study||0
6543070|NCT01683331|7464568|FG001|NOT COMPLETED|Overall Study||0
6543071|NCT01683383|7464576|FG000|STARTED|Overall Study||50
6543072|NCT01683383|7464577|FG001|STARTED|Overall Study||51
6543073|NCT01683383|7464576|FG000|Transported and Treated|Overall Study||49
6543074|NCT01683383|7464577|FG001|Transported and Treated|Overall Study||51
6543075|NCT01683383|7464576|FG000|COMPLETED|Overall Study||49
6543076|NCT01683383|7464577|FG001|COMPLETED|Overall Study||51
6543077|NCT01683383|7464576|FG000|NOT COMPLETED|Overall Study||1
6543078|NCT01683383|7464577|FG001|NOT COMPLETED|Overall Study||0
6543079|NCT01683409|7464588|FG000|STARTED|Treatment Period (Weeks 1-24)||27
6543080|NCT01683409|7464589|FG001|STARTED|Treatment Period (Weeks 1-24)||25
6543081|NCT01683409|7464590|FG002|STARTED|Treatment Period (Weeks 1-24)||27
6543082|NCT01683409|7464591|FG003|STARTED|Treatment Period (Weeks 1-24)||26
6543083|NCT01683409|7464592|FG004|STARTED|Treatment Period (Weeks 1-24)||25
6543084|NCT01683409|7464588|FG000|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
6543085|NCT01683409|7464589|FG001|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
6543086|NCT01683409|7464590|FG002|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
6543087|NCT01683409|7464591|FG003|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
6543088|NCT01683409|7464592|FG004|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
6543089|NCT01683409|7464588|FG000|COMPLETED|Treatment Period (Weeks 1-24)||27
6543090|NCT01683409|7464589|FG001|COMPLETED|Treatment Period (Weeks 1-24)||21
6543091|NCT01683409|7464590|FG002|COMPLETED|Treatment Period (Weeks 1-24)||26
6543092|NCT01683409|7464591|FG003|COMPLETED|Treatment Period (Weeks 1-24)||24
6543093|NCT01683409|7464592|FG004|COMPLETED|Treatment Period (Weeks 1-24)||23
6543094|NCT01683409|7464588|FG000|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
6543095|NCT01683409|7464589|FG001|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
6543096|NCT01683409|7464590|FG002|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
6543097|NCT01683409|7464591|FG003|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
6543098|NCT01683409|7464592|FG004|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
6543099|NCT01683409|7464588|FG000|STARTED|Washout Period 1 (Weeks 25-28)||27
6543100|NCT01683409|7464589|FG001|STARTED|Washout Period 1 (Weeks 25-28)||21
6543101|NCT01683409|7464590|FG002|STARTED|Washout Period 1 (Weeks 25-28)||26
6543102|NCT01683409|7464591|FG003|STARTED|Washout Period 1 (Weeks 25-28)||24
6543103|NCT01683409|7464592|FG004|STARTED|Washout Period 1 (Weeks 25-28)||23
6543104|NCT01683409|7464588|FG000|COMPLETED|Washout Period 1 (Weeks 25-28)||24
6543105|NCT01683409|7464589|FG001|COMPLETED|Washout Period 1 (Weeks 25-28)||17
6543106|NCT01683409|7464590|FG002|COMPLETED|Washout Period 1 (Weeks 25-28)||25
6543107|NCT01683409|7464591|FG003|COMPLETED|Washout Period 1 (Weeks 25-28)||22
6543108|NCT01683409|7464592|FG004|COMPLETED|Washout Period 1 (Weeks 25-28)||20
6543109|NCT01683409|7464588|FG000|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
6543110|NCT01683409|7464589|FG001|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
6543111|NCT01683409|7464590|FG002|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
6543112|NCT01683409|7464591|FG003|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
6543113|NCT01683409|7464592|FG004|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
6543114|NCT01683409|7464588|FG000|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
6543115|NCT01683409|7464589|FG001|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
6543116|NCT01683409|7464590|FG002|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
6543117|NCT01683409|7464591|FG003|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
6543118|NCT01683409|7464592|FG004|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
6543119|NCT01683409|7464588|FG000|COMPLETED|Washout Period 2 (Weeks 29-32)||6
6543120|NCT01683409|7464589|FG001|COMPLETED|Washout Period 2 (Weeks 29-32)||6
6543121|NCT01683409|7464590|FG002|COMPLETED|Washout Period 2 (Weeks 29-32)||7
6543122|NCT01683409|7464591|FG003|COMPLETED|Washout Period 2 (Weeks 29-32)||6
6543123|NCT01683409|7464592|FG004|COMPLETED|Washout Period 2 (Weeks 29-32)||9
6543124|NCT01683409|7464588|FG000|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
6543125|NCT01683409|7464589|FG001|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
6543126|NCT01683409|7464590|FG002|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
6543127|NCT01683409|7464591|FG003|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
6543128|NCT01683409|7464592|FG004|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
6543129|NCT01683422|7464618|FG000|STARTED|Overall Study||9
6543130|NCT01683422|7464618|FG000|COMPLETED|Overall Study||9
6543131|NCT01683422|7464618|FG000|NOT COMPLETED|Overall Study||0
6543132|NCT01683526|7464624|FG000|STARTED|Overall Study||60
6543133|NCT01683526|7464625|FG001|STARTED|Overall Study||57
6543134|NCT01683526|7464624|FG000|COMPLETED|Overall Study||60
6543135|NCT01683526|7464625|FG001|COMPLETED|Overall Study||57
6543136|NCT01683526|7464624|FG000|NOT COMPLETED|Overall Study||0
6543137|NCT01683526|7464625|FG001|NOT COMPLETED|Overall Study||0
6543138|NCT01683565|7464633|FG000|STARTED|Overall Study||15
6543139|NCT01683565|7464634|FG001|STARTED|Overall Study||16
6543140|NCT01683565|7464633|FG000|COMPLETED|Overall Study||12
6543141|NCT01683565|7464634|FG001|COMPLETED|Overall Study||15
6543142|NCT01683565|7464633|FG000|NOT COMPLETED|Overall Study||3
6543143|NCT01683565|7464634|FG001|NOT COMPLETED|Overall Study||1
6543144|NCT01683604|7464642|FG000|STARTED|Overall Study||37
6543145|NCT01683604|7464642|FG000|COMPLETED|Overall Study||32
6543146|NCT01683604|7464642|FG000|NOT COMPLETED|Overall Study||5
6543147|NCT01683630|7464653|FG000|STARTED|Overall Study||1404
6543148|NCT01683630|7464654|FG001|STARTED|Overall Study||445
6543149|NCT01683630|7464653|FG000|COMPLETED|Overall Study||1404
6543150|NCT01683630|7464654|FG001|COMPLETED|Overall Study||445
6543151|NCT01683630|7464653|FG000|NOT COMPLETED|Overall Study||0
6543152|NCT01683630|7464654|FG001|NOT COMPLETED|Overall Study||0
6543153|NCT01683812|7464660|FG000|STARTED|Overall Study||23
6543154|NCT01683812|7464660|FG000|COMPLETED|Overall Study||23
6543155|NCT01683812|7464660|FG000|NOT COMPLETED|Overall Study||0
6543156|NCT01683838|7464666|FG000|STARTED|Overall Study||104
6543157|NCT01683838|7464667|FG001|STARTED|Overall Study||100
6543158|NCT01683838|7464666|FG000|Intent to Treat (ITT) Population|Overall Study||103
6543159|NCT01683838|7464667|FG001|Intent to Treat (ITT) Population|Overall Study||100
6543160|NCT01683838|7464666|FG000|Safety Population|Overall Study||103
6543161|NCT01683838|7464667|FG001|Safety Population|Overall Study||100
6543162|NCT01683838|7464666|FG000|Efficacy Population|Overall Study||89
6543163|NCT01683838|7464667|FG001|Efficacy Population|Overall Study||93
6543164|NCT01683838|7464666|FG000|COMPLETED|Overall Study||78
6543165|NCT01683838|7464667|FG001|COMPLETED|Overall Study||88
6543166|NCT01683838|7464666|FG000|NOT COMPLETED|Overall Study||26
6543167|NCT01683838|7464667|FG001|NOT COMPLETED|Overall Study||12
6543168|NCT01683994|7464678|FG000|STARTED|Overall Study||4
6543169|NCT01683994|7464679|FG001|STARTED|Overall Study||8
6543170|NCT01683994|7464680|FG002|STARTED|Overall Study||7
6543171|NCT01683994|7464681|FG003|STARTED|Overall Study||13
6543172|NCT01683994|7464682|FG004|STARTED|Overall Study||13
6543173|NCT01683994|7464678|FG000|# of Patients Who Received Treatment|Overall Study||4
6543174|NCT01683994|7464679|FG001|# of Patients Who Received Treatment|Overall Study||8
6543175|NCT01683994|7464680|FG002|# of Patients Who Received Treatment|Overall Study||7
6543176|NCT01683994|7464681|FG003|# of Patients Who Received Treatment|Overall Study||12
6543177|NCT01683994|7464682|FG004|# of Patients Who Received Treatment|Overall Study||13
6543178|NCT01683994|7464678|FG000|COMPLETED|Overall Study||3
6543179|NCT01683994|7464679|FG001|COMPLETED|Overall Study||8
6543180|NCT01683994|7464680|FG002|COMPLETED|Overall Study||7
6543181|NCT01683994|7464681|FG003|COMPLETED|Overall Study||10
6543182|NCT01683994|7464682|FG004|COMPLETED|Overall Study||12
6543183|NCT01683994|7464678|FG000|NOT COMPLETED|Overall Study||1
6543184|NCT01683994|7464679|FG001|NOT COMPLETED|Overall Study||0
6543185|NCT01683994|7464680|FG002|NOT COMPLETED|Overall Study||0
6543186|NCT01683994|7464681|FG003|NOT COMPLETED|Overall Study||3
6543187|NCT01683994|7464682|FG004|NOT COMPLETED|Overall Study||1
6543188|NCT01684007|7464702|FG000|STARTED|Overall Study||53
6543189|NCT01684007|7464703|FG001|STARTED|Overall Study||50
6543190|NCT01684007|7464702|FG000|COMPLETED|Overall Study||53
6543191|NCT01684007|7464703|FG001|COMPLETED|Overall Study||50
6543192|NCT01684007|7464702|FG000|NOT COMPLETED|Overall Study||0
6543193|NCT01684007|7464703|FG001|NOT COMPLETED|Overall Study||0
6543194|NCT01684020|7464711|FG000|STARTED|Overall Study||5
6543195|NCT01684020|7464712|FG001|STARTED|Overall Study||5
6543196|NCT01684020|7464711|FG000|COMPLETED|Overall Study||4
6543197|NCT01684020|7464712|FG001|COMPLETED|Overall Study||5
6543198|NCT01684020|7464711|FG000|NOT COMPLETED|Overall Study||1
6543199|NCT01684020|7464712|FG001|NOT COMPLETED|Overall Study||0
6543200|NCT01684033|7464718|FG000|STARTED|Period 1, First 30 Days||99
6543201|NCT01684033|7464719|FG001|STARTED|Period 1, First 30 Days||99
6543202|NCT01684033|7464718|FG000|COMPLETED|Period 1, First 30 Days||95
6543203|NCT01684033|7464719|FG001|COMPLETED|Period 1, First 30 Days||98
6543204|NCT01684033|7464718|FG000|NOT COMPLETED|Period 1, First 30 Days||4
6543205|NCT01684033|7464719|FG001|NOT COMPLETED|Period 1, First 30 Days||1
6543206|NCT01684033|7464718|FG000|STARTED|Period 2, Second 30 Days||95
6543207|NCT01684033|7464719|FG001|STARTED|Period 2, Second 30 Days||98
6543208|NCT01684033|7464718|FG000|COMPLETED|Period 2, Second 30 Days||94
6543209|NCT01684033|7464719|FG001|COMPLETED|Period 2, Second 30 Days||98
6543210|NCT01684033|7464718|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
6543211|NCT01684033|7464719|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
6543212|NCT01684046|7464725|FG000|STARTED|Period 1, First 30 Days||97
6543213|NCT01684046|7464726|FG001|STARTED|Period 1, First 30 Days||95
6543214|NCT01684046|7464725|FG000|COMPLETED|Period 1, First 30 Days||97
6543215|NCT01684046|7464726|FG001|COMPLETED|Period 1, First 30 Days||93
6543216|NCT01684046|7464725|FG000|NOT COMPLETED|Period 1, First 30 Days||0
6543217|NCT01684046|7464726|FG001|NOT COMPLETED|Period 1, First 30 Days||2
6543218|NCT01684046|7464725|FG000|STARTED|Period 2, Second 30 Days||97
6543219|NCT01684046|7464726|FG001|STARTED|Period 2, Second 30 Days||93
6543220|NCT01684046|7464725|FG000|COMPLETED|Period 2, Second 30 Days||97
6543221|NCT01684046|7464726|FG001|COMPLETED|Period 2, Second 30 Days||93
6543222|NCT01684046|7464725|FG000|NOT COMPLETED|Period 2, Second 30 Days||0
6543223|NCT01684046|7464726|FG001|NOT COMPLETED|Period 2, Second 30 Days||0
6543224|NCT01684202|7464736|FG000|STARTED|Dose-escalation Period||15
6543225|NCT01684202|7464737|FG001|STARTED|Dose-escalation Period||8
6543226|NCT01684202|7464738|FG002|STARTED|Dose-escalation Period||9
6543227|NCT01684202|7464739|FG003|STARTED|Dose-escalation Period||11
6543228|NCT01684202|7464736|FG000|COMPLETED|Dose-escalation Period||14
6543229|NCT01684202|7464737|FG001|COMPLETED|Dose-escalation Period||7
6543230|NCT01684202|7464738|FG002|COMPLETED|Dose-escalation Period||9
6543231|NCT01684202|7464739|FG003|COMPLETED|Dose-escalation Period||11
6543232|NCT01684202|7464736|FG000|NOT COMPLETED|Dose-escalation Period||1
6543233|NCT01684202|7464737|FG001|NOT COMPLETED|Dose-escalation Period||1
6543234|NCT01684202|7464738|FG002|NOT COMPLETED|Dose-escalation Period||0
6543235|NCT01684202|7464739|FG003|NOT COMPLETED|Dose-escalation Period||0
6543236|NCT01684202|7464736|FG000|STARTED|Maintenance Period||14
6543237|NCT01684202|7464737|FG001|STARTED|Maintenance Period||7
6543238|NCT01684202|7464738|FG002|STARTED|Maintenance Period||9
6543239|NCT01684202|7464739|FG003|STARTED|Maintenance Period||11
6543240|NCT01684202|7464736|FG000|COMPLETED|Maintenance Period||13
6543241|NCT01684202|7464737|FG001|COMPLETED|Maintenance Period||4
6543242|NCT01684202|7464738|FG002|COMPLETED|Maintenance Period||8
6543243|NCT01684202|7464739|FG003|COMPLETED|Maintenance Period||10
6543244|NCT01684202|7464736|FG000|NOT COMPLETED|Maintenance Period||1
6543245|NCT01684202|7464737|FG001|NOT COMPLETED|Maintenance Period||3
6543246|NCT01684202|7464738|FG002|NOT COMPLETED|Maintenance Period||1
6543247|NCT01684202|7464739|FG003|NOT COMPLETED|Maintenance Period||1
6543248|NCT01684215|7464753|FG000|STARTED|Phase 1, Part 1||6
6543249|NCT01684215|7464754|FG001|STARTED|Phase 1, Part 1||6
6543250|NCT01684215|7464755|FG002|STARTED|Phase 1, Part 1||0
6543251|NCT01684215|7464756|FG003|STARTED|Phase 1, Part 1||0
6543252|NCT01684215|7464753|FG000|Treated|Phase 1, Part 1||6
6543253|NCT01684215|7464754|FG001|Treated|Phase 1, Part 1||6
6543254|NCT01684215|7464755|FG002|Treated|Phase 1, Part 1||0
6543255|NCT01684215|7464756|FG003|Treated|Phase 1, Part 1||0
6543256|NCT01684215|7464753|FG000|COMPLETED|Phase 1, Part 1||0
6543257|NCT01684215|7464754|FG001|COMPLETED|Phase 1, Part 1||0
6543258|NCT01684215|7464755|FG002|COMPLETED|Phase 1, Part 1||0
6543259|NCT01684215|7464756|FG003|COMPLETED|Phase 1, Part 1||0
6543260|NCT01684215|7464753|FG000|NOT COMPLETED|Phase 1, Part 1||6
6543261|NCT01684215|7464754|FG001|NOT COMPLETED|Phase 1, Part 1||6
6543262|NCT01684215|7464755|FG002|NOT COMPLETED|Phase 1, Part 1||0
6543263|NCT01684215|7464756|FG003|NOT COMPLETED|Phase 1, Part 1||0
6543264|NCT01684215|7464753|FG000|STARTED|Phase 1, Part 2||0
6543265|NCT01684215|7464754|FG001|STARTED|Phase 1, Part 2||0
6543266|NCT01684215|7464755|FG002|STARTED|Phase 1, Part 2|Eligible participants who consented for Phase 1 Part 2.|6
6543267|NCT01684215|7464756|FG003|STARTED|Phase 1, Part 2||0
6543268|NCT01684215|7464753|FG000|COMPLETED|Phase 1, Part 2||0
6543269|NCT01684215|7464754|FG001|COMPLETED|Phase 1, Part 2||0
6543270|NCT01684215|7464755|FG002|COMPLETED|Phase 1, Part 2||0
6543271|NCT01684215|7464756|FG003|COMPLETED|Phase 1, Part 2||0
6543272|NCT01684215|7464753|FG000|NOT COMPLETED|Phase 1, Part 2||0
6543273|NCT01684215|7464754|FG001|NOT COMPLETED|Phase 1, Part 2||0
6543274|NCT01684215|7464755|FG002|NOT COMPLETED|Phase 1, Part 2||6
6543275|NCT01684215|7464756|FG003|NOT COMPLETED|Phase 1, Part 2||0
6543276|NCT01684215|7464753|FG000|STARTED|Phase 2||0
6543277|NCT01684215|7464754|FG001|STARTED|Phase 2||0
6543278|NCT01684215|7464755|FG002|STARTED|Phase 2||0
6543279|NCT01684215|7464756|FG003|STARTED|Phase 2|Eligible participants who consented for Phase 2.|43
6543280|NCT01684215|7464753|FG000|Treated|Phase 2||0
6543281|NCT01684215|7464754|FG001|Treated|Phase 2||0
6543282|NCT01684215|7464755|FG002|Treated|Phase 2||0
6543283|NCT01684215|7464756|FG003|Treated|Phase 2||42
6543284|NCT01684215|7464753|FG000|COMPLETED|Phase 2||0
6543285|NCT01684215|7464754|FG001|COMPLETED|Phase 2||0
6543286|NCT01684215|7464755|FG002|COMPLETED|Phase 2||0
6543287|NCT01684215|7464756|FG003|COMPLETED|Phase 2||0
6543288|NCT01684215|7464753|FG000|NOT COMPLETED|Phase 2||0
6543289|NCT01684215|7464754|FG001|NOT COMPLETED|Phase 2||0
6543290|NCT01684215|7464755|FG002|NOT COMPLETED|Phase 2||0
6543291|NCT01684215|7464756|FG003|NOT COMPLETED|Phase 2||43
6543292|NCT01684410|7464772|FG000|STARTED|Overall Study||10
6543293|NCT01684410|7464773|FG001|STARTED|Overall Study||10
6543294|NCT01684410|7464774|FG002|STARTED|Overall Study||10
6543295|NCT01684410|7464772|FG000|COMPLETED|Overall Study||10
6543296|NCT01684410|7464773|FG001|COMPLETED|Overall Study||10
6543297|NCT01684410|7464774|FG002|COMPLETED|Overall Study||10
6543298|NCT01684410|7464772|FG000|NOT COMPLETED|Overall Study||0
6543299|NCT01684410|7464773|FG001|NOT COMPLETED|Overall Study||0
6543300|NCT01684410|7464774|FG002|NOT COMPLETED|Overall Study||0
6543301|NCT01684423|7464787|FG000|STARTED|Overall Study||11
6543302|NCT01684423|7464788|FG001|STARTED|Overall Study||13
6543303|NCT01684423|7464789|FG002|STARTED|Overall Study||13
6543304|NCT01684423|7464790|FG003|STARTED|Overall Study||19
6543305|NCT01684423|7464791|FG004|STARTED|Overall Study||7
6543306|NCT01684423|7464787|FG000|COMPLETED|Overall Study||11
6543307|NCT01684423|7464788|FG001|COMPLETED|Overall Study||13
6543308|NCT01684423|7464789|FG002|COMPLETED|Overall Study||12
6543309|NCT01684423|7464790|FG003|COMPLETED|Overall Study||19
6543310|NCT01684423|7464791|FG004|COMPLETED|Overall Study||7
6543311|NCT01684423|7464787|FG000|NOT COMPLETED|Overall Study||0
6543312|NCT01684423|7464788|FG001|NOT COMPLETED|Overall Study||0
6543313|NCT01684423|7464789|FG002|NOT COMPLETED|Overall Study||1
6543314|NCT01684423|7464790|FG003|NOT COMPLETED|Overall Study||0
6543315|NCT01684423|7464791|FG004|NOT COMPLETED|Overall Study||0
6543316|NCT01684436|7464805|FG000|STARTED|Overall Study||30
6543317|NCT01684436|7464805|FG000|COMPLETED|Overall Study||29
6543318|NCT01684436|7464805|FG000|NOT COMPLETED|Overall Study||1
6543319|NCT01684566|7464811|FG000|STARTED|Overall Study||60
6543320|NCT01684566|7464812|FG001|STARTED|Overall Study||56
6543321|NCT01684566|7464811|FG000|Treated (ITT)|Overall Study||57
6543322|NCT01684566|7464812|FG001|Treated (ITT)|Overall Study||52
6543323|NCT01684566|7464811|FG000|COMPLETED|Overall Study||44
6543324|NCT01684566|7464812|FG001|COMPLETED|Overall Study||49
6543325|NCT01684566|7464811|FG000|NOT COMPLETED|Overall Study||16
6543326|NCT01684566|7464812|FG001|NOT COMPLETED|Overall Study||7
6543327|NCT01684592|7464820|FG000|STARTED|Overall Study||64
6543328|NCT01684592|7464821|FG001|STARTED|Overall Study||64
6543329|NCT01684592|7464820|FG000|COMPLETED|Overall Study||38
6543330|NCT01684592|7464821|FG001|COMPLETED|Overall Study||40
6543331|NCT01684592|7464820|FG000|NOT COMPLETED|Overall Study||26
6543332|NCT01684592|7464821|FG001|NOT COMPLETED|Overall Study||24
6543333|NCT01684722|7464831|FG000|STARTED|Overall Study||333
6543334|NCT01684722|7464832|FG001|STARTED|Overall Study||289
6543335|NCT01684722|7464833|FG002|STARTED|Overall Study||320
6543336|NCT01684722|7464834|FG003|STARTED|Overall Study||370
6543337|NCT01684722|7464831|FG000|COMPLETED|Overall Study||236
6543338|NCT01684722|7464832|FG001|COMPLETED|Overall Study||212
6543339|NCT01684722|7464833|FG002|COMPLETED|Overall Study||226
6543340|NCT01684722|7464834|FG003|COMPLETED|Overall Study||260
6543341|NCT01684722|7464831|FG000|NOT COMPLETED|Overall Study||97
6543342|NCT01684722|7464832|FG001|NOT COMPLETED|Overall Study||77
6543343|NCT01684722|7464833|FG002|NOT COMPLETED|Overall Study||94
6543344|NCT01684722|7464834|FG003|NOT COMPLETED|Overall Study||110
6543345|NCT01684748|7464858|FG000|STARTED|First Intervention - 8 Weeks||10
6543346|NCT01684748|7464859|FG001|STARTED|First Intervention - 8 Weeks||10
6543347|NCT01684748|7464858|FG000|COMPLETED|First Intervention - 8 Weeks||8
6543348|NCT01684748|7464859|FG001|COMPLETED|First Intervention - 8 Weeks||8
6543349|NCT01684748|7464858|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
6543350|NCT01684748|7464859|FG001|NOT COMPLETED|First Intervention - 8 Weeks||2
6543351|NCT01684748|7464858|FG000|STARTED|Second Intervention - 8 Weeks||8
6543352|NCT01684748|7464859|FG001|STARTED|Second Intervention - 8 Weeks||8
6543353|NCT01684748|7464858|FG000|COMPLETED|Second Intervention - 8 Weeks||8
6543354|NCT01684748|7464859|FG001|COMPLETED|Second Intervention - 8 Weeks||8
6543355|NCT01684748|7464858|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
6543356|NCT01684748|7464859|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
6543357|NCT01684839|7464865|FG000|STARTED|Overall Study||9
6543358|NCT01684839|7464865|FG000|COMPLETED|Overall Study||9
6543359|NCT01684839|7464865|FG000|NOT COMPLETED|Overall Study||0
6543360|NCT01684878|7464873|FG000|STARTED|Part 1: Safety Run in Phase||22
6543361|NCT01684878|7464874|FG001|STARTED|Part 1: Safety Run in Phase||28
6543362|NCT01684878|7464875|FG002|STARTED|Part 1: Safety Run in Phase||0
6543363|NCT01684878|7464876|FG003|STARTED|Part 1: Safety Run in Phase||0
6543364|NCT01684878|7464873|FG000|COMPLETED|Part 1: Safety Run in Phase||6
6543365|NCT01684878|7464874|FG001|COMPLETED|Part 1: Safety Run in Phase||5
6543366|NCT01684878|7464875|FG002|COMPLETED|Part 1: Safety Run in Phase||0
6543367|NCT01684878|7464876|FG003|COMPLETED|Part 1: Safety Run in Phase||0
6543368|NCT01684878|7464873|FG000|NOT COMPLETED|Part 1: Safety Run in Phase||16
6543369|NCT01684878|7464874|FG001|NOT COMPLETED|Part 1: Safety Run in Phase||23
6543370|NCT01684878|7464875|FG002|NOT COMPLETED|Part 1: Safety Run in Phase||0
6543371|NCT01684878|7464876|FG003|NOT COMPLETED|Part 1: Safety Run in Phase||0
6543372|NCT01684878|7464873|FG000|STARTED|Part 2: Randomized Phase||0
6543373|NCT01684878|7464874|FG001|STARTED|Part 2: Randomized Phase||0
6543374|NCT01684878|7464875|FG002|STARTED|Part 2: Randomized Phase||78
6543375|NCT01684878|7464876|FG003|STARTED|Part 2: Randomized Phase||78
6543376|NCT01684878|7464873|FG000|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
6543377|NCT01684878|7464874|FG001|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
6543378|NCT01684878|7464875|FG002|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
6543379|NCT01684878|7464876|FG003|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
6543380|NCT01684878|7464873|FG000|Participants Mis-randomized|Part 2: Randomized Phase||0
6543381|NCT01684878|7464874|FG001|Participants Mis-randomized|Part 2: Randomized Phase||0
6543382|NCT01684878|7464875|FG002|Participants Mis-randomized|Part 2: Randomized Phase||2
6543383|NCT01684878|7464876|FG003|Participants Mis-randomized|Part 2: Randomized Phase||0
6543384|NCT01684878|7464873|FG000|COMPLETED|Part 2: Randomized Phase||0
6543385|NCT01684878|7464874|FG001|COMPLETED|Part 2: Randomized Phase||0
6543386|NCT01684878|7464875|FG002|COMPLETED|Part 2: Randomized Phase||0
6543387|NCT01684878|7464876|FG003|COMPLETED|Part 2: Randomized Phase||0
6543388|NCT01684878|7464873|FG000|NOT COMPLETED|Part 2: Randomized Phase||0
6543389|NCT01684878|7464874|FG001|NOT COMPLETED|Part 2: Randomized Phase||0
6543390|NCT01684878|7464875|FG002|NOT COMPLETED|Part 2: Randomized Phase||78
6543391|NCT01684878|7464876|FG003|NOT COMPLETED|Part 2: Randomized Phase||78
6543392|NCT01684917|7464890|FG000|STARTED|Overall Study||11
6543393|NCT01684917|7464891|FG001|STARTED|Overall Study||7
6543394|NCT01684917|7464892|FG002|STARTED|Overall Study||13
6543395|NCT01684917|7464893|FG003|STARTED|Overall Study||5
6543396|NCT01684917|7464890|FG000|COMPLETED|Overall Study||11
6543397|NCT01684917|7464891|FG001|COMPLETED|Overall Study||7
6543398|NCT01684917|7464892|FG002|COMPLETED|Overall Study||13
6543399|NCT01684917|7464893|FG003|COMPLETED|Overall Study||5
6543400|NCT01684917|7464890|FG000|NOT COMPLETED|Overall Study||0
6543401|NCT01684917|7464891|FG001|NOT COMPLETED|Overall Study||0
6543402|NCT01684917|7464892|FG002|NOT COMPLETED|Overall Study||0
6543403|NCT01684917|7464893|FG003|NOT COMPLETED|Overall Study||0
6543404|NCT01684930|7464905|FG000|STARTED|Overall Study||12
6543405|NCT01684930|7464906|FG001|STARTED|Overall Study||14
6543406|NCT01684930|7464905|FG000|COMPLETED|Overall Study||9
6543407|NCT01684930|7464906|FG001|COMPLETED|Overall Study||13
6543408|NCT01684930|7464905|FG000|NOT COMPLETED|Overall Study||3
6543409|NCT01684930|7464906|FG001|NOT COMPLETED|Overall Study||1
6543410|NCT01684943|7464915|FG000|STARTED|Overall Study||29
6543411|NCT01684943|7464916|FG001|STARTED|Overall Study||3
6543412|NCT01684943|7464917|FG002|STARTED|Overall Study||1
6543413|NCT01684943|7464915|FG000|COMPLETED|Overall Study||20
6543414|NCT01684943|7464916|FG001|COMPLETED|Overall Study||2
6543415|NCT01684943|7464917|FG002|COMPLETED|Overall Study||0
6543416|NCT01684943|7464915|FG000|NOT COMPLETED|Overall Study||9
6543417|NCT01684943|7464916|FG001|NOT COMPLETED|Overall Study||1
6543418|NCT01684943|7464917|FG002|NOT COMPLETED|Overall Study||1
6543419|NCT01685021|7464930|FG000|STARTED|Overall Study||22
6543420|NCT01685021|7464930|FG000|COMPLETED|Overall Study|Last patient last visit date. Study was Terminated prematurely.|6
6543421|NCT01685021|7464930|FG000|NOT COMPLETED|Overall Study||16
6543422|NCT01685047|7464934|FG000|STARTED|Overall Study|481 subjects signed the consent. 1 subject was withdrawn prior to the baseline visit.|481
6543423|NCT01685047|7464934|FG000|COMPLETED|Overall Study||396
6543424|NCT01685047|7464934|FG000|NOT COMPLETED|Overall Study||85
6543425|NCT01685060|7464938|FG000|STARTED|Overall Study||140
6543426|NCT01685060|7464938|FG000|Entered Post-treatment Efficacy f/u|Overall Study||7
6543427|NCT01685060|7464938|FG000|Entered Survival Follow up|Overall Study||98
6543428|NCT01685060|7464938|FG000|Discontinued From Study|Overall Study||35
6543429|NCT01685060|7464938|FG000|COMPLETED|Overall Study||0
6543430|NCT01685060|7464938|FG000|NOT COMPLETED|Overall Study||140
6543431|NCT01685073|7464944|FG000|STARTED|Overall Study|Randomized|62
6543432|NCT01685073|7464945|FG001|STARTED|Overall Study|Randomized|65
6543433|NCT01685073|7464944|FG000|COMPLETED|Overall Study|Retained in treatment through 12 weeks|32
6543434|NCT01685073|7464945|FG001|COMPLETED|Overall Study|Retained in treatment through 12 weeks|33
6543435|NCT01685073|7464944|FG000|NOT COMPLETED|Overall Study||30
6543436|NCT01685073|7464945|FG001|NOT COMPLETED|Overall Study||32
6562371|NCT01800916|7485365|FG003|STARTED|Test Period 1 (1 Week)||7
6562372|NCT01800916|7485366|FG004|STARTED|Test Period 1 (1 Week)||8
6562373|NCT01800916|7485367|FG005|STARTED|Test Period 1 (1 Week)||7
6562374|NCT01800916|7485368|FG006|STARTED|Test Period 1 (1 Week)||7
6562375|NCT01800916|7485369|FG007|STARTED|Test Period 1 (1 Week)||7
6562376|NCT01800916|7485370|FG008|STARTED|Test Period 1 (1 Week)||7
6562377|NCT01800916|7485362|FG000|COMPLETED|Test Period 1 (1 Week)||7
6562378|NCT01800916|7485363|FG001|COMPLETED|Test Period 1 (1 Week)||7
6562379|NCT01800916|7485364|FG002|COMPLETED|Test Period 1 (1 Week)||7
6562380|NCT01800916|7485365|FG003|COMPLETED|Test Period 1 (1 Week)||6
6562381|NCT01800916|7485366|FG004|COMPLETED|Test Period 1 (1 Week)||7
6562382|NCT01800916|7485367|FG005|COMPLETED|Test Period 1 (1 Week)||7
6562383|NCT01800916|7485368|FG006|COMPLETED|Test Period 1 (1 Week)||7
6562384|NCT01800916|7485369|FG007|COMPLETED|Test Period 1 (1 Week)||7
6562385|NCT01800916|7485370|FG008|COMPLETED|Test Period 1 (1 Week)||7
6562386|NCT01800916|7485362|FG000|NOT COMPLETED|Test Period 1 (1 Week)||0
6562387|NCT01800916|7485363|FG001|NOT COMPLETED|Test Period 1 (1 Week)||0
6562388|NCT01800916|7485364|FG002|NOT COMPLETED|Test Period 1 (1 Week)||0
6562389|NCT01800916|7485365|FG003|NOT COMPLETED|Test Period 1 (1 Week)||1
6562390|NCT01800916|7485366|FG004|NOT COMPLETED|Test Period 1 (1 Week)||1
6562391|NCT01800916|7485367|FG005|NOT COMPLETED|Test Period 1 (1 Week)||0
6562392|NCT01800916|7485368|FG006|NOT COMPLETED|Test Period 1 (1 Week)||0
6562393|NCT01800916|7485369|FG007|NOT COMPLETED|Test Period 1 (1 Week)||0
6562394|NCT01800916|7485370|FG008|NOT COMPLETED|Test Period 1 (1 Week)||0
6562395|NCT01800916|7485362|FG000|STARTED|Test Period 2 (1 Week)||7
6562396|NCT01800916|7485363|FG001|STARTED|Test Period 2 (1 Week)||7
6562397|NCT01800916|7485364|FG002|STARTED|Test Period 2 (1 Week)||7
6562398|NCT01800916|7485365|FG003|STARTED|Test Period 2 (1 Week)||6
6562399|NCT01800916|7485366|FG004|STARTED|Test Period 2 (1 Week)||7
6562400|NCT01800916|7485367|FG005|STARTED|Test Period 2 (1 Week)||7
6562401|NCT01800916|7485368|FG006|STARTED|Test Period 2 (1 Week)||7
6562402|NCT01800916|7485369|FG007|STARTED|Test Period 2 (1 Week)||7
6562403|NCT01800916|7485370|FG008|STARTED|Test Period 2 (1 Week)||7
6562404|NCT01800916|7485362|FG000|COMPLETED|Test Period 2 (1 Week)||7
6562405|NCT01800916|7485363|FG001|COMPLETED|Test Period 2 (1 Week)||7
6562406|NCT01800916|7485364|FG002|COMPLETED|Test Period 2 (1 Week)||7
6562407|NCT01800916|7485365|FG003|COMPLETED|Test Period 2 (1 Week)||6
6562408|NCT01800916|7485366|FG004|COMPLETED|Test Period 2 (1 Week)||7
6562409|NCT01800916|7485367|FG005|COMPLETED|Test Period 2 (1 Week)||7
6562410|NCT01800916|7485368|FG006|COMPLETED|Test Period 2 (1 Week)||7
6562411|NCT01800916|7485369|FG007|COMPLETED|Test Period 2 (1 Week)||7
6562412|NCT01800916|7485370|FG008|COMPLETED|Test Period 2 (1 Week)||7
6562413|NCT01800916|7485362|FG000|NOT COMPLETED|Test Period 2 (1 Week)||0
6562414|NCT01800916|7485363|FG001|NOT COMPLETED|Test Period 2 (1 Week)||0
6562415|NCT01800916|7485364|FG002|NOT COMPLETED|Test Period 2 (1 Week)||0
6562416|NCT01800916|7485365|FG003|NOT COMPLETED|Test Period 2 (1 Week)||0
6562417|NCT01800916|7485366|FG004|NOT COMPLETED|Test Period 2 (1 Week)||0
6562418|NCT01800916|7485367|FG005|NOT COMPLETED|Test Period 2 (1 Week)||0
6562419|NCT01800916|7485368|FG006|NOT COMPLETED|Test Period 2 (1 Week)||0
6562420|NCT01800916|7485369|FG007|NOT COMPLETED|Test Period 2 (1 Week)||0
6562421|NCT01800916|7485370|FG008|NOT COMPLETED|Test Period 2 (1 Week)||0
6562422|NCT01800916|7485362|FG000|STARTED|Test Period 3 (1 Week)||7
6562423|NCT01800916|7485363|FG001|STARTED|Test Period 3 (1 Week)||7
6562424|NCT01800916|7485364|FG002|STARTED|Test Period 3 (1 Week)||7
6562425|NCT01800916|7485365|FG003|STARTED|Test Period 3 (1 Week)||6
6562426|NCT01800916|7485366|FG004|STARTED|Test Period 3 (1 Week)||7
6562427|NCT01800916|7485367|FG005|STARTED|Test Period 3 (1 Week)||7
6562428|NCT01800916|7485368|FG006|STARTED|Test Period 3 (1 Week)||7
6562429|NCT01800916|7485369|FG007|STARTED|Test Period 3 (1 Week)||7
6562430|NCT01800916|7485370|FG008|STARTED|Test Period 3 (1 Week)||7
6562431|NCT01800916|7485362|FG000|COMPLETED|Test Period 3 (1 Week)||7
6562432|NCT01800916|7485363|FG001|COMPLETED|Test Period 3 (1 Week)||7
6562433|NCT01800916|7485364|FG002|COMPLETED|Test Period 3 (1 Week)||7
6743816|NCT03335566|7671861|FG001|COMPLETED|Overall Study||203
6743817|NCT03335566|7671860|FG000|NOT COMPLETED|Overall Study||4
6562434|NCT01800916|7485365|FG003|COMPLETED|Test Period 3 (1 Week)||6
6562435|NCT01800916|7485366|FG004|COMPLETED|Test Period 3 (1 Week)||7
6562436|NCT01800916|7485367|FG005|COMPLETED|Test Period 3 (1 Week)||7
6646875|NCT02383966|7575884|FG001|NOT COMPLETED|Overall Study||7
6646876|NCT02384044|7575892|FG000|STARTED|Overall Study||15
6562437|NCT01800916|7485368|FG006|COMPLETED|Test Period 3 (1 Week)||7
6562438|NCT01800916|7485369|FG007|COMPLETED|Test Period 3 (1 Week)||7
6562439|NCT01800916|7485370|FG008|COMPLETED|Test Period 3 (1 Week)||7
6562440|NCT01800916|7485362|FG000|NOT COMPLETED|Test Period 3 (1 Week)||0
6562441|NCT01800916|7485363|FG001|NOT COMPLETED|Test Period 3 (1 Week)||0
6562442|NCT01800916|7485364|FG002|NOT COMPLETED|Test Period 3 (1 Week)||0
6562443|NCT01800916|7485365|FG003|NOT COMPLETED|Test Period 3 (1 Week)||0
6646877|NCT02384044|7575893|FG001|STARTED|Overall Study||15
6543437|NCT01685138|7464951|FG000|STARTED|Overall Study||124
6543438|NCT01685138|7464951|FG000|Discontinued From Treatment Phase|Overall Study||124
6543439|NCT01685138|7464951|FG000|Entered Post-treatment Efficacy f/up|Overall Study||10
6543440|NCT01685138|7464951|FG000|Entered Survival Follow-up|Overall Study||63
6743818|NCT03335566|7671861|FG001|NOT COMPLETED|Overall Study||3
6743819|NCT03335761|7671870|FG000|STARTED|Overall Study||19
6743820|NCT03335761|7671871|FG001|STARTED|Overall Study||14
6543441|NCT01685138|7464951|FG000|Discontinued From Study|Overall Study||51
6543442|NCT01685138|7464951|FG000|COMPLETED|Overall Study||32
6743821|NCT03335761|7671872|FG002|STARTED|Overall Study||15
6743822|NCT03335761|7671870|FG000|Implanted With a Neurostimulator Device|Overall Study||18
6743823|NCT03335761|7671871|FG001|Implanted With a Neurostimulator Device|Overall Study||14
6743824|NCT03335761|7671872|FG002|Implanted With a Neurostimulator Device|Overall Study||14
6543443|NCT01685138|7464951|FG000|NOT COMPLETED|Overall Study||92
6543444|NCT01685203|7464962|FG000|STARTED|Overall Study||44
6543445|NCT01685203|7464963|FG001|STARTED|Overall Study||42
6543446|NCT01685203|7464964|FG002|STARTED|Overall Study||40
6543447|NCT01685203|7464965|FG003|STARTED|Overall Study||42
6543448|NCT01685203|7464966|FG004|STARTED|Overall Study||49
6543449|NCT01685203|7464967|FG005|STARTED|Overall Study||47
6543450|NCT01685203|7464968|FG006|STARTED|Overall Study||52
6543451|NCT01685203|7464962|FG000|Completed Study Drug|Overall Study||42
6543452|NCT01685203|7464963|FG001|Completed Study Drug|Overall Study||40
6543453|NCT01685203|7464964|FG002|Completed Study Drug|Overall Study||39
6543454|NCT01685203|7464965|FG003|Completed Study Drug|Overall Study||42
6543455|NCT01685203|7464966|FG004|Completed Study Drug|Overall Study||49
6543456|NCT01685203|7464967|FG005|Completed Study Drug|Overall Study||43
6543457|NCT01685203|7464968|FG006|Completed Study Drug|Overall Study||52
6543458|NCT01685203|7464962|FG000|COMPLETED|Overall Study||40
6543459|NCT01685203|7464963|FG001|COMPLETED|Overall Study||39
6543460|NCT01685203|7464964|FG002|COMPLETED|Overall Study||40
6543461|NCT01685203|7464965|FG003|COMPLETED|Overall Study||41
6543462|NCT01685203|7464966|FG004|COMPLETED|Overall Study||49
6543463|NCT01685203|7464967|FG005|COMPLETED|Overall Study||44
6543464|NCT01685203|7464968|FG006|COMPLETED|Overall Study||52
6543465|NCT01685203|7464962|FG000|NOT COMPLETED|Overall Study||4
6543466|NCT01685203|7464963|FG001|NOT COMPLETED|Overall Study||3
6543467|NCT01685203|7464964|FG002|NOT COMPLETED|Overall Study||0
6543468|NCT01685203|7464965|FG003|NOT COMPLETED|Overall Study||1
6543469|NCT01685203|7464966|FG004|NOT COMPLETED|Overall Study||0
6543470|NCT01685203|7464967|FG005|NOT COMPLETED|Overall Study||3
6543471|NCT01685203|7464968|FG006|NOT COMPLETED|Overall Study||0
6543472|NCT01685216|7464984|FG000|STARTED|Overall Study||7
6543473|NCT01685216|7464984|FG000|COMPLETED|Overall Study||6
6543474|NCT01685216|7464984|FG000|NOT COMPLETED|Overall Study||1
6543475|NCT01685229|7464990|FG000|STARTED|Overall Study||146
6543476|NCT01685229|7464991|FG001|STARTED|Overall Study||52
6543477|NCT01685229|7464990|FG000|COMPLETED|Overall Study||120
6543478|NCT01685229|7464991|FG001|COMPLETED|Overall Study||36
6543479|NCT01685229|7464990|FG000|NOT COMPLETED|Overall Study||26
6543480|NCT01685229|7464991|FG001|NOT COMPLETED|Overall Study||16
6543481|NCT01685242|7465002|FG000|STARTED|Overall Study||50
6543482|NCT01685242|7465003|FG001|STARTED|Overall Study||50
6543483|NCT01685242|7465002|FG000|COMPLETED|Overall Study||49
6543484|NCT01685242|7465003|FG001|COMPLETED|Overall Study||47
6543485|NCT01685242|7465002|FG000|NOT COMPLETED|Overall Study||1
6543486|NCT01685242|7465003|FG001|NOT COMPLETED|Overall Study||3
6543487|NCT01685320|7465011|FG000|STARTED|Overall Study||15
6543488|NCT01685320|7465012|FG001|STARTED|Overall Study||15
6543489|NCT01685320|7465011|FG000|COMPLETED|Overall Study||15
6543490|NCT01685320|7465012|FG001|COMPLETED|Overall Study||15
6543491|NCT01685320|7465011|FG000|NOT COMPLETED|Overall Study||0
6543492|NCT01685320|7465012|FG001|NOT COMPLETED|Overall Study||0
6543493|NCT01685372|7465020|FG000|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
6543494|NCT01685372|7465021|FG001|STARTED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
6543495|NCT01685372|7465020|FG000|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||7
6543496|NCT01685372|7465021|FG001|COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||9
6543497|NCT01685372|7465020|FG000|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
6543498|NCT01685372|7465021|FG001|NOT COMPLETED|Timepoint 1 (T1): Vaccine,1st Blood Draw||0
6543499|NCT01685372|7465020|FG000|STARTED|Timepoint 2 (T2): 2nd Blood Draw||7
6543500|NCT01685372|7465021|FG001|STARTED|Timepoint 2 (T2): 2nd Blood Draw||9
6543501|NCT01685372|7465020|FG000|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||7
6543502|NCT01685372|7465021|FG001|COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||9
6543503|NCT01685372|7465020|FG000|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
6543504|NCT01685372|7465021|FG001|NOT COMPLETED|Timepoint 2 (T2): 2nd Blood Draw||0
6543505|NCT01685372|7465020|FG000|STARTED|Timepoint 3 (T3): 3rd Blood Draw||7
6543506|NCT01685372|7465021|FG001|STARTED|Timepoint 3 (T3): 3rd Blood Draw||9
6543507|NCT01685372|7465020|FG000|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
6543508|NCT01685372|7465021|FG001|COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||5
6543509|NCT01685372|7465020|FG000|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||3
6543510|NCT01685372|7465021|FG001|NOT COMPLETED|Timepoint 3 (T3): 3rd Blood Draw||4
6543511|NCT01685411|7465027|FG000|STARTED|Overall Study||5
6543512|NCT01685411|7465027|FG000|COMPLETED|Overall Study||5
6543513|NCT01685411|7465027|FG000|NOT COMPLETED|Overall Study||0
6543514|NCT01685437|7465031|FG000|STARTED|Overall Study||189
6743825|NCT03335761|7671870|FG000|COMPLETED|Overall Study||17
6543515|NCT01685437|7465031|FG000|COMPLETED|Overall Study||158
6543516|NCT01685437|7465031|FG000|NOT COMPLETED|Overall Study||31
6543517|NCT01685463|7465037|FG000|STARTED|Overall Study||10
6543518|NCT01685463|7465038|FG001|STARTED|Overall Study||8
6543519|NCT01685463|7465037|FG000|COMPLETED|Overall Study||10
6543520|NCT01685463|7465038|FG001|COMPLETED|Overall Study||8
6543521|NCT01685463|7465037|FG000|NOT COMPLETED|Overall Study||0
6543522|NCT01685463|7465038|FG001|NOT COMPLETED|Overall Study||0
6543523|NCT01685567|7465044|FG000|STARTED|Overall Study||219
6543524|NCT01685567|7465044|FG000|COMPLETED|Overall Study||219
6543525|NCT01685567|7465044|FG000|NOT COMPLETED|Overall Study||0
6543526|NCT01685684|7465050|FG000|STARTED|Titration Phase||740
6543527|NCT01685684|7465051|FG001|STARTED|Titration Phase||0
6543528|NCT01685684|7465052|FG002|STARTED|Titration Phase||0
6543529|NCT01685684|7465050|FG000|COMPLETED|Titration Phase||389
6543530|NCT01685684|7465051|FG001|COMPLETED|Titration Phase||0
6543531|NCT01685684|7465052|FG002|COMPLETED|Titration Phase||0
6543532|NCT01685684|7465050|FG000|NOT COMPLETED|Titration Phase||351
6543533|NCT01685684|7465051|FG001|NOT COMPLETED|Titration Phase||0
6543534|NCT01685684|7465052|FG002|NOT COMPLETED|Titration Phase||0
6543535|NCT01685684|7465050|FG000|STARTED|Double-blind Maintenance Phase||0
6543536|NCT01685684|7465051|FG001|STARTED|Double-blind Maintenance Phase||193
6543537|NCT01685684|7465052|FG002|STARTED|Double-blind Maintenance Phase||196
6543538|NCT01685684|7465050|FG000|COMPLETED|Double-blind Maintenance Phase||0
6543539|NCT01685684|7465051|FG001|COMPLETED|Double-blind Maintenance Phase||122
6543540|NCT01685684|7465052|FG002|COMPLETED|Double-blind Maintenance Phase||100
6543541|NCT01685684|7465050|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
6543542|NCT01685684|7465051|FG001|NOT COMPLETED|Double-blind Maintenance Phase||71
6543543|NCT01685684|7465052|FG002|NOT COMPLETED|Double-blind Maintenance Phase||96
6543544|NCT01685697|7465062|FG000|STARTED|Overall Study||31
6543545|NCT01685697|7465063|FG001|STARTED|Overall Study||31
6543546|NCT01685697|7465062|FG000|COMPLETED|Overall Study||28
6543547|NCT01685697|7465063|FG001|COMPLETED|Overall Study||28
6543548|NCT01685697|7465062|FG000|NOT COMPLETED|Overall Study||3
6543549|NCT01685697|7465063|FG001|NOT COMPLETED|Overall Study||3
6543550|NCT01685801|7465073|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||5
6543551|NCT01685801|7465074|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||6
6543552|NCT01685801|7465075|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||7
6543553|NCT01685801|7465076|FG003|STARTED|Cycle 1 Period 1 (2 Weeks)||6
6543554|NCT01685801|7465073|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
6543555|NCT01685801|7465074|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
6543556|NCT01685801|7465075|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
6543557|NCT01685801|7465076|FG003|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
6543558|NCT01685801|7465073|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6543559|NCT01685801|7465074|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6543560|NCT01685801|7465075|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6543561|NCT01685801|7465076|FG003|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6543562|NCT01685801|7465073|FG000|STARTED|Cycle 1 Period 2 (2 Weeks)||5
6543563|NCT01685801|7465074|FG001|STARTED|Cycle 1 Period 2 (2 Weeks)||6
6543564|NCT01685801|7465075|FG002|STARTED|Cycle 1 Period 2 (2 Weeks)||7
6543565|NCT01685801|7465076|FG003|STARTED|Cycle 1 Period 2 (2 Weeks)||6
6543566|NCT01685801|7465073|FG000|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
6543567|NCT01685801|7465074|FG001|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
6543568|NCT01685801|7465075|FG002|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
6543569|NCT01685801|7465076|FG003|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
6543570|NCT01685801|7465073|FG000|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
6543571|NCT01685801|7465074|FG001|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
6543572|NCT01685801|7465075|FG002|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
6543573|NCT01685801|7465076|FG003|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
6543574|NCT01685801|7465073|FG000|STARTED|Washout Period 1 (4 Weeks)||5
6543575|NCT01685801|7465074|FG001|STARTED|Washout Period 1 (4 Weeks)||6
6543576|NCT01685801|7465075|FG002|STARTED|Washout Period 1 (4 Weeks)||7
6543577|NCT01685801|7465076|FG003|STARTED|Washout Period 1 (4 Weeks)||5
6543578|NCT01685801|7465073|FG000|COMPLETED|Washout Period 1 (4 Weeks)||5
6543579|NCT01685801|7465074|FG001|COMPLETED|Washout Period 1 (4 Weeks)||6
6543580|NCT01685801|7465075|FG002|COMPLETED|Washout Period 1 (4 Weeks)||7
6543581|NCT01685801|7465076|FG003|COMPLETED|Washout Period 1 (4 Weeks)||5
6543582|NCT01685801|7465073|FG000|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
6543583|NCT01685801|7465074|FG001|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
6543584|NCT01685801|7465075|FG002|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
6543585|NCT01685801|7465076|FG003|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
6543586|NCT01685801|7465073|FG000|STARTED|Cycle 2 Period 1 (2 Weeks)||5
6543587|NCT01685801|7465074|FG001|STARTED|Cycle 2 Period 1 (2 Weeks)||6
6543588|NCT01685801|7465075|FG002|STARTED|Cycle 2 Period 1 (2 Weeks)||7
6543589|NCT01685801|7465076|FG003|STARTED|Cycle 2 Period 1 (2 Weeks)||5
6543590|NCT01685801|7465073|FG000|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
6543591|NCT01685801|7465074|FG001|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
6543592|NCT01685801|7465075|FG002|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
6543593|NCT01685801|7465076|FG003|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
6543594|NCT01685801|7465073|FG000|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
6543595|NCT01685801|7465074|FG001|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
6543596|NCT01685801|7465075|FG002|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
6543597|NCT01685801|7465076|FG003|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
6543598|NCT01685801|7465073|FG000|STARTED|Cycle 2 Period 2 (2 Weeks)||5
6543599|NCT01685801|7465074|FG001|STARTED|Cycle 2 Period 2 (2 Weeks)||6
6543600|NCT01685801|7465075|FG002|STARTED|Cycle 2 Period 2 (2 Weeks)||7
6543601|NCT01685801|7465076|FG003|STARTED|Cycle 2 Period 2 (2 Weeks)||5
6543602|NCT01685801|7465073|FG000|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
6543603|NCT01685801|7465074|FG001|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
6543604|NCT01685801|7465075|FG002|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
6543605|NCT01685801|7465076|FG003|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
6543606|NCT01685801|7465073|FG000|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
6543607|NCT01685801|7465074|FG001|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
6543608|NCT01685801|7465075|FG002|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
6543609|NCT01685801|7465076|FG003|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
6543610|NCT01685801|7465073|FG000|STARTED|Washout Period 2 (4 Weeks)||5
6543611|NCT01685801|7465074|FG001|STARTED|Washout Period 2 (4 Weeks)||5
6543612|NCT01685801|7465075|FG002|STARTED|Washout Period 2 (4 Weeks)||7
6543613|NCT01685801|7465076|FG003|STARTED|Washout Period 2 (4 Weeks)||4
6543614|NCT01685801|7465073|FG000|COMPLETED|Washout Period 2 (4 Weeks)||5
6543615|NCT01685801|7465074|FG001|COMPLETED|Washout Period 2 (4 Weeks)||5
6543616|NCT01685801|7465075|FG002|COMPLETED|Washout Period 2 (4 Weeks)||7
6543617|NCT01685801|7465076|FG003|COMPLETED|Washout Period 2 (4 Weeks)||4
6543618|NCT01685801|7465073|FG000|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
6543619|NCT01685801|7465074|FG001|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
6543620|NCT01685801|7465075|FG002|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
6543621|NCT01685801|7465076|FG003|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
6543622|NCT01685801|7465073|FG000|STARTED|Open-label Period (8 Weeks)||5
6543623|NCT01685801|7465074|FG001|STARTED|Open-label Period (8 Weeks)||5
6543624|NCT01685801|7465075|FG002|STARTED|Open-label Period (8 Weeks)||7
6543625|NCT01685801|7465076|FG003|STARTED|Open-label Period (8 Weeks)||4
6543626|NCT01685801|7465073|FG000|COMPLETED|Open-label Period (8 Weeks)||5
6543627|NCT01685801|7465074|FG001|COMPLETED|Open-label Period (8 Weeks)||5
6543628|NCT01685801|7465075|FG002|COMPLETED|Open-label Period (8 Weeks)||7
6543629|NCT01685801|7465076|FG003|COMPLETED|Open-label Period (8 Weeks)||4
6543630|NCT01685801|7465073|FG000|NOT COMPLETED|Open-label Period (8 Weeks)||0
6543631|NCT01685801|7465074|FG001|NOT COMPLETED|Open-label Period (8 Weeks)||0
6543632|NCT01685801|7465075|FG002|NOT COMPLETED|Open-label Period (8 Weeks)||0
6543633|NCT01685801|7465076|FG003|NOT COMPLETED|Open-label Period (8 Weeks)||0
6543634|NCT01685840|7465095|FG000|STARTED|Overall Study||448
6543635|NCT01685840|7465096|FG001|STARTED|Overall Study||446
6543636|NCT01685840|7465095|FG000|COMPLETED|Overall Study||119
6543637|NCT01685840|7465096|FG001|COMPLETED|Overall Study||114
6543638|NCT01685840|7465095|FG000|NOT COMPLETED|Overall Study||329
6543639|NCT01685840|7465096|FG001|NOT COMPLETED|Overall Study||332
6543640|NCT01685983|7465104|FG000|STARTED|Overall Study||82
6543641|NCT01685983|7465104|FG000|COMPLETED|Overall Study||0
6543642|NCT01685983|7465104|FG000|NOT COMPLETED|Overall Study||82
6543643|NCT01685996|7465110|FG000|STARTED|Overall Study||34
6543644|NCT01685996|7465111|FG001|STARTED|Overall Study||40
6543645|NCT01685996|7465110|FG000|COMPLETED|Overall Study||18
6543646|NCT01685996|7465111|FG001|COMPLETED|Overall Study||27
6543647|NCT01685996|7465110|FG000|NOT COMPLETED|Overall Study||16
6543648|NCT01685996|7465111|FG001|NOT COMPLETED|Overall Study||13
6543649|NCT01686152|7465120|FG000|STARTED|Overall Study||252
6543650|NCT01686152|7465121|FG001|STARTED|Overall Study||253
6543651|NCT01686152|7465122|FG002|STARTED|Overall Study||84
6543652|NCT01686152|7465120|FG000|COMPLETED|Overall Study||211
6543653|NCT01686152|7465121|FG001|COMPLETED|Overall Study||218
6543654|NCT01686152|7465122|FG002|COMPLETED|Overall Study||75
6543655|NCT01686152|7465120|FG000|NOT COMPLETED|Overall Study||41
6543656|NCT01686152|7465121|FG001|NOT COMPLETED|Overall Study||35
6543657|NCT01686152|7465122|FG002|NOT COMPLETED|Overall Study||9
6543658|NCT01686165|7465130|FG000|STARTED|Overall Study||5
6543659|NCT01686165|7465130|FG000|COMPLETED|Overall Study||5
6543660|NCT01686165|7465130|FG000|NOT COMPLETED|Overall Study||0
6543661|NCT01686373|7465136|FG000|STARTED|Overall Study||34
6543662|NCT01686373|7465137|FG001|STARTED|Overall Study||40
6543663|NCT01686373|7465136|FG000|Received 15 Treatment Sessions|Overall Study||33
6543664|NCT01686373|7465137|FG001|Received 15 Treatment Sessions|Overall Study||39
6543665|NCT01686373|7465136|FG000|COMPLETED|Overall Study||31
6543666|NCT01686373|7465137|FG001|COMPLETED|Overall Study||38
6543667|NCT01686373|7465136|FG000|NOT COMPLETED|Overall Study||3
6543668|NCT01686373|7465137|FG001|NOT COMPLETED|Overall Study||2
6543669|NCT01686438|7465146|FG000|STARTED|Overall Study||15
6543670|NCT01686438|7465147|FG001|STARTED|Overall Study||35
6543671|NCT01686438|7465148|FG002|STARTED|Overall Study||37
6543672|NCT01686438|7465146|FG000|2-Week Follow Up|Overall Study||12
6543673|NCT01686438|7465147|FG001|2-Week Follow Up|Overall Study||31
6543674|NCT01686438|7465148|FG002|2-Week Follow Up|Overall Study||27
6543675|NCT01686438|7465146|FG000|3-Month Follow Up|Overall Study||7
6543676|NCT01686438|7465147|FG001|3-Month Follow Up|Overall Study||21
6543677|NCT01686438|7465148|FG002|3-Month Follow Up|Overall Study||17
6543678|NCT01686438|7465146|FG000|6-Month Follow Up|Overall Study||7
6543679|NCT01686438|7465147|FG001|6-Month Follow Up|Overall Study||26
6543680|NCT01686438|7465148|FG002|6-Month Follow Up|Overall Study||24
6543681|NCT01686438|7465146|FG000|COMPLETED|Overall Study||7
6543682|NCT01686438|7465147|FG001|COMPLETED|Overall Study||26
6543683|NCT01686438|7465148|FG002|COMPLETED|Overall Study||24
6543684|NCT01686438|7465146|FG000|NOT COMPLETED|Overall Study||8
6543685|NCT01686438|7465147|FG001|NOT COMPLETED|Overall Study||9
6646878|NCT02384044|7575892|FG000|COMPLETED|Overall Study||15
6646879|NCT02384044|7575893|FG001|COMPLETED|Overall Study||15
6646880|NCT02384044|7575892|FG000|NOT COMPLETED|Overall Study||0
6646881|NCT02384044|7575893|FG001|NOT COMPLETED|Overall Study||0
6646882|NCT02384070|7575902|FG000|STARTED|Overall Study||100
6646883|NCT02384070|7575903|FG001|STARTED|Overall Study||100
6646884|NCT02384070|7575904|FG002|STARTED|Overall Study||100
6646885|NCT02384070|7575902|FG000|COMPLETED|Overall Study||100
6646886|NCT02384070|7575903|FG001|COMPLETED|Overall Study||100
6543686|NCT01686438|7465148|FG002|NOT COMPLETED|Overall Study||13
6543687|NCT01686451|7465160|FG000|STARTED|Overall Study||33
6543688|NCT01686451|7465161|FG001|STARTED|Overall Study||27
6543689|NCT01686451|7465160|FG000|COMPLETED|Overall Study||33
6543690|NCT01686451|7465161|FG001|COMPLETED|Overall Study||27
6543691|NCT01686451|7465160|FG000|NOT COMPLETED|Overall Study||0
6543692|NCT01686451|7465161|FG001|NOT COMPLETED|Overall Study||0
6543693|NCT01686503|7465173|FG000|STARTED|Overall Study||66
6543694|NCT01686503|7465174|FG001|STARTED|Overall Study||66
6543695|NCT01686503|7465175|FG002|STARTED|Overall Study||66
6543696|NCT01686503|7465176|FG003|STARTED|Overall Study||33
6543697|NCT01686503|7465173|FG000|COMPLETED|Overall Study||65
6543698|NCT01686503|7465174|FG001|COMPLETED|Overall Study||63
6543699|NCT01686503|7465175|FG002|COMPLETED|Overall Study||64
6543700|NCT01686503|7465176|FG003|COMPLETED|Overall Study||32
6543701|NCT01686503|7465173|FG000|NOT COMPLETED|Overall Study||1
6543702|NCT01686503|7465174|FG001|NOT COMPLETED|Overall Study||3
6543703|NCT01686503|7465175|FG002|NOT COMPLETED|Overall Study||2
6543704|NCT01686503|7465176|FG003|NOT COMPLETED|Overall Study||1
6543705|NCT01686568|7465188|FG000|STARTED|Main Study||16
6543706|NCT01686568|7465189|FG001|STARTED|Main Study||15
6543707|NCT01686568|7465188|FG000|COMPLETED|Main Study||14
6543708|NCT01686568|7465189|FG001|COMPLETED|Main Study||11
6543709|NCT01686568|7465188|FG000|NOT COMPLETED|Main Study||2
6543710|NCT01686568|7465189|FG001|NOT COMPLETED|Main Study||4
6543711|NCT01686568|7465188|FG000|STARTED|Sub-Study||14
6543712|NCT01686568|7465189|FG001|STARTED|Sub-Study||11
6543713|NCT01686568|7465188|FG000|COMPLETED|Sub-Study||12
6543714|NCT01686568|7465189|FG001|COMPLETED|Sub-Study||9
6543715|NCT01686568|7465188|FG000|NOT COMPLETED|Sub-Study||2
6543716|NCT01686568|7465189|FG001|NOT COMPLETED|Sub-Study||2
6543717|NCT01686581|7465195|FG000|STARTED|Overall Study||641
6543718|NCT01686581|7465195|FG000|Safety Analysis Set; Received Study Drug|Overall Study||633
6543719|NCT01686581|7465195|FG000|Completed 24 Months|Overall Study||128
6543720|NCT01686581|7465195|FG000|COMPLETED|Overall Study||464
6543721|NCT01686581|7465195|FG000|NOT COMPLETED|Overall Study||177
6543722|NCT01686633|7465202|FG000|STARTED|Overall Study||347
6543723|NCT01686633|7465203|FG001|STARTED|Overall Study||346
6543724|NCT01686633|7465204|FG002|STARTED|Overall Study||346
6543725|NCT01686633|7465202|FG000|COMPLETED|Overall Study||296
6543726|NCT01686633|7465203|FG001|COMPLETED|Overall Study||314
6543727|NCT01686633|7465204|FG002|COMPLETED|Overall Study||321
6543728|NCT01686633|7465202|FG000|NOT COMPLETED|Overall Study||51
6543729|NCT01686633|7465203|FG001|NOT COMPLETED|Overall Study||32
6543730|NCT01686633|7465204|FG002|NOT COMPLETED|Overall Study||25
6543731|NCT01686646|7465216|FG000|STARTED|Overall Study||45
6543732|NCT01686646|7465217|FG001|STARTED|Overall Study||45
6543733|NCT01686646|7465218|FG002|STARTED|Overall Study||75
6646887|NCT02384070|7575904|FG002|COMPLETED|Overall Study||100
6646888|NCT02384070|7575902|FG000|NOT COMPLETED|Overall Study||0
6743826|NCT03335761|7671871|FG001|COMPLETED|Overall Study||13
6743827|NCT03335761|7671872|FG002|COMPLETED|Overall Study||13
6743828|NCT03335761|7671870|FG000|NOT COMPLETED|Overall Study||2
6743829|NCT03335761|7671871|FG001|NOT COMPLETED|Overall Study||1
6743830|NCT03335761|7671872|FG002|NOT COMPLETED|Overall Study||2
6779638|NCT03725722|7707818|FG001|NOT COMPLETED|Overall Study||6
6779639|NCT03725722|7707819|FG002|NOT COMPLETED|Overall Study||6
6779640|NCT03725722|7707820|FG003|NOT COMPLETED|Overall Study||6
6779641|NCT03725722|7707821|FG004|NOT COMPLETED|Overall Study||14
6779642|NCT03725098|7707835|FG000|STARTED|Overall Study||53
6779643|NCT03725098|7707836|FG001|STARTED|Overall Study||52
6779644|NCT03725098|7707835|FG000|COMPLETED|Overall Study||53
6779645|NCT03725098|7707836|FG001|COMPLETED|Overall Study||52
6779646|NCT03725098|7707835|FG000|NOT COMPLETED|Overall Study||0
6779647|NCT03725098|7707836|FG001|NOT COMPLETED|Overall Study||0
6779648|NCT03725085|7707842|FG000|STARTED|Overall Study||552
6779649|NCT03725085|7707842|FG000|COMPLETED|Overall Study||550
6779650|NCT03725085|7707842|FG000|NOT COMPLETED|Overall Study||2
6779651|NCT03725033|7707849|FG000|STARTED|Overall Study||105
6779652|NCT03725033|7707850|FG001|STARTED|Overall Study||97
6779653|NCT03725033|7707849|FG000|COMPLETED|Overall Study||105
6779654|NCT03725033|7707850|FG001|COMPLETED|Overall Study||97
6543734|NCT01686646|7465219|FG003|STARTED|Overall Study||75
6543735|NCT01686646|7465216|FG000|Intent to Treat Population|Overall Study||45
6543736|NCT01686646|7465217|FG001|Intent to Treat Population|Overall Study||45
6543737|NCT01686646|7465218|FG002|Intent to Treat Population|Overall Study||75
6543738|NCT01686646|7465219|FG003|Intent to Treat Population|Overall Study||75
6562444|NCT01800916|7485366|FG004|NOT COMPLETED|Test Period 3 (1 Week)||0
6646889|NCT02384070|7575903|FG001|NOT COMPLETED|Overall Study||0
6646890|NCT02384070|7575904|FG002|NOT COMPLETED|Overall Study||0
6779655|NCT03725033|7707849|FG000|NOT COMPLETED|Overall Study||0
6779656|NCT03725033|7707850|FG001|NOT COMPLETED|Overall Study||0
6779657|NCT03724981|7707858|FG000|STARTED|First Device||156
6743831|NCT03335800|7671880|FG000|STARTED|Overall Study||419927
6743832|NCT03335800|7671880|FG000|Received Irregular Pulse Notification|Overall Study||2161
6743833|NCT03335800|7671880|FG000|Attended First Study Visit|Overall Study||945
6743834|NCT03335800|7671880|FG000|ECG Patch Shipped|Overall Study||658
6743835|NCT03335800|7671880|FG000|ECG Patch Returned for Analysis|Overall Study||450
6743836|NCT03335800|7671880|FG000|Attended Second Study Visit|Overall Study||396
6743837|NCT03335800|7671880|FG000|COMPLETED|Overall Study||396
6743838|NCT03335800|7671880|FG000|NOT COMPLETED|Overall Study||419531
6743839|NCT03336450|7671884|FG000|STARTED|Overall Study||3
6743840|NCT03336450|7671884|FG000|COMPLETED|Overall Study||3
6743841|NCT03336450|7671884|FG000|NOT COMPLETED|Overall Study||0
6743842|NCT03336502|7671890|FG000|STARTED|Overall Study||30
6743843|NCT03336502|7671891|FG001|STARTED|Overall Study||40
6743844|NCT03336502|7671890|FG000|COMPLETED|Overall Study||26
6743845|NCT03336502|7671891|FG001|COMPLETED|Overall Study||31
6543739|NCT01686646|7465216|FG000|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
6543740|NCT01686646|7465217|FG001|Safety Population|Overall Study||45
6543741|NCT01686646|7465218|FG002|Safety Population|Overall Study||74
6543742|NCT01686646|7465219|FG003|Safety Population|Overall Study||75
6543743|NCT01686646|7465216|FG000|COMPLETED|Overall Study||45
6543744|NCT01686646|7465217|FG001|COMPLETED|Overall Study||45
6543745|NCT01686646|7465218|FG002|COMPLETED|Overall Study||75
6543746|NCT01686646|7465219|FG003|COMPLETED|Overall Study||75
6543747|NCT01686646|7465216|FG000|NOT COMPLETED|Overall Study||0
6543748|NCT01686646|7465217|FG001|NOT COMPLETED|Overall Study||0
6543749|NCT01686646|7465218|FG002|NOT COMPLETED|Overall Study||0
6543750|NCT01686646|7465219|FG003|NOT COMPLETED|Overall Study||0
6543751|NCT01686750|7465231|FG000|STARTED|Overall Study||11001
6543752|NCT01686750|7465232|FG001|STARTED|Overall Study||10725
6543753|NCT01686750|7465231|FG000|COMPLETED|Overall Study||11001
6543754|NCT01686750|7465232|FG001|COMPLETED|Overall Study||10725
6543755|NCT01686750|7465231|FG000|NOT COMPLETED|Overall Study||0
6543756|NCT01686750|7465232|FG001|NOT COMPLETED|Overall Study||0
6543757|NCT01686828|7465244|FG000|STARTED|Overall Study||13
6543758|NCT01686828|7465245|FG001|STARTED|Overall Study||14
6543759|NCT01686828|7465246|FG002|STARTED|Overall Study||13
6543760|NCT01686828|7465247|FG003|STARTED|Overall Study||13
6543761|NCT01686828|7465244|FG000|COMPLETED|Overall Study||12
6543762|NCT01686828|7465245|FG001|COMPLETED|Overall Study||13
6543763|NCT01686828|7465246|FG002|COMPLETED|Overall Study||12
6543764|NCT01686828|7465247|FG003|COMPLETED|Overall Study||13
6543765|NCT01686828|7465244|FG000|NOT COMPLETED|Overall Study||1
6543766|NCT01686828|7465245|FG001|NOT COMPLETED|Overall Study||1
6543767|NCT01686828|7465246|FG002|NOT COMPLETED|Overall Study||1
6543768|NCT01686828|7465247|FG003|NOT COMPLETED|Overall Study||0
6543769|NCT01686932|7465263|FG000|STARTED|Period 1||25
6543770|NCT01686932|7465264|FG001|STARTED|Period 1||26
6543771|NCT01686932|7465263|FG000|COMPLETED|Period 1||24
6543772|NCT01686932|7465264|FG001|COMPLETED|Period 1||25
6543773|NCT01686932|7465263|FG000|NOT COMPLETED|Period 1||1
6543774|NCT01686932|7465264|FG001|NOT COMPLETED|Period 1||1
6543775|NCT01686932|7465263|FG000|STARTED|Period 2||24
6543776|NCT01686932|7465264|FG001|STARTED|Period 2||25
6543777|NCT01686932|7465263|FG000|COMPLETED|Period 2||24
6543778|NCT01686932|7465264|FG001|COMPLETED|Period 2||25
6543779|NCT01686932|7465263|FG000|NOT COMPLETED|Period 2||0
6543780|NCT01686932|7465264|FG001|NOT COMPLETED|Period 2||0
6543781|NCT01686958|7465270|FG000|STARTED|Overall Study||30
6543782|NCT01686958|7465270|FG000|COMPLETED|Overall Study|No. of patients who completed ALL assessments at 12 months post treatment; 1 pt only had PSA test.|29
6543783|NCT01686958|7465270|FG000|NOT COMPLETED|Overall Study||1
6543784|NCT01687036|7465275|FG000|STARTED|Overall Study||10
6543785|NCT01687036|7465275|FG000|COMPLETED|Overall Study||10
6543786|NCT01687036|7465275|FG000|NOT COMPLETED|Overall Study||0
6543787|NCT01687088|7465281|FG000|STARTED|Overall Study||50
6543788|NCT01687088|7465282|FG001|STARTED|Overall Study||50
6543789|NCT01687088|7465281|FG000|COMPLETED|Overall Study||50
6543790|NCT01687088|7465282|FG001|COMPLETED|Overall Study||50
6543791|NCT01687088|7465281|FG000|NOT COMPLETED|Overall Study||0
6543792|NCT01687088|7465282|FG001|NOT COMPLETED|Overall Study||0
6543793|NCT01687101|7465288|FG000|STARTED|Overall Study||32
6543794|NCT01687101|7465288|FG000|COMPLETED|Overall Study||25
6543795|NCT01687101|7465288|FG000|NOT COMPLETED|Overall Study||7
6543796|NCT01687114|7465292|FG000|STARTED|Overall Study||5
6543797|NCT01687114|7465292|FG000|COMPLETED|Overall Study||5
6543798|NCT01687114|7465292|FG000|NOT COMPLETED|Overall Study||0
6543799|NCT01687166|7465300|FG000|STARTED|Overall Study||167
6743846|NCT03336502|7671890|FG000|NOT COMPLETED|Overall Study||4
6743847|NCT03336502|7671891|FG001|NOT COMPLETED|Overall Study||9
6743848|NCT03336645|7671897|FG000|STARTED|Overall Study||25
6743849|NCT03336645|7671897|FG000|COMPLETED|Overall Study||25
6543800|NCT01687166|7465301|FG001|STARTED|Overall Study||172
6543801|NCT01687166|7465302|FG002|STARTED|Overall Study||56
6543802|NCT01687166|7465303|FG003|STARTED|Overall Study||3
6543803|NCT01687166|7465300|FG000|COMPLETED|Overall Study||139
6543804|NCT01687166|7465301|FG001|COMPLETED|Overall Study||145
6543805|NCT01687166|7465302|FG002|COMPLETED|Overall Study||42
6543806|NCT01687166|7465303|FG003|COMPLETED|Overall Study||1
6543807|NCT01687166|7465300|FG000|NOT COMPLETED|Overall Study||28
6543808|NCT01687166|7465301|FG001|NOT COMPLETED|Overall Study||27
6543809|NCT01687166|7465302|FG002|NOT COMPLETED|Overall Study||14
6543810|NCT01687166|7465303|FG003|NOT COMPLETED|Overall Study||2
6543811|NCT01687179|7465311|FG000|STARTED|Overall Study||3
6543812|NCT01687179|7465312|FG001|STARTED|Overall Study||10
6543813|NCT01687179|7465311|FG000|COMPLETED|Overall Study||2
6543814|NCT01687179|7465312|FG001|COMPLETED|Overall Study||6
6543815|NCT01687179|7465311|FG000|NOT COMPLETED|Overall Study||1
6543816|NCT01687179|7465312|FG001|NOT COMPLETED|Overall Study||4
6543817|NCT01687218|7465324|FG000|STARTED|Overall Study||33
6543818|NCT01687218|7465325|FG001|STARTED|Overall Study||32
6543819|NCT01687218|7465326|FG002|STARTED|Overall Study||31
6543820|NCT01687218|7465327|FG003|STARTED|Overall Study||34
6543821|NCT01687218|7465328|FG004|STARTED|Overall Study||33
6543822|NCT01687218|7465329|FG005|STARTED|Overall Study||32
6543823|NCT01687218|7465324|FG000|COMPLETED|Overall Study||30
6543824|NCT01687218|7465325|FG001|COMPLETED|Overall Study||29
6543825|NCT01687218|7465326|FG002|COMPLETED|Overall Study||30
6543826|NCT01687218|7465327|FG003|COMPLETED|Overall Study||32
6543827|NCT01687218|7465328|FG004|COMPLETED|Overall Study||32
6543828|NCT01687218|7465329|FG005|COMPLETED|Overall Study||32
6543829|NCT01687218|7465324|FG000|NOT COMPLETED|Overall Study||3
6543830|NCT01687218|7465325|FG001|NOT COMPLETED|Overall Study||3
6543831|NCT01687218|7465326|FG002|NOT COMPLETED|Overall Study||1
6543832|NCT01687218|7465327|FG003|NOT COMPLETED|Overall Study||2
6543833|NCT01687218|7465328|FG004|NOT COMPLETED|Overall Study||1
6543834|NCT01687218|7465329|FG005|NOT COMPLETED|Overall Study||0
6543835|NCT01687244|7465339|FG000|STARTED|Overall Study||21
6543836|NCT01687244|7465340|FG001|STARTED|Overall Study||19
6543837|NCT01687244|7465339|FG000|COMPLETED|Overall Study||21
6543838|NCT01687244|7465340|FG001|COMPLETED|Overall Study||19
6543839|NCT01687244|7465339|FG000|NOT COMPLETED|Overall Study||0
6543840|NCT01687244|7465340|FG001|NOT COMPLETED|Overall Study||0
6543841|NCT01687257|7465356|FG000|STARTED|Overall Study||25
6543842|NCT01687257|7465357|FG001|STARTED|Overall Study||4
6543843|NCT01687257|7465358|FG002|STARTED|Overall Study||21
6543844|NCT01687257|7465356|FG000|COMPLETED|Overall Study||17
6543845|NCT01687257|7465357|FG001|COMPLETED|Overall Study||0
6543846|NCT01687257|7465358|FG002|COMPLETED|Overall Study||15
6543847|NCT01687257|7465356|FG000|NOT COMPLETED|Overall Study||8
6543848|NCT01687257|7465357|FG001|NOT COMPLETED|Overall Study||4
6543849|NCT01687257|7465358|FG002|NOT COMPLETED|Overall Study||6
6543850|NCT01687270|7465372|FG000|STARTED|Overall Study||40
6543851|NCT01687270|7465372|FG000|COMPLETED|Overall Study||28
6543852|NCT01687270|7465372|FG000|NOT COMPLETED|Overall Study||12
6543853|NCT01687283|7465378|FG000|STARTED|Overall Study||158
6543854|NCT01687283|7465379|FG001|STARTED|Overall Study||157
6543855|NCT01687283|7465378|FG000|COMPLETED|Overall Study||123
6543856|NCT01687283|7465379|FG001|COMPLETED|Overall Study||130
6543857|NCT01687283|7465378|FG000|NOT COMPLETED|Overall Study||35
6543858|NCT01687283|7465379|FG001|NOT COMPLETED|Overall Study||27
6543859|NCT01687296|7465387|FG000|STARTED|Overall Study||123
6543860|NCT01687296|7465388|FG001|STARTED|Overall Study||128
6543861|NCT01687296|7465387|FG000|COMPLETED|Overall Study||116
6543862|NCT01687296|7465388|FG001|COMPLETED|Overall Study||123
6543863|NCT01687296|7465387|FG000|NOT COMPLETED|Overall Study||7
6543864|NCT01687296|7465388|FG001|NOT COMPLETED|Overall Study||5
6543865|NCT01687387|7465397|FG000|STARTED|Overall Study||51
6543866|NCT01687387|7465398|FG001|STARTED|Overall Study||50
6543867|NCT01687387|7465399|FG002|STARTED|Overall Study||51
6543868|NCT01687387|7465397|FG000|COMPLETED|Overall Study||10
6543869|NCT01687387|7465398|FG001|COMPLETED|Overall Study||12
6543870|NCT01687387|7465399|FG002|COMPLETED|Overall Study||13
6543871|NCT01687387|7465397|FG000|NOT COMPLETED|Overall Study||41
6543872|NCT01687387|7465398|FG001|NOT COMPLETED|Overall Study||38
6543873|NCT01687387|7465399|FG002|NOT COMPLETED|Overall Study||38
6543874|NCT01687400|7465407|FG000|STARTED|Overall Study||114
6543875|NCT01687400|7465407|FG000|COMPLETED|Overall Study||114
6543876|NCT01687400|7465407|FG000|NOT COMPLETED|Overall Study||0
6543877|NCT01687413|7465418|FG000|STARTED|Overall Study||27
6543878|NCT01687413|7465419|FG001|STARTED|Overall Study||15
6543879|NCT01687413|7465418|FG000|COMPLETED|Overall Study||26
6543880|NCT01687413|7465419|FG001|COMPLETED|Overall Study||11
6543881|NCT01687413|7465418|FG000|NOT COMPLETED|Overall Study||1
6543882|NCT01687413|7465419|FG001|NOT COMPLETED|Overall Study||4
6543883|NCT01687478|7465445|FG000|STARTED|Overall Study||88
6543884|NCT01687478|7465446|FG001|STARTED|Overall Study||88
6543885|NCT01687478|7465445|FG000|Safety Analysis Set|Overall Study||88
6543886|NCT01687478|7465446|FG001|Safety Analysis Set|Overall Study||87
6543887|NCT01687478|7465445|FG000|COMPLETED|Overall Study||56
6543888|NCT01687478|7465446|FG001|COMPLETED|Overall Study||49
6543889|NCT01687478|7465445|FG000|NOT COMPLETED|Overall Study||32
6543890|NCT01687478|7465446|FG001|NOT COMPLETED|Overall Study||39
6543891|NCT01687595|7465454|FG000|STARTED|Overall Study||70
6543892|NCT01687595|7465455|FG001|STARTED|Overall Study||10
6543893|NCT01687595|7465454|FG000|Received at Least 1 Dose of Study Drug|Overall Study||70
6543894|NCT01687595|7465455|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
6543895|NCT01687595|7465454|FG000|COMPLETED|Overall Study||0
6543896|NCT01687595|7465455|FG001|COMPLETED|Overall Study||0
6543897|NCT01687595|7465454|FG000|NOT COMPLETED|Overall Study||70
6543898|NCT01687595|7465455|FG001|NOT COMPLETED|Overall Study||10
6543899|NCT01687673|7465461|FG000|STARTED|Overall Study||29
6543900|NCT01687673|7465461|FG000|COMPLETED|Overall Study||28
6543901|NCT01687673|7465461|FG000|NOT COMPLETED|Overall Study||1
6543902|NCT01687712|7465467|FG000|STARTED|Cycle 1||549
6543903|NCT01687712|7465468|FG001|STARTED|Cycle 1||551
6543904|NCT01687712|7465467|FG000|Received hCG|Cycle 1||516
6543905|NCT01687712|7465468|FG001|Received hCG|Cycle 1||520
6543906|NCT01687712|7465467|FG000|Oocyte/Ovum Pick Up|Cycle 1||513
6543907|NCT01687712|7465468|FG001|Oocyte/Ovum Pick Up|Cycle 1||517
6543908|NCT01687712|7465467|FG000|Fertilization Performed|Cycle 1||508
6543909|NCT01687712|7465468|FG001|Fertilization Performed|Cycle 1||512
6543910|NCT01687712|7465467|FG000|Embryo Transfer|Cycle 1||466
6543911|NCT01687712|7465468|FG001|Embryo Transfer|Cycle 1||483
6543912|NCT01687712|7465467|FG000|Biochemical Pregnancy|Cycle 1||163
6646891|NCT02384096|7575914|FG000|STARTED|First Intervention (7 Days)||5
6646892|NCT02384096|7575915|FG001|STARTED|First Intervention (7 Days)||7
6646893|NCT02384096|7575914|FG000|COMPLETED|First Intervention (7 Days)||4
6543913|NCT01687712|7465468|FG001|Biochemical Pregnancy|Cycle 1||203
6543914|NCT01687712|7465467|FG000|Clinical Pregnancy|Cycle 1||114
6543915|NCT01687712|7465468|FG001|Clinical Pregnancy|Cycle 1||138
6543916|NCT01687712|7465467|FG000|COMPLETED|Cycle 1||101
6543917|NCT01687712|7465468|FG001|COMPLETED|Cycle 1||122
6543918|NCT01687712|7465467|FG000|NOT COMPLETED|Cycle 1||448
6543919|NCT01687712|7465468|FG001|NOT COMPLETED|Cycle 1||429
6543920|NCT01687712|7465467|FG000|STARTED|Cycle 2||109
6743850|NCT03336645|7671897|FG000|NOT COMPLETED|Overall Study||0
6543921|NCT01687712|7465468|FG001|STARTED|Cycle 2||120
6543922|NCT01687712|7465467|FG000|Received hCG|Cycle 2||107
6543923|NCT01687712|7465468|FG001|Received hCG|Cycle 2||119
6543924|NCT01687712|7465467|FG000|Oocyte/Ovum Pick Up|Cycle 2||107
6543925|NCT01687712|7465468|FG001|Oocyte/Ovum Pick Up|Cycle 2||119
6543926|NCT01687712|7465467|FG000|Fertilization Performed|Cycle 2||106
6543927|NCT01687712|7465468|FG001|Fertilization Performed|Cycle 2||119
6543928|NCT01687712|7465467|FG000|Embryo Transfer|Cycle 2||101
6543929|NCT01687712|7465468|FG001|Embryo Transfer|Cycle 2||117
6543930|NCT01687712|7465467|FG000|Biochemical Pregnancy|Cycle 2||35
6543931|NCT01687712|7465468|FG001|Biochemical Pregnancy|Cycle 2||43
6543932|NCT01687712|7465467|FG000|Clinical Pregnancy|Cycle 2||17
6543933|NCT01687712|7465468|FG001|Clinical Pregnancy|Cycle 2||26
6543934|NCT01687712|7465467|FG000|COMPLETED|Cycle 2||16
6543935|NCT01687712|7465468|FG001|COMPLETED|Cycle 2||25
6543936|NCT01687712|7465467|FG000|NOT COMPLETED|Cycle 2||93
6543937|NCT01687712|7465468|FG001|NOT COMPLETED|Cycle 2||95
6543938|NCT01687712|7465467|FG000|STARTED|Cycle 3||28
6543939|NCT01687712|7465468|FG001|STARTED|Cycle 3||24
6543940|NCT01687712|7465467|FG000|Received hCG|Cycle 3||27
6543941|NCT01687712|7465468|FG001|Received hCG|Cycle 3||24
6543942|NCT01687712|7465467|FG000|Ooctye/Ovum Pick-Up|Cycle 3||27
6543943|NCT01687712|7465468|FG001|Ooctye/Ovum Pick-Up|Cycle 3||24
6543944|NCT01687712|7465467|FG000|Fertilization Performed|Cycle 3||27
6543945|NCT01687712|7465468|FG001|Fertilization Performed|Cycle 3||24
6543946|NCT01687712|7465467|FG000|Embryo Transfer|Cycle 3||26
6543947|NCT01687712|7465468|FG001|Embryo Transfer|Cycle 3||24
6543948|NCT01687712|7465467|FG000|Biochemically Pregnant|Cycle 3||7
6543949|NCT01687712|7465468|FG001|Biochemically Pregnant|Cycle 3||2
6543950|NCT01687712|7465467|FG000|Clinical Pregnancy|Cycle 3||5
6543951|NCT01687712|7465468|FG001|Clinical Pregnancy|Cycle 3||0
6543952|NCT01687712|7465467|FG000|COMPLETED|Cycle 3||4
6543953|NCT01687712|7465468|FG001|COMPLETED|Cycle 3||0
6543954|NCT01687712|7465467|FG000|NOT COMPLETED|Cycle 3||24
6543955|NCT01687712|7465468|FG001|NOT COMPLETED|Cycle 3||24
6543956|NCT01687790|7465478|FG000|STARTED|Overall Study||60
6543957|NCT01687790|7465478|FG000|COMPLETED|Overall Study||60
6543958|NCT01687790|7465478|FG000|NOT COMPLETED|Overall Study||0
6543959|NCT01687972|7465485|FG000|STARTED|Overall Study||44
6543960|NCT01687972|7465486|FG001|STARTED|Overall Study||44
6543961|NCT01687972|7465485|FG000|COMPLETED|Overall Study||44
6543962|NCT01687972|7465486|FG001|COMPLETED|Overall Study||44
6543963|NCT01687972|7465485|FG000|NOT COMPLETED|Overall Study||0
6543964|NCT01687972|7465486|FG001|NOT COMPLETED|Overall Study||0
6543965|NCT01687998|7465494|FG000|STARTED|Overall Study||6038
6543966|NCT01687998|7465495|FG001|STARTED|Overall Study||6054
6543967|NCT01687998|7465494|FG000|Received at Least One Dose of Study Drug|Overall Study||6036
6543968|NCT01687998|7465495|FG001|Received at Least One Dose of Study Drug|Overall Study||6052
6543969|NCT01687998|7465494|FG000|COMPLETED|Overall Study||5926
6543970|NCT01687998|7465495|FG001|COMPLETED|Overall Study||5934
6543971|NCT01687998|7465494|FG000|NOT COMPLETED|Overall Study||112
6543972|NCT01687998|7465495|FG001|NOT COMPLETED|Overall Study||120
6543973|NCT01688037|7465504|FG000|STARTED|Double-Blind Period (Week 0 to 6)||54
6543974|NCT01688037|7465505|FG001|STARTED|Double-Blind Period (Week 0 to 6)||28
6543975|NCT01688037|7465506|FG002|STARTED|Double-Blind Period (Week 0 to 6)||27
6543976|NCT01688037|7465504|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||47
6543977|NCT01688037|7465505|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||25
6543978|NCT01688037|7465506|FG002|COMPLETED|Double-Blind Period (Week 0 to 6)||21
6543979|NCT01688037|7465504|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
6543980|NCT01688037|7465505|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||3
6543981|NCT01688037|7465506|FG002|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||6
6543982|NCT01688037|7465504|FG000|STARTED|Open-Label Period (Week 6 to 12)||47
6543983|NCT01688037|7465505|FG001|STARTED|Open-Label Period (Week 6 to 12)||25
6543984|NCT01688037|7465506|FG002|STARTED|Open-Label Period (Week 6 to 12)||21
6646894|NCT02384096|7575915|FG001|COMPLETED|First Intervention (7 Days)||7
6543985|NCT01688037|7465504|FG000|COMPLETED|Open-Label Period (Week 6 to 12)||42
6543986|NCT01688037|7465505|FG001|COMPLETED|Open-Label Period (Week 6 to 12)||22
6543987|NCT01688037|7465506|FG002|COMPLETED|Open-Label Period (Week 6 to 12)||17
6543988|NCT01688037|7465504|FG000|NOT COMPLETED|Open-Label Period (Week 6 to 12)||5
6543989|NCT01688037|7465505|FG001|NOT COMPLETED|Open-Label Period (Week 6 to 12)||3
6543990|NCT01688037|7465506|FG002|NOT COMPLETED|Open-Label Period (Week 6 to 12)||4
6543991|NCT01688037|7465504|FG000|STARTED|Follow-up Period (Week 12 to 16)||42
6543992|NCT01688037|7465505|FG001|STARTED|Follow-up Period (Week 12 to 16)||22
6543993|NCT01688037|7465506|FG002|STARTED|Follow-up Period (Week 12 to 16)||17
6543994|NCT01688037|7465504|FG000|COMPLETED|Follow-up Period (Week 12 to 16)||42
6543995|NCT01688037|7465505|FG001|COMPLETED|Follow-up Period (Week 12 to 16)||21
6543996|NCT01688037|7465506|FG002|COMPLETED|Follow-up Period (Week 12 to 16)||17
6543997|NCT01688037|7465504|FG000|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
6543998|NCT01688037|7465505|FG001|NOT COMPLETED|Follow-up Period (Week 12 to 16)||1
6543999|NCT01688037|7465506|FG002|NOT COMPLETED|Follow-up Period (Week 12 to 16)||0
6544000|NCT01688050|7465518|FG000|STARTED|Overall Study||50
6544001|NCT01688050|7465518|FG000|5-Year|Overall Study|Patients eligible for Follow-up at 5 year|22
6544002|NCT01688050|7465518|FG000|COMPLETED|Overall Study||19
6544003|NCT01688050|7465518|FG000|NOT COMPLETED|Overall Study||31
6544004|NCT01688102|7465524|FG000|STARTED|Overall Study||60
6544005|NCT01688102|7465525|FG001|STARTED|Overall Study||58
6544006|NCT01688102|7465524|FG000|COMPLETED|Overall Study||44
6544007|NCT01688102|7465525|FG001|COMPLETED|Overall Study||40
6544008|NCT01688102|7465524|FG000|NOT COMPLETED|Overall Study||16
6544009|NCT01688102|7465525|FG001|NOT COMPLETED|Overall Study||18
6544010|NCT01688141|7465533|FG000|STARTED|Overall Study||11706
6544011|NCT01688141|7465534|FG001|STARTED|Overall Study||11651
6544012|NCT01688141|7465533|FG000|COMPLETED|Overall Study||11706
6544013|NCT01688141|7465534|FG001|COMPLETED|Overall Study||11651
6544014|NCT01688141|7465533|FG000|NOT COMPLETED|Overall Study||0
6544015|NCT01688141|7465534|FG001|NOT COMPLETED|Overall Study||0
6544016|NCT01688310|7465542|FG000|STARTED|Overall Study||100
6544017|NCT01688310|7465543|FG001|STARTED|Overall Study||100
6544018|NCT01688310|7465542|FG000|COMPLETED|Overall Study||100
6544019|NCT01688310|7465543|FG001|COMPLETED|Overall Study||100
6544020|NCT01688310|7465542|FG000|NOT COMPLETED|Overall Study||0
6544021|NCT01688310|7465543|FG001|NOT COMPLETED|Overall Study||0
6544022|NCT01688336|7465551|FG000|STARTED|Overall Study||9
6544023|NCT01688336|7465551|FG000|COMPLETED|Overall Study||9
6544024|NCT01688336|7465551|FG000|NOT COMPLETED|Overall Study||0
6544025|NCT01688466|7465558|FG000|STARTED|Overall Study||17
6544026|NCT01688466|7465559|FG001|STARTED|Overall Study||17
6544027|NCT01688466|7465558|FG000|COMPLETED|Overall Study||15
6544028|NCT01688466|7465559|FG001|COMPLETED|Overall Study||10
6544029|NCT01688466|7465558|FG000|NOT COMPLETED|Overall Study||2
6544030|NCT01688466|7465559|FG001|NOT COMPLETED|Overall Study||7
6544031|NCT01688596|7465567|FG000|STARTED|Overall Study||67
6544032|NCT01688596|7465568|FG001|STARTED|Overall Study||68
6544033|NCT01688596|7465567|FG000|COMPLETED|Overall Study||59
6544034|NCT01688596|7465568|FG001|COMPLETED|Overall Study||59
6544035|NCT01688596|7465567|FG000|NOT COMPLETED|Overall Study||8
6544036|NCT01688596|7465568|FG001|NOT COMPLETED|Overall Study||9
6544037|NCT01688609|7465574|FG000|STARTED|Overall Study||18
6544038|NCT01688609|7465574|FG000|COMPLETED|Overall Study||18
6544039|NCT01688609|7465574|FG000|NOT COMPLETED|Overall Study||0
6544040|NCT01688635|7465578|FG000|STARTED|Period 1||45
6544041|NCT01688635|7465579|FG001|STARTED|Period 1||46
6544042|NCT01688635|7465578|FG000|Received at Least 1 Dose of Study Drug|Period 1||45
6544043|NCT01688635|7465579|FG001|Received at Least 1 Dose of Study Drug|Period 1||46
6544044|NCT01688635|7465578|FG000|COMPLETED|Period 1||45
6544045|NCT01688635|7465579|FG001|COMPLETED|Period 1||46
6544046|NCT01688635|7465578|FG000|NOT COMPLETED|Period 1||0
6544047|NCT01688635|7465579|FG001|NOT COMPLETED|Period 1||0
6544048|NCT01688635|7465578|FG000|STARTED|Washout 1||45
6544049|NCT01688635|7465579|FG001|STARTED|Washout 1||46
6544050|NCT01688635|7465578|FG000|COMPLETED|Washout 1||44
6544051|NCT01688635|7465579|FG001|COMPLETED|Washout 1||44
6544052|NCT01688635|7465578|FG000|NOT COMPLETED|Washout 1||1
6544053|NCT01688635|7465579|FG001|NOT COMPLETED|Washout 1||2
6544054|NCT01688635|7465578|FG000|STARTED|Period 2||44
6544055|NCT01688635|7465579|FG001|STARTED|Period 2||44
6544056|NCT01688635|7465578|FG000|COMPLETED|Period 2||44
6544057|NCT01688635|7465579|FG001|COMPLETED|Period 2||44
6544058|NCT01688635|7465578|FG000|NOT COMPLETED|Period 2||0
6544059|NCT01688635|7465579|FG001|NOT COMPLETED|Period 2||0
6544060|NCT01688635|7465578|FG000|STARTED|Washout 2||44
6544061|NCT01688635|7465579|FG001|STARTED|Washout 2||44
6544062|NCT01688635|7465578|FG000|COMPLETED|Washout 2||41
6544063|NCT01688635|7465579|FG001|COMPLETED|Washout 2||42
6544064|NCT01688635|7465578|FG000|NOT COMPLETED|Washout 2||3
6544065|NCT01688635|7465579|FG001|NOT COMPLETED|Washout 2||2
6544066|NCT01688635|7465578|FG000|STARTED|Period 3||41
6544067|NCT01688635|7465579|FG001|STARTED|Period 3||42
6544068|NCT01688635|7465578|FG000|COMPLETED|Period 3||41
6544069|NCT01688635|7465579|FG001|COMPLETED|Period 3||42
6544070|NCT01688635|7465578|FG000|NOT COMPLETED|Period 3||0
6544071|NCT01688635|7465579|FG001|NOT COMPLETED|Period 3||0
6544072|NCT01688635|7465578|FG000|STARTED|Washout 3||41
6544073|NCT01688635|7465579|FG001|STARTED|Washout 3||42
6544074|NCT01688635|7465578|FG000|COMPLETED|Washout 3||40
6544075|NCT01688635|7465579|FG001|COMPLETED|Washout 3||42
6544076|NCT01688635|7465578|FG000|NOT COMPLETED|Washout 3||1
6544077|NCT01688635|7465579|FG001|NOT COMPLETED|Washout 3||0
6544078|NCT01688635|7465578|FG000|STARTED|Period 4||40
6544079|NCT01688635|7465579|FG001|STARTED|Period 4||42
6544080|NCT01688635|7465578|FG000|COMPLETED|Period 4||40
6544081|NCT01688635|7465579|FG001|COMPLETED|Period 4||42
6544082|NCT01688635|7465578|FG000|NOT COMPLETED|Period 4||0
6544083|NCT01688635|7465579|FG001|NOT COMPLETED|Period 4||0
6544084|NCT01688726|7465588|FG000|STARTED|Overall Study||46
6544085|NCT01688726|7465589|FG001|STARTED|Overall Study||45
6544086|NCT01688726|7465588|FG000|COMPLETED|Overall Study||45
6544087|NCT01688726|7465589|FG001|COMPLETED|Overall Study||44
6544088|NCT01688726|7465588|FG000|NOT COMPLETED|Overall Study||1
6544089|NCT01688726|7465589|FG001|NOT COMPLETED|Overall Study||1
6544090|NCT01688739|7465609|FG000|STARTED|Overall Study||13
6544091|NCT01688739|7465610|FG001|STARTED|Overall Study||3
6544092|NCT01688739|7465611|FG002|STARTED|Overall Study||3
6544093|NCT01688739|7465612|FG003|STARTED|Overall Study||6
6544094|NCT01688739|7465613|FG004|STARTED|Overall Study||6
6544095|NCT01688739|7465614|FG005|STARTED|Overall Study||6
6544096|NCT01688739|7465615|FG006|STARTED|Overall Study||6
6544097|NCT01688739|7465616|FG007|STARTED|Overall Study||6
6544098|NCT01688739|7465617|FG008|STARTED|Overall Study||6
6544099|NCT01688739|7465618|FG009|STARTED|Overall Study||6
6544100|NCT01688739|7465609|FG000|Received Study Drug|Overall Study||12
6544101|NCT01688739|7465610|FG001|Received Study Drug|Overall Study||3
6544102|NCT01688739|7465611|FG002|Received Study Drug|Overall Study||3
6544103|NCT01688739|7465612|FG003|Received Study Drug|Overall Study||6
6544104|NCT01688739|7465613|FG004|Received Study Drug|Overall Study||6
6544105|NCT01688739|7465614|FG005|Received Study Drug|Overall Study||6
6544106|NCT01688739|7465615|FG006|Received Study Drug|Overall Study||6
6544107|NCT01688739|7465616|FG007|Received Study Drug|Overall Study||6
6544108|NCT01688739|7465617|FG008|Received Study Drug|Overall Study||6
6544109|NCT01688739|7465618|FG009|Received Study Drug|Overall Study||6
6544110|NCT01688739|7465609|FG000|COMPLETED|Overall Study||12
6544111|NCT01688739|7465610|FG001|COMPLETED|Overall Study||3
6544112|NCT01688739|7465611|FG002|COMPLETED|Overall Study||3
6544113|NCT01688739|7465612|FG003|COMPLETED|Overall Study||6
6544114|NCT01688739|7465613|FG004|COMPLETED|Overall Study||6
6544115|NCT01688739|7465614|FG005|COMPLETED|Overall Study||6
6544116|NCT01688739|7465615|FG006|COMPLETED|Overall Study||6
6544117|NCT01688739|7465616|FG007|COMPLETED|Overall Study||6
6544118|NCT01688739|7465617|FG008|COMPLETED|Overall Study||6
6544119|NCT01688739|7465618|FG009|COMPLETED|Overall Study||6
6544120|NCT01688739|7465609|FG000|NOT COMPLETED|Overall Study||1
6544121|NCT01688739|7465610|FG001|NOT COMPLETED|Overall Study||0
6544122|NCT01688739|7465611|FG002|NOT COMPLETED|Overall Study||0
6544123|NCT01688739|7465612|FG003|NOT COMPLETED|Overall Study||0
6544124|NCT01688739|7465613|FG004|NOT COMPLETED|Overall Study||0
6544125|NCT01688739|7465614|FG005|NOT COMPLETED|Overall Study||0
6544126|NCT01688739|7465615|FG006|NOT COMPLETED|Overall Study||0
6544127|NCT01688739|7465616|FG007|NOT COMPLETED|Overall Study||0
6544128|NCT01688739|7465617|FG008|NOT COMPLETED|Overall Study||0
6544129|NCT01688739|7465618|FG009|NOT COMPLETED|Overall Study||0
6544130|NCT01688830|7465669|FG000|STARTED|Overall Study||21
6544131|NCT01688830|7465670|FG001|STARTED|Overall Study||6
6544132|NCT01688830|7465671|FG002|STARTED|Overall Study||6
6544133|NCT01688830|7465672|FG003|STARTED|Overall Study||6
6544134|NCT01688830|7465673|FG004|STARTED|Overall Study||5
6544135|NCT01688830|7465674|FG005|STARTED|Overall Study||6
6544136|NCT01688830|7465675|FG006|STARTED|Overall Study||12
6544137|NCT01688830|7465676|FG007|STARTED|Overall Study||6
6544138|NCT01688830|7465677|FG008|STARTED|Overall Study||6
6544139|NCT01688830|7465678|FG009|STARTED|Overall Study||6
6544140|NCT01688830|7465679|FG010|STARTED|Overall Study||6
6544141|NCT01688830|7465680|FG011|STARTED|Overall Study||6
6544142|NCT01688830|7465681|FG012|STARTED|Overall Study||6
6544143|NCT01688830|7465682|FG013|STARTED|Overall Study||6
6544144|NCT01688830|7465683|FG014|STARTED|Overall Study||6
6544145|NCT01688830|7465684|FG015|STARTED|Overall Study||9
6544146|NCT01688830|7465685|FG016|STARTED|Overall Study||9
6544147|NCT01688830|7465686|FG017|STARTED|Overall Study||9
6544148|NCT01688830|7465687|FG018|STARTED|Overall Study||8
6544149|NCT01688830|7465688|FG019|STARTED|Overall Study||3
6544150|NCT01688830|7465689|FG020|STARTED|Overall Study||9
6544151|NCT01688830|7465669|FG000|COMPLETED|Overall Study||21
6544152|NCT01688830|7465670|FG001|COMPLETED|Overall Study||6
6544153|NCT01688830|7465671|FG002|COMPLETED|Overall Study||6
6544154|NCT01688830|7465672|FG003|COMPLETED|Overall Study||6
6544155|NCT01688830|7465673|FG004|COMPLETED|Overall Study||5
6544156|NCT01688830|7465674|FG005|COMPLETED|Overall Study||6
6544157|NCT01688830|7465675|FG006|COMPLETED|Overall Study||12
6544158|NCT01688830|7465676|FG007|COMPLETED|Overall Study||6
6544159|NCT01688830|7465677|FG008|COMPLETED|Overall Study||6
6544160|NCT01688830|7465678|FG009|COMPLETED|Overall Study||6
6544161|NCT01688830|7465679|FG010|COMPLETED|Overall Study||5
6544162|NCT01688830|7465680|FG011|COMPLETED|Overall Study||6
6544163|NCT01688830|7465681|FG012|COMPLETED|Overall Study||6
6544164|NCT01688830|7465682|FG013|COMPLETED|Overall Study||6
6544165|NCT01688830|7465683|FG014|COMPLETED|Overall Study||6
6544166|NCT01688830|7465684|FG015|COMPLETED|Overall Study||9
6544167|NCT01688830|7465685|FG016|COMPLETED|Overall Study||9
6544168|NCT01688830|7465686|FG017|COMPLETED|Overall Study||9
6544169|NCT01688830|7465687|FG018|COMPLETED|Overall Study||8
6544170|NCT01688830|7465688|FG019|COMPLETED|Overall Study||3
6544171|NCT01688830|7465689|FG020|COMPLETED|Overall Study||9
6544172|NCT01688830|7465669|FG000|NOT COMPLETED|Overall Study||0
6544173|NCT01688830|7465670|FG001|NOT COMPLETED|Overall Study||0
6544174|NCT01688830|7465671|FG002|NOT COMPLETED|Overall Study||0
6544175|NCT01688830|7465672|FG003|NOT COMPLETED|Overall Study||0
6544176|NCT01688830|7465673|FG004|NOT COMPLETED|Overall Study||0
6544177|NCT01688830|7465674|FG005|NOT COMPLETED|Overall Study||0
6544178|NCT01688830|7465675|FG006|NOT COMPLETED|Overall Study||0
6544179|NCT01688830|7465676|FG007|NOT COMPLETED|Overall Study||0
6544180|NCT01688830|7465677|FG008|NOT COMPLETED|Overall Study||0
6544181|NCT01688830|7465678|FG009|NOT COMPLETED|Overall Study||0
6544182|NCT01688830|7465679|FG010|NOT COMPLETED|Overall Study||1
6544183|NCT01688830|7465680|FG011|NOT COMPLETED|Overall Study||0
6544184|NCT01688830|7465681|FG012|NOT COMPLETED|Overall Study||0
6544185|NCT01688830|7465682|FG013|NOT COMPLETED|Overall Study||0
6544186|NCT01688830|7465683|FG014|NOT COMPLETED|Overall Study||0
6544187|NCT01688830|7465684|FG015|NOT COMPLETED|Overall Study||0
6544188|NCT01688830|7465685|FG016|NOT COMPLETED|Overall Study||0
6544189|NCT01688830|7465686|FG017|NOT COMPLETED|Overall Study||0
6544190|NCT01688830|7465687|FG018|NOT COMPLETED|Overall Study||0
6544191|NCT01688830|7465688|FG019|NOT COMPLETED|Overall Study||0
6544192|NCT01688830|7465689|FG020|NOT COMPLETED|Overall Study||0
6544193|NCT01688843|7465773|FG000|STARTED|Overall Study||1060
6544194|NCT01688843|7465773|FG000|COMPLETED|Overall Study||1060
6544195|NCT01688843|7465773|FG000|NOT COMPLETED|Overall Study||0
6544196|NCT01688856|7465782|FG000|STARTED|Overall Study||28
6544197|NCT01688856|7465783|FG001|STARTED|Overall Study||28
6544198|NCT01688856|7465784|FG002|STARTED|Overall Study||11
6544199|NCT01688856|7465782|FG000|COMPLETED|Overall Study||21
6544200|NCT01688856|7465783|FG001|COMPLETED|Overall Study||24
6544201|NCT01688856|7465784|FG002|COMPLETED|Overall Study||8
6544202|NCT01688856|7465782|FG000|NOT COMPLETED|Overall Study||7
6544203|NCT01688856|7465783|FG001|NOT COMPLETED|Overall Study||4
6544204|NCT01688856|7465784|FG002|NOT COMPLETED|Overall Study||3
6544205|NCT01688882|7465794|FG000|STARTED|Overall Study||13
6544206|NCT01688882|7465795|FG001|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
6544207|NCT01688882|7465794|FG000|Safety Follow-up|Overall Study||11
6544208|NCT01688882|7465795|FG001|Safety Follow-up|Overall Study||5
6544209|NCT01688882|7465794|FG000|COMPLETED|Overall Study||10
6544210|NCT01688882|7465795|FG001|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
6544211|NCT01688882|7465794|FG000|NOT COMPLETED|Overall Study||3
6544212|NCT01688882|7465795|FG001|NOT COMPLETED|Overall Study||1
6544213|NCT01688895|7465805|FG000|STARTED|Overall Study||150
6544214|NCT01688895|7465805|FG000|COMPLETED|Overall Study||150
6544215|NCT01688895|7465805|FG000|NOT COMPLETED|Overall Study||0
6544216|NCT01688921|7465811|FG000|STARTED|Overall Study||627
6544217|NCT01688921|7465812|FG001|STARTED|Overall Study||623
6544218|NCT01688921|7465811|FG000|COMPLETED|Overall Study||611
6544219|NCT01688921|7465812|FG001|COMPLETED|Overall Study||608
6544220|NCT01688921|7465811|FG000|NOT COMPLETED|Overall Study||16
6544221|NCT01688921|7465812|FG001|NOT COMPLETED|Overall Study||15
6544222|NCT01688973|7465821|FG000|STARTED|Overall Study||27
6544223|NCT01688973|7465822|FG001|STARTED|Overall Study||28
6544224|NCT01688973|7465821|FG000|Eligible/Evaluable Patients|Overall Study||25
6544225|NCT01688973|7465822|FG001|Eligible/Evaluable Patients|Overall Study||25
6544226|NCT01688973|7465821|FG000|COMPLETED|Overall Study||25
6544227|NCT01688973|7465822|FG001|COMPLETED|Overall Study||25
6544228|NCT01688973|7465821|FG000|NOT COMPLETED|Overall Study||2
6544229|NCT01688973|7465822|FG001|NOT COMPLETED|Overall Study||3
6544230|NCT01688999|7465832|FG000|STARTED|Overall Study||50
6544231|NCT01688999|7465833|FG001|STARTED|Overall Study||6
6544232|NCT01688999|7465834|FG002|STARTED|Overall Study||13
6544233|NCT01688999|7465832|FG000|COMPLETED|Overall Study||42
6544234|NCT01688999|7465833|FG001|COMPLETED|Overall Study||5
6544235|NCT01688999|7465834|FG002|COMPLETED|Overall Study||10
6544236|NCT01688999|7465832|FG000|NOT COMPLETED|Overall Study||8
6544237|NCT01688999|7465833|FG001|NOT COMPLETED|Overall Study||1
6544238|NCT01688999|7465834|FG002|NOT COMPLETED|Overall Study||3
6544239|NCT01689155|7465841|FG000|STARTED|Overall Study||116
6544240|NCT01689155|7465841|FG000|COMPLETED|Overall Study||116
6544241|NCT01689155|7465841|FG000|NOT COMPLETED|Overall Study||0
6544242|NCT01689207|7465857|FG000|STARTED|Overall Study|Subjects randomised|4
6544243|NCT01689207|7465858|FG001|STARTED|Overall Study|Subjects randomised|8
6544244|NCT01689207|7465859|FG002|STARTED|Overall Study|Subjects randomised|16
6544245|NCT01689207|7465860|FG003|STARTED|Overall Study|Subjects randomised|8
6544246|NCT01689207|7465861|FG004|STARTED|Overall Study|Subjects randomised|4
6544247|NCT01689207|7465862|FG005|STARTED|Overall Study|Subjects randomised|8
6544248|NCT01689207|7465863|FG006|STARTED|Overall Study|Subjects randomised|10
6544249|NCT01689207|7465864|FG007|STARTED|Overall Study|Subjects randomised|10
6544250|NCT01689207|7465865|FG008|STARTED|Overall Study|Subjects randomised|6
6544251|NCT01689207|7465866|FG009|STARTED|Overall Study|Subjects randomised|10
6544252|NCT01689207|7465867|FG010|STARTED|Overall Study|Subjects randomised|8
6544253|NCT01689207|7465857|FG000|COMPLETED|Overall Study|Subjects completed study|4
6544254|NCT01689207|7465858|FG001|COMPLETED|Overall Study|Subjects completed study|7
6544255|NCT01689207|7465859|FG002|COMPLETED|Overall Study|Subjects completed study|16
6544256|NCT01689207|7465860|FG003|COMPLETED|Overall Study|Subjects completed study|8
6544257|NCT01689207|7465861|FG004|COMPLETED|Overall Study|Subjects completed study|2
6544258|NCT01689207|7465862|FG005|COMPLETED|Overall Study|Subjects completed study|7
6544259|NCT01689207|7465863|FG006|COMPLETED|Overall Study|Subjects completed study|10
6544260|NCT01689207|7465864|FG007|COMPLETED|Overall Study|Subjects completed study|10
6544261|NCT01689207|7465865|FG008|COMPLETED|Overall Study|Subjects completed study|5
6544262|NCT01689207|7465866|FG009|COMPLETED|Overall Study|Subjects completed study|10
6544263|NCT01689207|7465867|FG010|COMPLETED|Overall Study|Subjects completed study|8
6544264|NCT01689207|7465857|FG000|NOT COMPLETED|Overall Study||0
6544265|NCT01689207|7465858|FG001|NOT COMPLETED|Overall Study||1
6544266|NCT01689207|7465859|FG002|NOT COMPLETED|Overall Study||0
6544267|NCT01689207|7465860|FG003|NOT COMPLETED|Overall Study||0
6544268|NCT01689207|7465861|FG004|NOT COMPLETED|Overall Study||2
6544269|NCT01689207|7465862|FG005|NOT COMPLETED|Overall Study||1
6544270|NCT01689207|7465863|FG006|NOT COMPLETED|Overall Study||0
6544271|NCT01689207|7465864|FG007|NOT COMPLETED|Overall Study||0
6544272|NCT01689207|7465865|FG008|NOT COMPLETED|Overall Study||1
6544273|NCT01689207|7465866|FG009|NOT COMPLETED|Overall Study||0
6544274|NCT01689207|7465867|FG010|NOT COMPLETED|Overall Study||0
6544275|NCT01689324|7465897|FG000|STARTED|Overall Study||43
6544276|NCT01689324|7465897|FG000|COMPLETED|Overall Study||43
6544277|NCT01689324|7465897|FG000|NOT COMPLETED|Overall Study||0
6544278|NCT01689337|7465901|FG000|STARTED|Overall Study||1
6544279|NCT01689337|7465901|FG000|COMPLETED|Overall Study||0
6544280|NCT01689337|7465901|FG000|NOT COMPLETED|Overall Study||1
6544281|NCT01689350|7465909|FG000|STARTED|Overall Study||47
6544282|NCT01689350|7465910|FG001|STARTED|Overall Study||45
6544283|NCT01689350|7465909|FG000|COMPLETED|Overall Study||47
6544284|NCT01689350|7465910|FG001|COMPLETED|Overall Study||45
6544285|NCT01689350|7465909|FG000|NOT COMPLETED|Overall Study||0
6544286|NCT01689350|7465910|FG001|NOT COMPLETED|Overall Study||0
6544287|NCT01689363|7465916|FG000|STARTED|Overall Study||32
6544288|NCT01689363|7465917|FG001|STARTED|Overall Study||32
6544289|NCT01689363|7465918|FG002|STARTED|Overall Study||32
6544290|NCT01689363|7465919|FG003|STARTED|Overall Study||31
6544291|NCT01689363|7465920|FG004|STARTED|Overall Study||31
6544292|NCT01689363|7465921|FG005|STARTED|Overall Study||31
6544293|NCT01689363|7465922|FG006|STARTED|Overall Study||32
6544294|NCT01689363|7465923|FG007|STARTED|Overall Study||32
6544295|NCT01689363|7465916|FG000|COMPLETED|Overall Study||32
6544296|NCT01689363|7465917|FG001|COMPLETED|Overall Study||31
6544297|NCT01689363|7465918|FG002|COMPLETED|Overall Study||32
6544298|NCT01689363|7465919|FG003|COMPLETED|Overall Study||31
6544299|NCT01689363|7465920|FG004|COMPLETED|Overall Study||31
6544300|NCT01689363|7465921|FG005|COMPLETED|Overall Study||31
6544301|NCT01689363|7465922|FG006|COMPLETED|Overall Study||32
6544302|NCT01689363|7465923|FG007|COMPLETED|Overall Study||32
6544303|NCT01689363|7465916|FG000|NOT COMPLETED|Overall Study||0
6544304|NCT01689363|7465917|FG001|NOT COMPLETED|Overall Study||1
6544305|NCT01689363|7465918|FG002|NOT COMPLETED|Overall Study||0
6544306|NCT01689363|7465919|FG003|NOT COMPLETED|Overall Study||0
6544307|NCT01689363|7465920|FG004|NOT COMPLETED|Overall Study||0
6544308|NCT01689363|7465921|FG005|NOT COMPLETED|Overall Study||0
6544309|NCT01689363|7465922|FG006|NOT COMPLETED|Overall Study||0
6544310|NCT01689363|7465923|FG007|NOT COMPLETED|Overall Study||0
6544311|NCT01689441|7465936|FG000|STARTED|Overall Study||36
6544312|NCT01689441|7465937|FG001|STARTED|Overall Study||31
6544313|NCT01689441|7465936|FG000|COMPLETED|Overall Study||36
6544314|NCT01689441|7465937|FG001|COMPLETED|Overall Study||31
6544315|NCT01689441|7465936|FG000|NOT COMPLETED|Overall Study||0
6544316|NCT01689441|7465937|FG001|NOT COMPLETED|Overall Study||0
6544317|NCT01689519|7465945|FG000|STARTED|Intent to Treat||247
6544318|NCT01689519|7465946|FG001|STARTED|Intent to Treat||248
6544319|NCT01689519|7465945|FG000|COMPLETED|Intent to Treat||0
6544320|NCT01689519|7465946|FG001|COMPLETED|Intent to Treat||0
6544321|NCT01689519|7465945|FG000|NOT COMPLETED|Intent to Treat||247
6544322|NCT01689519|7465946|FG001|NOT COMPLETED|Intent to Treat||248
6544323|NCT01689519|7465945|FG000|STARTED|Safety Population||248
6544324|NCT01689519|7465946|FG001|STARTED|Safety Population||245
6544325|NCT01689519|7465945|FG000|COMPLETED|Safety Population||0
6544326|NCT01689519|7465946|FG001|COMPLETED|Safety Population||0
6544327|NCT01689519|7465945|FG000|NOT COMPLETED|Safety Population||248
6544328|NCT01689519|7465946|FG001|NOT COMPLETED|Safety Population||245
6544329|NCT01689532|7465954|FG000|STARTED|Overall Study||61
6544330|NCT01689532|7465955|FG001|STARTED|Overall Study||61
6544331|NCT01689532|7465954|FG000|COMPLETED|Overall Study||47
6544332|NCT01689532|7465955|FG001|COMPLETED|Overall Study||52
6544333|NCT01689532|7465954|FG000|NOT COMPLETED|Overall Study||14
6544334|NCT01689532|7465955|FG001|NOT COMPLETED|Overall Study||9
6544335|NCT01689649|7465961|FG000|STARTED|Overall Study||139
6544336|NCT01689649|7465961|FG000|COMPLETED|Overall Study||117
6544337|NCT01689649|7465961|FG000|NOT COMPLETED|Overall Study||22
6544338|NCT01689701|7465967|FG000|STARTED|Overall Study||27
6544339|NCT01689701|7465968|FG001|STARTED|Overall Study||27
6544340|NCT01689701|7465967|FG000|COMPLETED|Overall Study||22
6544341|NCT01689701|7465968|FG001|COMPLETED|Overall Study||21
6544342|NCT01689701|7465967|FG000|NOT COMPLETED|Overall Study||5
6544343|NCT01689701|7465968|FG001|NOT COMPLETED|Overall Study||6
6544344|NCT01689779|7465976|FG000|STARTED|Overall Study||28
6544345|NCT01689779|7465977|FG001|STARTED|Overall Study||32
6544346|NCT01689779|7465976|FG000|COMPLETED|Overall Study||28
6544347|NCT01689779|7465977|FG001|COMPLETED|Overall Study||32
6544348|NCT01689779|7465976|FG000|NOT COMPLETED|Overall Study||0
6544349|NCT01689779|7465977|FG001|NOT COMPLETED|Overall Study||0
6544350|NCT01689857|7465985|FG000|STARTED|Overall Study||20
6544351|NCT01689857|7465986|FG001|STARTED|Overall Study||20
6544352|NCT01689857|7465985|FG000|COMPLETED|Overall Study||15
6544353|NCT01689857|7465986|FG001|COMPLETED|Overall Study||18
6544354|NCT01689857|7465985|FG000|NOT COMPLETED|Overall Study||5
6544355|NCT01689857|7465986|FG001|NOT COMPLETED|Overall Study||2
6544356|NCT01690000|7465994|FG000|STARTED|Overall Study||40
6544357|NCT01690000|7465995|FG001|STARTED|Overall Study||41
6544358|NCT01690000|7465994|FG000|COMPLETED|Overall Study||37
6544359|NCT01690000|7465995|FG001|COMPLETED|Overall Study||35
6544360|NCT01690000|7465994|FG000|NOT COMPLETED|Overall Study||3
6544361|NCT01690000|7465995|FG001|NOT COMPLETED|Overall Study||6
6544362|NCT01690052|7466001|FG000|STARTED|FIRST INTERVENTION: 4 WEEKS||7
6544363|NCT01690052|7466002|FG001|STARTED|FIRST INTERVENTION: 4 WEEKS||8
6544364|NCT01690052|7466001|FG000|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
6544365|NCT01690052|7466002|FG001|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
6544366|NCT01690052|7466001|FG000|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
6544367|NCT01690052|7466002|FG001|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
6544368|NCT01690052|7466001|FG000|STARTED|Washout Period of 1 Week||6
6544369|NCT01690052|7466002|FG001|STARTED|Washout Period of 1 Week||6
6544370|NCT01690052|7466001|FG000|COMPLETED|Washout Period of 1 Week||6
6544371|NCT01690052|7466002|FG001|COMPLETED|Washout Period of 1 Week||6
6544372|NCT01690052|7466001|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6544373|NCT01690052|7466002|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6544374|NCT01690052|7466001|FG000|STARTED|SECOND INTERVENTION: 4 WEEKS||6
6544375|NCT01690052|7466002|FG001|STARTED|SECOND INTERVENTION: 4 WEEKS||6
6544376|NCT01690052|7466001|FG000|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
6544377|NCT01690052|7466002|FG001|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
6544378|NCT01690052|7466001|FG000|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
6544379|NCT01690052|7466002|FG001|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
6544380|NCT01690117|7466010|FG000|STARTED|Overall Study||47
6544381|NCT01690117|7466011|FG001|STARTED|Overall Study||45
6544382|NCT01690117|7466010|FG000|Post-Measurement|Overall Study||41
6544383|NCT01690117|7466011|FG001|Post-Measurement|Overall Study||40
6544384|NCT01690117|7466010|FG000|COMPLETED|Overall Study||31
6544385|NCT01690117|7466011|FG001|COMPLETED|Overall Study||31
6544386|NCT01690117|7466010|FG000|NOT COMPLETED|Overall Study||16
6544387|NCT01690117|7466011|FG001|NOT COMPLETED|Overall Study||14
6544388|NCT01690130|7466021|FG000|STARTED|Overall Study||10
6544389|NCT01690130|7466022|FG001|STARTED|Overall Study||9
6544390|NCT01690130|7466021|FG000|COMPLETED|Overall Study||9
6544391|NCT01690130|7466022|FG001|COMPLETED|Overall Study||9
6544392|NCT01690130|7466021|FG000|NOT COMPLETED|Overall Study||1
6544393|NCT01690130|7466022|FG001|NOT COMPLETED|Overall Study||0
6544394|NCT01690143|7466028|FG000|STARTED|Overall Study||45
6544395|NCT01690143|7466028|FG000|COMPLETED|Overall Study||44
6544396|NCT01690143|7466028|FG000|NOT COMPLETED|Overall Study||1
6544397|NCT01690273|7466036|FG000|STARTED|Overall Study||18
6544398|NCT01690273|7466037|FG001|STARTED|Overall Study||17
6544399|NCT01690273|7466038|FG002|STARTED|Overall Study||20
6544400|NCT01690273|7466036|FG000|COMPLETED|Overall Study||18
6544401|NCT01690273|7466037|FG001|COMPLETED|Overall Study||17
6544402|NCT01690273|7466038|FG002|COMPLETED|Overall Study||20
6544403|NCT01690273|7466036|FG000|NOT COMPLETED|Overall Study||0
6544404|NCT01690273|7466037|FG001|NOT COMPLETED|Overall Study||0
6544405|NCT01690273|7466038|FG002|NOT COMPLETED|Overall Study||0
6544406|NCT01690520|7466052|FG000|STARTED|Overall Study||78
6544407|NCT01690520|7466053|FG001|STARTED|Overall Study||82
6544408|NCT01690520|7466052|FG000|Modified Intent to Treat (mITT)|Overall Study||78
6544409|NCT01690520|7466053|FG001|Modified Intent to Treat (mITT)|Overall Study||80
6544410|NCT01690520|7466052|FG000|COMPLETED|Overall Study||27
6544411|NCT01690520|7466053|FG001|COMPLETED|Overall Study||35
6544412|NCT01690520|7466052|FG000|NOT COMPLETED|Overall Study||51
6544413|NCT01690520|7466053|FG001|NOT COMPLETED|Overall Study||47
6544414|NCT01690546|7466059|FG000|STARTED|Overall Study||35
6544415|NCT01690546|7466059|FG000|Extended Release Injectable NTX|Overall Study||27
6544416|NCT01690546|7466059|FG000|COMPLETED|Overall Study||26
6544417|NCT01690546|7466059|FG000|NOT COMPLETED|Overall Study||9
6544418|NCT01690663|7466067|FG000|STARTED|Overall Study||23
6544419|NCT01690663|7466068|FG001|STARTED|Overall Study||20
6544420|NCT01690663|7466069|FG002|STARTED|Overall Study||22
6544421|NCT01690663|7466070|FG003|STARTED|Overall Study||24
6544422|NCT01690663|7466067|FG000|COMPLETED|Overall Study||20
6544423|NCT01690663|7466068|FG001|COMPLETED|Overall Study||17
6544424|NCT01690663|7466069|FG002|COMPLETED|Overall Study||19
6544425|NCT01690663|7466070|FG003|COMPLETED|Overall Study||20
6544426|NCT01690663|7466067|FG000|NOT COMPLETED|Overall Study||3
6544427|NCT01690663|7466068|FG001|NOT COMPLETED|Overall Study||3
6544428|NCT01690663|7466069|FG002|NOT COMPLETED|Overall Study||3
6544429|NCT01690663|7466070|FG003|NOT COMPLETED|Overall Study||4
6544430|NCT01690923|7466080|FG000|STARTED|Overall Study||10
6544431|NCT01690923|7466081|FG001|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
6544432|NCT01690923|7466080|FG000|COMPLETED|Overall Study||10
6544433|NCT01690923|7466081|FG001|COMPLETED|Overall Study||10
6544434|NCT01690923|7466080|FG000|NOT COMPLETED|Overall Study||0
6544435|NCT01690923|7466081|FG001|NOT COMPLETED|Overall Study||1
6544436|NCT01690988|7466088|FG000|STARTED|Overall Study||227
6544437|NCT01690988|7466089|FG001|STARTED|Overall Study||222
6544438|NCT01690988|7466090|FG002|STARTED|Overall Study||223
6544439|NCT01690988|7466088|FG000|COMPLETED|Overall Study||221
6544440|NCT01690988|7466089|FG001|COMPLETED|Overall Study||217
6544441|NCT01690988|7466090|FG002|COMPLETED|Overall Study||216
6544442|NCT01690988|7466088|FG000|NOT COMPLETED|Overall Study||6
6544443|NCT01690988|7466089|FG001|NOT COMPLETED|Overall Study||5
6544444|NCT01690988|7466090|FG002|NOT COMPLETED|Overall Study||7
6544445|NCT01691014|7466105|FG000|STARTED|Overall Study||8
6544446|NCT01691014|7466106|FG001|STARTED|Overall Study||26
6544447|NCT01691014|7466107|FG002|STARTED|Overall Study||36
6544448|NCT01691014|7466108|FG003|STARTED|Overall Study||9
6544449|NCT01691014|7466105|FG000|COMPLETED|Overall Study||5
6544450|NCT01691014|7466106|FG001|COMPLETED|Overall Study||11
6544451|NCT01691014|7466107|FG002|COMPLETED|Overall Study||25
6544452|NCT01691014|7466108|FG003|COMPLETED|Overall Study||4
6544453|NCT01691014|7466105|FG000|NOT COMPLETED|Overall Study||3
6544454|NCT01691014|7466106|FG001|NOT COMPLETED|Overall Study||15
6544455|NCT01691014|7466107|FG002|NOT COMPLETED|Overall Study||11
6544456|NCT01691014|7466108|FG003|NOT COMPLETED|Overall Study||5
6544457|NCT01691027|7466118|FG000|STARTED|Scotoma Awareness|Four subjects started scotoma awareness training module|4
6544458|NCT01691027|7466118|FG000|COMPLETED|Scotoma Awareness|Four subjects were able to complete scotoma awareness training module|4
6544459|NCT01691027|7466118|FG000|NOT COMPLETED|Scotoma Awareness||0
6544460|NCT01691027|7466118|FG000|STARTED|Line and Circle Tracing Training|Four subjects started line and circle tracing training module|4
6544461|NCT01691027|7466118|FG000|COMPLETED|Line and Circle Tracing Training|Four subjects were able to complete line and circle tracing training module.|4
6544462|NCT01691027|7466118|FG000|NOT COMPLETED|Line and Circle Tracing Training||0
6544463|NCT01691027|7466118|FG000|STARTED|Video Games Training|Four subjects started video game training module|4
6544464|NCT01691027|7466118|FG000|COMPLETED|Video Games Training|Four subjects were able to complete video games training module|4
6544465|NCT01691027|7466118|FG000|NOT COMPLETED|Video Games Training||0
6544466|NCT01691092|7466123|FG000|STARTED|Overall Study||79
6544467|NCT01691092|7466123|FG000|COMPLETED|Overall Study||38
6544468|NCT01691092|7466123|FG000|NOT COMPLETED|Overall Study||41
6562445|NCT01800916|7485367|FG005|NOT COMPLETED|Test Period 3 (1 Week)||0
6562446|NCT01800916|7485368|FG006|NOT COMPLETED|Test Period 3 (1 Week)||0
6562447|NCT01800916|7485369|FG007|NOT COMPLETED|Test Period 3 (1 Week)||0
6562448|NCT01800916|7485370|FG008|NOT COMPLETED|Test Period 3 (1 Week)||0
6562449|NCT01800968|7485382|FG000|STARTED|Overall Study||154
6562450|NCT01800968|7485383|FG001|STARTED|Overall Study||146
6562451|NCT01800968|7485382|FG000|COMPLETED|Overall Study||118
6562452|NCT01800968|7485383|FG001|COMPLETED|Overall Study||114
6562453|NCT01800968|7485382|FG000|NOT COMPLETED|Overall Study||36
6562454|NCT01800968|7485383|FG001|NOT COMPLETED|Overall Study||32
6562455|NCT01801007|7485389|FG000|STARTED|Overall Study||145
6562456|NCT01801007|7485389|FG000|COMPLETED|Overall Study||134
6562457|NCT01801007|7485389|FG000|NOT COMPLETED|Overall Study||11
6562458|NCT01801111|7485393|FG000|STARTED|Overall Study||138
6562459|NCT01801111|7485393|FG000|COMPLETED|Overall Study||0
6562460|NCT01801111|7485393|FG000|NOT COMPLETED|Overall Study||138
6562461|NCT01801124|7485397|FG000|STARTED|Overall Study||13
6562462|NCT01801124|7485397|FG000|COMPLETED|Overall Study||13
6562463|NCT01801124|7485397|FG000|NOT COMPLETED|Overall Study||0
6562464|NCT01801241|7485403|FG000|STARTED|Overall Study||29
6562465|NCT01801241|7485404|FG001|STARTED|Overall Study||27
6562466|NCT01801241|7485403|FG000|COMPLETED|Overall Study||21
6562467|NCT01801241|7485404|FG001|COMPLETED|Overall Study||25
6562468|NCT01801241|7485403|FG000|NOT COMPLETED|Overall Study||8
6562469|NCT01801241|7485404|FG001|NOT COMPLETED|Overall Study||2
6562470|NCT01801280|7485414|FG000|STARTED|Period 1|Each period lasted 10-14 weeks|5
6562471|NCT01801280|7485415|FG001|STARTED|Period 1||5
6562472|NCT01801280|7485416|FG002|STARTED|Period 1||5
6562473|NCT01801280|7485417|FG003|STARTED|Period 1||5
6562474|NCT01801280|7485414|FG000|COMPLETED|Period 1||5
6562475|NCT01801280|7485415|FG001|COMPLETED|Period 1||4
6562476|NCT01801280|7485416|FG002|COMPLETED|Period 1||5
6562477|NCT01801280|7485417|FG003|COMPLETED|Period 1||5
6562478|NCT01801280|7485414|FG000|NOT COMPLETED|Period 1||0
6562479|NCT01801280|7485415|FG001|NOT COMPLETED|Period 1||1
6562480|NCT01801280|7485416|FG002|NOT COMPLETED|Period 1||0
6562481|NCT01801280|7485417|FG003|NOT COMPLETED|Period 1||0
6562482|NCT01801280|7485414|FG000|STARTED|Period 2||5
6562483|NCT01801280|7485415|FG001|STARTED|Period 2||4
6562484|NCT01801280|7485416|FG002|STARTED|Period 2||5
6562485|NCT01801280|7485417|FG003|STARTED|Period 2||5
6562486|NCT01801280|7485414|FG000|COMPLETED|Period 2||4
6562487|NCT01801280|7485415|FG001|COMPLETED|Period 2||4
6562488|NCT01801280|7485416|FG002|COMPLETED|Period 2||5
6562489|NCT01801280|7485417|FG003|COMPLETED|Period 2||5
6562490|NCT01801280|7485414|FG000|NOT COMPLETED|Period 2||1
6562491|NCT01801280|7485415|FG001|NOT COMPLETED|Period 2||0
6562492|NCT01801280|7485416|FG002|NOT COMPLETED|Period 2||0
6562493|NCT01801280|7485417|FG003|NOT COMPLETED|Period 2||0
6562494|NCT01801280|7485414|FG000|STARTED|Period 3||4
6562495|NCT01801280|7485415|FG001|STARTED|Period 3||4
6562496|NCT01801280|7485416|FG002|STARTED|Period 3||5
6562497|NCT01801280|7485417|FG003|STARTED|Period 3||5
6562498|NCT01801280|7485414|FG000|COMPLETED|Period 3||4
6562499|NCT01801280|7485415|FG001|COMPLETED|Period 3||4
6562500|NCT01801280|7485416|FG002|COMPLETED|Period 3||5
6562501|NCT01801280|7485417|FG003|COMPLETED|Period 3||5
6562502|NCT01801280|7485414|FG000|NOT COMPLETED|Period 3||0
6562503|NCT01801280|7485415|FG001|NOT COMPLETED|Period 3||0
6562504|NCT01801280|7485416|FG002|NOT COMPLETED|Period 3||0
6544469|NCT01691105|7466129|FG000|STARTED|Baseline||477
6544470|NCT01691105|7466130|FG001|STARTED|Baseline||567
6544471|NCT01691105|7466129|FG000|COMPLETED|Baseline||477
6646895|NCT02384096|7575914|FG000|NOT COMPLETED|First Intervention (7 Days)||1
6646896|NCT02384096|7575915|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6646897|NCT02384096|7575914|FG000|STARTED|Second Intervention (7 Days)||4
6646898|NCT02384096|7575915|FG001|STARTED|Second Intervention (7 Days)||7
6646899|NCT02384096|7575914|FG000|COMPLETED|Second Intervention (7 Days)||4
6646900|NCT02384096|7575915|FG001|COMPLETED|Second Intervention (7 Days)||6
6544472|NCT01691105|7466130|FG001|COMPLETED|Baseline||567
6544473|NCT01691105|7466129|FG000|NOT COMPLETED|Baseline||0
6544474|NCT01691105|7466130|FG001|NOT COMPLETED|Baseline||0
6544475|NCT01691105|7466129|FG000|STARTED|1 Month Follow-up||477
6544476|NCT01691105|7466130|FG001|STARTED|1 Month Follow-up||567
6544477|NCT01691105|7466129|FG000|COMPLETED|1 Month Follow-up||434
6544478|NCT01691105|7466130|FG001|COMPLETED|1 Month Follow-up||526
6544479|NCT01691105|7466129|FG000|NOT COMPLETED|1 Month Follow-up||43
6544480|NCT01691105|7466130|FG001|NOT COMPLETED|1 Month Follow-up||41
6544481|NCT01691105|7466129|FG000|STARTED|6 Month Follow-up||477
6544482|NCT01691105|7466130|FG001|STARTED|6 Month Follow-up||567
6544483|NCT01691105|7466129|FG000|COMPLETED|6 Month Follow-up||425
6544484|NCT01691105|7466130|FG001|COMPLETED|6 Month Follow-up||496
6544485|NCT01691105|7466129|FG000|NOT COMPLETED|6 Month Follow-up||52
6544486|NCT01691105|7466130|FG001|NOT COMPLETED|6 Month Follow-up||71
6544487|NCT01691105|7466129|FG000|STARTED|12 Month Follow-up||477
6544488|NCT01691105|7466130|FG001|STARTED|12 Month Follow-up||567
6544489|NCT01691105|7466129|FG000|COMPLETED|12 Month Follow-up||405
6544490|NCT01691105|7466130|FG001|COMPLETED|12 Month Follow-up||466
6544491|NCT01691105|7466129|FG000|NOT COMPLETED|12 Month Follow-up||72
6544492|NCT01691105|7466130|FG001|NOT COMPLETED|12 Month Follow-up||101
6544493|NCT01691105|7466129|FG000|STARTED|12 Month Biochemical Verification||477
6544494|NCT01691105|7466130|FG001|STARTED|12 Month Biochemical Verification||567
6544495|NCT01691105|7466129|FG000|COMPLETED|12 Month Biochemical Verification||53
6544496|NCT01691105|7466130|FG001|COMPLETED|12 Month Biochemical Verification||65
6544497|NCT01691105|7466129|FG000|NOT COMPLETED|12 Month Biochemical Verification||424
6544498|NCT01691105|7466130|FG001|NOT COMPLETED|12 Month Biochemical Verification||502
6544499|NCT01691248|7466138|FG000|STARTED|Overall Study|Randomized|305
6544500|NCT01691248|7466139|FG001|STARTED|Overall Study|Randomized|306
6544501|NCT01691248|7466138|FG000|Treated|Overall Study|Received at least 1 dose of study drug|301
6544502|NCT01691248|7466139|FG001|Treated|Overall Study|Received at least 1 dose of study drug|299
6544503|NCT01691248|7466138|FG000|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
6544504|NCT01691248|7466139|FG001|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
6544505|NCT01691248|7466138|FG000|COMPLETED|Overall Study||194
6544506|NCT01691248|7466139|FG001|COMPLETED|Overall Study||192
6544507|NCT01691248|7466138|FG000|NOT COMPLETED|Overall Study||111
6544508|NCT01691248|7466139|FG001|NOT COMPLETED|Overall Study||114
6544509|NCT01691313|7466149|FG000|STARTED|Overall Study||22
6544510|NCT01691313|7466150|FG001|STARTED|Overall Study||32
6544511|NCT01691313|7466151|FG002|STARTED|Overall Study||25
6544512|NCT01691313|7466152|FG003|STARTED|Overall Study||25
6544513|NCT01691313|7466149|FG000|COMPLETED|Overall Study||22
6544514|NCT01691313|7466150|FG001|COMPLETED|Overall Study||32
6544515|NCT01691313|7466151|FG002|COMPLETED|Overall Study||25
6544516|NCT01691313|7466152|FG003|COMPLETED|Overall Study||25
6544517|NCT01691313|7466149|FG000|NOT COMPLETED|Overall Study||0
6544518|NCT01691313|7466150|FG001|NOT COMPLETED|Overall Study||0
6544519|NCT01691313|7466151|FG002|NOT COMPLETED|Overall Study||0
6544520|NCT01691313|7466152|FG003|NOT COMPLETED|Overall Study||0
6544521|NCT01691326|7466164|FG000|STARTED|Overall Study||30
6544522|NCT01691326|7466165|FG001|STARTED|Overall Study||30
6544523|NCT01691326|7466164|FG000|COMPLETED|Overall Study||30
6544524|NCT01691326|7466165|FG001|COMPLETED|Overall Study||30
6544525|NCT01691326|7466164|FG000|NOT COMPLETED|Overall Study||0
6544526|NCT01691326|7466165|FG001|NOT COMPLETED|Overall Study||0
6544527|NCT01691339|7466177|FG000|STARTED|Overall Study||50
6544528|NCT01691339|7466178|FG001|STARTED|Overall Study||50
6544529|NCT01691339|7466179|FG002|STARTED|Overall Study||51
6544530|NCT01691339|7466180|FG003|STARTED|Overall Study||49
6544531|NCT01691339|7466177|FG000|COMPLETED|Overall Study||50
6544532|NCT01691339|7466178|FG001|COMPLETED|Overall Study||50
6544533|NCT01691339|7466179|FG002|COMPLETED|Overall Study||51
6544534|NCT01691339|7466180|FG003|COMPLETED|Overall Study||49
6544535|NCT01691339|7466177|FG000|NOT COMPLETED|Overall Study||0
6544536|NCT01691339|7466178|FG001|NOT COMPLETED|Overall Study||0
6544537|NCT01691339|7466179|FG002|NOT COMPLETED|Overall Study||0
6544538|NCT01691339|7466180|FG003|NOT COMPLETED|Overall Study||0
6544539|NCT01691378|7466192|FG000|STARTED|Overall Study||22
6544540|NCT01691378|7466193|FG001|STARTED|Overall Study||22
6544541|NCT01691378|7466192|FG000|COMPLETED|Overall Study||15
6544542|NCT01691378|7466193|FG001|COMPLETED|Overall Study||20
6544543|NCT01691378|7466192|FG000|NOT COMPLETED|Overall Study||7
6544544|NCT01691378|7466193|FG001|NOT COMPLETED|Overall Study||2
6544545|NCT01691430|7466201|FG000|STARTED|Overall Study||92
6544546|NCT01691430|7466202|FG001|STARTED|Overall Study||93
6544547|NCT01691430|7466201|FG000|Received Medication|Overall Study||92
6544548|NCT01691430|7466202|FG001|Received Medication|Overall Study||93
6646901|NCT02384096|7575914|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6544549|NCT01691430|7466201|FG000|COMPLETED|Overall Study||70
6544550|NCT01691430|7466202|FG001|COMPLETED|Overall Study||73
6544551|NCT01691430|7466201|FG000|NOT COMPLETED|Overall Study||22
6544552|NCT01691430|7466202|FG001|NOT COMPLETED|Overall Study||20
6544553|NCT01691482|7466208|FG000|STARTED|Treatment Period 1||28
6544554|NCT01691482|7466209|FG001|STARTED|Treatment Period 1||28
6544555|NCT01691482|7466208|FG000|COMPLETED|Treatment Period 1||28
6544556|NCT01691482|7466209|FG001|COMPLETED|Treatment Period 1||28
6544557|NCT01691482|7466208|FG000|NOT COMPLETED|Treatment Period 1||0
6544558|NCT01691482|7466209|FG001|NOT COMPLETED|Treatment Period 1||0
6544559|NCT01691482|7466208|FG000|STARTED|Treatment Period 2||28
6544560|NCT01691482|7466209|FG001|STARTED|Treatment Period 2||28
6544561|NCT01691482|7466208|FG000|COMPLETED|Treatment Period 2||27
6544562|NCT01691482|7466209|FG001|COMPLETED|Treatment Period 2||26
6544563|NCT01691482|7466208|FG000|NOT COMPLETED|Treatment Period 2||1
6544564|NCT01691482|7466209|FG001|NOT COMPLETED|Treatment Period 2||2
6544565|NCT01691508|7466218|FG000|STARTED|Overall Study||66
6544566|NCT01691508|7466219|FG001|STARTED|Overall Study||69
6544567|NCT01691508|7466218|FG000|COMPLETED|Overall Study||62
6544568|NCT01691508|7466219|FG001|COMPLETED|Overall Study||66
6544569|NCT01691508|7466218|FG000|NOT COMPLETED|Overall Study||4
6544570|NCT01691508|7466219|FG001|NOT COMPLETED|Overall Study||3
6544571|NCT01691521|7466228|FG000|STARTED|Overall Study||191
6544572|NCT01691521|7466229|FG001|STARTED|Overall Study||191
6544573|NCT01691521|7466230|FG002|STARTED|Overall Study||194
6544574|NCT01691521|7466228|FG000|COMPLETED|Overall Study||179
6544575|NCT01691521|7466229|FG001|COMPLETED|Overall Study||175
6544576|NCT01691521|7466230|FG002|COMPLETED|Overall Study||185
6544577|NCT01691521|7466228|FG000|NOT COMPLETED|Overall Study||12
6544578|NCT01691521|7466229|FG001|NOT COMPLETED|Overall Study||16
6544579|NCT01691521|7466230|FG002|NOT COMPLETED|Overall Study||9
6544580|NCT01691534|7466246|FG000|STARTED|Overall Study||15
6544581|NCT01691534|7466247|FG001|STARTED|Overall Study||15
6544582|NCT01691534|7466248|FG002|STARTED|Overall Study||15
6544583|NCT01691534|7466249|FG003|STARTED|Overall Study||15
6544584|NCT01691534|7466250|FG004|STARTED|Overall Study||15
6544585|NCT01691534|7466251|FG005|STARTED|Overall Study||15
6544586|NCT01691534|7466252|FG006|STARTED|Overall Study||15
6544587|NCT01691534|7466246|FG000|COMPLETED|Overall Study||15
6544588|NCT01691534|7466247|FG001|COMPLETED|Overall Study||14
6544589|NCT01691534|7466248|FG002|COMPLETED|Overall Study||14
6544590|NCT01691534|7466249|FG003|COMPLETED|Overall Study||14
6544591|NCT01691534|7466250|FG004|COMPLETED|Overall Study||15
6544592|NCT01691534|7466251|FG005|COMPLETED|Overall Study||14
6544593|NCT01691534|7466252|FG006|COMPLETED|Overall Study||14
6544594|NCT01691534|7466246|FG000|NOT COMPLETED|Overall Study||0
6544595|NCT01691534|7466247|FG001|NOT COMPLETED|Overall Study||1
6544596|NCT01691534|7466248|FG002|NOT COMPLETED|Overall Study||1
6544597|NCT01691534|7466249|FG003|NOT COMPLETED|Overall Study||1
6544598|NCT01691534|7466250|FG004|NOT COMPLETED|Overall Study||0
6544599|NCT01691534|7466251|FG005|NOT COMPLETED|Overall Study||1
6544600|NCT01691534|7466252|FG006|NOT COMPLETED|Overall Study||1
6544601|NCT01691560|7466273|FG000|STARTED|Overall Study||34
6544602|NCT01691560|7466274|FG001|STARTED|Overall Study||33
6544603|NCT01691560|7466275|FG002|STARTED|Overall Study||34
6544604|NCT01691560|7466276|FG003|STARTED|Overall Study||33
6544605|NCT01691560|7466273|FG000|COMPLETED|Overall Study||34
6544606|NCT01691560|7466274|FG001|COMPLETED|Overall Study||33
6544607|NCT01691560|7466275|FG002|COMPLETED|Overall Study||34
6544608|NCT01691560|7466276|FG003|COMPLETED|Overall Study||33
6544609|NCT01691560|7466273|FG000|NOT COMPLETED|Overall Study||0
6544610|NCT01691560|7466274|FG001|NOT COMPLETED|Overall Study||0
6544611|NCT01691560|7466275|FG002|NOT COMPLETED|Overall Study||0
6544612|NCT01691560|7466276|FG003|NOT COMPLETED|Overall Study||0
6544613|NCT01691612|7466286|FG000|STARTED|Overall Study||14
6544614|NCT01691612|7466286|FG000|First Visit (Allergen Challenge)|Overall Study||8
6544615|NCT01691612|7466286|FG000|Second Visit (Bronchoscopy)|Overall Study||7
6544616|NCT01691612|7466286|FG000|COMPLETED|Overall Study||7
6544617|NCT01691612|7466286|FG000|NOT COMPLETED|Overall Study||7
6544618|NCT01691690|7466292|FG000|STARTED|Overall Study||125
6544619|NCT01691690|7466293|FG001|STARTED|Overall Study||125
6544620|NCT01691690|7466292|FG000|COMPLETED|Overall Study||118
6544621|NCT01691690|7466293|FG001|COMPLETED|Overall Study||121
6544622|NCT01691690|7466292|FG000|NOT COMPLETED|Overall Study||7
6544623|NCT01691690|7466293|FG001|NOT COMPLETED|Overall Study||4
6544624|NCT01691768|7466304|FG000|STARTED|Overall Study||189
6544625|NCT01691768|7466305|FG001|STARTED|Overall Study||183
6544626|NCT01691768|7466304|FG000|COMPLETED|Overall Study||174
6544627|NCT01691768|7466305|FG001|COMPLETED|Overall Study||167
6544628|NCT01691768|7466304|FG000|NOT COMPLETED|Overall Study||15
6544629|NCT01691768|7466305|FG001|NOT COMPLETED|Overall Study||16
6544630|NCT01691781|7466314|FG000|STARTED|Overall Study||19
6544631|NCT01691781|7466315|FG001|STARTED|Overall Study||22
6544632|NCT01691781|7466314|FG000|COMPLETED|Overall Study||12
6544633|NCT01691781|7466315|FG001|COMPLETED|Overall Study||15
6544634|NCT01691781|7466314|FG000|NOT COMPLETED|Overall Study||7
6544635|NCT01691781|7466315|FG001|NOT COMPLETED|Overall Study||7
6544636|NCT01691794|7466324|FG000|STARTED|Overall Study||3
6544637|NCT01691794|7466325|FG001|STARTED|Overall Study||33
6544638|NCT01691794|7466326|FG002|STARTED|Overall Study||23
6544639|NCT01691794|7466324|FG000|COMPLETED|Overall Study|Completed baseline to End of Study|2
6544640|NCT01691794|7466325|FG001|COMPLETED|Overall Study|Completed baseline to End of Study|15
6544641|NCT01691794|7466326|FG002|COMPLETED|Overall Study|Completed baseline to End of Study|13
6544642|NCT01691794|7466324|FG000|NOT COMPLETED|Overall Study||1
6544643|NCT01691794|7466325|FG001|NOT COMPLETED|Overall Study||18
6544644|NCT01691794|7466326|FG002|NOT COMPLETED|Overall Study||10
6544645|NCT01691820|7466336|FG000|STARTED|Overall Study||210
6544646|NCT01691820|7466337|FG001|STARTED|Overall Study||152
6544647|NCT01691820|7466336|FG000|COMPLETED|Overall Study||184
6544648|NCT01691820|7466337|FG001|COMPLETED|Overall Study||115
6544649|NCT01691820|7466336|FG000|NOT COMPLETED|Overall Study||26
6544650|NCT01691820|7466337|FG001|NOT COMPLETED|Overall Study||37
6544651|NCT01691833|7466350|FG000|STARTED|Overall Study||50
6544652|NCT01691833|7466351|FG001|STARTED|Overall Study||50
6544653|NCT01691833|7466352|FG002|STARTED|Overall Study||13
6544654|NCT01691833|7466350|FG000|COMPLETED|Overall Study||49
6544655|NCT01691833|7466351|FG001|COMPLETED|Overall Study||49
6544656|NCT01691833|7466352|FG002|COMPLETED|Overall Study||13
6544657|NCT01691833|7466350|FG000|NOT COMPLETED|Overall Study||1
6544658|NCT01691833|7466351|FG001|NOT COMPLETED|Overall Study||1
6544659|NCT01691833|7466352|FG002|NOT COMPLETED|Overall Study||0
6544660|NCT01691859|7466360|FG000|STARTED|Overall Study||347
6544661|NCT01691859|7466360|FG000|COMPLETED|Overall Study||0
6544662|NCT01691859|7466360|FG000|NOT COMPLETED|Overall Study||347
6544663|NCT01691885|7466364|FG000|STARTED|Treatment Period 1(7-14 Days)||22
6544664|NCT01691885|7466365|FG001|STARTED|Treatment Period 1(7-14 Days)||23
6544665|NCT01691885|7466364|FG000|COMPLETED|Treatment Period 1(7-14 Days)||21
6544666|NCT01691885|7466365|FG001|COMPLETED|Treatment Period 1(7-14 Days)||22
6544667|NCT01691885|7466364|FG000|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
6544668|NCT01691885|7466365|FG001|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
6544669|NCT01691885|7466364|FG000|STARTED|Washout Period (7-9 Days)||21
6544670|NCT01691885|7466365|FG001|STARTED|Washout Period (7-9 Days)||22
6544671|NCT01691885|7466364|FG000|COMPLETED|Washout Period (7-9 Days)||21
6544672|NCT01691885|7466365|FG001|COMPLETED|Washout Period (7-9 Days)||21
6544673|NCT01691885|7466364|FG000|NOT COMPLETED|Washout Period (7-9 Days)||0
6544674|NCT01691885|7466365|FG001|NOT COMPLETED|Washout Period (7-9 Days)||1
6544675|NCT01691885|7466364|FG000|STARTED|Treatment Period 2 (7-14 Days)||21
6544676|NCT01691885|7466365|FG001|STARTED|Treatment Period 2 (7-14 Days)||21
6544677|NCT01691885|7466364|FG000|COMPLETED|Treatment Period 2 (7-14 Days)||21
6544678|NCT01691885|7466365|FG001|COMPLETED|Treatment Period 2 (7-14 Days)||21
6544679|NCT01691885|7466364|FG000|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
6544680|NCT01691885|7466365|FG001|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
6544681|NCT01691898|7466377|FG000|STARTED|Overall Study||63
6544682|NCT01691898|7466378|FG001|STARTED|Overall Study||59
6544683|NCT01691898|7466379|FG002|STARTED|Overall Study||20
6544684|NCT01691898|7466380|FG003|STARTED|Overall Study||9
6544685|NCT01691898|7466381|FG004|STARTED|Overall Study||40
6544686|NCT01691898|7466382|FG005|STARTED|Overall Study||40
6544687|NCT01691898|7466377|FG000|COMPLETED|Overall Study||16
6544688|NCT01691898|7466378|FG001|COMPLETED|Overall Study||15
6544689|NCT01691898|7466379|FG002|COMPLETED|Overall Study||11
6544690|NCT01691898|7466380|FG003|COMPLETED|Overall Study||4
6544691|NCT01691898|7466381|FG004|COMPLETED|Overall Study||26
6544692|NCT01691898|7466382|FG005|COMPLETED|Overall Study||5
6544693|NCT01691898|7466377|FG000|NOT COMPLETED|Overall Study||47
6544694|NCT01691898|7466378|FG001|NOT COMPLETED|Overall Study||44
6544695|NCT01691898|7466379|FG002|NOT COMPLETED|Overall Study||9
6544696|NCT01691898|7466380|FG003|NOT COMPLETED|Overall Study||5
6544697|NCT01691898|7466381|FG004|NOT COMPLETED|Overall Study||14
6544698|NCT01691898|7466382|FG005|NOT COMPLETED|Overall Study||35
6544699|NCT01691950|7466416|FG000|STARTED|Overall Study||20
6544700|NCT01691950|7466417|FG001|STARTED|Overall Study||10
6544701|NCT01691950|7466416|FG000|COMPLETED|Overall Study||10
6544702|NCT01691950|7466417|FG001|COMPLETED|Overall Study||10
6544703|NCT01691950|7466416|FG000|NOT COMPLETED|Overall Study||10
6544704|NCT01691950|7466417|FG001|NOT COMPLETED|Overall Study||0
6544705|NCT01692119|7466425|FG000|STARTED|Overall Study||130
6544706|NCT01692119|7466426|FG001|STARTED|Overall Study||128
6544707|NCT01692119|7466425|FG000|COMPLETED|Overall Study||110
6544708|NCT01692119|7466426|FG001|COMPLETED|Overall Study||127
6544709|NCT01692119|7466425|FG000|NOT COMPLETED|Overall Study||20
6544710|NCT01692119|7466426|FG001|NOT COMPLETED|Overall Study||1
6544711|NCT01692197|7466432|FG000|STARTED|Overall Study||43
6544712|NCT01692197|7466432|FG000|COMPLETED|Overall Study||40
6544713|NCT01692197|7466432|FG000|NOT COMPLETED|Overall Study||3
6544714|NCT01692275|7466443|FG000|STARTED|Overall Study||375
6544715|NCT01692275|7466444|FG001|STARTED|Overall Study||375
6544716|NCT01692275|7466443|FG000|COMPLETED|Overall Study||309
6544717|NCT01692275|7466444|FG001|COMPLETED|Overall Study||316
6544718|NCT01692275|7466443|FG000|NOT COMPLETED|Overall Study||66
6544719|NCT01692275|7466444|FG001|NOT COMPLETED|Overall Study||59
6544720|NCT01692301|7466464|FG000|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
6544721|NCT01692301|7466465|FG001|STARTED|Overall Study||225
6544722|NCT01692301|7466464|FG000|COMPLETED|Overall Study||184
6544723|NCT01692301|7466465|FG001|COMPLETED|Overall Study||183
6544724|NCT01692301|7466464|FG000|NOT COMPLETED|Overall Study||45
6544725|NCT01692301|7466465|FG001|NOT COMPLETED|Overall Study||42
6544726|NCT01692340|7466474|FG000|STARTED|Overall Study||8
6544727|NCT01692340|7466475|FG001|STARTED|Overall Study||4
6544728|NCT01692340|7466476|FG002|STARTED|Overall Study||0
6544729|NCT01692340|7466474|FG000|COMPLETED|Overall Study||8
6544730|NCT01692340|7466475|FG001|COMPLETED|Overall Study||4
6544731|NCT01692340|7466476|FG002|COMPLETED|Overall Study||0
6544732|NCT01692340|7466474|FG000|NOT COMPLETED|Overall Study||0
6544733|NCT01692340|7466475|FG001|NOT COMPLETED|Overall Study||0
6544734|NCT01692340|7466476|FG002|NOT COMPLETED|Overall Study||0
6544735|NCT01692496|7466485|FG000|STARTED|Overall Study||52
6544736|NCT01692496|7466485|FG000|3 Weeks Pazopanib (Per Protocol PP)|Overall Study||50
6544737|NCT01692496|7466485|FG000|COMPLETED|Overall Study||52
6544738|NCT01692496|7466485|FG000|NOT COMPLETED|Overall Study||0
6544739|NCT01692626|7466489|FG000|STARTED|Overall Study||6
6544740|NCT01692626|7466490|FG001|STARTED|Overall Study||7
6544741|NCT01692626|7466489|FG000|COMPLETED|Overall Study||2
6544742|NCT01692626|7466490|FG001|COMPLETED|Overall Study||1
6544743|NCT01692626|7466489|FG000|NOT COMPLETED|Overall Study||4
6544744|NCT01692626|7466490|FG001|NOT COMPLETED|Overall Study||6
6544745|NCT01692730|7466497|FG000|STARTED|Overall Study||723
6544746|NCT01692730|7466498|FG001|STARTED|Overall Study||729
6544747|NCT01692730|7466497|FG000|COMPLETED|Overall Study||498
6544748|NCT01692730|7466498|FG001|COMPLETED|Overall Study||502
6544749|NCT01692730|7466497|FG000|NOT COMPLETED|Overall Study||225
6544750|NCT01692730|7466498|FG001|NOT COMPLETED|Overall Study||227
6544751|NCT01692743|7466507|FG000|STARTED|Overall Study||117
6544752|NCT01692743|7466508|FG001|STARTED|Overall Study||116
6544753|NCT01692743|7466509|FG002|STARTED|Overall Study||115
6544754|NCT01692743|7466507|FG000|COMPLETED|Overall Study||90
6544755|NCT01692743|7466508|FG001|COMPLETED|Overall Study||81
6544756|NCT01692743|7466509|FG002|COMPLETED|Overall Study||88
6544757|NCT01692743|7466507|FG000|NOT COMPLETED|Overall Study||27
6544758|NCT01692743|7466508|FG001|NOT COMPLETED|Overall Study||35
6544759|NCT01692743|7466509|FG002|NOT COMPLETED|Overall Study||27
6544760|NCT01692756|7466521|FG000|STARTED|Overall Study||12
6544761|NCT01692756|7466522|FG001|STARTED|Overall Study||12
6544762|NCT01692756|7466523|FG002|STARTED|Overall Study||13
6544763|NCT01692756|7466524|FG003|STARTED|Overall Study||12
6544764|NCT01692756|7466521|FG000|COMPLETED|Overall Study||11
6544765|NCT01692756|7466522|FG001|COMPLETED|Overall Study||11
6544766|NCT01692756|7466523|FG002|COMPLETED|Overall Study||11
6544767|NCT01692756|7466524|FG003|COMPLETED|Overall Study||12
6544768|NCT01692756|7466521|FG000|NOT COMPLETED|Overall Study||1
6544769|NCT01692756|7466522|FG001|NOT COMPLETED|Overall Study||1
6544770|NCT01692756|7466523|FG002|NOT COMPLETED|Overall Study||2
6544771|NCT01692756|7466524|FG003|NOT COMPLETED|Overall Study||0
6544772|NCT01692782|7466537|FG000|STARTED|Overall Study||116
6544773|NCT01692782|7466538|FG001|STARTED|Overall Study||115
6544774|NCT01692782|7466539|FG002|STARTED|Overall Study||110
6544775|NCT01692782|7466537|FG000|COMPLETED|Overall Study||96
6544776|NCT01692782|7466538|FG001|COMPLETED|Overall Study||59
6544777|NCT01692782|7466539|FG002|COMPLETED|Overall Study||100
6544778|NCT01692782|7466537|FG000|NOT COMPLETED|Overall Study||20
6544779|NCT01692782|7466538|FG001|NOT COMPLETED|Overall Study||56
6544780|NCT01692782|7466539|FG002|NOT COMPLETED|Overall Study||10
6544781|NCT01692938|7466549|FG000|STARTED|Overall Study||16
6544782|NCT01692938|7466550|FG001|STARTED|Overall Study||16
6544783|NCT01692938|7466549|FG000|COMPLETED|Overall Study||12
6544784|NCT01692938|7466550|FG001|COMPLETED|Overall Study||12
6544785|NCT01692938|7466549|FG000|NOT COMPLETED|Overall Study||4
6544786|NCT01692938|7466550|FG001|NOT COMPLETED|Overall Study||4
6544787|NCT01692951|7466560|FG000|STARTED|Overall Study||37
6544788|NCT01692951|7466561|FG001|STARTED|Overall Study||111
6544789|NCT01692951|7466562|FG002|STARTED|Overall Study||18
6544790|NCT01692951|7466563|FG003|STARTED|Overall Study||54
6544791|NCT01692951|7466560|FG000|COMPLETED|Overall Study||37
6544792|NCT01692951|7466561|FG001|COMPLETED|Overall Study||111
6544793|NCT01692951|7466562|FG002|COMPLETED|Overall Study||18
6544794|NCT01692951|7466563|FG003|COMPLETED|Overall Study||54
6544795|NCT01692951|7466560|FG000|NOT COMPLETED|Overall Study||0
6544796|NCT01692951|7466561|FG001|NOT COMPLETED|Overall Study||0
6544797|NCT01692951|7466562|FG002|NOT COMPLETED|Overall Study||0
6544798|NCT01692951|7466563|FG003|NOT COMPLETED|Overall Study||0
6544799|NCT01692964|7466573|FG000|STARTED|Overall Study||237
6544800|NCT01692964|7466573|FG000|COMPLETED|Overall Study||237
6544801|NCT01692964|7466573|FG000|NOT COMPLETED|Overall Study||0
6544802|NCT01693029|7466580|FG000|STARTED|Overall Study||217
6544803|NCT01693029|7466581|FG001|STARTED|Overall Study||218
6544804|NCT01693029|7466580|FG000|COMPLETED|Overall Study||173
6544805|NCT01693029|7466581|FG001|COMPLETED|Overall Study||161
6544806|NCT01693029|7466580|FG000|NOT COMPLETED|Overall Study||44
6544807|NCT01693029|7466581|FG001|NOT COMPLETED|Overall Study||57
6544808|NCT01693068|7466589|FG000|STARTED|Randomization Period||64
6544809|NCT01693068|7466590|FG001|STARTED|Randomization Period||130
6544810|NCT01693068|7466591|FG002|STARTED|Randomization Period||0
6544811|NCT01693068|7466589|FG000|Treated|Randomization Period||61
6544812|NCT01693068|7466590|FG001|Treated|Randomization Period||130
6544813|NCT01693068|7466591|FG002|Treated|Randomization Period||0
6544814|NCT01693068|7466589|FG000|COMPLETED|Randomization Period||62
6544815|NCT01693068|7466590|FG001|COMPLETED|Randomization Period||125
6544816|NCT01693068|7466591|FG002|COMPLETED|Randomization Period||0
6544817|NCT01693068|7466589|FG000|NOT COMPLETED|Randomization Period||2
6544818|NCT01693068|7466590|FG001|NOT COMPLETED|Randomization Period||5
6544819|NCT01693068|7466591|FG002|NOT COMPLETED|Randomization Period||0
6544820|NCT01693068|7466589|FG000|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
6544821|NCT01693068|7466590|FG001|STARTED|Cross-over (Dacarbazine To Pimasertib)||0
6544822|NCT01693068|7466591|FG002|STARTED|Cross-over (Dacarbazine To Pimasertib)||41
6544823|NCT01693068|7466589|FG000|Treated|Cross-over (Dacarbazine To Pimasertib)||0
6544824|NCT01693068|7466590|FG001|Treated|Cross-over (Dacarbazine To Pimasertib)||0
6544825|NCT01693068|7466591|FG002|Treated|Cross-over (Dacarbazine To Pimasertib)||41
6544826|NCT01693068|7466589|FG000|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
6544827|NCT01693068|7466590|FG001|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
6544828|NCT01693068|7466591|FG002|COMPLETED|Cross-over (Dacarbazine To Pimasertib)||40
6544829|NCT01693068|7466589|FG000|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
6544830|NCT01693068|7466590|FG001|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||0
6544831|NCT01693068|7466591|FG002|NOT COMPLETED|Cross-over (Dacarbazine To Pimasertib)||1
6544832|NCT01693120|7466599|FG000|STARTED|Enrollment|70 subjects exited the study after consent, but prior to undergoing a study ablation procedure.|199
6544833|NCT01693120|7466599|FG000|COMPLETED|Enrollment|129 of the 199 enrolled subjects underwent a Phased RF study procedure|129
6544834|NCT01693120|7466599|FG000|NOT COMPLETED|Enrollment||70
6544835|NCT01693120|7466599|FG000|STARTED|Phased RF Study Procedure and Follow-up||129
6544836|NCT01693120|7466599|FG000|COMPLETED|Phased RF Study Procedure and Follow-up|112 of the 129 subjects with a Phased RF procedure completed the 6-month follow-up visit|112
6544837|NCT01693120|7466599|FG000|NOT COMPLETED|Phased RF Study Procedure and Follow-up||17
6544838|NCT01693185|7466605|FG000|STARTED|Overall Study||27
6544839|NCT01693185|7466606|FG001|STARTED|Overall Study||33
6544840|NCT01693185|7466605|FG000|COMPLETED|Overall Study||27
6544841|NCT01693185|7466606|FG001|COMPLETED|Overall Study||27
6544842|NCT01693185|7466605|FG000|NOT COMPLETED|Overall Study||0
6544843|NCT01693185|7466606|FG001|NOT COMPLETED|Overall Study||6
6544844|NCT01693250|7466614|FG000|STARTED|Overall Study|3 months post baseline assessment|23
6544845|NCT01693250|7466615|FG001|STARTED|Overall Study|three month post baseline assessment|17
6544846|NCT01693250|7466614|FG000|COMPLETED|Overall Study|21 teens completed 6 months post baseline assessment|21
6544847|NCT01693250|7466615|FG001|COMPLETED|Overall Study|15 teens completed 6 months post baseline assessment|15
6544848|NCT01693250|7466614|FG000|NOT COMPLETED|Overall Study||2
6544849|NCT01693250|7466615|FG001|NOT COMPLETED|Overall Study||2
6544850|NCT01693523|7466626|FG000|STARTED|Overall Study||23
6544851|NCT01693523|7466627|FG001|STARTED|Overall Study||21
6544852|NCT01693523|7466628|FG002|STARTED|Overall Study||35
6544853|NCT01693523|7466626|FG000|COMPLETED|Overall Study||18
6544854|NCT01693523|7466627|FG001|COMPLETED|Overall Study||13
6544855|NCT01693523|7466628|FG002|COMPLETED|Overall Study||27
6544856|NCT01693523|7466626|FG000|NOT COMPLETED|Overall Study||5
6544857|NCT01693523|7466627|FG001|NOT COMPLETED|Overall Study||8
6544858|NCT01693523|7466628|FG002|NOT COMPLETED|Overall Study||8
6544859|NCT01693562|7466658|FG000|STARTED|Escalation Phase||4
6544860|NCT01693562|7466659|FG001|STARTED|Escalation Phase||4
6544861|NCT01693562|7466660|FG002|STARTED|Escalation Phase||3
6544862|NCT01693562|7466661|FG003|STARTED|Escalation Phase||3
6544863|NCT01693562|7466662|FG004|STARTED|Escalation Phase||6
6544864|NCT01693562|7466663|FG005|STARTED|Escalation Phase||7
6544865|NCT01693562|7466664|FG006|STARTED|Escalation Phase||0
6544866|NCT01693562|7466665|FG007|STARTED|Escalation Phase||0
6544867|NCT01693562|7466666|FG008|STARTED|Escalation Phase||0
6544868|NCT01693562|7466667|FG009|STARTED|Escalation Phase||0
6544869|NCT01693562|7466668|FG010|STARTED|Escalation Phase||0
6544870|NCT01693562|7466669|FG011|STARTED|Escalation Phase||0
6544871|NCT01693562|7466670|FG012|STARTED|Escalation Phase||0
6544872|NCT01693562|7466671|FG013|STARTED|Escalation Phase||0
6544873|NCT01693562|7466672|FG014|STARTED|Escalation Phase||0
6544874|NCT01693562|7466673|FG015|STARTED|Escalation Phase||0
6544875|NCT01693562|7466674|FG016|STARTED|Escalation Phase||0
6544876|NCT01693562|7466675|FG017|STARTED|Escalation Phase||0
6544877|NCT01693562|7466676|FG018|STARTED|Escalation Phase||0
6544878|NCT01693562|7466677|FG019|STARTED|Escalation Phase||0
6544879|NCT01693562|7466678|FG020|STARTED|Escalation Phase||0
6544880|NCT01693562|7466679|FG021|STARTED|Escalation Phase||0
6544881|NCT01693562|7466680|FG022|STARTED|Escalation Phase||0
6544882|NCT01693562|7466658|FG000|COMPLETED|Escalation Phase||0
6544883|NCT01693562|7466659|FG001|COMPLETED|Escalation Phase||0
6544884|NCT01693562|7466660|FG002|COMPLETED|Escalation Phase||0
6544885|NCT01693562|7466661|FG003|COMPLETED|Escalation Phase||0
6544886|NCT01693562|7466662|FG004|COMPLETED|Escalation Phase||0
6544887|NCT01693562|7466663|FG005|COMPLETED|Escalation Phase||0
6544888|NCT01693562|7466664|FG006|COMPLETED|Escalation Phase||0
6544889|NCT01693562|7466665|FG007|COMPLETED|Escalation Phase||0
6544890|NCT01693562|7466666|FG008|COMPLETED|Escalation Phase||0
6544891|NCT01693562|7466667|FG009|COMPLETED|Escalation Phase||0
6544892|NCT01693562|7466668|FG010|COMPLETED|Escalation Phase||0
6544893|NCT01693562|7466669|FG011|COMPLETED|Escalation Phase||0
6544894|NCT01693562|7466670|FG012|COMPLETED|Escalation Phase||0
6544895|NCT01693562|7466671|FG013|COMPLETED|Escalation Phase||0
6544896|NCT01693562|7466672|FG014|COMPLETED|Escalation Phase||0
6544897|NCT01693562|7466673|FG015|COMPLETED|Escalation Phase||0
6544898|NCT01693562|7466674|FG016|COMPLETED|Escalation Phase||0
6544899|NCT01693562|7466675|FG017|COMPLETED|Escalation Phase||0
6544900|NCT01693562|7466676|FG018|COMPLETED|Escalation Phase||0
6544901|NCT01693562|7466677|FG019|COMPLETED|Escalation Phase||0
6544902|NCT01693562|7466678|FG020|COMPLETED|Escalation Phase||0
6544903|NCT01693562|7466679|FG021|COMPLETED|Escalation Phase||0
6544904|NCT01693562|7466680|FG022|COMPLETED|Escalation Phase||0
6544905|NCT01693562|7466658|FG000|NOT COMPLETED|Escalation Phase||4
6544906|NCT01693562|7466659|FG001|NOT COMPLETED|Escalation Phase||4
6544907|NCT01693562|7466660|FG002|NOT COMPLETED|Escalation Phase||3
6544908|NCT01693562|7466661|FG003|NOT COMPLETED|Escalation Phase||3
6544909|NCT01693562|7466662|FG004|NOT COMPLETED|Escalation Phase||6
6544910|NCT01693562|7466663|FG005|NOT COMPLETED|Escalation Phase||7
6544911|NCT01693562|7466664|FG006|NOT COMPLETED|Escalation Phase||0
6544912|NCT01693562|7466665|FG007|NOT COMPLETED|Escalation Phase||0
6544913|NCT01693562|7466666|FG008|NOT COMPLETED|Escalation Phase||0
6544914|NCT01693562|7466667|FG009|NOT COMPLETED|Escalation Phase||0
6544915|NCT01693562|7466668|FG010|NOT COMPLETED|Escalation Phase||0
6544916|NCT01693562|7466669|FG011|NOT COMPLETED|Escalation Phase||0
6544917|NCT01693562|7466670|FG012|NOT COMPLETED|Escalation Phase||0
6544918|NCT01693562|7466671|FG013|NOT COMPLETED|Escalation Phase||0
6544919|NCT01693562|7466672|FG014|NOT COMPLETED|Escalation Phase||0
6544920|NCT01693562|7466673|FG015|NOT COMPLETED|Escalation Phase||0
6544921|NCT01693562|7466674|FG016|NOT COMPLETED|Escalation Phase||0
6544922|NCT01693562|7466675|FG017|NOT COMPLETED|Escalation Phase||0
6544923|NCT01693562|7466676|FG018|NOT COMPLETED|Escalation Phase||0
6544924|NCT01693562|7466677|FG019|NOT COMPLETED|Escalation Phase||0
6544925|NCT01693562|7466678|FG020|NOT COMPLETED|Escalation Phase||0
6544926|NCT01693562|7466679|FG021|NOT COMPLETED|Escalation Phase||0
6544927|NCT01693562|7466680|FG022|NOT COMPLETED|Escalation Phase||0
6544928|NCT01693562|7466658|FG000|STARTED|Exploration Phase||0
6544929|NCT01693562|7466659|FG001|STARTED|Exploration Phase||0
6544930|NCT01693562|7466660|FG002|STARTED|Exploration Phase||0
6544931|NCT01693562|7466661|FG003|STARTED|Exploration Phase||0
6544932|NCT01693562|7466662|FG004|STARTED|Exploration Phase||0
6544933|NCT01693562|7466663|FG005|STARTED|Exploration Phase||0
6544934|NCT01693562|7466664|FG006|STARTED|Exploration Phase||21
6544935|NCT01693562|7466665|FG007|STARTED|Exploration Phase||0
6544936|NCT01693562|7466666|FG008|STARTED|Exploration Phase||0
6544937|NCT01693562|7466667|FG009|STARTED|Exploration Phase||0
6544938|NCT01693562|7466668|FG010|STARTED|Exploration Phase||0
6544939|NCT01693562|7466669|FG011|STARTED|Exploration Phase||0
6544940|NCT01693562|7466670|FG012|STARTED|Exploration Phase||0
6544941|NCT01693562|7466671|FG013|STARTED|Exploration Phase||0
6544942|NCT01693562|7466672|FG014|STARTED|Exploration Phase||0
6544943|NCT01693562|7466673|FG015|STARTED|Exploration Phase||0
6544944|NCT01693562|7466674|FG016|STARTED|Exploration Phase||0
6544945|NCT01693562|7466675|FG017|STARTED|Exploration Phase||0
6544946|NCT01693562|7466676|FG018|STARTED|Exploration Phase||0
6544947|NCT01693562|7466677|FG019|STARTED|Exploration Phase||0
6544948|NCT01693562|7466678|FG020|STARTED|Exploration Phase||0
6544949|NCT01693562|7466679|FG021|STARTED|Exploration Phase||0
6544950|NCT01693562|7466680|FG022|STARTED|Exploration Phase||0
6544951|NCT01693562|7466658|FG000|COMPLETED|Exploration Phase||0
6544952|NCT01693562|7466659|FG001|COMPLETED|Exploration Phase||0
6544953|NCT01693562|7466660|FG002|COMPLETED|Exploration Phase||0
6544954|NCT01693562|7466661|FG003|COMPLETED|Exploration Phase||0
6544955|NCT01693562|7466662|FG004|COMPLETED|Exploration Phase||0
6544956|NCT01693562|7466663|FG005|COMPLETED|Exploration Phase||0
6544957|NCT01693562|7466664|FG006|COMPLETED|Exploration Phase||0
6544958|NCT01693562|7466665|FG007|COMPLETED|Exploration Phase||0
6544959|NCT01693562|7466666|FG008|COMPLETED|Exploration Phase||0
6544960|NCT01693562|7466667|FG009|COMPLETED|Exploration Phase||0
6544961|NCT01693562|7466668|FG010|COMPLETED|Exploration Phase||0
6544962|NCT01693562|7466669|FG011|COMPLETED|Exploration Phase||0
6544963|NCT01693562|7466670|FG012|COMPLETED|Exploration Phase||0
6544964|NCT01693562|7466671|FG013|COMPLETED|Exploration Phase||0
6544965|NCT01693562|7466672|FG014|COMPLETED|Exploration Phase||0
6544966|NCT01693562|7466673|FG015|COMPLETED|Exploration Phase||0
6544967|NCT01693562|7466674|FG016|COMPLETED|Exploration Phase||0
6544968|NCT01693562|7466675|FG017|COMPLETED|Exploration Phase||0
6544969|NCT01693562|7466676|FG018|COMPLETED|Exploration Phase||0
6544970|NCT01693562|7466677|FG019|COMPLETED|Exploration Phase||0
6544971|NCT01693562|7466678|FG020|COMPLETED|Exploration Phase||0
6544972|NCT01693562|7466679|FG021|COMPLETED|Exploration Phase||0
6544973|NCT01693562|7466680|FG022|COMPLETED|Exploration Phase||0
6544974|NCT01693562|7466658|FG000|NOT COMPLETED|Exploration Phase||0
6544975|NCT01693562|7466659|FG001|NOT COMPLETED|Exploration Phase||0
6544976|NCT01693562|7466660|FG002|NOT COMPLETED|Exploration Phase||0
6544977|NCT01693562|7466661|FG003|NOT COMPLETED|Exploration Phase||0
6544978|NCT01693562|7466662|FG004|NOT COMPLETED|Exploration Phase||0
6544979|NCT01693562|7466663|FG005|NOT COMPLETED|Exploration Phase||0
6544980|NCT01693562|7466664|FG006|NOT COMPLETED|Exploration Phase||21
6544981|NCT01693562|7466665|FG007|NOT COMPLETED|Exploration Phase||0
6544982|NCT01693562|7466666|FG008|NOT COMPLETED|Exploration Phase||0
6544983|NCT01693562|7466667|FG009|NOT COMPLETED|Exploration Phase||0
6544984|NCT01693562|7466668|FG010|NOT COMPLETED|Exploration Phase||0
6544985|NCT01693562|7466669|FG011|NOT COMPLETED|Exploration Phase||0
6544986|NCT01693562|7466670|FG012|NOT COMPLETED|Exploration Phase||0
6544987|NCT01693562|7466671|FG013|NOT COMPLETED|Exploration Phase||0
6544988|NCT01693562|7466672|FG014|NOT COMPLETED|Exploration Phase||0
6544989|NCT01693562|7466673|FG015|NOT COMPLETED|Exploration Phase||0
6544990|NCT01693562|7466674|FG016|NOT COMPLETED|Exploration Phase||0
6544991|NCT01693562|7466675|FG017|NOT COMPLETED|Exploration Phase||0
6544992|NCT01693562|7466676|FG018|NOT COMPLETED|Exploration Phase||0
6544993|NCT01693562|7466677|FG019|NOT COMPLETED|Exploration Phase||0
6544994|NCT01693562|7466678|FG020|NOT COMPLETED|Exploration Phase||0
6544995|NCT01693562|7466679|FG021|NOT COMPLETED|Exploration Phase||0
6544996|NCT01693562|7466680|FG022|NOT COMPLETED|Exploration Phase||0
6544997|NCT01693562|7466658|FG000|STARTED|Expansion Phase||0
6544998|NCT01693562|7466659|FG001|STARTED|Expansion Phase||0
6544999|NCT01693562|7466660|FG002|STARTED|Expansion Phase||0
6545000|NCT01693562|7466661|FG003|STARTED|Expansion Phase||0
6545001|NCT01693562|7466662|FG004|STARTED|Expansion Phase||0
6545002|NCT01693562|7466663|FG005|STARTED|Expansion Phase||0
6545003|NCT01693562|7466664|FG006|STARTED|Expansion Phase||0
6545004|NCT01693562|7466665|FG007|STARTED|Expansion Phase||62
6545005|NCT01693562|7466666|FG008|STARTED|Expansion Phase||22
6545006|NCT01693562|7466667|FG009|STARTED|Expansion Phase|2 eligible NSCLC participants from dose-escalation were added to the dose expansion summaries.|304
6545007|NCT01693562|7466668|FG010|STARTED|Expansion Phase||40
6545008|NCT01693562|7466669|FG011|STARTED|Expansion Phase||21
6545009|NCT01693562|7466670|FG012|STARTED|Expansion Phase||24
6545010|NCT01693562|7466671|FG013|STARTED|Expansion Phase||51
6545011|NCT01693562|7466672|FG014|STARTED|Expansion Phase||40
6545012|NCT01693562|7466673|FG015|STARTED|Expansion Phase||31
6545013|NCT01693562|7466674|FG016|STARTED|Expansion Phase||201
6545014|NCT01693562|7466675|FG017|STARTED|Expansion Phase||20
6545015|NCT01693562|7466676|FG018|STARTED|Expansion Phase||47
6545016|NCT01693562|7466677|FG019|STARTED|Expansion Phase||20
6545017|NCT01693562|7466678|FG020|STARTED|Expansion Phase||21
6545018|NCT01693562|7466679|FG021|STARTED|Expansion Phase||62
6545019|NCT01693562|7466680|FG022|STARTED|Expansion Phase||10
6545020|NCT01693562|7466658|FG000|COMPLETED|Expansion Phase||0
6545021|NCT01693562|7466659|FG001|COMPLETED|Expansion Phase||0
6545022|NCT01693562|7466660|FG002|COMPLETED|Expansion Phase||0
6545023|NCT01693562|7466661|FG003|COMPLETED|Expansion Phase||0
6545024|NCT01693562|7466662|FG004|COMPLETED|Expansion Phase||0
6545025|NCT01693562|7466663|FG005|COMPLETED|Expansion Phase||0
6545026|NCT01693562|7466664|FG006|COMPLETED|Expansion Phase||0
6545027|NCT01693562|7466665|FG007|COMPLETED|Expansion Phase||0
6545028|NCT01693562|7466666|FG008|COMPLETED|Expansion Phase||0
6545029|NCT01693562|7466667|FG009|COMPLETED|Expansion Phase||4
6545030|NCT01693562|7466668|FG010|COMPLETED|Expansion Phase||0
6545031|NCT01693562|7466669|FG011|COMPLETED|Expansion Phase||0
6545032|NCT01693562|7466670|FG012|COMPLETED|Expansion Phase||1
6545033|NCT01693562|7466671|FG013|COMPLETED|Expansion Phase||0
6545034|NCT01693562|7466672|FG014|COMPLETED|Expansion Phase||0
6545035|NCT01693562|7466673|FG015|COMPLETED|Expansion Phase||0
6545036|NCT01693562|7466674|FG016|COMPLETED|Expansion Phase||4
6545037|NCT01693562|7466675|FG017|COMPLETED|Expansion Phase||0
6545038|NCT01693562|7466676|FG018|COMPLETED|Expansion Phase||0
6545039|NCT01693562|7466677|FG019|COMPLETED|Expansion Phase||0
6545040|NCT01693562|7466678|FG020|COMPLETED|Expansion Phase||0
6545041|NCT01693562|7466679|FG021|COMPLETED|Expansion Phase||0
6545042|NCT01693562|7466680|FG022|COMPLETED|Expansion Phase||0
6545043|NCT01693562|7466658|FG000|NOT COMPLETED|Expansion Phase||0
6545044|NCT01693562|7466659|FG001|NOT COMPLETED|Expansion Phase||0
6545045|NCT01693562|7466660|FG002|NOT COMPLETED|Expansion Phase||0
6545046|NCT01693562|7466661|FG003|NOT COMPLETED|Expansion Phase||0
6545047|NCT01693562|7466662|FG004|NOT COMPLETED|Expansion Phase||0
6545048|NCT01693562|7466663|FG005|NOT COMPLETED|Expansion Phase||0
6545049|NCT01693562|7466664|FG006|NOT COMPLETED|Expansion Phase||0
6545050|NCT01693562|7466665|FG007|NOT COMPLETED|Expansion Phase||62
6545051|NCT01693562|7466666|FG008|NOT COMPLETED|Expansion Phase||22
6545052|NCT01693562|7466667|FG009|NOT COMPLETED|Expansion Phase||300
6545053|NCT01693562|7466668|FG010|NOT COMPLETED|Expansion Phase||40
6545054|NCT01693562|7466669|FG011|NOT COMPLETED|Expansion Phase||21
6545055|NCT01693562|7466670|FG012|NOT COMPLETED|Expansion Phase||23
6545056|NCT01693562|7466671|FG013|NOT COMPLETED|Expansion Phase||51
6545057|NCT01693562|7466672|FG014|NOT COMPLETED|Expansion Phase||40
6545058|NCT01693562|7466673|FG015|NOT COMPLETED|Expansion Phase||31
6545059|NCT01693562|7466674|FG016|NOT COMPLETED|Expansion Phase||197
6545060|NCT01693562|7466675|FG017|NOT COMPLETED|Expansion Phase||20
6545061|NCT01693562|7466676|FG018|NOT COMPLETED|Expansion Phase||47
6545062|NCT01693562|7466677|FG019|NOT COMPLETED|Expansion Phase||20
6545063|NCT01693562|7466678|FG020|NOT COMPLETED|Expansion Phase||21
6545064|NCT01693562|7466679|FG021|NOT COMPLETED|Expansion Phase||62
6545065|NCT01693562|7466680|FG022|NOT COMPLETED|Expansion Phase||10
6545066|NCT01693614|7466766|FG000|STARTED|Overall Study||26
6545067|NCT01693614|7466767|FG001|STARTED|Overall Study||22
6545068|NCT01693614|7466768|FG002|STARTED|Overall Study||24
6545069|NCT01693614|7466766|FG000|COMPLETED|Overall Study||0
6545070|NCT01693614|7466767|FG001|COMPLETED|Overall Study||0
6545071|NCT01693614|7466768|FG002|COMPLETED|Overall Study||0
6545072|NCT01693614|7466766|FG000|NOT COMPLETED|Overall Study||26
6545073|NCT01693614|7466767|FG001|NOT COMPLETED|Overall Study||22
6545074|NCT01693614|7466768|FG002|NOT COMPLETED|Overall Study||24
6545075|NCT01693900|7466779|FG000|STARTED|Overall Study||25
6545076|NCT01693900|7466780|FG001|STARTED|Overall Study||25
6545077|NCT01693900|7466779|FG000|COMPLETED|Overall Study||25
6545078|NCT01693900|7466780|FG001|COMPLETED|Overall Study||25
6545079|NCT01693900|7466779|FG000|NOT COMPLETED|Overall Study||0
6545080|NCT01693900|7466780|FG001|NOT COMPLETED|Overall Study||0
6545081|NCT01694108|7466788|FG000|STARTED|Overall Study||2129
6545082|NCT01694108|7466789|FG001|STARTED|Overall Study||2133
6545083|NCT01694108|7466788|FG000|COMPLETED|Overall Study|100% follow-up|2129
6545084|NCT01694108|7466789|FG001|COMPLETED|Overall Study|100% follow-up|2133
6545085|NCT01694108|7466788|FG000|NOT COMPLETED|Overall Study||0
6545086|NCT01694108|7466789|FG001|NOT COMPLETED|Overall Study||0
6545087|NCT01694121|7466804|FG000|STARTED|Overall Study||228
6545088|NCT01694121|7466805|FG001|STARTED|Overall Study||227
6545089|NCT01694121|7466804|FG000|COMPLETED|Overall Study||227
6545090|NCT01694121|7466805|FG001|COMPLETED|Overall Study||227
6545091|NCT01694121|7466804|FG000|NOT COMPLETED|Overall Study||1
6545092|NCT01694121|7466805|FG001|NOT COMPLETED|Overall Study||0
6545093|NCT01694186|7466813|FG000|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|42
6545094|NCT01694186|7466814|FG001|STARTED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|87
6545095|NCT01694186|7466813|FG000|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|36
6545096|NCT01694186|7466814|FG001|COMPLETED|Overall Study|Two investigators each site Investigator 1 unmasked treating and investigator 2 masked follow up.|80
6545097|NCT01694186|7466813|FG000|NOT COMPLETED|Overall Study||6
6545098|NCT01694186|7466814|FG001|NOT COMPLETED|Overall Study||7
6545099|NCT01694199|7466822|FG000|STARTED|Overall Study||71
6545100|NCT01694199|7466823|FG001|STARTED|Overall Study||68
6545101|NCT01694199|7466822|FG000|COMPLETED|Overall Study||71
6545102|NCT01694199|7466823|FG001|COMPLETED|Overall Study||68
6545103|NCT01694199|7466822|FG000|NOT COMPLETED|Overall Study||0
6545104|NCT01694199|7466823|FG001|NOT COMPLETED|Overall Study||0
6545105|NCT01694420|7466829|FG000|STARTED|Overall Study||33
6545106|NCT01694420|7466829|FG000|COMPLETED|Overall Study||30
6545107|NCT01694420|7466829|FG000|NOT COMPLETED|Overall Study||3
6545108|NCT01694433|7466835|FG000|STARTED|Overall Study||33
6545109|NCT01694433|7466836|FG001|STARTED|Overall Study||33
6545110|NCT01694433|7466835|FG000|Baseline Visit|Overall Study||33
6545111|NCT01694433|7466836|FG001|Baseline Visit|Overall Study||32
6545112|NCT01694433|7466835|FG000|COMPLETED|Overall Study||22
6545113|NCT01694433|7466836|FG001|COMPLETED|Overall Study||29
6545114|NCT01694433|7466835|FG000|NOT COMPLETED|Overall Study||11
6545115|NCT01694433|7466836|FG001|NOT COMPLETED|Overall Study||4
6545116|NCT01694485|7466847|FG000|STARTED|Overall Study||117
6545117|NCT01694485|7466848|FG001|STARTED|Overall Study||22
6545118|NCT01694485|7466849|FG002|STARTED|Overall Study||40
6545119|NCT01694485|7466850|FG003|STARTED|Overall Study||100
6545120|NCT01694485|7466851|FG004|STARTED|Overall Study||80
6545121|NCT01694485|7466847|FG000|Received Treatment|Overall Study||116
6545122|NCT01694485|7466848|FG001|Received Treatment|Overall Study||21
6545123|NCT01694485|7466849|FG002|Received Treatment|Overall Study||40
6545124|NCT01694485|7466850|FG003|Received Treatment|Overall Study||98
6545125|NCT01694485|7466851|FG004|Received Treatment|Overall Study||79
6545126|NCT01694485|7466847|FG000|Completed Week 8 Assessment|Overall Study||106
6545127|NCT01694485|7466848|FG001|Completed Week 8 Assessment|Overall Study||18
6545128|NCT01694485|7466849|FG002|Completed Week 8 Assessment|Overall Study||38
6545129|NCT01694485|7466850|FG003|Completed Week 8 Assessment|Overall Study||94
6545130|NCT01694485|7466851|FG004|Completed Week 8 Assessment|Overall Study||76
6545131|NCT01694485|7466847|FG000|Entered Open-label Period|Overall Study||100
6545132|NCT01694485|7466848|FG001|Entered Open-label Period|Overall Study||19
6545133|NCT01694485|7466849|FG002|Entered Open-label Period|Overall Study||36
6545134|NCT01694485|7466850|FG003|Entered Open-label Period|Overall Study||88
6545135|NCT01694485|7466851|FG004|Entered Open-label Period|Overall Study||68
6545136|NCT01694485|7466847|FG000|COMPLETED|Overall Study||84
6545137|NCT01694485|7466848|FG001|COMPLETED|Overall Study||15
6545138|NCT01694485|7466849|FG002|COMPLETED|Overall Study||27
6545139|NCT01694485|7466850|FG003|COMPLETED|Overall Study||62
6545140|NCT01694485|7466851|FG004|COMPLETED|Overall Study||55
6545141|NCT01694485|7466847|FG000|NOT COMPLETED|Overall Study||33
6545142|NCT01694485|7466848|FG001|NOT COMPLETED|Overall Study||7
6545143|NCT01694485|7466849|FG002|NOT COMPLETED|Overall Study||13
6545144|NCT01694485|7466850|FG003|NOT COMPLETED|Overall Study||38
6545145|NCT01694485|7466851|FG004|NOT COMPLETED|Overall Study||25
6545146|NCT01694563|7466868|FG000|STARTED|Overall Study||365
6545147|NCT01694563|7466868|FG000|COMPLETED|Overall Study||278
6545148|NCT01694563|7466868|FG000|NOT COMPLETED|Overall Study||87
6545149|NCT01694641|7466877|FG000|STARTED|Overall Study||80
6545150|NCT01694641|7466878|FG001|STARTED|Overall Study||81
6545151|NCT01694641|7466877|FG000|COMPLETED|Overall Study||68
6545152|NCT01694641|7466878|FG001|COMPLETED|Overall Study||71
6545153|NCT01694641|7466877|FG000|NOT COMPLETED|Overall Study||12
6545154|NCT01694641|7466878|FG001|NOT COMPLETED|Overall Study||10
6545155|NCT01694667|7466887|FG000|STARTED|Overall Study||29
6545156|NCT01694667|7466888|FG001|STARTED|Overall Study||28
6545157|NCT01694667|7466887|FG000|COMPLETED|Overall Study||29
6545158|NCT01694667|7466888|FG001|COMPLETED|Overall Study||28
6545159|NCT01694667|7466887|FG000|NOT COMPLETED|Overall Study||0
6545160|NCT01694667|7466888|FG001|NOT COMPLETED|Overall Study||0
6545161|NCT01694706|7466894|FG000|STARTED|Overall Study||5
6545162|NCT01694706|7466895|FG001|STARTED|Overall Study||5
6545163|NCT01694706|7466896|FG002|STARTED|Overall Study||5
6545164|NCT01694706|7466894|FG000|Received Faldaprevir|Overall Study||5
6545165|NCT01694706|7466895|FG001|Received Faldaprevir|Overall Study||5
6545166|NCT01694706|7466896|FG002|Received Faldaprevir|Overall Study||5
6545167|NCT01694706|7466894|FG000|Received Faldaprevir +OMP|Overall Study||5
6545168|NCT01694706|7466895|FG001|Received Faldaprevir +OMP|Overall Study||5
6545169|NCT01694706|7466896|FG002|Received Faldaprevir +OMP|Overall Study||5
6545170|NCT01694706|7466894|FG000|Received Faldaprevir Fed|Overall Study||4
6545171|NCT01694706|7466895|FG001|Received Faldaprevir Fed|Overall Study||5
6545172|NCT01694706|7466896|FG002|Received Faldaprevir Fed|Overall Study||5
6545173|NCT01694706|7466894|FG000|COMPLETED|Overall Study||4
6545174|NCT01694706|7466895|FG001|COMPLETED|Overall Study||4
6545175|NCT01694706|7466896|FG002|COMPLETED|Overall Study||5
6545176|NCT01694706|7466894|FG000|NOT COMPLETED|Overall Study||1
6545177|NCT01694706|7466895|FG001|NOT COMPLETED|Overall Study||1
6545178|NCT01694706|7466896|FG002|NOT COMPLETED|Overall Study||0
6545179|NCT01694771|7466907|FG000|STARTED|Overall Study||567
6545180|NCT01694771|7466908|FG001|STARTED|Overall Study||565
6545181|NCT01694771|7466907|FG000|COMPLETED|Overall Study||527
6545182|NCT01694771|7466908|FG001|COMPLETED|Overall Study||525
6545183|NCT01694771|7466907|FG000|NOT COMPLETED|Overall Study||40
6545184|NCT01694771|7466908|FG001|NOT COMPLETED|Overall Study||40
6545185|NCT01694966|7466917|FG000|STARTED|Overall Study||504
6545186|NCT01694966|7466918|FG001|STARTED|Overall Study||247
6545187|NCT01694966|7466919|FG002|STARTED|Overall Study||498
6545188|NCT01694966|7466917|FG000|COMPLETED|Overall Study||470
6545189|NCT01694966|7466918|FG001|COMPLETED|Overall Study||232
6545190|NCT01694966|7466919|FG002|COMPLETED|Overall Study||464
6545191|NCT01694966|7466917|FG000|NOT COMPLETED|Overall Study||34
6545192|NCT01694966|7466918|FG001|NOT COMPLETED|Overall Study||15
6545193|NCT01694966|7466919|FG002|NOT COMPLETED|Overall Study||34
6545194|NCT01695044|7466929|FG000|STARTED|Overall Study||119
6545195|NCT01695044|7466929|FG000|COMPLETED|Overall Study||17
6545196|NCT01695044|7466929|FG000|NOT COMPLETED|Overall Study||102
6545197|NCT01695135|7466939|FG000|STARTED|Double-blind Treatment Phase||71
6545198|NCT01695135|7466940|FG001|STARTED|Double-blind Treatment Phase||143
6545199|NCT01695135|7466941|FG002|STARTED|Double-blind Treatment Phase||0
6545200|NCT01695135|7466942|FG003|STARTED|Double-blind Treatment Phase||0
6545201|NCT01695135|7466939|FG000|COMPLETED|Double-blind Treatment Phase||0
6545202|NCT01695135|7466940|FG001|COMPLETED|Double-blind Treatment Phase||4
6545203|NCT01695135|7466941|FG002|COMPLETED|Double-blind Treatment Phase||0
6545204|NCT01695135|7466942|FG003|COMPLETED|Double-blind Treatment Phase||0
6545205|NCT01695135|7466939|FG000|NOT COMPLETED|Double-blind Treatment Phase||71
6545206|NCT01695135|7466940|FG001|NOT COMPLETED|Double-blind Treatment Phase||139
6545207|NCT01695135|7466941|FG002|NOT COMPLETED|Double-blind Treatment Phase||0
6545208|NCT01695135|7466942|FG003|NOT COMPLETED|Double-blind Treatment Phase||0
6545209|NCT01695135|7466939|FG000|STARTED|Open Label Extension Treatment Phase||0
6545210|NCT01695135|7466940|FG001|STARTED|Open Label Extension Treatment Phase||0
6545211|NCT01695135|7466941|FG002|STARTED|Open Label Extension Treatment Phase||49
6545212|NCT01695135|7466942|FG003|STARTED|Open Label Extension Treatment Phase||80
6545213|NCT01695135|7466939|FG000|COMPLETED|Open Label Extension Treatment Phase||0
6545214|NCT01695135|7466940|FG001|COMPLETED|Open Label Extension Treatment Phase||0
6545215|NCT01695135|7466941|FG002|COMPLETED|Open Label Extension Treatment Phase||9
6545216|NCT01695135|7466942|FG003|COMPLETED|Open Label Extension Treatment Phase||10
6545217|NCT01695135|7466939|FG000|NOT COMPLETED|Open Label Extension Treatment Phase||0
6545218|NCT01695135|7466940|FG001|NOT COMPLETED|Open Label Extension Treatment Phase||0
6545219|NCT01695135|7466941|FG002|NOT COMPLETED|Open Label Extension Treatment Phase||40
6545220|NCT01695135|7466942|FG003|NOT COMPLETED|Open Label Extension Treatment Phase||70
6545221|NCT01695239|7466954|FG000|STARTED|Double-Blind (DB) Treatment Period||106
6545222|NCT01695239|7466955|FG001|STARTED|Double-Blind (DB) Treatment Period||101
6545223|NCT01695239|7466956|FG002|STARTED|Double-Blind (DB) Treatment Period||107
6545224|NCT01695239|7466957|FG003|STARTED|Double-Blind (DB) Treatment Period||103
6545225|NCT01695239|7466958|FG004|STARTED|Double-Blind (DB) Treatment Period||0
6545226|NCT01695239|7466959|FG005|STARTED|Double-Blind (DB) Treatment Period||0
6545227|NCT01695239|7466960|FG006|STARTED|Double-Blind (DB) Treatment Period||0
6545228|NCT01695239|7466961|FG007|STARTED|Double-Blind (DB) Treatment Period||0
6545229|NCT01695239|7466962|FG008|STARTED|Double-Blind (DB) Treatment Period||0
6545230|NCT01695239|7466963|FG009|STARTED|Double-Blind (DB) Treatment Period||0
6545231|NCT01695239|7466964|FG010|STARTED|Double-Blind (DB) Treatment Period||0
6545232|NCT01695239|7466965|FG011|STARTED|Double-Blind (DB) Treatment Period||0
6545233|NCT01695239|7466966|FG012|STARTED|Double-Blind (DB) Treatment Period||0
6545234|NCT01695239|7466967|FG013|STARTED|Double-Blind (DB) Treatment Period||0
6545235|NCT01695239|7466954|FG000|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||106
6545236|NCT01695239|7466955|FG001|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||101
6545237|NCT01695239|7466956|FG002|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||107
6545238|NCT01695239|7466957|FG003|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||102
6545239|NCT01695239|7466958|FG004|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545240|NCT01695239|7466959|FG005|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545241|NCT01695239|7466960|FG006|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545242|NCT01695239|7466961|FG007|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545243|NCT01695239|7466962|FG008|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545244|NCT01695239|7466963|FG009|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545245|NCT01695239|7466964|FG010|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545246|NCT01695239|7466965|FG011|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545247|NCT01695239|7466966|FG012|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545248|NCT01695239|7466967|FG013|Received at Least 1 Dose of Study Drug|Double-Blind (DB) Treatment Period||0
6545249|NCT01695239|7466954|FG000|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||27
6562505|NCT01801280|7485417|FG003|NOT COMPLETED|Period 3||0
6545250|NCT01695239|7466955|FG001|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||9
6545251|NCT01695239|7466956|FG002|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||11
6545252|NCT01695239|7466957|FG003|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||10
6545253|NCT01695239|7466958|FG004|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545254|NCT01695239|7466959|FG005|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545255|NCT01695239|7466960|FG006|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545256|NCT01695239|7466961|FG007|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545257|NCT01695239|7466962|FG008|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545258|NCT01695239|7466963|FG009|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545259|NCT01695239|7466964|FG010|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545260|NCT01695239|7466965|FG011|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545261|NCT01695239|7466966|FG012|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545262|NCT01695239|7466967|FG013|Classified as Inadequate Responder (IR)|Double-Blind (DB) Treatment Period||0
6545263|NCT01695239|7466954|FG000|COMPLETED|Double-Blind (DB) Treatment Period||91
6545264|NCT01695239|7466955|FG001|COMPLETED|Double-Blind (DB) Treatment Period||97
6545265|NCT01695239|7466956|FG002|COMPLETED|Double-Blind (DB) Treatment Period||97
6545266|NCT01695239|7466957|FG003|COMPLETED|Double-Blind (DB) Treatment Period||96
6545267|NCT01695239|7466958|FG004|COMPLETED|Double-Blind (DB) Treatment Period||0
6545268|NCT01695239|7466959|FG005|COMPLETED|Double-Blind (DB) Treatment Period||0
6545269|NCT01695239|7466960|FG006|COMPLETED|Double-Blind (DB) Treatment Period||0
6545270|NCT01695239|7466961|FG007|COMPLETED|Double-Blind (DB) Treatment Period||0
6545271|NCT01695239|7466962|FG008|COMPLETED|Double-Blind (DB) Treatment Period||0
6545272|NCT01695239|7466963|FG009|COMPLETED|Double-Blind (DB) Treatment Period||0
6545273|NCT01695239|7466964|FG010|COMPLETED|Double-Blind (DB) Treatment Period||0
6545274|NCT01695239|7466965|FG011|COMPLETED|Double-Blind (DB) Treatment Period||0
6545275|NCT01695239|7466966|FG012|COMPLETED|Double-Blind (DB) Treatment Period||0
6545276|NCT01695239|7466967|FG013|COMPLETED|Double-Blind (DB) Treatment Period||0
6545277|NCT01695239|7466954|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||15
6545278|NCT01695239|7466955|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||4
6545279|NCT01695239|7466956|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||10
6545280|NCT01695239|7466957|FG003|NOT COMPLETED|Double-Blind (DB) Treatment Period||7
6545281|NCT01695239|7466958|FG004|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545282|NCT01695239|7466959|FG005|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545283|NCT01695239|7466960|FG006|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545284|NCT01695239|7466961|FG007|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545285|NCT01695239|7466962|FG008|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545286|NCT01695239|7466963|FG009|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545287|NCT01695239|7466964|FG010|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545288|NCT01695239|7466965|FG011|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545289|NCT01695239|7466966|FG012|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545290|NCT01695239|7466967|FG013|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6545291|NCT01695239|7466954|FG000|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
6545292|NCT01695239|7466955|FG001|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
6545293|NCT01695239|7466956|FG002|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
6545294|NCT01695239|7466957|FG003|STARTED|IR Participants (Week 16 Up To Week 24)|Only inadequate responders were included.|0
6545295|NCT01695239|7466958|FG004|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ4W and IR from ixeQ4W.|24
6545296|NCT01695239|7466959|FG005|STARTED|IR Participants (Week 16 Up To Week 24)|IR from placebo who re-randomized to ixeQ2W and IR from ixeQ2W.|24
6545297|NCT01695239|7466960|FG006|STARTED|IR Participants (Week 16 Up To Week 24)|Adalimumab Q2W (IR) who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|9
6545298|NCT01695239|7466961|FG007|STARTED|IR Participants (Week 16 Up To Week 24)||0
6545299|NCT01695239|7466962|FG008|STARTED|IR Participants (Week 16 Up To Week 24)||0
6545300|NCT01695239|7466963|FG009|STARTED|IR Participants (Week 16 Up To Week 24)||0
6545301|NCT01695239|7466964|FG010|STARTED|IR Participants (Week 16 Up To Week 24)||0
6545302|NCT01695239|7466965|FG011|STARTED|IR Participants (Week 16 Up To Week 24)||0
6545303|NCT01695239|7466966|FG012|STARTED|IR Participants (Week 16 Up To Week 24)||0
6545304|NCT01695239|7466967|FG013|STARTED|IR Participants (Week 16 Up To Week 24)||0
6545305|NCT01695239|7466954|FG000|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545306|NCT01695239|7466955|FG001|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545307|NCT01695239|7466956|FG002|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545308|NCT01695239|7466957|FG003|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545309|NCT01695239|7466958|FG004|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
6545310|NCT01695239|7466959|FG005|COMPLETED|IR Participants (Week 16 Up To Week 24)||24
6545311|NCT01695239|7466960|FG006|COMPLETED|IR Participants (Week 16 Up To Week 24)||9
6545312|NCT01695239|7466961|FG007|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545313|NCT01695239|7466962|FG008|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6562506|NCT01801280|7485414|FG000|STARTED|Period 4||4
6743851|NCT03336853|7671903|FG000|STARTED|Overall Study||30
6743852|NCT03336853|7671904|FG001|STARTED|Overall Study||30
6743853|NCT03336853|7671903|FG000|COMPLETED|Overall Study||30
6545314|NCT01695239|7466963|FG009|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545315|NCT01695239|7466964|FG010|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545316|NCT01695239|7466965|FG011|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545317|NCT01695239|7466966|FG012|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545318|NCT01695239|7466967|FG013|COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545319|NCT01695239|7466954|FG000|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545320|NCT01695239|7466955|FG001|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545321|NCT01695239|7466956|FG002|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545322|NCT01695239|7466957|FG003|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545323|NCT01695239|7466958|FG004|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545324|NCT01695239|7466959|FG005|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545325|NCT01695239|7466960|FG006|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545326|NCT01695239|7466961|FG007|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545327|NCT01695239|7466962|FG008|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545328|NCT01695239|7466963|FG009|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545329|NCT01695239|7466964|FG010|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545330|NCT01695239|7466965|FG011|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545331|NCT01695239|7466966|FG012|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545332|NCT01695239|7466967|FG013|NOT COMPLETED|IR Participants (Week 16 Up To Week 24)||0
6545333|NCT01695239|7466954|FG000|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545334|NCT01695239|7466955|FG001|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545335|NCT01695239|7466956|FG002|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545336|NCT01695239|7466957|FG003|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545337|NCT01695239|7466958|FG004|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
6545338|NCT01695239|7466959|FG005|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
6545339|NCT01695239|7466960|FG006|STARTED|Placebo Washout (Week 24 Up To Week 32)|Only included PBO washout participants.|0
6545340|NCT01695239|7466961|FG007|STARTED|Placebo Washout (Week 24 Up To Week 32)|Adalimumab Q2W responders who re-randomized to IxeQ2W or IxeQ4W and PBO for ixe and adalimumab.|88
6545341|NCT01695239|7466962|FG008|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545342|NCT01695239|7466963|FG009|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545343|NCT01695239|7466964|FG010|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545344|NCT01695239|7466965|FG011|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545345|NCT01695239|7466966|FG012|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545346|NCT01695239|7466967|FG013|STARTED|Placebo Washout (Week 24 Up To Week 32)||0
6545347|NCT01695239|7466954|FG000|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545348|NCT01695239|7466955|FG001|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545349|NCT01695239|7466956|FG002|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545350|NCT01695239|7466957|FG003|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545351|NCT01695239|7466958|FG004|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545352|NCT01695239|7466959|FG005|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545353|NCT01695239|7466960|FG006|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545354|NCT01695239|7466961|FG007|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||77
6545355|NCT01695239|7466962|FG008|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545356|NCT01695239|7466963|FG009|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545357|NCT01695239|7466964|FG010|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545358|NCT01695239|7466965|FG011|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545359|NCT01695239|7466966|FG012|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545360|NCT01695239|7466967|FG013|COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545361|NCT01695239|7466954|FG000|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545362|NCT01695239|7466955|FG001|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545363|NCT01695239|7466956|FG002|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545364|NCT01695239|7466957|FG003|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545365|NCT01695239|7466958|FG004|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545366|NCT01695239|7466959|FG005|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545367|NCT01695239|7466960|FG006|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545368|NCT01695239|7466961|FG007|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||11
6545369|NCT01695239|7466962|FG008|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545370|NCT01695239|7466963|FG009|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545371|NCT01695239|7466964|FG010|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545372|NCT01695239|7466965|FG011|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545373|NCT01695239|7466966|FG012|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545374|NCT01695239|7466967|FG013|NOT COMPLETED|Placebo Washout (Week 24 Up To Week 32)||0
6545375|NCT01695239|7466954|FG000|STARTED|Extension Long-Term Extension Periods||0
6545376|NCT01695239|7466955|FG001|STARTED|Extension Long-Term Extension Periods||0
6545377|NCT01695239|7466956|FG002|STARTED|Extension Long-Term Extension Periods||0
6545378|NCT01695239|7466957|FG003|STARTED|Extension Long-Term Extension Periods||0
6545379|NCT01695239|7466958|FG004|STARTED|Extension Long-Term Extension Periods||0
6545380|NCT01695239|7466959|FG005|STARTED|Extension Long-Term Extension Periods||0
6545381|NCT01695239|7466960|FG006|STARTED|Extension Long-Term Extension Periods||0
6545382|NCT01695239|7466961|FG007|STARTED|Extension Long-Term Extension Periods|Only included combined extension participants.|0
6562507|NCT01801280|7485415|FG001|STARTED|Period 4||4
6545383|NCT01695239|7466962|FG008|STARTED|Extension Long-Term Extension Periods|IxeQ4W who re-randomized to ixeQ4W.|187
6545384|NCT01695239|7466963|FG009|STARTED|Extension Long-Term Extension Periods|IxeQ2W who re-randomized to ixeQ2W.|183
6545385|NCT01695239|7466964|FG010|STARTED|Extension Long-Term Extension Periods||0
6545386|NCT01695239|7466965|FG011|STARTED|Extension Long-Term Extension Periods||0
6545387|NCT01695239|7466966|FG012|STARTED|Extension Long-Term Extension Periods||0
6545388|NCT01695239|7466967|FG013|STARTED|Extension Long-Term Extension Periods||0
6545389|NCT01695239|7466954|FG000|COMPLETED|Extension Long-Term Extension Periods||0
6545390|NCT01695239|7466955|FG001|COMPLETED|Extension Long-Term Extension Periods||0
6545391|NCT01695239|7466956|FG002|COMPLETED|Extension Long-Term Extension Periods||0
6545392|NCT01695239|7466957|FG003|COMPLETED|Extension Long-Term Extension Periods||0
6545393|NCT01695239|7466958|FG004|COMPLETED|Extension Long-Term Extension Periods||0
6545394|NCT01695239|7466959|FG005|COMPLETED|Extension Long-Term Extension Periods||0
6545395|NCT01695239|7466960|FG006|COMPLETED|Extension Long-Term Extension Periods||0
6545396|NCT01695239|7466961|FG007|COMPLETED|Extension Long-Term Extension Periods||0
6545397|NCT01695239|7466962|FG008|COMPLETED|Extension Long-Term Extension Periods||121
6545398|NCT01695239|7466963|FG009|COMPLETED|Extension Long-Term Extension Periods||122
6545399|NCT01695239|7466964|FG010|COMPLETED|Extension Long-Term Extension Periods||0
6545400|NCT01695239|7466965|FG011|COMPLETED|Extension Long-Term Extension Periods||0
6545401|NCT01695239|7466966|FG012|COMPLETED|Extension Long-Term Extension Periods||0
6545402|NCT01695239|7466967|FG013|COMPLETED|Extension Long-Term Extension Periods||0
6545403|NCT01695239|7466954|FG000|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545404|NCT01695239|7466955|FG001|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545405|NCT01695239|7466956|FG002|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545406|NCT01695239|7466957|FG003|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545407|NCT01695239|7466958|FG004|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545408|NCT01695239|7466959|FG005|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545409|NCT01695239|7466960|FG006|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545410|NCT01695239|7466961|FG007|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545411|NCT01695239|7466962|FG008|NOT COMPLETED|Extension Long-Term Extension Periods||66
6545412|NCT01695239|7466963|FG009|NOT COMPLETED|Extension Long-Term Extension Periods||61
6545413|NCT01695239|7466964|FG010|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545414|NCT01695239|7466965|FG011|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545415|NCT01695239|7466966|FG012|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545416|NCT01695239|7466967|FG013|NOT COMPLETED|Extension Long-Term Extension Periods||0
6545417|NCT01695239|7466954|FG000|STARTED|Post-Treatment Follow-Up Period||0
6545418|NCT01695239|7466955|FG001|STARTED|Post-Treatment Follow-Up Period||0
6545419|NCT01695239|7466956|FG002|STARTED|Post-Treatment Follow-Up Period||0
6545420|NCT01695239|7466957|FG003|STARTED|Post-Treatment Follow-Up Period||0
6545421|NCT01695239|7466958|FG004|STARTED|Post-Treatment Follow-Up Period||0
6545422|NCT01695239|7466959|FG005|STARTED|Post-Treatment Follow-Up Period||0
6545423|NCT01695239|7466960|FG006|STARTED|Post-Treatment Follow-Up Period||0
6545424|NCT01695239|7466961|FG007|STARTED|Post-Treatment Follow-Up Period||0
6545425|NCT01695239|7466962|FG008|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
6545426|NCT01695239|7466963|FG009|STARTED|Post-Treatment Follow-Up Period|Only included post-treatment follow-up participants.|0
6545427|NCT01695239|7466964|FG010|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received PBO.|20
6545428|NCT01695239|7466965|FG011|STARTED|Post-Treatment Follow-Up Period|Participants who discontinued early and received adalimumab.|1
6545429|NCT01695239|7466966|FG012|STARTED|Post-Treatment Follow-Up Period|IxeQ4W participants who entered post-treatment follow-up.|165
6545430|NCT01695239|7466967|FG013|STARTED|Post-Treatment Follow-Up Period|IxeQ2W participants who entered post-treatment follow-up.|171
6545431|NCT01695239|7466954|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
6545432|NCT01695239|7466955|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
6545433|NCT01695239|7466956|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
6545434|NCT01695239|7466957|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
6545435|NCT01695239|7466958|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
6545436|NCT01695239|7466959|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
6545437|NCT01695239|7466960|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
6545438|NCT01695239|7466961|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
6545439|NCT01695239|7466962|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
6545440|NCT01695239|7466963|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
6545441|NCT01695239|7466964|FG010|COMPLETED|Post-Treatment Follow-Up Period||20
6545442|NCT01695239|7466965|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
6545443|NCT01695239|7466966|FG012|COMPLETED|Post-Treatment Follow-Up Period||156
6545444|NCT01695239|7466967|FG013|COMPLETED|Post-Treatment Follow-Up Period||166
6545445|NCT01695239|7466954|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545446|NCT01695239|7466955|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545447|NCT01695239|7466956|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545448|NCT01695239|7466957|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545449|NCT01695239|7466958|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545450|NCT01695239|7466959|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545451|NCT01695239|7466960|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545452|NCT01695239|7466961|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545453|NCT01695239|7466962|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545454|NCT01695239|7466963|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545455|NCT01695239|7466964|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6545456|NCT01695239|7466965|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||1
6545457|NCT01695239|7466966|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||9
6545458|NCT01695239|7466967|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||5
6545459|NCT01695291|7466991|FG000|STARTED|Overall Study||10
6545460|NCT01695291|7466992|FG001|STARTED|Overall Study||21
6545461|NCT01695291|7466991|FG000|COMPLETED|Overall Study||8
6545462|NCT01695291|7466992|FG001|COMPLETED|Overall Study||14
6545463|NCT01695291|7466991|FG000|NOT COMPLETED|Overall Study||2
6545464|NCT01695291|7466992|FG001|NOT COMPLETED|Overall Study||7
6545465|NCT01695304|7467000|FG000|STARTED|Overall Study||120
6545466|NCT01695304|7467001|FG001|STARTED|Overall Study||120
6545467|NCT01695304|7467000|FG000|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
6545468|NCT01695304|7467001|FG001|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
6545469|NCT01695304|7467000|FG000|NOT COMPLETED|Overall Study||0
6545470|NCT01695304|7467001|FG001|NOT COMPLETED|Overall Study||0
6545471|NCT01695330|7467009|FG000|STARTED|Overall Study||52
6545472|NCT01695330|7467010|FG001|STARTED|Overall Study||0
6545473|NCT01695330|7467009|FG000|COMPLETED|Overall Study||5
6545474|NCT01695330|7467010|FG001|COMPLETED|Overall Study||0
6545475|NCT01695330|7467009|FG000|NOT COMPLETED|Overall Study||47
6545476|NCT01695330|7467010|FG001|NOT COMPLETED|Overall Study||0
6545477|NCT01695369|7467014|FG000|STARTED|Overall Study||61
6545478|NCT01695369|7467014|FG000|COMPLETED|Overall Study||61
6545479|NCT01695369|7467014|FG000|NOT COMPLETED|Overall Study||0
6545480|NCT01695473|7467020|FG000|STARTED|Overall Study||11
6545481|NCT01695473|7467020|FG000|COMPLETED|Overall Study||11
6545482|NCT01695473|7467020|FG000|NOT COMPLETED|Overall Study||0
6545483|NCT01695668|7467027|FG000|STARTED|Overall Study||38
6545484|NCT01695668|7467028|FG001|STARTED|Overall Study||37
6545485|NCT01695668|7467027|FG000|COMPLETED|Overall Study||23
6545486|NCT01695668|7467028|FG001|COMPLETED|Overall Study||20
6545487|NCT01695668|7467027|FG000|NOT COMPLETED|Overall Study||15
6545488|NCT01695668|7467028|FG001|NOT COMPLETED|Overall Study||17
6545489|NCT01695746|7467034|FG000|STARTED|Overall Study||108
6545490|NCT01695746|7467034|FG000|COMPLETED|Overall Study||96
6545491|NCT01695746|7467034|FG000|NOT COMPLETED|Overall Study||12
6545492|NCT01695772|7467039|FG000|STARTED|Overall Study||50
6545493|NCT01695772|7467039|FG000|COMPLETED|Overall Study||12
6545494|NCT01695772|7467039|FG000|NOT COMPLETED|Overall Study||38
6545495|NCT01695954|7467045|FG000|STARTED|Overall Study||18
6545496|NCT01695954|7467046|FG001|STARTED|Overall Study||16
6545497|NCT01695954|7467045|FG000|COMPLETED|Overall Study||14
6545498|NCT01695954|7467046|FG001|COMPLETED|Overall Study||14
6545499|NCT01695954|7467045|FG000|NOT COMPLETED|Overall Study||4
6545500|NCT01695954|7467046|FG001|NOT COMPLETED|Overall Study||2
6545501|NCT01695993|7467057|FG000|STARTED|Overall Study||81
6545502|NCT01695993|7467058|FG001|STARTED|Overall Study||80
6545503|NCT01695993|7467059|FG002|STARTED|Overall Study||81
6545504|NCT01695993|7467057|FG000|COMPLETED|Overall Study||76
6545505|NCT01695993|7467058|FG001|COMPLETED|Overall Study||75
6545506|NCT01695993|7467059|FG002|COMPLETED|Overall Study||75
6545507|NCT01695993|7467057|FG000|NOT COMPLETED|Overall Study||5
6545508|NCT01695993|7467058|FG001|NOT COMPLETED|Overall Study||5
6545509|NCT01695993|7467059|FG002|NOT COMPLETED|Overall Study||6
6545510|NCT01696032|7467071|FG000|STARTED|Overall Study||14
6545511|NCT01696032|7467072|FG001|STARTED|Overall Study||6
6545512|NCT01696032|7467073|FG002|STARTED|Overall Study||51
6545513|NCT01696032|7467074|FG003|STARTED|Overall Study||49
6545514|NCT01696032|7467071|FG000|COMPLETED|Overall Study||0
6545515|NCT01696032|7467072|FG001|COMPLETED|Overall Study||0
6545516|NCT01696032|7467073|FG002|COMPLETED|Overall Study||0
6545517|NCT01696032|7467074|FG003|COMPLETED|Overall Study||27
6545518|NCT01696032|7467071|FG000|NOT COMPLETED|Overall Study||14
6545519|NCT01696032|7467072|FG001|NOT COMPLETED|Overall Study||6
6545520|NCT01696032|7467073|FG002|NOT COMPLETED|Overall Study||51
6545521|NCT01696032|7467074|FG003|NOT COMPLETED|Overall Study||22
6545522|NCT01696045|7467090|FG000|STARTED|Overall Study||4
6545523|NCT01696045|7467091|FG001|STARTED|Overall Study||8
6545524|NCT01696045|7467090|FG000|COMPLETED|Overall Study||1
6545525|NCT01696045|7467091|FG001|COMPLETED|Overall Study||1
6545526|NCT01696045|7467090|FG000|NOT COMPLETED|Overall Study||3
6545527|NCT01696045|7467091|FG001|NOT COMPLETED|Overall Study||7
6545528|NCT01696058|7467099|FG000|STARTED|Overall Study||566
6545529|NCT01696058|7467100|FG001|STARTED|Overall Study||569
6545530|NCT01696058|7467099|FG000|COMPLETED|Overall Study||523
6545531|NCT01696058|7467100|FG001|COMPLETED|Overall Study||538
6545532|NCT01696058|7467099|FG000|NOT COMPLETED|Overall Study||43
6545533|NCT01696058|7467100|FG001|NOT COMPLETED|Overall Study||31
6545534|NCT01696071|7467106|FG000|STARTED|Treatment Period 1: 4 Weeks||51
6545535|NCT01696071|7467107|FG001|STARTED|Treatment Period 1: 4 Weeks||47
6545536|NCT01696071|7467106|FG000|COMPLETED|Treatment Period 1: 4 Weeks||51
6545537|NCT01696071|7467107|FG001|COMPLETED|Treatment Period 1: 4 Weeks||47
6545538|NCT01696071|7467106|FG000|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
6545539|NCT01696071|7467107|FG001|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
6545540|NCT01696071|7467106|FG000|STARTED|Treatment Period 2: 4 Weeks||51
6545541|NCT01696071|7467107|FG001|STARTED|Treatment Period 2: 4 Weeks||47
6545542|NCT01696071|7467106|FG000|COMPLETED|Treatment Period 2: 4 Weeks||50
6545543|NCT01696071|7467107|FG001|COMPLETED|Treatment Period 2: 4 Weeks||47
6545544|NCT01696071|7467106|FG000|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
6545545|NCT01696071|7467107|FG001|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
6545546|NCT01696084|7467116|FG000|STARTED|Overall Study||153
6545547|NCT01696084|7467117|FG001|STARTED|Overall Study||156
6545548|NCT01696084|7467116|FG000|COMPLETED|Overall Study||22
6545549|NCT01696084|7467117|FG001|COMPLETED|Overall Study||10
6545550|NCT01696084|7467116|FG000|NOT COMPLETED|Overall Study||131
6545551|NCT01696084|7467117|FG001|NOT COMPLETED|Overall Study||146
6545552|NCT01696188|7467125|FG000|STARTED|Overall Study||41
6545553|NCT01696188|7467126|FG001|STARTED|Overall Study||43
6545554|NCT01696188|7467125|FG000|COMPLETED|Overall Study||40
6545555|NCT01696188|7467126|FG001|COMPLETED|Overall Study||42
6545556|NCT01696188|7467125|FG000|NOT COMPLETED|Overall Study||1
6545557|NCT01696188|7467126|FG001|NOT COMPLETED|Overall Study||1
6545558|NCT01696214|7467136|FG000|STARTED|Overall Study||5
6545559|NCT01696214|7467137|FG001|STARTED|Overall Study||5
6545560|NCT01696214|7467138|FG002|STARTED|Overall Study||5
6545561|NCT01696214|7467139|FG003|STARTED|Overall Study||5
6545562|NCT01696214|7467136|FG000|COMPLETED|Overall Study||4
6545563|NCT01696214|7467137|FG001|COMPLETED|Overall Study||5
6545564|NCT01696214|7467138|FG002|COMPLETED|Overall Study||5
6545565|NCT01696214|7467139|FG003|COMPLETED|Overall Study||5
6545566|NCT01696214|7467136|FG000|NOT COMPLETED|Overall Study||1
6545567|NCT01696214|7467137|FG001|NOT COMPLETED|Overall Study||0
6545568|NCT01696214|7467138|FG002|NOT COMPLETED|Overall Study||0
6545569|NCT01696214|7467139|FG003|NOT COMPLETED|Overall Study||0
6545570|NCT01696279|7467157|FG000|STARTED|Part 1: Single Dose Lanthanum Carbonate||20
6545571|NCT01696279|7467158|FG001|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
6545572|NCT01696279|7467159|FG002|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
6545573|NCT01696279|7467160|FG003|STARTED|Part 1: Single Dose Lanthanum Carbonate||0
6545574|NCT01696279|7467157|FG000|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||20
6545575|NCT01696279|7467158|FG001|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
6545576|NCT01696279|7467159|FG002|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
6545577|NCT01696279|7467160|FG003|Safety Analysis Set 1|Part 1: Single Dose Lanthanum Carbonate||0
6545578|NCT01696279|7467157|FG000|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||19
6545579|NCT01696279|7467158|FG001|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
6545580|NCT01696279|7467159|FG002|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
6545581|NCT01696279|7467160|FG003|Entered Part 2a|Part 1: Single Dose Lanthanum Carbonate||0
6545582|NCT01696279|7467157|FG000|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||19
6545583|NCT01696279|7467158|FG001|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6545584|NCT01696279|7467159|FG002|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6545585|NCT01696279|7467160|FG003|COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6545586|NCT01696279|7467157|FG000|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||1
6545587|NCT01696279|7467158|FG001|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6545588|NCT01696279|7467159|FG002|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6545589|NCT01696279|7467160|FG003|NOT COMPLETED|Part 1: Single Dose Lanthanum Carbonate||0
6545590|NCT01696279|7467157|FG000|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
6545591|NCT01696279|7467158|FG001|STARTED|Part 2a: Calcium Carbonate + Lanthanum|19 participants enrolled from Part 1 and 34 new participants enrolled in Part 2a|53
6545592|NCT01696279|7467159|FG002|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
6545593|NCT01696279|7467160|FG003|STARTED|Part 2a: Calcium Carbonate + Lanthanum||0
6545594|NCT01696279|7467157|FG000|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
6545595|NCT01696279|7467158|FG001|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||37
6545596|NCT01696279|7467159|FG002|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
6545597|NCT01696279|7467160|FG003|Safety Completer Set|Part 2a: Calcium Carbonate + Lanthanum||0
6545598|NCT01696279|7467157|FG000|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
6545599|NCT01696279|7467158|FG001|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||53
6545600|NCT01696279|7467159|FG002|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
6545601|NCT01696279|7467160|FG003|Full Analysis Set|Part 2a: Calcium Carbonate + Lanthanum||0
6545602|NCT01696279|7467157|FG000|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
6545603|NCT01696279|7467158|FG001|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||17
6545604|NCT01696279|7467159|FG002|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
6545605|NCT01696279|7467160|FG003|Per-protocol Set 1|Part 2a: Calcium Carbonate + Lanthanum||0
6545606|NCT01696279|7467157|FG000|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
6545607|NCT01696279|7467158|FG001|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||25
6545608|NCT01696279|7467159|FG002|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
6545609|NCT01696279|7467160|FG003|Per-protocol Set 2|Part 2a: Calcium Carbonate + Lanthanum||0
6545610|NCT01696279|7467157|FG000|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
6545611|NCT01696279|7467158|FG001|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||34
6545612|NCT01696279|7467159|FG002|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
6545613|NCT01696279|7467160|FG003|Entered Part 3|Part 2a: Calcium Carbonate + Lanthanum||0
6545614|NCT01696279|7467157|FG000|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6545615|NCT01696279|7467158|FG001|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||34
6545616|NCT01696279|7467159|FG002|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6545617|NCT01696279|7467160|FG003|COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6545618|NCT01696279|7467157|FG000|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6545619|NCT01696279|7467158|FG001|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||19
6545620|NCT01696279|7467159|FG002|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6545621|NCT01696279|7467160|FG003|NOT COMPLETED|Part 2a: Calcium Carbonate + Lanthanum||0
6545622|NCT01696279|7467157|FG000|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545623|NCT01696279|7467158|FG001|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545624|NCT01696279|7467159|FG002|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)|9 new participants were enrolled in Part 2b|9
6545625|NCT01696279|7467160|FG003|STARTED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545626|NCT01696279|7467157|FG000|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545627|NCT01696279|7467158|FG001|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545628|NCT01696279|7467159|FG002|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
6545629|NCT01696279|7467160|FG003|Safety Completer Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545630|NCT01696279|7467157|FG000|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545631|NCT01696279|7467158|FG001|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545632|NCT01696279|7467159|FG002|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||9
6545633|NCT01696279|7467160|FG003|Full Analysis Set|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545634|NCT01696279|7467157|FG000|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545635|NCT01696279|7467158|FG001|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545636|NCT01696279|7467159|FG002|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545637|NCT01696279|7467160|FG003|Per-protocol Set 1|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545638|NCT01696279|7467157|FG000|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545639|NCT01696279|7467158|FG001|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545640|NCT01696279|7467159|FG002|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||9
6545641|NCT01696279|7467160|FG003|Per-protocol Set 2|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545642|NCT01696279|7467157|FG000|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545643|NCT01696279|7467158|FG001|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545644|NCT01696279|7467159|FG002|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||8
6545645|NCT01696279|7467160|FG003|COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545646|NCT01696279|7467157|FG000|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545647|NCT01696279|7467158|FG001|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545648|NCT01696279|7467159|FG002|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||1
6545649|NCT01696279|7467160|FG003|NOT COMPLETED|Part 2b: Lanthanum Carbonate (8 Weeks)||0
6545650|NCT01696279|7467157|FG000|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
6545651|NCT01696279|7467158|FG001|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
6545652|NCT01696279|7467159|FG002|STARTED|Part 3: Lanthanum Carbonate (6 Months)||0
6545653|NCT01696279|7467160|FG003|STARTED|Part 3: Lanthanum Carbonate (6 Months)|34 participants from Part 2a and 8 participants from Part 2b continued to Part 3|42
6545654|NCT01696279|7467157|FG000|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6545655|NCT01696279|7467158|FG001|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6545656|NCT01696279|7467159|FG002|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6545657|NCT01696279|7467160|FG003|COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||34
6545658|NCT01696279|7467157|FG000|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6545659|NCT01696279|7467158|FG001|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6545660|NCT01696279|7467159|FG002|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||0
6545661|NCT01696279|7467160|FG003|NOT COMPLETED|Part 3: Lanthanum Carbonate (6 Months)||8
6545662|NCT01696357|7467171|FG000|STARTED|Overall Study||42
6545663|NCT01696357|7467172|FG001|STARTED|Overall Study||42
6545664|NCT01696357|7467171|FG000|COMPLETED|Overall Study||40
6545665|NCT01696357|7467172|FG001|COMPLETED|Overall Study||41
6545666|NCT01696357|7467171|FG000|NOT COMPLETED|Overall Study||2
6545667|NCT01696357|7467172|FG001|NOT COMPLETED|Overall Study||1
6545668|NCT01696396|7467182|FG000|STARTED|Overall Study||100
6545669|NCT01696396|7467183|FG001|STARTED|Overall Study||27
6545670|NCT01696396|7467184|FG002|STARTED|Overall Study||85
6545671|NCT01696396|7467185|FG003|STARTED|Overall Study||42
6545672|NCT01696396|7467182|FG000|Received Study Drug|Overall Study||98
6545673|NCT01696396|7467183|FG001|Received Study Drug|Overall Study||26
6545674|NCT01696396|7467184|FG002|Received Study Drug|Overall Study||84
6545675|NCT01696396|7467185|FG003|Received Study Drug|Overall Study||41
6545676|NCT01696396|7467182|FG000|Entered Open-label Period|Overall Study||84
6545677|NCT01696396|7467183|FG001|Entered Open-label Period|Overall Study||21
6545678|NCT01696396|7467184|FG002|Entered Open-label Period|Overall Study||75
6545679|NCT01696396|7467185|FG003|Entered Open-label Period|Overall Study||37
6545680|NCT01696396|7467182|FG000|COMPLETED|Overall Study||69
6545681|NCT01696396|7467183|FG001|COMPLETED|Overall Study||20
6545682|NCT01696396|7467184|FG002|COMPLETED|Overall Study||59
6545683|NCT01696396|7467185|FG003|COMPLETED|Overall Study||28
6545684|NCT01696396|7467182|FG000|NOT COMPLETED|Overall Study||31
6545685|NCT01696396|7467183|FG001|NOT COMPLETED|Overall Study||7
6545686|NCT01696396|7467184|FG002|NOT COMPLETED|Overall Study||26
6545687|NCT01696396|7467185|FG003|NOT COMPLETED|Overall Study||14
6545688|NCT01696643|7467201|FG000|STARTED|Overall Study||703
6545689|NCT01696643|7467202|FG001|STARTED|Overall Study||704
6545690|NCT01696643|7467201|FG000|Received at Least 1 Dose of Study Drug|Overall Study||701
6545691|NCT01696643|7467202|FG001|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
6545692|NCT01696643|7467201|FG000|COMPLETED|Overall Study||174
6545693|NCT01696643|7467202|FG001|COMPLETED|Overall Study||169
6545694|NCT01696643|7467201|FG000|NOT COMPLETED|Overall Study||529
6545695|NCT01696643|7467202|FG001|NOT COMPLETED|Overall Study||535
6545696|NCT01696695|7467208|FG000|STARTED|Overall Study||882
6545697|NCT01696695|7467208|FG000|COMPLETED|Overall Study||0
6545698|NCT01696695|7467208|FG000|NOT COMPLETED|Overall Study||882
6545699|NCT01696760|7467214|FG000|STARTED|Overall Study||9
6545700|NCT01696760|7467215|FG001|STARTED|Overall Study||3
6545701|NCT01696760|7467214|FG000|COMPLETED|Overall Study||9
6545702|NCT01696760|7467215|FG001|COMPLETED|Overall Study||3
6545703|NCT01696760|7467214|FG000|NOT COMPLETED|Overall Study||0
6304235|NCT00364832|7207525|FG011|COMPLETED|Extension Year 1||17
6304236|NCT00364832|7207514|FG000|NOT COMPLETED|Extension Year 1||0
6304237|NCT00364832|7207515|FG001|NOT COMPLETED|Extension Year 1||0
6304238|NCT00364832|7207516|FG002|NOT COMPLETED|Extension Year 1||0
6304239|NCT00364832|7207517|FG003|NOT COMPLETED|Extension Year 1||0
6304240|NCT00364832|7207518|FG004|NOT COMPLETED|Extension Year 1||0
6304241|NCT00364832|7207519|FG005|NOT COMPLETED|Extension Year 1||0
6304242|NCT00364832|7207520|FG006|NOT COMPLETED|Extension Year 1||0
6304243|NCT00364832|7207521|FG007|NOT COMPLETED|Extension Year 1||0
6304244|NCT00364832|7207522|FG008|NOT COMPLETED|Extension Year 1||0
6304245|NCT00364832|7207523|FG009|NOT COMPLETED|Extension Year 1||4
6545704|NCT01696760|7467215|FG001|NOT COMPLETED|Overall Study||0
6545705|NCT01696773|7467223|FG000|STARTED|Days 1-13, Washout||6
6545706|NCT01696773|7467224|FG001|STARTED|Days 1-13, Washout||6
6545707|NCT01696773|7467223|FG000|COMPLETED|Days 1-13, Washout||6
6545708|NCT01696773|7467224|FG001|COMPLETED|Days 1-13, Washout||6
6545709|NCT01696773|7467223|FG000|NOT COMPLETED|Days 1-13, Washout||0
6545710|NCT01696773|7467224|FG001|NOT COMPLETED|Days 1-13, Washout||0
6545711|NCT01696773|7467223|FG000|STARTED|Day 14, First Intervention||6
6545712|NCT01696773|7467224|FG001|STARTED|Day 14, First Intervention||6
6545713|NCT01696773|7467223|FG000|COMPLETED|Day 14, First Intervention||6
6545714|NCT01696773|7467224|FG001|COMPLETED|Day 14, First Intervention||6
6545715|NCT01696773|7467223|FG000|NOT COMPLETED|Day 14, First Intervention||0
6545716|NCT01696773|7467224|FG001|NOT COMPLETED|Day 14, First Intervention||0
6545717|NCT01696773|7467223|FG000|STARTED|Days 15-27, Washout||6
6545718|NCT01696773|7467224|FG001|STARTED|Days 15-27, Washout||6
6545719|NCT01696773|7467223|FG000|COMPLETED|Days 15-27, Washout||5
6545720|NCT01696773|7467224|FG001|COMPLETED|Days 15-27, Washout||6
6545721|NCT01696773|7467223|FG000|NOT COMPLETED|Days 15-27, Washout||1
6545722|NCT01696773|7467224|FG001|NOT COMPLETED|Days 15-27, Washout||0
6545723|NCT01696773|7467223|FG000|STARTED|Day 28, Second Intervention||5
6545724|NCT01696773|7467224|FG001|STARTED|Day 28, Second Intervention||6
6545725|NCT01696773|7467223|FG000|COMPLETED|Day 28, Second Intervention||5
6545726|NCT01696773|7467224|FG001|COMPLETED|Day 28, Second Intervention||6
6545727|NCT01696773|7467223|FG000|NOT COMPLETED|Day 28, Second Intervention||0
6545728|NCT01696773|7467224|FG001|NOT COMPLETED|Day 28, Second Intervention||0
6545729|NCT01696877|7467232|FG000|STARTED|Overall Study||15
6545730|NCT01696877|7467233|FG001|STARTED|Overall Study||14
6545731|NCT01696877|7467232|FG000|COMPLETED|Overall Study||15
6545732|NCT01696877|7467233|FG001|COMPLETED|Overall Study||13
6545733|NCT01696877|7467232|FG000|NOT COMPLETED|Overall Study||0
6545734|NCT01696877|7467233|FG001|NOT COMPLETED|Overall Study||1
6545735|NCT01696929|7467241|FG000|STARTED|Overall Study||6
6545736|NCT01696929|7467241|FG000|COMPLETED|Overall Study||5
6545737|NCT01696929|7467241|FG000|NOT COMPLETED|Overall Study||1
6545738|NCT01696942|7467247|FG000|STARTED|Overall Study||5
6545739|NCT01696942|7467248|FG001|STARTED|Overall Study||5
6545740|NCT01696942|7467247|FG000|COMPLETED|Overall Study||3
6545741|NCT01696942|7467248|FG001|COMPLETED|Overall Study||2
6545742|NCT01696942|7467247|FG000|NOT COMPLETED|Overall Study||2
6545743|NCT01696942|7467248|FG001|NOT COMPLETED|Overall Study||3
6545744|NCT01696955|7467256|FG000|STARTED|Main Study||42
6545745|NCT01696955|7467257|FG001|STARTED|Main Study||39
6545746|NCT01696955|7467256|FG000|COMPLETED|Main Study||40
6545747|NCT01696955|7467257|FG001|COMPLETED|Main Study||38
6545748|NCT01696955|7467256|FG000|NOT COMPLETED|Main Study||2
6545749|NCT01696955|7467257|FG001|NOT COMPLETED|Main Study||1
6545750|NCT01696955|7467256|FG000|STARTED|Failure on Cetuximab-Received Tivantinib||0
6545751|NCT01696955|7467257|FG001|STARTED|Failure on Cetuximab-Received Tivantinib||15
6545752|NCT01696955|7467256|FG000|COMPLETED|Failure on Cetuximab-Received Tivantinib||0
6545753|NCT01696955|7467257|FG001|COMPLETED|Failure on Cetuximab-Received Tivantinib|23 patients did not cross over|15
6545754|NCT01696955|7467256|FG000|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
6545755|NCT01696955|7467257|FG001|NOT COMPLETED|Failure on Cetuximab-Received Tivantinib||0
6545756|NCT01696968|7467272|FG000|STARTED|Overall Study||77456
6545757|NCT01696968|7467273|FG001|STARTED|Overall Study||77445
6545758|NCT01696968|7467272|FG000|COMPLETED|Overall Study||76255
6545759|NCT01696968|7467273|FG001|COMPLETED|Overall Study||70633
6545760|NCT01696968|7467272|FG000|NOT COMPLETED|Overall Study||1201
6545761|NCT01696968|7467273|FG001|NOT COMPLETED|Overall Study||6812
6545762|NCT01696981|7467282|FG000|STARTED|Overall Study||77455
6545763|NCT01696981|7467283|FG001|STARTED|Overall Study||77445
6545764|NCT01696981|7467282|FG000|COMPLETED|Overall Study||76254
6545765|NCT01696981|7467283|FG001|COMPLETED|Overall Study||67071
6545766|NCT01696981|7467282|FG000|NOT COMPLETED|Overall Study||1201
6545767|NCT01696981|7467283|FG001|NOT COMPLETED|Overall Study||10374
6545768|NCT01696994|7467291|FG000|STARTED|Overall Study||39111
6545769|NCT01696994|7467292|FG001|STARTED|Overall Study||39105
6545770|NCT01696994|7467291|FG000|COMPLETED|Overall Study||33919
6545771|NCT01696994|7467292|FG001|COMPLETED|Overall Study||30668
6545772|NCT01696994|7467291|FG000|NOT COMPLETED|Overall Study||5192
6545773|NCT01696994|7467292|FG001|NOT COMPLETED|Overall Study||8437
6545774|NCT01697319|7467300|FG000|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
6545775|NCT01697319|7467300|FG000|COMPLETED|Primary Phase||15
6545776|NCT01697319|7467300|FG000|NOT COMPLETED|Primary Phase||1
6545777|NCT01697319|7467300|FG000|STARTED|Extension Phase||15
6545778|NCT01697319|7467300|FG000|COMPLETED|Extension Phase||0
6545779|NCT01697319|7467300|FG000|NOT COMPLETED|Extension Phase||15
6545780|NCT01697345|7467304|FG000|STARTED|Overall Study||13
6545781|NCT01697345|7467304|FG000|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
6545782|NCT01697345|7467304|FG000|NOT COMPLETED|Overall Study||1
6545783|NCT01697358|7467325|FG000|STARTED|Period I: Randomization to 6 Months||110
6545784|NCT01697358|7467326|FG001|STARTED|Period I: Randomization to 6 Months||108
6545785|NCT01697358|7467325|FG000|COMPLETED|Period I: Randomization to 6 Months||97
6545786|NCT01697358|7467326|FG001|COMPLETED|Period I: Randomization to 6 Months||107
6545787|NCT01697358|7467325|FG000|NOT COMPLETED|Period I: Randomization to 6 Months||13
6545788|NCT01697358|7467326|FG001|NOT COMPLETED|Period I: Randomization to 6 Months||1
6545789|NCT01697358|7467325|FG000|STARTED|Period II: 6-24M Long-term Follow-up||97
6545790|NCT01697358|7467326|FG001|STARTED|Period II: 6-24M Long-term Follow-up||107
6545791|NCT01697358|7467325|FG000|COMPLETED|Period II: 6-24M Long-term Follow-up||48
6545792|NCT01697358|7467326|FG001|COMPLETED|Period II: 6-24M Long-term Follow-up||52
6545793|NCT01697358|7467325|FG000|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
6545794|NCT01697358|7467326|FG001|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
6545795|NCT01697449|7467332|FG000|STARTED|Overall Study||191
6545796|NCT01697449|7467332|FG000|COMPLETED|Overall Study||101
6545797|NCT01697449|7467332|FG000|NOT COMPLETED|Overall Study||90
6545798|NCT01697462|7467339|FG000|STARTED|Overall Study||258
6545799|NCT01697462|7467339|FG000|COMPLETED|Overall Study||181
6545800|NCT01697462|7467339|FG000|NOT COMPLETED|Overall Study||77
6545801|NCT01697501|7467343|FG000|STARTED|Overall Study||88
6545802|NCT01697501|7467343|FG000|COMPLETED|Overall Study||86
6545803|NCT01697501|7467343|FG000|NOT COMPLETED|Overall Study||2
6545804|NCT01697579|7467361|FG000|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|74
6545805|NCT01697579|7467362|FG001|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|43
6545806|NCT01697579|7467363|FG002|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|44
6545807|NCT01697579|7467364|FG003|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|41
6545808|NCT01697579|7467365|FG004|STARTED|Base Study-Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6 arms.|38
6545809|NCT01697579|7467366|FG005|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
6545810|NCT01697579|7467367|FG006|STARTED|Base Study-Cycle 1|Enrollment in Cycles 2-6 was optional.|0
6545811|NCT01697579|7467361|FG000|COMPLETED|Base Study-Cycle 1||72
6545812|NCT01697579|7467362|FG001|COMPLETED|Base Study-Cycle 1||42
6545813|NCT01697579|7467363|FG002|COMPLETED|Base Study-Cycle 1||43
6545814|NCT01697579|7467364|FG003|COMPLETED|Base Study-Cycle 1||40
6545815|NCT01697579|7467365|FG004|COMPLETED|Base Study-Cycle 1||35
6545816|NCT01697579|7467366|FG005|COMPLETED|Base Study-Cycle 1||0
6545817|NCT01697579|7467367|FG006|COMPLETED|Base Study-Cycle 1||0
6545818|NCT01697579|7467361|FG000|NOT COMPLETED|Base Study-Cycle 1||2
6545819|NCT01697579|7467362|FG001|NOT COMPLETED|Base Study-Cycle 1||1
6545820|NCT01697579|7467363|FG002|NOT COMPLETED|Base Study-Cycle 1||1
6545821|NCT01697579|7467364|FG003|NOT COMPLETED|Base Study-Cycle 1||1
6545822|NCT01697579|7467365|FG004|NOT COMPLETED|Base Study-Cycle 1||3
6545823|NCT01697579|7467366|FG005|NOT COMPLETED|Base Study-Cycle 1||0
6545824|NCT01697579|7467367|FG006|NOT COMPLETED|Base Study-Cycle 1||0
6545825|NCT01697579|7467361|FG000|STARTED|Optional Extension-Cycles 2-6|47 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 5 mg/kg|0
6545826|NCT01697579|7467362|FG001|STARTED|Optional Extension-Cycles 2-6|33 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
6545827|NCT01697579|7467363|FG002|STARTED|Optional Extension-Cycles 2-6|25 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
6545828|NCT01697579|7467364|FG003|STARTED|Optional Extension-Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
6545829|NCT01697579|7467365|FG004|STARTED|Optional Extension-Cycles 2-6|21 participants from this arm in Cycle 1 entered optional Cycles 2-6 at 3 mg/kg|0
6545830|NCT01697579|7467366|FG005|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|47
6545831|NCT01697579|7467367|FG006|STARTED|Optional Extension-Cycles 2-6|Enrollment in Cycles 2-6 was optional.|106
6545832|NCT01697579|7467361|FG000|COMPLETED|Optional Extension-Cycles 2-6||0
6545833|NCT01697579|7467362|FG001|COMPLETED|Optional Extension-Cycles 2-6||0
6545834|NCT01697579|7467363|FG002|COMPLETED|Optional Extension-Cycles 2-6||0
6545835|NCT01697579|7467364|FG003|COMPLETED|Optional Extension-Cycles 2-6||0
6545836|NCT01697579|7467365|FG004|COMPLETED|Optional Extension-Cycles 2-6||0
6545837|NCT01697579|7467366|FG005|COMPLETED|Optional Extension-Cycles 2-6||12
6545838|NCT01697579|7467367|FG006|COMPLETED|Optional Extension-Cycles 2-6||37
6545839|NCT01697579|7467361|FG000|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6545840|NCT01697579|7467362|FG001|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6545841|NCT01697579|7467363|FG002|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6545842|NCT01697579|7467364|FG003|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6545843|NCT01697579|7467365|FG004|NOT COMPLETED|Optional Extension-Cycles 2-6||0
6545844|NCT01697579|7467366|FG005|NOT COMPLETED|Optional Extension-Cycles 2-6||35
6545845|NCT01697579|7467367|FG006|NOT COMPLETED|Optional Extension-Cycles 2-6||69
6562508|NCT01801280|7485416|FG002|STARTED|Period 4||5
6562509|NCT01801280|7485417|FG003|STARTED|Period 4||5
6562510|NCT01801280|7485414|FG000|COMPLETED|Period 4||4
6562511|NCT01801280|7485415|FG001|COMPLETED|Period 4||4
6562512|NCT01801280|7485416|FG002|COMPLETED|Period 4||4
6562513|NCT01801280|7485417|FG003|COMPLETED|Period 4||5
6562514|NCT01801280|7485414|FG000|NOT COMPLETED|Period 4||0
6562515|NCT01801280|7485415|FG001|NOT COMPLETED|Period 4||0
6562516|NCT01801280|7485416|FG002|NOT COMPLETED|Period 4||1
6562517|NCT01801280|7485417|FG003|NOT COMPLETED|Period 4||0
6562518|NCT01801358|7485433|FG000|STARTED|Overall Study||6
6562519|NCT01801358|7485434|FG001|STARTED|Overall Study||6
6562520|NCT01801358|7485435|FG002|STARTED|Overall Study||6
6562521|NCT01801358|7485436|FG003|STARTED|Overall Study||6
6562522|NCT01801358|7485437|FG004|STARTED|Overall Study||6
6562523|NCT01801358|7485438|FG005|STARTED|Overall Study||8
6562524|NCT01801358|7485433|FG000|COMPLETED|Overall Study||0
6562525|NCT01801358|7485434|FG001|COMPLETED|Overall Study||0
6562526|NCT01801358|7485435|FG002|COMPLETED|Overall Study||0
6562527|NCT01801358|7485436|FG003|COMPLETED|Overall Study||0
6562528|NCT01801358|7485437|FG004|COMPLETED|Overall Study||0
6562529|NCT01801358|7485438|FG005|COMPLETED|Overall Study||0
6562530|NCT01801358|7485433|FG000|NOT COMPLETED|Overall Study||6
6562531|NCT01801358|7485434|FG001|NOT COMPLETED|Overall Study||6
6562532|NCT01801358|7485435|FG002|NOT COMPLETED|Overall Study||6
6562533|NCT01801358|7485436|FG003|NOT COMPLETED|Overall Study||6
6562534|NCT01801358|7485437|FG004|NOT COMPLETED|Overall Study||6
6562535|NCT01801358|7485438|FG005|NOT COMPLETED|Overall Study||8
6562536|NCT01801436|7485473|FG000|STARTED|Overall Study||14
6562537|NCT01801436|7485473|FG000|COMPLETED|Overall Study||5
6562538|NCT01801436|7485473|FG000|NOT COMPLETED|Overall Study||9
6562539|NCT01801449|7485477|FG000|STARTED|Overall Study||6
6562540|NCT01801449|7485477|FG000|COMPLETED|Overall Study||6
6562541|NCT01801449|7485477|FG000|NOT COMPLETED|Overall Study||0
6562542|NCT01801475|7485485|FG000|STARTED|Overall Study||10
6562543|NCT01801475|7485486|FG001|STARTED|Overall Study||30
6562544|NCT01801475|7485487|FG002|STARTED|Overall Study||10
6562545|NCT01801475|7485488|FG003|STARTED|Overall Study||10
6562546|NCT01801475|7485489|FG004|STARTED|Overall Study||40
6562547|NCT01801475|7485485|FG000|COMPLETED|Overall Study||10
6562548|NCT01801475|7485486|FG001|COMPLETED|Overall Study||30
6562549|NCT01801475|7485487|FG002|COMPLETED|Overall Study||10
6562550|NCT01801475|7485488|FG003|COMPLETED|Overall Study||10
6562551|NCT01801475|7485489|FG004|COMPLETED|Overall Study||39
6562552|NCT01801475|7485485|FG000|NOT COMPLETED|Overall Study||0
6562553|NCT01801475|7485486|FG001|NOT COMPLETED|Overall Study||0
6562554|NCT01801475|7485487|FG002|NOT COMPLETED|Overall Study||0
6562555|NCT01801475|7485488|FG003|NOT COMPLETED|Overall Study||0
6562556|NCT01801475|7485489|FG004|NOT COMPLETED|Overall Study||1
6562557|NCT01801735|7485498|FG000|STARTED|Overall Study||600
6562558|NCT01801735|7485498|FG000|COMPLETED|Overall Study||390
6562559|NCT01801735|7485498|FG000|NOT COMPLETED|Overall Study||210
6562560|NCT01801865|7485502|FG000|STARTED|Overall Study||657
6562561|NCT01801865|7485502|FG000|COMPLETED|Overall Study||615
6562562|NCT01801865|7485502|FG000|NOT COMPLETED|Overall Study||42
6562563|NCT01801917|7485510|FG000|STARTED|Period 1 - Randomized||7
6562564|NCT01801917|7485511|FG001|STARTED|Period 1 - Randomized||2
6562565|NCT01801917|7485512|FG002|STARTED|Period 1 - Randomized||4
6562566|NCT01801917|7485513|FG003|STARTED|Period 1 - Randomized||1
6562567|NCT01801917|7485510|FG000|COMPLETED|Period 1 - Randomized||6
6562568|NCT01801917|7485511|FG001|COMPLETED|Period 1 - Randomized||2
6562569|NCT01801917|7485512|FG002|COMPLETED|Period 1 - Randomized||3
6562570|NCT01801917|7485513|FG003|COMPLETED|Period 1 - Randomized||1
6562571|NCT01801917|7485510|FG000|NOT COMPLETED|Period 1 - Randomized||1
6562572|NCT01801917|7485511|FG001|NOT COMPLETED|Period 1 - Randomized||0
6562573|NCT01801917|7485512|FG002|NOT COMPLETED|Period 1 - Randomized||1
6562574|NCT01801917|7485513|FG003|NOT COMPLETED|Period 1 - Randomized||0
6562575|NCT01801917|7485510|FG000|STARTED|Extension - All Active||6
6562576|NCT01801917|7485511|FG001|STARTED|Extension - All Active||0
6562577|NCT01801917|7485512|FG002|STARTED|Extension - All Active||3
6562578|NCT01801917|7485513|FG003|STARTED|Extension - All Active||0
6562579|NCT01801917|7485510|FG000|COMPLETED|Extension - All Active||6
6562580|NCT01801917|7485511|FG001|COMPLETED|Extension - All Active||0
6562581|NCT01801917|7485512|FG002|COMPLETED|Extension - All Active||3
6562582|NCT01801917|7485513|FG003|COMPLETED|Extension - All Active||0
6562583|NCT01801917|7485510|FG000|NOT COMPLETED|Extension - All Active||0
6562584|NCT01801917|7485511|FG001|NOT COMPLETED|Extension - All Active||0
6562585|NCT01801917|7485512|FG002|NOT COMPLETED|Extension - All Active||0
6562586|NCT01801917|7485513|FG003|NOT COMPLETED|Extension - All Active||0
6562587|NCT01801930|7485528|FG000|STARTED|Overall Study||6
6562588|NCT01801930|7485529|FG001|STARTED|Overall Study||6
6562589|NCT01801930|7485530|FG002|STARTED|Overall Study||6
6562590|NCT01801930|7485531|FG003|STARTED|Overall Study||6
6562591|NCT01801930|7485528|FG000|COMPLETED|Overall Study||0
6562592|NCT01801930|7485529|FG001|COMPLETED|Overall Study||0
6562593|NCT01801930|7485530|FG002|COMPLETED|Overall Study||0
6562594|NCT01801930|7485531|FG003|COMPLETED|Overall Study||0
6562595|NCT01801930|7485528|FG000|NOT COMPLETED|Overall Study||6
6562596|NCT01801930|7485529|FG001|NOT COMPLETED|Overall Study||6
6562597|NCT01801930|7485530|FG002|NOT COMPLETED|Overall Study||6
6562598|NCT01801930|7485531|FG003|NOT COMPLETED|Overall Study||6
6545846|NCT01697592|7467405|FG000|STARTED|Phase A (Up to 24 Weeks)||126
6545847|NCT01697592|7467406|FG001|STARTED|Phase A (Up to 24 Weeks)||65
6545848|NCT01697592|7467407|FG002|STARTED|Phase A (Up to 24 Weeks)||66
6545849|NCT01697592|7467408|FG003|STARTED|Phase A (Up to 24 Weeks)||65
6545850|NCT01697592|7467409|FG004|STARTED|Phase A (Up to 24 Weeks)||67
6545851|NCT01697592|7467410|FG005|STARTED|Phase A (Up to 24 Weeks)||63
6545852|NCT01697592|7467411|FG006|STARTED|Phase A (Up to 24 Weeks)||34
6545853|NCT01697592|7467412|FG007|STARTED|Phase A (Up to 24 Weeks)||33
6545854|NCT01697592|7467413|FG008|STARTED|Phase A (Up to 24 Weeks)||34
6545855|NCT01697592|7467414|FG009|STARTED|Phase A (Up to 24 Weeks)||32
6545856|NCT01697592|7467405|FG000|COMPLETED|Phase A (Up to 24 Weeks)||123
6545857|NCT01697592|7467406|FG001|COMPLETED|Phase A (Up to 24 Weeks)||62
6545858|NCT01697592|7467407|FG002|COMPLETED|Phase A (Up to 24 Weeks)||65
6545859|NCT01697592|7467408|FG003|COMPLETED|Phase A (Up to 24 Weeks)||63
6545860|NCT01697592|7467409|FG004|COMPLETED|Phase A (Up to 24 Weeks)||67
6545861|NCT01697592|7467410|FG005|COMPLETED|Phase A (Up to 24 Weeks)||62
6545862|NCT01697592|7467411|FG006|COMPLETED|Phase A (Up to 24 Weeks)||32
6545863|NCT01697592|7467412|FG007|COMPLETED|Phase A (Up to 24 Weeks)||33
6545864|NCT01697592|7467413|FG008|COMPLETED|Phase A (Up to 24 Weeks)||34
6545865|NCT01697592|7467414|FG009|COMPLETED|Phase A (Up to 24 Weeks)||30
6545866|NCT01697592|7467405|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
6545867|NCT01697592|7467406|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
6545868|NCT01697592|7467407|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
6545869|NCT01697592|7467408|FG003|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
6545870|NCT01697592|7467409|FG004|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
6545871|NCT01697592|7467410|FG005|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
6545872|NCT01697592|7467411|FG006|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
6545873|NCT01697592|7467412|FG007|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
6545874|NCT01697592|7467413|FG008|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
6545875|NCT01697592|7467414|FG009|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
6545876|NCT01697592|7467405|FG000|STARTED|Phase B (Week 25 to Week 52)||123
6545877|NCT01697592|7467406|FG001|STARTED|Phase B (Week 25 to Week 52)||62
6545878|NCT01697592|7467407|FG002|STARTED|Phase B (Week 25 to Week 52)||65
6545879|NCT01697592|7467408|FG003|STARTED|Phase B (Week 25 to Week 52)||63
6545880|NCT01697592|7467409|FG004|STARTED|Phase B (Week 25 to Week 52)||67
6545881|NCT01697592|7467410|FG005|STARTED|Phase B (Week 25 to Week 52)||62
6545882|NCT01697592|7467411|FG006|STARTED|Phase B (Week 25 to Week 52)||32
6545883|NCT01697592|7467412|FG007|STARTED|Phase B (Week 25 to Week 52)||33
6545884|NCT01697592|7467413|FG008|STARTED|Phase B (Week 25 to Week 52)||34
6545885|NCT01697592|7467414|FG009|STARTED|Phase B (Week 25 to Week 52)||30
6545886|NCT01697592|7467405|FG000|COMPLETED|Phase B (Week 25 to Week 52)||118
6545887|NCT01697592|7467406|FG001|COMPLETED|Phase B (Week 25 to Week 52)||61
6545888|NCT01697592|7467407|FG002|COMPLETED|Phase B (Week 25 to Week 52)||64
6545889|NCT01697592|7467408|FG003|COMPLETED|Phase B (Week 25 to Week 52)||60
6545890|NCT01697592|7467409|FG004|COMPLETED|Phase B (Week 25 to Week 52)||67
6545891|NCT01697592|7467410|FG005|COMPLETED|Phase B (Week 25 to Week 52)||60
6545892|NCT01697592|7467411|FG006|COMPLETED|Phase B (Week 25 to Week 52)||31
6545893|NCT01697592|7467412|FG007|COMPLETED|Phase B (Week 25 to Week 52)||32
6545894|NCT01697592|7467413|FG008|COMPLETED|Phase B (Week 25 to Week 52)||32
6545895|NCT01697592|7467414|FG009|COMPLETED|Phase B (Week 25 to Week 52)||30
6545896|NCT01697592|7467405|FG000|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
6545897|NCT01697592|7467406|FG001|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
6545898|NCT01697592|7467407|FG002|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
6545899|NCT01697592|7467408|FG003|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
6545900|NCT01697592|7467409|FG004|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
6545901|NCT01697592|7467410|FG005|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
6545902|NCT01697592|7467411|FG006|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
6545903|NCT01697592|7467412|FG007|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
6545904|NCT01697592|7467413|FG008|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
6545905|NCT01697592|7467414|FG009|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
6545906|NCT01697696|7467452|FG000|STARTED|Overall Study||254
6545907|NCT01697696|7467453|FG001|STARTED|Overall Study||257
6545908|NCT01697696|7467452|FG000|Safety Set|Overall Study||251
6545909|NCT01697696|7467453|FG001|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
6545910|NCT01697696|7467452|FG000|Full Analysis Set (FAS)|Overall Study||251
6545911|NCT01697696|7467453|FG001|Full Analysis Set (FAS)|Overall Study||255
6545912|NCT01697696|7467452|FG000|COMPLETED|Overall Study||207
6545913|NCT01697696|7467453|FG001|COMPLETED|Overall Study||210
6545914|NCT01697696|7467452|FG000|NOT COMPLETED|Overall Study||47
6545915|NCT01697696|7467453|FG001|NOT COMPLETED|Overall Study||47
6545916|NCT01697709|7467461|FG000|STARTED|Overall Study||64
6545917|NCT01697709|7467462|FG001|STARTED|Overall Study||66
6545918|NCT01697709|7467461|FG000|COMPLETED|Overall Study||34
6545919|NCT01697709|7467462|FG001|COMPLETED|Overall Study||38
6545920|NCT01697709|7467461|FG000|NOT COMPLETED|Overall Study||30
6545921|NCT01697709|7467462|FG001|NOT COMPLETED|Overall Study||28
6545922|NCT01697748|7467470|FG000|STARTED|Overall Study||329
6545923|NCT01697748|7467471|FG001|STARTED|Overall Study||328
6545924|NCT01697748|7467470|FG000|COMPLETED|Overall Study||271
6545925|NCT01697748|7467471|FG001|COMPLETED|Overall Study||260
6545926|NCT01697748|7467470|FG000|NOT COMPLETED|Overall Study||58
6545927|NCT01697748|7467471|FG001|NOT COMPLETED|Overall Study||68
6545928|NCT01697956|7467479|FG000|STARTED|Overall Study|enrolled and randomized|67
6545929|NCT01697956|7467480|FG001|STARTED|Overall Study|enrolled and randomized|32
6545930|NCT01697956|7467479|FG000|Per Protocol Population|Overall Study||66
6545931|NCT01697956|7467480|FG001|Per Protocol Population|Overall Study||31
6545932|NCT01697956|7467479|FG000|COMPLETED|Overall Study||66
6545933|NCT01697956|7467480|FG001|COMPLETED|Overall Study||31
6545934|NCT01697956|7467479|FG000|NOT COMPLETED|Overall Study||1
6545935|NCT01697956|7467480|FG001|NOT COMPLETED|Overall Study||1
6545936|NCT01697969|7467492|FG000|STARTED|Overall Study||13
6545937|NCT01697969|7467492|FG000|COMPLETED|Overall Study||10
6545938|NCT01697969|7467492|FG000|NOT COMPLETED|Overall Study||3
6545939|NCT01698008|7467499|FG000|STARTED|Overall Study||3
6545940|NCT01698008|7467500|FG001|STARTED|Overall Study||2
6545941|NCT01698008|7467499|FG000|COMPLETED|Overall Study||2
6545942|NCT01698008|7467500|FG001|COMPLETED|Overall Study||0
6545943|NCT01698008|7467499|FG000|NOT COMPLETED|Overall Study||1
6545944|NCT01698008|7467500|FG001|NOT COMPLETED|Overall Study||2
6545945|NCT01698268|7467508|FG000|STARTED|Overall Study||25
6545946|NCT01698268|7467509|FG001|STARTED|Overall Study||25
6545947|NCT01698268|7467508|FG000|COMPLETED|Overall Study||23
6545948|NCT01698268|7467509|FG001|COMPLETED|Overall Study||24
6545949|NCT01698268|7467508|FG000|NOT COMPLETED|Overall Study||2
6545950|NCT01698268|7467509|FG001|NOT COMPLETED|Overall Study||1
6545951|NCT01698320|7467517|FG000|STARTED|Run-In Period (Week -1 to Day 0)||364
6545952|NCT01698320|7467518|FG001|STARTED|Run-In Period (Week -1 to Day 0)||0
6545953|NCT01698320|7467519|FG002|STARTED|Run-In Period (Week -1 to Day 0)||0
6545954|NCT01698320|7467517|FG000|COMPLETED|Run-In Period (Week -1 to Day 0)||337
6545955|NCT01698320|7467518|FG001|COMPLETED|Run-In Period (Week -1 to Day 0)||0
6545956|NCT01698320|7467519|FG002|COMPLETED|Run-In Period (Week -1 to Day 0)||0
6545957|NCT01698320|7467517|FG000|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
6545958|NCT01698320|7467518|FG001|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
6545959|NCT01698320|7467519|FG002|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
6545960|NCT01698320|7467517|FG000|STARTED|12-Week Double-Blind Period||0
6545961|NCT01698320|7467518|FG001|STARTED|12-Week Double-Blind Period||169
6545962|NCT01698320|7467519|FG002|STARTED|12-Week Double-Blind Period||168
6545963|NCT01698320|7467517|FG000|Safety Population|12-Week Double-Blind Period||0
6545964|NCT01698320|7467518|FG001|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
6545965|NCT01698320|7467519|FG002|Safety Population|12-Week Double-Blind Period||168
6545966|NCT01698320|7467517|FG000|COMPLETED|12-Week Double-Blind Period||0
6545967|NCT01698320|7467518|FG001|COMPLETED|12-Week Double-Blind Period||165
6545968|NCT01698320|7467519|FG002|COMPLETED|12-Week Double-Blind Period||156
6545969|NCT01698320|7467517|FG000|NOT COMPLETED|12-Week Double-Blind Period||0
6545970|NCT01698320|7467518|FG001|NOT COMPLETED|12-Week Double-Blind Period||4
6545971|NCT01698320|7467519|FG002|NOT COMPLETED|12-Week Double-Blind Period||12
6545972|NCT01698320|7467517|FG000|STARTED|40-Week Open-Label Period||0
6545973|NCT01698320|7467518|FG001|STARTED|40-Week Open-Label Period||165
6545974|NCT01698320|7467519|FG002|STARTED|40-Week Open-Label Period||156
6545975|NCT01698320|7467517|FG000|COMPLETED|40-Week Open-Label Period||0
6545976|NCT01698320|7467518|FG001|COMPLETED|40-Week Open-Label Period||146
6545977|NCT01698320|7467519|FG002|COMPLETED|40-Week Open-Label Period||146
6545978|NCT01698320|7467517|FG000|NOT COMPLETED|40-Week Open-Label Period||0
6545979|NCT01698320|7467518|FG001|NOT COMPLETED|40-Week Open-Label Period||19
6545980|NCT01698320|7467519|FG002|NOT COMPLETED|40-Week Open-Label Period||10
6545981|NCT01698333|7467527|FG000|STARTED|Overall Study||25
6545982|NCT01698333|7467527|FG000|COMPLETED|Overall Study||25
6545983|NCT01698333|7467527|FG000|NOT COMPLETED|Overall Study||0
6545984|NCT01698463|7467531|FG000|STARTED|Overall Study||11
6545985|NCT01698463|7467531|FG000|COMPLETED|Overall Study||11
6545986|NCT01698463|7467531|FG000|NOT COMPLETED|Overall Study||0
6545987|NCT01698502|7467537|FG000|STARTED|Overall Study||11
6545988|NCT01698502|7467538|FG001|STARTED|Overall Study||10
6545989|NCT01698502|7467537|FG000|COMPLETED|Overall Study||11
6545990|NCT01698502|7467538|FG001|COMPLETED|Overall Study||10
6545991|NCT01698502|7467537|FG000|NOT COMPLETED|Overall Study||0
6545992|NCT01698502|7467538|FG001|NOT COMPLETED|Overall Study||0
6545993|NCT01698528|7467546|FG000|STARTED|Overall Study||20
6545994|NCT01698528|7467547|FG001|STARTED|Overall Study||20
6545995|NCT01698528|7467546|FG000|COMPLETED|Overall Study||19
6545996|NCT01698528|7467547|FG001|COMPLETED|Overall Study||16
6545997|NCT01698528|7467546|FG000|NOT COMPLETED|Overall Study||1
6545998|NCT01698528|7467547|FG001|NOT COMPLETED|Overall Study||4
6545999|NCT01698554|7467557|FG000|STARTED|Overall Study||153
6546000|NCT01698554|7467558|FG001|STARTED|Overall Study||157
6546001|NCT01698554|7467559|FG002|STARTED|Overall Study||75
6546002|NCT01698554|7467560|FG003|STARTED|Overall Study||79
6546003|NCT01698554|7467557|FG000|COMPLETED|Overall Study||147
6546004|NCT01698554|7467558|FG001|COMPLETED|Overall Study||147
6546005|NCT01698554|7467559|FG002|COMPLETED|Overall Study||73
6546006|NCT01698554|7467560|FG003|COMPLETED|Overall Study||77
6546007|NCT01698554|7467557|FG000|NOT COMPLETED|Overall Study||6
6546008|NCT01698554|7467558|FG001|NOT COMPLETED|Overall Study||10
6546009|NCT01698554|7467559|FG002|NOT COMPLETED|Overall Study||2
6546010|NCT01698554|7467560|FG003|NOT COMPLETED|Overall Study||2
6546011|NCT01698684|7467573|FG000|STARTED|Overall Study||145
6546012|NCT01698684|7467574|FG001|STARTED|Overall Study||147
6546013|NCT01698684|7467575|FG002|STARTED|Overall Study||148
6546014|NCT01698684|7467573|FG000|ITT Population|Overall Study||136
6546015|NCT01698684|7467574|FG001|ITT Population|Overall Study||139
6546016|NCT01698684|7467575|FG002|ITT Population|Overall Study||139
6546017|NCT01698684|7467573|FG000|Safety Population|Overall Study||143
6546018|NCT01698684|7467574|FG001|Safety Population|Overall Study||146
6546019|NCT01698684|7467575|FG002|Safety Population|Overall Study||146
6546020|NCT01698684|7467573|FG000|COMPLETED|Overall Study||116
6546021|NCT01698684|7467574|FG001|COMPLETED|Overall Study||124
6546022|NCT01698684|7467575|FG002|COMPLETED|Overall Study||127
6546023|NCT01698684|7467573|FG000|NOT COMPLETED|Overall Study||29
6546024|NCT01698684|7467574|FG001|NOT COMPLETED|Overall Study||23
6546025|NCT01698684|7467575|FG002|NOT COMPLETED|Overall Study||21
6546026|NCT01698710|7467583|FG000|STARTED|Overall Study||5
6546027|NCT01698710|7467583|FG000|COMPLETED|Overall Study||5
6546028|NCT01698710|7467583|FG000|NOT COMPLETED|Overall Study||0
6546029|NCT01698775|7467589|FG000|STARTED|Phase A||107
6546030|NCT01698775|7467590|FG001|STARTED|Phase A||106
6546031|NCT01698775|7467589|FG000|COMPLETED|Phase A||98
6546032|NCT01698775|7467590|FG001|COMPLETED|Phase A||97
6546033|NCT01698775|7467589|FG000|NOT COMPLETED|Phase A||9
6546034|NCT01698775|7467590|FG001|NOT COMPLETED|Phase A||9
6546035|NCT01698775|7467589|FG000|STARTED|Phase B||98
6546036|NCT01698775|7467590|FG001|STARTED|Phase B||97
6546037|NCT01698775|7467589|FG000|COMPLETED|Phase B||84
6546038|NCT01698775|7467590|FG001|COMPLETED|Phase B||86
6546039|NCT01698775|7467589|FG000|NOT COMPLETED|Phase B||14
6546040|NCT01698775|7467590|FG001|NOT COMPLETED|Phase B||11
6546041|NCT01698801|7467600|FG000|STARTED|Treatment Phase||26
6546042|NCT01698801|7467600|FG000|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
6546043|NCT01698801|7467600|FG000|NOT COMPLETED|Treatment Phase||11
6546044|NCT01698801|7467600|FG000|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
6546045|NCT01698801|7467600|FG000|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
6546046|NCT01698801|7467600|FG000|NOT COMPLETED|Follow Up Phase||5
6546047|NCT01698814|7467607|FG000|STARTED|Overall Study||331
6546048|NCT01698814|7467608|FG001|STARTED|Overall Study||169
6546049|NCT01698814|7467607|FG000|COMPLETED|Overall Study||329
6546050|NCT01698814|7467608|FG001|COMPLETED|Overall Study||166
6546051|NCT01698814|7467607|FG000|NOT COMPLETED|Overall Study||2
6546052|NCT01698814|7467608|FG001|NOT COMPLETED|Overall Study||3
6546053|NCT01698879|7467617|FG000|STARTED|Overall Study||6
6546054|NCT01698879|7467618|FG001|STARTED|Overall Study||20
6546055|NCT01698879|7467619|FG002|STARTED|Overall Study||20
6546056|NCT01698879|7467617|FG000|COMPLETED|Overall Study||5
6546057|NCT01698879|7467618|FG001|COMPLETED|Overall Study||20
6546058|NCT01698879|7467619|FG002|COMPLETED|Overall Study||20
6546059|NCT01698879|7467617|FG000|NOT COMPLETED|Overall Study||1
6546060|NCT01698879|7467618|FG001|NOT COMPLETED|Overall Study||0
6546061|NCT01698879|7467619|FG002|NOT COMPLETED|Overall Study||0
6546062|NCT01699022|7467633|FG000|STARTED|Overall Study||17
6546063|NCT01699022|7467633|FG000|COMPLETED|Overall Study||14
6546064|NCT01699022|7467633|FG000|NOT COMPLETED|Overall Study||3
6546065|NCT01699087|7467638|FG000|STARTED|Overall Study||176
6546066|NCT01699087|7467638|FG000|Treated|Overall Study||161
6546067|NCT01699087|7467638|FG000|COMPLETED|Overall Study||152
6546068|NCT01699087|7467638|FG000|NOT COMPLETED|Overall Study||24
6546069|NCT01699178|7467645|FG000|STARTED|Overall Study||88
6546070|NCT01699178|7467646|FG001|STARTED|Overall Study||94
6546071|NCT01699178|7467645|FG000|COMPLETED|Overall Study||69
6546072|NCT01699178|7467646|FG001|COMPLETED|Overall Study||62
6546073|NCT01699178|7467645|FG000|NOT COMPLETED|Overall Study||19
6546074|NCT01699178|7467646|FG001|NOT COMPLETED|Overall Study||32
6546075|NCT01699373|7467654|FG000|STARTED|Overall Study||85
6546076|NCT01699373|7467655|FG001|STARTED|Overall Study||85
6546077|NCT01699373|7467654|FG000|COMPLETED|Overall Study||85
6546078|NCT01699373|7467655|FG001|COMPLETED|Overall Study||85
6546079|NCT01699373|7467654|FG000|NOT COMPLETED|Overall Study||0
6546080|NCT01699373|7467655|FG001|NOT COMPLETED|Overall Study||0
6546081|NCT01699503|7467663|FG000|STARTED|Overall Study||2008
6546082|NCT01699503|7467664|FG001|STARTED|Overall Study||1997
6546083|NCT01699503|7467663|FG000|Baseline|Overall Study||1723
6546084|NCT01699503|7467664|FG001|Baseline|Overall Study||1693
6546085|NCT01699503|7467663|FG000|1 Month Follow-up|Overall Study||998
6546086|NCT01699503|7467664|FG001|1 Month Follow-up|Overall Study||1022
6546087|NCT01699503|7467663|FG000|6 Month Follow-up|Overall Study||903
6546088|NCT01699503|7467664|FG001|6 Month Follow-up|Overall Study||893
6546089|NCT01699503|7467663|FG000|COMPLETED|Overall Study||1008
6546090|NCT01699503|7467664|FG001|COMPLETED|Overall Study||992
6546091|NCT01699503|7467663|FG000|NOT COMPLETED|Overall Study||1000
6546092|NCT01699503|7467664|FG001|NOT COMPLETED|Overall Study||1005
6546093|NCT01699542|7467672|FG000|STARTED|Overall Study||9
6546094|NCT01699542|7467673|FG001|STARTED|Overall Study||9
6546095|NCT01699542|7467672|FG000|COMPLETED|Overall Study||9
6546096|NCT01699542|7467673|FG001|COMPLETED|Overall Study||9
6546097|NCT01699542|7467672|FG000|NOT COMPLETED|Overall Study||0
6546098|NCT01699542|7467673|FG001|NOT COMPLETED|Overall Study||0
6546099|NCT01699607|7467681|FG000|STARTED|Overall Study||6
6546100|NCT01699607|7467682|FG001|STARTED|Overall Study||4
6546101|NCT01699607|7467681|FG000|COMPLETED|Overall Study||6
6546102|NCT01699607|7467682|FG001|COMPLETED|Overall Study||4
6546103|NCT01699607|7467681|FG000|NOT COMPLETED|Overall Study||0
6546104|NCT01699607|7467682|FG001|NOT COMPLETED|Overall Study||0
6546105|NCT01699685|7467689|FG000|STARTED|Period 1||39
6546106|NCT01699685|7467690|FG001|STARTED|Period 1||39
6546107|NCT01699685|7467689|FG000|Safety Population|Period 1||39
6546108|NCT01699685|7467690|FG001|Safety Population|Period 1||38
6546109|NCT01699685|7467689|FG000|Full Analysis Population (FAS)|Period 1||38
6546110|NCT01699685|7467690|FG001|Full Analysis Population (FAS)|Period 1||38
6546111|NCT01699685|7467689|FG000|COMPLETED|Period 1||36
6546112|NCT01699685|7467690|FG001|COMPLETED|Period 1||36
6546113|NCT01699685|7467689|FG000|NOT COMPLETED|Period 1||3
6546114|NCT01699685|7467690|FG001|NOT COMPLETED|Period 1||3
6546115|NCT01699685|7467689|FG000|STARTED|Period 2||36
6546116|NCT01699685|7467690|FG001|STARTED|Period 2||36
6546117|NCT01699685|7467689|FG000|COMPLETED|Period 2||35
6546118|NCT01699685|7467690|FG001|COMPLETED|Period 2||36
6546119|NCT01699685|7467689|FG000|NOT COMPLETED|Period 2||1
6546120|NCT01699685|7467690|FG001|NOT COMPLETED|Period 2||0
6546121|NCT01699698|7467698|FG000|STARTED|Overall Study||44
6546122|NCT01699698|7467699|FG001|STARTED|Overall Study||61
6546123|NCT01699698|7467698|FG000|COMPLETED|Overall Study||42
6546124|NCT01699698|7467699|FG001|COMPLETED|Overall Study||56
6546125|NCT01699698|7467698|FG000|NOT COMPLETED|Overall Study||2
6546126|NCT01699698|7467699|FG001|NOT COMPLETED|Overall Study||5
6546127|NCT01699750|7467708|FG000|STARTED|Overall Study||34
6546128|NCT01699750|7467709|FG001|STARTED|Overall Study||36
6546129|NCT01699750|7467708|FG000|COMPLETED|Overall Study||34
6546130|NCT01699750|7467709|FG001|COMPLETED|Overall Study||33
6546131|NCT01699750|7467708|FG000|NOT COMPLETED|Overall Study||0
6546132|NCT01699750|7467709|FG001|NOT COMPLETED|Overall Study||3
6546133|NCT01699763|7467719|FG000|STARTED|Overall Study||112
6546134|NCT01699763|7467719|FG000|COMPLETED|Overall Study||112
6546135|NCT01699763|7467719|FG000|NOT COMPLETED|Overall Study||0
6546136|NCT01699789|7467725|FG000|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
6546137|NCT01699789|7467726|FG001|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
6546138|NCT01699789|7467725|FG000|Baseline|Overall Study||492
6546139|NCT01699789|7467726|FG001|Baseline|Overall Study||489
6546140|NCT01699789|7467725|FG000|6-Month Follow-Up|Overall Study||380
6546141|NCT01699789|7467726|FG001|6-Month Follow-Up|Overall Study||379
6546142|NCT01699789|7467725|FG000|12-Month Follow-Up|Overall Study||364
6546143|NCT01699789|7467726|FG001|12-Month Follow-Up|Overall Study||369
6546144|NCT01699789|7467725|FG000|3-Year Follow-up|Overall Study||293
6546145|NCT01699789|7467726|FG001|3-Year Follow-up|Overall Study||307
6546146|NCT01699789|7467725|FG000|4-Year Follow-up|Overall Study||143
6546147|NCT01699789|7467726|FG001|4-Year Follow-up|Overall Study||140
6546148|NCT01699789|7467725|FG000|COMPLETED|Overall Study|Clients in 44 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|504
6546149|NCT01699789|7467726|FG001|COMPLETED|Overall Study|Clients in 46 programs with completed at least 1 data point at baseline, 6, or 12 mo FUP analyzed|514
6546150|NCT01699789|7467725|FG000|NOT COMPLETED|Overall Study||102
6546151|NCT01699789|7467726|FG001|NOT COMPLETED|Overall Study||126
6546152|NCT01699815|7467736|FG000|STARTED|Overall Study||62
6546153|NCT01699815|7467737|FG001|STARTED|Overall Study||64
6546154|NCT01699815|7467736|FG000|COMPLETED|Overall Study||57
6546155|NCT01699815|7467737|FG001|COMPLETED|Overall Study||56
6546156|NCT01699815|7467736|FG000|NOT COMPLETED|Overall Study||5
6546157|NCT01699815|7467737|FG001|NOT COMPLETED|Overall Study||8
6546158|NCT01699867|7467743|FG000|STARTED|Overall Study||50
6546159|NCT01699867|7467743|FG000|COMPLETED|Overall Study||47
6546160|NCT01699867|7467743|FG000|NOT COMPLETED|Overall Study||3
6546161|NCT01700036|7467747|FG000|STARTED|Overall Study||40
6546162|NCT01700036|7467747|FG000|COMPLETED|Overall Study||40
6546163|NCT01700036|7467747|FG000|NOT COMPLETED|Overall Study||0
6546164|NCT01700049|7467751|FG000|STARTED|Overall Study||28
6546165|NCT01700049|7467751|FG000|COMPLETED|Overall Study||27
6546166|NCT01700049|7467751|FG000|NOT COMPLETED|Overall Study||1
6546167|NCT01700140|7467759|FG000|STARTED|Overall Study||61
6546168|NCT01700140|7467760|FG001|STARTED|Overall Study||66
6546169|NCT01700140|7467761|FG002|STARTED|Overall Study||62
6546170|NCT01700140|7467759|FG000|COMPLETED|Overall Study||55
6546171|NCT01700140|7467760|FG001|COMPLETED|Overall Study||57
6546172|NCT01700140|7467761|FG002|COMPLETED|Overall Study||61
6546173|NCT01700140|7467759|FG000|NOT COMPLETED|Overall Study||6
6546174|NCT01700140|7467760|FG001|NOT COMPLETED|Overall Study||9
6546175|NCT01700140|7467761|FG002|NOT COMPLETED|Overall Study||1
6546176|NCT01700179|7467772|FG000|STARTED|Overall Study||8
6546177|NCT01700179|7467772|FG000|COMPLETED|Overall Study||6
6546178|NCT01700179|7467772|FG000|NOT COMPLETED|Overall Study||2
6546179|NCT01700192|7467778|FG000|STARTED|Overall Study||741
6546180|NCT01700192|7467779|FG001|STARTED|Overall Study||741
6546181|NCT01700192|7467778|FG000|Treated|Overall Study||740
6546182|NCT01700192|7467779|FG001|Treated|Overall Study||741
6546183|NCT01700192|7467778|FG000|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
6546184|NCT01700192|7467779|FG001|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
6546185|NCT01700192|7467778|FG000|COMPLETED|Overall Study||561
6546186|NCT01700192|7467779|FG001|COMPLETED|Overall Study||613
6546187|NCT01700192|7467778|FG000|NOT COMPLETED|Overall Study||180
6546188|NCT01700192|7467779|FG001|NOT COMPLETED|Overall Study||128
6546189|NCT01700205|7467787|FG000|STARTED|Overall Study|Mother-Infant Dyads|59
6546190|NCT01700205|7467788|FG001|STARTED|Overall Study|Mother-Infant Dyads|54
6546191|NCT01700205|7467787|FG000|COMPLETED|Overall Study|Mother-Infant Dyads|44
6546192|NCT01700205|7467788|FG001|COMPLETED|Overall Study|Mother-Infant Dyads|39
6546193|NCT01700205|7467787|FG000|NOT COMPLETED|Overall Study||15
6546194|NCT01700205|7467788|FG001|NOT COMPLETED|Overall Study||15
6546195|NCT01700335|7467794|FG000|STARTED|Overall Study||3
6546196|NCT01700335|7467795|FG001|STARTED|Overall Study||6
6546197|NCT01700335|7467794|FG000|COMPLETED|Overall Study||2
6546198|NCT01700335|7467795|FG001|COMPLETED|Overall Study||2
6546199|NCT01700335|7467794|FG000|NOT COMPLETED|Overall Study||1
6546200|NCT01700335|7467795|FG001|NOT COMPLETED|Overall Study||4
6546201|NCT01700387|7467804|FG000|STARTED|Overall Study||10
6546202|NCT01700387|7467805|FG001|STARTED|Overall Study||10
6546203|NCT01700387|7467804|FG000|COMPLETED|Overall Study||6
6546204|NCT01700387|7467805|FG001|COMPLETED|Overall Study||6
6546205|NCT01700387|7467804|FG000|NOT COMPLETED|Overall Study||4
6546206|NCT01700387|7467805|FG001|NOT COMPLETED|Overall Study||4
6546207|NCT01700517|7467818|FG000|STARTED|Overall Study||40
6546208|NCT01700517|7467819|FG001|STARTED|Overall Study||40
6546209|NCT01700517|7467820|FG002|STARTED|Overall Study||40
6546210|NCT01700517|7467818|FG000|COMPLETED|Overall Study||40
6546211|NCT01700517|7467819|FG001|COMPLETED|Overall Study||40
6546212|NCT01700517|7467820|FG002|COMPLETED|Overall Study||40
6546213|NCT01700517|7467818|FG000|NOT COMPLETED|Overall Study||0
6546214|NCT01700517|7467819|FG001|NOT COMPLETED|Overall Study||0
6546215|NCT01700517|7467820|FG002|NOT COMPLETED|Overall Study||0
6546216|NCT01700530|7467831|FG000|STARTED|Overall Study||9
6546217|NCT01700530|7467832|FG001|STARTED|Overall Study||21
6546218|NCT01700530|7467833|FG002|STARTED|Overall Study||20
6546219|NCT01700530|7467831|FG000|COMPLETED|Overall Study||9
6546220|NCT01700530|7467832|FG001|COMPLETED|Overall Study||18
6546221|NCT01700530|7467833|FG002|COMPLETED|Overall Study||19
6546222|NCT01700530|7467831|FG000|NOT COMPLETED|Overall Study||0
6546223|NCT01700530|7467832|FG001|NOT COMPLETED|Overall Study||3
6546224|NCT01700530|7467833|FG002|NOT COMPLETED|Overall Study||1
6546225|NCT01700621|7467843|FG000|STARTED|Received Study Vaccines||240
6546226|NCT01700621|7467844|FG001|STARTED|Received Study Vaccines||240
6546227|NCT01700621|7467843|FG000|COMPLETED|Received Study Vaccines||240
6546228|NCT01700621|7467844|FG001|COMPLETED|Received Study Vaccines||240
6546229|NCT01700621|7467843|FG000|NOT COMPLETED|Received Study Vaccines||0
6546230|NCT01700621|7467844|FG001|NOT COMPLETED|Received Study Vaccines||0
6546231|NCT01700621|7467843|FG000|STARTED|Analyzed for Immunogenicity||240
6546232|NCT01700621|7467844|FG001|STARTED|Analyzed for Immunogenicity||240
6546233|NCT01700621|7467843|FG000|COMPLETED|Analyzed for Immunogenicity||227
6546234|NCT01700621|7467844|FG001|COMPLETED|Analyzed for Immunogenicity||233
6546235|NCT01700621|7467843|FG000|NOT COMPLETED|Analyzed for Immunogenicity||13
6546236|NCT01700621|7467844|FG001|NOT COMPLETED|Analyzed for Immunogenicity||7
6546237|NCT01700673|7467854|FG000|STARTED|Overall Study||1
6546238|NCT01700673|7467855|FG001|STARTED|Overall Study||23
6546239|NCT01700673|7467856|FG002|STARTED|Overall Study||1
6546240|NCT01700673|7467854|FG000|COMPLETED|Overall Study||1
6546241|NCT01700673|7467855|FG001|COMPLETED|Overall Study||17
6546242|NCT01700673|7467856|FG002|COMPLETED|Overall Study||1
6546243|NCT01700673|7467854|FG000|NOT COMPLETED|Overall Study||0
6546244|NCT01700673|7467855|FG001|NOT COMPLETED|Overall Study||6
6546245|NCT01700673|7467856|FG002|NOT COMPLETED|Overall Study||0
6546246|NCT01700725|7467868|FG000|STARTED|Overall Study||14
6546247|NCT01700725|7467869|FG001|STARTED|Overall Study||14
6546248|NCT01700725|7467870|FG002|STARTED|Overall Study||12
6546249|NCT01700725|7467868|FG000|COMPLETED|Overall Study||14
6546250|NCT01700725|7467869|FG001|COMPLETED|Overall Study||14
6546251|NCT01700725|7467870|FG002|COMPLETED|Overall Study||12
6546252|NCT01700725|7467868|FG000|NOT COMPLETED|Overall Study||0
6546253|NCT01700725|7467869|FG001|NOT COMPLETED|Overall Study||0
6546254|NCT01700725|7467870|FG002|NOT COMPLETED|Overall Study||0
6546255|NCT01700816|7467880|FG000|STARTED|Overall Study||21
6546256|NCT01700816|7467881|FG001|STARTED|Overall Study||19
6546257|NCT01700816|7467880|FG000|COMPLETED|Overall Study||21
6546258|NCT01700816|7467881|FG001|COMPLETED|Overall Study||19
6546259|NCT01700816|7467880|FG000|NOT COMPLETED|Overall Study||0
6546260|NCT01700816|7467881|FG001|NOT COMPLETED|Overall Study||0
6546261|NCT01700829|7467889|FG000|STARTED|Overall Study||41
6546262|NCT01700829|7467890|FG001|STARTED|Overall Study||41
6546263|NCT01700829|7467889|FG000|COMPLETED|Overall Study||40
6546264|NCT01700829|7467890|FG001|COMPLETED|Overall Study||40
6546265|NCT01700829|7467889|FG000|NOT COMPLETED|Overall Study||1
6546266|NCT01700829|7467890|FG001|NOT COMPLETED|Overall Study||1
6546267|NCT01700907|7467898|FG000|STARTED|Overall Study||10
6546268|NCT01700907|7467899|FG001|STARTED|Overall Study||10
6546269|NCT01700907|7467898|FG000|COMPLETED|Overall Study||10
6546270|NCT01700907|7467899|FG001|COMPLETED|Overall Study||10
6546271|NCT01700907|7467898|FG000|NOT COMPLETED|Overall Study||0
6546272|NCT01700907|7467899|FG001|NOT COMPLETED|Overall Study||0
6546273|NCT01700959|7467911|FG000|STARTED|Overall Study||89
6546274|NCT01700959|7467912|FG001|STARTED|Overall Study||88
6546275|NCT01700959|7467913|FG002|STARTED|Overall Study||105
6546276|NCT01700959|7467914|FG003|STARTED|Overall Study||105
6546277|NCT01700959|7467915|FG004|STARTED|Overall Study||96
6546278|NCT01700959|7467916|FG005|STARTED|Overall Study||97
6546279|NCT01700959|7467911|FG000|COMPLETED|Overall Study||62
6546280|NCT01700959|7467912|FG001|COMPLETED|Overall Study||64
6546281|NCT01700959|7467913|FG002|COMPLETED|Overall Study||65
6546282|NCT01700959|7467914|FG003|COMPLETED|Overall Study||70
6546283|NCT01700959|7467915|FG004|COMPLETED|Overall Study||69
6546284|NCT01700959|7467916|FG005|COMPLETED|Overall Study||72
6546285|NCT01700959|7467911|FG000|NOT COMPLETED|Overall Study||27
6546286|NCT01700959|7467912|FG001|NOT COMPLETED|Overall Study||24
6546287|NCT01700959|7467913|FG002|NOT COMPLETED|Overall Study||40
6546288|NCT01700959|7467914|FG003|NOT COMPLETED|Overall Study||35
6546289|NCT01700959|7467915|FG004|NOT COMPLETED|Overall Study||27
6546290|NCT01700959|7467916|FG005|NOT COMPLETED|Overall Study||25
6546291|NCT01700985|7467934|FG000|STARTED|Overall Study||23
6546292|NCT01700985|7467935|FG001|STARTED|Overall Study||21
6546293|NCT01700985|7467934|FG000|COMPLETED|Overall Study||23
6546294|NCT01700985|7467935|FG001|COMPLETED|Overall Study||20
6546295|NCT01700985|7467934|FG000|NOT COMPLETED|Overall Study||0
6546296|NCT01700985|7467935|FG001|NOT COMPLETED|Overall Study||1
6546297|NCT01701011|7467944|FG000|STARTED|Overall Study||127
6546298|NCT01701011|7467945|FG001|STARTED|Overall Study||126
6546299|NCT01701011|7467946|FG002|STARTED|Overall Study||124
6546300|NCT01701011|7467944|FG000|COMPLETED|Overall Study||92
6546301|NCT01701011|7467945|FG001|COMPLETED|Overall Study||102
6546302|NCT01701011|7467946|FG002|COMPLETED|Overall Study||90
6546303|NCT01701011|7467944|FG000|NOT COMPLETED|Overall Study||35
6546304|NCT01701011|7467945|FG001|NOT COMPLETED|Overall Study||24
6546305|NCT01701011|7467946|FG002|NOT COMPLETED|Overall Study||34
6546306|NCT01701024|7467957|FG000|STARTED|Overall Study||253
6546307|NCT01701024|7467958|FG001|STARTED|Overall Study||245
6546308|NCT01701024|7467957|FG000|COMPLETED|Overall Study||243
6546309|NCT01701024|7467958|FG001|COMPLETED|Overall Study||236
6546310|NCT01701024|7467957|FG000|NOT COMPLETED|Overall Study||10
6546311|NCT01701024|7467958|FG001|NOT COMPLETED|Overall Study||9
6546312|NCT01701037|7467964|FG000|STARTED|Overall Study||13
6546313|NCT01701037|7467964|FG000|COMPLETED|Overall Study||13
6546314|NCT01701037|7467964|FG000|NOT COMPLETED|Overall Study||0
6546315|NCT01701063|7467972|FG000|STARTED|Overall Study||13
6546316|NCT01701063|7467973|FG001|STARTED|Overall Study||19
6546317|NCT01701063|7467974|FG002|STARTED|Overall Study||10
6546318|NCT01701063|7467972|FG000|COMPLETED|Overall Study||13
6546319|NCT01701063|7467973|FG001|COMPLETED|Overall Study||18
6546320|NCT01701063|7467974|FG002|COMPLETED|Overall Study||8
6546321|NCT01701063|7467972|FG000|NOT COMPLETED|Overall Study||0
6546322|NCT01701063|7467973|FG001|NOT COMPLETED|Overall Study||1
6546323|NCT01701063|7467974|FG002|NOT COMPLETED|Overall Study||2
6546324|NCT01701102|7467987|FG000|STARTED|Overall Study||22
6546325|NCT01701102|7467988|FG001|STARTED|Overall Study||6
6546326|NCT01701102|7467989|FG002|STARTED|Overall Study||10
6546327|NCT01701102|7467990|FG003|STARTED|Overall Study||18
6546328|NCT01701102|7467987|FG000|COMPLETED|Overall Study||22
6546329|NCT01701102|7467988|FG001|COMPLETED|Overall Study||6
6546330|NCT01701102|7467989|FG002|COMPLETED|Overall Study||10
6546331|NCT01701102|7467990|FG003|COMPLETED|Overall Study||18
6546332|NCT01701102|7467987|FG000|NOT COMPLETED|Overall Study||0
6546333|NCT01701102|7467988|FG001|NOT COMPLETED|Overall Study||0
6546334|NCT01701102|7467989|FG002|NOT COMPLETED|Overall Study||0
6546335|NCT01701102|7467990|FG003|NOT COMPLETED|Overall Study||0
6546336|NCT01701115|7468002|FG000|STARTED|Overall Study||77
6546337|NCT01701115|7468003|FG001|STARTED|Overall Study||77
6546338|NCT01701115|7468002|FG000|COMPLETED|Overall Study||75
6546339|NCT01701115|7468003|FG001|COMPLETED|Overall Study||77
6546340|NCT01701115|7468002|FG000|NOT COMPLETED|Overall Study||2
6546341|NCT01701115|7468003|FG001|NOT COMPLETED|Overall Study||0
6546342|NCT01701193|7468013|FG000|STARTED|Overall Study||18
6546343|NCT01701193|7468014|FG001|STARTED|Overall Study||19
6546344|NCT01701193|7468015|FG002|STARTED|Overall Study||5
6546345|NCT01701193|7468016|FG003|STARTED|Overall Study||5
6546346|NCT01701193|7468013|FG000|COMPLETED|Overall Study||15
6546347|NCT01701193|7468014|FG001|COMPLETED|Overall Study||17
6546348|NCT01701193|7468015|FG002|COMPLETED|Overall Study||4
6546349|NCT01701193|7468016|FG003|COMPLETED|Overall Study||3
6546350|NCT01701193|7468013|FG000|NOT COMPLETED|Overall Study||3
6546351|NCT01701193|7468014|FG001|NOT COMPLETED|Overall Study||2
6546352|NCT01701193|7468015|FG002|NOT COMPLETED|Overall Study||1
6546353|NCT01701193|7468016|FG003|NOT COMPLETED|Overall Study||2
6546354|NCT01701245|7468031|FG000|STARTED|Overall Study||49
6546355|NCT01701245|7468032|FG001|STARTED|Overall Study||48
6546356|NCT01701245|7468031|FG000|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
6546357|NCT01701245|7468032|FG001|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
6546358|NCT01701245|7468031|FG000|FAS Matched Data|Overall Study||42
6546359|NCT01701245|7468032|FG001|FAS Matched Data|Overall Study||32
6546360|NCT01701245|7468031|FG000|COMPLETED|Overall Study||37
6546361|NCT01701245|7468032|FG001|COMPLETED|Overall Study||33
6546362|NCT01701245|7468031|FG000|NOT COMPLETED|Overall Study||12
6546363|NCT01701245|7468032|FG001|NOT COMPLETED|Overall Study||15
6546364|NCT01701258|7468042|FG000|STARTED|Assessment and Scheduling||153
6546365|NCT01701258|7468043|FG001|STARTED|Assessment and Scheduling||0
6546366|NCT01701258|7468044|FG002|STARTED|Assessment and Scheduling||0
6546367|NCT01701258|7468045|FG003|STARTED|Assessment and Scheduling||0
6546368|NCT01701258|7468046|FG004|STARTED|Assessment and Scheduling||0
6546369|NCT01701258|7468047|FG005|STARTED|Assessment and Scheduling||0
6546370|NCT01701258|7468048|FG006|STARTED|Assessment and Scheduling||0
6546371|NCT01701258|7468049|FG007|STARTED|Assessment and Scheduling||0
6546372|NCT01701258|7468050|FG008|STARTED|Assessment and Scheduling||0
6546373|NCT01701258|7468051|FG009|STARTED|Assessment and Scheduling||0
6546374|NCT01701258|7468052|FG010|STARTED|Assessment and Scheduling||0
6546375|NCT01701258|7468053|FG011|STARTED|Assessment and Scheduling||0
6546376|NCT01701258|7468054|FG012|STARTED|Assessment and Scheduling||0
6546377|NCT01701258|7468042|FG000|Eligible After Screening Visit|Assessment and Scheduling||96
6546378|NCT01701258|7468043|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
6546379|NCT01701258|7468044|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
6546380|NCT01701258|7468045|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
6546381|NCT01701258|7468046|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
6546382|NCT01701258|7468047|FG005|Eligible After Screening Visit|Assessment and Scheduling||0
6546383|NCT01701258|7468048|FG006|Eligible After Screening Visit|Assessment and Scheduling||0
6546384|NCT01701258|7468049|FG007|Eligible After Screening Visit|Assessment and Scheduling||0
6546385|NCT01701258|7468050|FG008|Eligible After Screening Visit|Assessment and Scheduling||0
6546386|NCT01701258|7468051|FG009|Eligible After Screening Visit|Assessment and Scheduling||0
6546387|NCT01701258|7468052|FG010|Eligible After Screening Visit|Assessment and Scheduling||0
6546388|NCT01701258|7468053|FG011|Eligible After Screening Visit|Assessment and Scheduling||0
6546389|NCT01701258|7468054|FG012|Eligible After Screening Visit|Assessment and Scheduling||0
6546390|NCT01701258|7468042|FG000|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||68
6546391|NCT01701258|7468043|FG001|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546392|NCT01701258|7468044|FG002|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546393|NCT01701258|7468045|FG003|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546394|NCT01701258|7468046|FG004|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546395|NCT01701258|7468047|FG005|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546396|NCT01701258|7468048|FG006|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546397|NCT01701258|7468049|FG007|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546398|NCT01701258|7468050|FG008|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546399|NCT01701258|7468051|FG009|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546400|NCT01701258|7468052|FG010|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546401|NCT01701258|7468053|FG011|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546402|NCT01701258|7468054|FG012|Returned for Drug+fMRI (Session 2)|Assessment and Scheduling||0
6546403|NCT01701258|7468042|FG000|Returned for PET (Session 3)|Assessment and Scheduling||73
6546404|NCT01701258|7468043|FG001|Returned for PET (Session 3)|Assessment and Scheduling||0
6546405|NCT01701258|7468044|FG002|Returned for PET (Session 3)|Assessment and Scheduling||0
6546406|NCT01701258|7468045|FG003|Returned for PET (Session 3)|Assessment and Scheduling||0
6546407|NCT01701258|7468046|FG004|Returned for PET (Session 3)|Assessment and Scheduling||0
6546408|NCT01701258|7468047|FG005|Returned for PET (Session 3)|Assessment and Scheduling||0
6546409|NCT01701258|7468048|FG006|Returned for PET (Session 3)|Assessment and Scheduling||0
6546410|NCT01701258|7468049|FG007|Returned for PET (Session 3)|Assessment and Scheduling||0
6546411|NCT01701258|7468050|FG008|Returned for PET (Session 3)|Assessment and Scheduling||0
6546412|NCT01701258|7468051|FG009|Returned for PET (Session 3)|Assessment and Scheduling||0
6546413|NCT01701258|7468052|FG010|Returned for PET (Session 3)|Assessment and Scheduling||0
6546414|NCT01701258|7468053|FG011|Returned for PET (Session 3)|Assessment and Scheduling||0
6546415|NCT01701258|7468054|FG012|Returned for PET (Session 3)|Assessment and Scheduling||0
6546416|NCT01701258|7468042|FG000|Returned for EEG (Session 4)|Assessment and Scheduling||66
6546417|NCT01701258|7468043|FG001|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546418|NCT01701258|7468044|FG002|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546419|NCT01701258|7468045|FG003|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546420|NCT01701258|7468046|FG004|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546421|NCT01701258|7468047|FG005|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546422|NCT01701258|7468048|FG006|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546423|NCT01701258|7468049|FG007|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546424|NCT01701258|7468050|FG008|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546425|NCT01701258|7468051|FG009|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546426|NCT01701258|7468052|FG010|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546427|NCT01701258|7468053|FG011|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546428|NCT01701258|7468054|FG012|Returned for EEG (Session 4)|Assessment and Scheduling||0
6546429|NCT01701258|7468042|FG000|COMPLETED|Assessment and Scheduling||70
6546430|NCT01701258|7468043|FG001|COMPLETED|Assessment and Scheduling||0
6546431|NCT01701258|7468044|FG002|COMPLETED|Assessment and Scheduling||0
6546432|NCT01701258|7468045|FG003|COMPLETED|Assessment and Scheduling||0
6546433|NCT01701258|7468046|FG004|COMPLETED|Assessment and Scheduling||0
6546434|NCT01701258|7468047|FG005|COMPLETED|Assessment and Scheduling||0
6546435|NCT01701258|7468048|FG006|COMPLETED|Assessment and Scheduling||0
6546436|NCT01701258|7468049|FG007|COMPLETED|Assessment and Scheduling||0
6546437|NCT01701258|7468050|FG008|COMPLETED|Assessment and Scheduling||0
6646902|NCT02384096|7575915|FG001|NOT COMPLETED|Second Intervention (7 Days)||1
6646903|NCT02384200|7575922|FG000|STARTED|Overall Study||43
6646904|NCT02384200|7575923|FG001|STARTED|Overall Study||43
6646905|NCT02384200|7575922|FG000|COMPLETED|Overall Study||43
6646906|NCT02384200|7575923|FG001|COMPLETED|Overall Study||43
6646907|NCT02384200|7575922|FG000|NOT COMPLETED|Overall Study||0
6646908|NCT02384200|7575923|FG001|NOT COMPLETED|Overall Study||0
6546438|NCT01701258|7468051|FG009|COMPLETED|Assessment and Scheduling||0
6546439|NCT01701258|7468052|FG010|COMPLETED|Assessment and Scheduling||0
6546440|NCT01701258|7468053|FG011|COMPLETED|Assessment and Scheduling||0
6546441|NCT01701258|7468054|FG012|COMPLETED|Assessment and Scheduling||0
6546442|NCT01701258|7468042|FG000|NOT COMPLETED|Assessment and Scheduling||83
6546443|NCT01701258|7468043|FG001|NOT COMPLETED|Assessment and Scheduling||0
6546444|NCT01701258|7468044|FG002|NOT COMPLETED|Assessment and Scheduling||0
6546445|NCT01701258|7468045|FG003|NOT COMPLETED|Assessment and Scheduling||0
6546446|NCT01701258|7468046|FG004|NOT COMPLETED|Assessment and Scheduling||0
6546447|NCT01701258|7468047|FG005|NOT COMPLETED|Assessment and Scheduling||0
6546448|NCT01701258|7468048|FG006|NOT COMPLETED|Assessment and Scheduling||0
6546449|NCT01701258|7468049|FG007|NOT COMPLETED|Assessment and Scheduling||0
6546450|NCT01701258|7468050|FG008|NOT COMPLETED|Assessment and Scheduling||0
6546451|NCT01701258|7468051|FG009|NOT COMPLETED|Assessment and Scheduling||0
6546452|NCT01701258|7468052|FG010|NOT COMPLETED|Assessment and Scheduling||0
6546453|NCT01701258|7468053|FG011|NOT COMPLETED|Assessment and Scheduling||0
6546454|NCT01701258|7468054|FG012|NOT COMPLETED|Assessment and Scheduling||0
6546455|NCT01701258|7468042|FG000|STARTED|Drug+fMRI (Session 2)||0
6546456|NCT01701258|7468043|FG001|STARTED|Drug+fMRI (Session 2)||0
6546457|NCT01701258|7468044|FG002|STARTED|Drug+fMRI (Session 2)||11
6546458|NCT01701258|7468045|FG003|STARTED|Drug+fMRI (Session 2)||11
6546459|NCT01701258|7468046|FG004|STARTED|Drug+fMRI (Session 2)||0
6546460|NCT01701258|7468047|FG005|STARTED|Drug+fMRI (Session 2)||9
6546461|NCT01701258|7468048|FG006|STARTED|Drug+fMRI (Session 2)||8
6546462|NCT01701258|7468049|FG007|STARTED|Drug+fMRI (Session 2)||0
6546463|NCT01701258|7468050|FG008|STARTED|Drug+fMRI (Session 2)||6
6546464|NCT01701258|7468051|FG009|STARTED|Drug+fMRI (Session 2)||6
6546465|NCT01701258|7468052|FG010|STARTED|Drug+fMRI (Session 2)||0
6546466|NCT01701258|7468053|FG011|STARTED|Drug+fMRI (Session 2)||10
6546467|NCT01701258|7468054|FG012|STARTED|Drug+fMRI (Session 2)||7
6546468|NCT01701258|7468042|FG000|Received Drug Challenge|Drug+fMRI (Session 2)||0
6546469|NCT01701258|7468043|FG001|Received Drug Challenge|Drug+fMRI (Session 2)||0
6546470|NCT01701258|7468044|FG002|Received Drug Challenge|Drug+fMRI (Session 2)||11
6546471|NCT01701258|7468045|FG003|Received Drug Challenge|Drug+fMRI (Session 2)||11
6546472|NCT01701258|7468046|FG004|Received Drug Challenge|Drug+fMRI (Session 2)||0
6546473|NCT01701258|7468047|FG005|Received Drug Challenge|Drug+fMRI (Session 2)||9
6546474|NCT01701258|7468048|FG006|Received Drug Challenge|Drug+fMRI (Session 2)||8
6546475|NCT01701258|7468049|FG007|Received Drug Challenge|Drug+fMRI (Session 2)||0
6546476|NCT01701258|7468050|FG008|Received Drug Challenge|Drug+fMRI (Session 2)||6
6546477|NCT01701258|7468051|FG009|Received Drug Challenge|Drug+fMRI (Session 2)||6
6546478|NCT01701258|7468052|FG010|Received Drug Challenge|Drug+fMRI (Session 2)||0
6546479|NCT01701258|7468053|FG011|Received Drug Challenge|Drug+fMRI (Session 2)||10
6546480|NCT01701258|7468054|FG012|Received Drug Challenge|Drug+fMRI (Session 2)||7
6546481|NCT01701258|7468042|FG000|COMPLETED|Drug+fMRI (Session 2)||0
6546482|NCT01701258|7468043|FG001|COMPLETED|Drug+fMRI (Session 2)||0
6546483|NCT01701258|7468044|FG002|COMPLETED|Drug+fMRI (Session 2)||11
6546484|NCT01701258|7468045|FG003|COMPLETED|Drug+fMRI (Session 2)||11
6546485|NCT01701258|7468046|FG004|COMPLETED|Drug+fMRI (Session 2)||0
6546486|NCT01701258|7468047|FG005|COMPLETED|Drug+fMRI (Session 2)||9
6546487|NCT01701258|7468048|FG006|COMPLETED|Drug+fMRI (Session 2)||8
6546488|NCT01701258|7468049|FG007|COMPLETED|Drug+fMRI (Session 2)||0
6546489|NCT01701258|7468050|FG008|COMPLETED|Drug+fMRI (Session 2)||6
6546490|NCT01701258|7468051|FG009|COMPLETED|Drug+fMRI (Session 2)||6
6546491|NCT01701258|7468052|FG010|COMPLETED|Drug+fMRI (Session 2)||0
6546492|NCT01701258|7468053|FG011|COMPLETED|Drug+fMRI (Session 2)||10
6546493|NCT01701258|7468054|FG012|COMPLETED|Drug+fMRI (Session 2)||7
6546494|NCT01701258|7468042|FG000|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546495|NCT01701258|7468043|FG001|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546496|NCT01701258|7468044|FG002|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546497|NCT01701258|7468045|FG003|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546498|NCT01701258|7468046|FG004|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546499|NCT01701258|7468047|FG005|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546500|NCT01701258|7468048|FG006|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546501|NCT01701258|7468049|FG007|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546502|NCT01701258|7468050|FG008|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546503|NCT01701258|7468051|FG009|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546504|NCT01701258|7468052|FG010|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546505|NCT01701258|7468053|FG011|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546506|NCT01701258|7468054|FG012|NOT COMPLETED|Drug+fMRI (Session 2)||0
6546507|NCT01701258|7468042|FG000|STARTED|PET (Session 3)||0
6546508|NCT01701258|7468043|FG001|STARTED|PET (Session 3)||20
6546509|NCT01701258|7468044|FG002|STARTED|PET (Session 3)||0
6546510|NCT01701258|7468045|FG003|STARTED|PET (Session 3)||0
6546511|NCT01701258|7468046|FG004|STARTED|PET (Session 3)||16
6546512|NCT01701258|7468047|FG005|STARTED|PET (Session 3)||0
6546513|NCT01701258|7468048|FG006|STARTED|PET (Session 3)||0
6546514|NCT01701258|7468049|FG007|STARTED|PET (Session 3)||19
6546515|NCT01701258|7468050|FG008|STARTED|PET (Session 3)||0
6546516|NCT01701258|7468051|FG009|STARTED|PET (Session 3)||0
6546517|NCT01701258|7468052|FG010|STARTED|PET (Session 3)||18
6546518|NCT01701258|7468053|FG011|STARTED|PET (Session 3)||0
6546519|NCT01701258|7468054|FG012|STARTED|PET (Session 3)||0
6546520|NCT01701258|7468042|FG000|COMPLETED|PET (Session 3)||0
6546521|NCT01701258|7468043|FG001|COMPLETED|PET (Session 3)||20
6546522|NCT01701258|7468044|FG002|COMPLETED|PET (Session 3)||0
6546523|NCT01701258|7468045|FG003|COMPLETED|PET (Session 3)||0
6546524|NCT01701258|7468046|FG004|COMPLETED|PET (Session 3)||16
6546525|NCT01701258|7468047|FG005|COMPLETED|PET (Session 3)||0
6546526|NCT01701258|7468048|FG006|COMPLETED|PET (Session 3)||0
6546527|NCT01701258|7468049|FG007|COMPLETED|PET (Session 3)||19
6546528|NCT01701258|7468050|FG008|COMPLETED|PET (Session 3)||0
6546529|NCT01701258|7468051|FG009|COMPLETED|PET (Session 3)||0
6546530|NCT01701258|7468052|FG010|COMPLETED|PET (Session 3)||18
6546531|NCT01701258|7468053|FG011|COMPLETED|PET (Session 3)||0
6546532|NCT01701258|7468054|FG012|COMPLETED|PET (Session 3)||0
6546533|NCT01701258|7468042|FG000|NOT COMPLETED|PET (Session 3)||0
6546534|NCT01701258|7468043|FG001|NOT COMPLETED|PET (Session 3)||0
6546535|NCT01701258|7468044|FG002|NOT COMPLETED|PET (Session 3)||0
6546536|NCT01701258|7468045|FG003|NOT COMPLETED|PET (Session 3)||0
6546537|NCT01701258|7468046|FG004|NOT COMPLETED|PET (Session 3)||0
6546538|NCT01701258|7468047|FG005|NOT COMPLETED|PET (Session 3)||0
6546539|NCT01701258|7468048|FG006|NOT COMPLETED|PET (Session 3)||0
6546540|NCT01701258|7468049|FG007|NOT COMPLETED|PET (Session 3)||0
6546541|NCT01701258|7468050|FG008|NOT COMPLETED|PET (Session 3)||0
6546542|NCT01701258|7468051|FG009|NOT COMPLETED|PET (Session 3)||0
6546543|NCT01701258|7468052|FG010|NOT COMPLETED|PET (Session 3)||0
6546544|NCT01701258|7468053|FG011|NOT COMPLETED|PET (Session 3)||0
6546545|NCT01701258|7468054|FG012|NOT COMPLETED|PET (Session 3)||0
6546546|NCT01701258|7468042|FG000|STARTED|EEG (Session 4)||0
6546547|NCT01701258|7468043|FG001|STARTED|EEG (Session 4)||19
6546548|NCT01701258|7468044|FG002|STARTED|EEG (Session 4)||0
6546549|NCT01701258|7468045|FG003|STARTED|EEG (Session 4)||0
6546550|NCT01701258|7468046|FG004|STARTED|EEG (Session 4)||14
6546551|NCT01701258|7468047|FG005|STARTED|EEG (Session 4)||0
6546552|NCT01701258|7468048|FG006|STARTED|EEG (Session 4)||0
6546553|NCT01701258|7468049|FG007|STARTED|EEG (Session 4)||16
6546554|NCT01701258|7468050|FG008|STARTED|EEG (Session 4)||0
6546555|NCT01701258|7468051|FG009|STARTED|EEG (Session 4)||0
6546556|NCT01701258|7468052|FG010|STARTED|EEG (Session 4)||17
6546557|NCT01701258|7468053|FG011|STARTED|EEG (Session 4)||0
6546558|NCT01701258|7468054|FG012|STARTED|EEG (Session 4)||0
6546559|NCT01701258|7468042|FG000|COMPLETED|EEG (Session 4)||0
6546560|NCT01701258|7468043|FG001|COMPLETED|EEG (Session 4)||19
6546561|NCT01701258|7468044|FG002|COMPLETED|EEG (Session 4)||0
6546562|NCT01701258|7468045|FG003|COMPLETED|EEG (Session 4)||0
6546563|NCT01701258|7468046|FG004|COMPLETED|EEG (Session 4)||14
6546564|NCT01701258|7468047|FG005|COMPLETED|EEG (Session 4)||0
6546565|NCT01701258|7468048|FG006|COMPLETED|EEG (Session 4)||0
6546566|NCT01701258|7468049|FG007|COMPLETED|EEG (Session 4)||16
6546567|NCT01701258|7468050|FG008|COMPLETED|EEG (Session 4)||0
6546568|NCT01701258|7468051|FG009|COMPLETED|EEG (Session 4)||0
6546569|NCT01701258|7468052|FG010|COMPLETED|EEG (Session 4)||17
6546570|NCT01701258|7468053|FG011|COMPLETED|EEG (Session 4)||0
6546571|NCT01701258|7468054|FG012|COMPLETED|EEG (Session 4)||0
6546572|NCT01701258|7468042|FG000|NOT COMPLETED|EEG (Session 4)||0
6546573|NCT01701258|7468043|FG001|NOT COMPLETED|EEG (Session 4)||0
6546574|NCT01701258|7468044|FG002|NOT COMPLETED|EEG (Session 4)||0
6546575|NCT01701258|7468045|FG003|NOT COMPLETED|EEG (Session 4)||0
6546576|NCT01701258|7468046|FG004|NOT COMPLETED|EEG (Session 4)||0
6546577|NCT01701258|7468047|FG005|NOT COMPLETED|EEG (Session 4)||0
6546578|NCT01701258|7468048|FG006|NOT COMPLETED|EEG (Session 4)||0
6546579|NCT01701258|7468049|FG007|NOT COMPLETED|EEG (Session 4)||0
6546580|NCT01701258|7468050|FG008|NOT COMPLETED|EEG (Session 4)||0
6546581|NCT01701258|7468051|FG009|NOT COMPLETED|EEG (Session 4)||0
6546582|NCT01701258|7468052|FG010|NOT COMPLETED|EEG (Session 4)||0
6546583|NCT01701258|7468053|FG011|NOT COMPLETED|EEG (Session 4)||0
6546584|NCT01701258|7468054|FG012|NOT COMPLETED|EEG (Session 4)||0
6546585|NCT01701271|7468082|FG000|STARTED|Overall Study||20
6546586|NCT01701271|7468082|FG000|COMPLETED|Overall Study||20
6546587|NCT01701271|7468082|FG000|NOT COMPLETED|Overall Study||0
6546588|NCT01701362|7468089|FG000|STARTED|Overall Study||275
6546589|NCT01701362|7468090|FG001|STARTED|Overall Study||267
6546590|NCT01701362|7468089|FG000|TREATED|Overall Study||274
6546591|NCT01701362|7468090|FG001|TREATED|Overall Study||265
6546592|NCT01701362|7468089|FG000|COMPLETED|Overall Study||233
6546593|NCT01701362|7468090|FG001|COMPLETED|Overall Study||211
6546594|NCT01701362|7468089|FG000|NOT COMPLETED|Overall Study||42
6546595|NCT01701362|7468090|FG001|NOT COMPLETED|Overall Study||56
6546596|NCT01701375|7468096|FG000|STARTED|Overall Study||2
6546597|NCT01701375|7468096|FG000|COMPLETED|Overall Study||2
6546598|NCT01701375|7468096|FG000|NOT COMPLETED|Overall Study||0
6546599|NCT01701401|7468104|FG000|STARTED|Overall Study||217
6546600|NCT01701401|7468105|FG001|STARTED|Overall Study||218
6546601|NCT01701401|7468106|FG002|STARTED|Overall Study||217
6546602|NCT01701401|7468107|FG003|STARTED|Overall Study||218
6546603|NCT01701401|7468104|FG000|COMPLETED|Overall Study||207
6546604|NCT01701401|7468105|FG001|COMPLETED|Overall Study||209
6546605|NCT01701401|7468106|FG002|COMPLETED|Overall Study||212
6546606|NCT01701401|7468107|FG003|COMPLETED|Overall Study||212
6546607|NCT01701401|7468104|FG000|NOT COMPLETED|Overall Study||10
6546608|NCT01701401|7468105|FG001|NOT COMPLETED|Overall Study||9
6546609|NCT01701401|7468106|FG002|NOT COMPLETED|Overall Study||5
6546610|NCT01701401|7468107|FG003|NOT COMPLETED|Overall Study||6
6546611|NCT01701414|7468119|FG000|STARTED|Overall Study||19
6546612|NCT01701414|7468120|FG001|STARTED|Overall Study||19
6546613|NCT01701414|7468119|FG000|COMPLETED|Overall Study||18
6546614|NCT01701414|7468120|FG001|COMPLETED|Overall Study||18
6546615|NCT01701414|7468119|FG000|NOT COMPLETED|Overall Study||1
6546616|NCT01701414|7468120|FG001|NOT COMPLETED|Overall Study||1
6546617|NCT01701505|7468132|FG000|STARTED|Overall Study||8
6546618|NCT01701505|7468133|FG001|STARTED|Overall Study||8
6546619|NCT01701505|7468134|FG002|STARTED|Overall Study||8
6546620|NCT01701505|7468135|FG003|STARTED|Overall Study||8
6546621|NCT01701505|7468136|FG004|STARTED|Overall Study||8
6546622|NCT01701505|7468137|FG005|STARTED|Overall Study||8
6546623|NCT01701505|7468132|FG000|COMPLETED|Overall Study||8
6546624|NCT01701505|7468133|FG001|COMPLETED|Overall Study||8
6546625|NCT01701505|7468134|FG002|COMPLETED|Overall Study||8
6546626|NCT01701505|7468135|FG003|COMPLETED|Overall Study||8
6546627|NCT01701505|7468136|FG004|COMPLETED|Overall Study||8
6546628|NCT01701505|7468137|FG005|COMPLETED|Overall Study||8
6546629|NCT01701505|7468132|FG000|NOT COMPLETED|Overall Study||0
6546630|NCT01701505|7468133|FG001|NOT COMPLETED|Overall Study||0
6546631|NCT01701505|7468134|FG002|NOT COMPLETED|Overall Study||0
6546632|NCT01701505|7468135|FG003|NOT COMPLETED|Overall Study||0
6546633|NCT01701505|7468136|FG004|NOT COMPLETED|Overall Study||0
6546634|NCT01701505|7468137|FG005|NOT COMPLETED|Overall Study||0
6546635|NCT01701973|7468154|FG000|STARTED|Aim 1: First Intervention (1 Day)||23
6546636|NCT01701973|7468155|FG001|STARTED|Aim 1: First Intervention (1 Day)||21
6546637|NCT01701973|7468156|FG002|STARTED|Aim 1: First Intervention (1 Day)||0
6546638|NCT01701973|7468157|FG003|STARTED|Aim 1: First Intervention (1 Day)||0
6546639|NCT01701973|7468158|FG004|STARTED|Aim 1: First Intervention (1 Day)||0
6546640|NCT01701973|7468159|FG005|STARTED|Aim 1: First Intervention (1 Day)||0
6546641|NCT01701973|7468160|FG006|STARTED|Aim 1: First Intervention (1 Day)||0
6546642|NCT01701973|7468161|FG007|STARTED|Aim 1: First Intervention (1 Day)||0
6546643|NCT01701973|7468154|FG000|COMPLETED|Aim 1: First Intervention (1 Day)||23
6546644|NCT01701973|7468155|FG001|COMPLETED|Aim 1: First Intervention (1 Day)||20
6546645|NCT01701973|7468156|FG002|COMPLETED|Aim 1: First Intervention (1 Day)||0
6546646|NCT01701973|7468157|FG003|COMPLETED|Aim 1: First Intervention (1 Day)||0
6546647|NCT01701973|7468158|FG004|COMPLETED|Aim 1: First Intervention (1 Day)||0
6546648|NCT01701973|7468159|FG005|COMPLETED|Aim 1: First Intervention (1 Day)||0
6546649|NCT01701973|7468160|FG006|COMPLETED|Aim 1: First Intervention (1 Day)||0
6546650|NCT01701973|7468161|FG007|COMPLETED|Aim 1: First Intervention (1 Day)||0
6546651|NCT01701973|7468154|FG000|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6546652|NCT01701973|7468155|FG001|NOT COMPLETED|Aim 1: First Intervention (1 Day)||1
6546653|NCT01701973|7468156|FG002|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6546654|NCT01701973|7468157|FG003|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6546655|NCT01701973|7468158|FG004|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6546656|NCT01701973|7468159|FG005|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6546657|NCT01701973|7468160|FG006|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6546658|NCT01701973|7468161|FG007|NOT COMPLETED|Aim 1: First Intervention (1 Day)||0
6546659|NCT01701973|7468154|FG000|STARTED|Aim 1: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 1 and 2.|22
6546660|NCT01701973|7468155|FG001|STARTED|Aim 1: Second Intervention (1 Day)|3 subjects were lost to follow-up in between Periods 1 and 2.|17
6546661|NCT01701973|7468156|FG002|STARTED|Aim 1: Second Intervention (1 Day)||0
6546662|NCT01701973|7468157|FG003|STARTED|Aim 1: Second Intervention (1 Day)||0
6546663|NCT01701973|7468158|FG004|STARTED|Aim 1: Second Intervention (1 Day)||0
6546664|NCT01701973|7468159|FG005|STARTED|Aim 1: Second Intervention (1 Day)||0
6546665|NCT01701973|7468160|FG006|STARTED|Aim 1: Second Intervention (1 Day)||0
6546666|NCT01701973|7468161|FG007|STARTED|Aim 1: Second Intervention (1 Day)||0
6546667|NCT01701973|7468154|FG000|COMPLETED|Aim 1: Second Intervention (1 Day)||22
6546668|NCT01701973|7468155|FG001|COMPLETED|Aim 1: Second Intervention (1 Day)||17
6546669|NCT01701973|7468156|FG002|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546670|NCT01701973|7468157|FG003|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546671|NCT01701973|7468158|FG004|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546672|NCT01701973|7468159|FG005|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546673|NCT01701973|7468160|FG006|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546674|NCT01701973|7468161|FG007|COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546675|NCT01701973|7468154|FG000|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546676|NCT01701973|7468155|FG001|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546677|NCT01701973|7468156|FG002|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546678|NCT01701973|7468157|FG003|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546679|NCT01701973|7468158|FG004|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546680|NCT01701973|7468159|FG005|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546681|NCT01701973|7468160|FG006|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546682|NCT01701973|7468161|FG007|NOT COMPLETED|Aim 1: Second Intervention (1 Day)||0
6546683|NCT01701973|7468154|FG000|STARTED|Aim 2: First Intervention (1 Day)||0
6546684|NCT01701973|7468155|FG001|STARTED|Aim 2: First Intervention (1 Day)||0
6546685|NCT01701973|7468156|FG002|STARTED|Aim 2: First Intervention (1 Day)||5
6546686|NCT01701973|7468157|FG003|STARTED|Aim 2: First Intervention (1 Day)||4
6546687|NCT01701973|7468158|FG004|STARTED|Aim 2: First Intervention (1 Day)||2
6546688|NCT01701973|7468159|FG005|STARTED|Aim 2: First Intervention (1 Day)||3
6546689|NCT01701973|7468160|FG006|STARTED|Aim 2: First Intervention (1 Day)||5
6546690|NCT01701973|7468161|FG007|STARTED|Aim 2: First Intervention (1 Day)||4
6546691|NCT01701973|7468154|FG000|COMPLETED|Aim 2: First Intervention (1 Day)||0
6546692|NCT01701973|7468155|FG001|COMPLETED|Aim 2: First Intervention (1 Day)||0
6546693|NCT01701973|7468156|FG002|COMPLETED|Aim 2: First Intervention (1 Day)||5
6546694|NCT01701973|7468157|FG003|COMPLETED|Aim 2: First Intervention (1 Day)||4
6546695|NCT01701973|7468158|FG004|COMPLETED|Aim 2: First Intervention (1 Day)||2
6546696|NCT01701973|7468159|FG005|COMPLETED|Aim 2: First Intervention (1 Day)||3
6546697|NCT01701973|7468160|FG006|COMPLETED|Aim 2: First Intervention (1 Day)||5
6546698|NCT01701973|7468161|FG007|COMPLETED|Aim 2: First Intervention (1 Day)||4
6546699|NCT01701973|7468154|FG000|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6546700|NCT01701973|7468155|FG001|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6546701|NCT01701973|7468156|FG002|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6546702|NCT01701973|7468157|FG003|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6546703|NCT01701973|7468158|FG004|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6546704|NCT01701973|7468159|FG005|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6546705|NCT01701973|7468160|FG006|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6546706|NCT01701973|7468161|FG007|NOT COMPLETED|Aim 2: First Intervention (1 Day)||0
6546707|NCT01701973|7468154|FG000|STARTED|Aim 2: Second Intervention (1 Day)||0
6546708|NCT01701973|7468155|FG001|STARTED|Aim 2: Second Intervention (1 Day)||0
6546709|NCT01701973|7468156|FG002|STARTED|Aim 2: Second Intervention (1 Day)||5
6546710|NCT01701973|7468157|FG003|STARTED|Aim 2: Second Intervention (1 Day)||4
6546711|NCT01701973|7468158|FG004|STARTED|Aim 2: Second Intervention (1 Day)||2
6546712|NCT01701973|7468159|FG005|STARTED|Aim 2: Second Intervention (1 Day)||3
6546713|NCT01701973|7468160|FG006|STARTED|Aim 2: Second Intervention (1 Day)||5
6546714|NCT01701973|7468161|FG007|STARTED|Aim 2: Second Intervention (1 Day)|1 subject was lost to follow-up in between Periods 3 and 4.|3
6546715|NCT01701973|7468154|FG000|COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546716|NCT01701973|7468155|FG001|COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546717|NCT01701973|7468156|FG002|COMPLETED|Aim 2: Second Intervention (1 Day)||5
6546718|NCT01701973|7468157|FG003|COMPLETED|Aim 2: Second Intervention (1 Day)||4
6546719|NCT01701973|7468158|FG004|COMPLETED|Aim 2: Second Intervention (1 Day)||2
6546720|NCT01701973|7468159|FG005|COMPLETED|Aim 2: Second Intervention (1 Day)||3
6546721|NCT01701973|7468160|FG006|COMPLETED|Aim 2: Second Intervention (1 Day)||5
6546722|NCT01701973|7468161|FG007|COMPLETED|Aim 2: Second Intervention (1 Day)||3
6546723|NCT01701973|7468154|FG000|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546724|NCT01701973|7468155|FG001|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546725|NCT01701973|7468156|FG002|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546726|NCT01701973|7468157|FG003|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546727|NCT01701973|7468158|FG004|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546728|NCT01701973|7468159|FG005|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546729|NCT01701973|7468160|FG006|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546730|NCT01701973|7468161|FG007|NOT COMPLETED|Aim 2: Second Intervention (1 Day)||0
6546731|NCT01701999|7468203|FG000|STARTED|Overall Study||8
6546732|NCT01701999|7468204|FG001|STARTED|Overall Study||37
6546733|NCT01701999|7468203|FG000|COMPLETED|Overall Study||8
6546734|NCT01701999|7468204|FG001|COMPLETED|Overall Study||37
6546735|NCT01701999|7468203|FG000|NOT COMPLETED|Overall Study||0
6546736|NCT01701999|7468204|FG001|NOT COMPLETED|Overall Study||0
6546737|NCT01702025|7468214|FG000|STARTED|Overall Study||11
6546738|NCT01702025|7468215|FG001|STARTED|Overall Study||10
6546739|NCT01702025|7468216|FG002|STARTED|Overall Study||10
6546740|NCT01702025|7468217|FG003|STARTED|Overall Study||10
6546741|NCT01702025|7468214|FG000|COMPLETED|Overall Study||9
6546742|NCT01702025|7468215|FG001|COMPLETED|Overall Study||9
6546743|NCT01702025|7468216|FG002|COMPLETED|Overall Study||9
6546744|NCT01702025|7468217|FG003|COMPLETED|Overall Study||10
6546745|NCT01702025|7468214|FG000|NOT COMPLETED|Overall Study||2
6546746|NCT01702025|7468215|FG001|NOT COMPLETED|Overall Study||1
6546747|NCT01702025|7468216|FG002|NOT COMPLETED|Overall Study||1
6546748|NCT01702025|7468217|FG003|NOT COMPLETED|Overall Study||0
6546749|NCT01702233|7468234|FG000|STARTED|Overall Study||72
6546750|NCT01702233|7468235|FG001|STARTED|Overall Study||67
6546751|NCT01702233|7468236|FG002|STARTED|Overall Study||36
6546752|NCT01702233|7468234|FG000|Full Analysis Set (ITT)|Overall Study||66
6546753|NCT01702233|7468235|FG001|Full Analysis Set (ITT)|Overall Study||63
6546754|NCT01702233|7468236|FG002|Full Analysis Set (ITT)|Overall Study||31
6546755|NCT01702233|7468234|FG000|Per Protocol Set|Overall Study||58
6546756|NCT01702233|7468235|FG001|Per Protocol Set|Overall Study||58
6546757|NCT01702233|7468236|FG002|Per Protocol Set|Overall Study||27
6546758|NCT01702233|7468234|FG000|COMPLETED|Overall Study||66
6546759|NCT01702233|7468235|FG001|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
6546760|NCT01702233|7468236|FG002|COMPLETED|Overall Study||31
6546761|NCT01702233|7468234|FG000|NOT COMPLETED|Overall Study||6
6546762|NCT01702233|7468235|FG001|NOT COMPLETED|Overall Study||3
6546763|NCT01702233|7468236|FG002|NOT COMPLETED|Overall Study||5
6546764|NCT01702246|7468245|FG000|STARTED|Overall Study||24
6546765|NCT01702246|7468245|FG000|COMPLETED|Overall Study||19
6546766|NCT01702246|7468245|FG000|NOT COMPLETED|Overall Study||5
6546767|NCT01702259|7468254|FG000|STARTED|Overall Study||34
6546768|NCT01702259|7468255|FG001|STARTED|Overall Study||34
6546769|NCT01702259|7468254|FG000|COMPLETED|Overall Study||34
6546770|NCT01702259|7468255|FG001|COMPLETED|Overall Study||34
6546771|NCT01702259|7468254|FG000|NOT COMPLETED|Overall Study||0
6546772|NCT01702259|7468255|FG001|NOT COMPLETED|Overall Study||0
6546773|NCT01702298|7468261|FG000|STARTED|Overall Study||42
6546774|NCT01702298|7468261|FG000|COMPLETED|Overall Study||41
6546775|NCT01702298|7468261|FG000|NOT COMPLETED|Overall Study||1
6546776|NCT01702311|7468267|FG000|STARTED|Overall Study||122
6546777|NCT01702311|7468268|FG001|STARTED|Overall Study||113
6546778|NCT01702311|7468267|FG000|COMPLETED|Overall Study||106
6546779|NCT01702311|7468268|FG001|COMPLETED|Overall Study||100
6546780|NCT01702311|7468267|FG000|NOT COMPLETED|Overall Study||16
6546781|NCT01702311|7468268|FG001|NOT COMPLETED|Overall Study||13
6546782|NCT01702363|7468277|FG000|STARTED|Overall Study||131
6546783|NCT01702363|7468277|FG000|COMPLETED|Overall Study||111
6546784|NCT01702363|7468277|FG000|NOT COMPLETED|Overall Study||20
6546785|NCT01702428|7468286|FG000|STARTED|Overall Study||1239
6546786|NCT01702428|7468287|FG001|STARTED|Overall Study||1232
6546787|NCT01702428|7468288|FG002|STARTED|Overall Study||1243
6546788|NCT01702428|7468289|FG003|STARTED|Overall Study||1289
6546789|NCT01702428|7468286|FG000|COMPLETED|Overall Study||1175
6546790|NCT01702428|7468287|FG001|COMPLETED|Overall Study||1162
6546791|NCT01702428|7468288|FG002|COMPLETED|Overall Study||1190
6546792|NCT01702428|7468289|FG003|COMPLETED|Overall Study||1232
6546793|NCT01702428|7468286|FG000|NOT COMPLETED|Overall Study||64
6546794|NCT01702428|7468287|FG001|NOT COMPLETED|Overall Study||70
6546795|NCT01702428|7468288|FG002|NOT COMPLETED|Overall Study||53
6546796|NCT01702428|7468289|FG003|NOT COMPLETED|Overall Study||57
6546797|NCT01702454|7468308|FG000|STARTED|Overall Study||241
6546798|NCT01702454|7468309|FG001|STARTED|Overall Study||229
6546799|NCT01702454|7468308|FG000|COMPLETED|Overall Study||238
6546800|NCT01702454|7468309|FG001|COMPLETED|Overall Study||221
6546801|NCT01702454|7468308|FG000|NOT COMPLETED|Overall Study||3
6546802|NCT01702454|7468309|FG001|NOT COMPLETED|Overall Study||8
6546803|NCT01702519|7468320|FG000|STARTED|Period 1||20
6546804|NCT01702519|7468321|FG001|STARTED|Period 1||20
6546805|NCT01702519|7468320|FG000|COMPLETED|Period 1||20
6546806|NCT01702519|7468321|FG001|COMPLETED|Period 1||20
6546807|NCT01702519|7468320|FG000|NOT COMPLETED|Period 1||0
6546808|NCT01702519|7468321|FG001|NOT COMPLETED|Period 1||0
6546809|NCT01702519|7468320|FG000|STARTED|Washout Period||20
6546810|NCT01702519|7468321|FG001|STARTED|Washout Period||20
6546811|NCT01702519|7468320|FG000|COMPLETED|Washout Period||19
6546812|NCT01702519|7468321|FG001|COMPLETED|Washout Period||18
6546813|NCT01702519|7468320|FG000|NOT COMPLETED|Washout Period||1
6546814|NCT01702519|7468321|FG001|NOT COMPLETED|Washout Period||2
6546815|NCT01702519|7468320|FG000|STARTED|Period 2||19
6546816|NCT01702519|7468321|FG001|STARTED|Period 2||18
6546817|NCT01702519|7468320|FG000|COMPLETED|Period 2||19
6546818|NCT01702519|7468321|FG001|COMPLETED|Period 2||18
6546819|NCT01702519|7468320|FG000|NOT COMPLETED|Period 2||0
6546820|NCT01702519|7468321|FG001|NOT COMPLETED|Period 2||0
6546821|NCT01702532|7468333|FG000|STARTED|Overall Study||161
6546822|NCT01702532|7468334|FG001|STARTED|Overall Study||161
6546823|NCT01702532|7468333|FG000|Safety Population|Overall Study||161
6546824|NCT01702532|7468334|FG001|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
6546825|NCT01702532|7468333|FG000|COMPLETED|Overall Study||161
6546826|NCT01702532|7468334|FG001|COMPLETED|Overall Study||160
6546827|NCT01702532|7468333|FG000|NOT COMPLETED|Overall Study||0
6546828|NCT01702532|7468334|FG001|NOT COMPLETED|Overall Study||1
6546829|NCT01702558|7468346|FG000|STARTED|Overall Study||7
6546830|NCT01702558|7468347|FG001|STARTED|Overall Study||5
6546831|NCT01702558|7468348|FG002|STARTED|Overall Study||6
6546832|NCT01702558|7468349|FG003|STARTED|Overall Study||81
6546833|NCT01702558|7468350|FG004|STARTED|Overall Study||80
6546834|NCT01702558|7468346|FG000|COMPLETED|Overall Study||3
6546835|NCT01702558|7468347|FG001|COMPLETED|Overall Study||1
6546836|NCT01702558|7468348|FG002|COMPLETED|Overall Study||1
6546837|NCT01702558|7468349|FG003|COMPLETED|Overall Study||34
6546838|NCT01702558|7468350|FG004|COMPLETED|Overall Study||38
6546839|NCT01702558|7468346|FG000|NOT COMPLETED|Overall Study||4
6546840|NCT01702558|7468347|FG001|NOT COMPLETED|Overall Study||4
6546841|NCT01702558|7468348|FG002|NOT COMPLETED|Overall Study||5
6546842|NCT01702558|7468349|FG003|NOT COMPLETED|Overall Study||47
6546843|NCT01702558|7468350|FG004|NOT COMPLETED|Overall Study||42
6546844|NCT01702844|7468363|FG000|STARTED|Overall Study||42
6546845|NCT01702844|7468363|FG000|Disease Progression|Overall Study||23
6546846|NCT01702844|7468363|FG000|COMPLETED|Overall Study||23
6546847|NCT01702844|7468363|FG000|NOT COMPLETED|Overall Study||19
6546848|NCT01702961|7468367|FG000|STARTED|Overall Study||75
6546849|NCT01702961|7468367|FG000|COMPLETED|Overall Study||28
6546850|NCT01702961|7468367|FG000|NOT COMPLETED|Overall Study||47
6546851|NCT01702987|7468373|FG000|STARTED|Overall Study||10
6546852|NCT01702987|7468374|FG001|STARTED|Overall Study||12
6546853|NCT01702987|7468373|FG000|COMPLETED|Overall Study||9
6546854|NCT01702987|7468374|FG001|COMPLETED|Overall Study||12
6546855|NCT01702987|7468373|FG000|NOT COMPLETED|Overall Study||1
6546856|NCT01702987|7468374|FG001|NOT COMPLETED|Overall Study||0
6546857|NCT01703000|7468380|FG000|STARTED|Overall Study||100
6546858|NCT01703000|7468380|FG000|COMPLETED|Overall Study||99
6546859|NCT01703000|7468380|FG000|NOT COMPLETED|Overall Study||1
6546860|NCT01703039|7468386|FG000|STARTED|Overall Study||9
6546861|NCT01703039|7468387|FG001|STARTED|Overall Study||12
6546862|NCT01703039|7468386|FG000|COMPLETED|Overall Study||6
6546863|NCT01703039|7468387|FG001|COMPLETED|Overall Study||7
6546864|NCT01703039|7468386|FG000|NOT COMPLETED|Overall Study||3
6546865|NCT01703039|7468387|FG001|NOT COMPLETED|Overall Study||5
6546866|NCT01703065|7468397|FG000|STARTED|Overall Study||9
6546867|NCT01703065|7468398|FG001|STARTED|Overall Study||0
6546868|NCT01703065|7468397|FG000|COMPLETED|Overall Study||8
6546869|NCT01703065|7468398|FG001|COMPLETED|Overall Study||0
6546870|NCT01703065|7468397|FG000|NOT COMPLETED|Overall Study||1
6546871|NCT01703065|7468398|FG001|NOT COMPLETED|Overall Study||0
6546872|NCT01703091|7468407|FG000|STARTED|Overall Study||98
6546873|NCT01703091|7468408|FG001|STARTED|Overall Study||99
6546874|NCT01703091|7468407|FG000|Received at Least One Dose of Study Drug|Overall Study||94
6546875|NCT01703091|7468408|FG001|Received at Least One Dose of Study Drug|Overall Study||98
6546876|NCT01703091|7468407|FG000|COMPLETED|Overall Study||89
6546877|NCT01703091|7468408|FG001|COMPLETED|Overall Study||95
6546878|NCT01703091|7468407|FG000|NOT COMPLETED|Overall Study||9
6546879|NCT01703091|7468408|FG001|NOT COMPLETED|Overall Study||4
6546880|NCT01703117|7468416|FG000|STARTED|Overall Study||26
6546881|NCT01703117|7468417|FG001|STARTED|Overall Study||24
6546882|NCT01703117|7468416|FG000|COMPLETED|Overall Study||22
6546883|NCT01703117|7468417|FG001|COMPLETED|Overall Study||20
6546884|NCT01703117|7468416|FG000|NOT COMPLETED|Overall Study||4
6546885|NCT01703117|7468417|FG001|NOT COMPLETED|Overall Study||4
6546886|NCT01703169|7468425|FG000|STARTED|Overall Study||13
6546887|NCT01703169|7468425|FG000|COMPLETED|Overall Study||13
6546888|NCT01703169|7468425|FG000|NOT COMPLETED|Overall Study||0
6546889|NCT01703208|7468431|FG000|STARTED|Overall Study||2100
6546890|NCT01703208|7468432|FG001|STARTED|Overall Study||2102
6546891|NCT01703208|7468431|FG000|Treated|Overall Study||2092
6546892|NCT01703208|7468432|FG001|Treated|Overall Study||2100
6546893|NCT01703208|7468431|FG000|COMPLETED|Overall Study||0
6546894|NCT01703208|7468432|FG001|COMPLETED|Overall Study||0
6546895|NCT01703208|7468431|FG000|NOT COMPLETED|Overall Study||2100
6546896|NCT01703208|7468432|FG001|NOT COMPLETED|Overall Study||2102
6546897|NCT01703221|7468441|FG000|STARTED|Phase A (Up to 24 Weeks)||166
6546898|NCT01703221|7468442|FG001|STARTED|Phase A (Up to 24 Weeks)||165
6546899|NCT01703221|7468443|FG002|STARTED|Phase A (Up to 24 Weeks)||83
6546900|NCT01703221|7468441|FG000|COMPLETED|Phase A (Up to 24 Weeks)||159
6546901|NCT01703221|7468442|FG001|COMPLETED|Phase A (Up to 24 Weeks)||161
6546902|NCT01703221|7468443|FG002|COMPLETED|Phase A (Up to 24 Weeks)||80
6546903|NCT01703221|7468441|FG000|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
6546904|NCT01703221|7468442|FG001|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
6546905|NCT01703221|7468443|FG002|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
6546906|NCT01703221|7468441|FG000|STARTED|Phase B - (Week 25 to 52)||159
6546907|NCT01703221|7468442|FG001|STARTED|Phase B - (Week 25 to 52)||161
6546908|NCT01703221|7468443|FG002|STARTED|Phase B - (Week 25 to 52)||80
6546909|NCT01703221|7468441|FG000|COMPLETED|Phase B - (Week 25 to 52)||143
6546910|NCT01703221|7468442|FG001|COMPLETED|Phase B - (Week 25 to 52)||147
6546911|NCT01703221|7468443|FG002|COMPLETED|Phase B - (Week 25 to 52)||75
6546912|NCT01703221|7468441|FG000|NOT COMPLETED|Phase B - (Week 25 to 52)||16
6546913|NCT01703221|7468442|FG001|NOT COMPLETED|Phase B - (Week 25 to 52)||14
6546914|NCT01703221|7468443|FG002|NOT COMPLETED|Phase B - (Week 25 to 52)||5
6546915|NCT01703260|7468460|FG000|STARTED|Overall Study||7
6546916|NCT01703260|7468461|FG001|STARTED|Overall Study||7
6546917|NCT01703260|7468462|FG002|STARTED|Overall Study||6
6546918|NCT01703260|7468460|FG000|COMPLETED|Overall Study||4
6546919|NCT01703260|7468461|FG001|COMPLETED|Overall Study||3
6546920|NCT01703260|7468462|FG002|COMPLETED|Overall Study||3
6546921|NCT01703260|7468460|FG000|NOT COMPLETED|Overall Study||3
6546922|NCT01703260|7468461|FG001|NOT COMPLETED|Overall Study||4
6546923|NCT01703260|7468462|FG002|NOT COMPLETED|Overall Study||3
6546924|NCT01703286|7468470|FG000|STARTED|Period 1 Including Washout||7
6546925|NCT01703286|7468471|FG001|STARTED|Period 1 Including Washout||7
6546926|NCT01703286|7468472|FG002|STARTED|Period 1 Including Washout||7
6546927|NCT01703286|7468473|FG003|STARTED|Period 1 Including Washout||7
6546928|NCT01703286|7468474|FG004|STARTED|Period 1 Including Washout||7
6546929|NCT01703286|7468475|FG005|STARTED|Period 1 Including Washout||7
6546930|NCT01703286|7468470|FG000|COMPLETED|Period 1 Including Washout||7
6546931|NCT01703286|7468471|FG001|COMPLETED|Period 1 Including Washout||7
6546932|NCT01703286|7468472|FG002|COMPLETED|Period 1 Including Washout||7
6546933|NCT01703286|7468473|FG003|COMPLETED|Period 1 Including Washout||6
6546934|NCT01703286|7468474|FG004|COMPLETED|Period 1 Including Washout||7
6546935|NCT01703286|7468475|FG005|COMPLETED|Period 1 Including Washout||6
6546936|NCT01703286|7468470|FG000|NOT COMPLETED|Period 1 Including Washout||0
6546937|NCT01703286|7468471|FG001|NOT COMPLETED|Period 1 Including Washout||0
6546938|NCT01703286|7468472|FG002|NOT COMPLETED|Period 1 Including Washout||0
6546939|NCT01703286|7468473|FG003|NOT COMPLETED|Period 1 Including Washout||1
6546940|NCT01703286|7468474|FG004|NOT COMPLETED|Period 1 Including Washout||0
6546941|NCT01703286|7468475|FG005|NOT COMPLETED|Period 1 Including Washout||1
6546942|NCT01703286|7468470|FG000|STARTED|Period 2 Including Washout||7
6546943|NCT01703286|7468471|FG001|STARTED|Period 2 Including Washout||7
6546944|NCT01703286|7468472|FG002|STARTED|Period 2 Including Washout||7
6546945|NCT01703286|7468473|FG003|STARTED|Period 2 Including Washout||6
6546946|NCT01703286|7468474|FG004|STARTED|Period 2 Including Washout||7
6546947|NCT01703286|7468475|FG005|STARTED|Period 2 Including Washout||6
6546948|NCT01703286|7468470|FG000|COMPLETED|Period 2 Including Washout||7
6546949|NCT01703286|7468471|FG001|COMPLETED|Period 2 Including Washout||7
6546950|NCT01703286|7468472|FG002|COMPLETED|Period 2 Including Washout||7
6546951|NCT01703286|7468473|FG003|COMPLETED|Period 2 Including Washout||5
6546952|NCT01703286|7468474|FG004|COMPLETED|Period 2 Including Washout||7
6546953|NCT01703286|7468475|FG005|COMPLETED|Period 2 Including Washout||6
6546954|NCT01703286|7468470|FG000|NOT COMPLETED|Period 2 Including Washout||0
6546955|NCT01703286|7468471|FG001|NOT COMPLETED|Period 2 Including Washout||0
6546956|NCT01703286|7468472|FG002|NOT COMPLETED|Period 2 Including Washout||0
6546957|NCT01703286|7468473|FG003|NOT COMPLETED|Period 2 Including Washout||1
6546958|NCT01703286|7468474|FG004|NOT COMPLETED|Period 2 Including Washout||0
6546959|NCT01703286|7468475|FG005|NOT COMPLETED|Period 2 Including Washout||0
6546960|NCT01703286|7468470|FG000|STARTED|Period 3 Including Washout||7
6546961|NCT01703286|7468471|FG001|STARTED|Period 3 Including Washout||7
6546962|NCT01703286|7468472|FG002|STARTED|Period 3 Including Washout||7
6546963|NCT01703286|7468473|FG003|STARTED|Period 3 Including Washout||5
6546964|NCT01703286|7468474|FG004|STARTED|Period 3 Including Washout||7
6546965|NCT01703286|7468475|FG005|STARTED|Period 3 Including Washout||6
6546966|NCT01703286|7468470|FG000|COMPLETED|Period 3 Including Washout||7
6546967|NCT01703286|7468471|FG001|COMPLETED|Period 3 Including Washout||7
6546968|NCT01703286|7468472|FG002|COMPLETED|Period 3 Including Washout||7
6546969|NCT01703286|7468473|FG003|COMPLETED|Period 3 Including Washout||5
6546970|NCT01703286|7468474|FG004|COMPLETED|Period 3 Including Washout||7
6546971|NCT01703286|7468475|FG005|COMPLETED|Period 3 Including Washout||6
6546972|NCT01703286|7468470|FG000|NOT COMPLETED|Period 3 Including Washout||0
6546973|NCT01703286|7468471|FG001|NOT COMPLETED|Period 3 Including Washout||0
6546974|NCT01703286|7468472|FG002|NOT COMPLETED|Period 3 Including Washout||0
6546975|NCT01703286|7468473|FG003|NOT COMPLETED|Period 3 Including Washout||0
6546976|NCT01703286|7468474|FG004|NOT COMPLETED|Period 3 Including Washout||0
6546977|NCT01703286|7468475|FG005|NOT COMPLETED|Period 3 Including Washout||0
6546978|NCT01703507|7468488|FG000|STARTED|Overall Study||6
6546979|NCT01703507|7468489|FG001|STARTED|Overall Study||11
6546980|NCT01703507|7468488|FG000|COMPLETED|Overall Study||5
6546981|NCT01703507|7468489|FG001|COMPLETED|Overall Study||11
6546982|NCT01703507|7468488|FG000|NOT COMPLETED|Overall Study||1
6546983|NCT01703507|7468489|FG001|NOT COMPLETED|Overall Study||0
6546984|NCT01703598|7468495|FG000|STARTED|Overall Study||69
6546985|NCT01703598|7468495|FG000|COMPLETED|Overall Study||69
6646909|NCT02384382|7575929|FG000|STARTED|Overall Study||23
6646910|NCT02384382|7575929|FG000|COMPLETED|Overall Study||0
6646911|NCT02384382|7575929|FG000|NOT COMPLETED|Overall Study||23
6646912|NCT02384395|7575933|FG000|STARTED|Overall Study||40
6646913|NCT02384395|7575933|FG000|Enrolled|Overall Study||40
6646914|NCT02384395|7575933|FG000|Initiated Treatment|Overall Study||37
6646915|NCT02384395|7575933|FG000|Completed Week 24|Overall Study||34
6546986|NCT01703598|7468495|FG000|NOT COMPLETED|Overall Study||0
6546987|NCT01703663|7468499|FG000|STARTED|First Treatment Period||20
6546988|NCT01703663|7468500|FG001|STARTED|First Treatment Period||20
6546989|NCT01703663|7468499|FG000|COMPLETED|First Treatment Period||20
6546990|NCT01703663|7468500|FG001|COMPLETED|First Treatment Period||20
6546991|NCT01703663|7468499|FG000|NOT COMPLETED|First Treatment Period||0
6546992|NCT01703663|7468500|FG001|NOT COMPLETED|First Treatment Period||0
6546993|NCT01703663|7468499|FG000|STARTED|Second Treatment Period||11
6546994|NCT01703663|7468500|FG001|STARTED|Second Treatment Period||8
6546995|NCT01703663|7468499|FG000|COMPLETED|Second Treatment Period||11
6546996|NCT01703663|7468500|FG001|COMPLETED|Second Treatment Period||8
6546997|NCT01703663|7468499|FG000|NOT COMPLETED|Second Treatment Period||0
6546998|NCT01703663|7468500|FG001|NOT COMPLETED|Second Treatment Period||0
6546999|NCT01703702|7468508|FG000|STARTED|Overall Study||308
6547000|NCT01703702|7468509|FG001|STARTED|Overall Study||310
6547001|NCT01703702|7468508|FG000|COMPLETED|Overall Study||272
6547002|NCT01703702|7468509|FG001|COMPLETED|Overall Study||288
6547003|NCT01703702|7468508|FG000|NOT COMPLETED|Overall Study||36
6547004|NCT01703702|7468509|FG001|NOT COMPLETED|Overall Study||22
6547005|NCT01703741|7468520|FG000|STARTED|Overall Study||145
6547006|NCT01703741|7468520|FG000|Per Protocol (PP) Population|Overall Study|Subjects having 24 hr pharmacokinetic (PK) data for testosterone, with no major protocol violations.|106
6547007|NCT01703741|7468520|FG000|COMPLETED|Overall Study||127
6547008|NCT01703741|7468520|FG000|NOT COMPLETED|Overall Study||18
6547009|NCT01703819|7468526|FG000|STARTED|Overall Study||34
6547010|NCT01703819|7468527|FG001|STARTED|Overall Study||32
6547011|NCT01703819|7468526|FG000|COMPLETED|Overall Study||34
6547012|NCT01703819|7468527|FG001|COMPLETED|Overall Study||30
6547013|NCT01703819|7468526|FG000|NOT COMPLETED|Overall Study||0
6547014|NCT01703819|7468527|FG001|NOT COMPLETED|Overall Study||2
6562599|NCT01801982|7485541|FG000|STARTED|Overall Study||1
6562600|NCT01801982|7485541|FG000|COMPLETED|Overall Study||0
6562601|NCT01801982|7485541|FG000|NOT COMPLETED|Overall Study||1
6562602|NCT01802073|7485547|FG000|STARTED|Overall Study||14
6562603|NCT01802073|7485548|FG001|STARTED|Overall Study||20
6562604|NCT01802073|7485547|FG000|COMPLETED|Overall Study||9
6562605|NCT01802073|7485548|FG001|COMPLETED|Overall Study||9
6562606|NCT01802073|7485547|FG000|NOT COMPLETED|Overall Study||5
6562607|NCT01802073|7485548|FG001|NOT COMPLETED|Overall Study||11
6562608|NCT01802151|7485558|FG000|STARTED|Overall Study||20
6562609|NCT01802151|7485559|FG001|STARTED|Overall Study||21
6562610|NCT01802151|7485560|FG002|STARTED|Overall Study||22
6562611|NCT01802151|7485561|FG003|STARTED|Overall Study||20
6646916|NCT02384395|7575933|FG000|Completed Week 48|Overall Study||33
6562612|NCT01802151|7485558|FG000|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
6562613|NCT01802151|7485559|FG001|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
6562907|NCT01803464|7485826|FG000|STARTED|Overall Study||5
6547015|NCT01703832|7468535|FG000|STARTED|Overall Study||33
6547016|NCT01703832|7468536|FG001|STARTED|Overall Study||32
6547017|NCT01703832|7468535|FG000|COMPLETED|Overall Study||32
6547018|NCT01703832|7468536|FG001|COMPLETED|Overall Study||32
6547019|NCT01703832|7468535|FG000|NOT COMPLETED|Overall Study||1
6547020|NCT01703832|7468536|FG001|NOT COMPLETED|Overall Study||0
6547021|NCT01703845|7468544|FG000|STARTED|Overall Study|started are actually the randomized|16
6547022|NCT01703845|7468545|FG001|STARTED|Overall Study|started are actually the randomized|16
6547023|NCT01703845|7468544|FG000|COMPLETED|Overall Study||13
6547024|NCT01703845|7468545|FG001|COMPLETED|Overall Study||16
6547025|NCT01703845|7468544|FG000|NOT COMPLETED|Overall Study||3
6547026|NCT01703845|7468545|FG001|NOT COMPLETED|Overall Study||0
6547027|NCT01703858|7468556|FG000|STARTED|Overall Study||5
6547028|NCT01703858|7468557|FG001|STARTED|Overall Study||5
6547029|NCT01703858|7468558|FG002|STARTED|Overall Study||5
6547030|NCT01703858|7468556|FG000|COMPLETED|Overall Study||5
6547031|NCT01703858|7468557|FG001|COMPLETED|Overall Study||4
6547032|NCT01703858|7468558|FG002|COMPLETED|Overall Study||5
6547033|NCT01703858|7468556|FG000|NOT COMPLETED|Overall Study||0
6547034|NCT01703858|7468557|FG001|NOT COMPLETED|Overall Study||1
6547035|NCT01703858|7468558|FG002|NOT COMPLETED|Overall Study||0
6547036|NCT01703988|7468575|FG000|STARTED|Overall Study||8
6547037|NCT01703988|7468576|FG001|STARTED|Overall Study||8
6547038|NCT01703988|7468577|FG002|STARTED|Overall Study||9
6547039|NCT01703988|7468578|FG003|STARTED|Overall Study||9
6547040|NCT01703988|7468575|FG000|COMPLETED|Overall Study||8
6547041|NCT01703988|7468576|FG001|COMPLETED|Overall Study||8
6547042|NCT01703988|7468577|FG002|COMPLETED|Overall Study||9
6547043|NCT01703988|7468578|FG003|COMPLETED|Overall Study||8
6547044|NCT01703988|7468575|FG000|NOT COMPLETED|Overall Study||0
6547045|NCT01703988|7468576|FG001|NOT COMPLETED|Overall Study||0
6547046|NCT01703988|7468577|FG002|NOT COMPLETED|Overall Study||0
6547047|NCT01703988|7468578|FG003|NOT COMPLETED|Overall Study||1
6547048|NCT01704079|7468591|FG000|STARTED|Overall Study||72
6547049|NCT01704079|7468592|FG001|STARTED|Overall Study||144
6547050|NCT01704079|7468591|FG000|Entered Extension Study|Overall Study||53
6547051|NCT01704079|7468592|FG001|Entered Extension Study|Overall Study||102
6547052|NCT01704079|7468591|FG000|COMPLETED|Overall Study||58
6547053|NCT01704079|7468592|FG001|COMPLETED|Overall Study||121
6547054|NCT01704079|7468591|FG000|NOT COMPLETED|Overall Study||14
6547055|NCT01704079|7468592|FG001|NOT COMPLETED|Overall Study||23
6547056|NCT01704196|7468600|FG000|STARTED|Overall Study||90
6547057|NCT01704196|7468601|FG001|STARTED|Overall Study||89
6547058|NCT01704196|7468600|FG000|COMPLETED|Overall Study||71
6547059|NCT01704196|7468601|FG001|COMPLETED|Overall Study||65
6547060|NCT01704196|7468600|FG000|NOT COMPLETED|Overall Study||19
6547061|NCT01704196|7468601|FG001|NOT COMPLETED|Overall Study||24
6547062|NCT01704261|7468609|FG000|STARTED|Overall Study||154
6547063|NCT01704261|7468610|FG001|STARTED|Overall Study||153
6547064|NCT01704261|7468609|FG000|COMPLETED|Overall Study||141
6547065|NCT01704261|7468610|FG001|COMPLETED|Overall Study||138
6547066|NCT01704261|7468609|FG000|NOT COMPLETED|Overall Study||13
6547067|NCT01704261|7468610|FG001|NOT COMPLETED|Overall Study||15
6547068|NCT01704287|7468619|FG000|STARTED|Initial Treatment Period||180
6547069|NCT01704287|7468620|FG001|STARTED|Initial Treatment Period||181
6547070|NCT01704287|7468621|FG002|STARTED|Initial Treatment Period||179
6547071|NCT01704287|7468622|FG003|STARTED|Initial Treatment Period||0
6547072|NCT01704287|7468623|FG004|STARTED|Initial Treatment Period||0
6547073|NCT01704287|7468619|FG000|Treated|Initial Treatment Period||178
6547074|NCT01704287|7468620|FG001|Treated|Initial Treatment Period||179
6547075|NCT01704287|7468621|FG002|Treated|Initial Treatment Period||171
6547076|NCT01704287|7468622|FG003|Treated|Initial Treatment Period||0
6547077|NCT01704287|7468623|FG004|Treated|Initial Treatment Period||0
6547078|NCT01704287|7468619|FG000|COMPLETED|Initial Treatment Period||33
6547079|NCT01704287|7468620|FG001|COMPLETED|Initial Treatment Period||47
6547080|NCT01704287|7468621|FG002|COMPLETED|Initial Treatment Period||6
6547081|NCT01704287|7468622|FG003|COMPLETED|Initial Treatment Period||0
6547082|NCT01704287|7468623|FG004|COMPLETED|Initial Treatment Period||0
6547083|NCT01704287|7468619|FG000|NOT COMPLETED|Initial Treatment Period||147
6547084|NCT01704287|7468620|FG001|NOT COMPLETED|Initial Treatment Period||134
6547085|NCT01704287|7468621|FG002|NOT COMPLETED|Initial Treatment Period||173
6547086|NCT01704287|7468622|FG003|NOT COMPLETED|Initial Treatment Period||0
6547087|NCT01704287|7468623|FG004|NOT COMPLETED|Initial Treatment Period||0
6547088|NCT01704287|7468619|FG000|STARTED|Switch to Pembrolizumab Treatment Period||0
6547089|NCT01704287|7468620|FG001|STARTED|Switch to Pembrolizumab Treatment Period||0
6547090|NCT01704287|7468621|FG002|STARTED|Switch to Pembrolizumab Treatment Period||0
6547091|NCT01704287|7468622|FG003|STARTED|Switch to Pembrolizumab Treatment Period||53
6547092|NCT01704287|7468623|FG004|STARTED|Switch to Pembrolizumab Treatment Period||45
6547093|NCT01704287|7468619|FG000|COMPLETED|Switch to Pembrolizumab Treatment Period||0
6547094|NCT01704287|7468620|FG001|COMPLETED|Switch to Pembrolizumab Treatment Period||0
6547095|NCT01704287|7468621|FG002|COMPLETED|Switch to Pembrolizumab Treatment Period||0
6547096|NCT01704287|7468622|FG003|COMPLETED|Switch to Pembrolizumab Treatment Period||15
6547097|NCT01704287|7468623|FG004|COMPLETED|Switch to Pembrolizumab Treatment Period||7
6547098|NCT01704287|7468619|FG000|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
6547099|NCT01704287|7468620|FG001|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
6547100|NCT01704287|7468621|FG002|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
6547101|NCT01704287|7468622|FG003|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
6547102|NCT01704287|7468623|FG004|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||38
6547103|NCT01704456|7468644|FG000|STARTED|Overall Study||67
6547104|NCT01704456|7468645|FG001|STARTED|Overall Study||63
6547105|NCT01704456|7468644|FG000|COMPLETED|Overall Study||59
6547106|NCT01704456|7468645|FG001|COMPLETED|Overall Study||49
6547107|NCT01704456|7468644|FG000|NOT COMPLETED|Overall Study||8
6547108|NCT01704456|7468645|FG001|NOT COMPLETED|Overall Study||14
6547109|NCT01704495|7468655|FG000|STARTED|Subjects Randomized||162
6547110|NCT01704495|7468656|FG001|STARTED|Subjects Randomized||156
6547111|NCT01704495|7468657|FG002|STARTED|Subjects Randomized||160
6547112|NCT01704495|7468658|FG003|STARTED|Subjects Randomized||162
6646917|NCT02384395|7575933|FG000|Completed Week 96|Overall Study||30
6646918|NCT02384395|7575933|FG000|COMPLETED|Overall Study||30
6646919|NCT02384395|7575933|FG000|NOT COMPLETED|Overall Study||10
6547113|NCT01704495|7468655|FG000|COMPLETED|Subjects Randomized||140
6547114|NCT01704495|7468656|FG001|COMPLETED|Subjects Randomized||141
6547115|NCT01704495|7468657|FG002|COMPLETED|Subjects Randomized||144
6547116|NCT01704495|7468658|FG003|COMPLETED|Subjects Randomized||145
6547117|NCT01704495|7468655|FG000|NOT COMPLETED|Subjects Randomized||22
6547118|NCT01704495|7468656|FG001|NOT COMPLETED|Subjects Randomized||15
6547119|NCT01704495|7468657|FG002|NOT COMPLETED|Subjects Randomized||16
6547120|NCT01704495|7468658|FG003|NOT COMPLETED|Subjects Randomized||17
6547121|NCT01704495|7468655|FG000|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
6547122|NCT01704495|7468656|FG001|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
6547123|NCT01704495|7468657|FG002|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
6547124|NCT01704495|7468658|FG003|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
6547125|NCT01704495|7468655|FG000|COMPLETED|Optional Safety Extension||87
6547126|NCT01704495|7468656|FG001|COMPLETED|Optional Safety Extension||88
6547127|NCT01704495|7468657|FG002|COMPLETED|Optional Safety Extension||83
6547128|NCT01704495|7468658|FG003|COMPLETED|Optional Safety Extension||85
6547129|NCT01704495|7468655|FG000|NOT COMPLETED|Optional Safety Extension||29
6547130|NCT01704495|7468656|FG001|NOT COMPLETED|Optional Safety Extension||33
6547131|NCT01704495|7468657|FG002|NOT COMPLETED|Optional Safety Extension||31
6547132|NCT01704495|7468658|FG003|NOT COMPLETED|Optional Safety Extension||31
6547133|NCT01704521|7468670|FG000|STARTED|Overall Study||3
6547134|NCT01704521|7468671|FG001|STARTED|Overall Study||2
6547135|NCT01704521|7468670|FG000|COMPLETED|Overall Study||3
6547136|NCT01704521|7468671|FG001|COMPLETED|Overall Study||2
6547137|NCT01704521|7468670|FG000|NOT COMPLETED|Overall Study||0
6547138|NCT01704521|7468671|FG001|NOT COMPLETED|Overall Study||0
6547139|NCT01704599|7468677|FG000|STARTED|Overall Study|Study was started January 22, 2010|8
6547140|NCT01704599|7468677|FG000|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
6547141|NCT01704599|7468677|FG000|NOT COMPLETED|Overall Study||1
6547142|NCT01704651|7468706|FG000|STARTED|Overall Study||71
6547143|NCT01704651|7468707|FG001|STARTED|Overall Study||75
6547144|NCT01704651|7468706|FG000|COMPLETED|Overall Study||66
6547145|NCT01704651|7468707|FG001|COMPLETED|Overall Study||68
6547146|NCT01704651|7468706|FG000|NOT COMPLETED|Overall Study||5
6547147|NCT01704651|7468707|FG001|NOT COMPLETED|Overall Study||7
6547148|NCT01704755|7468715|FG000|STARTED|Overall Study||208
6547149|NCT01704755|7468716|FG001|STARTED|Overall Study||172
6547150|NCT01704755|7468715|FG000|Completed Study Drug|Overall Study||204
6547151|NCT01704755|7468716|FG001|Completed Study Drug|Overall Study||163
6547152|NCT01704755|7468715|FG000|COMPLETED|Overall Study||196
6547153|NCT01704755|7468716|FG001|COMPLETED|Overall Study||165
6547154|NCT01704755|7468715|FG000|NOT COMPLETED|Overall Study||12
6547155|NCT01704755|7468716|FG001|NOT COMPLETED|Overall Study||7
6547156|NCT01704781|7468727|FG000|STARTED|Overall Study||3
6547157|NCT01704781|7468728|FG001|STARTED|Overall Study||3
6646920|NCT02384460|7575939|FG000|STARTED|Overall Study||82
6646921|NCT02384460|7575940|FG001|STARTED|Overall Study||87
6646922|NCT02384460|7575939|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
6646923|NCT02384460|7575940|FG001|Received at Least 1 Dose of Study Drug|Overall Study||87
6646924|NCT02384460|7575939|FG000|COMPLETED|Overall Study||75
6646925|NCT02384460|7575940|FG001|COMPLETED|Overall Study||80
6646926|NCT02384460|7575939|FG000|NOT COMPLETED|Overall Study||7
6646927|NCT02384460|7575940|FG001|NOT COMPLETED|Overall Study||7
6646928|NCT02384538|7575948|FG000|STARTED|Overall Study||67
6646929|NCT02384538|7575949|FG001|STARTED|Overall Study||64
6646930|NCT02384538|7575948|FG000|COMPLETED|Overall Study||61
6646931|NCT02384538|7575949|FG001|COMPLETED|Overall Study||49
6646932|NCT02384538|7575948|FG000|NOT COMPLETED|Overall Study||6
6646933|NCT02384538|7575949|FG001|NOT COMPLETED|Overall Study||15
6646934|NCT02384941|7575958|FG000|STARTED|Overall Study||268
6646935|NCT02384941|7575959|FG001|STARTED|Overall Study||263
6646936|NCT02384941|7575960|FG002|STARTED|Overall Study||262
6547158|NCT01704781|7468729|FG002|STARTED|Overall Study||6
6547159|NCT01704781|7468730|FG003|STARTED|Overall Study||12
6646937|NCT02384941|7575958|FG000|COMPLETED|Overall Study||218
6646938|NCT02384941|7575959|FG001|COMPLETED|Overall Study||228
6547160|NCT01704781|7468731|FG004|STARTED|Overall Study||12
6547161|NCT01704781|7468727|FG000|COMPLETED|Overall Study||3
6547162|NCT01704781|7468728|FG001|COMPLETED|Overall Study||3
6547163|NCT01704781|7468729|FG002|COMPLETED|Overall Study||6
6646939|NCT02384941|7575960|FG002|COMPLETED|Overall Study||221
6646940|NCT02384941|7575958|FG000|NOT COMPLETED|Overall Study||50
6547164|NCT01704781|7468730|FG003|COMPLETED|Overall Study||12
6547165|NCT01704781|7468731|FG004|COMPLETED|Overall Study||12
6547166|NCT01704781|7468727|FG000|NOT COMPLETED|Overall Study||0
6547167|NCT01704781|7468728|FG001|NOT COMPLETED|Overall Study||0
6547168|NCT01704781|7468729|FG002|NOT COMPLETED|Overall Study||0
6547169|NCT01704781|7468730|FG003|NOT COMPLETED|Overall Study||0
6547170|NCT01704781|7468731|FG004|NOT COMPLETED|Overall Study||0
6547171|NCT01704846|7468747|FG000|STARTED|Treatment Period 1||30
6547172|NCT01704846|7468748|FG001|STARTED|Treatment Period 1||30
6547173|NCT01704846|7468747|FG000|COMPLETED|Treatment Period 1||30
6547174|NCT01704846|7468748|FG001|COMPLETED|Treatment Period 1||30
6547175|NCT01704846|7468747|FG000|NOT COMPLETED|Treatment Period 1||0
6547176|NCT01704846|7468748|FG001|NOT COMPLETED|Treatment Period 1||0
6547177|NCT01704846|7468747|FG000|STARTED|Treatment Period 2||30
6547178|NCT01704846|7468748|FG001|STARTED|Treatment Period 2||30
6547179|NCT01704846|7468747|FG000|COMPLETED|Treatment Period 2||30
6547180|NCT01704846|7468748|FG001|COMPLETED|Treatment Period 2||29
6547181|NCT01704846|7468747|FG000|NOT COMPLETED|Treatment Period 2||0
6547182|NCT01704846|7468748|FG001|NOT COMPLETED|Treatment Period 2||1
6547183|NCT01704846|7468747|FG000|STARTED|Treatment Period 3||30
6547184|NCT01704846|7468748|FG001|STARTED|Treatment Period 3||29
6547185|NCT01704846|7468747|FG000|COMPLETED|Treatment Period 3||30
6547186|NCT01704846|7468748|FG001|COMPLETED|Treatment Period 3||29
6547187|NCT01704846|7468747|FG000|NOT COMPLETED|Treatment Period 3||0
6547188|NCT01704846|7468748|FG001|NOT COMPLETED|Treatment Period 3||0
6547189|NCT01704846|7468747|FG000|STARTED|Treatment Period 4||30
6547190|NCT01704846|7468748|FG001|STARTED|Treatment Period 4||29
6547191|NCT01704846|7468747|FG000|COMPLETED|Treatment Period 4||30
6547192|NCT01704846|7468748|FG001|COMPLETED|Treatment Period 4||29
6547193|NCT01704846|7468747|FG000|NOT COMPLETED|Treatment Period 4||0
6547194|NCT01704846|7468748|FG001|NOT COMPLETED|Treatment Period 4||0
6547195|NCT01704976|7468756|FG000|STARTED|Overall Study||14
6547196|NCT01704976|7468757|FG001|STARTED|Overall Study||13
6547197|NCT01704976|7468756|FG000|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
6547198|NCT01704976|7468757|FG001|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
6547199|NCT01704976|7468756|FG000|NOT COMPLETED|Overall Study||1
6547200|NCT01704976|7468757|FG001|NOT COMPLETED|Overall Study||2
6547201|NCT01705080|7468766|FG000|STARTED|Overall Study||147
6547202|NCT01705080|7468767|FG001|STARTED|Overall Study||101
6547203|NCT01705080|7468768|FG002|STARTED|Overall Study||28
6547204|NCT01705080|7468766|FG000|Renal Artery Ablation Procedure|Overall Study||147
6547205|NCT01705080|7468767|FG001|Renal Artery Ablation Procedure|Overall Study||101
6547206|NCT01705080|7468768|FG002|Renal Artery Ablation Procedure|Overall Study||28
6547207|NCT01705080|7468766|FG000|Discharge Following Renal Artery Ablation Procedure|Overall Study||147
6547208|NCT01705080|7468767|FG001|Discharge Following Renal Artery Ablation Procedure|Overall Study|Reason Not Completed: Withdrawal by Subject=1|100
6547209|NCT01705080|7468768|FG002|Discharge Following Renal Artery Ablation Procedure|Overall Study||28
6547210|NCT01705080|7468766|FG000|COMPLETED|Overall Study||72
6547211|NCT01705080|7468767|FG001|COMPLETED|Overall Study||49
6547212|NCT01705080|7468768|FG002|COMPLETED|Overall Study||12
6547213|NCT01705080|7468766|FG000|NOT COMPLETED|Overall Study||75
6547214|NCT01705080|7468767|FG001|NOT COMPLETED|Overall Study||52
6547215|NCT01705080|7468768|FG002|NOT COMPLETED|Overall Study||16
6547216|NCT01705145|7468776|FG000|STARTED|Part A||9
6547217|NCT01705145|7468776|FG000|COMPLETED|Part A||9
6547218|NCT01705145|7468776|FG000|NOT COMPLETED|Part A||0
6547219|NCT01705145|7468776|FG000|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
6547220|NCT01705145|7468776|FG000|COMPLETED|Part B||33
6547221|NCT01705145|7468776|FG000|NOT COMPLETED|Part B||1
6547222|NCT01705236|7468792|FG000|STARTED|Overall Study||87
6547223|NCT01705236|7468792|FG000|COMPLETED|Overall Study||60
6547224|NCT01705236|7468792|FG000|NOT COMPLETED|Overall Study||27
6547225|NCT01705288|7468798|FG000|STARTED|Overall Study||52
6547226|NCT01705288|7468799|FG001|STARTED|Overall Study||51
6547227|NCT01705288|7468798|FG000|COMPLETED|Overall Study||52
6547228|NCT01705288|7468799|FG001|COMPLETED|Overall Study||51
6547229|NCT01705288|7468798|FG000|NOT COMPLETED|Overall Study||0
6547230|NCT01705288|7468799|FG001|NOT COMPLETED|Overall Study||0
6547231|NCT01705496|7468805|FG000|STARTED|Overall Study||23
6547232|NCT01705496|7468805|FG000|COMPLETED|Overall Study||19
6547233|NCT01705496|7468805|FG000|NOT COMPLETED|Overall Study||4
6547234|NCT01705509|7468809|FG000|STARTED|Inclusion CPET||14
6547235|NCT01705509|7468809|FG000|COMPLETED|Inclusion CPET||7
6547236|NCT01705509|7468809|FG000|NOT COMPLETED|Inclusion CPET||7
6547237|NCT01705509|7468809|FG000|STARTED|CPET w/ Ranexa||7
6547238|NCT01705509|7468809|FG000|COMPLETED|CPET w/ Ranexa||5
6547239|NCT01705509|7468809|FG000|NOT COMPLETED|CPET w/ Ranexa||2
6547240|NCT01705574|7468815|FG000|STARTED|Double-Blind Phase||293
6547241|NCT01705574|7468816|FG001|STARTED|Double-Blind Phase||290
6547242|NCT01705574|7468817|FG002|STARTED|Double-Blind Phase||0
6547243|NCT01705574|7468818|FG003|STARTED|Double-Blind Phase||0
6547244|NCT01705574|7468815|FG000|COMPLETED|Double-Blind Phase||260
6547245|NCT01705574|7468816|FG001|COMPLETED|Double-Blind Phase||249
6547246|NCT01705574|7468817|FG002|COMPLETED|Double-Blind Phase||0
6547247|NCT01705574|7468818|FG003|COMPLETED|Double-Blind Phase||0
6547248|NCT01705574|7468815|FG000|NOT COMPLETED|Double-Blind Phase||33
6547249|NCT01705574|7468816|FG001|NOT COMPLETED|Double-Blind Phase||41
6547250|NCT01705574|7468817|FG002|NOT COMPLETED|Double-Blind Phase||0
6547251|NCT01705574|7468818|FG003|NOT COMPLETED|Double-Blind Phase||0
6547252|NCT01705574|7468815|FG000|STARTED|Open-Label Extension Phase||246
6547253|NCT01705574|7468816|FG001|STARTED|Open-Label Extension Phase|Participants either entered the OL GEN arm or OL ATV+RTV+TVD arm.|0
6547254|NCT01705574|7468817|FG002|STARTED|Open-Label Extension Phase|159 participants entered from the DB ATV+RTV+TVD arm.|159
6547255|NCT01705574|7468818|FG003|STARTED|Open-Label Extension Phase|53 participants entered from the DB ATV+ RTV + TVD arm.|53
6547256|NCT01705574|7468815|FG000|COMPLETED|Open-Label Extension Phase||231
6547257|NCT01705574|7468816|FG001|COMPLETED|Open-Label Extension Phase||0
6547258|NCT01705574|7468817|FG002|COMPLETED|Open-Label Extension Phase||148
6547259|NCT01705574|7468818|FG003|COMPLETED|Open-Label Extension Phase||48
6547260|NCT01705574|7468815|FG000|NOT COMPLETED|Open-Label Extension Phase||15
6547261|NCT01705574|7468816|FG001|NOT COMPLETED|Open-Label Extension Phase||0
6547262|NCT01705574|7468817|FG002|NOT COMPLETED|Open-Label Extension Phase||11
6547263|NCT01705574|7468818|FG003|NOT COMPLETED|Open-Label Extension Phase||5
6547264|NCT01705587|7468836|FG000|STARTED|Overall Study||7
6547265|NCT01705587|7468837|FG001|STARTED|Overall Study||6
6547266|NCT01705587|7468836|FG000|COMPLETED|Overall Study||7
6547267|NCT01705587|7468837|FG001|COMPLETED|Overall Study||5
6547268|NCT01705587|7468836|FG000|NOT COMPLETED|Overall Study||0
6547269|NCT01705587|7468837|FG001|NOT COMPLETED|Overall Study||1
6547270|NCT01705652|7468845|FG000|STARTED|Overall Study||9
6547271|NCT01705652|7468846|FG001|STARTED|Overall Study||12
6547272|NCT01705652|7468845|FG000|COMPLETED|Overall Study||6
6547273|NCT01705652|7468846|FG001|COMPLETED|Overall Study||9
6547274|NCT01705652|7468845|FG000|NOT COMPLETED|Overall Study||3
6547275|NCT01705652|7468846|FG001|NOT COMPLETED|Overall Study||3
6547276|NCT01705691|7468854|FG000|STARTED|Overall Study||19
6547277|NCT01705691|7468855|FG001|STARTED|Overall Study||30
6547278|NCT01705691|7468854|FG000|COMPLETED|Overall Study||16
6547279|NCT01705691|7468855|FG001|COMPLETED|Overall Study||24
6547280|NCT01705691|7468854|FG000|NOT COMPLETED|Overall Study||3
6547281|NCT01705691|7468855|FG001|NOT COMPLETED|Overall Study||6
6547282|NCT01705717|7468863|FG000|STARTED|Overall Study||37
6547283|NCT01705717|7468864|FG001|STARTED|Overall Study||12
6547284|NCT01705717|7468863|FG000|COMPLETED|Overall Study||35
6547285|NCT01705717|7468864|FG001|COMPLETED|Overall Study||7
6547286|NCT01705717|7468863|FG000|NOT COMPLETED|Overall Study||2
6547287|NCT01705717|7468864|FG001|NOT COMPLETED|Overall Study||5
6547288|NCT01705730|7468869|FG000|STARTED|Overall Study|Participants who received study drug|68
6547289|NCT01705730|7468869|FG000|COMPLETED|Overall Study||59
6547290|NCT01705730|7468869|FG000|NOT COMPLETED|Overall Study||9
6547291|NCT01705964|7468875|FG000|STARTED|Overall Study||25
6547292|NCT01705964|7468876|FG001|STARTED|Overall Study||24
6547293|NCT01705964|7468875|FG000|COMPLETED|Overall Study||25
6547294|NCT01705964|7468876|FG001|COMPLETED|Overall Study||24
6547295|NCT01705964|7468875|FG000|NOT COMPLETED|Overall Study||0
6547296|NCT01705964|7468876|FG001|NOT COMPLETED|Overall Study||0
6547297|NCT01706003|7468884|FG000|STARTED|Overall Study||23
6547298|NCT01706003|7468885|FG001|STARTED|Overall Study||22
6547299|NCT01706003|7468884|FG000|COMPLETED|Overall Study||12
6547300|NCT01706003|7468885|FG001|COMPLETED|Overall Study||18
6547301|NCT01706003|7468884|FG000|NOT COMPLETED|Overall Study||11
6547302|NCT01706003|7468885|FG001|NOT COMPLETED|Overall Study||4
6547303|NCT01706081|7468893|FG000|STARTED|Overall Study||40
6547304|NCT01706081|7468894|FG001|STARTED|Overall Study||42
6547305|NCT01706081|7468893|FG000|COMPLETED|Overall Study||40
6547306|NCT01706081|7468894|FG001|COMPLETED|Overall Study||42
6547307|NCT01706081|7468893|FG000|NOT COMPLETED|Overall Study||0
6547308|NCT01706081|7468894|FG001|NOT COMPLETED|Overall Study||0
6547309|NCT01706146|7468900|FG000|STARTED|Overall Study||59
6547310|NCT01706146|7468900|FG000|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
6547311|NCT01706146|7468900|FG000|NOT COMPLETED|Overall Study||6
6547312|NCT01706159|7468906|FG000|STARTED|Overall Study||14
6547313|NCT01706159|7468907|FG001|STARTED|Overall Study||6
6547314|NCT01706159|7468906|FG000|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
6547315|NCT01706159|7468907|FG001|Exposed|Overall Study|One subject was not exposed to placebo.|5
6547316|NCT01706159|7468906|FG000|Completers (With Baron Score at Week 8)|Overall Study||6
6547317|NCT01706159|7468907|FG001|Completers (With Baron Score at Week 8)|Overall Study||3
6547318|NCT01706159|7468906|FG000|COMPLETED|Overall Study||6
6547319|NCT01706159|7468907|FG001|COMPLETED|Overall Study||4
6547320|NCT01706159|7468906|FG000|NOT COMPLETED|Overall Study||8
6547321|NCT01706159|7468907|FG001|NOT COMPLETED|Overall Study||2
6547322|NCT01706198|7468915|FG000|STARTED|Overall Study||2119
6547323|NCT01706198|7468916|FG001|STARTED|Overall Study||2114
6547324|NCT01706198|7468915|FG000|COMPLETED|Overall Study||1946
6547325|NCT01706198|7468916|FG001|COMPLETED|Overall Study||1920
6547326|NCT01706198|7468915|FG000|NOT COMPLETED|Overall Study||173
6547327|NCT01706198|7468916|FG001|NOT COMPLETED|Overall Study||194
6547328|NCT01706250|7468922|FG000|STARTED|Overall Study||20
6547329|NCT01706250|7468922|FG000|COMPLETED|Overall Study||18
6547330|NCT01706250|7468922|FG000|NOT COMPLETED|Overall Study||2
6547331|NCT01706263|7468931|FG000|STARTED|Overall Study||28
6547332|NCT01706263|7468931|FG000|COMPLETED|Overall Study||28
6547333|NCT01706263|7468931|FG000|NOT COMPLETED|Overall Study||0
6547334|NCT01706328|7468938|FG000|STARTED|2-week Run-in Period||993
6547335|NCT01706328|7468939|FG001|STARTED|2-week Run-in Period||0
6547336|NCT01706328|7468940|FG002|STARTED|2-week Run-in Period||0
6547337|NCT01706328|7468938|FG000|COMPLETED|2-week Run-in Period||828
6547338|NCT01706328|7468939|FG001|COMPLETED|2-week Run-in Period||0
6547339|NCT01706328|7468940|FG002|COMPLETED|2-week Run-in Period||0
6743854|NCT03336853|7671904|FG001|COMPLETED|Overall Study||30
6743855|NCT03336853|7671903|FG000|NOT COMPLETED|Overall Study||0
6547340|NCT01706328|7468938|FG000|NOT COMPLETED|2-week Run-in Period||165
6547341|NCT01706328|7468939|FG001|NOT COMPLETED|2-week Run-in Period||0
6547342|NCT01706328|7468940|FG002|NOT COMPLETED|2-week Run-in Period||0
6547343|NCT01706328|7468938|FG000|STARTED|12-week Double-blind Treatment Period||0
6547344|NCT01706328|7468939|FG001|STARTED|12-week Double-blind Treatment Period||412
6547345|NCT01706328|7468940|FG002|STARTED|12-week Double-blind Treatment Period||416
6547346|NCT01706328|7468938|FG000|COMPLETED|12-week Double-blind Treatment Period||0
6547347|NCT01706328|7468939|FG001|COMPLETED|12-week Double-blind Treatment Period||366
6547348|NCT01706328|7468940|FG002|COMPLETED|12-week Double-blind Treatment Period||371
6547349|NCT01706328|7468938|FG000|NOT COMPLETED|12-week Double-blind Treatment Period||0
6547350|NCT01706328|7468939|FG001|NOT COMPLETED|12-week Double-blind Treatment Period||46
6547351|NCT01706328|7468940|FG002|NOT COMPLETED|12-week Double-blind Treatment Period||45
6547352|NCT01706458|7468948|FG000|STARTED|Overall Study||9
6547353|NCT01706458|7468949|FG001|STARTED|Overall Study||9
6547354|NCT01706458|7468948|FG000|COMPLETED|Overall Study||6
6547355|NCT01706458|7468949|FG001|COMPLETED|Overall Study||5
6547356|NCT01706458|7468948|FG000|NOT COMPLETED|Overall Study||3
6547357|NCT01706458|7468949|FG001|NOT COMPLETED|Overall Study||4
6547358|NCT01706497|7468955|FG000|STARTED|Overall Study||177
6547359|NCT01706497|7468955|FG000|COMPLETED|Overall Study||177
6547360|NCT01706497|7468955|FG000|NOT COMPLETED|Overall Study||0
6547361|NCT01706536|7468964|FG000|STARTED|Overall Study||57
6547362|NCT01706536|7468965|FG001|STARTED|Overall Study||55
6547363|NCT01706536|7468966|FG002|STARTED|Overall Study||54
6547364|NCT01706536|7468967|FG003|STARTED|Overall Study||57
6547365|NCT01706536|7468968|FG004|STARTED|Overall Study||59
6547366|NCT01706536|7468964|FG000|COMPLETED|Overall Study||53
6547367|NCT01706536|7468965|FG001|COMPLETED|Overall Study||51
6547368|NCT01706536|7468966|FG002|COMPLETED|Overall Study||49
6547369|NCT01706536|7468967|FG003|COMPLETED|Overall Study||53
6547370|NCT01706536|7468968|FG004|COMPLETED|Overall Study||57
6547371|NCT01706536|7468964|FG000|NOT COMPLETED|Overall Study||4
6547372|NCT01706536|7468965|FG001|NOT COMPLETED|Overall Study||4
6547373|NCT01706536|7468966|FG002|NOT COMPLETED|Overall Study||5
6547374|NCT01706536|7468967|FG003|NOT COMPLETED|Overall Study||4
6547375|NCT01706536|7468968|FG004|NOT COMPLETED|Overall Study||2
6547376|NCT01706549|7468981|FG000|STARTED|Overall Study||16
6547377|NCT01706549|7468981|FG000|COMPLETED|Overall Study||16
6547378|NCT01706549|7468981|FG000|NOT COMPLETED|Overall Study||0
6547379|NCT01706575|7468985|FG000|STARTED|Overall Study||76
6547380|NCT01706575|7468985|FG000|Treated|Overall Study||70
6547381|NCT01706575|7468985|FG000|COMPLETED|Overall Study||64
6547382|NCT01706575|7468985|FG000|NOT COMPLETED|Overall Study||12
6547383|NCT01706588|7468994|FG000|STARTED|Overall Study||15
6547384|NCT01706588|7468995|FG001|STARTED|Overall Study||15
6547385|NCT01706588|7468996|FG002|STARTED|Overall Study||15
6547386|NCT01706588|7468997|FG003|STARTED|Overall Study||14
6547387|NCT01706588|7468998|FG004|STARTED|Overall Study||16
6547388|NCT01706588|7468994|FG000|COMPLETED|Overall Study||15
6547389|NCT01706588|7468995|FG001|COMPLETED|Overall Study||15
6547390|NCT01706588|7468996|FG002|COMPLETED|Overall Study||15
6547391|NCT01706588|7468997|FG003|COMPLETED|Overall Study||14
6547392|NCT01706588|7468998|FG004|COMPLETED|Overall Study||16
6547393|NCT01706588|7468994|FG000|NOT COMPLETED|Overall Study||0
6547394|NCT01706588|7468995|FG001|NOT COMPLETED|Overall Study||0
6547395|NCT01706588|7468996|FG002|NOT COMPLETED|Overall Study||0
6547396|NCT01706588|7468997|FG003|NOT COMPLETED|Overall Study||0
6547397|NCT01706588|7468998|FG004|NOT COMPLETED|Overall Study||0
6547398|NCT01706666|7469013|FG000|STARTED|Overall Study||1
6547399|NCT01706666|7469014|FG001|STARTED|Overall Study||1
6547400|NCT01706666|7469015|FG002|STARTED|Overall Study||1
6547401|NCT01706666|7469013|FG000|COMPLETED|Overall Study||1
6547402|NCT01706666|7469014|FG001|COMPLETED|Overall Study||1
6547403|NCT01706666|7469015|FG002|COMPLETED|Overall Study||1
6547404|NCT01706666|7469013|FG000|NOT COMPLETED|Overall Study||0
6547405|NCT01706666|7469014|FG001|NOT COMPLETED|Overall Study||0
6547406|NCT01706666|7469015|FG002|NOT COMPLETED|Overall Study||0
6547407|NCT01706770|7469025|FG000|STARTED|Overall Study||33
6547408|NCT01706770|7469026|FG001|STARTED|Overall Study||17
6547409|NCT01706770|7469025|FG000|COMPLETED|Overall Study||31
6547410|NCT01706770|7469026|FG001|COMPLETED|Overall Study||17
6547411|NCT01706770|7469025|FG000|NOT COMPLETED|Overall Study||2
6547412|NCT01706770|7469026|FG001|NOT COMPLETED|Overall Study||0
6547413|NCT01706822|7469032|FG000|STARTED|Overall Study||8
6547414|NCT01706822|7469032|FG000|COMPLETED|Overall Study||8
6547415|NCT01706822|7469032|FG000|NOT COMPLETED|Overall Study||0
6547416|NCT01706926|7469040|FG000|STARTED|Overall Study||81
6547417|NCT01706926|7469041|FG001|STARTED|Overall Study||81
6547418|NCT01706926|7469042|FG002|STARTED|Overall Study||85
6547419|NCT01706926|7469043|FG003|STARTED|Overall Study||79
6743856|NCT03336853|7671904|FG001|NOT COMPLETED|Overall Study||0
6547420|NCT01706926|7469040|FG000|COMPLETED|Overall Study||75
6547421|NCT01706926|7469041|FG001|COMPLETED|Overall Study||77
6547422|NCT01706926|7469042|FG002|COMPLETED|Overall Study||79
6547423|NCT01706926|7469043|FG003|COMPLETED|Overall Study||74
6547424|NCT01706926|7469040|FG000|NOT COMPLETED|Overall Study||6
6547425|NCT01706926|7469041|FG001|NOT COMPLETED|Overall Study||4
6547426|NCT01706926|7469042|FG002|NOT COMPLETED|Overall Study||6
6547427|NCT01706926|7469043|FG003|NOT COMPLETED|Overall Study||5
6547428|NCT01706952|7469056|FG000|STARTED|Overall Study||45
6547429|NCT01706952|7469056|FG000|COMPLETED|Overall Study||37
6547430|NCT01706952|7469056|FG000|NOT COMPLETED|Overall Study||8
6547431|NCT01706965|7469064|FG000|STARTED|Overall Study||14
6547432|NCT01706965|7469065|FG001|STARTED|Overall Study||13
6547433|NCT01706965|7469064|FG000|COMPLETED|Overall Study||13
6547434|NCT01706965|7469065|FG001|COMPLETED|Overall Study||12
6547435|NCT01706965|7469064|FG000|NOT COMPLETED|Overall Study||1
6547436|NCT01706965|7469065|FG001|NOT COMPLETED|Overall Study||1
6547437|NCT01706978|7469073|FG000|STARTED|Overall Study||47
6547438|NCT01706978|7469074|FG001|STARTED|Overall Study||41
6547439|NCT01706978|7469073|FG000|COMPLETED|Overall Study||38
6547440|NCT01706978|7469074|FG001|COMPLETED|Overall Study||35
6547441|NCT01706978|7469073|FG000|NOT COMPLETED|Overall Study||9
6547442|NCT01706978|7469074|FG001|NOT COMPLETED|Overall Study||6
6547443|NCT01707004|7469080|FG000|STARTED|Overall Study||20
6547444|NCT01707004|7469080|FG000|COMPLETED|Overall Study|3 participants were not eligible to proceed to Bone Marrow Transplant due to significant infections.|17
6547445|NCT01707004|7469080|FG000|NOT COMPLETED|Overall Study||3
6547446|NCT01707030|7469087|FG000|STARTED|Overall Study||67
6547447|NCT01707030|7469088|FG001|STARTED|Overall Study||71
6547448|NCT01707030|7469087|FG000|COMPLETED|Overall Study||56
6547449|NCT01707030|7469088|FG001|COMPLETED|Overall Study||54
6547450|NCT01707030|7469087|FG000|NOT COMPLETED|Overall Study||11
6547451|NCT01707030|7469088|FG001|NOT COMPLETED|Overall Study||17
6547452|NCT01707043|7469100|FG000|STARTED|Overall Study||10
6547453|NCT01707043|7469101|FG001|STARTED|Overall Study||10
6547454|NCT01707043|7469100|FG000|COMPLETED|Overall Study||10
6547455|NCT01707043|7469101|FG001|COMPLETED|Overall Study||10
6547456|NCT01707043|7469100|FG000|NOT COMPLETED|Overall Study||0
6547457|NCT01707043|7469101|FG001|NOT COMPLETED|Overall Study||0
6547458|NCT01707095|7469109|FG000|STARTED|Overall Study||42
6547459|NCT01707095|7469110|FG001|STARTED|Overall Study||42
6547460|NCT01707095|7469109|FG000|COMPLETED|Overall Study||42
6646941|NCT02384941|7575959|FG001|NOT COMPLETED|Overall Study||35
6646942|NCT02384941|7575960|FG002|NOT COMPLETED|Overall Study||41
6646943|NCT02385084|7575969|FG000|STARTED|Period 1||3
6646944|NCT02385084|7575970|FG001|STARTED|Period 1||3
6646945|NCT02385084|7575971|FG002|STARTED|Period 1||3
6646946|NCT02385084|7575972|FG003|STARTED|Period 1||3
6547461|NCT01707095|7469110|FG001|COMPLETED|Overall Study||42
6547462|NCT01707095|7469109|FG000|NOT COMPLETED|Overall Study||0
6547463|NCT01707095|7469110|FG001|NOT COMPLETED|Overall Study||0
6547464|NCT01707108|7469116|FG000|STARTED|Overall Study||60
6547465|NCT01707108|7469116|FG000|1 Year|Overall Study||60
6547466|NCT01707108|7469116|FG000|COMPLETED|Overall Study||60
6547467|NCT01707108|7469116|FG000|NOT COMPLETED|Overall Study||0
6547468|NCT01707147|7469121|FG000|STARTED|Overall Study||3219
6547469|NCT01707147|7469121|FG000|COMPLETED|Overall Study||3119
6547470|NCT01707147|7469121|FG000|NOT COMPLETED|Overall Study||100
6547471|NCT01707225|7469125|FG000|STARTED|Overall Study||10
6547472|NCT01707225|7469125|FG000|COMPLETED|Overall Study||10
6547473|NCT01707225|7469125|FG000|NOT COMPLETED|Overall Study||0
6547474|NCT01707238|7469131|FG000|STARTED|Overall Study||48
6547475|NCT01707238|7469132|FG001|STARTED|Overall Study||52
6547476|NCT01707238|7469131|FG000|COMPLETED|Overall Study||48
6547477|NCT01707238|7469132|FG001|COMPLETED|Overall Study||52
6547478|NCT01707238|7469131|FG000|NOT COMPLETED|Overall Study||0
6547479|NCT01707238|7469132|FG001|NOT COMPLETED|Overall Study||0
6547480|NCT01707290|7469141|FG000|STARTED|Overall Study||121
6547481|NCT01707290|7469142|FG001|STARTED|Overall Study||4
6547482|NCT01707290|7469141|FG000|COMPLETED|Overall Study||35
6547483|NCT01707290|7469142|FG001|COMPLETED|Overall Study||3
6547484|NCT01707290|7469141|FG000|NOT COMPLETED|Overall Study||86
6547485|NCT01707290|7469142|FG001|NOT COMPLETED|Overall Study||1
6547486|NCT01707368|7469151|FG000|STARTED|Overall Study||561
6547487|NCT01707368|7469151|FG000|COMPLETED|Overall Study||393
6547488|NCT01707368|7469151|FG000|NOT COMPLETED|Overall Study||168
6547489|NCT01707381|7469155|FG000|STARTED|Period 1||12
6547490|NCT01707381|7469156|FG001|STARTED|Period 1||13
6547491|NCT01707381|7469155|FG000|COMPLETED|Period 1||10
6646947|NCT02385084|7575973|FG004|STARTED|Period 1||3
6646948|NCT02385084|7575974|FG005|STARTED|Period 1||3
6646949|NCT02385084|7575969|FG000|Received LY2409021|Period 1||3
6646950|NCT02385084|7575970|FG001|Received LY2409021|Period 1||3
6547492|NCT01707381|7469156|FG001|COMPLETED|Period 1||11
6547493|NCT01707381|7469155|FG000|NOT COMPLETED|Period 1||2
6547494|NCT01707381|7469156|FG001|NOT COMPLETED|Period 1||2
6547495|NCT01707381|7469155|FG000|STARTED|Period 2||10
6646951|NCT02385084|7575971|FG002|Received LY2409021|Period 1||3
6646952|NCT02385084|7575972|FG003|Received LY2409021|Period 1||3
6547496|NCT01707381|7469156|FG001|STARTED|Period 2||11
6547497|NCT01707381|7469155|FG000|COMPLETED|Period 2||10
6547498|NCT01707381|7469156|FG001|COMPLETED|Period 2||11
6547499|NCT01707381|7469155|FG000|NOT COMPLETED|Period 2||0
6547500|NCT01707381|7469156|FG001|NOT COMPLETED|Period 2||0
6547501|NCT01707420|7469164|FG000|STARTED|Overall Study||18
6547502|NCT01707420|7469165|FG001|STARTED|Overall Study||18
6547503|NCT01707420|7469164|FG000|COMPLETED|Overall Study||18
6547504|NCT01707420|7469165|FG001|COMPLETED|Overall Study||18
6547505|NCT01707420|7469164|FG000|NOT COMPLETED|Overall Study||0
6547506|NCT01707420|7469165|FG001|NOT COMPLETED|Overall Study||0
6547507|NCT01707472|7469176|FG000|STARTED|Overall Study||4
6547508|NCT01707472|7469177|FG001|STARTED|Overall Study||6
6547509|NCT01707472|7469178|FG002|STARTED|Overall Study||8
6547510|NCT01707472|7469176|FG000|COMPLETED|Overall Study||4
6547511|NCT01707472|7469177|FG001|COMPLETED|Overall Study||6
6547512|NCT01707472|7469178|FG002|COMPLETED|Overall Study||8
6547513|NCT01707472|7469176|FG000|NOT COMPLETED|Overall Study||0
6547514|NCT01707472|7469177|FG001|NOT COMPLETED|Overall Study||0
6547515|NCT01707472|7469178|FG002|NOT COMPLETED|Overall Study||0
6547516|NCT01707654|7469186|FG000|STARTED|Overall Study||9
6547517|NCT01707654|7469186|FG000|COMPLETED|Overall Study||9
6547518|NCT01707654|7469186|FG000|NOT COMPLETED|Overall Study||0
6547519|NCT01707667|7469192|FG000|STARTED|Period 1||7
6547520|NCT01707667|7469193|FG001|STARTED|Period 1||6
6547521|NCT01707667|7469192|FG000|COMPLETED|Period 1||6
6547522|NCT01707667|7469193|FG001|COMPLETED|Period 1||6
6547523|NCT01707667|7469192|FG000|NOT COMPLETED|Period 1||1
6547524|NCT01707667|7469193|FG001|NOT COMPLETED|Period 1||0
6547525|NCT01707667|7469192|FG000|STARTED|Period 2||6
6547526|NCT01707667|7469193|FG001|STARTED|Period 2||6
6547527|NCT01707667|7469192|FG000|COMPLETED|Period 2||6
6547528|NCT01707667|7469193|FG001|COMPLETED|Period 2||6
6547529|NCT01707667|7469192|FG000|NOT COMPLETED|Period 2||0
6547530|NCT01707667|7469193|FG001|NOT COMPLETED|Period 2||0
6547531|NCT01707693|7469201|FG000|STARTED|Overall Study Allocation||59
6547532|NCT01707693|7469202|FG001|STARTED|Overall Study Allocation||62
6547533|NCT01707693|7469201|FG000|COMPLETED|Overall Study Allocation||46
6547534|NCT01707693|7469202|FG001|COMPLETED|Overall Study Allocation||54
6547535|NCT01707693|7469201|FG000|NOT COMPLETED|Overall Study Allocation||13
6547536|NCT01707693|7469202|FG001|NOT COMPLETED|Overall Study Allocation||8
6547537|NCT01707693|7469201|FG000|STARTED|Time 3 Measures @ 6 Mth||46
6547538|NCT01707693|7469202|FG001|STARTED|Time 3 Measures @ 6 Mth||54
6547539|NCT01707693|7469201|FG000|COMPLETED|Time 3 Measures @ 6 Mth||46
6547540|NCT01707693|7469202|FG001|COMPLETED|Time 3 Measures @ 6 Mth||49
6547541|NCT01707693|7469201|FG000|NOT COMPLETED|Time 3 Measures @ 6 Mth||0
6547542|NCT01707693|7469202|FG001|NOT COMPLETED|Time 3 Measures @ 6 Mth||5
6547543|NCT01707992|7469212|FG000|STARTED|Placebo-Controlled Phase (24 Months)||740
6547544|NCT01707992|7469213|FG001|STARTED|Placebo-Controlled Phase (24 Months)||727
6547545|NCT01707992|7469214|FG002|STARTED|Placebo-Controlled Phase (24 Months)||732
6547546|NCT01707992|7469215|FG003|STARTED|Placebo-Controlled Phase (24 Months)||0
6547547|NCT01707992|7469216|FG004|STARTED|Placebo-Controlled Phase (24 Months)||0
6547548|NCT01707992|7469217|FG005|STARTED|Placebo-Controlled Phase (24 Months)||0
6547549|NCT01707992|7469212|FG000|COMPLETED|Placebo-Controlled Phase (24 Months)||596
6547550|NCT01707992|7469213|FG001|COMPLETED|Placebo-Controlled Phase (24 Months)||623
6547551|NCT01707992|7469214|FG002|COMPLETED|Placebo-Controlled Phase (24 Months)||532
6547552|NCT01707992|7469215|FG003|COMPLETED|Placebo-Controlled Phase (24 Months)||0
6547553|NCT01707992|7469216|FG004|COMPLETED|Placebo-Controlled Phase (24 Months)||0
6547554|NCT01707992|7469217|FG005|COMPLETED|Placebo-Controlled Phase (24 Months)||0
6547555|NCT01707992|7469212|FG000|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||144
6547556|NCT01707992|7469213|FG001|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||104
6547557|NCT01707992|7469214|FG002|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||200
6547558|NCT01707992|7469215|FG003|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
6547559|NCT01707992|7469216|FG004|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
6547560|NCT01707992|7469217|FG005|NOT COMPLETED|Placebo-Controlled Phase (24 Months)||0
6547561|NCT01707992|7469212|FG000|STARTED|Active Treatment Phase (24 Months)||0
6547562|NCT01707992|7469213|FG001|STARTED|Active Treatment Phase (24 Months)||0
6547563|NCT01707992|7469214|FG002|STARTED|Active Treatment Phase (24 Months)||0
6547564|NCT01707992|7469215|FG003|STARTED|Active Treatment Phase (24 Months)||891
6547565|NCT01707992|7469216|FG004|STARTED|Active Treatment Phase (24 Months)||504
6547566|NCT01707992|7469217|FG005|STARTED|Active Treatment Phase (24 Months)||215
6547567|NCT01707992|7469212|FG000|COMPLETED|Active Treatment Phase (24 Months)||0
6547568|NCT01707992|7469213|FG001|COMPLETED|Active Treatment Phase (24 Months)||0
6547569|NCT01707992|7469214|FG002|COMPLETED|Active Treatment Phase (24 Months)||0
6547570|NCT01707992|7469215|FG003|COMPLETED|Active Treatment Phase (24 Months)||7
6547571|NCT01707992|7469216|FG004|COMPLETED|Active Treatment Phase (24 Months)||10
6547572|NCT01707992|7469217|FG005|COMPLETED|Active Treatment Phase (24 Months)||0
6547573|NCT01707992|7469212|FG000|NOT COMPLETED|Active Treatment Phase (24 Months)||0
6547574|NCT01707992|7469213|FG001|NOT COMPLETED|Active Treatment Phase (24 Months)||0
6547575|NCT01707992|7469214|FG002|NOT COMPLETED|Active Treatment Phase (24 Months)||0
6547576|NCT01707992|7469215|FG003|NOT COMPLETED|Active Treatment Phase (24 Months)||884
6547577|NCT01707992|7469216|FG004|NOT COMPLETED|Active Treatment Phase (24 Months)||494
6547578|NCT01707992|7469217|FG005|NOT COMPLETED|Active Treatment Phase (24 Months)||215
6547579|NCT01708122|7469234|FG000|STARTED|Overall Study||27
6547580|NCT01708122|7469235|FG001|STARTED|Overall Study||26
6547581|NCT01708122|7469234|FG000|COMPLETED|Overall Study||27
6547582|NCT01708122|7469235|FG001|COMPLETED|Overall Study||26
6547583|NCT01708122|7469234|FG000|NOT COMPLETED|Overall Study||0
6547584|NCT01708122|7469235|FG001|NOT COMPLETED|Overall Study||0
6547585|NCT01708161|7469247|FG000|STARTED|Overall Study||4
6547586|NCT01708161|7469248|FG001|STARTED|Overall Study||10
6547587|NCT01708161|7469249|FG002|STARTED|Overall Study||10
6547588|NCT01708161|7469250|FG003|STARTED|Overall Study||16
6547589|NCT01708161|7469251|FG004|STARTED|Overall Study||6
6547590|NCT01708161|7469252|FG005|STARTED|Overall Study||1
6547591|NCT01708161|7469247|FG000|COMPLETED|Overall Study||0
6547592|NCT01708161|7469248|FG001|COMPLETED|Overall Study||0
6547593|NCT01708161|7469249|FG002|COMPLETED|Overall Study||0
6547594|NCT01708161|7469250|FG003|COMPLETED|Overall Study||0
6547595|NCT01708161|7469251|FG004|COMPLETED|Overall Study||0
6547596|NCT01708161|7469252|FG005|COMPLETED|Overall Study||0
6547597|NCT01708161|7469247|FG000|NOT COMPLETED|Overall Study||4
6547598|NCT01708161|7469248|FG001|NOT COMPLETED|Overall Study||10
6547599|NCT01708161|7469249|FG002|NOT COMPLETED|Overall Study||10
6547600|NCT01708161|7469250|FG003|NOT COMPLETED|Overall Study||16
6547601|NCT01708161|7469251|FG004|NOT COMPLETED|Overall Study||6
6646953|NCT02385084|7575973|FG004|Received LY2409021|Period 1||3
6646954|NCT02385084|7575974|FG005|Received LY2409021|Period 1||3
6646955|NCT02385084|7575969|FG000|Washout|Period 1||3
6646956|NCT02385084|7575970|FG001|Washout|Period 1||3
6646957|NCT02385084|7575971|FG002|Washout|Period 1||3
6646958|NCT02385084|7575972|FG003|Washout|Period 1||3
6646959|NCT02385084|7575973|FG004|Washout|Period 1||3
6646960|NCT02385084|7575974|FG005|Washout|Period 1||3
6646961|NCT02385084|7575969|FG000|COMPLETED|Period 1||3
6646962|NCT02385084|7575970|FG001|COMPLETED|Period 1||3
6646963|NCT02385084|7575971|FG002|COMPLETED|Period 1||3
6646964|NCT02385084|7575972|FG003|COMPLETED|Period 1||3
6646965|NCT02385084|7575973|FG004|COMPLETED|Period 1||3
6646966|NCT02385084|7575974|FG005|COMPLETED|Period 1||3
6646967|NCT02385084|7575969|FG000|NOT COMPLETED|Period 1||0
6646968|NCT02385084|7575970|FG001|NOT COMPLETED|Period 1||0
6547602|NCT01708161|7469252|FG005|NOT COMPLETED|Overall Study||1
6547603|NCT01708174|7469269|FG000|STARTED|Treatment Period||2
6547604|NCT01708174|7469270|FG001|STARTED|Treatment Period||16
6547605|NCT01708174|7469271|FG002|STARTED|Treatment Period||4
6547606|NCT01708174|7469269|FG000|Pharmacokinetic Analysis Set|Treatment Period||2
6547607|NCT01708174|7469270|FG001|Pharmacokinetic Analysis Set|Treatment Period||13
6547608|NCT01708174|7469271|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
6547609|NCT01708174|7469269|FG000|COMPLETED|Treatment Period||1
6547610|NCT01708174|7469270|FG001|COMPLETED|Treatment Period||14
6547611|NCT01708174|7469271|FG002|COMPLETED|Treatment Period||3
6547612|NCT01708174|7469269|FG000|NOT COMPLETED|Treatment Period||1
6547613|NCT01708174|7469270|FG001|NOT COMPLETED|Treatment Period||2
6547614|NCT01708174|7469271|FG002|NOT COMPLETED|Treatment Period||1
6547615|NCT01708174|7469269|FG000|STARTED|Survival Follow-up||1
6547616|NCT01708174|7469270|FG001|STARTED|Survival Follow-up||10
6547617|NCT01708174|7469271|FG002|STARTED|Survival Follow-up||0
6547618|NCT01708174|7469269|FG000|COMPLETED|Survival Follow-up||1
6547619|NCT01708174|7469270|FG001|COMPLETED|Survival Follow-up||10
6547620|NCT01708174|7469271|FG002|COMPLETED|Survival Follow-up||0
6547621|NCT01708174|7469269|FG000|NOT COMPLETED|Survival Follow-up||0
6547622|NCT01708174|7469270|FG001|NOT COMPLETED|Survival Follow-up||0
6547623|NCT01708174|7469271|FG002|NOT COMPLETED|Survival Follow-up||0
6547624|NCT01708187|7469282|FG000|STARTED|Overall Study||1
6547625|NCT01708187|7469283|FG001|STARTED|Overall Study||1
6547626|NCT01708187|7469282|FG000|COMPLETED|Overall Study||1
6547627|NCT01708187|7469283|FG001|COMPLETED|Overall Study||0
6547628|NCT01708187|7469282|FG000|NOT COMPLETED|Overall Study||0
6547629|NCT01708187|7469283|FG001|NOT COMPLETED|Overall Study||1
6547630|NCT01708213|7469289|FG000|STARTED|Overall Study||72
6547631|NCT01708213|7469289|FG000|COMPLETED|Overall Study||71
6547632|NCT01708213|7469289|FG000|NOT COMPLETED|Overall Study||1
6547633|NCT01708278|7469299|FG000|STARTED|Overall Study||1
6547634|NCT01708278|7469300|FG001|STARTED|Overall Study||2
6547635|NCT01708278|7469301|FG002|STARTED|Overall Study||2
6547636|NCT01708278|7469302|FG003|STARTED|Overall Study||2
6547637|NCT01708278|7469303|FG004|STARTED|Overall Study||1
6547638|NCT01708278|7469304|FG005|STARTED|Overall Study||1
6547639|NCT01708278|7469299|FG000|COMPLETED|Overall Study||1
6547640|NCT01708278|7469300|FG001|COMPLETED|Overall Study||2
6547641|NCT01708278|7469301|FG002|COMPLETED|Overall Study||2
6547642|NCT01708278|7469302|FG003|COMPLETED|Overall Study||2
6547643|NCT01708278|7469303|FG004|COMPLETED|Overall Study||1
6646969|NCT02385084|7575971|FG002|NOT COMPLETED|Period 1||0
6646970|NCT02385084|7575972|FG003|NOT COMPLETED|Period 1||0
6646971|NCT02385084|7575973|FG004|NOT COMPLETED|Period 1||0
6547644|NCT01708278|7469304|FG005|COMPLETED|Overall Study||1
6547645|NCT01708278|7469299|FG000|NOT COMPLETED|Overall Study||0
6547646|NCT01708278|7469300|FG001|NOT COMPLETED|Overall Study||0
6547647|NCT01708278|7469301|FG002|NOT COMPLETED|Overall Study||0
6547648|NCT01708278|7469302|FG003|NOT COMPLETED|Overall Study||0
6547649|NCT01708278|7469303|FG004|NOT COMPLETED|Overall Study||0
6547650|NCT01708278|7469304|FG005|NOT COMPLETED|Overall Study||0
6646972|NCT02385084|7575974|FG005|NOT COMPLETED|Period 1||0
6646973|NCT02385084|7575969|FG000|STARTED|Period 2|1 participant discontinued after Period 1 - physician decision. Did not enter Period 2.|2
6646974|NCT02385084|7575970|FG001|STARTED|Period 2||3
6547651|NCT01708291|7469320|FG000|STARTED|Overall Study||21
6547652|NCT01708291|7469321|FG001|STARTED|Overall Study||21
6646975|NCT02385084|7575971|FG002|STARTED|Period 2||3
6646976|NCT02385084|7575972|FG003|STARTED|Period 2||3
6547653|NCT01708291|7469320|FG000|COMPLETED|Overall Study||19
6547654|NCT01708291|7469321|FG001|COMPLETED|Overall Study||20
6547655|NCT01708291|7469320|FG000|NOT COMPLETED|Overall Study||2
6547656|NCT01708291|7469321|FG001|NOT COMPLETED|Overall Study||1
6547657|NCT01708317|7469327|FG000|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
6547658|NCT01708317|7469327|FG000|COMPLETED|2010 Control Period||3929
6547659|NCT01708317|7469327|FG000|NOT COMPLETED|2010 Control Period||0
6547660|NCT01708317|7469327|FG000|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
6547661|NCT01708317|7469327|FG000|COMPLETED|Initial Education Period||982
6547662|NCT01708317|7469327|FG000|NOT COMPLETED|Initial Education Period||0
6547663|NCT01708317|7469327|FG000|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
6547664|NCT01708317|7469327|FG000|COMPLETED|ACASI + Education Period||2601
6547665|NCT01708317|7469327|FG000|NOT COMPLETED|ACASI + Education Period||0
6547666|NCT01708317|7469327|FG000|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
6547667|NCT01708317|7469327|FG000|COMPLETED|Final Education Period||909
6547668|NCT01708317|7469327|FG000|NOT COMPLETED|Final Education Period||0
6547669|NCT01708525|7469334|FG000|STARTED|Overall Study||2
6547670|NCT01708525|7469334|FG000|COMPLETED|Overall Study||2
6547671|NCT01708525|7469334|FG000|NOT COMPLETED|Overall Study||0
6547672|NCT01708590|7469342|FG000|STARTED|Induction Phase||222
6547673|NCT01708590|7469343|FG001|STARTED|Induction Phase||219
6547674|NCT01708590|7469344|FG002|STARTED|Induction Phase||220
6547675|NCT01708590|7469345|FG003|STARTED|Induction Phase||0
6547676|NCT01708590|7469346|FG004|STARTED|Induction Phase||0
6547677|NCT01708590|7469347|FG005|STARTED|Induction Phase||0
6547678|NCT01708590|7469348|FG006|STARTED|Induction Phase||0
6547679|NCT01708590|7469342|FG000|COMPLETED|Induction Phase||212
6547680|NCT01708590|7469343|FG001|COMPLETED|Induction Phase||212
6547681|NCT01708590|7469344|FG002|COMPLETED|Induction Phase||209
6547682|NCT01708590|7469345|FG003|COMPLETED|Induction Phase||0
6547683|NCT01708590|7469346|FG004|COMPLETED|Induction Phase||0
6547684|NCT01708590|7469347|FG005|COMPLETED|Induction Phase||0
6547685|NCT01708590|7469348|FG006|COMPLETED|Induction Phase||0
6547686|NCT01708590|7469342|FG000|NOT COMPLETED|Induction Phase||10
6547687|NCT01708590|7469343|FG001|NOT COMPLETED|Induction Phase||7
6547688|NCT01708590|7469344|FG002|NOT COMPLETED|Induction Phase||11
6547689|NCT01708590|7469345|FG003|NOT COMPLETED|Induction Phase||0
6547690|NCT01708590|7469346|FG004|NOT COMPLETED|Induction Phase||0
6547691|NCT01708590|7469347|FG005|NOT COMPLETED|Induction Phase||0
6547692|NCT01708590|7469348|FG006|NOT COMPLETED|Induction Phase||0
6547693|NCT01708590|7469342|FG000|STARTED|Withdrawal Phase||0
6547694|NCT01708590|7469343|FG001|STARTED|Withdrawal Phase||0
6547695|NCT01708590|7469344|FG002|STARTED|Withdrawal Phase||0
6547696|NCT01708590|7469345|FG003|STARTED|Withdrawal Phase||59
6547697|NCT01708590|7469346|FG004|STARTED|Withdrawal Phase||57
6547698|NCT01708590|7469347|FG005|STARTED|Withdrawal Phase||84
6547699|NCT01708590|7469348|FG006|STARTED|Withdrawal Phase||83
6547700|NCT01708590|7469342|FG000|COMPLETED|Withdrawal Phase||0
6547701|NCT01708590|7469343|FG001|COMPLETED|Withdrawal Phase||0
6547702|NCT01708590|7469344|FG002|COMPLETED|Withdrawal Phase||0
6547703|NCT01708590|7469345|FG003|COMPLETED|Withdrawal Phase||6
6547704|NCT01708590|7469346|FG004|COMPLETED|Withdrawal Phase||45
6547705|NCT01708590|7469347|FG005|COMPLETED|Withdrawal Phase||2
6547706|NCT01708590|7469348|FG006|COMPLETED|Withdrawal Phase||74
6547707|NCT01708590|7469342|FG000|NOT COMPLETED|Withdrawal Phase||0
6547708|NCT01708590|7469343|FG001|NOT COMPLETED|Withdrawal Phase||0
6547709|NCT01708590|7469344|FG002|NOT COMPLETED|Withdrawal Phase||0
6547710|NCT01708590|7469345|FG003|NOT COMPLETED|Withdrawal Phase||53
6547711|NCT01708590|7469346|FG004|NOT COMPLETED|Withdrawal Phase||12
6547712|NCT01708590|7469347|FG005|NOT COMPLETED|Withdrawal Phase||82
6547713|NCT01708590|7469348|FG006|NOT COMPLETED|Withdrawal Phase||9
6547714|NCT01708603|7469365|FG000|STARTED|Overall Study||612
6547715|NCT01708603|7469366|FG001|STARTED|Overall Study||610
6547716|NCT01708603|7469367|FG002|STARTED|Overall Study||300
6547717|NCT01708603|7469368|FG003|STARTED|Overall Study||309
6547718|NCT01708603|7469365|FG000|COMPLETED|Overall Study||597
6547719|NCT01708603|7469366|FG001|COMPLETED|Overall Study||588
6547720|NCT01708603|7469367|FG002|COMPLETED|Overall Study||291
6547721|NCT01708603|7469368|FG003|COMPLETED|Overall Study||300
6547722|NCT01708603|7469365|FG000|NOT COMPLETED|Overall Study||15
6646977|NCT02385084|7575973|FG004|STARTED|Period 2||3
6646978|NCT02385084|7575974|FG005|STARTED|Period 2||3
6646979|NCT02385084|7575969|FG000|Received LY2409021|Period 2||2
6646980|NCT02385084|7575970|FG001|Received LY2409021|Period 2||3
6646981|NCT02385084|7575971|FG002|Received LY2409021|Period 2||3
6646982|NCT02385084|7575972|FG003|Received LY2409021|Period 2||3
6547723|NCT01708603|7469366|FG001|NOT COMPLETED|Overall Study||22
6547724|NCT01708603|7469367|FG002|NOT COMPLETED|Overall Study||9
6547725|NCT01708603|7469368|FG003|NOT COMPLETED|Overall Study||9
6547726|NCT01708629|7469387|FG000|STARTED|Overall Study||624
6547727|NCT01708629|7469388|FG001|STARTED|Overall Study||629
6547728|NCT01708629|7469389|FG002|STARTED|Overall Study||313
6547729|NCT01708629|7469390|FG003|STARTED|Overall Study||315
6646983|NCT02385084|7575973|FG004|Received LY2409021|Period 2||3
6547730|NCT01708629|7469387|FG000|COMPLETED|Overall Study||608
6547731|NCT01708629|7469388|FG001|COMPLETED|Overall Study||604
6547732|NCT01708629|7469389|FG002|COMPLETED|Overall Study||303
6547733|NCT01708629|7469390|FG003|COMPLETED|Overall Study||301
6547734|NCT01708629|7469387|FG000|NOT COMPLETED|Overall Study||16
6547735|NCT01708629|7469388|FG001|NOT COMPLETED|Overall Study||25
6547736|NCT01708629|7469389|FG002|NOT COMPLETED|Overall Study||10
6547737|NCT01708629|7469390|FG003|NOT COMPLETED|Overall Study||14
6547738|NCT01708902|7469407|FG000|STARTED|Overall Study||147
6547739|NCT01708902|7469408|FG001|STARTED|Overall Study||145
6547740|NCT01708902|7469409|FG002|STARTED|Overall Study||144
6547741|NCT01708902|7469410|FG003|STARTED|Overall Study||147
6547742|NCT01708902|7469411|FG004|STARTED|Overall Study||147
6547743|NCT01708902|7469412|FG005|STARTED|Overall Study||71
6547744|NCT01708902|7469413|FG006|STARTED|Overall Study||72
6547745|NCT01708902|7469407|FG000|COMPLETED|Overall Study||130
6547746|NCT01708902|7469408|FG001|COMPLETED|Overall Study||137
6547747|NCT01708902|7469409|FG002|COMPLETED|Overall Study||127
6547748|NCT01708902|7469410|FG003|COMPLETED|Overall Study||137
6547749|NCT01708902|7469411|FG004|COMPLETED|Overall Study||131
6547750|NCT01708902|7469412|FG005|COMPLETED|Overall Study||64
6547751|NCT01708902|7469413|FG006|COMPLETED|Overall Study||65
6547752|NCT01708902|7469407|FG000|NOT COMPLETED|Overall Study||17
6547753|NCT01708902|7469408|FG001|NOT COMPLETED|Overall Study||8
6547754|NCT01708902|7469409|FG002|NOT COMPLETED|Overall Study||17
6547755|NCT01708902|7469410|FG003|NOT COMPLETED|Overall Study||10
6547756|NCT01708902|7469411|FG004|NOT COMPLETED|Overall Study||16
6547757|NCT01708902|7469412|FG005|NOT COMPLETED|Overall Study||7
6547758|NCT01708902|7469413|FG006|NOT COMPLETED|Overall Study||7
6547759|NCT01708915|7469436|FG000|STARTED|Overall Study||204
6547760|NCT01708915|7469437|FG001|STARTED|Overall Study||201
6547761|NCT01708915|7469438|FG002|STARTED|Overall Study||198
6547762|NCT01708915|7469439|FG003|STARTED|Overall Study||202
6547763|NCT01708915|7469436|FG000|COMPLETED|Overall Study||118
6547764|NCT01708915|7469437|FG001|COMPLETED|Overall Study||139
6547765|NCT01708915|7469438|FG002|COMPLETED|Overall Study||152
6547766|NCT01708915|7469439|FG003|COMPLETED|Overall Study||169
6547767|NCT01708915|7469436|FG000|NOT COMPLETED|Overall Study||86
6547768|NCT01708915|7469437|FG001|NOT COMPLETED|Overall Study||62
6547769|NCT01708915|7469438|FG002|NOT COMPLETED|Overall Study||46
6547770|NCT01708915|7469439|FG003|NOT COMPLETED|Overall Study||33
6547771|NCT01708967|7469451|FG000|STARTED|Overall Study||50
6547772|NCT01708967|7469452|FG001|STARTED|Overall Study||50
6547773|NCT01708967|7469451|FG000|COMPLETED|Overall Study||50
6547774|NCT01708967|7469452|FG001|COMPLETED|Overall Study||43
6547775|NCT01708967|7469451|FG000|NOT COMPLETED|Overall Study||0
6547776|NCT01708967|7469452|FG001|NOT COMPLETED|Overall Study||7
6547777|NCT01709032|7469458|FG000|STARTED|Overall Study||9
6547778|NCT01709032|7469458|FG000|COMPLETED|Overall Study||6
6547779|NCT01709032|7469458|FG000|NOT COMPLETED|Overall Study||3
6547780|NCT01709084|7469465|FG000|STARTED|Overall Study||213
6547781|NCT01709084|7469466|FG001|STARTED|Overall Study||213
6547782|NCT01709084|7469465|FG000|Treated|Overall Study||213
6547783|NCT01709084|7469466|FG001|Treated|Overall Study||211
6547784|NCT01709084|7469465|FG000|COMPLETED|Overall Study||197
6547785|NCT01709084|7469466|FG001|COMPLETED|Overall Study||198
6547786|NCT01709084|7469465|FG000|NOT COMPLETED|Overall Study||16
6547787|NCT01709084|7469466|FG001|NOT COMPLETED|Overall Study||15
6547788|NCT01709110|7469474|FG000|STARTED|Overall Study||683
6547789|NCT01709110|7469475|FG001|STARTED|Overall Study||683
6547790|NCT01709110|7469474|FG000|Received at Least One Dose of Study Drug|Overall Study||680
6547791|NCT01709110|7469475|FG001|Received at Least One Dose of Study Drug|Overall Study||680
6547792|NCT01709110|7469474|FG000|COMPLETED|Overall Study||498
6547793|NCT01709110|7469475|FG001|COMPLETED|Overall Study||515
6646984|NCT02385084|7575974|FG005|Received LY2409021|Period 2||3
6646985|NCT02385084|7575969|FG000|Washout|Period 2||2
6646986|NCT02385084|7575970|FG001|Washout|Period 2||3
6646987|NCT02385084|7575971|FG002|Washout|Period 2||3
6646988|NCT02385084|7575972|FG003|Washout|Period 2||3
6646989|NCT02385084|7575973|FG004|Washout|Period 2||3
6646990|NCT02385084|7575974|FG005|Washout|Period 2||3
6646991|NCT02385084|7575969|FG000|COMPLETED|Period 2||2
6646992|NCT02385084|7575970|FG001|COMPLETED|Period 2||3
6646993|NCT02385084|7575971|FG002|COMPLETED|Period 2||2
6547794|NCT01709110|7469474|FG000|NOT COMPLETED|Overall Study||185
6547795|NCT01709110|7469475|FG001|NOT COMPLETED|Overall Study||168
6646994|NCT02385084|7575972|FG003|COMPLETED|Period 2||3
6646995|NCT02385084|7575973|FG004|COMPLETED|Period 2||3
6646996|NCT02385084|7575974|FG005|COMPLETED|Period 2||3
6646997|NCT02385084|7575969|FG000|NOT COMPLETED|Period 2||0
6646998|NCT02385084|7575970|FG001|NOT COMPLETED|Period 2||0
6547796|NCT01709149|7469484|FG000|STARTED|Open-label Lead-in Phase||711
6547797|NCT01709149|7469485|FG001|STARTED|Open-label Lead-in Phase||0
6547798|NCT01709149|7469486|FG002|STARTED|Open-label Lead-in Phase||0
6547799|NCT01709149|7469484|FG000|COMPLETED|Open-label Lead-in Phase||596
6547800|NCT01709149|7469485|FG001|COMPLETED|Open-label Lead-in Phase||0
6547801|NCT01709149|7469486|FG002|COMPLETED|Open-label Lead-in Phase||0
6547802|NCT01709149|7469484|FG000|NOT COMPLETED|Open-label Lead-in Phase||115
6547803|NCT01709149|7469485|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
6547804|NCT01709149|7469486|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
6547805|NCT01709149|7469484|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
6646999|NCT02385084|7575971|FG002|NOT COMPLETED|Period 2||1
6547806|NCT01709149|7469485|FG001|STARTED|Double-blind, Placebo-controlled Phase||295
6547807|NCT01709149|7469486|FG002|STARTED|Double-blind, Placebo-controlled Phase||301
6547808|NCT01709149|7469484|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
6547809|NCT01709149|7469485|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||269
6547810|NCT01709149|7469486|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||204
6547811|NCT01709149|7469484|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6547812|NCT01709149|7469485|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||26
6547813|NCT01709149|7469486|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||97
6547814|NCT01709162|7469495|FG000|STARTED|Overall Study|Randomized|18
6547815|NCT01709162|7469496|FG001|STARTED|Overall Study|Randomized|5
6547816|NCT01709162|7469495|FG000|Received Treatment|Overall Study||18
6547817|NCT01709162|7469496|FG001|Received Treatment|Overall Study||4
6547818|NCT01709162|7469495|FG000|Still Receiving Treatment|Overall Study||0
6547819|NCT01709162|7469496|FG001|Still Receiving Treatment|Overall Study||0
6547820|NCT01709162|7469495|FG000|COMPLETED|Overall Study|Completed treatment as per protocol|12
6547821|NCT01709162|7469496|FG001|COMPLETED|Overall Study|Completed treatment as per protocol|0
6547822|NCT01709162|7469495|FG000|NOT COMPLETED|Overall Study||6
6547823|NCT01709162|7469496|FG001|NOT COMPLETED|Overall Study||5
6547824|NCT01709227|7469504|FG000|STARTED|Overall Study||32
6547825|NCT01709227|7469505|FG001|STARTED|Overall Study||41
6547826|NCT01709227|7469504|FG000|COMPLETED|Overall Study||31
6547827|NCT01709227|7469505|FG001|COMPLETED|Overall Study||32
6547828|NCT01709227|7469504|FG000|NOT COMPLETED|Overall Study||1
6547829|NCT01709227|7469505|FG001|NOT COMPLETED|Overall Study||9
6547830|NCT01709305|7469512|FG000|STARTED|Phase 1||5570
6547831|NCT01709305|7469513|FG001|STARTED|Phase 1||0
6547832|NCT01709305|7469514|FG002|STARTED|Phase 1||0
6547833|NCT01709305|7469515|FG003|STARTED|Phase 1||0
6547834|NCT01709305|7469516|FG004|STARTED|Phase 1||0
6547835|NCT01709305|7469512|FG000|COMPLETED|Phase 1||4933
6547836|NCT01709305|7469513|FG001|COMPLETED|Phase 1||0
6547837|NCT01709305|7469514|FG002|COMPLETED|Phase 1||0
6547838|NCT01709305|7469515|FG003|COMPLETED|Phase 1||0
6547839|NCT01709305|7469516|FG004|COMPLETED|Phase 1||0
6547840|NCT01709305|7469512|FG000|NOT COMPLETED|Phase 1||637
6547841|NCT01709305|7469513|FG001|NOT COMPLETED|Phase 1||0
6547842|NCT01709305|7469514|FG002|NOT COMPLETED|Phase 1||0
6547843|NCT01709305|7469515|FG003|NOT COMPLETED|Phase 1||0
6547844|NCT01709305|7469516|FG004|NOT COMPLETED|Phase 1||0
6547845|NCT01709305|7469512|FG000|STARTED|Phase 2||0
6547846|NCT01709305|7469513|FG001|STARTED|Phase 2||552
6547847|NCT01709305|7469514|FG002|STARTED|Phase 2||550
6547848|NCT01709305|7469515|FG003|STARTED|Phase 2||556
6547849|NCT01709305|7469516|FG004|STARTED|Phase 2||554
6547850|NCT01709305|7469512|FG000|COMPLETED|Phase 2||0
6547851|NCT01709305|7469513|FG001|COMPLETED|Phase 2||500
6547852|NCT01709305|7469514|FG002|COMPLETED|Phase 2||505
6547853|NCT01709305|7469515|FG003|COMPLETED|Phase 2||508
6547854|NCT01709305|7469516|FG004|COMPLETED|Phase 2||507
6547855|NCT01709305|7469512|FG000|NOT COMPLETED|Phase 2||0
6547856|NCT01709305|7469513|FG001|NOT COMPLETED|Phase 2||52
6547857|NCT01709305|7469514|FG002|NOT COMPLETED|Phase 2||45
6547858|NCT01709305|7469515|FG003|NOT COMPLETED|Phase 2||48
6547859|NCT01709305|7469516|FG004|NOT COMPLETED|Phase 2||47
6547860|NCT01709383|7469533|FG000|STARTED|Overall Study||24
6547861|NCT01709383|7469534|FG001|STARTED|Overall Study||14
6547862|NCT01709383|7469533|FG000|Completed Treatment|Overall Study||24
6547863|NCT01709383|7469534|FG001|Completed Treatment|Overall Study||14
6547864|NCT01709383|7469533|FG000|Completed Follow-ups|Overall Study||23
6547865|NCT01709383|7469534|FG001|Completed Follow-ups|Overall Study||14
6547866|NCT01709383|7469533|FG000|Included in Analysis|Overall Study||22
6547867|NCT01709383|7469534|FG001|Included in Analysis|Overall Study||13
6547868|NCT01709383|7469533|FG000|COMPLETED|Overall Study||23
6547869|NCT01709383|7469534|FG001|COMPLETED|Overall Study||14
6547870|NCT01709383|7469533|FG000|NOT COMPLETED|Overall Study||1
6547871|NCT01709383|7469534|FG001|NOT COMPLETED|Overall Study||0
6547872|NCT01709409|7469544|FG000|STARTED|Overall Study||43
6547873|NCT01709409|7469545|FG001|STARTED|Overall Study||45
6547874|NCT01709409|7469544|FG000|COMPLETED|Overall Study||42
6547875|NCT01709409|7469545|FG001|COMPLETED|Overall Study||45
6547876|NCT01709409|7469544|FG000|NOT COMPLETED|Overall Study||1
6547877|NCT01709409|7469545|FG001|NOT COMPLETED|Overall Study||0
6547878|NCT01709422|7469553|FG000|STARTED|Overall Study||70
6547879|NCT01709422|7469554|FG001|STARTED|Overall Study||70
6547880|NCT01709422|7469553|FG000|COMPLETED|Overall Study||70
6547881|NCT01709422|7469554|FG001|COMPLETED|Overall Study||70
6547882|NCT01709422|7469553|FG000|NOT COMPLETED|Overall Study||0
6547883|NCT01709422|7469554|FG001|NOT COMPLETED|Overall Study||0
6547884|NCT01709474|7469564|FG000|STARTED|Overall Study||3
6547885|NCT01709474|7469565|FG001|STARTED|Overall Study||4
6547886|NCT01709474|7469564|FG000|COMPLETED|Overall Study||3
6547887|NCT01709474|7469565|FG001|COMPLETED|Overall Study||4
6547888|NCT01709474|7469564|FG000|NOT COMPLETED|Overall Study||0
6547889|NCT01709474|7469565|FG001|NOT COMPLETED|Overall Study||0
6547890|NCT01709500|7469573|FG000|STARTED|Overall Study||167
6547891|NCT01709500|7469574|FG001|STARTED|Overall Study||82
6547892|NCT01709500|7469573|FG000|Treated|Overall Study||167
6547893|NCT01709500|7469574|FG001|Treated|Overall Study||81
6547894|NCT01709500|7469573|FG000|COMPLETED|Overall Study||0
6547895|NCT01709500|7469574|FG001|COMPLETED|Overall Study||0
6547896|NCT01709500|7469573|FG000|NOT COMPLETED|Overall Study||167
6547897|NCT01709500|7469574|FG001|NOT COMPLETED|Overall Study||82
6547898|NCT01709513|7469583|FG000|STARTED|Overall Study||63
6547899|NCT01709513|7469584|FG001|STARTED|Overall Study||125
6547900|NCT01709513|7469585|FG002|STARTED|Overall Study||126
6547901|NCT01709513|7469583|FG000|Treated|Overall Study||63
6547902|NCT01709513|7469584|FG001|Treated|Overall Study||124
6547903|NCT01709513|7469585|FG002|Treated|Overall Study||126
6547904|NCT01709513|7469583|FG000|COMPLETED|Overall Study||42
6547905|NCT01709513|7469584|FG001|COMPLETED|Overall Study||82
6547906|NCT01709513|7469585|FG002|COMPLETED|Overall Study||96
6547907|NCT01709513|7469583|FG000|NOT COMPLETED|Overall Study||21
6547908|NCT01709513|7469584|FG001|NOT COMPLETED|Overall Study||43
6547909|NCT01709513|7469585|FG002|NOT COMPLETED|Overall Study||30
6547910|NCT01709578|7469599|FG000|STARTED|Overall Study||181
6547911|NCT01709578|7469600|FG001|STARTED|Overall Study||181
6547912|NCT01709578|7469601|FG002|STARTED|Overall Study||184
6547913|NCT01709578|7469599|FG000|COMPLETED|Overall Study||101
6547914|NCT01709578|7469600|FG001|COMPLETED|Overall Study||125
6547915|NCT01709578|7469601|FG002|COMPLETED|Overall Study||133
6547916|NCT01709578|7469599|FG000|NOT COMPLETED|Overall Study||80
6547917|NCT01709578|7469600|FG001|NOT COMPLETED|Overall Study||56
6547918|NCT01709578|7469601|FG002|NOT COMPLETED|Overall Study||51
6547919|NCT01709695|7469611|FG000|STARTED|Overall Study||13
6547920|NCT01709695|7469612|FG001|STARTED|Overall Study||14
6547921|NCT01709695|7469611|FG000|COMPLETED|Overall Study||12
6547922|NCT01709695|7469612|FG001|COMPLETED|Overall Study||13
6547923|NCT01709695|7469611|FG000|NOT COMPLETED|Overall Study||1
6547924|NCT01709695|7469612|FG001|NOT COMPLETED|Overall Study||1
6547925|NCT01709708|7469620|FG000|STARTED|Overall Study||27
6547926|NCT01709708|7469621|FG001|STARTED|Overall Study||14
6547927|NCT01709708|7469620|FG000|COMPLETED|Overall Study||26
6547928|NCT01709708|7469621|FG001|COMPLETED|Overall Study||12
6547929|NCT01709708|7469620|FG000|NOT COMPLETED|Overall Study||1
6547930|NCT01709708|7469621|FG001|NOT COMPLETED|Overall Study||2
6547931|NCT01709721|7469631|FG000|STARTED|Open Label Phase||41
6547932|NCT01709721|7469632|FG001|STARTED|Open Label Phase||40
6547933|NCT01709721|7469633|FG002|STARTED|Open Label Phase||72
6547934|NCT01709721|7469631|FG000|COMPLETED|Open Label Phase||41
6547935|NCT01709721|7469632|FG001|COMPLETED|Open Label Phase||40
6547936|NCT01709721|7469633|FG002|COMPLETED|Open Label Phase||0
6547937|NCT01709721|7469631|FG000|NOT COMPLETED|Open Label Phase||0
6547938|NCT01709721|7469632|FG001|NOT COMPLETED|Open Label Phase||0
6547939|NCT01709721|7469633|FG002|NOT COMPLETED|Open Label Phase||72
6547940|NCT01709721|7469631|FG000|STARTED|Randomized Phase||41
6547941|NCT01709721|7469632|FG001|STARTED|Randomized Phase||40
6547942|NCT01709721|7469633|FG002|STARTED|Randomized Phase||0
6547943|NCT01709721|7469631|FG000|COMPLETED|Randomized Phase||38
6547944|NCT01709721|7469632|FG001|COMPLETED|Randomized Phase||34
6547945|NCT01709721|7469633|FG002|COMPLETED|Randomized Phase||0
6547946|NCT01709721|7469631|FG000|NOT COMPLETED|Randomized Phase||3
6547947|NCT01709721|7469632|FG001|NOT COMPLETED|Randomized Phase||6
6547948|NCT01709721|7469633|FG002|NOT COMPLETED|Randomized Phase||0
6562614|NCT01802151|7485560|FG002|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
6562615|NCT01802151|7485561|FG003|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
6562616|NCT01802151|7485558|FG000|NOT COMPLETED|Overall Study||0
6562617|NCT01802151|7485559|FG001|NOT COMPLETED|Overall Study||0
6562618|NCT01802151|7485560|FG002|NOT COMPLETED|Overall Study||2
6562619|NCT01802151|7485561|FG003|NOT COMPLETED|Overall Study||0
6562620|NCT01802216|7485573|FG000|STARTED|Baseline||17
6562621|NCT01802216|7485574|FG001|STARTED|Baseline||34
6562622|NCT01802216|7485573|FG000|COMPLETED|Baseline||17
6562623|NCT01802216|7485574|FG001|COMPLETED|Baseline||34
6562624|NCT01802216|7485573|FG000|NOT COMPLETED|Baseline||0
6562625|NCT01802216|7485574|FG001|NOT COMPLETED|Baseline||0
6562626|NCT01802216|7485573|FG000|STARTED|4 Month Visit||17
6562627|NCT01802216|7485574|FG001|STARTED|4 Month Visit||34
6562628|NCT01802216|7485573|FG000|COMPLETED|4 Month Visit||14
6562629|NCT01802216|7485574|FG001|COMPLETED|4 Month Visit||30
6562630|NCT01802216|7485573|FG000|NOT COMPLETED|4 Month Visit||3
6562631|NCT01802216|7485574|FG001|NOT COMPLETED|4 Month Visit||4
6562632|NCT01802216|7485573|FG000|STARTED|8 Month Visit||17
6562633|NCT01802216|7485574|FG001|STARTED|8 Month Visit||34
6562634|NCT01802216|7485573|FG000|COMPLETED|8 Month Visit||14
6562635|NCT01802216|7485574|FG001|COMPLETED|8 Month Visit||29
6562636|NCT01802216|7485573|FG000|NOT COMPLETED|8 Month Visit||3
6562637|NCT01802216|7485574|FG001|NOT COMPLETED|8 Month Visit||5
6562638|NCT01802216|7485573|FG000|STARTED|12 Month Visit||17
6562639|NCT01802216|7485574|FG001|STARTED|12 Month Visit||34
6562640|NCT01802216|7485573|FG000|COMPLETED|12 Month Visit||14
6562641|NCT01802216|7485574|FG001|COMPLETED|12 Month Visit||30
6562642|NCT01802216|7485573|FG000|NOT COMPLETED|12 Month Visit||3
6562643|NCT01802216|7485574|FG001|NOT COMPLETED|12 Month Visit||4
6562644|NCT01802320|7485580|FG000|STARTED|Overall Study||18
6562645|NCT01802320|7485580|FG000|COMPLETED|Overall Study||16
6562646|NCT01802320|7485580|FG000|NOT COMPLETED|Overall Study||2
6562647|NCT01802333|7485587|FG000|STARTED|Overall Study||263
6562648|NCT01802333|7485588|FG001|STARTED|Overall Study||267
6562649|NCT01802333|7485589|FG002|STARTED|Overall Study||224
6562650|NCT01802333|7485587|FG000|High Risk Patients|Overall Study||60
6562651|NCT01802333|7485588|FG001|High Risk Patients|Overall Study||61
6562652|NCT01802333|7485589|FG002|High Risk Patients|Overall Study||38
6562653|NCT01802333|7485587|FG000|High Risk Patients Achieved CR/CRi|Overall Study||38
6547949|NCT01709747|7469641|FG000|STARTED|Overall Study||364
6547950|NCT01709747|7469641|FG000|COMPLETED|Overall Study||287
6547951|NCT01709747|7469641|FG000|NOT COMPLETED|Overall Study||77
6547952|NCT01709786|7469646|FG000|STARTED|Overall Study||88
6547953|NCT01709786|7469646|FG000|COMPLETED|Overall Study||88
6547954|NCT01709786|7469646|FG000|NOT COMPLETED|Overall Study||0
6547955|NCT01709799|7469655|FG000|STARTED|Overall Study||25
6547956|NCT01709799|7469656|FG001|STARTED|Overall Study||21
6547957|NCT01709799|7469657|FG002|STARTED|Overall Study||18
6647000|NCT02385084|7575972|FG003|NOT COMPLETED|Period 2||0
6647001|NCT02385084|7575973|FG004|NOT COMPLETED|Period 2||0
6647002|NCT02385084|7575974|FG005|NOT COMPLETED|Period 2||0
6647003|NCT02385084|7575969|FG000|STARTED|Period 3||2
6647004|NCT02385084|7575970|FG001|STARTED|Period 3||3
6647005|NCT02385084|7575971|FG002|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|1
6547958|NCT01709799|7469655|FG000|COMPLETED|Overall Study||22
6547959|NCT01709799|7469656|FG001|COMPLETED|Overall Study||18
6547960|NCT01709799|7469657|FG002|COMPLETED|Overall Study||15
6547961|NCT01709799|7469655|FG000|NOT COMPLETED|Overall Study||3
6547962|NCT01709799|7469656|FG001|NOT COMPLETED|Overall Study||3
6547963|NCT01709799|7469657|FG002|NOT COMPLETED|Overall Study||3
6547964|NCT01709838|7469665|FG000|STARTED|Overall Study||134
6547965|NCT01709838|7469665|FG000|COMPLETED|Overall Study||67
6547966|NCT01709838|7469665|FG000|NOT COMPLETED|Overall Study||67
6547967|NCT01709864|7469673|FG000|STARTED|Overall Study||222
6547968|NCT01709864|7469674|FG001|STARTED|Overall Study||219
6547969|NCT01709864|7469673|FG000|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
6547970|NCT01709864|7469674|FG001|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
6547971|NCT01709864|7469673|FG000|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
6547972|NCT01709864|7469674|FG001|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
6547973|NCT01709864|7469673|FG000|COMPLETED|Overall Study||215
6547974|NCT01709864|7469674|FG001|COMPLETED|Overall Study||208
6547975|NCT01709864|7469673|FG000|NOT COMPLETED|Overall Study||7
6547976|NCT01709864|7469674|FG001|NOT COMPLETED|Overall Study||11
6547977|NCT01709903|7469682|FG000|STARTED|Overall Study|Randomized set|372
6547978|NCT01709903|7469683|FG001|STARTED|Overall Study|Randomized set|372
6547979|NCT01709903|7469682|FG000|COMPLETED|Overall Study||343
6547980|NCT01709903|7469683|FG001|COMPLETED|Overall Study||333
6547981|NCT01709903|7469682|FG000|NOT COMPLETED|Overall Study||29
6547982|NCT01709903|7469683|FG001|NOT COMPLETED|Overall Study||39
6547983|NCT01709981|7469691|FG000|STARTED|Overall Study||141
6547984|NCT01709981|7469692|FG001|STARTED|Overall Study||139
6547985|NCT01709981|7469691|FG000|COMPLETED|Overall Study||141
6547986|NCT01709981|7469692|FG001|COMPLETED|Overall Study||139
6547987|NCT01709981|7469691|FG000|NOT COMPLETED|Overall Study||0
6547988|NCT01709981|7469692|FG001|NOT COMPLETED|Overall Study||0
6547989|NCT01710020|7469698|FG000|STARTED|Period 1||12
6547990|NCT01710020|7469698|FG000|COMPLETED|Period 1||11
6547991|NCT01710020|7469698|FG000|NOT COMPLETED|Period 1||1
6547992|NCT01710020|7469698|FG000|STARTED|Washout Period (at Least 14 Days)||11
6547993|NCT01710020|7469698|FG000|COMPLETED|Washout Period (at Least 14 Days)||11
6547994|NCT01710020|7469698|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6547995|NCT01710020|7469698|FG000|STARTED|Period 2||11
6547996|NCT01710020|7469698|FG000|COMPLETED|Period 2||11
6547997|NCT01710020|7469698|FG000|NOT COMPLETED|Period 2||0
6547998|NCT01710033|7469708|FG000|STARTED|Stage 1||6
6547999|NCT01710033|7469709|FG001|STARTED|Stage 1||6
6548000|NCT01710033|7469710|FG002|STARTED|Stage 1||6
6548001|NCT01710033|7469711|FG003|STARTED|Stage 1||6
6548002|NCT01710033|7469712|FG004|STARTED|Stage 1||0
6548003|NCT01710033|7469708|FG000|COMPLETED|Stage 1||6
6548004|NCT01710033|7469709|FG001|COMPLETED|Stage 1||6
6548005|NCT01710033|7469710|FG002|COMPLETED|Stage 1||6
6548006|NCT01710033|7469711|FG003|COMPLETED|Stage 1||6
6548007|NCT01710033|7469712|FG004|COMPLETED|Stage 1||0
6548008|NCT01710033|7469708|FG000|NOT COMPLETED|Stage 1||0
6548009|NCT01710033|7469709|FG001|NOT COMPLETED|Stage 1||0
6548010|NCT01710033|7469710|FG002|NOT COMPLETED|Stage 1||0
6548011|NCT01710033|7469711|FG003|NOT COMPLETED|Stage 1||0
6548012|NCT01710033|7469712|FG004|NOT COMPLETED|Stage 1||0
6548013|NCT01710033|7469708|FG000|STARTED|Stage 2||0
6548014|NCT01710033|7469709|FG001|STARTED|Stage 2||0
6548015|NCT01710033|7469710|FG002|STARTED|Stage 2||0
6548016|NCT01710033|7469711|FG003|STARTED|Stage 2||0
6647006|NCT02385084|7575972|FG003|STARTED|Period 3||3
6647007|NCT02385084|7575973|FG004|STARTED|Period 3|1 participant discontinued after Period 2 - adverse event. Did not enter Period 3.|2
6647008|NCT02385084|7575974|FG005|STARTED|Period 3||3
6647009|NCT02385084|7575969|FG000|Received LY2409021|Period 3||2
6548017|NCT01710033|7469712|FG004|STARTED|Stage 2||4
6548018|NCT01710033|7469708|FG000|COMPLETED|Stage 2||0
6647010|NCT02385084|7575970|FG001|Received LY2409021|Period 3||3
6647011|NCT02385084|7575971|FG002|Received LY2409021|Period 3||1
6548019|NCT01710033|7469709|FG001|COMPLETED|Stage 2||0
6548020|NCT01710033|7469710|FG002|COMPLETED|Stage 2||0
6548021|NCT01710033|7469711|FG003|COMPLETED|Stage 2||0
6548022|NCT01710033|7469712|FG004|COMPLETED|Stage 2||3
6548023|NCT01710033|7469708|FG000|NOT COMPLETED|Stage 2||0
6548024|NCT01710033|7469709|FG001|NOT COMPLETED|Stage 2||0
6548025|NCT01710033|7469710|FG002|NOT COMPLETED|Stage 2||0
6548026|NCT01710033|7469711|FG003|NOT COMPLETED|Stage 2||0
6548027|NCT01710033|7469712|FG004|NOT COMPLETED|Stage 2||1
6548028|NCT01710046|7469727|FG000|STARTED|Overall Study||9
6548029|NCT01710046|7469728|FG001|STARTED|Overall Study||3
6548030|NCT01710046|7469727|FG000|COMPLETED|Overall Study||8
6548031|NCT01710046|7469728|FG001|COMPLETED|Overall Study||3
6548032|NCT01710046|7469727|FG000|NOT COMPLETED|Overall Study||1
6548033|NCT01710046|7469728|FG001|NOT COMPLETED|Overall Study||0
6548034|NCT01710137|7469736|FG000|STARTED|Overall Study||89
6548035|NCT01710137|7469737|FG001|STARTED|Overall Study||90
6548036|NCT01710137|7469736|FG000|COMPLETED|Overall Study||65
6548037|NCT01710137|7469737|FG001|COMPLETED|Overall Study||76
6647012|NCT02385084|7575972|FG003|Received LY2409021|Period 3||3
6647013|NCT02385084|7575973|FG004|Received LY2409021|Period 3||2
6647014|NCT02385084|7575974|FG005|Received LY2409021|Period 3||3
6647015|NCT02385084|7575969|FG000|Washout|Period 3||2
6647016|NCT02385084|7575970|FG001|Washout|Period 3||3
6647017|NCT02385084|7575971|FG002|Washout|Period 3||1
6647018|NCT02385084|7575972|FG003|Washout|Period 3||3
6647019|NCT02385084|7575973|FG004|Washout|Period 3||2
6548038|NCT01710137|7469736|FG000|NOT COMPLETED|Overall Study||24
6548039|NCT01710137|7469737|FG001|NOT COMPLETED|Overall Study||14
6548040|NCT01710254|7469743|FG000|STARTED|Overall Study||30
6548041|NCT01710254|7469743|FG000|COMPLETED|Overall Study||30
6548042|NCT01710254|7469743|FG000|NOT COMPLETED|Overall Study||0
6548043|NCT01710306|7469749|FG000|STARTED|Overall Study||86
6548044|NCT01710306|7469750|FG001|STARTED|Overall Study||85
6548045|NCT01710306|7469749|FG000|COMPLETED|Overall Study||68
6548046|NCT01710306|7469750|FG001|COMPLETED|Overall Study||55
6548047|NCT01710306|7469749|FG000|NOT COMPLETED|Overall Study||18
6548048|NCT01710306|7469750|FG001|NOT COMPLETED|Overall Study||30
6548049|NCT01710332|7469759|FG000|STARTED|Overall Study||6
6548050|NCT01710332|7469760|FG001|STARTED|Overall Study||6
6548051|NCT01710332|7469759|FG000|COMPLETED|Overall Study||6
6548052|NCT01710332|7469760|FG001|COMPLETED|Overall Study||6
6548053|NCT01710332|7469759|FG000|NOT COMPLETED|Overall Study||0
6548054|NCT01710332|7469760|FG001|NOT COMPLETED|Overall Study||0
6548055|NCT01710345|7469769|FG000|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
6548056|NCT01710345|7469770|FG001|STARTED|Overall Study||40
6548057|NCT01710345|7469771|FG002|STARTED|Overall Study||20
6548058|NCT01710345|7469769|FG000|COMPLETED|Overall Study||37
6548059|NCT01710345|7469770|FG001|COMPLETED|Overall Study||35
6548060|NCT01710345|7469771|FG002|COMPLETED|Overall Study||19
6548061|NCT01710345|7469769|FG000|NOT COMPLETED|Overall Study||3
6548062|NCT01710345|7469770|FG001|NOT COMPLETED|Overall Study||5
6548063|NCT01710345|7469771|FG002|NOT COMPLETED|Overall Study||1
6548064|NCT01710358|7469782|FG000|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
6548065|NCT01710358|7469783|FG001|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
6548066|NCT01710358|7469784|FG002|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
6548067|NCT01710358|7469782|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
6548068|NCT01710358|7469783|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
6548069|NCT01710358|7469784|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
6548070|NCT01710358|7469782|FG000|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
6548071|NCT01710358|7469783|FG001|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
6548072|NCT01710358|7469784|FG002|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
6548073|NCT01710358|7469782|FG000|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
6548074|NCT01710358|7469783|FG001|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
6548075|NCT01710358|7469784|FG002|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
6548076|NCT01710358|7469782|FG000|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
6548077|NCT01710358|7469783|FG001|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
6548078|NCT01710358|7469784|FG002|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
6548079|NCT01710358|7469782|FG000|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
6548080|NCT01710358|7469783|FG001|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
6548081|NCT01710358|7469784|FG002|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
6548082|NCT01710358|7469782|FG000|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
6548083|NCT01710358|7469783|FG001|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
6548084|NCT01710358|7469784|FG002|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
6548085|NCT01710358|7469782|FG000|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
6548086|NCT01710358|7469783|FG001|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
6548087|NCT01710358|7469784|FG002|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
6548088|NCT01710358|7469782|FG000|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
6548089|NCT01710358|7469783|FG001|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
6647020|NCT02385084|7575974|FG005|Washout|Period 3||3
6647021|NCT02385084|7575969|FG000|COMPLETED|Period 3||2
6647022|NCT02385084|7575970|FG001|COMPLETED|Period 3||3
6647023|NCT02385084|7575971|FG002|COMPLETED|Period 3||1
6647024|NCT02385084|7575972|FG003|COMPLETED|Period 3||3
6647025|NCT02385084|7575973|FG004|COMPLETED|Period 3||2
6647026|NCT02385084|7575974|FG005|COMPLETED|Period 3||3
6548090|NCT01710358|7469784|FG002|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
6548091|NCT01710358|7469782|FG000|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
6548092|NCT01710358|7469783|FG001|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
6548093|NCT01710358|7469784|FG002|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
6548094|NCT01710358|7469782|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6548095|NCT01710358|7469783|FG001|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
6548096|NCT01710358|7469784|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6548097|NCT01710358|7469782|FG000|COMPLETED|Rescue Period||0
6548098|NCT01710358|7469783|FG001|COMPLETED|Rescue Period||196
6548099|NCT01710358|7469784|FG002|COMPLETED|Rescue Period||0
6548100|NCT01710358|7469782|FG000|NOT COMPLETED|Rescue Period||0
6548101|NCT01710358|7469783|FG001|NOT COMPLETED|Rescue Period||31
6548102|NCT01710358|7469784|FG002|NOT COMPLETED|Rescue Period||0
6548103|NCT01710358|7469782|FG000|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
6548104|NCT01710358|7469783|FG001|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
6548105|NCT01710358|7469784|FG002|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
6548106|NCT01710358|7469782|FG000|COMPLETED|Follow-up Period||33
6548107|NCT01710358|7469783|FG001|COMPLETED|Follow-up Period||76
6548108|NCT01710358|7469784|FG002|COMPLETED|Follow-up Period||20
6548109|NCT01710358|7469782|FG000|NOT COMPLETED|Follow-up Period||0
6548110|NCT01710358|7469783|FG001|NOT COMPLETED|Follow-up Period||0
6548111|NCT01710358|7469784|FG002|NOT COMPLETED|Follow-up Period||0
6548112|NCT01710501|7469808|FG000|STARTED|Overall Study||29
6548113|NCT01710501|7469809|FG001|STARTED|Overall Study||28
6548114|NCT01710501|7469810|FG002|STARTED|Overall Study||30
6548115|NCT01710501|7469808|FG000|COMPLETED|Overall Study||27
6548116|NCT01710501|7469809|FG001|COMPLETED|Overall Study||28
6548117|NCT01710501|7469810|FG002|COMPLETED|Overall Study||30
6548118|NCT01710501|7469808|FG000|NOT COMPLETED|Overall Study||2
6548119|NCT01710501|7469809|FG001|NOT COMPLETED|Overall Study||0
6548120|NCT01710501|7469810|FG002|NOT COMPLETED|Overall Study||0
6548121|NCT01710514|7469820|FG000|STARTED|Overall Study||54
6548122|NCT01710514|7469821|FG001|STARTED|Overall Study||54
6548123|NCT01710514|7469820|FG000|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
6548124|NCT01710514|7469821|FG001|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
6548125|NCT01710514|7469820|FG000|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
6548126|NCT01710514|7469821|FG001|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
6548127|NCT01710514|7469820|FG000|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
6548128|NCT01710514|7469821|FG001|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
6548129|NCT01710514|7469820|FG000|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
6548130|NCT01710514|7469821|FG001|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
6548131|NCT01710514|7469820|FG000|COMPLETED|Overall Study||47
6548132|NCT01710514|7469821|FG001|COMPLETED|Overall Study||47
6548133|NCT01710514|7469820|FG000|NOT COMPLETED|Overall Study||7
6548134|NCT01710514|7469821|FG001|NOT COMPLETED|Overall Study||7
6548135|NCT01710527|7469830|FG000|STARTED|Period 1: Intervention Period 1||16
6548136|NCT01710527|7469831|FG001|STARTED|Period 1: Intervention Period 1||16
6548137|NCT01710527|7469830|FG000|COMPLETED|Period 1: Intervention Period 1||16
6548138|NCT01710527|7469831|FG001|COMPLETED|Period 1: Intervention Period 1||16
6548139|NCT01710527|7469830|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
6548140|NCT01710527|7469831|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
6548141|NCT01710527|7469830|FG000|STARTED|Period 2: Washout Period (7 Days)||16
6548142|NCT01710527|7469831|FG001|STARTED|Period 2: Washout Period (7 Days)||16
6548143|NCT01710527|7469830|FG000|COMPLETED|Period 2: Washout Period (7 Days)||16
6548144|NCT01710527|7469831|FG001|COMPLETED|Period 2: Washout Period (7 Days)||15
6548145|NCT01710527|7469830|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6548146|NCT01710527|7469831|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
6548147|NCT01710527|7469830|FG000|STARTED|Period 3: Intervention Period 2||16
6548148|NCT01710527|7469831|FG001|STARTED|Period 3: Intervention Period 2||15
6548149|NCT01710527|7469830|FG000|COMPLETED|Period 3: Intervention Period 2||16
6548150|NCT01710527|7469831|FG001|COMPLETED|Period 3: Intervention Period 2||15
6548151|NCT01710527|7469830|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
6548152|NCT01710527|7469831|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
6548153|NCT01710657|7469840|FG000|STARTED|Overall Study||184
6548154|NCT01710657|7469841|FG001|STARTED|Overall Study||183
6548155|NCT01710657|7469842|FG002|STARTED|Overall Study||180
6548156|NCT01710657|7469840|FG000|Titration Period (4 Weeks)|Overall Study||184
6548157|NCT01710657|7469841|FG001|Titration Period (4 Weeks)|Overall Study||183
6548158|NCT01710657|7469842|FG002|Titration Period (4 Weeks)|Overall Study||180
6548159|NCT01710657|7469840|FG000|Maintenance Period (12 Weeks)|Overall Study||176
6548160|NCT01710657|7469841|FG001|Maintenance Period (12 Weeks)|Overall Study||175
6548161|NCT01710657|7469842|FG002|Maintenance Period (12 Weeks)|Overall Study||168
6548162|NCT01710657|7469840|FG000|COMPLETED|Overall Study||166
6548163|NCT01710657|7469841|FG001|COMPLETED|Overall Study||171
6548164|NCT01710657|7469842|FG002|COMPLETED|Overall Study||148
6548165|NCT01710657|7469840|FG000|NOT COMPLETED|Overall Study||18
6548166|NCT01710657|7469841|FG001|NOT COMPLETED|Overall Study||12
6548167|NCT01710657|7469842|FG002|NOT COMPLETED|Overall Study||32
6548168|NCT01710709|7469850|FG000|STARTED|Overall Study||464
6548169|NCT01710709|7469850|FG000|COMPLETED|Overall Study||291
6548170|NCT01710709|7469850|FG000|NOT COMPLETED|Overall Study||173
6548171|NCT01710787|7469858|FG000|STARTED|Overall Study||44
6548172|NCT01710787|7469859|FG001|STARTED|Overall Study||44
6548173|NCT01710787|7469860|FG002|STARTED|Overall Study||22
6548174|NCT01710787|7469858|FG000|COMPLETED|Overall Study||44
6548175|NCT01710787|7469859|FG001|COMPLETED|Overall Study||44
6548176|NCT01710787|7469860|FG002|COMPLETED|Overall Study||22
6548177|NCT01710787|7469858|FG000|NOT COMPLETED|Overall Study||0
6548178|NCT01710787|7469859|FG001|NOT COMPLETED|Overall Study||0
6548179|NCT01710787|7469860|FG002|NOT COMPLETED|Overall Study||0
6548180|NCT01710800|7469868|FG000|STARTED|Overall Study|63 patients consented to be part of the study|63
6548181|NCT01710800|7469868|FG000|Received PPI Intervention|Overall Study||44
6548182|NCT01710800|7469868|FG000|Received Placebo Intervention|Overall Study||45
6548183|NCT01710800|7469868|FG000|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
6548184|NCT01710800|7469868|FG000|NOT COMPLETED|Overall Study||22
6548185|NCT01710839|7469876|FG000|STARTED|Overall Study||24
6548186|NCT01710839|7469877|FG001|STARTED|Overall Study||6
6548187|NCT01710839|7469876|FG000|COMPLETED|Overall Study||23
6548188|NCT01710839|7469877|FG001|COMPLETED|Overall Study||0
6548189|NCT01710839|7469876|FG000|NOT COMPLETED|Overall Study||1
6548190|NCT01710839|7469877|FG001|NOT COMPLETED|Overall Study||6
6548191|NCT01710891|7469885|FG000|STARTED|Overall Study||95
6548192|NCT01710891|7469886|FG001|STARTED|Overall Study||103
6548193|NCT01710891|7469885|FG000|COMPLETED|Overall Study||95
6548194|NCT01710891|7469886|FG001|COMPLETED|Overall Study||103
6548195|NCT01710891|7469885|FG000|NOT COMPLETED|Overall Study||0
6548196|NCT01710891|7469886|FG001|NOT COMPLETED|Overall Study||0
6548197|NCT01711177|7469895|FG000|STARTED|Overall Study||10
6548198|NCT01711177|7469896|FG001|STARTED|Overall Study||3
6548199|NCT01711177|7469897|FG002|STARTED|Overall Study||3
6548200|NCT01711177|7469895|FG000|COMPLETED|Overall Study||10
6548201|NCT01711177|7469896|FG001|COMPLETED|Overall Study||3
6548202|NCT01711177|7469897|FG002|COMPLETED|Overall Study||3
6548203|NCT01711177|7469895|FG000|NOT COMPLETED|Overall Study||0
6548204|NCT01711177|7469896|FG001|NOT COMPLETED|Overall Study||0
6548205|NCT01711177|7469897|FG002|NOT COMPLETED|Overall Study||0
6548206|NCT01711216|7469905|FG000|STARTED|Overall Study||999
6548207|NCT01711216|7469905|FG000|COMPLETED|Overall Study||782
6548208|NCT01711216|7469905|FG000|NOT COMPLETED|Overall Study||217
6548209|NCT01711294|7469912|FG000|STARTED|Overall Study||121
6548210|NCT01711294|7469913|FG001|STARTED|Overall Study||65
6548211|NCT01711294|7469914|FG002|STARTED|Overall Study||64
6548212|NCT01711294|7469912|FG000|COMPLETED|Overall Study||121
6548213|NCT01711294|7469913|FG001|COMPLETED|Overall Study||65
6548214|NCT01711294|7469914|FG002|COMPLETED|Overall Study||64
6548215|NCT01711294|7469912|FG000|NOT COMPLETED|Overall Study||0
6548216|NCT01711294|7469913|FG001|NOT COMPLETED|Overall Study||0
6548217|NCT01711294|7469914|FG002|NOT COMPLETED|Overall Study||0
6548218|NCT01711359|7469925|FG000|STARTED|Treatment Period||213
6548219|NCT01711359|7469926|FG001|STARTED|Treatment Period||160
6548220|NCT01711359|7469927|FG002|STARTED|Treatment Period||215
6548221|NCT01711359|7469925|FG000|Received at Least One Dose of Study Drug|Treatment Period||210
6548222|NCT01711359|7469926|FG001|Received at Least One Dose of Study Drug|Treatment Period||159
6548223|NCT01711359|7469927|FG002|Received at Least One Dose of Study Drug|Treatment Period||215
6548224|NCT01711359|7469925|FG000|Rescued|Treatment Period||26
6548225|NCT01711359|7469926|FG001|Rescued|Treatment Period||7
6548226|NCT01711359|7469927|FG002|Rescued|Treatment Period||6
6548227|NCT01711359|7469925|FG000|COMPLETED|Treatment Period||161
6548228|NCT01711359|7469926|FG001|COMPLETED|Treatment Period||136
6548229|NCT01711359|7469927|FG002|COMPLETED|Treatment Period||173
6548230|NCT01711359|7469925|FG000|NOT COMPLETED|Treatment Period||52
6548231|NCT01711359|7469926|FG001|NOT COMPLETED|Treatment Period||24
6548232|NCT01711359|7469927|FG002|NOT COMPLETED|Treatment Period||42
6548233|NCT01711359|7469925|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
6548234|NCT01711359|7469926|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
6548235|NCT01711359|7469927|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
6548236|NCT01711359|7469925|FG000|COMPLETED|Follow Up||0
6548237|NCT01711359|7469926|FG001|COMPLETED|Follow Up||0
6548238|NCT01711359|7469927|FG002|COMPLETED|Follow Up||0
6548239|NCT01711359|7469925|FG000|NOT COMPLETED|Follow Up||25
6548240|NCT01711359|7469926|FG001|NOT COMPLETED|Follow Up||15
6647027|NCT02385084|7575969|FG000|NOT COMPLETED|Period 3||0
6647028|NCT02385084|7575970|FG001|NOT COMPLETED|Period 3||0
6548241|NCT01711359|7469927|FG002|NOT COMPLETED|Follow Up||28
6548242|NCT01711372|7469942|FG000|STARTED|Overall Study||66
6548243|NCT01711372|7469943|FG001|STARTED|Overall Study||47
6548244|NCT01711372|7469942|FG000|COMPLETED|Overall Study||66
6548245|NCT01711372|7469943|FG001|COMPLETED|Overall Study||47
6647029|NCT02385084|7575971|FG002|NOT COMPLETED|Period 3||0
6548246|NCT01711372|7469942|FG000|NOT COMPLETED|Overall Study||0
6548247|NCT01711372|7469943|FG001|NOT COMPLETED|Overall Study||0
6548248|NCT01711424|7469948|FG000|STARTED|Overall Study||1209
6548249|NCT01711424|7469948|FG000|COMPLETED|Overall Study||1209
6548250|NCT01711424|7469948|FG000|NOT COMPLETED|Overall Study||0
6548251|NCT01711619|7469954|FG000|STARTED|Overall Study||56
6548252|NCT01711619|7469955|FG001|STARTED|Overall Study||60
6548253|NCT01711619|7469954|FG000|COMPLETED|Overall Study||38
6548254|NCT01711619|7469955|FG001|COMPLETED|Overall Study||36
6548255|NCT01711619|7469954|FG000|NOT COMPLETED|Overall Study||18
6548256|NCT01711619|7469955|FG001|NOT COMPLETED|Overall Study||24
6548257|NCT01711645|7469961|FG000|STARTED|Overall Study||55
6548258|NCT01711645|7469961|FG000|COMPLETED|Overall Study||36
6548259|NCT01711645|7469961|FG000|NOT COMPLETED|Overall Study||19
6548260|NCT01711658|7469967|FG000|STARTED|Overall Study||64
6548261|NCT01711658|7469968|FG001|STARTED|Overall Study||63
6548262|NCT01711658|7469967|FG000|Participants Who Started Protocol Treatment|Overall Study||59
6548263|NCT01711658|7469968|FG001|Participants Who Started Protocol Treatment|Overall Study||60
6548264|NCT01711658|7469967|FG000|COMPLETED|Overall Study||64
6548265|NCT01711658|7469968|FG001|COMPLETED|Overall Study||63
6548266|NCT01711658|7469967|FG000|NOT COMPLETED|Overall Study||0
6548267|NCT01711658|7469968|FG001|NOT COMPLETED|Overall Study||0
6548268|NCT01711736|7469976|FG000|STARTED|Overall Study||299
6548269|NCT01711736|7469977|FG001|STARTED|Overall Study||302
6548270|NCT01711736|7469976|FG000|COMPLETED|Overall Study|Up to Day 180|287
6548271|NCT01711736|7469977|FG001|COMPLETED|Overall Study|Up to Day 180|294
6548272|NCT01711736|7469976|FG000|NOT COMPLETED|Overall Study||12
6548273|NCT01711736|7469977|FG001|NOT COMPLETED|Overall Study||8
6548274|NCT01711853|7469984|FG000|STARTED|Overall Study||19
6548275|NCT01711853|7469984|FG000|COMPLETED|Overall Study||16
6548276|NCT01711853|7469984|FG000|NOT COMPLETED|Overall Study||3
6548277|NCT01711866|7469988|FG000|STARTED|Overall Study||87
6548278|NCT01711866|7469988|FG000|COMPLETED|Overall Study||79
6548279|NCT01711866|7469988|FG000|NOT COMPLETED|Overall Study||8
6548280|NCT01711918|7469992|FG000|STARTED|Overall Study||9
6548281|NCT01711918|7469992|FG000|COMPLETED|Overall Study||7
6548282|NCT01711918|7469992|FG000|NOT COMPLETED|Overall Study||2
6548283|NCT01711983|7469996|FG000|STARTED|6-Month Clinical Success Evaluation||400
6548284|NCT01711983|7469996|FG000|COMPLETED|6-Month Clinical Success Evaluation||368
6548285|NCT01711983|7469996|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||32
6548286|NCT01711983|7469996|FG000|STARTED|6-Month Closure Evaluation||368
6548287|NCT01711983|7469996|FG000|COMPLETED|6-Month Closure Evaluation||342
6548288|NCT01711983|7469996|FG000|NOT COMPLETED|6-Month Closure Evaluation||26
6548289|NCT01711983|7469996|FG000|STARTED|36-Month Closure Evaluation||342
6548290|NCT01711983|7469996|FG000|COMPLETED|36-Month Closure Evaluation||278
6548291|NCT01711983|7469996|FG000|NOT COMPLETED|36-Month Closure Evaluation||64
6548292|NCT01712009|7470003|FG000|STARTED|Overall Study||198
6548293|NCT01712009|7470004|FG001|STARTED|Overall Study||200
6548294|NCT01712009|7470005|FG002|STARTED|Overall Study||202
6548295|NCT01712009|7470003|FG000|Received Pegfilgrastim|Overall Study||191
6548296|NCT01712009|7470004|FG001|Received Pegfilgrastim|Overall Study||196
6548297|NCT01712009|7470005|FG002|Received Pegfilgrastim|Overall Study||200
6548298|NCT01712009|7470003|FG000|Received Naproxen / Loratadine|Overall Study||0
6548299|NCT01712009|7470004|FG001|Received Naproxen / Loratadine|Overall Study||193
6548300|NCT01712009|7470005|FG002|Received Naproxen / Loratadine|Overall Study||198
6548301|NCT01712009|7470003|FG000|COMPLETED|Overall Study||160
6548302|NCT01712009|7470004|FG001|COMPLETED|Overall Study||171
6548303|NCT01712009|7470005|FG002|COMPLETED|Overall Study||181
6548304|NCT01712009|7470003|FG000|NOT COMPLETED|Overall Study||38
6548305|NCT01712009|7470004|FG001|NOT COMPLETED|Overall Study||29
6548306|NCT01712009|7470005|FG002|NOT COMPLETED|Overall Study||21
6548307|NCT01712061|7470015|FG000|STARTED|Overall Study||30
6548308|NCT01712061|7470016|FG001|STARTED|Overall Study||140
6548309|NCT01712061|7470017|FG002|STARTED|Overall Study||56
6548310|NCT01712061|7470015|FG000|COMPLETED|Overall Study||20
6548311|NCT01712061|7470016|FG001|COMPLETED|Overall Study||114
6548312|NCT01712061|7470017|FG002|COMPLETED|Overall Study||45
6548313|NCT01712061|7470015|FG000|NOT COMPLETED|Overall Study||10
6548314|NCT01712061|7470016|FG001|NOT COMPLETED|Overall Study||26
6548315|NCT01712061|7470017|FG002|NOT COMPLETED|Overall Study||11
6548316|NCT01712074|7470029|FG000|STARTED|Placebo Run-in Period||195
6548317|NCT01712074|7470030|FG001|STARTED|Placebo Run-in Period||0
6548318|NCT01712074|7470031|FG002|STARTED|Placebo Run-in Period||0
6548319|NCT01712074|7470029|FG000|COMPLETED|Placebo Run-in Period||185
6548320|NCT01712074|7470030|FG001|COMPLETED|Placebo Run-in Period||0
6548321|NCT01712074|7470031|FG002|COMPLETED|Placebo Run-in Period||0
6548322|NCT01712074|7470029|FG000|NOT COMPLETED|Placebo Run-in Period||10
6548323|NCT01712074|7470030|FG001|NOT COMPLETED|Placebo Run-in Period||0
6548324|NCT01712074|7470031|FG002|NOT COMPLETED|Placebo Run-in Period||0
6548325|NCT01712074|7470029|FG000|STARTED|Double Blind Period||0
6548326|NCT01712074|7470030|FG001|STARTED|Double Blind Period||91
6548327|NCT01712074|7470031|FG002|STARTED|Double Blind Period||94
6548328|NCT01712074|7470029|FG000|COMPLETED|Double Blind Period||0
6548329|NCT01712074|7470030|FG001|COMPLETED|Double Blind Period||77
6548330|NCT01712074|7470031|FG002|COMPLETED|Double Blind Period||86
6548331|NCT01712074|7470029|FG000|NOT COMPLETED|Double Blind Period||0
6548332|NCT01712074|7470030|FG001|NOT COMPLETED|Double Blind Period||14
6548333|NCT01712074|7470031|FG002|NOT COMPLETED|Double Blind Period||8
6548334|NCT01712178|7470048|FG000|STARTED|Overall Study||50
6548335|NCT01712178|7470049|FG001|STARTED|Overall Study||50
6548336|NCT01712178|7470048|FG000|COMPLETED|Overall Study||49
6548337|NCT01712178|7470049|FG001|COMPLETED|Overall Study||47
6548338|NCT01712178|7470048|FG000|NOT COMPLETED|Overall Study||1
6548339|NCT01712178|7470049|FG001|NOT COMPLETED|Overall Study||3
6548340|NCT01712204|7470057|FG000|STARTED|Overall Study||41
6548341|NCT01712204|7470058|FG001|STARTED|Overall Study||41
6548342|NCT01712204|7470057|FG000|COMPLETED|Overall Study||33
6548343|NCT01712204|7470058|FG001|COMPLETED|Overall Study||36
6548344|NCT01712204|7470057|FG000|NOT COMPLETED|Overall Study||8
6548345|NCT01712204|7470058|FG001|NOT COMPLETED|Overall Study||5
6548346|NCT01712230|7470067|FG000|STARTED|Overall Study||11
6548347|NCT01712230|7470068|FG001|STARTED|Overall Study||18
6548348|NCT01712230|7470069|FG002|STARTED|Overall Study||18
6548349|NCT01712230|7470067|FG000|COMPLETED|Overall Study||9
6548350|NCT01712230|7470068|FG001|COMPLETED|Overall Study||14
6548351|NCT01712230|7470069|FG002|COMPLETED|Overall Study||11
6548352|NCT01712230|7470067|FG000|NOT COMPLETED|Overall Study||2
6548353|NCT01712230|7470068|FG001|NOT COMPLETED|Overall Study||4
6548354|NCT01712230|7470069|FG002|NOT COMPLETED|Overall Study||7
6548355|NCT01712256|7470077|FG000|STARTED|Overall Study||33
6548356|NCT01712256|7470077|FG000|COMPLETED|Overall Study||32
6548357|NCT01712256|7470077|FG000|NOT COMPLETED|Overall Study||1
6548358|NCT01712334|7470081|FG000|STARTED|Treatment Period 1||44
6548359|NCT01712334|7470082|FG001|STARTED|Treatment Period 1||43
6548360|NCT01712334|7470081|FG000|Received Treatment|Treatment Period 1||44
6548361|NCT01712334|7470082|FG001|Received Treatment|Treatment Period 1||41
6548362|NCT01712334|7470081|FG000|COMPLETED|Treatment Period 1||44
6548363|NCT01712334|7470082|FG001|COMPLETED|Treatment Period 1||41
6548364|NCT01712334|7470081|FG000|NOT COMPLETED|Treatment Period 1||0
6548365|NCT01712334|7470082|FG001|NOT COMPLETED|Treatment Period 1||2
6548366|NCT01712334|7470081|FG000|STARTED|Treatment Period 2||44
6548367|NCT01712334|7470082|FG001|STARTED|Treatment Period 2||41
6548368|NCT01712334|7470081|FG000|COMPLETED|Treatment Period 2||44
6548369|NCT01712334|7470082|FG001|COMPLETED|Treatment Period 2||41
6548370|NCT01712334|7470081|FG000|NOT COMPLETED|Treatment Period 2||0
6548371|NCT01712334|7470082|FG001|NOT COMPLETED|Treatment Period 2||0
6548372|NCT01712360|7470092|FG000|STARTED|Overall Study||22
6548373|NCT01712360|7470093|FG001|STARTED|Overall Study||22
6548374|NCT01712360|7470094|FG002|STARTED|Overall Study||6
6548375|NCT01712360|7470095|FG003|STARTED|Overall Study||6
6548376|NCT01712360|7470092|FG000|COMPLETED|Overall Study||22
6548377|NCT01712360|7470093|FG001|COMPLETED|Overall Study||21
6548378|NCT01712360|7470094|FG002|COMPLETED|Overall Study||6
6548379|NCT01712360|7470095|FG003|COMPLETED|Overall Study||4
6548380|NCT01712360|7470092|FG000|NOT COMPLETED|Overall Study||0
6548381|NCT01712360|7470093|FG001|NOT COMPLETED|Overall Study||1
6548382|NCT01712360|7470094|FG002|NOT COMPLETED|Overall Study||0
6548383|NCT01712360|7470095|FG003|NOT COMPLETED|Overall Study||2
6548384|NCT01712399|7470111|FG000|STARTED|Overall Study||397
6548385|NCT01712399|7470111|FG000|COMPLETED|Overall Study||0
6548386|NCT01712399|7470111|FG000|NOT COMPLETED|Overall Study||397
6548387|NCT01712438|7470115|FG000|STARTED|Overall Study||110
6548388|NCT01712438|7470115|FG000|SAF Population|Overall Study||108
6548389|NCT01712438|7470115|FG000|ITT Population|Overall Study||108
6548390|NCT01712438|7470115|FG000|PP Population|Overall Study||95
6548391|NCT01712438|7470115|FG000|PROPH Population|Overall Study||103
6647030|NCT02385084|7575972|FG003|NOT COMPLETED|Period 3||0
6647031|NCT02385084|7575973|FG004|NOT COMPLETED|Period 3||0
6647032|NCT02385084|7575974|FG005|NOT COMPLETED|Period 3||0
6647033|NCT02385097|7575985|FG000|STARTED|Overall Study||106
6647034|NCT02385097|7575986|FG001|STARTED|Overall Study||105
6647035|NCT02385097|7575985|FG000|COMPLETED|Overall Study||106
6647036|NCT02385097|7575986|FG001|COMPLETED|Overall Study||105
6647037|NCT02385097|7575985|FG000|NOT COMPLETED|Overall Study||0
6647038|NCT02385097|7575986|FG001|NOT COMPLETED|Overall Study||0
6647039|NCT02385240|7575995|FG000|STARTED|Overall Study||183
6548392|NCT01712438|7470115|FG000|BLEED Population|Overall Study||94
6548393|NCT01712438|7470115|FG000|SURG Population|Overall Study||24
6548394|NCT01712438|7470115|FG000|COMPLETED|Overall Study||73
6548395|NCT01712438|7470115|FG000|NOT COMPLETED|Overall Study||37
6548396|NCT01712516|7470128|FG000|STARTED|Overall Study||250
6548397|NCT01712516|7470129|FG001|STARTED|Overall Study||251
6548398|NCT01712516|7470130|FG002|STARTED|Overall Study||251
6548399|NCT01712516|7470131|FG003|STARTED|Overall Study||249
6548400|NCT01712516|7470128|FG000|Safety Set|Overall Study||250
6548401|NCT01712516|7470129|FG001|Safety Set|Overall Study||251
6548402|NCT01712516|7470130|FG002|Safety Set|Overall Study||251
6647040|NCT02385240|7575996|FG001|STARTED|Overall Study||184
6647041|NCT02385240|7575997|FG002|STARTED|Overall Study||185
6548403|NCT01712516|7470131|FG003|Safety Set|Overall Study||248
6548404|NCT01712516|7470128|FG000|Full Analysis Set|Overall Study||250
6548405|NCT01712516|7470129|FG001|Full Analysis Set|Overall Study||251
6647042|NCT02385240|7575995|FG000|COMPLETED|Overall Study||182
6548406|NCT01712516|7470130|FG002|Full Analysis Set|Overall Study||250
6548407|NCT01712516|7470131|FG003|Full Analysis Set|Overall Study||247
6548408|NCT01712516|7470128|FG000|COMPLETED|Overall Study||244
6548409|NCT01712516|7470129|FG001|COMPLETED|Overall Study||241
6548410|NCT01712516|7470130|FG002|COMPLETED|Overall Study||245
6548411|NCT01712516|7470131|FG003|COMPLETED|Overall Study||236
6548412|NCT01712516|7470128|FG000|NOT COMPLETED|Overall Study||6
6548413|NCT01712516|7470129|FG001|NOT COMPLETED|Overall Study||10
6548414|NCT01712516|7470130|FG002|NOT COMPLETED|Overall Study||6
6548415|NCT01712516|7470131|FG003|NOT COMPLETED|Overall Study||13
6548416|NCT01712685|7470141|FG000|STARTED|Overall Study||12
6548417|NCT01712685|7470141|FG000|COMPLETED|Overall Study||11
6548418|NCT01712685|7470141|FG000|NOT COMPLETED|Overall Study||1
6548419|NCT01712711|7470147|FG000|STARTED|Overall Study||20
6548420|NCT01712711|7470148|FG001|STARTED|Overall Study||20
6548421|NCT01712711|7470147|FG000|COMPLETED|Overall Study||20
6548422|NCT01712711|7470148|FG001|COMPLETED|Overall Study||20
6548423|NCT01712711|7470147|FG000|NOT COMPLETED|Overall Study||0
6548424|NCT01712711|7470148|FG001|NOT COMPLETED|Overall Study||0
6548425|NCT01712776|7470156|FG000|STARTED|Overall Study||50
6548426|NCT01712776|7470157|FG001|STARTED|Overall Study||50
6548427|NCT01712776|7470156|FG000|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
6548428|NCT01712776|7470157|FG001|COMPLETED|Overall Study||50
6548429|NCT01712776|7470156|FG000|NOT COMPLETED|Overall Study||0
6548430|NCT01712776|7470157|FG001|NOT COMPLETED|Overall Study||0
6548431|NCT01712984|7470166|FG000|STARTED|Overall Study||1672
6548432|NCT01712984|7470167|FG001|STARTED|Overall Study||837
6548433|NCT01712984|7470168|FG002|STARTED|Overall Study||846
6548434|NCT01712984|7470166|FG000|COMPLETED|Overall Study||1656
6548435|NCT01712984|7470167|FG001|COMPLETED|Overall Study||821
6548436|NCT01712984|7470168|FG002|COMPLETED|Overall Study||836
6548437|NCT01712984|7470166|FG000|NOT COMPLETED|Overall Study||16
6548438|NCT01712984|7470167|FG001|NOT COMPLETED|Overall Study||16
6548439|NCT01712984|7470168|FG002|NOT COMPLETED|Overall Study||10
6548440|NCT01713036|7470176|FG000|STARTED|Overall Study||6
6548441|NCT01713036|7470176|FG000|COMPLETED|Overall Study||5
6548442|NCT01713036|7470176|FG000|NOT COMPLETED|Overall Study||1
6548443|NCT01713283|7470190|FG000|STARTED|Overall Study||31
6548444|NCT01713283|7470191|FG001|STARTED|Overall Study||29
6548445|NCT01713283|7470190|FG000|COMPLETED|Overall Study||20
6548446|NCT01713283|7470191|FG001|COMPLETED|Overall Study||26
6548447|NCT01713283|7470190|FG000|NOT COMPLETED|Overall Study||11
6548448|NCT01713283|7470191|FG001|NOT COMPLETED|Overall Study||3
6548449|NCT01713348|7470205|FG000|STARTED|Overall Study||29
6548450|NCT01713348|7470206|FG001|STARTED|Overall Study||13
6548451|NCT01713348|7470207|FG002|STARTED|Overall Study||30
6548452|NCT01713348|7470208|FG003|STARTED|Overall Study||15
6548453|NCT01713348|7470205|FG000|COMPLETED|Overall Study||25
6548454|NCT01713348|7470206|FG001|COMPLETED|Overall Study||11
6548455|NCT01713348|7470207|FG002|COMPLETED|Overall Study||28
6548456|NCT01713348|7470208|FG003|COMPLETED|Overall Study||15
6548457|NCT01713348|7470205|FG000|NOT COMPLETED|Overall Study||4
6548458|NCT01713348|7470206|FG001|NOT COMPLETED|Overall Study||2
6548459|NCT01713348|7470207|FG002|NOT COMPLETED|Overall Study||2
6548460|NCT01713348|7470208|FG003|NOT COMPLETED|Overall Study||0
6548461|NCT01713400|7470220|FG000|STARTED|Overall Study||15
6548462|NCT01713400|7470221|FG001|STARTED|Overall Study||15
6548463|NCT01713400|7470220|FG000|COMPLETED|Overall Study||15
6548464|NCT01713400|7470221|FG001|COMPLETED|Overall Study||15
6548465|NCT01713400|7470220|FG000|NOT COMPLETED|Overall Study||0
6548466|NCT01713400|7470221|FG001|NOT COMPLETED|Overall Study||0
6548467|NCT01713530|7470229|FG000|STARTED|Overall Study||138
6548468|NCT01713530|7470230|FG001|STARTED|Overall Study||136
6548469|NCT01713530|7470229|FG000|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
6548470|NCT01713530|7470230|FG001|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
6548471|NCT01713530|7470229|FG000|COMPLETED|Overall Study||113
6548472|NCT01713530|7470230|FG001|COMPLETED|Overall Study||117
6548473|NCT01713530|7470229|FG000|NOT COMPLETED|Overall Study||25
6548474|NCT01713530|7470230|FG001|NOT COMPLETED|Overall Study||19
6548475|NCT01713582|7470257|FG000|STARTED|Overall Study|Number treated|3
6548476|NCT01713582|7470258|FG001|STARTED|Overall Study|Number treated|3
6548477|NCT01713582|7470259|FG002|STARTED|Overall Study|Number treated|4
6548478|NCT01713582|7470260|FG003|STARTED|Overall Study|Number treated|3
6548479|NCT01713582|7470261|FG004|STARTED|Overall Study|Number treated|4
6548480|NCT01713582|7470262|FG005|STARTED|Overall Study|Number treated|8
6548481|NCT01713582|7470263|FG006|STARTED|Overall Study|Number treated|7
6548482|NCT01713582|7470264|FG007|STARTED|Overall Study|Number treated|6
6548483|NCT01713582|7470265|FG008|STARTED|Overall Study|Number treated|6
6548484|NCT01713582|7470266|FG009|STARTED|Overall Study|Number treated|18
6548485|NCT01713582|7470267|FG010|STARTED|Overall Study|Number treated|16
6548486|NCT01713582|7470268|FG011|STARTED|Overall Study|Number treated|5
6548487|NCT01713582|7470269|FG012|STARTED|Overall Study|Number treated|3
6548488|NCT01713582|7470270|FG013|STARTED|Overall Study|Number treated|4
6548489|NCT01713582|7470271|FG014|STARTED|Overall Study|Number treated|7
6548490|NCT01713582|7470272|FG015|STARTED|Overall Study|Number treated|6
6548491|NCT01713582|7470273|FG016|STARTED|Overall Study|Number treated|7
6548492|NCT01713582|7470274|FG017|STARTED|Overall Study|Number treated|3
6548493|NCT01713582|7470275|FG018|STARTED|Overall Study|Number treated|5
6548494|NCT01713582|7470276|FG019|STARTED|Overall Study|Number treated|5
6548495|NCT01713582|7470277|FG020|STARTED|Overall Study|Number treated|15
6548496|NCT01713582|7470257|FG000|COMPLETED|Overall Study||0
6548497|NCT01713582|7470258|FG001|COMPLETED|Overall Study||0
6548498|NCT01713582|7470259|FG002|COMPLETED|Overall Study||0
6548499|NCT01713582|7470260|FG003|COMPLETED|Overall Study||0
6548500|NCT01713582|7470261|FG004|COMPLETED|Overall Study||0
6548501|NCT01713582|7470262|FG005|COMPLETED|Overall Study||0
6548502|NCT01713582|7470263|FG006|COMPLETED|Overall Study||0
6548503|NCT01713582|7470264|FG007|COMPLETED|Overall Study||0
6548504|NCT01713582|7470265|FG008|COMPLETED|Overall Study||0
6548505|NCT01713582|7470266|FG009|COMPLETED|Overall Study||0
6548506|NCT01713582|7470267|FG010|COMPLETED|Overall Study||0
6548507|NCT01713582|7470268|FG011|COMPLETED|Overall Study||0
6548508|NCT01713582|7470269|FG012|COMPLETED|Overall Study||0
6548509|NCT01713582|7470270|FG013|COMPLETED|Overall Study||0
6548510|NCT01713582|7470271|FG014|COMPLETED|Overall Study||0
6548511|NCT01713582|7470272|FG015|COMPLETED|Overall Study||0
6548512|NCT01713582|7470273|FG016|COMPLETED|Overall Study||0
6548513|NCT01713582|7470274|FG017|COMPLETED|Overall Study||0
6548514|NCT01713582|7470275|FG018|COMPLETED|Overall Study||0
6548515|NCT01713582|7470276|FG019|COMPLETED|Overall Study||0
6548516|NCT01713582|7470277|FG020|COMPLETED|Overall Study||0
6548517|NCT01713582|7470257|FG000|NOT COMPLETED|Overall Study||3
6548518|NCT01713582|7470258|FG001|NOT COMPLETED|Overall Study||3
6548519|NCT01713582|7470259|FG002|NOT COMPLETED|Overall Study||4
6548520|NCT01713582|7470260|FG003|NOT COMPLETED|Overall Study||3
6548521|NCT01713582|7470261|FG004|NOT COMPLETED|Overall Study||4
6548522|NCT01713582|7470262|FG005|NOT COMPLETED|Overall Study||8
6548523|NCT01713582|7470263|FG006|NOT COMPLETED|Overall Study||7
6548524|NCT01713582|7470264|FG007|NOT COMPLETED|Overall Study||6
6548525|NCT01713582|7470265|FG008|NOT COMPLETED|Overall Study||6
6548526|NCT01713582|7470266|FG009|NOT COMPLETED|Overall Study||18
6548527|NCT01713582|7470267|FG010|NOT COMPLETED|Overall Study||16
6548528|NCT01713582|7470268|FG011|NOT COMPLETED|Overall Study||5
6548529|NCT01713582|7470269|FG012|NOT COMPLETED|Overall Study||3
6548530|NCT01713582|7470270|FG013|NOT COMPLETED|Overall Study||4
6548531|NCT01713582|7470271|FG014|NOT COMPLETED|Overall Study||7
6548532|NCT01713582|7470272|FG015|NOT COMPLETED|Overall Study||6
6548533|NCT01713582|7470273|FG016|NOT COMPLETED|Overall Study||7
6548534|NCT01713582|7470274|FG017|NOT COMPLETED|Overall Study||3
6548535|NCT01713582|7470275|FG018|NOT COMPLETED|Overall Study||5
6548536|NCT01713582|7470276|FG019|NOT COMPLETED|Overall Study||5
6548537|NCT01713582|7470277|FG020|NOT COMPLETED|Overall Study||15
6548538|NCT01713608|7470339|FG000|STARTED|Overall Study||8
6548539|NCT01713608|7470340|FG001|STARTED|Overall Study||6
6548540|NCT01713608|7470341|FG002|STARTED|Overall Study||8
6548541|NCT01713608|7470342|FG003|STARTED|Overall Study||12
6548542|NCT01713608|7470339|FG000|COMPLETED|Overall Study||8
6548543|NCT01713608|7470340|FG001|COMPLETED|Overall Study||6
6548544|NCT01713608|7470341|FG002|COMPLETED|Overall Study||8
6548545|NCT01713608|7470342|FG003|COMPLETED|Overall Study||12
6548546|NCT01713608|7470339|FG000|NOT COMPLETED|Overall Study||0
6548547|NCT01713608|7470340|FG001|NOT COMPLETED|Overall Study||0
6548548|NCT01713608|7470341|FG002|NOT COMPLETED|Overall Study||0
6548549|NCT01713608|7470342|FG003|NOT COMPLETED|Overall Study||0
6548550|NCT01713621|7470353|FG000|STARTED|Overall Study||8
6548551|NCT01713621|7470354|FG001|STARTED|Overall Study||17
6548552|NCT01713621|7470353|FG000|COMPLETED|Overall Study||1
6548553|NCT01713621|7470354|FG001|COMPLETED|Overall Study||1
6548554|NCT01713621|7470353|FG000|NOT COMPLETED|Overall Study||7
6548555|NCT01713621|7470354|FG001|NOT COMPLETED|Overall Study||16
6548556|NCT01713660|7470360|FG000|STARTED|Overall Study||37
6548557|NCT01713660|7470360|FG000|COMPLETED|Overall Study||37
6548558|NCT01713660|7470360|FG000|NOT COMPLETED|Overall Study||0
6548559|NCT01713686|7470364|FG000|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
6548560|NCT01713686|7470364|FG000|COMPLETED|Overall Study||110
6548561|NCT01713686|7470364|FG000|NOT COMPLETED|Overall Study||15
6548562|NCT01713868|7470372|FG000|STARTED|Overall Study||400
6548563|NCT01713868|7470373|FG001|STARTED|Overall Study||400
6548564|NCT01713868|7470374|FG002|STARTED|Overall Study||400
6647043|NCT02385240|7575996|FG001|COMPLETED|Overall Study||178
6647044|NCT02385240|7575997|FG002|COMPLETED|Overall Study||184
6647045|NCT02385240|7575995|FG000|NOT COMPLETED|Overall Study||1
6647046|NCT02385240|7575996|FG001|NOT COMPLETED|Overall Study||6
6647047|NCT02385240|7575997|FG002|NOT COMPLETED|Overall Study||1
6647048|NCT02385318|7576008|FG000|STARTED|Overall Study||204
6647049|NCT02385318|7576009|FG001|STARTED|Overall Study||210
6647050|NCT02385318|7576010|FG002|STARTED|Overall Study||105
6647051|NCT02385318|7576008|FG000|COMPLETED|Overall Study||200
6647052|NCT02385318|7576009|FG001|COMPLETED|Overall Study||203
6647053|NCT02385318|7576010|FG002|COMPLETED|Overall Study||99
6647054|NCT02385318|7576008|FG000|NOT COMPLETED|Overall Study||4
6647055|NCT02385318|7576009|FG001|NOT COMPLETED|Overall Study||7
6647056|NCT02385318|7576010|FG002|NOT COMPLETED|Overall Study||6
6647057|NCT02385526|7576021|FG000|STARTED|Overall Study||22
6743857|NCT03337139|7671912|FG000|STARTED|Phase I||87
6548565|NCT01713868|7470375|FG003|STARTED|Overall Study||400
6548566|NCT01713868|7470372|FG000|COMPLETED|Overall Study||303
6548567|NCT01713868|7470373|FG001|COMPLETED|Overall Study||335
6548568|NCT01713868|7470374|FG002|COMPLETED|Overall Study||320
6647058|NCT02385526|7576022|FG001|STARTED|Overall Study||20
6743858|NCT03337139|7671913|FG001|STARTED|Phase I|There were not two conditions in Phase I: all participants received standard group LM treatment.|0
6647059|NCT02385526|7576023|FG002|STARTED|Overall Study||20
6647060|NCT02385526|7576021|FG000|COMPLETED|Overall Study||20
6647061|NCT02385526|7576022|FG001|COMPLETED|Overall Study||17
6548569|NCT01713868|7470375|FG003|COMPLETED|Overall Study||305
6548570|NCT01713868|7470372|FG000|NOT COMPLETED|Overall Study||97
6548571|NCT01713868|7470373|FG001|NOT COMPLETED|Overall Study||65
6548572|NCT01713868|7470374|FG002|NOT COMPLETED|Overall Study||80
6548573|NCT01713868|7470375|FG003|NOT COMPLETED|Overall Study||95
6548574|NCT01713933|7470387|FG000|STARTED|Overall Study||37
6548575|NCT01713933|7470387|FG000|COMPLETED|Overall Study||31
6548576|NCT01713933|7470387|FG000|NOT COMPLETED|Overall Study||6
6548577|NCT01713946|7470394|FG000|STARTED|Overall Study||117
6548578|NCT01713946|7470395|FG001|STARTED|Overall Study||130
6548579|NCT01713946|7470396|FG002|STARTED|Overall Study|Of the 119 patients initially randomized to the Placebo arm, 5 patients never switched to everolimus|119
6548580|NCT01713946|7470394|FG000|Completed Core Phase|Overall Study||110
6548581|NCT01713946|7470395|FG001|Completed Core Phase|Overall Study||122
6548582|NCT01713946|7470396|FG002|Completed Core Phase|Overall Study||114
6548583|NCT01713946|7470394|FG000|Continued in Ext. Phase|Overall Study||110
6548584|NCT01713946|7470395|FG001|Continued in Ext. Phase|Overall Study||119
6548585|NCT01713946|7470396|FG002|Continued in Ext. Phase|Overall Study||114
6548586|NCT01713946|7470394|FG000|Completed Ext. Phase|Overall Study||79
6548587|NCT01713946|7470395|FG001|Completed Ext. Phase|Overall Study||92
6548588|NCT01713946|7470396|FG002|Completed Ext. Phase|Overall Study||81
6548589|NCT01713946|7470394|FG000|Continued in Post-Ext. Phase|Overall Study||78
6548590|NCT01713946|7470395|FG001|Continued in Post-Ext. Phase|Overall Study||90
6548591|NCT01713946|7470396|FG002|Continued in Post-Ext. Phase|Overall Study||81
6548592|NCT01713946|7470394|FG000|Completed Post-Ext Phase|Overall Study||74
6548593|NCT01713946|7470395|FG001|Completed Post-Ext Phase|Overall Study||85
6548594|NCT01713946|7470396|FG002|Completed Post-Ext Phase|Overall Study||75
6548595|NCT01713946|7470394|FG000|Did Not Continue in Ext Phase|Overall Study||0
6548596|NCT01713946|7470395|FG001|Did Not Continue in Ext Phase|Overall Study||3
6548597|NCT01713946|7470396|FG002|Did Not Continue in Ext Phase|Overall Study||0
6548598|NCT01713946|7470394|FG000|Did Not Cont. in Post-Ext Phase|Overall Study||1
6548599|NCT01713946|7470395|FG001|Did Not Cont. in Post-Ext Phase|Overall Study||2
6548600|NCT01713946|7470396|FG002|Did Not Cont. in Post-Ext Phase|Overall Study||0
6548601|NCT01713946|7470394|FG000|COMPLETED|Overall Study||74
6548602|NCT01713946|7470395|FG001|COMPLETED|Overall Study||85
6548603|NCT01713946|7470396|FG002|COMPLETED|Overall Study||75
6548604|NCT01713946|7470394|FG000|NOT COMPLETED|Overall Study||43
6548605|NCT01713946|7470395|FG001|NOT COMPLETED|Overall Study||45
6548606|NCT01713946|7470396|FG002|NOT COMPLETED|Overall Study||44
6548607|NCT01713998|7470425|FG000|STARTED|Overall Study||16
6548608|NCT01713998|7470426|FG001|STARTED|Overall Study||15
6548609|NCT01713998|7470427|FG002|STARTED|Overall Study||16
6548610|NCT01713998|7470425|FG000|COMPLETED|Overall Study||13
6548611|NCT01713998|7470426|FG001|COMPLETED|Overall Study||15
6548612|NCT01713998|7470427|FG002|COMPLETED|Overall Study||14
6548613|NCT01713998|7470425|FG000|NOT COMPLETED|Overall Study||3
6548614|NCT01713998|7470426|FG001|NOT COMPLETED|Overall Study||0
6548615|NCT01713998|7470427|FG002|NOT COMPLETED|Overall Study||2
6548616|NCT01714024|7470438|FG000|STARTED|Overall Study||13
6548617|NCT01714024|7470439|FG001|STARTED|Overall Study||18
6548618|NCT01714024|7470440|FG002|STARTED|Overall Study||11
6548619|NCT01714024|7470438|FG000|COMPLETED|Overall Study||12
6548620|NCT01714024|7470439|FG001|COMPLETED|Overall Study||12
6548621|NCT01714024|7470440|FG002|COMPLETED|Overall Study||8
6548622|NCT01714024|7470438|FG000|NOT COMPLETED|Overall Study||1
6548623|NCT01714024|7470439|FG001|NOT COMPLETED|Overall Study||6
6548624|NCT01714024|7470440|FG002|NOT COMPLETED|Overall Study||3
6548625|NCT01714063|7470457|FG000|STARTED|Overall Study||34
6548626|NCT01714063|7470457|FG000|COMPLETED|Overall Study||32
6548627|NCT01714063|7470457|FG000|NOT COMPLETED|Overall Study||2
6548628|NCT01714232|7470465|FG000|STARTED|Overall Study||106
6548629|NCT01714232|7470465|FG000|COMPLETED|Overall Study||106
6548630|NCT01714232|7470465|FG000|NOT COMPLETED|Overall Study||0
6647062|NCT02385526|7576023|FG002|COMPLETED|Overall Study||20
6647063|NCT02385526|7576021|FG000|NOT COMPLETED|Overall Study||2
6647064|NCT02385526|7576022|FG001|NOT COMPLETED|Overall Study||3
6647065|NCT02385526|7576023|FG002|NOT COMPLETED|Overall Study||0
6647066|NCT02385669|7576031|FG000|STARTED|Overall Study||3
6647067|NCT02385669|7576031|FG000|COMPLETED|Overall Study||1
6647068|NCT02385669|7576031|FG000|NOT COMPLETED|Overall Study||2
6647069|NCT02385708|7576037|FG000|STARTED|Overall Study||81
6647070|NCT02385708|7576038|FG001|STARTED|Overall Study||82
6647071|NCT02385708|7576037|FG000|Intervention Started|Overall Study||81
6647072|NCT02385708|7576038|FG001|Intervention Started|Overall Study||82
6647073|NCT02385708|7576037|FG000|COMPLETED|Overall Study||73
6647074|NCT02385708|7576038|FG001|COMPLETED|Overall Study||67
6647075|NCT02385708|7576037|FG000|NOT COMPLETED|Overall Study||8
6647076|NCT02385708|7576038|FG001|NOT COMPLETED|Overall Study||15
6647077|NCT02385721|7576044|FG000|STARTED|Overall Study||601
6647078|NCT02385721|7576044|FG000|COMPLETED|Overall Study||371
6647079|NCT02385721|7576044|FG000|NOT COMPLETED|Overall Study||230
6647080|NCT02385799|7576050|FG000|STARTED|Overall Study||26
6647081|NCT02385799|7576051|FG001|STARTED|Overall Study||32
6647082|NCT02385799|7576050|FG000|Completed End-of-Treatment Visit|Overall Study||21
6647083|NCT02385799|7576051|FG001|Completed End-of-Treatment Visit|Overall Study||26
6548631|NCT01714310|7470472|FG000|STARTED|Open Lisdexamfetamine Titration||0
6548632|NCT01714310|7470473|FG001|STARTED|Open Lisdexamfetamine Titration||0
6548633|NCT01714310|7470474|FG002|STARTED|Open Lisdexamfetamine Titration||34
6548634|NCT01714310|7470472|FG000|COMPLETED|Open Lisdexamfetamine Titration||0
6548635|NCT01714310|7470473|FG001|COMPLETED|Open Lisdexamfetamine Titration||0
6548636|NCT01714310|7470474|FG002|COMPLETED|Open Lisdexamfetamine Titration||30
6548637|NCT01714310|7470472|FG000|NOT COMPLETED|Open Lisdexamfetamine Titration||0
6548638|NCT01714310|7470473|FG001|NOT COMPLETED|Open Lisdexamfetamine Titration||0
6548639|NCT01714310|7470474|FG002|NOT COMPLETED|Open Lisdexamfetamine Titration||4
6548640|NCT01714310|7470472|FG000|STARTED|Double Blind Adjunctive Treatment|Adjunctive fluoxetine treatment was initiated at beginning of Period 2, at study week 4.|12
6548641|NCT01714310|7470473|FG001|STARTED|Double Blind Adjunctive Treatment|Adjunctive placebo was initiated at beginning of Period 2, at study week 4.|14
6548642|NCT01714310|7470474|FG002|STARTED|Double Blind Adjunctive Treatment|No one remained on lisdexamfetamine alone in Period 2.|0
6548643|NCT01714310|7470472|FG000|COMPLETED|Double Blind Adjunctive Treatment||10
6548644|NCT01714310|7470473|FG001|COMPLETED|Double Blind Adjunctive Treatment||11
6548645|NCT01714310|7470474|FG002|COMPLETED|Double Blind Adjunctive Treatment||0
6548646|NCT01714310|7470472|FG000|NOT COMPLETED|Double Blind Adjunctive Treatment||2
6548647|NCT01714310|7470473|FG001|NOT COMPLETED|Double Blind Adjunctive Treatment||3
6548648|NCT01714310|7470474|FG002|NOT COMPLETED|Double Blind Adjunctive Treatment||0
6548649|NCT01714323|7470494|FG000|STARTED|Overall Study||677
6548650|NCT01714323|7470495|FG001|STARTED|Overall Study||680
6548651|NCT01714323|7470494|FG000|COMPLETED|Overall Study||513
6548652|NCT01714323|7470495|FG001|COMPLETED|Overall Study||508
6548653|NCT01714323|7470494|FG000|NOT COMPLETED|Overall Study||164
6548654|NCT01714323|7470495|FG001|NOT COMPLETED|Overall Study||172
6548655|NCT01714336|7470503|FG000|STARTED|Overall Study||69
6548656|NCT01714336|7470504|FG001|STARTED|Overall Study||69
6548657|NCT01714336|7470503|FG000|COMPLETED|Overall Study||69
6548658|NCT01714336|7470504|FG001|COMPLETED|Overall Study||69
6548659|NCT01714336|7470503|FG000|NOT COMPLETED|Overall Study||0
6548660|NCT01714336|7470504|FG001|NOT COMPLETED|Overall Study||0
6548661|NCT01714492|7470510|FG000|STARTED|Overall Study||8
6548662|NCT01714492|7470510|FG000|COMPLETED|Overall Study||8
6548663|NCT01714492|7470510|FG000|NOT COMPLETED|Overall Study||0
6548664|NCT01714505|7470515|FG000|STARTED|Admission 1 (40 Hours)||10
6548665|NCT01714505|7470516|FG001|STARTED|Admission 1 (40 Hours)||10
6548666|NCT01714505|7470515|FG000|COMPLETED|Admission 1 (40 Hours)||9
6548667|NCT01714505|7470516|FG001|COMPLETED|Admission 1 (40 Hours)||9
6548668|NCT01714505|7470515|FG000|NOT COMPLETED|Admission 1 (40 Hours)||1
6548669|NCT01714505|7470516|FG001|NOT COMPLETED|Admission 1 (40 Hours)||1
6548670|NCT01714505|7470515|FG000|STARTED|Admission 2 (40 Hours)||9
6548671|NCT01714505|7470516|FG001|STARTED|Admission 2 (40 Hours)||9
6548672|NCT01714505|7470515|FG000|COMPLETED|Admission 2 (40 Hours)||9
6548673|NCT01714505|7470516|FG001|COMPLETED|Admission 2 (40 Hours)||9
6548674|NCT01714505|7470515|FG000|NOT COMPLETED|Admission 2 (40 Hours)||0
6548675|NCT01714505|7470516|FG001|NOT COMPLETED|Admission 2 (40 Hours)||0
6548676|NCT01714544|7470522|FG000|STARTED|Overall Study||60
6548677|NCT01714544|7470522|FG000|COMPLETED|Overall Study||57
6548678|NCT01714544|7470522|FG000|NOT COMPLETED|Overall Study||3
6548679|NCT01714609|7470528|FG000|STARTED|Overall Study||5
6548680|NCT01714609|7470529|FG001|STARTED|Overall Study||5
6548681|NCT01714609|7470528|FG000|COMPLETED|Overall Study||4
6548682|NCT01714609|7470529|FG001|COMPLETED|Overall Study||5
6548683|NCT01714609|7470528|FG000|NOT COMPLETED|Overall Study||1
6548684|NCT01714609|7470529|FG001|NOT COMPLETED|Overall Study||0
6548685|NCT01714635|7470538|FG000|STARTED|Overall Study||147
6548686|NCT01714635|7470539|FG001|STARTED|Overall Study||150
6548687|NCT01714635|7470540|FG002|STARTED|Overall Study||148
6548688|NCT01714635|7470538|FG000|COMPLETED|Overall Study||145
6548689|NCT01714635|7470539|FG001|COMPLETED|Overall Study||150
6548690|NCT01714635|7470540|FG002|COMPLETED|Overall Study||146
6548691|NCT01714635|7470538|FG000|NOT COMPLETED|Overall Study||2
6548692|NCT01714635|7470539|FG001|NOT COMPLETED|Overall Study||0
6548693|NCT01714635|7470540|FG002|NOT COMPLETED|Overall Study||2
6548694|NCT01714687|7470550|FG000|STARTED|Overall Study||29
6548695|NCT01714687|7470551|FG001|STARTED|Overall Study||30
6548696|NCT01714687|7470550|FG000|COMPLETED|Overall Study||26
6548697|NCT01714687|7470551|FG001|COMPLETED|Overall Study||26
6548698|NCT01714687|7470550|FG000|NOT COMPLETED|Overall Study||3
6548699|NCT01714687|7470551|FG001|NOT COMPLETED|Overall Study||4
6548700|NCT01714726|7470561|FG000|STARTED|Double-Blinded Induction Period||60
6548701|NCT01714726|7470562|FG001|STARTED|Double-Blinded Induction Period||59
6548702|NCT01714726|7470563|FG002|STARTED|Double-Blinded Induction Period||0
6548703|NCT01714726|7470564|FG003|STARTED|Double-Blinded Induction Period||0
6647084|NCT02385799|7576050|FG000|COMPLETED|Overall Study||21
6647085|NCT02385799|7576051|FG001|COMPLETED|Overall Study||24
6647086|NCT02385799|7576050|FG000|NOT COMPLETED|Overall Study||5
6647087|NCT02385799|7576051|FG001|NOT COMPLETED|Overall Study||8
6548704|NCT01714726|7470561|FG000|COMPLETED|Double-Blinded Induction Period||52
6548705|NCT01714726|7470562|FG001|COMPLETED|Double-Blinded Induction Period||52
6548706|NCT01714726|7470563|FG002|COMPLETED|Double-Blinded Induction Period||0
6548707|NCT01714726|7470564|FG003|COMPLETED|Double-Blinded Induction Period||0
6548708|NCT01714726|7470561|FG000|NOT COMPLETED|Double-Blinded Induction Period||8
6548709|NCT01714726|7470562|FG001|NOT COMPLETED|Double-Blinded Induction Period||7
6548710|NCT01714726|7470563|FG002|NOT COMPLETED|Double-Blinded Induction Period||0
6548711|NCT01714726|7470564|FG003|NOT COMPLETED|Double-Blinded Induction Period||0
6548712|NCT01714726|7470561|FG000|STARTED|Open-Label Period||0
6647088|NCT02386098|7576062|FG000|STARTED|Stage 1 (96 Weeks)||43
6548713|NCT01714726|7470562|FG001|STARTED|Open-Label Period||0
6548714|NCT01714726|7470563|FG002|STARTED|Open-Label Period||52
6548715|NCT01714726|7470564|FG003|STARTED|Open-Label Period||52
6548716|NCT01714726|7470561|FG000|COMPLETED|Open-Label Period||0
6548717|NCT01714726|7470562|FG001|COMPLETED|Open-Label Period||0
6548718|NCT01714726|7470563|FG002|COMPLETED|Open-Label Period||33
6548719|NCT01714726|7470564|FG003|COMPLETED|Open-Label Period||24
6548720|NCT01714726|7470561|FG000|NOT COMPLETED|Open-Label Period||0
6548721|NCT01714726|7470562|FG001|NOT COMPLETED|Open-Label Period||0
6548722|NCT01714726|7470563|FG002|NOT COMPLETED|Open-Label Period||19
6548723|NCT01714726|7470564|FG003|NOT COMPLETED|Open-Label Period||28
6548724|NCT01714804|7470576|FG000|STARTED|Overall Study||30
6548725|NCT01714804|7470577|FG001|STARTED|Overall Study||30
6548726|NCT01714804|7470576|FG000|COMPLETED|Overall Study||29
6548727|NCT01714804|7470577|FG001|COMPLETED|Overall Study||30
6548728|NCT01714804|7470576|FG000|NOT COMPLETED|Overall Study||1
6548729|NCT01714804|7470577|FG001|NOT COMPLETED|Overall Study||0
6548730|NCT01714921|7470585|FG000|STARTED|Overall Study||504
6548731|NCT01714921|7470585|FG000|COMPLETED|Overall Study||311
6548732|NCT01714921|7470585|FG000|NOT COMPLETED|Overall Study||193
6548733|NCT01714947|7470590|FG000|STARTED|Part A||3
6548734|NCT01714947|7470590|FG000|COMPLETED|Part A||3
6548735|NCT01714947|7470590|FG000|NOT COMPLETED|Part A||0
6548736|NCT01714947|7470590|FG000|STARTED|Part B||3
6548737|NCT01714947|7470590|FG000|COMPLETED|Part B||0
6548738|NCT01714947|7470590|FG000|NOT COMPLETED|Part B||3
6548739|NCT01715064|7470596|FG000|STARTED|Overall Study||18
6548740|NCT01715064|7470597|FG001|STARTED|Overall Study||18
6548741|NCT01715064|7470596|FG000|COMPLETED|Overall Study||18
6548742|NCT01715064|7470597|FG001|COMPLETED|Overall Study||18
6548743|NCT01715064|7470596|FG000|NOT COMPLETED|Overall Study||0
6548744|NCT01715064|7470597|FG001|NOT COMPLETED|Overall Study||0
6548745|NCT01715129|7470603|FG000|STARTED|Overall Study||126
6548746|NCT01715129|7470603|FG000|COMPLETED|Overall Study||117
6548747|NCT01715129|7470603|FG000|NOT COMPLETED|Overall Study||9
6548748|NCT01715207|7470609|FG000|STARTED|Overall Study||15
6548749|NCT01715207|7470610|FG001|STARTED|Overall Study||15
6548750|NCT01715207|7470609|FG000|COMPLETED|Overall Study||14
6548751|NCT01715207|7470610|FG001|COMPLETED|Overall Study||14
6548752|NCT01715207|7470609|FG000|NOT COMPLETED|Overall Study||1
6548753|NCT01715207|7470610|FG001|NOT COMPLETED|Overall Study||1
6548754|NCT01715233|7470618|FG000|STARTED|Overall Study||21
6548755|NCT01715233|7470618|FG000|COMPLETED|Overall Study||21
6548756|NCT01715233|7470618|FG000|NOT COMPLETED|Overall Study||0
6548757|NCT01715298|7470625|FG000|STARTED|Overall Study||216
6548758|NCT01715298|7470626|FG001|STARTED|Overall Study||216
6548759|NCT01715298|7470625|FG000|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
6548760|NCT01715298|7470626|FG001|Full Analysis Set (FAS)|Overall Study||214
6548761|NCT01715298|7470625|FG000|COMPLETED|Overall Study||209
6548762|NCT01715298|7470626|FG001|COMPLETED|Overall Study||205
6548763|NCT01715298|7470625|FG000|NOT COMPLETED|Overall Study||7
6548764|NCT01715298|7470626|FG001|NOT COMPLETED|Overall Study||11
6548765|NCT01715415|7470634|FG000|STARTED|Double-blind Treatment||297
6548766|NCT01715415|7470635|FG001|STARTED|Double-blind Treatment||98
6548767|NCT01715415|7470634|FG000|Randomized But Not Treated|Double-blind Treatment||0
6548768|NCT01715415|7470635|FG001|Randomized But Not Treated|Double-blind Treatment||1
6548769|NCT01715415|7470634|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
6548770|NCT01715415|7470635|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
6548771|NCT01715415|7470634|FG000|NOT COMPLETED|Double-blind Treatment||5
6548772|NCT01715415|7470635|FG001|NOT COMPLETED|Double-blind Treatment||2
6548773|NCT01715415|7470634|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
6548774|NCT01715415|7470635|FG001|STARTED|Open-label Treatment||96
6548775|NCT01715415|7470634|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
6548776|NCT01715415|7470635|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
6548777|NCT01715415|7470634|FG000|NOT COMPLETED|Open-label Treatment||0
6548778|NCT01715415|7470635|FG001|NOT COMPLETED|Open-label Treatment||2
6548779|NCT01715571|7470642|FG000|STARTED|Overall Study||11
6548780|NCT01715571|7470642|FG000|COMPLETED|Overall Study||3
6548781|NCT01715571|7470642|FG000|NOT COMPLETED|Overall Study||8
6548782|NCT01715805|7470646|FG000|STARTED|Placebo + ADT Lead-in Period||1022
6548783|NCT01715805|7470647|FG001|STARTED|Placebo + ADT Lead-in Period||0
6548784|NCT01715805|7470648|FG002|STARTED|Placebo + ADT Lead-in Period||0
6548785|NCT01715805|7470649|FG003|STARTED|Placebo + ADT Lead-in Period||0
6548786|NCT01715805|7470646|FG000|COMPLETED|Placebo + ADT Lead-in Period||807
6548787|NCT01715805|7470647|FG001|COMPLETED|Placebo + ADT Lead-in Period||0
6548788|NCT01715805|7470648|FG002|COMPLETED|Placebo + ADT Lead-in Period||0
6548789|NCT01715805|7470649|FG003|COMPLETED|Placebo + ADT Lead-in Period||0
6548790|NCT01715805|7470646|FG000|NOT COMPLETED|Placebo + ADT Lead-in Period||215
6548791|NCT01715805|7470647|FG001|NOT COMPLETED|Placebo + ADT Lead-in Period||0
6548792|NCT01715805|7470648|FG002|NOT COMPLETED|Placebo + ADT Lead-in Period||0
6548793|NCT01715805|7470649|FG003|NOT COMPLETED|Placebo + ADT Lead-in Period||0
6548794|NCT01715805|7470646|FG000|STARTED|Double-Blind or Continued Treatment||0
6548795|NCT01715805|7470647|FG001|STARTED|Double-Blind or Continued Treatment||261
6548796|NCT01715805|7470648|FG002|STARTED|Double-Blind or Continued Treatment||269
6548797|NCT01715805|7470649|FG003|STARTED|Double-Blind or Continued Treatment||270
6548798|NCT01715805|7470646|FG000|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
6548799|NCT01715805|7470647|FG001|Double-Blind Safety Population|Double-Blind or Continued Treatment||258
6548800|NCT01715805|7470648|FG002|Double-Blind Safety Population|Double-Blind or Continued Treatment||269
6548801|NCT01715805|7470649|FG003|Double-Blind Safety Population|Double-Blind or Continued Treatment||0
6548802|NCT01715805|7470646|FG000|COMPLETED|Double-Blind or Continued Treatment||0
6548803|NCT01715805|7470647|FG001|COMPLETED|Double-Blind or Continued Treatment||222
6548804|NCT01715805|7470648|FG002|COMPLETED|Double-Blind or Continued Treatment||213
6548805|NCT01715805|7470649|FG003|COMPLETED|Double-Blind or Continued Treatment||222
6548806|NCT01715805|7470646|FG000|NOT COMPLETED|Double-Blind or Continued Treatment||0
6548807|NCT01715805|7470647|FG001|NOT COMPLETED|Double-Blind or Continued Treatment||39
6548808|NCT01715805|7470648|FG002|NOT COMPLETED|Double-Blind or Continued Treatment||56
6548809|NCT01715805|7470649|FG003|NOT COMPLETED|Double-Blind or Continued Treatment||48
6548810|NCT01715831|7470657|FG000|STARTED|Overall Study||26
6548811|NCT01715831|7470657|FG000|COMPLETED|Overall Study||25
6548812|NCT01715831|7470657|FG000|NOT COMPLETED|Overall Study||1
6548813|NCT01715857|7470661|FG000|STARTED|Overall Study||4100
6548814|NCT01715857|7470661|FG000|COMPLETED|Overall Study||4004
6548815|NCT01715857|7470661|FG000|NOT COMPLETED|Overall Study||96
6548816|NCT01715883|7470665|FG000|STARTED|Overall Study||3
6548817|NCT01715883|7470665|FG000|COMPLETED|Overall Study||2
6548818|NCT01715883|7470665|FG000|NOT COMPLETED|Overall Study||1
6548819|NCT01715896|7470672|FG000|STARTED|Overall Study||68
6548820|NCT01715896|7470673|FG001|STARTED|Overall Study||70
6548821|NCT01715896|7470672|FG000|COMPLETED|Overall Study||65
6548822|NCT01715896|7470673|FG001|COMPLETED|Overall Study||59
6548823|NCT01715896|7470672|FG000|NOT COMPLETED|Overall Study||3
6548824|NCT01715896|7470673|FG001|NOT COMPLETED|Overall Study||11
6548825|NCT01715948|7470680|FG000|STARTED|Overall Study||9
6548826|NCT01715948|7470680|FG000|COMPLETED|Overall Study||8
6548827|NCT01715948|7470680|FG000|NOT COMPLETED|Overall Study||1
6548828|NCT01716013|7470701|FG000|STARTED|Overall Study||108
6548829|NCT01716013|7470702|FG001|STARTED|Overall Study||54
6548830|NCT01716013|7470701|FG000|COMPLETED|Overall Study||105
6548831|NCT01716013|7470702|FG001|COMPLETED|Overall Study||54
6548832|NCT01716013|7470701|FG000|NOT COMPLETED|Overall Study||3
6548833|NCT01716013|7470702|FG001|NOT COMPLETED|Overall Study||0
6548834|NCT01716039|7470711|FG000|STARTED|Overall Study||4
6548835|NCT01716039|7470712|FG001|STARTED|Overall Study||8
6548836|NCT01716039|7470713|FG002|STARTED|Overall Study||10
6548837|NCT01716039|7470711|FG000|COMPLETED|Overall Study||3
6548838|NCT01716039|7470712|FG001|COMPLETED|Overall Study||6
6548839|NCT01716039|7470713|FG002|COMPLETED|Overall Study||8
6548840|NCT01716039|7470711|FG000|NOT COMPLETED|Overall Study||1
6548841|NCT01716039|7470712|FG001|NOT COMPLETED|Overall Study||2
6548842|NCT01716039|7470713|FG002|NOT COMPLETED|Overall Study||2
6562654|NCT01802333|7485588|FG001|High Risk Patients Achieved CR/CRi|Overall Study||40
6562655|NCT01802333|7485589|FG002|High Risk Patients Achieved CR/CRi|Overall Study||29
6562656|NCT01802333|7485587|FG000|Known NPM1 Status at Baseline|Overall Study||169
6562657|NCT01802333|7485588|FG001|Known NPM1 Status at Baseline|Overall Study||156
6562658|NCT01802333|7485589|FG002|Known NPM1 Status at Baseline|Overall Study||142
6562659|NCT01802333|7485587|FG000|Known Cytogenetic Risk at Baseline|Overall Study||252
6562660|NCT01802333|7485588|FG001|Known Cytogenetic Risk at Baseline|Overall Study||250
6562661|NCT01802333|7485589|FG002|Known Cytogenetic Risk at Baseline|Overall Study||210
6562662|NCT01802333|7485587|FG000|COMPLETED|Overall Study||214
6562663|NCT01802333|7485588|FG001|COMPLETED|Overall Study||206
6562664|NCT01802333|7485589|FG002|COMPLETED|Overall Study||161
6562665|NCT01802333|7485587|FG000|NOT COMPLETED|Overall Study||49
6562666|NCT01802333|7485588|FG001|NOT COMPLETED|Overall Study||61
6562667|NCT01802333|7485589|FG002|NOT COMPLETED|Overall Study||63
6562668|NCT01802385|7485605|FG000|STARTED|Overall Study||231
6562669|NCT01802385|7485606|FG001|STARTED|Overall Study||229
6562670|NCT01802385|7485605|FG000|COMPLETED|Overall Study||125
6562671|NCT01802385|7485606|FG001|COMPLETED|Overall Study||109
6562672|NCT01802385|7485605|FG000|NOT COMPLETED|Overall Study||106
6562673|NCT01802385|7485606|FG001|NOT COMPLETED|Overall Study||120
6562674|NCT01802411|7485614|FG000|STARTED|Overall Study||96
6562675|NCT01802411|7485615|FG001|STARTED|Overall Study||95
6562676|NCT01802411|7485614|FG000|COMPLETED|Overall Study||82
6562677|NCT01802411|7485615|FG001|COMPLETED|Overall Study||74
6562678|NCT01802411|7485614|FG000|NOT COMPLETED|Overall Study||14
6562679|NCT01802411|7485615|FG001|NOT COMPLETED|Overall Study||21
6562680|NCT01802437|7485623|FG000|STARTED|Overall Study||20
6562681|NCT01802437|7485624|FG001|STARTED|Overall Study||20
6562682|NCT01802437|7485623|FG000|COMPLETED|Overall Study||16
6562683|NCT01802437|7485624|FG001|COMPLETED|Overall Study||16
6562684|NCT01802437|7485623|FG000|NOT COMPLETED|Overall Study||4
6562685|NCT01802437|7485624|FG001|NOT COMPLETED|Overall Study||4
6562686|NCT01802515|7485633|FG000|STARTED|Overall Study||5
6562687|NCT01802515|7485634|FG001|STARTED|Overall Study||5
6562688|NCT01802515|7485635|FG002|STARTED|Overall Study||4
6562689|NCT01802515|7485633|FG000|COMPLETED|Overall Study||2
6562690|NCT01802515|7485634|FG001|COMPLETED|Overall Study||5
6562691|NCT01802515|7485635|FG002|COMPLETED|Overall Study||4
6562692|NCT01802515|7485633|FG000|NOT COMPLETED|Overall Study||3
6562693|NCT01802515|7485634|FG001|NOT COMPLETED|Overall Study||0
6562694|NCT01802515|7485635|FG002|NOT COMPLETED|Overall Study||0
6562695|NCT01802554|7485645|FG000|STARTED|Overall Study||51
6548843|NCT01716104|7470725|FG000|STARTED|Overall Study||125
6548844|NCT01716104|7470726|FG001|STARTED|Overall Study||124
6548845|NCT01716104|7470725|FG000|COMPLETED|Overall Study||119
6548846|NCT01716104|7470726|FG001|COMPLETED|Overall Study||117
6548847|NCT01716104|7470725|FG000|NOT COMPLETED|Overall Study||6
6548848|NCT01716104|7470726|FG001|NOT COMPLETED|Overall Study||7
6548849|NCT01716156|7470735|FG000|STARTED|Overall Study||9
6548850|NCT01716156|7470736|FG001|STARTED|Overall Study||4
6548851|NCT01716156|7470737|FG002|STARTED|Overall Study||13
6548852|NCT01716156|7470735|FG000|COMPLETED|Overall Study||7
6548853|NCT01716156|7470736|FG001|COMPLETED|Overall Study||3
6548854|NCT01716156|7470737|FG002|COMPLETED|Overall Study||11
6548855|NCT01716156|7470735|FG000|NOT COMPLETED|Overall Study||2
6548856|NCT01716156|7470736|FG001|NOT COMPLETED|Overall Study||1
6548857|NCT01716156|7470737|FG002|NOT COMPLETED|Overall Study||2
6548858|NCT01716169|7470749|FG000|STARTED|Overall Study||10
6548859|NCT01716169|7470749|FG000|Standard of Care Dressings Used|Overall Study||7
6548860|NCT01716169|7470749|FG000|COMPLETED|Overall Study||6
6548861|NCT01716169|7470749|FG000|NOT COMPLETED|Overall Study||4
6548862|NCT01716195|7470755|FG000|STARTED|Overall Study||18
6548863|NCT01716195|7470755|FG000|COMPLETED|Overall Study||17
6548864|NCT01716195|7470755|FG000|NOT COMPLETED|Overall Study||1
6548865|NCT01716208|7470759|FG000|STARTED|Overall Study||12
6548866|NCT01716208|7470759|FG000|COMPLETED|Overall Study||12
6548867|NCT01716208|7470759|FG000|NOT COMPLETED|Overall Study||0
6548868|NCT01716221|7470763|FG000|STARTED|Overall Study||1
6548869|NCT01716221|7470763|FG000|COMPLETED|Overall Study||1
6548870|NCT01716221|7470763|FG000|NOT COMPLETED|Overall Study||0
6548871|NCT01716234|7470786|FG000|STARTED|Overall Study||24
6548872|NCT01716234|7470787|FG001|STARTED|Overall Study||22
6548873|NCT01716234|7470788|FG002|STARTED|Overall Study||20
6548874|NCT01716234|7470789|FG003|STARTED|Overall Study||28
6548875|NCT01716234|7470790|FG004|STARTED|Overall Study||15
6548876|NCT01716234|7470791|FG005|STARTED|Overall Study||32
6548877|NCT01716234|7470792|FG006|STARTED|Overall Study||1
6548878|NCT01716234|7470786|FG000|Treated|Overall Study||22
6548879|NCT01716234|7470787|FG001|Treated|Overall Study||21
6548880|NCT01716234|7470788|FG002|Treated|Overall Study||19
6548881|NCT01716234|7470789|FG003|Treated|Overall Study||28
6548882|NCT01716234|7470790|FG004|Treated|Overall Study||15
6548883|NCT01716234|7470791|FG005|Treated|Overall Study||30
6548884|NCT01716234|7470792|FG006|Treated|Overall Study||1
6548885|NCT01716234|7470786|FG000|COMPLETED|Overall Study||14
6548886|NCT01716234|7470787|FG001|COMPLETED|Overall Study||12
6548887|NCT01716234|7470788|FG002|COMPLETED|Overall Study||15
6548888|NCT01716234|7470789|FG003|COMPLETED|Overall Study||16
6548889|NCT01716234|7470790|FG004|COMPLETED|Overall Study||10
6548890|NCT01716234|7470791|FG005|COMPLETED|Overall Study||18
6548891|NCT01716234|7470792|FG006|COMPLETED|Overall Study||1
6548892|NCT01716234|7470786|FG000|NOT COMPLETED|Overall Study||10
6548893|NCT01716234|7470787|FG001|NOT COMPLETED|Overall Study||10
6548894|NCT01716234|7470788|FG002|NOT COMPLETED|Overall Study||5
6548895|NCT01716234|7470789|FG003|NOT COMPLETED|Overall Study||12
6548896|NCT01716234|7470790|FG004|NOT COMPLETED|Overall Study||5
6548897|NCT01716234|7470791|FG005|NOT COMPLETED|Overall Study||14
6548898|NCT01716234|7470792|FG006|NOT COMPLETED|Overall Study||0
6548899|NCT01716455|7470814|FG000|STARTED|Overall Study||8
6548900|NCT01716455|7470815|FG001|STARTED|Overall Study||8
6548901|NCT01716455|7470816|FG002|STARTED|Overall Study||8
6548902|NCT01716455|7470817|FG003|STARTED|Overall Study||8
6548903|NCT01716455|7470818|FG004|STARTED|Overall Study||26
6548904|NCT01716455|7470819|FG005|STARTED|Overall Study||8
6548905|NCT01716455|7470814|FG000|COMPLETED|Overall Study||8
6548906|NCT01716455|7470815|FG001|COMPLETED|Overall Study||8
6548907|NCT01716455|7470816|FG002|COMPLETED|Overall Study||8
6548908|NCT01716455|7470817|FG003|COMPLETED|Overall Study||8
6548909|NCT01716455|7470818|FG004|COMPLETED|Overall Study||26
6548910|NCT01716455|7470819|FG005|COMPLETED|Overall Study||8
6548911|NCT01716455|7470814|FG000|NOT COMPLETED|Overall Study||0
6548912|NCT01716455|7470815|FG001|NOT COMPLETED|Overall Study||0
6548913|NCT01716455|7470816|FG002|NOT COMPLETED|Overall Study||0
6548914|NCT01716455|7470817|FG003|NOT COMPLETED|Overall Study||0
6548915|NCT01716455|7470818|FG004|NOT COMPLETED|Overall Study||0
6548916|NCT01716455|7470819|FG005|NOT COMPLETED|Overall Study||0
6548917|NCT01716468|7470830|FG000|STARTED|Overall Study||17
6548918|NCT01716468|7470830|FG000|COMPLETED|Overall Study||11
6548919|NCT01716468|7470830|FG000|NOT COMPLETED|Overall Study||6
6548920|NCT01716520|7470834|FG000|STARTED|Treatment Period 1 (14 Days)||31
6548921|NCT01716520|7470835|FG001|STARTED|Treatment Period 1 (14 Days)||30
6548922|NCT01716520|7470836|FG002|STARTED|Treatment Period 1 (14 Days)||30
6548923|NCT01716520|7470837|FG003|STARTED|Treatment Period 1 (14 Days)||30
6548924|NCT01716520|7470838|FG004|STARTED|Treatment Period 1 (14 Days)||31
6548925|NCT01716520|7470839|FG005|STARTED|Treatment Period 1 (14 Days)||30
6548926|NCT01716520|7470834|FG000|COMPLETED|Treatment Period 1 (14 Days)||29
6548927|NCT01716520|7470835|FG001|COMPLETED|Treatment Period 1 (14 Days)||29
6548928|NCT01716520|7470836|FG002|COMPLETED|Treatment Period 1 (14 Days)||28
6548929|NCT01716520|7470837|FG003|COMPLETED|Treatment Period 1 (14 Days)||29
6548930|NCT01716520|7470838|FG004|COMPLETED|Treatment Period 1 (14 Days)||31
6548931|NCT01716520|7470839|FG005|COMPLETED|Treatment Period 1 (14 Days)||29
6548932|NCT01716520|7470834|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6548933|NCT01716520|7470835|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6548934|NCT01716520|7470836|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6548935|NCT01716520|7470837|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6548936|NCT01716520|7470838|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6548937|NCT01716520|7470839|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6548938|NCT01716520|7470834|FG000|STARTED|Washout Period 1 (10 to 14 Days)||29
6548939|NCT01716520|7470835|FG001|STARTED|Washout Period 1 (10 to 14 Days)||29
6548940|NCT01716520|7470836|FG002|STARTED|Washout Period 1 (10 to 14 Days)||28
6548941|NCT01716520|7470837|FG003|STARTED|Washout Period 1 (10 to 14 Days)||29
6548942|NCT01716520|7470838|FG004|STARTED|Washout Period 1 (10 to 14 Days)||31
6548943|NCT01716520|7470839|FG005|STARTED|Washout Period 1 (10 to 14 Days)||29
6548944|NCT01716520|7470834|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||29
6548945|NCT01716520|7470835|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||28
6548946|NCT01716520|7470836|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||27
6548947|NCT01716520|7470837|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||29
6548948|NCT01716520|7470838|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||31
6548949|NCT01716520|7470839|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||27
6548950|NCT01716520|7470834|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6548951|NCT01716520|7470835|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
6548952|NCT01716520|7470836|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
6548953|NCT01716520|7470837|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6548954|NCT01716520|7470838|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6548955|NCT01716520|7470839|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
6548956|NCT01716520|7470834|FG000|STARTED|Treatment Period 2 (14 Days)||29
6548957|NCT01716520|7470835|FG001|STARTED|Treatment Period 2 (14 Days)||28
6548958|NCT01716520|7470836|FG002|STARTED|Treatment Period 2 (14 Days)||27
6548959|NCT01716520|7470837|FG003|STARTED|Treatment Period 2 (14 Days)||29
6548960|NCT01716520|7470838|FG004|STARTED|Treatment Period 2 (14 Days)||31
6548961|NCT01716520|7470839|FG005|STARTED|Treatment Period 2 (14 Days)||27
6548962|NCT01716520|7470834|FG000|COMPLETED|Treatment Period 2 (14 Days)||29
6548963|NCT01716520|7470835|FG001|COMPLETED|Treatment Period 2 (14 Days)||28
6548964|NCT01716520|7470836|FG002|COMPLETED|Treatment Period 2 (14 Days)||27
6548965|NCT01716520|7470837|FG003|COMPLETED|Treatment Period 2 (14 Days)||28
6548966|NCT01716520|7470838|FG004|COMPLETED|Treatment Period 2 (14 Days)||29
6548967|NCT01716520|7470839|FG005|COMPLETED|Treatment Period 2 (14 Days)||27
6548968|NCT01716520|7470834|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6548969|NCT01716520|7470835|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6548970|NCT01716520|7470836|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6548971|NCT01716520|7470837|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6548972|NCT01716520|7470838|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||2
6548973|NCT01716520|7470839|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6548974|NCT01716520|7470834|FG000|STARTED|Washout Period 2 (10 to 14 Days)||29
6548975|NCT01716520|7470835|FG001|STARTED|Washout Period 2 (10 to 14 Days)||28
6548976|NCT01716520|7470836|FG002|STARTED|Washout Period 2 (10 to 14 Days)||27
6548977|NCT01716520|7470837|FG003|STARTED|Washout Period 2 (10 to 14 Days)||28
6548978|NCT01716520|7470838|FG004|STARTED|Washout Period 2 (10 to 14 Days)||29
6548979|NCT01716520|7470839|FG005|STARTED|Washout Period 2 (10 to 14 Days)||27
6548980|NCT01716520|7470834|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||27
6548981|NCT01716520|7470835|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||27
6548982|NCT01716520|7470836|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||26
6548983|NCT01716520|7470837|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||28
6548984|NCT01716520|7470838|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||29
6548985|NCT01716520|7470839|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||25
6548986|NCT01716520|7470834|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
6548987|NCT01716520|7470835|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
6548988|NCT01716520|7470836|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
6548989|NCT01716520|7470837|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6548990|NCT01716520|7470838|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6548991|NCT01716520|7470839|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
6548992|NCT01716520|7470834|FG000|STARTED|Treatment Period 3 (14 Days)||27
6548993|NCT01716520|7470835|FG001|STARTED|Treatment Period 3 (14 Days)||27
6548994|NCT01716520|7470836|FG002|STARTED|Treatment Period 3 (14 Days)||26
6548995|NCT01716520|7470837|FG003|STARTED|Treatment Period 3 (14 Days)||28
6548996|NCT01716520|7470838|FG004|STARTED|Treatment Period 3 (14 Days)||29
6548997|NCT01716520|7470839|FG005|STARTED|Treatment Period 3 (14 Days)||25
6548998|NCT01716520|7470834|FG000|COMPLETED|Treatment Period 3 (14 Days)||27
6548999|NCT01716520|7470835|FG001|COMPLETED|Treatment Period 3 (14 Days)||27
6549000|NCT01716520|7470836|FG002|COMPLETED|Treatment Period 3 (14 Days)||25
6549001|NCT01716520|7470837|FG003|COMPLETED|Treatment Period 3 (14 Days)||28
6549002|NCT01716520|7470838|FG004|COMPLETED|Treatment Period 3 (14 Days)||29
6549003|NCT01716520|7470839|FG005|COMPLETED|Treatment Period 3 (14 Days)||23
6549004|NCT01716520|7470834|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6549005|NCT01716520|7470835|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6549006|NCT01716520|7470836|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6549007|NCT01716520|7470837|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6549008|NCT01716520|7470838|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6549009|NCT01716520|7470839|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
6549010|NCT01716533|7470851|FG000|STARTED|Overall Study||7
6549011|NCT01716533|7470852|FG001|STARTED|Overall Study||25
6647089|NCT02386098|7576063|FG001|STARTED|Stage 1 (96 Weeks)||43
6647090|NCT02386098|7576064|FG002|STARTED|Stage 1 (96 Weeks)||0
6647091|NCT02386098|7576065|FG003|STARTED|Stage 1 (96 Weeks)||0
6647092|NCT02386098|7576066|FG004|STARTED|Stage 1 (96 Weeks)||0
6647093|NCT02386098|7576062|FG000|COMPLETED|Stage 1 (96 Weeks)||0
6647094|NCT02386098|7576063|FG001|COMPLETED|Stage 1 (96 Weeks)||0
6647095|NCT02386098|7576064|FG002|COMPLETED|Stage 1 (96 Weeks)||0
6549012|NCT01716533|7470853|FG002|STARTED|Overall Study||5
6549013|NCT01716533|7470854|FG003|STARTED|Overall Study||9
6549014|NCT01716533|7470851|FG000|COMPLETED|Overall Study||7
6549015|NCT01716533|7470852|FG001|COMPLETED|Overall Study||25
6549016|NCT01716533|7470853|FG002|COMPLETED|Overall Study||0
6549017|NCT01716533|7470854|FG003|COMPLETED|Overall Study||1
6549018|NCT01716533|7470851|FG000|NOT COMPLETED|Overall Study||0
6549019|NCT01716533|7470852|FG001|NOT COMPLETED|Overall Study||0
6549020|NCT01716533|7470853|FG002|NOT COMPLETED|Overall Study||5
6549021|NCT01716533|7470854|FG003|NOT COMPLETED|Overall Study||8
6549022|NCT01716559|7470868|FG000|STARTED|Overall Study||160
6549023|NCT01716559|7470868|FG000|COMPLETED|Overall Study||49
6549024|NCT01716559|7470868|FG000|NOT COMPLETED|Overall Study||111
6549025|NCT01716585|7470874|FG000|STARTED|Double-blind Treatment||477
6549026|NCT01716585|7470875|FG001|STARTED|Double-blind Treatment||159
6549027|NCT01716585|7470874|FG000|Randomized But Not Treated|Double-blind Treatment||4
6549028|NCT01716585|7470875|FG001|Randomized But Not Treated|Double-blind Treatment||1
6549029|NCT01716585|7470874|FG000|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
6549030|NCT01716585|7470875|FG001|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
6549031|NCT01716585|7470874|FG000|NOT COMPLETED|Double-blind Treatment||13
6549032|NCT01716585|7470875|FG001|NOT COMPLETED|Double-blind Treatment||2
6549033|NCT01716585|7470874|FG000|STARTED|Open-label Treatment|not applicable to this arm|0
6549034|NCT01716585|7470875|FG001|STARTED|Open-label Treatment||157
6549035|NCT01716585|7470874|FG000|COMPLETED|Open-label Treatment|not applicable to this arm|0
6549036|NCT01716585|7470875|FG001|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
6549037|NCT01716585|7470874|FG000|NOT COMPLETED|Open-label Treatment||0
6549038|NCT01716585|7470875|FG001|NOT COMPLETED|Open-label Treatment||7
6549039|NCT01716663|7470882|FG000|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
6549040|NCT01716663|7470882|FG000|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
6549041|NCT01716663|7470882|FG000|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
6549042|NCT01716663|7470882|FG000|NOT COMPLETED|Overall Study||6
6549043|NCT01716715|7470888|FG000|STARTED|Overall Study||57
6549044|NCT01716715|7470889|FG001|STARTED|Overall Study||54
6549045|NCT01716715|7470888|FG000|COMPLETED|Overall Study||55
6549046|NCT01716715|7470889|FG001|COMPLETED|Overall Study||50
6549047|NCT01716715|7470888|FG000|NOT COMPLETED|Overall Study||2
6549048|NCT01716715|7470889|FG001|NOT COMPLETED|Overall Study||4
6549049|NCT01716754|7470901|FG000|STARTED|Overall Study||199
6549050|NCT01716754|7470902|FG001|STARTED|Overall Study||40
6549051|NCT01716754|7470903|FG002|STARTED|Overall Study||135
6549052|NCT01716754|7470904|FG003|STARTED|Overall Study||97
6549053|NCT01716754|7470901|FG000|FAS|Overall Study||199
6549054|NCT01716754|7470902|FG001|FAS|Overall Study||40
6549055|NCT01716754|7470903|FG002|FAS|Overall Study||131
6549056|NCT01716754|7470904|FG003|FAS|Overall Study||96
6549057|NCT01716754|7470901|FG000|Safety Set|Overall Study||199
6549058|NCT01716754|7470902|FG001|Safety Set|Overall Study||40
6549059|NCT01716754|7470903|FG002|Safety Set|Overall Study||131
6647096|NCT02386098|7576065|FG003|COMPLETED|Stage 1 (96 Weeks)||0
6549060|NCT01716754|7470904|FG003|Safety Set|Overall Study||96
6549061|NCT01716754|7470901|FG000|COMPLETED|Overall Study||188
6549062|NCT01716754|7470902|FG001|COMPLETED|Overall Study||36
6549063|NCT01716754|7470903|FG002|COMPLETED|Overall Study||121
6549064|NCT01716754|7470904|FG003|COMPLETED|Overall Study||89
6549065|NCT01716754|7470901|FG000|NOT COMPLETED|Overall Study||11
6549066|NCT01716754|7470902|FG001|NOT COMPLETED|Overall Study||4
6549067|NCT01716754|7470903|FG002|NOT COMPLETED|Overall Study||14
6549068|NCT01716754|7470904|FG003|NOT COMPLETED|Overall Study||8
6549069|NCT01717001|7470915|FG000|STARTED|Overall Study||38
6549070|NCT01717001|7470916|FG001|STARTED|Overall Study||28
6549071|NCT01717001|7470915|FG000|COMPLETED|Overall Study||32
6549072|NCT01717001|7470916|FG001|COMPLETED|Overall Study||24
6549073|NCT01717001|7470915|FG000|NOT COMPLETED|Overall Study||6
6549074|NCT01717001|7470916|FG001|NOT COMPLETED|Overall Study||4
6549075|NCT01717014|7470922|FG000|STARTED|Overall Study||8
6549076|NCT01717014|7470922|FG000|COMPLETED|Overall Study||8
6549077|NCT01717014|7470922|FG000|NOT COMPLETED|Overall Study||0
6549078|NCT01717040|7470928|FG000|STARTED|Overall Study||17
6647097|NCT02386098|7576066|FG004|COMPLETED|Stage 1 (96 Weeks)||0
6647098|NCT02386098|7576062|FG000|NOT COMPLETED|Stage 1 (96 Weeks)||43
6647099|NCT02386098|7576063|FG001|NOT COMPLETED|Stage 1 (96 Weeks)||43
6647100|NCT02386098|7576064|FG002|NOT COMPLETED|Stage 1 (96 Weeks)||0
6549079|NCT01717040|7470929|FG001|STARTED|Overall Study||20
6549080|NCT01717040|7470928|FG000|COMPLETED|Overall Study||12
6549081|NCT01717040|7470929|FG001|COMPLETED|Overall Study||15
6549082|NCT01717040|7470928|FG000|NOT COMPLETED|Overall Study||5
6549083|NCT01717040|7470929|FG001|NOT COMPLETED|Overall Study||5
6549084|NCT01717053|7470935|FG000|STARTED|Overall Study||37
6549085|NCT01717053|7470935|FG000|COMPLETED|Overall Study||33
6549086|NCT01717053|7470935|FG000|NOT COMPLETED|Overall Study||4
6549087|NCT01717209|7470939|FG000|STARTED|Overall Study||14
6549088|NCT01717209|7470939|FG000|COMPLETED|Overall Study||14
6549089|NCT01717209|7470939|FG000|NOT COMPLETED|Overall Study||0
6549090|NCT01717287|7470945|FG000|STARTED|Overall Study||4
6549091|NCT01717287|7470946|FG001|STARTED|Overall Study||28
6549092|NCT01717287|7470945|FG000|COMPLETED|Overall Study||4
6549093|NCT01717287|7470946|FG001|COMPLETED|Overall Study||25
6549094|NCT01717287|7470945|FG000|NOT COMPLETED|Overall Study||0
6549095|NCT01717287|7470946|FG001|NOT COMPLETED|Overall Study||3
6549096|NCT01717313|7470954|FG000|STARTED|Phase A (Weeks 0 to 24)||165
6549097|NCT01717313|7470955|FG001|STARTED|Phase A (Weeks 0 to 24)||164
6549098|NCT01717313|7470954|FG000|COMPLETED|Phase A (Weeks 0 to 24)||147
6549099|NCT01717313|7470955|FG001|COMPLETED|Phase A (Weeks 0 to 24)||151
6549100|NCT01717313|7470954|FG000|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
6549101|NCT01717313|7470955|FG001|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
6549102|NCT01717313|7470954|FG000|STARTED|Interphase||147
6549103|NCT01717313|7470955|FG001|STARTED|Interphase||151
6549104|NCT01717313|7470954|FG000|COMPLETED|Interphase||146
6549105|NCT01717313|7470955|FG001|COMPLETED|Interphase||151
6549106|NCT01717313|7470954|FG000|NOT COMPLETED|Interphase||1
6549107|NCT01717313|7470955|FG001|NOT COMPLETED|Interphase||0
6549108|NCT01717313|7470954|FG000|STARTED|Phase B (Weeks 24 to 54)||146
6549109|NCT01717313|7470955|FG001|STARTED|Phase B (Weeks 24 to 54)||151
6549110|NCT01717313|7470954|FG000|COMPLETED|Phase B (Weeks 24 to 54)||134
6549111|NCT01717313|7470955|FG001|COMPLETED|Phase B (Weeks 24 to 54)||135
6549112|NCT01717313|7470954|FG000|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
6549113|NCT01717313|7470955|FG001|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
6549114|NCT01717326|7470981|FG000|STARTED|Overall Study||25
6549115|NCT01717326|7470982|FG001|STARTED|Overall Study||27
6549116|NCT01717326|7470983|FG002|STARTED|Overall Study||13
6549117|NCT01717326|7470984|FG003|STARTED|Overall Study||30
6549118|NCT01717326|7470985|FG004|STARTED|Overall Study||33
6549119|NCT01717326|7470986|FG005|STARTED|Overall Study||31
6549120|NCT01717326|7470987|FG006|STARTED|Overall Study||31
6549121|NCT01717326|7470988|FG007|STARTED|Overall Study||29
6549122|NCT01717326|7470989|FG008|STARTED|Overall Study||32
6549123|NCT01717326|7470990|FG009|STARTED|Overall Study||31
6549124|NCT01717326|7470991|FG010|STARTED|Overall Study||32
6549125|NCT01717326|7470992|FG011|STARTED|Overall Study||33
6549126|NCT01717326|7470993|FG012|STARTED|Overall Study||33
6549127|NCT01717326|7470994|FG013|STARTED|Overall Study||32
6549128|NCT01717326|7470995|FG014|STARTED|Overall Study||29
6549129|NCT01717326|7470996|FG015|STARTED|Overall Study||30
6549130|NCT01717326|7470997|FG016|STARTED|Overall Study||30
6549131|NCT01717326|7470998|FG017|STARTED|Overall Study||31
6549132|NCT01717326|7470999|FG018|STARTED|Overall Study||20
6549133|NCT01717326|7471000|FG019|STARTED|Overall Study||21
6549134|NCT01717326|7470981|FG000|Treated|Overall Study||25
6549135|NCT01717326|7470982|FG001|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
6549136|NCT01717326|7470983|FG002|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
6549137|NCT01717326|7470984|FG003|Treated|Overall Study||30
6549138|NCT01717326|7470985|FG004|Treated|Overall Study||33
6549139|NCT01717326|7470986|FG005|Treated|Overall Study||31
6549140|NCT01717326|7470987|FG006|Treated|Overall Study||31
6549141|NCT01717326|7470988|FG007|Treated|Overall Study||29
6549142|NCT01717326|7470989|FG008|Treated|Overall Study||32
6549143|NCT01717326|7470990|FG009|Treated|Overall Study||31
6549144|NCT01717326|7470991|FG010|Treated|Overall Study||32
6549145|NCT01717326|7470992|FG011|Treated|Overall Study||33
6549146|NCT01717326|7470993|FG012|Treated|Overall Study||33
6549147|NCT01717326|7470994|FG013|Treated|Overall Study||32
6549148|NCT01717326|7470995|FG014|Treated|Overall Study||29
6549149|NCT01717326|7470996|FG015|Treated|Overall Study||30
6549150|NCT01717326|7470997|FG016|Treated|Overall Study||30
6549151|NCT01717326|7470998|FG017|Treated|Overall Study||31
6549152|NCT01717326|7470999|FG018|Treated|Overall Study||20
6549153|NCT01717326|7471000|FG019|Treated|Overall Study||21
6647101|NCT02386098|7576065|FG003|NOT COMPLETED|Stage 1 (96 Weeks)||0
6647102|NCT02386098|7576066|FG004|NOT COMPLETED|Stage 1 (96 Weeks)||0
6647103|NCT02386098|7576062|FG000|STARTED|Stage 2 (96 Weeks)||0
6647104|NCT02386098|7576063|FG001|STARTED|Stage 2 (96 Weeks)||0
6647105|NCT02386098|7576064|FG002|STARTED|Stage 2 (96 Weeks)||0
6647106|NCT02386098|7576065|FG003|STARTED|Stage 2 (96 Weeks)||0
6647107|NCT02386098|7576066|FG004|STARTED|Stage 2 (96 Weeks)||0
6647108|NCT02386098|7576062|FG000|COMPLETED|Stage 2 (96 Weeks)||0
6647109|NCT02386098|7576063|FG001|COMPLETED|Stage 2 (96 Weeks)||0
6647110|NCT02386098|7576064|FG002|COMPLETED|Stage 2 (96 Weeks)||0
6647111|NCT02386098|7576065|FG003|COMPLETED|Stage 2 (96 Weeks)||0
6549154|NCT01717326|7470981|FG000|COMPLETED|Overall Study||22
6549155|NCT01717326|7470982|FG001|COMPLETED|Overall Study||26
6549156|NCT01717326|7470983|FG002|COMPLETED|Overall Study||13
6549157|NCT01717326|7470984|FG003|COMPLETED|Overall Study||28
6549158|NCT01717326|7470985|FG004|COMPLETED|Overall Study||31
6549159|NCT01717326|7470986|FG005|COMPLETED|Overall Study||31
6549160|NCT01717326|7470987|FG006|COMPLETED|Overall Study||30
6549161|NCT01717326|7470988|FG007|COMPLETED|Overall Study||29
6549162|NCT01717326|7470989|FG008|COMPLETED|Overall Study||32
6549163|NCT01717326|7470990|FG009|COMPLETED|Overall Study||29
6549164|NCT01717326|7470991|FG010|COMPLETED|Overall Study||30
6549165|NCT01717326|7470992|FG011|COMPLETED|Overall Study||33
6549166|NCT01717326|7470993|FG012|COMPLETED|Overall Study||32
6549167|NCT01717326|7470994|FG013|COMPLETED|Overall Study||32
6549168|NCT01717326|7470995|FG014|COMPLETED|Overall Study||29
6549169|NCT01717326|7470996|FG015|COMPLETED|Overall Study||27
6549170|NCT01717326|7470997|FG016|COMPLETED|Overall Study||29
6549171|NCT01717326|7470998|FG017|COMPLETED|Overall Study||31
6549172|NCT01717326|7470999|FG018|COMPLETED|Overall Study||16
6549173|NCT01717326|7471000|FG019|COMPLETED|Overall Study||15
6549174|NCT01717326|7470981|FG000|NOT COMPLETED|Overall Study||3
6549175|NCT01717326|7470982|FG001|NOT COMPLETED|Overall Study||1
6549176|NCT01717326|7470983|FG002|NOT COMPLETED|Overall Study||0
6549177|NCT01717326|7470984|FG003|NOT COMPLETED|Overall Study||2
6549178|NCT01717326|7470985|FG004|NOT COMPLETED|Overall Study||2
6549179|NCT01717326|7470986|FG005|NOT COMPLETED|Overall Study||0
6549180|NCT01717326|7470987|FG006|NOT COMPLETED|Overall Study||1
6549181|NCT01717326|7470988|FG007|NOT COMPLETED|Overall Study||0
6549182|NCT01717326|7470989|FG008|NOT COMPLETED|Overall Study||0
6549183|NCT01717326|7470990|FG009|NOT COMPLETED|Overall Study||2
6549184|NCT01717326|7470991|FG010|NOT COMPLETED|Overall Study||2
6549185|NCT01717326|7470992|FG011|NOT COMPLETED|Overall Study||0
6549186|NCT01717326|7470993|FG012|NOT COMPLETED|Overall Study||1
6647112|NCT02386098|7576066|FG004|COMPLETED|Stage 2 (96 Weeks)||0
6647113|NCT02386098|7576062|FG000|NOT COMPLETED|Stage 2 (96 Weeks)||0
6647114|NCT02386098|7576063|FG001|NOT COMPLETED|Stage 2 (96 Weeks)||0
6647115|NCT02386098|7576064|FG002|NOT COMPLETED|Stage 2 (96 Weeks)||0
6647116|NCT02386098|7576065|FG003|NOT COMPLETED|Stage 2 (96 Weeks)||0
6549187|NCT01717326|7470994|FG013|NOT COMPLETED|Overall Study||0
6549188|NCT01717326|7470995|FG014|NOT COMPLETED|Overall Study||0
6549189|NCT01717326|7470996|FG015|NOT COMPLETED|Overall Study||3
6549190|NCT01717326|7470997|FG016|NOT COMPLETED|Overall Study||1
6549191|NCT01717326|7470998|FG017|NOT COMPLETED|Overall Study||0
6549192|NCT01717326|7470999|FG018|NOT COMPLETED|Overall Study||4
6549193|NCT01717326|7471000|FG019|NOT COMPLETED|Overall Study||6
6549194|NCT01717391|7471042|FG000|STARTED|Overall Study||36
6549195|NCT01717391|7471042|FG000|COMPLETED|Overall Study||27
6549196|NCT01717391|7471042|FG000|NOT COMPLETED|Overall Study||9
6549197|NCT01717456|7471050|FG000|STARTED|End of Treatment||11
6549198|NCT01717456|7471051|FG001|STARTED|End of Treatment||8
6549199|NCT01717456|7471050|FG000|COMPLETED|End of Treatment||11
6549200|NCT01717456|7471051|FG001|COMPLETED|End of Treatment||6
6549201|NCT01717456|7471050|FG000|NOT COMPLETED|End of Treatment||0
6549202|NCT01717456|7471051|FG001|NOT COMPLETED|End of Treatment||2
6549203|NCT01717456|7471050|FG000|STARTED|Follow-Up 6 Months After End of Tx||11
6549204|NCT01717456|7471051|FG001|STARTED|Follow-Up 6 Months After End of Tx||6
6549205|NCT01717456|7471050|FG000|COMPLETED|Follow-Up 6 Months After End of Tx||7
6549206|NCT01717456|7471051|FG001|COMPLETED|Follow-Up 6 Months After End of Tx||2
6549207|NCT01717456|7471050|FG000|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
6549208|NCT01717456|7471051|FG001|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
6549209|NCT01717521|7471058|FG000|STARTED|Overall Study||20
6549210|NCT01717521|7471058|FG000|COMPLETED|Overall Study||20
6549211|NCT01717521|7471058|FG000|NOT COMPLETED|Overall Study||0
6549212|NCT01717638|7471075|FG000|STARTED|Overall Study||67
6549213|NCT01717638|7471076|FG001|STARTED|Overall Study||61
6549214|NCT01717638|7471077|FG002|STARTED|Overall Study||60
6549215|NCT01717638|7471078|FG003|STARTED|Overall Study||66
6549216|NCT01717638|7471079|FG004|STARTED|Overall Study||64
6549217|NCT01717638|7471080|FG005|STARTED|Overall Study||55
6549218|NCT01717638|7471081|FG006|STARTED|Overall Study||43
6549219|NCT01717638|7471082|FG007|STARTED|Overall Study||29
6549220|NCT01717638|7471083|FG008|STARTED|Overall Study||28
6549221|NCT01717638|7471084|FG009|STARTED|Overall Study||100
6549222|NCT01717638|7471085|FG010|STARTED|Overall Study||11
6549223|NCT01717638|7471086|FG011|STARTED|Overall Study||12
6549224|NCT01717638|7471087|FG012|STARTED|Overall Study||209
6549225|NCT01717638|7471075|FG000|COMPLETED|Overall Study||67
6549226|NCT01717638|7471076|FG001|COMPLETED|Overall Study||60
6549227|NCT01717638|7471077|FG002|COMPLETED|Overall Study||59
6549228|NCT01717638|7471078|FG003|COMPLETED|Overall Study||66
6549229|NCT01717638|7471079|FG004|COMPLETED|Overall Study||63
6549230|NCT01717638|7471080|FG005|COMPLETED|Overall Study||54
6549231|NCT01717638|7471081|FG006|COMPLETED|Overall Study||41
6549232|NCT01717638|7471082|FG007|COMPLETED|Overall Study||28
6549233|NCT01717638|7471083|FG008|COMPLETED|Overall Study||26
6549234|NCT01717638|7471084|FG009|COMPLETED|Overall Study||99
6549235|NCT01717638|7471085|FG010|COMPLETED|Overall Study||11
6549236|NCT01717638|7471086|FG011|COMPLETED|Overall Study||12
6549237|NCT01717638|7471087|FG012|COMPLETED|Overall Study||190
6549238|NCT01717638|7471075|FG000|NOT COMPLETED|Overall Study||0
6549239|NCT01717638|7471076|FG001|NOT COMPLETED|Overall Study||1
6549240|NCT01717638|7471077|FG002|NOT COMPLETED|Overall Study||1
6549241|NCT01717638|7471078|FG003|NOT COMPLETED|Overall Study||0
6549242|NCT01717638|7471079|FG004|NOT COMPLETED|Overall Study||1
6549243|NCT01717638|7471080|FG005|NOT COMPLETED|Overall Study||1
6549244|NCT01717638|7471081|FG006|NOT COMPLETED|Overall Study||2
6549245|NCT01717638|7471082|FG007|NOT COMPLETED|Overall Study||1
6549246|NCT01717638|7471083|FG008|NOT COMPLETED|Overall Study||2
6549247|NCT01717638|7471084|FG009|NOT COMPLETED|Overall Study||1
6549248|NCT01717638|7471085|FG010|NOT COMPLETED|Overall Study||0
6549249|NCT01717638|7471086|FG011|NOT COMPLETED|Overall Study||0
6647117|NCT02386098|7576066|FG004|NOT COMPLETED|Stage 2 (96 Weeks)||0
6549250|NCT01717638|7471087|FG012|NOT COMPLETED|Overall Study||19
6549251|NCT01717742|7471123|FG000|STARTED|Overall Study||48
6647118|NCT02386189|7576080|FG000|STARTED|Overall Study||30
6647119|NCT02386189|7576081|FG001|STARTED|Overall Study||33
6647120|NCT02386189|7576080|FG000|COMPLETED|Overall Study||26
6647121|NCT02386189|7576081|FG001|COMPLETED|Overall Study||30
6647122|NCT02386189|7576080|FG000|NOT COMPLETED|Overall Study||4
6647123|NCT02386189|7576081|FG001|NOT COMPLETED|Overall Study||3
6647124|NCT02386319|7576089|FG000|STARTED|Overall Study||18
6647125|NCT02386319|7576090|FG001|STARTED|Overall Study||18
6647126|NCT02386319|7576089|FG000|COMPLETED|Overall Study||16
6647127|NCT02386319|7576090|FG001|COMPLETED|Overall Study||17
6647128|NCT02386319|7576089|FG000|NOT COMPLETED|Overall Study||2
6549252|NCT01717742|7471124|FG001|STARTED|Overall Study||49
6549253|NCT01717742|7471123|FG000|COMPLETED|Overall Study||43
6549254|NCT01717742|7471124|FG001|COMPLETED|Overall Study||47
6549255|NCT01717742|7471123|FG000|NOT COMPLETED|Overall Study||5
6549256|NCT01717742|7471124|FG001|NOT COMPLETED|Overall Study||2
6549257|NCT01717768|7471140|FG000|STARTED|Part 1 (Duration of 15 Days)||17
6549258|NCT01717768|7471141|FG001|STARTED|Part 1 (Duration of 15 Days)||17
6549259|NCT01717768|7471142|FG002|STARTED|Part 1 (Duration of 15 Days)||0
6549260|NCT01717768|7471143|FG003|STARTED|Part 1 (Duration of 15 Days)||0
6549261|NCT01717768|7471144|FG004|STARTED|Part 1 (Duration of 15 Days)||0
6549262|NCT01717768|7471145|FG005|STARTED|Part 1 (Duration of 15 Days)||0
6549263|NCT01717768|7471146|FG006|STARTED|Part 1 (Duration of 15 Days)||0
6549264|NCT01717768|7471147|FG007|STARTED|Part 1 (Duration of 15 Days)||0
6549265|NCT01717768|7471148|FG008|STARTED|Part 1 (Duration of 15 Days)||0
6549266|NCT01717768|7471149|FG009|STARTED|Part 1 (Duration of 15 Days)||0
6549267|NCT01717768|7471150|FG010|STARTED|Part 1 (Duration of 15 Days)||0
6549268|NCT01717768|7471151|FG011|STARTED|Part 1 (Duration of 15 Days)||0
6549269|NCT01717768|7471140|FG000|COMPLETED|Part 1 (Duration of 15 Days)||17
6549270|NCT01717768|7471141|FG001|COMPLETED|Part 1 (Duration of 15 Days)||16
6549271|NCT01717768|7471142|FG002|COMPLETED|Part 1 (Duration of 15 Days)||0
6549272|NCT01717768|7471143|FG003|COMPLETED|Part 1 (Duration of 15 Days)||0
6549273|NCT01717768|7471144|FG004|COMPLETED|Part 1 (Duration of 15 Days)||0
6549274|NCT01717768|7471145|FG005|COMPLETED|Part 1 (Duration of 15 Days)||0
6549275|NCT01717768|7471146|FG006|COMPLETED|Part 1 (Duration of 15 Days)||0
6549276|NCT01717768|7471147|FG007|COMPLETED|Part 1 (Duration of 15 Days)||0
6549277|NCT01717768|7471148|FG008|COMPLETED|Part 1 (Duration of 15 Days)||0
6549278|NCT01717768|7471149|FG009|COMPLETED|Part 1 (Duration of 15 Days)||0
6549279|NCT01717768|7471150|FG010|COMPLETED|Part 1 (Duration of 15 Days)||0
6549280|NCT01717768|7471151|FG011|COMPLETED|Part 1 (Duration of 15 Days)||0
6549281|NCT01717768|7471140|FG000|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549282|NCT01717768|7471141|FG001|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
6549283|NCT01717768|7471142|FG002|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549284|NCT01717768|7471143|FG003|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549285|NCT01717768|7471144|FG004|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549286|NCT01717768|7471145|FG005|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549287|NCT01717768|7471146|FG006|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549288|NCT01717768|7471147|FG007|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549289|NCT01717768|7471148|FG008|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549290|NCT01717768|7471149|FG009|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549291|NCT01717768|7471150|FG010|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549292|NCT01717768|7471151|FG011|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
6549293|NCT01717768|7471140|FG000|STARTED|Part 2 (Duration of 15 Days)||0
6549294|NCT01717768|7471141|FG001|STARTED|Part 2 (Duration of 15 Days)||0
6549295|NCT01717768|7471142|FG002|STARTED|Part 2 (Duration of 15 Days)||17
6549296|NCT01717768|7471143|FG003|STARTED|Part 2 (Duration of 15 Days)||0
6549297|NCT01717768|7471144|FG004|STARTED|Part 2 (Duration of 15 Days)||0
6549298|NCT01717768|7471145|FG005|STARTED|Part 2 (Duration of 15 Days)||0
6647129|NCT02386319|7576090|FG001|NOT COMPLETED|Overall Study||1
6647130|NCT02386345|7576096|FG000|STARTED|Overall Study||299
6647131|NCT02386345|7576096|FG000|COMPLETED|Overall Study||197
6647132|NCT02386345|7576096|FG000|NOT COMPLETED|Overall Study||102
6647133|NCT02386605|7576102|FG000|STARTED|Overall Study||41
6647134|NCT02386605|7576103|FG001|STARTED|Overall Study||38
6647135|NCT02386605|7576102|FG000|COMPLETED|Overall Study||34
6647136|NCT02386605|7576103|FG001|COMPLETED|Overall Study||28
6647137|NCT02386605|7576102|FG000|NOT COMPLETED|Overall Study||7
6647138|NCT02386605|7576103|FG001|NOT COMPLETED|Overall Study||10
6647139|NCT02386995|7576109|FG000|STARTED|Overall Study||30
6647140|NCT02386995|7576109|FG000|COMPLETED|Overall Study||30
6647141|NCT02386995|7576109|FG000|NOT COMPLETED|Overall Study||0
6647142|NCT02387008|7576117|FG000|STARTED|Overall Study||2
6647143|NCT02387008|7576118|FG001|STARTED|Overall Study||0
6647144|NCT02387008|7576119|FG002|STARTED|Overall Study||4
6647145|NCT02387008|7576117|FG000|COMPLETED|Overall Study||2
6647146|NCT02387008|7576118|FG001|COMPLETED|Overall Study||0
6549299|NCT01717768|7471146|FG006|STARTED|Part 2 (Duration of 15 Days)||0
6549300|NCT01717768|7471147|FG007|STARTED|Part 2 (Duration of 15 Days)||0
6549301|NCT01717768|7471148|FG008|STARTED|Part 2 (Duration of 15 Days)||0
6549302|NCT01717768|7471149|FG009|STARTED|Part 2 (Duration of 15 Days)||0
6647147|NCT02387008|7576119|FG002|COMPLETED|Overall Study||4
6647148|NCT02387008|7576117|FG000|NOT COMPLETED|Overall Study||0
6647149|NCT02387008|7576118|FG001|NOT COMPLETED|Overall Study||0
6647150|NCT02387008|7576119|FG002|NOT COMPLETED|Overall Study||0
6647151|NCT02387164|7576129|FG000|STARTED|Overall Study||13
6549303|NCT01717768|7471150|FG010|STARTED|Part 2 (Duration of 15 Days)||0
6549304|NCT01717768|7471151|FG011|STARTED|Part 2 (Duration of 15 Days)||0
6549305|NCT01717768|7471140|FG000|COMPLETED|Part 2 (Duration of 15 Days)||0
6549306|NCT01717768|7471141|FG001|COMPLETED|Part 2 (Duration of 15 Days)||0
6549307|NCT01717768|7471142|FG002|COMPLETED|Part 2 (Duration of 15 Days)||17
6549308|NCT01717768|7471143|FG003|COMPLETED|Part 2 (Duration of 15 Days)||0
6549309|NCT01717768|7471144|FG004|COMPLETED|Part 2 (Duration of 15 Days)||0
6549310|NCT01717768|7471145|FG005|COMPLETED|Part 2 (Duration of 15 Days)||0
6549311|NCT01717768|7471146|FG006|COMPLETED|Part 2 (Duration of 15 Days)||0
6549312|NCT01717768|7471147|FG007|COMPLETED|Part 2 (Duration of 15 Days)||0
6549313|NCT01717768|7471148|FG008|COMPLETED|Part 2 (Duration of 15 Days)||0
6549314|NCT01717768|7471149|FG009|COMPLETED|Part 2 (Duration of 15 Days)||0
6549315|NCT01717768|7471150|FG010|COMPLETED|Part 2 (Duration of 15 Days)||0
6549316|NCT01717768|7471151|FG011|COMPLETED|Part 2 (Duration of 15 Days)||0
6549317|NCT01717768|7471140|FG000|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549318|NCT01717768|7471141|FG001|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549319|NCT01717768|7471142|FG002|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549320|NCT01717768|7471143|FG003|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549321|NCT01717768|7471144|FG004|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549322|NCT01717768|7471145|FG005|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549323|NCT01717768|7471146|FG006|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549324|NCT01717768|7471147|FG007|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549325|NCT01717768|7471148|FG008|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549326|NCT01717768|7471149|FG009|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549327|NCT01717768|7471150|FG010|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549328|NCT01717768|7471151|FG011|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
6549329|NCT01717768|7471140|FG000|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549330|NCT01717768|7471141|FG001|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549331|NCT01717768|7471142|FG002|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549332|NCT01717768|7471143|FG003|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
6549333|NCT01717768|7471144|FG004|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
6549334|NCT01717768|7471145|FG005|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
6549335|NCT01717768|7471146|FG006|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549336|NCT01717768|7471147|FG007|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549337|NCT01717768|7471148|FG008|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549338|NCT01717768|7471149|FG009|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549339|NCT01717768|7471150|FG010|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549340|NCT01717768|7471151|FG011|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549341|NCT01717768|7471140|FG000|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549342|NCT01717768|7471141|FG001|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549343|NCT01717768|7471142|FG002|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549344|NCT01717768|7471143|FG003|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
6549345|NCT01717768|7471144|FG004|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
6549346|NCT01717768|7471145|FG005|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
6549347|NCT01717768|7471146|FG006|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549348|NCT01717768|7471147|FG007|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549349|NCT01717768|7471148|FG008|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549350|NCT01717768|7471149|FG009|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549351|NCT01717768|7471150|FG010|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549352|NCT01717768|7471151|FG011|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549353|NCT01717768|7471140|FG000|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549354|NCT01717768|7471141|FG001|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549355|NCT01717768|7471142|FG002|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549356|NCT01717768|7471143|FG003|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549357|NCT01717768|7471144|FG004|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549358|NCT01717768|7471145|FG005|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549359|NCT01717768|7471146|FG006|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549360|NCT01717768|7471147|FG007|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549361|NCT01717768|7471148|FG008|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549362|NCT01717768|7471149|FG009|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549363|NCT01717768|7471150|FG010|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549364|NCT01717768|7471151|FG011|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
6549365|NCT01717768|7471140|FG000|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549366|NCT01717768|7471141|FG001|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549367|NCT01717768|7471142|FG002|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549368|NCT01717768|7471143|FG003|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
6549369|NCT01717768|7471144|FG004|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
6549370|NCT01717768|7471145|FG005|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
6549371|NCT01717768|7471146|FG006|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549372|NCT01717768|7471147|FG007|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549373|NCT01717768|7471148|FG008|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549374|NCT01717768|7471149|FG009|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549375|NCT01717768|7471150|FG010|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549376|NCT01717768|7471151|FG011|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549377|NCT01717768|7471140|FG000|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549378|NCT01717768|7471141|FG001|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549379|NCT01717768|7471142|FG002|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549380|NCT01717768|7471143|FG003|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
6549381|NCT01717768|7471144|FG004|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
6549382|NCT01717768|7471145|FG005|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
6549383|NCT01717768|7471146|FG006|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549384|NCT01717768|7471147|FG007|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549385|NCT01717768|7471148|FG008|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549386|NCT01717768|7471149|FG009|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549387|NCT01717768|7471150|FG010|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549388|NCT01717768|7471151|FG011|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549389|NCT01717768|7471140|FG000|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549390|NCT01717768|7471141|FG001|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549391|NCT01717768|7471142|FG002|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549392|NCT01717768|7471143|FG003|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549393|NCT01717768|7471144|FG004|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549394|NCT01717768|7471145|FG005|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549395|NCT01717768|7471146|FG006|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549396|NCT01717768|7471147|FG007|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549397|NCT01717768|7471148|FG008|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549398|NCT01717768|7471149|FG009|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549399|NCT01717768|7471150|FG010|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549400|NCT01717768|7471151|FG011|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
6549401|NCT01717768|7471140|FG000|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549402|NCT01717768|7471141|FG001|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549403|NCT01717768|7471142|FG002|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549404|NCT01717768|7471143|FG003|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
6549405|NCT01717768|7471144|FG004|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
6549406|NCT01717768|7471145|FG005|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
6549407|NCT01717768|7471146|FG006|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549408|NCT01717768|7471147|FG007|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549409|NCT01717768|7471148|FG008|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549410|NCT01717768|7471149|FG009|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549411|NCT01717768|7471150|FG010|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549412|NCT01717768|7471151|FG011|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549413|NCT01717768|7471140|FG000|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549414|NCT01717768|7471141|FG001|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549415|NCT01717768|7471142|FG002|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549416|NCT01717768|7471143|FG003|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
6549417|NCT01717768|7471144|FG004|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
6549418|NCT01717768|7471145|FG005|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
6549419|NCT01717768|7471146|FG006|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549420|NCT01717768|7471147|FG007|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549421|NCT01717768|7471148|FG008|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549422|NCT01717768|7471149|FG009|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549423|NCT01717768|7471150|FG010|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549424|NCT01717768|7471151|FG011|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549425|NCT01717768|7471140|FG000|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549426|NCT01717768|7471141|FG001|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549427|NCT01717768|7471142|FG002|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549428|NCT01717768|7471143|FG003|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549429|NCT01717768|7471144|FG004|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549430|NCT01717768|7471145|FG005|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549431|NCT01717768|7471146|FG006|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549432|NCT01717768|7471147|FG007|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549433|NCT01717768|7471148|FG008|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549434|NCT01717768|7471149|FG009|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549435|NCT01717768|7471150|FG010|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549436|NCT01717768|7471151|FG011|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
6549437|NCT01717768|7471140|FG000|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549438|NCT01717768|7471141|FG001|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549439|NCT01717768|7471142|FG002|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549440|NCT01717768|7471143|FG003|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549441|NCT01717768|7471144|FG004|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549442|NCT01717768|7471145|FG005|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549443|NCT01717768|7471146|FG006|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
6549444|NCT01717768|7471147|FG007|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549445|NCT01717768|7471148|FG008|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
6549446|NCT01717768|7471149|FG009|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549447|NCT01717768|7471150|FG010|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
6549448|NCT01717768|7471151|FG011|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
6549449|NCT01717768|7471140|FG000|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549450|NCT01717768|7471141|FG001|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549451|NCT01717768|7471142|FG002|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549452|NCT01717768|7471143|FG003|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549453|NCT01717768|7471144|FG004|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549454|NCT01717768|7471145|FG005|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549455|NCT01717768|7471146|FG006|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
6549456|NCT01717768|7471147|FG007|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549457|NCT01717768|7471148|FG008|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
6549458|NCT01717768|7471149|FG009|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549459|NCT01717768|7471150|FG010|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
6549460|NCT01717768|7471151|FG011|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
6549461|NCT01717768|7471140|FG000|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549462|NCT01717768|7471141|FG001|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549463|NCT01717768|7471142|FG002|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549464|NCT01717768|7471143|FG003|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549465|NCT01717768|7471144|FG004|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549466|NCT01717768|7471145|FG005|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549467|NCT01717768|7471146|FG006|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549468|NCT01717768|7471147|FG007|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549469|NCT01717768|7471148|FG008|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549470|NCT01717768|7471149|FG009|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549471|NCT01717768|7471150|FG010|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
6549472|NCT01717768|7471151|FG011|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
6549473|NCT01717768|7471140|FG000|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549474|NCT01717768|7471141|FG001|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549475|NCT01717768|7471142|FG002|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549476|NCT01717768|7471143|FG003|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549477|NCT01717768|7471144|FG004|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549478|NCT01717768|7471145|FG005|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549479|NCT01717768|7471146|FG006|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549480|NCT01717768|7471147|FG007|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
6549481|NCT01717768|7471148|FG008|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549482|NCT01717768|7471149|FG009|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
6549483|NCT01717768|7471150|FG010|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549484|NCT01717768|7471151|FG011|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549485|NCT01717768|7471140|FG000|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549486|NCT01717768|7471141|FG001|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549487|NCT01717768|7471142|FG002|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549488|NCT01717768|7471143|FG003|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549489|NCT01717768|7471144|FG004|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549490|NCT01717768|7471145|FG005|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549491|NCT01717768|7471146|FG006|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549492|NCT01717768|7471147|FG007|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
6549493|NCT01717768|7471148|FG008|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549494|NCT01717768|7471149|FG009|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
6562696|NCT01802554|7485646|FG001|STARTED|Overall Study||49
6647152|NCT02387164|7576130|FG001|STARTED|Overall Study||13
6647153|NCT02387164|7576129|FG000|COMPLETED|Overall Study||10
6647154|NCT02387164|7576130|FG001|COMPLETED|Overall Study||11
6647155|NCT02387164|7576129|FG000|NOT COMPLETED|Overall Study||3
6647156|NCT02387164|7576130|FG001|NOT COMPLETED|Overall Study||2
6647157|NCT02387216|7576138|FG000|STARTED|Overall Study||103
6647158|NCT02387216|7576139|FG001|STARTED|Overall Study||49
6647159|NCT02387216|7576138|FG000|COMPLETED|Overall Study||3
6647160|NCT02387216|7576139|FG001|COMPLETED|Overall Study||2
6647161|NCT02387216|7576138|FG000|NOT COMPLETED|Overall Study||100
6647162|NCT02387216|7576139|FG001|NOT COMPLETED|Overall Study||47
6647163|NCT02387268|7576145|FG000|STARTED|Overall Study||10
6647164|NCT02387268|7576145|FG000|COMPLETED|Overall Study||9
6647165|NCT02387268|7576145|FG000|NOT COMPLETED|Overall Study||1
6647166|NCT02387294|7576151|FG000|STARTED|Overall Study||60
6647167|NCT02387294|7576152|FG001|STARTED|Overall Study||60
6647168|NCT02387294|7576151|FG000|COMPLETED|Overall Study||60
6647169|NCT02387294|7576152|FG001|COMPLETED|Overall Study||60
6647170|NCT02387294|7576151|FG000|NOT COMPLETED|Overall Study||0
6647171|NCT02387294|7576152|FG001|NOT COMPLETED|Overall Study||0
6647172|NCT02387359|7576162|FG000|STARTED|Overall Study||354
6647173|NCT02387359|7576163|FG001|STARTED|Overall Study||351
6647174|NCT02387359|7576164|FG002|STARTED|Overall Study||349
6647175|NCT02387359|7576162|FG000|COMPLETED|Overall Study||295
6647176|NCT02387359|7576163|FG001|COMPLETED|Overall Study||309
6647177|NCT02387359|7576164|FG002|COMPLETED|Overall Study||293
6647178|NCT02387359|7576162|FG000|NOT COMPLETED|Overall Study||59
6647179|NCT02387359|7576163|FG001|NOT COMPLETED|Overall Study||42
6647180|NCT02387359|7576164|FG002|NOT COMPLETED|Overall Study||56
6647181|NCT02387372|7576174|FG000|STARTED|Overall Study||27
6647182|NCT02387372|7576175|FG001|STARTED|Overall Study||10
6549495|NCT01717768|7471150|FG010|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549496|NCT01717768|7471151|FG011|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549497|NCT01717768|7471140|FG000|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549498|NCT01717768|7471141|FG001|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549499|NCT01717768|7471142|FG002|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549500|NCT01717768|7471143|FG003|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549501|NCT01717768|7471144|FG004|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549502|NCT01717768|7471145|FG005|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549503|NCT01717768|7471146|FG006|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549504|NCT01717768|7471147|FG007|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
6549505|NCT01717768|7471148|FG008|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549506|NCT01717768|7471149|FG009|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
6549507|NCT01717768|7471150|FG010|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549508|NCT01717768|7471151|FG011|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
6549509|NCT01717859|7471177|FG000|STARTED|Overall Study||54
6549510|NCT01717859|7471177|FG000|3 Month|Overall Study||50
6549511|NCT01717859|7471177|FG000|COMPLETED|Overall Study||44
6549512|NCT01717859|7471177|FG000|NOT COMPLETED|Overall Study||10
6549513|NCT01717872|7471190|FG000|STARTED|Overall Study||25
6549514|NCT01717872|7471191|FG001|STARTED|Overall Study||25
6549515|NCT01717872|7471190|FG000|COMPLETED|Overall Study||25
6549516|NCT01717872|7471191|FG001|COMPLETED|Overall Study||25
6549517|NCT01717872|7471190|FG000|NOT COMPLETED|Overall Study||0
6549518|NCT01717872|7471191|FG001|NOT COMPLETED|Overall Study||0
6549519|NCT01717898|7471201|FG000|STARTED|Overall Study||6
6549520|NCT01717898|7471202|FG001|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
6549521|NCT01717898|7471203|FG002|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
6549522|NCT01717898|7471204|FG003|STARTED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
6549523|NCT01717898|7471201|FG000|COMPLETED|Overall Study|Study was terminated during Phase I, Dose level 1 due to toxicity.|0
6647183|NCT02387372|7576174|FG000|Treated|Overall Study||26
6647184|NCT02387372|7576175|FG001|Treated|Overall Study||10
6647185|NCT02387372|7576174|FG000|COMPLETED|Overall Study||26
6647186|NCT02387372|7576175|FG001|COMPLETED|Overall Study||10
6647187|NCT02387372|7576174|FG000|NOT COMPLETED|Overall Study||1
6647188|NCT02387372|7576175|FG001|NOT COMPLETED|Overall Study||0
6647189|NCT02387476|7576191|FG000|STARTED|Overall Study||25
6647190|NCT02387476|7576192|FG001|STARTED|Overall Study||22
6647191|NCT02387476|7576191|FG000|COMPLETED|Overall Study||19
6647192|NCT02387476|7576192|FG001|COMPLETED|Overall Study||17
6647193|NCT02387476|7576191|FG000|NOT COMPLETED|Overall Study||6
6647194|NCT02387476|7576192|FG001|NOT COMPLETED|Overall Study||5
6647195|NCT02387502|7576203|FG000|STARTED|Overall Study||40
6647196|NCT02387502|7576204|FG001|STARTED|Overall Study||40
6647197|NCT02387502|7576205|FG002|STARTED|Overall Study||40
6647198|NCT02387502|7576203|FG000|COMPLETED|Overall Study||40
6647199|NCT02387502|7576204|FG001|COMPLETED|Overall Study||40
6647200|NCT02387502|7576205|FG002|COMPLETED|Overall Study||40
6647201|NCT02387502|7576203|FG000|NOT COMPLETED|Overall Study||0
6647202|NCT02387502|7576204|FG001|NOT COMPLETED|Overall Study||0
6647203|NCT02387502|7576205|FG002|NOT COMPLETED|Overall Study||0
6647204|NCT02387554|7576217|FG000|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
6647205|NCT02387554|7576218|FG001|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
6647206|NCT02387554|7576219|FG002|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
6647207|NCT02387554|7576220|FG003|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
6647208|NCT02387554|7576217|FG000|COMPLETED|Overall Study||7
6647209|NCT02387554|7576218|FG001|COMPLETED|Overall Study||7
6647210|NCT02387554|7576219|FG002|COMPLETED|Overall Study||6
6647211|NCT02387554|7576220|FG003|COMPLETED|Overall Study||6
6647212|NCT02387554|7576217|FG000|NOT COMPLETED|Overall Study||3
6647213|NCT02387554|7576218|FG001|NOT COMPLETED|Overall Study||0
6647214|NCT02387554|7576219|FG002|NOT COMPLETED|Overall Study||2
6647215|NCT02387554|7576220|FG003|NOT COMPLETED|Overall Study||2
6647216|NCT02387580|7576236|FG000|STARTED|Overall Study||8
6647217|NCT02387580|7576237|FG001|STARTED|Overall Study||8
6647218|NCT02387580|7576238|FG002|STARTED|Overall Study||8
6647219|NCT02387580|7576239|FG003|STARTED|Overall Study||8
6647220|NCT02387580|7576240|FG004|STARTED|Overall Study||8
6647221|NCT02387580|7576241|FG005|STARTED|Overall Study||8
6647222|NCT02387580|7576236|FG000|COMPLETED|Overall Study||8
6647223|NCT02387580|7576237|FG001|COMPLETED|Overall Study||8
6549524|NCT01717898|7471202|FG001|COMPLETED|Overall Study||0
6549525|NCT01717898|7471203|FG002|COMPLETED|Overall Study||0
6549526|NCT01717898|7471204|FG003|COMPLETED|Overall Study||0
6549527|NCT01717898|7471201|FG000|NOT COMPLETED|Overall Study||6
6549528|NCT01717898|7471202|FG001|NOT COMPLETED|Overall Study||0
6549529|NCT01717898|7471203|FG002|NOT COMPLETED|Overall Study||0
6549530|NCT01717898|7471204|FG003|NOT COMPLETED|Overall Study||0
6549531|NCT01717976|7471216|FG000|STARTED|Overall Study||257
6549532|NCT01717976|7471217|FG001|STARTED|Overall Study||257
6549533|NCT01717976|7471216|FG000|COMPLETED|Overall Study||257
6549534|NCT01717976|7471217|FG001|COMPLETED|Overall Study||256
6549535|NCT01717976|7471216|FG000|NOT COMPLETED|Overall Study||0
6549536|NCT01717976|7471217|FG001|NOT COMPLETED|Overall Study||1
6549537|NCT01717989|7471223|FG000|STARTED|Overall Study||2248
6549538|NCT01717989|7471223|FG000|COMPLETED|Overall Study||1182
6549539|NCT01717989|7471223|FG000|NOT COMPLETED|Overall Study||1066
6549540|NCT01718028|7471244|FG000|STARTED|Overall Study||25
6549541|NCT01718028|7471245|FG001|STARTED|Overall Study||24
6549542|NCT01718028|7471244|FG000|COMPLETED|Overall Study||25
6549543|NCT01718028|7471245|FG001|COMPLETED|Overall Study||24
6549544|NCT01718028|7471244|FG000|NOT COMPLETED|Overall Study||0
6549545|NCT01718028|7471245|FG001|NOT COMPLETED|Overall Study||0
6549546|NCT01718353|7471253|FG000|STARTED|Overall Study||41
6549547|NCT01718353|7471254|FG001|STARTED|Overall Study||22
6549548|NCT01718353|7471253|FG000|Treated|Overall Study||39
6549549|NCT01718353|7471254|FG001|Treated|Overall Study||22
6549550|NCT01718353|7471253|FG000|Treated up to End of Cycle 4|Overall Study|7 participants discontinued before Cycle 5|32
6549551|NCT01718353|7471254|FG001|Treated up to End of Cycle 4|Overall Study|6 participants discontinued before Cycle 5|16
6549552|NCT01718353|7471253|FG000|Treated From Cycle 5|Overall Study|12 participants switched from Treatment A to B & 3 participants switched from Treatment B to A.|23
6549553|NCT01718353|7471254|FG001|Treated From Cycle 5|Overall Study|3 participants switched from Treatment B to A & 12 participants switched from Treatment A to B.|25
6549554|NCT01718353|7471253|FG000|COMPLETED|Overall Study|Participants at study cut-off, Adverse Event (AE), DP & consent withdrawn were considered completed.|29
6549555|NCT01718353|7471254|FG001|COMPLETED|Overall Study|Participants at study cut-off, AE, DP and consent withdrawn were considered completed.|17
6549556|NCT01718353|7471253|FG000|NOT COMPLETED|Overall Study||12
6549557|NCT01718353|7471254|FG001|NOT COMPLETED|Overall Study||5
6549558|NCT01718483|7471264|FG000|STARTED|Overall Study||191
6549559|NCT01718483|7471265|FG001|STARTED|Overall Study||192
6549560|NCT01718483|7471264|FG000|Treated|Overall Study||187
6549561|NCT01718483|7471265|FG001|Treated|Overall Study||192
6549562|NCT01718483|7471264|FG000|COMPLETED|Overall Study||157
6549563|NCT01718483|7471265|FG001|COMPLETED|Overall Study||158
6549564|NCT01718483|7471264|FG000|NOT COMPLETED|Overall Study||34
6549565|NCT01718483|7471265|FG001|NOT COMPLETED|Overall Study||34
6549566|NCT01718509|7471273|FG000|STARTED|Overall Study||195
6549567|NCT01718509|7471274|FG001|STARTED|Overall Study||195
6549568|NCT01718509|7471273|FG000|COMPLETED|Overall Study||147
6549569|NCT01718509|7471274|FG001|COMPLETED|Overall Study||147
6549570|NCT01718509|7471273|FG000|NOT COMPLETED|Overall Study||48
6549571|NCT01718509|7471274|FG001|NOT COMPLETED|Overall Study||48
6549572|NCT01718522|7471280|FG000|STARTED|Overall Study||75
6549573|NCT01718522|7471280|FG000|COMPLETED|Overall Study||67
6549574|NCT01718522|7471280|FG000|NOT COMPLETED|Overall Study||8
6549575|NCT01718535|7471297|FG000|STARTED|Overall Study||131
6549576|NCT01718535|7471298|FG001|STARTED|Overall Study||95
6549577|NCT01718535|7471299|FG002|STARTED|Overall Study||19
6549578|NCT01718535|7471300|FG003|STARTED|Overall Study||8
6549579|NCT01718535|7471301|FG004|STARTED|Overall Study||1
6549580|NCT01718535|7471302|FG005|STARTED|Overall Study||40
6549581|NCT01718535|7471303|FG006|STARTED|Overall Study||11
6549582|NCT01718535|7471304|FG007|STARTED|Overall Study||6
6549583|NCT01718535|7471305|FG008|STARTED|Overall Study||15
6549584|NCT01718535|7471306|FG009|STARTED|Overall Study||1
6549585|NCT01718535|7471297|FG000|First Pass|Overall Study||128
6549586|NCT01718535|7471298|FG001|First Pass|Overall Study||94
6549587|NCT01718535|7471299|FG002|First Pass|Overall Study||19
6549588|NCT01718535|7471300|FG003|First Pass|Overall Study||7
6549589|NCT01718535|7471301|FG004|First Pass|Overall Study||1
6549590|NCT01718535|7471302|FG005|First Pass|Overall Study||39
6549591|NCT01718535|7471303|FG006|First Pass|Overall Study||11
6549592|NCT01718535|7471304|FG007|First Pass|Overall Study||6
6549593|NCT01718535|7471305|FG008|First Pass|Overall Study||15
6549594|NCT01718535|7471306|FG009|First Pass|Overall Study||1
6549595|NCT01718535|7471297|FG000|COMPLETED|Overall Study||130
6549596|NCT01718535|7471298|FG001|COMPLETED|Overall Study||95
6549597|NCT01718535|7471299|FG002|COMPLETED|Overall Study||19
6549598|NCT01718535|7471300|FG003|COMPLETED|Overall Study||7
6549599|NCT01718535|7471301|FG004|COMPLETED|Overall Study||1
6549600|NCT01718535|7471302|FG005|COMPLETED|Overall Study||40
6549601|NCT01718535|7471303|FG006|COMPLETED|Overall Study||11
6549602|NCT01718535|7471304|FG007|COMPLETED|Overall Study||6
6549603|NCT01718535|7471305|FG008|COMPLETED|Overall Study||15
6549604|NCT01718535|7471306|FG009|COMPLETED|Overall Study||1
6549605|NCT01718535|7471297|FG000|NOT COMPLETED|Overall Study||1
6549606|NCT01718535|7471298|FG001|NOT COMPLETED|Overall Study||0
6549607|NCT01718535|7471299|FG002|NOT COMPLETED|Overall Study||0
6549608|NCT01718535|7471300|FG003|NOT COMPLETED|Overall Study||1
6549609|NCT01718535|7471301|FG004|NOT COMPLETED|Overall Study||0
6647224|NCT02387580|7576238|FG002|COMPLETED|Overall Study||8
6647225|NCT02387580|7576239|FG003|COMPLETED|Overall Study||7
6647226|NCT02387580|7576240|FG004|COMPLETED|Overall Study||8
6549610|NCT01718535|7471302|FG005|NOT COMPLETED|Overall Study||0
6549611|NCT01718535|7471303|FG006|NOT COMPLETED|Overall Study||0
6549612|NCT01718535|7471304|FG007|NOT COMPLETED|Overall Study||0
6549613|NCT01718535|7471305|FG008|NOT COMPLETED|Overall Study||0
6549614|NCT01718535|7471306|FG009|NOT COMPLETED|Overall Study||0
6549615|NCT01718691|7471330|FG000|STARTED|Overall Study||60
6549616|NCT01718691|7471331|FG001|STARTED|Overall Study||10
6549617|NCT01718691|7471330|FG000|COMPLETED|Overall Study||42
6647227|NCT02387580|7576241|FG005|COMPLETED|Overall Study||8
6647228|NCT02387580|7576236|FG000|NOT COMPLETED|Overall Study||0
6647229|NCT02387580|7576237|FG001|NOT COMPLETED|Overall Study||0
6549618|NCT01718691|7471331|FG001|COMPLETED|Overall Study||9
6549619|NCT01718691|7471330|FG000|NOT COMPLETED|Overall Study||18
6549620|NCT01718691|7471331|FG001|NOT COMPLETED|Overall Study||1
6549621|NCT01719003|7471350|FG000|STARTED|Overall Study||170
6549622|NCT01719003|7471351|FG001|STARTED|Overall Study||170
6549623|NCT01719003|7471352|FG002|STARTED|Overall Study||171
6549624|NCT01719003|7471353|FG003|STARTED|Overall Study||169
6549625|NCT01719003|7471354|FG004|STARTED|Overall Study||167
6549626|NCT01719003|7471355|FG005|STARTED|Overall Study||172
6549627|NCT01719003|7471356|FG006|STARTED|Overall Study||170
6549628|NCT01719003|7471357|FG007|STARTED|Overall Study||171
6549629|NCT01719003|7471358|FG008|STARTED|Overall Study||53
6549630|NCT01719003|7471350|FG000|COMPLETED|Overall Study||161
6549631|NCT01719003|7471351|FG001|COMPLETED|Overall Study||153
6549632|NCT01719003|7471352|FG002|COMPLETED|Overall Study||154
6549633|NCT01719003|7471353|FG003|COMPLETED|Overall Study||156
6549634|NCT01719003|7471354|FG004|COMPLETED|Overall Study||150
6549635|NCT01719003|7471355|FG005|COMPLETED|Overall Study||160
6549636|NCT01719003|7471356|FG006|COMPLETED|Overall Study||150
6549637|NCT01719003|7471357|FG007|COMPLETED|Overall Study||151
6549638|NCT01719003|7471358|FG008|COMPLETED|Overall Study||49
6549639|NCT01719003|7471350|FG000|NOT COMPLETED|Overall Study||9
6549640|NCT01719003|7471351|FG001|NOT COMPLETED|Overall Study||17
6549641|NCT01719003|7471352|FG002|NOT COMPLETED|Overall Study||17
6549642|NCT01719003|7471353|FG003|NOT COMPLETED|Overall Study||13
6549643|NCT01719003|7471354|FG004|NOT COMPLETED|Overall Study||17
6549644|NCT01719003|7471355|FG005|NOT COMPLETED|Overall Study||12
6549645|NCT01719003|7471356|FG006|NOT COMPLETED|Overall Study||20
6549646|NCT01719003|7471357|FG007|NOT COMPLETED|Overall Study||20
6549647|NCT01719003|7471358|FG008|NOT COMPLETED|Overall Study||4
6549648|NCT01719172|7471377|FG000|STARTED|Overall Study||30
6549649|NCT01719172|7471377|FG000|COMPLETED|Overall Study||28
6549650|NCT01719172|7471377|FG000|NOT COMPLETED|Overall Study||2
6549651|NCT01719224|7471381|FG000|STARTED|Intervention 1: Sleeping Position 1||18
6549652|NCT01719224|7471382|FG001|STARTED|Intervention 1: Sleeping Position 1||18
6549653|NCT01719224|7471381|FG000|COMPLETED|Intervention 1: Sleeping Position 1||14
6549654|NCT01719224|7471382|FG001|COMPLETED|Intervention 1: Sleeping Position 1||16
6549655|NCT01719224|7471381|FG000|NOT COMPLETED|Intervention 1: Sleeping Position 1||4
6549656|NCT01719224|7471382|FG001|NOT COMPLETED|Intervention 1: Sleeping Position 1||2
6549657|NCT01719224|7471381|FG000|STARTED|Intervention 2: Position Change(At 3.5h)||14
6549658|NCT01719224|7471382|FG001|STARTED|Intervention 2: Position Change(At 3.5h)||16
6549659|NCT01719224|7471381|FG000|COMPLETED|Intervention 2: Position Change(At 3.5h)||14
6549660|NCT01719224|7471382|FG001|COMPLETED|Intervention 2: Position Change(At 3.5h)||16
6549661|NCT01719224|7471381|FG000|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
6549662|NCT01719224|7471382|FG001|NOT COMPLETED|Intervention 2: Position Change(At 3.5h)||0
6549663|NCT01719367|7471391|FG000|STARTED|Overall Study||19
6549664|NCT01719367|7471392|FG001|STARTED|Overall Study||19
6549665|NCT01719367|7471391|FG000|COMPLETED|Overall Study||19
6549666|NCT01719367|7471392|FG001|COMPLETED|Overall Study||19
6647230|NCT02387580|7576238|FG002|NOT COMPLETED|Overall Study||0
6647231|NCT02387580|7576239|FG003|NOT COMPLETED|Overall Study||1
6647232|NCT02387580|7576240|FG004|NOT COMPLETED|Overall Study||0
6647233|NCT02387580|7576241|FG005|NOT COMPLETED|Overall Study||0
6647234|NCT02387710|7576257|FG000|STARTED|First Study Night||9
6647235|NCT02387710|7576258|FG001|STARTED|First Study Night||9
6647236|NCT02387710|7576257|FG000|COMPLETED|First Study Night||9
6647237|NCT02387710|7576258|FG001|COMPLETED|First Study Night||9
6647238|NCT02387710|7576257|FG000|NOT COMPLETED|First Study Night||0
6647239|NCT02387710|7576258|FG001|NOT COMPLETED|First Study Night||0
6647240|NCT02387710|7576257|FG000|STARTED|Second Study Night||9
6647241|NCT02387710|7576258|FG001|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
6647242|NCT02387710|7576257|FG000|COMPLETED|Second Study Night||9
6647243|NCT02387710|7576258|FG001|COMPLETED|Second Study Night||7
6647244|NCT02387710|7576257|FG000|NOT COMPLETED|Second Study Night||0
6647245|NCT02387710|7576258|FG001|NOT COMPLETED|Second Study Night||0
6647246|NCT02387749|7576266|FG000|STARTED|Overall Study||10
6647247|NCT02387749|7576266|FG000|COMPLETED|Overall Study||10
6647248|NCT02387749|7576266|FG000|NOT COMPLETED|Overall Study||0
6647249|NCT02387762|7576277|FG000|STARTED|Overall Study||16
6647250|NCT02387762|7576278|FG001|STARTED|Overall Study||15
6647251|NCT02387762|7576277|FG000|COMPLETED|Overall Study||15
6647252|NCT02387762|7576278|FG001|COMPLETED|Overall Study||15
6647253|NCT02387762|7576277|FG000|NOT COMPLETED|Overall Study||1
6647254|NCT02387762|7576278|FG001|NOT COMPLETED|Overall Study||0
6647255|NCT02387801|7576286|FG000|STARTED|Induction Dosing Period||6
6647256|NCT02387801|7576287|FG001|STARTED|Induction Dosing Period||6
6647257|NCT02387801|7576286|FG000|COMPLETED|Induction Dosing Period||6
6647258|NCT02387801|7576287|FG001|COMPLETED|Induction Dosing Period||6
6647259|NCT02387801|7576286|FG000|NOT COMPLETED|Induction Dosing Period||0
6647260|NCT02387801|7576287|FG001|NOT COMPLETED|Induction Dosing Period||0
6549667|NCT01719367|7471391|FG000|NOT COMPLETED|Overall Study||0
6549668|NCT01719367|7471392|FG001|NOT COMPLETED|Overall Study||0
6549669|NCT01719380|7471408|FG000|STARTED|Overall Study||2
6647261|NCT02387801|7576286|FG000|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
6549670|NCT01719380|7471409|FG001|STARTED|Overall Study||7
6549671|NCT01719380|7471410|FG002|STARTED|Overall Study||9
6549672|NCT01719380|7471411|FG003|STARTED|Overall Study||8
6549673|NCT01719380|7471412|FG004|STARTED|Overall Study||3
6549674|NCT01719380|7471413|FG005|STARTED|Overall Study||8
6549675|NCT01719380|7471414|FG006|STARTED|Overall Study||10
6549676|NCT01719380|7471415|FG007|STARTED|Overall Study||7
6549677|NCT01719380|7471416|FG008|STARTED|Overall Study||50
6549678|NCT01719380|7471417|FG009|STARTED|Overall Study||52
6549679|NCT01719380|7471408|FG000|COMPLETED|Overall Study||0
6549680|NCT01719380|7471409|FG001|COMPLETED|Overall Study||0
6549681|NCT01719380|7471410|FG002|COMPLETED|Overall Study||0
6549682|NCT01719380|7471411|FG003|COMPLETED|Overall Study||0
6549683|NCT01719380|7471412|FG004|COMPLETED|Overall Study||0
6549684|NCT01719380|7471413|FG005|COMPLETED|Overall Study||0
6549685|NCT01719380|7471414|FG006|COMPLETED|Overall Study||0
6549686|NCT01719380|7471415|FG007|COMPLETED|Overall Study||0
6549687|NCT01719380|7471416|FG008|COMPLETED|Overall Study||0
6549688|NCT01719380|7471417|FG009|COMPLETED|Overall Study||1
6549689|NCT01719380|7471408|FG000|NOT COMPLETED|Overall Study||2
6549690|NCT01719380|7471409|FG001|NOT COMPLETED|Overall Study||7
6549691|NCT01719380|7471410|FG002|NOT COMPLETED|Overall Study||9
6549692|NCT01719380|7471411|FG003|NOT COMPLETED|Overall Study||8
6549693|NCT01719380|7471412|FG004|NOT COMPLETED|Overall Study||3
6549694|NCT01719380|7471413|FG005|NOT COMPLETED|Overall Study||8
6549695|NCT01719380|7471414|FG006|NOT COMPLETED|Overall Study||10
6549696|NCT01719380|7471415|FG007|NOT COMPLETED|Overall Study||7
6549697|NCT01719380|7471416|FG008|NOT COMPLETED|Overall Study||50
6549698|NCT01719380|7471417|FG009|NOT COMPLETED|Overall Study||51
6549699|NCT01719653|7471451|FG000|STARTED|Overall Study||209
6549700|NCT01719653|7471452|FG001|STARTED|Overall Study||213
6549701|NCT01719653|7471453|FG002|STARTED|Overall Study||218
6549702|NCT01719653|7471454|FG003|STARTED|Overall Study||218
6549703|NCT01719653|7471455|FG004|STARTED|Overall Study||221
6549704|NCT01719653|7471451|FG000|COMPLETED|Overall Study||200
6549705|NCT01719653|7471452|FG001|COMPLETED|Overall Study||200
6549706|NCT01719653|7471453|FG002|COMPLETED|Overall Study||200
6549707|NCT01719653|7471454|FG003|COMPLETED|Overall Study||200
6549708|NCT01719653|7471455|FG004|COMPLETED|Overall Study||200
6549709|NCT01719653|7471451|FG000|NOT COMPLETED|Overall Study||9
6549710|NCT01719653|7471452|FG001|NOT COMPLETED|Overall Study||13
6549711|NCT01719653|7471453|FG002|NOT COMPLETED|Overall Study||18
6549712|NCT01719653|7471454|FG003|NOT COMPLETED|Overall Study||18
6549713|NCT01719653|7471455|FG004|NOT COMPLETED|Overall Study||21
6549714|NCT01719744|7471467|FG000|STARTED|Overall Study||25
6549715|NCT01719744|7471467|FG000|COMPLETED|Overall Study||25
6549716|NCT01719744|7471467|FG000|NOT COMPLETED|Overall Study||0
6549717|NCT01719757|7471471|FG000|STARTED|Overall Study||359
6549718|NCT01719757|7471471|FG000|COMPLETED|Overall Study||258
6549719|NCT01719757|7471471|FG000|NOT COMPLETED|Overall Study||101
6549720|NCT01719783|7471479|FG000|STARTED|Dose 1||30
6549721|NCT01719783|7471480|FG001|STARTED|Dose 1||10
6549722|NCT01719783|7471479|FG000|COMPLETED|Dose 1||30
6549723|NCT01719783|7471480|FG001|COMPLETED|Dose 1||10
6549724|NCT01719783|7471479|FG000|NOT COMPLETED|Dose 1||0
6549725|NCT01719783|7471480|FG001|NOT COMPLETED|Dose 1||0
6549726|NCT01719783|7471479|FG000|STARTED|Dose 2||30
6647262|NCT02387801|7576287|FG001|STARTED|Maintenance Dosing Period||12
6647263|NCT02387801|7576286|FG000|COMPLETED|Maintenance Dosing Period||0
6647264|NCT02387801|7576287|FG001|COMPLETED|Maintenance Dosing Period||12
6647265|NCT02387801|7576286|FG000|NOT COMPLETED|Maintenance Dosing Period||0
6647266|NCT02387801|7576287|FG001|NOT COMPLETED|Maintenance Dosing Period||0
6647267|NCT02387801|7576286|FG000|STARTED|Post-Treatment Follow-up||0
6647268|NCT02387801|7576287|FG001|STARTED|Post-Treatment Follow-up||12
6647269|NCT02387801|7576286|FG000|COMPLETED|Post-Treatment Follow-up||0
6647270|NCT02387801|7576287|FG001|COMPLETED|Post-Treatment Follow-up||12
6647271|NCT02387801|7576286|FG000|NOT COMPLETED|Post-Treatment Follow-up||0
6647272|NCT02387801|7576287|FG001|NOT COMPLETED|Post-Treatment Follow-up||0
6647273|NCT02387814|7576299|FG000|STARTED|Overall Study||10
6647274|NCT02387814|7576300|FG001|STARTED|Overall Study||9
6647275|NCT02387814|7576301|FG002|STARTED|Overall Study||10
6647276|NCT02387814|7576302|FG003|STARTED|Overall Study||6
6647277|NCT02387814|7576299|FG000|Received Abemaciclib|Overall Study||10
6647278|NCT02387814|7576300|FG001|Received Abemaciclib|Overall Study||9
6647279|NCT02387814|7576301|FG002|Received Abemaciclib|Overall Study||10
6647280|NCT02387814|7576302|FG003|Received Abemaciclib|Overall Study||6
6647281|NCT02387814|7576299|FG000|COMPLETED|Overall Study||10
6647282|NCT02387814|7576300|FG001|COMPLETED|Overall Study||9
6647283|NCT02387814|7576301|FG002|COMPLETED|Overall Study||10
6647284|NCT02387814|7576302|FG003|COMPLETED|Overall Study||6
6647285|NCT02387814|7576299|FG000|NOT COMPLETED|Overall Study||0
6647286|NCT02387814|7576300|FG001|NOT COMPLETED|Overall Study||0
6647287|NCT02387814|7576301|FG002|NOT COMPLETED|Overall Study||0
6647288|NCT02387814|7576302|FG003|NOT COMPLETED|Overall Study||0
6549727|NCT01719783|7471480|FG001|STARTED|Dose 2||10
6549728|NCT01719783|7471479|FG000|COMPLETED|Dose 2||29
6549729|NCT01719783|7471480|FG001|COMPLETED|Dose 2||10
6549730|NCT01719783|7471479|FG000|NOT COMPLETED|Dose 2||1
6549731|NCT01719783|7471480|FG001|NOT COMPLETED|Dose 2||0
6549732|NCT01719861|7471506|FG000|STARTED|Cycle 1||6
6549733|NCT01719861|7471506|FG000|COMPLETED|Cycle 1||2
6549734|NCT01719861|7471506|FG000|NOT COMPLETED|Cycle 1||4
6549735|NCT01719861|7471506|FG000|STARTED|Cycle 2||2
6549736|NCT01719861|7471506|FG000|COMPLETED|Cycle 2||1
6647289|NCT02387840|7576318|FG000|STARTED|Overall Study||4
6549737|NCT01719861|7471506|FG000|NOT COMPLETED|Cycle 2||1
6549738|NCT01719900|7471513|FG000|STARTED|Overall Study||29
6549739|NCT01719900|7471514|FG001|STARTED|Overall Study||24
6549740|NCT01719900|7471513|FG000|COMPLETED|Overall Study||22
6549741|NCT01719900|7471514|FG001|COMPLETED|Overall Study||22
6549742|NCT01719900|7471513|FG000|NOT COMPLETED|Overall Study||7
6549743|NCT01719900|7471514|FG001|NOT COMPLETED|Overall Study||2
6549744|NCT01720043|7471520|FG000|STARTED|Overall Study||8
6549745|NCT01720043|7471520|FG000|COMPLETED|Overall Study||7
6549746|NCT01720043|7471520|FG000|NOT COMPLETED|Overall Study||1
6549747|NCT01720069|7471527|FG000|STARTED|Overall Study||62
6549748|NCT01720069|7471528|FG001|STARTED|Overall Study||71
6549749|NCT01720069|7471529|FG002|STARTED|Overall Study||63
6549750|NCT01720069|7471527|FG000|Full Anaylsis Set|Overall Study||62
6549751|NCT01720069|7471528|FG001|Full Anaylsis Set|Overall Study||71
6549752|NCT01720069|7471529|FG002|Full Anaylsis Set|Overall Study||63
6549753|NCT01720069|7471527|FG000|COMPLETED|Overall Study||57
6549754|NCT01720069|7471528|FG001|COMPLETED|Overall Study||56
6549755|NCT01720069|7471529|FG002|COMPLETED|Overall Study||48
6549756|NCT01720069|7471527|FG000|NOT COMPLETED|Overall Study||5
6549757|NCT01720069|7471528|FG001|NOT COMPLETED|Overall Study||15
6549758|NCT01720069|7471529|FG002|NOT COMPLETED|Overall Study||15
6549759|NCT01720173|7471537|FG000|STARTED|Overall Study||30
6549760|NCT01720173|7471537|FG000|COMPLETED|Overall Study||30
6549761|NCT01720173|7471537|FG000|NOT COMPLETED|Overall Study||0
6549762|NCT01720225|7471543|FG000|STARTED|Overall Study||73
6549763|NCT01720225|7471544|FG001|STARTED|Overall Study||40
6549764|NCT01720225|7471543|FG000|COMPLETED|Overall Study||70
6549765|NCT01720225|7471544|FG001|COMPLETED|Overall Study||39
6549766|NCT01720225|7471543|FG000|NOT COMPLETED|Overall Study||3
6549767|NCT01720225|7471544|FG001|NOT COMPLETED|Overall Study||1
6549768|NCT01720251|7471553|FG000|STARTED|Overall Study||79
6549769|NCT01720251|7471554|FG001|STARTED|Overall Study||79
6549770|NCT01720251|7471555|FG002|STARTED|Overall Study||82
6549771|NCT01720251|7471553|FG000|COMPLETED|Overall Study||78
6549772|NCT01720251|7471554|FG001|COMPLETED|Overall Study||77
6549773|NCT01720251|7471555|FG002|COMPLETED|Overall Study||82
6549774|NCT01720251|7471553|FG000|NOT COMPLETED|Overall Study||1
6549775|NCT01720251|7471554|FG001|NOT COMPLETED|Overall Study||2
6549776|NCT01720251|7471555|FG002|NOT COMPLETED|Overall Study||0
6549777|NCT01720264|7471563|FG000|STARTED|Transplant With Sitagliptin for 15 Days||15
6549778|NCT01720264|7471563|FG000|COMPLETED|Transplant With Sitagliptin for 15 Days||14
6549779|NCT01720264|7471563|FG000|NOT COMPLETED|Transplant With Sitagliptin for 15 Days||1
6549780|NCT01720264|7471563|FG000|STARTED|Post-transplant (Day 16) to 1 Year||14
6549781|NCT01720264|7471563|FG000|COMPLETED|Post-transplant (Day 16) to 1 Year||2
6549782|NCT01720264|7471563|FG000|NOT COMPLETED|Post-transplant (Day 16) to 1 Year||12
6549783|NCT01720277|7471569|FG000|STARTED|Overall Study||1461
6549784|NCT01720277|7471570|FG001|STARTED|Overall Study||1496
6549785|NCT01720277|7471569|FG000|COMPLETED|Overall Study|intent-to-treat approach|958
6549786|NCT01720277|7471570|FG001|COMPLETED|Overall Study|intent-to-treat approach|938
6549787|NCT01720277|7471569|FG000|NOT COMPLETED|Overall Study||503
6549788|NCT01720277|7471570|FG001|NOT COMPLETED|Overall Study||558
6549789|NCT01720316|7471580|FG000|STARTED|Double-Blind Glycine Placebo Crossover||1
6549790|NCT01720316|7471581|FG001|STARTED|Double-Blind Glycine Placebo Crossover||1
6549791|NCT01720316|7471580|FG000|COMPLETED|Double-Blind Glycine Placebo Crossover||1
6549792|NCT01720316|7471581|FG001|COMPLETED|Double-Blind Glycine Placebo Crossover||1
6549793|NCT01720316|7471580|FG000|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
6549794|NCT01720316|7471581|FG001|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
6549795|NCT01720316|7471580|FG000|STARTED|Open-label Glycine||1
6549796|NCT01720316|7471581|FG001|STARTED|Open-label Glycine||1
6549797|NCT01720316|7471580|FG000|COMPLETED|Open-label Glycine||1
6549798|NCT01720316|7471581|FG001|COMPLETED|Open-label Glycine||1
6549799|NCT01720316|7471580|FG000|NOT COMPLETED|Open-label Glycine||0
6549800|NCT01720316|7471581|FG001|NOT COMPLETED|Open-label Glycine||0
6549801|NCT01720446|7471617|FG000|STARTED|Overall Study||826
6549802|NCT01720446|7471618|FG001|STARTED|Overall Study||822
6549803|NCT01720446|7471619|FG002|STARTED|Overall Study||824
6549804|NCT01720446|7471620|FG003|STARTED|Overall Study||825
6549805|NCT01720446|7471617|FG000|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|164
6549806|NCT01720446|7471618|FG001|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|186
6549807|NCT01720446|7471619|FG002|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|151
6549808|NCT01720446|7471620|FG003|Premature Treatment Discontinuers|Overall Study|Premature treatment discontinuers were allowed to continue participation in the trial.|159
6549809|NCT01720446|7471617|FG000|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|812
6549810|NCT01720446|7471618|FG001|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|811
6549811|NCT01720446|7471619|FG002|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|804
6549812|NCT01720446|7471620|FG003|COMPLETED|Overall Study|Subjects who did not permanently discontinue treatment prematurely.|805
6549813|NCT01720446|7471617|FG000|NOT COMPLETED|Overall Study||14
6549814|NCT01720446|7471618|FG001|NOT COMPLETED|Overall Study||11
6549815|NCT01720446|7471619|FG002|NOT COMPLETED|Overall Study||20
6549816|NCT01720446|7471620|FG003|NOT COMPLETED|Overall Study||20
6549817|NCT01720524|7471635|FG000|STARTED|Part A||29
6549818|NCT01720524|7471636|FG001|STARTED|Part A||30
6549819|NCT01720524|7471635|FG000|COMPLETED|Part A||22
6549820|NCT01720524|7471636|FG001|COMPLETED|Part A||18
6549821|NCT01720524|7471635|FG000|NOT COMPLETED|Part A||7
6549822|NCT01720524|7471636|FG001|NOT COMPLETED|Part A||12
6549823|NCT01720524|7471635|FG000|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|27
6549824|NCT01720524|7471636|FG001|STARTED|Part B|Participants who did not complete Part A could also participate in Part B.|26
6549825|NCT01720524|7471635|FG000|COMPLETED|Part B||22
6549826|NCT01720524|7471636|FG001|COMPLETED|Part B||17
6549827|NCT01720524|7471635|FG000|NOT COMPLETED|Part B||5
6549828|NCT01720524|7471636|FG001|NOT COMPLETED|Part B||9
6549829|NCT01720602|7471644|FG000|STARTED|Overall Study||15
6549830|NCT01720602|7471644|FG000|COMPLETED|Overall Study||10
6549831|NCT01720602|7471644|FG000|NOT COMPLETED|Overall Study||5
6549832|NCT01720667|7471650|FG000|STARTED|Overall Study||64
6549833|NCT01720667|7471651|FG001|STARTED|Overall Study||42
6549834|NCT01720667|7471650|FG000|Recieved Second Infusion of Same Drug|Overall Study||50
6549835|NCT01720667|7471651|FG001|Recieved Second Infusion of Same Drug|Overall Study||20
6549836|NCT01720667|7471650|FG000|Recieved Alternate Intervention|Overall Study||45
6549837|NCT01720667|7471651|FG001|Recieved Alternate Intervention|Overall Study||10
6549838|NCT01720667|7471650|FG000|Received 2nd Infusion of Alternate Drug|Overall Study||27
6549839|NCT01720667|7471651|FG001|Received 2nd Infusion of Alternate Drug|Overall Study||6
6549840|NCT01720667|7471650|FG000|Modified ITT|Overall Study||53
6549841|NCT01720667|7471651|FG001|Modified ITT|Overall Study||30
6549842|NCT01720667|7471650|FG000|COMPLETED|Overall Study||60
6549843|NCT01720667|7471651|FG001|COMPLETED|Overall Study||41
6549844|NCT01720667|7471650|FG000|NOT COMPLETED|Overall Study||4
6549845|NCT01720667|7471651|FG001|NOT COMPLETED|Overall Study||1
6549846|NCT01720797|7471661|FG000|STARTED|Overall Study||12
6549847|NCT01720797|7471662|FG001|STARTED|Overall Study||9
6549848|NCT01720797|7471661|FG000|COMPLETED|Overall Study||9
6549849|NCT01720797|7471662|FG001|COMPLETED|Overall Study||9
6549850|NCT01720797|7471661|FG000|NOT COMPLETED|Overall Study||3
6549851|NCT01720797|7471662|FG001|NOT COMPLETED|Overall Study||0
6549852|NCT01721044|7471671|FG000|STARTED|Treatment Period||176
6549853|NCT01721044|7471672|FG001|STARTED|Treatment Period|Randomized to 4mg (N=11) but received 2mg due to moderate renal impairment were included in 4mg arm|174
6549854|NCT01721044|7471673|FG002|STARTED|Treatment Period||177
6549855|NCT01721044|7471671|FG000|Rescue Week 16-24|Treatment Period||56
6549856|NCT01721044|7471672|FG001|Rescue Week 16-24|Treatment Period||38
6549857|NCT01721044|7471673|FG002|Rescue Week 16-24|Treatment Period||33
6549858|NCT01721044|7471671|FG000|COMPLETED|Treatment Period||144
6549859|NCT01721044|7471672|FG001|COMPLETED|Treatment Period||157
6549860|NCT01721044|7471673|FG002|COMPLETED|Treatment Period||158
6549861|NCT01721044|7471671|FG000|NOT COMPLETED|Treatment Period||32
6549862|NCT01721044|7471672|FG001|NOT COMPLETED|Treatment Period||17
6549863|NCT01721044|7471673|FG002|NOT COMPLETED|Treatment Period||19
6549864|NCT01721044|7471671|FG000|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
6549865|NCT01721044|7471672|FG001|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|9
6549866|NCT01721044|7471673|FG002|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|20
6549867|NCT01721044|7471671|FG000|COMPLETED|Follow Up||19
6549868|NCT01721044|7471672|FG001|COMPLETED|Follow Up||9
6743859|NCT03337139|7671912|FG000|COMPLETED|Phase I||77
6743860|NCT03337139|7671913|FG001|COMPLETED|Phase I||0
6743861|NCT03337139|7671912|FG000|NOT COMPLETED|Phase I||10
6549869|NCT01721044|7471673|FG002|COMPLETED|Follow Up||20
6549870|NCT01721044|7471671|FG000|NOT COMPLETED|Follow Up||0
6549871|NCT01721044|7471672|FG001|NOT COMPLETED|Follow Up||0
6549872|NCT01721044|7471673|FG002|NOT COMPLETED|Follow Up||0
6549873|NCT01721057|7471695|FG000|STARTED|Treatment Period||228
6647290|NCT02387840|7576319|FG001|STARTED|Overall Study||6
6647291|NCT02387840|7576320|FG002|STARTED|Overall Study||6
6647292|NCT02387840|7576321|FG003|STARTED|Overall Study||8
6647293|NCT02387840|7576322|FG004|STARTED|Overall Study||4
6647294|NCT02387840|7576323|FG005|STARTED|Overall Study||6
6647295|NCT02387840|7576318|FG000|COMPLETED|Overall Study||4
6647296|NCT02387840|7576319|FG001|COMPLETED|Overall Study||6
6647297|NCT02387840|7576320|FG002|COMPLETED|Overall Study||6
6647298|NCT02387840|7576321|FG003|COMPLETED|Overall Study||8
6647299|NCT02387840|7576322|FG004|COMPLETED|Overall Study||4
6647300|NCT02387840|7576323|FG005|COMPLETED|Overall Study||5
6743862|NCT03337139|7671913|FG001|NOT COMPLETED|Phase I||0
6743863|NCT03337139|7671912|FG000|STARTED|Phase II||38
6743864|NCT03337139|7671913|FG001|STARTED|Phase II||39
6743865|NCT03337139|7671912|FG000|26 Week Assessment|Phase II||34
6743866|NCT03337139|7671913|FG001|26 Week Assessment|Phase II||37
6743867|NCT03337139|7671912|FG000|COMPLETED|Phase II||33
6743868|NCT03337139|7671913|FG001|COMPLETED|Phase II||36
6743869|NCT03337139|7671912|FG000|NOT COMPLETED|Phase II||5
6549874|NCT01721057|7471696|FG001|STARTED|Treatment Period||229
6549875|NCT01721057|7471697|FG002|STARTED|Treatment Period||227
6549876|NCT01721057|7471698|FG003|STARTED|Treatment Period||0
6549877|NCT01721057|7471699|FG004|STARTED|Treatment Period||0
6647301|NCT02387840|7576318|FG000|NOT COMPLETED|Overall Study||0
6647302|NCT02387840|7576319|FG001|NOT COMPLETED|Overall Study||0
6647303|NCT02387840|7576320|FG002|NOT COMPLETED|Overall Study||0
6743870|NCT03337139|7671913|FG001|NOT COMPLETED|Phase II||3
6743871|NCT03337152|7671921|FG000|STARTED|Overall Study||24
6743872|NCT03337152|7671922|FG001|STARTED|Overall Study||24
6549878|NCT01721057|7471700|FG005|STARTED|Treatment Period||0
6549879|NCT01721057|7471701|FG006|STARTED|Treatment Period||0
6549880|NCT01721057|7471695|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||228
6549881|NCT01721057|7471696|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||229
6549882|NCT01721057|7471697|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||227
6549883|NCT01721057|7471698|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
6549884|NCT01721057|7471699|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
6549885|NCT01721057|7471700|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||0
6549886|NCT01721057|7471701|FG006|Received at Least 1 Dose of Study Drug|Treatment Period||0
6549887|NCT01721057|7471695|FG000|Rescued|Treatment Period||55
6549888|NCT01721057|7471696|FG001|Rescued|Treatment Period||21
6549889|NCT01721057|7471697|FG002|Rescued|Treatment Period||15
6549890|NCT01721057|7471698|FG003|Rescued|Treatment Period||0
6549891|NCT01721057|7471699|FG004|Rescued|Treatment Period||0
6549892|NCT01721057|7471700|FG005|Rescued|Treatment Period||0
6549893|NCT01721057|7471701|FG006|Rescued|Treatment Period||0
6549894|NCT01721057|7471695|FG000|COMPLETED|Treatment Period|"Completers include rescued participants."|200
6549895|NCT01721057|7471696|FG001|COMPLETED|Treatment Period|"Completers include rescued participants."|210
6549896|NCT01721057|7471697|FG002|COMPLETED|Treatment Period|"Completers include rescued participants."|204
6549897|NCT01721057|7471698|FG003|COMPLETED|Treatment Period||0
6549898|NCT01721057|7471699|FG004|COMPLETED|Treatment Period||0
6549899|NCT01721057|7471700|FG005|COMPLETED|Treatment Period||0
6549900|NCT01721057|7471701|FG006|COMPLETED|Treatment Period||0
6549901|NCT01721057|7471695|FG000|NOT COMPLETED|Treatment Period||28
6549902|NCT01721057|7471696|FG001|NOT COMPLETED|Treatment Period||19
6549903|NCT01721057|7471697|FG002|NOT COMPLETED|Treatment Period||23
6549904|NCT01721057|7471698|FG003|NOT COMPLETED|Treatment Period||0
6549905|NCT01721057|7471699|FG004|NOT COMPLETED|Treatment Period||0
6549906|NCT01721057|7471700|FG005|NOT COMPLETED|Treatment Period||0
6549907|NCT01721057|7471701|FG006|NOT COMPLETED|Treatment Period||0
6549908|NCT01721057|7471695|FG000|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6647304|NCT02387840|7576321|FG003|NOT COMPLETED|Overall Study||0
6647305|NCT02387840|7576322|FG004|NOT COMPLETED|Overall Study||0
6647306|NCT02387840|7576323|FG005|NOT COMPLETED|Overall Study||1
6647307|NCT02387853|7576343|FG000|STARTED|Overall Study||106
6647308|NCT02387853|7576343|FG000|COMPLETED|Overall Study||103
6647309|NCT02387853|7576343|FG000|NOT COMPLETED|Overall Study||3
6647310|NCT02387957|7576350|FG000|STARTED|Overall Study||21
6647311|NCT02387957|7576351|FG001|STARTED|Overall Study||21
6647312|NCT02387957|7576352|FG002|STARTED|Overall Study||21
6647313|NCT02387957|7576350|FG000|COMPLETED|Overall Study|The study was discontinued|0
6647314|NCT02387957|7576351|FG001|COMPLETED|Overall Study|The study was discontinued|0
6647315|NCT02387957|7576352|FG002|COMPLETED|Overall Study|The study was discontinued|1
6647316|NCT02387957|7576350|FG000|NOT COMPLETED|Overall Study||21
6647317|NCT02387957|7576351|FG001|NOT COMPLETED|Overall Study||21
6647318|NCT02387957|7576352|FG002|NOT COMPLETED|Overall Study||20
6647319|NCT02387970|7576362|FG000|STARTED|Overall Study||27
6647320|NCT02387970|7576363|FG001|STARTED|Overall Study||25
6647321|NCT02387970|7576362|FG000|COMPLETED|Overall Study||26
6647322|NCT02387970|7576363|FG001|COMPLETED|Overall Study||23
6647323|NCT02387970|7576362|FG000|NOT COMPLETED|Overall Study||1
6647324|NCT02387970|7576363|FG001|NOT COMPLETED|Overall Study||2
6647325|NCT02387983|7576369|FG000|STARTED|Overall Study||65
6647326|NCT02387983|7576369|FG000|COMPLETED|Overall Study||58
6647327|NCT02387983|7576369|FG000|NOT COMPLETED|Overall Study||7
6647328|NCT02388074|7576373|FG000|STARTED|Overall Study||25
6647329|NCT02388074|7576373|FG000|COMPLETED|Overall Study||22
6647330|NCT02388074|7576373|FG000|NOT COMPLETED|Overall Study||3
6647331|NCT02388165|7576379|FG000|STARTED|Overall Study||1726
6647332|NCT02388165|7576380|FG001|STARTED|Overall Study||1724
6647333|NCT02388165|7576379|FG000|Vaccinated (Safety Population)|Overall Study||1708
6647334|NCT02388165|7576380|FG001|Vaccinated (Safety Population)|Overall Study||1709
6647335|NCT02388165|7576379|FG000|COMPLETED|Overall Study||1599
6647336|NCT02388165|7576380|FG001|COMPLETED|Overall Study||1594
6647337|NCT02388165|7576379|FG000|NOT COMPLETED|Overall Study||127
6647338|NCT02388165|7576380|FG001|NOT COMPLETED|Overall Study||130
6647339|NCT02388191|7576388|FG000|STARTED|Overall Study||59
6647340|NCT02388191|7576389|FG001|STARTED|Overall Study||60
6647341|NCT02388191|7576388|FG000|COMPLETED|Overall Study||58
6647342|NCT02388191|7576389|FG001|COMPLETED|Overall Study||60
6647343|NCT02388191|7576388|FG000|NOT COMPLETED|Overall Study||1
6647344|NCT02388191|7576389|FG001|NOT COMPLETED|Overall Study||0
6647345|NCT02388269|7576399|FG000|STARTED|Overall Study||41
6647346|NCT02388269|7576400|FG001|STARTED|Overall Study||40
6647347|NCT02388269|7576401|FG002|STARTED|Overall Study||10
6647348|NCT02388269|7576399|FG000|Randomised Period|Overall Study||41
6647349|NCT02388269|7576400|FG001|Randomised Period|Overall Study||40
6647350|NCT02388269|7576401|FG002|Randomised Period|Overall Study||0
6647351|NCT02388269|7576399|FG000|Open Label|Overall Study||37
6647352|NCT02388269|7576400|FG001|Open Label|Overall Study||38
6647353|NCT02388269|7576401|FG002|Open Label|Overall Study||0
6647354|NCT02388269|7576399|FG000|COMPLETED|Overall Study||32
6647355|NCT02388269|7576400|FG001|COMPLETED|Overall Study||38
6647356|NCT02388269|7576401|FG002|COMPLETED|Overall Study||0
6647357|NCT02388269|7576399|FG000|NOT COMPLETED|Overall Study||9
6647358|NCT02388269|7576400|FG001|NOT COMPLETED|Overall Study||2
6549909|NCT01721057|7471696|FG001|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6549910|NCT01721057|7471697|FG002|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
6549911|NCT01721057|7471698|FG003|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
6549912|NCT01721057|7471699|FG004|STARTED|Rescue Period||0
6549913|NCT01721057|7471700|FG005|STARTED|Rescue Period||0
6549914|NCT01721057|7471701|FG006|STARTED|Rescue Period||0
6549915|NCT01721057|7471695|FG000|COMPLETED|Rescue Period||0
6549916|NCT01721057|7471696|FG001|COMPLETED|Rescue Period||0
6549917|NCT01721057|7471697|FG002|COMPLETED|Rescue Period||0
6549918|NCT01721057|7471698|FG003|COMPLETED|Rescue Period||88
6549919|NCT01721057|7471699|FG004|COMPLETED|Rescue Period||0
6549920|NCT01721057|7471700|FG005|COMPLETED|Rescue Period||0
6549921|NCT01721057|7471701|FG006|COMPLETED|Rescue Period||0
6549922|NCT01721057|7471695|FG000|NOT COMPLETED|Rescue Period||0
6549923|NCT01721057|7471696|FG001|NOT COMPLETED|Rescue Period||0
6549924|NCT01721057|7471697|FG002|NOT COMPLETED|Rescue Period||0
6549925|NCT01721057|7471698|FG003|NOT COMPLETED|Rescue Period||3
6549926|NCT01721057|7471699|FG004|NOT COMPLETED|Rescue Period||0
6549927|NCT01721057|7471700|FG005|NOT COMPLETED|Rescue Period||0
6549928|NCT01721057|7471701|FG006|NOT COMPLETED|Rescue Period||0
6549929|NCT01721057|7471695|FG000|STARTED|Follow Up||0
6549930|NCT01721057|7471696|FG001|STARTED|Follow Up||0
6549931|NCT01721057|7471697|FG002|STARTED|Follow Up||0
6549932|NCT01721057|7471698|FG003|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
6549933|NCT01721057|7471699|FG004|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
6549934|NCT01721057|7471700|FG005|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
6549935|NCT01721057|7471701|FG006|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
6549936|NCT01721057|7471695|FG000|COMPLETED|Follow Up||0
6549937|NCT01721057|7471696|FG001|COMPLETED|Follow Up||0
6549938|NCT01721057|7471697|FG002|COMPLETED|Follow Up||0
6549939|NCT01721057|7471698|FG003|COMPLETED|Follow Up||0
6549940|NCT01721057|7471699|FG004|COMPLETED|Follow Up||17
6549941|NCT01721057|7471700|FG005|COMPLETED|Follow Up||19
6549942|NCT01721057|7471701|FG006|COMPLETED|Follow Up||22
6549943|NCT01721057|7471695|FG000|NOT COMPLETED|Follow Up||0
6549944|NCT01721057|7471696|FG001|NOT COMPLETED|Follow Up||0
6549945|NCT01721057|7471697|FG002|NOT COMPLETED|Follow Up||0
6549946|NCT01721057|7471698|FG003|NOT COMPLETED|Follow Up||0
6549947|NCT01721057|7471699|FG004|NOT COMPLETED|Follow Up||0
6549948|NCT01721057|7471700|FG005|NOT COMPLETED|Follow Up||0
6549949|NCT01721057|7471701|FG006|NOT COMPLETED|Follow Up||0
6549950|NCT01721070|7471728|FG000|STARTED|SUF NT 15 mcg||19
6549951|NCT01721070|7471728|FG000|COMPLETED|SUF NT 15 mcg||19
6549952|NCT01721070|7471728|FG000|NOT COMPLETED|SUF NT 15 mcg||0
6549953|NCT01721070|7471728|FG000|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
6549954|NCT01721070|7471728|FG000|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
6549955|NCT01721070|7471728|FG000|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
6549956|NCT01721096|7471737|FG000|STARTED|Overall Study||323
6549957|NCT01721096|7471738|FG001|STARTED|Overall Study||213
6549958|NCT01721096|7471737|FG000|COMPLETED|Overall Study||3
6549959|NCT01721096|7471738|FG001|COMPLETED|Overall Study||9
6549960|NCT01721096|7471737|FG000|NOT COMPLETED|Overall Study||320
6549961|NCT01721096|7471738|FG001|NOT COMPLETED|Overall Study||204
6549962|NCT01721109|7471746|FG000|STARTED|Overall Study||50
6549963|NCT01721109|7471746|FG000|COMPLETED|Overall Study|34 participants transitioned to commercial Stribild or to an individual patient use (IPU) program|43
6549964|NCT01721109|7471746|FG000|NOT COMPLETED|Overall Study||7
6549965|NCT01721161|7471752|FG000|STARTED|Overall Study||41
6549966|NCT01721161|7471753|FG001|STARTED|Overall Study||41
6549967|NCT01721161|7471752|FG000|COMPLETED|Overall Study||37
6549968|NCT01721161|7471753|FG001|COMPLETED|Overall Study||34
6549969|NCT01721161|7471752|FG000|NOT COMPLETED|Overall Study||4
6549970|NCT01721161|7471753|FG001|NOT COMPLETED|Overall Study||7
6549971|NCT01721200|7471762|FG000|STARTED|Overall Study||62
6549972|NCT01721200|7471763|FG001|STARTED|Overall Study||63
6549973|NCT01721200|7471762|FG000|Completed 2 Week Follow-up|Overall Study||60
6549974|NCT01721200|7471763|FG001|Completed 2 Week Follow-up|Overall Study||61
6549975|NCT01721200|7471762|FG000|COMPLETED|Overall Study||59
6549976|NCT01721200|7471763|FG001|COMPLETED|Overall Study||58
6549977|NCT01721200|7471762|FG000|NOT COMPLETED|Overall Study||3
6549978|NCT01721200|7471763|FG001|NOT COMPLETED|Overall Study||5
6549979|NCT01721226|7471776|FG000|STARTED|Overall Study||55
6549980|NCT01721226|7471777|FG001|STARTED|Overall Study||57
6549981|NCT01721226|7471776|FG000|Baseline|Overall Study||53
6549982|NCT01721226|7471777|FG001|Baseline|Overall Study||57
6549983|NCT01721226|7471776|FG000|Week 12|Overall Study||48
6549984|NCT01721226|7471777|FG001|Week 12|Overall Study||53
6549985|NCT01721226|7471776|FG000|Week 24|Overall Study||50
6549986|NCT01721226|7471777|FG001|Week 24|Overall Study||50
6549987|NCT01721226|7471776|FG000|COMPLETED|Overall Study||50
6549988|NCT01721226|7471777|FG001|COMPLETED|Overall Study||50
6549989|NCT01721226|7471776|FG000|NOT COMPLETED|Overall Study||5
6549990|NCT01721226|7471777|FG001|NOT COMPLETED|Overall Study||7
6549991|NCT01721317|7471785|FG000|STARTED|Overall Study||2
6549992|NCT01721317|7471786|FG001|STARTED|Overall Study||4
6549993|NCT01721317|7471785|FG000|COMPLETED|Overall Study||0
6549994|NCT01721317|7471786|FG001|COMPLETED|Overall Study||0
6549995|NCT01721317|7471785|FG000|NOT COMPLETED|Overall Study||2
6549996|NCT01721317|7471786|FG001|NOT COMPLETED|Overall Study||4
6549997|NCT01721330|7471794|FG000|STARTED|Overall Study||1
6549998|NCT01721330|7471795|FG001|STARTED|Overall Study||2
6549999|NCT01721330|7471794|FG000|COMPLETED|Overall Study||1
6550000|NCT01721330|7471795|FG001|COMPLETED|Overall Study||1
6550001|NCT01721330|7471794|FG000|NOT COMPLETED|Overall Study||0
6550002|NCT01721330|7471795|FG001|NOT COMPLETED|Overall Study||1
6550003|NCT01721369|7471801|FG000|STARTED|Overall Study||581
6550004|NCT01721369|7471801|FG000|COMPLETED|Overall Study||569
6550005|NCT01721369|7471801|FG000|NOT COMPLETED|Overall Study||12
6550006|NCT01721408|7471807|FG000|STARTED|Overall Study|Number of participants treated.|232
6550007|NCT01721408|7471808|FG001|STARTED|Overall Study|Number of participants treated.|231
6550008|NCT01721408|7471807|FG000|COMPLETED|Overall Study||196
6550009|NCT01721408|7471808|FG001|COMPLETED|Overall Study||207
6550010|NCT01721408|7471807|FG000|NOT COMPLETED|Overall Study||36
6550011|NCT01721408|7471808|FG001|NOT COMPLETED|Overall Study||24
6550012|NCT01721447|7471814|FG000|STARTED|Overall Study||100
6550013|NCT01721447|7471814|FG000|COMPLETED|Overall Study||100
6550014|NCT01721447|7471814|FG000|NOT COMPLETED|Overall Study||0
6550015|NCT01721460|7471819|FG000|STARTED|Overall Study||6
6550016|NCT01721460|7471819|FG000|COMPLETED|Overall Study||5
6550017|NCT01721460|7471819|FG000|NOT COMPLETED|Overall Study||1
6550018|NCT01721473|7471831|FG000|STARTED|Overall Study||47
6550019|NCT01721473|7471832|FG001|STARTED|Overall Study||22
6550020|NCT01721473|7471833|FG002|STARTED|Overall Study||41
6550021|NCT01721473|7471834|FG003|STARTED|Overall Study||34
6550022|NCT01721473|7471835|FG004|STARTED|Overall Study||22
6550023|NCT01721473|7471836|FG005|STARTED|Overall Study||18
6550024|NCT01721473|7471831|FG000|COMPLETED|Overall Study||47
6550025|NCT01721473|7471832|FG001|COMPLETED|Overall Study||22
6550026|NCT01721473|7471833|FG002|COMPLETED|Overall Study||41
6550027|NCT01721473|7471834|FG003|COMPLETED|Overall Study||34
6550028|NCT01721473|7471835|FG004|COMPLETED|Overall Study||22
6550029|NCT01721473|7471836|FG005|COMPLETED|Overall Study||18
6550030|NCT01721473|7471831|FG000|NOT COMPLETED|Overall Study||0
6550031|NCT01721473|7471832|FG001|NOT COMPLETED|Overall Study||0
6550032|NCT01721473|7471833|FG002|NOT COMPLETED|Overall Study||0
6550033|NCT01721473|7471834|FG003|NOT COMPLETED|Overall Study||0
6550034|NCT01721473|7471835|FG004|NOT COMPLETED|Overall Study||0
6550035|NCT01721473|7471836|FG005|NOT COMPLETED|Overall Study||0
6550036|NCT01721486|7471847|FG000|STARTED|Overall Study||21
6550037|NCT01721486|7471848|FG001|STARTED|Overall Study||20
6550038|NCT01721486|7471847|FG000|COMPLETED|Overall Study||20
6550039|NCT01721486|7471848|FG001|COMPLETED|Overall Study||19
6550040|NCT01721486|7471847|FG000|NOT COMPLETED|Overall Study||1
6550041|NCT01721486|7471848|FG001|NOT COMPLETED|Overall Study||1
6550042|NCT01721564|7471854|FG000|STARTED|Overall Study||8
6550043|NCT01721564|7471854|FG000|COMPLETED|Overall Study||8
6550044|NCT01721564|7471854|FG000|NOT COMPLETED|Overall Study||0
6550045|NCT01721603|7471858|FG000|STARTED|Overall Study||2
6550046|NCT01721603|7471858|FG000|COMPLETED|Overall Study||2
6550047|NCT01721603|7471858|FG000|NOT COMPLETED|Overall Study||0
6550048|NCT01721681|7471862|FG000|STARTED|Overall Study||9
6550049|NCT01721681|7471862|FG000|COMPLETED|Overall Study||9
6550050|NCT01721681|7471862|FG000|NOT COMPLETED|Overall Study||0
6550051|NCT01721772|7471868|FG000|STARTED|Overall Study||206
6550052|NCT01721772|7471869|FG001|STARTED|Overall Study||205
6647359|NCT02388269|7576401|FG002|NOT COMPLETED|Overall Study||10
6647360|NCT02388295|7576428|FG000|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
6647361|NCT02388295|7576429|FG001|STARTED|Dose Escalation Week 1|Number randomized to treatment|19
6647362|NCT02388295|7576430|FG002|STARTED|Dose Escalation Week 1|Number randomized to treatment|20
6647363|NCT02388295|7576428|FG000|COMPLETED|Dose Escalation Week 1||17
6647364|NCT02388295|7576429|FG001|COMPLETED|Dose Escalation Week 1||16
6647365|NCT02388295|7576430|FG002|COMPLETED|Dose Escalation Week 1||18
6647366|NCT02388295|7576428|FG000|NOT COMPLETED|Dose Escalation Week 1||2
6647367|NCT02388295|7576429|FG001|NOT COMPLETED|Dose Escalation Week 1||3
6647368|NCT02388295|7576430|FG002|NOT COMPLETED|Dose Escalation Week 1||2
6647369|NCT02388295|7576428|FG000|STARTED|Dose Escalation Week 2||17
6647370|NCT02388295|7576429|FG001|STARTED|Dose Escalation Week 2||16
6647371|NCT02388295|7576430|FG002|STARTED|Dose Escalation Week 2||18
6647372|NCT02388295|7576428|FG000|COMPLETED|Dose Escalation Week 2||16
6647373|NCT02388295|7576429|FG001|COMPLETED|Dose Escalation Week 2||14
6647374|NCT02388295|7576430|FG002|COMPLETED|Dose Escalation Week 2||17
6647375|NCT02388295|7576428|FG000|NOT COMPLETED|Dose Escalation Week 2||1
6647376|NCT02388295|7576429|FG001|NOT COMPLETED|Dose Escalation Week 2||2
6550053|NCT01721772|7471868|FG000|COMPLETED|Overall Study|Continuing in treatment period|95
6550054|NCT01721772|7471869|FG001|COMPLETED|Overall Study|Continuing in treatment period|13
6550055|NCT01721772|7471868|FG000|NOT COMPLETED|Overall Study||111
6550056|NCT01721772|7471869|FG001|NOT COMPLETED|Overall Study||192
6550057|NCT01721837|7471875|FG000|STARTED|Overall Study||2120
6550058|NCT01721837|7471875|FG000|COMPLETED|Overall Study||2120
6550059|NCT01721837|7471875|FG000|NOT COMPLETED|Overall Study||0
6550060|NCT01721876|7471881|FG000|STARTED|Overall Study||222
6550061|NCT01721876|7471882|FG001|STARTED|Overall Study||444
6550062|NCT01721876|7471881|FG000|Treated|Overall Study||221
6647377|NCT02388295|7576430|FG002|NOT COMPLETED|Dose Escalation Week 2||1
6550063|NCT01721876|7471882|FG001|Treated|Overall Study||440
6550064|NCT01721876|7471881|FG000|COMPLETED|Overall Study||0
6550065|NCT01721876|7471882|FG001|COMPLETED|Overall Study||0
6550066|NCT01721876|7471881|FG000|NOT COMPLETED|Overall Study||222
6550067|NCT01721876|7471882|FG001|NOT COMPLETED|Overall Study||444
6550068|NCT01721954|7471890|FG000|STARTED|Overall Study||105
6550069|NCT01721954|7471891|FG001|STARTED|Overall Study||104
6550070|NCT01721954|7471890|FG000|COMPLETED|Overall Study||35
6550071|NCT01721954|7471891|FG001|COMPLETED|Overall Study||35
6550072|NCT01721954|7471890|FG000|NOT COMPLETED|Overall Study||70
6550073|NCT01721954|7471891|FG001|NOT COMPLETED|Overall Study||69
6550074|NCT01721967|7471897|FG000|STARTED|Overall Study||14
6550075|NCT01721967|7471897|FG000|COMPLETED|Overall Study||11
6550076|NCT01721967|7471897|FG000|NOT COMPLETED|Overall Study||3
6550077|NCT01722045|7471901|FG000|STARTED|Overall Study||154
6550078|NCT01722045|7471901|FG000|COMPLETED|Overall Study||126
6550079|NCT01722045|7471901|FG000|NOT COMPLETED|Overall Study||28
6550080|NCT01722071|7471905|FG000|STARTED|Overall Study||10
6550081|NCT01722071|7471906|FG001|STARTED|Overall Study||10
6550082|NCT01722071|7471905|FG000|COMPLETED|Overall Study||9
6550083|NCT01722071|7471906|FG001|COMPLETED|Overall Study||10
6550084|NCT01722071|7471905|FG000|NOT COMPLETED|Overall Study||1
6550085|NCT01722071|7471906|FG001|NOT COMPLETED|Overall Study||0
6550086|NCT01722097|7471914|FG000|STARTED|Overall Study||55
6550087|NCT01722097|7471915|FG001|STARTED|Overall Study||55
6550088|NCT01722097|7471914|FG000|COMPLETED|Overall Study||49
6550089|NCT01722097|7471915|FG001|COMPLETED|Overall Study||50
6550090|NCT01722097|7471914|FG000|NOT COMPLETED|Overall Study||6
6550091|NCT01722097|7471915|FG001|NOT COMPLETED|Overall Study||5
6550092|NCT01722162|7471923|FG000|STARTED|Overall Study||23
6550093|NCT01722162|7471924|FG001|STARTED|Overall Study||24
6550094|NCT01722162|7471923|FG000|COMPLETED|Overall Study||18
6550095|NCT01722162|7471924|FG001|COMPLETED|Overall Study||18
6550096|NCT01722162|7471923|FG000|NOT COMPLETED|Overall Study||5
6550097|NCT01722162|7471924|FG001|NOT COMPLETED|Overall Study||6
6550098|NCT01722266|7471934|FG000|STARTED|Overall Study||18
6550099|NCT01722266|7471935|FG001|STARTED|Overall Study||18
6550100|NCT01722266|7471936|FG002|STARTED|Overall Study||18
6550101|NCT01722266|7471937|FG003|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
6550102|NCT01722266|7471934|FG000|COMPLETED|Overall Study||17
6550103|NCT01722266|7471935|FG001|COMPLETED|Overall Study||15
6550104|NCT01722266|7471936|FG002|COMPLETED|Overall Study||13
6550105|NCT01722266|7471937|FG003|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
6550106|NCT01722266|7471934|FG000|NOT COMPLETED|Overall Study||1
6550107|NCT01722266|7471935|FG001|NOT COMPLETED|Overall Study||3
6550108|NCT01722266|7471936|FG002|NOT COMPLETED|Overall Study||5
6550109|NCT01722266|7471937|FG003|NOT COMPLETED|Overall Study||0
6550110|NCT01722292|7471950|FG000|STARTED|Overall Study||6
6550111|NCT01722292|7471951|FG001|STARTED|Overall Study||6
6550112|NCT01722292|7471952|FG002|STARTED|Overall Study||14
6550113|NCT01722292|7471950|FG000|Received at Least One Dose of Study Drug|Overall Study||6
6550114|NCT01722292|7471951|FG001|Received at Least One Dose of Study Drug|Overall Study||6
6550115|NCT01722292|7471952|FG002|Received at Least One Dose of Study Drug|Overall Study||14
6550116|NCT01722292|7471950|FG000|COMPLETED|Overall Study||6
6550117|NCT01722292|7471951|FG001|COMPLETED|Overall Study||6
6550118|NCT01722292|7471952|FG002|COMPLETED|Overall Study||14
6550119|NCT01722292|7471950|FG000|NOT COMPLETED|Overall Study||0
6550120|NCT01722292|7471951|FG001|NOT COMPLETED|Overall Study||0
6550121|NCT01722292|7471952|FG002|NOT COMPLETED|Overall Study||0
6550122|NCT01722318|7471982|FG000|STARTED|Overall Study||86
6550123|NCT01722318|7471983|FG001|STARTED|Overall Study||85
6647378|NCT02388295|7576428|FG000|STARTED|Treatment Weeks 3 to 12||16
6647379|NCT02388295|7576429|FG001|STARTED|Treatment Weeks 3 to 12||14
6647380|NCT02388295|7576430|FG002|STARTED|Treatment Weeks 3 to 12||17
6647381|NCT02388295|7576428|FG000|COMPLETED|Treatment Weeks 3 to 12||15
6647382|NCT02388295|7576429|FG001|COMPLETED|Treatment Weeks 3 to 12||13
6647383|NCT02388295|7576430|FG002|COMPLETED|Treatment Weeks 3 to 12||17
6647384|NCT02388295|7576428|FG000|NOT COMPLETED|Treatment Weeks 3 to 12||1
6647385|NCT02388295|7576429|FG001|NOT COMPLETED|Treatment Weeks 3 to 12||1
6647386|NCT02388295|7576430|FG002|NOT COMPLETED|Treatment Weeks 3 to 12||0
6647387|NCT02388321|7576440|FG000|STARTED|Overall Study||11
6647388|NCT02388321|7576441|FG001|STARTED|Overall Study||11
6647389|NCT02388321|7576440|FG000|COMPLETED|Overall Study||11
6647390|NCT02388321|7576441|FG001|COMPLETED|Overall Study||11
6647391|NCT02388321|7576440|FG000|NOT COMPLETED|Overall Study||0
6647392|NCT02388321|7576441|FG001|NOT COMPLETED|Overall Study||0
6647393|NCT02388347|7576452|FG000|STARTED|Overall Study||8
6647394|NCT02388347|7576453|FG001|STARTED|Overall Study||6
6647395|NCT02388347|7576454|FG002|STARTED|Overall Study||6
6647396|NCT02388347|7576455|FG003|STARTED|Overall Study||6
6647397|NCT02388347|7576456|FG004|STARTED|Overall Study||6
6647398|NCT02388347|7576452|FG000|COMPLETED|Overall Study||8
6647399|NCT02388347|7576453|FG001|COMPLETED|Overall Study||6
6550124|NCT01722318|7471984|FG002|STARTED|Overall Study||86
6550125|NCT01722318|7471985|FG003|STARTED|Overall Study||85
6550126|NCT01722318|7471986|FG004|STARTED|Overall Study||86
6550127|NCT01722318|7471982|FG000|COMPLETED|Overall Study||72
6550128|NCT01722318|7471983|FG001|COMPLETED|Overall Study||65
6550129|NCT01722318|7471984|FG002|COMPLETED|Overall Study||66
6550130|NCT01722318|7471985|FG003|COMPLETED|Overall Study||65
6550131|NCT01722318|7471986|FG004|COMPLETED|Overall Study||68
6550132|NCT01722318|7471982|FG000|NOT COMPLETED|Overall Study||14
6550133|NCT01722318|7471983|FG001|NOT COMPLETED|Overall Study||20
6550134|NCT01722318|7471984|FG002|NOT COMPLETED|Overall Study||20
6550135|NCT01722318|7471985|FG003|NOT COMPLETED|Overall Study||20
6550136|NCT01722318|7471986|FG004|NOT COMPLETED|Overall Study||18
6550137|NCT01722435|7471998|FG000|STARTED|Overall Study||78
6550138|NCT01722435|7471998|FG000|COMPLETED|Overall Study||78
6550139|NCT01722435|7471998|FG000|NOT COMPLETED|Overall Study||0
6550140|NCT01722487|7472008|FG000|STARTED|Overall Study||136
6550141|NCT01722487|7472009|FG001|STARTED|Overall Study||133
6550142|NCT01722487|7472008|FG000|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
6550143|NCT01722487|7472009|FG001|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
6550144|NCT01722487|7472008|FG000|NOT COMPLETED|Overall Study||2
6550145|NCT01722487|7472009|FG001|NOT COMPLETED|Overall Study||7
6550146|NCT01722552|7472016|FG000|STARTED|Overall Study|Number of subjects enrolled|120
6550147|NCT01722552|7472016|FG000|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
6550148|NCT01722552|7472016|FG000|NOT COMPLETED|Overall Study||4
6562697|NCT01802554|7485645|FG000|COMPLETED|Overall Study||43
6562698|NCT01802554|7485646|FG001|COMPLETED|Overall Study||43
6562699|NCT01802554|7485645|FG000|NOT COMPLETED|Overall Study||8
6562700|NCT01802554|7485646|FG001|NOT COMPLETED|Overall Study||6
6562701|NCT01802580|7485654|FG000|STARTED|Overall Study||20
6562702|NCT01802580|7485655|FG001|STARTED|Overall Study||20
6562703|NCT01802580|7485654|FG000|COMPLETED|Overall Study||11
6562704|NCT01802580|7485655|FG001|COMPLETED|Overall Study||9
6562705|NCT01802580|7485654|FG000|NOT COMPLETED|Overall Study||9
6647400|NCT02388347|7576454|FG002|COMPLETED|Overall Study||5
6647401|NCT02388347|7576455|FG003|COMPLETED|Overall Study||6
6647402|NCT02388347|7576456|FG004|COMPLETED|Overall Study||6
6647403|NCT02388347|7576452|FG000|NOT COMPLETED|Overall Study||0
6647404|NCT02388347|7576453|FG001|NOT COMPLETED|Overall Study||0
6647405|NCT02388347|7576454|FG002|NOT COMPLETED|Overall Study||1
6647406|NCT02388347|7576455|FG003|NOT COMPLETED|Overall Study||0
6647407|NCT02388347|7576456|FG004|NOT COMPLETED|Overall Study||0
6647408|NCT02388386|7576472|FG000|STARTED|Overall Study||10
6647409|NCT02388386|7576472|FG000|COMPLETED|Overall Study||10
6647410|NCT02388386|7576472|FG000|NOT COMPLETED|Overall Study||0
6655963|NCT02457247|7586100|FG002|STARTED|Period 2||68
6655964|NCT02457247|7586101|FG003|STARTED|Period 2||70
6655965|NCT02457247|7586098|FG000|COMPLETED|Period 2||64
6655966|NCT02457247|7586099|FG001|COMPLETED|Period 2||65
6655967|NCT02457247|7586100|FG002|COMPLETED|Period 2||68
6655968|NCT02457247|7586101|FG003|COMPLETED|Period 2||70
6655969|NCT02457247|7586098|FG000|NOT COMPLETED|Period 2||2
6655970|NCT02457247|7586099|FG001|NOT COMPLETED|Period 2||3
6655971|NCT02457247|7586100|FG002|NOT COMPLETED|Period 2||0
6655972|NCT02457247|7586101|FG003|NOT COMPLETED|Period 2||0
6655973|NCT02457260|7586120|FG000|STARTED|Overall Study||12
6655974|NCT02457260|7586121|FG001|STARTED|Overall Study||7
6655975|NCT02457260|7586122|FG002|STARTED|Overall Study||2
6655976|NCT02457260|7586120|FG000|COMPLETED|Overall Study||10
6655977|NCT02457260|7586121|FG001|COMPLETED|Overall Study||4
6655978|NCT02457260|7586122|FG002|COMPLETED|Overall Study||1
6655979|NCT02457260|7586120|FG000|NOT COMPLETED|Overall Study||2
6655980|NCT02457260|7586121|FG001|NOT COMPLETED|Overall Study||3
6655981|NCT02457260|7586122|FG002|NOT COMPLETED|Overall Study||1
6655982|NCT02457325|7586133|FG000|STARTED|First Intervention (1 Day)||25
6655983|NCT02457325|7586134|FG001|STARTED|First Intervention (1 Day)||25
6655984|NCT02457325|7586133|FG000|COMPLETED|First Intervention (1 Day)||23
6655985|NCT02457325|7586134|FG001|COMPLETED|First Intervention (1 Day)||23
6655986|NCT02457325|7586133|FG000|NOT COMPLETED|First Intervention (1 Day)||2
6655987|NCT02457325|7586134|FG001|NOT COMPLETED|First Intervention (1 Day)||2
6655988|NCT02457325|7586133|FG000|STARTED|Washout (1-2 Months)||23
6655989|NCT02457325|7586134|FG001|STARTED|Washout (1-2 Months)||23
6655990|NCT02457325|7586133|FG000|COMPLETED|Washout (1-2 Months)||23
6655991|NCT02457325|7586134|FG001|COMPLETED|Washout (1-2 Months)||23
6655992|NCT02457325|7586133|FG000|NOT COMPLETED|Washout (1-2 Months)||0
6655993|NCT02457325|7586134|FG001|NOT COMPLETED|Washout (1-2 Months)||0
6655994|NCT02457325|7586133|FG000|STARTED|Second Intervention (1 Day)||23
6655995|NCT02457325|7586134|FG001|STARTED|Second Intervention (1 Day)||23
6655996|NCT02457325|7586133|FG000|COMPLETED|Second Intervention (1 Day)||23
6655997|NCT02457325|7586134|FG001|COMPLETED|Second Intervention (1 Day)||23
6655998|NCT02457325|7586133|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6655999|NCT02457325|7586134|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6656000|NCT02457403|7586142|FG000|STARTED|Overall Study|34 participants|34
6656001|NCT02457403|7586143|FG001|STARTED|Overall Study|34 historic controls|34
6656002|NCT02457403|7586142|FG000|COMPLETED|Overall Study||34
6656003|NCT02457403|7586143|FG001|COMPLETED|Overall Study||34
6656004|NCT02457403|7586142|FG000|NOT COMPLETED|Overall Study||0
6562706|NCT01802580|7485655|FG001|NOT COMPLETED|Overall Study||11
6562707|NCT01802710|7485663|FG000|STARTED|From T0 to T1||76
6562708|NCT01802710|7485664|FG001|STARTED|From T0 to T1||82
6562709|NCT01802710|7485663|FG000|COMPLETED|From T0 to T1||60
6562710|NCT01802710|7485664|FG001|COMPLETED|From T0 to T1||72
6562711|NCT01802710|7485663|FG000|NOT COMPLETED|From T0 to T1||16
6562712|NCT01802710|7485664|FG001|NOT COMPLETED|From T0 to T1||10
6656005|NCT02457403|7586143|FG001|NOT COMPLETED|Overall Study||0
6656006|NCT02457520|7586151|FG000|STARTED|Active Treatment Phase|All subjects received treatment according to the same regimen.|201
6550149|NCT01722604|7472024|FG000|STARTED|Overall Study||129
6550150|NCT01722604|7472025|FG001|STARTED|Overall Study||129
6550151|NCT01722604|7472024|FG000|COMPLETED|Overall Study||123
6550152|NCT01722604|7472025|FG001|COMPLETED|Overall Study||120
6550153|NCT01722604|7472024|FG000|NOT COMPLETED|Overall Study||6
6550154|NCT01722604|7472025|FG001|NOT COMPLETED|Overall Study||9
6550155|NCT01722643|7472033|FG000|STARTED|Overall Study||30
6550156|NCT01722643|7472034|FG001|STARTED|Overall Study||31
6550157|NCT01722643|7472033|FG000|COMPLETED|Overall Study||30
6550158|NCT01722643|7472034|FG001|COMPLETED|Overall Study||30
6550159|NCT01722643|7472033|FG000|NOT COMPLETED|Overall Study||0
6550160|NCT01722643|7472034|FG001|NOT COMPLETED|Overall Study||1
6550161|NCT01722669|7472046|FG000|STARTED|Overall Study||5
6550162|NCT01722669|7472047|FG001|STARTED|Overall Study||5
6550163|NCT01722669|7472048|FG002|STARTED|Overall Study||5
6550164|NCT01722669|7472049|FG003|STARTED|Overall Study||5
6550165|NCT01722669|7472050|FG004|STARTED|Overall Study||10
6550166|NCT01722669|7472051|FG005|STARTED|Overall Study|Antiphospholipid Antibody (ARM D): 6 evaluable and 2 withdrew consent without any data collected|8
6550167|NCT01722669|7472046|FG000|COMPLETED|Overall Study||5
6550168|NCT01722669|7472047|FG001|COMPLETED|Overall Study||5
6550169|NCT01722669|7472048|FG002|COMPLETED|Overall Study||5
6550170|NCT01722669|7472049|FG003|COMPLETED|Overall Study||5
6550171|NCT01722669|7472050|FG004|COMPLETED|Overall Study||10
6550172|NCT01722669|7472051|FG005|COMPLETED|Overall Study||6
6550173|NCT01722669|7472046|FG000|NOT COMPLETED|Overall Study||0
6550174|NCT01722669|7472047|FG001|NOT COMPLETED|Overall Study||0
6550175|NCT01722669|7472048|FG002|NOT COMPLETED|Overall Study||0
6550176|NCT01722669|7472049|FG003|NOT COMPLETED|Overall Study||0
6550177|NCT01722669|7472050|FG004|NOT COMPLETED|Overall Study||0
6550178|NCT01722669|7472051|FG005|NOT COMPLETED|Overall Study||2
6550179|NCT01722734|7472074|FG000|STARTED|Overall Study||554
6550180|NCT01722734|7472075|FG001|STARTED|Overall Study||277
6550181|NCT01722734|7472076|FG002|STARTED|Overall Study||309
6550182|NCT01722734|7472074|FG000|COMPLETED|Overall Study||552
6550183|NCT01722734|7472075|FG001|COMPLETED|Overall Study||276
6550184|NCT01722734|7472076|FG002|COMPLETED|Overall Study||307
6550185|NCT01722734|7472074|FG000|NOT COMPLETED|Overall Study||2
6550186|NCT01722734|7472075|FG001|NOT COMPLETED|Overall Study||1
6550187|NCT01722734|7472076|FG002|NOT COMPLETED|Overall Study||2
6550188|NCT01722877|7472084|FG000|STARTED|Overall Study||29
6550189|NCT01722877|7472084|FG000|COMPLETED|Overall Study||27
6550190|NCT01722877|7472084|FG000|NOT COMPLETED|Overall Study||2
6647411|NCT02388568|7576482|FG000|STARTED|Overall Study||69
6647412|NCT02388568|7576483|FG001|STARTED|Overall Study||68
6647413|NCT02388568|7576482|FG000|COMPLETED|Overall Study||59
6647414|NCT02388568|7576483|FG001|COMPLETED|Overall Study||53
6647415|NCT02388568|7576482|FG000|NOT COMPLETED|Overall Study||10
6647416|NCT02388568|7576483|FG001|NOT COMPLETED|Overall Study||15
6550191|NCT01722994|7472092|FG000|STARTED|Overall Study||49
6550192|NCT01722994|7472093|FG001|STARTED|Overall Study||48
6550193|NCT01722994|7472092|FG000|COMPLETED|Overall Study||24
6550194|NCT01722994|7472093|FG001|COMPLETED|Overall Study||31
6550195|NCT01722994|7472092|FG000|NOT COMPLETED|Overall Study||25
6550196|NCT01722994|7472093|FG001|NOT COMPLETED|Overall Study||17
6550197|NCT01723072|7472103|FG000|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|44
6550198|NCT01723072|7472104|FG001|STARTED|Overall Study|28-week treatment period and 8-week follow-up period|47
6550199|NCT01723072|7472103|FG000|COMPLETED|Overall Study||33
6550200|NCT01723072|7472104|FG001|COMPLETED|Overall Study||26
6550201|NCT01723072|7472103|FG000|NOT COMPLETED|Overall Study||11
6550202|NCT01723072|7472104|FG001|NOT COMPLETED|Overall Study||21
6647417|NCT02388633|7576489|FG000|STARTED|Overall Study||8
6647418|NCT02388633|7576489|FG000|COMPLETED|Overall Study||8
6647419|NCT02388633|7576489|FG000|NOT COMPLETED|Overall Study||0
6647420|NCT02388646|7576496|FG000|STARTED|Overall Study||20
6647421|NCT02388646|7576497|FG001|STARTED|Overall Study||20
6647422|NCT02388646|7576498|FG002|STARTED|Overall Study||20
6647423|NCT02388646|7576496|FG000|COMPLETED|Overall Study||16
6647424|NCT02388646|7576497|FG001|COMPLETED|Overall Study||19
6647425|NCT02388646|7576498|FG002|COMPLETED|Overall Study||14
6647426|NCT02388646|7576496|FG000|NOT COMPLETED|Overall Study||4
6647427|NCT02388646|7576497|FG001|NOT COMPLETED|Overall Study||1
6647428|NCT02388646|7576498|FG002|NOT COMPLETED|Overall Study||6
6647429|NCT02388724|7576508|FG000|STARTED|Overall Study||244
6647430|NCT02388724|7576509|FG001|STARTED|Overall Study||237
6647431|NCT02388724|7576508|FG000|Safety Set: Randomized But Not Treated|Overall Study||0
6647432|NCT02388724|7576509|FG001|Safety Set: Randomized But Not Treated|Overall Study||2
6647433|NCT02388724|7576508|FG000|COMPLETED|Overall Study||232
6647434|NCT02388724|7576509|FG001|COMPLETED|Overall Study||224
6647435|NCT02388724|7576508|FG000|NOT COMPLETED|Overall Study||12
6647436|NCT02388724|7576509|FG001|NOT COMPLETED|Overall Study||13
6647437|NCT02388737|7576518|FG000|STARTED|Overall Study||235
6550203|NCT01723163|7472112|FG000|STARTED|Baseline||156
6550204|NCT01723163|7472113|FG001|STARTED|Baseline||154
6550205|NCT01723163|7472112|FG000|COMPLETED|Baseline||156
6550206|NCT01723163|7472113|FG001|COMPLETED|Baseline||154
6550207|NCT01723163|7472112|FG000|NOT COMPLETED|Baseline||0
6550208|NCT01723163|7472113|FG001|NOT COMPLETED|Baseline||0
6550209|NCT01723163|7472112|FG000|STARTED|Treatment Phase||156
6550210|NCT01723163|7472113|FG001|STARTED|Treatment Phase||154
6550211|NCT01723163|7472112|FG000|COMPLETED|Treatment Phase||137
6550212|NCT01723163|7472113|FG001|COMPLETED|Treatment Phase||147
6550213|NCT01723163|7472112|FG000|NOT COMPLETED|Treatment Phase||19
6550214|NCT01723163|7472113|FG001|NOT COMPLETED|Treatment Phase||7
6550215|NCT01723163|7472112|FG000|STARTED|3-Month Follow-up||137
6550216|NCT01723163|7472113|FG001|STARTED|3-Month Follow-up||147
6550217|NCT01723163|7472112|FG000|COMPLETED|3-Month Follow-up||124
6550218|NCT01723163|7472113|FG001|COMPLETED|3-Month Follow-up||128
6550219|NCT01723163|7472112|FG000|NOT COMPLETED|3-Month Follow-up||13
6550220|NCT01723163|7472113|FG001|NOT COMPLETED|3-Month Follow-up||19
6550221|NCT01723163|7472112|FG000|STARTED|6-Month Follow-up||136
6550222|NCT01723163|7472113|FG001|STARTED|6-Month Follow-up||147
6550223|NCT01723163|7472112|FG000|COMPLETED|6-Month Follow-up||118
6550224|NCT01723163|7472113|FG001|COMPLETED|6-Month Follow-up||132
6550225|NCT01723163|7472112|FG000|NOT COMPLETED|6-Month Follow-up||18
6647438|NCT02388737|7576519|FG001|STARTED|Overall Study||226
6647439|NCT02388737|7576520|FG002|STARTED|Overall Study||242
6647440|NCT02388737|7576518|FG000|COMPLETED|Overall Study||181
6647441|NCT02388737|7576519|FG001|COMPLETED|Overall Study||166
6647442|NCT02388737|7576520|FG002|COMPLETED|Overall Study||180
6647443|NCT02388737|7576518|FG000|NOT COMPLETED|Overall Study||54
6550226|NCT01723163|7472113|FG001|NOT COMPLETED|6-Month Follow-up||15
6550227|NCT01723163|7472112|FG000|STARTED|12-Month Follow-up||135
6550228|NCT01723163|7472113|FG001|STARTED|12-Month Follow-up||147
6550229|NCT01723163|7472112|FG000|COMPLETED|12-Month Follow-up||111
6550230|NCT01723163|7472113|FG001|COMPLETED|12-Month Follow-up||119
6550231|NCT01723163|7472112|FG000|NOT COMPLETED|12-Month Follow-up||24
6550232|NCT01723163|7472113|FG001|NOT COMPLETED|12-Month Follow-up||28
6550233|NCT01723228|7472121|FG000|STARTED|Overall Study||86
6550234|NCT01723228|7472122|FG001|STARTED|Overall Study||84
6550235|NCT01723228|7472121|FG000|COMPLETED|Overall Study||78
6550236|NCT01723228|7472122|FG001|COMPLETED|Overall Study||73
6550237|NCT01723228|7472121|FG000|NOT COMPLETED|Overall Study||8
6647444|NCT02388737|7576519|FG001|NOT COMPLETED|Overall Study||60
6647445|NCT02388737|7576520|FG002|NOT COMPLETED|Overall Study||62
6647446|NCT02388763|7576528|FG000|STARTED|Habitual, 10 Days of Wear||32
6647447|NCT02388763|7576529|FG001|STARTED|Habitual, 10 Days of Wear||32
6647448|NCT02388763|7576528|FG000|COMPLETED|Habitual, 10 Days of Wear||31
6647449|NCT02388763|7576529|FG001|COMPLETED|Habitual, 10 Days of Wear||31
6647450|NCT02388763|7576528|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||1
6647451|NCT02388763|7576529|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||1
6647452|NCT02388763|7576528|FG000|STARTED|Period 1, 10 Days of Wear||31
6647453|NCT02388763|7576529|FG001|STARTED|Period 1, 10 Days of Wear||31
6647454|NCT02388763|7576528|FG000|COMPLETED|Period 1, 10 Days of Wear||30
6647455|NCT02388763|7576529|FG001|COMPLETED|Period 1, 10 Days of Wear||30
6647456|NCT02388763|7576528|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||1
6647457|NCT02388763|7576529|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||1
6647458|NCT02388763|7576528|FG000|STARTED|Period 2, 10 Days of Wear||30
6647459|NCT02388763|7576529|FG001|STARTED|Period 2, 10 Days of Wear||30
6647460|NCT02388763|7576528|FG000|COMPLETED|Period 2, 10 Days of Wear||30
6647461|NCT02388763|7576529|FG001|COMPLETED|Period 2, 10 Days of Wear||30
6647462|NCT02388763|7576528|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||0
6647463|NCT02388763|7576529|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
6647464|NCT02388815|7576538|FG000|STARTED|Overall Study||89
6647465|NCT02388815|7576538|FG000|COMPLETED|Overall Study||85
6647466|NCT02388815|7576538|FG000|NOT COMPLETED|Overall Study||4
6647467|NCT02388880|7576542|FG000|STARTED|Overall Study||3
6647468|NCT02388880|7576542|FG000|COMPLETED|Overall Study||3
6647469|NCT02388880|7576542|FG000|NOT COMPLETED|Overall Study||0
6647470|NCT02388932|7576546|FG000|STARTED|Overall Study||3
6647471|NCT02388932|7576546|FG000|COMPLETED|Overall Study||2
6647472|NCT02388932|7576546|FG000|NOT COMPLETED|Overall Study||1
6647473|NCT02388997|7576553|FG000|STARTED|Overall Study||15
6647474|NCT02388997|7576554|FG001|STARTED|Overall Study||16
6647475|NCT02388997|7576553|FG000|COMPLETED|Overall Study||12
6647476|NCT02388997|7576554|FG001|COMPLETED|Overall Study||10
6647477|NCT02388997|7576553|FG000|NOT COMPLETED|Overall Study||3
6647478|NCT02388997|7576554|FG001|NOT COMPLETED|Overall Study||6
6647479|NCT02389088|7576560|FG000|STARTED|Overall Study - Phase I||9
6647480|NCT02389088|7576560|FG000|COMPLETED|Overall Study - Phase I||9
6647481|NCT02389088|7576560|FG000|NOT COMPLETED|Overall Study - Phase I||0
6647482|NCT02389088|7576560|FG000|STARTED|Phase II - All Study Participants||9
6647483|NCT02389088|7576560|FG000|COMPLETED|Phase II - All Study Participants||9
6647484|NCT02389088|7576560|FG000|NOT COMPLETED|Phase II - All Study Participants||0
6647485|NCT02389101|7576574|FG000|STARTED|Overall Study||21
6647486|NCT02389101|7576574|FG000|COMPLETED|Overall Study||21
6647487|NCT02389101|7576574|FG000|NOT COMPLETED|Overall Study||0
6647488|NCT02389361|7576580|FG000|STARTED|Overall Study||24
6647489|NCT02389361|7576581|FG001|STARTED|Overall Study||27
6647490|NCT02389361|7576580|FG000|COMPLETED|Overall Study||24
6647491|NCT02389361|7576581|FG001|COMPLETED|Overall Study||27
6647492|NCT02389361|7576580|FG000|NOT COMPLETED|Overall Study||0
6550238|NCT01723228|7472122|FG001|NOT COMPLETED|Overall Study||11
6550239|NCT01723254|7472136|FG000|STARTED|Overall Study||6
6550240|NCT01723254|7472137|FG001|STARTED|Overall Study||21
6647493|NCT02389361|7576581|FG001|NOT COMPLETED|Overall Study||0
6550241|NCT01723254|7472138|FG002|STARTED|Overall Study||20
6647494|NCT02389374|7576590|FG000|STARTED|Overall Study||55
6647495|NCT02389374|7576591|FG001|STARTED|Overall Study||115
6550242|NCT01723254|7472139|FG003|STARTED|Overall Study||20
6550243|NCT01723254|7472140|FG004|STARTED|Overall Study||20
6647496|NCT02389374|7576592|FG002|STARTED|Overall Study||11
6550244|NCT01723254|7472141|FG005|STARTED|Overall Study||20
6550245|NCT01723254|7472142|FG006|STARTED|Overall Study||20
6550246|NCT01723254|7472143|FG007|STARTED|Overall Study||63
6550247|NCT01723254|7472136|FG000|COMPLETED|Overall Study||5
6550248|NCT01723254|7472137|FG001|COMPLETED|Overall Study||18
6550249|NCT01723254|7472138|FG002|COMPLETED|Overall Study||17
6550250|NCT01723254|7472139|FG003|COMPLETED|Overall Study||18
6550251|NCT01723254|7472140|FG004|COMPLETED|Overall Study||18
6550252|NCT01723254|7472141|FG005|COMPLETED|Overall Study||18
6550253|NCT01723254|7472142|FG006|COMPLETED|Overall Study||19
6550254|NCT01723254|7472143|FG007|COMPLETED|Overall Study||60
6550255|NCT01723254|7472136|FG000|NOT COMPLETED|Overall Study||1
6550256|NCT01723254|7472137|FG001|NOT COMPLETED|Overall Study||3
6550257|NCT01723254|7472138|FG002|NOT COMPLETED|Overall Study||3
6550258|NCT01723254|7472139|FG003|NOT COMPLETED|Overall Study||2
6550259|NCT01723254|7472140|FG004|NOT COMPLETED|Overall Study||2
6550260|NCT01723254|7472141|FG005|NOT COMPLETED|Overall Study||2
6550261|NCT01723254|7472142|FG006|NOT COMPLETED|Overall Study||1
6550262|NCT01723254|7472143|FG007|NOT COMPLETED|Overall Study||3
6550263|NCT01723384|7472163|FG000|STARTED|Overall Study||15
6550264|NCT01723384|7472164|FG001|STARTED|Overall Study||15
6550265|NCT01723384|7472163|FG000|COMPLETED|Overall Study||15
6647497|NCT02389374|7576590|FG000|COMPLETED|Overall Study||46
6647498|NCT02389374|7576591|FG001|COMPLETED|Overall Study||87
6647499|NCT02389374|7576592|FG002|COMPLETED|Overall Study||10
6647500|NCT02389374|7576590|FG000|NOT COMPLETED|Overall Study||9
6647501|NCT02389374|7576591|FG001|NOT COMPLETED|Overall Study||28
6647502|NCT02389374|7576592|FG002|NOT COMPLETED|Overall Study||1
6647503|NCT02389452|7576601|FG000|STARTED|Overall Study||394
6647504|NCT02389452|7576601|FG000|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
6647505|NCT02389452|7576601|FG000|COMPLETED|Overall Study||369
6647506|NCT02389452|7576601|FG000|NOT COMPLETED|Overall Study||25
6647507|NCT02389621|7576608|FG000|STARTED|Treatment Period||108
6647508|NCT02389621|7576609|FG001|STARTED|Treatment Period||107
6647509|NCT02389621|7576608|FG000|Received Study Drug|Treatment Period||107
6647510|NCT02389621|7576609|FG001|Received Study Drug|Treatment Period||107
6647511|NCT02389621|7576608|FG000|COMPLETED|Treatment Period||107
6647512|NCT02389621|7576609|FG001|COMPLETED|Treatment Period||106
6647513|NCT02389621|7576608|FG000|NOT COMPLETED|Treatment Period||1
6647514|NCT02389621|7576609|FG001|NOT COMPLETED|Treatment Period||1
6647515|NCT02389621|7576608|FG000|STARTED|Posttreatment Period||107
6647516|NCT02389621|7576609|FG001|STARTED|Posttreatment Period||106
6647517|NCT02389621|7576608|FG000|COMPLETED|Posttreatment Period||98
6647518|NCT02389621|7576609|FG001|COMPLETED|Posttreatment Period||102
6647519|NCT02389621|7576608|FG000|NOT COMPLETED|Posttreatment Period||9
6647520|NCT02389621|7576609|FG001|NOT COMPLETED|Posttreatment Period||4
6647521|NCT02389725|7576621|FG000|STARTED|Overall Study||59
6647522|NCT02389725|7576622|FG001|STARTED|Overall Study||60
6647523|NCT02389725|7576621|FG000|COMPLETED|Overall Study||59
6647524|NCT02389725|7576622|FG001|COMPLETED|Overall Study||60
6647525|NCT02389725|7576621|FG000|NOT COMPLETED|Overall Study||0
6647526|NCT02389725|7576622|FG001|NOT COMPLETED|Overall Study||0
6647527|NCT02389738|7576630|FG000|STARTED|Overall Study||6
6647528|NCT02389738|7576630|FG000|COMPLETED|Overall Study||5
6647529|NCT02389738|7576630|FG000|NOT COMPLETED|Overall Study||1
6647530|NCT02389764|7576634|FG000|STARTED|Overall Study||9
6647531|NCT02389764|7576634|FG000|COMPLETED|Overall Study||0
6647532|NCT02389764|7576634|FG000|NOT COMPLETED|Overall Study||9
6647533|NCT02389816|7576641|FG000|STARTED|Overall Study||164
6647534|NCT02389816|7576642|FG001|STARTED|Overall Study||165
6647535|NCT02389816|7576643|FG002|STARTED|Overall Study||164
6647536|NCT02389816|7576641|FG000|COMPLETED|Overall Study||149
6647537|NCT02389816|7576642|FG001|COMPLETED|Overall Study||152
6647538|NCT02389816|7576643|FG002|COMPLETED|Overall Study||152
6647539|NCT02389816|7576641|FG000|NOT COMPLETED|Overall Study||15
6647540|NCT02389816|7576642|FG001|NOT COMPLETED|Overall Study||13
6647541|NCT02389816|7576643|FG002|NOT COMPLETED|Overall Study||12
6647542|NCT02389829|7576653|FG000|STARTED|Overall Study||64
6647543|NCT02389829|7576654|FG001|STARTED|Overall Study||63
6647544|NCT02389829|7576653|FG000|COMPLETED|Overall Study||64
6647545|NCT02389829|7576654|FG001|COMPLETED|Overall Study||62
6647546|NCT02389829|7576653|FG000|NOT COMPLETED|Overall Study||0
6647547|NCT02389829|7576654|FG001|NOT COMPLETED|Overall Study||1
6647548|NCT02389881|7576667|FG000|STARTED|Overall Study||6
6647549|NCT02389881|7576668|FG001|STARTED|Overall Study||6
6647550|NCT02389881|7576669|FG002|STARTED|Overall Study||6
6647551|NCT02389881|7576670|FG003|STARTED|Overall Study||6
6647552|NCT02389881|7576671|FG004|STARTED|Overall Study||6
6647553|NCT02389881|7576672|FG005|STARTED|Overall Study||8
6647554|NCT02389881|7576673|FG006|STARTED|Overall Study||2
6647555|NCT02389881|7576667|FG000|COMPLETED|Overall Study||6
6647556|NCT02389881|7576668|FG001|COMPLETED|Overall Study||6
6550266|NCT01723384|7472164|FG001|COMPLETED|Overall Study||15
6550267|NCT01723384|7472163|FG000|NOT COMPLETED|Overall Study||0
6550268|NCT01723384|7472164|FG001|NOT COMPLETED|Overall Study||0
6550269|NCT01723397|7472172|FG000|STARTED|Study Period 1||7
6550270|NCT01723397|7472173|FG001|STARTED|Study Period 1||7
6550271|NCT01723397|7472172|FG000|COMPLETED|Study Period 1||7
6550272|NCT01723397|7472173|FG001|COMPLETED|Study Period 1||6
6550273|NCT01723397|7472172|FG000|NOT COMPLETED|Study Period 1||0
6550274|NCT01723397|7472173|FG001|NOT COMPLETED|Study Period 1||1
6550275|NCT01723397|7472172|FG000|STARTED|Washout||7
6550276|NCT01723397|7472173|FG001|STARTED|Washout||6
6647557|NCT02389881|7576669|FG002|COMPLETED|Overall Study||6
6647558|NCT02389881|7576670|FG003|COMPLETED|Overall Study||6
6647559|NCT02389881|7576671|FG004|COMPLETED|Overall Study||6
6550277|NCT01723397|7472172|FG000|COMPLETED|Washout||7
6550278|NCT01723397|7472173|FG001|COMPLETED|Washout||6
6550279|NCT01723397|7472172|FG000|NOT COMPLETED|Washout||0
6550280|NCT01723397|7472173|FG001|NOT COMPLETED|Washout||0
6550281|NCT01723397|7472172|FG000|STARTED|Study Period 2||7
6550282|NCT01723397|7472173|FG001|STARTED|Study Period 2||6
6550283|NCT01723397|7472172|FG000|COMPLETED|Study Period 2||7
6550284|NCT01723397|7472173|FG001|COMPLETED|Study Period 2||5
6550285|NCT01723397|7472172|FG000|NOT COMPLETED|Study Period 2||0
6550286|NCT01723397|7472173|FG001|NOT COMPLETED|Study Period 2||1
6550287|NCT01723514|7472187|FG000|STARTED|Overall Study||8
6550288|NCT01723514|7472188|FG001|STARTED|Overall Study||6
6550289|NCT01723514|7472189|FG002|STARTED|Overall Study||6
6550290|NCT01723514|7472190|FG003|STARTED|Overall Study||6
6550291|NCT01723514|7472191|FG004|STARTED|Overall Study||6
6550292|NCT01723514|7472192|FG005|STARTED|Overall Study||4
6550293|NCT01723514|7472193|FG006|STARTED|Overall Study||6
6550294|NCT01723514|7472194|FG007|STARTED|Overall Study||6
6550295|NCT01723514|7472187|FG000|COMPLETED|Overall Study||8
6647560|NCT02389881|7576672|FG005|COMPLETED|Overall Study||8
6647561|NCT02389881|7576673|FG006|COMPLETED|Overall Study||2
6647562|NCT02389881|7576667|FG000|NOT COMPLETED|Overall Study||0
6647563|NCT02389881|7576668|FG001|NOT COMPLETED|Overall Study||0
6647564|NCT02389881|7576669|FG002|NOT COMPLETED|Overall Study||0
6647565|NCT02389881|7576670|FG003|NOT COMPLETED|Overall Study||0
6647566|NCT02389881|7576671|FG004|NOT COMPLETED|Overall Study||0
6647567|NCT02389881|7576672|FG005|NOT COMPLETED|Overall Study||0
6647568|NCT02389881|7576673|FG006|NOT COMPLETED|Overall Study||0
6647569|NCT02389894|7576692|FG000|STARTED|Overall Study||133
6647570|NCT02389894|7576693|FG001|STARTED|Overall Study||118
6647571|NCT02389894|7576694|FG002|STARTED|Overall Study||132
6647572|NCT02389894|7576692|FG000|COMPLETED|Overall Study||125
6647573|NCT02389894|7576693|FG001|COMPLETED|Overall Study||108
6647574|NCT02389894|7576694|FG002|COMPLETED|Overall Study||123
6647575|NCT02389894|7576692|FG000|NOT COMPLETED|Overall Study||8
6647576|NCT02389894|7576693|FG001|NOT COMPLETED|Overall Study||10
6647577|NCT02389894|7576694|FG002|NOT COMPLETED|Overall Study||9
6647584|NCT02389959|7576713|FG000|STARTED|Overall Study||20
6647585|NCT02389959|7576714|FG001|STARTED|Overall Study||20
6647586|NCT02389959|7576713|FG000|COMPLETED|Overall Study||18
6647587|NCT02389959|7576714|FG001|COMPLETED|Overall Study||19
6647588|NCT02389959|7576713|FG000|NOT COMPLETED|Overall Study||2
6647589|NCT02389959|7576714|FG001|NOT COMPLETED|Overall Study||1
6647590|NCT02389998|7576722|FG000|STARTED|Overall Study||16
6647591|NCT02389998|7576723|FG001|STARTED|Overall Study||15
6647592|NCT02389998|7576722|FG000|COMPLETED|Overall Study||15
6647593|NCT02389998|7576723|FG001|COMPLETED|Overall Study||15
6647594|NCT02389998|7576722|FG000|NOT COMPLETED|Overall Study||1
6647595|NCT02389998|7576723|FG001|NOT COMPLETED|Overall Study||0
6647596|NCT02390050|7576735|FG000|STARTED|Overall Study||72
6647597|NCT02390050|7576736|FG001|STARTED|Overall Study||72
6647598|NCT02390050|7576737|FG002|STARTED|Overall Study||72
6647599|NCT02390050|7576738|FG003|STARTED|Overall Study||76
6647600|NCT02390050|7576735|FG000|COMPLETED|Overall Study||65
6647601|NCT02390050|7576736|FG001|COMPLETED|Overall Study||67
6647602|NCT02390050|7576737|FG002|COMPLETED|Overall Study||68
6647603|NCT02390050|7576738|FG003|COMPLETED|Overall Study||69
6647604|NCT02390050|7576735|FG000|NOT COMPLETED|Overall Study||7
6647605|NCT02390050|7576736|FG001|NOT COMPLETED|Overall Study||5
6647606|NCT02390050|7576737|FG002|NOT COMPLETED|Overall Study||4
6647607|NCT02390050|7576738|FG003|NOT COMPLETED|Overall Study||7
6647608|NCT02390076|7576751|FG000|STARTED|Overall Study||18
6647609|NCT02390076|7576752|FG001|STARTED|Overall Study||18
6647610|NCT02390076|7576753|FG002|STARTED|Overall Study||15
6647611|NCT02390076|7576751|FG000|COMPLETED|Overall Study||16
6647612|NCT02390076|7576752|FG001|COMPLETED|Overall Study||17
6647613|NCT02390076|7576753|FG002|COMPLETED|Overall Study||11
6647614|NCT02390076|7576751|FG000|NOT COMPLETED|Overall Study||2
6550296|NCT01723514|7472188|FG001|COMPLETED|Overall Study||6
6550297|NCT01723514|7472189|FG002|COMPLETED|Overall Study||6
6647615|NCT02390076|7576752|FG001|NOT COMPLETED|Overall Study||1
6647616|NCT02390076|7576753|FG002|NOT COMPLETED|Overall Study||4
6647617|NCT02390167|7576761|FG000|STARTED|Overall Study||376
6647618|NCT02390167|7576761|FG000|With Diabetes|Overall Study||333
6647619|NCT02390167|7576761|FG000|Without Diabetes|Overall Study||43
6647620|NCT02390167|7576761|FG000|COMPLETED|Overall Study||375
6647621|NCT02390167|7576761|FG000|NOT COMPLETED|Overall Study||1
6647622|NCT02390219|7576769|FG000|STARTED|Overall Study||46
6647623|NCT02390219|7576769|FG000|COMPLETED|Overall Study||33
6550298|NCT01723514|7472190|FG003|COMPLETED|Overall Study||6
6550299|NCT01723514|7472191|FG004|COMPLETED|Overall Study||6
6550300|NCT01723514|7472192|FG005|COMPLETED|Overall Study||4
6550301|NCT01723514|7472193|FG006|COMPLETED|Overall Study||6
6647624|NCT02390219|7576769|FG000|NOT COMPLETED|Overall Study||13
6647625|NCT02390557|7576776|FG000|STARTED|Wave 1||160
6647626|NCT02390557|7576777|FG001|STARTED|Wave 1||156
6647627|NCT02390557|7576778|FG002|STARTED|Wave 1||135
6647628|NCT02390557|7576776|FG000|COMPLETED|Wave 1||160
6647629|NCT02390557|7576777|FG001|COMPLETED|Wave 1||156
6647630|NCT02390557|7576778|FG002|COMPLETED|Wave 1||135
6647631|NCT02390557|7576776|FG000|NOT COMPLETED|Wave 1||0
6647632|NCT02390557|7576777|FG001|NOT COMPLETED|Wave 1||0
6647633|NCT02390557|7576778|FG002|NOT COMPLETED|Wave 1||0
6647634|NCT02390557|7576776|FG000|STARTED|Wave 2||160
6647635|NCT02390557|7576777|FG001|STARTED|Wave 2||156
6647636|NCT02390557|7576778|FG002|STARTED|Wave 2||135
6647637|NCT02390557|7576776|FG000|COMPLETED|Wave 2||88
6647638|NCT02390557|7576777|FG001|COMPLETED|Wave 2||115
6304246|NCT00364832|7207524|FG010|NOT COMPLETED|Extension Year 1||2
6304247|NCT00364832|7207525|FG011|NOT COMPLETED|Extension Year 1||10
6304248|NCT00364832|7207514|FG000|STARTED|Extension Year 2||0
6304249|NCT00364832|7207515|FG001|STARTED|Extension Year 2||0
6304250|NCT00364832|7207516|FG002|STARTED|Extension Year 2||0
6304251|NCT00364832|7207517|FG003|STARTED|Extension Year 2||0
6304252|NCT00364832|7207518|FG004|STARTED|Extension Year 2||0
6304253|NCT00364832|7207519|FG005|STARTED|Extension Year 2||0
6304254|NCT00364832|7207520|FG006|STARTED|Extension Year 2||0
6304255|NCT00364832|7207521|FG007|STARTED|Extension Year 2||0
6304256|NCT00364832|7207522|FG008|STARTED|Extension Year 2||0
6304257|NCT00364832|7207523|FG009|STARTED|Extension Year 2||14
6304258|NCT00364832|7207524|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
6304259|NCT00364832|7207525|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
6304260|NCT00364832|7207514|FG000|COMPLETED|Extension Year 2||0
6304261|NCT00364832|7207515|FG001|COMPLETED|Extension Year 2||0
6304262|NCT00364832|7207516|FG002|COMPLETED|Extension Year 2||0
6304263|NCT00364832|7207517|FG003|COMPLETED|Extension Year 2||0
6304264|NCT00364832|7207518|FG004|COMPLETED|Extension Year 2||0
6304265|NCT00364832|7207519|FG005|COMPLETED|Extension Year 2||0
6304266|NCT00364832|7207520|FG006|COMPLETED|Extension Year 2||0
6304267|NCT00364832|7207521|FG007|COMPLETED|Extension Year 2||0
6304268|NCT00364832|7207522|FG008|COMPLETED|Extension Year 2||0
6304269|NCT00364832|7207523|FG009|COMPLETED|Extension Year 2||9
6304270|NCT00364832|7207524|FG010|COMPLETED|Extension Year 2||9
6304271|NCT00364832|7207525|FG011|COMPLETED|Extension Year 2||11
6304272|NCT00364832|7207514|FG000|NOT COMPLETED|Extension Year 2||0
6304273|NCT00364832|7207515|FG001|NOT COMPLETED|Extension Year 2||0
6304274|NCT00364832|7207516|FG002|NOT COMPLETED|Extension Year 2||0
6304275|NCT00364832|7207517|FG003|NOT COMPLETED|Extension Year 2||0
6304276|NCT00364832|7207518|FG004|NOT COMPLETED|Extension Year 2||0
6304277|NCT00364832|7207519|FG005|NOT COMPLETED|Extension Year 2||0
6304278|NCT00364832|7207520|FG006|NOT COMPLETED|Extension Year 2||0
6304279|NCT00364832|7207521|FG007|NOT COMPLETED|Extension Year 2||0
6304280|NCT00364832|7207522|FG008|NOT COMPLETED|Extension Year 2||0
6304281|NCT00364832|7207523|FG009|NOT COMPLETED|Extension Year 2||5
6304282|NCT00364832|7207524|FG010|NOT COMPLETED|Extension Year 2||5
6304283|NCT00364832|7207525|FG011|NOT COMPLETED|Extension Year 2||3
6304284|NCT00364845|7207544|FG000|STARTED|Overall Study||28
6304285|NCT00364845|7207545|FG001|STARTED|Overall Study||23
6304286|NCT00364845|7207544|FG000|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
6304287|NCT00364845|7207545|FG001|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
6647639|NCT02390557|7576778|FG002|COMPLETED|Wave 2||112
6647640|NCT02390557|7576776|FG000|NOT COMPLETED|Wave 2||72
6647641|NCT02390557|7576777|FG001|NOT COMPLETED|Wave 2||41
6647642|NCT02390557|7576778|FG002|NOT COMPLETED|Wave 2||23
6647643|NCT02390791|7576788|FG000|STARTED|Overall Study||40
6647644|NCT02390791|7576789|FG001|STARTED|Overall Study||45
6647645|NCT02390791|7576788|FG000|COMPLETED|Overall Study||40
6647646|NCT02390791|7576789|FG001|COMPLETED|Overall Study||45
6647647|NCT02390791|7576788|FG000|NOT COMPLETED|Overall Study||0
6647648|NCT02390791|7576789|FG001|NOT COMPLETED|Overall Study||0
6647649|NCT02390908|7576800|FG000|STARTED|Overall Study||40
6647650|NCT02390908|7576801|FG001|STARTED|Overall Study||22
6304288|NCT00364845|7207544|FG000|NOT COMPLETED|Overall Study||11
6304289|NCT00364845|7207545|FG001|NOT COMPLETED|Overall Study||11
6304290|NCT00364858|7207553|FG000|STARTED|Overall Study||33
6304291|NCT00364858|7207554|FG001|STARTED|Overall Study||62
6304292|NCT00364858|7207553|FG000|COMPLETED|Overall Study||26
6304293|NCT00364858|7207554|FG001|COMPLETED|Overall Study||40
6304294|NCT00364858|7207553|FG000|NOT COMPLETED|Overall Study||7
6304295|NCT00364858|7207554|FG001|NOT COMPLETED|Overall Study||22
6304296|NCT00364923|7207561|FG000|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
6304297|NCT00364923|7207561|FG000|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
6304298|NCT00364923|7207561|FG000|NOT COMPLETED|Treatment With Pralatrexate||4
6374819|NCT00752206|7285373|FG000|STARTED|Overall Study||19
6647651|NCT02390908|7576802|FG002|STARTED|Overall Study||22
6647652|NCT02390908|7576803|FG003|STARTED|Overall Study||90
6647653|NCT02390908|7576804|FG004|STARTED|Overall Study||120
6647654|NCT02390908|7576800|FG000|COMPLETED|Overall Study||40
6647655|NCT02390908|7576801|FG001|COMPLETED|Overall Study||22
6647656|NCT02390908|7576802|FG002|COMPLETED|Overall Study||22
6647657|NCT02390908|7576803|FG003|COMPLETED|Overall Study||90
6647658|NCT02390908|7576804|FG004|COMPLETED|Overall Study||120
6304299|NCT00364923|7207561|FG000|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
6304300|NCT00364923|7207561|FG000|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
6304301|NCT00364923|7207561|FG000|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
6304302|NCT00364949|7207567|FG000|STARTED|Overall Study||31
6304303|NCT00364949|7207568|FG001|STARTED|Overall Study||39
6304304|NCT00364949|7207567|FG000|COMPLETED|Overall Study||31
6304305|NCT00364949|7207568|FG001|COMPLETED|Overall Study||39
6304306|NCT00364949|7207567|FG000|NOT COMPLETED|Overall Study||0
6304307|NCT00364949|7207568|FG001|NOT COMPLETED|Overall Study||0
6304308|NCT00365053|7207574|FG000|STARTED|Overall Study||13
6304309|NCT00365053|7207574|FG000|COMPLETED|Overall Study||13
6304310|NCT00365053|7207574|FG000|NOT COMPLETED|Overall Study||0
6304311|NCT00365105|7207580|FG000|STARTED|Overall Study||129
6304312|NCT00365105|7207581|FG001|STARTED|Overall Study||132
6304313|NCT00365105|7207580|FG000|Eligible|Overall Study||124
6304314|NCT00365105|7207581|FG001|Eligible|Overall Study||124
6304315|NCT00365105|7207580|FG000|Eligible With Adverse Event Data|Overall Study||123
6304316|NCT00365105|7207581|FG001|Eligible With Adverse Event Data|Overall Study||124
6304317|NCT00365105|7207580|FG000|COMPLETED|Overall Study||124
6304318|NCT00365105|7207581|FG001|COMPLETED|Overall Study||124
6304319|NCT00365105|7207580|FG000|NOT COMPLETED|Overall Study||5
6304320|NCT00365105|7207581|FG001|NOT COMPLETED|Overall Study||8
6304321|NCT00365144|7207587|FG000|STARTED|Overall Study||36
6304322|NCT00365144|7207587|FG000|COMPLETED|Overall Study||36
6304323|NCT00365144|7207587|FG000|NOT COMPLETED|Overall Study||0
6304324|NCT00365209|7207592|FG000|STARTED|Stage 1: Receiving 2g Curcumin||23
6304325|NCT00365209|7207592|FG000|COMPLETED|Stage 1: Receiving 2g Curcumin||21
6304326|NCT00365209|7207592|FG000|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
6304327|NCT00365209|7207592|FG000|STARTED|Stage 2: Receiving 4g Curcumin||21
6304328|NCT00365209|7207592|FG000|COMPLETED|Stage 2: Receiving 4g Curcumin||19
6304329|NCT00365209|7207592|FG000|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
6304330|NCT00365261|7207599|FG000|STARTED|Overall Study||23
6304331|NCT00365261|7207600|FG001|STARTED|Overall Study||22
6304332|NCT00365261|7207599|FG000|COMPLETED|Overall Study||20
6304333|NCT00365261|7207600|FG001|COMPLETED|Overall Study||19
6304334|NCT00365261|7207599|FG000|NOT COMPLETED|Overall Study||3
6304335|NCT00365261|7207600|FG001|NOT COMPLETED|Overall Study||3
6647659|NCT02390908|7576800|FG000|NOT COMPLETED|Overall Study||0
6647660|NCT02390908|7576801|FG001|NOT COMPLETED|Overall Study||0
6647661|NCT02390908|7576802|FG002|NOT COMPLETED|Overall Study||0
6647662|NCT02390908|7576803|FG003|NOT COMPLETED|Overall Study||0
6647663|NCT02390908|7576804|FG004|NOT COMPLETED|Overall Study||0
6647664|NCT02391038|7576821|FG000|STARTED|Overall Study||3
6647665|NCT02391038|7576822|FG001|STARTED|Overall Study||3
6647666|NCT02391038|7576823|FG002|STARTED|Overall Study||6
6647667|NCT02391038|7576821|FG000|COMPLETED|Overall Study||0
6647668|NCT02391038|7576822|FG001|COMPLETED|Overall Study||0
6647669|NCT02391038|7576823|FG002|COMPLETED|Overall Study||0
6647670|NCT02391038|7576821|FG000|NOT COMPLETED|Overall Study||3
6647671|NCT02391038|7576822|FG001|NOT COMPLETED|Overall Study||3
6647672|NCT02391038|7576823|FG002|NOT COMPLETED|Overall Study||6
6647673|NCT02391116|7576832|FG000|STARTED|Treatment||67
6647674|NCT02391116|7576832|FG000|Included in Per Protocol Set|Treatment||40
6647675|NCT02391116|7576832|FG000|COMPLETED|Treatment|Reasons for completion in this period included death (2), PD (50) and lack of efficacy (1)|53
6647676|NCT02391116|7576832|FG000|NOT COMPLETED|Treatment||14
6647677|NCT02391116|7576832|FG000|STARTED|Safety Follow-up|This period excludes 2 deaths on treatment and 9 participants entering active follow-up|56
6647678|NCT02391116|7576832|FG000|COMPLETED|Safety Follow-up|14 participants were considered completed due to death|43
6647679|NCT02391116|7576832|FG000|NOT COMPLETED|Safety Follow-up||13
6647680|NCT02391116|7576832|FG000|STARTED|Active Follow-up|This period incorporates safety follow-up with radiological|9
6647681|NCT02391116|7576832|FG000|COMPLETED|Active Follow-up|Reasons for completion in this period included death (2) and PD (4)|6
6647682|NCT02391116|7576832|FG000|NOT COMPLETED|Active Follow-up||3
6647683|NCT02391116|7576832|FG000|STARTED|Survival Follow-up|21 participants discontinued from treatment didn't enter due to withdrawal by subject (3) and death|46
6647684|NCT02391116|7576832|FG000|COMPLETED|Survival Follow-up|Reason for completed in this period included death (35) and clinical endpoint reached (7)|42
6647685|NCT02391116|7576832|FG000|NOT COMPLETED|Survival Follow-up||4
6647686|NCT02391311|7576845|FG000|STARTED|Overall Study||21
6647687|NCT02391311|7576846|FG001|STARTED|Overall Study||21
6647688|NCT02391311|7576845|FG000|COMPLETED|Overall Study||18
6647689|NCT02391311|7576846|FG001|COMPLETED|Overall Study||19
6647690|NCT02391311|7576845|FG000|NOT COMPLETED|Overall Study||3
6647691|NCT02391311|7576846|FG001|NOT COMPLETED|Overall Study||2
6743873|NCT03337152|7671921|FG000|COMPLETED|Overall Study||13
6743874|NCT03337152|7671922|FG001|COMPLETED|Overall Study||13
6304336|NCT00365274|7207608|FG000|STARTED|Overall Study||6
6304337|NCT00365274|7207608|FG000|COMPLETED|Overall Study||6
6304338|NCT00365274|7207608|FG000|NOT COMPLETED|Overall Study||0
6304339|NCT00365300|7207614|FG000|STARTED|Open-label Phase||129
6304340|NCT00365300|7207615|FG001|STARTED|Open-label Phase||0
6304341|NCT00365300|7207614|FG000|COMPLETED|Open-label Phase||107
6304342|NCT00365300|7207615|FG001|COMPLETED|Open-label Phase||0
6304343|NCT00365300|7207614|FG000|NOT COMPLETED|Open-label Phase||22
6304344|NCT00365300|7207615|FG001|NOT COMPLETED|Open-label Phase||0
6304345|NCT00365300|7207614|FG000|STARTED|Double-blind Phase||54
6304346|NCT00365300|7207615|FG001|STARTED|Double-blind Phase||54
6304347|NCT00365300|7207614|FG000|COMPLETED|Double-blind Phase||43
6304348|NCT00365300|7207615|FG001|COMPLETED|Double-blind Phase||45
6304349|NCT00365300|7207614|FG000|NOT COMPLETED|Double-blind Phase||11
6304350|NCT00365300|7207615|FG001|NOT COMPLETED|Double-blind Phase||9
6304351|NCT00365352|7207627|FG000|STARTED|Overall Study||97
6304352|NCT00365352|7207628|FG001|STARTED|Overall Study||115
6304353|NCT00365352|7207629|FG002|STARTED|Overall Study||113
6304354|NCT00365352|7207627|FG000|Safety Population|Overall Study||96
6304355|NCT00365352|7207628|FG001|Safety Population|Overall Study||115
6304356|NCT00365352|7207629|FG002|Safety Population|Overall Study||111
6304357|NCT00365352|7207627|FG000|Modified Intent-to-Treat Population|Overall Study||96
6304358|NCT00365352|7207628|FG001|Modified Intent-to-Treat Population|Overall Study||114
6304359|NCT00365352|7207629|FG002|Modified Intent-to-Treat Population|Overall Study||111
6304360|NCT00365352|7207627|FG000|COMPLETED|Overall Study||77
6304361|NCT00365352|7207628|FG001|COMPLETED|Overall Study||104
6304362|NCT00365352|7207629|FG002|COMPLETED|Overall Study||98
6304363|NCT00365352|7207627|FG000|NOT COMPLETED|Overall Study||20
6304364|NCT00365352|7207628|FG001|NOT COMPLETED|Overall Study||11
6304365|NCT00365352|7207629|FG002|NOT COMPLETED|Overall Study||15
6304366|NCT00365365|7207643|FG000|STARTED|Overall Study||78
6304367|NCT00365365|7207644|FG001|STARTED|Overall Study||77
6304368|NCT00365365|7207645|FG002|STARTED|Overall Study||59
6304369|NCT00365365|7207643|FG000|TREATED (SAFETY POPULATION)|Overall Study||78
6304370|NCT00365365|7207644|FG001|TREATED (SAFETY POPULATION)|Overall Study||75
6304371|NCT00365365|7207645|FG002|TREATED (SAFETY POPULATION)|Overall Study||59
6304372|NCT00365365|7207643|FG000|COMPLETED TREATMENT|Overall Study||38
6304373|NCT00365365|7207644|FG001|COMPLETED TREATMENT|Overall Study||36
6304374|NCT00365365|7207645|FG002|COMPLETED TREATMENT|Overall Study||45
6304375|NCT00365365|7207643|FG000|COMPLETED|Overall Study||44
6304376|NCT00365365|7207644|FG001|COMPLETED|Overall Study||41
6304377|NCT00365365|7207645|FG002|COMPLETED|Overall Study||44
6304378|NCT00365365|7207643|FG000|NOT COMPLETED|Overall Study||34
6304379|NCT00365365|7207644|FG001|NOT COMPLETED|Overall Study||36
6304380|NCT00365365|7207645|FG002|NOT COMPLETED|Overall Study||15
6304381|NCT00365378|7207655|FG000|STARTED|Vaccination (Day 1 to Month 7)||1204
6304382|NCT00365378|7207656|FG001|STARTED|Vaccination (Day 1 to Month 7)||1205
6304383|NCT00365378|7207657|FG002|STARTED|Vaccination (Day 1 to Month 7)||0
6304384|NCT00365378|7207655|FG000|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
6304385|NCT00365378|7207656|FG001|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
6304386|NCT00365378|7207657|FG002|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
6304387|NCT00365378|7207655|FG000|COMPLETED|Vaccination (Day 1 to Month 7)||993
6304388|NCT00365378|7207656|FG001|COMPLETED|Vaccination (Day 1 to Month 7)||1038
6304389|NCT00365378|7207657|FG002|COMPLETED|Vaccination (Day 1 to Month 7)||0
6304390|NCT00365378|7207655|FG000|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
6304391|NCT00365378|7207656|FG001|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
6304392|NCT00365378|7207657|FG002|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
6304393|NCT00365378|7207655|FG000|STARTED|Follow-up (Month 7 Though Month 48)||993
6304394|NCT00365378|7207656|FG001|STARTED|Follow-up (Month 7 Though Month 48)||1038
6304395|NCT00365378|7207657|FG002|STARTED|Follow-up (Month 7 Though Month 48)||0
6304396|NCT00365378|7207655|FG000|COMPLETED|Follow-up (Month 7 Though Month 48)||835
6304397|NCT00365378|7207656|FG001|COMPLETED|Follow-up (Month 7 Though Month 48)||836
6304398|NCT00365378|7207657|FG002|COMPLETED|Follow-up (Month 7 Though Month 48)||0
6304399|NCT00365378|7207655|FG000|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
6304400|NCT00365378|7207656|FG001|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
6304401|NCT00365378|7207657|FG002|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
6304402|NCT00365378|7207655|FG000|STARTED|Extension||0
6304403|NCT00365378|7207656|FG001|STARTED|Extension||0
6304404|NCT00365378|7207657|FG002|STARTED|Extension||400
6304405|NCT00365378|7207655|FG000|COMPLETED|Extension||0
6304406|NCT00365378|7207656|FG001|COMPLETED|Extension||0
6304407|NCT00365378|7207657|FG002|COMPLETED|Extension||203
6304408|NCT00365378|7207655|FG000|NOT COMPLETED|Extension||0
6304409|NCT00365378|7207656|FG001|NOT COMPLETED|Extension||0
6304410|NCT00365378|7207657|FG002|NOT COMPLETED|Extension||197
6304411|NCT00365391|7207664|FG000|STARTED|Overall Study||27
6304412|NCT00365391|7207664|FG000|COMPLETED|Overall Study||27
6304413|NCT00365391|7207664|FG000|NOT COMPLETED|Overall Study||0
6304414|NCT00365417|7207668|FG000|STARTED|Overall Study||45
6304415|NCT00365417|7207668|FG000|COMPLETED|Overall Study||45
6304416|NCT00365417|7207668|FG000|NOT COMPLETED|Overall Study||0
6304417|NCT00365456|7207673|FG000|STARTED|Trial Period I (12 Months)||407
6304418|NCT00365456|7207674|FG001|STARTED|Trial Period I (12 Months)||0
6304419|NCT00365456|7207673|FG000|COMPLETED|Trial Period I (12 Months)||282
6304420|NCT00365456|7207674|FG001|COMPLETED|Trial Period I (12 Months)||0
6304421|NCT00365456|7207673|FG000|NOT COMPLETED|Trial Period I (12 Months)||125
6304422|NCT00365456|7207674|FG001|NOT COMPLETED|Trial Period I (12 Months)||0
6304423|NCT00365456|7207673|FG000|STARTED|Trial Period II (12 Months)||0
6304424|NCT00365456|7207674|FG001|STARTED|Trial Period II (12 Months)||282
6304425|NCT00365456|7207673|FG000|COMPLETED|Trial Period II (12 Months)||0
6304426|NCT00365456|7207674|FG001|COMPLETED|Trial Period II (12 Months)||268
6304427|NCT00365456|7207673|FG000|NOT COMPLETED|Trial Period II (12 Months)||0
6304428|NCT00365456|7207674|FG001|NOT COMPLETED|Trial Period II (12 Months)||14
6304429|NCT00365456|7207673|FG000|STARTED|Trial Period III (12 Months)||136
6304430|NCT00365456|7207674|FG001|STARTED|Trial Period III (12 Months)||132
6550302|NCT01723514|7472194|FG007|COMPLETED|Overall Study||6
6550303|NCT01723514|7472187|FG000|NOT COMPLETED|Overall Study||0
6550304|NCT01723514|7472188|FG001|NOT COMPLETED|Overall Study||0
6550305|NCT01723514|7472189|FG002|NOT COMPLETED|Overall Study||0
6550306|NCT01723514|7472190|FG003|NOT COMPLETED|Overall Study||0
6550307|NCT01723514|7472191|FG004|NOT COMPLETED|Overall Study||0
6550308|NCT01723514|7472192|FG005|NOT COMPLETED|Overall Study||0
6550309|NCT01723514|7472193|FG006|NOT COMPLETED|Overall Study||0
6550310|NCT01723514|7472194|FG007|NOT COMPLETED|Overall Study||0
6550311|NCT01723696|7472214|FG000|STARTED|Overall Study||126
6550312|NCT01723696|7472215|FG001|STARTED|Overall Study||126
6550313|NCT01723696|7472214|FG000|COMPLETED|Overall Study||109
6550314|NCT01723696|7472215|FG001|COMPLETED|Overall Study||113
6550315|NCT01723696|7472214|FG000|NOT COMPLETED|Overall Study||17
6550316|NCT01723696|7472215|FG001|NOT COMPLETED|Overall Study||13
6647692|NCT02391337|7576854|FG000|STARTED|Baseline||80
6647693|NCT02391337|7576855|FG001|STARTED|Baseline||81
6647694|NCT02391337|7576854|FG000|COMPLETED|Baseline||80
6647695|NCT02391337|7576855|FG001|COMPLETED|Baseline||81
6647696|NCT02391337|7576854|FG000|NOT COMPLETED|Baseline||0
6647697|NCT02391337|7576855|FG001|NOT COMPLETED|Baseline||0
6647698|NCT02391337|7576854|FG000|STARTED|6 Months Follow-up||80
6647699|NCT02391337|7576855|FG001|STARTED|6 Months Follow-up||81
6647700|NCT02391337|7576854|FG000|COMPLETED|6 Months Follow-up||74
6647701|NCT02391337|7576855|FG001|COMPLETED|6 Months Follow-up||76
6647702|NCT02391337|7576854|FG000|NOT COMPLETED|6 Months Follow-up||6
6647703|NCT02391337|7576855|FG001|NOT COMPLETED|6 Months Follow-up||5
6647704|NCT02391337|7576854|FG000|STARTED|12 Months Follow-up||74
6647705|NCT02391337|7576855|FG001|STARTED|12 Months Follow-up||76
6647706|NCT02391337|7576854|FG000|COMPLETED|12 Months Follow-up||72
6647707|NCT02391337|7576855|FG001|COMPLETED|12 Months Follow-up||73
6647708|NCT02391337|7576854|FG000|NOT COMPLETED|12 Months Follow-up||2
6647709|NCT02391337|7576855|FG001|NOT COMPLETED|12 Months Follow-up||3
6647710|NCT02391350|7576863|FG000|STARTED|Overall Study||110
6647711|NCT02391350|7576864|FG001|STARTED|Overall Study||110
6647712|NCT02391350|7576863|FG000|4-week Follow-up|Overall Study||106
6647713|NCT02391350|7576864|FG001|4-week Follow-up|Overall Study||105
6647714|NCT02391350|7576863|FG000|6-month Follow-up|Overall Study||100
6647715|NCT02391350|7576864|FG001|6-month Follow-up|Overall Study||96
6647716|NCT02391350|7576863|FG000|COMPLETED|Overall Study||98
6647717|NCT02391350|7576864|FG001|COMPLETED|Overall Study||93
6647718|NCT02391350|7576863|FG000|NOT COMPLETED|Overall Study||12
6647719|NCT02391350|7576864|FG001|NOT COMPLETED|Overall Study||17
6647720|NCT02391363|7576872|FG000|STARTED|Overall Study||70
6647721|NCT02391363|7576873|FG001|STARTED|Overall Study||64
6647722|NCT02391363|7576872|FG000|COMPLETED|Overall Study||59
6647723|NCT02391363|7576873|FG001|COMPLETED|Overall Study||56
6647724|NCT02391363|7576872|FG000|NOT COMPLETED|Overall Study||11
6647725|NCT02391363|7576873|FG001|NOT COMPLETED|Overall Study||8
6647726|NCT02391545|7576881|FG000|STARTED|Overall Study||27
6647727|NCT02391545|7576882|FG001|STARTED|Overall Study||28
6647728|NCT02391545|7576881|FG000|COMPLETED|Overall Study||1
6647729|NCT02391545|7576882|FG001|COMPLETED|Overall Study||0
6647730|NCT02391545|7576881|FG000|NOT COMPLETED|Overall Study||26
6647731|NCT02391545|7576882|FG001|NOT COMPLETED|Overall Study||28
6647732|NCT02391584|7576891|FG000|STARTED|Primary Endpoint (6-weeks)||31
6647733|NCT02391584|7576892|FG001|STARTED|Primary Endpoint (6-weeks)||29
6647734|NCT02391584|7576891|FG000|COMPLETED|Primary Endpoint (6-weeks)||29
6647735|NCT02391584|7576892|FG001|COMPLETED|Primary Endpoint (6-weeks)||27
6647736|NCT02391584|7576891|FG000|NOT COMPLETED|Primary Endpoint (6-weeks)||2
6647737|NCT02391584|7576892|FG001|NOT COMPLETED|Primary Endpoint (6-weeks)||2
6647738|NCT02391584|7576891|FG000|STARTED|3 Month|Includes 30 balloon dilation and 23 crossover participants|53
6647739|NCT02391584|7576892|FG001|STARTED|3 Month|23 Crossover participants are included in balloon dilation arm for remainder of study visits.|0
6647740|NCT02391584|7576891|FG000|COMPLETED|3 Month||52
6647741|NCT02391584|7576892|FG001|COMPLETED|3 Month||0
6647742|NCT02391584|7576891|FG000|NOT COMPLETED|3 Month||1
6647743|NCT02391584|7576892|FG001|NOT COMPLETED|3 Month||0
6647744|NCT02391584|7576891|FG000|STARTED|6 Month||52
6647745|NCT02391584|7576892|FG001|STARTED|6 Month||0
6647746|NCT02391584|7576891|FG000|COMPLETED|6 Month||51
6647747|NCT02391584|7576892|FG001|COMPLETED|6 Month||0
6647748|NCT02391584|7576891|FG000|NOT COMPLETED|6 Month||1
6647749|NCT02391584|7576892|FG001|NOT COMPLETED|6 Month||0
6647750|NCT02391584|7576891|FG000|STARTED|12 Month (End of Study)||51
6647751|NCT02391584|7576892|FG001|STARTED|12 Month (End of Study)||0
6647752|NCT02391584|7576891|FG000|COMPLETED|12 Month (End of Study)||49
6647753|NCT02391584|7576892|FG001|COMPLETED|12 Month (End of Study)||0
6647754|NCT02391584|7576891|FG000|NOT COMPLETED|12 Month (End of Study)||2
6647755|NCT02391584|7576892|FG001|NOT COMPLETED|12 Month (End of Study)||0
6647756|NCT02391701|7576903|FG000|STARTED|Overall Study||367
6647757|NCT02391701|7576904|FG001|STARTED|Overall Study||353
6647758|NCT02391701|7576903|FG000|COMPLETED|Overall Study||346
6647759|NCT02391701|7576904|FG001|COMPLETED|Overall Study||315
6647760|NCT02391701|7576903|FG000|NOT COMPLETED|Overall Study||21
6550317|NCT01723722|7472225|FG000|STARTED|Overall Study||20
6550318|NCT01723722|7472226|FG001|STARTED|Overall Study||20
6550319|NCT01723722|7472225|FG000|COMPLETED|Overall Study||20
6550320|NCT01723722|7472226|FG001|COMPLETED|Overall Study||20
6550321|NCT01723722|7472225|FG000|NOT COMPLETED|Overall Study||0
6550322|NCT01723722|7472226|FG001|NOT COMPLETED|Overall Study||0
6550323|NCT01723826|7472236|FG000|STARTED|Overall Study||47
6647761|NCT02391701|7576904|FG001|NOT COMPLETED|Overall Study||38
6647762|NCT02391714|7576912|FG000|STARTED|Overall Study||40
6647763|NCT02391714|7576913|FG001|STARTED|Overall Study||40
6647764|NCT02391714|7576912|FG000|COMPLETED|Overall Study||40
6647765|NCT02391714|7576913|FG001|COMPLETED|Overall Study||40
6647766|NCT02391714|7576912|FG000|NOT COMPLETED|Overall Study||0
6647767|NCT02391714|7576913|FG001|NOT COMPLETED|Overall Study||0
6647768|NCT02391948|7576926|FG000|STARTED|Baseline||227
6647769|NCT02391948|7576927|FG001|STARTED|Baseline||161
6647770|NCT02391948|7576928|FG002|STARTED|Baseline||80
6647771|NCT02391948|7576929|FG003|STARTED|Baseline||129
6647772|NCT02391948|7576930|FG004|STARTED|Baseline||111
6647773|NCT02391948|7576926|FG000|COMPLETED|Baseline||227
6647774|NCT02391948|7576927|FG001|COMPLETED|Baseline||161
6647775|NCT02391948|7576928|FG002|COMPLETED|Baseline||80
6647776|NCT02391948|7576929|FG003|COMPLETED|Baseline||129
6647777|NCT02391948|7576930|FG004|COMPLETED|Baseline||111
6647778|NCT02391948|7576926|FG000|NOT COMPLETED|Baseline||0
6647779|NCT02391948|7576927|FG001|NOT COMPLETED|Baseline||0
6550324|NCT01723826|7472237|FG001|STARTED|Overall Study||63
6550325|NCT01723826|7472238|FG002|STARTED|Overall Study||101
6647780|NCT02391948|7576928|FG002|NOT COMPLETED|Baseline||0
6647781|NCT02391948|7576929|FG003|NOT COMPLETED|Baseline||0
6647782|NCT02391948|7576930|FG004|NOT COMPLETED|Baseline||0
6647783|NCT02391948|7576926|FG000|STARTED|6-month Assessment||227
6647784|NCT02391948|7576927|FG001|STARTED|6-month Assessment||161
6647785|NCT02391948|7576928|FG002|STARTED|6-month Assessment||80
6647786|NCT02391948|7576929|FG003|STARTED|6-month Assessment||129
6647787|NCT02391948|7576930|FG004|STARTED|6-month Assessment||111
6647788|NCT02391948|7576926|FG000|COMPLETED|6-month Assessment||148
6647789|NCT02391948|7576927|FG001|COMPLETED|6-month Assessment||105
6647790|NCT02391948|7576928|FG002|COMPLETED|6-month Assessment||49
6647791|NCT02391948|7576929|FG003|COMPLETED|6-month Assessment||84
6647792|NCT02391948|7576930|FG004|COMPLETED|6-month Assessment||85
6647793|NCT02391948|7576926|FG000|NOT COMPLETED|6-month Assessment||79
6647794|NCT02391948|7576927|FG001|NOT COMPLETED|6-month Assessment||56
6647795|NCT02391948|7576928|FG002|NOT COMPLETED|6-month Assessment||31
6647796|NCT02391948|7576929|FG003|NOT COMPLETED|6-month Assessment||45
6647797|NCT02391948|7576930|FG004|NOT COMPLETED|6-month Assessment||26
6647798|NCT02391948|7576926|FG000|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 77 of the Not Completed remained active.|225
6647799|NCT02391948|7576927|FG001|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 51 of the Not Completed remained active.|156
6647800|NCT02391948|7576928|FG002|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 28 of the Not Completed remained active.|77
6647801|NCT02391948|7576929|FG003|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 41 of the Not Completed remained active.|125
6647802|NCT02391948|7576930|FG004|STARTED|12-month Assessment|Started at 12-month is not equal to Completed at 6-month: 24 of the Not Completed remained active.|109
6647803|NCT02391948|7576926|FG000|COMPLETED|12-month Assessment||217
6647804|NCT02391948|7576927|FG001|COMPLETED|12-month Assessment||147
6647805|NCT02391948|7576928|FG002|COMPLETED|12-month Assessment||73
6647806|NCT02391948|7576929|FG003|COMPLETED|12-month Assessment||116
6550326|NCT01723826|7472239|FG003|STARTED|Overall Study||149
6550327|NCT01723826|7472236|FG000|COMPLETED|Overall Study||20
6550328|NCT01723826|7472237|FG001|COMPLETED|Overall Study||27
6550329|NCT01723826|7472238|FG002|COMPLETED|Overall Study||44
6550330|NCT01723826|7472239|FG003|COMPLETED|Overall Study||59
6550331|NCT01723826|7472236|FG000|NOT COMPLETED|Overall Study||27
6550332|NCT01723826|7472237|FG001|NOT COMPLETED|Overall Study||36
6550333|NCT01723826|7472238|FG002|NOT COMPLETED|Overall Study||57
6550334|NCT01723826|7472239|FG003|NOT COMPLETED|Overall Study||90
6550335|NCT01723904|7472249|FG000|STARTED|Overall Study||90
6550336|NCT01723904|7472249|FG000|COMPLETED|Overall Study||79
6550337|NCT01723904|7472249|FG000|NOT COMPLETED|Overall Study||11
6550338|NCT01724021|7472255|FG000|STARTED|Overall Study||371
6550339|NCT01724021|7472256|FG001|STARTED|Overall Study||369
6550340|NCT01724021|7472255|FG000|COMPLETED|Overall Study||244
6550341|NCT01724021|7472256|FG001|COMPLETED|Overall Study||236
6550342|NCT01724021|7472255|FG000|NOT COMPLETED|Overall Study||127
6550343|NCT01724021|7472256|FG001|NOT COMPLETED|Overall Study||133
6550344|NCT01724060|7472272|FG000|STARTED|Overall Study||10
6550345|NCT01724060|7472273|FG001|STARTED|Overall Study||10
6550346|NCT01724060|7472274|FG002|STARTED|Overall Study||10
6550347|NCT01724060|7472275|FG003|STARTED|Overall Study||10
6550348|NCT01724060|7472276|FG004|STARTED|Overall Study||10
6550349|NCT01724060|7472277|FG005|STARTED|Overall Study||10
6550350|NCT01724060|7472278|FG006|STARTED|Overall Study||10
6550351|NCT01724060|7472279|FG007|STARTED|Overall Study||10
6550352|NCT01724060|7472272|FG000|COMPLETED|Overall Study||10
6550353|NCT01724060|7472273|FG001|COMPLETED|Overall Study||10
6550354|NCT01724060|7472274|FG002|COMPLETED|Overall Study||10
6550355|NCT01724060|7472275|FG003|COMPLETED|Overall Study||10
6550356|NCT01724060|7472276|FG004|COMPLETED|Overall Study||10
6550357|NCT01724060|7472277|FG005|COMPLETED|Overall Study||10
6550358|NCT01724060|7472278|FG006|COMPLETED|Overall Study||10
6550359|NCT01724060|7472279|FG007|COMPLETED|Overall Study||10
6550360|NCT01724060|7472272|FG000|NOT COMPLETED|Overall Study||0
6550361|NCT01724060|7472273|FG001|NOT COMPLETED|Overall Study||0
6550362|NCT01724060|7472274|FG002|NOT COMPLETED|Overall Study||0
6550363|NCT01724060|7472275|FG003|NOT COMPLETED|Overall Study||0
6550364|NCT01724060|7472276|FG004|NOT COMPLETED|Overall Study||0
6550365|NCT01724060|7472277|FG005|NOT COMPLETED|Overall Study||0
6550366|NCT01724060|7472278|FG006|NOT COMPLETED|Overall Study||0
6550367|NCT01724060|7472279|FG007|NOT COMPLETED|Overall Study||0
6550368|NCT01724177|7472297|FG000|STARTED|Overall Study||26
6550369|NCT01724177|7472297|FG000|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
6550370|NCT01724177|7472297|FG000|COMPLETED|Overall Study||0
6550371|NCT01724177|7472297|FG000|NOT COMPLETED|Overall Study||26
6550372|NCT01724216|7472302|FG000|STARTED|Overall Study||11
6550373|NCT01724216|7472302|FG000|COMPLETED|Overall Study||10
6550374|NCT01724216|7472302|FG000|NOT COMPLETED|Overall Study||1
6550375|NCT01724359|7472306|FG000|STARTED|Overall Study||95
6550376|NCT01724359|7472306|FG000|COMPLETED|Overall Study||64
6550377|NCT01724359|7472306|FG000|NOT COMPLETED|Overall Study||31
6550378|NCT01724489|7472314|FG000|STARTED|Overall Study||39
6550379|NCT01724489|7472315|FG001|STARTED|Overall Study||38
6550380|NCT01724489|7472314|FG000|COMPLETED|Overall Study||23
6550381|NCT01724489|7472315|FG001|COMPLETED|Overall Study||26
6550382|NCT01724489|7472314|FG000|NOT COMPLETED|Overall Study||16
6550383|NCT01724489|7472315|FG001|NOT COMPLETED|Overall Study||12
6550384|NCT01724528|7472323|FG000|STARTED|Overall Study||173
6550385|NCT01724528|7472324|FG001|STARTED|Overall Study||173
6550386|NCT01724528|7472323|FG000|COMPLETED|Overall Study||169
6550387|NCT01724528|7472324|FG001|COMPLETED|Overall Study||170
6550388|NCT01724528|7472323|FG000|NOT COMPLETED|Overall Study||4
6550389|NCT01724528|7472324|FG001|NOT COMPLETED|Overall Study||3
6550390|NCT01725126|7472336|FG000|STARTED|Overall Study||4
6550391|NCT01725126|7472337|FG001|STARTED|Overall Study||11
6550392|NCT01725126|7472338|FG002|STARTED|Overall Study||6
6550393|NCT01725126|7472339|FG003|STARTED|Overall Study||14
6550394|NCT01725126|7472340|FG004|STARTED|Overall Study||6
6550395|NCT01725126|7472341|FG005|STARTED|Overall Study||12
6550396|NCT01725126|7472336|FG000|COMPLETED|Overall Study||4
6550397|NCT01725126|7472337|FG001|COMPLETED|Overall Study||10
6550398|NCT01725126|7472338|FG002|COMPLETED|Overall Study||6
6550399|NCT01725126|7472339|FG003|COMPLETED|Overall Study||13
6550400|NCT01725126|7472340|FG004|COMPLETED|Overall Study||6
6550401|NCT01725126|7472341|FG005|COMPLETED|Overall Study||12
6550402|NCT01725126|7472336|FG000|NOT COMPLETED|Overall Study||0
6550403|NCT01725126|7472337|FG001|NOT COMPLETED|Overall Study||1
6550404|NCT01725126|7472338|FG002|NOT COMPLETED|Overall Study||0
6550405|NCT01725126|7472339|FG003|NOT COMPLETED|Overall Study||1
6550406|NCT01725126|7472340|FG004|NOT COMPLETED|Overall Study||0
6550407|NCT01725126|7472341|FG005|NOT COMPLETED|Overall Study||0
6550408|NCT01725217|7472367|FG000|STARTED|Overall Study||66
6550409|NCT01725217|7472368|FG001|STARTED|Overall Study||66
6550410|NCT01725217|7472369|FG002|STARTED|Overall Study||66
6550411|NCT01725217|7472367|FG000|COMPLETED|Overall Study||65
6550412|NCT01725217|7472368|FG001|COMPLETED|Overall Study||66
6550413|NCT01725217|7472369|FG002|COMPLETED|Overall Study||66
6647807|NCT02391948|7576930|FG004|COMPLETED|12-month Assessment||103
6647808|NCT02391948|7576926|FG000|NOT COMPLETED|12-month Assessment||8
6647809|NCT02391948|7576927|FG001|NOT COMPLETED|12-month Assessment||9
6647810|NCT02391948|7576928|FG002|NOT COMPLETED|12-month Assessment||4
6647811|NCT02391948|7576929|FG003|NOT COMPLETED|12-month Assessment||9
6647812|NCT02391948|7576930|FG004|NOT COMPLETED|12-month Assessment||6
6647813|NCT02391948|7576926|FG000|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|219
6647814|NCT02391948|7576927|FG001|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 4 of the Not Completed remained active.|151
6647815|NCT02391948|7576928|FG002|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 1 of the Not Completed remained active.|74
6647816|NCT02391948|7576929|FG003|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 3 of the Not Completed remained active.|119
6647817|NCT02391948|7576930|FG004|STARTED|18-month Assessment|Started at 18-month is not equal to Completed at 12-month: 2 of the Not Completed remained active.|105
6647818|NCT02391948|7576926|FG000|COMPLETED|18-month Assessment||147
6647819|NCT02391948|7576927|FG001|COMPLETED|18-month Assessment||101
6647820|NCT02391948|7576928|FG002|COMPLETED|18-month Assessment||48
6647821|NCT02391948|7576929|FG003|COMPLETED|18-month Assessment||83
6647822|NCT02391948|7576930|FG004|COMPLETED|18-month Assessment||75
6647823|NCT02391948|7576926|FG000|NOT COMPLETED|18-month Assessment||72
6647824|NCT02391948|7576927|FG001|NOT COMPLETED|18-month Assessment||50
6647825|NCT02391948|7576928|FG002|NOT COMPLETED|18-month Assessment||26
6647826|NCT02391948|7576929|FG003|NOT COMPLETED|18-month Assessment||36
6647827|NCT02391948|7576930|FG004|NOT COMPLETED|18-month Assessment||30
6647828|NCT02391948|7576926|FG000|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 2 of the Not Completed remained active.|149
6647829|NCT02391948|7576927|FG001|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 6 of the Not Completed remained active.|107
6647830|NCT02391948|7576928|FG002|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 3 of the Not Completed remained active.|51
6647831|NCT02391948|7576929|FG003|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 1 of the Not Completed remained active.|84
6550414|NCT01725217|7472367|FG000|NOT COMPLETED|Overall Study||1
6550415|NCT01725217|7472368|FG001|NOT COMPLETED|Overall Study||0
6550416|NCT01725217|7472369|FG002|NOT COMPLETED|Overall Study||0
6550417|NCT01725282|7472390|FG000|STARTED|Overall Study||44
6550418|NCT01725282|7472391|FG001|STARTED|Overall Study||44
6550419|NCT01725282|7472392|FG002|STARTED|Overall Study||41
6550420|NCT01725282|7472393|FG003|STARTED|Overall Study||43
6550421|NCT01725282|7472390|FG000|COMPLETED|Overall Study||42
6550422|NCT01725282|7472391|FG001|COMPLETED|Overall Study||39
6550423|NCT01725282|7472392|FG002|COMPLETED|Overall Study||33
6550424|NCT01725282|7472393|FG003|COMPLETED|Overall Study||36
6550425|NCT01725282|7472390|FG000|NOT COMPLETED|Overall Study||2
6550426|NCT01725282|7472391|FG001|NOT COMPLETED|Overall Study||5
6550427|NCT01725282|7472392|FG002|NOT COMPLETED|Overall Study||8
6550428|NCT01725282|7472393|FG003|NOT COMPLETED|Overall Study||7
6550429|NCT01725308|7472406|FG000|STARTED|Treatment Period I||178
6550430|NCT01725308|7472407|FG001|STARTED|Treatment Period I||74
6550431|NCT01725308|7472408|FG002|STARTED|Treatment Period I||179
6550432|NCT01725308|7472406|FG000|Treated|Treatment Period I||177
6550433|NCT01725308|7472407|FG001|Treated|Treatment Period I||74
6550434|NCT01725308|7472408|FG002|Treated|Treatment Period I||179
6550435|NCT01725308|7472406|FG000|COMPLETED|Treatment Period I||134
6550436|NCT01725308|7472407|FG001|COMPLETED|Treatment Period I||60
6550437|NCT01725308|7472408|FG002|COMPLETED|Treatment Period I||138
6550438|NCT01725308|7472406|FG000|NOT COMPLETED|Treatment Period I||44
6550439|NCT01725308|7472407|FG001|NOT COMPLETED|Treatment Period I||14
6550440|NCT01725308|7472408|FG002|NOT COMPLETED|Treatment Period I||41
6550441|NCT01725308|7472406|FG000|STARTED|Treatment Period II||134
6550442|NCT01725308|7472407|FG001|STARTED|Treatment Period II||60
6550443|NCT01725308|7472408|FG002|STARTED|Treatment Period II||138
6550444|NCT01725308|7472406|FG000|Treated|Treatment Period II||120
6550445|NCT01725308|7472407|FG001|Treated|Treatment Period II||53
6550446|NCT01725308|7472408|FG002|Treated|Treatment Period II||130
6550447|NCT01725308|7472406|FG000|COMPLETED|Treatment Period II||79
6550448|NCT01725308|7472407|FG001|COMPLETED|Treatment Period II||31
6550449|NCT01725308|7472408|FG002|COMPLETED|Treatment Period II||74
6550450|NCT01725308|7472406|FG000|NOT COMPLETED|Treatment Period II||55
6550451|NCT01725308|7472407|FG001|NOT COMPLETED|Treatment Period II||29
6550452|NCT01725308|7472408|FG002|NOT COMPLETED|Treatment Period II||64
6550453|NCT01725386|7472425|FG000|STARTED|Overall Study||188
6550454|NCT01725386|7472426|FG001|STARTED|Overall Study||63
6550455|NCT01725386|7472425|FG000|COMPLETED|Overall Study||13
6550456|NCT01725386|7472426|FG001|COMPLETED|Overall Study||17
6550457|NCT01725386|7472425|FG000|NOT COMPLETED|Overall Study||175
6550458|NCT01725386|7472426|FG001|NOT COMPLETED|Overall Study||46
6550459|NCT01725451|7472432|FG000|STARTED|Period 1||8
6550460|NCT01725451|7472433|FG001|STARTED|Period 1||7
6647832|NCT02391948|7576930|FG004|STARTED|24-month Assessment|Started at 24-month is not equal to Completed at 18-month: 4 of the Not Completed remained active.|79
6647833|NCT02391948|7576926|FG000|COMPLETED|24-month Assessment||135
6647834|NCT02391948|7576927|FG001|COMPLETED|24-month Assessment||97
6647835|NCT02391948|7576928|FG002|COMPLETED|24-month Assessment||48
6647836|NCT02391948|7576929|FG003|COMPLETED|24-month Assessment||75
6647837|NCT02391948|7576930|FG004|COMPLETED|24-month Assessment||69
6647838|NCT02391948|7576926|FG000|NOT COMPLETED|24-month Assessment||14
6647839|NCT02391948|7576927|FG001|NOT COMPLETED|24-month Assessment||10
6647840|NCT02391948|7576928|FG002|NOT COMPLETED|24-month Assessment||3
6647841|NCT02391948|7576929|FG003|NOT COMPLETED|24-month Assessment||9
6647842|NCT02391948|7576930|FG004|NOT COMPLETED|24-month Assessment||10
6647843|NCT02391961|7576947|FG000|STARTED|First Intervention (4 Weeks)||10
6647844|NCT02391961|7576948|FG001|STARTED|First Intervention (4 Weeks)||9
6647845|NCT02391961|7576947|FG000|COMPLETED|First Intervention (4 Weeks)||8
6647846|NCT02391961|7576948|FG001|COMPLETED|First Intervention (4 Weeks)||9
6647847|NCT02391961|7576947|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
6647848|NCT02391961|7576948|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6647849|NCT02391961|7576947|FG000|STARTED|Washout (2 Weeks)||8
6647850|NCT02391961|7576948|FG001|STARTED|Washout (2 Weeks)||9
6647851|NCT02391961|7576947|FG000|COMPLETED|Washout (2 Weeks)||7
6647852|NCT02391961|7576948|FG001|COMPLETED|Washout (2 Weeks)||8
6647853|NCT02391961|7576947|FG000|NOT COMPLETED|Washout (2 Weeks)||1
6647854|NCT02391961|7576948|FG001|NOT COMPLETED|Washout (2 Weeks)||1
6647855|NCT02391961|7576947|FG000|STARTED|Second Intervention (4 Weeks)||7
6647856|NCT02391961|7576948|FG001|STARTED|Second Intervention (4 Weeks)||8
6647857|NCT02391961|7576947|FG000|COMPLETED|Second Intervention (4 Weeks)||6
6647858|NCT02391961|7576948|FG001|COMPLETED|Second Intervention (4 Weeks)||7
6647859|NCT02391961|7576947|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
6647860|NCT02391961|7576948|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
6647861|NCT02391987|7576956|FG000|STARTED|Overall Study||54
6550461|NCT01725451|7472434|FG002|STARTED|Period 1||8
6647862|NCT02391987|7576957|FG001|STARTED|Overall Study||58
6647863|NCT02391987|7576956|FG000|COMPLETED|Overall Study||54
6647864|NCT02391987|7576957|FG001|COMPLETED|Overall Study||58
6647865|NCT02391987|7576956|FG000|NOT COMPLETED|Overall Study||0
6647866|NCT02391987|7576957|FG001|NOT COMPLETED|Overall Study||0
6550462|NCT01725451|7472435|FG003|STARTED|Period 1||7
6550463|NCT01725451|7472432|FG000|COMPLETED|Period 1||7
6550464|NCT01725451|7472433|FG001|COMPLETED|Period 1||7
6550465|NCT01725451|7472434|FG002|COMPLETED|Period 1||8
6550466|NCT01725451|7472435|FG003|COMPLETED|Period 1||7
6647867|NCT02392000|7576963|FG000|STARTED|Overall Study||38
6647868|NCT02392000|7576963|FG000|COMPLETED|Overall Study||11
6550467|NCT01725451|7472432|FG000|NOT COMPLETED|Period 1||1
6550468|NCT01725451|7472433|FG001|NOT COMPLETED|Period 1||0
6550469|NCT01725451|7472434|FG002|NOT COMPLETED|Period 1||0
6550470|NCT01725451|7472435|FG003|NOT COMPLETED|Period 1||0
6550471|NCT01725451|7472432|FG000|STARTED|Washout From Period 1||7
6550472|NCT01725451|7472433|FG001|STARTED|Washout From Period 1||7
6550473|NCT01725451|7472434|FG002|STARTED|Washout From Period 1||8
6550474|NCT01725451|7472435|FG003|STARTED|Washout From Period 1||7
6550475|NCT01725451|7472432|FG000|COMPLETED|Washout From Period 1||7
6550476|NCT01725451|7472433|FG001|COMPLETED|Washout From Period 1||7
6550477|NCT01725451|7472434|FG002|COMPLETED|Washout From Period 1||8
6647869|NCT02392000|7576963|FG000|NOT COMPLETED|Overall Study||27
6647870|NCT02392104|7576968|FG000|STARTED|Overall Study|one participant enrolled but was removed prior to starting study protocol|50
6647871|NCT02392104|7576968|FG000|COMPLETED|Overall Study||39
6647872|NCT02392104|7576968|FG000|NOT COMPLETED|Overall Study||11
6647873|NCT02392195|7576972|FG000|STARTED|Overall Study||10
6647874|NCT02392195|7576972|FG000|COMPLETED|Overall Study||2
6647875|NCT02392195|7576972|FG000|NOT COMPLETED|Overall Study||8
6647876|NCT02392208|7576976|FG000|STARTED|Telavancin Before Hemodialysis||8
6647877|NCT02392208|7576976|FG000|COMPLETED|Telavancin Before Hemodialysis||8
6647878|NCT02392208|7576976|FG000|NOT COMPLETED|Telavancin Before Hemodialysis||0
6647879|NCT02392208|7576976|FG000|STARTED|Telavancin After Hemodialysis||8
6647880|NCT02392208|7576976|FG000|COMPLETED|Telavancin After Hemodialysis||8
6647881|NCT02392208|7576976|FG000|NOT COMPLETED|Telavancin After Hemodialysis||0
6647882|NCT02392234|7576987|FG000|STARTED|Treatment Period 1 (8 Weeks)||41
6647883|NCT02392234|7576988|FG001|STARTED|Treatment Period 1 (8 Weeks)||43
6647884|NCT02392234|7576989|FG002|STARTED|Treatment Period 1 (8 Weeks)||40
6647885|NCT02392234|7576990|FG003|STARTED|Treatment Period 1 (8 Weeks)||42
6647886|NCT02392234|7576991|FG004|STARTED|Treatment Period 1 (8 Weeks)||41
6647887|NCT02392234|7576992|FG005|STARTED|Treatment Period 1 (8 Weeks)||41
6647888|NCT02392234|7576987|FG000|Treated|Treatment Period 1 (8 Weeks)||41
6647889|NCT02392234|7576988|FG001|Treated|Treatment Period 1 (8 Weeks)||43
6647890|NCT02392234|7576989|FG002|Treated|Treatment Period 1 (8 Weeks)||39
6647891|NCT02392234|7576990|FG003|Treated|Treatment Period 1 (8 Weeks)||42
6647892|NCT02392234|7576991|FG004|Treated|Treatment Period 1 (8 Weeks)||40
6647893|NCT02392234|7576992|FG005|Treated|Treatment Period 1 (8 Weeks)||41
6647894|NCT02392234|7576987|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||38
6647895|NCT02392234|7576988|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||43
6647896|NCT02392234|7576989|FG002|COMPLETED|Treatment Period 1 (8 Weeks)||38
6647897|NCT02392234|7576990|FG003|COMPLETED|Treatment Period 1 (8 Weeks)||41
6647898|NCT02392234|7576991|FG004|COMPLETED|Treatment Period 1 (8 Weeks)||37
6647899|NCT02392234|7576992|FG005|COMPLETED|Treatment Period 1 (8 Weeks)||38
6647900|NCT02392234|7576987|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
6647901|NCT02392234|7576988|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
6647902|NCT02392234|7576989|FG002|NOT COMPLETED|Treatment Period 1 (8 Weeks)||2
6647903|NCT02392234|7576990|FG003|NOT COMPLETED|Treatment Period 1 (8 Weeks)||1
6647904|NCT02392234|7576991|FG004|NOT COMPLETED|Treatment Period 1 (8 Weeks)||4
6647905|NCT02392234|7576992|FG005|NOT COMPLETED|Treatment Period 1 (8 Weeks)||3
6647906|NCT02392234|7576987|FG000|STARTED|Treatment Period 2 (8 Weeks)||38
6647907|NCT02392234|7576988|FG001|STARTED|Treatment Period 2 (8 Weeks)||43
6647908|NCT02392234|7576989|FG002|STARTED|Treatment Period 2 (8 Weeks)||38
6647909|NCT02392234|7576990|FG003|STARTED|Treatment Period 2 (8 Weeks)||41
6647910|NCT02392234|7576991|FG004|STARTED|Treatment Period 2 (8 Weeks)||37
6647911|NCT02392234|7576992|FG005|STARTED|Treatment Period 2 (8 Weeks)||38
6647912|NCT02392234|7576987|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||37
6647913|NCT02392234|7576988|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||43
6647914|NCT02392234|7576989|FG002|COMPLETED|Treatment Period 2 (8 Weeks)||38
6647915|NCT02392234|7576990|FG003|COMPLETED|Treatment Period 2 (8 Weeks)||41
6647916|NCT02392234|7576991|FG004|COMPLETED|Treatment Period 2 (8 Weeks)||37
6647917|NCT02392234|7576992|FG005|COMPLETED|Treatment Period 2 (8 Weeks)||38
6647918|NCT02392234|7576987|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||1
6647919|NCT02392234|7576988|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6647920|NCT02392234|7576989|FG002|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6647921|NCT02392234|7576990|FG003|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6647922|NCT02392234|7576991|FG004|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6647923|NCT02392234|7576992|FG005|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6647924|NCT02392247|7577003|FG000|STARTED|Overall Study||52
6647925|NCT02392247|7577003|FG000|COMPLETED|Overall Study||50
6647926|NCT02392247|7577003|FG000|NOT COMPLETED|Overall Study||2
6647927|NCT02392286|7577009|FG000|STARTED|Overall Study||7
6647928|NCT02392286|7577010|FG001|STARTED|Overall Study||8
6647929|NCT02392286|7577009|FG000|COMPLETED|Overall Study||4
6647930|NCT02392286|7577010|FG001|COMPLETED|Overall Study||6
6647931|NCT02392286|7577009|FG000|NOT COMPLETED|Overall Study||3
6647932|NCT02392286|7577010|FG001|NOT COMPLETED|Overall Study||2
6647933|NCT02392351|7577018|FG000|STARTED|Overall Study||34
6647934|NCT02392351|7577019|FG001|STARTED|Overall Study||17
6647935|NCT02392351|7577018|FG000|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
6647936|NCT02392351|7577019|FG001|COMPLETED|Overall Study|Primary endpoint: only observational results available.|0
6647937|NCT02392351|7577018|FG000|NOT COMPLETED|Overall Study||34
6550478|NCT01725451|7472435|FG003|COMPLETED|Washout From Period 1||7
6647938|NCT02392351|7577019|FG001|NOT COMPLETED|Overall Study||17
6550479|NCT01725451|7472432|FG000|NOT COMPLETED|Washout From Period 1||0
6550480|NCT01725451|7472433|FG001|NOT COMPLETED|Washout From Period 1||0
6550481|NCT01725451|7472434|FG002|NOT COMPLETED|Washout From Period 1||0
6550482|NCT01725451|7472435|FG003|NOT COMPLETED|Washout From Period 1||0
6550483|NCT01725451|7472432|FG000|STARTED|Period 2||7
6550484|NCT01725451|7472433|FG001|STARTED|Period 2||7
6647939|NCT02392403|7577025|FG000|STARTED|Overall Study||45
6647940|NCT02392403|7577025|FG000|COMPLETED|Overall Study||42
6647941|NCT02392403|7577025|FG000|NOT COMPLETED|Overall Study||3
6647942|NCT02392481|7577033|FG000|STARTED|Overall Study||10
6647943|NCT02392481|7577034|FG001|STARTED|Overall Study||12
6647944|NCT02392481|7577035|FG002|STARTED|Overall Study||20
6647945|NCT02392481|7577036|FG003|STARTED|Overall Study||27
6647946|NCT02392481|7577033|FG000|COMPLETED|Overall Study||10
6647947|NCT02392481|7577034|FG001|COMPLETED|Overall Study||12
6647948|NCT02392481|7577035|FG002|COMPLETED|Overall Study||18
6647949|NCT02392481|7577036|FG003|COMPLETED|Overall Study||25
6647950|NCT02392481|7577033|FG000|NOT COMPLETED|Overall Study||0
6647951|NCT02392481|7577034|FG001|NOT COMPLETED|Overall Study||0
6647952|NCT02392481|7577035|FG002|NOT COMPLETED|Overall Study||2
6647953|NCT02392481|7577036|FG003|NOT COMPLETED|Overall Study||2
6647954|NCT02392494|7577049|FG000|STARTED|Overall Study||3
6647955|NCT02392494|7577050|FG001|STARTED|Overall Study||3
6647956|NCT02392494|7577051|FG002|STARTED|Overall Study||3
6647957|NCT02392494|7577052|FG003|STARTED|Overall Study||0
6647958|NCT02392494|7577049|FG000|COMPLETED|Overall Study||3
6647959|NCT02392494|7577050|FG001|COMPLETED|Overall Study||3
6647960|NCT02392494|7577051|FG002|COMPLETED|Overall Study||3
6647961|NCT02392494|7577052|FG003|COMPLETED|Overall Study||0
6647962|NCT02392494|7577049|FG000|NOT COMPLETED|Overall Study||0
6647963|NCT02392494|7577050|FG001|NOT COMPLETED|Overall Study||0
6647964|NCT02392494|7577051|FG002|NOT COMPLETED|Overall Study||0
6647965|NCT02392494|7577052|FG003|NOT COMPLETED|Overall Study||0
6647966|NCT02392507|7577060|FG000|STARTED|Induction Regimen||54
6647967|NCT02392507|7577060|FG000|Received at Least 1 Dose of Study Drug|Induction Regimen||54
6647968|NCT02392507|7577060|FG000|COMPLETED|Induction Regimen||47
6647969|NCT02392507|7577060|FG000|NOT COMPLETED|Induction Regimen||7
6647970|NCT02392507|7577060|FG000|STARTED|Maintenance Regimen|After induction regimen participants with disease response are eligible for maintenance regimen.|34
6647971|NCT02392507|7577060|FG000|COMPLETED|Maintenance Regimen||32
6647972|NCT02392507|7577060|FG000|NOT COMPLETED|Maintenance Regimen||2
6647973|NCT02392559|7577071|FG000|STARTED|Overall Study||53
6647974|NCT02392559|7577072|FG001|STARTED|Overall Study||105
6647975|NCT02392559|7577071|FG000|Randomized and Dosed|Overall Study||53
6647976|NCT02392559|7577072|FG001|Randomized and Dosed|Overall Study||104
6550485|NCT01725451|7472434|FG002|STARTED|Period 2||8
6550486|NCT01725451|7472435|FG003|STARTED|Period 2||7
6550487|NCT01725451|7472432|FG000|COMPLETED|Period 2||7
6550488|NCT01725451|7472433|FG001|COMPLETED|Period 2||7
6550489|NCT01725451|7472434|FG002|COMPLETED|Period 2||8
6550490|NCT01725451|7472435|FG003|COMPLETED|Period 2||7
6550491|NCT01725451|7472432|FG000|NOT COMPLETED|Period 2||0
6550492|NCT01725451|7472433|FG001|NOT COMPLETED|Period 2||0
6550493|NCT01725451|7472434|FG002|NOT COMPLETED|Period 2||0
6550494|NCT01725451|7472435|FG003|NOT COMPLETED|Period 2||0
6550495|NCT01725451|7472432|FG000|STARTED|Washout From Period 2||7
6550496|NCT01725451|7472433|FG001|STARTED|Washout From Period 2||7
6550497|NCT01725451|7472434|FG002|STARTED|Washout From Period 2||8
6550498|NCT01725451|7472435|FG003|STARTED|Washout From Period 2||7
6550499|NCT01725451|7472432|FG000|COMPLETED|Washout From Period 2||7
6550500|NCT01725451|7472433|FG001|COMPLETED|Washout From Period 2||7
6550501|NCT01725451|7472434|FG002|COMPLETED|Washout From Period 2||8
6550502|NCT01725451|7472435|FG003|COMPLETED|Washout From Period 2||7
6550503|NCT01725451|7472432|FG000|NOT COMPLETED|Washout From Period 2||0
6550504|NCT01725451|7472433|FG001|NOT COMPLETED|Washout From Period 2||0
6550505|NCT01725451|7472434|FG002|NOT COMPLETED|Washout From Period 2||0
6550506|NCT01725451|7472435|FG003|NOT COMPLETED|Washout From Period 2||0
6550507|NCT01725451|7472432|FG000|STARTED|Period 3||7
6550508|NCT01725451|7472433|FG001|STARTED|Period 3||7
6550509|NCT01725451|7472434|FG002|STARTED|Period 3||8
6550510|NCT01725451|7472435|FG003|STARTED|Period 3||7
6550511|NCT01725451|7472432|FG000|COMPLETED|Period 3||7
6550512|NCT01725451|7472433|FG001|COMPLETED|Period 3||7
6550513|NCT01725451|7472434|FG002|COMPLETED|Period 3||8
6550514|NCT01725451|7472435|FG003|COMPLETED|Period 3||7
6550515|NCT01725451|7472432|FG000|NOT COMPLETED|Period 3||0
6550516|NCT01725451|7472433|FG001|NOT COMPLETED|Period 3||0
6550517|NCT01725451|7472434|FG002|NOT COMPLETED|Period 3||0
6550518|NCT01725451|7472435|FG003|NOT COMPLETED|Period 3||0
6550519|NCT01725451|7472432|FG000|STARTED|Washout From Period 3||7
6550520|NCT01725451|7472433|FG001|STARTED|Washout From Period 3||7
6550521|NCT01725451|7472434|FG002|STARTED|Washout From Period 3||8
6550522|NCT01725451|7472435|FG003|STARTED|Washout From Period 3||7
6550523|NCT01725451|7472432|FG000|COMPLETED|Washout From Period 3||7
6550524|NCT01725451|7472433|FG001|COMPLETED|Washout From Period 3||6
6550525|NCT01725451|7472434|FG002|COMPLETED|Washout From Period 3||7
6550526|NCT01725451|7472435|FG003|COMPLETED|Washout From Period 3||7
6550527|NCT01725451|7472432|FG000|NOT COMPLETED|Washout From Period 3||0
6550528|NCT01725451|7472433|FG001|NOT COMPLETED|Washout From Period 3||1
6647977|NCT02392559|7577071|FG000|COMPLETED|Overall Study||53
6647978|NCT02392559|7577072|FG001|COMPLETED|Overall Study||104
6550529|NCT01725451|7472434|FG002|NOT COMPLETED|Washout From Period 3||1
6647979|NCT02392559|7577071|FG000|NOT COMPLETED|Overall Study||0
6550530|NCT01725451|7472435|FG003|NOT COMPLETED|Washout From Period 3||0
6647980|NCT02392559|7577072|FG001|NOT COMPLETED|Overall Study||1
6647981|NCT02392611|7577088|FG000|STARTED|Overall Study||2
6647982|NCT02392611|7577089|FG001|STARTED|Overall Study||1
6647983|NCT02392611|7577090|FG002|STARTED|Overall Study||1
6647984|NCT02392611|7577091|FG003|STARTED|Overall Study||9
6647985|NCT02392611|7577092|FG004|STARTED|Overall Study||6
6647986|NCT02392611|7577093|FG005|STARTED|Overall Study||4
6647987|NCT02392611|7577094|FG006|STARTED|Overall Study||4
6647988|NCT02392611|7577095|FG007|STARTED|Overall Study||3
6647989|NCT02392611|7577096|FG008|STARTED|Overall Study||3
6647990|NCT02392611|7577088|FG000|COMPLETED|Overall Study||1
6647991|NCT02392611|7577089|FG001|COMPLETED|Overall Study||1
6647992|NCT02392611|7577090|FG002|COMPLETED|Overall Study||1
6647993|NCT02392611|7577091|FG003|COMPLETED|Overall Study||3
6647994|NCT02392611|7577092|FG004|COMPLETED|Overall Study||5
6647995|NCT02392611|7577093|FG005|COMPLETED|Overall Study||3
6647996|NCT02392611|7577094|FG006|COMPLETED|Overall Study||3
6647997|NCT02392611|7577095|FG007|COMPLETED|Overall Study||3
6647998|NCT02392611|7577096|FG008|COMPLETED|Overall Study||3
6647999|NCT02392611|7577088|FG000|NOT COMPLETED|Overall Study||1
6648000|NCT02392611|7577089|FG001|NOT COMPLETED|Overall Study||0
6648001|NCT02392611|7577090|FG002|NOT COMPLETED|Overall Study||0
6648002|NCT02392611|7577091|FG003|NOT COMPLETED|Overall Study||6
6648003|NCT02392611|7577092|FG004|NOT COMPLETED|Overall Study||1
6648004|NCT02392611|7577093|FG005|NOT COMPLETED|Overall Study||1
6648005|NCT02392611|7577094|FG006|NOT COMPLETED|Overall Study||1
6648006|NCT02392611|7577095|FG007|NOT COMPLETED|Overall Study||0
6648007|NCT02392611|7577096|FG008|NOT COMPLETED|Overall Study||0
6648008|NCT02392624|7577119|FG000|STARTED|Overall Study||71
6648009|NCT02392624|7577120|FG001|STARTED|Overall Study||81
6648010|NCT02392624|7577121|FG002|STARTED|Overall Study||53
6648011|NCT02392624|7577119|FG000|COMPLETED|Overall Study||0
6648012|NCT02392624|7577120|FG001|COMPLETED|Overall Study||66
6648013|NCT02392624|7577121|FG002|COMPLETED|Overall Study||40
6648014|NCT02392624|7577119|FG000|NOT COMPLETED|Overall Study||71
6648015|NCT02392624|7577120|FG001|NOT COMPLETED|Overall Study||15
6648016|NCT02392624|7577121|FG002|NOT COMPLETED|Overall Study||13
6648017|NCT02392767|7577131|FG000|STARTED|Overall Study||12
6648018|NCT02392767|7577132|FG001|STARTED|Overall Study||13
6648019|NCT02392767|7577131|FG000|COMPLETED|Overall Study||12
6648020|NCT02392767|7577132|FG001|COMPLETED|Overall Study||13
6648021|NCT02392767|7577131|FG000|NOT COMPLETED|Overall Study||0
6648022|NCT02392767|7577132|FG001|NOT COMPLETED|Overall Study||0
6648023|NCT02392806|7577142|FG000|STARTED|Overall Study||22
6648024|NCT02392806|7577143|FG001|STARTED|Overall Study||21
6648025|NCT02392806|7577142|FG000|COMPLETED|Overall Study||22
6648026|NCT02392806|7577143|FG001|COMPLETED|Overall Study||21
6648027|NCT02392806|7577142|FG000|NOT COMPLETED|Overall Study||0
6648028|NCT02392806|7577143|FG001|NOT COMPLETED|Overall Study||0
6648029|NCT02393209|7577151|FG000|STARTED|Overall Study||6
6648030|NCT02393209|7577152|FG001|STARTED|Overall Study||8
6648031|NCT02393209|7577153|FG002|STARTED|Overall Study||0
6648032|NCT02393209|7577154|FG003|STARTED|Overall Study||0
6648033|NCT02393209|7577151|FG000|COMPLETED|Overall Study||0
6648034|NCT02393209|7577152|FG001|COMPLETED|Overall Study||0
6648035|NCT02393209|7577153|FG002|COMPLETED|Overall Study||0
6648036|NCT02393209|7577154|FG003|COMPLETED|Overall Study||0
6550531|NCT01725451|7472432|FG000|STARTED|Period 4||7
6550532|NCT01725451|7472433|FG001|STARTED|Period 4||6
6550533|NCT01725451|7472434|FG002|STARTED|Period 4||7
6550534|NCT01725451|7472435|FG003|STARTED|Period 4||7
6550535|NCT01725451|7472432|FG000|COMPLETED|Period 4||7
6550536|NCT01725451|7472433|FG001|COMPLETED|Period 4||6
6550537|NCT01725451|7472434|FG002|COMPLETED|Period 4||6
6550538|NCT01725451|7472435|FG003|COMPLETED|Period 4||7
6550539|NCT01725451|7472432|FG000|NOT COMPLETED|Period 4||0
6550540|NCT01725451|7472433|FG001|NOT COMPLETED|Period 4||0
6550541|NCT01725451|7472434|FG002|NOT COMPLETED|Period 4||1
6550542|NCT01725451|7472435|FG003|NOT COMPLETED|Period 4||0
6550543|NCT01725451|7472432|FG000|STARTED|Washout From Period 4||7
6550544|NCT01725451|7472433|FG001|STARTED|Washout From Period 4||6
6550545|NCT01725451|7472434|FG002|STARTED|Washout From Period 4||6
6550546|NCT01725451|7472435|FG003|STARTED|Washout From Period 4||7
6648037|NCT02393209|7577151|FG000|NOT COMPLETED|Overall Study||6
6648038|NCT02393209|7577152|FG001|NOT COMPLETED|Overall Study||8
6648039|NCT02393209|7577153|FG002|NOT COMPLETED|Overall Study||0
6648040|NCT02393209|7577154|FG003|NOT COMPLETED|Overall Study||0
6648041|NCT02393339|7577165|FG000|STARTED|Overall Study||58
6648042|NCT02393339|7577166|FG001|STARTED|Overall Study||56
6648043|NCT02393339|7577165|FG000|COMPLETED|Overall Study||51
6648044|NCT02393339|7577166|FG001|COMPLETED|Overall Study||51
6648045|NCT02393339|7577165|FG000|NOT COMPLETED|Overall Study||7
6648046|NCT02393339|7577166|FG001|NOT COMPLETED|Overall Study||5
6648047|NCT02393378|7577174|FG000|STARTED|Overall Study||3
6648048|NCT02393378|7577175|FG001|STARTED|Overall Study||4
6648049|NCT02393378|7577174|FG000|COMPLETED|Overall Study||3
6550547|NCT01725451|7472432|FG000|COMPLETED|Washout From Period 4||7
6550548|NCT01725451|7472433|FG001|COMPLETED|Washout From Period 4||6
6550549|NCT01725451|7472434|FG002|COMPLETED|Washout From Period 4||6
6550550|NCT01725451|7472435|FG003|COMPLETED|Washout From Period 4||7
6648050|NCT02393378|7577175|FG001|COMPLETED|Overall Study||4
6648051|NCT02393378|7577174|FG000|NOT COMPLETED|Overall Study||0
6550551|NCT01725451|7472432|FG000|NOT COMPLETED|Washout From Period 4||0
6550552|NCT01725451|7472433|FG001|NOT COMPLETED|Washout From Period 4||0
6550553|NCT01725451|7472434|FG002|NOT COMPLETED|Washout From Period 4||0
6550554|NCT01725451|7472435|FG003|NOT COMPLETED|Washout From Period 4||0
6550555|NCT01725451|7472432|FG000|STARTED|Period 5||7
6550556|NCT01725451|7472433|FG001|STARTED|Period 5||6
6550557|NCT01725451|7472434|FG002|STARTED|Period 5||6
6550558|NCT01725451|7472435|FG003|STARTED|Period 5||7
6648052|NCT02393378|7577175|FG001|NOT COMPLETED|Overall Study||0
6648053|NCT02393417|7577185|FG000|STARTED|Overall Study||43
6648054|NCT02393417|7577186|FG001|STARTED|Overall Study||45
6648055|NCT02393417|7577187|FG002|STARTED|Overall Study||40
6648056|NCT02393417|7577188|FG003|STARTED|Overall Study||41
6648057|NCT02393417|7577185|FG000|Completed Treatment|Overall Study||30
6648058|NCT02393417|7577186|FG001|Completed Treatment|Overall Study||34
6648059|NCT02393417|7577187|FG002|Completed Treatment|Overall Study||32
6648060|NCT02393417|7577188|FG003|Completed Treatment|Overall Study||30
6648061|NCT02393417|7577185|FG000|COMPLETED|Overall Study||28
6648062|NCT02393417|7577186|FG001|COMPLETED|Overall Study||32
6648063|NCT02393417|7577187|FG002|COMPLETED|Overall Study||30
6648064|NCT02393417|7577188|FG003|COMPLETED|Overall Study||29
6648065|NCT02393417|7577185|FG000|NOT COMPLETED|Overall Study||15
6648066|NCT02393417|7577186|FG001|NOT COMPLETED|Overall Study||13
6648067|NCT02393417|7577187|FG002|NOT COMPLETED|Overall Study||10
6648068|NCT02393417|7577188|FG003|NOT COMPLETED|Overall Study||12
6648069|NCT02393547|7577199|FG000|STARTED|Overall Study||20
6648070|NCT02393547|7577199|FG000|COMPLETED|Overall Study||14
6648071|NCT02393547|7577199|FG000|NOT COMPLETED|Overall Study||6
6648072|NCT02393677|7577205|FG000|STARTED|Overall Study||40
6648073|NCT02393677|7577206|FG001|STARTED|Overall Study||40
6648074|NCT02393677|7577205|FG000|COMPLETED|Overall Study||40
6648075|NCT02393677|7577206|FG001|COMPLETED|Overall Study||40
6648076|NCT02393677|7577205|FG000|NOT COMPLETED|Overall Study||0
6648077|NCT02393677|7577206|FG001|NOT COMPLETED|Overall Study||0
6648078|NCT02393755|7577214|FG000|STARTED|Overall Study||3
6648079|NCT02393755|7577215|FG001|STARTED|Overall Study||39
6648080|NCT02393755|7577214|FG000|COMPLETED|Overall Study||3
6648081|NCT02393755|7577215|FG001|COMPLETED|Overall Study||32
6648082|NCT02393755|7577214|FG000|NOT COMPLETED|Overall Study||0
6648083|NCT02393755|7577215|FG001|NOT COMPLETED|Overall Study||7
6648084|NCT02393950|7577222|FG000|STARTED|Overall Study||9
6648085|NCT02393950|7577223|FG001|STARTED|Overall Study||9
6648086|NCT02393950|7577222|FG000|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
6743875|NCT03337152|7671921|FG000|NOT COMPLETED|Overall Study||11
6743876|NCT03337152|7671922|FG001|NOT COMPLETED|Overall Study||11
6743877|NCT03337308|7671934|FG000|STARTED|Overall Study||108
6743878|NCT03337308|7671935|FG001|STARTED|Overall Study||110
6743879|NCT03337308|7671936|FG002|STARTED|Overall Study||109
6743880|NCT03337308|7671937|FG003|STARTED|Overall Study||55
6743881|NCT03337308|7671934|FG000|COMPLETED|Overall Study||103
6743882|NCT03337308|7671935|FG001|COMPLETED|Overall Study||103
6743883|NCT03337308|7671936|FG002|COMPLETED|Overall Study||104
6743884|NCT03337308|7671937|FG003|COMPLETED|Overall Study||53
6743885|NCT03337308|7671934|FG000|NOT COMPLETED|Overall Study||5
6743886|NCT03337308|7671935|FG001|NOT COMPLETED|Overall Study||7
6743887|NCT03337308|7671936|FG002|NOT COMPLETED|Overall Study||5
6743888|NCT03337308|7671937|FG003|NOT COMPLETED|Overall Study||2
6743889|NCT03337477|7671949|FG000|STARTED|Overall Study||33
6743890|NCT03337477|7671950|FG001|STARTED|Overall Study||37
6743891|NCT03337477|7671949|FG000|COMPLETED|Overall Study||22
6743892|NCT03337477|7671950|FG001|COMPLETED|Overall Study||24
6743893|NCT03337477|7671949|FG000|NOT COMPLETED|Overall Study||11
6743894|NCT03337477|7671950|FG001|NOT COMPLETED|Overall Study||13
6743895|NCT03337490|7671961|FG000|STARTED|Overall Study||128
6743896|NCT03337490|7671962|FG001|STARTED|Overall Study||126
6743897|NCT03337490|7671963|FG002|STARTED|Overall Study||42
6743898|NCT03337490|7671961|FG000|COMPLETED|Overall Study||117
6743899|NCT03337490|7671962|FG001|COMPLETED|Overall Study||112
6743900|NCT03337490|7671963|FG002|COMPLETED|Overall Study||7
6743901|NCT03337490|7671961|FG000|NOT COMPLETED|Overall Study||11
6743902|NCT03337490|7671962|FG001|NOT COMPLETED|Overall Study||14
6743903|NCT03337490|7671963|FG002|NOT COMPLETED|Overall Study||35
6550559|NCT01725451|7472432|FG000|COMPLETED|Period 5||7
6550560|NCT01725451|7472433|FG001|COMPLETED|Period 5||6
6550561|NCT01725451|7472434|FG002|COMPLETED|Period 5||6
6550562|NCT01725451|7472435|FG003|COMPLETED|Period 5||7
6743904|NCT03337542|7671971|FG000|STARTED|Overall Study||243
6743905|NCT03337542|7671971|FG000|Safety Population|Overall Study||242
6743906|NCT03337542|7671971|FG000|COMPLETED|Overall Study||222
6743907|NCT03337542|7671971|FG000|NOT COMPLETED|Overall Study||21
6743908|NCT03338010|7671978|FG000|STARTED|Overall Study||359
6743909|NCT03338010|7671979|FG001|STARTED|Overall Study||177
6648087|NCT02393950|7577223|FG001|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
6743910|NCT03338010|7671978|FG000|Received at Least One Dose of Study Drug|Overall Study||359
6743911|NCT03338010|7671979|FG001|Received at Least One Dose of Study Drug|Overall Study||177
6743912|NCT03338010|7671978|FG000|COMPLETED|Overall Study||336
6550563|NCT01725451|7472432|FG000|NOT COMPLETED|Period 5||0
6648088|NCT02393950|7577222|FG000|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
6743913|NCT03338010|7671979|FG001|COMPLETED|Overall Study||159
6743914|NCT03338010|7671978|FG000|NOT COMPLETED|Overall Study||23
6550564|NCT01725451|7472433|FG001|NOT COMPLETED|Period 5||0
6550565|NCT01725451|7472434|FG002|NOT COMPLETED|Period 5||0
6550566|NCT01725451|7472435|FG003|NOT COMPLETED|Period 5||0
6550567|NCT01725451|7472432|FG000|STARTED|Washout From Period 5||7
6550568|NCT01725451|7472433|FG001|STARTED|Washout From Period 5||6
6550569|NCT01725451|7472434|FG002|STARTED|Washout From Period 5||6
6550570|NCT01725451|7472435|FG003|STARTED|Washout From Period 5||7
6550571|NCT01725451|7472432|FG000|COMPLETED|Washout From Period 5||7
6550572|NCT01725451|7472433|FG001|COMPLETED|Washout From Period 5||6
6550573|NCT01725451|7472434|FG002|COMPLETED|Washout From Period 5||6
6550574|NCT01725451|7472435|FG003|COMPLETED|Washout From Period 5||7
6550575|NCT01725451|7472432|FG000|NOT COMPLETED|Washout From Period 5||0
6550576|NCT01725451|7472433|FG001|NOT COMPLETED|Washout From Period 5||0
6550577|NCT01725451|7472434|FG002|NOT COMPLETED|Washout From Period 5||0
6550578|NCT01725451|7472435|FG003|NOT COMPLETED|Washout From Period 5||0
6550579|NCT01725451|7472432|FG000|STARTED|Period 6||7
6550580|NCT01725451|7472433|FG001|STARTED|Period 6||6
6550581|NCT01725451|7472434|FG002|STARTED|Period 6||6
6550582|NCT01725451|7472435|FG003|STARTED|Period 6||7
6550583|NCT01725451|7472432|FG000|COMPLETED|Period 6||7
6550584|NCT01725451|7472433|FG001|COMPLETED|Period 6||6
6550585|NCT01725451|7472434|FG002|COMPLETED|Period 6||6
6550586|NCT01725451|7472435|FG003|COMPLETED|Period 6||7
6550587|NCT01725451|7472432|FG000|NOT COMPLETED|Period 6||0
6550588|NCT01725451|7472433|FG001|NOT COMPLETED|Period 6||0
6550589|NCT01725451|7472434|FG002|NOT COMPLETED|Period 6||0
6550590|NCT01725451|7472435|FG003|NOT COMPLETED|Period 6||0
6550591|NCT01725529|7472453|FG000|STARTED|Overall Study||152
6550592|NCT01725529|7472454|FG001|STARTED|Overall Study||153
6550593|NCT01725529|7472455|FG002|STARTED|Overall Study||152
6550594|NCT01725529|7472453|FG000|COMPLETED|Overall Study||137
6550595|NCT01725529|7472454|FG001|COMPLETED|Overall Study||137
6550596|NCT01725529|7472455|FG002|COMPLETED|Overall Study||142
6550597|NCT01725529|7472453|FG000|NOT COMPLETED|Overall Study||15
6550598|NCT01725529|7472454|FG001|NOT COMPLETED|Overall Study||16
6550599|NCT01725529|7472455|FG002|NOT COMPLETED|Overall Study||10
6550600|NCT01725750|7472465|FG000|STARTED|Overall Study||44
6550601|NCT01725750|7472466|FG001|STARTED|Overall Study||44
6550602|NCT01725750|7472465|FG000|COMPLETED|Overall Study||42
6550603|NCT01725750|7472466|FG001|COMPLETED|Overall Study||34
6550604|NCT01725750|7472465|FG000|NOT COMPLETED|Overall Study||2
6550605|NCT01725750|7472466|FG001|NOT COMPLETED|Overall Study||10
6550606|NCT01725815|7472476|FG000|STARTED|Overall Study||198
6550607|NCT01725815|7472477|FG001|STARTED|Overall Study||202
6550608|NCT01725815|7472476|FG000|COMPLETED|Overall Study||198
6550609|NCT01725815|7472477|FG001|COMPLETED|Overall Study||202
6550610|NCT01725815|7472476|FG000|NOT COMPLETED|Overall Study||0
6550611|NCT01725815|7472477|FG001|NOT COMPLETED|Overall Study||0
6550612|NCT01725984|7472485|FG000|STARTED|Overall Study||39
6550613|NCT01725984|7472486|FG001|STARTED|Overall Study||41
6550614|NCT01725984|7472485|FG000|COMPLETED|Overall Study||39
6550615|NCT01725984|7472486|FG001|COMPLETED|Overall Study||41
6550616|NCT01725984|7472485|FG000|NOT COMPLETED|Overall Study||0
6550617|NCT01725984|7472486|FG001|NOT COMPLETED|Overall Study||0
6550618|NCT01726023|7472494|FG000|STARTED|Overall Study||219
6550619|NCT01726023|7472495|FG001|STARTED|Overall Study||222
6550620|NCT01726023|7472494|FG000|COMPLETED|Overall Study||190
6550621|NCT01726023|7472495|FG001|COMPLETED|Overall Study||196
6550622|NCT01726023|7472494|FG000|NOT COMPLETED|Overall Study||29
6550623|NCT01726023|7472495|FG001|NOT COMPLETED|Overall Study||26
6550624|NCT01726036|7472510|FG000|STARTED|Overall Study||137
6550625|NCT01726036|7472511|FG001|STARTED|Overall Study||137
6550626|NCT01726036|7472510|FG000|COMPLETED|Overall Study||121
6550627|NCT01726036|7472511|FG001|COMPLETED|Overall Study||130
6550628|NCT01726036|7472510|FG000|NOT COMPLETED|Overall Study||16
6550629|NCT01726036|7472511|FG001|NOT COMPLETED|Overall Study||7
6550630|NCT01726049|7472519|FG000|STARTED|Overall Study||26
6550631|NCT01726049|7472520|FG001|STARTED|Overall Study||26
6550632|NCT01726049|7472519|FG000|COMPLETED|Overall Study||21
6550633|NCT01726049|7472520|FG001|COMPLETED|Overall Study||22
6550634|NCT01726049|7472519|FG000|NOT COMPLETED|Overall Study||5
6550635|NCT01726049|7472520|FG001|NOT COMPLETED|Overall Study||4
6550636|NCT01726270|7472526|FG000|STARTED|Part 1, Self-Selection Phase||689
6550637|NCT01726270|7472526|FG000|COMPLETED|Part 1, Self-Selection Phase||679
6550638|NCT01726270|7472526|FG000|NOT COMPLETED|Part 1, Self-Selection Phase||10
6550639|NCT01726270|7472526|FG000|STARTED|Eligibility for Part 2|No. of subjects potentially eligible for Part 2|389
6550640|NCT01726270|7472526|FG000|COMPLETED|Eligibility for Part 2||369
6550641|NCT01726270|7472526|FG000|NOT COMPLETED|Eligibility for Part 2||20
6550642|NCT01726270|7472526|FG000|STARTED|Part 2, Actual-Use Phase|20 subjects were eligible for Part 2 but did not enter Part 2|369
6550643|NCT01726270|7472526|FG000|COMPLETED|Part 2, Actual-Use Phase||330
6550644|NCT01726270|7472526|FG000|NOT COMPLETED|Part 2, Actual-Use Phase||39
6550645|NCT01726335|7472532|FG000|STARTED|Overall Study||53
6550646|NCT01726335|7472532|FG000|COMPLETED|Overall Study||29
6550647|NCT01726335|7472532|FG000|NOT COMPLETED|Overall Study||24
6550648|NCT01726504|7472538|FG000|STARTED|Overall Study||536
6550649|NCT01726504|7472539|FG001|STARTED|Overall Study||539
6550650|NCT01726504|7472538|FG000|COMPLETED|Overall Study||524
6550651|NCT01726504|7472539|FG001|COMPLETED|Overall Study||511
6550652|NCT01726504|7472538|FG000|NOT COMPLETED|Overall Study||12
6550653|NCT01726504|7472539|FG001|NOT COMPLETED|Overall Study||28
6550654|NCT01726517|7472550|FG000|STARTED|Overall Study||20
6550655|NCT01726517|7472551|FG001|STARTED|Overall Study||21
6550656|NCT01726517|7472552|FG002|STARTED|Overall Study||19
6550657|NCT01726517|7472553|FG003|STARTED|Overall Study||19
6550658|NCT01726517|7472554|FG004|STARTED|Overall Study||21
6550659|NCT01726517|7472550|FG000|COMPLETED|Overall Study||20
6550660|NCT01726517|7472551|FG001|COMPLETED|Overall Study||21
6550661|NCT01726517|7472552|FG002|COMPLETED|Overall Study||18
6550662|NCT01726517|7472553|FG003|COMPLETED|Overall Study||19
6550663|NCT01726517|7472554|FG004|COMPLETED|Overall Study||21
6550664|NCT01726517|7472550|FG000|NOT COMPLETED|Overall Study||0
6550665|NCT01726517|7472551|FG001|NOT COMPLETED|Overall Study||0
6550666|NCT01726517|7472552|FG002|NOT COMPLETED|Overall Study||1
6550667|NCT01726517|7472553|FG003|NOT COMPLETED|Overall Study||0
6550668|NCT01726517|7472554|FG004|NOT COMPLETED|Overall Study||0
6550669|NCT01726621|7472566|FG000|STARTED|Overall Study||55
6550670|NCT01726621|7472566|FG000|COMPLETED|Overall Study||51
6550671|NCT01726621|7472566|FG000|NOT COMPLETED|Overall Study||4
6648089|NCT02393950|7577223|FG001|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
6648090|NCT02393950|7577222|FG000|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
6648091|NCT02393950|7577223|FG001|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
6648092|NCT02393950|7577222|FG000|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
6648093|NCT02393950|7577223|FG001|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
6648094|NCT02393950|7577222|FG000|COMPLETED|Overall Study||8
6648095|NCT02393950|7577223|FG001|COMPLETED|Overall Study||8
6648096|NCT02393950|7577222|FG000|NOT COMPLETED|Overall Study||1
6648097|NCT02393950|7577223|FG001|NOT COMPLETED|Overall Study||1
6648098|NCT02394275|7577258|FG000|STARTED|Overall Study||140
6648099|NCT02394275|7577258|FG000|Safety Population|Overall Study||133
6648100|NCT02394275|7577258|FG000|Evaluable at 13 Weeks|Overall Study||133
6648101|NCT02394275|7577258|FG000|COMPLETED|Overall Study||111
6648102|NCT02394275|7577258|FG000|NOT COMPLETED|Overall Study||29
6648103|NCT02394340|7577263|FG000|STARTED|Overall Study||20
6648104|NCT02394340|7577263|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
6648105|NCT02394340|7577263|FG000|COMPLETED|Overall Study||18
6648106|NCT02394340|7577263|FG000|NOT COMPLETED|Overall Study||2
6648107|NCT02394457|7577269|FG000|STARTED|Overall Study||15
6648108|NCT02394457|7577270|FG001|STARTED|Overall Study||13
6648109|NCT02394457|7577269|FG000|COMPLETED|Overall Study||15
6648110|NCT02394457|7577270|FG001|COMPLETED|Overall Study||13
6648111|NCT02394457|7577269|FG000|NOT COMPLETED|Overall Study||0
6648112|NCT02394457|7577270|FG001|NOT COMPLETED|Overall Study||0
6648113|NCT02394561|7577278|FG000|STARTED|CORE Phase||185
6648114|NCT02394561|7577279|FG001|STARTED|CORE Phase||246
6648115|NCT02394561|7577278|FG000|Full Analysis Set|CORE Phase||185
6648116|NCT02394561|7577279|FG001|Full Analysis Set|CORE Phase||246
6648117|NCT02394561|7577278|FG000|Safety Set|CORE Phase||185
6648118|NCT02394561|7577279|FG001|Safety Set|CORE Phase||246
6648119|NCT02394561|7577278|FG000|ITT Set|CORE Phase||184
6648120|NCT02394561|7577279|FG001|ITT Set|CORE Phase||246
6648121|NCT02394561|7577278|FG000|COMPLETED|CORE Phase||172
6648122|NCT02394561|7577279|FG001|COMPLETED|CORE Phase||227
6648123|NCT02394561|7577278|FG000|NOT COMPLETED|CORE Phase||13
6648124|NCT02394561|7577279|FG001|NOT COMPLETED|CORE Phase||19
6648125|NCT02394561|7577278|FG000|STARTED|Extension Phase||162
6648126|NCT02394561|7577279|FG001|STARTED|Extension Phase||219
6648127|NCT02394561|7577278|FG000|COMPLETED|Extension Phase||151
6648128|NCT02394561|7577279|FG001|COMPLETED|Extension Phase||207
6648129|NCT02394561|7577278|FG000|NOT COMPLETED|Extension Phase||11
6648130|NCT02394561|7577279|FG001|NOT COMPLETED|Extension Phase||12
6648131|NCT02394600|7577290|FG000|STARTED|Overall Study||47
6648132|NCT02394600|7577291|FG001|STARTED|Overall Study||46
6648133|NCT02394600|7577290|FG000|COMPLETED|Overall Study||43
6648134|NCT02394600|7577291|FG001|COMPLETED|Overall Study||44
6648135|NCT02394600|7577290|FG000|NOT COMPLETED|Overall Study||4
6648136|NCT02394600|7577291|FG001|NOT COMPLETED|Overall Study||2
6648137|NCT02394730|7577299|FG000|STARTED|Overall Study||34
6648138|NCT02394730|7577300|FG001|STARTED|Overall Study||31
6743915|NCT03338010|7671979|FG001|NOT COMPLETED|Overall Study||18
6743916|NCT03338023|7671987|FG000|STARTED|Overall Study||137
6743917|NCT03338023|7671988|FG001|STARTED|Overall Study||135
6743918|NCT03338023|7671987|FG000|Received at Least One Dose of Study Drug|Overall Study||137
6743919|NCT03338023|7671988|FG001|Received at Least One Dose of Study Drug|Overall Study||135
6743920|NCT03338023|7671987|FG000|COMPLETED|Overall Study||128
6743921|NCT03338023|7671988|FG001|COMPLETED|Overall Study||125
6743922|NCT03338023|7671987|FG000|NOT COMPLETED|Overall Study||9
6743923|NCT03338023|7671988|FG001|NOT COMPLETED|Overall Study||10
6550672|NCT01726673|7472572|FG000|STARTED|Overall Study||30
6550673|NCT01726673|7472573|FG001|STARTED|Overall Study||24
6648139|NCT02394730|7577299|FG000|COMPLETED|Overall Study||33
6648140|NCT02394730|7577300|FG001|COMPLETED|Overall Study||30
6648141|NCT02394730|7577299|FG000|NOT COMPLETED|Overall Study||1
6550674|NCT01726673|7472572|FG000|COMPLETED|Overall Study||24
6648142|NCT02394730|7577300|FG001|NOT COMPLETED|Overall Study||1
6648143|NCT02394756|7577306|FG000|STARTED|Period 1||7
6743924|NCT03338036|7671998|FG000|STARTED|Overall Study||0
6550675|NCT01726673|7472573|FG001|COMPLETED|Overall Study||21
6550676|NCT01726673|7472572|FG000|NOT COMPLETED|Overall Study||6
6648144|NCT02394756|7577307|FG001|STARTED|Period 1||7
6648145|NCT02394756|7577308|FG002|STARTED|Period 1||7
6550677|NCT01726673|7472573|FG001|NOT COMPLETED|Overall Study||3
6550678|NCT01726738|7472579|FG000|STARTED|Overall Study||17
6550679|NCT01726738|7472579|FG000|COMPLETED|Overall Study||17
6550680|NCT01726738|7472579|FG000|NOT COMPLETED|Overall Study||0
6550681|NCT01726803|7472585|FG000|STARTED|Overall Study||112
6550682|NCT01726803|7472586|FG001|STARTED|Overall Study||108
6550683|NCT01726803|7472585|FG000|COMPLETED|Overall Study||105
6550684|NCT01726803|7472586|FG001|COMPLETED|Overall Study||107
6648146|NCT02394756|7577309|FG003|STARTED|Period 1||7
6648147|NCT02394756|7577310|FG004|STARTED|Period 1||7
6648148|NCT02394756|7577311|FG005|STARTED|Period 1||7
6648149|NCT02394756|7577306|FG000|COMPLETED|Period 1||7
6648150|NCT02394756|7577307|FG001|COMPLETED|Period 1||6
6648151|NCT02394756|7577308|FG002|COMPLETED|Period 1||6
6648152|NCT02394756|7577309|FG003|COMPLETED|Period 1||6
6648153|NCT02394756|7577310|FG004|COMPLETED|Period 1||7
6648154|NCT02394756|7577311|FG005|COMPLETED|Period 1||6
6648155|NCT02394756|7577306|FG000|NOT COMPLETED|Period 1||0
6648156|NCT02394756|7577307|FG001|NOT COMPLETED|Period 1||1
6648157|NCT02394756|7577308|FG002|NOT COMPLETED|Period 1||1
6648158|NCT02394756|7577309|FG003|NOT COMPLETED|Period 1||1
6648159|NCT02394756|7577310|FG004|NOT COMPLETED|Period 1||0
6648160|NCT02394756|7577311|FG005|NOT COMPLETED|Period 1||1
6648161|NCT02394756|7577306|FG000|STARTED|Period 2||7
6648162|NCT02394756|7577307|FG001|STARTED|Period 2||6
6648163|NCT02394756|7577308|FG002|STARTED|Period 2||6
6648164|NCT02394756|7577309|FG003|STARTED|Period 2||6
6648165|NCT02394756|7577310|FG004|STARTED|Period 2||7
6648166|NCT02394756|7577311|FG005|STARTED|Period 2||6
6648167|NCT02394756|7577306|FG000|COMPLETED|Period 2||7
6648168|NCT02394756|7577307|FG001|COMPLETED|Period 2||6
6648169|NCT02394756|7577308|FG002|COMPLETED|Period 2||6
6648170|NCT02394756|7577309|FG003|COMPLETED|Period 2||6
6648171|NCT02394756|7577310|FG004|COMPLETED|Period 2||6
6648172|NCT02394756|7577311|FG005|COMPLETED|Period 2||6
6648173|NCT02394756|7577306|FG000|NOT COMPLETED|Period 2||0
6648174|NCT02394756|7577307|FG001|NOT COMPLETED|Period 2||0
6648175|NCT02394756|7577308|FG002|NOT COMPLETED|Period 2||0
6648176|NCT02394756|7577309|FG003|NOT COMPLETED|Period 2||0
6648177|NCT02394756|7577310|FG004|NOT COMPLETED|Period 2||1
6648178|NCT02394756|7577311|FG005|NOT COMPLETED|Period 2||0
6648179|NCT02394756|7577306|FG000|STARTED|Period 3||7
6648180|NCT02394756|7577307|FG001|STARTED|Period 3||6
6648181|NCT02394756|7577308|FG002|STARTED|Period 3||6
6648182|NCT02394756|7577309|FG003|STARTED|Period 3||6
6648183|NCT02394756|7577310|FG004|STARTED|Period 3||6
6648184|NCT02394756|7577311|FG005|STARTED|Period 3||6
6648185|NCT02394756|7577306|FG000|COMPLETED|Period 3||7
6648186|NCT02394756|7577307|FG001|COMPLETED|Period 3||6
6648187|NCT02394756|7577308|FG002|COMPLETED|Period 3||6
6648188|NCT02394756|7577309|FG003|COMPLETED|Period 3||6
6648189|NCT02394756|7577310|FG004|COMPLETED|Period 3||6
6648190|NCT02394756|7577311|FG005|COMPLETED|Period 3||6
6648191|NCT02394756|7577306|FG000|NOT COMPLETED|Period 3||0
6648192|NCT02394756|7577307|FG001|NOT COMPLETED|Period 3||0
6648193|NCT02394756|7577308|FG002|NOT COMPLETED|Period 3||0
6648194|NCT02394756|7577309|FG003|NOT COMPLETED|Period 3||0
6648195|NCT02394756|7577310|FG004|NOT COMPLETED|Period 3||0
6648196|NCT02394756|7577311|FG005|NOT COMPLETED|Period 3||0
6648197|NCT02394769|7577322|FG000|STARTED|Overall Study||60
6648198|NCT02394769|7577323|FG001|STARTED|Overall Study||60
6648199|NCT02394769|7577324|FG002|STARTED|Overall Study||60
6648200|NCT02394769|7577322|FG000|COMPLETED|Overall Study||58
6648201|NCT02394769|7577323|FG001|COMPLETED|Overall Study||57
6648202|NCT02394769|7577324|FG002|COMPLETED|Overall Study||54
6648203|NCT02394769|7577322|FG000|NOT COMPLETED|Overall Study||2
6648204|NCT02394769|7577323|FG001|NOT COMPLETED|Overall Study||3
6648205|NCT02394769|7577324|FG002|NOT COMPLETED|Overall Study||6
6648206|NCT02394808|7577332|FG000|STARTED|Period 1||25
6550685|NCT01726803|7472585|FG000|NOT COMPLETED|Overall Study||7
6550686|NCT01726803|7472586|FG001|NOT COMPLETED|Overall Study||1
6550687|NCT01727024|7472592|FG000|STARTED|Period 1||71
6550688|NCT01727024|7472593|FG001|STARTED|Period 1||68
6550689|NCT01727024|7472592|FG000|COMPLETED|Period 1||68
6550690|NCT01727024|7472593|FG001|COMPLETED|Period 1||64
6550691|NCT01727024|7472592|FG000|NOT COMPLETED|Period 1||3
6648207|NCT02394808|7577333|FG001|STARTED|Period 1||29
6550692|NCT01727024|7472593|FG001|NOT COMPLETED|Period 1||4
6550693|NCT01727024|7472592|FG000|STARTED|Period 2||68
6550694|NCT01727024|7472593|FG001|STARTED|Period 2||64
6550695|NCT01727024|7472592|FG000|COMPLETED|Period 2||68
6648208|NCT02394808|7577332|FG000|COMPLETED|Period 1||25
6648209|NCT02394808|7577333|FG001|COMPLETED|Period 1||28
6648210|NCT02394808|7577332|FG000|NOT COMPLETED|Period 1||0
6648211|NCT02394808|7577333|FG001|NOT COMPLETED|Period 1||1
6648212|NCT02394808|7577332|FG000|STARTED|Period 2||25
6648213|NCT02394808|7577333|FG001|STARTED|Period 2||28
6648214|NCT02394808|7577332|FG000|COMPLETED|Period 2||24
6648215|NCT02394808|7577333|FG001|COMPLETED|Period 2||28
6648216|NCT02394808|7577332|FG000|NOT COMPLETED|Period 2||1
6648217|NCT02394808|7577333|FG001|NOT COMPLETED|Period 2||0
6648218|NCT02394912|7577339|FG000|STARTED|Overall Study||21
6648219|NCT02394912|7577339|FG000|COMPLETED|Overall Study||21
6648220|NCT02394912|7577339|FG000|NOT COMPLETED|Overall Study||0
6648221|NCT02394925|7577345|FG000|STARTED|Overall Study||108
6648222|NCT02394925|7577345|FG000|COMPLETED|Overall Study||79
6648223|NCT02394925|7577345|FG000|NOT COMPLETED|Overall Study||29
6648224|NCT02394951|7577351|FG000|STARTED|Period I||12
6550696|NCT01727024|7472593|FG001|COMPLETED|Period 2||64
6550697|NCT01727024|7472592|FG000|NOT COMPLETED|Period 2||0
6550698|NCT01727024|7472593|FG001|NOT COMPLETED|Period 2||0
6550699|NCT01727089|7472601|FG000|STARTED|Overall Study||29
6550700|NCT01727089|7472602|FG001|STARTED|Overall Study||30
6550701|NCT01727089|7472601|FG000|COMPLETED|Overall Study||29
6550702|NCT01727089|7472602|FG001|COMPLETED|Overall Study||30
6648225|NCT02394951|7577352|FG001|STARTED|Period I||14
6648226|NCT02394951|7577351|FG000|COMPLETED|Period I||11
6648227|NCT02394951|7577352|FG001|COMPLETED|Period I||13
6648228|NCT02394951|7577351|FG000|NOT COMPLETED|Period I||1
6648229|NCT02394951|7577352|FG001|NOT COMPLETED|Period I||1
6648230|NCT02394951|7577351|FG000|STARTED|Period II||11
6648231|NCT02394951|7577352|FG001|STARTED|Period II||13
6648232|NCT02394951|7577351|FG000|COMPLETED|Period II||11
6648233|NCT02394951|7577352|FG001|COMPLETED|Period II||9
6648234|NCT02394951|7577351|FG000|NOT COMPLETED|Period II||0
6648235|NCT02394951|7577352|FG001|NOT COMPLETED|Period II||4
6648236|NCT02395042|7577361|FG000|STARTED|Treatment 1 Period||12
6648237|NCT02395042|7577362|FG001|STARTED|Treatment 1 Period||31
6648238|NCT02395042|7577363|FG002|STARTED|Treatment 1 Period||16
6648239|NCT02395042|7577361|FG000|COMPLETED|Treatment 1 Period||9
6648240|NCT02395042|7577362|FG001|COMPLETED|Treatment 1 Period||25
6648241|NCT02395042|7577363|FG002|COMPLETED|Treatment 1 Period||14
6648242|NCT02395042|7577361|FG000|NOT COMPLETED|Treatment 1 Period||3
6648243|NCT02395042|7577362|FG001|NOT COMPLETED|Treatment 1 Period||6
6648244|NCT02395042|7577363|FG002|NOT COMPLETED|Treatment 1 Period||2
6648245|NCT02395042|7577361|FG000|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|10
6648246|NCT02395042|7577362|FG001|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|24
6648247|NCT02395042|7577363|FG002|STARTED|Treatment 2 Period|Not all participants participated in Treatment 2 Period.|13
6648248|NCT02395042|7577361|FG000|COMPLETED|Treatment 2 Period||9
6648249|NCT02395042|7577362|FG001|COMPLETED|Treatment 2 Period||23
6648250|NCT02395042|7577363|FG002|COMPLETED|Treatment 2 Period||13
6648251|NCT02395042|7577361|FG000|NOT COMPLETED|Treatment 2 Period||1
6648252|NCT02395042|7577362|FG001|NOT COMPLETED|Treatment 2 Period||1
6648253|NCT02395042|7577363|FG002|NOT COMPLETED|Treatment 2 Period||0
6648254|NCT02395055|7577376|FG000|STARTED|Overall Study||47
6648255|NCT02395055|7577377|FG001|STARTED|Overall Study||47
6648256|NCT02395055|7577376|FG000|COMPLETED|Overall Study||40
6648257|NCT02395055|7577377|FG001|COMPLETED|Overall Study||44
6648258|NCT02395055|7577376|FG000|NOT COMPLETED|Overall Study||7
6648259|NCT02395055|7577377|FG001|NOT COMPLETED|Overall Study||3
6648260|NCT02395081|7577386|FG000|STARTED|Overall Study||119
6648261|NCT02395081|7577387|FG001|STARTED|Overall Study||121
6648262|NCT02395081|7577388|FG002|STARTED|Overall Study||120
6648263|NCT02395081|7577386|FG000|COMPLETED|Overall Study||112
6648264|NCT02395081|7577387|FG001|COMPLETED|Overall Study||116
6648265|NCT02395081|7577388|FG002|COMPLETED|Overall Study||116
6648266|NCT02395081|7577386|FG000|NOT COMPLETED|Overall Study||7
6648267|NCT02395081|7577387|FG001|NOT COMPLETED|Overall Study||5
6648268|NCT02395081|7577388|FG002|NOT COMPLETED|Overall Study||4
6648269|NCT02395133|7577403|FG000|STARTED|Overall Study||83
6648270|NCT02395133|7577404|FG001|STARTED|Overall Study||84
6648271|NCT02395133|7577405|FG002|STARTED|Overall Study||86
6648272|NCT02395133|7577406|FG003|STARTED|Overall Study||169
6648273|NCT02395133|7577403|FG000|COMPLETED|Overall Study||69
6648274|NCT02395133|7577404|FG001|COMPLETED|Overall Study||75
6648275|NCT02395133|7577405|FG002|COMPLETED|Overall Study||76
6648276|NCT02395133|7577406|FG003|COMPLETED|Overall Study||155
6648277|NCT02395133|7577403|FG000|NOT COMPLETED|Overall Study||14
6648278|NCT02395133|7577404|FG001|NOT COMPLETED|Overall Study||9
6648279|NCT02395133|7577405|FG002|NOT COMPLETED|Overall Study||10
6648280|NCT02395133|7577406|FG003|NOT COMPLETED|Overall Study||14
6648281|NCT02395172|7577418|FG000|STARTED|Overall Study||396
6648282|NCT02395172|7577419|FG001|STARTED|Overall Study||396
6648283|NCT02395172|7577418|FG000|Treated|Overall Study||393
6648284|NCT02395172|7577419|FG001|Treated|Overall Study||365
6648285|NCT02395172|7577418|FG000|COMPLETED|Overall Study||393
6648286|NCT02395172|7577419|FG001|COMPLETED|Overall Study||365
6648287|NCT02395172|7577418|FG000|NOT COMPLETED|Overall Study||3
6648288|NCT02395172|7577419|FG001|NOT COMPLETED|Overall Study||31
6648289|NCT02395185|7577425|FG000|STARTED|Overall Study|32 guardians participated with these infants. one infant did not have a guardian participate.|33
6648290|NCT02395185|7577425|FG000|Sequence 1 (s,s,m,m,w,w)|Overall Study|one of the participants in this milestone did not have a guardian enrolled due to age.|2
6550703|NCT01727089|7472601|FG000|NOT COMPLETED|Overall Study||0
6648291|NCT02395185|7577425|FG000|Sequence 2 (w,s,s,m,m,w)|Overall Study||2
6648292|NCT02395185|7577425|FG000|Sequence 3 (w,w,s,s,m,m)|Overall Study||2
6648293|NCT02395185|7577425|FG000|Sequence 4 (m,w,w,s,s,m)|Overall Study||2
6648294|NCT02395185|7577425|FG000|Sequence 5 (m,m,w,w,s,s)|Overall Study||2
6648295|NCT02395185|7577425|FG000|Sequence 6 (s,m,m,w,w,s)|Overall Study||2
6648296|NCT02395185|7577425|FG000|Sequence 7 (s,s,w,w,m,m)|Overall Study||2
6648297|NCT02395185|7577425|FG000|Sequence 8 (m,s,s,w,w,m)|Overall Study||2
6648298|NCT02395185|7577425|FG000|Sequence 9 (m,m,s,s,w,w)|Overall Study||2
6648299|NCT02395185|7577425|FG000|Sequence 10 (w,m,m,s,s,w)|Overall Study||2
6550704|NCT01727089|7472602|FG001|NOT COMPLETED|Overall Study||0
6550705|NCT01727141|7472612|FG000|STARTED|Overall Study||260
6648300|NCT02395185|7577425|FG000|Sequence 11 (w,w,m,m,s,s)|Overall Study||2
6648301|NCT02395185|7577425|FG000|Sequence 12 (s,w,w,m,m,s)|Overall Study||2
6648302|NCT02395185|7577425|FG000|Sequence 13 (s,m,w,m,s,w)|Overall Study||2
6648303|NCT02395185|7577425|FG000|Sequence 14 (w,s,m,w,m,s)|Overall Study||2
6648304|NCT02395185|7577425|FG000|Sequence 15 (s,w,s,m,w,m)|Overall Study||2
6648305|NCT02395185|7577425|FG000|Sequence 16 (m,s,w,s,m,w)|Overall Study||1
6648306|NCT02395185|7577425|FG000|Sequence 17 (w,m,s,w,s,m)|Overall Study||1
6648307|NCT02395185|7577425|FG000|Sequence 18 (m,w,m,s,w,s)|Overall Study||1
6648308|NCT02395185|7577425|FG000|COMPLETED|Overall Study||33
6648309|NCT02395185|7577425|FG000|NOT COMPLETED|Overall Study||0
6648310|NCT02395302|7577433|FG000|STARTED|Overall Study||28
6648311|NCT02395302|7577433|FG000|COMPLETED|Overall Study||14
6648312|NCT02395302|7577433|FG000|NOT COMPLETED|Overall Study||14
6648313|NCT02395471|7577439|FG000|STARTED|Overall Study||129
6648314|NCT02395471|7577440|FG001|STARTED|Overall Study||62
6648315|NCT02395471|7577439|FG000|COMPLETED|Overall Study||122
6648316|NCT02395471|7577440|FG001|COMPLETED|Overall Study||59
6648317|NCT02395471|7577439|FG000|NOT COMPLETED|Overall Study||7
6648318|NCT02395471|7577440|FG001|NOT COMPLETED|Overall Study||3
6648319|NCT02395536|7577457|FG000|STARTED|Overall Study||264
6648320|NCT02395536|7577458|FG001|STARTED|Overall Study||257
6648321|NCT02395536|7577457|FG000|REVEAL LINQ Insertion|Overall Study||251
6648322|NCT02395536|7577458|FG001|REVEAL LINQ Insertion|Overall Study||231
6648323|NCT02395536|7577457|FG000|COMPLETED|Overall Study||244
6648324|NCT02395536|7577458|FG001|COMPLETED|Overall Study||227
6648325|NCT02395536|7577457|FG000|NOT COMPLETED|Overall Study||20
6648326|NCT02395536|7577458|FG001|NOT COMPLETED|Overall Study||30
6648327|NCT02395627|7577467|FG000|STARTED|Overall Study||18
6648328|NCT02395627|7577468|FG001|STARTED|Overall Study||16
6648329|NCT02395627|7577469|FG002|STARTED|Overall Study||4
6648330|NCT02395627|7577467|FG000|COMPLETED|Overall Study||15
6648331|NCT02395627|7577468|FG001|COMPLETED|Overall Study||13
6648332|NCT02395627|7577469|FG002|COMPLETED|Overall Study||4
6648333|NCT02395627|7577467|FG000|NOT COMPLETED|Overall Study||3
6648334|NCT02395627|7577468|FG001|NOT COMPLETED|Overall Study||3
6648335|NCT02395627|7577469|FG002|NOT COMPLETED|Overall Study||0
6648336|NCT02395653|7577479|FG000|STARTED|Overall Study||71
6648337|NCT02395653|7577479|FG000|Received at Least 1 Dose of Study Drug|Overall Study||61
6648338|NCT02395653|7577479|FG000|COMPLETED|Overall Study||59
6648339|NCT02395653|7577479|FG000|NOT COMPLETED|Overall Study||12
6648340|NCT02395692|7577483|FG000|STARTED|Overall Study||19
6648341|NCT02395692|7577484|FG001|STARTED|Overall Study||0
6648342|NCT02395692|7577483|FG000|COMPLETED|Overall Study||19
6648343|NCT02395692|7577484|FG001|COMPLETED|Overall Study||0
6648344|NCT02395692|7577483|FG000|NOT COMPLETED|Overall Study||0
6648345|NCT02395692|7577484|FG001|NOT COMPLETED|Overall Study||0
6648346|NCT02395822|7577491|FG000|STARTED|Overall Study||17
6648347|NCT02395822|7577491|FG000|COMPLETED|Overall Study||15
6648348|NCT02395822|7577491|FG000|NOT COMPLETED|Overall Study||2
6648349|NCT02395978|7577500|FG000|STARTED|Overall Study||6
6648350|NCT02395978|7577501|FG001|STARTED|Overall Study||6
6648351|NCT02395978|7577502|FG002|STARTED|Overall Study||21
6648352|NCT02395978|7577503|FG003|STARTED|Overall Study||19
6648353|NCT02395978|7577504|FG004|STARTED|Overall Study||20
6648354|NCT02395978|7577500|FG000|COMPLETED|Overall Study||6
6648355|NCT02395978|7577501|FG001|COMPLETED|Overall Study||6
6648356|NCT02395978|7577502|FG002|COMPLETED|Overall Study||19
6648357|NCT02395978|7577503|FG003|COMPLETED|Overall Study||14
6648358|NCT02395978|7577504|FG004|COMPLETED|Overall Study||15
6648359|NCT02395978|7577500|FG000|NOT COMPLETED|Overall Study||0
6648360|NCT02395978|7577501|FG001|NOT COMPLETED|Overall Study||0
6648361|NCT02395978|7577502|FG002|NOT COMPLETED|Overall Study||2
6648362|NCT02395978|7577503|FG003|NOT COMPLETED|Overall Study||5
6648363|NCT02395978|7577504|FG004|NOT COMPLETED|Overall Study||5
6648364|NCT02395991|7577517|FG000|STARTED|Overall Study||60
6648365|NCT02395991|7577517|FG000|COMPLETED|Overall Study||59
6648366|NCT02395991|7577517|FG000|NOT COMPLETED|Overall Study||1
6648367|NCT02396147|7577524|FG000|STARTED|Period 1||27
6648368|NCT02396147|7577525|FG001|STARTED|Period 1||27
6648369|NCT02396147|7577524|FG000|COMPLETED|Period 1||27
6648370|NCT02396147|7577525|FG001|COMPLETED|Period 1||27
6648371|NCT02396147|7577524|FG000|NOT COMPLETED|Period 1||0
6648372|NCT02396147|7577525|FG001|NOT COMPLETED|Period 1||0
6648373|NCT02396147|7577524|FG000|STARTED|Period 2||27
6648374|NCT02396147|7577525|FG001|STARTED|Period 2||27
6648375|NCT02396147|7577524|FG000|COMPLETED|Period 2||27
6648376|NCT02396147|7577525|FG001|COMPLETED|Period 2||27
6648377|NCT02396147|7577524|FG000|NOT COMPLETED|Period 2||0
6648378|NCT02396147|7577525|FG001|NOT COMPLETED|Period 2||0
6648379|NCT02396147|7577524|FG000|STARTED|Period 3||27
6648380|NCT02396147|7577525|FG001|STARTED|Period 3||27
6648381|NCT02396147|7577524|FG000|COMPLETED|Period 3||27
6648382|NCT02396147|7577525|FG001|COMPLETED|Period 3||27
6648383|NCT02396147|7577524|FG000|NOT COMPLETED|Period 3||0
6648384|NCT02396147|7577525|FG001|NOT COMPLETED|Period 3||0
6648385|NCT02396160|7577541|FG000|STARTED|Overall Study||75
6648386|NCT02396160|7577542|FG001|STARTED|Overall Study||75
6648387|NCT02396160|7577541|FG000|COMPLETED|Overall Study||69
6648388|NCT02396160|7577542|FG001|COMPLETED|Overall Study||73
6648389|NCT02396160|7577541|FG000|NOT COMPLETED|Overall Study||6
6648390|NCT02396160|7577542|FG001|NOT COMPLETED|Overall Study||2
6656007|NCT02457520|7586151|FG000|COMPLETED|Active Treatment Phase||167
6656008|NCT02457520|7586151|FG000|NOT COMPLETED|Active Treatment Phase||34
6656009|NCT02457520|7586151|FG000|STARTED|Post-treatment Period||167
6656010|NCT02457520|7586151|FG000|COMPLETED|Post-treatment Period||119
6648391|NCT02396212|7577548|FG000|STARTED|Overall Study||19
6648392|NCT02396212|7577548|FG000|COMPLETED|Overall Study||16
6648393|NCT02396212|7577548|FG000|NOT COMPLETED|Overall Study||3
6648394|NCT02396251|7577554|FG000|STARTED|Overall Study||36
6648395|NCT02396251|7577555|FG001|STARTED|Overall Study||12
6648396|NCT02396251|7577554|FG000|COMPLETED|Overall Study||23
6648397|NCT02396251|7577555|FG001|COMPLETED|Overall Study||7
6648398|NCT02396251|7577554|FG000|NOT COMPLETED|Overall Study||13
6648399|NCT02396251|7577555|FG001|NOT COMPLETED|Overall Study||5
6648400|NCT02396316|7577562|FG000|STARTED|Overall Study||27
6648401|NCT02396316|7577563|FG001|STARTED|Overall Study||27
6648402|NCT02396316|7577562|FG000|Treated|Overall Study||27
6648403|NCT02396316|7577563|FG001|Treated|Overall Study||27
6648404|NCT02396316|7577562|FG000|Received Sham Injection at Week 1|Overall Study||10
6648405|NCT02396316|7577563|FG001|Received Sham Injection at Week 1|Overall Study||0
6648406|NCT02396316|7577562|FG000|Received AFL Injection at Week 1|Overall Study||0
6648407|NCT02396316|7577563|FG001|Received AFL Injection at Week 1|Overall Study||22
6648408|NCT02396316|7577562|FG000|Received Active Injection at Week 5|Overall Study||4
6648409|NCT02396316|7577563|FG001|Received Active Injection at Week 5|Overall Study||4
6648410|NCT02396316|7577562|FG000|Received Active Injection at Week 9|Overall Study||2
6648411|NCT02396316|7577563|FG001|Received Active Injection at Week 9|Overall Study||1
6648412|NCT02396316|7577562|FG000|COMPLETED|Overall Study||20
6648413|NCT02396316|7577563|FG001|COMPLETED|Overall Study||22
6648414|NCT02396316|7577562|FG000|NOT COMPLETED|Overall Study||7
6648415|NCT02396316|7577563|FG001|NOT COMPLETED|Overall Study||5
6648416|NCT02396381|7577575|FG000|STARTED|Overall Study||488
6648417|NCT02396381|7577576|FG001|STARTED|Overall Study||496
6648418|NCT02396381|7577575|FG000|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||414
6648419|NCT02396381|7577576|FG001|Full Analysis Set - As Exposed (FAS-EX)|Overall Study||443
6648420|NCT02396381|7577575|FG000|COMPLETED|Overall Study||381
6648421|NCT02396381|7577576|FG001|COMPLETED|Overall Study||422
6648422|NCT02396381|7577575|FG000|NOT COMPLETED|Overall Study||107
6648423|NCT02396381|7577576|FG001|NOT COMPLETED|Overall Study||74
6648424|NCT02396420|7577585|FG000|STARTED|Overall Study||2
6648425|NCT02396420|7577585|FG000|1 Month Post PAE|Overall Study||2
6648426|NCT02396420|7577585|FG000|3 Months Post PAE|Overall Study||2
6648427|NCT02396420|7577585|FG000|6 Months Post PAE|Overall Study||2
6648428|NCT02396420|7577585|FG000|COMPLETED|Overall Study||1
6648429|NCT02396420|7577585|FG000|NOT COMPLETED|Overall Study||1
6648430|NCT02396511|7577590|FG000|STARTED|Overall Study||2
6648431|NCT02396511|7577590|FG000|COMPLETED|Overall Study||2
6648432|NCT02396511|7577590|FG000|NOT COMPLETED|Overall Study||0
6648433|NCT02396537|7577596|FG000|STARTED|Overall Study||40
6648434|NCT02396537|7577597|FG001|STARTED|Overall Study||37
6648435|NCT02396537|7577596|FG000|COMPLETED|Overall Study||40
6648436|NCT02396537|7577597|FG001|COMPLETED|Overall Study||36
6648437|NCT02396537|7577596|FG000|NOT COMPLETED|Overall Study||0
6648438|NCT02396537|7577597|FG001|NOT COMPLETED|Overall Study||1
6648439|NCT02396732|7577605|FG000|STARTED|Overall Study||14
6648440|NCT02396732|7577606|FG001|STARTED|Overall Study||17
6648441|NCT02396732|7577605|FG000|COMPLETED|Overall Study||14
6648442|NCT02396732|7577606|FG001|COMPLETED|Overall Study||17
6648443|NCT02396732|7577605|FG000|NOT COMPLETED|Overall Study||0
6648444|NCT02396732|7577606|FG001|NOT COMPLETED|Overall Study||0
6648445|NCT02396745|7577612|FG000|STARTED|Overall Study||1
6648446|NCT02396745|7577612|FG000|COMPLETED|Overall Study||1
6648447|NCT02396745|7577612|FG000|NOT COMPLETED|Overall Study||0
6648448|NCT02396758|7577620|FG000|STARTED|Overall Study||38
6648449|NCT02396758|7577621|FG001|STARTED|Overall Study||37
6648450|NCT02396758|7577622|FG002|STARTED|Overall Study||38
6648451|NCT02396758|7577623|FG003|STARTED|Overall Study||18
6648452|NCT02396758|7577620|FG000|COMPLETED|Overall Study||26
6648453|NCT02396758|7577621|FG001|COMPLETED|Overall Study||31
6648454|NCT02396758|7577622|FG002|COMPLETED|Overall Study||34
6550706|NCT01727141|7472613|FG001|STARTED|Overall Study||260
6550707|NCT01727141|7472614|FG002|STARTED|Overall Study||261
6550708|NCT01727141|7472615|FG003|STARTED|Overall Study||261
6550709|NCT01727141|7472612|FG000|Safety Set|Overall Study||258
6550710|NCT01727141|7472613|FG001|Safety Set|Overall Study||260
6550711|NCT01727141|7472614|FG002|Safety Set|Overall Study||262
6550712|NCT01727141|7472615|FG003|Safety Set|Overall Study||260
6550713|NCT01727141|7472612|FG000|Full Analysis Set|Overall Study||258
6550714|NCT01727141|7472613|FG001|Full Analysis Set|Overall Study||260
6550715|NCT01727141|7472614|FG002|Full Analysis Set|Overall Study||261
6550716|NCT01727141|7472615|FG003|Full Analysis Set|Overall Study||261
6550717|NCT01727141|7472612|FG000|COMPLETED|Overall Study||255
6550718|NCT01727141|7472613|FG001|COMPLETED|Overall Study||251
6648455|NCT02396758|7577623|FG003|COMPLETED|Overall Study||13
6648456|NCT02396758|7577620|FG000|NOT COMPLETED|Overall Study||12
6648457|NCT02396758|7577621|FG001|NOT COMPLETED|Overall Study||6
6648458|NCT02396758|7577622|FG002|NOT COMPLETED|Overall Study||4
6648459|NCT02396758|7577623|FG003|NOT COMPLETED|Overall Study||5
6648460|NCT02396849|7577635|FG000|STARTED|Overall Study||29
6648461|NCT02396849|7577636|FG001|STARTED|Overall Study||30
6648462|NCT02396849|7577635|FG000|COMPLETED|Overall Study||27
6648463|NCT02396849|7577636|FG001|COMPLETED|Overall Study||28
6648464|NCT02396849|7577635|FG000|NOT COMPLETED|Overall Study||2
6648465|NCT02396849|7577636|FG001|NOT COMPLETED|Overall Study||2
6648466|NCT02396953|7577647|FG000|STARTED|Overall Study||9
6550719|NCT01727141|7472614|FG002|COMPLETED|Overall Study||258
6550720|NCT01727141|7472615|FG003|COMPLETED|Overall Study||246
6648467|NCT02396953|7577648|FG001|STARTED|Overall Study||9
6648468|NCT02396953|7577649|FG002|STARTED|Overall Study||10
6648469|NCT02396953|7577647|FG000|COMPLETED|Overall Study||5
6648470|NCT02396953|7577648|FG001|COMPLETED|Overall Study||6
6648471|NCT02396953|7577649|FG002|COMPLETED|Overall Study||7
6648472|NCT02396953|7577647|FG000|NOT COMPLETED|Overall Study||4
6648473|NCT02396953|7577648|FG001|NOT COMPLETED|Overall Study||3
6648474|NCT02396953|7577649|FG002|NOT COMPLETED|Overall Study||3
6648475|NCT02397057|7577666|FG000|STARTED|Overall Study|"Two Normal Saline participants received Injectafer. The data presented is considered accurate."|105
6648476|NCT02397057|7577667|FG001|STARTED|Overall Study||104
6648477|NCT02397057|7577666|FG000|COMPLETED|Overall Study||94
6648478|NCT02397057|7577667|FG001|COMPLETED|Overall Study||91
6648479|NCT02397057|7577666|FG000|NOT COMPLETED|Overall Study||11
6648480|NCT02397057|7577667|FG001|NOT COMPLETED|Overall Study||13
6648481|NCT02397096|7577675|FG000|STARTED|Day 1 to Week 24||447
6648482|NCT02397096|7577676|FG001|STARTED|Day 1 to Week 24||223
6648483|NCT02397096|7577675|FG000|COMPLETED|Day 1 to Week 24||427
6648484|NCT02397096|7577676|FG001|COMPLETED|Day 1 to Week 24||209
6648485|NCT02397096|7577675|FG000|NOT COMPLETED|Day 1 to Week 24||20
6648486|NCT02397096|7577676|FG001|NOT COMPLETED|Day 1 to Week 24||14
6648487|NCT02397096|7577675|FG000|STARTED|Week 24 to Week 48||427
6648488|NCT02397096|7577676|FG001|STARTED|Week 24 to Week 48||209
6648489|NCT02397096|7577675|FG000|COMPLETED|Week 24 to Week 48||407
6648490|NCT02397096|7577676|FG001|COMPLETED|Week 24 to Week 48||202
6648491|NCT02397096|7577675|FG000|NOT COMPLETED|Week 24 to Week 48||20
6648492|NCT02397096|7577676|FG001|NOT COMPLETED|Week 24 to Week 48||7
6648493|NCT02397096|7577675|FG000|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|399
6648494|NCT02397096|7577676|FG001|STARTED|Study Extensions|The extension study is optional; not all eligible participants enrolled.|202
6648495|NCT02397096|7577675|FG000|COMPLETED|Study Extensions|The extension study is ongoing.|0
6648496|NCT02397096|7577676|FG001|COMPLETED|Study Extensions|The extension study is ongoing.|0
6648497|NCT02397096|7577675|FG000|NOT COMPLETED|Study Extensions||399
6648498|NCT02397096|7577676|FG001|NOT COMPLETED|Study Extensions||202
6648499|NCT02397122|7577688|FG000|STARTED|Overall Study||20
6648500|NCT02397122|7577689|FG001|STARTED|Overall Study||20
6648501|NCT02397122|7577688|FG000|COMPLETED|Overall Study||20
6648502|NCT02397122|7577689|FG001|COMPLETED|Overall Study||20
6648503|NCT02397122|7577688|FG000|NOT COMPLETED|Overall Study||0
6648504|NCT02397122|7577689|FG001|NOT COMPLETED|Overall Study||0
6648505|NCT02397265|7577699|FG000|STARTED|First Intervention of Three||2
6648506|NCT02397265|7577700|FG001|STARTED|First Intervention of Three||2
6648507|NCT02397265|7577701|FG002|STARTED|First Intervention of Three||2
6648508|NCT02397265|7577699|FG000|COMPLETED|First Intervention of Three||2
6648509|NCT02397265|7577700|FG001|COMPLETED|First Intervention of Three||2
6648510|NCT02397265|7577701|FG002|COMPLETED|First Intervention of Three||2
6648511|NCT02397265|7577699|FG000|NOT COMPLETED|First Intervention of Three||0
6648512|NCT02397265|7577700|FG001|NOT COMPLETED|First Intervention of Three||0
6648513|NCT02397265|7577701|FG002|NOT COMPLETED|First Intervention of Three||0
6648514|NCT02397265|7577699|FG000|STARTED|Second Intervention of Three||2
6648515|NCT02397265|7577700|FG001|STARTED|Second Intervention of Three||2
6648516|NCT02397265|7577701|FG002|STARTED|Second Intervention of Three||2
6648517|NCT02397265|7577699|FG000|COMPLETED|Second Intervention of Three||2
6648518|NCT02397265|7577700|FG001|COMPLETED|Second Intervention of Three||2
6648519|NCT02397265|7577701|FG002|COMPLETED|Second Intervention of Three||2
6648520|NCT02397265|7577699|FG000|NOT COMPLETED|Second Intervention of Three||0
6648521|NCT02397265|7577700|FG001|NOT COMPLETED|Second Intervention of Three||0
6648522|NCT02397265|7577701|FG002|NOT COMPLETED|Second Intervention of Three||0
6648523|NCT02397265|7577699|FG000|STARTED|Third Intervention of Three||2
6648524|NCT02397265|7577700|FG001|STARTED|Third Intervention of Three||2
6648525|NCT02397265|7577701|FG002|STARTED|Third Intervention of Three||2
6648526|NCT02397265|7577699|FG000|COMPLETED|Third Intervention of Three||2
6648527|NCT02397265|7577700|FG001|COMPLETED|Third Intervention of Three||2
6648528|NCT02397265|7577701|FG002|COMPLETED|Third Intervention of Three||2
6648529|NCT02397265|7577699|FG000|NOT COMPLETED|Third Intervention of Three||0
6648530|NCT02397265|7577700|FG001|NOT COMPLETED|Third Intervention of Three||0
6648531|NCT02397265|7577701|FG002|NOT COMPLETED|Third Intervention of Three||0
6648532|NCT02397278|7577711|FG000|STARTED|Overall Study||7
6648533|NCT02397278|7577712|FG001|STARTED|Overall Study||8
6648534|NCT02397278|7577711|FG000|COMPLETED|Overall Study||6
6648535|NCT02397278|7577712|FG001|COMPLETED|Overall Study||5
6648536|NCT02397278|7577711|FG000|NOT COMPLETED|Overall Study||1
6648537|NCT02397278|7577712|FG001|NOT COMPLETED|Overall Study||3
6648538|NCT02397291|7577720|FG000|STARTED|Overall Study||19
6648539|NCT02397291|7577721|FG001|STARTED|Overall Study||5
6648540|NCT02397291|7577720|FG000|COMPLETED|Overall Study||19
6648541|NCT02397291|7577721|FG001|COMPLETED|Overall Study||5
6648542|NCT02397291|7577720|FG000|NOT COMPLETED|Overall Study||0
6648543|NCT02397291|7577721|FG001|NOT COMPLETED|Overall Study||0
6648544|NCT02397408|7577727|FG000|STARTED|Overall Study||18
6648545|NCT02397408|7577727|FG000|Completed Surgery Per Protocol|Overall Study||16
6648546|NCT02397408|7577727|FG000|COMPLETED|Overall Study||12
6648547|NCT02397408|7577727|FG000|NOT COMPLETED|Overall Study||6
6648548|NCT02397447|7577733|FG000|STARTED|Overall Study||12
6648549|NCT02397447|7577734|FG001|STARTED|Overall Study||12
6648550|NCT02397447|7577733|FG000|COMPLETED|Overall Study||10
6648551|NCT02397447|7577734|FG001|COMPLETED|Overall Study||10
6648552|NCT02397447|7577733|FG000|NOT COMPLETED|Overall Study||2
6648553|NCT02397447|7577734|FG001|NOT COMPLETED|Overall Study||2
6648554|NCT02397460|7577748|FG000|STARTED|Treatment Period 1||7
6648555|NCT02397460|7577749|FG001|STARTED|Treatment Period 1||7
6648556|NCT02397460|7577750|FG002|STARTED|Treatment Period 1||6
6648557|NCT02397460|7577751|FG003|STARTED|Treatment Period 1||6
6648558|NCT02397460|7577752|FG004|STARTED|Treatment Period 1||6
6648559|NCT02397460|7577753|FG005|STARTED|Treatment Period 1||6
6648560|NCT02397460|7577754|FG006|STARTED|Treatment Period 1||6
6648561|NCT02397460|7577755|FG007|STARTED|Treatment Period 1||6
6648562|NCT02397460|7577748|FG000|COMPLETED|Treatment Period 1||7
6648563|NCT02397460|7577749|FG001|COMPLETED|Treatment Period 1||7
6648564|NCT02397460|7577750|FG002|COMPLETED|Treatment Period 1||6
6648565|NCT02397460|7577751|FG003|COMPLETED|Treatment Period 1||6
6648566|NCT02397460|7577752|FG004|COMPLETED|Treatment Period 1||6
6648567|NCT02397460|7577753|FG005|COMPLETED|Treatment Period 1||6
6648568|NCT02397460|7577754|FG006|COMPLETED|Treatment Period 1||6
6648569|NCT02397460|7577755|FG007|COMPLETED|Treatment Period 1||6
6648570|NCT02397460|7577748|FG000|NOT COMPLETED|Treatment Period 1||0
6648571|NCT02397460|7577749|FG001|NOT COMPLETED|Treatment Period 1||0
6648572|NCT02397460|7577750|FG002|NOT COMPLETED|Treatment Period 1||0
6648573|NCT02397460|7577751|FG003|NOT COMPLETED|Treatment Period 1||0
6648574|NCT02397460|7577752|FG004|NOT COMPLETED|Treatment Period 1||0
6648575|NCT02397460|7577753|FG005|NOT COMPLETED|Treatment Period 1||0
6648576|NCT02397460|7577754|FG006|NOT COMPLETED|Treatment Period 1||0
6648577|NCT02397460|7577755|FG007|NOT COMPLETED|Treatment Period 1||0
6648578|NCT02397460|7577748|FG000|STARTED|Treatment Period 2||7
6648579|NCT02397460|7577749|FG001|STARTED|Treatment Period 2||7
6648580|NCT02397460|7577750|FG002|STARTED|Treatment Period 2||6
6648581|NCT02397460|7577751|FG003|STARTED|Treatment Period 2||6
6648582|NCT02397460|7577752|FG004|STARTED|Treatment Period 2||6
6648583|NCT02397460|7577753|FG005|STARTED|Treatment Period 2||6
6648584|NCT02397460|7577754|FG006|STARTED|Treatment Period 2||6
6648585|NCT02397460|7577755|FG007|STARTED|Treatment Period 2||6
6648586|NCT02397460|7577748|FG000|COMPLETED|Treatment Period 2||7
6648587|NCT02397460|7577749|FG001|COMPLETED|Treatment Period 2||7
6648588|NCT02397460|7577750|FG002|COMPLETED|Treatment Period 2||6
6648589|NCT02397460|7577751|FG003|COMPLETED|Treatment Period 2||6
6648590|NCT02397460|7577752|FG004|COMPLETED|Treatment Period 2||6
6648591|NCT02397460|7577753|FG005|COMPLETED|Treatment Period 2||6
6648592|NCT02397460|7577754|FG006|COMPLETED|Treatment Period 2||6
6648593|NCT02397460|7577755|FG007|COMPLETED|Treatment Period 2||5
6648594|NCT02397460|7577748|FG000|NOT COMPLETED|Treatment Period 2||0
6648595|NCT02397460|7577749|FG001|NOT COMPLETED|Treatment Period 2||0
6648596|NCT02397460|7577750|FG002|NOT COMPLETED|Treatment Period 2||0
6648597|NCT02397460|7577751|FG003|NOT COMPLETED|Treatment Period 2||0
6648598|NCT02397460|7577752|FG004|NOT COMPLETED|Treatment Period 2||0
6648599|NCT02397460|7577753|FG005|NOT COMPLETED|Treatment Period 2||0
6648600|NCT02397460|7577754|FG006|NOT COMPLETED|Treatment Period 2||0
6648601|NCT02397460|7577755|FG007|NOT COMPLETED|Treatment Period 2||1
6648602|NCT02397460|7577748|FG000|STARTED|Treatment Period 3||7
6648603|NCT02397460|7577749|FG001|STARTED|Treatment Period 3||7
6648604|NCT02397460|7577750|FG002|STARTED|Treatment Period 3||6
6648605|NCT02397460|7577751|FG003|STARTED|Treatment Period 3||6
6648606|NCT02397460|7577752|FG004|STARTED|Treatment Period 3||6
6648607|NCT02397460|7577753|FG005|STARTED|Treatment Period 3||6
6648608|NCT02397460|7577754|FG006|STARTED|Treatment Period 3||6
6648609|NCT02397460|7577755|FG007|STARTED|Treatment Period 3||5
6648610|NCT02397460|7577748|FG000|COMPLETED|Treatment Period 3||7
6648611|NCT02397460|7577749|FG001|COMPLETED|Treatment Period 3||7
6648612|NCT02397460|7577750|FG002|COMPLETED|Treatment Period 3||6
6648613|NCT02397460|7577751|FG003|COMPLETED|Treatment Period 3||6
6648614|NCT02397460|7577752|FG004|COMPLETED|Treatment Period 3||6
6648615|NCT02397460|7577753|FG005|COMPLETED|Treatment Period 3||6
6648616|NCT02397460|7577754|FG006|COMPLETED|Treatment Period 3||6
6648617|NCT02397460|7577755|FG007|COMPLETED|Treatment Period 3||5
6648618|NCT02397460|7577748|FG000|NOT COMPLETED|Treatment Period 3||0
6648619|NCT02397460|7577749|FG001|NOT COMPLETED|Treatment Period 3||0
6648620|NCT02397460|7577750|FG002|NOT COMPLETED|Treatment Period 3||0
6648621|NCT02397460|7577751|FG003|NOT COMPLETED|Treatment Period 3||0
6648622|NCT02397460|7577752|FG004|NOT COMPLETED|Treatment Period 3||0
6648623|NCT02397460|7577753|FG005|NOT COMPLETED|Treatment Period 3||0
6648624|NCT02397460|7577754|FG006|NOT COMPLETED|Treatment Period 3||0
6648625|NCT02397460|7577755|FG007|NOT COMPLETED|Treatment Period 3||0
6648626|NCT02397460|7577748|FG000|STARTED|Treatment Period 4||7
6648627|NCT02397460|7577749|FG001|STARTED|Treatment Period 4||7
6648628|NCT02397460|7577750|FG002|STARTED|Treatment Period 4||6
6648629|NCT02397460|7577751|FG003|STARTED|Treatment Period 4||6
6648630|NCT02397460|7577752|FG004|STARTED|Treatment Period 4||6
6648631|NCT02397460|7577753|FG005|STARTED|Treatment Period 4||6
6648632|NCT02397460|7577754|FG006|STARTED|Treatment Period 4||6
6648633|NCT02397460|7577755|FG007|STARTED|Treatment Period 4||5
6648634|NCT02397460|7577748|FG000|COMPLETED|Treatment Period 4||7
6648635|NCT02397460|7577749|FG001|COMPLETED|Treatment Period 4||6
6648636|NCT02397460|7577750|FG002|COMPLETED|Treatment Period 4||6
6648637|NCT02397460|7577751|FG003|COMPLETED|Treatment Period 4||6
6648638|NCT02397460|7577752|FG004|COMPLETED|Treatment Period 4||5
6648639|NCT02397460|7577753|FG005|COMPLETED|Treatment Period 4||6
6648640|NCT02397460|7577754|FG006|COMPLETED|Treatment Period 4||6
6648641|NCT02397460|7577755|FG007|COMPLETED|Treatment Period 4||5
6648642|NCT02397460|7577748|FG000|NOT COMPLETED|Treatment Period 4||0
6648643|NCT02397460|7577749|FG001|NOT COMPLETED|Treatment Period 4||1
6648644|NCT02397460|7577750|FG002|NOT COMPLETED|Treatment Period 4||0
6648645|NCT02397460|7577751|FG003|NOT COMPLETED|Treatment Period 4||0
6648646|NCT02397460|7577752|FG004|NOT COMPLETED|Treatment Period 4||1
6648647|NCT02397460|7577753|FG005|NOT COMPLETED|Treatment Period 4||0
6648648|NCT02397460|7577754|FG006|NOT COMPLETED|Treatment Period 4||0
6648649|NCT02397460|7577755|FG007|NOT COMPLETED|Treatment Period 4||0
6648650|NCT02397473|7577831|FG000|STARTED|Treatment Phase||57
6648651|NCT02397473|7577832|FG001|STARTED|Treatment Phase||52
6648652|NCT02397473|7577831|FG000|Received at Least One Dose of Study Drug|Treatment Phase||57
6648653|NCT02397473|7577832|FG001|Received at Least One Dose of Study Drug|Treatment Phase||49
6648654|NCT02397473|7577831|FG000|COMPLETED|Treatment Phase||45
6648655|NCT02397473|7577832|FG001|COMPLETED|Treatment Phase||45
6648656|NCT02397473|7577831|FG000|NOT COMPLETED|Treatment Phase||12
6648657|NCT02397473|7577832|FG001|NOT COMPLETED|Treatment Phase||7
6648658|NCT02397473|7577831|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued treatment period had an option to enter post treatment phase.|50
6648659|NCT02397473|7577832|FG001|STARTED|Post Treatment Follow-up Phase||47
6648660|NCT02397473|7577831|FG000|COMPLETED|Post Treatment Follow-up Phase||47
6648661|NCT02397473|7577832|FG001|COMPLETED|Post Treatment Follow-up Phase||45
6648662|NCT02397473|7577831|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||3
6648663|NCT02397473|7577832|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||2
6648664|NCT02397564|7577841|FG000|STARTED|Overall Study||20
6648665|NCT02397564|7577841|FG000|COMPLETED|Overall Study||16
6648666|NCT02397564|7577841|FG000|NOT COMPLETED|Overall Study||4
6648667|NCT02397655|7577846|FG000|STARTED|Overall Study||12012
6648668|NCT02397655|7577846|FG000|COMPLETED|Overall Study||10711
6648669|NCT02397655|7577846|FG000|NOT COMPLETED|Overall Study||1301
6648670|NCT02397694|7577852|FG000|STARTED|Double-Blinded Phase||65
6648671|NCT02397694|7577853|FG001|STARTED|Double-Blinded Phase||33
6648672|NCT02397694|7577852|FG000|COMPLETED|Double-Blinded Phase||62
6648673|NCT02397694|7577853|FG001|COMPLETED|Double-Blinded Phase||30
6648674|NCT02397694|7577852|FG000|NOT COMPLETED|Double-Blinded Phase||3
6648675|NCT02397694|7577853|FG001|NOT COMPLETED|Double-Blinded Phase||3
6648676|NCT02397694|7577852|FG000|STARTED|Open Label Extension Phase||62
6648677|NCT02397694|7577853|FG001|STARTED|Open Label Extension Phase||30
6648678|NCT02397694|7577852|FG000|COMPLETED|Open Label Extension Phase||54
6648679|NCT02397694|7577853|FG001|COMPLETED|Open Label Extension Phase||29
6648680|NCT02397694|7577852|FG000|NOT COMPLETED|Open Label Extension Phase||8
6648681|NCT02397694|7577853|FG001|NOT COMPLETED|Open Label Extension Phase||1
6648682|NCT02397707|7577866|FG000|STARTED|Overall Study||14
6648683|NCT02397707|7577867|FG001|STARTED|Overall Study||10
6648684|NCT02397707|7577868|FG002|STARTED|Overall Study||9
6648685|NCT02397707|7577866|FG000|COMPLETED|Overall Study||14
6648686|NCT02397707|7577867|FG001|COMPLETED|Overall Study||10
6648687|NCT02397707|7577868|FG002|COMPLETED|Overall Study||9
6648688|NCT02397707|7577866|FG000|NOT COMPLETED|Overall Study||0
6648689|NCT02397707|7577867|FG001|NOT COMPLETED|Overall Study||0
6648690|NCT02397707|7577868|FG002|NOT COMPLETED|Overall Study||0
6648691|NCT02397785|7577879|FG000|STARTED|Overall Study||24
6648692|NCT02397785|7577880|FG001|STARTED|Overall Study||34
6648693|NCT02397785|7577879|FG000|COMPLETED|Overall Study||22
6648694|NCT02397785|7577880|FG001|COMPLETED|Overall Study||25
6648695|NCT02397785|7577879|FG000|NOT COMPLETED|Overall Study||2
6648696|NCT02397785|7577880|FG001|NOT COMPLETED|Overall Study||9
6648697|NCT02397837|7577888|FG000|STARTED|Overall Study||33
6648698|NCT02397837|7577889|FG001|STARTED|Overall Study||30
6648699|NCT02397837|7577888|FG000|COMPLETED|Overall Study||26
6648700|NCT02397837|7577889|FG001|COMPLETED|Overall Study||24
6648701|NCT02397837|7577888|FG000|NOT COMPLETED|Overall Study||7
6648702|NCT02397837|7577889|FG001|NOT COMPLETED|Overall Study||6
6648703|NCT02397889|7577897|FG000|STARTED|Overall Study||15
6648704|NCT02397889|7577898|FG001|STARTED|Overall Study||15
6648705|NCT02397889|7577897|FG000|COMPLETED|Overall Study||14
6648706|NCT02397889|7577898|FG001|COMPLETED|Overall Study||15
6648707|NCT02397889|7577897|FG000|NOT COMPLETED|Overall Study||1
6648708|NCT02397889|7577898|FG001|NOT COMPLETED|Overall Study||0
6648709|NCT02397915|7577904|FG000|STARTED|Period 1||150
6648710|NCT02397915|7577905|FG001|STARTED|Period 1||150
6648711|NCT02397915|7577906|FG002|STARTED|Period 1||0
6648712|NCT02397915|7577907|FG003|STARTED|Period 1||0
6648713|NCT02397915|7577904|FG000|COMPLETED|Period 1||149
6648714|NCT02397915|7577905|FG001|COMPLETED|Period 1||149
6648715|NCT02397915|7577906|FG002|COMPLETED|Period 1||0
6648716|NCT02397915|7577907|FG003|COMPLETED|Period 1||0
6648717|NCT02397915|7577904|FG000|NOT COMPLETED|Period 1||1
6648718|NCT02397915|7577905|FG001|NOT COMPLETED|Period 1||1
6648719|NCT02397915|7577906|FG002|NOT COMPLETED|Period 1||0
6648720|NCT02397915|7577907|FG003|NOT COMPLETED|Period 1||0
6648721|NCT02397915|7577904|FG000|STARTED|Period 2||0
6648722|NCT02397915|7577905|FG001|STARTED|Period 2||0
6648723|NCT02397915|7577906|FG002|STARTED|Period 2||149
6648724|NCT02397915|7577907|FG003|STARTED|Period 2||149
6648725|NCT02397915|7577904|FG000|COMPLETED|Period 2||0
6648726|NCT02397915|7577905|FG001|COMPLETED|Period 2||0
6648727|NCT02397915|7577906|FG002|COMPLETED|Period 2||149
6648728|NCT02397915|7577907|FG003|COMPLETED|Period 2||149
6648729|NCT02397915|7577904|FG000|NOT COMPLETED|Period 2||0
6648730|NCT02397915|7577905|FG001|NOT COMPLETED|Period 2||0
6648731|NCT02397915|7577906|FG002|NOT COMPLETED|Period 2||0
6648732|NCT02397915|7577907|FG003|NOT COMPLETED|Period 2||0
6648733|NCT02397954|7577915|FG000|STARTED|Overall Study||4
6648734|NCT02397954|7577915|FG000|COMPLETED|Overall Study||4
6648735|NCT02397954|7577915|FG000|NOT COMPLETED|Overall Study||0
6648736|NCT02398188|7577921|FG000|STARTED|Overall Study||398
6648737|NCT02398188|7577922|FG001|STARTED|Overall Study||395
6648738|NCT02398188|7577921|FG000|COMPLETED|Overall Study||371
6648739|NCT02398188|7577922|FG001|COMPLETED|Overall Study||361
6648740|NCT02398188|7577921|FG000|NOT COMPLETED|Overall Study||27
6648741|NCT02398188|7577922|FG001|NOT COMPLETED|Overall Study||34
6648742|NCT02398227|7577930|FG000|STARTED|Overall Study||83
6648743|NCT02398227|7577931|FG001|STARTED|Overall Study||89
6648744|NCT02398227|7577930|FG000|COMPLETED|Overall Study||56
6648745|NCT02398227|7577931|FG001|COMPLETED|Overall Study||71
6648746|NCT02398227|7577930|FG000|NOT COMPLETED|Overall Study||27
6648747|NCT02398227|7577931|FG001|NOT COMPLETED|Overall Study||18
6648748|NCT02398409|7577939|FG000|STARTED|Overall Study||69
6648749|NCT02398409|7577940|FG001|STARTED|Overall Study||68
6648750|NCT02398409|7577939|FG000|COMPLETED|Overall Study||67
6648751|NCT02398409|7577940|FG001|COMPLETED|Overall Study||63
6648752|NCT02398409|7577939|FG000|NOT COMPLETED|Overall Study||2
6648753|NCT02398409|7577940|FG001|NOT COMPLETED|Overall Study||5
6648754|NCT02399085|7577946|FG000|STARTED|Overall Study||81
6648755|NCT02399085|7577946|FG000|COMPLETED|Overall Study|30 patients completed the combination treatment on both study drugs (12 cycles).|30
6648756|NCT02399085|7577946|FG000|NOT COMPLETED|Overall Study||51
6648757|NCT02399163|7577950|FG000|STARTED|Overall Study||62
6648758|NCT02399163|7577950|FG000|COMPLETED|Overall Study||53
6648759|NCT02399163|7577950|FG000|NOT COMPLETED|Overall Study||9
6648760|NCT02399228|7577962|FG000|STARTED|Overall Study||13
6648761|NCT02399228|7577962|FG000|COMPLETED|Overall Study||7
6648762|NCT02399228|7577962|FG000|NOT COMPLETED|Overall Study||6
6648763|NCT02399254|7577966|FG000|STARTED|Overall Study||21
6648764|NCT02399254|7577966|FG000|COMPLETED|Overall Study||19
6648765|NCT02399254|7577966|FG000|NOT COMPLETED|Overall Study||2
6648766|NCT02399345|7577971|FG000|STARTED|Overall Study||10
6648767|NCT02399345|7577971|FG000|COMPLETED|Overall Study||10
6648768|NCT02399345|7577971|FG000|NOT COMPLETED|Overall Study||0
6648769|NCT02399475|7577977|FG000|STARTED|Overall Study||7
6648770|NCT02399475|7577978|FG001|STARTED|Overall Study||7
6648771|NCT02399475|7577977|FG000|COMPLETED|Overall Study||6
6648772|NCT02399475|7577978|FG001|COMPLETED|Overall Study||7
6648773|NCT02399475|7577977|FG000|NOT COMPLETED|Overall Study||1
6648774|NCT02399475|7577978|FG001|NOT COMPLETED|Overall Study||0
6648775|NCT02399917|7577987|FG000|STARTED|Overall Study||6
6648776|NCT02399917|7577988|FG001|STARTED|Overall Study||6
6648777|NCT02399917|7577989|FG002|STARTED|Overall Study||24
6648778|NCT02399917|7577987|FG000|COMPLETED|Overall Study||6
6648779|NCT02399917|7577988|FG001|COMPLETED|Overall Study||6
6648780|NCT02399917|7577989|FG002|COMPLETED|Overall Study||24
6648781|NCT02399917|7577987|FG000|NOT COMPLETED|Overall Study||0
6648782|NCT02399917|7577988|FG001|NOT COMPLETED|Overall Study||0
6648783|NCT02399917|7577989|FG002|NOT COMPLETED|Overall Study||0
6648784|NCT02400073|7577998|FG000|STARTED|Overall Study||122
6648785|NCT02400073|7577998|FG000|COMPLETED|Overall Study||111
6648786|NCT02400073|7577998|FG000|NOT COMPLETED|Overall Study||11
6648787|NCT02400307|7578004|FG000|STARTED|Overall Study||11
6648788|NCT02400307|7578005|FG001|STARTED|Overall Study||8
6648789|NCT02400307|7578004|FG000|COMPLETED|Overall Study||10
6648790|NCT02400307|7578005|FG001|COMPLETED|Overall Study||8
6648791|NCT02400307|7578004|FG000|NOT COMPLETED|Overall Study||1
6648792|NCT02400307|7578005|FG001|NOT COMPLETED|Overall Study||0
6648793|NCT02400333|7578015|FG000|STARTED|Overall Study||9
6648794|NCT02400333|7578016|FG001|STARTED|Overall Study||9
6648795|NCT02400333|7578017|FG002|STARTED|Overall Study||9
6648796|NCT02400333|7578018|FG003|STARTED|Overall Study||9
6648797|NCT02400333|7578015|FG000|COMPLETED|Overall Study||8
6648798|NCT02400333|7578016|FG001|COMPLETED|Overall Study||8
6648799|NCT02400333|7578017|FG002|COMPLETED|Overall Study||7
6648800|NCT02400333|7578018|FG003|COMPLETED|Overall Study||7
6648801|NCT02400333|7578015|FG000|NOT COMPLETED|Overall Study||1
6648802|NCT02400333|7578016|FG001|NOT COMPLETED|Overall Study||1
6648803|NCT02400333|7578017|FG002|NOT COMPLETED|Overall Study||2
6648804|NCT02400333|7578018|FG003|NOT COMPLETED|Overall Study||2
6648805|NCT02400346|7578029|FG000|STARTED|Overall Study||132
6648806|NCT02400346|7578029|FG000|COMPLETED|Overall Study||88
6648807|NCT02400346|7578029|FG000|NOT COMPLETED|Overall Study||44
6648808|NCT02400437|7578033|FG000|STARTED|Overall Study||26
6648809|NCT02400437|7578033|FG000|COMPLETED|Overall Study||26
6648810|NCT02400437|7578033|FG000|NOT COMPLETED|Overall Study||0
6648811|NCT02400463|7578039|FG000|STARTED|Overall Study||6
6648812|NCT02400463|7578039|FG000|COMPLETED|Overall Study||6
6648813|NCT02400463|7578039|FG000|NOT COMPLETED|Overall Study||0
6648814|NCT02400580|7578045|FG000|STARTED|Overall Study||91
6648815|NCT02400580|7578046|FG001|STARTED|Overall Study||92
6648816|NCT02400580|7578045|FG000|COMPLETED|Overall Study||89
6648817|NCT02400580|7578046|FG001|COMPLETED|Overall Study||91
6648818|NCT02400580|7578045|FG000|NOT COMPLETED|Overall Study||2
6648819|NCT02400580|7578046|FG001|NOT COMPLETED|Overall Study||1
6648820|NCT02400710|7578054|FG000|STARTED|Overall Study||10
6648821|NCT02400710|7578055|FG001|STARTED|Overall Study||10
6648822|NCT02400710|7578054|FG000|COMPLETED|Overall Study||10
6648823|NCT02400710|7578055|FG001|COMPLETED|Overall Study||10
6648824|NCT02400710|7578054|FG000|NOT COMPLETED|Overall Study||0
6648825|NCT02400710|7578055|FG001|NOT COMPLETED|Overall Study||0
6648826|NCT02400749|7578063|FG000|STARTED|Week 0 -16||50
6648827|NCT02400749|7578064|FG001|STARTED|Week 0 -16||50
6648828|NCT02400749|7578063|FG000|COMPLETED|Week 0 -16||39
6648829|NCT02400749|7578064|FG001|COMPLETED|Week 0 -16||44
6648830|NCT02400749|7578063|FG000|NOT COMPLETED|Week 0 -16||11
6648831|NCT02400749|7578064|FG001|NOT COMPLETED|Week 0 -16||6
6648832|NCT02400749|7578063|FG000|STARTED|Week 17 - 32||39
6648833|NCT02400749|7578064|FG001|STARTED|Week 17 - 32||44
6648834|NCT02400749|7578063|FG000|COMPLETED|Week 17 - 32||34
6648835|NCT02400749|7578064|FG001|COMPLETED|Week 17 - 32||41
6648836|NCT02400749|7578063|FG000|NOT COMPLETED|Week 17 - 32||5
6648837|NCT02400749|7578064|FG001|NOT COMPLETED|Week 17 - 32||3
6648838|NCT02400905|7578070|FG000|STARTED|Overall Study||271
6648839|NCT02400905|7578070|FG000|30-Days Follow-up|Overall Study||268
6648840|NCT02400905|7578070|FG000|12-Months Follow-up|Overall Study||256
6648841|NCT02400905|7578070|FG000|24-Months Follow-up|Overall Study||225
6648842|NCT02400905|7578070|FG000|36 Months-Follow-up|Overall Study||208
6648843|NCT02400905|7578070|FG000|COMPLETED|Overall Study||208
6648844|NCT02400905|7578070|FG000|NOT COMPLETED|Overall Study||63
6648845|NCT02400996|7578075|FG000|STARTED|Overall Study||40
6648846|NCT02400996|7578075|FG000|COMPLETED|Overall Study||40
6648847|NCT02400996|7578075|FG000|NOT COMPLETED|Overall Study||0
6648848|NCT02401022|7578081|FG000|STARTED|Overall Study||104
6648849|NCT02401022|7578082|FG001|STARTED|Overall Study||110
6648850|NCT02401022|7578081|FG000|COMPLETED|Overall Study||89
6648851|NCT02401022|7578082|FG001|COMPLETED|Overall Study||90
6648852|NCT02401022|7578081|FG000|NOT COMPLETED|Overall Study||15
6648853|NCT02401022|7578082|FG001|NOT COMPLETED|Overall Study||20
6648854|NCT02401048|7578090|FG000|STARTED|Overall Study||27
6648855|NCT02401048|7578091|FG001|STARTED|Overall Study||34
6648856|NCT02401048|7578090|FG000|COMPLETED|Overall Study||5
6648857|NCT02401048|7578091|FG001|COMPLETED|Overall Study||4
6648858|NCT02401048|7578090|FG000|NOT COMPLETED|Overall Study||22
6648859|NCT02401048|7578091|FG001|NOT COMPLETED|Overall Study||30
6648860|NCT02401230|7578105|FG000|STARTED|Overall Study||26
6648861|NCT02401230|7578106|FG001|STARTED|Overall Study||25
6648862|NCT02401230|7578107|FG002|STARTED|Overall Study||25
6648863|NCT02401230|7578105|FG000|COMPLETED|Overall Study||20
6648864|NCT02401230|7578106|FG001|COMPLETED|Overall Study||19
6648865|NCT02401230|7578107|FG002|COMPLETED|Overall Study||21
6648866|NCT02401230|7578105|FG000|NOT COMPLETED|Overall Study||6
6648867|NCT02401230|7578106|FG001|NOT COMPLETED|Overall Study||6
6648868|NCT02401230|7578107|FG002|NOT COMPLETED|Overall Study||4
6648869|NCT02401256|7578119|FG000|STARTED|Overall Study||70
6648870|NCT02401256|7578119|FG000|Finished Phase 1|Overall Study||64
6648871|NCT02401256|7578119|FG000|Finished Phase 2|Overall Study||58
6648872|NCT02401256|7578119|FG000|Finished Phase 3|Overall Study||53
6648873|NCT02401256|7578119|FG000|Analysed|Overall Study|Volunteers that completed at least until Phase 2 inpatient visit (Volunteers with Efavirenz PK data)|61
6648874|NCT02401256|7578119|FG000|COMPLETED|Overall Study||53
6648875|NCT02401256|7578119|FG000|NOT COMPLETED|Overall Study||17
6648876|NCT02401412|7578127|FG000|STARTED|Overall Study||89
6648877|NCT02401412|7578128|FG001|STARTED|Overall Study||81
6648878|NCT02401412|7578127|FG000|Received Study Device|Overall Study||89
6648879|NCT02401412|7578128|FG001|Received Study Device|Overall Study||80
6648880|NCT02401412|7578127|FG000|COMPLETED|Overall Study||59
6648881|NCT02401412|7578128|FG001|COMPLETED|Overall Study||49
6648882|NCT02401412|7578127|FG000|NOT COMPLETED|Overall Study||30
6648883|NCT02401412|7578128|FG001|NOT COMPLETED|Overall Study||32
6648884|NCT02401464|7578138|FG000|STARTED|Intervention Period 1 (6 Days)||13
6648885|NCT02401464|7578139|FG001|STARTED|Intervention Period 1 (6 Days)||13
6648886|NCT02401464|7578140|FG002|STARTED|Intervention Period 1 (6 Days)||13
6648887|NCT02401464|7578141|FG003|STARTED|Intervention Period 1 (6 Days)||13
6648888|NCT02401464|7578138|FG000|COMPLETED|Intervention Period 1 (6 Days)||13
6648889|NCT02401464|7578139|FG001|COMPLETED|Intervention Period 1 (6 Days)||13
6648890|NCT02401464|7578140|FG002|COMPLETED|Intervention Period 1 (6 Days)||13
6648891|NCT02401464|7578141|FG003|COMPLETED|Intervention Period 1 (6 Days)||13
6648892|NCT02401464|7578138|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6743925|NCT03338036|7671999|FG001|STARTED|Overall Study||11
6743926|NCT03338036|7672000|FG002|STARTED|Overall Study||12
6648893|NCT02401464|7578139|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6648894|NCT02401464|7578140|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6648895|NCT02401464|7578141|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6648896|NCT02401464|7578138|FG000|STARTED|Washout Period (At Least 6 Days)||13
6648897|NCT02401464|7578139|FG001|STARTED|Washout Period (At Least 6 Days)||13
6648898|NCT02401464|7578140|FG002|STARTED|Washout Period (At Least 6 Days)||13
6648899|NCT02401464|7578141|FG003|STARTED|Washout Period (At Least 6 Days)||13
6648900|NCT02401464|7578138|FG000|COMPLETED|Washout Period (At Least 6 Days)||13
6648901|NCT02401464|7578139|FG001|COMPLETED|Washout Period (At Least 6 Days)||13
6648902|NCT02401464|7578140|FG002|COMPLETED|Washout Period (At Least 6 Days)||13
6648903|NCT02401464|7578141|FG003|COMPLETED|Washout Period (At Least 6 Days)||13
6648904|NCT02401464|7578138|FG000|NOT COMPLETED|Washout Period (At Least 6 Days)||0
6743927|NCT03338036|7672001|FG003|STARTED|Overall Study||8
6648905|NCT02401464|7578139|FG001|NOT COMPLETED|Washout Period (At Least 6 Days)||0
6648906|NCT02401464|7578140|FG002|NOT COMPLETED|Washout Period (At Least 6 Days)||0
6648907|NCT02401464|7578141|FG003|NOT COMPLETED|Washout Period (At Least 6 Days)||0
6648908|NCT02401464|7578138|FG000|STARTED|Intervention Period 2 (6 Days)||13
6648909|NCT02401464|7578139|FG001|STARTED|Intervention Period 2 (6 Days)||13
6648910|NCT02401464|7578140|FG002|STARTED|Intervention Period 2 (6 Days)||13
6648911|NCT02401464|7578141|FG003|STARTED|Intervention Period 2 (6 Days)||13
6648912|NCT02401464|7578138|FG000|COMPLETED|Intervention Period 2 (6 Days)||13
6648913|NCT02401464|7578139|FG001|COMPLETED|Intervention Period 2 (6 Days)||13
6648914|NCT02401464|7578140|FG002|COMPLETED|Intervention Period 2 (6 Days)||13
6648915|NCT02401464|7578141|FG003|COMPLETED|Intervention Period 2 (6 Days)||13
6648916|NCT02401464|7578138|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6648917|NCT02401464|7578139|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6648918|NCT02401464|7578140|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6648919|NCT02401464|7578141|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6648920|NCT02401529|7578155|FG000|STARTED|Overall Study||59
6648921|NCT02401529|7578156|FG001|STARTED|Overall Study||57
6648922|NCT02401529|7578155|FG000|COMPLETED|Overall Study||50
6648923|NCT02401529|7578156|FG001|COMPLETED|Overall Study||50
6648924|NCT02401529|7578155|FG000|NOT COMPLETED|Overall Study||9
6648925|NCT02401529|7578156|FG001|NOT COMPLETED|Overall Study||7
6648926|NCT02401542|7578166|FG000|STARTED|Overall Study||41
6648927|NCT02401542|7578167|FG001|STARTED|Overall Study||30
6648928|NCT02401542|7578168|FG002|STARTED|Overall Study||0
6648929|NCT02401542|7578166|FG000|COMPLETED|Overall Study||40
6648930|NCT02401542|7578167|FG001|COMPLETED|Overall Study||30
6648931|NCT02401542|7578168|FG002|COMPLETED|Overall Study||0
6648932|NCT02401542|7578166|FG000|NOT COMPLETED|Overall Study||1
6648933|NCT02401542|7578167|FG001|NOT COMPLETED|Overall Study||0
6648934|NCT02401542|7578168|FG002|NOT COMPLETED|Overall Study||0
6648935|NCT02401555|7578181|FG000|STARTED|Overall Study||87
6648936|NCT02401555|7578182|FG001|STARTED|Overall Study||212
6648937|NCT02401555|7578183|FG002|STARTED|Overall Study||120
6648938|NCT02401555|7578181|FG000|COMPLETED|Overall Study||87
6648939|NCT02401555|7578182|FG001|COMPLETED|Overall Study||212
6648940|NCT02401555|7578183|FG002|COMPLETED|Overall Study||120
6648941|NCT02401555|7578181|FG000|NOT COMPLETED|Overall Study||0
6648942|NCT02401555|7578182|FG001|NOT COMPLETED|Overall Study||0
6648943|NCT02401555|7578183|FG002|NOT COMPLETED|Overall Study||0
6648944|NCT02401672|7578193|FG000|STARTED|Overall Study||22
6648945|NCT02401672|7578194|FG001|STARTED|Overall Study||20
6648946|NCT02401672|7578193|FG000|COMPLETED|Overall Study||21
6648947|NCT02401672|7578194|FG001|COMPLETED|Overall Study||17
6648948|NCT02401672|7578193|FG000|NOT COMPLETED|Overall Study||1
6648949|NCT02401672|7578194|FG001|NOT COMPLETED|Overall Study||3
6648950|NCT02401867|7578200|FG000|STARTED|Enrolled||150
6648951|NCT02401867|7578200|FG000|COMPLETED|Enrolled||150
6648952|NCT02401867|7578200|FG000|NOT COMPLETED|Enrolled||0
6648953|NCT02401867|7578200|FG000|STARTED|Specimen Collection||150
6648954|NCT02401867|7578200|FG000|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
6648955|NCT02401867|7578200|FG000|NOT COMPLETED|Specimen Collection||10
6648956|NCT02401867|7578200|FG000|STARTED|Analysis||140
6648957|NCT02401867|7578200|FG000|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
6648958|NCT02401867|7578200|FG000|NOT COMPLETED|Analysis||9
6648959|NCT02402062|7578205|FG000|STARTED|Overall Study||17
6648960|NCT02402062|7578205|FG000|COMPLETED|Overall Study||17
6648961|NCT02402062|7578205|FG000|NOT COMPLETED|Overall Study||0
6648962|NCT02402127|7578215|FG000|STARTED|First Wear Period (1 Day)||4
6648963|NCT02402127|7578216|FG001|STARTED|First Wear Period (1 Day)||4
6648964|NCT02402127|7578217|FG002|STARTED|First Wear Period (1 Day)||4
6648965|NCT02402127|7578218|FG003|STARTED|First Wear Period (1 Day)||4
6648966|NCT02402127|7578219|FG004|STARTED|First Wear Period (1 Day)||4
6648967|NCT02402127|7578220|FG005|STARTED|First Wear Period (1 Day)||4
6648968|NCT02402127|7578215|FG000|Randomized and Treated|First Wear Period (1 Day)||4
6648969|NCT02402127|7578216|FG001|Randomized and Treated|First Wear Period (1 Day)||4
6648970|NCT02402127|7578217|FG002|Randomized and Treated|First Wear Period (1 Day)||4
6648971|NCT02402127|7578218|FG003|Randomized and Treated|First Wear Period (1 Day)||4
6648972|NCT02402127|7578219|FG004|Randomized and Treated|First Wear Period (1 Day)||4
6648973|NCT02402127|7578220|FG005|Randomized and Treated|First Wear Period (1 Day)||4
6648974|NCT02402127|7578215|FG000|COMPLETED|First Wear Period (1 Day)||4
6648975|NCT02402127|7578216|FG001|COMPLETED|First Wear Period (1 Day)||4
6648976|NCT02402127|7578217|FG002|COMPLETED|First Wear Period (1 Day)||4
6648977|NCT02402127|7578218|FG003|COMPLETED|First Wear Period (1 Day)||4
6648978|NCT02402127|7578219|FG004|COMPLETED|First Wear Period (1 Day)||4
6648979|NCT02402127|7578220|FG005|COMPLETED|First Wear Period (1 Day)||4
6648980|NCT02402127|7578215|FG000|NOT COMPLETED|First Wear Period (1 Day)||0
6648981|NCT02402127|7578216|FG001|NOT COMPLETED|First Wear Period (1 Day)||0
6648982|NCT02402127|7578217|FG002|NOT COMPLETED|First Wear Period (1 Day)||0
6648983|NCT02402127|7578218|FG003|NOT COMPLETED|First Wear Period (1 Day)||0
6648984|NCT02402127|7578219|FG004|NOT COMPLETED|First Wear Period (1 Day)||0
6648985|NCT02402127|7578220|FG005|NOT COMPLETED|First Wear Period (1 Day)||0
6648986|NCT02402127|7578215|FG000|STARTED|Second Wear Period (1 Day)||4
6648987|NCT02402127|7578216|FG001|STARTED|Second Wear Period (1 Day)||4
6648988|NCT02402127|7578217|FG002|STARTED|Second Wear Period (1 Day)||4
6648989|NCT02402127|7578218|FG003|STARTED|Second Wear Period (1 Day)||4
6648990|NCT02402127|7578219|FG004|STARTED|Second Wear Period (1 Day)||4
6648991|NCT02402127|7578220|FG005|STARTED|Second Wear Period (1 Day)||4
6648992|NCT02402127|7578215|FG000|COMPLETED|Second Wear Period (1 Day)||4
6648993|NCT02402127|7578216|FG001|COMPLETED|Second Wear Period (1 Day)||4
6648994|NCT02402127|7578217|FG002|COMPLETED|Second Wear Period (1 Day)||4
6648995|NCT02402127|7578218|FG003|COMPLETED|Second Wear Period (1 Day)||4
6648996|NCT02402127|7578219|FG004|COMPLETED|Second Wear Period (1 Day)||4
6648997|NCT02402127|7578220|FG005|COMPLETED|Second Wear Period (1 Day)||4
6648998|NCT02402127|7578215|FG000|NOT COMPLETED|Second Wear Period (1 Day)||0
6648999|NCT02402127|7578216|FG001|NOT COMPLETED|Second Wear Period (1 Day)||0
6649000|NCT02402127|7578217|FG002|NOT COMPLETED|Second Wear Period (1 Day)||0
6649001|NCT02402127|7578218|FG003|NOT COMPLETED|Second Wear Period (1 Day)||0
6649002|NCT02402127|7578219|FG004|NOT COMPLETED|Second Wear Period (1 Day)||0
6649003|NCT02402127|7578220|FG005|NOT COMPLETED|Second Wear Period (1 Day)||0
6649004|NCT02402127|7578215|FG000|STARTED|Third Wear Period (1 Day)||4
6649005|NCT02402127|7578216|FG001|STARTED|Third Wear Period (1 Day)||4
6649006|NCT02402127|7578217|FG002|STARTED|Third Wear Period (1 Day)||4
6649007|NCT02402127|7578218|FG003|STARTED|Third Wear Period (1 Day)||4
6649008|NCT02402127|7578219|FG004|STARTED|Third Wear Period (1 Day)||4
6649009|NCT02402127|7578220|FG005|STARTED|Third Wear Period (1 Day)||4
6649010|NCT02402127|7578215|FG000|COMPLETED|Third Wear Period (1 Day)||4
6649011|NCT02402127|7578216|FG001|COMPLETED|Third Wear Period (1 Day)||4
6649012|NCT02402127|7578217|FG002|COMPLETED|Third Wear Period (1 Day)||4
6649013|NCT02402127|7578218|FG003|COMPLETED|Third Wear Period (1 Day)||4
6649014|NCT02402127|7578219|FG004|COMPLETED|Third Wear Period (1 Day)||4
6649015|NCT02402127|7578220|FG005|COMPLETED|Third Wear Period (1 Day)||4
6649016|NCT02402127|7578215|FG000|NOT COMPLETED|Third Wear Period (1 Day)||0
6649017|NCT02402127|7578216|FG001|NOT COMPLETED|Third Wear Period (1 Day)||0
6649018|NCT02402127|7578217|FG002|NOT COMPLETED|Third Wear Period (1 Day)||0
6649019|NCT02402127|7578218|FG003|NOT COMPLETED|Third Wear Period (1 Day)||0
6649020|NCT02402127|7578219|FG004|NOT COMPLETED|Third Wear Period (1 Day)||0
6649021|NCT02402127|7578220|FG005|NOT COMPLETED|Third Wear Period (1 Day)||0
6649022|NCT02402153|7578231|FG000|STARTED|Overall Study||18
6649023|NCT02402153|7578231|FG000|COMPLETED|Overall Study||18
6649024|NCT02402153|7578231|FG000|NOT COMPLETED|Overall Study||0
6649025|NCT02402166|7578235|FG000|STARTED|Overall Study||24
6649026|NCT02402166|7578235|FG000|COMPLETED|Overall Study||19
6649027|NCT02402166|7578235|FG000|NOT COMPLETED|Overall Study||5
6649028|NCT02402218|7578256|FG000|STARTED|Overall Study||36
6649029|NCT02402218|7578257|FG001|STARTED|Overall Study||54
6649030|NCT02402218|7578258|FG002|STARTED|Overall Study||54
6649031|NCT02402218|7578256|FG000|Initiated Treatment With LDV/SOF|Overall Study||24
6649032|NCT02402218|7578257|FG001|Initiated Treatment With LDV/SOF|Overall Study||45
6649033|NCT02402218|7578258|FG002|Initiated Treatment With LDV/SOF|Overall Study||41
6649034|NCT02402218|7578256|FG000|Completed Treatment With LDV/SOF|Overall Study||23
6649035|NCT02402218|7578257|FG001|Completed Treatment With LDV/SOF|Overall Study||42
6649036|NCT02402218|7578258|FG002|Completed Treatment With LDV/SOF|Overall Study||39
6649037|NCT02402218|7578256|FG000|Achieved Sustained Virologic Response|Overall Study||22
6649038|NCT02402218|7578257|FG001|Achieved Sustained Virologic Response|Overall Study||41
6649039|NCT02402218|7578258|FG002|Achieved Sustained Virologic Response|Overall Study||37
6649040|NCT02402218|7578256|FG000|COMPLETED|Overall Study||22
6649041|NCT02402218|7578257|FG001|COMPLETED|Overall Study||41
6649042|NCT02402218|7578258|FG002|COMPLETED|Overall Study||37
6649043|NCT02402218|7578256|FG000|NOT COMPLETED|Overall Study||14
6649044|NCT02402218|7578257|FG001|NOT COMPLETED|Overall Study||13
6649045|NCT02402218|7578258|FG002|NOT COMPLETED|Overall Study||17
6649046|NCT02402296|7578268|FG000|STARTED|Overall Study||15
6649047|NCT02402296|7578269|FG001|STARTED|Overall Study||15
6649048|NCT02402296|7578268|FG000|COMPLETED|Overall Study||15
6649049|NCT02402296|7578269|FG001|COMPLETED|Overall Study||15
6649050|NCT02402296|7578268|FG000|NOT COMPLETED|Overall Study||0
6649051|NCT02402296|7578269|FG001|NOT COMPLETED|Overall Study||0
6649052|NCT02402322|7578278|FG000|STARTED|Pretreatment||27
6649053|NCT02402322|7578279|FG001|STARTED|Pretreatment||25
6649054|NCT02402322|7578280|FG002|STARTED|Pretreatment||25
6649055|NCT02402322|7578278|FG000|Posttreatment Measures|Pretreatment||24
6649056|NCT02402322|7578279|FG001|Posttreatment Measures|Pretreatment||24
6649057|NCT02402322|7578280|FG002|Posttreatment Measures|Pretreatment||24
6649058|NCT02402322|7578278|FG000|COMPLETED|Pretreatment||24
6649059|NCT02402322|7578279|FG001|COMPLETED|Pretreatment||24
6649060|NCT02402322|7578280|FG002|COMPLETED|Pretreatment||24
6649061|NCT02402322|7578278|FG000|NOT COMPLETED|Pretreatment||3
6649062|NCT02402322|7578279|FG001|NOT COMPLETED|Pretreatment||1
6649063|NCT02402322|7578280|FG002|NOT COMPLETED|Pretreatment||1
6649064|NCT02402322|7578278|FG000|STARTED|Follow-up||24
6649065|NCT02402322|7578279|FG001|STARTED|Follow-up||24
6649066|NCT02402322|7578280|FG002|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
6649067|NCT02402322|7578278|FG000|COMPLETED|Follow-up||18
6649068|NCT02402322|7578279|FG001|COMPLETED|Follow-up||21
6649069|NCT02402322|7578280|FG002|COMPLETED|Follow-up||0
6649070|NCT02402322|7578278|FG000|NOT COMPLETED|Follow-up||6
6649071|NCT02402322|7578279|FG001|NOT COMPLETED|Follow-up||3
6649072|NCT02402322|7578280|FG002|NOT COMPLETED|Follow-up||24
6649073|NCT02402452|7578290|FG000|STARTED|Overall Study||10
6649074|NCT02402452|7578291|FG001|STARTED|Overall Study||10
6649075|NCT02402452|7578290|FG000|COMPLETED|Overall Study||10
6649076|NCT02402452|7578291|FG001|COMPLETED|Overall Study||10
6649077|NCT02402452|7578290|FG000|NOT COMPLETED|Overall Study||0
6649078|NCT02402452|7578291|FG001|NOT COMPLETED|Overall Study||0
6649079|NCT02402764|7578297|FG000|STARTED|Overall Study||10
6649080|NCT02402764|7578297|FG000|COMPLETED|Overall Study||10
6649081|NCT02402764|7578297|FG000|NOT COMPLETED|Overall Study||0
6649082|NCT02402881|7578303|FG000|STARTED|Pre-Intervention Study Period||2222
6649083|NCT02402881|7578304|FG001|STARTED|Pre-Intervention Study Period||5657
6649084|NCT02402881|7578303|FG000|COMPLETED|Pre-Intervention Study Period||2222
6649085|NCT02402881|7578304|FG001|COMPLETED|Pre-Intervention Study Period||5657
6649086|NCT02402881|7578303|FG000|NOT COMPLETED|Pre-Intervention Study Period||0
6649087|NCT02402881|7578304|FG001|NOT COMPLETED|Pre-Intervention Study Period||0
6649088|NCT02402881|7578303|FG000|STARTED|Post-Intervention Study Period||3111
6649089|NCT02402881|7578304|FG001|STARTED|Post-Intervention Study Period||8662
6649090|NCT02402881|7578303|FG000|COMPLETED|Post-Intervention Study Period||3111
6649091|NCT02402881|7578304|FG001|COMPLETED|Post-Intervention Study Period||8662
6649092|NCT02402881|7578303|FG000|NOT COMPLETED|Post-Intervention Study Period||0
6649093|NCT02402881|7578304|FG001|NOT COMPLETED|Post-Intervention Study Period||0
6649094|NCT02402907|7578312|FG000|STARTED|Overall Study||682
6649095|NCT02402907|7578313|FG001|STARTED|Overall Study||674
6649096|NCT02402907|7578312|FG000|COMPLETED|Overall Study||662
6649097|NCT02402907|7578313|FG001|COMPLETED|Overall Study||647
6649098|NCT02402907|7578312|FG000|NOT COMPLETED|Overall Study||20
6649099|NCT02402907|7578313|FG001|NOT COMPLETED|Overall Study||27
6649100|NCT02402933|7578319|FG000|STARTED|Overall Study||26
6649101|NCT02402933|7578319|FG000|Received at Least One Dose of Study Drug|Overall Study||22
6649102|NCT02402933|7578319|FG000|COMPLETED|Overall Study||12
6649103|NCT02402933|7578319|FG000|NOT COMPLETED|Overall Study||14
6649104|NCT02403180|7578325|FG000|STARTED|Pre-Treatment Period||36
6649105|NCT02403180|7578326|FG001|STARTED|Pre-Treatment Period||34
6649106|NCT02403180|7578325|FG000|COMPLETED|Pre-Treatment Period||36
6649107|NCT02403180|7578326|FG001|COMPLETED|Pre-Treatment Period||33
6649108|NCT02403180|7578325|FG000|NOT COMPLETED|Pre-Treatment Period||0
6649109|NCT02403180|7578326|FG001|NOT COMPLETED|Pre-Treatment Period||1
6649110|NCT02403180|7578325|FG000|STARTED|Period 1 (5 Days)||36
6649111|NCT02403180|7578326|FG001|STARTED|Period 1 (5 Days)||33
6649112|NCT02403180|7578325|FG000|Randomized|Period 1 (5 Days)||36
6649113|NCT02403180|7578326|FG001|Randomized|Period 1 (5 Days)||33
6649114|NCT02403180|7578325|FG000|COMPLETED|Period 1 (5 Days)||36
6649115|NCT02403180|7578326|FG001|COMPLETED|Period 1 (5 Days)||33
6649116|NCT02403180|7578325|FG000|NOT COMPLETED|Period 1 (5 Days)||0
6649117|NCT02403180|7578326|FG001|NOT COMPLETED|Period 1 (5 Days)||0
6649118|NCT02403180|7578325|FG000|STARTED|Period 2 (5 Days)||36
6649119|NCT02403180|7578326|FG001|STARTED|Period 2 (5 Days)||33
6649120|NCT02403180|7578325|FG000|COMPLETED|Period 2 (5 Days)||36
6743928|NCT03338036|7671998|FG000|COMPLETED|Overall Study||0
6743929|NCT03338036|7671999|FG001|COMPLETED|Overall Study||7
6743930|NCT03338036|7672000|FG002|COMPLETED|Overall Study||9
6743931|NCT03338036|7672001|FG003|COMPLETED|Overall Study||8
6743932|NCT03338036|7671998|FG000|NOT COMPLETED|Overall Study||0
6743933|NCT03338036|7671999|FG001|NOT COMPLETED|Overall Study||4
6743934|NCT03338036|7672000|FG002|NOT COMPLETED|Overall Study||3
6743935|NCT03338036|7672001|FG003|NOT COMPLETED|Overall Study||0
6743936|NCT03338062|7672011|FG000|STARTED|Overall Study||10
6743937|NCT03338062|7672012|FG001|STARTED|Overall Study||5
6743938|NCT03338062|7672011|FG000|COMPLETED|Overall Study||9
6743939|NCT03338062|7672012|FG001|COMPLETED|Overall Study||5
6743940|NCT03338062|7672011|FG000|NOT COMPLETED|Overall Study||1
6743941|NCT03338062|7672012|FG001|NOT COMPLETED|Overall Study||0
6743942|NCT03338296|7672021|FG000|STARTED|Overall Study||139
6743943|NCT03338296|7672022|FG001|STARTED|Overall Study||139
6743944|NCT03338296|7672021|FG000|Safety Analysis Set|Overall Study||139
6743945|NCT03338296|7672022|FG001|Safety Analysis Set|Overall Study||136
6743946|NCT03338296|7672021|FG000|COMPLETED|Overall Study||36
6743947|NCT03338296|7672022|FG001|COMPLETED|Overall Study||31
6743948|NCT03338296|7672021|FG000|NOT COMPLETED|Overall Study||103
6743949|NCT03338296|7672022|FG001|NOT COMPLETED|Overall Study||108
6743950|NCT03338400|7672030|FG000|STARTED|Overall Study||25
6743951|NCT03338400|7672031|FG001|STARTED|Overall Study||26
6743952|NCT03338400|7672030|FG000|COMPLETED|Overall Study||24
6743953|NCT03338400|7672031|FG001|COMPLETED|Overall Study||24
6743954|NCT03338400|7672030|FG000|NOT COMPLETED|Overall Study||1
6743955|NCT03338400|7672031|FG001|NOT COMPLETED|Overall Study||2
6649121|NCT02403180|7578326|FG001|COMPLETED|Period 2 (5 Days)||32
6649122|NCT02403180|7578325|FG000|NOT COMPLETED|Period 2 (5 Days)||0
6649123|NCT02403180|7578326|FG001|NOT COMPLETED|Period 2 (5 Days)||1
6649124|NCT02403206|7578334|FG000|STARTED|Overall Study||194
6649125|NCT02403206|7578335|FG001|STARTED|Overall Study||196
6743956|NCT03338556|7672049|FG000|STARTED|Overall Study||25
6743957|NCT03338556|7672050|FG001|STARTED|Overall Study||27
6743958|NCT03338556|7672051|FG002|STARTED|Overall Study||24
6743959|NCT03338556|7672052|FG003|STARTED|Overall Study||26
6743960|NCT03338556|7672049|FG000|COMPLETED|Overall Study||23
6743961|NCT03338556|7672050|FG001|COMPLETED|Overall Study||23
6743962|NCT03338556|7672051|FG002|COMPLETED|Overall Study||22
6743963|NCT03338556|7672052|FG003|COMPLETED|Overall Study||24
6743964|NCT03338556|7672049|FG000|NOT COMPLETED|Overall Study||2
6743965|NCT03338556|7672050|FG001|NOT COMPLETED|Overall Study||4
6743966|NCT03338556|7672051|FG002|NOT COMPLETED|Overall Study||2
6550721|NCT01727141|7472612|FG000|NOT COMPLETED|Overall Study||5
6550722|NCT01727141|7472613|FG001|NOT COMPLETED|Overall Study||9
6550723|NCT01727141|7472614|FG002|NOT COMPLETED|Overall Study||3
6649126|NCT02403206|7578334|FG000|Treated Prior to Randomization|Overall Study||0
6649127|NCT02403206|7578335|FG001|Treated Prior to Randomization|Overall Study||1
6649128|NCT02403206|7578334|FG000|Randomized and Treated|Overall Study||188
6649129|NCT02403206|7578335|FG001|Randomized and Treated|Overall Study||190
6649130|NCT02403206|7578334|FG000|COMPLETED|Overall Study||183
6649131|NCT02403206|7578335|FG001|COMPLETED|Overall Study||186
6649132|NCT02403206|7578334|FG000|NOT COMPLETED|Overall Study||11
6649133|NCT02403206|7578335|FG001|NOT COMPLETED|Overall Study||10
6649134|NCT02403271|7578342|FG000|STARTED|Period 1|All Phase 1b participants went on to participate in Phase 2.|7
6649135|NCT02403271|7578343|FG001|STARTED|Period 1||0
6649136|NCT02403271|7578342|FG000|COMPLETED|Period 1||6
6649137|NCT02403271|7578343|FG001|COMPLETED|Period 1||0
6649138|NCT02403271|7578342|FG000|NOT COMPLETED|Period 1||1
6649139|NCT02403271|7578343|FG001|NOT COMPLETED|Period 1||0
6649140|NCT02403271|7578342|FG000|STARTED|Period 2||0
6649141|NCT02403271|7578343|FG001|STARTED|Period 2|Phase 2 includes all subjects who participated in Phase 1b.|124
6649142|NCT02403271|7578342|FG000|COMPLETED|Period 2||0
6649143|NCT02403271|7578343|FG001|COMPLETED|Period 2||0
6649144|NCT02403271|7578342|FG000|NOT COMPLETED|Period 2||0
6649145|NCT02403271|7578343|FG001|NOT COMPLETED|Period 2||124
6649146|NCT02403479|7578351|FG000|STARTED|Overall Study||10
6649147|NCT02403479|7578352|FG001|STARTED|Overall Study||12
6649148|NCT02403479|7578351|FG000|COMPLETED|Overall Study||8
6649149|NCT02403479|7578352|FG001|COMPLETED|Overall Study||12
6649150|NCT02403479|7578351|FG000|NOT COMPLETED|Overall Study||2
6649151|NCT02403479|7578352|FG001|NOT COMPLETED|Overall Study||0
6649152|NCT02403622|7578360|FG000|STARTED|Overall Study||15
6649153|NCT02403622|7578360|FG000|COMPLETED|Overall Study||13
6649154|NCT02403622|7578360|FG000|NOT COMPLETED|Overall Study||2
6649155|NCT02403635|7578364|FG000|STARTED|Overall Study||27
6649156|NCT02403635|7578364|FG000|Screening (28 Days)|Overall Study||27
6649157|NCT02403635|7578364|FG000|Received the First Dose|Overall Study||18
6649158|NCT02403635|7578364|FG000|COMPLETED|Overall Study||18
6649159|NCT02403635|7578364|FG000|NOT COMPLETED|Overall Study||9
6649160|NCT02403674|7578386|FG000|STARTED|Overall Study||368
6649161|NCT02403674|7578387|FG001|STARTED|Overall Study||366
6649162|NCT02403674|7578386|FG000|Treated|Overall Study||364
6649163|NCT02403674|7578387|FG001|Treated|Overall Study||364
6649164|NCT02403674|7578386|FG000|COMPLETED|Overall Study||313
6649165|NCT02403674|7578387|FG001|COMPLETED|Overall Study||303
6649166|NCT02403674|7578386|FG000|NOT COMPLETED|Overall Study||55
6649167|NCT02403674|7578387|FG001|NOT COMPLETED|Overall Study||63
6649168|NCT02403778|7578395|FG000|STARTED|Overall Study||6
6649169|NCT02403778|7578396|FG001|STARTED|Overall Study||4
6649170|NCT02403778|7578395|FG000|COMPLETED|Overall Study||6
6649171|NCT02403778|7578396|FG001|COMPLETED|Overall Study||4
6649172|NCT02403778|7578395|FG000|NOT COMPLETED|Overall Study||0
6649173|NCT02403778|7578396|FG001|NOT COMPLETED|Overall Study||0
6649174|NCT02403817|7578404|FG000|STARTED|Overall Study||28
6649175|NCT02403817|7578405|FG001|STARTED|Overall Study||2
6649176|NCT02403817|7578404|FG000|COMPLETED|Overall Study||23
6649177|NCT02403817|7578405|FG001|COMPLETED|Overall Study||2
6649178|NCT02403817|7578404|FG000|NOT COMPLETED|Overall Study||5
6649179|NCT02403817|7578405|FG001|NOT COMPLETED|Overall Study||0
6649180|NCT02403830|7578411|FG000|STARTED|Visit 1||15
6649181|NCT02403830|7578412|FG001|STARTED|Visit 1||15
6649182|NCT02403830|7578411|FG000|COMPLETED|Visit 1||15
6649183|NCT02403830|7578412|FG001|COMPLETED|Visit 1||15
6649184|NCT02403830|7578411|FG000|NOT COMPLETED|Visit 1||0
6649185|NCT02403830|7578412|FG001|NOT COMPLETED|Visit 1||0
6649186|NCT02403830|7578411|FG000|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
6649187|NCT02403830|7578412|FG001|STARTED|Visit 2||15
6649188|NCT02403830|7578411|FG000|COMPLETED|Visit 2||14
6649189|NCT02403830|7578412|FG001|COMPLETED|Visit 2||15
6649190|NCT02403830|7578411|FG000|NOT COMPLETED|Visit 2||0
6649191|NCT02403830|7578412|FG001|NOT COMPLETED|Visit 2||0
6550724|NCT01727141|7472615|FG003|NOT COMPLETED|Overall Study||15
6550725|NCT01727154|7472625|FG000|STARTED|Overall Study||139
6550726|NCT01727154|7472625|FG000|COMPLETED|Overall Study||80
6550727|NCT01727154|7472625|FG000|NOT COMPLETED|Overall Study||59
6550728|NCT01727180|7472629|FG000|STARTED|Overall Study||108
6550729|NCT01727180|7472629|FG000|COMPLETED|Overall Study||108
6550730|NCT01727180|7472629|FG000|NOT COMPLETED|Overall Study||0
6550731|NCT01727258|7472636|FG000|STARTED|Overall Study||51
6550732|NCT01727258|7472637|FG001|STARTED|Overall Study||51
6550733|NCT01727258|7472638|FG002|STARTED|Overall Study||51
6550734|NCT01727258|7472636|FG000|COMPLETED|Overall Study||49
6550735|NCT01727258|7472637|FG001|COMPLETED|Overall Study||48
6550736|NCT01727258|7472638|FG002|COMPLETED|Overall Study||50
6550737|NCT01727258|7472636|FG000|NOT COMPLETED|Overall Study||2
6550738|NCT01727258|7472637|FG001|NOT COMPLETED|Overall Study||3
6550739|NCT01727258|7472638|FG002|NOT COMPLETED|Overall Study||1
6649192|NCT02403895|7578418|FG000|STARTED|Overall Study||11
6649193|NCT02403895|7578418|FG000|COMPLETED|Overall Study||11
6649194|NCT02403895|7578418|FG000|NOT COMPLETED|Overall Study||0
6649195|NCT02403986|7578424|FG000|STARTED|Overall Study||26
6649196|NCT02403986|7578425|FG001|STARTED|Overall Study||27
6649197|NCT02403986|7578424|FG000|COMPLETED|Overall Study||21
6649198|NCT02403986|7578425|FG001|COMPLETED|Overall Study||23
6649199|NCT02403986|7578424|FG000|NOT COMPLETED|Overall Study||5
6649200|NCT02403986|7578425|FG001|NOT COMPLETED|Overall Study||4
6649201|NCT02403999|7578434|FG000|STARTED|Overall Study||10
6649202|NCT02403999|7578435|FG001|STARTED|Overall Study||10
6649203|NCT02403999|7578436|FG002|STARTED|Overall Study||11
6649204|NCT02403999|7578434|FG000|COMPLETED|Overall Study||10
6649205|NCT02403999|7578435|FG001|COMPLETED|Overall Study||10
6649206|NCT02403999|7578436|FG002|COMPLETED|Overall Study||11
6649207|NCT02403999|7578434|FG000|NOT COMPLETED|Overall Study||0
6649208|NCT02403999|7578435|FG001|NOT COMPLETED|Overall Study||0
6649209|NCT02403999|7578436|FG002|NOT COMPLETED|Overall Study||0
6649210|NCT02404025|7578444|FG000|STARTED|Overall Study||10
6649211|NCT02404025|7578444|FG000|COMPLETED|Overall Study||6
6649212|NCT02404025|7578444|FG000|NOT COMPLETED|Overall Study||4
6649213|NCT02404103|7578450|FG000|STARTED|Overall Study||14
6649214|NCT02404103|7578451|FG001|STARTED|Overall Study||12
6649215|NCT02404103|7578450|FG000|COMPLETED|Overall Study||10
6649216|NCT02404103|7578451|FG001|COMPLETED|Overall Study||9
6649217|NCT02404103|7578450|FG000|NOT COMPLETED|Overall Study||4
6649218|NCT02404103|7578451|FG001|NOT COMPLETED|Overall Study||3
6649219|NCT02404168|7578467|FG000|STARTED|Overall Study||4
6649220|NCT02404168|7578467|FG000|COMPLETED|Overall Study||4
6649221|NCT02404168|7578467|FG000|NOT COMPLETED|Overall Study||0
6649222|NCT02404220|7578477|FG000|STARTED|Overall Study||5
6649223|NCT02404220|7578478|FG001|STARTED|Overall Study||8
6649224|NCT02404220|7578479|FG002|STARTED|Overall Study||7
6649225|NCT02404220|7578480|FG003|STARTED|Overall Study||10
6649226|NCT02404220|7578477|FG000|COMPLETED|Overall Study||0
6649227|NCT02404220|7578478|FG001|COMPLETED|Overall Study||0
6649228|NCT02404220|7578479|FG002|COMPLETED|Overall Study||0
6649229|NCT02404220|7578480|FG003|COMPLETED|Overall Study||0
6649230|NCT02404220|7578477|FG000|NOT COMPLETED|Overall Study||5
6649231|NCT02404220|7578478|FG001|NOT COMPLETED|Overall Study||8
6649232|NCT02404220|7578479|FG002|NOT COMPLETED|Overall Study||7
6649233|NCT02404220|7578480|FG003|NOT COMPLETED|Overall Study||10
6649234|NCT02404285|7578492|FG000|STARTED|Overall Study||33
6649235|NCT02404285|7578493|FG001|STARTED|Overall Study||35
6649236|NCT02404285|7578492|FG000|COMPLETED|Overall Study||31
6649237|NCT02404285|7578493|FG001|COMPLETED|Overall Study||33
6649238|NCT02404285|7578492|FG000|NOT COMPLETED|Overall Study||2
6649239|NCT02404285|7578493|FG001|NOT COMPLETED|Overall Study||2
6649240|NCT02404311|7578510|FG000|STARTED|Part A: Month 0-18||210
6649241|NCT02404311|7578511|FG001|STARTED|Part A: Month 0-18||42
6649242|NCT02404311|7578512|FG002|STARTED|Part A: Month 0-18||0
6649243|NCT02404311|7578513|FG003|STARTED|Part A: Month 0-18||0
6649244|NCT02404311|7578514|FG004|STARTED|Part A: Month 0-18||0
6649245|NCT02404311|7578510|FG000|Per Protocol|Part A: Month 0-18||185
6649246|NCT02404311|7578511|FG001|Per Protocol|Part A: Month 0-18||37
6649247|NCT02404311|7578512|FG002|Per Protocol|Part A: Month 0-18||0
6649248|NCT02404311|7578513|FG003|Per Protocol|Part A: Month 0-18||0
6649249|NCT02404311|7578514|FG004|Per Protocol|Part A: Month 0-18||0
6649250|NCT02404311|7578510|FG000|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||194
6649251|NCT02404311|7578511|FG001|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||37
6649252|NCT02404311|7578512|FG002|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6649253|NCT02404311|7578513|FG003|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6649254|NCT02404311|7578514|FG004|Month 6.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6649255|NCT02404311|7578510|FG000|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||186
6649256|NCT02404311|7578511|FG001|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||33
6649257|NCT02404311|7578512|FG002|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6649258|NCT02404311|7578513|FG003|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6649259|NCT02404311|7578514|FG004|Month 12.5 Immunogenicity Timepoint|Part A: Month 0-18||0
6649260|NCT02404311|7578510|FG000|COMPLETED|Part A: Month 0-18||184
6649261|NCT02404311|7578511|FG001|COMPLETED|Part A: Month 0-18||36
6649262|NCT02404311|7578512|FG002|COMPLETED|Part A: Month 0-18||0
6649263|NCT02404311|7578513|FG003|COMPLETED|Part A: Month 0-18||0
6550740|NCT01727297|7472646|FG000|STARTED|Overall Study||395
6550741|NCT01727297|7472647|FG001|STARTED|Overall Study||51
6550742|NCT01727297|7472646|FG000|COMPLETED|Overall Study||293
6550743|NCT01727297|7472647|FG001|COMPLETED|Overall Study||0
6550744|NCT01727297|7472646|FG000|NOT COMPLETED|Overall Study||102
6550745|NCT01727297|7472647|FG001|NOT COMPLETED|Overall Study||51
6550746|NCT01727336|7472666|FG000|STARTED|Part 1 Dalantercept Dose Escalation||6
6550747|NCT01727336|7472667|FG001|STARTED|Part 1 Dalantercept Dose Escalation||9
6550748|NCT01727336|7472668|FG002|STARTED|Part 1 Dalantercept Dose Escalation||14
6550749|NCT01727336|7472669|FG003|STARTED|Part 1 Dalantercept Dose Escalation||0
6550750|NCT01727336|7472670|FG004|STARTED|Part 1 Dalantercept Dose Escalation||0
6550751|NCT01727336|7472671|FG005|STARTED|Part 1 Dalantercept Dose Escalation||0
6550752|NCT01727336|7472666|FG000|COMPLETED|Part 1 Dalantercept Dose Escalation||3
6550753|NCT01727336|7472667|FG001|COMPLETED|Part 1 Dalantercept Dose Escalation||7
6550754|NCT01727336|7472668|FG002|COMPLETED|Part 1 Dalantercept Dose Escalation||6
6649264|NCT02404311|7578514|FG004|COMPLETED|Part A: Month 0-18||0
6649265|NCT02404311|7578510|FG000|NOT COMPLETED|Part A: Month 0-18||26
6649266|NCT02404311|7578511|FG001|NOT COMPLETED|Part A: Month 0-18||6
6649267|NCT02404311|7578512|FG002|NOT COMPLETED|Part A: Month 0-18||0
6649268|NCT02404311|7578513|FG003|NOT COMPLETED|Part A: Month 0-18||0
6550755|NCT01727336|7472669|FG003|COMPLETED|Part 1 Dalantercept Dose Escalation||0
6649269|NCT02404311|7578514|FG004|NOT COMPLETED|Part A: Month 0-18||0
6550756|NCT01727336|7472670|FG004|COMPLETED|Part 1 Dalantercept Dose Escalation||0
6550757|NCT01727336|7472671|FG005|COMPLETED|Part 1 Dalantercept Dose Escalation||0
6550758|NCT01727336|7472666|FG000|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||3
6550759|NCT01727336|7472667|FG001|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||2
6550760|NCT01727336|7472668|FG002|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||8
6550761|NCT01727336|7472669|FG003|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
6550762|NCT01727336|7472670|FG004|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
6550763|NCT01727336|7472671|FG005|NOT COMPLETED|Part 1 Dalantercept Dose Escalation||0
6550764|NCT01727336|7472666|FG000|STARTED|Part 2 Blinded||0
6550765|NCT01727336|7472667|FG001|STARTED|Part 2 Blinded||0
6550766|NCT01727336|7472668|FG002|STARTED|Part 2 Blinded||0
6550767|NCT01727336|7472669|FG003|STARTED|Part 2 Blinded||0
6550768|NCT01727336|7472670|FG004|STARTED|Part 2 Blinded||63
6550769|NCT01727336|7472671|FG005|STARTED|Part 2 Blinded||68
6550770|NCT01727336|7472666|FG000|COMPLETED|Part 2 Blinded||0
6550771|NCT01727336|7472667|FG001|COMPLETED|Part 2 Blinded||0
6550772|NCT01727336|7472668|FG002|COMPLETED|Part 2 Blinded||0
6550773|NCT01727336|7472669|FG003|COMPLETED|Part 2 Blinded||0
6550774|NCT01727336|7472670|FG004|COMPLETED|Part 2 Blinded||0
6550775|NCT01727336|7472671|FG005|COMPLETED|Part 2 Blinded||0
6550776|NCT01727336|7472666|FG000|NOT COMPLETED|Part 2 Blinded||0
6550777|NCT01727336|7472667|FG001|NOT COMPLETED|Part 2 Blinded||0
6550778|NCT01727336|7472668|FG002|NOT COMPLETED|Part 2 Blinded||0
6550779|NCT01727336|7472669|FG003|NOT COMPLETED|Part 2 Blinded||0
6550780|NCT01727336|7472670|FG004|NOT COMPLETED|Part 2 Blinded||63
6550781|NCT01727336|7472671|FG005|NOT COMPLETED|Part 2 Blinded||68
6550782|NCT01727414|7472693|FG000|STARTED|Overall Study||126
6550783|NCT01727414|7472694|FG001|STARTED|Overall Study||45
6550784|NCT01727414|7472693|FG000|COMPLETED|Overall Study||123
6550785|NCT01727414|7472694|FG001|COMPLETED|Overall Study||45
6550786|NCT01727414|7472693|FG000|NOT COMPLETED|Overall Study||3
6550787|NCT01727414|7472694|FG001|NOT COMPLETED|Overall Study||0
6550788|NCT01727505|7472700|FG000|STARTED|First 24 Hours||14
6550789|NCT01727505|7472701|FG001|STARTED|First 24 Hours||12
6550790|NCT01727505|7472700|FG000|COMPLETED|First 24 Hours||14
6550791|NCT01727505|7472701|FG001|COMPLETED|First 24 Hours||11
6550792|NCT01727505|7472700|FG000|NOT COMPLETED|First 24 Hours||0
6550793|NCT01727505|7472701|FG001|NOT COMPLETED|First 24 Hours||1
6550794|NCT01727505|7472700|FG000|STARTED|Second 24 Hours||14
6550795|NCT01727505|7472701|FG001|STARTED|Second 24 Hours||11
6550796|NCT01727505|7472700|FG000|COMPLETED|Second 24 Hours||14
6550797|NCT01727505|7472701|FG001|COMPLETED|Second 24 Hours||10
6550798|NCT01727505|7472700|FG000|NOT COMPLETED|Second 24 Hours||0
6550799|NCT01727505|7472701|FG001|NOT COMPLETED|Second 24 Hours||1
6550800|NCT01727700|7472710|FG000|STARTED|Overall Study||44
6550801|NCT01727700|7472711|FG001|STARTED|Overall Study||45
6550802|NCT01727700|7472712|FG002|STARTED|Overall Study||44
6550803|NCT01727700|7472710|FG000|COMPLETED|Overall Study||42
6550804|NCT01727700|7472711|FG001|COMPLETED|Overall Study||35
6550805|NCT01727700|7472712|FG002|COMPLETED|Overall Study||42
6550806|NCT01727700|7472710|FG000|NOT COMPLETED|Overall Study||2
6550807|NCT01727700|7472711|FG001|NOT COMPLETED|Overall Study||10
6550808|NCT01727700|7472712|FG002|NOT COMPLETED|Overall Study||2
6550809|NCT01727713|7472720|FG000|STARTED|Overall Study||110
6550810|NCT01727713|7472720|FG000|COMPLETED|Overall Study||75
6550811|NCT01727713|7472720|FG000|NOT COMPLETED|Overall Study||35
6304431|NCT00365456|7207673|FG000|COMPLETED|Trial Period III (12 Months)||118
6304432|NCT00365456|7207674|FG001|COMPLETED|Trial Period III (12 Months)||127
6304433|NCT00365456|7207673|FG000|NOT COMPLETED|Trial Period III (12 Months)||18
6304434|NCT00365456|7207674|FG001|NOT COMPLETED|Trial Period III (12 Months)||5
6304435|NCT00365508|7207682|FG000|STARTED|Overall Study||321
6304436|NCT00365508|7207683|FG001|STARTED|Overall Study||321
6304437|NCT00365508|7207682|FG000|COMPLETED|Overall Study||182
6304438|NCT00365508|7207683|FG001|COMPLETED|Overall Study||167
6304439|NCT00365508|7207682|FG000|NOT COMPLETED|Overall Study||139
6304440|NCT00365508|7207683|FG001|NOT COMPLETED|Overall Study||154
6304441|NCT00365547|7207689|FG000|STARTED|Overall Study||46
6304442|NCT00365547|7207689|FG000|COMPLETED|Overall Study||43
6304443|NCT00365547|7207689|FG000|NOT COMPLETED|Overall Study||3
6304444|NCT00365599|7207696|FG000|STARTED|Overall Study||43
6304445|NCT00365599|7207696|FG000|COMPLETED|Overall Study||43
6304446|NCT00365599|7207696|FG000|NOT COMPLETED|Overall Study||0
6304447|NCT00365716|7207705|FG000|STARTED|Base Study (Day 1 to Month 7)||290
6304448|NCT00365716|7207706|FG001|STARTED|Base Study (Day 1 to Month 7)||284
6304449|NCT00365716|7207707|FG002|STARTED|Base Study (Day 1 to Month 7)||292
6304450|NCT00365716|7207708|FG003|STARTED|Base Study (Day 1 to Month 7)||146
6304451|NCT00365716|7207709|FG004|STARTED|Base Study (Day 1 to Month 7)||146
6304452|NCT00365716|7207710|FG005|STARTED|Base Study (Day 1 to Month 7)||0
6304453|NCT00365716|7207711|FG006|STARTED|Base Study (Day 1 to Month 7)||0
6304454|NCT00365716|7207705|FG000|COMPLETED|Base Study (Day 1 to Month 7)||269
6304455|NCT00365716|7207706|FG001|COMPLETED|Base Study (Day 1 to Month 7)||260
6304456|NCT00365716|7207707|FG002|COMPLETED|Base Study (Day 1 to Month 7)||271
6304457|NCT00365716|7207708|FG003|COMPLETED|Base Study (Day 1 to Month 7)||136
6304458|NCT00365716|7207709|FG004|COMPLETED|Base Study (Day 1 to Month 7)||139
6304459|NCT00365716|7207710|FG005|COMPLETED|Base Study (Day 1 to Month 7)||0
6304460|NCT00365716|7207711|FG006|COMPLETED|Base Study (Day 1 to Month 7)||0
6304461|NCT00365716|7207705|FG000|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
6304462|NCT00365716|7207706|FG001|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
6304463|NCT00365716|7207707|FG002|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
6304464|NCT00365716|7207708|FG003|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
6304465|NCT00365716|7207709|FG004|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
6304466|NCT00365716|7207710|FG005|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
6304467|NCT00365716|7207711|FG006|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
6304468|NCT00365716|7207705|FG000|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
6304469|NCT00365716|7207706|FG001|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
6304470|NCT00365716|7207707|FG002|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
6304471|NCT00365716|7207708|FG003|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
6304472|NCT00365716|7207709|FG004|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
6304473|NCT00365716|7207710|FG005|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
6304474|NCT00365716|7207711|FG006|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
6304475|NCT00365716|7207705|FG000|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
6304476|NCT00365716|7207706|FG001|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
6304477|NCT00365716|7207707|FG002|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
6304478|NCT00365716|7207708|FG003|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
6304479|NCT00365716|7207709|FG004|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
6550812|NCT01727726|7472727|FG000|STARTED|Overall Study||197
6550813|NCT01727726|7472728|FG001|STARTED|Overall Study||100
6550814|NCT01727726|7472729|FG002|STARTED|Overall Study||206
6550815|NCT01727726|7472727|FG000|COMPLETED|Overall Study||171
6550816|NCT01727726|7472728|FG001|COMPLETED|Overall Study||86
6550817|NCT01727726|7472729|FG002|COMPLETED|Overall Study||186
6550818|NCT01727726|7472727|FG000|NOT COMPLETED|Overall Study||26
6550819|NCT01727726|7472728|FG001|NOT COMPLETED|Overall Study||14
6550820|NCT01727726|7472729|FG002|NOT COMPLETED|Overall Study||20
6550821|NCT01727765|7472739|FG000|STARTED|Overall Study||8
6550822|NCT01727765|7472740|FG001|STARTED|Overall Study||8
6550823|NCT01727765|7472739|FG000|COMPLETED|Overall Study||8
6550824|NCT01727765|7472740|FG001|COMPLETED|Overall Study||8
6550825|NCT01727765|7472739|FG000|NOT COMPLETED|Overall Study||0
6550826|NCT01727765|7472740|FG001|NOT COMPLETED|Overall Study||0
6550827|NCT01727791|7472746|FG000|STARTED|Overall Study||10
6550828|NCT01727791|7472746|FG000|COMPLETED|Overall Study||10
6550829|NCT01727791|7472746|FG000|NOT COMPLETED|Overall Study||0
6550830|NCT01727895|7472752|FG000|STARTED|Overall Study||10
6304480|NCT00365716|7207710|FG005|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
6304481|NCT00365716|7207711|FG006|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
6304482|NCT00365716|7207705|FG000|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
6304483|NCT00365716|7207706|FG001|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
6304484|NCT00365716|7207707|FG002|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
6304485|NCT00365716|7207708|FG003|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
6304486|NCT00365716|7207709|FG004|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
6304487|NCT00365716|7207710|FG005|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
6304488|NCT00365716|7207711|FG006|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
6304489|NCT00365716|7207705|FG000|STARTED|Extension 1||0
6304490|NCT00365716|7207706|FG001|STARTED|Extension 1||0
6304491|NCT00365716|7207707|FG002|STARTED|Extension 1||0
6304492|NCT00365716|7207708|FG003|STARTED|Extension 1||0
6304493|NCT00365716|7207709|FG004|STARTED|Extension 1||0
6304494|NCT00365716|7207710|FG005|STARTED|Extension 1||241
6304495|NCT00365716|7207711|FG006|STARTED|Extension 1||0
6304496|NCT00365716|7207705|FG000|COMPLETED|Extension 1||0
6304497|NCT00365716|7207706|FG001|COMPLETED|Extension 1||0
6304498|NCT00365716|7207707|FG002|COMPLETED|Extension 1||0
6304499|NCT00365716|7207708|FG003|COMPLETED|Extension 1||0
6304500|NCT00365716|7207709|FG004|COMPLETED|Extension 1||0
6304501|NCT00365716|7207710|FG005|COMPLETED|Extension 1||219
6304502|NCT00365716|7207711|FG006|COMPLETED|Extension 1||0
6304503|NCT00365716|7207705|FG000|NOT COMPLETED|Extension 1||0
6304504|NCT00365716|7207706|FG001|NOT COMPLETED|Extension 1||0
6304505|NCT00365716|7207707|FG002|NOT COMPLETED|Extension 1||0
6304506|NCT00365716|7207708|FG003|NOT COMPLETED|Extension 1||0
6304507|NCT00365716|7207709|FG004|NOT COMPLETED|Extension 1||0
6304508|NCT00365716|7207710|FG005|NOT COMPLETED|Extension 1||22
6304509|NCT00365716|7207711|FG006|NOT COMPLETED|Extension 1||0
6304510|NCT00365716|7207705|FG000|STARTED|Extension 2||0
6304511|NCT00365716|7207706|FG001|STARTED|Extension 2||0
6304512|NCT00365716|7207707|FG002|STARTED|Extension 2||0
6304513|NCT00365716|7207708|FG003|STARTED|Extension 2||0
6304514|NCT00365716|7207709|FG004|STARTED|Extension 2||0
6304515|NCT00365716|7207710|FG005|STARTED|Extension 2||0
6304516|NCT00365716|7207711|FG006|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
6304517|NCT00365716|7207705|FG000|COMPLETED|Extension 2||0
6304518|NCT00365716|7207706|FG001|COMPLETED|Extension 2||0
6304519|NCT00365716|7207707|FG002|COMPLETED|Extension 2||0
6304520|NCT00365716|7207708|FG003|COMPLETED|Extension 2||0
6304521|NCT00365716|7207709|FG004|COMPLETED|Extension 2||0
6304522|NCT00365716|7207710|FG005|COMPLETED|Extension 2||0
6304523|NCT00365716|7207711|FG006|COMPLETED|Extension 2||7
6304524|NCT00365716|7207705|FG000|NOT COMPLETED|Extension 2||0
6304525|NCT00365716|7207706|FG001|NOT COMPLETED|Extension 2||0
6304526|NCT00365716|7207707|FG002|NOT COMPLETED|Extension 2||0
6304527|NCT00365716|7207708|FG003|NOT COMPLETED|Extension 2||0
6304528|NCT00365716|7207709|FG004|NOT COMPLETED|Extension 2||0
6304529|NCT00365716|7207710|FG005|NOT COMPLETED|Extension 2||0
6304530|NCT00365716|7207711|FG006|NOT COMPLETED|Extension 2||10
6304531|NCT00365768|7207727|FG000|STARTED|Overall Study||24
6304532|NCT00365768|7207728|FG001|STARTED|Overall Study||25
6304533|NCT00365768|7207727|FG000|COMPLETED|Overall Study||24
6304534|NCT00365768|7207728|FG001|COMPLETED|Overall Study||25
6304535|NCT00365768|7207727|FG000|NOT COMPLETED|Overall Study||0
6304536|NCT00365768|7207728|FG001|NOT COMPLETED|Overall Study||0
6304537|NCT00365794|7207734|FG000|STARTED|Overall Study|22 subjects were enrolled since only 20 completed all post treatment measures.|22
6304538|NCT00365794|7207734|FG000|COMPLETED|Overall Study||20
6304539|NCT00365794|7207734|FG000|NOT COMPLETED|Overall Study||2
6304540|NCT00365846|7207739|FG000|STARTED|Overall Study||29
6304541|NCT00365846|7207739|FG000|COMPLETED|Overall Study||28
6304542|NCT00365846|7207739|FG000|NOT COMPLETED|Overall Study||1
6304543|NCT00365859|7207748|FG000|STARTED|Overall Study||86
6304544|NCT00365859|7207749|FG001|STARTED|Overall Study||70
6304545|NCT00365859|7207750|FG002|STARTED|Overall Study||174
6304546|NCT00365859|7207751|FG003|STARTED|Overall Study||330
6304547|NCT00365859|7207748|FG000|Safety Population|Overall Study||86
6304548|NCT00365859|7207749|FG001|Safety Population|Overall Study||70
6304549|NCT00365859|7207750|FG002|Safety Population|Overall Study||174
6304550|NCT00365859|7207751|FG003|Safety Population|Overall Study||330
6304551|NCT00365859|7207748|FG000|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
6374820|NCT00752206|7285374|FG001|STARTED|Overall Study||19
6374821|NCT00752206|7285373|FG000|COMPLETED|Overall Study||10
6550831|NCT01727895|7472753|FG001|STARTED|Overall Study||5
6550832|NCT01727895|7472752|FG000|COMPLETED|Overall Study||10
6550833|NCT01727895|7472753|FG001|COMPLETED|Overall Study||5
6550834|NCT01727895|7472752|FG000|NOT COMPLETED|Overall Study||0
6550835|NCT01727895|7472753|FG001|NOT COMPLETED|Overall Study||0
6550836|NCT01728077|7472761|FG000|STARTED|Overall Study||19
6304552|NCT00365859|7207749|FG001|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
6304553|NCT00365859|7207750|FG002|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
6304554|NCT00365859|7207751|FG003|Efficacy Population|Overall Study||322
6304555|NCT00365859|7207748|FG000|COMPLETED|Overall Study||55
6304556|NCT00365859|7207749|FG001|COMPLETED|Overall Study||37
6304557|NCT00365859|7207750|FG002|COMPLETED|Overall Study||107
6304558|NCT00365859|7207751|FG003|COMPLETED|Overall Study||199
6304559|NCT00365859|7207748|FG000|NOT COMPLETED|Overall Study||31
6304560|NCT00365859|7207749|FG001|NOT COMPLETED|Overall Study||33
6304561|NCT00365859|7207750|FG002|NOT COMPLETED|Overall Study||67
6304562|NCT00365859|7207751|FG003|NOT COMPLETED|Overall Study||131
6304563|NCT00365872|7207763|FG000|STARTED|Overall Study||5
6550837|NCT01728077|7472762|FG001|STARTED|Overall Study||7
6550838|NCT01728077|7472761|FG000|COMPLETED|Overall Study||11
6550839|NCT01728077|7472762|FG001|COMPLETED|Overall Study||2
6550840|NCT01728077|7472761|FG000|NOT COMPLETED|Overall Study||8
6550841|NCT01728077|7472762|FG001|NOT COMPLETED|Overall Study||5
6550842|NCT01728116|7472771|FG000|STARTED|Overall Study|EndoBarrier mITT Subjects|213
6550843|NCT01728116|7472772|FG001|STARTED|Overall Study|Sham mITT subjects|107
6550844|NCT01728116|7472771|FG000|COMPLETED|Overall Study|Completed to Week 78|52
6649270|NCT02404311|7578510|FG000|STARTED|Part B: Month 30-36||0
6304564|NCT00365872|7207764|FG001|STARTED|Overall Study||6
6304565|NCT00365872|7207765|FG002|STARTED|Overall Study||6
6550845|NCT01728116|7472772|FG001|COMPLETED|Overall Study|Completed to Week 52|60
6550846|NCT01728116|7472771|FG000|NOT COMPLETED|Overall Study||161
6550847|NCT01728116|7472772|FG001|NOT COMPLETED|Overall Study||47
6550848|NCT01728194|7472781|FG000|STARTED|Overall Study||54
6550849|NCT01728194|7472782|FG001|STARTED|Overall Study||67
6550850|NCT01728194|7472781|FG000|COMPLETED|Overall Study||34
6550851|NCT01728194|7472782|FG001|COMPLETED|Overall Study||61
6649271|NCT02404311|7578511|FG001|STARTED|Part B: Month 30-36||0
6550852|NCT01728194|7472781|FG000|NOT COMPLETED|Overall Study||20
6550853|NCT01728194|7472782|FG001|NOT COMPLETED|Overall Study||6
6550854|NCT01728246|7472790|FG000|STARTED|Overall Study||242
6550855|NCT01728246|7472791|FG001|STARTED|Overall Study||231
6550856|NCT01728246|7472790|FG000|COMPLETED|Overall Study||206
6649272|NCT02404311|7578512|FG002|STARTED|Part B: Month 30-36||32
6649273|NCT02404311|7578513|FG003|STARTED|Part B: Month 30-36||31
6649274|NCT02404311|7578514|FG004|STARTED|Part B: Month 30-36||7
6304566|NCT00365872|7207763|FG000|COMPLETED|Overall Study||5
6649275|NCT02404311|7578510|FG000|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
6649276|NCT02404311|7578511|FG001|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||0
6304567|NCT00365872|7207764|FG001|COMPLETED|Overall Study||6
6550857|NCT01728246|7472791|FG001|COMPLETED|Overall Study||195
6550858|NCT01728246|7472790|FG000|NOT COMPLETED|Overall Study||36
6550859|NCT01728246|7472791|FG001|NOT COMPLETED|Overall Study||36
6550860|NCT01728324|7472800|FG000|STARTED|Termination of DBV||211
6550861|NCT01728324|7472801|FG001|STARTED|Termination of DBV||213
6550862|NCT01728324|7472802|FG002|STARTED|Termination of DBV||72
6550863|NCT01728324|7472800|FG000|COMPLETED|Termination of DBV||173
6550864|NCT01728324|7472801|FG001|COMPLETED|Termination of DBV||177
6550865|NCT01728324|7472802|FG002|COMPLETED|Termination of DBV||58
6550866|NCT01728324|7472800|FG000|NOT COMPLETED|Termination of DBV||38
6550867|NCT01728324|7472801|FG001|NOT COMPLETED|Termination of DBV||36
6550868|NCT01728324|7472802|FG002|NOT COMPLETED|Termination of DBV||14
6550869|NCT01728324|7472800|FG000|STARTED|Termination of FDV||211
6550870|NCT01728324|7472801|FG001|STARTED|Termination of FDV||213
6550871|NCT01728324|7472802|FG002|STARTED|Termination of FDV||72
6550872|NCT01728324|7472800|FG000|COMPLETED|Termination of FDV||173
6550873|NCT01728324|7472801|FG001|COMPLETED|Termination of FDV||177
6550874|NCT01728324|7472802|FG002|COMPLETED|Termination of FDV||58
6550875|NCT01728324|7472800|FG000|NOT COMPLETED|Termination of FDV||38
6550876|NCT01728324|7472801|FG001|NOT COMPLETED|Termination of FDV||36
6550877|NCT01728324|7472802|FG002|NOT COMPLETED|Termination of FDV||14
6550878|NCT01728324|7472800|FG000|STARTED|Termination of RBV||211
6550879|NCT01728324|7472801|FG001|STARTED|Termination of RBV||213
6550880|NCT01728324|7472802|FG002|STARTED|Termination of RBV||72
6550881|NCT01728324|7472800|FG000|COMPLETED|Termination of RBV||172
6550882|NCT01728324|7472801|FG001|COMPLETED|Termination of RBV||176
6550883|NCT01728324|7472802|FG002|COMPLETED|Termination of RBV||57
6550884|NCT01728324|7472800|FG000|NOT COMPLETED|Termination of RBV||39
6550885|NCT01728324|7472801|FG001|NOT COMPLETED|Termination of RBV||37
6550886|NCT01728324|7472802|FG002|NOT COMPLETED|Termination of RBV||15
6550887|NCT01728337|7472812|FG000|STARTED|Overall Study||80
6550888|NCT01728337|7472812|FG000|COMPLETED|Overall Study||80
6550889|NCT01728337|7472812|FG000|NOT COMPLETED|Overall Study||0
6550890|NCT01728376|7472824|FG000|STARTED|Overall Study||22
6550891|NCT01728376|7472825|FG001|STARTED|Overall Study||11
6550892|NCT01728376|7472826|FG002|STARTED|Overall Study||19
6550893|NCT01728376|7472827|FG003|STARTED|Overall Study||9
6649277|NCT02404311|7578512|FG002|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||28
6649278|NCT02404311|7578513|FG003|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||30
6649279|NCT02404311|7578514|FG004|Month 30.5 Immunogenicity Timepoint|Part B: Month 30-36||6
6649280|NCT02404311|7578510|FG000|COMPLETED|Part B: Month 30-36||0
6649281|NCT02404311|7578511|FG001|COMPLETED|Part B: Month 30-36||0
6649282|NCT02404311|7578512|FG002|COMPLETED|Part B: Month 30-36||32
6649283|NCT02404311|7578513|FG003|COMPLETED|Part B: Month 30-36||31
6649284|NCT02404311|7578514|FG004|COMPLETED|Part B: Month 30-36||7
6649285|NCT02404311|7578510|FG000|NOT COMPLETED|Part B: Month 30-36||0
6649286|NCT02404311|7578511|FG001|NOT COMPLETED|Part B: Month 30-36||0
6649287|NCT02404311|7578512|FG002|NOT COMPLETED|Part B: Month 30-36||0
6649288|NCT02404311|7578513|FG003|NOT COMPLETED|Part B: Month 30-36||0
6649289|NCT02404311|7578514|FG004|NOT COMPLETED|Part B: Month 30-36||0
6649290|NCT02404350|7578530|FG000|STARTED|Overall Study||222
6649291|NCT02404350|7578531|FG001|STARTED|Overall Study||220
6743967|NCT03338556|7672052|FG003|NOT COMPLETED|Overall Study||2
6743968|NCT03338569|7672064|FG000|STARTED|Overall Study||64
6743969|NCT03338569|7672065|FG001|STARTED|Overall Study||61
6743970|NCT03338569|7672064|FG000|COMPLETED|Overall Study||56
6743971|NCT03338569|7672065|FG001|COMPLETED|Overall Study||56
6743972|NCT03338569|7672064|FG000|NOT COMPLETED|Overall Study||8
6743973|NCT03338569|7672065|FG001|NOT COMPLETED|Overall Study||5
6743974|NCT03338673|7672073|FG000|STARTED|Overall Study||6
6743975|NCT03338673|7672074|FG001|STARTED|Overall Study||6
6743976|NCT03338673|7672073|FG000|COMPLETED|Overall Study||5
6743977|NCT03338673|7672074|FG001|COMPLETED|Overall Study||5
6743978|NCT03338673|7672073|FG000|NOT COMPLETED|Overall Study||1
6743979|NCT03338673|7672074|FG001|NOT COMPLETED|Overall Study||1
6743980|NCT03338686|7672083|FG000|STARTED|Overall Study||2
6743981|NCT03338686|7672084|FG001|STARTED|Overall Study||5
6743982|NCT03338686|7672085|FG002|STARTED|Overall Study|12 FGG implant sites and 7 CTG implant sites for this Arm/Group|7
6743983|NCT03338686|7672083|FG000|COMPLETED|Overall Study||2
6743984|NCT03338686|7672084|FG001|COMPLETED|Overall Study||5
6743985|NCT03338686|7672085|FG002|COMPLETED|Overall Study||7
6743986|NCT03338686|7672083|FG000|NOT COMPLETED|Overall Study||0
6743987|NCT03338686|7672084|FG001|NOT COMPLETED|Overall Study||0
6743988|NCT03338686|7672085|FG002|NOT COMPLETED|Overall Study||0
6743989|NCT03338803|7672092|FG000|STARTED|Overall Study||11001
6743990|NCT03338803|7672092|FG000|COMPLETED|Overall Study||11001
6743991|NCT03338803|7672092|FG000|NOT COMPLETED|Overall Study||0
6743992|NCT03338816|7672098|FG000|STARTED|6-Month Double-blind Period||46
6743993|NCT03338816|7672099|FG001|STARTED|6-Month Double-blind Period||48
6743994|NCT03338816|7672098|FG000|COMPLETED|6-Month Double-blind Period||46
6422266|NCT01001078|7336849|FG001|Received Crossover|Overall Study||3
6422267|NCT01001078|7336848|FG000|Intubated|Overall Study||2
6422268|NCT01001078|7336849|FG001|Intubated|Overall Study||1
6422269|NCT01001078|7336848|FG000|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
6422270|NCT01001078|7336849|FG001|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
6422271|NCT01001078|7336848|FG000|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
6422272|NCT01001078|7336849|FG001|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
6422273|NCT01001078|7336848|FG000|NOT COMPLETED|Overall Study||0
6422274|NCT01001078|7336849|FG001|NOT COMPLETED|Overall Study||0
6422275|NCT01001104|7336861|FG000|STARTED|Overall Study||35
6422276|NCT01001104|7336862|FG001|STARTED|Overall Study||37
6422277|NCT01001104|7336863|FG002|STARTED|Overall Study||36
6422278|NCT01001104|7336864|FG003|STARTED|Overall Study||37
6422279|NCT01001104|7336861|FG000|COMPLETED|Overall Study||33
6422280|NCT01001104|7336862|FG001|COMPLETED|Overall Study||36
6304568|NCT00365872|7207765|FG002|COMPLETED|Overall Study||6
6304569|NCT00365872|7207763|FG000|NOT COMPLETED|Overall Study||0
6304570|NCT00365872|7207764|FG001|NOT COMPLETED|Overall Study||0
6304571|NCT00365872|7207765|FG002|NOT COMPLETED|Overall Study||0
6304572|NCT00365976|7207774|FG000|STARTED|Overall Study||33
6550894|NCT01728376|7472828|FG004|STARTED|Overall Study||14
6550895|NCT01728376|7472829|FG005|STARTED|Overall Study||7
6550896|NCT01728376|7472824|FG000|Treated|Overall Study||22
6550897|NCT01728376|7472825|FG001|Treated|Overall Study||10
6550898|NCT01728376|7472826|FG002|Treated|Overall Study||19
6304573|NCT00365976|7207775|FG001|STARTED|Overall Study||25
6304574|NCT00365976|7207774|FG000|COMPLETED|Overall Study||32
6304575|NCT00365976|7207775|FG001|COMPLETED|Overall Study||20
6304576|NCT00365976|7207774|FG000|NOT COMPLETED|Overall Study||1
6304577|NCT00365976|7207775|FG001|NOT COMPLETED|Overall Study||5
6304578|NCT00365989|7207781|FG000|STARTED|Overall Study||50
6304579|NCT00365989|7207781|FG000|COMPLETED|Overall Study||48
6304580|NCT00365989|7207781|FG000|NOT COMPLETED|Overall Study||2
6304581|NCT00366028|7207788|FG000|STARTED|Overall Study||889
6304582|NCT00366028|7207789|FG001|STARTED|Overall Study||735
6304583|NCT00366028|7207788|FG000|COMPLETED|Overall Study||889
6304584|NCT00366028|7207789|FG001|COMPLETED|Overall Study||735
6304585|NCT00366028|7207788|FG000|NOT COMPLETED|Overall Study||0
6304586|NCT00366028|7207789|FG001|NOT COMPLETED|Overall Study||0
6304587|NCT00366106|7207797|FG000|STARTED|Overall Study||32
6304588|NCT00366106|7207797|FG000|COMPLETED|Overall Study||32
6304589|NCT00366106|7207797|FG000|NOT COMPLETED|Overall Study||0
6304590|NCT00366249|7207803|FG000|STARTED|Overall Study||553
6304591|NCT00366249|7207804|FG001|STARTED|Overall Study||508
6304592|NCT00366249|7207803|FG000|COMPLETED|Overall Study||422
6304593|NCT00366249|7207804|FG001|COMPLETED|Overall Study||430
6304594|NCT00366249|7207803|FG000|NOT COMPLETED|Overall Study||131
6304595|NCT00366249|7207804|FG001|NOT COMPLETED|Overall Study||78
6304596|NCT00366275|7207810|FG000|STARTED|Overall Study||64
6550899|NCT01728376|7472827|FG003|Treated|Overall Study||9
6304597|NCT00366275|7207810|FG000|COMPLETED|Overall Study||58
6422281|NCT01001104|7336863|FG002|COMPLETED|Overall Study||35
6422282|NCT01001104|7336864|FG003|COMPLETED|Overall Study||34
6422283|NCT01001104|7336861|FG000|NOT COMPLETED|Overall Study||2
6550900|NCT01728376|7472828|FG004|Treated|Overall Study||14
6422284|NCT01001104|7336862|FG001|NOT COMPLETED|Overall Study||1
6422285|NCT01001104|7336863|FG002|NOT COMPLETED|Overall Study||1
6422286|NCT01001104|7336864|FG003|NOT COMPLETED|Overall Study||3
6422287|NCT01001169|7336879|FG000|STARTED|Overall Study||30
6422288|NCT01001169|7336880|FG001|STARTED|Overall Study||30
6422289|NCT01001169|7336879|FG000|COMPLETED|Overall Study||28
6422290|NCT01001169|7336880|FG001|COMPLETED|Overall Study||29
6422291|NCT01001169|7336879|FG000|NOT COMPLETED|Overall Study||2
6422292|NCT01001169|7336880|FG001|NOT COMPLETED|Overall Study||1
6422293|NCT01001195|7336898|FG000|STARTED|Overall Study||39
6422294|NCT01001195|7336899|FG001|STARTED|Overall Study||41
6422295|NCT01001195|7336900|FG002|STARTED|Overall Study||44
6422296|NCT01001195|7336901|FG003|STARTED|Overall Study||41
6422297|NCT01001195|7336898|FG000|COMPLETED|Overall Study||37
6422298|NCT01001195|7336899|FG001|COMPLETED|Overall Study||39
6422299|NCT01001195|7336900|FG002|COMPLETED|Overall Study||44
6422300|NCT01001195|7336901|FG003|COMPLETED|Overall Study||41
6422301|NCT01001195|7336898|FG000|NOT COMPLETED|Overall Study||2
6422302|NCT01001195|7336899|FG001|NOT COMPLETED|Overall Study||2
6422303|NCT01001195|7336900|FG002|NOT COMPLETED|Overall Study||0
6422304|NCT01001195|7336901|FG003|NOT COMPLETED|Overall Study||0
6422305|NCT01001208|7336913|FG000|STARTED|Overall Study||239
6422306|NCT01001208|7336914|FG001|STARTED|Overall Study||239
6422307|NCT01001208|7336913|FG000|COMPLETED|Overall Study||211
6649292|NCT02404350|7578532|FG002|STARTED|Overall Study||222
6649293|NCT02404350|7578533|FG003|STARTED|Overall Study||332
6649294|NCT02404350|7578530|FG000|COMPLETED|Overall Study||207
6649295|NCT02404350|7578531|FG001|COMPLETED|Overall Study||214
6649296|NCT02404350|7578532|FG002|COMPLETED|Overall Study||216
6649297|NCT02404350|7578533|FG003|COMPLETED|Overall Study||295
6649298|NCT02404350|7578530|FG000|NOT COMPLETED|Overall Study||15
6649299|NCT02404350|7578531|FG001|NOT COMPLETED|Overall Study||6
6649300|NCT02404350|7578532|FG002|NOT COMPLETED|Overall Study||6
6649301|NCT02404350|7578533|FG003|NOT COMPLETED|Overall Study||37
6649302|NCT02404389|7578549|FG000|STARTED|Overall Study||20
6649303|NCT02404389|7578550|FG001|STARTED|Overall Study||20
6550901|NCT01728376|7472829|FG005|Treated|Overall Study||7
6550902|NCT01728376|7472824|FG000|COMPLETED|Overall Study||18
6550903|NCT01728376|7472825|FG001|COMPLETED|Overall Study||9
6550904|NCT01728376|7472826|FG002|COMPLETED|Overall Study||17
6550905|NCT01728376|7472827|FG003|COMPLETED|Overall Study||7
6550906|NCT01728376|7472828|FG004|COMPLETED|Overall Study||12
6550907|NCT01728376|7472829|FG005|COMPLETED|Overall Study||5
6550908|NCT01728376|7472824|FG000|NOT COMPLETED|Overall Study||4
6649304|NCT02404389|7578551|FG002|STARTED|Overall Study||11
6649305|NCT02404389|7578552|FG003|STARTED|Overall Study||10
6649306|NCT02404389|7578553|FG004|STARTED|Overall Study||21
6649307|NCT02404389|7578549|FG000|COMPLETED|Overall Study||18
6304598|NCT00366275|7207810|FG000|NOT COMPLETED|Overall Study||6
6422308|NCT01001208|7336914|FG001|COMPLETED|Overall Study||206
6422309|NCT01001208|7336913|FG000|NOT COMPLETED|Overall Study||28
6550909|NCT01728376|7472825|FG001|NOT COMPLETED|Overall Study||2
6550910|NCT01728376|7472826|FG002|NOT COMPLETED|Overall Study||2
6550911|NCT01728376|7472827|FG003|NOT COMPLETED|Overall Study||2
6550912|NCT01728376|7472828|FG004|NOT COMPLETED|Overall Study||2
6550913|NCT01728376|7472829|FG005|NOT COMPLETED|Overall Study||2
6550914|NCT01728454|7472846|FG000|STARTED|Stage 1 and 2||17
6550915|NCT01728454|7472847|FG001|STARTED|Stage 1 and 2||20
6649308|NCT02404389|7578550|FG001|COMPLETED|Overall Study||20
6649309|NCT02404389|7578551|FG002|COMPLETED|Overall Study||10
6649310|NCT02404389|7578552|FG003|COMPLETED|Overall Study||9
6649311|NCT02404389|7578553|FG004|COMPLETED|Overall Study||18
6743995|NCT03338816|7672099|FG001|COMPLETED|6-Month Double-blind Period|1 participant discontinued treatment during the 6-month DB period but completed the 6-month DB Visit|47
6743996|NCT03338816|7672098|FG000|NOT COMPLETED|6-Month Double-blind Period||0
6743997|NCT03338816|7672099|FG001|NOT COMPLETED|6-Month Double-blind Period||1
6743998|NCT03338816|7672098|FG000|STARTED|Open-Label Extension Period||46
6743999|NCT03338816|7672099|FG001|STARTED|Open-Label Extension Period||47
6744000|NCT03338816|7672098|FG000|COMPLETED|Open-Label Extension Period||0
6744001|NCT03338816|7672099|FG001|COMPLETED|Open-Label Extension Period||0
6744002|NCT03338816|7672098|FG000|NOT COMPLETED|Open-Label Extension Period||46
6744003|NCT03338816|7672099|FG001|NOT COMPLETED|Open-Label Extension Period||47
6744004|NCT03338855|7672107|FG000|STARTED|Overall Study||12
6744005|NCT03338855|7672108|FG001|STARTED|Overall Study||14
6744006|NCT03338855|7672107|FG000|Received Treatment in Period 1|Overall Study||12
6744007|NCT03338855|7672108|FG001|Received Treatment in Period 1|Overall Study||14
6744008|NCT03338855|7672107|FG000|Received Treatment in Period 2|Overall Study||11
6744009|NCT03338855|7672108|FG001|Received Treatment in Period 2|Overall Study||14
6744010|NCT03338855|7672107|FG000|COMPLETED|Overall Study||11
6744011|NCT03338855|7672108|FG001|COMPLETED|Overall Study||14
6744012|NCT03338855|7672107|FG000|NOT COMPLETED|Overall Study||1
6744013|NCT03338855|7672108|FG001|NOT COMPLETED|Overall Study||0
6744014|NCT03338894|7672114|FG000|STARTED|Overall Study||66
6744015|NCT03338894|7672114|FG000|COMPLETED|Overall Study||56
6744016|NCT03338894|7672114|FG000|NOT COMPLETED|Overall Study||10
6744017|NCT03338998|7672120|FG000|STARTED|Treatment Period||16
6744018|NCT03338998|7672121|FG001|STARTED|Treatment Period||13
6744019|NCT03338998|7672120|FG000|COMPLETED|Treatment Period||8
6744020|NCT03338998|7672121|FG001|COMPLETED|Treatment Period||10
6744021|NCT03338998|7672120|FG000|NOT COMPLETED|Treatment Period||8
6744022|NCT03338998|7672121|FG001|NOT COMPLETED|Treatment Period||3
6744023|NCT03338998|7672120|FG000|STARTED|Safety Follow-Up Period||16
6744024|NCT03338998|7672121|FG001|STARTED|Safety Follow-Up Period||13
6744025|NCT03338998|7672120|FG000|COMPLETED|Safety Follow-Up Period||14
6744026|NCT03338998|7672121|FG001|COMPLETED|Safety Follow-Up Period||12
6744027|NCT03338998|7672120|FG000|NOT COMPLETED|Safety Follow-Up Period||2
6744028|NCT03338998|7672121|FG001|NOT COMPLETED|Safety Follow-Up Period||1
6744029|NCT03339206|7672131|FG000|STARTED|Overall Study||262
6744030|NCT03339206|7672132|FG001|STARTED|Overall Study||263
6744031|NCT03339206|7672133|FG002|STARTED|Overall Study||264
6744032|NCT03339206|7672131|FG000|COMPLETED|Overall Study||262
6744033|NCT03339206|7672132|FG001|COMPLETED|Overall Study||263
6744034|NCT03339206|7672133|FG002|COMPLETED|Overall Study||264
6744035|NCT03339206|7672131|FG000|NOT COMPLETED|Overall Study||0
6744036|NCT03339206|7672132|FG001|NOT COMPLETED|Overall Study||0
6744037|NCT03339206|7672133|FG002|NOT COMPLETED|Overall Study||0
6744038|NCT03339219|7672141|FG000|STARTED|Overall Study||35
6744039|NCT03339219|7672141|FG000|COMPLETED|Overall Study||0
6744040|NCT03339219|7672141|FG000|NOT COMPLETED|Overall Study||35
6744041|NCT03339297|7672147|FG000|STARTED|Overall Study||79
6744042|NCT03339297|7672148|FG001|STARTED|Overall Study||73
6744043|NCT03339297|7672147|FG000|COMPLETED|Overall Study||56
6744044|NCT03339297|7672148|FG001|COMPLETED|Overall Study||59
6744045|NCT03339297|7672147|FG000|NOT COMPLETED|Overall Study||23
6744046|NCT03339297|7672148|FG001|NOT COMPLETED|Overall Study||14
6744047|NCT03339453|7672156|FG000|STARTED|First Visit of Glucagon Treatment||35
6744048|NCT03339453|7672157|FG001|STARTED|First Visit of Glucagon Treatment||35
6744049|NCT03339453|7672156|FG000|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
6744050|NCT03339453|7672157|FG001|Received at Least 1 Dose of Study Drug|First Visit of Glucagon Treatment||35
6744051|NCT03339453|7672156|FG000|COMPLETED|First Visit of Glucagon Treatment||35
6744052|NCT03339453|7672157|FG001|COMPLETED|First Visit of Glucagon Treatment||34
6744053|NCT03339453|7672156|FG000|NOT COMPLETED|First Visit of Glucagon Treatment||0
6744054|NCT03339453|7672157|FG001|NOT COMPLETED|First Visit of Glucagon Treatment||1
6744055|NCT03339453|7672156|FG000|STARTED|Second Visit for Alternate Glucagon||35
6744056|NCT03339453|7672157|FG001|STARTED|Second Visit for Alternate Glucagon||34
6304599|NCT00366301|7207818|FG000|STARTED|Overall Study||124
6304600|NCT00366301|7207819|FG001|STARTED|Overall Study||126
6649312|NCT02404389|7578549|FG000|NOT COMPLETED|Overall Study||2
6649313|NCT02404389|7578550|FG001|NOT COMPLETED|Overall Study||0
6649314|NCT02404389|7578551|FG002|NOT COMPLETED|Overall Study||1
6649315|NCT02404389|7578552|FG003|NOT COMPLETED|Overall Study||1
6649316|NCT02404389|7578553|FG004|NOT COMPLETED|Overall Study||3
6649317|NCT02404441|7578577|FG000|STARTED|Phase 1 Part||16
6649318|NCT02404441|7578578|FG001|STARTED|Phase 1 Part||15
6649319|NCT02404441|7578579|FG002|STARTED|Phase 1 Part||11
6649320|NCT02404441|7578580|FG003|STARTED|Phase 1 Part||6
6649321|NCT02404441|7578581|FG004|STARTED|Phase 1 Part||10
6649322|NCT02404441|7578582|FG005|STARTED|Phase 1 Part||0
6649323|NCT02404441|7578583|FG006|STARTED|Phase 1 Part||0
6649324|NCT02404441|7578584|FG007|STARTED|Phase 1 Part||0
6649325|NCT02404441|7578585|FG008|STARTED|Phase 1 Part||0
6649326|NCT02404441|7578586|FG009|STARTED|Phase 1 Part||0
6649327|NCT02404441|7578577|FG000|COMPLETED|Phase 1 Part||0
6649328|NCT02404441|7578578|FG001|COMPLETED|Phase 1 Part||0
6649329|NCT02404441|7578579|FG002|COMPLETED|Phase 1 Part||0
6649330|NCT02404441|7578580|FG003|COMPLETED|Phase 1 Part||0
6649331|NCT02404441|7578581|FG004|COMPLETED|Phase 1 Part||0
6649332|NCT02404441|7578582|FG005|COMPLETED|Phase 1 Part||0
6550916|NCT01728454|7472848|FG002|STARTED|Stage 1 and 2||23
6550917|NCT01728454|7472846|FG000|COMPLETED|Stage 1 and 2||12
6550918|NCT01728454|7472847|FG001|COMPLETED|Stage 1 and 2||16
6550919|NCT01728454|7472848|FG002|COMPLETED|Stage 1 and 2||19
6649333|NCT02404441|7578583|FG006|COMPLETED|Phase 1 Part||0
6649334|NCT02404441|7578584|FG007|COMPLETED|Phase 1 Part||0
6649335|NCT02404441|7578585|FG008|COMPLETED|Phase 1 Part||0
6649336|NCT02404441|7578586|FG009|COMPLETED|Phase 1 Part||0
6649337|NCT02404441|7578577|FG000|NOT COMPLETED|Phase 1 Part||16
6649338|NCT02404441|7578578|FG001|NOT COMPLETED|Phase 1 Part||15
6649339|NCT02404441|7578579|FG002|NOT COMPLETED|Phase 1 Part||11
6649340|NCT02404441|7578580|FG003|NOT COMPLETED|Phase 1 Part||6
6649341|NCT02404441|7578581|FG004|NOT COMPLETED|Phase 1 Part||10
6304601|NCT00366301|7207820|FG002|STARTED|Overall Study||126
6304602|NCT00366301|7207821|FG003|STARTED|Overall Study||124
6304603|NCT00366301|7207818|FG000|Either 6W or 14W CRP Obtained|Overall Study||120
6304604|NCT00366301|7207819|FG001|Either 6W or 14W CRP Obtained|Overall Study||124
6304605|NCT00366301|7207820|FG002|Either 6W or 14W CRP Obtained|Overall Study||124
6304606|NCT00366301|7207821|FG003|Either 6W or 14W CRP Obtained|Overall Study||119
6304607|NCT00366301|7207818|FG000|COMPLETED|Overall Study||116
6304608|NCT00366301|7207819|FG001|COMPLETED|Overall Study||120
6304609|NCT00366301|7207820|FG002|COMPLETED|Overall Study||122
6304610|NCT00366301|7207821|FG003|COMPLETED|Overall Study||116
6304611|NCT00366301|7207818|FG000|NOT COMPLETED|Overall Study||8
6304612|NCT00366301|7207819|FG001|NOT COMPLETED|Overall Study||6
6304613|NCT00366301|7207820|FG002|NOT COMPLETED|Overall Study||4
6304614|NCT00366301|7207821|FG003|NOT COMPLETED|Overall Study||8
6304615|NCT00366340|7207833|FG000|STARTED|Infant Series||301
6304616|NCT00366340|7207834|FG001|STARTED|Infant Series||303
6304617|NCT00366340|7207833|FG000|Vaccinated Dose 1|Infant Series||300
6304618|NCT00366340|7207834|FG001|Vaccinated Dose 1|Infant Series||303
6304619|NCT00366340|7207833|FG000|Vaccinated Dose 2|Infant Series||296
6304620|NCT00366340|7207834|FG001|Vaccinated Dose 2|Infant Series||297
6304621|NCT00366340|7207833|FG000|Vaccinated Dose 3|Infant Series||294
6304622|NCT00366340|7207834|FG001|Vaccinated Dose 3|Infant Series||293
6304623|NCT00366340|7207833|FG000|COMPLETED|Infant Series||293
6304624|NCT00366340|7207834|FG001|COMPLETED|Infant Series||293
6304625|NCT00366340|7207833|FG000|NOT COMPLETED|Infant Series||8
6304626|NCT00366340|7207834|FG001|NOT COMPLETED|Infant Series||10
6304627|NCT00366340|7207833|FG000|STARTED|After the Infant Series||293
6304628|NCT00366340|7207834|FG001|STARTED|After the Infant Series||293
6304629|NCT00366340|7207833|FG000|COMPLETED|After the Infant Series||290
6304630|NCT00366340|7207834|FG001|COMPLETED|After the Infant Series||287
6304631|NCT00366340|7207833|FG000|NOT COMPLETED|After the Infant Series||3
6304632|NCT00366340|7207834|FG001|NOT COMPLETED|After the Infant Series||6
6304633|NCT00366340|7207833|FG000|STARTED|Toddler Dose||290
6304634|NCT00366340|7207834|FG001|STARTED|Toddler Dose||287
6304635|NCT00366340|7207833|FG000|COMPLETED|Toddler Dose||289
6304636|NCT00366340|7207834|FG001|COMPLETED|Toddler Dose||286
6304637|NCT00366340|7207833|FG000|NOT COMPLETED|Toddler Dose||1
6550920|NCT01728454|7472846|FG000|NOT COMPLETED|Stage 1 and 2||5
6550921|NCT01728454|7472847|FG001|NOT COMPLETED|Stage 1 and 2||4
6550922|NCT01728454|7472848|FG002|NOT COMPLETED|Stage 1 and 2||4
6550923|NCT01728454|7472846|FG000|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|6
6550924|NCT01728454|7472847|FG001|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|5
6550925|NCT01728454|7472848|FG002|STARTED|Stage 3|Eligible participants who opted to participate in Stage 3.|11
6550926|NCT01728454|7472846|FG000|COMPLETED|Stage 3||3
6550927|NCT01728454|7472847|FG001|COMPLETED|Stage 3||1
6550928|NCT01728454|7472848|FG002|COMPLETED|Stage 3||7
6550929|NCT01728454|7472846|FG000|NOT COMPLETED|Stage 3||3
6550930|NCT01728454|7472847|FG001|NOT COMPLETED|Stage 3||4
6550931|NCT01728454|7472848|FG002|NOT COMPLETED|Stage 3||4
6649342|NCT02404441|7578582|FG005|NOT COMPLETED|Phase 1 Part||0
6550932|NCT01728584|7472863|FG000|STARTED|Overall Study|Randomized|36
6649343|NCT02404441|7578583|FG006|NOT COMPLETED|Phase 1 Part||0
6649344|NCT02404441|7578584|FG007|NOT COMPLETED|Phase 1 Part||0
6550933|NCT01728584|7472864|FG001|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
6550934|NCT01728584|7472865|FG002|STARTED|Overall Study|Randomized|31
6550935|NCT01728584|7472866|FG003|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
6550936|NCT01728584|7472863|FG000|COMPLETED|Overall Study||28
6550937|NCT01728584|7472864|FG001|COMPLETED|Overall Study||30
6649345|NCT02404441|7578585|FG008|NOT COMPLETED|Phase 1 Part||0
6649346|NCT02404441|7578586|FG009|NOT COMPLETED|Phase 1 Part||0
6649347|NCT02404441|7578577|FG000|STARTED|Phase 2 Part||0
6744057|NCT03339453|7672156|FG000|COMPLETED|Second Visit for Alternate Glucagon||35
6649348|NCT02404441|7578578|FG001|STARTED|Phase 2 Part||0
6744058|NCT03339453|7672157|FG001|COMPLETED|Second Visit for Alternate Glucagon||34
6744059|NCT03339453|7672156|FG000|NOT COMPLETED|Second Visit for Alternate Glucagon||0
6744060|NCT03339453|7672157|FG001|NOT COMPLETED|Second Visit for Alternate Glucagon||0
6744061|NCT03339570|7672163|FG000|STARTED|Overall Study||20
6744062|NCT03339570|7672163|FG000|COMPLETED|Overall Study||16
6744063|NCT03339570|7672163|FG000|NOT COMPLETED|Overall Study||4
6744064|NCT03339583|7672178|FG000|STARTED|First Intervention (14 Days)||19
6744065|NCT03339583|7672179|FG001|STARTED|First Intervention (14 Days)||23
6744066|NCT03339583|7672178|FG000|COMPLETED|First Intervention (14 Days)||18
6744067|NCT03339583|7672179|FG001|COMPLETED|First Intervention (14 Days)||23
6744068|NCT03339583|7672178|FG000|NOT COMPLETED|First Intervention (14 Days)||1
6744069|NCT03339583|7672179|FG001|NOT COMPLETED|First Intervention (14 Days)||0
6744070|NCT03339583|7672178|FG000|STARTED|Washout (14 Days)||18
6744071|NCT03339583|7672179|FG001|STARTED|Washout (14 Days)||23
6744072|NCT03339583|7672178|FG000|COMPLETED|Washout (14 Days)||18
6744073|NCT03339583|7672179|FG001|COMPLETED|Washout (14 Days)||23
6744074|NCT03339583|7672178|FG000|NOT COMPLETED|Washout (14 Days)||0
6744075|NCT03339583|7672179|FG001|NOT COMPLETED|Washout (14 Days)||0
6744076|NCT03339583|7672178|FG000|STARTED|Second Intervention (14 Days)||18
6744077|NCT03339583|7672179|FG001|STARTED|Second Intervention (14 Days)||23
6744078|NCT03339583|7672178|FG000|COMPLETED|Second Intervention (14 Days)||18
6744079|NCT03339583|7672179|FG001|COMPLETED|Second Intervention (14 Days)||21
6744080|NCT03339583|7672178|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
6744081|NCT03339583|7672179|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
6744082|NCT03339583|7672178|FG000|STARTED|Follow-up (14 Days)||18
6744083|NCT03339583|7672179|FG001|STARTED|Follow-up (14 Days)||21
6744084|NCT03339583|7672178|FG000|COMPLETED|Follow-up (14 Days)||12
6744085|NCT03339583|7672179|FG001|COMPLETED|Follow-up (14 Days)||18
6744086|NCT03339583|7672178|FG000|NOT COMPLETED|Follow-up (14 Days)||6
6744087|NCT03339583|7672179|FG001|NOT COMPLETED|Follow-up (14 Days)||3
6744088|NCT03339713|7672189|FG000|STARTED|Overall Study||90
6744089|NCT03339713|7672190|FG001|STARTED|Overall Study||90
6744090|NCT03339713|7672189|FG000|COMPLETED|Overall Study||86
6744091|NCT03339713|7672190|FG001|COMPLETED|Overall Study||88
6744092|NCT03339713|7672189|FG000|NOT COMPLETED|Overall Study||4
6744093|NCT03339713|7672190|FG001|NOT COMPLETED|Overall Study||2
6744094|NCT03339726|7672201|FG000|STARTED|Overall Study||64
6744095|NCT03339726|7672202|FG001|STARTED|Overall Study||66
6744096|NCT03339726|7672203|FG002|STARTED|Overall Study||63
6744097|NCT03339726|7672201|FG000|COMPLETED|Overall Study||63
6744098|NCT03339726|7672202|FG001|COMPLETED|Overall Study||65
6744099|NCT03339726|7672203|FG002|COMPLETED|Overall Study||63
6744100|NCT03339726|7672201|FG000|NOT COMPLETED|Overall Study||1
6744101|NCT03339726|7672202|FG001|NOT COMPLETED|Overall Study||1
6744102|NCT03339726|7672203|FG002|NOT COMPLETED|Overall Study||0
6744103|NCT03339999|7672215|FG000|STARTED|Overall Study||7
6744104|NCT03339999|7672216|FG001|STARTED|Overall Study||6
6744105|NCT03339999|7672217|FG002|STARTED|Overall Study||6
6744106|NCT03339999|7672218|FG003|STARTED|Overall Study||5
6744107|NCT03339999|7672215|FG000|Modified Intent-to-Treat Population|Overall Study||7
6744108|NCT03339999|7672216|FG001|Modified Intent-to-Treat Population|Overall Study||6
6744109|NCT03339999|7672217|FG002|Modified Intent-to-Treat Population|Overall Study||5
6744110|NCT03339999|7672218|FG003|Modified Intent-to-Treat Population|Overall Study||4
6744111|NCT03339999|7672215|FG000|Safety Population: Received Treatment|Overall Study||7
6744112|NCT03339999|7672216|FG001|Safety Population: Received Treatment|Overall Study||6
6744113|NCT03339999|7672217|FG002|Safety Population: Received Treatment|Overall Study||6
6744114|NCT03339999|7672218|FG003|Safety Population: Received Treatment|Overall Study||4
6744115|NCT03339999|7672215|FG000|COMPLETED|Overall Study||0
6744116|NCT03339999|7672216|FG001|COMPLETED|Overall Study||0
6744117|NCT03339999|7672217|FG002|COMPLETED|Overall Study||0
6744118|NCT03339999|7672218|FG003|COMPLETED|Overall Study||0
6744119|NCT03339999|7672215|FG000|NOT COMPLETED|Overall Study||7
6744120|NCT03339999|7672216|FG001|NOT COMPLETED|Overall Study||6
6744121|NCT03339999|7672217|FG002|NOT COMPLETED|Overall Study||6
6744122|NCT03339999|7672218|FG003|NOT COMPLETED|Overall Study||5
6744123|NCT03340025|7672233|FG000|STARTED|Overall Study||11
6550938|NCT01728584|7472865|FG002|COMPLETED|Overall Study||30
6550939|NCT01728584|7472866|FG003|COMPLETED|Overall Study||29
6550940|NCT01728584|7472863|FG000|NOT COMPLETED|Overall Study||8
6550941|NCT01728584|7472864|FG001|NOT COMPLETED|Overall Study||0
6550942|NCT01728584|7472865|FG002|NOT COMPLETED|Overall Study||1
6550943|NCT01728584|7472866|FG003|NOT COMPLETED|Overall Study||1
6550944|NCT01728623|7472883|FG000|STARTED|Overall Study||51
6550945|NCT01728623|7472883|FG000|DTC|Overall Study||25
6550946|NCT01728623|7472883|FG000|MTC|Overall Study||9
6550947|NCT01728623|7472883|FG000|ATC|Overall Study||17
6550948|NCT01728623|7472883|FG000|COMPLETED|Overall Study||23
6550949|NCT01728623|7472883|FG000|NOT COMPLETED|Overall Study||28
6550950|NCT01728636|7472892|FG000|STARTED|Overall Study||31
6550951|NCT01728636|7472893|FG001|STARTED|Overall Study||30
6550952|NCT01728636|7472892|FG000|COMPLETED|Overall Study||31
6649349|NCT02404441|7578579|FG002|STARTED|Phase 2 Part||0
6649350|NCT02404441|7578580|FG003|STARTED|Phase 2 Part||0
6649351|NCT02404441|7578581|FG004|STARTED|Phase 2 Part||0
6649352|NCT02404441|7578582|FG005|STARTED|Phase 2 Part||59
6649353|NCT02404441|7578583|FG006|STARTED|Phase 2 Part||61
6649354|NCT02404441|7578584|FG007|STARTED|Phase 2 Part||40
6649355|NCT02404441|7578585|FG008|STARTED|Phase 2 Part||59
6649356|NCT02404441|7578586|FG009|STARTED|Phase 2 Part||42
6649357|NCT02404441|7578577|FG000|Entered Post-treatment Follow-up|Phase 2 Part||0
6649358|NCT02404441|7578578|FG001|Entered Post-treatment Follow-up|Phase 2 Part||0
6649359|NCT02404441|7578579|FG002|Entered Post-treatment Follow-up|Phase 2 Part||0
6744124|NCT03340025|7672234|FG001|STARTED|Overall Study||9
6744125|NCT03340025|7672233|FG000|COMPLETED|Overall Study||9
6649360|NCT02404441|7578580|FG003|Entered Post-treatment Follow-up|Phase 2 Part||0
6649361|NCT02404441|7578581|FG004|Entered Post-treatment Follow-up|Phase 2 Part||0
6649362|NCT02404441|7578582|FG005|Entered Post-treatment Follow-up|Phase 2 Part||2
6649363|NCT02404441|7578583|FG006|Entered Post-treatment Follow-up|Phase 2 Part||6
6649364|NCT02404441|7578584|FG007|Entered Post-treatment Follow-up|Phase 2 Part||1
6649365|NCT02404441|7578585|FG008|Entered Post-treatment Follow-up|Phase 2 Part||6
6649366|NCT02404441|7578586|FG009|Entered Post-treatment Follow-up|Phase 2 Part||1
6649367|NCT02404441|7578577|FG000|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
6649368|NCT02404441|7578578|FG001|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
6649369|NCT02404441|7578579|FG002|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
6744126|NCT03340025|7672234|FG001|COMPLETED|Overall Study||7
6304638|NCT00366340|7207834|FG001|NOT COMPLETED|Toddler Dose||1
6304639|NCT00366444|7207866|FG000|STARTED|Overall Study||102
6304640|NCT00366444|7207867|FG001|STARTED|Overall Study||99
6304641|NCT00366444|7207866|FG000|COMPLETED|Overall Study||101
6304642|NCT00366444|7207867|FG001|COMPLETED|Overall Study||97
6304643|NCT00366444|7207866|FG000|NOT COMPLETED|Overall Study||1
6304644|NCT00366444|7207867|FG001|NOT COMPLETED|Overall Study||2
6304645|NCT00366457|7207873|FG000|STARTED|Overall Study||32
6304646|NCT00366457|7207873|FG000|COMPLETED|Overall Study||30
6304647|NCT00366457|7207873|FG000|NOT COMPLETED|Overall Study||2
6304648|NCT00366535|7207879|FG000|STARTED|First Phase: 12 Weeks||27
6304649|NCT00366535|7207880|FG001|STARTED|First Phase: 12 Weeks||29
6304650|NCT00366535|7207879|FG000|COMPLETED|First Phase: 12 Weeks||24
6304651|NCT00366535|7207880|FG001|COMPLETED|First Phase: 12 Weeks||21
6304652|NCT00366535|7207879|FG000|NOT COMPLETED|First Phase: 12 Weeks||3
6304653|NCT00366535|7207880|FG001|NOT COMPLETED|First Phase: 12 Weeks||8
6304654|NCT00366535|7207879|FG000|STARTED|Washout Period (at Least a Week)||24
6304655|NCT00366535|7207880|FG001|STARTED|Washout Period (at Least a Week)||21
6304656|NCT00366535|7207879|FG000|COMPLETED|Washout Period (at Least a Week)||24
6304657|NCT00366535|7207880|FG001|COMPLETED|Washout Period (at Least a Week)||21
6304658|NCT00366535|7207879|FG000|NOT COMPLETED|Washout Period (at Least a Week)||0
6304659|NCT00366535|7207880|FG001|NOT COMPLETED|Washout Period (at Least a Week)||0
6304660|NCT00366535|7207879|FG000|STARTED|Second Phase: 12 Weeks||24
6304661|NCT00366535|7207880|FG001|STARTED|Second Phase: 12 Weeks||21
6304662|NCT00366535|7207879|FG000|COMPLETED|Second Phase: 12 Weeks||21
6304663|NCT00366535|7207880|FG001|COMPLETED|Second Phase: 12 Weeks||18
6304664|NCT00366535|7207879|FG000|NOT COMPLETED|Second Phase: 12 Weeks||3
6304665|NCT00366535|7207880|FG001|NOT COMPLETED|Second Phase: 12 Weeks||3
6304666|NCT00366548|7207896|FG000|STARTED|Infant Series||250
6304667|NCT00366548|7207897|FG001|STARTED|Infant Series||250
6304668|NCT00366548|7207896|FG000|Vaccinated Dose 1|Infant Series||250
6304669|NCT00366548|7207897|FG001|Vaccinated Dose 1|Infant Series||250
6304670|NCT00366548|7207896|FG000|Vaccinated Dose 2|Infant Series||246
6304671|NCT00366548|7207897|FG001|Vaccinated Dose 2|Infant Series||249
6304672|NCT00366548|7207896|FG000|Vaccinated Dose 3|Infant Series||246
6304673|NCT00366548|7207897|FG001|Vaccinated Dose 3|Infant Series||247
6304674|NCT00366548|7207896|FG000|COMPLETED|Infant Series||246
6304675|NCT00366548|7207897|FG001|COMPLETED|Infant Series||245
6304676|NCT00366548|7207896|FG000|NOT COMPLETED|Infant Series||4
6304677|NCT00366548|7207897|FG001|NOT COMPLETED|Infant Series||5
6304678|NCT00366548|7207896|FG000|STARTED|After Infant Series||246
6304679|NCT00366548|7207897|FG001|STARTED|After Infant Series||245
6304680|NCT00366548|7207896|FG000|COMPLETED|After Infant Series||240
6304681|NCT00366548|7207897|FG001|COMPLETED|After Infant Series||244
6304682|NCT00366548|7207896|FG000|NOT COMPLETED|After Infant Series||6
6304683|NCT00366548|7207897|FG001|NOT COMPLETED|After Infant Series||1
6304684|NCT00366548|7207896|FG000|STARTED|Toddler Dose||240
6304685|NCT00366548|7207897|FG001|STARTED|Toddler Dose||244
6304686|NCT00366548|7207896|FG000|COMPLETED|Toddler Dose||240
6304687|NCT00366548|7207897|FG001|COMPLETED|Toddler Dose||244
6304688|NCT00366548|7207896|FG000|NOT COMPLETED|Toddler Dose||0
6304689|NCT00366548|7207897|FG001|NOT COMPLETED|Toddler Dose||0
6304690|NCT00366626|7207923|FG000|STARTED|Overall Study||38
6304691|NCT00366626|7207924|FG001|STARTED|Overall Study||45
6304692|NCT00366626|7207923|FG000|COMPLETED|Overall Study||38
6304693|NCT00366626|7207924|FG001|COMPLETED|Overall Study||45
6304694|NCT00366626|7207923|FG000|NOT COMPLETED|Overall Study||0
6304695|NCT00366626|7207924|FG001|NOT COMPLETED|Overall Study||0
6304696|NCT00366678|7207934|FG000|STARTED|Infant Series||304
6304697|NCT00366678|7207935|FG001|STARTED|Infant Series||309
6304698|NCT00366678|7207936|FG002|STARTED|Infant Series||0
6304699|NCT00366678|7207934|FG000|Vaccinated Dose 1|Infant Series||302
6304700|NCT00366678|7207935|FG001|Vaccinated Dose 1|Infant Series||309
6304701|NCT00366678|7207936|FG002|Vaccinated Dose 1|Infant Series||0
6304702|NCT00366678|7207934|FG000|Vaccinated Dose 2|Infant Series||295
6304703|NCT00366678|7207935|FG001|Vaccinated Dose 2|Infant Series||304
6304704|NCT00366678|7207936|FG002|Vaccinated Dose 2|Infant Series||0
6304705|NCT00366678|7207934|FG000|Vaccinated Dose 3|Infant Series||291
6304706|NCT00366678|7207935|FG001|Vaccinated Dose 3|Infant Series||302
6304707|NCT00366678|7207936|FG002|Vaccinated Dose 3|Infant Series||0
6304708|NCT00366678|7207934|FG000|COMPLETED|Infant Series||290
6304709|NCT00366678|7207935|FG001|COMPLETED|Infant Series||299
6304710|NCT00366678|7207936|FG002|COMPLETED|Infant Series||0
6304711|NCT00366678|7207934|FG000|NOT COMPLETED|Infant Series||14
6304712|NCT00366678|7207935|FG001|NOT COMPLETED|Infant Series||10
6304713|NCT00366678|7207936|FG002|NOT COMPLETED|Infant Series||0
6304714|NCT00366678|7207934|FG000|STARTED|After Infant||290
6304715|NCT00366678|7207935|FG001|STARTED|After Infant||299
6304716|NCT00366678|7207936|FG002|STARTED|After Infant||0
6304717|NCT00366678|7207934|FG000|COMPLETED|After Infant||273
6550953|NCT01728636|7472893|FG001|COMPLETED|Overall Study||30
6550954|NCT01728636|7472892|FG000|NOT COMPLETED|Overall Study||0
6550955|NCT01728636|7472893|FG001|NOT COMPLETED|Overall Study||0
6550956|NCT01728779|7472899|FG000|STARTED|Overall Study||38
6550957|NCT01728779|7472899|FG000|COMPLETED|Overall Study||37
6550958|NCT01728779|7472899|FG000|NOT COMPLETED|Overall Study||1
6550959|NCT01728792|7472908|FG000|STARTED|Overall Study||14
6550960|NCT01728792|7472909|FG001|STARTED|Overall Study||16
6550961|NCT01728792|7472910|FG002|STARTED|Overall Study||17
6550962|NCT01728792|7472911|FG003|STARTED|Overall Study||17
6550963|NCT01728792|7472912|FG004|STARTED|Overall Study||16
6550964|NCT01728792|7472908|FG000|COMPLETED|Overall Study||11
6550965|NCT01728792|7472909|FG001|COMPLETED|Overall Study||14
6550966|NCT01728792|7472910|FG002|COMPLETED|Overall Study||13
6550967|NCT01728792|7472911|FG003|COMPLETED|Overall Study||14
6550968|NCT01728792|7472912|FG004|COMPLETED|Overall Study||16
6550969|NCT01728792|7472908|FG000|NOT COMPLETED|Overall Study||3
6550970|NCT01728792|7472909|FG001|NOT COMPLETED|Overall Study||2
6550971|NCT01728792|7472910|FG002|NOT COMPLETED|Overall Study||4
6550972|NCT01728792|7472911|FG003|NOT COMPLETED|Overall Study||3
6550973|NCT01728792|7472912|FG004|NOT COMPLETED|Overall Study||0
6550974|NCT01728805|7472926|FG000|STARTED|Randomization Period||186
6550975|NCT01728805|7472927|FG001|STARTED|Randomization Period||186
6550976|NCT01728805|7472928|FG002|STARTED|Randomization Period||0
6550977|NCT01728805|7472926|FG000|COMPLETED|Randomization Period||186
6550978|NCT01728805|7472927|FG001|COMPLETED|Randomization Period||186
6550979|NCT01728805|7472928|FG002|COMPLETED|Randomization Period||0
6550980|NCT01728805|7472926|FG000|NOT COMPLETED|Randomization Period||0
6550981|NCT01728805|7472927|FG001|NOT COMPLETED|Randomization Period||0
6550982|NCT01728805|7472928|FG002|NOT COMPLETED|Randomization Period||0
6550983|NCT01728805|7472926|FG000|STARTED|Crossover Period||0
6550984|NCT01728805|7472927|FG001|STARTED|Crossover Period||0
6550985|NCT01728805|7472928|FG002|STARTED|Crossover Period||136
6304718|NCT00366678|7207935|FG001|COMPLETED|After Infant||289
6304719|NCT00366678|7207936|FG002|COMPLETED|After Infant||0
6304720|NCT00366678|7207934|FG000|NOT COMPLETED|After Infant||17
6304721|NCT00366678|7207935|FG001|NOT COMPLETED|After Infant||10
6304722|NCT00366678|7207936|FG002|NOT COMPLETED|After Infant||0
6304723|NCT00366678|7207934|FG000|STARTED|Toddler Dose||273
6304724|NCT00366678|7207935|FG001|STARTED|Toddler Dose||152
6304725|NCT00366678|7207936|FG002|STARTED|Toddler Dose||137
6304726|NCT00366678|7207934|FG000|COMPLETED|Toddler Dose||268
6304727|NCT00366678|7207935|FG001|COMPLETED|Toddler Dose||151
6304728|NCT00366678|7207936|FG002|COMPLETED|Toddler Dose||137
6304729|NCT00366678|7207934|FG000|NOT COMPLETED|Toddler Dose||5
6304730|NCT00366678|7207935|FG001|NOT COMPLETED|Toddler Dose||1
6304731|NCT00366678|7207936|FG002|NOT COMPLETED|Toddler Dose||0
6304732|NCT00366899|7207983|FG000|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
6304733|NCT00366899|7207984|FG001|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
6304734|NCT00366899|7207983|FG000|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
6304735|NCT00366899|7207984|FG001|Vaccinated Dose 1|Infant Series||302
6304736|NCT00366899|7207983|FG000|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
6304737|NCT00366899|7207984|FG001|Vaccinated Dose 2|Infant Series||293
6304738|NCT00366899|7207983|FG000|COMPLETED|Infant Series||294
6304739|NCT00366899|7207984|FG001|COMPLETED|Infant Series||291
6304740|NCT00366899|7207983|FG000|NOT COMPLETED|Infant Series||9
6304741|NCT00366899|7207984|FG001|NOT COMPLETED|Infant Series||12
6304742|NCT00366899|7207983|FG000|STARTED|After Infant Series||294
6304743|NCT00366899|7207984|FG001|STARTED|After Infant Series||291
6304744|NCT00366899|7207983|FG000|COMPLETED|After Infant Series||287
6304745|NCT00366899|7207984|FG001|COMPLETED|After Infant Series||282
6304746|NCT00366899|7207983|FG000|NOT COMPLETED|After Infant Series||7
6304747|NCT00366899|7207984|FG001|NOT COMPLETED|After Infant Series||9
6304748|NCT00366899|7207983|FG000|STARTED|Toddler Dose||287
6304749|NCT00366899|7207984|FG001|STARTED|Toddler Dose||282
6304750|NCT00366899|7207983|FG000|COMPLETED|Toddler Dose||285
6304751|NCT00366899|7207984|FG001|COMPLETED|Toddler Dose||281
6304752|NCT00366899|7207983|FG000|NOT COMPLETED|Toddler Dose||2
6304753|NCT00366899|7207984|FG001|NOT COMPLETED|Toddler Dose||1
6374822|NCT00752206|7285374|FG001|COMPLETED|Overall Study||8
6374823|NCT00752206|7285373|FG000|NOT COMPLETED|Overall Study||9
6374824|NCT00752206|7285374|FG001|NOT COMPLETED|Overall Study||11
6374825|NCT00752219|7285382|FG000|STARTED|Overall Study||102
6374826|NCT00752219|7285383|FG001|STARTED|Overall Study||102
6649370|NCT02404441|7578580|FG003|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
6649371|NCT02404441|7578581|FG004|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||0
6649372|NCT02404441|7578582|FG005|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||2
6649373|NCT02404441|7578583|FG006|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
6649374|NCT02404441|7578584|FG007|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
6649375|NCT02404441|7578585|FG008|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||6
6649376|NCT02404441|7578586|FG009|No Longer Being Followed for Post-treatment Follow-up|Phase 2 Part||1
6649377|NCT02404441|7578577|FG000|Entered Survival Follow-up|Phase 2 Part||0
6649378|NCT02404441|7578578|FG001|Entered Survival Follow-up|Phase 2 Part||0
6649379|NCT02404441|7578579|FG002|Entered Survival Follow-up|Phase 2 Part||0
6649380|NCT02404441|7578580|FG003|Entered Survival Follow-up|Phase 2 Part||0
6649381|NCT02404441|7578581|FG004|Entered Survival Follow-up|Phase 2 Part||0
6649382|NCT02404441|7578582|FG005|Entered Survival Follow-up|Phase 2 Part||38
6649383|NCT02404441|7578583|FG006|Entered Survival Follow-up|Phase 2 Part||34
6649384|NCT02404441|7578584|FG007|Entered Survival Follow-up|Phase 2 Part||26
6649385|NCT02404441|7578585|FG008|Entered Survival Follow-up|Phase 2 Part||35
6550986|NCT01728805|7472926|FG000|COMPLETED|Crossover Period||0
6550987|NCT01728805|7472927|FG001|COMPLETED|Crossover Period||0
6550988|NCT01728805|7472928|FG002|COMPLETED|Crossover Period||136
6550989|NCT01728805|7472926|FG000|NOT COMPLETED|Crossover Period||0
6550990|NCT01728805|7472927|FG001|NOT COMPLETED|Crossover Period||0
6550991|NCT01728805|7472928|FG002|NOT COMPLETED|Crossover Period||0
6550992|NCT01728844|7472939|FG000|STARTED|Overall Study||22
6550993|NCT01728844|7472940|FG001|STARTED|Overall Study||21
6550994|NCT01728844|7472941|FG002|STARTED|Overall Study||22
6649386|NCT02404441|7578586|FG009|Entered Survival Follow-up|Phase 2 Part||25
6550995|NCT01728844|7472942|FG003|STARTED|Overall Study||23
6550996|NCT01728844|7472939|FG000|COMPLETED|Overall Study||21
6550997|NCT01728844|7472940|FG001|COMPLETED|Overall Study||21
6550998|NCT01728844|7472941|FG002|COMPLETED|Overall Study||22
6550999|NCT01728844|7472942|FG003|COMPLETED|Overall Study||21
6551000|NCT01728844|7472939|FG000|NOT COMPLETED|Overall Study||1
6551001|NCT01728844|7472940|FG001|NOT COMPLETED|Overall Study||0
6304754|NCT00367003|7208016|FG000|STARTED|Overall Study||37
6551002|NCT01728844|7472941|FG002|NOT COMPLETED|Overall Study||0
6551003|NCT01728844|7472942|FG003|NOT COMPLETED|Overall Study||2
6551004|NCT01729026|7472954|FG000|STARTED|Randomization to 3-month Follow-up||9
6551005|NCT01729026|7472955|FG001|STARTED|Randomization to 3-month Follow-up||10
6304755|NCT00367003|7208016|FG000|COMPLETED|Overall Study||28
6304756|NCT00367003|7208016|FG000|NOT COMPLETED|Overall Study||9
6304757|NCT00367016|7208022|FG000|STARTED|Overall Study||3
6304758|NCT00367016|7208023|FG001|STARTED|Overall Study||3
6304759|NCT00367016|7208022|FG000|First Intervention|Overall Study||3
6304760|NCT00367016|7208023|FG001|First Intervention|Overall Study||3
6304761|NCT00367016|7208022|FG000|Second Intervention|Overall Study||3
6304762|NCT00367016|7208023|FG001|Second Intervention|Overall Study||3
6304763|NCT00367016|7208022|FG000|COMPLETED|Overall Study||3
6304764|NCT00367016|7208023|FG001|COMPLETED|Overall Study||3
6304765|NCT00367016|7208022|FG000|NOT COMPLETED|Overall Study||0
6304766|NCT00367016|7208023|FG001|NOT COMPLETED|Overall Study||0
6304767|NCT00367055|7208033|FG000|STARTED|Overall Study||43
6304768|NCT00367055|7208034|FG001|STARTED|Overall Study||41
6304769|NCT00367055|7208033|FG000|COMPLETED|Overall Study||32
6304770|NCT00367055|7208034|FG001|COMPLETED|Overall Study||30
6304771|NCT00367055|7208033|FG000|NOT COMPLETED|Overall Study||11
6304772|NCT00367055|7208034|FG001|NOT COMPLETED|Overall Study||11
6304773|NCT00367133|7208043|FG000|STARTED|2 Years|Number of Eyes|330
6304774|NCT00367133|7208044|FG001|STARTED|2 Years|Number of Eyes|256
6304775|NCT00367133|7208045|FG002|STARTED|2 Years|Number of Eyes|254
6304776|NCT00367133|7208043|FG000|COMPLETED|2 Years||272
6304777|NCT00367133|7208044|FG001|COMPLETED|2 Years||220
6304778|NCT00367133|7208045|FG002|COMPLETED|2 Years||205
6304779|NCT00367133|7208043|FG000|NOT COMPLETED|2 Years||58
6304780|NCT00367133|7208044|FG001|NOT COMPLETED|2 Years||36
6304781|NCT00367133|7208045|FG002|NOT COMPLETED|2 Years||49
6304782|NCT00367133|7208043|FG000|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
6304783|NCT00367133|7208044|FG001|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
6304784|NCT00367133|7208045|FG002|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
6304785|NCT00367133|7208043|FG000|COMPLETED|3 Years||115
6304786|NCT00367133|7208044|FG001|COMPLETED|3 Years||93
6304787|NCT00367133|7208045|FG002|COMPLETED|3 Years||98
6304788|NCT00367133|7208043|FG000|NOT COMPLETED|3 Years||28
6304789|NCT00367133|7208044|FG001|NOT COMPLETED|3 Years||23
6304790|NCT00367133|7208045|FG002|NOT COMPLETED|3 Years||18
6304791|NCT00367237|7208055|FG000|STARTED|Overall Study|Number of subjects randomized|57
6304792|NCT00367237|7208056|FG001|STARTED|Overall Study|Number of subjects randomized|58
6304793|NCT00367237|7208055|FG000|COMPLETED|Overall Study||47
6304794|NCT00367237|7208056|FG001|COMPLETED|Overall Study||47
6304795|NCT00367237|7208055|FG000|NOT COMPLETED|Overall Study||10
6304796|NCT00367237|7208056|FG001|NOT COMPLETED|Overall Study||11
6304797|NCT00367341|7208064|FG000|STARTED|Overall Study||42
6304798|NCT00367341|7208065|FG001|STARTED|Overall Study||40
6304799|NCT00367341|7208064|FG000|COMPLETED|Overall Study||40
6304800|NCT00367341|7208065|FG001|COMPLETED|Overall Study||40
6304801|NCT00367341|7208064|FG000|NOT COMPLETED|Overall Study||2
6304802|NCT00367341|7208065|FG001|NOT COMPLETED|Overall Study||0
6304803|NCT00367380|7208074|FG000|STARTED|Overall Study||6
6304804|NCT00367380|7208075|FG001|STARTED|Overall Study||6
6304805|NCT00367380|7208076|FG002|STARTED|Overall Study||6
6304806|NCT00367380|7208074|FG000|COMPLETED|Overall Study||6
6649387|NCT02404441|7578577|FG000|COMPLETED|Phase 2 Part||0
6744127|NCT03340025|7672233|FG000|NOT COMPLETED|Overall Study||2
6304807|NCT00367380|7208075|FG001|COMPLETED|Overall Study||6
6304808|NCT00367380|7208076|FG002|COMPLETED|Overall Study||6
6649388|NCT02404441|7578578|FG001|COMPLETED|Phase 2 Part||0
6649389|NCT02404441|7578579|FG002|COMPLETED|Phase 2 Part||0
6649390|NCT02404441|7578580|FG003|COMPLETED|Phase 2 Part||0
6649391|NCT02404441|7578581|FG004|COMPLETED|Phase 2 Part||0
6304809|NCT00367380|7208074|FG000|NOT COMPLETED|Overall Study||0
6304810|NCT00367380|7208075|FG001|NOT COMPLETED|Overall Study||0
6304811|NCT00367380|7208076|FG002|NOT COMPLETED|Overall Study||0
6304812|NCT00367432|7208084|FG000|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
6304813|NCT00367432|7208085|FG001|STARTED|First Period (16 Weeks)||0
6304814|NCT00367432|7208084|FG000|COMPLETED|First Period (16 Weeks)||275
6304815|NCT00367432|7208085|FG001|COMPLETED|First Period (16 Weeks)||0
6304816|NCT00367432|7208084|FG000|NOT COMPLETED|First Period (16 Weeks)||38
6304817|NCT00367432|7208085|FG001|NOT COMPLETED|First Period (16 Weeks)||0
6304818|NCT00367432|7208084|FG000|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
6304819|NCT00367432|7208085|FG001|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
6304820|NCT00367432|7208084|FG000|COMPLETED|Second Period (up to 54 Months)||188
6304821|NCT00367432|7208085|FG001|COMPLETED|Second Period (up to 54 Months)||69
6304822|NCT00367432|7208084|FG000|NOT COMPLETED|Second Period (up to 54 Months)||87
6304823|NCT00367432|7208085|FG001|NOT COMPLETED|Second Period (up to 54 Months)||16
6304824|NCT00367458|7208091|FG000|STARTED|First Intervention - 8 Weeks||12
6304825|NCT00367458|7208092|FG001|STARTED|First Intervention - 8 Weeks||12
6304826|NCT00367458|7208091|FG000|COMPLETED|First Intervention - 8 Weeks||10
6304827|NCT00367458|7208092|FG001|COMPLETED|First Intervention - 8 Weeks||12
6304828|NCT00367458|7208091|FG000|NOT COMPLETED|First Intervention - 8 Weeks||2
6649392|NCT02404441|7578582|FG005|COMPLETED|Phase 2 Part||0
6649393|NCT02404441|7578583|FG006|COMPLETED|Phase 2 Part||0
6304829|NCT00367458|7208092|FG001|NOT COMPLETED|First Intervention - 8 Weeks||0
6304830|NCT00367458|7208091|FG000|STARTED|Washout Period - 4-6 Weeks||10
6304831|NCT00367458|7208092|FG001|STARTED|Washout Period - 4-6 Weeks||12
6649394|NCT02404441|7578584|FG007|COMPLETED|Phase 2 Part||0
6649395|NCT02404441|7578585|FG008|COMPLETED|Phase 2 Part||0
6649396|NCT02404441|7578586|FG009|COMPLETED|Phase 2 Part||0
6649397|NCT02404441|7578577|FG000|NOT COMPLETED|Phase 2 Part||0
6649398|NCT02404441|7578578|FG001|NOT COMPLETED|Phase 2 Part||0
6649399|NCT02404441|7578579|FG002|NOT COMPLETED|Phase 2 Part||0
6649400|NCT02404441|7578580|FG003|NOT COMPLETED|Phase 2 Part||0
6649401|NCT02404441|7578581|FG004|NOT COMPLETED|Phase 2 Part||0
6649402|NCT02404441|7578582|FG005|NOT COMPLETED|Phase 2 Part||59
6649403|NCT02404441|7578583|FG006|NOT COMPLETED|Phase 2 Part||61
6649404|NCT02404441|7578584|FG007|NOT COMPLETED|Phase 2 Part||40
6649405|NCT02404441|7578585|FG008|NOT COMPLETED|Phase 2 Part||59
6649406|NCT02404441|7578586|FG009|NOT COMPLETED|Phase 2 Part||42
6649407|NCT02404493|7578632|FG000|STARTED|Overall Study||17
6649408|NCT02404493|7578633|FG001|STARTED|Overall Study||6
6649409|NCT02404493|7578632|FG000|COMPLETED|Overall Study||16
6649410|NCT02404493|7578633|FG001|COMPLETED|Overall Study||5
6649411|NCT02404493|7578632|FG000|NOT COMPLETED|Overall Study||1
6649412|NCT02404493|7578633|FG001|NOT COMPLETED|Overall Study||1
6649413|NCT02404532|7578639|FG000|STARTED|Overall Study||29
6649414|NCT02404532|7578639|FG000|COMPLETED|Overall Study||29
6649415|NCT02404532|7578639|FG000|NOT COMPLETED|Overall Study||0
6649416|NCT02404610|7578650|FG000|STARTED|Overall Study||54
6649417|NCT02404610|7578651|FG001|STARTED|Overall Study||53
6649418|NCT02404610|7578650|FG000|COMPLETED|Overall Study||54
6649419|NCT02404610|7578651|FG001|COMPLETED|Overall Study||53
6649420|NCT02404610|7578650|FG000|NOT COMPLETED|Overall Study||0
6649421|NCT02404610|7578651|FG001|NOT COMPLETED|Overall Study||0
6656011|NCT02457520|7586151|FG000|NOT COMPLETED|Post-treatment Period||48
6656012|NCT02457546|7586183|FG000|STARTED|Overall Study||114
6656013|NCT02457546|7586184|FG001|STARTED|Overall Study||120
6656014|NCT02457546|7586183|FG000|COMPLETED|Overall Study||105
6649422|NCT02404649|7578659|FG000|STARTED|Overall Study||17
6649423|NCT02404649|7578660|FG001|STARTED|Overall Study||16
6649424|NCT02404649|7578659|FG000|COMPLETED|Overall Study||16
6649425|NCT02404649|7578660|FG001|COMPLETED|Overall Study||14
6304832|NCT00367458|7208091|FG000|COMPLETED|Washout Period - 4-6 Weeks||10
6304833|NCT00367458|7208092|FG001|COMPLETED|Washout Period - 4-6 Weeks||12
6304834|NCT00367458|7208091|FG000|NOT COMPLETED|Washout Period - 4-6 Weeks||0
6304835|NCT00367458|7208092|FG001|NOT COMPLETED|Washout Period - 4-6 Weeks||0
6304836|NCT00367458|7208091|FG000|STARTED|Second Intervention - 8 Weeks||10
6304837|NCT00367458|7208092|FG001|STARTED|Second Intervention - 8 Weeks||12
6304838|NCT00367458|7208091|FG000|COMPLETED|Second Intervention - 8 Weeks||10
6304839|NCT00367458|7208092|FG001|COMPLETED|Second Intervention - 8 Weeks||12
6304840|NCT00367458|7208091|FG000|NOT COMPLETED|Second Intervention - 8 Weeks||0
6304841|NCT00367458|7208092|FG001|NOT COMPLETED|Second Intervention - 8 Weeks||0
6304842|NCT00367484|7208098|FG000|STARTED|Overall Study||460
6304843|NCT00367484|7208098|FG000|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
6304844|NCT00367484|7208098|FG000|NOT COMPLETED|Overall Study||17
6304845|NCT00367601|7208102|FG000|STARTED|Overall Study||25
6304846|NCT00367601|7208102|FG000|COMPLETED|Overall Study||25
6304847|NCT00367601|7208102|FG000|NOT COMPLETED|Overall Study||0
6304848|NCT00367640|7208111|FG000|STARTED|Overall Study||157
6304849|NCT00367640|7208112|FG001|STARTED|Overall Study||155
6304850|NCT00367640|7208113|FG002|STARTED|Overall Study||160
6304851|NCT00367640|7208114|FG003|STARTED|Overall Study||156
6304852|NCT00367640|7208111|FG000|COMPLETED|Overall Study||139
6649426|NCT02404649|7578659|FG000|NOT COMPLETED|Overall Study||1
6649427|NCT02404649|7578660|FG001|NOT COMPLETED|Overall Study||2
6649428|NCT02404792|7578668|FG000|STARTED|Overall Study||32
6649429|NCT02404792|7578669|FG001|STARTED|Overall Study||37
6649430|NCT02404792|7578668|FG000|COMPLETED|Overall Study||27
6649431|NCT02404792|7578669|FG001|COMPLETED|Overall Study||29
6649432|NCT02404792|7578668|FG000|NOT COMPLETED|Overall Study||5
6649433|NCT02404792|7578669|FG001|NOT COMPLETED|Overall Study||8
6649434|NCT02404805|7578683|FG000|STARTED|Overall Study||5
6649435|NCT02404805|7578684|FG001|STARTED|Overall Study||3
6649436|NCT02404805|7578685|FG002|STARTED|Overall Study||5
6649437|NCT02404805|7578686|FG003|STARTED|Overall Study||5
6649438|NCT02404805|7578687|FG004|STARTED|Overall Study||3
6649439|NCT02404805|7578688|FG005|STARTED|Overall Study||4
6649440|NCT02404805|7578683|FG000|COMPLETED|Overall Study||4
6304853|NCT00367640|7208112|FG001|COMPLETED|Overall Study||133
6304854|NCT00367640|7208113|FG002|COMPLETED|Overall Study||141
6304855|NCT00367640|7208114|FG003|COMPLETED|Overall Study||146
6304856|NCT00367640|7208111|FG000|NOT COMPLETED|Overall Study||18
6304857|NCT00367640|7208112|FG001|NOT COMPLETED|Overall Study||22
6304858|NCT00367640|7208113|FG002|NOT COMPLETED|Overall Study||19
6304859|NCT00367640|7208114|FG003|NOT COMPLETED|Overall Study||10
6304860|NCT00367679|7208124|FG000|STARTED|Overall Study||35
6304861|NCT00367679|7208124|FG000|COMPLETED|Overall Study||35
6304862|NCT00367679|7208124|FG000|NOT COMPLETED|Overall Study||0
6304863|NCT00367744|7208132|FG000|STARTED|Overall Study||34
6304864|NCT00367744|7208133|FG001|STARTED|Overall Study||37
6304865|NCT00367744|7208132|FG000|COMPLETED|Overall Study||30
6304866|NCT00367744|7208133|FG001|COMPLETED|Overall Study||32
6304867|NCT00367744|7208132|FG000|NOT COMPLETED|Overall Study||4
6304868|NCT00367744|7208133|FG001|NOT COMPLETED|Overall Study||5
6304869|NCT00367770|7208140|FG000|STARTED|Overall Study||37
6304870|NCT00367770|7208140|FG000|COMPLETED|Overall Study||35
6304871|NCT00367770|7208140|FG000|NOT COMPLETED|Overall Study||2
6304872|NCT00367835|7208146|FG000|STARTED|Overall Study||138
6304873|NCT00367835|7208147|FG001|STARTED|Overall Study||79
6304874|NCT00367835|7208146|FG000|COMPLETED|Overall Study||109
6304875|NCT00367835|7208147|FG001|COMPLETED|Overall Study||48
6304876|NCT00367835|7208146|FG000|NOT COMPLETED|Overall Study||29
6304877|NCT00367835|7208147|FG001|NOT COMPLETED|Overall Study||31
6304878|NCT00367991|7208155|FG000|STARTED|Overall Study||29
6304879|NCT00367991|7208156|FG001|STARTED|Overall Study||15
6304880|NCT00367991|7208155|FG000|COMPLETED|Overall Study||27
6304881|NCT00367991|7208156|FG001|COMPLETED|Overall Study||13
6304882|NCT00367991|7208155|FG000|NOT COMPLETED|Overall Study||2
6304883|NCT00367991|7208156|FG001|NOT COMPLETED|Overall Study||2
6304884|NCT00368069|7208164|FG000|STARTED|Overall Study||79
6304885|NCT00368069|7208165|FG001|STARTED|Overall Study||79
6304886|NCT00368069|7208164|FG000|COMPLETED|Overall Study||71
6304887|NCT00368069|7208165|FG001|COMPLETED|Overall Study||72
6304888|NCT00368069|7208164|FG000|NOT COMPLETED|Overall Study||8
6304889|NCT00368069|7208165|FG001|NOT COMPLETED|Overall Study||7
6304890|NCT00368108|7208174|FG000|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
6304891|NCT00368108|7208175|FG001|STARTED|Overall Study||251
6304892|NCT00368108|7208176|FG002|STARTED|Overall Study||250
6304893|NCT00368108|7208174|FG000|COMPLETED|Overall Study||187
6304894|NCT00368108|7208175|FG001|COMPLETED|Overall Study||198
6304895|NCT00368108|7208176|FG002|COMPLETED|Overall Study||182
6304896|NCT00368108|7208174|FG000|NOT COMPLETED|Overall Study||64
6304897|NCT00368108|7208175|FG001|NOT COMPLETED|Overall Study||53
6304898|NCT00368108|7208176|FG002|NOT COMPLETED|Overall Study||68
6304899|NCT00368251|7208187|FG000|STARTED|Overall Study||18
6304900|NCT00368251|7208188|FG001|STARTED|Overall Study||20
6649441|NCT02404805|7578684|FG001|COMPLETED|Overall Study||3
6649442|NCT02404805|7578685|FG002|COMPLETED|Overall Study||5
6649443|NCT02404805|7578686|FG003|COMPLETED|Overall Study||5
6649444|NCT02404805|7578687|FG004|COMPLETED|Overall Study||3
6649445|NCT02404805|7578688|FG005|COMPLETED|Overall Study||4
6649446|NCT02404805|7578683|FG000|NOT COMPLETED|Overall Study||1
6649447|NCT02404805|7578684|FG001|NOT COMPLETED|Overall Study||0
6649448|NCT02404805|7578685|FG002|NOT COMPLETED|Overall Study||0
6649449|NCT02404805|7578686|FG003|NOT COMPLETED|Overall Study||0
6649450|NCT02404805|7578687|FG004|NOT COMPLETED|Overall Study||0
6649451|NCT02404805|7578688|FG005|NOT COMPLETED|Overall Study||0
6649452|NCT02405091|7578700|FG000|STARTED|Overall Study||49
6649453|NCT02405091|7578701|FG001|STARTED|Overall Study||107
6649454|NCT02405091|7578702|FG002|STARTED|Overall Study||11
6551006|NCT01729026|7472954|FG000|COMPLETED|Randomization to 3-month Follow-up||7
6551007|NCT01729026|7472955|FG001|COMPLETED|Randomization to 3-month Follow-up||8
6562713|NCT01802710|7485663|FG000|STARTED|From T1 to T2||60
6649455|NCT02405091|7578700|FG000|COMPLETED|Overall Study||20
6649456|NCT02405091|7578701|FG001|COMPLETED|Overall Study||74
6649457|NCT02405091|7578702|FG002|COMPLETED|Overall Study||9
6649458|NCT02405091|7578700|FG000|NOT COMPLETED|Overall Study||29
6649459|NCT02405091|7578701|FG001|NOT COMPLETED|Overall Study||33
6649460|NCT02405091|7578702|FG002|NOT COMPLETED|Overall Study||2
6649461|NCT02405195|7578713|FG000|STARTED|Overall Study||18
6649462|NCT02405195|7578713|FG000|COMPLETED|Overall Study||18
6551008|NCT01729026|7472954|FG000|NOT COMPLETED|Randomization to 3-month Follow-up||2
6551009|NCT01729026|7472955|FG001|NOT COMPLETED|Randomization to 3-month Follow-up||2
6551010|NCT01729026|7472954|FG000|STARTED|3-month to 6-month (Final) Follow-up||7
6551011|NCT01729026|7472955|FG001|STARTED|3-month to 6-month (Final) Follow-up||8
6551012|NCT01729026|7472954|FG000|COMPLETED|3-month to 6-month (Final) Follow-up||6
6551013|NCT01729026|7472955|FG001|COMPLETED|3-month to 6-month (Final) Follow-up||6
6304901|NCT00368251|7208189|FG002|STARTED|Overall Study||18
6304902|NCT00368251|7208187|FG000|COMPLETED|Overall Study||17
6304903|NCT00368251|7208188|FG001|COMPLETED|Overall Study||20
6304904|NCT00368251|7208189|FG002|COMPLETED|Overall Study||17
6304905|NCT00368251|7208187|FG000|NOT COMPLETED|Overall Study||1
6304906|NCT00368251|7208188|FG001|NOT COMPLETED|Overall Study||0
6304907|NCT00368251|7208189|FG002|NOT COMPLETED|Overall Study||1
6744128|NCT03340025|7672234|FG001|NOT COMPLETED|Overall Study||2
6744129|NCT03340337|7672240|FG000|STARTED|Overall Study||30
6744130|NCT03340337|7672240|FG000|Received Neo-Russian|Overall Study||30
6744131|NCT03340337|7672240|FG000|Received Aussie|Overall Study||30
6744132|NCT03340337|7672240|FG000|Received RBS|Overall Study||30
6744133|NCT03340337|7672240|FG000|COMPLETED|Overall Study||30
6744134|NCT03340337|7672240|FG000|NOT COMPLETED|Overall Study||0
6744135|NCT03340350|7672255|FG000|STARTED|Overall Study||10
6744136|NCT03340350|7672255|FG000|COMPLETED|Overall Study||4
6744137|NCT03340350|7672255|FG000|NOT COMPLETED|Overall Study||6
6744138|NCT03340415|7672262|FG000|STARTED|Overall Study||29
6744139|NCT03340415|7672263|FG001|STARTED|Overall Study||24
6744140|NCT03340415|7672262|FG000|COMPLETED|Overall Study||29
6744141|NCT03340415|7672263|FG001|COMPLETED|Overall Study||21
6744142|NCT03340415|7672262|FG000|NOT COMPLETED|Overall Study||0
6744143|NCT03340415|7672263|FG001|NOT COMPLETED|Overall Study||3
6744144|NCT03340428|7672273|FG000|STARTED|Overall Study||117
6744145|NCT03340428|7672274|FG001|STARTED|Overall Study||59
6744146|NCT03340428|7672273|FG000|COMPLETED|Overall Study||116
6744147|NCT03340428|7672274|FG001|COMPLETED|Overall Study||59
6744148|NCT03340428|7672273|FG000|NOT COMPLETED|Overall Study||1
6304908|NCT00368277|7208199|FG000|STARTED|Overall Study||457
6304909|NCT00368277|7208200|FG001|STARTED|Overall Study||444
6744149|NCT03340428|7672274|FG001|NOT COMPLETED|Overall Study||0
6744150|NCT03340610|7672280|FG000|STARTED|Overall Study||30
6744151|NCT03340610|7672280|FG000|COMPLETED|Overall Study||27
6304910|NCT00368277|7208199|FG000|COMPLETED|Overall Study||344
6304911|NCT00368277|7208200|FG001|COMPLETED|Overall Study||336
6744152|NCT03340610|7672280|FG000|NOT COMPLETED|Overall Study||3
6744153|NCT03340805|7672286|FG000|STARTED|Overall Study||24
6744154|NCT03340805|7672287|FG001|STARTED|Overall Study||26
6744155|NCT03340805|7672286|FG000|COMPLETED|Overall Study|1 subject withdrew early from study fluid administration but stayed in trial for outcome assessment|24
6649463|NCT02405195|7578713|FG000|NOT COMPLETED|Overall Study||0
6649464|NCT02405325|7578719|FG000|STARTED|Overall Study||267
6649465|NCT02405325|7578720|FG001|STARTED|Overall Study||209
6649466|NCT02405325|7578719|FG000|COMPLETED|Overall Study||203
6649467|NCT02405325|7578720|FG001|COMPLETED|Overall Study||175
6649468|NCT02405325|7578719|FG000|NOT COMPLETED|Overall Study||64
6304912|NCT00368277|7208199|FG000|NOT COMPLETED|Overall Study||113
6304913|NCT00368277|7208200|FG001|NOT COMPLETED|Overall Study||108
6304914|NCT00368290|7208208|FG000|STARTED|Overall Study||47
6304915|NCT00368290|7208209|FG001|STARTED|Overall Study||47
6304916|NCT00368290|7208208|FG000|COMPLETED|Overall Study||34
6304917|NCT00368290|7208209|FG001|COMPLETED|Overall Study||37
6304918|NCT00368290|7208208|FG000|NOT COMPLETED|Overall Study||13
6304919|NCT00368290|7208209|FG001|NOT COMPLETED|Overall Study||10
6304920|NCT00368316|7208217|FG000|STARTED|Overall Study||1434
6304921|NCT00368316|7208218|FG001|STARTED|Overall Study||1365
6304922|NCT00368316|7208217|FG000|COMPLETED|Overall Study||1392
6304923|NCT00368316|7208218|FG001|COMPLETED|Overall Study||1319
6304924|NCT00368316|7208217|FG000|NOT COMPLETED|Overall Study||42
6304925|NCT00368316|7208218|FG001|NOT COMPLETED|Overall Study||46
6304926|NCT00368355|7208226|FG000|STARTED|Overall Study||18
6304927|NCT00368355|7208227|FG001|STARTED|Overall Study||28
6304928|NCT00368355|7208226|FG000|COMPLETED|Overall Study||7
6304929|NCT00368355|7208227|FG001|COMPLETED|Overall Study||11
6304930|NCT00368355|7208226|FG000|NOT COMPLETED|Overall Study||11
6304931|NCT00368355|7208227|FG001|NOT COMPLETED|Overall Study||17
6304932|NCT00368459|7208235|FG000|STARTED|Overall Study||21
6304933|NCT00368459|7208236|FG001|STARTED|Overall Study||21
6304934|NCT00368459|7208235|FG000|COMPLETED|Overall Study||19
6304935|NCT00368459|7208236|FG001|COMPLETED|Overall Study||20
6304936|NCT00368459|7208235|FG000|NOT COMPLETED|Overall Study||2
6304937|NCT00368459|7208236|FG001|NOT COMPLETED|Overall Study||1
6304938|NCT00368472|7208242|FG000|STARTED|Overall Study||138
6304939|NCT00368472|7208242|FG000|COMPLETED|Overall Study||33
6304940|NCT00368472|7208242|FG000|NOT COMPLETED|Overall Study||105
6304941|NCT00368537|7208248|FG000|STARTED|Randomization||281
6304942|NCT00368537|7208249|FG001|STARTED|Randomization||269
6304943|NCT00368537|7208248|FG000|COMPLETED|Randomization||268
6304944|NCT00368537|7208249|FG001|COMPLETED|Randomization||263
6304945|NCT00368537|7208248|FG000|NOT COMPLETED|Randomization||13
6304946|NCT00368537|7208249|FG001|NOT COMPLETED|Randomization||6
6304947|NCT00368537|7208248|FG000|STARTED|Baseline Participants||268
6304948|NCT00368537|7208249|FG001|STARTED|Baseline Participants||263
6304949|NCT00368537|7208248|FG000|COMPLETED|Baseline Participants||244
6304950|NCT00368537|7208249|FG001|COMPLETED|Baseline Participants||239
6304951|NCT00368537|7208248|FG000|NOT COMPLETED|Baseline Participants||24
6304952|NCT00368537|7208249|FG001|NOT COMPLETED|Baseline Participants||24
6304953|NCT00368550|7208257|FG000|STARTED|Overall Study||63
6304954|NCT00368550|7208258|FG001|STARTED|Overall Study||71
6304955|NCT00368550|7208257|FG000|COMPLETED|Overall Study||35
6304956|NCT00368550|7208258|FG001|COMPLETED|Overall Study||48
6551014|NCT01729026|7472954|FG000|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
6551015|NCT01729026|7472955|FG001|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
6551016|NCT01729039|7472966|FG000|STARTED|Overall Study||23
6551017|NCT01729039|7472967|FG001|STARTED|Overall Study||26
6551018|NCT01729039|7472966|FG000|COMPLETED|Overall Study||13
6551019|NCT01729039|7472967|FG001|COMPLETED|Overall Study||14
6551020|NCT01729039|7472966|FG000|NOT COMPLETED|Overall Study||10
6551021|NCT01729039|7472967|FG001|NOT COMPLETED|Overall Study||12
6551022|NCT01729156|7472979|FG000|STARTED|Overall Study||12
6551023|NCT01729156|7472980|FG001|STARTED|Overall Study||12
6551024|NCT01729156|7472981|FG002|STARTED|Overall Study||12
6649469|NCT02405325|7578720|FG001|NOT COMPLETED|Overall Study||34
6649470|NCT02405390|7578728|FG000|STARTED|Overall Study||46
6649471|NCT02405390|7578729|FG001|STARTED|Overall Study||46
6649472|NCT02405390|7578728|FG000|COMPLETED|Overall Study||46
6649473|NCT02405390|7578729|FG001|COMPLETED|Overall Study||46
6649474|NCT02405390|7578728|FG000|NOT COMPLETED|Overall Study||0
6649475|NCT02405390|7578729|FG001|NOT COMPLETED|Overall Study||0
6649476|NCT02405429|7578735|FG000|STARTED|Overall Study||49
6649477|NCT02405429|7578735|FG000|COMPLETED|Overall Study||49
6649478|NCT02405429|7578735|FG000|NOT COMPLETED|Overall Study||0
6649479|NCT02405442|7578743|FG000|STARTED|Double-Blind Phase (up to Week 8)||53
6649480|NCT02405442|7578744|FG001|STARTED|Double-Blind Phase (up to Week 8)||53
6649481|NCT02405442|7578745|FG002|STARTED|Double-Blind Phase (up to Week 8)||53
6649482|NCT02405442|7578746|FG003|STARTED|Double-Blind Phase (up to Week 8)||28
6649483|NCT02405442|7578743|FG000|COMPLETED|Double-Blind Phase (up to Week 8)||52
6649484|NCT02405442|7578744|FG001|COMPLETED|Double-Blind Phase (up to Week 8)||48
6649485|NCT02405442|7578745|FG002|COMPLETED|Double-Blind Phase (up to Week 8)||47
6649486|NCT02405442|7578746|FG003|COMPLETED|Double-Blind Phase (up to Week 8)||27
6649487|NCT02405442|7578743|FG000|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
6649488|NCT02405442|7578744|FG001|NOT COMPLETED|Double-Blind Phase (up to Week 8)||5
6649489|NCT02405442|7578745|FG002|NOT COMPLETED|Double-Blind Phase (up to Week 8)||6
6649490|NCT02405442|7578746|FG003|NOT COMPLETED|Double-Blind Phase (up to Week 8)||1
6649491|NCT02405442|7578743|FG000|STARTED|Open-Label Phase (up to Week 52)||52
6649492|NCT02405442|7578744|FG001|STARTED|Open-Label Phase (up to Week 52)||48
6649493|NCT02405442|7578745|FG002|STARTED|Open-Label Phase (up to Week 52)||47
6649494|NCT02405442|7578746|FG003|STARTED|Open-Label Phase (up to Week 52)|1 participant completed Double-Blind Phase, but did not continue in Open-Label Phase.|26
6649495|NCT02405442|7578743|FG000|COMPLETED|Open-Label Phase (up to Week 52)||4
6649496|NCT02405442|7578744|FG001|COMPLETED|Open-Label Phase (up to Week 52)||3
6649497|NCT02405442|7578745|FG002|COMPLETED|Open-Label Phase (up to Week 52)||2
6649498|NCT02405442|7578746|FG003|COMPLETED|Open-Label Phase (up to Week 52)||2
6649499|NCT02405442|7578743|FG000|NOT COMPLETED|Open-Label Phase (up to Week 52)||48
6649500|NCT02405442|7578744|FG001|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
6649501|NCT02405442|7578745|FG002|NOT COMPLETED|Open-Label Phase (up to Week 52)||45
6649502|NCT02405442|7578746|FG003|NOT COMPLETED|Open-Label Phase (up to Week 52)||24
6649503|NCT02405442|7578743|FG000|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|3
6649504|NCT02405442|7578744|FG001|STARTED|Extended Treatment Phase(up to Week 208)|1 participant completed Open-Label Phase, but did not continue in Extended Treatment Phase.|2
6649505|NCT02405442|7578745|FG002|STARTED|Extended Treatment Phase(up to Week 208)||2
6649506|NCT02405442|7578746|FG003|STARTED|Extended Treatment Phase(up to Week 208)||2
6649507|NCT02405442|7578743|FG000|COMPLETED|Extended Treatment Phase(up to Week 208)||0
6649508|NCT02405442|7578744|FG001|COMPLETED|Extended Treatment Phase(up to Week 208)||0
6649509|NCT02405442|7578745|FG002|COMPLETED|Extended Treatment Phase(up to Week 208)||0
6649510|NCT02405442|7578746|FG003|COMPLETED|Extended Treatment Phase(up to Week 208)||0
6649511|NCT02405442|7578743|FG000|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||3
6649512|NCT02405442|7578744|FG001|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
6649513|NCT02405442|7578745|FG002|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
6649514|NCT02405442|7578746|FG003|NOT COMPLETED|Extended Treatment Phase(up to Week 208)||2
6649515|NCT02405780|7578764|FG000|STARTED|Period I||216
6649516|NCT02405780|7578765|FG001|STARTED|Period I||108
6649517|NCT02405780|7578766|FG002|STARTED|Period I||108
6649518|NCT02405780|7578767|FG003|STARTED|Period I||213
6649519|NCT02405780|7578764|FG000|COMPLETED|Period I||189
6649520|NCT02405780|7578765|FG001|COMPLETED|Period I||100
6649521|NCT02405780|7578766|FG002|COMPLETED|Period I||93
6649522|NCT02405780|7578767|FG003|COMPLETED|Period I||190
6649523|NCT02405780|7578764|FG000|NOT COMPLETED|Period I||27
6649524|NCT02405780|7578765|FG001|NOT COMPLETED|Period I||8
6649525|NCT02405780|7578766|FG002|NOT COMPLETED|Period I||15
6649526|NCT02405780|7578767|FG003|NOT COMPLETED|Period I||23
6649527|NCT02405780|7578764|FG000|STARTED|Period II||189
6649528|NCT02405780|7578765|FG001|STARTED|Period II||100
6649529|NCT02405780|7578766|FG002|STARTED|Period II||93
6649530|NCT02405780|7578767|FG003|STARTED|Period II||190
6649531|NCT02405780|7578764|FG000|COMPLETED|Period II||174
6649532|NCT02405780|7578765|FG001|COMPLETED|Period II||88
6649533|NCT02405780|7578766|FG002|COMPLETED|Period II||81
6649534|NCT02405780|7578767|FG003|COMPLETED|Period II||172
6649535|NCT02405780|7578764|FG000|NOT COMPLETED|Period II||15
6649536|NCT02405780|7578765|FG001|NOT COMPLETED|Period II||12
6649537|NCT02405780|7578766|FG002|NOT COMPLETED|Period II||12
6649538|NCT02405780|7578767|FG003|NOT COMPLETED|Period II||18
6649539|NCT02405962|7578794|FG000|STARTED|Overall Study||84
6649540|NCT02405962|7578795|FG001|STARTED|Overall Study||84
6649541|NCT02405962|7578794|FG000|Post-intervention|Overall Study||80
6649542|NCT02405962|7578795|FG001|Post-intervention|Overall Study||81
6649543|NCT02405962|7578794|FG000|3 Months After the Intervention|Overall Study||80
6649544|NCT02405962|7578795|FG001|3 Months After the Intervention|Overall Study||79
6649545|NCT02405962|7578794|FG000|COMPLETED|Overall Study||83
6649546|NCT02405962|7578795|FG001|COMPLETED|Overall Study||79
6649547|NCT02405962|7578794|FG000|NOT COMPLETED|Overall Study||1
6649548|NCT02405962|7578795|FG001|NOT COMPLETED|Overall Study||5
6649549|NCT02406027|7578804|FG000|STARTED|Double-blind Treatment Phase (Period 1)||35
6649550|NCT02406027|7578805|FG001|STARTED|Double-blind Treatment Phase (Period 1)||29
6649551|NCT02406027|7578806|FG002|STARTED|Double-blind Treatment Phase (Period 1)||26
6649552|NCT02406027|7578807|FG003|STARTED|Double-blind Treatment Phase (Period 1)||0
6649553|NCT02406027|7578808|FG004|STARTED|Double-blind Treatment Phase (Period 1)||0
6649554|NCT02406027|7578809|FG005|STARTED|Double-blind Treatment Phase (Period 1)||0
6649555|NCT02406027|7578810|FG006|STARTED|Double-blind Treatment Phase (Period 1)||0
6649556|NCT02406027|7578804|FG000|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
6649557|NCT02406027|7578805|FG001|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||8
6649558|NCT02406027|7578806|FG002|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||6
6649559|NCT02406027|7578807|FG003|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
6649560|NCT02406027|7578808|FG004|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
6649561|NCT02406027|7578809|FG005|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
6649562|NCT02406027|7578810|FG006|Asymptomatic at Risk|Double-blind Treatment Phase (Period 1)||0
6649563|NCT02406027|7578804|FG000|Prodromal|Double-blind Treatment Phase (Period 1)||29
6649564|NCT02406027|7578805|FG001|Prodromal|Double-blind Treatment Phase (Period 1)||21
6649565|NCT02406027|7578806|FG002|Prodromal|Double-blind Treatment Phase (Period 1)||20
6649566|NCT02406027|7578807|FG003|Prodromal|Double-blind Treatment Phase (Period 1)||0
6649567|NCT02406027|7578808|FG004|Prodromal|Double-blind Treatment Phase (Period 1)||0
6649568|NCT02406027|7578809|FG005|Prodromal|Double-blind Treatment Phase (Period 1)||0
6649569|NCT02406027|7578810|FG006|Prodromal|Double-blind Treatment Phase (Period 1)||0
6649570|NCT02406027|7578804|FG000|COMPLETED|Double-blind Treatment Phase (Period 1)||29
6649571|NCT02406027|7578805|FG001|COMPLETED|Double-blind Treatment Phase (Period 1)||26
6649572|NCT02406027|7578806|FG002|COMPLETED|Double-blind Treatment Phase (Period 1)||22
6649573|NCT02406027|7578807|FG003|COMPLETED|Double-blind Treatment Phase (Period 1)||0
6649574|NCT02406027|7578808|FG004|COMPLETED|Double-blind Treatment Phase (Period 1)||0
6649575|NCT02406027|7578809|FG005|COMPLETED|Double-blind Treatment Phase (Period 1)||0
6649576|NCT02406027|7578810|FG006|COMPLETED|Double-blind Treatment Phase (Period 1)||0
6649577|NCT02406027|7578804|FG000|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||6
6649578|NCT02406027|7578805|FG001|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||3
6649579|NCT02406027|7578806|FG002|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||4
6649580|NCT02406027|7578807|FG003|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
6649581|NCT02406027|7578808|FG004|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
6649582|NCT02406027|7578809|FG005|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
6649583|NCT02406027|7578810|FG006|NOT COMPLETED|Double-blind Treatment Phase (Period 1)||0
6649584|NCT02406027|7578804|FG000|STARTED|Open-label Phase (Period 2)||0
6649585|NCT02406027|7578805|FG001|STARTED|Open-label Phase (Period 2)||0
6649586|NCT02406027|7578806|FG002|STARTED|Open-label Phase (Period 2)||0
6649587|NCT02406027|7578807|FG003|STARTED|Open-label Phase (Period 2)||15
6649588|NCT02406027|7578808|FG004|STARTED|Open-label Phase (Period 2)||14
6649589|NCT02406027|7578809|FG005|STARTED|Open-label Phase (Period 2)||26
6649590|NCT02406027|7578810|FG006|STARTED|Open-label Phase (Period 2)||22
6649591|NCT02406027|7578804|FG000|COMPLETED|Open-label Phase (Period 2)||0
6649592|NCT02406027|7578805|FG001|COMPLETED|Open-label Phase (Period 2)||0
6649593|NCT02406027|7578806|FG002|COMPLETED|Open-label Phase (Period 2)||0
6649594|NCT02406027|7578807|FG003|COMPLETED|Open-label Phase (Period 2)||0
6649595|NCT02406027|7578808|FG004|COMPLETED|Open-label Phase (Period 2)||0
6649596|NCT02406027|7578809|FG005|COMPLETED|Open-label Phase (Period 2)||0
6649597|NCT02406027|7578810|FG006|COMPLETED|Open-label Phase (Period 2)||0
6649598|NCT02406027|7578804|FG000|NOT COMPLETED|Open-label Phase (Period 2)||0
6649599|NCT02406027|7578805|FG001|NOT COMPLETED|Open-label Phase (Period 2)||0
6649600|NCT02406027|7578806|FG002|NOT COMPLETED|Open-label Phase (Period 2)||0
6649601|NCT02406027|7578807|FG003|NOT COMPLETED|Open-label Phase (Period 2)||15
6649602|NCT02406027|7578808|FG004|NOT COMPLETED|Open-label Phase (Period 2)||14
6649603|NCT02406027|7578809|FG005|NOT COMPLETED|Open-label Phase (Period 2)||26
6649604|NCT02406027|7578810|FG006|NOT COMPLETED|Open-label Phase (Period 2)||22
6649605|NCT02406248|7578826|FG000|STARTED|Overall Study||108
6649606|NCT02406248|7578826|FG000|COMPLETED|Overall Study||99
6649607|NCT02406248|7578826|FG000|NOT COMPLETED|Overall Study||9
6649608|NCT02406261|7578832|FG000|STARTED|Period 1||50
6649609|NCT02406261|7578833|FG001|STARTED|Period 1||32
6649610|NCT02406261|7578832|FG000|Received at Least One Dose of Study Drug|Period 1||50
6304957|NCT00368550|7208257|FG000|NOT COMPLETED|Overall Study||28
6304958|NCT00368550|7208258|FG001|NOT COMPLETED|Overall Study||23
6304959|NCT00368641|7208266|FG000|STARTED|Overall Study||6
6304960|NCT00368641|7208267|FG001|STARTED|Overall Study||6
6304961|NCT00368641|7208266|FG000|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
6304962|NCT00368641|7208267|FG001|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
6304963|NCT00368641|7208266|FG000|NOT COMPLETED|Overall Study||6
6304964|NCT00368641|7208267|FG001|NOT COMPLETED|Overall Study||6
6304965|NCT00368745|7208275|FG000|STARTED|Randomized to Double-blind Treatment||57
6304966|NCT00368745|7208276|FG001|STARTED|Randomized to Double-blind Treatment||51
6374827|NCT00752219|7285382|FG000|Treated|Overall Study||101
6304967|NCT00368745|7208275|FG000|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
6304968|NCT00368745|7208276|FG001|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
6304969|NCT00368745|7208275|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||1
6304970|NCT00368745|7208276|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
6304971|NCT00368745|7208275|FG000|STARTED|Double-blind Treatment Period||56
6304972|NCT00368745|7208276|FG001|STARTED|Double-blind Treatment Period||50
6304973|NCT00368745|7208275|FG000|COMPLETED|Double-blind Treatment Period||30
6304974|NCT00368745|7208276|FG001|COMPLETED|Double-blind Treatment Period||19
6304975|NCT00368745|7208275|FG000|NOT COMPLETED|Double-blind Treatment Period||26
6304976|NCT00368745|7208276|FG001|NOT COMPLETED|Double-blind Treatment Period||31
6304977|NCT00368849|7208282|FG000|STARTED|Overall Study||10
6304978|NCT00368849|7208283|FG001|STARTED|Overall Study||10
6304979|NCT00368849|7208282|FG000|COMPLETED|Overall Study||10
6304980|NCT00368849|7208283|FG001|COMPLETED|Overall Study||8
6304981|NCT00368849|7208282|FG000|NOT COMPLETED|Overall Study||0
6304982|NCT00368849|7208283|FG001|NOT COMPLETED|Overall Study||2
6304983|NCT00368875|7208290|FG000|STARTED|Overall Study||6
6304984|NCT00368875|7208291|FG001|STARTED|Overall Study||48
6304985|NCT00368875|7208290|FG000|COMPLETED|Overall Study||0
6304986|NCT00368875|7208291|FG001|COMPLETED|Overall Study||0
6304987|NCT00368875|7208290|FG000|NOT COMPLETED|Overall Study||6
6304988|NCT00368875|7208291|FG001|NOT COMPLETED|Overall Study||48
6304989|NCT00368927|7208299|FG000|STARTED|Overall Study||31
6304990|NCT00368927|7208300|FG001|STARTED|Overall Study||30
6304991|NCT00368927|7208299|FG000|COMPLETED|Overall Study||26
6304992|NCT00368927|7208300|FG001|COMPLETED|Overall Study||27
6304993|NCT00368927|7208299|FG000|NOT COMPLETED|Overall Study||5
6304994|NCT00368927|7208300|FG001|NOT COMPLETED|Overall Study||3
6304995|NCT00368940|7208308|FG000|STARTED|Intention-to-Treat||37
6304996|NCT00368940|7208309|FG001|STARTED|Intention-to-Treat||37
6304997|NCT00368940|7208308|FG000|COMPLETED|Intention-to-Treat||37
6304998|NCT00368940|7208309|FG001|COMPLETED|Intention-to-Treat||37
6304999|NCT00368940|7208308|FG000|NOT COMPLETED|Intention-to-Treat||0
6305000|NCT00368940|7208309|FG001|NOT COMPLETED|Intention-to-Treat||0
6305001|NCT00368940|7208308|FG000|STARTED|Completed 12-wk Treatment||37
6305002|NCT00368940|7208309|FG001|STARTED|Completed 12-wk Treatment||37
6305003|NCT00368940|7208308|FG000|COMPLETED|Completed 12-wk Treatment||31
6305004|NCT00368940|7208309|FG001|COMPLETED|Completed 12-wk Treatment||32
6305005|NCT00368940|7208308|FG000|NOT COMPLETED|Completed 12-wk Treatment||6
6305006|NCT00368940|7208309|FG001|NOT COMPLETED|Completed 12-wk Treatment||5
6305007|NCT00368966|7208318|FG000|STARTED|Infant Series||315
6305008|NCT00368966|7208319|FG001|STARTED|Infant Series||304
6305009|NCT00368966|7208318|FG000|Vaccinated Dose 1|Infant Series||314
6305010|NCT00368966|7208319|FG001|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
6551025|NCT01729156|7472979|FG000|COMPLETED|Overall Study||11
6551026|NCT01729156|7472980|FG001|COMPLETED|Overall Study||12
6551027|NCT01729156|7472981|FG002|COMPLETED|Overall Study||12
6551028|NCT01729156|7472979|FG000|NOT COMPLETED|Overall Study||1
6551029|NCT01729156|7472980|FG001|NOT COMPLETED|Overall Study||0
6551030|NCT01729156|7472981|FG002|NOT COMPLETED|Overall Study||0
6551031|NCT01729208|7472992|FG000|STARTED|Baseline||70
6551032|NCT01729208|7472993|FG001|STARTED|Baseline||74
6551033|NCT01729208|7472992|FG000|COMPLETED|Baseline||65
6551034|NCT01729208|7472993|FG001|COMPLETED|Baseline||70
6551035|NCT01729208|7472992|FG000|NOT COMPLETED|Baseline||5
6551036|NCT01729208|7472993|FG001|NOT COMPLETED|Baseline||4
6551037|NCT01729208|7472992|FG000|STARTED|12 Months Follow-up||65
6649611|NCT02406261|7578833|FG001|Received at Least One Dose of Study Drug|Period 1||32
6649612|NCT02406261|7578832|FG000|COMPLETED|Period 1||47
6551038|NCT01729208|7472993|FG001|STARTED|12 Months Follow-up||70
6551039|NCT01729208|7472992|FG000|COMPLETED|12 Months Follow-up||58
6551040|NCT01729208|7472993|FG001|COMPLETED|12 Months Follow-up||60
6551041|NCT01729208|7472992|FG000|NOT COMPLETED|12 Months Follow-up||7
6649613|NCT02406261|7578833|FG001|COMPLETED|Period 1||32
6551042|NCT01729208|7472993|FG001|NOT COMPLETED|12 Months Follow-up||10
6551043|NCT01729208|7472992|FG000|STARTED|24 Months Follow-up||58
6551044|NCT01729208|7472993|FG001|STARTED|24 Months Follow-up||60
6551045|NCT01729208|7472992|FG000|COMPLETED|24 Months Follow-up||55
6551046|NCT01729208|7472993|FG001|COMPLETED|24 Months Follow-up||60
6551047|NCT01729208|7472992|FG000|NOT COMPLETED|24 Months Follow-up||3
6551048|NCT01729208|7472993|FG001|NOT COMPLETED|24 Months Follow-up||0
6551049|NCT01729208|7472992|FG000|STARTED|36 Months Follow-up||55
6551050|NCT01729208|7472993|FG001|STARTED|36 Months Follow-up||60
6551051|NCT01729208|7472992|FG000|COMPLETED|36 Months Follow-up||52
6649614|NCT02406261|7578832|FG000|NOT COMPLETED|Period 1||3
6649615|NCT02406261|7578833|FG001|NOT COMPLETED|Period 1||0
6649616|NCT02406261|7578832|FG000|STARTED|Period 2|Cohort A participated in Period 1 only|0
6649617|NCT02406261|7578833|FG001|STARTED|Period 2||32
6649618|NCT02406261|7578832|FG000|COMPLETED|Period 2||0
6649619|NCT02406261|7578833|FG001|COMPLETED|Period 2||29
6649620|NCT02406261|7578832|FG000|NOT COMPLETED|Period 2||0
6649621|NCT02406261|7578833|FG001|NOT COMPLETED|Period 2||3
6649622|NCT02406443|7578842|FG000|STARTED|Overall Study||18
6649623|NCT02406443|7578843|FG001|STARTED|Overall Study||18
6649624|NCT02406443|7578842|FG000|COMPLETED|Overall Study||16
6649625|NCT02406443|7578843|FG001|COMPLETED|Overall Study||16
6649626|NCT02406443|7578842|FG000|NOT COMPLETED|Overall Study||2
6649627|NCT02406443|7578843|FG001|NOT COMPLETED|Overall Study||2
6649628|NCT02406495|7578849|FG000|STARTED|Overall Study||40
6649629|NCT02406495|7578849|FG000|COMPLETED|Overall Study||40
6649630|NCT02406495|7578849|FG000|NOT COMPLETED|Overall Study||0
6649631|NCT02406573|7578862|FG000|STARTED|Overall Study||30
6649632|NCT02406573|7578862|FG000|COMPLETED|Overall Study||30
6649633|NCT02406573|7578862|FG000|NOT COMPLETED|Overall Study||0
6649634|NCT02406586|7578869|FG000|STARTED|Overall Study||12
6649635|NCT02406586|7578870|FG001|STARTED|Overall Study||12
6649636|NCT02406586|7578871|FG002|STARTED|Overall Study||12
6649637|NCT02406586|7578869|FG000|COMPLETED|Overall Study||11
6649638|NCT02406586|7578870|FG001|COMPLETED|Overall Study||8
6649639|NCT02406586|7578871|FG002|COMPLETED|Overall Study||10
6649640|NCT02406586|7578869|FG000|NOT COMPLETED|Overall Study||1
6649641|NCT02406586|7578870|FG001|NOT COMPLETED|Overall Study||4
6649642|NCT02406586|7578871|FG002|NOT COMPLETED|Overall Study||2
6649643|NCT02406612|7578884|FG000|STARTED|Overall Study||26
6649644|NCT02406612|7578885|FG001|STARTED|Overall Study||21
6649645|NCT02406612|7578884|FG000|COMPLETED|Overall Study||22
6649646|NCT02406612|7578885|FG001|COMPLETED|Overall Study||17
6649647|NCT02406612|7578884|FG000|NOT COMPLETED|Overall Study||4
6649648|NCT02406612|7578885|FG001|NOT COMPLETED|Overall Study||4
6649649|NCT02406651|7578891|FG000|STARTED|Overall Study||30
6649650|NCT02406651|7578891|FG000|COMPLETED|Overall Study||27
6649651|NCT02406651|7578891|FG000|NOT COMPLETED|Overall Study||3
6649652|NCT02406677|7578898|FG000|STARTED|Overall Study||6436
6649653|NCT02406677|7578899|FG001|STARTED|Overall Study||4565
6649654|NCT02406677|7578898|FG000|COMPLETED|Overall Study||6135
6649655|NCT02406677|7578899|FG001|COMPLETED|Overall Study||3967
6649656|NCT02406677|7578898|FG000|NOT COMPLETED|Overall Study||301
6649657|NCT02406677|7578899|FG001|NOT COMPLETED|Overall Study||598
6649658|NCT02406742|7578912|FG000|STARTED|Overall Study||14
6649659|NCT02406742|7578913|FG001|STARTED|Overall Study||16
6649660|NCT02406742|7578914|FG002|STARTED|Overall Study||16
6649661|NCT02406742|7578912|FG000|Dose Escalation 1|Overall Study||3
6649662|NCT02406742|7578913|FG001|Dose Escalation 1|Overall Study||0
6649663|NCT02406742|7578914|FG002|Dose Escalation 1|Overall Study||0
6649664|NCT02406742|7578912|FG000|Dose Escalation 2|Overall Study||9
6649665|NCT02406742|7578913|FG001|Dose Escalation 2|Overall Study||5
6649666|NCT02406742|7578914|FG002|Dose Escalation 2|Overall Study||3
6649667|NCT02406742|7578912|FG000|Dose Escalation 3|Overall Study||2
6649668|NCT02406742|7578913|FG001|Dose Escalation 3|Overall Study||3
6649669|NCT02406742|7578914|FG002|Dose Escalation 3|Overall Study||3
6649670|NCT02406742|7578912|FG000|Dose Escalation 4|Overall Study||0
6649671|NCT02406742|7578913|FG001|Dose Escalation 4|Overall Study||3
6649672|NCT02406742|7578914|FG002|Dose Escalation 4|Overall Study||3
6649673|NCT02406742|7578912|FG000|Dose Escalation 5|Overall Study||0
6649674|NCT02406742|7578913|FG001|Dose Escalation 5|Overall Study||5
6649675|NCT02406742|7578914|FG002|Dose Escalation 5|Overall Study||5
6649676|NCT02406742|7578912|FG000|COMPLETED|Overall Study||0
6649677|NCT02406742|7578913|FG001|COMPLETED|Overall Study||0
6649678|NCT02406742|7578914|FG002|COMPLETED|Overall Study||0
6649679|NCT02406742|7578912|FG000|NOT COMPLETED|Overall Study||14
6649680|NCT02406742|7578913|FG001|NOT COMPLETED|Overall Study||16
6649681|NCT02406742|7578914|FG002|NOT COMPLETED|Overall Study||16
6649682|NCT02406859|7578925|FG000|STARTED|Part 1 - Manometric Parameters||15
6649683|NCT02406859|7578926|FG001|STARTED|Part 1 - Manometric Parameters||14
6649684|NCT02406859|7578927|FG002|STARTED|Part 1 - Manometric Parameters||21
6649685|NCT02406859|7578925|FG000|COMPLETED|Part 1 - Manometric Parameters||12
6649686|NCT02406859|7578926|FG001|COMPLETED|Part 1 - Manometric Parameters||13
6649687|NCT02406859|7578927|FG002|COMPLETED|Part 1 - Manometric Parameters||17
6649688|NCT02406859|7578925|FG000|NOT COMPLETED|Part 1 - Manometric Parameters||3
6649689|NCT02406859|7578926|FG001|NOT COMPLETED|Part 1 - Manometric Parameters||1
6649690|NCT02406859|7578927|FG002|NOT COMPLETED|Part 1 - Manometric Parameters||4
6649691|NCT02406859|7578925|FG000|STARTED|Part 2 - Biofeedback Training||12
6649692|NCT02406859|7578926|FG001|STARTED|Part 2 - Biofeedback Training||13
6649693|NCT02406859|7578927|FG002|STARTED|Part 2 - Biofeedback Training||17
6649694|NCT02406859|7578925|FG000|COMPLETED|Part 2 - Biofeedback Training||12
6649695|NCT02406859|7578926|FG001|COMPLETED|Part 2 - Biofeedback Training||13
6649696|NCT02406859|7578927|FG002|COMPLETED|Part 2 - Biofeedback Training||17
6649697|NCT02406859|7578925|FG000|NOT COMPLETED|Part 2 - Biofeedback Training||0
6649698|NCT02406859|7578926|FG001|NOT COMPLETED|Part 2 - Biofeedback Training||0
6649699|NCT02406859|7578927|FG002|NOT COMPLETED|Part 2 - Biofeedback Training||0
6649700|NCT02406885|7578946|FG000|STARTED|Overall Study||17
6649701|NCT02406885|7578947|FG001|STARTED|Overall Study||16
6649702|NCT02406885|7578946|FG000|COMPLETED|Overall Study||14
6649703|NCT02406885|7578947|FG001|COMPLETED|Overall Study||14
6649704|NCT02406885|7578946|FG000|NOT COMPLETED|Overall Study||3
6649705|NCT02406885|7578947|FG001|NOT COMPLETED|Overall Study||2
6649706|NCT02406937|7578956|FG000|STARTED|Overall Study||60
6649707|NCT02406937|7578957|FG001|STARTED|Overall Study||60
6649708|NCT02406937|7578958|FG002|STARTED|Overall Study||60
6649709|NCT02406937|7578956|FG000|COMPLETED|Overall Study||59
6649710|NCT02406937|7578957|FG001|COMPLETED|Overall Study||59
6649711|NCT02406937|7578958|FG002|COMPLETED|Overall Study||58
6649712|NCT02406937|7578956|FG000|NOT COMPLETED|Overall Study||1
6649713|NCT02406937|7578957|FG001|NOT COMPLETED|Overall Study||1
6649714|NCT02406937|7578958|FG002|NOT COMPLETED|Overall Study||2
6649715|NCT02407041|7578969|FG000|STARTED|Overall Study||5
6649716|NCT02407041|7578969|FG000|COMPLETED|Overall Study||5
6649717|NCT02407041|7578969|FG000|NOT COMPLETED|Overall Study||0
6649718|NCT02407054|7578976|FG000|STARTED|Overall Study||13
6649719|NCT02407054|7578977|FG001|STARTED|Overall Study||65
6649720|NCT02407054|7578978|FG002|STARTED|Overall Study||64
6649721|NCT02407054|7578976|FG000|Received at Least One Dose of Study Drug|Overall Study||13
6656015|NCT02457546|7586184|FG001|COMPLETED|Overall Study||116
6649722|NCT02407054|7578977|FG001|Received at Least One Dose of Study Drug|Overall Study||65
6649723|NCT02407054|7578978|FG002|Received at Least One Dose of Study Drug|Overall Study||64
6649724|NCT02407054|7578976|FG000|COMPLETED|Overall Study||6
6649725|NCT02407054|7578977|FG001|COMPLETED|Overall Study||47
6649726|NCT02407054|7578978|FG002|COMPLETED|Overall Study||57
6649727|NCT02407054|7578976|FG000|NOT COMPLETED|Overall Study||7
6649728|NCT02407054|7578977|FG001|NOT COMPLETED|Overall Study||18
6649729|NCT02407054|7578978|FG002|NOT COMPLETED|Overall Study||7
6649730|NCT02407132|7578989|FG000|STARTED|Immediate Post-intervention||110
6649731|NCT02407132|7578990|FG001|STARTED|Immediate Post-intervention||111
6649732|NCT02407132|7578989|FG000|COMPLETED|Immediate Post-intervention||107
6649733|NCT02407132|7578990|FG001|COMPLETED|Immediate Post-intervention||101
6649734|NCT02407132|7578989|FG000|NOT COMPLETED|Immediate Post-intervention||3
6551052|NCT01729208|7472993|FG001|COMPLETED|36 Months Follow-up||56
6551053|NCT01729208|7472992|FG000|NOT COMPLETED|36 Months Follow-up||3
6551054|NCT01729208|7472993|FG001|NOT COMPLETED|36 Months Follow-up||4
6551055|NCT01729247|7472999|FG000|STARTED|Overall Study||50
6649735|NCT02407132|7578990|FG001|NOT COMPLETED|Immediate Post-intervention||10
6649736|NCT02407132|7578989|FG000|STARTED|6 Months Post-intervention||107
6649737|NCT02407132|7578990|FG001|STARTED|6 Months Post-intervention||101
6649738|NCT02407132|7578989|FG000|COMPLETED|6 Months Post-intervention||96
6649739|NCT02407132|7578990|FG001|COMPLETED|6 Months Post-intervention||92
6649740|NCT02407132|7578989|FG000|NOT COMPLETED|6 Months Post-intervention||11
6649741|NCT02407132|7578990|FG001|NOT COMPLETED|6 Months Post-intervention||9
6649742|NCT02407132|7578989|FG000|STARTED|12 Months Post-intervention||96
6649743|NCT02407132|7578990|FG001|STARTED|12 Months Post-intervention||92
6649744|NCT02407132|7578989|FG000|COMPLETED|12 Months Post-intervention||83
6649745|NCT02407132|7578990|FG001|COMPLETED|12 Months Post-intervention||90
6649746|NCT02407132|7578989|FG000|NOT COMPLETED|12 Months Post-intervention||13
6649747|NCT02407132|7578990|FG001|NOT COMPLETED|12 Months Post-intervention||2
6649748|NCT02407223|7578999|FG000|STARTED|Overall Study||116
6649749|NCT02407223|7579000|FG001|STARTED|Overall Study||118
6649750|NCT02407223|7579001|FG002|STARTED|Overall Study||122
6649751|NCT02407223|7578999|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|22
6649752|NCT02407223|7579000|FG001|Early Escape at Week 16|Overall Study||0
6649753|NCT02407223|7579001|FG002|Early Escape at Week 16|Overall Study||0
6649754|NCT02407223|7578999|FG000|Cross Over at Week 24|Overall Study|Study discontinuation/completion reported under randomization group|60
6649755|NCT02407223|7579000|FG001|Cross Over at Week 24|Overall Study||0
6649756|NCT02407223|7579001|FG002|Cross Over at Week 24|Overall Study||0
6551056|NCT01729247|7472999|FG000|COMPLETED|Overall Study||50
6551057|NCT01729247|7472999|FG000|NOT COMPLETED|Overall Study||0
6551058|NCT01729338|7473010|FG000|STARTED|Overall Study||16
6551059|NCT01729338|7473010|FG000|COMPLETED|Overall Study||14
6551060|NCT01729338|7473010|FG000|NOT COMPLETED|Overall Study||2
6551061|NCT01729494|7473017|FG000|STARTED|Overall Study||107
6551062|NCT01729494|7473018|FG001|STARTED|Overall Study||104
6551063|NCT01729494|7473019|FG002|STARTED|Overall Study||105
6551064|NCT01729494|7473017|FG000|COMPLETED|Overall Study||97
6551065|NCT01729494|7473018|FG001|COMPLETED|Overall Study||93
6551066|NCT01729494|7473019|FG002|COMPLETED|Overall Study||94
6551067|NCT01729494|7473017|FG000|NOT COMPLETED|Overall Study||10
6551068|NCT01729494|7473018|FG001|NOT COMPLETED|Overall Study||11
6649757|NCT02407223|7578999|FG000|Qualified Re-randomization at Week 52|Overall Study||0
6551069|NCT01729494|7473019|FG002|NOT COMPLETED|Overall Study||11
6551070|NCT01729559|7473029|FG000|STARTED|Overall Study||251
6551071|NCT01729559|7473030|FG001|STARTED|Overall Study||244
6551072|NCT01729559|7473029|FG000|COMPLETED|Overall Study||220
6551073|NCT01729559|7473030|FG001|COMPLETED|Overall Study||216
6551074|NCT01729559|7473029|FG000|NOT COMPLETED|Overall Study||31
6649758|NCT02407223|7579000|FG001|Qualified Re-randomization at Week 52|Overall Study||3
6649759|NCT02407223|7579001|FG002|Qualified Re-randomization at Week 52|Overall Study||2
6649760|NCT02407223|7578999|FG000|COMPLETED|Overall Study||0
6649761|NCT02407223|7579000|FG001|COMPLETED|Overall Study||0
6649762|NCT02407223|7579001|FG002|COMPLETED|Overall Study||0
6649763|NCT02407223|7578999|FG000|NOT COMPLETED|Overall Study||116
6649764|NCT02407223|7579000|FG001|NOT COMPLETED|Overall Study||118
6649765|NCT02407223|7579001|FG002|NOT COMPLETED|Overall Study||122
6649766|NCT02407249|7579011|FG000|STARTED|Overall Study||73
6649767|NCT02407249|7579011|FG000|Treated|Overall Study||60
6649768|NCT02407249|7579011|FG000|COMPLETED|Overall Study||47
6649769|NCT02407249|7579011|FG000|NOT COMPLETED|Overall Study||26
6649770|NCT02407457|7579017|FG000|STARTED|Baseline||235
6649771|NCT02407457|7579018|FG001|STARTED|Baseline||220
6649772|NCT02407457|7579017|FG000|COMPLETED|Baseline||235
6649773|NCT02407457|7579018|FG001|COMPLETED|Baseline||220
6649774|NCT02407457|7579017|FG000|NOT COMPLETED|Baseline||0
6551075|NCT01729559|7473030|FG001|NOT COMPLETED|Overall Study||28
6551076|NCT01729598|7473038|FG000|STARTED|Overall Study||10
6649775|NCT02407457|7579018|FG001|NOT COMPLETED|Baseline||0
6551077|NCT01729598|7473039|FG001|STARTED|Overall Study||4
6551078|NCT01729598|7473038|FG000|COMPLETED|Overall Study||10
6649776|NCT02407457|7579017|FG000|STARTED|1 Month||235
6649777|NCT02407457|7579018|FG001|STARTED|1 Month||220
6305011|NCT00368966|7208318|FG000|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
6305012|NCT00368966|7208319|FG001|Vaccinated Dose 2|Infant Series||298
6305013|NCT00368966|7208318|FG000|Vaccinated Dose 3|Infant Series||301
6305014|NCT00368966|7208319|FG001|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
6305015|NCT00368966|7208318|FG000|COMPLETED|Infant Series||299
6305016|NCT00368966|7208319|FG001|COMPLETED|Infant Series||294
6305017|NCT00368966|7208318|FG000|NOT COMPLETED|Infant Series||16
6305018|NCT00368966|7208319|FG001|NOT COMPLETED|Infant Series||10
6305019|NCT00368966|7208318|FG000|STARTED|After Infant||299
6305020|NCT00368966|7208319|FG001|STARTED|After Infant||294
6305021|NCT00368966|7208318|FG000|COMPLETED|After Infant||293
6305022|NCT00368966|7208319|FG001|COMPLETED|After Infant||289
6305023|NCT00368966|7208318|FG000|NOT COMPLETED|After Infant||6
6305024|NCT00368966|7208319|FG001|NOT COMPLETED|After Infant||5
6305025|NCT00368966|7208318|FG000|STARTED|Toddler Dose||293
6305026|NCT00368966|7208319|FG001|STARTED|Toddler Dose||289
6305027|NCT00368966|7208318|FG000|COMPLETED|Toddler Dose||292
6305028|NCT00368966|7208319|FG001|COMPLETED|Toddler Dose||286
6305029|NCT00368966|7208318|FG000|NOT COMPLETED|Toddler Dose||1
6305030|NCT00368966|7208319|FG001|NOT COMPLETED|Toddler Dose||3
6305031|NCT00368979|7208352|FG000|STARTED|Overall Study||185
6305032|NCT00368979|7208353|FG001|STARTED|Overall Study||193
6305033|NCT00368979|7208352|FG000|COMPLETED|Overall Study||160
6305034|NCT00368979|7208353|FG001|COMPLETED|Overall Study||163
6305035|NCT00368979|7208352|FG000|NOT COMPLETED|Overall Study||25
6305036|NCT00368979|7208353|FG001|NOT COMPLETED|Overall Study||30
6305037|NCT00368992|7208359|FG000|STARTED|Overall Study||110
6305038|NCT00368992|7208359|FG000|COMPLETED|Overall Study||0
6305039|NCT00368992|7208359|FG000|NOT COMPLETED|Overall Study||110
6305040|NCT00369122|7208364|FG000|STARTED|Overall Study||60
6305041|NCT00369122|7208364|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
6305042|NCT00369122|7208364|FG000|NOT COMPLETED|Overall Study||11
6305043|NCT00369161|7208370|FG000|STARTED|Overall Study|"Started indicates randomized and safety population."|109
6305044|NCT00369161|7208371|FG001|STARTED|Overall Study||119
6305045|NCT00369161|7208370|FG000|Intention to Treat (ITT)|Overall Study||107
6305046|NCT00369161|7208371|FG001|Intention to Treat (ITT)|Overall Study||117
6305047|NCT00369161|7208370|FG000|COMPLETED|Overall Study||82
6305048|NCT00369161|7208371|FG001|COMPLETED|Overall Study||95
6305049|NCT00369161|7208370|FG000|NOT COMPLETED|Overall Study||27
6305050|NCT00369161|7208371|FG001|NOT COMPLETED|Overall Study||24
6305051|NCT00369226|7208379|FG000|STARTED|Phase I (45 Days)||13
6305052|NCT00369226|7208380|FG001|STARTED|Phase I (45 Days)||0
6305053|NCT00369226|7208379|FG000|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
6305054|NCT00369226|7208380|FG001|COMPLETED|Phase I (45 Days)||0
6305055|NCT00369226|7208379|FG000|NOT COMPLETED|Phase I (45 Days)||0
6305056|NCT00369226|7208380|FG001|NOT COMPLETED|Phase I (45 Days)||0
6305057|NCT00369226|7208379|FG000|STARTED|Phase II (45 Days)||0
6305058|NCT00369226|7208380|FG001|STARTED|Phase II (45 Days)||32
6305059|NCT00369226|7208379|FG000|COMPLETED|Phase II (45 Days)||0
6305060|NCT00369226|7208380|FG001|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
6305061|NCT00369226|7208379|FG000|NOT COMPLETED|Phase II (45 Days)||0
6305062|NCT00369226|7208380|FG001|NOT COMPLETED|Phase II (45 Days)||0
6305063|NCT00369278|7208391|FG000|STARTED|Overall Study||63
6305064|NCT00369278|7208392|FG001|STARTED|Overall Study||65
6305065|NCT00369278|7208391|FG000|COMPLETED|Overall Study||39
6305066|NCT00369278|7208392|FG001|COMPLETED|Overall Study||44
6305067|NCT00369278|7208391|FG000|NOT COMPLETED|Overall Study||24
6305068|NCT00369278|7208392|FG001|NOT COMPLETED|Overall Study||21
6305069|NCT00369343|7208400|FG000|STARTED|Double-blind Phase||256
6305070|NCT00369343|7208401|FG001|STARTED|Double-blind Phase||125
6649778|NCT02407457|7579017|FG000|COMPLETED|1 Month||229
6649779|NCT02407457|7579018|FG001|COMPLETED|1 Month||213
6649780|NCT02407457|7579017|FG000|NOT COMPLETED|1 Month||6
6649781|NCT02407457|7579018|FG001|NOT COMPLETED|1 Month||7
6649782|NCT02407457|7579017|FG000|STARTED|6-Month||231
6649783|NCT02407457|7579018|FG001|STARTED|6-Month||219
6649784|NCT02407457|7579017|FG000|COMPLETED|6-Month||211
6649785|NCT02407457|7579018|FG001|COMPLETED|6-Month||194
6649786|NCT02407457|7579017|FG000|NOT COMPLETED|6-Month||20
6649787|NCT02407457|7579018|FG001|NOT COMPLETED|6-Month||25
6649788|NCT02407457|7579017|FG000|STARTED|1 Year||227
6649789|NCT02407457|7579018|FG001|STARTED|1 Year||208
6649790|NCT02407457|7579017|FG000|COMPLETED|1 Year||194
6649791|NCT02407457|7579018|FG001|COMPLETED|1 Year||180
6305071|NCT00369343|7208400|FG000|COMPLETED|Double-blind Phase||212
6305072|NCT00369343|7208401|FG001|COMPLETED|Double-blind Phase||109
6305073|NCT00369343|7208400|FG000|NOT COMPLETED|Double-blind Phase||44
6305074|NCT00369343|7208401|FG001|NOT COMPLETED|Double-blind Phase||16
6305075|NCT00369343|7208400|FG000|STARTED|Open-label Phase||212
6305076|NCT00369343|7208401|FG001|STARTED|Open-label Phase||109
6305077|NCT00369343|7208400|FG000|COMPLETED|Open-label Phase||155
6305078|NCT00369343|7208401|FG001|COMPLETED|Open-label Phase||79
6305079|NCT00369343|7208400|FG000|NOT COMPLETED|Open-label Phase||57
6649792|NCT02407457|7579017|FG000|NOT COMPLETED|1 Year||33
6649793|NCT02407457|7579018|FG001|NOT COMPLETED|1 Year||28
6649794|NCT02407457|7579017|FG000|STARTED|2-year||218
6649795|NCT02407457|7579018|FG001|STARTED|2-year||194
6649796|NCT02407457|7579017|FG000|COMPLETED|2-year||184
6649797|NCT02407457|7579018|FG001|COMPLETED|2-year||159
6649798|NCT02407457|7579017|FG000|NOT COMPLETED|2-year||34
6649799|NCT02407457|7579018|FG001|NOT COMPLETED|2-year||35
6649800|NCT02407457|7579017|FG000|STARTED|3-year||198
6649801|NCT02407457|7579018|FG001|STARTED|3-year||175
6649802|NCT02407457|7579017|FG000|COMPLETED|3-year||156
6649803|NCT02407457|7579018|FG001|COMPLETED|3-year||137
6649804|NCT02407457|7579017|FG000|NOT COMPLETED|3-year||42
6649805|NCT02407457|7579018|FG001|NOT COMPLETED|3-year||38
6649806|NCT02407457|7579017|FG000|STARTED|4-year||181
6649807|NCT02407457|7579018|FG001|STARTED|4-year||156
6649808|NCT02407457|7579017|FG000|COMPLETED|4-year||100
6649809|NCT02407457|7579018|FG001|COMPLETED|4-year||95
6649810|NCT02407457|7579017|FG000|NOT COMPLETED|4-year||81
6649811|NCT02407457|7579018|FG001|NOT COMPLETED|4-year||61
6649812|NCT02407457|7579017|FG000|STARTED|5-year||123
6649813|NCT02407457|7579018|FG001|STARTED|5-year||113
6649814|NCT02407457|7579017|FG000|COMPLETED|5-year|Due to the time frame of the study - subjects have not passed 5-year.|31
6649815|NCT02407457|7579018|FG001|COMPLETED|5-year||36
6649816|NCT02407457|7579017|FG000|NOT COMPLETED|5-year||92
6649817|NCT02407457|7579018|FG001|NOT COMPLETED|5-year||77
6649818|NCT02407704|7579028|FG000|STARTED|Overall Study||2
6649819|NCT02407704|7579029|FG001|STARTED|Overall Study||3
6649820|NCT02407704|7579030|FG002|STARTED|Overall Study||5
6649821|NCT02407704|7579031|FG003|STARTED|Overall Study||5
6649822|NCT02407704|7579028|FG000|COMPLETED|Overall Study||2
6649823|NCT02407704|7579029|FG001|COMPLETED|Overall Study||3
6649824|NCT02407704|7579030|FG002|COMPLETED|Overall Study||4
6649825|NCT02407704|7579031|FG003|COMPLETED|Overall Study||2
6649826|NCT02407704|7579028|FG000|NOT COMPLETED|Overall Study||0
6649827|NCT02407704|7579029|FG001|NOT COMPLETED|Overall Study||0
6649828|NCT02407704|7579030|FG002|NOT COMPLETED|Overall Study||1
6649829|NCT02407704|7579031|FG003|NOT COMPLETED|Overall Study||3
6649830|NCT02407756|7579049|FG000|STARTED|Overall Study||20
6649831|NCT02407756|7579050|FG001|STARTED|Overall Study||18
6649832|NCT02407756|7579051|FG002|STARTED|Overall Study||20
6649833|NCT02407756|7579052|FG003|STARTED|Overall Study||19
6649834|NCT02407756|7579049|FG000|Treated|Overall Study||20
6649835|NCT02407756|7579050|FG001|Treated|Overall Study||18
6649836|NCT02407756|7579051|FG002|Treated|Overall Study||20
6649837|NCT02407756|7579052|FG003|Treated|Overall Study||19
6649838|NCT02407756|7579049|FG000|COMPLETED|Overall Study||20
6649839|NCT02407756|7579050|FG001|COMPLETED|Overall Study||18
6649840|NCT02407756|7579051|FG002|COMPLETED|Overall Study||20
6649841|NCT02407756|7579052|FG003|COMPLETED|Overall Study||19
6649842|NCT02407756|7579049|FG000|NOT COMPLETED|Overall Study||0
6649843|NCT02407756|7579050|FG001|NOT COMPLETED|Overall Study||0
6649844|NCT02407756|7579051|FG002|NOT COMPLETED|Overall Study||0
6649845|NCT02407756|7579052|FG003|NOT COMPLETED|Overall Study||0
6649846|NCT02407990|7579070|FG000|STARTED|Overall Study||3
6649847|NCT02407990|7579071|FG001|STARTED|Overall Study||26
6649848|NCT02407990|7579072|FG002|STARTED|Overall Study||26
6649849|NCT02407990|7579073|FG003|STARTED|Overall Study||7
6649850|NCT02407990|7579074|FG004|STARTED|Overall Study||21
6649851|NCT02407990|7579075|FG005|STARTED|Overall Study||20
6649852|NCT02407990|7579076|FG006|STARTED|Overall Study||13
6551079|NCT01729598|7473039|FG001|COMPLETED|Overall Study||4
6551080|NCT01729598|7473038|FG000|NOT COMPLETED|Overall Study||0
6551081|NCT01729598|7473039|FG001|NOT COMPLETED|Overall Study||0
6551082|NCT01729728|7473048|FG000|STARTED|Overall Study||21
6551083|NCT01729728|7473049|FG001|STARTED|Overall Study||28
6551084|NCT01729728|7473050|FG002|STARTED|Overall Study||17
6551085|NCT01729728|7473048|FG000|COMPLETED|Overall Study||20
6551086|NCT01729728|7473049|FG001|COMPLETED|Overall Study||22
6551087|NCT01729728|7473050|FG002|COMPLETED|Overall Study||16
6551088|NCT01729728|7473048|FG000|NOT COMPLETED|Overall Study||1
6551089|NCT01729728|7473049|FG001|NOT COMPLETED|Overall Study||6
6551090|NCT01729728|7473050|FG002|NOT COMPLETED|Overall Study||1
6551091|NCT01729819|7473183|FG000|STARTED|Overall Study||49
6551092|NCT01729819|7473184|FG001|STARTED|Overall Study||57
6551093|NCT01729819|7473183|FG000|COMPLETED|Overall Study||43
6551094|NCT01729819|7473184|FG001|COMPLETED|Overall Study||50
6551095|NCT01729819|7473183|FG000|NOT COMPLETED|Overall Study||6
6551096|NCT01729819|7473184|FG001|NOT COMPLETED|Overall Study||7
6551097|NCT01729845|7473196|FG000|STARTED|Safety/Tolerability of Dec/MEC||6
6551098|NCT01729845|7473197|FG001|STARTED|Safety/Tolerability of Dec/MEC||34
6305080|NCT00369343|7208401|FG001|NOT COMPLETED|Open-label Phase||30
6305081|NCT00369382|7208416|FG000|STARTED|Overall Study||59
6305082|NCT00369382|7208417|FG001|STARTED|Overall Study||57
6305083|NCT00369382|7208416|FG000|Received Treatment|Overall Study||57
6305084|NCT00369382|7208417|FG001|Received Treatment|Overall Study||57
6305085|NCT00369382|7208416|FG000|Completed Assigned Treatment Regimen|Overall Study||48
6305086|NCT00369382|7208417|FG001|Completed Assigned Treatment Regimen|Overall Study||33
6305087|NCT00369382|7208416|FG000|COMPLETED|Overall Study||49
6305088|NCT00369382|7208417|FG001|COMPLETED|Overall Study||54
6305089|NCT00369382|7208416|FG000|NOT COMPLETED|Overall Study||10
6305090|NCT00369382|7208417|FG001|NOT COMPLETED|Overall Study||3
6305091|NCT00369486|7208429|FG000|STARTED|4-Week Visit|Number of eyes|38
6305092|NCT00369486|7208430|FG001|STARTED|4-Week Visit|Number of eyes|21
6305093|NCT00369486|7208431|FG002|STARTED|4-Week Visit|Number of eyes|23
6305094|NCT00369486|7208432|FG003|STARTED|4-Week Visit|Number of eyes|22
6305095|NCT00369486|7208433|FG004|STARTED|4-Week Visit|Number of eyes|25
6305096|NCT00369486|7208429|FG000|COMPLETED|4-Week Visit|Number of eyes|36
6305097|NCT00369486|7208430|FG001|COMPLETED|4-Week Visit|Number of eyes;|19
6305098|NCT00369486|7208431|FG002|COMPLETED|4-Week Visit|Number of eyes|22
6305099|NCT00369486|7208432|FG003|COMPLETED|4-Week Visit|Number of eyes|20
6305100|NCT00369486|7208433|FG004|COMPLETED|4-Week Visit|Number of eyes|24
6305101|NCT00369486|7208429|FG000|NOT COMPLETED|4-Week Visit||2
6305102|NCT00369486|7208430|FG001|NOT COMPLETED|4-Week Visit||2
6305103|NCT00369486|7208431|FG002|NOT COMPLETED|4-Week Visit||1
6305104|NCT00369486|7208432|FG003|NOT COMPLETED|4-Week Visit||2
6305105|NCT00369486|7208433|FG004|NOT COMPLETED|4-Week Visit||1
6305106|NCT00369486|7208429|FG000|STARTED|8-Week Visit|Number of eyes|38
6305107|NCT00369486|7208430|FG001|STARTED|8-Week Visit|Number of eyes|21
6305108|NCT00369486|7208431|FG002|STARTED|8-Week Visit|Number of eyes|22
6305109|NCT00369486|7208432|FG003|STARTED|8-Week Visit|Number of eyes|22
6305110|NCT00369486|7208433|FG004|STARTED|8-Week Visit|Number of eyes|25
6305111|NCT00369486|7208429|FG000|COMPLETED|8-Week Visit|Number of eyes|38
6305112|NCT00369486|7208430|FG001|COMPLETED|8-Week Visit|Number of eyes|20
6305113|NCT00369486|7208431|FG002|COMPLETED|8-Week Visit|Number of eyes|22
6305114|NCT00369486|7208432|FG003|COMPLETED|8-Week Visit|Number of eyes|21
6305115|NCT00369486|7208433|FG004|COMPLETED|8-Week Visit|Number of eyes|24
6305116|NCT00369486|7208429|FG000|NOT COMPLETED|8-Week Visit||0
6305117|NCT00369486|7208430|FG001|NOT COMPLETED|8-Week Visit||1
6305118|NCT00369486|7208431|FG002|NOT COMPLETED|8-Week Visit||0
6305119|NCT00369486|7208432|FG003|NOT COMPLETED|8-Week Visit||1
6305120|NCT00369486|7208433|FG004|NOT COMPLETED|8-Week Visit||1
6305121|NCT00369486|7208429|FG000|STARTED|17-Week Visit|Number of eyes|38
6305122|NCT00369486|7208430|FG001|STARTED|17-Week Visit|Number of eyes|21
6305123|NCT00369486|7208431|FG002|STARTED|17-Week Visit|Number of eyes|23
6305124|NCT00369486|7208432|FG003|STARTED|17-Week Visit|Number of eyes|22
6305125|NCT00369486|7208433|FG004|STARTED|17-Week Visit|Number of eyes|25
6305126|NCT00369486|7208429|FG000|COMPLETED|17-Week Visit|Number of eyes|38
6305127|NCT00369486|7208430|FG001|COMPLETED|17-Week Visit|Number of eyes|21
6305128|NCT00369486|7208431|FG002|COMPLETED|17-Week Visit|Number of eyes|22
6305129|NCT00369486|7208432|FG003|COMPLETED|17-Week Visit|Number of eyes|21
6305130|NCT00369486|7208433|FG004|COMPLETED|17-Week Visit|Number of eyes|24
6305131|NCT00369486|7208429|FG000|NOT COMPLETED|17-Week Visit||0
6305132|NCT00369486|7208430|FG001|NOT COMPLETED|17-Week Visit||0
6305133|NCT00369486|7208431|FG002|NOT COMPLETED|17-Week Visit||1
6305134|NCT00369486|7208432|FG003|NOT COMPLETED|17-Week Visit||1
6305135|NCT00369486|7208433|FG004|NOT COMPLETED|17-Week Visit||1
6305136|NCT00369486|7208429|FG000|STARTED|34-Week Visit|Number of eyes|38
6305137|NCT00369486|7208430|FG001|STARTED|34-Week Visit|Number of eyes|21
6305138|NCT00369486|7208431|FG002|STARTED|34-Week Visit|Number of eyes|23
6305139|NCT00369486|7208432|FG003|STARTED|34-Week Visit|Number of eyes|22
6305140|NCT00369486|7208433|FG004|STARTED|34-Week Visit|Number of eyes that|25
6305141|NCT00369486|7208429|FG000|COMPLETED|34-Week Visit|Number of eyes|38
6305142|NCT00369486|7208430|FG001|COMPLETED|34-Week Visit|Number of eyes|20
6305143|NCT00369486|7208431|FG002|COMPLETED|34-Week Visit|Number of eyes|22
6305144|NCT00369486|7208432|FG003|COMPLETED|34-Week Visit|Number of eyes|19
6551099|NCT01729845|7473198|FG002|STARTED|Safety/Tolerability of Dec/MEC||12
6551100|NCT01729845|7473196|FG000|COMPLETED|Safety/Tolerability of Dec/MEC||6
6551101|NCT01729845|7473197|FG001|COMPLETED|Safety/Tolerability of Dec/MEC||34
6551102|NCT01729845|7473198|FG002|COMPLETED|Safety/Tolerability of Dec/MEC||12
6649853|NCT02407990|7579077|FG007|STARTED|Overall Study||335
6649854|NCT02407990|7579070|FG000|COMPLETED|Overall Study||0
6649855|NCT02407990|7579071|FG001|COMPLETED|Overall Study||0
6649856|NCT02407990|7579072|FG002|COMPLETED|Overall Study||0
6649857|NCT02407990|7579073|FG003|COMPLETED|Overall Study||0
6649858|NCT02407990|7579074|FG004|COMPLETED|Overall Study||0
6649859|NCT02407990|7579075|FG005|COMPLETED|Overall Study||0
6649860|NCT02407990|7579076|FG006|COMPLETED|Overall Study||0
6649861|NCT02407990|7579077|FG007|COMPLETED|Overall Study||0
6649862|NCT02407990|7579070|FG000|NOT COMPLETED|Overall Study||3
6649863|NCT02407990|7579071|FG001|NOT COMPLETED|Overall Study||26
6649864|NCT02407990|7579072|FG002|NOT COMPLETED|Overall Study||26
6649865|NCT02407990|7579073|FG003|NOT COMPLETED|Overall Study||7
6649866|NCT02407990|7579074|FG004|NOT COMPLETED|Overall Study||21
6649867|NCT02407990|7579075|FG005|NOT COMPLETED|Overall Study||20
6649868|NCT02407990|7579076|FG006|NOT COMPLETED|Overall Study||13
6649869|NCT02407990|7579077|FG007|NOT COMPLETED|Overall Study||335
6649870|NCT02408016|7579104|FG000|STARTED|Overall Study||6
6649871|NCT02408016|7579105|FG001|STARTED|Overall Study||4
6649872|NCT02408016|7579106|FG002|STARTED|Overall Study||0
6649873|NCT02408016|7579104|FG000|COMPLETED|Overall Study||0
6649874|NCT02408016|7579105|FG001|COMPLETED|Overall Study||1
6649875|NCT02408016|7579106|FG002|COMPLETED|Overall Study||0
6649876|NCT02408016|7579104|FG000|NOT COMPLETED|Overall Study||6
6649877|NCT02408016|7579105|FG001|NOT COMPLETED|Overall Study||3
6649878|NCT02408016|7579106|FG002|NOT COMPLETED|Overall Study||0
6649879|NCT02408068|7579114|FG000|STARTED|Treatment 1 (1.5 Days)||3
6649880|NCT02408068|7579115|FG001|STARTED|Treatment 1 (1.5 Days)||3
6649881|NCT02408068|7579116|FG002|STARTED|Treatment 1 (1.5 Days)||3
6649882|NCT02408068|7579117|FG003|STARTED|Treatment 1 (1.5 Days)||3
6649883|NCT02408068|7579118|FG004|STARTED|Treatment 1 (1.5 Days)||3
6649884|NCT02408068|7579119|FG005|STARTED|Treatment 1 (1.5 Days)||3
6649885|NCT02408068|7579114|FG000|COMPLETED|Treatment 1 (1.5 Days)||3
6649886|NCT02408068|7579115|FG001|COMPLETED|Treatment 1 (1.5 Days)||3
6649887|NCT02408068|7579116|FG002|COMPLETED|Treatment 1 (1.5 Days)||3
6649888|NCT02408068|7579117|FG003|COMPLETED|Treatment 1 (1.5 Days)||3
6649889|NCT02408068|7579118|FG004|COMPLETED|Treatment 1 (1.5 Days)||3
6649890|NCT02408068|7579119|FG005|COMPLETED|Treatment 1 (1.5 Days)||3
6649891|NCT02408068|7579114|FG000|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6649892|NCT02408068|7579115|FG001|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6649893|NCT02408068|7579116|FG002|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6649894|NCT02408068|7579117|FG003|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6649895|NCT02408068|7579118|FG004|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6649896|NCT02408068|7579119|FG005|NOT COMPLETED|Treatment 1 (1.5 Days)||0
6649897|NCT02408068|7579114|FG000|STARTED|Washout Period 1 (7 Days)||3
6649898|NCT02408068|7579115|FG001|STARTED|Washout Period 1 (7 Days)||3
6649899|NCT02408068|7579116|FG002|STARTED|Washout Period 1 (7 Days)||3
6649900|NCT02408068|7579117|FG003|STARTED|Washout Period 1 (7 Days)||3
6649901|NCT02408068|7579118|FG004|STARTED|Washout Period 1 (7 Days)||3
6649902|NCT02408068|7579119|FG005|STARTED|Washout Period 1 (7 Days)||3
6649903|NCT02408068|7579114|FG000|COMPLETED|Washout Period 1 (7 Days)||3
6649904|NCT02408068|7579115|FG001|COMPLETED|Washout Period 1 (7 Days)||3
6649905|NCT02408068|7579116|FG002|COMPLETED|Washout Period 1 (7 Days)||3
6649906|NCT02408068|7579117|FG003|COMPLETED|Washout Period 1 (7 Days)||3
6649907|NCT02408068|7579118|FG004|COMPLETED|Washout Period 1 (7 Days)||3
6649908|NCT02408068|7579119|FG005|COMPLETED|Washout Period 1 (7 Days)||3
6649909|NCT02408068|7579114|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6649910|NCT02408068|7579115|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6649911|NCT02408068|7579116|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6649912|NCT02408068|7579117|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6649913|NCT02408068|7579118|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
6649914|NCT02408068|7579119|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
6649915|NCT02408068|7579114|FG000|STARTED|Treatment 2 (1.5 Days)||3
6649916|NCT02408068|7579115|FG001|STARTED|Treatment 2 (1.5 Days)||3
6649917|NCT02408068|7579116|FG002|STARTED|Treatment 2 (1.5 Days)||3
6649918|NCT02408068|7579117|FG003|STARTED|Treatment 2 (1.5 Days)||3
6649919|NCT02408068|7579118|FG004|STARTED|Treatment 2 (1.5 Days)||3
6649920|NCT02408068|7579119|FG005|STARTED|Treatment 2 (1.5 Days)||3
6649921|NCT02408068|7579114|FG000|COMPLETED|Treatment 2 (1.5 Days)||3
6649922|NCT02408068|7579115|FG001|COMPLETED|Treatment 2 (1.5 Days)||3
6649923|NCT02408068|7579116|FG002|COMPLETED|Treatment 2 (1.5 Days)||3
6649924|NCT02408068|7579117|FG003|COMPLETED|Treatment 2 (1.5 Days)||3
6649925|NCT02408068|7579118|FG004|COMPLETED|Treatment 2 (1.5 Days)||3
6649926|NCT02408068|7579119|FG005|COMPLETED|Treatment 2 (1.5 Days)||3
6649927|NCT02408068|7579114|FG000|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6649928|NCT02408068|7579115|FG001|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6649929|NCT02408068|7579116|FG002|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6649930|NCT02408068|7579117|FG003|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6649931|NCT02408068|7579118|FG004|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6649932|NCT02408068|7579119|FG005|NOT COMPLETED|Treatment 2 (1.5 Days)||0
6649933|NCT02408068|7579114|FG000|STARTED|Washout Period 2 (7 Days)||3
6649934|NCT02408068|7579115|FG001|STARTED|Washout Period 2 (7 Days)||3
6649935|NCT02408068|7579116|FG002|STARTED|Washout Period 2 (7 Days)||3
6649936|NCT02408068|7579117|FG003|STARTED|Washout Period 2 (7 Days)||3
6649937|NCT02408068|7579118|FG004|STARTED|Washout Period 2 (7 Days)||3
6649938|NCT02408068|7579119|FG005|STARTED|Washout Period 2 (7 Days)||3
6649939|NCT02408068|7579114|FG000|COMPLETED|Washout Period 2 (7 Days)||3
6649940|NCT02408068|7579115|FG001|COMPLETED|Washout Period 2 (7 Days)||3
6649941|NCT02408068|7579116|FG002|COMPLETED|Washout Period 2 (7 Days)||3
6649942|NCT02408068|7579117|FG003|COMPLETED|Washout Period 2 (7 Days)||3
6649943|NCT02408068|7579118|FG004|COMPLETED|Washout Period 2 (7 Days)||3
6649944|NCT02408068|7579119|FG005|COMPLETED|Washout Period 2 (7 Days)||3
6649945|NCT02408068|7579114|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6649946|NCT02408068|7579115|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6649947|NCT02408068|7579116|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6649948|NCT02408068|7579117|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6649949|NCT02408068|7579118|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6649950|NCT02408068|7579119|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6649951|NCT02408068|7579114|FG000|STARTED|Treatment 3 (1.5 Days)||3
6649952|NCT02408068|7579115|FG001|STARTED|Treatment 3 (1.5 Days)||3
6649953|NCT02408068|7579116|FG002|STARTED|Treatment 3 (1.5 Days)||3
6649954|NCT02408068|7579117|FG003|STARTED|Treatment 3 (1.5 Days)||3
6649955|NCT02408068|7579118|FG004|STARTED|Treatment 3 (1.5 Days)||3
6649956|NCT02408068|7579119|FG005|STARTED|Treatment 3 (1.5 Days)||3
6649957|NCT02408068|7579114|FG000|COMPLETED|Treatment 3 (1.5 Days)||3
6649958|NCT02408068|7579115|FG001|COMPLETED|Treatment 3 (1.5 Days)||3
6649959|NCT02408068|7579116|FG002|COMPLETED|Treatment 3 (1.5 Days)||2
6649960|NCT02408068|7579117|FG003|COMPLETED|Treatment 3 (1.5 Days)||3
6649961|NCT02408068|7579118|FG004|COMPLETED|Treatment 3 (1.5 Days)||3
6649962|NCT02408068|7579119|FG005|COMPLETED|Treatment 3 (1.5 Days)||3
6649963|NCT02408068|7579114|FG000|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6744156|NCT03340805|7672287|FG001|COMPLETED|Overall Study||26
6744157|NCT03340805|7672286|FG000|NOT COMPLETED|Overall Study||0
6744158|NCT03340805|7672287|FG001|NOT COMPLETED|Overall Study||0
6744159|NCT03340883|7672295|FG000|STARTED|Overall Study||4
6744160|NCT03340883|7672296|FG001|STARTED|Overall Study||3
6744161|NCT03340883|7672297|FG002|STARTED|Overall Study||4
6744162|NCT03340883|7672298|FG003|STARTED|Overall Study||4
6744163|NCT03340883|7672299|FG004|STARTED|Overall Study||3
6744164|NCT03340883|7672300|FG005|STARTED|Overall Study||3
6744165|NCT03340883|7672295|FG000|COMPLETED|Overall Study||4
6744166|NCT03340883|7672296|FG001|COMPLETED|Overall Study||3
6744167|NCT03340883|7672297|FG002|COMPLETED|Overall Study||4
6744168|NCT03340883|7672298|FG003|COMPLETED|Overall Study||4
6744169|NCT03340883|7672299|FG004|COMPLETED|Overall Study||3
6744170|NCT03340883|7672300|FG005|COMPLETED|Overall Study||3
6744171|NCT03340883|7672295|FG000|NOT COMPLETED|Overall Study||0
6744172|NCT03340883|7672296|FG001|NOT COMPLETED|Overall Study||0
6744173|NCT03340883|7672297|FG002|NOT COMPLETED|Overall Study||0
6744174|NCT03340883|7672298|FG003|NOT COMPLETED|Overall Study||0
6744175|NCT03340883|7672299|FG004|NOT COMPLETED|Overall Study||0
6744176|NCT03340883|7672300|FG005|NOT COMPLETED|Overall Study||0
6744177|NCT03340961|7672318|FG000|STARTED|Overall Study||53
6744178|NCT03340961|7672319|FG001|STARTED|Overall Study||50
6744179|NCT03340961|7672320|FG002|STARTED|Overall Study||49
6744180|NCT03340961|7672321|FG003|STARTED|Overall Study||53
6744181|NCT03340961|7672318|FG000|COMPLETED|Overall Study||47
6744182|NCT03340961|7672319|FG001|COMPLETED|Overall Study||38
6744183|NCT03340961|7672320|FG002|COMPLETED|Overall Study||40
6744184|NCT03340961|7672321|FG003|COMPLETED|Overall Study||35
6744185|NCT03340961|7672318|FG000|NOT COMPLETED|Overall Study||6
6744186|NCT03340961|7672319|FG001|NOT COMPLETED|Overall Study||12
6744187|NCT03340961|7672320|FG002|NOT COMPLETED|Overall Study||9
6744188|NCT03340961|7672321|FG003|NOT COMPLETED|Overall Study||18
6744189|NCT03341273|7672333|FG000|STARTED|Overall Study||249
6744190|NCT03341273|7672334|FG001|STARTED|Overall Study||250
6744191|NCT03341273|7672333|FG000|COMPLETED|Overall Study||229
6744192|NCT03341273|7672334|FG001|COMPLETED|Overall Study||238
6744193|NCT03341273|7672333|FG000|NOT COMPLETED|Overall Study||20
6744194|NCT03341273|7672334|FG001|NOT COMPLETED|Overall Study||12
6744195|NCT03341299|7672340|FG000|STARTED|Period 1||9
6744196|NCT03341299|7672341|FG001|STARTED|Period 1||9
6744197|NCT03341299|7672342|FG002|STARTED|Period 1||9
6744198|NCT03341299|7672343|FG003|STARTED|Period 1||9
6744199|NCT03341299|7672340|FG000|COMPLETED|Period 1||9
6744200|NCT03341299|7672341|FG001|COMPLETED|Period 1||9
6744201|NCT03341299|7672342|FG002|COMPLETED|Period 1||9
6744202|NCT03341299|7672343|FG003|COMPLETED|Period 1||9
6744203|NCT03341299|7672340|FG000|NOT COMPLETED|Period 1||0
6744204|NCT03341299|7672341|FG001|NOT COMPLETED|Period 1||0
6744205|NCT03341299|7672342|FG002|NOT COMPLETED|Period 1||0
6744206|NCT03341299|7672343|FG003|NOT COMPLETED|Period 1||0
6744207|NCT03341299|7672340|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
6744208|NCT03341299|7672341|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
6744209|NCT03341299|7672342|FG002|STARTED|Washout (A Minimum of 21 Hours)||9
6744210|NCT03341299|7672343|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
6744211|NCT03341299|7672340|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
6744212|NCT03341299|7672341|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
6744213|NCT03341299|7672342|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
6649964|NCT02408068|7579115|FG001|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6649965|NCT02408068|7579116|FG002|NOT COMPLETED|Treatment 3 (1.5 Days)||1
6649966|NCT02408068|7579117|FG003|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6649967|NCT02408068|7579118|FG004|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6649968|NCT02408068|7579119|FG005|NOT COMPLETED|Treatment 3 (1.5 Days)||0
6649969|NCT02408120|7579132|FG000|STARTED|Overall Study||112
6649970|NCT02408120|7579133|FG001|STARTED|Overall Study||112
6649971|NCT02408120|7579132|FG000|COMPLETED|Overall Study||108
6649972|NCT02408120|7579133|FG001|COMPLETED|Overall Study||107
6649973|NCT02408120|7579132|FG000|NOT COMPLETED|Overall Study||4
6649974|NCT02408120|7579133|FG001|NOT COMPLETED|Overall Study||5
6649975|NCT02408198|7579141|FG000|STARTED|Overall Study||13
6649976|NCT02408198|7579142|FG001|STARTED|Overall Study||5
6649977|NCT02408198|7579141|FG000|COMPLETED|Overall Study||10
6649978|NCT02408198|7579142|FG001|COMPLETED|Overall Study||5
6649979|NCT02408198|7579141|FG000|NOT COMPLETED|Overall Study||3
6649980|NCT02408198|7579142|FG001|NOT COMPLETED|Overall Study||0
6649981|NCT02408263|7579148|FG000|STARTED|Overall Study||25
6649982|NCT02408263|7579149|FG001|STARTED|Overall Study||25
6649983|NCT02408263|7579148|FG000|COMPLETED|Overall Study||25
6649984|NCT02408263|7579149|FG001|COMPLETED|Overall Study||25
6649985|NCT02408263|7579148|FG000|NOT COMPLETED|Overall Study||0
6649986|NCT02408263|7579149|FG001|NOT COMPLETED|Overall Study||0
6649987|NCT02408445|7579156|FG000|STARTED|Overall Study||10
6649988|NCT02408445|7579157|FG001|STARTED|Overall Study||10
6649989|NCT02408445|7579156|FG000|COMPLETED|Overall Study||10
6649990|NCT02408445|7579157|FG001|COMPLETED|Overall Study||10
6649991|NCT02408445|7579156|FG000|NOT COMPLETED|Overall Study||0
6649992|NCT02408445|7579157|FG001|NOT COMPLETED|Overall Study||0
6649993|NCT02408484|7579162|FG000|STARTED|Overall Study||15
6649994|NCT02408484|7579162|FG000|SAF Population|Overall Study||14
6649995|NCT02408484|7579162|FG000|FAS Population|Overall Study||14
6649996|NCT02408484|7579162|FG000|PK Population|Overall Study||13
6649997|NCT02408484|7579162|FG000|firstBLEED Population|Overall Study||8
6649998|NCT02408484|7579162|FG000|BLEED Population|Overall Study||8
6649999|NCT02408484|7579162|FG000|SURG Population|Overall Study||3
6650000|NCT02408484|7579162|FG000|COMPLETED|Overall Study||11
6650001|NCT02408484|7579162|FG000|NOT COMPLETED|Overall Study||4
6650002|NCT02408523|7579184|FG000|STARTED|Overall Study||121
6650003|NCT02408523|7579185|FG001|STARTED|Overall Study||121
6650004|NCT02408523|7579184|FG000|Completed Treatment Period|Overall Study||110
6650005|NCT02408523|7579185|FG001|Completed Treatment Period|Overall Study||103
6650006|NCT02408523|7579184|FG000|Enrolled Transition Period|Overall Study||108
6650007|NCT02408523|7579185|FG001|Enrolled Transition Period|Overall Study||101
6650008|NCT02408523|7579184|FG000|Enrolled Taper Period|Overall Study||7
6650009|NCT02408523|7579185|FG001|Enrolled Taper Period|Overall Study||9
6650010|NCT02408523|7579184|FG000|Enrolled Safety Folllow-up Period|Overall Study||10
6650011|NCT02408523|7579185|FG001|Enrolled Safety Folllow-up Period|Overall Study||11
6650012|NCT02408523|7579184|FG000|COMPLETED|Overall Study||110
6650013|NCT02408523|7579185|FG001|COMPLETED|Overall Study||103
6650014|NCT02408523|7579184|FG000|NOT COMPLETED|Overall Study||11
6650015|NCT02408523|7579185|FG001|NOT COMPLETED|Overall Study||18
6650016|NCT02408692|7579202|FG000|STARTED|Overall Study||5
6650017|NCT02408692|7579203|FG001|STARTED|Overall Study||5
6650018|NCT02408692|7579204|FG002|STARTED|Overall Study||5
6650019|NCT02408692|7579202|FG000|COMPLETED|Overall Study||5
6650020|NCT02408692|7579203|FG001|COMPLETED|Overall Study||5
6650021|NCT02408692|7579204|FG002|COMPLETED|Overall Study||5
6650022|NCT02408692|7579202|FG000|NOT COMPLETED|Overall Study||0
6650023|NCT02408692|7579203|FG001|NOT COMPLETED|Overall Study||0
6650024|NCT02408692|7579204|FG002|NOT COMPLETED|Overall Study||0
6650025|NCT02408796|7579212|FG000|STARTED|Overall Study||39
6650026|NCT02408796|7579212|FG000|COMPLETED|Overall Study||39
6650027|NCT02408796|7579212|FG000|NOT COMPLETED|Overall Study||0
6650028|NCT02408965|7579218|FG000|STARTED|Overall Study||140
6650029|NCT02408965|7579219|FG001|STARTED|Overall Study||144
6650030|NCT02408965|7579218|FG000|COMPLETED|Overall Study||140
6650031|NCT02408965|7579219|FG001|COMPLETED|Overall Study||144
6650032|NCT02408965|7579218|FG000|NOT COMPLETED|Overall Study||0
6650033|NCT02408965|7579219|FG001|NOT COMPLETED|Overall Study||0
6650034|NCT02409277|7579228|FG000|STARTED|Overall Study||267
6650035|NCT02409277|7579229|FG001|STARTED|Overall Study||60
6650036|NCT02409277|7579230|FG002|STARTED|Overall Study||599
6650037|NCT02409277|7579228|FG000|3 Months Follow-up|Overall Study||178
6650038|NCT02409277|7579229|FG001|3 Months Follow-up|Overall Study||40
6650039|NCT02409277|7579230|FG002|3 Months Follow-up|Overall Study||599
6650040|NCT02409277|7579228|FG000|6 Months Follow-up|Overall Study||182
6650041|NCT02409277|7579229|FG001|6 Months Follow-up|Overall Study||42
6650042|NCT02409277|7579230|FG002|6 Months Follow-up|Overall Study||599
6650043|NCT02409277|7579228|FG000|12 Months Follow-up|Overall Study||167
6650044|NCT02409277|7579229|FG001|12 Months Follow-up|Overall Study||43
6650045|NCT02409277|7579230|FG002|12 Months Follow-up|Overall Study||599
6650046|NCT02409277|7579228|FG000|COMPLETED|Overall Study||167
6650047|NCT02409277|7579229|FG001|COMPLETED|Overall Study||43
6650048|NCT02409277|7579230|FG002|COMPLETED|Overall Study||599
6650049|NCT02409277|7579228|FG000|NOT COMPLETED|Overall Study||100
6650050|NCT02409277|7579229|FG001|NOT COMPLETED|Overall Study||17
6650051|NCT02409277|7579230|FG002|NOT COMPLETED|Overall Study||0
6650052|NCT02409329|7579258|FG000|STARTED|Overall Study||127
6650053|NCT02409329|7579259|FG001|STARTED|Overall Study||126
6650054|NCT02409329|7579260|FG002|STARTED|Overall Study||253
6650055|NCT02409329|7579258|FG000|COMPLETED|Overall Study||122
6650056|NCT02409329|7579259|FG001|COMPLETED|Overall Study||120
6650057|NCT02409329|7579260|FG002|COMPLETED|Overall Study||244
6650058|NCT02409329|7579258|FG000|NOT COMPLETED|Overall Study||5
6650059|NCT02409329|7579259|FG001|NOT COMPLETED|Overall Study||6
6650060|NCT02409329|7579260|FG002|NOT COMPLETED|Overall Study||9
6650061|NCT02409459|7579271|FG000|STARTED|Overall Study||41
6650062|NCT02409459|7579272|FG001|STARTED|Overall Study||40
6650063|NCT02409459|7579271|FG000|COMPLETED|Overall Study||40
6650064|NCT02409459|7579272|FG001|COMPLETED|Overall Study||39
6650065|NCT02409459|7579271|FG000|NOT COMPLETED|Overall Study||1
6650066|NCT02409459|7579272|FG001|NOT COMPLETED|Overall Study||1
6650067|NCT02409667|7579278|FG000|STARTED|Treatment Period 1, Baseline to Week 24||1647
6650068|NCT02409667|7579279|FG001|STARTED|Treatment Period 1, Baseline to Week 24||0
6650069|NCT02409667|7579280|FG002|STARTED|Treatment Period 1, Baseline to Week 24||0
6650070|NCT02409667|7579281|FG003|STARTED|Treatment Period 1, Baseline to Week 24||0
6650071|NCT02409667|7579282|FG004|STARTED|Treatment Period 1, Baseline to Week 24||0
6650072|NCT02409667|7579278|FG000|COMPLETED|Treatment Period 1, Baseline to Week 24||1526
6650073|NCT02409667|7579279|FG001|COMPLETED|Treatment Period 1, Baseline to Week 24||0
6650074|NCT02409667|7579280|FG002|COMPLETED|Treatment Period 1, Baseline to Week 24||0
6650075|NCT02409667|7579281|FG003|COMPLETED|Treatment Period 1, Baseline to Week 24||0
6650076|NCT02409667|7579282|FG004|COMPLETED|Treatment Period 1, Baseline to Week 24||0
6650077|NCT02409667|7579278|FG000|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||121
6650078|NCT02409667|7579279|FG001|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
6650079|NCT02409667|7579280|FG002|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
6650080|NCT02409667|7579281|FG003|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
6650081|NCT02409667|7579282|FG004|NOT COMPLETED|Treatment Period 1, Baseline to Week 24||0
6650082|NCT02409667|7579278|FG000|STARTED|Treatment Period 2, Week 24 to Week 52)||0
6650083|NCT02409667|7579279|FG001|STARTED|Treatment Period 2, Week 24 to Week 52)||644
6650084|NCT02409667|7579280|FG002|STARTED|Treatment Period 2, Week 24 to Week 52)||662
6650085|NCT02409667|7579281|FG003|STARTED|Treatment Period 2, Week 24 to Week 52)||114
6650086|NCT02409667|7579282|FG004|STARTED|Treatment Period 2, Week 24 to Week 52)||93
6650087|NCT02409667|7579278|FG000|COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
6650088|NCT02409667|7579279|FG001|COMPLETED|Treatment Period 2, Week 24 to Week 52)||621
6650089|NCT02409667|7579280|FG002|COMPLETED|Treatment Period 2, Week 24 to Week 52)||641
6650090|NCT02409667|7579281|FG003|COMPLETED|Treatment Period 2, Week 24 to Week 52)||106
6650091|NCT02409667|7579282|FG004|COMPLETED|Treatment Period 2, Week 24 to Week 52)||90
6650092|NCT02409667|7579278|FG000|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||0
6650093|NCT02409667|7579279|FG001|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||23
6650094|NCT02409667|7579280|FG002|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||21
6650095|NCT02409667|7579281|FG003|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||8
6650096|NCT02409667|7579282|FG004|NOT COMPLETED|Treatment Period 2, Week 24 to Week 52)||3
6650097|NCT02409680|7579295|FG000|STARTED|Overall Study||5990
6650098|NCT02409680|7579296|FG001|STARTED|Overall Study||5986
6650099|NCT02409680|7579295|FG000|Treated|Overall Study||5943
6650100|NCT02409680|7579296|FG001|Treated|Overall Study||5936
6650101|NCT02409680|7579295|FG000|Included in mITT Analysis|Overall Study||5787
6650102|NCT02409680|7579296|FG001|Included in mITT Analysis|Overall Study||5771
6650103|NCT02409680|7579295|FG000|COMPLETED|Overall Study||5975
6650104|NCT02409680|7579296|FG001|COMPLETED|Overall Study||5956
6650105|NCT02409680|7579295|FG000|NOT COMPLETED|Overall Study||15
6650106|NCT02409680|7579296|FG001|NOT COMPLETED|Overall Study||30
6650107|NCT02409719|7579304|FG000|STARTED|Overall Study||31
6650108|NCT02409719|7579305|FG001|STARTED|Overall Study||45
6650109|NCT02409719|7579304|FG000|2 Weeks|Overall Study||28
6650110|NCT02409719|7579305|FG001|2 Weeks|Overall Study||42
6650111|NCT02409719|7579304|FG000|4 Weeks|Overall Study||28
6650112|NCT02409719|7579305|FG001|4 Weeks|Overall Study||42
6650113|NCT02409719|7579304|FG000|6 Weeks|Overall Study||28
6650114|NCT02409719|7579305|FG001|6 Weeks|Overall Study||42
6650115|NCT02409719|7579304|FG000|3 Months|Overall Study||28
6650116|NCT02409719|7579305|FG001|3 Months|Overall Study||42
6650117|NCT02409719|7579304|FG000|6 Months|Overall Study||28
6650118|NCT02409719|7579305|FG001|6 Months|Overall Study||42
6650119|NCT02409719|7579304|FG000|12 Months|Overall Study||28
6650120|NCT02409719|7579305|FG001|12 Months|Overall Study||42
6650121|NCT02409719|7579304|FG000|COMPLETED|Overall Study||28
6650122|NCT02409719|7579305|FG001|COMPLETED|Overall Study||42
6650123|NCT02409719|7579304|FG000|NOT COMPLETED|Overall Study||3
6650124|NCT02409719|7579305|FG001|NOT COMPLETED|Overall Study||3
6650125|NCT02409732|7579311|FG000|STARTED|Overall Study|First patient consented on 4/23/15|20
6650126|NCT02409732|7579311|FG000|COMPLETED|Overall Study||14
6650127|NCT02409732|7579311|FG000|NOT COMPLETED|Overall Study||6
6650128|NCT02409784|7579316|FG000|STARTED|Overall Study||10
6650129|NCT02409784|7579316|FG000|COMPLETED|Overall Study||10
6650130|NCT02409784|7579316|FG000|NOT COMPLETED|Overall Study||0
6650131|NCT02409914|7579321|FG000|STARTED|Overall Study||7
6650132|NCT02409914|7579321|FG000|COMPLETED|Overall Study||7
6650133|NCT02409914|7579321|FG000|NOT COMPLETED|Overall Study||0
6650134|NCT02409927|7579325|FG000|STARTED|Overall Study||10
6650135|NCT02409927|7579325|FG000|COMPLETED|Overall Study||10
6650136|NCT02409927|7579325|FG000|NOT COMPLETED|Overall Study||0
6650137|NCT02410018|7579331|FG000|STARTED|Overall Study||2
6650138|NCT02410018|7579332|FG001|STARTED|Overall Study||1
6650139|NCT02410018|7579331|FG000|COMPLETED|Overall Study||2
6650140|NCT02410018|7579332|FG001|COMPLETED|Overall Study||1
6650141|NCT02410018|7579331|FG000|NOT COMPLETED|Overall Study||0
6650142|NCT02410018|7579332|FG001|NOT COMPLETED|Overall Study||0
6650143|NCT02410161|7579340|FG000|STARTED|Overall Study||10
6650144|NCT02410161|7579341|FG001|STARTED|Overall Study||10
6650145|NCT02410161|7579340|FG000|COMPLETED|Overall Study||10
6650146|NCT02410161|7579341|FG001|COMPLETED|Overall Study||10
6650147|NCT02410161|7579340|FG000|NOT COMPLETED|Overall Study||0
6650148|NCT02410161|7579341|FG001|NOT COMPLETED|Overall Study||0
6650149|NCT02410200|7579347|FG000|STARTED|Overall Study||22
6650150|NCT02410200|7579347|FG000|COMPLETED|Overall Study||20
6650151|NCT02410200|7579347|FG000|NOT COMPLETED|Overall Study||2
6650152|NCT02410213|7579351|FG000|STARTED|Overall Study||16
6650153|NCT02410213|7579352|FG001|STARTED|Overall Study||19
6650154|NCT02410213|7579351|FG000|COMPLETED|Overall Study||16
6650155|NCT02410213|7579352|FG001|COMPLETED|Overall Study||19
6650156|NCT02410213|7579351|FG000|NOT COMPLETED|Overall Study||0
6650157|NCT02410213|7579352|FG001|NOT COMPLETED|Overall Study||0
6650158|NCT02410252|7579358|FG000|STARTED|Overall Study||25
6650159|NCT02410252|7579358|FG000|COMPLETED|Overall Study||19
6650160|NCT02410252|7579358|FG000|NOT COMPLETED|Overall Study||6
6650161|NCT02410278|7579366|FG000|STARTED|Run-in Period||102
6650162|NCT02410278|7579367|FG001|STARTED|Run-in Period||0
6650163|NCT02410278|7579368|FG002|STARTED|Run-in Period||0
6650164|NCT02410278|7579366|FG000|Received at Least 1 Dose of DMF|Run-in Period||98
6650165|NCT02410278|7579367|FG001|Received at Least 1 Dose of DMF|Run-in Period||0
6650166|NCT02410278|7579368|FG002|Received at Least 1 Dose of DMF|Run-in Period||0
6650167|NCT02410278|7579366|FG000|COMPLETED|Run-in Period||64
6650168|NCT02410278|7579367|FG001|COMPLETED|Run-in Period||0
6650169|NCT02410278|7579368|FG002|COMPLETED|Run-in Period||0
6650170|NCT02410278|7579366|FG000|NOT COMPLETED|Run-in Period||38
6650171|NCT02410278|7579367|FG001|NOT COMPLETED|Run-in Period||0
6650172|NCT02410278|7579368|FG002|NOT COMPLETED|Run-in Period||0
6650173|NCT02410278|7579366|FG000|STARTED|Study Treatment Period||0
6650174|NCT02410278|7579367|FG001|STARTED|Study Treatment Period||31
6650175|NCT02410278|7579368|FG002|STARTED|Study Treatment Period||33
6650176|NCT02410278|7579366|FG000|Modified Intent-to Treat(mITT)Population|Study Treatment Period||0
6650177|NCT02410278|7579367|FG001|Modified Intent-to Treat(mITT)Population|Study Treatment Period||30
6650178|NCT02410278|7579368|FG002|Modified Intent-to Treat(mITT)Population|Study Treatment Period||33
6650179|NCT02410278|7579366|FG000|Completed Randomized Study Treatment|Study Treatment Period||0
6650180|NCT02410278|7579367|FG001|Completed Randomized Study Treatment|Study Treatment Period||20
6305145|NCT00369486|7208433|FG004|COMPLETED|34-Week Visit|Number of eyes|22
6650181|NCT02410278|7579368|FG002|Completed Randomized Study Treatment|Study Treatment Period||29
6650182|NCT02410278|7579366|FG000|COMPLETED|Study Treatment Period||0
6650183|NCT02410278|7579367|FG001|COMPLETED|Study Treatment Period||20
6650184|NCT02410278|7579368|FG002|COMPLETED|Study Treatment Period||29
6650185|NCT02410278|7579366|FG000|NOT COMPLETED|Study Treatment Period||0
6650186|NCT02410278|7579367|FG001|NOT COMPLETED|Study Treatment Period||11
6650187|NCT02410278|7579368|FG002|NOT COMPLETED|Study Treatment Period||4
6650188|NCT02410291|7579377|FG000|STARTED|Overall Study||29
6650189|NCT02410291|7579378|FG001|STARTED|Overall Study||29
6650190|NCT02410291|7579377|FG000|COMPLETED|Overall Study||29
6650191|NCT02410291|7579378|FG001|COMPLETED|Overall Study||29
6650192|NCT02410291|7579377|FG000|NOT COMPLETED|Overall Study||0
6650193|NCT02410291|7579378|FG001|NOT COMPLETED|Overall Study||0
6650194|NCT02410382|7579386|FG000|STARTED|Overall Study||0
6650195|NCT02410382|7579387|FG001|STARTED|Overall Study||0
6650196|NCT02410382|7579386|FG000|COMPLETED|Overall Study|Study was terminated by IRB - attempts made to obtain info were unsuccessful.|0
6650197|NCT02410382|7579387|FG001|COMPLETED|Overall Study||0
6650198|NCT02410382|7579386|FG000|NOT COMPLETED|Overall Study||0
6650199|NCT02410382|7579387|FG001|NOT COMPLETED|Overall Study||0
6650200|NCT02410629|7579395|FG000|STARTED|Overall Study||8
6650201|NCT02410629|7579396|FG001|STARTED|Overall Study||9
6650202|NCT02410629|7579395|FG000|COMPLETED|Overall Study|5 subjects from the music glove group were crossed over to conventional hand exercise group.|5
6650203|NCT02410629|7579396|FG001|COMPLETED|Overall Study|6 subjects from the conventional hand exercise group were crossed over to music glove group.|6
6650204|NCT02410629|7579395|FG000|NOT COMPLETED|Overall Study||3
6650205|NCT02410629|7579396|FG001|NOT COMPLETED|Overall Study||3
6650206|NCT02410707|7579402|FG000|STARTED|Overall Study||43
6650207|NCT02410707|7579402|FG000|COMPLETED|Overall Study||43
6650208|NCT02410707|7579402|FG000|NOT COMPLETED|Overall Study||0
6650209|NCT02410772|7579411|FG000|STARTED|Overall Study||829
6650210|NCT02410772|7579412|FG001|STARTED|Overall Study||838
6650211|NCT02410772|7579413|FG002|STARTED|Overall Study||849
6650212|NCT02410772|7579411|FG000|Microbiologically Eligible Analysis Population|Overall Study||768
6650213|NCT02410772|7579412|FG001|Microbiologically Eligible Analysis Population|Overall Study||784
6650214|NCT02410772|7579413|FG002|Microbiologically Eligible Analysis Population|Overall Study||791
6650215|NCT02410772|7579411|FG000|Assessable Population|Overall Study||726
6650216|NCT02410772|7579412|FG001|Assessable Population|Overall Study||752
6650217|NCT02410772|7579413|FG002|Assessable Population|Overall Study||756
6650218|NCT02410772|7579411|FG000|COMPLETED|Overall Study||726
6650219|NCT02410772|7579412|FG001|COMPLETED|Overall Study||752
6650220|NCT02410772|7579413|FG002|COMPLETED|Overall Study||756
6650221|NCT02410772|7579411|FG000|NOT COMPLETED|Overall Study||103
6650222|NCT02410772|7579412|FG001|NOT COMPLETED|Overall Study||86
6650223|NCT02410772|7579413|FG002|NOT COMPLETED|Overall Study||93
6650224|NCT02410798|7579421|FG000|STARTED|Overall Study||12
6650225|NCT02410798|7579421|FG000|COMPLETED|Overall Study||12
6650226|NCT02410798|7579421|FG000|NOT COMPLETED|Overall Study||0
6650227|NCT02410811|7579430|FG000|STARTED|Overall Study||5
6650228|NCT02410811|7579431|FG001|STARTED|Overall Study||10
6650229|NCT02410811|7579432|FG002|STARTED|Overall Study||11
6650230|NCT02410811|7579433|FG003|STARTED|Overall Study||7
6650231|NCT02410811|7579430|FG000|COMPLETED|Overall Study||5
6650232|NCT02410811|7579431|FG001|COMPLETED|Overall Study||10
6650233|NCT02410811|7579432|FG002|COMPLETED|Overall Study||10
6650234|NCT02410811|7579433|FG003|COMPLETED|Overall Study||7
6650235|NCT02410811|7579430|FG000|NOT COMPLETED|Overall Study||0
6650236|NCT02410811|7579431|FG001|NOT COMPLETED|Overall Study||0
6650237|NCT02410811|7579432|FG002|NOT COMPLETED|Overall Study||1
6650238|NCT02410811|7579433|FG003|NOT COMPLETED|Overall Study||0
6650239|NCT02410824|7579443|FG000|STARTED|First Intervention (One Week)||22
6650240|NCT02410824|7579444|FG001|STARTED|First Intervention (One Week)||23
6650241|NCT02410824|7579443|FG000|COMPLETED|First Intervention (One Week)||22
6650242|NCT02410824|7579444|FG001|COMPLETED|First Intervention (One Week)||22
6650243|NCT02410824|7579443|FG000|NOT COMPLETED|First Intervention (One Week)||0
6650244|NCT02410824|7579444|FG001|NOT COMPLETED|First Intervention (One Week)||1
6650245|NCT02410824|7579443|FG000|STARTED|Second Intervention (One Week)||22
6650246|NCT02410824|7579444|FG001|STARTED|Second Intervention (One Week)||22
6650247|NCT02410824|7579443|FG000|COMPLETED|Second Intervention (One Week)||22
6650248|NCT02410824|7579444|FG001|COMPLETED|Second Intervention (One Week)||22
6650249|NCT02410824|7579443|FG000|NOT COMPLETED|Second Intervention (One Week)||0
6650250|NCT02410824|7579444|FG001|NOT COMPLETED|Second Intervention (One Week)||0
6650251|NCT02410837|7579451|FG000|STARTED|Overall Study||1388
6650252|NCT02410837|7579451|FG000|Procedure|Overall Study||1388
6650253|NCT02410837|7579451|FG000|1-Month|Overall Study||1374
6650254|NCT02410837|7579451|FG000|12-Month|Overall Study||1121
6650255|NCT02410837|7579451|FG000|24-Month|Overall Study||900
6650256|NCT02410837|7579451|FG000|COMPLETED|Overall Study||900
6650257|NCT02410837|7579451|FG000|NOT COMPLETED|Overall Study||488
6650258|NCT02410967|7579457|FG000|STARTED|Treatment Phase (4 Weeks)||27
6650259|NCT02410967|7579458|FG001|STARTED|Treatment Phase (4 Weeks)||26
6650260|NCT02410967|7579457|FG000|COMPLETED|Treatment Phase (4 Weeks)||26
6650261|NCT02410967|7579458|FG001|COMPLETED|Treatment Phase (4 Weeks)||22
6650262|NCT02410967|7579457|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||1
6650263|NCT02410967|7579458|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||4
6650264|NCT02410967|7579457|FG000|STARTED|Follow-up Phase (8 Weeks)||26
6650265|NCT02410967|7579458|FG001|STARTED|Follow-up Phase (8 Weeks)||22
6650266|NCT02410967|7579457|FG000|COMPLETED|Follow-up Phase (8 Weeks)||22
6650267|NCT02410967|7579458|FG001|COMPLETED|Follow-up Phase (8 Weeks)||16
6650268|NCT02410967|7579457|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||4
6650269|NCT02410967|7579458|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||6
6650270|NCT02411084|7579466|FG000|STARTED|Overall Study||18
6650271|NCT02411084|7579467|FG001|STARTED|Overall Study||18
6650272|NCT02411084|7579466|FG000|COMPLETED|Overall Study||5
6650273|NCT02411084|7579467|FG001|COMPLETED|Overall Study||5
6650274|NCT02411084|7579466|FG000|NOT COMPLETED|Overall Study||13
6650275|NCT02411084|7579467|FG001|NOT COMPLETED|Overall Study||13
6650276|NCT02411110|7579475|FG000|STARTED|Treatment Period 1||65
6650277|NCT02411110|7579476|FG001|STARTED|Treatment Period 1||66
6650278|NCT02411110|7579475|FG000|COMPLETED|Treatment Period 1||56
6650279|NCT02411110|7579476|FG001|COMPLETED|Treatment Period 1||59
6650280|NCT02411110|7579475|FG000|NOT COMPLETED|Treatment Period 1||9
6650281|NCT02411110|7579476|FG001|NOT COMPLETED|Treatment Period 1||7
6650282|NCT02411110|7579475|FG000|STARTED|Treatment Period 2|Period 2 was optional.|50
6650283|NCT02411110|7579476|FG001|STARTED|Treatment Period 2|Period 2 was optional.|48
6650284|NCT02411110|7579475|FG000|COMPLETED|Treatment Period 2||49
6650285|NCT02411110|7579476|FG001|COMPLETED|Treatment Period 2||44
6650286|NCT02411110|7579475|FG000|NOT COMPLETED|Treatment Period 2||1
6650287|NCT02411110|7579476|FG001|NOT COMPLETED|Treatment Period 2||4
6650288|NCT02411201|7579484|FG000|STARTED|Overall Study||51
6650289|NCT02411201|7579484|FG000|COMPLETED|Overall Study||45
6650290|NCT02411201|7579484|FG000|NOT COMPLETED|Overall Study||6
6650291|NCT02411292|7579490|FG000|STARTED|Overall Study||110
6650292|NCT02411292|7579490|FG000|COMPLETED|Overall Study||89
6650293|NCT02411292|7579490|FG000|NOT COMPLETED|Overall Study||21
6650294|NCT02411396|7579496|FG000|STARTED|Overall Study||483
6650295|NCT02411396|7579496|FG000|COMPLETED|Overall Study||442
6650296|NCT02411396|7579496|FG000|NOT COMPLETED|Overall Study||41
6650297|NCT02411448|7579508|FG000|STARTED|Overall Study||14
6650298|NCT02411448|7579509|FG001|STARTED|Overall Study||224
6650299|NCT02411448|7579510|FG002|STARTED|Overall Study||225
6650300|NCT02411448|7579508|FG000|Received at Least One Dose of Study Drug|Overall Study||14
6650301|NCT02411448|7579509|FG001|Received at Least One Dose of Study Drug|Overall Study||221
6650302|NCT02411448|7579510|FG002|Received at Least One Dose of Study Drug|Overall Study||225
6650303|NCT02411448|7579508|FG000|COMPLETED|Overall Study||10
6650304|NCT02411448|7579509|FG001|COMPLETED|Overall Study||141
6650305|NCT02411448|7579510|FG002|COMPLETED|Overall Study||173
6650306|NCT02411448|7579508|FG000|NOT COMPLETED|Overall Study||4
6650307|NCT02411448|7579509|FG001|NOT COMPLETED|Overall Study||83
6650308|NCT02411448|7579510|FG002|NOT COMPLETED|Overall Study||52
6650309|NCT02411461|7579525|FG000|STARTED|Overall Study||16
6650310|NCT02411461|7579526|FG001|STARTED|Overall Study||8
6650311|NCT02411461|7579527|FG002|STARTED|Overall Study||15
6650312|NCT02411461|7579525|FG000|COMPLETED|Overall Study||16
6650313|NCT02411461|7579526|FG001|COMPLETED|Overall Study||8
6650314|NCT02411461|7579527|FG002|COMPLETED|Overall Study||15
6650315|NCT02411461|7579525|FG000|NOT COMPLETED|Overall Study||0
6650316|NCT02411461|7579526|FG001|NOT COMPLETED|Overall Study||0
6650317|NCT02411461|7579527|FG002|NOT COMPLETED|Overall Study||0
6650318|NCT02411539|7579537|FG000|STARTED|Overall Study||20
6650319|NCT02411539|7579538|FG001|STARTED|Overall Study||20
6650320|NCT02411539|7579537|FG000|COMPLETED|Overall Study||18
6650321|NCT02411539|7579538|FG001|COMPLETED|Overall Study||19
6650322|NCT02411539|7579537|FG000|NOT COMPLETED|Overall Study||2
6650323|NCT02411539|7579538|FG001|NOT COMPLETED|Overall Study||1
6650324|NCT02411565|7579549|FG000|STARTED|Overall Study||1
6650325|NCT02411565|7579550|FG001|STARTED|Overall Study||2
6650326|NCT02411565|7579549|FG000|COMPLETED|Overall Study||1
6650327|NCT02411565|7579550|FG001|COMPLETED|Overall Study||2
6650328|NCT02411565|7579549|FG000|NOT COMPLETED|Overall Study||0
6650329|NCT02411565|7579550|FG001|NOT COMPLETED|Overall Study||0
6650330|NCT02411578|7579558|FG000|STARTED|Crossover Trial Phase||8
6650331|NCT02411578|7579559|FG001|STARTED|Crossover Trial Phase||12
6650332|NCT02411578|7579558|FG000|COMPLETED|Crossover Trial Phase||8
6650333|NCT02411578|7579559|FG001|COMPLETED|Crossover Trial Phase||11
6650334|NCT02411578|7579558|FG000|NOT COMPLETED|Crossover Trial Phase||0
6650335|NCT02411578|7579559|FG001|NOT COMPLETED|Crossover Trial Phase||1
6650336|NCT02411578|7579558|FG000|STARTED|Extension Phase||8
6650337|NCT02411578|7579559|FG001|STARTED|Extension Phase|2 Crossover Trial participants could not continue due to study syringes expiration|9
6650338|NCT02411578|7579558|FG000|COMPLETED|Extension Phase||8
6650339|NCT02411578|7579559|FG001|COMPLETED|Extension Phase||9
6650340|NCT02411578|7579558|FG000|NOT COMPLETED|Extension Phase||0
6650341|NCT02411578|7579559|FG001|NOT COMPLETED|Extension Phase||0
6650342|NCT02411591|7579570|FG000|STARTED|Overall Study||3
6650343|NCT02411591|7579571|FG001|STARTED|Overall Study||57
6650344|NCT02411591|7579572|FG002|STARTED|Overall Study||6
6650345|NCT02411591|7579570|FG000|Part A|Overall Study||3
6650346|NCT02411591|7579571|FG001|Part A|Overall Study||6
6650347|NCT02411591|7579572|FG002|Part A|Overall Study||6
6650348|NCT02411591|7579570|FG000|Expansion Cohort Part B|Overall Study||0
6650349|NCT02411591|7579571|FG001|Expansion Cohort Part B|Overall Study||51
6650350|NCT02411591|7579572|FG002|Expansion Cohort Part B|Overall Study||0
6650351|NCT02411591|7579570|FG000|Progressive Disease|Overall Study||3
6650352|NCT02411591|7579571|FG001|Progressive Disease|Overall Study||42
6650353|NCT02411591|7579572|FG002|Progressive Disease|Overall Study||3
6650354|NCT02411591|7579570|FG000|Death|Overall Study||0
6650355|NCT02411591|7579571|FG001|Death|Overall Study||2
6650356|NCT02411591|7579572|FG002|Death|Overall Study||0
6650357|NCT02411591|7579570|FG000|COMPLETED|Overall Study||3
6650358|NCT02411591|7579571|FG001|COMPLETED|Overall Study||47
6650359|NCT02411591|7579572|FG002|COMPLETED|Overall Study||3
6650360|NCT02411591|7579570|FG000|NOT COMPLETED|Overall Study||0
6650361|NCT02411591|7579571|FG001|NOT COMPLETED|Overall Study||10
6650362|NCT02411591|7579572|FG002|NOT COMPLETED|Overall Study||3
6650363|NCT02411747|7579590|FG000|STARTED|Overall Study||16
6650364|NCT02411747|7579591|FG001|STARTED|Overall Study||16
6650365|NCT02411747|7579590|FG000|Simulation Training Completed|Overall Study||16
6650366|NCT02411747|7579591|FG001|Simulation Training Completed|Overall Study||16
6650367|NCT02411747|7579590|FG000|COMPLETED|Overall Study||13
6650368|NCT02411747|7579591|FG001|COMPLETED|Overall Study||12
6650369|NCT02411747|7579590|FG000|NOT COMPLETED|Overall Study||3
6650370|NCT02411747|7579591|FG001|NOT COMPLETED|Overall Study||4
6650371|NCT02411916|7579599|FG000|STARTED|Overall Study||73
6650372|NCT02411916|7579600|FG001|STARTED|Overall Study||70
6650373|NCT02411916|7579599|FG000|COMPLETED|Overall Study||73
6650374|NCT02411916|7579600|FG001|COMPLETED|Overall Study||70
6650375|NCT02411916|7579599|FG000|NOT COMPLETED|Overall Study||0
6650376|NCT02411916|7579600|FG001|NOT COMPLETED|Overall Study||0
6650377|NCT02411929|7579606|FG000|STARTED|Period 1||8
6650378|NCT02411929|7579606|FG000|COMPLETED|Period 1||8
6650379|NCT02411929|7579606|FG000|NOT COMPLETED|Period 1||0
6650380|NCT02411929|7579606|FG000|STARTED|Washout Period||8
6650381|NCT02411929|7579606|FG000|COMPLETED|Washout Period||8
6650382|NCT02411929|7579606|FG000|NOT COMPLETED|Washout Period||0
6650383|NCT02411929|7579606|FG000|STARTED|Period 2||8
6650384|NCT02411929|7579606|FG000|COMPLETED|Period 2||8
6650385|NCT02411929|7579606|FG000|NOT COMPLETED|Period 2||0
6650386|NCT02412098|7579618|FG000|STARTED|Overall Study||14
6650387|NCT02412098|7579619|FG001|STARTED|Overall Study||14
6650388|NCT02412098|7579620|FG002|STARTED|Overall Study||21
6650389|NCT02412098|7579618|FG000|COMPLETED|Overall Study||14
6650390|NCT02412098|7579619|FG001|COMPLETED|Overall Study||14
6650391|NCT02412098|7579620|FG002|COMPLETED|Overall Study||21
6650392|NCT02412098|7579618|FG000|NOT COMPLETED|Overall Study||0
6650393|NCT02412098|7579619|FG001|NOT COMPLETED|Overall Study||0
6650394|NCT02412098|7579620|FG002|NOT COMPLETED|Overall Study||0
6650395|NCT02412111|7579634|FG000|STARTED|Ivacaftor Run-in Period (4 Weeks)||156
6650396|NCT02412111|7579635|FG001|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
6650397|NCT02412111|7579636|FG002|STARTED|Ivacaftor Run-in Period (4 Weeks)||0
6650398|NCT02412111|7579634|FG000|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||153
6650399|NCT02412111|7579635|FG001|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
6650400|NCT02412111|7579636|FG002|COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
6650401|NCT02412111|7579634|FG000|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||3
6650402|NCT02412111|7579635|FG001|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
6650403|NCT02412111|7579636|FG002|NOT COMPLETED|Ivacaftor Run-in Period (4 Weeks)||0
6650404|NCT02412111|7579634|FG000|STARTED|Active Comparator Period (8 Weeks)||0
6650405|NCT02412111|7579635|FG001|STARTED|Active Comparator Period (8 Weeks)||76
6650406|NCT02412111|7579636|FG002|STARTED|Active Comparator Period (8 Weeks)||75
6650407|NCT02412111|7579634|FG000|Full Analysis Set|Active Comparator Period (8 Weeks)||0
6650408|NCT02412111|7579635|FG001|Full Analysis Set|Active Comparator Period (8 Weeks)||76
6650409|NCT02412111|7579636|FG002|Full Analysis Set|Active Comparator Period (8 Weeks)||74
6650410|NCT02412111|7579634|FG000|COMPLETED|Active Comparator Period (8 Weeks)||0
6650411|NCT02412111|7579635|FG001|COMPLETED|Active Comparator Period (8 Weeks)||75
6650412|NCT02412111|7579636|FG002|COMPLETED|Active Comparator Period (8 Weeks)||69
6650413|NCT02412111|7579634|FG000|NOT COMPLETED|Active Comparator Period (8 Weeks)||0
6650414|NCT02412111|7579635|FG001|NOT COMPLETED|Active Comparator Period (8 Weeks)||1
6650415|NCT02412111|7579636|FG002|NOT COMPLETED|Active Comparator Period (8 Weeks)||6
6650416|NCT02412228|7579646|FG000|STARTED|Overall Study||12
6650417|NCT02412228|7579646|FG000|COMPLETED|Overall Study||12
6650418|NCT02412228|7579646|FG000|NOT COMPLETED|Overall Study||0
6650419|NCT02412306|7579655|FG000|STARTED|Overall Study||5
6650420|NCT02412306|7579656|FG001|STARTED|Overall Study||9
6650421|NCT02412306|7579657|FG002|STARTED|Overall Study||21
6650422|NCT02412306|7579658|FG003|STARTED|Overall Study||14
6650423|NCT02412306|7579659|FG004|STARTED|Overall Study||17
6650424|NCT02412306|7579655|FG000|COMPLETED|Overall Study||0
6650425|NCT02412306|7579656|FG001|COMPLETED|Overall Study||1
6650426|NCT02412306|7579657|FG002|COMPLETED|Overall Study||5
6650427|NCT02412306|7579658|FG003|COMPLETED|Overall Study||14
6650428|NCT02412306|7579659|FG004|COMPLETED|Overall Study||15
6650429|NCT02412306|7579655|FG000|NOT COMPLETED|Overall Study||5
6650430|NCT02412306|7579656|FG001|NOT COMPLETED|Overall Study||8
6650431|NCT02412306|7579657|FG002|NOT COMPLETED|Overall Study||16
6650432|NCT02412306|7579658|FG003|NOT COMPLETED|Overall Study||0
6650433|NCT02412306|7579659|FG004|NOT COMPLETED|Overall Study||2
6650434|NCT02412371|7579686|FG000|STARTED|Overall Study||7
6650435|NCT02412371|7579687|FG001|STARTED|Overall Study||9
6650436|NCT02412371|7579688|FG002|STARTED|Overall Study||7
6650437|NCT02412371|7579689|FG003|STARTED|Overall Study||8
6650438|NCT02412371|7579690|FG004|STARTED|Overall Study||12
6650439|NCT02412371|7579691|FG005|STARTED|Overall Study||5
6650440|NCT02412371|7579686|FG000|COMPLETED|Overall Study||0
6650441|NCT02412371|7579687|FG001|COMPLETED|Overall Study||0
6650442|NCT02412371|7579688|FG002|COMPLETED|Overall Study||0
6650443|NCT02412371|7579689|FG003|COMPLETED|Overall Study||0
6650444|NCT02412371|7579690|FG004|COMPLETED|Overall Study||0
6650445|NCT02412371|7579691|FG005|COMPLETED|Overall Study||0
6650446|NCT02412371|7579686|FG000|NOT COMPLETED|Overall Study||7
6650447|NCT02412371|7579687|FG001|NOT COMPLETED|Overall Study||9
6650448|NCT02412371|7579688|FG002|NOT COMPLETED|Overall Study||7
6650449|NCT02412371|7579689|FG003|NOT COMPLETED|Overall Study||8
6650450|NCT02412371|7579690|FG004|NOT COMPLETED|Overall Study||12
6650451|NCT02412371|7579691|FG005|NOT COMPLETED|Overall Study||5
6650452|NCT02412436|7579706|FG000|STARTED|Overall Study||62
6650453|NCT02412436|7579706|FG000|COMPLETED|Overall Study||44
6650454|NCT02412436|7579706|FG000|NOT COMPLETED|Overall Study||18
6650455|NCT02412488|7579710|FG000|STARTED|Overall Study||192
6650456|NCT02412488|7579710|FG000|Reveal LINQ Implanted|Overall Study||191
6650457|NCT02412488|7579710|FG000|COMPLETED|Overall Study||174
6650458|NCT02412488|7579710|FG000|NOT COMPLETED|Overall Study||18
6650459|NCT02412501|7579714|FG000|STARTED|Overall Study||101
6650460|NCT02412501|7579714|FG000|COMPLETED|Overall Study||101
6650461|NCT02412501|7579714|FG000|NOT COMPLETED|Overall Study||0
6650462|NCT02412631|7579721|FG000|STARTED|Overall Study||44
6650463|NCT02412631|7579722|FG001|STARTED|Overall Study||40
6650464|NCT02412631|7579721|FG000|COMPLETED|Overall Study||18
6650465|NCT02412631|7579722|FG001|COMPLETED|Overall Study||16
6650466|NCT02412631|7579721|FG000|NOT COMPLETED|Overall Study||26
6650467|NCT02412631|7579722|FG001|NOT COMPLETED|Overall Study||24
6650468|NCT02412644|7579730|FG000|STARTED|Overall Study||21
6650469|NCT02412644|7579731|FG001|STARTED|Overall Study||8
6650470|NCT02412644|7579730|FG000|COMPLETED|Overall Study||6
6650471|NCT02412644|7579731|FG001|COMPLETED|Overall Study||4
6650472|NCT02412644|7579730|FG000|NOT COMPLETED|Overall Study||15
6650473|NCT02412644|7579731|FG001|NOT COMPLETED|Overall Study||4
6650474|NCT02412657|7579744|FG000|STARTED|Overall Study||25
6650475|NCT02412657|7579745|FG001|STARTED|Overall Study||25
6650476|NCT02412657|7579746|FG002|STARTED|Overall Study||25
6650477|NCT02412657|7579744|FG000|COMPLETED|Overall Study||24
6650478|NCT02412657|7579745|FG001|COMPLETED|Overall Study||23
6650479|NCT02412657|7579746|FG002|COMPLETED|Overall Study||22
6650480|NCT02412657|7579744|FG000|NOT COMPLETED|Overall Study||1
6650481|NCT02412657|7579745|FG001|NOT COMPLETED|Overall Study||2
6650482|NCT02412657|7579746|FG002|NOT COMPLETED|Overall Study||3
6650483|NCT02412722|7579760|FG000|STARTED|Overall Study||11
6650484|NCT02412722|7579761|FG001|STARTED|Overall Study||8
6650485|NCT02412722|7579762|FG002|STARTED|Overall Study||7
6650486|NCT02412722|7579763|FG003|STARTED|Overall Study||15
6650487|NCT02412722|7579764|FG004|STARTED|Overall Study||7
6650488|NCT02412722|7579765|FG005|STARTED|Overall Study||13
6650489|NCT02412722|7579760|FG000|Safety Population|Overall Study||11
6650490|NCT02412722|7579761|FG001|Safety Population|Overall Study||6
6650491|NCT02412722|7579762|FG002|Safety Population|Overall Study||7
6650492|NCT02412722|7579763|FG003|Safety Population|Overall Study||15
6650493|NCT02412722|7579764|FG004|Safety Population|Overall Study||7
6650494|NCT02412722|7579765|FG005|Safety Population|Overall Study||13
6650495|NCT02412722|7579760|FG000|COMPLETED|Overall Study||0
6650496|NCT02412722|7579761|FG001|COMPLETED|Overall Study||0
6650497|NCT02412722|7579762|FG002|COMPLETED|Overall Study||0
6650498|NCT02412722|7579763|FG003|COMPLETED|Overall Study||0
6650499|NCT02412722|7579764|FG004|COMPLETED|Overall Study||0
6650500|NCT02412722|7579765|FG005|COMPLETED|Overall Study||0
6650501|NCT02412722|7579760|FG000|NOT COMPLETED|Overall Study||11
6650502|NCT02412722|7579761|FG001|NOT COMPLETED|Overall Study||8
6650503|NCT02412722|7579762|FG002|NOT COMPLETED|Overall Study||7
6650504|NCT02412722|7579763|FG003|NOT COMPLETED|Overall Study||15
6650505|NCT02412722|7579764|FG004|NOT COMPLETED|Overall Study||7
6650506|NCT02412722|7579765|FG005|NOT COMPLETED|Overall Study||13
6650507|NCT02412761|7579799|FG000|STARTED|First Intervention (2 Weeks)||5
6650508|NCT02412761|7579800|FG001|STARTED|First Intervention (2 Weeks)||6
6650509|NCT02412761|7579801|FG002|STARTED|First Intervention (2 Weeks)||5
6650510|NCT02412761|7579802|FG003|STARTED|First Intervention (2 Weeks)||8
6650511|NCT02412761|7579803|FG004|STARTED|First Intervention (2 Weeks)||4
6650512|NCT02412761|7579804|FG005|STARTED|First Intervention (2 Weeks)||7
6650513|NCT02412761|7579799|FG000|COMPLETED|First Intervention (2 Weeks)||5
6650514|NCT02412761|7579800|FG001|COMPLETED|First Intervention (2 Weeks)||5
6650515|NCT02412761|7579801|FG002|COMPLETED|First Intervention (2 Weeks)||4
6650516|NCT02412761|7579802|FG003|COMPLETED|First Intervention (2 Weeks)||8
6650517|NCT02412761|7579803|FG004|COMPLETED|First Intervention (2 Weeks)||4
6650518|NCT02412761|7579804|FG005|COMPLETED|First Intervention (2 Weeks)||6
6650519|NCT02412761|7579799|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6650520|NCT02412761|7579800|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
6650521|NCT02412761|7579801|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
6650522|NCT02412761|7579802|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
6650523|NCT02412761|7579803|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
6650524|NCT02412761|7579804|FG005|NOT COMPLETED|First Intervention (2 Weeks)||1
6650525|NCT02412761|7579799|FG000|STARTED|Second Intervention (2 Weeks)||5
6650526|NCT02412761|7579800|FG001|STARTED|Second Intervention (2 Weeks)||5
6650527|NCT02412761|7579801|FG002|STARTED|Second Intervention (2 Weeks)||4
6650528|NCT02412761|7579802|FG003|STARTED|Second Intervention (2 Weeks)||8
6650529|NCT02412761|7579803|FG004|STARTED|Second Intervention (2 Weeks)||4
6650530|NCT02412761|7579804|FG005|STARTED|Second Intervention (2 Weeks)||6
6650531|NCT02412761|7579799|FG000|COMPLETED|Second Intervention (2 Weeks)||5
6650532|NCT02412761|7579800|FG001|COMPLETED|Second Intervention (2 Weeks)||5
6650533|NCT02412761|7579801|FG002|COMPLETED|Second Intervention (2 Weeks)||4
6650534|NCT02412761|7579802|FG003|COMPLETED|Second Intervention (2 Weeks)||8
6650535|NCT02412761|7579803|FG004|COMPLETED|Second Intervention (2 Weeks)||4
6650536|NCT02412761|7579804|FG005|COMPLETED|Second Intervention (2 Weeks)||6
6650537|NCT02412761|7579799|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6650538|NCT02412761|7579800|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6650539|NCT02412761|7579801|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
6650540|NCT02412761|7579802|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
6650541|NCT02412761|7579803|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
6650542|NCT02412761|7579804|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||0
6650543|NCT02412761|7579799|FG000|STARTED|Third Intervention (2 Weeks)||5
6650544|NCT02412761|7579800|FG001|STARTED|Third Intervention (2 Weeks)||5
6650545|NCT02412761|7579801|FG002|STARTED|Third Intervention (2 Weeks)||4
6650546|NCT02412761|7579802|FG003|STARTED|Third Intervention (2 Weeks)||8
6650547|NCT02412761|7579803|FG004|STARTED|Third Intervention (2 Weeks)||4
6650548|NCT02412761|7579804|FG005|STARTED|Third Intervention (2 Weeks)||6
6650549|NCT02412761|7579799|FG000|COMPLETED|Third Intervention (2 Weeks)||5
6650550|NCT02412761|7579800|FG001|COMPLETED|Third Intervention (2 Weeks)||5
6650551|NCT02412761|7579801|FG002|COMPLETED|Third Intervention (2 Weeks)||4
6650552|NCT02412761|7579802|FG003|COMPLETED|Third Intervention (2 Weeks)||8
6650553|NCT02412761|7579803|FG004|COMPLETED|Third Intervention (2 Weeks)||4
6650554|NCT02412761|7579804|FG005|COMPLETED|Third Intervention (2 Weeks)||6
6650555|NCT02412761|7579799|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
6650556|NCT02412761|7579800|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
6650557|NCT02412761|7579801|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
6650558|NCT02412761|7579802|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
6650559|NCT02412761|7579803|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
6650560|NCT02412761|7579804|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
6650561|NCT02412852|7579816|FG000|STARTED|Overall Study||4
6650562|NCT02412852|7579817|FG001|STARTED|Overall Study||8
6650563|NCT02412852|7579818|FG002|STARTED|Overall Study||5
6650564|NCT02412852|7579819|FG003|STARTED|Overall Study||9
6650565|NCT02412852|7579816|FG000|COMPLETED|Overall Study||4
6650566|NCT02412852|7579817|FG001|COMPLETED|Overall Study||7
6650567|NCT02412852|7579818|FG002|COMPLETED|Overall Study||5
6650568|NCT02412852|7579819|FG003|COMPLETED|Overall Study||8
6650569|NCT02412852|7579816|FG000|NOT COMPLETED|Overall Study||0
6650570|NCT02412852|7579817|FG001|NOT COMPLETED|Overall Study||1
6650571|NCT02412852|7579818|FG002|NOT COMPLETED|Overall Study||0
6650572|NCT02412852|7579819|FG003|NOT COMPLETED|Overall Study||1
6650573|NCT02412878|7579829|FG000|STARTED|Overall Study||238
6650574|NCT02412878|7579830|FG001|STARTED|Overall Study||240
6650575|NCT02412878|7579829|FG000|Received Carfilzomib|Overall Study||235
6650576|NCT02412878|7579830|FG001|Received Carfilzomib|Overall Study||238
6650577|NCT02412878|7579829|FG000|COMPLETED|Overall Study||217
6650578|NCT02412878|7579830|FG001|COMPLETED|Overall Study||227
6650579|NCT02412878|7579829|FG000|NOT COMPLETED|Overall Study||21
6650580|NCT02412878|7579830|FG001|NOT COMPLETED|Overall Study||13
6656016|NCT02457546|7586183|FG000|NOT COMPLETED|Overall Study||9
6656017|NCT02457546|7586184|FG001|NOT COMPLETED|Overall Study||4
6656018|NCT02457611|7586190|FG000|STARTED|Overall Study||26
6656019|NCT02457611|7586190|FG000|COMPLETED|Overall Study||23
6656020|NCT02457611|7586190|FG000|NOT COMPLETED|Overall Study||3
6656021|NCT02457637|7586194|FG000|STARTED|Recruitment|2600 is the number of inpatients who met our eligibility.|2600
6656022|NCT02457637|7586194|FG000|COMPLETED|Recruitment|2361 patients were excluded according to our exclusion criteria,2600 patients remained.|2600
6656023|NCT02457637|7586194|FG000|NOT COMPLETED|Recruitment||0
6656024|NCT02457637|7586194|FG000|STARTED|28-Days Hospitalization and Observation||2600
6656025|NCT02457637|7586194|FG000|Liver Transplantation|28-Days Hospitalization and Observation||124
6656026|NCT02457637|7586194|FG000|Death|28-Days Hospitalization and Observation||74
6656027|NCT02457637|7586194|FG000|COMPLETED|28-Days Hospitalization and Observation|Death and receiving Liver transplantation are two end points of our observation.|2600
6656028|NCT02457637|7586194|FG000|NOT COMPLETED|28-Days Hospitalization and Observation||0
6656029|NCT02457637|7586194|FG000|STARTED|Clinic or Telephone Follow-up||2600
6656030|NCT02457637|7586194|FG000|One-year Liver Transplantation|Clinic or Telephone Follow-up||182
6656031|NCT02457637|7586194|FG000|One-year Death|Clinic or Telephone Follow-up||475
6656032|NCT02457637|7586194|FG000|COMPLETED|Clinic or Telephone Follow-up||2529
6656033|NCT02457637|7586194|FG000|NOT COMPLETED|Clinic or Telephone Follow-up||71
6656034|NCT02457728|7586199|FG000|STARTED|Overall Study||34
6656035|NCT02457728|7586199|FG000|COMPLETED|Overall Study||34
6656036|NCT02457728|7586199|FG000|NOT COMPLETED|Overall Study||0
6656037|NCT02457793|7586209|FG000|STARTED|Overall Study||1
6656038|NCT02457793|7586210|FG001|STARTED|Overall Study||5
6656039|NCT02457793|7586211|FG002|STARTED|Overall Study||3
6656040|NCT02457793|7586212|FG003|STARTED|Overall Study||5
6656041|NCT02457793|7586213|FG004|STARTED|Overall Study||4
6656042|NCT02457793|7586214|FG005|STARTED|Overall Study||6
6656043|NCT02457793|7586209|FG000|COMPLETED|Overall Study||0
6656044|NCT02457793|7586210|FG001|COMPLETED|Overall Study||1
6656045|NCT02457793|7586211|FG002|COMPLETED|Overall Study||0
6656046|NCT02457793|7586212|FG003|COMPLETED|Overall Study||0
6656047|NCT02457793|7586213|FG004|COMPLETED|Overall Study||0
6656048|NCT02457793|7586214|FG005|COMPLETED|Overall Study||0
6656049|NCT02457793|7586209|FG000|NOT COMPLETED|Overall Study||1
6656050|NCT02457793|7586210|FG001|NOT COMPLETED|Overall Study||4
6656051|NCT02457793|7586211|FG002|NOT COMPLETED|Overall Study||3
6656052|NCT02457793|7586212|FG003|NOT COMPLETED|Overall Study||5
6656053|NCT02457793|7586213|FG004|NOT COMPLETED|Overall Study||4
6656054|NCT02457793|7586214|FG005|NOT COMPLETED|Overall Study||6
6656055|NCT02457819|7586229|FG000|STARTED|Overall Study||237
6650581|NCT02412956|7579838|FG000|STARTED|Overall Study||44
6650582|NCT02412956|7579839|FG001|STARTED|Overall Study||47
6650583|NCT02412956|7579840|FG002|STARTED|Overall Study||8
6650584|NCT02412956|7579838|FG000|COMPLETED|Overall Study||35
6650585|NCT02412956|7579839|FG001|COMPLETED|Overall Study||30
6650586|NCT02412956|7579840|FG002|COMPLETED|Overall Study||8
6650587|NCT02412956|7579838|FG000|NOT COMPLETED|Overall Study||9
6650588|NCT02412956|7579839|FG001|NOT COMPLETED|Overall Study||17
6650589|NCT02412956|7579840|FG002|NOT COMPLETED|Overall Study||0
6650590|NCT02412982|7579848|FG000|STARTED|Primary Endpoint||51
6650591|NCT02412982|7579849|FG001|STARTED|Primary Endpoint||52
6650592|NCT02412982|7579848|FG000|COMPLETED|Primary Endpoint||47
6650593|NCT02412982|7579849|FG001|COMPLETED|Primary Endpoint||49
6650594|NCT02412982|7579848|FG000|NOT COMPLETED|Primary Endpoint||4
6650595|NCT02412982|7579849|FG001|NOT COMPLETED|Primary Endpoint||3
6650596|NCT02412982|7579848|FG000|STARTED|Intervention Group: Randomization|Control group patients did not undergo randomization (see study protocol section)|0
6650597|NCT02412982|7579849|FG001|STARTED|Intervention Group: Randomization|52 patients in the intervention group underwent 1:1 randomization to the two intervention study arms: 26 patients in 40 mg every 12 hours with escalation to 50 mg every 12 hours and 26 patients in 30 mg every 8 hours.|52
6650598|NCT02412982|7579848|FG000|COMPLETED|Intervention Group: Randomization||0
6650599|NCT02412982|7579849|FG001|COMPLETED|Intervention Group: Randomization||51
6650600|NCT02412982|7579848|FG000|NOT COMPLETED|Intervention Group: Randomization||0
6650601|NCT02412982|7579849|FG001|NOT COMPLETED|Intervention Group: Randomization||1
6650602|NCT02413008|7579857|FG000|STARTED|Overall Study||50
6650603|NCT02413008|7579858|FG001|STARTED|Overall Study||11
6650604|NCT02413008|7579857|FG000|COMPLETED|Overall Study||43
6650605|NCT02413008|7579858|FG001|COMPLETED|Overall Study||9
6650606|NCT02413008|7579857|FG000|NOT COMPLETED|Overall Study||7
6650607|NCT02413008|7579858|FG001|NOT COMPLETED|Overall Study||2
6650608|NCT02413034|7579869|FG000|STARTED|Overall Study||14
6650609|NCT02413034|7579870|FG001|STARTED|Overall Study||14
6650610|NCT02413034|7579869|FG000|COMPLETED|Overall Study||14
6650611|NCT02413034|7579870|FG001|COMPLETED|Overall Study||14
6650612|NCT02413034|7579869|FG000|NOT COMPLETED|Overall Study||0
6650613|NCT02413034|7579870|FG001|NOT COMPLETED|Overall Study||0
6650614|NCT02413151|7579878|FG000|STARTED|Overall Study||32
6650615|NCT02413151|7579879|FG001|STARTED|Overall Study||30
6650616|NCT02413151|7579878|FG000|COMPLETED|Overall Study||22
6650617|NCT02413151|7579879|FG001|COMPLETED|Overall Study||28
6650618|NCT02413151|7579878|FG000|NOT COMPLETED|Overall Study||10
6650619|NCT02413151|7579879|FG001|NOT COMPLETED|Overall Study||2
6650620|NCT02413190|7579886|FG000|STARTED|Overall Study||94
6650621|NCT02413190|7579886|FG000|COMPLETED|Overall Study||94
6650622|NCT02413190|7579886|FG000|NOT COMPLETED|Overall Study||0
6650623|NCT02413203|7579892|FG000|STARTED|Overall Study||10
6650624|NCT02413203|7579893|FG001|STARTED|Overall Study||10
6650625|NCT02413203|7579892|FG000|COMPLETED|Overall Study||10
6650626|NCT02413203|7579893|FG001|COMPLETED|Overall Study||10
6650627|NCT02413203|7579892|FG000|NOT COMPLETED|Overall Study||0
6650628|NCT02413203|7579893|FG001|NOT COMPLETED|Overall Study||0
6650629|NCT02413229|7579907|FG000|STARTED|Overall Study||25
6650630|NCT02413229|7579908|FG001|STARTED|Overall Study||12
6650631|NCT02413229|7579909|FG002|STARTED|Overall Study||26
6650632|NCT02413229|7579910|FG003|STARTED|Overall Study||12
6650633|NCT02413229|7579911|FG004|STARTED|Overall Study||24
6650634|NCT02413229|7579912|FG005|STARTED|Overall Study||12
6650635|NCT02413229|7579913|FG006|STARTED|Overall Study||25
6650636|NCT02413229|7579914|FG007|STARTED|Overall Study||15
6650637|NCT02413229|7579907|FG000|COMPLETED|Overall Study||24
6650638|NCT02413229|7579908|FG001|COMPLETED|Overall Study||11
6650639|NCT02413229|7579909|FG002|COMPLETED|Overall Study||25
6650640|NCT02413229|7579910|FG003|COMPLETED|Overall Study||11
6650641|NCT02413229|7579911|FG004|COMPLETED|Overall Study||21
6650642|NCT02413229|7579912|FG005|COMPLETED|Overall Study||12
6650643|NCT02413229|7579913|FG006|COMPLETED|Overall Study||25
6650644|NCT02413229|7579914|FG007|COMPLETED|Overall Study||11
6650645|NCT02413229|7579907|FG000|NOT COMPLETED|Overall Study||1
6650646|NCT02413229|7579908|FG001|NOT COMPLETED|Overall Study||1
6650647|NCT02413229|7579909|FG002|NOT COMPLETED|Overall Study||1
6650648|NCT02413229|7579910|FG003|NOT COMPLETED|Overall Study||1
6650649|NCT02413229|7579911|FG004|NOT COMPLETED|Overall Study||3
6650650|NCT02413229|7579912|FG005|NOT COMPLETED|Overall Study||0
6650651|NCT02413229|7579913|FG006|NOT COMPLETED|Overall Study||0
6650652|NCT02413229|7579914|FG007|NOT COMPLETED|Overall Study||4
6650653|NCT02413255|7579949|FG000|STARTED|Overall Study||18
6650654|NCT02413255|7579950|FG001|STARTED|Overall Study||6
6650655|NCT02413255|7579951|FG002|STARTED|Overall Study||6
6650656|NCT02413255|7579952|FG003|STARTED|Overall Study||6
6650657|NCT02413255|7579953|FG004|STARTED|Overall Study||6
6650658|NCT02413255|7579954|FG005|STARTED|Overall Study||6
6650659|NCT02413255|7579955|FG006|STARTED|Overall Study||6
6650660|NCT02413255|7579956|FG007|STARTED|Overall Study||6
6650661|NCT02413255|7579957|FG008|STARTED|Overall Study||6
6650662|NCT02413255|7579958|FG009|STARTED|Overall Study||6
6650663|NCT02413255|7579959|FG010|STARTED|Overall Study||12
6650664|NCT02413255|7579960|FG011|STARTED|Overall Study||6
6650665|NCT02413255|7579961|FG012|STARTED|Overall Study||6
6650666|NCT02413255|7579962|FG013|STARTED|Overall Study||6
6650667|NCT02413255|7579963|FG014|STARTED|Overall Study||6
6650668|NCT02413255|7579964|FG015|STARTED|Overall Study||6
6650669|NCT02413255|7579965|FG016|STARTED|Overall Study||6
6650670|NCT02413255|7579949|FG000|COMPLETED|Overall Study||18
6650671|NCT02413255|7579950|FG001|COMPLETED|Overall Study||6
6650672|NCT02413255|7579951|FG002|COMPLETED|Overall Study||6
6650673|NCT02413255|7579952|FG003|COMPLETED|Overall Study||6
6650674|NCT02413255|7579953|FG004|COMPLETED|Overall Study||6
6650675|NCT02413255|7579954|FG005|COMPLETED|Overall Study||6
6650676|NCT02413255|7579955|FG006|COMPLETED|Overall Study||6
6650677|NCT02413255|7579956|FG007|COMPLETED|Overall Study||6
6650678|NCT02413255|7579957|FG008|COMPLETED|Overall Study||6
6650679|NCT02413255|7579958|FG009|COMPLETED|Overall Study||6
6650680|NCT02413255|7579959|FG010|COMPLETED|Overall Study||12
6650681|NCT02413255|7579960|FG011|COMPLETED|Overall Study||6
6650682|NCT02413255|7579961|FG012|COMPLETED|Overall Study||6
6650683|NCT02413255|7579962|FG013|COMPLETED|Overall Study||6
6650684|NCT02413255|7579963|FG014|COMPLETED|Overall Study||5
6650685|NCT02413255|7579964|FG015|COMPLETED|Overall Study||6
6650686|NCT02413255|7579965|FG016|COMPLETED|Overall Study||6
6650687|NCT02413255|7579949|FG000|NOT COMPLETED|Overall Study||0
6650688|NCT02413255|7579950|FG001|NOT COMPLETED|Overall Study||0
6650689|NCT02413255|7579951|FG002|NOT COMPLETED|Overall Study||0
6650690|NCT02413255|7579952|FG003|NOT COMPLETED|Overall Study||0
6650691|NCT02413255|7579953|FG004|NOT COMPLETED|Overall Study||0
6650692|NCT02413255|7579954|FG005|NOT COMPLETED|Overall Study||0
6650693|NCT02413255|7579955|FG006|NOT COMPLETED|Overall Study||0
6650694|NCT02413255|7579956|FG007|NOT COMPLETED|Overall Study||0
6650695|NCT02413255|7579957|FG008|NOT COMPLETED|Overall Study||0
6650696|NCT02413255|7579958|FG009|NOT COMPLETED|Overall Study||0
6650697|NCT02413255|7579959|FG010|NOT COMPLETED|Overall Study||0
6650698|NCT02413255|7579960|FG011|NOT COMPLETED|Overall Study||0
6650699|NCT02413255|7579961|FG012|NOT COMPLETED|Overall Study||0
6650700|NCT02413255|7579962|FG013|NOT COMPLETED|Overall Study||0
6650701|NCT02413255|7579963|FG014|NOT COMPLETED|Overall Study||1
6650702|NCT02413255|7579964|FG015|NOT COMPLETED|Overall Study||0
6650703|NCT02413255|7579965|FG016|NOT COMPLETED|Overall Study||0
6650704|NCT02413294|7580016|FG000|STARTED|Overall Study||12
6650705|NCT02413294|7580016|FG000|COMPLETED|Overall Study||11
6650706|NCT02413294|7580016|FG000|NOT COMPLETED|Overall Study||1
6650707|NCT02413320|7580022|FG000|STARTED|Overall Study||49
6650708|NCT02413320|7580023|FG001|STARTED|Overall Study||52
6650709|NCT02413320|7580022|FG000|COMPLETED|Overall Study||48
6650710|NCT02413320|7580023|FG001|COMPLETED|Overall Study||52
6650711|NCT02413320|7580022|FG000|NOT COMPLETED|Overall Study||1
6650712|NCT02413320|7580023|FG001|NOT COMPLETED|Overall Study||0
6650713|NCT02413333|7580033|FG000|STARTED|Period 1||66
6650714|NCT02413333|7580034|FG001|STARTED|Period 1||66
6650715|NCT02413333|7580033|FG000|Randomized and Treated|Period 1||66
6650716|NCT02413333|7580034|FG001|Randomized and Treated|Period 1||66
6650717|NCT02413333|7580033|FG000|COMPLETED|Period 1||65
6650718|NCT02413333|7580034|FG001|COMPLETED|Period 1||65
6650719|NCT02413333|7580033|FG000|NOT COMPLETED|Period 1||1
6650720|NCT02413333|7580034|FG001|NOT COMPLETED|Period 1||1
6650721|NCT02413333|7580033|FG000|STARTED|Period 2||65
6650722|NCT02413333|7580034|FG001|STARTED|Period 2||65
6650723|NCT02413333|7580033|FG000|COMPLETED|Period 2||64
6650724|NCT02413333|7580034|FG001|COMPLETED|Period 2||65
6650725|NCT02413333|7580033|FG000|NOT COMPLETED|Period 2||1
6650726|NCT02413333|7580034|FG001|NOT COMPLETED|Period 2||0
6650727|NCT02413346|7580042|FG000|STARTED|Overall Study||236
6650728|NCT02413346|7580043|FG001|STARTED|Overall Study||247
6650729|NCT02413346|7580042|FG000|COMPLETED|Overall Study||177
6650730|NCT02413346|7580043|FG001|COMPLETED|Overall Study||177
6650731|NCT02413346|7580042|FG000|NOT COMPLETED|Overall Study||59
6650732|NCT02413346|7580043|FG001|NOT COMPLETED|Overall Study||70
6650733|NCT02413372|7580052|FG000|STARTED|Treatment||25
6650734|NCT02413372|7580053|FG001|STARTED|Treatment||24
6650735|NCT02413372|7580054|FG002|STARTED|Treatment||26
6650736|NCT02413372|7580052|FG000|COMPLETED|Treatment||24
6650737|NCT02413372|7580053|FG001|COMPLETED|Treatment||22
6650738|NCT02413372|7580054|FG002|COMPLETED|Treatment||25
6650739|NCT02413372|7580052|FG000|NOT COMPLETED|Treatment||1
6650740|NCT02413372|7580053|FG001|NOT COMPLETED|Treatment||2
6650741|NCT02413372|7580054|FG002|NOT COMPLETED|Treatment||1
6650742|NCT02413372|7580052|FG000|STARTED|Follow-up||22
6650743|NCT02413372|7580053|FG001|STARTED|Follow-up||21
6650744|NCT02413372|7580054|FG002|STARTED|Follow-up||25
6650745|NCT02413372|7580052|FG000|COMPLETED|Follow-up||20
6650746|NCT02413372|7580053|FG001|COMPLETED|Follow-up||20
6650747|NCT02413372|7580054|FG002|COMPLETED|Follow-up||23
6650748|NCT02413372|7580052|FG000|NOT COMPLETED|Follow-up||2
6650749|NCT02413372|7580053|FG001|NOT COMPLETED|Follow-up||1
6650750|NCT02413372|7580054|FG002|NOT COMPLETED|Follow-up||2
6650751|NCT02413398|7580064|FG000|STARTED|Overall Study||160
6650752|NCT02413398|7580065|FG001|STARTED|Overall Study||161
6650753|NCT02413398|7580064|FG000|COMPLETED|Overall Study||156
6650754|NCT02413398|7580065|FG001|COMPLETED|Overall Study||154
6650755|NCT02413398|7580064|FG000|NOT COMPLETED|Overall Study||4
6650756|NCT02413398|7580065|FG001|NOT COMPLETED|Overall Study||7
6650757|NCT02413463|7580073|FG000|STARTED|Overall Study||30
6650758|NCT02413463|7580074|FG001|STARTED|Overall Study||30
6650759|NCT02413463|7580073|FG000|COMPLETED|Overall Study||25
6650760|NCT02413463|7580074|FG001|COMPLETED|Overall Study||28
6650761|NCT02413463|7580073|FG000|NOT COMPLETED|Overall Study||5
6650762|NCT02413463|7580074|FG001|NOT COMPLETED|Overall Study||2
6650763|NCT02413489|7580083|FG000|STARTED|Overall Study||15
6650764|NCT02413489|7580084|FG001|STARTED|Overall Study||16
6650765|NCT02413489|7580085|FG002|STARTED|Overall Study||5
6650766|NCT02413489|7580083|FG000|COMPLETED|Overall Study||0
6650767|NCT02413489|7580084|FG001|COMPLETED|Overall Study||0
6650768|NCT02413489|7580085|FG002|COMPLETED|Overall Study||0
6650769|NCT02413489|7580083|FG000|NOT COMPLETED|Overall Study||15
6650770|NCT02413489|7580084|FG001|NOT COMPLETED|Overall Study||16
6650771|NCT02413489|7580085|FG002|NOT COMPLETED|Overall Study||5
6650772|NCT02413580|7580093|FG000|STARTED|Overall Study||49
6650773|NCT02413580|7580093|FG000|COMPLETED|Overall Study||46
6650774|NCT02413580|7580093|FG000|NOT COMPLETED|Overall Study||3
6422310|NCT01001208|7336914|FG001|NOT COMPLETED|Overall Study||33
6422311|NCT01001221|7336924|FG000|STARTED|Overall Study||5
6422312|NCT01001221|7336925|FG001|STARTED|Overall Study||5
6650775|NCT02413593|7580097|FG000|STARTED|Overall Study||111
6650776|NCT02413593|7580097|FG000|COMPLETED|Overall Study||107
6650777|NCT02413593|7580097|FG000|NOT COMPLETED|Overall Study||4
6650778|NCT02413684|7580101|FG000|STARTED|Overall Study||53
6650779|NCT02413684|7580101|FG000|COMPLETED|Overall Study||40
6650780|NCT02413684|7580101|FG000|NOT COMPLETED|Overall Study||13
6650781|NCT02413879|7580105|FG000|STARTED|Overall Study||86
6650782|NCT02413879|7580105|FG000|COMPLETED|Overall Study||86
6650783|NCT02413879|7580105|FG000|NOT COMPLETED|Overall Study||0
6650784|NCT02413918|7580109|FG000|STARTED|Overall Study||41
6650785|NCT02413918|7580109|FG000|COMPLETED|Overall Study||16
6650786|NCT02413918|7580109|FG000|NOT COMPLETED|Overall Study||25
6650787|NCT02413996|7580118|FG000|STARTED|Overall Study||44
6650788|NCT02413996|7580119|FG001|STARTED|Overall Study||41
6650789|NCT02413996|7580118|FG000|COMPLETED|Overall Study||35
6650790|NCT02413996|7580119|FG001|COMPLETED|Overall Study||39
6650791|NCT02413996|7580118|FG000|NOT COMPLETED|Overall Study||9
6650792|NCT02413996|7580119|FG001|NOT COMPLETED|Overall Study||2
6650793|NCT02414204|7580127|FG000|STARTED|Overall Study||2
6650794|NCT02414204|7580128|FG001|STARTED|Overall Study||2
6650795|NCT02414204|7580127|FG000|COMPLETED|Overall Study||2
6650796|NCT02414204|7580128|FG001|COMPLETED|Overall Study||2
6650797|NCT02414204|7580127|FG000|NOT COMPLETED|Overall Study||0
6650798|NCT02414204|7580128|FG001|NOT COMPLETED|Overall Study||0
6650799|NCT02414243|7580136|FG000|STARTED|Overall Study||19
6650800|NCT02414243|7580137|FG001|STARTED|Overall Study||21
6650801|NCT02414243|7580136|FG000|Moved to the Other Group|Overall Study||17
6650802|NCT02414243|7580137|FG001|Moved to the Other Group|Overall Study||20
6650803|NCT02414243|7580136|FG000|Entered Open Challenge at Home|Overall Study||17
6650804|NCT02414243|7580137|FG001|Entered Open Challenge at Home|Overall Study||20
6650805|NCT02414243|7580136|FG000|COMPLETED|Overall Study||13
6650806|NCT02414243|7580137|FG001|COMPLETED|Overall Study||17
6650807|NCT02414243|7580136|FG000|NOT COMPLETED|Overall Study||6
6650808|NCT02414243|7580137|FG001|NOT COMPLETED|Overall Study||4
6650809|NCT02414633|7580144|FG000|STARTED|Overall Study||148
6650810|NCT02414633|7580144|FG000|COMPLETED|Overall Study||148
6650811|NCT02414633|7580144|FG000|NOT COMPLETED|Overall Study||0
6650812|NCT02414828|7580152|FG000|STARTED|Overall Study||11
6650813|NCT02414828|7580153|FG001|STARTED|Overall Study||10
6650814|NCT02414828|7580154|FG002|STARTED|Overall Study||20
6650815|NCT02414828|7580155|FG003|STARTED|Overall Study||31
6650816|NCT02414828|7580152|FG000|COMPLETED|Overall Study||11
6650817|NCT02414828|7580153|FG001|COMPLETED|Overall Study||9
6650818|NCT02414828|7580154|FG002|COMPLETED|Overall Study||19
6650819|NCT02414828|7580155|FG003|COMPLETED|Overall Study||29
6650820|NCT02414828|7580152|FG000|NOT COMPLETED|Overall Study||0
6650821|NCT02414828|7580153|FG001|NOT COMPLETED|Overall Study||1
6650822|NCT02414828|7580154|FG002|NOT COMPLETED|Overall Study||1
6650823|NCT02414828|7580155|FG003|NOT COMPLETED|Overall Study||2
6650824|NCT02414841|7580168|FG000|STARTED|Overall Study||405
6650825|NCT02414841|7580169|FG001|STARTED|Overall Study||208
6650826|NCT02414841|7580168|FG000|COMPLETED|Overall Study||349
6650827|NCT02414841|7580169|FG001|COMPLETED|Overall Study||175
6650828|NCT02414841|7580168|FG000|NOT COMPLETED|Overall Study||56
6650829|NCT02414841|7580169|FG001|NOT COMPLETED|Overall Study||33
6650830|NCT02414854|7580181|FG000|STARTED|Overall Study||317
6650831|NCT02414854|7580182|FG001|STARTED|Overall Study||631
6650832|NCT02414854|7580183|FG002|STARTED|Overall Study||321
6650833|NCT02414854|7580184|FG003|STARTED|Overall Study||633
6650834|NCT02414854|7580181|FG000|Treated|Overall Study|2 got other treatment (1 each dupilumab 200+300) than assigned + were allocated to those in AE table|315
6650835|NCT02414854|7580182|FG001|Treated|Overall Study||629
6650836|NCT02414854|7580183|FG002|Treated|Overall Study||321
6650837|NCT02414854|7580184|FG003|Treated|Overall Study|1 got other treatment (dupilumab 200) than assigned + was allocated to that in AE table|632
6650838|NCT02414854|7580181|FG000|COMPLETED|Overall Study||295
6650839|NCT02414854|7580182|FG001|COMPLETED|Overall Study||586
6650840|NCT02414854|7580183|FG002|COMPLETED|Overall Study||301
6650841|NCT02414854|7580184|FG003|COMPLETED|Overall Study||582
6650842|NCT02414854|7580181|FG000|NOT COMPLETED|Overall Study||22
6650843|NCT02414854|7580182|FG001|NOT COMPLETED|Overall Study||45
6650844|NCT02414854|7580183|FG002|NOT COMPLETED|Overall Study||20
6650845|NCT02414854|7580184|FG003|NOT COMPLETED|Overall Study||51
6650846|NCT02414932|7580196|FG000|STARTED|Overall Study||3
6650847|NCT02414932|7580197|FG001|STARTED|Overall Study||3
6650848|NCT02414932|7580196|FG000|COMPLETED|Overall Study||0
6305146|NCT00369486|7208429|FG000|NOT COMPLETED|34-Week Visit||0
6305147|NCT00369486|7208430|FG001|NOT COMPLETED|34-Week Visit||1
6305148|NCT00369486|7208431|FG002|NOT COMPLETED|34-Week Visit||1
6305149|NCT00369486|7208432|FG003|NOT COMPLETED|34-Week Visit||3
6305150|NCT00369486|7208433|FG004|NOT COMPLETED|34-Week Visit||3
6305151|NCT00369512|7208445|FG000|STARTED|Overall Study||15
6305152|NCT00369512|7208445|FG000|COMPLETED|Overall Study||15
6305153|NCT00369512|7208445|FG000|NOT COMPLETED|Overall Study||0
6305154|NCT00369564|7208451|FG000|STARTED|Overall Study||127
6305155|NCT00369564|7208452|FG001|STARTED|Overall Study||123
6305156|NCT00369564|7208451|FG000|COMPLETED|Overall Study||84
6305157|NCT00369564|7208452|FG001|COMPLETED|Overall Study||100
6305158|NCT00369564|7208451|FG000|NOT COMPLETED|Overall Study||43
6305159|NCT00369564|7208452|FG001|NOT COMPLETED|Overall Study||23
6305160|NCT00369577|7208465|FG000|STARTED|Overall Study||43
6305161|NCT00369577|7208466|FG001|STARTED|Overall Study||45
6305162|NCT00369577|7208467|FG002|STARTED|Overall Study||41
6305163|NCT00369577|7208465|FG000|COMPLETED|Overall Study||43
6305164|NCT00369577|7208466|FG001|COMPLETED|Overall Study||45
6305165|NCT00369577|7208467|FG002|COMPLETED|Overall Study||40
6305166|NCT00369577|7208465|FG000|NOT COMPLETED|Overall Study||0
6305167|NCT00369577|7208466|FG001|NOT COMPLETED|Overall Study||0
6305168|NCT00369577|7208467|FG002|NOT COMPLETED|Overall Study||1
6305169|NCT00369590|7208477|FG000|STARTED|Overall Study||16
6305170|NCT00369590|7208478|FG001|STARTED|Overall Study||42
6305171|NCT00369590|7208477|FG000|COMPLETED|Overall Study||16
6305172|NCT00369590|7208478|FG001|COMPLETED|Overall Study||42
6305173|NCT00369590|7208477|FG000|NOT COMPLETED|Overall Study||0
6305174|NCT00369590|7208478|FG001|NOT COMPLETED|Overall Study||0
6305175|NCT00369629|7208483|FG000|STARTED|Treated 2 Cycles/Reached First Response||6
6305176|NCT00369629|7208484|FG001|STARTED|Treated 2 Cycles/Reached First Response||3
6305177|NCT00369629|7208485|FG002|STARTED|Treated 2 Cycles/Reached First Response||5
6305178|NCT00369629|7208486|FG003|STARTED|Treated 2 Cycles/Reached First Response|No patients were enrolled at this dose level as the study closed early due to lack of funding.|0
6305179|NCT00369629|7208483|FG000|COMPLETED|Treated 2 Cycles/Reached First Response||4
6305180|NCT00369629|7208484|FG001|COMPLETED|Treated 2 Cycles/Reached First Response||2
6305181|NCT00369629|7208485|FG002|COMPLETED|Treated 2 Cycles/Reached First Response||3
6305182|NCT00369629|7208486|FG003|COMPLETED|Treated 2 Cycles/Reached First Response||0
6305183|NCT00369629|7208483|FG000|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
6305184|NCT00369629|7208484|FG001|NOT COMPLETED|Treated 2 Cycles/Reached First Response||1
6305185|NCT00369629|7208485|FG002|NOT COMPLETED|Treated 2 Cycles/Reached First Response||2
6305186|NCT00369629|7208486|FG003|NOT COMPLETED|Treated 2 Cycles/Reached First Response||0
6305187|NCT00369629|7208483|FG000|STARTED|Moved on to 4 More Cycles||4
6305188|NCT00369629|7208484|FG001|STARTED|Moved on to 4 More Cycles||2
6562714|NCT01802710|7485664|FG001|STARTED|From T1 to T2||72
6551103|NCT01729845|7473196|FG000|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
6551104|NCT01729845|7473197|FG001|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
6551105|NCT01729845|7473198|FG002|NOT COMPLETED|Safety/Tolerability of Dec/MEC||0
6551106|NCT01729845|7473196|FG000|STARTED|Efficacy of Dec/MEC||0
6551107|NCT01729845|7473197|FG001|STARTED|Efficacy of Dec/MEC||22
6551108|NCT01729845|7473198|FG002|STARTED|Efficacy of Dec/MEC||0
6551109|NCT01729845|7473196|FG000|COMPLETED|Efficacy of Dec/MEC||0
6551110|NCT01729845|7473197|FG001|COMPLETED|Efficacy of Dec/MEC||22
6305189|NCT00369629|7208485|FG002|STARTED|Moved on to 4 More Cycles||3
6305190|NCT00369629|7208486|FG003|STARTED|Moved on to 4 More Cycles||0
6305191|NCT00369629|7208483|FG000|COMPLETED|Moved on to 4 More Cycles||4
6305192|NCT00369629|7208484|FG001|COMPLETED|Moved on to 4 More Cycles||2
6305193|NCT00369629|7208485|FG002|COMPLETED|Moved on to 4 More Cycles||2
6305194|NCT00369629|7208486|FG003|COMPLETED|Moved on to 4 More Cycles||0
6305195|NCT00369629|7208483|FG000|NOT COMPLETED|Moved on to 4 More Cycles||0
6305196|NCT00369629|7208484|FG001|NOT COMPLETED|Moved on to 4 More Cycles||0
6305197|NCT00369629|7208485|FG002|NOT COMPLETED|Moved on to 4 More Cycles||1
6650849|NCT02414932|7580197|FG001|COMPLETED|Overall Study||0
6650850|NCT02414932|7580196|FG000|NOT COMPLETED|Overall Study||3
6650851|NCT02414932|7580197|FG001|NOT COMPLETED|Overall Study||3
6305198|NCT00369629|7208486|FG003|NOT COMPLETED|Moved on to 4 More Cycles||0
6305199|NCT00369629|7208483|FG000|STARTED|Completed 4 More Cycles||4
6305200|NCT00369629|7208484|FG001|STARTED|Completed 4 More Cycles||2
6305201|NCT00369629|7208485|FG002|STARTED|Completed 4 More Cycles||2
6305202|NCT00369629|7208486|FG003|STARTED|Completed 4 More Cycles||0
6305203|NCT00369629|7208483|FG000|COMPLETED|Completed 4 More Cycles||0
6305204|NCT00369629|7208484|FG001|COMPLETED|Completed 4 More Cycles||0
6305205|NCT00369629|7208485|FG002|COMPLETED|Completed 4 More Cycles||0
6305206|NCT00369629|7208486|FG003|COMPLETED|Completed 4 More Cycles||0
6305207|NCT00369629|7208483|FG000|NOT COMPLETED|Completed 4 More Cycles||4
6305208|NCT00369629|7208484|FG001|NOT COMPLETED|Completed 4 More Cycles||2
6305209|NCT00369629|7208485|FG002|NOT COMPLETED|Completed 4 More Cycles||2
6305210|NCT00369629|7208486|FG003|NOT COMPLETED|Completed 4 More Cycles||0
6305211|NCT00369629|7208483|FG000|STARTED|Follow up for 1 Year|All patients treated on study go into the follow up period|6
6305212|NCT00369629|7208484|FG001|STARTED|Follow up for 1 Year||3
6305213|NCT00369629|7208485|FG002|STARTED|Follow up for 1 Year||5
6305214|NCT00369629|7208486|FG003|STARTED|Follow up for 1 Year||0
6650852|NCT02414958|7580206|FG000|STARTED|Overall Study||243
6650853|NCT02414958|7580207|FG001|STARTED|Overall Study||243
6422313|NCT01001221|7336926|FG002|STARTED|Overall Study||3
6422314|NCT01001221|7336927|FG003|STARTED|Overall Study||6
6422315|NCT01001221|7336928|FG004|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
6422316|NCT01001221|7336924|FG000|Treated|Overall Study||5
6422317|NCT01001221|7336925|FG001|Treated|Overall Study||5
6422318|NCT01001221|7336926|FG002|Treated|Overall Study||2
6422319|NCT01001221|7336927|FG003|Treated|Overall Study||6
6305215|NCT00369629|7208483|FG000|COMPLETED|Follow up for 1 Year||4
6305216|NCT00369629|7208484|FG001|COMPLETED|Follow up for 1 Year||1
6305217|NCT00369629|7208485|FG002|COMPLETED|Follow up for 1 Year||2
6305218|NCT00369629|7208486|FG003|COMPLETED|Follow up for 1 Year||0
6305219|NCT00369629|7208483|FG000|NOT COMPLETED|Follow up for 1 Year||2
6305220|NCT00369629|7208484|FG001|NOT COMPLETED|Follow up for 1 Year||2
6305221|NCT00369629|7208485|FG002|NOT COMPLETED|Follow up for 1 Year||3
6305222|NCT00369629|7208486|FG003|NOT COMPLETED|Follow up for 1 Year||0
6305223|NCT00369655|7208496|FG000|STARTED|Overall Study||21
6305224|NCT00369655|7208496|FG000|COMPLETED|Overall Study||19
6305225|NCT00369655|7208496|FG000|NOT COMPLETED|Overall Study||2
6305226|NCT00369668|7208503|FG000|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
6650854|NCT02414958|7580208|FG002|STARTED|Overall Study||244
6650855|NCT02414958|7580206|FG000|COMPLETED|Overall Study||211
6650856|NCT02414958|7580207|FG001|COMPLETED|Overall Study||223
6650857|NCT02414958|7580208|FG002|COMPLETED|Overall Study||230
6650858|NCT02414958|7580206|FG000|NOT COMPLETED|Overall Study||32
6650859|NCT02414958|7580207|FG001|NOT COMPLETED|Overall Study||20
6650860|NCT02414958|7580208|FG002|NOT COMPLETED|Overall Study||14
6551111|NCT01729845|7473198|FG002|COMPLETED|Efficacy of Dec/MEC||0
6551112|NCT01729845|7473196|FG000|NOT COMPLETED|Efficacy of Dec/MEC||0
6551113|NCT01729845|7473197|FG001|NOT COMPLETED|Efficacy of Dec/MEC||0
6305227|NCT00369668|7208504|FG001|STARTED|Overall Study||10
6305228|NCT00369668|7208505|FG002|STARTED|Overall Study||10
6305229|NCT00369668|7208503|FG000|COMPLETED|Overall Study||6
6305230|NCT00369668|7208504|FG001|COMPLETED|Overall Study||5
6305231|NCT00369668|7208505|FG002|COMPLETED|Overall Study||3
6551114|NCT01729845|7473198|FG002|NOT COMPLETED|Efficacy of Dec/MEC||0
6551115|NCT01729871|7473210|FG000|STARTED|Overall Study||124
6551116|NCT01729871|7473211|FG001|STARTED|Overall Study||124
6551117|NCT01729871|7473210|FG000|COMPLETED|Overall Study||112
6551118|NCT01729871|7473211|FG001|COMPLETED|Overall Study||101
6551119|NCT01729871|7473210|FG000|NOT COMPLETED|Overall Study||12
6551120|NCT01729871|7473211|FG001|NOT COMPLETED|Overall Study||23
6551121|NCT01729923|7473217|FG000|STARTED|Overall Study||27
6551122|NCT01729923|7473217|FG000|COMPLETED|Overall Study||0
6551123|NCT01729923|7473217|FG000|NOT COMPLETED|Overall Study||27
6551124|NCT01730040|7473228|FG000|STARTED|Overall Study||57
6551125|NCT01730040|7473229|FG001|STARTED|Overall Study||55
6551126|NCT01730040|7473230|FG002|STARTED|Overall Study||57
6551127|NCT01730040|7473231|FG003|STARTED|Overall Study||47
6551128|NCT01730040|7473232|FG004|STARTED|Overall Study||45
6650861|NCT02415127|7580218|FG000|STARTED|Overall Study||47
6650862|NCT02415127|7580219|FG001|STARTED|Overall Study||45
6650863|NCT02415127|7580218|FG000|COMPLETED|Overall Study||46
6650864|NCT02415127|7580219|FG001|COMPLETED|Overall Study||45
6650865|NCT02415127|7580218|FG000|NOT COMPLETED|Overall Study||1
6650866|NCT02415127|7580219|FG001|NOT COMPLETED|Overall Study||0
6650867|NCT02415244|7580227|FG000|STARTED|Overall Study||50
6650868|NCT02415244|7580228|FG001|STARTED|Overall Study||25
6650869|NCT02415244|7580227|FG000|COMPLETED|Overall Study||50
6650870|NCT02415244|7580228|FG001|COMPLETED|Overall Study||25
6650871|NCT02415244|7580227|FG000|NOT COMPLETED|Overall Study||0
6650872|NCT02415244|7580228|FG001|NOT COMPLETED|Overall Study||0
6650873|NCT02415400|7580238|FG000|STARTED|Overall Study||1153
6650874|NCT02415400|7580239|FG001|STARTED|Overall Study||1153
6650875|NCT02415400|7580240|FG002|STARTED|Overall Study||1154
6650876|NCT02415400|7580241|FG003|STARTED|Overall Study||1154
6650877|NCT02415400|7580238|FG000|COMPLETED|Overall Study||1087
6650878|NCT02415400|7580239|FG001|COMPLETED|Overall Study||1091
6650879|NCT02415400|7580240|FG002|COMPLETED|Overall Study||1069
6305232|NCT00369668|7208503|FG000|NOT COMPLETED|Overall Study||4
6305233|NCT00369668|7208504|FG001|NOT COMPLETED|Overall Study||5
6305234|NCT00369668|7208505|FG002|NOT COMPLETED|Overall Study||7
6305235|NCT00369681|7208516|FG000|STARTED|Overall Study||50
6305236|NCT00369681|7208516|FG000|COMPLETED|Overall Study||49
6305237|NCT00369681|7208516|FG000|NOT COMPLETED|Overall Study||1
6305238|NCT00369707|7208520|FG000|STARTED|Induction Part A (1 Cycle -35 Days)||42
6305239|NCT00369707|7208520|FG000|COMPLETED|Induction Part A (1 Cycle -35 Days)||42
6305240|NCT00369707|7208520|FG000|NOT COMPLETED|Induction Part A (1 Cycle -35 Days)||0
6305241|NCT00369707|7208520|FG000|STARTED|Induction Part B (2 Cycles)||42
6305242|NCT00369707|7208520|FG000|COMPLETED|Induction Part B (2 Cycles)||35
6305243|NCT00369707|7208520|FG000|NOT COMPLETED|Induction Part B (2 Cycles)||7
6305244|NCT00369707|7208520|FG000|STARTED|Maintenance Period (up to 4 Cycles)||35
6305245|NCT00369707|7208520|FG000|COMPLETED|Maintenance Period (up to 4 Cycles)||27
6305246|NCT00369707|7208520|FG000|NOT COMPLETED|Maintenance Period (up to 4 Cycles)||8
6305247|NCT00369707|7208520|FG000|STARTED|Follow up for 2 Years After Treatment||41
6305248|NCT00369707|7208520|FG000|COMPLETED|Follow up for 2 Years After Treatment||38
6305249|NCT00369707|7208520|FG000|NOT COMPLETED|Follow up for 2 Years After Treatment||3
6305250|NCT00369746|7208526|FG000|STARTED|Overall Study||138
6305251|NCT00369746|7208527|FG001|STARTED|Overall Study||536
6305252|NCT00369746|7208526|FG000|COMPLETED|Overall Study||138
6305253|NCT00369746|7208527|FG001|COMPLETED|Overall Study||536
6305254|NCT00369746|7208526|FG000|NOT COMPLETED|Overall Study||0
6305255|NCT00369746|7208527|FG001|NOT COMPLETED|Overall Study||0
6305256|NCT00369785|7208535|FG000|STARTED|Overall Study||99
6305257|NCT00369785|7208536|FG001|STARTED|Overall Study||99
6305258|NCT00369785|7208535|FG000|COMPLETED|Overall Study||72
6305259|NCT00369785|7208536|FG001|COMPLETED|Overall Study||74
6305260|NCT00369785|7208535|FG000|NOT COMPLETED|Overall Study||27
6305261|NCT00369785|7208536|FG001|NOT COMPLETED|Overall Study||25
6305262|NCT00369824|7208548|FG000|STARTED|Overall Study||212
6305263|NCT00369824|7208549|FG001|STARTED|Overall Study||214
6650880|NCT02415400|7580241|FG003|COMPLETED|Overall Study||1071
6650881|NCT02415400|7580238|FG000|NOT COMPLETED|Overall Study||66
6650882|NCT02415400|7580239|FG001|NOT COMPLETED|Overall Study||62
6650883|NCT02415400|7580240|FG002|NOT COMPLETED|Overall Study||85
6650884|NCT02415400|7580241|FG003|NOT COMPLETED|Overall Study||83
6650885|NCT02415439|7580268|FG000|STARTED|Overall Study||6
6650886|NCT02415439|7580269|FG001|STARTED|Overall Study||6
6650887|NCT02415439|7580270|FG002|STARTED|Overall Study||6
6650888|NCT02415439|7580271|FG003|STARTED|Overall Study||6
6650889|NCT02415439|7580272|FG004|STARTED|Overall Study||6
6650890|NCT02415439|7580273|FG005|STARTED|Overall Study||6
6305264|NCT00369824|7208550|FG002|STARTED|Overall Study||214
6305265|NCT00369824|7208551|FG003|STARTED|Overall Study||214
6305266|NCT00369824|7208552|FG004|STARTED|Overall Study||214
6305267|NCT00369824|7208553|FG005|STARTED|Overall Study||215
6305268|NCT00369824|7208548|FG000|COMPLETED|Overall Study||197
6305269|NCT00369824|7208549|FG001|COMPLETED|Overall Study||195
6305270|NCT00369824|7208550|FG002|COMPLETED|Overall Study||202
6305271|NCT00369824|7208551|FG003|COMPLETED|Overall Study||199
6305272|NCT00369824|7208552|FG004|COMPLETED|Overall Study||196
6305273|NCT00369824|7208553|FG005|COMPLETED|Overall Study||204
6305274|NCT00369824|7208548|FG000|NOT COMPLETED|Overall Study||15
6305275|NCT00369824|7208549|FG001|NOT COMPLETED|Overall Study||19
6305276|NCT00369824|7208550|FG002|NOT COMPLETED|Overall Study||12
6305277|NCT00369824|7208551|FG003|NOT COMPLETED|Overall Study||15
6305278|NCT00369824|7208552|FG004|NOT COMPLETED|Overall Study||18
6305279|NCT00369824|7208553|FG005|NOT COMPLETED|Overall Study||11
6305280|NCT00369915|7208569|FG000|STARTED|Overall Study||10
6305281|NCT00369915|7208570|FG001|STARTED|Overall Study||7
6305282|NCT00369915|7208569|FG000|COMPLETED|Overall Study||4
6650891|NCT02415439|7580274|FG006|STARTED|Overall Study||6
6650892|NCT02415439|7580275|FG007|STARTED|Overall Study||12
6305283|NCT00369915|7208570|FG001|COMPLETED|Overall Study||4
6305284|NCT00369915|7208569|FG000|NOT COMPLETED|Overall Study||6
6650893|NCT02415439|7580276|FG008|STARTED|Overall Study||6
6650894|NCT02415439|7580277|FG009|STARTED|Overall Study||6
6650895|NCT02415439|7580278|FG010|STARTED|Overall Study||6
6650896|NCT02415439|7580279|FG011|STARTED|Overall Study||6
6650897|NCT02415439|7580280|FG012|STARTED|Overall Study||8
6650898|NCT02415439|7580268|FG000|COMPLETED|Overall Study||6
6650899|NCT02415439|7580269|FG001|COMPLETED|Overall Study||6
6650900|NCT02415439|7580270|FG002|COMPLETED|Overall Study||6
6650901|NCT02415439|7580271|FG003|COMPLETED|Overall Study||6
6650902|NCT02415439|7580272|FG004|COMPLETED|Overall Study||6
6650903|NCT02415439|7580273|FG005|COMPLETED|Overall Study||6
6650904|NCT02415439|7580274|FG006|COMPLETED|Overall Study||6
6650905|NCT02415439|7580275|FG007|COMPLETED|Overall Study||12
6650906|NCT02415439|7580276|FG008|COMPLETED|Overall Study||5
6650907|NCT02415439|7580277|FG009|COMPLETED|Overall Study||6
6551129|NCT01730040|7473233|FG005|STARTED|Overall Study||47
6551130|NCT01730040|7473234|FG006|STARTED|Overall Study||47
6551131|NCT01730040|7473228|FG000|Treated|Overall Study||57
6551132|NCT01730040|7473229|FG001|Treated|Overall Study||55
6551133|NCT01730040|7473230|FG002|Treated|Overall Study||57
6551134|NCT01730040|7473231|FG003|Treated|Overall Study||47
6551135|NCT01730040|7473232|FG004|Treated|Overall Study||45
6551136|NCT01730040|7473233|FG005|Treated|Overall Study||46
6551137|NCT01730040|7473234|FG006|Treated|Overall Study||47
6551138|NCT01730040|7473228|FG000|COMPLETED|Overall Study||44
6650908|NCT02415439|7580278|FG010|COMPLETED|Overall Study||6
6650909|NCT02415439|7580279|FG011|COMPLETED|Overall Study||6
6650910|NCT02415439|7580280|FG012|COMPLETED|Overall Study||8
6551139|NCT01730040|7473229|FG001|COMPLETED|Overall Study||40
6551140|NCT01730040|7473230|FG002|COMPLETED|Overall Study||46
6551141|NCT01730040|7473231|FG003|COMPLETED|Overall Study||39
6650911|NCT02415439|7580268|FG000|NOT COMPLETED|Overall Study||0
6650912|NCT02415439|7580269|FG001|NOT COMPLETED|Overall Study||0
6650913|NCT02415439|7580270|FG002|NOT COMPLETED|Overall Study||0
6650914|NCT02415439|7580271|FG003|NOT COMPLETED|Overall Study||0
6650915|NCT02415439|7580272|FG004|NOT COMPLETED|Overall Study||0
6650916|NCT02415439|7580273|FG005|NOT COMPLETED|Overall Study||0
6650917|NCT02415439|7580274|FG006|NOT COMPLETED|Overall Study||0
6305285|NCT00369915|7208570|FG001|NOT COMPLETED|Overall Study||3
6305286|NCT00369928|7208579|FG000|STARTED|Overall Study||85
6305287|NCT00369928|7208580|FG001|STARTED|Overall Study||85
6305288|NCT00369928|7208581|FG002|STARTED|Overall Study||86
6305289|NCT00369928|7208579|FG000|COMPLETED|Overall Study||77
6305290|NCT00369928|7208580|FG001|COMPLETED|Overall Study||69
6305291|NCT00369928|7208581|FG002|COMPLETED|Overall Study||66
6305292|NCT00369928|7208579|FG000|NOT COMPLETED|Overall Study||8
6305293|NCT00369928|7208580|FG001|NOT COMPLETED|Overall Study||16
6305294|NCT00369928|7208581|FG002|NOT COMPLETED|Overall Study||20
6305295|NCT00369941|7208591|FG000|STARTED|Overall Study||282
6305296|NCT00369941|7208592|FG001|STARTED|Overall Study||284
6305297|NCT00369941|7208591|FG000|Treated|Overall Study||281
6305298|NCT00369941|7208592|FG001|Treated|Overall Study||282
6305299|NCT00369941|7208591|FG000|COMPLETED|Overall Study||210
6305300|NCT00369941|7208592|FG001|COMPLETED|Overall Study||184
6305301|NCT00369941|7208591|FG000|NOT COMPLETED|Overall Study||72
6305302|NCT00369941|7208592|FG001|NOT COMPLETED|Overall Study||100
6305303|NCT00369967|7208601|FG000|STARTED|Overall Study||31
6650918|NCT02415439|7580275|FG007|NOT COMPLETED|Overall Study||0
6650919|NCT02415439|7580276|FG008|NOT COMPLETED|Overall Study||1
6305304|NCT00369967|7208602|FG001|STARTED|Overall Study||17
6305305|NCT00369967|7208601|FG000|COMPLETED|Overall Study||8
6305306|NCT00369967|7208602|FG001|COMPLETED|Overall Study||5
6305307|NCT00369967|7208601|FG000|NOT COMPLETED|Overall Study||23
6305308|NCT00369967|7208602|FG001|NOT COMPLETED|Overall Study||12
6305309|NCT00370032|7208614|FG000|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
6305310|NCT00370032|7208615|FG001|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
6305311|NCT00370032|7208614|FG000|COMPLETED|Treatment Period 1||24
6305312|NCT00370032|7208615|FG001|COMPLETED|Treatment Period 1||24
6305313|NCT00370032|7208614|FG000|NOT COMPLETED|Treatment Period 1||0
6305314|NCT00370032|7208615|FG001|NOT COMPLETED|Treatment Period 1||1
6305315|NCT00370032|7208614|FG000|STARTED|Washout Period||24
6305316|NCT00370032|7208615|FG001|STARTED|Washout Period||24
6305317|NCT00370032|7208614|FG000|COMPLETED|Washout Period||23
6305318|NCT00370032|7208615|FG001|COMPLETED|Washout Period||22
6305319|NCT00370032|7208614|FG000|NOT COMPLETED|Washout Period||1
6305320|NCT00370032|7208615|FG001|NOT COMPLETED|Washout Period||2
6305321|NCT00370032|7208614|FG000|STARTED|Treatment Period 2||23
6305322|NCT00370032|7208615|FG001|STARTED|Treatment Period 2||22
6305323|NCT00370032|7208614|FG000|COMPLETED|Treatment Period 2||23
6305324|NCT00370032|7208615|FG001|COMPLETED|Treatment Period 2||22
6305325|NCT00370032|7208614|FG000|NOT COMPLETED|Treatment Period 2||0
6305326|NCT00370032|7208615|FG001|NOT COMPLETED|Treatment Period 2||0
6305327|NCT00370032|7208614|FG000|STARTED|Follow-up Period||23
6305328|NCT00370032|7208615|FG001|STARTED|Follow-up Period||22
6305329|NCT00370032|7208614|FG000|COMPLETED|Follow-up Period||22
6305330|NCT00370032|7208615|FG001|COMPLETED|Follow-up Period||22
6305331|NCT00370032|7208614|FG000|NOT COMPLETED|Follow-up Period||1
6305332|NCT00370032|7208615|FG001|NOT COMPLETED|Follow-up Period||0
6305333|NCT00370071|7208630|FG000|STARTED|Overall Study||39
6305334|NCT00370071|7208630|FG000|COMPLETED|Overall Study||37
6305335|NCT00370071|7208630|FG000|NOT COMPLETED|Overall Study||2
6305336|NCT00370149|7208636|FG000|STARTED|Overall Study||165
6305337|NCT00370149|7208637|FG001|STARTED|Overall Study||161
6305338|NCT00370149|7208636|FG000|COMPLETED|Overall Study||146
6305339|NCT00370149|7208637|FG001|COMPLETED|Overall Study||142
6305340|NCT00370149|7208636|FG000|NOT COMPLETED|Overall Study||19
6305341|NCT00370149|7208637|FG001|NOT COMPLETED|Overall Study||19
6305342|NCT00370292|7208648|FG000|STARTED|Overall Study||19
6305343|NCT00370292|7208648|FG000|COMPLETED|Overall Study||6
6305344|NCT00370292|7208648|FG000|NOT COMPLETED|Overall Study||13
6374828|NCT00752219|7285383|FG001|Treated|Overall Study||102
6374829|NCT00752219|7285382|FG000|COMPLETED|Overall Study||91
6374830|NCT00752219|7285383|FG001|COMPLETED|Overall Study||96
6374831|NCT00752219|7285382|FG000|NOT COMPLETED|Overall Study||11
6374832|NCT00752219|7285383|FG001|NOT COMPLETED|Overall Study||6
6374833|NCT00752232|7285396|FG000|STARTED|Overall Study||6
6374834|NCT00752232|7285397|FG001|STARTED|Overall Study||6
6374835|NCT00752232|7285398|FG002|STARTED|Overall Study||6
6374836|NCT00752232|7285399|FG003|STARTED|Overall Study||6
6374837|NCT00752232|7285400|FG004|STARTED|Overall Study||6
6374838|NCT00752232|7285401|FG005|STARTED|Overall Study||6
6374839|NCT00752232|7285402|FG006|STARTED|Overall Study||4
6374840|NCT00752232|7285396|FG000|COMPLETED|Overall Study||4
6374841|NCT00752232|7285397|FG001|COMPLETED|Overall Study||6
6374842|NCT00752232|7285398|FG002|COMPLETED|Overall Study||5
6374843|NCT00752232|7285399|FG003|COMPLETED|Overall Study||5
6374844|NCT00752232|7285400|FG004|COMPLETED|Overall Study||3
6551142|NCT01730040|7473232|FG004|COMPLETED|Overall Study||39
6551143|NCT01730040|7473233|FG005|COMPLETED|Overall Study||40
6374845|NCT00752232|7285401|FG005|COMPLETED|Overall Study||5
6374846|NCT00752232|7285402|FG006|COMPLETED|Overall Study||4
6374847|NCT00752232|7285396|FG000|NOT COMPLETED|Overall Study||2
6374848|NCT00752232|7285397|FG001|NOT COMPLETED|Overall Study||0
6374849|NCT00752232|7285398|FG002|NOT COMPLETED|Overall Study||1
6374850|NCT00752232|7285399|FG003|NOT COMPLETED|Overall Study||1
6374851|NCT00752232|7285400|FG004|NOT COMPLETED|Overall Study||3
6374852|NCT00752232|7285401|FG005|NOT COMPLETED|Overall Study||1
6374853|NCT00752232|7285402|FG006|NOT COMPLETED|Overall Study||0
6374854|NCT00752557|7285422|FG000|STARTED|Overall Study||17
6374855|NCT00752557|7285423|FG001|STARTED|Overall Study||16
6374856|NCT00752557|7285424|FG002|STARTED|Overall Study||17
6374857|NCT00752557|7285422|FG000|COMPLETED|Overall Study||12
6374858|NCT00752557|7285423|FG001|COMPLETED|Overall Study||11
6374859|NCT00752557|7285424|FG002|COMPLETED|Overall Study||11
6374860|NCT00752557|7285422|FG000|NOT COMPLETED|Overall Study||5
6374861|NCT00752557|7285423|FG001|NOT COMPLETED|Overall Study||5
6374862|NCT00752557|7285424|FG002|NOT COMPLETED|Overall Study||6
6374863|NCT00752609|7285436|FG000|STARTED|Overall Study||53
6374864|NCT00752609|7285437|FG001|STARTED|Overall Study||49
6374865|NCT00752609|7285436|FG000|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
6374866|NCT00752609|7285437|FG001|Full Analysis Set|Overall Study||49
6374867|NCT00752609|7285436|FG000|COMPLETED|Overall Study||44
6374868|NCT00752609|7285437|FG001|COMPLETED|Overall Study||47
6374869|NCT00752609|7285436|FG000|NOT COMPLETED|Overall Study||9
6374870|NCT00752609|7285437|FG001|NOT COMPLETED|Overall Study||2
6374871|NCT00752622|7285446|FG000|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
6551144|NCT01730040|7473234|FG006|COMPLETED|Overall Study||38
6374872|NCT00752622|7285446|FG000|COMPLETED|Induction Phase||65
6374873|NCT00752622|7285446|FG000|NOT COMPLETED|Induction Phase||35
6374874|NCT00752622|7285446|FG000|STARTED|Observational Phase||65
6374875|NCT00752622|7285446|FG000|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
6374876|NCT00752622|7285446|FG000|NOT COMPLETED|Observational Phase||43
6374877|NCT00752622|7285446|FG000|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
6374878|NCT00752622|7285446|FG000|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
6374879|NCT00752622|7285446|FG000|NOT COMPLETED|Interventional Phase||8
6374880|NCT00752726|7285453|FG000|STARTED|Overall Study||65
6374881|NCT00752726|7285454|FG001|STARTED|Overall Study||66
6551145|NCT01730040|7473228|FG000|NOT COMPLETED|Overall Study||13
6551146|NCT01730040|7473229|FG001|NOT COMPLETED|Overall Study||15
6551147|NCT01730040|7473230|FG002|NOT COMPLETED|Overall Study||11
6551148|NCT01730040|7473231|FG003|NOT COMPLETED|Overall Study||8
6551149|NCT01730040|7473232|FG004|NOT COMPLETED|Overall Study||6
6551150|NCT01730040|7473233|FG005|NOT COMPLETED|Overall Study||7
6551151|NCT01730040|7473234|FG006|NOT COMPLETED|Overall Study||9
6551152|NCT01730053|7473256|FG000|STARTED|Overall Study||48
6551153|NCT01730053|7473257|FG001|STARTED|Overall Study||48
6551154|NCT01730053|7473258|FG002|STARTED|Overall Study||49
6551155|NCT01730053|7473259|FG003|STARTED|Overall Study||53
6551156|NCT01730053|7473260|FG004|STARTED|Overall Study||53
6551157|NCT01730053|7473261|FG005|STARTED|Overall Study||54
6551158|NCT01730053|7473256|FG000|Treated|Overall Study||48
6551159|NCT01730053|7473257|FG001|Treated|Overall Study||48
6551160|NCT01730053|7473258|FG002|Treated|Overall Study||49
6551161|NCT01730053|7473259|FG003|Treated|Overall Study||53
6551162|NCT01730053|7473260|FG004|Treated|Overall Study||53
6551163|NCT01730053|7473261|FG005|Treated|Overall Study||54
6551164|NCT01730053|7473256|FG000|COMPLETED|Overall Study||43
6551165|NCT01730053|7473257|FG001|COMPLETED|Overall Study||34
6551166|NCT01730053|7473258|FG002|COMPLETED|Overall Study||38
6551167|NCT01730053|7473259|FG003|COMPLETED|Overall Study||45
6551168|NCT01730053|7473260|FG004|COMPLETED|Overall Study||44
6551169|NCT01730053|7473261|FG005|COMPLETED|Overall Study||41
6551170|NCT01730053|7473256|FG000|NOT COMPLETED|Overall Study||5
6551171|NCT01730053|7473257|FG001|NOT COMPLETED|Overall Study||14
6551172|NCT01730053|7473258|FG002|NOT COMPLETED|Overall Study||11
6551173|NCT01730053|7473259|FG003|NOT COMPLETED|Overall Study||8
6551174|NCT01730053|7473260|FG004|NOT COMPLETED|Overall Study||9
6551175|NCT01730053|7473261|FG005|NOT COMPLETED|Overall Study||13
6551176|NCT01730339|7473278|FG000|STARTED|Overall Study||45
6551177|NCT01730339|7473279|FG001|STARTED|Overall Study||55
6551178|NCT01730339|7473278|FG000|COMPLETED|Overall Study||40
6551179|NCT01730339|7473279|FG001|COMPLETED|Overall Study||52
6551180|NCT01730339|7473278|FG000|NOT COMPLETED|Overall Study||5
6551181|NCT01730339|7473279|FG001|NOT COMPLETED|Overall Study||3
6551182|NCT01730378|7473297|FG000|STARTED|Overall Study||84
6551183|NCT01730378|7473298|FG001|STARTED|Overall Study||47
6551184|NCT01730378|7473297|FG000|COMPLETED|Overall Study||83
6551185|NCT01730378|7473298|FG001|COMPLETED|Overall Study||47
6551186|NCT01730378|7473297|FG000|NOT COMPLETED|Overall Study||1
6551187|NCT01730378|7473298|FG001|NOT COMPLETED|Overall Study||0
6551188|NCT01730534|7473307|FG000|STARTED|Overall Study||8582
6551189|NCT01730534|7473308|FG001|STARTED|Overall Study||8578
6551190|NCT01730534|7473307|FG000|COMPLETED|Overall Study||8473
6551191|NCT01730534|7473308|FG001|COMPLETED|Overall Study||8433
6551192|NCT01730534|7473307|FG000|NOT COMPLETED|Overall Study||109
6551193|NCT01730534|7473308|FG001|NOT COMPLETED|Overall Study||145
6551194|NCT01730586|7473314|FG000|STARTED|Overall Study||34
6551195|NCT01730586|7473314|FG000|COMPLETED|Overall Study||21
6551196|NCT01730586|7473314|FG000|NOT COMPLETED|Overall Study||13
6551197|NCT01730729|7473320|FG000|STARTED|Overall Study||20
6551198|NCT01730729|7473320|FG000|Completed 2 Cycles/Reached 1st Response|Overall Study||18
6551199|NCT01730729|7473320|FG000|Treated Cycle 3 and Beyond|Overall Study||6
6551200|NCT01730729|7473320|FG000|COMPLETED|Overall Study||6
6551201|NCT01730729|7473320|FG000|NOT COMPLETED|Overall Study||14
6551202|NCT01730846|7473327|FG000|STARTED|Overall Study||11
6551203|NCT01730846|7473328|FG001|STARTED|Overall Study||11
6551204|NCT01730846|7473329|FG002|STARTED|Overall Study||13
6551205|NCT01730846|7473327|FG000|COMPLETED|Overall Study||11
6551206|NCT01730846|7473328|FG001|COMPLETED|Overall Study||11
6551207|NCT01730846|7473329|FG002|COMPLETED|Overall Study||13
6551208|NCT01730846|7473327|FG000|NOT COMPLETED|Overall Study||0
6551209|NCT01730846|7473328|FG001|NOT COMPLETED|Overall Study||0
6551210|NCT01730846|7473329|FG002|NOT COMPLETED|Overall Study||0
6551211|NCT01730872|7473340|FG000|STARTED|Overall Study||8
6551212|NCT01730872|7473341|FG001|STARTED|Overall Study||5
6551213|NCT01730872|7473342|FG002|STARTED|Overall Study||3
6551214|NCT01730872|7473340|FG000|Full Analysis Set|Overall Study||8
6551215|NCT01730872|7473341|FG001|Full Analysis Set|Overall Study|1 subject did not complete the last post-CAE measurement on Day 6 and was excluded from the FAS|4
6551216|NCT01730872|7473342|FG002|Full Analysis Set|Overall Study||0
6551217|NCT01730872|7473340|FG000|COMPLETED|Overall Study||8
6551218|NCT01730872|7473341|FG001|COMPLETED|Overall Study||5
6551219|NCT01730872|7473342|FG002|COMPLETED|Overall Study||3
6551220|NCT01730872|7473340|FG000|NOT COMPLETED|Overall Study||0
6551221|NCT01730872|7473341|FG001|NOT COMPLETED|Overall Study||0
6551222|NCT01730872|7473342|FG002|NOT COMPLETED|Overall Study||0
6551223|NCT01730950|7473351|FG000|STARTED|Overall Study||90
6551224|NCT01730950|7473352|FG001|STARTED|Overall Study||92
6551225|NCT01730950|7473351|FG000|Eligible Population|Overall Study||84
6551226|NCT01730950|7473352|FG001|Eligible Population|Overall Study||86
6551227|NCT01730950|7473351|FG000|Adverse Event Population|Overall Study||76
6551228|NCT01730950|7473352|FG001|Adverse Event Population|Overall Study||83
6551229|NCT01730950|7473351|FG000|Response Population|Overall Study||78
6551230|NCT01730950|7473352|FG001|Response Population|Overall Study||77
6551231|NCT01730950|7473351|FG000|6-month Progression-free Analysis|Overall Study||79
6551232|NCT01730950|7473352|FG001|6-month Progression-free Analysis|Overall Study||81
6551233|NCT01730950|7473351|FG000|Delayed Toxicity Population|Overall Study||0
6551234|NCT01730950|7473352|FG001|Delayed Toxicity Population|Overall Study||83
6551235|NCT01730950|7473351|FG000|COMPLETED|Overall Study||84
6551236|NCT01730950|7473352|FG001|COMPLETED|Overall Study||86
6551237|NCT01730950|7473351|FG000|NOT COMPLETED|Overall Study||6
6551238|NCT01730950|7473352|FG001|NOT COMPLETED|Overall Study||6
6562715|NCT01802710|7485663|FG000|COMPLETED|From T1 to T2||58
6562716|NCT01802710|7485664|FG001|COMPLETED|From T1 to T2||70
6562717|NCT01802710|7485663|FG000|NOT COMPLETED|From T1 to T2||2
6562718|NCT01802710|7485664|FG001|NOT COMPLETED|From T1 to T2||2
6562719|NCT01802775|7485674|FG000|STARTED|Overall Study||102
6562720|NCT01802775|7485675|FG001|STARTED|Overall Study||101
6562721|NCT01802775|7485674|FG000|Received Drug (Safety Analysis Set)|Overall Study||101
6562722|NCT01802775|7485675|FG001|Received Drug (Safety Analysis Set)|Overall Study||100
6562723|NCT01802775|7485674|FG000|COMPLETED|Overall Study||96
6562724|NCT01802775|7485675|FG001|COMPLETED|Overall Study||89
6562725|NCT01802775|7485674|FG000|NOT COMPLETED|Overall Study||6
6562726|NCT01802775|7485675|FG001|NOT COMPLETED|Overall Study||12
6562727|NCT01802879|7485681|FG000|STARTED|Overall Study||8
6562728|NCT01802879|7485681|FG000|COMPLETED|Overall Study||0
6562729|NCT01802879|7485681|FG000|NOT COMPLETED|Overall Study||8
6562730|NCT01803074|7485699|FG000|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6562731|NCT01803074|7485700|FG001|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6562732|NCT01803074|7485701|FG002|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6551239|NCT01731002|7473362|FG000|STARTED|Overall Study||75
6551240|NCT01731002|7473363|FG001|STARTED|Overall Study||72
6551241|NCT01731002|7473364|FG002|STARTED|Overall Study||77
6551242|NCT01731002|7473362|FG000|COMPLETED|Overall Study||71
6422320|NCT01001221|7336928|FG004|Treated|Overall Study||0
6422321|NCT01001221|7336924|FG000|Completed 1st Treatment Cycle|Overall Study||5
6422322|NCT01001221|7336925|FG001|Completed 1st Treatment Cycle|Overall Study||5
6422323|NCT01001221|7336926|FG002|Completed 1st Treatment Cycle|Overall Study||2
6422324|NCT01001221|7336927|FG003|Completed 1st Treatment Cycle|Overall Study||6
6422325|NCT01001221|7336928|FG004|Completed 1st Treatment Cycle|Overall Study||0
6422326|NCT01001221|7336924|FG000|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
6422327|NCT01001221|7336925|FG001|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
6422328|NCT01001221|7336926|FG002|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
6422329|NCT01001221|7336927|FG003|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
6422330|NCT01001221|7336928|FG004|COMPLETED|Overall Study||0
6422331|NCT01001221|7336924|FG000|NOT COMPLETED|Overall Study||5
6422332|NCT01001221|7336925|FG001|NOT COMPLETED|Overall Study||5
6422333|NCT01001221|7336926|FG002|NOT COMPLETED|Overall Study||3
6422334|NCT01001221|7336927|FG003|NOT COMPLETED|Overall Study||6
6422335|NCT01001221|7336928|FG004|NOT COMPLETED|Overall Study||0
6551243|NCT01731002|7473363|FG001|COMPLETED|Overall Study||68
6551244|NCT01731002|7473364|FG002|COMPLETED|Overall Study||74
6305345|NCT04876274|7208661|FG000|STARTED|Overall Study||91
6305346|NCT04876274|7208662|FG001|STARTED|Overall Study||90
6305347|NCT04876274|7208661|FG000|COMPLETED|Overall Study||82
6305348|NCT04876274|7208662|FG001|COMPLETED|Overall Study||78
6305349|NCT04876274|7208661|FG000|NOT COMPLETED|Overall Study||9
6305350|NCT04876274|7208662|FG001|NOT COMPLETED|Overall Study||12
6305351|NCT04656691|7208668|FG000|STARTED|Overall Study||139
6305352|NCT04656691|7208668|FG000|COMPLETED|Overall Study||138
6305353|NCT04656691|7208668|FG000|NOT COMPLETED|Overall Study||1
6305354|NCT04615299|7208674|FG000|STARTED|Overall Study||36
6305355|NCT04615299|7208675|FG001|STARTED|Overall Study||36
6305356|NCT04615299|7208674|FG000|COMPLETED|Overall Study||36
6305357|NCT04615299|7208675|FG001|COMPLETED|Overall Study||36
6305358|NCT04615299|7208674|FG000|NOT COMPLETED|Overall Study||0
6305359|NCT04615299|7208675|FG001|NOT COMPLETED|Overall Study||0
6305360|NCT04555096|7208683|FG000|STARTED|Overall Study||9
6305361|NCT04555096|7208684|FG001|STARTED|Overall Study||7
6305362|NCT04555096|7208683|FG000|COMPLETED|Overall Study||4
6305363|NCT04555096|7208684|FG001|COMPLETED|Overall Study||2
6305364|NCT04555096|7208683|FG000|NOT COMPLETED|Overall Study||5
6305365|NCT04555096|7208684|FG001|NOT COMPLETED|Overall Study||5
6305366|NCT04150341|7208690|FG000|STARTED|Overall Study||4
6305367|NCT04150341|7208691|FG001|STARTED|Overall Study||4
6305368|NCT04150341|7208692|FG002|STARTED|Overall Study||4
6305369|NCT04150341|7208693|FG003|STARTED|Overall Study||4
6305370|NCT04150341|7208694|FG004|STARTED|Overall Study||4
6305371|NCT04150341|7208695|FG005|STARTED|Overall Study||4
6305372|NCT04150341|7208690|FG000|COMPLETED|Overall Study||4
6305373|NCT04150341|7208691|FG001|COMPLETED|Overall Study||4
6305374|NCT04150341|7208692|FG002|COMPLETED|Overall Study||3
6305375|NCT04150341|7208693|FG003|COMPLETED|Overall Study||4
6305376|NCT04150341|7208694|FG004|COMPLETED|Overall Study||3
6305377|NCT04150341|7208695|FG005|COMPLETED|Overall Study||4
6305378|NCT04150341|7208690|FG000|NOT COMPLETED|Overall Study||0
6305379|NCT04150341|7208691|FG001|NOT COMPLETED|Overall Study||0
6305380|NCT04150341|7208692|FG002|NOT COMPLETED|Overall Study||1
6305381|NCT04150341|7208693|FG003|NOT COMPLETED|Overall Study||0
6305382|NCT04150341|7208694|FG004|NOT COMPLETED|Overall Study||1
6305383|NCT04150341|7208695|FG005|NOT COMPLETED|Overall Study||0
6305384|NCT04115839|7208708|FG000|STARTED|Main Study (Up to 16 Weeks)||36
6305385|NCT04115839|7208709|FG001|STARTED|Main Study (Up to 16 Weeks)||34
6305386|NCT04115839|7208710|FG002|STARTED|Main Study (Up to 16 Weeks)||36
6305387|NCT04115839|7208711|FG003|STARTED|Main Study (Up to 16 Weeks)||0
6305388|NCT04115839|7208712|FG004|STARTED|Main Study (Up to 16 Weeks)||0
6305389|NCT04115839|7208713|FG005|STARTED|Main Study (Up to 16 Weeks)||0
6305390|NCT04115839|7208714|FG006|STARTED|Main Study (Up to 16 Weeks)||0
6305391|NCT04115839|7208708|FG000|COMPLETED|Main Study (Up to 16 Weeks)||18
6305392|NCT04115839|7208709|FG001|COMPLETED|Main Study (Up to 16 Weeks)||20
6305393|NCT04115839|7208710|FG002|COMPLETED|Main Study (Up to 16 Weeks)||18
6305394|NCT04115839|7208711|FG003|COMPLETED|Main Study (Up to 16 Weeks)||0
6305395|NCT04115839|7208712|FG004|COMPLETED|Main Study (Up to 16 Weeks)||0
6305396|NCT04115839|7208713|FG005|COMPLETED|Main Study (Up to 16 Weeks)||0
6305397|NCT04115839|7208714|FG006|COMPLETED|Main Study (Up to 16 Weeks)||0
6305398|NCT04115839|7208708|FG000|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
6305399|NCT04115839|7208709|FG001|NOT COMPLETED|Main Study (Up to 16 Weeks)||14
6305400|NCT04115839|7208710|FG002|NOT COMPLETED|Main Study (Up to 16 Weeks)||18
6305401|NCT04115839|7208711|FG003|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
6305402|NCT04115839|7208712|FG004|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
6305403|NCT04115839|7208713|FG005|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
6305404|NCT04115839|7208714|FG006|NOT COMPLETED|Main Study (Up to 16 Weeks)||0
6305405|NCT04115839|7208708|FG000|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
6305406|NCT04115839|7208709|FG001|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|0
6305407|NCT04115839|7208710|FG002|STARTED|LTE Phase (After Week 16 to Week 63)|18 participants who completed main study did not enter LTE phase.|0
6305408|NCT04115839|7208711|FG003|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|18
6305409|NCT04115839|7208712|FG004|STARTED|LTE Phase (After Week 16 to Week 63)|Participants who completed main study were randomised in LTE phase to receive filgotinib 200 mg or 100 mg.|20
6551245|NCT01731002|7473362|FG000|NOT COMPLETED|Overall Study||4
6551246|NCT01731002|7473363|FG001|NOT COMPLETED|Overall Study||4
6551247|NCT01731002|7473364|FG002|NOT COMPLETED|Overall Study||3
6551248|NCT01731041|7473374|FG000|STARTED|Overall Study||30
6551249|NCT01731041|7473375|FG001|STARTED|Overall Study||30
6551250|NCT01731041|7473374|FG000|COMPLETED|Overall Study||30
6551251|NCT01731041|7473375|FG001|COMPLETED|Overall Study||30
6551252|NCT01731041|7473374|FG000|NOT COMPLETED|Overall Study||0
6551253|NCT01731041|7473375|FG001|NOT COMPLETED|Overall Study||0
6551254|NCT01731119|7473381|FG000|STARTED|Overall Study||9
6551255|NCT01731119|7473381|FG000|COMPLETED|Overall Study||7
6551256|NCT01731119|7473381|FG000|NOT COMPLETED|Overall Study||2
6551257|NCT01731171|7473387|FG000|STARTED|Overall Study||33
6551258|NCT01731171|7473388|FG001|STARTED|Overall Study||33
6551259|NCT01731171|7473387|FG000|COMPLETED|Overall Study||26
6551260|NCT01731171|7473388|FG001|COMPLETED|Overall Study||26
6551261|NCT01731171|7473387|FG000|NOT COMPLETED|Overall Study||7
6551262|NCT01731171|7473388|FG001|NOT COMPLETED|Overall Study||7
6551263|NCT01731470|7473394|FG000|STARTED|Overall Study|Number of patients consented to participate in the study|16
6551264|NCT01731470|7473394|FG000|COMPLETED|Overall Study|Number of patients enrolled in the study|14
6551265|NCT01731470|7473394|FG000|NOT COMPLETED|Overall Study||2
6551266|NCT01731600|7473400|FG000|STARTED|Overall Study||34
6551267|NCT01731600|7473401|FG001|STARTED|Overall Study||34
6551268|NCT01731600|7473400|FG000|COMPLETED|Overall Study||28
6551269|NCT01731600|7473401|FG001|COMPLETED|Overall Study||34
6551270|NCT01731600|7473400|FG000|NOT COMPLETED|Overall Study||6
6551271|NCT01731600|7473401|FG001|NOT COMPLETED|Overall Study||0
6551272|NCT01731678|7473411|FG000|STARTED|Overall Study||39
6551273|NCT01731678|7473411|FG000|COMPLETED|Overall Study||32
6551274|NCT01731678|7473411|FG000|NOT COMPLETED|Overall Study||7
6551275|NCT01731691|7473418|FG000|STARTED|Overall Study||3
6551276|NCT01731691|7473419|FG001|STARTED|Overall Study||5
6551277|NCT01731691|7473420|FG002|STARTED|Overall Study||4
6551278|NCT01731691|7473418|FG000|COMPLETED|Overall Study||3
6551279|NCT01731691|7473419|FG001|COMPLETED|Overall Study||5
6551280|NCT01731691|7473420|FG002|COMPLETED|Overall Study||4
6551281|NCT01731691|7473418|FG000|NOT COMPLETED|Overall Study||0
6551282|NCT01731691|7473419|FG001|NOT COMPLETED|Overall Study||0
6551283|NCT01731691|7473420|FG002|NOT COMPLETED|Overall Study||0
6551284|NCT01731886|7473433|FG000|STARTED|Overall Study||31
6551285|NCT01731886|7473434|FG001|STARTED|Overall Study||29
6551286|NCT01731886|7473433|FG000|COMPLETED|Overall Study||29
6551287|NCT01731886|7473434|FG001|COMPLETED|Overall Study||28
6551288|NCT01731886|7473433|FG000|NOT COMPLETED|Overall Study||2
6551289|NCT01731886|7473434|FG001|NOT COMPLETED|Overall Study||1
6551290|NCT01731912|7473441|FG000|STARTED|Overall Study||16
6551291|NCT01731912|7473441|FG000|COMPLETED|Overall Study||14
6551292|NCT01731912|7473441|FG000|NOT COMPLETED|Overall Study||2
6551293|NCT01731938|7473449|FG000|STARTED|Preliminary Part I||51
6551294|NCT01731938|7473450|FG001|STARTED|Preliminary Part I||52
6551295|NCT01731938|7473449|FG000|COMPLETED|Preliminary Part I||48
6551296|NCT01731938|7473450|FG001|COMPLETED|Preliminary Part I||44
6551297|NCT01731938|7473449|FG000|NOT COMPLETED|Preliminary Part I||3
6551298|NCT01731938|7473450|FG001|NOT COMPLETED|Preliminary Part I||8
6551299|NCT01731938|7473449|FG000|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
6551300|NCT01731938|7473450|FG001|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
6551301|NCT01731938|7473449|FG000|COMPLETED|Primary Part II||103
6551302|NCT01731938|7473450|FG001|COMPLETED|Primary Part II||95
6551303|NCT01731938|7473449|FG000|NOT COMPLETED|Primary Part II||13
6551304|NCT01731938|7473450|FG001|NOT COMPLETED|Primary Part II||13
6551305|NCT01731951|7473463|FG000|STARTED|Overall Study||19
6551306|NCT01731951|7473464|FG001|STARTED|Overall Study||16
6551307|NCT01731951|7473465|FG002|STARTED|Overall Study||9
6551308|NCT01731951|7473466|FG003|STARTED|Overall Study||9
6551309|NCT01731951|7473467|FG004|STARTED|Overall Study||18
6551310|NCT01731951|7473468|FG005|STARTED|Overall Study||9
6551311|NCT01731951|7473463|FG000|COMPLETED|Overall Study||2
6551312|NCT01731951|7473464|FG001|COMPLETED|Overall Study||1
6551313|NCT01731951|7473465|FG002|COMPLETED|Overall Study||0
6551314|NCT01731951|7473466|FG003|COMPLETED|Overall Study||0
6551315|NCT01731951|7473467|FG004|COMPLETED|Overall Study||6
6551316|NCT01731951|7473468|FG005|COMPLETED|Overall Study||0
6551317|NCT01731951|7473463|FG000|NOT COMPLETED|Overall Study||17
6551318|NCT01731951|7473464|FG001|NOT COMPLETED|Overall Study||15
6551319|NCT01731951|7473465|FG002|NOT COMPLETED|Overall Study||9
6551320|NCT01731951|7473466|FG003|NOT COMPLETED|Overall Study||9
6551321|NCT01731951|7473467|FG004|NOT COMPLETED|Overall Study||12
6551322|NCT01731951|7473468|FG005|NOT COMPLETED|Overall Study||9
6551323|NCT01731990|7473488|FG000|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
6551324|NCT01731990|7473489|FG001|STARTED|Overall Study||20
6551325|NCT01731990|7473488|FG000|COMPLETED|Overall Study||14
6551326|NCT01731990|7473489|FG001|COMPLETED|Overall Study||12
6551327|NCT01731990|7473488|FG000|NOT COMPLETED|Overall Study||4
6551328|NCT01731990|7473489|FG001|NOT COMPLETED|Overall Study||8
6551329|NCT01732107|7473495|FG000|STARTED|Overall Study||13
6551330|NCT01732107|7473495|FG000|COMPLETED|Overall Study||0
6650920|NCT02415439|7580277|FG009|NOT COMPLETED|Overall Study||0
6650921|NCT02415439|7580278|FG010|NOT COMPLETED|Overall Study||0
6650922|NCT02415439|7580279|FG011|NOT COMPLETED|Overall Study||0
6650923|NCT02415439|7580280|FG012|NOT COMPLETED|Overall Study||0
6650924|NCT02415556|7580314|FG000|STARTED|Overall Study||57
6650925|NCT02415556|7580315|FG001|STARTED|Overall Study||58
6650926|NCT02415556|7580316|FG002|STARTED|Overall Study||65
6650927|NCT02415556|7580317|FG003|STARTED|Overall Study||64
6650928|NCT02415556|7580314|FG000|COMPLETED|Overall Study||32
6650929|NCT02415556|7580315|FG001|COMPLETED|Overall Study||37
6650930|NCT02415556|7580316|FG002|COMPLETED|Overall Study||43
6650931|NCT02415556|7580317|FG003|COMPLETED|Overall Study||44
6650932|NCT02415556|7580314|FG000|NOT COMPLETED|Overall Study||25
6650933|NCT02415556|7580315|FG001|NOT COMPLETED|Overall Study||21
6650934|NCT02415556|7580316|FG002|NOT COMPLETED|Overall Study||22
6650935|NCT02415556|7580317|FG003|NOT COMPLETED|Overall Study||20
6650936|NCT02415595|7580331|FG000|STARTED|Overall Study||50
6650937|NCT02415595|7580332|FG001|STARTED|Overall Study||52
6650938|NCT02415595|7580333|FG002|STARTED|Overall Study||51
6650939|NCT02415595|7580334|FG003|STARTED|Overall Study||53
6650940|NCT02415595|7580331|FG000|COMPLETED|Overall Study||0
6650941|NCT02415595|7580332|FG001|COMPLETED|Overall Study||0
6650942|NCT02415595|7580333|FG002|COMPLETED|Overall Study||0
6650943|NCT02415595|7580334|FG003|COMPLETED|Overall Study||0
6551331|NCT01732107|7473495|FG000|NOT COMPLETED|Overall Study||13
6551332|NCT01732263|7473501|FG000|STARTED|Overall Study||23
6551333|NCT01732263|7473502|FG001|STARTED|Overall Study||20
6551334|NCT01732263|7473501|FG000|COMPLETED|Overall Study||23
6551335|NCT01732263|7473502|FG001|COMPLETED|Overall Study||20
6551336|NCT01732263|7473501|FG000|NOT COMPLETED|Overall Study||0
6650944|NCT02415595|7580331|FG000|NOT COMPLETED|Overall Study||50
6650945|NCT02415595|7580332|FG001|NOT COMPLETED|Overall Study||52
6650946|NCT02415595|7580333|FG002|NOT COMPLETED|Overall Study||51
6650947|NCT02415595|7580334|FG003|NOT COMPLETED|Overall Study||53
6650948|NCT02415608|7580347|FG000|STARTED|Overall Study||3
6650949|NCT02415608|7580348|FG001|STARTED|Overall Study||1
6650950|NCT02415608|7580347|FG000|COMPLETED|Overall Study||3
6650951|NCT02415608|7580348|FG001|COMPLETED|Overall Study||1
6650952|NCT02415608|7580347|FG000|NOT COMPLETED|Overall Study||0
6650953|NCT02415608|7580348|FG001|NOT COMPLETED|Overall Study||0
6650954|NCT02415842|7580367|FG000|STARTED|Overall Study||29
6650955|NCT02415842|7580368|FG001|STARTED|Overall Study||29
6650956|NCT02415842|7580369|FG002|STARTED|Overall Study||29
6650957|NCT02415842|7580370|FG003|STARTED|Overall Study||27
6650958|NCT02415842|7580371|FG004|STARTED|Overall Study||30
6551337|NCT01732263|7473502|FG001|NOT COMPLETED|Overall Study||0
6551338|NCT01732406|7473515|FG000|STARTED|Overall Study||31
6650959|NCT02415842|7580372|FG005|STARTED|Overall Study||30
6551339|NCT01732406|7473516|FG001|STARTED|Overall Study||60
6551340|NCT01732406|7473517|FG002|STARTED|Overall Study||35
6551341|NCT01732406|7473515|FG000|COMPLETED|Overall Study||31
6650960|NCT02415842|7580373|FG006|STARTED|Overall Study||30
6650961|NCT02415842|7580374|FG007|STARTED|Overall Study||26
6650962|NCT02415842|7580375|FG008|STARTED|Overall Study||29
6650963|NCT02415842|7580376|FG009|STARTED|Overall Study||53
6650964|NCT02415842|7580377|FG010|STARTED|Overall Study||49
6650965|NCT02415842|7580378|FG011|STARTED|Overall Study||33
6650966|NCT02415842|7580379|FG012|STARTED|Overall Study||20
6650967|NCT02415842|7580367|FG000|COMPLETED|Overall Study||29
6650968|NCT02415842|7580368|FG001|COMPLETED|Overall Study||29
6650969|NCT02415842|7580369|FG002|COMPLETED|Overall Study||29
6650970|NCT02415842|7580370|FG003|COMPLETED|Overall Study||27
6650971|NCT02415842|7580371|FG004|COMPLETED|Overall Study||30
6551342|NCT01732406|7473516|FG001|COMPLETED|Overall Study||60
6551343|NCT01732406|7473517|FG002|COMPLETED|Overall Study||35
6551344|NCT01732406|7473515|FG000|NOT COMPLETED|Overall Study||0
6305410|NCT04115839|7208713|FG005|STARTED|LTE Phase (After Week 16 to Week 63)|10 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 200 mg.|10
6305411|NCT04115839|7208714|FG006|STARTED|LTE Phase (After Week 16 to Week 63)|8 participants who received placebo and completed main study were randomised in LTE phase to receive filgotinib 100 mg.|8
6305412|NCT04115839|7208708|FG000|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6305413|NCT04115839|7208709|FG001|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6305414|NCT04115839|7208710|FG002|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6305415|NCT04115839|7208711|FG003|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6305416|NCT04115839|7208712|FG004|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6422336|NCT01001299|7336939|FG000|STARTED|Overall Study||25
6422337|NCT01001299|7336939|FG000|COMPLETED|Overall Study||0
6422338|NCT01001299|7336939|FG000|NOT COMPLETED|Overall Study||25
6422339|NCT01001325|7336945|FG000|STARTED|Overall Study||234
6422340|NCT01001325|7336946|FG001|STARTED|Overall Study||234
6422341|NCT01001325|7336945|FG000|COMPLETED|Overall Study||216
6422342|NCT01001325|7336946|FG001|COMPLETED|Overall Study||224
6422343|NCT01001325|7336945|FG000|NOT COMPLETED|Overall Study||18
6422344|NCT01001325|7336946|FG001|NOT COMPLETED|Overall Study||10
6551345|NCT01732406|7473516|FG001|NOT COMPLETED|Overall Study||0
6551346|NCT01732406|7473517|FG002|NOT COMPLETED|Overall Study||0
6551347|NCT01732419|7473531|FG000|STARTED|Overall Study||45
6551348|NCT01732419|7473532|FG001|STARTED|Overall Study||45
6551349|NCT01732419|7473531|FG000|COMPLETED|Overall Study||37
6551350|NCT01732419|7473532|FG001|COMPLETED|Overall Study||41
6551351|NCT01732419|7473531|FG000|NOT COMPLETED|Overall Study||8
6305417|NCT04115839|7208713|FG005|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6650972|NCT02415842|7580372|FG005|COMPLETED|Overall Study||30
6650973|NCT02415842|7580373|FG006|COMPLETED|Overall Study||30
6650974|NCT02415842|7580374|FG007|COMPLETED|Overall Study||26
6650975|NCT02415842|7580375|FG008|COMPLETED|Overall Study||29
6650976|NCT02415842|7580376|FG009|COMPLETED|Overall Study||53
6650977|NCT02415842|7580377|FG010|COMPLETED|Overall Study||49
6551352|NCT01732419|7473532|FG001|NOT COMPLETED|Overall Study||4
6551353|NCT01732445|7473538|FG000|STARTED|Overall Study||14
6305418|NCT04115839|7208714|FG006|COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6377841|NCT00765375|7288501|FG000|NOT COMPLETED|Overall Study||0
6305419|NCT04115839|7208708|FG000|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6305420|NCT04115839|7208709|FG001|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6305421|NCT04115839|7208710|FG002|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||0
6305422|NCT04115839|7208711|FG003|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||18
6305423|NCT04115839|7208712|FG004|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||20
6305424|NCT04115839|7208713|FG005|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||10
6305425|NCT04115839|7208714|FG006|NOT COMPLETED|LTE Phase (After Week 16 to Week 63)||8
6305426|NCT04078126|7208739|FG000|STARTED|Period 1||18
6305427|NCT04078126|7208740|FG001|STARTED|Period 1||17
6305428|NCT04078126|7208739|FG000|COMPLETED|Period 1||18
6305429|NCT04078126|7208740|FG001|COMPLETED|Period 1||17
6305430|NCT04078126|7208739|FG000|NOT COMPLETED|Period 1||0
6305431|NCT04078126|7208740|FG001|NOT COMPLETED|Period 1||0
6305432|NCT04078126|7208739|FG000|STARTED|Washout||18
6305433|NCT04078126|7208740|FG001|STARTED|Washout||17
6305434|NCT04078126|7208739|FG000|COMPLETED|Washout||18
6305435|NCT04078126|7208740|FG001|COMPLETED|Washout||15
6305436|NCT04078126|7208739|FG000|NOT COMPLETED|Washout||0
6305437|NCT04078126|7208740|FG001|NOT COMPLETED|Washout||2
6305438|NCT04078126|7208739|FG000|STARTED|Period 2||18
6305439|NCT04078126|7208740|FG001|STARTED|Period 2||15
6305440|NCT04078126|7208739|FG000|COMPLETED|Period 2||17
6305441|NCT04078126|7208740|FG001|COMPLETED|Period 2||14
6305442|NCT04078126|7208739|FG000|NOT COMPLETED|Period 2||1
6305443|NCT04078126|7208740|FG001|NOT COMPLETED|Period 2||1
6374882|NCT00752726|7285453|FG000|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
6305444|NCT03825341|7208748|FG000|STARTED|Overall Study||0
6305445|NCT03825341|7208749|FG001|STARTED|Overall Study||1
6305446|NCT03825341|7208748|FG000|COMPLETED|Overall Study||0
6305447|NCT03825341|7208749|FG001|COMPLETED|Overall Study||0
6305448|NCT03825341|7208748|FG000|NOT COMPLETED|Overall Study||0
6305449|NCT03825341|7208749|FG001|NOT COMPLETED|Overall Study||1
6305450|NCT03751631|7208757|FG000|STARTED|Overall Study||10
6305451|NCT03751631|7208758|FG001|STARTED|Overall Study||11
6305452|NCT03751631|7208759|FG002|STARTED|Overall Study||11
6305453|NCT03751631|7208760|FG003|STARTED|Overall Study||11
6305454|NCT03751631|7208761|FG004|STARTED|Overall Study||10
6305455|NCT03751631|7208762|FG005|STARTED|Overall Study||11
6650978|NCT02415842|7580378|FG011|COMPLETED|Overall Study||33
6650979|NCT02415842|7580379|FG012|COMPLETED|Overall Study||20
6650980|NCT02415842|7580367|FG000|NOT COMPLETED|Overall Study||0
6650981|NCT02415842|7580368|FG001|NOT COMPLETED|Overall Study||0
6650982|NCT02415842|7580369|FG002|NOT COMPLETED|Overall Study||0
6650983|NCT02415842|7580370|FG003|NOT COMPLETED|Overall Study||0
6650984|NCT02415842|7580371|FG004|NOT COMPLETED|Overall Study||0
6650985|NCT02415842|7580372|FG005|NOT COMPLETED|Overall Study||0
6650986|NCT02415842|7580373|FG006|NOT COMPLETED|Overall Study||0
6650987|NCT02415842|7580374|FG007|NOT COMPLETED|Overall Study||0
6650988|NCT02415842|7580375|FG008|NOT COMPLETED|Overall Study||0
6650989|NCT02415842|7580376|FG009|NOT COMPLETED|Overall Study||0
6650990|NCT02415842|7580377|FG010|NOT COMPLETED|Overall Study||0
6650991|NCT02415842|7580378|FG011|NOT COMPLETED|Overall Study||0
6650992|NCT02415842|7580379|FG012|NOT COMPLETED|Overall Study||0
6650993|NCT02415855|7580426|FG000|STARTED|Overall Study||37
6650994|NCT02415855|7580427|FG001|STARTED|Overall Study||64
6650995|NCT02415855|7580426|FG000|COMPLETED|Overall Study||34
6650996|NCT02415855|7580427|FG001|COMPLETED|Overall Study||62
6650997|NCT02415855|7580426|FG000|NOT COMPLETED|Overall Study||3
6650998|NCT02415855|7580427|FG001|NOT COMPLETED|Overall Study||2
6650999|NCT02415959|7580438|FG000|STARTED|Overall Study||14
6651000|NCT02415959|7580439|FG001|STARTED|Overall Study||14
6651001|NCT02415959|7580440|FG002|STARTED|Overall Study||14
6651002|NCT02415959|7580441|FG003|STARTED|Overall Study||14
6551354|NCT01732445|7473538|FG000|COMPLETED|Overall Study||14
6551355|NCT01732445|7473538|FG000|NOT COMPLETED|Overall Study||0
6551356|NCT01732458|7473546|FG000|STARTED|Overall Study||60
6551357|NCT01732458|7473547|FG001|STARTED|Overall Study||58
6551358|NCT01732458|7473548|FG002|STARTED|Overall Study||58
6551359|NCT01732458|7473549|FG003|STARTED|Overall Study||52
6551360|NCT01732458|7473546|FG000|Treated|Overall Study||57
6551361|NCT01732458|7473547|FG001|Treated|Overall Study||55
6551362|NCT01732458|7473548|FG002|Treated|Overall Study||56
6651003|NCT02415959|7580442|FG004|STARTED|Overall Study||14
6551363|NCT01732458|7473549|FG003|Treated|Overall Study||52
6551364|NCT01732458|7473546|FG000|COMPLETED|Overall Study||57
6551365|NCT01732458|7473547|FG001|COMPLETED|Overall Study||53
6551366|NCT01732458|7473548|FG002|COMPLETED|Overall Study||55
6551367|NCT01732458|7473549|FG003|COMPLETED|Overall Study||50
6551368|NCT01732458|7473546|FG000|NOT COMPLETED|Overall Study||3
6551369|NCT01732458|7473547|FG001|NOT COMPLETED|Overall Study||5
6551370|NCT01732458|7473548|FG002|NOT COMPLETED|Overall Study||3
6551371|NCT01732458|7473549|FG003|NOT COMPLETED|Overall Study||2
6551372|NCT01732471|7473571|FG000|STARTED|Overall Study||90
6551373|NCT01732471|7473571|FG000|COMPLETED|Overall Study||89
6551374|NCT01732471|7473571|FG000|NOT COMPLETED|Overall Study||1
6551375|NCT01732484|7473575|FG000|STARTED|Overall Study||100
6551376|NCT01732484|7473575|FG000|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
6551377|NCT01732484|7473575|FG000|Allocation|Overall Study||100
6551378|NCT01732484|7473575|FG000|COMPLETED|Overall Study||74
6744214|NCT03341299|7672343|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
6744215|NCT03341299|7672340|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744216|NCT03341299|7672341|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744217|NCT03341299|7672342|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||1
6744218|NCT03341299|7672343|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744219|NCT03341299|7672340|FG000|STARTED|Period 2||9
6744220|NCT03341299|7672341|FG001|STARTED|Period 2||9
6744221|NCT03341299|7672342|FG002|STARTED|Period 2||8
6744222|NCT03341299|7672343|FG003|STARTED|Period 2||9
6744223|NCT03341299|7672340|FG000|COMPLETED|Period 2||9
6744224|NCT03341299|7672341|FG001|COMPLETED|Period 2||9
6744225|NCT03341299|7672342|FG002|COMPLETED|Period 2||8
6744226|NCT03341299|7672343|FG003|COMPLETED|Period 2||9
6744227|NCT03341299|7672340|FG000|NOT COMPLETED|Period 2||0
6744228|NCT03341299|7672341|FG001|NOT COMPLETED|Period 2||0
6744229|NCT03341299|7672342|FG002|NOT COMPLETED|Period 2||0
6744230|NCT03341299|7672343|FG003|NOT COMPLETED|Period 2||0
6744231|NCT03341299|7672340|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
6744232|NCT03341299|7672341|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
6744233|NCT03341299|7672342|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
6744234|NCT03341299|7672343|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
6744235|NCT03341299|7672340|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
6744236|NCT03341299|7672341|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
6551379|NCT01732484|7473575|FG000|NOT COMPLETED|Overall Study||26
6551380|NCT01732510|7473588|FG000|STARTED|Overall Study||9
6305456|NCT03751631|7208757|FG000|Received 1st Drug in Sequence|Overall Study||10
6305457|NCT03751631|7208758|FG001|Received 1st Drug in Sequence|Overall Study||11
6305458|NCT03751631|7208759|FG002|Received 1st Drug in Sequence|Overall Study||11
6305459|NCT03751631|7208760|FG003|Received 1st Drug in Sequence|Overall Study||11
6305460|NCT03751631|7208761|FG004|Received 1st Drug in Sequence|Overall Study||10
6305461|NCT03751631|7208762|FG005|Received 1st Drug in Sequence|Overall Study||11
6305462|NCT03751631|7208757|FG000|Received 2nd Drug in Sequence|Overall Study||10
6305463|NCT03751631|7208758|FG001|Received 2nd Drug in Sequence|Overall Study||11
6305464|NCT03751631|7208759|FG002|Received 2nd Drug in Sequence|Overall Study||10
6305465|NCT03751631|7208760|FG003|Received 2nd Drug in Sequence|Overall Study||10
6305466|NCT03751631|7208761|FG004|Received 2nd Drug in Sequence|Overall Study||10
6305467|NCT03751631|7208762|FG005|Received 2nd Drug in Sequence|Overall Study||11
6305468|NCT03751631|7208757|FG000|Received 3rd Drug in Sequence|Overall Study||10
6305469|NCT03751631|7208758|FG001|Received 3rd Drug in Sequence|Overall Study||11
6305470|NCT03751631|7208759|FG002|Received 3rd Drug in Sequence|Overall Study||10
6305471|NCT03751631|7208760|FG003|Received 3rd Drug in Sequence|Overall Study||10
6305472|NCT03751631|7208761|FG004|Received 3rd Drug in Sequence|Overall Study||10
6305473|NCT03751631|7208762|FG005|Received 3rd Drug in Sequence|Overall Study||11
6305474|NCT03751631|7208757|FG000|COMPLETED|Overall Study||10
6305475|NCT03751631|7208758|FG001|COMPLETED|Overall Study||11
6305476|NCT03751631|7208759|FG002|COMPLETED|Overall Study||10
6305477|NCT03751631|7208760|FG003|COMPLETED|Overall Study||10
6305478|NCT03751631|7208761|FG004|COMPLETED|Overall Study||10
6305479|NCT03751631|7208762|FG005|COMPLETED|Overall Study||11
6305480|NCT03751631|7208757|FG000|NOT COMPLETED|Overall Study||0
6305481|NCT03751631|7208758|FG001|NOT COMPLETED|Overall Study||0
6305482|NCT03751631|7208759|FG002|NOT COMPLETED|Overall Study||1
6305483|NCT03751631|7208760|FG003|NOT COMPLETED|Overall Study||1
6305484|NCT03751631|7208761|FG004|NOT COMPLETED|Overall Study||0
6305485|NCT03751631|7208762|FG005|NOT COMPLETED|Overall Study||0
6305486|NCT03751098|7208773|FG000|STARTED|Overall Study||37
6305487|NCT03751098|7208774|FG001|STARTED|Overall Study||33
6305488|NCT03751098|7208773|FG000|COMPLETED|Overall Study||37
6305489|NCT03751098|7208774|FG001|COMPLETED|Overall Study||32
6305490|NCT03751098|7208773|FG000|NOT COMPLETED|Overall Study||0
6305491|NCT03751098|7208774|FG001|NOT COMPLETED|Overall Study||1
6305492|NCT03673345|7208790|FG000|STARTED|Overall Study||5
6305493|NCT03673345|7208791|FG001|STARTED|Overall Study||3
6305494|NCT03673345|7208792|FG002|STARTED|Overall Study||57
6305495|NCT03673345|7208793|FG003|STARTED|Overall Study||12
6305496|NCT03673345|7208794|FG004|STARTED|Overall Study||21
6305497|NCT03673345|7208795|FG005|STARTED|Overall Study||7
6305498|NCT03673345|7208796|FG006|STARTED|Overall Study||20
6305499|NCT03673345|7208797|FG007|STARTED|Overall Study||0
6305500|NCT03673345|7208790|FG000|COMPLETED|Overall Study||3
6305501|NCT03673345|7208791|FG001|COMPLETED|Overall Study||3
6305502|NCT03673345|7208792|FG002|COMPLETED|Overall Study||48
6305503|NCT03673345|7208793|FG003|COMPLETED|Overall Study||7
6305504|NCT03673345|7208794|FG004|COMPLETED|Overall Study||19
6305505|NCT03673345|7208795|FG005|COMPLETED|Overall Study||6
6305506|NCT03673345|7208796|FG006|COMPLETED|Overall Study||20
6305507|NCT03673345|7208797|FG007|COMPLETED|Overall Study||0
6305508|NCT03673345|7208790|FG000|NOT COMPLETED|Overall Study||2
6305509|NCT03673345|7208791|FG001|NOT COMPLETED|Overall Study||0
6305510|NCT03673345|7208792|FG002|NOT COMPLETED|Overall Study||9
6305511|NCT03673345|7208793|FG003|NOT COMPLETED|Overall Study||5
6305512|NCT03673345|7208794|FG004|NOT COMPLETED|Overall Study||2
6305513|NCT03673345|7208795|FG005|NOT COMPLETED|Overall Study||1
6305514|NCT03673345|7208796|FG006|NOT COMPLETED|Overall Study||0
6305515|NCT03673345|7208797|FG007|NOT COMPLETED|Overall Study||0
6305516|NCT03418675|7208817|FG000|STARTED|Overall Study||40
6551381|NCT01732510|7473589|FG001|STARTED|Overall Study||9
6551382|NCT01732510|7473590|FG002|STARTED|Overall Study||8
6551383|NCT01732510|7473591|FG003|STARTED|Overall Study||10
6551384|NCT01732510|7473592|FG004|STARTED|Overall Study||8
6551385|NCT01732510|7473593|FG005|STARTED|Overall Study||13
6551386|NCT01732510|7473594|FG006|STARTED|Overall Study||8
6551387|NCT01732510|7473588|FG000|COMPLETED|Overall Study||8
6551388|NCT01732510|7473589|FG001|COMPLETED|Overall Study||4
6551389|NCT01732510|7473590|FG002|COMPLETED|Overall Study||4
6551390|NCT01732510|7473591|FG003|COMPLETED|Overall Study||5
6551391|NCT01732510|7473592|FG004|COMPLETED|Overall Study||3
6305517|NCT03418675|7208818|FG001|STARTED|Overall Study||40
6305518|NCT03418675|7208817|FG000|Completed All Baseline Measures|Overall Study||37
6305519|NCT03418675|7208818|FG001|Completed All Baseline Measures|Overall Study||40
6651004|NCT02415959|7580438|FG000|COMPLETED|Overall Study||14
6651005|NCT02415959|7580439|FG001|COMPLETED|Overall Study||13
6651006|NCT02415959|7580440|FG002|COMPLETED|Overall Study||14
6651007|NCT02415959|7580441|FG003|COMPLETED|Overall Study||13
6305520|NCT03418675|7208817|FG000|Completed One-post Randomization Visit|Overall Study||34
6305521|NCT03418675|7208818|FG001|Completed One-post Randomization Visit|Overall Study||35
6305522|NCT03418675|7208817|FG000|COMPLETED|Overall Study||25
6305523|NCT03418675|7208818|FG001|COMPLETED|Overall Study||30
6305524|NCT03418675|7208817|FG000|NOT COMPLETED|Overall Study||15
6305525|NCT03418675|7208818|FG001|NOT COMPLETED|Overall Study||10
6305526|NCT03367910|7208824|FG000|STARTED|Overall Study||1
6305527|NCT03367910|7208824|FG000|COMPLETED|Overall Study||1
6305528|NCT03367910|7208824|FG000|NOT COMPLETED|Overall Study||0
6305529|NCT03329690|7208833|FG000|STARTED|Overall Study||126
6305530|NCT03329690|7208834|FG001|STARTED|Overall Study||55
6305531|NCT03329690|7208835|FG002|STARTED|Overall Study||7
6551392|NCT01732510|7473593|FG005|COMPLETED|Overall Study||0
6551393|NCT01732510|7473594|FG006|COMPLETED|Overall Study||0
6551394|NCT01732510|7473588|FG000|NOT COMPLETED|Overall Study||1
6305532|NCT03329690|7208836|FG003|STARTED|Overall Study||21
6305533|NCT03329690|7208837|FG004|STARTED|Overall Study||24
6305534|NCT03329690|7208833|FG000|Received Treatment|Overall Study||125
6305535|NCT03329690|7208834|FG001|Received Treatment|Overall Study||55
6305536|NCT03329690|7208835|FG002|Received Treatment|Overall Study||7
6305537|NCT03329690|7208836|FG003|Received Treatment|Overall Study||20
6305538|NCT03329690|7208837|FG004|Received Treatment|Overall Study||24
6305539|NCT03329690|7208833|FG000|COMPLETED|Overall Study||0
6305540|NCT03329690|7208834|FG001|COMPLETED|Overall Study||0
6305541|NCT03329690|7208835|FG002|COMPLETED|Overall Study||0
6305542|NCT03329690|7208836|FG003|COMPLETED|Overall Study||0
6305543|NCT03329690|7208837|FG004|COMPLETED|Overall Study||0
6305544|NCT03329690|7208833|FG000|NOT COMPLETED|Overall Study||126
6305545|NCT03329690|7208834|FG001|NOT COMPLETED|Overall Study||55
6305546|NCT03329690|7208835|FG002|NOT COMPLETED|Overall Study||7
6305547|NCT03329690|7208836|FG003|NOT COMPLETED|Overall Study||21
6305548|NCT03329690|7208837|FG004|NOT COMPLETED|Overall Study||24
6305549|NCT03320564|7208855|FG000|STARTED|Overall Study||2
6305550|NCT03320564|7208855|FG000|COMPLETED|Overall Study||1
6305551|NCT03320564|7208855|FG000|NOT COMPLETED|Overall Study||1
6305552|NCT03302234|7208861|FG000|STARTED|Overall Study||284
6305553|NCT03302234|7208862|FG001|STARTED|Overall Study||284
6305554|NCT03302234|7208861|FG000|COMPLETED|Overall Study||146
6305555|NCT03302234|7208862|FG001|COMPLETED|Overall Study||147
6305556|NCT03302234|7208861|FG000|NOT COMPLETED|Overall Study||138
6305557|NCT03302234|7208862|FG001|NOT COMPLETED|Overall Study||137
6305558|NCT03235817|7208872|FG000|STARTED|Overall Study||13
6305559|NCT03235817|7208873|FG001|STARTED|Overall Study||13
6305560|NCT03235817|7208874|FG002|STARTED|Overall Study||13
6305561|NCT03235817|7208872|FG000|COMPLETED|Overall Study||10
6305562|NCT03235817|7208873|FG001|COMPLETED|Overall Study||12
6305563|NCT03235817|7208874|FG002|COMPLETED|Overall Study||11
6305564|NCT03235817|7208872|FG000|NOT COMPLETED|Overall Study||3
6305565|NCT03235817|7208873|FG001|NOT COMPLETED|Overall Study||1
6305566|NCT03235817|7208874|FG002|NOT COMPLETED|Overall Study||2
6374883|NCT00752726|7285454|FG001|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
6374884|NCT00752726|7285453|FG000|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
6374885|NCT00752726|7285454|FG001|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
6374886|NCT00752726|7285453|FG000|COMPLETED|Overall Study||54
6374887|NCT00752726|7285454|FG001|COMPLETED|Overall Study||53
6374888|NCT00752726|7285453|FG000|NOT COMPLETED|Overall Study||11
6374889|NCT00752726|7285454|FG001|NOT COMPLETED|Overall Study||13
6374890|NCT00752791|7285460|FG000|STARTED|Overall Study||59
6374891|NCT00752791|7285460|FG000|COMPLETED|Overall Study||43
6374892|NCT00752791|7285460|FG000|NOT COMPLETED|Overall Study||16
6374893|NCT00752856|7285466|FG000|STARTED|Overall Study||26
6374894|NCT00752856|7285467|FG001|STARTED|Overall Study||25
6374895|NCT00752856|7285466|FG000|COMPLETED|Overall Study||26
6374896|NCT00752856|7285467|FG001|COMPLETED|Overall Study||24
6551395|NCT01732510|7473589|FG001|NOT COMPLETED|Overall Study||5
6374897|NCT00752856|7285466|FG000|NOT COMPLETED|Overall Study||0
6374898|NCT00752856|7285467|FG001|NOT COMPLETED|Overall Study||1
6374899|NCT00752895|7285475|FG000|STARTED|Overall Study||147
6374900|NCT00752895|7285476|FG001|STARTED|Overall Study||146
6374901|NCT00752895|7285475|FG000|COMPLETED|Overall Study||139
6374902|NCT00752895|7285476|FG001|COMPLETED|Overall Study||143
6374903|NCT00752895|7285475|FG000|NOT COMPLETED|Overall Study||8
6551396|NCT01732510|7473590|FG002|NOT COMPLETED|Overall Study||4
6551397|NCT01732510|7473591|FG003|NOT COMPLETED|Overall Study||5
6551398|NCT01732510|7473592|FG004|NOT COMPLETED|Overall Study||5
6551399|NCT01732510|7473593|FG005|NOT COMPLETED|Overall Study||13
6551400|NCT01732510|7473594|FG006|NOT COMPLETED|Overall Study||8
6551401|NCT01732536|7473615|FG000|STARTED|Overall Study||53
6551402|NCT01732536|7473616|FG001|STARTED|Overall Study||47
6551403|NCT01732536|7473615|FG000|COMPLETED|Overall Study||52
6551404|NCT01732536|7473616|FG001|COMPLETED|Overall Study||46
6551405|NCT01732536|7473615|FG000|NOT COMPLETED|Overall Study||1
6551406|NCT01732536|7473616|FG001|NOT COMPLETED|Overall Study||1
6551407|NCT01732549|7473627|FG000|STARTED|Overall Study||71
6551408|NCT01732549|7473628|FG001|STARTED|Overall Study||73
6551409|NCT01732549|7473627|FG000|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
6551410|NCT01732549|7473628|FG001|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
6551411|NCT01732549|7473627|FG000|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
6551412|NCT01732549|7473628|FG001|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
6551413|NCT01732549|7473627|FG000|Ongoing Treatment Period:Final Analysis|Overall Study||0
6551414|NCT01732549|7473628|FG001|Ongoing Treatment Period:Final Analysis|Overall Study||0
6551415|NCT01732549|7473627|FG000|Withdrawn During Treatment:Final Analysi|Overall Study||71
6551416|NCT01732549|7473628|FG001|Withdrawn During Treatment:Final Analysi|Overall Study||73
6651008|NCT02415959|7580442|FG004|COMPLETED|Overall Study||14
6651009|NCT02415959|7580438|FG000|NOT COMPLETED|Overall Study||0
6651010|NCT02415959|7580439|FG001|NOT COMPLETED|Overall Study||1
6551417|NCT01732549|7473627|FG000|COMPLETED|Overall Study||0
6551418|NCT01732549|7473628|FG001|COMPLETED|Overall Study||0
6551419|NCT01732549|7473627|FG000|NOT COMPLETED|Overall Study||71
6551420|NCT01732549|7473628|FG001|NOT COMPLETED|Overall Study||73
6551421|NCT01732588|7473638|FG000|STARTED|First Intervention (7 Days)||4
6551422|NCT01732588|7473639|FG001|STARTED|First Intervention (7 Days)||3
6551423|NCT01732588|7473640|FG002|STARTED|First Intervention (7 Days)||4
6551424|NCT01732588|7473638|FG000|COMPLETED|First Intervention (7 Days)||4
6551425|NCT01732588|7473639|FG001|COMPLETED|First Intervention (7 Days)||2
6551426|NCT01732588|7473640|FG002|COMPLETED|First Intervention (7 Days)||4
6551427|NCT01732588|7473638|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6551428|NCT01732588|7473639|FG001|NOT COMPLETED|First Intervention (7 Days)||1
6551429|NCT01732588|7473640|FG002|NOT COMPLETED|First Intervention (7 Days)||0
6551430|NCT01732588|7473638|FG000|STARTED|Second Intervention (7 Days)||4
6651011|NCT02415959|7580440|FG002|NOT COMPLETED|Overall Study||0
6651012|NCT02415959|7580441|FG003|NOT COMPLETED|Overall Study||1
6651013|NCT02415959|7580442|FG004|NOT COMPLETED|Overall Study||0
6651014|NCT02415998|7580454|FG000|STARTED|Overall Study||25
6551431|NCT01732588|7473639|FG001|STARTED|Second Intervention (7 Days)||2
6651015|NCT02415998|7580454|FG000|COMPLETED|Overall Study||20
6651016|NCT02415998|7580454|FG000|NOT COMPLETED|Overall Study||5
6651017|NCT02416102|7580461|FG000|STARTED|Overall Study||16
6305567|NCT03165955|7208883|FG000|STARTED|Screening/Baseline||31
6305568|NCT03165955|7208883|FG000|COMPLETED|Screening/Baseline||28
6305569|NCT03165955|7208883|FG000|NOT COMPLETED|Screening/Baseline||3
6305570|NCT03165955|7208883|FG000|STARTED|Treatment||28
6305571|NCT03165955|7208883|FG000|COMPLETED|Treatment||20
6305572|NCT03165955|7208883|FG000|NOT COMPLETED|Treatment||8
6305573|NCT03133793|7208891|FG000|STARTED|Overall Study||39
6305574|NCT03133793|7208892|FG001|STARTED|Overall Study||39
6305575|NCT03133793|7208893|FG002|STARTED|Overall Study||37
6305576|NCT03133793|7208894|FG003|STARTED|Overall Study||38
6305577|NCT03133793|7208891|FG000|COMPLETED|Overall Study||38
6305578|NCT03133793|7208892|FG001|COMPLETED|Overall Study||35
6305579|NCT03133793|7208893|FG002|COMPLETED|Overall Study||33
6305580|NCT03133793|7208894|FG003|COMPLETED|Overall Study||33
6305581|NCT03133793|7208891|FG000|NOT COMPLETED|Overall Study||1
6305582|NCT03133793|7208892|FG001|NOT COMPLETED|Overall Study||4
6305583|NCT03133793|7208893|FG002|NOT COMPLETED|Overall Study||4
6305584|NCT03133793|7208894|FG003|NOT COMPLETED|Overall Study||5
6305585|NCT03103542|7208908|FG000|STARTED|Overall Study|18 - screened 16 - enrolled|16
6305586|NCT03103542|7208908|FG000|COMPLETED|Overall Study||9
6305587|NCT03103542|7208908|FG000|NOT COMPLETED|Overall Study||7
6305588|NCT03086317|7208915|FG000|STARTED|Overall Study||10
6305589|NCT03086317|7208916|FG001|STARTED|Overall Study||8
6305590|NCT03086317|7208915|FG000|COMPLETED|Overall Study||10
6305591|NCT03086317|7208916|FG001|COMPLETED|Overall Study||8
6305592|NCT03086317|7208915|FG000|NOT COMPLETED|Overall Study||0
6551432|NCT01732588|7473640|FG002|STARTED|Second Intervention (7 Days)||4
6551433|NCT01732588|7473638|FG000|COMPLETED|Second Intervention (7 Days)||4
6551434|NCT01732588|7473639|FG001|COMPLETED|Second Intervention (7 Days)||2
6551435|NCT01732588|7473640|FG002|COMPLETED|Second Intervention (7 Days)||4
6551436|NCT01732588|7473638|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6551437|NCT01732588|7473639|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6551438|NCT01732588|7473640|FG002|NOT COMPLETED|Second Intervention (7 Days)||0
6551439|NCT01732588|7473638|FG000|STARTED|Third Intervention (7 Days)||4
6551440|NCT01732588|7473639|FG001|STARTED|Third Intervention (7 Days)||2
6551441|NCT01732588|7473640|FG002|STARTED|Third Intervention (7 Days)||4
6305593|NCT03086317|7208916|FG001|NOT COMPLETED|Overall Study||0
6305594|NCT03063203|7208922|FG000|STARTED|Overall Study||17
6305595|NCT03063203|7208922|FG000|COMPLETED|Overall Study||3
6305596|NCT03063203|7208922|FG000|NOT COMPLETED|Overall Study||14
6305597|NCT02676765|7208935|FG000|STARTED|Overall Study||10
6305598|NCT02676765|7208936|FG001|STARTED|Overall Study||10
6305599|NCT02676765|7208935|FG000|COMPLETED|Overall Study||10
6305600|NCT02676765|7208936|FG001|COMPLETED|Overall Study||9
6305601|NCT02676765|7208935|FG000|NOT COMPLETED|Overall Study||0
6305602|NCT02676765|7208936|FG001|NOT COMPLETED|Overall Study||1
6305603|NCT02539563|7208944|FG000|STARTED|Overall Study||45
6305604|NCT02539563|7208945|FG001|STARTED|Overall Study||56
6305605|NCT02539563|7208944|FG000|COMPLETED|Overall Study||39
6305606|NCT02539563|7208945|FG001|COMPLETED|Overall Study||42
6305607|NCT02539563|7208944|FG000|NOT COMPLETED|Overall Study||6
6305608|NCT02539563|7208945|FG001|NOT COMPLETED|Overall Study||14
6374904|NCT00752895|7285476|FG001|NOT COMPLETED|Overall Study||3
6374905|NCT00752908|7285484|FG000|STARTED|Overall Study||14
6374906|NCT00752908|7285485|FG001|STARTED|Overall Study||13
6374907|NCT00752908|7285484|FG000|COMPLETED|Overall Study||14
6374908|NCT00752908|7285485|FG001|COMPLETED|Overall Study||13
6374909|NCT00752908|7285484|FG000|NOT COMPLETED|Overall Study||0
6374910|NCT00752908|7285485|FG001|NOT COMPLETED|Overall Study||0
6374911|NCT00752973|7285491|FG000|STARTED|Overall Study||12
6374912|NCT00752973|7285491|FG000|COMPLETED|Overall Study||12
6374913|NCT00752973|7285491|FG000|NOT COMPLETED|Overall Study||0
6374914|NCT00753012|7285499|FG000|STARTED|Overall Study||15
6374915|NCT00753012|7285500|FG001|STARTED|Overall Study||9
6374916|NCT00753012|7285499|FG000|COMPLETED|Overall Study||7
6374917|NCT00753012|7285500|FG001|COMPLETED|Overall Study||8
6374918|NCT00753012|7285499|FG000|NOT COMPLETED|Overall Study||8
6374919|NCT00753012|7285500|FG001|NOT COMPLETED|Overall Study||1
6374920|NCT00753142|7285510|FG000|STARTED|Overall Study||8
6374921|NCT00753142|7285511|FG001|STARTED|Overall Study||7
6374922|NCT00753142|7285512|FG002|STARTED|Overall Study||13
6374923|NCT00753142|7285510|FG000|COMPLETED|Overall Study||8
6305612|NCT02422446|7208957|FG000|STARTED|Overall Study||1
6305613|NCT02422446|7208958|FG001|STARTED|Overall Study||1
6651018|NCT02416102|7580462|FG001|STARTED|Overall Study||15
6651019|NCT02416102|7580463|FG002|STARTED|Overall Study||0
6651020|NCT02416102|7580461|FG000|COMPLETED|Overall Study||7
6651021|NCT02416102|7580462|FG001|COMPLETED|Overall Study||7
6651022|NCT02416102|7580463|FG002|COMPLETED|Overall Study||0
6551442|NCT01732588|7473638|FG000|COMPLETED|Third Intervention (7 Days)||4
6551443|NCT01732588|7473639|FG001|COMPLETED|Third Intervention (7 Days)||2
6551444|NCT01732588|7473640|FG002|COMPLETED|Third Intervention (7 Days)||4
6551445|NCT01732588|7473638|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
6551446|NCT01732588|7473639|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
6551447|NCT01732588|7473640|FG002|NOT COMPLETED|Third Intervention (7 Days)||0
6551448|NCT01732640|7473648|FG000|STARTED|Overall Study||6
6551449|NCT01732640|7473649|FG001|STARTED|Overall Study||3
6551450|NCT01732640|7473648|FG000|COMPLETED|Overall Study||6
6551451|NCT01732640|7473649|FG001|COMPLETED|Overall Study||1
6551452|NCT01732640|7473648|FG000|NOT COMPLETED|Overall Study||0
6551453|NCT01732640|7473649|FG001|NOT COMPLETED|Overall Study||2
6551454|NCT01732692|7473661|FG000|STARTED|Overall Study||70
6551455|NCT01732692|7473662|FG001|STARTED|Overall Study||70
6651023|NCT02416102|7580461|FG000|NOT COMPLETED|Overall Study||9
6551456|NCT01732692|7473661|FG000|COMPLETED|Overall Study||70
6651024|NCT02416102|7580462|FG001|NOT COMPLETED|Overall Study||8
6651025|NCT02416102|7580463|FG002|NOT COMPLETED|Overall Study||0
6651026|NCT02416180|7580471|FG000|STARTED|Overall Study||111
6551457|NCT01732692|7473662|FG001|COMPLETED|Overall Study||69
6551458|NCT01732692|7473661|FG000|NOT COMPLETED|Overall Study||0
6551459|NCT01732692|7473662|FG001|NOT COMPLETED|Overall Study||1
6551460|NCT01732718|7473668|FG000|STARTED|First Intervention||7
6551461|NCT01732718|7473669|FG001|STARTED|First Intervention||6
6551462|NCT01732718|7473668|FG000|COMPLETED|First Intervention||7
6551463|NCT01732718|7473669|FG001|COMPLETED|First Intervention||6
6551464|NCT01732718|7473668|FG000|NOT COMPLETED|First Intervention||0
6551465|NCT01732718|7473669|FG001|NOT COMPLETED|First Intervention||0
6551466|NCT01732718|7473668|FG000|STARTED|Washout (4 Weeks)||7
6551467|NCT01732718|7473669|FG001|STARTED|Washout (4 Weeks)||6
6551468|NCT01732718|7473668|FG000|COMPLETED|Washout (4 Weeks)||7
6305614|NCT02422446|7208957|FG000|COMPLETED|Overall Study||1
6305615|NCT02422446|7208958|FG001|COMPLETED|Overall Study||1
6305616|NCT02422446|7208957|FG000|NOT COMPLETED|Overall Study||0
6305617|NCT02422446|7208958|FG001|NOT COMPLETED|Overall Study||0
6305618|NCT02362451|7208966|FG000|STARTED|Overall Study||6
6305619|NCT02362451|7208967|FG001|STARTED|Overall Study||1
6305620|NCT02362451|7208966|FG000|COMPLETED|Overall Study||2
6305621|NCT02362451|7208967|FG001|COMPLETED|Overall Study||0
6305622|NCT02362451|7208966|FG000|NOT COMPLETED|Overall Study||4
6305623|NCT02362451|7208967|FG001|NOT COMPLETED|Overall Study||1
6305624|NCT02282020|7208975|FG000|STARTED|Overall Study||178
6305625|NCT02282020|7208976|FG001|STARTED|Overall Study||88
6305626|NCT02282020|7208975|FG000|Received Treatment|Overall Study||178
6305627|NCT02282020|7208976|FG001|Received Treatment|Overall Study||76
6305628|NCT02282020|7208975|FG000|COMPLETED|Overall Study||43
6305629|NCT02282020|7208976|FG001|COMPLETED|Overall Study||1
6305630|NCT02282020|7208975|FG000|NOT COMPLETED|Overall Study||135
6305631|NCT02282020|7208976|FG001|NOT COMPLETED|Overall Study||87
6305632|NCT02271230|7208986|FG000|STARTED|Overall Study||6463
6305633|NCT02271230|7208987|FG001|STARTED|Overall Study||6464
6305634|NCT02271230|7208988|FG002|STARTED|Overall Study||6470
6305635|NCT02271230|7208989|FG003|STARTED|Overall Study||6474
6305636|NCT02271230|7208986|FG000|COMPLETED|Overall Study||6463
6305637|NCT02271230|7208987|FG001|COMPLETED|Overall Study||6464
6305638|NCT02271230|7208988|FG002|COMPLETED|Overall Study||6470
6305639|NCT02271230|7208989|FG003|COMPLETED|Overall Study||6474
6305640|NCT02271230|7208986|FG000|NOT COMPLETED|Overall Study||0
6305641|NCT02271230|7208987|FG001|NOT COMPLETED|Overall Study||0
6305642|NCT02271230|7208988|FG002|NOT COMPLETED|Overall Study||0
6305643|NCT02271230|7208989|FG003|NOT COMPLETED|Overall Study||0
6305644|NCT02180724|7209001|FG000|STARTED|Overall Study||92
6305645|NCT02180724|7209002|FG001|STARTED|Overall Study||14
6305646|NCT02180724|7209001|FG000|Enrolled|Overall Study||92
6305647|NCT02180724|7209002|FG001|Enrolled|Overall Study||14
6305648|NCT02180724|7209001|FG000|Received Study Medication|Overall Study||92
6305649|NCT02180724|7209002|FG001|Received Study Medication|Overall Study||14
6305650|NCT02180724|7209001|FG000|Discontinued Study|Overall Study||14
6305651|NCT02180724|7209002|FG001|Discontinued Study|Overall Study||3
6305652|NCT02180724|7209001|FG000|Discontinued Treatment|Overall Study||23
6305653|NCT02180724|7209002|FG001|Discontinued Treatment|Overall Study||7
6305654|NCT02180724|7209001|FG000|COMPLETED|Overall Study||0
6305655|NCT02180724|7209002|FG001|COMPLETED|Overall Study||0
6305656|NCT02180724|7209001|FG000|NOT COMPLETED|Overall Study||92
6305657|NCT02180724|7209002|FG001|NOT COMPLETED|Overall Study||14
6305658|NCT02038777|7209016|FG000|STARTED|Overall Study||3
6305659|NCT02038777|7209017|FG001|STARTED|Overall Study||5
6305660|NCT02038777|7209018|FG002|STARTED|Overall Study||6
6305661|NCT02038777|7209019|FG003|STARTED|Overall Study||6
6305662|NCT02038777|7209020|FG004|STARTED|Overall Study||6
6305663|NCT02038777|7209021|FG005|STARTED|Overall Study||6
6305664|NCT02038777|7209022|FG006|STARTED|Overall Study||1
6305665|NCT02038777|7209023|FG007|STARTED|Overall Study||15
6305666|NCT02038777|7209016|FG000|Treated (Safety Set)|Overall Study||3
6305667|NCT02038777|7209017|FG001|Treated (Safety Set)|Overall Study||4
6305668|NCT02038777|7209018|FG002|Treated (Safety Set)|Overall Study||6
6305669|NCT02038777|7209019|FG003|Treated (Safety Set)|Overall Study||6
6305670|NCT02038777|7209020|FG004|Treated (Safety Set)|Overall Study||6
6305671|NCT02038777|7209021|FG005|Treated (Safety Set)|Overall Study||6
6305672|NCT02038777|7209022|FG006|Treated (Safety Set)|Overall Study||1
6305673|NCT02038777|7209023|FG007|Treated (Safety Set)|Overall Study||15
6305674|NCT02038777|7209016|FG000|COMPLETED|Overall Study||2
6305675|NCT02038777|7209017|FG001|COMPLETED|Overall Study||1
6305676|NCT02038777|7209018|FG002|COMPLETED|Overall Study||3
6305677|NCT02038777|7209019|FG003|COMPLETED|Overall Study||2
6305678|NCT02038777|7209020|FG004|COMPLETED|Overall Study||3
6305679|NCT02038777|7209021|FG005|COMPLETED|Overall Study||2
6305680|NCT02038777|7209022|FG006|COMPLETED|Overall Study||1
6305681|NCT02038777|7209023|FG007|COMPLETED|Overall Study||5
6305682|NCT02038777|7209016|FG000|NOT COMPLETED|Overall Study||1
6305683|NCT02038777|7209017|FG001|NOT COMPLETED|Overall Study||4
6305684|NCT02038777|7209018|FG002|NOT COMPLETED|Overall Study||3
6305685|NCT02038777|7209019|FG003|NOT COMPLETED|Overall Study||4
6305686|NCT02038777|7209020|FG004|NOT COMPLETED|Overall Study||3
6305687|NCT02038777|7209021|FG005|NOT COMPLETED|Overall Study||4
6305688|NCT02038777|7209022|FG006|NOT COMPLETED|Overall Study||0
6305689|NCT02038777|7209023|FG007|NOT COMPLETED|Overall Study||10
6305690|NCT01996449|7209042|FG000|STARTED|Period 1: First Drug||6
6305691|NCT01996449|7209043|FG001|STARTED|Period 1: First Drug||8
6305692|NCT01996449|7209042|FG000|COMPLETED|Period 1: First Drug||6
6305693|NCT01996449|7209043|FG001|COMPLETED|Period 1: First Drug||8
6305694|NCT01996449|7209042|FG000|NOT COMPLETED|Period 1: First Drug||0
6305695|NCT01996449|7209043|FG001|NOT COMPLETED|Period 1: First Drug||0
6305696|NCT01996449|7209042|FG000|STARTED|Period 2: Second Drug||6
6305697|NCT01996449|7209043|FG001|STARTED|Period 2: Second Drug||8
6305698|NCT01996449|7209042|FG000|COMPLETED|Period 2: Second Drug||6
6305699|NCT01996449|7209043|FG001|COMPLETED|Period 2: Second Drug||8
6305700|NCT01996449|7209042|FG000|NOT COMPLETED|Period 2: Second Drug||0
6305701|NCT01996449|7209043|FG001|NOT COMPLETED|Period 2: Second Drug||0
6305702|NCT01927419|7209053|FG000|STARTED|Pre-Treatment Period||95
6305703|NCT01927419|7209054|FG001|STARTED|Pre-Treatment Period||47
6422345|NCT01001377|7336954|FG000|STARTED|Overall Study||504
6422346|NCT01001377|7336955|FG001|STARTED|Overall Study||506
6422347|NCT01001377|7336954|FG000|Received Treatment|Overall Study||500
6422348|NCT01001377|7336955|FG001|Received Treatment|Overall Study||499
6422349|NCT01001377|7336954|FG000|COMPLETED|Overall Study|Indicates participants continuing in study|78
6422350|NCT01001377|7336955|FG001|COMPLETED|Overall Study|Indicates participants continuing in study|85
6422351|NCT01001377|7336954|FG000|NOT COMPLETED|Overall Study||426
6422352|NCT01001377|7336955|FG001|NOT COMPLETED|Overall Study||421
6422353|NCT01001403|7336963|FG000|STARTED|Overall Study||31
6422354|NCT01001403|7336964|FG001|STARTED|Overall Study||31
6422355|NCT01001403|7336963|FG000|COMPLETED|Overall Study||31
6422356|NCT01001403|7336964|FG001|COMPLETED|Overall Study||31
6422357|NCT01001403|7336963|FG000|NOT COMPLETED|Overall Study||0
6422358|NCT01001403|7336964|FG001|NOT COMPLETED|Overall Study||0
6422359|NCT01001429|7336972|FG000|STARTED|Overall Study||39
6422360|NCT01001429|7336973|FG001|STARTED|Overall Study||38
6422361|NCT01001429|7336972|FG000|COMPLETED|Overall Study||39
6422362|NCT01001429|7336973|FG001|COMPLETED|Overall Study||37
6422363|NCT01001429|7336972|FG000|NOT COMPLETED|Overall Study||0
6422364|NCT01001429|7336973|FG001|NOT COMPLETED|Overall Study||1
6422365|NCT01001442|7337011|FG000|STARTED|Overall Study||4
6422366|NCT01001442|7337012|FG001|STARTED|Overall Study||3
6422367|NCT01001442|7337013|FG002|STARTED|Overall Study||4
6422368|NCT01001442|7337014|FG003|STARTED|Overall Study||3
6422369|NCT01001442|7337015|FG004|STARTED|Overall Study||4
6422370|NCT01001442|7337016|FG005|STARTED|Overall Study||3
6422371|NCT01001442|7337017|FG006|STARTED|Overall Study||10
6422372|NCT01001442|7337018|FG007|STARTED|Overall Study||4
6422373|NCT01001442|7337011|FG000|COMPLETED|Overall Study||4
6422374|NCT01001442|7337012|FG001|COMPLETED|Overall Study||3
6422375|NCT01001442|7337013|FG002|COMPLETED|Overall Study||4
6422376|NCT01001442|7337014|FG003|COMPLETED|Overall Study||3
6422377|NCT01001442|7337015|FG004|COMPLETED|Overall Study||2
6422378|NCT01001442|7337016|FG005|COMPLETED|Overall Study||3
6305704|NCT01927419|7209053|FG000|COMPLETED|Pre-Treatment Period||94
6422379|NCT01001442|7337017|FG006|COMPLETED|Overall Study||6
6422380|NCT01001442|7337018|FG007|COMPLETED|Overall Study||2
6422381|NCT01001442|7337011|FG000|NOT COMPLETED|Overall Study||0
6422382|NCT01001442|7337012|FG001|NOT COMPLETED|Overall Study||0
6422383|NCT01001442|7337013|FG002|NOT COMPLETED|Overall Study||0
6422384|NCT01001442|7337014|FG003|NOT COMPLETED|Overall Study||0
6422385|NCT01001442|7337015|FG004|NOT COMPLETED|Overall Study||2
6422386|NCT01001442|7337016|FG005|NOT COMPLETED|Overall Study||0
6422387|NCT01001442|7337017|FG006|NOT COMPLETED|Overall Study||4
6422388|NCT01001442|7337018|FG007|NOT COMPLETED|Overall Study||2
6422389|NCT01001494|7337043|FG000|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
6422390|NCT01001494|7337044|FG001|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
6422391|NCT01001494|7337045|FG002|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
6422392|NCT01001494|7337043|FG000|COMPLETED|Overall Study||253
6422393|NCT01001494|7337044|FG001|COMPLETED|Overall Study||252
6422394|NCT01001494|7337045|FG002|COMPLETED|Overall Study||232
6422395|NCT01001494|7337043|FG000|NOT COMPLETED|Overall Study||24
6422396|NCT01001494|7337044|FG001|NOT COMPLETED|Overall Study||17
6422397|NCT01001494|7337045|FG002|NOT COMPLETED|Overall Study||41
6422398|NCT01001520|7337053|FG000|STARTED|Medication Period 1||22
6422399|NCT01001520|7337054|FG001|STARTED|Medication Period 1||24
6422400|NCT01001520|7337053|FG000|COMPLETED|Medication Period 1||18
6422401|NCT01001520|7337054|FG001|COMPLETED|Medication Period 1||17
6422402|NCT01001520|7337053|FG000|NOT COMPLETED|Medication Period 1||4
6551469|NCT01732718|7473669|FG001|COMPLETED|Washout (4 Weeks)||6
6551470|NCT01732718|7473668|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6551471|NCT01732718|7473669|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6551472|NCT01732718|7473668|FG000|STARTED|Second Intervention||7
6651027|NCT02416180|7580471|FG000|COMPLETED|Overall Study||110
6422403|NCT01001520|7337054|FG001|NOT COMPLETED|Medication Period 1||7
6422404|NCT01001520|7337053|FG000|STARTED|Washout Period||18
6422405|NCT01001520|7337054|FG001|STARTED|Washout Period||17
6422406|NCT01001520|7337053|FG000|COMPLETED|Washout Period||16
6422407|NCT01001520|7337054|FG001|COMPLETED|Washout Period||16
6422408|NCT01001520|7337053|FG000|NOT COMPLETED|Washout Period||2
6422409|NCT01001520|7337054|FG001|NOT COMPLETED|Washout Period||1
6422410|NCT01001520|7337053|FG000|STARTED|Medication Period 2||16
6422411|NCT01001520|7337054|FG001|STARTED|Medication Period 2||16
6422412|NCT01001520|7337053|FG000|COMPLETED|Medication Period 2||16
6422413|NCT01001520|7337054|FG001|COMPLETED|Medication Period 2||13
6422414|NCT01001520|7337053|FG000|NOT COMPLETED|Medication Period 2||0
6422415|NCT01001520|7337054|FG001|NOT COMPLETED|Medication Period 2||3
6422416|NCT01001546|7337065|FG000|STARTED|Overall Study||206
6422417|NCT01001546|7337066|FG001|STARTED|Overall Study||207
6422418|NCT01001546|7337065|FG000|COMPLETED|Overall Study||206
6422419|NCT01001546|7337066|FG001|COMPLETED|Overall Study||207
6422420|NCT01001546|7337065|FG000|NOT COMPLETED|Overall Study||0
6422421|NCT01001546|7337066|FG001|NOT COMPLETED|Overall Study||0
6422422|NCT01001559|7337074|FG000|STARTED|Overall Study||95
6422423|NCT01001559|7337075|FG001|STARTED|Overall Study||147
6422424|NCT01001559|7337074|FG000|COMPLETED|Overall Study||95
6422425|NCT01001559|7337075|FG001|COMPLETED|Overall Study||147
6422426|NCT01001559|7337074|FG000|NOT COMPLETED|Overall Study||0
6422427|NCT01001559|7337075|FG001|NOT COMPLETED|Overall Study||0
6422428|NCT01001572|7337083|FG000|STARTED|Single-Blind Valsartan 160 mg||932
6422429|NCT01001572|7337084|FG001|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
6422430|NCT01001572|7337085|FG002|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
6422431|NCT01001572|7337083|FG000|COMPLETED|Single-Blind Valsartan 160 mg||654
6422432|NCT01001572|7337084|FG001|COMPLETED|Single-Blind Valsartan 160 mg||0
6422433|NCT01001572|7337085|FG002|COMPLETED|Single-Blind Valsartan 160 mg||0
6422434|NCT01001572|7337083|FG000|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
6422435|NCT01001572|7337084|FG001|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
6422436|NCT01001572|7337085|FG002|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
6422437|NCT01001572|7337083|FG000|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
6422438|NCT01001572|7337084|FG001|STARTED|Double-Blind Treatment Phase||329
6422439|NCT01001572|7337085|FG002|STARTED|Double-Blind Treatment Phase||325
6422440|NCT01001572|7337083|FG000|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
6422441|NCT01001572|7337084|FG001|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
6422442|NCT01001572|7337085|FG002|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
6422443|NCT01001572|7337083|FG000|COMPLETED|Double-Blind Treatment Phase||0
6422444|NCT01001572|7337084|FG001|COMPLETED|Double-Blind Treatment Phase||319
6422445|NCT01001572|7337085|FG002|COMPLETED|Double-Blind Treatment Phase||306
6422446|NCT01001572|7337083|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
6422447|NCT01001572|7337084|FG001|NOT COMPLETED|Double-Blind Treatment Phase||10
6422448|NCT01001572|7337085|FG002|NOT COMPLETED|Double-Blind Treatment Phase||19
6422449|NCT01001598|7337091|FG000|STARTED|Overall Study||5
6422450|NCT01001598|7337091|FG000|COMPLETED|Overall Study|3 completed study (2 FA and 1 DC) in 2011|3
6422451|NCT01001598|7337091|FG000|NOT COMPLETED|Overall Study||2
6422452|NCT01001702|7337095|FG000|STARTED|Overall Study||85
6422453|NCT01001702|7337095|FG000|COMPLETED|Overall Study||13
6422454|NCT01001702|7337095|FG000|NOT COMPLETED|Overall Study||72
6422455|NCT01001767|7337101|FG000|STARTED|Overall Study||18
6422456|NCT01001767|7337102|FG001|STARTED|Overall Study||17
6422457|NCT01001767|7337101|FG000|COMPLETED|Overall Study||14
6422458|NCT01001767|7337102|FG001|COMPLETED|Overall Study||17
6551473|NCT01732718|7473669|FG001|STARTED|Second Intervention||6
6422459|NCT01001767|7337101|FG000|NOT COMPLETED|Overall Study||4
6422460|NCT01001767|7337102|FG001|NOT COMPLETED|Overall Study||0
6422461|NCT01001806|7337111|FG000|STARTED|Overall Study||42
6422462|NCT01001806|7337112|FG001|STARTED|Overall Study||42
6422463|NCT01001806|7337113|FG002|STARTED|Overall Study||42
6422464|NCT01001806|7337111|FG000|COMPLETED|Overall Study||42
6422465|NCT01001806|7337112|FG001|COMPLETED|Overall Study||41
6422466|NCT01001806|7337113|FG002|COMPLETED|Overall Study||38
6422467|NCT01001806|7337111|FG000|NOT COMPLETED|Overall Study||0
6422468|NCT01001806|7337112|FG001|NOT COMPLETED|Overall Study||1
6422469|NCT01001806|7337113|FG002|NOT COMPLETED|Overall Study||4
6422470|NCT01001832|7337123|FG000|STARTED|Short-term Period||59
6422471|NCT01001832|7337124|FG001|STARTED|Short-term Period||59
6422472|NCT01001832|7337123|FG000|COMPLETED|Short-term Period||57
6422473|NCT01001832|7337124|FG001|COMPLETED|Short-term Period||56
6422474|NCT01001832|7337123|FG000|NOT COMPLETED|Short-term Period||2
6422475|NCT01001832|7337124|FG001|NOT COMPLETED|Short-term Period||3
6422476|NCT01001832|7337123|FG000|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
6422477|NCT01001832|7337124|FG001|STARTED|Long-term Period||56
6651028|NCT02416180|7580471|FG000|NOT COMPLETED|Overall Study||1
6651029|NCT02416193|7580477|FG000|STARTED|Overall Study||15
6422478|NCT01001832|7337123|FG000|COMPLETED|Long-term Period||52
6422479|NCT01001832|7337124|FG001|COMPLETED|Long-term Period||51
6422480|NCT01001832|7337123|FG000|NOT COMPLETED|Long-term Period||4
6422481|NCT01001832|7337124|FG001|NOT COMPLETED|Long-term Period||5
6422482|NCT01001832|7337123|FG000|STARTED|Follow-up Period||52
6422483|NCT01001832|7337124|FG001|STARTED|Follow-up Period||51
6422484|NCT01001832|7337123|FG000|COMPLETED|Follow-up Period||34
6422485|NCT01001832|7337124|FG001|COMPLETED|Follow-up Period||30
6422486|NCT01001832|7337123|FG000|NOT COMPLETED|Follow-up Period||18
6422487|NCT01001832|7337124|FG001|NOT COMPLETED|Follow-up Period||21
6422488|NCT01001910|7337133|FG000|STARTED|Overall Study|We screened and started 28 patients in the study. However only 22 patients were evaluable for outcome, because 6 patients did not receive adequate number of cycles of treatment for analysis. While we could not evaluate these 6 patients for their outcome, their treatment-cycles were included in the safe analysis.|28
6422489|NCT01001910|7337133|FG000|COMPLETED|Overall Study|6 patients did not receive 3 cycles required for evaluation of response as per protocol s7.1.1|22
6422490|NCT01001910|7337133|FG000|NOT COMPLETED|Overall Study||6
6422491|NCT01001975|7337139|FG000|STARTED|Overall Study||5
6422492|NCT01001975|7337140|FG001|STARTED|Overall Study||5
6422493|NCT01001975|7337139|FG000|COMPLETED|Overall Study||5
6422494|NCT01001975|7337140|FG001|COMPLETED|Overall Study||5
6422495|NCT01001975|7337139|FG000|NOT COMPLETED|Overall Study||0
6422496|NCT01001975|7337140|FG001|NOT COMPLETED|Overall Study||0
6422497|NCT01001988|7337146|FG000|STARTED|Overall Study||596
6422498|NCT01001988|7337146|FG000|COMPLETED|Overall Study||479
6422499|NCT01001988|7337146|FG000|NOT COMPLETED|Overall Study||117
6422500|NCT01002105|7337152|FG000|STARTED|Overall Study||32
6422501|NCT01002105|7337153|FG001|STARTED|Overall Study||32
6422502|NCT01002105|7337152|FG000|COMPLETED|Overall Study||13
6422503|NCT01002105|7337153|FG001|COMPLETED|Overall Study||11
6422504|NCT01002105|7337152|FG000|NOT COMPLETED|Overall Study||19
6422505|NCT01002105|7337153|FG001|NOT COMPLETED|Overall Study||21
6422506|NCT01002118|7337162|FG000|STARTED|Overall Study||1
6422507|NCT01002118|7337162|FG000|Randomized Only Patient|Overall Study||1
6422508|NCT01002118|7337162|FG000|COMPLETED|Overall Study||1
6422509|NCT01002118|7337162|FG000|NOT COMPLETED|Overall Study||0
6422510|NCT01002287|7337168|FG000|STARTED|Overall Study||8
6422511|NCT01002287|7337169|FG001|STARTED|Overall Study||3
6422512|NCT01002287|7337168|FG000|COMPLETED|Overall Study||8
6422513|NCT01002287|7337169|FG001|COMPLETED|Overall Study||3
6422514|NCT01002287|7337168|FG000|NOT COMPLETED|Overall Study||0
6422515|NCT01002287|7337169|FG001|NOT COMPLETED|Overall Study||0
6422516|NCT01002339|7337178|FG000|STARTED|Overall Study||44
6422517|NCT01002339|7337179|FG001|STARTED|Overall Study||43
6422518|NCT01002339|7337180|FG002|STARTED|Overall Study||47
6422519|NCT01002339|7337178|FG000|COMPLETED|Overall Study||44
6422520|NCT01002339|7337179|FG001|COMPLETED|Overall Study||42
6422521|NCT01002339|7337180|FG002|COMPLETED|Overall Study||42
6422522|NCT01002339|7337178|FG000|NOT COMPLETED|Overall Study||0
6422523|NCT01002339|7337179|FG001|NOT COMPLETED|Overall Study||1
6422524|NCT01002339|7337180|FG002|NOT COMPLETED|Overall Study||5
6422525|NCT01002456|7337190|FG000|STARTED|Overall Study||98
6422526|NCT01002456|7337191|FG001|STARTED|Overall Study||122
6422527|NCT01002456|7337190|FG000|COMPLETED|Overall Study||98
6422528|NCT01002456|7337191|FG001|COMPLETED|Overall Study||122
6422529|NCT01002456|7337190|FG000|NOT COMPLETED|Overall Study||0
6422530|NCT01002456|7337191|FG001|NOT COMPLETED|Overall Study||0
6422531|NCT01002482|7337201|FG000|STARTED|Overall Study||1351
6422532|NCT01002482|7337202|FG001|STARTED|Overall Study||1333
6422533|NCT01002482|7337201|FG000|COMPLETED|Overall Study||1336
6422534|NCT01002482|7337202|FG001|COMPLETED|Overall Study||1312
6422535|NCT01002482|7337201|FG000|NOT COMPLETED|Overall Study||15
6422536|NCT01002482|7337202|FG001|NOT COMPLETED|Overall Study||21
6422537|NCT01002547|7337211|FG000|STARTED|Overall Study||32
6422538|NCT01002547|7337212|FG001|STARTED|Overall Study||36
6422539|NCT01002547|7337213|FG002|STARTED|Overall Study||37
6422540|NCT01002547|7337211|FG000|COMPLETED|Overall Study||24
6651030|NCT02416193|7580478|FG001|STARTED|Overall Study||15
6651031|NCT02416193|7580477|FG000|COMPLETED|Overall Study||15
6651032|NCT02416193|7580478|FG001|COMPLETED|Overall Study||15
6422541|NCT01002547|7337212|FG001|COMPLETED|Overall Study||33
6422542|NCT01002547|7337213|FG002|COMPLETED|Overall Study||29
6422543|NCT01002547|7337211|FG000|NOT COMPLETED|Overall Study||8
6422544|NCT01002547|7337212|FG001|NOT COMPLETED|Overall Study||3
6422545|NCT01002547|7337213|FG002|NOT COMPLETED|Overall Study||8
6422546|NCT01002573|7337223|FG000|STARTED|Overall Study||58
6422547|NCT01002573|7337224|FG001|STARTED|Overall Study||60
6422548|NCT01002573|7337223|FG000|COMPLETED|Overall Study||47
6422549|NCT01002573|7337224|FG001|COMPLETED|Overall Study||53
6422550|NCT01002573|7337223|FG000|NOT COMPLETED|Overall Study||11
6422551|NCT01002573|7337224|FG001|NOT COMPLETED|Overall Study||7
6422552|NCT01002742|7337232|FG000|STARTED|Overall Study||119
6422553|NCT01002742|7337233|FG001|STARTED|Overall Study||117
6422554|NCT01002742|7337232|FG000|COMPLETED|Overall Study||119
6422555|NCT01002742|7337233|FG001|COMPLETED|Overall Study||116
6422556|NCT01002742|7337232|FG000|NOT COMPLETED|Overall Study||0
6422557|NCT01002742|7337233|FG001|NOT COMPLETED|Overall Study||1
6422558|NCT01002755|7337239|FG000|STARTED|Overall Study||36
6422559|NCT01002755|7337239|FG000|COMPLETED|Overall Study||36
6422560|NCT01002755|7337239|FG000|NOT COMPLETED|Overall Study||0
6422561|NCT01002989|7337243|FG000|STARTED|Overall Study||98
6422562|NCT01002989|7337243|FG000|COMPLETED|Overall Study||93
6422563|NCT01002989|7337243|FG000|NOT COMPLETED|Overall Study||5
6422564|NCT01003067|7337249|FG000|STARTED|Overall Study||136
6422565|NCT01003067|7337250|FG001|STARTED|Overall Study||131
6422566|NCT01003067|7337249|FG000|COMPLETED|Overall Study||103
6422567|NCT01003067|7337250|FG001|COMPLETED|Overall Study||107
6422568|NCT01003067|7337249|FG000|NOT COMPLETED|Overall Study||33
6422569|NCT01003067|7337250|FG001|NOT COMPLETED|Overall Study||24
6422570|NCT01003080|7337258|FG000|STARTED|Overall Study||50
6422571|NCT01003080|7337259|FG001|STARTED|Overall Study||61
6422572|NCT01003080|7337258|FG000|COMPLETED|Overall Study||50
6422573|NCT01003080|7337259|FG001|COMPLETED|Overall Study||61
6422574|NCT01003080|7337258|FG000|NOT COMPLETED|Overall Study||0
6422575|NCT01003080|7337259|FG001|NOT COMPLETED|Overall Study||0
6422576|NCT01003106|7337269|FG000|STARTED|Baseline to Month 6||22
6422577|NCT01003106|7337270|FG001|STARTED|Baseline to Month 6||20
6422578|NCT01003106|7337271|FG002|STARTED|Baseline to Month 6||0
6422579|NCT01003106|7337272|FG003|STARTED|Baseline to Month 6||0
6422580|NCT01003106|7337273|FG004|STARTED|Baseline to Month 6||19
6422581|NCT01003106|7337274|FG005|STARTED|Baseline to Month 6||20
6422582|NCT01003106|7337275|FG006|STARTED|Baseline to Month 6||0
6422583|NCT01003106|7337276|FG007|STARTED|Baseline to Month 6||0
6422584|NCT01003106|7337269|FG000|COMPLETED|Baseline to Month 6||22
6422585|NCT01003106|7337270|FG001|COMPLETED|Baseline to Month 6||20
6422586|NCT01003106|7337271|FG002|COMPLETED|Baseline to Month 6||0
6422587|NCT01003106|7337272|FG003|COMPLETED|Baseline to Month 6||0
6422588|NCT01003106|7337273|FG004|COMPLETED|Baseline to Month 6||19
6422589|NCT01003106|7337274|FG005|COMPLETED|Baseline to Month 6||20
6422590|NCT01003106|7337275|FG006|COMPLETED|Baseline to Month 6||0
6422591|NCT01003106|7337276|FG007|COMPLETED|Baseline to Month 6||0
6422592|NCT01003106|7337269|FG000|NOT COMPLETED|Baseline to Month 6||0
6422593|NCT01003106|7337270|FG001|NOT COMPLETED|Baseline to Month 6||0
6422594|NCT01003106|7337271|FG002|NOT COMPLETED|Baseline to Month 6||0
6422595|NCT01003106|7337272|FG003|NOT COMPLETED|Baseline to Month 6||0
6422596|NCT01003106|7337273|FG004|NOT COMPLETED|Baseline to Month 6||0
6422597|NCT01003106|7337274|FG005|NOT COMPLETED|Baseline to Month 6||0
6422598|NCT01003106|7337275|FG006|NOT COMPLETED|Baseline to Month 6||0
6551474|NCT01732718|7473668|FG000|COMPLETED|Second Intervention||7
6551475|NCT01732718|7473669|FG001|COMPLETED|Second Intervention||6
6551476|NCT01732718|7473668|FG000|NOT COMPLETED|Second Intervention||0
6551477|NCT01732718|7473669|FG001|NOT COMPLETED|Second Intervention||0
6551478|NCT01732757|7473684|FG000|STARTED|Overall Study||53
6551479|NCT01732757|7473685|FG001|STARTED|Overall Study||52
6551480|NCT01732757|7473686|FG002|STARTED|Overall Study||52
6422599|NCT01003106|7337276|FG007|NOT COMPLETED|Baseline to Month 6||0
6422600|NCT01003106|7337269|FG000|STARTED|Month 6-Month 36||0
6422601|NCT01003106|7337270|FG001|STARTED|Month 6-Month 36||0
6422602|NCT01003106|7337271|FG002|STARTED|Month 6-Month 36||19
6422603|NCT01003106|7337272|FG003|STARTED|Month 6-Month 36||20
6422604|NCT01003106|7337273|FG004|STARTED|Month 6-Month 36||0
6422605|NCT01003106|7337274|FG005|STARTED|Month 6-Month 36||0
6422606|NCT01003106|7337275|FG006|STARTED|Month 6-Month 36||20
6422607|NCT01003106|7337276|FG007|STARTED|Month 6-Month 36||18
6422608|NCT01003106|7337269|FG000|COMPLETED|Month 6-Month 36||0
6422609|NCT01003106|7337270|FG001|COMPLETED|Month 6-Month 36||0
6422610|NCT01003106|7337271|FG002|COMPLETED|Month 6-Month 36||18
6422611|NCT01003106|7337272|FG003|COMPLETED|Month 6-Month 36||20
6422612|NCT01003106|7337273|FG004|COMPLETED|Month 6-Month 36||0
6422613|NCT01003106|7337274|FG005|COMPLETED|Month 6-Month 36||0
6422614|NCT01003106|7337275|FG006|COMPLETED|Month 6-Month 36||19
6422615|NCT01003106|7337276|FG007|COMPLETED|Month 6-Month 36||18
6551481|NCT01732757|7473684|FG000|COMPLETED|Overall Study||52
6422616|NCT01003106|7337269|FG000|NOT COMPLETED|Month 6-Month 36||0
6422617|NCT01003106|7337270|FG001|NOT COMPLETED|Month 6-Month 36||0
6422618|NCT01003106|7337271|FG002|NOT COMPLETED|Month 6-Month 36||1
6551482|NCT01732757|7473685|FG001|COMPLETED|Overall Study||52
6551483|NCT01732757|7473686|FG002|COMPLETED|Overall Study||52
6422619|NCT01003106|7337272|FG003|NOT COMPLETED|Month 6-Month 36||0
6422620|NCT01003106|7337273|FG004|NOT COMPLETED|Month 6-Month 36||0
6422621|NCT01003106|7337274|FG005|NOT COMPLETED|Month 6-Month 36||0
6422622|NCT01003106|7337275|FG006|NOT COMPLETED|Month 6-Month 36||1
6422623|NCT01003106|7337276|FG007|NOT COMPLETED|Month 6-Month 36||0
6422624|NCT01003184|7337292|FG000|STARTED|Overall Study||111
6422625|NCT01003184|7337293|FG001|STARTED|Overall Study||111
6422626|NCT01003184|7337292|FG000|Full Analysis Set (FAS)|Overall Study||111
6422627|NCT01003184|7337293|FG001|Full Analysis Set (FAS)|Overall Study||105
6422628|NCT01003184|7337292|FG000|COMPLETED|Overall Study||92
6422629|NCT01003184|7337293|FG001|COMPLETED|Overall Study||99
6422630|NCT01003184|7337292|FG000|NOT COMPLETED|Overall Study||19
6422631|NCT01003184|7337293|FG001|NOT COMPLETED|Overall Study||12
6422632|NCT01003210|7337301|FG000|STARTED|Overall Study||105
6422633|NCT01003210|7337302|FG001|STARTED|Overall Study||105
6422634|NCT01003210|7337301|FG000|COMPLETED|Overall Study||104
6422635|NCT01003210|7337302|FG001|COMPLETED|Overall Study||102
6422636|NCT01003210|7337301|FG000|NOT COMPLETED|Overall Study||1
6422637|NCT01003210|7337302|FG001|NOT COMPLETED|Overall Study||3
6422638|NCT01003249|7337308|FG000|STARTED|First Intervention (4 Weeks)||7
6422639|NCT01003249|7337309|FG001|STARTED|First Intervention (4 Weeks)||5
6422640|NCT01003249|7337308|FG000|Received Intervention|First Intervention (4 Weeks)||7
6422641|NCT01003249|7337309|FG001|Received Intervention|First Intervention (4 Weeks)||5
6422642|NCT01003249|7337308|FG000|COMPLETED|First Intervention (4 Weeks)||5
6422643|NCT01003249|7337309|FG001|COMPLETED|First Intervention (4 Weeks)||3
6422644|NCT01003249|7337308|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
6422645|NCT01003249|7337309|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
6422646|NCT01003249|7337308|FG000|STARTED|Washout (3 Weeks)||4
6422647|NCT01003249|7337309|FG001|STARTED|Washout (3 Weeks)||3
6422648|NCT01003249|7337308|FG000|COMPLETED|Washout (3 Weeks)||4
6422649|NCT01003249|7337309|FG001|COMPLETED|Washout (3 Weeks)||3
6422650|NCT01003249|7337308|FG000|NOT COMPLETED|Washout (3 Weeks)||0
6422651|NCT01003249|7337309|FG001|NOT COMPLETED|Washout (3 Weeks)||0
6422652|NCT01003249|7337308|FG000|STARTED|Second Intervention (4 Weeks)||4
6422653|NCT01003249|7337309|FG001|STARTED|Second Intervention (4 Weeks)||3
6422654|NCT01003249|7337308|FG000|COMPLETED|Second Intervention (4 Weeks)||3
6422655|NCT01003249|7337309|FG001|COMPLETED|Second Intervention (4 Weeks)||2
6422656|NCT01003249|7337308|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
6422657|NCT01003249|7337309|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
6422658|NCT01003275|7337321|FG000|STARTED|Overall Study||11
6422659|NCT01003275|7337322|FG001|STARTED|Overall Study||11
6422660|NCT01003275|7337321|FG000|COMPLETED|Overall Study||10
6422661|NCT01003275|7337322|FG001|COMPLETED|Overall Study||11
6422662|NCT01003275|7337321|FG000|NOT COMPLETED|Overall Study||1
6422663|NCT01003275|7337322|FG001|NOT COMPLETED|Overall Study||0
6422664|NCT01003288|7337330|FG000|STARTED|Overall Study||255
6422665|NCT01003288|7337330|FG000|COMPLETED|Overall Study||255
6422666|NCT01003288|7337330|FG000|NOT COMPLETED|Overall Study||0
6422667|NCT01003301|7337337|FG000|STARTED|Overall Study||10
6422668|NCT01003301|7337338|FG001|STARTED|Overall Study||9
6422669|NCT01003301|7337337|FG000|COMPLETED|Overall Study||10
6422670|NCT01003301|7337338|FG001|COMPLETED|Overall Study||9
6422671|NCT01003301|7337337|FG000|NOT COMPLETED|Overall Study||0
6422672|NCT01003301|7337338|FG001|NOT COMPLETED|Overall Study||0
6422673|NCT01003418|7337346|FG000|STARTED|Overall Study||5
6422674|NCT01003418|7337347|FG001|STARTED|Overall Study||3
6422675|NCT01003418|7337346|FG000|COMPLETED|Overall Study||5
6422676|NCT01003418|7337347|FG001|COMPLETED|Overall Study||3
6422677|NCT01003418|7337346|FG000|NOT COMPLETED|Overall Study||0
6422678|NCT01003418|7337347|FG001|NOT COMPLETED|Overall Study||0
6422679|NCT01003639|7337355|FG000|STARTED|Overall Study||86
6422680|NCT01003639|7337356|FG001|STARTED|Overall Study||79
6422681|NCT01003639|7337355|FG000|COMPLETED|Overall Study||69
6422682|NCT01003639|7337356|FG001|COMPLETED|Overall Study||57
6422683|NCT01003639|7337355|FG000|NOT COMPLETED|Overall Study||17
6422684|NCT01003639|7337356|FG001|NOT COMPLETED|Overall Study||22
6422685|NCT01003769|7337362|FG000|STARTED|Overall Study||5
6422686|NCT01003769|7337362|FG000|COMPLETED|Overall Study||5
6422687|NCT01003769|7337362|FG000|NOT COMPLETED|Overall Study||0
6422688|NCT01003886|7337366|FG000|STARTED|Overall Study||989
6422689|NCT01003886|7337366|FG000|COMPLETED|Overall Study||759
6422690|NCT01003886|7337366|FG000|NOT COMPLETED|Overall Study||230
6422691|NCT01003899|7337370|FG000|STARTED|Overall Study|enrolled|47
6422692|NCT01003899|7337370|FG000|COMPLETED|Overall Study||0
6422693|NCT01003899|7337370|FG000|NOT COMPLETED|Overall Study||47
6422694|NCT01003938|7337374|FG000|STARTED|Overall Study||6
6422695|NCT01003938|7337374|FG000|COMPLETED|Overall Study||6
6422696|NCT01003938|7337374|FG000|NOT COMPLETED|Overall Study||0
6422697|NCT01003990|7337381|FG000|STARTED|Overall Study||459
6422698|NCT01003990|7337382|FG001|STARTED|Overall Study||154
6422699|NCT01003990|7337383|FG002|STARTED|Overall Study||96
6422700|NCT01003990|7337381|FG000|COMPLETED|Overall Study||367
6422701|NCT01003990|7337382|FG001|COMPLETED|Overall Study||103
6422702|NCT01003990|7337383|FG002|COMPLETED|Overall Study||53
6422703|NCT01003990|7337381|FG000|NOT COMPLETED|Overall Study||92
6422704|NCT01003990|7337382|FG001|NOT COMPLETED|Overall Study||51
6422705|NCT01003990|7337383|FG002|NOT COMPLETED|Overall Study||43
6422706|NCT01004003|7337400|FG000|STARTED|Overall Study||6
6422707|NCT01004003|7337401|FG001|STARTED|Overall Study||3
6422708|NCT01004003|7337402|FG002|STARTED|Overall Study||4
6422709|NCT01004003|7337403|FG003|STARTED|Overall Study||3
6422710|NCT01004003|7337404|FG004|STARTED|Overall Study||4
6422711|NCT01004003|7337405|FG005|STARTED|Overall Study||4
6422712|NCT01004003|7337406|FG006|STARTED|Overall Study||8
6422713|NCT01004003|7337407|FG007|STARTED|Overall Study||62
6422714|NCT01004003|7337408|FG008|STARTED|Overall Study||31
6422715|NCT01004003|7337400|FG000|COMPLETED|Overall Study||0
6422716|NCT01004003|7337401|FG001|COMPLETED|Overall Study||0
6422717|NCT01004003|7337402|FG002|COMPLETED|Overall Study||0
6422718|NCT01004003|7337403|FG003|COMPLETED|Overall Study||0
6422719|NCT01004003|7337404|FG004|COMPLETED|Overall Study||0
6422720|NCT01004003|7337405|FG005|COMPLETED|Overall Study||0
6422721|NCT01004003|7337406|FG006|COMPLETED|Overall Study||0
6422722|NCT01004003|7337407|FG007|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
6422723|NCT01004003|7337408|FG008|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
6422724|NCT01004003|7337400|FG000|NOT COMPLETED|Overall Study||6
6422725|NCT01004003|7337401|FG001|NOT COMPLETED|Overall Study||3
6422726|NCT01004003|7337402|FG002|NOT COMPLETED|Overall Study||4
6422727|NCT01004003|7337403|FG003|NOT COMPLETED|Overall Study||3
6422728|NCT01004003|7337404|FG004|NOT COMPLETED|Overall Study||4
6422729|NCT01004003|7337405|FG005|NOT COMPLETED|Overall Study||4
6422730|NCT01004003|7337406|FG006|NOT COMPLETED|Overall Study||8
6422731|NCT01004003|7337407|FG007|NOT COMPLETED|Overall Study||60
6422732|NCT01004003|7337408|FG008|NOT COMPLETED|Overall Study||30
6422733|NCT01004029|7337432|FG000|STARTED|Overall Study||578
6422734|NCT01004029|7337433|FG001|STARTED|Overall Study||1130
6422735|NCT01004029|7337432|FG000|Safety Population|Overall Study||578
6422736|NCT01004029|7337433|FG001|Safety Population|Overall Study||1128
6422737|NCT01004029|7337432|FG000|COMPLETED|Overall Study||530
6422738|NCT01004029|7337433|FG001|COMPLETED|Overall Study||1057
6422739|NCT01004029|7337432|FG000|NOT COMPLETED|Overall Study||48
6422740|NCT01004029|7337433|FG001|NOT COMPLETED|Overall Study||73
6422741|NCT01004042|7337442|FG000|STARTED|Overall Study||25
6422742|NCT01004042|7337443|FG001|STARTED|Overall Study||25
6422743|NCT01004042|7337442|FG000|COMPLETED|Overall Study||21
6422744|NCT01004042|7337443|FG001|COMPLETED|Overall Study||25
6422745|NCT01004042|7337442|FG000|NOT COMPLETED|Overall Study||4
6422746|NCT01004042|7337443|FG001|NOT COMPLETED|Overall Study||0
6422747|NCT01004107|7337451|FG000|STARTED|Overall Study||76
6422748|NCT01004107|7337452|FG001|STARTED|Overall Study||25
6422749|NCT01004107|7337451|FG000|COMPLETED|Overall Study||75
6422750|NCT01004107|7337452|FG001|COMPLETED|Overall Study||23
6422751|NCT01004107|7337451|FG000|NOT COMPLETED|Overall Study||1
6422752|NCT01004107|7337452|FG001|NOT COMPLETED|Overall Study||2
6422753|NCT01004146|7337479|FG000|STARTED|Overall Study||25
6422754|NCT01004146|7337480|FG001|STARTED|Overall Study||25
6422755|NCT01004146|7337479|FG000|Have Incentive Spirometry Data|Overall Study||21
6422756|NCT01004146|7337480|FG001|Have Incentive Spirometry Data|Overall Study||20
6422757|NCT01004146|7337479|FG000|COMPLETED|Overall Study||21
6422758|NCT01004146|7337480|FG001|COMPLETED|Overall Study||20
6422759|NCT01004146|7337479|FG000|NOT COMPLETED|Overall Study||4
6422760|NCT01004146|7337480|FG001|NOT COMPLETED|Overall Study||5
6422761|NCT01004159|7337486|FG000|STARTED|Overall Study||20
6422762|NCT01004159|7337486|FG000|COMPLETED|Overall Study||0
6422763|NCT01004159|7337486|FG000|NOT COMPLETED|Overall Study||20
6422764|NCT01004172|7337490|FG000|STARTED|Overall Study||38
6422765|NCT01004172|7337490|FG000|COMPLETED|Overall Study||0
6422766|NCT01004172|7337490|FG000|NOT COMPLETED|Overall Study||38
6422767|NCT01004185|7337497|FG000|STARTED|Overall Study||19
6422768|NCT01004185|7337498|FG001|STARTED|Overall Study||20
6422769|NCT01004185|7337497|FG000|COMPLETED|Overall Study||10
6422770|NCT01004185|7337498|FG001|COMPLETED|Overall Study||11
6422771|NCT01004185|7337497|FG000|NOT COMPLETED|Overall Study||9
6422772|NCT01004185|7337498|FG001|NOT COMPLETED|Overall Study||9
6422773|NCT01004250|7337504|FG000|STARTED|Induction Therapy Period||109
6422774|NCT01004250|7337504|FG000|Received at Least One Dose of Study Drug|Induction Therapy Period||109
6422775|NCT01004250|7337504|FG000|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
6422776|NCT01004250|7337504|FG000|COMPLETED|Induction Therapy Period||94
6422777|NCT01004250|7337504|FG000|NOT COMPLETED|Induction Therapy Period||15
6422778|NCT01004250|7337504|FG000|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
6422779|NCT01004250|7337504|FG000|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
6422780|NCT01004250|7337504|FG000|COMPLETED|Maintenance Therapy Period||46
6422781|NCT01004250|7337504|FG000|NOT COMPLETED|Maintenance Therapy Period||26
6422782|NCT01004250|7337504|FG000|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
6422783|NCT01004250|7337504|FG000|COMPLETED|Follow-Up (FU) Period||100
6422784|NCT01004250|7337504|FG000|NOT COMPLETED|Follow-Up (FU) Period||1
6422785|NCT01004354|7337512|FG000|STARTED|Overall Study||12
6422786|NCT01004354|7337512|FG000|COMPLETED|Overall Study||12
6422787|NCT01004354|7337512|FG000|NOT COMPLETED|Overall Study||0
6422788|NCT01004393|7337516|FG000|STARTED|Overall Study||12
6422789|NCT01004393|7337516|FG000|COMPLETED|Overall Study||12
6422790|NCT01004393|7337516|FG000|NOT COMPLETED|Overall Study||0
6422791|NCT01004406|7337522|FG000|STARTED|Overall Study||21
6422792|NCT01004406|7337523|FG001|STARTED|Overall Study||10
6422793|NCT01004406|7337522|FG000|COMPLETED|Overall Study||18
6422794|NCT01004406|7337523|FG001|COMPLETED|Overall Study||10
6422795|NCT01004406|7337522|FG000|NOT COMPLETED|Overall Study||3
6422796|NCT01004406|7337523|FG001|NOT COMPLETED|Overall Study||0
6422797|NCT01004432|7337529|FG000|STARTED|Open-label (OL) Period (Week 0 - 16)||433
6422798|NCT01004432|7337530|FG001|STARTED|Open-label (OL) Period (Week 0 - 16)||0
6422799|NCT01004432|7337531|FG002|STARTED|Open-label (OL) Period (Week 0 - 16)||0
6422800|NCT01004432|7337532|FG003|STARTED|Open-label (OL) Period (Week 0 - 16)||0
6422801|NCT01004432|7337533|FG004|STARTED|Open-label (OL) Period (Week 0 - 16)||0
6422802|NCT01004432|7337529|FG000|COMPLETED|Open-label (OL) Period (Week 0 - 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
6422803|NCT01004432|7337530|FG001|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6422804|NCT01004432|7337531|FG002|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6422805|NCT01004432|7337532|FG003|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6422806|NCT01004432|7337533|FG004|COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6422807|NCT01004432|7337529|FG000|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||83
6422808|NCT01004432|7337530|FG001|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6422809|NCT01004432|7337531|FG002|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6422810|NCT01004432|7337532|FG003|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6422811|NCT01004432|7337533|FG004|NOT COMPLETED|Open-label (OL) Period (Week 0 - 16)||0
6422812|NCT01004432|7337529|FG000|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
6422813|NCT01004432|7337530|FG001|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
6422814|NCT01004432|7337531|FG002|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
6422815|NCT01004432|7337532|FG003|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
6422816|NCT01004432|7337533|FG004|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
6422817|NCT01004432|7337529|FG000|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
6422818|NCT01004432|7337530|FG001|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
6422819|NCT01004432|7337531|FG002|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
6422820|NCT01004432|7337532|FG003|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
6422821|NCT01004432|7337533|FG004|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
6422822|NCT01004432|7337529|FG000|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
6422823|NCT01004432|7337530|FG001|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
6551484|NCT01732757|7473684|FG000|NOT COMPLETED|Overall Study||1
6551485|NCT01732757|7473685|FG001|NOT COMPLETED|Overall Study||0
6551486|NCT01732757|7473686|FG002|NOT COMPLETED|Overall Study||0
6551487|NCT01732770|7473696|FG000|STARTED|Overall Study||322
6551488|NCT01732770|7473697|FG001|STARTED|Overall Study||321
6551489|NCT01732770|7473696|FG000|Received Study Treatment|Overall Study||320
6551490|NCT01732770|7473697|FG001|Received Study Treatment|Overall Study||320
6551491|NCT01732770|7473696|FG000|COMPLETED|Overall Study||312
6551492|NCT01732770|7473697|FG001|COMPLETED|Overall Study||313
6551493|NCT01732770|7473696|FG000|NOT COMPLETED|Overall Study||10
6551494|NCT01732770|7473697|FG001|NOT COMPLETED|Overall Study||8
6551495|NCT01732783|7473706|FG000|STARTED|Overall Study||164
6551496|NCT01732783|7473707|FG001|STARTED|Overall Study||37
6551497|NCT01732783|7473708|FG002|STARTED|Overall Study||12
6551498|NCT01732783|7473706|FG000|COMPLETED|Overall Study|Completed 12-month observation period.|29
6551499|NCT01732783|7473707|FG001|COMPLETED|Overall Study|Completed 12-month observation period.|5
6551500|NCT01732783|7473708|FG002|COMPLETED|Overall Study|Completed 12-month observation period.|2
6551501|NCT01732783|7473706|FG000|NOT COMPLETED|Overall Study||135
6551502|NCT01732783|7473707|FG001|NOT COMPLETED|Overall Study||32
6551503|NCT01732783|7473708|FG002|NOT COMPLETED|Overall Study||10
6551504|NCT01732796|7473719|FG000|STARTED|Overall Study||208
6551505|NCT01732796|7473720|FG001|STARTED|Overall Study||211
6551506|NCT01732796|7473721|FG002|STARTED|Overall Study||51
6551507|NCT01732796|7473719|FG000|COMPLETED|Overall Study||162
6551508|NCT01732796|7473720|FG001|COMPLETED|Overall Study||169
6551509|NCT01732796|7473721|FG002|COMPLETED|Overall Study||38
6551510|NCT01732796|7473719|FG000|NOT COMPLETED|Overall Study||46
6551511|NCT01732796|7473720|FG001|NOT COMPLETED|Overall Study||42
6551512|NCT01732796|7473721|FG002|NOT COMPLETED|Overall Study||13
6562733|NCT01803074|7485702|FG003|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6562734|NCT01803074|7485703|FG004|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6422824|NCT01004432|7337531|FG002|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
6422825|NCT01004432|7337532|FG003|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
6422826|NCT01004432|7337533|FG004|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
6422827|NCT01004432|7337529|FG000|STARTED|OL Study Extension (Week 52 - 76)||0
6422828|NCT01004432|7337530|FG001|STARTED|OL Study Extension (Week 52 - 76)||0
6422829|NCT01004432|7337531|FG002|STARTED|OL Study Extension (Week 52 - 76)||0
6422830|NCT01004432|7337532|FG003|STARTED|OL Study Extension (Week 52 - 76)||0
6422831|NCT01004432|7337533|FG004|STARTED|OL Study Extension (Week 52 - 76)||212
6422832|NCT01004432|7337529|FG000|COMPLETED|OL Study Extension (Week 52 - 76)||0
6422833|NCT01004432|7337530|FG001|COMPLETED|OL Study Extension (Week 52 - 76)||0
6422834|NCT01004432|7337531|FG002|COMPLETED|OL Study Extension (Week 52 - 76)||0
6422835|NCT01004432|7337532|FG003|COMPLETED|OL Study Extension (Week 52 - 76)||0
6422836|NCT01004432|7337533|FG004|COMPLETED|OL Study Extension (Week 52 - 76)||194
6422837|NCT01004432|7337529|FG000|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
6422838|NCT01004432|7337530|FG001|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
6422839|NCT01004432|7337531|FG002|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
6562735|NCT01803074|7485704|FG005|STARTED|Period 1: Part A (HIV-1 Clade B)||8
6562736|NCT01803074|7485705|FG006|STARTED|Period 1: Part A (HIV-1 Clade B)||12
6562737|NCT01803074|7485706|FG007|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6422840|NCT01004432|7337532|FG003|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
6422841|NCT01004432|7337533|FG004|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
6422842|NCT01004614|7337551|FG000|STARTED|First Intervention||12
6422843|NCT01004614|7337552|FG001|STARTED|First Intervention||12
6422844|NCT01004614|7337553|FG002|STARTED|First Intervention||12
6422845|NCT01004614|7337554|FG003|STARTED|First Intervention||12
6422846|NCT01004614|7337551|FG000|COMPLETED|First Intervention||12
6422847|NCT01004614|7337552|FG001|COMPLETED|First Intervention||12
6422848|NCT01004614|7337553|FG002|COMPLETED|First Intervention||12
6422849|NCT01004614|7337554|FG003|COMPLETED|First Intervention||12
6422850|NCT01004614|7337551|FG000|NOT COMPLETED|First Intervention||0
6422851|NCT01004614|7337552|FG001|NOT COMPLETED|First Intervention||0
6422852|NCT01004614|7337553|FG002|NOT COMPLETED|First Intervention||0
6422853|NCT01004614|7337554|FG003|NOT COMPLETED|First Intervention||0
6422854|NCT01004614|7337551|FG000|STARTED|Washout||12
6422855|NCT01004614|7337552|FG001|STARTED|Washout||12
6422856|NCT01004614|7337553|FG002|STARTED|Washout||12
6422857|NCT01004614|7337554|FG003|STARTED|Washout||12
6422858|NCT01004614|7337551|FG000|COMPLETED|Washout||12
6422859|NCT01004614|7337552|FG001|COMPLETED|Washout||11
6422860|NCT01004614|7337553|FG002|COMPLETED|Washout||12
6422861|NCT01004614|7337554|FG003|COMPLETED|Washout||12
6422862|NCT01004614|7337551|FG000|NOT COMPLETED|Washout||0
6422863|NCT01004614|7337552|FG001|NOT COMPLETED|Washout||1
6551513|NCT04848662|7473733|FG000|STARTED|Period 1 (First Treatment Intervention)||6
6551514|NCT04848662|7473734|FG001|STARTED|Period 1 (First Treatment Intervention)||6
6551515|NCT04848662|7473733|FG000|COMPLETED|Period 1 (First Treatment Intervention)||6
6551516|NCT04848662|7473734|FG001|COMPLETED|Period 1 (First Treatment Intervention)||6
6422864|NCT01004614|7337553|FG002|NOT COMPLETED|Washout||0
6422865|NCT01004614|7337554|FG003|NOT COMPLETED|Washout||0
6422866|NCT01004614|7337551|FG000|STARTED|Second Intervention||12
6422867|NCT01004614|7337552|FG001|STARTED|Second Intervention||11
6422868|NCT01004614|7337553|FG002|STARTED|Second Intervention||12
6422869|NCT01004614|7337554|FG003|STARTED|Second Intervention||12
6422870|NCT01004614|7337551|FG000|COMPLETED|Second Intervention||12
6422871|NCT01004614|7337552|FG001|COMPLETED|Second Intervention||11
6422872|NCT01004614|7337553|FG002|COMPLETED|Second Intervention||12
6422873|NCT01004614|7337554|FG003|COMPLETED|Second Intervention||12
6422874|NCT01004614|7337551|FG000|NOT COMPLETED|Second Intervention||0
6422875|NCT01004614|7337552|FG001|NOT COMPLETED|Second Intervention||0
6422876|NCT01004614|7337553|FG002|NOT COMPLETED|Second Intervention||0
6422877|NCT01004614|7337554|FG003|NOT COMPLETED|Second Intervention||0
6422878|NCT01004705|7337564|FG000|STARTED|Run-In||44
6422879|NCT01004705|7337565|FG001|STARTED|Run-In||0
6422880|NCT01004705|7337566|FG002|STARTED|Run-In||0
6422881|NCT01004705|7337564|FG000|COMPLETED|Run-In||36
6422882|NCT01004705|7337565|FG001|COMPLETED|Run-In||0
6422883|NCT01004705|7337566|FG002|COMPLETED|Run-In||0
6422884|NCT01004705|7337564|FG000|NOT COMPLETED|Run-In||8
6422885|NCT01004705|7337565|FG001|NOT COMPLETED|Run-In||0
6422886|NCT01004705|7337566|FG002|NOT COMPLETED|Run-In||0
6422887|NCT01004705|7337564|FG000|STARTED|Period 1 (12 Weeks)||0
6422888|NCT01004705|7337565|FG001|STARTED|Period 1 (12 Weeks)||18
6422889|NCT01004705|7337566|FG002|STARTED|Period 1 (12 Weeks)||18
6422890|NCT01004705|7337564|FG000|COMPLETED|Period 1 (12 Weeks)||0
6422891|NCT01004705|7337565|FG001|COMPLETED|Period 1 (12 Weeks)||13
6422892|NCT01004705|7337566|FG002|COMPLETED|Period 1 (12 Weeks)||13
6422893|NCT01004705|7337564|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
6422894|NCT01004705|7337565|FG001|NOT COMPLETED|Period 1 (12 Weeks)||5
6422895|NCT01004705|7337566|FG002|NOT COMPLETED|Period 1 (12 Weeks)||5
6422896|NCT01004705|7337564|FG000|STARTED|Washout Period (6 Weeks)||0
6422897|NCT01004705|7337565|FG001|STARTED|Washout Period (6 Weeks)||13
6422898|NCT01004705|7337566|FG002|STARTED|Washout Period (6 Weeks)||13
6422899|NCT01004705|7337564|FG000|COMPLETED|Washout Period (6 Weeks)||0
6422900|NCT01004705|7337565|FG001|COMPLETED|Washout Period (6 Weeks)||13
6422901|NCT01004705|7337566|FG002|COMPLETED|Washout Period (6 Weeks)||13
6422902|NCT01004705|7337564|FG000|NOT COMPLETED|Washout Period (6 Weeks)||0
6422903|NCT01004705|7337565|FG001|NOT COMPLETED|Washout Period (6 Weeks)||0
6422904|NCT01004705|7337566|FG002|NOT COMPLETED|Washout Period (6 Weeks)||0
6422905|NCT01004705|7337564|FG000|STARTED|Period 2 (12 Weeks)||0
6422906|NCT01004705|7337565|FG001|STARTED|Period 2 (12 Weeks)||13
6422907|NCT01004705|7337566|FG002|STARTED|Period 2 (12 Weeks)||13
6422908|NCT01004705|7337564|FG000|COMPLETED|Period 2 (12 Weeks)||0
6422909|NCT01004705|7337565|FG001|COMPLETED|Period 2 (12 Weeks)||13
6422910|NCT01004705|7337566|FG002|COMPLETED|Period 2 (12 Weeks)||9
6422911|NCT01004705|7337564|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
6422912|NCT01004705|7337565|FG001|NOT COMPLETED|Period 2 (12 Weeks)||0
6422913|NCT01004705|7337566|FG002|NOT COMPLETED|Period 2 (12 Weeks)||4
6422914|NCT01004718|7337573|FG000|STARTED|Overall Study||10
6422915|NCT01004718|7337573|FG000|COMPLETED|Overall Study||10
6422916|NCT01004718|7337573|FG000|NOT COMPLETED|Overall Study||0
6422917|NCT01004744|7337578|FG000|STARTED|Overall Study||10
6422918|NCT01004744|7337578|FG000|COMPLETED|Overall Study||10
6422919|NCT01004744|7337578|FG000|NOT COMPLETED|Overall Study||0
6422920|NCT01004770|7337587|FG000|STARTED|Overall Study||10
6422921|NCT01004770|7337588|FG001|STARTED|Overall Study||10
6422922|NCT01004770|7337589|FG002|STARTED|Overall Study||10
6422923|NCT01004770|7337590|FG003|STARTED|Overall Study||10
6422924|NCT01004770|7337591|FG004|STARTED|Overall Study||10
6422925|NCT01004770|7337587|FG000|COMPLETED|Overall Study||10
6422926|NCT01004770|7337588|FG001|COMPLETED|Overall Study||10
6422927|NCT01004770|7337589|FG002|COMPLETED|Overall Study||10
6422928|NCT01004770|7337590|FG003|COMPLETED|Overall Study||10
6422929|NCT01004770|7337591|FG004|COMPLETED|Overall Study||10
6422930|NCT01004770|7337587|FG000|NOT COMPLETED|Overall Study||0
6422931|NCT01004770|7337588|FG001|NOT COMPLETED|Overall Study||0
6422932|NCT01004770|7337589|FG002|NOT COMPLETED|Overall Study||0
6422933|NCT01004770|7337590|FG003|NOT COMPLETED|Overall Study||0
6422934|NCT01004770|7337591|FG004|NOT COMPLETED|Overall Study||0
6422935|NCT01004822|7337611|FG000|STARTED|Overall Study||3
6422936|NCT01004822|7337612|FG001|STARTED|Overall Study||3
6422937|NCT01004822|7337613|FG002|STARTED|Overall Study||4
6422938|NCT01004822|7337614|FG003|STARTED|Overall Study||4
6422939|NCT01004822|7337615|FG004|STARTED|Overall Study||4
6422940|NCT01004822|7337616|FG005|STARTED|Overall Study||4
6422941|NCT01004822|7337617|FG006|STARTED|Overall Study||4
6422942|NCT01004822|7337618|FG007|STARTED|Overall Study||5
6422943|NCT01004822|7337611|FG000|Treated|Overall Study||3
6422944|NCT01004822|7337612|FG001|Treated|Overall Study||3
6422945|NCT01004822|7337613|FG002|Treated|Overall Study||3
6422946|NCT01004822|7337614|FG003|Treated|Overall Study||4
6422947|NCT01004822|7337615|FG004|Treated|Overall Study||4
6422948|NCT01004822|7337616|FG005|Treated|Overall Study||4
6422949|NCT01004822|7337617|FG006|Treated|Overall Study||4
6422950|NCT01004822|7337618|FG007|Treated|Overall Study||5
6422951|NCT01004822|7337611|FG000|COMPLETED|Overall Study||0
6422952|NCT01004822|7337612|FG001|COMPLETED|Overall Study||0
6422953|NCT01004822|7337613|FG002|COMPLETED|Overall Study||0
6422954|NCT01004822|7337614|FG003|COMPLETED|Overall Study||0
6422955|NCT01004822|7337615|FG004|COMPLETED|Overall Study||0
6422956|NCT01004822|7337616|FG005|COMPLETED|Overall Study||0
6422957|NCT01004822|7337617|FG006|COMPLETED|Overall Study||0
6422958|NCT01004822|7337618|FG007|COMPLETED|Overall Study||0
6422959|NCT01004822|7337611|FG000|NOT COMPLETED|Overall Study||3
6422960|NCT01004822|7337612|FG001|NOT COMPLETED|Overall Study||3
6422961|NCT01004822|7337613|FG002|NOT COMPLETED|Overall Study||4
6422962|NCT01004822|7337614|FG003|NOT COMPLETED|Overall Study||4
6422963|NCT01004822|7337615|FG004|NOT COMPLETED|Overall Study||4
6422964|NCT01004822|7337616|FG005|NOT COMPLETED|Overall Study||4
6422965|NCT01004822|7337617|FG006|NOT COMPLETED|Overall Study||4
6422966|NCT01004822|7337618|FG007|NOT COMPLETED|Overall Study||5
6422967|NCT01004848|7337640|FG000|STARTED|Overall Study||210
6422968|NCT01004848|7337641|FG001|STARTED|Overall Study||192
6422969|NCT01004848|7337640|FG000|COMPLETED|Overall Study||155
6422970|NCT01004848|7337641|FG001|COMPLETED|Overall Study||147
6422971|NCT01004848|7337640|FG000|NOT COMPLETED|Overall Study||55
6422972|NCT01004848|7337641|FG001|NOT COMPLETED|Overall Study||45
6422973|NCT01004939|7337649|FG000|STARTED|Overall Study||120
6422974|NCT01004939|7337649|FG000|COMPLETED|Overall Study||120
6422975|NCT01004939|7337649|FG000|NOT COMPLETED|Overall Study||0
6422976|NCT01004991|7337655|FG000|STARTED|Overall Study||12
6422977|NCT01004991|7337655|FG000|COMPLETED|Overall Study||12
6422978|NCT01004991|7337655|FG000|NOT COMPLETED|Overall Study||0
6422979|NCT01005251|7337664|FG000|STARTED|Overall Study||134
6422980|NCT01005251|7337665|FG001|STARTED|Overall Study||125
6422981|NCT01005251|7337666|FG002|STARTED|Overall Study||136
6422982|NCT01005251|7337667|FG003|STARTED|Overall Study||126
6422983|NCT01005251|7337668|FG004|STARTED|Overall Study||140
6422984|NCT01005251|7337664|FG000|COMPLETED|Overall Study||121
6422985|NCT01005251|7337665|FG001|COMPLETED|Overall Study||109
6422986|NCT01005251|7337666|FG002|COMPLETED|Overall Study||114
6422987|NCT01005251|7337667|FG003|COMPLETED|Overall Study||114
6422988|NCT01005251|7337668|FG004|COMPLETED|Overall Study||122
6422989|NCT01005251|7337664|FG000|NOT COMPLETED|Overall Study||13
6422990|NCT01005251|7337665|FG001|NOT COMPLETED|Overall Study||16
6422991|NCT01005251|7337666|FG002|NOT COMPLETED|Overall Study||22
6422992|NCT01005251|7337667|FG003|NOT COMPLETED|Overall Study||12
6422993|NCT01005251|7337668|FG004|NOT COMPLETED|Overall Study||18
6422994|NCT01005290|7337680|FG000|STARTED|Run-In||52
6422995|NCT01005290|7337681|FG001|STARTED|Run-In||0
6422996|NCT01005290|7337682|FG002|STARTED|Run-In||0
6422997|NCT01005290|7337680|FG000|COMPLETED|Run-In||38
6422998|NCT01005290|7337681|FG001|COMPLETED|Run-In||0
6551517|NCT04848662|7473733|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
6551518|NCT04848662|7473734|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
6551519|NCT04848662|7473733|FG000|STARTED|Period 2 (Second Treatment Intervention)||6
6551520|NCT04848662|7473734|FG001|STARTED|Period 2 (Second Treatment Intervention)||6
6422999|NCT01005290|7337682|FG002|COMPLETED|Run-In||0
6423000|NCT01005290|7337680|FG000|NOT COMPLETED|Run-In||14
6423001|NCT01005290|7337681|FG001|NOT COMPLETED|Run-In||0
6423002|NCT01005290|7337682|FG002|NOT COMPLETED|Run-In||0
6423003|NCT01005290|7337680|FG000|STARTED|Period 1 (5 Weeks)||0
6423004|NCT01005290|7337681|FG001|STARTED|Period 1 (5 Weeks)||20
6423005|NCT01005290|7337682|FG002|STARTED|Period 1 (5 Weeks)||18
6423006|NCT01005290|7337680|FG000|COMPLETED|Period 1 (5 Weeks)||0
6423007|NCT01005290|7337681|FG001|COMPLETED|Period 1 (5 Weeks)||13
6423008|NCT01005290|7337682|FG002|COMPLETED|Period 1 (5 Weeks)||9
6423009|NCT01005290|7337680|FG000|NOT COMPLETED|Period 1 (5 Weeks)||0
6423010|NCT01005290|7337681|FG001|NOT COMPLETED|Period 1 (5 Weeks)||7
6423011|NCT01005290|7337682|FG002|NOT COMPLETED|Period 1 (5 Weeks)||9
6423012|NCT01005290|7337680|FG000|STARTED|Washout Period (2 Weeks)||0
6423013|NCT01005290|7337681|FG001|STARTED|Washout Period (2 Weeks)||13
6423014|NCT01005290|7337682|FG002|STARTED|Washout Period (2 Weeks)||9
6423015|NCT01005290|7337680|FG000|COMPLETED|Washout Period (2 Weeks)||0
6423016|NCT01005290|7337681|FG001|COMPLETED|Washout Period (2 Weeks)||13
6423017|NCT01005290|7337682|FG002|COMPLETED|Washout Period (2 Weeks)||9
6423018|NCT01005290|7337680|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
6423019|NCT01005290|7337681|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
6423020|NCT01005290|7337682|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
6423021|NCT01005290|7337680|FG000|STARTED|Period 2 (5 Weeks)||0
6423022|NCT01005290|7337681|FG001|STARTED|Period 2 (5 Weeks)||13
6423023|NCT01005290|7337682|FG002|STARTED|Period 2 (5 Weeks)||9
6423024|NCT01005290|7337680|FG000|COMPLETED|Period 2 (5 Weeks)||0
6423025|NCT01005290|7337681|FG001|COMPLETED|Period 2 (5 Weeks)||13
6423026|NCT01005290|7337682|FG002|COMPLETED|Period 2 (5 Weeks)||7
6423027|NCT01005290|7337680|FG000|NOT COMPLETED|Period 2 (5 Weeks)||0
6423028|NCT01005290|7337681|FG001|NOT COMPLETED|Period 2 (5 Weeks)||0
6423029|NCT01005290|7337682|FG002|NOT COMPLETED|Period 2 (5 Weeks)||2
6423030|NCT01005316|7337692|FG000|STARTED|Overall Study||50
6423031|NCT01005316|7337693|FG001|STARTED|Overall Study||97
6423032|NCT01005316|7337694|FG002|STARTED|Overall Study||16
6423033|NCT01005316|7337695|FG003|STARTED|Overall Study||127
6423034|NCT01005316|7337692|FG000|COMPLETED|Overall Study||0
6423035|NCT01005316|7337693|FG001|COMPLETED|Overall Study||21
6423036|NCT01005316|7337694|FG002|COMPLETED|Overall Study||5
6423037|NCT01005316|7337695|FG003|COMPLETED|Overall Study||19
6423038|NCT01005316|7337692|FG000|NOT COMPLETED|Overall Study||50
6423039|NCT01005316|7337693|FG001|NOT COMPLETED|Overall Study||76
6423040|NCT01005316|7337694|FG002|NOT COMPLETED|Overall Study||11
6423041|NCT01005316|7337695|FG003|NOT COMPLETED|Overall Study||108
6551521|NCT04848662|7473733|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||5
6562738|NCT01803074|7485707|FG008|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6651033|NCT02416193|7580477|FG000|NOT COMPLETED|Overall Study||0
6423042|NCT01005329|7337706|FG000|STARTED|Overall Study||34
6423043|NCT01005329|7337706|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
6423044|NCT01005329|7337706|FG000|NOT COMPLETED|Overall Study||4
6423045|NCT01005355|7337714|FG000|STARTED|Overall Study||3
6423046|NCT01005355|7337715|FG001|STARTED|Overall Study||6
6423047|NCT01005355|7337716|FG002|STARTED|Overall Study||6
6423048|NCT01005355|7337714|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6423049|NCT01005355|7337715|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6423050|NCT01005355|7337716|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6423051|NCT01005355|7337714|FG000|COMPLETED|Overall Study||3
6423052|NCT01005355|7337715|FG001|COMPLETED|Overall Study||6
6423053|NCT01005355|7337716|FG002|COMPLETED|Overall Study||6
6423054|NCT01005355|7337714|FG000|NOT COMPLETED|Overall Study||0
6423055|NCT01005355|7337715|FG001|NOT COMPLETED|Overall Study||0
6423056|NCT01005355|7337716|FG002|NOT COMPLETED|Overall Study||0
6423057|NCT01005407|7337729|FG000|STARTED|Overall Study||1969
6423058|NCT01005407|7337730|FG001|STARTED|Overall Study||483
6423059|NCT01005407|7337729|FG000|COMPLETED|Overall Study||1818
6423060|NCT01005407|7337730|FG001|COMPLETED|Overall Study||451
6423061|NCT01005407|7337729|FG000|NOT COMPLETED|Overall Study||151
6423062|NCT01005407|7337730|FG001|NOT COMPLETED|Overall Study||32
6423063|NCT01005459|7337738|FG000|STARTED|Overall Study||23
6423064|NCT01005459|7337739|FG001|STARTED|Overall Study||23
6423065|NCT01005459|7337738|FG000|COMPLETED|Overall Study||23
6423066|NCT01005459|7337739|FG001|COMPLETED|Overall Study||23
6423067|NCT01005459|7337738|FG000|NOT COMPLETED|Overall Study||0
6423068|NCT01005459|7337739|FG001|NOT COMPLETED|Overall Study||0
6423069|NCT01005576|7337745|FG000|STARTED|Overall Study||21
6423070|NCT01005576|7337745|FG000|COMPLETED|Overall Study|All participants completed the conditioning regimen and received their stem cell transplant|21
6423071|NCT01005576|7337745|FG000|NOT COMPLETED|Overall Study||0
6423072|NCT01005602|7337751|FG000|STARTED|Overall Study||66
6423073|NCT01005602|7337752|FG001|STARTED|Overall Study||66
6423074|NCT01005602|7337751|FG000|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
6423075|NCT01005602|7337752|FG001|COMPLETED|Overall Study||66
6423076|NCT01005602|7337751|FG000|NOT COMPLETED|Overall Study||1
6423077|NCT01005602|7337752|FG001|NOT COMPLETED|Overall Study||0
6423078|NCT01005680|7337767|FG000|STARTED|Overall Study||126
6423079|NCT01005680|7337768|FG001|STARTED|Overall Study||130
6423080|NCT01005680|7337767|FG000|Received at Least 1 Dose of Study Drug|Overall Study||125
6423081|NCT01005680|7337768|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
6423082|NCT01005680|7337767|FG000|COMPLETED|Overall Study||120
6651034|NCT02416193|7580478|FG001|NOT COMPLETED|Overall Study||0
6651035|NCT02416453|7580495|FG000|STARTED|Overall Study||10
6651036|NCT02416453|7580496|FG001|STARTED|Overall Study||10
6423083|NCT01005680|7337768|FG001|COMPLETED|Overall Study||119
6423084|NCT01005680|7337767|FG000|NOT COMPLETED|Overall Study||6
6423085|NCT01005680|7337768|FG001|NOT COMPLETED|Overall Study||11
6423086|NCT01005706|7337777|FG000|STARTED|Overall Study||23
6423087|NCT01005706|7337778|FG001|STARTED|Overall Study||17
6423088|NCT01005706|7337777|FG000|COMPLETED|Overall Study||23
6423089|NCT01005706|7337778|FG001|COMPLETED|Overall Study||17
6651037|NCT02416453|7580497|FG002|STARTED|Overall Study||10
6651038|NCT02416453|7580498|FG003|STARTED|Overall Study||112
6651039|NCT02416453|7580499|FG004|STARTED|Overall Study||13
6651040|NCT02416453|7580500|FG005|STARTED|Overall Study||114
6423090|NCT01005706|7337777|FG000|NOT COMPLETED|Overall Study||0
6423091|NCT01005706|7337778|FG001|NOT COMPLETED|Overall Study||0
6423092|NCT01005719|7337784|FG000|STARTED|Period 1||10
6423093|NCT01005719|7337785|FG001|STARTED|Period 1||10
6423094|NCT01005719|7337786|FG002|STARTED|Period 1||10
6423095|NCT01005719|7337787|FG003|STARTED|Period 1||11
6423096|NCT01005719|7337788|FG004|STARTED|Period 1||11
6423097|NCT01005719|7337789|FG005|STARTED|Period 1||11
6423098|NCT01005719|7337784|FG000|COMPLETED|Period 1||10
6423099|NCT01005719|7337785|FG001|COMPLETED|Period 1||10
6423100|NCT01005719|7337786|FG002|COMPLETED|Period 1||10
6423101|NCT01005719|7337787|FG003|COMPLETED|Period 1||10
6423102|NCT01005719|7337788|FG004|COMPLETED|Period 1||11
6423103|NCT01005719|7337789|FG005|COMPLETED|Period 1||10
6423104|NCT01005719|7337784|FG000|NOT COMPLETED|Period 1||0
6423105|NCT01005719|7337785|FG001|NOT COMPLETED|Period 1||0
6423106|NCT01005719|7337786|FG002|NOT COMPLETED|Period 1||0
6423107|NCT01005719|7337787|FG003|NOT COMPLETED|Period 1||1
6423108|NCT01005719|7337788|FG004|NOT COMPLETED|Period 1||0
6423109|NCT01005719|7337789|FG005|NOT COMPLETED|Period 1||1
6423110|NCT01005719|7337784|FG000|STARTED|Period 2||10
6423111|NCT01005719|7337785|FG001|STARTED|Period 2||10
6423112|NCT01005719|7337786|FG002|STARTED|Period 2||10
6423113|NCT01005719|7337787|FG003|STARTED|Period 2||10
6423114|NCT01005719|7337788|FG004|STARTED|Period 2||11
6423115|NCT01005719|7337789|FG005|STARTED|Period 2||10
6423116|NCT01005719|7337784|FG000|COMPLETED|Period 2||10
6423117|NCT01005719|7337785|FG001|COMPLETED|Period 2||10
6423118|NCT01005719|7337786|FG002|COMPLETED|Period 2||10
6423119|NCT01005719|7337787|FG003|COMPLETED|Period 2||10
6423120|NCT01005719|7337788|FG004|COMPLETED|Period 2||10
6423121|NCT01005719|7337789|FG005|COMPLETED|Period 2||9
6423122|NCT01005719|7337784|FG000|NOT COMPLETED|Period 2||0
6423123|NCT01005719|7337785|FG001|NOT COMPLETED|Period 2||0
6423124|NCT01005719|7337786|FG002|NOT COMPLETED|Period 2||0
6423125|NCT01005719|7337787|FG003|NOT COMPLETED|Period 2||0
6423126|NCT01005719|7337788|FG004|NOT COMPLETED|Period 2||1
6423127|NCT01005719|7337789|FG005|NOT COMPLETED|Period 2||1
6423128|NCT01005719|7337784|FG000|STARTED|Period 3||10
6423129|NCT01005719|7337785|FG001|STARTED|Period 3||10
6423130|NCT01005719|7337786|FG002|STARTED|Period 3||10
6423131|NCT01005719|7337787|FG003|STARTED|Period 3||10
6423132|NCT01005719|7337788|FG004|STARTED|Period 3||10
6423133|NCT01005719|7337789|FG005|STARTED|Period 3||9
6423134|NCT01005719|7337784|FG000|COMPLETED|Period 3||10
6423135|NCT01005719|7337785|FG001|COMPLETED|Period 3||10
6423136|NCT01005719|7337786|FG002|COMPLETED|Period 3||10
6551522|NCT04848662|7473734|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||6
6551523|NCT04848662|7473733|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
6423137|NCT01005719|7337787|FG003|COMPLETED|Period 3||10
6423138|NCT01005719|7337788|FG004|COMPLETED|Period 3||10
6423139|NCT01005719|7337789|FG005|COMPLETED|Period 3||9
6423140|NCT01005719|7337784|FG000|NOT COMPLETED|Period 3||0
6423141|NCT01005719|7337785|FG001|NOT COMPLETED|Period 3||0
6423142|NCT01005719|7337786|FG002|NOT COMPLETED|Period 3||0
6423143|NCT01005719|7337787|FG003|NOT COMPLETED|Period 3||0
6423144|NCT01005719|7337788|FG004|NOT COMPLETED|Period 3||0
6423145|NCT01005719|7337789|FG005|NOT COMPLETED|Period 3||0
6423146|NCT01005732|7337798|FG000|STARTED|Overall Study||54
6423147|NCT01005732|7337798|FG000|COMPLETED|Overall Study||43
6423148|NCT01005732|7337798|FG000|NOT COMPLETED|Overall Study||11
6499437|NCT01417780|7418128|FG001|NOT COMPLETED|Overall Study||3
6499438|NCT01417780|7418129|FG002|NOT COMPLETED|Overall Study||2
6499439|NCT01417936|7418137|FG000|STARTED|Overall Study||26
6499440|NCT01417936|7418137|FG000|COMPLETED|Overall Study||26
6499441|NCT01417936|7418137|FG000|NOT COMPLETED|Overall Study||0
6499442|NCT01418001|7418141|FG000|STARTED|Overall Study||5
6499443|NCT01418001|7418141|FG000|COMPLETED|Overall Study||5
6499444|NCT01418001|7418141|FG000|NOT COMPLETED|Overall Study||0
6499445|NCT01418209|7418149|FG000|STARTED|Overall Study||97
6499446|NCT01418209|7418150|FG001|STARTED|Overall Study||96
6499447|NCT01418209|7418151|FG002|STARTED|Overall Study||146
6499448|NCT01418209|7418149|FG000|COMPLETED|Overall Study||95
6499449|NCT01418209|7418150|FG001|COMPLETED|Overall Study||93
6499450|NCT01418209|7418151|FG002|COMPLETED|Overall Study||142
6499451|NCT01418209|7418149|FG000|NOT COMPLETED|Overall Study||2
6499452|NCT01418209|7418150|FG001|NOT COMPLETED|Overall Study||3
6499453|NCT01418209|7418151|FG002|NOT COMPLETED|Overall Study||4
6499454|NCT01418339|7418161|FG000|STARTED|Overall Study||90
6499455|NCT01418339|7418162|FG001|STARTED|Overall Study||45
6499456|NCT01418339|7418161|FG000|COMPLETED|Overall Study||78
6499457|NCT01418339|7418162|FG001|COMPLETED|Overall Study||35
6499458|NCT01418339|7418161|FG000|NOT COMPLETED|Overall Study||12
6499459|NCT01418339|7418162|FG001|NOT COMPLETED|Overall Study||10
6499460|NCT01418352|7418172|FG000|STARTED|Overall Study||20
6499461|NCT01418352|7418173|FG001|STARTED|Overall Study||21
6499462|NCT01418352|7418174|FG002|STARTED|Overall Study||21
6499463|NCT01418352|7418175|FG003|STARTED|Overall Study||21
6499464|NCT01418352|7418172|FG000|COMPLETED|Overall Study||17
6499465|NCT01418352|7418173|FG001|COMPLETED|Overall Study||17
6499466|NCT01418352|7418174|FG002|COMPLETED|Overall Study||16
6499467|NCT01418352|7418175|FG003|COMPLETED|Overall Study||18
6499468|NCT01418352|7418172|FG000|NOT COMPLETED|Overall Study||3
6499469|NCT01418352|7418173|FG001|NOT COMPLETED|Overall Study||4
6499470|NCT01418352|7418174|FG002|NOT COMPLETED|Overall Study||5
6499471|NCT01418352|7418175|FG003|NOT COMPLETED|Overall Study||3
6423149|NCT01005810|7337808|FG000|STARTED|Overall Study||58
6423150|NCT01005810|7337809|FG001|STARTED|Overall Study||58
6423151|NCT01005810|7337808|FG000|COMPLETED|Overall Study||37
6423152|NCT01005810|7337809|FG001|COMPLETED|Overall Study||33
6423153|NCT01005810|7337808|FG000|NOT COMPLETED|Overall Study||21
6423154|NCT01005810|7337809|FG001|NOT COMPLETED|Overall Study||25
6423155|NCT01005875|7337815|FG000|STARTED|Overall Study||5
6423156|NCT01005875|7337815|FG000|COMPLETED|Overall Study||2
6423157|NCT01005875|7337815|FG000|NOT COMPLETED|Overall Study||3
6423158|NCT01005888|7337823|FG000|STARTED|First Intervention||12
6423159|NCT01005888|7337824|FG001|STARTED|First Intervention||12
6423160|NCT01005888|7337823|FG000|COMPLETED|First Intervention||11
6423161|NCT01005888|7337824|FG001|COMPLETED|First Intervention||11
6423162|NCT01005888|7337823|FG000|NOT COMPLETED|First Intervention||1
6423163|NCT01005888|7337824|FG001|NOT COMPLETED|First Intervention||1
6423164|NCT01005888|7337823|FG000|STARTED|Second Intervention||11
6423165|NCT01005888|7337824|FG001|STARTED|Second Intervention||11
6423166|NCT01005888|7337823|FG000|COMPLETED|Second Intervention||10
6423167|NCT01005888|7337824|FG001|COMPLETED|Second Intervention||10
6423168|NCT01005888|7337823|FG000|NOT COMPLETED|Second Intervention||1
6423169|NCT01005888|7337824|FG001|NOT COMPLETED|Second Intervention||1
6423170|NCT01005901|7337832|FG000|STARTED|Overall Study||552
6423171|NCT01005901|7337833|FG001|STARTED|Overall Study||270
6423172|NCT01005901|7337832|FG000|Safety Population|Overall Study||550
6423173|NCT01005901|7337833|FG001|Safety Population|Overall Study||267
6423174|NCT01005901|7337832|FG000|Full Analysis Set|Overall Study||534
6423175|NCT01005901|7337833|FG001|Full Analysis Set|Overall Study||260
6423176|NCT01005901|7337832|FG000|COMPLETED|Overall Study||450
6423177|NCT01005901|7337833|FG001|COMPLETED|Overall Study||212
6423178|NCT01005901|7337832|FG000|NOT COMPLETED|Overall Study||102
6423179|NCT01005901|7337833|FG001|NOT COMPLETED|Overall Study||58
6423180|NCT01005966|7337839|FG000|STARTED|Treatment Period 1 (14 Days)||13
6423181|NCT01005966|7337840|FG001|STARTED|Treatment Period 1 (14 Days)||13
6423182|NCT01005966|7337841|FG002|STARTED|Treatment Period 1 (14 Days)||13
6423183|NCT01005966|7337842|FG003|STARTED|Treatment Period 1 (14 Days)||13
6423184|NCT01005966|7337843|FG004|STARTED|Treatment Period 1 (14 Days)||13
6423185|NCT01005966|7337839|FG000|COMPLETED|Treatment Period 1 (14 Days)||11
6423186|NCT01005966|7337840|FG001|COMPLETED|Treatment Period 1 (14 Days)||13
6423187|NCT01005966|7337841|FG002|COMPLETED|Treatment Period 1 (14 Days)||12
6423188|NCT01005966|7337842|FG003|COMPLETED|Treatment Period 1 (14 Days)||13
6423189|NCT01005966|7337843|FG004|COMPLETED|Treatment Period 1 (14 Days)||13
6423190|NCT01005966|7337839|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6423191|NCT01005966|7337840|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6423192|NCT01005966|7337841|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6423193|NCT01005966|7337842|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6423194|NCT01005966|7337843|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6423195|NCT01005966|7337839|FG000|STARTED|Washout Period 1 (4 Days)||11
6423196|NCT01005966|7337840|FG001|STARTED|Washout Period 1 (4 Days)||13
6423197|NCT01005966|7337841|FG002|STARTED|Washout Period 1 (4 Days)||12
6423198|NCT01005966|7337842|FG003|STARTED|Washout Period 1 (4 Days)||13
6423199|NCT01005966|7337843|FG004|STARTED|Washout Period 1 (4 Days)||13
6423200|NCT01005966|7337839|FG000|COMPLETED|Washout Period 1 (4 Days)||11
6423201|NCT01005966|7337840|FG001|COMPLETED|Washout Period 1 (4 Days)||13
6423202|NCT01005966|7337841|FG002|COMPLETED|Washout Period 1 (4 Days)||12
6423203|NCT01005966|7337842|FG003|COMPLETED|Washout Period 1 (4 Days)||12
6423204|NCT01005966|7337843|FG004|COMPLETED|Washout Period 1 (4 Days)||13
6423205|NCT01005966|7337839|FG000|NOT COMPLETED|Washout Period 1 (4 Days)||0
6423206|NCT01005966|7337840|FG001|NOT COMPLETED|Washout Period 1 (4 Days)||0
6423207|NCT01005966|7337841|FG002|NOT COMPLETED|Washout Period 1 (4 Days)||0
6423208|NCT01005966|7337842|FG003|NOT COMPLETED|Washout Period 1 (4 Days)||1
6423209|NCT01005966|7337843|FG004|NOT COMPLETED|Washout Period 1 (4 Days)||0
6423210|NCT01005966|7337839|FG000|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
6423211|NCT01005966|7337840|FG001|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
6423212|NCT01005966|7337841|FG002|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
6423213|NCT01005966|7337842|FG003|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
6423214|NCT01005966|7337843|FG004|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
6423215|NCT01005966|7337839|FG000|COMPLETED|Treatment Period 2 (14 Days)||13
6423216|NCT01005966|7337840|FG001|COMPLETED|Treatment Period 2 (14 Days)||12
6423217|NCT01005966|7337841|FG002|COMPLETED|Treatment Period 2 (14 Days)||10
6423218|NCT01005966|7337842|FG003|COMPLETED|Treatment Period 2 (14 Days)||11
6423219|NCT01005966|7337843|FG004|COMPLETED|Treatment Period 2 (14 Days)||11
6423220|NCT01005966|7337839|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6423221|NCT01005966|7337840|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6423222|NCT01005966|7337841|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
6423223|NCT01005966|7337842|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6423224|NCT01005966|7337843|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6423225|NCT01005966|7337839|FG000|STARTED|Washout Period 2 (4 Days)||13
6423226|NCT01005966|7337840|FG001|STARTED|Washout Period 2 (4 Days)||12
6423227|NCT01005966|7337841|FG002|STARTED|Washout Period 2 (4 Days)||10
6551524|NCT04848662|7473734|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
6423228|NCT01005966|7337842|FG003|STARTED|Washout Period 2 (4 Days)||11
6423229|NCT01005966|7337843|FG004|STARTED|Washout Period 2 (4 Days)||11
6423230|NCT01005966|7337839|FG000|COMPLETED|Washout Period 2 (4 Days)||13
6423231|NCT01005966|7337840|FG001|COMPLETED|Washout Period 2 (4 Days)||12
6423232|NCT01005966|7337841|FG002|COMPLETED|Washout Period 2 (4 Days)||10
6423233|NCT01005966|7337842|FG003|COMPLETED|Washout Period 2 (4 Days)||11
6423234|NCT01005966|7337843|FG004|COMPLETED|Washout Period 2 (4 Days)||11
6423235|NCT01005966|7337839|FG000|NOT COMPLETED|Washout Period 2 (4 Days)||0
6423236|NCT01005966|7337840|FG001|NOT COMPLETED|Washout Period 2 (4 Days)||0
6423237|NCT01005966|7337841|FG002|NOT COMPLETED|Washout Period 2 (4 Days)||0
6423238|NCT01005966|7337842|FG003|NOT COMPLETED|Washout Period 2 (4 Days)||0
6423239|NCT01005966|7337843|FG004|NOT COMPLETED|Washout Period 2 (4 Days)||0
6423240|NCT01005966|7337839|FG000|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6423241|NCT01005966|7337840|FG001|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
6423242|NCT01005966|7337841|FG002|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6423243|NCT01005966|7337842|FG003|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
6423244|NCT01005966|7337843|FG004|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
6423245|NCT01005966|7337839|FG000|COMPLETED|Treatment Period 3 (14 Days)||12
6423246|NCT01005966|7337840|FG001|COMPLETED|Treatment Period 3 (14 Days)||7
6423247|NCT01005966|7337841|FG002|COMPLETED|Treatment Period 3 (14 Days)||12
6423248|NCT01005966|7337842|FG003|COMPLETED|Treatment Period 3 (14 Days)||13
6423249|NCT01005966|7337843|FG004|COMPLETED|Treatment Period 3 (14 Days)||11
6423250|NCT01005966|7337839|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6423251|NCT01005966|7337840|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6423252|NCT01005966|7337841|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6423253|NCT01005966|7337842|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6423254|NCT01005966|7337843|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6423255|NCT01005966|7337839|FG000|STARTED|Washout Period 3 ( 4 Days)||12
6423256|NCT01005966|7337840|FG001|STARTED|Washout Period 3 ( 4 Days)||7
6423257|NCT01005966|7337841|FG002|STARTED|Washout Period 3 ( 4 Days)||12
6423258|NCT01005966|7337842|FG003|STARTED|Washout Period 3 ( 4 Days)||13
6423259|NCT01005966|7337843|FG004|STARTED|Washout Period 3 ( 4 Days)||11
6423260|NCT01005966|7337839|FG000|COMPLETED|Washout Period 3 ( 4 Days)||12
6423261|NCT01005966|7337840|FG001|COMPLETED|Washout Period 3 ( 4 Days)||7
6423262|NCT01005966|7337841|FG002|COMPLETED|Washout Period 3 ( 4 Days)||12
6423263|NCT01005966|7337842|FG003|COMPLETED|Washout Period 3 ( 4 Days)||13
6423264|NCT01005966|7337843|FG004|COMPLETED|Washout Period 3 ( 4 Days)||11
6423265|NCT01005966|7337839|FG000|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6423266|NCT01005966|7337840|FG001|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6423267|NCT01005966|7337841|FG002|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6423268|NCT01005966|7337842|FG003|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6423269|NCT01005966|7337843|FG004|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
6423270|NCT01005966|7337839|FG000|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
6423271|NCT01005966|7337840|FG001|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
6423272|NCT01005966|7337841|FG002|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
6423273|NCT01005966|7337842|FG003|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
6423274|NCT01005966|7337843|FG004|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
6423275|NCT01005966|7337839|FG000|COMPLETED|Treatment Period 4 (14 Days)||10
6423276|NCT01005966|7337840|FG001|COMPLETED|Treatment Period 4 (14 Days)||10
6423277|NCT01005966|7337841|FG002|COMPLETED|Treatment Period 4 (14 Days)||11
6423278|NCT01005966|7337842|FG003|COMPLETED|Treatment Period 4 (14 Days)||10
6423279|NCT01005966|7337843|FG004|COMPLETED|Treatment Period 4 (14 Days)||12
6423280|NCT01005966|7337839|FG000|NOT COMPLETED|Treatment Period 4 (14 Days)||0
6423281|NCT01005966|7337840|FG001|NOT COMPLETED|Treatment Period 4 (14 Days)||1
6423282|NCT01005966|7337841|FG002|NOT COMPLETED|Treatment Period 4 (14 Days)||0
6423283|NCT01005966|7337842|FG003|NOT COMPLETED|Treatment Period 4 (14 Days)||0
6423284|NCT01005966|7337843|FG004|NOT COMPLETED|Treatment Period 4 (14 Days)||1
6423285|NCT01005966|7337839|FG000|STARTED|Washout Period 4 (4 Days)||10
6423286|NCT01005966|7337840|FG001|STARTED|Washout Period 4 (4 Days)||10
6423287|NCT01005966|7337841|FG002|STARTED|Washout Period 4 (4 Days)||11
6423288|NCT01005966|7337842|FG003|STARTED|Washout Period 4 (4 Days)||10
6423289|NCT01005966|7337843|FG004|STARTED|Washout Period 4 (4 Days)||12
6423290|NCT01005966|7337839|FG000|COMPLETED|Washout Period 4 (4 Days)||10
6423291|NCT01005966|7337840|FG001|COMPLETED|Washout Period 4 (4 Days)||10
6423292|NCT01005966|7337841|FG002|COMPLETED|Washout Period 4 (4 Days)||11
6423293|NCT01005966|7337842|FG003|COMPLETED|Washout Period 4 (4 Days)||10
6423294|NCT01005966|7337843|FG004|COMPLETED|Washout Period 4 (4 Days)||12
6423295|NCT01005966|7337839|FG000|NOT COMPLETED|Washout Period 4 (4 Days)||0
6423296|NCT01005966|7337840|FG001|NOT COMPLETED|Washout Period 4 (4 Days)||0
6423297|NCT01005966|7337841|FG002|NOT COMPLETED|Washout Period 4 (4 Days)||0
6423298|NCT01005966|7337842|FG003|NOT COMPLETED|Washout Period 4 (4 Days)||0
6423299|NCT01005966|7337843|FG004|NOT COMPLETED|Washout Period 4 (4 Days)||0
6423300|NCT01005966|7337839|FG000|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
6423301|NCT01005966|7337840|FG001|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
6423302|NCT01005966|7337841|FG002|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
6423303|NCT01005966|7337842|FG003|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
6423304|NCT01005966|7337843|FG004|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
6423305|NCT01005966|7337839|FG000|COMPLETED|Treatment Period 5 (14 Days)||9
6423306|NCT01005966|7337840|FG001|COMPLETED|Treatment Period 5 (14 Days)||12
6423307|NCT01005966|7337841|FG002|COMPLETED|Treatment Period 5 (14 Days)||11
6423308|NCT01005966|7337842|FG003|COMPLETED|Treatment Period 5 (14 Days)||11
6423309|NCT01005966|7337843|FG004|COMPLETED|Treatment Period 5 (14 Days)||10
6423310|NCT01005966|7337839|FG000|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6423311|NCT01005966|7337840|FG001|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6423312|NCT01005966|7337841|FG002|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6423313|NCT01005966|7337842|FG003|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6423314|NCT01005966|7337843|FG004|NOT COMPLETED|Treatment Period 5 (14 Days)||0
6423315|NCT01006122|7337860|FG000|STARTED|First Double-blind Intervention Period||47
6423316|NCT01006122|7337861|FG001|STARTED|First Double-blind Intervention Period||48
6423317|NCT01006122|7337860|FG000|COMPLETED|First Double-blind Intervention Period||31
6423318|NCT01006122|7337861|FG001|COMPLETED|First Double-blind Intervention Period||31
6423319|NCT01006122|7337860|FG000|NOT COMPLETED|First Double-blind Intervention Period||16
6423320|NCT01006122|7337861|FG001|NOT COMPLETED|First Double-blind Intervention Period||17
6423321|NCT01006122|7337860|FG000|STARTED|Wash-out Period (at Least 7 Days)||31
6423322|NCT01006122|7337861|FG001|STARTED|Wash-out Period (at Least 7 Days)||31
6423323|NCT01006122|7337860|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||31
6423324|NCT01006122|7337861|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||31
6423325|NCT01006122|7337860|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6423326|NCT01006122|7337861|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6423327|NCT01006122|7337860|FG000|STARTED|Second Double-blind Intervention Period||31
6423328|NCT01006122|7337861|FG001|STARTED|Second Double-blind Intervention Period||31
6423329|NCT01006122|7337860|FG000|COMPLETED|Second Double-blind Intervention Period||29
6423330|NCT01006122|7337861|FG001|COMPLETED|Second Double-blind Intervention Period||24
6423331|NCT01006122|7337860|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
6423332|NCT01006122|7337861|FG001|NOT COMPLETED|Second Double-blind Intervention Period||7
6423333|NCT01006135|7337867|FG000|STARTED|Overall Study||4852
6423334|NCT01006135|7337867|FG000|COMPLETED|Overall Study||4712
6423335|NCT01006135|7337867|FG000|NOT COMPLETED|Overall Study||140
6423336|NCT01006252|7337873|FG000|STARTED|Overall Study||168
6423337|NCT01006252|7337874|FG001|STARTED|Overall Study||168
6423338|NCT01006252|7337873|FG000|Received Treatment|Overall Study||164
6423339|NCT01006252|7337874|FG001|Received Treatment|Overall Study||161
6423340|NCT01006252|7337873|FG000|COMPLETED|Overall Study||168
6423341|NCT01006252|7337874|FG001|COMPLETED|Overall Study||168
6423342|NCT01006252|7337873|FG000|NOT COMPLETED|Overall Study||0
6423343|NCT01006252|7337874|FG001|NOT COMPLETED|Overall Study||0
6423344|NCT01006291|7337887|FG000|STARTED|Overall Study||229
6423345|NCT01006291|7337888|FG001|STARTED|Overall Study||228
6423346|NCT01006291|7337889|FG002|STARTED|Overall Study||230
6423347|NCT01006291|7337887|FG000|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
6423348|NCT01006291|7337888|FG001|Exposed|Overall Study|2 subjects received IDeg OD FF|226
6423349|NCT01006291|7337889|FG002|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
6423350|NCT01006291|7337887|FG000|COMPLETED|Overall Study||203
6423351|NCT01006291|7337888|FG001|COMPLETED|Overall Study||204
6423352|NCT01006291|7337889|FG002|COMPLETED|Overall Study||203
6423353|NCT01006291|7337887|FG000|NOT COMPLETED|Overall Study||26
6423354|NCT01006291|7337888|FG001|NOT COMPLETED|Overall Study||24
6423355|NCT01006291|7337889|FG002|NOT COMPLETED|Overall Study||27
6423356|NCT01006356|7337897|FG000|STARTED|Overall Study||141
6423357|NCT01006356|7337897|FG000|COMPLETED|Overall Study||99
6423358|NCT01006356|7337897|FG000|NOT COMPLETED|Overall Study||42
6423359|NCT01006369|7337903|FG000|STARTED|Overall Study||13
6423360|NCT01006369|7337904|FG001|STARTED|Overall Study||25
6423361|NCT01006369|7337903|FG000|COMPLETED|Overall Study||1
6423362|NCT01006369|7337904|FG001|COMPLETED|Overall Study||0
6423363|NCT01006369|7337903|FG000|NOT COMPLETED|Overall Study||12
6423364|NCT01006369|7337904|FG001|NOT COMPLETED|Overall Study||25
6423365|NCT01006538|7337911|FG000|STARTED|Overall Study||244
6423366|NCT01006538|7337912|FG001|STARTED|Overall Study||119
6423367|NCT01006538|7337911|FG000|COMPLETED|Overall Study||233
6423368|NCT01006538|7337912|FG001|COMPLETED|Overall Study||115
6423369|NCT01006538|7337911|FG000|NOT COMPLETED|Overall Study||11
6423370|NCT01006538|7337912|FG001|NOT COMPLETED|Overall Study||4
6423371|NCT01006590|7337920|FG000|STARTED|Overall Study|Randomised and treated|147
6423372|NCT01006590|7337921|FG001|STARTED|Overall Study|Randomised and treated|139
6423373|NCT01006590|7337920|FG000|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
6423374|NCT01006590|7337921|FG001|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
6423375|NCT01006590|7337920|FG000|NOT COMPLETED|Overall Study||28
6423376|NCT01006590|7337921|FG001|NOT COMPLETED|Overall Study||32
6423377|NCT01006603|7337929|FG000|STARTED|Overall Study|Completed lead-in period and were randomised|360
6423378|NCT01006603|7337930|FG001|STARTED|Overall Study|Completed lead-in period and were randomised|360
6423379|NCT01006603|7337929|FG000|COMPLETED|Overall Study||289
6423380|NCT01006603|7337930|FG001|COMPLETED|Overall Study||285
6423381|NCT01006603|7337929|FG000|NOT COMPLETED|Overall Study||71
6423382|NCT01006603|7337930|FG001|NOT COMPLETED|Overall Study||75
6423383|NCT01006616|7337940|FG000|STARTED|Period 1 (6 Months)||152
6423384|NCT01006616|7337941|FG001|STARTED|Period 1 (6 Months)||156
6423385|NCT01006616|7337942|FG002|STARTED|Period 1 (6 Months)||153
6423386|NCT01006616|7337943|FG003|STARTED|Period 1 (6 Months)||155
6423387|NCT01006616|7337940|FG000|Treated|Period 1 (6 Months)||152
6423388|NCT01006616|7337941|FG001|Treated|Period 1 (6 Months)||156
6423389|NCT01006616|7337942|FG002|Treated|Period 1 (6 Months)||152
6423390|NCT01006616|7337943|FG003|Treated|Period 1 (6 Months)||154
6423391|NCT01006616|7337940|FG000|COMPLETED|Period 1 (6 Months)||126
6423392|NCT01006616|7337941|FG001|COMPLETED|Period 1 (6 Months)||102
6423393|NCT01006616|7337942|FG002|COMPLETED|Period 1 (6 Months)||102
6423394|NCT01006616|7337943|FG003|COMPLETED|Period 1 (6 Months)||128
6651041|NCT02416453|7580501|FG006|STARTED|Overall Study||13
6651042|NCT02416453|7580502|FG007|STARTED|Overall Study||106
6651043|NCT02416453|7580503|FG008|STARTED|Overall Study||18
6423395|NCT01006616|7337940|FG000|NOT COMPLETED|Period 1 (6 Months)||26
6423396|NCT01006616|7337941|FG001|NOT COMPLETED|Period 1 (6 Months)||54
6423397|NCT01006616|7337942|FG002|NOT COMPLETED|Period 1 (6 Months)||51
6423398|NCT01006616|7337943|FG003|NOT COMPLETED|Period 1 (6 Months)||27
6423399|NCT01006616|7337940|FG000|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
6423400|NCT01006616|7337941|FG001|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
6423401|NCT01006616|7337942|FG002|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
6423402|NCT01006616|7337943|FG003|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
6423403|NCT01006616|7337940|FG000|Treated|Period 2 (18 Months)||75
6423404|NCT01006616|7337941|FG001|Treated|Period 2 (18 Months)||63
6423405|NCT01006616|7337942|FG002|Treated|Period 2 (18 Months)||55
6423406|NCT01006616|7337943|FG003|Treated|Period 2 (18 Months)||82
6423407|NCT01006616|7337940|FG000|COMPLETED|Period 2 (18 Months)||0
6423408|NCT01006616|7337941|FG001|COMPLETED|Period 2 (18 Months)||0
6423409|NCT01006616|7337942|FG002|COMPLETED|Period 2 (18 Months)||0
6423410|NCT01006616|7337943|FG003|COMPLETED|Period 2 (18 Months)||0
6423411|NCT01006616|7337940|FG000|NOT COMPLETED|Period 2 (18 Months)||75
6423412|NCT01006616|7337941|FG001|NOT COMPLETED|Period 2 (18 Months)||63
6423413|NCT01006616|7337942|FG002|NOT COMPLETED|Period 2 (18 Months)||55
6423414|NCT01006616|7337943|FG003|NOT COMPLETED|Period 2 (18 Months)||82
6423415|NCT01006629|7337953|FG000|STARTED|Overall Study||100
6423416|NCT01006629|7337953|FG000|COMPLETED|Overall Study||94
6423417|NCT01006629|7337953|FG000|NOT COMPLETED|Overall Study||6
6423418|NCT01006655|7337959|FG000|STARTED|First Intervention||11
6423419|NCT01006655|7337960|FG001|STARTED|First Intervention||10
6423420|NCT01006655|7337959|FG000|COMPLETED|First Intervention||11
6423421|NCT01006655|7337960|FG001|COMPLETED|First Intervention||10
6423422|NCT01006655|7337959|FG000|NOT COMPLETED|First Intervention||0
6423423|NCT01006655|7337960|FG001|NOT COMPLETED|First Intervention||0
6423424|NCT01006655|7337959|FG000|STARTED|Washout Period of 2 Weeks||11
6551525|NCT04537234|7473742|FG000|STARTED|Overall Study||82
6551526|NCT04537234|7473743|FG001|STARTED|Overall Study||83
6551527|NCT04537234|7473742|FG000|COMPLETED|Overall Study||80
6651044|NCT02416453|7580504|FG009|STARTED|Overall Study||13
6651045|NCT02416453|7580505|FG010|STARTED|Overall Study||2
6651046|NCT02416453|7580495|FG000|COMPLETED|Overall Study||7
6651047|NCT02416453|7580496|FG001|COMPLETED|Overall Study||7
6651048|NCT02416453|7580497|FG002|COMPLETED|Overall Study||9
6651049|NCT02416453|7580498|FG003|COMPLETED|Overall Study||97
6651050|NCT02416453|7580499|FG004|COMPLETED|Overall Study||12
6651051|NCT02416453|7580500|FG005|COMPLETED|Overall Study||98
6651052|NCT02416453|7580501|FG006|COMPLETED|Overall Study||11
6651053|NCT02416453|7580502|FG007|COMPLETED|Overall Study||94
6651054|NCT02416453|7580503|FG008|COMPLETED|Overall Study||13
6651055|NCT02416453|7580504|FG009|COMPLETED|Overall Study||13
6423425|NCT01006655|7337960|FG001|STARTED|Washout Period of 2 Weeks||10
6423426|NCT01006655|7337959|FG000|COMPLETED|Washout Period of 2 Weeks||11
6423427|NCT01006655|7337960|FG001|COMPLETED|Washout Period of 2 Weeks||10
6423428|NCT01006655|7337959|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6551528|NCT04537234|7473743|FG001|COMPLETED|Overall Study||83
6551529|NCT04537234|7473742|FG000|NOT COMPLETED|Overall Study||2
6551530|NCT04537234|7473743|FG001|NOT COMPLETED|Overall Study||0
6551531|NCT04371471|7473749|FG000|STARTED|Overall Study||91
6551532|NCT04371471|7473749|FG000|COMPLETED|Overall Study||81
6551533|NCT04371471|7473749|FG000|NOT COMPLETED|Overall Study||10
6562739|NCT01803074|7485708|FG009|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6562740|NCT01803074|7485709|FG010|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6651056|NCT02416453|7580505|FG010|COMPLETED|Overall Study||2
6651057|NCT02416453|7580495|FG000|NOT COMPLETED|Overall Study||3
6651058|NCT02416453|7580496|FG001|NOT COMPLETED|Overall Study||3
6423429|NCT01006655|7337960|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6423430|NCT01006655|7337959|FG000|STARTED|Second Intervention||11
6423431|NCT01006655|7337960|FG001|STARTED|Second Intervention||10
6423432|NCT01006655|7337959|FG000|COMPLETED|Second Intervention||11
6423433|NCT01006655|7337960|FG001|COMPLETED|Second Intervention||10
6423434|NCT01006655|7337959|FG000|NOT COMPLETED|Second Intervention||0
6423435|NCT01006655|7337960|FG001|NOT COMPLETED|Second Intervention||0
6423436|NCT01006707|7337966|FG000|STARTED|Study Session 1||15
6423437|NCT01006707|7337967|FG001|STARTED|Study Session 1||0
6423438|NCT01006707|7337968|FG002|STARTED|Study Session 1||0
6423439|NCT01006707|7337966|FG000|COMPLETED|Study Session 1||10
6423440|NCT01006707|7337967|FG001|COMPLETED|Study Session 1||0
6423441|NCT01006707|7337968|FG002|COMPLETED|Study Session 1||0
6423442|NCT01006707|7337966|FG000|NOT COMPLETED|Study Session 1||5
6423443|NCT01006707|7337967|FG001|NOT COMPLETED|Study Session 1||0
6423444|NCT01006707|7337968|FG002|NOT COMPLETED|Study Session 1||0
6423445|NCT01006707|7337966|FG000|STARTED|Study Session 2||0
6423446|NCT01006707|7337967|FG001|STARTED|Study Session 2||4
6423447|NCT01006707|7337968|FG002|STARTED|Study Session 2||6
6423448|NCT01006707|7337966|FG000|COMPLETED|Study Session 2||0
6423449|NCT01006707|7337967|FG001|COMPLETED|Study Session 2||4
6423450|NCT01006707|7337968|FG002|COMPLETED|Study Session 2||6
6423451|NCT01006707|7337966|FG000|NOT COMPLETED|Study Session 2||0
6423452|NCT01006707|7337967|FG001|NOT COMPLETED|Study Session 2||0
6423453|NCT01006707|7337968|FG002|NOT COMPLETED|Study Session 2||0
6423454|NCT01006707|7337966|FG000|STARTED|Study Session 3||0
6423455|NCT01006707|7337967|FG001|STARTED|Study Session 3||4
6423456|NCT01006707|7337968|FG002|STARTED|Study Session 3||6
6423457|NCT01006707|7337966|FG000|COMPLETED|Study Session 3||0
6423458|NCT01006707|7337967|FG001|COMPLETED|Study Session 3||4
6423459|NCT01006707|7337968|FG002|COMPLETED|Study Session 3||6
6423460|NCT01006707|7337966|FG000|NOT COMPLETED|Study Session 3||0
6423461|NCT01006707|7337967|FG001|NOT COMPLETED|Study Session 3||0
6423462|NCT01006707|7337968|FG002|NOT COMPLETED|Study Session 3||0
6423463|NCT01006889|7337976|FG000|STARTED|Overall Study||20
6423464|NCT01006889|7337976|FG000|COMPLETED|Overall Study||17
6423465|NCT01006889|7337976|FG000|NOT COMPLETED|Overall Study||3
6423466|NCT01006967|7337983|FG000|STARTED|Overall Study||253
6423467|NCT01006967|7337984|FG001|STARTED|Overall Study||253
6423468|NCT01006967|7337983|FG000|Received Treatment|Overall Study||245
6423469|NCT01006967|7337984|FG001|Received Treatment|Overall Study||245
6423470|NCT01006967|7337983|FG000|3 Month Follow-up|Overall Study||212
6423471|NCT01006967|7337984|FG001|3 Month Follow-up|Overall Study||210
6423472|NCT01006967|7337983|FG000|COMPLETED|Overall Study||187
6423473|NCT01006967|7337984|FG001|COMPLETED|Overall Study||190
6423474|NCT01006967|7337983|FG000|NOT COMPLETED|Overall Study||66
6423475|NCT01006967|7337984|FG001|NOT COMPLETED|Overall Study||63
6423476|NCT01006980|7337994|FG000|STARTED|Vemurafenib and Dacarbazine||337
6423477|NCT01006980|7337995|FG001|STARTED|Vemurafenib and Dacarbazine||338
6423478|NCT01006980|7337994|FG000|Treated|Vemurafenib and Dacarbazine||336
6423479|NCT01006980|7337995|FG001|Treated|Vemurafenib and Dacarbazine||293
6423480|NCT01006980|7337994|FG000|COMPLETED|Vemurafenib and Dacarbazine||0
6423481|NCT01006980|7337995|FG001|COMPLETED|Vemurafenib and Dacarbazine||0
6423482|NCT01006980|7337994|FG000|NOT COMPLETED|Vemurafenib and Dacarbazine||337
6423483|NCT01006980|7337995|FG001|NOT COMPLETED|Vemurafenib and Dacarbazine||338
6423484|NCT01006980|7337994|FG000|STARTED|Crossover: Dacarbazine to Vemurafenib||0
6423485|NCT01006980|7337995|FG001|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
6423486|NCT01006980|7337994|FG000|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
6423487|NCT01006980|7337995|FG001|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
6423488|NCT01006980|7337994|FG000|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
6423489|NCT01006980|7337995|FG001|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
6423490|NCT01007032|7338006|FG000|STARTED|Overall Study||4
6423491|NCT01007032|7338007|FG001|STARTED|Overall Study||7
6423492|NCT01007032|7338008|FG002|STARTED|Overall Study||3
6423493|NCT01007032|7338009|FG003|STARTED|Overall Study||7
6423494|NCT01007032|7338006|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
6423495|NCT01007032|7338007|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
6423496|NCT01007032|7338008|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6423497|NCT01007032|7338009|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
6423498|NCT01007032|7338006|FG000|COMPLETED|Overall Study||4
6423499|NCT01007032|7338007|FG001|COMPLETED|Overall Study||6
6423500|NCT01007032|7338008|FG002|COMPLETED|Overall Study||2
6423501|NCT01007032|7338009|FG003|COMPLETED|Overall Study||6
6551534|NCT04172701|7473757|FG000|STARTED|Overall Study||6352
6551535|NCT04172701|7473758|FG001|STARTED|Overall Study||2932
6551536|NCT04172701|7473757|FG000|Propensity Score (PS) Matched Population|Overall Study||2444
6551537|NCT04172701|7473758|FG001|Propensity Score (PS) Matched Population|Overall Study||2444
6423502|NCT01007032|7338006|FG000|NOT COMPLETED|Overall Study||0
6423503|NCT01007032|7338007|FG001|NOT COMPLETED|Overall Study||1
6423504|NCT01007032|7338008|FG002|NOT COMPLETED|Overall Study||1
6423505|NCT01007032|7338009|FG003|NOT COMPLETED|Overall Study||1
6551538|NCT04172701|7473757|FG000|COMPLETED|Overall Study||6352
6423506|NCT01007071|7338026|FG000|STARTED|Overall Study||6
6423507|NCT01007071|7338027|FG001|STARTED|Overall Study||5
6423508|NCT01007071|7338026|FG000|COMPLETED|Overall Study||6
6423509|NCT01007071|7338027|FG001|COMPLETED|Overall Study||5
6423510|NCT01007071|7338026|FG000|NOT COMPLETED|Overall Study||0
6423511|NCT01007071|7338027|FG001|NOT COMPLETED|Overall Study||0
6423512|NCT01007110|7338036|FG000|STARTED|Allocation||32
6423513|NCT01007110|7338037|FG001|STARTED|Allocation||35
6423514|NCT01007110|7338036|FG000|COMPLETED|Allocation||25
6423515|NCT01007110|7338037|FG001|COMPLETED|Allocation||27
6423516|NCT01007110|7338036|FG000|NOT COMPLETED|Allocation||7
6423517|NCT01007110|7338037|FG001|NOT COMPLETED|Allocation||8
6423518|NCT01007110|7338036|FG000|STARTED|Follow-Up at 24 Weeks||25
6423519|NCT01007110|7338037|FG001|STARTED|Follow-Up at 24 Weeks||27
6423520|NCT01007110|7338036|FG000|COMPLETED|Follow-Up at 24 Weeks||25
6423521|NCT01007110|7338037|FG001|COMPLETED|Follow-Up at 24 Weeks||23
6423522|NCT01007110|7338036|FG000|NOT COMPLETED|Follow-Up at 24 Weeks||0
6423523|NCT01007110|7338037|FG001|NOT COMPLETED|Follow-Up at 24 Weeks||4
6423524|NCT01007110|7338036|FG000|STARTED|Follow-Up at 32 Weeks||25
6423525|NCT01007110|7338037|FG001|STARTED|Follow-Up at 32 Weeks||23
6423526|NCT01007110|7338036|FG000|COMPLETED|Follow-Up at 32 Weeks||24
6423527|NCT01007110|7338037|FG001|COMPLETED|Follow-Up at 32 Weeks||22
6423528|NCT01007110|7338036|FG000|NOT COMPLETED|Follow-Up at 32 Weeks||1
6423529|NCT01007110|7338037|FG001|NOT COMPLETED|Follow-Up at 32 Weeks||1
6423530|NCT01007110|7338036|FG000|STARTED|Follow-Up at 36 Weeks||24
6423531|NCT01007110|7338037|FG001|STARTED|Follow-Up at 36 Weeks||22
6423532|NCT01007110|7338036|FG000|COMPLETED|Follow-Up at 36 Weeks||24
6423533|NCT01007110|7338037|FG001|COMPLETED|Follow-Up at 36 Weeks||20
6423534|NCT01007110|7338036|FG000|NOT COMPLETED|Follow-Up at 36 Weeks||0
6423535|NCT01007110|7338037|FG001|NOT COMPLETED|Follow-Up at 36 Weeks||2
6423536|NCT01007110|7338036|FG000|STARTED|Neonatal Behavioral Assessment Scale (NB||24
6423537|NCT01007110|7338037|FG001|STARTED|Neonatal Behavioral Assessment Scale (NB||20
6423538|NCT01007110|7338036|FG000|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
6423539|NCT01007110|7338037|FG001|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
6423540|NCT01007110|7338036|FG000|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
6423541|NCT01007110|7338037|FG001|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
6423542|NCT01007123|7338048|FG000|STARTED|Overall Study||48
6423543|NCT01007123|7338049|FG001|STARTED|Overall Study||47
6423544|NCT01007123|7338050|FG002|STARTED|Overall Study||48
6423545|NCT01007123|7338051|FG003|STARTED|Overall Study||47
6423546|NCT01007123|7338048|FG000|COMPLETED|Overall Study||42
6423547|NCT01007123|7338049|FG001|COMPLETED|Overall Study||41
6423548|NCT01007123|7338050|FG002|COMPLETED|Overall Study||37
6423549|NCT01007123|7338051|FG003|COMPLETED|Overall Study||41
6423550|NCT01007123|7338048|FG000|NOT COMPLETED|Overall Study||6
6423551|NCT01007123|7338049|FG001|NOT COMPLETED|Overall Study||6
6423552|NCT01007123|7338050|FG002|NOT COMPLETED|Overall Study||11
6423553|NCT01007123|7338051|FG003|NOT COMPLETED|Overall Study||6
6423554|NCT01007136|7338067|FG000|STARTED|Overall Study||19
6423555|NCT01007136|7338068|FG001|STARTED|Overall Study|One additional subject was excluded prior to randomization due to illicit drug use.|17
6423556|NCT01007136|7338069|FG002|STARTED|Overall Study||15
6423557|NCT01007136|7338070|FG003|STARTED|Overall Study||6
6423558|NCT01007136|7338071|FG004|STARTED|Overall Study||4
6423559|NCT01007136|7338067|FG000|COMPLETED|Overall Study||15
6423560|NCT01007136|7338068|FG001|COMPLETED|Overall Study||13
6423561|NCT01007136|7338069|FG002|COMPLETED|Overall Study||15
6423562|NCT01007136|7338070|FG003|COMPLETED|Overall Study||6
6423563|NCT01007136|7338071|FG004|COMPLETED|Overall Study||4
6423564|NCT01007136|7338067|FG000|NOT COMPLETED|Overall Study||4
6423565|NCT01007136|7338068|FG001|NOT COMPLETED|Overall Study||4
6423566|NCT01007136|7338069|FG002|NOT COMPLETED|Overall Study||0
6423567|NCT01007136|7338070|FG003|NOT COMPLETED|Overall Study||0
6423568|NCT01007136|7338071|FG004|NOT COMPLETED|Overall Study||0
6423569|NCT01007149|7338084|FG000|STARTED|Overall Study||20
6551539|NCT04172701|7473758|FG001|COMPLETED|Overall Study||2932
6551540|NCT04172701|7473757|FG000|NOT COMPLETED|Overall Study||0
6551541|NCT04172701|7473758|FG001|NOT COMPLETED|Overall Study||0
6562741|NCT01803074|7485710|FG011|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6562742|NCT01803074|7485711|FG012|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6562743|NCT01803074|7485712|FG013|STARTED|Period 1: Part A (HIV-1 Clade B)||0
6562744|NCT01803074|7485699|FG000|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6562745|NCT01803074|7485700|FG001|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6562746|NCT01803074|7485701|FG002|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6562747|NCT01803074|7485702|FG003|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6562748|NCT01803074|7485703|FG004|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6562749|NCT01803074|7485704|FG005|COMPLETED|Period 1: Part A (HIV-1 Clade B)||8
6562750|NCT01803074|7485705|FG006|COMPLETED|Period 1: Part A (HIV-1 Clade B)||12
6562751|NCT01803074|7485706|FG007|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562752|NCT01803074|7485707|FG008|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562753|NCT01803074|7485708|FG009|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562754|NCT01803074|7485709|FG010|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562755|NCT01803074|7485710|FG011|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562756|NCT01803074|7485711|FG012|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6423570|NCT01007149|7338085|FG001|STARTED|Overall Study||21
6423571|NCT01007149|7338084|FG000|COMPLETED|Overall Study||20
6423572|NCT01007149|7338085|FG001|COMPLETED|Overall Study||20
6423573|NCT01007149|7338084|FG000|NOT COMPLETED|Overall Study||0
6423574|NCT01007149|7338085|FG001|NOT COMPLETED|Overall Study||1
6423575|NCT01007253|7338091|FG000|STARTED|First Intervention||6
6423576|NCT01007253|7338092|FG001|STARTED|First Intervention||5
6423577|NCT01007253|7338093|FG002|STARTED|First Intervention||5
6423578|NCT01007253|7338094|FG003|STARTED|First Intervention||5
6423579|NCT01007253|7338091|FG000|COMPLETED|First Intervention||6
6423580|NCT01007253|7338092|FG001|COMPLETED|First Intervention||5
6423581|NCT01007253|7338093|FG002|COMPLETED|First Intervention||5
6423582|NCT01007253|7338094|FG003|COMPLETED|First Intervention||5
6423583|NCT01007253|7338091|FG000|NOT COMPLETED|First Intervention||0
6423584|NCT01007253|7338092|FG001|NOT COMPLETED|First Intervention||0
6423585|NCT01007253|7338093|FG002|NOT COMPLETED|First Intervention||0
6423586|NCT01007253|7338094|FG003|NOT COMPLETED|First Intervention||0
6423587|NCT01007253|7338091|FG000|STARTED|Washout Period (2 Weeks) # 1||6
6423588|NCT01007253|7338092|FG001|STARTED|Washout Period (2 Weeks) # 1||5
6423589|NCT01007253|7338093|FG002|STARTED|Washout Period (2 Weeks) # 1||5
6423590|NCT01007253|7338094|FG003|STARTED|Washout Period (2 Weeks) # 1||5
6423591|NCT01007253|7338091|FG000|COMPLETED|Washout Period (2 Weeks) # 1||6
6423592|NCT01007253|7338092|FG001|COMPLETED|Washout Period (2 Weeks) # 1||5
6423593|NCT01007253|7338093|FG002|COMPLETED|Washout Period (2 Weeks) # 1||5
6423594|NCT01007253|7338094|FG003|COMPLETED|Washout Period (2 Weeks) # 1||5
6423595|NCT01007253|7338091|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
6423596|NCT01007253|7338092|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
6423597|NCT01007253|7338093|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
6423598|NCT01007253|7338094|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
6423599|NCT01007253|7338091|FG000|STARTED|Second Intervention||6
6423600|NCT01007253|7338092|FG001|STARTED|Second Intervention||5
6423601|NCT01007253|7338093|FG002|STARTED|Second Intervention||5
6423602|NCT01007253|7338094|FG003|STARTED|Second Intervention||5
6423603|NCT01007253|7338091|FG000|COMPLETED|Second Intervention||6
6423604|NCT01007253|7338092|FG001|COMPLETED|Second Intervention||5
6423605|NCT01007253|7338093|FG002|COMPLETED|Second Intervention||5
6423606|NCT01007253|7338094|FG003|COMPLETED|Second Intervention||5
6423607|NCT01007253|7338091|FG000|NOT COMPLETED|Second Intervention||0
6423608|NCT01007253|7338092|FG001|NOT COMPLETED|Second Intervention||0
6423609|NCT01007253|7338093|FG002|NOT COMPLETED|Second Intervention||0
6423610|NCT01007253|7338094|FG003|NOT COMPLETED|Second Intervention||0
6423611|NCT01007253|7338091|FG000|STARTED|Washout Period (2 Weeks) # 2||6
6423612|NCT01007253|7338092|FG001|STARTED|Washout Period (2 Weeks) # 2||5
6423613|NCT01007253|7338093|FG002|STARTED|Washout Period (2 Weeks) # 2||5
6423614|NCT01007253|7338094|FG003|STARTED|Washout Period (2 Weeks) # 2||5
6423615|NCT01007253|7338091|FG000|COMPLETED|Washout Period (2 Weeks) # 2||6
6423616|NCT01007253|7338092|FG001|COMPLETED|Washout Period (2 Weeks) # 2||5
6423617|NCT01007253|7338093|FG002|COMPLETED|Washout Period (2 Weeks) # 2||5
6423618|NCT01007253|7338094|FG003|COMPLETED|Washout Period (2 Weeks) # 2||5
6423619|NCT01007253|7338091|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
6423620|NCT01007253|7338092|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
6423621|NCT01007253|7338093|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
6423622|NCT01007253|7338094|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
6423623|NCT01007253|7338091|FG000|STARTED|Third Intervention||6
6423624|NCT01007253|7338092|FG001|STARTED|Third Intervention||5
6423625|NCT01007253|7338093|FG002|STARTED|Third Intervention||5
6423626|NCT01007253|7338094|FG003|STARTED|Third Intervention||5
6423627|NCT01007253|7338091|FG000|COMPLETED|Third Intervention||6
6423628|NCT01007253|7338092|FG001|COMPLETED|Third Intervention||5
6423629|NCT01007253|7338093|FG002|COMPLETED|Third Intervention||5
6423630|NCT01007253|7338094|FG003|COMPLETED|Third Intervention||5
6423631|NCT01007253|7338091|FG000|NOT COMPLETED|Third Intervention||0
6423632|NCT01007253|7338092|FG001|NOT COMPLETED|Third Intervention||0
6423633|NCT01007253|7338093|FG002|NOT COMPLETED|Third Intervention||0
6423634|NCT01007253|7338094|FG003|NOT COMPLETED|Third Intervention||0
6423635|NCT01007253|7338091|FG000|STARTED|Washout Period (2 Weeks) # 3||6
6423636|NCT01007253|7338092|FG001|STARTED|Washout Period (2 Weeks) # 3||5
6423637|NCT01007253|7338093|FG002|STARTED|Washout Period (2 Weeks) # 3||5
6423638|NCT01007253|7338094|FG003|STARTED|Washout Period (2 Weeks) # 3||5
6423639|NCT01007253|7338091|FG000|COMPLETED|Washout Period (2 Weeks) # 3||5
6423640|NCT01007253|7338092|FG001|COMPLETED|Washout Period (2 Weeks) # 3||5
6423641|NCT01007253|7338093|FG002|COMPLETED|Washout Period (2 Weeks) # 3||5
6423642|NCT01007253|7338094|FG003|COMPLETED|Washout Period (2 Weeks) # 3||5
6423643|NCT01007253|7338091|FG000|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
6423644|NCT01007253|7338092|FG001|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
6423645|NCT01007253|7338093|FG002|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
6423646|NCT01007253|7338094|FG003|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
6423647|NCT01007253|7338091|FG000|STARTED|Fourth Intervention||5
6423648|NCT01007253|7338092|FG001|STARTED|Fourth Intervention||5
6423649|NCT01007253|7338093|FG002|STARTED|Fourth Intervention||5
6423650|NCT01007253|7338094|FG003|STARTED|Fourth Intervention||5
6423651|NCT01007253|7338091|FG000|COMPLETED|Fourth Intervention||5
6423652|NCT01007253|7338092|FG001|COMPLETED|Fourth Intervention||5
6423653|NCT01007253|7338093|FG002|COMPLETED|Fourth Intervention||5
6423654|NCT01007253|7338094|FG003|COMPLETED|Fourth Intervention||5
6423655|NCT01007253|7338091|FG000|NOT COMPLETED|Fourth Intervention||0
6423656|NCT01007253|7338092|FG001|NOT COMPLETED|Fourth Intervention||0
6423657|NCT01007253|7338093|FG002|NOT COMPLETED|Fourth Intervention||0
6423658|NCT01007253|7338094|FG003|NOT COMPLETED|Fourth Intervention||0
6423659|NCT01007396|7338104|FG000|STARTED|Overall Study||322
6423660|NCT01007396|7338104|FG000|COMPLETED|Overall Study||275
6423661|NCT01007396|7338104|FG000|NOT COMPLETED|Overall Study||47
6423662|NCT01007435|7338112|FG000|STARTED|Overall Study||289
6423663|NCT01007435|7338113|FG001|STARTED|Overall Study||290
6423664|NCT01007435|7338114|FG002|STARTED|Overall Study||291
6423665|NCT01007435|7338115|FG003|STARTED|Overall Study||292
6423666|NCT01007435|7338112|FG000|COMPLETED|Overall Study||226
6423667|NCT01007435|7338113|FG001|COMPLETED|Overall Study||231
6423668|NCT01007435|7338114|FG002|COMPLETED|Overall Study||227
6423669|NCT01007435|7338115|FG003|COMPLETED|Overall Study||236
6423670|NCT01007435|7338112|FG000|NOT COMPLETED|Overall Study||63
6423671|NCT01007435|7338113|FG001|NOT COMPLETED|Overall Study||59
6423672|NCT01007435|7338114|FG002|NOT COMPLETED|Overall Study||64
6423673|NCT01007435|7338115|FG003|NOT COMPLETED|Overall Study||56
6423674|NCT01007448|7338127|FG000|STARTED|Overall Study||30
6423675|NCT01007448|7338128|FG001|STARTED|Overall Study||29
6423676|NCT01007448|7338127|FG000|Full Analysis Population|Overall Study||30
6423677|NCT01007448|7338128|FG001|Full Analysis Population|Overall Study||29
6423678|NCT01007448|7338127|FG000|Safety Population|Overall Study||30
6423679|NCT01007448|7338128|FG001|Safety Population|Overall Study||29
6423680|NCT01007448|7338127|FG000|COMPLETED|Overall Study||20
6423681|NCT01007448|7338128|FG001|COMPLETED|Overall Study||20
6423682|NCT01007448|7338127|FG000|NOT COMPLETED|Overall Study||10
6423683|NCT01007448|7338128|FG001|NOT COMPLETED|Overall Study||9
6423684|NCT01007526|7338134|FG000|STARTED|Overall Study||31
6423685|NCT01007526|7338134|FG000|COMPLETED|Overall Study||31
6423686|NCT01007526|7338134|FG000|NOT COMPLETED|Overall Study||0
6423687|NCT01007552|7338138|FG000|STARTED|Overall Study||50
6423688|NCT01007552|7338138|FG000|COMPLETED|Overall Study||49
6423689|NCT01007552|7338138|FG000|NOT COMPLETED|Overall Study||1
6423690|NCT01007591|7338144|FG000|STARTED|Overall Study||27
6423691|NCT01007591|7338145|FG001|STARTED|Overall Study||13
6423692|NCT01007591|7338144|FG000|COMPLETED|Overall Study||26
6423693|NCT01007591|7338145|FG001|COMPLETED|Overall Study||12
6423694|NCT01007591|7338144|FG000|NOT COMPLETED|Overall Study||1
6423695|NCT01007591|7338145|FG001|NOT COMPLETED|Overall Study||1
6423696|NCT01007643|7338153|FG000|STARTED|Overall Study||8
6423697|NCT01007643|7338154|FG001|STARTED|Overall Study||14
6423698|NCT01007643|7338153|FG000|COMPLETED|Overall Study||8
6423699|NCT01007643|7338154|FG001|COMPLETED|Overall Study||14
6423700|NCT01007643|7338153|FG000|NOT COMPLETED|Overall Study||0
6423701|NCT01007643|7338154|FG001|NOT COMPLETED|Overall Study||0
6423702|NCT01007656|7338160|FG000|STARTED|Overall Study||31
6423703|NCT01007656|7338160|FG000|COMPLETED|Overall Study||31
6423704|NCT01007656|7338160|FG000|NOT COMPLETED|Overall Study||0
6423705|NCT01007812|7338164|FG000|STARTED|Period 1, One Week||25
6423706|NCT01007812|7338165|FG001|STARTED|Period 1, One Week||25
6423707|NCT01007812|7338164|FG000|COMPLETED|Period 1, One Week||24
6423708|NCT01007812|7338165|FG001|COMPLETED|Period 1, One Week||24
6423709|NCT01007812|7338164|FG000|NOT COMPLETED|Period 1, One Week||1
6423710|NCT01007812|7338165|FG001|NOT COMPLETED|Period 1, One Week||1
6423711|NCT01007812|7338164|FG000|STARTED|Period 2, One Week||24
6423712|NCT01007812|7338165|FG001|STARTED|Period 2, One Week||24
6423713|NCT01007812|7338164|FG000|COMPLETED|Period 2, One Week||24
6423714|NCT01007812|7338165|FG001|COMPLETED|Period 2, One Week||24
6423715|NCT01007812|7338164|FG000|NOT COMPLETED|Period 2, One Week||0
6423716|NCT01007812|7338165|FG001|NOT COMPLETED|Period 2, One Week||0
6423717|NCT01007838|7338175|FG000|STARTED|Overall Study||12
6423718|NCT01007838|7338176|FG001|STARTED|Overall Study||11
6423719|NCT01007838|7338177|FG002|STARTED|Overall Study||5
6423720|NCT01007838|7338178|FG003|STARTED|Overall Study||4
6423721|NCT01007838|7338175|FG000|COMPLETED|Overall Study||9
6423722|NCT01007838|7338176|FG001|COMPLETED|Overall Study||11
6423723|NCT01007838|7338177|FG002|COMPLETED|Overall Study||5
6423724|NCT01007838|7338178|FG003|COMPLETED|Overall Study||4
6423725|NCT01007838|7338175|FG000|NOT COMPLETED|Overall Study||3
6423726|NCT01007838|7338176|FG001|NOT COMPLETED|Overall Study||0
6423727|NCT01007838|7338177|FG002|NOT COMPLETED|Overall Study||0
6423728|NCT01007838|7338178|FG003|NOT COMPLETED|Overall Study||0
6651059|NCT02416453|7580497|FG002|NOT COMPLETED|Overall Study||1
6651060|NCT02416453|7580498|FG003|NOT COMPLETED|Overall Study||15
6651061|NCT02416453|7580499|FG004|NOT COMPLETED|Overall Study||1
6651062|NCT02416453|7580500|FG005|NOT COMPLETED|Overall Study||16
6651063|NCT02416453|7580501|FG006|NOT COMPLETED|Overall Study||2
6651064|NCT02416453|7580502|FG007|NOT COMPLETED|Overall Study||12
6651065|NCT02416453|7580503|FG008|NOT COMPLETED|Overall Study||5
6651066|NCT02416453|7580504|FG009|NOT COMPLETED|Overall Study||0
6651067|NCT02416453|7580505|FG010|NOT COMPLETED|Overall Study||0
6423729|NCT01007916|7338188|FG000|STARTED|Period 1, 4 Weeks of Wear||23
6423730|NCT01007916|7338189|FG001|STARTED|Period 1, 4 Weeks of Wear||26
6423731|NCT01007916|7338188|FG000|COMPLETED|Period 1, 4 Weeks of Wear||22
6423732|NCT01007916|7338189|FG001|COMPLETED|Period 1, 4 Weeks of Wear||26
6423733|NCT01007916|7338188|FG000|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
6651068|NCT02416622|7580538|FG000|STARTED|Overall Study||6
6651069|NCT02416622|7580539|FG001|STARTED|Overall Study||8
6423734|NCT01007916|7338189|FG001|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
6423735|NCT01007916|7338188|FG000|STARTED|Period 2, 4 Weeks of Wear||22
6423736|NCT01007916|7338189|FG001|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
6423737|NCT01007916|7338188|FG000|COMPLETED|Period 2, 4 Weeks of Wear||21
6651070|NCT02416622|7580540|FG002|STARTED|Overall Study||13
6423738|NCT01007916|7338189|FG001|COMPLETED|Period 2, 4 Weeks of Wear||25
6423739|NCT01007916|7338188|FG000|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
6423740|NCT01007916|7338189|FG001|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
6423741|NCT01007942|7338197|FG000|STARTED|Overall Study||284
6423742|NCT01007942|7338198|FG001|STARTED|Overall Study||285
6423743|NCT01007942|7338197|FG000|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
6423744|NCT01007942|7338198|FG001|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
6423745|NCT01007942|7338197|FG000|NOT COMPLETED|Overall Study||281
6423746|NCT01007942|7338198|FG001|NOT COMPLETED|Overall Study||278
6423747|NCT01007994|7338210|FG000|STARTED|Overall Study||17
6423748|NCT01007994|7338211|FG001|STARTED|Overall Study||16
6423749|NCT01007994|7338210|FG000|COMPLETED|Overall Study||15
6423750|NCT01007994|7338211|FG001|COMPLETED|Overall Study||14
6423751|NCT01007994|7338210|FG000|NOT COMPLETED|Overall Study||2
6423752|NCT01007994|7338211|FG001|NOT COMPLETED|Overall Study||2
6423753|NCT01008059|7338217|FG000|STARTED|Control Sequential Alfentanil||6
6423754|NCT01008059|7338218|FG001|STARTED|Control Sequential Alfentanil||0
6423755|NCT01008059|7338219|FG002|STARTED|Control Sequential Alfentanil||0
6423756|NCT01008059|7338220|FG003|STARTED|Control Sequential Alfentanil||0
6423757|NCT01008059|7338221|FG004|STARTED|Control Sequential Alfentanil||0
6423758|NCT01008059|7338222|FG005|STARTED|Control Sequential Alfentanil||0
6423759|NCT01008059|7338223|FG006|STARTED|Control Sequential Alfentanil||0
6423760|NCT01008059|7338224|FG007|STARTED|Control Sequential Alfentanil||0
6423761|NCT01008059|7338217|FG000|COMPLETED|Control Sequential Alfentanil||6
6423762|NCT01008059|7338218|FG001|COMPLETED|Control Sequential Alfentanil||0
6423763|NCT01008059|7338219|FG002|COMPLETED|Control Sequential Alfentanil||0
6423764|NCT01008059|7338220|FG003|COMPLETED|Control Sequential Alfentanil||0
6423765|NCT01008059|7338221|FG004|COMPLETED|Control Sequential Alfentanil||0
6423766|NCT01008059|7338222|FG005|COMPLETED|Control Sequential Alfentanil||0
6423767|NCT01008059|7338223|FG006|COMPLETED|Control Sequential Alfentanil||0
6423768|NCT01008059|7338224|FG007|COMPLETED|Control Sequential Alfentanil||0
6423769|NCT01008059|7338217|FG000|NOT COMPLETED|Control Sequential Alfentanil||0
6423770|NCT01008059|7338218|FG001|NOT COMPLETED|Control Sequential Alfentanil||0
6423771|NCT01008059|7338219|FG002|NOT COMPLETED|Control Sequential Alfentanil||0
6423772|NCT01008059|7338220|FG003|NOT COMPLETED|Control Sequential Alfentanil||0
6423773|NCT01008059|7338221|FG004|NOT COMPLETED|Control Sequential Alfentanil||0
6423774|NCT01008059|7338222|FG005|NOT COMPLETED|Control Sequential Alfentanil||0
6423775|NCT01008059|7338223|FG006|NOT COMPLETED|Control Sequential Alfentanil||0
6423776|NCT01008059|7338224|FG007|NOT COMPLETED|Control Sequential Alfentanil||0
6423777|NCT01008059|7338217|FG000|STARTED|Rifampin Sequential Alfentanil||0
6423778|NCT01008059|7338218|FG001|STARTED|Rifampin Sequential Alfentanil||6
6423779|NCT01008059|7338219|FG002|STARTED|Rifampin Sequential Alfentanil||0
6423780|NCT01008059|7338220|FG003|STARTED|Rifampin Sequential Alfentanil||0
6423781|NCT01008059|7338221|FG004|STARTED|Rifampin Sequential Alfentanil||0
6423782|NCT01008059|7338222|FG005|STARTED|Rifampin Sequential Alfentanil||0
6423783|NCT01008059|7338223|FG006|STARTED|Rifampin Sequential Alfentanil||0
6423784|NCT01008059|7338224|FG007|STARTED|Rifampin Sequential Alfentanil||0
6423785|NCT01008059|7338217|FG000|COMPLETED|Rifampin Sequential Alfentanil||0
6423786|NCT01008059|7338218|FG001|COMPLETED|Rifampin Sequential Alfentanil||6
6423787|NCT01008059|7338219|FG002|COMPLETED|Rifampin Sequential Alfentanil||0
6423788|NCT01008059|7338220|FG003|COMPLETED|Rifampin Sequential Alfentanil||0
6423789|NCT01008059|7338221|FG004|COMPLETED|Rifampin Sequential Alfentanil||0
6423790|NCT01008059|7338222|FG005|COMPLETED|Rifampin Sequential Alfentanil||0
6423791|NCT01008059|7338223|FG006|COMPLETED|Rifampin Sequential Alfentanil||0
6423792|NCT01008059|7338224|FG007|COMPLETED|Rifampin Sequential Alfentanil||0
6423793|NCT01008059|7338217|FG000|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6423794|NCT01008059|7338218|FG001|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6423795|NCT01008059|7338219|FG002|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6423796|NCT01008059|7338220|FG003|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6423797|NCT01008059|7338221|FG004|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6423798|NCT01008059|7338222|FG005|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6423799|NCT01008059|7338223|FG006|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6423800|NCT01008059|7338224|FG007|NOT COMPLETED|Rifampin Sequential Alfentanil||0
6423801|NCT01008059|7338217|FG000|STARTED|Grapefruit Juice Sequential Alfentanil||0
6423802|NCT01008059|7338218|FG001|STARTED|Grapefruit Juice Sequential Alfentanil||0
6423803|NCT01008059|7338219|FG002|STARTED|Grapefruit Juice Sequential Alfentanil||6
6423804|NCT01008059|7338220|FG003|STARTED|Grapefruit Juice Sequential Alfentanil||0
6423805|NCT01008059|7338221|FG004|STARTED|Grapefruit Juice Sequential Alfentanil||0
6423806|NCT01008059|7338222|FG005|STARTED|Grapefruit Juice Sequential Alfentanil||0
6423807|NCT01008059|7338223|FG006|STARTED|Grapefruit Juice Sequential Alfentanil||0
6423808|NCT01008059|7338224|FG007|STARTED|Grapefruit Juice Sequential Alfentanil||0
6423809|NCT01008059|7338217|FG000|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423810|NCT01008059|7338218|FG001|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423811|NCT01008059|7338219|FG002|COMPLETED|Grapefruit Juice Sequential Alfentanil||6
6423812|NCT01008059|7338220|FG003|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423813|NCT01008059|7338221|FG004|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423814|NCT01008059|7338222|FG005|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423815|NCT01008059|7338223|FG006|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423816|NCT01008059|7338224|FG007|COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423817|NCT01008059|7338217|FG000|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423818|NCT01008059|7338218|FG001|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423819|NCT01008059|7338219|FG002|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423820|NCT01008059|7338220|FG003|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423821|NCT01008059|7338221|FG004|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423822|NCT01008059|7338222|FG005|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423823|NCT01008059|7338223|FG006|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423824|NCT01008059|7338224|FG007|NOT COMPLETED|Grapefruit Juice Sequential Alfentanil||0
6423825|NCT01008059|7338217|FG000|STARTED|Ketoconazole Sequential Alfentanil||0
6423826|NCT01008059|7338218|FG001|STARTED|Ketoconazole Sequential Alfentanil||0
6423827|NCT01008059|7338219|FG002|STARTED|Ketoconazole Sequential Alfentanil||0
6423828|NCT01008059|7338220|FG003|STARTED|Ketoconazole Sequential Alfentanil||6
6423829|NCT01008059|7338221|FG004|STARTED|Ketoconazole Sequential Alfentanil||0
6423830|NCT01008059|7338222|FG005|STARTED|Ketoconazole Sequential Alfentanil||0
6423831|NCT01008059|7338223|FG006|STARTED|Ketoconazole Sequential Alfentanil||0
6423832|NCT01008059|7338224|FG007|STARTED|Ketoconazole Sequential Alfentanil||0
6423833|NCT01008059|7338217|FG000|COMPLETED|Ketoconazole Sequential Alfentanil||0
6423834|NCT01008059|7338218|FG001|COMPLETED|Ketoconazole Sequential Alfentanil||0
6423835|NCT01008059|7338219|FG002|COMPLETED|Ketoconazole Sequential Alfentanil||0
6423836|NCT01008059|7338220|FG003|COMPLETED|Ketoconazole Sequential Alfentanil||6
6423837|NCT01008059|7338221|FG004|COMPLETED|Ketoconazole Sequential Alfentanil||0
6423838|NCT01008059|7338222|FG005|COMPLETED|Ketoconazole Sequential Alfentanil||0
6423839|NCT01008059|7338223|FG006|COMPLETED|Ketoconazole Sequential Alfentanil||0
6423840|NCT01008059|7338224|FG007|COMPLETED|Ketoconazole Sequential Alfentanil||0
6423841|NCT01008059|7338217|FG000|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6423842|NCT01008059|7338218|FG001|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6423843|NCT01008059|7338219|FG002|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6423844|NCT01008059|7338220|FG003|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6423845|NCT01008059|7338221|FG004|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6423846|NCT01008059|7338222|FG005|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6423847|NCT01008059|7338223|FG006|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6423848|NCT01008059|7338224|FG007|NOT COMPLETED|Ketoconazole Sequential Alfentanil||0
6423849|NCT01008059|7338217|FG000|STARTED|Control Simultaneous Alfentanil||0
6651071|NCT02416622|7580538|FG000|Completed Month 12|Overall Study||6
6651072|NCT02416622|7580539|FG001|Completed Month 12|Overall Study||8
6651073|NCT02416622|7580540|FG002|Completed Month 12|Overall Study||13
6651074|NCT02416622|7580538|FG000|Started Long-Term Follow-Up|Overall Study||6
6651075|NCT02416622|7580539|FG001|Started Long-Term Follow-Up|Overall Study||8
6651076|NCT02416622|7580540|FG002|Started Long-Term Follow-Up|Overall Study||13
6423850|NCT01008059|7338218|FG001|STARTED|Control Simultaneous Alfentanil||0
6423851|NCT01008059|7338219|FG002|STARTED|Control Simultaneous Alfentanil||0
6423852|NCT01008059|7338220|FG003|STARTED|Control Simultaneous Alfentanil||0
6423853|NCT01008059|7338221|FG004|STARTED|Control Simultaneous Alfentanil||6
6423854|NCT01008059|7338222|FG005|STARTED|Control Simultaneous Alfentanil||0
6423855|NCT01008059|7338223|FG006|STARTED|Control Simultaneous Alfentanil||0
6423856|NCT01008059|7338224|FG007|STARTED|Control Simultaneous Alfentanil||0
6423857|NCT01008059|7338217|FG000|COMPLETED|Control Simultaneous Alfentanil||0
6423858|NCT01008059|7338218|FG001|COMPLETED|Control Simultaneous Alfentanil||0
6423859|NCT01008059|7338219|FG002|COMPLETED|Control Simultaneous Alfentanil||0
6423860|NCT01008059|7338220|FG003|COMPLETED|Control Simultaneous Alfentanil||0
6423861|NCT01008059|7338221|FG004|COMPLETED|Control Simultaneous Alfentanil||6
6423862|NCT01008059|7338222|FG005|COMPLETED|Control Simultaneous Alfentanil||0
6423863|NCT01008059|7338223|FG006|COMPLETED|Control Simultaneous Alfentanil||0
6423864|NCT01008059|7338224|FG007|COMPLETED|Control Simultaneous Alfentanil||0
6423865|NCT01008059|7338217|FG000|NOT COMPLETED|Control Simultaneous Alfentanil||0
6423866|NCT01008059|7338218|FG001|NOT COMPLETED|Control Simultaneous Alfentanil||0
6423867|NCT01008059|7338219|FG002|NOT COMPLETED|Control Simultaneous Alfentanil||0
6423868|NCT01008059|7338220|FG003|NOT COMPLETED|Control Simultaneous Alfentanil||0
6423869|NCT01008059|7338221|FG004|NOT COMPLETED|Control Simultaneous Alfentanil||0
6423870|NCT01008059|7338222|FG005|NOT COMPLETED|Control Simultaneous Alfentanil||0
6423871|NCT01008059|7338223|FG006|NOT COMPLETED|Control Simultaneous Alfentanil||0
6423872|NCT01008059|7338224|FG007|NOT COMPLETED|Control Simultaneous Alfentanil||0
6423873|NCT01008059|7338217|FG000|STARTED|Rifampin Simultaneous Alfentanil||0
6423874|NCT01008059|7338218|FG001|STARTED|Rifampin Simultaneous Alfentanil||0
6423875|NCT01008059|7338219|FG002|STARTED|Rifampin Simultaneous Alfentanil||0
6423876|NCT01008059|7338220|FG003|STARTED|Rifampin Simultaneous Alfentanil||0
6423877|NCT01008059|7338221|FG004|STARTED|Rifampin Simultaneous Alfentanil||0
6423878|NCT01008059|7338222|FG005|STARTED|Rifampin Simultaneous Alfentanil||6
6423879|NCT01008059|7338223|FG006|STARTED|Rifampin Simultaneous Alfentanil||0
6423880|NCT01008059|7338224|FG007|STARTED|Rifampin Simultaneous Alfentanil||0
6651077|NCT02416622|7580538|FG000|COMPLETED|Overall Study||0
6651078|NCT02416622|7580539|FG001|COMPLETED|Overall Study||0
6651079|NCT02416622|7580540|FG002|COMPLETED|Overall Study||0
6651080|NCT02416622|7580538|FG000|NOT COMPLETED|Overall Study||6
6651081|NCT02416622|7580539|FG001|NOT COMPLETED|Overall Study||8
6651082|NCT02416622|7580540|FG002|NOT COMPLETED|Overall Study||13
6651083|NCT02416713|7580552|FG000|STARTED|Overall Study||8
6423881|NCT01008059|7338217|FG000|COMPLETED|Rifampin Simultaneous Alfentanil||0
6423882|NCT01008059|7338218|FG001|COMPLETED|Rifampin Simultaneous Alfentanil||0
6423883|NCT01008059|7338219|FG002|COMPLETED|Rifampin Simultaneous Alfentanil||0
6423884|NCT01008059|7338220|FG003|COMPLETED|Rifampin Simultaneous Alfentanil||0
6423885|NCT01008059|7338221|FG004|COMPLETED|Rifampin Simultaneous Alfentanil||0
6423886|NCT01008059|7338222|FG005|COMPLETED|Rifampin Simultaneous Alfentanil||6
6423887|NCT01008059|7338223|FG006|COMPLETED|Rifampin Simultaneous Alfentanil||0
6423888|NCT01008059|7338224|FG007|COMPLETED|Rifampin Simultaneous Alfentanil||0
6423889|NCT01008059|7338217|FG000|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6423890|NCT01008059|7338218|FG001|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6423891|NCT01008059|7338219|FG002|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6423892|NCT01008059|7338220|FG003|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6423893|NCT01008059|7338221|FG004|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6423894|NCT01008059|7338222|FG005|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6423895|NCT01008059|7338223|FG006|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6423896|NCT01008059|7338224|FG007|NOT COMPLETED|Rifampin Simultaneous Alfentanil||0
6423897|NCT01008059|7338217|FG000|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6423898|NCT01008059|7338218|FG001|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6423899|NCT01008059|7338219|FG002|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6423900|NCT01008059|7338220|FG003|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6423901|NCT01008059|7338221|FG004|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6423902|NCT01008059|7338222|FG005|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6423903|NCT01008059|7338223|FG006|STARTED|Grapefruit Juice Simultaneous Alfentanil||6
6423904|NCT01008059|7338224|FG007|STARTED|Grapefruit Juice Simultaneous Alfentanil||0
6423905|NCT01008059|7338217|FG000|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423906|NCT01008059|7338218|FG001|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423907|NCT01008059|7338219|FG002|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423908|NCT01008059|7338220|FG003|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423909|NCT01008059|7338221|FG004|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423910|NCT01008059|7338222|FG005|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423911|NCT01008059|7338223|FG006|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||6
6423912|NCT01008059|7338224|FG007|COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423913|NCT01008059|7338217|FG000|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423914|NCT01008059|7338218|FG001|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423915|NCT01008059|7338219|FG002|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423916|NCT01008059|7338220|FG003|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423917|NCT01008059|7338221|FG004|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423918|NCT01008059|7338222|FG005|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423919|NCT01008059|7338223|FG006|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423920|NCT01008059|7338224|FG007|NOT COMPLETED|Grapefruit Juice Simultaneous Alfentanil||0
6423921|NCT01008059|7338217|FG000|STARTED|Ketoconazole Simultaneous Alfentanil||0
6423922|NCT01008059|7338218|FG001|STARTED|Ketoconazole Simultaneous Alfentanil||0
6423923|NCT01008059|7338219|FG002|STARTED|Ketoconazole Simultaneous Alfentanil||0
6423924|NCT01008059|7338220|FG003|STARTED|Ketoconazole Simultaneous Alfentanil||0
6423925|NCT01008059|7338221|FG004|STARTED|Ketoconazole Simultaneous Alfentanil||0
6423926|NCT01008059|7338222|FG005|STARTED|Ketoconazole Simultaneous Alfentanil||0
6423927|NCT01008059|7338223|FG006|STARTED|Ketoconazole Simultaneous Alfentanil||0
6423928|NCT01008059|7338224|FG007|STARTED|Ketoconazole Simultaneous Alfentanil||6
6423929|NCT01008059|7338217|FG000|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423930|NCT01008059|7338218|FG001|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423931|NCT01008059|7338219|FG002|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423932|NCT01008059|7338220|FG003|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423933|NCT01008059|7338221|FG004|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423934|NCT01008059|7338222|FG005|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423935|NCT01008059|7338223|FG006|COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423936|NCT01008059|7338224|FG007|COMPLETED|Ketoconazole Simultaneous Alfentanil||6
6423937|NCT01008059|7338217|FG000|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423938|NCT01008059|7338218|FG001|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423939|NCT01008059|7338219|FG002|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423940|NCT01008059|7338220|FG003|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423941|NCT01008059|7338221|FG004|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423942|NCT01008059|7338222|FG005|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423943|NCT01008059|7338223|FG006|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423944|NCT01008059|7338224|FG007|NOT COMPLETED|Ketoconazole Simultaneous Alfentanil||0
6423945|NCT01008150|7338239|FG000|STARTED|Overall Study||43
6423946|NCT01008150|7338240|FG001|STARTED|Overall Study||43
6423947|NCT01008150|7338241|FG002|STARTED|Overall Study||43
6423948|NCT01008150|7338242|FG003|STARTED|Overall Study||12
6423949|NCT01008150|7338239|FG000|COMPLETED|Overall Study||42
6423950|NCT01008150|7338240|FG001|COMPLETED|Overall Study||42
6423951|NCT01008150|7338241|FG002|COMPLETED|Overall Study||42
6423952|NCT01008150|7338242|FG003|COMPLETED|Overall Study||12
6423953|NCT01008150|7338239|FG000|NOT COMPLETED|Overall Study||1
6423954|NCT01008150|7338240|FG001|NOT COMPLETED|Overall Study||1
6423955|NCT01008150|7338241|FG002|NOT COMPLETED|Overall Study||1
6423956|NCT01008150|7338242|FG003|NOT COMPLETED|Overall Study||0
6423957|NCT01008280|7338255|FG000|STARTED|Overall Study||88
6423958|NCT01008280|7338256|FG001|STARTED|Overall Study||92
6423959|NCT01008280|7338255|FG000|COMPLETED|Overall Study||67
6423960|NCT01008280|7338256|FG001|COMPLETED|Overall Study||73
6423961|NCT01008280|7338255|FG000|NOT COMPLETED|Overall Study||21
6423962|NCT01008280|7338256|FG001|NOT COMPLETED|Overall Study||19
6423963|NCT01008319|7338264|FG000|STARTED|Overall Study||60
6423964|NCT01008319|7338265|FG001|STARTED|Overall Study||60
6423965|NCT01008319|7338264|FG000|COMPLETED|Overall Study||60
6423966|NCT01008319|7338265|FG001|COMPLETED|Overall Study||60
6423967|NCT01008319|7338264|FG000|NOT COMPLETED|Overall Study||0
6423968|NCT01008319|7338265|FG001|NOT COMPLETED|Overall Study||0
6423969|NCT01008410|7338277|FG000|STARTED|Overall Study||133
6423970|NCT01008410|7338278|FG001|STARTED|Overall Study||132
6423971|NCT01008410|7338277|FG000|Received at Least 1 Dose of Study Drug|Overall Study||133
6423972|NCT01008410|7338278|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
6423973|NCT01008410|7338277|FG000|COMPLETED|Overall Study||108
6423974|NCT01008410|7338278|FG001|COMPLETED|Overall Study||116
6423975|NCT01008410|7338277|FG000|NOT COMPLETED|Overall Study||25
6423976|NCT01008410|7338278|FG001|NOT COMPLETED|Overall Study||16
6423977|NCT01008423|7338286|FG000|STARTED|Overall Study||134
6423978|NCT01008423|7338287|FG001|STARTED|Overall Study||147
6423979|NCT01008423|7338286|FG000|Received at Least 1 Dose of Study Drug|Overall Study||134
6423980|NCT01008423|7338287|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
6423981|NCT01008423|7338286|FG000|COMPLETED|Overall Study||115
6423982|NCT01008423|7338287|FG001|COMPLETED|Overall Study||125
6423983|NCT01008423|7338286|FG000|NOT COMPLETED|Overall Study||19
6423984|NCT01008423|7338287|FG001|NOT COMPLETED|Overall Study||22
6423985|NCT01008449|7338295|FG000|STARTED|Overall Study||200
6423986|NCT01008449|7338296|FG001|STARTED|Overall Study||198
6423987|NCT01008449|7338295|FG000|COMPLETED|Overall Study||171
6423988|NCT01008449|7338296|FG001|COMPLETED|Overall Study||179
6423989|NCT01008449|7338295|FG000|NOT COMPLETED|Overall Study||29
6423990|NCT01008449|7338296|FG001|NOT COMPLETED|Overall Study||19
6423991|NCT01008462|7338302|FG000|STARTED|Overall Study||16
6423992|NCT01008462|7338302|FG000|COMPLETED|Overall Study||16
6423993|NCT01008462|7338302|FG000|NOT COMPLETED|Overall Study||0
6423994|NCT01008475|7338313|FG000|STARTED|Overall Study||3
6423995|NCT01008475|7338314|FG001|STARTED|Overall Study||3
6423996|NCT01008475|7338315|FG002|STARTED|Overall Study||7
6423997|NCT01008475|7338316|FG003|STARTED|Overall Study||3
6423998|NCT01008475|7338317|FG004|STARTED|Overall Study||72
6423999|NCT01008475|7338318|FG005|STARTED|Overall Study||73
6424000|NCT01008475|7338319|FG006|STARTED|Overall Study||71
6424001|NCT01008475|7338313|FG000|Safety Analysis Set|Overall Study||3
6424002|NCT01008475|7338314|FG001|Safety Analysis Set|Overall Study||3
6424003|NCT01008475|7338315|FG002|Safety Analysis Set|Overall Study||7
6424004|NCT01008475|7338316|FG003|Safety Analysis Set|Overall Study||3
6424005|NCT01008475|7338317|FG004|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
6424006|NCT01008475|7338318|FG005|Safety Analysis Set|Overall Study||72
6424007|NCT01008475|7338319|FG006|Safety Analysis Set|Overall Study||69
6424008|NCT01008475|7338313|FG000|COMPLETED|Overall Study||3
6424009|NCT01008475|7338314|FG001|COMPLETED|Overall Study||3
6424010|NCT01008475|7338315|FG002|COMPLETED|Overall Study||7
6651084|NCT02416713|7580553|FG001|STARTED|Overall Study||9
6651085|NCT02416713|7580554|FG002|STARTED|Overall Study||8
6651086|NCT02416713|7580555|FG003|STARTED|Overall Study||10
6424011|NCT01008475|7338316|FG003|COMPLETED|Overall Study||3
6424012|NCT01008475|7338317|FG004|COMPLETED|Overall Study||67
6424013|NCT01008475|7338318|FG005|COMPLETED|Overall Study||67
6424014|NCT01008475|7338319|FG006|COMPLETED|Overall Study||67
6424015|NCT01008475|7338313|FG000|NOT COMPLETED|Overall Study||0
6424016|NCT01008475|7338314|FG001|NOT COMPLETED|Overall Study||0
6424017|NCT01008475|7338315|FG002|NOT COMPLETED|Overall Study||0
6424018|NCT01008475|7338316|FG003|NOT COMPLETED|Overall Study||0
6424019|NCT01008475|7338317|FG004|NOT COMPLETED|Overall Study||5
6424020|NCT01008475|7338318|FG005|NOT COMPLETED|Overall Study||6
6424021|NCT01008475|7338319|FG006|NOT COMPLETED|Overall Study||4
6424022|NCT01008553|7338335|FG000|STARTED|Period 1 (Titration Period)||258
6424023|NCT01008553|7338336|FG001|STARTED|Period 1 (Titration Period)||0
6424024|NCT01008553|7338337|FG002|STARTED|Period 1 (Titration Period)||0
6424025|NCT01008553|7338335|FG000|COMPLETED|Period 1 (Titration Period)||163
6424026|NCT01008553|7338336|FG001|COMPLETED|Period 1 (Titration Period)||0
6424027|NCT01008553|7338337|FG002|COMPLETED|Period 1 (Titration Period)||0
6424028|NCT01008553|7338335|FG000|NOT COMPLETED|Period 1 (Titration Period)||95
6424029|NCT01008553|7338336|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
6651087|NCT02416713|7580552|FG000|COMPLETED|Overall Study||8
6651088|NCT02416713|7580553|FG001|COMPLETED|Overall Study||9
6651089|NCT02416713|7580554|FG002|COMPLETED|Overall Study||8
6424030|NCT01008553|7338337|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
6424031|NCT01008553|7338335|FG000|STARTED|Period 2 (Double-Blind Period)||0
6424032|NCT01008553|7338336|FG001|STARTED|Period 2 (Double-Blind Period)||84
6424033|NCT01008553|7338337|FG002|STARTED|Period 2 (Double-Blind Period)||79
6424034|NCT01008553|7338335|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
6651090|NCT02416713|7580555|FG003|COMPLETED|Overall Study||10
6651091|NCT02416713|7580552|FG000|NOT COMPLETED|Overall Study||0
6651092|NCT02416713|7580553|FG001|NOT COMPLETED|Overall Study||0
6424035|NCT01008553|7338336|FG001|COMPLETED|Period 2 (Double-Blind Period)||47
6424036|NCT01008553|7338337|FG002|COMPLETED|Period 2 (Double-Blind Period)||28
6424037|NCT01008553|7338335|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
6424038|NCT01008553|7338336|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||37
6424039|NCT01008553|7338337|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||51
6424040|NCT01008605|7338346|FG000|STARTED|Overall Study||48
6424041|NCT01008605|7338346|FG000|COMPLETED|Overall Study||48
6424042|NCT01008605|7338346|FG000|NOT COMPLETED|Overall Study||0
6424043|NCT01008618|7338358|FG000|STARTED|Period 1 (Titration Period)||218
6424044|NCT01008618|7338359|FG001|STARTED|Period 1 (Titration Period)||0
6424045|NCT01008618|7338360|FG002|STARTED|Period 1 (Titration Period)||0
6424046|NCT01008618|7338358|FG000|COMPLETED|Period 1 (Titration Period)||150
6424047|NCT01008618|7338359|FG001|COMPLETED|Period 1 (Titration Period)||0
6424048|NCT01008618|7338360|FG002|COMPLETED|Period 1 (Titration Period)||0
6424049|NCT01008618|7338358|FG000|NOT COMPLETED|Period 1 (Titration Period)||68
6424050|NCT01008618|7338359|FG001|NOT COMPLETED|Period 1 (Titration Period)||0
6424051|NCT01008618|7338360|FG002|NOT COMPLETED|Period 1 (Titration Period)||0
6424052|NCT01008618|7338358|FG000|STARTED|Period 2 (Double-Blind Period)||0
6424053|NCT01008618|7338359|FG001|STARTED|Period 2 (Double-Blind Period)||73
6424054|NCT01008618|7338360|FG002|STARTED|Period 2 (Double-Blind Period)||77
6424055|NCT01008618|7338358|FG000|COMPLETED|Period 2 (Double-Blind Period)||0
6424056|NCT01008618|7338359|FG001|COMPLETED|Period 2 (Double-Blind Period)||37
6424057|NCT01008618|7338360|FG002|COMPLETED|Period 2 (Double-Blind Period)||39
6424058|NCT01008618|7338358|FG000|NOT COMPLETED|Period 2 (Double-Blind Period)||0
6424059|NCT01008618|7338359|FG001|NOT COMPLETED|Period 2 (Double-Blind Period)||36
6424060|NCT01008618|7338360|FG002|NOT COMPLETED|Period 2 (Double-Blind Period)||38
6424061|NCT01008696|7338371|FG000|STARTED|Overall Study||108
6424062|NCT01008696|7338372|FG001|STARTED|Overall Study||109
6424063|NCT01008696|7338371|FG000|COMPLETED|Overall Study||91
6424064|NCT01008696|7338372|FG001|COMPLETED|Overall Study||92
6424065|NCT01008696|7338371|FG000|NOT COMPLETED|Overall Study||17
6424066|NCT01008696|7338372|FG001|NOT COMPLETED|Overall Study||17
6651093|NCT02416713|7580554|FG002|NOT COMPLETED|Overall Study||0
6651094|NCT02416713|7580555|FG003|NOT COMPLETED|Overall Study||0
6651095|NCT02416791|7580568|FG000|STARTED|6 Weeks||3
6651096|NCT02416791|7580569|FG001|STARTED|6 Weeks||3
6651097|NCT02416791|7580570|FG002|STARTED|6 Weeks||3
6651098|NCT02416791|7580568|FG000|COMPLETED|6 Weeks||3
6651099|NCT02416791|7580569|FG001|COMPLETED|6 Weeks||3
6651100|NCT02416791|7580570|FG002|COMPLETED|6 Weeks||3
6651101|NCT02416791|7580568|FG000|NOT COMPLETED|6 Weeks||0
6651102|NCT02416791|7580569|FG001|NOT COMPLETED|6 Weeks||0
6651103|NCT02416791|7580570|FG002|NOT COMPLETED|6 Weeks||0
6651104|NCT02416791|7580568|FG000|STARTED|6 Months||3
6424067|NCT01008722|7338381|FG000|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
6424068|NCT01008722|7338382|FG001|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
6424069|NCT01008722|7338381|FG000|COMPLETED|Overall Study||36
6424070|NCT01008722|7338382|FG001|COMPLETED|Overall Study||71
6424071|NCT01008722|7338381|FG000|NOT COMPLETED|Overall Study||0
6424072|NCT01008722|7338382|FG001|NOT COMPLETED|Overall Study||0
6424073|NCT01008748|7338388|FG000|STARTED|Overall Study||200
6424074|NCT01008748|7338388|FG000|Baseline|Overall Study||188
6424075|NCT01008748|7338388|FG000|Week 0|Overall Study||182
6651105|NCT02416791|7580569|FG001|STARTED|6 Months||3
6651106|NCT02416791|7580570|FG002|STARTED|6 Months||3
6651107|NCT02416791|7580568|FG000|COMPLETED|6 Months||3
6651108|NCT02416791|7580569|FG001|COMPLETED|6 Months||3
6651109|NCT02416791|7580570|FG002|COMPLETED|6 Months||2
6651110|NCT02416791|7580568|FG000|NOT COMPLETED|6 Months||0
6651111|NCT02416791|7580569|FG001|NOT COMPLETED|6 Months||0
6651112|NCT02416791|7580570|FG002|NOT COMPLETED|6 Months||1
6651113|NCT02416908|7580581|FG000|STARTED|Dose Escalation Phase||6
6651114|NCT02416908|7580582|FG001|STARTED|Dose Escalation Phase||0
6651115|NCT02416908|7580583|FG002|STARTED|Dose Escalation Phase||34
6651116|NCT02416908|7580584|FG003|STARTED|Dose Escalation Phase||0
6651117|NCT02416908|7580581|FG000|COMPLETED|Dose Escalation Phase||6
6651118|NCT02416908|7580582|FG001|COMPLETED|Dose Escalation Phase||0
6651119|NCT02416908|7580583|FG002|COMPLETED|Dose Escalation Phase||30
6651120|NCT02416908|7580584|FG003|COMPLETED|Dose Escalation Phase||0
6424076|NCT01008748|7338388|FG000|Week 3|Overall Study||168
6424077|NCT01008748|7338388|FG000|Week 26|Overall Study||119
6424078|NCT01008748|7338388|FG000|COMPLETED|Overall Study||119
6424079|NCT01008748|7338388|FG000|NOT COMPLETED|Overall Study||81
6424080|NCT01008904|7338392|FG000|STARTED|Overall Study||29
6424081|NCT01008904|7338392|FG000|COMPLETED|Overall Study||25
6424082|NCT01008904|7338392|FG000|NOT COMPLETED|Overall Study||4
6651121|NCT02416908|7580581|FG000|NOT COMPLETED|Dose Escalation Phase||0
6651122|NCT02416908|7580582|FG001|NOT COMPLETED|Dose Escalation Phase||0
6651123|NCT02416908|7580583|FG002|NOT COMPLETED|Dose Escalation Phase||4
6651124|NCT02416908|7580584|FG003|NOT COMPLETED|Dose Escalation Phase||0
6651125|NCT02416908|7580581|FG000|STARTED|Maintenance Phase||0
6651126|NCT02416908|7580582|FG001|STARTED|Maintenance Phase||0
6651127|NCT02416908|7580583|FG002|STARTED|Maintenance Phase||0
6651128|NCT02416908|7580584|FG003|STARTED|Maintenance Phase||2
6651129|NCT02416908|7580581|FG000|COMPLETED|Maintenance Phase||0
6651130|NCT02416908|7580582|FG001|COMPLETED|Maintenance Phase||0
6651131|NCT02416908|7580583|FG002|COMPLETED|Maintenance Phase||0
6424083|NCT01008943|7338396|FG000|STARTED|Overall Study||16
6424084|NCT01008943|7338396|FG000|COMPLETED|Overall Study||15
6424085|NCT01008943|7338396|FG000|NOT COMPLETED|Overall Study||1
6424086|NCT01008969|7338400|FG000|STARTED|Overall Study||10
6424087|NCT01008969|7338400|FG000|COMPLETED|Overall Study||10
6424088|NCT01008969|7338400|FG000|NOT COMPLETED|Overall Study||0
6424089|NCT01008995|7338406|FG000|STARTED|Controlled Period||162
6424090|NCT01008995|7338407|FG001|STARTED|Controlled Period||160
6424091|NCT01008995|7338408|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6424092|NCT01008995|7338409|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6424093|NCT01008995|7338406|FG000|COMPLETED|Controlled Period||159
6424094|NCT01008995|7338407|FG001|COMPLETED|Controlled Period||157
6424095|NCT01008995|7338408|FG002|COMPLETED|Controlled Period||0
6424096|NCT01008995|7338409|FG003|COMPLETED|Controlled Period||0
6424097|NCT01008995|7338406|FG000|NOT COMPLETED|Controlled Period||3
6424098|NCT01008995|7338407|FG001|NOT COMPLETED|Controlled Period||3
6424099|NCT01008995|7338408|FG002|NOT COMPLETED|Controlled Period||0
6424100|NCT01008995|7338409|FG003|NOT COMPLETED|Controlled Period||0
6424101|NCT01008995|7338406|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6424102|NCT01008995|7338407|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6424103|NCT01008995|7338408|FG002|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
6424104|NCT01008995|7338409|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
6424105|NCT01008995|7338406|FG000|COMPLETED|After Controlled Period||0
6424106|NCT01008995|7338407|FG001|COMPLETED|After Controlled Period||0
6424107|NCT01008995|7338408|FG002|COMPLETED|After Controlled Period||156
6424108|NCT01008995|7338409|FG003|COMPLETED|After Controlled Period||156
6424109|NCT01008995|7338406|FG000|NOT COMPLETED|After Controlled Period||0
6424110|NCT01008995|7338407|FG001|NOT COMPLETED|After Controlled Period||0
6424111|NCT01008995|7338408|FG002|NOT COMPLETED|After Controlled Period||2
6424112|NCT01008995|7338409|FG003|NOT COMPLETED|After Controlled Period||1
6424113|NCT01009034|7338417|FG000|STARTED|Overall Study||14
6424114|NCT01009034|7338417|FG000|COMPLETED|Overall Study||10
6424115|NCT01009034|7338417|FG000|NOT COMPLETED|Overall Study||4
6424116|NCT01009047|7338423|FG000|STARTED|Overall Study||113
6424117|NCT01009047|7338424|FG001|STARTED|Overall Study||115
6424118|NCT01009047|7338423|FG000|COMPLETED|Overall Study||85
6424119|NCT01009047|7338424|FG001|COMPLETED|Overall Study||89
6424120|NCT01009047|7338423|FG000|NOT COMPLETED|Overall Study||28
6424121|NCT01009047|7338424|FG001|NOT COMPLETED|Overall Study||26
6424122|NCT01009060|7338432|FG000|STARTED|Overall Study||25
6424123|NCT01009060|7338433|FG001|STARTED|Overall Study||25
6424124|NCT01009060|7338432|FG000|COMPLETED|Overall Study||21
6424125|NCT01009060|7338433|FG001|COMPLETED|Overall Study||20
6424126|NCT01009060|7338432|FG000|NOT COMPLETED|Overall Study||4
6424127|NCT01009060|7338433|FG001|NOT COMPLETED|Overall Study||5
6424128|NCT01009086|7338446|FG000|STARTED|Overall Study||206
6424129|NCT01009086|7338447|FG001|STARTED|Overall Study||205
6424130|NCT01009086|7338448|FG002|STARTED|Overall Study||204
6424131|NCT01009086|7338446|FG000|COMPLETED|Overall Study||162
6424132|NCT01009086|7338447|FG001|COMPLETED|Overall Study||158
6424133|NCT01009086|7338448|FG002|COMPLETED|Overall Study||170
6424134|NCT01009086|7338446|FG000|NOT COMPLETED|Overall Study||44
6424135|NCT01009086|7338447|FG001|NOT COMPLETED|Overall Study||47
6424136|NCT01009086|7338448|FG002|NOT COMPLETED|Overall Study||34
6424137|NCT01009099|7338463|FG000|STARTED|Overall Study||58
6424138|NCT01009099|7338464|FG001|STARTED|Overall Study||61
6424139|NCT01009099|7338463|FG000|COMPLETED|Overall Study||53
6424140|NCT01009099|7338464|FG001|COMPLETED|Overall Study||57
6424141|NCT01009099|7338463|FG000|NOT COMPLETED|Overall Study||5
6424142|NCT01009099|7338464|FG001|NOT COMPLETED|Overall Study||4
6424143|NCT01009138|7338472|FG000|STARTED|Overall Study||106
6424144|NCT01009138|7338473|FG001|STARTED|Overall Study||108
6424145|NCT01009138|7338472|FG000|COMPLETED|Overall Study||93
6424146|NCT01009138|7338473|FG001|COMPLETED|Overall Study||88
6424147|NCT01009138|7338472|FG000|NOT COMPLETED|Overall Study||13
6424148|NCT01009138|7338473|FG001|NOT COMPLETED|Overall Study||20
6424149|NCT01009203|7338479|FG000|STARTED|Overall Study||13
6424150|NCT01009203|7338479|FG000|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
6424151|NCT01009203|7338479|FG000|COMPLETED|Overall Study||6
6424152|NCT01009203|7338479|FG000|NOT COMPLETED|Overall Study||7
6424153|NCT01009281|7338483|FG000|STARTED|Overall Study||7
6424154|NCT01009281|7338483|FG000|COMPLETED|Overall Study||0
6424155|NCT01009281|7338483|FG000|NOT COMPLETED|Overall Study||7
6424156|NCT01009333|7338487|FG000|STARTED|Week 1||2
6424157|NCT01009333|7338488|FG001|STARTED|Week 1||3
6424158|NCT01009333|7338489|FG002|STARTED|Week 1||2
6424159|NCT01009333|7338490|FG003|STARTED|Week 1||2
6424160|NCT01009333|7338491|FG004|STARTED|Week 1||2
6424161|NCT01009333|7338492|FG005|STARTED|Week 1||2
6424162|NCT01009333|7338487|FG000|COMPLETED|Week 1||2
6424163|NCT01009333|7338488|FG001|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
6424164|NCT01009333|7338489|FG002|COMPLETED|Week 1||2
6424165|NCT01009333|7338490|FG003|COMPLETED|Week 1||2
6424166|NCT01009333|7338491|FG004|COMPLETED|Week 1||2
6424167|NCT01009333|7338492|FG005|COMPLETED|Week 1||2
6424168|NCT01009333|7338487|FG000|NOT COMPLETED|Week 1||0
6424169|NCT01009333|7338488|FG001|NOT COMPLETED|Week 1||0
6424170|NCT01009333|7338489|FG002|NOT COMPLETED|Week 1||0
6424171|NCT01009333|7338490|FG003|NOT COMPLETED|Week 1||0
6424172|NCT01009333|7338491|FG004|NOT COMPLETED|Week 1||0
6424173|NCT01009333|7338492|FG005|NOT COMPLETED|Week 1||0
6424174|NCT01009333|7338487|FG000|STARTED|Week 2||2
6424175|NCT01009333|7338488|FG001|STARTED|Week 2||2
6424176|NCT01009333|7338489|FG002|STARTED|Week 2||2
6424177|NCT01009333|7338490|FG003|STARTED|Week 2||2
6424178|NCT01009333|7338491|FG004|STARTED|Week 2||2
6424179|NCT01009333|7338492|FG005|STARTED|Week 2||2
6424180|NCT01009333|7338487|FG000|COMPLETED|Week 2||2
6424181|NCT01009333|7338488|FG001|COMPLETED|Week 2||2
6424182|NCT01009333|7338489|FG002|COMPLETED|Week 2||2
6424183|NCT01009333|7338490|FG003|COMPLETED|Week 2||2
6424184|NCT01009333|7338491|FG004|COMPLETED|Week 2||2
6551542|NCT03813199|7473767|FG000|STARTED|Overall Study||21
6551543|NCT03813199|7473768|FG001|STARTED|Overall Study||19
6551544|NCT03813199|7473769|FG002|STARTED|Overall Study||20
6551545|NCT03813199|7473767|FG000|COMPLETED|Overall Study||18
6424185|NCT01009333|7338492|FG005|COMPLETED|Week 2||2
6424186|NCT01009333|7338487|FG000|NOT COMPLETED|Week 2||0
6424187|NCT01009333|7338488|FG001|NOT COMPLETED|Week 2||0
6424188|NCT01009333|7338489|FG002|NOT COMPLETED|Week 2||0
6424189|NCT01009333|7338490|FG003|NOT COMPLETED|Week 2||0
6424190|NCT01009333|7338491|FG004|NOT COMPLETED|Week 2||0
6424191|NCT01009333|7338492|FG005|NOT COMPLETED|Week 2||0
6424192|NCT01009333|7338487|FG000|STARTED|Week 3||2
6424193|NCT01009333|7338488|FG001|STARTED|Week 3||2
6424194|NCT01009333|7338489|FG002|STARTED|Week 3||2
6424195|NCT01009333|7338490|FG003|STARTED|Week 3||2
6424196|NCT01009333|7338491|FG004|STARTED|Week 3||2
6424197|NCT01009333|7338492|FG005|STARTED|Week 3||2
6424198|NCT01009333|7338487|FG000|COMPLETED|Week 3||2
6424199|NCT01009333|7338488|FG001|COMPLETED|Week 3||2
6424200|NCT01009333|7338489|FG002|COMPLETED|Week 3||2
6424201|NCT01009333|7338490|FG003|COMPLETED|Week 3||2
6424202|NCT01009333|7338491|FG004|COMPLETED|Week 3||2
6424203|NCT01009333|7338492|FG005|COMPLETED|Week 3||2
6424204|NCT01009333|7338487|FG000|NOT COMPLETED|Week 3||0
6424205|NCT01009333|7338488|FG001|NOT COMPLETED|Week 3||0
6424206|NCT01009333|7338489|FG002|NOT COMPLETED|Week 3||0
6424207|NCT01009333|7338490|FG003|NOT COMPLETED|Week 3||0
6424208|NCT01009333|7338491|FG004|NOT COMPLETED|Week 3||0
6424209|NCT01009333|7338492|FG005|NOT COMPLETED|Week 3||0
6424210|NCT01009346|7338500|FG000|STARTED|Overall Study||9
6424211|NCT01009346|7338500|FG000|COMPLETED|Overall Study||5
6651132|NCT02416908|7580584|FG003|COMPLETED|Maintenance Phase||2
6651133|NCT02416908|7580581|FG000|NOT COMPLETED|Maintenance Phase||0
6651134|NCT02416908|7580582|FG001|NOT COMPLETED|Maintenance Phase||0
6424212|NCT01009346|7338500|FG000|NOT COMPLETED|Overall Study||4
6424213|NCT01009463|7338509|FG000|STARTED|4-week, Open-label Run-In Period||2071
6424214|NCT01009463|7338510|FG001|STARTED|4-week, Open-label Run-In Period||0
6424215|NCT01009463|7338511|FG002|STARTED|4-week, Open-label Run-In Period||0
6424216|NCT01009463|7338512|FG003|STARTED|4-week, Open-label Run-In Period||0
6424217|NCT01009463|7338513|FG004|STARTED|4-week, Open-label Run-In Period||0
6424218|NCT01009463|7338509|FG000|COMPLETED|4-week, Open-label Run-In Period||1622
6424219|NCT01009463|7338510|FG001|COMPLETED|4-week, Open-label Run-In Period||0
6551546|NCT03813199|7473768|FG001|COMPLETED|Overall Study||6
6551547|NCT03813199|7473769|FG002|COMPLETED|Overall Study||19
6551548|NCT03813199|7473767|FG000|NOT COMPLETED|Overall Study||3
6551549|NCT03813199|7473768|FG001|NOT COMPLETED|Overall Study||13
6651135|NCT02416908|7580583|FG002|NOT COMPLETED|Maintenance Phase||0
6651136|NCT02416908|7580584|FG003|NOT COMPLETED|Maintenance Phase||0
6651137|NCT02416934|7580593|FG000|STARTED|Overall Study||36
6651138|NCT02416934|7580594|FG001|STARTED|Overall Study||38
6651139|NCT02416934|7580593|FG000|Double Blind (0-52 Weeks)|Overall Study||36
6651140|NCT02416934|7580594|FG001|Double Blind (0-52 Weeks)|Overall Study||38
6651141|NCT02416934|7580593|FG000|Last Participant Completed 1 yr|Overall Study||33
6651142|NCT02416934|7580594|FG001|Last Participant Completed 1 yr|Overall Study||31
6651143|NCT02416934|7580593|FG000|COMPLETED|Overall Study||33
6651144|NCT02416934|7580594|FG001|COMPLETED|Overall Study||31
6424220|NCT01009463|7338511|FG002|COMPLETED|4-week, Open-label Run-In Period||0
6424221|NCT01009463|7338512|FG003|COMPLETED|4-week, Open-label Run-In Period||0
6424222|NCT01009463|7338513|FG004|COMPLETED|4-week, Open-label Run-In Period||0
6424223|NCT01009463|7338509|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||449
6424224|NCT01009463|7338510|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
6424225|NCT01009463|7338511|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
6424226|NCT01009463|7338512|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
6424227|NCT01009463|7338513|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
6424228|NCT01009463|7338509|FG000|STARTED|52-week, Double-blind Treatment Period||0
6424229|NCT01009463|7338510|FG001|STARTED|52-week, Double-blind Treatment Period||409
6424230|NCT01009463|7338511|FG002|STARTED|52-week, Double-blind Treatment Period||408
6424231|NCT01009463|7338512|FG003|STARTED|52-week, Double-blind Treatment Period||403
6424232|NCT01009463|7338513|FG004|STARTED|52-week, Double-blind Treatment Period||402
6551550|NCT03813199|7473769|FG002|NOT COMPLETED|Overall Study||1
6551551|NCT03594955|7473777|FG000|STARTED|Overall Study||7
6551552|NCT03594955|7473777|FG000|COMPLETED|Overall Study||0
6651145|NCT02416934|7580593|FG000|NOT COMPLETED|Overall Study||3
6651146|NCT02416934|7580594|FG001|NOT COMPLETED|Overall Study||7
6651147|NCT02416973|7580609|FG000|STARTED|Overall Study||14
6651148|NCT02416973|7580610|FG001|STARTED|Overall Study||13
6424233|NCT01009463|7338509|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
6424234|NCT01009463|7338510|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
6424235|NCT01009463|7338511|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
6424236|NCT01009463|7338512|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
6424237|NCT01009463|7338513|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
6424238|NCT01009463|7338509|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
6424239|NCT01009463|7338510|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
6424240|NCT01009463|7338511|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
6424241|NCT01009463|7338512|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
6424242|NCT01009463|7338513|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
6424243|NCT01009463|7338509|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
6424244|NCT01009463|7338510|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||115
6424245|NCT01009463|7338511|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||93
6424246|NCT01009463|7338512|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||91
6424247|NCT01009463|7338513|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||101
6424248|NCT01009515|7338524|FG000|STARTED|Overall Study||19
6424249|NCT01009515|7338524|FG000|COMPLETED|Overall Study||16
6424250|NCT01009515|7338524|FG000|NOT COMPLETED|Overall Study||3
6424251|NCT01009554|7338530|FG000|STARTED|Overall Study||48
6424252|NCT01009554|7338531|FG001|STARTED|Overall Study||48
6424253|NCT01009554|7338530|FG000|COMPLETED|Overall Study||46
6424254|NCT01009554|7338531|FG001|COMPLETED|Overall Study||41
6424255|NCT01009554|7338530|FG000|NOT COMPLETED|Overall Study||2
6424256|NCT01009554|7338531|FG001|NOT COMPLETED|Overall Study||7
6424257|NCT01009580|7338539|FG000|STARTED|Overall Study||224
6424258|NCT01009580|7338540|FG001|STARTED|Overall Study||223
6424259|NCT01009580|7338539|FG000|Exposed|Overall Study||224
6424260|NCT01009580|7338540|FG001|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
6424261|NCT01009580|7338539|FG000|COMPLETED|Overall Study||197
6424262|NCT01009580|7338540|FG001|COMPLETED|Overall Study||188
6424263|NCT01009580|7338539|FG000|NOT COMPLETED|Overall Study||27
6424264|NCT01009580|7338540|FG001|NOT COMPLETED|Overall Study||35
6424265|NCT01009619|7338548|FG000|STARTED|Overall Study||40
6424266|NCT01009619|7338549|FG001|STARTED|Overall Study||43
6424267|NCT01009619|7338548|FG000|COMPLETED|Overall Study||40
6424268|NCT01009619|7338549|FG001|COMPLETED|Overall Study||43
6424269|NCT01009619|7338548|FG000|NOT COMPLETED|Overall Study||0
6424270|NCT01009619|7338549|FG001|NOT COMPLETED|Overall Study||0
6424271|NCT01009645|7338559|FG000|STARTED|Overall Study||31
6424272|NCT01009645|7338560|FG001|STARTED|Overall Study||31
6424273|NCT01009645|7338561|FG002|STARTED|Overall Study||32
6424274|NCT01009645|7338562|FG003|STARTED|Overall Study||31
6424275|NCT01009645|7338559|FG000|COMPLETED|Overall Study||29
6424276|NCT01009645|7338560|FG001|COMPLETED|Overall Study||23
6424277|NCT01009645|7338561|FG002|COMPLETED|Overall Study||28
6424278|NCT01009645|7338562|FG003|COMPLETED|Overall Study||26
6424279|NCT01009645|7338559|FG000|NOT COMPLETED|Overall Study||2
6424280|NCT01009645|7338560|FG001|NOT COMPLETED|Overall Study||8
6424281|NCT01009645|7338561|FG002|NOT COMPLETED|Overall Study||4
6424282|NCT01009645|7338562|FG003|NOT COMPLETED|Overall Study||5
6424283|NCT01009762|7338574|FG000|STARTED|Overall Study||1
6424284|NCT01009762|7338575|FG001|STARTED|Overall Study||10
6424285|NCT01009762|7338574|FG000|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
6424286|NCT01009762|7338575|FG001|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
6424287|NCT01009762|7338574|FG000|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
6424288|NCT01009762|7338575|FG001|COMPLETED|Overall Study|10 participants received vaccine|10
6424289|NCT01009762|7338574|FG000|NOT COMPLETED|Overall Study||0
6424290|NCT01009762|7338575|FG001|NOT COMPLETED|Overall Study||0
6424291|NCT01009814|7338588|FG000|STARTED|Overall Study||10
6424292|NCT01009814|7338589|FG001|STARTED|Overall Study||10
6424293|NCT01009814|7338590|FG002|STARTED|Overall Study||10
6424294|NCT01009814|7338591|FG003|STARTED|Overall Study||10
6424295|NCT01009814|7338592|FG004|STARTED|Overall Study||10
6424296|NCT01009814|7338588|FG000|COMPLETED|Overall Study||9
6424297|NCT01009814|7338589|FG001|COMPLETED|Overall Study||9
6651149|NCT02416973|7580611|FG002|STARTED|Overall Study||14
6651150|NCT02416973|7580609|FG000|COMPLETED|Overall Study||13
6651151|NCT02416973|7580610|FG001|COMPLETED|Overall Study||10
6651152|NCT02416973|7580611|FG002|COMPLETED|Overall Study||13
6651153|NCT02416973|7580609|FG000|NOT COMPLETED|Overall Study||1
6651154|NCT02416973|7580610|FG001|NOT COMPLETED|Overall Study||3
6651155|NCT02416973|7580611|FG002|NOT COMPLETED|Overall Study||1
6651156|NCT02417064|7580622|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||117
6651157|NCT02417064|7580623|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||116
6424298|NCT01009814|7338590|FG002|COMPLETED|Overall Study||10
6424299|NCT01009814|7338591|FG003|COMPLETED|Overall Study||10
6424300|NCT01009814|7338592|FG004|COMPLETED|Overall Study||10
6424301|NCT01009814|7338588|FG000|NOT COMPLETED|Overall Study||1
6424302|NCT01009814|7338589|FG001|NOT COMPLETED|Overall Study||1
6424303|NCT01009814|7338590|FG002|NOT COMPLETED|Overall Study||0
6424304|NCT01009814|7338591|FG003|NOT COMPLETED|Overall Study||0
6424305|NCT01009814|7338592|FG004|NOT COMPLETED|Overall Study||0
6424306|NCT01009840|7338608|FG000|STARTED|Overall Study||30
6424307|NCT01009840|7338608|FG000|COMPLETED|Overall Study||16
6424308|NCT01009840|7338608|FG000|NOT COMPLETED|Overall Study||14
6424309|NCT01009918|7338615|FG000|STARTED|Overall Study||158
6424310|NCT01009918|7338616|FG001|STARTED|Overall Study||156
6424311|NCT01009918|7338617|FG002|STARTED|Overall Study||154
6424312|NCT01009918|7338615|FG000|COMPLETED|Overall Study||134
6424313|NCT01009918|7338616|FG001|COMPLETED|Overall Study||132
6424314|NCT01009918|7338617|FG002|COMPLETED|Overall Study||124
6424315|NCT01009918|7338615|FG000|NOT COMPLETED|Overall Study||24
6424316|NCT01009918|7338616|FG001|NOT COMPLETED|Overall Study||24
6424317|NCT01009918|7338617|FG002|NOT COMPLETED|Overall Study||30
6424318|NCT01009983|7338625|FG000|STARTED|Overall Study||14
6424319|NCT01009983|7338625|FG000|COMPLETED|Overall Study||13
6424320|NCT01009983|7338625|FG000|NOT COMPLETED|Overall Study||1
6424321|NCT01010009|7338632|FG000|STARTED|Overall Study||8
6424322|NCT01010009|7338633|FG001|STARTED|Overall Study||8
6424323|NCT01010009|7338634|FG002|STARTED|Overall Study||8
6424324|NCT01010009|7338632|FG000|COMPLETED|Overall Study||8
6424325|NCT01010009|7338633|FG001|COMPLETED|Overall Study||8
6424326|NCT01010009|7338634|FG002|COMPLETED|Overall Study||8
6424327|NCT01010009|7338632|FG000|NOT COMPLETED|Overall Study||0
6551553|NCT03594955|7473777|FG000|NOT COMPLETED|Overall Study||7
6424328|NCT01010009|7338633|FG001|NOT COMPLETED|Overall Study||0
6424329|NCT01010009|7338634|FG002|NOT COMPLETED|Overall Study||0
6424330|NCT01010061|7338644|FG000|STARTED|Overall Study||238
6424331|NCT01010061|7338645|FG001|STARTED|Overall Study||118
6424332|NCT01010061|7338644|FG000|Received Study Drug|Overall Study||236
6424333|NCT01010061|7338645|FG001|Received Study Drug|Overall Study||116
6424334|NCT01010061|7338644|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|190
6424335|NCT01010061|7338645|FG001|COMPLETED|Overall Study||78
6424336|NCT01010061|7338644|FG000|NOT COMPLETED|Overall Study||48
6424337|NCT01010061|7338645|FG001|NOT COMPLETED|Overall Study||40
6424338|NCT01010126|7338659|FG000|STARTED|Overall Study||27
6424339|NCT01010126|7338660|FG001|STARTED|Overall Study||58
6424340|NCT01010126|7338661|FG002|STARTED|Overall Study||28
6424341|NCT01010126|7338662|FG003|STARTED|Overall Study||57
6424342|NCT01010126|7338663|FG004|STARTED|Overall Study||58
6424343|NCT01010126|7338664|FG005|STARTED|Overall Study||24
6424344|NCT01010126|7338659|FG000|COMPLETED|Overall Study||26
6424345|NCT01010126|7338660|FG001|COMPLETED|Overall Study||58
6424346|NCT01010126|7338661|FG002|COMPLETED|Overall Study||27
6424347|NCT01010126|7338662|FG003|COMPLETED|Overall Study||57
6424348|NCT01010126|7338663|FG004|COMPLETED|Overall Study||55
6424349|NCT01010126|7338664|FG005|COMPLETED|Overall Study||24
6424350|NCT01010126|7338659|FG000|NOT COMPLETED|Overall Study||1
6424351|NCT01010126|7338660|FG001|NOT COMPLETED|Overall Study||0
6424352|NCT01010126|7338661|FG002|NOT COMPLETED|Overall Study||1
6424353|NCT01010126|7338662|FG003|NOT COMPLETED|Overall Study||0
6424354|NCT01010126|7338663|FG004|NOT COMPLETED|Overall Study||3
6424355|NCT01010126|7338664|FG005|NOT COMPLETED|Overall Study||0
6424356|NCT01010204|7338680|FG000|STARTED|Overall Study||31
6424357|NCT01010204|7338681|FG001|STARTED|Overall Study||29
6424358|NCT01010204|7338680|FG000|COMPLETED|Overall Study||24
6424359|NCT01010204|7338681|FG001|COMPLETED|Overall Study||20
6424360|NCT01010204|7338680|FG000|NOT COMPLETED|Overall Study||7
6424361|NCT01010204|7338681|FG001|NOT COMPLETED|Overall Study||9
6424362|NCT01010217|7338692|FG000|STARTED|Overall Study||89
6424363|NCT01010217|7338693|FG001|STARTED|Overall Study||56
6424364|NCT01010217|7338694|FG002|STARTED|Overall Study||22
6424365|NCT01010217|7338695|FG003|STARTED|Overall Study||6
6424366|NCT01010217|7338696|FG004|STARTED|Overall Study||3
6424367|NCT01010217|7338692|FG000|COMPLETED|Overall Study||84
6424368|NCT01010217|7338693|FG001|COMPLETED|Overall Study||51
6424369|NCT01010217|7338694|FG002|COMPLETED|Overall Study||21
6424370|NCT01010217|7338695|FG003|COMPLETED|Overall Study||0
6424371|NCT01010217|7338696|FG004|COMPLETED|Overall Study||0
6424372|NCT01010217|7338692|FG000|NOT COMPLETED|Overall Study||5
6424373|NCT01010217|7338693|FG001|NOT COMPLETED|Overall Study||5
6424374|NCT01010217|7338694|FG002|NOT COMPLETED|Overall Study||1
6424375|NCT01010217|7338695|FG003|NOT COMPLETED|Overall Study||6
6424376|NCT01010217|7338696|FG004|NOT COMPLETED|Overall Study||3
6424377|NCT01010230|7338710|FG000|STARTED|Overall Study||32
6424378|NCT01010230|7338711|FG001|STARTED|Overall Study||33
6424379|NCT01010230|7338710|FG000|COMPLETED|Overall Study||22
6424380|NCT01010230|7338711|FG001|COMPLETED|Overall Study||26
6424381|NCT01010230|7338710|FG000|NOT COMPLETED|Overall Study||10
6424382|NCT01010230|7338711|FG001|NOT COMPLETED|Overall Study||7
6424383|NCT01010282|7338720|FG000|STARTED|Overall Study||97
6424384|NCT01010282|7338721|FG001|STARTED|Overall Study||95
6424385|NCT01010282|7338722|FG002|STARTED|Overall Study||96
6424386|NCT01010282|7338720|FG000|COMPLETED|Overall Study||91
6424387|NCT01010282|7338721|FG001|COMPLETED|Overall Study||88
6424388|NCT01010282|7338722|FG002|COMPLETED|Overall Study||77
6551554|NCT03478956|7473783|FG000|STARTED|Overall Study||12
6424389|NCT01010282|7338720|FG000|NOT COMPLETED|Overall Study||6
6424390|NCT01010282|7338721|FG001|NOT COMPLETED|Overall Study||7
6424391|NCT01010282|7338722|FG002|NOT COMPLETED|Overall Study||19
6424392|NCT01010399|7338730|FG000|STARTED|Overall Study||36
6424393|NCT01010399|7338730|FG000|COMPLETED|Overall Study||31
6424394|NCT01010399|7338730|FG000|NOT COMPLETED|Overall Study||5
6424395|NCT01010477|7338736|FG000|STARTED|Overall Study||27
6424396|NCT01010477|7338737|FG001|STARTED|Overall Study||25
6424397|NCT01010477|7338736|FG000|COMPLETED|Overall Study||21
6424398|NCT01010477|7338737|FG001|COMPLETED|Overall Study||22
6424399|NCT01010477|7338736|FG000|NOT COMPLETED|Overall Study||6
6424400|NCT01010477|7338737|FG001|NOT COMPLETED|Overall Study||3
6424401|NCT01010503|7338743|FG000|STARTED|Overall Study||32
6424402|NCT01010503|7338743|FG000|COMPLETED|Overall Study||30
6424403|NCT01010503|7338743|FG000|NOT COMPLETED|Overall Study||2
6424404|NCT01010555|7338747|FG000|STARTED|First Four Weeks of Wear||11
6424405|NCT01010555|7338748|FG001|STARTED|First Four Weeks of Wear||10
6424406|NCT01010555|7338747|FG000|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
6424407|NCT01010555|7338748|FG001|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
6424408|NCT01010555|7338747|FG000|NOT COMPLETED|First Four Weeks of Wear||0
6424409|NCT01010555|7338748|FG001|NOT COMPLETED|First Four Weeks of Wear||0
6424410|NCT01010555|7338747|FG000|STARTED|Second Four Weeks of Wear||10
6424411|NCT01010555|7338748|FG001|STARTED|Second Four Weeks of Wear||9
6424412|NCT01010555|7338747|FG000|COMPLETED|Second Four Weeks of Wear||10
6424413|NCT01010555|7338748|FG001|COMPLETED|Second Four Weeks of Wear||9
6424414|NCT01010555|7338747|FG000|NOT COMPLETED|Second Four Weeks of Wear||0
6424415|NCT01010555|7338748|FG001|NOT COMPLETED|Second Four Weeks of Wear||0
6424416|NCT01010568|7338758|FG000|STARTED|Overall Study||10
6424417|NCT01010568|7338758|FG000|COMPLETED|Overall Study||5
6424418|NCT01010568|7338758|FG000|NOT COMPLETED|Overall Study||5
6424419|NCT01010633|7338765|FG000|STARTED|Overall Study||203
6424420|NCT01010633|7338766|FG001|STARTED|Overall Study||203
6424421|NCT01010633|7338765|FG000|COMPLETED|Overall Study||199
6424422|NCT01010633|7338766|FG001|COMPLETED|Overall Study||198
6424423|NCT01010633|7338765|FG000|NOT COMPLETED|Overall Study||4
6424424|NCT01010633|7338766|FG001|NOT COMPLETED|Overall Study||5
6424425|NCT01010750|7338778|FG000|STARTED|First Intervention||3
6424426|NCT01010750|7338779|FG001|STARTED|First Intervention||4
6424427|NCT01010750|7338780|FG002|STARTED|First Intervention||3
6424428|NCT01010750|7338781|FG003|STARTED|First Intervention||3
6424429|NCT01010750|7338782|FG004|STARTED|First Intervention||2
6424430|NCT01010750|7338783|FG005|STARTED|First Intervention||3
6424431|NCT01010750|7338778|FG000|COMPLETED|First Intervention||3
6424432|NCT01010750|7338779|FG001|COMPLETED|First Intervention||4
6424433|NCT01010750|7338780|FG002|COMPLETED|First Intervention||3
6424434|NCT01010750|7338781|FG003|COMPLETED|First Intervention||3
6424435|NCT01010750|7338782|FG004|COMPLETED|First Intervention||2
6424436|NCT01010750|7338783|FG005|COMPLETED|First Intervention||3
6424437|NCT01010750|7338778|FG000|NOT COMPLETED|First Intervention||0
6424438|NCT01010750|7338779|FG001|NOT COMPLETED|First Intervention||0
6424439|NCT01010750|7338780|FG002|NOT COMPLETED|First Intervention||0
6424440|NCT01010750|7338781|FG003|NOT COMPLETED|First Intervention||0
6424441|NCT01010750|7338782|FG004|NOT COMPLETED|First Intervention||0
6424442|NCT01010750|7338783|FG005|NOT COMPLETED|First Intervention||0
6424443|NCT01010750|7338778|FG000|STARTED|Second Intervention||3
6424444|NCT01010750|7338779|FG001|STARTED|Second Intervention||4
6424445|NCT01010750|7338780|FG002|STARTED|Second Intervention||3
6424446|NCT01010750|7338781|FG003|STARTED|Second Intervention||3
6424447|NCT01010750|7338782|FG004|STARTED|Second Intervention||2
6424448|NCT01010750|7338783|FG005|STARTED|Second Intervention||3
6424449|NCT01010750|7338778|FG000|COMPLETED|Second Intervention||3
6424450|NCT01010750|7338779|FG001|COMPLETED|Second Intervention||3
6424451|NCT01010750|7338780|FG002|COMPLETED|Second Intervention||3
6424452|NCT01010750|7338781|FG003|COMPLETED|Second Intervention||3
6424453|NCT01010750|7338782|FG004|COMPLETED|Second Intervention||2
6424454|NCT01010750|7338783|FG005|COMPLETED|Second Intervention||3
6424455|NCT01010750|7338778|FG000|NOT COMPLETED|Second Intervention||0
6424456|NCT01010750|7338779|FG001|NOT COMPLETED|Second Intervention||1
6424457|NCT01010750|7338780|FG002|NOT COMPLETED|Second Intervention||0
6424458|NCT01010750|7338781|FG003|NOT COMPLETED|Second Intervention||0
6424459|NCT01010750|7338782|FG004|NOT COMPLETED|Second Intervention||0
6424460|NCT01010750|7338783|FG005|NOT COMPLETED|Second Intervention||0
6424461|NCT01010750|7338778|FG000|STARTED|Third Intervention||3
6424462|NCT01010750|7338779|FG001|STARTED|Third Intervention||3
6424463|NCT01010750|7338780|FG002|STARTED|Third Intervention||3
6424464|NCT01010750|7338781|FG003|STARTED|Third Intervention||3
6424465|NCT01010750|7338782|FG004|STARTED|Third Intervention||2
6424466|NCT01010750|7338783|FG005|STARTED|Third Intervention||3
6424467|NCT01010750|7338778|FG000|COMPLETED|Third Intervention||3
6424468|NCT01010750|7338779|FG001|COMPLETED|Third Intervention||3
6424469|NCT01010750|7338780|FG002|COMPLETED|Third Intervention||3
6424470|NCT01010750|7338781|FG003|COMPLETED|Third Intervention||3
6424471|NCT01010750|7338782|FG004|COMPLETED|Third Intervention||2
6424472|NCT01010750|7338783|FG005|COMPLETED|Third Intervention||3
6424473|NCT01010750|7338778|FG000|NOT COMPLETED|Third Intervention||0
6424474|NCT01010750|7338779|FG001|NOT COMPLETED|Third Intervention||0
6424475|NCT01010750|7338780|FG002|NOT COMPLETED|Third Intervention||0
6424476|NCT01010750|7338781|FG003|NOT COMPLETED|Third Intervention||0
6424477|NCT01010750|7338782|FG004|NOT COMPLETED|Third Intervention||0
6424478|NCT01010750|7338783|FG005|NOT COMPLETED|Third Intervention||0
6424479|NCT01010763|7338793|FG000|STARTED|Overall Study||96
6551555|NCT03478956|7473784|FG001|STARTED|Overall Study||12
6551556|NCT03478956|7473783|FG000|Received at Least One Dose of Study Drug|Overall Study||12
6551557|NCT03478956|7473784|FG001|Received at Least One Dose of Study Drug|Overall Study||12
6424480|NCT01010763|7338794|FG001|STARTED|Overall Study||84
6424481|NCT01010763|7338793|FG000|COMPLETED|Overall Study||61
6651158|NCT02417064|7580624|FG002|STARTED|Double-blind Induction Phase (4 Weeks)||113
6651159|NCT02417064|7580622|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||115
6651160|NCT02417064|7580623|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||114
6651161|NCT02417064|7580624|FG002|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||113
6651162|NCT02417064|7580622|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||115
6651163|NCT02417064|7580623|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||116
6651164|NCT02417064|7580624|FG002|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||113
6651165|NCT02417064|7580622|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||111
6424482|NCT01010763|7338794|FG001|COMPLETED|Overall Study||54
6424483|NCT01010763|7338793|FG000|NOT COMPLETED|Overall Study||35
6424484|NCT01010763|7338794|FG001|NOT COMPLETED|Overall Study||30
6551558|NCT03478956|7473783|FG000|Completed Randomized Treatment Phase|Overall Study||11
6551559|NCT03478956|7473784|FG001|Completed Randomized Treatment Phase|Overall Study||10
6651166|NCT02417064|7580623|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||97
6424485|NCT01010776|7338800|FG000|STARTED|Main Phase||223
6424486|NCT01010776|7338800|FG000|Treated|Main Phase||218
6424487|NCT01010776|7338800|FG000|COMPLETED|Main Phase||174
6424488|NCT01010776|7338800|FG000|NOT COMPLETED|Main Phase||49
6424489|NCT01010776|7338800|FG000|STARTED|In-Between Main Phase & Extension Phase||174
6424490|NCT01010776|7338800|FG000|COMPLETED|In-Between Main Phase & Extension Phase||159
6424491|NCT01010776|7338800|FG000|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
6424492|NCT01010776|7338800|FG000|STARTED|Extension Phase||159
6424493|NCT01010776|7338800|FG000|COMPLETED|Extension Phase||156
6424494|NCT01010776|7338800|FG000|NOT COMPLETED|Extension Phase||3
6424495|NCT01010854|7338815|FG000|STARTED|Overall Study||6
6424496|NCT01010854|7338815|FG000|COMPLETED|Overall Study||6
6424497|NCT01010854|7338815|FG000|NOT COMPLETED|Overall Study||0
6424498|NCT01010867|7338819|FG000|STARTED|Overall Study||31
6424499|NCT01010867|7338819|FG000|COMPLETED|Overall Study||30
6424500|NCT01010867|7338819|FG000|NOT COMPLETED|Overall Study||1
6424501|NCT01010906|7338829|FG000|STARTED|Overall Study||10
6424502|NCT01010906|7338830|FG001|STARTED|Overall Study||10
6424503|NCT01010906|7338831|FG002|STARTED|Overall Study||10
6424504|NCT01010906|7338832|FG003|STARTED|Overall Study||10
6424505|NCT01010906|7338833|FG004|STARTED|Overall Study||10
6424506|NCT01010906|7338834|FG005|STARTED|Overall Study||10
6424507|NCT01010906|7338829|FG000|COMPLETED|Overall Study||10
6424508|NCT01010906|7338830|FG001|COMPLETED|Overall Study||10
6424509|NCT01010906|7338831|FG002|COMPLETED|Overall Study||10
6424510|NCT01010906|7338832|FG003|COMPLETED|Overall Study||10
6424511|NCT01010906|7338833|FG004|COMPLETED|Overall Study||10
6424512|NCT01010906|7338834|FG005|COMPLETED|Overall Study||10
6424513|NCT01010906|7338829|FG000|NOT COMPLETED|Overall Study||0
6424514|NCT01010906|7338830|FG001|NOT COMPLETED|Overall Study||0
6424515|NCT01010906|7338831|FG002|NOT COMPLETED|Overall Study||0
6424516|NCT01010906|7338832|FG003|NOT COMPLETED|Overall Study||0
6424517|NCT01010906|7338833|FG004|NOT COMPLETED|Overall Study||0
6551560|NCT03478956|7473783|FG000|Started OLE Treatment Phase|Overall Study||11
6651167|NCT02417064|7580624|FG002|COMPLETED|Double-blind Induction Phase (4 Weeks)||107
6651168|NCT02417064|7580622|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
6651169|NCT02417064|7580623|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||19
6651170|NCT02417064|7580624|FG002|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
6651171|NCT02417064|7580622|FG000|STARTED|Follow-up Phase (24 Weeks)||47
6651172|NCT02417064|7580623|FG001|STARTED|Follow-up Phase (24 Weeks)||52
6651173|NCT02417064|7580624|FG002|STARTED|Follow-up Phase (24 Weeks)||69
6651174|NCT02417064|7580622|FG000|COMPLETED|Follow-up Phase (24 Weeks)||8
6651175|NCT02417064|7580623|FG001|COMPLETED|Follow-up Phase (24 Weeks)||10
6651176|NCT02417064|7580624|FG002|COMPLETED|Follow-up Phase (24 Weeks)||18
6651177|NCT02417064|7580622|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||39
6651178|NCT02417064|7580623|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||42
6651179|NCT02417064|7580624|FG002|NOT COMPLETED|Follow-up Phase (24 Weeks)||51
6651180|NCT02417129|7580635|FG000|STARTED|Overall Study||2
6551561|NCT03478956|7473784|FG001|Started OLE Treatment Phase|Overall Study||10
6551562|NCT03478956|7473783|FG000|Completed OLE Treatment Phase|Overall Study||0
6551563|NCT03478956|7473784|FG001|Completed OLE Treatment Phase|Overall Study||0
6551564|NCT03478956|7473783|FG000|Started PML Safety Monitoring Phase|Overall Study||1
6651181|NCT02417129|7580636|FG001|STARTED|Overall Study||0
6651182|NCT02417129|7580635|FG000|COMPLETED|Overall Study||2
6424518|NCT01010906|7338834|FG005|NOT COMPLETED|Overall Study||0
6499472|NCT01418365|7418187|FG000|STARTED|First Intervention||15
6499473|NCT01418365|7418188|FG001|STARTED|First Intervention||15
6499474|NCT01418365|7418187|FG000|COMPLETED|First Intervention||14
6499475|NCT01418365|7418188|FG001|COMPLETED|First Intervention||14
6499476|NCT01418365|7418187|FG000|NOT COMPLETED|First Intervention||1
6499477|NCT01418365|7418188|FG001|NOT COMPLETED|First Intervention||1
6424519|NCT01010932|7338848|FG000|STARTED|Overall Study||222
6424520|NCT01010932|7338848|FG000|COMPLETED|Overall Study||200
6424521|NCT01010932|7338848|FG000|NOT COMPLETED|Overall Study||22
6424522|NCT01010971|7338859|FG000|STARTED|Overall Study||225
6424523|NCT01010971|7338860|FG001|STARTED|Overall Study||226
6424524|NCT01010971|7338861|FG002|STARTED|Overall Study||220
6424525|NCT01010971|7338859|FG000|COMPLETED|Overall Study||222
6424526|NCT01010971|7338860|FG001|COMPLETED|Overall Study||218
6424527|NCT01010971|7338861|FG002|COMPLETED|Overall Study||207
6424528|NCT01010971|7338859|FG000|NOT COMPLETED|Overall Study||3
6424529|NCT01010971|7338860|FG001|NOT COMPLETED|Overall Study||8
6424530|NCT01010971|7338861|FG002|NOT COMPLETED|Overall Study||13
6424531|NCT01010984|7338869|FG000|STARTED|Overall Study||20
6424532|NCT01010984|7338869|FG000|COMPLETED|Overall Study||20
6424533|NCT01010984|7338869|FG000|NOT COMPLETED|Overall Study||0
6424534|NCT01011049|7338878|FG000|STARTED|Overall Study||507
6424535|NCT01011049|7338879|FG001|STARTED|Overall Study||252
6424536|NCT01011049|7338880|FG002|STARTED|Overall Study||243
6424537|NCT01011049|7338881|FG003|STARTED|Overall Study||246
6424538|NCT01011049|7338878|FG000|COMPLETED|Overall Study||506
6424539|NCT01011049|7338879|FG001|COMPLETED|Overall Study||250
6424540|NCT01011049|7338880|FG002|COMPLETED|Overall Study||239
6424541|NCT01011049|7338881|FG003|COMPLETED|Overall Study||246
6424542|NCT01011049|7338878|FG000|NOT COMPLETED|Overall Study||1
6424543|NCT01011049|7338879|FG001|NOT COMPLETED|Overall Study||2
6424544|NCT01011049|7338880|FG002|NOT COMPLETED|Overall Study||4
6424545|NCT01011049|7338881|FG003|NOT COMPLETED|Overall Study||0
6424546|NCT01011075|7338891|FG000|STARTED|Overall Study||34
6424547|NCT01011075|7338891|FG000|COMPLETED|Overall Study||34
6424548|NCT01011075|7338891|FG000|NOT COMPLETED|Overall Study||0
6424549|NCT01011153|7338898|FG000|STARTED|Overall Study||54
6424550|NCT01011153|7338899|FG001|STARTED|Overall Study||75
6424551|NCT01011153|7338900|FG002|STARTED|Overall Study||54
6424552|NCT01011153|7338898|FG000|COMPLETED|Overall Study||46
6424553|NCT01011153|7338899|FG001|COMPLETED|Overall Study||64
6424554|NCT01011153|7338900|FG002|COMPLETED|Overall Study||45
6424555|NCT01011153|7338898|FG000|NOT COMPLETED|Overall Study||8
6424556|NCT01011153|7338899|FG001|NOT COMPLETED|Overall Study||11
6424557|NCT01011153|7338900|FG002|NOT COMPLETED|Overall Study||9
6424558|NCT01011179|7338918|FG000|STARTED|Overall Study||24
6424559|NCT01011179|7338919|FG001|STARTED|Overall Study||22
6424560|NCT01011179|7338918|FG000|COMPLETED|Overall Study||20
6424561|NCT01011179|7338919|FG001|COMPLETED|Overall Study||20
6424562|NCT01011179|7338918|FG000|NOT COMPLETED|Overall Study||4
6424563|NCT01011179|7338919|FG001|NOT COMPLETED|Overall Study||2
6424564|NCT01011218|7338931|FG000|STARTED|Overall Study||9
6424565|NCT01011218|7338932|FG001|STARTED|Overall Study||9
6424566|NCT01011218|7338933|FG002|STARTED|Overall Study||26
6424567|NCT01011218|7338934|FG003|STARTED|Overall Study||26
6424568|NCT01011218|7338931|FG000|COMPLETED|Overall Study||9
6424569|NCT01011218|7338932|FG001|COMPLETED|Overall Study||9
6424570|NCT01011218|7338933|FG002|COMPLETED|Overall Study||26
6424571|NCT01011218|7338934|FG003|COMPLETED|Overall Study||26
6424572|NCT01011218|7338931|FG000|NOT COMPLETED|Overall Study||0
6424573|NCT01011218|7338932|FG001|NOT COMPLETED|Overall Study||0
6424574|NCT01011218|7338933|FG002|NOT COMPLETED|Overall Study||0
6424575|NCT01011218|7338934|FG003|NOT COMPLETED|Overall Study||0
6424576|NCT01011283|7338946|FG000|STARTED|Overall Study||13
6424577|NCT01011283|7338947|FG001|STARTED|Overall Study||13
6424578|NCT01011283|7338946|FG000|COMPLETED|Overall Study||2
6424579|NCT01011283|7338947|FG001|COMPLETED|Overall Study||2
6424580|NCT01011283|7338946|FG000|NOT COMPLETED|Overall Study||11
6424581|NCT01011283|7338947|FG001|NOT COMPLETED|Overall Study||11
6424582|NCT01011309|7338956|FG000|STARTED|Overall Study||14
6424583|NCT01011309|7338957|FG001|STARTED|Overall Study||10
6424584|NCT01011309|7338958|FG002|STARTED|Overall Study||21
6424585|NCT01011309|7338956|FG000|COMPLETED|Overall Study||12
6424586|NCT01011309|7338957|FG001|COMPLETED|Overall Study||7
6424587|NCT01011309|7338958|FG002|COMPLETED|Overall Study||16
6424588|NCT01011309|7338956|FG000|NOT COMPLETED|Overall Study||2
6424589|NCT01011309|7338957|FG001|NOT COMPLETED|Overall Study||3
6651183|NCT02417129|7580636|FG001|COMPLETED|Overall Study||0
6651184|NCT02417129|7580635|FG000|NOT COMPLETED|Overall Study||0
6651185|NCT02417129|7580636|FG001|NOT COMPLETED|Overall Study||0
6651186|NCT02417233|7580645|FG000|STARTED|Overall Study||169
6651187|NCT02417233|7580646|FG001|STARTED|Overall Study||289
6651188|NCT02417233|7580647|FG002|STARTED|Overall Study||298
6651189|NCT02417233|7580645|FG000|COMPLETED|Overall Study||133
6651190|NCT02417233|7580646|FG001|COMPLETED|Overall Study||238
6651191|NCT02417233|7580647|FG002|COMPLETED|Overall Study||239
6651192|NCT02417233|7580645|FG000|NOT COMPLETED|Overall Study||36
6424590|NCT01011309|7338958|FG002|NOT COMPLETED|Overall Study||5
6424591|NCT01011335|7338970|FG000|STARTED|Overall Study||11
6424592|NCT01011335|7338971|FG001|STARTED|Overall Study||12
6651193|NCT02417233|7580646|FG001|NOT COMPLETED|Overall Study||51
6424593|NCT01011335|7338972|FG002|STARTED|Overall Study||12
6424594|NCT01011335|7338973|FG003|STARTED|Overall Study||12
6424595|NCT01011335|7338974|FG004|STARTED|Overall Study||13
6424596|NCT01011335|7338975|FG005|STARTED|Overall Study||12
6424597|NCT01011335|7338976|FG006|STARTED|Overall Study||12
6424598|NCT01011335|7338977|FG007|STARTED|Overall Study||12
6424599|NCT01011335|7338978|FG008|STARTED|Overall Study||12
6424600|NCT01011335|7338979|FG009|STARTED|Overall Study||12
6651194|NCT02417233|7580647|FG002|NOT COMPLETED|Overall Study||59
6424601|NCT01011335|7338980|FG010|STARTED|Overall Study||12
6424602|NCT01011335|7338981|FG011|STARTED|Overall Study||22
6424603|NCT01011335|7338982|FG012|STARTED|Overall Study||22
6424604|NCT01011335|7338970|FG000|COMPLETED|Overall Study||10
6424605|NCT01011335|7338971|FG001|COMPLETED|Overall Study||11
6424606|NCT01011335|7338972|FG002|COMPLETED|Overall Study||11
6424607|NCT01011335|7338973|FG003|COMPLETED|Overall Study||10
6424608|NCT01011335|7338974|FG004|COMPLETED|Overall Study||12
6424609|NCT01011335|7338975|FG005|COMPLETED|Overall Study||11
6424610|NCT01011335|7338976|FG006|COMPLETED|Overall Study||9
6424611|NCT01011335|7338977|FG007|COMPLETED|Overall Study||10
6424612|NCT01011335|7338978|FG008|COMPLETED|Overall Study||10
6424613|NCT01011335|7338979|FG009|COMPLETED|Overall Study||12
6424614|NCT01011335|7338980|FG010|COMPLETED|Overall Study||6
6424615|NCT01011335|7338981|FG011|COMPLETED|Overall Study||21
6424616|NCT01011335|7338982|FG012|COMPLETED|Overall Study||19
6424617|NCT01011335|7338970|FG000|NOT COMPLETED|Overall Study||1
6424618|NCT01011335|7338971|FG001|NOT COMPLETED|Overall Study||1
6424619|NCT01011335|7338972|FG002|NOT COMPLETED|Overall Study||1
6424620|NCT01011335|7338973|FG003|NOT COMPLETED|Overall Study||2
6424621|NCT01011335|7338974|FG004|NOT COMPLETED|Overall Study||1
6424622|NCT01011335|7338975|FG005|NOT COMPLETED|Overall Study||1
6424623|NCT01011335|7338976|FG006|NOT COMPLETED|Overall Study||3
6424624|NCT01011335|7338977|FG007|NOT COMPLETED|Overall Study||2
6424625|NCT01011335|7338978|FG008|NOT COMPLETED|Overall Study||2
6424626|NCT01011335|7338979|FG009|NOT COMPLETED|Overall Study||0
6424627|NCT01011335|7338980|FG010|NOT COMPLETED|Overall Study||6
6424628|NCT01011335|7338981|FG011|NOT COMPLETED|Overall Study||1
6424629|NCT01011335|7338982|FG012|NOT COMPLETED|Overall Study||3
6424630|NCT01011387|7339019|FG000|STARTED|Overall Study||16
6424631|NCT01011387|7339019|FG000|COMPLETED|Overall Study||10
6424632|NCT01011387|7339019|FG000|NOT COMPLETED|Overall Study||6
6424633|NCT01011413|7339025|FG000|STARTED|Overall Study|312 randomised|312
6424634|NCT01011413|7339026|FG001|STARTED|Overall Study|324 randomised|324
6424635|NCT01011413|7339025|FG000|Did Not Start Study Drug|Overall Study||3
6424636|NCT01011413|7339026|FG001|Did Not Start Study Drug|Overall Study||3
6424637|NCT01011413|7339025|FG000|In Modified ITT|Overall Study||309
6424638|NCT01011413|7339026|FG001|In Modified ITT|Overall Study||321
6424639|NCT01011413|7339025|FG000|Died Before Week 48|Overall Study||3
6424640|NCT01011413|7339026|FG001|Died Before Week 48|Overall Study||2
6424641|NCT01011413|7339025|FG000|Lost to Follow up Before w48|Overall Study||3
6424642|NCT01011413|7339026|FG001|Lost to Follow up Before w48|Overall Study||4
6424643|NCT01011413|7339025|FG000|Withdrew Consent Before w48|Overall Study||3
6424644|NCT01011413|7339026|FG001|Withdrew Consent Before w48|Overall Study||3
6424645|NCT01011413|7339025|FG000|Attended w48 Visit|Overall Study||295
6424646|NCT01011413|7339026|FG001|Attended w48 Visit|Overall Study||311
6424647|NCT01011413|7339025|FG000|Died Between Week 48 and 96|Overall Study||2
6651195|NCT02417246|7580658|FG000|STARTED|Phase 1 Brand Name Metoprolol ER||24
6651196|NCT02417246|7580659|FG001|STARTED|Phase 1 Brand Name Metoprolol ER||24
6651197|NCT02417246|7580658|FG000|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
6651198|NCT02417246|7580659|FG001|COMPLETED|Phase 1 Brand Name Metoprolol ER||20
6651199|NCT02417246|7580658|FG000|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
6651200|NCT02417246|7580659|FG001|NOT COMPLETED|Phase 1 Brand Name Metoprolol ER||4
6651201|NCT02417246|7580658|FG000|STARTED|Phase 2 1st Generic Administered||20
6651202|NCT02417246|7580659|FG001|STARTED|Phase 2 1st Generic Administered||20
6651203|NCT02417246|7580658|FG000|COMPLETED|Phase 2 1st Generic Administered||19
6651204|NCT02417246|7580659|FG001|COMPLETED|Phase 2 1st Generic Administered||20
6651205|NCT02417246|7580658|FG000|NOT COMPLETED|Phase 2 1st Generic Administered||1
6651206|NCT02417246|7580659|FG001|NOT COMPLETED|Phase 2 1st Generic Administered||0
6651207|NCT02417246|7580658|FG000|STARTED|Phase 3 Brand Name Metoprolol ER #2||19
6651208|NCT02417246|7580659|FG001|STARTED|Phase 3 Brand Name Metoprolol ER #2||20
6651209|NCT02417246|7580658|FG000|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||18
6651210|NCT02417246|7580659|FG001|COMPLETED|Phase 3 Brand Name Metoprolol ER #2||20
6651211|NCT02417246|7580658|FG000|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||1
6651212|NCT02417246|7580659|FG001|NOT COMPLETED|Phase 3 Brand Name Metoprolol ER #2||0
6651213|NCT02417246|7580658|FG000|STARTED|Phase 4 2nd Generic Administered||18
6651214|NCT02417246|7580659|FG001|STARTED|Phase 4 2nd Generic Administered||20
6651215|NCT02417246|7580658|FG000|COMPLETED|Phase 4 2nd Generic Administered||18
6651216|NCT02417246|7580659|FG001|COMPLETED|Phase 4 2nd Generic Administered||20
6651217|NCT02417246|7580658|FG000|NOT COMPLETED|Phase 4 2nd Generic Administered||0
6651218|NCT02417246|7580659|FG001|NOT COMPLETED|Phase 4 2nd Generic Administered||0
6651219|NCT02417376|7580669|FG000|STARTED|Overall Study||35
6651220|NCT02417376|7580670|FG001|STARTED|Overall Study||35
6651221|NCT02417376|7580669|FG000|COMPLETED|Overall Study||30
6651222|NCT02417376|7580670|FG001|COMPLETED|Overall Study||25
6651223|NCT02417376|7580669|FG000|NOT COMPLETED|Overall Study||5
6651224|NCT02417376|7580670|FG001|NOT COMPLETED|Overall Study||10
6651225|NCT02417441|7580678|FG000|STARTED|Overall Study||645
6651226|NCT02417441|7580679|FG001|STARTED|Overall Study||325
6651227|NCT02417441|7580678|FG000|COMPLETED|Overall Study||593
6651228|NCT02417441|7580679|FG001|COMPLETED|Overall Study||306
6651229|NCT02417441|7580678|FG000|NOT COMPLETED|Overall Study||52
6424648|NCT01011413|7339026|FG001|Died Between Week 48 and 96|Overall Study||3
6424649|NCT01011413|7339025|FG000|Withdrew Consent Between Week 48 and 96|Overall Study||2
6424650|NCT01011413|7339026|FG001|Withdrew Consent Between Week 48 and 96|Overall Study||6
6551565|NCT03478956|7473784|FG001|Started PML Safety Monitoring Phase|Overall Study||2
6551566|NCT03478956|7473783|FG000|COMPLETED|Overall Study||0
6551567|NCT03478956|7473784|FG001|COMPLETED|Overall Study||0
6424651|NCT01011413|7339025|FG000|Lost to Follow-up Between Week 48 and 96|Overall Study||10
6424652|NCT01011413|7339026|FG001|Lost to Follow-up Between Week 48 and 96|Overall Study||4
6424653|NCT01011413|7339025|FG000|COMPLETED|Overall Study||286
6424654|NCT01011413|7339026|FG001|COMPLETED|Overall Study||299
6424655|NCT01011413|7339025|FG000|NOT COMPLETED|Overall Study||26
6424656|NCT01011413|7339026|FG001|NOT COMPLETED|Overall Study||25
6424657|NCT01011439|7339039|FG000|STARTED|Overall Study||72
6424658|NCT01011439|7339039|FG000|COMPLETED|Overall Study||15
6424659|NCT01011439|7339039|FG000|NOT COMPLETED|Overall Study||57
6424660|NCT01011465|7339052|FG000|STARTED|Overall Study||36
6424661|NCT01011465|7339053|FG001|STARTED|Overall Study||20
6424662|NCT01011465|7339054|FG002|STARTED|Overall Study||36
6424663|NCT01011465|7339055|FG003|STARTED|Overall Study||18
6424664|NCT01011465|7339056|FG004|STARTED|Overall Study||47
6424665|NCT01011465|7339057|FG005|STARTED|Overall Study||29
6424666|NCT01011465|7339058|FG006|STARTED|Overall Study||52
6424667|NCT01011465|7339059|FG007|STARTED|Overall Study||32
6424668|NCT01011465|7339052|FG000|COMPLETED|Overall Study||34
6424669|NCT01011465|7339053|FG001|COMPLETED|Overall Study||19
6424670|NCT01011465|7339054|FG002|COMPLETED|Overall Study||36
6424671|NCT01011465|7339055|FG003|COMPLETED|Overall Study||18
6424672|NCT01011465|7339056|FG004|COMPLETED|Overall Study||46
6424673|NCT01011465|7339057|FG005|COMPLETED|Overall Study||29
6424674|NCT01011465|7339058|FG006|COMPLETED|Overall Study||51
6424675|NCT01011465|7339059|FG007|COMPLETED|Overall Study||32
6424676|NCT01011465|7339052|FG000|NOT COMPLETED|Overall Study||2
6424677|NCT01011465|7339053|FG001|NOT COMPLETED|Overall Study||1
6424678|NCT01011465|7339054|FG002|NOT COMPLETED|Overall Study||0
6424679|NCT01011465|7339055|FG003|NOT COMPLETED|Overall Study||0
6424680|NCT01011465|7339056|FG004|NOT COMPLETED|Overall Study||1
6424681|NCT01011465|7339057|FG005|NOT COMPLETED|Overall Study||0
6424682|NCT01011465|7339058|FG006|NOT COMPLETED|Overall Study||1
6424683|NCT01011465|7339059|FG007|NOT COMPLETED|Overall Study||0
6424684|NCT01011556|7339079|FG000|STARTED|Overall Study||58
6424685|NCT01011556|7339080|FG001|STARTED|Overall Study||56
6424686|NCT01011556|7339081|FG002|STARTED|Overall Study||55
6424687|NCT01011556|7339082|FG003|STARTED|Overall Study||64
6424688|NCT01011556|7339079|FG000|Received at Least 1 Dose of Study Drug|Overall Study||57
6424689|NCT01011556|7339080|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
6424690|NCT01011556|7339081|FG002|Received at Least 1 Dose of Study Drug|Overall Study||54
6424691|NCT01011556|7339082|FG003|Received at Least 1 Dose of Study Drug|Overall Study||64
6424692|NCT01011556|7339079|FG000|COMPLETED|Overall Study||52
6424693|NCT01011556|7339080|FG001|COMPLETED|Overall Study||48
6424694|NCT01011556|7339081|FG002|COMPLETED|Overall Study||45
6424695|NCT01011556|7339082|FG003|COMPLETED|Overall Study||51
6424696|NCT01011556|7339079|FG000|NOT COMPLETED|Overall Study||6
6424697|NCT01011556|7339080|FG001|NOT COMPLETED|Overall Study||8
6424698|NCT01011556|7339081|FG002|NOT COMPLETED|Overall Study||10
6424699|NCT01011556|7339082|FG003|NOT COMPLETED|Overall Study||13
6424700|NCT01011673|7339097|FG000|STARTED|Randomized||62
6424701|NCT01011673|7339098|FG001|STARTED|Randomized||61
6424702|NCT01011673|7339097|FG000|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
6424703|NCT01011673|7339098|FG001|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
6424704|NCT01011673|7339097|FG000|NOT COMPLETED|Randomized||2
6424705|NCT01011673|7339098|FG001|NOT COMPLETED|Randomized||1
6424706|NCT01011673|7339097|FG000|STARTED|Emergency Department Portion||60
6424707|NCT01011673|7339098|FG001|STARTED|Emergency Department Portion||60
6424708|NCT01011673|7339097|FG000|COMPLETED|Emergency Department Portion||60
6424709|NCT01011673|7339098|FG001|COMPLETED|Emergency Department Portion||60
6424710|NCT01011673|7339097|FG000|NOT COMPLETED|Emergency Department Portion||0
6424711|NCT01011673|7339098|FG001|NOT COMPLETED|Emergency Department Portion||0
6424712|NCT01011673|7339097|FG000|STARTED|24 Hour Follow-up||60
6424713|NCT01011673|7339098|FG001|STARTED|24 Hour Follow-up||60
6424714|NCT01011673|7339097|FG000|COMPLETED|24 Hour Follow-up||57
6424715|NCT01011673|7339098|FG001|COMPLETED|24 Hour Follow-up||57
6424716|NCT01011673|7339097|FG000|NOT COMPLETED|24 Hour Follow-up||3
6424717|NCT01011673|7339098|FG001|NOT COMPLETED|24 Hour Follow-up||3
6424718|NCT01011738|7339107|FG000|STARTED|Overall Study||877
6424719|NCT01011738|7339108|FG001|STARTED|Overall Study||912
6424720|NCT01011738|7339109|FG002|STARTED|Overall Study||53
6424721|NCT01011738|7339107|FG000|COMPLETED|Overall Study||553
6424722|NCT01011738|7339108|FG001|COMPLETED|Overall Study||618
6424723|NCT01011738|7339109|FG002|COMPLETED|Overall Study||36
6424724|NCT01011738|7339107|FG000|NOT COMPLETED|Overall Study||324
6424725|NCT01011738|7339108|FG001|NOT COMPLETED|Overall Study||294
6424726|NCT01011738|7339109|FG002|NOT COMPLETED|Overall Study||17
6424727|NCT01011816|7339120|FG000|STARTED|26-Week Primary Endpoint||164
6424728|NCT01011816|7339121|FG001|STARTED|26-Week Primary Endpoint||56
6424729|NCT01011816|7339120|FG000|COMPLETED|26-Week Primary Endpoint||157
6424730|NCT01011816|7339121|FG001|COMPLETED|26-Week Primary Endpoint||54
6424731|NCT01011816|7339120|FG000|NOT COMPLETED|26-Week Primary Endpoint||7
6424732|NCT01011816|7339121|FG001|NOT COMPLETED|26-Week Primary Endpoint||2
6424733|NCT01011816|7339120|FG000|STARTED|78-Week Extended Follow-up||157
6424734|NCT01011816|7339121|FG001|STARTED|78-Week Extended Follow-up||54
6424735|NCT01011816|7339120|FG000|COMPLETED|78-Week Extended Follow-up||85
6651230|NCT02417441|7580679|FG001|NOT COMPLETED|Overall Study||19
6651231|NCT02417532|7580686|FG000|STARTED|Overall Study||56
6651232|NCT02417532|7580686|FG000|COMPLETED|Overall Study||56
6651233|NCT02417532|7580686|FG000|NOT COMPLETED|Overall Study||0
6651234|NCT02417753|7580692|FG000|STARTED|Overall Study||1
6651235|NCT02417753|7580692|FG000|COMPLETED|Overall Study||0
6651236|NCT02417753|7580692|FG000|NOT COMPLETED|Overall Study||1
6424736|NCT01011816|7339121|FG001|COMPLETED|78-Week Extended Follow-up||26
6424737|NCT01011816|7339120|FG000|NOT COMPLETED|78-Week Extended Follow-up||72
6424738|NCT01011816|7339121|FG001|NOT COMPLETED|78-Week Extended Follow-up||28
6424739|NCT01011829|7339131|FG000|STARTED|Overall Study||10
6424740|NCT01011829|7339132|FG001|STARTED|Overall Study||10
6424741|NCT01011829|7339131|FG000|COMPLETED|Overall Study||6
6424742|NCT01011829|7339132|FG001|COMPLETED|Overall Study||1
6424743|NCT01011829|7339131|FG000|NOT COMPLETED|Overall Study||4
6424744|NCT01011829|7339132|FG001|NOT COMPLETED|Overall Study||9
6424745|NCT01011868|7339141|FG000|STARTED|After Week 18 Follow-up||170
6424746|NCT01011868|7339142|FG001|STARTED|After Week 18 Follow-up||169
6424747|NCT01011868|7339143|FG002|STARTED|After Week 18 Follow-up||155
6424748|NCT01011868|7339141|FG000|COMPLETED|After Week 18 Follow-up||147
6424749|NCT01011868|7339142|FG001|COMPLETED|After Week 18 Follow-up||153
6424750|NCT01011868|7339143|FG002|COMPLETED|After Week 18 Follow-up||129
6424751|NCT01011868|7339141|FG000|NOT COMPLETED|After Week 18 Follow-up||23
6424752|NCT01011868|7339142|FG001|NOT COMPLETED|After Week 18 Follow-up||16
6424753|NCT01011868|7339143|FG002|NOT COMPLETED|After Week 18 Follow-up||26
6424754|NCT01011868|7339141|FG000|STARTED|After Week 78 Follow-up||170
6424755|NCT01011868|7339142|FG001|STARTED|After Week 78 Follow-up||169
6424756|NCT01011868|7339143|FG002|STARTED|After Week 78 Follow-up||155
6424757|NCT01011868|7339141|FG000|COMPLETED|After Week 78 Follow-up||118
6424758|NCT01011868|7339142|FG001|COMPLETED|After Week 78 Follow-up||131
6424759|NCT01011868|7339143|FG002|COMPLETED|After Week 78 Follow-up||111
6424760|NCT01011868|7339141|FG000|NOT COMPLETED|After Week 78 Follow-up||52
6424761|NCT01011868|7339142|FG001|NOT COMPLETED|After Week 78 Follow-up||38
6424762|NCT01011868|7339143|FG002|NOT COMPLETED|After Week 78 Follow-up||44
6424763|NCT01011894|7339151|FG000|STARTED|Overall Study||26
6424764|NCT01011894|7339151|FG000|COMPLETED|Overall Study||26
6424765|NCT01011894|7339151|FG000|NOT COMPLETED|Overall Study||0
6424766|NCT01011907|7339157|FG000|STARTED|Overall Study||31
6424767|NCT01011907|7339158|FG001|STARTED|Overall Study||33
6424768|NCT01011907|7339157|FG000|COMPLETED|Overall Study||17
6424769|NCT01011907|7339158|FG001|COMPLETED|Overall Study||18
6424770|NCT01011907|7339157|FG000|NOT COMPLETED|Overall Study||14
6424771|NCT01011907|7339158|FG001|NOT COMPLETED|Overall Study||15
6424772|NCT01011933|7339164|FG000|STARTED|Overall Study|total enrolled|54
6424773|NCT01011933|7339164|FG000|COMPLETED|Overall Study|total eligible and evaluable|50
6424774|NCT01011933|7339164|FG000|NOT COMPLETED|Overall Study||4
6424775|NCT01011946|7339174|FG000|STARTED|Overall Study||36
6424776|NCT01011946|7339174|FG000|COMPLETED|Overall Study||33
6424777|NCT01011946|7339174|FG000|NOT COMPLETED|Overall Study||3
6424778|NCT01012037|7339181|FG000|STARTED|Overall Study||44
6424779|NCT01012037|7339182|FG001|STARTED|Overall Study||223
6424780|NCT01012037|7339183|FG002|STARTED|Overall Study||224
6424781|NCT01012037|7339181|FG000|COMPLETED|Overall Study||43
6424782|NCT01012037|7339182|FG001|COMPLETED|Overall Study||207
6424783|NCT01012037|7339183|FG002|COMPLETED|Overall Study||214
6424784|NCT01012037|7339181|FG000|NOT COMPLETED|Overall Study||1
6424785|NCT01012037|7339182|FG001|NOT COMPLETED|Overall Study||16
6424786|NCT01012037|7339183|FG002|NOT COMPLETED|Overall Study||10
6424787|NCT01012089|7339193|FG000|STARTED|Overall Study||6
6424788|NCT01012089|7339193|FG000|COMPLETED|Overall Study||6
6424789|NCT01012089|7339193|FG000|NOT COMPLETED|Overall Study||0
6424790|NCT01012219|7339199|FG000|STARTED|Period 1|Number randomized|36
6424791|NCT01012219|7339199|FG000|COMPLETED|Period 1||35
6424792|NCT01012219|7339199|FG000|NOT COMPLETED|Period 1||1
6424793|NCT01012219|7339199|FG000|STARTED|Period 2|Number who completed Period 1|35
6424794|NCT01012219|7339199|FG000|COMPLETED|Period 2||34
6424795|NCT01012219|7339199|FG000|NOT COMPLETED|Period 2||1
6424796|NCT01012219|7339199|FG000|STARTED|Period 3|of the 36 who started Period 1|20
6424797|NCT01012219|7339199|FG000|COMPLETED|Period 3||20
6424798|NCT01012219|7339199|FG000|NOT COMPLETED|Period 3||0
6424799|NCT01012245|7339210|FG000|STARTED|Overall Study||28812
6424800|NCT01012245|7339210|FG000|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
6424801|NCT01012245|7339210|FG000|NOT COMPLETED|Overall Study||2427
6424802|NCT01012258|7339221|FG000|STARTED|Overall Study||66
6424803|NCT01012258|7339221|FG000|COMPLETED|Overall Study||0
6424804|NCT01012258|7339221|FG000|NOT COMPLETED|Overall Study||66
6424805|NCT01012297|7339228|FG000|STARTED|Overall Study||54
6424806|NCT01012297|7339229|FG001|STARTED|Overall Study||53
6424807|NCT01012297|7339228|FG000|COMPLETED|Overall Study||54
6424808|NCT01012297|7339229|FG001|COMPLETED|Overall Study||53
6424809|NCT01012297|7339228|FG000|NOT COMPLETED|Overall Study||0
6651237|NCT02417831|7580696|FG000|STARTED|Period 1: Treatment Period 1 + Washout||17
6651238|NCT02417831|7580697|FG001|STARTED|Period 1: Treatment Period 1 + Washout||17
6424810|NCT01012297|7339229|FG001|NOT COMPLETED|Overall Study||0
6424811|NCT01012323|7339235|FG000|STARTED|Overall Study||51
6424812|NCT01012323|7339235|FG000|COMPLETED|Overall Study||50
6651239|NCT02417831|7580696|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||17
6424813|NCT01012323|7339235|FG000|NOT COMPLETED|Overall Study||1
6424814|NCT01012336|7339239|FG000|STARTED|Overall Study||85
6424815|NCT01012336|7339239|FG000|COMPLETED|Overall Study||85
6424816|NCT01012336|7339239|FG000|NOT COMPLETED|Overall Study||0
6424817|NCT01012362|7339248|FG000|STARTED|Overall Study||9
6424818|NCT01012362|7339249|FG001|STARTED|Overall Study||6
6424819|NCT01012362|7339250|FG002|STARTED|Overall Study||3
6424820|NCT01012362|7339251|FG003|STARTED|Overall Study||4
6424821|NCT01012362|7339252|FG004|STARTED|Overall Study||9
6424822|NCT01012362|7339248|FG000|COMPLETED|Overall Study||9
6424823|NCT01012362|7339249|FG001|COMPLETED|Overall Study||6
6424824|NCT01012362|7339250|FG002|COMPLETED|Overall Study||3
6424825|NCT01012362|7339251|FG003|COMPLETED|Overall Study||4
6424826|NCT01012362|7339252|FG004|COMPLETED|Overall Study||9
6424827|NCT01012362|7339248|FG000|NOT COMPLETED|Overall Study||0
6424828|NCT01012362|7339249|FG001|NOT COMPLETED|Overall Study||0
6424829|NCT01012362|7339250|FG002|NOT COMPLETED|Overall Study||0
6424830|NCT01012362|7339251|FG003|NOT COMPLETED|Overall Study||0
6551568|NCT03478956|7473783|FG000|NOT COMPLETED|Overall Study||12
6551569|NCT03478956|7473784|FG001|NOT COMPLETED|Overall Study||12
6562757|NCT01803074|7485712|FG013|COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6424831|NCT01012362|7339252|FG004|NOT COMPLETED|Overall Study||0
6424832|NCT01012388|7339268|FG000|STARTED|Overall Study||100
6424833|NCT01012388|7339268|FG000|COMPLETED|Overall Study||100
6424834|NCT01012388|7339268|FG000|NOT COMPLETED|Overall Study||0
6424835|NCT01012440|7339272|FG000|STARTED|Overall Study||5
6424836|NCT01012440|7339272|FG000|COMPLETED|Overall Study||3
6424837|NCT01012440|7339272|FG000|NOT COMPLETED|Overall Study||2
6424838|NCT01012492|7339276|FG000|STARTED|Overall Study||10
6424839|NCT01012492|7339276|FG000|COMPLETED|Overall Study||10
6424840|NCT01012492|7339276|FG000|NOT COMPLETED|Overall Study||0
6424841|NCT01012622|7339280|FG000|STARTED|Overall Study||142
6424842|NCT01012622|7339280|FG000|COMPLETED|Overall Study||111
6424843|NCT01012622|7339280|FG000|NOT COMPLETED|Overall Study||31
6424844|NCT01012661|7339284|FG000|STARTED|Overall Study||50
6562758|NCT01803074|7485699|FG000|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562759|NCT01803074|7485700|FG001|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562760|NCT01803074|7485701|FG002|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6424845|NCT01012661|7339284|FG000|COMPLETED|Overall Study||50
6424846|NCT01012661|7339284|FG000|NOT COMPLETED|Overall Study||0
6424847|NCT01012674|7339290|FG000|STARTED|Overall Study||211
6424848|NCT01012674|7339290|FG000|COMPLETED|Overall Study||187
6424849|NCT01012674|7339290|FG000|NOT COMPLETED|Overall Study||24
6424850|NCT01012713|7339298|FG000|STARTED|Overall Study||30
6424851|NCT01012713|7339298|FG000|COMPLETED|Overall Study||27
6424852|NCT01012713|7339298|FG000|NOT COMPLETED|Overall Study||3
6424853|NCT01012739|7339303|FG000|STARTED|Treatment Period 1||9
6424854|NCT01012739|7339304|FG001|STARTED|Treatment Period 1||8
6424855|NCT01012739|7339305|FG002|STARTED|Treatment Period 1||9
6651240|NCT02417831|7580697|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||17
6651241|NCT02417831|7580696|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
6651242|NCT02417831|7580697|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
6651243|NCT02417831|7580696|FG000|STARTED|Period 2: Treatment Period 2 + Washout||17
6651244|NCT02417831|7580697|FG001|STARTED|Period 2: Treatment Period 2 + Washout||17
6424856|NCT01012739|7339306|FG003|STARTED|Treatment Period 1||9
6424857|NCT01012739|7339303|FG000|COMPLETED|Treatment Period 1||9
6424858|NCT01012739|7339304|FG001|COMPLETED|Treatment Period 1||8
6424859|NCT01012739|7339305|FG002|COMPLETED|Treatment Period 1||9
6424860|NCT01012739|7339306|FG003|COMPLETED|Treatment Period 1||8
6562761|NCT01803074|7485702|FG003|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562762|NCT01803074|7485703|FG004|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562763|NCT01803074|7485704|FG005|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562764|NCT01803074|7485705|FG006|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562765|NCT01803074|7485706|FG007|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562766|NCT01803074|7485707|FG008|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562767|NCT01803074|7485708|FG009|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562768|NCT01803074|7485709|FG010|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562769|NCT01803074|7485710|FG011|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6424861|NCT01012739|7339303|FG000|NOT COMPLETED|Treatment Period 1||0
6424862|NCT01012739|7339304|FG001|NOT COMPLETED|Treatment Period 1||0
6424863|NCT01012739|7339305|FG002|NOT COMPLETED|Treatment Period 1||0
6424864|NCT01012739|7339306|FG003|NOT COMPLETED|Treatment Period 1||1
6424865|NCT01012739|7339303|FG000|STARTED|Treatment Period 2||9
6424866|NCT01012739|7339304|FG001|STARTED|Treatment Period 2||8
6424867|NCT01012739|7339305|FG002|STARTED|Treatment Period 2||9
6424868|NCT01012739|7339306|FG003|STARTED|Treatment Period 2||8
6424869|NCT01012739|7339303|FG000|COMPLETED|Treatment Period 2||9
6424870|NCT01012739|7339304|FG001|COMPLETED|Treatment Period 2||8
6424871|NCT01012739|7339305|FG002|COMPLETED|Treatment Period 2||9
6424872|NCT01012739|7339306|FG003|COMPLETED|Treatment Period 2||7
6424873|NCT01012739|7339303|FG000|NOT COMPLETED|Treatment Period 2||0
6424874|NCT01012739|7339304|FG001|NOT COMPLETED|Treatment Period 2||0
6424875|NCT01012739|7339305|FG002|NOT COMPLETED|Treatment Period 2||0
6424876|NCT01012739|7339306|FG003|NOT COMPLETED|Treatment Period 2||1
6424877|NCT01012739|7339303|FG000|STARTED|Treatment Period 3||9
6424878|NCT01012739|7339304|FG001|STARTED|Treatment Period 3||8
6424879|NCT01012739|7339305|FG002|STARTED|Treatment Period 3||9
6424880|NCT01012739|7339306|FG003|STARTED|Treatment Period 3||7
6424881|NCT01012739|7339303|FG000|COMPLETED|Treatment Period 3||9
6424882|NCT01012739|7339304|FG001|COMPLETED|Treatment Period 3||8
6424883|NCT01012739|7339305|FG002|COMPLETED|Treatment Period 3||9
6424884|NCT01012739|7339306|FG003|COMPLETED|Treatment Period 3||7
6424885|NCT01012739|7339303|FG000|NOT COMPLETED|Treatment Period 3||0
6424886|NCT01012739|7339304|FG001|NOT COMPLETED|Treatment Period 3||0
6424887|NCT01012739|7339305|FG002|NOT COMPLETED|Treatment Period 3||0
6424888|NCT01012739|7339306|FG003|NOT COMPLETED|Treatment Period 3||0
6424889|NCT01012739|7339303|FG000|STARTED|Treatment Period 4||9
6424890|NCT01012739|7339304|FG001|STARTED|Treatment Period 4||8
6424891|NCT01012739|7339305|FG002|STARTED|Treatment Period 4||9
6424892|NCT01012739|7339306|FG003|STARTED|Treatment Period 4||7
6424893|NCT01012739|7339303|FG000|COMPLETED|Treatment Period 4||9
6424894|NCT01012739|7339304|FG001|COMPLETED|Treatment Period 4||8
6424895|NCT01012739|7339305|FG002|COMPLETED|Treatment Period 4||9
6424896|NCT01012739|7339306|FG003|COMPLETED|Treatment Period 4||7
6424897|NCT01012739|7339303|FG000|NOT COMPLETED|Treatment Period 4||0
6424898|NCT01012739|7339304|FG001|NOT COMPLETED|Treatment Period 4||0
6424899|NCT01012739|7339305|FG002|NOT COMPLETED|Treatment Period 4||0
6424900|NCT01012739|7339306|FG003|NOT COMPLETED|Treatment Period 4||0
6424901|NCT01012765|7339317|FG000|STARTED|Treatment Period 1||20
6424902|NCT01012765|7339318|FG001|STARTED|Treatment Period 1||21
6424903|NCT01012765|7339319|FG002|STARTED|Treatment Period 1||23
6424904|NCT01012765|7339320|FG003|STARTED|Treatment Period 1||18
6424905|NCT01012765|7339321|FG004|STARTED|Treatment Period 1||22
6424906|NCT01012765|7339322|FG005|STARTED|Treatment Period 1||25
6424907|NCT01012765|7339317|FG000|COMPLETED|Treatment Period 1||17
6424908|NCT01012765|7339318|FG001|COMPLETED|Treatment Period 1||21
6424909|NCT01012765|7339319|FG002|COMPLETED|Treatment Period 1||21
6424910|NCT01012765|7339320|FG003|COMPLETED|Treatment Period 1||15
6424911|NCT01012765|7339321|FG004|COMPLETED|Treatment Period 1||19
6424912|NCT01012765|7339322|FG005|COMPLETED|Treatment Period 1||25
6424913|NCT01012765|7339317|FG000|NOT COMPLETED|Treatment Period 1||3
6424914|NCT01012765|7339318|FG001|NOT COMPLETED|Treatment Period 1||0
6424915|NCT01012765|7339319|FG002|NOT COMPLETED|Treatment Period 1||2
6424916|NCT01012765|7339320|FG003|NOT COMPLETED|Treatment Period 1||3
6424917|NCT01012765|7339321|FG004|NOT COMPLETED|Treatment Period 1||3
6424918|NCT01012765|7339322|FG005|NOT COMPLETED|Treatment Period 1||0
6424919|NCT01012765|7339317|FG000|STARTED|Treatment Period 2||17
6424920|NCT01012765|7339318|FG001|STARTED|Treatment Period 2||21
6424921|NCT01012765|7339319|FG002|STARTED|Treatment Period 2||21
6424922|NCT01012765|7339320|FG003|STARTED|Treatment Period 2||15
6424923|NCT01012765|7339321|FG004|STARTED|Treatment Period 2||19
6424924|NCT01012765|7339322|FG005|STARTED|Treatment Period 2||25
6424925|NCT01012765|7339317|FG000|COMPLETED|Treatment Period 2||16
6424926|NCT01012765|7339318|FG001|COMPLETED|Treatment Period 2||19
6424927|NCT01012765|7339319|FG002|COMPLETED|Treatment Period 2||18
6424928|NCT01012765|7339320|FG003|COMPLETED|Treatment Period 2||15
6424929|NCT01012765|7339321|FG004|COMPLETED|Treatment Period 2||18
6424930|NCT01012765|7339322|FG005|COMPLETED|Treatment Period 2||24
6424931|NCT01012765|7339317|FG000|NOT COMPLETED|Treatment Period 2||1
6424932|NCT01012765|7339318|FG001|NOT COMPLETED|Treatment Period 2||2
6424933|NCT01012765|7339319|FG002|NOT COMPLETED|Treatment Period 2||3
6424934|NCT01012765|7339320|FG003|NOT COMPLETED|Treatment Period 2||0
6424935|NCT01012765|7339321|FG004|NOT COMPLETED|Treatment Period 2||1
6424936|NCT01012765|7339322|FG005|NOT COMPLETED|Treatment Period 2||1
6424937|NCT01012765|7339317|FG000|STARTED|Treatment Period 3||16
6424938|NCT01012765|7339318|FG001|STARTED|Treatment Period 3||19
6424939|NCT01012765|7339319|FG002|STARTED|Treatment Period 3||18
6424940|NCT01012765|7339320|FG003|STARTED|Treatment Period 3||15
6424941|NCT01012765|7339321|FG004|STARTED|Treatment Period 3||18
6424942|NCT01012765|7339322|FG005|STARTED|Treatment Period 3||24
6424943|NCT01012765|7339317|FG000|COMPLETED|Treatment Period 3||16
6651245|NCT02417831|7580696|FG000|COMPLETED|Period 2: Treatment Period 2 + Washout||17
6651246|NCT02417831|7580697|FG001|COMPLETED|Period 2: Treatment Period 2 + Washout||17
6651247|NCT02417831|7580696|FG000|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
6651248|NCT02417831|7580697|FG001|NOT COMPLETED|Period 2: Treatment Period 2 + Washout||0
6651249|NCT02417844|7580703|FG000|STARTED|Overall Study||17
6651250|NCT02417844|7580704|FG001|STARTED|Overall Study||17
6651251|NCT02417844|7580703|FG000|COMPLETED|Overall Study||17
6651252|NCT02417844|7580704|FG001|COMPLETED|Overall Study||17
6651253|NCT02417844|7580703|FG000|NOT COMPLETED|Overall Study||0
6651254|NCT02417844|7580704|FG001|NOT COMPLETED|Overall Study||0
6651255|NCT02417935|7580712|FG000|STARTED|Treatment Period||151
6651256|NCT02417935|7580713|FG001|STARTED|Treatment Period||153
6424944|NCT01012765|7339318|FG001|COMPLETED|Treatment Period 3||19
6424945|NCT01012765|7339319|FG002|COMPLETED|Treatment Period 3||18
6651257|NCT02417935|7580712|FG000|Received at Least One Dose of Study Drug|Treatment Period||151
6424946|NCT01012765|7339320|FG003|COMPLETED|Treatment Period 3||15
6424947|NCT01012765|7339321|FG004|COMPLETED|Treatment Period 3||18
6424948|NCT01012765|7339322|FG005|COMPLETED|Treatment Period 3||24
6424949|NCT01012765|7339317|FG000|NOT COMPLETED|Treatment Period 3||0
6424950|NCT01012765|7339318|FG001|NOT COMPLETED|Treatment Period 3||0
6424951|NCT01012765|7339319|FG002|NOT COMPLETED|Treatment Period 3||0
6424952|NCT01012765|7339320|FG003|NOT COMPLETED|Treatment Period 3||0
6424953|NCT01012765|7339321|FG004|NOT COMPLETED|Treatment Period 3||0
6424954|NCT01012765|7339322|FG005|NOT COMPLETED|Treatment Period 3||0
6424955|NCT01012921|7339332|FG000|STARTED|Overall Study||57
6424956|NCT01012921|7339333|FG001|STARTED|Overall Study||60
6424957|NCT01012921|7339332|FG000|COMPLETED|Overall Study||47
6424958|NCT01012921|7339333|FG001|COMPLETED|Overall Study||47
6424959|NCT01012921|7339332|FG000|NOT COMPLETED|Overall Study||10
6424960|NCT01012921|7339333|FG001|NOT COMPLETED|Overall Study||13
6424961|NCT01012947|7339344|FG000|STARTED|Overall Study||212
6424962|NCT01012947|7339345|FG001|STARTED|Overall Study||215
6424963|NCT01012947|7339346|FG002|STARTED|Overall Study||241
6424964|NCT01012947|7339347|FG003|STARTED|Overall Study||211
6424965|NCT01012947|7339348|FG004|STARTED|Overall Study||236
6424966|NCT01012947|7339344|FG000|COMPLETED|Overall Study||81
6424967|NCT01012947|7339345|FG001|COMPLETED|Overall Study||80
6424968|NCT01012947|7339346|FG002|COMPLETED|Overall Study||111
6424969|NCT01012947|7339347|FG003|COMPLETED|Overall Study||93
6424970|NCT01012947|7339348|FG004|COMPLETED|Overall Study||94
6424971|NCT01012947|7339344|FG000|NOT COMPLETED|Overall Study||131
6424972|NCT01012947|7339345|FG001|NOT COMPLETED|Overall Study||135
6424973|NCT01012947|7339346|FG002|NOT COMPLETED|Overall Study||130
6424974|NCT01012947|7339347|FG003|NOT COMPLETED|Overall Study||118
6424975|NCT01012947|7339348|FG004|NOT COMPLETED|Overall Study||142
6424976|NCT01012973|7339362|FG000|STARTED|Overall Study||106
6424977|NCT01012973|7339363|FG001|STARTED|Overall Study||71
6424978|NCT01012973|7339362|FG000|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
6424979|NCT01012973|7339363|FG001|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
6424980|NCT01012973|7339362|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
6424981|NCT01012973|7339363|FG001|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
6424982|NCT01012973|7339362|FG000|Completed Week 24, From FAS|Overall Study||97
6424983|NCT01012973|7339363|FG001|Completed Week 24, From FAS|Overall Study||57
6424984|NCT01012973|7339362|FG000|Completed Week 52, From FAS|Overall Study||91
6424985|NCT01012973|7339363|FG001|Completed Week 52, From FAS|Overall Study||52
6424986|NCT01012973|7339362|FG000|COMPLETED|Overall Study||90
6424987|NCT01012973|7339363|FG001|COMPLETED|Overall Study||52
6424988|NCT01012973|7339362|FG000|NOT COMPLETED|Overall Study||16
6424989|NCT01012973|7339363|FG001|NOT COMPLETED|Overall Study||19
6424990|NCT01012999|7339373|FG000|STARTED|Overall Study||16
6424991|NCT01012999|7339373|FG000|COMPLETED|Overall Study||15
6424992|NCT01012999|7339373|FG000|NOT COMPLETED|Overall Study||1
6424993|NCT01013194|7339379|FG000|STARTED|Overall Study||9
6424994|NCT01013194|7339380|FG001|STARTED|Overall Study||16
6424995|NCT01013194|7339379|FG000|COMPLETED|Overall Study|Consecutive patients|9
6424996|NCT01013194|7339380|FG001|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
6424997|NCT01013194|7339379|FG000|NOT COMPLETED|Overall Study||0
6424998|NCT01013194|7339380|FG001|NOT COMPLETED|Overall Study||0
6424999|NCT01013207|7339390|FG000|STARTED|CPAP Pre Nexus (S9)||50
6425000|NCT01013207|7339390|FG000|COMPLETED|CPAP Pre Nexus (S9)||50
6425001|NCT01013207|7339390|FG000|NOT COMPLETED|CPAP Pre Nexus (S9)||0
6425002|NCT01013207|7339390|FG000|STARTED|Nexus (S9)||50
6425003|NCT01013207|7339390|FG000|COMPLETED|Nexus (S9)||50
6425004|NCT01013207|7339390|FG000|NOT COMPLETED|Nexus (S9)||0
6425005|NCT01013207|7339390|FG000|STARTED|CPAP Post Nexus (S9)||50
6425006|NCT01013207|7339390|FG000|COMPLETED|CPAP Post Nexus (S9)||44
6425007|NCT01013207|7339390|FG000|NOT COMPLETED|CPAP Post Nexus (S9)||6
6425008|NCT01013285|7339396|FG000|STARTED|Overall Study||70
6425009|NCT01013285|7339397|FG001|STARTED|Overall Study||110
6425010|NCT01013285|7339396|FG000|COMPLETED|Overall Study||22
6425011|NCT01013285|7339397|FG001|COMPLETED|Overall Study||21
6425012|NCT01013285|7339396|FG000|NOT COMPLETED|Overall Study||48
6651258|NCT02417935|7580713|FG001|Received at Least One Dose of Study Drug|Treatment Period||152
6651259|NCT02417935|7580712|FG000|COMPLETED|Treatment Period||130
6651260|NCT02417935|7580713|FG001|COMPLETED|Treatment Period||137
6651261|NCT02417935|7580712|FG000|NOT COMPLETED|Treatment Period||21
6651262|NCT02417935|7580713|FG001|NOT COMPLETED|Treatment Period||16
6651263|NCT02417935|7580712|FG000|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|134
6651264|NCT02417935|7580713|FG001|STARTED|Tapering Period|Participants who discontinued treatment period had an option to enter the taper period|142
6651265|NCT02417935|7580712|FG000|COMPLETED|Tapering Period||134
6651266|NCT02417935|7580713|FG001|COMPLETED|Tapering Period||142
6651267|NCT02417935|7580712|FG000|NOT COMPLETED|Tapering Period||0
6651268|NCT02417935|7580713|FG001|NOT COMPLETED|Tapering Period||0
6651269|NCT02417961|7580719|FG000|STARTED|Overall Study||116
6651270|NCT02417961|7580719|FG000|COMPLETED|Overall Study||112
6651271|NCT02417961|7580719|FG000|NOT COMPLETED|Overall Study||4
6651272|NCT02418000|7580728|FG000|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||7
6651273|NCT02418000|7580729|FG001|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651274|NCT02418000|7580730|FG002|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651275|NCT02418000|7580731|FG003|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6425013|NCT01013285|7339397|FG001|NOT COMPLETED|Overall Study||89
6425014|NCT01013350|7339404|FG000|STARTED|Overall Study||198
6425015|NCT01013350|7339405|FG001|STARTED|Overall Study||963
6425016|NCT01013350|7339404|FG000|Safety Analysis Set|Overall Study||198
6425017|NCT01013350|7339405|FG001|Safety Analysis Set|Overall Study||950
6425018|NCT01013350|7339404|FG000|COMPLETED|Overall Study||160
6425019|NCT01013350|7339405|FG001|COMPLETED|Overall Study||771
6425020|NCT01013350|7339404|FG000|NOT COMPLETED|Overall Study||38
6425021|NCT01013350|7339405|FG001|NOT COMPLETED|Overall Study||192
6425022|NCT01013597|7339412|FG000|STARTED|Overall Study||13
6425023|NCT01013597|7339412|FG000|COMPLETED|Overall Study||12
6425024|NCT01013597|7339412|FG000|NOT COMPLETED|Overall Study||1
6425025|NCT01013740|7339418|FG000|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
6425026|NCT01013740|7339419|FG001|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
6425027|NCT01013740|7339418|FG000|Ongoing|Overall Study||0
6425028|NCT01013740|7339419|FG001|Ongoing|Overall Study||0
6425029|NCT01013740|7339418|FG000|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
6425030|NCT01013740|7339419|FG001|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
6425031|NCT01013740|7339418|FG000|NOT COMPLETED|Overall Study||11
6425032|NCT01013740|7339419|FG001|NOT COMPLETED|Overall Study||19
6425033|NCT01013753|7339427|FG000|STARTED|Overall Study|Entered and treated|198
6425034|NCT01013753|7339427|FG000|Received Placebo|Overall Study||125
6425035|NCT01013753|7339427|FG000|Received Olo 2 mcg qd|Overall Study||121
6425036|NCT01013753|7339427|FG000|Received Olo 5 mcg qd|Overall Study||130
6425037|NCT01013753|7339427|FG000|Received Olo 10 mcg qd|Overall Study||127
6425038|NCT01013753|7339427|FG000|Received Olo 20 mcg qd|Overall Study||124
6425039|NCT01013753|7339427|FG000|Received Form 12 mcg Bid|Overall Study||125
6425040|NCT01013753|7339427|FG000|COMPLETED|Overall Study||182
6425041|NCT01013753|7339427|FG000|NOT COMPLETED|Overall Study||16
6425042|NCT01013792|7339443|FG000|STARTED|Overall Study||14
6425043|NCT01013792|7339444|FG001|STARTED|Overall Study||16
6425044|NCT01013792|7339443|FG000|COMPLETED|Overall Study||12
6425045|NCT01013792|7339444|FG001|COMPLETED|Overall Study||11
6551570|NCT03348930|7473790|FG000|STARTED|First Intervention (2 Weeks)||10
6551571|NCT03348930|7473791|FG001|STARTED|First Intervention (2 Weeks)||10
6551572|NCT03348930|7473790|FG000|COMPLETED|First Intervention (2 Weeks)||10
6551573|NCT03348930|7473791|FG001|COMPLETED|First Intervention (2 Weeks)||10
6551574|NCT03348930|7473790|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6551575|NCT03348930|7473791|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
6651276|NCT02418000|7580732|FG004|STARTED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651277|NCT02418000|7580728|FG000|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651278|NCT02418000|7580729|FG001|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651279|NCT02418000|7580730|FG002|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651280|NCT02418000|7580731|FG003|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651281|NCT02418000|7580732|FG004|COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651282|NCT02418000|7580728|FG000|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||7
6651283|NCT02418000|7580729|FG001|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651284|NCT02418000|7580730|FG002|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651285|NCT02418000|7580731|FG003|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651286|NCT02418000|7580732|FG004|NOT COMPLETED|Cohort 1: E6201 240 mg/m^2 Weekly||0
6651287|NCT02418000|7580728|FG000|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651288|NCT02418000|7580729|FG001|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||10
6651289|NCT02418000|7580730|FG002|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651290|NCT02418000|7580731|FG003|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651291|NCT02418000|7580732|FG004|STARTED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651292|NCT02418000|7580728|FG000|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651293|NCT02418000|7580729|FG001|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651294|NCT02418000|7580730|FG002|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651295|NCT02418000|7580731|FG003|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651296|NCT02418000|7580732|FG004|COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651297|NCT02418000|7580728|FG000|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651298|NCT02418000|7580729|FG001|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||10
6651299|NCT02418000|7580730|FG002|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651300|NCT02418000|7580731|FG003|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651301|NCT02418000|7580732|FG004|NOT COMPLETED|Cohort 2: E6201 320 mg/m^2 Weekly||0
6651302|NCT02418000|7580728|FG000|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651303|NCT02418000|7580729|FG001|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651304|NCT02418000|7580730|FG002|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||3
6651305|NCT02418000|7580731|FG003|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651306|NCT02418000|7580732|FG004|STARTED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651307|NCT02418000|7580728|FG000|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651308|NCT02418000|7580729|FG001|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651309|NCT02418000|7580730|FG002|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651310|NCT02418000|7580731|FG003|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6425046|NCT01013792|7339443|FG000|NOT COMPLETED|Overall Study||2
6425047|NCT01013792|7339444|FG001|NOT COMPLETED|Overall Study||5
6551576|NCT03348930|7473790|FG000|STARTED|Washout (1 Week)||10
6551577|NCT03348930|7473791|FG001|STARTED|Washout (1 Week)||10
6551578|NCT03348930|7473790|FG000|COMPLETED|Washout (1 Week)||9
6425048|NCT01013844|7339452|FG000|STARTED|Overall Study||65
6425049|NCT01013844|7339453|FG001|STARTED|Overall Study||65
6425050|NCT01013844|7339452|FG000|COMPLETED|Overall Study||65
6425051|NCT01013844|7339453|FG001|COMPLETED|Overall Study||65
6425052|NCT01013844|7339452|FG000|NOT COMPLETED|Overall Study||0
6425053|NCT01013844|7339453|FG001|NOT COMPLETED|Overall Study||0
6425054|NCT01013870|7339465|FG000|STARTED|Overall Study||28
6425055|NCT01013870|7339466|FG001|STARTED|Overall Study||24
6425056|NCT01013870|7339465|FG000|COMPLETED|Overall Study||27
6425057|NCT01013870|7339466|FG001|COMPLETED|Overall Study||21
6425058|NCT01013870|7339465|FG000|NOT COMPLETED|Overall Study||1
6425059|NCT01013870|7339466|FG001|NOT COMPLETED|Overall Study||3
6425060|NCT01013883|7339474|FG000|STARTED|Overall Study||270
6425061|NCT01013883|7339475|FG001|STARTED|Overall Study||243
6425062|NCT01013883|7339474|FG000|COMPLETED|Overall Study||268
6425063|NCT01013883|7339475|FG001|COMPLETED|Overall Study||241
6425064|NCT01013883|7339474|FG000|NOT COMPLETED|Overall Study||2
6425065|NCT01013883|7339475|FG001|NOT COMPLETED|Overall Study||2
6425066|NCT01013961|7339483|FG000|STARTED|Overall Study||16
6425067|NCT01013961|7339484|FG001|STARTED|Overall Study||15
6425068|NCT01013961|7339483|FG000|COMPLETED|Overall Study||13
6425069|NCT01013961|7339484|FG001|COMPLETED|Overall Study||12
6425070|NCT01013961|7339483|FG000|NOT COMPLETED|Overall Study||3
6425071|NCT01013961|7339484|FG001|NOT COMPLETED|Overall Study||3
6425072|NCT01014013|7339492|FG000|STARTED|Overall Study||135
6425073|NCT01014013|7339493|FG001|STARTED|Overall Study||136
6425074|NCT01014013|7339492|FG000|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
6425075|NCT01014013|7339493|FG001|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
6425076|NCT01014013|7339492|FG000|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous~infusion at least 3 days"|87
6425077|NCT01014013|7339493|FG001|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
6425078|NCT01014013|7339492|FG000|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
6425079|NCT01014013|7339493|FG001|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
6425080|NCT01014013|7339492|FG000|NOT COMPLETED|Overall Study||51
6425081|NCT01014013|7339493|FG001|NOT COMPLETED|Overall Study||56
6425082|NCT01014091|7339507|FG000|STARTED|Overall Study||7
6425083|NCT01014091|7339508|FG001|STARTED|Overall Study||13
6425084|NCT01014091|7339509|FG002|STARTED|Overall Study||5
6425085|NCT01014091|7339510|FG003|STARTED|Overall Study||15
6425086|NCT01014091|7339511|FG004|STARTED|Overall Study||6
6425087|NCT01014091|7339512|FG005|STARTED|Overall Study||12
6425088|NCT01014091|7339507|FG000|COMPLETED|Overall Study||7
6425089|NCT01014091|7339508|FG001|COMPLETED|Overall Study||13
6551579|NCT03348930|7473791|FG001|COMPLETED|Washout (1 Week)||9
6551580|NCT03348930|7473790|FG000|NOT COMPLETED|Washout (1 Week)||1
6551581|NCT03348930|7473791|FG001|NOT COMPLETED|Washout (1 Week)||1
6551582|NCT03348930|7473790|FG000|STARTED|Second Intervention (2 Weeks)||9
6551583|NCT03348930|7473791|FG001|STARTED|Second Intervention (2 Weeks)||9
6551584|NCT03348930|7473790|FG000|COMPLETED|Second Intervention (2 Weeks)||9
6551585|NCT03348930|7473791|FG001|COMPLETED|Second Intervention (2 Weeks)||9
6551586|NCT03348930|7473790|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6551587|NCT03348930|7473791|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6551588|NCT03282240|7473800|FG000|STARTED|Overall Study||1777
6551589|NCT03282240|7473801|FG001|STARTED|Overall Study||443
6551590|NCT03282240|7473802|FG002|STARTED|Overall Study||450
6551591|NCT03282240|7473800|FG000|COMPLETED|Overall Study||1767
6551592|NCT03282240|7473801|FG001|COMPLETED|Overall Study||440
6551593|NCT03282240|7473802|FG002|COMPLETED|Overall Study||447
6551594|NCT03282240|7473800|FG000|NOT COMPLETED|Overall Study||10
6551595|NCT03282240|7473801|FG001|NOT COMPLETED|Overall Study||3
6551596|NCT03282240|7473802|FG002|NOT COMPLETED|Overall Study||3
6551597|NCT03260868|7473815|FG000|STARTED|Overall Study||8
6551598|NCT03260868|7473816|FG001|STARTED|Overall Study||7
6551599|NCT03260868|7473815|FG000|Safety Population|Overall Study||8
6551600|NCT03260868|7473816|FG001|Safety Population|Overall Study||6
6551601|NCT03260868|7473815|FG000|COMPLETED|Overall Study||5
6551602|NCT03260868|7473816|FG001|COMPLETED|Overall Study||4
6551603|NCT03260868|7473815|FG000|NOT COMPLETED|Overall Study||3
6551604|NCT03260868|7473816|FG001|NOT COMPLETED|Overall Study||3
6651311|NCT02418000|7580732|FG004|COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651312|NCT02418000|7580728|FG000|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651313|NCT02418000|7580729|FG001|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651314|NCT02418000|7580730|FG002|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||3
6651315|NCT02418000|7580731|FG003|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6651316|NCT02418000|7580732|FG004|NOT COMPLETED|Cohort 3: 160 mg/m^2 Twice Weekly||0
6425090|NCT01014091|7339509|FG002|COMPLETED|Overall Study||5
6425091|NCT01014091|7339510|FG003|COMPLETED|Overall Study||15
6425092|NCT01014091|7339511|FG004|COMPLETED|Overall Study||6
6425093|NCT01014091|7339512|FG005|COMPLETED|Overall Study||12
6425094|NCT01014091|7339507|FG000|NOT COMPLETED|Overall Study||0
6425095|NCT01014091|7339508|FG001|NOT COMPLETED|Overall Study||0
6425096|NCT01014091|7339509|FG002|NOT COMPLETED|Overall Study||0
6551605|NCT03245580|7473824|FG000|STARTED|Overall Study||75
6551606|NCT03245580|7473825|FG001|STARTED|Overall Study||78
6551607|NCT03245580|7473824|FG000|COMPLETED|Overall Study||75
6651317|NCT02418000|7580728|FG000|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651318|NCT02418000|7580729|FG001|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651319|NCT02418000|7580730|FG002|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651320|NCT02418000|7580731|FG003|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||3
6651321|NCT02418000|7580732|FG004|STARTED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651322|NCT02418000|7580728|FG000|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651323|NCT02418000|7580729|FG001|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651324|NCT02418000|7580730|FG002|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651325|NCT02418000|7580731|FG003|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651326|NCT02418000|7580732|FG004|COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651327|NCT02418000|7580728|FG000|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651328|NCT02418000|7580729|FG001|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651329|NCT02418000|7580730|FG002|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651330|NCT02418000|7580731|FG003|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||3
6651331|NCT02418000|7580732|FG004|NOT COMPLETED|Cohort 4: 240 mg/m^2 Twice Weekly||0
6651332|NCT02418000|7580728|FG000|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651333|NCT02418000|7580729|FG001|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651334|NCT02418000|7580730|FG002|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651335|NCT02418000|7580731|FG003|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651336|NCT02418000|7580732|FG004|STARTED|Cohort 5: 320 mg/m^2 Twice Weekly||4
6651337|NCT02418000|7580728|FG000|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651338|NCT02418000|7580729|FG001|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651339|NCT02418000|7580730|FG002|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651340|NCT02418000|7580731|FG003|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651341|NCT02418000|7580732|FG004|COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651342|NCT02418000|7580728|FG000|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651343|NCT02418000|7580729|FG001|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651344|NCT02418000|7580730|FG002|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651345|NCT02418000|7580731|FG003|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||0
6651346|NCT02418000|7580732|FG004|NOT COMPLETED|Cohort 5: 320 mg/m^2 Twice Weekly||4
6651347|NCT02418026|7580758|FG000|STARTED|Overall Study||44
6651348|NCT02418026|7580759|FG001|STARTED|Overall Study||35
6651349|NCT02418026|7580758|FG000|COMPLETED|Overall Study||44
6651350|NCT02418026|7580759|FG001|COMPLETED|Overall Study||35
6651351|NCT02418026|7580758|FG000|NOT COMPLETED|Overall Study||0
6651352|NCT02418026|7580759|FG001|NOT COMPLETED|Overall Study||0
6551608|NCT03245580|7473825|FG001|COMPLETED|Overall Study||78
6551609|NCT03245580|7473824|FG000|NOT COMPLETED|Overall Study||0
6551610|NCT03245580|7473825|FG001|NOT COMPLETED|Overall Study||0
6551611|NCT03164616|7473834|FG000|STARTED|Overall Study||338
6551612|NCT03164616|7473835|FG001|STARTED|Overall Study||338
6551613|NCT03164616|7473836|FG002|STARTED|Overall Study||337
6551614|NCT03164616|7473834|FG000|Received Treatment|Overall Study||331
6551615|NCT03164616|7473835|FG001|Received Treatment|Overall Study||335
6551616|NCT03164616|7473836|FG002|Received Treatment|Overall Study||331
6651353|NCT02418156|7580765|FG000|STARTED|Overall Study||38
6651354|NCT02418156|7580765|FG000|COMPLETED|Overall Study||21
6651355|NCT02418156|7580765|FG000|NOT COMPLETED|Overall Study||17
6651356|NCT02418182|7580771|FG000|STARTED|Overall Study||49
6651357|NCT02418182|7580772|FG001|STARTED|Overall Study||50
6651358|NCT02418182|7580771|FG000|COMPLETED|Overall Study||31
6651359|NCT02418182|7580772|FG001|COMPLETED|Overall Study||33
6651360|NCT02418182|7580771|FG000|NOT COMPLETED|Overall Study||18
6651361|NCT02418182|7580772|FG001|NOT COMPLETED|Overall Study||17
6651362|NCT02418234|7580778|FG000|STARTED|Overall Study||314
6551617|NCT03164616|7473834|FG000|COMPLETED|Overall Study||80
6551618|NCT03164616|7473835|FG001|COMPLETED|Overall Study||65
6551619|NCT03164616|7473836|FG002|COMPLETED|Overall Study||40
6551620|NCT03164616|7473834|FG000|NOT COMPLETED|Overall Study||258
6551621|NCT03164616|7473835|FG001|NOT COMPLETED|Overall Study||273
6551622|NCT03164616|7473836|FG002|NOT COMPLETED|Overall Study||297
6551623|NCT03157037|7473846|FG000|STARTED|Overall Study||15
6551624|NCT03157037|7473846|FG000|COMPLETED|Overall Study||14
6551625|NCT03157037|7473846|FG000|NOT COMPLETED|Overall Study||1
6551626|NCT03143218|7473860|FG000|STARTED|Overall Study||1965
6551627|NCT03143218|7473861|FG001|STARTED|Overall Study||1988
6551628|NCT03143218|7473862|FG002|STARTED|Overall Study||1967
6551629|NCT03143218|7473860|FG000|COMPLETED|Overall Study||1716
6551630|NCT03143218|7473861|FG001|COMPLETED|Overall Study||1734
6551631|NCT03143218|7473862|FG002|COMPLETED|Overall Study||1740
6551632|NCT03143218|7473860|FG000|NOT COMPLETED|Overall Study||249
6551633|NCT03143218|7473861|FG001|NOT COMPLETED|Overall Study||254
6551634|NCT03143218|7473862|FG002|NOT COMPLETED|Overall Study||227
6551635|NCT03128931|7473870|FG000|STARTED|Overall Study||45
6551636|NCT03128931|7473870|FG000|COMPLETED|Overall Study||41
6551637|NCT03128931|7473870|FG000|NOT COMPLETED|Overall Study||4
6551638|NCT02611960|7473876|FG000|STARTED|Overall Study||117
6551639|NCT02611960|7473877|FG001|STARTED|Overall Study||116
6551640|NCT02611960|7473876|FG000|Treated|Overall Study||116
6551641|NCT02611960|7473877|FG001|Treated|Overall Study||112
6551642|NCT02611960|7473876|FG000|COMPLETED|Overall Study||0
6551643|NCT02611960|7473877|FG001|COMPLETED|Overall Study||0
6551644|NCT02611960|7473876|FG000|NOT COMPLETED|Overall Study||117
6551645|NCT02611960|7473877|FG001|NOT COMPLETED|Overall Study||116
6562770|NCT01803074|7485711|FG012|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6551646|NCT02498392|7473886|FG000|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||160
6551647|NCT02498392|7473887|FG001|STARTED|Double-blind(DB) Lead-in Period(3 Weeks)||0
6551648|NCT02498392|7473886|FG000|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||153
6551649|NCT02498392|7473887|FG001|Treated|Double-blind(DB) Lead-in Period(3 Weeks)||0
6551650|NCT02498392|7473886|FG000|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||153
6551651|NCT02498392|7473887|FG001|COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
6551652|NCT02498392|7473886|FG000|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||7
6651363|NCT02418234|7580778|FG000|COMPLETED|Overall Study||314
6651364|NCT02418234|7580778|FG000|NOT COMPLETED|Overall Study||0
6651365|NCT02418312|7580788|FG000|STARTED|Overall Study||114
6551653|NCT02498392|7473887|FG001|NOT COMPLETED|Double-blind(DB) Lead-in Period(3 Weeks)||0
6551654|NCT02498392|7473886|FG000|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||76
6551655|NCT02498392|7473887|FG001|STARTED|DB Treatment (6 Weeks)+Withdrawal Period||77
6551656|NCT02498392|7473886|FG000|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||70
6551657|NCT02498392|7473887|FG001|COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||67
6551658|NCT02498392|7473886|FG000|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||6
6551659|NCT02498392|7473887|FG001|NOT COMPLETED|DB Treatment (6 Weeks)+Withdrawal Period||10
6551660|NCT02478775|7473898|FG000|STARTED|Overall Study||6
6551661|NCT02478775|7473899|FG001|STARTED|Overall Study||27
6551662|NCT02478775|7473900|FG002|STARTED|Overall Study||27
6551663|NCT02478775|7473898|FG000|COMPLETED|Overall Study||6
6551664|NCT02478775|7473899|FG001|COMPLETED|Overall Study||27
6551665|NCT02478775|7473900|FG002|COMPLETED|Overall Study||27
6551666|NCT02478775|7473898|FG000|NOT COMPLETED|Overall Study||0
6551667|NCT02478775|7473899|FG001|NOT COMPLETED|Overall Study||0
6551668|NCT02478775|7473900|FG002|NOT COMPLETED|Overall Study||0
6551669|NCT01899729|7473912|FG000|STARTED|Overall Study||9
6551670|NCT01899729|7473913|FG001|STARTED|Overall Study||9
6551671|NCT01899729|7473914|FG002|STARTED|Overall Study||8
6551672|NCT01899729|7473915|FG003|STARTED|Overall Study||9
6651366|NCT02418312|7580789|FG001|STARTED|Overall Study||114
6651367|NCT02418312|7580788|FG000|COMPLETED|Overall Study||114
6651368|NCT02418312|7580789|FG001|COMPLETED|Overall Study||114
6425097|NCT01014091|7339510|FG003|NOT COMPLETED|Overall Study||0
6425098|NCT01014091|7339511|FG004|NOT COMPLETED|Overall Study||0
6425099|NCT01014091|7339512|FG005|NOT COMPLETED|Overall Study||0
6425100|NCT01014143|7339538|FG000|STARTED|First Intervention||10
6425101|NCT01014143|7339539|FG001|STARTED|First Intervention||9
6425102|NCT01014143|7339540|FG002|STARTED|First Intervention||9
6651369|NCT02418312|7580788|FG000|NOT COMPLETED|Overall Study||0
6651370|NCT02418312|7580789|FG001|NOT COMPLETED|Overall Study||0
6651371|NCT02418455|7580795|FG000|STARTED|48-Week Treatment Period||8
6651372|NCT02418455|7580795|FG000|Emergency IND (eIND)|48-Week Treatment Period||1
6651373|NCT02418455|7580795|FG000|COMPLETED|48-Week Treatment Period||7
6651374|NCT02418455|7580795|FG000|NOT COMPLETED|48-Week Treatment Period||1
6651375|NCT02418455|7580795|FG000|STARTED|Continuation Period||7
6651376|NCT02418455|7580795|FG000|COMPLETED|Continuation Period||0
6651377|NCT02418455|7580795|FG000|NOT COMPLETED|Continuation Period||7
6651378|NCT02418468|7580803|FG000|STARTED|Overall Study||13
6651379|NCT02418468|7580804|FG001|STARTED|Overall Study||11
6651380|NCT02418468|7580803|FG000|COMPLETED|Overall Study||11
6651381|NCT02418468|7580804|FG001|COMPLETED|Overall Study||10
6651382|NCT02418468|7580803|FG000|NOT COMPLETED|Overall Study||2
6651383|NCT02418468|7580804|FG001|NOT COMPLETED|Overall Study||1
6651384|NCT02418546|7580813|FG000|STARTED|Overall Study||26
6651385|NCT02418546|7580814|FG001|STARTED|Overall Study||26
6651386|NCT02418546|7580815|FG002|STARTED|Overall Study||26
6651387|NCT02418546|7580813|FG000|COMPLETED|Overall Study||19
6651388|NCT02418546|7580814|FG001|COMPLETED|Overall Study||20
6651389|NCT02418546|7580815|FG002|COMPLETED|Overall Study||23
6651390|NCT02418546|7580813|FG000|NOT COMPLETED|Overall Study||7
6651391|NCT02418546|7580814|FG001|NOT COMPLETED|Overall Study||6
6651392|NCT02418546|7580815|FG002|NOT COMPLETED|Overall Study||3
6651393|NCT02418585|7580825|FG000|STARTED|Double Blind (DB) Phase (4 Weeks)||116
6651394|NCT02418585|7580826|FG001|STARTED|Double Blind (DB) Phase (4 Weeks)||111
6651395|NCT02418585|7580825|FG000|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||115
6651396|NCT02418585|7580826|FG001|Safety Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
6651397|NCT02418585|7580825|FG000|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||114
6651398|NCT02418585|7580826|FG001|Full Analysis Set|Double Blind (DB) Phase (4 Weeks)||109
6651399|NCT02418585|7580825|FG000|COMPLETED|Double Blind (DB) Phase (4 Weeks)||98
6651400|NCT02418585|7580826|FG001|COMPLETED|Double Blind (DB) Phase (4 Weeks)||99
6651401|NCT02418585|7580825|FG000|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||18
6651402|NCT02418585|7580826|FG001|NOT COMPLETED|Double Blind (DB) Phase (4 Weeks)||12
6651403|NCT02418585|7580825|FG000|STARTED|Follow-up Phase (24 Weeks)||34
6651404|NCT02418585|7580826|FG001|STARTED|Follow-up Phase (24 Weeks)||52
6651405|NCT02418585|7580825|FG000|COMPLETED|Follow-up Phase (24 Weeks)||16
6651406|NCT02418585|7580826|FG001|COMPLETED|Follow-up Phase (24 Weeks)||27
6651407|NCT02418585|7580825|FG000|NOT COMPLETED|Follow-up Phase (24 Weeks)||18
6651408|NCT02418585|7580826|FG001|NOT COMPLETED|Follow-up Phase (24 Weeks)||25
6651409|NCT02418676|7580837|FG000|STARTED|Overall Study||5
6425103|NCT01014143|7339538|FG000|COMPLETED|First Intervention||10
6425104|NCT01014143|7339539|FG001|COMPLETED|First Intervention||9
6551673|NCT01899729|7473916|FG004|STARTED|Overall Study||11
6551674|NCT01899729|7473912|FG000|COMPLETED|Overall Study||7
6551675|NCT01899729|7473913|FG001|COMPLETED|Overall Study||7
6425105|NCT01014143|7339540|FG002|COMPLETED|First Intervention||9
6425106|NCT01014143|7339538|FG000|NOT COMPLETED|First Intervention||0
6425107|NCT01014143|7339539|FG001|NOT COMPLETED|First Intervention||0
6425108|NCT01014143|7339540|FG002|NOT COMPLETED|First Intervention||0
6425109|NCT01014143|7339538|FG000|STARTED|Washout Period After 1st Intervention||10
6425110|NCT01014143|7339539|FG001|STARTED|Washout Period After 1st Intervention||9
6425111|NCT01014143|7339540|FG002|STARTED|Washout Period After 1st Intervention||9
6425112|NCT01014143|7339538|FG000|COMPLETED|Washout Period After 1st Intervention||10
6425113|NCT01014143|7339539|FG001|COMPLETED|Washout Period After 1st Intervention||9
6425114|NCT01014143|7339540|FG002|COMPLETED|Washout Period After 1st Intervention||9
6425115|NCT01014143|7339538|FG000|NOT COMPLETED|Washout Period After 1st Intervention||0
6425116|NCT01014143|7339539|FG001|NOT COMPLETED|Washout Period After 1st Intervention||0
6425117|NCT01014143|7339540|FG002|NOT COMPLETED|Washout Period After 1st Intervention||0
6425118|NCT01014143|7339538|FG000|STARTED|Second Intervention||10
6425119|NCT01014143|7339539|FG001|STARTED|Second Intervention||9
6425120|NCT01014143|7339540|FG002|STARTED|Second Intervention||9
6425121|NCT01014143|7339538|FG000|COMPLETED|Second Intervention||8
6651410|NCT02418676|7580838|FG001|STARTED|Overall Study||5
6651411|NCT02418676|7580839|FG002|STARTED|Overall Study||5
6651412|NCT02418676|7580837|FG000|COMPLETED|Overall Study||5
6651413|NCT02418676|7580838|FG001|COMPLETED|Overall Study||5
6651414|NCT02418676|7580839|FG002|COMPLETED|Overall Study||5
6651415|NCT02418676|7580837|FG000|NOT COMPLETED|Overall Study||0
6651416|NCT02418676|7580838|FG001|NOT COMPLETED|Overall Study||0
6651417|NCT02418676|7580839|FG002|NOT COMPLETED|Overall Study||0
6651418|NCT02418754|7580850|FG000|STARTED|Period 1 (Day 1 to Week 12)||103
6651419|NCT02418754|7580851|FG001|STARTED|Period 1 (Day 1 to Week 12)||200
6651420|NCT02418754|7580852|FG002|STARTED|Period 1 (Day 1 to Week 12)||202
6651421|NCT02418754|7580853|FG003|STARTED|Period 1 (Day 1 to Week 12)||0
6651422|NCT02418754|7580854|FG004|STARTED|Period 1 (Day 1 to Week 12)||0
6651423|NCT02418754|7580850|FG000|COMPLETED|Period 1 (Day 1 to Week 12)||101
6651424|NCT02418754|7580851|FG001|COMPLETED|Period 1 (Day 1 to Week 12)||196
6651425|NCT02418754|7580852|FG002|COMPLETED|Period 1 (Day 1 to Week 12)||200
6651426|NCT02418754|7580853|FG003|COMPLETED|Period 1 (Day 1 to Week 12)||0
6651427|NCT02418754|7580854|FG004|COMPLETED|Period 1 (Day 1 to Week 12)||0
6651428|NCT02418754|7580850|FG000|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
6651429|NCT02418754|7580851|FG001|NOT COMPLETED|Period 1 (Day 1 to Week 12)||4
6651430|NCT02418754|7580852|FG002|NOT COMPLETED|Period 1 (Day 1 to Week 12)||2
6651431|NCT02418754|7580853|FG003|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
6651432|NCT02418754|7580854|FG004|NOT COMPLETED|Period 1 (Day 1 to Week 12)||0
6651433|NCT02418754|7580850|FG000|STARTED|Period 2 (Day 1 to Week 52/End of Study)||103
6651434|NCT02418754|7580851|FG001|STARTED|Period 2 (Day 1 to Week 52/End of Study)||106
6651435|NCT02418754|7580852|FG002|STARTED|Period 2 (Day 1 to Week 52/End of Study)||108
6651436|NCT02418754|7580853|FG003|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
6651437|NCT02418754|7580854|FG004|STARTED|Period 2 (Day 1 to Week 52/End of Study)||94
6651438|NCT02418754|7580850|FG000|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||70
6651439|NCT02418754|7580851|FG001|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||64
6651440|NCT02418754|7580852|FG002|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||71
6651441|NCT02418754|7580853|FG003|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
6651442|NCT02418754|7580854|FG004|COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||67
6651443|NCT02418754|7580850|FG000|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||33
6651444|NCT02418754|7580851|FG001|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||42
6651445|NCT02418754|7580852|FG002|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||37
6651446|NCT02418754|7580853|FG003|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
6651447|NCT02418754|7580854|FG004|NOT COMPLETED|Period 2 (Day 1 to Week 52/End of Study)||27
6651448|NCT02418819|7580868|FG000|STARTED|Overall Study||22
6651449|NCT02418819|7580869|FG001|STARTED|Overall Study||16
6651450|NCT02418819|7580870|FG002|STARTED|Overall Study||33
6651451|NCT02418819|7580871|FG003|STARTED|Overall Study||29
6651452|NCT02418819|7580868|FG000|COMPLETED|Overall Study||21
6651453|NCT02418819|7580869|FG001|COMPLETED|Overall Study||16
6425122|NCT01014143|7339539|FG001|COMPLETED|Second Intervention||9
6425123|NCT01014143|7339540|FG002|COMPLETED|Second Intervention||9
6425124|NCT01014143|7339538|FG000|NOT COMPLETED|Second Intervention||2
6425125|NCT01014143|7339539|FG001|NOT COMPLETED|Second Intervention||0
6425126|NCT01014143|7339540|FG002|NOT COMPLETED|Second Intervention||0
6425127|NCT01014143|7339538|FG000|STARTED|Washout After 2nd Intervention||8
6425128|NCT01014143|7339539|FG001|STARTED|Washout After 2nd Intervention||9
6425129|NCT01014143|7339540|FG002|STARTED|Washout After 2nd Intervention||9
6425130|NCT01014143|7339538|FG000|COMPLETED|Washout After 2nd Intervention||8
6425131|NCT01014143|7339539|FG001|COMPLETED|Washout After 2nd Intervention||9
6425132|NCT01014143|7339540|FG002|COMPLETED|Washout After 2nd Intervention||9
6425133|NCT01014143|7339538|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
6425134|NCT01014143|7339539|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
6425135|NCT01014143|7339540|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
6425136|NCT01014143|7339538|FG000|STARTED|Third Intervention||8
6425137|NCT01014143|7339539|FG001|STARTED|Third Intervention||9
6425138|NCT01014143|7339540|FG002|STARTED|Third Intervention||9
6425139|NCT01014143|7339538|FG000|COMPLETED|Third Intervention||8
6425140|NCT01014143|7339539|FG001|COMPLETED|Third Intervention||9
6551676|NCT01899729|7473914|FG002|COMPLETED|Overall Study||6
6551677|NCT01899729|7473915|FG003|COMPLETED|Overall Study||9
6551678|NCT01899729|7473916|FG004|COMPLETED|Overall Study||9
6425141|NCT01014143|7339540|FG002|COMPLETED|Third Intervention||9
6425142|NCT01014143|7339538|FG000|NOT COMPLETED|Third Intervention||0
6425143|NCT01014143|7339539|FG001|NOT COMPLETED|Third Intervention||0
6425144|NCT01014143|7339540|FG002|NOT COMPLETED|Third Intervention||0
6425145|NCT01014169|7339550|FG000|STARTED|Overall Study||65
6425146|NCT01014169|7339551|FG001|STARTED|Overall Study||61
6425147|NCT01014169|7339550|FG000|COMPLETED|Overall Study||58
6425148|NCT01014169|7339551|FG001|COMPLETED|Overall Study||48
6425149|NCT01014169|7339550|FG000|NOT COMPLETED|Overall Study||7
6425150|NCT01014169|7339551|FG001|NOT COMPLETED|Overall Study||13
6425151|NCT01014208|7339559|FG000|STARTED|Overall Study||225
6425152|NCT01014208|7339560|FG001|STARTED|Overall Study||222
6425153|NCT01014208|7339559|FG000|Intent-to-Treat Population|Overall Study||223
6425154|NCT01014208|7339560|FG001|Intent-to-Treat Population|Overall Study||222
6425155|NCT01014208|7339559|FG000|COMPLETED|Overall Study||131
6425156|NCT01014208|7339560|FG001|COMPLETED|Overall Study||122
6425157|NCT01014208|7339559|FG000|NOT COMPLETED|Overall Study||94
6425158|NCT01014208|7339560|FG001|NOT COMPLETED|Overall Study||100
6425159|NCT01014351|7339566|FG000|STARTED|Overall Study||70
6425160|NCT01014351|7339566|FG000|COMPLETED|Overall Study||33
6425161|NCT01014351|7339566|FG000|NOT COMPLETED|Overall Study||37
6425162|NCT01014390|7339570|FG000|STARTED|Overall Study||187
6425163|NCT01014390|7339570|FG000|COMPLETED|Overall Study||177
6425164|NCT01014390|7339570|FG000|NOT COMPLETED|Overall Study||10
6425165|NCT01014403|7339576|FG000|STARTED|Overall Study||34
6425166|NCT01014403|7339577|FG001|STARTED|Overall Study||28
6425167|NCT01014403|7339576|FG000|COMPLETED|Overall Study||34
6425168|NCT01014403|7339577|FG001|COMPLETED|Overall Study||28
6651454|NCT02418819|7580870|FG002|COMPLETED|Overall Study||29
6651455|NCT02418819|7580871|FG003|COMPLETED|Overall Study||28
6651456|NCT02418819|7580868|FG000|NOT COMPLETED|Overall Study||1
6651457|NCT02418819|7580869|FG001|NOT COMPLETED|Overall Study||0
6651458|NCT02418819|7580870|FG002|NOT COMPLETED|Overall Study||4
6651459|NCT02418819|7580871|FG003|NOT COMPLETED|Overall Study||1
6651460|NCT02418845|7580883|FG000|STARTED|Overall Study||125
6651461|NCT02418845|7580884|FG001|STARTED|Overall Study||64
6651462|NCT02418845|7580883|FG000|COMPLETED|Overall Study||109
6651463|NCT02418845|7580884|FG001|COMPLETED|Overall Study||52
6651464|NCT02418845|7580883|FG000|NOT COMPLETED|Overall Study||16
6651465|NCT02418845|7580884|FG001|NOT COMPLETED|Overall Study||12
6651466|NCT02418910|7580890|FG000|STARTED|Overall Study||50
6651467|NCT02418910|7580890|FG000|COMPLETED|Overall Study||43
6425169|NCT01014403|7339576|FG000|NOT COMPLETED|Overall Study||0
6425170|NCT01014403|7339577|FG001|NOT COMPLETED|Overall Study||0
6425171|NCT01014442|7339585|FG000|STARTED|Overall Study||33
6551679|NCT01899729|7473912|FG000|NOT COMPLETED|Overall Study||2
6551680|NCT01899729|7473913|FG001|NOT COMPLETED|Overall Study||2
6551681|NCT01899729|7473914|FG002|NOT COMPLETED|Overall Study||2
6551682|NCT01899729|7473915|FG003|NOT COMPLETED|Overall Study||0
6551683|NCT01899729|7473916|FG004|NOT COMPLETED|Overall Study||2
6551684|NCT01784848|7473930|FG000|STARTED|Overall Study||50
6551685|NCT01784848|7473931|FG001|STARTED|Overall Study||50
6551686|NCT01784848|7473930|FG000|COMPLETED|Overall Study||49
6551687|NCT01784848|7473931|FG001|COMPLETED|Overall Study||47
6551688|NCT01784848|7473930|FG000|NOT COMPLETED|Overall Study||1
6551689|NCT01784848|7473931|FG001|NOT COMPLETED|Overall Study||3
6551690|NCT01648205|7473937|FG000|STARTED|Placebo||25
6551691|NCT01648205|7473937|FG000|COMPLETED|Placebo||21
6551692|NCT01648205|7473937|FG000|NOT COMPLETED|Placebo||4
6551693|NCT01648205|7473937|FG000|STARTED|Ranolazine||23
6551694|NCT01648205|7473937|FG000|COMPLETED|Ranolazine||18
6551695|NCT01648205|7473937|FG000|NOT COMPLETED|Ranolazine||5
6551696|NCT01622088|7473945|FG000|STARTED|Overall Study||616
6551697|NCT01622088|7473945|FG000|COMPLETED|Overall Study||0
6551698|NCT01622088|7473945|FG000|NOT COMPLETED|Overall Study||616
6551699|NCT01312922|7473953|FG000|STARTED|Overall Study||185
6551700|NCT01312922|7473954|FG001|STARTED|Overall Study||185
6551701|NCT01312922|7473955|FG002|STARTED|Overall Study||185
6551702|NCT01312922|7473953|FG000|COMPLETED|Overall Study||117
6551703|NCT01312922|7473954|FG001|COMPLETED|Overall Study||131
6551704|NCT01312922|7473955|FG002|COMPLETED|Overall Study||135
6551705|NCT01312922|7473953|FG000|NOT COMPLETED|Overall Study||68
6551706|NCT01312922|7473954|FG001|NOT COMPLETED|Overall Study||54
6551707|NCT01312922|7473955|FG002|NOT COMPLETED|Overall Study||50
6551708|NCT01063517|7473965|FG000|STARTED|Overall Study||62
6551709|NCT01063517|7473966|FG001|STARTED|Overall Study||62
6551710|NCT01063517|7473965|FG000|Received Randomised Treatment|Overall Study||61
6551711|NCT01063517|7473966|FG001|Received Randomised Treatment|Overall Study||62
6551712|NCT01063517|7473965|FG000|COMPLETED|Overall Study||4
6551713|NCT01063517|7473966|FG001|COMPLETED|Overall Study||2
6551714|NCT01063517|7473965|FG000|NOT COMPLETED|Overall Study||58
6551715|NCT01063517|7473966|FG001|NOT COMPLETED|Overall Study||60
6651468|NCT02418910|7580890|FG000|NOT COMPLETED|Overall Study||7
6425172|NCT01014442|7339586|FG001|STARTED|Overall Study||35
6425173|NCT01014442|7339585|FG000|COMPLETED|Overall Study||26
6425174|NCT01014442|7339586|FG001|COMPLETED|Overall Study||16
6425175|NCT01014442|7339585|FG000|NOT COMPLETED|Overall Study||7
6425176|NCT01014442|7339586|FG001|NOT COMPLETED|Overall Study||19
6425177|NCT01014455|7339598|FG000|STARTED|Overall Study||82
6425178|NCT01014455|7339599|FG001|STARTED|Overall Study||87
6425179|NCT01014455|7339598|FG000|COMPLETED|Overall Study||82
6425180|NCT01014455|7339599|FG001|COMPLETED|Overall Study||87
6425181|NCT01014455|7339598|FG000|NOT COMPLETED|Overall Study||0
6425182|NCT01014455|7339599|FG001|NOT COMPLETED|Overall Study||0
6425183|NCT01014533|7339607|FG000|STARTED|Overall Study||29
6425184|NCT01014533|7339608|FG001|STARTED|Overall Study||30
6425185|NCT01014533|7339607|FG000|COMPLETED|Overall Study||24
6425186|NCT01014533|7339608|FG001|COMPLETED|Overall Study||25
6425187|NCT01014533|7339607|FG000|NOT COMPLETED|Overall Study||5
6425188|NCT01014533|7339608|FG001|NOT COMPLETED|Overall Study||5
6651469|NCT02418949|7580898|FG000|STARTED|Overall Study||23
6651470|NCT02418949|7580899|FG001|STARTED|Overall Study||22
6651471|NCT02418949|7580900|FG002|STARTED|Overall Study||26
6651472|NCT02418949|7580901|FG003|STARTED|Overall Study||25
6651473|NCT02418949|7580898|FG000|COMPLETED|Overall Study||20
6651474|NCT02418949|7580899|FG001|COMPLETED|Overall Study||21
6651475|NCT02418949|7580900|FG002|COMPLETED|Overall Study||23
6651476|NCT02418949|7580901|FG003|COMPLETED|Overall Study||24
6651477|NCT02418949|7580898|FG000|NOT COMPLETED|Overall Study||3
6651478|NCT02418949|7580899|FG001|NOT COMPLETED|Overall Study||1
6651479|NCT02418949|7580900|FG002|NOT COMPLETED|Overall Study||3
6651480|NCT02418949|7580901|FG003|NOT COMPLETED|Overall Study||1
6651481|NCT02419001|7580913|FG000|STARTED|Period 1- Ceftriaxone Without SYN-004||6
6651482|NCT02419001|7580914|FG001|STARTED|Period 1- Ceftriaxone Without SYN-004||5
6651483|NCT02419001|7580913|FG000|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
6651484|NCT02419001|7580914|FG001|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
6651485|NCT02419001|7580913|FG000|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
6651486|NCT02419001|7580914|FG001|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
6651487|NCT02419001|7580913|FG000|STARTED|Period 2- Ceftriaxone With SYN-004||5
6651488|NCT02419001|7580914|FG001|STARTED|Period 2- Ceftriaxone With SYN-004||5
6651489|NCT02419001|7580913|FG000|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
6651490|NCT02419001|7580914|FG001|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
6651491|NCT02419001|7580913|FG000|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
6651492|NCT02419001|7580914|FG001|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
6651493|NCT02419313|7580920|FG000|STARTED|First Intervention||18
6651494|NCT02419313|7580921|FG001|STARTED|First Intervention||15
6651495|NCT02419313|7580920|FG000|COMPLETED|First Intervention||16
6651496|NCT02419313|7580921|FG001|COMPLETED|First Intervention||15
6651497|NCT02419313|7580920|FG000|NOT COMPLETED|First Intervention||2
6651498|NCT02419313|7580921|FG001|NOT COMPLETED|First Intervention||0
6651499|NCT02419313|7580920|FG000|STARTED|Second Intervention||16
6651500|NCT02419313|7580921|FG001|STARTED|Second Intervention||15
6651501|NCT02419313|7580920|FG000|COMPLETED|Second Intervention||15
6651502|NCT02419313|7580921|FG001|COMPLETED|Second Intervention||15
6651503|NCT02419313|7580920|FG000|NOT COMPLETED|Second Intervention||1
6651504|NCT02419313|7580921|FG001|NOT COMPLETED|Second Intervention||0
6651505|NCT02419469|7580927|FG000|STARTED|Overall Study||1
6651506|NCT02419469|7580927|FG000|COMPLETED|Overall Study||0
6651507|NCT02419469|7580927|FG000|NOT COMPLETED|Overall Study||1
6651508|NCT02419508|7580933|FG000|STARTED|Overall Study||96
6651509|NCT02419508|7580934|FG001|STARTED|Overall Study||92
6651510|NCT02419508|7580933|FG000|Full Analysis Set|Overall Study||95
6651511|NCT02419508|7580934|FG001|Full Analysis Set|Overall Study||92
6651512|NCT02419508|7580933|FG000|Safety Analysis Set|Overall Study||95
6651513|NCT02419508|7580934|FG001|Safety Analysis Set|Overall Study||92
6651514|NCT02419508|7580933|FG000|COMPLETED|Overall Study||86
6651515|NCT02419508|7580934|FG001|COMPLETED|Overall Study||88
6651516|NCT02419508|7580933|FG000|NOT COMPLETED|Overall Study||10
6651517|NCT02419508|7580934|FG001|NOT COMPLETED|Overall Study||4
6651518|NCT02419521|7580940|FG000|STARTED|Overall Study||75
6651519|NCT02419521|7580940|FG000|COMPLETED|Overall Study||74
6651520|NCT02419521|7580940|FG000|NOT COMPLETED|Overall Study||1
6651521|NCT02419547|7580944|FG000|STARTED|Overall Study||11
6651522|NCT02419547|7580944|FG000|COMPLETED|Overall Study||11
6651523|NCT02419547|7580944|FG000|NOT COMPLETED|Overall Study||0
6651524|NCT02419573|7580950|FG000|STARTED|Overall Study||1499
6651525|NCT02419573|7580951|FG001|STARTED|Overall Study||1505
6651526|NCT02419573|7580950|FG000|COMPLETED|Overall Study||1495
6651527|NCT02419573|7580951|FG001|COMPLETED|Overall Study||1505
6651528|NCT02419573|7580950|FG000|NOT COMPLETED|Overall Study||4
6651529|NCT02419573|7580951|FG001|NOT COMPLETED|Overall Study||0
6651530|NCT02419612|7580959|FG000|STARTED|Short-term Treatment Period||227
6651531|NCT02419612|7580960|FG001|STARTED|Short-term Treatment Period||217
6651532|NCT02419612|7580959|FG000|Recevied Treatment|Short-term Treatment Period||227
6651533|NCT02419612|7580960|FG001|Recevied Treatment|Short-term Treatment Period||216
6651534|NCT02419612|7580959|FG000|COMPLETED|Short-term Treatment Period||210
6425189|NCT01014585|7339619|FG000|STARTED|Overall Study||51
6425190|NCT01014585|7339620|FG001|STARTED|Overall Study||100
6425191|NCT01014585|7339621|FG002|STARTED|Overall Study||60
6425192|NCT01014585|7339622|FG003|STARTED|Overall Study||129
6425193|NCT01014585|7339619|FG000|COMPLETED|Overall Study||31
6425194|NCT01014585|7339620|FG001|COMPLETED|Overall Study||75
6425195|NCT01014585|7339621|FG002|COMPLETED|Overall Study||37
6425196|NCT01014585|7339622|FG003|COMPLETED|Overall Study||99
6425197|NCT01014585|7339619|FG000|NOT COMPLETED|Overall Study||20
6425198|NCT01014585|7339620|FG001|NOT COMPLETED|Overall Study||25
6425199|NCT01014585|7339621|FG002|NOT COMPLETED|Overall Study||23
6425200|NCT01014585|7339622|FG003|NOT COMPLETED|Overall Study||30
6425201|NCT01014624|7339634|FG000|STARTED|Overall Study||29
6425202|NCT01014624|7339635|FG001|STARTED|Overall Study||27
6425203|NCT01014624|7339634|FG000|COMPLETED|Overall Study||27
6425204|NCT01014624|7339635|FG001|COMPLETED|Overall Study||26
6425205|NCT01014624|7339634|FG000|NOT COMPLETED|Overall Study||2
6551716|NCT00915681|7473972|FG000|STARTED|Overall Study||148
6551717|NCT00915681|7473972|FG000|COMPLETED|Overall Study||102
6551718|NCT00915681|7473972|FG000|NOT COMPLETED|Overall Study||46
6551719|NCT00145158|7473978|FG000|STARTED|Overall Study||16
6551720|NCT00145158|7473979|FG001|STARTED|Overall Study||7
6651535|NCT02419612|7580960|FG001|COMPLETED|Short-term Treatment Period||194
6425206|NCT01014624|7339635|FG001|NOT COMPLETED|Overall Study||1
6425207|NCT01014689|7339645|FG000|STARTED|Overall Study||191
6425208|NCT01014689|7339646|FG001|STARTED|Overall Study||187
6425209|NCT01014689|7339645|FG000|COMPLETED|Overall Study||178
6425210|NCT01014689|7339646|FG001|COMPLETED|Overall Study||174
6425211|NCT01014689|7339645|FG000|NOT COMPLETED|Overall Study||13
6425212|NCT01014689|7339646|FG001|NOT COMPLETED|Overall Study||13
6551721|NCT00145158|7473978|FG000|COMPLETED|Overall Study||14
6651536|NCT02419612|7580959|FG000|NOT COMPLETED|Short-term Treatment Period||17
6651537|NCT02419612|7580960|FG001|NOT COMPLETED|Short-term Treatment Period||23
6651538|NCT02419612|7580959|FG000|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|196
6651539|NCT02419612|7580960|FG001|STARTED|Long-term Treatment Period|Not all subjects who completed the previous period were eligible to enter the long-term period.|186
6651540|NCT02419612|7580959|FG000|Received Treatment|Long-term Treatment Period||196
6651541|NCT02419612|7580960|FG001|Received Treatment|Long-term Treatment Period||183
6651542|NCT02419612|7580959|FG000|COMPLETED|Long-term Treatment Period||174
6651543|NCT02419612|7580960|FG001|COMPLETED|Long-term Treatment Period||164
6651544|NCT02419612|7580959|FG000|NOT COMPLETED|Long-term Treatment Period||22
6651545|NCT02419612|7580960|FG001|NOT COMPLETED|Long-term Treatment Period||22
6651546|NCT02419690|7580968|FG000|STARTED|Overall Study||122
6651547|NCT02419690|7580969|FG001|STARTED|Overall Study||122
6651548|NCT02419690|7580968|FG000|COMPLETED|Overall Study||122
6651549|NCT02419690|7580969|FG001|COMPLETED|Overall Study||122
6651550|NCT02419690|7580968|FG000|NOT COMPLETED|Overall Study||0
6651551|NCT02419690|7580969|FG001|NOT COMPLETED|Overall Study||0
6651552|NCT02419755|7580977|FG000|STARTED|Overall Study||6
6651553|NCT02419755|7580978|FG001|STARTED|Overall Study||6
6651554|NCT02419755|7580977|FG000|COMPLETED|Overall Study||3
6651555|NCT02419755|7580978|FG001|COMPLETED|Overall Study||2
6651556|NCT02419755|7580977|FG000|NOT COMPLETED|Overall Study||3
6651557|NCT02419755|7580978|FG001|NOT COMPLETED|Overall Study||4
6651558|NCT02419807|7580984|FG000|STARTED|Overall Study||102
6651559|NCT02419807|7580984|FG000|COMPLETED|Overall Study||92
6651560|NCT02419807|7580984|FG000|NOT COMPLETED|Overall Study||10
6651561|NCT02419924|7580988|FG000|STARTED|Overall Study||12
6651562|NCT02419924|7580988|FG000|COMPLETED|Overall Study||12
6651563|NCT02419924|7580988|FG000|NOT COMPLETED|Overall Study||0
6651564|NCT02419937|7580994|FG000|STARTED|Overall Study||12
6651565|NCT02419937|7580995|FG001|STARTED|Overall Study||16
6651566|NCT02419937|7580994|FG000|COMPLETED|Overall Study||11
6651567|NCT02419937|7580995|FG001|COMPLETED|Overall Study||16
6651568|NCT02419937|7580994|FG000|NOT COMPLETED|Overall Study||1
6651569|NCT02419937|7580995|FG001|NOT COMPLETED|Overall Study||0
6651570|NCT02420015|7581003|FG000|STARTED|Overall Study||21
6651571|NCT02420015|7581004|FG001|STARTED|Overall Study||13
6651572|NCT02420015|7581003|FG000|COMPLETED|Overall Study||21
6651573|NCT02420015|7581004|FG001|COMPLETED|Overall Study||13
6651574|NCT02420015|7581003|FG000|NOT COMPLETED|Overall Study||0
6651575|NCT02420015|7581004|FG001|NOT COMPLETED|Overall Study||0
6651576|NCT02420041|7581012|FG000|STARTED|Overall Study||14
6651577|NCT02420041|7581013|FG001|STARTED|Overall Study||14
6651578|NCT02420041|7581012|FG000|COMPLETED|Overall Study||14
6651579|NCT02420041|7581013|FG001|COMPLETED|Overall Study||14
6651580|NCT02420041|7581012|FG000|NOT COMPLETED|Overall Study||0
6651581|NCT02420041|7581013|FG001|NOT COMPLETED|Overall Study||0
6651582|NCT02420093|7581021|FG000|STARTED|Overall Study||9
6651583|NCT02420093|7581022|FG001|STARTED|Overall Study||8
6425213|NCT01014728|7339654|FG000|STARTED|Overall Study||18
6425214|NCT01014728|7339655|FG001|STARTED|Overall Study||15
6425215|NCT01014728|7339654|FG000|COMPLETED|Overall Study||18
6425216|NCT01014728|7339655|FG001|COMPLETED|Overall Study||15
6425217|NCT01014728|7339654|FG000|NOT COMPLETED|Overall Study||0
6425218|NCT01014728|7339655|FG001|NOT COMPLETED|Overall Study||0
6425219|NCT01014741|7339663|FG000|STARTED|Overall Study||105
6425220|NCT01014741|7339664|FG001|STARTED|Overall Study||95
6425221|NCT01014741|7339663|FG000|COMPLETED|Overall Study||94
6425222|NCT01014741|7339664|FG001|COMPLETED|Overall Study||90
6425223|NCT01014741|7339663|FG000|NOT COMPLETED|Overall Study||11
6425224|NCT01014741|7339664|FG001|NOT COMPLETED|Overall Study||5
6425225|NCT01014871|7339670|FG000|STARTED|Overall Study||30
6551722|NCT00145158|7473979|FG001|COMPLETED|Overall Study||4
6551723|NCT00145158|7473978|FG000|NOT COMPLETED|Overall Study||2
6551724|NCT00145158|7473979|FG001|NOT COMPLETED|Overall Study||3
6551725|NCT01732809|7473988|FG000|STARTED|Overall Study||9
6551726|NCT01732809|7473989|FG001|STARTED|Overall Study||10
6551727|NCT01732809|7473988|FG000|COMPLETED|Overall Study||9
6551728|NCT01732809|7473989|FG001|COMPLETED|Overall Study||9
6425226|NCT01014871|7339670|FG000|COMPLETED|Overall Study||30
6425227|NCT01014871|7339670|FG000|NOT COMPLETED|Overall Study||0
6425228|NCT01014910|7339678|FG000|STARTED|Overall Study||80
6425229|NCT01014910|7339679|FG001|STARTED|Overall Study||81
6425230|NCT01014910|7339678|FG000|COMPLETED|Overall Study||80
6425231|NCT01014910|7339679|FG001|COMPLETED|Overall Study||79
6425232|NCT01014910|7339678|FG000|NOT COMPLETED|Overall Study||0
6425233|NCT01014910|7339679|FG001|NOT COMPLETED|Overall Study||2
6425234|NCT01014936|7339688|FG000|STARTED|Overall Study||42
6425235|NCT01014936|7339689|FG001|STARTED|Overall Study||45
6425236|NCT01014936|7339690|FG002|STARTED|Overall Study||62
6425237|NCT01014936|7339688|FG000|COMPLETED|Overall Study||42
6425238|NCT01014936|7339689|FG001|COMPLETED|Overall Study||45
6425239|NCT01014936|7339690|FG002|COMPLETED|Overall Study||62
6425240|NCT01014936|7339688|FG000|NOT COMPLETED|Overall Study||0
6425241|NCT01014936|7339689|FG001|NOT COMPLETED|Overall Study||0
6425242|NCT01014936|7339690|FG002|NOT COMPLETED|Overall Study||0
6425243|NCT01014975|7339756|FG000|STARTED|Overall Study||8
6651584|NCT02420093|7581021|FG000|COMPLETED|Overall Study||8
6651585|NCT02420093|7581022|FG001|COMPLETED|Overall Study||7
6651586|NCT02420093|7581021|FG000|NOT COMPLETED|Overall Study||1
6651587|NCT02420093|7581022|FG001|NOT COMPLETED|Overall Study||1
6656056|NCT02457819|7586229|FG000|Safety Population|Overall Study||236
6656057|NCT02457819|7586229|FG000|COMPLETED|Overall Study||138
6656058|NCT02457819|7586229|FG000|NOT COMPLETED|Overall Study||99
6656059|NCT02457897|7586233|FG000|STARTED|Part 1 Short-term (2 Weeks) Study||7
6656060|NCT02457897|7586233|FG000|COMPLETED|Part 1 Short-term (2 Weeks) Study||7
6656061|NCT02457897|7586233|FG000|NOT COMPLETED|Part 1 Short-term (2 Weeks) Study||0
6656062|NCT02457897|7586233|FG000|STARTED|Part 2 Long-term (6 Month) Study|Two patients were not eligible for Part 2 study because their HbA1c was less than 7.|5
6656063|NCT02457897|7586233|FG000|COMPLETED|Part 2 Long-term (6 Month) Study||5
6656064|NCT02457897|7586233|FG000|NOT COMPLETED|Part 2 Long-term (6 Month) Study||0
6656065|NCT02458092|7586239|FG000|STARTED|Overall Study||20
6656066|NCT02458092|7586240|FG001|STARTED|Overall Study||10
6656067|NCT02458092|7586239|FG000|COMPLETED|Overall Study||19
6656068|NCT02458092|7586240|FG001|COMPLETED|Overall Study||10
6656069|NCT02458092|7586239|FG000|NOT COMPLETED|Overall Study||1
6656070|NCT02458092|7586240|FG001|NOT COMPLETED|Overall Study||0
6656071|NCT02458235|7586247|FG000|STARTED|Overall Study||17
6656072|NCT02458235|7586247|FG000|COMPLETED|Overall Study||17
6656073|NCT02458235|7586247|FG000|NOT COMPLETED|Overall Study||0
6656074|NCT02458287|7586255|FG000|STARTED|Overall Study||50
6656075|NCT02458287|7586256|FG001|STARTED|Overall Study||100
6656076|NCT02458287|7586257|FG002|STARTED|Overall Study||49
6656077|NCT02458287|7586258|FG003|STARTED|Overall Study||100
6656078|NCT02458287|7586255|FG000|COMPLETED|Overall Study||50
6656079|NCT02458287|7586256|FG001|COMPLETED|Overall Study||96
6656080|NCT02458287|7586257|FG002|COMPLETED|Overall Study||46
6656081|NCT02458287|7586258|FG003|COMPLETED|Overall Study||97
6656082|NCT02458287|7586255|FG000|NOT COMPLETED|Overall Study||0
6656083|NCT02458287|7586256|FG001|NOT COMPLETED|Overall Study||4
6656084|NCT02458287|7586257|FG002|NOT COMPLETED|Overall Study||3
6656085|NCT02458287|7586258|FG003|NOT COMPLETED|Overall Study||3
6656086|NCT02458352|7586274|FG000|STARTED|Overall Study||105
6656087|NCT02458352|7586274|FG000|COMPLETED|Overall Study||105
6656088|NCT02458352|7586274|FG000|NOT COMPLETED|Overall Study||0
6656089|NCT02458365|7586282|FG000|STARTED|Overall Study||2000
6656090|NCT02458365|7586283|FG001|STARTED|Overall Study||1901
6656091|NCT02458365|7586282|FG000|COMPLETED|Overall Study||1723
6656092|NCT02458365|7586283|FG001|COMPLETED|Overall Study||1607
6656093|NCT02458365|7586282|FG000|NOT COMPLETED|Overall Study||277
6656094|NCT02458365|7586283|FG001|NOT COMPLETED|Overall Study||294
6656095|NCT02458469|7586290|FG000|STARTED|First Intervention (2 Weeks)||3
6656096|NCT02458469|7586291|FG001|STARTED|First Intervention (2 Weeks)||2
6656097|NCT02458469|7586292|FG002|STARTED|First Intervention (2 Weeks)||3
6656098|NCT02458469|7586293|FG003|STARTED|First Intervention (2 Weeks)||0
6656099|NCT02458469|7586294|FG004|STARTED|First Intervention (2 Weeks)||1
6656100|NCT02458469|7586295|FG005|STARTED|First Intervention (2 Weeks)||2
6656101|NCT02458469|7586290|FG000|COMPLETED|First Intervention (2 Weeks)||2
6656102|NCT02458469|7586291|FG001|COMPLETED|First Intervention (2 Weeks)||2
6656103|NCT02458469|7586292|FG002|COMPLETED|First Intervention (2 Weeks)||2
6656104|NCT02458469|7586293|FG003|COMPLETED|First Intervention (2 Weeks)||0
6656105|NCT02458469|7586294|FG004|COMPLETED|First Intervention (2 Weeks)||1
6656106|NCT02458469|7586295|FG005|COMPLETED|First Intervention (2 Weeks)||2
6656107|NCT02458469|7586290|FG000|NOT COMPLETED|First Intervention (2 Weeks)||1
6656108|NCT02458469|7586291|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
6656109|NCT02458469|7586292|FG002|NOT COMPLETED|First Intervention (2 Weeks)||1
6656110|NCT02458469|7586293|FG003|NOT COMPLETED|First Intervention (2 Weeks)||0
6656111|NCT02458469|7586294|FG004|NOT COMPLETED|First Intervention (2 Weeks)||0
6656112|NCT02458469|7586295|FG005|NOT COMPLETED|First Intervention (2 Weeks)||0
6656113|NCT02458469|7586290|FG000|STARTED|First Washout (2 Weeks)||2
6656114|NCT02458469|7586291|FG001|STARTED|First Washout (2 Weeks)||2
6656115|NCT02458469|7586292|FG002|STARTED|First Washout (2 Weeks)||2
6656116|NCT02458469|7586293|FG003|STARTED|First Washout (2 Weeks)||0
6425244|NCT01014975|7339757|FG001|STARTED|Overall Study||16
6425245|NCT01014975|7339758|FG002|STARTED|Overall Study||16
6425246|NCT01014975|7339756|FG000|COMPLETED|Overall Study||4
6425247|NCT01014975|7339757|FG001|COMPLETED|Overall Study||13
6425248|NCT01014975|7339758|FG002|COMPLETED|Overall Study||10
6425249|NCT01014975|7339756|FG000|NOT COMPLETED|Overall Study||4
6425250|NCT01014975|7339757|FG001|NOT COMPLETED|Overall Study||3
6425251|NCT01014975|7339758|FG002|NOT COMPLETED|Overall Study||6
6425252|NCT01014988|7339772|FG000|STARTED|Overall Study||130
6425253|NCT01014988|7339773|FG001|STARTED|Overall Study||7
6425254|NCT01014988|7339774|FG002|STARTED|Overall Study||11
6425255|NCT01014988|7339775|FG003|STARTED|Overall Study||12
6425256|NCT01014988|7339776|FG004|STARTED|Overall Study||27
6425257|NCT01014988|7339777|FG005|STARTED|Overall Study||14
6425258|NCT01014988|7339772|FG000|COMPLETED|Overall Study||107
6425259|NCT01014988|7339773|FG001|COMPLETED|Overall Study||7
6425260|NCT01014988|7339774|FG002|COMPLETED|Overall Study||9
6425261|NCT01014988|7339775|FG003|COMPLETED|Overall Study||12
6651588|NCT02420210|7581028|FG000|STARTED|Overall Study||2
6651589|NCT02420210|7581028|FG000|COMPLETED|Overall Study||2
6651590|NCT02420210|7581028|FG000|NOT COMPLETED|Overall Study||0
6651591|NCT02420223|7581034|FG000|STARTED|Overall Study||12
6651592|NCT02420223|7581035|FG001|STARTED|Overall Study||13
6651593|NCT02420223|7581034|FG000|COMPLETED|Overall Study||11
6651594|NCT02420223|7581035|FG001|COMPLETED|Overall Study||11
6651595|NCT02420223|7581034|FG000|NOT COMPLETED|Overall Study||1
6651596|NCT02420223|7581035|FG001|NOT COMPLETED|Overall Study||2
6651597|NCT02420262|7581043|FG000|STARTED|Overall Study||252
6651598|NCT02420262|7581044|FG001|STARTED|Overall Study||254
6651599|NCT02420262|7581043|FG000|Exposed|Overall Study||252
6651600|NCT02420262|7581044|FG001|Exposed|Overall Study|One subject withdrew consent before exposure to trial product due to personal reasons.|253
6651601|NCT02420262|7581043|FG000|COMPLETED|Overall Study||250
6651602|NCT02420262|7581044|FG001|COMPLETED|Overall Study||249
6651603|NCT02420262|7581043|FG000|NOT COMPLETED|Overall Study||2
6651604|NCT02420262|7581044|FG001|NOT COMPLETED|Overall Study||5
6651605|NCT02420327|7581050|FG000|STARTED|Overall Study||43
6651606|NCT02420327|7581050|FG000|COMPLETED|Overall Study||27
6651607|NCT02420327|7581050|FG000|NOT COMPLETED|Overall Study||16
6656117|NCT02458469|7586294|FG004|STARTED|First Washout (2 Weeks)||1
6656118|NCT02458469|7586295|FG005|STARTED|First Washout (2 Weeks)||2
6656119|NCT02458469|7586290|FG000|COMPLETED|First Washout (2 Weeks)||2
6656120|NCT02458469|7586291|FG001|COMPLETED|First Washout (2 Weeks)||2
6656121|NCT02458469|7586292|FG002|COMPLETED|First Washout (2 Weeks)||2
6656122|NCT02458469|7586293|FG003|COMPLETED|First Washout (2 Weeks)||0
6656123|NCT02458469|7586294|FG004|COMPLETED|First Washout (2 Weeks)||1
6656124|NCT02458469|7586295|FG005|COMPLETED|First Washout (2 Weeks)||2
6656125|NCT02458469|7586290|FG000|NOT COMPLETED|First Washout (2 Weeks)||0
6656126|NCT02458469|7586291|FG001|NOT COMPLETED|First Washout (2 Weeks)||0
6656127|NCT02458469|7586292|FG002|NOT COMPLETED|First Washout (2 Weeks)||0
6656128|NCT02458469|7586293|FG003|NOT COMPLETED|First Washout (2 Weeks)||0
6656129|NCT02458469|7586294|FG004|NOT COMPLETED|First Washout (2 Weeks)||0
6656130|NCT02458469|7586295|FG005|NOT COMPLETED|First Washout (2 Weeks)||0
6656131|NCT02458469|7586290|FG000|STARTED|Second Intervention (2 Weeks)||2
6656132|NCT02458469|7586291|FG001|STARTED|Second Intervention (2 Weeks)||2
6656133|NCT02458469|7586292|FG002|STARTED|Second Intervention (2 Weeks)||2
6656134|NCT02458469|7586293|FG003|STARTED|Second Intervention (2 Weeks)||0
6656135|NCT02458469|7586294|FG004|STARTED|Second Intervention (2 Weeks)||1
6656136|NCT02458469|7586295|FG005|STARTED|Second Intervention (2 Weeks)||2
6656137|NCT02458469|7586290|FG000|COMPLETED|Second Intervention (2 Weeks)||2
6656138|NCT02458469|7586291|FG001|COMPLETED|Second Intervention (2 Weeks)||2
6656139|NCT02458469|7586292|FG002|COMPLETED|Second Intervention (2 Weeks)||2
6656140|NCT02458469|7586293|FG003|COMPLETED|Second Intervention (2 Weeks)||0
6656141|NCT02458469|7586294|FG004|COMPLETED|Second Intervention (2 Weeks)||1
6656142|NCT02458469|7586295|FG005|COMPLETED|Second Intervention (2 Weeks)||1
6656143|NCT02458469|7586290|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6656144|NCT02458469|7586291|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6656145|NCT02458469|7586292|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
6656146|NCT02458469|7586293|FG003|NOT COMPLETED|Second Intervention (2 Weeks)||0
6656147|NCT02458469|7586294|FG004|NOT COMPLETED|Second Intervention (2 Weeks)||0
6656148|NCT02458469|7586295|FG005|NOT COMPLETED|Second Intervention (2 Weeks)||1
6656149|NCT02458469|7586290|FG000|STARTED|Second Washout (2 Weeks)||2
6656150|NCT02458469|7586291|FG001|STARTED|Second Washout (2 Weeks)||2
6656151|NCT02458469|7586292|FG002|STARTED|Second Washout (2 Weeks)||2
6656152|NCT02458469|7586293|FG003|STARTED|Second Washout (2 Weeks)||0
6656153|NCT02458469|7586294|FG004|STARTED|Second Washout (2 Weeks)||1
6656154|NCT02458469|7586295|FG005|STARTED|Second Washout (2 Weeks)||1
6656155|NCT02458469|7586290|FG000|COMPLETED|Second Washout (2 Weeks)||2
6656156|NCT02458469|7586291|FG001|COMPLETED|Second Washout (2 Weeks)||2
6656157|NCT02458469|7586292|FG002|COMPLETED|Second Washout (2 Weeks)||2
6656158|NCT02458469|7586293|FG003|COMPLETED|Second Washout (2 Weeks)||0
6656159|NCT02458469|7586294|FG004|COMPLETED|Second Washout (2 Weeks)||1
6656160|NCT02458469|7586295|FG005|COMPLETED|Second Washout (2 Weeks)||1
6656161|NCT02458469|7586290|FG000|NOT COMPLETED|Second Washout (2 Weeks)||0
6656162|NCT02458469|7586291|FG001|NOT COMPLETED|Second Washout (2 Weeks)||0
6656163|NCT02458469|7586292|FG002|NOT COMPLETED|Second Washout (2 Weeks)||0
6656164|NCT02458469|7586293|FG003|NOT COMPLETED|Second Washout (2 Weeks)||0
6656165|NCT02458469|7586294|FG004|NOT COMPLETED|Second Washout (2 Weeks)||0
6425262|NCT01014988|7339776|FG004|COMPLETED|Overall Study||26
6425263|NCT01014988|7339777|FG005|COMPLETED|Overall Study||11
6425264|NCT01014988|7339772|FG000|NOT COMPLETED|Overall Study||23
6425265|NCT01014988|7339773|FG001|NOT COMPLETED|Overall Study||0
6425266|NCT01014988|7339774|FG002|NOT COMPLETED|Overall Study||2
6425267|NCT01014988|7339775|FG003|NOT COMPLETED|Overall Study||0
6425268|NCT01014988|7339776|FG004|NOT COMPLETED|Overall Study||1
6425269|NCT01014988|7339777|FG005|NOT COMPLETED|Overall Study||3
6425270|NCT01015118|7339801|FG000|STARTED|Overall Study||911
6425271|NCT01015118|7339802|FG001|STARTED|Overall Study||455
6425272|NCT01015118|7339801|FG000|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|242
6425273|NCT01015118|7339802|FG001|COMPLETED|Overall Study|Patients who completed max trial therapy duration.|128
6425274|NCT01015118|7339801|FG000|NOT COMPLETED|Overall Study||669
6425275|NCT01015118|7339802|FG001|NOT COMPLETED|Overall Study||327
6425276|NCT01015131|7339808|FG000|STARTED|Overall Study||44
6425277|NCT01015131|7339808|FG000|COMPLETED|Overall Study||36
6425278|NCT01015131|7339808|FG000|NOT COMPLETED|Overall Study||8
6425279|NCT01015170|7339812|FG000|STARTED|Overall Study||454
6425280|NCT01015170|7339812|FG000|COMPLETED|Overall Study||215
6425281|NCT01015170|7339812|FG000|NOT COMPLETED|Overall Study||239
6425282|NCT01015287|7339820|FG000|STARTED|Overall Study||1996
6425283|NCT01015287|7339821|FG001|STARTED|Overall Study||2037
6651608|NCT02420353|7581062|FG000|STARTED|Overall Study||10
6651609|NCT02420353|7581063|FG001|STARTED|Overall Study||10
6651610|NCT02420353|7581062|FG000|Allocation to Intervention|Overall Study||10
6651611|NCT02420353|7581063|FG001|Allocation to Intervention|Overall Study||10
6651612|NCT02420353|7581062|FG000|COMPLETED|Overall Study||10
6651613|NCT02420353|7581063|FG001|COMPLETED|Overall Study||9
6651614|NCT02420353|7581062|FG000|NOT COMPLETED|Overall Study||0
6651615|NCT02420353|7581063|FG001|NOT COMPLETED|Overall Study||1
6651616|NCT02420379|7581071|FG000|STARTED|Overall Study||26
6651617|NCT02420379|7581072|FG001|STARTED|Overall Study||7
6651618|NCT02420379|7581071|FG000|COMPLETED|Overall Study||25
6651619|NCT02420379|7581072|FG001|COMPLETED|Overall Study||3
6651620|NCT02420379|7581071|FG000|NOT COMPLETED|Overall Study||1
6651621|NCT02420379|7581072|FG001|NOT COMPLETED|Overall Study||4
6651622|NCT02420639|7581078|FG000|STARTED|Overall Study|Study obtained 12 patients|12
6651623|NCT02420639|7581078|FG000|COMPLETED|Overall Study|Total of 12 patients enrolled|12
6651624|NCT02420639|7581078|FG000|NOT COMPLETED|Overall Study||0
6651625|NCT02420691|7581082|FG000|STARTED|Overall Study||20
6651626|NCT02420691|7581082|FG000|COMPLETED|Overall Study||14
6651627|NCT02420691|7581082|FG000|NOT COMPLETED|Overall Study||6
6651628|NCT02420873|7581089|FG000|STARTED|Overall Study||9
6651629|NCT02420873|7581090|FG001|STARTED|Overall Study||0
6651630|NCT02420873|7581091|FG002|STARTED|Overall Study||0
6651631|NCT02420873|7581089|FG000|COMPLETED|Overall Study||9
6651632|NCT02420873|7581090|FG001|COMPLETED|Overall Study||0
6651633|NCT02420873|7581091|FG002|COMPLETED|Overall Study||0
6651634|NCT02420873|7581089|FG000|NOT COMPLETED|Overall Study||0
6651635|NCT02420873|7581090|FG001|NOT COMPLETED|Overall Study||0
6651636|NCT02420873|7581091|FG002|NOT COMPLETED|Overall Study||0
6651637|NCT02420951|7581101|FG000|STARTED|Overall Study||25
6651638|NCT02420951|7581102|FG001|STARTED|Overall Study||25
6651639|NCT02420951|7581101|FG000|COMPLETED|Overall Study||25
6651640|NCT02420951|7581102|FG001|COMPLETED|Overall Study||25
6651641|NCT02420951|7581101|FG000|NOT COMPLETED|Overall Study||0
6651642|NCT02420951|7581102|FG001|NOT COMPLETED|Overall Study||0
6651643|NCT02421055|7581110|FG000|STARTED|Overall Study||34
6651644|NCT02421055|7581111|FG001|STARTED|Overall Study||50
6651645|NCT02421055|7581112|FG002|STARTED|Overall Study||74
6651646|NCT02421055|7581110|FG000|Pre-operative Serum Sample (Minimum)|Overall Study||34
6651647|NCT02421055|7581111|FG001|Pre-operative Serum Sample (Minimum)|Overall Study||50
6651648|NCT02421055|7581112|FG002|Pre-operative Serum Sample (Minimum)|Overall Study||74
6651649|NCT02421055|7581110|FG000|Pre-operative Complete Sample Set|Overall Study||23
6651650|NCT02421055|7581111|FG001|Pre-operative Complete Sample Set|Overall Study||22
6651651|NCT02421055|7581112|FG002|Pre-operative Complete Sample Set|Overall Study||36
6651652|NCT02421055|7581110|FG000|Post-operative Serum Sample (Minimum)|Overall Study||0
6651653|NCT02421055|7581111|FG001|Post-operative Serum Sample (Minimum)|Overall Study||23
6651654|NCT02421055|7581112|FG002|Post-operative Serum Sample (Minimum)|Overall Study||26
6651655|NCT02421055|7581110|FG000|Post-operative Complete Sample Set|Overall Study||0
6651656|NCT02421055|7581111|FG001|Post-operative Complete Sample Set|Overall Study||13
6651657|NCT02421055|7581112|FG002|Post-operative Complete Sample Set|Overall Study||14
6651658|NCT02421055|7581110|FG000|COMPLETED|Overall Study||0
6651659|NCT02421055|7581111|FG001|COMPLETED|Overall Study||50
6651660|NCT02421055|7581112|FG002|COMPLETED|Overall Study||74
6651661|NCT02421055|7581110|FG000|NOT COMPLETED|Overall Study||34
6651662|NCT02421055|7581111|FG001|NOT COMPLETED|Overall Study||0
6651663|NCT02421055|7581112|FG002|NOT COMPLETED|Overall Study||0
6425284|NCT01015287|7339820|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1996
6651664|NCT02421094|7581123|FG000|STARTED|Overall Study||15
6651665|NCT02421094|7581124|FG001|STARTED|Overall Study||15
6651666|NCT02421094|7581123|FG000|COMPLETED|Overall Study||15
6651667|NCT02421094|7581124|FG001|COMPLETED|Overall Study||15
6651668|NCT02421094|7581123|FG000|NOT COMPLETED|Overall Study||0
6651669|NCT02421094|7581124|FG001|NOT COMPLETED|Overall Study||0
6651670|NCT02421120|7581130|FG000|STARTED|Overall Study||21
6651671|NCT02421120|7581130|FG000|COMPLETED|Overall Study||20
6651672|NCT02421120|7581130|FG000|NOT COMPLETED|Overall Study||1
6651673|NCT02421146|7581138|FG000|STARTED|Overall Study||2
6651674|NCT02421146|7581139|FG001|STARTED|Overall Study||4
6425285|NCT01015287|7339821|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2037
6425286|NCT01015287|7339820|FG000|COMPLETED|Overall Study||1924
6425287|NCT01015287|7339821|FG001|COMPLETED|Overall Study||1958
6425288|NCT01015287|7339820|FG000|NOT COMPLETED|Overall Study||72
6551729|NCT01732809|7473988|FG000|NOT COMPLETED|Overall Study||0
6551730|NCT01732809|7473989|FG001|NOT COMPLETED|Overall Study||1
6551731|NCT01732822|7473997|FG000|STARTED|Overall Study||6930
6551732|NCT01732822|7473998|FG001|STARTED|Overall Study||6955
6551733|NCT01732822|7473997|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6807
6551734|NCT01732822|7473998|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the PACD|6842
6551735|NCT01732822|7473997|FG000|NOT COMPLETED|Overall Study||123
6551736|NCT01732822|7473998|FG001|NOT COMPLETED|Overall Study||113
6551737|NCT01732835|7474026|FG000|STARTED|6-month Primary Endpoint||68
6551738|NCT01732835|7474026|FG000|COMPLETED|6-month Primary Endpoint||44
6425289|NCT01015287|7339821|FG001|NOT COMPLETED|Overall Study||79
6425290|NCT01015326|7339831|FG000|STARTED|Overall Study||12
6425291|NCT01015326|7339832|FG001|STARTED|Overall Study||20
6425292|NCT01015326|7339831|FG000|COMPLETED|Overall Study||11
6425293|NCT01015326|7339832|FG001|COMPLETED|Overall Study||18
6425294|NCT01015326|7339831|FG000|NOT COMPLETED|Overall Study||1
6425295|NCT01015326|7339832|FG001|NOT COMPLETED|Overall Study||2
6425296|NCT01015443|7339840|FG000|STARTED|Overall Study||191
6425297|NCT01015443|7339841|FG001|STARTED|Overall Study||94
6425298|NCT01015443|7339840|FG000|Treated|Overall Study||191
6425299|NCT01015443|7339841|FG001|Treated|Overall Study||93
6425300|NCT01015443|7339840|FG000|COMPLETED|Overall Study||191
6425301|NCT01015443|7339841|FG001|COMPLETED|Overall Study||94
6425302|NCT01015443|7339840|FG000|NOT COMPLETED|Overall Study||0
6425303|NCT01015443|7339841|FG001|NOT COMPLETED|Overall Study||0
6425304|NCT01015534|7339849|FG000|STARTED|Overall Study||28
6425305|NCT01015534|7339850|FG001|STARTED|Overall Study||27
6425306|NCT01015534|7339849|FG000|COMPLETED|Overall Study||27
6425307|NCT01015534|7339850|FG001|COMPLETED|Overall Study||27
6425308|NCT01015534|7339849|FG000|NOT COMPLETED|Overall Study||1
6425309|NCT01015534|7339850|FG001|NOT COMPLETED|Overall Study||0
6425310|NCT01015560|7339859|FG000|STARTED|Overall Study||44
6425311|NCT01015560|7339859|FG000|Eligible and Analyzable|Overall Study||43
6425312|NCT01015560|7339859|FG000|COMPLETED|Overall Study||41
6425313|NCT01015560|7339859|FG000|NOT COMPLETED|Overall Study||3
6425314|NCT01015586|7339865|FG000|STARTED|Overall Study||21
6425315|NCT01015586|7339866|FG001|STARTED|Overall Study||22
6425316|NCT01015586|7339865|FG000|COMPLETED|Overall Study||14
6425317|NCT01015586|7339866|FG001|COMPLETED|Overall Study||11
6651675|NCT02421146|7581140|FG002|STARTED|Overall Study||3
6651676|NCT02421146|7581141|FG003|STARTED|Overall Study||3
6651677|NCT02421146|7581138|FG000|COMPLETED|Overall Study||2
6651678|NCT02421146|7581139|FG001|COMPLETED|Overall Study||4
6651679|NCT02421146|7581140|FG002|COMPLETED|Overall Study||3
6651680|NCT02421146|7581141|FG003|COMPLETED|Overall Study||3
6651681|NCT02421146|7581138|FG000|NOT COMPLETED|Overall Study||0
6651682|NCT02421146|7581139|FG001|NOT COMPLETED|Overall Study||0
6651683|NCT02421146|7581140|FG002|NOT COMPLETED|Overall Study||0
6651684|NCT02421146|7581141|FG003|NOT COMPLETED|Overall Study||0
6651685|NCT02421172|7581153|FG000|STARTED|Period 1||33
6651686|NCT02421172|7581154|FG001|STARTED|Period 1||33
6651687|NCT02421172|7581155|FG002|STARTED|Period 1||0
6651688|NCT02421172|7581156|FG003|STARTED|Period 1||0
6651689|NCT02421172|7581157|FG004|STARTED|Period 1||0
6651690|NCT02421172|7581153|FG000|PD Analysis Set Period 1|Period 1||31
6651691|NCT02421172|7581154|FG001|PD Analysis Set Period 1|Period 1||33
6651692|NCT02421172|7581155|FG002|PD Analysis Set Period 1|Period 1||0
6651693|NCT02421172|7581156|FG003|PD Analysis Set Period 1|Period 1||0
6651694|NCT02421172|7581157|FG004|PD Analysis Set Period 1|Period 1||0
6651695|NCT02421172|7581153|FG000|PK Analysis Set Period 1|Period 1||33
6651696|NCT02421172|7581154|FG001|PK Analysis Set Period 1|Period 1||0
6651697|NCT02421172|7581155|FG002|PK Analysis Set Period 1|Period 1||0
6651698|NCT02421172|7581156|FG003|PK Analysis Set Period 1|Period 1||0
6651699|NCT02421172|7581157|FG004|PK Analysis Set Period 1|Period 1||0
6651700|NCT02421172|7581153|FG000|COMPLETED|Period 1||29
6651701|NCT02421172|7581154|FG001|COMPLETED|Period 1||31
6651702|NCT02421172|7581155|FG002|COMPLETED|Period 1||0
6651703|NCT02421172|7581156|FG003|COMPLETED|Period 1||0
6651704|NCT02421172|7581157|FG004|COMPLETED|Period 1||0
6651705|NCT02421172|7581153|FG000|NOT COMPLETED|Period 1||4
6651706|NCT02421172|7581154|FG001|NOT COMPLETED|Period 1||2
6651707|NCT02421172|7581155|FG002|NOT COMPLETED|Period 1||0
6651708|NCT02421172|7581156|FG003|NOT COMPLETED|Period 1||0
6651709|NCT02421172|7581157|FG004|NOT COMPLETED|Period 1||0
6425318|NCT01015586|7339865|FG000|NOT COMPLETED|Overall Study||7
6425319|NCT01015586|7339866|FG001|NOT COMPLETED|Overall Study||11
6425320|NCT01015612|7339872|FG000|STARTED|Overall Study||634
6425321|NCT01015612|7339872|FG000|COMPLETED|Overall Study||481
6425322|NCT01015612|7339872|FG000|NOT COMPLETED|Overall Study||153
6425323|NCT01015638|7339878|FG000|STARTED|Overall Study||17
6651710|NCT02421172|7581153|FG000|STARTED|Period 2||0
6651711|NCT02421172|7581154|FG001|STARTED|Period 2||0
6651712|NCT02421172|7581155|FG002|STARTED|Period 2||29
6651713|NCT02421172|7581156|FG003|STARTED|Period 2||16
6651714|NCT02421172|7581157|FG004|STARTED|Period 2||15
6651715|NCT02421172|7581153|FG000|COMPLETED|Period 2||0
6425324|NCT01015638|7339879|FG001|STARTED|Overall Study||19
6425325|NCT01015638|7339878|FG000|COMPLETED|Overall Study||16
6425326|NCT01015638|7339879|FG001|COMPLETED|Overall Study||19
6425327|NCT01015638|7339878|FG000|NOT COMPLETED|Overall Study||1
6425328|NCT01015638|7339879|FG001|NOT COMPLETED|Overall Study||0
6425329|NCT01015677|7339888|FG000|STARTED|Overall Study||34
6425330|NCT01015677|7339889|FG001|STARTED|Overall Study||32
6425331|NCT01015677|7339890|FG002|STARTED|Overall Study||33
6425332|NCT01015677|7339888|FG000|COMPLETED|Overall Study||33
6425333|NCT01015677|7339889|FG001|COMPLETED|Overall Study||28
6425334|NCT01015677|7339890|FG002|COMPLETED|Overall Study||33
6551739|NCT01732835|7474026|FG000|NOT COMPLETED|6-month Primary Endpoint||24
6551740|NCT01732835|7474026|FG000|STARTED|2-year Extended Follow-up||44
6551741|NCT01732835|7474026|FG000|COMPLETED|2-year Extended Follow-up||39
6551742|NCT01732835|7474026|FG000|NOT COMPLETED|2-year Extended Follow-up||5
6551743|NCT01732874|7474032|FG000|STARTED|Overall Study||16
6551744|NCT01732874|7474033|FG001|STARTED|Overall Study||11
6551745|NCT01732874|7474032|FG000|COMPLETED|Overall Study||8
6551746|NCT01732874|7474033|FG001|COMPLETED|Overall Study||8
6551747|NCT01732874|7474032|FG000|NOT COMPLETED|Overall Study||8
6551748|NCT01732874|7474033|FG001|NOT COMPLETED|Overall Study||3
6551749|NCT01733056|7474042|FG000|STARTED|Overall Study||21
6551750|NCT01733056|7474043|FG001|STARTED|Overall Study||10
6551751|NCT01733056|7474044|FG002|STARTED|Overall Study||12
6425335|NCT01015677|7339888|FG000|NOT COMPLETED|Overall Study||1
6425336|NCT01015677|7339889|FG001|NOT COMPLETED|Overall Study||4
6425337|NCT01015677|7339890|FG002|NOT COMPLETED|Overall Study||0
6425338|NCT01015703|7339903|FG000|STARTED|Overall Study||10
6425339|NCT01015703|7339904|FG001|STARTED|Overall Study||10
6425340|NCT01015703|7339905|FG002|STARTED|Overall Study||10
6425341|NCT01015703|7339906|FG003|STARTED|Overall Study||10
6425342|NCT01015703|7339907|FG004|STARTED|Overall Study||10
6425343|NCT01015703|7339903|FG000|COMPLETED|Overall Study||8
6425344|NCT01015703|7339904|FG001|COMPLETED|Overall Study||9
6425345|NCT01015703|7339905|FG002|COMPLETED|Overall Study||10
6425346|NCT01015703|7339906|FG003|COMPLETED|Overall Study||10
6425347|NCT01015703|7339907|FG004|COMPLETED|Overall Study||10
6425348|NCT01015703|7339903|FG000|NOT COMPLETED|Overall Study||2
6425349|NCT01015703|7339904|FG001|NOT COMPLETED|Overall Study||1
6425350|NCT01015703|7339905|FG002|NOT COMPLETED|Overall Study||0
6425351|NCT01015703|7339906|FG003|NOT COMPLETED|Overall Study||0
6425352|NCT01015703|7339907|FG004|NOT COMPLETED|Overall Study||0
6425353|NCT01015768|7339919|FG000|STARTED|Overall Study||30
6425354|NCT01015768|7339920|FG001|STARTED|Overall Study||30
6425355|NCT01015768|7339919|FG000|COMPLETED|Overall Study||26
6425356|NCT01015768|7339920|FG001|COMPLETED|Overall Study||26
6425357|NCT01015768|7339919|FG000|NOT COMPLETED|Overall Study||4
6425358|NCT01015768|7339920|FG001|NOT COMPLETED|Overall Study||4
6425359|NCT01015781|7339930|FG000|STARTED|Overall Study||150
6425360|NCT01015781|7339931|FG001|STARTED|Overall Study||150
6425361|NCT01015781|7339930|FG000|COMPLETED|Overall Study||113
6425362|NCT01015781|7339931|FG001|COMPLETED|Overall Study||121
6425363|NCT01015781|7339930|FG000|NOT COMPLETED|Overall Study||37
6425364|NCT01015781|7339931|FG001|NOT COMPLETED|Overall Study||29
6425365|NCT01015807|7339940|FG000|STARTED|Overall Study||30
6425366|NCT01015807|7339941|FG001|STARTED|Overall Study||30
6425367|NCT01015807|7339942|FG002|STARTED|Overall Study||30
6425368|NCT01015807|7339940|FG000|COMPLETED|Overall Study||30
6425369|NCT01015807|7339941|FG001|COMPLETED|Overall Study||30
6425370|NCT01015807|7339942|FG002|COMPLETED|Overall Study||30
6425371|NCT01015807|7339940|FG000|NOT COMPLETED|Overall Study||0
6425372|NCT01015807|7339941|FG001|NOT COMPLETED|Overall Study||0
6425373|NCT01015807|7339942|FG002|NOT COMPLETED|Overall Study||0
6425374|NCT01015820|7339952|FG000|STARTED|Overall Study||15
6425375|NCT01015820|7339953|FG001|STARTED|Overall Study||15
6425376|NCT01015820|7339952|FG000|COMPLETED|Overall Study||14
6425377|NCT01015820|7339953|FG001|COMPLETED|Overall Study||15
6425378|NCT01015820|7339952|FG000|NOT COMPLETED|Overall Study||1
6425379|NCT01015820|7339953|FG001|NOT COMPLETED|Overall Study||0
6425380|NCT01015976|7339959|FG000|STARTED|Overall Study||5
6425381|NCT01015976|7339960|FG001|STARTED|Overall Study||5
6425382|NCT01015976|7339959|FG000|COMPLETED|Overall Study||5
6425383|NCT01015976|7339960|FG001|COMPLETED|Overall Study||5
6425384|NCT01015976|7339959|FG000|NOT COMPLETED|Overall Study||0
6425385|NCT01015976|7339960|FG001|NOT COMPLETED|Overall Study||0
6425386|NCT01016015|7339964|FG000|STARTED|Overall Study||178
6425387|NCT01016015|7339964|FG000|COMPLETED|Overall Study||159
6425388|NCT01016015|7339964|FG000|NOT COMPLETED|Overall Study||19
6425389|NCT01016067|7339970|FG000|STARTED|Overall Study||11
6425390|NCT01016067|7339971|FG001|STARTED|Overall Study||12
6425391|NCT01016067|7339970|FG000|COMPLETED|Overall Study||9
6425392|NCT01016067|7339971|FG001|COMPLETED|Overall Study||8
6425393|NCT01016067|7339970|FG000|NOT COMPLETED|Overall Study||2
6425394|NCT01016067|7339971|FG001|NOT COMPLETED|Overall Study||4
6499478|NCT01418365|7418187|FG000|STARTED|Second Intervention||14
6499479|NCT01418365|7418188|FG001|STARTED|Second Intervention||14
6499480|NCT01418365|7418187|FG000|COMPLETED|Second Intervention||14
6499481|NCT01418365|7418188|FG001|COMPLETED|Second Intervention||13
6499482|NCT01418365|7418187|FG000|NOT COMPLETED|Second Intervention||0
6499483|NCT01418365|7418188|FG001|NOT COMPLETED|Second Intervention||1
6499484|NCT01418378|7418196|FG000|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|90
6499485|NCT01418378|7418197|FG001|STARTED|Overall Study|A total of 191 subjects were enrolled into the study. 13/191 did not receive a study implant|88
6551752|NCT01733056|7474042|FG000|COMPLETED|Overall Study||21
6425395|NCT01016106|7339979|FG000|STARTED|Overall Study||17
6425396|NCT01016106|7339980|FG001|STARTED|Overall Study||18
6425397|NCT01016106|7339979|FG000|COMPLETED|Overall Study||17
6425398|NCT01016106|7339980|FG001|COMPLETED|Overall Study||18
6425399|NCT01016106|7339979|FG000|NOT COMPLETED|Overall Study||0
6425400|NCT01016106|7339980|FG001|NOT COMPLETED|Overall Study||0
6425401|NCT01016132|7339986|FG000|STARTED|Overall Study||152
6425402|NCT01016132|7339986|FG000|COMPLETED|Overall Study||151
6425403|NCT01016132|7339986|FG000|NOT COMPLETED|Overall Study||1
6425404|NCT01016262|7339993|FG000|STARTED|Double-blind Phase||41
6425405|NCT01016262|7339994|FG001|STARTED|Double-blind Phase||39
6425406|NCT01016262|7339995|FG002|STARTED|Double-blind Phase||39
6425407|NCT01016262|7339996|FG003|STARTED|Double-blind Phase||0
6425408|NCT01016262|7339997|FG004|STARTED|Double-blind Phase||0
6425409|NCT01016262|7339998|FG005|STARTED|Double-blind Phase||0
6425410|NCT01016262|7339993|FG000|COMPLETED|Double-blind Phase||40
6425411|NCT01016262|7339994|FG001|COMPLETED|Double-blind Phase||38
6425412|NCT01016262|7339995|FG002|COMPLETED|Double-blind Phase||30
6425413|NCT01016262|7339996|FG003|COMPLETED|Double-blind Phase||0
6425414|NCT01016262|7339997|FG004|COMPLETED|Double-blind Phase||0
6425415|NCT01016262|7339998|FG005|COMPLETED|Double-blind Phase||0
6425416|NCT01016262|7339993|FG000|NOT COMPLETED|Double-blind Phase||1
6425417|NCT01016262|7339994|FG001|NOT COMPLETED|Double-blind Phase||1
6425418|NCT01016262|7339995|FG002|NOT COMPLETED|Double-blind Phase||9
6425419|NCT01016262|7339996|FG003|NOT COMPLETED|Double-blind Phase||0
6425420|NCT01016262|7339997|FG004|NOT COMPLETED|Double-blind Phase||0
6425421|NCT01016262|7339998|FG005|NOT COMPLETED|Double-blind Phase||0
6425422|NCT01016262|7339993|FG000|STARTED|Open-Label Phase||0
6425423|NCT01016262|7339994|FG001|STARTED|Open-Label Phase||0
6425424|NCT01016262|7339995|FG002|STARTED|Open-Label Phase||0
6425425|NCT01016262|7339996|FG003|STARTED|Open-Label Phase||44
6425426|NCT01016262|7339997|FG004|STARTED|Open-Label Phase||52
6425427|NCT01016262|7339998|FG005|STARTED|Open-Label Phase||20
6425428|NCT01016262|7339993|FG000|COMPLETED|Open-Label Phase||0
6425429|NCT01016262|7339994|FG001|COMPLETED|Open-Label Phase||0
6425430|NCT01016262|7339995|FG002|COMPLETED|Open-Label Phase||0
6425431|NCT01016262|7339996|FG003|COMPLETED|Open-Label Phase||42
6425432|NCT01016262|7339997|FG004|COMPLETED|Open-Label Phase||50
6425433|NCT01016262|7339998|FG005|COMPLETED|Open-Label Phase||20
6425434|NCT01016262|7339993|FG000|NOT COMPLETED|Open-Label Phase||0
6425435|NCT01016262|7339994|FG001|NOT COMPLETED|Open-Label Phase||0
6425436|NCT01016262|7339995|FG002|NOT COMPLETED|Open-Label Phase||0
6425437|NCT01016262|7339996|FG003|NOT COMPLETED|Open-Label Phase||2
6425438|NCT01016262|7339997|FG004|NOT COMPLETED|Open-Label Phase||2
6425439|NCT01016262|7339998|FG005|NOT COMPLETED|Open-Label Phase||0
6425440|NCT01016353|7340011|FG000|STARTED|Overall Study||180
6425441|NCT01016353|7340012|FG001|STARTED|Overall Study||103
6425442|NCT01016353|7340011|FG000|COMPLETED|Overall Study||178
6425443|NCT01016353|7340012|FG001|COMPLETED|Overall Study||102
6425444|NCT01016353|7340011|FG000|NOT COMPLETED|Overall Study||2
6425445|NCT01016353|7340012|FG001|NOT COMPLETED|Overall Study||1
6425446|NCT01016483|7340022|FG000|STARTED|Safety Run-in Part||27
6425447|NCT01016483|7340023|FG001|STARTED|Safety Run-in Part||26
6425448|NCT01016483|7340024|FG002|STARTED|Safety Run-in Part||0
6425449|NCT01016483|7340025|FG003|STARTED|Safety Run-in Part||0
6425450|NCT01016483|7340022|FG000|COMPLETED|Safety Run-in Part||27
6425451|NCT01016483|7340023|FG001|COMPLETED|Safety Run-in Part||26
6425452|NCT01016483|7340024|FG002|COMPLETED|Safety Run-in Part||0
6425453|NCT01016483|7340025|FG003|COMPLETED|Safety Run-in Part||0
6425454|NCT01016483|7340022|FG000|NOT COMPLETED|Safety Run-in Part||0
6425455|NCT01016483|7340023|FG001|NOT COMPLETED|Safety Run-in Part||0
6425456|NCT01016483|7340024|FG002|NOT COMPLETED|Safety Run-in Part||0
6425457|NCT01016483|7340025|FG003|NOT COMPLETED|Safety Run-in Part||0
6425458|NCT01016483|7340022|FG000|STARTED|Phase II||0
6425459|NCT01016483|7340023|FG001|STARTED|Phase II||0
6425460|NCT01016483|7340024|FG002|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
6425461|NCT01016483|7340025|FG003|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
6425462|NCT01016483|7340022|FG000|Treated (Safety Analysis Set [SAF])|Phase II||0
6425463|NCT01016483|7340023|FG001|Treated (Safety Analysis Set [SAF])|Phase II||0
6425464|NCT01016483|7340024|FG002|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
6425465|NCT01016483|7340025|FG003|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
6425466|NCT01016483|7340022|FG000|COMPLETED|Phase II||0
6425467|NCT01016483|7340023|FG001|COMPLETED|Phase II||0
6425468|NCT01016483|7340024|FG002|COMPLETED|Phase II||44
6425469|NCT01016483|7340025|FG003|COMPLETED|Phase II||44
6425470|NCT01016483|7340022|FG000|NOT COMPLETED|Phase II||0
6425471|NCT01016483|7340023|FG001|NOT COMPLETED|Phase II||0
6425472|NCT01016483|7340024|FG002|NOT COMPLETED|Phase II||0
6425473|NCT01016483|7340025|FG003|NOT COMPLETED|Phase II||0
6425474|NCT01016600|7340067|FG000|STARTED|Overall Study||9
6425475|NCT01016600|7340068|FG001|STARTED|Overall Study||4
6425476|NCT01016600|7340069|FG002|STARTED|Overall Study||6
6425477|NCT01016600|7340070|FG003|STARTED|Overall Study||12
6425478|NCT01016600|7340067|FG000|COMPLETED|Overall Study||8
6425479|NCT01016600|7340068|FG001|COMPLETED|Overall Study||4
6425480|NCT01016600|7340069|FG002|COMPLETED|Overall Study||6
6425481|NCT01016600|7340070|FG003|COMPLETED|Overall Study||12
6551753|NCT01733056|7474043|FG001|COMPLETED|Overall Study||10
6425482|NCT01016600|7340067|FG000|NOT COMPLETED|Overall Study||1
6425483|NCT01016600|7340068|FG001|NOT COMPLETED|Overall Study||0
6425484|NCT01016600|7340069|FG002|NOT COMPLETED|Overall Study||0
6425485|NCT01016600|7340070|FG003|NOT COMPLETED|Overall Study||0
6425486|NCT01016652|7340083|FG000|STARTED|Period 1||25
6425487|NCT01016652|7340084|FG001|STARTED|Period 1||24
6425488|NCT01016652|7340083|FG000|COMPLETED|Period 1||25
6425489|NCT01016652|7340084|FG001|COMPLETED|Period 1||24
6425490|NCT01016652|7340083|FG000|NOT COMPLETED|Period 1||0
6425491|NCT01016652|7340084|FG001|NOT COMPLETED|Period 1||0
6425492|NCT01016652|7340083|FG000|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
6425493|NCT01016652|7340084|FG001|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
6425494|NCT01016652|7340083|FG000|COMPLETED|Period 2||25
6551754|NCT01733056|7474044|FG002|COMPLETED|Overall Study||12
6551755|NCT01733056|7474042|FG000|NOT COMPLETED|Overall Study||0
6551756|NCT01733056|7474043|FG001|NOT COMPLETED|Overall Study||0
6551757|NCT01733056|7474044|FG002|NOT COMPLETED|Overall Study||0
6551758|NCT01733069|7474057|FG000|STARTED|Overall Study||264
6551759|NCT01733069|7474058|FG001|STARTED|Overall Study||1598
6651716|NCT02421172|7581154|FG001|COMPLETED|Period 2||0
6651717|NCT02421172|7581155|FG002|COMPLETED|Period 2||22
6651718|NCT02421172|7581156|FG003|COMPLETED|Period 2||13
6651719|NCT02421172|7581157|FG004|COMPLETED|Period 2||14
6651720|NCT02421172|7581153|FG000|NOT COMPLETED|Period 2||0
6651721|NCT02421172|7581154|FG001|NOT COMPLETED|Period 2||0
6651722|NCT02421172|7581155|FG002|NOT COMPLETED|Period 2||7
6651723|NCT02421172|7581156|FG003|NOT COMPLETED|Period 2||3
6651724|NCT02421172|7581157|FG004|NOT COMPLETED|Period 2||1
6651725|NCT02421211|7581170|FG000|STARTED|Overall Study||20
6651726|NCT02421211|7581171|FG001|STARTED|Overall Study||20
6651727|NCT02421211|7581170|FG000|COMPLETED|Overall Study||20
6651728|NCT02421211|7581171|FG001|COMPLETED|Overall Study||20
6651729|NCT02421211|7581170|FG000|NOT COMPLETED|Overall Study||0
6651730|NCT02421211|7581171|FG001|NOT COMPLETED|Overall Study||0
6651731|NCT02421224|7581190|FG000|STARTED|Overall Study||444
6651732|NCT02421224|7581191|FG001|STARTED|Overall Study||397
6651733|NCT02421224|7581192|FG002|STARTED|Overall Study||508
6651734|NCT02421224|7581193|FG003|STARTED|Overall Study||482
6651735|NCT02421224|7581194|FG004|STARTED|Overall Study||495
6651736|NCT02421224|7581195|FG005|STARTED|Overall Study||515
6651737|NCT02421224|7581196|FG006|STARTED|Overall Study||489
6651738|NCT02421224|7581197|FG007|STARTED|Overall Study||364
6651739|NCT02421224|7581198|FG008|STARTED|Overall Study||496
6651740|NCT02421224|7581190|FG000|COMPLETED|Overall Study||442
6651741|NCT02421224|7581191|FG001|COMPLETED|Overall Study||394
6651742|NCT02421224|7581192|FG002|COMPLETED|Overall Study||507
6651743|NCT02421224|7581193|FG003|COMPLETED|Overall Study||479
6651744|NCT02421224|7581194|FG004|COMPLETED|Overall Study||491
6651745|NCT02421224|7581195|FG005|COMPLETED|Overall Study||513
6651746|NCT02421224|7581196|FG006|COMPLETED|Overall Study||489
6651747|NCT02421224|7581197|FG007|COMPLETED|Overall Study||362
6651748|NCT02421224|7581198|FG008|COMPLETED|Overall Study||495
6651749|NCT02421224|7581190|FG000|NOT COMPLETED|Overall Study||2
6651750|NCT02421224|7581191|FG001|NOT COMPLETED|Overall Study||3
6651751|NCT02421224|7581192|FG002|NOT COMPLETED|Overall Study||1
6651752|NCT02421224|7581193|FG003|NOT COMPLETED|Overall Study||3
6651753|NCT02421224|7581194|FG004|NOT COMPLETED|Overall Study||4
6651754|NCT02421224|7581195|FG005|NOT COMPLETED|Overall Study||2
6651755|NCT02421224|7581196|FG006|NOT COMPLETED|Overall Study||0
6651756|NCT02421224|7581197|FG007|NOT COMPLETED|Overall Study||2
6651757|NCT02421224|7581198|FG008|NOT COMPLETED|Overall Study||1
6651758|NCT02421354|7581218|FG000|STARTED|Overall Study||8
6651759|NCT02421354|7581218|FG000|COMPLETED|Overall Study||8
6651760|NCT02421354|7581218|FG000|NOT COMPLETED|Overall Study||0
6651761|NCT02421419|7581225|FG000|STARTED|Overall Study||6
6651762|NCT02421419|7581226|FG001|STARTED|Overall Study||11
6651763|NCT02421419|7581227|FG002|STARTED|Overall Study||9
6425495|NCT01016652|7340084|FG001|COMPLETED|Period 2||24
6425496|NCT01016652|7340083|FG000|NOT COMPLETED|Period 2||0
6425497|NCT01016652|7340084|FG001|NOT COMPLETED|Period 2||0
6551760|NCT01733069|7474057|FG000|COMPLETED|Overall Study||264
6551761|NCT01733069|7474058|FG001|COMPLETED|Overall Study||1598
6551762|NCT01733069|7474057|FG000|NOT COMPLETED|Overall Study||0
6551763|NCT01733069|7474058|FG001|NOT COMPLETED|Overall Study||0
6551764|NCT01733121|7474066|FG000|STARTED|Double-Blind Period (Week 0 to 6)||51
6551765|NCT01733121|7474067|FG001|STARTED|Double-Blind Period (Week 0 to 6)||51
6651764|NCT02421419|7581225|FG000|COMPLETED|Overall Study||6
6651765|NCT02421419|7581226|FG001|COMPLETED|Overall Study||11
6651766|NCT02421419|7581227|FG002|COMPLETED|Overall Study||8
6651767|NCT02421419|7581225|FG000|NOT COMPLETED|Overall Study||0
6651768|NCT02421419|7581226|FG001|NOT COMPLETED|Overall Study||0
6651769|NCT02421419|7581227|FG002|NOT COMPLETED|Overall Study||1
6651770|NCT02421510|7581238|FG000|STARTED|Overall Study||258
6651771|NCT02421510|7581239|FG001|STARTED|Overall Study||261
6651772|NCT02421510|7581240|FG002|STARTED|Overall Study||263
6651773|NCT02421510|7581238|FG000|Completed the 24 Week Treatment Period|Overall Study||236
6651774|NCT02421510|7581239|FG001|Completed the 24 Week Treatment Period|Overall Study||239
6651775|NCT02421510|7581240|FG002|Completed the 24 Week Treatment Period|Overall Study||240
6651776|NCT02421510|7581238|FG000|COMPLETED|Overall Study||225
6651777|NCT02421510|7581239|FG001|COMPLETED|Overall Study||226
6651778|NCT02421510|7581240|FG002|COMPLETED|Overall Study||227
6425498|NCT01016678|7340092|FG000|STARTED|Overall Study||20
6425499|NCT01016678|7340093|FG001|STARTED|Overall Study||17
6425500|NCT01016678|7340094|FG002|STARTED|Overall Study||19
6425501|NCT01016678|7340095|FG003|STARTED|Overall Study||19
6425502|NCT01016678|7340096|FG004|STARTED|Overall Study||19
6425503|NCT01016678|7340092|FG000|COMPLETED|Overall Study||18
6425504|NCT01016678|7340093|FG001|COMPLETED|Overall Study||14
6425505|NCT01016678|7340094|FG002|COMPLETED|Overall Study||15
6425506|NCT01016678|7340095|FG003|COMPLETED|Overall Study||19
6425507|NCT01016678|7340096|FG004|COMPLETED|Overall Study||13
6425508|NCT01016678|7340092|FG000|NOT COMPLETED|Overall Study||2
6425509|NCT01016678|7340093|FG001|NOT COMPLETED|Overall Study||3
6425510|NCT01016678|7340094|FG002|NOT COMPLETED|Overall Study||4
6425511|NCT01016678|7340095|FG003|NOT COMPLETED|Overall Study||0
6425512|NCT01016678|7340096|FG004|NOT COMPLETED|Overall Study||6
6425513|NCT01016691|7340117|FG000|STARTED|Overall Study||17
6425514|NCT01016691|7340118|FG001|STARTED|Overall Study||12
6425515|NCT01016691|7340119|FG002|STARTED|Overall Study||18
6425516|NCT01016691|7340117|FG000|COMPLETED|Overall Study||17
6425517|NCT01016691|7340118|FG001|COMPLETED|Overall Study||12
6425518|NCT01016691|7340119|FG002|COMPLETED|Overall Study||18
6425519|NCT01016691|7340117|FG000|NOT COMPLETED|Overall Study||0
6425520|NCT01016691|7340118|FG001|NOT COMPLETED|Overall Study||0
6425521|NCT01016691|7340119|FG002|NOT COMPLETED|Overall Study||0
6425522|NCT01016769|7340131|FG000|STARTED|Overall Study||4
6651779|NCT02421510|7581238|FG000|NOT COMPLETED|Overall Study||33
6651780|NCT02421510|7581239|FG001|NOT COMPLETED|Overall Study||35
6651781|NCT02421510|7581240|FG002|NOT COMPLETED|Overall Study||36
6651782|NCT02421588|7581250|FG000|STARTED|Overall Study||221
6651783|NCT02421588|7581251|FG001|STARTED|Overall Study||221
6651784|NCT02421588|7581250|FG000|COMPLETED|Overall Study||0
6651785|NCT02421588|7581251|FG001|COMPLETED|Overall Study||0
6651786|NCT02421588|7581250|FG000|NOT COMPLETED|Overall Study||221
6651787|NCT02421588|7581251|FG001|NOT COMPLETED|Overall Study||221
6651788|NCT02421601|7581257|FG000|STARTED|Overall Study||991
6651789|NCT02421601|7581257|FG000|COMPLETED|Overall Study||909
6651790|NCT02421601|7581257|FG000|NOT COMPLETED|Overall Study||82
6651791|NCT02421666|7581263|FG000|STARTED|Overall Study Baseline||272
6651792|NCT02421666|7581264|FG001|STARTED|Overall Study Baseline||260
6651793|NCT02421666|7581263|FG000|COMPLETED|Overall Study Baseline||272
6651794|NCT02421666|7581264|FG001|COMPLETED|Overall Study Baseline||260
6651795|NCT02421666|7581263|FG000|NOT COMPLETED|Overall Study Baseline||0
6651796|NCT02421666|7581264|FG001|NOT COMPLETED|Overall Study Baseline||0
6651797|NCT02421666|7581263|FG000|STARTED|6-month Follow-up||272
6651798|NCT02421666|7581264|FG001|STARTED|6-month Follow-up||260
6651799|NCT02421666|7581263|FG000|COMPLETED|6-month Follow-up||259
6651800|NCT02421666|7581264|FG001|COMPLETED|6-month Follow-up||247
6651801|NCT02421666|7581263|FG000|NOT COMPLETED|6-month Follow-up||13
6651802|NCT02421666|7581264|FG001|NOT COMPLETED|6-month Follow-up||13
6651803|NCT02421666|7581263|FG000|STARTED|12-month Follow-up||259
6651804|NCT02421666|7581264|FG001|STARTED|12-month Follow-up||247
6651805|NCT02421666|7581263|FG000|COMPLETED|12-month Follow-up||248
6651806|NCT02421666|7581264|FG001|COMPLETED|12-month Follow-up||231
6651807|NCT02421666|7581263|FG000|NOT COMPLETED|12-month Follow-up||11
6651808|NCT02421666|7581264|FG001|NOT COMPLETED|12-month Follow-up||16
6651809|NCT02421757|7581272|FG000|STARTED|Overall Study||11
6651810|NCT02421757|7581273|FG001|STARTED|Overall Study||9
6651811|NCT02421757|7581272|FG000|COMPLETED|Overall Study||11
6651812|NCT02421757|7581273|FG001|COMPLETED|Overall Study||9
6651813|NCT02421757|7581272|FG000|NOT COMPLETED|Overall Study||0
6651814|NCT02421757|7581273|FG001|NOT COMPLETED|Overall Study||0
6651815|NCT02421887|7581281|FG000|STARTED|Overall Study||85
6651816|NCT02421887|7581282|FG001|STARTED|Overall Study||86
6651817|NCT02421887|7581281|FG000|COMPLETED|Overall Study||68
6425523|NCT01016769|7340132|FG001|STARTED|Overall Study||7
6425524|NCT01016769|7340133|FG002|STARTED|Overall Study||7
6425525|NCT01016769|7340134|FG003|STARTED|Overall Study||30
6425526|NCT01016769|7340131|FG000|COMPLETED|Overall Study||3
6651818|NCT02421887|7581282|FG001|COMPLETED|Overall Study||77
6651819|NCT02421887|7581281|FG000|NOT COMPLETED|Overall Study||17
6651820|NCT02421887|7581282|FG001|NOT COMPLETED|Overall Study||9
6651821|NCT02421952|7581288|FG000|STARTED|Overall Study||208
6651822|NCT02421952|7581288|FG000|Excluded From PACU and Post-Analysis|Overall Study||16
6651823|NCT02421952|7581288|FG000|Included in PACU Analysis|Overall Study||192
6651824|NCT02421952|7581288|FG000|COMPLETED|Overall Study||99
6651825|NCT02421952|7581288|FG000|NOT COMPLETED|Overall Study||109
6651826|NCT02422186|7581297|FG000|STARTED|Double-blind Induction Phase (4 Weeks)||72
6651827|NCT02422186|7581298|FG001|STARTED|Double-blind Induction Phase (4 Weeks)||66
6651828|NCT02422186|7581297|FG000|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||72
6651829|NCT02422186|7581298|FG001|Full Analysis Set (FAS)|Double-blind Induction Phase (4 Weeks)||65
6651830|NCT02422186|7581297|FG000|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||72
6651831|NCT02422186|7581298|FG001|Safety Analysis Set|Double-blind Induction Phase (4 Weeks)||65
6651832|NCT02422186|7581297|FG000|COMPLETED|Double-blind Induction Phase (4 Weeks)||62
6651833|NCT02422186|7581298|FG001|COMPLETED|Double-blind Induction Phase (4 Weeks)||60
6651834|NCT02422186|7581297|FG000|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||10
6651835|NCT02422186|7581298|FG001|NOT COMPLETED|Double-blind Induction Phase (4 Weeks)||6
6651836|NCT02422186|7581297|FG000|STARTED|Follow-up Phase (2 Weeks)||12
6651837|NCT02422186|7581298|FG001|STARTED|Follow-up Phase (2 Weeks)||3
6425527|NCT01016769|7340132|FG001|COMPLETED|Overall Study||6
6425528|NCT01016769|7340133|FG002|COMPLETED|Overall Study||6
6425529|NCT01016769|7340134|FG003|COMPLETED|Overall Study||30
6425530|NCT01016769|7340131|FG000|NOT COMPLETED|Overall Study||1
6425531|NCT01016769|7340132|FG001|NOT COMPLETED|Overall Study||1
6425532|NCT01016769|7340133|FG002|NOT COMPLETED|Overall Study||1
6425533|NCT01016769|7340134|FG003|NOT COMPLETED|Overall Study||0
6425534|NCT01016834|7340143|FG000|STARTED|Overall Study||242
6425535|NCT01016834|7340143|FG000|COMPLETED|Overall Study||220
6425536|NCT01016834|7340143|FG000|NOT COMPLETED|Overall Study||22
6425537|NCT01016873|7340150|FG000|STARTED|12 Months||75
6425538|NCT01016873|7340151|FG001|STARTED|12 Months||75
6425539|NCT01016873|7340152|FG002|STARTED|12 Months||80
6425540|NCT01016873|7340150|FG000|COMPLETED|12 Months||74
6425541|NCT01016873|7340151|FG001|COMPLETED|12 Months||72
6425542|NCT01016873|7340152|FG002|COMPLETED|12 Months||79
6425543|NCT01016873|7340150|FG000|NOT COMPLETED|12 Months||1
6425544|NCT01016873|7340151|FG001|NOT COMPLETED|12 Months||3
6551766|NCT01733121|7474066|FG000|COMPLETED|Double-Blind Period (Week 0 to 6)||44
6551767|NCT01733121|7474067|FG001|COMPLETED|Double-Blind Period (Week 0 to 6)||46
6551768|NCT01733121|7474066|FG000|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
6651838|NCT02422186|7581297|FG000|COMPLETED|Follow-up Phase (2 Weeks)||8
6651839|NCT02422186|7581298|FG001|COMPLETED|Follow-up Phase (2 Weeks)||3
6651840|NCT02422186|7581297|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
6651841|NCT02422186|7581298|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||0
6651842|NCT02422264|7581308|FG000|STARTED|Overall Study||296
6651843|NCT02422264|7581309|FG001|STARTED|Overall Study||305
6651844|NCT02422264|7581308|FG000|COMPLETED|Overall Study||291
6651845|NCT02422264|7581309|FG001|COMPLETED|Overall Study||301
6651846|NCT02422264|7581308|FG000|NOT COMPLETED|Overall Study||5
6651847|NCT02422264|7581309|FG001|NOT COMPLETED|Overall Study||4
6651848|NCT02422290|7581315|FG000|STARTED|Overall Study||5
6651849|NCT02422290|7581315|FG000|COMPLETED|Overall Study||5
6651850|NCT02422290|7581315|FG000|NOT COMPLETED|Overall Study||0
6651851|NCT02422511|7581327|FG000|STARTED|Overall Study||255
6651852|NCT02422511|7581328|FG001|STARTED|Overall Study||128
6651853|NCT02422511|7581329|FG002|STARTED|Overall Study||257
6651854|NCT02422511|7581330|FG003|STARTED|Overall Study||129
6651855|NCT02422511|7581331|FG004|STARTED|Overall Study||66
6651856|NCT02422511|7581332|FG005|STARTED|Overall Study||33
6651857|NCT02422511|7581333|FG006|STARTED|Overall Study||68
6651858|NCT02422511|7581334|FG007|STARTED|Overall Study||34
6651859|NCT02422511|7581327|FG000|Received Disclosure|Overall Study||158
6651860|NCT02422511|7581328|FG001|Received Disclosure|Overall Study|Newborns did not receive disclosure|79
6651861|NCT02422511|7581329|FG002|Received Disclosure|Overall Study||194
6651862|NCT02422511|7581330|FG003|Received Disclosure|Overall Study||97
6651863|NCT02422511|7581331|FG004|Received Disclosure|Overall Study||43
6651864|NCT02422511|7581332|FG005|Received Disclosure|Overall Study||21
6651865|NCT02422511|7581333|FG006|Received Disclosure|Overall Study||38
6651866|NCT02422511|7581334|FG007|Received Disclosure|Overall Study||19
6651867|NCT02422511|7581327|FG000|COMPLETED|Overall Study||143
6651868|NCT02422511|7581328|FG001|COMPLETED|Overall Study|Newborns did not complete survey|0
6651869|NCT02422511|7581329|FG002|COMPLETED|Overall Study||168
6651870|NCT02422511|7581330|FG003|COMPLETED|Overall Study|Newborns did not complete survey|0
6651871|NCT02422511|7581331|FG004|COMPLETED|Overall Study||39
6651872|NCT02422511|7581332|FG005|COMPLETED|Overall Study|Newborns did not complete survey|0
6651873|NCT02422511|7581333|FG006|COMPLETED|Overall Study||38
6651874|NCT02422511|7581334|FG007|COMPLETED|Overall Study|Newborns did not complete survey|0
6651875|NCT02422511|7581327|FG000|NOT COMPLETED|Overall Study||112
6425545|NCT01016873|7340152|FG002|NOT COMPLETED|12 Months||1
6425546|NCT01016873|7340150|FG000|STARTED|24 Months||74
6425547|NCT01016873|7340151|FG001|STARTED|24 Months||72
6425548|NCT01016873|7340152|FG002|STARTED|24 Months||79
6425549|NCT01016873|7340150|FG000|COMPLETED|24 Months||69
6551769|NCT01733121|7474067|FG001|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
6551770|NCT01733121|7474066|FG000|STARTED|Follow-Up Period (Week 6 to 8)||44
6551771|NCT01733121|7474067|FG001|STARTED|Follow-Up Period (Week 6 to 8)||46
6551772|NCT01733121|7474066|FG000|COMPLETED|Follow-Up Period (Week 6 to 8)||44
6551773|NCT01733121|7474067|FG001|COMPLETED|Follow-Up Period (Week 6 to 8)||46
6651876|NCT02422511|7581328|FG001|NOT COMPLETED|Overall Study||128
6651877|NCT02422511|7581329|FG002|NOT COMPLETED|Overall Study||89
6651878|NCT02422511|7581330|FG003|NOT COMPLETED|Overall Study||129
6651879|NCT02422511|7581331|FG004|NOT COMPLETED|Overall Study||27
6651880|NCT02422511|7581332|FG005|NOT COMPLETED|Overall Study||33
6651881|NCT02422511|7581333|FG006|NOT COMPLETED|Overall Study||30
6651882|NCT02422511|7581334|FG007|NOT COMPLETED|Overall Study||34
6651883|NCT02422940|7581354|FG000|STARTED|Overall Study||152
6651884|NCT02422940|7581355|FG001|STARTED|Overall Study||142
6651885|NCT02422940|7581354|FG000|COMPLETED|Overall Study||31
6651886|NCT02422940|7581355|FG001|COMPLETED|Overall Study||21
6651887|NCT02422940|7581354|FG000|NOT COMPLETED|Overall Study||121
6651888|NCT02422940|7581355|FG001|NOT COMPLETED|Overall Study||121
6651889|NCT02423109|7581361|FG000|STARTED|Lens 1||19
6651890|NCT02423109|7581362|FG001|STARTED|Lens 1||14
6651891|NCT02423109|7581361|FG000|COMPLETED|Lens 1||18
6651892|NCT02423109|7581362|FG001|COMPLETED|Lens 1||14
6651893|NCT02423109|7581361|FG000|NOT COMPLETED|Lens 1||1
6651894|NCT02423109|7581362|FG001|NOT COMPLETED|Lens 1||0
6651895|NCT02423109|7581361|FG000|STARTED|Lens 2||18
6651896|NCT02423109|7581362|FG001|STARTED|Lens 2||14
6651897|NCT02423109|7581361|FG000|COMPLETED|Lens 2||18
6551774|NCT01733121|7474066|FG000|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
6551775|NCT01733121|7474067|FG001|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
6551776|NCT01733186|7474077|FG000|STARTED|Overall Study||6
6551777|NCT01733186|7474078|FG001|STARTED|Overall Study||6
6551778|NCT01733186|7474077|FG000|COMPLETED|Overall Study||6
6551779|NCT01733186|7474078|FG001|COMPLETED|Overall Study||6
6551780|NCT01733186|7474077|FG000|NOT COMPLETED|Overall Study||0
6551781|NCT01733186|7474078|FG001|NOT COMPLETED|Overall Study||0
6551782|NCT01733212|7474086|FG000|STARTED|Overall Study||116
6551783|NCT01733212|7474087|FG001|STARTED|Overall Study||123
6551784|NCT01733212|7474086|FG000|COMPLETED|Overall Study||116
6551785|NCT01733212|7474087|FG001|COMPLETED|Overall Study||123
6425550|NCT01016873|7340151|FG001|COMPLETED|24 Months||68
6425551|NCT01016873|7340152|FG002|COMPLETED|24 Months||73
6425552|NCT01016873|7340150|FG000|NOT COMPLETED|24 Months||5
6425553|NCT01016873|7340151|FG001|NOT COMPLETED|24 Months||4
6425554|NCT01016873|7340152|FG002|NOT COMPLETED|24 Months||6
6425555|NCT01016873|7340150|FG000|STARTED|36 Months||69
6425556|NCT01016873|7340151|FG001|STARTED|36 Months||68
6425557|NCT01016873|7340152|FG002|STARTED|36 Months||73
6425558|NCT01016873|7340150|FG000|COMPLETED|36 Months||58
6425559|NCT01016873|7340151|FG001|COMPLETED|36 Months||64
6425560|NCT01016873|7340152|FG002|COMPLETED|36 Months||67
6425561|NCT01016873|7340150|FG000|NOT COMPLETED|36 Months||11
6425562|NCT01016873|7340151|FG001|NOT COMPLETED|36 Months||4
6425563|NCT01016873|7340152|FG002|NOT COMPLETED|36 Months||6
6425564|NCT01016912|7340165|FG000|STARTED|End of Treatment Period||8
6425565|NCT01016912|7340166|FG001|STARTED|End of Treatment Period||9
6425566|NCT01016912|7340167|FG002|STARTED|End of Treatment Period||10
6425567|NCT01016912|7340168|FG003|STARTED|End of Treatment Period||9
6425568|NCT01016912|7340169|FG004|STARTED|End of Treatment Period||9
6425569|NCT01016912|7340165|FG000|Received Treatment|End of Treatment Period||8
6425570|NCT01016912|7340166|FG001|Received Treatment|End of Treatment Period||9
6425571|NCT01016912|7340167|FG002|Received Treatment|End of Treatment Period||10
6425572|NCT01016912|7340168|FG003|Received Treatment|End of Treatment Period||9
6425573|NCT01016912|7340169|FG004|Received Treatment|End of Treatment Period||9
6425574|NCT01016912|7340165|FG000|COMPLETED|End of Treatment Period||8
6425575|NCT01016912|7340166|FG001|COMPLETED|End of Treatment Period||6
6425576|NCT01016912|7340167|FG002|COMPLETED|End of Treatment Period||9
6425577|NCT01016912|7340168|FG003|COMPLETED|End of Treatment Period||5
6425578|NCT01016912|7340169|FG004|COMPLETED|End of Treatment Period||5
6425579|NCT01016912|7340165|FG000|NOT COMPLETED|End of Treatment Period||0
6425580|NCT01016912|7340166|FG001|NOT COMPLETED|End of Treatment Period||3
6425581|NCT01016912|7340167|FG002|NOT COMPLETED|End of Treatment Period||1
6425582|NCT01016912|7340168|FG003|NOT COMPLETED|End of Treatment Period||4
6425583|NCT01016912|7340169|FG004|NOT COMPLETED|End of Treatment Period||4
6425584|NCT01016912|7340165|FG000|STARTED|Follow-up Period||8
6425585|NCT01016912|7340166|FG001|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
6425586|NCT01016912|7340167|FG002|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
6425587|NCT01016912|7340168|FG003|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
6425588|NCT01016912|7340169|FG004|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
6425589|NCT01016912|7340165|FG000|COMPLETED|Follow-up Period||8
6425590|NCT01016912|7340166|FG001|COMPLETED|Follow-up Period||9
6425591|NCT01016912|7340167|FG002|COMPLETED|Follow-up Period||9
6425592|NCT01016912|7340168|FG003|COMPLETED|Follow-up Period||8
6425593|NCT01016912|7340169|FG004|COMPLETED|Follow-up Period||9
6425594|NCT01016912|7340165|FG000|NOT COMPLETED|Follow-up Period||0
6425595|NCT01016912|7340166|FG001|NOT COMPLETED|Follow-up Period||0
6425596|NCT01016912|7340167|FG002|NOT COMPLETED|Follow-up Period||1
6425597|NCT01016912|7340168|FG003|NOT COMPLETED|Follow-up Period||1
6425598|NCT01016912|7340169|FG004|NOT COMPLETED|Follow-up Period||0
6425599|NCT01016938|7340201|FG000|STARTED|Overall Study||16
6425600|NCT01016938|7340201|FG000|COMPLETED|Overall Study||7
6425601|NCT01016938|7340201|FG000|NOT COMPLETED|Overall Study||9
6551786|NCT01733212|7474086|FG000|NOT COMPLETED|Overall Study||0
6551787|NCT01733212|7474087|FG001|NOT COMPLETED|Overall Study||0
6551788|NCT01733238|7474093|FG000|STARTED|Overall Study||13
6551789|NCT01733238|7474093|FG000|COMPLETED|Overall Study|8 subjects completed the Induction Phase and 7 subjects started Maintenance Phase|8
6551790|NCT01733238|7474093|FG000|NOT COMPLETED|Overall Study||5
6551791|NCT01733277|7474099|FG000|STARTED|Overall Study||25
6551792|NCT01733277|7474100|FG001|STARTED|Overall Study||25
6551793|NCT01733277|7474099|FG000|COMPLETED|Overall Study||25
6551794|NCT01733277|7474100|FG001|COMPLETED|Overall Study||25
6551795|NCT01733277|7474099|FG000|NOT COMPLETED|Overall Study||0
6551796|NCT01733277|7474100|FG001|NOT COMPLETED|Overall Study||0
6551797|NCT01733316|7474106|FG000|STARTED|Cystagon® Phase||41
6551798|NCT01733316|7474106|FG000|COMPLETED|Cystagon® Phase||41
6551799|NCT01733316|7474106|FG000|NOT COMPLETED|Cystagon® Phase||0
6551800|NCT01733316|7474106|FG000|STARTED|RP103 Phase||41
6551801|NCT01733316|7474106|FG000|COMPLETED|RP103 Phase||40
6551802|NCT01733316|7474106|FG000|NOT COMPLETED|RP103 Phase||1
6551803|NCT01733316|7474106|FG000|STARTED|Long Term Extension Phase|Two participants did not enter the long term follow up period.|38
6551804|NCT01733316|7474106|FG000|COMPLETED|Long Term Extension Phase||33
6425602|NCT01016964|7340208|FG000|STARTED|Overall Study||21
6425603|NCT01016964|7340209|FG001|STARTED|Overall Study||42
6425604|NCT01016964|7340208|FG000|COMPLETED|Overall Study||18
6425605|NCT01016964|7340209|FG001|COMPLETED|Overall Study||39
6551805|NCT01733316|7474106|FG000|NOT COMPLETED|Long Term Extension Phase||5
6551806|NCT01733329|7474119|FG000|STARTED|Overall Study||62
6551807|NCT01733329|7474120|FG001|STARTED|Overall Study||61
6551808|NCT01733329|7474119|FG000|COMPLETED|Overall Study||60
6551809|NCT01733329|7474120|FG001|COMPLETED|Overall Study||60
6551810|NCT01733329|7474119|FG000|NOT COMPLETED|Overall Study||2
6551811|NCT01733329|7474120|FG001|NOT COMPLETED|Overall Study||1
6651898|NCT02423109|7581362|FG001|COMPLETED|Lens 2||14
6651899|NCT02423109|7581361|FG000|NOT COMPLETED|Lens 2||0
6651900|NCT02423109|7581362|FG001|NOT COMPLETED|Lens 2||0
6651901|NCT02423122|7581372|FG000|STARTED|Overall Study||9
6651902|NCT02423122|7581373|FG001|STARTED|Overall Study||7
6651903|NCT02423122|7581372|FG000|COMPLETED|Overall Study||9
6651904|NCT02423122|7581373|FG001|COMPLETED|Overall Study||7
6651905|NCT02423122|7581372|FG000|NOT COMPLETED|Overall Study||0
6651906|NCT02423122|7581373|FG001|NOT COMPLETED|Overall Study||0
6651907|NCT02423200|7581381|FG000|STARTED|Overall Study||8
6651908|NCT02423200|7581382|FG001|STARTED|Overall Study||1
6651909|NCT02423200|7581381|FG000|COMPLETED|Overall Study||7
6651910|NCT02423200|7581382|FG001|COMPLETED|Overall Study||1
6651911|NCT02423200|7581381|FG000|NOT COMPLETED|Overall Study||1
6651912|NCT02423200|7581382|FG001|NOT COMPLETED|Overall Study||0
6651913|NCT02423291|7581389|FG000|STARTED|Overall Study|Patients enrolled|15
6651914|NCT02423291|7581389|FG000|COMPLETED|Overall Study|Patients that have completed therapy|0
6651915|NCT02423291|7581389|FG000|NOT COMPLETED|Overall Study||15
6651916|NCT02423317|7581395|FG000|STARTED|Overall Study||30
6651917|NCT02423317|7581396|FG001|STARTED|Overall Study||30
6651918|NCT02423317|7581395|FG000|COMPLETED|Overall Study||30
6651919|NCT02423317|7581396|FG001|COMPLETED|Overall Study||30
6651920|NCT02423317|7581395|FG000|NOT COMPLETED|Overall Study||0
6651921|NCT02423317|7581396|FG001|NOT COMPLETED|Overall Study||0
6651922|NCT02423343|7581408|FG000|STARTED|Overall Study||3
6651923|NCT02423343|7581409|FG001|STARTED|Overall Study||5
6651924|NCT02423343|7581410|FG002|STARTED|Overall Study||3
6651925|NCT02423343|7581411|FG003|STARTED|Overall Study||4
6651926|NCT02423343|7581412|FG004|STARTED|Overall Study||25
6651927|NCT02423343|7581413|FG005|STARTED|Overall Study||1
6651928|NCT02423343|7581408|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6651929|NCT02423343|7581409|FG001|Received at Least One Dose of Study Drug|Overall Study||5
6651930|NCT02423343|7581410|FG002|Received at Least One Dose of Study Drug|Overall Study||3
6651931|NCT02423343|7581411|FG003|Received at Least One Dose of Study Drug|Overall Study||4
6744237|NCT03341299|7672342|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
6744238|NCT03341299|7672343|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
6744239|NCT03341299|7672340|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744240|NCT03341299|7672341|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744241|NCT03341299|7672342|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744242|NCT03341299|7672343|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744243|NCT03341299|7672340|FG000|STARTED|Period 3||9
6744244|NCT03341299|7672341|FG001|STARTED|Period 3||9
6744245|NCT03341299|7672342|FG002|STARTED|Period 3||8
6744246|NCT03341299|7672343|FG003|STARTED|Period 3||9
6744247|NCT03341299|7672340|FG000|COMPLETED|Period 3||9
6744248|NCT03341299|7672341|FG001|COMPLETED|Period 3||9
6744249|NCT03341299|7672342|FG002|COMPLETED|Period 3||8
6744250|NCT03341299|7672343|FG003|COMPLETED|Period 3||9
6744251|NCT03341299|7672340|FG000|NOT COMPLETED|Period 3||0
6744252|NCT03341299|7672341|FG001|NOT COMPLETED|Period 3||0
6744253|NCT03341299|7672342|FG002|NOT COMPLETED|Period 3||0
6744254|NCT03341299|7672343|FG003|NOT COMPLETED|Period 3||0
6744255|NCT03341299|7672340|FG000|STARTED|Washout (A Minimum of 21 Hours)||9
6744256|NCT03341299|7672341|FG001|STARTED|Washout (A Minimum of 21 Hours)||9
6744257|NCT03341299|7672342|FG002|STARTED|Washout (A Minimum of 21 Hours)||8
6551812|NCT01733368|7474126|FG000|STARTED|Overall Study||198
6551813|NCT01733368|7474126|FG000|COMPLETED|Overall Study||167
6551814|NCT01733368|7474126|FG000|NOT COMPLETED|Overall Study||31
6551815|NCT01733407|7474134|FG000|STARTED|Overall Study||9
6744258|NCT03341299|7672343|FG003|STARTED|Washout (A Minimum of 21 Hours)||9
6744259|NCT03341299|7672340|FG000|COMPLETED|Washout (A Minimum of 21 Hours)||9
6744260|NCT03341299|7672341|FG001|COMPLETED|Washout (A Minimum of 21 Hours)||9
6744261|NCT03341299|7672342|FG002|COMPLETED|Washout (A Minimum of 21 Hours)||8
6744262|NCT03341299|7672343|FG003|COMPLETED|Washout (A Minimum of 21 Hours)||9
6744263|NCT03341299|7672340|FG000|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744264|NCT03341299|7672341|FG001|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744265|NCT03341299|7672342|FG002|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6551816|NCT01733407|7474135|FG001|STARTED|Overall Study||9
6551817|NCT01733407|7474134|FG000|COMPLETED|Overall Study||7
6551818|NCT01733407|7474135|FG001|COMPLETED|Overall Study||9
6651932|NCT02423343|7581412|FG004|Received at Least One Dose of Study Drug|Overall Study||25
6651933|NCT02423343|7581413|FG005|Received at Least One Dose of Study Drug|Overall Study||1
6651934|NCT02423343|7581408|FG000|COMPLETED|Overall Study||3
6651935|NCT02423343|7581409|FG001|COMPLETED|Overall Study||4
6651936|NCT02423343|7581410|FG002|COMPLETED|Overall Study||3
6651937|NCT02423343|7581411|FG003|COMPLETED|Overall Study||4
6651938|NCT02423343|7581412|FG004|COMPLETED|Overall Study||20
6651939|NCT02423343|7581413|FG005|COMPLETED|Overall Study||1
6651940|NCT02423343|7581408|FG000|NOT COMPLETED|Overall Study||0
6425606|NCT01016964|7340208|FG000|NOT COMPLETED|Overall Study||3
6425607|NCT01016964|7340209|FG001|NOT COMPLETED|Overall Study||3
6425608|NCT01016977|7340217|FG000|STARTED|Overall Study||20
6425609|NCT01016977|7340218|FG001|STARTED|Overall Study||20
6425610|NCT01016977|7340217|FG000|COMPLETED|Overall Study||17
6425611|NCT01016977|7340218|FG001|COMPLETED|Overall Study||18
6425612|NCT01016977|7340217|FG000|NOT COMPLETED|Overall Study||3
6425613|NCT01016977|7340218|FG001|NOT COMPLETED|Overall Study||2
6425614|NCT01017003|7340227|FG000|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
6425615|NCT01017003|7340227|FG000|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
6651941|NCT02423343|7581409|FG001|NOT COMPLETED|Overall Study||1
6651942|NCT02423343|7581410|FG002|NOT COMPLETED|Overall Study||0
6651943|NCT02423343|7581411|FG003|NOT COMPLETED|Overall Study||0
6651944|NCT02423343|7581412|FG004|NOT COMPLETED|Overall Study||5
6651945|NCT02423343|7581413|FG005|NOT COMPLETED|Overall Study||0
6651946|NCT02423408|7581443|FG000|STARTED|Overall Study||83
6651947|NCT02423408|7581444|FG001|STARTED|Overall Study||82
6651948|NCT02423408|7581443|FG000|COMPLETED|Overall Study||82
6651949|NCT02423408|7581444|FG001|COMPLETED|Overall Study||80
6651950|NCT02423408|7581443|FG000|NOT COMPLETED|Overall Study||1
6651951|NCT02423408|7581444|FG001|NOT COMPLETED|Overall Study||2
6651952|NCT02423447|7581450|FG000|STARTED|Overall Study||13
6651953|NCT02423447|7581451|FG001|STARTED|Overall Study||12
6651954|NCT02423447|7581450|FG000|COMPLETED|Overall Study||13
6651955|NCT02423447|7581451|FG001|COMPLETED|Overall Study||12
6651956|NCT02423447|7581450|FG000|NOT COMPLETED|Overall Study||0
6651957|NCT02423447|7581451|FG001|NOT COMPLETED|Overall Study||0
6651958|NCT02423577|7581462|FG000|STARTED|Overall Study||53
6651959|NCT02423577|7581463|FG001|STARTED|Overall Study||26
6651960|NCT02423577|7581462|FG000|COMPLETED|Overall Study||53
6651961|NCT02423577|7581463|FG001|COMPLETED|Overall Study||26
6651962|NCT02423577|7581462|FG000|NOT COMPLETED|Overall Study||0
6651963|NCT02423577|7581463|FG001|NOT COMPLETED|Overall Study||0
6651964|NCT02423798|7581469|FG000|STARTED|Overall Study||24
6651965|NCT02423798|7581469|FG000|COMPLETED|Overall Study||21
6651966|NCT02423798|7581469|FG000|NOT COMPLETED|Overall Study||3
6651967|NCT02423980|7581474|FG000|STARTED|Overall Study||7
6651968|NCT02423980|7581474|FG000|COMPLETED|Overall Study||7
6651969|NCT02423980|7581474|FG000|NOT COMPLETED|Overall Study||0
6651970|NCT02423993|7581484|FG000|STARTED|Overall Study||19
6651971|NCT02423993|7581485|FG001|STARTED|Overall Study||16
6651972|NCT02423993|7581486|FG002|STARTED|Overall Study||23
6651973|NCT02423993|7581487|FG003|STARTED|Overall Study||19
6651974|NCT02423993|7581484|FG000|COMPLETED|Overall Study||19
6651975|NCT02423993|7581485|FG001|COMPLETED|Overall Study||16
6651976|NCT02423993|7581486|FG002|COMPLETED|Overall Study||23
6651977|NCT02423993|7581487|FG003|COMPLETED|Overall Study||19
6651978|NCT02423993|7581484|FG000|NOT COMPLETED|Overall Study||0
6651979|NCT02423993|7581485|FG001|NOT COMPLETED|Overall Study||0
6651980|NCT02423993|7581486|FG002|NOT COMPLETED|Overall Study||0
6651981|NCT02423993|7581487|FG003|NOT COMPLETED|Overall Study||0
6651982|NCT02424097|7581499|FG000|STARTED|Overall Study||20
6651983|NCT02424097|7581500|FG001|STARTED|Overall Study||20
6651984|NCT02424097|7581499|FG000|COMPLETED|Overall Study||19
6651985|NCT02424097|7581500|FG001|COMPLETED|Overall Study||18
6651986|NCT02424097|7581499|FG000|NOT COMPLETED|Overall Study||1
6651987|NCT02424097|7581500|FG001|NOT COMPLETED|Overall Study||2
6651988|NCT02424149|7581508|FG000|STARTED|Overall Study||54
6651989|NCT02424149|7581509|FG001|STARTED|Overall Study||53
6651990|NCT02424149|7581508|FG000|COMPLETED|Overall Study||52
6651991|NCT02424149|7581509|FG001|COMPLETED|Overall Study||52
6651992|NCT02424149|7581508|FG000|NOT COMPLETED|Overall Study||2
6651993|NCT02424149|7581509|FG001|NOT COMPLETED|Overall Study||1
6651994|NCT02424175|7581515|FG000|STARTED|Overall Study||10
6651995|NCT02424175|7581515|FG000|COMPLETED|Overall Study||10
6651996|NCT02424175|7581515|FG000|NOT COMPLETED|Overall Study||0
6651997|NCT02424253|7581521|FG000|STARTED|Overall Study||65
6651998|NCT02424253|7581522|FG001|STARTED|Overall Study||33
6651999|NCT02424253|7581521|FG000|COMPLETED|Overall Study||54
6652000|NCT02424253|7581522|FG001|COMPLETED|Overall Study||24
6652001|NCT02424253|7581521|FG000|NOT COMPLETED|Overall Study||11
6652002|NCT02424253|7581522|FG001|NOT COMPLETED|Overall Study||9
6652003|NCT02424344|7581530|FG000|STARTED|Overall Study||134
6652004|NCT02424344|7581531|FG001|STARTED|Overall Study||133
6652005|NCT02424344|7581530|FG000|COMPLETED|Overall Study||127
6425616|NCT01017003|7340227|FG000|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
6425617|NCT01017003|7340227|FG000|STARTED|14 Day Washout Period||13
6652006|NCT02424344|7581531|FG001|COMPLETED|Overall Study||123
6652007|NCT02424344|7581530|FG000|NOT COMPLETED|Overall Study||7
6652008|NCT02424344|7581531|FG001|NOT COMPLETED|Overall Study||10
6652009|NCT02424357|7581539|FG000|STARTED|Overall Study||35
6652010|NCT02424357|7581540|FG001|STARTED|Overall Study||30
6652011|NCT02424357|7581539|FG000|COMPLETED|Overall Study||35
6652012|NCT02424357|7581540|FG001|COMPLETED|Overall Study||30
6652013|NCT02424357|7581539|FG000|NOT COMPLETED|Overall Study||0
6652014|NCT02424357|7581540|FG001|NOT COMPLETED|Overall Study||0
6652015|NCT02424383|7581548|FG000|STARTED|Overall Study||1005
6652016|NCT02424383|7581548|FG000|Per-Protocol Population|Overall Study||966
6652017|NCT02424383|7581548|FG000|COMPLETED|Overall Study||629
6652018|NCT02424383|7581548|FG000|NOT COMPLETED|Overall Study||376
6652019|NCT02424526|7581554|FG000|STARTED|Overall Study||9
6652020|NCT02424526|7581555|FG001|STARTED|Overall Study||10
6425618|NCT01017003|7340227|FG000|COMPLETED|14 Day Washout Period||13
6425619|NCT01017003|7340227|FG000|NOT COMPLETED|14 Day Washout Period||0
6652021|NCT02424526|7581554|FG000|COMPLETED|Overall Study||9
6652022|NCT02424526|7581555|FG001|COMPLETED|Overall Study||10
6652023|NCT02424526|7581554|FG000|NOT COMPLETED|Overall Study||0
6652024|NCT02424526|7581555|FG001|NOT COMPLETED|Overall Study||0
6652025|NCT02424539|7581566|FG000|STARTED|Overall Study||120
6652026|NCT02424539|7581567|FG001|STARTED|Overall Study||119
6652027|NCT02424539|7581568|FG002|STARTED|Overall Study||119
6652028|NCT02424539|7581566|FG000|COMPLETED|Overall Study||106
6652029|NCT02424539|7581567|FG001|COMPLETED|Overall Study||111
6652030|NCT02424539|7581568|FG002|COMPLETED|Overall Study||111
6652031|NCT02424539|7581566|FG000|NOT COMPLETED|Overall Study||14
6652032|NCT02424539|7581567|FG001|NOT COMPLETED|Overall Study||8
6652033|NCT02424539|7581568|FG002|NOT COMPLETED|Overall Study||8
6652034|NCT02424578|7581578|FG000|STARTED|Overall Study||15
6652035|NCT02424578|7581579|FG001|STARTED|Overall Study||15
6652036|NCT02424578|7581578|FG000|COMPLETED|Overall Study||15
6652037|NCT02424578|7581579|FG001|COMPLETED|Overall Study||14
6652038|NCT02424578|7581578|FG000|NOT COMPLETED|Overall Study||0
6652039|NCT02424578|7581579|FG001|NOT COMPLETED|Overall Study||1
6652040|NCT02424591|7581587|FG000|STARTED|Overall Study||22
6652041|NCT02424591|7581588|FG001|STARTED|Overall Study||23
6652042|NCT02424591|7581587|FG000|COMPLETED|Overall Study||20
6652043|NCT02424591|7581588|FG001|COMPLETED|Overall Study||20
6652044|NCT02424591|7581587|FG000|NOT COMPLETED|Overall Study||2
6652045|NCT02424591|7581588|FG001|NOT COMPLETED|Overall Study||3
6652046|NCT02424630|7581596|FG000|STARTED|Overall Study||25
6652047|NCT02424630|7581597|FG001|STARTED|Overall Study||27
6652048|NCT02424630|7581596|FG000|COMPLETED|Overall Study||24
6652049|NCT02424630|7581597|FG001|COMPLETED|Overall Study||24
6652050|NCT02424630|7581596|FG000|NOT COMPLETED|Overall Study||1
6652051|NCT02424630|7581597|FG001|NOT COMPLETED|Overall Study||3
6652052|NCT02424734|7581606|FG000|STARTED|Overall Study||4
6652053|NCT02424734|7581607|FG001|STARTED|Overall Study||5
6652054|NCT02424734|7581608|FG002|STARTED|Overall Study||2
6652055|NCT02424734|7581606|FG000|Treated|Overall Study||4
6652056|NCT02424734|7581607|FG001|Treated|Overall Study||5
6652057|NCT02424734|7581608|FG002|Treated|Overall Study||2
6652058|NCT02424734|7581606|FG000|COMPLETED|Overall Study||2
6652059|NCT02424734|7581607|FG001|COMPLETED|Overall Study||3
6652060|NCT02424734|7581608|FG002|COMPLETED|Overall Study||2
6652061|NCT02424734|7581606|FG000|NOT COMPLETED|Overall Study||2
6652062|NCT02424734|7581607|FG001|NOT COMPLETED|Overall Study||2
6652063|NCT02424734|7581608|FG002|NOT COMPLETED|Overall Study||0
6652064|NCT02424799|7581623|FG000|STARTED|Part A (Up to Day 11)||9
6652065|NCT02424799|7581624|FG001|STARTED|Part A (Up to Day 11)||8
6652066|NCT02424799|7581625|FG002|STARTED|Part A (Up to Day 11)||0
6652067|NCT02424799|7581626|FG003|STARTED|Part A (Up to Day 11)||0
6652068|NCT02424799|7581627|FG004|STARTED|Part A (Up to Day 11)||0
6652069|NCT02424799|7581628|FG005|STARTED|Part A (Up to Day 11)||0
6652070|NCT02424799|7581623|FG000|COMPLETED|Part A (Up to Day 11)||9
6652071|NCT02424799|7581624|FG001|COMPLETED|Part A (Up to Day 11)||8
6652072|NCT02424799|7581625|FG002|COMPLETED|Part A (Up to Day 11)||0
6652073|NCT02424799|7581626|FG003|COMPLETED|Part A (Up to Day 11)||0
6652074|NCT02424799|7581627|FG004|COMPLETED|Part A (Up to Day 11)||0
6652075|NCT02424799|7581628|FG005|COMPLETED|Part A (Up to Day 11)||0
6652076|NCT02424799|7581623|FG000|NOT COMPLETED|Part A (Up to Day 11)||0
6652077|NCT02424799|7581624|FG001|NOT COMPLETED|Part A (Up to Day 11)||0
6652078|NCT02424799|7581625|FG002|NOT COMPLETED|Part A (Up to Day 11)||0
6652079|NCT02424799|7581626|FG003|NOT COMPLETED|Part A (Up to Day 11)||0
6652080|NCT02424799|7581627|FG004|NOT COMPLETED|Part A (Up to Day 11)||0
6652081|NCT02424799|7581628|FG005|NOT COMPLETED|Part A (Up to Day 11)||0
6652082|NCT02424799|7581623|FG000|STARTED|Part B (Up to Day 19)||0
6652083|NCT02424799|7581624|FG001|STARTED|Part B (Up to Day 19)||0
6652084|NCT02424799|7581625|FG002|STARTED|Part B (Up to Day 19)||3
6652085|NCT02424799|7581626|FG003|STARTED|Part B (Up to Day 19)||9
6652086|NCT02424799|7581627|FG004|STARTED|Part B (Up to Day 19)||0
6652087|NCT02424799|7581628|FG005|STARTED|Part B (Up to Day 19)||0
6652088|NCT02424799|7581623|FG000|COMPLETED|Part B (Up to Day 19)||0
6652089|NCT02424799|7581624|FG001|COMPLETED|Part B (Up to Day 19)||0
6652090|NCT02424799|7581625|FG002|COMPLETED|Part B (Up to Day 19)||3
6652091|NCT02424799|7581626|FG003|COMPLETED|Part B (Up to Day 19)||9
6652092|NCT02424799|7581627|FG004|COMPLETED|Part B (Up to Day 19)||0
6652093|NCT02424799|7581628|FG005|COMPLETED|Part B (Up to Day 19)||0
6652094|NCT02424799|7581623|FG000|NOT COMPLETED|Part B (Up to Day 19)||0
6652095|NCT02424799|7581624|FG001|NOT COMPLETED|Part B (Up to Day 19)||0
6652096|NCT02424799|7581625|FG002|NOT COMPLETED|Part B (Up to Day 19)||0
6652097|NCT02424799|7581626|FG003|NOT COMPLETED|Part B (Up to Day 19)||0
6502050|NCT01432327|7420690|FG001|NOT COMPLETED|Posttest 6 Months||0
6652098|NCT02424799|7581627|FG004|NOT COMPLETED|Part B (Up to Day 19)||0
6652099|NCT02424799|7581628|FG005|NOT COMPLETED|Part B (Up to Day 19)||0
6652100|NCT02424799|7581623|FG000|STARTED|Part C (Up to Day 23)||0
6652101|NCT02424799|7581624|FG001|STARTED|Part C (Up to Day 23)||0
6652102|NCT02424799|7581625|FG002|STARTED|Part C (Up to Day 23)||0
6652103|NCT02424799|7581626|FG003|STARTED|Part C (Up to Day 23)||0
6652104|NCT02424799|7581627|FG004|STARTED|Part C (Up to Day 23)||1
6652105|NCT02424799|7581628|FG005|STARTED|Part C (Up to Day 23)||4
6652106|NCT02424799|7581623|FG000|COMPLETED|Part C (Up to Day 23)||0
6652107|NCT02424799|7581624|FG001|COMPLETED|Part C (Up to Day 23)||0
6425620|NCT01017003|7340227|FG000|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
6425621|NCT01017003|7340227|FG000|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
6425622|NCT01017003|7340227|FG000|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
6425623|NCT01017003|7340227|FG000|STARTED|Colchicine 0.6 mg Final Dose||13
6425624|NCT01017003|7340227|FG000|COMPLETED|Colchicine 0.6 mg Final Dose||13
6425625|NCT01017003|7340227|FG000|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
6425626|NCT01017029|7340235|FG000|STARTED|Overall Study||89
6425627|NCT01017029|7340236|FG001|STARTED|Overall Study||92
6425628|NCT01017029|7340235|FG000|COMPLETED|Overall Study||85
6425629|NCT01017029|7340236|FG001|COMPLETED|Overall Study||90
6425630|NCT01017029|7340235|FG000|NOT COMPLETED|Overall Study||4
6425631|NCT01017029|7340236|FG001|NOT COMPLETED|Overall Study||2
6425632|NCT01017042|7340242|FG000|STARTED|Overall Study||13
6425633|NCT01017042|7340242|FG000|COMPLETED|Overall Study||13
6425634|NCT01017042|7340242|FG000|NOT COMPLETED|Overall Study||0
6425635|NCT01017120|7340253|FG000|STARTED|Overall Study||373
6425636|NCT01017120|7340254|FG001|STARTED|Overall Study||369
6425637|NCT01017120|7340253|FG000|COMPLETED|Overall Study||307
6425638|NCT01017120|7340254|FG001|COMPLETED|Overall Study||334
6425639|NCT01017120|7340253|FG000|NOT COMPLETED|Overall Study||66
6425640|NCT01017120|7340254|FG001|NOT COMPLETED|Overall Study||35
6425641|NCT01017146|7340262|FG000|STARTED|Overall Study||372
6425642|NCT01017146|7340263|FG001|STARTED|Overall Study||372
6425643|NCT01017146|7340262|FG000|COMPLETED|Overall Study||306
6425644|NCT01017146|7340263|FG001|COMPLETED|Overall Study||333
6425645|NCT01017146|7340262|FG000|NOT COMPLETED|Overall Study||66
6425646|NCT01017146|7340263|FG001|NOT COMPLETED|Overall Study||39
6425647|NCT01017237|7340271|FG000|STARTED|Overall Study||10
6425648|NCT01017237|7340272|FG001|STARTED|Overall Study||8
6425649|NCT01017237|7340271|FG000|COMPLETED|Overall Study||5
6425650|NCT01017237|7340272|FG001|COMPLETED|Overall Study||6
6425651|NCT01017237|7340271|FG000|NOT COMPLETED|Overall Study||5
6425652|NCT01017237|7340272|FG001|NOT COMPLETED|Overall Study||2
6425653|NCT01017250|7340281|FG000|STARTED|Overall Study||15
6425654|NCT01017250|7340281|FG000|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
6425655|NCT01017250|7340281|FG000|COMPLETED|Overall Study||15
6425656|NCT01017250|7340281|FG000|NOT COMPLETED|Overall Study||0
6425657|NCT01017497|7340286|FG000|STARTED|Overall Study||49
6425658|NCT01017497|7340286|FG000|COMPLETED|Overall Study||49
6425659|NCT01017497|7340286|FG000|NOT COMPLETED|Overall Study||0
6425660|NCT01017536|7340294|FG000|STARTED|Overall Study||13
6425661|NCT01017536|7340295|FG001|STARTED|Overall Study||13
6425662|NCT01017536|7340294|FG000|COMPLETED|Overall Study||13
6425663|NCT01017536|7340295|FG001|COMPLETED|Overall Study||13
6425664|NCT01017536|7340294|FG000|NOT COMPLETED|Overall Study||0
6425665|NCT01017536|7340295|FG001|NOT COMPLETED|Overall Study||0
6425666|NCT01017549|7340301|FG000|STARTED|Eligibility Through 6 Month Follow-up||44
6425667|NCT01017549|7340301|FG000|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
6425668|NCT01017549|7340301|FG000|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
6425669|NCT01017549|7340301|FG000|STARTED|One-year Follow-up||43
6425670|NCT01017549|7340301|FG000|COMPLETED|One-year Follow-up||36
6425671|NCT01017549|7340301|FG000|NOT COMPLETED|One-year Follow-up||7
6425672|NCT01017549|7340301|FG000|STARTED|5 Year Follow-up||36
6425673|NCT01017549|7340301|FG000|COMPLETED|5 Year Follow-up||24
6425674|NCT01017549|7340301|FG000|NOT COMPLETED|5 Year Follow-up||12
6425675|NCT01017575|7340310|FG000|STARTED|Overall Study||8
6425676|NCT01017575|7340311|FG001|STARTED|Overall Study||9
6425677|NCT01017575|7340312|FG002|STARTED|Overall Study||8
6425678|NCT01017575|7340313|FG003|STARTED|Overall Study||8
6425679|NCT01017575|7340314|FG004|STARTED|Overall Study||9
6425680|NCT01017575|7340310|FG000|COMPLETED|Overall Study||7
6425681|NCT01017575|7340311|FG001|COMPLETED|Overall Study||7
6425682|NCT01017575|7340312|FG002|COMPLETED|Overall Study||8
6425683|NCT01017575|7340313|FG003|COMPLETED|Overall Study||7
6425684|NCT01017575|7340314|FG004|COMPLETED|Overall Study||6
6425685|NCT01017575|7340310|FG000|NOT COMPLETED|Overall Study||1
6425686|NCT01017575|7340311|FG001|NOT COMPLETED|Overall Study||2
6425687|NCT01017575|7340312|FG002|NOT COMPLETED|Overall Study||0
6425688|NCT01017575|7340313|FG003|NOT COMPLETED|Overall Study||1
6425689|NCT01017575|7340314|FG004|NOT COMPLETED|Overall Study||3
6425690|NCT01017601|7340328|FG000|STARTED|Overall Study||26
6425691|NCT01017601|7340329|FG001|STARTED|Overall Study||24
6425692|NCT01017601|7340328|FG000|COMPLETED|Overall Study||14
6425693|NCT01017601|7340329|FG001|COMPLETED|Overall Study||11
6425694|NCT01017601|7340328|FG000|NOT COMPLETED|Overall Study||12
6425695|NCT01017601|7340329|FG001|NOT COMPLETED|Overall Study||13
6425696|NCT01017653|7340335|FG000|STARTED|Overall Study||16
6425697|NCT01017653|7340335|FG000|COMPLETED|Overall Study||16
6425698|NCT01017653|7340335|FG000|NOT COMPLETED|Overall Study||0
6425699|NCT01017731|7340339|FG000|STARTED|Overall Study||68
6425700|NCT01017731|7340339|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
6425701|NCT01017731|7340339|FG000|COMPLETED|Overall Study||60
6425702|NCT01017731|7340339|FG000|NOT COMPLETED|Overall Study||8
6425703|NCT01017874|7340346|FG000|STARTED|Overall Study||118
6425704|NCT01017874|7340347|FG001|STARTED|Overall Study||118
6425705|NCT01017874|7340346|FG000|Received at Least 1 Dose of Study Drug|Overall Study||114
6425706|NCT01017874|7340347|FG001|Received at Least 1 Dose of Study Drug|Overall Study||118
6425707|NCT01017874|7340346|FG000|COMPLETED|Overall Study||88
6425708|NCT01017874|7340347|FG001|COMPLETED|Overall Study||92
6425709|NCT01017874|7340346|FG000|NOT COMPLETED|Overall Study||30
6425710|NCT01017874|7340347|FG001|NOT COMPLETED|Overall Study||26
6425711|NCT01017952|7340357|FG000|STARTED|4-week, Open-label Run-In Period||2092
6425712|NCT01017952|7340358|FG001|STARTED|4-week, Open-label Run-In Period||0
6425713|NCT01017952|7340359|FG002|STARTED|4-week, Open-label Run-In Period||0
6425714|NCT01017952|7340360|FG003|STARTED|4-week, Open-label Run-In Period||0
6425715|NCT01017952|7340361|FG004|STARTED|4-week, Open-label Run-In Period||0
6425716|NCT01017952|7340357|FG000|COMPLETED|4-week, Open-label Run-In Period||1633
6425717|NCT01017952|7340358|FG001|COMPLETED|4-week, Open-label Run-In Period||0
6425718|NCT01017952|7340359|FG002|COMPLETED|4-week, Open-label Run-In Period||0
6425719|NCT01017952|7340360|FG003|COMPLETED|4-week, Open-label Run-In Period||0
6425720|NCT01017952|7340361|FG004|COMPLETED|4-week, Open-label Run-In Period||0
6425721|NCT01017952|7340357|FG000|NOT COMPLETED|4-week, Open-label Run-In Period||459
6425722|NCT01017952|7340358|FG001|NOT COMPLETED|4-week, Open-label Run-In Period||0
6425723|NCT01017952|7340359|FG002|NOT COMPLETED|4-week, Open-label Run-In Period||0
6425724|NCT01017952|7340360|FG003|NOT COMPLETED|4-week, Open-label Run-In Period||0
6425725|NCT01017952|7340361|FG004|NOT COMPLETED|4-week, Open-label Run-In Period||0
6425726|NCT01017952|7340357|FG000|STARTED|52-week, Double-blind Treatment Period||0
6425727|NCT01017952|7340358|FG001|STARTED|52-week, Double-blind Treatment Period||409
6425728|NCT01017952|7340359|FG002|STARTED|52-week, Double-blind Treatment Period||412
6425729|NCT01017952|7340360|FG003|STARTED|52-week, Double-blind Treatment Period||403
6425730|NCT01017952|7340361|FG004|STARTED|52-week, Double-blind Treatment Period||409
6425731|NCT01017952|7340357|FG000|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
6425732|NCT01017952|7340358|FG001|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
6425733|NCT01017952|7340359|FG002|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
6425734|NCT01017952|7340360|FG003|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
6425735|NCT01017952|7340361|FG004|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
6425736|NCT01017952|7340357|FG000|COMPLETED|52-week, Double-blind Treatment Period||0
6425737|NCT01017952|7340358|FG001|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
6425738|NCT01017952|7340359|FG002|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
6425739|NCT01017952|7340360|FG003|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
6425740|NCT01017952|7340361|FG004|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
6652108|NCT02424799|7581625|FG002|COMPLETED|Part C (Up to Day 23)||0
6652109|NCT02424799|7581626|FG003|COMPLETED|Part C (Up to Day 23)||0
6652110|NCT02424799|7581627|FG004|COMPLETED|Part C (Up to Day 23)||1
6652111|NCT02424799|7581628|FG005|COMPLETED|Part C (Up to Day 23)||4
6551819|NCT01733407|7474134|FG000|NOT COMPLETED|Overall Study||2
6551820|NCT01733407|7474135|FG001|NOT COMPLETED|Overall Study||0
6551821|NCT01733472|7474143|FG000|STARTED|Overall Study||60
6551822|NCT01733472|7474144|FG001|STARTED|Overall Study||60
6652112|NCT02424799|7581623|FG000|NOT COMPLETED|Part C (Up to Day 23)||0
6425741|NCT01017952|7340357|FG000|NOT COMPLETED|52-week, Double-blind Treatment Period||0
6425742|NCT01017952|7340358|FG001|NOT COMPLETED|52-week, Double-blind Treatment Period||125
6425743|NCT01017952|7340359|FG002|NOT COMPLETED|52-week, Double-blind Treatment Period||109
6425744|NCT01017952|7340360|FG003|NOT COMPLETED|52-week, Double-blind Treatment Period||112
6425745|NCT01017952|7340361|FG004|NOT COMPLETED|52-week, Double-blind Treatment Period||103
6425746|NCT01018030|7340374|FG000|STARTED|Overall Study||246
6425747|NCT01018030|7340375|FG001|STARTED|Overall Study||243
6425748|NCT01018030|7340376|FG002|STARTED|Overall Study||252
6425749|NCT01018030|7340374|FG000|COMPLETED|Overall Study||227
6425750|NCT01018030|7340375|FG001|COMPLETED|Overall Study||232
6425751|NCT01018030|7340376|FG002|COMPLETED|Overall Study||239
6425752|NCT01018030|7340374|FG000|NOT COMPLETED|Overall Study||19
6425753|NCT01018030|7340375|FG001|NOT COMPLETED|Overall Study||11
6425754|NCT01018030|7340376|FG002|NOT COMPLETED|Overall Study||13
6425755|NCT01018056|7340389|FG000|STARTED|Overall Study||12
6425756|NCT01018056|7340390|FG001|STARTED|Overall Study||12
6425757|NCT01018056|7340391|FG002|STARTED|Overall Study||6
6425758|NCT01018056|7340389|FG000|COMPLETED|Overall Study||9
6425759|NCT01018056|7340390|FG001|COMPLETED|Overall Study||10
6551823|NCT01733472|7474143|FG000|COMPLETED|Overall Study||60
6551824|NCT01733472|7474144|FG001|COMPLETED|Overall Study||60
6551825|NCT01733472|7474143|FG000|NOT COMPLETED|Overall Study||0
6551826|NCT01733472|7474144|FG001|NOT COMPLETED|Overall Study||0
6551827|NCT01733628|7474151|FG000|STARTED|Overall Study||143
6551828|NCT01733628|7474151|FG000|COMPLETED|Overall Study||143
6551829|NCT01733628|7474151|FG000|NOT COMPLETED|Overall Study||0
6551830|NCT01733680|7474157|FG000|STARTED|Overall Study||2
6551831|NCT01733680|7474158|FG001|STARTED|Overall Study||1
6551832|NCT01733680|7474157|FG000|COMPLETED|Overall Study||2
6551833|NCT01733680|7474158|FG001|COMPLETED|Overall Study||0
6551834|NCT01733680|7474157|FG000|NOT COMPLETED|Overall Study||0
6425760|NCT01018056|7340391|FG002|COMPLETED|Overall Study||5
6425761|NCT01018056|7340389|FG000|NOT COMPLETED|Overall Study||3
6425762|NCT01018056|7340390|FG001|NOT COMPLETED|Overall Study||2
6425763|NCT01018056|7340391|FG002|NOT COMPLETED|Overall Study||1
6425764|NCT01018095|7340404|FG000|STARTED|Overall Study||135
6425765|NCT01018095|7340405|FG001|STARTED|Overall Study||135
6425766|NCT01018095|7340404|FG000|COMPLETED|Overall Study||79
6425767|NCT01018095|7340405|FG001|COMPLETED|Overall Study||73
6425768|NCT01018095|7340404|FG000|NOT COMPLETED|Overall Study||56
6425769|NCT01018095|7340405|FG001|NOT COMPLETED|Overall Study||62
6425770|NCT01018134|7340417|FG000|STARTED|Overall Study||30
6425771|NCT01018134|7340418|FG001|STARTED|Overall Study||31
6425772|NCT01018134|7340419|FG002|STARTED|Overall Study||30
6425773|NCT01018134|7340420|FG003|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
6425774|NCT01018134|7340421|FG004|STARTED|Overall Study||15
6425775|NCT01018134|7340422|FG005|STARTED|Overall Study||15
6425776|NCT01018134|7340417|FG000|COMPLETED|Overall Study||30
6425777|NCT01018134|7340418|FG001|COMPLETED|Overall Study||30
6425778|NCT01018134|7340419|FG002|COMPLETED|Overall Study||29
6425779|NCT01018134|7340420|FG003|COMPLETED|Overall Study||29
6425780|NCT01018134|7340421|FG004|COMPLETED|Overall Study||15
6425781|NCT01018134|7340422|FG005|COMPLETED|Overall Study||15
6425782|NCT01018134|7340417|FG000|NOT COMPLETED|Overall Study||0
6425783|NCT01018134|7340418|FG001|NOT COMPLETED|Overall Study||1
6425784|NCT01018134|7340419|FG002|NOT COMPLETED|Overall Study||1
6425785|NCT01018134|7340420|FG003|NOT COMPLETED|Overall Study||0
6425786|NCT01018134|7340421|FG004|NOT COMPLETED|Overall Study||0
6425787|NCT01018134|7340422|FG005|NOT COMPLETED|Overall Study||0
6425788|NCT01018186|7340439|FG000|STARTED|2-week Run-in Period||617
6425789|NCT01018186|7340440|FG001|STARTED|2-week Run-in Period||0
6425790|NCT01018186|7340441|FG002|STARTED|2-week Run-in Period||0
6425791|NCT01018186|7340442|FG003|STARTED|2-week Run-in Period||0
6425792|NCT01018186|7340439|FG000|COMPLETED|2-week Run-in Period||503
6425793|NCT01018186|7340440|FG001|COMPLETED|2-week Run-in Period||0
6425794|NCT01018186|7340441|FG002|COMPLETED|2-week Run-in Period||0
6425795|NCT01018186|7340442|FG003|COMPLETED|2-week Run-in Period||0
6425796|NCT01018186|7340439|FG000|NOT COMPLETED|2-week Run-in Period||114
6425797|NCT01018186|7340440|FG001|NOT COMPLETED|2-week Run-in Period||0
6425798|NCT01018186|7340441|FG002|NOT COMPLETED|2-week Run-in Period||0
6425799|NCT01018186|7340442|FG003|NOT COMPLETED|2-week Run-in Period||0
6425800|NCT01018186|7340439|FG000|STARTED|52-week Double-blind Treatment Period||0
6425801|NCT01018186|7340440|FG001|STARTED|52-week Double-blind Treatment Period||201
6425802|NCT01018186|7340441|FG002|STARTED|52-week Double-blind Treatment Period||202
6425803|NCT01018186|7340442|FG003|STARTED|52-week Double-blind Treatment Period||100
6425804|NCT01018186|7340439|FG000|COMPLETED|52-week Double-blind Treatment Period||0
6425805|NCT01018186|7340440|FG001|COMPLETED|52-week Double-blind Treatment Period||161
6425806|NCT01018186|7340441|FG002|COMPLETED|52-week Double-blind Treatment Period||161
6425807|NCT01018186|7340442|FG003|COMPLETED|52-week Double-blind Treatment Period||71
6425808|NCT01018186|7340439|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
6425809|NCT01018186|7340440|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||40
6425810|NCT01018186|7340441|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||41
6425811|NCT01018186|7340442|FG003|NOT COMPLETED|52-week Double-blind Treatment Period||29
6425812|NCT01018264|7340456|FG000|STARTED|Overall Study||10
6425813|NCT01018264|7340457|FG001|STARTED|Overall Study||13
6425814|NCT01018264|7340456|FG000|COMPLETED|Overall Study||9
6425815|NCT01018264|7340457|FG001|COMPLETED|Overall Study||12
6425816|NCT01018264|7340456|FG000|NOT COMPLETED|Overall Study||1
6425817|NCT01018264|7340457|FG001|NOT COMPLETED|Overall Study||1
6425818|NCT01018394|7340465|FG000|STARTED|Overall Study||40
6425819|NCT01018394|7340466|FG001|STARTED|Overall Study||41
6425820|NCT01018394|7340465|FG000|COMPLETED|Overall Study||31
6425821|NCT01018394|7340466|FG001|COMPLETED|Overall Study||33
6425822|NCT01018394|7340465|FG000|NOT COMPLETED|Overall Study||9
6425823|NCT01018394|7340466|FG001|NOT COMPLETED|Overall Study||8
6425824|NCT01018420|7340474|FG000|STARTED|Overall Study||15
6425825|NCT01018420|7340475|FG001|STARTED|Overall Study||3
6425826|NCT01018420|7340474|FG000|COMPLETED|Overall Study||15
6425827|NCT01018420|7340475|FG001|COMPLETED|Overall Study||3
6425828|NCT01018420|7340474|FG000|NOT COMPLETED|Overall Study||0
6425829|NCT01018420|7340475|FG001|NOT COMPLETED|Overall Study||0
6425830|NCT01018511|7340502|FG000|STARTED|Overall Study||341
6425831|NCT01018511|7340503|FG001|STARTED|Overall Study||327
6425832|NCT01018511|7340504|FG002|STARTED|Overall Study||339
6425833|NCT01018511|7340505|FG003|STARTED|Overall Study||327
6425834|NCT01018511|7340502|FG000|Randomized and Treated|Overall Study||341
6425835|NCT01018511|7340503|FG001|Randomized and Treated|Overall Study||326
6425836|NCT01018511|7340504|FG002|Randomized and Treated|Overall Study||338
6425837|NCT01018511|7340505|FG003|Randomized and Treated|Overall Study||324
6425838|NCT01018511|7340502|FG000|COMPLETED|Overall Study||315
6425839|NCT01018511|7340503|FG001|COMPLETED|Overall Study||295
6425840|NCT01018511|7340504|FG002|COMPLETED|Overall Study||299
6425841|NCT01018511|7340505|FG003|COMPLETED|Overall Study||294
6425842|NCT01018511|7340502|FG000|NOT COMPLETED|Overall Study||26
6425843|NCT01018511|7340503|FG001|NOT COMPLETED|Overall Study||32
6425844|NCT01018511|7340504|FG002|NOT COMPLETED|Overall Study||40
6425845|NCT01018511|7340505|FG003|NOT COMPLETED|Overall Study||33
6425846|NCT01018680|7340523|FG000|STARTED|Overall Study||260
6425847|NCT01018680|7340524|FG001|STARTED|Overall Study||264
6425848|NCT01018680|7340523|FG000|COMPLETED|Overall Study||199
6425849|NCT01018680|7340524|FG001|COMPLETED|Overall Study||189
6425850|NCT01018680|7340523|FG000|NOT COMPLETED|Overall Study||61
6425851|NCT01018680|7340524|FG001|NOT COMPLETED|Overall Study||75
6425852|NCT01018732|7340533|FG000|STARTED|Overall Study||50
6425853|NCT01018732|7340534|FG001|STARTED|Overall Study||51
6425854|NCT01018732|7340535|FG002|STARTED|Overall Study||54
6425855|NCT01018732|7340533|FG000|COMPLETED|Overall Study||49
6425856|NCT01018732|7340534|FG001|COMPLETED|Overall Study||49
6425857|NCT01018732|7340535|FG002|COMPLETED|Overall Study||50
6425858|NCT01018732|7340533|FG000|NOT COMPLETED|Overall Study||1
6425859|NCT01018732|7340534|FG001|NOT COMPLETED|Overall Study||2
6425860|NCT01018732|7340535|FG002|NOT COMPLETED|Overall Study||4
6425861|NCT01018862|7340546|FG000|STARTED|Overall Study||161
6425862|NCT01018862|7340547|FG001|STARTED|Overall Study||166
6425863|NCT01018862|7340548|FG002|STARTED|Overall Study||162
6425864|NCT01018862|7340546|FG000|COMPLETED|Overall Study||148
6425865|NCT01018862|7340547|FG001|COMPLETED|Overall Study||156
6425866|NCT01018862|7340548|FG002|COMPLETED|Overall Study||146
6425867|NCT01018862|7340546|FG000|NOT COMPLETED|Overall Study||13
6425868|NCT01018862|7340547|FG001|NOT COMPLETED|Overall Study||10
6425869|NCT01018862|7340548|FG002|NOT COMPLETED|Overall Study||16
6425870|NCT01018953|7340556|FG000|STARTED|Overall Study||8
6425871|NCT01018953|7340556|FG000|BIM 23A760 1 mg|Overall Study||3
6425872|NCT01018953|7340556|FG000|BIM 23A760 2 mg|Overall Study||2
6425873|NCT01018953|7340556|FG000|BIM 23A760 4 mg|Overall Study||3
6425874|NCT01018953|7340556|FG000|COMPLETED|Overall Study||0
6425875|NCT01018953|7340556|FG000|NOT COMPLETED|Overall Study||8
6425876|NCT01018979|7340563|FG000|STARTED|Overall Study||7
6425877|NCT01018979|7340564|FG001|STARTED|Overall Study|A total of 20 subjects were randomized.|13
6425878|NCT01018979|7340563|FG000|Received at Least One Dose|Overall Study||7
6425879|NCT01018979|7340564|FG001|Received at Least One Dose|Overall Study||12
6425880|NCT01018979|7340563|FG000|COMPLETED|Overall Study||4
6425881|NCT01018979|7340564|FG001|COMPLETED|Overall Study||3
6425882|NCT01018979|7340563|FG000|NOT COMPLETED|Overall Study||3
6425883|NCT01018979|7340564|FG001|NOT COMPLETED|Overall Study||10
6425884|NCT01018992|7340575|FG000|STARTED|Overall Study||63
6425885|NCT01018992|7340576|FG001|STARTED|Overall Study||65
6425886|NCT01018992|7340575|FG000|COMPLETED|Overall Study||47
6425887|NCT01018992|7340576|FG001|COMPLETED|Overall Study||49
6425888|NCT01018992|7340575|FG000|NOT COMPLETED|Overall Study||16
6425889|NCT01018992|7340576|FG001|NOT COMPLETED|Overall Study||16
6425890|NCT01019135|7340585|FG000|STARTED|Overall Study||55
6425891|NCT01019135|7340586|FG001|STARTED|Overall Study||59
6551835|NCT01733680|7474158|FG001|NOT COMPLETED|Overall Study||1
6551836|NCT01733732|7474170|FG000|STARTED|Overall Study||27
6551837|NCT01733732|7474171|FG001|STARTED|Overall Study||27
6551838|NCT01733732|7474170|FG000|COMPLETED|Overall Study||25
6551839|NCT01733732|7474171|FG001|COMPLETED|Overall Study||27
6551840|NCT01733732|7474170|FG000|NOT COMPLETED|Overall Study||2
6551841|NCT01733732|7474171|FG001|NOT COMPLETED|Overall Study||0
6551842|NCT01733745|7474189|FG000|STARTED|Overall Study||13
6551843|NCT01733745|7474190|FG001|STARTED|Overall Study||13
6551844|NCT01733745|7474189|FG000|COMPLETED|Overall Study||13
6551845|NCT01733745|7474190|FG001|COMPLETED|Overall Study||13
6551846|NCT01733745|7474189|FG000|NOT COMPLETED|Overall Study||0
6551847|NCT01733745|7474190|FG001|NOT COMPLETED|Overall Study||0
6551848|NCT01733758|7474200|FG000|STARTED|Overall Study||77
6551849|NCT01733758|7474201|FG001|STARTED|Overall Study||160
6425892|NCT01019135|7340587|FG002|STARTED|Overall Study||55
6425893|NCT01019135|7340585|FG000|COMPLETED|Overall Study||35
6425894|NCT01019135|7340586|FG001|COMPLETED|Overall Study||40
6425895|NCT01019135|7340587|FG002|COMPLETED|Overall Study||24
6425896|NCT01019135|7340585|FG000|NOT COMPLETED|Overall Study||20
6425897|NCT01019135|7340586|FG001|NOT COMPLETED|Overall Study||19
6425898|NCT01019135|7340587|FG002|NOT COMPLETED|Overall Study||31
6425899|NCT01019252|7340597|FG000|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|24
6425900|NCT01019252|7340598|FG001|STARTED|Initial CBT for ADHD vs. Wait List|Stratified based on biological sex and clinician-rated severity (CGI score)|22
6425901|NCT01019252|7340597|FG000|COMPLETED|Initial CBT for ADHD vs. Wait List||21
6425902|NCT01019252|7340598|FG001|COMPLETED|Initial CBT for ADHD vs. Wait List||22
6425903|NCT01019252|7340597|FG000|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||3
6425904|NCT01019252|7340598|FG001|NOT COMPLETED|Initial CBT for ADHD vs. Wait List||0
6425905|NCT01019252|7340597|FG000|STARTED|Wait List Cross-over to CBT for ADHD|Lost to follow up, did not start treatment following wait list completion (n=3)|21
6425906|NCT01019252|7340598|FG001|STARTED|Wait List Cross-over to CBT for ADHD||22
6425907|NCT01019252|7340597|FG000|COMPLETED|Wait List Cross-over to CBT for ADHD||21
6425908|NCT01019252|7340598|FG001|COMPLETED|Wait List Cross-over to CBT for ADHD||15
6425909|NCT01019252|7340597|FG000|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||0
6551850|NCT01733758|7474202|FG002|STARTED|Overall Study||150
6551851|NCT01733758|7474203|FG003|STARTED|Overall Study||103
6551852|NCT01733758|7474200|FG000|COMPLETED|Overall Study||62
6551853|NCT01733758|7474201|FG001|COMPLETED|Overall Study||148
6551854|NCT01733758|7474202|FG002|COMPLETED|Overall Study||135
6425910|NCT01019252|7340598|FG001|NOT COMPLETED|Wait List Cross-over to CBT for ADHD||7
6425911|NCT01019317|7340604|FG000|STARTED|Overall Study||151
6425912|NCT01019317|7340604|FG000|COMPLETED|Overall Study||147
6551855|NCT01733758|7474203|FG003|COMPLETED|Overall Study||95
6425913|NCT01019317|7340604|FG000|NOT COMPLETED|Overall Study||4
6425914|NCT01019369|7340610|FG000|STARTED|Overall Study||86
6425915|NCT01019369|7340611|FG001|STARTED|Overall Study||46
6425916|NCT01019369|7340610|FG000|COMPLETED|Overall Study||76
6425917|NCT01019369|7340611|FG001|COMPLETED|Overall Study||39
6425918|NCT01019369|7340610|FG000|NOT COMPLETED|Overall Study||10
6425919|NCT01019369|7340611|FG001|NOT COMPLETED|Overall Study||7
6425920|NCT01019486|7340621|FG000|STARTED|Overall Study||5
6425921|NCT01019486|7340622|FG001|STARTED|Overall Study||5
6425922|NCT01019486|7340623|FG002|STARTED|Overall Study||16
6425923|NCT01019486|7340621|FG000|COMPLETED|Overall Study||4
6425924|NCT01019486|7340622|FG001|COMPLETED|Overall Study||4
6425925|NCT01019486|7340623|FG002|COMPLETED|Overall Study||15
6425926|NCT01019486|7340621|FG000|NOT COMPLETED|Overall Study||1
6425927|NCT01019486|7340622|FG001|NOT COMPLETED|Overall Study||1
6425928|NCT01019486|7340623|FG002|NOT COMPLETED|Overall Study||1
6425929|NCT01019694|7340635|FG000|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
6425930|NCT01019694|7340636|FG001|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
6425931|NCT01019694|7340637|FG002|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
6425932|NCT01019694|7340635|FG000|COMPLETED|Overall Study||133
6425933|NCT01019694|7340636|FG001|COMPLETED|Overall Study||118
6425934|NCT01019694|7340637|FG002|COMPLETED|Overall Study||110
6425935|NCT01019694|7340635|FG000|NOT COMPLETED|Overall Study||24
6425936|NCT01019694|7340636|FG001|NOT COMPLETED|Overall Study||38
6425937|NCT01019694|7340637|FG002|NOT COMPLETED|Overall Study||47
6425938|NCT01019707|7340645|FG000|STARTED|First Phase||3
6425939|NCT01019707|7340646|FG001|STARTED|First Phase||3
6425940|NCT01019707|7340645|FG000|COMPLETED|First Phase||3
6425941|NCT01019707|7340646|FG001|COMPLETED|First Phase||3
6425942|NCT01019707|7340645|FG000|NOT COMPLETED|First Phase||0
6425943|NCT01019707|7340646|FG001|NOT COMPLETED|First Phase||0
6425944|NCT01019707|7340645|FG000|STARTED|Washout||3
6425945|NCT01019707|7340646|FG001|STARTED|Washout||3
6425946|NCT01019707|7340645|FG000|COMPLETED|Washout||3
6425947|NCT01019707|7340646|FG001|COMPLETED|Washout||1
6425948|NCT01019707|7340645|FG000|NOT COMPLETED|Washout||0
6425949|NCT01019707|7340646|FG001|NOT COMPLETED|Washout||2
6425950|NCT01019707|7340645|FG000|STARTED|Second Phase||3
6425951|NCT01019707|7340646|FG001|STARTED|Second Phase||1
6425952|NCT01019707|7340645|FG000|COMPLETED|Second Phase||3
6425953|NCT01019707|7340646|FG001|COMPLETED|Second Phase||1
6425954|NCT01019707|7340645|FG000|NOT COMPLETED|Second Phase||0
6425955|NCT01019707|7340646|FG001|NOT COMPLETED|Second Phase||0
6425956|NCT01019928|7340654|FG000|STARTED|Period 1||7
6425957|NCT01019928|7340655|FG001|STARTED|Period 1||7
6425958|NCT01019928|7340654|FG000|COMPLETED|Period 1||7
6425959|NCT01019928|7340655|FG001|COMPLETED|Period 1||7
6425960|NCT01019928|7340654|FG000|NOT COMPLETED|Period 1||0
6425961|NCT01019928|7340655|FG001|NOT COMPLETED|Period 1||0
6425962|NCT01019928|7340654|FG000|STARTED|Period 2||7
6425963|NCT01019928|7340655|FG001|STARTED|Period 2||7
6425964|NCT01019928|7340654|FG000|COMPLETED|Period 2||7
6425965|NCT01019928|7340655|FG001|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
6425966|NCT01019928|7340654|FG000|NOT COMPLETED|Period 2||0
6425967|NCT01019928|7340655|FG001|NOT COMPLETED|Period 2||1
6425968|NCT01019928|7340654|FG000|STARTED|Period 3||7
6425969|NCT01019928|7340655|FG001|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
6425970|NCT01019928|7340654|FG000|COMPLETED|Period 3||7
6425971|NCT01019928|7340655|FG001|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
6425972|NCT01019928|7340654|FG000|NOT COMPLETED|Period 3||0
6425973|NCT01019928|7340655|FG001|NOT COMPLETED|Period 3||0
6425974|NCT01020006|7340664|FG000|STARTED|Overall Study||8
6425975|NCT01020006|7340665|FG001|STARTED|Overall Study||18
6425976|NCT01020006|7340666|FG002|STARTED|Overall Study||16
6425977|NCT01020006|7340664|FG000|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
6425978|NCT01020006|7340665|FG001|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
6425979|NCT01020006|7340666|FG002|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
6425980|NCT01020006|7340664|FG000|NOT COMPLETED|Overall Study||8
6425981|NCT01020006|7340665|FG001|NOT COMPLETED|Overall Study||18
6425982|NCT01020006|7340666|FG002|NOT COMPLETED|Overall Study||16
6425983|NCT01020019|7340676|FG000|STARTED|Overall Study||61
6425984|NCT01020019|7340677|FG001|STARTED|Overall Study||61
6425985|NCT01020019|7340676|FG000|COMPLETED|Overall Study||35
6425986|NCT01020019|7340677|FG001|COMPLETED|Overall Study||32
6425987|NCT01020019|7340676|FG000|NOT COMPLETED|Overall Study||26
6425988|NCT01020019|7340677|FG001|NOT COMPLETED|Overall Study||29
6425989|NCT01020123|7340690|FG000|STARTED|Main Period||93
6425990|NCT01020123|7340691|FG001|STARTED|Main Period||91
6425991|NCT01020123|7340692|FG002|STARTED|Main Period||52
6425992|NCT01020123|7340693|FG003|STARTED|Main Period||40
6425993|NCT01020123|7340694|FG004|STARTED|Main Period||88
6425994|NCT01020123|7340695|FG005|STARTED|Main Period||94
6425995|NCT01020123|7340696|FG006|STARTED|Main Period||72
6425996|NCT01020123|7340690|FG000|COMPLETED|Main Period||76
6425997|NCT01020123|7340691|FG001|COMPLETED|Main Period||77
6425998|NCT01020123|7340692|FG002|COMPLETED|Main Period||44
6425999|NCT01020123|7340693|FG003|COMPLETED|Main Period||33
6426000|NCT01020123|7340694|FG004|COMPLETED|Main Period||77
6426001|NCT01020123|7340695|FG005|COMPLETED|Main Period||83
6426002|NCT01020123|7340696|FG006|COMPLETED|Main Period||61
6426003|NCT01020123|7340690|FG000|NOT COMPLETED|Main Period||17
6426004|NCT01020123|7340691|FG001|NOT COMPLETED|Main Period||14
6426005|NCT01020123|7340692|FG002|NOT COMPLETED|Main Period||8
6426006|NCT01020123|7340693|FG003|NOT COMPLETED|Main Period||7
6426007|NCT01020123|7340694|FG004|NOT COMPLETED|Main Period||11
6426008|NCT01020123|7340695|FG005|NOT COMPLETED|Main Period||11
6426009|NCT01020123|7340696|FG006|NOT COMPLETED|Main Period||11
6426010|NCT01020123|7340690|FG000|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
6426011|NCT01020123|7340691|FG001|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
6426012|NCT01020123|7340692|FG002|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
6426013|NCT01020123|7340693|FG003|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
6426014|NCT01020123|7340694|FG004|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
6426015|NCT01020123|7340695|FG005|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
6426016|NCT01020123|7340696|FG006|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
6426017|NCT01020123|7340690|FG000|COMPLETED|Extention Period||37
6426018|NCT01020123|7340691|FG001|COMPLETED|Extention Period||33
6426019|NCT01020123|7340692|FG002|COMPLETED|Extention Period||17
6426020|NCT01020123|7340693|FG003|COMPLETED|Extention Period||12
6426021|NCT01020123|7340694|FG004|COMPLETED|Extention Period||31
6426022|NCT01020123|7340695|FG005|COMPLETED|Extention Period||36
6426023|NCT01020123|7340696|FG006|COMPLETED|Extention Period||18
6426024|NCT01020123|7340690|FG000|NOT COMPLETED|Extention Period||3
6426025|NCT01020123|7340691|FG001|NOT COMPLETED|Extention Period||2
6426026|NCT01020123|7340692|FG002|NOT COMPLETED|Extention Period||2
6426027|NCT01020123|7340693|FG003|NOT COMPLETED|Extention Period||1
6426028|NCT01020123|7340694|FG004|NOT COMPLETED|Extention Period||0
6426029|NCT01020123|7340695|FG005|NOT COMPLETED|Extention Period||2
6426030|NCT01020123|7340696|FG006|NOT COMPLETED|Extention Period||1
6426031|NCT01020305|7340713|FG000|STARTED|Overall Study||5
6426032|NCT01020305|7340713|FG000|COMPLETED|Overall Study||3
6426033|NCT01020305|7340713|FG000|NOT COMPLETED|Overall Study||2
6426034|NCT01020435|7340719|FG000|STARTED|Overall Study||24
6426035|NCT01020435|7340720|FG001|STARTED|Overall Study||27
6426036|NCT01020435|7340719|FG000|COMPLETED|Overall Study||24
6426037|NCT01020435|7340720|FG001|COMPLETED|Overall Study||26
6426038|NCT01020435|7340719|FG000|NOT COMPLETED|Overall Study||0
6426039|NCT01020435|7340720|FG001|NOT COMPLETED|Overall Study||1
6426040|NCT01020448|7340727|FG000|STARTED|Pre-assignment||339
6426041|NCT01020448|7340727|FG000|COMPLETED|Pre-assignment||326
6426042|NCT01020448|7340727|FG000|NOT COMPLETED|Pre-assignment||13
6426043|NCT01020448|7340727|FG000|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
6426044|NCT01020448|7340727|FG000|COMPLETED|Treatment||299
6426045|NCT01020448|7340727|FG000|NOT COMPLETED|Treatment||26
6426046|NCT01020474|7340734|FG000|STARTED|Overall Study||54
6426047|NCT01020474|7340735|FG001|STARTED|Overall Study||53
6426048|NCT01020474|7340734|FG000|COMPLETED|Overall Study||44
6426049|NCT01020474|7340735|FG001|COMPLETED|Overall Study||36
6551856|NCT01733758|7474200|FG000|NOT COMPLETED|Overall Study||15
6426050|NCT01020474|7340734|FG000|NOT COMPLETED|Overall Study||10
6426051|NCT01020474|7340735|FG001|NOT COMPLETED|Overall Study||17
6426052|NCT01020487|7340744|FG000|STARTED|Part 1||12
6426053|NCT01020487|7340745|FG001|STARTED|Part 1||0
6426054|NCT01020487|7340746|FG002|STARTED|Part 1||0
6426055|NCT01020487|7340744|FG000|COMPLETED|Part 1||12
6426056|NCT01020487|7340745|FG001|COMPLETED|Part 1||0
6426057|NCT01020487|7340746|FG002|COMPLETED|Part 1||0
6426058|NCT01020487|7340744|FG000|NOT COMPLETED|Part 1||0
6426059|NCT01020487|7340745|FG001|NOT COMPLETED|Part 1||0
6426060|NCT01020487|7340746|FG002|NOT COMPLETED|Part 1||0
6426061|NCT01020487|7340744|FG000|STARTED|Part 2 Double-blind Treatment Period||0
6426062|NCT01020487|7340745|FG001|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
6426063|NCT01020487|7340746|FG002|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
6426064|NCT01020487|7340744|FG000|Received Treatment|Part 2 Double-blind Treatment Period||0
6426065|NCT01020487|7340745|FG001|Received Treatment|Part 2 Double-blind Treatment Period||18
6426066|NCT01020487|7340746|FG002|Received Treatment|Part 2 Double-blind Treatment Period||18
6426067|NCT01020487|7340744|FG000|COMPLETED|Part 2 Double-blind Treatment Period||0
6426068|NCT01020487|7340745|FG001|COMPLETED|Part 2 Double-blind Treatment Period||16
6426069|NCT01020487|7340746|FG002|COMPLETED|Part 2 Double-blind Treatment Period||13
6426070|NCT01020487|7340744|FG000|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
6426071|NCT01020487|7340745|FG001|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
6426072|NCT01020487|7340746|FG002|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
6426073|NCT01020487|7340744|FG000|STARTED|Part 2 Open-label Period||0
6426074|NCT01020487|7340745|FG001|STARTED|Part 2 Open-label Period||16
6426075|NCT01020487|7340746|FG002|STARTED|Part 2 Open-label Period||13
6551857|NCT01733758|7474201|FG001|NOT COMPLETED|Overall Study||12
6426076|NCT01020487|7340744|FG000|COMPLETED|Part 2 Open-label Period||0
6426077|NCT01020487|7340745|FG001|COMPLETED|Part 2 Open-label Period||12
6426078|NCT01020487|7340746|FG002|COMPLETED|Part 2 Open-label Period||12
6426079|NCT01020487|7340744|FG000|NOT COMPLETED|Part 2 Open-label Period||0
6426080|NCT01020487|7340745|FG001|NOT COMPLETED|Part 2 Open-label Period||4
6426081|NCT01020487|7340746|FG002|NOT COMPLETED|Part 2 Open-label Period||1
6426082|NCT01020526|7340756|FG000|STARTED|Overall Study||63
6426083|NCT01020526|7340756|FG000|COMPLETED|Overall Study||49
6426084|NCT01020526|7340756|FG000|NOT COMPLETED|Overall Study||14
6426085|NCT01020591|7340762|FG000|STARTED|Overall Study||15
6426086|NCT01020591|7340763|FG001|STARTED|Overall Study||15
6426087|NCT01020591|7340762|FG000|COMPLETED|Overall Study||15
6426088|NCT01020591|7340763|FG001|COMPLETED|Overall Study||15
6426089|NCT01020591|7340762|FG000|NOT COMPLETED|Overall Study||0
6426090|NCT01020591|7340763|FG001|NOT COMPLETED|Overall Study||0
6426091|NCT01020747|7340771|FG000|STARTED|Overall Study||20
6426092|NCT01020747|7340771|FG000|COMPLETED|Overall Study||19
6426093|NCT01020747|7340771|FG000|NOT COMPLETED|Overall Study||1
6426094|NCT01020773|7340778|FG000|STARTED|Overall Study||35
6426095|NCT01020773|7340779|FG001|STARTED|Overall Study||32
6426096|NCT01020773|7340778|FG000|COMPLETED|Overall Study||31
6426097|NCT01020773|7340779|FG001|COMPLETED|Overall Study||29
6426098|NCT01020773|7340778|FG000|NOT COMPLETED|Overall Study||4
6426099|NCT01020773|7340779|FG001|NOT COMPLETED|Overall Study||3
6426100|NCT01020786|7340785|FG000|STARTED|Induction Period||109
6426101|NCT01020786|7340785|FG000|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
6426102|NCT01020786|7340785|FG000|NOT COMPLETED|Induction Period||49
6426103|NCT01020786|7340785|FG000|STARTED|Maintenance Period||60
6426104|NCT01020786|7340785|FG000|COMPLETED|Maintenance Period||0
6426105|NCT01020786|7340785|FG000|NOT COMPLETED|Maintenance Period||60
6426106|NCT01020799|7340793|FG000|STARTED|Overall Study||98
6426107|NCT01020799|7340794|FG001|STARTED|Overall Study||99
6426108|NCT01020799|7340795|FG002|STARTED|Overall Study||50
6426109|NCT01020799|7340793|FG000|Patients Received Treatment|Overall Study||96
6426110|NCT01020799|7340794|FG001|Patients Received Treatment|Overall Study||99
6426111|NCT01020799|7340795|FG002|Patients Received Treatment|Overall Study||50
6426112|NCT01020799|7340793|FG000|Full Analysis Set|Overall Study||91
6426113|NCT01020799|7340794|FG001|Full Analysis Set|Overall Study||94
6426114|NCT01020799|7340795|FG002|Full Analysis Set|Overall Study||49
6426115|NCT01020799|7340793|FG000|COMPLETED|Overall Study||79
6426116|NCT01020799|7340794|FG001|COMPLETED|Overall Study||85
6426117|NCT01020799|7340795|FG002|COMPLETED|Overall Study||43
6426118|NCT01020799|7340793|FG000|NOT COMPLETED|Overall Study||19
6426119|NCT01020799|7340794|FG001|NOT COMPLETED|Overall Study||14
6426120|NCT01020799|7340795|FG002|NOT COMPLETED|Overall Study||7
6426121|NCT01020812|7340803|FG000|STARTED|Overall Study||11
6426122|NCT01020812|7340803|FG000|COMPLETED|Overall Study||8
6426123|NCT01020812|7340803|FG000|NOT COMPLETED|Overall Study||3
6426124|NCT01020838|7340807|FG000|STARTED|Overall Study||218
6551858|NCT01733758|7474202|FG002|NOT COMPLETED|Overall Study||15
6551859|NCT01733758|7474203|FG003|NOT COMPLETED|Overall Study||8
6551860|NCT01733953|7474217|FG000|STARTED|Overall Study||14
6551861|NCT01733953|7474218|FG001|STARTED|Overall Study||13
6551862|NCT01733953|7474217|FG000|COMPLETED|Overall Study||9
6551863|NCT01733953|7474218|FG001|COMPLETED|Overall Study||6
6551864|NCT01733953|7474217|FG000|NOT COMPLETED|Overall Study||5
6551865|NCT01733953|7474218|FG001|NOT COMPLETED|Overall Study||7
6551866|NCT01734161|7474226|FG000|STARTED|Overall Study||61
6551867|NCT01734161|7474227|FG001|STARTED|Overall Study||61
6551868|NCT01734161|7474226|FG000|COMPLETED|Overall Study||55
6551869|NCT01734161|7474227|FG001|COMPLETED|Overall Study||53
6551870|NCT01734161|7474226|FG000|NOT COMPLETED|Overall Study||6
6551871|NCT01734161|7474227|FG001|NOT COMPLETED|Overall Study||8
6551872|NCT01734239|7474235|FG000|STARTED|Overall Study||52
6426125|NCT01020838|7340807|FG000|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
6426126|NCT01020838|7340807|FG000|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
6426127|NCT01020838|7340807|FG000|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
6426128|NCT01020838|7340807|FG000|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
6426129|NCT01020838|7340807|FG000|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
6426130|NCT01020838|7340807|FG000|COMPLETED|Overall Study||35
6426131|NCT01020838|7340807|FG000|NOT COMPLETED|Overall Study||183
6426132|NCT01020877|7340822|FG000|STARTED|First Intervention||19
6426133|NCT01020877|7340823|FG001|STARTED|First Intervention||19
6426134|NCT01020877|7340822|FG000|COMPLETED|First Intervention||19
6426135|NCT01020877|7340823|FG001|COMPLETED|First Intervention||19
6426136|NCT01020877|7340822|FG000|NOT COMPLETED|First Intervention||0
6426137|NCT01020877|7340823|FG001|NOT COMPLETED|First Intervention||0
6426138|NCT01020877|7340822|FG000|STARTED|Washout of 7 Days||19
6426139|NCT01020877|7340823|FG001|STARTED|Washout of 7 Days||19
6426140|NCT01020877|7340822|FG000|COMPLETED|Washout of 7 Days||19
6426141|NCT01020877|7340823|FG001|COMPLETED|Washout of 7 Days||19
6551873|NCT01734239|7474236|FG001|STARTED|Overall Study||50
6551874|NCT01734239|7474235|FG000|COMPLETED|Overall Study||52
6551875|NCT01734239|7474236|FG001|COMPLETED|Overall Study||50
6551876|NCT01734239|7474235|FG000|NOT COMPLETED|Overall Study||0
6426142|NCT01020877|7340822|FG000|NOT COMPLETED|Washout of 7 Days||0
6426143|NCT01020877|7340823|FG001|NOT COMPLETED|Washout of 7 Days||0
6426144|NCT01020877|7340822|FG000|STARTED|Second Intervention||19
6426145|NCT01020877|7340823|FG001|STARTED|Second Intervention||19
6426146|NCT01020877|7340822|FG000|COMPLETED|Second Intervention||18
6426147|NCT01020877|7340823|FG001|COMPLETED|Second Intervention||19
6426148|NCT01020877|7340822|FG000|NOT COMPLETED|Second Intervention||1
6426149|NCT01020877|7340823|FG001|NOT COMPLETED|Second Intervention||0
6426150|NCT01020981|7340831|FG000|STARTED|Overall Study||150
6426151|NCT01020981|7340832|FG001|STARTED|Overall Study||150
6426152|NCT01020981|7340831|FG000|COMPLETED|Overall Study||66
6426153|NCT01020981|7340832|FG001|COMPLETED|Overall Study||60
6551877|NCT01734239|7474236|FG001|NOT COMPLETED|Overall Study||0
6551878|NCT01734317|7474241|FG000|STARTED|Overall Study||10
6551879|NCT01734317|7474241|FG000|COMPLETED|Overall Study||10
6551880|NCT01734317|7474241|FG000|NOT COMPLETED|Overall Study||0
6551881|NCT01734382|7474249|FG000|STARTED|Part 1||19
6551882|NCT01734382|7474250|FG001|STARTED|Part 1||0
6426154|NCT01020981|7340831|FG000|NOT COMPLETED|Overall Study||84
6426155|NCT01020981|7340832|FG001|NOT COMPLETED|Overall Study||90
6426156|NCT01021007|7340842|FG000|STARTED|Overall Study||36
6426157|NCT01021007|7340843|FG001|STARTED|Overall Study||37
6426158|NCT01021007|7340842|FG000|COMPLETED|Overall Study||34
6426159|NCT01021007|7340843|FG001|COMPLETED|Overall Study||33
6426160|NCT01021007|7340842|FG000|NOT COMPLETED|Overall Study||2
6426161|NCT01021007|7340843|FG001|NOT COMPLETED|Overall Study||4
6426162|NCT01021020|7340849|FG000|STARTED|Period I||28
6426163|NCT01021020|7340849|FG000|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
6426164|NCT01021020|7340849|FG000|NOT COMPLETED|Period I||2
6426165|NCT01021020|7340849|FG000|STARTED|14 Day Washout Period A||26
6551883|NCT01734382|7474251|FG002|STARTED|Part 1||0
6551884|NCT01734382|7474249|FG000|COMPLETED|Part 1||17
6551885|NCT01734382|7474250|FG001|COMPLETED|Part 1||0
6652113|NCT02424799|7581624|FG001|NOT COMPLETED|Part C (Up to Day 23)||0
6426166|NCT01021020|7340849|FG000|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
6426167|NCT01021020|7340849|FG000|NOT COMPLETED|14 Day Washout Period A||1
6426168|NCT01021020|7340849|FG000|STARTED|Period II||25
6426169|NCT01021020|7340849|FG000|COMPLETED|Period II||25
6426170|NCT01021020|7340849|FG000|NOT COMPLETED|Period II||0
6426171|NCT01021020|7340849|FG000|STARTED|14 Day Washout Period B||25
6426172|NCT01021020|7340849|FG000|COMPLETED|14 Day Washout Period B||25
6426173|NCT01021020|7340849|FG000|NOT COMPLETED|14 Day Washout Period B||0
6426174|NCT01021020|7340849|FG000|STARTED|Period III||25
6426175|NCT01021020|7340849|FG000|COMPLETED|Period III||25
6426176|NCT01021020|7340849|FG000|NOT COMPLETED|Period III||0
6426177|NCT01021111|7340861|FG000|STARTED|Overall Study||17
6426178|NCT01021111|7340861|FG000|COMPLETED|Overall Study||17
6426179|NCT01021111|7340861|FG000|NOT COMPLETED|Overall Study||0
6426180|NCT01021137|7340869|FG000|STARTED|Overall Study||62
6426181|NCT01021137|7340870|FG001|STARTED|Overall Study||20
6426182|NCT01021137|7340871|FG002|STARTED|Overall Study||11
6426183|NCT01021137|7340872|FG003|STARTED|Overall Study||41
6426184|NCT01021137|7340869|FG000|COMPLETED|Overall Study||52
6426185|NCT01021137|7340870|FG001|COMPLETED|Overall Study||16
6426186|NCT01021137|7340871|FG002|COMPLETED|Overall Study||9
6426187|NCT01021137|7340872|FG003|COMPLETED|Overall Study||32
6426188|NCT01021137|7340869|FG000|NOT COMPLETED|Overall Study||10
6426189|NCT01021137|7340870|FG001|NOT COMPLETED|Overall Study||4
6426190|NCT01021137|7340871|FG002|NOT COMPLETED|Overall Study||2
6426191|NCT01021137|7340872|FG003|NOT COMPLETED|Overall Study||9
6426192|NCT01021215|7340885|FG000|STARTED|Overall Study||60
6426193|NCT01021215|7340886|FG001|STARTED|Overall Study||20
6426194|NCT01021215|7340885|FG000|Received Allocated Intervention|Overall Study||60
6426195|NCT01021215|7340886|FG001|Received Allocated Intervention|Overall Study||20
6426196|NCT01021215|7340885|FG000|COMPLETED|Overall Study||57
6426197|NCT01021215|7340886|FG001|COMPLETED|Overall Study||20
6426198|NCT01021215|7340885|FG000|NOT COMPLETED|Overall Study||3
6426199|NCT01021215|7340886|FG001|NOT COMPLETED|Overall Study||0
6426200|NCT01021293|7340894|FG000|STARTED|Overall Study||550
6426201|NCT01021293|7340895|FG001|STARTED|Overall Study||550
6426202|NCT01021293|7340894|FG000|COMPLETED|Overall Study||538
6426203|NCT01021293|7340895|FG001|COMPLETED|Overall Study||526
6426204|NCT01021293|7340894|FG000|NOT COMPLETED|Overall Study||12
6426205|NCT01021293|7340895|FG001|NOT COMPLETED|Overall Study||24
6426206|NCT01021306|7340906|FG000|STARTED|2 Month (Primary Outcome)||20
6426207|NCT01021306|7340907|FG001|STARTED|2 Month (Primary Outcome)||20
6551886|NCT01734382|7474251|FG002|COMPLETED|Part 1||0
6551887|NCT01734382|7474249|FG000|NOT COMPLETED|Part 1||2
6652114|NCT02424799|7581625|FG002|NOT COMPLETED|Part C (Up to Day 23)||0
6652115|NCT02424799|7581626|FG003|NOT COMPLETED|Part C (Up to Day 23)||0
6652116|NCT02424799|7581627|FG004|NOT COMPLETED|Part C (Up to Day 23)||0
6652117|NCT02424799|7581628|FG005|NOT COMPLETED|Part C (Up to Day 23)||0
6652118|NCT02424968|7581660|FG000|STARTED|Overall Study||18
6652119|NCT02424968|7581660|FG000|COMPLETED|Overall Study||18
6652120|NCT02424968|7581660|FG000|NOT COMPLETED|Overall Study||0
6426208|NCT01021306|7340908|FG002|STARTED|2 Month (Primary Outcome)||19
6426209|NCT01021306|7340909|FG003|STARTED|2 Month (Primary Outcome)||21
6426210|NCT01021306|7340906|FG000|COMPLETED|2 Month (Primary Outcome)||14
6426211|NCT01021306|7340907|FG001|COMPLETED|2 Month (Primary Outcome)||14
6551888|NCT01734382|7474250|FG001|NOT COMPLETED|Part 1||0
6652121|NCT02425098|7581666|FG000|STARTED|Overall Study||176
6652122|NCT02425098|7581667|FG001|STARTED|Overall Study||175
6652123|NCT02425098|7581666|FG000|COMPLETED|Overall Study||163
6652124|NCT02425098|7581667|FG001|COMPLETED|Overall Study||159
6652125|NCT02425098|7581666|FG000|NOT COMPLETED|Overall Study||13
6652126|NCT02425098|7581667|FG001|NOT COMPLETED|Overall Study||16
6551889|NCT01734382|7474251|FG002|NOT COMPLETED|Part 1||0
6551890|NCT01734382|7474249|FG000|STARTED|Part 2||0
6551891|NCT01734382|7474250|FG001|STARTED|Part 2||7
6551892|NCT01734382|7474251|FG002|STARTED|Part 2||15
6551893|NCT01734382|7474249|FG000|COMPLETED|Part 2||0
6551894|NCT01734382|7474250|FG001|COMPLETED|Part 2||5
6551895|NCT01734382|7474251|FG002|COMPLETED|Part 2||8
6551896|NCT01734382|7474249|FG000|NOT COMPLETED|Part 2||0
6551897|NCT01734382|7474250|FG001|NOT COMPLETED|Part 2||2
6551898|NCT01734382|7474251|FG002|NOT COMPLETED|Part 2||7
6652127|NCT02425111|7581673|FG000|STARTED|Part A: Treatment Period||101
6652128|NCT02425111|7581673|FG000|COMPLETED|Part A: Treatment Period||78
6652129|NCT02425111|7581673|FG000|NOT COMPLETED|Part A: Treatment Period||23
6652130|NCT02425111|7581673|FG000|STARTED|Part B: Treatment Extension Period||56
6652131|NCT02425111|7581673|FG000|COMPLETED|Part B: Treatment Extension Period||46
6426212|NCT01021306|7340908|FG002|COMPLETED|2 Month (Primary Outcome)||14
6426213|NCT01021306|7340909|FG003|COMPLETED|2 Month (Primary Outcome)||17
6426214|NCT01021306|7340906|FG000|NOT COMPLETED|2 Month (Primary Outcome)||6
6426215|NCT01021306|7340907|FG001|NOT COMPLETED|2 Month (Primary Outcome)||6
6426216|NCT01021306|7340908|FG002|NOT COMPLETED|2 Month (Primary Outcome)||5
6426217|NCT01021306|7340909|FG003|NOT COMPLETED|2 Month (Primary Outcome)||4
6426218|NCT01021306|7340906|FG000|STARTED|6 Month (Follow-up)||14
6426219|NCT01021306|7340907|FG001|STARTED|6 Month (Follow-up)||14
6426220|NCT01021306|7340908|FG002|STARTED|6 Month (Follow-up)||14
6426221|NCT01021306|7340909|FG003|STARTED|6 Month (Follow-up)||17
6426222|NCT01021306|7340906|FG000|COMPLETED|6 Month (Follow-up)||11
6426223|NCT01021306|7340907|FG001|COMPLETED|6 Month (Follow-up)||13
6426224|NCT01021306|7340908|FG002|COMPLETED|6 Month (Follow-up)||14
6426225|NCT01021306|7340909|FG003|COMPLETED|6 Month (Follow-up)||14
6426226|NCT01021306|7340906|FG000|NOT COMPLETED|6 Month (Follow-up)||3
6426227|NCT01021306|7340907|FG001|NOT COMPLETED|6 Month (Follow-up)||1
6426228|NCT01021306|7340908|FG002|NOT COMPLETED|6 Month (Follow-up)||0
6426229|NCT01021306|7340909|FG003|NOT COMPLETED|6 Month (Follow-up)||3
6426230|NCT01021332|7340919|FG000|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
6426231|NCT01021332|7340919|FG000|Safety Analysis Set (SAF)|Overall Study||1066
6426232|NCT01021332|7340919|FG000|Full Analysis Set (FAS)|Overall Study||1009
6426233|NCT01021332|7340919|FG000|COMPLETED|Overall Study||960
6426234|NCT01021332|7340919|FG000|NOT COMPLETED|Overall Study||106
6426235|NCT01021423|7340927|FG000|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
6426236|NCT01021423|7340928|FG001|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
6426237|NCT01021423|7340927|FG000|COMPLETED|Overall Study||0
6426238|NCT01021423|7340928|FG001|COMPLETED|Overall Study||0
6426239|NCT01021423|7340927|FG000|NOT COMPLETED|Overall Study||4
6426240|NCT01021423|7340928|FG001|NOT COMPLETED|Overall Study||5
6426241|NCT01021553|7340937|FG000|STARTED|Overall Study||27
6426242|NCT01021553|7340938|FG001|STARTED|Overall Study||22
6426243|NCT01021553|7340939|FG002|STARTED|Overall Study||28
6426244|NCT01021553|7340937|FG000|COMPLETED|Overall Study||23
6551899|NCT01734395|7474263|FG000|STARTED|Overall Study||1882
6551900|NCT01734395|7474263|FG000|COMPLETED|Overall Study||1472
6551901|NCT01734395|7474263|FG000|NOT COMPLETED|Overall Study||410
6562771|NCT01803074|7485712|FG013|NOT COMPLETED|Period 1: Part A (HIV-1 Clade B)||0
6562772|NCT01803074|7485699|FG000|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6562773|NCT01803074|7485700|FG001|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6426245|NCT01021553|7340938|FG001|COMPLETED|Overall Study||17
6426246|NCT01021553|7340939|FG002|COMPLETED|Overall Study||25
6426247|NCT01021553|7340937|FG000|NOT COMPLETED|Overall Study||4
6426248|NCT01021553|7340938|FG001|NOT COMPLETED|Overall Study||5
6426249|NCT01021553|7340939|FG002|NOT COMPLETED|Overall Study||3
6426250|NCT01021618|7340954|FG000|STARTED|Overall Study||44
6426251|NCT01021618|7340955|FG001|STARTED|Overall Study||96
6426252|NCT01021618|7340954|FG000|COMPLETED|Overall Study||44
6426253|NCT01021618|7340955|FG001|COMPLETED|Overall Study||96
6426254|NCT01021618|7340954|FG000|NOT COMPLETED|Overall Study||0
6426255|NCT01021618|7340955|FG001|NOT COMPLETED|Overall Study||0
6426256|NCT01021683|7340961|FG000|STARTED|Overall Study||203
6426257|NCT01021683|7340961|FG000|COMPLETED|Overall Study||132
6426258|NCT01021683|7340961|FG000|NOT COMPLETED|Overall Study||71
6426259|NCT01021748|7340974|FG000|STARTED|Overall Study||6
6426260|NCT01021748|7340975|FG001|STARTED|Overall Study||5
6426261|NCT01021748|7340976|FG002|STARTED|Overall Study||7
6426262|NCT01021748|7340977|FG003|STARTED|Overall Study||7
6562774|NCT01803074|7485701|FG002|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6562775|NCT01803074|7485702|FG003|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6562776|NCT01803074|7485703|FG004|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6562777|NCT01803074|7485704|FG005|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6562778|NCT01803074|7485705|FG006|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6562779|NCT01803074|7485706|FG007|STARTED|Period 2: Part B (HIV-1 Clade B)||8
6562780|NCT01803074|7485707|FG008|STARTED|Period 2: Part B (HIV-1 Clade B)||8
6562781|NCT01803074|7485708|FG009|STARTED|Period 2: Part B (HIV-1 Clade B)||4
6562782|NCT01803074|7485709|FG010|STARTED|Period 2: Part B (HIV-1 Clade B)||8
6426263|NCT01021748|7340978|FG004|STARTED|Overall Study||9
6426264|NCT01021748|7340979|FG005|STARTED|Overall Study||3
6426265|NCT01021748|7340980|FG006|STARTED|Overall Study||3
6426266|NCT01021748|7340981|FG007|STARTED|Overall Study||6
6426267|NCT01021748|7340982|FG008|STARTED|Overall Study||17
6426268|NCT01021748|7340974|FG000|Treated|Overall Study||6
6426269|NCT01021748|7340975|FG001|Treated|Overall Study|One participant was allocated, but not treated.|4
6426270|NCT01021748|7340976|FG002|Treated|Overall Study||7
6426271|NCT01021748|7340977|FG003|Treated|Overall Study||7
6426272|NCT01021748|7340978|FG004|Treated|Overall Study||9
6426273|NCT01021748|7340979|FG005|Treated|Overall Study||3
6426274|NCT01021748|7340980|FG006|Treated|Overall Study||3
6426275|NCT01021748|7340981|FG007|Treated|Overall Study||6
6426276|NCT01021748|7340982|FG008|Treated|Overall Study||17
6426277|NCT01021748|7340974|FG000|COMPLETED|Overall Study||0
6426278|NCT01021748|7340975|FG001|COMPLETED|Overall Study||0
6426279|NCT01021748|7340976|FG002|COMPLETED|Overall Study||0
6426280|NCT01021748|7340977|FG003|COMPLETED|Overall Study||0
6426281|NCT01021748|7340978|FG004|COMPLETED|Overall Study||0
6426282|NCT01021748|7340979|FG005|COMPLETED|Overall Study||0
6426283|NCT01021748|7340980|FG006|COMPLETED|Overall Study||0
6426284|NCT01021748|7340981|FG007|COMPLETED|Overall Study||0
6426285|NCT01021748|7340982|FG008|COMPLETED|Overall Study||1
6426286|NCT01021748|7340974|FG000|NOT COMPLETED|Overall Study||6
6426287|NCT01021748|7340975|FG001|NOT COMPLETED|Overall Study||5
6426288|NCT01021748|7340976|FG002|NOT COMPLETED|Overall Study||7
6426289|NCT01021748|7340977|FG003|NOT COMPLETED|Overall Study||7
6426290|NCT01021748|7340978|FG004|NOT COMPLETED|Overall Study||9
6426291|NCT01021748|7340979|FG005|NOT COMPLETED|Overall Study||3
6426292|NCT01021748|7340980|FG006|NOT COMPLETED|Overall Study||3
6426293|NCT01021748|7340981|FG007|NOT COMPLETED|Overall Study||6
6426294|NCT01021748|7340982|FG008|NOT COMPLETED|Overall Study||16
6426295|NCT01021761|7341005|FG000|STARTED|Overall Study||42
6426296|NCT01021761|7341006|FG001|STARTED|Overall Study||42
6426297|NCT01021761|7341007|FG002|STARTED|Overall Study||42
6426298|NCT01021761|7341005|FG000|COMPLETED|Overall Study||41
6426299|NCT01021761|7341006|FG001|COMPLETED|Overall Study||38
6426300|NCT01021761|7341007|FG002|COMPLETED|Overall Study||42
6426301|NCT01021761|7341005|FG000|NOT COMPLETED|Overall Study||1
6426302|NCT01021761|7341006|FG001|NOT COMPLETED|Overall Study||4
6426303|NCT01021761|7341007|FG002|NOT COMPLETED|Overall Study||0
6426304|NCT01021813|7341017|FG000|STARTED|DB Treatment Phase||522
6426305|NCT01021813|7341018|FG001|STARTED|DB Treatment Phase||259
6426306|NCT01021813|7341019|FG002|STARTED|DB Treatment Phase||0
6426307|NCT01021813|7341020|FG003|STARTED|DB Treatment Phase||0
6426308|NCT01021813|7341021|FG004|STARTED|DB Treatment Phase||0
6426309|NCT01021813|7341017|FG000|Treated|DB Treatment Phase||521
6426310|NCT01021813|7341018|FG001|Treated|DB Treatment Phase||258
6426311|NCT01021813|7341019|FG002|Treated|DB Treatment Phase||0
6426312|NCT01021813|7341020|FG003|Treated|DB Treatment Phase||0
6426313|NCT01021813|7341021|FG004|Treated|DB Treatment Phase||0
6426314|NCT01021813|7341017|FG000|COMPLETED|DB Treatment Phase||322
6426315|NCT01021813|7341018|FG001|COMPLETED|DB Treatment Phase||162
6426316|NCT01021813|7341019|FG002|COMPLETED|DB Treatment Phase||0
6426317|NCT01021813|7341020|FG003|COMPLETED|DB Treatment Phase||0
6426318|NCT01021813|7341021|FG004|COMPLETED|DB Treatment Phase||0
6426319|NCT01021813|7341017|FG000|NOT COMPLETED|DB Treatment Phase||200
6426320|NCT01021813|7341018|FG001|NOT COMPLETED|DB Treatment Phase||97
6426321|NCT01021813|7341019|FG002|NOT COMPLETED|DB Treatment Phase||0
6426322|NCT01021813|7341020|FG003|NOT COMPLETED|DB Treatment Phase||0
6426323|NCT01021813|7341021|FG004|NOT COMPLETED|DB Treatment Phase||0
6426324|NCT01021813|7341017|FG000|STARTED|DB Randomized Discontinuation Phase||0
6426325|NCT01021813|7341018|FG001|STARTED|DB Randomized Discontinuation Phase||0
6426326|NCT01021813|7341019|FG002|STARTED|DB Randomized Discontinuation Phase||156
6426327|NCT01021813|7341020|FG003|STARTED|DB Randomized Discontinuation Phase||166
6426328|NCT01021813|7341021|FG004|STARTED|DB Randomized Discontinuation Phase||162
6426329|NCT01021813|7341017|FG000|COMPLETED|DB Randomized Discontinuation Phase||0
6426330|NCT01021813|7341018|FG001|COMPLETED|DB Randomized Discontinuation Phase||0
6426331|NCT01021813|7341019|FG002|COMPLETED|DB Randomized Discontinuation Phase||152
6426332|NCT01021813|7341020|FG003|COMPLETED|DB Randomized Discontinuation Phase||161
6426333|NCT01021813|7341021|FG004|COMPLETED|DB Randomized Discontinuation Phase||157
6426334|NCT01021813|7341017|FG000|NOT COMPLETED|DB Randomized Discontinuation Phase||0
6426335|NCT01021813|7341018|FG001|NOT COMPLETED|DB Randomized Discontinuation Phase||0
6426336|NCT01021813|7341019|FG002|NOT COMPLETED|DB Randomized Discontinuation Phase||4
6426337|NCT01021813|7341020|FG003|NOT COMPLETED|DB Randomized Discontinuation Phase||5
6426338|NCT01021813|7341021|FG004|NOT COMPLETED|DB Randomized Discontinuation Phase||5
6426339|NCT01021852|7341046|FG000|STARTED|Treatment Period 1||40
6426340|NCT01021852|7341047|FG001|STARTED|Treatment Period 1||40
6426341|NCT01021852|7341048|FG002|STARTED|Treatment Period 1||41
6426342|NCT01021852|7341049|FG003|STARTED|Treatment Period 1||40
6426343|NCT01021852|7341050|FG004|STARTED|Treatment Period 1||42
6426344|NCT01021852|7341051|FG005|STARTED|Treatment Period 1||41
6426345|NCT01021852|7341052|FG006|STARTED|Treatment Period 1||41
6426346|NCT01021852|7341053|FG007|STARTED|Treatment Period 1||41
6426347|NCT01021852|7341046|FG000|Treated|Treatment Period 1||40
6426348|NCT01021852|7341047|FG001|Treated|Treatment Period 1||40
6426349|NCT01021852|7341048|FG002|Treated|Treatment Period 1||41
6426350|NCT01021852|7341049|FG003|Treated|Treatment Period 1||38
6426351|NCT01021852|7341050|FG004|Treated|Treatment Period 1||42
6426352|NCT01021852|7341051|FG005|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
6426353|NCT01021852|7341052|FG006|Treated|Treatment Period 1||41
6426354|NCT01021852|7341053|FG007|Treated|Treatment Period 1||41
6426355|NCT01021852|7341046|FG000|COMPLETED|Treatment Period 1||37
6426356|NCT01021852|7341047|FG001|COMPLETED|Treatment Period 1||39
6426357|NCT01021852|7341048|FG002|COMPLETED|Treatment Period 1||39
6426358|NCT01021852|7341049|FG003|COMPLETED|Treatment Period 1||38
6426359|NCT01021852|7341050|FG004|COMPLETED|Treatment Period 1||39
6426360|NCT01021852|7341051|FG005|COMPLETED|Treatment Period 1||39
6426361|NCT01021852|7341052|FG006|COMPLETED|Treatment Period 1||41
6426362|NCT01021852|7341053|FG007|COMPLETED|Treatment Period 1||40
6426363|NCT01021852|7341046|FG000|NOT COMPLETED|Treatment Period 1||3
6426364|NCT01021852|7341047|FG001|NOT COMPLETED|Treatment Period 1||1
6426365|NCT01021852|7341048|FG002|NOT COMPLETED|Treatment Period 1||2
6426366|NCT01021852|7341049|FG003|NOT COMPLETED|Treatment Period 1||2
6426367|NCT01021852|7341050|FG004|NOT COMPLETED|Treatment Period 1||3
6426368|NCT01021852|7341051|FG005|NOT COMPLETED|Treatment Period 1||2
6426369|NCT01021852|7341052|FG006|NOT COMPLETED|Treatment Period 1||0
6426370|NCT01021852|7341053|FG007|NOT COMPLETED|Treatment Period 1||1
6426371|NCT01021852|7341046|FG000|STARTED|Washout Period-Placebo||37
6426372|NCT01021852|7341047|FG001|STARTED|Washout Period-Placebo||39
6426373|NCT01021852|7341048|FG002|STARTED|Washout Period-Placebo||39
6426374|NCT01021852|7341049|FG003|STARTED|Washout Period-Placebo||38
6426375|NCT01021852|7341050|FG004|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
6426376|NCT01021852|7341051|FG005|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
6426377|NCT01021852|7341052|FG006|STARTED|Washout Period-Placebo||41
6426378|NCT01021852|7341053|FG007|STARTED|Washout Period-Placebo||40
6426379|NCT01021852|7341046|FG000|COMPLETED|Washout Period-Placebo||37
6426380|NCT01021852|7341047|FG001|COMPLETED|Washout Period-Placebo||39
6426381|NCT01021852|7341048|FG002|COMPLETED|Washout Period-Placebo||39
6426382|NCT01021852|7341049|FG003|COMPLETED|Washout Period-Placebo||37
6426383|NCT01021852|7341050|FG004|COMPLETED|Washout Period-Placebo||39
6426384|NCT01021852|7341051|FG005|COMPLETED|Washout Period-Placebo||38
6426385|NCT01021852|7341052|FG006|COMPLETED|Washout Period-Placebo||40
6426386|NCT01021852|7341053|FG007|COMPLETED|Washout Period-Placebo||40
6426387|NCT01021852|7341046|FG000|NOT COMPLETED|Washout Period-Placebo||0
6426388|NCT01021852|7341047|FG001|NOT COMPLETED|Washout Period-Placebo||0
6426389|NCT01021852|7341048|FG002|NOT COMPLETED|Washout Period-Placebo||0
6426390|NCT01021852|7341049|FG003|NOT COMPLETED|Washout Period-Placebo||1
6426391|NCT01021852|7341050|FG004|NOT COMPLETED|Washout Period-Placebo||1
6426392|NCT01021852|7341051|FG005|NOT COMPLETED|Washout Period-Placebo||1
6426393|NCT01021852|7341052|FG006|NOT COMPLETED|Washout Period-Placebo||1
6426394|NCT01021852|7341053|FG007|NOT COMPLETED|Washout Period-Placebo||0
6426395|NCT01021852|7341046|FG000|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
6426396|NCT01021852|7341047|FG001|STARTED|Washout Period-No Drug||39
6426397|NCT01021852|7341048|FG002|STARTED|Washout Period-No Drug||39
6426398|NCT01021852|7341049|FG003|STARTED|Washout Period-No Drug||37
6426399|NCT01021852|7341050|FG004|STARTED|Washout Period-No Drug||39
6426400|NCT01021852|7341051|FG005|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
6426401|NCT01021852|7341052|FG006|STARTED|Washout Period-No Drug||40
6426402|NCT01021852|7341053|FG007|STARTED|Washout Period-No Drug||40
6426403|NCT01021852|7341046|FG000|COMPLETED|Washout Period-No Drug||37
6426404|NCT01021852|7341047|FG001|COMPLETED|Washout Period-No Drug||39
6426405|NCT01021852|7341048|FG002|COMPLETED|Washout Period-No Drug||39
6426406|NCT01021852|7341049|FG003|COMPLETED|Washout Period-No Drug||37
6426407|NCT01021852|7341050|FG004|COMPLETED|Washout Period-No Drug||39
6426408|NCT01021852|7341051|FG005|COMPLETED|Washout Period-No Drug||38
6426409|NCT01021852|7341052|FG006|COMPLETED|Washout Period-No Drug||40
6426410|NCT01021852|7341053|FG007|COMPLETED|Washout Period-No Drug||40
6426411|NCT01021852|7341046|FG000|NOT COMPLETED|Washout Period-No Drug||1
6426412|NCT01021852|7341047|FG001|NOT COMPLETED|Washout Period-No Drug||0
6426413|NCT01021852|7341048|FG002|NOT COMPLETED|Washout Period-No Drug||0
6426414|NCT01021852|7341049|FG003|NOT COMPLETED|Washout Period-No Drug||0
6426415|NCT01021852|7341050|FG004|NOT COMPLETED|Washout Period-No Drug||0
6426416|NCT01021852|7341051|FG005|NOT COMPLETED|Washout Period-No Drug||1
6426417|NCT01021852|7341052|FG006|NOT COMPLETED|Washout Period-No Drug||0
6426418|NCT01021852|7341053|FG007|NOT COMPLETED|Washout Period-No Drug||0
6426419|NCT01021852|7341046|FG000|STARTED|Treatment Period 2||37
6426420|NCT01021852|7341047|FG001|STARTED|Treatment Period 2||39
6426421|NCT01021852|7341048|FG002|STARTED|Treatment Period 2||39
6426422|NCT01021852|7341049|FG003|STARTED|Treatment Period 2||37
6426423|NCT01021852|7341050|FG004|STARTED|Treatment Period 2||39
6426424|NCT01021852|7341051|FG005|STARTED|Treatment Period 2||38
6426425|NCT01021852|7341052|FG006|STARTED|Treatment Period 2||40
6426426|NCT01021852|7341053|FG007|STARTED|Treatment Period 2||40
6426427|NCT01021852|7341046|FG000|COMPLETED|Treatment Period 2||37
6426428|NCT01021852|7341047|FG001|COMPLETED|Treatment Period 2||38
6426429|NCT01021852|7341048|FG002|COMPLETED|Treatment Period 2||38
6426430|NCT01021852|7341049|FG003|COMPLETED|Treatment Period 2||37
6426431|NCT01021852|7341050|FG004|COMPLETED|Treatment Period 2||37
6426432|NCT01021852|7341051|FG005|COMPLETED|Treatment Period 2||37
6426433|NCT01021852|7341052|FG006|COMPLETED|Treatment Period 2||37
6426434|NCT01021852|7341053|FG007|COMPLETED|Treatment Period 2||38
6426435|NCT01021852|7341046|FG000|NOT COMPLETED|Treatment Period 2||0
6426436|NCT01021852|7341047|FG001|NOT COMPLETED|Treatment Period 2||1
6426437|NCT01021852|7341048|FG002|NOT COMPLETED|Treatment Period 2||1
6426438|NCT01021852|7341049|FG003|NOT COMPLETED|Treatment Period 2||0
6426439|NCT01021852|7341050|FG004|NOT COMPLETED|Treatment Period 2||2
6426440|NCT01021852|7341051|FG005|NOT COMPLETED|Treatment Period 2||1
6426441|NCT01021852|7341052|FG006|NOT COMPLETED|Treatment Period 2||3
6426442|NCT01021852|7341053|FG007|NOT COMPLETED|Treatment Period 2||2
6426443|NCT01021878|7341069|FG000|STARTED|Overall Study||33
6426444|NCT01021878|7341070|FG001|STARTED|Overall Study||27
6426445|NCT01021878|7341069|FG000|Completed Follow-up|Overall Study||17
6426446|NCT01021878|7341070|FG001|Completed Follow-up|Overall Study||17
6426447|NCT01021878|7341069|FG000|COMPLETED|Overall Study||17
6426448|NCT01021878|7341070|FG001|COMPLETED|Overall Study||17
6426449|NCT01021878|7341069|FG000|NOT COMPLETED|Overall Study||16
6426450|NCT01021878|7341070|FG001|NOT COMPLETED|Overall Study||10
6551902|NCT01734434|7474271|FG000|STARTED|Overall Study||500
6551903|NCT01734434|7474272|FG001|STARTED|Overall Study||500
6551904|NCT01734434|7474273|FG002|STARTED|Overall Study||1992
6551905|NCT01734434|7474274|FG003|STARTED|Overall Study||251
6551906|NCT01734434|7474271|FG000|COMPLETED|Overall Study||490
6551907|NCT01734434|7474272|FG001|COMPLETED|Overall Study||488
6551908|NCT01734434|7474273|FG002|COMPLETED|Overall Study||1863
6551909|NCT01734434|7474274|FG003|COMPLETED|Overall Study||228
6551910|NCT01734434|7474271|FG000|NOT COMPLETED|Overall Study||10
6551911|NCT01734434|7474272|FG001|NOT COMPLETED|Overall Study||12
6551912|NCT01734434|7474273|FG002|NOT COMPLETED|Overall Study||129
6551913|NCT01734434|7474274|FG003|NOT COMPLETED|Overall Study||23
6426451|NCT01021956|7341083|FG000|STARTED|Overall Study||3
6426452|NCT01021956|7341084|FG001|STARTED|Overall Study||3
6426453|NCT01021956|7341085|FG002|STARTED|Overall Study||3
6426454|NCT01021956|7341086|FG003|STARTED|Overall Study||1
6426455|NCT01021956|7341083|FG000|COMPLETED|Overall Study||3
6426456|NCT01021956|7341084|FG001|COMPLETED|Overall Study||3
6426457|NCT01021956|7341085|FG002|COMPLETED|Overall Study||3
6426458|NCT01021956|7341086|FG003|COMPLETED|Overall Study||1
6426459|NCT01021956|7341083|FG000|NOT COMPLETED|Overall Study||0
6426460|NCT01021956|7341084|FG001|NOT COMPLETED|Overall Study||0
6426461|NCT01021956|7341085|FG002|NOT COMPLETED|Overall Study||0
6551914|NCT01734512|7474292|FG000|STARTED|Overall Study||65
6551915|NCT01734512|7474292|FG000|COMPLETED|Overall Study||65
6551916|NCT01734512|7474292|FG000|NOT COMPLETED|Overall Study||0
6426462|NCT01021956|7341086|FG003|NOT COMPLETED|Overall Study||0
6426463|NCT01022073|7341099|FG000|STARTED|Overall Study||86
6426464|NCT01022073|7341100|FG001|STARTED|Overall Study||70
6426465|NCT01022073|7341099|FG000|COMPLETED|Overall Study||67
6426466|NCT01022073|7341100|FG001|COMPLETED|Overall Study||52
6426467|NCT01022073|7341099|FG000|NOT COMPLETED|Overall Study||19
6426468|NCT01022073|7341100|FG001|NOT COMPLETED|Overall Study||18
6426469|NCT01022112|7341111|FG000|STARTED|Overall Study||82
6426470|NCT01022112|7341112|FG001|STARTED|Overall Study||74
6426471|NCT01022112|7341113|FG002|STARTED|Overall Study||77
6426472|NCT01022112|7341114|FG003|STARTED|Overall Study||75
6426473|NCT01022112|7341115|FG004|STARTED|Overall Study||75
6426474|NCT01022112|7341111|FG000|COMPLETED|Overall Study||79
6426475|NCT01022112|7341112|FG001|COMPLETED|Overall Study||71
6426476|NCT01022112|7341113|FG002|COMPLETED|Overall Study||74
6426477|NCT01022112|7341114|FG003|COMPLETED|Overall Study||72
6426478|NCT01022112|7341115|FG004|COMPLETED|Overall Study||65
6426479|NCT01022112|7341111|FG000|NOT COMPLETED|Overall Study||3
6426480|NCT01022112|7341112|FG001|NOT COMPLETED|Overall Study||3
6426481|NCT01022112|7341113|FG002|NOT COMPLETED|Overall Study||3
6426482|NCT01022112|7341114|FG003|NOT COMPLETED|Overall Study||3
6426483|NCT01022112|7341115|FG004|NOT COMPLETED|Overall Study||10
6426484|NCT01022190|7341127|FG000|STARTED|Overall Study||42
6426485|NCT01022190|7341127|FG000|COMPLETED|Overall Study||42
6426486|NCT01022190|7341127|FG000|NOT COMPLETED|Overall Study||0
6426487|NCT01022203|7341133|FG000|STARTED|PreTreatment Assessment||58
6426488|NCT01022203|7341134|FG001|STARTED|PreTreatment Assessment||56
6426489|NCT01022203|7341133|FG000|COMPLETED|PreTreatment Assessment||58
6426490|NCT01022203|7341134|FG001|COMPLETED|PreTreatment Assessment||56
6426491|NCT01022203|7341133|FG000|NOT COMPLETED|PreTreatment Assessment||0
6426492|NCT01022203|7341134|FG001|NOT COMPLETED|PreTreatment Assessment||0
6426493|NCT01022203|7341133|FG000|STARTED|Post Treatment Assessment||58
6426494|NCT01022203|7341134|FG001|STARTED|Post Treatment Assessment||56
6426495|NCT01022203|7341133|FG000|COMPLETED|Post Treatment Assessment||44
6426496|NCT01022203|7341134|FG001|COMPLETED|Post Treatment Assessment||42
6551917|NCT01734525|7474296|FG000|STARTED|Overall Study||85
6652132|NCT02425111|7581673|FG000|NOT COMPLETED|Part B: Treatment Extension Period||10
6426497|NCT01022203|7341133|FG000|NOT COMPLETED|Post Treatment Assessment||14
6551918|NCT01734525|7474296|FG000|COMPLETED|Overall Study||85
6426498|NCT01022203|7341134|FG001|NOT COMPLETED|Post Treatment Assessment||14
6426499|NCT01022203|7341133|FG000|STARTED|Follow-Up Assessment||44
6426500|NCT01022203|7341134|FG001|STARTED|Follow-Up Assessment||42
6426501|NCT01022203|7341133|FG000|COMPLETED|Follow-Up Assessment||42
6426502|NCT01022203|7341134|FG001|COMPLETED|Follow-Up Assessment||40
6426503|NCT01022203|7341133|FG000|NOT COMPLETED|Follow-Up Assessment||2
6551919|NCT01734525|7474296|FG000|NOT COMPLETED|Overall Study||0
6426504|NCT01022203|7341134|FG001|NOT COMPLETED|Follow-Up Assessment||2
6426505|NCT01022242|7341145|FG000|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
6426506|NCT01022242|7341146|FG001|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
6426507|NCT01022242|7341145|FG000|COMPLETED|Overall Study||49
6426508|NCT01022242|7341146|FG001|COMPLETED|Overall Study||46
6426509|NCT01022242|7341145|FG000|NOT COMPLETED|Overall Study||21
6426510|NCT01022242|7341146|FG001|NOT COMPLETED|Overall Study||19
6426511|NCT01022307|7341154|FG000|STARTED|Overall Study||184
6426512|NCT01022307|7341155|FG001|STARTED|Overall Study||28
6426513|NCT01022307|7341154|FG000|COMPLETED|Overall Study||184
6426514|NCT01022307|7341155|FG001|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
6426515|NCT01022307|7341154|FG000|NOT COMPLETED|Overall Study||0
6426516|NCT01022307|7341155|FG001|NOT COMPLETED|Overall Study||4
6426517|NCT01022359|7341163|FG000|STARTED|Overall Study||39
6426518|NCT01022359|7341164|FG001|STARTED|Overall Study||41
6426519|NCT01022359|7341163|FG000|COMPLETED|Overall Study||39
6426520|NCT01022359|7341164|FG001|COMPLETED|Overall Study||41
6426521|NCT01022359|7341163|FG000|NOT COMPLETED|Overall Study||0
6426522|NCT01022359|7341164|FG001|NOT COMPLETED|Overall Study||0
6426523|NCT01022424|7341170|FG000|STARTED|Overall Study||13
6426524|NCT01022424|7341170|FG000|COMPLETED|Overall Study||9
6426525|NCT01022424|7341170|FG000|NOT COMPLETED|Overall Study||4
6426526|NCT01022502|7341178|FG000|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
6426527|NCT01022502|7341178|FG000|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
6426528|NCT01022502|7341178|FG000|NOT COMPLETED|Overall Study||3
6499486|NCT01418378|7418196|FG000|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|90
6499487|NCT01418378|7418197|FG001|Subjects Who Received Study Implant|Overall Study|the number of subjects implanted with study implant|88
6499488|NCT01418378|7418196|FG000|COMPLETED|Overall Study||89
6499489|NCT01418378|7418197|FG001|COMPLETED|Overall Study||83
6499490|NCT01418378|7418196|FG000|NOT COMPLETED|Overall Study||1
6551920|NCT01734551|7474302|FG000|STARTED|Overall Study||15
6551921|NCT01734551|7474303|FG001|STARTED|Overall Study||16
6551922|NCT01734551|7474302|FG000|COMPLETED|Overall Study||15
6551923|NCT01734551|7474303|FG001|COMPLETED|Overall Study||16
6499491|NCT01418378|7418197|FG001|NOT COMPLETED|Overall Study||5
6499492|NCT01418482|7418203|FG000|STARTED|Overall Study||15
6499493|NCT01418482|7418203|FG000|COMPLETED|Overall Study||15
6499494|NCT01418482|7418203|FG000|NOT COMPLETED|Overall Study||0
6499495|NCT01418703|7418209|FG000|STARTED|Overall Study||13
6499496|NCT01418703|7418210|FG001|STARTED|Overall Study||13
6499497|NCT01418703|7418211|FG002|STARTED|Overall Study||6
6499498|NCT01418703|7418212|FG003|STARTED|Overall Study||6
6499499|NCT01418703|7418209|FG000|COMPLETED|Overall Study||13
6499500|NCT01418703|7418210|FG001|COMPLETED|Overall Study||13
6499501|NCT01418703|7418211|FG002|COMPLETED|Overall Study||6
6499502|NCT01418703|7418212|FG003|COMPLETED|Overall Study||6
6499503|NCT01418703|7418209|FG000|NOT COMPLETED|Overall Study||0
6499504|NCT01418703|7418210|FG001|NOT COMPLETED|Overall Study||0
6499505|NCT01418703|7418211|FG002|NOT COMPLETED|Overall Study||0
6499506|NCT01418703|7418212|FG003|NOT COMPLETED|Overall Study||0
6499507|NCT01418937|7418219|FG000|STARTED|Overall Study||164
6499508|NCT01418937|7418219|FG000|COMPLETED|Overall Study||156
6499509|NCT01418937|7418219|FG000|NOT COMPLETED|Overall Study||8
6499510|NCT01419015|7418223|FG000|STARTED|Overall Study||17
6499511|NCT01419015|7418223|FG000|COMPLETED|Overall Study||15
6499512|NCT01419015|7418223|FG000|NOT COMPLETED|Overall Study||2
6499513|NCT01419028|7418227|FG000|STARTED|Overall Study||48
6499514|NCT01419028|7418227|FG000|COMPLETED|Overall Study||48
6499515|NCT01419028|7418227|FG000|NOT COMPLETED|Overall Study||0
6499516|NCT01419080|7418231|FG000|STARTED|Overall Study||797
6499517|NCT01419080|7418231|FG000|COMPLETED|Overall Study||666
6499518|NCT01419080|7418231|FG000|NOT COMPLETED|Overall Study||131
6502051|NCT01432327|7420691|FG002|NOT COMPLETED|Posttest 6 Months||5
6502052|NCT01432327|7420692|FG003|NOT COMPLETED|Posttest 6 Months||2
6502053|NCT01432327|7420689|FG000|STARTED|Posttest 1 Year||52
6502054|NCT01432327|7420690|FG001|STARTED|Posttest 1 Year||55
6502055|NCT01432327|7420691|FG002|STARTED|Posttest 1 Year||50
6502056|NCT01432327|7420692|FG003|STARTED|Posttest 1 Year||54
6502057|NCT01432327|7420689|FG000|COMPLETED|Posttest 1 Year||28
6502058|NCT01432327|7420690|FG001|COMPLETED|Posttest 1 Year||27
6502059|NCT01432327|7420691|FG002|COMPLETED|Posttest 1 Year||30
6502060|NCT01432327|7420692|FG003|COMPLETED|Posttest 1 Year||31
6502061|NCT01432327|7420689|FG000|NOT COMPLETED|Posttest 1 Year||24
6502062|NCT01432327|7420690|FG001|NOT COMPLETED|Posttest 1 Year||28
6502063|NCT01432327|7420691|FG002|NOT COMPLETED|Posttest 1 Year||20
6502064|NCT01432327|7420692|FG003|NOT COMPLETED|Posttest 1 Year||23
6502065|NCT01432366|7420702|FG000|STARTED|Overall Study||460
6502066|NCT01432366|7420702|FG000|COMPLETED|Overall Study||392
6502067|NCT01432366|7420702|FG000|NOT COMPLETED|Overall Study||68
6502068|NCT01432379|7420706|FG000|STARTED|Overall Study||1168
6502069|NCT01432379|7420706|FG000|COMPLETED|Overall Study||783
6502070|NCT01432379|7420706|FG000|NOT COMPLETED|Overall Study||385
6502071|NCT01432405|7420712|FG000|STARTED|Overall Study||12
6502072|NCT01432405|7420713|FG001|STARTED|Overall Study||12
6426529|NCT01022567|7341186|FG000|STARTED|Overall Study||273
6426530|NCT01022567|7341187|FG001|STARTED|Overall Study||257
6426531|NCT01022567|7341186|FG000|COMPLETED|Overall Study||272
6426532|NCT01022567|7341187|FG001|COMPLETED|Overall Study||242
6426533|NCT01022567|7341186|FG000|NOT COMPLETED|Overall Study||1
6426534|NCT01022567|7341187|FG001|NOT COMPLETED|Overall Study||15
6426535|NCT01022580|7341195|FG000|STARTED|Overall Study||252
6426536|NCT01022580|7341196|FG001|STARTED|Overall Study||259
6426537|NCT01022580|7341195|FG000|COMPLETED|Overall Study|Survived to discharge|234
6426538|NCT01022580|7341196|FG001|COMPLETED|Overall Study|Survived to discharge.|237
6426539|NCT01022580|7341195|FG000|NOT COMPLETED|Overall Study||18
6426540|NCT01022580|7341196|FG001|NOT COMPLETED|Overall Study||22
6426541|NCT01022762|7341210|FG000|STARTED|Overall Study||218
6426542|NCT01022762|7341211|FG001|STARTED|Overall Study||222
6426543|NCT01022762|7341210|FG000|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
6426544|NCT01022762|7341211|FG001|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
6426545|NCT01022762|7341210|FG000|COMPLETED|Overall Study||196
6426546|NCT01022762|7341211|FG001|COMPLETED|Overall Study||194
6426547|NCT01022762|7341210|FG000|NOT COMPLETED|Overall Study||22
6426548|NCT01022762|7341211|FG001|NOT COMPLETED|Overall Study||28
6426549|NCT01022853|7341222|FG000|STARTED|Overall Study|entered and treated|3
6426550|NCT01022853|7341223|FG001|STARTED|Overall Study|entered and treated|4
6426551|NCT01022853|7341224|FG002|STARTED|Overall Study|entered and treated|13
6426552|NCT01022853|7341225|FG003|STARTED|Overall Study|entered and treated|8
6426553|NCT01022853|7341226|FG004|STARTED|Overall Study|entered and treated|2
6426554|NCT01022853|7341222|FG000|COMPLETED|Overall Study||0
6426555|NCT01022853|7341223|FG001|COMPLETED|Overall Study||0
6426556|NCT01022853|7341224|FG002|COMPLETED|Overall Study||0
6426557|NCT01022853|7341225|FG003|COMPLETED|Overall Study||0
6426558|NCT01022853|7341226|FG004|COMPLETED|Overall Study||0
6551924|NCT01734551|7474302|FG000|NOT COMPLETED|Overall Study||0
6551925|NCT01734551|7474303|FG001|NOT COMPLETED|Overall Study||0
6551926|NCT01734655|7474309|FG000|STARTED|Overall Study||40
6551927|NCT01734655|7474309|FG000|COMPLETED|Overall Study||40
6551928|NCT01734655|7474309|FG000|NOT COMPLETED|Overall Study||0
6551929|NCT01734746|7474316|FG000|STARTED|Overall Study||22
6551930|NCT01734746|7474316|FG000|COMPLETED|Overall Study||21
6551931|NCT01734746|7474316|FG000|NOT COMPLETED|Overall Study||1
6426559|NCT01022853|7341222|FG000|NOT COMPLETED|Overall Study||3
6426560|NCT01022853|7341223|FG001|NOT COMPLETED|Overall Study||4
6426561|NCT01022853|7341224|FG002|NOT COMPLETED|Overall Study||13
6426562|NCT01022853|7341225|FG003|NOT COMPLETED|Overall Study||8
6426563|NCT01022853|7341226|FG004|NOT COMPLETED|Overall Study||2
6426564|NCT01022996|7341241|FG000|STARTED|Overall Study||57
6426565|NCT01022996|7341241|FG000|COMPLETED|Overall Study||0
6426566|NCT01022996|7341241|FG000|NOT COMPLETED|Overall Study||57
6426567|NCT01023022|7341245|FG000|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
6426568|NCT01023022|7341245|FG000|COMPLETED|Overall Study||162
6426569|NCT01023022|7341245|FG000|NOT COMPLETED|Overall Study||14
6426570|NCT01023035|7341252|FG000|STARTED|Treatment Period||249
6426571|NCT01023035|7341253|FG001|STARTED|Treatment Period||251
6426572|NCT01023035|7341254|FG002|STARTED|Treatment Period||187
6426573|NCT01023035|7341252|FG000|COMPLETED|Treatment Period||177
6426574|NCT01023035|7341253|FG001|COMPLETED|Treatment Period||166
6426575|NCT01023035|7341254|FG002|COMPLETED|Treatment Period||69
6426576|NCT01023035|7341252|FG000|NOT COMPLETED|Treatment Period||72
6426577|NCT01023035|7341253|FG001|NOT COMPLETED|Treatment Period||85
6426578|NCT01023035|7341254|FG002|NOT COMPLETED|Treatment Period||118
6426579|NCT01023035|7341252|FG000|STARTED|Follow-up Period (up to Week 72)||238
6426580|NCT01023035|7341253|FG001|STARTED|Follow-up Period (up to Week 72)||235
6426581|NCT01023035|7341254|FG002|STARTED|Follow-up Period (up to Week 72)||147
6426582|NCT01023035|7341252|FG000|COMPLETED|Follow-up Period (up to Week 72)||210
6426583|NCT01023035|7341253|FG001|COMPLETED|Follow-up Period (up to Week 72)||207
6426584|NCT01023035|7341254|FG002|COMPLETED|Follow-up Period (up to Week 72)||108
6426585|NCT01023035|7341252|FG000|NOT COMPLETED|Follow-up Period (up to Week 72)||28
6426586|NCT01023035|7341253|FG001|NOT COMPLETED|Follow-up Period (up to Week 72)||28
6426587|NCT01023035|7341254|FG002|NOT COMPLETED|Follow-up Period (up to Week 72)||39
6426588|NCT01023061|7341264|FG000|STARTED|Overall Study||24
6426589|NCT01023061|7341264|FG000|COMPLETED|Overall Study||22
6426590|NCT01023061|7341264|FG000|NOT COMPLETED|Overall Study||2
6426591|NCT01023074|7341271|FG000|STARTED|Overall Study||26
6426592|NCT01023074|7341272|FG001|STARTED|Overall Study||13
6426593|NCT01023074|7341273|FG002|STARTED|Overall Study||13
6426594|NCT01023074|7341271|FG000|COMPLETED|Overall Study||26
6426595|NCT01023074|7341272|FG001|COMPLETED|Overall Study||13
6426596|NCT01023074|7341273|FG002|COMPLETED|Overall Study||13
6426597|NCT01023074|7341271|FG000|NOT COMPLETED|Overall Study||0
6426598|NCT01023074|7341272|FG001|NOT COMPLETED|Overall Study||0
6426599|NCT01023074|7341273|FG002|NOT COMPLETED|Overall Study||0
6426600|NCT01023178|7341288|FG000|STARTED|Overall Study||5
6426601|NCT01023178|7341289|FG001|STARTED|Overall Study||8
6551932|NCT01734772|7474323|FG000|STARTED|Overall Study||24
6426602|NCT01023178|7341290|FG002|STARTED|Overall Study||7
6426603|NCT01023178|7341288|FG000|COMPLETED|Overall Study||3
6551933|NCT01734772|7474324|FG001|STARTED|Overall Study||24
6551934|NCT01734772|7474323|FG000|COMPLETED|Overall Study||23
6426604|NCT01023178|7341289|FG001|COMPLETED|Overall Study||6
6426605|NCT01023178|7341290|FG002|COMPLETED|Overall Study||4
6426606|NCT01023178|7341288|FG000|NOT COMPLETED|Overall Study||2
6426607|NCT01023178|7341289|FG001|NOT COMPLETED|Overall Study||2
6426608|NCT01023178|7341290|FG002|NOT COMPLETED|Overall Study||3
6426609|NCT01023217|7341300|FG000|STARTED|Overall Study||45
6426610|NCT01023217|7341301|FG001|STARTED|Overall Study||45
6426611|NCT01023217|7341300|FG000|COMPLETED|Overall Study||44
6426612|NCT01023217|7341301|FG001|COMPLETED|Overall Study||45
6426613|NCT01023217|7341300|FG000|NOT COMPLETED|Overall Study||1
6426614|NCT01023217|7341301|FG001|NOT COMPLETED|Overall Study||0
6426615|NCT01023256|7341311|FG000|STARTED|Overall Study||25
6426616|NCT01023256|7341312|FG001|STARTED|Overall Study||22
6426617|NCT01023256|7341313|FG002|STARTED|Overall Study||24
6426618|NCT01023256|7341314|FG003|STARTED|Overall Study||27
6426619|NCT01023256|7341311|FG000|COMPLETED|Overall Study||21
6426620|NCT01023256|7341312|FG001|COMPLETED|Overall Study||19
6426621|NCT01023256|7341313|FG002|COMPLETED|Overall Study||23
6426622|NCT01023256|7341314|FG003|COMPLETED|Overall Study||22
6426623|NCT01023256|7341311|FG000|NOT COMPLETED|Overall Study||4
6426624|NCT01023256|7341312|FG001|NOT COMPLETED|Overall Study||3
6426625|NCT01023256|7341313|FG002|NOT COMPLETED|Overall Study||1
6426626|NCT01023256|7341314|FG003|NOT COMPLETED|Overall Study||5
6426627|NCT01023269|7341327|FG000|STARTED|Overall Study||3
6426628|NCT01023269|7341328|FG001|STARTED|Overall Study||2
6426629|NCT01023269|7341327|FG000|COMPLETED|Overall Study||1
6426630|NCT01023269|7341328|FG001|COMPLETED|Overall Study||2
6426631|NCT01023269|7341327|FG000|NOT COMPLETED|Overall Study||2
6426632|NCT01023269|7341328|FG001|NOT COMPLETED|Overall Study||0
6426633|NCT01023308|7341334|FG000|STARTED|Overall Study||387
6426634|NCT01023308|7341335|FG001|STARTED|Overall Study||381
6426635|NCT01023308|7341334|FG000|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
6426636|NCT01023308|7341335|FG001|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
6426637|NCT01023308|7341334|FG000|NOT COMPLETED|Overall Study||285
6426638|NCT01023308|7341335|FG001|NOT COMPLETED|Overall Study||279
6426639|NCT01023477|7341343|FG000|STARTED|Overall Study||7
6426640|NCT01023477|7341344|FG001|STARTED|Overall Study||5
6426641|NCT01023477|7341343|FG000|COMPLETED|Overall Study||7
6426642|NCT01023477|7341344|FG001|COMPLETED|Overall Study||5
6652133|NCT02425306|7581682|FG000|STARTED|Overall Study||3
6652134|NCT02425306|7581683|FG001|STARTED|Overall Study||7
6652135|NCT02425306|7581684|FG002|STARTED|Overall Study||6
6652136|NCT02425306|7581685|FG003|STARTED|Overall Study||32
6652137|NCT02425306|7581682|FG000|COMPLETED|Overall Study||3
6652138|NCT02425306|7581683|FG001|COMPLETED|Overall Study||6
6652139|NCT02425306|7581684|FG002|COMPLETED|Overall Study||5
6652140|NCT02425306|7581685|FG003|COMPLETED|Overall Study||18
6652141|NCT02425306|7581682|FG000|NOT COMPLETED|Overall Study||0
6652142|NCT02425306|7581683|FG001|NOT COMPLETED|Overall Study||1
6652143|NCT02425306|7581684|FG002|NOT COMPLETED|Overall Study||1
6652144|NCT02425306|7581685|FG003|NOT COMPLETED|Overall Study||14
6426643|NCT01023477|7341343|FG000|NOT COMPLETED|Overall Study||0
6426644|NCT01023477|7341344|FG001|NOT COMPLETED|Overall Study||0
6426645|NCT01023516|7341352|FG000|STARTED|Overall Study||313
6426646|NCT01023516|7341353|FG001|STARTED|Overall Study||302
6426647|NCT01023516|7341352|FG000|COMPLETED|Overall Study||289
6426648|NCT01023516|7341353|FG001|COMPLETED|Overall Study||284
6426649|NCT01023516|7341352|FG000|NOT COMPLETED|Overall Study||24
6426650|NCT01023516|7341353|FG001|NOT COMPLETED|Overall Study||18
6426651|NCT01023568|7341362|FG000|STARTED|Overall Study||45
6426652|NCT01023568|7341363|FG001|STARTED|Overall Study||44
6426653|NCT01023568|7341364|FG002|STARTED|Overall Study||45
6426654|NCT01023568|7341362|FG000|COMPLETED|Overall Study||45
6426655|NCT01023568|7341363|FG001|COMPLETED|Overall Study||44
6426656|NCT01023568|7341364|FG002|COMPLETED|Overall Study||45
6426657|NCT01023568|7341362|FG000|NOT COMPLETED|Overall Study||0
6426658|NCT01023568|7341363|FG001|NOT COMPLETED|Overall Study||0
6426659|NCT01023568|7341364|FG002|NOT COMPLETED|Overall Study||0
6426660|NCT01023581|7341379|FG000|STARTED|Overall Study||109
6426661|NCT01023581|7341380|FG001|STARTED|Overall Study||112
6426662|NCT01023581|7341381|FG002|STARTED|Overall Study||113
6426663|NCT01023581|7341382|FG003|STARTED|Overall Study||114
6426664|NCT01023581|7341383|FG004|STARTED|Overall Study||111
6426665|NCT01023581|7341384|FG005|STARTED|Overall Study||111
6426666|NCT01023581|7341385|FG006|STARTED|Overall Study||114
6426667|NCT01023581|7341379|FG000|Received Study Treatment|Overall Study||106
6426668|NCT01023581|7341380|FG001|Received Study Treatment|Overall Study||112
6426669|NCT01023581|7341381|FG002|Received Study Treatment|Overall Study||110
6426670|NCT01023581|7341382|FG003|Received Study Treatment|Overall Study||109
6426671|NCT01023581|7341383|FG004|Received Study Treatment|Overall Study||111
6426672|NCT01023581|7341384|FG005|Received Study Treatment|Overall Study||106
6426673|NCT01023581|7341385|FG006|Received Study Treatment|Overall Study||114
6426674|NCT01023581|7341379|FG000|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
6426675|NCT01023581|7341380|FG001|COMPLETED|Overall Study||89
6426676|NCT01023581|7341381|FG002|COMPLETED|Overall Study||71
6426677|NCT01023581|7341382|FG003|COMPLETED|Overall Study||94
6426678|NCT01023581|7341383|FG004|COMPLETED|Overall Study||95
6426679|NCT01023581|7341384|FG005|COMPLETED|Overall Study||92
6426680|NCT01023581|7341385|FG006|COMPLETED|Overall Study||94
6426681|NCT01023581|7341379|FG000|NOT COMPLETED|Overall Study||35
6426682|NCT01023581|7341380|FG001|NOT COMPLETED|Overall Study||23
6426683|NCT01023581|7341381|FG002|NOT COMPLETED|Overall Study||42
6426684|NCT01023581|7341382|FG003|NOT COMPLETED|Overall Study||20
6426685|NCT01023581|7341383|FG004|NOT COMPLETED|Overall Study||16
6426686|NCT01023581|7341384|FG005|NOT COMPLETED|Overall Study||19
6426687|NCT01023581|7341385|FG006|NOT COMPLETED|Overall Study||20
6426688|NCT01023659|7341404|FG000|STARTED|Overall Study||258
6426689|NCT01023659|7341405|FG001|STARTED|Overall Study||365
6426690|NCT01023659|7341406|FG002|STARTED|Overall Study||264
6426691|NCT01023659|7341404|FG000|COMPLETED|Overall Study||185
6426692|NCT01023659|7341405|FG001|COMPLETED|Overall Study||137
6426693|NCT01023659|7341406|FG002|COMPLETED|Overall Study||165
6426694|NCT01023659|7341404|FG000|NOT COMPLETED|Overall Study||73
6426695|NCT01023659|7341405|FG001|NOT COMPLETED|Overall Study||228
6426696|NCT01023659|7341406|FG002|NOT COMPLETED|Overall Study||99
6426697|NCT01023672|7341415|FG000|STARTED|Overall Study||20
6426698|NCT01023672|7341415|FG000|COMPLETED|Overall Study||17
6426699|NCT01023672|7341415|FG000|NOT COMPLETED|Overall Study||3
6426700|NCT01023711|7341419|FG000|STARTED|Overall Study||107
6426701|NCT01023711|7341419|FG000|COMPLETED|Overall Study||107
6426702|NCT01023711|7341419|FG000|NOT COMPLETED|Overall Study||0
6426703|NCT01023724|7341426|FG000|STARTED|Overall Study||25
6426704|NCT01023724|7341427|FG001|STARTED|Overall Study||25
6426705|NCT01023724|7341426|FG000|COMPLETED|Overall Study||21
6426706|NCT01023724|7341427|FG001|COMPLETED|Overall Study||22
6426707|NCT01023724|7341426|FG000|NOT COMPLETED|Overall Study||4
6426708|NCT01023724|7341427|FG001|NOT COMPLETED|Overall Study||3
6426709|NCT01023776|7341433|FG000|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
6426710|NCT01023776|7341433|FG000|COMPLETED|Overall Study||20
6426711|NCT01023776|7341433|FG000|NOT COMPLETED|Overall Study||0
6426712|NCT01023789|7341437|FG000|STARTED|30-day Follow-up Visit|Intent-to-treat population (ITT).|812
6426713|NCT01023789|7341437|FG000|COMPLETED|30-day Follow-up Visit||812
6426714|NCT01023789|7341437|FG000|NOT COMPLETED|30-day Follow-up Visit||0
6426715|NCT01023789|7341437|FG000|STARTED|180-day Clinical Follow-up||812
6426716|NCT01023789|7341437|FG000|COMPLETED|180-day Clinical Follow-up||812
6426717|NCT01023789|7341437|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
6426718|NCT01023789|7341437|FG000|STARTED|1 - Year Visit||812
6426719|NCT01023789|7341437|FG000|COMPLETED|1 - Year Visit||812
6426720|NCT01023789|7341437|FG000|NOT COMPLETED|1 - Year Visit||0
6426721|NCT01023789|7341437|FG000|STARTED|2 - Year Visit||812
6426722|NCT01023789|7341437|FG000|COMPLETED|2 - Year Visit||812
6426723|NCT01023789|7341437|FG000|NOT COMPLETED|2 - Year Visit||0
6426724|NCT01023789|7341437|FG000|STARTED|3 - Year Visit||812
6426725|NCT01023789|7341437|FG000|COMPLETED|3 - Year Visit||769
6426726|NCT01023789|7341437|FG000|NOT COMPLETED|3 - Year Visit||43
6426727|NCT01023815|7341445|FG000|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
6426728|NCT01023815|7341446|FG001|STARTED|Pre-randomization Period (Day 1 to 90)||0
6426729|NCT01023815|7341447|FG002|STARTED|Pre-randomization Period (Day 1 to 90)||0
6426730|NCT01023815|7341448|FG003|STARTED|Pre-randomization Period (Day 1 to 90)||0
6426731|NCT01023815|7341445|FG000|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
6426732|NCT01023815|7341446|FG001|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6426733|NCT01023815|7341447|FG002|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6426734|NCT01023815|7341448|FG003|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6426735|NCT01023815|7341445|FG000|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
6426736|NCT01023815|7341446|FG001|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6426737|NCT01023815|7341447|FG002|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6652145|NCT02425449|7581700|FG000|STARTED|Overall Study||0
6652146|NCT02425449|7581701|FG001|STARTED|Overall Study||4
6652147|NCT02425449|7581702|FG002|STARTED|Overall Study||5
6652148|NCT02425449|7581703|FG003|STARTED|Overall Study||5
6652149|NCT02425449|7581704|FG004|STARTED|Overall Study||5
6652150|NCT02425449|7581700|FG000|COMPLETED|Overall Study||0
6426738|NCT01023815|7341448|FG003|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
6426739|NCT01023815|7341445|FG000|STARTED|Randomized Period (Day 90 to Month 12)||0
6426740|NCT01023815|7341446|FG001|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
6426741|NCT01023815|7341447|FG002|STARTED|Randomized Period (Day 90 to Month 12)||68
6426742|NCT01023815|7341448|FG003|STARTED|Randomized Period (Day 90 to Month 12)||71
6426743|NCT01023815|7341445|FG000|COMPLETED|Randomized Period (Day 90 to Month 12)||0
6426744|NCT01023815|7341446|FG001|COMPLETED|Randomized Period (Day 90 to Month 12)||42
6426745|NCT01023815|7341447|FG002|COMPLETED|Randomized Period (Day 90 to Month 12)||60
6426746|NCT01023815|7341448|FG003|COMPLETED|Randomized Period (Day 90 to Month 12)||68
6426747|NCT01023815|7341445|FG000|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
6426748|NCT01023815|7341446|FG001|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
6426749|NCT01023815|7341447|FG002|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
6426750|NCT01023815|7341448|FG003|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
6426751|NCT01023841|7341461|FG000|STARTED|Overall Study||48
6426752|NCT01023841|7341462|FG001|STARTED|Overall Study||23
6426753|NCT01023841|7341461|FG000|COMPLETED|Overall Study||47
6426754|NCT01023841|7341462|FG001|COMPLETED|Overall Study||23
6426755|NCT01023841|7341461|FG000|NOT COMPLETED|Overall Study||1
6426756|NCT01023841|7341462|FG001|NOT COMPLETED|Overall Study||0
6426757|NCT01023958|7341468|FG000|STARTED|Overall Study||50
6426758|NCT01023958|7341468|FG000|COMPLETED|Overall Study||0
6426759|NCT01023958|7341468|FG000|NOT COMPLETED|Overall Study||50
6426760|NCT01024010|7341474|FG000|STARTED|Overall Study||48
6426761|NCT01024010|7341475|FG001|STARTED|Overall Study||34
6426762|NCT01024010|7341474|FG000|COMPLETED|Overall Study||48
6426763|NCT01024010|7341475|FG001|COMPLETED|Overall Study||34
6426764|NCT01024010|7341474|FG000|NOT COMPLETED|Overall Study||0
6426765|NCT01024010|7341475|FG001|NOT COMPLETED|Overall Study||0
6426766|NCT01024036|7341483|FG000|STARTED|Blinded Treatment||53
6426767|NCT01024036|7341484|FG001|STARTED|Blinded Treatment||26
6426768|NCT01024036|7341483|FG000|COMPLETED|Blinded Treatment||31
6426769|NCT01024036|7341484|FG001|COMPLETED|Blinded Treatment||6
6426770|NCT01024036|7341483|FG000|NOT COMPLETED|Blinded Treatment||22
6426771|NCT01024036|7341484|FG001|NOT COMPLETED|Blinded Treatment||20
6426772|NCT01024036|7341483|FG000|STARTED|Unblinded Treatment|No participants in this group received treatment during unblinded treatment period|0
6426773|NCT01024036|7341484|FG001|STARTED|Unblinded Treatment|Placebo participants had an option to receive siltuximab in unblinded treatment period|13
6426774|NCT01024036|7341483|FG000|COMPLETED|Unblinded Treatment||0
6426775|NCT01024036|7341484|FG001|COMPLETED|Unblinded Treatment||10
6426776|NCT01024036|7341483|FG000|NOT COMPLETED|Unblinded Treatment||0
6426777|NCT01024036|7341484|FG001|NOT COMPLETED|Unblinded Treatment||3
6426778|NCT01024036|7341483|FG000|STARTED|Follow-Up Period||14
6426779|NCT01024036|7341484|FG001|STARTED|Follow-Up Period||6
6426780|NCT01024036|7341483|FG000|COMPLETED|Follow-Up Period||9
6426781|NCT01024036|7341484|FG001|COMPLETED|Follow-Up Period||3
6426782|NCT01024036|7341483|FG000|NOT COMPLETED|Follow-Up Period||5
6426783|NCT01024036|7341484|FG001|NOT COMPLETED|Follow-Up Period||3
6426784|NCT01024231|7341500|FG000|STARTED|Overall Study||14
6426785|NCT01024231|7341501|FG001|STARTED|Overall Study||17
6652151|NCT02425449|7581701|FG001|COMPLETED|Overall Study||4
6652152|NCT02425449|7581702|FG002|COMPLETED|Overall Study||5
6652153|NCT02425449|7581703|FG003|COMPLETED|Overall Study||5
6426786|NCT01024231|7341502|FG002|STARTED|Overall Study||16
6426787|NCT01024231|7341503|FG003|STARTED|Overall Study||6
6426788|NCT01024231|7341504|FG004|STARTED|Overall Study||17
6426789|NCT01024231|7341505|FG005|STARTED|Overall Study||16
6426790|NCT01024231|7341506|FG006|STARTED|Overall Study||41
6426791|NCT01024231|7341500|FG000|COMPLETED|Overall Study||2
6426792|NCT01024231|7341501|FG001|COMPLETED|Overall Study||2
6426793|NCT01024231|7341502|FG002|COMPLETED|Overall Study||6
6426794|NCT01024231|7341503|FG003|COMPLETED|Overall Study||1
6426795|NCT01024231|7341504|FG004|COMPLETED|Overall Study||0
6426796|NCT01024231|7341505|FG005|COMPLETED|Overall Study||0
6426797|NCT01024231|7341506|FG006|COMPLETED|Overall Study||20
6426798|NCT01024231|7341500|FG000|NOT COMPLETED|Overall Study||12
6426799|NCT01024231|7341501|FG001|NOT COMPLETED|Overall Study||15
6426800|NCT01024231|7341502|FG002|NOT COMPLETED|Overall Study||10
6426801|NCT01024231|7341503|FG003|NOT COMPLETED|Overall Study||5
6652154|NCT02425449|7581704|FG004|COMPLETED|Overall Study||5
6652155|NCT02425449|7581700|FG000|NOT COMPLETED|Overall Study||0
6652156|NCT02425449|7581701|FG001|NOT COMPLETED|Overall Study||0
6652157|NCT02425449|7581702|FG002|NOT COMPLETED|Overall Study||0
6426802|NCT01024231|7341504|FG004|NOT COMPLETED|Overall Study||17
6426803|NCT01024231|7341505|FG005|NOT COMPLETED|Overall Study||16
6426804|NCT01024231|7341506|FG006|NOT COMPLETED|Overall Study||21
6426805|NCT01024244|7341532|FG000|STARTED|Overall Study||22
6426806|NCT01024244|7341533|FG001|STARTED|Overall Study||12
6426807|NCT01024244|7341534|FG002|STARTED|Overall Study||15
6426808|NCT01024244|7341535|FG003|STARTED|Overall Study||14
6426809|NCT01024244|7341536|FG004|STARTED|Overall Study||15
6426810|NCT01024244|7341532|FG000|COMPLETED|Overall Study||5
6426811|NCT01024244|7341533|FG001|COMPLETED|Overall Study||1
6426812|NCT01024244|7341534|FG002|COMPLETED|Overall Study||1
6426813|NCT01024244|7341535|FG003|COMPLETED|Overall Study||1
6426814|NCT01024244|7341536|FG004|COMPLETED|Overall Study||1
6426815|NCT01024244|7341532|FG000|NOT COMPLETED|Overall Study||17
6426816|NCT01024244|7341533|FG001|NOT COMPLETED|Overall Study||11
6426817|NCT01024244|7341534|FG002|NOT COMPLETED|Overall Study||14
6426818|NCT01024244|7341535|FG003|NOT COMPLETED|Overall Study||13
6426819|NCT01024244|7341536|FG004|NOT COMPLETED|Overall Study||14
6426820|NCT01024296|7341548|FG000|STARTED|Overall Study||4
6426821|NCT01024296|7341548|FG000|COMPLETED|Overall Study||4
6426822|NCT01024296|7341548|FG000|NOT COMPLETED|Overall Study||0
6426823|NCT01024309|7341554|FG000|STARTED|Overall Study||35
6426824|NCT01024309|7341555|FG001|STARTED|Overall Study||31
6426825|NCT01024309|7341554|FG000|COMPLETED|Overall Study||27
6426826|NCT01024309|7341555|FG001|COMPLETED|Overall Study||27
6426827|NCT01024309|7341554|FG000|NOT COMPLETED|Overall Study||8
6426828|NCT01024309|7341555|FG001|NOT COMPLETED|Overall Study||4
6426829|NCT01024335|7341563|FG000|STARTED|Overall Study||20
6426830|NCT01024335|7341564|FG001|STARTED|Overall Study||40
6426831|NCT01024335|7341563|FG000|COMPLETED|Overall Study||7
6426832|NCT01024335|7341564|FG001|COMPLETED|Overall Study||14
6426833|NCT01024335|7341563|FG000|NOT COMPLETED|Overall Study||13
6426834|NCT01024335|7341564|FG001|NOT COMPLETED|Overall Study||26
6426835|NCT01024387|7341570|FG000|STARTED|Overall Study||60
6426836|NCT01024387|7341570|FG000|Evaluable for PFS|Overall Study||54
6426837|NCT01024387|7341570|FG000|Evaluable for Response|Overall Study||53
6426838|NCT01024387|7341570|FG000|COMPLETED|Overall Study||0
6426839|NCT01024387|7341570|FG000|NOT COMPLETED|Overall Study||60
6426840|NCT01024465|7341574|FG000|STARTED|Overall Study||26
6426841|NCT01024465|7341574|FG000|COMPLETED|Overall Study||23
6652158|NCT02425449|7581703|FG003|NOT COMPLETED|Overall Study||0
6426842|NCT01024465|7341574|FG000|NOT COMPLETED|Overall Study||3
6426843|NCT01024569|7341580|FG000|STARTED|Overall Study||276
6426844|NCT01024569|7341581|FG001|STARTED|Overall Study||279
6426845|NCT01024569|7341580|FG000|COMPLETED|Overall Study||251
6426846|NCT01024569|7341581|FG001|COMPLETED|Overall Study||268
6426847|NCT01024569|7341580|FG000|NOT COMPLETED|Overall Study||25
6426848|NCT01024569|7341581|FG001|NOT COMPLETED|Overall Study||11
6426849|NCT01024686|7341592|FG000|STARTED|Overall Study|July 11, 2010: unexpected adverse event, (1) participant|6
6426850|NCT01024686|7341593|FG001|STARTED|Overall Study||0
6426851|NCT01024686|7341594|FG002|STARTED|Overall Study||0
6426852|NCT01024686|7341592|FG000|COMPLETED|Overall Study||6
6426853|NCT01024686|7341593|FG001|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
6426854|NCT01024686|7341594|FG002|COMPLETED|Overall Study|(0) participants because the clinical trial was terminated prior to enrollment.|0
6426855|NCT01024686|7341592|FG000|NOT COMPLETED|Overall Study||0
6426856|NCT01024686|7341593|FG001|NOT COMPLETED|Overall Study||0
6426857|NCT01024686|7341594|FG002|NOT COMPLETED|Overall Study||0
6426858|NCT01024738|7341605|FG000|STARTED|First Intervention:||7
6426859|NCT01024738|7341606|FG001|STARTED|First Intervention:||7
6426860|NCT01024738|7341607|FG002|STARTED|First Intervention:||8
6426861|NCT01024738|7341605|FG000|COMPLETED|First Intervention:||7
6426862|NCT01024738|7341606|FG001|COMPLETED|First Intervention:||7
6426863|NCT01024738|7341607|FG002|COMPLETED|First Intervention:||8
6426864|NCT01024738|7341605|FG000|NOT COMPLETED|First Intervention:||0
6426865|NCT01024738|7341606|FG001|NOT COMPLETED|First Intervention:||0
6426866|NCT01024738|7341607|FG002|NOT COMPLETED|First Intervention:||0
6426867|NCT01024738|7341605|FG000|STARTED|Washout After 1st Intervention||7
6426868|NCT01024738|7341606|FG001|STARTED|Washout After 1st Intervention||7
6426869|NCT01024738|7341607|FG002|STARTED|Washout After 1st Intervention||8
6426870|NCT01024738|7341605|FG000|COMPLETED|Washout After 1st Intervention||7
6426871|NCT01024738|7341606|FG001|COMPLETED|Washout After 1st Intervention||7
6426872|NCT01024738|7341607|FG002|COMPLETED|Washout After 1st Intervention||8
6426873|NCT01024738|7341605|FG000|NOT COMPLETED|Washout After 1st Intervention||0
6426874|NCT01024738|7341606|FG001|NOT COMPLETED|Washout After 1st Intervention||0
6426875|NCT01024738|7341607|FG002|NOT COMPLETED|Washout After 1st Intervention||0
6426876|NCT01024738|7341605|FG000|STARTED|Second Intervention:||7
6426877|NCT01024738|7341606|FG001|STARTED|Second Intervention:||7
6426878|NCT01024738|7341607|FG002|STARTED|Second Intervention:||8
6426879|NCT01024738|7341605|FG000|COMPLETED|Second Intervention:||7
6426880|NCT01024738|7341606|FG001|COMPLETED|Second Intervention:||7
6426881|NCT01024738|7341607|FG002|COMPLETED|Second Intervention:||8
6426882|NCT01024738|7341605|FG000|NOT COMPLETED|Second Intervention:||0
6426883|NCT01024738|7341606|FG001|NOT COMPLETED|Second Intervention:||0
6426884|NCT01024738|7341607|FG002|NOT COMPLETED|Second Intervention:||0
6426885|NCT01024738|7341605|FG000|STARTED|Washout After 2nd Intervention||7
6426886|NCT01024738|7341606|FG001|STARTED|Washout After 2nd Intervention||7
6426887|NCT01024738|7341607|FG002|STARTED|Washout After 2nd Intervention||8
6426888|NCT01024738|7341605|FG000|COMPLETED|Washout After 2nd Intervention||7
6426889|NCT01024738|7341606|FG001|COMPLETED|Washout After 2nd Intervention||7
6426890|NCT01024738|7341607|FG002|COMPLETED|Washout After 2nd Intervention||8
6426891|NCT01024738|7341605|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
6426892|NCT01024738|7341606|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
6426893|NCT01024738|7341607|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
6426894|NCT01024738|7341605|FG000|STARTED|Third Intervention:||7
6426895|NCT01024738|7341606|FG001|STARTED|Third Intervention:||7
6426896|NCT01024738|7341607|FG002|STARTED|Third Intervention:||8
6426897|NCT01024738|7341605|FG000|COMPLETED|Third Intervention:||7
6426898|NCT01024738|7341606|FG001|COMPLETED|Third Intervention:||7
6426899|NCT01024738|7341607|FG002|COMPLETED|Third Intervention:||8
6426900|NCT01024738|7341605|FG000|NOT COMPLETED|Third Intervention:||0
6426901|NCT01024738|7341606|FG001|NOT COMPLETED|Third Intervention:||0
6426902|NCT01024738|7341607|FG002|NOT COMPLETED|Third Intervention:||0
6426903|NCT01024751|7341617|FG000|STARTED|Enrolled Participants||156
6426904|NCT01024751|7341618|FG001|STARTED|Enrolled Participants||156
6426905|NCT01024751|7341617|FG000|COMPLETED|Enrolled Participants||153
6426906|NCT01024751|7341618|FG001|COMPLETED|Enrolled Participants||152
6426907|NCT01024751|7341617|FG000|NOT COMPLETED|Enrolled Participants||3
6426908|NCT01024751|7341618|FG001|NOT COMPLETED|Enrolled Participants||4
6426909|NCT01024751|7341617|FG000|STARTED|Eligible Participants||153
6426910|NCT01024751|7341618|FG001|STARTED|Eligible Participants||152
6426911|NCT01024751|7341617|FG000|COMPLETED|Eligible Participants||153
6426912|NCT01024751|7341618|FG001|COMPLETED|Eligible Participants||149
6426913|NCT01024751|7341617|FG000|NOT COMPLETED|Eligible Participants||0
6426914|NCT01024751|7341618|FG001|NOT COMPLETED|Eligible Participants||3
6426915|NCT01024855|7341624|FG000|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
6426916|NCT01024855|7341624|FG000|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
6426917|NCT01024855|7341624|FG000|NOT COMPLETED|Overall Study||1
6426918|NCT01024920|7341631|FG000|STARTED|Overall Study||67
6426919|NCT01024920|7341632|FG001|STARTED|Overall Study||32
6426920|NCT01024920|7341631|FG000|Treated|Overall Study||64
6426921|NCT01024920|7341632|FG001|Treated|Overall Study||32
6426922|NCT01024920|7341631|FG000|COMPLETED|Overall Study||0
6426923|NCT01024920|7341632|FG001|COMPLETED|Overall Study||0
6426924|NCT01024920|7341631|FG000|NOT COMPLETED|Overall Study||67
6426925|NCT01024920|7341632|FG001|NOT COMPLETED|Overall Study||32
6426926|NCT01024946|7341638|FG000|STARTED|Overall Study||11
6426927|NCT01024946|7341638|FG000|COMPLETED|Overall Study||6
6426928|NCT01024946|7341638|FG000|NOT COMPLETED|Overall Study||5
6426929|NCT01024959|7341642|FG000|STARTED|Overall Study||507
6426930|NCT01024959|7341642|FG000|COMPLETED|Overall Study||466
6426931|NCT01024959|7341642|FG000|NOT COMPLETED|Overall Study||41
6426932|NCT01024972|7341653|FG000|STARTED|Overall Study||16
6426933|NCT01024972|7341654|FG001|STARTED|Overall Study||15
6426934|NCT01024972|7341653|FG000|COMPLETED|Overall Study||16
6426935|NCT01024972|7341654|FG001|COMPLETED|Overall Study||15
6426936|NCT01024972|7341653|FG000|NOT COMPLETED|Overall Study||0
6426937|NCT01024972|7341654|FG001|NOT COMPLETED|Overall Study||0
6426938|NCT01025037|7341661|FG000|STARTED|Overall Study||61
6426939|NCT01025037|7341661|FG000|COMPLETED|Overall Study||50
6426940|NCT01025037|7341661|FG000|NOT COMPLETED|Overall Study||11
6426941|NCT01025076|7341665|FG000|STARTED|Overall Study||14
6426942|NCT01025076|7341665|FG000|COMPLETED|Overall Study||14
6426943|NCT01025076|7341665|FG000|NOT COMPLETED|Overall Study||0
6426944|NCT01025154|7341669|FG000|STARTED|Overall Study||59
6426945|NCT01025154|7341669|FG000|COMPLETED|Overall Study||57
6426946|NCT01025154|7341669|FG000|NOT COMPLETED|Overall Study||2
6426947|NCT01025193|7341673|FG000|STARTED|Overall Study||8
6426948|NCT01025193|7341673|FG000|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
6426949|NCT01025193|7341673|FG000|NOT COMPLETED|Overall Study||4
6426950|NCT01025232|7341683|FG000|STARTED|Overall Study||46
6426951|NCT01025232|7341684|FG001|STARTED|Overall Study||42
6426952|NCT01025232|7341683|FG000|COMPLETED|Overall Study||43
6426953|NCT01025232|7341684|FG001|COMPLETED|Overall Study||36
6426954|NCT01025232|7341683|FG000|NOT COMPLETED|Overall Study||3
6426955|NCT01025232|7341684|FG001|NOT COMPLETED|Overall Study||6
6426956|NCT01025284|7341693|FG000|STARTED|Overall Study||38
6426957|NCT01025284|7341694|FG001|STARTED|Overall Study||18
6426958|NCT01025284|7341695|FG002|STARTED|Overall Study||8
6426959|NCT01025284|7341693|FG000|Received at Least 1 Dose of Study Drug|Overall Study||38
6426960|NCT01025284|7341694|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
6426961|NCT01025284|7341695|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
6426962|NCT01025284|7341693|FG000|COMPLETED|Overall Study||38
6426963|NCT01025284|7341694|FG001|COMPLETED|Overall Study||16
6426964|NCT01025284|7341695|FG002|COMPLETED|Overall Study||8
6426965|NCT01025284|7341693|FG000|NOT COMPLETED|Overall Study||0
6426966|NCT01025284|7341694|FG001|NOT COMPLETED|Overall Study||2
6652159|NCT02425449|7581704|FG004|NOT COMPLETED|Overall Study||0
6652160|NCT02425891|7581718|FG000|STARTED|Overall Study||451
6652161|NCT02425891|7581719|FG001|STARTED|Overall Study||451
6652162|NCT02425891|7581718|FG000|COMPLETED|Overall Study||0
6652163|NCT02425891|7581719|FG001|COMPLETED|Overall Study||0
6652164|NCT02425891|7581718|FG000|NOT COMPLETED|Overall Study||451
6652165|NCT02425891|7581719|FG001|NOT COMPLETED|Overall Study||451
6652166|NCT02425956|7581726|FG000|STARTED|Overall Study||21
6652167|NCT02425956|7581726|FG000|COMPLETED|Overall Study||21
6652168|NCT02425956|7581726|FG000|NOT COMPLETED|Overall Study||0
6652169|NCT02426086|7581732|FG000|STARTED|Overall Study||48
6652170|NCT02426086|7581733|FG001|STARTED|Overall Study||59
6426967|NCT01025284|7341695|FG002|NOT COMPLETED|Overall Study||0
6426968|NCT01025336|7341710|FG000|STARTED|Overall Study||130
6426969|NCT01025336|7341711|FG001|STARTED|Overall Study||210
6426970|NCT01025336|7341712|FG002|STARTED|Overall Study||179
6426971|NCT01025336|7341713|FG003|STARTED|Overall Study||221
6426972|NCT01025336|7341714|FG004|STARTED|Overall Study||222
6426973|NCT01025336|7341710|FG000|COMPLETED|Overall Study||130
6426974|NCT01025336|7341711|FG001|COMPLETED|Overall Study||210
6426975|NCT01025336|7341712|FG002|COMPLETED|Overall Study||179
6426976|NCT01025336|7341713|FG003|COMPLETED|Overall Study||219
6426977|NCT01025336|7341714|FG004|COMPLETED|Overall Study||222
6426978|NCT01025336|7341710|FG000|NOT COMPLETED|Overall Study||0
6426979|NCT01025336|7341711|FG001|NOT COMPLETED|Overall Study||0
6426980|NCT01025336|7341712|FG002|NOT COMPLETED|Overall Study||0
6426981|NCT01025336|7341713|FG003|NOT COMPLETED|Overall Study||2
6426982|NCT01025336|7341714|FG004|NOT COMPLETED|Overall Study||0
6652171|NCT02426086|7581732|FG000|Treated|Overall Study||48
6426983|NCT01025427|7341738|FG000|STARTED|Overall Study||16
6426984|NCT01025427|7341738|FG000|COMPLETED|Overall Study||16
6426985|NCT01025427|7341738|FG000|NOT COMPLETED|Overall Study||0
6426986|NCT01025453|7341742|FG000|STARTED|Overall Study||37
6426987|NCT01025453|7341742|FG000|COMPLETED|Overall Study||37
6426988|NCT01025453|7341742|FG000|NOT COMPLETED|Overall Study||0
6426989|NCT01025635|7341748|FG000|STARTED|Overall Study||198
6426990|NCT01025635|7341749|FG001|STARTED|Overall Study||203
6426991|NCT01025635|7341748|FG000|COMPLETED|Overall Study||175
6426992|NCT01025635|7341749|FG001|COMPLETED|Overall Study||178
6426993|NCT01025635|7341748|FG000|NOT COMPLETED|Overall Study||23
6426994|NCT01025635|7341749|FG001|NOT COMPLETED|Overall Study||25
6426995|NCT01025752|7341757|FG000|STARTED|Overall Study||62
6426996|NCT01025752|7341758|FG001|STARTED|Overall Study||63
6426997|NCT01025752|7341757|FG000|COMPLETED|Overall Study||54
6426998|NCT01025752|7341758|FG001|COMPLETED|Overall Study||50
6426999|NCT01025752|7341757|FG000|NOT COMPLETED|Overall Study||8
6652172|NCT02426086|7581733|FG001|Treated|Overall Study||59
6652173|NCT02426086|7581732|FG000|COMPLETED|Overall Study||0
6652174|NCT02426086|7581733|FG001|COMPLETED|Overall Study||0
6427000|NCT01025752|7341758|FG001|NOT COMPLETED|Overall Study||13
6427001|NCT01025791|7341767|FG000|STARTED|Period 1||2
6427002|NCT01025791|7341768|FG001|STARTED|Period 1||2
6427003|NCT01025791|7341769|FG002|STARTED|Period 1||2
6427004|NCT01025791|7341770|FG003|STARTED|Period 1||2
6427005|NCT01025791|7341771|FG004|STARTED|Period 1||2
6427006|NCT01025791|7341772|FG005|STARTED|Period 1||2
6427007|NCT01025791|7341773|FG006|STARTED|Period 1||2
6427008|NCT01025791|7341774|FG007|STARTED|Period 1||2
6427009|NCT01025791|7341775|FG008|STARTED|Period 1||2
6427010|NCT01025791|7341776|FG009|STARTED|Period 1||1
6427011|NCT01025791|7341777|FG010|STARTED|Period 1||2
6427012|NCT01025791|7341778|FG011|STARTED|Period 1||1
6427013|NCT01025791|7341779|FG012|STARTED|Period 1||2
6427014|NCT01025791|7341780|FG013|STARTED|Period 1||1
6427015|NCT01025791|7341767|FG000|COMPLETED|Period 1||2
6427016|NCT01025791|7341768|FG001|COMPLETED|Period 1||2
6427017|NCT01025791|7341769|FG002|COMPLETED|Period 1||2
6427018|NCT01025791|7341770|FG003|COMPLETED|Period 1||2
6427019|NCT01025791|7341771|FG004|COMPLETED|Period 1||2
6652175|NCT02426086|7581732|FG000|NOT COMPLETED|Overall Study||48
6652176|NCT02426086|7581733|FG001|NOT COMPLETED|Overall Study||59
6652177|NCT02426138|7581746|FG000|STARTED|First Intervention (12 Weeks)||21
6652178|NCT02426138|7581747|FG001|STARTED|First Intervention (12 Weeks)||23
6652179|NCT02426138|7581746|FG000|COMPLETED|First Intervention (12 Weeks)||20
6652180|NCT02426138|7581747|FG001|COMPLETED|First Intervention (12 Weeks)||22
6652181|NCT02426138|7581746|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
6652182|NCT02426138|7581747|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
6652183|NCT02426138|7581746|FG000|STARTED|Second Intervention (12 Weeks)||20
6427020|NCT01025791|7341772|FG005|COMPLETED|Period 1||2
6427021|NCT01025791|7341773|FG006|COMPLETED|Period 1||2
6427022|NCT01025791|7341774|FG007|COMPLETED|Period 1||2
6427023|NCT01025791|7341775|FG008|COMPLETED|Period 1||2
6427024|NCT01025791|7341776|FG009|COMPLETED|Period 1||1
6427025|NCT01025791|7341777|FG010|COMPLETED|Period 1||2
6427026|NCT01025791|7341778|FG011|COMPLETED|Period 1||1
6427027|NCT01025791|7341779|FG012|COMPLETED|Period 1||2
6427028|NCT01025791|7341780|FG013|COMPLETED|Period 1||1
6427029|NCT01025791|7341767|FG000|NOT COMPLETED|Period 1||0
6427030|NCT01025791|7341768|FG001|NOT COMPLETED|Period 1||0
6427031|NCT01025791|7341769|FG002|NOT COMPLETED|Period 1||0
6427032|NCT01025791|7341770|FG003|NOT COMPLETED|Period 1||0
6427033|NCT01025791|7341771|FG004|NOT COMPLETED|Period 1||0
6427034|NCT01025791|7341772|FG005|NOT COMPLETED|Period 1||0
6427035|NCT01025791|7341773|FG006|NOT COMPLETED|Period 1||0
6427036|NCT01025791|7341774|FG007|NOT COMPLETED|Period 1||0
6427037|NCT01025791|7341775|FG008|NOT COMPLETED|Period 1||0
6427038|NCT01025791|7341776|FG009|NOT COMPLETED|Period 1||0
6427039|NCT01025791|7341777|FG010|NOT COMPLETED|Period 1||0
6427040|NCT01025791|7341778|FG011|NOT COMPLETED|Period 1||0
6427041|NCT01025791|7341779|FG012|NOT COMPLETED|Period 1||0
6427042|NCT01025791|7341780|FG013|NOT COMPLETED|Period 1||0
6427043|NCT01025791|7341767|FG000|STARTED|Period 2||2
6427044|NCT01025791|7341768|FG001|STARTED|Period 2||2
6427045|NCT01025791|7341769|FG002|STARTED|Period 2||2
6427046|NCT01025791|7341770|FG003|STARTED|Period 2||2
6427047|NCT01025791|7341771|FG004|STARTED|Period 2||2
6427048|NCT01025791|7341772|FG005|STARTED|Period 2||2
6427049|NCT01025791|7341773|FG006|STARTED|Period 2||2
6427050|NCT01025791|7341774|FG007|STARTED|Period 2||2
6427051|NCT01025791|7341775|FG008|STARTED|Period 2||2
6427052|NCT01025791|7341776|FG009|STARTED|Period 2||1
6427053|NCT01025791|7341777|FG010|STARTED|Period 2||2
6427054|NCT01025791|7341778|FG011|STARTED|Period 2||1
6427055|NCT01025791|7341779|FG012|STARTED|Period 2||2
6427056|NCT01025791|7341780|FG013|STARTED|Period 2||1
6427057|NCT01025791|7341767|FG000|COMPLETED|Period 2||2
6427058|NCT01025791|7341768|FG001|COMPLETED|Period 2||2
6427059|NCT01025791|7341769|FG002|COMPLETED|Period 2||2
6427060|NCT01025791|7341770|FG003|COMPLETED|Period 2||2
6427061|NCT01025791|7341771|FG004|COMPLETED|Period 2||2
6427062|NCT01025791|7341772|FG005|COMPLETED|Period 2||2
6427063|NCT01025791|7341773|FG006|COMPLETED|Period 2||2
6427064|NCT01025791|7341774|FG007|COMPLETED|Period 2||2
6427065|NCT01025791|7341775|FG008|COMPLETED|Period 2||2
6427066|NCT01025791|7341776|FG009|COMPLETED|Period 2||1
6427067|NCT01025791|7341777|FG010|COMPLETED|Period 2||2
6427068|NCT01025791|7341778|FG011|COMPLETED|Period 2||1
6427069|NCT01025791|7341779|FG012|COMPLETED|Period 2||2
6427070|NCT01025791|7341780|FG013|COMPLETED|Period 2||1
6427071|NCT01025791|7341767|FG000|NOT COMPLETED|Period 2||0
6427072|NCT01025791|7341768|FG001|NOT COMPLETED|Period 2||0
6427073|NCT01025791|7341769|FG002|NOT COMPLETED|Period 2||0
6427074|NCT01025791|7341770|FG003|NOT COMPLETED|Period 2||0
6427075|NCT01025791|7341771|FG004|NOT COMPLETED|Period 2||0
6427076|NCT01025791|7341772|FG005|NOT COMPLETED|Period 2||0
6427077|NCT01025791|7341773|FG006|NOT COMPLETED|Period 2||0
6427078|NCT01025791|7341774|FG007|NOT COMPLETED|Period 2||0
6427079|NCT01025791|7341775|FG008|NOT COMPLETED|Period 2||0
6427080|NCT01025791|7341776|FG009|NOT COMPLETED|Period 2||0
6427081|NCT01025791|7341777|FG010|NOT COMPLETED|Period 2||0
6427082|NCT01025791|7341778|FG011|NOT COMPLETED|Period 2||0
6427083|NCT01025791|7341779|FG012|NOT COMPLETED|Period 2||0
6427084|NCT01025791|7341780|FG013|NOT COMPLETED|Period 2||0
6652184|NCT02426138|7581747|FG001|STARTED|Second Intervention (12 Weeks)||22
6652185|NCT02426138|7581746|FG000|COMPLETED|Second Intervention (12 Weeks)||20
6652186|NCT02426138|7581747|FG001|COMPLETED|Second Intervention (12 Weeks)||22
6427085|NCT01025791|7341767|FG000|STARTED|Period 3||2
6427086|NCT01025791|7341768|FG001|STARTED|Period 3||2
6427087|NCT01025791|7341769|FG002|STARTED|Period 3||2
6427088|NCT01025791|7341770|FG003|STARTED|Period 3||2
6427089|NCT01025791|7341771|FG004|STARTED|Period 3||2
6427090|NCT01025791|7341772|FG005|STARTED|Period 3||2
6427091|NCT01025791|7341773|FG006|STARTED|Period 3||2
6427092|NCT01025791|7341774|FG007|STARTED|Period 3||2
6427093|NCT01025791|7341775|FG008|STARTED|Period 3||2
6427094|NCT01025791|7341776|FG009|STARTED|Period 3||1
6427095|NCT01025791|7341777|FG010|STARTED|Period 3||2
6427096|NCT01025791|7341778|FG011|STARTED|Period 3||1
6427097|NCT01025791|7341779|FG012|STARTED|Period 3||2
6427098|NCT01025791|7341780|FG013|STARTED|Period 3||1
6427099|NCT01025791|7341767|FG000|COMPLETED|Period 3||2
6427100|NCT01025791|7341768|FG001|COMPLETED|Period 3||2
6427101|NCT01025791|7341769|FG002|COMPLETED|Period 3||2
6427102|NCT01025791|7341770|FG003|COMPLETED|Period 3||2
6427103|NCT01025791|7341771|FG004|COMPLETED|Period 3||2
6427104|NCT01025791|7341772|FG005|COMPLETED|Period 3||2
6427105|NCT01025791|7341773|FG006|COMPLETED|Period 3||2
6427106|NCT01025791|7341774|FG007|COMPLETED|Period 3||2
6427107|NCT01025791|7341775|FG008|COMPLETED|Period 3||2
6427108|NCT01025791|7341776|FG009|COMPLETED|Period 3||1
6427109|NCT01025791|7341777|FG010|COMPLETED|Period 3||2
6427110|NCT01025791|7341778|FG011|COMPLETED|Period 3||1
6427111|NCT01025791|7341779|FG012|COMPLETED|Period 3||2
6427112|NCT01025791|7341780|FG013|COMPLETED|Period 3||1
6427113|NCT01025791|7341767|FG000|NOT COMPLETED|Period 3||0
6427114|NCT01025791|7341768|FG001|NOT COMPLETED|Period 3||0
6427115|NCT01025791|7341769|FG002|NOT COMPLETED|Period 3||0
6427116|NCT01025791|7341770|FG003|NOT COMPLETED|Period 3||0
6427117|NCT01025791|7341771|FG004|NOT COMPLETED|Period 3||0
6427118|NCT01025791|7341772|FG005|NOT COMPLETED|Period 3||0
6427119|NCT01025791|7341773|FG006|NOT COMPLETED|Period 3||0
6427120|NCT01025791|7341774|FG007|NOT COMPLETED|Period 3||0
6427121|NCT01025791|7341775|FG008|NOT COMPLETED|Period 3||0
6427122|NCT01025791|7341776|FG009|NOT COMPLETED|Period 3||0
6427123|NCT01025791|7341777|FG010|NOT COMPLETED|Period 3||0
6744266|NCT03341299|7672343|FG003|NOT COMPLETED|Washout (A Minimum of 21 Hours)||0
6744267|NCT03341299|7672340|FG000|STARTED|Period 4||9
6744268|NCT03341299|7672341|FG001|STARTED|Period 4||9
6744269|NCT03341299|7672342|FG002|STARTED|Period 4||8
6744270|NCT03341299|7672343|FG003|STARTED|Period 4||9
6744271|NCT03341299|7672340|FG000|COMPLETED|Period 4||9
6744272|NCT03341299|7672341|FG001|COMPLETED|Period 4||9
6744273|NCT03341299|7672342|FG002|COMPLETED|Period 4||8
6744274|NCT03341299|7672343|FG003|COMPLETED|Period 4||9
6744275|NCT03341299|7672340|FG000|NOT COMPLETED|Period 4||0
6427124|NCT01025791|7341778|FG011|NOT COMPLETED|Period 3||0
6427125|NCT01025791|7341779|FG012|NOT COMPLETED|Period 3||0
6427126|NCT01025791|7341780|FG013|NOT COMPLETED|Period 3||0
6427127|NCT01025791|7341767|FG000|STARTED|Period 4||2
6427128|NCT01025791|7341768|FG001|STARTED|Period 4||2
6427129|NCT01025791|7341769|FG002|STARTED|Period 4||2
6427130|NCT01025791|7341770|FG003|STARTED|Period 4||2
6427131|NCT01025791|7341771|FG004|STARTED|Period 4||2
6427132|NCT01025791|7341772|FG005|STARTED|Period 4||2
6427133|NCT01025791|7341773|FG006|STARTED|Period 4||2
6427134|NCT01025791|7341774|FG007|STARTED|Period 4||2
6427135|NCT01025791|7341775|FG008|STARTED|Period 4||2
6427136|NCT01025791|7341776|FG009|STARTED|Period 4||1
6427137|NCT01025791|7341777|FG010|STARTED|Period 4||2
6427138|NCT01025791|7341778|FG011|STARTED|Period 4||1
6427139|NCT01025791|7341779|FG012|STARTED|Period 4||2
6427140|NCT01025791|7341780|FG013|STARTED|Period 4||1
6427141|NCT01025791|7341767|FG000|COMPLETED|Period 4||2
6427142|NCT01025791|7341768|FG001|COMPLETED|Period 4||2
6427143|NCT01025791|7341769|FG002|COMPLETED|Period 4||2
6427144|NCT01025791|7341770|FG003|COMPLETED|Period 4||2
6427145|NCT01025791|7341771|FG004|COMPLETED|Period 4||2
6427146|NCT01025791|7341772|FG005|COMPLETED|Period 4||2
6427147|NCT01025791|7341773|FG006|COMPLETED|Period 4||2
6427148|NCT01025791|7341774|FG007|COMPLETED|Period 4||2
6427149|NCT01025791|7341775|FG008|COMPLETED|Period 4||2
6427150|NCT01025791|7341776|FG009|COMPLETED|Period 4||1
6427151|NCT01025791|7341777|FG010|COMPLETED|Period 4||2
6551935|NCT01734772|7474324|FG001|COMPLETED|Overall Study||21
6551936|NCT01734772|7474323|FG000|NOT COMPLETED|Overall Study||1
6551937|NCT01734772|7474324|FG001|NOT COMPLETED|Overall Study||3
6427152|NCT01025791|7341778|FG011|COMPLETED|Period 4||1
6551938|NCT01734785|7474339|FG000|STARTED|Open-Label Period||0
6551939|NCT01734785|7474340|FG001|STARTED|Open-Label Period||0
6551940|NCT01734785|7474341|FG002|STARTED|Open-Label Period||0
6744276|NCT03341299|7672341|FG001|NOT COMPLETED|Period 4||0
6744277|NCT03341299|7672342|FG002|NOT COMPLETED|Period 4||0
6427153|NCT01025791|7341779|FG012|COMPLETED|Period 4||2
6427154|NCT01025791|7341780|FG013|COMPLETED|Period 4||1
6427155|NCT01025791|7341767|FG000|NOT COMPLETED|Period 4||0
6427156|NCT01025791|7341768|FG001|NOT COMPLETED|Period 4||0
6427157|NCT01025791|7341769|FG002|NOT COMPLETED|Period 4||0
6427158|NCT01025791|7341770|FG003|NOT COMPLETED|Period 4||0
6427159|NCT01025791|7341771|FG004|NOT COMPLETED|Period 4||0
6427160|NCT01025791|7341772|FG005|NOT COMPLETED|Period 4||0
6427161|NCT01025791|7341773|FG006|NOT COMPLETED|Period 4||0
6427162|NCT01025791|7341774|FG007|NOT COMPLETED|Period 4||0
6427163|NCT01025791|7341775|FG008|NOT COMPLETED|Period 4||0
6427164|NCT01025791|7341776|FG009|NOT COMPLETED|Period 4||0
6744278|NCT03341299|7672343|FG003|NOT COMPLETED|Period 4||0
6551941|NCT01734785|7474342|FG003|STARTED|Open-Label Period||606
6551942|NCT01734785|7474339|FG000|COMPLETED|Open-Label Period||0
6551943|NCT01734785|7474340|FG001|COMPLETED|Open-Label Period||0
6551944|NCT01734785|7474341|FG002|COMPLETED|Open-Label Period||0
6551945|NCT01734785|7474342|FG003|COMPLETED|Open-Label Period||333
6551946|NCT01734785|7474339|FG000|NOT COMPLETED|Open-Label Period||0
6551947|NCT01734785|7474340|FG001|NOT COMPLETED|Open-Label Period||0
6551948|NCT01734785|7474341|FG002|NOT COMPLETED|Open-Label Period||0
6551949|NCT01734785|7474342|FG003|NOT COMPLETED|Open-Label Period||273
6551950|NCT01734785|7474339|FG000|STARTED|Double-Blind Period||111
6551951|NCT01734785|7474340|FG001|STARTED|Double-Blind Period||112
6551952|NCT01734785|7474341|FG002|STARTED|Double-Blind Period||110
6551953|NCT01734785|7474342|FG003|STARTED|Double-Blind Period||0
6551954|NCT01734785|7474339|FG000|COMPLETED|Double-Blind Period||106
6551955|NCT01734785|7474340|FG001|COMPLETED|Double-Blind Period||103
6551956|NCT01734785|7474341|FG002|COMPLETED|Double-Blind Period||105
6551957|NCT01734785|7474342|FG003|COMPLETED|Double-Blind Period||0
6551958|NCT01734785|7474339|FG000|NOT COMPLETED|Double-Blind Period||5
6551959|NCT01734785|7474340|FG001|NOT COMPLETED|Double-Blind Period||9
6551960|NCT01734785|7474341|FG002|NOT COMPLETED|Double-Blind Period||5
6551961|NCT01734785|7474342|FG003|NOT COMPLETED|Double-Blind Period||0
6551962|NCT01734811|7474353|FG000|STARTED|Overall Study||58
6551963|NCT01734811|7474354|FG001|STARTED|Overall Study||62
6551964|NCT01734811|7474353|FG000|COMPLETED|Overall Study||54
6427165|NCT01025791|7341777|FG010|NOT COMPLETED|Period 4||0
6427166|NCT01025791|7341778|FG011|NOT COMPLETED|Period 4||0
6427167|NCT01025791|7341779|FG012|NOT COMPLETED|Period 4||0
6427168|NCT01025791|7341780|FG013|NOT COMPLETED|Period 4||0
6427169|NCT01025791|7341767|FG000|STARTED|Period 5||2
6427170|NCT01025791|7341768|FG001|STARTED|Period 5||2
6427171|NCT01025791|7341769|FG002|STARTED|Period 5||2
6427172|NCT01025791|7341770|FG003|STARTED|Period 5||2
6427173|NCT01025791|7341771|FG004|STARTED|Period 5||0
6427174|NCT01025791|7341772|FG005|STARTED|Period 5||0
6427175|NCT01025791|7341773|FG006|STARTED|Period 5||0
6427176|NCT01025791|7341774|FG007|STARTED|Period 5||0
6427177|NCT01025791|7341775|FG008|STARTED|Period 5||0
6427178|NCT01025791|7341776|FG009|STARTED|Period 5||0
6427179|NCT01025791|7341777|FG010|STARTED|Period 5||0
6427180|NCT01025791|7341778|FG011|STARTED|Period 5||0
6427181|NCT01025791|7341779|FG012|STARTED|Period 5||0
6427182|NCT01025791|7341780|FG013|STARTED|Period 5||0
6427183|NCT01025791|7341767|FG000|COMPLETED|Period 5||2
6427184|NCT01025791|7341768|FG001|COMPLETED|Period 5||2
6427185|NCT01025791|7341769|FG002|COMPLETED|Period 5||2
6427186|NCT01025791|7341770|FG003|COMPLETED|Period 5||2
6427187|NCT01025791|7341771|FG004|COMPLETED|Period 5||0
6427188|NCT01025791|7341772|FG005|COMPLETED|Period 5||0
6427189|NCT01025791|7341773|FG006|COMPLETED|Period 5||0
6427190|NCT01025791|7341774|FG007|COMPLETED|Period 5||0
6427191|NCT01025791|7341775|FG008|COMPLETED|Period 5||0
6427192|NCT01025791|7341776|FG009|COMPLETED|Period 5||0
6427193|NCT01025791|7341777|FG010|COMPLETED|Period 5||0
6427194|NCT01025791|7341778|FG011|COMPLETED|Period 5||0
6427195|NCT01025791|7341779|FG012|COMPLETED|Period 5||0
6427196|NCT01025791|7341780|FG013|COMPLETED|Period 5||0
6427197|NCT01025791|7341767|FG000|NOT COMPLETED|Period 5||0
6427198|NCT01025791|7341768|FG001|NOT COMPLETED|Period 5||0
6427199|NCT01025791|7341769|FG002|NOT COMPLETED|Period 5||0
6427200|NCT01025791|7341770|FG003|NOT COMPLETED|Period 5||0
6427201|NCT01025791|7341771|FG004|NOT COMPLETED|Period 5||0
6427202|NCT01025791|7341772|FG005|NOT COMPLETED|Period 5||0
6427203|NCT01025791|7341773|FG006|NOT COMPLETED|Period 5||0
6427204|NCT01025791|7341774|FG007|NOT COMPLETED|Period 5||0
6427205|NCT01025791|7341775|FG008|NOT COMPLETED|Period 5||0
6427206|NCT01025791|7341776|FG009|NOT COMPLETED|Period 5||0
6427207|NCT01025791|7341777|FG010|NOT COMPLETED|Period 5||0
6427208|NCT01025791|7341778|FG011|NOT COMPLETED|Period 5||0
6427209|NCT01025791|7341779|FG012|NOT COMPLETED|Period 5||0
6427210|NCT01025791|7341780|FG013|NOT COMPLETED|Period 5||0
6427211|NCT01025817|7341833|FG000|STARTED|Completed Study Medication||309
6427212|NCT01025817|7341834|FG001|STARTED|Completed Study Medication||304
6427213|NCT01025817|7341833|FG000|COMPLETED|Completed Study Medication||204
6427214|NCT01025817|7341834|FG001|COMPLETED|Completed Study Medication||232
6427215|NCT01025817|7341833|FG000|NOT COMPLETED|Completed Study Medication||105
6427216|NCT01025817|7341834|FG001|NOT COMPLETED|Completed Study Medication||72
6427217|NCT01025817|7341833|FG000|STARTED|Completed Study||309
6427218|NCT01025817|7341834|FG001|STARTED|Completed Study||304
6427219|NCT01025817|7341833|FG000|COMPLETED|Completed Study|Completed study phase|293
6427220|NCT01025817|7341834|FG001|COMPLETED|Completed Study|Completed study phase|282
6427221|NCT01025817|7341833|FG000|NOT COMPLETED|Completed Study||16
6427222|NCT01025817|7341834|FG001|NOT COMPLETED|Completed Study||22
6551965|NCT01734811|7474354|FG001|COMPLETED|Overall Study||59
6551966|NCT01734811|7474353|FG000|NOT COMPLETED|Overall Study||4
6551967|NCT01734811|7474354|FG001|NOT COMPLETED|Overall Study||3
6551968|NCT01734850|7474363|FG000|STARTED|Overall Study||4
6427223|NCT01025830|7341840|FG000|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
6427224|NCT01025830|7341841|FG001|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
6427225|NCT01025830|7341840|FG000|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
6427226|NCT01025830|7341841|FG001|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
6427227|NCT01025830|7341840|FG000|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
6551969|NCT01734850|7474364|FG001|STARTED|Overall Study||4
6427228|NCT01025830|7341841|FG001|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
6427229|NCT01025830|7341840|FG000|STARTED|Washout Period of 30 Days||8
6427230|NCT01025830|7341841|FG001|STARTED|Washout Period of 30 Days||12
6427231|NCT01025830|7341840|FG000|COMPLETED|Washout Period of 30 Days||8
6427232|NCT01025830|7341841|FG001|COMPLETED|Washout Period of 30 Days||12
6427233|NCT01025830|7341840|FG000|NOT COMPLETED|Washout Period of 30 Days||0
6427234|NCT01025830|7341841|FG001|NOT COMPLETED|Washout Period of 30 Days||0
6427235|NCT01025830|7341840|FG000|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
6427236|NCT01025830|7341841|FG001|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
6427237|NCT01025830|7341840|FG000|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
6427238|NCT01025830|7341841|FG001|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
6427239|NCT01025830|7341840|FG000|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
6427240|NCT01025830|7341841|FG001|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
6427241|NCT01025843|7341862|FG000|STARTED|Period 1||2
6427242|NCT01025843|7341863|FG001|STARTED|Period 1||2
6427243|NCT01025843|7341864|FG002|STARTED|Period 1||2
6427244|NCT01025843|7341865|FG003|STARTED|Period 1||2
6427245|NCT01025843|7341866|FG004|STARTED|Period 1||2
6427246|NCT01025843|7341867|FG005|STARTED|Period 1||2
6427247|NCT01025843|7341868|FG006|STARTED|Period 1||2
6427248|NCT01025843|7341869|FG007|STARTED|Period 1||2
6427249|NCT01025843|7341870|FG008|STARTED|Period 1||2
6427250|NCT01025843|7341871|FG009|STARTED|Period 1||2
6427251|NCT01025843|7341862|FG000|COMPLETED|Period 1||2
6427252|NCT01025843|7341863|FG001|COMPLETED|Period 1||2
6427253|NCT01025843|7341864|FG002|COMPLETED|Period 1||2
6427254|NCT01025843|7341865|FG003|COMPLETED|Period 1||2
6427255|NCT01025843|7341866|FG004|COMPLETED|Period 1||2
6427256|NCT01025843|7341867|FG005|COMPLETED|Period 1||2
6427257|NCT01025843|7341868|FG006|COMPLETED|Period 1||2
6427258|NCT01025843|7341869|FG007|COMPLETED|Period 1||2
6427259|NCT01025843|7341870|FG008|COMPLETED|Period 1||2
6427260|NCT01025843|7341871|FG009|COMPLETED|Period 1||2
6427261|NCT01025843|7341862|FG000|NOT COMPLETED|Period 1||0
6427262|NCT01025843|7341863|FG001|NOT COMPLETED|Period 1||0
6427263|NCT01025843|7341864|FG002|NOT COMPLETED|Period 1||0
6427264|NCT01025843|7341865|FG003|NOT COMPLETED|Period 1||0
6427265|NCT01025843|7341866|FG004|NOT COMPLETED|Period 1||0
6427266|NCT01025843|7341867|FG005|NOT COMPLETED|Period 1||0
6427267|NCT01025843|7341868|FG006|NOT COMPLETED|Period 1||0
6427268|NCT01025843|7341869|FG007|NOT COMPLETED|Period 1||0
6427269|NCT01025843|7341870|FG008|NOT COMPLETED|Period 1||0
6427270|NCT01025843|7341871|FG009|NOT COMPLETED|Period 1||0
6427271|NCT01025843|7341862|FG000|STARTED|Washout 1||2
6427272|NCT01025843|7341863|FG001|STARTED|Washout 1||2
6427273|NCT01025843|7341864|FG002|STARTED|Washout 1||2
6427274|NCT01025843|7341865|FG003|STARTED|Washout 1||2
6427275|NCT01025843|7341866|FG004|STARTED|Washout 1||2
6427276|NCT01025843|7341867|FG005|STARTED|Washout 1||2
6427277|NCT01025843|7341868|FG006|STARTED|Washout 1||2
6427278|NCT01025843|7341869|FG007|STARTED|Washout 1||2
6427279|NCT01025843|7341870|FG008|STARTED|Washout 1||2
6427280|NCT01025843|7341871|FG009|STARTED|Washout 1||2
6427281|NCT01025843|7341862|FG000|COMPLETED|Washout 1||2
6427282|NCT01025843|7341863|FG001|COMPLETED|Washout 1||2
6427283|NCT01025843|7341864|FG002|COMPLETED|Washout 1||2
6427284|NCT01025843|7341865|FG003|COMPLETED|Washout 1||2
6652187|NCT02426138|7581746|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
6427285|NCT01025843|7341866|FG004|COMPLETED|Washout 1||2
6427286|NCT01025843|7341867|FG005|COMPLETED|Washout 1||2
6427287|NCT01025843|7341868|FG006|COMPLETED|Washout 1||2
6427288|NCT01025843|7341869|FG007|COMPLETED|Washout 1||2
6427289|NCT01025843|7341870|FG008|COMPLETED|Washout 1||2
6427290|NCT01025843|7341871|FG009|COMPLETED|Washout 1||2
6427291|NCT01025843|7341862|FG000|NOT COMPLETED|Washout 1||0
6427292|NCT01025843|7341863|FG001|NOT COMPLETED|Washout 1||0
6427293|NCT01025843|7341864|FG002|NOT COMPLETED|Washout 1||0
6427294|NCT01025843|7341865|FG003|NOT COMPLETED|Washout 1||0
6427295|NCT01025843|7341866|FG004|NOT COMPLETED|Washout 1||0
6427296|NCT01025843|7341867|FG005|NOT COMPLETED|Washout 1||0
6427297|NCT01025843|7341868|FG006|NOT COMPLETED|Washout 1||0
6427298|NCT01025843|7341869|FG007|NOT COMPLETED|Washout 1||0
6427299|NCT01025843|7341870|FG008|NOT COMPLETED|Washout 1||0
6427300|NCT01025843|7341871|FG009|NOT COMPLETED|Washout 1||0
6427301|NCT01025843|7341862|FG000|STARTED|Period 2||2
6427302|NCT01025843|7341863|FG001|STARTED|Period 2||2
6427303|NCT01025843|7341864|FG002|STARTED|Period 2||2
6427304|NCT01025843|7341865|FG003|STARTED|Period 2||2
6427305|NCT01025843|7341866|FG004|STARTED|Period 2||2
6427306|NCT01025843|7341867|FG005|STARTED|Period 2||2
6427307|NCT01025843|7341868|FG006|STARTED|Period 2||2
6427308|NCT01025843|7341869|FG007|STARTED|Period 2||2
6427309|NCT01025843|7341870|FG008|STARTED|Period 2||2
6656166|NCT02458469|7586295|FG005|NOT COMPLETED|Second Washout (2 Weeks)||0
6427310|NCT01025843|7341871|FG009|STARTED|Period 2||2
6427311|NCT01025843|7341862|FG000|COMPLETED|Period 2||2
6427312|NCT01025843|7341863|FG001|COMPLETED|Period 2||2
6427313|NCT01025843|7341864|FG002|COMPLETED|Period 2||2
6427314|NCT01025843|7341865|FG003|COMPLETED|Period 2||2
6427315|NCT01025843|7341866|FG004|COMPLETED|Period 2||2
6427316|NCT01025843|7341867|FG005|COMPLETED|Period 2||2
6427317|NCT01025843|7341868|FG006|COMPLETED|Period 2||2
6427318|NCT01025843|7341869|FG007|COMPLETED|Period 2||2
6427319|NCT01025843|7341870|FG008|COMPLETED|Period 2||2
6427320|NCT01025843|7341871|FG009|COMPLETED|Period 2||2
6427321|NCT01025843|7341862|FG000|NOT COMPLETED|Period 2||0
6427322|NCT01025843|7341863|FG001|NOT COMPLETED|Period 2||0
6427323|NCT01025843|7341864|FG002|NOT COMPLETED|Period 2||0
6427324|NCT01025843|7341865|FG003|NOT COMPLETED|Period 2||0
6427325|NCT01025843|7341866|FG004|NOT COMPLETED|Period 2||0
6427326|NCT01025843|7341867|FG005|NOT COMPLETED|Period 2||0
6427327|NCT01025843|7341868|FG006|NOT COMPLETED|Period 2||0
6427328|NCT01025843|7341869|FG007|NOT COMPLETED|Period 2||0
6427329|NCT01025843|7341870|FG008|NOT COMPLETED|Period 2||0
6427330|NCT01025843|7341871|FG009|NOT COMPLETED|Period 2||0
6427331|NCT01025843|7341862|FG000|STARTED|Washout 2||2
6427332|NCT01025843|7341863|FG001|STARTED|Washout 2||2
6427333|NCT01025843|7341864|FG002|STARTED|Washout 2||2
6427334|NCT01025843|7341865|FG003|STARTED|Washout 2||2
6427335|NCT01025843|7341866|FG004|STARTED|Washout 2||2
6427336|NCT01025843|7341867|FG005|STARTED|Washout 2||2
6427337|NCT01025843|7341868|FG006|STARTED|Washout 2||2
6427338|NCT01025843|7341869|FG007|STARTED|Washout 2||2
6427339|NCT01025843|7341870|FG008|STARTED|Washout 2||2
6427340|NCT01025843|7341871|FG009|STARTED|Washout 2||2
6427341|NCT01025843|7341862|FG000|COMPLETED|Washout 2||2
6427342|NCT01025843|7341863|FG001|COMPLETED|Washout 2||2
6427343|NCT01025843|7341864|FG002|COMPLETED|Washout 2||2
6427344|NCT01025843|7341865|FG003|COMPLETED|Washout 2||2
6427345|NCT01025843|7341866|FG004|COMPLETED|Washout 2||2
6427346|NCT01025843|7341867|FG005|COMPLETED|Washout 2||2
6427347|NCT01025843|7341868|FG006|COMPLETED|Washout 2||2
6427348|NCT01025843|7341869|FG007|COMPLETED|Washout 2||2
6427349|NCT01025843|7341870|FG008|COMPLETED|Washout 2||2
6427350|NCT01025843|7341871|FG009|COMPLETED|Washout 2||2
6427351|NCT01025843|7341862|FG000|NOT COMPLETED|Washout 2||0
6427352|NCT01025843|7341863|FG001|NOT COMPLETED|Washout 2||0
6427353|NCT01025843|7341864|FG002|NOT COMPLETED|Washout 2||0
6427354|NCT01025843|7341865|FG003|NOT COMPLETED|Washout 2||0
6427355|NCT01025843|7341866|FG004|NOT COMPLETED|Washout 2||0
6427356|NCT01025843|7341867|FG005|NOT COMPLETED|Washout 2||0
6427357|NCT01025843|7341868|FG006|NOT COMPLETED|Washout 2||0
6427358|NCT01025843|7341869|FG007|NOT COMPLETED|Washout 2||0
6427359|NCT01025843|7341870|FG008|NOT COMPLETED|Washout 2||0
6427360|NCT01025843|7341871|FG009|NOT COMPLETED|Washout 2||0
6427361|NCT01025843|7341862|FG000|STARTED|Period 3||2
6427362|NCT01025843|7341863|FG001|STARTED|Period 3||2
6427363|NCT01025843|7341864|FG002|STARTED|Period 3||2
6427364|NCT01025843|7341865|FG003|STARTED|Period 3||2
6427365|NCT01025843|7341866|FG004|STARTED|Period 3||2
6427366|NCT01025843|7341867|FG005|STARTED|Period 3||2
6427367|NCT01025843|7341868|FG006|STARTED|Period 3||2
6427368|NCT01025843|7341869|FG007|STARTED|Period 3||2
6427369|NCT01025843|7341870|FG008|STARTED|Period 3||2
6427370|NCT01025843|7341871|FG009|STARTED|Period 3||2
6427371|NCT01025843|7341862|FG000|COMPLETED|Period 3||2
6427372|NCT01025843|7341863|FG001|COMPLETED|Period 3||2
6427373|NCT01025843|7341864|FG002|COMPLETED|Period 3||2
6427374|NCT01025843|7341865|FG003|COMPLETED|Period 3||2
6427375|NCT01025843|7341866|FG004|COMPLETED|Period 3||2
6427376|NCT01025843|7341867|FG005|COMPLETED|Period 3||2
6427377|NCT01025843|7341868|FG006|COMPLETED|Period 3||2
6427378|NCT01025843|7341869|FG007|COMPLETED|Period 3||2
6427379|NCT01025843|7341870|FG008|COMPLETED|Period 3||2
6427380|NCT01025843|7341871|FG009|COMPLETED|Period 3||2
6427381|NCT01025843|7341862|FG000|NOT COMPLETED|Period 3||0
6427382|NCT01025843|7341863|FG001|NOT COMPLETED|Period 3||0
6427383|NCT01025843|7341864|FG002|NOT COMPLETED|Period 3||0
6427384|NCT01025843|7341865|FG003|NOT COMPLETED|Period 3||0
6427385|NCT01025843|7341866|FG004|NOT COMPLETED|Period 3||0
6427386|NCT01025843|7341867|FG005|NOT COMPLETED|Period 3||0
6427387|NCT01025843|7341868|FG006|NOT COMPLETED|Period 3||0
6427388|NCT01025843|7341869|FG007|NOT COMPLETED|Period 3||0
6551970|NCT01734850|7474365|FG002|STARTED|Overall Study||5
6551971|NCT01734850|7474363|FG000|COMPLETED|Overall Study||1
6551972|NCT01734850|7474364|FG001|COMPLETED|Overall Study||2
6551973|NCT01734850|7474365|FG002|COMPLETED|Overall Study||1
6551974|NCT01734850|7474363|FG000|NOT COMPLETED|Overall Study||3
6551975|NCT01734850|7474364|FG001|NOT COMPLETED|Overall Study||2
6427389|NCT01025843|7341870|FG008|NOT COMPLETED|Period 3||0
6427390|NCT01025843|7341871|FG009|NOT COMPLETED|Period 3||0
6427391|NCT01025843|7341862|FG000|STARTED|Washout 3||2
6427392|NCT01025843|7341863|FG001|STARTED|Washout 3||2
6427393|NCT01025843|7341864|FG002|STARTED|Washout 3||2
6427394|NCT01025843|7341865|FG003|STARTED|Washout 3||2
6427395|NCT01025843|7341866|FG004|STARTED|Washout 3||2
6427396|NCT01025843|7341867|FG005|STARTED|Washout 3||2
6427397|NCT01025843|7341868|FG006|STARTED|Washout 3||2
6427398|NCT01025843|7341869|FG007|STARTED|Washout 3||2
6551976|NCT01734850|7474365|FG002|NOT COMPLETED|Overall Study||4
6427399|NCT01025843|7341870|FG008|STARTED|Washout 3||2
6427400|NCT01025843|7341871|FG009|STARTED|Washout 3||2
6427401|NCT01025843|7341862|FG000|COMPLETED|Washout 3||2
6427402|NCT01025843|7341863|FG001|COMPLETED|Washout 3||2
6427403|NCT01025843|7341864|FG002|COMPLETED|Washout 3||2
6551977|NCT01734889|7474376|FG000|STARTED|Overall Study||18
6551978|NCT01734889|7474376|FG000|COMPLETED|Overall Study||18
6551979|NCT01734889|7474376|FG000|NOT COMPLETED|Overall Study||0
6427404|NCT01025843|7341865|FG003|COMPLETED|Washout 3||2
6427405|NCT01025843|7341866|FG004|COMPLETED|Washout 3||2
6427406|NCT01025843|7341867|FG005|COMPLETED|Washout 3||2
6427407|NCT01025843|7341868|FG006|COMPLETED|Washout 3||2
6427408|NCT01025843|7341869|FG007|COMPLETED|Washout 3||2
6427409|NCT01025843|7341870|FG008|COMPLETED|Washout 3||2
6427410|NCT01025843|7341871|FG009|COMPLETED|Washout 3||2
6427411|NCT01025843|7341862|FG000|NOT COMPLETED|Washout 3||0
6427412|NCT01025843|7341863|FG001|NOT COMPLETED|Washout 3||0
6427413|NCT01025843|7341864|FG002|NOT COMPLETED|Washout 3||0
6427414|NCT01025843|7341865|FG003|NOT COMPLETED|Washout 3||0
6427415|NCT01025843|7341866|FG004|NOT COMPLETED|Washout 3||0
6427416|NCT01025843|7341867|FG005|NOT COMPLETED|Washout 3||0
6427417|NCT01025843|7341868|FG006|NOT COMPLETED|Washout 3||0
6427418|NCT01025843|7341869|FG007|NOT COMPLETED|Washout 3||0
6427419|NCT01025843|7341870|FG008|NOT COMPLETED|Washout 3||0
6427420|NCT01025843|7341871|FG009|NOT COMPLETED|Washout 3||0
6427421|NCT01025843|7341862|FG000|STARTED|Period 4||2
6427422|NCT01025843|7341863|FG001|STARTED|Period 4||2
6427423|NCT01025843|7341864|FG002|STARTED|Period 4||2
6427424|NCT01025843|7341865|FG003|STARTED|Period 4||2
6427425|NCT01025843|7341866|FG004|STARTED|Period 4||2
6427426|NCT01025843|7341867|FG005|STARTED|Period 4||2
6427427|NCT01025843|7341868|FG006|STARTED|Period 4||2
6427428|NCT01025843|7341869|FG007|STARTED|Period 4||2
6427429|NCT01025843|7341870|FG008|STARTED|Period 4||2
6427430|NCT01025843|7341871|FG009|STARTED|Period 4||2
6427431|NCT01025843|7341862|FG000|COMPLETED|Period 4||2
6427432|NCT01025843|7341863|FG001|COMPLETED|Period 4||2
6427433|NCT01025843|7341864|FG002|COMPLETED|Period 4||2
6427434|NCT01025843|7341865|FG003|COMPLETED|Period 4||2
6427435|NCT01025843|7341866|FG004|COMPLETED|Period 4||2
6427436|NCT01025843|7341867|FG005|COMPLETED|Period 4||2
6427437|NCT01025843|7341868|FG006|COMPLETED|Period 4||2
6427438|NCT01025843|7341869|FG007|COMPLETED|Period 4||2
6427439|NCT01025843|7341870|FG008|COMPLETED|Period 4||2
6427440|NCT01025843|7341871|FG009|COMPLETED|Period 4||2
6427441|NCT01025843|7341862|FG000|NOT COMPLETED|Period 4||0
6427442|NCT01025843|7341863|FG001|NOT COMPLETED|Period 4||0
6427443|NCT01025843|7341864|FG002|NOT COMPLETED|Period 4||0
6427444|NCT01025843|7341865|FG003|NOT COMPLETED|Period 4||0
6427445|NCT01025843|7341866|FG004|NOT COMPLETED|Period 4||0
6427446|NCT01025843|7341867|FG005|NOT COMPLETED|Period 4||0
6427447|NCT01025843|7341868|FG006|NOT COMPLETED|Period 4||0
6427448|NCT01025843|7341869|FG007|NOT COMPLETED|Period 4||0
6427449|NCT01025843|7341870|FG008|NOT COMPLETED|Period 4||0
6427450|NCT01025843|7341871|FG009|NOT COMPLETED|Period 4||0
6427451|NCT01025843|7341862|FG000|STARTED|Washout 4||2
6427452|NCT01025843|7341863|FG001|STARTED|Washout 4||2
6427453|NCT01025843|7341864|FG002|STARTED|Washout 4||2
6427454|NCT01025843|7341865|FG003|STARTED|Washout 4||2
6427455|NCT01025843|7341866|FG004|STARTED|Washout 4||2
6427456|NCT01025843|7341867|FG005|STARTED|Washout 4||2
6427457|NCT01025843|7341868|FG006|STARTED|Washout 4||2
6427458|NCT01025843|7341869|FG007|STARTED|Washout 4||2
6427459|NCT01025843|7341870|FG008|STARTED|Washout 4||2
6427460|NCT01025843|7341871|FG009|STARTED|Washout 4||2
6427461|NCT01025843|7341862|FG000|COMPLETED|Washout 4||2
6427462|NCT01025843|7341863|FG001|COMPLETED|Washout 4||2
6427463|NCT01025843|7341864|FG002|COMPLETED|Washout 4||1
6427464|NCT01025843|7341865|FG003|COMPLETED|Washout 4||1
6427465|NCT01025843|7341866|FG004|COMPLETED|Washout 4||2
6427466|NCT01025843|7341867|FG005|COMPLETED|Washout 4||2
6427467|NCT01025843|7341868|FG006|COMPLETED|Washout 4||2
6427468|NCT01025843|7341869|FG007|COMPLETED|Washout 4||2
6427469|NCT01025843|7341870|FG008|COMPLETED|Washout 4||2
6427470|NCT01025843|7341871|FG009|COMPLETED|Washout 4||2
6427471|NCT01025843|7341862|FG000|NOT COMPLETED|Washout 4||0
6427472|NCT01025843|7341863|FG001|NOT COMPLETED|Washout 4||0
6427473|NCT01025843|7341864|FG002|NOT COMPLETED|Washout 4||1
6427474|NCT01025843|7341865|FG003|NOT COMPLETED|Washout 4||1
6427475|NCT01025843|7341866|FG004|NOT COMPLETED|Washout 4||0
6427476|NCT01025843|7341867|FG005|NOT COMPLETED|Washout 4||0
6427477|NCT01025843|7341868|FG006|NOT COMPLETED|Washout 4||0
6427478|NCT01025843|7341869|FG007|NOT COMPLETED|Washout 4||0
6427479|NCT01025843|7341870|FG008|NOT COMPLETED|Washout 4||0
6427480|NCT01025843|7341871|FG009|NOT COMPLETED|Washout 4||0
6427481|NCT01025843|7341862|FG000|STARTED|Period 5||2
6551980|NCT01734902|7474383|FG000|STARTED|Overall Study||14
6551981|NCT01734902|7474384|FG001|STARTED|Overall Study||16
6551982|NCT01734902|7474383|FG000|COMPLETED|Overall Study||14
6551983|NCT01734902|7474384|FG001|COMPLETED|Overall Study||14
6551984|NCT01734902|7474383|FG000|NOT COMPLETED|Overall Study||0
6551985|NCT01734902|7474384|FG001|NOT COMPLETED|Overall Study||2
6551986|NCT01734993|7474390|FG000|STARTED|Overall Study||11
6427482|NCT01025843|7341863|FG001|STARTED|Period 5||2
6427483|NCT01025843|7341864|FG002|STARTED|Period 5||1
6427484|NCT01025843|7341865|FG003|STARTED|Period 5||1
6427485|NCT01025843|7341866|FG004|STARTED|Period 5||2
6551987|NCT01734993|7474390|FG000|COMPLETED|Overall Study||9
6427486|NCT01025843|7341867|FG005|STARTED|Period 5||2
6427487|NCT01025843|7341868|FG006|STARTED|Period 5||2
6427488|NCT01025843|7341869|FG007|STARTED|Period 5||2
6427489|NCT01025843|7341870|FG008|STARTED|Period 5||2
6427490|NCT01025843|7341871|FG009|STARTED|Period 5||2
6427491|NCT01025843|7341862|FG000|COMPLETED|Period 5||2
6427492|NCT01025843|7341863|FG001|COMPLETED|Period 5||2
6427493|NCT01025843|7341864|FG002|COMPLETED|Period 5||1
6427494|NCT01025843|7341865|FG003|COMPLETED|Period 5||1
6427495|NCT01025843|7341866|FG004|COMPLETED|Period 5||2
6427496|NCT01025843|7341867|FG005|COMPLETED|Period 5||2
6427497|NCT01025843|7341868|FG006|COMPLETED|Period 5||2
6427498|NCT01025843|7341869|FG007|COMPLETED|Period 5||2
6427499|NCT01025843|7341870|FG008|COMPLETED|Period 5||2
6427500|NCT01025843|7341871|FG009|COMPLETED|Period 5||2
6427501|NCT01025843|7341862|FG000|NOT COMPLETED|Period 5||0
6551988|NCT01734993|7474390|FG000|NOT COMPLETED|Overall Study||2
6551989|NCT01735175|7474397|FG000|STARTED|Overall Study||159
6551990|NCT01735175|7474398|FG001|STARTED|Overall Study||157
6652188|NCT02426138|7581747|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
6652189|NCT02426138|7581746|FG000|STARTED|Intent to Treat Population Milestone||20
6652190|NCT02426138|7581747|FG001|STARTED|Intent to Treat Population Milestone||22
6427502|NCT01025843|7341863|FG001|NOT COMPLETED|Period 5||0
6427503|NCT01025843|7341864|FG002|NOT COMPLETED|Period 5||0
6427504|NCT01025843|7341865|FG003|NOT COMPLETED|Period 5||0
6427505|NCT01025843|7341866|FG004|NOT COMPLETED|Period 5||0
6427506|NCT01025843|7341867|FG005|NOT COMPLETED|Period 5||0
6427507|NCT01025843|7341868|FG006|NOT COMPLETED|Period 5||0
6427508|NCT01025843|7341869|FG007|NOT COMPLETED|Period 5||0
6427509|NCT01025843|7341870|FG008|NOT COMPLETED|Period 5||0
6427510|NCT01025843|7341871|FG009|NOT COMPLETED|Period 5||0
6427511|NCT01026012|7341899|FG000|STARTED|Overall Study||40
6427512|NCT01026012|7341899|FG000|COMPLETED|Overall Study||40
6427513|NCT01026012|7341899|FG000|NOT COMPLETED|Overall Study||0
6427514|NCT01026038|7341906|FG000|STARTED|Overall Study||130
6427515|NCT01026038|7341907|FG001|STARTED|Overall Study||65
6427516|NCT01026038|7341908|FG002|STARTED|Overall Study||67
6427517|NCT01026038|7341906|FG000|COMPLETED|Overall Study||129
6427518|NCT01026038|7341907|FG001|COMPLETED|Overall Study||64
6427519|NCT01026038|7341908|FG002|COMPLETED|Overall Study||67
6427520|NCT01026038|7341906|FG000|NOT COMPLETED|Overall Study||1
6427521|NCT01026038|7341907|FG001|NOT COMPLETED|Overall Study||1
6427522|NCT01026038|7341908|FG002|NOT COMPLETED|Overall Study||0
6427523|NCT01026103|7341916|FG000|STARTED|Overall Study||30
6427524|NCT01026103|7341916|FG000|Consented|Overall Study||30
6427525|NCT01026103|7341916|FG000|COMPLETED|Overall Study||28
6427526|NCT01026103|7341916|FG000|NOT COMPLETED|Overall Study||2
6427527|NCT01026142|7341922|FG000|STARTED|Overall Study||224
6427528|NCT01026142|7341923|FG001|STARTED|Overall Study||228
6427529|NCT01026142|7341922|FG000|COMPLETED|Overall Study||52
6427530|NCT01026142|7341923|FG001|COMPLETED|Overall Study||65
6427531|NCT01026142|7341922|FG000|NOT COMPLETED|Overall Study||172
6427532|NCT01026142|7341923|FG001|NOT COMPLETED|Overall Study||163
6427533|NCT01026181|7341932|FG000|STARTED|Overall Study||51
6427534|NCT01026181|7341933|FG001|STARTED|Overall Study||51
6427535|NCT01026181|7341934|FG002|STARTED|Overall Study||48
6427536|NCT01026181|7341932|FG000|COMPLETED|Overall Study||51
6427537|NCT01026181|7341933|FG001|COMPLETED|Overall Study||51
6427538|NCT01026181|7341934|FG002|COMPLETED|Overall Study||48
6427539|NCT01026181|7341932|FG000|NOT COMPLETED|Overall Study||0
6427540|NCT01026181|7341933|FG001|NOT COMPLETED|Overall Study||0
6427541|NCT01026181|7341934|FG002|NOT COMPLETED|Overall Study||0
6427542|NCT01026194|7341944|FG000|STARTED|Period 1：Double Blind Period||101
6427543|NCT01026194|7341945|FG001|STARTED|Period 1：Double Blind Period||103
6427544|NCT01026194|7341944|FG000|COMPLETED|Period 1：Double Blind Period||98
6427545|NCT01026194|7341945|FG001|COMPLETED|Period 1：Double Blind Period||98
6427546|NCT01026194|7341944|FG000|NOT COMPLETED|Period 1：Double Blind Period||3
6427547|NCT01026194|7341945|FG001|NOT COMPLETED|Period 1：Double Blind Period||5
6427548|NCT01026194|7341944|FG000|STARTED|Period 2：Open-label Period||98
6427549|NCT01026194|7341945|FG001|STARTED|Period 2：Open-label Period||98
6427550|NCT01026194|7341944|FG000|COMPLETED|Period 2：Open-label Period||91
6427551|NCT01026194|7341945|FG001|COMPLETED|Period 2：Open-label Period||88
6427552|NCT01026194|7341944|FG000|NOT COMPLETED|Period 2：Open-label Period||7
6427553|NCT01026194|7341945|FG001|NOT COMPLETED|Period 2：Open-label Period||10
6427554|NCT01026324|7341956|FG000|STARTED|Treatment Allocation||5
6427555|NCT01026324|7341957|FG001|STARTED|Treatment Allocation||3
6427556|NCT01026324|7341958|FG002|STARTED|Treatment Allocation||4
6427557|NCT01026324|7341956|FG000|Discontinued Intervention (Toxicity)|Treatment Allocation||1
6551991|NCT01735175|7474397|FG000|Completed All Cycles|Overall Study||141
6652191|NCT02426138|7581746|FG000|COMPLETED|Intent to Treat Population Milestone||20
6652192|NCT02426138|7581747|FG001|COMPLETED|Intent to Treat Population Milestone||22
6652193|NCT02426138|7581746|FG000|NOT COMPLETED|Intent to Treat Population Milestone||0
6652194|NCT02426138|7581747|FG001|NOT COMPLETED|Intent to Treat Population Milestone||0
6427558|NCT01026324|7341957|FG001|Discontinued Intervention (Toxicity)|Treatment Allocation||0
6427559|NCT01026324|7341958|FG002|Discontinued Intervention (Toxicity)|Treatment Allocation||0
6427560|NCT01026324|7341956|FG000|Discontinuted Intervention (Progression)|Treatment Allocation||3
6551992|NCT01735175|7474398|FG001|Completed All Cycles|Overall Study||150
6551993|NCT01735175|7474397|FG000|Completed All Treatments as Planned|Overall Study||140
6551994|NCT01735175|7474398|FG001|Completed All Treatments as Planned|Overall Study||150
6551995|NCT01735175|7474397|FG000|Completed the 6-month SFU Visit|Overall Study||120
6551996|NCT01735175|7474398|FG001|Completed the 6-month SFU Visit|Overall Study||138
6551997|NCT01735175|7474397|FG000|COMPLETED|Overall Study||130
6551998|NCT01735175|7474398|FG001|COMPLETED|Overall Study||144
6551999|NCT01735175|7474397|FG000|NOT COMPLETED|Overall Study||29
6552000|NCT01735175|7474398|FG001|NOT COMPLETED|Overall Study||13
6552001|NCT01735201|7474412|FG000|STARTED|Overall Study||45
6552002|NCT01735201|7474413|FG001|STARTED|Overall Study||44
6552003|NCT01735201|7474414|FG002|STARTED|Overall Study||44
6552004|NCT01735201|7474415|FG003|STARTED|Overall Study||44
6552005|NCT01735201|7474416|FG004|STARTED|Overall Study||45
6552006|NCT01735201|7474417|FG005|STARTED|Overall Study||45
6552007|NCT01735201|7474418|FG006|STARTED|Overall Study||45
6552008|NCT01735201|7474419|FG007|STARTED|Overall Study||44
6552009|NCT01735201|7474412|FG000|COMPLETED|Overall Study||42
6552010|NCT01735201|7474413|FG001|COMPLETED|Overall Study||43
6552011|NCT01735201|7474414|FG002|COMPLETED|Overall Study||44
6552012|NCT01735201|7474415|FG003|COMPLETED|Overall Study||42
6552013|NCT01735201|7474416|FG004|COMPLETED|Overall Study||44
6552014|NCT01735201|7474417|FG005|COMPLETED|Overall Study||40
6427561|NCT01026324|7341957|FG001|Discontinuted Intervention (Progression)|Treatment Allocation||3
6427562|NCT01026324|7341958|FG002|Discontinuted Intervention (Progression)|Treatment Allocation||4
6427563|NCT01026324|7341956|FG000|Discontinued Intervention (Withdrew)|Treatment Allocation||1
6427564|NCT01026324|7341957|FG001|Discontinued Intervention (Withdrew)|Treatment Allocation||0
6427565|NCT01026324|7341958|FG002|Discontinued Intervention (Withdrew)|Treatment Allocation||0
6427566|NCT01026324|7341956|FG000|COMPLETED|Treatment Allocation||5
6427567|NCT01026324|7341957|FG001|COMPLETED|Treatment Allocation||3
6427568|NCT01026324|7341958|FG002|COMPLETED|Treatment Allocation||4
6427569|NCT01026324|7341956|FG000|NOT COMPLETED|Treatment Allocation||0
6427570|NCT01026324|7341957|FG001|NOT COMPLETED|Treatment Allocation||0
6427571|NCT01026324|7341958|FG002|NOT COMPLETED|Treatment Allocation||0
6427572|NCT01026324|7341956|FG000|STARTED|Follow up/Survival||5
6427573|NCT01026324|7341957|FG001|STARTED|Follow up/Survival||3
6427574|NCT01026324|7341958|FG002|STARTED|Follow up/Survival||4
6427575|NCT01026324|7341956|FG000|Follow up Discontinuation (Death)|Follow up/Survival||4
6427576|NCT01026324|7341957|FG001|Follow up Discontinuation (Death)|Follow up/Survival||3
6427577|NCT01026324|7341958|FG002|Follow up Discontinuation (Death)|Follow up/Survival||4
6427578|NCT01026324|7341956|FG000|COMPLETED|Follow up/Survival||4
6427579|NCT01026324|7341957|FG001|COMPLETED|Follow up/Survival||3
6427580|NCT01026324|7341958|FG002|COMPLETED|Follow up/Survival||4
6427581|NCT01026324|7341956|FG000|NOT COMPLETED|Follow up/Survival||1
6427582|NCT01026324|7341957|FG001|NOT COMPLETED|Follow up/Survival||0
6427583|NCT01026324|7341958|FG002|NOT COMPLETED|Follow up/Survival||0
6427584|NCT01026389|7341969|FG000|STARTED|Overall Study||93
6427585|NCT01026389|7341970|FG001|STARTED|Overall Study||93
6427586|NCT01026389|7341969|FG000|COMPLETED|Overall Study||88
6427587|NCT01026389|7341970|FG001|COMPLETED|Overall Study||88
6427588|NCT01026389|7341969|FG000|NOT COMPLETED|Overall Study||5
6427589|NCT01026389|7341970|FG001|NOT COMPLETED|Overall Study||5
6427590|NCT01026402|7341993|FG000|STARTED|Overall Study||6
6427591|NCT01026402|7341994|FG001|STARTED|Overall Study||8
6427592|NCT01026402|7341995|FG002|STARTED|Overall Study||33
6427593|NCT01026402|7341996|FG003|STARTED|Overall Study||18
6427594|NCT01026402|7341997|FG004|STARTED|Overall Study||3
6427595|NCT01026402|7341998|FG005|STARTED|Overall Study||5
6427596|NCT01026402|7341999|FG006|STARTED|Overall Study||8
6427597|NCT01026402|7342000|FG007|STARTED|Overall Study||3
6427598|NCT01026402|7342001|FG008|STARTED|Overall Study||7
6427599|NCT01026402|7342002|FG009|STARTED|Overall Study||3
6427600|NCT01026402|7342003|FG010|STARTED|Overall Study||7
6427601|NCT01026402|7342004|FG011|STARTED|Overall Study||8
6427602|NCT01026402|7342005|FG012|STARTED|Overall Study||8
6427603|NCT01026402|7342006|FG013|STARTED|Overall Study||6
6427604|NCT01026402|7342007|FG014|STARTED|Overall Study||3
6427605|NCT01026402|7342008|FG015|STARTED|Overall Study||5
6427606|NCT01026402|7342009|FG016|STARTED|Overall Study||4
6427607|NCT01026402|7341993|FG000|COMPLETED|Overall Study||6
6427608|NCT01026402|7341994|FG001|COMPLETED|Overall Study||8
6427609|NCT01026402|7341995|FG002|COMPLETED|Overall Study||33
6427610|NCT01026402|7341996|FG003|COMPLETED|Overall Study||18
6427611|NCT01026402|7341997|FG004|COMPLETED|Overall Study||3
6427612|NCT01026402|7341998|FG005|COMPLETED|Overall Study||5
6427613|NCT01026402|7341999|FG006|COMPLETED|Overall Study||8
6427614|NCT01026402|7342000|FG007|COMPLETED|Overall Study||3
6427615|NCT01026402|7342001|FG008|COMPLETED|Overall Study||7
6427616|NCT01026402|7342002|FG009|COMPLETED|Overall Study||3
6427617|NCT01026402|7342003|FG010|COMPLETED|Overall Study||7
6427618|NCT01026402|7342004|FG011|COMPLETED|Overall Study||8
6427619|NCT01026402|7342005|FG012|COMPLETED|Overall Study||8
6427620|NCT01026402|7342006|FG013|COMPLETED|Overall Study||6
6427621|NCT01026402|7342007|FG014|COMPLETED|Overall Study||3
6427622|NCT01026402|7342008|FG015|COMPLETED|Overall Study||5
6427623|NCT01026402|7342009|FG016|COMPLETED|Overall Study||4
6427624|NCT01026402|7341993|FG000|NOT COMPLETED|Overall Study||0
6427625|NCT01026402|7341994|FG001|NOT COMPLETED|Overall Study||0
6427626|NCT01026402|7341995|FG002|NOT COMPLETED|Overall Study||0
6427627|NCT01026402|7341996|FG003|NOT COMPLETED|Overall Study||0
6427628|NCT01026402|7341997|FG004|NOT COMPLETED|Overall Study||0
6427629|NCT01026402|7341998|FG005|NOT COMPLETED|Overall Study||0
6427630|NCT01026402|7341999|FG006|NOT COMPLETED|Overall Study||0
6427631|NCT01026402|7342000|FG007|NOT COMPLETED|Overall Study||0
6552015|NCT01735201|7474418|FG006|COMPLETED|Overall Study||42
6552016|NCT01735201|7474419|FG007|COMPLETED|Overall Study||42
6427632|NCT01026402|7342001|FG008|NOT COMPLETED|Overall Study||0
6427633|NCT01026402|7342002|FG009|NOT COMPLETED|Overall Study||0
6427634|NCT01026402|7342003|FG010|NOT COMPLETED|Overall Study||0
6427635|NCT01026402|7342004|FG011|NOT COMPLETED|Overall Study||0
6427636|NCT01026402|7342005|FG012|NOT COMPLETED|Overall Study||0
6552017|NCT01735201|7474412|FG000|NOT COMPLETED|Overall Study||3
6552018|NCT01735201|7474413|FG001|NOT COMPLETED|Overall Study||1
6552019|NCT01735201|7474414|FG002|NOT COMPLETED|Overall Study||0
6552020|NCT01735201|7474415|FG003|NOT COMPLETED|Overall Study||2
6552021|NCT01735201|7474416|FG004|NOT COMPLETED|Overall Study||1
6427637|NCT01026402|7342006|FG013|NOT COMPLETED|Overall Study||0
6427638|NCT01026402|7342007|FG014|NOT COMPLETED|Overall Study||0
6427639|NCT01026402|7342008|FG015|NOT COMPLETED|Overall Study||0
6427640|NCT01026402|7342009|FG016|NOT COMPLETED|Overall Study||0
6427641|NCT01026454|7342050|FG000|STARTED|First Intervention||18
6427642|NCT01026454|7342051|FG001|STARTED|First Intervention||14
6427643|NCT01026454|7342050|FG000|COMPLETED|First Intervention||18
6427644|NCT01026454|7342051|FG001|COMPLETED|First Intervention||14
6427645|NCT01026454|7342050|FG000|NOT COMPLETED|First Intervention||0
6427646|NCT01026454|7342051|FG001|NOT COMPLETED|First Intervention||0
6427647|NCT01026454|7342050|FG000|STARTED|Washout||18
6427648|NCT01026454|7342051|FG001|STARTED|Washout||14
6427649|NCT01026454|7342050|FG000|COMPLETED|Washout||18
6427650|NCT01026454|7342051|FG001|COMPLETED|Washout||14
6427651|NCT01026454|7342050|FG000|NOT COMPLETED|Washout||0
6427652|NCT01026454|7342051|FG001|NOT COMPLETED|Washout||0
6427653|NCT01026454|7342050|FG000|STARTED|Second Intervention||17
6427654|NCT01026454|7342051|FG001|STARTED|Second Intervention||14
6427655|NCT01026454|7342050|FG000|COMPLETED|Second Intervention||16
6427656|NCT01026454|7342051|FG001|COMPLETED|Second Intervention||13
6427657|NCT01026454|7342050|FG000|NOT COMPLETED|Second Intervention||1
6427658|NCT01026454|7342051|FG001|NOT COMPLETED|Second Intervention||1
6427659|NCT01026493|7342065|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
6427660|NCT01026493|7342066|FG001|STARTED|Overall Study||7
6427661|NCT01026493|7342067|FG002|STARTED|Overall Study||9
6427662|NCT01026493|7342068|FG003|STARTED|Overall Study||8
6427663|NCT01026493|7342069|FG004|STARTED|Overall Study||75
6427664|NCT01026493|7342070|FG005|STARTED|Overall Study||76
6427665|NCT01026493|7342071|FG006|STARTED|Overall Study||36
6427666|NCT01026493|7342072|FG007|STARTED|Overall Study||38
6427667|NCT01026493|7342065|FG000|COMPLETED|Overall Study||8
6427668|NCT01026493|7342066|FG001|COMPLETED|Overall Study||6
6427669|NCT01026493|7342067|FG002|COMPLETED|Overall Study||9
6427670|NCT01026493|7342068|FG003|COMPLETED|Overall Study||8
6427671|NCT01026493|7342069|FG004|COMPLETED|Overall Study||73
6427672|NCT01026493|7342070|FG005|COMPLETED|Overall Study||73
6427673|NCT01026493|7342071|FG006|COMPLETED|Overall Study||32
6427674|NCT01026493|7342072|FG007|COMPLETED|Overall Study||37
6427675|NCT01026493|7342065|FG000|NOT COMPLETED|Overall Study||0
6427676|NCT01026493|7342066|FG001|NOT COMPLETED|Overall Study||1
6427677|NCT01026493|7342067|FG002|NOT COMPLETED|Overall Study||0
6427678|NCT01026493|7342068|FG003|NOT COMPLETED|Overall Study||0
6427679|NCT01026493|7342069|FG004|NOT COMPLETED|Overall Study||2
6427680|NCT01026493|7342070|FG005|NOT COMPLETED|Overall Study||3
6427681|NCT01026493|7342071|FG006|NOT COMPLETED|Overall Study||4
6427682|NCT01026493|7342072|FG007|NOT COMPLETED|Overall Study||1
6427683|NCT01026623|7342093|FG000|STARTED|Overall Study||6
6427684|NCT01026623|7342094|FG001|STARTED|Overall Study||5
6427685|NCT01026623|7342095|FG002|STARTED|Overall Study||5
6427686|NCT01026623|7342093|FG000|COMPLETED|Overall Study||6
6427687|NCT01026623|7342094|FG001|COMPLETED|Overall Study||5
6427688|NCT01026623|7342095|FG002|COMPLETED|Overall Study||5
6427689|NCT01026623|7342093|FG000|NOT COMPLETED|Overall Study||0
6427690|NCT01026623|7342094|FG001|NOT COMPLETED|Overall Study||0
6427691|NCT01026623|7342095|FG002|NOT COMPLETED|Overall Study||0
6427692|NCT01026792|7342104|FG000|STARTED|Overall Study||38
6427693|NCT01026792|7342104|FG000|COMPLETED|Overall Study||37
6427694|NCT01026792|7342104|FG000|NOT COMPLETED|Overall Study||1
6427695|NCT01026805|7342108|FG000|STARTED|Overall Study||11
6427696|NCT01026805|7342108|FG000|COMPLETED|Overall Study||11
6427697|NCT01026805|7342108|FG000|NOT COMPLETED|Overall Study||0
6427698|NCT01026818|7342115|FG000|STARTED|Screening Period||583
6427699|NCT01026818|7342116|FG001|STARTED|Screening Period||0
6427700|NCT01026818|7342117|FG002|STARTED|Screening Period||0
6427701|NCT01026818|7342118|FG003|STARTED|Screening Period||0
6427702|NCT01026818|7342115|FG000|COMPLETED|Screening Period||423
6427703|NCT01026818|7342116|FG001|COMPLETED|Screening Period||0
6427704|NCT01026818|7342117|FG002|COMPLETED|Screening Period||0
6427705|NCT01026818|7342118|FG003|COMPLETED|Screening Period||0
6427706|NCT01026818|7342115|FG000|NOT COMPLETED|Screening Period||160
6427707|NCT01026818|7342116|FG001|NOT COMPLETED|Screening Period||0
6427708|NCT01026818|7342117|FG002|NOT COMPLETED|Screening Period||0
6427709|NCT01026818|7342118|FG003|NOT COMPLETED|Screening Period||0
6427710|NCT01026818|7342115|FG000|STARTED|DB Treatment Period (Month 0 - 9)||0
6427711|NCT01026818|7342116|FG001|STARTED|DB Treatment Period (Month 0 - 9)||139
6427712|NCT01026818|7342117|FG002|STARTED|DB Treatment Period (Month 0 - 9)||143
6427713|NCT01026818|7342118|FG003|STARTED|DB Treatment Period (Month 0 - 9)||141
6427714|NCT01026818|7342115|FG000|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
6427715|NCT01026818|7342116|FG001|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
6427716|NCT01026818|7342117|FG002|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
6427717|NCT01026818|7342118|FG003|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
6427718|NCT01026818|7342115|FG000|COMPLETED|DB Treatment Period (Month 0 - 9)||0
6427719|NCT01026818|7342116|FG001|COMPLETED|DB Treatment Period (Month 0 - 9)||114
6427720|NCT01026818|7342117|FG002|COMPLETED|DB Treatment Period (Month 0 - 9)||122
6427721|NCT01026818|7342118|FG003|COMPLETED|DB Treatment Period (Month 0 - 9)||115
6427722|NCT01026818|7342115|FG000|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
6427723|NCT01026818|7342116|FG001|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
6427724|NCT01026818|7342117|FG002|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
6427725|NCT01026818|7342118|FG003|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
6427726|NCT01026818|7342115|FG000|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
6427727|NCT01026818|7342116|FG001|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
6427728|NCT01026818|7342117|FG002|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
6427729|NCT01026818|7342118|FG003|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
6427730|NCT01026818|7342115|FG000|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
6427731|NCT01026818|7342116|FG001|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
6427732|NCT01026818|7342117|FG002|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
6427733|NCT01026818|7342118|FG003|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
6427734|NCT01026818|7342115|FG000|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
6427735|NCT01026818|7342116|FG001|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
6427736|NCT01026818|7342117|FG002|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
6427737|NCT01026818|7342118|FG003|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
6427738|NCT01026818|7342115|FG000|STARTED|OL Period (Month 10.5 - 13.5)||0
6427739|NCT01026818|7342116|FG001|STARTED|OL Period (Month 10.5 - 13.5)||105
6427740|NCT01026818|7342117|FG002|STARTED|OL Period (Month 10.5 - 13.5)||117
6427741|NCT01026818|7342118|FG003|STARTED|OL Period (Month 10.5 - 13.5)||108
6427742|NCT01026818|7342115|FG000|COMPLETED|OL Period (Month 10.5 - 13.5)||0
6427743|NCT01026818|7342116|FG001|COMPLETED|OL Period (Month 10.5 - 13.5)||98
6427744|NCT01026818|7342117|FG002|COMPLETED|OL Period (Month 10.5 - 13.5)||112
6427745|NCT01026818|7342118|FG003|COMPLETED|OL Period (Month 10.5 - 13.5)||105
6427746|NCT01026818|7342115|FG000|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
6427747|NCT01026818|7342116|FG001|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
6427748|NCT01026818|7342117|FG002|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
6427749|NCT01026818|7342118|FG003|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
6427750|NCT01026831|7342132|FG000|STARTED|Overall Study|randomized|320
6427751|NCT01026831|7342133|FG001|STARTED|Overall Study|randomized|323
6427752|NCT01026831|7342132|FG000|COMPLETED|Overall Study||306
6427753|NCT01026831|7342133|FG001|COMPLETED|Overall Study||312
6427754|NCT01026831|7342132|FG000|NOT COMPLETED|Overall Study||14
6427755|NCT01026831|7342133|FG001|NOT COMPLETED|Overall Study||11
6427756|NCT01026844|7342141|FG000|STARTED|Overall Study||19
6427757|NCT01026844|7342142|FG001|STARTED|Overall Study||8
6427758|NCT01026844|7342141|FG000|COMPLETED|Overall Study||19
6427759|NCT01026844|7342142|FG001|COMPLETED|Overall Study||8
6427760|NCT01026844|7342141|FG000|NOT COMPLETED|Overall Study||0
6427761|NCT01026844|7342142|FG001|NOT COMPLETED|Overall Study||0
6427762|NCT01026909|7342150|FG000|STARTED|Overall Study||1
6427763|NCT01026909|7342151|FG001|STARTED|Overall Study||2
6427764|NCT01026909|7342150|FG000|COMPLETED|Overall Study||1
6427765|NCT01026909|7342151|FG001|COMPLETED|Overall Study||2
6427766|NCT01026909|7342150|FG000|NOT COMPLETED|Overall Study||0
6427767|NCT01026909|7342151|FG001|NOT COMPLETED|Overall Study||0
6427768|NCT01026948|7342157|FG000|STARTED|Overall Study||70
6427769|NCT01026948|7342157|FG000|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
6427770|NCT01026948|7342157|FG000|NOT COMPLETED|Overall Study||8
6427771|NCT01026974|7342166|FG000|STARTED|Overall Study||16
6427772|NCT01026974|7342167|FG001|STARTED|Overall Study||14
6427773|NCT01026974|7342168|FG002|STARTED|Overall Study||41
6427774|NCT01026974|7342169|FG003|STARTED|Overall Study||49
6427775|NCT01026974|7342166|FG000|COMPLETED|Overall Study||15
6427776|NCT01026974|7342167|FG001|COMPLETED|Overall Study||12
6427777|NCT01026974|7342168|FG002|COMPLETED|Overall Study||29
6427778|NCT01026974|7342169|FG003|COMPLETED|Overall Study||46
6427779|NCT01026974|7342166|FG000|NOT COMPLETED|Overall Study||1
6427780|NCT01026974|7342167|FG001|NOT COMPLETED|Overall Study||2
6427781|NCT01026974|7342168|FG002|NOT COMPLETED|Overall Study||12
6427782|NCT01026974|7342169|FG003|NOT COMPLETED|Overall Study||3
6427783|NCT01027000|7342184|FG000|STARTED|Overall Study||68
6427784|NCT01027000|7342184|FG000|COMPLETED|Overall Study||68
6427785|NCT01027000|7342184|FG000|NOT COMPLETED|Overall Study||0
6427786|NCT01027195|7342190|FG000|STARTED|Overall Study||71
6427787|NCT01027195|7342191|FG001|STARTED|Overall Study||69
6427788|NCT01027195|7342190|FG000|COMPLETED|Overall Study||71
6427789|NCT01027195|7342191|FG001|COMPLETED|Overall Study||69
6427790|NCT01027195|7342190|FG000|NOT COMPLETED|Overall Study||0
6427791|NCT01027195|7342191|FG001|NOT COMPLETED|Overall Study||0
6427792|NCT01027273|7342199|FG000|STARTED|Overall Study||301
6427793|NCT01027273|7342200|FG001|STARTED|Overall Study||299
6427794|NCT01027273|7342199|FG000|COMPLETED|Overall Study||242
6427795|NCT01027273|7342200|FG001|COMPLETED|Overall Study||266
6427796|NCT01027273|7342199|FG000|NOT COMPLETED|Overall Study||59
6427797|NCT01027273|7342200|FG001|NOT COMPLETED|Overall Study||33
6427798|NCT01027286|7342208|FG000|STARTED|Overall Study||50
6427799|NCT01027286|7342209|FG001|STARTED|Overall Study||50
6427800|NCT01027286|7342208|FG000|Preoperative|Overall Study||50
6427801|NCT01027286|7342209|FG001|Preoperative|Overall Study||50
6427802|NCT01027286|7342208|FG000|Day of Surgery|Overall Study||50
6427803|NCT01027286|7342209|FG001|Day of Surgery|Overall Study||50
6427804|NCT01027286|7342208|FG000|4 Week Postoperative|Overall Study||49
6427805|NCT01027286|7342209|FG001|4 Week Postoperative|Overall Study||50
6427806|NCT01027286|7342208|FG000|12 Week Postoperative|Overall Study||49
6427807|NCT01027286|7342209|FG001|12 Week Postoperative|Overall Study||49
6427808|NCT01027286|7342208|FG000|COMPLETED|Overall Study||49
6427809|NCT01027286|7342209|FG001|COMPLETED|Overall Study||49
6427810|NCT01027286|7342208|FG000|NOT COMPLETED|Overall Study||1
6427811|NCT01027286|7342209|FG001|NOT COMPLETED|Overall Study||1
6427812|NCT01027351|7342221|FG000|STARTED|Overall Study||29
6427813|NCT01027351|7342222|FG001|STARTED|Overall Study||19
6427814|NCT01027351|7342223|FG002|STARTED|Overall Study||14
6427815|NCT01027351|7342224|FG003|STARTED|Overall Study||8
6427816|NCT01027351|7342225|FG004|STARTED|Overall Study||43
6427817|NCT01027351|7342226|FG005|STARTED|Overall Study||50
6427818|NCT01027351|7342221|FG000|COMPLETED|Overall Study||26
6427819|NCT01027351|7342222|FG001|COMPLETED|Overall Study||18
6427820|NCT01027351|7342223|FG002|COMPLETED|Overall Study||13
6427821|NCT01027351|7342224|FG003|COMPLETED|Overall Study||6
6427822|NCT01027351|7342225|FG004|COMPLETED|Overall Study||32
6427823|NCT01027351|7342226|FG005|COMPLETED|Overall Study||45
6427824|NCT01027351|7342221|FG000|NOT COMPLETED|Overall Study||3
6427825|NCT01027351|7342222|FG001|NOT COMPLETED|Overall Study||1
6427826|NCT01027351|7342223|FG002|NOT COMPLETED|Overall Study||1
6427827|NCT01027351|7342224|FG003|NOT COMPLETED|Overall Study||2
6427828|NCT01027351|7342225|FG004|NOT COMPLETED|Overall Study||11
6427829|NCT01027351|7342226|FG005|NOT COMPLETED|Overall Study||5
6427830|NCT01027364|7342251|FG000|STARTED|Overall Study||63
6427831|NCT01027364|7342252|FG001|STARTED|Overall Study||29
6427832|NCT01027364|7342253|FG002|STARTED|Overall Study||27
6427833|NCT01027364|7342254|FG003|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
6427834|NCT01027364|7342251|FG000|Enrolled in Sequential PK Subgroup|Overall Study||22
6427835|NCT01027364|7342252|FG001|Enrolled in Sequential PK Subgroup|Overall Study||0
6427836|NCT01027364|7342253|FG002|Enrolled in Sequential PK Subgroup|Overall Study||0
6427837|NCT01027364|7342254|FG003|Enrolled in Sequential PK Subgroup|Overall Study||0
6427838|NCT01027364|7342251|FG000|Joined Arm 4 for Surgery Then Returned|Overall Study||5
6427839|NCT01027364|7342252|FG001|Joined Arm 4 for Surgery Then Returned|Overall Study||0
6427840|NCT01027364|7342253|FG002|Joined Arm 4 for Surgery Then Returned|Overall Study||1
6427841|NCT01027364|7342254|FG003|Joined Arm 4 for Surgery Then Returned|Overall Study||0
6427842|NCT01027364|7342251|FG000|Started Arm 4 Then Joined Another Arm|Overall Study||2
6427843|NCT01027364|7342252|FG001|Started Arm 4 Then Joined Another Arm|Overall Study||0
6427844|NCT01027364|7342253|FG002|Started Arm 4 Then Joined Another Arm|Overall Study||0
6427845|NCT01027364|7342254|FG003|Started Arm 4 Then Joined Another Arm|Overall Study||0
6427846|NCT01027364|7342251|FG000|COMPLETED|Overall Study||59
6427847|NCT01027364|7342252|FG001|COMPLETED|Overall Study||27
6427848|NCT01027364|7342253|FG002|COMPLETED|Overall Study||26
6652195|NCT02426476|7581757|FG000|STARTED|Overall Study||57
6652196|NCT02426476|7581758|FG001|STARTED|Overall Study||56
6652197|NCT02426476|7581757|FG000|COMPLETED|Overall Study||38
6652198|NCT02426476|7581758|FG001|COMPLETED|Overall Study||39
6652199|NCT02426476|7581757|FG000|NOT COMPLETED|Overall Study||19
6652200|NCT02426476|7581758|FG001|NOT COMPLETED|Overall Study||17
6652201|NCT02426541|7581768|FG000|STARTED|Overall Study||16
6652202|NCT02426541|7581769|FG001|STARTED|Overall Study||16
6652203|NCT02426541|7581768|FG000|COMPLETED|Overall Study||15
6427849|NCT01027364|7342254|FG003|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
6427850|NCT01027364|7342251|FG000|NOT COMPLETED|Overall Study||4
6427851|NCT01027364|7342252|FG001|NOT COMPLETED|Overall Study||2
6427852|NCT01027364|7342253|FG002|NOT COMPLETED|Overall Study||1
6427853|NCT01027364|7342254|FG003|NOT COMPLETED|Overall Study||1
6427854|NCT01027416|7342282|FG000|STARTED|Overall Study||31
6427855|NCT01027416|7342283|FG001|STARTED|Overall Study||28
6427856|NCT01027416|7342282|FG000|COMPLETED|Overall Study||30
6427857|NCT01027416|7342283|FG001|COMPLETED|Overall Study||23
6427858|NCT01027416|7342282|FG000|NOT COMPLETED|Overall Study||1
6427859|NCT01027416|7342283|FG001|NOT COMPLETED|Overall Study||5
6427860|NCT01027468|7342289|FG000|STARTED|Overall Study||160
6427861|NCT01027468|7342289|FG000|COMPLETED|Overall Study||160
6427862|NCT01027468|7342289|FG000|NOT COMPLETED|Overall Study||0
6427863|NCT01027559|7342296|FG000|STARTED|Overall Study||26
6427864|NCT01027559|7342297|FG001|STARTED|Overall Study||34
6427865|NCT01027559|7342298|FG002|STARTED|Overall Study||31
6427866|NCT01027559|7342296|FG000|COMPLETED|Overall Study||20
6427867|NCT01027559|7342297|FG001|COMPLETED|Overall Study||26
6427868|NCT01027559|7342298|FG002|COMPLETED|Overall Study||22
6427869|NCT01027559|7342296|FG000|NOT COMPLETED|Overall Study||6
6427870|NCT01027559|7342297|FG001|NOT COMPLETED|Overall Study||8
6427871|NCT01027559|7342298|FG002|NOT COMPLETED|Overall Study||9
6427872|NCT01027598|7342309|FG000|STARTED|Overall Study|One patient was enrolled but not treated|134
6427873|NCT01027598|7342310|FG001|STARTED|Overall Study||67
6427874|NCT01027598|7342309|FG000|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
6427875|NCT01027598|7342310|FG001|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
6427876|NCT01027598|7342309|FG000|NOT COMPLETED|Overall Study||134
6427877|NCT01027598|7342310|FG001|NOT COMPLETED|Overall Study||67
6427878|NCT01027650|7342324|FG000|STARTED|Overall Study||6
6427879|NCT01027650|7342325|FG001|STARTED|Overall Study||6
6427880|NCT01027650|7342326|FG002|STARTED|Overall Study||6
6652204|NCT02426541|7581769|FG001|COMPLETED|Overall Study||16
6652205|NCT02426541|7581768|FG000|NOT COMPLETED|Overall Study||1
6652206|NCT02426541|7581769|FG001|NOT COMPLETED|Overall Study||0
6652207|NCT02426580|7581777|FG000|STARTED|Overall Study|April 2015|70
6427881|NCT01027650|7342327|FG003|STARTED|Overall Study||3
6427882|NCT01027650|7342328|FG004|STARTED|Overall Study||25
6427883|NCT01027650|7342329|FG005|STARTED|Overall Study||26
6427884|NCT01027650|7342330|FG006|STARTED|Overall Study||25
6427885|NCT01027650|7342331|FG007|STARTED|Overall Study||24
6427886|NCT01027650|7342324|FG000|COMPLETED|Overall Study||6
6427887|NCT01027650|7342325|FG001|COMPLETED|Overall Study||6
6427888|NCT01027650|7342326|FG002|COMPLETED|Overall Study||6
6427889|NCT01027650|7342327|FG003|COMPLETED|Overall Study||3
6427890|NCT01027650|7342328|FG004|COMPLETED|Overall Study||23
6427891|NCT01027650|7342329|FG005|COMPLETED|Overall Study||24
6427892|NCT01027650|7342330|FG006|COMPLETED|Overall Study||24
6427893|NCT01027650|7342331|FG007|COMPLETED|Overall Study||24
6427894|NCT01027650|7342324|FG000|NOT COMPLETED|Overall Study||0
6427895|NCT01027650|7342325|FG001|NOT COMPLETED|Overall Study||0
6427896|NCT01027650|7342326|FG002|NOT COMPLETED|Overall Study||0
6427897|NCT01027650|7342327|FG003|NOT COMPLETED|Overall Study||0
6427898|NCT01027650|7342328|FG004|NOT COMPLETED|Overall Study||2
6427899|NCT01027650|7342329|FG005|NOT COMPLETED|Overall Study||2
6427900|NCT01027650|7342330|FG006|NOT COMPLETED|Overall Study||1
6427901|NCT01027650|7342331|FG007|NOT COMPLETED|Overall Study||0
6427902|NCT01027754|7342351|FG000|STARTED|Overall Study||57
6427903|NCT01027754|7342352|FG001|STARTED|Overall Study||55
6427904|NCT01027754|7342351|FG000|COMPLETED|Overall Study||55
6427905|NCT01027754|7342352|FG001|COMPLETED|Overall Study||47
6427906|NCT01027754|7342351|FG000|NOT COMPLETED|Overall Study||2
6427907|NCT01027754|7342352|FG001|NOT COMPLETED|Overall Study||8
6427908|NCT01027780|7342360|FG000|STARTED|Overall Study||105
6427909|NCT01027780|7342361|FG001|STARTED|Overall Study||103
6427910|NCT01027780|7342360|FG000|COMPLETED|Overall Study||105
6427911|NCT01027780|7342361|FG001|COMPLETED|Overall Study||102
6427912|NCT01027780|7342360|FG000|NOT COMPLETED|Overall Study||0
6427913|NCT01027780|7342361|FG001|NOT COMPLETED|Overall Study||1
6427914|NCT01027793|7342370|FG000|STARTED|Overall Study||17
6427915|NCT01027793|7342371|FG001|STARTED|Overall Study||15
6427916|NCT01027793|7342370|FG000|COMPLETED|Overall Study||10
6427917|NCT01027793|7342371|FG001|COMPLETED|Overall Study||12
6427918|NCT01027793|7342370|FG000|NOT COMPLETED|Overall Study||7
6427919|NCT01027793|7342371|FG001|NOT COMPLETED|Overall Study||3
6427920|NCT01027806|7342379|FG000|STARTED|Overall Study||32
6427921|NCT01027806|7342380|FG001|STARTED|Overall Study||32
6427922|NCT01027806|7342379|FG000|COMPLETED|Overall Study||28
6427923|NCT01027806|7342380|FG001|COMPLETED|Overall Study||29
6427924|NCT01027806|7342379|FG000|NOT COMPLETED|Overall Study||4
6427925|NCT01027806|7342380|FG001|NOT COMPLETED|Overall Study||3
6427926|NCT01027819|7342388|FG000|STARTED|Overall Study||40
6427927|NCT01027819|7342389|FG001|STARTED|Overall Study||40
6427928|NCT01027819|7342388|FG000|COMPLETED|Overall Study||40
6427929|NCT01027819|7342389|FG001|COMPLETED|Overall Study||40
6427930|NCT01027819|7342388|FG000|NOT COMPLETED|Overall Study||0
6427931|NCT01027819|7342389|FG001|NOT COMPLETED|Overall Study||0
6427932|NCT01027845|7342397|FG000|STARTED|Primary Vaccination Phase||237
6427933|NCT01027845|7342398|FG001|STARTED|Primary Vaccination Phase||123
6427934|NCT01027845|7342399|FG002|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
6427935|NCT01027845|7342400|FG003|STARTED|Primary Vaccination Phase|Subjects were not yet assigned to this group at the time of the primary vaccination|0
6427936|NCT01027845|7342397|FG000|COMPLETED|Primary Vaccination Phase||233
6427937|NCT01027845|7342398|FG001|COMPLETED|Primary Vaccination Phase||122
6427938|NCT01027845|7342399|FG002|COMPLETED|Primary Vaccination Phase||0
6427939|NCT01027845|7342400|FG003|COMPLETED|Primary Vaccination Phase||0
6427940|NCT01027845|7342397|FG000|NOT COMPLETED|Primary Vaccination Phase||4
6652208|NCT02426580|7581778|FG001|STARTED|Overall Study|January 2014|70
6652209|NCT02426580|7581777|FG000|COMPLETED|Overall Study|the last patient enrolled in this group in April 2017|59
6652210|NCT02426580|7581778|FG001|COMPLETED|Overall Study|the last patient in this group enrolled in April 2017|54
6427941|NCT01027845|7342398|FG001|NOT COMPLETED|Primary Vaccination Phase||1
6427942|NCT01027845|7342399|FG002|NOT COMPLETED|Primary Vaccination Phase||0
6427943|NCT01027845|7342400|FG003|NOT COMPLETED|Primary Vaccination Phase||0
6427944|NCT01027845|7342397|FG000|STARTED|Booster Vaccination Phase||228
6427945|NCT01027845|7342398|FG001|STARTED|Booster Vaccination Phase|Subjects from this group were assigned to DTPa+Prevenar&DTPa-No Prevenar Groups in the booster phase|0
6427946|NCT01027845|7342399|FG002|STARTED|Booster Vaccination Phase||119
6427947|NCT01027845|7342400|FG003|STARTED|Booster Vaccination Phase||1
6427948|NCT01027845|7342397|FG000|COMPLETED|Booster Vaccination Phase||226
6427949|NCT01027845|7342398|FG001|COMPLETED|Booster Vaccination Phase||0
6427950|NCT01027845|7342399|FG002|COMPLETED|Booster Vaccination Phase||119
6427951|NCT01027845|7342400|FG003|COMPLETED|Booster Vaccination Phase||1
6427952|NCT01027845|7342397|FG000|NOT COMPLETED|Booster Vaccination Phase||2
6427953|NCT01027845|7342398|FG001|NOT COMPLETED|Booster Vaccination Phase||0
6427954|NCT01027845|7342399|FG002|NOT COMPLETED|Booster Vaccination Phase||0
6427955|NCT01027845|7342400|FG003|NOT COMPLETED|Booster Vaccination Phase||0
6427956|NCT01027871|7342412|FG000|STARTED|Overall Study||93
6427957|NCT01027871|7342413|FG001|STARTED|Overall Study||98
6427958|NCT01027871|7342414|FG002|STARTED|Overall Study||98
6427959|NCT01027871|7342412|FG000|Received at Least One Dose of Study Drug|Overall Study||93
6427960|NCT01027871|7342413|FG001|Received at Least One Dose of Study Drug|Overall Study||98
6427961|NCT01027871|7342414|FG002|Received at Least One Dose of Study Drug|Overall Study||97
6427962|NCT01027871|7342412|FG000|COMPLETED|Overall Study||91
6427963|NCT01027871|7342413|FG001|COMPLETED|Overall Study||85
6427964|NCT01027871|7342414|FG002|COMPLETED|Overall Study||91
6427965|NCT01027871|7342412|FG000|NOT COMPLETED|Overall Study||2
6427966|NCT01027871|7342413|FG001|NOT COMPLETED|Overall Study||13
6427967|NCT01027871|7342414|FG002|NOT COMPLETED|Overall Study||7
6427968|NCT01027884|7342429|FG000|STARTED|Overall Study||34
6427969|NCT01027884|7342430|FG001|STARTED|Overall Study||32
6427970|NCT01027884|7342429|FG000|COMPLETED|Overall Study||30
6427971|NCT01027884|7342430|FG001|COMPLETED|Overall Study||25
6427972|NCT01027884|7342429|FG000|NOT COMPLETED|Overall Study||4
6427973|NCT01027884|7342430|FG001|NOT COMPLETED|Overall Study||7
6427974|NCT01027897|7342438|FG000|STARTED|Overall Study||30
6427975|NCT01027897|7342438|FG000|COMPLETED|Overall Study||28
6427976|NCT01027897|7342438|FG000|NOT COMPLETED|Overall Study||2
6499519|NCT01419171|7418237|FG000|STARTED|Overall Study||328
6499520|NCT01419171|7418237|FG000|COMPLETED|Overall Study||328
6499521|NCT01419171|7418237|FG000|NOT COMPLETED|Overall Study||0
6499522|NCT01419184|7418243|FG000|STARTED|Overall Study||128
6552022|NCT01735201|7474417|FG005|NOT COMPLETED|Overall Study||5
6499523|NCT01419184|7418244|FG001|STARTED|Overall Study||121
6499524|NCT01419184|7418243|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
6499525|NCT01419184|7418244|FG001|Received at Least 1 Dose of Study Drug|Overall Study||106
6499526|NCT01419184|7418243|FG000|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
6499527|NCT01419184|7418244|FG001|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
6499528|NCT01419184|7418243|FG000|NOT COMPLETED|Overall Study||10
6499529|NCT01419184|7418244|FG001|NOT COMPLETED|Overall Study||15
6499530|NCT01419197|7418252|FG000|STARTED|Overall Study||404
6499531|NCT01419197|7418253|FG001|STARTED|Overall Study||198
6499532|NCT01419197|7418252|FG000|Switched to Trastuzumab Emtansine|Overall Study||0
6499533|NCT01419197|7418253|FG001|Switched to Trastuzumab Emtansine|Overall Study||94
6499534|NCT01419197|7418252|FG000|COMPLETED|Overall Study||0
6499535|NCT01419197|7418253|FG001|COMPLETED|Overall Study||0
6499536|NCT01419197|7418252|FG000|NOT COMPLETED|Overall Study||404
6499537|NCT01419197|7418253|FG001|NOT COMPLETED|Overall Study||198
6499538|NCT01419236|7418262|FG000|STARTED|Overall Study||36
6499539|NCT01419236|7418263|FG001|STARTED|Overall Study||40
6499540|NCT01419236|7418262|FG000|Received at Least 1 Dose of Study Drug|Overall Study||35
6499541|NCT01419236|7418263|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
6499542|NCT01419236|7418262|FG000|COMPLETED|Overall Study||31
6499543|NCT01419236|7418263|FG001|COMPLETED|Overall Study||35
6499544|NCT01419236|7418262|FG000|NOT COMPLETED|Overall Study||5
6499545|NCT01419236|7418263|FG001|NOT COMPLETED|Overall Study||5
6499546|NCT01419249|7418271|FG000|STARTED|Overall Study||318
6499547|NCT01419249|7418272|FG001|STARTED|Overall Study||140
6499548|NCT01419249|7418271|FG000|COMPLETED|Overall Study||318
6499549|NCT01419249|7418272|FG001|COMPLETED|Overall Study||140
6499550|NCT01419249|7418271|FG000|NOT COMPLETED|Overall Study||0
6499551|NCT01419249|7418272|FG001|NOT COMPLETED|Overall Study||0
6499552|NCT01419275|7418279|FG000|STARTED|Overall Study||126
6499553|NCT01419275|7418279|FG000|COMPLETED|Overall Study||126
6499554|NCT01419275|7418279|FG000|NOT COMPLETED|Overall Study||0
6499555|NCT01419314|7418285|FG000|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
6499556|NCT01419314|7418286|FG001|STARTED|Start of Study|No comfort issues reported.|22
6499557|NCT01419314|7418285|FG000|COMPLETED|Start of Study||23
6499558|NCT01419314|7418286|FG001|COMPLETED|Start of Study||22
6499559|NCT01419314|7418285|FG000|NOT COMPLETED|Start of Study||0
6499560|NCT01419314|7418286|FG001|NOT COMPLETED|Start of Study||0
6499561|NCT01419314|7418285|FG000|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
6499562|NCT01419314|7418286|FG001|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
6499563|NCT01419314|7418285|FG000|COMPLETED|Follow-up at Week 3 of the Trial||17
6499564|NCT01419314|7418286|FG001|COMPLETED|Follow-up at Week 3 of the Trial||21
6499565|NCT01419314|7418285|FG000|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
6499566|NCT01419314|7418286|FG001|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
6499567|NCT01419314|7418285|FG000|STARTED|Follow-up at Week 6 of the Trial||17
6499568|NCT01419314|7418286|FG001|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
6499569|NCT01419314|7418285|FG000|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
6499570|NCT01419314|7418286|FG001|COMPLETED|Follow-up at Week 6 of the Trial||19
6499571|NCT01419314|7418285|FG000|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
6499572|NCT01419314|7418286|FG001|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
6499573|NCT01419535|7418298|FG000|STARTED|Overall Study||9
6499574|NCT01419535|7418299|FG001|STARTED|Overall Study||10
6499575|NCT01419535|7418298|FG000|COMPLETED|Overall Study||8
6499576|NCT01419535|7418299|FG001|COMPLETED|Overall Study||8
6499577|NCT01419535|7418298|FG000|NOT COMPLETED|Overall Study||1
6499578|NCT01419535|7418299|FG001|NOT COMPLETED|Overall Study||2
6499579|NCT01419626|7418308|FG000|STARTED|Overall Study||46
6499580|NCT01419626|7418309|FG001|STARTED|Overall Study||47
6499581|NCT01419626|7418310|FG002|STARTED|Overall Study||47
6499582|NCT01419626|7418308|FG000|COMPLETED|Overall Study||42
6499583|NCT01419626|7418309|FG001|COMPLETED|Overall Study||44
6499584|NCT01419626|7418310|FG002|COMPLETED|Overall Study||44
6552023|NCT01735201|7474418|FG006|NOT COMPLETED|Overall Study||3
6427977|NCT01027910|7342444|FG000|STARTED|Overall Study||6
6427978|NCT01027910|7342445|FG001|STARTED|Overall Study||14
6427979|NCT01027910|7342444|FG000|COMPLETED|Overall Study||6
6427980|NCT01027910|7342445|FG001|COMPLETED|Overall Study||14
6427981|NCT01027910|7342444|FG000|NOT COMPLETED|Overall Study||0
6427982|NCT01027910|7342445|FG001|NOT COMPLETED|Overall Study||0
6427983|NCT01027949|7342453|FG000|STARTED|Overall Study||894
6427984|NCT01027949|7342453|FG000|COMPLETED|Overall Study||208
6427985|NCT01027949|7342453|FG000|NOT COMPLETED|Overall Study||686
6427986|NCT01028014|7342463|FG000|STARTED|Overall Study||10
6427987|NCT01028014|7342464|FG001|STARTED|Overall Study||10
6427988|NCT01028014|7342465|FG002|STARTED|Overall Study||10
6427989|NCT01028014|7342466|FG003|STARTED|Overall Study||10
6427990|NCT01028014|7342467|FG004|STARTED|Overall Study||10
6427991|NCT01028014|7342468|FG005|STARTED|Overall Study||6
6427992|NCT01028014|7342463|FG000|COMPLETED|Overall Study||9
6427993|NCT01028014|7342464|FG001|COMPLETED|Overall Study||8
6427994|NCT01028014|7342465|FG002|COMPLETED|Overall Study||10
6427995|NCT01028014|7342466|FG003|COMPLETED|Overall Study||9
6427996|NCT01028014|7342467|FG004|COMPLETED|Overall Study||9
6427997|NCT01028014|7342468|FG005|COMPLETED|Overall Study||4
6427998|NCT01028014|7342463|FG000|NOT COMPLETED|Overall Study||1
6427999|NCT01028014|7342464|FG001|NOT COMPLETED|Overall Study||2
6428000|NCT01028014|7342465|FG002|NOT COMPLETED|Overall Study||0
6428001|NCT01028014|7342466|FG003|NOT COMPLETED|Overall Study||1
6428002|NCT01028014|7342467|FG004|NOT COMPLETED|Overall Study||1
6428003|NCT01028014|7342468|FG005|NOT COMPLETED|Overall Study||2
6428004|NCT01028027|7342484|FG000|STARTED|Overall Study||180
6428005|NCT01028027|7342485|FG001|STARTED|Overall Study||177
6428006|NCT01028027|7342484|FG000|COMPLETED|Overall Study||164
6552024|NCT01735201|7474419|FG007|NOT COMPLETED|Overall Study||2
6552025|NCT01735214|7474437|FG000|STARTED|Overall Study||358
6552026|NCT01735214|7474437|FG000|COMPLETED|Overall Study||358
6552027|NCT01735214|7474437|FG000|NOT COMPLETED|Overall Study||0
6552028|NCT01735279|7474443|FG000|STARTED|Overall Study||29
6552029|NCT01735279|7474444|FG001|STARTED|Overall Study||29
6552030|NCT01735279|7474443|FG000|COMPLETED|Overall Study||18
6552031|NCT01735279|7474444|FG001|COMPLETED|Overall Study||21
6652211|NCT02426580|7581777|FG000|NOT COMPLETED|Overall Study||11
6652212|NCT02426580|7581778|FG001|NOT COMPLETED|Overall Study||16
6652213|NCT02426658|7581784|FG000|STARTED|Overall Study||16
6652214|NCT02426658|7581784|FG000|COMPLETED|Overall Study||13
6428007|NCT01028027|7342485|FG001|COMPLETED|Overall Study||164
6428008|NCT01028027|7342484|FG000|NOT COMPLETED|Overall Study||16
6428009|NCT01028027|7342485|FG001|NOT COMPLETED|Overall Study||13
6428010|NCT01028053|7342491|FG000|STARTED|Overall Study||365
6428011|NCT01028053|7342491|FG000|COMPLETED|Overall Study||232
6428012|NCT01028053|7342491|FG000|NOT COMPLETED|Overall Study||133
6428013|NCT01028131|7342501|FG000|STARTED|Overall Study||26
6428014|NCT01028131|7342502|FG001|STARTED|Overall Study||26
6428015|NCT01028131|7342503|FG002|STARTED|Overall Study||28
6428016|NCT01028131|7342504|FG003|STARTED|Overall Study||30
6428017|NCT01028131|7342501|FG000|Completed Intervention/Control Session|Overall Study||26
6428018|NCT01028131|7342502|FG001|Completed Intervention/Control Session|Overall Study||26
6428019|NCT01028131|7342503|FG002|Completed Intervention/Control Session|Overall Study||28
6428020|NCT01028131|7342504|FG003|Completed Intervention/Control Session|Overall Study||30
6428021|NCT01028131|7342501|FG000|COMPLETED|Overall Study||23
6428022|NCT01028131|7342502|FG001|COMPLETED|Overall Study||23
6428023|NCT01028131|7342503|FG002|COMPLETED|Overall Study||22
6652215|NCT02426658|7581784|FG000|NOT COMPLETED|Overall Study||3
6428024|NCT01028131|7342504|FG003|COMPLETED|Overall Study||26
6428025|NCT01028131|7342501|FG000|NOT COMPLETED|Overall Study||3
6428026|NCT01028131|7342502|FG001|NOT COMPLETED|Overall Study||3
6428027|NCT01028131|7342503|FG002|NOT COMPLETED|Overall Study||6
6428028|NCT01028131|7342504|FG003|NOT COMPLETED|Overall Study||4
6428029|NCT01028222|7342516|FG000|STARTED|Overall Study||42
6428030|NCT01028222|7342517|FG001|STARTED|Overall Study||13
6428031|NCT01028222|7342516|FG000|Cross Over From DTIC to Nilotinib|Overall Study||0
6428032|NCT01028222|7342517|FG001|Cross Over From DTIC to Nilotinib|Overall Study||10
6428033|NCT01028222|7342516|FG000|COMPLETED|Overall Study||4
6428034|NCT01028222|7342517|FG001|COMPLETED|Overall Study||0
6428035|NCT01028222|7342516|FG000|NOT COMPLETED|Overall Study||38
6428036|NCT01028222|7342517|FG001|NOT COMPLETED|Overall Study||13
6428037|NCT01028352|7342524|FG000|STARTED|Overall Study||35
6428038|NCT01028352|7342524|FG000|COMPLETED|Overall Study||29
6428039|NCT01028352|7342524|FG000|NOT COMPLETED|Overall Study||6
6428040|NCT01028378|7342528|FG000|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
6428041|NCT01028378|7342528|FG000|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
6428042|NCT01028378|7342528|FG000|NOT COMPLETED|Overall Study||17
6428043|NCT01028391|7342534|FG000|STARTED|Overall Study||164
6552032|NCT01735279|7474443|FG000|NOT COMPLETED|Overall Study||11
6652216|NCT02426749|7581790|FG000|STARTED|Overall Study||12
6652217|NCT02426749|7581791|FG001|STARTED|Overall Study||10
6428044|NCT01028391|7342535|FG001|STARTED|Overall Study||153
6428045|NCT01028391|7342534|FG000|COMPLETED|Overall Study||150
6552033|NCT01735279|7474444|FG001|NOT COMPLETED|Overall Study||8
6652218|NCT02426749|7581790|FG000|COMPLETED|Overall Study||9
6652219|NCT02426749|7581791|FG001|COMPLETED|Overall Study||9
6652220|NCT02426749|7581790|FG000|NOT COMPLETED|Overall Study||3
6652221|NCT02426749|7581791|FG001|NOT COMPLETED|Overall Study||1
6652222|NCT02426918|7581802|FG000|STARTED|Overall Study||110
6428046|NCT01028391|7342535|FG001|COMPLETED|Overall Study||142
6428047|NCT01028391|7342534|FG000|NOT COMPLETED|Overall Study||14
6428048|NCT01028391|7342535|FG001|NOT COMPLETED|Overall Study||11
6428049|NCT01028560|7342543|FG000|STARTED|Overall Study|4 of 27 withdrew consent immediately after randomization and are excluded from outcome analysis|27
6428050|NCT01028560|7342544|FG001|STARTED|Overall Study|4 of 31 withdrew consent immediately after randomization and are excluded from outcome analysis|31
6428051|NCT01028560|7342543|FG000|Started Study Protocol|Overall Study||23
6428052|NCT01028560|7342544|FG001|Started Study Protocol|Overall Study||27
6428053|NCT01028560|7342543|FG000|COMPLETED|Overall Study||17
6428054|NCT01028560|7342544|FG001|COMPLETED|Overall Study||13
6428055|NCT01028560|7342543|FG000|NOT COMPLETED|Overall Study||10
6428056|NCT01028560|7342544|FG001|NOT COMPLETED|Overall Study||18
6428057|NCT01028651|7342551|FG000|STARTED|Overall Study||13
6428058|NCT01028651|7342551|FG000|COMPLETED|Overall Study||10
6428059|NCT01028651|7342551|FG000|NOT COMPLETED|Overall Study||3
6428060|NCT01028677|7342559|FG000|STARTED|Overall Study||10
6428061|NCT01028677|7342560|FG001|STARTED|Overall Study||7
6428062|NCT01028677|7342559|FG000|COMPLETED|Overall Study||8
6428063|NCT01028677|7342560|FG001|COMPLETED|Overall Study||6
6428064|NCT01028677|7342559|FG000|NOT COMPLETED|Overall Study||2
6428065|NCT01028677|7342560|FG001|NOT COMPLETED|Overall Study||1
6428066|NCT01028820|7342566|FG000|STARTED|Overall Study||13
6428067|NCT01028820|7342566|FG000|COMPLETED|Overall Study||12
6428068|NCT01028820|7342566|FG000|NOT COMPLETED|Overall Study||1
6428069|NCT01028911|7342573|FG000|STARTED|Overall Study||7
6428070|NCT01028911|7342574|FG001|STARTED|Overall Study||2
6428071|NCT01028911|7342573|FG000|COMPLETED|Overall Study||7
6428072|NCT01028911|7342574|FG001|COMPLETED|Overall Study||2
6428073|NCT01028911|7342573|FG000|NOT COMPLETED|Overall Study||0
6428074|NCT01028911|7342574|FG001|NOT COMPLETED|Overall Study||0
6428075|NCT01028937|7342580|FG000|STARTED|Overall Study||6
6428076|NCT01028937|7342580|FG000|COMPLETED|Overall Study||6
6428077|NCT01028937|7342580|FG000|NOT COMPLETED|Overall Study||0
6428078|NCT01029054|7342584|FG000|STARTED|Phase I||4
6428079|NCT01029054|7342585|FG001|STARTED|Phase I||13
6428080|NCT01029054|7342586|FG002|STARTED|Phase I||18
6428081|NCT01029054|7342584|FG000|COMPLETED|Phase I||4
6428082|NCT01029054|7342585|FG001|COMPLETED|Phase I||13
6428083|NCT01029054|7342586|FG002|COMPLETED|Phase I||18
6428084|NCT01029054|7342584|FG000|NOT COMPLETED|Phase I||0
6428085|NCT01029054|7342585|FG001|NOT COMPLETED|Phase I||0
6428086|NCT01029054|7342586|FG002|NOT COMPLETED|Phase I||0
6428087|NCT01029054|7342584|FG000|STARTED|Phase II||0
6428088|NCT01029054|7342585|FG001|STARTED|Phase II||0
6428089|NCT01029054|7342586|FG002|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
6428090|NCT01029054|7342584|FG000|COMPLETED|Phase II||0
6428091|NCT01029054|7342585|FG001|COMPLETED|Phase II||0
6428092|NCT01029054|7342586|FG002|COMPLETED|Phase II||18
6428093|NCT01029054|7342584|FG000|NOT COMPLETED|Phase II||0
6428094|NCT01029054|7342585|FG001|NOT COMPLETED|Phase II||0
6428095|NCT01029054|7342586|FG002|NOT COMPLETED|Phase II||0
6428096|NCT01029262|7342592|FG000|STARTED|Overall Study||79
6428097|NCT01029262|7342593|FG001|STARTED|Overall Study||160
6428098|NCT01029262|7342592|FG000|COMPLETED|Overall Study||0
6428099|NCT01029262|7342593|FG001|COMPLETED|Overall Study||0
6428100|NCT01029262|7342592|FG000|NOT COMPLETED|Overall Study||79
6428101|NCT01029262|7342593|FG001|NOT COMPLETED|Overall Study||160
6428102|NCT01029340|7342609|FG000|STARTED|Part A Treatment Period||14
6428103|NCT01029340|7342610|FG001|STARTED|Part A Treatment Period||14
6428104|NCT01029340|7342611|FG002|STARTED|Part A Treatment Period||0
6428105|NCT01029340|7342612|FG003|STARTED|Part A Treatment Period||0
6428106|NCT01029340|7342613|FG004|STARTED|Part A Treatment Period||0
6428107|NCT01029340|7342614|FG005|STARTED|Part A Treatment Period||0
6428108|NCT01029340|7342609|FG000|Participants Received Treatment|Part A Treatment Period||14
6428109|NCT01029340|7342610|FG001|Participants Received Treatment|Part A Treatment Period||14
6428110|NCT01029340|7342611|FG002|Participants Received Treatment|Part A Treatment Period||0
6428111|NCT01029340|7342612|FG003|Participants Received Treatment|Part A Treatment Period||0
6428112|NCT01029340|7342613|FG004|Participants Received Treatment|Part A Treatment Period||0
6428113|NCT01029340|7342614|FG005|Participants Received Treatment|Part A Treatment Period||0
6428114|NCT01029340|7342609|FG000|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
6428115|NCT01029340|7342610|FG001|Safety Population|Part A Treatment Period||14
6428116|NCT01029340|7342611|FG002|Safety Population|Part A Treatment Period||0
6428117|NCT01029340|7342612|FG003|Safety Population|Part A Treatment Period||0
6428118|NCT01029340|7342613|FG004|Safety Population|Part A Treatment Period||0
6428119|NCT01029340|7342614|FG005|Safety Population|Part A Treatment Period||0
6428120|NCT01029340|7342609|FG000|COMPLETED|Part A Treatment Period||14
6428121|NCT01029340|7342610|FG001|COMPLETED|Part A Treatment Period||14
6428122|NCT01029340|7342611|FG002|COMPLETED|Part A Treatment Period||0
6428123|NCT01029340|7342612|FG003|COMPLETED|Part A Treatment Period||0
6428124|NCT01029340|7342613|FG004|COMPLETED|Part A Treatment Period||0
6428125|NCT01029340|7342614|FG005|COMPLETED|Part A Treatment Period||0
6428126|NCT01029340|7342609|FG000|NOT COMPLETED|Part A Treatment Period||0
6428127|NCT01029340|7342610|FG001|NOT COMPLETED|Part A Treatment Period||0
6428128|NCT01029340|7342611|FG002|NOT COMPLETED|Part A Treatment Period||0
6428129|NCT01029340|7342612|FG003|NOT COMPLETED|Part A Treatment Period||0
6428130|NCT01029340|7342613|FG004|NOT COMPLETED|Part A Treatment Period||0
6428131|NCT01029340|7342614|FG005|NOT COMPLETED|Part A Treatment Period||0
6428132|NCT01029340|7342609|FG000|STARTED|Part A Follow up Period||14
6428133|NCT01029340|7342610|FG001|STARTED|Part A Follow up Period||14
6428134|NCT01029340|7342611|FG002|STARTED|Part A Follow up Period||0
6428135|NCT01029340|7342612|FG003|STARTED|Part A Follow up Period||0
6428136|NCT01029340|7342613|FG004|STARTED|Part A Follow up Period||0
6428137|NCT01029340|7342614|FG005|STARTED|Part A Follow up Period||0
6428138|NCT01029340|7342609|FG000|COMPLETED|Part A Follow up Period||14
6428139|NCT01029340|7342610|FG001|COMPLETED|Part A Follow up Period||14
6428140|NCT01029340|7342611|FG002|COMPLETED|Part A Follow up Period||0
6428141|NCT01029340|7342612|FG003|COMPLETED|Part A Follow up Period||0
6428142|NCT01029340|7342613|FG004|COMPLETED|Part A Follow up Period||0
6428143|NCT01029340|7342614|FG005|COMPLETED|Part A Follow up Period||0
6428144|NCT01029340|7342609|FG000|NOT COMPLETED|Part A Follow up Period||0
6428145|NCT01029340|7342610|FG001|NOT COMPLETED|Part A Follow up Period||0
6428146|NCT01029340|7342611|FG002|NOT COMPLETED|Part A Follow up Period||0
6428147|NCT01029340|7342612|FG003|NOT COMPLETED|Part A Follow up Period||0
6428148|NCT01029340|7342613|FG004|NOT COMPLETED|Part A Follow up Period||0
6428149|NCT01029340|7342614|FG005|NOT COMPLETED|Part A Follow up Period||0
6428150|NCT01029340|7342609|FG000|STARTED|Part B Treatment Period||0
6428151|NCT01029340|7342610|FG001|STARTED|Part B Treatment Period||0
6428152|NCT01029340|7342611|FG002|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
6428153|NCT01029340|7342612|FG003|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
6428154|NCT01029340|7342613|FG004|STARTED|Part B Treatment Period||0
6428155|NCT01029340|7342614|FG005|STARTED|Part B Treatment Period||0
6428156|NCT01029340|7342609|FG000|Participants Received Treatment|Part B Treatment Period||0
6428157|NCT01029340|7342610|FG001|Participants Received Treatment|Part B Treatment Period||0
6428158|NCT01029340|7342611|FG002|Participants Received Treatment|Part B Treatment Period||30
6428159|NCT01029340|7342612|FG003|Participants Received Treatment|Part B Treatment Period||32
6428160|NCT01029340|7342613|FG004|Participants Received Treatment|Part B Treatment Period||0
6428161|NCT01029340|7342614|FG005|Participants Received Treatment|Part B Treatment Period||0
6428162|NCT01029340|7342609|FG000|COMPLETED|Part B Treatment Period||0
6428163|NCT01029340|7342610|FG001|COMPLETED|Part B Treatment Period||0
6428164|NCT01029340|7342611|FG002|COMPLETED|Part B Treatment Period||29
6428165|NCT01029340|7342612|FG003|COMPLETED|Part B Treatment Period||32
6428166|NCT01029340|7342613|FG004|COMPLETED|Part B Treatment Period||0
6428167|NCT01029340|7342614|FG005|COMPLETED|Part B Treatment Period||0
6428168|NCT01029340|7342609|FG000|NOT COMPLETED|Part B Treatment Period||0
6428169|NCT01029340|7342610|FG001|NOT COMPLETED|Part B Treatment Period||0
6428170|NCT01029340|7342611|FG002|NOT COMPLETED|Part B Treatment Period||2
6428171|NCT01029340|7342612|FG003|NOT COMPLETED|Part B Treatment Period||0
6428172|NCT01029340|7342613|FG004|NOT COMPLETED|Part B Treatment Period||0
6428173|NCT01029340|7342614|FG005|NOT COMPLETED|Part B Treatment Period||0
6428174|NCT01029340|7342609|FG000|STARTED|Part B Follow up Period||0
6428175|NCT01029340|7342610|FG001|STARTED|Part B Follow up Period||0
6428176|NCT01029340|7342611|FG002|STARTED|Part B Follow up Period||29
6428177|NCT01029340|7342612|FG003|STARTED|Part B Follow up Period||32
6428178|NCT01029340|7342613|FG004|STARTED|Part B Follow up Period||0
6552034|NCT01735396|7474450|FG000|STARTED|Overall Study||11
6552035|NCT01735396|7474450|FG000|COMPLETED|Overall Study||10
6552036|NCT01735396|7474450|FG000|NOT COMPLETED|Overall Study||1
6552037|NCT01735617|7474454|FG000|STARTED|Overall Study||16
6552038|NCT01735617|7474454|FG000|COMPLETED|Overall Study||16
6552039|NCT01735617|7474454|FG000|NOT COMPLETED|Overall Study||0
6552040|NCT01735630|7474463|FG000|STARTED|Overall Study||175
6552041|NCT01735630|7474464|FG001|STARTED|Overall Study||175
6428179|NCT01029340|7342614|FG005|STARTED|Part B Follow up Period||0
6428180|NCT01029340|7342609|FG000|COMPLETED|Part B Follow up Period||0
6428181|NCT01029340|7342610|FG001|COMPLETED|Part B Follow up Period||0
6428182|NCT01029340|7342611|FG002|COMPLETED|Part B Follow up Period||29
6428183|NCT01029340|7342612|FG003|COMPLETED|Part B Follow up Period||32
6428184|NCT01029340|7342613|FG004|COMPLETED|Part B Follow up Period||0
6428185|NCT01029340|7342614|FG005|COMPLETED|Part B Follow up Period||0
6428186|NCT01029340|7342609|FG000|NOT COMPLETED|Part B Follow up Period||0
6428187|NCT01029340|7342610|FG001|NOT COMPLETED|Part B Follow up Period||0
6428188|NCT01029340|7342611|FG002|NOT COMPLETED|Part B Follow up Period||0
6428189|NCT01029340|7342612|FG003|NOT COMPLETED|Part B Follow up Period||0
6428190|NCT01029340|7342613|FG004|NOT COMPLETED|Part B Follow up Period||0
6428191|NCT01029340|7342614|FG005|NOT COMPLETED|Part B Follow up Period||0
6428192|NCT01029340|7342609|FG000|STARTED|Extension Period||0
6428193|NCT01029340|7342610|FG001|STARTED|Extension Period||0
6428194|NCT01029340|7342611|FG002|STARTED|Extension Period||0
6428195|NCT01029340|7342612|FG003|STARTED|Extension Period||0
6428196|NCT01029340|7342613|FG004|STARTED|Extension Period||0
6428197|NCT01029340|7342614|FG005|STARTED|Extension Period||55
6428198|NCT01029340|7342609|FG000|COMPLETED|Extension Period||0
6428199|NCT01029340|7342610|FG001|COMPLETED|Extension Period||0
6428200|NCT01029340|7342611|FG002|COMPLETED|Extension Period||0
6428201|NCT01029340|7342612|FG003|COMPLETED|Extension Period||0
6428202|NCT01029340|7342613|FG004|COMPLETED|Extension Period||0
6428203|NCT01029340|7342614|FG005|COMPLETED|Extension Period||43
6428204|NCT01029340|7342609|FG000|NOT COMPLETED|Extension Period||0
6428205|NCT01029340|7342610|FG001|NOT COMPLETED|Extension Period||0
6552042|NCT01735630|7474463|FG000|COMPLETED|Overall Study||157
6552043|NCT01735630|7474464|FG001|COMPLETED|Overall Study||157
6428206|NCT01029340|7342611|FG002|NOT COMPLETED|Extension Period||0
6428207|NCT01029340|7342612|FG003|NOT COMPLETED|Extension Period||0
6428208|NCT01029340|7342613|FG004|NOT COMPLETED|Extension Period||0
6428209|NCT01029340|7342614|FG005|NOT COMPLETED|Extension Period||12
6428210|NCT01029340|7342609|FG000|STARTED|Part C Treatment Period||0
6428211|NCT01029340|7342610|FG001|STARTED|Part C Treatment Period||0
6428212|NCT01029340|7342611|FG002|STARTED|Part C Treatment Period||0
6428213|NCT01029340|7342612|FG003|STARTED|Part C Treatment Period||0
6428214|NCT01029340|7342613|FG004|STARTED|Part C Treatment Period||5
6428215|NCT01029340|7342614|FG005|STARTED|Part C Treatment Period||0
6428216|NCT01029340|7342609|FG000|Participants Received Treatment|Part C Treatment Period||0
6428217|NCT01029340|7342610|FG001|Participants Received Treatment|Part C Treatment Period||0
6428218|NCT01029340|7342611|FG002|Participants Received Treatment|Part C Treatment Period||0
6428219|NCT01029340|7342612|FG003|Participants Received Treatment|Part C Treatment Period||0
6428220|NCT01029340|7342613|FG004|Participants Received Treatment|Part C Treatment Period||5
6428221|NCT01029340|7342614|FG005|Participants Received Treatment|Part C Treatment Period||0
6428222|NCT01029340|7342609|FG000|COMPLETED|Part C Treatment Period||0
6428223|NCT01029340|7342610|FG001|COMPLETED|Part C Treatment Period||0
6428224|NCT01029340|7342611|FG002|COMPLETED|Part C Treatment Period||0
6428225|NCT01029340|7342612|FG003|COMPLETED|Part C Treatment Period||0
6428226|NCT01029340|7342613|FG004|COMPLETED|Part C Treatment Period||5
6428227|NCT01029340|7342614|FG005|COMPLETED|Part C Treatment Period||0
6428228|NCT01029340|7342609|FG000|NOT COMPLETED|Part C Treatment Period||0
6428229|NCT01029340|7342610|FG001|NOT COMPLETED|Part C Treatment Period||0
6428230|NCT01029340|7342611|FG002|NOT COMPLETED|Part C Treatment Period||0
6428231|NCT01029340|7342612|FG003|NOT COMPLETED|Part C Treatment Period||0
6428232|NCT01029340|7342613|FG004|NOT COMPLETED|Part C Treatment Period||0
6428233|NCT01029340|7342614|FG005|NOT COMPLETED|Part C Treatment Period||0
6428234|NCT01029340|7342609|FG000|STARTED|Part C Follow up Period||0
6428235|NCT01029340|7342610|FG001|STARTED|Part C Follow up Period||0
6428236|NCT01029340|7342611|FG002|STARTED|Part C Follow up Period||0
6428237|NCT01029340|7342612|FG003|STARTED|Part C Follow up Period||0
6428238|NCT01029340|7342613|FG004|STARTED|Part C Follow up Period||5
6428239|NCT01029340|7342614|FG005|STARTED|Part C Follow up Period||0
6428240|NCT01029340|7342609|FG000|COMPLETED|Part C Follow up Period||0
6428241|NCT01029340|7342610|FG001|COMPLETED|Part C Follow up Period||0
6428242|NCT01029340|7342611|FG002|COMPLETED|Part C Follow up Period||0
6428243|NCT01029340|7342612|FG003|COMPLETED|Part C Follow up Period||0
6428244|NCT01029340|7342613|FG004|COMPLETED|Part C Follow up Period||5
6428245|NCT01029340|7342614|FG005|COMPLETED|Part C Follow up Period||0
6428246|NCT01029340|7342609|FG000|NOT COMPLETED|Part C Follow up Period||0
6428247|NCT01029340|7342610|FG001|NOT COMPLETED|Part C Follow up Period||0
6428248|NCT01029340|7342611|FG002|NOT COMPLETED|Part C Follow up Period||0
6428249|NCT01029340|7342612|FG003|NOT COMPLETED|Part C Follow up Period||0
6428250|NCT01029340|7342613|FG004|NOT COMPLETED|Part C Follow up Period||0
6428251|NCT01029340|7342614|FG005|NOT COMPLETED|Part C Follow up Period||0
6428252|NCT01029353|7342631|FG000|STARTED|Overall Study||148
6428253|NCT01029353|7342632|FG001|STARTED|Overall Study||162
6428254|NCT01029353|7342633|FG002|STARTED|Overall Study||100
6428255|NCT01029353|7342634|FG003|STARTED|Overall Study||119
6428256|NCT01029353|7342631|FG000|Included in ITT Analysis|Overall Study||146
6428257|NCT01029353|7342632|FG001|Included in ITT Analysis|Overall Study||162
6428258|NCT01029353|7342633|FG002|Included in ITT Analysis|Overall Study||100
6428259|NCT01029353|7342634|FG003|Included in ITT Analysis|Overall Study||119
6428260|NCT01029353|7342631|FG000|Reached Network Status|Overall Study||146
6428261|NCT01029353|7342632|FG001|Reached Network Status|Overall Study||162
6428262|NCT01029353|7342633|FG002|Reached Network Status|Overall Study||100
6428263|NCT01029353|7342634|FG003|Reached Network Status|Overall Study||119
6428264|NCT01029353|7342631|FG000|COMPLETED|Overall Study||141
6652223|NCT02426918|7581803|FG001|STARTED|Overall Study||109
6652224|NCT02426918|7581804|FG002|STARTED|Overall Study||111
6652225|NCT02426918|7581802|FG000|Safety Population|Overall Study||110
6652226|NCT02426918|7581803|FG001|Safety Population|Overall Study||107
6428265|NCT01029353|7342632|FG001|COMPLETED|Overall Study||154
6428266|NCT01029353|7342633|FG002|COMPLETED|Overall Study||93
6428267|NCT01029353|7342634|FG003|COMPLETED|Overall Study||115
6428268|NCT01029353|7342631|FG000|NOT COMPLETED|Overall Study||7
6428269|NCT01029353|7342632|FG001|NOT COMPLETED|Overall Study||8
6428270|NCT01029353|7342633|FG002|NOT COMPLETED|Overall Study||7
6428271|NCT01029353|7342634|FG003|NOT COMPLETED|Overall Study||4
6428272|NCT01029366|7342646|FG000|STARTED|Overall Study||18
6428273|NCT01029366|7342647|FG001|STARTED|Overall Study||8
6428274|NCT01029366|7342646|FG000|COMPLETED|Overall Study||14
6428275|NCT01029366|7342647|FG001|COMPLETED|Overall Study||6
6428276|NCT01029366|7342646|FG000|NOT COMPLETED|Overall Study||4
6428277|NCT01029366|7342647|FG001|NOT COMPLETED|Overall Study||2
6428278|NCT01029392|7342656|FG000|STARTED|Overall Study||37
6428279|NCT01029392|7342657|FG001|STARTED|Overall Study||38
6428280|NCT01029392|7342656|FG000|COMPLETED|Overall Study||17
6428281|NCT01029392|7342657|FG001|COMPLETED|Overall Study||27
6428282|NCT01029392|7342656|FG000|NOT COMPLETED|Overall Study||20
6652227|NCT02426918|7581804|FG002|Safety Population|Overall Study||107
6428283|NCT01029392|7342657|FG001|NOT COMPLETED|Overall Study||11
6428284|NCT01029405|7342669|FG000|STARTED|Overall Study||36
6428285|NCT01029405|7342670|FG001|STARTED|Overall Study||37
6428286|NCT01029405|7342671|FG002|STARTED|Overall Study||35
6652228|NCT02426918|7581802|FG000|COMPLETED|Overall Study||93
6652229|NCT02426918|7581803|FG001|COMPLETED|Overall Study||90
6652230|NCT02426918|7581804|FG002|COMPLETED|Overall Study||97
6652231|NCT02426918|7581802|FG000|NOT COMPLETED|Overall Study||17
6652232|NCT02426918|7581803|FG001|NOT COMPLETED|Overall Study||19
6428287|NCT01029405|7342672|FG003|STARTED|Overall Study||37
6428288|NCT01029405|7342669|FG000|COMPLETED|Overall Study||34
6428289|NCT01029405|7342670|FG001|COMPLETED|Overall Study||34
6428290|NCT01029405|7342671|FG002|COMPLETED|Overall Study||31
6428291|NCT01029405|7342672|FG003|COMPLETED|Overall Study||32
6428292|NCT01029405|7342669|FG000|NOT COMPLETED|Overall Study||2
6428293|NCT01029405|7342670|FG001|NOT COMPLETED|Overall Study||3
6428294|NCT01029405|7342671|FG002|NOT COMPLETED|Overall Study||4
6428295|NCT01029405|7342672|FG003|NOT COMPLETED|Overall Study||5
6428296|NCT01029535|7342682|FG000|STARTED|Overall Study||103
6428297|NCT01029535|7342682|FG000|COMPLETED|Overall Study||72
6428298|NCT01029535|7342682|FG000|NOT COMPLETED|Overall Study||31
6428299|NCT01029587|7342687|FG000|STARTED|Overall Study||1
6428300|NCT01029587|7342687|FG000|COMPLETED|Overall Study||1
6428301|NCT01029587|7342687|FG000|NOT COMPLETED|Overall Study||0
6428302|NCT01029652|7342693|FG000|STARTED|Core Study (0-12 Weeks)||115
6428303|NCT01029652|7342694|FG001|STARTED|Core Study (0-12 Weeks)||115
6428304|NCT01029652|7342693|FG000|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
6428305|NCT01029652|7342694|FG001|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
6428306|NCT01029652|7342693|FG000|COMPLETED|Core Study (0-12 Weeks)||109
6428307|NCT01029652|7342694|FG001|COMPLETED|Core Study (0-12 Weeks)||105
6428308|NCT01029652|7342693|FG000|NOT COMPLETED|Core Study (0-12 Weeks)||6
6428309|NCT01029652|7342694|FG001|NOT COMPLETED|Core Study (0-12 Weeks)||10
6428310|NCT01029652|7342693|FG000|STARTED|Extension Study 1 (12-24 Weeks)||90
6428311|NCT01029652|7342694|FG001|STARTED|Extension Study 1 (12-24 Weeks)||85
6428312|NCT01029652|7342693|FG000|COMPLETED|Extension Study 1 (12-24 Weeks)||87
6428313|NCT01029652|7342694|FG001|COMPLETED|Extension Study 1 (12-24 Weeks)||80
6428314|NCT01029652|7342693|FG000|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
6428315|NCT01029652|7342694|FG001|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
6428316|NCT01029652|7342693|FG000|STARTED|Extension Study 2 (25-72 Weeks)||69
6428317|NCT01029652|7342694|FG001|STARTED|Extension Study 2 (25-72 Weeks)||66
6428318|NCT01029652|7342693|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
6428319|NCT01029652|7342694|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
6428320|NCT01029652|7342693|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||68
6428321|NCT01029652|7342694|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||63
6428322|NCT01029652|7342693|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
6428323|NCT01029652|7342694|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
6428324|NCT01029691|7342721|FG000|STARTED|APAP Initiation to Week 1 or Delivery||20
6428325|NCT01029691|7342722|FG001|STARTED|APAP Initiation to Week 1 or Delivery|4 delivered before APAP initiation 7 elected not to have APAP following baseline study|27
6428326|NCT01029691|7342723|FG002|STARTED|APAP Initiation to Week 1 or Delivery||77
6428327|NCT01029691|7342721|FG000|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||20
6428328|NCT01029691|7342722|FG001|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||23
6428329|NCT01029691|7342723|FG002|Baseline Sleep Study|APAP Initiation to Week 1 or Delivery||77
6428330|NCT01029691|7342721|FG000|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||20
6428331|NCT01029691|7342722|FG001|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||16
6428332|NCT01029691|7342723|FG002|Began Actual APAP Use|APAP Initiation to Week 1 or Delivery||77
6428333|NCT01029691|7342721|FG000|COMPLETED|APAP Initiation to Week 1 or Delivery||20
6428334|NCT01029691|7342722|FG001|COMPLETED|APAP Initiation to Week 1 or Delivery||16
6428335|NCT01029691|7342723|FG002|COMPLETED|APAP Initiation to Week 1 or Delivery||77
6428336|NCT01029691|7342721|FG000|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
6428337|NCT01029691|7342722|FG001|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||11
6428338|NCT01029691|7342723|FG002|NOT COMPLETED|APAP Initiation to Week 1 or Delivery||0
6428339|NCT01029691|7342721|FG000|STARTED|Continued APAP to Delivery||20
6552044|NCT01735630|7474463|FG000|NOT COMPLETED|Overall Study||18
6552045|NCT01735630|7474464|FG001|NOT COMPLETED|Overall Study||18
6428340|NCT01029691|7342722|FG001|STARTED|Continued APAP to Delivery||16
6428341|NCT01029691|7342723|FG002|STARTED|Continued APAP to Delivery||77
6428342|NCT01029691|7342721|FG000|COMPLETED|Continued APAP to Delivery||20
6428343|NCT01029691|7342722|FG001|COMPLETED|Continued APAP to Delivery||16
6428344|NCT01029691|7342723|FG002|COMPLETED|Continued APAP to Delivery||76
6428345|NCT01029691|7342721|FG000|NOT COMPLETED|Continued APAP to Delivery||0
6428346|NCT01029691|7342722|FG001|NOT COMPLETED|Continued APAP to Delivery||0
6428347|NCT01029691|7342723|FG002|NOT COMPLETED|Continued APAP to Delivery||1
6428348|NCT01029704|7342741|FG000|STARTED|Overall Study||5
6428349|NCT01029704|7342742|FG001|STARTED|Overall Study||5
6428350|NCT01029704|7342743|FG002|STARTED|Overall Study||5
6428351|NCT01029704|7342744|FG003|STARTED|Overall Study||5
6428352|NCT01029704|7342745|FG004|STARTED|Overall Study||28
6428353|NCT01029704|7342746|FG005|STARTED|Overall Study||24
6428354|NCT01029704|7342747|FG006|STARTED|Overall Study||23
6552046|NCT01735877|7474472|FG000|STARTED|Overall Study||27
6552047|NCT01735877|7474473|FG001|STARTED|Overall Study||21
6552048|NCT01735877|7474472|FG000|COMPLETED|Overall Study||26
6552049|NCT01735877|7474473|FG001|COMPLETED|Overall Study||21
6652233|NCT02426918|7581804|FG002|NOT COMPLETED|Overall Study||14
6428355|NCT01029704|7342748|FG007|STARTED|Overall Study||28
6428356|NCT01029704|7342749|FG008|STARTED|Overall Study||26
6428357|NCT01029704|7342741|FG000|COMPLETED|Overall Study||5
6428358|NCT01029704|7342742|FG001|COMPLETED|Overall Study||5
6428359|NCT01029704|7342743|FG002|COMPLETED|Overall Study||5
6428360|NCT01029704|7342744|FG003|COMPLETED|Overall Study||5
6428361|NCT01029704|7342745|FG004|COMPLETED|Overall Study||23
6428362|NCT01029704|7342746|FG005|COMPLETED|Overall Study||20
6428363|NCT01029704|7342747|FG006|COMPLETED|Overall Study||19
6428364|NCT01029704|7342748|FG007|COMPLETED|Overall Study||22
6428365|NCT01029704|7342749|FG008|COMPLETED|Overall Study||25
6428366|NCT01029704|7342741|FG000|NOT COMPLETED|Overall Study||0
6428367|NCT01029704|7342742|FG001|NOT COMPLETED|Overall Study||0
6428368|NCT01029704|7342743|FG002|NOT COMPLETED|Overall Study||0
6428369|NCT01029704|7342744|FG003|NOT COMPLETED|Overall Study||0
6428370|NCT01029704|7342745|FG004|NOT COMPLETED|Overall Study||5
6428371|NCT01029704|7342746|FG005|NOT COMPLETED|Overall Study||4
6428372|NCT01029704|7342747|FG006|NOT COMPLETED|Overall Study||4
6428373|NCT01029704|7342748|FG007|NOT COMPLETED|Overall Study||6
6428374|NCT01029704|7342749|FG008|NOT COMPLETED|Overall Study||1
6428375|NCT01029730|7342769|FG000|STARTED|Combination Therapy||55
6428376|NCT01029730|7342769|FG000|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
6428377|NCT01029730|7342769|FG000|NOT COMPLETED|Combination Therapy||16
6428378|NCT01029730|7342769|FG000|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
6428379|NCT01029730|7342769|FG000|COMPLETED|Maintenance Therapy||14
6428380|NCT01029730|7342769|FG000|NOT COMPLETED|Maintenance Therapy||23
6428381|NCT01029782|7342775|FG000|STARTED|Overall Study||102
6428382|NCT01029782|7342776|FG001|STARTED|Overall Study||104
6428383|NCT01029782|7342775|FG000|COMPLETED|Overall Study||99
6428384|NCT01029782|7342776|FG001|COMPLETED|Overall Study||96
6428385|NCT01029782|7342775|FG000|NOT COMPLETED|Overall Study||3
6428386|NCT01029782|7342776|FG001|NOT COMPLETED|Overall Study||8
6428387|NCT01029795|7342784|FG000|STARTED|Overall Study||16
6428388|NCT01029795|7342785|FG001|STARTED|Overall Study||22
6428389|NCT01029795|7342784|FG000|COMPLETED|Overall Study||0
6428390|NCT01029795|7342785|FG001|COMPLETED|Overall Study||0
6428391|NCT01029795|7342784|FG000|NOT COMPLETED|Overall Study||16
6428392|NCT01029795|7342785|FG001|NOT COMPLETED|Overall Study||22
6428393|NCT01029886|7342793|FG000|STARTED|Overall Study||461
6428394|NCT01029886|7342794|FG001|STARTED|Overall Study||451
6428395|NCT01029886|7342793|FG000|Intent to Treat (ITT)|Overall Study||461
6428396|NCT01029886|7342794|FG001|Intent to Treat (ITT)|Overall Study||450
6428397|NCT01029886|7342793|FG000|COMPLETED|Overall Study||400
6428398|NCT01029886|7342794|FG001|COMPLETED|Overall Study||391
6428399|NCT01029886|7342793|FG000|NOT COMPLETED|Overall Study||61
6428400|NCT01029886|7342794|FG001|NOT COMPLETED|Overall Study||60
6428401|NCT01029912|7342806|FG000|STARTED|Overall Study||14
6428402|NCT01029912|7342807|FG001|STARTED|Overall Study||12
6428403|NCT01029912|7342806|FG000|COMPLETED|Overall Study||12
6428404|NCT01029912|7342807|FG001|COMPLETED|Overall Study||12
6428405|NCT01029912|7342806|FG000|NOT COMPLETED|Overall Study||2
6428406|NCT01029912|7342807|FG001|NOT COMPLETED|Overall Study||0
6428407|NCT01029925|7342813|FG000|STARTED|Completion of Cycle 1 (28 Days)||7
6428408|NCT01029925|7342813|FG000|COMPLETED|Completion of Cycle 1 (28 Days)||3
6428409|NCT01029925|7342813|FG000|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
6428410|NCT01029925|7342813|FG000|STARTED|Completion of Cycle 2 (56 Days)||3
6428411|NCT01029925|7342813|FG000|COMPLETED|Completion of Cycle 2 (56 Days)||2
6428412|NCT01029925|7342813|FG000|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
6428413|NCT01030133|7342819|FG000|STARTED|Overall Study||14
6428414|NCT01030133|7342820|FG001|STARTED|Overall Study||14
6428415|NCT01030133|7342819|FG000|COMPLETED|Overall Study||12
6428416|NCT01030133|7342820|FG001|COMPLETED|Overall Study||12
6428417|NCT01030133|7342819|FG000|NOT COMPLETED|Overall Study||2
6428418|NCT01030133|7342820|FG001|NOT COMPLETED|Overall Study||2
6428419|NCT01030289|7342830|FG000|STARTED|Overall Study||9
6428420|NCT01030289|7342831|FG001|STARTED|Overall Study||10
6428421|NCT01030289|7342830|FG000|COMPLETED|Overall Study||9
6428422|NCT01030289|7342831|FG001|COMPLETED|Overall Study||10
6428423|NCT01030289|7342830|FG000|NOT COMPLETED|Overall Study||0
6428424|NCT01030289|7342831|FG001|NOT COMPLETED|Overall Study||0
6428425|NCT01030406|7342843|FG000|STARTED|Overall Study||10
6428426|NCT01030406|7342844|FG001|STARTED|Overall Study||10
6428427|NCT01030406|7342845|FG002|STARTED|Overall Study||10
6428428|NCT01030406|7342846|FG003|STARTED|Overall Study||10
6428429|NCT01030406|7342847|FG004|STARTED|Overall Study||9
6428430|NCT01030406|7342843|FG000|COMPLETED|Overall Study||10
6428431|NCT01030406|7342844|FG001|COMPLETED|Overall Study||10
6428432|NCT01030406|7342845|FG002|COMPLETED|Overall Study||9
6428433|NCT01030406|7342846|FG003|COMPLETED|Overall Study||9
6428434|NCT01030406|7342847|FG004|COMPLETED|Overall Study||9
6428435|NCT01030406|7342843|FG000|NOT COMPLETED|Overall Study||0
6428436|NCT01030406|7342844|FG001|NOT COMPLETED|Overall Study||0
6428437|NCT01030406|7342845|FG002|NOT COMPLETED|Overall Study||1
6428438|NCT01030406|7342846|FG003|NOT COMPLETED|Overall Study||1
6428439|NCT01030406|7342847|FG004|NOT COMPLETED|Overall Study||0
6428440|NCT01030458|7342861|FG000|STARTED|Overall Study||94
6428441|NCT01030458|7342862|FG001|STARTED|Overall Study||89
6428442|NCT01030458|7342861|FG000|COMPLETED|Overall Study||67
6428443|NCT01030458|7342862|FG001|COMPLETED|Overall Study||57
6428444|NCT01030458|7342861|FG000|NOT COMPLETED|Overall Study||27
6428445|NCT01030458|7342862|FG001|NOT COMPLETED|Overall Study||32
6428446|NCT01030523|7342870|FG000|STARTED|Overall Study||50
6428447|NCT01030523|7342871|FG001|STARTED|Overall Study||51
6428448|NCT01030523|7342870|FG000|COMPLETED|Overall Study||44
6428449|NCT01030523|7342871|FG001|COMPLETED|Overall Study||46
6428450|NCT01030523|7342870|FG000|NOT COMPLETED|Overall Study||6
6428451|NCT01030523|7342871|FG001|NOT COMPLETED|Overall Study||5
6428452|NCT01030536|7342882|FG000|STARTED|Overall Study||7
6428453|NCT01030536|7342883|FG001|STARTED|Overall Study||6
6428454|NCT01030536|7342884|FG002|STARTED|Overall Study||6
6428455|NCT01030536|7342885|FG003|STARTED|Overall Study||3
6428456|NCT01030536|7342886|FG004|STARTED|Overall Study||1
6428457|NCT01030536|7342882|FG000|COMPLETED|Overall Study||0
6428458|NCT01030536|7342883|FG001|COMPLETED|Overall Study||0
6428459|NCT01030536|7342884|FG002|COMPLETED|Overall Study||0
6428460|NCT01030536|7342885|FG003|COMPLETED|Overall Study||0
6428461|NCT01030536|7342886|FG004|COMPLETED|Overall Study||0
6428462|NCT01030536|7342882|FG000|NOT COMPLETED|Overall Study||7
6428463|NCT01030536|7342883|FG001|NOT COMPLETED|Overall Study||6
6428464|NCT01030536|7342884|FG002|NOT COMPLETED|Overall Study||6
6428465|NCT01030536|7342885|FG003|NOT COMPLETED|Overall Study||3
6428466|NCT01030536|7342886|FG004|NOT COMPLETED|Overall Study||1
6428467|NCT01030653|7342904|FG000|STARTED|Loading Dose & First Maintenance Regimen||4
6428468|NCT01030653|7342905|FG001|STARTED|Loading Dose & First Maintenance Regimen||4
6428469|NCT01030653|7342904|FG000|COMPLETED|Loading Dose & First Maintenance Regimen||4
6428470|NCT01030653|7342905|FG001|COMPLETED|Loading Dose & First Maintenance Regimen||4
6652234|NCT02427100|7581814|FG000|STARTED|Overall Study||15
6652235|NCT02427100|7581815|FG001|STARTED|Overall Study||17
6652236|NCT02427100|7581814|FG000|COMPLETED|Overall Study||15
6652237|NCT02427100|7581815|FG001|COMPLETED|Overall Study||15
6652238|NCT02427100|7581814|FG000|NOT COMPLETED|Overall Study||0
6652239|NCT02427100|7581815|FG001|NOT COMPLETED|Overall Study||2
6652240|NCT02427399|7581826|FG000|STARTED|Overall Study||220
6652241|NCT02427399|7581827|FG001|STARTED|Overall Study||220
6652242|NCT02427399|7581828|FG002|STARTED|Overall Study||220
6652243|NCT02427399|7581829|FG003|STARTED|Overall Study||220
6652244|NCT02427399|7581830|FG004|STARTED|Overall Study||220
6652245|NCT02427399|7581826|FG000|COMPLETED|Overall Study||206
6652246|NCT02427399|7581827|FG001|COMPLETED|Overall Study||204
6652247|NCT02427399|7581828|FG002|COMPLETED|Overall Study||208
6652248|NCT02427399|7581829|FG003|COMPLETED|Overall Study||202
6652249|NCT02427399|7581830|FG004|COMPLETED|Overall Study||205
6652250|NCT02427399|7581826|FG000|NOT COMPLETED|Overall Study||14
6652251|NCT02427399|7581827|FG001|NOT COMPLETED|Overall Study||16
6652252|NCT02427399|7581828|FG002|NOT COMPLETED|Overall Study||12
6428471|NCT01030653|7342904|FG000|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
6428472|NCT01030653|7342905|FG001|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
6428473|NCT01030653|7342904|FG000|STARTED|7-Day Washout Period||4
6428474|NCT01030653|7342905|FG001|STARTED|7-Day Washout Period||4
6428475|NCT01030653|7342904|FG000|COMPLETED|7-Day Washout Period||4
6428476|NCT01030653|7342905|FG001|COMPLETED|7-Day Washout Period||4
6428477|NCT01030653|7342904|FG000|NOT COMPLETED|7-Day Washout Period||0
6428478|NCT01030653|7342905|FG001|NOT COMPLETED|7-Day Washout Period||0
6428479|NCT01030653|7342904|FG000|STARTED|Loading Dose & 2nd Maintenance Regimen||4
6428480|NCT01030653|7342905|FG001|STARTED|Loading Dose & 2nd Maintenance Regimen||4
6428481|NCT01030653|7342904|FG000|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
6428482|NCT01030653|7342905|FG001|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
6428483|NCT01030653|7342904|FG000|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
6428484|NCT01030653|7342905|FG001|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
6428485|NCT01030666|7342914|FG000|STARTED|Overall Study||28
6428486|NCT01030666|7342915|FG001|STARTED|Overall Study||33
6428487|NCT01030666|7342914|FG000|COMPLETED|Overall Study||25
6428488|NCT01030666|7342915|FG001|COMPLETED|Overall Study||31
6428489|NCT01030666|7342914|FG000|NOT COMPLETED|Overall Study||3
6428490|NCT01030666|7342915|FG001|NOT COMPLETED|Overall Study||2
6428491|NCT01030718|7342925|FG000|STARTED|Studies CA180-031 and -036 Combined||30
6428492|NCT01030718|7342926|FG001|STARTED|Studies CA180-031 and -036 Combined||11
6428493|NCT01030718|7342927|FG002|STARTED|Studies CA180-031 and -036 Combined||13
6428494|NCT01030718|7342925|FG000|COMPLETED|Studies CA180-031 and -036 Combined||26
6428495|NCT01030718|7342926|FG001|COMPLETED|Studies CA180-031 and -036 Combined||2
6428496|NCT01030718|7342927|FG002|COMPLETED|Studies CA180-031 and -036 Combined||1
6428497|NCT01030718|7342925|FG000|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
6428498|NCT01030718|7342926|FG001|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
6428499|NCT01030718|7342927|FG002|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
6652253|NCT02427399|7581829|FG003|NOT COMPLETED|Overall Study||18
6652254|NCT02427399|7581830|FG004|NOT COMPLETED|Overall Study||15
6652255|NCT02427477|7581844|FG000|STARTED|Period 1||60
6652256|NCT02427477|7581845|FG001|STARTED|Period 1||60
6652257|NCT02427477|7581844|FG000|COMPLETED|Period 1||59
6428500|NCT01030718|7342925|FG000|STARTED|Study CA180-036 Only||29
6428501|NCT01030718|7342926|FG001|STARTED|Study CA180-036 Only||9
6652258|NCT02427477|7581845|FG001|COMPLETED|Period 1||60
6428502|NCT01030718|7342927|FG002|STARTED|Study CA180-036 Only||6
6652259|NCT02427477|7581844|FG000|NOT COMPLETED|Period 1||1
6652260|NCT02427477|7581845|FG001|NOT COMPLETED|Period 1||0
6428503|NCT01030718|7342925|FG000|COMPLETED|Study CA180-036 Only||26
6428504|NCT01030718|7342926|FG001|COMPLETED|Study CA180-036 Only||2
6428505|NCT01030718|7342927|FG002|COMPLETED|Study CA180-036 Only||1
6428506|NCT01030718|7342925|FG000|NOT COMPLETED|Study CA180-036 Only||3
6428507|NCT01030718|7342926|FG001|NOT COMPLETED|Study CA180-036 Only||7
6428508|NCT01030718|7342927|FG002|NOT COMPLETED|Study CA180-036 Only||5
6428509|NCT01030783|7342947|FG000|STARTED|Overall Study||260
6428510|NCT01030783|7342948|FG001|STARTED|Overall Study||257
6428511|NCT01030783|7342947|FG000|COMPLETED|Overall Study||211
6428512|NCT01030783|7342948|FG001|COMPLETED|Overall Study||231
6428513|NCT01030783|7342947|FG000|NOT COMPLETED|Overall Study||49
6428514|NCT01030783|7342948|FG001|NOT COMPLETED|Overall Study||26
6428515|NCT01030822|7342957|FG000|STARTED|Overall Study||100
6428516|NCT01030822|7342958|FG001|STARTED|Overall Study||95
6428517|NCT01030822|7342959|FG002|STARTED|Overall Study||87
6428518|NCT01030822|7342957|FG000|COMPLETED|Overall Study||69
6428519|NCT01030822|7342958|FG001|COMPLETED|Overall Study||71
6428520|NCT01030822|7342959|FG002|COMPLETED|Overall Study||61
6428521|NCT01030822|7342957|FG000|NOT COMPLETED|Overall Study||31
6428522|NCT01030822|7342958|FG001|NOT COMPLETED|Overall Study||24
6428523|NCT01030822|7342959|FG002|NOT COMPLETED|Overall Study||26
6428524|NCT01030861|7342970|FG000|STARTED|Overall Study||44
6428525|NCT01030861|7342971|FG001|STARTED|Overall Study||32
6428526|NCT01030861|7342970|FG000|COMPLETED|Overall Study||44
6428527|NCT01030861|7342971|FG001|COMPLETED|Overall Study||32
6428528|NCT01030861|7342970|FG000|NOT COMPLETED|Overall Study||0
6428529|NCT01030861|7342971|FG001|NOT COMPLETED|Overall Study||0
6428530|NCT01030874|7342979|FG000|STARTED|Overall Study|1 with impaired decision making capacity|178
6428531|NCT01030874|7342980|FG001|STARTED|Overall Study|1 with impaired decision making capacity|178
6428532|NCT01030874|7342979|FG000|COMPLETED|Overall Study||160
6428533|NCT01030874|7342980|FG001|COMPLETED|Overall Study||162
6428534|NCT01030874|7342979|FG000|NOT COMPLETED|Overall Study||18
6428535|NCT01030874|7342980|FG001|NOT COMPLETED|Overall Study||16
6428536|NCT01030952|7342988|FG000|STARTED|Overall Study||51
6428537|NCT01030952|7342989|FG001|STARTED|Overall Study||52
6428538|NCT01030952|7342988|FG000|COMPLETED|Overall Study||49
6428539|NCT01030952|7342989|FG001|COMPLETED|Overall Study||49
6428540|NCT01030952|7342988|FG000|NOT COMPLETED|Overall Study||2
6428541|NCT01030952|7342989|FG001|NOT COMPLETED|Overall Study||3
6428542|NCT01030965|7343001|FG000|STARTED|Overall Study||71
6428543|NCT01030965|7343002|FG001|STARTED|Overall Study||71
6428544|NCT01030965|7343003|FG002|STARTED|Overall Study||72
6428545|NCT01030965|7343004|FG003|STARTED|Overall Study||71
6428546|NCT01030965|7343001|FG000|COMPLETED|Overall Study||67
6428547|NCT01030965|7343002|FG001|COMPLETED|Overall Study||65
6428548|NCT01030965|7343003|FG002|COMPLETED|Overall Study||68
6428549|NCT01030965|7343004|FG003|COMPLETED|Overall Study||64
6428550|NCT01030965|7343001|FG000|NOT COMPLETED|Overall Study||4
6428551|NCT01030965|7343002|FG001|NOT COMPLETED|Overall Study||6
6428552|NCT01030965|7343003|FG002|NOT COMPLETED|Overall Study||4
6428553|NCT01030965|7343004|FG003|NOT COMPLETED|Overall Study||7
6428554|NCT01031004|7343016|FG000|STARTED|Overall Study||25
6428555|NCT01031004|7343017|FG001|STARTED|Overall Study||25
6428556|NCT01031004|7343016|FG000|COMPLETED|Overall Study||24
6428557|NCT01031004|7343017|FG001|COMPLETED|Overall Study||24
6428558|NCT01031004|7343016|FG000|NOT COMPLETED|Overall Study||1
6428559|NCT01031004|7343017|FG001|NOT COMPLETED|Overall Study||1
6428560|NCT01031043|7343023|FG000|STARTED|Overall Study||5
6428561|NCT01031043|7343023|FG000|COMPLETED|Overall Study||4
6428562|NCT01031043|7343023|FG000|NOT COMPLETED|Overall Study||1
6428563|NCT01031069|7343031|FG000|STARTED|Overall Study||129
6428564|NCT01031069|7343032|FG001|STARTED|Overall Study||128
6428565|NCT01031069|7343033|FG002|STARTED|Overall Study||144
6428566|NCT01031069|7343034|FG003|STARTED|Overall Study||145
6428567|NCT01031069|7343031|FG000|COMPLETED|Overall Study||117
6428568|NCT01031069|7343032|FG001|COMPLETED|Overall Study||117
6428569|NCT01031069|7343033|FG002|COMPLETED|Overall Study||103
6428570|NCT01031069|7343034|FG003|COMPLETED|Overall Study||111
6428571|NCT01031069|7343031|FG000|NOT COMPLETED|Overall Study||12
6428572|NCT01031069|7343032|FG001|NOT COMPLETED|Overall Study||11
6428573|NCT01031069|7343033|FG002|NOT COMPLETED|Overall Study||41
6428574|NCT01031069|7343034|FG003|NOT COMPLETED|Overall Study||34
6428575|NCT01031095|7343048|FG000|STARTED|Overall Study||100
6428576|NCT01031095|7343049|FG001|STARTED|Overall Study||100
6428577|NCT01031095|7343048|FG000|COMPLETED|Overall Study||100
6428578|NCT01031095|7343049|FG001|COMPLETED|Overall Study||100
6428579|NCT01031095|7343048|FG000|NOT COMPLETED|Overall Study||0
6428580|NCT01031095|7343049|FG001|NOT COMPLETED|Overall Study||0
6428581|NCT01031134|7343057|FG000|STARTED|Overall Study||114
6428582|NCT01031134|7343058|FG001|STARTED|Overall Study||88
6428583|NCT01031134|7343057|FG000|COMPLETED|Overall Study||103
6428584|NCT01031134|7343058|FG001|COMPLETED|Overall Study||78
6428585|NCT01031134|7343057|FG000|NOT COMPLETED|Overall Study||11
6428586|NCT01031134|7343058|FG001|NOT COMPLETED|Overall Study||10
6428587|NCT01031381|7343064|FG000|STARTED|Overall Study||59
6428588|NCT01031381|7343064|FG000|COMPLETED|Overall Study||50
6428589|NCT01031381|7343064|FG000|NOT COMPLETED|Overall Study||9
6428590|NCT01031420|7343069|FG000|STARTED|Overall Study||54
6428591|NCT01031420|7343069|FG000|COMPLETED|Overall Study||44
6428592|NCT01031420|7343069|FG000|NOT COMPLETED|Overall Study||10
6428593|NCT01031446|7343073|FG000|STARTED|Overall Study||55
6428594|NCT01031446|7343073|FG000|COMPLETED|Overall Study||0
6428595|NCT01031446|7343073|FG000|NOT COMPLETED|Overall Study||55
6428596|NCT01031498|7343082|FG000|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
6428597|NCT01031498|7343083|FG001|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
6428598|NCT01031498|7343084|FG002|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
6428599|NCT01031498|7343082|FG000|COMPLETED|Overall Study||47
6428600|NCT01031498|7343083|FG001|COMPLETED|Overall Study||48
6428601|NCT01031498|7343084|FG002|COMPLETED|Overall Study||48
6428602|NCT01031498|7343082|FG000|NOT COMPLETED|Overall Study||2
6428603|NCT01031498|7343083|FG001|NOT COMPLETED|Overall Study||3
6428604|NCT01031498|7343084|FG002|NOT COMPLETED|Overall Study||2
6428605|NCT01031537|7343092|FG000|STARTED|Overall Study||66
6428606|NCT01031537|7343092|FG000|COMPLETED|Overall Study||34
6428607|NCT01031537|7343092|FG000|NOT COMPLETED|Overall Study||32
6428608|NCT01031680|7343098|FG000|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
6428609|NCT01031680|7343099|FG001|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
6428610|NCT01031680|7343098|FG000|COMPLETED|Overall Study||403
6428611|NCT01031680|7343099|FG001|COMPLETED|Overall Study||404
6428612|NCT01031680|7343098|FG000|NOT COMPLETED|Overall Study||57
6428613|NCT01031680|7343099|FG001|NOT COMPLETED|Overall Study||58
6428614|NCT01031706|7343107|FG000|STARTED|Overall Study||14
6428615|NCT01031706|7343108|FG001|STARTED|Overall Study||9
6428616|NCT01031706|7343107|FG000|COMPLETED|Overall Study||12
6428617|NCT01031706|7343108|FG001|COMPLETED|Overall Study||8
6428618|NCT01031706|7343107|FG000|NOT COMPLETED|Overall Study||2
6428619|NCT01031706|7343108|FG001|NOT COMPLETED|Overall Study||1
6428620|NCT01031810|7343114|FG000|STARTED|Overall Study||13
6428621|NCT01031810|7343114|FG000|COMPLETED|Overall Study||9
6428622|NCT01031810|7343114|FG000|NOT COMPLETED|Overall Study||4
6428623|NCT01031836|7343126|FG000|STARTED|Stage I||5
6428624|NCT01031836|7343127|FG001|STARTED|Stage I||5
6428625|NCT01031836|7343128|FG002|STARTED|Stage I||5
6428626|NCT01031836|7343129|FG003|STARTED|Stage I||5
6428627|NCT01031836|7343130|FG004|STARTED|Stage I||5
6428628|NCT01031836|7343131|FG005|STARTED|Stage I||5
6428629|NCT01031836|7343126|FG000|COMPLETED|Stage I||4
6428630|NCT01031836|7343127|FG001|COMPLETED|Stage I||3
6428631|NCT01031836|7343128|FG002|COMPLETED|Stage I||5
6428632|NCT01031836|7343129|FG003|COMPLETED|Stage I||5
6428633|NCT01031836|7343130|FG004|COMPLETED|Stage I||5
6428634|NCT01031836|7343131|FG005|COMPLETED|Stage I||4
6428635|NCT01031836|7343126|FG000|NOT COMPLETED|Stage I||1
6428636|NCT01031836|7343127|FG001|NOT COMPLETED|Stage I||2
6428637|NCT01031836|7343128|FG002|NOT COMPLETED|Stage I||0
6428638|NCT01031836|7343129|FG003|NOT COMPLETED|Stage I||0
6428639|NCT01031836|7343130|FG004|NOT COMPLETED|Stage I||0
6428640|NCT01031836|7343131|FG005|NOT COMPLETED|Stage I||1
6428641|NCT01031836|7343126|FG000|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|3
6428642|NCT01031836|7343127|FG001|STARTED|Stage II|2 patient who completed the study treatment in Stage I did not register in Stage II.|1
6428643|NCT01031836|7343128|FG002|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
6428644|NCT01031836|7343129|FG003|STARTED|Stage II|1 patient who completed the study treatment in Stage I did not register in Stage II.|4
6428645|NCT01031836|7343130|FG004|STARTED|Stage II||5
6428646|NCT01031836|7343131|FG005|STARTED|Stage II||4
6428647|NCT01031836|7343126|FG000|COMPLETED|Stage II||1
6428648|NCT01031836|7343127|FG001|COMPLETED|Stage II||1
6428649|NCT01031836|7343128|FG002|COMPLETED|Stage II||2
6428650|NCT01031836|7343129|FG003|COMPLETED|Stage II||1
6428651|NCT01031836|7343130|FG004|COMPLETED|Stage II||3
6428652|NCT01031836|7343131|FG005|COMPLETED|Stage II||3
6428653|NCT01031836|7343126|FG000|NOT COMPLETED|Stage II||2
6428654|NCT01031836|7343127|FG001|NOT COMPLETED|Stage II||0
6428655|NCT01031836|7343128|FG002|NOT COMPLETED|Stage II||2
6428656|NCT01031836|7343129|FG003|NOT COMPLETED|Stage II||3
6428657|NCT01031836|7343130|FG004|NOT COMPLETED|Stage II||2
6428658|NCT01031836|7343131|FG005|NOT COMPLETED|Stage II||1
6428659|NCT01031914|7343145|FG000|STARTED|Overall Study||36
6428660|NCT01031914|7343145|FG000|COMPLETED|Overall Study||36
6428661|NCT01031914|7343145|FG000|NOT COMPLETED|Overall Study||0
6428662|NCT01031953|7343149|FG000|STARTED|Overall Study||11
6428663|NCT01031953|7343149|FG000|COMPLETED|Overall Study||11
6428664|NCT01031953|7343149|FG000|NOT COMPLETED|Overall Study||0
6428665|NCT01031979|7343161|FG000|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
6428666|NCT01031979|7343162|FG001|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
6428667|NCT01031979|7343161|FG000|Completed Primary Outcome Measure|Overall Study||12
6428668|NCT01031979|7343162|FG001|Completed Primary Outcome Measure|Overall Study||12
6428669|NCT01031979|7343161|FG000|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
6428670|NCT01031979|7343162|FG001|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
6428671|NCT01031979|7343161|FG000|NOT COMPLETED|Overall Study||5
6428672|NCT01031979|7343162|FG001|NOT COMPLETED|Overall Study||4
6428673|NCT01032018|7343170|FG000|STARTED|Overall Study||77
6428674|NCT01032018|7343171|FG001|STARTED|Overall Study||73
6428675|NCT01032018|7343170|FG000|COMPLETED|Overall Study||71
6428676|NCT01032018|7343171|FG001|COMPLETED|Overall Study||67
6428677|NCT01032018|7343170|FG000|NOT COMPLETED|Overall Study||6
6428678|NCT01032018|7343171|FG001|NOT COMPLETED|Overall Study||6
6428679|NCT01032044|7343179|FG000|STARTED|Overall Study||82
6428680|NCT01032044|7343180|FG001|STARTED|Overall Study||82
6428681|NCT01032044|7343179|FG000|Procedure|Overall Study||74
6428682|NCT01032044|7343180|FG001|Procedure|Overall Study||75
6428683|NCT01032044|7343179|FG000|COMPLETED|Overall Study||57
6428684|NCT01032044|7343180|FG001|COMPLETED|Overall Study||62
6428685|NCT01032044|7343179|FG000|NOT COMPLETED|Overall Study||25
6428686|NCT01032044|7343180|FG001|NOT COMPLETED|Overall Study||20
6428687|NCT01032070|7343188|FG000|STARTED|Overall Study||13
6428688|NCT01032070|7343189|FG001|STARTED|Overall Study||12
6428689|NCT01032070|7343188|FG000|COMPLETED|Overall Study||0
6428690|NCT01032070|7343189|FG001|COMPLETED|Overall Study||0
6428691|NCT01032070|7343188|FG000|NOT COMPLETED|Overall Study||13
6428692|NCT01032070|7343189|FG001|NOT COMPLETED|Overall Study||12
6428693|NCT01032135|7343200|FG000|STARTED|2 Week Randomization||311
6428694|NCT01032135|7343201|FG001|STARTED|2 Week Randomization||93
6428695|NCT01032135|7343202|FG002|STARTED|2 Week Randomization||96
6428696|NCT01032135|7343203|FG003|STARTED|2 Week Randomization||0
6428697|NCT01032135|7343204|FG004|STARTED|2 Week Randomization||0
6428698|NCT01032135|7343205|FG005|STARTED|2 Week Randomization||0
6428699|NCT01032135|7343206|FG006|STARTED|2 Week Randomization||0
6428700|NCT01032135|7343200|FG000|COMPLETED|2 Week Randomization||311
6428701|NCT01032135|7343201|FG001|COMPLETED|2 Week Randomization||93
6428702|NCT01032135|7343202|FG002|COMPLETED|2 Week Randomization||96
6428703|NCT01032135|7343203|FG003|COMPLETED|2 Week Randomization||0
6428704|NCT01032135|7343204|FG004|COMPLETED|2 Week Randomization||0
6428705|NCT01032135|7343205|FG005|COMPLETED|2 Week Randomization||0
6428706|NCT01032135|7343206|FG006|COMPLETED|2 Week Randomization||0
6428707|NCT01032135|7343200|FG000|NOT COMPLETED|2 Week Randomization||0
6428708|NCT01032135|7343201|FG001|NOT COMPLETED|2 Week Randomization||0
6428709|NCT01032135|7343202|FG002|NOT COMPLETED|2 Week Randomization||0
6428710|NCT01032135|7343203|FG003|NOT COMPLETED|2 Week Randomization||0
6428711|NCT01032135|7343204|FG004|NOT COMPLETED|2 Week Randomization||0
6428712|NCT01032135|7343205|FG005|NOT COMPLETED|2 Week Randomization||0
6428713|NCT01032135|7343206|FG006|NOT COMPLETED|2 Week Randomization||0
6428714|NCT01032135|7343200|FG000|STARTED|8 Week Randomization||227
6428715|NCT01032135|7343201|FG001|STARTED|8 Week Randomization||0
6428716|NCT01032135|7343202|FG002|STARTED|8 Week Randomization||0
6428717|NCT01032135|7343203|FG003|STARTED|8 Week Randomization||41
6428718|NCT01032135|7343204|FG004|STARTED|8 Week Randomization||43
6428719|NCT01032135|7343205|FG005|STARTED|8 Week Randomization||48
6428720|NCT01032135|7343206|FG006|STARTED|8 Week Randomization||54
6428721|NCT01032135|7343200|FG000|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
6428722|NCT01032135|7343201|FG001|12 Week Follow up|8 Week Randomization||0
6428723|NCT01032135|7343202|FG002|12 Week Follow up|8 Week Randomization||0
6428724|NCT01032135|7343203|FG003|12 Week Follow up|8 Week Randomization||34
6428725|NCT01032135|7343204|FG004|12 Week Follow up|8 Week Randomization||38
6428726|NCT01032135|7343205|FG005|12 Week Follow up|8 Week Randomization||36
6428727|NCT01032135|7343206|FG006|12 Week Follow up|8 Week Randomization||41
6428728|NCT01032135|7343200|FG000|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
6428729|NCT01032135|7343201|FG001|COMPLETED|8 Week Randomization||0
6428730|NCT01032135|7343202|FG002|COMPLETED|8 Week Randomization||0
6428731|NCT01032135|7343203|FG003|COMPLETED|8 Week Randomization||30
6428732|NCT01032135|7343204|FG004|COMPLETED|8 Week Randomization||34
6428733|NCT01032135|7343205|FG005|COMPLETED|8 Week Randomization||31
6428734|NCT01032135|7343206|FG006|COMPLETED|8 Week Randomization||36
6428735|NCT01032135|7343200|FG000|NOT COMPLETED|8 Week Randomization||26
6428736|NCT01032135|7343201|FG001|NOT COMPLETED|8 Week Randomization||0
6428737|NCT01032135|7343202|FG002|NOT COMPLETED|8 Week Randomization||0
6428738|NCT01032135|7343203|FG003|NOT COMPLETED|8 Week Randomization||11
6428739|NCT01032135|7343204|FG004|NOT COMPLETED|8 Week Randomization||9
6428740|NCT01032135|7343205|FG005|NOT COMPLETED|8 Week Randomization||17
6428741|NCT01032135|7343206|FG006|NOT COMPLETED|8 Week Randomization||18
6428742|NCT01032174|7343222|FG000|STARTED|Overall Study||63
6428743|NCT01032174|7343223|FG001|STARTED|Overall Study||60
6428744|NCT01032174|7343222|FG000|COMPLETED|Overall Study||63
6428745|NCT01032174|7343223|FG001|COMPLETED|Overall Study||59
6428746|NCT01032174|7343222|FG000|NOT COMPLETED|Overall Study||0
6428747|NCT01032174|7343223|FG001|NOT COMPLETED|Overall Study||1
6428748|NCT01032200|7343231|FG000|STARTED|Overall Study||26
6428749|NCT01032200|7343232|FG001|STARTED|Overall Study||28
6428750|NCT01032200|7343231|FG000|COMPLETED|Overall Study||22
6428751|NCT01032200|7343232|FG001|COMPLETED|Overall Study||21
6428752|NCT01032200|7343231|FG000|NOT COMPLETED|Overall Study||4
6428753|NCT01032200|7343232|FG001|NOT COMPLETED|Overall Study||7
6428754|NCT01032239|7343240|FG000|STARTED|Overall Study|randomized to ITB arm|31
6428755|NCT01032239|7343241|FG001|STARTED|Overall Study|randomized to BMT arm|29
6428756|NCT01032239|7343240|FG000|Implant|Overall Study|implanted|25
6428757|NCT01032239|7343241|FG001|Implant|Overall Study||0
6428758|NCT01032239|7343240|FG000|COMPLETED|Overall Study||24
6428759|NCT01032239|7343241|FG001|COMPLETED|Overall Study||24
6428760|NCT01032239|7343240|FG000|NOT COMPLETED|Overall Study||7
6428761|NCT01032239|7343241|FG001|NOT COMPLETED|Overall Study||5
6428762|NCT01032291|7343250|FG000|STARTED|Safety Lead-in||8
6428763|NCT01032291|7343251|FG001|STARTED|Safety Lead-in||0
6428764|NCT01032291|7343252|FG002|STARTED|Safety Lead-in||0
6428765|NCT01032291|7343250|FG000|COMPLETED|Safety Lead-in|Participants with disease progression|6
6428766|NCT01032291|7343251|FG001|COMPLETED|Safety Lead-in||0
6428767|NCT01032291|7343252|FG002|COMPLETED|Safety Lead-in||0
6428768|NCT01032291|7343250|FG000|NOT COMPLETED|Safety Lead-in||2
6428769|NCT01032291|7343251|FG001|NOT COMPLETED|Safety Lead-in||0
6428770|NCT01032291|7343252|FG002|NOT COMPLETED|Safety Lead-in||0
6428771|NCT01032291|7343250|FG000|STARTED|Proof of Concept||0
6428772|NCT01032291|7343251|FG001|STARTED|Proof of Concept||22
6428773|NCT01032291|7343252|FG002|STARTED|Proof of Concept||21
6428774|NCT01032291|7343250|FG000|Intent to Treat and Safety Populations|Proof of Concept||0
6428775|NCT01032291|7343251|FG001|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
6428776|NCT01032291|7343252|FG002|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
6428777|NCT01032291|7343250|FG000|COMPLETED|Proof of Concept||0
6428778|NCT01032291|7343251|FG001|COMPLETED|Proof of Concept|Participants with disease progression|14
6428779|NCT01032291|7343252|FG002|COMPLETED|Proof of Concept|Participants with disease progression|18
6428780|NCT01032291|7343250|FG000|NOT COMPLETED|Proof of Concept||0
6428781|NCT01032291|7343251|FG001|NOT COMPLETED|Proof of Concept||8
6652261|NCT02427477|7581844|FG000|STARTED|Period 2||59
6652262|NCT02427477|7581845|FG001|STARTED|Period 2||60
6652263|NCT02427477|7581844|FG000|COMPLETED|Period 2||59
6652264|NCT02427477|7581845|FG001|COMPLETED|Period 2||60
6652265|NCT02427477|7581844|FG000|NOT COMPLETED|Period 2||0
6652266|NCT02427477|7581845|FG001|NOT COMPLETED|Period 2||0
6428782|NCT01032291|7343252|FG002|NOT COMPLETED|Proof of Concept||3
6428783|NCT01032330|7343267|FG000|STARTED|Overall Study||183
6428784|NCT01032330|7343268|FG001|STARTED|Overall Study||175
6428785|NCT01032330|7343269|FG002|STARTED|Overall Study||97
6428786|NCT01032330|7343270|FG003|STARTED|Overall Study||104
6428787|NCT01032330|7343267|FG000|COMPLETED|Overall Study||165
6428788|NCT01032330|7343268|FG001|COMPLETED|Overall Study||151
6428789|NCT01032330|7343269|FG002|COMPLETED|Overall Study||87
6428790|NCT01032330|7343270|FG003|COMPLETED|Overall Study||90
6428791|NCT01032330|7343267|FG000|NOT COMPLETED|Overall Study||18
6428792|NCT01032330|7343268|FG001|NOT COMPLETED|Overall Study||24
6428793|NCT01032330|7343269|FG002|NOT COMPLETED|Overall Study||10
6428794|NCT01032330|7343270|FG003|NOT COMPLETED|Overall Study||14
6428795|NCT01032382|7343290|FG000|STARTED|Overall Study||16
6428796|NCT01032382|7343291|FG001|STARTED|Overall Study||14
6652267|NCT02427477|7581844|FG000|STARTED|Period 3||59
6652268|NCT02427477|7581845|FG001|STARTED|Period 3||60
6652269|NCT02427477|7581844|FG000|COMPLETED|Period 3||59
6428797|NCT01032382|7343290|FG000|COMPLETED|Overall Study||11
6428798|NCT01032382|7343291|FG001|COMPLETED|Overall Study||9
6428799|NCT01032382|7343290|FG000|NOT COMPLETED|Overall Study||5
6652270|NCT02427477|7581845|FG001|COMPLETED|Period 3||60
6652271|NCT02427477|7581844|FG000|NOT COMPLETED|Period 3||0
6652272|NCT02427477|7581845|FG001|NOT COMPLETED|Period 3||0
6428800|NCT01032382|7343291|FG001|NOT COMPLETED|Overall Study||5
6428801|NCT01032538|7343297|FG000|STARTED|Overall Study|Knees|99
6428802|NCT01032538|7343297|FG000|COMPLETED|Overall Study|Knees|99
6428803|NCT01032538|7343297|FG000|NOT COMPLETED|Overall Study||0
6428804|NCT01032629|7343306|FG000|STARTED|Overall Study||1442
6428805|NCT01032629|7343307|FG001|STARTED|Overall Study||1445
6428806|NCT01032629|7343308|FG002|STARTED|Overall Study||1443
6428807|NCT01032629|7343306|FG000|Treated|Overall Study||1441
6428808|NCT01032629|7343307|FG001|Treated|Overall Study||1445
6428809|NCT01032629|7343308|FG002|Treated|Overall Study||1441
6428810|NCT01032629|7343306|FG000|COMPLETED|Overall Study|Participants who died on trial were considered completed|1297
6428811|NCT01032629|7343307|FG001|COMPLETED|Overall Study|Participants who died on trial were considered completed|1344
6428812|NCT01032629|7343308|FG002|COMPLETED|Overall Study|Participants who died on trial were considered completed|1355
6428813|NCT01032629|7343306|FG000|NOT COMPLETED|Overall Study||145
6428814|NCT01032629|7343307|FG001|NOT COMPLETED|Overall Study||101
6428815|NCT01032629|7343308|FG002|NOT COMPLETED|Overall Study||88
6428816|NCT01032694|7343319|FG000|STARTED|Overall Study||20
6428817|NCT01032694|7343320|FG001|STARTED|Overall Study||10
6428818|NCT01032694|7343319|FG000|COMPLETED|Overall Study||20
6428819|NCT01032694|7343320|FG001|COMPLETED|Overall Study||10
6428820|NCT01032694|7343319|FG000|NOT COMPLETED|Overall Study||0
6428821|NCT01032694|7343320|FG001|NOT COMPLETED|Overall Study||0
6428822|NCT01032733|7343328|FG000|STARTED|Overall Study||17
6428823|NCT01032733|7343329|FG001|STARTED|Overall Study||17
6428824|NCT01032733|7343328|FG000|COMPLETED|Overall Study||16
6428825|NCT01032733|7343329|FG001|COMPLETED|Overall Study||16
6428826|NCT01032733|7343328|FG000|NOT COMPLETED|Overall Study||1
6428827|NCT01032733|7343329|FG001|NOT COMPLETED|Overall Study||1
6428828|NCT01032759|7343338|FG000|STARTED|Overall Study||32
6428829|NCT01032759|7343339|FG001|STARTED|Overall Study||31
6428830|NCT01032759|7343338|FG000|Completed 24 Hour Assessment|Overall Study||32
6652273|NCT02427607|7581851|FG000|STARTED|Overall Study||7
6652274|NCT02427607|7581851|FG000|COMPLETED|Overall Study||6
6652275|NCT02427607|7581851|FG000|NOT COMPLETED|Overall Study||1
6428831|NCT01032759|7343339|FG001|Completed 24 Hour Assessment|Overall Study||30
6428832|NCT01032759|7343338|FG000|Completed 48 Hour Assessment|Overall Study||31
6428833|NCT01032759|7343339|FG001|Completed 48 Hour Assessment|Overall Study||28
6428834|NCT01032759|7343338|FG000|COMPLETED|Overall Study||31
6428835|NCT01032759|7343339|FG001|COMPLETED|Overall Study||28
6428836|NCT01032759|7343338|FG000|NOT COMPLETED|Overall Study||1
6652276|NCT02427646|7581857|FG000|STARTED|Overall Study||24
6652277|NCT02427646|7581858|FG001|STARTED|Overall Study||28
6428837|NCT01032759|7343339|FG001|NOT COMPLETED|Overall Study||3
6428838|NCT01032837|7343349|FG000|STARTED|Overall Study||26
6428839|NCT01032837|7343350|FG001|STARTED|Overall Study||26
6428840|NCT01032837|7343351|FG002|STARTED|Overall Study||25
6428841|NCT01032837|7343352|FG003|STARTED|Overall Study||25
6428842|NCT01032837|7343349|FG000|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
6428843|NCT01032837|7343350|FG001|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
6428844|NCT01032837|7343351|FG002|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
6428845|NCT01032837|7343352|FG003|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
6428846|NCT01032837|7343349|FG000|COMPLETED|Overall Study|Represents patients who completed treatment.|26
6428847|NCT01032837|7343350|FG001|COMPLETED|Overall Study|Represents patients who completed treatment.|23
6428848|NCT01032837|7343351|FG002|COMPLETED|Overall Study|Represents patients who completed treatment.|24
6428849|NCT01032837|7343352|FG003|COMPLETED|Overall Study|Represents patients who completed treatment.|22
6428850|NCT01032837|7343349|FG000|NOT COMPLETED|Overall Study||0
6428851|NCT01032837|7343350|FG001|NOT COMPLETED|Overall Study||3
6428852|NCT01032837|7343351|FG002|NOT COMPLETED|Overall Study||1
6428853|NCT01032837|7343352|FG003|NOT COMPLETED|Overall Study||3
6428854|NCT01032850|7343362|FG000|STARTED|Overall Study||15
6428855|NCT01032850|7343362|FG000|COMPLETED|Overall Study||13
6428856|NCT01032850|7343362|FG000|NOT COMPLETED|Overall Study||2
6428857|NCT01032889|7343369|FG000|STARTED|Overall Study||41
6428858|NCT01032889|7343370|FG001|STARTED|Overall Study||43
6428859|NCT01032889|7343371|FG002|STARTED|Overall Study||45
6428860|NCT01032889|7343369|FG000|Received Treatment|Overall Study||41
6428861|NCT01032889|7343370|FG001|Received Treatment|Overall Study||43
6428862|NCT01032889|7343371|FG002|Received Treatment|Overall Study||45
6428863|NCT01032889|7343369|FG000|COMPLETED|Overall Study||33
6428864|NCT01032889|7343370|FG001|COMPLETED|Overall Study||28
6428865|NCT01032889|7343371|FG002|COMPLETED|Overall Study||42
6428866|NCT01032889|7343369|FG000|NOT COMPLETED|Overall Study||8
6428867|NCT01032889|7343370|FG001|NOT COMPLETED|Overall Study||15
6428868|NCT01032889|7343371|FG002|NOT COMPLETED|Overall Study||3
6428869|NCT01032915|7343383|FG000|STARTED|Overall Study||29
6428870|NCT01032915|7343384|FG001|STARTED|Overall Study||31
6428871|NCT01032915|7343385|FG002|STARTED|Overall Study||31
6428872|NCT01032915|7343386|FG003|STARTED|Overall Study||34
6552050|NCT01735877|7474472|FG000|NOT COMPLETED|Overall Study||1
6552051|NCT01735877|7474473|FG001|NOT COMPLETED|Overall Study||0
6552052|NCT01735916|7474482|FG000|STARTED|Overall Study||18
6552053|NCT01735916|7474483|FG001|STARTED|Overall Study||19
6552054|NCT01735916|7474484|FG002|STARTED|Overall Study||7
6552055|NCT01735916|7474482|FG000|COMPLETED|Overall Study||0
6552056|NCT01735916|7474483|FG001|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
6552057|NCT01735916|7474484|FG002|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
6552058|NCT01735916|7474482|FG000|NOT COMPLETED|Overall Study||18
6552059|NCT01735916|7474483|FG001|NOT COMPLETED|Overall Study||19
6552060|NCT01735916|7474484|FG002|NOT COMPLETED|Overall Study||7
6552061|NCT01735981|7474493|FG000|STARTED|Allocated||13
6552062|NCT01735981|7474494|FG001|STARTED|Allocated||11
6552063|NCT01735981|7474493|FG000|COMPLETED|Allocated||11
6552064|NCT01735981|7474494|FG001|COMPLETED|Allocated||8
6552065|NCT01735981|7474493|FG000|NOT COMPLETED|Allocated||2
6552066|NCT01735981|7474494|FG001|NOT COMPLETED|Allocated||3
6552067|NCT01735981|7474493|FG000|STARTED|Crossed Over||11
6552068|NCT01735981|7474494|FG001|STARTED|Crossed Over|N=1 lost to cross over before DDR intervention|7
6552069|NCT01735981|7474493|FG000|COMPLETED|Crossed Over||11
6552070|NCT01735981|7474494|FG001|COMPLETED|Crossed Over||7
6552071|NCT01735981|7474493|FG000|NOT COMPLETED|Crossed Over||0
6552072|NCT01735981|7474494|FG001|NOT COMPLETED|Crossed Over||0
6552073|NCT01735994|7474504|FG000|STARTED|Overall Study||263
6552074|NCT01735994|7474505|FG001|STARTED|Overall Study||218
6552075|NCT01735994|7474504|FG000|Post Intervention (3 Weeks)|Overall Study||239
6552076|NCT01735994|7474505|FG001|Post Intervention (3 Weeks)|Overall Study||198
6428873|NCT01032915|7343383|FG000|COMPLETED|Overall Study||21
6428874|NCT01032915|7343384|FG001|COMPLETED|Overall Study||20
6428875|NCT01032915|7343385|FG002|COMPLETED|Overall Study||24
6428876|NCT01032915|7343386|FG003|COMPLETED|Overall Study||27
6428877|NCT01032915|7343383|FG000|NOT COMPLETED|Overall Study||8
6428878|NCT01032915|7343384|FG001|NOT COMPLETED|Overall Study||11
6428879|NCT01032915|7343385|FG002|NOT COMPLETED|Overall Study||7
6428880|NCT01032915|7343386|FG003|NOT COMPLETED|Overall Study||7
6428881|NCT01032928|7343396|FG000|STARTED|Overall Study||30
6428882|NCT01032928|7343396|FG000|COMPLETED|Overall Study||30
6428883|NCT01032928|7343396|FG000|NOT COMPLETED|Overall Study||0
6428884|NCT01032954|7343407|FG000|STARTED|Overall Study||30
6428885|NCT01032954|7343408|FG001|STARTED|Overall Study||30
6428886|NCT01032954|7343409|FG002|STARTED|Overall Study||30
6428887|NCT01032954|7343407|FG000|COMPLETED|Overall Study||26
6428888|NCT01032954|7343408|FG001|COMPLETED|Overall Study||29
6428889|NCT01032954|7343409|FG002|COMPLETED|Overall Study||30
6428890|NCT01032954|7343407|FG000|NOT COMPLETED|Overall Study||4
6428891|NCT01032954|7343408|FG001|NOT COMPLETED|Overall Study||1
6428892|NCT01032954|7343409|FG002|NOT COMPLETED|Overall Study||0
6428893|NCT01032993|7343419|FG000|STARTED|Overall Study||19
6428894|NCT01032993|7343420|FG001|STARTED|Overall Study||20
6428895|NCT01032993|7343419|FG000|COMPLETED|Overall Study||19
6428896|NCT01032993|7343420|FG001|COMPLETED|Overall Study||20
6428897|NCT01032993|7343419|FG000|NOT COMPLETED|Overall Study||0
6428898|NCT01032993|7343420|FG001|NOT COMPLETED|Overall Study||0
6428899|NCT01033019|7343428|FG000|STARTED|Overall Study||16
6428900|NCT01033019|7343429|FG001|STARTED|Overall Study||8
6428901|NCT01033019|7343428|FG000|COMPLETED|Overall Study||15
6428902|NCT01033019|7343429|FG001|COMPLETED|Overall Study||8
6428903|NCT01033019|7343428|FG000|NOT COMPLETED|Overall Study||1
6428904|NCT01033019|7343429|FG001|NOT COMPLETED|Overall Study||0
6428905|NCT01033032|7343436|FG000|STARTED|Phase I||3
6428906|NCT01033032|7343437|FG001|STARTED|Phase I||3
6428907|NCT01033032|7343438|FG002|STARTED|Phase I||3
6428908|NCT01033032|7343439|FG003|STARTED|Phase I||6
6428909|NCT01033032|7343436|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6428910|NCT01033032|7343437|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6428911|NCT01033032|7343438|FG002|COMPLETED|Phase I||3
6428912|NCT01033032|7343439|FG003|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6428913|NCT01033032|7343436|FG000|NOT COMPLETED|Phase I||3
6428914|NCT01033032|7343437|FG001|NOT COMPLETED|Phase I||3
6428915|NCT01033032|7343438|FG002|NOT COMPLETED|Phase I||0
6428916|NCT01033032|7343439|FG003|NOT COMPLETED|Phase I||6
6428917|NCT01033032|7343436|FG000|STARTED|Phase II||0
6428918|NCT01033032|7343437|FG001|STARTED|Phase II||0
6428919|NCT01033032|7343438|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
6428920|NCT01033032|7343439|FG003|STARTED|Phase II||0
6428921|NCT01033032|7343436|FG000|COMPLETED|Phase II||0
6428922|NCT01033032|7343437|FG001|COMPLETED|Phase II||0
6428923|NCT01033032|7343438|FG002|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
6428924|NCT01033032|7343439|FG003|COMPLETED|Phase II||0
6428925|NCT01033032|7343436|FG000|NOT COMPLETED|Phase II||0
6428926|NCT01033032|7343437|FG001|NOT COMPLETED|Phase II||0
6428927|NCT01033032|7343438|FG002|NOT COMPLETED|Phase II||66
6428928|NCT01033032|7343439|FG003|NOT COMPLETED|Phase II||0
6428929|NCT01033071|7343446|FG000|STARTED|Overall Study||355
6428930|NCT01033071|7343447|FG001|STARTED|Overall Study||352
6428931|NCT01033071|7343448|FG002|STARTED|Overall Study||364
6428932|NCT01033071|7343446|FG000|COMPLETED|Overall Study||300
6428933|NCT01033071|7343447|FG001|COMPLETED|Overall Study||275
6428934|NCT01033071|7343448|FG002|COMPLETED|Overall Study||317
6428935|NCT01033071|7343446|FG000|NOT COMPLETED|Overall Study||55
6428936|NCT01033071|7343447|FG001|NOT COMPLETED|Overall Study||77
6428937|NCT01033071|7343448|FG002|NOT COMPLETED|Overall Study||47
6428938|NCT01033136|7343458|FG000|STARTED|Baseline Assessment||36
6428939|NCT01033136|7343459|FG001|STARTED|Baseline Assessment||32
6428940|NCT01033136|7343458|FG000|COMPLETED|Baseline Assessment||30
6428941|NCT01033136|7343459|FG001|COMPLETED|Baseline Assessment||26
6428942|NCT01033136|7343458|FG000|NOT COMPLETED|Baseline Assessment||6
6428943|NCT01033136|7343459|FG001|NOT COMPLETED|Baseline Assessment||6
6428944|NCT01033136|7343458|FG000|STARTED|Post-Treatment (1 Week)||30
6428945|NCT01033136|7343459|FG001|STARTED|Post-Treatment (1 Week)||26
6428946|NCT01033136|7343458|FG000|COMPLETED|Post-Treatment (1 Week)||16
6428947|NCT01033136|7343459|FG001|COMPLETED|Post-Treatment (1 Week)||15
6428948|NCT01033136|7343458|FG000|NOT COMPLETED|Post-Treatment (1 Week)||14
6428949|NCT01033136|7343459|FG001|NOT COMPLETED|Post-Treatment (1 Week)||11
6428950|NCT01033136|7343458|FG000|STARTED|Follow-Up (3 Month)||16
6428951|NCT01033136|7343459|FG001|STARTED|Follow-Up (3 Month)||15
6428952|NCT01033136|7343458|FG000|COMPLETED|Follow-Up (3 Month)||14
6428953|NCT01033136|7343459|FG001|COMPLETED|Follow-Up (3 Month)||13
6428954|NCT01033136|7343458|FG000|NOT COMPLETED|Follow-Up (3 Month)||2
6428955|NCT01033136|7343459|FG001|NOT COMPLETED|Follow-Up (3 Month)||2
6428956|NCT01033227|7343469|FG000|STARTED|Overall Study||3
6428957|NCT01033227|7343470|FG001|STARTED|Overall Study||2
6428958|NCT01033227|7343469|FG000|COMPLETED|Overall Study||3
6428959|NCT01033227|7343470|FG001|COMPLETED|Overall Study||2
6428960|NCT01033227|7343469|FG000|NOT COMPLETED|Overall Study||0
6428961|NCT01033227|7343470|FG001|NOT COMPLETED|Overall Study||0
6428962|NCT01033240|7343481|FG000|STARTED|Overall Study||55
6428963|NCT01033240|7343482|FG001|STARTED|Overall Study||53
6428964|NCT01033240|7343483|FG002|STARTED|Overall Study||55
6428965|NCT01033240|7343481|FG000|COMPLETED|Overall Study||6
6428966|NCT01033240|7343482|FG001|COMPLETED|Overall Study||3
6428967|NCT01033240|7343483|FG002|COMPLETED|Overall Study||2
6428968|NCT01033240|7343481|FG000|NOT COMPLETED|Overall Study||49
6428969|NCT01033240|7343482|FG001|NOT COMPLETED|Overall Study||50
6428970|NCT01033240|7343483|FG002|NOT COMPLETED|Overall Study||53
6428971|NCT01033383|7343495|FG000|STARTED|Overall Study||20
6428972|NCT01033383|7343496|FG001|STARTED|Overall Study||20
6428973|NCT01033383|7343497|FG002|STARTED|Overall Study||20
6428974|NCT01033383|7343498|FG003|STARTED|Overall Study||20
6428975|NCT01033383|7343495|FG000|COMPLETED|Overall Study||20
6428976|NCT01033383|7343496|FG001|COMPLETED|Overall Study||20
6428977|NCT01033383|7343497|FG002|COMPLETED|Overall Study||20
6428978|NCT01033383|7343498|FG003|COMPLETED|Overall Study||20
6428979|NCT01033383|7343495|FG000|NOT COMPLETED|Overall Study||0
6428980|NCT01033383|7343496|FG001|NOT COMPLETED|Overall Study||0
6428981|NCT01033383|7343497|FG002|NOT COMPLETED|Overall Study||0
6428982|NCT01033383|7343498|FG003|NOT COMPLETED|Overall Study||0
6428983|NCT01033422|7343511|FG000|STARTED|Overall Study||34
6428984|NCT01033422|7343512|FG001|STARTED|Overall Study||32
6428985|NCT01033422|7343513|FG002|STARTED|Overall Study||23
6428986|NCT01033422|7343511|FG000|COMPLETED|Overall Study||33
6428987|NCT01033422|7343512|FG001|COMPLETED|Overall Study||28
6428988|NCT01033422|7343513|FG002|COMPLETED|Overall Study||22
6428989|NCT01033422|7343511|FG000|NOT COMPLETED|Overall Study||1
6428990|NCT01033422|7343512|FG001|NOT COMPLETED|Overall Study||4
6428991|NCT01033422|7343513|FG002|NOT COMPLETED|Overall Study||1
6428992|NCT01033448|7343521|FG000|STARTED|Overall Study||59
6428993|NCT01033448|7343521|FG000|COMPLETED|Overall Study||47
6428994|NCT01033448|7343521|FG000|NOT COMPLETED|Overall Study||12
6428995|NCT01033487|7343527|FG000|STARTED|First Intervention Period||2
6428996|NCT01033487|7343528|FG001|STARTED|First Intervention Period||3
6428997|NCT01033487|7343529|FG002|STARTED|First Intervention Period||2
6428998|NCT01033487|7343530|FG003|STARTED|First Intervention Period||2
6428999|NCT01033487|7343531|FG004|STARTED|First Intervention Period||2
6429000|NCT01033487|7343532|FG005|STARTED|First Intervention Period||2
6429001|NCT01033487|7343533|FG006|STARTED|First Intervention Period||2
6429002|NCT01033487|7343534|FG007|STARTED|First Intervention Period||3
6429003|NCT01033487|7343535|FG008|STARTED|First Intervention Period||2
6429004|NCT01033487|7343536|FG009|STARTED|First Intervention Period||2
6429005|NCT01033487|7343527|FG000|COMPLETED|First Intervention Period||2
6429006|NCT01033487|7343528|FG001|COMPLETED|First Intervention Period||3
6429007|NCT01033487|7343529|FG002|COMPLETED|First Intervention Period||2
6429008|NCT01033487|7343530|FG003|COMPLETED|First Intervention Period||2
6429009|NCT01033487|7343531|FG004|COMPLETED|First Intervention Period||2
6429010|NCT01033487|7343532|FG005|COMPLETED|First Intervention Period||2
6429011|NCT01033487|7343533|FG006|COMPLETED|First Intervention Period||2
6429012|NCT01033487|7343534|FG007|COMPLETED|First Intervention Period||3
6429013|NCT01033487|7343535|FG008|COMPLETED|First Intervention Period||2
6429014|NCT01033487|7343536|FG009|COMPLETED|First Intervention Period||2
6429015|NCT01033487|7343527|FG000|NOT COMPLETED|First Intervention Period||0
6429016|NCT01033487|7343528|FG001|NOT COMPLETED|First Intervention Period||0
6429017|NCT01033487|7343529|FG002|NOT COMPLETED|First Intervention Period||0
6429018|NCT01033487|7343530|FG003|NOT COMPLETED|First Intervention Period||0
6429019|NCT01033487|7343531|FG004|NOT COMPLETED|First Intervention Period||0
6429020|NCT01033487|7343532|FG005|NOT COMPLETED|First Intervention Period||0
6429021|NCT01033487|7343533|FG006|NOT COMPLETED|First Intervention Period||0
6429022|NCT01033487|7343534|FG007|NOT COMPLETED|First Intervention Period||0
6429023|NCT01033487|7343535|FG008|NOT COMPLETED|First Intervention Period||0
6429024|NCT01033487|7343536|FG009|NOT COMPLETED|First Intervention Period||0
6429025|NCT01033487|7343527|FG000|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6429026|NCT01033487|7343528|FG001|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
6429027|NCT01033487|7343529|FG002|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6429028|NCT01033487|7343530|FG003|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6429029|NCT01033487|7343531|FG004|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6429030|NCT01033487|7343532|FG005|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6429031|NCT01033487|7343533|FG006|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6429032|NCT01033487|7343534|FG007|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
6429033|NCT01033487|7343535|FG008|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6429034|NCT01033487|7343536|FG009|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
6429035|NCT01033487|7343527|FG000|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6429036|NCT01033487|7343528|FG001|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
6429037|NCT01033487|7343529|FG002|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6429038|NCT01033487|7343530|FG003|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6429039|NCT01033487|7343531|FG004|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6429040|NCT01033487|7343532|FG005|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6429041|NCT01033487|7343533|FG006|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6429042|NCT01033487|7343534|FG007|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
6429043|NCT01033487|7343535|FG008|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6429044|NCT01033487|7343536|FG009|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
6429045|NCT01033487|7343527|FG000|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429046|NCT01033487|7343528|FG001|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429047|NCT01033487|7343529|FG002|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429048|NCT01033487|7343530|FG003|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429049|NCT01033487|7343531|FG004|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429050|NCT01033487|7343532|FG005|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429051|NCT01033487|7343533|FG006|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429052|NCT01033487|7343534|FG007|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429053|NCT01033487|7343535|FG008|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429054|NCT01033487|7343536|FG009|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
6429055|NCT01033487|7343527|FG000|STARTED|Second Intervention Period||2
6429056|NCT01033487|7343528|FG001|STARTED|Second Intervention Period||3
6429057|NCT01033487|7343529|FG002|STARTED|Second Intervention Period||2
6429058|NCT01033487|7343530|FG003|STARTED|Second Intervention Period||2
6429059|NCT01033487|7343531|FG004|STARTED|Second Intervention Period||2
6429060|NCT01033487|7343532|FG005|STARTED|Second Intervention Period||2
6429061|NCT01033487|7343533|FG006|STARTED|Second Intervention Period||2
6429062|NCT01033487|7343534|FG007|STARTED|Second Intervention Period||3
6429063|NCT01033487|7343535|FG008|STARTED|Second Intervention Period||2
6429064|NCT01033487|7343536|FG009|STARTED|Second Intervention Period||2
6429065|NCT01033487|7343527|FG000|COMPLETED|Second Intervention Period||2
6429066|NCT01033487|7343528|FG001|COMPLETED|Second Intervention Period||3
6429067|NCT01033487|7343529|FG002|COMPLETED|Second Intervention Period||2
6429068|NCT01033487|7343530|FG003|COMPLETED|Second Intervention Period||2
6429069|NCT01033487|7343531|FG004|COMPLETED|Second Intervention Period||2
6429070|NCT01033487|7343532|FG005|COMPLETED|Second Intervention Period||2
6552077|NCT01735994|7474504|FG000|Follow-Up #1 (6 Months)|Overall Study||213
6429071|NCT01033487|7343533|FG006|COMPLETED|Second Intervention Period||2
6429072|NCT01033487|7343534|FG007|COMPLETED|Second Intervention Period||3
6429073|NCT01033487|7343535|FG008|COMPLETED|Second Intervention Period||2
6429074|NCT01033487|7343536|FG009|COMPLETED|Second Intervention Period||2
6429075|NCT01033487|7343527|FG000|NOT COMPLETED|Second Intervention Period||0
6429076|NCT01033487|7343528|FG001|NOT COMPLETED|Second Intervention Period||0
6429077|NCT01033487|7343529|FG002|NOT COMPLETED|Second Intervention Period||0
6429078|NCT01033487|7343530|FG003|NOT COMPLETED|Second Intervention Period||0
6429079|NCT01033487|7343531|FG004|NOT COMPLETED|Second Intervention Period||0
6429080|NCT01033487|7343532|FG005|NOT COMPLETED|Second Intervention Period||0
6429081|NCT01033487|7343533|FG006|NOT COMPLETED|Second Intervention Period||0
6429082|NCT01033487|7343534|FG007|NOT COMPLETED|Second Intervention Period||0
6429083|NCT01033487|7343535|FG008|NOT COMPLETED|Second Intervention Period||0
6429084|NCT01033487|7343536|FG009|NOT COMPLETED|Second Intervention Period||0
6429085|NCT01033487|7343527|FG000|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6429086|NCT01033487|7343528|FG001|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
6429087|NCT01033487|7343529|FG002|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6429088|NCT01033487|7343530|FG003|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6429089|NCT01033487|7343531|FG004|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6429090|NCT01033487|7343532|FG005|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6429091|NCT01033487|7343533|FG006|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6429092|NCT01033487|7343534|FG007|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
6429093|NCT01033487|7343535|FG008|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6429094|NCT01033487|7343536|FG009|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
6429095|NCT01033487|7343527|FG000|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6429096|NCT01033487|7343528|FG001|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
6429097|NCT01033487|7343529|FG002|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6429098|NCT01033487|7343530|FG003|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6429099|NCT01033487|7343531|FG004|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6429100|NCT01033487|7343532|FG005|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6429101|NCT01033487|7343533|FG006|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6429102|NCT01033487|7343534|FG007|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
6429103|NCT01033487|7343535|FG008|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6429104|NCT01033487|7343536|FG009|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
6429105|NCT01033487|7343527|FG000|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429106|NCT01033487|7343528|FG001|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429107|NCT01033487|7343529|FG002|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429108|NCT01033487|7343530|FG003|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429109|NCT01033487|7343531|FG004|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429110|NCT01033487|7343532|FG005|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429111|NCT01033487|7343533|FG006|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429112|NCT01033487|7343534|FG007|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429113|NCT01033487|7343535|FG008|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429114|NCT01033487|7343536|FG009|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
6429115|NCT01033487|7343527|FG000|STARTED|Third Intervention Period||2
6429116|NCT01033487|7343528|FG001|STARTED|Third Intervention Period||3
6429117|NCT01033487|7343529|FG002|STARTED|Third Intervention Period||2
6429118|NCT01033487|7343530|FG003|STARTED|Third Intervention Period||2
6429119|NCT01033487|7343531|FG004|STARTED|Third Intervention Period||2
6429120|NCT01033487|7343532|FG005|STARTED|Third Intervention Period||2
6429121|NCT01033487|7343533|FG006|STARTED|Third Intervention Period||2
6429122|NCT01033487|7343534|FG007|STARTED|Third Intervention Period||3
6429123|NCT01033487|7343535|FG008|STARTED|Third Intervention Period||2
6429124|NCT01033487|7343536|FG009|STARTED|Third Intervention Period||2
6429125|NCT01033487|7343527|FG000|COMPLETED|Third Intervention Period||2
6429126|NCT01033487|7343528|FG001|COMPLETED|Third Intervention Period||3
6429127|NCT01033487|7343529|FG002|COMPLETED|Third Intervention Period||2
6429128|NCT01033487|7343530|FG003|COMPLETED|Third Intervention Period||2
6429129|NCT01033487|7343531|FG004|COMPLETED|Third Intervention Period||2
6429130|NCT01033487|7343532|FG005|COMPLETED|Third Intervention Period||2
6429131|NCT01033487|7343533|FG006|COMPLETED|Third Intervention Period||2
6429132|NCT01033487|7343534|FG007|COMPLETED|Third Intervention Period||3
6429133|NCT01033487|7343535|FG008|COMPLETED|Third Intervention Period||2
6429134|NCT01033487|7343536|FG009|COMPLETED|Third Intervention Period||2
6429135|NCT01033487|7343527|FG000|NOT COMPLETED|Third Intervention Period||0
6429136|NCT01033487|7343528|FG001|NOT COMPLETED|Third Intervention Period||0
6552078|NCT01735994|7474505|FG001|Follow-Up #1 (6 Months)|Overall Study||163
6429137|NCT01033487|7343529|FG002|NOT COMPLETED|Third Intervention Period||0
6429138|NCT01033487|7343530|FG003|NOT COMPLETED|Third Intervention Period||0
6429139|NCT01033487|7343531|FG004|NOT COMPLETED|Third Intervention Period||0
6429140|NCT01033487|7343532|FG005|NOT COMPLETED|Third Intervention Period||0
6429141|NCT01033487|7343533|FG006|NOT COMPLETED|Third Intervention Period||0
6429142|NCT01033487|7343534|FG007|NOT COMPLETED|Third Intervention Period||0
6429143|NCT01033487|7343535|FG008|NOT COMPLETED|Third Intervention Period||0
6429144|NCT01033487|7343536|FG009|NOT COMPLETED|Third Intervention Period||0
6429145|NCT01033487|7343527|FG000|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6429146|NCT01033487|7343528|FG001|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
6429147|NCT01033487|7343529|FG002|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6429148|NCT01033487|7343530|FG003|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6429149|NCT01033487|7343531|FG004|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6429150|NCT01033487|7343532|FG005|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6429151|NCT01033487|7343533|FG006|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6429152|NCT01033487|7343534|FG007|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
6429153|NCT01033487|7343535|FG008|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6429154|NCT01033487|7343536|FG009|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
6429155|NCT01033487|7343527|FG000|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6429156|NCT01033487|7343528|FG001|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
6429157|NCT01033487|7343529|FG002|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6429158|NCT01033487|7343530|FG003|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6429159|NCT01033487|7343531|FG004|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6429160|NCT01033487|7343532|FG005|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6429161|NCT01033487|7343533|FG006|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6429162|NCT01033487|7343534|FG007|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
6429163|NCT01033487|7343535|FG008|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6429164|NCT01033487|7343536|FG009|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
6429165|NCT01033487|7343527|FG000|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429166|NCT01033487|7343528|FG001|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429167|NCT01033487|7343529|FG002|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429168|NCT01033487|7343530|FG003|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429169|NCT01033487|7343531|FG004|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429170|NCT01033487|7343532|FG005|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429171|NCT01033487|7343533|FG006|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429172|NCT01033487|7343534|FG007|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6552079|NCT01735994|7474504|FG000|Follow-Up #2 (12 Months)|Overall Study||212
6552080|NCT01735994|7474505|FG001|Follow-Up #2 (12 Months)|Overall Study||174
6552081|NCT01735994|7474504|FG000|COMPLETED|Overall Study||200
6552082|NCT01735994|7474505|FG001|COMPLETED|Overall Study||152
6552083|NCT01735994|7474504|FG000|NOT COMPLETED|Overall Study||63
6552084|NCT01735994|7474505|FG001|NOT COMPLETED|Overall Study||66
6552085|NCT01736085|7474517|FG000|STARTED|Overall Study||529
6552086|NCT01736085|7474518|FG001|STARTED|Overall Study||530
6552087|NCT01736085|7474519|FG002|STARTED|Overall Study||793
6429173|NCT01033487|7343535|FG008|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429174|NCT01033487|7343536|FG009|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
6429175|NCT01033487|7343527|FG000|STARTED|Fourth Intervention Period||2
6429176|NCT01033487|7343528|FG001|STARTED|Fourth Intervention Period||3
6429177|NCT01033487|7343529|FG002|STARTED|Fourth Intervention Period||2
6429178|NCT01033487|7343530|FG003|STARTED|Fourth Intervention Period||2
6429179|NCT01033487|7343531|FG004|STARTED|Fourth Intervention Period||2
6429180|NCT01033487|7343532|FG005|STARTED|Fourth Intervention Period||2
6429181|NCT01033487|7343533|FG006|STARTED|Fourth Intervention Period||2
6429182|NCT01033487|7343534|FG007|STARTED|Fourth Intervention Period||3
6429183|NCT01033487|7343535|FG008|STARTED|Fourth Intervention Period||2
6429184|NCT01033487|7343536|FG009|STARTED|Fourth Intervention Period||2
6429185|NCT01033487|7343527|FG000|COMPLETED|Fourth Intervention Period||2
6429186|NCT01033487|7343528|FG001|COMPLETED|Fourth Intervention Period||3
6429187|NCT01033487|7343529|FG002|COMPLETED|Fourth Intervention Period||2
6429188|NCT01033487|7343530|FG003|COMPLETED|Fourth Intervention Period||2
6429189|NCT01033487|7343531|FG004|COMPLETED|Fourth Intervention Period||2
6429190|NCT01033487|7343532|FG005|COMPLETED|Fourth Intervention Period||2
6429191|NCT01033487|7343533|FG006|COMPLETED|Fourth Intervention Period||2
6429192|NCT01033487|7343534|FG007|COMPLETED|Fourth Intervention Period||3
6429193|NCT01033487|7343535|FG008|COMPLETED|Fourth Intervention Period||1
6429194|NCT01033487|7343536|FG009|COMPLETED|Fourth Intervention Period||2
6429195|NCT01033487|7343527|FG000|NOT COMPLETED|Fourth Intervention Period||0
6429196|NCT01033487|7343528|FG001|NOT COMPLETED|Fourth Intervention Period||0
6429197|NCT01033487|7343529|FG002|NOT COMPLETED|Fourth Intervention Period||0
6429198|NCT01033487|7343530|FG003|NOT COMPLETED|Fourth Intervention Period||0
6429199|NCT01033487|7343531|FG004|NOT COMPLETED|Fourth Intervention Period||0
6429200|NCT01033487|7343532|FG005|NOT COMPLETED|Fourth Intervention Period||0
6429201|NCT01033487|7343533|FG006|NOT COMPLETED|Fourth Intervention Period||0
6552088|NCT01736085|7474520|FG003|STARTED|Overall Study||530
6552089|NCT01736085|7474521|FG004|STARTED|Overall Study||530
6552090|NCT01736085|7474522|FG005|STARTED|Overall Study||794
6552091|NCT01736085|7474517|FG000|COMPLETED|Overall Study||529
6429202|NCT01033487|7343534|FG007|NOT COMPLETED|Fourth Intervention Period||0
6429203|NCT01033487|7343535|FG008|NOT COMPLETED|Fourth Intervention Period||1
6429204|NCT01033487|7343536|FG009|NOT COMPLETED|Fourth Intervention Period||0
6429205|NCT01033487|7343527|FG000|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6429206|NCT01033487|7343528|FG001|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
6429207|NCT01033487|7343529|FG002|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6429208|NCT01033487|7343530|FG003|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6429209|NCT01033487|7343531|FG004|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6429210|NCT01033487|7343532|FG005|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6429211|NCT01033487|7343533|FG006|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6429212|NCT01033487|7343534|FG007|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
6429213|NCT01033487|7343535|FG008|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
6429214|NCT01033487|7343536|FG009|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
6429215|NCT01033487|7343527|FG000|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6429216|NCT01033487|7343528|FG001|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
6429217|NCT01033487|7343529|FG002|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6429218|NCT01033487|7343530|FG003|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6429219|NCT01033487|7343531|FG004|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6429220|NCT01033487|7343532|FG005|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6429221|NCT01033487|7343533|FG006|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6429222|NCT01033487|7343534|FG007|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
6429223|NCT01033487|7343535|FG008|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
6429224|NCT01033487|7343536|FG009|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
6429225|NCT01033487|7343527|FG000|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429226|NCT01033487|7343528|FG001|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429227|NCT01033487|7343529|FG002|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429228|NCT01033487|7343530|FG003|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429229|NCT01033487|7343531|FG004|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429230|NCT01033487|7343532|FG005|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429231|NCT01033487|7343533|FG006|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429232|NCT01033487|7343534|FG007|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429233|NCT01033487|7343535|FG008|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429234|NCT01033487|7343536|FG009|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
6429235|NCT01033487|7343527|FG000|STARTED|Fifth Intervention Period||2
6429236|NCT01033487|7343528|FG001|STARTED|Fifth Intervention Period||3
6429237|NCT01033487|7343529|FG002|STARTED|Fifth Intervention Period||2
6429238|NCT01033487|7343530|FG003|STARTED|Fifth Intervention Period||2
6429239|NCT01033487|7343531|FG004|STARTED|Fifth Intervention Period||2
6429240|NCT01033487|7343532|FG005|STARTED|Fifth Intervention Period||2
6552092|NCT01736085|7474518|FG001|COMPLETED|Overall Study||530
6552093|NCT01736085|7474519|FG002|COMPLETED|Overall Study||793
6429241|NCT01033487|7343533|FG006|STARTED|Fifth Intervention Period||2
6429242|NCT01033487|7343534|FG007|STARTED|Fifth Intervention Period||3
6429243|NCT01033487|7343535|FG008|STARTED|Fifth Intervention Period||1
6429244|NCT01033487|7343536|FG009|STARTED|Fifth Intervention Period||2
6429245|NCT01033487|7343527|FG000|COMPLETED|Fifth Intervention Period||2
6429246|NCT01033487|7343528|FG001|COMPLETED|Fifth Intervention Period||3
6429247|NCT01033487|7343529|FG002|COMPLETED|Fifth Intervention Period||2
6429248|NCT01033487|7343530|FG003|COMPLETED|Fifth Intervention Period||2
6429249|NCT01033487|7343531|FG004|COMPLETED|Fifth Intervention Period||2
6429250|NCT01033487|7343532|FG005|COMPLETED|Fifth Intervention Period||2
6429251|NCT01033487|7343533|FG006|COMPLETED|Fifth Intervention Period||2
6429252|NCT01033487|7343534|FG007|COMPLETED|Fifth Intervention Period||3
6429253|NCT01033487|7343535|FG008|COMPLETED|Fifth Intervention Period||1
6429254|NCT01033487|7343536|FG009|COMPLETED|Fifth Intervention Period||2
6429255|NCT01033487|7343527|FG000|NOT COMPLETED|Fifth Intervention Period||0
6429256|NCT01033487|7343528|FG001|NOT COMPLETED|Fifth Intervention Period||0
6429257|NCT01033487|7343529|FG002|NOT COMPLETED|Fifth Intervention Period||0
6429258|NCT01033487|7343530|FG003|NOT COMPLETED|Fifth Intervention Period||0
6429259|NCT01033487|7343531|FG004|NOT COMPLETED|Fifth Intervention Period||0
6429260|NCT01033487|7343532|FG005|NOT COMPLETED|Fifth Intervention Period||0
6429261|NCT01033487|7343533|FG006|NOT COMPLETED|Fifth Intervention Period||0
6429262|NCT01033487|7343534|FG007|NOT COMPLETED|Fifth Intervention Period||0
6429263|NCT01033487|7343535|FG008|NOT COMPLETED|Fifth Intervention Period||0
6429264|NCT01033487|7343536|FG009|NOT COMPLETED|Fifth Intervention Period||0
6429265|NCT01033565|7343550|FG000|STARTED|Overall Study||1
6429266|NCT01033565|7343550|FG000|COMPLETED|Overall Study||1
6429267|NCT01033565|7343550|FG000|NOT COMPLETED|Overall Study||0
6429268|NCT01033643|7343559|FG000|STARTED|Overall Study||6
6429269|NCT01033643|7343560|FG001|STARTED|Overall Study||6
6429270|NCT01033643|7343561|FG002|STARTED|Overall Study||6
6429271|NCT01033643|7343562|FG003|STARTED|Overall Study||4
6429272|NCT01033643|7343563|FG004|STARTED|Overall Study||0
6429273|NCT01033643|7343564|FG005|STARTED|Overall Study||8
6429274|NCT01033643|7343559|FG000|COMPLETED|Overall Study||6
6429275|NCT01033643|7343560|FG001|COMPLETED|Overall Study||3
6429276|NCT01033643|7343561|FG002|COMPLETED|Overall Study||6
6429277|NCT01033643|7343562|FG003|COMPLETED|Overall Study||4
6429278|NCT01033643|7343563|FG004|COMPLETED|Overall Study||0
6429279|NCT01033643|7343564|FG005|COMPLETED|Overall Study||7
6429280|NCT01033643|7343559|FG000|NOT COMPLETED|Overall Study||0
6429281|NCT01033643|7343560|FG001|NOT COMPLETED|Overall Study||3
6429282|NCT01033643|7343561|FG002|NOT COMPLETED|Overall Study||0
6552094|NCT01736085|7474520|FG003|COMPLETED|Overall Study||530
6552095|NCT01736085|7474521|FG004|COMPLETED|Overall Study||530
6552096|NCT01736085|7474522|FG005|COMPLETED|Overall Study||794
6552097|NCT01736085|7474517|FG000|NOT COMPLETED|Overall Study||0
6552098|NCT01736085|7474518|FG001|NOT COMPLETED|Overall Study||0
6552099|NCT01736085|7474519|FG002|NOT COMPLETED|Overall Study||0
6429283|NCT01033643|7343562|FG003|NOT COMPLETED|Overall Study||0
6429284|NCT01033643|7343563|FG004|NOT COMPLETED|Overall Study||0
6429285|NCT01033643|7343564|FG005|NOT COMPLETED|Overall Study||1
6499585|NCT01419626|7418308|FG000|NOT COMPLETED|Overall Study||4
6499586|NCT01419626|7418309|FG001|NOT COMPLETED|Overall Study||3
6499587|NCT01419626|7418310|FG002|NOT COMPLETED|Overall Study||3
6499588|NCT01419639|7418318|FG000|STARTED|Overall Study||10
6499589|NCT01419639|7418318|FG000|COMPLETED|Overall Study||9
6499590|NCT01419639|7418318|FG000|NOT COMPLETED|Overall Study||1
6499591|NCT01419665|7418324|FG000|STARTED|Combination Treatment||312
6499592|NCT01419665|7418325|FG001|STARTED|Combination Treatment||315
6499593|NCT01419665|7418324|FG000|COMPLETED|Combination Treatment||274
6499594|NCT01419665|7418325|FG001|COMPLETED|Combination Treatment||274
6499595|NCT01419665|7418324|FG000|NOT COMPLETED|Combination Treatment||38
6499596|NCT01419665|7418325|FG001|NOT COMPLETED|Combination Treatment||41
6499597|NCT01419665|7418324|FG000|STARTED|Maintenance Treatment and/or Follow up||254
6499598|NCT01419665|7418325|FG001|STARTED|Maintenance Treatment and/or Follow up||252
6499599|NCT01419665|7418324|FG000|COMPLETED|Maintenance Treatment and/or Follow up||132
6499600|NCT01419665|7418325|FG001|COMPLETED|Maintenance Treatment and/or Follow up||150
6499601|NCT01419665|7418324|FG000|NOT COMPLETED|Maintenance Treatment and/or Follow up||122
6499602|NCT01419665|7418325|FG001|NOT COMPLETED|Maintenance Treatment and/or Follow up||102
6499603|NCT01419665|7418324|FG000|STARTED|Open Label Phase||44
6499604|NCT01419665|7418325|FG001|STARTED|Open Label Phase||39
6499605|NCT01419665|7418324|FG000|COMPLETED|Open Label Phase||43
6499606|NCT01419665|7418325|FG001|COMPLETED|Open Label Phase||38
6499607|NCT01419665|7418324|FG000|NOT COMPLETED|Open Label Phase||1
6499608|NCT01419665|7418325|FG001|NOT COMPLETED|Open Label Phase||1
6499609|NCT01419717|7418333|FG000|STARTED|Overall Study||129
6499610|NCT01419717|7418333|FG000|Received Denosumab|Overall Study||128
6499611|NCT01419717|7418333|FG000|COMPLETED|Overall Study||4
6499612|NCT01419717|7418333|FG000|NOT COMPLETED|Overall Study||125
6499613|NCT01419769|7418337|FG000|STARTED|Overall Study||33
6499614|NCT01419769|7418337|FG000|COMPLETED|Overall Study||29
6499615|NCT01419769|7418337|FG000|NOT COMPLETED|Overall Study||4
6499616|NCT01419795|7418343|FG000|STARTED|Overall Study||3
6499617|NCT01419795|7418344|FG001|STARTED|Overall Study||0
6499618|NCT01419795|7418343|FG000|COMPLETED|Overall Study||3
6499619|NCT01419795|7418344|FG001|COMPLETED|Overall Study||0
6499620|NCT01419795|7418343|FG000|NOT COMPLETED|Overall Study||0
6499621|NCT01419795|7418344|FG001|NOT COMPLETED|Overall Study||0
6499622|NCT01419977|7418352|FG000|STARTED|Overall Study||16
6499623|NCT01419977|7418353|FG001|STARTED|Overall Study||13
6499624|NCT01419977|7418352|FG000|COMPLETED|Overall Study||16
6499625|NCT01419977|7418353|FG001|COMPLETED|Overall Study||13
6499626|NCT01419977|7418352|FG000|NOT COMPLETED|Overall Study||0
6499627|NCT01419977|7418353|FG001|NOT COMPLETED|Overall Study||0
6499628|NCT01420016|7418361|FG000|STARTED|Primary Analysis||6970
6499629|NCT01420016|7418362|FG001|STARTED|Primary Analysis||6411
6499630|NCT01420016|7418363|FG002|STARTED|Primary Analysis||0
6499631|NCT01420016|7418364|FG003|STARTED|Primary Analysis||0
6499632|NCT01420016|7418361|FG000|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|4043
6499633|NCT01420016|7418362|FG001|COMPLETED|Primary Analysis|Reflects patient participants included in final analysis.|3871
6499634|NCT01420016|7418363|FG002|COMPLETED|Primary Analysis||0
6499635|NCT01420016|7418364|FG003|COMPLETED|Primary Analysis||0
6499636|NCT01420016|7418361|FG000|NOT COMPLETED|Primary Analysis||2927
6499637|NCT01420016|7418362|FG001|NOT COMPLETED|Primary Analysis||2540
6499638|NCT01420016|7418363|FG002|NOT COMPLETED|Primary Analysis||0
6499639|NCT01420016|7418364|FG003|NOT COMPLETED|Primary Analysis||0
6499640|NCT01420016|7418361|FG000|STARTED|Safety Analysis||0
6499641|NCT01420016|7418362|FG001|STARTED|Safety Analysis||0
6499642|NCT01420016|7418363|FG002|STARTED|Safety Analysis||6392
6499643|NCT01420016|7418364|FG003|STARTED|Safety Analysis||5159
6499644|NCT01420016|7418361|FG000|COMPLETED|Safety Analysis||0
6499645|NCT01420016|7418362|FG001|COMPLETED|Safety Analysis||0
6499646|NCT01420016|7418363|FG002|COMPLETED|Safety Analysis||6392
6499647|NCT01420016|7418364|FG003|COMPLETED|Safety Analysis||5159
6499648|NCT01420016|7418361|FG000|NOT COMPLETED|Safety Analysis||0
6499649|NCT01420016|7418362|FG001|NOT COMPLETED|Safety Analysis||0
6499650|NCT01420016|7418363|FG002|NOT COMPLETED|Safety Analysis||0
6552100|NCT01736085|7474520|FG003|NOT COMPLETED|Overall Study||0
6552101|NCT01736085|7474521|FG004|NOT COMPLETED|Overall Study||0
6552102|NCT01736085|7474522|FG005|NOT COMPLETED|Overall Study||0
6499651|NCT01420016|7418364|FG003|NOT COMPLETED|Safety Analysis||0
6499652|NCT01420068|7418372|FG000|STARTED|Overall Study||51
6499653|NCT01420068|7418373|FG001|STARTED|Overall Study||55
6499654|NCT01420068|7418372|FG000|COMPLETED|Overall Study||49
6499655|NCT01420068|7418373|FG001|COMPLETED|Overall Study||50
6499656|NCT01420068|7418372|FG000|NOT COMPLETED|Overall Study||2
6499657|NCT01420068|7418373|FG001|NOT COMPLETED|Overall Study||5
6552103|NCT01736124|7474535|FG000|STARTED|Baseline||90
6429286|NCT01033734|7343578|FG000|STARTED|Overall Study||8
6429287|NCT01033734|7343578|FG000|COMPLETED|Overall Study||7
6429288|NCT01033734|7343578|FG000|NOT COMPLETED|Overall Study||1
6429289|NCT01033747|7343593|FG000|STARTED|Overall Study||51
6429290|NCT01033747|7343594|FG001|STARTED|Overall Study||19
6429291|NCT01033747|7343593|FG000|COMPLETED|Overall Study||14
6429292|NCT01033747|7343594|FG001|COMPLETED|Overall Study||4
6429293|NCT01033747|7343593|FG000|NOT COMPLETED|Overall Study||37
6429294|NCT01033747|7343594|FG001|NOT COMPLETED|Overall Study||15
6429295|NCT01033773|7343600|FG000|STARTED|Overall Study||86
6429296|NCT01033773|7343600|FG000|COMPLETED|Overall Study||51
6429297|NCT01033773|7343600|FG000|NOT COMPLETED|Overall Study||35
6429298|NCT01033825|7343611|FG000|STARTED|Overall Study||51
6429299|NCT01033825|7343612|FG001|STARTED|Overall Study||60
6429300|NCT01033825|7343613|FG002|STARTED|Overall Study||57
6429301|NCT01033825|7343614|FG003|STARTED|Overall Study||48
6429302|NCT01033825|7343615|FG004|STARTED|Overall Study||58
6429303|NCT01033825|7343616|FG005|STARTED|Overall Study||18
6429304|NCT01033825|7343617|FG006|STARTED|Overall Study||18
6429305|NCT01033825|7343611|FG000|COMPLETED|Overall Study||48
6429306|NCT01033825|7343612|FG001|COMPLETED|Overall Study||57
6429307|NCT01033825|7343613|FG002|COMPLETED|Overall Study||55
6429308|NCT01033825|7343614|FG003|COMPLETED|Overall Study||46
6429309|NCT01033825|7343615|FG004|COMPLETED|Overall Study||56
6429310|NCT01033825|7343616|FG005|COMPLETED|Overall Study||18
6429311|NCT01033825|7343617|FG006|COMPLETED|Overall Study||18
6429312|NCT01033825|7343611|FG000|NOT COMPLETED|Overall Study||3
6429313|NCT01033825|7343612|FG001|NOT COMPLETED|Overall Study||3
6429314|NCT01033825|7343613|FG002|NOT COMPLETED|Overall Study||2
6429315|NCT01033825|7343614|FG003|NOT COMPLETED|Overall Study||2
6429316|NCT01033825|7343615|FG004|NOT COMPLETED|Overall Study||2
6429317|NCT01033825|7343616|FG005|NOT COMPLETED|Overall Study||0
6429318|NCT01033825|7343617|FG006|NOT COMPLETED|Overall Study||0
6429319|NCT01033851|7343637|FG000|STARTED|Overall Study||48
6429320|NCT01033851|7343638|FG001|STARTED|Overall Study||41
6429321|NCT01033851|7343637|FG000|COMPLETED|Overall Study||45
6429322|NCT01033851|7343638|FG001|COMPLETED|Overall Study||34
6429323|NCT01033851|7343637|FG000|NOT COMPLETED|Overall Study||3
6429324|NCT01033851|7343638|FG001|NOT COMPLETED|Overall Study||7
6429325|NCT01033864|7343646|FG000|STARTED|Overall Study||12
6429326|NCT01033864|7343647|FG001|STARTED|Overall Study||11
6429327|NCT01033864|7343646|FG000|COMPLETED|Overall Study||12
6429328|NCT01033864|7343647|FG001|COMPLETED|Overall Study||11
6429329|NCT01033864|7343646|FG000|NOT COMPLETED|Overall Study||0
6429330|NCT01033864|7343647|FG001|NOT COMPLETED|Overall Study||0
6429331|NCT01033942|7343656|FG000|STARTED|Overall Study||20
6429332|NCT01033942|7343657|FG001|STARTED|Overall Study||19
6429333|NCT01033942|7343658|FG002|STARTED|Overall Study||19
6429334|NCT01033942|7343656|FG000|COMPLETED|Overall Study||18
6429335|NCT01033942|7343657|FG001|COMPLETED|Overall Study||15
6429336|NCT01033942|7343658|FG002|COMPLETED|Overall Study||18
6429337|NCT01033942|7343656|FG000|NOT COMPLETED|Overall Study||2
6429338|NCT01033942|7343657|FG001|NOT COMPLETED|Overall Study||4
6429339|NCT01033942|7343658|FG002|NOT COMPLETED|Overall Study||1
6429340|NCT01034111|7343668|FG000|STARTED|Overall Study||30
6429341|NCT01034111|7343668|FG000|COMPLETED|Overall Study||30
6429342|NCT01034111|7343668|FG000|NOT COMPLETED|Overall Study||0
6429343|NCT01034137|7343675|FG000|STARTED|Overall Study||106
6429344|NCT01034137|7343676|FG001|STARTED|Overall Study||103
6429345|NCT01034137|7343677|FG002|STARTED|Overall Study||108
6429346|NCT01034137|7343675|FG000|COMPLETED|Overall Study||78
6429347|NCT01034137|7343676|FG001|COMPLETED|Overall Study||81
6429348|NCT01034137|7343677|FG002|COMPLETED|Overall Study||78
6429349|NCT01034137|7343675|FG000|NOT COMPLETED|Overall Study||28
6429350|NCT01034137|7343676|FG001|NOT COMPLETED|Overall Study||22
6429351|NCT01034137|7343677|FG002|NOT COMPLETED|Overall Study||30
6429352|NCT01034163|7343688|FG000|STARTED|Overall Study||27
6429353|NCT01034163|7343689|FG001|STARTED|Overall Study||14
6429354|NCT01034163|7343688|FG000|Untreated (Not in Safety Set)|Overall Study||1
6429355|NCT01034163|7343689|FG001|Untreated (Not in Safety Set)|Overall Study||2
6429356|NCT01034163|7343688|FG000|Safety Set|Overall Study||26
6552104|NCT01736124|7474536|FG001|STARTED|Baseline||90
6552105|NCT01736124|7474535|FG000|COMPLETED|Baseline||90
6552106|NCT01736124|7474536|FG001|COMPLETED|Baseline||90
6552107|NCT01736124|7474535|FG000|NOT COMPLETED|Baseline||0
6552108|NCT01736124|7474536|FG001|NOT COMPLETED|Baseline||0
6552109|NCT01736124|7474535|FG000|STARTED|Post-intervention Assessment||90
6552110|NCT01736124|7474536|FG001|STARTED|Post-intervention Assessment||90
6429357|NCT01034163|7343689|FG001|Safety Set|Overall Study||12
6429358|NCT01034163|7343688|FG000|In Open Label Phase After Unblinding|Overall Study||5
6429359|NCT01034163|7343689|FG001|In Open Label Phase After Unblinding|Overall Study||0
6429360|NCT01034163|7343688|FG000|COMPLETED|Overall Study||0
6429361|NCT01034163|7343689|FG001|COMPLETED|Overall Study||0
6429362|NCT01034163|7343688|FG000|NOT COMPLETED|Overall Study||27
6429363|NCT01034163|7343689|FG001|NOT COMPLETED|Overall Study||14
6429364|NCT01034176|7343697|FG000|STARTED|Overall Study||22
6429365|NCT01034176|7343698|FG001|STARTED|Overall Study||21
6429366|NCT01034176|7343697|FG000|COMPLETED|Overall Study||20
6429367|NCT01034176|7343698|FG001|COMPLETED|Overall Study||19
6429368|NCT01034176|7343697|FG000|NOT COMPLETED|Overall Study||2
6429369|NCT01034176|7343698|FG001|NOT COMPLETED|Overall Study||2
6429370|NCT01034358|7343704|FG000|STARTED|Overall Study||15
6429371|NCT01034358|7343704|FG000|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
6429372|NCT01034358|7343704|FG000|NOT COMPLETED|Overall Study||2
6429373|NCT01034397|7343710|FG000|STARTED|Overall Study||35
6429374|NCT01034397|7343711|FG001|STARTED|Overall Study||19
6429375|NCT01034397|7343710|FG000|COMPLETED|Overall Study||28
6429376|NCT01034397|7343711|FG001|COMPLETED|Overall Study||17
6429377|NCT01034397|7343710|FG000|NOT COMPLETED|Overall Study||7
6429378|NCT01034397|7343711|FG001|NOT COMPLETED|Overall Study||2
6429379|NCT01034462|7343728|FG000|STARTED|Overall Study||217
6429380|NCT01034462|7343729|FG001|STARTED|Overall Study||217
6429381|NCT01034462|7343728|FG000|COMPLETED|Overall Study||172
6429382|NCT01034462|7343729|FG001|COMPLETED|Overall Study||163
6429383|NCT01034462|7343728|FG000|NOT COMPLETED|Overall Study||45
6429384|NCT01034462|7343729|FG001|NOT COMPLETED|Overall Study||54
6429385|NCT01034527|7343739|FG000|STARTED|Overall Study||307
6429386|NCT01034527|7343740|FG001|STARTED|Overall Study||216
6429387|NCT01034527|7343739|FG000|COMPLETED|Overall Study||307
6429388|NCT01034527|7343740|FG001|COMPLETED|Overall Study||216
6429389|NCT01034527|7343739|FG000|NOT COMPLETED|Overall Study||0
6429390|NCT01034527|7343740|FG001|NOT COMPLETED|Overall Study||0
6552111|NCT01736124|7474535|FG000|COMPLETED|Post-intervention Assessment||59
6552112|NCT01736124|7474536|FG001|COMPLETED|Post-intervention Assessment||69
6552113|NCT01736124|7474535|FG000|NOT COMPLETED|Post-intervention Assessment||31
6552114|NCT01736124|7474536|FG001|NOT COMPLETED|Post-intervention Assessment||21
6552115|NCT01736124|7474535|FG000|STARTED|6 Mo. Post-Intervention Assessment|"Includes 3 who were temporarily away at Period 2 who did not permanently withdraw from the study."|62
6552116|NCT01736124|7474536|FG001|STARTED|6 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 2 but did not permanently withdraw."|70
6552117|NCT01736124|7474535|FG000|COMPLETED|6 Mo. Post-Intervention Assessment||57
6552118|NCT01736124|7474536|FG001|COMPLETED|6 Mo. Post-Intervention Assessment||58
6429391|NCT01034540|7343748|FG000|STARTED|Overall Study||11
6429392|NCT01034540|7343749|FG001|STARTED|Overall Study||12
6429393|NCT01034540|7343748|FG000|Completed 1st Treatment Intervention|Overall Study||11
6429394|NCT01034540|7343749|FG001|Completed 1st Treatment Intervention|Overall Study||11
6429395|NCT01034540|7343748|FG000|COMPLETED|Overall Study||11
6429396|NCT01034540|7343749|FG001|COMPLETED|Overall Study||11
6429397|NCT01034540|7343748|FG000|NOT COMPLETED|Overall Study||0
6429398|NCT01034540|7343749|FG001|NOT COMPLETED|Overall Study||1
6429399|NCT01034553|7343757|FG000|STARTED|Overall Study||3
6429400|NCT01034553|7343758|FG001|STARTED|Overall Study||4
6429401|NCT01034553|7343759|FG002|STARTED|Overall Study||3
6429402|NCT01034553|7343760|FG003|STARTED|Overall Study||3
6429403|NCT01034553|7343761|FG004|STARTED|Overall Study||6
6429404|NCT01034553|7343762|FG005|STARTED|Overall Study||7
6429405|NCT01034553|7343757|FG000|COMPLETED|Overall Study||3
6429406|NCT01034553|7343758|FG001|COMPLETED|Overall Study||4
6429407|NCT01034553|7343759|FG002|COMPLETED|Overall Study||3
6429408|NCT01034553|7343760|FG003|COMPLETED|Overall Study||3
6429409|NCT01034553|7343761|FG004|COMPLETED|Overall Study||6
6429410|NCT01034553|7343762|FG005|COMPLETED|Overall Study||7
6429411|NCT01034553|7343757|FG000|NOT COMPLETED|Overall Study||0
6429412|NCT01034553|7343758|FG001|NOT COMPLETED|Overall Study||0
6429413|NCT01034553|7343759|FG002|NOT COMPLETED|Overall Study||0
6429414|NCT01034553|7343760|FG003|NOT COMPLETED|Overall Study||0
6429415|NCT01034553|7343761|FG004|NOT COMPLETED|Overall Study||0
6429416|NCT01034553|7343762|FG005|NOT COMPLETED|Overall Study||0
6429417|NCT01034579|7343778|FG000|STARTED|Overall Study||158
6429418|NCT01034579|7343779|FG001|STARTED|Overall Study||166
6429419|NCT01034579|7343778|FG000|COMPLETED|Overall Study||158
6429420|NCT01034579|7343779|FG001|COMPLETED|Overall Study||166
6429421|NCT01034579|7343778|FG000|NOT COMPLETED|Overall Study||0
6429422|NCT01034579|7343779|FG001|NOT COMPLETED|Overall Study||0
6429423|NCT01034592|7343785|FG000|STARTED|Overall Study||2
6429424|NCT01034592|7343785|FG000|COMPLETED|Overall Study||2
6429425|NCT01034592|7343785|FG000|NOT COMPLETED|Overall Study||0
6429426|NCT01034631|7343793|FG000|STARTED|Phase I||15
6429427|NCT01034631|7343794|FG001|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
6429428|NCT01034631|7343795|FG002|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
6429429|NCT01034631|7343793|FG000|COMPLETED|Phase I||12
6429430|NCT01034631|7343794|FG001|COMPLETED|Phase I||0
6429431|NCT01034631|7343795|FG002|COMPLETED|Phase I||0
6429432|NCT01034631|7343793|FG000|NOT COMPLETED|Phase I||3
6429433|NCT01034631|7343794|FG001|NOT COMPLETED|Phase I||0
6429434|NCT01034631|7343795|FG002|NOT COMPLETED|Phase I||0
6429435|NCT01034631|7343793|FG000|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
6429436|NCT01034631|7343794|FG001|STARTED|Phase II||70
6429437|NCT01034631|7343795|FG002|STARTED|Phase II||69
6429438|NCT01034631|7343793|FG000|COMPLETED|Phase II||0
6429439|NCT01034631|7343794|FG001|COMPLETED|Phase II||69
6429440|NCT01034631|7343795|FG002|COMPLETED|Phase II||67
6429441|NCT01034631|7343793|FG000|NOT COMPLETED|Phase II||0
6429442|NCT01034631|7343794|FG001|NOT COMPLETED|Phase II||1
6429443|NCT01034631|7343795|FG002|NOT COMPLETED|Phase II||2
6429444|NCT01034657|7343805|FG000|STARTED|Core Phase||34
6429445|NCT01034657|7343806|FG001|STARTED|Core Phase||0
6429446|NCT01034657|7343807|FG002|STARTED|Core Phase||0
6429447|NCT01034657|7343805|FG000|COMPLETED|Core Phase||20
6429448|NCT01034657|7343806|FG001|COMPLETED|Core Phase||0
6429449|NCT01034657|7343807|FG002|COMPLETED|Core Phase||0
6429450|NCT01034657|7343805|FG000|NOT COMPLETED|Core Phase||14
6429451|NCT01034657|7343806|FG001|NOT COMPLETED|Core Phase||0
6429452|NCT01034657|7343807|FG002|NOT COMPLETED|Core Phase||0
6429453|NCT01034657|7343805|FG000|STARTED|Randomized Phase||6
6429454|NCT01034657|7343806|FG001|STARTED|Randomized Phase||6
6429455|NCT01034657|7343807|FG002|STARTED|Randomized Phase||1
6429456|NCT01034657|7343805|FG000|COMPLETED|Randomized Phase||1
6429457|NCT01034657|7343806|FG001|COMPLETED|Randomized Phase||0
6429458|NCT01034657|7343807|FG002|COMPLETED|Randomized Phase||0
6429459|NCT01034657|7343805|FG000|NOT COMPLETED|Randomized Phase||5
6429460|NCT01034657|7343806|FG001|NOT COMPLETED|Randomized Phase||6
6429461|NCT01034657|7343807|FG002|NOT COMPLETED|Randomized Phase||1
6429462|NCT01034709|7343819|FG000|STARTED|Overall Study||53
6429463|NCT01034709|7343820|FG001|STARTED|Overall Study||58
6552119|NCT01736124|7474535|FG000|NOT COMPLETED|6 Mo. Post-Intervention Assessment||5
6552120|NCT01736124|7474536|FG001|NOT COMPLETED|6 Mo. Post-Intervention Assessment||12
6552121|NCT01736124|7474535|FG000|STARTED|12 Mo. Post-Intervention Assessment|"Includes 1 who was temporarily away at Period 3 but did not permanently withdraw."|58
6552122|NCT01736124|7474536|FG001|STARTED|12 Mo. Post-Intervention Assessment|"Includes 4 who were temporarily away at Period 3 but did not permanently withdraw."|62
6552123|NCT01736124|7474535|FG000|COMPLETED|12 Mo. Post-Intervention Assessment||46
6552124|NCT01736124|7474536|FG001|COMPLETED|12 Mo. Post-Intervention Assessment||50
6429464|NCT01034709|7343819|FG000|COMPLETED|Overall Study||44
6429465|NCT01034709|7343820|FG001|COMPLETED|Overall Study||42
6429466|NCT01034709|7343819|FG000|NOT COMPLETED|Overall Study||9
6429467|NCT01034709|7343820|FG001|NOT COMPLETED|Overall Study||16
6429468|NCT01035047|7343828|FG000|STARTED|Overall Study||52
6429469|NCT01035047|7343829|FG001|STARTED|Overall Study||53
6429470|NCT01035047|7343828|FG000|COMPLETED|Overall Study||52
6429471|NCT01035047|7343829|FG001|COMPLETED|Overall Study||53
6429472|NCT01035047|7343828|FG000|NOT COMPLETED|Overall Study||0
6429473|NCT01035047|7343829|FG001|NOT COMPLETED|Overall Study||0
6429474|NCT01035060|7343837|FG000|STARTED|Overall Study||39
6429475|NCT01035060|7343838|FG001|STARTED|Overall Study||29
6429476|NCT01035060|7343837|FG000|COMPLETED|Overall Study||15
6429477|NCT01035060|7343838|FG001|COMPLETED|Overall Study||15
6429478|NCT01035060|7343837|FG000|NOT COMPLETED|Overall Study||24
6429479|NCT01035060|7343838|FG001|NOT COMPLETED|Overall Study||14
6429480|NCT01035099|7343846|FG000|STARTED|Overall Study||18
6429481|NCT01035099|7343847|FG001|STARTED|Overall Study||22
6429482|NCT01035099|7343846|FG000|COMPLETED|Overall Study||18
6429483|NCT01035099|7343847|FG001|COMPLETED|Overall Study||22
6429484|NCT01035099|7343846|FG000|NOT COMPLETED|Overall Study||0
6552125|NCT01736124|7474535|FG000|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
6552126|NCT01736124|7474536|FG001|NOT COMPLETED|12 Mo. Post-Intervention Assessment||12
6552127|NCT01736176|7474544|FG000|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
6429485|NCT01035099|7343847|FG001|NOT COMPLETED|Overall Study||0
6429486|NCT01035138|7343857|FG000|STARTED|Overall Study||73
6429487|NCT01035138|7343858|FG001|STARTED|Overall Study||60
6429488|NCT01035138|7343859|FG002|STARTED|Overall Study||47
6429489|NCT01035138|7343857|FG000|COMPLETED|Overall Study||0
6429490|NCT01035138|7343858|FG001|COMPLETED|Overall Study||0
6429491|NCT01035138|7343859|FG002|COMPLETED|Overall Study||0
6429492|NCT01035138|7343857|FG000|NOT COMPLETED|Overall Study||73
6429493|NCT01035138|7343858|FG001|NOT COMPLETED|Overall Study||60
6429494|NCT01035138|7343859|FG002|NOT COMPLETED|Overall Study||47
6429495|NCT01035151|7343871|FG000|STARTED|Overall Study||209
6429496|NCT01035151|7343872|FG001|STARTED|Overall Study||200
6429497|NCT01035151|7343871|FG000|COMPLETED|Overall Study||188
6429498|NCT01035151|7343872|FG001|COMPLETED|Overall Study||185
6429499|NCT01035151|7343871|FG000|NOT COMPLETED|Overall Study||21
6429500|NCT01035151|7343872|FG001|NOT COMPLETED|Overall Study||15
6429501|NCT01035229|7343880|FG000|STARTED|Overall Study||362
6429502|NCT01035229|7343881|FG001|STARTED|Overall Study||184
6429503|NCT01035229|7343880|FG000|COMPLETED|Overall Study||0
6429504|NCT01035229|7343881|FG001|COMPLETED|Overall Study||0
6429505|NCT01035229|7343880|FG000|NOT COMPLETED|Overall Study||362
6429506|NCT01035229|7343881|FG001|NOT COMPLETED|Overall Study||184
6429507|NCT01035255|7343891|FG000|STARTED|Overall Study||4209
6429508|NCT01035255|7343892|FG001|STARTED|Overall Study||4233
6429509|NCT01035255|7343891|FG000|GCP Violations|Overall Study||18
6429510|NCT01035255|7343892|FG001|GCP Violations|Overall Study||19
6429511|NCT01035255|7343891|FG000|Mis-randomized|Overall Study||4
6429512|NCT01035255|7343892|FG001|Mis-randomized|Overall Study||2
6429513|NCT01035255|7343891|FG000|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
6429514|NCT01035255|7343892|FG001|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
6429515|NCT01035255|7343891|FG000|COMPLETED|Overall Study||3468
6429516|NCT01035255|7343892|FG001|COMPLETED|Overall Study||3371
6552128|NCT01736176|7474544|FG000|Received LCIG|Overall Study||38
6552129|NCT01736176|7474544|FG000|COMPLETED|Overall Study||28
6429517|NCT01035255|7343891|FG000|NOT COMPLETED|Overall Study||741
6429518|NCT01035255|7343892|FG001|NOT COMPLETED|Overall Study||862
6429519|NCT01035333|7343898|FG000|STARTED|Overall Study||19
6429520|NCT01035333|7343898|FG000|COMPLETED|Overall Study||9
6429521|NCT01035333|7343898|FG000|NOT COMPLETED|Overall Study||10
6429522|NCT01035346|7343904|FG000|STARTED|Overall Study||7
6429523|NCT01035346|7343905|FG001|STARTED|Overall Study||9
6429524|NCT01035346|7343904|FG000|COMPLETED|Overall Study||7
6429525|NCT01035346|7343905|FG001|COMPLETED|Overall Study||9
6429526|NCT01035346|7343904|FG000|NOT COMPLETED|Overall Study||0
6429527|NCT01035346|7343905|FG001|NOT COMPLETED|Overall Study||0
6429528|NCT01035463|7343913|FG000|STARTED|Overall Study||6
6429529|NCT01035463|7343914|FG001|STARTED|Overall Study||3
6429530|NCT01035463|7343915|FG002|STARTED|Overall Study||6
6429531|NCT01035463|7343916|FG003|STARTED|Overall Study||4
6429532|NCT01035463|7343917|FG004|STARTED|Overall Study||7
6429533|NCT01035463|7343918|FG005|STARTED|Overall Study||33
6429534|NCT01035463|7343913|FG000|COMPLETED|Overall Study||6
6429535|NCT01035463|7343914|FG001|COMPLETED|Overall Study||1
6429536|NCT01035463|7343915|FG002|COMPLETED|Overall Study||1
6429537|NCT01035463|7343916|FG003|COMPLETED|Overall Study||2
6429538|NCT01035463|7343917|FG004|COMPLETED|Overall Study||1
6429539|NCT01035463|7343918|FG005|COMPLETED|Overall Study||15
6429540|NCT01035463|7343913|FG000|NOT COMPLETED|Overall Study||0
6429541|NCT01035463|7343914|FG001|NOT COMPLETED|Overall Study||2
6429542|NCT01035463|7343915|FG002|NOT COMPLETED|Overall Study||5
6429543|NCT01035463|7343916|FG003|NOT COMPLETED|Overall Study||2
6429544|NCT01035463|7343917|FG004|NOT COMPLETED|Overall Study||6
6429545|NCT01035463|7343918|FG005|NOT COMPLETED|Overall Study||18
6429546|NCT01035606|7343928|FG000|STARTED|Overall Study||19
6429547|NCT01035606|7343929|FG001|STARTED|Overall Study||19
6429548|NCT01035606|7343930|FG002|STARTED|Overall Study||11
6429549|NCT01035606|7343928|FG000|COMPLETED|Overall Study||16
6429550|NCT01035606|7343929|FG001|COMPLETED|Overall Study||16
6429551|NCT01035606|7343930|FG002|COMPLETED|Overall Study||7
6429552|NCT01035606|7343928|FG000|NOT COMPLETED|Overall Study||3
6429553|NCT01035606|7343929|FG001|NOT COMPLETED|Overall Study||3
6429554|NCT01035606|7343930|FG002|NOT COMPLETED|Overall Study||4
6429555|NCT01035658|7343942|FG000|STARTED|Overall Study||5
6429556|NCT01035658|7343943|FG001|STARTED|Overall Study||8
6429557|NCT01035658|7343944|FG002|STARTED|Overall Study||3
6429558|NCT01035658|7343945|FG003|STARTED|Overall Study||6
6429559|NCT01035658|7343942|FG000|COMPLETED|Overall Study||5
6429560|NCT01035658|7343943|FG001|COMPLETED|Overall Study||8
6429561|NCT01035658|7343944|FG002|COMPLETED|Overall Study||3
6429562|NCT01035658|7343945|FG003|COMPLETED|Overall Study||6
6429563|NCT01035658|7343942|FG000|NOT COMPLETED|Overall Study||0
6429564|NCT01035658|7343943|FG001|NOT COMPLETED|Overall Study||0
6429565|NCT01035658|7343944|FG002|NOT COMPLETED|Overall Study||0
6429566|NCT01035658|7343945|FG003|NOT COMPLETED|Overall Study||0
6429567|NCT01035749|7343962|FG000|STARTED|Overall Study||66
6429568|NCT01035749|7343963|FG001|STARTED|Overall Study||66
6429569|NCT01035749|7343964|FG002|STARTED|Overall Study||68
6552130|NCT01736176|7474544|FG000|NOT COMPLETED|Overall Study||11
6552131|NCT01736189|7474552|FG000|STARTED|Overall Study||346
6552132|NCT01736189|7474552|FG000|COMPLETED|Overall Study||300
6552133|NCT01736189|7474552|FG000|NOT COMPLETED|Overall Study||46
6552134|NCT01736215|7474556|FG000|STARTED|Overall Study||33
6552135|NCT01736215|7474556|FG000|Treated|Overall Study||25
6552136|NCT01736215|7474556|FG000|COMPLETED|Overall Study||19
6552137|NCT01736215|7474556|FG000|NOT COMPLETED|Overall Study||14
6552138|NCT01736241|7474567|FG000|STARTED|Overall Study||6
6652278|NCT02427646|7581857|FG000|COMPLETED|Overall Study||16
6429570|NCT01035749|7343965|FG003|STARTED|Overall Study||110
6652279|NCT02427646|7581858|FG001|COMPLETED|Overall Study||14
6652280|NCT02427646|7581857|FG000|NOT COMPLETED|Overall Study||8
6652281|NCT02427646|7581858|FG001|NOT COMPLETED|Overall Study||14
6652282|NCT02427672|7581868|FG000|STARTED|Overall Study||40
6652283|NCT02427672|7581869|FG001|STARTED|Overall Study||44
6652284|NCT02427672|7581868|FG000|COMPLETED|Overall Study||39
6652285|NCT02427672|7581869|FG001|COMPLETED|Overall Study||42
6429571|NCT01035749|7343962|FG000|COMPLETED|Overall Study||66
6429572|NCT01035749|7343963|FG001|COMPLETED|Overall Study||66
6429573|NCT01035749|7343964|FG002|COMPLETED|Overall Study||68
6429574|NCT01035749|7343965|FG003|COMPLETED|Overall Study||110
6429575|NCT01035749|7343962|FG000|NOT COMPLETED|Overall Study||0
6429576|NCT01035749|7343963|FG001|NOT COMPLETED|Overall Study||0
6429577|NCT01035749|7343964|FG002|NOT COMPLETED|Overall Study||0
6429578|NCT01035749|7343965|FG003|NOT COMPLETED|Overall Study||0
6429579|NCT01035788|7343977|FG000|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
6429580|NCT01035788|7343978|FG001|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
6429581|NCT01035788|7343977|FG000|COMPLETED|Overall Study||17
6429582|NCT01035788|7343978|FG001|COMPLETED|Overall Study||9
6429583|NCT01035788|7343977|FG000|NOT COMPLETED|Overall Study||6
6429584|NCT01035788|7343978|FG001|NOT COMPLETED|Overall Study||14
6429585|NCT01035905|7343986|FG000|STARTED|Overall Study||32
6429586|NCT01035905|7343987|FG001|STARTED|Overall Study||31
6429587|NCT01035905|7343986|FG000|COMPLETED|Overall Study||31
6429588|NCT01035905|7343987|FG001|COMPLETED|Overall Study||30
6429589|NCT01035905|7343986|FG000|NOT COMPLETED|Overall Study||1
6552139|NCT01736241|7474568|FG001|STARTED|Overall Study||6
6552140|NCT01736241|7474569|FG002|STARTED|Overall Study||6
6552141|NCT01736241|7474570|FG003|STARTED|Overall Study||5
6552142|NCT01736241|7474571|FG004|STARTED|Overall Study||6
6429590|NCT01035905|7343987|FG001|NOT COMPLETED|Overall Study||1
6429591|NCT01036009|7343995|FG000|STARTED|Overall Study||17
6429592|NCT01036009|7343996|FG001|STARTED|Overall Study||26
6429593|NCT01036009|7343995|FG000|COMPLETED|Overall Study||17
6429594|NCT01036009|7343996|FG001|COMPLETED|Overall Study||26
6429595|NCT01036009|7343995|FG000|NOT COMPLETED|Overall Study||0
6429596|NCT01036009|7343996|FG001|NOT COMPLETED|Overall Study||0
6429597|NCT01036022|7344009|FG000|STARTED|Overall Study||15
6429598|NCT01036022|7344010|FG001|STARTED|Overall Study||11
6429599|NCT01036022|7344011|FG002|STARTED|Overall Study||12
6429600|NCT01036022|7344012|FG003|STARTED|Overall Study||12
6429601|NCT01036022|7344013|FG004|STARTED|Overall Study||12
6429602|NCT01036022|7344014|FG005|STARTED|Overall Study||16
6429603|NCT01036022|7344009|FG000|COMPLETED|Overall Study||13
6429604|NCT01036022|7344010|FG001|COMPLETED|Overall Study||7
6429605|NCT01036022|7344011|FG002|COMPLETED|Overall Study||8
6429606|NCT01036022|7344012|FG003|COMPLETED|Overall Study||10
6429607|NCT01036022|7344013|FG004|COMPLETED|Overall Study||9
6429608|NCT01036022|7344014|FG005|COMPLETED|Overall Study||13
6429609|NCT01036022|7344009|FG000|NOT COMPLETED|Overall Study||2
6429610|NCT01036022|7344010|FG001|NOT COMPLETED|Overall Study||4
6429611|NCT01036022|7344011|FG002|NOT COMPLETED|Overall Study||4
6429612|NCT01036022|7344012|FG003|NOT COMPLETED|Overall Study||2
6429613|NCT01036022|7344013|FG004|NOT COMPLETED|Overall Study||3
6429614|NCT01036022|7344014|FG005|NOT COMPLETED|Overall Study||3
6429615|NCT01036165|7344036|FG000|STARTED|Overall Study||103
6429616|NCT01036165|7344036|FG000|COMPLETED|Overall Study||88
6429617|NCT01036165|7344036|FG000|NOT COMPLETED|Overall Study||15
6429618|NCT01036321|7344042|FG000|STARTED|Overall Study||36
6429619|NCT01036321|7344043|FG001|STARTED|Overall Study||35
6429620|NCT01036321|7344042|FG000|COMPLETED|Overall Study||31
6429621|NCT01036321|7344043|FG001|COMPLETED|Overall Study||31
6429622|NCT01036321|7344042|FG000|NOT COMPLETED|Overall Study||5
6429623|NCT01036321|7344043|FG001|NOT COMPLETED|Overall Study||4
6429624|NCT01036438|7344051|FG000|STARTED|Overall Study||101
6429625|NCT01036438|7344052|FG001|STARTED|Overall Study||100
6429626|NCT01036438|7344051|FG000|COMPLETED|Overall Study||91
6429627|NCT01036438|7344052|FG001|COMPLETED|Overall Study||90
6429628|NCT01036438|7344051|FG000|NOT COMPLETED|Overall Study||10
6429629|NCT01036438|7344052|FG001|NOT COMPLETED|Overall Study||10
6429630|NCT01036490|7344060|FG000|STARTED|Overall Study||18
6429631|NCT01036490|7344061|FG001|STARTED|Overall Study||18
6429632|NCT01036490|7344060|FG000|COMPLETED|Overall Study||14
6429633|NCT01036490|7344061|FG001|COMPLETED|Overall Study||18
6429634|NCT01036490|7344060|FG000|NOT COMPLETED|Overall Study||4
6429635|NCT01036490|7344061|FG001|NOT COMPLETED|Overall Study||0
6429636|NCT01036529|7344069|FG000|STARTED|Overall Study||13
6429637|NCT01036529|7344070|FG001|STARTED|Overall Study||15
6429638|NCT01036529|7344069|FG000|Baseline Visit|Overall Study||10
6429639|NCT01036529|7344070|FG001|Baseline Visit|Overall Study||13
6429640|NCT01036529|7344069|FG000|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
6429641|NCT01036529|7344070|FG001|Index Procedure|Overall Study|Index Procedure: Surgery|11
6429642|NCT01036529|7344069|FG000|3 Month Follow-up|Overall Study||7
6429643|NCT01036529|7344070|FG001|3 Month Follow-up|Overall Study||9
6429644|NCT01036529|7344069|FG000|6 Month Follow-up|Overall Study||6
6429645|NCT01036529|7344070|FG001|6 Month Follow-up|Overall Study||7
6429646|NCT01036529|7344069|FG000|12 Month Follow-up|Overall Study||4
6429647|NCT01036529|7344070|FG001|12 Month Follow-up|Overall Study||3
6429648|NCT01036529|7344069|FG000|Requested Crossover|Overall Study||1
6429649|NCT01036529|7344070|FG001|Requested Crossover|Overall Study||2
6429650|NCT01036529|7344069|FG000|Crossover to Other Group|Overall Study||1
6429651|NCT01036529|7344070|FG001|Crossover to Other Group|Overall Study||1
6429652|NCT01036529|7344069|FG000|COMPLETED|Overall Study||0
6429653|NCT01036529|7344070|FG001|COMPLETED|Overall Study||0
6429654|NCT01036529|7344069|FG000|NOT COMPLETED|Overall Study||13
6429655|NCT01036529|7344070|FG001|NOT COMPLETED|Overall Study||15
6429656|NCT01036594|7344076|FG000|STARTED|Run-In: Ketoconazole Only (200 mg)||32
6429657|NCT01036594|7344077|FG001|STARTED|Run-In: Ketoconazole Only (200 mg)|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
6429658|NCT01036594|7344076|FG000|COMPLETED|Run-In: Ketoconazole Only (200 mg)||31
6429659|NCT01036594|7344077|FG001|COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
6429660|NCT01036594|7344076|FG000|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||1
6429661|NCT01036594|7344077|FG001|NOT COMPLETED|Run-In: Ketoconazole Only (200 mg)||0
6429662|NCT01036594|7344076|FG000|STARTED|First Treatment Regimen||31
6429663|NCT01036594|7344077|FG001|STARTED|First Treatment Regimen|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
6429664|NCT01036594|7344076|FG000|COMPLETED|First Treatment Regimen||30
6429665|NCT01036594|7344077|FG001|COMPLETED|First Treatment Regimen||0
6429666|NCT01036594|7344076|FG000|NOT COMPLETED|First Treatment Regimen||1
6429667|NCT01036594|7344077|FG001|NOT COMPLETED|First Treatment Regimen||0
6429668|NCT01036594|7344076|FG000|STARTED|Week 12 Evaluation||30
6429669|NCT01036594|7344077|FG001|STARTED|Week 12 Evaluation|Dexamethasone not introduced as treatment option until after Week 12 evaluation|0
6429670|NCT01036594|7344076|FG000|COMPLETED|Week 12 Evaluation||24
6429671|NCT01036594|7344077|FG001|COMPLETED|Week 12 Evaluation||0
6429672|NCT01036594|7344076|FG000|NOT COMPLETED|Week 12 Evaluation||6
6429673|NCT01036594|7344077|FG001|NOT COMPLETED|Week 12 Evaluation||0
6429674|NCT01036594|7344076|FG000|STARTED|Treatment Regiments Post Week 12||15
6429675|NCT01036594|7344077|FG001|STARTED|Treatment Regiments Post Week 12||9
6429676|NCT01036594|7344076|FG000|COMPLETED|Treatment Regiments Post Week 12||13
6429677|NCT01036594|7344077|FG001|COMPLETED|Treatment Regiments Post Week 12||5
6429678|NCT01036594|7344076|FG000|NOT COMPLETED|Treatment Regiments Post Week 12||2
6429679|NCT01036594|7344077|FG001|NOT COMPLETED|Treatment Regiments Post Week 12||4
6429680|NCT01036724|7344085|FG000|STARTED|Overall Study||52
6429681|NCT01036724|7344086|FG001|STARTED|Overall Study||55
6429682|NCT01036724|7344085|FG000|COMPLETED|Overall Study||46
6429683|NCT01036724|7344086|FG001|COMPLETED|Overall Study||47
6429684|NCT01036724|7344085|FG000|NOT COMPLETED|Overall Study||6
6429685|NCT01036724|7344086|FG001|NOT COMPLETED|Overall Study||8
6429686|NCT01036763|7344092|FG000|STARTED|Overall Study||1264
6429687|NCT01036763|7344092|FG000|COMPLETED|Overall Study||1171
6429688|NCT01036763|7344092|FG000|NOT COMPLETED|Overall Study||93
6429689|NCT01036802|7344098|FG000|STARTED|Overall Study||2
6429690|NCT01036802|7344099|FG001|STARTED|Overall Study||1
6429691|NCT01036802|7344098|FG000|COMPLETED|Overall Study||2
6429692|NCT01036802|7344099|FG001|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
6429693|NCT01036802|7344098|FG000|NOT COMPLETED|Overall Study||0
6429694|NCT01036802|7344099|FG001|NOT COMPLETED|Overall Study||0
6429695|NCT01037088|7344106|FG000|STARTED|Overall Study||39
6429696|NCT01037088|7344106|FG000|Received 3.53% THC|Overall Study||36
6429697|NCT01037088|7344106|FG000|Received 1.29% THC|Overall Study||37
6429698|NCT01037088|7344106|FG000|Received Placebo|Overall Study||38
6429699|NCT01037088|7344106|FG000|COMPLETED|Overall Study||36
6429700|NCT01037088|7344106|FG000|NOT COMPLETED|Overall Study||3
6429701|NCT01037114|7344115|FG000|STARTED|Year 16||49
6429702|NCT01037114|7344115|FG000|COMPLETED|Year 16||49
6429703|NCT01037114|7344115|FG000|NOT COMPLETED|Year 16||0
6429704|NCT01037114|7344115|FG000|STARTED|Year 17||48
6429705|NCT01037114|7344115|FG000|COMPLETED|Year 17||48
6429706|NCT01037114|7344115|FG000|NOT COMPLETED|Year 17||0
6429707|NCT01037114|7344115|FG000|STARTED|Year 18||44
6429708|NCT01037114|7344115|FG000|COMPLETED|Year 18||44
6429709|NCT01037114|7344115|FG000|NOT COMPLETED|Year 18||0
6429710|NCT01037114|7344115|FG000|STARTED|Year 19||45
6429711|NCT01037114|7344115|FG000|COMPLETED|Year 19||45
6429712|NCT01037114|7344115|FG000|NOT COMPLETED|Year 19||0
6429713|NCT01037114|7344115|FG000|STARTED|Year 20||45
6429714|NCT01037114|7344115|FG000|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
6429715|NCT01037114|7344115|FG000|NOT COMPLETED|Year 20||1
6429716|NCT01037127|7344121|FG000|STARTED|Overall Study||40
6429717|NCT01037127|7344122|FG001|STARTED|Overall Study||57
6429718|NCT01037127|7344121|FG000|COMPLETED|Overall Study||35
6429719|NCT01037127|7344122|FG001|COMPLETED|Overall Study||36
6429720|NCT01037127|7344121|FG000|NOT COMPLETED|Overall Study||5
6429721|NCT01037127|7344122|FG001|NOT COMPLETED|Overall Study||21
6429722|NCT01037192|7344140|FG000|STARTED|Overall Study||3
6429723|NCT01037192|7344141|FG001|STARTED|Overall Study||1
6429724|NCT01037192|7344140|FG000|COMPLETED|Overall Study||3
6429725|NCT01037192|7344141|FG001|COMPLETED|Overall Study||1
6429726|NCT01037192|7344140|FG000|NOT COMPLETED|Overall Study||0
6429727|NCT01037192|7344141|FG001|NOT COMPLETED|Overall Study||0
6429728|NCT01037218|7344153|FG000|STARTED|Overall Study||147
6429729|NCT01037218|7344154|FG001|STARTED|Overall Study||149
6429730|NCT01037218|7344155|FG002|STARTED|Overall Study||155
6429731|NCT01037218|7344156|FG003|STARTED|Overall Study||150
6429732|NCT01037218|7344153|FG000|Safety Population|Overall Study||147
6429733|NCT01037218|7344154|FG001|Safety Population|Overall Study||148
6429734|NCT01037218|7344155|FG002|Safety Population|Overall Study||154
6429735|NCT01037218|7344156|FG003|Safety Population|Overall Study||150
6429736|NCT01037218|7344153|FG000|mITT Population|Overall Study||141
6429737|NCT01037218|7344154|FG001|mITT Population|Overall Study||140
6429738|NCT01037218|7344155|FG002|mITT Population|Overall Study||147
6429739|NCT01037218|7344156|FG003|mITT Population|Overall Study||141
6429740|NCT01037218|7344153|FG000|COMPLETED|Overall Study||131
6429741|NCT01037218|7344154|FG001|COMPLETED|Overall Study||128
6429742|NCT01037218|7344155|FG002|COMPLETED|Overall Study||134
6429743|NCT01037218|7344156|FG003|COMPLETED|Overall Study||134
6429744|NCT01037218|7344153|FG000|NOT COMPLETED|Overall Study||16
6429745|NCT01037218|7344154|FG001|NOT COMPLETED|Overall Study||21
6429746|NCT01037218|7344155|FG002|NOT COMPLETED|Overall Study||21
6429747|NCT01037218|7344156|FG003|NOT COMPLETED|Overall Study||16
6429748|NCT01037244|7344170|FG000|STARTED|Overall Study||154
6429749|NCT01037244|7344171|FG001|STARTED|Overall Study||152
6429750|NCT01037244|7344172|FG002|STARTED|Overall Study||158
6429751|NCT01037244|7344173|FG003|STARTED|Overall Study||154
6429752|NCT01037244|7344170|FG000|mITT (Modified Intent-to-Treat)|Overall Study||150
6429753|NCT01037244|7344171|FG001|mITT (Modified Intent-to-Treat)|Overall Study||148
6429754|NCT01037244|7344172|FG002|mITT (Modified Intent-to-Treat)|Overall Study||154
6429755|NCT01037244|7344173|FG003|mITT (Modified Intent-to-Treat)|Overall Study||153
6429756|NCT01037244|7344170|FG000|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
6429757|NCT01037244|7344171|FG001|Safety Population|Overall Study||150
6429758|NCT01037244|7344172|FG002|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
6429759|NCT01037244|7344173|FG003|Safety Population|Overall Study||152
6429760|NCT01037244|7344170|FG000|COMPLETED|Overall Study||141
6429761|NCT01037244|7344171|FG001|COMPLETED|Overall Study||138
6429762|NCT01037244|7344172|FG002|COMPLETED|Overall Study||144
6429763|NCT01037244|7344173|FG003|COMPLETED|Overall Study||140
6429764|NCT01037244|7344170|FG000|NOT COMPLETED|Overall Study||13
6429765|NCT01037244|7344171|FG001|NOT COMPLETED|Overall Study||14
6429766|NCT01037244|7344172|FG002|NOT COMPLETED|Overall Study||14
6429767|NCT01037244|7344173|FG003|NOT COMPLETED|Overall Study||14
6429768|NCT01037309|7344189|FG000|STARTED|Subcutaneous Cohort 1 - 6||3
6429769|NCT01037309|7344190|FG001|STARTED|Subcutaneous Cohort 1 - 6||3
6429770|NCT01037309|7344191|FG002|STARTED|Subcutaneous Cohort 1 - 6||3
6429771|NCT01037309|7344192|FG003|STARTED|Subcutaneous Cohort 1 - 6||3
6429772|NCT01037309|7344193|FG004|STARTED|Subcutaneous Cohort 1 - 6||3
6429773|NCT01037309|7344194|FG005|STARTED|Subcutaneous Cohort 1 - 6||3
6429774|NCT01037309|7344195|FG006|STARTED|Subcutaneous Cohort 1 - 6||0
6429775|NCT01037309|7344196|FG007|STARTED|Subcutaneous Cohort 1 - 6||0
6429776|NCT01037309|7344197|FG008|STARTED|Subcutaneous Cohort 1 - 6||0
6429777|NCT01037309|7344189|FG000|COMPLETED|Subcutaneous Cohort 1 - 6||3
6429778|NCT01037309|7344190|FG001|COMPLETED|Subcutaneous Cohort 1 - 6||3
6429779|NCT01037309|7344191|FG002|COMPLETED|Subcutaneous Cohort 1 - 6||3
6429780|NCT01037309|7344192|FG003|COMPLETED|Subcutaneous Cohort 1 - 6||3
6429781|NCT01037309|7344193|FG004|COMPLETED|Subcutaneous Cohort 1 - 6||3
6429782|NCT01037309|7344194|FG005|COMPLETED|Subcutaneous Cohort 1 - 6||3
6429783|NCT01037309|7344195|FG006|COMPLETED|Subcutaneous Cohort 1 - 6||0
6429784|NCT01037309|7344196|FG007|COMPLETED|Subcutaneous Cohort 1 - 6||0
6429785|NCT01037309|7344197|FG008|COMPLETED|Subcutaneous Cohort 1 - 6||0
6429786|NCT01037309|7344189|FG000|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429787|NCT01037309|7344190|FG001|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429788|NCT01037309|7344191|FG002|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429789|NCT01037309|7344192|FG003|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429790|NCT01037309|7344193|FG004|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429791|NCT01037309|7344194|FG005|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429792|NCT01037309|7344195|FG006|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429793|NCT01037309|7344196|FG007|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429794|NCT01037309|7344197|FG008|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
6429795|NCT01037309|7344189|FG000|STARTED|Intravenous Period 7 - 9||0
6429796|NCT01037309|7344190|FG001|STARTED|Intravenous Period 7 - 9||0
6429797|NCT01037309|7344191|FG002|STARTED|Intravenous Period 7 - 9||0
6429798|NCT01037309|7344192|FG003|STARTED|Intravenous Period 7 - 9||0
6429799|NCT01037309|7344193|FG004|STARTED|Intravenous Period 7 - 9||0
6429800|NCT01037309|7344194|FG005|STARTED|Intravenous Period 7 - 9||0
6429801|NCT01037309|7344195|FG006|STARTED|Intravenous Period 7 - 9||3
6429802|NCT01037309|7344196|FG007|STARTED|Intravenous Period 7 - 9||3
6429803|NCT01037309|7344197|FG008|STARTED|Intravenous Period 7 - 9||3
6429804|NCT01037309|7344189|FG000|COMPLETED|Intravenous Period 7 - 9||0
6429805|NCT01037309|7344190|FG001|COMPLETED|Intravenous Period 7 - 9||0
6429806|NCT01037309|7344191|FG002|COMPLETED|Intravenous Period 7 - 9||0
6429807|NCT01037309|7344192|FG003|COMPLETED|Intravenous Period 7 - 9||0
6429808|NCT01037309|7344193|FG004|COMPLETED|Intravenous Period 7 - 9||0
6429809|NCT01037309|7344194|FG005|COMPLETED|Intravenous Period 7 - 9||0
6429810|NCT01037309|7344195|FG006|COMPLETED|Intravenous Period 7 - 9||3
6429811|NCT01037309|7344196|FG007|COMPLETED|Intravenous Period 7 - 9||3
6429812|NCT01037309|7344197|FG008|COMPLETED|Intravenous Period 7 - 9||3
6429813|NCT01037309|7344189|FG000|NOT COMPLETED|Intravenous Period 7 - 9||0
6429814|NCT01037309|7344190|FG001|NOT COMPLETED|Intravenous Period 7 - 9||0
6429815|NCT01037309|7344191|FG002|NOT COMPLETED|Intravenous Period 7 - 9||0
6429816|NCT01037309|7344192|FG003|NOT COMPLETED|Intravenous Period 7 - 9||0
6429817|NCT01037309|7344193|FG004|NOT COMPLETED|Intravenous Period 7 - 9||0
6429818|NCT01037309|7344194|FG005|NOT COMPLETED|Intravenous Period 7 - 9||0
6429819|NCT01037309|7344195|FG006|NOT COMPLETED|Intravenous Period 7 - 9||0
6429820|NCT01037309|7344196|FG007|NOT COMPLETED|Intravenous Period 7 - 9||0
6429821|NCT01037309|7344197|FG008|NOT COMPLETED|Intravenous Period 7 - 9||0
6429822|NCT01037413|7344220|FG000|STARTED|Part A: Skin Testing||25
6429823|NCT01037413|7344221|FG001|STARTED|Part A: Skin Testing||0
6429824|NCT01037413|7344220|FG000|COMPLETED|Part A: Skin Testing||23
6429825|NCT01037413|7344221|FG001|COMPLETED|Part A: Skin Testing||0
6429826|NCT01037413|7344220|FG000|NOT COMPLETED|Part A: Skin Testing||2
6429827|NCT01037413|7344221|FG001|NOT COMPLETED|Part A: Skin Testing||0
6429828|NCT01037413|7344220|FG000|STARTED|Part B: Scar Revision|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
6429829|NCT01037413|7344221|FG001|STARTED|Part B: Scar Revision|Participants who completed Part A of the study and were negative for skin sensitization.|23
6429830|NCT01037413|7344220|FG000|Treated|Part B: Scar Revision||0
6429831|NCT01037413|7344221|FG001|Treated|Part B: Scar Revision||22
6429832|NCT01037413|7344220|FG000|COMPLETED|Part B: Scar Revision||0
6429833|NCT01037413|7344221|FG001|COMPLETED|Part B: Scar Revision||21
6429834|NCT01037413|7344220|FG000|NOT COMPLETED|Part B: Scar Revision||0
6429835|NCT01037413|7344221|FG001|NOT COMPLETED|Part B: Scar Revision||2
6429836|NCT01037452|7344238|FG000|STARTED|Overall Study||30
6429837|NCT01037452|7344239|FG001|STARTED|Overall Study||30
6429838|NCT01037452|7344240|FG002|STARTED|Overall Study||30
6429839|NCT01037452|7344241|FG003|STARTED|Overall Study||30
6429840|NCT01037452|7344238|FG000|COMPLETED|Overall Study||30
6429841|NCT01037452|7344239|FG001|COMPLETED|Overall Study||30
6429842|NCT01037452|7344240|FG002|COMPLETED|Overall Study||30
6429843|NCT01037452|7344241|FG003|COMPLETED|Overall Study||30
6429844|NCT01037452|7344238|FG000|NOT COMPLETED|Overall Study||0
6429845|NCT01037452|7344239|FG001|NOT COMPLETED|Overall Study||0
6429846|NCT01037452|7344240|FG002|NOT COMPLETED|Overall Study||0
6429847|NCT01037452|7344241|FG003|NOT COMPLETED|Overall Study||0
6429848|NCT01037790|7344256|FG000|STARTED|Overall Study||63
6429849|NCT01037790|7344257|FG001|STARTED|Overall Study||18
6429850|NCT01037790|7344258|FG002|STARTED|Overall Study||19
6429851|NCT01037790|7344259|FG003|STARTED|Overall Study||30
6429852|NCT01037790|7344260|FG004|STARTED|Overall Study||11
6429853|NCT01037790|7344256|FG000|COMPLETED|Overall Study||63
6429854|NCT01037790|7344257|FG001|COMPLETED|Overall Study||18
6429855|NCT01037790|7344258|FG002|COMPLETED|Overall Study||19
6429856|NCT01037790|7344259|FG003|COMPLETED|Overall Study||30
6429857|NCT01037790|7344260|FG004|COMPLETED|Overall Study||11
6429858|NCT01037790|7344256|FG000|NOT COMPLETED|Overall Study||0
6429859|NCT01037790|7344257|FG001|NOT COMPLETED|Overall Study||0
6429860|NCT01037790|7344258|FG002|NOT COMPLETED|Overall Study||0
6429861|NCT01037790|7344259|FG003|NOT COMPLETED|Overall Study||0
6429862|NCT01037790|7344260|FG004|NOT COMPLETED|Overall Study||0
6429863|NCT01037881|7344279|FG000|STARTED|Overall Study||25
6429864|NCT01037881|7344280|FG001|STARTED|Overall Study||24
6429865|NCT01037881|7344281|FG002|STARTED|Overall Study||25
6429866|NCT01037881|7344282|FG003|STARTED|Overall Study||25
6429867|NCT01037881|7344283|FG004|STARTED|Overall Study||29
6429868|NCT01037881|7344284|FG005|STARTED|Overall Study||30
6429869|NCT01037881|7344285|FG006|STARTED|Overall Study||25
6429870|NCT01037881|7344279|FG000|COMPLETED|Overall Study||19
6429871|NCT01037881|7344280|FG001|COMPLETED|Overall Study||22
6429872|NCT01037881|7344281|FG002|COMPLETED|Overall Study||22
6429873|NCT01037881|7344282|FG003|COMPLETED|Overall Study||24
6429874|NCT01037881|7344283|FG004|COMPLETED|Overall Study||26
6429875|NCT01037881|7344284|FG005|COMPLETED|Overall Study||27
6429876|NCT01037881|7344285|FG006|COMPLETED|Overall Study||23
6429877|NCT01037881|7344279|FG000|NOT COMPLETED|Overall Study||6
6429878|NCT01037881|7344280|FG001|NOT COMPLETED|Overall Study||2
6429879|NCT01037881|7344281|FG002|NOT COMPLETED|Overall Study||3
6429880|NCT01037881|7344282|FG003|NOT COMPLETED|Overall Study||1
6429881|NCT01037881|7344283|FG004|NOT COMPLETED|Overall Study||3
6429882|NCT01037881|7344284|FG005|NOT COMPLETED|Overall Study||3
6429883|NCT01037881|7344285|FG006|NOT COMPLETED|Overall Study||2
6429884|NCT01037985|7344310|FG000|STARTED|Part A: Skin Testing (50 Days)||41
6429885|NCT01037985|7344311|FG001|STARTED|Part A: Skin Testing (50 Days)||0
6429886|NCT01037985|7344310|FG000|COMPLETED|Part A: Skin Testing (50 Days)||37
6429887|NCT01037985|7344311|FG001|COMPLETED|Part A: Skin Testing (50 Days)||0
6429888|NCT01037985|7344310|FG000|NOT COMPLETED|Part A: Skin Testing (50 Days)||4
6429889|NCT01037985|7344311|FG001|NOT COMPLETED|Part A: Skin Testing (50 Days)||0
6429890|NCT01037985|7344310|FG000|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who tested negative for skin sensitization proceeded to Part B of the study. .|0
6429891|NCT01037985|7344311|FG001|STARTED|Part B:Abdominoplasty Surgery (24 Weeks)|Participants who completed Part A of the study and were negative for skin sensitization.|37
6429892|NCT01037985|7344310|FG000|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||0
6429893|NCT01037985|7344311|FG001|Treated|Part B:Abdominoplasty Surgery (24 Weeks)||33
6429894|NCT01037985|7344310|FG000|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
6429895|NCT01037985|7344311|FG001|COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||32
6429896|NCT01037985|7344310|FG000|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||0
6429897|NCT01037985|7344311|FG001|NOT COMPLETED|Part B:Abdominoplasty Surgery (24 Weeks)||5
6429898|NCT01038128|7344321|FG000|STARTED|Overall Study||5
6429899|NCT01038128|7344321|FG000|Baseline Visit|Overall Study||3
6429900|NCT01038128|7344321|FG000|COMPLETED|Overall Study||1
6429901|NCT01038128|7344321|FG000|NOT COMPLETED|Overall Study||4
6429902|NCT01038297|7344330|FG000|STARTED|Part A: Skin Testing Phase (50 Days)||10
6429903|NCT01038297|7344331|FG001|STARTED|Part A: Skin Testing Phase (50 Days)||10
6429904|NCT01038297|7344332|FG002|STARTED|Part A: Skin Testing Phase (50 Days)||10
6429905|NCT01038297|7344330|FG000|COMPLETED|Part A: Skin Testing Phase (50 Days)||9
6429906|NCT01038297|7344331|FG001|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
6429907|NCT01038297|7344332|FG002|COMPLETED|Part A: Skin Testing Phase (50 Days)||10
6429908|NCT01038297|7344330|FG000|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||1
6429909|NCT01038297|7344331|FG001|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
6429910|NCT01038297|7344332|FG002|NOT COMPLETED|Part A: Skin Testing Phase (50 Days)||0
6429911|NCT01038297|7344330|FG000|STARTED|Part B: Active Dosing Phase (13 Weeks)||9
6429912|NCT01038297|7344331|FG001|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
6429913|NCT01038297|7344332|FG002|STARTED|Part B: Active Dosing Phase (13 Weeks)||10
6429914|NCT01038297|7344330|FG000|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||9
6429915|NCT01038297|7344331|FG001|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
6429916|NCT01038297|7344332|FG002|COMPLETED|Part B: Active Dosing Phase (13 Weeks)||10
6429917|NCT01038297|7344330|FG000|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
6429918|NCT01038297|7344331|FG001|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
6429919|NCT01038297|7344332|FG002|NOT COMPLETED|Part B: Active Dosing Phase (13 Weeks)||0
6429920|NCT01038323|7344352|FG000|STARTED|Overall Study||20
6429921|NCT01038323|7344353|FG001|STARTED|Overall Study||19
6429922|NCT01038323|7344354|FG002|STARTED|Overall Study||19
6429923|NCT01038323|7344352|FG000|COMPLETED|Overall Study||17
6429924|NCT01038323|7344353|FG001|COMPLETED|Overall Study||17
6429925|NCT01038323|7344354|FG002|COMPLETED|Overall Study||15
6429926|NCT01038323|7344352|FG000|NOT COMPLETED|Overall Study||3
6429927|NCT01038323|7344353|FG001|NOT COMPLETED|Overall Study||2
6429928|NCT01038323|7344354|FG002|NOT COMPLETED|Overall Study||4
6429929|NCT01038336|7344365|FG000|STARTED|Overall Study||43
6429930|NCT01038336|7344366|FG001|STARTED|Overall Study||42
6429931|NCT01038336|7344367|FG002|STARTED|Overall Study||44
6429932|NCT01038336|7344365|FG000|COMPLETED|Overall Study||43
6429933|NCT01038336|7344366|FG001|COMPLETED|Overall Study||42
6429934|NCT01038336|7344367|FG002|COMPLETED|Overall Study||44
6652286|NCT02427672|7581868|FG000|NOT COMPLETED|Overall Study||1
6652287|NCT02427672|7581869|FG001|NOT COMPLETED|Overall Study||2
6652288|NCT02427737|7581877|FG000|STARTED|OSU Baseline Q4FY15||4158
6652289|NCT02427737|7581878|FG001|STARTED|OSU Baseline Q4FY15||3446
6652290|NCT02427737|7581877|FG000|COMPLETED|OSU Baseline Q4FY15||3940
6652291|NCT02427737|7581878|FG001|COMPLETED|OSU Baseline Q4FY15||3230
6652292|NCT02427737|7581877|FG000|NOT COMPLETED|OSU Baseline Q4FY15||218
6652293|NCT02427737|7581878|FG001|NOT COMPLETED|OSU Baseline Q4FY15||216
6652294|NCT02427737|7581877|FG000|STARTED|OSU Q1FY16 (First Post-Training Quarter)||4030
6652295|NCT02427737|7581878|FG001|STARTED|OSU Q1FY16 (First Post-Training Quarter)||3246
6652296|NCT02427737|7581877|FG000|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3815
6652297|NCT02427737|7581878|FG001|COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||3032
6652298|NCT02427737|7581877|FG000|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||215
6652299|NCT02427737|7581878|FG001|NOT COMPLETED|OSU Q1FY16 (First Post-Training Quarter)||214
6652300|NCT02427737|7581877|FG000|STARTED|OSU Q2FY16(Second Post Training Quarter)||4121
6652301|NCT02427737|7581878|FG001|STARTED|OSU Q2FY16(Second Post Training Quarter)||3070
6652302|NCT02427737|7581877|FG000|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||3907
6652303|NCT02427737|7581878|FG001|COMPLETED|OSU Q2FY16(Second Post Training Quarter)||2857
6652304|NCT02427737|7581877|FG000|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||214
6652305|NCT02427737|7581878|FG001|NOT COMPLETED|OSU Q2FY16(Second Post Training Quarter)||213
6652306|NCT02427737|7581877|FG000|STARTED|OSU Q3FY16 (Third Post Training Quarter)||4148
6652307|NCT02427737|7581878|FG001|STARTED|OSU Q3FY16 (Third Post Training Quarter)||2931
6652308|NCT02427737|7581877|FG000|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||3928
6652309|NCT02427737|7581878|FG001|COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||2716
6652310|NCT02427737|7581877|FG000|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||220
6652311|NCT02427737|7581878|FG001|NOT COMPLETED|OSU Q3FY16 (Third Post Training Quarter)||215
6652312|NCT02427737|7581877|FG000|STARTED|Duke Pre- and Post-Training Groups|Note this is a pre-training to post-training comparison.|9658
6652313|NCT02427737|7581878|FG001|STARTED|Duke Pre- and Post-Training Groups|Note Control=Baseline|4446
6652314|NCT02427737|7581877|FG000|COMPLETED|Duke Pre- and Post-Training Groups||8879
6652315|NCT02427737|7581878|FG001|COMPLETED|Duke Pre- and Post-Training Groups||4051
6652316|NCT02427737|7581877|FG000|NOT COMPLETED|Duke Pre- and Post-Training Groups||779
6652317|NCT02427737|7581878|FG001|NOT COMPLETED|Duke Pre- and Post-Training Groups||395
6652318|NCT02427750|7581894|FG000|STARTED|Overall Study||63
6652319|NCT02427750|7581895|FG001|STARTED|Overall Study||63
6652320|NCT02427750|7581894|FG000|COMPLETED|Overall Study||63
6652321|NCT02427750|7581895|FG001|COMPLETED|Overall Study||63
6652322|NCT02427750|7581894|FG000|NOT COMPLETED|Overall Study||0
6652323|NCT02427750|7581895|FG001|NOT COMPLETED|Overall Study||0
6652324|NCT02427802|7581905|FG000|STARTED|Overall Study||305
6652325|NCT02427802|7581906|FG001|STARTED|Overall Study||154
6652326|NCT02427802|7581907|FG002|STARTED|Overall Study||153
6652327|NCT02427802|7581905|FG000|COMPLETED|Overall Study||246
6652328|NCT02427802|7581906|FG001|COMPLETED|Overall Study||120
6652329|NCT02427802|7581907|FG002|COMPLETED|Overall Study||110
6652330|NCT02427802|7581905|FG000|NOT COMPLETED|Overall Study||59
6652331|NCT02427802|7581906|FG001|NOT COMPLETED|Overall Study||34
6652332|NCT02427802|7581907|FG002|NOT COMPLETED|Overall Study||43
6652333|NCT02427841|7581915|FG000|STARTED|Overall Study||19
6652334|NCT02427841|7581915|FG000|COMPLETED|Overall Study||11
6652335|NCT02427841|7581915|FG000|NOT COMPLETED|Overall Study||8
6652336|NCT02427984|7581922|FG000|STARTED|Overall Study||53
6652337|NCT02427984|7581923|FG001|STARTED|Overall Study||45
6652338|NCT02427984|7581924|FG002|STARTED|Overall Study||50
6652339|NCT02427984|7581922|FG000|COMPLETED|Overall Study||40
6652340|NCT02427984|7581923|FG001|COMPLETED|Overall Study||40
6652341|NCT02427984|7581924|FG002|COMPLETED|Overall Study||32
6652342|NCT02427984|7581922|FG000|NOT COMPLETED|Overall Study||13
6652343|NCT02427984|7581923|FG001|NOT COMPLETED|Overall Study||5
6652344|NCT02427984|7581924|FG002|NOT COMPLETED|Overall Study||18
6652345|NCT02428192|7581935|FG000|STARTED|Overall Study||12
6652346|NCT02428192|7581936|FG001|STARTED|Overall Study||8
6652347|NCT02428192|7581935|FG000|COMPLETED|Overall Study||0
6652348|NCT02428192|7581936|FG001|COMPLETED|Overall Study||7
6652349|NCT02428192|7581935|FG000|NOT COMPLETED|Overall Study||12
6652350|NCT02428192|7581936|FG001|NOT COMPLETED|Overall Study||1
6652351|NCT02428296|7581943|FG000|STARTED|Overall Study||39
6652352|NCT02428296|7581943|FG000|Treated|Overall Study||39
6429935|NCT01038336|7344365|FG000|NOT COMPLETED|Overall Study||0
6429936|NCT01038336|7344366|FG001|NOT COMPLETED|Overall Study||0
6429937|NCT01038336|7344367|FG002|NOT COMPLETED|Overall Study||0
6429938|NCT01038427|7344383|FG000|STARTED|Overall Study||317
6429939|NCT01038427|7344384|FG001|STARTED|Overall Study||320
6429940|NCT01038427|7344385|FG002|STARTED|Overall Study||158
6429941|NCT01038427|7344383|FG000|Per-Protocol (PPP) Population|Overall Study||306
6429942|NCT01038427|7344384|FG001|Per-Protocol (PPP) Population|Overall Study||307
6429943|NCT01038427|7344385|FG002|Per-Protocol (PPP) Population|Overall Study||150
6652353|NCT02428296|7581943|FG000|COMPLETED|Overall Study|Number of participants who completed the full course of treatment.|30
6652354|NCT02428296|7581943|FG000|NOT COMPLETED|Overall Study||9
6652355|NCT02428309|7581950|FG000|STARTED|Overall Study||1
6652356|NCT02428309|7581950|FG000|COMPLETED|Overall Study|The enrolled participant completed treatment and was followed through week 152, per protocol.|1
6652357|NCT02428309|7581950|FG000|NOT COMPLETED|Overall Study||0
6652358|NCT02428413|7581957|FG000|STARTED|Overall Study||64
6429944|NCT01038427|7344383|FG000|Intent-to-Treat (ITT) Population|Overall Study||314
6429945|NCT01038427|7344384|FG001|Intent-to-Treat (ITT) Population|Overall Study||314
6429946|NCT01038427|7344385|FG002|Intent-to-Treat (ITT) Population|Overall Study||156
6429947|NCT01038427|7344383|FG000|COMPLETED|Overall Study||314
6429948|NCT01038427|7344384|FG001|COMPLETED|Overall Study||314
6429949|NCT01038427|7344385|FG002|COMPLETED|Overall Study||154
6429950|NCT01038427|7344383|FG000|NOT COMPLETED|Overall Study||3
6429951|NCT01038427|7344384|FG001|NOT COMPLETED|Overall Study||6
6429952|NCT01038427|7344385|FG002|NOT COMPLETED|Overall Study||4
6429953|NCT01038557|7344396|FG000|STARTED|Overall Study||82
6429954|NCT01038557|7344397|FG001|STARTED|Overall Study||86
6429955|NCT01038557|7344398|FG002|STARTED|Overall Study||86
6429956|NCT01038557|7344396|FG000|COMPLETED|Overall Study||82
6429957|NCT01038557|7344397|FG001|COMPLETED|Overall Study||86
6429958|NCT01038557|7344398|FG002|COMPLETED|Overall Study||86
6429959|NCT01038557|7344396|FG000|NOT COMPLETED|Overall Study||0
6429960|NCT01038557|7344397|FG001|NOT COMPLETED|Overall Study||0
6429961|NCT01038557|7344398|FG002|NOT COMPLETED|Overall Study||0
6429962|NCT01038609|7344411|FG000|STARTED|Overall Study||50
6429963|NCT01038609|7344412|FG001|STARTED|Overall Study||52
6429964|NCT01038609|7344413|FG002|STARTED|Overall Study||49
6429965|NCT01038609|7344414|FG003|STARTED|Overall Study||48
6429966|NCT01038609|7344415|FG004|STARTED|Overall Study||51
6429967|NCT01038609|7344411|FG000|COMPLETED|Overall Study||49
6429968|NCT01038609|7344412|FG001|COMPLETED|Overall Study||51
6429969|NCT01038609|7344413|FG002|COMPLETED|Overall Study||48
6429970|NCT01038609|7344414|FG003|COMPLETED|Overall Study||47
6429971|NCT01038609|7344415|FG004|COMPLETED|Overall Study||50
6429972|NCT01038609|7344411|FG000|NOT COMPLETED|Overall Study||1
6429973|NCT01038609|7344412|FG001|NOT COMPLETED|Overall Study||1
6429974|NCT01038609|7344413|FG002|NOT COMPLETED|Overall Study||1
6429975|NCT01038609|7344414|FG003|NOT COMPLETED|Overall Study||1
6429976|NCT01038609|7344415|FG004|NOT COMPLETED|Overall Study||1
6429977|NCT01038635|7344436|FG000|STARTED|Overall Study||5
6429978|NCT01038635|7344437|FG001|STARTED|Overall Study||3
6429979|NCT01038635|7344438|FG002|STARTED|Overall Study||3
6429980|NCT01038635|7344439|FG003|STARTED|Overall Study||3
6429981|NCT01038635|7344440|FG004|STARTED|Overall Study||4
6429982|NCT01038635|7344441|FG005|STARTED|Overall Study||3
6429983|NCT01038635|7344442|FG006|STARTED|Overall Study||7
6429984|NCT01038635|7344443|FG007|STARTED|Overall Study||20
6429985|NCT01038635|7344444|FG008|STARTED|Overall Study||40
6429986|NCT01038635|7344436|FG000|COMPLETED|Overall Study||3
6429987|NCT01038635|7344437|FG001|COMPLETED|Overall Study||3
6429988|NCT01038635|7344438|FG002|COMPLETED|Overall Study||3
6429989|NCT01038635|7344439|FG003|COMPLETED|Overall Study||3
6429990|NCT01038635|7344440|FG004|COMPLETED|Overall Study||3
6429991|NCT01038635|7344441|FG005|COMPLETED|Overall Study||3
6429992|NCT01038635|7344442|FG006|COMPLETED|Overall Study||5
6429993|NCT01038635|7344443|FG007|COMPLETED|Overall Study||15
6429994|NCT01038635|7344444|FG008|COMPLETED|Overall Study||38
6429995|NCT01038635|7344436|FG000|NOT COMPLETED|Overall Study||2
6429996|NCT01038635|7344437|FG001|NOT COMPLETED|Overall Study||0
6429997|NCT01038635|7344438|FG002|NOT COMPLETED|Overall Study||0
6429998|NCT01038635|7344439|FG003|NOT COMPLETED|Overall Study||0
6429999|NCT01038635|7344440|FG004|NOT COMPLETED|Overall Study||1
6430000|NCT01038635|7344441|FG005|NOT COMPLETED|Overall Study||0
6430001|NCT01038635|7344442|FG006|NOT COMPLETED|Overall Study||2
6430002|NCT01038635|7344443|FG007|NOT COMPLETED|Overall Study||5
6430003|NCT01038635|7344444|FG008|NOT COMPLETED|Overall Study||2
6430004|NCT01038687|7344468|FG000|STARTED|Overall Study||12
6430005|NCT01038687|7344469|FG001|STARTED|Overall Study||11
6430006|NCT01038687|7344470|FG002|STARTED|Overall Study||13
6430007|NCT01038687|7344468|FG000|COMPLETED|Overall Study||12
6430008|NCT01038687|7344469|FG001|COMPLETED|Overall Study||9
6430009|NCT01038687|7344470|FG002|COMPLETED|Overall Study||12
6430010|NCT01038687|7344468|FG000|NOT COMPLETED|Overall Study||0
6430011|NCT01038687|7344469|FG001|NOT COMPLETED|Overall Study||2
6430012|NCT01038687|7344470|FG002|NOT COMPLETED|Overall Study||1
6430013|NCT01038713|7344481|FG000|STARTED|Overall Study||26
6430014|NCT01038713|7344482|FG001|STARTED|Overall Study||20
6430015|NCT01038713|7344483|FG002|STARTED|Overall Study||17
6430016|NCT01038713|7344481|FG000|COMPLETED|Overall Study||21
6430017|NCT01038713|7344482|FG001|COMPLETED|Overall Study||17
6430018|NCT01038713|7344483|FG002|COMPLETED|Overall Study||16
6430019|NCT01038713|7344481|FG000|NOT COMPLETED|Overall Study||5
6430020|NCT01038713|7344482|FG001|NOT COMPLETED|Overall Study||3
6430021|NCT01038713|7344483|FG002|NOT COMPLETED|Overall Study||1
6430022|NCT01038778|7344493|FG000|STARTED|Overall Study||3
6430023|NCT01038778|7344494|FG001|STARTED|Overall Study||8
6430024|NCT01038778|7344495|FG002|STARTED|Overall Study||36
6430025|NCT01038778|7344493|FG000|COMPLETED|Overall Study||3
6430026|NCT01038778|7344494|FG001|COMPLETED|Overall Study||6
6430027|NCT01038778|7344495|FG002|COMPLETED|Overall Study||33
6430028|NCT01038778|7344493|FG000|NOT COMPLETED|Overall Study||0
6430029|NCT01038778|7344494|FG001|NOT COMPLETED|Overall Study||2
6430030|NCT01038778|7344495|FG002|NOT COMPLETED|Overall Study||3
6430031|NCT01038856|7344502|FG000|STARTED|Overall Study||5
6430032|NCT01038856|7344502|FG000|COMPLETED|Overall Study||3
6430033|NCT01038856|7344502|FG000|NOT COMPLETED|Overall Study||2
6430034|NCT01038869|7344508|FG000|STARTED|Overall Study||20
6430035|NCT01038869|7344508|FG000|COMPLETED|Overall Study||13
6430036|NCT01038869|7344508|FG000|NOT COMPLETED|Overall Study||7
6430037|NCT01038921|7344518|FG000|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
6430038|NCT01038921|7344519|FG001|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
6430039|NCT01038921|7344518|FG000|COMPLETED|Overall Study|2 subjects withdrew|17
6430040|NCT01038921|7344519|FG001|COMPLETED|Overall Study||20
6430041|NCT01038921|7344518|FG000|NOT COMPLETED|Overall Study||2
6430042|NCT01038921|7344519|FG001|NOT COMPLETED|Overall Study||0
6430043|NCT01039207|7344525|FG000|STARTED|Overall Study||31
6430044|NCT01039207|7344525|FG000|COMPLETED|Overall Study||31
6430045|NCT01039207|7344525|FG000|NOT COMPLETED|Overall Study||0
6430046|NCT01039376|7344531|FG000|STARTED|Overall Study||240
6430047|NCT01039376|7344532|FG001|STARTED|Overall Study||240
6430048|NCT01039376|7344531|FG000|COMPLETED|Overall Study||110
6430049|NCT01039376|7344532|FG001|COMPLETED|Overall Study||114
6430050|NCT01039376|7344531|FG000|NOT COMPLETED|Overall Study||130
6430051|NCT01039376|7344532|FG001|NOT COMPLETED|Overall Study||126
6430052|NCT01039428|7344541|FG000|STARTED|Overall Study||35
6430053|NCT01039428|7344542|FG001|STARTED|Overall Study||28
6430054|NCT01039428|7344541|FG000|COMPLETED|Overall Study||33
6430055|NCT01039428|7344542|FG001|COMPLETED|Overall Study||28
6430056|NCT01039428|7344541|FG000|NOT COMPLETED|Overall Study||2
6430057|NCT01039428|7344542|FG001|NOT COMPLETED|Overall Study||0
6430058|NCT01039467|7344550|FG000|STARTED|Overall Study||196
6430059|NCT01039467|7344551|FG001|STARTED|Overall Study||189
6430060|NCT01039467|7344550|FG000|COMPLETED|Overall Study||156
6430061|NCT01039467|7344551|FG001|COMPLETED|Overall Study||140
6430062|NCT01039467|7344550|FG000|NOT COMPLETED|Overall Study||40
6430063|NCT01039467|7344551|FG001|NOT COMPLETED|Overall Study||49
6430064|NCT01039519|7344559|FG000|STARTED|Treatment||27
6430065|NCT01039519|7344559|FG000|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
6430066|NCT01039519|7344559|FG000|NOT COMPLETED|Treatment||27
6430067|NCT01039519|7344559|FG000|STARTED|Survival Follow-up||27
6430068|NCT01039519|7344559|FG000|COMPLETED|Survival Follow-up||0
6430069|NCT01039519|7344559|FG000|NOT COMPLETED|Survival Follow-up||27
6430070|NCT01039584|7344566|FG000|STARTED|Overall Study||246
6430071|NCT01039584|7344567|FG001|STARTED|Overall Study||243
6430072|NCT01039584|7344568|FG002|STARTED|Overall Study||122
6430073|NCT01039584|7344566|FG000|COMPLETED|Overall Study||143
6430074|NCT01039584|7344567|FG001|COMPLETED|Overall Study||146
6430075|NCT01039584|7344568|FG002|COMPLETED|Overall Study||65
6430076|NCT01039584|7344566|FG000|NOT COMPLETED|Overall Study||103
6430077|NCT01039584|7344567|FG001|NOT COMPLETED|Overall Study||97
6430078|NCT01039584|7344568|FG002|NOT COMPLETED|Overall Study||57
6430079|NCT01039675|7344578|FG000|STARTED|Overall Study||9
6430080|NCT01039675|7344579|FG001|STARTED|Overall Study||42
6430081|NCT01039675|7344578|FG000|COMPLETED|Overall Study||9
6430082|NCT01039675|7344579|FG001|COMPLETED|Overall Study||35
6430083|NCT01039675|7344578|FG000|NOT COMPLETED|Overall Study||0
6430084|NCT01039675|7344579|FG001|NOT COMPLETED|Overall Study||7
6430085|NCT01039688|7344588|FG000|STARTED|Overall Study||373
6430086|NCT01039688|7344589|FG001|STARTED|Overall Study||397
6430087|NCT01039688|7344590|FG002|STARTED|Overall Study||186
6430088|NCT01039688|7344588|FG000|COMPLETED|Overall Study||266
6430089|NCT01039688|7344589|FG001|COMPLETED|Overall Study||286
6430090|NCT01039688|7344590|FG002|COMPLETED|Overall Study||106
6430091|NCT01039688|7344588|FG000|NOT COMPLETED|Overall Study||107
6430092|NCT01039688|7344589|FG001|NOT COMPLETED|Overall Study||111
6430093|NCT01039688|7344590|FG002|NOT COMPLETED|Overall Study||80
6430094|NCT01039792|7344603|FG000|STARTED|Overall Study||29
6430095|NCT01039792|7344604|FG001|STARTED|Overall Study||28
6430096|NCT01039792|7344603|FG000|COMPLETED|Overall Study||23
6430097|NCT01039792|7344604|FG001|COMPLETED|Overall Study||27
6430098|NCT01039792|7344603|FG000|NOT COMPLETED|Overall Study||6
6430099|NCT01039792|7344604|FG001|NOT COMPLETED|Overall Study||1
6430100|NCT01040052|7344610|FG000|STARTED|Overall Study||30
6430101|NCT01040052|7344610|FG000|COMPLETED|Overall Study||30
6430102|NCT01040052|7344610|FG000|NOT COMPLETED|Overall Study||0
6430103|NCT01040130|7344614|FG000|STARTED|Overall Study|Number of patients entered and treated|25
6430104|NCT01040130|7344615|FG001|STARTED|Overall Study||25
6430105|NCT01040130|7344616|FG002|STARTED|Overall Study||25
6430106|NCT01040130|7344617|FG003|STARTED|Overall Study||25
6430107|NCT01040130|7344618|FG004|STARTED|Overall Study||25
6430108|NCT01040130|7344619|FG005|STARTED|Overall Study||26
6430109|NCT01040130|7344614|FG000|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
6430110|NCT01040130|7344615|FG001|COMPLETED|Overall Study||22
6430111|NCT01040130|7344616|FG002|COMPLETED|Overall Study||23
6430112|NCT01040130|7344617|FG003|COMPLETED|Overall Study||20
6430113|NCT01040130|7344618|FG004|COMPLETED|Overall Study||25
6430114|NCT01040130|7344619|FG005|COMPLETED|Overall Study||22
6430115|NCT01040130|7344614|FG000|NOT COMPLETED|Overall Study||3
6430116|NCT01040130|7344615|FG001|NOT COMPLETED|Overall Study||3
6430117|NCT01040130|7344616|FG002|NOT COMPLETED|Overall Study||2
6430118|NCT01040130|7344617|FG003|NOT COMPLETED|Overall Study||5
6430119|NCT01040130|7344618|FG004|NOT COMPLETED|Overall Study||0
6430120|NCT01040130|7344619|FG005|NOT COMPLETED|Overall Study||4
6430121|NCT01040169|7344631|FG000|STARTED|Overall Study||35
6430122|NCT01040169|7344632|FG001|STARTED|Overall Study||44
6430123|NCT01040169|7344631|FG000|COMPLETED|Overall Study||32
6430124|NCT01040169|7344632|FG001|COMPLETED|Overall Study||36
6430125|NCT01040169|7344631|FG000|NOT COMPLETED|Overall Study||3
6430126|NCT01040169|7344632|FG001|NOT COMPLETED|Overall Study||8
6430127|NCT01040208|7344641|FG000|STARTED|Overall Study||45
6430128|NCT01040208|7344642|FG001|STARTED|Overall Study||28
6430129|NCT01040208|7344643|FG002|STARTED|Overall Study||38
6430130|NCT01040208|7344641|FG000|COMPLETED|Overall Study||39
6430131|NCT01040208|7344642|FG001|COMPLETED|Overall Study||15
6430132|NCT01040208|7344643|FG002|COMPLETED|Overall Study||35
6430133|NCT01040208|7344641|FG000|NOT COMPLETED|Overall Study||6
6430134|NCT01040208|7344642|FG001|NOT COMPLETED|Overall Study||13
6430135|NCT01040208|7344643|FG002|NOT COMPLETED|Overall Study||3
6430136|NCT01040260|7344658|FG000|STARTED|Overall Study||53
6430137|NCT01040260|7344659|FG001|STARTED|Overall Study||50
6430138|NCT01040260|7344658|FG000|COMPLETED|Overall Study||38
6652359|NCT02428413|7581958|FG001|STARTED|Overall Study||61
6652360|NCT02428413|7581957|FG000|COMPLETED|Overall Study||56
6652361|NCT02428413|7581958|FG001|COMPLETED|Overall Study||52
6652362|NCT02428413|7581957|FG000|NOT COMPLETED|Overall Study||8
6652363|NCT02428413|7581958|FG001|NOT COMPLETED|Overall Study||9
6652364|NCT02428478|7581964|FG000|STARTED|First Study Night||9
6652365|NCT02428478|7581965|FG001|STARTED|First Study Night||8
6652366|NCT02428478|7581964|FG000|COMPLETED|First Study Night||9
6652367|NCT02428478|7581965|FG001|COMPLETED|First Study Night||8
6652368|NCT02428478|7581964|FG000|NOT COMPLETED|First Study Night||0
6652369|NCT02428478|7581965|FG001|NOT COMPLETED|First Study Night||0
6652370|NCT02428478|7581964|FG000|STARTED|Second Study Night|1 participant did not return for the second study night|8
6652371|NCT02428478|7581965|FG001|STARTED|Second Study Night|2 participants did not return for the second study night|6
6652372|NCT02428478|7581964|FG000|COMPLETED|Second Study Night||8
6652373|NCT02428478|7581965|FG001|COMPLETED|Second Study Night||6
6652374|NCT02428478|7581964|FG000|NOT COMPLETED|Second Study Night||0
6652375|NCT02428478|7581965|FG001|NOT COMPLETED|Second Study Night||0
6652376|NCT02428595|7581971|FG000|STARTED|Fitting||137
6652377|NCT02428595|7581971|FG000|COMPLETED|Fitting||73
6652378|NCT02428595|7581971|FG000|NOT COMPLETED|Fitting||64
6652379|NCT02428595|7581971|FG000|STARTED|Treatment||73
6652380|NCT02428595|7581971|FG000|COMPLETED|Treatment||54
6652381|NCT02428595|7581971|FG000|NOT COMPLETED|Treatment||19
6652382|NCT02428608|7581984|FG000|STARTED|Overall Study||570
6652383|NCT02428608|7581984|FG000|COMPLETED|Overall Study||487
6652384|NCT02428608|7581984|FG000|NOT COMPLETED|Overall Study||83
6652385|NCT02428699|7581989|FG000|STARTED|Period 1||25
6652386|NCT02428699|7581990|FG001|STARTED|Period 1||25
6652387|NCT02428699|7581989|FG000|COMPLETED|Period 1||25
6652388|NCT02428699|7581990|FG001|COMPLETED|Period 1||25
6652389|NCT02428699|7581989|FG000|NOT COMPLETED|Period 1||0
6652390|NCT02428699|7581990|FG001|NOT COMPLETED|Period 1||0
6652391|NCT02428699|7581989|FG000|STARTED|Washout Period 1||25
6652392|NCT02428699|7581990|FG001|STARTED|Washout Period 1||25
6652393|NCT02428699|7581989|FG000|COMPLETED|Washout Period 1||24
6652394|NCT02428699|7581990|FG001|COMPLETED|Washout Period 1||23
6652395|NCT02428699|7581989|FG000|NOT COMPLETED|Washout Period 1||1
6652396|NCT02428699|7581990|FG001|NOT COMPLETED|Washout Period 1||2
6652397|NCT02428699|7581989|FG000|STARTED|Period 2||24
6652398|NCT02428699|7581990|FG001|STARTED|Period 2||23
6652399|NCT02428699|7581989|FG000|COMPLETED|Period 2||24
6652400|NCT02428699|7581990|FG001|COMPLETED|Period 2||23
6652401|NCT02428699|7581989|FG000|NOT COMPLETED|Period 2||0
6652402|NCT02428699|7581990|FG001|NOT COMPLETED|Period 2||0
6652403|NCT02428855|7582001|FG000|STARTED|Overall Study||8
6652404|NCT02428855|7582001|FG000|COMPLETED|Overall Study||6
6652405|NCT02428855|7582001|FG000|NOT COMPLETED|Overall Study||2
6430139|NCT01040260|7344659|FG001|COMPLETED|Overall Study||39
6430140|NCT01040260|7344658|FG000|NOT COMPLETED|Overall Study||15
6430141|NCT01040260|7344659|FG001|NOT COMPLETED|Overall Study||11
6430142|NCT01040351|7344667|FG000|STARTED|Overall Study|October 2006|55
6430143|NCT01040351|7344668|FG001|STARTED|Overall Study|October 2006|55
6430144|NCT01040351|7344667|FG000|COMPLETED|Overall Study|May 2010|54
6430145|NCT01040351|7344668|FG001|COMPLETED|Overall Study|May 2010|53
6430146|NCT01040351|7344667|FG000|NOT COMPLETED|Overall Study||1
6430147|NCT01040351|7344668|FG001|NOT COMPLETED|Overall Study||2
6430148|NCT01040403|7344674|FG000|STARTED|Overall Study||233
6430149|NCT01040403|7344674|FG000|Completed Olo 5|Overall Study||106
6430150|NCT01040403|7344674|FG000|Completed T+O 1.25/5|Overall Study||105
6430151|NCT01040403|7344674|FG000|Completed T+O 2.5/5|Overall Study||111
6430152|NCT01040403|7344674|FG000|Completed T+O 5/5|Overall Study||106
6430153|NCT01040403|7344674|FG000|Completed Olo 10|Overall Study||109
6430154|NCT01040403|7344674|FG000|Completed T+O 1.25/10|Overall Study||106
6430155|NCT01040403|7344674|FG000|Completed T+O 2.5/10|Overall Study||110
6430156|NCT01040403|7344674|FG000|Completed T+O 5/10|Overall Study||107
6430157|NCT01040403|7344674|FG000|COMPLETED|Overall Study|All treatment periods|213
6430158|NCT01040403|7344674|FG000|NOT COMPLETED|Overall Study||20
6430159|NCT01040689|7344693|FG000|STARTED|Overall Study||27
6430160|NCT01040689|7344694|FG001|STARTED|Overall Study||27
6430161|NCT01040689|7344695|FG002|STARTED|Overall Study||27
6430162|NCT01040689|7344696|FG003|STARTED|Overall Study||27
6652406|NCT02429115|7582011|FG000|STARTED|Overall Study||52
6652407|NCT02429115|7582012|FG001|STARTED|Overall Study||52
6652408|NCT02429115|7582013|FG002|STARTED|Overall Study||51
6652409|NCT02429115|7582014|FG003|STARTED|Overall Study||29
6652410|NCT02429115|7582015|FG004|STARTED|Overall Study||29
6430163|NCT01040689|7344693|FG000|COMPLETED|Overall Study||24
6652411|NCT02429115|7582016|FG005|STARTED|Overall Study||28
6430164|NCT01040689|7344694|FG001|COMPLETED|Overall Study||25
6430165|NCT01040689|7344695|FG002|COMPLETED|Overall Study||23
6430166|NCT01040689|7344696|FG003|COMPLETED|Overall Study||23
6430167|NCT01040689|7344693|FG000|NOT COMPLETED|Overall Study||3
6430168|NCT01040689|7344694|FG001|NOT COMPLETED|Overall Study||2
6430169|NCT01040689|7344695|FG002|NOT COMPLETED|Overall Study||4
6430170|NCT01040689|7344696|FG003|NOT COMPLETED|Overall Study||4
6430171|NCT01040728|7344711|FG000|STARTED|Overall Study||31
6430172|NCT01040728|7344712|FG001|STARTED|Overall Study||30
6430173|NCT01040728|7344713|FG002|STARTED|Overall Study||31
6430174|NCT01040728|7344714|FG003|STARTED|Overall Study||30
6430175|NCT01040728|7344711|FG000|COMPLETED|Overall Study||27
6430176|NCT01040728|7344712|FG001|COMPLETED|Overall Study||19
6430177|NCT01040728|7344713|FG002|COMPLETED|Overall Study||30
6430178|NCT01040728|7344714|FG003|COMPLETED|Overall Study||24
6430179|NCT01040728|7344711|FG000|NOT COMPLETED|Overall Study||4
6430180|NCT01040728|7344712|FG001|NOT COMPLETED|Overall Study||11
6430181|NCT01040728|7344713|FG002|NOT COMPLETED|Overall Study||1
6430182|NCT01040728|7344714|FG003|NOT COMPLETED|Overall Study||6
6430183|NCT01040780|7344732|FG000|STARTED|Overall Study||200
6430184|NCT01040780|7344733|FG001|STARTED|Overall Study||199
6430185|NCT01040780|7344732|FG000|COMPLETED|Overall Study||199
6430186|NCT01040780|7344733|FG001|COMPLETED|Overall Study||196
6430187|NCT01040780|7344732|FG000|NOT COMPLETED|Overall Study||1
6430188|NCT01040780|7344733|FG001|NOT COMPLETED|Overall Study||3
6430189|NCT01040793|7344742|FG000|STARTED|Overall Study|Entered and treated|26
6430190|NCT01040793|7344743|FG001|STARTED|Overall Study||26
6430191|NCT01040793|7344744|FG002|STARTED|Overall Study||26
6430192|NCT01040793|7344745|FG003|STARTED|Overall Study||26
6430193|NCT01040793|7344746|FG004|STARTED|Overall Study||26
6430194|NCT01040793|7344747|FG005|STARTED|Overall Study||27
6430195|NCT01040793|7344742|FG000|COMPLETED|Overall Study||20
6430196|NCT01040793|7344743|FG001|COMPLETED|Overall Study||21
6430197|NCT01040793|7344744|FG002|COMPLETED|Overall Study||23
6430198|NCT01040793|7344745|FG003|COMPLETED|Overall Study||22
6430199|NCT01040793|7344746|FG004|COMPLETED|Overall Study||22
6430200|NCT01040793|7344747|FG005|COMPLETED|Overall Study||26
6430201|NCT01040793|7344742|FG000|NOT COMPLETED|Overall Study||6
6430202|NCT01040793|7344743|FG001|NOT COMPLETED|Overall Study||5
6430203|NCT01040793|7344744|FG002|NOT COMPLETED|Overall Study||3
6552143|NCT01736241|7474572|FG005|STARTED|Overall Study||6
6552144|NCT01736241|7474573|FG006|STARTED|Overall Study||6
6552145|NCT01736241|7474567|FG000|Received at Least One Dose of Study Drug|Overall Study||6
6552146|NCT01736241|7474568|FG001|Received at Least One Dose of Study Drug|Overall Study||6
6552147|NCT01736241|7474569|FG002|Received at Least One Dose of Study Drug|Overall Study||6
6552148|NCT01736241|7474570|FG003|Received at Least One Dose of Study Drug|Overall Study||5
6552149|NCT01736241|7474571|FG004|Received at Least One Dose of Study Drug|Overall Study||6
6552150|NCT01736241|7474572|FG005|Received at Least One Dose of Study Drug|Overall Study||6
6552151|NCT01736241|7474573|FG006|Received at Least One Dose of Study Drug|Overall Study||6
6430204|NCT01040793|7344745|FG003|NOT COMPLETED|Overall Study||4
6430205|NCT01040793|7344746|FG004|NOT COMPLETED|Overall Study||4
6430206|NCT01040793|7344747|FG005|NOT COMPLETED|Overall Study||1
6430207|NCT01040819|7344759|FG000|STARTED|Overall Study||13
6430208|NCT01040819|7344760|FG001|STARTED|Overall Study||12
6430209|NCT01040819|7344759|FG000|COMPLETED|Overall Study||13
6430210|NCT01040819|7344760|FG001|COMPLETED|Overall Study||12
6430211|NCT01040819|7344759|FG000|NOT COMPLETED|Overall Study||0
6430212|NCT01040819|7344760|FG001|NOT COMPLETED|Overall Study||0
6430213|NCT01040832|7344768|FG000|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
6430214|NCT01040832|7344769|FG001|STARTED|Overall Study||53
6430215|NCT01040832|7344768|FG000|COMPLETED|Overall Study||8
6430216|NCT01040832|7344769|FG001|COMPLETED|Overall Study||16
6430217|NCT01040832|7344768|FG000|NOT COMPLETED|Overall Study||46
6430218|NCT01040832|7344769|FG001|NOT COMPLETED|Overall Study||37
6430219|NCT01040845|7344777|FG000|STARTED|Overall Study||15
6430220|NCT01040845|7344778|FG001|STARTED|Overall Study||15
6430221|NCT01040845|7344777|FG000|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
6430222|NCT01040845|7344778|FG001|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
6430223|NCT01040845|7344777|FG000|NOT COMPLETED|Overall Study||2
6430224|NCT01040845|7344778|FG001|NOT COMPLETED|Overall Study||1
6430225|NCT01040858|7344788|FG000|STARTED|Overall Study||59
6430226|NCT01040858|7344789|FG001|STARTED|Overall Study||69
6430227|NCT01040858|7344788|FG000|COMPLETED|Overall Study||50
6430228|NCT01040858|7344789|FG001|COMPLETED|Overall Study||69
6430229|NCT01040858|7344788|FG000|NOT COMPLETED|Overall Study||9
6430230|NCT01040858|7344789|FG001|NOT COMPLETED|Overall Study||0
6430231|NCT01040871|7344800|FG000|STARTED|Overall Study|Intent to Treat, Randomized|84
6430232|NCT01040871|7344801|FG001|STARTED|Overall Study|Intent to Treat, Randomized|80
6430233|NCT01040871|7344800|FG000|COMPLETED|Overall Study||71
6430234|NCT01040871|7344801|FG001|COMPLETED|Overall Study||73
6430235|NCT01040871|7344800|FG000|NOT COMPLETED|Overall Study||13
6430236|NCT01040871|7344801|FG001|NOT COMPLETED|Overall Study||7
6430237|NCT01041209|7344809|FG000|STARTED|Overall Study||60
6430238|NCT01041209|7344810|FG001|STARTED|Overall Study||60
6430239|NCT01041209|7344809|FG000|COMPLETED|Overall Study||60
6430240|NCT01041209|7344810|FG001|COMPLETED|Overall Study||60
6430241|NCT01041209|7344809|FG000|NOT COMPLETED|Overall Study||0
6430242|NCT01041209|7344810|FG001|NOT COMPLETED|Overall Study||0
6430243|NCT01041248|7344817|FG000|STARTED|Overall Study|January 2010|1
6430244|NCT01041248|7344817|FG000|COMPLETED|Overall Study||1
6430245|NCT01041248|7344817|FG000|NOT COMPLETED|Overall Study||0
6430246|NCT01041274|7344824|FG000|STARTED|Overall Study||49
6430247|NCT01041274|7344825|FG001|STARTED|Overall Study||46
6430248|NCT01041274|7344824|FG000|COMPLETED|Overall Study||26
6430249|NCT01041274|7344825|FG001|COMPLETED|Overall Study||25
6430250|NCT01041274|7344824|FG000|NOT COMPLETED|Overall Study||23
6430251|NCT01041274|7344825|FG001|NOT COMPLETED|Overall Study||21
6430252|NCT01041287|7344833|FG000|STARTED|Treatment Period 1 (3 Months)||19
6430253|NCT01041287|7344834|FG001|STARTED|Treatment Period 1 (3 Months)||19
6430254|NCT01041287|7344833|FG000|COMPLETED|Treatment Period 1 (3 Months)||19
6430255|NCT01041287|7344834|FG001|COMPLETED|Treatment Period 1 (3 Months)||19
6430256|NCT01041287|7344833|FG000|NOT COMPLETED|Treatment Period 1 (3 Months)||0
6430257|NCT01041287|7344834|FG001|NOT COMPLETED|Treatment Period 1 (3 Months)||0
6430258|NCT01041287|7344833|FG000|STARTED|Treatment Period 2 (3 Months)||19
6430259|NCT01041287|7344834|FG001|STARTED|Treatment Period 2 (3 Months)||19
6430260|NCT01041287|7344833|FG000|COMPLETED|Treatment Period 2 (3 Months)||16
6430261|NCT01041287|7344834|FG001|COMPLETED|Treatment Period 2 (3 Months)||14
6430262|NCT01041287|7344833|FG000|NOT COMPLETED|Treatment Period 2 (3 Months)||3
6430263|NCT01041287|7344834|FG001|NOT COMPLETED|Treatment Period 2 (3 Months)||5
6430264|NCT01041404|7344842|FG000|STARTED|Overall Study||290
6430265|NCT01041404|7344843|FG001|STARTED|Overall Study||294
6430266|NCT01041404|7344842|FG000|Entered Follow-Up|Overall Study||251
6430267|NCT01041404|7344843|FG001|Entered Follow-Up|Overall Study||251
6430268|NCT01041404|7344842|FG000|Died in Follow-up|Overall Study||199
6430269|NCT01041404|7344843|FG001|Died in Follow-up|Overall Study||200
6430270|NCT01041404|7344842|FG000|Lost to Follow-up|Overall Study||12
6430271|NCT01041404|7344843|FG001|Lost to Follow-up|Overall Study||10
6430272|NCT01041404|7344842|FG000|Alive in Follow-up|Overall Study||40
6430273|NCT01041404|7344843|FG001|Alive in Follow-up|Overall Study||41
6430274|NCT01041404|7344842|FG000|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
6430275|NCT01041404|7344843|FG001|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
6430276|NCT01041404|7344842|FG000|NOT COMPLETED|Overall Study||290
6430277|NCT01041404|7344843|FG001|NOT COMPLETED|Overall Study||294
6430278|NCT01041417|7344854|FG000|STARTED|Overall Study||80
6430279|NCT01041417|7344855|FG001|STARTED|Overall Study||79
6430280|NCT01041417|7344854|FG000|COMPLETED|Overall Study||73
6430281|NCT01041417|7344855|FG001|COMPLETED|Overall Study||76
6430282|NCT01041417|7344854|FG000|NOT COMPLETED|Overall Study||7
6430283|NCT01041417|7344855|FG001|NOT COMPLETED|Overall Study||3
6430284|NCT01041495|7344865|FG000|STARTED|Overall Study||16
6430285|NCT01041495|7344866|FG001|STARTED|Overall Study||12
6430286|NCT01041495|7344865|FG000|COMPLETED|Overall Study||12
6430287|NCT01041495|7344866|FG001|COMPLETED|Overall Study||5
6430288|NCT01041495|7344865|FG000|NOT COMPLETED|Overall Study||4
6430289|NCT01041495|7344866|FG001|NOT COMPLETED|Overall Study||7
6430290|NCT01041521|7344874|FG000|STARTED|Overall Study||61
6430291|NCT01041521|7344875|FG001|STARTED|Overall Study||56
6430292|NCT01041521|7344874|FG000|COMPLETED|Overall Study||44
6430293|NCT01041521|7344875|FG001|COMPLETED|Overall Study||40
6430294|NCT01041521|7344874|FG000|NOT COMPLETED|Overall Study||17
6430295|NCT01041521|7344875|FG001|NOT COMPLETED|Overall Study||16
6430296|NCT01041573|7344885|FG000|STARTED|Overall Study||540
6430297|NCT01041573|7344886|FG001|STARTED|Overall Study||871
6430298|NCT01041573|7344887|FG002|STARTED|Overall Study||394
6430299|NCT01041573|7344888|FG003|STARTED|Overall Study||64
6430300|NCT01041573|7344885|FG000|COMPLETED|Overall Study||535
6430301|NCT01041573|7344886|FG001|COMPLETED|Overall Study||858
6430302|NCT01041573|7344887|FG002|COMPLETED|Overall Study||387
6430303|NCT01041573|7344888|FG003|COMPLETED|Overall Study||62
6430304|NCT01041573|7344885|FG000|NOT COMPLETED|Overall Study||5
6552152|NCT01736241|7474567|FG000|COMPLETED|Overall Study||6
6552153|NCT01736241|7474568|FG001|COMPLETED|Overall Study||6
6552154|NCT01736241|7474569|FG002|COMPLETED|Overall Study||6
6552155|NCT01736241|7474570|FG003|COMPLETED|Overall Study||5
6552156|NCT01736241|7474571|FG004|COMPLETED|Overall Study||6
6430305|NCT01041573|7344886|FG001|NOT COMPLETED|Overall Study||13
6430306|NCT01041573|7344887|FG002|NOT COMPLETED|Overall Study||7
6430307|NCT01041573|7344888|FG003|NOT COMPLETED|Overall Study||2
6430308|NCT01041638|7344907|FG000|STARTED|Overall Study||105
6430309|NCT01041638|7344907|FG000|COMPLETED|Overall Study||78
6430310|NCT01041638|7344907|FG000|NOT COMPLETED|Overall Study||27
6430311|NCT01041781|7344913|FG000|STARTED|Overall Study||154
6430312|NCT01041781|7344914|FG001|STARTED|Overall Study||158
6430313|NCT01041781|7344913|FG000|COMPLETED|Overall Study||154
6430314|NCT01041781|7344914|FG001|COMPLETED|Overall Study||158
6430315|NCT01041781|7344913|FG000|NOT COMPLETED|Overall Study||0
6430316|NCT01041781|7344914|FG001|NOT COMPLETED|Overall Study||0
6430317|NCT01041859|7344930|FG000|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
6430318|NCT01041859|7344931|FG001|STARTED|Open-Label Titration||0
6430319|NCT01041859|7344932|FG002|STARTED|Open-Label Titration||0
6430320|NCT01041859|7344930|FG000|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
6552157|NCT01736241|7474572|FG005|COMPLETED|Overall Study||6
6552158|NCT01736241|7474573|FG006|COMPLETED|Overall Study||6
6430321|NCT01041859|7344931|FG001|COMPLETED|Open-Label Titration||0
6430322|NCT01041859|7344932|FG002|COMPLETED|Open-Label Titration||0
6430323|NCT01041859|7344930|FG000|NOT COMPLETED|Open-Label Titration||101
6430324|NCT01041859|7344931|FG001|NOT COMPLETED|Open-Label Titration||0
6430325|NCT01041859|7344932|FG002|NOT COMPLETED|Open-Label Titration||0
6430326|NCT01041859|7344930|FG000|STARTED|Double-Blind Maintenance||0
6430327|NCT01041859|7344931|FG001|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
6430328|NCT01041859|7344932|FG002|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
6430329|NCT01041859|7344930|FG000|COMPLETED|Double-Blind Maintenance||0
6430330|NCT01041859|7344931|FG001|COMPLETED|Double-Blind Maintenance||120
6430331|NCT01041859|7344932|FG002|COMPLETED|Double-Blind Maintenance||107
6430332|NCT01041859|7344930|FG000|NOT COMPLETED|Double-Blind Maintenance||0
6430333|NCT01041859|7344931|FG001|NOT COMPLETED|Double-Blind Maintenance||46
6430334|NCT01041859|7344932|FG002|NOT COMPLETED|Double-Blind Maintenance||45
6430335|NCT01041976|7344941|FG000|STARTED|Overall Study||42
6430336|NCT01041976|7344942|FG001|STARTED|Overall Study||42
6430337|NCT01041976|7344941|FG000|6 Month Follow-up|Overall Study||39
6430338|NCT01041976|7344942|FG001|6 Month Follow-up|Overall Study||41
6430339|NCT01041976|7344941|FG000|12 Month Follow-up|Overall Study||37
6430340|NCT01041976|7344942|FG001|12 Month Follow-up|Overall Study||38
6430341|NCT01041976|7344941|FG000|18 Month Follow-up|Overall Study||37
6430342|NCT01041976|7344942|FG001|18 Month Follow-up|Overall Study||38
6430343|NCT01041976|7344941|FG000|COMPLETED|Overall Study||37
6430344|NCT01041976|7344942|FG001|COMPLETED|Overall Study||38
6430345|NCT01041976|7344941|FG000|NOT COMPLETED|Overall Study||5
6430346|NCT01041976|7344942|FG001|NOT COMPLETED|Overall Study||4
6430347|NCT01042093|7344952|FG000|STARTED|Overall Study||40
6430348|NCT01042093|7344953|FG001|STARTED|Overall Study||40
6430349|NCT01042093|7344954|FG002|STARTED|Overall Study||40
6430350|NCT01042093|7344955|FG003|STARTED|Overall Study||40
6430351|NCT01042093|7344952|FG000|COMPLETED|Overall Study||38
6430352|NCT01042093|7344953|FG001|COMPLETED|Overall Study||38
6430353|NCT01042093|7344954|FG002|COMPLETED|Overall Study||38
6430354|NCT01042093|7344955|FG003|COMPLETED|Overall Study||36
6430355|NCT01042093|7344952|FG000|NOT COMPLETED|Overall Study||2
6430356|NCT01042093|7344953|FG001|NOT COMPLETED|Overall Study||2
6430357|NCT01042093|7344954|FG002|NOT COMPLETED|Overall Study||2
6430358|NCT01042093|7344955|FG003|NOT COMPLETED|Overall Study||4
6430359|NCT01042145|7344970|FG000|STARTED|Overall Study||41
6430360|NCT01042145|7344971|FG001|STARTED|Overall Study||46
6430361|NCT01042145|7344970|FG000|COMPLETED|Overall Study||40
6430362|NCT01042145|7344971|FG001|COMPLETED|Overall Study||45
6430363|NCT01042145|7344970|FG000|NOT COMPLETED|Overall Study||1
6430364|NCT01042145|7344971|FG001|NOT COMPLETED|Overall Study||1
6430365|NCT01042158|7344977|FG000|STARTED|Overall Study||25
6430366|NCT01042158|7344977|FG000|COMPLETED|Overall Study||24
6430367|NCT01042158|7344977|FG000|NOT COMPLETED|Overall Study||1
6430368|NCT01042236|7344981|FG000|STARTED|Treatment Period 1||3
6430369|NCT01042236|7344982|FG001|STARTED|Treatment Period 1||4
6430370|NCT01042236|7344983|FG002|STARTED|Treatment Period 1||3
6430371|NCT01042236|7344984|FG003|STARTED|Treatment Period 1||5
6430372|NCT01042236|7344985|FG004|STARTED|Treatment Period 1||4
6430373|NCT01042236|7344986|FG005|STARTED|Treatment Period 1||3
6430374|NCT01042236|7344981|FG000|COMPLETED|Treatment Period 1||3
6430375|NCT01042236|7344982|FG001|COMPLETED|Treatment Period 1||3
6430376|NCT01042236|7344983|FG002|COMPLETED|Treatment Period 1||3
6430377|NCT01042236|7344984|FG003|COMPLETED|Treatment Period 1||5
6430378|NCT01042236|7344985|FG004|COMPLETED|Treatment Period 1||3
6430379|NCT01042236|7344986|FG005|COMPLETED|Treatment Period 1||3
6430380|NCT01042236|7344981|FG000|NOT COMPLETED|Treatment Period 1||0
6430381|NCT01042236|7344982|FG001|NOT COMPLETED|Treatment Period 1||1
6430382|NCT01042236|7344983|FG002|NOT COMPLETED|Treatment Period 1||0
6430383|NCT01042236|7344984|FG003|NOT COMPLETED|Treatment Period 1||0
6430384|NCT01042236|7344985|FG004|NOT COMPLETED|Treatment Period 1||1
6430385|NCT01042236|7344986|FG005|NOT COMPLETED|Treatment Period 1||0
6430386|NCT01042236|7344981|FG000|STARTED|Treatment Period 2||3
6430387|NCT01042236|7344982|FG001|STARTED|Treatment Period 2||3
6430388|NCT01042236|7344983|FG002|STARTED|Treatment Period 2||3
6430389|NCT01042236|7344984|FG003|STARTED|Treatment Period 2||5
6430390|NCT01042236|7344985|FG004|STARTED|Treatment Period 2||3
6430391|NCT01042236|7344986|FG005|STARTED|Treatment Period 2||3
6430392|NCT01042236|7344981|FG000|COMPLETED|Treatment Period 2||3
6430393|NCT01042236|7344982|FG001|COMPLETED|Treatment Period 2||3
6430394|NCT01042236|7344983|FG002|COMPLETED|Treatment Period 2||3
6430395|NCT01042236|7344984|FG003|COMPLETED|Treatment Period 2||5
6430396|NCT01042236|7344985|FG004|COMPLETED|Treatment Period 2||3
6430397|NCT01042236|7344986|FG005|COMPLETED|Treatment Period 2||3
6430398|NCT01042236|7344981|FG000|NOT COMPLETED|Treatment Period 2||0
6430399|NCT01042236|7344982|FG001|NOT COMPLETED|Treatment Period 2||0
6430400|NCT01042236|7344983|FG002|NOT COMPLETED|Treatment Period 2||0
6430401|NCT01042236|7344984|FG003|NOT COMPLETED|Treatment Period 2||0
6430402|NCT01042236|7344985|FG004|NOT COMPLETED|Treatment Period 2||0
6430403|NCT01042236|7344986|FG005|NOT COMPLETED|Treatment Period 2||0
6430404|NCT01042236|7344981|FG000|STARTED|Treatment Period 3||3
6430405|NCT01042236|7344982|FG001|STARTED|Treatment Period 3||3
6430406|NCT01042236|7344983|FG002|STARTED|Treatment Period 3||3
6430407|NCT01042236|7344984|FG003|STARTED|Treatment Period 3||5
6430408|NCT01042236|7344985|FG004|STARTED|Treatment Period 3||3
6430409|NCT01042236|7344986|FG005|STARTED|Treatment Period 3||3
6430410|NCT01042236|7344981|FG000|COMPLETED|Treatment Period 3||3
6430411|NCT01042236|7344982|FG001|COMPLETED|Treatment Period 3||3
6430412|NCT01042236|7344983|FG002|COMPLETED|Treatment Period 3||3
6744279|NCT03341312|7672355|FG000|STARTED|Period 1||9
6744280|NCT03341312|7672356|FG001|STARTED|Period 1||10
6744281|NCT03341312|7672357|FG002|STARTED|Period 1||9
6744282|NCT03341312|7672358|FG003|STARTED|Period 1||8
6744283|NCT03341312|7672355|FG000|Received at Least One Dose of Study Drug|Period 1||9
6744284|NCT03341312|7672356|FG001|Received at Least One Dose of Study Drug|Period 1||10
6744285|NCT03341312|7672357|FG002|Received at Least One Dose of Study Drug|Period 1||9
6744286|NCT03341312|7672358|FG003|Received at Least One Dose of Study Drug|Period 1||8
6430413|NCT01042236|7344984|FG003|COMPLETED|Treatment Period 3||3
6430414|NCT01042236|7344985|FG004|COMPLETED|Treatment Period 3||3
6430415|NCT01042236|7344986|FG005|COMPLETED|Treatment Period 3||3
6430416|NCT01042236|7344981|FG000|NOT COMPLETED|Treatment Period 3||0
6430417|NCT01042236|7344982|FG001|NOT COMPLETED|Treatment Period 3||0
6430418|NCT01042236|7344983|FG002|NOT COMPLETED|Treatment Period 3||0
6430419|NCT01042236|7344984|FG003|NOT COMPLETED|Treatment Period 3||2
6430420|NCT01042236|7344985|FG004|NOT COMPLETED|Treatment Period 3||0
6430421|NCT01042236|7344986|FG005|NOT COMPLETED|Treatment Period 3||0
6430422|NCT01042288|7344994|FG000|STARTED|Overall Study||69
6430423|NCT01042288|7344994|FG000|Maintenance|Overall Study||27
6430424|NCT01042288|7344994|FG000|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
6430425|NCT01042288|7344994|FG000|NOT COMPLETED|Overall Study||69
6430426|NCT01042366|7345001|FG000|STARTED|Overall Study||5
6430427|NCT01042366|7345002|FG001|STARTED|Overall Study||6
6430428|NCT01042366|7345003|FG002|STARTED|Overall Study||4
6430429|NCT01042366|7345001|FG000|COMPLETED|Overall Study||5
6430430|NCT01042366|7345002|FG001|COMPLETED|Overall Study||6
6430431|NCT01042366|7345003|FG002|COMPLETED|Overall Study||4
6430432|NCT01042366|7345001|FG000|NOT COMPLETED|Overall Study||0
6430433|NCT01042366|7345002|FG001|NOT COMPLETED|Overall Study||0
6430434|NCT01042366|7345003|FG002|NOT COMPLETED|Overall Study||0
6430435|NCT01042392|7345011|FG000|STARTED|Period II(Randomized,Double Blinded,8wk)||257
6430436|NCT01042392|7345012|FG001|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
6430437|NCT01042392|7345013|FG002|STARTED|Period II(Randomized,Double Blinded,8wk)||249
6430438|NCT01042392|7345014|FG003|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
6430439|NCT01042392|7345011|FG000|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
6430440|NCT01042392|7345012|FG001|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
6430441|NCT01042392|7345013|FG002|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
6430442|NCT01042392|7345014|FG003|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
6430443|NCT01042392|7345011|FG000|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
6430444|NCT01042392|7345012|FG001|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
6430445|NCT01042392|7345013|FG002|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
6430446|NCT01042392|7345014|FG003|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
6430447|NCT01042392|7345011|FG000|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
6430448|NCT01042392|7345012|FG001|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
6430449|NCT01042392|7345013|FG002|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
6430450|NCT01042392|7345014|FG003|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
6430451|NCT01042392|7345011|FG000|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
6430452|NCT01042392|7345012|FG001|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
6430453|NCT01042392|7345013|FG002|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
6430454|NCT01042392|7345014|FG003|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
6430455|NCT01042392|7345011|FG000|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
6430456|NCT01042392|7345012|FG001|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
6430457|NCT01042392|7345013|FG002|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
6430458|NCT01042392|7345014|FG003|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
6430459|NCT01042392|7345011|FG000|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
6430460|NCT01042392|7345012|FG001|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
6430461|NCT01042392|7345013|FG002|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
6430462|NCT01042392|7345014|FG003|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
6430463|NCT01042392|7345011|FG000|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
6430464|NCT01042392|7345012|FG001|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
6430465|NCT01042392|7345013|FG002|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
6430466|NCT01042392|7345014|FG003|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
6430467|NCT01042496|7345028|FG000|STARTED|Overall Study||29
6430468|NCT01042496|7345029|FG001|STARTED|Overall Study||33
6430469|NCT01042496|7345028|FG000|COMPLETED|Overall Study||29
6430470|NCT01042496|7345029|FG001|COMPLETED|Overall Study||33
6430471|NCT01042496|7345028|FG000|NOT COMPLETED|Overall Study||0
6430472|NCT01042496|7345029|FG001|NOT COMPLETED|Overall Study||0
6430473|NCT01042509|7345039|FG000|STARTED|Overall Study||15
6430474|NCT01042509|7345039|FG000|COMPLETED|Overall Study||15
6744287|NCT03341312|7672355|FG000|COMPLETED|Period 1||9
6744288|NCT03341312|7672356|FG001|COMPLETED|Period 1||9
6430475|NCT01042509|7345039|FG000|NOT COMPLETED|Overall Study||0
6430476|NCT01042535|7345043|FG000|STARTED|Overall Study||44
6430477|NCT01042535|7345043|FG000|COMPLETED|Overall Study||36
6430478|NCT01042535|7345043|FG000|NOT COMPLETED|Overall Study||8
6430479|NCT01042600|7345049|FG000|STARTED|Overall Study||31
6430480|NCT01042600|7345050|FG001|STARTED|Overall Study||30
6430481|NCT01042600|7345049|FG000|COMPLETED|Overall Study||30
6430482|NCT01042600|7345050|FG001|COMPLETED|Overall Study||30
6430483|NCT01042600|7345049|FG000|NOT COMPLETED|Overall Study||1
6430484|NCT01042600|7345050|FG001|NOT COMPLETED|Overall Study||0
6430485|NCT01042613|7345059|FG000|STARTED|Overall Study||72
6430486|NCT01042613|7345060|FG001|STARTED|Overall Study||74
6430487|NCT01042613|7345059|FG000|COMPLETED|Overall Study||72
6430488|NCT01042613|7345060|FG001|COMPLETED|Overall Study||74
6430489|NCT01042613|7345059|FG000|NOT COMPLETED|Overall Study||0
6430490|NCT01042613|7345060|FG001|NOT COMPLETED|Overall Study||0
6430491|NCT01042678|7345069|FG000|STARTED|Overall Study||6
6430492|NCT01042678|7345070|FG001|STARTED|Overall Study||6
6430493|NCT01042678|7345071|FG002|STARTED|Overall Study||6
6430494|NCT01042678|7345072|FG003|STARTED|Overall Study||0
6430495|NCT01042678|7345073|FG004|STARTED|Overall Study||0
6430496|NCT01042678|7345074|FG005|STARTED|Overall Study||0
6430497|NCT01042678|7345069|FG000|COMPLETED|Overall Study||5
6430498|NCT01042678|7345070|FG001|COMPLETED|Overall Study||6
6430499|NCT01042678|7345071|FG002|COMPLETED|Overall Study||6
6430500|NCT01042678|7345072|FG003|COMPLETED|Overall Study||0
6430501|NCT01042678|7345073|FG004|COMPLETED|Overall Study||0
6430502|NCT01042678|7345074|FG005|COMPLETED|Overall Study||0
6430503|NCT01042678|7345069|FG000|NOT COMPLETED|Overall Study||1
6430504|NCT01042678|7345070|FG001|NOT COMPLETED|Overall Study||0
6430505|NCT01042678|7345071|FG002|NOT COMPLETED|Overall Study||0
6430506|NCT01042678|7345072|FG003|NOT COMPLETED|Overall Study||0
6430507|NCT01042678|7345073|FG004|NOT COMPLETED|Overall Study||0
6430508|NCT01042678|7345074|FG005|NOT COMPLETED|Overall Study||0
6430509|NCT01042795|7345082|FG000|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
6430510|NCT01042795|7345082|FG000|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
6430511|NCT01042795|7345082|FG000|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
6430512|NCT01042795|7345082|FG000|STARTED|Follow up - 22 Months After Drug Start||2
6430513|NCT01042795|7345082|FG000|COMPLETED|Follow up - 22 Months After Drug Start||0
6430514|NCT01042795|7345082|FG000|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
6430515|NCT01042938|7345088|FG000|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
6430516|NCT01042938|7345089|FG001|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
6430517|NCT01042938|7345088|FG000|COMPLETED|Overall Study||14
6430518|NCT01042938|7345089|FG001|COMPLETED|Overall Study||16
6430519|NCT01042938|7345088|FG000|NOT COMPLETED|Overall Study||3
6430520|NCT01042938|7345089|FG001|NOT COMPLETED|Overall Study||2
6430521|NCT01042977|7345099|FG000|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
6430522|NCT01042977|7345100|FG001|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
6430523|NCT01042977|7345099|FG000|COMPLETED|Overall Study||441
6430524|NCT01042977|7345100|FG001|COMPLETED|Overall Study||428
6430525|NCT01042977|7345099|FG000|NOT COMPLETED|Overall Study||41
6430526|NCT01042977|7345100|FG001|NOT COMPLETED|Overall Study||55
6430527|NCT01043094|7345108|FG000|STARTED|Overall Study||8
6430528|NCT01043094|7345109|FG001|STARTED|Overall Study||8
6430529|NCT01043094|7345108|FG000|COMPLETED|Overall Study||8
6430530|NCT01043094|7345109|FG001|COMPLETED|Overall Study||8
6430531|NCT01043094|7345108|FG000|NOT COMPLETED|Overall Study||0
6430532|NCT01043094|7345109|FG001|NOT COMPLETED|Overall Study||0
6430533|NCT01043133|7345117|FG000|STARTED|Overall Study||75
6430534|NCT01043133|7345118|FG001|STARTED|Overall Study||80
6430535|NCT01043133|7345117|FG000|COMPLETED|Overall Study||74
6430536|NCT01043133|7345118|FG001|COMPLETED|Overall Study||78
6430537|NCT01043133|7345117|FG000|NOT COMPLETED|Overall Study||1
6430538|NCT01043133|7345118|FG001|NOT COMPLETED|Overall Study||2
6430539|NCT01043146|7345130|FG000|STARTED|Overall Study||10
6430540|NCT01043146|7345131|FG001|STARTED|Overall Study||8
6430541|NCT01043146|7345132|FG002|STARTED|Overall Study||8
6430542|NCT01043146|7345133|FG003|STARTED|Overall Study||8
6430543|NCT01043146|7345134|FG004|STARTED|Overall Study||8
6430544|NCT01043146|7345135|FG005|STARTED|Overall Study||8
6430545|NCT01043146|7345130|FG000|COMPLETED|Overall Study||10
6430546|NCT01043146|7345131|FG001|COMPLETED|Overall Study||8
6430547|NCT01043146|7345132|FG002|COMPLETED|Overall Study||8
6430548|NCT01043146|7345133|FG003|COMPLETED|Overall Study||8
6430549|NCT01043146|7345134|FG004|COMPLETED|Overall Study||8
6430550|NCT01043146|7345135|FG005|COMPLETED|Overall Study||8
6430551|NCT01043146|7345130|FG000|NOT COMPLETED|Overall Study||0
6430552|NCT01043146|7345131|FG001|NOT COMPLETED|Overall Study||0
6430553|NCT01043146|7345132|FG002|NOT COMPLETED|Overall Study||0
6430554|NCT01043146|7345133|FG003|NOT COMPLETED|Overall Study||0
6430555|NCT01043146|7345134|FG004|NOT COMPLETED|Overall Study||0
6430556|NCT01043146|7345135|FG005|NOT COMPLETED|Overall Study||0
6430557|NCT01043185|7345149|FG000|STARTED|Period 1 - First Intervention||3
6430558|NCT01043185|7345150|FG001|STARTED|Period 1 - First Intervention||2
6430559|NCT01043185|7345151|FG002|STARTED|Period 1 - First Intervention||3
6430560|NCT01043185|7345152|FG003|STARTED|Period 1 - First Intervention||2
6430561|NCT01043185|7345153|FG004|STARTED|Period 1 - First Intervention||2
6430562|NCT01043185|7345154|FG005|STARTED|Period 1 - First Intervention||3
6430563|NCT01043185|7345155|FG006|STARTED|Period 1 - First Intervention||3
6430564|NCT01043185|7345156|FG007|STARTED|Period 1 - First Intervention||3
6430565|NCT01043185|7345157|FG008|STARTED|Period 1 - First Intervention||3
6430566|NCT01043185|7345158|FG009|STARTED|Period 1 - First Intervention||3
6430567|NCT01043185|7345149|FG000|COMPLETED|Period 1 - First Intervention||3
6430568|NCT01043185|7345150|FG001|COMPLETED|Period 1 - First Intervention||2
6430569|NCT01043185|7345151|FG002|COMPLETED|Period 1 - First Intervention||3
6430570|NCT01043185|7345152|FG003|COMPLETED|Period 1 - First Intervention||2
6430571|NCT01043185|7345153|FG004|COMPLETED|Period 1 - First Intervention||2
6430572|NCT01043185|7345154|FG005|COMPLETED|Period 1 - First Intervention||3
6430573|NCT01043185|7345155|FG006|COMPLETED|Period 1 - First Intervention||3
6430574|NCT01043185|7345156|FG007|COMPLETED|Period 1 - First Intervention||3
6430575|NCT01043185|7345157|FG008|COMPLETED|Period 1 - First Intervention||3
6430576|NCT01043185|7345158|FG009|COMPLETED|Period 1 - First Intervention||3
6430577|NCT01043185|7345149|FG000|NOT COMPLETED|Period 1 - First Intervention||0
6430578|NCT01043185|7345150|FG001|NOT COMPLETED|Period 1 - First Intervention||0
6430579|NCT01043185|7345151|FG002|NOT COMPLETED|Period 1 - First Intervention||0
6430580|NCT01043185|7345152|FG003|NOT COMPLETED|Period 1 - First Intervention||0
6430581|NCT01043185|7345153|FG004|NOT COMPLETED|Period 1 - First Intervention||0
6430582|NCT01043185|7345154|FG005|NOT COMPLETED|Period 1 - First Intervention||0
6430583|NCT01043185|7345155|FG006|NOT COMPLETED|Period 1 - First Intervention||0
6430584|NCT01043185|7345156|FG007|NOT COMPLETED|Period 1 - First Intervention||0
6430585|NCT01043185|7345157|FG008|NOT COMPLETED|Period 1 - First Intervention||0
6430586|NCT01043185|7345158|FG009|NOT COMPLETED|Period 1 - First Intervention||0
6430587|NCT01043185|7345149|FG000|STARTED|Period 2 - First Washout Period||3
6430588|NCT01043185|7345150|FG001|STARTED|Period 2 - First Washout Period||2
6430589|NCT01043185|7345151|FG002|STARTED|Period 2 - First Washout Period||3
6430590|NCT01043185|7345152|FG003|STARTED|Period 2 - First Washout Period||2
6430591|NCT01043185|7345153|FG004|STARTED|Period 2 - First Washout Period||2
6430592|NCT01043185|7345154|FG005|STARTED|Period 2 - First Washout Period||3
6430593|NCT01043185|7345155|FG006|STARTED|Period 2 - First Washout Period||3
6430594|NCT01043185|7345156|FG007|STARTED|Period 2 - First Washout Period||3
6430595|NCT01043185|7345157|FG008|STARTED|Period 2 - First Washout Period||3
6430596|NCT01043185|7345158|FG009|STARTED|Period 2 - First Washout Period||3
6430597|NCT01043185|7345149|FG000|COMPLETED|Period 2 - First Washout Period||3
6430598|NCT01043185|7345150|FG001|COMPLETED|Period 2 - First Washout Period||2
6430599|NCT01043185|7345151|FG002|COMPLETED|Period 2 - First Washout Period||3
6430600|NCT01043185|7345152|FG003|COMPLETED|Period 2 - First Washout Period||2
6430601|NCT01043185|7345153|FG004|COMPLETED|Period 2 - First Washout Period||2
6430602|NCT01043185|7345154|FG005|COMPLETED|Period 2 - First Washout Period||3
6430603|NCT01043185|7345155|FG006|COMPLETED|Period 2 - First Washout Period||3
6430604|NCT01043185|7345156|FG007|COMPLETED|Period 2 - First Washout Period||3
6430605|NCT01043185|7345157|FG008|COMPLETED|Period 2 - First Washout Period||3
6430606|NCT01043185|7345158|FG009|COMPLETED|Period 2 - First Washout Period||3
6430607|NCT01043185|7345149|FG000|NOT COMPLETED|Period 2 - First Washout Period||0
6430608|NCT01043185|7345150|FG001|NOT COMPLETED|Period 2 - First Washout Period||0
6430609|NCT01043185|7345151|FG002|NOT COMPLETED|Period 2 - First Washout Period||0
6430610|NCT01043185|7345152|FG003|NOT COMPLETED|Period 2 - First Washout Period||0
6430611|NCT01043185|7345153|FG004|NOT COMPLETED|Period 2 - First Washout Period||0
6430612|NCT01043185|7345154|FG005|NOT COMPLETED|Period 2 - First Washout Period||0
6430613|NCT01043185|7345155|FG006|NOT COMPLETED|Period 2 - First Washout Period||0
6430614|NCT01043185|7345156|FG007|NOT COMPLETED|Period 2 - First Washout Period||0
6430615|NCT01043185|7345157|FG008|NOT COMPLETED|Period 2 - First Washout Period||0
6430616|NCT01043185|7345158|FG009|NOT COMPLETED|Period 2 - First Washout Period||0
6430617|NCT01043185|7345149|FG000|STARTED|Period 3 - Second Intervention||3
6430618|NCT01043185|7345150|FG001|STARTED|Period 3 - Second Intervention||2
6430619|NCT01043185|7345151|FG002|STARTED|Period 3 - Second Intervention||3
6430620|NCT01043185|7345152|FG003|STARTED|Period 3 - Second Intervention||2
6430621|NCT01043185|7345153|FG004|STARTED|Period 3 - Second Intervention||2
6430622|NCT01043185|7345154|FG005|STARTED|Period 3 - Second Intervention||3
6430623|NCT01043185|7345155|FG006|STARTED|Period 3 - Second Intervention||3
6430624|NCT01043185|7345156|FG007|STARTED|Period 3 - Second Intervention||3
6430625|NCT01043185|7345157|FG008|STARTED|Period 3 - Second Intervention||3
6430626|NCT01043185|7345158|FG009|STARTED|Period 3 - Second Intervention||3
6430627|NCT01043185|7345149|FG000|COMPLETED|Period 3 - Second Intervention||3
6430628|NCT01043185|7345150|FG001|COMPLETED|Period 3 - Second Intervention||2
6430629|NCT01043185|7345151|FG002|COMPLETED|Period 3 - Second Intervention||3
6430630|NCT01043185|7345152|FG003|COMPLETED|Period 3 - Second Intervention||2
6430631|NCT01043185|7345153|FG004|COMPLETED|Period 3 - Second Intervention||2
6430632|NCT01043185|7345154|FG005|COMPLETED|Period 3 - Second Intervention||3
6430633|NCT01043185|7345155|FG006|COMPLETED|Period 3 - Second Intervention||3
6430634|NCT01043185|7345156|FG007|COMPLETED|Period 3 - Second Intervention||3
6430635|NCT01043185|7345157|FG008|COMPLETED|Period 3 - Second Intervention||3
6430636|NCT01043185|7345158|FG009|COMPLETED|Period 3 - Second Intervention||3
6430637|NCT01043185|7345149|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
6430638|NCT01043185|7345150|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
6430639|NCT01043185|7345151|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
6430640|NCT01043185|7345152|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
6430641|NCT01043185|7345153|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
6430642|NCT01043185|7345154|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
6430643|NCT01043185|7345155|FG006|NOT COMPLETED|Period 3 - Second Intervention||0
6430644|NCT01043185|7345156|FG007|NOT COMPLETED|Period 3 - Second Intervention||0
6430645|NCT01043185|7345157|FG008|NOT COMPLETED|Period 3 - Second Intervention||0
6430646|NCT01043185|7345158|FG009|NOT COMPLETED|Period 3 - Second Intervention||0
6430647|NCT01043185|7345149|FG000|STARTED|Period 4 - Second Washout Period||3
6430648|NCT01043185|7345150|FG001|STARTED|Period 4 - Second Washout Period||2
6430649|NCT01043185|7345151|FG002|STARTED|Period 4 - Second Washout Period||3
6430650|NCT01043185|7345152|FG003|STARTED|Period 4 - Second Washout Period||2
6430651|NCT01043185|7345153|FG004|STARTED|Period 4 - Second Washout Period||2
6430652|NCT01043185|7345154|FG005|STARTED|Period 4 - Second Washout Period||3
6430653|NCT01043185|7345155|FG006|STARTED|Period 4 - Second Washout Period||3
6430654|NCT01043185|7345156|FG007|STARTED|Period 4 - Second Washout Period||3
6430655|NCT01043185|7345157|FG008|STARTED|Period 4 - Second Washout Period||3
6430656|NCT01043185|7345158|FG009|STARTED|Period 4 - Second Washout Period||3
6430657|NCT01043185|7345149|FG000|COMPLETED|Period 4 - Second Washout Period||3
6430658|NCT01043185|7345150|FG001|COMPLETED|Period 4 - Second Washout Period||2
6430659|NCT01043185|7345151|FG002|COMPLETED|Period 4 - Second Washout Period||3
6430660|NCT01043185|7345152|FG003|COMPLETED|Period 4 - Second Washout Period||2
6430661|NCT01043185|7345153|FG004|COMPLETED|Period 4 - Second Washout Period||2
6652412|NCT02429115|7582011|FG000|COMPLETED|Overall Study||40
6652413|NCT02429115|7582012|FG001|COMPLETED|Overall Study||42
6652414|NCT02429115|7582013|FG002|COMPLETED|Overall Study||35
6430662|NCT01043185|7345154|FG005|COMPLETED|Period 4 - Second Washout Period||3
6430663|NCT01043185|7345155|FG006|COMPLETED|Period 4 - Second Washout Period||3
6430664|NCT01043185|7345156|FG007|COMPLETED|Period 4 - Second Washout Period||3
6430665|NCT01043185|7345157|FG008|COMPLETED|Period 4 - Second Washout Period||3
6430666|NCT01043185|7345158|FG009|COMPLETED|Period 4 - Second Washout Period||3
6430667|NCT01043185|7345149|FG000|NOT COMPLETED|Period 4 - Second Washout Period||0
6430668|NCT01043185|7345150|FG001|NOT COMPLETED|Period 4 - Second Washout Period||0
6430669|NCT01043185|7345151|FG002|NOT COMPLETED|Period 4 - Second Washout Period||0
6430670|NCT01043185|7345152|FG003|NOT COMPLETED|Period 4 - Second Washout Period||0
6430671|NCT01043185|7345153|FG004|NOT COMPLETED|Period 4 - Second Washout Period||0
6430672|NCT01043185|7345154|FG005|NOT COMPLETED|Period 4 - Second Washout Period||0
6430673|NCT01043185|7345155|FG006|NOT COMPLETED|Period 4 - Second Washout Period||0
6430674|NCT01043185|7345156|FG007|NOT COMPLETED|Period 4 - Second Washout Period||0
6430675|NCT01043185|7345157|FG008|NOT COMPLETED|Period 4 - Second Washout Period||0
6430676|NCT01043185|7345158|FG009|NOT COMPLETED|Period 4 - Second Washout Period||0
6430677|NCT01043185|7345149|FG000|STARTED|Period 5 - Third Intervention||3
6430678|NCT01043185|7345150|FG001|STARTED|Period 5 - Third Intervention||2
6430679|NCT01043185|7345151|FG002|STARTED|Period 5 - Third Intervention||3
6430680|NCT01043185|7345152|FG003|STARTED|Period 5 - Third Intervention||2
6430681|NCT01043185|7345153|FG004|STARTED|Period 5 - Third Intervention||2
6430682|NCT01043185|7345154|FG005|STARTED|Period 5 - Third Intervention||3
6430683|NCT01043185|7345155|FG006|STARTED|Period 5 - Third Intervention||3
6430684|NCT01043185|7345156|FG007|STARTED|Period 5 - Third Intervention||3
6430685|NCT01043185|7345157|FG008|STARTED|Period 5 - Third Intervention||3
6430686|NCT01043185|7345158|FG009|STARTED|Period 5 - Third Intervention||3
6430687|NCT01043185|7345149|FG000|COMPLETED|Period 5 - Third Intervention||3
6430688|NCT01043185|7345150|FG001|COMPLETED|Period 5 - Third Intervention||2
6430689|NCT01043185|7345151|FG002|COMPLETED|Period 5 - Third Intervention||3
6430690|NCT01043185|7345152|FG003|COMPLETED|Period 5 - Third Intervention||2
6430691|NCT01043185|7345153|FG004|COMPLETED|Period 5 - Third Intervention||2
6430692|NCT01043185|7345154|FG005|COMPLETED|Period 5 - Third Intervention||3
6430693|NCT01043185|7345155|FG006|COMPLETED|Period 5 - Third Intervention||3
6430694|NCT01043185|7345156|FG007|COMPLETED|Period 5 - Third Intervention||3
6430695|NCT01043185|7345157|FG008|COMPLETED|Period 5 - Third Intervention||3
6430696|NCT01043185|7345158|FG009|COMPLETED|Period 5 - Third Intervention||3
6430697|NCT01043185|7345149|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
6430698|NCT01043185|7345150|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
6430699|NCT01043185|7345151|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
6430700|NCT01043185|7345152|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
6430701|NCT01043185|7345153|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
6430702|NCT01043185|7345154|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
6430703|NCT01043185|7345155|FG006|NOT COMPLETED|Period 5 - Third Intervention||0
6430704|NCT01043185|7345156|FG007|NOT COMPLETED|Period 5 - Third Intervention||0
6430705|NCT01043185|7345157|FG008|NOT COMPLETED|Period 5 - Third Intervention||0
6430706|NCT01043185|7345158|FG009|NOT COMPLETED|Period 5 - Third Intervention||0
6430707|NCT01043185|7345149|FG000|STARTED|Period 6 - Third Washout Period||3
6430708|NCT01043185|7345150|FG001|STARTED|Period 6 - Third Washout Period||2
6430709|NCT01043185|7345151|FG002|STARTED|Period 6 - Third Washout Period||3
6430710|NCT01043185|7345152|FG003|STARTED|Period 6 - Third Washout Period||2
6430711|NCT01043185|7345153|FG004|STARTED|Period 6 - Third Washout Period||2
6652415|NCT02429115|7582014|FG003|COMPLETED|Overall Study||21
6652416|NCT02429115|7582015|FG004|COMPLETED|Overall Study||22
6652417|NCT02429115|7582016|FG005|COMPLETED|Overall Study||27
6652418|NCT02429115|7582011|FG000|NOT COMPLETED|Overall Study||12
6430712|NCT01043185|7345154|FG005|STARTED|Period 6 - Third Washout Period||3
6430713|NCT01043185|7345155|FG006|STARTED|Period 6 - Third Washout Period||3
6430714|NCT01043185|7345156|FG007|STARTED|Period 6 - Third Washout Period||3
6430715|NCT01043185|7345157|FG008|STARTED|Period 6 - Third Washout Period||3
6430716|NCT01043185|7345158|FG009|STARTED|Period 6 - Third Washout Period||3
6430717|NCT01043185|7345149|FG000|COMPLETED|Period 6 - Third Washout Period||3
6430718|NCT01043185|7345150|FG001|COMPLETED|Period 6 - Third Washout Period||2
6430719|NCT01043185|7345151|FG002|COMPLETED|Period 6 - Third Washout Period||3
6430720|NCT01043185|7345152|FG003|COMPLETED|Period 6 - Third Washout Period||2
6430721|NCT01043185|7345153|FG004|COMPLETED|Period 6 - Third Washout Period||2
6430722|NCT01043185|7345154|FG005|COMPLETED|Period 6 - Third Washout Period||3
6430723|NCT01043185|7345155|FG006|COMPLETED|Period 6 - Third Washout Period||3
6430724|NCT01043185|7345156|FG007|COMPLETED|Period 6 - Third Washout Period||3
6430725|NCT01043185|7345157|FG008|COMPLETED|Period 6 - Third Washout Period||2
6430726|NCT01043185|7345158|FG009|COMPLETED|Period 6 - Third Washout Period||3
6430727|NCT01043185|7345149|FG000|NOT COMPLETED|Period 6 - Third Washout Period||0
6430728|NCT01043185|7345150|FG001|NOT COMPLETED|Period 6 - Third Washout Period||0
6430729|NCT01043185|7345151|FG002|NOT COMPLETED|Period 6 - Third Washout Period||0
6430730|NCT01043185|7345152|FG003|NOT COMPLETED|Period 6 - Third Washout Period||0
6430731|NCT01043185|7345153|FG004|NOT COMPLETED|Period 6 - Third Washout Period||0
6430732|NCT01043185|7345154|FG005|NOT COMPLETED|Period 6 - Third Washout Period||0
6430733|NCT01043185|7345155|FG006|NOT COMPLETED|Period 6 - Third Washout Period||0
6430734|NCT01043185|7345156|FG007|NOT COMPLETED|Period 6 - Third Washout Period||0
6430735|NCT01043185|7345157|FG008|NOT COMPLETED|Period 6 - Third Washout Period||1
6430736|NCT01043185|7345158|FG009|NOT COMPLETED|Period 6 - Third Washout Period||0
6430737|NCT01043185|7345149|FG000|STARTED|Period 7 - Fourth Intervention||3
6430738|NCT01043185|7345150|FG001|STARTED|Period 7 - Fourth Intervention||2
6430739|NCT01043185|7345151|FG002|STARTED|Period 7 - Fourth Intervention||3
6430740|NCT01043185|7345152|FG003|STARTED|Period 7 - Fourth Intervention||2
6430741|NCT01043185|7345153|FG004|STARTED|Period 7 - Fourth Intervention||2
6430742|NCT01043185|7345154|FG005|STARTED|Period 7 - Fourth Intervention||3
6430743|NCT01043185|7345155|FG006|STARTED|Period 7 - Fourth Intervention||3
6430744|NCT01043185|7345156|FG007|STARTED|Period 7 - Fourth Intervention||3
6430745|NCT01043185|7345157|FG008|STARTED|Period 7 - Fourth Intervention||2
6430746|NCT01043185|7345158|FG009|STARTED|Period 7 - Fourth Intervention||3
6430747|NCT01043185|7345149|FG000|COMPLETED|Period 7 - Fourth Intervention||3
6430748|NCT01043185|7345150|FG001|COMPLETED|Period 7 - Fourth Intervention||2
6430749|NCT01043185|7345151|FG002|COMPLETED|Period 7 - Fourth Intervention||3
6430750|NCT01043185|7345152|FG003|COMPLETED|Period 7 - Fourth Intervention||2
6430751|NCT01043185|7345153|FG004|COMPLETED|Period 7 - Fourth Intervention||2
6430752|NCT01043185|7345154|FG005|COMPLETED|Period 7 - Fourth Intervention||3
6430753|NCT01043185|7345155|FG006|COMPLETED|Period 7 - Fourth Intervention||3
6430754|NCT01043185|7345156|FG007|COMPLETED|Period 7 - Fourth Intervention||3
6430755|NCT01043185|7345157|FG008|COMPLETED|Period 7 - Fourth Intervention||2
6430756|NCT01043185|7345158|FG009|COMPLETED|Period 7 - Fourth Intervention||3
6430757|NCT01043185|7345149|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430758|NCT01043185|7345150|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430759|NCT01043185|7345151|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430760|NCT01043185|7345152|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430761|NCT01043185|7345153|FG004|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430762|NCT01043185|7345154|FG005|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430763|NCT01043185|7345155|FG006|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430764|NCT01043185|7345156|FG007|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430765|NCT01043185|7345157|FG008|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430766|NCT01043185|7345158|FG009|NOT COMPLETED|Period 7 - Fourth Intervention||0
6430767|NCT01043393|7345172|FG000|STARTED|Overall Study||12
6430768|NCT01043393|7345173|FG001|STARTED|Overall Study||12
6430769|NCT01043393|7345172|FG000|COMPLETED|Overall Study||12
6430770|NCT01043393|7345173|FG001|COMPLETED|Overall Study||12
6430771|NCT01043393|7345172|FG000|NOT COMPLETED|Overall Study||0
6430772|NCT01043393|7345173|FG001|NOT COMPLETED|Overall Study||0
6430773|NCT01043432|7345183|FG000|STARTED|Overall Study||22
6430774|NCT01043432|7345184|FG001|STARTED|Overall Study||51
6430775|NCT01043432|7345185|FG002|STARTED|Overall Study||12
6430776|NCT01043432|7345186|FG003|STARTED|Overall Study||48
6430777|NCT01043432|7345183|FG000|COMPLETED|Overall Study||22
6430778|NCT01043432|7345184|FG001|COMPLETED|Overall Study||51
6430779|NCT01043432|7345185|FG002|COMPLETED|Overall Study||12
6430780|NCT01043432|7345186|FG003|COMPLETED|Overall Study||48
6430781|NCT01043432|7345183|FG000|NOT COMPLETED|Overall Study||0
6430782|NCT01043432|7345184|FG001|NOT COMPLETED|Overall Study||0
6430783|NCT01043432|7345185|FG002|NOT COMPLETED|Overall Study||0
6430784|NCT01043432|7345186|FG003|NOT COMPLETED|Overall Study||0
6430785|NCT01043523|7345193|FG000|STARTED|Overall Study||52
6430786|NCT01043523|7345193|FG000|Participants With Unenhanced Images|Overall Study||51
6430787|NCT01043523|7345193|FG000|COMPLETED|Overall Study||52
6430788|NCT01043523|7345193|FG000|NOT COMPLETED|Overall Study||0
6430789|NCT01043562|7345201|FG000|STARTED|Overall Study||20
6430790|NCT01043562|7345201|FG000|COMPLETED|Overall Study||20
6430791|NCT01043562|7345201|FG000|NOT COMPLETED|Overall Study||0
6430792|NCT01043640|7345208|FG000|STARTED|Overall Study||46
6430793|NCT01043640|7345208|FG000|COMPLETED|Overall Study||46
6430794|NCT01043640|7345208|FG000|NOT COMPLETED|Overall Study||0
6430795|NCT01043653|7345212|FG000|STARTED|Overall Study||250
6430796|NCT01043653|7345212|FG000|COMPLETED|Overall Study||186
6430797|NCT01043653|7345212|FG000|NOT COMPLETED|Overall Study||64
6430798|NCT01043705|7345219|FG000|STARTED|Overall Study||459
6430799|NCT01043705|7345220|FG001|STARTED|Overall Study||578
6430800|NCT01043705|7345221|FG002|STARTED|Overall Study||578
6430801|NCT01043705|7345219|FG000|COMPLETED|Overall Study||352
6430802|NCT01043705|7345220|FG001|COMPLETED|Overall Study||447
6430803|NCT01043705|7345221|FG002|COMPLETED|Overall Study||498
6430804|NCT01043705|7345219|FG000|NOT COMPLETED|Overall Study||107
6430805|NCT01043705|7345220|FG001|NOT COMPLETED|Overall Study||131
6430806|NCT01043705|7345221|FG002|NOT COMPLETED|Overall Study||80
6430807|NCT01043874|7345229|FG000|STARTED|Overall Study||45
6430808|NCT01043874|7345229|FG000|COMPLETED|Overall Study||39
6430809|NCT01043874|7345229|FG000|NOT COMPLETED|Overall Study||6
6430810|NCT01043926|7345235|FG000|STARTED|Overall Study||8
6430811|NCT01043926|7345236|FG001|STARTED|Overall Study||8
6430812|NCT01043926|7345237|FG002|STARTED|Overall Study||0
6430813|NCT01043926|7345238|FG003|STARTED|Overall Study||0
6430814|NCT01043926|7345235|FG000|COMPLETED|Overall Study||8
6430815|NCT01043926|7345236|FG001|COMPLETED|Overall Study||8
6430816|NCT01043926|7345237|FG002|COMPLETED|Overall Study||0
6430817|NCT01043926|7345238|FG003|COMPLETED|Overall Study||0
6430818|NCT01043926|7345235|FG000|NOT COMPLETED|Overall Study||0
6430819|NCT01043926|7345236|FG001|NOT COMPLETED|Overall Study||0
6430820|NCT01043926|7345237|FG002|NOT COMPLETED|Overall Study||0
6430821|NCT01043926|7345238|FG003|NOT COMPLETED|Overall Study||0
6430822|NCT01043939|7345246|FG000|STARTED|First Intervention||12
6430823|NCT01043939|7345247|FG001|STARTED|First Intervention||12
6430824|NCT01043939|7345246|FG000|COMPLETED|First Intervention||12
6430825|NCT01043939|7345247|FG001|COMPLETED|First Intervention||12
6430826|NCT01043939|7345246|FG000|NOT COMPLETED|First Intervention||0
6430827|NCT01043939|7345247|FG001|NOT COMPLETED|First Intervention||0
6430828|NCT01043939|7345246|FG000|STARTED|Washout Period||12
6652419|NCT02429115|7582012|FG001|NOT COMPLETED|Overall Study||10
6652420|NCT02429115|7582013|FG002|NOT COMPLETED|Overall Study||16
6652421|NCT02429115|7582014|FG003|NOT COMPLETED|Overall Study||8
6430829|NCT01043939|7345247|FG001|STARTED|Washout Period||12
6430830|NCT01043939|7345246|FG000|COMPLETED|Washout Period||12
6430831|NCT01043939|7345247|FG001|COMPLETED|Washout Period||12
6430832|NCT01043939|7345246|FG000|NOT COMPLETED|Washout Period||0
6430833|NCT01043939|7345247|FG001|NOT COMPLETED|Washout Period||0
6430834|NCT01043939|7345246|FG000|STARTED|Second Intervention||12
6430835|NCT01043939|7345247|FG001|STARTED|Second Intervention||12
6430836|NCT01043939|7345246|FG000|COMPLETED|Second Intervention||12
6430837|NCT01043939|7345247|FG001|COMPLETED|Second Intervention||12
6430838|NCT01043939|7345246|FG000|NOT COMPLETED|Second Intervention||0
6430839|NCT01043939|7345247|FG001|NOT COMPLETED|Second Intervention||0
6430840|NCT01044030|7345256|FG000|STARTED|Overall Study||160
6430841|NCT01044030|7345257|FG001|STARTED|Overall Study||166
6430842|NCT01044030|7345256|FG000|COMPLETED|Overall Study||141
6430843|NCT01044030|7345257|FG001|COMPLETED|Overall Study||146
6430844|NCT01044030|7345256|FG000|NOT COMPLETED|Overall Study||19
6430845|NCT01044030|7345257|FG001|NOT COMPLETED|Overall Study||20
6430846|NCT01044212|7345265|FG000|STARTED|Overall Study||35
6430847|NCT01044212|7345266|FG001|STARTED|Overall Study||37
6430848|NCT01044212|7345265|FG000|COMPLETED|Overall Study||30
6430849|NCT01044212|7345266|FG001|COMPLETED|Overall Study||30
6430850|NCT01044212|7345265|FG000|NOT COMPLETED|Overall Study||5
6430851|NCT01044212|7345266|FG001|NOT COMPLETED|Overall Study||7
6430852|NCT01044264|7345275|FG000|STARTED|Overall Study||200
6430853|NCT01044264|7345276|FG001|STARTED|Overall Study||202
6430854|NCT01044264|7345277|FG002|STARTED|Overall Study||200
6430855|NCT01044264|7345275|FG000|COMPLETED|Overall Study||110
6430856|NCT01044264|7345276|FG001|COMPLETED|Overall Study||108
6430857|NCT01044264|7345277|FG002|COMPLETED|Overall Study||108
6430858|NCT01044264|7345275|FG000|NOT COMPLETED|Overall Study||90
6430859|NCT01044264|7345276|FG001|NOT COMPLETED|Overall Study||94
6430860|NCT01044264|7345277|FG002|NOT COMPLETED|Overall Study||92
6430861|NCT01044290|7345288|FG000|STARTED|Randomization||75
6430862|NCT01044290|7345289|FG001|STARTED|Randomization||74
6430863|NCT01044290|7345290|FG002|STARTED|Randomization||72
6552159|NCT01736241|7474567|FG000|NOT COMPLETED|Overall Study||0
6552160|NCT01736241|7474568|FG001|NOT COMPLETED|Overall Study||0
6552161|NCT01736241|7474569|FG002|NOT COMPLETED|Overall Study||0
6552162|NCT01736241|7474570|FG003|NOT COMPLETED|Overall Study||0
6552163|NCT01736241|7474571|FG004|NOT COMPLETED|Overall Study||0
6552164|NCT01736241|7474572|FG005|NOT COMPLETED|Overall Study||0
6430864|NCT01044290|7345288|FG000|Randomized|Randomization||75
6430865|NCT01044290|7345289|FG001|Randomized|Randomization||74
6430866|NCT01044290|7345290|FG002|Randomized|Randomization||72
6552165|NCT01736241|7474573|FG006|NOT COMPLETED|Overall Study||0
6552166|NCT01736254|7474590|FG000|STARTED|Period 1 (Day 1)||24
6552167|NCT01736254|7474590|FG000|Received at Least One Dose of Study Drug|Period 1 (Day 1)||24
6552168|NCT01736254|7474590|FG000|COMPLETED|Period 1 (Day 1)||24
6552169|NCT01736254|7474590|FG000|NOT COMPLETED|Period 1 (Day 1)||0
6552170|NCT01736254|7474590|FG000|STARTED|Period 2 (Days 2 to 12)||24
6430867|NCT01044290|7345288|FG000|COMPLETED|Randomization||75
6430868|NCT01044290|7345289|FG001|COMPLETED|Randomization||74
6430869|NCT01044290|7345290|FG002|COMPLETED|Randomization||72
6430870|NCT01044290|7345288|FG000|NOT COMPLETED|Randomization||0
6430871|NCT01044290|7345289|FG001|NOT COMPLETED|Randomization||0
6430872|NCT01044290|7345290|FG002|NOT COMPLETED|Randomization||0
6430873|NCT01044290|7345288|FG000|STARTED|Follow-up 1||75
6430874|NCT01044290|7345289|FG001|STARTED|Follow-up 1||74
6430875|NCT01044290|7345290|FG002|STARTED|Follow-up 1||72
6430876|NCT01044290|7345288|FG000|Completed F1 Interview|Follow-up 1||61
6430877|NCT01044290|7345289|FG001|Completed F1 Interview|Follow-up 1||60
6430878|NCT01044290|7345290|FG002|Completed F1 Interview|Follow-up 1||61
6430879|NCT01044290|7345288|FG000|COMPLETED|Follow-up 1||70
6430880|NCT01044290|7345289|FG001|COMPLETED|Follow-up 1||69
6430881|NCT01044290|7345290|FG002|COMPLETED|Follow-up 1||71
6430882|NCT01044290|7345288|FG000|NOT COMPLETED|Follow-up 1||5
6430883|NCT01044290|7345289|FG001|NOT COMPLETED|Follow-up 1||5
6430884|NCT01044290|7345290|FG002|NOT COMPLETED|Follow-up 1||1
6430885|NCT01044290|7345288|FG000|STARTED|Follow-Up 2||70
6430886|NCT01044290|7345289|FG001|STARTED|Follow-Up 2||69
6430887|NCT01044290|7345290|FG002|STARTED|Follow-Up 2||71
6430888|NCT01044290|7345288|FG000|Completed F2 Interview|Follow-Up 2||64
6430889|NCT01044290|7345289|FG001|Completed F2 Interview|Follow-Up 2||57
6430890|NCT01044290|7345290|FG002|Completed F2 Interview|Follow-Up 2||64
6430891|NCT01044290|7345288|FG000|COMPLETED|Follow-Up 2||70
6430892|NCT01044290|7345289|FG001|COMPLETED|Follow-Up 2||67
6430893|NCT01044290|7345290|FG002|COMPLETED|Follow-Up 2||69
6430894|NCT01044290|7345288|FG000|NOT COMPLETED|Follow-Up 2||0
6430895|NCT01044290|7345289|FG001|NOT COMPLETED|Follow-Up 2||2
6430896|NCT01044290|7345290|FG002|NOT COMPLETED|Follow-Up 2||2
6430897|NCT01044303|7345308|FG000|STARTED|Overall Study||32
6430898|NCT01044303|7345308|FG000|COMPLETED|Overall Study||30
6430899|NCT01044303|7345308|FG000|NOT COMPLETED|Overall Study||2
6430900|NCT01044433|7345315|FG000|STARTED|Overall Study||44
6430901|NCT01044433|7345315|FG000|COMPLETED|Overall Study||38
6430902|NCT01044433|7345315|FG000|NOT COMPLETED|Overall Study||6
6430903|NCT01044459|7345322|FG000|STARTED|Overall Study||312
6430904|NCT01044459|7345323|FG001|STARTED|Overall Study||293
6430905|NCT01044459|7345322|FG000|COMPLETED|Overall Study||179
6430906|NCT01044459|7345323|FG001|COMPLETED|Overall Study||162
6430907|NCT01044459|7345322|FG000|NOT COMPLETED|Overall Study||133
6430908|NCT01044459|7345323|FG001|NOT COMPLETED|Overall Study||131
6430909|NCT01044498|7345331|FG000|STARTED|Overall Study||23
6430910|NCT01044498|7345332|FG001|STARTED|Overall Study||23
6430911|NCT01044498|7345331|FG000|COMPLETED|Overall Study||20
6430912|NCT01044498|7345332|FG001|COMPLETED|Overall Study||21
6430913|NCT01044498|7345331|FG000|NOT COMPLETED|Overall Study||3
6430914|NCT01044498|7345332|FG001|NOT COMPLETED|Overall Study||2
6430915|NCT01044537|7345345|FG000|STARTED|Overall Study||6
6552171|NCT01736254|7474590|FG000|COMPLETED|Period 2 (Days 2 to 12)||21
6552172|NCT01736254|7474590|FG000|NOT COMPLETED|Period 2 (Days 2 to 12)||3
6552173|NCT01736254|7474590|FG000|STARTED|Period 3 (Days 13 to 23)||21
6552174|NCT01736254|7474590|FG000|COMPLETED|Period 3 (Days 13 to 23)||20
6552175|NCT01736254|7474590|FG000|NOT COMPLETED|Period 3 (Days 13 to 23)||1
6430916|NCT01044537|7345346|FG001|STARTED|Overall Study||6
6430917|NCT01044537|7345347|FG002|STARTED|Overall Study||6
6430918|NCT01044537|7345348|FG003|STARTED|Overall Study||6
6430919|NCT01044537|7345349|FG004|STARTED|Overall Study||5
6430920|NCT01044537|7345350|FG005|STARTED|Overall Study||5
6430921|NCT01044537|7345351|FG006|STARTED|Overall Study||16
6430922|NCT01044537|7345345|FG000|COMPLETED|Overall Study||6
6430923|NCT01044537|7345346|FG001|COMPLETED|Overall Study||6
6430924|NCT01044537|7345347|FG002|COMPLETED|Overall Study||6
6430925|NCT01044537|7345348|FG003|COMPLETED|Overall Study||6
6430926|NCT01044537|7345349|FG004|COMPLETED|Overall Study||5
6430927|NCT01044537|7345350|FG005|COMPLETED|Overall Study||5
6430928|NCT01044537|7345351|FG006|COMPLETED|Overall Study||16
6430929|NCT01044537|7345345|FG000|NOT COMPLETED|Overall Study||0
6430930|NCT01044537|7345346|FG001|NOT COMPLETED|Overall Study||0
6430931|NCT01044537|7345347|FG002|NOT COMPLETED|Overall Study||0
6430932|NCT01044537|7345348|FG003|NOT COMPLETED|Overall Study||0
6430933|NCT01044537|7345349|FG004|NOT COMPLETED|Overall Study||0
6430934|NCT01044537|7345350|FG005|NOT COMPLETED|Overall Study||0
6430935|NCT01044537|7345351|FG006|NOT COMPLETED|Overall Study||0
6430936|NCT01044576|7345367|FG000|STARTED|Overall Study||200
6430937|NCT01044576|7345367|FG000|COMPLETED|Overall Study||200
6430938|NCT01044576|7345367|FG000|NOT COMPLETED|Overall Study||0
6430939|NCT01044589|7345373|FG000|STARTED|Overall Study||6
6430940|NCT01044589|7345374|FG001|STARTED|Overall Study||7
6430941|NCT01044589|7345373|FG000|COMPLETED|Overall Study||3
6430942|NCT01044589|7345374|FG001|COMPLETED|Overall Study||2
6430943|NCT01044589|7345373|FG000|NOT COMPLETED|Overall Study||3
6430944|NCT01044589|7345374|FG001|NOT COMPLETED|Overall Study||5
6430945|NCT01044693|7345380|FG000|STARTED|Overall Study||3
6430946|NCT01044693|7345381|FG001|STARTED|Overall Study||1
6430947|NCT01044693|7345382|FG002|STARTED|Overall Study||1
6430948|NCT01044693|7345383|FG003|STARTED|Overall Study||1
6430949|NCT01044693|7345384|FG004|STARTED|Overall Study||1
6430950|NCT01044693|7345385|FG005|STARTED|Overall Study||2
6430951|NCT01044693|7345386|FG006|STARTED|Overall Study||1
6552176|NCT01736267|7474598|FG000|STARTED|Overall Study||3
6430952|NCT01044693|7345387|FG007|STARTED|Overall Study||1
6430953|NCT01044693|7345388|FG008|STARTED|Overall Study||1
6552177|NCT01736267|7474598|FG000|COMPLETED|Overall Study||3
6552178|NCT01736267|7474598|FG000|NOT COMPLETED|Overall Study||0
6430954|NCT01044693|7345389|FG009|STARTED|Overall Study||1
6430955|NCT01044693|7345390|FG010|STARTED|Overall Study||1
6430956|NCT01044693|7345391|FG011|STARTED|Overall Study||1
6430957|NCT01044693|7345392|FG012|STARTED|Overall Study||2
6430958|NCT01044693|7345393|FG013|STARTED|Overall Study||1
6430959|NCT01044693|7345394|FG014|STARTED|Overall Study||1
6430960|NCT01044693|7345395|FG015|STARTED|Overall Study||1
6430961|NCT01044693|7345380|FG000|COMPLETED|Overall Study||3
6430962|NCT01044693|7345381|FG001|COMPLETED|Overall Study||1
6430963|NCT01044693|7345382|FG002|COMPLETED|Overall Study||1
6430964|NCT01044693|7345383|FG003|COMPLETED|Overall Study||1
6430965|NCT01044693|7345384|FG004|COMPLETED|Overall Study||1
6430966|NCT01044693|7345385|FG005|COMPLETED|Overall Study||2
6430967|NCT01044693|7345386|FG006|COMPLETED|Overall Study||1
6430968|NCT01044693|7345387|FG007|COMPLETED|Overall Study||1
6430969|NCT01044693|7345388|FG008|COMPLETED|Overall Study||1
6430970|NCT01044693|7345389|FG009|COMPLETED|Overall Study||1
6430971|NCT01044693|7345390|FG010|COMPLETED|Overall Study||1
6430972|NCT01044693|7345391|FG011|COMPLETED|Overall Study||1
6430973|NCT01044693|7345392|FG012|COMPLETED|Overall Study||2
6430974|NCT01044693|7345393|FG013|COMPLETED|Overall Study||1
6430975|NCT01044693|7345394|FG014|COMPLETED|Overall Study||1
6430976|NCT01044693|7345395|FG015|COMPLETED|Overall Study||1
6430977|NCT01044693|7345380|FG000|NOT COMPLETED|Overall Study||0
6430978|NCT01044693|7345381|FG001|NOT COMPLETED|Overall Study||0
6430979|NCT01044693|7345382|FG002|NOT COMPLETED|Overall Study||0
6430980|NCT01044693|7345383|FG003|NOT COMPLETED|Overall Study||0
6430981|NCT01044693|7345384|FG004|NOT COMPLETED|Overall Study||0
6430982|NCT01044693|7345385|FG005|NOT COMPLETED|Overall Study||0
6430983|NCT01044693|7345386|FG006|NOT COMPLETED|Overall Study||0
6430984|NCT01044693|7345387|FG007|NOT COMPLETED|Overall Study||0
6430985|NCT01044693|7345388|FG008|NOT COMPLETED|Overall Study||0
6430986|NCT01044693|7345389|FG009|NOT COMPLETED|Overall Study||0
6430987|NCT01044693|7345390|FG010|NOT COMPLETED|Overall Study||0
6430988|NCT01044693|7345391|FG011|NOT COMPLETED|Overall Study||0
6430989|NCT01044693|7345392|FG012|NOT COMPLETED|Overall Study||0
6430990|NCT01044693|7345393|FG013|NOT COMPLETED|Overall Study||0
6430991|NCT01044693|7345394|FG014|NOT COMPLETED|Overall Study||0
6430992|NCT01044693|7345395|FG015|NOT COMPLETED|Overall Study||0
6430993|NCT01044706|7345407|FG000|STARTED|Overall Study||30
6430994|NCT01044706|7345408|FG001|STARTED|Overall Study||30
6430995|NCT01044706|7345407|FG000|COMPLETED|Overall Study||30
6430996|NCT01044706|7345408|FG001|COMPLETED|Overall Study||30
6430997|NCT01044706|7345407|FG000|NOT COMPLETED|Overall Study||0
6430998|NCT01044706|7345408|FG001|NOT COMPLETED|Overall Study||0
6430999|NCT01044732|7345416|FG000|STARTED|Overall Study||222
6431000|NCT01044732|7345417|FG001|STARTED|Overall Study||226
6431001|NCT01044732|7345416|FG000|COMPLETED|Overall Study||173
6431002|NCT01044732|7345417|FG001|COMPLETED|Overall Study||176
6431003|NCT01044732|7345416|FG000|NOT COMPLETED|Overall Study||49
6431004|NCT01044732|7345417|FG001|NOT COMPLETED|Overall Study||50
6431005|NCT01044745|7345425|FG000|STARTED|Overall Study||20
6431006|NCT01044745|7345425|FG000|COMPLETED|Overall Study||18
6431007|NCT01044745|7345425|FG000|NOT COMPLETED|Overall Study||2
6431008|NCT01044758|7345437|FG000|STARTED|Overall Study||12
6431009|NCT01044758|7345438|FG001|STARTED|Overall Study||12
6431010|NCT01044758|7345439|FG002|STARTED|Overall Study||11
6431011|NCT01044758|7345440|FG003|STARTED|Overall Study||12
6431012|NCT01044758|7345441|FG004|STARTED|Overall Study||11
6431013|NCT01044758|7345442|FG005|STARTED|Overall Study||11
6431014|NCT01044758|7345443|FG006|STARTED|Overall Study||27
6431015|NCT01044758|7345437|FG000|COMPLETED|Overall Study||8
6431016|NCT01044758|7345438|FG001|COMPLETED|Overall Study||12
6431017|NCT01044758|7345439|FG002|COMPLETED|Overall Study||7
6431018|NCT01044758|7345440|FG003|COMPLETED|Overall Study||10
6431019|NCT01044758|7345441|FG004|COMPLETED|Overall Study||9
6431020|NCT01044758|7345442|FG005|COMPLETED|Overall Study||8
6431021|NCT01044758|7345443|FG006|COMPLETED|Overall Study||17
6431022|NCT01044758|7345437|FG000|NOT COMPLETED|Overall Study||4
6431023|NCT01044758|7345438|FG001|NOT COMPLETED|Overall Study||0
6431024|NCT01044758|7345439|FG002|NOT COMPLETED|Overall Study||4
6431025|NCT01044758|7345440|FG003|NOT COMPLETED|Overall Study||2
6431026|NCT01044758|7345441|FG004|NOT COMPLETED|Overall Study||2
6431027|NCT01044758|7345442|FG005|NOT COMPLETED|Overall Study||3
6431028|NCT01044758|7345443|FG006|NOT COMPLETED|Overall Study||10
6431029|NCT01044771|7345462|FG000|STARTED|Overall Study||20
6431030|NCT01044771|7345462|FG000|COMPLETED|Overall Study||20
6431031|NCT01044771|7345462|FG000|NOT COMPLETED|Overall Study||0
6431032|NCT01044862|7345470|FG000|STARTED|Overall Study||299
6431033|NCT01044862|7345471|FG001|STARTED|Overall Study||300
6431034|NCT01044862|7345472|FG002|STARTED|Overall Study||301
6431035|NCT01044862|7345470|FG000|COMPLETED|Overall Study||246
6431036|NCT01044862|7345471|FG001|COMPLETED|Overall Study||251
6431037|NCT01044862|7345472|FG002|COMPLETED|Overall Study||249
6431038|NCT01044862|7345470|FG000|NOT COMPLETED|Overall Study||53
6431039|NCT01044862|7345471|FG001|NOT COMPLETED|Overall Study||49
6431040|NCT01044862|7345472|FG002|NOT COMPLETED|Overall Study||52
6431041|NCT01044966|7345480|FG000|STARTED|Induction Phase||12
6431042|NCT01044966|7345480|FG000|COMPLETED|Induction Phase||12
6431043|NCT01044966|7345480|FG000|NOT COMPLETED|Induction Phase||0
6431044|NCT01044966|7345480|FG000|STARTED|Consolidation Phase||12
6431045|NCT01044966|7345480|FG000|COMPLETED|Consolidation Phase||2
6431046|NCT01044966|7345480|FG000|NOT COMPLETED|Consolidation Phase||10
6431047|NCT01045031|7345487|FG000|STARTED|Overall Study||58
6431048|NCT01045031|7345488|FG001|STARTED|Overall Study||56
6431049|NCT01045031|7345487|FG000|COMPLETED|Overall Study||49
6431050|NCT01045031|7345488|FG001|COMPLETED|Overall Study||50
6431051|NCT01045031|7345487|FG000|NOT COMPLETED|Overall Study||9
6431052|NCT01045031|7345488|FG001|NOT COMPLETED|Overall Study||6
6431053|NCT01045057|7345498|FG000|STARTED|Overall Study||27
6431054|NCT01045057|7345498|FG000|COMPLETED|Overall Study||27
6431055|NCT01045057|7345498|FG000|NOT COMPLETED|Overall Study||0
6431056|NCT01045096|7345507|FG000|STARTED|Overall Study||12
6431057|NCT01045096|7345508|FG001|STARTED|Overall Study||12
6431058|NCT01045096|7345509|FG002|STARTED|Overall Study||12
6431059|NCT01045096|7345507|FG000|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
6431060|NCT01045096|7345508|FG001|Pharmacokinetic Set|Overall Study||11
6552179|NCT01736358|7474604|FG000|STARTED|Overall Study||25
6552180|NCT01736358|7474605|FG001|STARTED|Overall Study||25
6552181|NCT01736358|7474604|FG000|COMPLETED|Overall Study||20
6552182|NCT01736358|7474605|FG001|COMPLETED|Overall Study||23
6652422|NCT02429115|7582015|FG004|NOT COMPLETED|Overall Study||7
6652423|NCT02429115|7582016|FG005|NOT COMPLETED|Overall Study||1
6431061|NCT01045096|7345509|FG002|Pharmacokinetic Set|Overall Study||11
6431062|NCT01045096|7345507|FG000|COMPLETED|Overall Study||9
6431063|NCT01045096|7345508|FG001|COMPLETED|Overall Study||12
6431064|NCT01045096|7345509|FG002|COMPLETED|Overall Study||12
6431065|NCT01045096|7345507|FG000|NOT COMPLETED|Overall Study||3
6431066|NCT01045096|7345508|FG001|NOT COMPLETED|Overall Study||0
6431067|NCT01045096|7345509|FG002|NOT COMPLETED|Overall Study||0
6431068|NCT01045122|7345517|FG000|STARTED|Dexmedetomidine Then Propofol||5
6431069|NCT01045122|7345518|FG001|STARTED|Dexmedetomidine Then Propofol||6
6431070|NCT01045122|7345517|FG000|COMPLETED|Dexmedetomidine Then Propofol||5
6431071|NCT01045122|7345518|FG001|COMPLETED|Dexmedetomidine Then Propofol||6
6431072|NCT01045122|7345517|FG000|NOT COMPLETED|Dexmedetomidine Then Propofol||0
6431073|NCT01045122|7345518|FG001|NOT COMPLETED|Dexmedetomidine Then Propofol||0
6431074|NCT01045122|7345517|FG000|STARTED|Propofol Then Dexmedetomidine||5
6431075|NCT01045122|7345518|FG001|STARTED|Propofol Then Dexmedetomidine||6
6431076|NCT01045122|7345517|FG000|COMPLETED|Propofol Then Dexmedetomidine||5
6431077|NCT01045122|7345518|FG001|COMPLETED|Propofol Then Dexmedetomidine||6
6431078|NCT01045122|7345517|FG000|NOT COMPLETED|Propofol Then Dexmedetomidine||0
6431079|NCT01045122|7345518|FG001|NOT COMPLETED|Propofol Then Dexmedetomidine||0
6431080|NCT01045135|7345524|FG000|STARTED|Overall Study||300
6431081|NCT01045135|7345524|FG000|COMPLETED|Overall Study||274
6431082|NCT01045135|7345524|FG000|NOT COMPLETED|Overall Study||26
6431083|NCT01045161|7345533|FG000|STARTED|Part A - 12 Weeks Double Blind Treatment||182
6431084|NCT01045161|7345534|FG001|STARTED|Part A - 12 Weeks Double Blind Treatment||184
6431085|NCT01045161|7345535|FG002|STARTED|Part A - 12 Weeks Double Blind Treatment||178
6431086|NCT01045161|7345533|FG000|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
6431087|NCT01045161|7345534|FG001|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
6431088|NCT01045161|7345535|FG002|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
6431089|NCT01045161|7345533|FG000|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
6431090|NCT01045161|7345534|FG001|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
6431091|NCT01045161|7345535|FG002|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
6431092|NCT01045161|7345533|FG000|STARTED|Part B - 40 Additional Weeks Open Label||147
6431093|NCT01045161|7345534|FG001|STARTED|Part B - 40 Additional Weeks Open Label||154
6431094|NCT01045161|7345535|FG002|STARTED|Part B - 40 Additional Weeks Open Label||147
6431095|NCT01045161|7345533|FG000|COMPLETED|Part B - 40 Additional Weeks Open Label||111
6431096|NCT01045161|7345534|FG001|COMPLETED|Part B - 40 Additional Weeks Open Label||118
6431097|NCT01045161|7345535|FG002|COMPLETED|Part B - 40 Additional Weeks Open Label||115
6431098|NCT01045161|7345533|FG000|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
6431099|NCT01045161|7345534|FG001|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
6431100|NCT01045161|7345535|FG002|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
6431101|NCT01045174|7345554|FG000|STARTED|Overall Study||90
6431102|NCT01045174|7345555|FG001|STARTED|Overall Study||90
6431103|NCT01045174|7345554|FG000|COMPLETED|Overall Study||90
6431104|NCT01045174|7345555|FG001|COMPLETED|Overall Study||90
6431105|NCT01045174|7345554|FG000|NOT COMPLETED|Overall Study||0
6431106|NCT01045174|7345555|FG001|NOT COMPLETED|Overall Study||0
6431107|NCT01045187|7345561|FG000|STARTED|Overall Study||15
6431108|NCT01045187|7345561|FG000|COMPLETED|Overall Study||15
6552183|NCT01736358|7474604|FG000|NOT COMPLETED|Overall Study||5
6652424|NCT02429258|7582032|FG000|STARTED|Overall Study||50
6431109|NCT01045187|7345561|FG000|NOT COMPLETED|Overall Study||0
6431110|NCT01045265|7345565|FG000|STARTED|Overall Study||16
6431111|NCT01045265|7345565|FG000|COMPLETED|Overall Study||16
6431112|NCT01045265|7345565|FG000|NOT COMPLETED|Overall Study||0
6552184|NCT01736358|7474605|FG001|NOT COMPLETED|Overall Study||2
6431113|NCT01045421|7345575|FG000|STARTED|Phase 1||1
6431114|NCT01045421|7345576|FG001|STARTED|Phase 1||3
6431115|NCT01045421|7345577|FG002|STARTED|Phase 1||4
6431116|NCT01045421|7345578|FG003|STARTED|Phase 1||12
6431117|NCT01045421|7345579|FG004|STARTED|Phase 1||3
6431118|NCT01045421|7345580|FG005|STARTED|Phase 1||1
6431119|NCT01045421|7345581|FG006|STARTED|Phase 1||0
6431120|NCT01045421|7345582|FG007|STARTED|Phase 1||0
6431121|NCT01045421|7345583|FG008|STARTED|Phase 1||0
6552185|NCT01736397|7474613|FG000|STARTED|Overall Study||75
6552186|NCT01736397|7474614|FG001|STARTED|Overall Study||74
6552187|NCT01736397|7474613|FG000|COMPLETED|Overall Study||61
6552188|NCT01736397|7474614|FG001|COMPLETED|Overall Study||50
6431122|NCT01045421|7345584|FG009|STARTED|Phase 1||0
6431123|NCT01045421|7345585|FG010|STARTED|Phase 1||0
6431124|NCT01045421|7345575|FG000|COMPLETED|Phase 1||1
6431125|NCT01045421|7345576|FG001|COMPLETED|Phase 1||3
6431126|NCT01045421|7345577|FG002|COMPLETED|Phase 1||4
6431127|NCT01045421|7345578|FG003|COMPLETED|Phase 1||11
6431128|NCT01045421|7345579|FG004|COMPLETED|Phase 1||2
6431129|NCT01045421|7345580|FG005|COMPLETED|Phase 1||1
6431130|NCT01045421|7345581|FG006|COMPLETED|Phase 1||0
6552189|NCT01736397|7474613|FG000|NOT COMPLETED|Overall Study||14
6552190|NCT01736397|7474614|FG001|NOT COMPLETED|Overall Study||24
6552191|NCT01736475|7474622|FG000|STARTED|Overall Study||121
6552192|NCT01736475|7474623|FG001|STARTED|Overall Study||17
6552193|NCT01736475|7474622|FG000|COMPLETED|Overall Study||109
6552194|NCT01736475|7474623|FG001|COMPLETED|Overall Study||17
6552195|NCT01736475|7474622|FG000|NOT COMPLETED|Overall Study||12
6552196|NCT01736475|7474623|FG001|NOT COMPLETED|Overall Study||0
6431131|NCT01045421|7345582|FG007|COMPLETED|Phase 1||0
6431132|NCT01045421|7345583|FG008|COMPLETED|Phase 1||0
6431133|NCT01045421|7345584|FG009|COMPLETED|Phase 1||0
6431134|NCT01045421|7345585|FG010|COMPLETED|Phase 1||0
6431135|NCT01045421|7345575|FG000|NOT COMPLETED|Phase 1||0
6431136|NCT01045421|7345576|FG001|NOT COMPLETED|Phase 1||0
6431137|NCT01045421|7345577|FG002|NOT COMPLETED|Phase 1||0
6431138|NCT01045421|7345578|FG003|NOT COMPLETED|Phase 1||1
6431139|NCT01045421|7345579|FG004|NOT COMPLETED|Phase 1||1
6431140|NCT01045421|7345580|FG005|NOT COMPLETED|Phase 1||0
6431141|NCT01045421|7345581|FG006|NOT COMPLETED|Phase 1||0
6431142|NCT01045421|7345582|FG007|NOT COMPLETED|Phase 1||0
6431143|NCT01045421|7345583|FG008|NOT COMPLETED|Phase 1||0
6431144|NCT01045421|7345584|FG009|NOT COMPLETED|Phase 1||0
6431145|NCT01045421|7345585|FG010|NOT COMPLETED|Phase 1||0
6431146|NCT01045421|7345575|FG000|STARTED|Phase 2||0
6431147|NCT01045421|7345576|FG001|STARTED|Phase 2||0
6431148|NCT01045421|7345577|FG002|STARTED|Phase 2||0
6431149|NCT01045421|7345578|FG003|STARTED|Phase 2||0
6431150|NCT01045421|7345579|FG004|STARTED|Phase 2||0
6431151|NCT01045421|7345580|FG005|STARTED|Phase 2||0
6431152|NCT01045421|7345581|FG006|STARTED|Phase 2||53
6431153|NCT01045421|7345582|FG007|STARTED|Phase 2||55
6431154|NCT01045421|7345583|FG008|STARTED|Phase 2||55
6431155|NCT01045421|7345584|FG009|STARTED|Phase 2||26
6431156|NCT01045421|7345585|FG010|STARTED|Phase 2||60
6431157|NCT01045421|7345575|FG000|COMPLETED|Phase 2||0
6431158|NCT01045421|7345576|FG001|COMPLETED|Phase 2||0
6431159|NCT01045421|7345577|FG002|COMPLETED|Phase 2||0
6431160|NCT01045421|7345578|FG003|COMPLETED|Phase 2||0
6431161|NCT01045421|7345579|FG004|COMPLETED|Phase 2||0
6431162|NCT01045421|7345580|FG005|COMPLETED|Phase 2||0
6431163|NCT01045421|7345581|FG006|COMPLETED|Phase 2||53
6431164|NCT01045421|7345582|FG007|COMPLETED|Phase 2||50
6431165|NCT01045421|7345583|FG008|COMPLETED|Phase 2||53
6431166|NCT01045421|7345584|FG009|COMPLETED|Phase 2||23
6431167|NCT01045421|7345585|FG010|COMPLETED|Phase 2||58
6431168|NCT01045421|7345575|FG000|NOT COMPLETED|Phase 2||0
6431169|NCT01045421|7345576|FG001|NOT COMPLETED|Phase 2||0
6431170|NCT01045421|7345577|FG002|NOT COMPLETED|Phase 2||0
6431171|NCT01045421|7345578|FG003|NOT COMPLETED|Phase 2||0
6431172|NCT01045421|7345579|FG004|NOT COMPLETED|Phase 2||0
6431173|NCT01045421|7345580|FG005|NOT COMPLETED|Phase 2||0
6431174|NCT01045421|7345581|FG006|NOT COMPLETED|Phase 2||0
6431175|NCT01045421|7345582|FG007|NOT COMPLETED|Phase 2||5
6431176|NCT01045421|7345583|FG008|NOT COMPLETED|Phase 2||2
6431177|NCT01045421|7345584|FG009|NOT COMPLETED|Phase 2||3
6431178|NCT01045421|7345585|FG010|NOT COMPLETED|Phase 2||2
6431179|NCT01045447|7345608|FG000|STARTED|Overall Study||232
6431180|NCT01045447|7345609|FG001|STARTED|Overall Study||233
6431181|NCT01045447|7345608|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
6431182|NCT01045447|7345609|FG001|Exposed|Overall Study||233
6431183|NCT01045447|7345608|FG000|COMPLETED|Overall Study||196
6431184|NCT01045447|7345609|FG001|COMPLETED|Overall Study||205
6431185|NCT01045447|7345608|FG000|NOT COMPLETED|Overall Study||36
6431186|NCT01045447|7345609|FG001|NOT COMPLETED|Overall Study||28
6552197|NCT01736527|7474640|FG000|STARTED|Overall Study||12
6431187|NCT01045460|7345617|FG000|STARTED|Overall Study||17
6431188|NCT01045460|7345618|FG001|STARTED|Overall Study||18
6431189|NCT01045460|7345617|FG000|COMPLETED|Overall Study||11
6431190|NCT01045460|7345618|FG001|COMPLETED|Overall Study||15
6431191|NCT01045460|7345617|FG000|NOT COMPLETED|Overall Study||6
6431192|NCT01045460|7345618|FG001|NOT COMPLETED|Overall Study||3
6431193|NCT01045499|7345626|FG000|STARTED|Overall Study||137
6552198|NCT01736527|7474640|FG000|COMPLETED|Overall Study||12
6431194|NCT01045499|7345626|FG000|COMPLETED|Overall Study||127
6431195|NCT01045499|7345626|FG000|NOT COMPLETED|Overall Study||10
6431196|NCT01045551|7345630|FG000|STARTED|Overall Study||10
6431197|NCT01045551|7345630|FG000|COMPLETED|Overall Study||10
6431198|NCT01045551|7345630|FG000|NOT COMPLETED|Overall Study||0
6431199|NCT01045707|7345637|FG000|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
6431200|NCT01045707|7345638|FG001|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
6431201|NCT01045707|7345637|FG000|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
6431202|NCT01045707|7345638|FG001|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
6431203|NCT01045707|7345637|FG000|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
6431204|NCT01045707|7345638|FG001|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
6431205|NCT01045707|7345637|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
6431206|NCT01045707|7345638|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
6431207|NCT01045707|7345637|FG000|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
6431208|NCT01045707|7345638|FG001|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
6431209|NCT01045707|7345637|FG000|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
6431210|NCT01045707|7345638|FG001|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
6431211|NCT01045707|7345637|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
6431212|NCT01045707|7345638|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
6431213|NCT01045798|7345646|FG000|STARTED|Overall Study||6
6431214|NCT01045798|7345647|FG001|STARTED|Overall Study||9
6431215|NCT01045798|7345646|FG000|COMPLETED|Overall Study||4
6431216|NCT01045798|7345647|FG001|COMPLETED|Overall Study||5
6431217|NCT01045798|7345646|FG000|NOT COMPLETED|Overall Study||2
6431218|NCT01045798|7345647|FG001|NOT COMPLETED|Overall Study||4
6431219|NCT01045967|7345655|FG000|STARTED|First Intervention||28
6431220|NCT01045967|7345656|FG001|STARTED|First Intervention||28
6431221|NCT01045967|7345655|FG000|COMPLETED|First Intervention||28
6431222|NCT01045967|7345656|FG001|COMPLETED|First Intervention||28
6431223|NCT01045967|7345655|FG000|NOT COMPLETED|First Intervention||0
6431224|NCT01045967|7345656|FG001|NOT COMPLETED|First Intervention||0
6431225|NCT01045967|7345655|FG000|STARTED|Washout of 7 Days||28
6431226|NCT01045967|7345656|FG001|STARTED|Washout of 7 Days||28
6431227|NCT01045967|7345655|FG000|COMPLETED|Washout of 7 Days||28
6431228|NCT01045967|7345656|FG001|COMPLETED|Washout of 7 Days||28
6431229|NCT01045967|7345655|FG000|NOT COMPLETED|Washout of 7 Days||0
6431230|NCT01045967|7345656|FG001|NOT COMPLETED|Washout of 7 Days||0
6431231|NCT01045967|7345655|FG000|STARTED|Second Intervention||28
6431232|NCT01045967|7345656|FG001|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
6431233|NCT01045967|7345655|FG000|COMPLETED|Second Intervention||28
6431234|NCT01045967|7345656|FG001|COMPLETED|Second Intervention||27
6431235|NCT01045967|7345655|FG000|NOT COMPLETED|Second Intervention||0
6431236|NCT01045967|7345656|FG001|NOT COMPLETED|Second Intervention||1
6431237|NCT01045993|7345666|FG000|STARTED|Overall Study||26
6431238|NCT01045993|7345667|FG001|STARTED|Overall Study||5
6431239|NCT01045993|7345668|FG002|STARTED|Overall Study||5
6431240|NCT01045993|7345669|FG003|STARTED|Overall Study||25
6431241|NCT01045993|7345666|FG000|COMPLETED|Overall Study||26
6431242|NCT01045993|7345667|FG001|COMPLETED|Overall Study||4
6431243|NCT01045993|7345668|FG002|COMPLETED|Overall Study||5
6431244|NCT01045993|7345669|FG003|COMPLETED|Overall Study||25
6431245|NCT01045993|7345666|FG000|NOT COMPLETED|Overall Study||0
6431246|NCT01045993|7345667|FG001|NOT COMPLETED|Overall Study||1
6431247|NCT01045993|7345668|FG002|NOT COMPLETED|Overall Study||0
6431248|NCT01045993|7345669|FG003|NOT COMPLETED|Overall Study||0
6431249|NCT01046084|7345681|FG000|STARTED|First Intervention||25
6431250|NCT01046084|7345682|FG001|STARTED|First Intervention||25
6431251|NCT01046084|7345681|FG000|COMPLETED|First Intervention||25
6431252|NCT01046084|7345682|FG001|COMPLETED|First Intervention||25
6431253|NCT01046084|7345681|FG000|NOT COMPLETED|First Intervention||0
6552199|NCT01736527|7474640|FG000|NOT COMPLETED|Overall Study||0
6552200|NCT01736540|7474644|FG000|STARTED|Overall Study||243
6552201|NCT01736540|7474644|FG000|COMPLETED|Overall Study||228
6552202|NCT01736540|7474644|FG000|NOT COMPLETED|Overall Study||15
6552203|NCT01736553|7474657|FG000|STARTED|Overall Study||26
6552204|NCT01736553|7474658|FG001|STARTED|Overall Study||27
6431254|NCT01046084|7345682|FG001|NOT COMPLETED|First Intervention||0
6431255|NCT01046084|7345681|FG000|STARTED|First Washout of 7 Days||25
6431256|NCT01046084|7345682|FG001|STARTED|First Washout of 7 Days||25
6431257|NCT01046084|7345681|FG000|COMPLETED|First Washout of 7 Days||25
6431258|NCT01046084|7345682|FG001|COMPLETED|First Washout of 7 Days||25
6431259|NCT01046084|7345681|FG000|NOT COMPLETED|First Washout of 7 Days||0
6431260|NCT01046084|7345682|FG001|NOT COMPLETED|First Washout of 7 Days||0
6431261|NCT01046084|7345681|FG000|STARTED|Second Intervention||25
6431262|NCT01046084|7345682|FG001|STARTED|Second Intervention||25
6431263|NCT01046084|7345681|FG000|COMPLETED|Second Intervention||25
6431264|NCT01046084|7345682|FG001|COMPLETED|Second Intervention||25
6431265|NCT01046084|7345681|FG000|NOT COMPLETED|Second Intervention||0
6431266|NCT01046084|7345682|FG001|NOT COMPLETED|Second Intervention||0
6431267|NCT01046084|7345681|FG000|STARTED|Second Washout of 7 Days||25
6431268|NCT01046084|7345682|FG001|STARTED|Second Washout of 7 Days||25
6431269|NCT01046084|7345681|FG000|COMPLETED|Second Washout of 7 Days||25
6552205|NCT01736553|7474657|FG000|COMPLETED|Overall Study||7
6552206|NCT01736553|7474658|FG001|COMPLETED|Overall Study||23
6552207|NCT01736553|7474657|FG000|NOT COMPLETED|Overall Study||19
6552208|NCT01736553|7474658|FG001|NOT COMPLETED|Overall Study||4
6552209|NCT01736566|7474687|FG000|STARTED|Main Study||51
6552210|NCT01736566|7474688|FG001|STARTED|Main Study||50
6552211|NCT01736566|7474689|FG002|STARTED|Main Study||50
6431270|NCT01046084|7345682|FG001|COMPLETED|Second Washout of 7 Days||25
6431271|NCT01046084|7345681|FG000|NOT COMPLETED|Second Washout of 7 Days||0
6431272|NCT01046084|7345682|FG001|NOT COMPLETED|Second Washout of 7 Days||0
6431273|NCT01046084|7345681|FG000|STARTED|Third Intervention||25
6431274|NCT01046084|7345682|FG001|STARTED|Third Intervention||25
6431275|NCT01046084|7345681|FG000|COMPLETED|Third Intervention||25
6431276|NCT01046084|7345682|FG001|COMPLETED|Third Intervention||25
6431277|NCT01046084|7345681|FG000|NOT COMPLETED|Third Intervention||0
6552212|NCT01736566|7474690|FG003|STARTED|Main Study||52
6552213|NCT01736566|7474691|FG004|STARTED|Main Study||10
6431278|NCT01046084|7345682|FG001|NOT COMPLETED|Third Intervention||0
6431279|NCT01046084|7345681|FG000|STARTED|Third Washout of 7 Days||25
6431280|NCT01046084|7345682|FG001|STARTED|Third Washout of 7 Days||25
6431281|NCT01046084|7345681|FG000|COMPLETED|Third Washout of 7 Days||23
6431282|NCT01046084|7345682|FG001|COMPLETED|Third Washout of 7 Days||25
6431283|NCT01046084|7345681|FG000|NOT COMPLETED|Third Washout of 7 Days||2
6431284|NCT01046084|7345682|FG001|NOT COMPLETED|Third Washout of 7 Days||0
6431285|NCT01046084|7345681|FG000|STARTED|Fourth Intervention||23
6431286|NCT01046084|7345682|FG001|STARTED|Fourth Intervention||25
6431287|NCT01046084|7345681|FG000|COMPLETED|Fourth Intervention||23
6431288|NCT01046084|7345682|FG001|COMPLETED|Fourth Intervention||25
6431289|NCT01046084|7345681|FG000|NOT COMPLETED|Fourth Intervention||0
6431290|NCT01046084|7345682|FG001|NOT COMPLETED|Fourth Intervention||0
6431291|NCT01046110|7345690|FG000|STARTED|Overall Study||229
6431292|NCT01046110|7345691|FG001|STARTED|Overall Study||229
6431293|NCT01046110|7345690|FG000|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
6431294|NCT01046110|7345691|FG001|Exposed|Overall Study|1 subject was randomised in error|228
6431295|NCT01046110|7345690|FG000|COMPLETED|Overall Study||174
6431296|NCT01046110|7345691|FG001|COMPLETED|Overall Study||174
6431297|NCT01046110|7345690|FG000|NOT COMPLETED|Overall Study||55
6431298|NCT01046110|7345691|FG001|NOT COMPLETED|Overall Study||55
6431299|NCT01046136|7345699|FG000|STARTED|Overall Study||188
6431300|NCT01046136|7345700|FG001|STARTED|Overall Study||190
6431301|NCT01046136|7345699|FG000|COMPLETED|Overall Study||184
6431302|NCT01046136|7345700|FG001|COMPLETED|Overall Study||182
6431303|NCT01046136|7345699|FG000|NOT COMPLETED|Overall Study||4
6431304|NCT01046136|7345700|FG001|NOT COMPLETED|Overall Study||8
6431305|NCT01046253|7345710|FG000|STARTED|First Intervention||25
6431306|NCT01046253|7345711|FG001|STARTED|First Intervention||25
6431307|NCT01046253|7345710|FG000|COMPLETED|First Intervention||25
6431308|NCT01046253|7345711|FG001|COMPLETED|First Intervention||25
6431309|NCT01046253|7345710|FG000|NOT COMPLETED|First Intervention||0
6431310|NCT01046253|7345711|FG001|NOT COMPLETED|First Intervention||0
6431311|NCT01046253|7345710|FG000|STARTED|First Washout of 7 Days||25
6431312|NCT01046253|7345711|FG001|STARTED|First Washout of 7 Days||25
6431313|NCT01046253|7345710|FG000|COMPLETED|First Washout of 7 Days||25
6431314|NCT01046253|7345711|FG001|COMPLETED|First Washout of 7 Days||25
6431315|NCT01046253|7345710|FG000|NOT COMPLETED|First Washout of 7 Days||0
6431316|NCT01046253|7345711|FG001|NOT COMPLETED|First Washout of 7 Days||0
6431317|NCT01046253|7345710|FG000|STARTED|Second Intervention||25
6431318|NCT01046253|7345711|FG001|STARTED|Second Intervention||25
6431319|NCT01046253|7345710|FG000|COMPLETED|Second Intervention||25
6431320|NCT01046253|7345711|FG001|COMPLETED|Second Intervention||23
6552214|NCT01736566|7474687|FG000|COMPLETED|Main Study||50
6552215|NCT01736566|7474688|FG001|COMPLETED|Main Study||50
6552216|NCT01736566|7474689|FG002|COMPLETED|Main Study||49
6552217|NCT01736566|7474690|FG003|COMPLETED|Main Study||51
6552218|NCT01736566|7474691|FG004|COMPLETED|Main Study||6
6552219|NCT01736566|7474687|FG000|NOT COMPLETED|Main Study||1
6431321|NCT01046253|7345710|FG000|NOT COMPLETED|Second Intervention||0
6431322|NCT01046253|7345711|FG001|NOT COMPLETED|Second Intervention||2
6431323|NCT01046253|7345710|FG000|STARTED|Second Washout of 7 Days||25
6431324|NCT01046253|7345711|FG001|STARTED|Second Washout of 7 Days||23
6431325|NCT01046253|7345710|FG000|COMPLETED|Second Washout of 7 Days||25
6431326|NCT01046253|7345711|FG001|COMPLETED|Second Washout of 7 Days||23
6431327|NCT01046253|7345710|FG000|NOT COMPLETED|Second Washout of 7 Days||0
6431328|NCT01046253|7345711|FG001|NOT COMPLETED|Second Washout of 7 Days||0
6431329|NCT01046253|7345710|FG000|STARTED|Third Intervention||25
6431330|NCT01046253|7345711|FG001|STARTED|Third Intervention||23
6431331|NCT01046253|7345710|FG000|COMPLETED|Third Intervention||25
6431332|NCT01046253|7345711|FG001|COMPLETED|Third Intervention||23
6431333|NCT01046253|7345710|FG000|NOT COMPLETED|Third Intervention||0
6431334|NCT01046253|7345711|FG001|NOT COMPLETED|Third Intervention||0
6431335|NCT01046253|7345710|FG000|STARTED|Third Washout of 7 Days||25
6431336|NCT01046253|7345711|FG001|STARTED|Third Washout of 7 Days||23
6431337|NCT01046253|7345710|FG000|COMPLETED|Third Washout of 7 Days||25
6431338|NCT01046253|7345711|FG001|COMPLETED|Third Washout of 7 Days||23
6431339|NCT01046253|7345710|FG000|NOT COMPLETED|Third Washout of 7 Days||0
6431340|NCT01046253|7345711|FG001|NOT COMPLETED|Third Washout of 7 Days||0
6431341|NCT01046253|7345710|FG000|STARTED|Fourth Intervention||25
6431342|NCT01046253|7345711|FG001|STARTED|Fourth Intervention||23
6431343|NCT01046253|7345710|FG000|COMPLETED|Fourth Intervention||25
6431344|NCT01046253|7345711|FG001|COMPLETED|Fourth Intervention||23
6431345|NCT01046253|7345710|FG000|NOT COMPLETED|Fourth Intervention||0
6431346|NCT01046253|7345711|FG001|NOT COMPLETED|Fourth Intervention||0
6431347|NCT01046396|7345717|FG000|STARTED|Overall Study||69
6431348|NCT01046396|7345717|FG000|COMPLETED|Overall Study||64
6431349|NCT01046396|7345717|FG000|NOT COMPLETED|Overall Study||5
6431350|NCT01046565|7345724|FG000|STARTED|Overall Study||75
6431351|NCT01046565|7345724|FG000|COMPLETED|Overall Study||66
6431352|NCT01046565|7345724|FG000|NOT COMPLETED|Overall Study||9
6431353|NCT01046643|7345735|FG000|STARTED|First Period Treatment or Placebo||9
6431354|NCT01046643|7345736|FG001|STARTED|First Period Treatment or Placebo||7
6431355|NCT01046643|7345737|FG002|STARTED|First Period Treatment or Placebo||7
6431356|NCT01046643|7345738|FG003|STARTED|First Period Treatment or Placebo||7
6431357|NCT01046643|7345735|FG000|COMPLETED|First Period Treatment or Placebo||9
6552220|NCT01736566|7474688|FG001|NOT COMPLETED|Main Study||0
6431358|NCT01046643|7345736|FG001|COMPLETED|First Period Treatment or Placebo||6
6431359|NCT01046643|7345737|FG002|COMPLETED|First Period Treatment or Placebo||7
6431360|NCT01046643|7345738|FG003|COMPLETED|First Period Treatment or Placebo||7
6431361|NCT01046643|7345735|FG000|NOT COMPLETED|First Period Treatment or Placebo||0
6431362|NCT01046643|7345736|FG001|NOT COMPLETED|First Period Treatment or Placebo||1
6431363|NCT01046643|7345737|FG002|NOT COMPLETED|First Period Treatment or Placebo||0
6431364|NCT01046643|7345738|FG003|NOT COMPLETED|First Period Treatment or Placebo||0
6431365|NCT01046643|7345735|FG000|STARTED|Washout Period||9
6431366|NCT01046643|7345736|FG001|STARTED|Washout Period||6
6431367|NCT01046643|7345737|FG002|STARTED|Washout Period||7
6431368|NCT01046643|7345738|FG003|STARTED|Washout Period||7
6431369|NCT01046643|7345735|FG000|COMPLETED|Washout Period||9
6431370|NCT01046643|7345736|FG001|COMPLETED|Washout Period||6
6431371|NCT01046643|7345737|FG002|COMPLETED|Washout Period||7
6431372|NCT01046643|7345738|FG003|COMPLETED|Washout Period||7
6431373|NCT01046643|7345735|FG000|NOT COMPLETED|Washout Period||0
6431374|NCT01046643|7345736|FG001|NOT COMPLETED|Washout Period||0
6431375|NCT01046643|7345737|FG002|NOT COMPLETED|Washout Period||0
6431376|NCT01046643|7345738|FG003|NOT COMPLETED|Washout Period||0
6431377|NCT01046643|7345735|FG000|STARTED|Second Period Treatment or Placebo||9
6431378|NCT01046643|7345736|FG001|STARTED|Second Period Treatment or Placebo||6
6431379|NCT01046643|7345737|FG002|STARTED|Second Period Treatment or Placebo||7
6431380|NCT01046643|7345738|FG003|STARTED|Second Period Treatment or Placebo||7
6431381|NCT01046643|7345735|FG000|COMPLETED|Second Period Treatment or Placebo||9
6431382|NCT01046643|7345736|FG001|COMPLETED|Second Period Treatment or Placebo||6
6431383|NCT01046643|7345737|FG002|COMPLETED|Second Period Treatment or Placebo||7
6431384|NCT01046643|7345738|FG003|COMPLETED|Second Period Treatment or Placebo||7
6431385|NCT01046643|7345735|FG000|NOT COMPLETED|Second Period Treatment or Placebo||0
6431386|NCT01046643|7345736|FG001|NOT COMPLETED|Second Period Treatment or Placebo||0
6431387|NCT01046643|7345737|FG002|NOT COMPLETED|Second Period Treatment or Placebo||0
6431388|NCT01046643|7345738|FG003|NOT COMPLETED|Second Period Treatment or Placebo||0
6431389|NCT01046669|7345750|FG000|STARTED|Overall Study||226
6431390|NCT01046669|7345751|FG001|STARTED|Overall Study||224
6431391|NCT01046669|7345750|FG000|COMPLETED|Overall Study||226
6431392|NCT01046669|7345751|FG001|COMPLETED|Overall Study||223
6431393|NCT01046669|7345750|FG000|NOT COMPLETED|Overall Study||0
6431394|NCT01046669|7345751|FG001|NOT COMPLETED|Overall Study||1
6431395|NCT01046682|7345759|FG000|STARTED|Overall Study||20
6431396|NCT01046682|7345760|FG001|STARTED|Overall Study||20
6431397|NCT01046682|7345759|FG000|COMPLETED|Overall Study||18
6431398|NCT01046682|7345760|FG001|COMPLETED|Overall Study||20
6431399|NCT01046682|7345759|FG000|NOT COMPLETED|Overall Study||2
6431400|NCT01046682|7345760|FG001|NOT COMPLETED|Overall Study||0
6431401|NCT01046695|7345768|FG000|STARTED|Overall Study||20
6431402|NCT01046695|7345769|FG001|STARTED|Overall Study||22
6431403|NCT01046695|7345768|FG000|COMPLETED|Overall Study||20
6431404|NCT01046695|7345769|FG001|COMPLETED|Overall Study||20
6431405|NCT01046695|7345768|FG000|NOT COMPLETED|Overall Study||0
6431406|NCT01046695|7345769|FG001|NOT COMPLETED|Overall Study||2
6431407|NCT01046877|7345775|FG000|STARTED|Overall Study||25
6431408|NCT01046877|7345775|FG000|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
6431409|NCT01046877|7345775|FG000|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
6431410|NCT01046877|7345775|FG000|COMPLETED|Overall Study||7
6431411|NCT01046877|7345775|FG000|NOT COMPLETED|Overall Study||18
6431412|NCT01046903|7345779|FG000|STARTED|Overall Study||503
6431413|NCT01046903|7345779|FG000|COMPLETED|Overall Study||475
6431414|NCT01046903|7345779|FG000|NOT COMPLETED|Overall Study||28
6431415|NCT01047007|7345787|FG000|STARTED|Overall Study||3
6431416|NCT01047007|7345788|FG001|STARTED|Overall Study||6
6431417|NCT01047007|7345789|FG002|STARTED|Overall Study||2
6431418|NCT01047007|7345790|FG003|STARTED|Overall Study||0
6431419|NCT01047007|7345787|FG000|Treated|Overall Study||3
6431420|NCT01047007|7345788|FG001|Treated|Overall Study||6
6431421|NCT01047007|7345789|FG002|Treated|Overall Study||2
6431422|NCT01047007|7345790|FG003|Treated|Overall Study||0
6431423|NCT01047007|7345787|FG000|COMPLETED|Overall Study||1
6431424|NCT01047007|7345788|FG001|COMPLETED|Overall Study||0
6431425|NCT01047007|7345789|FG002|COMPLETED|Overall Study||0
6431426|NCT01047007|7345790|FG003|COMPLETED|Overall Study||0
6431427|NCT01047007|7345787|FG000|NOT COMPLETED|Overall Study||2
6431428|NCT01047007|7345788|FG001|NOT COMPLETED|Overall Study||6
6431429|NCT01047007|7345789|FG002|NOT COMPLETED|Overall Study||2
6431430|NCT01047007|7345790|FG003|NOT COMPLETED|Overall Study||0
6431431|NCT01047189|7345802|FG000|STARTED|Overall Study||13
6431432|NCT01047189|7345803|FG001|STARTED|Overall Study||13
6431433|NCT01047189|7345802|FG000|COMPLETED|Overall Study||9
6431434|NCT01047189|7345803|FG001|COMPLETED|Overall Study||13
6431435|NCT01047189|7345802|FG000|NOT COMPLETED|Overall Study||4
6431436|NCT01047189|7345803|FG001|NOT COMPLETED|Overall Study||0
6431437|NCT01047241|7345809|FG000|STARTED|Overall Study||50
6431438|NCT01047241|7345809|FG000|COMPLETED|Overall Study||50
6431439|NCT01047241|7345809|FG000|NOT COMPLETED|Overall Study||0
6431440|NCT01047293|7345816|FG000|STARTED|Overall Study||4
6431441|NCT01047293|7345817|FG001|STARTED|Overall Study||8
6431442|NCT01047293|7345818|FG002|STARTED|Overall Study||9
6431443|NCT01047293|7345819|FG003|STARTED|Overall Study||26
6431444|NCT01047293|7345816|FG000|COMPLETED|Overall Study||3
6431445|NCT01047293|7345817|FG001|COMPLETED|Overall Study||7
6431446|NCT01047293|7345818|FG002|COMPLETED|Overall Study||9
6431447|NCT01047293|7345819|FG003|COMPLETED|Overall Study||26
6431448|NCT01047293|7345816|FG000|NOT COMPLETED|Overall Study||1
6431449|NCT01047293|7345817|FG001|NOT COMPLETED|Overall Study||1
6431450|NCT01047293|7345818|FG002|NOT COMPLETED|Overall Study||0
6431451|NCT01047293|7345819|FG003|NOT COMPLETED|Overall Study||0
6431452|NCT01047306|7345828|FG000|STARTED|Overall Study||19
6431453|NCT01047306|7345829|FG001|STARTED|Overall Study||6
6431454|NCT01047306|7345828|FG000|Discontinued From the Study|Overall Study||3
6431455|NCT01047306|7345829|FG001|Discontinued From the Study|Overall Study||0
6431456|NCT01047306|7345828|FG000|COMPLETED|Overall Study||16
6431457|NCT01047306|7345829|FG001|COMPLETED|Overall Study||6
6431458|NCT01047306|7345828|FG000|NOT COMPLETED|Overall Study||3
6431459|NCT01047306|7345829|FG001|NOT COMPLETED|Overall Study||0
6431460|NCT01047332|7345839|FG000|STARTED|Overall Study||61
6431461|NCT01047332|7345840|FG001|STARTED|Overall Study||68
6431462|NCT01047332|7345839|FG000|COMPLETED|Overall Study|Alive at final follow-up|4
6431463|NCT01047332|7345840|FG001|COMPLETED|Overall Study|Alive at final follow-up|4
6431464|NCT01047332|7345839|FG000|NOT COMPLETED|Overall Study||57
6431465|NCT01047332|7345840|FG001|NOT COMPLETED|Overall Study||64
6431466|NCT01047345|7345848|FG000|STARTED|Base Study||618
6431467|NCT01047345|7345849|FG001|STARTED|Base Study||306
6431468|NCT01047345|7345850|FG002|STARTED|Base Study||0
6431469|NCT01047345|7345848|FG000|Vaccination 1|Base Study||615
6431470|NCT01047345|7345849|FG001|Vaccination 1|Base Study||306
6431471|NCT01047345|7345850|FG002|Vaccination 1|Base Study||0
6431472|NCT01047345|7345848|FG000|Vaccination 2|Base Study||604
6431473|NCT01047345|7345849|FG001|Vaccination 2|Base Study||304
6431474|NCT01047345|7345850|FG002|Vaccination 2|Base Study||0
6431475|NCT01047345|7345848|FG000|Vaccination 3|Base Study||597
6431476|NCT01047345|7345849|FG001|Vaccination 3|Base Study||300
6431477|NCT01047345|7345850|FG002|Vaccination 3|Base Study||0
6431478|NCT01047345|7345848|FG000|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
6431479|NCT01047345|7345849|FG001|COMPLETED|Base Study||300
6431480|NCT01047345|7345850|FG002|COMPLETED|Base Study||0
6431481|NCT01047345|7345848|FG000|NOT COMPLETED|Base Study||22
6431482|NCT01047345|7345849|FG001|NOT COMPLETED|Base Study||6
6431483|NCT01047345|7345850|FG002|NOT COMPLETED|Base Study||0
6431484|NCT01047345|7345848|FG000|STARTED|Extension||0
6431485|NCT01047345|7345849|FG001|STARTED|Extension||0
6431486|NCT01047345|7345850|FG002|STARTED|Extension|Not all eligible participants elected to participate in extension|102
6431487|NCT01047345|7345848|FG000|Vaccination 4|Extension||0
6431488|NCT01047345|7345849|FG001|Vaccination 4|Extension||0
6431489|NCT01047345|7345850|FG002|Vaccination 4|Extension||102
6431490|NCT01047345|7345848|FG000|Vaccination 5|Extension||0
6431491|NCT01047345|7345849|FG001|Vaccination 5|Extension||0
6431492|NCT01047345|7345850|FG002|Vaccination 5|Extension||99
6431493|NCT01047345|7345848|FG000|Vaccination 6|Extension||0
6431494|NCT01047345|7345849|FG001|Vaccination 6|Extension||0
6431495|NCT01047345|7345850|FG002|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
6431496|NCT01047345|7345848|FG000|COMPLETED|Extension||0
6431497|NCT01047345|7345849|FG001|COMPLETED|Extension||0
6431498|NCT01047345|7345850|FG002|COMPLETED|Extension||96
6431499|NCT01047345|7345848|FG000|NOT COMPLETED|Extension||0
6431500|NCT01047345|7345849|FG001|NOT COMPLETED|Extension||0
6431501|NCT01047345|7345850|FG002|NOT COMPLETED|Extension||6
6431502|NCT01047358|7345858|FG000|STARTED|Overall Study||206
6431503|NCT01047358|7345858|FG000|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
6431504|NCT01047358|7345858|FG000|NOT COMPLETED|Overall Study||0
6431505|NCT01047436|7345865|FG000|STARTED|Overall Study||16
6431506|NCT01047436|7345866|FG001|STARTED|Overall Study||15
6431507|NCT01047436|7345865|FG000|COMPLETED|Overall Study||15
6431508|NCT01047436|7345866|FG001|COMPLETED|Overall Study||15
6431509|NCT01047436|7345865|FG000|NOT COMPLETED|Overall Study||1
6431510|NCT01047436|7345866|FG001|NOT COMPLETED|Overall Study||0
6499658|NCT01420081|7418388|FG000|STARTED|Overall Study||3
6499659|NCT01420081|7418389|FG001|STARTED|Overall Study||1
6499660|NCT01420081|7418390|FG002|STARTED|Overall Study||11
6499661|NCT01420081|7418391|FG003|STARTED|Overall Study||3
6499662|NCT01420081|7418392|FG004|STARTED|Overall Study||20
6499663|NCT01420081|7418393|FG005|STARTED|Overall Study||20
6552221|NCT01736566|7474689|FG002|NOT COMPLETED|Main Study||1
6552222|NCT01736566|7474690|FG003|NOT COMPLETED|Main Study||1
6552223|NCT01736566|7474691|FG004|NOT COMPLETED|Main Study||4
6552224|NCT01736566|7474687|FG000|STARTED|Long Term Follow-up||42
6552225|NCT01736566|7474688|FG001|STARTED|Long Term Follow-up||0
6552226|NCT01736566|7474689|FG002|STARTED|Long Term Follow-up||49
6552227|NCT01736566|7474690|FG003|STARTED|Long Term Follow-up||0
6552228|NCT01736566|7474691|FG004|STARTED|Long Term Follow-up||1
6552229|NCT01736566|7474687|FG000|COMPLETED|Long Term Follow-up||0
6652425|NCT02429258|7582033|FG001|STARTED|Overall Study||50
6652426|NCT02429258|7582032|FG000|COMPLETED|Overall Study||48
6552230|NCT01736566|7474688|FG001|COMPLETED|Long Term Follow-up||0
6499664|NCT01420081|7418394|FG006|STARTED|Overall Study||3
6499665|NCT01420081|7418395|FG007|STARTED|Overall Study||3
6499666|NCT01420081|7418396|FG008|STARTED|Overall Study||3
6499667|NCT01420081|7418388|FG000|COMPLETED|Overall Study||0
6499668|NCT01420081|7418389|FG001|COMPLETED|Overall Study||0
6499669|NCT01420081|7418390|FG002|COMPLETED|Overall Study||0
6499670|NCT01420081|7418391|FG003|COMPLETED|Overall Study||0
6431511|NCT01047475|7345874|FG000|STARTED|Overall Study||34
6431512|NCT01047475|7345875|FG001|STARTED|Overall Study||38
6431513|NCT01047475|7345874|FG000|COMPLETED|Overall Study||29
6431514|NCT01047475|7345875|FG001|COMPLETED|Overall Study||31
6431515|NCT01047475|7345874|FG000|NOT COMPLETED|Overall Study||5
6431516|NCT01047475|7345875|FG001|NOT COMPLETED|Overall Study||7
6431517|NCT01047527|7345884|FG000|STARTED|Overall Study||180
6431518|NCT01047527|7345885|FG001|STARTED|Overall Study||173
6431519|NCT01047527|7345886|FG002|STARTED|Overall Study||172
6431520|NCT01047527|7345884|FG000|8 Weeks|Overall Study||148
6431521|NCT01047527|7345885|FG001|8 Weeks|Overall Study||142
6431522|NCT01047527|7345886|FG002|8 Weeks|Overall Study||138
6431523|NCT01047527|7345884|FG000|24 Weeks|Overall Study||111
6431524|NCT01047527|7345885|FG001|24 Weeks|Overall Study||123
6431525|NCT01047527|7345886|FG002|24 Weeks|Overall Study||119
6431526|NCT01047527|7345884|FG000|COMPLETED|Overall Study||95
6431527|NCT01047527|7345885|FG001|COMPLETED|Overall Study||112
6431528|NCT01047527|7345886|FG002|COMPLETED|Overall Study||107
6431529|NCT01047527|7345884|FG000|NOT COMPLETED|Overall Study||85
6431530|NCT01047527|7345885|FG001|NOT COMPLETED|Overall Study||61
6431531|NCT01047527|7345886|FG002|NOT COMPLETED|Overall Study||65
6431532|NCT01047553|7345897|FG000|STARTED|Overall Study||125
6431533|NCT01047553|7345898|FG001|STARTED|Overall Study||126
6431534|NCT01047553|7345897|FG000|COMPLETED|Overall Study||108
6431535|NCT01047553|7345898|FG001|COMPLETED|Overall Study||117
6431536|NCT01047553|7345897|FG000|NOT COMPLETED|Overall Study||17
6431537|NCT01047553|7345898|FG001|NOT COMPLETED|Overall Study||9
6431538|NCT01047709|7345904|FG000|STARTED|Positional Therapy (1 Night)||9
6431539|NCT01047709|7345905|FG001|STARTED|Positional Therapy (1 Night)||9
6431540|NCT01047709|7345904|FG000|COMPLETED|Positional Therapy (1 Night)||9
6552231|NCT01736566|7474689|FG002|COMPLETED|Long Term Follow-up||0
6552232|NCT01736566|7474690|FG003|COMPLETED|Long Term Follow-up||0
6552233|NCT01736566|7474691|FG004|COMPLETED|Long Term Follow-up||0
6552234|NCT01736566|7474687|FG000|NOT COMPLETED|Long Term Follow-up||42
6552235|NCT01736566|7474688|FG001|NOT COMPLETED|Long Term Follow-up||0
6552236|NCT01736566|7474689|FG002|NOT COMPLETED|Long Term Follow-up||49
6552237|NCT01736566|7474690|FG003|NOT COMPLETED|Long Term Follow-up||0
6552238|NCT01736566|7474691|FG004|NOT COMPLETED|Long Term Follow-up||1
6552239|NCT01736579|7474718|FG000|STARTED|Overall Study||2
6552240|NCT01736579|7474719|FG001|STARTED|Overall Study||2
6552241|NCT01736579|7474718|FG000|COMPLETED|Overall Study||0
6552242|NCT01736579|7474719|FG001|COMPLETED|Overall Study||0
6552243|NCT01736579|7474718|FG000|NOT COMPLETED|Overall Study||2
6552244|NCT01736579|7474719|FG001|NOT COMPLETED|Overall Study||2
6552245|NCT01736657|7474725|FG000|STARTED|Overall Study||73
6552246|NCT01736657|7474725|FG000|COMPLETED|Overall Study||72
6431541|NCT01047709|7345905|FG001|COMPLETED|Positional Therapy (1 Night)||9
6431542|NCT01047709|7345904|FG000|NOT COMPLETED|Positional Therapy (1 Night)||0
6431543|NCT01047709|7345905|FG001|NOT COMPLETED|Positional Therapy (1 Night)||0
6431544|NCT01047709|7345904|FG000|STARTED|Control/Positioning ad Lib (1 Night)||9
6431545|NCT01047709|7345905|FG001|STARTED|Control/Positioning ad Lib (1 Night)||9
6431546|NCT01047709|7345904|FG000|COMPLETED|Control/Positioning ad Lib (1 Night)||9
6431547|NCT01047709|7345905|FG001|COMPLETED|Control/Positioning ad Lib (1 Night)||9
6431548|NCT01047709|7345904|FG000|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
6431549|NCT01047709|7345905|FG001|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
6431550|NCT01047839|7345914|FG000|STARTED|Overall Study||12
6431551|NCT01047839|7345915|FG001|STARTED|Overall Study||29
6431552|NCT01047839|7345916|FG002|STARTED|Overall Study||59
6431553|NCT01047839|7345914|FG000|COMPLETED|Overall Study||10
6431554|NCT01047839|7345915|FG001|COMPLETED|Overall Study||29
6431555|NCT01047839|7345916|FG002|COMPLETED|Overall Study||53
6431556|NCT01047839|7345914|FG000|NOT COMPLETED|Overall Study||2
6431557|NCT01047839|7345915|FG001|NOT COMPLETED|Overall Study||0
6431558|NCT01047839|7345916|FG002|NOT COMPLETED|Overall Study||6
6431559|NCT01048099|7345931|FG000|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
6431560|NCT01048099|7345931|FG000|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
6431561|NCT01048099|7345931|FG000|NOT COMPLETED|Patients Enrolled and Blood Collected||57
6431562|NCT01048099|7345931|FG000|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
6431563|NCT01048099|7345931|FG000|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
6431564|NCT01048099|7345931|FG000|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
6431565|NCT01048099|7345931|FG000|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
6431566|NCT01048099|7345931|FG000|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
6431567|NCT01048099|7345931|FG000|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
6431568|NCT01048099|7345931|FG000|STARTED|Treatment Per Protocol||14
6431569|NCT01048099|7345931|FG000|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
6431570|NCT01048099|7345931|FG000|NOT COMPLETED|Treatment Per Protocol||14
6431571|NCT01048242|7345939|FG000|STARTED|Overall Study||12
6552247|NCT01736657|7474725|FG000|NOT COMPLETED|Overall Study||1
6552248|NCT01736683|7474734|FG000|STARTED|Overall Study||7
6552249|NCT01736683|7474735|FG001|STARTED|Overall Study||6
6552250|NCT01736683|7474736|FG002|STARTED|Overall Study||21
6552251|NCT01736683|7474737|FG003|STARTED|Overall Study||35
6552252|NCT01736683|7474738|FG004|STARTED|Overall Study||5
6431572|NCT01048242|7345940|FG001|STARTED|Overall Study||15
6431573|NCT01048242|7345939|FG000|COMPLETED|Overall Study||8
6431574|NCT01048242|7345940|FG001|COMPLETED|Overall Study||13
6431575|NCT01048242|7345939|FG000|NOT COMPLETED|Overall Study||4
6431576|NCT01048242|7345940|FG001|NOT COMPLETED|Overall Study||2
6431577|NCT01048333|7345946|FG000|STARTED|Treatment Period 1||21
6431578|NCT01048333|7345947|FG001|STARTED|Treatment Period 1||19
6431579|NCT01048333|7345948|FG002|STARTED|Treatment Period 1||16
6431580|NCT01048333|7345949|FG003|STARTED|Treatment Period 1||18
6431581|NCT01048333|7345950|FG004|STARTED|Treatment Period 1||17
6431582|NCT01048333|7345951|FG005|STARTED|Treatment Period 1||18
6431583|NCT01048333|7345946|FG000|COMPLETED|Treatment Period 1||21
6431584|NCT01048333|7345947|FG001|COMPLETED|Treatment Period 1||19
6431585|NCT01048333|7345948|FG002|COMPLETED|Treatment Period 1||16
6431586|NCT01048333|7345949|FG003|COMPLETED|Treatment Period 1||18
6431587|NCT01048333|7345950|FG004|COMPLETED|Treatment Period 1||17
6431588|NCT01048333|7345951|FG005|COMPLETED|Treatment Period 1||18
6431589|NCT01048333|7345946|FG000|NOT COMPLETED|Treatment Period 1||0
6431590|NCT01048333|7345947|FG001|NOT COMPLETED|Treatment Period 1||0
6431591|NCT01048333|7345948|FG002|NOT COMPLETED|Treatment Period 1||0
6431592|NCT01048333|7345949|FG003|NOT COMPLETED|Treatment Period 1||0
6431593|NCT01048333|7345950|FG004|NOT COMPLETED|Treatment Period 1||0
6431594|NCT01048333|7345951|FG005|NOT COMPLETED|Treatment Period 1||0
6431595|NCT01048333|7345946|FG000|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
6431596|NCT01048333|7345947|FG001|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
6431597|NCT01048333|7345948|FG002|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
6431598|NCT01048333|7345949|FG003|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
6431599|NCT01048333|7345950|FG004|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
6431600|NCT01048333|7345951|FG005|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
6431601|NCT01048333|7345946|FG000|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
6431602|NCT01048333|7345947|FG001|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
6431603|NCT01048333|7345948|FG002|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
6431604|NCT01048333|7345949|FG003|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
6431605|NCT01048333|7345950|FG004|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
6431606|NCT01048333|7345951|FG005|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
6431607|NCT01048333|7345946|FG000|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6431608|NCT01048333|7345947|FG001|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6431609|NCT01048333|7345948|FG002|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6431610|NCT01048333|7345949|FG003|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6431611|NCT01048333|7345950|FG004|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6431612|NCT01048333|7345951|FG005|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
6431613|NCT01048333|7345946|FG000|STARTED|Treatment Period 2||21
6431614|NCT01048333|7345947|FG001|STARTED|Treatment Period 2||19
6431615|NCT01048333|7345948|FG002|STARTED|Treatment Period 2||16
6431616|NCT01048333|7345949|FG003|STARTED|Treatment Period 2||18
6431617|NCT01048333|7345950|FG004|STARTED|Treatment Period 2||17
6431618|NCT01048333|7345951|FG005|STARTED|Treatment Period 2||18
6431619|NCT01048333|7345946|FG000|COMPLETED|Treatment Period 2||21
6431620|NCT01048333|7345947|FG001|COMPLETED|Treatment Period 2||19
6431621|NCT01048333|7345948|FG002|COMPLETED|Treatment Period 2||16
6431622|NCT01048333|7345949|FG003|COMPLETED|Treatment Period 2||18
6431623|NCT01048333|7345950|FG004|COMPLETED|Treatment Period 2||17
6431624|NCT01048333|7345951|FG005|COMPLETED|Treatment Period 2||18
6431625|NCT01048333|7345946|FG000|NOT COMPLETED|Treatment Period 2||0
6431626|NCT01048333|7345947|FG001|NOT COMPLETED|Treatment Period 2||0
6552253|NCT01736683|7474734|FG000|COMPLETED|Overall Study|# who completed treatment|0
6431627|NCT01048333|7345948|FG002|NOT COMPLETED|Treatment Period 2||0
6431628|NCT01048333|7345949|FG003|NOT COMPLETED|Treatment Period 2||0
6431629|NCT01048333|7345950|FG004|NOT COMPLETED|Treatment Period 2||0
6431630|NCT01048333|7345951|FG005|NOT COMPLETED|Treatment Period 2||0
6431631|NCT01048333|7345946|FG000|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
6431632|NCT01048333|7345947|FG001|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
6431633|NCT01048333|7345948|FG002|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
6431634|NCT01048333|7345949|FG003|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
6431635|NCT01048333|7345950|FG004|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
6431636|NCT01048333|7345951|FG005|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
6431637|NCT01048333|7345946|FG000|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
6431638|NCT01048333|7345947|FG001|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
6431639|NCT01048333|7345948|FG002|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
6431640|NCT01048333|7345949|FG003|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
6431641|NCT01048333|7345950|FG004|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
6431642|NCT01048333|7345951|FG005|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
6431643|NCT01048333|7345946|FG000|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6431644|NCT01048333|7345947|FG001|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
6431645|NCT01048333|7345948|FG002|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6431646|NCT01048333|7345949|FG003|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6431647|NCT01048333|7345950|FG004|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6431648|NCT01048333|7345951|FG005|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
6431649|NCT01048333|7345946|FG000|STARTED|Treatment Period 3||21
6431650|NCT01048333|7345947|FG001|STARTED|Treatment Period 3||18
6431651|NCT01048333|7345948|FG002|STARTED|Treatment Period 3||16
6431652|NCT01048333|7345949|FG003|STARTED|Treatment Period 3||18
6431653|NCT01048333|7345950|FG004|STARTED|Treatment Period 3||17
6562783|NCT01803074|7485710|FG011|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6431654|NCT01048333|7345951|FG005|STARTED|Treatment Period 3||18
6431655|NCT01048333|7345946|FG000|COMPLETED|Treatment Period 3||21
6431656|NCT01048333|7345947|FG001|COMPLETED|Treatment Period 3||18
6431657|NCT01048333|7345948|FG002|COMPLETED|Treatment Period 3||16
6431658|NCT01048333|7345949|FG003|COMPLETED|Treatment Period 3||18
6431659|NCT01048333|7345950|FG004|COMPLETED|Treatment Period 3||17
6431660|NCT01048333|7345951|FG005|COMPLETED|Treatment Period 3||18
6431661|NCT01048333|7345946|FG000|NOT COMPLETED|Treatment Period 3||0
6431662|NCT01048333|7345947|FG001|NOT COMPLETED|Treatment Period 3||0
6431663|NCT01048333|7345948|FG002|NOT COMPLETED|Treatment Period 3||0
6431664|NCT01048333|7345949|FG003|NOT COMPLETED|Treatment Period 3||0
6431665|NCT01048333|7345950|FG004|NOT COMPLETED|Treatment Period 3||0
6431666|NCT01048333|7345951|FG005|NOT COMPLETED|Treatment Period 3||0
6431667|NCT01048424|7345961|FG000|STARTED|Overall Study||10
6431668|NCT01048424|7345962|FG001|STARTED|Overall Study||10
6431669|NCT01048424|7345961|FG000|COMPLETED|Overall Study||8
6431670|NCT01048424|7345962|FG001|COMPLETED|Overall Study||10
6431671|NCT01048424|7345961|FG000|NOT COMPLETED|Overall Study||2
6431672|NCT01048424|7345962|FG001|NOT COMPLETED|Overall Study||0
6431673|NCT01048502|7345973|FG000|STARTED|Overall Study||24
6552254|NCT01736683|7474735|FG001|COMPLETED|Overall Study|# who completed treatment|0
6552255|NCT01736683|7474736|FG002|COMPLETED|Overall Study|# who completed treatment|0
6552256|NCT01736683|7474737|FG003|COMPLETED|Overall Study|# who completed treatment|0
6431674|NCT01048502|7345974|FG001|STARTED|Overall Study||23
6431675|NCT01048502|7345975|FG002|STARTED|Overall Study||28
6431676|NCT01048502|7345976|FG003|STARTED|Overall Study||25
6431677|NCT01048502|7345973|FG000|COMPLETED|Overall Study||20
6431678|NCT01048502|7345974|FG001|COMPLETED|Overall Study||16
6431679|NCT01048502|7345975|FG002|COMPLETED|Overall Study||23
6431680|NCT01048502|7345976|FG003|COMPLETED|Overall Study||21
6431681|NCT01048502|7345973|FG000|NOT COMPLETED|Overall Study||4
6431682|NCT01048502|7345974|FG001|NOT COMPLETED|Overall Study||7
6431683|NCT01048502|7345975|FG002|NOT COMPLETED|Overall Study||5
6431684|NCT01048502|7345976|FG003|NOT COMPLETED|Overall Study||4
6431685|NCT01048541|7345987|FG000|STARTED|Overall Study||18
6431686|NCT01048541|7345988|FG001|STARTED|Overall Study||19
6431687|NCT01048541|7345987|FG000|COMPLETED|Overall Study||17
6431688|NCT01048541|7345988|FG001|COMPLETED|Overall Study||19
6431689|NCT01048541|7345987|FG000|NOT COMPLETED|Overall Study||1
6431690|NCT01048541|7345988|FG001|NOT COMPLETED|Overall Study||0
6431691|NCT01048593|7345997|FG000|STARTED|Overall Study||3
6431692|NCT01048593|7345998|FG001|STARTED|Overall Study||2
6431693|NCT01048593|7345999|FG002|STARTED|Overall Study||1
6431694|NCT01048593|7345997|FG000|COMPLETED|Overall Study||3
6431695|NCT01048593|7345998|FG001|COMPLETED|Overall Study||2
6431696|NCT01048593|7345999|FG002|COMPLETED|Overall Study||1
6431697|NCT01048593|7345997|FG000|NOT COMPLETED|Overall Study||0
6431698|NCT01048593|7345998|FG001|NOT COMPLETED|Overall Study||0
6431699|NCT01048593|7345999|FG002|NOT COMPLETED|Overall Study||0
6431700|NCT01048606|7346011|FG000|STARTED|Overall Study||28
6431701|NCT01048606|7346012|FG001|STARTED|Overall Study||15
6431702|NCT01048606|7346013|FG002|STARTED|Overall Study||26
6431703|NCT01048606|7346014|FG003|STARTED|Overall Study||10
6431704|NCT01048606|7346011|FG000|COMPLETED|Overall Study||16
6431705|NCT01048606|7346012|FG001|COMPLETED|Overall Study||8
6431706|NCT01048606|7346013|FG002|COMPLETED|Overall Study||16
6431707|NCT01048606|7346014|FG003|COMPLETED|Overall Study||5
6431708|NCT01048606|7346011|FG000|NOT COMPLETED|Overall Study||12
6431709|NCT01048606|7346012|FG001|NOT COMPLETED|Overall Study||7
6431710|NCT01048606|7346013|FG002|NOT COMPLETED|Overall Study||10
6431711|NCT01048606|7346014|FG003|NOT COMPLETED|Overall Study||5
6431712|NCT01048658|7346026|FG000|STARTED|Overall Study||80
6552257|NCT01736683|7474738|FG004|COMPLETED|Overall Study|# who completed treatment|0
6552258|NCT01736683|7474734|FG000|NOT COMPLETED|Overall Study||7
6552259|NCT01736683|7474735|FG001|NOT COMPLETED|Overall Study||6
6552260|NCT01736683|7474736|FG002|NOT COMPLETED|Overall Study||21
6431713|NCT01048658|7346027|FG001|STARTED|Overall Study||80
6431714|NCT01048658|7346026|FG000|COMPLETED|Overall Study||80
6431715|NCT01048658|7346027|FG001|COMPLETED|Overall Study||80
6431716|NCT01048658|7346026|FG000|NOT COMPLETED|Overall Study||0
6431717|NCT01048658|7346027|FG001|NOT COMPLETED|Overall Study||0
6431718|NCT01048671|7346036|FG000|STARTED|Overall Study||66
6431719|NCT01048671|7346037|FG001|STARTED|Overall Study||264
6552261|NCT01736683|7474737|FG003|NOT COMPLETED|Overall Study||35
6552262|NCT01736683|7474738|FG004|NOT COMPLETED|Overall Study||5
6552263|NCT01736696|7474759|FG000|STARTED|Overall Study||5
6552264|NCT01736696|7474760|FG001|STARTED|Overall Study||5
6552265|NCT01736696|7474761|FG002|STARTED|Overall Study||10
6431720|NCT01048671|7346038|FG002|STARTED|Overall Study||152
6431721|NCT01048671|7346036|FG000|COMPLETED|Overall Study||66
6431722|NCT01048671|7346037|FG001|COMPLETED|Overall Study||263
6431723|NCT01048671|7346038|FG002|COMPLETED|Overall Study||151
6431724|NCT01048671|7346036|FG000|NOT COMPLETED|Overall Study||0
6431725|NCT01048671|7346037|FG001|NOT COMPLETED|Overall Study||1
6431726|NCT01048671|7346038|FG002|NOT COMPLETED|Overall Study||1
6431727|NCT01048697|7346046|FG000|STARTED|Overall Study||18
6431728|NCT01048697|7346046|FG000|COMPLETED|Overall Study||18
6431729|NCT01048697|7346046|FG000|NOT COMPLETED|Overall Study||0
6431730|NCT01048788|7346053|FG000|STARTED|Overall Study||8
6431731|NCT01048788|7346054|FG001|STARTED|Overall Study||30
6431732|NCT01048788|7346055|FG002|STARTED|Overall Study||13
6431733|NCT01048788|7346053|FG000|COMPLETED|Overall Study||3
6431734|NCT01048788|7346054|FG001|COMPLETED|Overall Study||28
6431735|NCT01048788|7346055|FG002|COMPLETED|Overall Study||11
6431736|NCT01048788|7346053|FG000|NOT COMPLETED|Overall Study||5
6431737|NCT01048788|7346054|FG001|NOT COMPLETED|Overall Study||2
6431738|NCT01048788|7346055|FG002|NOT COMPLETED|Overall Study||2
6431739|NCT01048866|7346065|FG000|STARTED|Overall Study||101
6431740|NCT01048866|7346066|FG001|STARTED|Overall Study||97
6431741|NCT01048866|7346065|FG000|COMPLETED|Overall Study||97
6431742|NCT01048866|7346066|FG001|COMPLETED|Overall Study||92
6431743|NCT01048866|7346065|FG000|NOT COMPLETED|Overall Study||4
6431744|NCT01048866|7346066|FG001|NOT COMPLETED|Overall Study||5
6431745|NCT01048879|7346075|FG000|STARTED|Overall Study||1
6431746|NCT01048879|7346076|FG001|STARTED|Overall Study||9
6431747|NCT01048879|7346077|FG002|STARTED|Overall Study||5
6431748|NCT01048879|7346075|FG000|COMPLETED|Overall Study||1
6431749|NCT01048879|7346076|FG001|COMPLETED|Overall Study||9
6552266|NCT01736696|7474762|FG003|STARTED|Overall Study||9
6552267|NCT01736696|7474763|FG004|STARTED|Overall Study||9
6552268|NCT01736696|7474764|FG005|STARTED|Overall Study||8
6552269|NCT01736696|7474765|FG006|STARTED|Overall Study||13
6552270|NCT01736696|7474759|FG000|COMPLETED|Overall Study||5
6431750|NCT01048879|7346077|FG002|COMPLETED|Overall Study||5
6431751|NCT01048879|7346075|FG000|NOT COMPLETED|Overall Study||0
6431752|NCT01048879|7346076|FG001|NOT COMPLETED|Overall Study||0
6431753|NCT01048879|7346077|FG002|NOT COMPLETED|Overall Study||0
6431754|NCT01048905|7346085|FG000|STARTED|Overall Study||13
6431755|NCT01048905|7346085|FG000|COMPLETED|Overall Study||12
6431756|NCT01048905|7346085|FG000|NOT COMPLETED|Overall Study||1
6431757|NCT01048944|7346093|FG000|STARTED|Overall Study||32
6431758|NCT01048944|7346094|FG001|STARTED|Overall Study||38
6431759|NCT01048944|7346095|FG002|STARTED|Overall Study||35
6431760|NCT01048944|7346096|FG003|STARTED|Overall Study||21
6431761|NCT01048944|7346093|FG000|COMPLETED|Overall Study||24
6431762|NCT01048944|7346094|FG001|COMPLETED|Overall Study||28
6431763|NCT01048944|7346095|FG002|COMPLETED|Overall Study||25
6431764|NCT01048944|7346096|FG003|COMPLETED|Overall Study||19
6431765|NCT01048944|7346093|FG000|NOT COMPLETED|Overall Study||8
6431766|NCT01048944|7346094|FG001|NOT COMPLETED|Overall Study||10
6431767|NCT01048944|7346095|FG002|NOT COMPLETED|Overall Study||10
6431768|NCT01048944|7346096|FG003|NOT COMPLETED|Overall Study||2
6431769|NCT01049009|7346108|FG000|STARTED|Treatment Period 1 (12 Weeks)||23
6431770|NCT01049009|7346109|FG001|STARTED|Treatment Period 1 (12 Weeks)||21
6431771|NCT01049009|7346108|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||21
6431772|NCT01049009|7346109|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||18
6431773|NCT01049009|7346108|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
6431774|NCT01049009|7346109|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
6431775|NCT01049009|7346108|FG000|STARTED|Treatment Period 2 (12 Weeks)||21
6431776|NCT01049009|7346109|FG001|STARTED|Treatment Period 2 (12 Weeks)||18
6431777|NCT01049009|7346108|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||11
6431778|NCT01049009|7346109|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||8
6431779|NCT01049009|7346108|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
6431780|NCT01049009|7346109|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
6431781|NCT01049217|7346117|FG000|STARTED|Overall Study||183
6431782|NCT01049217|7346118|FG001|STARTED|Overall Study||194
6431783|NCT01049217|7346117|FG000|Treated|Overall Study||183
6431784|NCT01049217|7346118|FG001|Treated|Overall Study||192
6431785|NCT01049217|7346117|FG000|COMPLETED|Overall Study||127
6431786|NCT01049217|7346118|FG001|COMPLETED|Overall Study||131
6431787|NCT01049217|7346117|FG000|NOT COMPLETED|Overall Study||56
6431788|NCT01049217|7346118|FG001|NOT COMPLETED|Overall Study||63
6431789|NCT01049243|7346124|FG000|STARTED|Overall Study||20
6431790|NCT01049243|7346124|FG000|COMPLETED|Overall Study||18
6431791|NCT01049243|7346124|FG000|NOT COMPLETED|Overall Study||2
6431792|NCT01049308|7346129|FG000|STARTED|Evaluation of Cognitive Impairment||251
6431793|NCT01049308|7346129|FG000|COMPLETED|Evaluation of Cognitive Impairment||251
6431794|NCT01049308|7346129|FG000|NOT COMPLETED|Evaluation of Cognitive Impairment||0
6431795|NCT01049308|7346129|FG000|STARTED|Pill Counts||251
6431796|NCT01049308|7346129|FG000|COMPLETED|Pill Counts||168
6431797|NCT01049308|7346129|FG000|NOT COMPLETED|Pill Counts||83
6431798|NCT01049334|7346138|FG000|STARTED|Overall Study||102
6431799|NCT01049334|7346139|FG001|STARTED|Overall Study||102
6431800|NCT01049334|7346138|FG000|COMPLETED|Overall Study||93
6431801|NCT01049334|7346139|FG001|COMPLETED|Overall Study||95
6431802|NCT01049334|7346138|FG000|NOT COMPLETED|Overall Study||9
6431803|NCT01049334|7346139|FG001|NOT COMPLETED|Overall Study||7
6431804|NCT01049360|7346145|FG000|STARTED|Period 1||6
6431805|NCT01049360|7346146|FG001|STARTED|Period 1||6
6431806|NCT01049360|7346147|FG002|STARTED|Period 1||7
6431807|NCT01049360|7346148|FG003|STARTED|Period 1||7
6431808|NCT01049360|7346149|FG004|STARTED|Period 1||7
6431809|NCT01049360|7346150|FG005|STARTED|Period 1||6
6431810|NCT01049360|7346151|FG006|STARTED|Period 1||6
6431811|NCT01049360|7346152|FG007|STARTED|Period 1||6
6431812|NCT01049360|7346153|FG008|STARTED|Period 1||7
6431813|NCT01049360|7346154|FG009|STARTED|Period 1||6
6431814|NCT01049360|7346155|FG010|STARTED|Period 1||6
6431815|NCT01049360|7346156|FG011|STARTED|Period 1||6
6431816|NCT01049360|7346157|FG012|STARTED|Period 1||6
6431817|NCT01049360|7346158|FG013|STARTED|Period 1||7
6431818|NCT01049360|7346159|FG014|STARTED|Period 1||7
6431819|NCT01049360|7346160|FG015|STARTED|Period 1||7
6431820|NCT01049360|7346161|FG016|STARTED|Period 1||6
6431821|NCT01049360|7346162|FG017|STARTED|Period 1||6
6431822|NCT01049360|7346163|FG018|STARTED|Period 1||6
6431823|NCT01049360|7346164|FG019|STARTED|Period 1||7
6431824|NCT01049360|7346145|FG000|COMPLETED|Period 1||6
6431825|NCT01049360|7346146|FG001|COMPLETED|Period 1||5
6431826|NCT01049360|7346147|FG002|COMPLETED|Period 1||7
6431827|NCT01049360|7346148|FG003|COMPLETED|Period 1||6
6431828|NCT01049360|7346149|FG004|COMPLETED|Period 1||7
6431829|NCT01049360|7346150|FG005|COMPLETED|Period 1||6
6431830|NCT01049360|7346151|FG006|COMPLETED|Period 1||6
6431831|NCT01049360|7346152|FG007|COMPLETED|Period 1||4
6431832|NCT01049360|7346153|FG008|COMPLETED|Period 1||5
6431833|NCT01049360|7346154|FG009|COMPLETED|Period 1||6
6431834|NCT01049360|7346155|FG010|COMPLETED|Period 1||5
6431835|NCT01049360|7346156|FG011|COMPLETED|Period 1||6
6431836|NCT01049360|7346157|FG012|COMPLETED|Period 1||4
6431837|NCT01049360|7346158|FG013|COMPLETED|Period 1||6
6431838|NCT01049360|7346159|FG014|COMPLETED|Period 1||7
6431839|NCT01049360|7346160|FG015|COMPLETED|Period 1||7
6431840|NCT01049360|7346161|FG016|COMPLETED|Period 1||5
6431841|NCT01049360|7346162|FG017|COMPLETED|Period 1||6
6431842|NCT01049360|7346163|FG018|COMPLETED|Period 1||5
6431843|NCT01049360|7346164|FG019|COMPLETED|Period 1||7
6431844|NCT01049360|7346145|FG000|NOT COMPLETED|Period 1||0
6431845|NCT01049360|7346146|FG001|NOT COMPLETED|Period 1||1
6431846|NCT01049360|7346147|FG002|NOT COMPLETED|Period 1||0
6431847|NCT01049360|7346148|FG003|NOT COMPLETED|Period 1||1
6431848|NCT01049360|7346149|FG004|NOT COMPLETED|Period 1||0
6431849|NCT01049360|7346150|FG005|NOT COMPLETED|Period 1||0
6431850|NCT01049360|7346151|FG006|NOT COMPLETED|Period 1||0
6431851|NCT01049360|7346152|FG007|NOT COMPLETED|Period 1||2
6431852|NCT01049360|7346153|FG008|NOT COMPLETED|Period 1||2
6431853|NCT01049360|7346154|FG009|NOT COMPLETED|Period 1||0
6431854|NCT01049360|7346155|FG010|NOT COMPLETED|Period 1||1
6431855|NCT01049360|7346156|FG011|NOT COMPLETED|Period 1||0
6431856|NCT01049360|7346157|FG012|NOT COMPLETED|Period 1||2
6431857|NCT01049360|7346158|FG013|NOT COMPLETED|Period 1||1
6431858|NCT01049360|7346159|FG014|NOT COMPLETED|Period 1||0
6431859|NCT01049360|7346160|FG015|NOT COMPLETED|Period 1||0
6431860|NCT01049360|7346161|FG016|NOT COMPLETED|Period 1||1
6431861|NCT01049360|7346162|FG017|NOT COMPLETED|Period 1||0
6431862|NCT01049360|7346163|FG018|NOT COMPLETED|Period 1||1
6431863|NCT01049360|7346164|FG019|NOT COMPLETED|Period 1||0
6431864|NCT01049360|7346145|FG000|STARTED|Period 2||6
6431865|NCT01049360|7346146|FG001|STARTED|Period 2||5
6431866|NCT01049360|7346147|FG002|STARTED|Period 2||7
6431867|NCT01049360|7346148|FG003|STARTED|Period 2||6
6431868|NCT01049360|7346149|FG004|STARTED|Period 2||7
6431869|NCT01049360|7346150|FG005|STARTED|Period 2||6
6431870|NCT01049360|7346151|FG006|STARTED|Period 2||6
6431871|NCT01049360|7346152|FG007|STARTED|Period 2||4
6431872|NCT01049360|7346153|FG008|STARTED|Period 2||5
6431873|NCT01049360|7346154|FG009|STARTED|Period 2||6
6431874|NCT01049360|7346155|FG010|STARTED|Period 2||5
6431875|NCT01049360|7346156|FG011|STARTED|Period 2||6
6431876|NCT01049360|7346157|FG012|STARTED|Period 2||4
6431877|NCT01049360|7346158|FG013|STARTED|Period 2||6
6431878|NCT01049360|7346159|FG014|STARTED|Period 2||7
6431879|NCT01049360|7346160|FG015|STARTED|Period 2||7
6431880|NCT01049360|7346161|FG016|STARTED|Period 2||5
6431881|NCT01049360|7346162|FG017|STARTED|Period 2||6
6431882|NCT01049360|7346163|FG018|STARTED|Period 2||5
6431883|NCT01049360|7346164|FG019|STARTED|Period 2||7
6431884|NCT01049360|7346145|FG000|COMPLETED|Period 2||6
6431885|NCT01049360|7346146|FG001|COMPLETED|Period 2||4
6431886|NCT01049360|7346147|FG002|COMPLETED|Period 2||7
6431887|NCT01049360|7346148|FG003|COMPLETED|Period 2||4
6431888|NCT01049360|7346149|FG004|COMPLETED|Period 2||7
6431889|NCT01049360|7346150|FG005|COMPLETED|Period 2||5
6431890|NCT01049360|7346151|FG006|COMPLETED|Period 2||6
6431891|NCT01049360|7346152|FG007|COMPLETED|Period 2||4
6652427|NCT02429258|7582033|FG001|COMPLETED|Overall Study||49
6652428|NCT02429258|7582032|FG000|NOT COMPLETED|Overall Study||2
6652429|NCT02429258|7582033|FG001|NOT COMPLETED|Overall Study||1
6652430|NCT02429310|7582041|FG000|STARTED|Overall Study||22
6652431|NCT02429310|7582042|FG001|STARTED|Overall Study||20
6652432|NCT02429310|7582041|FG000|COMPLETED|Overall Study||20
6652433|NCT02429310|7582042|FG001|COMPLETED|Overall Study||17
6652434|NCT02429310|7582041|FG000|NOT COMPLETED|Overall Study||2
6652435|NCT02429310|7582042|FG001|NOT COMPLETED|Overall Study||3
6431892|NCT01049360|7346153|FG008|COMPLETED|Period 2||4
6431893|NCT01049360|7346154|FG009|COMPLETED|Period 2||6
6431894|NCT01049360|7346155|FG010|COMPLETED|Period 2||5
6431895|NCT01049360|7346156|FG011|COMPLETED|Period 2||6
6431896|NCT01049360|7346157|FG012|COMPLETED|Period 2||4
6431897|NCT01049360|7346158|FG013|COMPLETED|Period 2||6
6431898|NCT01049360|7346159|FG014|COMPLETED|Period 2||5
6431899|NCT01049360|7346160|FG015|COMPLETED|Period 2||6
6431900|NCT01049360|7346161|FG016|COMPLETED|Period 2||5
6431901|NCT01049360|7346162|FG017|COMPLETED|Period 2||6
6431902|NCT01049360|7346163|FG018|COMPLETED|Period 2||5
6431903|NCT01049360|7346164|FG019|COMPLETED|Period 2||5
6431904|NCT01049360|7346145|FG000|NOT COMPLETED|Period 2||0
6431905|NCT01049360|7346146|FG001|NOT COMPLETED|Period 2||1
6431906|NCT01049360|7346147|FG002|NOT COMPLETED|Period 2||0
6431907|NCT01049360|7346148|FG003|NOT COMPLETED|Period 2||2
6431908|NCT01049360|7346149|FG004|NOT COMPLETED|Period 2||0
6431909|NCT01049360|7346150|FG005|NOT COMPLETED|Period 2||1
6431910|NCT01049360|7346151|FG006|NOT COMPLETED|Period 2||0
6431911|NCT01049360|7346152|FG007|NOT COMPLETED|Period 2||0
6431912|NCT01049360|7346153|FG008|NOT COMPLETED|Period 2||1
6431913|NCT01049360|7346154|FG009|NOT COMPLETED|Period 2||0
6431914|NCT01049360|7346155|FG010|NOT COMPLETED|Period 2||0
6431915|NCT01049360|7346156|FG011|NOT COMPLETED|Period 2||0
6431916|NCT01049360|7346157|FG012|NOT COMPLETED|Period 2||0
6431917|NCT01049360|7346158|FG013|NOT COMPLETED|Period 2||0
6431918|NCT01049360|7346159|FG014|NOT COMPLETED|Period 2||2
6431919|NCT01049360|7346160|FG015|NOT COMPLETED|Period 2||1
6431920|NCT01049360|7346161|FG016|NOT COMPLETED|Period 2||0
6431921|NCT01049360|7346162|FG017|NOT COMPLETED|Period 2||0
6431922|NCT01049360|7346163|FG018|NOT COMPLETED|Period 2||0
6431923|NCT01049360|7346164|FG019|NOT COMPLETED|Period 2||2
6431924|NCT01049360|7346145|FG000|STARTED|Period 3||6
6431925|NCT01049360|7346146|FG001|STARTED|Period 3||4
6431926|NCT01049360|7346147|FG002|STARTED|Period 3||7
6431927|NCT01049360|7346148|FG003|STARTED|Period 3||4
6431928|NCT01049360|7346149|FG004|STARTED|Period 3||7
6431929|NCT01049360|7346150|FG005|STARTED|Period 3||5
6431930|NCT01049360|7346151|FG006|STARTED|Period 3||6
6431931|NCT01049360|7346152|FG007|STARTED|Period 3||4
6431932|NCT01049360|7346153|FG008|STARTED|Period 3||4
6431933|NCT01049360|7346154|FG009|STARTED|Period 3||6
6431934|NCT01049360|7346155|FG010|STARTED|Period 3||5
6431935|NCT01049360|7346156|FG011|STARTED|Period 3||6
6431936|NCT01049360|7346157|FG012|STARTED|Period 3||4
6431937|NCT01049360|7346158|FG013|STARTED|Period 3||6
6431938|NCT01049360|7346159|FG014|STARTED|Period 3||5
6431939|NCT01049360|7346160|FG015|STARTED|Period 3||6
6431940|NCT01049360|7346161|FG016|STARTED|Period 3||5
6552271|NCT01736696|7474760|FG001|COMPLETED|Overall Study||5
6552272|NCT01736696|7474761|FG002|COMPLETED|Overall Study||9
6552273|NCT01736696|7474762|FG003|COMPLETED|Overall Study||9
6552274|NCT01736696|7474763|FG004|COMPLETED|Overall Study||9
6552275|NCT01736696|7474764|FG005|COMPLETED|Overall Study||8
6431941|NCT01049360|7346162|FG017|STARTED|Period 3||6
6431942|NCT01049360|7346163|FG018|STARTED|Period 3||5
6431943|NCT01049360|7346164|FG019|STARTED|Period 3||5
6431944|NCT01049360|7346145|FG000|COMPLETED|Period 3||6
6431945|NCT01049360|7346146|FG001|COMPLETED|Period 3||4
6431946|NCT01049360|7346147|FG002|COMPLETED|Period 3||7
6431947|NCT01049360|7346148|FG003|COMPLETED|Period 3||4
6431948|NCT01049360|7346149|FG004|COMPLETED|Period 3||7
6431949|NCT01049360|7346150|FG005|COMPLETED|Period 3||5
6431950|NCT01049360|7346151|FG006|COMPLETED|Period 3||6
6431951|NCT01049360|7346152|FG007|COMPLETED|Period 3||4
6431952|NCT01049360|7346153|FG008|COMPLETED|Period 3||4
6431953|NCT01049360|7346154|FG009|COMPLETED|Period 3||6
6431954|NCT01049360|7346155|FG010|COMPLETED|Period 3||5
6431955|NCT01049360|7346156|FG011|COMPLETED|Period 3||6
6431956|NCT01049360|7346157|FG012|COMPLETED|Period 3||4
6431957|NCT01049360|7346158|FG013|COMPLETED|Period 3||6
6431958|NCT01049360|7346159|FG014|COMPLETED|Period 3||5
6431959|NCT01049360|7346160|FG015|COMPLETED|Period 3||6
6431960|NCT01049360|7346161|FG016|COMPLETED|Period 3||5
6431961|NCT01049360|7346162|FG017|COMPLETED|Period 3||6
6431962|NCT01049360|7346163|FG018|COMPLETED|Period 3||5
6431963|NCT01049360|7346164|FG019|COMPLETED|Period 3||5
6431964|NCT01049360|7346145|FG000|NOT COMPLETED|Period 3||0
6431965|NCT01049360|7346146|FG001|NOT COMPLETED|Period 3||0
6431966|NCT01049360|7346147|FG002|NOT COMPLETED|Period 3||0
6431967|NCT01049360|7346148|FG003|NOT COMPLETED|Period 3||0
6431968|NCT01049360|7346149|FG004|NOT COMPLETED|Period 3||0
6431969|NCT01049360|7346150|FG005|NOT COMPLETED|Period 3||0
6431970|NCT01049360|7346151|FG006|NOT COMPLETED|Period 3||0
6431971|NCT01049360|7346152|FG007|NOT COMPLETED|Period 3||0
6431972|NCT01049360|7346153|FG008|NOT COMPLETED|Period 3||0
6431973|NCT01049360|7346154|FG009|NOT COMPLETED|Period 3||0
6431974|NCT01049360|7346155|FG010|NOT COMPLETED|Period 3||0
6431975|NCT01049360|7346156|FG011|NOT COMPLETED|Period 3||0
6431976|NCT01049360|7346157|FG012|NOT COMPLETED|Period 3||0
6431977|NCT01049360|7346158|FG013|NOT COMPLETED|Period 3||0
6431978|NCT01049360|7346159|FG014|NOT COMPLETED|Period 3||0
6431979|NCT01049360|7346160|FG015|NOT COMPLETED|Period 3||0
6431980|NCT01049360|7346161|FG016|NOT COMPLETED|Period 3||0
6431981|NCT01049360|7346162|FG017|NOT COMPLETED|Period 3||0
6431982|NCT01049360|7346163|FG018|NOT COMPLETED|Period 3||0
6431983|NCT01049360|7346164|FG019|NOT COMPLETED|Period 3||0
6431984|NCT01049360|7346145|FG000|STARTED|Period 4||6
6431985|NCT01049360|7346146|FG001|STARTED|Period 4||4
6431986|NCT01049360|7346147|FG002|STARTED|Period 4||7
6431987|NCT01049360|7346148|FG003|STARTED|Period 4||4
6431988|NCT01049360|7346149|FG004|STARTED|Period 4||7
6431989|NCT01049360|7346150|FG005|STARTED|Period 4||5
6431990|NCT01049360|7346151|FG006|STARTED|Period 4||6
6431991|NCT01049360|7346152|FG007|STARTED|Period 4||4
6431992|NCT01049360|7346153|FG008|STARTED|Period 4||4
6431993|NCT01049360|7346154|FG009|STARTED|Period 4||6
6431994|NCT01049360|7346155|FG010|STARTED|Period 4||5
6431995|NCT01049360|7346156|FG011|STARTED|Period 4||6
6431996|NCT01049360|7346157|FG012|STARTED|Period 4||4
6431997|NCT01049360|7346158|FG013|STARTED|Period 4||6
6431998|NCT01049360|7346159|FG014|STARTED|Period 4||5
6431999|NCT01049360|7346160|FG015|STARTED|Period 4||6
6432000|NCT01049360|7346161|FG016|STARTED|Period 4||5
6432001|NCT01049360|7346162|FG017|STARTED|Period 4||6
6432002|NCT01049360|7346163|FG018|STARTED|Period 4||5
6432003|NCT01049360|7346164|FG019|STARTED|Period 4||5
6432004|NCT01049360|7346145|FG000|COMPLETED|Period 4||6
6432005|NCT01049360|7346146|FG001|COMPLETED|Period 4||4
6552276|NCT01736696|7474765|FG006|COMPLETED|Overall Study||13
6432006|NCT01049360|7346147|FG002|COMPLETED|Period 4||7
6432007|NCT01049360|7346148|FG003|COMPLETED|Period 4||3
6432008|NCT01049360|7346149|FG004|COMPLETED|Period 4||7
6432009|NCT01049360|7346150|FG005|COMPLETED|Period 4||5
6432010|NCT01049360|7346151|FG006|COMPLETED|Period 4||6
6432011|NCT01049360|7346152|FG007|COMPLETED|Period 4||4
6432012|NCT01049360|7346153|FG008|COMPLETED|Period 4||4
6432013|NCT01049360|7346154|FG009|COMPLETED|Period 4||6
6432014|NCT01049360|7346155|FG010|COMPLETED|Period 4||5
6432015|NCT01049360|7346156|FG011|COMPLETED|Period 4||6
6432016|NCT01049360|7346157|FG012|COMPLETED|Period 4||4
6432017|NCT01049360|7346158|FG013|COMPLETED|Period 4||6
6432018|NCT01049360|7346159|FG014|COMPLETED|Period 4||5
6432019|NCT01049360|7346160|FG015|COMPLETED|Period 4||6
6432020|NCT01049360|7346161|FG016|COMPLETED|Period 4||5
6432021|NCT01049360|7346162|FG017|COMPLETED|Period 4||5
6432022|NCT01049360|7346163|FG018|COMPLETED|Period 4||5
6432023|NCT01049360|7346164|FG019|COMPLETED|Period 4||5
6432024|NCT01049360|7346145|FG000|NOT COMPLETED|Period 4||0
6432025|NCT01049360|7346146|FG001|NOT COMPLETED|Period 4||0
6432026|NCT01049360|7346147|FG002|NOT COMPLETED|Period 4||0
6432027|NCT01049360|7346148|FG003|NOT COMPLETED|Period 4||1
6432028|NCT01049360|7346149|FG004|NOT COMPLETED|Period 4||0
6432029|NCT01049360|7346150|FG005|NOT COMPLETED|Period 4||0
6432030|NCT01049360|7346151|FG006|NOT COMPLETED|Period 4||0
6432031|NCT01049360|7346152|FG007|NOT COMPLETED|Period 4||0
6432032|NCT01049360|7346153|FG008|NOT COMPLETED|Period 4||0
6432033|NCT01049360|7346154|FG009|NOT COMPLETED|Period 4||0
6432034|NCT01049360|7346155|FG010|NOT COMPLETED|Period 4||0
6432035|NCT01049360|7346156|FG011|NOT COMPLETED|Period 4||0
6432036|NCT01049360|7346157|FG012|NOT COMPLETED|Period 4||0
6432037|NCT01049360|7346158|FG013|NOT COMPLETED|Period 4||0
6432038|NCT01049360|7346159|FG014|NOT COMPLETED|Period 4||0
6432039|NCT01049360|7346160|FG015|NOT COMPLETED|Period 4||0
6432040|NCT01049360|7346161|FG016|NOT COMPLETED|Period 4||0
6432041|NCT01049360|7346162|FG017|NOT COMPLETED|Period 4||1
6432042|NCT01049360|7346163|FG018|NOT COMPLETED|Period 4||0
6432043|NCT01049360|7346164|FG019|NOT COMPLETED|Period 4||0
6432044|NCT01049373|7346178|FG000|STARTED|Overall Study||112
6432045|NCT01049373|7346179|FG001|STARTED|Overall Study||109
6432046|NCT01049373|7346178|FG000|COMPLETED|Overall Study||73
6432047|NCT01049373|7346179|FG001|COMPLETED|Overall Study||65
6432048|NCT01049373|7346178|FG000|NOT COMPLETED|Overall Study||39
6432049|NCT01049373|7346179|FG001|NOT COMPLETED|Overall Study||44
6432050|NCT01049412|7346189|FG000|STARTED|Period I||70
6432051|NCT01049412|7346190|FG001|STARTED|Period I||68
6432052|NCT01049412|7346189|FG000|Took at Least One Dose of Study Drug|Period I||69
6432053|NCT01049412|7346190|FG001|Took at Least One Dose of Study Drug|Period I||68
6432054|NCT01049412|7346189|FG000|COMPLETED|Period I||62
6432055|NCT01049412|7346190|FG001|COMPLETED|Period I||55
6432056|NCT01049412|7346189|FG000|NOT COMPLETED|Period I||8
6432057|NCT01049412|7346190|FG001|NOT COMPLETED|Period I||13
6432058|NCT01049412|7346189|FG000|STARTED|Period II||62
6652436|NCT02429427|7582050|FG000|STARTED|Overall Study||1763
6652437|NCT02429427|7582051|FG001|STARTED|Overall Study||876
6432059|NCT01049412|7346190|FG001|STARTED|Period II||55
6432060|NCT01049412|7346189|FG000|COMPLETED|Period II||58
6432061|NCT01049412|7346190|FG001|COMPLETED|Period II||52
6432062|NCT01049412|7346189|FG000|NOT COMPLETED|Period II||4
6432063|NCT01049412|7346190|FG001|NOT COMPLETED|Period II||3
6432064|NCT01049503|7346204|FG000|STARTED|Overall Study||52
6432065|NCT01049503|7346205|FG001|STARTED|Overall Study||48
6432066|NCT01049503|7346206|FG002|STARTED|Overall Study||56
6432067|NCT01049503|7346207|FG003|STARTED|Overall Study||55
6432068|NCT01049503|7346208|FG004|STARTED|Overall Study||56
6432069|NCT01049503|7346209|FG005|STARTED|Overall Study||48
6432070|NCT01049503|7346204|FG000|COMPLETED|Overall Study||41
6432071|NCT01049503|7346205|FG001|COMPLETED|Overall Study||36
6432072|NCT01049503|7346206|FG002|COMPLETED|Overall Study||32
6432073|NCT01049503|7346207|FG003|COMPLETED|Overall Study||29
6432074|NCT01049503|7346208|FG004|COMPLETED|Overall Study||29
6432075|NCT01049503|7346209|FG005|COMPLETED|Overall Study||40
6432076|NCT01049503|7346204|FG000|NOT COMPLETED|Overall Study||11
6432077|NCT01049503|7346205|FG001|NOT COMPLETED|Overall Study||12
6432078|NCT01049503|7346206|FG002|NOT COMPLETED|Overall Study||24
6432079|NCT01049503|7346207|FG003|NOT COMPLETED|Overall Study||26
6432080|NCT01049503|7346208|FG004|NOT COMPLETED|Overall Study||27
6552277|NCT01736696|7474759|FG000|NOT COMPLETED|Overall Study||0
6552278|NCT01736696|7474760|FG001|NOT COMPLETED|Overall Study||0
6552279|NCT01736696|7474761|FG002|NOT COMPLETED|Overall Study||1
6432081|NCT01049503|7346209|FG005|NOT COMPLETED|Overall Study||8
6432082|NCT01049581|7346234|FG000|STARTED|Overall Study||13
6652438|NCT02429427|7582050|FG000|COMPLETED|Overall Study||1392
6432083|NCT01049581|7346235|FG001|STARTED|Overall Study||14
6432084|NCT01049581|7346234|FG000|COMPLETED|Overall Study||11
6432085|NCT01049581|7346235|FG001|COMPLETED|Overall Study||13
6432086|NCT01049581|7346234|FG000|NOT COMPLETED|Overall Study||2
6432087|NCT01049581|7346235|FG001|NOT COMPLETED|Overall Study||1
6432088|NCT01049776|7346244|FG000|STARTED|Overall Study||32
6432089|NCT01049776|7346244|FG000|COMPLETED|Overall Study||12
6432090|NCT01049776|7346244|FG000|NOT COMPLETED|Overall Study||20
6432091|NCT01049802|7346250|FG000|STARTED|Overall Study||20
6432092|NCT01049802|7346251|FG001|STARTED|Overall Study||10
6432093|NCT01049802|7346250|FG000|COMPLETED|Overall Study||20
6432094|NCT01049802|7346251|FG001|COMPLETED|Overall Study||10
6432095|NCT01049802|7346250|FG000|NOT COMPLETED|Overall Study||0
6432096|NCT01049802|7346251|FG001|NOT COMPLETED|Overall Study||0
6432097|NCT01049919|7346259|FG000|STARTED|Overall Study||117
6432098|NCT01049919|7346260|FG001|STARTED|Overall Study|One participant is counted in both treatment groups due to one leg being randomized to each group.|36
6432099|NCT01049919|7346259|FG000|COMPLETED|Overall Study||65
6432100|NCT01049919|7346260|FG001|COMPLETED|Overall Study|Incl. 11 participants that received crossover treatment after completing 52 week primary follow up.|19
6432101|NCT01049919|7346259|FG000|NOT COMPLETED|Overall Study||52
6432102|NCT01049919|7346260|FG001|NOT COMPLETED|Overall Study||17
6432103|NCT01049945|7346268|FG000|STARTED|Overall Study||3
6432104|NCT01049945|7346269|FG001|STARTED|Overall Study||6
6432105|NCT01049945|7346270|FG002|STARTED|Overall Study||3
6432106|NCT01049945|7346271|FG003|STARTED|Overall Study||6
6552280|NCT01736696|7474762|FG003|NOT COMPLETED|Overall Study||0
6552281|NCT01736696|7474763|FG004|NOT COMPLETED|Overall Study||0
6552282|NCT01736696|7474764|FG005|NOT COMPLETED|Overall Study||0
6552283|NCT01736696|7474765|FG006|NOT COMPLETED|Overall Study||0
6552284|NCT01736852|7474791|FG000|STARTED|Overall Study||65
6552285|NCT01736852|7474792|FG001|STARTED|Overall Study||64
6552286|NCT01736852|7474791|FG000|COMPLETED|Overall Study||63
6432107|NCT01049945|7346272|FG004|STARTED|Overall Study||3
6432108|NCT01049945|7346273|FG005|STARTED|Overall Study||49
6432109|NCT01049945|7346268|FG000|COMPLETED|Overall Study||3
6432110|NCT01049945|7346269|FG001|COMPLETED|Overall Study||6
6432111|NCT01049945|7346270|FG002|COMPLETED|Overall Study||3
6432112|NCT01049945|7346271|FG003|COMPLETED|Overall Study||6
6432113|NCT01049945|7346272|FG004|COMPLETED|Overall Study||3
6432114|NCT01049945|7346273|FG005|COMPLETED|Overall Study||49
6432115|NCT01049945|7346268|FG000|NOT COMPLETED|Overall Study||0
6432116|NCT01049945|7346269|FG001|NOT COMPLETED|Overall Study||0
6432117|NCT01049945|7346270|FG002|NOT COMPLETED|Overall Study||0
6432118|NCT01049945|7346271|FG003|NOT COMPLETED|Overall Study||0
6432119|NCT01049945|7346272|FG004|NOT COMPLETED|Overall Study||0
6432120|NCT01049945|7346273|FG005|NOT COMPLETED|Overall Study||0
6432121|NCT01049984|7346289|FG000|STARTED|Overall Study||163
6432122|NCT01049984|7346290|FG001|STARTED|Overall Study||165
6432123|NCT01049984|7346289|FG000|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
6432124|NCT01049984|7346290|FG001|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
6432125|NCT01049984|7346289|FG000|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
6432126|NCT01049984|7346290|FG001|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
6432127|NCT01049984|7346289|FG000|COMPLETED|Overall Study||144
6432128|NCT01049984|7346290|FG001|COMPLETED|Overall Study||146
6432129|NCT01049984|7346289|FG000|NOT COMPLETED|Overall Study||19
6432130|NCT01049984|7346290|FG001|NOT COMPLETED|Overall Study||19
6432131|NCT01050062|7346298|FG000|STARTED|Overall Study||1070
6432132|NCT01050062|7346299|FG001|STARTED|Overall Study||355
6432133|NCT01050062|7346298|FG000|COMPLETED|Overall Study||799
6432134|NCT01050062|7346299|FG001|COMPLETED|Overall Study||243
6432135|NCT01050062|7346298|FG000|NOT COMPLETED|Overall Study||271
6432136|NCT01050062|7346299|FG001|NOT COMPLETED|Overall Study||112
6432137|NCT01050153|7346309|FG000|STARTED|Overall Study||25
6432138|NCT01050153|7346310|FG001|STARTED|Overall Study||25
6432139|NCT01050153|7346309|FG000|COMPLETED|Overall Study||25
6432140|NCT01050153|7346310|FG001|COMPLETED|Overall Study||25
6432141|NCT01050153|7346309|FG000|NOT COMPLETED|Overall Study||0
6432142|NCT01050153|7346310|FG001|NOT COMPLETED|Overall Study||0
6432143|NCT01050205|7346318|FG000|STARTED|Overall Study||148
6432144|NCT01050205|7346319|FG001|STARTED|Overall Study||75
6432145|NCT01050205|7346318|FG000|COMPLETED|Overall Study||137
6432146|NCT01050205|7346319|FG001|COMPLETED|Overall Study||71
6432147|NCT01050205|7346318|FG000|NOT COMPLETED|Overall Study||11
6432148|NCT01050205|7346319|FG001|NOT COMPLETED|Overall Study||4
6432149|NCT01050231|7346327|FG000|STARTED|Overall Study||10
6432150|NCT01050231|7346328|FG001|STARTED|Overall Study||10
6432151|NCT01050231|7346327|FG000|COMPLETED|Overall Study||10
6432152|NCT01050231|7346328|FG001|COMPLETED|Overall Study||10
6432153|NCT01050231|7346327|FG000|NOT COMPLETED|Overall Study||0
6432154|NCT01050231|7346328|FG001|NOT COMPLETED|Overall Study||0
6432155|NCT01050257|7346337|FG000|STARTED|Overall Study||50
6432156|NCT01050257|7346338|FG001|STARTED|Overall Study||53
6432157|NCT01050257|7346339|FG002|STARTED|Overall Study||15
6552287|NCT01736852|7474792|FG001|COMPLETED|Overall Study||61
6552288|NCT01736852|7474791|FG000|NOT COMPLETED|Overall Study||2
6432158|NCT01050257|7346337|FG000|Received Treatment|Overall Study||49
6432159|NCT01050257|7346338|FG001|Received Treatment|Overall Study||50
6432160|NCT01050257|7346339|FG002|Received Treatment|Overall Study||14
6432161|NCT01050257|7346337|FG000|Safety Population: Actual Dose Received|Overall Study||48
6432162|NCT01050257|7346338|FG001|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
6432163|NCT01050257|7346339|FG002|Safety Population: Actual Dose Received|Overall Study||14
6432164|NCT01050257|7346337|FG000|Intent-to-treat Infected Confirmed|Overall Study||30
6432165|NCT01050257|7346338|FG001|Intent-to-treat Infected Confirmed|Overall Study||32
6432166|NCT01050257|7346339|FG002|Intent-to-treat Infected Confirmed|Overall Study||10
6432167|NCT01050257|7346337|FG000|Switched to Oral Treatment|Overall Study||28
6552289|NCT01736852|7474792|FG001|NOT COMPLETED|Overall Study||3
6432168|NCT01050257|7346338|FG001|Switched to Oral Treatment|Overall Study||31
6432169|NCT01050257|7346339|FG002|Switched to Oral Treatment|Overall Study||3
6432170|NCT01050257|7346337|FG000|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
6432171|NCT01050257|7346338|FG001|COMPLETED|Overall Study||40
6432172|NCT01050257|7346339|FG002|COMPLETED|Overall Study||8
6432173|NCT01050257|7346337|FG000|NOT COMPLETED|Overall Study||11
6432174|NCT01050257|7346338|FG001|NOT COMPLETED|Overall Study||13
6432175|NCT01050257|7346339|FG002|NOT COMPLETED|Overall Study||7
6432176|NCT01050530|7346349|FG000|STARTED|Overall Study||82
6432177|NCT01050530|7346350|FG001|STARTED|Overall Study||80
6432178|NCT01050530|7346349|FG000|COMPLETED|Overall Study||74
6432179|NCT01050530|7346350|FG001|COMPLETED|Overall Study||70
6432180|NCT01050530|7346349|FG000|NOT COMPLETED|Overall Study||8
6432181|NCT01050530|7346350|FG001|NOT COMPLETED|Overall Study||10
6432182|NCT01050543|7346358|FG000|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
6432183|NCT01050543|7346359|FG001|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
6432184|NCT01050543|7346358|FG000|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
6432185|NCT01050543|7346359|FG001|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
6432186|NCT01050543|7346358|FG000|NOT COMPLETED|Overall Study||4
6432187|NCT01050543|7346359|FG001|NOT COMPLETED|Overall Study||4
6432188|NCT01050569|7346368|FG000|STARTED|Overall Study||79
6432189|NCT01050569|7346369|FG001|STARTED|Overall Study||76
6432190|NCT01050569|7346370|FG002|STARTED|Overall Study||80
6432191|NCT01050569|7346368|FG000|COMPLETED|Overall Study||41
6432192|NCT01050569|7346369|FG001|COMPLETED|Overall Study||52
6432193|NCT01050569|7346370|FG002|COMPLETED|Overall Study||47
6432194|NCT01050569|7346368|FG000|NOT COMPLETED|Overall Study||38
6432195|NCT01050569|7346369|FG001|NOT COMPLETED|Overall Study||24
6432196|NCT01050569|7346370|FG002|NOT COMPLETED|Overall Study||33
6432197|NCT01050582|7346384|FG000|STARTED|Overall Study||133
6432198|NCT01050582|7346385|FG001|STARTED|Overall Study||51
6432199|NCT01050582|7346384|FG000|COMPLETED|Overall Study||133
6432200|NCT01050582|7346385|FG001|COMPLETED|Overall Study||51
6432201|NCT01050582|7346384|FG000|NOT COMPLETED|Overall Study||0
6432202|NCT01050582|7346385|FG001|NOT COMPLETED|Overall Study||0
6432203|NCT01050634|7346391|FG000|STARTED|Overall Study||980
6432204|NCT01050634|7346391|FG000|Received Treatment|Overall Study||924
6432205|NCT01050634|7346391|FG000|COMPLETED|Overall Study||852
6432206|NCT01050634|7346391|FG000|NOT COMPLETED|Overall Study||128
6432207|NCT01050647|7346397|FG000|STARTED|Overall Study||10
6432208|NCT01050647|7346398|FG001|STARTED|Overall Study||11
6432209|NCT01050647|7346397|FG000|COMPLETED|Overall Study||10
6432210|NCT01050647|7346398|FG001|COMPLETED|Overall Study||11
6432211|NCT01050647|7346397|FG000|NOT COMPLETED|Overall Study||0
6432212|NCT01050647|7346398|FG001|NOT COMPLETED|Overall Study||0
6432213|NCT01050660|7346406|FG000|STARTED|Overall Study||67
6432214|NCT01050660|7346407|FG001|STARTED|Overall Study||69
6432215|NCT01050660|7346406|FG000|COMPLETED|Overall Study||67
6432216|NCT01050660|7346407|FG001|COMPLETED|Overall Study||69
6432217|NCT01050660|7346406|FG000|NOT COMPLETED|Overall Study||0
6432218|NCT01050660|7346407|FG001|NOT COMPLETED|Overall Study||0
6432219|NCT01050673|7346415|FG000|STARTED|Overall Study||21
6432220|NCT01050673|7346416|FG001|STARTED|Overall Study||19
6432221|NCT01050673|7346415|FG000|COMPLETED|Overall Study||17
6432222|NCT01050673|7346416|FG001|COMPLETED|Overall Study||14
6432223|NCT01050673|7346415|FG000|NOT COMPLETED|Overall Study||4
6432224|NCT01050673|7346416|FG001|NOT COMPLETED|Overall Study||5
6432225|NCT01050764|7346422|FG000|STARTED|Overall Study||10
6432226|NCT01050764|7346422|FG000|Received HSCT Graft|Overall Study||8
6432227|NCT01050764|7346422|FG000|Received Infusion of T-reg Cells|Overall Study||7
6432228|NCT01050764|7346422|FG000|Received Infusion of T-con Cells|Overall Study||7
6432229|NCT01050764|7346422|FG000|COMPLETED|Overall Study||7
6432230|NCT01050764|7346422|FG000|NOT COMPLETED|Overall Study||3
6432231|NCT01050790|7346426|FG000|STARTED|Overall Study||17
6432232|NCT01050790|7346426|FG000|COMPLETED|Overall Study||16
6432233|NCT01050790|7346426|FG000|NOT COMPLETED|Overall Study||1
6432234|NCT01050816|7346431|FG000|STARTED|Overall Study||30
6432235|NCT01050816|7346431|FG000|COMPLETED|Overall Study||26
6432236|NCT01050816|7346431|FG000|NOT COMPLETED|Overall Study||4
6432237|NCT01050907|7346435|FG000|STARTED|Overall Study||4
6432238|NCT01050907|7346435|FG000|COMPLETED|Overall Study||4
6432239|NCT01050907|7346435|FG000|NOT COMPLETED|Overall Study||0
6432240|NCT01050946|7346439|FG000|STARTED|Overall Study||1
6432241|NCT01050946|7346439|FG000|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
6432242|NCT01050946|7346439|FG000|NOT COMPLETED|Overall Study||0
6432243|NCT01050998|7346449|FG000|STARTED|Overall Study||48
6432244|NCT01050998|7346450|FG001|STARTED|Overall Study||49
6432245|NCT01050998|7346451|FG002|STARTED|Overall Study||49
6432246|NCT01050998|7346452|FG003|STARTED|Overall Study||48
6432247|NCT01050998|7346453|FG004|STARTED|Overall Study||96
6432248|NCT01050998|7346449|FG000|COMPLETED|Overall Study||44
6432249|NCT01050998|7346450|FG001|COMPLETED|Overall Study||47
6432250|NCT01050998|7346451|FG002|COMPLETED|Overall Study||46
6432251|NCT01050998|7346452|FG003|COMPLETED|Overall Study||45
6432252|NCT01050998|7346453|FG004|COMPLETED|Overall Study||82
6432253|NCT01050998|7346449|FG000|NOT COMPLETED|Overall Study||4
6432254|NCT01050998|7346450|FG001|NOT COMPLETED|Overall Study||2
6432255|NCT01050998|7346451|FG002|NOT COMPLETED|Overall Study||3
6432256|NCT01050998|7346452|FG003|NOT COMPLETED|Overall Study||3
6432257|NCT01050998|7346453|FG004|NOT COMPLETED|Overall Study||14
6432258|NCT01051063|7346471|FG000|STARTED|Overall Study||12
6432259|NCT01051063|7346472|FG001|STARTED|Overall Study||5
6432260|NCT01051063|7346471|FG000|COMPLETED|Overall Study||2
6432261|NCT01051063|7346472|FG001|COMPLETED|Overall Study||1
6432262|NCT01051063|7346471|FG000|NOT COMPLETED|Overall Study||10
6432263|NCT01051063|7346472|FG001|NOT COMPLETED|Overall Study||4
6432264|NCT01051310|7346479|FG000|STARTED|Overall Study||18
6432265|NCT01051310|7346479|FG000|COMPLETED|Overall Study||13
6432266|NCT01051310|7346479|FG000|NOT COMPLETED|Overall Study||5
6432267|NCT01051323|7346485|FG000|STARTED|Overall Study||1580
6432268|NCT01051323|7346485|FG000|Received at Least One Dose|Overall Study||1547
6432269|NCT01051323|7346485|FG000|COMPLETED|Overall Study||1041
6432270|NCT01051323|7346485|FG000|NOT COMPLETED|Overall Study||539
6432271|NCT01051349|7346493|FG000|STARTED|Overall Study||410
6432272|NCT01051349|7346493|FG000|COMPLETED|Overall Study||237
6432273|NCT01051349|7346493|FG000|NOT COMPLETED|Overall Study||173
6432274|NCT01051440|7346502|FG000|STARTED|Overall Study||1
6432275|NCT01051440|7346503|FG001|STARTED|Overall Study||1
6432276|NCT01051440|7346502|FG000|COMPLETED|Overall Study||1
6432277|NCT01051440|7346503|FG001|COMPLETED|Overall Study||1
6432278|NCT01051440|7346502|FG000|NOT COMPLETED|Overall Study||0
6432279|NCT01051440|7346503|FG001|NOT COMPLETED|Overall Study||0
6432280|NCT01051466|7346511|FG000|STARTED|Overall Study||32
6432281|NCT01051466|7346512|FG001|STARTED|Overall Study||28
6432282|NCT01051466|7346511|FG000|COMPLETED|Overall Study||24
6432283|NCT01051466|7346512|FG001|COMPLETED|Overall Study||23
6432284|NCT01051466|7346511|FG000|NOT COMPLETED|Overall Study||8
6432285|NCT01051466|7346512|FG001|NOT COMPLETED|Overall Study||5
6432286|NCT01051518|7346522|FG000|STARTED|Overall Study||126
6432287|NCT01051518|7346522|FG000|COMPLETED|Overall Study||53
6432288|NCT01051518|7346522|FG000|NOT COMPLETED|Overall Study||73
6432289|NCT01051557|7346538|FG000|STARTED|Overall Study||4
6432290|NCT01051557|7346539|FG001|STARTED|Overall Study||3
6432291|NCT01051557|7346540|FG002|STARTED|Overall Study||6
6432292|NCT01051557|7346541|FG003|STARTED|Overall Study||3
6432293|NCT01051557|7346542|FG004|STARTED|Overall Study||8
6432294|NCT01051557|7346543|FG005|STARTED|Overall Study||6
6432295|NCT01051557|7346544|FG006|STARTED|Overall Study||6
6432296|NCT01051557|7346538|FG000|COMPLETED|Overall Study||0
6432297|NCT01051557|7346539|FG001|COMPLETED|Overall Study||0
6432298|NCT01051557|7346540|FG002|COMPLETED|Overall Study||0
6432299|NCT01051557|7346541|FG003|COMPLETED|Overall Study||0
6432300|NCT01051557|7346542|FG004|COMPLETED|Overall Study||1
6432301|NCT01051557|7346543|FG005|COMPLETED|Overall Study||0
6432302|NCT01051557|7346544|FG006|COMPLETED|Overall Study||0
6432303|NCT01051557|7346538|FG000|NOT COMPLETED|Overall Study||4
6432304|NCT01051557|7346539|FG001|NOT COMPLETED|Overall Study||3
6432305|NCT01051557|7346540|FG002|NOT COMPLETED|Overall Study||6
6432306|NCT01051557|7346541|FG003|NOT COMPLETED|Overall Study||3
6432307|NCT01051557|7346542|FG004|NOT COMPLETED|Overall Study||7
6432308|NCT01051557|7346543|FG005|NOT COMPLETED|Overall Study||6
6432309|NCT01051557|7346544|FG006|NOT COMPLETED|Overall Study||6
6432310|NCT01051570|7346561|FG000|STARTED|Overall Study||26
6432311|NCT01051570|7346561|FG000|COMPLETED|Overall Study||26
6432312|NCT01051570|7346561|FG000|NOT COMPLETED|Overall Study||0
6432313|NCT01051596|7346565|FG000|STARTED|Overall Study||75
6432314|NCT01051596|7346565|FG000|COMPLETED|Overall Study||75
6432315|NCT01051596|7346565|FG000|NOT COMPLETED|Overall Study||0
6432316|NCT01051661|7346575|FG000|STARTED|Overall Study||610
6432317|NCT01051661|7346576|FG001|STARTED|Overall Study||1438
6432318|NCT01051661|7346577|FG002|STARTED|Overall Study||612
6432319|NCT01051661|7346578|FG003|STARTED|Overall Study||1436
6432320|NCT01051661|7346579|FG004|STARTED|Overall Study||613
6552290|NCT01736865|7474800|FG000|STARTED|Overall Study||61
6552291|NCT01736865|7474801|FG001|STARTED|Overall Study||66
6552292|NCT01736865|7474800|FG000|COMPLETED|Overall Study||61
6552293|NCT01736865|7474801|FG001|COMPLETED|Overall Study||66
6552294|NCT01736865|7474800|FG000|NOT COMPLETED|Overall Study||0
6552295|NCT01736865|7474801|FG001|NOT COMPLETED|Overall Study||0
6552296|NCT01736917|7474807|FG000|STARTED|Overall Study||65
6552297|NCT01736917|7474807|FG000|COMPLETED|Overall Study||54
6552298|NCT01736917|7474807|FG000|NOT COMPLETED|Overall Study||11
6552299|NCT01736930|7474813|FG000|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
6552300|NCT01736930|7474813|FG000|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
6552301|NCT01736930|7474813|FG000|NOT COMPLETED|Overall Study||1
6552302|NCT01736943|7474819|FG000|STARTED|Overall Study||25
6552303|NCT01736943|7474819|FG000|COMPLETED|Overall Study||25
6552304|NCT01736943|7474819|FG000|NOT COMPLETED|Overall Study||0
6552305|NCT01737021|7474825|FG000|STARTED|Overall Study||22
6432321|NCT01051661|7346580|FG005|STARTED|Overall Study||1436
6432322|NCT01051661|7346575|FG000|COMPLETED|Overall Study||576
6432323|NCT01051661|7346576|FG001|COMPLETED|Overall Study||1375
6432324|NCT01051661|7346577|FG002|COMPLETED|Overall Study||573
6432325|NCT01051661|7346578|FG003|COMPLETED|Overall Study||1380
6432326|NCT01051661|7346579|FG004|COMPLETED|Overall Study||578
6432327|NCT01051661|7346580|FG005|COMPLETED|Overall Study||1369
6432328|NCT01051661|7346575|FG000|NOT COMPLETED|Overall Study||34
6432329|NCT01051661|7346576|FG001|NOT COMPLETED|Overall Study||63
6552306|NCT01737021|7474826|FG001|STARTED|Overall Study||9
6552307|NCT01737021|7474825|FG000|COMPLETED|Overall Study||17
6552308|NCT01737021|7474826|FG001|COMPLETED|Overall Study||6
6552309|NCT01737021|7474825|FG000|NOT COMPLETED|Overall Study||5
6552310|NCT01737021|7474826|FG001|NOT COMPLETED|Overall Study||3
6552311|NCT01737268|7474832|FG000|STARTED|Overall Study||20
6552312|NCT01737268|7474832|FG000|Treated|Overall Study||20
6552313|NCT01737268|7474832|FG000|COMPLETED|Overall Study||11
6552314|NCT01737268|7474832|FG000|NOT COMPLETED|Overall Study||9
6552315|NCT01737281|7474839|FG000|STARTED|Overall Study||969
6552316|NCT01737281|7474840|FG001|STARTED|Overall Study||969
6552317|NCT01737281|7474839|FG000|COMPLETED|Overall Study||603
6552318|NCT01737281|7474840|FG001|COMPLETED|Overall Study||689
6552319|NCT01737281|7474839|FG000|NOT COMPLETED|Overall Study||366
6552320|NCT01737281|7474840|FG001|NOT COMPLETED|Overall Study||280
6552321|NCT01737398|7474848|FG000|STARTED|Overall Study||113
6552322|NCT01737398|7474849|FG001|STARTED|Overall Study||60
6552323|NCT01737398|7474848|FG000|Received at Least 1 Dose of Study Drug|Overall Study||112
6552324|NCT01737398|7474849|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
6552325|NCT01737398|7474848|FG000|Safety Set|Overall Study||112
6552326|NCT01737398|7474849|FG001|Safety Set|Overall Study||60
6552327|NCT01737398|7474848|FG000|COMPLETED|Overall Study||87
6552328|NCT01737398|7474849|FG001|COMPLETED|Overall Study||52
6552329|NCT01737398|7474848|FG000|NOT COMPLETED|Overall Study||26
6552330|NCT01737398|7474849|FG001|NOT COMPLETED|Overall Study||8
6552331|NCT01737593|7474861|FG000|STARTED|Overall Study||37
6552332|NCT01737593|7474862|FG001|STARTED|Overall Study||32
6552333|NCT01737593|7474863|FG002|STARTED|Overall Study||39
6552334|NCT01737593|7474861|FG000|COMPLETED|Overall Study||37
6552335|NCT01737593|7474862|FG001|COMPLETED|Overall Study||32
6552336|NCT01737593|7474863|FG002|COMPLETED|Overall Study||39
6552337|NCT01737593|7474861|FG000|NOT COMPLETED|Overall Study||0
6552338|NCT01737593|7474862|FG001|NOT COMPLETED|Overall Study||0
6552339|NCT01737593|7474863|FG002|NOT COMPLETED|Overall Study||0
6552340|NCT01737684|7474876|FG000|STARTED|Overall Study||8
6552341|NCT01737684|7474877|FG001|STARTED|Overall Study||8
6552342|NCT01737684|7474878|FG002|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
6552343|NCT01737684|7474876|FG000|COMPLETED|Overall Study||8
6552344|NCT01737684|7474877|FG001|COMPLETED|Overall Study||8
6552345|NCT01737684|7474878|FG002|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
6552346|NCT01737684|7474876|FG000|NOT COMPLETED|Overall Study||0
6552347|NCT01737684|7474877|FG001|NOT COMPLETED|Overall Study||0
6552348|NCT01737684|7474878|FG002|NOT COMPLETED|Overall Study||0
6552349|NCT01737697|7474889|FG000|STARTED|Acute Phase-Initial 48 Hours||158
6552350|NCT01737697|7474890|FG001|STARTED|Acute Phase-Initial 48 Hours||154
6552351|NCT01737697|7474891|FG002|STARTED|Acute Phase-Initial 48 Hours||141
6552352|NCT01737697|7474892|FG003|STARTED|Acute Phase-Initial 48 Hours||158
6552353|NCT01737697|7474893|FG004|STARTED|Acute Phase-Initial 48 Hours||143
6552354|NCT01737697|7474894|FG005|STARTED|Acute Phase-Initial 48 Hours||0
6552355|NCT01737697|7474895|FG006|STARTED|Acute Phase-Initial 48 Hours||0
6432330|NCT01051661|7346577|FG002|NOT COMPLETED|Overall Study||39
6432331|NCT01051661|7346578|FG003|NOT COMPLETED|Overall Study||56
6432332|NCT01051661|7346579|FG004|NOT COMPLETED|Overall Study||35
6432333|NCT01051661|7346580|FG005|NOT COMPLETED|Overall Study||67
6432334|NCT01051739|7346617|FG000|STARTED|Overall Study||120
6432335|NCT01051739|7346618|FG001|STARTED|Overall Study||60
6432336|NCT01051739|7346617|FG000|COMPLETED|Overall Study||92
6432337|NCT01051739|7346618|FG001|COMPLETED|Overall Study||47
6432338|NCT01051739|7346617|FG000|NOT COMPLETED|Overall Study||28
6432339|NCT01051739|7346618|FG001|NOT COMPLETED|Overall Study||13
6432340|NCT01051778|7346626|FG000|STARTED|Overall Study|June 2006|30
6432341|NCT01051778|7346627|FG001|STARTED|Overall Study|June 2006|30
6432342|NCT01051778|7346626|FG000|COMPLETED|Overall Study|November 2009|30
6432343|NCT01051778|7346627|FG001|COMPLETED|Overall Study|November 2009|30
6432344|NCT01051778|7346626|FG000|NOT COMPLETED|Overall Study||0
6432345|NCT01051778|7346627|FG001|NOT COMPLETED|Overall Study||0
6432346|NCT01051791|7346633|FG000|STARTED|Overall Study||13
6552356|NCT01737697|7474896|FG007|STARTED|Acute Phase-Initial 48 Hours||0
6552357|NCT01737697|7474897|FG008|STARTED|Acute Phase-Initial 48 Hours||0
6552358|NCT01737697|7474898|FG009|STARTED|Acute Phase-Initial 48 Hours||0
6552359|NCT01737697|7474899|FG010|STARTED|Acute Phase-Initial 48 Hours||0
6552360|NCT01737697|7474900|FG011|STARTED|Acute Phase-Initial 48 Hours||0
6552361|NCT01737697|7474901|FG012|STARTED|Acute Phase-Initial 48 Hours||0
6432347|NCT01051791|7346633|FG000|COMPLETED|Overall Study||9
6432348|NCT01051791|7346633|FG000|NOT COMPLETED|Overall Study||4
6432349|NCT01051817|7346640|FG000|STARTED|Overall Study||38
6552362|NCT01737697|7474902|FG013|STARTED|Acute Phase-Initial 48 Hours||0
6552363|NCT01737697|7474903|FG014|STARTED|Acute Phase-Initial 48 Hours||0
6552364|NCT01737697|7474889|FG000|COMPLETED|Acute Phase-Initial 48 Hours||157
6552365|NCT01737697|7474890|FG001|COMPLETED|Acute Phase-Initial 48 Hours||150
6552366|NCT01737697|7474891|FG002|COMPLETED|Acute Phase-Initial 48 Hours||137
6552367|NCT01737697|7474892|FG003|COMPLETED|Acute Phase-Initial 48 Hours||152
6552368|NCT01737697|7474893|FG004|COMPLETED|Acute Phase-Initial 48 Hours||140
6552369|NCT01737697|7474894|FG005|COMPLETED|Acute Phase-Initial 48 Hours||0
6432350|NCT01051817|7346641|FG001|STARTED|Overall Study||35
6432351|NCT01051817|7346640|FG000|COMPLETED|Overall Study||35
6432352|NCT01051817|7346641|FG001|COMPLETED|Overall Study||26
6432353|NCT01051817|7346640|FG000|NOT COMPLETED|Overall Study||3
6432354|NCT01051817|7346641|FG001|NOT COMPLETED|Overall Study||9
6432355|NCT01051856|7346649|FG000|STARTED|Overall Study||33
6432356|NCT01051856|7346650|FG001|STARTED|Overall Study||35
6432357|NCT01051856|7346649|FG000|COMPLETED|Overall Study||32
6432358|NCT01051856|7346650|FG001|COMPLETED|Overall Study||35
6432359|NCT01051856|7346649|FG000|NOT COMPLETED|Overall Study||1
6432360|NCT01051856|7346650|FG001|NOT COMPLETED|Overall Study||0
6432361|NCT01051960|7346656|FG000|STARTED|Overall Study||12
6432362|NCT01051960|7346656|FG000|COMPLETED|Overall Study||11
6432363|NCT01051960|7346656|FG000|NOT COMPLETED|Overall Study||1
6432364|NCT01051986|7346662|FG000|STARTED|Overall Study||112
6432365|NCT01051986|7346663|FG001|STARTED|Overall Study||112
6432366|NCT01051986|7346662|FG000|COMPLETED|Overall Study||107
6432367|NCT01051986|7346663|FG001|COMPLETED|Overall Study||108
6432368|NCT01051986|7346662|FG000|NOT COMPLETED|Overall Study||5
6432369|NCT01051986|7346663|FG001|NOT COMPLETED|Overall Study||4
6432370|NCT01052012|7346675|FG000|STARTED|Overall Study||32
6432371|NCT01052012|7346676|FG001|STARTED|Overall Study||23
6432372|NCT01052012|7346677|FG002|STARTED|Overall Study||30
6432373|NCT01052012|7346678|FG003|STARTED|Overall Study||20
6432374|NCT01052012|7346679|FG004|STARTED|Overall Study||140
6432375|NCT01052012|7346680|FG005|STARTED|Overall Study||86
6432376|NCT01052012|7346675|FG000|COMPLETED|Overall Study||28
6432377|NCT01052012|7346676|FG001|COMPLETED|Overall Study||17
6432378|NCT01052012|7346677|FG002|COMPLETED|Overall Study||30
6432379|NCT01052012|7346678|FG003|COMPLETED|Overall Study||19
6432380|NCT01052012|7346679|FG004|COMPLETED|Overall Study||124
6432381|NCT01052012|7346680|FG005|COMPLETED|Overall Study||76
6432382|NCT01052012|7346675|FG000|NOT COMPLETED|Overall Study||4
6432383|NCT01052012|7346676|FG001|NOT COMPLETED|Overall Study||6
6432384|NCT01052012|7346677|FG002|NOT COMPLETED|Overall Study||0
6432385|NCT01052012|7346678|FG003|NOT COMPLETED|Overall Study||1
6432386|NCT01052012|7346679|FG004|NOT COMPLETED|Overall Study||16
6432387|NCT01052012|7346680|FG005|NOT COMPLETED|Overall Study||10
6432388|NCT01052038|7346697|FG000|STARTED|Overall Study||40
6432389|NCT01052038|7346698|FG001|STARTED|Overall Study||40
6432390|NCT01052038|7346699|FG002|STARTED|Overall Study||40
6432391|NCT01052038|7346697|FG000|COMPLETED|Overall Study||36
6432392|NCT01052038|7346698|FG001|COMPLETED|Overall Study||34
6432393|NCT01052038|7346699|FG002|COMPLETED|Overall Study||36
6432394|NCT01052038|7346697|FG000|NOT COMPLETED|Overall Study||4
6432395|NCT01052038|7346698|FG001|NOT COMPLETED|Overall Study||6
6432396|NCT01052038|7346699|FG002|NOT COMPLETED|Overall Study||4
6432397|NCT01052077|7346709|FG000|STARTED|Phase A||769
6432398|NCT01052077|7346710|FG001|STARTED|Phase A||0
6432399|NCT01052077|7346711|FG002|STARTED|Phase A||0
6432400|NCT01052077|7346712|FG003|STARTED|Phase A||0
6432401|NCT01052077|7346709|FG000|COMPLETED|Phase A||623
6432402|NCT01052077|7346710|FG001|COMPLETED|Phase A||0
6432403|NCT01052077|7346711|FG002|COMPLETED|Phase A||0
6432404|NCT01052077|7346712|FG003|COMPLETED|Phase A||0
6432405|NCT01052077|7346709|FG000|NOT COMPLETED|Phase A||146
6432406|NCT01052077|7346710|FG001|NOT COMPLETED|Phase A||0
6432407|NCT01052077|7346711|FG002|NOT COMPLETED|Phase A||0
6652439|NCT02429427|7582051|FG001|COMPLETED|Overall Study||697
6652440|NCT02429427|7582050|FG000|NOT COMPLETED|Overall Study||371
6652441|NCT02429427|7582051|FG001|NOT COMPLETED|Overall Study||179
6652442|NCT02429778|7582059|FG000|STARTED|Overall Study||20
6652443|NCT02429778|7582060|FG001|STARTED|Overall Study||20
6652444|NCT02429778|7582059|FG000|COMPLETED|Overall Study||13
6652445|NCT02429778|7582060|FG001|COMPLETED|Overall Study||20
6652446|NCT02429778|7582059|FG000|NOT COMPLETED|Overall Study||7
6652447|NCT02429778|7582060|FG001|NOT COMPLETED|Overall Study||0
6432408|NCT01052077|7346712|FG003|NOT COMPLETED|Phase A||0
6432409|NCT01052077|7346709|FG000|STARTED|Phase B||0
6432410|NCT01052077|7346710|FG001|STARTED|Phase B||185
6432411|NCT01052077|7346711|FG002|STARTED|Phase B||187
6432412|NCT01052077|7346712|FG003|STARTED|Phase B||0
6432413|NCT01052077|7346709|FG000|COMPLETED|Phase B||0
6432414|NCT01052077|7346710|FG001|COMPLETED|Phase B||167
6432415|NCT01052077|7346711|FG002|COMPLETED|Phase B||171
6432416|NCT01052077|7346712|FG003|COMPLETED|Phase B||0
6432417|NCT01052077|7346709|FG000|NOT COMPLETED|Phase B||0
6432418|NCT01052077|7346710|FG001|NOT COMPLETED|Phase B||18
6432419|NCT01052077|7346711|FG002|NOT COMPLETED|Phase B||16
6432420|NCT01052077|7346712|FG003|NOT COMPLETED|Phase B||0
6432421|NCT01052077|7346709|FG000|STARTED|Phase A+||0
6432422|NCT01052077|7346710|FG001|STARTED|Phase A+||0
6432423|NCT01052077|7346711|FG002|STARTED|Phase A+||0
6432424|NCT01052077|7346712|FG003|STARTED|Phase A+||251
6432425|NCT01052077|7346709|FG000|COMPLETED|Phase A+||0
6432426|NCT01052077|7346710|FG001|COMPLETED|Phase A+||0
6652448|NCT02429856|7582068|FG000|STARTED|Overall Study||49
6432427|NCT01052077|7346711|FG002|COMPLETED|Phase A+||0
6432428|NCT01052077|7346712|FG003|COMPLETED|Phase A+||230
6432429|NCT01052077|7346709|FG000|NOT COMPLETED|Phase A+||0
6432430|NCT01052077|7346710|FG001|NOT COMPLETED|Phase A+||0
6432431|NCT01052077|7346711|FG002|NOT COMPLETED|Phase A+||0
6432432|NCT01052077|7346712|FG003|NOT COMPLETED|Phase A+||21
6432433|NCT01052103|7346720|FG000|STARTED|Overall Study||84
6432434|NCT01052103|7346721|FG001|STARTED|Overall Study||83
6432435|NCT01052103|7346720|FG000|Received at Least 1 Dose of Study Drug|Overall Study||82
6432436|NCT01052103|7346721|FG001|Received at Least 1 Dose of Study Drug|Overall Study||82
6432437|NCT01052103|7346720|FG000|COMPLETED|Overall Study||50
6432438|NCT01052103|7346721|FG001|COMPLETED|Overall Study||60
6432439|NCT01052103|7346720|FG000|NOT COMPLETED|Overall Study||34
6432440|NCT01052103|7346721|FG001|NOT COMPLETED|Overall Study||23
6432441|NCT01052116|7346730|FG000|STARTED|Overall Study||193
6432442|NCT01052116|7346731|FG001|STARTED|Overall Study||193
6432443|NCT01052116|7346730|FG000|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
6432444|NCT01052116|7346731|FG001|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
6432445|NCT01052116|7346730|FG000|NOT COMPLETED|Overall Study||14
6432446|NCT01052116|7346731|FG001|NOT COMPLETED|Overall Study||27
6432447|NCT01052207|7346739|FG000|STARTED|Overall Study||60
6432448|NCT01052207|7346740|FG001|STARTED|Overall Study||42
6432449|NCT01052207|7346739|FG000|COMPLETED|Overall Study||60
6432450|NCT01052207|7346740|FG001|COMPLETED|Overall Study||42
6432451|NCT01052207|7346739|FG000|NOT COMPLETED|Overall Study||0
6432452|NCT01052207|7346740|FG001|NOT COMPLETED|Overall Study||0
6432453|NCT01052272|7346750|FG000|STARTED|Overall Study||18
6432454|NCT01052272|7346751|FG001|STARTED|Overall Study||18
6432455|NCT01052272|7346752|FG002|STARTED|Overall Study||18
6432456|NCT01052272|7346753|FG003|STARTED|Overall Study||18
6432457|NCT01052272|7346750|FG000|COMPLETED|Overall Study||13
6432458|NCT01052272|7346751|FG001|COMPLETED|Overall Study||11
6432459|NCT01052272|7346752|FG002|COMPLETED|Overall Study||10
6432460|NCT01052272|7346753|FG003|COMPLETED|Overall Study||11
6432461|NCT01052272|7346750|FG000|NOT COMPLETED|Overall Study||5
6432462|NCT01052272|7346751|FG001|NOT COMPLETED|Overall Study||7
6432463|NCT01052272|7346752|FG002|NOT COMPLETED|Overall Study||8
6432464|NCT01052272|7346753|FG003|NOT COMPLETED|Overall Study||7
6432465|NCT01052428|7346765|FG000|STARTED|Overall Study||19
6432466|NCT01052428|7346766|FG001|STARTED|Overall Study||19
6432467|NCT01052428|7346765|FG000|COMPLETED|Overall Study||18
6432468|NCT01052428|7346766|FG001|COMPLETED|Overall Study||18
6432469|NCT01052428|7346765|FG000|NOT COMPLETED|Overall Study||1
6432470|NCT01052428|7346766|FG001|NOT COMPLETED|Overall Study||1
6432471|NCT01052480|7346774|FG000|STARTED|Overall Study||49
6432472|NCT01052480|7346775|FG001|STARTED|Overall Study||49
6432473|NCT01052480|7346774|FG000|COMPLETED|Overall Study||41
6432474|NCT01052480|7346775|FG001|COMPLETED|Overall Study||32
6432475|NCT01052480|7346774|FG000|NOT COMPLETED|Overall Study||8
6432476|NCT01052480|7346775|FG001|NOT COMPLETED|Overall Study||17
6432477|NCT01052493|7346781|FG000|STARTED|Intervention 1 (Up to 10 Days)||4
6432478|NCT01052493|7346782|FG001|STARTED|Intervention 1 (Up to 10 Days)||4
6432479|NCT01052493|7346783|FG002|STARTED|Intervention 1 (Up to 10 Days)||4
6432480|NCT01052493|7346781|FG000|COMPLETED|Intervention 1 (Up to 10 Days)||3
6432481|NCT01052493|7346782|FG001|COMPLETED|Intervention 1 (Up to 10 Days)||4
6432482|NCT01052493|7346783|FG002|COMPLETED|Intervention 1 (Up to 10 Days)||4
6432483|NCT01052493|7346781|FG000|NOT COMPLETED|Intervention 1 (Up to 10 Days)||1
6432484|NCT01052493|7346782|FG001|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
6432485|NCT01052493|7346783|FG002|NOT COMPLETED|Intervention 1 (Up to 10 Days)||0
6432486|NCT01052493|7346781|FG000|STARTED|Washout Period 1 (up to 5 Days)||3
6432487|NCT01052493|7346782|FG001|STARTED|Washout Period 1 (up to 5 Days)||4
6432488|NCT01052493|7346783|FG002|STARTED|Washout Period 1 (up to 5 Days)||4
6432489|NCT01052493|7346781|FG000|COMPLETED|Washout Period 1 (up to 5 Days)||3
6432490|NCT01052493|7346782|FG001|COMPLETED|Washout Period 1 (up to 5 Days)||4
6432491|NCT01052493|7346783|FG002|COMPLETED|Washout Period 1 (up to 5 Days)||4
6432492|NCT01052493|7346781|FG000|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
6432493|NCT01052493|7346782|FG001|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
6432494|NCT01052493|7346783|FG002|NOT COMPLETED|Washout Period 1 (up to 5 Days)||0
6432495|NCT01052493|7346781|FG000|STARTED|Intervention 2 (up to 10 Days)|Replacement subject recruited|4
6432496|NCT01052493|7346782|FG001|STARTED|Intervention 2 (up to 10 Days)||4
6432497|NCT01052493|7346783|FG002|STARTED|Intervention 2 (up to 10 Days)||4
6432498|NCT01052493|7346781|FG000|COMPLETED|Intervention 2 (up to 10 Days)||4
6432499|NCT01052493|7346782|FG001|COMPLETED|Intervention 2 (up to 10 Days)||4
6432500|NCT01052493|7346783|FG002|COMPLETED|Intervention 2 (up to 10 Days)||4
6432501|NCT01052493|7346781|FG000|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
6432502|NCT01052493|7346782|FG001|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
6432503|NCT01052493|7346783|FG002|NOT COMPLETED|Intervention 2 (up to 10 Days)||0
6432504|NCT01052493|7346781|FG000|STARTED|Washout Period 2 (up to 5 Days)||4
6432505|NCT01052493|7346782|FG001|STARTED|Washout Period 2 (up to 5 Days)||4
6432506|NCT01052493|7346783|FG002|STARTED|Washout Period 2 (up to 5 Days)||4
6432507|NCT01052493|7346781|FG000|COMPLETED|Washout Period 2 (up to 5 Days)||4
6432508|NCT01052493|7346782|FG001|COMPLETED|Washout Period 2 (up to 5 Days)||4
6432509|NCT01052493|7346783|FG002|COMPLETED|Washout Period 2 (up to 5 Days)||4
6432510|NCT01052493|7346781|FG000|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
6432511|NCT01052493|7346782|FG001|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
6432512|NCT01052493|7346783|FG002|NOT COMPLETED|Washout Period 2 (up to 5 Days)||0
6432513|NCT01052493|7346781|FG000|STARTED|Intervention 3 (up to 10 Days)||4
6432514|NCT01052493|7346782|FG001|STARTED|Intervention 3 (up to 10 Days)||4
6432515|NCT01052493|7346783|FG002|STARTED|Intervention 3 (up to 10 Days)||4
6432516|NCT01052493|7346781|FG000|COMPLETED|Intervention 3 (up to 10 Days)||4
6432517|NCT01052493|7346782|FG001|COMPLETED|Intervention 3 (up to 10 Days)||4
6432518|NCT01052493|7346783|FG002|COMPLETED|Intervention 3 (up to 10 Days)||4
6432519|NCT01052493|7346781|FG000|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
6432520|NCT01052493|7346782|FG001|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
6432521|NCT01052493|7346783|FG002|NOT COMPLETED|Intervention 3 (up to 10 Days)||0
6432522|NCT01052545|7346798|FG000|STARTED|Overall Study||867
6432523|NCT01052545|7346799|FG001|STARTED|Overall Study||731
6432524|NCT01052545|7346798|FG000|COMPLETED|Overall Study||867
6432525|NCT01052545|7346799|FG001|COMPLETED|Overall Study||731
6432526|NCT01052545|7346798|FG000|NOT COMPLETED|Overall Study||0
6432527|NCT01052545|7346799|FG001|NOT COMPLETED|Overall Study||0
6432528|NCT01052662|7346820|FG000|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
6432529|NCT01052662|7346821|FG001|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
6432530|NCT01052662|7346822|FG002|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
6432531|NCT01052662|7346820|FG000|Stabilization Phase|Overall Study||21
6432532|NCT01052662|7346821|FG001|Stabilization Phase|Overall Study||21
6432533|NCT01052662|7346822|FG002|Stabilization Phase|Overall Study||26
6432534|NCT01052662|7346820|FG000|Discontinuation Phase|Overall Study||6
6432535|NCT01052662|7346821|FG001|Discontinuation Phase|Overall Study||5
6432536|NCT01052662|7346822|FG002|Discontinuation Phase|Overall Study||10
6432537|NCT01052662|7346820|FG000|COMPLETED|Overall Study||6
6432538|NCT01052662|7346821|FG001|COMPLETED|Overall Study||5
6432539|NCT01052662|7346822|FG002|COMPLETED|Overall Study||10
6432540|NCT01052662|7346820|FG000|NOT COMPLETED|Overall Study||22
6432541|NCT01052662|7346821|FG001|NOT COMPLETED|Overall Study||22
6432542|NCT01052662|7346822|FG002|NOT COMPLETED|Overall Study||22
6432543|NCT01052701|7346832|FG000|STARTED|Overall Study||14
6432544|NCT01052701|7346833|FG001|STARTED|Overall Study||12
6432545|NCT01052701|7346832|FG000|COMPLETED|Overall Study||14
6432546|NCT01052701|7346833|FG001|COMPLETED|Overall Study||12
6432547|NCT01052701|7346832|FG000|NOT COMPLETED|Overall Study||0
6432548|NCT01052701|7346833|FG001|NOT COMPLETED|Overall Study||0
6432549|NCT01052714|7346841|FG000|STARTED|Overall Study||42
6432550|NCT01052714|7346842|FG001|STARTED|Overall Study||62
6432551|NCT01052714|7346843|FG002|STARTED|Overall Study||17
6432552|NCT01052714|7346841|FG000|COMPLETED|Overall Study||17
6432553|NCT01052714|7346842|FG001|COMPLETED|Overall Study||33
6432554|NCT01052714|7346843|FG002|COMPLETED|Overall Study||15
6432555|NCT01052714|7346841|FG000|NOT COMPLETED|Overall Study||25
6432556|NCT01052714|7346842|FG001|NOT COMPLETED|Overall Study||29
6432557|NCT01052714|7346843|FG002|NOT COMPLETED|Overall Study||2
6432558|NCT01052779|7346851|FG000|STARTED|Overall Study||80
6432559|NCT01052779|7346852|FG001|STARTED|Overall Study||82
6432560|NCT01052779|7346851|FG000|Received at Least 1 Dose of Study Drug|Overall Study||80
6432561|NCT01052779|7346852|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
6432562|NCT01052779|7346851|FG000|COMPLETED|Overall Study||75
6432563|NCT01052779|7346852|FG001|COMPLETED|Overall Study||73
6432564|NCT01052779|7346851|FG000|NOT COMPLETED|Overall Study||5
6432565|NCT01052779|7346852|FG001|NOT COMPLETED|Overall Study||9
6432566|NCT01052831|7346860|FG000|STARTED|Overall Study||26
6432567|NCT01052831|7346861|FG001|STARTED|Overall Study||24
6432568|NCT01052831|7346860|FG000|COMPLETED|Overall Study||22
6432569|NCT01052831|7346861|FG001|COMPLETED|Overall Study||23
6432570|NCT01052831|7346860|FG000|NOT COMPLETED|Overall Study||4
6432571|NCT01052831|7346861|FG001|NOT COMPLETED|Overall Study||1
6432572|NCT01052844|7346869|FG000|STARTED|Overall Study||40
6432573|NCT01052844|7346870|FG001|STARTED|Overall Study||40
6432574|NCT01052844|7346869|FG000|COMPLETED|Overall Study||40
6432575|NCT01052844|7346870|FG001|COMPLETED|Overall Study||39
6432576|NCT01052844|7346869|FG000|NOT COMPLETED|Overall Study||0
6432577|NCT01052844|7346870|FG001|NOT COMPLETED|Overall Study||1
6432578|NCT01052948|7346880|FG000|STARTED|Overall Study||27812
6432579|NCT01052948|7346881|FG001|STARTED|Overall Study||14669
6432580|NCT01052948|7346882|FG002|STARTED|Overall Study||15147
6432581|NCT01052948|7346883|FG003|STARTED|Overall Study||29311
6432582|NCT01052948|7346880|FG000|COMPLETED|Overall Study||27812
6432583|NCT01052948|7346881|FG001|COMPLETED|Overall Study||14669
6432584|NCT01052948|7346882|FG002|COMPLETED|Overall Study||15147
6432585|NCT01052948|7346883|FG003|COMPLETED|Overall Study||29311
6432586|NCT01052948|7346880|FG000|NOT COMPLETED|Overall Study||0
6432587|NCT01052948|7346881|FG001|NOT COMPLETED|Overall Study||0
6432588|NCT01052948|7346882|FG002|NOT COMPLETED|Overall Study||0
6432589|NCT01052948|7346883|FG003|NOT COMPLETED|Overall Study||0
6432590|NCT01053000|7346893|FG000|STARTED|Overall Study||5
6432591|NCT01053000|7346894|FG001|STARTED|Overall Study||5
6432592|NCT01053000|7346893|FG000|COMPLETED|Overall Study||5
6432593|NCT01053000|7346894|FG001|COMPLETED|Overall Study||5
6432594|NCT01053000|7346893|FG000|NOT COMPLETED|Overall Study||0
6432595|NCT01053000|7346894|FG001|NOT COMPLETED|Overall Study||0
6432596|NCT01053013|7346902|FG000|STARTED|Overall Study||24
6432597|NCT01053013|7346903|FG001|STARTED|Overall Study||34
6432598|NCT01053013|7346902|FG000|COMPLETED|Overall Study||24
6432599|NCT01053013|7346903|FG001|COMPLETED|Overall Study||34
6432600|NCT01053013|7346902|FG000|NOT COMPLETED|Overall Study||0
6432601|NCT01053013|7346903|FG001|NOT COMPLETED|Overall Study||0
6432602|NCT01053078|7347007|FG000|STARTED|Overall Study||14
6432603|NCT01053078|7347008|FG001|STARTED|Overall Study||15
6432604|NCT01053078|7347007|FG000|COMPLETED|Overall Study||10
6432605|NCT01053078|7347008|FG001|COMPLETED|Overall Study||12
6432606|NCT01053078|7347007|FG000|NOT COMPLETED|Overall Study||4
6432607|NCT01053078|7347008|FG001|NOT COMPLETED|Overall Study||3
6432608|NCT01053156|7347018|FG000|STARTED|First Intervention (Week 1-12)||33
6432609|NCT01053156|7347019|FG001|STARTED|First Intervention (Week 1-12)||33
6432610|NCT01053156|7347018|FG000|COMPLETED|First Intervention (Week 1-12)||28
6432611|NCT01053156|7347019|FG001|COMPLETED|First Intervention (Week 1-12)||27
6432612|NCT01053156|7347018|FG000|NOT COMPLETED|First Intervention (Week 1-12)||5
6432613|NCT01053156|7347019|FG001|NOT COMPLETED|First Intervention (Week 1-12)||6
6432614|NCT01053156|7347018|FG000|STARTED|Second Intervention (Week 13-24)||28
6432615|NCT01053156|7347019|FG001|STARTED|Second Intervention (Week 13-24)||27
6432616|NCT01053156|7347018|FG000|COMPLETED|Second Intervention (Week 13-24)||26
6432617|NCT01053156|7347019|FG001|COMPLETED|Second Intervention (Week 13-24)||22
6432618|NCT01053156|7347018|FG000|NOT COMPLETED|Second Intervention (Week 13-24)||2
6432619|NCT01053156|7347019|FG001|NOT COMPLETED|Second Intervention (Week 13-24)||5
6432620|NCT01053247|7347031|FG000|STARTED|Overall Study||269
6432621|NCT01053247|7347032|FG001|STARTED|Overall Study||260
6432622|NCT01053247|7347033|FG002|STARTED|Overall Study||264
6432623|NCT01053247|7347031|FG000|COMPLETED|Overall Study||249
6432624|NCT01053247|7347032|FG001|COMPLETED|Overall Study||241
6432625|NCT01053247|7347033|FG002|COMPLETED|Overall Study||236
6432626|NCT01053247|7347031|FG000|NOT COMPLETED|Overall Study||20
6432627|NCT01053247|7347032|FG001|NOT COMPLETED|Overall Study||19
6432628|NCT01053247|7347033|FG002|NOT COMPLETED|Overall Study||28
6432629|NCT01053312|7347041|FG000|STARTED|Overall Study||7
6432630|NCT01053312|7347041|FG000|COMPLETED|Overall Study||7
6432631|NCT01053312|7347041|FG000|NOT COMPLETED|Overall Study||0
6432632|NCT01053429|7347059|FG000|STARTED|Overall Study||3391
6432633|NCT01053429|7347059|FG000|COMPLETED|Overall Study||3018
6432634|NCT01053429|7347059|FG000|NOT COMPLETED|Overall Study||373
6432635|NCT01053507|7347065|FG000|STARTED|Overall Study||11
6432636|NCT01053507|7347066|FG001|STARTED|Overall Study||12
6432637|NCT01053507|7347065|FG000|COMPLETED|Overall Study||8
6432638|NCT01053507|7347066|FG001|COMPLETED|Overall Study||11
6432639|NCT01053507|7347065|FG000|NOT COMPLETED|Overall Study||3
6432640|NCT01053507|7347066|FG001|NOT COMPLETED|Overall Study||1
6432641|NCT01053663|7347075|FG000|STARTED|Overall Study||9
6432642|NCT01053663|7347075|FG000|COMPLETED|Overall Study||3
6432643|NCT01053663|7347075|FG000|NOT COMPLETED|Overall Study||6
6499671|NCT01420081|7418392|FG004|COMPLETED|Overall Study||0
6499672|NCT01420081|7418393|FG005|COMPLETED|Overall Study||0
6499673|NCT01420081|7418394|FG006|COMPLETED|Overall Study||0
6499674|NCT01420081|7418395|FG007|COMPLETED|Overall Study||0
6499675|NCT01420081|7418396|FG008|COMPLETED|Overall Study||0
6499676|NCT01420081|7418388|FG000|NOT COMPLETED|Overall Study||3
6499677|NCT01420081|7418389|FG001|NOT COMPLETED|Overall Study||1
6499678|NCT01420081|7418390|FG002|NOT COMPLETED|Overall Study||11
6499679|NCT01420081|7418391|FG003|NOT COMPLETED|Overall Study||3
6499680|NCT01420081|7418392|FG004|NOT COMPLETED|Overall Study||20
6499681|NCT01420081|7418393|FG005|NOT COMPLETED|Overall Study||20
6499682|NCT01420081|7418394|FG006|NOT COMPLETED|Overall Study||3
6499683|NCT01420081|7418395|FG007|NOT COMPLETED|Overall Study||3
6499684|NCT01420081|7418396|FG008|NOT COMPLETED|Overall Study||3
6499685|NCT01420146|7418412|FG000|STARTED|Overall Study||20
6499686|NCT01420146|7418412|FG000|COMPLETED|Overall Study||20
6499687|NCT01420146|7418412|FG000|NOT COMPLETED|Overall Study||0
6499688|NCT01420289|7418418|FG000|STARTED|Overall Study||18
6499689|NCT01420289|7418419|FG001|STARTED|Overall Study||16
6499690|NCT01420289|7418418|FG000|COMPLETED|Overall Study||18
6499691|NCT01420289|7418419|FG001|COMPLETED|Overall Study||16
6499692|NCT01420289|7418418|FG000|NOT COMPLETED|Overall Study||0
6499693|NCT01420289|7418419|FG001|NOT COMPLETED|Overall Study||0
6499694|NCT01420536|7418427|FG000|STARTED|Period 1 (30 Days)||22
6499695|NCT01420536|7418428|FG001|STARTED|Period 1 (30 Days)||22
6499696|NCT01420536|7418427|FG000|COMPLETED|Period 1 (30 Days)|Participants declined to participate further before changing interventions.|19
6552370|NCT01737697|7474895|FG006|COMPLETED|Acute Phase-Initial 48 Hours||0
6552371|NCT01737697|7474896|FG007|COMPLETED|Acute Phase-Initial 48 Hours||0
6552372|NCT01737697|7474897|FG008|COMPLETED|Acute Phase-Initial 48 Hours||0
6552373|NCT01737697|7474898|FG009|COMPLETED|Acute Phase-Initial 48 Hours||0
6552374|NCT01737697|7474899|FG010|COMPLETED|Acute Phase-Initial 48 Hours||0
6552375|NCT01737697|7474900|FG011|COMPLETED|Acute Phase-Initial 48 Hours||0
6552376|NCT01737697|7474901|FG012|COMPLETED|Acute Phase-Initial 48 Hours||0
6552377|NCT01737697|7474902|FG013|COMPLETED|Acute Phase-Initial 48 Hours||0
6552378|NCT01737697|7474903|FG014|COMPLETED|Acute Phase-Initial 48 Hours||0
6552379|NCT01737697|7474889|FG000|NOT COMPLETED|Acute Phase-Initial 48 Hours||1
6499697|NCT01420536|7418428|FG001|COMPLETED|Period 1 (30 Days)||22
6499698|NCT01420536|7418427|FG000|NOT COMPLETED|Period 1 (30 Days)||3
6499699|NCT01420536|7418428|FG001|NOT COMPLETED|Period 1 (30 Days)||0
6499700|NCT01420536|7418427|FG000|STARTED|Period 2 (30 Days)||19
6499701|NCT01420536|7418428|FG001|STARTED|Period 2 (30 Days)||22
6499702|NCT01420536|7418427|FG000|COMPLETED|Period 2 (30 Days)||19
6499703|NCT01420536|7418428|FG001|COMPLETED|Period 2 (30 Days)||22
6499704|NCT01420536|7418427|FG000|NOT COMPLETED|Period 2 (30 Days)||0
6499705|NCT01420536|7418428|FG001|NOT COMPLETED|Period 2 (30 Days)||0
6499706|NCT01420549|7418438|FG000|STARTED|Overall Study||66
6499707|NCT01420549|7418439|FG001|STARTED|Overall Study||63
6499708|NCT01420549|7418438|FG000|COMPLETED|Overall Study||59
6499709|NCT01420549|7418439|FG001|COMPLETED|Overall Study||58
6499710|NCT01420549|7418438|FG000|NOT COMPLETED|Overall Study||7
6499711|NCT01420549|7418439|FG001|NOT COMPLETED|Overall Study||5
6499712|NCT01420627|7418445|FG000|STARTED|Adagen Lead-in Period||7
6499713|NCT01420627|7418445|FG000|COMPLETED|Adagen Lead-in Period||7
6499714|NCT01420627|7418445|FG000|NOT COMPLETED|Adagen Lead-in Period||0
6432644|NCT01053741|7347087|FG000|STARTED|1st Intervention||5
6432645|NCT01053741|7347088|FG001|STARTED|1st Intervention||6
6432646|NCT01053741|7347087|FG000|COMPLETED|1st Intervention||5
6432647|NCT01053741|7347088|FG001|COMPLETED|1st Intervention||6
6432648|NCT01053741|7347087|FG000|NOT COMPLETED|1st Intervention||0
6432649|NCT01053741|7347088|FG001|NOT COMPLETED|1st Intervention||0
6432650|NCT01053741|7347087|FG000|STARTED|14 Day Washout||5
6432651|NCT01053741|7347088|FG001|STARTED|14 Day Washout||6
6432652|NCT01053741|7347087|FG000|COMPLETED|14 Day Washout||5
6432653|NCT01053741|7347088|FG001|COMPLETED|14 Day Washout||6
6432654|NCT01053741|7347087|FG000|NOT COMPLETED|14 Day Washout||0
6432655|NCT01053741|7347088|FG001|NOT COMPLETED|14 Day Washout||0
6432656|NCT01053741|7347087|FG000|STARTED|2nd Study Intervention||5
6432657|NCT01053741|7347088|FG001|STARTED|2nd Study Intervention||6
6432658|NCT01053741|7347087|FG000|COMPLETED|2nd Study Intervention||5
6432659|NCT01053741|7347088|FG001|COMPLETED|2nd Study Intervention||5
6432660|NCT01053741|7347087|FG000|NOT COMPLETED|2nd Study Intervention||0
6432661|NCT01053741|7347088|FG001|NOT COMPLETED|2nd Study Intervention||1
6432662|NCT01053819|7347094|FG000|STARTED|Overall Study||6
6432663|NCT01053819|7347094|FG000|COMPLETED|Overall Study||6
6432664|NCT01053819|7347094|FG000|NOT COMPLETED|Overall Study||0
6432665|NCT01053897|7347099|FG000|STARTED|Overall Study||5
6432666|NCT01053897|7347099|FG000|COMPLETED|Overall Study||5
6432667|NCT01053897|7347099|FG000|NOT COMPLETED|Overall Study||0
6432668|NCT01053962|7347114|FG000|STARTED|Pretreatment Period||14
6432669|NCT01053962|7347115|FG001|STARTED|Pretreatment Period||15
6432670|NCT01053962|7347116|FG002|STARTED|Pretreatment Period||16
6432671|NCT01053962|7347117|FG003|STARTED|Pretreatment Period||17
6432672|NCT01053962|7347118|FG004|STARTED|Pretreatment Period||22
6432673|NCT01053962|7347114|FG000|COMPLETED|Pretreatment Period||14
6432674|NCT01053962|7347115|FG001|COMPLETED|Pretreatment Period||14
6432675|NCT01053962|7347116|FG002|COMPLETED|Pretreatment Period||15
6432676|NCT01053962|7347117|FG003|COMPLETED|Pretreatment Period||15
6432677|NCT01053962|7347118|FG004|COMPLETED|Pretreatment Period||20
6432678|NCT01053962|7347114|FG000|NOT COMPLETED|Pretreatment Period||0
6432679|NCT01053962|7347115|FG001|NOT COMPLETED|Pretreatment Period||1
6432680|NCT01053962|7347116|FG002|NOT COMPLETED|Pretreatment Period||1
6432681|NCT01053962|7347117|FG003|NOT COMPLETED|Pretreatment Period||2
6432682|NCT01053962|7347118|FG004|NOT COMPLETED|Pretreatment Period||2
6432683|NCT01053962|7347114|FG000|STARTED|Treatment Period||14
6432684|NCT01053962|7347115|FG001|STARTED|Treatment Period||14
6432685|NCT01053962|7347116|FG002|STARTED|Treatment Period||15
6432686|NCT01053962|7347117|FG003|STARTED|Treatment Period||15
6432687|NCT01053962|7347118|FG004|STARTED|Treatment Period||20
6432688|NCT01053962|7347114|FG000|COMPLETED|Treatment Period||13
6432689|NCT01053962|7347115|FG001|COMPLETED|Treatment Period||14
6432690|NCT01053962|7347116|FG002|COMPLETED|Treatment Period||15
6432691|NCT01053962|7347117|FG003|COMPLETED|Treatment Period||15
6432692|NCT01053962|7347118|FG004|COMPLETED|Treatment Period||17
6432693|NCT01053962|7347114|FG000|NOT COMPLETED|Treatment Period||1
6432694|NCT01053962|7347115|FG001|NOT COMPLETED|Treatment Period||0
6432695|NCT01053962|7347116|FG002|NOT COMPLETED|Treatment Period||0
6432696|NCT01053962|7347117|FG003|NOT COMPLETED|Treatment Period||0
6432697|NCT01053962|7347118|FG004|NOT COMPLETED|Treatment Period||3
6432698|NCT01053962|7347114|FG000|STARTED|Follow-up Period||13
6432699|NCT01053962|7347115|FG001|STARTED|Follow-up Period||14
6432700|NCT01053962|7347116|FG002|STARTED|Follow-up Period||15
6432701|NCT01053962|7347117|FG003|STARTED|Follow-up Period||15
6432702|NCT01053962|7347118|FG004|STARTED|Follow-up Period||17
6432703|NCT01053962|7347114|FG000|COMPLETED|Follow-up Period||13
6432704|NCT01053962|7347115|FG001|COMPLETED|Follow-up Period||14
6432705|NCT01053962|7347116|FG002|COMPLETED|Follow-up Period||15
6432706|NCT01053962|7347117|FG003|COMPLETED|Follow-up Period||15
6432707|NCT01053962|7347118|FG004|COMPLETED|Follow-up Period||17
6432708|NCT01053962|7347114|FG000|NOT COMPLETED|Follow-up Period||0
6432709|NCT01053962|7347115|FG001|NOT COMPLETED|Follow-up Period||0
6432710|NCT01053962|7347116|FG002|NOT COMPLETED|Follow-up Period||0
6432711|NCT01053962|7347117|FG003|NOT COMPLETED|Follow-up Period||0
6432712|NCT01053962|7347118|FG004|NOT COMPLETED|Follow-up Period||0
6432713|NCT01053988|7347140|FG000|STARTED|2-week, Single-blind Run-In Period||1390
6432714|NCT01053988|7347141|FG001|STARTED|2-week, Single-blind Run-In Period||0
6432715|NCT01053988|7347142|FG002|STARTED|2-week, Single-blind Run-In Period||0
6432716|NCT01053988|7347143|FG003|STARTED|2-week, Single-blind Run-In Period||0
6432717|NCT01053988|7347144|FG004|STARTED|2-week, Single-blind Run-In Period||0
6432718|NCT01053988|7347145|FG005|STARTED|2-week, Single-blind Run-In Period||0
6432719|NCT01053988|7347140|FG000|COMPLETED|2-week, Single-blind Run-In Period||1030
6432720|NCT01053988|7347141|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
6432721|NCT01053988|7347142|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
6432722|NCT01053988|7347143|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
6432723|NCT01053988|7347144|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
6432724|NCT01053988|7347145|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
6432725|NCT01053988|7347140|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||360
6432726|NCT01053988|7347141|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432727|NCT01053988|7347142|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432728|NCT01053988|7347143|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432729|NCT01053988|7347144|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432730|NCT01053988|7347145|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432731|NCT01053988|7347140|FG000|STARTED|24-week, Double-blind Treatment Period||0
6432732|NCT01053988|7347141|FG001|STARTED|24-week, Double-blind Treatment Period||207
6432733|NCT01053988|7347142|FG002|STARTED|24-week, Double-blind Treatment Period||206
6432734|NCT01053988|7347143|FG003|STARTED|24-week, Double-blind Treatment Period||205
6432735|NCT01053988|7347144|FG004|STARTED|24-week, Double-blind Treatment Period||206
6432736|NCT01053988|7347145|FG005|STARTED|24-week, Double-blind Treatment Period||206
6432737|NCT01053988|7347140|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
6432738|NCT01053988|7347141|FG001|COMPLETED|24-week, Double-blind Treatment Period||138
6432739|NCT01053988|7347142|FG002|COMPLETED|24-week, Double-blind Treatment Period||145
6432740|NCT01053988|7347143|FG003|COMPLETED|24-week, Double-blind Treatment Period||142
6432741|NCT01053988|7347144|FG004|COMPLETED|24-week, Double-blind Treatment Period||147
6432742|NCT01053988|7347145|FG005|COMPLETED|24-week, Double-blind Treatment Period||151
6432743|NCT01053988|7347140|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
6432744|NCT01053988|7347141|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||69
6432745|NCT01053988|7347142|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||61
6432746|NCT01053988|7347143|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||63
6432747|NCT01053988|7347144|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||59
6432748|NCT01053988|7347145|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||55
6432749|NCT01054079|7347157|FG000|STARTED|Overall Study||20
6432750|NCT01054079|7347157|FG000|# Recieved Proper PSA Testing|Overall Study||10
6432751|NCT01054079|7347157|FG000|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
6432752|NCT01054079|7347157|FG000|NOT COMPLETED|Overall Study||0
6432753|NCT01054144|7347161|FG000|STARTED|Overall Study||27
6432754|NCT01054144|7347161|FG000|COMPLETED|Overall Study||25
6432755|NCT01054144|7347161|FG000|NOT COMPLETED|Overall Study||2
6432756|NCT01054170|7347170|FG000|STARTED|Overall Study||25
6432757|NCT01054170|7347171|FG001|STARTED|Overall Study||27
6432758|NCT01054170|7347170|FG000|COMPLETED|Overall Study||21
6432759|NCT01054170|7347171|FG001|COMPLETED|Overall Study||21
6432760|NCT01054170|7347170|FG000|NOT COMPLETED|Overall Study||4
6432761|NCT01054170|7347171|FG001|NOT COMPLETED|Overall Study||6
6432762|NCT01054183|7347179|FG000|STARTED|Overall Study||10
6432763|NCT01054183|7347180|FG001|STARTED|Overall Study||12
6432764|NCT01054183|7347179|FG000|COMPLETED|Overall Study||10
6432765|NCT01054183|7347180|FG001|COMPLETED|Overall Study||12
6432766|NCT01054183|7347179|FG000|NOT COMPLETED|Overall Study||0
6432767|NCT01054183|7347180|FG001|NOT COMPLETED|Overall Study||0
6432768|NCT01054209|7347188|FG000|STARTED|Overall Study||58
6432769|NCT01054209|7347189|FG001|STARTED|Overall Study||58
6432770|NCT01054209|7347188|FG000|COMPLETED|Overall Study||58
6432771|NCT01054209|7347189|FG001|COMPLETED|Overall Study||58
6432772|NCT01054209|7347188|FG000|NOT COMPLETED|Overall Study||0
6432773|NCT01054209|7347189|FG001|NOT COMPLETED|Overall Study||0
6432774|NCT01054222|7347195|FG000|STARTED|Overall Study||31
6432775|NCT01054222|7347195|FG000|COMPLETED|Overall Study||20
6432776|NCT01054222|7347195|FG000|NOT COMPLETED|Overall Study||11
6432777|NCT01054300|7347201|FG000|STARTED|Period 1||13
6552380|NCT01737697|7474890|FG001|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
6552381|NCT01737697|7474891|FG002|NOT COMPLETED|Acute Phase-Initial 48 Hours||4
6552382|NCT01737697|7474892|FG003|NOT COMPLETED|Acute Phase-Initial 48 Hours||6
6552383|NCT01737697|7474893|FG004|NOT COMPLETED|Acute Phase-Initial 48 Hours||3
6432778|NCT01054300|7347202|FG001|STARTED|Period 1||13
6432779|NCT01054300|7347203|FG002|STARTED|Period 1||13
6432780|NCT01054300|7347204|FG003|STARTED|Period 1||13
6432781|NCT01054300|7347201|FG000|COMPLETED|Period 1|Discontinuation occurred prior to Period 2 dose.|12
6432782|NCT01054300|7347202|FG001|COMPLETED|Period 1||13
6432783|NCT01054300|7347203|FG002|COMPLETED|Period 1||13
6432784|NCT01054300|7347204|FG003|COMPLETED|Period 1||13
6432785|NCT01054300|7347201|FG000|NOT COMPLETED|Period 1||1
6432786|NCT01054300|7347202|FG001|NOT COMPLETED|Period 1||0
6432787|NCT01054300|7347203|FG002|NOT COMPLETED|Period 1||0
6432788|NCT01054300|7347204|FG003|NOT COMPLETED|Period 1||0
6432789|NCT01054300|7347201|FG000|STARTED|Period 2||12
6432790|NCT01054300|7347202|FG001|STARTED|Period 2||13
6432791|NCT01054300|7347203|FG002|STARTED|Period 2||13
6432792|NCT01054300|7347204|FG003|STARTED|Period 2||13
6432793|NCT01054300|7347201|FG000|COMPLETED|Period 2||12
6432794|NCT01054300|7347202|FG001|COMPLETED|Period 2||13
6432795|NCT01054300|7347203|FG002|COMPLETED|Period 2||12
6432796|NCT01054300|7347204|FG003|COMPLETED|Period 2||13
6432797|NCT01054300|7347201|FG000|NOT COMPLETED|Period 2||0
6432798|NCT01054300|7347202|FG001|NOT COMPLETED|Period 2||0
6432799|NCT01054300|7347203|FG002|NOT COMPLETED|Period 2||1
6432800|NCT01054300|7347204|FG003|NOT COMPLETED|Period 2||0
6432801|NCT01054339|7347217|FG000|STARTED|Overall Study||3
6432802|NCT01054339|7347218|FG001|STARTED|Overall Study||3
6432803|NCT01054339|7347219|FG002|STARTED|Overall Study||3
6432804|NCT01054339|7347217|FG000|COMPLETED|Overall Study||3
6432805|NCT01054339|7347218|FG001|COMPLETED|Overall Study||3
6432806|NCT01054339|7347219|FG002|COMPLETED|Overall Study||3
6432807|NCT01054339|7347217|FG000|NOT COMPLETED|Overall Study||0
6432808|NCT01054339|7347218|FG001|NOT COMPLETED|Overall Study||0
6432809|NCT01054339|7347219|FG002|NOT COMPLETED|Overall Study||0
6432810|NCT01054404|7347231|FG000|STARTED|Overall Study||10
6432811|NCT01054404|7347232|FG001|STARTED|Overall Study||13
6432812|NCT01054404|7347231|FG000|COMPLETED|Overall Study||10
6432813|NCT01054404|7347232|FG001|COMPLETED|Overall Study||13
6432814|NCT01054404|7347231|FG000|NOT COMPLETED|Overall Study||0
6432815|NCT01054404|7347232|FG001|NOT COMPLETED|Overall Study||0
6432816|NCT01054443|7347242|FG000|STARTED|Overall Study||5
6432817|NCT01054443|7347243|FG001|STARTED|Overall Study||5
6432818|NCT01054443|7347244|FG002|STARTED|Overall Study||5
6432819|NCT01054443|7347245|FG003|STARTED|Overall Study||5
6432820|NCT01054443|7347242|FG000|COMPLETED|Overall Study||5
6432821|NCT01054443|7347243|FG001|COMPLETED|Overall Study||5
6432822|NCT01054443|7347244|FG002|COMPLETED|Overall Study||5
6432823|NCT01054443|7347245|FG003|COMPLETED|Overall Study||4
6432824|NCT01054443|7347242|FG000|NOT COMPLETED|Overall Study||0
6432825|NCT01054443|7347243|FG001|NOT COMPLETED|Overall Study||0
6432826|NCT01054443|7347244|FG002|NOT COMPLETED|Overall Study||0
6432827|NCT01054443|7347245|FG003|NOT COMPLETED|Overall Study||1
6432828|NCT01054456|7347258|FG000|STARTED|Overall Study||36
6432829|NCT01054456|7347258|FG000|COMPLETED|Overall Study||35
6432830|NCT01054456|7347258|FG000|NOT COMPLETED|Overall Study||1
6432831|NCT01054560|7347264|FG000|STARTED|Overall Study||58
6432832|NCT01054560|7347265|FG001|STARTED|Overall Study||55
6432833|NCT01054560|7347264|FG000|COMPLETED|Overall Study||45
6432834|NCT01054560|7347265|FG001|COMPLETED|Overall Study||27
6432835|NCT01054560|7347264|FG000|NOT COMPLETED|Overall Study||13
6432836|NCT01054560|7347265|FG001|NOT COMPLETED|Overall Study||28
6432837|NCT01054573|7347277|FG000|STARTED|Overall Study||9
6432838|NCT01054573|7347278|FG001|STARTED|Overall Study||32
6432839|NCT01054573|7347279|FG002|STARTED|Overall Study||22
6432840|NCT01054573|7347280|FG003|STARTED|Overall Study||27
6432841|NCT01054573|7347277|FG000|COMPLETED|Overall Study||8
6432842|NCT01054573|7347278|FG001|COMPLETED|Overall Study||28
6432843|NCT01054573|7347279|FG002|COMPLETED|Overall Study||19
6432844|NCT01054573|7347280|FG003|COMPLETED|Overall Study||25
6432845|NCT01054573|7347277|FG000|NOT COMPLETED|Overall Study||1
6432846|NCT01054573|7347278|FG001|NOT COMPLETED|Overall Study||4
6432847|NCT01054573|7347279|FG002|NOT COMPLETED|Overall Study||3
6432848|NCT01054573|7347280|FG003|NOT COMPLETED|Overall Study||2
6432849|NCT01054586|7347303|FG000|STARTED|Overall Study||43
6432850|NCT01054586|7347304|FG001|STARTED|Overall Study||15
6432851|NCT01054586|7347305|FG002|STARTED|Overall Study||8
6432852|NCT01054586|7347306|FG003|STARTED|Overall Study||101
6432853|NCT01054586|7347303|FG000|COMPLETED|Overall Study||43
6432854|NCT01054586|7347304|FG001|COMPLETED|Overall Study||15
6432855|NCT01054586|7347305|FG002|COMPLETED|Overall Study||8
6432856|NCT01054586|7347306|FG003|COMPLETED|Overall Study||101
6432857|NCT01054586|7347303|FG000|NOT COMPLETED|Overall Study||0
6432858|NCT01054586|7347304|FG001|NOT COMPLETED|Overall Study||0
6432859|NCT01054586|7347305|FG002|NOT COMPLETED|Overall Study||0
6432860|NCT01054586|7347306|FG003|NOT COMPLETED|Overall Study||0
6432861|NCT01054599|7347328|FG000|STARTED|Overall Study||13
6432862|NCT01054599|7347329|FG001|STARTED|Overall Study||16
6432863|NCT01054599|7347328|FG000|COMPLETED|Overall Study||9
6432864|NCT01054599|7347329|FG001|COMPLETED|Overall Study||9
6432865|NCT01054599|7347328|FG000|NOT COMPLETED|Overall Study||4
6432866|NCT01054599|7347329|FG001|NOT COMPLETED|Overall Study||7
6432867|NCT01054625|7347338|FG000|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
6432868|NCT01054625|7347339|FG001|STARTED|Overall Study||12
6432869|NCT01054625|7347340|FG002|STARTED|Overall Study||10
6432870|NCT01054625|7347338|FG000|COMPLETED|Overall Study||6
6432871|NCT01054625|7347339|FG001|COMPLETED|Overall Study||9
6432872|NCT01054625|7347340|FG002|COMPLETED|Overall Study||9
6432873|NCT01054625|7347338|FG000|NOT COMPLETED|Overall Study||2
6432874|NCT01054625|7347339|FG001|NOT COMPLETED|Overall Study||3
6432875|NCT01054625|7347340|FG002|NOT COMPLETED|Overall Study||1
6432876|NCT01054703|7347348|FG000|STARTED|Overall Study||14
6432877|NCT01054703|7347348|FG000|COMPLETED|Overall Study||14
6432878|NCT01054703|7347348|FG000|NOT COMPLETED|Overall Study||0
6432879|NCT01054729|7347356|FG000|STARTED|Overall Study||16
6432880|NCT01054729|7347357|FG001|STARTED|Overall Study||19
6432881|NCT01054729|7347358|FG002|STARTED|Overall Study||15
6432882|NCT01054729|7347359|FG003|STARTED|Overall Study||14
6432883|NCT01054729|7347356|FG000|Randomized and Treated|Overall Study||16
6432884|NCT01054729|7347357|FG001|Randomized and Treated|Overall Study||18
6432885|NCT01054729|7347358|FG002|Randomized and Treated|Overall Study||15
6432886|NCT01054729|7347359|FG003|Randomized and Treated|Overall Study||14
6432887|NCT01054729|7347356|FG000|COMPLETED|Overall Study||12
6432888|NCT01054729|7347357|FG001|COMPLETED|Overall Study||14
6432889|NCT01054729|7347358|FG002|COMPLETED|Overall Study||9
6432890|NCT01054729|7347359|FG003|COMPLETED|Overall Study||11
6432891|NCT01054729|7347356|FG000|NOT COMPLETED|Overall Study||4
6432892|NCT01054729|7347357|FG001|NOT COMPLETED|Overall Study||5
6432893|NCT01054729|7347358|FG002|NOT COMPLETED|Overall Study||6
6552384|NCT01737697|7474894|FG005|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6552385|NCT01737697|7474895|FG006|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6552386|NCT01737697|7474896|FG007|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6432894|NCT01054729|7347359|FG003|NOT COMPLETED|Overall Study||3
6432895|NCT01054742|7347369|FG000|STARTED|Overall Study||2
6432896|NCT01054742|7347369|FG000|COMPLETED|Overall Study||2
6432897|NCT01054742|7347369|FG000|NOT COMPLETED|Overall Study||0
6432898|NCT01054768|7347375|FG000|STARTED|Overall Study||17
6432899|NCT01054768|7347376|FG001|STARTED|Overall Study||20
6432900|NCT01054768|7347375|FG000|COMPLETED|Overall Study||9
6432901|NCT01054768|7347376|FG001|COMPLETED|Overall Study||17
6432902|NCT01054768|7347375|FG000|NOT COMPLETED|Overall Study||8
6432903|NCT01054768|7347376|FG001|NOT COMPLETED|Overall Study||3
6432904|NCT01054820|7347382|FG000|STARTED|Overall Study||123
6432905|NCT01054820|7347382|FG000|COMPLETED|Overall Study||121
6432906|NCT01054820|7347382|FG000|NOT COMPLETED|Overall Study||2
6432907|NCT01054846|7347388|FG000|STARTED|Overall Study||322
6432908|NCT01054846|7347389|FG001|STARTED|Overall Study||68
6432909|NCT01054846|7347388|FG000|COMPLETED|Overall Study||246
6432910|NCT01054846|7347389|FG001|COMPLETED|Overall Study||51
6432911|NCT01054846|7347388|FG000|NOT COMPLETED|Overall Study||76
6432912|NCT01054846|7347389|FG001|NOT COMPLETED|Overall Study||17
6432913|NCT01054885|7347400|FG000|STARTED|2-week, Single-blind Run-In Period||1577
6432914|NCT01054885|7347401|FG001|STARTED|2-week, Single-blind Run-In Period||0
6432915|NCT01054885|7347402|FG002|STARTED|2-week, Single-blind Run-In Period||0
6432916|NCT01054885|7347403|FG003|STARTED|2-week, Single-blind Run-In Period||0
6432917|NCT01054885|7347404|FG004|STARTED|2-week, Single-blind Run-In Period||0
6432918|NCT01054885|7347405|FG005|STARTED|2-week, Single-blind Run-In Period||0
6432919|NCT01054885|7347406|FG006|STARTED|2-week, Single-blind Run-In Period||0
6432920|NCT01054885|7347400|FG000|COMPLETED|2-week, Single-blind Run-In Period||1226
6432921|NCT01054885|7347401|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
6432922|NCT01054885|7347402|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
6432923|NCT01054885|7347403|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
6432924|NCT01054885|7347404|FG004|COMPLETED|2-week, Single-blind Run-In Period||0
6432925|NCT01054885|7347405|FG005|COMPLETED|2-week, Single-blind Run-In Period||0
6432926|NCT01054885|7347406|FG006|COMPLETED|2-week, Single-blind Run-In Period||0
6432927|NCT01054885|7347400|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||351
6432928|NCT01054885|7347401|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432929|NCT01054885|7347402|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432930|NCT01054885|7347403|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432931|NCT01054885|7347404|FG004|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432932|NCT01054885|7347405|FG005|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432933|NCT01054885|7347406|FG006|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6432934|NCT01054885|7347400|FG000|STARTED|24-week, Double-blind Treatment Period||0
6432935|NCT01054885|7347401|FG001|STARTED|24-week, Double-blind Treatment Period||205
6432936|NCT01054885|7347402|FG002|STARTED|24-week, Double-blind Treatment Period||204
6432937|NCT01054885|7347403|FG003|STARTED|24-week, Double-blind Treatment Period||203
6432938|NCT01054885|7347404|FG004|STARTED|24-week, Double-blind Treatment Period||203
6432939|NCT01054885|7347405|FG005|STARTED|24-week, Double-blind Treatment Period||204
6432940|NCT01054885|7347406|FG006|STARTED|24-week, Double-blind Treatment Period||205
6432941|NCT01054885|7347400|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
6432942|NCT01054885|7347401|FG001|COMPLETED|24-week, Double-blind Treatment Period||146
6432943|NCT01054885|7347402|FG002|COMPLETED|24-week, Double-blind Treatment Period||155
6432944|NCT01054885|7347403|FG003|COMPLETED|24-week, Double-blind Treatment Period||160
6432945|NCT01054885|7347404|FG004|COMPLETED|24-week, Double-blind Treatment Period||161
6432946|NCT01054885|7347405|FG005|COMPLETED|24-week, Double-blind Treatment Period||144
6432947|NCT01054885|7347406|FG006|COMPLETED|24-week, Double-blind Treatment Period||158
6432948|NCT01054885|7347400|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
6432949|NCT01054885|7347401|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||59
6432950|NCT01054885|7347402|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||49
6432951|NCT01054885|7347403|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||43
6432952|NCT01054885|7347404|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||42
6432953|NCT01054885|7347405|FG005|NOT COMPLETED|24-week, Double-blind Treatment Period||60
6432954|NCT01054885|7347406|FG006|NOT COMPLETED|24-week, Double-blind Treatment Period||47
6432955|NCT01054911|7347421|FG000|STARTED|Overall Study||5
6432956|NCT01054911|7347421|FG000|COMPLETED|Overall Study||5
6432957|NCT01054911|7347421|FG000|NOT COMPLETED|Overall Study||0
6432958|NCT01054976|7347427|FG000|STARTED|Overall Study||92
6432959|NCT01054976|7347427|FG000|COMPLETED|Overall Study||57
6432960|NCT01054976|7347427|FG000|NOT COMPLETED|Overall Study||35
6432961|NCT01055028|7347433|FG000|STARTED|Screening||9
6432962|NCT01055028|7347434|FG001|STARTED|Screening||9
6552387|NCT01737697|7474897|FG008|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6552388|NCT01737697|7474898|FG009|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6552389|NCT01737697|7474899|FG010|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6552390|NCT01737697|7474900|FG011|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6432963|NCT01055028|7347433|FG000|COMPLETED|Screening||8
6432964|NCT01055028|7347434|FG001|COMPLETED|Screening||8
6432965|NCT01055028|7347433|FG000|NOT COMPLETED|Screening||1
6432966|NCT01055028|7347434|FG001|NOT COMPLETED|Screening||1
6432967|NCT01055028|7347433|FG000|STARTED|Treatment Cycles 1 to 3||8
6432968|NCT01055028|7347434|FG001|STARTED|Treatment Cycles 1 to 3||8
6432969|NCT01055028|7347433|FG000|COMPLETED|Treatment Cycles 1 to 3||6
6432970|NCT01055028|7347434|FG001|COMPLETED|Treatment Cycles 1 to 3||5
6432971|NCT01055028|7347433|FG000|NOT COMPLETED|Treatment Cycles 1 to 3||2
6432972|NCT01055028|7347434|FG001|NOT COMPLETED|Treatment Cycles 1 to 3||3
6432973|NCT01055028|7347433|FG000|STARTED|Inter-treatment Period||6
6432974|NCT01055028|7347434|FG001|STARTED|Inter-treatment Period||5
6432975|NCT01055028|7347433|FG000|COMPLETED|Inter-treatment Period||6
6432976|NCT01055028|7347434|FG001|COMPLETED|Inter-treatment Period||2
6432977|NCT01055028|7347433|FG000|NOT COMPLETED|Inter-treatment Period||0
6432978|NCT01055028|7347434|FG001|NOT COMPLETED|Inter-treatment Period||3
6432979|NCT01055028|7347433|FG000|STARTED|Treatment Cycles 4 to 6||6
6432980|NCT01055028|7347434|FG001|STARTED|Treatment Cycles 4 to 6||2
6432981|NCT01055028|7347433|FG000|COMPLETED|Treatment Cycles 4 to 6||6
6432982|NCT01055028|7347434|FG001|COMPLETED|Treatment Cycles 4 to 6||2
6432983|NCT01055028|7347433|FG000|NOT COMPLETED|Treatment Cycles 4 to 6||0
6552391|NCT01737697|7474901|FG012|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6552392|NCT01737697|7474902|FG013|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6432984|NCT01055028|7347434|FG001|NOT COMPLETED|Treatment Cycles 4 to 6||0
6432985|NCT01055067|7347444|FG000|STARTED|Overall Study||27
6432986|NCT01055067|7347444|FG000|COMPLETED|Overall Study||27
6432987|NCT01055067|7347444|FG000|NOT COMPLETED|Overall Study||0
6432988|NCT01055132|7347450|FG000|STARTED|Period 1 (5-9 Days)||36
6432989|NCT01055132|7347451|FG001|STARTED|Period 1 (5-9 Days)||33
6432990|NCT01055132|7347450|FG000|COMPLETED|Period 1 (5-9 Days)||35
6432991|NCT01055132|7347451|FG001|COMPLETED|Period 1 (5-9 Days)||33
6432992|NCT01055132|7347450|FG000|NOT COMPLETED|Period 1 (5-9 Days)||1
6432993|NCT01055132|7347451|FG001|NOT COMPLETED|Period 1 (5-9 Days)||0
6432994|NCT01055132|7347450|FG000|STARTED|Period 2 (5-9 Days)||35
6432995|NCT01055132|7347451|FG001|STARTED|Period 2 (5-9 Days)||33
6432996|NCT01055132|7347450|FG000|COMPLETED|Period 2 (5-9 Days)||35
6432997|NCT01055132|7347451|FG001|COMPLETED|Period 2 (5-9 Days)||32
6432998|NCT01055132|7347450|FG000|NOT COMPLETED|Period 2 (5-9 Days)||0
6432999|NCT01055132|7347451|FG001|NOT COMPLETED|Period 2 (5-9 Days)||1
6433000|NCT01055171|7347463|FG000|STARTED|Overall Study|Randomized to receive medication.|29
6433001|NCT01055171|7347464|FG001|STARTED|Overall Study|Randomized to receive placebo.|28
6433002|NCT01055171|7347463|FG000|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
6433003|NCT01055171|7347464|FG001|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
6433004|NCT01055171|7347463|FG000|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
6433005|NCT01055171|7347464|FG001|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
6433006|NCT01055171|7347463|FG000|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
6433007|NCT01055171|7347464|FG001|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
6433008|NCT01055171|7347463|FG000|NOT COMPLETED|Overall Study||11
6433009|NCT01055171|7347464|FG001|NOT COMPLETED|Overall Study||7
6433010|NCT01055184|7347470|FG000|STARTED|Overall Study||34
6433011|NCT01055184|7347470|FG000|COMPLETED|Overall Study||34
6433012|NCT01055184|7347470|FG000|NOT COMPLETED|Overall Study||0
6433013|NCT01055197|7347476|FG000|STARTED|Overall Study||51
6433014|NCT01055197|7347477|FG001|STARTED|Overall Study||46
6433015|NCT01055197|7347476|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
6433016|NCT01055197|7347477|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
6433017|NCT01055197|7347476|FG000|NOT COMPLETED|Overall Study||9
6433018|NCT01055197|7347477|FG001|NOT COMPLETED|Overall Study||2
6433019|NCT01055223|7347483|FG000|STARTED|Overall Study||98483
6433020|NCT01055223|7347483|FG000|COMPLETED|Overall Study||98483
6433021|NCT01055223|7347483|FG000|NOT COMPLETED|Overall Study||0
6433022|NCT01055262|7347496|FG000|STARTED|Overall Study||169
6433023|NCT01055262|7347496|FG000|COMPLETED|Overall Study||160
6433024|NCT01055262|7347496|FG000|NOT COMPLETED|Overall Study||9
6433025|NCT01055314|7347502|FG000|STARTED|Overall Study||100
6433026|NCT01055314|7347503|FG001|STARTED|Overall Study||75
6433027|NCT01055314|7347502|FG000|COMPLETED|Overall Study||55
6433028|NCT01055314|7347503|FG001|COMPLETED|Overall Study||37
6433029|NCT01055314|7347502|FG000|NOT COMPLETED|Overall Study||45
6433030|NCT01055314|7347503|FG001|NOT COMPLETED|Overall Study||38
6433031|NCT01055457|7347520|FG000|STARTED|Overall Study||40
6433032|NCT01055457|7347521|FG001|STARTED|Overall Study||40
6433033|NCT01055457|7347522|FG002|STARTED|Overall Study||38
6433034|NCT01055457|7347523|FG003|STARTED|Overall Study||40
6433035|NCT01055457|7347524|FG004|STARTED|Overall Study||41
6433036|NCT01055457|7347525|FG005|STARTED|Overall Study||18
6433037|NCT01055457|7347526|FG006|STARTED|Overall Study||19
6433038|NCT01055457|7347527|FG007|STARTED|Overall Study||19
6433039|NCT01055457|7347528|FG008|STARTED|Overall Study||20
6433040|NCT01055457|7347529|FG009|STARTED|Overall Study||20
6433041|NCT01055457|7347520|FG000|COMPLETED|Overall Study||39
6433042|NCT01055457|7347521|FG001|COMPLETED|Overall Study||39
6433043|NCT01055457|7347522|FG002|COMPLETED|Overall Study||36
6433044|NCT01055457|7347523|FG003|COMPLETED|Overall Study||37
6433045|NCT01055457|7347524|FG004|COMPLETED|Overall Study||38
6433046|NCT01055457|7347525|FG005|COMPLETED|Overall Study||15
6433047|NCT01055457|7347526|FG006|COMPLETED|Overall Study||18
6433048|NCT01055457|7347527|FG007|COMPLETED|Overall Study||18
6433049|NCT01055457|7347528|FG008|COMPLETED|Overall Study||20
6433050|NCT01055457|7347529|FG009|COMPLETED|Overall Study||19
6433051|NCT01055457|7347520|FG000|NOT COMPLETED|Overall Study||1
6433052|NCT01055457|7347521|FG001|NOT COMPLETED|Overall Study||1
6433053|NCT01055457|7347522|FG002|NOT COMPLETED|Overall Study||2
6433054|NCT01055457|7347523|FG003|NOT COMPLETED|Overall Study||3
6552393|NCT01737697|7474903|FG014|NOT COMPLETED|Acute Phase-Initial 48 Hours||0
6433055|NCT01055457|7347524|FG004|NOT COMPLETED|Overall Study||3
6433056|NCT01055457|7347525|FG005|NOT COMPLETED|Overall Study||3
6433057|NCT01055457|7347526|FG006|NOT COMPLETED|Overall Study||1
6433058|NCT01055457|7347527|FG007|NOT COMPLETED|Overall Study||1
6433059|NCT01055457|7347528|FG008|NOT COMPLETED|Overall Study||0
6433060|NCT01055457|7347529|FG009|NOT COMPLETED|Overall Study||1
6433061|NCT01055496|7347553|FG000|STARTED|Overall Study||48
6433062|NCT01055496|7347554|FG001|STARTED|Overall Study||55
6433063|NCT01055496|7347553|FG000|COMPLETED|Overall Study||33
6433064|NCT01055496|7347554|FG001|COMPLETED|Overall Study||25
6433065|NCT01055496|7347553|FG000|NOT COMPLETED|Overall Study||15
6433066|NCT01055496|7347554|FG001|NOT COMPLETED|Overall Study||30
6433067|NCT01055613|7347583|FG000|STARTED|Overall Study||200
6433068|NCT01055613|7347584|FG001|STARTED|Overall Study||100
6433069|NCT01055613|7347583|FG000|COMPLETED|Overall Study||191
6433070|NCT01055613|7347584|FG001|COMPLETED|Overall Study||96
6433071|NCT01055613|7347583|FG000|NOT COMPLETED|Overall Study||9
6433072|NCT01055613|7347584|FG001|NOT COMPLETED|Overall Study||4
6433073|NCT01055639|7347592|FG000|STARTED|Overall Study||66
6433074|NCT01055639|7347593|FG001|STARTED|Overall Study||60
6433075|NCT01055639|7347592|FG000|COMPLETED|Overall Study||45
6433076|NCT01055639|7347593|FG001|COMPLETED|Overall Study||31
6433077|NCT01055639|7347592|FG000|NOT COMPLETED|Overall Study||21
6433078|NCT01055639|7347593|FG001|NOT COMPLETED|Overall Study||29
6433079|NCT01055704|7347603|FG000|STARTED|Overall Study||16
6433080|NCT01055704|7347604|FG001|STARTED|Overall Study||8
6433081|NCT01055704|7347605|FG002|STARTED|Overall Study||16
6433082|NCT01055704|7347606|FG003|STARTED|Overall Study||8
6433083|NCT01055704|7347603|FG000|COMPLETED|Overall Study||16
6433084|NCT01055704|7347604|FG001|COMPLETED|Overall Study||8
6433085|NCT01055704|7347605|FG002|COMPLETED|Overall Study||16
6433086|NCT01055704|7347606|FG003|COMPLETED|Overall Study||8
6433087|NCT01055704|7347603|FG000|NOT COMPLETED|Overall Study||0
6433088|NCT01055704|7347604|FG001|NOT COMPLETED|Overall Study||0
6433089|NCT01055704|7347605|FG002|NOT COMPLETED|Overall Study||0
6433090|NCT01055704|7347606|FG003|NOT COMPLETED|Overall Study||0
6433091|NCT01055769|7347616|FG000|STARTED|First Intervention||10
6433092|NCT01055769|7347617|FG001|STARTED|First Intervention||10
6433093|NCT01055769|7347616|FG000|COMPLETED|First Intervention||10
6433094|NCT01055769|7347617|FG001|COMPLETED|First Intervention||10
6433095|NCT01055769|7347616|FG000|NOT COMPLETED|First Intervention||0
6433096|NCT01055769|7347617|FG001|NOT COMPLETED|First Intervention||0
6433097|NCT01055769|7347616|FG000|STARTED|Washout Period of Atleast 4 Days||10
6433098|NCT01055769|7347617|FG001|STARTED|Washout Period of Atleast 4 Days||10
6433099|NCT01055769|7347616|FG000|COMPLETED|Washout Period of Atleast 4 Days||10
6433100|NCT01055769|7347617|FG001|COMPLETED|Washout Period of Atleast 4 Days||10
6433101|NCT01055769|7347616|FG000|NOT COMPLETED|Washout Period of Atleast 4 Days||0
6433102|NCT01055769|7347617|FG001|NOT COMPLETED|Washout Period of Atleast 4 Days||0
6433103|NCT01055769|7347616|FG000|STARTED|Second Intervention||10
6433104|NCT01055769|7347617|FG001|STARTED|Second Intervention||10
6433105|NCT01055769|7347616|FG000|COMPLETED|Second Intervention||10
6433106|NCT01055769|7347617|FG001|COMPLETED|Second Intervention||10
6433107|NCT01055769|7347616|FG000|NOT COMPLETED|Second Intervention||0
6433108|NCT01055769|7347617|FG001|NOT COMPLETED|Second Intervention||0
6433109|NCT01055782|7347626|FG000|STARTED|Overall Study||555
6433110|NCT01055782|7347627|FG001|STARTED|Overall Study||449
6433111|NCT01055782|7347626|FG000|COMPLETED|Overall Study||555
6433112|NCT01055782|7347627|FG001|COMPLETED|Overall Study||449
6433113|NCT01055782|7347626|FG000|NOT COMPLETED|Overall Study||0
6433114|NCT01055782|7347627|FG001|NOT COMPLETED|Overall Study||0
6433115|NCT01055834|7347637|FG000|STARTED|Treatment Period I||21
6433116|NCT01055834|7347638|FG001|STARTED|Treatment Period I||21
6433117|NCT01055834|7347637|FG000|COMPLETED|Treatment Period I||20
6433118|NCT01055834|7347638|FG001|COMPLETED|Treatment Period I||21
6433119|NCT01055834|7347637|FG000|NOT COMPLETED|Treatment Period I||1
6433120|NCT01055834|7347638|FG001|NOT COMPLETED|Treatment Period I||0
6433121|NCT01055834|7347637|FG000|STARTED|Treatment Period II||20
6433122|NCT01055834|7347638|FG001|STARTED|Treatment Period II||21
6433123|NCT01055834|7347637|FG000|COMPLETED|Treatment Period II||20
6433124|NCT01055834|7347638|FG001|COMPLETED|Treatment Period II||21
6433125|NCT01055834|7347637|FG000|NOT COMPLETED|Treatment Period II||0
6433126|NCT01055834|7347638|FG001|NOT COMPLETED|Treatment Period II||0
6433127|NCT01055834|7347637|FG000|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
6433128|NCT01055834|7347638|FG001|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
6433129|NCT01055834|7347637|FG000|COMPLETED|Treatment Period III||0
6433130|NCT01055834|7347638|FG001|COMPLETED|Treatment Period III||14
6433131|NCT01055834|7347637|FG000|NOT COMPLETED|Treatment Period III||0
6433132|NCT01055834|7347638|FG001|NOT COMPLETED|Treatment Period III||0
6433133|NCT01055886|7347649|FG000|STARTED|Overall Study||33
6433134|NCT01055886|7347650|FG001|STARTED|Overall Study||32
6433135|NCT01055886|7347649|FG000|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
6433136|NCT01055886|7347650|FG001|Reached Pre-quit Period|Overall Study|1 lost to contact|31
6433137|NCT01055886|7347649|FG000|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
6433138|NCT01055886|7347650|FG001|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
6433139|NCT01055886|7347649|FG000|NOT COMPLETED|Overall Study||5
6433140|NCT01055886|7347650|FG001|NOT COMPLETED|Overall Study||11
6499715|NCT01420627|7418445|FG000|STARTED|EZN-2279 Treatment Period||7
6433141|NCT01056016|7347658|FG000|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
6433142|NCT01056016|7347659|FG001|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
6433143|NCT01056016|7347658|FG000|COMPLETED|Overall Study||20
6433144|NCT01056016|7347659|FG001|COMPLETED|Overall Study||26
6433145|NCT01056016|7347658|FG000|NOT COMPLETED|Overall Study||2
6433146|NCT01056016|7347659|FG001|NOT COMPLETED|Overall Study||1
6433147|NCT01056107|7347669|FG000|STARTED|Overall Study||11
6433148|NCT01056107|7347670|FG001|STARTED|Overall Study||11
6433149|NCT01056107|7347671|FG002|STARTED|Overall Study||12
6433150|NCT01056107|7347672|FG003|STARTED|Overall Study||12
6433151|NCT01056107|7347669|FG000|COMPLETED|Overall Study||11
6433152|NCT01056107|7347670|FG001|COMPLETED|Overall Study||10
6433153|NCT01056107|7347671|FG002|COMPLETED|Overall Study||9
6433154|NCT01056107|7347672|FG003|COMPLETED|Overall Study||12
6433155|NCT01056107|7347669|FG000|NOT COMPLETED|Overall Study||0
6433156|NCT01056107|7347670|FG001|NOT COMPLETED|Overall Study||1
6433157|NCT01056107|7347671|FG002|NOT COMPLETED|Overall Study||3
6433158|NCT01056107|7347672|FG003|NOT COMPLETED|Overall Study||0
6433159|NCT01056198|7347684|FG000|STARTED|Overall Study||24
6433160|NCT01056198|7347685|FG001|STARTED|Overall Study||24
6433161|NCT01056198|7347684|FG000|COMPLETED|Overall Study||24
6433162|NCT01056198|7347685|FG001|COMPLETED|Overall Study||24
6433163|NCT01056198|7347684|FG000|NOT COMPLETED|Overall Study||0
6433164|NCT01056198|7347685|FG001|NOT COMPLETED|Overall Study||0
6433165|NCT01056263|7347693|FG000|STARTED|Overall Study||52
6433166|NCT01056263|7347693|FG000|COMPLETED|Overall Study||0
6433167|NCT01056263|7347693|FG000|NOT COMPLETED|Overall Study||52
6433168|NCT01056276|7347699|FG000|STARTED|Treatment Period-Cycles 1-8||18
6433169|NCT01056276|7347700|FG001|STARTED|Treatment Period-Cycles 1-8||41
6433170|NCT01056276|7347699|FG000|COMPLETED|Treatment Period-Cycles 1-8||5
6433171|NCT01056276|7347700|FG001|COMPLETED|Treatment Period-Cycles 1-8||33
6433172|NCT01056276|7347699|FG000|NOT COMPLETED|Treatment Period-Cycles 1-8||13
6433173|NCT01056276|7347700|FG001|NOT COMPLETED|Treatment Period-Cycles 1-8||8
6433174|NCT01056276|7347699|FG000|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
6433175|NCT01056276|7347700|FG001|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
6433176|NCT01056276|7347699|FG000|COMPLETED|Maintenance Therapy||0
6433177|NCT01056276|7347700|FG001|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
6433178|NCT01056276|7347699|FG000|NOT COMPLETED|Maintenance Therapy||0
6433179|NCT01056276|7347700|FG001|NOT COMPLETED|Maintenance Therapy||28
6433180|NCT01056289|7347711|FG000|STARTED|Open-label Phase||480
6433181|NCT01056289|7347712|FG001|STARTED|Open-label Phase||0
6433182|NCT01056289|7347713|FG002|STARTED|Open-label Phase||0
6433183|NCT01056289|7347714|FG003|STARTED|Open-label Phase||0
6433184|NCT01056289|7347711|FG000|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
6433185|NCT01056289|7347712|FG001|COMPLETED|Open-label Phase||0
6433186|NCT01056289|7347713|FG002|COMPLETED|Open-label Phase||0
6433187|NCT01056289|7347714|FG003|COMPLETED|Open-label Phase||0
6433188|NCT01056289|7347711|FG000|NOT COMPLETED|Open-label Phase||119
6433189|NCT01056289|7347712|FG001|NOT COMPLETED|Open-label Phase||0
6433190|NCT01056289|7347713|FG002|NOT COMPLETED|Open-label Phase||0
6433191|NCT01056289|7347714|FG003|NOT COMPLETED|Open-label Phase||0
6433192|NCT01056289|7347711|FG000|STARTED|Double-blind Phase||0
6433193|NCT01056289|7347712|FG001|STARTED|Double-blind Phase||73
6433194|NCT01056289|7347713|FG002|STARTED|Double-blind Phase||140
6433195|NCT01056289|7347714|FG003|STARTED|Double-blind Phase||148
6433196|NCT01056289|7347711|FG000|COMPLETED|Double-blind Phase||0
6433197|NCT01056289|7347712|FG001|COMPLETED|Double-blind Phase||69
6433198|NCT01056289|7347713|FG002|COMPLETED|Double-blind Phase||127
6433199|NCT01056289|7347714|FG003|COMPLETED|Double-blind Phase||138
6433200|NCT01056289|7347711|FG000|NOT COMPLETED|Double-blind Phase||0
6433201|NCT01056289|7347712|FG001|NOT COMPLETED|Double-blind Phase||4
6433202|NCT01056289|7347713|FG002|NOT COMPLETED|Double-blind Phase||13
6433203|NCT01056289|7347714|FG003|NOT COMPLETED|Double-blind Phase||10
6433204|NCT01056302|7347724|FG000|STARTED|Overall Study||3
6433205|NCT01056302|7347724|FG000|COMPLETED|Overall Study|The study was completed with 3 datasets from patients who had maxillofacial trauma and were treated|3
6433206|NCT01056302|7347724|FG000|NOT COMPLETED|Overall Study||0
6433207|NCT01056328|7347731|FG000|STARTED|Overall Study||164
6433208|NCT01056328|7347732|FG001|STARTED|Overall Study||160
6433209|NCT01056328|7347731|FG000|COMPLETED|Overall Study||147
6433210|NCT01056328|7347732|FG001|COMPLETED|Overall Study||144
6433211|NCT01056328|7347731|FG000|NOT COMPLETED|Overall Study||17
6433212|NCT01056328|7347732|FG001|NOT COMPLETED|Overall Study||16
6433213|NCT01056341|7347746|FG000|STARTED|Overall Study||55
6433214|NCT01056341|7347747|FG001|STARTED|Overall Study||99
6433215|NCT01056341|7347748|FG002|STARTED|Overall Study||103
6433216|NCT01056341|7347749|FG003|STARTED|Overall Study||101
6433217|NCT01056341|7347750|FG004|STARTED|Overall Study||102
6433218|NCT01056341|7347746|FG000|Interim Analysis|Overall Study||25
6433219|NCT01056341|7347747|FG001|Interim Analysis|Overall Study||41
6433220|NCT01056341|7347748|FG002|Interim Analysis|Overall Study||41
6433221|NCT01056341|7347749|FG003|Interim Analysis|Overall Study||40
6433222|NCT01056341|7347750|FG004|Interim Analysis|Overall Study||43
6433223|NCT01056341|7347746|FG000|COMPLETED|Overall Study||19
6433224|NCT01056341|7347747|FG001|COMPLETED|Overall Study||63
6433225|NCT01056341|7347748|FG002|COMPLETED|Overall Study||88
6433226|NCT01056341|7347749|FG003|COMPLETED|Overall Study||65
6433227|NCT01056341|7347750|FG004|COMPLETED|Overall Study||88
6433228|NCT01056341|7347746|FG000|NOT COMPLETED|Overall Study||36
6433229|NCT01056341|7347747|FG001|NOT COMPLETED|Overall Study||36
6433230|NCT01056341|7347748|FG002|NOT COMPLETED|Overall Study||15
6433231|NCT01056341|7347749|FG003|NOT COMPLETED|Overall Study||36
6433232|NCT01056341|7347750|FG004|NOT COMPLETED|Overall Study||14
6433233|NCT01056380|7347770|FG000|STARTED|Overall Study||37
6433234|NCT01056380|7347771|FG001|STARTED|Overall Study||42
6433235|NCT01056380|7347770|FG000|COMPLETED|Overall Study||35
6433236|NCT01056380|7347771|FG001|COMPLETED|Overall Study||39
6433237|NCT01056380|7347770|FG000|NOT COMPLETED|Overall Study||2
6433238|NCT01056380|7347771|FG001|NOT COMPLETED|Overall Study||3
6433239|NCT01056484|7347781|FG000|STARTED|Randomized Controlled Trial||64
6433240|NCT01056484|7347782|FG001|STARTED|Randomized Controlled Trial||59
6433241|NCT01056484|7347781|FG000|COMPLETED|Randomized Controlled Trial||57
6433242|NCT01056484|7347782|FG001|COMPLETED|Randomized Controlled Trial||58
6433243|NCT01056484|7347781|FG000|NOT COMPLETED|Randomized Controlled Trial||7
6433244|NCT01056484|7347782|FG001|NOT COMPLETED|Randomized Controlled Trial||1
6433245|NCT01056484|7347781|FG000|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
6433246|NCT01056484|7347782|FG001|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
6433247|NCT01056484|7347781|FG000|COMPLETED|Follow up - Non-randomized||57
6433248|NCT01056484|7347782|FG001|COMPLETED|Follow up - Non-randomized||56
6433249|NCT01056484|7347781|FG000|NOT COMPLETED|Follow up - Non-randomized||0
6433250|NCT01056484|7347782|FG001|NOT COMPLETED|Follow up - Non-randomized||2
6433251|NCT01056510|7347791|FG000|STARTED|Overall Study||178
6433252|NCT01056510|7347792|FG001|STARTED|Overall Study||179
6433253|NCT01056510|7347791|FG000|COMPLETED|Overall Study||124
6433254|NCT01056510|7347792|FG001|COMPLETED|Overall Study||115
6433255|NCT01056510|7347791|FG000|NOT COMPLETED|Overall Study||54
6433256|NCT01056510|7347792|FG001|NOT COMPLETED|Overall Study||64
6433257|NCT01056523|7347798|FG000|STARTED|Overall Study||4
6433258|NCT01056523|7347799|FG001|STARTED|Overall Study||3
6433259|NCT01056523|7347800|FG002|STARTED|Overall Study||5
6652449|NCT02429856|7582069|FG001|STARTED|Overall Study||51
6652450|NCT02429856|7582068|FG000|COMPLETED|Overall Study||30
6652451|NCT02429856|7582069|FG001|COMPLETED|Overall Study||32
6652452|NCT02429856|7582068|FG000|NOT COMPLETED|Overall Study||19
6433260|NCT01056523|7347801|FG003|STARTED|Overall Study||6
6433261|NCT01056523|7347802|FG004|STARTED|Overall Study||3
6433262|NCT01056523|7347803|FG005|STARTED|Overall Study||3
6433263|NCT01056523|7347804|FG006|STARTED|Overall Study||5
6433264|NCT01056523|7347798|FG000|COMPLETED|Overall Study||3
6433265|NCT01056523|7347799|FG001|COMPLETED|Overall Study||3
6433266|NCT01056523|7347800|FG002|COMPLETED|Overall Study||3
6433267|NCT01056523|7347801|FG003|COMPLETED|Overall Study||3
6433268|NCT01056523|7347802|FG004|COMPLETED|Overall Study||3
6433269|NCT01056523|7347803|FG005|COMPLETED|Overall Study||3
6433270|NCT01056523|7347804|FG006|COMPLETED|Overall Study||4
6433271|NCT01056523|7347798|FG000|NOT COMPLETED|Overall Study||1
6433272|NCT01056523|7347799|FG001|NOT COMPLETED|Overall Study||0
6433273|NCT01056523|7347800|FG002|NOT COMPLETED|Overall Study||2
6433274|NCT01056523|7347801|FG003|NOT COMPLETED|Overall Study||3
6433275|NCT01056523|7347802|FG004|NOT COMPLETED|Overall Study||0
6433276|NCT01056523|7347803|FG005|NOT COMPLETED|Overall Study||0
6433277|NCT01056523|7347804|FG006|NOT COMPLETED|Overall Study||1
6433278|NCT01056536|7347812|FG000|STARTED|Overall Study||596
6433279|NCT01056536|7347813|FG001|STARTED|Overall Study||356
6433280|NCT01056536|7347814|FG002|STARTED|Overall Study||729
6433281|NCT01056536|7347812|FG000|COMPLETED|Overall Study||394
6433282|NCT01056536|7347813|FG001|COMPLETED|Overall Study||240
6433283|NCT01056536|7347814|FG002|COMPLETED|Overall Study||481
6433284|NCT01056536|7347812|FG000|NOT COMPLETED|Overall Study||202
6433285|NCT01056536|7347813|FG001|NOT COMPLETED|Overall Study||116
6433286|NCT01056536|7347814|FG002|NOT COMPLETED|Overall Study||248
6433287|NCT01056601|7347822|FG000|STARTED|Overall Study||7
6433288|NCT01056601|7347822|FG000|COMPLETED|Overall Study||7
6433289|NCT01056601|7347822|FG000|NOT COMPLETED|Overall Study||0
6433290|NCT01056640|7347828|FG000|STARTED|Overall Study||102
6433291|NCT01056640|7347829|FG001|STARTED|Overall Study||103
6433292|NCT01056640|7347828|FG000|COMPLETED|Overall Study||76
6433293|NCT01056640|7347829|FG001|COMPLETED|Overall Study||91
6433294|NCT01056640|7347828|FG000|NOT COMPLETED|Overall Study||26
6433295|NCT01056640|7347829|FG001|NOT COMPLETED|Overall Study||12
6433296|NCT01056653|7347838|FG000|STARTED|Overall Study||46
6433297|NCT01056653|7347839|FG001|STARTED|Overall Study||23
6433298|NCT01056653|7347840|FG002|STARTED|Overall Study||44
6433299|NCT01056653|7347838|FG000|COMPLETED|Overall Study||46
6433300|NCT01056653|7347839|FG001|COMPLETED|Overall Study||23
6433301|NCT01056653|7347840|FG002|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
6433302|NCT01056653|7347838|FG000|NOT COMPLETED|Overall Study||0
6433303|NCT01056653|7347839|FG001|NOT COMPLETED|Overall Study||0
6433304|NCT01056653|7347840|FG002|NOT COMPLETED|Overall Study||2
6433305|NCT01056718|7347849|FG000|STARTED|Overall Study||53
6433306|NCT01056718|7347849|FG000|COMPLETED|Overall Study||50
6433307|NCT01056718|7347849|FG000|NOT COMPLETED|Overall Study||3
6433308|NCT01056822|7347856|FG000|STARTED|Overall Study||47
6433309|NCT01056822|7347857|FG001|STARTED|Overall Study||42
6433310|NCT01056822|7347856|FG000|Intention-to-treat (ITT) Population: YES|Overall Study||43
6433311|NCT01056822|7347857|FG001|Intention-to-treat (ITT) Population: YES|Overall Study||38
6433312|NCT01056822|7347856|FG000|Intention-to-treat (ITT) Population: NO|Overall Study||4
6433313|NCT01056822|7347857|FG001|Intention-to-treat (ITT) Population: NO|Overall Study||4
6433314|NCT01056822|7347856|FG000|Per-protocol (PP) Population: YES|Overall Study||29
6433315|NCT01056822|7347857|FG001|Per-protocol (PP) Population: YES|Overall Study||25
6433316|NCT01056822|7347856|FG000|Per-protocol (PP) Population: NO|Overall Study||18
6433317|NCT01056822|7347857|FG001|Per-protocol (PP) Population: NO|Overall Study||17
6433318|NCT01056822|7347856|FG000|Safety (SAF) Population: YES|Overall Study||46
6433319|NCT01056822|7347857|FG001|Safety (SAF) Population: YES|Overall Study||40
6433320|NCT01056822|7347856|FG000|Safety (SAF) Population: NO|Overall Study||1
6433321|NCT01056822|7347857|FG001|Safety (SAF) Population: NO|Overall Study||2
6433322|NCT01056822|7347856|FG000|COMPLETED|Overall Study||39
6433323|NCT01056822|7347857|FG001|COMPLETED|Overall Study||35
6433324|NCT01056822|7347856|FG000|NOT COMPLETED|Overall Study||8
6433325|NCT01056822|7347857|FG001|NOT COMPLETED|Overall Study||7
6433326|NCT01056913|7347864|FG000|STARTED|Overall Study||62
6433327|NCT01056913|7347864|FG000|COMPLETED|Overall Study||62
6433328|NCT01056913|7347864|FG000|NOT COMPLETED|Overall Study||0
6433329|NCT01057017|7347868|FG000|STARTED|Overall Study||5
6433330|NCT01057017|7347868|FG000|COMPLETED|Overall Study||5
6433331|NCT01057017|7347868|FG000|NOT COMPLETED|Overall Study||0
6433332|NCT01057225|7347872|FG000|STARTED|Overall Study||3
6433333|NCT01057225|7347873|FG001|STARTED|Overall Study||3
6433334|NCT01057225|7347874|FG002|STARTED|Overall Study||6
6433335|NCT01057225|7347875|FG003|STARTED|Overall Study||7
6433336|NCT01057225|7347876|FG004|STARTED|Overall Study||22
6433337|NCT01057225|7347877|FG005|STARTED|Overall Study||23
6433338|NCT01057225|7347872|FG000|COMPLETED|Overall Study||3
6433339|NCT01057225|7347873|FG001|COMPLETED|Overall Study||3
6433340|NCT01057225|7347874|FG002|COMPLETED|Overall Study||6
6433341|NCT01057225|7347875|FG003|COMPLETED|Overall Study||7
6433342|NCT01057225|7347876|FG004|COMPLETED|Overall Study||22
6433343|NCT01057225|7347877|FG005|COMPLETED|Overall Study||23
6433344|NCT01057225|7347872|FG000|NOT COMPLETED|Overall Study||0
6433345|NCT01057225|7347873|FG001|NOT COMPLETED|Overall Study||0
6433346|NCT01057225|7347874|FG002|NOT COMPLETED|Overall Study||0
6433347|NCT01057225|7347875|FG003|NOT COMPLETED|Overall Study||0
6433348|NCT01057225|7347876|FG004|NOT COMPLETED|Overall Study||0
6433349|NCT01057225|7347877|FG005|NOT COMPLETED|Overall Study||0
6433350|NCT01057251|7347892|FG000|STARTED|Overall Study||290
6433351|NCT01057251|7347893|FG001|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
6433352|NCT01057251|7347892|FG000|COMPLETED|Overall Study||262
6433353|NCT01057251|7347893|FG001|COMPLETED|Overall Study||114
6433354|NCT01057251|7347892|FG000|NOT COMPLETED|Overall Study||28
6433355|NCT01057251|7347893|FG001|NOT COMPLETED|Overall Study||29
6433356|NCT01057277|7347899|FG000|STARTED|Overall Study||3
6433357|NCT01057277|7347899|FG000|COMPLETED|Overall Study||3
6433358|NCT01057277|7347899|FG000|NOT COMPLETED|Overall Study||0
6433359|NCT01057381|7347907|FG000|STARTED|Overall Study||26
6433360|NCT01057381|7347908|FG001|STARTED|Overall Study||27
6433361|NCT01057381|7347909|FG002|STARTED|Overall Study||30
6433362|NCT01057381|7347910|FG003|STARTED|Overall Study||26
6433363|NCT01057381|7347907|FG000|COMPLETED|Overall Study||26
6433364|NCT01057381|7347908|FG001|COMPLETED|Overall Study||27
6433365|NCT01057381|7347909|FG002|COMPLETED|Overall Study||30
6433366|NCT01057381|7347910|FG003|COMPLETED|Overall Study||26
6433367|NCT01057381|7347907|FG000|NOT COMPLETED|Overall Study||0
6433368|NCT01057381|7347908|FG001|NOT COMPLETED|Overall Study||0
6433369|NCT01057381|7347909|FG002|NOT COMPLETED|Overall Study||0
6433370|NCT01057381|7347910|FG003|NOT COMPLETED|Overall Study||0
6433371|NCT01057394|7347920|FG000|STARTED|Overall Study||0
6433372|NCT01057394|7347921|FG001|STARTED|Overall Study|21 enrolled participants|21
6433373|NCT01057394|7347920|FG000|COMPLETED|Overall Study||0
6433374|NCT01057394|7347921|FG001|COMPLETED|Overall Study|19 treated participants|19
6433375|NCT01057394|7347920|FG000|NOT COMPLETED|Overall Study||0
6433376|NCT01057394|7347921|FG001|NOT COMPLETED|Overall Study||2
6433377|NCT01057433|7347925|FG000|STARTED|Overall Study||24
6433378|NCT01057433|7347925|FG000|COMPLETED|Overall Study||23
6433379|NCT01057433|7347925|FG000|NOT COMPLETED|Overall Study||1
6433380|NCT01057589|7347929|FG000|STARTED|Overall Study||66
6433381|NCT01057589|7347929|FG000|COMPLETED|Overall Study||0
6433382|NCT01057589|7347929|FG000|NOT COMPLETED|Overall Study||66
6433383|NCT01057693|7347933|FG000|STARTED|Single-Blind Phase (Up to Week 6)||665
6652453|NCT02429856|7582069|FG001|NOT COMPLETED|Overall Study||19
6652454|NCT02429869|7582077|FG000|STARTED|Overall Study||10
6433384|NCT01057693|7347934|FG001|STARTED|Single-Blind Phase (Up to Week 6)||0
6433385|NCT01057693|7347935|FG002|STARTED|Single-Blind Phase (Up to Week 6)||0
6433386|NCT01057693|7347933|FG000|COMPLETED|Single-Blind Phase (Up to Week 6)||566
6652455|NCT02429869|7582077|FG000|COMPLETED|Overall Study||10
6433387|NCT01057693|7347934|FG001|COMPLETED|Single-Blind Phase (Up to Week 6)||0
6433388|NCT01057693|7347935|FG002|COMPLETED|Single-Blind Phase (Up to Week 6)||0
6433389|NCT01057693|7347933|FG000|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
6433390|NCT01057693|7347934|FG001|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
6433391|NCT01057693|7347935|FG002|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
6433392|NCT01057693|7347933|FG000|STARTED|Between Single-Blind and Double-Blind||566
6433393|NCT01057693|7347934|FG001|STARTED|Between Single-Blind and Double-Blind||0
6433394|NCT01057693|7347935|FG002|STARTED|Between Single-Blind and Double-Blind||0
6433395|NCT01057693|7347933|FG000|COMPLETED|Between Single-Blind and Double-Blind||296
6433396|NCT01057693|7347934|FG001|COMPLETED|Between Single-Blind and Double-Blind||0
6433397|NCT01057693|7347935|FG002|COMPLETED|Between Single-Blind and Double-Blind||0
6433398|NCT01057693|7347933|FG000|NOT COMPLETED|Between Single-Blind and Double-Blind||270
6433399|NCT01057693|7347934|FG001|NOT COMPLETED|Between Single-Blind and Double-Blind||0
6433400|NCT01057693|7347935|FG002|NOT COMPLETED|Between Single-Blind and Double-Blind||0
6433401|NCT01057693|7347933|FG000|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
6433402|NCT01057693|7347934|FG001|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
6433403|NCT01057693|7347935|FG002|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
6433404|NCT01057693|7347933|FG000|Treated|Double-Blind Phase (Week 7 to Week 19)||0
6433405|NCT01057693|7347934|FG001|Treated|Double-Blind Phase (Week 7 to Week 19)||147
6433406|NCT01057693|7347935|FG002|Treated|Double-Blind Phase (Week 7 to Week 19)||147
6433407|NCT01057693|7347933|FG000|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
6433408|NCT01057693|7347934|FG001|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
6433409|NCT01057693|7347935|FG002|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
6433410|NCT01057693|7347933|FG000|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
6433411|NCT01057693|7347934|FG001|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
6433412|NCT01057693|7347935|FG002|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
6433413|NCT01057810|7347945|FG000|STARTED|Overall Study||199
6433414|NCT01057810|7347946|FG001|STARTED|Overall Study||399
6433415|NCT01057810|7347945|FG000|COMPLETED|Overall Study||1
6433416|NCT01057810|7347946|FG001|COMPLETED|Overall Study||1
6433417|NCT01057810|7347945|FG000|NOT COMPLETED|Overall Study||198
6433418|NCT01057810|7347946|FG001|NOT COMPLETED|Overall Study||398
6433419|NCT01057862|7347954|FG000|STARTED|Overall Study||5
6433420|NCT01057862|7347955|FG001|STARTED|Overall Study||4
6433421|NCT01057862|7347954|FG000|COMPLETED|Overall Study||4
6433422|NCT01057862|7347955|FG001|COMPLETED|Overall Study||2
6433423|NCT01057862|7347954|FG000|NOT COMPLETED|Overall Study||1
6433424|NCT01057862|7347955|FG001|NOT COMPLETED|Overall Study||2
6433425|NCT01057888|7347964|FG000|STARTED|Overall Study||2504
6433426|NCT01057888|7347965|FG001|STARTED|Overall Study||2406
6433427|NCT01057888|7347966|FG002|STARTED|Overall Study||2494
6433428|NCT01057888|7347964|FG000|COMPLETED|Overall Study||2504
6433429|NCT01057888|7347965|FG001|COMPLETED|Overall Study||2406
6433430|NCT01057888|7347966|FG002|COMPLETED|Overall Study||2494
6433431|NCT01057888|7347964|FG000|NOT COMPLETED|Overall Study||0
6433432|NCT01057888|7347965|FG001|NOT COMPLETED|Overall Study||0
6433433|NCT01057888|7347966|FG002|NOT COMPLETED|Overall Study||0
6433434|NCT01057901|7347974|FG000|STARTED|Overall Study||376
6433435|NCT01057901|7347975|FG001|STARTED|Overall Study||372
6433436|NCT01057901|7347974|FG000|COMPLETED|Overall Study||116
6433437|NCT01057901|7347975|FG001|COMPLETED|Overall Study||126
6433438|NCT01057901|7347974|FG000|NOT COMPLETED|Overall Study||260
6433439|NCT01057901|7347975|FG001|NOT COMPLETED|Overall Study||246
6433440|NCT01058005|7347984|FG000|STARTED|Overall Study||38
6433441|NCT01058005|7347985|FG001|STARTED|Overall Study||25
6433442|NCT01058005|7347986|FG002|STARTED|Overall Study||21
6433443|NCT01058005|7347984|FG000|Dosed With Study Treatment|Overall Study||36
6433444|NCT01058005|7347985|FG001|Dosed With Study Treatment|Overall Study||22
6433445|NCT01058005|7347986|FG002|Dosed With Study Treatment|Overall Study||17
6433446|NCT01058005|7347984|FG000|COMPLETED|Overall Study||0
6433447|NCT01058005|7347985|FG001|COMPLETED|Overall Study||0
6433448|NCT01058005|7347986|FG002|COMPLETED|Overall Study||1
6433449|NCT01058005|7347984|FG000|NOT COMPLETED|Overall Study||38
6433450|NCT01058005|7347985|FG001|NOT COMPLETED|Overall Study||25
6433451|NCT01058005|7347986|FG002|NOT COMPLETED|Overall Study||20
6433452|NCT01058070|7347994|FG000|STARTED|Overall Study||44
6433453|NCT01058070|7347994|FG000|COMPLETED|Overall Study||33
6433454|NCT01058070|7347994|FG000|NOT COMPLETED|Overall Study||11
6433455|NCT01058096|7348001|FG000|STARTED|Double-blind Treatment Phase||154
6433456|NCT01058096|7348002|FG001|STARTED|Double-blind Treatment Phase||158
6433457|NCT01058096|7348001|FG000|COMPLETED|Double-blind Treatment Phase||106
6433458|NCT01058096|7348002|FG001|COMPLETED|Double-blind Treatment Phase||108
6433459|NCT01058096|7348001|FG000|NOT COMPLETED|Double-blind Treatment Phase||48
6433460|NCT01058096|7348002|FG001|NOT COMPLETED|Double-blind Treatment Phase||50
6433461|NCT01058096|7348001|FG000|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
6433462|NCT01058096|7348002|FG001|STARTED|Safety Follow-up||134
6433463|NCT01058096|7348001|FG000|COMPLETED|Safety Follow-up||129
6433464|NCT01058096|7348002|FG001|COMPLETED|Safety Follow-up||130
6433465|NCT01058096|7348001|FG000|NOT COMPLETED|Safety Follow-up||4
6433466|NCT01058096|7348002|FG001|NOT COMPLETED|Safety Follow-up||4
6433467|NCT01058239|7348008|FG000|STARTED|Overall Study||7
6433468|NCT01058239|7348008|FG000|COMPLETED|Overall Study||7
6433469|NCT01058239|7348008|FG000|NOT COMPLETED|Overall Study||0
6433470|NCT01058265|7348014|FG000|STARTED|Overall Study||22
6433471|NCT01058265|7348015|FG001|STARTED|Overall Study||25
6433472|NCT01058265|7348014|FG000|COMPLETED|Overall Study||11
6433473|NCT01058265|7348015|FG001|COMPLETED|Overall Study||13
6433474|NCT01058265|7348014|FG000|NOT COMPLETED|Overall Study||11
6433475|NCT01058265|7348015|FG001|NOT COMPLETED|Overall Study||12
6433476|NCT01058304|7348023|FG000|STARTED|Overall Study||159
6433477|NCT01058304|7348024|FG001|STARTED|Overall Study||161
6433478|NCT01058304|7348023|FG000|COMPLETED|Overall Study||132
6433479|NCT01058304|7348024|FG001|COMPLETED|Overall Study||128
6433480|NCT01058304|7348023|FG000|NOT COMPLETED|Overall Study||27
6433481|NCT01058304|7348024|FG001|NOT COMPLETED|Overall Study||33
6433482|NCT01058356|7348030|FG000|STARTED|Overall Study||214
6433483|NCT01058356|7348030|FG000|COMPLETED|Overall Study||172
6433484|NCT01058356|7348030|FG000|NOT COMPLETED|Overall Study||42
6433485|NCT01058395|7348036|FG000|STARTED|Overall Study||7
6433486|NCT01058395|7348037|FG001|STARTED|Overall Study||8
6433487|NCT01058395|7348036|FG000|COMPLETED|Overall Study|Two died, and one was lost to followup.|4
6433488|NCT01058395|7348037|FG001|COMPLETED|Overall Study|One died after enrollment. The patient died in the first 48 hours.|7
6433489|NCT01058395|7348036|FG000|NOT COMPLETED|Overall Study||3
6433490|NCT01058395|7348037|FG001|NOT COMPLETED|Overall Study||1
6433491|NCT01058421|7348045|FG000|STARTED|1 Month Outcomes||59
6433492|NCT01058421|7348046|FG001|STARTED|1 Month Outcomes||61
6433493|NCT01058421|7348045|FG000|COMPLETED|1 Month Outcomes||20
6433494|NCT01058421|7348046|FG001|COMPLETED|1 Month Outcomes||19
6433495|NCT01058421|7348045|FG000|NOT COMPLETED|1 Month Outcomes||39
6433496|NCT01058421|7348046|FG001|NOT COMPLETED|1 Month Outcomes||42
6433497|NCT01058421|7348045|FG000|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
6433498|NCT01058421|7348046|FG001|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
6433499|NCT01058421|7348045|FG000|COMPLETED|3 Month Outcomes||29
6433500|NCT01058421|7348046|FG001|COMPLETED|3 Month Outcomes||29
6433501|NCT01058421|7348045|FG000|NOT COMPLETED|3 Month Outcomes||20
6433502|NCT01058421|7348046|FG001|NOT COMPLETED|3 Month Outcomes||26
6433503|NCT01058421|7348045|FG000|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
6433504|NCT01058421|7348046|FG001|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
6552394|NCT01737697|7474889|FG000|STARTED|Subacute Phase||0
6552395|NCT01737697|7474890|FG001|STARTED|Subacute Phase||0
6552396|NCT01737697|7474891|FG002|STARTED|Subacute Phase||0
6552397|NCT01737697|7474892|FG003|STARTED|Subacute Phase||0
6552398|NCT01737697|7474893|FG004|STARTED|Subacute Phase||0
6552399|NCT01737697|7474894|FG005|STARTED|Subacute Phase||41
6552400|NCT01737697|7474895|FG006|STARTED|Subacute Phase||49
6552401|NCT01737697|7474896|FG007|STARTED|Subacute Phase||46
6552402|NCT01737697|7474897|FG008|STARTED|Subacute Phase||54
6433505|NCT01058421|7348045|FG000|COMPLETED|6 Month Outcomes||27
6433506|NCT01058421|7348046|FG001|COMPLETED|6 Month Outcomes||24
6433507|NCT01058421|7348045|FG000|NOT COMPLETED|6 Month Outcomes||19
6433508|NCT01058421|7348046|FG001|NOT COMPLETED|6 Month Outcomes||26
6433509|NCT01058655|7348056|FG000|STARTED|Overall Study||3
6433510|NCT01058655|7348057|FG001|STARTED|Overall Study||3
6433511|NCT01058655|7348058|FG002|STARTED|Overall Study||8
6433512|NCT01058655|7348059|FG003|STARTED|Overall Study||42
6433513|NCT01058655|7348056|FG000|Evaluable|Overall Study||3
6433514|NCT01058655|7348057|FG001|Evaluable|Overall Study||3
6433515|NCT01058655|7348058|FG002|Evaluable|Overall Study||6
6433516|NCT01058655|7348059|FG003|Evaluable|Overall Study||40
6433517|NCT01058655|7348056|FG000|COMPLETED|Overall Study||0
6433518|NCT01058655|7348057|FG001|COMPLETED|Overall Study||0
6433519|NCT01058655|7348058|FG002|COMPLETED|Overall Study||0
6433520|NCT01058655|7348059|FG003|COMPLETED|Overall Study||0
6433521|NCT01058655|7348056|FG000|NOT COMPLETED|Overall Study||3
6433522|NCT01058655|7348057|FG001|NOT COMPLETED|Overall Study||3
6433523|NCT01058655|7348058|FG002|NOT COMPLETED|Overall Study||8
6433524|NCT01058655|7348059|FG003|NOT COMPLETED|Overall Study||42
6433525|NCT01058668|7348073|FG000|STARTED|Double-blind Treatment Phase||161
6433526|NCT01058668|7348074|FG001|STARTED|Double-blind Treatment Phase||167
6433527|NCT01058668|7348075|FG002|STARTED|Double-blind Treatment Phase||169
6433528|NCT01058668|7348073|FG000|COMPLETED|Double-blind Treatment Phase||122
6433529|NCT01058668|7348074|FG001|COMPLETED|Double-blind Treatment Phase||129
6433530|NCT01058668|7348075|FG002|COMPLETED|Double-blind Treatment Phase||119
6433531|NCT01058668|7348073|FG000|NOT COMPLETED|Double-blind Treatment Phase||39
6433532|NCT01058668|7348074|FG001|NOT COMPLETED|Double-blind Treatment Phase||38
6433533|NCT01058668|7348075|FG002|NOT COMPLETED|Double-blind Treatment Phase||50
6433534|NCT01058668|7348073|FG000|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
6433535|NCT01058668|7348074|FG001|STARTED|Safety Follow-up||146
6433536|NCT01058668|7348075|FG002|STARTED|Safety Follow-up||148
6433537|NCT01058668|7348073|FG000|COMPLETED|Safety Follow-up||139
6433538|NCT01058668|7348074|FG001|COMPLETED|Safety Follow-up||146
6433539|NCT01058668|7348075|FG002|COMPLETED|Safety Follow-up||141
6552403|NCT01737697|7474898|FG009|STARTED|Subacute Phase||68
6433540|NCT01058668|7348073|FG000|NOT COMPLETED|Safety Follow-up||5
6433541|NCT01058668|7348074|FG001|NOT COMPLETED|Safety Follow-up||0
6433542|NCT01058668|7348075|FG002|NOT COMPLETED|Safety Follow-up||7
6433543|NCT01058707|7348090|FG000|STARTED|Overall Study||31
6552404|NCT01737697|7474899|FG010|STARTED|Subacute Phase||65
6552405|NCT01737697|7474900|FG011|STARTED|Subacute Phase||61
6552406|NCT01737697|7474901|FG012|STARTED|Subacute Phase||63
6552407|NCT01737697|7474902|FG013|STARTED|Subacute Phase||46
6433544|NCT01058707|7348091|FG001|STARTED|Overall Study||30
6433545|NCT01058707|7348092|FG002|STARTED|Overall Study||33
6433546|NCT01058707|7348093|FG003|STARTED|Overall Study||22
6552408|NCT01737697|7474903|FG014|STARTED|Subacute Phase||50
6552409|NCT01737697|7474889|FG000|COMPLETED|Subacute Phase||0
6552410|NCT01737697|7474890|FG001|COMPLETED|Subacute Phase||0
6552411|NCT01737697|7474891|FG002|COMPLETED|Subacute Phase||0
6433547|NCT01058707|7348094|FG004|STARTED|Overall Study||39
6433548|NCT01058707|7348095|FG005|STARTED|Overall Study||17
6433549|NCT01058707|7348096|FG006|STARTED|Overall Study||26
6433550|NCT01058707|7348090|FG000|COMPLETED|Overall Study||0
6433551|NCT01058707|7348091|FG001|COMPLETED|Overall Study||0
6433552|NCT01058707|7348092|FG002|COMPLETED|Overall Study||0
6433553|NCT01058707|7348093|FG003|COMPLETED|Overall Study||0
6433554|NCT01058707|7348094|FG004|COMPLETED|Overall Study||0
6433555|NCT01058707|7348095|FG005|COMPLETED|Overall Study||0
6433556|NCT01058707|7348096|FG006|COMPLETED|Overall Study||0
6433557|NCT01058707|7348090|FG000|NOT COMPLETED|Overall Study||31
6433558|NCT01058707|7348091|FG001|NOT COMPLETED|Overall Study||30
6433559|NCT01058707|7348092|FG002|NOT COMPLETED|Overall Study||33
6433560|NCT01058707|7348093|FG003|NOT COMPLETED|Overall Study||22
6433561|NCT01058707|7348094|FG004|NOT COMPLETED|Overall Study||39
6433562|NCT01058707|7348095|FG005|NOT COMPLETED|Overall Study||17
6433563|NCT01058707|7348096|FG006|NOT COMPLETED|Overall Study||26
6433564|NCT01058863|7348134|FG000|STARTED|Overall Study||72
6433565|NCT01058863|7348134|FG000|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
6433566|NCT01058863|7348134|FG000|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
6433567|NCT01058863|7348134|FG000|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
6433568|NCT01058863|7348134|FG000|Treated With ProAir® HFA 90 mcg|Overall Study||70
6433569|NCT01058863|7348134|FG000|Treated With ProAir® HFA 180 mcg|Overall Study||68
6433570|NCT01058863|7348134|FG000|Treated With Placebo Inhaler|Overall Study||69
6433571|NCT01058863|7348134|FG000|COMPLETED|Overall Study||68
6433572|NCT01058863|7348134|FG000|NOT COMPLETED|Overall Study||4
6433573|NCT01058941|7348149|FG000|STARTED|Overall Study||34
6433574|NCT01058941|7348150|FG001|STARTED|Overall Study||33
6433575|NCT01058941|7348149|FG000|COMPLETED|Overall Study||25
6433576|NCT01058941|7348150|FG001|COMPLETED|Overall Study||22
6433577|NCT01058941|7348149|FG000|NOT COMPLETED|Overall Study||9
6433578|NCT01058941|7348150|FG001|NOT COMPLETED|Overall Study||11
6433579|NCT01058993|7348156|FG000|STARTED|Overall Study||6
6433580|NCT01058993|7348156|FG000|COMPLETED|Overall Study||6
6433581|NCT01058993|7348156|FG000|NOT COMPLETED|Overall Study||0
6433582|NCT01059175|7348162|FG000|STARTED|Overall Study||43
6433583|NCT01059175|7348163|FG001|STARTED|Overall Study||41
6433584|NCT01059175|7348162|FG000|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
6433585|NCT01059175|7348163|FG001|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
6433586|NCT01059175|7348162|FG000|NOT COMPLETED|Overall Study||21
6433587|NCT01059175|7348163|FG001|NOT COMPLETED|Overall Study||20
6433588|NCT01059305|7348169|FG000|STARTED|Overall Study||10
6433589|NCT01059305|7348169|FG000|COMPLETED|Overall Study||10
6433590|NCT01059305|7348169|FG000|NOT COMPLETED|Overall Study||0
6433591|NCT01059318|7348173|FG000|STARTED|Core Study (26 Week)|This is safety set and Pharmacodynamic set|24
6433592|NCT01059318|7348173|FG000|Everolimus 2.5 mg for 4 Weeks|Core Study (26 Week)||24
6433593|NCT01059318|7348173|FG000|Everolimus 5 mg for 4 Weeks|Core Study (26 Week)||24
6433594|NCT01059318|7348173|FG000|Everolimus 10 mg for 18 Weeks|Core Study (26 Week)||24
6433595|NCT01059318|7348173|FG000|Pharmacokinetics (PK) Analysis Set|Core Study (26 Week)|For 8 patients plasma rather than whole blood sample was collected, hence excluded from PK set.|16
6433596|NCT01059318|7348173|FG000|COMPLETED|Core Study (26 Week)||20
6433597|NCT01059318|7348173|FG000|NOT COMPLETED|Core Study (26 Week)||4
6433598|NCT01059318|7348173|FG000|STARTED|Extension (36 Week)||20
6433599|NCT01059318|7348173|FG000|COMPLETED|Extension (36 Week)||17
6433600|NCT01059318|7348173|FG000|NOT COMPLETED|Extension (36 Week)||3
6433601|NCT01059344|7348182|FG000|STARTED|Overall Study||140
6433602|NCT01059344|7348183|FG001|STARTED|Overall Study||141
6433603|NCT01059344|7348182|FG000|COMPLETED|Overall Study||118
6433604|NCT01059344|7348183|FG001|COMPLETED|Overall Study||95
6433605|NCT01059344|7348182|FG000|NOT COMPLETED|Overall Study||22
6433606|NCT01059344|7348183|FG001|NOT COMPLETED|Overall Study||46
6499716|NCT01420627|7418445|FG000|COMPLETED|EZN-2279 Treatment Period||6
6499717|NCT01420627|7418445|FG000|NOT COMPLETED|EZN-2279 Treatment Period||1
6499718|NCT01420627|7418445|FG000|STARTED|EZN-2279 Maintenance Period||6
6499719|NCT01420627|7418445|FG000|COMPLETED|EZN-2279 Maintenance Period||6
6499720|NCT01420627|7418445|FG000|NOT COMPLETED|EZN-2279 Maintenance Period||0
6499721|NCT01420653|7418457|FG000|STARTED|Overall Study||110
6499722|NCT01420653|7418458|FG001|STARTED|Overall Study||111
6499723|NCT01420653|7418459|FG002|STARTED|Overall Study||112
6499724|NCT01420653|7418460|FG003|STARTED|Overall Study||75
6499725|NCT01420653|7418457|FG000|COMPLETED|Overall Study||107
6499726|NCT01420653|7418458|FG001|COMPLETED|Overall Study||108
6499727|NCT01420653|7418459|FG002|COMPLETED|Overall Study||108
6499728|NCT01420653|7418460|FG003|COMPLETED|Overall Study||68
6499729|NCT01420653|7418457|FG000|NOT COMPLETED|Overall Study||3
6499730|NCT01420653|7418458|FG001|NOT COMPLETED|Overall Study||3
6499731|NCT01420653|7418459|FG002|NOT COMPLETED|Overall Study||4
6499732|NCT01420653|7418460|FG003|NOT COMPLETED|Overall Study||7
6499733|NCT01420679|7418472|FG000|STARTED|Overall Study||14
6499734|NCT01420679|7418473|FG001|STARTED|Overall Study||7
6499735|NCT01420679|7418472|FG000|COMPLETED|Overall Study||0
6499736|NCT01420679|7418473|FG001|COMPLETED|Overall Study||0
6499737|NCT01420679|7418472|FG000|NOT COMPLETED|Overall Study||14
6499738|NCT01420679|7418473|FG001|NOT COMPLETED|Overall Study||7
6499739|NCT01420848|7418482|FG000|STARTED|Overall Study||24
6499740|NCT01420848|7418483|FG001|STARTED|Overall Study||25
6433607|NCT01059357|7348191|FG000|STARTED|Overall Study||58
6433608|NCT01059357|7348191|FG000|COMPLETED|Overall Study||54
6433609|NCT01059357|7348191|FG000|NOT COMPLETED|Overall Study||4
6433610|NCT01059435|7348205|FG000|STARTED|Overall Study||14
6433611|NCT01059435|7348206|FG001|STARTED|Overall Study||6
6433612|NCT01059435|7348207|FG002|STARTED|Overall Study||8
6433613|NCT01059435|7348208|FG003|STARTED|Overall Study||9
6433614|NCT01059435|7348209|FG004|STARTED|Overall Study||6
6433615|NCT01059435|7348210|FG005|STARTED|Overall Study||9
6433616|NCT01059435|7348211|FG006|STARTED|Overall Study||6
6433617|NCT01059435|7348212|FG007|STARTED|Overall Study||4
6433618|NCT01059435|7348213|FG008|STARTED|Overall Study||6
6433619|NCT01059435|7348214|FG009|STARTED|Overall Study||6
6433620|NCT01059435|7348205|FG000|Received Study Drug|Overall Study||14
6433621|NCT01059435|7348206|FG001|Received Study Drug|Overall Study||6
6433622|NCT01059435|7348207|FG002|Received Study Drug|Overall Study||6
6433623|NCT01059435|7348208|FG003|Received Study Drug|Overall Study||9
6433624|NCT01059435|7348209|FG004|Received Study Drug|Overall Study||6
6433625|NCT01059435|7348210|FG005|Received Study Drug|Overall Study||9
6433626|NCT01059435|7348211|FG006|Received Study Drug|Overall Study||6
6433627|NCT01059435|7348212|FG007|Received Study Drug|Overall Study||4
6433628|NCT01059435|7348213|FG008|Received Study Drug|Overall Study||6
6433629|NCT01059435|7348214|FG009|Received Study Drug|Overall Study||6
6433630|NCT01059435|7348205|FG000|COMPLETED|Overall Study||14
6433631|NCT01059435|7348206|FG001|COMPLETED|Overall Study||6
6433632|NCT01059435|7348207|FG002|COMPLETED|Overall Study||6
6433633|NCT01059435|7348208|FG003|COMPLETED|Overall Study||9
6433634|NCT01059435|7348209|FG004|COMPLETED|Overall Study||6
6433635|NCT01059435|7348210|FG005|COMPLETED|Overall Study||9
6652456|NCT02429869|7582077|FG000|NOT COMPLETED|Overall Study||0
6652457|NCT02429934|7582083|FG000|STARTED|Overall Study||15
6652458|NCT02429934|7582084|FG001|STARTED|Overall Study||13
6652459|NCT02429934|7582083|FG000|COMPLETED|Overall Study||11
6652460|NCT02429934|7582084|FG001|COMPLETED|Overall Study||10
6433636|NCT01059435|7348211|FG006|COMPLETED|Overall Study||6
6433637|NCT01059435|7348212|FG007|COMPLETED|Overall Study||4
6433638|NCT01059435|7348213|FG008|COMPLETED|Overall Study||6
6433639|NCT01059435|7348214|FG009|COMPLETED|Overall Study||6
6433640|NCT01059435|7348205|FG000|NOT COMPLETED|Overall Study||0
6433641|NCT01059435|7348206|FG001|NOT COMPLETED|Overall Study||0
6433642|NCT01059435|7348207|FG002|NOT COMPLETED|Overall Study||2
6433643|NCT01059435|7348208|FG003|NOT COMPLETED|Overall Study||0
6433644|NCT01059435|7348209|FG004|NOT COMPLETED|Overall Study||0
6433645|NCT01059435|7348210|FG005|NOT COMPLETED|Overall Study||0
6433646|NCT01059435|7348211|FG006|NOT COMPLETED|Overall Study||0
6433647|NCT01059435|7348212|FG007|NOT COMPLETED|Overall Study||0
6433648|NCT01059435|7348213|FG008|NOT COMPLETED|Overall Study||0
6433649|NCT01059435|7348214|FG009|NOT COMPLETED|Overall Study||0
6433650|NCT01059526|7348248|FG000|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
6433651|NCT01059526|7348249|FG001|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
6433652|NCT01059526|7348248|FG000|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
6433653|NCT01059526|7348249|FG001|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
6433654|NCT01059526|7348248|FG000|COMPLETED|Overall Study||11
6433655|NCT01059526|7348249|FG001|COMPLETED|Overall Study||18
6433656|NCT01059526|7348248|FG000|NOT COMPLETED|Overall Study||30
6433657|NCT01059526|7348249|FG001|NOT COMPLETED|Overall Study||22
6433658|NCT01059539|7348255|FG000|STARTED|Overall Study||403
6433659|NCT01059539|7348255|FG000|COMPLETED|Overall Study||132
6433660|NCT01059539|7348255|FG000|NOT COMPLETED|Overall Study||271
6433661|NCT01059565|7348261|FG000|STARTED|24-Week Randomized Phase||49
6433662|NCT01059565|7348262|FG001|STARTED|24-Week Randomized Phase||52
6433663|NCT01059565|7348261|FG000|Randomized and Treated|24-Week Randomized Phase||48
6433664|NCT01059565|7348262|FG001|Randomized and Treated|24-Week Randomized Phase||52
6433665|NCT01059565|7348261|FG000|COMPLETED|24-Week Randomized Phase||39
6433666|NCT01059565|7348262|FG001|COMPLETED|24-Week Randomized Phase||45
6433667|NCT01059565|7348261|FG000|NOT COMPLETED|24-Week Randomized Phase||10
6433668|NCT01059565|7348262|FG001|NOT COMPLETED|24-Week Randomized Phase||7
6433669|NCT01059565|7348261|FG000|STARTED|24-Week Open-Label Phase||39
6433670|NCT01059565|7348262|FG001|STARTED|24-Week Open-Label Phase||45
6433671|NCT01059565|7348261|FG000|COMPLETED|24-Week Open-Label Phase||34
6433672|NCT01059565|7348262|FG001|COMPLETED|24-Week Open-Label Phase||42
6433673|NCT01059565|7348261|FG000|NOT COMPLETED|24-Week Open-Label Phase||5
6433674|NCT01059565|7348262|FG001|NOT COMPLETED|24-Week Open-Label Phase||3
6433675|NCT01059617|7348274|FG000|STARTED|Overall Study||33
6433676|NCT01059617|7348275|FG001|STARTED|Overall Study||34
6433677|NCT01059617|7348276|FG002|STARTED|Overall Study||33
6433678|NCT01059617|7348277|FG003|STARTED|Overall Study||33
6433679|NCT01059617|7348274|FG000|COMPLETED|Overall Study||26
6433680|NCT01059617|7348275|FG001|COMPLETED|Overall Study||33
6433681|NCT01059617|7348276|FG002|COMPLETED|Overall Study||25
6433682|NCT01059617|7348277|FG003|COMPLETED|Overall Study||27
6433683|NCT01059617|7348274|FG000|NOT COMPLETED|Overall Study||7
6433684|NCT01059617|7348275|FG001|NOT COMPLETED|Overall Study||1
6433685|NCT01059617|7348276|FG002|NOT COMPLETED|Overall Study||8
6652461|NCT02429934|7582083|FG000|NOT COMPLETED|Overall Study||4
6433686|NCT01059617|7348277|FG003|NOT COMPLETED|Overall Study||6
6433687|NCT01059630|7348297|FG000|STARTED|Overall Study||209
6433688|NCT01059630|7348298|FG001|STARTED|Overall Study||204
6433689|NCT01059630|7348297|FG000|COMPLETED|Overall Study||82
6433690|NCT01059630|7348298|FG001|COMPLETED|Overall Study||101
6433691|NCT01059630|7348297|FG000|NOT COMPLETED|Overall Study||127
6433692|NCT01059630|7348298|FG001|NOT COMPLETED|Overall Study||103
6433693|NCT01059643|7348304|FG000|STARTED|Overall Study||103
6433694|NCT01059643|7348304|FG000|Received at Least 1 Dose of Study Drug|Overall Study||103
6433695|NCT01059643|7348304|FG000|COMPLETED|Overall Study||97
6433696|NCT01059643|7348304|FG000|NOT COMPLETED|Overall Study||6
6433697|NCT01059682|7348313|FG000|STARTED|Overall Study||474
6433698|NCT01059682|7348314|FG001|STARTED|Overall Study||462
6433699|NCT01059682|7348313|FG000|COMPLETED|Overall Study||464
6433700|NCT01059682|7348314|FG001|COMPLETED|Overall Study||444
6433701|NCT01059682|7348313|FG000|NOT COMPLETED|Overall Study||10
6433702|NCT01059682|7348314|FG001|NOT COMPLETED|Overall Study||18
6433703|NCT01059760|7348322|FG000|STARTED|Overall Study||16
6433704|NCT01059760|7348323|FG001|STARTED|Overall Study||14
6433705|NCT01059760|7348322|FG000|COMPLETED|Overall Study||16
6433706|NCT01059760|7348323|FG001|COMPLETED|Overall Study||14
6433707|NCT01059760|7348322|FG000|NOT COMPLETED|Overall Study||0
6433708|NCT01059760|7348323|FG001|NOT COMPLETED|Overall Study||0
6433709|NCT01059773|7348332|FG000|STARTED|Overall Study||244
6433710|NCT01059773|7348333|FG001|STARTED|Overall Study||245
6433711|NCT01059773|7348332|FG000|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
6433712|NCT01059773|7348333|FG001|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
6433713|NCT01059773|7348332|FG000|NOT COMPLETED|Overall Study||20
6433714|NCT01059773|7348333|FG001|NOT COMPLETED|Overall Study||24
6433715|NCT01059799|7348346|FG000|STARTED|Overall Study||289
6433716|NCT01059799|7348347|FG001|STARTED|Overall Study||146
6433717|NCT01059799|7348346|FG000|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
6433718|NCT01059799|7348347|FG001|Exposed|Overall Study||146
6433719|NCT01059799|7348346|FG000|COMPLETED|Overall Study||258
6433720|NCT01059799|7348347|FG001|COMPLETED|Overall Study||136
6433721|NCT01059799|7348346|FG000|NOT COMPLETED|Overall Study||31
6433722|NCT01059799|7348347|FG001|NOT COMPLETED|Overall Study||10
6433723|NCT01059812|7348355|FG000|STARTED|Overall Study||282
6433724|NCT01059812|7348356|FG001|STARTED|Overall Study||142
6433725|NCT01059812|7348355|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
6433726|NCT01059812|7348356|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
6433727|NCT01059812|7348355|FG000|COMPLETED|Overall Study||245
6433728|NCT01059812|7348356|FG001|COMPLETED|Overall Study||126
6433729|NCT01059812|7348355|FG000|NOT COMPLETED|Overall Study||37
6433730|NCT01059812|7348356|FG001|NOT COMPLETED|Overall Study||16
6433731|NCT01059825|7348368|FG000|STARTED|Enrolled, Run-in Period||0
6433732|NCT01059825|7348369|FG001|STARTED|Enrolled, Run-in Period||0
6433733|NCT01059825|7348370|FG002|STARTED|Enrolled, Run-in Period||0
6433734|NCT01059825|7348371|FG003|STARTED|Enrolled, Run-in Period||0
6433735|NCT01059825|7348372|FG004|STARTED|Enrolled, Run-in Period||0
6433736|NCT01059825|7348373|FG005|STARTED|Enrolled, Run-in Period||0
6433737|NCT01059825|7348374|FG006|STARTED|Enrolled, Run-in Period||375
6652462|NCT02429934|7582084|FG001|NOT COMPLETED|Overall Study||3
6652463|NCT02430090|7582095|FG000|STARTED|Overall Study||15
6652464|NCT02430090|7582096|FG001|STARTED|Overall Study||15
6652465|NCT02430090|7582097|FG002|STARTED|Overall Study||15
6652466|NCT02430090|7582095|FG000|COMPLETED|Overall Study||15
6652467|NCT02430090|7582096|FG001|COMPLETED|Overall Study||15
6652468|NCT02430090|7582097|FG002|COMPLETED|Overall Study||15
6652469|NCT02430090|7582095|FG000|NOT COMPLETED|Overall Study||0
6652470|NCT02430090|7582096|FG001|NOT COMPLETED|Overall Study||0
6652471|NCT02430090|7582097|FG002|NOT COMPLETED|Overall Study||0
6652472|NCT02430311|7582107|FG000|STARTED|Part A||20
6652473|NCT02430311|7582108|FG001|STARTED|Part A||16
6652474|NCT02430311|7582107|FG000|Received Olaparib|Part A||20
6652475|NCT02430311|7582108|FG001|Received Olaparib|Part A||16
6652476|NCT02430311|7582107|FG000|Received Paclitaxel|Part A|Cohort 1 patients are planned to receive olaparib monotherapy|0
6652477|NCT02430311|7582108|FG001|Received Paclitaxel|Part A||16
6652478|NCT02430311|7582107|FG000|COMPLETED|Part A||19
6652479|NCT02430311|7582108|FG001|COMPLETED|Part A||15
6652480|NCT02430311|7582107|FG000|NOT COMPLETED|Part A||1
6652481|NCT02430311|7582108|FG001|NOT COMPLETED|Part A||1
6652482|NCT02430311|7582107|FG000|STARTED|Part B||19
6652483|NCT02430311|7582108|FG001|STARTED|Part B||15
6652484|NCT02430311|7582107|FG000|Received Olaparib|Part B||19
6652485|NCT02430311|7582108|FG001|Received Olaparib|Part B||15
6652486|NCT02430311|7582107|FG000|Received Paclitaxel|Part B|Cohort 1 patients are planned to receive olaparib monotherapy|0
6652487|NCT02430311|7582108|FG001|Received Paclitaxel|Part B||14
6433738|NCT01059825|7348368|FG000|COMPLETED|Enrolled, Run-in Period||0
6433739|NCT01059825|7348369|FG001|COMPLETED|Enrolled, Run-in Period||0
6433740|NCT01059825|7348370|FG002|COMPLETED|Enrolled, Run-in Period||0
6433741|NCT01059825|7348371|FG003|COMPLETED|Enrolled, Run-in Period||0
6433742|NCT01059825|7348372|FG004|COMPLETED|Enrolled, Run-in Period||0
6433743|NCT01059825|7348373|FG005|COMPLETED|Enrolled, Run-in Period||0
6652488|NCT02430311|7582107|FG000|COMPLETED|Part B||9
6652489|NCT02430311|7582108|FG001|COMPLETED|Part B||7
6652490|NCT02430311|7582107|FG000|NOT COMPLETED|Part B||10
6652491|NCT02430311|7582108|FG001|NOT COMPLETED|Part B||8
6652492|NCT02430337|7582125|FG000|STARTED|Overall Study||11
6433744|NCT01059825|7348374|FG006|COMPLETED|Enrolled, Run-in Period||328
6433745|NCT01059825|7348368|FG000|NOT COMPLETED|Enrolled, Run-in Period||0
6433746|NCT01059825|7348369|FG001|NOT COMPLETED|Enrolled, Run-in Period||0
6433747|NCT01059825|7348370|FG002|NOT COMPLETED|Enrolled, Run-in Period||0
6433748|NCT01059825|7348371|FG003|NOT COMPLETED|Enrolled, Run-in Period||0
6433749|NCT01059825|7348372|FG004|NOT COMPLETED|Enrolled, Run-in Period||0
6433750|NCT01059825|7348373|FG005|NOT COMPLETED|Enrolled, Run-in Period||0
6433751|NCT01059825|7348374|FG006|NOT COMPLETED|Enrolled, Run-in Period||47
6433752|NCT01059825|7348368|FG000|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
6433753|NCT01059825|7348369|FG001|STARTED|Treatment Period|54 participants who completed the run-in period were randomized to this treatment group.|54
6433754|NCT01059825|7348370|FG002|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
6433755|NCT01059825|7348371|FG003|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
6433756|NCT01059825|7348372|FG004|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
6433757|NCT01059825|7348373|FG005|STARTED|Treatment Period|55 participants who completed the run-in period were randomized to this treatment group.|55
6433758|NCT01059825|7348374|FG006|STARTED|Treatment Period|Participants who completed run-in were randomized to 1 of 6 treatment groups.|0
6433759|NCT01059825|7348368|FG000|COMPLETED|Treatment Period||44
6433760|NCT01059825|7348369|FG001|COMPLETED|Treatment Period||50
6433761|NCT01059825|7348370|FG002|COMPLETED|Treatment Period||49
6433762|NCT01059825|7348371|FG003|COMPLETED|Treatment Period||44
6433763|NCT01059825|7348372|FG004|COMPLETED|Treatment Period||47
6433764|NCT01059825|7348373|FG005|COMPLETED|Treatment Period||52
6433765|NCT01059825|7348374|FG006|COMPLETED|Treatment Period||0
6433766|NCT01059825|7348368|FG000|NOT COMPLETED|Treatment Period||10
6433767|NCT01059825|7348369|FG001|NOT COMPLETED|Treatment Period||4
6433768|NCT01059825|7348370|FG002|NOT COMPLETED|Treatment Period||6
6433769|NCT01059825|7348371|FG003|NOT COMPLETED|Treatment Period||11
6433770|NCT01059825|7348372|FG004|NOT COMPLETED|Treatment Period||8
6433771|NCT01059825|7348373|FG005|NOT COMPLETED|Treatment Period||3
6433772|NCT01059825|7348374|FG006|NOT COMPLETED|Treatment Period||0
6433773|NCT01059851|7348392|FG000|STARTED|Overall Study||8
6433774|NCT01059851|7348393|FG001|STARTED|Overall Study||8
6433775|NCT01059851|7348394|FG002|STARTED|Overall Study||0
6433776|NCT01059851|7348395|FG003|STARTED|Overall Study||0
6433777|NCT01059851|7348396|FG004|STARTED|Overall Study||0
6433778|NCT01059851|7348397|FG005|STARTED|Overall Study||0
6433779|NCT01059851|7348392|FG000|COMPLETED|Overall Study||8
6433780|NCT01059851|7348393|FG001|COMPLETED|Overall Study||8
6433781|NCT01059851|7348394|FG002|COMPLETED|Overall Study||0
6433782|NCT01059851|7348395|FG003|COMPLETED|Overall Study||0
6433783|NCT01059851|7348396|FG004|COMPLETED|Overall Study||0
6433784|NCT01059851|7348397|FG005|COMPLETED|Overall Study||0
6433785|NCT01059851|7348392|FG000|NOT COMPLETED|Overall Study||0
6433786|NCT01059851|7348393|FG001|NOT COMPLETED|Overall Study||0
6433787|NCT01059851|7348394|FG002|NOT COMPLETED|Overall Study||0
6433788|NCT01059851|7348395|FG003|NOT COMPLETED|Overall Study||0
6433789|NCT01059851|7348396|FG004|NOT COMPLETED|Overall Study||0
6433790|NCT01059851|7348397|FG005|NOT COMPLETED|Overall Study||0
6433791|NCT01059864|7348407|FG000|STARTED|Open-Label Run-In Phase||111
6433792|NCT01059864|7348408|FG001|STARTED|Open-Label Run-In Phase||0
6433793|NCT01059864|7348409|FG002|STARTED|Open-Label Run-In Phase||0
6433794|NCT01059864|7348407|FG000|COMPLETED|Open-Label Run-In Phase||98
6433795|NCT01059864|7348408|FG001|COMPLETED|Open-Label Run-In Phase||0
6433796|NCT01059864|7348409|FG002|COMPLETED|Open-Label Run-In Phase||0
6433797|NCT01059864|7348407|FG000|NOT COMPLETED|Open-Label Run-In Phase||13
6433798|NCT01059864|7348408|FG001|NOT COMPLETED|Open-Label Run-In Phase||0
6433799|NCT01059864|7348409|FG002|NOT COMPLETED|Open-Label Run-In Phase||0
6433800|NCT01059864|7348407|FG000|STARTED|Double-Blind Treatment Phase||0
6433801|NCT01059864|7348408|FG001|STARTED|Double-Blind Treatment Phase||50
6433802|NCT01059864|7348409|FG002|STARTED|Double-Blind Treatment Phase||48
6433803|NCT01059864|7348407|FG000|Treated|Double-Blind Treatment Phase||0
6433804|NCT01059864|7348408|FG001|Treated|Double-Blind Treatment Phase||50
6433805|NCT01059864|7348409|FG002|Treated|Double-Blind Treatment Phase||47
6433806|NCT01059864|7348407|FG000|COMPLETED|Double-Blind Treatment Phase||0
6433807|NCT01059864|7348408|FG001|COMPLETED|Double-Blind Treatment Phase||47
6433808|NCT01059864|7348409|FG002|COMPLETED|Double-Blind Treatment Phase||45
6433809|NCT01059864|7348407|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
6433810|NCT01059864|7348408|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
6433811|NCT01059864|7348409|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
6433812|NCT01059877|7348418|FG000|STARTED|Overall Study||6
6433813|NCT01059877|7348419|FG001|STARTED|Overall Study||5
6433814|NCT01059877|7348418|FG000|COMPLETED|Overall Study||6
6433815|NCT01059877|7348419|FG001|COMPLETED|Overall Study||3
6433816|NCT01059877|7348418|FG000|NOT COMPLETED|Overall Study||0
6433817|NCT01059877|7348419|FG001|NOT COMPLETED|Overall Study||2
6433818|NCT01059903|7348427|FG000|STARTED|Period 1: First Intervention- 24 Hours||25
6433819|NCT01059903|7348428|FG001|STARTED|Period 1: First Intervention- 24 Hours||25
6433820|NCT01059903|7348427|FG000|COMPLETED|Period 1: First Intervention- 24 Hours||24
6433821|NCT01059903|7348428|FG001|COMPLETED|Period 1: First Intervention- 24 Hours||24
6433822|NCT01059903|7348427|FG000|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
6433823|NCT01059903|7348428|FG001|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
6433824|NCT01059903|7348427|FG000|STARTED|Period 2: Washout Period (>= 5 Days)||24
6433825|NCT01059903|7348428|FG001|STARTED|Period 2: Washout Period (>= 5 Days)||24
6433826|NCT01059903|7348427|FG000|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
6433827|NCT01059903|7348428|FG001|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
6433828|NCT01059903|7348427|FG000|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
6433829|NCT01059903|7348428|FG001|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
6433830|NCT01059903|7348427|FG000|STARTED|Period 3: Second Intervention- 24 Hours||24
6433831|NCT01059903|7348428|FG001|STARTED|Period 3: Second Intervention- 24 Hours||24
6433832|NCT01059903|7348427|FG000|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
6433833|NCT01059903|7348428|FG001|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
6433834|NCT01059903|7348427|FG000|COMPLETED|Period 3: Second Intervention- 24 Hours||24
6433835|NCT01059903|7348428|FG001|COMPLETED|Period 3: Second Intervention- 24 Hours||24
6433836|NCT01059903|7348427|FG000|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
6433837|NCT01059903|7348428|FG001|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
6433838|NCT01059929|7348436|FG000|STARTED|Overall Study||20
6433839|NCT01059929|7348437|FG001|STARTED|Overall Study||21
6433840|NCT01059929|7348436|FG000|COMPLETED|Overall Study||20
6433841|NCT01059929|7348437|FG001|COMPLETED|Overall Study||21
6433842|NCT01059929|7348436|FG000|NOT COMPLETED|Overall Study||0
6433843|NCT01059929|7348437|FG001|NOT COMPLETED|Overall Study||0
6433844|NCT01059994|7348447|FG000|STARTED|Overall Study||3
6433845|NCT01059994|7348448|FG001|STARTED|Overall Study||2
6433846|NCT01059994|7348449|FG002|STARTED|Overall Study||3
6433847|NCT01059994|7348450|FG003|STARTED|Overall Study||4
6433848|NCT01059994|7348447|FG000|COMPLETED|Overall Study||3
6433849|NCT01059994|7348448|FG001|COMPLETED|Overall Study||2
6433850|NCT01059994|7348449|FG002|COMPLETED|Overall Study||3
6433851|NCT01059994|7348450|FG003|COMPLETED|Overall Study||3
6433852|NCT01059994|7348447|FG000|NOT COMPLETED|Overall Study||0
6433853|NCT01059994|7348448|FG001|NOT COMPLETED|Overall Study||0
6433854|NCT01059994|7348449|FG002|NOT COMPLETED|Overall Study||0
6433855|NCT01059994|7348450|FG003|NOT COMPLETED|Overall Study||1
6433856|NCT01060007|7348460|FG000|STARTED|Overall Study||80
6552412|NCT01737697|7474892|FG003|COMPLETED|Subacute Phase||0
6552413|NCT01737697|7474893|FG004|COMPLETED|Subacute Phase||0
6552414|NCT01737697|7474894|FG005|COMPLETED|Subacute Phase||38
6552415|NCT01737697|7474895|FG006|COMPLETED|Subacute Phase||48
6552416|NCT01737697|7474896|FG007|COMPLETED|Subacute Phase||43
6552417|NCT01737697|7474897|FG008|COMPLETED|Subacute Phase||52
6552418|NCT01737697|7474898|FG009|COMPLETED|Subacute Phase||66
6552419|NCT01737697|7474899|FG010|COMPLETED|Subacute Phase||59
6652493|NCT02430337|7582126|FG001|STARTED|Overall Study||20
6652494|NCT02430337|7582125|FG000|COMPLETED|Overall Study||11
6652495|NCT02430337|7582126|FG001|COMPLETED|Overall Study||20
6652496|NCT02430337|7582125|FG000|NOT COMPLETED|Overall Study||0
6652497|NCT02430337|7582126|FG001|NOT COMPLETED|Overall Study||0
6652498|NCT02430389|7582136|FG000|STARTED|Overall Study||10
6652499|NCT02430389|7582137|FG001|STARTED|Overall Study||10
6652500|NCT02430389|7582136|FG000|COMPLETED|Overall Study||10
6652501|NCT02430389|7582137|FG001|COMPLETED|Overall Study||10
6433857|NCT01060007|7348460|FG000|COMPLETED|Overall Study||76
6433858|NCT01060007|7348460|FG000|NOT COMPLETED|Overall Study||4
6433859|NCT01060020|7348467|FG000|STARTED|Overall Study||20
6433860|NCT01060020|7348467|FG000|COMPLETED|Overall Study||20
6433861|NCT01060020|7348467|FG000|NOT COMPLETED|Overall Study||0
6433862|NCT01060059|7348474|FG000|STARTED|Overall Study||444
6433863|NCT01060059|7348475|FG001|STARTED|Overall Study||438
6433864|NCT01060059|7348474|FG000|COMPLETED|Overall Study||377
6433865|NCT01060059|7348475|FG001|COMPLETED|Overall Study||371
6433866|NCT01060059|7348474|FG000|NOT COMPLETED|Overall Study||67
6433867|NCT01060059|7348475|FG001|NOT COMPLETED|Overall Study||67
6433868|NCT01060072|7348485|FG000|STARTED|Overall Study||206
6433869|NCT01060072|7348486|FG001|STARTED|Overall Study||201
6433870|NCT01060072|7348485|FG000|COMPLETED|Overall Study||204
6433871|NCT01060072|7348486|FG001|COMPLETED|Overall Study||196
6552420|NCT01737697|7474900|FG011|COMPLETED|Subacute Phase||58
6552421|NCT01737697|7474901|FG012|COMPLETED|Subacute Phase||61
6552422|NCT01737697|7474902|FG013|COMPLETED|Subacute Phase||44
6552423|NCT01737697|7474903|FG014|COMPLETED|Subacute Phase||49
6552424|NCT01737697|7474889|FG000|NOT COMPLETED|Subacute Phase||0
6552425|NCT01737697|7474890|FG001|NOT COMPLETED|Subacute Phase||0
6552426|NCT01737697|7474891|FG002|NOT COMPLETED|Subacute Phase||0
6552427|NCT01737697|7474892|FG003|NOT COMPLETED|Subacute Phase||0
6552428|NCT01737697|7474893|FG004|NOT COMPLETED|Subacute Phase||0
6552429|NCT01737697|7474894|FG005|NOT COMPLETED|Subacute Phase||3
6552430|NCT01737697|7474895|FG006|NOT COMPLETED|Subacute Phase||1
6552431|NCT01737697|7474896|FG007|NOT COMPLETED|Subacute Phase||3
6552432|NCT01737697|7474897|FG008|NOT COMPLETED|Subacute Phase||2
6552433|NCT01737697|7474898|FG009|NOT COMPLETED|Subacute Phase||2
6552434|NCT01737697|7474899|FG010|NOT COMPLETED|Subacute Phase||6
6552435|NCT01737697|7474900|FG011|NOT COMPLETED|Subacute Phase||3
6552436|NCT01737697|7474901|FG012|NOT COMPLETED|Subacute Phase||2
6552437|NCT01737697|7474902|FG013|NOT COMPLETED|Subacute Phase||2
6552438|NCT01737697|7474903|FG014|NOT COMPLETED|Subacute Phase||1
6552439|NCT01737710|7474941|FG000|STARTED|Overall Study||114
6552440|NCT01737710|7474942|FG001|STARTED|Overall Study||105
6652502|NCT02430389|7582136|FG000|NOT COMPLETED|Overall Study||0
6433872|NCT01060072|7348485|FG000|NOT COMPLETED|Overall Study||2
6433873|NCT01060072|7348486|FG001|NOT COMPLETED|Overall Study||5
6433874|NCT01060098|7348495|FG000|STARTED|Overall Study||25
6433875|NCT01060098|7348496|FG001|STARTED|Overall Study||15
6433876|NCT01060098|7348497|FG002|STARTED|Overall Study||8
6433877|NCT01060098|7348495|FG000|COMPLETED|Overall Study||25
6433878|NCT01060098|7348496|FG001|COMPLETED|Overall Study||15
6433879|NCT01060098|7348497|FG002|COMPLETED|Overall Study||8
6433880|NCT01060098|7348495|FG000|NOT COMPLETED|Overall Study||0
6433881|NCT01060098|7348496|FG001|NOT COMPLETED|Overall Study||0
6433882|NCT01060098|7348497|FG002|NOT COMPLETED|Overall Study||0
6433883|NCT01060111|7348508|FG000|STARTED|Overall Study||81
6433884|NCT01060111|7348509|FG001|STARTED|Overall Study||84
6433885|NCT01060111|7348510|FG002|STARTED|Overall Study||80
6433886|NCT01060111|7348508|FG000|Treated|Overall Study||81
6433887|NCT01060111|7348509|FG001|Treated|Overall Study||83
6433888|NCT01060111|7348510|FG002|Treated|Overall Study||79
6433889|NCT01060111|7348508|FG000|COMPLETED|Overall Study||54
6433890|NCT01060111|7348509|FG001|COMPLETED|Overall Study||61
6433891|NCT01060111|7348510|FG002|COMPLETED|Overall Study||45
6433892|NCT01060111|7348508|FG000|NOT COMPLETED|Overall Study||27
6433893|NCT01060111|7348509|FG001|NOT COMPLETED|Overall Study||23
6433894|NCT01060111|7348510|FG002|NOT COMPLETED|Overall Study||35
6433895|NCT01060124|7348521|FG000|STARTED|Overall Study||103
6433896|NCT01060124|7348521|FG000|COMPLETED|Overall Study||66
6433897|NCT01060124|7348521|FG000|NOT COMPLETED|Overall Study||37
6433898|NCT01060150|7348525|FG000|STARTED|Overall Study||115
6433899|NCT01060150|7348525|FG000|Treated|Overall Study||113
6433900|NCT01060150|7348525|FG000|COMPLETED|Overall Study||92
6433901|NCT01060150|7348525|FG000|NOT COMPLETED|Overall Study||23
6433902|NCT01060345|7348529|FG000|STARTED|Overall Study||20
6433903|NCT01060345|7348529|FG000|COMPLETED|Overall Study||20
6433904|NCT01060345|7348529|FG000|NOT COMPLETED|Overall Study||0
6433905|NCT01060384|7348533|FG000|STARTED|Overall Study||6
6433906|NCT01060384|7348534|FG001|STARTED|Overall Study||4
6433907|NCT01060384|7348535|FG002|STARTED|Overall Study||0
6433908|NCT01060384|7348536|FG003|STARTED|Overall Study||0
6433909|NCT01060384|7348537|FG004|STARTED|Overall Study||36
6433910|NCT01060384|7348533|FG000|COMPLETED|Overall Study||6
6433911|NCT01060384|7348534|FG001|COMPLETED|Overall Study||3
6433912|NCT01060384|7348535|FG002|COMPLETED|Overall Study||0
6433913|NCT01060384|7348536|FG003|COMPLETED|Overall Study||0
6433914|NCT01060384|7348537|FG004|COMPLETED|Overall Study||34
6433915|NCT01060384|7348533|FG000|NOT COMPLETED|Overall Study||0
6433916|NCT01060384|7348534|FG001|NOT COMPLETED|Overall Study||1
6433917|NCT01060384|7348535|FG002|NOT COMPLETED|Overall Study||0
6433918|NCT01060384|7348536|FG003|NOT COMPLETED|Overall Study||0
6433919|NCT01060384|7348537|FG004|NOT COMPLETED|Overall Study||2
6433920|NCT01060540|7348548|FG000|STARTED|Overall Study||303
6433921|NCT01060540|7348549|FG001|STARTED|Overall Study||298
6433922|NCT01060540|7348548|FG000|COMPLETED|Overall Study||239
6433923|NCT01060540|7348549|FG001|COMPLETED|Overall Study||233
6433924|NCT01060540|7348548|FG000|NOT COMPLETED|Overall Study||64
6433925|NCT01060540|7348549|FG001|NOT COMPLETED|Overall Study||65
6433926|NCT01060553|7348557|FG000|STARTED|Overall Study||15
6433927|NCT01060553|7348558|FG001|STARTED|Overall Study||15
6433928|NCT01060553|7348557|FG000|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
6433929|NCT01060553|7348558|FG001|COMPLETED|Overall Study||5
6433930|NCT01060553|7348557|FG000|NOT COMPLETED|Overall Study||9
6433931|NCT01060553|7348558|FG001|NOT COMPLETED|Overall Study||10
6433932|NCT01060592|7348565|FG000|STARTED|4-6w||35
6433933|NCT01060592|7348566|FG001|STARTED|4-6w||49
6433934|NCT01060592|7348565|FG000|COMPLETED|4-6w||23
6433935|NCT01060592|7348566|FG001|COMPLETED|4-6w||39
6433936|NCT01060592|7348565|FG000|NOT COMPLETED|4-6w||12
6433937|NCT01060592|7348566|FG001|NOT COMPLETED|4-6w||10
6433938|NCT01060592|7348565|FG000|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
6433939|NCT01060592|7348566|FG001|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
6433940|NCT01060592|7348565|FG000|COMPLETED|12m||35
6433941|NCT01060592|7348566|FG001|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
6433942|NCT01060592|7348565|FG000|NOT COMPLETED|12m||0
6433943|NCT01060592|7348566|FG001|NOT COMPLETED|12m||18
6433944|NCT01060670|7348574|FG000|STARTED|Run In||0
6433945|NCT01060670|7348575|FG001|STARTED|Run In||545
6433946|NCT01060670|7348574|FG000|COMPLETED|Run In||0
6433947|NCT01060670|7348575|FG001|COMPLETED|Run In||307
6433948|NCT01060670|7348574|FG000|NOT COMPLETED|Run In||0
6433949|NCT01060670|7348575|FG001|NOT COMPLETED|Run In||238
6433950|NCT01060670|7348574|FG000|STARTED|Treatment Phase||154
6433951|NCT01060670|7348575|FG001|STARTED|Treatment Phase||153
6433952|NCT01060670|7348574|FG000|Healed at End of Treatment Phase|Treatment Phase||79
6433953|NCT01060670|7348575|FG001|Healed at End of Treatment Phase|Treatment Phase||49
6433954|NCT01060670|7348574|FG000|Did Not Heal by Treatment Visit 17|Treatment Phase||49
6433955|NCT01060670|7348575|FG001|Did Not Heal by Treatment Visit 17|Treatment Phase||68
6433956|NCT01060670|7348574|FG000|Withdrew From Treatment|Treatment Phase||26
6433957|NCT01060670|7348575|FG001|Withdrew From Treatment|Treatment Phase||36
6433958|NCT01060670|7348574|FG000|COMPLETED|Treatment Phase||128
6433959|NCT01060670|7348575|FG001|COMPLETED|Treatment Phase||117
6433960|NCT01060670|7348574|FG000|NOT COMPLETED|Treatment Phase||26
6433961|NCT01060670|7348575|FG001|NOT COMPLETED|Treatment Phase||36
6433962|NCT01060670|7348574|FG000|STARTED|Follow up Phase||128
6433963|NCT01060670|7348575|FG001|STARTED|Follow up Phase||117
6433964|NCT01060670|7348574|FG000|Recurrence|Follow up Phase||14
6433965|NCT01060670|7348575|FG001|Recurrence|Follow up Phase||9
6433966|NCT01060670|7348574|FG000|Withdrew From Follow up Phase|Follow up Phase||22
6433967|NCT01060670|7348575|FG001|Withdrew From Follow up Phase|Follow up Phase||35
6433968|NCT01060670|7348574|FG000|COMPLETED|Follow up Phase||106
6433969|NCT01060670|7348575|FG001|COMPLETED|Follow up Phase||82
6433970|NCT01060670|7348574|FG000|NOT COMPLETED|Follow up Phase||22
6433971|NCT01060670|7348575|FG001|NOT COMPLETED|Follow up Phase||35
6433972|NCT01061008|7348585|FG000|STARTED|Overall Study||16
6433973|NCT01061008|7348586|FG001|STARTED|Overall Study||15
6433974|NCT01061008|7348585|FG000|COMPLETED|Overall Study||10
6433975|NCT01061008|7348586|FG001|COMPLETED|Overall Study||9
6433976|NCT01061008|7348585|FG000|NOT COMPLETED|Overall Study||6
6433977|NCT01061008|7348586|FG001|NOT COMPLETED|Overall Study||6
6433978|NCT01061034|7348592|FG000|STARTED|Aspirin||9
6433979|NCT01061034|7348592|FG000|COMPLETED|Aspirin||9
6433980|NCT01061034|7348592|FG000|NOT COMPLETED|Aspirin||0
6433981|NCT01061034|7348592|FG000|STARTED|Aspirin Plus Omeprazole||9
6433982|NCT01061034|7348592|FG000|COMPLETED|Aspirin Plus Omeprazole||9
6433983|NCT01061034|7348592|FG000|NOT COMPLETED|Aspirin Plus Omeprazole||0
6433984|NCT01061177|7348596|FG000|STARTED|Overall Study||1089
6433985|NCT01061177|7348596|FG000|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
6433986|NCT01061177|7348596|FG000|ITT_CyR (Ph+ Patients Only)|Overall Study||983
6433987|NCT01061177|7348596|FG000|COMPLETED|Overall Study||881
6433988|NCT01061177|7348596|FG000|NOT COMPLETED|Overall Study||208
6433989|NCT01061333|7348600|FG000|STARTED|Period 1: Placebo Run-in||8
6433990|NCT01061333|7348601|FG001|STARTED|Period 1: Placebo Run-in||8
6433991|NCT01061333|7348600|FG000|COMPLETED|Period 1: Placebo Run-in||8
6433992|NCT01061333|7348601|FG001|COMPLETED|Period 1: Placebo Run-in||8
6433993|NCT01061333|7348600|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
6433994|NCT01061333|7348601|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
6433995|NCT01061333|7348600|FG000|STARTED|Period 2: 20-day Washout||8
6433996|NCT01061333|7348601|FG001|STARTED|Period 2: 20-day Washout||8
6433997|NCT01061333|7348600|FG000|COMPLETED|Period 2: 20-day Washout||8
6433998|NCT01061333|7348601|FG001|COMPLETED|Period 2: 20-day Washout||8
6433999|NCT01061333|7348600|FG000|NOT COMPLETED|Period 2: 20-day Washout||0
6434000|NCT01061333|7348601|FG001|NOT COMPLETED|Period 2: 20-day Washout||0
6434001|NCT01061333|7348600|FG000|STARTED|Period 3: Nedocromil-Montelukast X-over||8
6434002|NCT01061333|7348601|FG001|STARTED|Period 3: Nedocromil-Montelukast X-over||8
6434003|NCT01061333|7348600|FG000|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
6434004|NCT01061333|7348601|FG001|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
6434005|NCT01061333|7348600|FG000|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
6434006|NCT01061333|7348601|FG001|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
6434007|NCT01061333|7348600|FG000|STARTED|Period 4: 20-day Washout||8
6434008|NCT01061333|7348601|FG001|STARTED|Period 4: 20-day Washout||8
6434009|NCT01061333|7348600|FG000|COMPLETED|Period 4: 20-day Washout||8
6434010|NCT01061333|7348601|FG001|COMPLETED|Period 4: 20-day Washout||7
6434011|NCT01061333|7348600|FG000|NOT COMPLETED|Period 4: 20-day Washout||0
6434012|NCT01061333|7348601|FG001|NOT COMPLETED|Period 4: 20-day Washout||1
6434013|NCT01061333|7348600|FG000|STARTED|Period 5: Nedocromil-Montelukast X-over||8
6434014|NCT01061333|7348601|FG001|STARTED|Period 5: Nedocromil-Montelukast X-over||7
6434015|NCT01061333|7348600|FG000|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
6434016|NCT01061333|7348601|FG001|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
6434017|NCT01061333|7348600|FG000|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
6434018|NCT01061333|7348601|FG001|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
6434019|NCT01061333|7348600|FG000|STARTED|Period 6: 20-day Washout||8
6434020|NCT01061333|7348601|FG001|STARTED|Period 6: 20-day Washout||7
6434021|NCT01061333|7348600|FG000|COMPLETED|Period 6: 20-day Washout||8
6434022|NCT01061333|7348601|FG001|COMPLETED|Period 6: 20-day Washout||7
6434023|NCT01061333|7348600|FG000|NOT COMPLETED|Period 6: 20-day Washout||0
6434024|NCT01061333|7348601|FG001|NOT COMPLETED|Period 6: 20-day Washout||0
6434025|NCT01061333|7348600|FG000|STARTED|Period 7: Mometasone||8
6434026|NCT01061333|7348601|FG001|STARTED|Period 7: Mometasone||7
6434027|NCT01061333|7348600|FG000|COMPLETED|Period 7: Mometasone||8
6434028|NCT01061333|7348601|FG001|COMPLETED|Period 7: Mometasone||7
6434029|NCT01061333|7348600|FG000|NOT COMPLETED|Period 7: Mometasone||0
6434030|NCT01061333|7348601|FG001|NOT COMPLETED|Period 7: Mometasone||0
6434031|NCT01061359|7348612|FG000|STARTED|Overall Study||1972
6434032|NCT01061359|7348612|FG000|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
6434033|NCT01061359|7348612|FG000|NOT COMPLETED|Overall Study||1302
6434034|NCT01061385|7348618|FG000|STARTED|Overall Study||21
6434035|NCT01061385|7348619|FG001|STARTED|Overall Study||9
6434036|NCT01061385|7348618|FG000|COMPLETED|Overall Study||20
6434037|NCT01061385|7348619|FG001|COMPLETED|Overall Study||8
6434038|NCT01061385|7348618|FG000|NOT COMPLETED|Overall Study||1
6434039|NCT01061385|7348619|FG001|NOT COMPLETED|Overall Study||1
6434040|NCT01061476|7348626|FG000|STARTED|Overall Study||12
6434041|NCT01061476|7348626|FG000|COMPLETED|Overall Study||12
6434042|NCT01061476|7348626|FG000|NOT COMPLETED|Overall Study||0
6434043|NCT01061528|7348632|FG000|STARTED|Overall Study||62
6434044|NCT01061528|7348633|FG001|STARTED|Overall Study||54
6434045|NCT01061528|7348632|FG000|COMPLETED|Overall Study||59
6434046|NCT01061528|7348633|FG001|COMPLETED|Overall Study||52
6652503|NCT02430389|7582137|FG001|NOT COMPLETED|Overall Study||0
6656167|NCT02458469|7586290|FG000|STARTED|Third Intervention (2 Weeks)||2
6656168|NCT02458469|7586291|FG001|STARTED|Third Intervention (2 Weeks)||2
6656169|NCT02458469|7586292|FG002|STARTED|Third Intervention (2 Weeks)||2
6656170|NCT02458469|7586293|FG003|STARTED|Third Intervention (2 Weeks)||0
6656171|NCT02458469|7586294|FG004|STARTED|Third Intervention (2 Weeks)||1
6656172|NCT02458469|7586295|FG005|STARTED|Third Intervention (2 Weeks)||1
6656173|NCT02458469|7586290|FG000|COMPLETED|Third Intervention (2 Weeks)||2
6656174|NCT02458469|7586291|FG001|COMPLETED|Third Intervention (2 Weeks)||2
6434047|NCT01061528|7348632|FG000|NOT COMPLETED|Overall Study||3
6434048|NCT01061528|7348633|FG001|NOT COMPLETED|Overall Study||2
6434049|NCT01061567|7348639|FG000|STARTED|Overall Study||1814
6434050|NCT01061567|7348639|FG000|COMPLETED|Overall Study||1738
6434051|NCT01061567|7348639|FG000|NOT COMPLETED|Overall Study||76
6434052|NCT01061606|7348643|FG000|STARTED|Overall Study||8
6434053|NCT01061606|7348643|FG000|COMPLETED|Overall Study||0
6434054|NCT01061606|7348643|FG000|NOT COMPLETED|Overall Study||8
6434055|NCT01061671|7348649|FG000|STARTED|Overall Study||433
6434056|NCT01061671|7348650|FG001|STARTED|Overall Study||452
6434057|NCT01061671|7348649|FG000|COMPLETED|Overall Study||386
6434058|NCT01061671|7348650|FG001|COMPLETED|Overall Study||397
6434059|NCT01061671|7348649|FG000|NOT COMPLETED|Overall Study||47
6434060|NCT01061671|7348650|FG001|NOT COMPLETED|Overall Study||55
6434061|NCT01061710|7348656|FG000|STARTED|Overall Study||20
6434062|NCT01061710|7348656|FG000|COMPLETED|Overall Study||6
6434063|NCT01061710|7348656|FG000|NOT COMPLETED|Overall Study||14
6434064|NCT01061723|7348666|FG000|STARTED|Overall Study||50
6434065|NCT01061723|7348667|FG001|STARTED|Overall Study||49
6434066|NCT01061723|7348668|FG002|STARTED|Overall Study||50
6434067|NCT01061723|7348669|FG003|STARTED|Overall Study||52
6434068|NCT01061723|7348670|FG004|STARTED|Overall Study||50
6434069|NCT01061723|7348671|FG005|STARTED|Overall Study||50
6434070|NCT01061723|7348666|FG000|Treated|Overall Study||50
6434071|NCT01061723|7348667|FG001|Treated|Overall Study||49
6434072|NCT01061723|7348668|FG002|Treated|Overall Study||50
6434073|NCT01061723|7348669|FG003|Treated|Overall Study||52
6434074|NCT01061723|7348670|FG004|Treated|Overall Study||50
6434075|NCT01061723|7348671|FG005|Treated|Overall Study||49
6434076|NCT01061723|7348666|FG000|COMPLETED|Overall Study||46
6434077|NCT01061723|7348667|FG001|COMPLETED|Overall Study||43
6434078|NCT01061723|7348668|FG002|COMPLETED|Overall Study||40
6434079|NCT01061723|7348669|FG003|COMPLETED|Overall Study||44
6434080|NCT01061723|7348670|FG004|COMPLETED|Overall Study||47
6434081|NCT01061723|7348671|FG005|COMPLETED|Overall Study||41
6434082|NCT01061723|7348666|FG000|NOT COMPLETED|Overall Study||4
6434083|NCT01061723|7348667|FG001|NOT COMPLETED|Overall Study||6
6434084|NCT01061723|7348668|FG002|NOT COMPLETED|Overall Study||10
6434085|NCT01061723|7348669|FG003|NOT COMPLETED|Overall Study||8
6434086|NCT01061723|7348670|FG004|NOT COMPLETED|Overall Study||3
6434087|NCT01061723|7348671|FG005|NOT COMPLETED|Overall Study||9
6434088|NCT01061736|7348700|FG000|STARTED|Overall Study||50
6434089|NCT01061736|7348701|FG001|STARTED|Overall Study||50
6434090|NCT01061736|7348702|FG002|STARTED|Overall Study||51
6434091|NCT01061736|7348703|FG003|STARTED|Overall Study||51
6434092|NCT01061736|7348704|FG004|STARTED|Overall Study||52
6434093|NCT01061736|7348705|FG005|STARTED|Overall Study||52
6434094|NCT01061736|7348706|FG006|STARTED|Overall Study||84
6434095|NCT01061736|7348707|FG007|STARTED|Overall Study||430
6434096|NCT01061736|7348708|FG008|STARTED|Overall Study||427
6434097|NCT01061736|7348709|FG009|STARTED|Overall Study||428
6434098|NCT01061736|7348700|FG000|Treated|Overall Study||50
6434099|NCT01061736|7348701|FG001|Treated|Overall Study||50
6434100|NCT01061736|7348702|FG002|Treated|Overall Study||51
6434101|NCT01061736|7348703|FG003|Treated|Overall Study||51
6434102|NCT01061736|7348704|FG004|Treated|Overall Study||51
6434103|NCT01061736|7348705|FG005|Treated|Overall Study||52
6434104|NCT01061736|7348706|FG006|Treated|Overall Study||84
6434105|NCT01061736|7348707|FG007|Treated|Overall Study||428
6434106|NCT01061736|7348708|FG008|Treated|Overall Study||426
6434107|NCT01061736|7348709|FG009|Treated|Overall Study||428
6434108|NCT01061736|7348700|FG000|Rescued|Overall Study||0
6434109|NCT01061736|7348701|FG001|Rescued|Overall Study||0
6434110|NCT01061736|7348702|FG002|Rescued|Overall Study||0
6656175|NCT02458469|7586292|FG002|COMPLETED|Third Intervention (2 Weeks)||2
6656176|NCT02458469|7586293|FG003|COMPLETED|Third Intervention (2 Weeks)||0
6656177|NCT02458469|7586294|FG004|COMPLETED|Third Intervention (2 Weeks)||1
6434111|NCT01061736|7348703|FG003|Rescued|Overall Study||0
6434112|NCT01061736|7348704|FG004|Rescued|Overall Study||0
6434113|NCT01061736|7348705|FG005|Rescued|Overall Study||0
6434114|NCT01061736|7348706|FG006|Rescued|Overall Study||0
6434115|NCT01061736|7348707|FG007|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
6434116|NCT01061736|7348708|FG008|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
6434117|NCT01061736|7348709|FG009|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
6434118|NCT01061736|7348700|FG000|COMPLETED|Overall Study||37
6434119|NCT01061736|7348701|FG001|COMPLETED|Overall Study||46
6434120|NCT01061736|7348702|FG002|COMPLETED|Overall Study||45
6434121|NCT01061736|7348703|FG003|COMPLETED|Overall Study||48
6434122|NCT01061736|7348704|FG004|COMPLETED|Overall Study||45
6434123|NCT01061736|7348705|FG005|COMPLETED|Overall Study||49
6434124|NCT01061736|7348706|FG006|COMPLETED|Overall Study||0
6434125|NCT01061736|7348707|FG007|COMPLETED|Overall Study||336
6434126|NCT01061736|7348708|FG008|COMPLETED|Overall Study||330
6434127|NCT01061736|7348709|FG009|COMPLETED|Overall Study||354
6434128|NCT01061736|7348700|FG000|NOT COMPLETED|Overall Study||13
6434129|NCT01061736|7348701|FG001|NOT COMPLETED|Overall Study||4
6434130|NCT01061736|7348702|FG002|NOT COMPLETED|Overall Study||6
6434131|NCT01061736|7348703|FG003|NOT COMPLETED|Overall Study||3
6434132|NCT01061736|7348704|FG004|NOT COMPLETED|Overall Study||7
6434133|NCT01061736|7348705|FG005|NOT COMPLETED|Overall Study||3
6434134|NCT01061736|7348706|FG006|NOT COMPLETED|Overall Study||84
6434135|NCT01061736|7348707|FG007|NOT COMPLETED|Overall Study||94
6434136|NCT01061736|7348708|FG008|NOT COMPLETED|Overall Study||97
6434137|NCT01061736|7348709|FG009|NOT COMPLETED|Overall Study||74
6434138|NCT01061775|7348734|FG000|STARTED|Overall Study||19
6434139|NCT01061775|7348734|FG000|COMPLETED|Overall Study||16
6434140|NCT01061775|7348734|FG000|NOT COMPLETED|Overall Study||3
6434141|NCT01061866|7348739|FG000|STARTED|Overall Study||7
6434142|NCT01061866|7348739|FG000|COMPLETED|Overall Study||5
6434143|NCT01061866|7348739|FG000|NOT COMPLETED|Overall Study||2
6434144|NCT01062009|7348747|FG000|STARTED|Overall Study||7
6434145|NCT01062009|7348748|FG001|STARTED|Overall Study||6
6434146|NCT01062009|7348749|FG002|STARTED|Overall Study||6
6434147|NCT01062009|7348750|FG003|STARTED|Overall Study||6
6434148|NCT01062009|7348747|FG000|COMPLETED|Overall Study||6
6434149|NCT01062009|7348748|FG001|COMPLETED|Overall Study||6
6434150|NCT01062009|7348749|FG002|COMPLETED|Overall Study||6
6434151|NCT01062009|7348750|FG003|COMPLETED|Overall Study||6
6434152|NCT01062009|7348747|FG000|NOT COMPLETED|Overall Study||1
6434153|NCT01062009|7348748|FG001|NOT COMPLETED|Overall Study||0
6434154|NCT01062009|7348749|FG002|NOT COMPLETED|Overall Study||0
6434155|NCT01062009|7348750|FG003|NOT COMPLETED|Overall Study||0
6434156|NCT01062061|7348760|FG000|STARTED|Overall Study||754
6434157|NCT01062061|7348760|FG000|COMPLETED|Overall Study||727
6434158|NCT01062061|7348760|FG000|NOT COMPLETED|Overall Study||27
6434159|NCT01062074|7348768|FG000|STARTED|Overall Study||3605
6434160|NCT01062074|7348768|FG000|COMPLETED|Overall Study||3605
6434161|NCT01062074|7348768|FG000|NOT COMPLETED|Overall Study||0
6434162|NCT01062113|7348775|FG000|STARTED|Overall Study||133
6434163|NCT01062113|7348776|FG001|STARTED|Overall Study||64
6434164|NCT01062113|7348777|FG002|STARTED|Overall Study||58
6434165|NCT01062113|7348775|FG000|COMPLETED|Overall Study||93
6434166|NCT01062113|7348776|FG001|COMPLETED|Overall Study||42
6434167|NCT01062113|7348777|FG002|COMPLETED|Overall Study||27
6434168|NCT01062113|7348775|FG000|NOT COMPLETED|Overall Study||40
6434169|NCT01062113|7348776|FG001|NOT COMPLETED|Overall Study||22
6434170|NCT01062113|7348777|FG002|NOT COMPLETED|Overall Study||31
6434171|NCT01062126|7348785|FG000|STARTED|Overall Study||3389
6434172|NCT01062126|7348785|FG000|COMPLETED|Overall Study||2856
6434173|NCT01062126|7348785|FG000|NOT COMPLETED|Overall Study||533
6434174|NCT01062165|7348789|FG000|STARTED|Overall Study||18
6434175|NCT01062165|7348789|FG000|COMPLETED|Overall Study||18
6434176|NCT01062165|7348789|FG000|NOT COMPLETED|Overall Study||0
6434177|NCT01062230|7348793|FG000|STARTED|Overall Study||6
6434178|NCT01062230|7348793|FG000|COMPLETED|Overall Study||6
6434179|NCT01062230|7348793|FG000|NOT COMPLETED|Overall Study||0
6434180|NCT01062256|7348800|FG000|STARTED|Overall Study||55
6434181|NCT01062256|7348801|FG001|STARTED|Overall Study||103
6434182|NCT01062256|7348802|FG002|STARTED|Overall Study||107
6434183|NCT01062256|7348800|FG000|COMPLETED|Overall Study||52
6434184|NCT01062256|7348801|FG001|COMPLETED|Overall Study||96
6434185|NCT01062256|7348802|FG002|COMPLETED|Overall Study||103
6434186|NCT01062256|7348800|FG000|NOT COMPLETED|Overall Study||3
6434187|NCT01062256|7348801|FG001|NOT COMPLETED|Overall Study||7
6434188|NCT01062256|7348802|FG002|NOT COMPLETED|Overall Study||4
6434189|NCT01062269|7348810|FG000|STARTED|Overall Study||42
6434190|NCT01062269|7348810|FG000|COMPLETED|Overall Study||42
6434191|NCT01062269|7348810|FG000|NOT COMPLETED|Overall Study||0
6434192|NCT01062308|7348820|FG000|STARTED|Overall Study||80
6434193|NCT01062308|7348821|FG001|STARTED|Overall Study||82
6434194|NCT01062308|7348820|FG000|COMPLETED|Overall Study||64
6434195|NCT01062308|7348821|FG001|COMPLETED|Overall Study||72
6434196|NCT01062308|7348820|FG000|NOT COMPLETED|Overall Study||16
6434197|NCT01062308|7348821|FG001|NOT COMPLETED|Overall Study||10
6434198|NCT01062399|7348832|FG000|STARTED|Overall Study||8
6434199|NCT01062399|7348833|FG001|STARTED|Overall Study||10
6434200|NCT01062399|7348834|FG002|STARTED|Overall Study||8
6434201|NCT01062399|7348835|FG003|STARTED|Overall Study||89
6434202|NCT01062399|7348836|FG004|STARTED|Overall Study||92
6434203|NCT01062399|7348832|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analyses are considered to have completed the study.|8
6434204|NCT01062399|7348833|FG001|COMPLETED|Overall Study||9
6434205|NCT01062399|7348834|FG002|COMPLETED|Overall Study||8
6434206|NCT01062399|7348835|FG003|COMPLETED|Overall Study||83
6434207|NCT01062399|7348836|FG004|COMPLETED|Overall Study||88
6434208|NCT01062399|7348832|FG000|NOT COMPLETED|Overall Study||0
6434209|NCT01062399|7348833|FG001|NOT COMPLETED|Overall Study||1
6434210|NCT01062399|7348834|FG002|NOT COMPLETED|Overall Study||0
6434211|NCT01062399|7348835|FG003|NOT COMPLETED|Overall Study||6
6434212|NCT01062399|7348836|FG004|NOT COMPLETED|Overall Study||4
6434213|NCT01062555|7348850|FG000|STARTED|Phase 1||266
6434214|NCT01062555|7348851|FG001|STARTED|Phase 1||261
6434215|NCT01062555|7348852|FG002|STARTED|Phase 1||0
6434216|NCT01062555|7348853|FG003|STARTED|Phase 1||0
6434217|NCT01062555|7348850|FG000|COMPLETED|Phase 1||243
6434218|NCT01062555|7348851|FG001|COMPLETED|Phase 1||235
6434219|NCT01062555|7348852|FG002|COMPLETED|Phase 1||0
6434220|NCT01062555|7348853|FG003|COMPLETED|Phase 1||0
6434221|NCT01062555|7348850|FG000|NOT COMPLETED|Phase 1||23
6434222|NCT01062555|7348851|FG001|NOT COMPLETED|Phase 1||26
6434223|NCT01062555|7348852|FG002|NOT COMPLETED|Phase 1||0
6434224|NCT01062555|7348853|FG003|NOT COMPLETED|Phase 1||0
6434225|NCT01062555|7348850|FG000|STARTED|Phase 2||0
6434226|NCT01062555|7348851|FG001|STARTED|Phase 2||0
6434227|NCT01062555|7348852|FG002|STARTED|Phase 2||86
6434228|NCT01062555|7348853|FG003|STARTED|Phase 2||87
6434229|NCT01062555|7348850|FG000|COMPLETED|Phase 2||0
6434230|NCT01062555|7348851|FG001|COMPLETED|Phase 2||0
6434231|NCT01062555|7348852|FG002|COMPLETED|Phase 2||71
6434232|NCT01062555|7348853|FG003|COMPLETED|Phase 2||53
6434233|NCT01062555|7348850|FG000|NOT COMPLETED|Phase 2||0
6434234|NCT01062555|7348851|FG001|NOT COMPLETED|Phase 2||0
6434235|NCT01062555|7348852|FG002|NOT COMPLETED|Phase 2||15
6434236|NCT01062555|7348853|FG003|NOT COMPLETED|Phase 2||34
6434237|NCT01062568|7348865|FG000|STARTED|Overall Study||10
6434238|NCT01062568|7348866|FG001|STARTED|Overall Study||40
6434239|NCT01062568|7348865|FG000|COMPLETED|Overall Study||10
6434240|NCT01062568|7348866|FG001|COMPLETED|Overall Study||40
6434241|NCT01062568|7348865|FG000|NOT COMPLETED|Overall Study||0
6434242|NCT01062568|7348866|FG001|NOT COMPLETED|Overall Study||0
6434243|NCT01062763|7348879|FG000|STARTED|Overall Study|119 randomized.|58
6434244|NCT01062763|7348880|FG001|STARTED|Overall Study||61
6434245|NCT01062763|7348879|FG000|COMPLETED|Overall Study||55
6434246|NCT01062763|7348880|FG001|COMPLETED|Overall Study||57
6434247|NCT01062763|7348879|FG000|NOT COMPLETED|Overall Study||3
6434248|NCT01062763|7348880|FG001|NOT COMPLETED|Overall Study||4
6434249|NCT01062841|7348888|FG000|STARTED|Overall Study||203
6434250|NCT01062841|7348889|FG001|STARTED|Overall Study||215
6434251|NCT01062841|7348888|FG000|COMPLETED|Overall Study||154
6434252|NCT01062841|7348889|FG001|COMPLETED|Overall Study||162
6434253|NCT01062841|7348888|FG000|NOT COMPLETED|Overall Study||49
6434254|NCT01062841|7348889|FG001|NOT COMPLETED|Overall Study||53
6434255|NCT01062893|7348897|FG000|STARTED|Overall Study||41
6434256|NCT01062893|7348898|FG001|STARTED|Overall Study||41
6434257|NCT01062893|7348897|FG000|COMPLETED|Overall Study||27
6434258|NCT01062893|7348898|FG001|COMPLETED|Overall Study||28
6434259|NCT01062893|7348897|FG000|NOT COMPLETED|Overall Study||14
6434260|NCT01062893|7348898|FG001|NOT COMPLETED|Overall Study||13
6434261|NCT01062971|7348906|FG000|STARTED|Overall Study||60
6434262|NCT01062971|7348907|FG001|STARTED|Overall Study||63
6434263|NCT01062971|7348906|FG000|COMPLETED|Overall Study||56
6434264|NCT01062971|7348907|FG001|COMPLETED|Overall Study||56
6434265|NCT01062971|7348906|FG000|NOT COMPLETED|Overall Study||4
6434266|NCT01062971|7348907|FG001|NOT COMPLETED|Overall Study||7
6434267|NCT01063036|7348913|FG000|STARTED|Participants Treated With Study Drug||92
6434268|NCT01063036|7348913|FG000|COMPLETED|Participants Treated With Study Drug||86
6434269|NCT01063036|7348913|FG000|NOT COMPLETED|Participants Treated With Study Drug||6
6434270|NCT01063036|7348913|FG000|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
6434271|NCT01063036|7348913|FG000|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
6434272|NCT01063036|7348913|FG000|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
6434273|NCT01063049|7348920|FG000|STARTED|Overall Study||200
6434274|NCT01063049|7348921|FG001|STARTED|Overall Study||200
6434275|NCT01063049|7348922|FG002|STARTED|Overall Study||200
6434276|NCT01063049|7348920|FG000|COMPLETED|Overall Study||200
6434277|NCT01063049|7348921|FG001|COMPLETED|Overall Study||200
6434278|NCT01063049|7348922|FG002|COMPLETED|Overall Study||200
6434279|NCT01063049|7348920|FG000|NOT COMPLETED|Overall Study||0
6434280|NCT01063049|7348921|FG001|NOT COMPLETED|Overall Study||0
6434281|NCT01063049|7348922|FG002|NOT COMPLETED|Overall Study||0
6434282|NCT01063062|7348932|FG000|STARTED|Overall Study||30
6434283|NCT01063062|7348933|FG001|STARTED|Overall Study||77
6434284|NCT01063062|7348932|FG000|Received Study Drug|Overall Study||29
6434285|NCT01063062|7348933|FG001|Received Study Drug|Overall Study||76
6434286|NCT01063062|7348932|FG000|COMPLETED|Overall Study||22
6434287|NCT01063062|7348933|FG001|COMPLETED|Overall Study||65
6434288|NCT01063062|7348932|FG000|NOT COMPLETED|Overall Study||8
6434289|NCT01063062|7348933|FG001|NOT COMPLETED|Overall Study||12
6434290|NCT01063075|7348940|FG000|STARTED|Overall Study||2
6434291|NCT01063075|7348941|FG001|STARTED|Overall Study||3
6434292|NCT01063075|7348942|FG002|STARTED|Overall Study||14
6552441|NCT01737710|7474943|FG002|STARTED|Overall Study||105
6552442|NCT01737710|7474944|FG003|STARTED|Overall Study||23
6552443|NCT01737710|7474945|FG004|STARTED|Overall Study||21
6552444|NCT01737710|7474941|FG000|COMPLETED|Overall Study||112
6552445|NCT01737710|7474942|FG001|COMPLETED|Overall Study||101
6434293|NCT01063075|7348943|FG003|STARTED|Overall Study||15
6434294|NCT01063075|7348940|FG000|COMPLETED|Overall Study||1
6434295|NCT01063075|7348941|FG001|COMPLETED|Overall Study||1
6552446|NCT01737710|7474943|FG002|COMPLETED|Overall Study||102
6552447|NCT01737710|7474944|FG003|COMPLETED|Overall Study||23
6552448|NCT01737710|7474945|FG004|COMPLETED|Overall Study||21
6434296|NCT01063075|7348942|FG002|COMPLETED|Overall Study||9
6434297|NCT01063075|7348943|FG003|COMPLETED|Overall Study||14
6434298|NCT01063075|7348940|FG000|NOT COMPLETED|Overall Study||1
6434299|NCT01063075|7348941|FG001|NOT COMPLETED|Overall Study||2
6434300|NCT01063075|7348942|FG002|NOT COMPLETED|Overall Study||5
6434301|NCT01063075|7348943|FG003|NOT COMPLETED|Overall Study||1
6434302|NCT01063153|7348955|FG000|STARTED|Overall Study||33
6434303|NCT01063153|7348956|FG001|STARTED|Overall Study||38
6434304|NCT01063153|7348955|FG000|COMPLETED|Overall Study||31
6434305|NCT01063153|7348956|FG001|COMPLETED|Overall Study||26
6434306|NCT01063153|7348955|FG000|NOT COMPLETED|Overall Study||2
6434307|NCT01063153|7348956|FG001|NOT COMPLETED|Overall Study||12
6434308|NCT01063283|7348968|FG000|STARTED|Cycle 1||20
6434309|NCT01063283|7348969|FG001|STARTED|Cycle 1||0
6434310|NCT01063283|7348970|FG002|STARTED|Cycle 1||0
6434311|NCT01063283|7348968|FG000|COMPLETED|Cycle 1||17
6434312|NCT01063283|7348969|FG001|COMPLETED|Cycle 1||0
6434313|NCT01063283|7348970|FG002|COMPLETED|Cycle 1||0
6434314|NCT01063283|7348968|FG000|NOT COMPLETED|Cycle 1||3
6434315|NCT01063283|7348969|FG001|NOT COMPLETED|Cycle 1||0
6434316|NCT01063283|7348970|FG002|NOT COMPLETED|Cycle 1||0
6434317|NCT01063283|7348968|FG000|STARTED|Randomized Phase (Cycle 2 and Beyond)||0
6434318|NCT01063283|7348969|FG001|STARTED|Randomized Phase (Cycle 2 and Beyond)||6
6434319|NCT01063283|7348970|FG002|STARTED|Randomized Phase (Cycle 2 and Beyond)||11
6434320|NCT01063283|7348968|FG000|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
6434321|NCT01063283|7348969|FG001|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||6
6434322|NCT01063283|7348970|FG002|COMPLETED|Randomized Phase (Cycle 2 and Beyond)||11
6434323|NCT01063283|7348968|FG000|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
6434324|NCT01063283|7348969|FG001|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
6434325|NCT01063283|7348970|FG002|NOT COMPLETED|Randomized Phase (Cycle 2 and Beyond)||0
6434326|NCT01063348|7348978|FG000|STARTED|Overall Study||35
6434327|NCT01063348|7348979|FG001|STARTED|Overall Study||31
6434328|NCT01063348|7348978|FG000|COMPLETED|Overall Study||32
6434329|NCT01063348|7348979|FG001|COMPLETED|Overall Study||21
6434330|NCT01063348|7348978|FG000|NOT COMPLETED|Overall Study||3
6434331|NCT01063348|7348979|FG001|NOT COMPLETED|Overall Study||10
6434332|NCT01063595|7348985|FG000|STARTED|Enrolled in Study and Randomized||32
6434333|NCT01063595|7348986|FG001|STARTED|Enrolled in Study and Randomized||31
6434334|NCT01063595|7348985|FG000|Received Treatment|Enrolled in Study and Randomized||31
6434335|NCT01063595|7348986|FG001|Received Treatment|Enrolled in Study and Randomized||29
6434336|NCT01063595|7348985|FG000|COMPLETED|Enrolled in Study and Randomized||31
6434337|NCT01063595|7348986|FG001|COMPLETED|Enrolled in Study and Randomized||29
6434338|NCT01063595|7348985|FG000|NOT COMPLETED|Enrolled in Study and Randomized||1
6434339|NCT01063595|7348986|FG001|NOT COMPLETED|Enrolled in Study and Randomized||2
6434340|NCT01063595|7348985|FG000|STARTED|First Intervention||31
6434341|NCT01063595|7348986|FG001|STARTED|First Intervention||29
6434342|NCT01063595|7348985|FG000|COMPLETED|First Intervention||29
6434343|NCT01063595|7348986|FG001|COMPLETED|First Intervention||24
6434344|NCT01063595|7348985|FG000|NOT COMPLETED|First Intervention||2
6434345|NCT01063595|7348986|FG001|NOT COMPLETED|First Intervention||5
6434346|NCT01063595|7348985|FG000|STARTED|Second Intervention||29
6434347|NCT01063595|7348986|FG001|STARTED|Second Intervention||24
6434348|NCT01063595|7348985|FG000|COMPLETED|Second Intervention||29
6434349|NCT01063595|7348986|FG001|COMPLETED|Second Intervention||24
6434350|NCT01063595|7348985|FG000|NOT COMPLETED|Second Intervention||0
6434351|NCT01063595|7348986|FG001|NOT COMPLETED|Second Intervention||0
6434352|NCT01063712|7348992|FG000|STARTED|Overall Study||29
6434353|NCT01063712|7348992|FG000|COMPLETED|Overall Study||29
6434354|NCT01063712|7348992|FG000|NOT COMPLETED|Overall Study||0
6434355|NCT01063764|7348997|FG000|STARTED|1st Period (From Week 8 to Week 22)||73
6434356|NCT01063764|7348997|FG000|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
6434357|NCT01063764|7348997|FG000|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
6434358|NCT01063764|7348997|FG000|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
6434359|NCT01063764|7348997|FG000|COMPLETED|2nd Period (Week 22 to the End of Study)||35
6434360|NCT01063764|7348997|FG000|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
6434361|NCT01063829|7349005|FG000|STARTED|Overall Study||33
6434362|NCT01063829|7349006|FG001|STARTED|Overall Study||31
6434363|NCT01063829|7349007|FG002|STARTED|Overall Study||34
6434364|NCT01063829|7349008|FG003|STARTED|Overall Study||33
6434365|NCT01063829|7349005|FG000|COMPLETED|Overall Study|Non-completers considered as failure; FAS|17
6434366|NCT01063829|7349006|FG001|COMPLETED|Overall Study|Non-completers considered as failure; FAS|21
6434367|NCT01063829|7349007|FG002|COMPLETED|Overall Study|Non-completers considered as failure; FAS|24
6434368|NCT01063829|7349008|FG003|COMPLETED|Overall Study|Non-completers considered as failure; FAS|12
6434369|NCT01063829|7349005|FG000|NOT COMPLETED|Overall Study||16
6434370|NCT01063829|7349006|FG001|NOT COMPLETED|Overall Study||10
6434371|NCT01063829|7349007|FG002|NOT COMPLETED|Overall Study||10
6434372|NCT01063829|7349008|FG003|NOT COMPLETED|Overall Study||21
6434373|NCT01063855|7349020|FG000|STARTED|Overall Study||245
6434374|NCT01063855|7349021|FG001|STARTED|Overall Study||250
6434375|NCT01063855|7349020|FG000|COMPLETED|Overall Study||208
6434376|NCT01063855|7349021|FG001|COMPLETED|Overall Study||221
6434377|NCT01063855|7349020|FG000|NOT COMPLETED|Overall Study||37
6434378|NCT01063855|7349021|FG001|NOT COMPLETED|Overall Study||29
6552449|NCT01737710|7474941|FG000|NOT COMPLETED|Overall Study||2
6552450|NCT01737710|7474942|FG001|NOT COMPLETED|Overall Study||4
6552451|NCT01737710|7474943|FG002|NOT COMPLETED|Overall Study||3
6552452|NCT01737710|7474944|FG003|NOT COMPLETED|Overall Study||0
6552453|NCT01737710|7474945|FG004|NOT COMPLETED|Overall Study||0
6552454|NCT01737762|7474958|FG000|STARTED|Overall Study||77
6552455|NCT01737762|7474959|FG001|STARTED|Overall Study||78
6552456|NCT01737762|7474958|FG000|COMPLETED|Overall Study||57
6552457|NCT01737762|7474959|FG001|COMPLETED|Overall Study||61
6552458|NCT01737762|7474958|FG000|NOT COMPLETED|Overall Study||20
6552459|NCT01737762|7474959|FG001|NOT COMPLETED|Overall Study||17
6552460|NCT01737840|7474967|FG000|STARTED|Overall Study||35
6552461|NCT01737840|7474968|FG001|STARTED|Overall Study||35
6552462|NCT01737840|7474967|FG000|COMPLETED|Overall Study||33
6552463|NCT01737840|7474968|FG001|COMPLETED|Overall Study||33
6434379|NCT01063868|7349033|FG000|STARTED|Overall Study||35
6434380|NCT01063868|7349034|FG001|STARTED|Overall Study||12
6434381|NCT01063868|7349033|FG000|COMPLETED|Overall Study||0
6434382|NCT01063868|7349034|FG001|COMPLETED|Overall Study||0
6434383|NCT01063868|7349033|FG000|NOT COMPLETED|Overall Study||35
6434384|NCT01063868|7349034|FG001|NOT COMPLETED|Overall Study||12
6434385|NCT01063881|7349043|FG000|STARTED|Overall Study||147
6434386|NCT01063881|7349044|FG001|STARTED|Overall Study||125
6434387|NCT01063881|7349045|FG002|STARTED|Overall Study||13
6434388|NCT01063881|7349043|FG000|COMPLETED|Overall Study||92
6434389|NCT01063881|7349044|FG001|COMPLETED|Overall Study||114
6434390|NCT01063881|7349045|FG002|COMPLETED|Overall Study||12
6434391|NCT01063881|7349043|FG000|NOT COMPLETED|Overall Study||55
6434392|NCT01063881|7349044|FG001|NOT COMPLETED|Overall Study||11
6434393|NCT01063881|7349045|FG002|NOT COMPLETED|Overall Study||1
6434394|NCT01063907|7349060|FG000|STARTED|Overall Study||15
6434395|NCT01063907|7349061|FG001|STARTED|Overall Study||80
6434396|NCT01063907|7349060|FG000|COMPLETED|Overall Study||15
6434397|NCT01063907|7349061|FG001|COMPLETED|Overall Study||80
6434398|NCT01063907|7349060|FG000|NOT COMPLETED|Overall Study||0
6434399|NCT01063907|7349061|FG001|NOT COMPLETED|Overall Study||0
6434400|NCT01063972|7349085|FG000|STARTED|Overall Study||310
6434401|NCT01063972|7349086|FG001|STARTED|Overall Study||296
6434402|NCT01063972|7349085|FG000|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|296
6434403|NCT01063972|7349086|FG001|COMPLETED|Overall Study|Participants who were deceased or incarcerated were excluded.|284
6434404|NCT01063972|7349085|FG000|NOT COMPLETED|Overall Study||14
6434405|NCT01063972|7349086|FG001|NOT COMPLETED|Overall Study||12
6434406|NCT01064076|7349092|FG000|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
6434407|NCT01064076|7349092|FG000|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
6434408|NCT01064076|7349092|FG000|NOT COMPLETED|Overall Study||18
6434409|NCT01064167|7349099|FG000|STARTED|Overall Study||130
6434410|NCT01064167|7349100|FG001|STARTED|Overall Study||130
6434411|NCT01064167|7349099|FG000|COMPLETED|Overall Study||116
6434412|NCT01064167|7349100|FG001|COMPLETED|Overall Study||115
6434413|NCT01064167|7349099|FG000|NOT COMPLETED|Overall Study||14
6434414|NCT01064167|7349100|FG001|NOT COMPLETED|Overall Study||15
6434415|NCT01064284|7349108|FG000|STARTED|Overall Study|Taking into account the analyzed patients only|125
6434416|NCT01064284|7349109|FG001|STARTED|Overall Study|Taking into account the analyzed patients only|126
6434417|NCT01064284|7349108|FG000|COMPLETED|Overall Study||107
6434418|NCT01064284|7349109|FG001|COMPLETED|Overall Study||109
6434419|NCT01064284|7349108|FG000|NOT COMPLETED|Overall Study||18
6434420|NCT01064284|7349109|FG001|NOT COMPLETED|Overall Study||17
6434421|NCT01064297|7349119|FG000|STARTED|Overall Study||2567
6434422|NCT01064297|7349120|FG001|STARTED|Overall Study||219
6434423|NCT01064297|7349121|FG002|STARTED|Overall Study||630
6434424|NCT01064297|7349119|FG000|COMPLETED|Overall Study||1776
6434425|NCT01064297|7349120|FG001|COMPLETED|Overall Study||171
6434426|NCT01064297|7349121|FG002|COMPLETED|Overall Study||497
6434427|NCT01064297|7349119|FG000|NOT COMPLETED|Overall Study||791
6434428|NCT01064297|7349120|FG001|NOT COMPLETED|Overall Study||48
6434429|NCT01064297|7349121|FG002|NOT COMPLETED|Overall Study||133
6434430|NCT01064310|7349138|FG000|STARTED|Period 1||82
6434431|NCT01064310|7349139|FG001|STARTED|Period 1||86
6434432|NCT01064310|7349140|FG002|STARTED|Period 1||0
6434433|NCT01064310|7349138|FG000|COMPLETED|Period 1||68
6434434|NCT01064310|7349139|FG001|COMPLETED|Period 1||68
6434435|NCT01064310|7349140|FG002|COMPLETED|Period 1||0
6434436|NCT01064310|7349138|FG000|NOT COMPLETED|Period 1||14
6434437|NCT01064310|7349139|FG001|NOT COMPLETED|Period 1||18
6434438|NCT01064310|7349140|FG002|NOT COMPLETED|Period 1||0
6434439|NCT01064310|7349138|FG000|STARTED|Period 2||68
6434440|NCT01064310|7349139|FG001|STARTED|Period 2||68
6434441|NCT01064310|7349140|FG002|STARTED|Period 2||0
6434442|NCT01064310|7349138|FG000|COMPLETED|Period 2||64
6434443|NCT01064310|7349139|FG001|COMPLETED|Period 2||62
6434444|NCT01064310|7349140|FG002|COMPLETED|Period 2||0
6434445|NCT01064310|7349138|FG000|NOT COMPLETED|Period 2||4
6434446|NCT01064310|7349139|FG001|NOT COMPLETED|Period 2||6
6434447|NCT01064310|7349140|FG002|NOT COMPLETED|Period 2||0
6434448|NCT01064310|7349138|FG000|STARTED|Open Label Pazopinib||0
6434449|NCT01064310|7349139|FG001|STARTED|Open Label Pazopinib||0
6434450|NCT01064310|7349140|FG002|STARTED|Open Label Pazopinib||84
6434451|NCT01064310|7349138|FG000|COMPLETED|Open Label Pazopinib||0
6434452|NCT01064310|7349139|FG001|COMPLETED|Open Label Pazopinib||0
6552464|NCT01737840|7474967|FG000|NOT COMPLETED|Overall Study||2
6552465|NCT01737840|7474968|FG001|NOT COMPLETED|Overall Study||2
6434453|NCT01064310|7349140|FG002|COMPLETED|Open Label Pazopinib||0
6434454|NCT01064310|7349138|FG000|NOT COMPLETED|Open Label Pazopinib||0
6434455|NCT01064310|7349139|FG001|NOT COMPLETED|Open Label Pazopinib||0
6434456|NCT01064310|7349140|FG002|NOT COMPLETED|Open Label Pazopinib||84
6434457|NCT01064323|7349149|FG000|STARTED|Overall Study||10
6434458|NCT01064323|7349149|FG000|COMPLETED|Overall Study||10
6434459|NCT01064323|7349149|FG000|NOT COMPLETED|Overall Study||0
6434460|NCT01064362|7349155|FG000|STARTED|Overall Study||1559
6434461|NCT01064362|7349156|FG001|STARTED|Overall Study||11883
6434462|NCT01064362|7349155|FG000|COMPLETED|Overall Study||1559
6434463|NCT01064362|7349156|FG001|COMPLETED|Overall Study||11883
6434464|NCT01064362|7349155|FG000|NOT COMPLETED|Overall Study||0
6434465|NCT01064362|7349156|FG001|NOT COMPLETED|Overall Study||0
6434466|NCT01064401|7349164|FG000|STARTED|Overall Study||922
6434467|NCT01064401|7349165|FG001|STARTED|Overall Study||919
6434468|NCT01064401|7349164|FG000|COMPLETED|Overall Study||694
6434469|NCT01064401|7349165|FG001|COMPLETED|Overall Study||724
6434470|NCT01064401|7349164|FG000|NOT COMPLETED|Overall Study||228
6434471|NCT01064401|7349165|FG001|NOT COMPLETED|Overall Study||195
6434472|NCT01064414|7349175|FG000|STARTED|Core Period: Baseline to Week 26||90
6434473|NCT01064414|7349176|FG001|STARTED|Core Period: Baseline to Week 26||90
6434474|NCT01064414|7349177|FG002|STARTED|Core Period: Baseline to Week 26||89
6434475|NCT01064414|7349175|FG000|COMPLETED|Core Period: Baseline to Week 26||77
6434476|NCT01064414|7349176|FG001|COMPLETED|Core Period: Baseline to Week 26||75
6434477|NCT01064414|7349177|FG002|COMPLETED|Core Period: Baseline to Week 26||82
6434478|NCT01064414|7349175|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||13
6434479|NCT01064414|7349176|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||15
6434480|NCT01064414|7349177|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||7
6434481|NCT01064414|7349175|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
6434482|NCT01064414|7349176|FG001|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
6434483|NCT01064414|7349177|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
6434484|NCT01064414|7349175|FG000|COMPLETED|Extension Period: Week 26 to Week 52||64
6434485|NCT01064414|7349176|FG001|COMPLETED|Extension Period: Week 26 to Week 52||67
6434486|NCT01064414|7349177|FG002|COMPLETED|Extension Period: Week 26 to Week 52||76
6434487|NCT01064414|7349175|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
6434488|NCT01064414|7349176|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
6434489|NCT01064414|7349177|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
6434490|NCT01064531|7349190|FG000|STARTED|Overall Study||21
6434491|NCT01064531|7349191|FG001|STARTED|Overall Study||20
6434492|NCT01064531|7349190|FG000|COMPLETED|Overall Study||18
6434493|NCT01064531|7349191|FG001|COMPLETED|Overall Study||13
6434494|NCT01064531|7349190|FG000|NOT COMPLETED|Overall Study||3
6434495|NCT01064531|7349191|FG001|NOT COMPLETED|Overall Study||7
6434496|NCT01064622|7349200|FG000|STARTED|Lead-in Phase I||0
6434497|NCT01064622|7349201|FG001|STARTED|Lead-in Phase I||7
6434498|NCT01064622|7349200|FG000|COMPLETED|Lead-in Phase I||0
6434499|NCT01064622|7349201|FG001|COMPLETED|Lead-in Phase I||7
6434500|NCT01064622|7349200|FG000|NOT COMPLETED|Lead-in Phase I||0
6434501|NCT01064622|7349201|FG001|NOT COMPLETED|Lead-in Phase I||0
6434502|NCT01064622|7349200|FG000|STARTED|Randomized Phase II||55
6434503|NCT01064622|7349201|FG001|STARTED|Randomized Phase II||56
6434504|NCT01064622|7349200|FG000|COMPLETED|Randomized Phase II||53
6434505|NCT01064622|7349201|FG001|COMPLETED|Randomized Phase II||53
6434506|NCT01064622|7349200|FG000|NOT COMPLETED|Randomized Phase II||2
6434507|NCT01064622|7349201|FG001|NOT COMPLETED|Randomized Phase II||3
6434508|NCT01064622|7349200|FG000|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
6434509|NCT01064622|7349201|FG001|STARTED|Crossover of Arm I||0
6434510|NCT01064622|7349200|FG000|COMPLETED|Crossover of Arm I||22
6434511|NCT01064622|7349201|FG001|COMPLETED|Crossover of Arm I||0
6434512|NCT01064622|7349200|FG000|NOT COMPLETED|Crossover of Arm I||0
6434513|NCT01064622|7349201|FG001|NOT COMPLETED|Crossover of Arm I||0
6434514|NCT01064687|7349214|FG000|STARTED|Overall Study||279
6434515|NCT01064687|7349215|FG001|STARTED|Overall Study||280
6434516|NCT01064687|7349216|FG002|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
6434517|NCT01064687|7349217|FG003|STARTED|Overall Study||141
6434518|NCT01064687|7349214|FG000|Received at Least 1 Dose of Study Drug|Overall Study||279
6434519|NCT01064687|7349215|FG001|Received at Least 1 Dose of Study Drug|Overall Study||280
6434520|NCT01064687|7349216|FG002|Received at Least 1 Dose of Study Drug|Overall Study||276
6434521|NCT01064687|7349217|FG003|Received at Least 1 Dose of Study Drug|Overall Study||141
6434522|NCT01064687|7349214|FG000|Completed 26 Weeks|Overall Study||260
6434523|NCT01064687|7349215|FG001|Completed 26 Weeks|Overall Study||263
6434524|NCT01064687|7349216|FG002|Completed 26 Weeks|Overall Study||252
6434525|NCT01064687|7349217|FG003|Completed 26 Weeks|Overall Study||124
6434526|NCT01064687|7349214|FG000|COMPLETED|Overall Study||245
6434527|NCT01064687|7349215|FG001|COMPLETED|Overall Study||254
6434528|NCT01064687|7349216|FG002|COMPLETED|Overall Study||237
6434529|NCT01064687|7349217|FG003|COMPLETED|Overall Study||124
6434530|NCT01064687|7349214|FG000|NOT COMPLETED|Overall Study||34
6434531|NCT01064687|7349215|FG001|NOT COMPLETED|Overall Study||26
6434532|NCT01064687|7349216|FG002|NOT COMPLETED|Overall Study||41
6434533|NCT01064687|7349217|FG003|NOT COMPLETED|Overall Study||17
6434534|NCT01064713|7349240|FG000|STARTED|Overall Study||13
6434535|NCT01064713|7349241|FG001|STARTED|Overall Study||4
6434536|NCT01064713|7349240|FG000|COMPLETED|Overall Study||13
6434537|NCT01064713|7349241|FG001|COMPLETED|Overall Study||4
6434538|NCT01064713|7349240|FG000|NOT COMPLETED|Overall Study||0
6434539|NCT01064713|7349241|FG001|NOT COMPLETED|Overall Study||0
6499741|NCT01420848|7418484|FG002|STARTED|Overall Study||22
6434540|NCT01064739|7349247|FG000|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
6434541|NCT01064739|7349247|FG000|COMPLETED|Fixed Sodium Study Diet||14
6434542|NCT01064739|7349247|FG000|NOT COMPLETED|Fixed Sodium Study Diet||0
6434543|NCT01064739|7349247|FG000|STARTED|Fixed Sodium Diet + Fava Beans||14
6434544|NCT01064739|7349247|FG000|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
6434545|NCT01064739|7349247|FG000|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
6434558|NCT01064830|7349268|FG000|STARTED|Overall Study||10
6434559|NCT01064830|7349269|FG001|STARTED|Overall Study||11
6434560|NCT01064830|7349268|FG000|COMPLETED|Overall Study||8
6434561|NCT01064830|7349269|FG001|COMPLETED|Overall Study||7
6434562|NCT01064830|7349268|FG000|NOT COMPLETED|Overall Study||2
6434563|NCT01064830|7349269|FG001|NOT COMPLETED|Overall Study||4
6434564|NCT01064856|7349279|FG000|STARTED|Double-blind (DB) Period||84
6434565|NCT01064856|7349280|FG001|STARTED|Double-blind (DB) Period||81
6434566|NCT01064856|7349281|FG002|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
6434567|NCT01064856|7349282|FG003|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
6434568|NCT01064856|7349279|FG000|COMPLETED|Double-blind (DB) Period||82
6434569|NCT01064856|7349280|FG001|COMPLETED|Double-blind (DB) Period||81
6434570|NCT01064856|7349281|FG002|COMPLETED|Double-blind (DB) Period||0
6434571|NCT01064856|7349282|FG003|COMPLETED|Double-blind (DB) Period||0
6434572|NCT01064856|7349279|FG000|NOT COMPLETED|Double-blind (DB) Period||2
6434573|NCT01064856|7349280|FG001|NOT COMPLETED|Double-blind (DB) Period||0
6434574|NCT01064856|7349281|FG002|NOT COMPLETED|Double-blind (DB) Period||0
6434575|NCT01064856|7349282|FG003|NOT COMPLETED|Double-blind (DB) Period||0
6434576|NCT01064856|7349279|FG000|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
6434577|NCT01064856|7349280|FG001|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
6434578|NCT01064856|7349281|FG002|STARTED|Open-label (OL) Period||82
6434579|NCT01064856|7349282|FG003|STARTED|Open-label (OL) Period||81
6434580|NCT01064856|7349279|FG000|COMPLETED|Open-label (OL) Period||0
6434581|NCT01064856|7349280|FG001|COMPLETED|Open-label (OL) Period||0
6434582|NCT01064856|7349281|FG002|COMPLETED|Open-label (OL) Period||56
6434583|NCT01064856|7349282|FG003|COMPLETED|Open-label (OL) Period||61
6434584|NCT01064856|7349279|FG000|NOT COMPLETED|Open-label (OL) Period||0
6434585|NCT01064856|7349280|FG001|NOT COMPLETED|Open-label (OL) Period||0
6434586|NCT01064856|7349281|FG002|NOT COMPLETED|Open-label (OL) Period||26
6434587|NCT01064856|7349282|FG003|NOT COMPLETED|Open-label (OL) Period||20
6499742|NCT01420848|7418482|FG000|COMPLETED|Overall Study||24
6499743|NCT01420848|7418483|FG001|COMPLETED|Overall Study||25
6499744|NCT01420848|7418484|FG002|COMPLETED|Overall Study||22
6499745|NCT01420848|7418482|FG000|NOT COMPLETED|Overall Study||0
6499746|NCT01420848|7418483|FG001|NOT COMPLETED|Overall Study||0
6499747|NCT01420848|7418484|FG002|NOT COMPLETED|Overall Study||0
6499748|NCT01421017|7418495|FG000|STARTED|Overall Study||12
6499749|NCT01421017|7418496|FG001|STARTED|Overall Study||12
6499750|NCT01421017|7418497|FG002|STARTED|Overall Study||7
6499751|NCT01421017|7418495|FG000|COMPLETED|Overall Study||10
6499752|NCT01421017|7418496|FG001|COMPLETED|Overall Study||6
6499753|NCT01421017|7418497|FG002|COMPLETED|Overall Study||4
6499754|NCT01421017|7418495|FG000|NOT COMPLETED|Overall Study||2
6499755|NCT01421017|7418496|FG001|NOT COMPLETED|Overall Study||6
6499756|NCT01421017|7418497|FG002|NOT COMPLETED|Overall Study||3
6499757|NCT01421134|7418507|FG000|STARTED|Overall Study||109
6499758|NCT01421134|7418508|FG001|STARTED|Overall Study||102
6499759|NCT01421134|7418507|FG000|COMPLETED|Overall Study||102
6499760|NCT01421134|7418508|FG001|COMPLETED|Overall Study||87
6499761|NCT01421134|7418507|FG000|NOT COMPLETED|Overall Study||7
6499762|NCT01421134|7418508|FG001|NOT COMPLETED|Overall Study||15
6499763|NCT01421147|7418516|FG000|STARTED|Treatment Period||269
6499764|NCT01421147|7418517|FG001|STARTED|Treatment Period||267
6499765|NCT01421147|7418516|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||268
6499766|NCT01421147|7418517|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||267
6499767|NCT01421147|7418516|FG000|COMPLETED|Treatment Period||253
6499768|NCT01421147|7418517|FG001|COMPLETED|Treatment Period||256
6499769|NCT01421147|7418516|FG000|NOT COMPLETED|Treatment Period||16
6499770|NCT01421147|7418517|FG001|NOT COMPLETED|Treatment Period||11
6499771|NCT01421147|7418516|FG000|STARTED|Extension Period||253
6499772|NCT01421147|7418517|FG001|STARTED|Extension Period||256
6499773|NCT01421147|7418516|FG000|COMPLETED|Extension Period||245
6499774|NCT01421147|7418517|FG001|COMPLETED|Extension Period||245
6499775|NCT01421147|7418516|FG000|NOT COMPLETED|Extension Period||8
6499776|NCT01421147|7418517|FG001|NOT COMPLETED|Extension Period||11
6434588|NCT01064882|7349292|FG000|STARTED|Overall Study||36
6434589|NCT01064882|7349293|FG001|STARTED|Overall Study||34
6434590|NCT01064882|7349294|FG002|STARTED|Overall Study||34
6434591|NCT01064882|7349292|FG000|COMPLETED|Overall Study||34
6434592|NCT01064882|7349293|FG001|COMPLETED|Overall Study||32
6434593|NCT01064882|7349294|FG002|COMPLETED|Overall Study||32
6434594|NCT01064882|7349292|FG000|NOT COMPLETED|Overall Study||2
6434595|NCT01064882|7349293|FG001|NOT COMPLETED|Overall Study||2
6434596|NCT01064882|7349294|FG002|NOT COMPLETED|Overall Study||2
6434597|NCT01064947|7349302|FG000|STARTED|Overall Study||70
6434598|NCT01064947|7349302|FG000|COMPLETED|Overall Study||29
6434599|NCT01064947|7349302|FG000|NOT COMPLETED|Overall Study||41
6434600|NCT01065350|7349312|FG000|STARTED|Overall Study||43
6434601|NCT01065350|7349313|FG001|STARTED|Overall Study||42
6434602|NCT01065350|7349312|FG000|COMPLETED|Overall Study||43
6434603|NCT01065350|7349313|FG001|COMPLETED|Overall Study||41
6434604|NCT01065350|7349312|FG000|NOT COMPLETED|Overall Study||0
6434605|NCT01065350|7349313|FG001|NOT COMPLETED|Overall Study||1
6434606|NCT01065428|7349321|FG000|STARTED|Overall Study||17
6434607|NCT01065428|7349322|FG001|STARTED|Overall Study||35
6434608|NCT01065428|7349321|FG000|COMPLETED|Overall Study||17
6434609|NCT01065428|7349322|FG001|COMPLETED|Overall Study||35
6434610|NCT01065428|7349321|FG000|NOT COMPLETED|Overall Study||0
6434611|NCT01065428|7349322|FG001|NOT COMPLETED|Overall Study||0
6434612|NCT01065480|7349330|FG000|STARTED|Overall Study||48
6434613|NCT01065480|7349331|FG001|STARTED|Overall Study||43
6434614|NCT01065480|7349330|FG000|COMPLETED|Overall Study||48
6434615|NCT01065480|7349331|FG001|COMPLETED|Overall Study||43
6434616|NCT01065480|7349330|FG000|NOT COMPLETED|Overall Study||0
6434617|NCT01065480|7349331|FG001|NOT COMPLETED|Overall Study||0
6434618|NCT01065506|7349339|FG000|STARTED|Overall Study||64
6434619|NCT01065506|7349340|FG001|STARTED|Overall Study||72
6434620|NCT01065506|7349339|FG000|End of Treatment|Overall Study||44
6434621|NCT01065506|7349340|FG001|End of Treatment|Overall Study||37
6434622|NCT01065506|7349339|FG000|4-Month Follow-Up|Overall Study||35
6434623|NCT01065506|7349340|FG001|4-Month Follow-Up|Overall Study||34
6434624|NCT01065506|7349339|FG000|COMPLETED|Overall Study||32
6434625|NCT01065506|7349340|FG001|COMPLETED|Overall Study||34
6434626|NCT01065506|7349339|FG000|NOT COMPLETED|Overall Study||32
6434627|NCT01065506|7349340|FG001|NOT COMPLETED|Overall Study||38
6434628|NCT01065558|7349346|FG000|STARTED|Overall Study||5
6434629|NCT01065558|7349346|FG000|COMPLETED|Overall Study||5
6434630|NCT01065558|7349346|FG000|NOT COMPLETED|Overall Study||0
6434631|NCT01065571|7349352|FG000|STARTED|Overall Study||10
6434632|NCT01065571|7349353|FG001|STARTED|Overall Study||5
6434633|NCT01065571|7349352|FG000|COMPLETED|Overall Study||7
6434634|NCT01065571|7349353|FG001|COMPLETED|Overall Study||5
6434635|NCT01065571|7349352|FG000|NOT COMPLETED|Overall Study||3
6434636|NCT01065571|7349353|FG001|NOT COMPLETED|Overall Study||0
6434637|NCT01065597|7349361|FG000|STARTED|Overall Study||13
6434638|NCT01065597|7349361|FG000|COMPLETED|Overall Study||12
6434639|NCT01065597|7349361|FG000|NOT COMPLETED|Overall Study||1
6434640|NCT01065714|7349365|FG000|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
6434641|NCT01065714|7349365|FG000|COMPLETED|Overall Study||20
6434642|NCT01065714|7349365|FG000|NOT COMPLETED|Overall Study||0
6434643|NCT01065766|7349372|FG000|STARTED|Overall Study||4065
6434644|NCT01065766|7349372|FG000|COMPLETED|Overall Study||4033
6434645|NCT01065766|7349372|FG000|NOT COMPLETED|Overall Study||32
6434646|NCT01065844|7349376|FG000|STARTED|Overall Study||15
6434647|NCT01065844|7349376|FG000|COMPLETED|Overall Study||10
6434648|NCT01065844|7349376|FG000|NOT COMPLETED|Overall Study||5
6434649|NCT01066000|7349380|FG000|STARTED|Overall Study||33
6434650|NCT01066000|7349380|FG000|COMPLETED|Overall Study||24
6652504|NCT02430480|7582145|FG000|STARTED|Overall Study||39
6652505|NCT02430480|7582145|FG000|COMPLETED|Overall Study||36
6652506|NCT02430480|7582145|FG000|NOT COMPLETED|Overall Study||3
6652507|NCT02430818|7582154|FG000|STARTED|Overall Study||7
6652508|NCT02430818|7582155|FG001|STARTED|Overall Study||6
6652509|NCT02430818|7582154|FG000|COMPLETED|Overall Study||7
6434651|NCT01066000|7349380|FG000|NOT COMPLETED|Overall Study||9
6434652|NCT01066026|7349384|FG000|STARTED|Overall Study|Each patient was injected with hyaluronic acid in each nasolabial fold (total: 2 injections)|25
6434653|NCT01066026|7349384|FG000|COMPLETED|Overall Study||23
6434654|NCT01066026|7349384|FG000|NOT COMPLETED|Overall Study||2
6434655|NCT01066039|7349390|FG000|STARTED|Overall Study||202
6434656|NCT01066039|7349390|FG000|Treated|Overall Study||200
6434657|NCT01066039|7349390|FG000|COMPLETED|Overall Study||158
6434658|NCT01066039|7349390|FG000|NOT COMPLETED|Overall Study||44
6434659|NCT01066052|7349396|FG000|STARTED|Overall Study||64
6434660|NCT01066052|7349397|FG001|STARTED|Overall Study||51
6434661|NCT01066052|7349396|FG000|Treated|Overall Study||61
6434662|NCT01066052|7349397|FG001|Treated|Overall Study||0
6434663|NCT01066052|7349396|FG000|COMPLETED|Overall Study||61
6434664|NCT01066052|7349397|FG001|COMPLETED|Overall Study||51
6434665|NCT01066052|7349396|FG000|NOT COMPLETED|Overall Study||3
6434666|NCT01066052|7349397|FG001|NOT COMPLETED|Overall Study||0
6434667|NCT01066104|7349404|FG000|STARTED|Overall Study||14
6434668|NCT01066104|7349405|FG001|STARTED|Overall Study||13
6434669|NCT01066104|7349404|FG000|COMPLETED|Overall Study||12
6434670|NCT01066104|7349405|FG001|COMPLETED|Overall Study||12
6434671|NCT01066104|7349404|FG000|NOT COMPLETED|Overall Study||2
6434672|NCT01066104|7349405|FG001|NOT COMPLETED|Overall Study||1
6652510|NCT02430818|7582155|FG001|COMPLETED|Overall Study||6
6434673|NCT01066143|7349411|FG000|STARTED|Overall Study||8
6434674|NCT01066143|7349411|FG000|COMPLETED|Overall Study||0
6434675|NCT01066143|7349411|FG000|NOT COMPLETED|Overall Study||8
6434676|NCT01066156|7349415|FG000|STARTED|Overall Study||34
6434677|NCT01066156|7349415|FG000|COMPLETED|Overall Study||24
6434678|NCT01066156|7349415|FG000|NOT COMPLETED|Overall Study||10
6434679|NCT01066364|7349421|FG000|STARTED|Overall Study||25
6434680|NCT01066364|7349422|FG001|STARTED|Overall Study||25
6434681|NCT01066364|7349421|FG000|COMPLETED|Overall Study||22
6434682|NCT01066364|7349422|FG001|COMPLETED|Overall Study||23
6434683|NCT01066364|7349421|FG000|NOT COMPLETED|Overall Study||3
6434684|NCT01066364|7349422|FG001|NOT COMPLETED|Overall Study||2
6434685|NCT01066520|7349431|FG000|STARTED|Overall Study||143
6434686|NCT01066520|7349432|FG001|STARTED|Overall Study||140
6434687|NCT01066520|7349433|FG002|STARTED|Overall Study||137
6434688|NCT01066520|7349431|FG000|COMPLETED|Overall Study||143
6434689|NCT01066520|7349432|FG001|COMPLETED|Overall Study||140
6434690|NCT01066520|7349433|FG002|COMPLETED|Overall Study||137
6434691|NCT01066520|7349431|FG000|NOT COMPLETED|Overall Study||0
6434692|NCT01066520|7349432|FG001|NOT COMPLETED|Overall Study||0
6434693|NCT01066520|7349433|FG002|NOT COMPLETED|Overall Study||0
6652511|NCT02430818|7582154|FG000|NOT COMPLETED|Overall Study||0
6652512|NCT02430818|7582155|FG001|NOT COMPLETED|Overall Study||0
6652513|NCT02430870|7582173|FG000|STARTED|Part 1||6
6434694|NCT01066546|7349441|FG000|STARTED|Overall Study||5
6434695|NCT01066546|7349441|FG000|COMPLETED|Overall Study||0
6434696|NCT01066546|7349441|FG000|NOT COMPLETED|Overall Study||5
6434697|NCT01066585|7349447|FG000|STARTED|Overall Study||211
6434698|NCT01066585|7349448|FG001|STARTED|Overall Study||199
6434699|NCT01066585|7349447|FG000|COMPLETED|Overall Study||210
6434700|NCT01066585|7349448|FG001|COMPLETED|Overall Study||196
6434701|NCT01066585|7349447|FG000|NOT COMPLETED|Overall Study||1
6434702|NCT01066585|7349448|FG001|NOT COMPLETED|Overall Study||3
6434703|NCT01066624|7349457|FG000|STARTED|Overall Study||38
6434704|NCT01066624|7349458|FG001|STARTED|Overall Study||40
6434705|NCT01066624|7349459|FG002|STARTED|Overall Study||39
6434706|NCT01066624|7349457|FG000|COMPLETED|Overall Study||38
6434707|NCT01066624|7349458|FG001|COMPLETED|Overall Study||40
6434708|NCT01066624|7349459|FG002|COMPLETED|Overall Study||39
6434709|NCT01066624|7349457|FG000|NOT COMPLETED|Overall Study||0
6434710|NCT01066624|7349458|FG001|NOT COMPLETED|Overall Study||0
6652514|NCT02430870|7582174|FG001|STARTED|Part 1||6
6652515|NCT02430870|7582175|FG002|STARTED|Part 1||4
6652516|NCT02430870|7582176|FG003|STARTED|Part 1||0
6652517|NCT02430870|7582177|FG004|STARTED|Part 1||0
6652518|NCT02430870|7582178|FG005|STARTED|Part 1||0
6652519|NCT02430870|7582179|FG006|STARTED|Part 1||0
6652520|NCT02430870|7582180|FG007|STARTED|Part 1||0
6652521|NCT02430870|7582173|FG000|COMPLETED|Part 1||6
6652522|NCT02430870|7582174|FG001|COMPLETED|Part 1||6
6652523|NCT02430870|7582175|FG002|COMPLETED|Part 1||4
6652524|NCT02430870|7582176|FG003|COMPLETED|Part 1||0
6652525|NCT02430870|7582177|FG004|COMPLETED|Part 1||0
6652526|NCT02430870|7582178|FG005|COMPLETED|Part 1||0
6652527|NCT02430870|7582179|FG006|COMPLETED|Part 1||0
6652528|NCT02430870|7582180|FG007|COMPLETED|Part 1||0
6652529|NCT02430870|7582173|FG000|NOT COMPLETED|Part 1||0
6652530|NCT02430870|7582174|FG001|NOT COMPLETED|Part 1||0
6652531|NCT02430870|7582175|FG002|NOT COMPLETED|Part 1||0
6652532|NCT02430870|7582176|FG003|NOT COMPLETED|Part 1||0
6652533|NCT02430870|7582177|FG004|NOT COMPLETED|Part 1||0
6652534|NCT02430870|7582178|FG005|NOT COMPLETED|Part 1||0
6652535|NCT02430870|7582179|FG006|NOT COMPLETED|Part 1||0
6652536|NCT02430870|7582180|FG007|NOT COMPLETED|Part 1||0
6652537|NCT02430870|7582173|FG000|STARTED|Part 2||0
6652538|NCT02430870|7582174|FG001|STARTED|Part 2||0
6652539|NCT02430870|7582175|FG002|STARTED|Part 2||0
6652540|NCT02430870|7582176|FG003|STARTED|Part 2||6
6652541|NCT02430870|7582177|FG004|STARTED|Part 2||6
6652542|NCT02430870|7582178|FG005|STARTED|Part 2||6
6652543|NCT02430870|7582179|FG006|STARTED|Part 2||6
6434711|NCT01066624|7349459|FG002|NOT COMPLETED|Overall Study||0
6434712|NCT01066780|7349467|FG000|STARTED|Overall Study||24
6434713|NCT01066780|7349468|FG001|STARTED|Overall Study||24
6434714|NCT01066780|7349467|FG000|COMPLETED|Overall Study||23
6434715|NCT01066780|7349468|FG001|COMPLETED|Overall Study||23
6434716|NCT01066780|7349467|FG000|NOT COMPLETED|Overall Study||1
6434717|NCT01066780|7349468|FG001|NOT COMPLETED|Overall Study||1
6434718|NCT01066793|7349478|FG000|STARTED|Overall Study||1128
6434719|NCT01066793|7349479|FG001|STARTED|Overall Study||572
6434720|NCT01066793|7349480|FG002|STARTED|Overall Study||484
6434721|NCT01066793|7349481|FG003|STARTED|Overall Study||143
6434722|NCT01066793|7349482|FG004|STARTED|Overall Study||11
6652544|NCT02430870|7582180|FG007|STARTED|Part 2||8
6434723|NCT01066793|7349483|FG005|STARTED|Overall Study||5
6434724|NCT01066793|7349478|FG000|COMPLETED|Overall Study||754
6434725|NCT01066793|7349479|FG001|COMPLETED|Overall Study||495
6434726|NCT01066793|7349480|FG002|COMPLETED|Overall Study||369
6434727|NCT01066793|7349481|FG003|COMPLETED|Overall Study||94
6434728|NCT01066793|7349482|FG004|COMPLETED|Overall Study||11
6434729|NCT01066793|7349483|FG005|COMPLETED|Overall Study||4
6434730|NCT01066793|7349478|FG000|NOT COMPLETED|Overall Study||374
6434731|NCT01066793|7349479|FG001|NOT COMPLETED|Overall Study||77
6652545|NCT02430870|7582173|FG000|COMPLETED|Part 2||0
6652546|NCT02430870|7582174|FG001|COMPLETED|Part 2||0
6652547|NCT02430870|7582175|FG002|COMPLETED|Part 2||0
6652548|NCT02430870|7582176|FG003|COMPLETED|Part 2||6
6652549|NCT02430870|7582177|FG004|COMPLETED|Part 2||6
6434732|NCT01066793|7349480|FG002|NOT COMPLETED|Overall Study||115
6434733|NCT01066793|7349481|FG003|NOT COMPLETED|Overall Study||49
6434734|NCT01066793|7349482|FG004|NOT COMPLETED|Overall Study||0
6434735|NCT01066793|7349483|FG005|NOT COMPLETED|Overall Study||1
6434736|NCT01066819|7349504|FG000|STARTED|Overall Study||1006
6434737|NCT01066819|7349505|FG001|STARTED|Overall Study||348
6434738|NCT01066819|7349506|FG002|STARTED|Overall Study||257
6434739|NCT01066819|7349507|FG003|STARTED|Overall Study||25
6434740|NCT01066819|7349508|FG004|STARTED|Overall Study||7
6434741|NCT01066819|7349509|FG005|STARTED|Overall Study||13
6434742|NCT01066819|7349504|FG000|COMPLETED|Overall Study||317
6434743|NCT01066819|7349505|FG001|COMPLETED|Overall Study||177
6434744|NCT01066819|7349506|FG002|COMPLETED|Overall Study||111
6552466|NCT01737879|7474976|FG000|STARTED|Overall Study||41
6552467|NCT01737879|7474976|FG000|Received Peginesatide|Overall Study||34
6552468|NCT01737879|7474976|FG000|Transitioned to Epoetin Alfa|Overall Study||0
6552469|NCT01737879|7474976|FG000|COMPLETED|Overall Study||0
6552470|NCT01737879|7474976|FG000|NOT COMPLETED|Overall Study||41
6652550|NCT02430870|7582178|FG005|COMPLETED|Part 2||6
6652551|NCT02430870|7582179|FG006|COMPLETED|Part 2||5
6652552|NCT02430870|7582180|FG007|COMPLETED|Part 2||7
6652553|NCT02430870|7582173|FG000|NOT COMPLETED|Part 2||0
6434745|NCT01066819|7349507|FG003|COMPLETED|Overall Study||8
6434746|NCT01066819|7349508|FG004|COMPLETED|Overall Study||3
6434747|NCT01066819|7349509|FG005|COMPLETED|Overall Study||7
6434748|NCT01066819|7349504|FG000|NOT COMPLETED|Overall Study||689
6434749|NCT01066819|7349505|FG001|NOT COMPLETED|Overall Study||171
6434750|NCT01066819|7349506|FG002|NOT COMPLETED|Overall Study||146
6552471|NCT01737931|7474983|FG000|STARTED|Overall Study||38
6552472|NCT01737931|7474984|FG001|STARTED|Overall Study||40
6552473|NCT01737931|7474985|FG002|STARTED|Overall Study||39
6552474|NCT01737931|7474983|FG000|COMPLETED|Overall Study||38
6552475|NCT01737931|7474984|FG001|COMPLETED|Overall Study||38
6552476|NCT01737931|7474985|FG002|COMPLETED|Overall Study||38
6552477|NCT01737931|7474983|FG000|NOT COMPLETED|Overall Study||0
6552478|NCT01737931|7474984|FG001|NOT COMPLETED|Overall Study||2
6552479|NCT01737931|7474985|FG002|NOT COMPLETED|Overall Study||1
6552480|NCT01737944|7474995|FG000|STARTED|Overall Study||9
6552481|NCT01737944|7474996|FG001|STARTED|Overall Study||9
6552482|NCT01737944|7474997|FG002|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
6552483|NCT01737944|7474998|FG003|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
6552484|NCT01737944|7474995|FG000|COMPLETED|Overall Study||9
6552485|NCT01737944|7474996|FG001|COMPLETED|Overall Study||9
6552486|NCT01737944|7474997|FG002|COMPLETED|Overall Study||9
6552487|NCT01737944|7474998|FG003|COMPLETED|Overall Study||9
6552488|NCT01737944|7474995|FG000|NOT COMPLETED|Overall Study||0
6552489|NCT01737944|7474996|FG001|NOT COMPLETED|Overall Study||0
6552490|NCT01737944|7474997|FG002|NOT COMPLETED|Overall Study||0
6552491|NCT01737944|7474998|FG003|NOT COMPLETED|Overall Study||0
6552492|NCT01737996|7475010|FG000|STARTED|Overall Study||8
6552493|NCT01737996|7475011|FG001|STARTED|Overall Study||8
6552494|NCT01737996|7475012|FG002|STARTED|Overall Study||16
6552495|NCT01737996|7475010|FG000|COMPLETED|Overall Study||8
6552496|NCT01737996|7475011|FG001|COMPLETED|Overall Study||7
6552497|NCT01737996|7475012|FG002|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
6552498|NCT01737996|7475010|FG000|NOT COMPLETED|Overall Study||0
6552499|NCT01737996|7475011|FG001|NOT COMPLETED|Overall Study||1
6552500|NCT01737996|7475012|FG002|NOT COMPLETED|Overall Study||2
6552501|NCT01738191|7475022|FG000|STARTED|Overall Study||15
6552502|NCT01738191|7475023|FG001|STARTED|Overall Study||15
6552503|NCT01738191|7475022|FG000|COMPLETED|Overall Study||11
6552504|NCT01738191|7475023|FG001|COMPLETED|Overall Study||14
6552505|NCT01738191|7475022|FG000|NOT COMPLETED|Overall Study||4
6552506|NCT01738191|7475023|FG001|NOT COMPLETED|Overall Study||1
6552507|NCT01738321|7475031|FG000|STARTED|Overall Study||33
6552508|NCT01738321|7475032|FG001|STARTED|Overall Study||30
6552509|NCT01738321|7475031|FG000|COMPLETED|Overall Study||33
6552510|NCT01738321|7475032|FG001|COMPLETED|Overall Study||30
6552511|NCT01738321|7475031|FG000|NOT COMPLETED|Overall Study||0
6552512|NCT01738321|7475032|FG001|NOT COMPLETED|Overall Study||0
6552513|NCT01738438|7475038|FG000|STARTED|Overall Study||35
6552514|NCT01738438|7475038|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6552515|NCT01738438|7475038|FG000|NOT COMPLETED|Overall Study||35
6552516|NCT01738477|7475044|FG000|STARTED|Overall Study||37
6552517|NCT01738477|7475045|FG001|STARTED|Overall Study||128
6552518|NCT01738477|7475044|FG000|COMPLETED|Overall Study||36
6552519|NCT01738477|7475045|FG001|COMPLETED|Overall Study||124
6552520|NCT01738477|7475044|FG000|NOT COMPLETED|Overall Study||1
6552521|NCT01738477|7475045|FG001|NOT COMPLETED|Overall Study||4
6552522|NCT01738503|7475059|FG000|STARTED|Induction/Stabilization (Days -14 to -1)||124
6552523|NCT01738503|7475060|FG001|STARTED|Induction/Stabilization (Days -14 to -1)||0
6652554|NCT02430870|7582174|FG001|NOT COMPLETED|Part 2||0
6434751|NCT01066819|7349507|FG003|NOT COMPLETED|Overall Study||17
6434752|NCT01066819|7349508|FG004|NOT COMPLETED|Overall Study||4
6434753|NCT01066819|7349509|FG005|NOT COMPLETED|Overall Study||6
6434754|NCT01066871|7349525|FG000|STARTED|Overall Study||20
6434755|NCT01066871|7349526|FG001|STARTED|Overall Study||18
6434756|NCT01066871|7349527|FG002|STARTED|Overall Study||18
6434757|NCT01066871|7349528|FG003|STARTED|Overall Study||18
6434758|NCT01066871|7349525|FG000|COMPLETED|Overall Study||16
6434759|NCT01066871|7349526|FG001|COMPLETED|Overall Study||13
6434760|NCT01066871|7349527|FG002|COMPLETED|Overall Study||12
6434761|NCT01066871|7349528|FG003|COMPLETED|Overall Study||13
6434762|NCT01066871|7349525|FG000|NOT COMPLETED|Overall Study||4
6434763|NCT01066871|7349526|FG001|NOT COMPLETED|Overall Study||5
6434764|NCT01066871|7349527|FG002|NOT COMPLETED|Overall Study||6
6434765|NCT01066871|7349528|FG003|NOT COMPLETED|Overall Study||5
6434766|NCT01066897|7349545|FG000|STARTED|Overall Study||7
6434767|NCT01066897|7349546|FG001|STARTED|Overall Study||9
6434768|NCT01066897|7349545|FG000|COMPLETED|Overall Study||5
6434769|NCT01066897|7349546|FG001|COMPLETED|Overall Study||9
6434770|NCT01066897|7349545|FG000|NOT COMPLETED|Overall Study||2
6434771|NCT01066897|7349546|FG001|NOT COMPLETED|Overall Study||0
6434772|NCT01066923|7349557|FG000|STARTED|Overall Study||28
6434773|NCT01066923|7349558|FG001|STARTED|Overall Study||32
6434774|NCT01066923|7349559|FG002|STARTED|Overall Study||33
6434775|NCT01066923|7349560|FG003|STARTED|Overall Study||31
6434776|NCT01066923|7349557|FG000|Platelet Closure Time|Overall Study||25
6434777|NCT01066923|7349558|FG001|Platelet Closure Time|Overall Study||29
6434778|NCT01066923|7349559|FG002|Platelet Closure Time|Overall Study||25
6434779|NCT01066923|7349560|FG003|Platelet Closure Time|Overall Study||23
6434780|NCT01066923|7349557|FG000|Vascular Function|Overall Study||13
6434781|NCT01066923|7349558|FG001|Vascular Function|Overall Study||14
6434782|NCT01066923|7349559|FG002|Vascular Function|Overall Study||12
6434783|NCT01066923|7349560|FG003|Vascular Function|Overall Study||13
6434784|NCT01066923|7349557|FG000|Activation of Coagulation|Overall Study||0
6434785|NCT01066923|7349558|FG001|Activation of Coagulation|Overall Study||0
6434786|NCT01066923|7349559|FG002|Activation of Coagulation|Overall Study||0
6434787|NCT01066923|7349560|FG003|Activation of Coagulation|Overall Study||0
6434788|NCT01066923|7349557|FG000|Retinal Imaging|Overall Study||0
6434789|NCT01066923|7349558|FG001|Retinal Imaging|Overall Study||0
6434790|NCT01066923|7349559|FG002|Retinal Imaging|Overall Study||0
6434791|NCT01066923|7349560|FG003|Retinal Imaging|Overall Study||0
6434792|NCT01066923|7349557|FG000|COMPLETED|Overall Study||25
6434793|NCT01066923|7349558|FG001|COMPLETED|Overall Study||29
6434794|NCT01066923|7349559|FG002|COMPLETED|Overall Study||25
6434795|NCT01066923|7349560|FG003|COMPLETED|Overall Study||23
6434796|NCT01066923|7349557|FG000|NOT COMPLETED|Overall Study||3
6434797|NCT01066923|7349558|FG001|NOT COMPLETED|Overall Study||3
6434798|NCT01066923|7349559|FG002|NOT COMPLETED|Overall Study||8
6434799|NCT01066923|7349560|FG003|NOT COMPLETED|Overall Study||8
6434800|NCT01066936|7349570|FG000|STARTED|Overall Study||20
6434801|NCT01066936|7349570|FG000|COMPLETED|Overall Study||10
6434802|NCT01066936|7349570|FG000|NOT COMPLETED|Overall Study||10
6434803|NCT01067105|7349576|FG000|STARTED|Overall Study||824
6434804|NCT01067105|7349576|FG000|COMPLETED|Overall Study||683
6434805|NCT01067105|7349576|FG000|NOT COMPLETED|Overall Study||141
6434806|NCT01067144|7349582|FG000|STARTED|Treatment||207
6434807|NCT01067144|7349583|FG001|STARTED|Treatment||215
6434808|NCT01067144|7349582|FG000|COMPLETED|Treatment||203
6434809|NCT01067144|7349583|FG001|COMPLETED|Treatment||208
6434810|NCT01067144|7349582|FG000|NOT COMPLETED|Treatment||4
6434811|NCT01067144|7349583|FG001|NOT COMPLETED|Treatment||7
6434812|NCT01067144|7349582|FG000|STARTED|Follow-up||203
6434813|NCT01067144|7349583|FG001|STARTED|Follow-up||208
6434814|NCT01067144|7349582|FG000|Intention-to-Treat Analysis Set|Follow-up||202
6434815|NCT01067144|7349583|FG001|Intention-to-Treat Analysis Set|Follow-up||208
6434816|NCT01067144|7349582|FG000|COMPLETED|Follow-up||144
6434817|NCT01067144|7349583|FG001|COMPLETED|Follow-up||152
6434818|NCT01067144|7349582|FG000|NOT COMPLETED|Follow-up||59
6434819|NCT01067144|7349583|FG001|NOT COMPLETED|Follow-up||56
6434820|NCT01067326|7349591|FG000|STARTED|Overall Study||14
6434821|NCT01067326|7349592|FG001|STARTED|Overall Study||8
6434822|NCT01067326|7349591|FG000|COMPLETED|Overall Study||12
6434823|NCT01067326|7349592|FG001|COMPLETED|Overall Study||5
6434824|NCT01067326|7349591|FG000|NOT COMPLETED|Overall Study||2
6434825|NCT01067326|7349592|FG001|NOT COMPLETED|Overall Study||3
6434826|NCT01067339|7349600|FG000|STARTED|Overall Study||31
6434827|NCT01067339|7349601|FG001|STARTED|Overall Study||34
6434828|NCT01067339|7349600|FG000|COMPLETED|Overall Study||25
6434829|NCT01067339|7349601|FG001|COMPLETED|Overall Study||29
6434830|NCT01067339|7349600|FG000|NOT COMPLETED|Overall Study||6
6434831|NCT01067339|7349601|FG001|NOT COMPLETED|Overall Study||5
6434832|NCT01067352|7349610|FG000|STARTED|Overall Study||9
6434833|NCT01067352|7349611|FG001|STARTED|Overall Study||6
6434834|NCT01067352|7349612|FG002|STARTED|Overall Study||10
6434835|NCT01067352|7349610|FG000|COMPLETED|Overall Study||8
6434836|NCT01067352|7349611|FG001|COMPLETED|Overall Study||3
6434837|NCT01067352|7349612|FG002|COMPLETED|Overall Study||9
6434838|NCT01067352|7349610|FG000|NOT COMPLETED|Overall Study||1
6434839|NCT01067352|7349611|FG001|NOT COMPLETED|Overall Study||3
6434840|NCT01067352|7349612|FG002|NOT COMPLETED|Overall Study||1
6434841|NCT01067456|7349622|FG000|STARTED|Overall Study||30
6434842|NCT01067456|7349623|FG001|STARTED|Overall Study||29
6434843|NCT01067456|7349622|FG000|COMPLETED|Overall Study||30
6434844|NCT01067456|7349623|FG001|COMPLETED|Overall Study||29
6434845|NCT01067456|7349622|FG000|NOT COMPLETED|Overall Study||0
6434846|NCT01067456|7349623|FG001|NOT COMPLETED|Overall Study||0
6434847|NCT01067469|7349633|FG000|STARTED|Overall Study||36
6434848|NCT01067469|7349634|FG001|STARTED|Overall Study||35
6434849|NCT01067469|7349633|FG000|90 mg/m^2|Overall Study||0
6434850|NCT01067469|7349634|FG001|90 mg/m^2|Overall Study||12
6434851|NCT01067469|7349633|FG000|75 mg/m^2|Overall Study||0
6434852|NCT01067469|7349634|FG001|75 mg/m^2|Overall Study||21
6434853|NCT01067469|7349633|FG000|COMPLETED|Overall Study||36
6434854|NCT01067469|7349634|FG001|COMPLETED|Overall Study||33
6434855|NCT01067469|7349633|FG000|NOT COMPLETED|Overall Study||0
6434856|NCT01067469|7349634|FG001|NOT COMPLETED|Overall Study||2
6434857|NCT01067508|7349642|FG000|STARTED|Overall Study||10
6434858|NCT01067508|7349643|FG001|STARTED|Overall Study||9
6434859|NCT01067508|7349642|FG000|COMPLETED|Overall Study||10
6434860|NCT01067508|7349643|FG001|COMPLETED|Overall Study||7
6434861|NCT01067508|7349642|FG000|NOT COMPLETED|Overall Study||0
6434862|NCT01067508|7349643|FG001|NOT COMPLETED|Overall Study||2
6434863|NCT01067716|7349652|FG000|STARTED|Overall Study|110 eyes|57
6434864|NCT01067716|7349653|FG001|STARTED|Overall Study|25 eyes|13
6434865|NCT01067716|7349654|FG002|STARTED|Overall Study|15 eyes|9
6434866|NCT01067716|7349652|FG000|COMPLETED|Overall Study|110 eyes|57
6434867|NCT01067716|7349653|FG001|COMPLETED|Overall Study|25 eyes|13
6434868|NCT01067716|7349654|FG002|COMPLETED|Overall Study|15 eyes|9
6434869|NCT01067716|7349652|FG000|NOT COMPLETED|Overall Study||0
6434870|NCT01067716|7349653|FG001|NOT COMPLETED|Overall Study||0
6434871|NCT01067716|7349654|FG002|NOT COMPLETED|Overall Study||0
6434872|NCT01067768|7349664|FG000|STARTED|Overall Study||604
6434873|NCT01067768|7349665|FG001|STARTED|Overall Study||605
6434874|NCT01067768|7349664|FG000|COMPLETED|Overall Study||604
6434875|NCT01067768|7349665|FG001|COMPLETED|Overall Study||605
6434876|NCT01067768|7349664|FG000|NOT COMPLETED|Overall Study||0
6434877|NCT01067768|7349665|FG001|NOT COMPLETED|Overall Study||0
6434878|NCT01067781|7349675|FG000|STARTED|Up to Day 180||203
6434879|NCT01067781|7349676|FG001|STARTED|Up to Day 180||199
6434880|NCT01067781|7349677|FG002|STARTED|Up to Day 180||97
6434881|NCT01067781|7349678|FG003|STARTED|Up to Day 180||101
6434882|NCT01067781|7349675|FG000|COMPLETED|Up to Day 180||173
6434883|NCT01067781|7349676|FG001|COMPLETED|Up to Day 180||168
6434884|NCT01067781|7349677|FG002|COMPLETED|Up to Day 180||89
6434885|NCT01067781|7349678|FG003|COMPLETED|Up to Day 180||89
6434886|NCT01067781|7349675|FG000|NOT COMPLETED|Up to Day 180||30
6434887|NCT01067781|7349676|FG001|NOT COMPLETED|Up to Day 180||31
6434888|NCT01067781|7349677|FG002|NOT COMPLETED|Up to Day 180||8
6434889|NCT01067781|7349678|FG003|NOT COMPLETED|Up to Day 180||12
6434890|NCT01067781|7349675|FG000|STARTED|180 to Day 720||173
6434891|NCT01067781|7349676|FG001|STARTED|180 to Day 720||168
6434892|NCT01067781|7349677|FG002|STARTED|180 to Day 720||89
6434893|NCT01067781|7349678|FG003|STARTED|180 to Day 720||89
6434894|NCT01067781|7349675|FG000|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
6434895|NCT01067781|7349676|FG001|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
6434896|NCT01067781|7349677|FG002|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
6434897|NCT01067781|7349678|FG003|COMPLETED|180 to Day 720|all subjects followed till Day180;if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
6434898|NCT01067781|7349675|FG000|NOT COMPLETED|180 to Day 720||170
6434899|NCT01067781|7349676|FG001|NOT COMPLETED|180 to Day 720||164
6434900|NCT01067781|7349677|FG002|NOT COMPLETED|180 to Day 720||89
6434901|NCT01067781|7349678|FG003|NOT COMPLETED|180 to Day 720||89
6434902|NCT01067846|7349692|FG000|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
6434903|NCT01067846|7349693|FG001|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
6434904|NCT01067846|7349692|FG000|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
6434905|NCT01067846|7349693|FG001|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
6434906|NCT01067846|7349692|FG000|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
6434907|NCT01067846|7349693|FG001|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
6434908|NCT01067846|7349692|FG000|NOT COMPLETED|Overall Study||19
6434909|NCT01067846|7349693|FG001|NOT COMPLETED|Overall Study||19
6434910|NCT01067976|7349699|FG000|STARTED|Overall Study|screened and enrolled|446
6434911|NCT01067976|7349699|FG000|Received Treatment|Overall Study|treatment started|426
6434912|NCT01067976|7349699|FG000|Fulfilled Requirements of FAS Population|Overall Study||390
6434913|NCT01067976|7349699|FG000|COMPLETED|Overall Study|study course completed|424
6434914|NCT01067976|7349699|FG000|NOT COMPLETED|Overall Study||22
6434915|NCT01068158|7349719|FG000|STARTED|Overall Study||169
6434916|NCT01068158|7349720|FG001|STARTED|Overall Study||202
6434917|NCT01068158|7349719|FG000|COMPLETED|Overall Study||161
6434918|NCT01068158|7349720|FG001|COMPLETED|Overall Study||198
6434919|NCT01068158|7349719|FG000|NOT COMPLETED|Overall Study||8
6434920|NCT01068158|7349720|FG001|NOT COMPLETED|Overall Study||4
6434921|NCT01068262|7349730|FG000|STARTED|Overall Study||23
6434922|NCT01068262|7349731|FG001|STARTED|Overall Study||9
6434923|NCT01068262|7349732|FG002|STARTED|Overall Study||10
6434924|NCT01068262|7349733|FG003|STARTED|Overall Study||2
6434925|NCT01068262|7349730|FG000|COMPLETED|Overall Study||20
6434926|NCT01068262|7349731|FG001|COMPLETED|Overall Study||8
6434927|NCT01068262|7349732|FG002|COMPLETED|Overall Study||9
6434928|NCT01068262|7349733|FG003|COMPLETED|Overall Study||2
6434929|NCT01068262|7349730|FG000|NOT COMPLETED|Overall Study||3
6434930|NCT01068262|7349731|FG001|NOT COMPLETED|Overall Study||1
6434931|NCT01068262|7349732|FG002|NOT COMPLETED|Overall Study||1
6434932|NCT01068262|7349733|FG003|NOT COMPLETED|Overall Study||0
6434933|NCT01068418|7349746|FG000|STARTED|Overall Study|26 participants found to be eligible|26
6434934|NCT01068418|7349746|FG000|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
6434935|NCT01068418|7349746|FG000|COMPLETED|Overall Study|14 participants completed all study procedures.|14
6434936|NCT01068418|7349746|FG000|NOT COMPLETED|Overall Study||12
6552524|NCT01738503|7475061|FG002|STARTED|Induction/Stabilization (Days -14 to -1)||0
6552525|NCT01738503|7475062|FG003|STARTED|Induction/Stabilization (Days -14 to -1)||0
6434937|NCT01068509|7349753|FG000|STARTED|Overall Study||7
6434938|NCT01068509|7349754|FG001|STARTED|Overall Study||29
6434939|NCT01068509|7349755|FG002|STARTED|Overall Study||27
6434940|NCT01068509|7349753|FG000|COMPLETED|Overall Study||1
6434941|NCT01068509|7349754|FG001|COMPLETED|Overall Study||7
6434942|NCT01068509|7349755|FG002|COMPLETED|Overall Study||6
6434943|NCT01068509|7349753|FG000|NOT COMPLETED|Overall Study||6
6434944|NCT01068509|7349754|FG001|NOT COMPLETED|Overall Study||22
6434945|NCT01068509|7349755|FG002|NOT COMPLETED|Overall Study||21
6434946|NCT01068548|7349764|FG000|STARTED|Overall Study||66
6434947|NCT01068548|7349765|FG001|STARTED|Overall Study||63
6434948|NCT01068548|7349764|FG000|COMPLETED|Overall Study||66
6434949|NCT01068548|7349765|FG001|COMPLETED|Overall Study||63
6434950|NCT01068548|7349764|FG000|NOT COMPLETED|Overall Study||0
6434951|NCT01068548|7349765|FG001|NOT COMPLETED|Overall Study||0
6434952|NCT01068600|7349774|FG000|STARTED|Overall Study||159
6434953|NCT01068600|7349775|FG001|STARTED|Overall Study||159
6434954|NCT01068600|7349774|FG000|COMPLETED|Overall Study||148
6434955|NCT01068600|7349775|FG001|COMPLETED|Overall Study||142
6434956|NCT01068600|7349774|FG000|NOT COMPLETED|Overall Study||11
6434957|NCT01068600|7349775|FG001|NOT COMPLETED|Overall Study||17
6434958|NCT01068626|7349783|FG000|STARTED|Overall Study||30
6434959|NCT01068626|7349784|FG001|STARTED|Overall Study||29
6434960|NCT01068626|7349783|FG000|COMPLETED|Overall Study||27
6434961|NCT01068626|7349784|FG001|COMPLETED|Overall Study||27
6434962|NCT01068626|7349783|FG000|NOT COMPLETED|Overall Study||3
6434963|NCT01068626|7349784|FG001|NOT COMPLETED|Overall Study||2
6434964|NCT01068652|7349792|FG000|STARTED|Overall Study||200
6434965|NCT01068652|7349793|FG001|STARTED|Overall Study||203
6434966|NCT01068652|7349792|FG000|COMPLETED|Overall Study||182
6434967|NCT01068652|7349793|FG001|COMPLETED|Overall Study||188
6434968|NCT01068652|7349792|FG000|NOT COMPLETED|Overall Study||18
6434969|NCT01068652|7349793|FG001|NOT COMPLETED|Overall Study||15
6434970|NCT01068665|7349801|FG000|STARTED|Overall Study||230
6434971|NCT01068665|7349802|FG001|STARTED|Overall Study||230
6434972|NCT01068665|7349801|FG000|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
6434973|NCT01068665|7349802|FG001|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
6434974|NCT01068665|7349801|FG000|Exposed|Overall Study||228
6434975|NCT01068665|7349802|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
6434976|NCT01068665|7349801|FG000|COMPLETED|Overall Study||200
6434977|NCT01068665|7349802|FG001|COMPLETED|Overall Study||201
6434978|NCT01068665|7349801|FG000|NOT COMPLETED|Overall Study||30
6434979|NCT01068665|7349802|FG001|NOT COMPLETED|Overall Study||29
6434980|NCT01068678|7349810|FG000|STARTED|Overall Study||230
6434981|NCT01068678|7349811|FG001|STARTED|Overall Study||230
6434982|NCT01068678|7349810|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
6434983|NCT01068678|7349811|FG001|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
6434984|NCT01068678|7349810|FG000|COMPLETED|Overall Study||192
6434985|NCT01068678|7349811|FG001|COMPLETED|Overall Study||206
6434986|NCT01068678|7349810|FG000|NOT COMPLETED|Overall Study||38
6434987|NCT01068678|7349811|FG001|NOT COMPLETED|Overall Study||24
6434988|NCT01068717|7349817|FG000|STARTED|Period 1: Treatment Schedule Phase 1||7
6434989|NCT01068717|7349818|FG001|STARTED|Period 1: Treatment Schedule Phase 1||6
6434990|NCT01068717|7349819|FG002|STARTED|Period 1: Treatment Schedule Phase 1||7
6434991|NCT01068717|7349820|FG003|STARTED|Period 1: Treatment Schedule Phase 1||7
6434992|NCT01068717|7349817|FG000|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
6434993|NCT01068717|7349818|FG001|COMPLETED|Period 1: Treatment Schedule Phase 1||6
6434994|NCT01068717|7349819|FG002|COMPLETED|Period 1: Treatment Schedule Phase 1||7
6434995|NCT01068717|7349820|FG003|COMPLETED|Period 1: Treatment Schedule Phase 1||7
6434996|NCT01068717|7349817|FG000|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
6434997|NCT01068717|7349818|FG001|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
6434998|NCT01068717|7349819|FG002|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
6434999|NCT01068717|7349820|FG003|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
6435000|NCT01068717|7349817|FG000|STARTED|Period 2: Treatment Schedule Phase 2||6
6435001|NCT01068717|7349818|FG001|STARTED|Period 2: Treatment Schedule Phase 2||6
6435002|NCT01068717|7349819|FG002|STARTED|Period 2: Treatment Schedule Phase 2||7
6435003|NCT01068717|7349820|FG003|STARTED|Period 2: Treatment Schedule Phase 2||7
6435004|NCT01068717|7349817|FG000|COMPLETED|Period 2: Treatment Schedule Phase 2||6
6435005|NCT01068717|7349818|FG001|COMPLETED|Period 2: Treatment Schedule Phase 2||6
6435006|NCT01068717|7349819|FG002|COMPLETED|Period 2: Treatment Schedule Phase 2||7
6435007|NCT01068717|7349820|FG003|COMPLETED|Period 2: Treatment Schedule Phase 2||7
6435008|NCT01068717|7349817|FG000|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
6435009|NCT01068717|7349818|FG001|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
6435010|NCT01068717|7349819|FG002|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
6435011|NCT01068717|7349820|FG003|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
6435012|NCT01068717|7349817|FG000|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
6435013|NCT01068717|7349818|FG001|STARTED|Period 3: Treatment Schedule Phase 3||6
6435014|NCT01068717|7349819|FG002|STARTED|Period 3: Treatment Schedule Phase 3||7
6435015|NCT01068717|7349820|FG003|STARTED|Period 3: Treatment Schedule Phase 3||7
6435016|NCT01068717|7349817|FG000|COMPLETED|Period 3: Treatment Schedule Phase 3||7
6435017|NCT01068717|7349818|FG001|COMPLETED|Period 3: Treatment Schedule Phase 3||6
6435018|NCT01068717|7349819|FG002|COMPLETED|Period 3: Treatment Schedule Phase 3||7
6435019|NCT01068717|7349820|FG003|COMPLETED|Period 3: Treatment Schedule Phase 3||7
6435020|NCT01068717|7349817|FG000|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
6435021|NCT01068717|7349818|FG001|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
6435022|NCT01068717|7349819|FG002|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
6435023|NCT01068717|7349820|FG003|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
6435024|NCT01068717|7349817|FG000|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
6435025|NCT01068717|7349818|FG001|STARTED|Period 4: Treatment Schedule Phase 4||6
6435026|NCT01068717|7349819|FG002|STARTED|Period 4: Treatment Schedule Phase 4||7
6435027|NCT01068717|7349820|FG003|STARTED|Period 4: Treatment Schedule Phase 4||7
6435028|NCT01068717|7349817|FG000|COMPLETED|Period 4: Treatment Schedule Phase 4||7
6435029|NCT01068717|7349818|FG001|COMPLETED|Period 4: Treatment Schedule Phase 4||6
6435030|NCT01068717|7349819|FG002|COMPLETED|Period 4: Treatment Schedule Phase 4||7
6435031|NCT01068717|7349820|FG003|COMPLETED|Period 4: Treatment Schedule Phase 4||7
6435032|NCT01068717|7349817|FG000|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
6435033|NCT01068717|7349818|FG001|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
6435034|NCT01068717|7349819|FG002|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
6435035|NCT01068717|7349820|FG003|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
6435036|NCT01068730|7349834|FG000|STARTED|Period 1||7
6435037|NCT01068730|7349835|FG001|STARTED|Period 1||7
6435038|NCT01068730|7349836|FG002|STARTED|Period 1||7
6435039|NCT01068730|7349837|FG003|STARTED|Period 1||7
6435040|NCT01068730|7349834|FG000|COMPLETED|Period 1||7
6435041|NCT01068730|7349835|FG001|COMPLETED|Period 1||7
6435042|NCT01068730|7349836|FG002|COMPLETED|Period 1||7
6435043|NCT01068730|7349837|FG003|COMPLETED|Period 1||7
6435044|NCT01068730|7349834|FG000|NOT COMPLETED|Period 1||0
6435045|NCT01068730|7349835|FG001|NOT COMPLETED|Period 1||0
6435046|NCT01068730|7349836|FG002|NOT COMPLETED|Period 1||0
6435047|NCT01068730|7349837|FG003|NOT COMPLETED|Period 1||0
6652555|NCT02430870|7582175|FG002|NOT COMPLETED|Part 2||0
6652556|NCT02430870|7582176|FG003|NOT COMPLETED|Part 2||0
6652557|NCT02430870|7582177|FG004|NOT COMPLETED|Part 2||0
6652558|NCT02430870|7582178|FG005|NOT COMPLETED|Part 2||0
6652559|NCT02430870|7582179|FG006|NOT COMPLETED|Part 2||1
6652560|NCT02430870|7582180|FG007|NOT COMPLETED|Part 2||1
6652561|NCT02431052|7582203|FG000|STARTED|Overall Study||53
6652562|NCT02431052|7582204|FG001|STARTED|Overall Study||50
6652563|NCT02431052|7582205|FG002|STARTED|Overall Study||106
6652564|NCT02431052|7582206|FG003|STARTED|Overall Study||110
6652565|NCT02431052|7582207|FG004|STARTED|Overall Study||101
6652566|NCT02431052|7582203|FG000|COMPLETED|Overall Study||42
6652567|NCT02431052|7582204|FG001|COMPLETED|Overall Study||46
6652568|NCT02431052|7582205|FG002|COMPLETED|Overall Study||94
6652569|NCT02431052|7582206|FG003|COMPLETED|Overall Study||94
6652570|NCT02431052|7582207|FG004|COMPLETED|Overall Study||86
6652571|NCT02431052|7582203|FG000|NOT COMPLETED|Overall Study||11
6652572|NCT02431052|7582204|FG001|NOT COMPLETED|Overall Study||4
6652573|NCT02431052|7582205|FG002|NOT COMPLETED|Overall Study||12
6652574|NCT02431052|7582206|FG003|NOT COMPLETED|Overall Study||16
6652575|NCT02431052|7582207|FG004|NOT COMPLETED|Overall Study||15
6652576|NCT02431260|7582238|FG000|STARTED|Overall Study||4
6652577|NCT02431260|7582239|FG001|STARTED|Overall Study||5
6652578|NCT02431260|7582240|FG002|STARTED|Overall Study||6
6652579|NCT02431260|7582241|FG003|STARTED|Overall Study||5
6652580|NCT02431260|7582242|FG004|STARTED|Overall Study||3
6652581|NCT02431260|7582243|FG005|STARTED|Overall Study||4
6652582|NCT02431260|7582244|FG006|STARTED|Overall Study||4
6652583|NCT02431260|7582245|FG007|STARTED|Overall Study||3
6652584|NCT02431260|7582246|FG008|STARTED|Overall Study||8
6652585|NCT02431260|7582247|FG009|STARTED|Overall Study||8
6652586|NCT02431260|7582248|FG010|STARTED|Overall Study||4
6652587|NCT02431260|7582249|FG011|STARTED|Overall Study||4
6652588|NCT02431260|7582250|FG012|STARTED|Overall Study||10
6652589|NCT02431260|7582251|FG013|STARTED|Overall Study||1
6652590|NCT02431260|7582238|FG000|COMPLETED|Overall Study||0
6652591|NCT02431260|7582239|FG001|COMPLETED|Overall Study||0
6652592|NCT02431260|7582240|FG002|COMPLETED|Overall Study||0
6652593|NCT02431260|7582241|FG003|COMPLETED|Overall Study||0
6652594|NCT02431260|7582242|FG004|COMPLETED|Overall Study||0
6652595|NCT02431260|7582243|FG005|COMPLETED|Overall Study||0
6652596|NCT02431260|7582244|FG006|COMPLETED|Overall Study||0
6652597|NCT02431260|7582245|FG007|COMPLETED|Overall Study||0
6652598|NCT02431260|7582246|FG008|COMPLETED|Overall Study||0
6652599|NCT02431260|7582247|FG009|COMPLETED|Overall Study||0
6435048|NCT01068730|7349834|FG000|STARTED|Period 2||7
6435049|NCT01068730|7349835|FG001|STARTED|Period 2||7
6435050|NCT01068730|7349836|FG002|STARTED|Period 2||7
6435051|NCT01068730|7349837|FG003|STARTED|Period 2||7
6552526|NCT01738503|7475063|FG004|STARTED|Induction/Stabilization (Days -14 to -1)||0
6652600|NCT02431260|7582248|FG010|COMPLETED|Overall Study||0
6652601|NCT02431260|7582249|FG011|COMPLETED|Overall Study||0
6435052|NCT01068730|7349834|FG000|COMPLETED|Period 2||7
6435053|NCT01068730|7349835|FG001|COMPLETED|Period 2||7
6435054|NCT01068730|7349836|FG002|COMPLETED|Period 2||7
6435055|NCT01068730|7349837|FG003|COMPLETED|Period 2||7
6435056|NCT01068730|7349834|FG000|NOT COMPLETED|Period 2||0
6435057|NCT01068730|7349835|FG001|NOT COMPLETED|Period 2||0
6435058|NCT01068730|7349836|FG002|NOT COMPLETED|Period 2||0
6435059|NCT01068730|7349837|FG003|NOT COMPLETED|Period 2||0
6435060|NCT01068730|7349834|FG000|STARTED|Period 3||7
6435061|NCT01068730|7349835|FG001|STARTED|Period 3||7
6435062|NCT01068730|7349836|FG002|STARTED|Period 3||7
6435063|NCT01068730|7349837|FG003|STARTED|Period 3||7
6435064|NCT01068730|7349834|FG000|COMPLETED|Period 3||6
6435065|NCT01068730|7349835|FG001|COMPLETED|Period 3||7
6435066|NCT01068730|7349836|FG002|COMPLETED|Period 3||7
6435067|NCT01068730|7349837|FG003|COMPLETED|Period 3||7
6435068|NCT01068730|7349834|FG000|NOT COMPLETED|Period 3||1
6435069|NCT01068730|7349835|FG001|NOT COMPLETED|Period 3||0
6435070|NCT01068730|7349836|FG002|NOT COMPLETED|Period 3||0
6435071|NCT01068730|7349837|FG003|NOT COMPLETED|Period 3||0
6435072|NCT01068730|7349834|FG000|STARTED|Period 4||6
6435073|NCT01068730|7349835|FG001|STARTED|Period 4||7
6435074|NCT01068730|7349836|FG002|STARTED|Period 4||7
6435075|NCT01068730|7349837|FG003|STARTED|Period 4||7
6435076|NCT01068730|7349834|FG000|COMPLETED|Period 4||6
6435077|NCT01068730|7349835|FG001|COMPLETED|Period 4||6
6435078|NCT01068730|7349836|FG002|COMPLETED|Period 4||7
6435079|NCT01068730|7349837|FG003|COMPLETED|Period 4||7
6435080|NCT01068730|7349834|FG000|NOT COMPLETED|Period 4||0
6435081|NCT01068730|7349835|FG001|NOT COMPLETED|Period 4||1
6435082|NCT01068730|7349836|FG002|NOT COMPLETED|Period 4||0
6435083|NCT01068730|7349837|FG003|NOT COMPLETED|Period 4||0
6435084|NCT01068743|7349854|FG000|STARTED|Period 1||6
6435085|NCT01068743|7349855|FG001|STARTED|Period 1||6
6435086|NCT01068743|7349856|FG002|STARTED|Period 1||6
6435087|NCT01068743|7349857|FG003|STARTED|Period 1||6
6435088|NCT01068743|7349854|FG000|COMPLETED|Period 1||6
6652602|NCT02431260|7582250|FG012|COMPLETED|Overall Study||0
6652603|NCT02431260|7582251|FG013|COMPLETED|Overall Study||0
6652604|NCT02431260|7582238|FG000|NOT COMPLETED|Overall Study||4
6652605|NCT02431260|7582239|FG001|NOT COMPLETED|Overall Study||5
6652606|NCT02431260|7582240|FG002|NOT COMPLETED|Overall Study||6
6652607|NCT02431260|7582241|FG003|NOT COMPLETED|Overall Study||5
6652608|NCT02431260|7582242|FG004|NOT COMPLETED|Overall Study||3
6652609|NCT02431260|7582243|FG005|NOT COMPLETED|Overall Study||4
6652610|NCT02431260|7582244|FG006|NOT COMPLETED|Overall Study||4
6652611|NCT02431260|7582245|FG007|NOT COMPLETED|Overall Study||3
6652612|NCT02431260|7582246|FG008|NOT COMPLETED|Overall Study||8
6652613|NCT02431260|7582247|FG009|NOT COMPLETED|Overall Study||8
6652614|NCT02431260|7582248|FG010|NOT COMPLETED|Overall Study||4
6652615|NCT02431260|7582249|FG011|NOT COMPLETED|Overall Study||4
6435089|NCT01068743|7349855|FG001|COMPLETED|Period 1||6
6435090|NCT01068743|7349856|FG002|COMPLETED|Period 1||6
6435091|NCT01068743|7349857|FG003|COMPLETED|Period 1||6
6435092|NCT01068743|7349854|FG000|NOT COMPLETED|Period 1||0
6435093|NCT01068743|7349855|FG001|NOT COMPLETED|Period 1||0
6435094|NCT01068743|7349856|FG002|NOT COMPLETED|Period 1||0
6435095|NCT01068743|7349857|FG003|NOT COMPLETED|Period 1||0
6435096|NCT01068743|7349854|FG000|STARTED|Period 2||6
6435097|NCT01068743|7349855|FG001|STARTED|Period 2||6
6552527|NCT01738503|7475064|FG005|STARTED|Induction/Stabilization (Days -14 to -1)||0
6552528|NCT01738503|7475065|FG006|STARTED|Induction/Stabilization (Days -14 to -1)||0
6552529|NCT01738503|7475059|FG000|COMPLETED|Induction/Stabilization (Days -14 to -1)||89
6552530|NCT01738503|7475060|FG001|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552531|NCT01738503|7475061|FG002|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552532|NCT01738503|7475062|FG003|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552533|NCT01738503|7475063|FG004|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552534|NCT01738503|7475064|FG005|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552535|NCT01738503|7475065|FG006|COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552536|NCT01738503|7475059|FG000|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||35
6552537|NCT01738503|7475060|FG001|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552538|NCT01738503|7475061|FG002|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552539|NCT01738503|7475062|FG003|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552540|NCT01738503|7475063|FG004|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552541|NCT01738503|7475064|FG005|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552542|NCT01738503|7475065|FG006|NOT COMPLETED|Induction/Stabilization (Days -14 to -1)||0
6552543|NCT01738503|7475059|FG000|STARTED|Treatment Period||0
6552544|NCT01738503|7475060|FG001|STARTED|Treatment Period||15
6552545|NCT01738503|7475061|FG002|STARTED|Treatment Period||15
6435098|NCT01068743|7349856|FG002|STARTED|Period 2||6
6435099|NCT01068743|7349857|FG003|STARTED|Period 2||6
6435100|NCT01068743|7349854|FG000|COMPLETED|Period 2||6
6435101|NCT01068743|7349855|FG001|COMPLETED|Period 2||6
6435102|NCT01068743|7349856|FG002|COMPLETED|Period 2||6
6435103|NCT01068743|7349857|FG003|COMPLETED|Period 2||6
6435104|NCT01068743|7349854|FG000|NOT COMPLETED|Period 2||0
6435105|NCT01068743|7349855|FG001|NOT COMPLETED|Period 2||0
6435106|NCT01068743|7349856|FG002|NOT COMPLETED|Period 2||0
6435107|NCT01068743|7349857|FG003|NOT COMPLETED|Period 2||0
6435108|NCT01068743|7349854|FG000|STARTED|Period 3||6
6435109|NCT01068743|7349855|FG001|STARTED|Period 3||6
6435110|NCT01068743|7349856|FG002|STARTED|Period 3||6
6435111|NCT01068743|7349857|FG003|STARTED|Period 3||6
6435112|NCT01068743|7349854|FG000|COMPLETED|Period 3||6
6435113|NCT01068743|7349855|FG001|COMPLETED|Period 3||5
6435114|NCT01068743|7349856|FG002|COMPLETED|Period 3||6
6435115|NCT01068743|7349857|FG003|COMPLETED|Period 3||6
6435116|NCT01068743|7349854|FG000|NOT COMPLETED|Period 3||0
6435117|NCT01068743|7349855|FG001|NOT COMPLETED|Period 3||1
6435118|NCT01068743|7349856|FG002|NOT COMPLETED|Period 3||0
6435119|NCT01068743|7349857|FG003|NOT COMPLETED|Period 3||0
6435120|NCT01068743|7349854|FG000|STARTED|Period 4||6
6435121|NCT01068743|7349855|FG001|STARTED|Period 4||5
6435122|NCT01068743|7349856|FG002|STARTED|Period 4||6
6435123|NCT01068743|7349857|FG003|STARTED|Period 4||6
6435124|NCT01068743|7349854|FG000|COMPLETED|Period 4||6
6435125|NCT01068743|7349855|FG001|COMPLETED|Period 4||5
6435126|NCT01068743|7349856|FG002|COMPLETED|Period 4||6
6435127|NCT01068743|7349857|FG003|COMPLETED|Period 4||6
6435128|NCT01068743|7349854|FG000|NOT COMPLETED|Period 4||0
6435129|NCT01068743|7349855|FG001|NOT COMPLETED|Period 4||0
6435130|NCT01068743|7349856|FG002|NOT COMPLETED|Period 4||0
6435131|NCT01068743|7349857|FG003|NOT COMPLETED|Period 4||0
6435132|NCT01068769|7349870|FG000|STARTED|Overall Study||34
6435133|NCT01068769|7349870|FG000|COMPLETED|Overall Study||33
6435134|NCT01068769|7349870|FG000|NOT COMPLETED|Overall Study||1
6435135|NCT01068821|7349876|FG000|STARTED|Overall Study||31
6435136|NCT01068821|7349877|FG001|STARTED|Overall Study||29
6435137|NCT01068821|7349876|FG000|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
6435138|NCT01068821|7349877|FG001|COMPLETED|Overall Study||29
6435139|NCT01068821|7349876|FG000|NOT COMPLETED|Overall Study||1
6435140|NCT01068821|7349877|FG001|NOT COMPLETED|Overall Study||0
6435141|NCT01068860|7349893|FG000|STARTED|Overall Study||33
6435142|NCT01068860|7349894|FG001|STARTED|Overall Study||17
6435143|NCT01068860|7349895|FG002|STARTED|Overall Study||33
6435144|NCT01068860|7349896|FG003|STARTED|Overall Study||17
6435145|NCT01068860|7349897|FG004|STARTED|Overall Study||32
6435146|NCT01068860|7349898|FG005|STARTED|Overall Study||16
6435147|NCT01068860|7349899|FG006|STARTED|Overall Study||28
6435148|NCT01068860|7349900|FG007|STARTED|Overall Study||15
6435149|NCT01068860|7349901|FG008|STARTED|Overall Study||28
6435150|NCT01068860|7349902|FG009|STARTED|Overall Study||27
6435151|NCT01068860|7349893|FG000|COMPLETED|Overall Study||33
6435152|NCT01068860|7349894|FG001|COMPLETED|Overall Study||16
6435153|NCT01068860|7349895|FG002|COMPLETED|Overall Study||33
6435154|NCT01068860|7349896|FG003|COMPLETED|Overall Study||16
6435155|NCT01068860|7349897|FG004|COMPLETED|Overall Study||32
6435156|NCT01068860|7349898|FG005|COMPLETED|Overall Study||14
6435157|NCT01068860|7349899|FG006|COMPLETED|Overall Study||28
6435158|NCT01068860|7349900|FG007|COMPLETED|Overall Study||15
6435159|NCT01068860|7349901|FG008|COMPLETED|Overall Study||28
6435160|NCT01068860|7349902|FG009|COMPLETED|Overall Study||23
6435161|NCT01068860|7349893|FG000|NOT COMPLETED|Overall Study||0
6435162|NCT01068860|7349894|FG001|NOT COMPLETED|Overall Study||1
6435163|NCT01068860|7349895|FG002|NOT COMPLETED|Overall Study||0
6435164|NCT01068860|7349896|FG003|NOT COMPLETED|Overall Study||1
6435165|NCT01068860|7349897|FG004|NOT COMPLETED|Overall Study||0
6435166|NCT01068860|7349898|FG005|NOT COMPLETED|Overall Study||2
6435167|NCT01068860|7349899|FG006|NOT COMPLETED|Overall Study||0
6435168|NCT01068860|7349900|FG007|NOT COMPLETED|Overall Study||0
6435169|NCT01068860|7349901|FG008|NOT COMPLETED|Overall Study||0
6435170|NCT01068860|7349902|FG009|NOT COMPLETED|Overall Study||4
6435171|NCT01068873|7349924|FG000|STARTED|Overall Study||1
6435172|NCT01068873|7349924|FG000|COMPLETED|Overall Study||1
6435173|NCT01068873|7349924|FG000|NOT COMPLETED|Overall Study||0
6435174|NCT01068912|7349931|FG000|STARTED|Overall Study||134
6435175|NCT01068912|7349932|FG001|STARTED|Overall Study||195
6435176|NCT01068912|7349933|FG002|STARTED|Overall Study||201
6435177|NCT01068912|7349931|FG000|COMPLETED|Overall Study||123
6435178|NCT01068912|7349932|FG001|COMPLETED|Overall Study||173
6435179|NCT01068912|7349933|FG002|COMPLETED|Overall Study||186
6435180|NCT01068912|7349931|FG000|NOT COMPLETED|Overall Study||11
6435181|NCT01068912|7349932|FG001|NOT COMPLETED|Overall Study||22
6435182|NCT01068912|7349933|FG002|NOT COMPLETED|Overall Study||15
6435183|NCT01068964|7349943|FG000|STARTED|Overall Study||121
6435184|NCT01068964|7349944|FG001|STARTED|Overall Study||114
6435185|NCT01068964|7349943|FG000|COMPLETED|Overall Study||113
6435186|NCT01068964|7349944|FG001|COMPLETED|Overall Study||104
6435187|NCT01068964|7349943|FG000|NOT COMPLETED|Overall Study||8
6435188|NCT01068964|7349944|FG001|NOT COMPLETED|Overall Study||10
6435189|NCT01069003|7349953|FG000|STARTED|Overall Study||399
6435190|NCT01069003|7349954|FG001|STARTED|Overall Study||412
6435191|NCT01069003|7349955|FG002|STARTED|Overall Study||1451
6435192|NCT01069003|7349953|FG000|COMPLETED|Overall Study||353
6435193|NCT01069003|7349954|FG001|COMPLETED|Overall Study||358
6435194|NCT01069003|7349955|FG002|COMPLETED|Overall Study||976
6435195|NCT01069003|7349953|FG000|NOT COMPLETED|Overall Study||46
6435196|NCT01069003|7349954|FG001|NOT COMPLETED|Overall Study||54
6435197|NCT01069003|7349955|FG002|NOT COMPLETED|Overall Study||475
6435198|NCT01069172|7349965|FG000|STARTED|Overall Study|30 eyes|30
6435199|NCT01069172|7349966|FG001|STARTED|Overall Study|30 eyes|30
6435200|NCT01069172|7349965|FG000|COMPLETED|Overall Study|29 eyes|29
6435201|NCT01069172|7349966|FG001|COMPLETED|Overall Study|30 eyes|30
6435202|NCT01069172|7349965|FG000|NOT COMPLETED|Overall Study||1
6435203|NCT01069172|7349966|FG001|NOT COMPLETED|Overall Study||0
6435204|NCT01069185|7349975|FG000|STARTED|Overall Study||47
6435205|NCT01069185|7349976|FG001|STARTED|Overall Study||45
6435206|NCT01069185|7349975|FG000|COMPLETED|Overall Study||47
6435207|NCT01069185|7349976|FG001|COMPLETED|Overall Study||45
6435208|NCT01069185|7349975|FG000|NOT COMPLETED|Overall Study||0
6435209|NCT01069185|7349976|FG001|NOT COMPLETED|Overall Study||0
6435210|NCT01069289|7349984|FG000|STARTED|Overall Study||636
6435211|NCT01069289|7349985|FG001|STARTED|Overall Study||657
6435212|NCT01069289|7349984|FG000|COMPLETED|Overall Study||594
6435213|NCT01069289|7349985|FG001|COMPLETED|Overall Study||601
6435214|NCT01069289|7349984|FG000|NOT COMPLETED|Overall Study||42
6435215|NCT01069289|7349985|FG001|NOT COMPLETED|Overall Study||56
6435216|NCT01069315|7349995|FG000|STARTED|Overall Study||27
6435217|NCT01069315|7349996|FG001|STARTED|Overall Study||30
6435218|NCT01069315|7349997|FG002|STARTED|Overall Study||28
6435219|NCT01069315|7349998|FG003|STARTED|Overall Study||26
6435220|NCT01069315|7349995|FG000|COMPLETED|Overall Study||23
6435221|NCT01069315|7349996|FG001|COMPLETED|Overall Study||24
6435222|NCT01069315|7349997|FG002|COMPLETED|Overall Study||23
6435223|NCT01069315|7349998|FG003|COMPLETED|Overall Study||19
6435224|NCT01069315|7349995|FG000|NOT COMPLETED|Overall Study||4
6435225|NCT01069315|7349996|FG001|NOT COMPLETED|Overall Study||6
6652616|NCT02431260|7582250|FG012|NOT COMPLETED|Overall Study||10
6652617|NCT02431260|7582251|FG013|NOT COMPLETED|Overall Study||1
6652618|NCT02431273|7582294|FG000|STARTED|TDF (Single IVR)||6
6652619|NCT02431273|7582294|FG000|COMPLETED|TDF (Single IVR)||6
6652620|NCT02431273|7582294|FG000|NOT COMPLETED|TDF (Single IVR)||0
6652621|NCT02431273|7582294|FG000|STARTED|TDF-FTC (Dual IVR)||6
6652622|NCT02431273|7582294|FG000|COMPLETED|TDF-FTC (Dual IVR)||6
6652623|NCT02431273|7582294|FG000|NOT COMPLETED|TDF-FTC (Dual IVR)||0
6652624|NCT02431273|7582294|FG000|STARTED|TDF-FTC-MVC (Triple IVR)||6
6652625|NCT02431273|7582294|FG000|COMPLETED|TDF-FTC-MVC (Triple IVR)||6
6652626|NCT02431273|7582294|FG000|NOT COMPLETED|TDF-FTC-MVC (Triple IVR)||0
6652627|NCT02431299|7582304|FG000|STARTED|Overall Study||236
6652628|NCT02431299|7582305|FG001|STARTED|Overall Study||63
6652629|NCT02431299|7582304|FG000|COMPLETED|Overall Study||183
6652630|NCT02431299|7582305|FG001|COMPLETED|Overall Study||62
6744289|NCT03341312|7672357|FG002|COMPLETED|Period 1||9
6744290|NCT03341312|7672358|FG003|COMPLETED|Period 1||8
6744291|NCT03341312|7672355|FG000|NOT COMPLETED|Period 1||0
6744292|NCT03341312|7672356|FG001|NOT COMPLETED|Period 1||1
6744293|NCT03341312|7672357|FG002|NOT COMPLETED|Period 1||0
6744294|NCT03341312|7672358|FG003|NOT COMPLETED|Period 1||0
6744295|NCT03341312|7672355|FG000|STARTED|Period 2||9
6744296|NCT03341312|7672356|FG001|STARTED|Period 2||9
6744297|NCT03341312|7672357|FG002|STARTED|Period 2||9
6744298|NCT03341312|7672358|FG003|STARTED|Period 2||8
6744299|NCT03341312|7672355|FG000|COMPLETED|Period 2||9
6744300|NCT03341312|7672356|FG001|COMPLETED|Period 2||9
6744301|NCT03341312|7672357|FG002|COMPLETED|Period 2||9
6744302|NCT03341312|7672358|FG003|COMPLETED|Period 2||8
6744303|NCT03341312|7672355|FG000|NOT COMPLETED|Period 2||0
6744304|NCT03341312|7672356|FG001|NOT COMPLETED|Period 2||0
6744305|NCT03341312|7672357|FG002|NOT COMPLETED|Period 2||0
6744306|NCT03341312|7672358|FG003|NOT COMPLETED|Period 2||0
6744307|NCT03341312|7672355|FG000|STARTED|Period 3||9
6744308|NCT03341312|7672356|FG001|STARTED|Period 3||9
6744309|NCT03341312|7672357|FG002|STARTED|Period 3||9
6744310|NCT03341312|7672358|FG003|STARTED|Period 3||8
6744311|NCT03341312|7672355|FG000|COMPLETED|Period 3||9
6744312|NCT03341312|7672356|FG001|COMPLETED|Period 3||9
6744313|NCT03341312|7672357|FG002|COMPLETED|Period 3||9
6744314|NCT03341312|7672358|FG003|COMPLETED|Period 3||8
6744315|NCT03341312|7672355|FG000|NOT COMPLETED|Period 3||0
6744316|NCT03341312|7672356|FG001|NOT COMPLETED|Period 3||0
6744317|NCT03341312|7672357|FG002|NOT COMPLETED|Period 3||0
6744318|NCT03341312|7672358|FG003|NOT COMPLETED|Period 3||0
6744319|NCT03341312|7672355|FG000|STARTED|Period 4||9
6744320|NCT03341312|7672356|FG001|STARTED|Period 4||9
6744321|NCT03341312|7672357|FG002|STARTED|Period 4||9
6744322|NCT03341312|7672358|FG003|STARTED|Period 4||8
6744323|NCT03341312|7672355|FG000|COMPLETED|Period 4||9
6744324|NCT03341312|7672356|FG001|COMPLETED|Period 4||9
6744325|NCT03341312|7672357|FG002|COMPLETED|Period 4||9
6435226|NCT01069315|7349997|FG002|NOT COMPLETED|Overall Study||5
6652631|NCT02431299|7582304|FG000|NOT COMPLETED|Overall Study||53
6744326|NCT03341312|7672358|FG003|COMPLETED|Period 4||8
6744327|NCT03341312|7672355|FG000|NOT COMPLETED|Period 4||0
6744328|NCT03341312|7672356|FG001|NOT COMPLETED|Period 4||0
6744329|NCT03341312|7672357|FG002|NOT COMPLETED|Period 4||0
6435227|NCT01069315|7349998|FG003|NOT COMPLETED|Overall Study||7
6435228|NCT01069341|7350012|FG000|STARTED|Overall Study||4
6435229|NCT01069341|7350012|FG000|COMPLETED|Overall Study||3
6744330|NCT03341312|7672358|FG003|NOT COMPLETED|Period 4||0
6744331|NCT03341507|7672370|FG000|STARTED|Overall Study||64
6744332|NCT03341507|7672370|FG000|COMPLETED|Overall Study||30
6744333|NCT03341507|7672370|FG000|NOT COMPLETED|Overall Study||34
6435230|NCT01069341|7350012|FG000|NOT COMPLETED|Overall Study||1
6435231|NCT01069354|7350016|FG000|STARTED|Overall Study||102
6435232|NCT01069354|7350016|FG000|COMPLETED|Overall Study|One subject's treatment fold not injected due to adverse event during control fold injection|101
6435233|NCT01069354|7350016|FG000|NOT COMPLETED|Overall Study||1
6435234|NCT01069419|7350024|FG000|STARTED|Overall Study||1117
6435235|NCT01069419|7350024|FG000|Safety Set|Overall Study||1111
6435236|NCT01069419|7350024|FG000|Full Analysis Set|Overall Study||851
6435237|NCT01069419|7350024|FG000|COMPLETED|Overall Study||402
6435238|NCT01069419|7350024|FG000|NOT COMPLETED|Overall Study||715
6435239|NCT01069484|7350030|FG000|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
6435240|NCT01069484|7350031|FG001|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
6435241|NCT01069484|7350030|FG000|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
6435242|NCT01069484|7350031|FG001|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
6435243|NCT01069484|7350030|FG000|NOT COMPLETED|Overall Study||12
6435244|NCT01069484|7350031|FG001|NOT COMPLETED|Overall Study||3
6435245|NCT01069510|7350040|FG000|STARTED|Overall Study||8
6435246|NCT01069510|7350041|FG001|STARTED|Overall Study||7
6435247|NCT01069510|7350040|FG000|COMPLETED|Overall Study||8
6435248|NCT01069510|7350041|FG001|COMPLETED|Overall Study||7
6435249|NCT01069510|7350040|FG000|NOT COMPLETED|Overall Study||0
6435250|NCT01069510|7350041|FG001|NOT COMPLETED|Overall Study||0
6435251|NCT01069523|7350049|FG000|STARTED|Overall Study||13
6435252|NCT01069523|7350050|FG001|STARTED|Overall Study||16
6435253|NCT01069523|7350049|FG000|COMPLETED|Overall Study||9
6435254|NCT01069523|7350050|FG001|COMPLETED|Overall Study||9
6435255|NCT01069523|7350049|FG000|NOT COMPLETED|Overall Study||4
6435256|NCT01069523|7350050|FG001|NOT COMPLETED|Overall Study||7
6435257|NCT01069562|7350060|FG000|STARTED|Overall Study||20
6435258|NCT01069562|7350061|FG001|STARTED|Overall Study||20
6435259|NCT01069562|7350060|FG000|COMPLETED|Overall Study||20
6435260|NCT01069562|7350061|FG001|COMPLETED|Overall Study||20
6435261|NCT01069562|7350060|FG000|NOT COMPLETED|Overall Study||0
6435262|NCT01069562|7350061|FG001|NOT COMPLETED|Overall Study||0
6435263|NCT01069627|7350067|FG000|STARTED|Overall Study||20
6435264|NCT01069627|7350067|FG000|COMPLETED|Overall Study||0
6435265|NCT01069627|7350067|FG000|NOT COMPLETED|Overall Study||20
6435266|NCT01069705|7350071|FG000|STARTED|Overall Study||49
6435267|NCT01069705|7350071|FG000|COMPLETED|Overall Study||46
6435268|NCT01069705|7350071|FG000|NOT COMPLETED|Overall Study||3
6435269|NCT01069900|7350077|FG000|STARTED|Overall Study||305
6435270|NCT01069900|7350078|FG001|STARTED|Overall Study||153
6435271|NCT01069900|7350077|FG000|Treated|Overall Study||301
6435272|NCT01069900|7350078|FG001|Treated|Overall Study||150
6435273|NCT01069900|7350077|FG000|COMPLETED|Overall Study||287
6435274|NCT01069900|7350078|FG001|COMPLETED|Overall Study||149
6435275|NCT01069900|7350077|FG000|NOT COMPLETED|Overall Study||18
6435276|NCT01069900|7350078|FG001|NOT COMPLETED|Overall Study||4
6435277|NCT01069939|7350086|FG000|STARTED|Randomised and Included in the Analyses||213
6435278|NCT01069939|7350087|FG001|STARTED|Randomised and Included in the Analyses||214
6435279|NCT01069939|7350086|FG000|COMPLETED|Randomised and Included in the Analyses||164
6435280|NCT01069939|7350087|FG001|COMPLETED|Randomised and Included in the Analyses||137
6435281|NCT01069939|7350086|FG000|NOT COMPLETED|Randomised and Included in the Analyses||49
6435282|NCT01069939|7350087|FG001|NOT COMPLETED|Randomised and Included in the Analyses||77
6435283|NCT01069939|7350086|FG000|STARTED|At Data Cut Off Date (26 Feb 2011)||213
6435284|NCT01069939|7350087|FG001|STARTED|At Data Cut Off Date (26 Feb 2011)||214
6435285|NCT01069939|7350086|FG000|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
6435286|NCT01069939|7350087|FG001|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
6435287|NCT01069939|7350086|FG000|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
6435288|NCT01069939|7350087|FG001|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
6435289|NCT01070043|7350095|FG000|STARTED|Run-In Phase||60
6435290|NCT01070043|7350096|FG001|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
6435291|NCT01070043|7350097|FG002|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
6435292|NCT01070043|7350095|FG000|COMPLETED|Run-In Phase||42
6435293|NCT01070043|7350096|FG001|COMPLETED|Run-In Phase||0
6435294|NCT01070043|7350097|FG002|COMPLETED|Run-In Phase||0
6435295|NCT01070043|7350095|FG000|NOT COMPLETED|Run-In Phase||18
6435296|NCT01070043|7350096|FG001|NOT COMPLETED|Run-In Phase||0
6652632|NCT02431299|7582305|FG001|NOT COMPLETED|Overall Study||1
6652633|NCT02431364|7582316|FG000|STARTED|Overall Study||8
6652634|NCT02431364|7582317|FG001|STARTED|Overall Study||6
6652635|NCT02431364|7582318|FG002|STARTED|Overall Study||6
6652636|NCT02431364|7582319|FG003|STARTED|Overall Study||7
6652637|NCT02431364|7582320|FG004|STARTED|Overall Study||6
6652638|NCT02431364|7582316|FG000|Treated|Overall Study||8
6652639|NCT02431364|7582317|FG001|Treated|Overall Study||6
6652640|NCT02431364|7582318|FG002|Treated|Overall Study||6
6652641|NCT02431364|7582319|FG003|Treated|Overall Study||6
6652642|NCT02431364|7582320|FG004|Treated|Overall Study||6
6652643|NCT02431364|7582316|FG000|COMPLETED|Overall Study||8
6652644|NCT02431364|7582317|FG001|COMPLETED|Overall Study||5
6435297|NCT01070043|7350097|FG002|NOT COMPLETED|Run-In Phase||0
6435298|NCT01070043|7350095|FG000|STARTED|Double-Blind Treatment||0
6652645|NCT02431364|7582318|FG002|COMPLETED|Overall Study||6
6435299|NCT01070043|7350096|FG001|STARTED|Double-Blind Treatment||21
6435300|NCT01070043|7350097|FG002|STARTED|Double-Blind Treatment||21
6435301|NCT01070043|7350095|FG000|COMPLETED|Double-Blind Treatment||0
6435302|NCT01070043|7350096|FG001|COMPLETED|Double-Blind Treatment||21
6435303|NCT01070043|7350097|FG002|COMPLETED|Double-Blind Treatment||19
6435304|NCT01070043|7350095|FG000|NOT COMPLETED|Double-Blind Treatment||0
6435305|NCT01070043|7350096|FG001|NOT COMPLETED|Double-Blind Treatment||0
6435306|NCT01070043|7350097|FG002|NOT COMPLETED|Double-Blind Treatment||2
6435307|NCT01070095|7350103|FG000|STARTED|Baseline Period||19
6435308|NCT01070095|7350104|FG001|STARTED|Baseline Period||830
6435309|NCT01070095|7350103|FG000|COMPLETED|Baseline Period||18
6435310|NCT01070095|7350104|FG001|COMPLETED|Baseline Period||830
6435311|NCT01070095|7350103|FG000|NOT COMPLETED|Baseline Period||1
6435312|NCT01070095|7350104|FG001|NOT COMPLETED|Baseline Period||0
6435313|NCT01070095|7350103|FG000|STARTED|Intervention Period||18
6435314|NCT01070095|7350104|FG001|STARTED|Intervention Period||890
6435315|NCT01070095|7350103|FG000|COMPLETED|Intervention Period||18
6435316|NCT01070095|7350104|FG001|COMPLETED|Intervention Period||890
6435317|NCT01070095|7350103|FG000|NOT COMPLETED|Intervention Period||0
6435318|NCT01070095|7350104|FG001|NOT COMPLETED|Intervention Period||0
6435319|NCT01070173|7350114|FG000|STARTED|Overall Study||33
6435320|NCT01070173|7350115|FG001|STARTED|Overall Study||8
6435321|NCT01070173|7350116|FG002|STARTED|Overall Study||11
6435322|NCT01070173|7350114|FG000|COMPLETED|Overall Study||33
6435323|NCT01070173|7350115|FG001|COMPLETED|Overall Study||8
6435324|NCT01070173|7350116|FG002|COMPLETED|Overall Study||11
6435325|NCT01070173|7350114|FG000|NOT COMPLETED|Overall Study||0
6435326|NCT01070173|7350115|FG001|NOT COMPLETED|Overall Study||0
6435327|NCT01070173|7350116|FG002|NOT COMPLETED|Overall Study||0
6435328|NCT01070303|7350126|FG000|STARTED|Overall Study||177
6435329|NCT01070303|7350126|FG000|COMPLETED|Overall Study||88
6435330|NCT01070303|7350126|FG000|NOT COMPLETED|Overall Study||89
6435331|NCT01070316|7350136|FG000|STARTED|Main Phase||20
6435332|NCT01070316|7350136|FG000|COMPLETED|Main Phase||20
6435333|NCT01070316|7350136|FG000|NOT COMPLETED|Main Phase||0
6435334|NCT01070316|7350136|FG000|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
6435335|NCT01070316|7350136|FG000|COMPLETED|Extension Phase||14
6435336|NCT01070316|7350136|FG000|NOT COMPLETED|Extension Phase||4
6435337|NCT01070329|7350142|FG000|STARTED|Overall Study||261
6652646|NCT02431364|7582319|FG003|COMPLETED|Overall Study||6
6652647|NCT02431364|7582320|FG004|COMPLETED|Overall Study||6
6652648|NCT02431364|7582316|FG000|NOT COMPLETED|Overall Study||0
6652649|NCT02431364|7582317|FG001|NOT COMPLETED|Overall Study||1
6652650|NCT02431364|7582318|FG002|NOT COMPLETED|Overall Study||0
6652651|NCT02431364|7582319|FG003|NOT COMPLETED|Overall Study||1
6652652|NCT02431364|7582320|FG004|NOT COMPLETED|Overall Study||0
6652653|NCT02431455|7582338|FG000|STARTED|Overall Study||112
6652654|NCT02431455|7582339|FG001|STARTED|Overall Study||112
6652655|NCT02431455|7582338|FG000|COMPLETED|Overall Study||112
6652656|NCT02431455|7582339|FG001|COMPLETED|Overall Study||112
6652657|NCT02431455|7582338|FG000|NOT COMPLETED|Overall Study||0
6652658|NCT02431455|7582339|FG001|NOT COMPLETED|Overall Study||0
6652659|NCT02431468|7582348|FG000|STARTED|Overall Study||46
6652660|NCT02431468|7582349|FG001|STARTED|Overall Study||47
6652661|NCT02431468|7582350|FG002|STARTED|Overall Study||48
6652662|NCT02431468|7582348|FG000|COMPLETED|Overall Study||38
6652663|NCT02431468|7582349|FG001|COMPLETED|Overall Study||29
6652664|NCT02431468|7582350|FG002|COMPLETED|Overall Study||39
6652665|NCT02431468|7582348|FG000|NOT COMPLETED|Overall Study||8
6652666|NCT02431468|7582349|FG001|NOT COMPLETED|Overall Study||18
6652667|NCT02431468|7582350|FG002|NOT COMPLETED|Overall Study||9
6652668|NCT02431533|7582366|FG000|STARTED|Overall Study||25
6652669|NCT02431533|7582367|FG001|STARTED|Overall Study||25
6652670|NCT02431533|7582366|FG000|COMPLETED|Overall Study||23
6652671|NCT02431533|7582367|FG001|COMPLETED|Overall Study||22
6652672|NCT02431533|7582366|FG000|NOT COMPLETED|Overall Study||2
6652673|NCT02431533|7582367|FG001|NOT COMPLETED|Overall Study||3
6652674|NCT02431559|7582377|FG000|STARTED|Overall Study||3
6652675|NCT02431559|7582378|FG001|STARTED|Overall Study||4
6652676|NCT02431559|7582379|FG002|STARTED|Overall Study||6
6652677|NCT02431559|7582380|FG003|STARTED|Overall Study||40
6652678|NCT02431559|7582377|FG000|COMPLETED|Overall Study||1
6652679|NCT02431559|7582378|FG001|COMPLETED|Overall Study||1
6435338|NCT01070329|7350143|FG001|STARTED|Overall Study||266
6435339|NCT01070329|7350142|FG000|COMPLETED|Overall Study||209
6435340|NCT01070329|7350143|FG001|COMPLETED|Overall Study||217
6435341|NCT01070329|7350142|FG000|NOT COMPLETED|Overall Study||52
6435342|NCT01070329|7350143|FG001|NOT COMPLETED|Overall Study||49
6435343|NCT01070381|7350149|FG000|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
6435344|NCT01070381|7350150|FG001|STARTED|Period 1, 1 Week of Wear||107
6435345|NCT01070381|7350149|FG000|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
6435346|NCT01070381|7350150|FG001|COMPLETED|Period 1, 1 Week of Wear||107
6652680|NCT02431559|7582379|FG002|COMPLETED|Overall Study||2
6652681|NCT02431559|7582380|FG003|COMPLETED|Overall Study||9
6652682|NCT02431559|7582377|FG000|NOT COMPLETED|Overall Study||2
6652683|NCT02431559|7582378|FG001|NOT COMPLETED|Overall Study||3
6652684|NCT02431559|7582379|FG002|NOT COMPLETED|Overall Study||4
6652685|NCT02431559|7582380|FG003|NOT COMPLETED|Overall Study||31
6652686|NCT02431572|7582393|FG000|STARTED|Overall Study||1
6552546|NCT01738503|7475062|FG003|STARTED|Treatment Period||15
6552547|NCT01738503|7475063|FG004|STARTED|Treatment Period||15
6552548|NCT01738503|7475064|FG005|STARTED|Treatment Period||15
6552549|NCT01738503|7475065|FG006|STARTED|Treatment Period||14
6552550|NCT01738503|7475059|FG000|COMPLETED|Treatment Period||0
6552551|NCT01738503|7475060|FG001|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
6552552|NCT01738503|7475061|FG002|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|10
6652687|NCT02431572|7582394|FG001|STARTED|Overall Study||1
6435347|NCT01070381|7350149|FG000|NOT COMPLETED|Period 1, 1 Week of Wear||0
6435348|NCT01070381|7350150|FG001|NOT COMPLETED|Period 1, 1 Week of Wear||0
6435349|NCT01070381|7350149|FG000|STARTED|Period 2, 1 Week of Wear||109
6435350|NCT01070381|7350150|FG001|STARTED|Period 2, 1 Week of Wear||107
6435351|NCT01070381|7350149|FG000|COMPLETED|Period 2, 1 Week of Wear||108
6435352|NCT01070381|7350150|FG001|COMPLETED|Period 2, 1 Week of Wear||106
6435353|NCT01070381|7350149|FG000|NOT COMPLETED|Period 2, 1 Week of Wear||1
6435354|NCT01070381|7350150|FG001|NOT COMPLETED|Period 2, 1 Week of Wear||1
6435355|NCT01070394|7350156|FG000|STARTED|Overall Study||40
6435356|NCT01070394|7350156|FG000|COMPLETED|Overall Study||33
6435357|NCT01070394|7350156|FG000|NOT COMPLETED|Overall Study||7
6435358|NCT01070550|7350168|FG000|STARTED|Overall Study||3356
6435359|NCT01070550|7350169|FG001|STARTED|Overall Study||316
6435360|NCT01070550|7350170|FG002|STARTED|Overall Study||744
6435361|NCT01070550|7350171|FG003|STARTED|Overall Study||201
6435362|NCT01070550|7350172|FG004|STARTED|Overall Study||21
6435363|NCT01070550|7350173|FG005|STARTED|Overall Study||42
6435364|NCT01070550|7350168|FG000|COMPLETED|Overall Study||2071
6435365|NCT01070550|7350169|FG001|COMPLETED|Overall Study||254
6435366|NCT01070550|7350170|FG002|COMPLETED|Overall Study||528
6435367|NCT01070550|7350171|FG003|COMPLETED|Overall Study||124
6435368|NCT01070550|7350172|FG004|COMPLETED|Overall Study||20
6435369|NCT01070550|7350173|FG005|COMPLETED|Overall Study||35
6435370|NCT01070550|7350168|FG000|NOT COMPLETED|Overall Study||1285
6435371|NCT01070550|7350169|FG001|NOT COMPLETED|Overall Study||62
6435372|NCT01070550|7350170|FG002|NOT COMPLETED|Overall Study||216
6435373|NCT01070550|7350171|FG003|NOT COMPLETED|Overall Study||77
6435374|NCT01070550|7350172|FG004|NOT COMPLETED|Overall Study||1
6435375|NCT01070550|7350173|FG005|NOT COMPLETED|Overall Study||7
6435376|NCT01070693|7350190|FG000|STARTED|Overall Study||150
6435377|NCT01070693|7350191|FG001|STARTED|Overall Study||149
6435378|NCT01070693|7350190|FG000|COMPLETED|Overall Study||122
6435379|NCT01070693|7350191|FG001|COMPLETED|Overall Study||110
6435380|NCT01070693|7350190|FG000|NOT COMPLETED|Overall Study||28
6435381|NCT01070693|7350191|FG001|NOT COMPLETED|Overall Study||39
6435382|NCT01070771|7350197|FG000|STARTED|Overall Study|September 2008|203
6435383|NCT01070771|7350197|FG000|COMPLETED|Overall Study|August 2012|200
6435384|NCT01070771|7350197|FG000|NOT COMPLETED|Overall Study||3
6435385|NCT01070784|7350204|FG000|STARTED|Overall Study||130
6435386|NCT01070784|7350205|FG001|STARTED|Overall Study||130
6435387|NCT01070784|7350204|FG000|COMPLETED|Overall Study||110
6435388|NCT01070784|7350205|FG001|COMPLETED|Overall Study||112
6435389|NCT01070784|7350204|FG000|NOT COMPLETED|Overall Study||20
6435390|NCT01070784|7350205|FG001|NOT COMPLETED|Overall Study||18
6435391|NCT01070810|7350213|FG000|STARTED|Overall Study||45
6435392|NCT01070810|7350214|FG001|STARTED|Overall Study||43
6435393|NCT01070810|7350213|FG000|COMPLETED|Overall Study||45
6435394|NCT01070810|7350214|FG001|COMPLETED|Overall Study||43
6435395|NCT01070810|7350213|FG000|NOT COMPLETED|Overall Study||0
6435396|NCT01070810|7350214|FG001|NOT COMPLETED|Overall Study||0
6435397|NCT01070888|7350224|FG000|STARTED|First Intervention (14 Days)||2
6435398|NCT01070888|7350225|FG001|STARTED|First Intervention (14 Days)||4
6435399|NCT01070888|7350224|FG000|COMPLETED|First Intervention (14 Days)||2
6435400|NCT01070888|7350225|FG001|COMPLETED|First Intervention (14 Days)||2
6435401|NCT01070888|7350224|FG000|NOT COMPLETED|First Intervention (14 Days)||0
6435402|NCT01070888|7350225|FG001|NOT COMPLETED|First Intervention (14 Days)||2
6435403|NCT01070888|7350224|FG000|STARTED|Washout (14 Days)||2
6435404|NCT01070888|7350225|FG001|STARTED|Washout (14 Days)||2
6435405|NCT01070888|7350224|FG000|COMPLETED|Washout (14 Days)||1
6435406|NCT01070888|7350225|FG001|COMPLETED|Washout (14 Days)||2
6435407|NCT01070888|7350224|FG000|NOT COMPLETED|Washout (14 Days)||1
6435408|NCT01070888|7350225|FG001|NOT COMPLETED|Washout (14 Days)||0
6435409|NCT01070888|7350224|FG000|STARTED|Second Intervention (14 Days)||1
6435410|NCT01070888|7350225|FG001|STARTED|Second Intervention (14 Days)||2
6435411|NCT01070888|7350224|FG000|COMPLETED|Second Intervention (14 Days)||1
6435412|NCT01070888|7350225|FG001|COMPLETED|Second Intervention (14 Days)||2
6435413|NCT01070888|7350224|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
6435414|NCT01070888|7350225|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
6652688|NCT02431572|7582395|FG002|STARTED|Overall Study||9
6435415|NCT01070979|7350234|FG000|STARTED|Overall Study||79
6435416|NCT01070979|7350235|FG001|STARTED|Overall Study||85
6435417|NCT01070979|7350236|FG002|STARTED|Overall Study||85
6435418|NCT01070979|7350234|FG000|COMPLETED|Overall Study||68
6435419|NCT01070979|7350235|FG001|COMPLETED|Overall Study||73
6435420|NCT01070979|7350236|FG002|COMPLETED|Overall Study||72
6435421|NCT01070979|7350234|FG000|NOT COMPLETED|Overall Study||11
6435422|NCT01070979|7350235|FG001|NOT COMPLETED|Overall Study||12
6552553|NCT01738503|7475062|FG003|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
6552554|NCT01738503|7475063|FG004|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|7
6552555|NCT01738503|7475064|FG005|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|9
6435423|NCT01070979|7350236|FG002|NOT COMPLETED|Overall Study||13
6435424|NCT01071044|7350246|FG000|STARTED|Overall Study||15
6435425|NCT01071044|7350247|FG001|STARTED|Overall Study||11
6435426|NCT01071044|7350246|FG000|COMPLETED|Overall Study||13
6435427|NCT01071044|7350247|FG001|COMPLETED|Overall Study||11
6435428|NCT01071044|7350246|FG000|NOT COMPLETED|Overall Study||2
6435429|NCT01071044|7350247|FG001|NOT COMPLETED|Overall Study||0
6435430|NCT01071070|7350258|FG000|STARTED|Overall Study||108
6435431|NCT01071070|7350259|FG001|STARTED|Overall Study||108
6435432|NCT01071070|7350258|FG000|COMPLETED|Overall Study||104
6435433|NCT01071070|7350259|FG001|COMPLETED|Overall Study||105
6435434|NCT01071070|7350258|FG000|NOT COMPLETED|Overall Study||4
6435435|NCT01071070|7350259|FG001|NOT COMPLETED|Overall Study||3
6435436|NCT01071083|7350270|FG000|STARTED|Overall Study||42
6435437|NCT01071083|7350271|FG001|STARTED|Overall Study||45
6435438|NCT01071083|7350272|FG002|STARTED|Overall Study||17
6435439|NCT01071083|7350273|FG003|STARTED|Overall Study||17
6435440|NCT01071083|7350274|FG004|STARTED|Overall Study||54
6435441|NCT01071083|7350270|FG000|COMPLETED|Overall Study||35
6435442|NCT01071083|7350271|FG001|COMPLETED|Overall Study||43
6435443|NCT01071083|7350272|FG002|COMPLETED|Overall Study||12
6435444|NCT01071083|7350273|FG003|COMPLETED|Overall Study||15
6435445|NCT01071083|7350274|FG004|COMPLETED|Overall Study||46
6435446|NCT01071083|7350270|FG000|NOT COMPLETED|Overall Study||7
6435447|NCT01071083|7350271|FG001|NOT COMPLETED|Overall Study||2
6435448|NCT01071083|7350272|FG002|NOT COMPLETED|Overall Study||5
6435449|NCT01071083|7350273|FG003|NOT COMPLETED|Overall Study||2
6435450|NCT01071083|7350274|FG004|NOT COMPLETED|Overall Study||8
6435451|NCT01071096|7350286|FG000|STARTED|First Intervention (90 Days)||10
6435452|NCT01071096|7350287|FG001|STARTED|First Intervention (90 Days)||10
6435453|NCT01071096|7350286|FG000|COMPLETED|First Intervention (90 Days)||9
6435454|NCT01071096|7350287|FG001|COMPLETED|First Intervention (90 Days)||10
6435455|NCT01071096|7350286|FG000|NOT COMPLETED|First Intervention (90 Days)||1
6435456|NCT01071096|7350287|FG001|NOT COMPLETED|First Intervention (90 Days)||0
6435457|NCT01071096|7350286|FG000|STARTED|Washout Period (30 Days)||9
6435458|NCT01071096|7350287|FG001|STARTED|Washout Period (30 Days)||10
6435459|NCT01071096|7350286|FG000|COMPLETED|Washout Period (30 Days)||9
6652689|NCT02431572|7582393|FG000|COMPLETED|Overall Study||0
6652690|NCT02431572|7582394|FG001|COMPLETED|Overall Study||1
6652691|NCT02431572|7582395|FG002|COMPLETED|Overall Study||9
6652692|NCT02431572|7582393|FG000|NOT COMPLETED|Overall Study||1
6652693|NCT02431572|7582394|FG001|NOT COMPLETED|Overall Study||0
6652694|NCT02431572|7582395|FG002|NOT COMPLETED|Overall Study||0
6652695|NCT02431598|7582403|FG000|STARTED|Overall Study||6
6652696|NCT02431598|7582404|FG001|STARTED|Overall Study||9
6652697|NCT02431598|7582405|FG002|STARTED|Overall Study||9
6652698|NCT02431598|7582406|FG003|STARTED|Overall Study||7
6652699|NCT02431598|7582407|FG004|STARTED|Overall Study||7
6652700|NCT02431598|7582408|FG005|STARTED|Overall Study||6
6652701|NCT02431598|7582403|FG000|COMPLETED|Overall Study||6
6652702|NCT02431598|7582404|FG001|COMPLETED|Overall Study||9
6652703|NCT02431598|7582405|FG002|COMPLETED|Overall Study||9
6652704|NCT02431598|7582406|FG003|COMPLETED|Overall Study||7
6652705|NCT02431598|7582407|FG004|COMPLETED|Overall Study||7
6652706|NCT02431598|7582408|FG005|COMPLETED|Overall Study||6
6652707|NCT02431598|7582403|FG000|NOT COMPLETED|Overall Study||0
6652708|NCT02431598|7582404|FG001|NOT COMPLETED|Overall Study||0
6652709|NCT02431598|7582405|FG002|NOT COMPLETED|Overall Study||0
6652710|NCT02431598|7582406|FG003|NOT COMPLETED|Overall Study||0
6652711|NCT02431598|7582407|FG004|NOT COMPLETED|Overall Study||0
6652712|NCT02431598|7582408|FG005|NOT COMPLETED|Overall Study||0
6652713|NCT02431637|7582425|FG000|STARTED|Overall Study||6
6652714|NCT02431637|7582425|FG000|COMPLETED|Overall Study||6
6652715|NCT02431637|7582425|FG000|NOT COMPLETED|Overall Study||0
6652716|NCT02431650|7582431|FG000|STARTED|Overall Study||5
6652717|NCT02431650|7582432|FG001|STARTED|Overall Study||6
6652718|NCT02431650|7582431|FG000|COMPLETED|Overall Study||5
6652719|NCT02431650|7582432|FG001|COMPLETED|Overall Study||6
6652720|NCT02431650|7582431|FG000|NOT COMPLETED|Overall Study||0
6652721|NCT02431650|7582432|FG001|NOT COMPLETED|Overall Study||0
6652722|NCT02431676|7582441|FG000|STARTED|Overall Study||40
6652723|NCT02431676|7582442|FG001|STARTED|Overall Study||39
6652724|NCT02431676|7582443|FG002|STARTED|Overall Study||42
6652725|NCT02431676|7582441|FG000|COMPLETED|Overall Study||40
6652726|NCT02431676|7582442|FG001|COMPLETED|Overall Study||38
6652727|NCT02431676|7582443|FG002|COMPLETED|Overall Study||40
6652728|NCT02431676|7582441|FG000|NOT COMPLETED|Overall Study||0
6652729|NCT02431676|7582442|FG001|NOT COMPLETED|Overall Study||1
6652730|NCT02431676|7582443|FG002|NOT COMPLETED|Overall Study||2
6652731|NCT02431741|7582451|FG000|STARTED|Overall Study||14
6652732|NCT02431741|7582451|FG000|COMPLETED|Overall Study||14
6652733|NCT02431741|7582451|FG000|NOT COMPLETED|Overall Study||0
6652734|NCT02431754|7582457|FG000|STARTED|Period 1 (8 Weeks)||85
6435460|NCT01071096|7350287|FG001|COMPLETED|Washout Period (30 Days)||10
6435461|NCT01071096|7350286|FG000|NOT COMPLETED|Washout Period (30 Days)||0
6435462|NCT01071096|7350287|FG001|NOT COMPLETED|Washout Period (30 Days)||0
6435463|NCT01071096|7350286|FG000|STARTED|Second Intervention (90 Days)||9
6652735|NCT02431754|7582458|FG001|STARTED|Period 1 (8 Weeks)||86
6652736|NCT02431754|7582457|FG000|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
6435464|NCT01071096|7350287|FG001|STARTED|Second Intervention (90 Days)||10
6552556|NCT01738503|7475065|FG006|COMPLETED|Treatment Period|Completed to Day 113 (4 injections)|6
6552557|NCT01738503|7475059|FG000|NOT COMPLETED|Treatment Period||0
6552558|NCT01738503|7475060|FG001|NOT COMPLETED|Treatment Period||5
6435465|NCT01071096|7350286|FG000|COMPLETED|Second Intervention (90 Days)||9
6435466|NCT01071096|7350287|FG001|COMPLETED|Second Intervention (90 Days)||10
6435467|NCT01071096|7350286|FG000|NOT COMPLETED|Second Intervention (90 Days)||0
6435468|NCT01071096|7350287|FG001|NOT COMPLETED|Second Intervention (90 Days)||0
6435469|NCT01071200|7350306|FG000|STARTED|Overall Study||67
6435470|NCT01071200|7350307|FG001|STARTED|Overall Study||66
6435471|NCT01071200|7350306|FG000|COMPLETED|Overall Study||60
6435472|NCT01071200|7350307|FG001|COMPLETED|Overall Study||63
6435473|NCT01071200|7350306|FG000|NOT COMPLETED|Overall Study||7
6435474|NCT01071200|7350307|FG001|NOT COMPLETED|Overall Study||3
6435475|NCT01071252|7350318|FG000|STARTED|Overall Study||29
6435476|NCT01071252|7350319|FG001|STARTED|Overall Study||26
6435477|NCT01071252|7350320|FG002|STARTED|Overall Study||21
6435478|NCT01071252|7350321|FG003|STARTED|Overall Study||27
6435479|NCT01071252|7350322|FG004|STARTED|Overall Study||22
6435480|NCT01071252|7350318|FG000|COMPLETED|Overall Study||14
6435481|NCT01071252|7350319|FG001|COMPLETED|Overall Study||16
6435482|NCT01071252|7350320|FG002|COMPLETED|Overall Study||17
6435483|NCT01071252|7350321|FG003|COMPLETED|Overall Study||20
6435484|NCT01071252|7350322|FG004|COMPLETED|Overall Study||11
6435485|NCT01071252|7350318|FG000|NOT COMPLETED|Overall Study||15
6435486|NCT01071252|7350319|FG001|NOT COMPLETED|Overall Study||10
6435487|NCT01071252|7350320|FG002|NOT COMPLETED|Overall Study||4
6435488|NCT01071252|7350321|FG003|NOT COMPLETED|Overall Study||7
6435489|NCT01071252|7350322|FG004|NOT COMPLETED|Overall Study||11
6499777|NCT01421186|7418528|FG000|STARTED|Overall Study||31
6499778|NCT01421186|7418529|FG001|STARTED|Overall Study||4
6499779|NCT01421186|7418530|FG002|STARTED|Overall Study||18
6499780|NCT01421186|7418531|FG003|STARTED|Overall Study||21
6499781|NCT01421186|7418532|FG004|STARTED|Overall Study||17
6499782|NCT01421186|7418528|FG000|COMPLETED|Overall Study||31
6499783|NCT01421186|7418529|FG001|COMPLETED|Overall Study||4
6499784|NCT01421186|7418530|FG002|COMPLETED|Overall Study||18
6499785|NCT01421186|7418531|FG003|COMPLETED|Overall Study||21
6499786|NCT01421186|7418532|FG004|COMPLETED|Overall Study||17
6499787|NCT01421186|7418528|FG000|NOT COMPLETED|Overall Study||0
6499788|NCT01421186|7418529|FG001|NOT COMPLETED|Overall Study||0
6499789|NCT01421186|7418530|FG002|NOT COMPLETED|Overall Study||0
6499790|NCT01421186|7418531|FG003|NOT COMPLETED|Overall Study||0
6499791|NCT01421186|7418532|FG004|NOT COMPLETED|Overall Study||0
6499792|NCT01421225|7418552|FG000|STARTED|Overall Study||4
6499793|NCT01421225|7418553|FG001|STARTED|Overall Study||6
6499794|NCT01421225|7418552|FG000|COMPLETED|Overall Study||4
6499795|NCT01421225|7418553|FG001|COMPLETED|Overall Study||5
6499796|NCT01421225|7418552|FG000|NOT COMPLETED|Overall Study||0
6499797|NCT01421225|7418553|FG001|NOT COMPLETED|Overall Study||1
6499798|NCT01421277|7418562|FG000|STARTED|Overall Study||25
6499799|NCT01421277|7418563|FG001|STARTED|Overall Study||191
6499800|NCT01421277|7418562|FG000|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
6499801|NCT01421277|7418563|FG001|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
6499802|NCT01421277|7418562|FG000|NOT COMPLETED|Overall Study||0
6499803|NCT01421277|7418563|FG001|NOT COMPLETED|Overall Study||92
6499804|NCT01421303|7418569|FG000|STARTED|Overall Study||80
6499805|NCT01421303|7418569|FG000|COMPLETED|Overall Study||58
6499806|NCT01421303|7418569|FG000|NOT COMPLETED|Overall Study||22
6499807|NCT01421342|7418576|FG000|STARTED|Acute Treatment Phase (12 Weeks)||511
6499808|NCT01421342|7418577|FG001|STARTED|Acute Treatment Phase (12 Weeks)||506
6499809|NCT01421342|7418578|FG002|STARTED|Acute Treatment Phase (12 Weeks)||505
6499810|NCT01421342|7418576|FG000|COMPLETED|Acute Treatment Phase (12 Weeks)||353
6499811|NCT01421342|7418577|FG001|COMPLETED|Acute Treatment Phase (12 Weeks)||378
6499812|NCT01421342|7418578|FG002|COMPLETED|Acute Treatment Phase (12 Weeks)||406
6499813|NCT01421342|7418576|FG000|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||158
6499814|NCT01421342|7418577|FG001|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||128
6499815|NCT01421342|7418578|FG002|NOT COMPLETED|Acute Treatment Phase (12 Weeks)||99
6499816|NCT01421342|7418576|FG000|STARTED|Completed to Week 12 But Then Withdrawn||353
6499817|NCT01421342|7418577|FG001|STARTED|Completed to Week 12 But Then Withdrawn||378
6499818|NCT01421342|7418578|FG002|STARTED|Completed to Week 12 But Then Withdrawn||406
6499819|NCT01421342|7418576|FG000|COMPLETED|Completed to Week 12 But Then Withdrawn||204
6499820|NCT01421342|7418577|FG001|COMPLETED|Completed to Week 12 But Then Withdrawn||253
6499821|NCT01421342|7418578|FG002|COMPLETED|Completed to Week 12 But Then Withdrawn||268
6552559|NCT01738503|7475061|FG002|NOT COMPLETED|Treatment Period||5
6552560|NCT01738503|7475062|FG003|NOT COMPLETED|Treatment Period||6
6552561|NCT01738503|7475063|FG004|NOT COMPLETED|Treatment Period||8
6552562|NCT01738503|7475064|FG005|NOT COMPLETED|Treatment Period||6
6552563|NCT01738503|7475065|FG006|NOT COMPLETED|Treatment Period||8
6552564|NCT01738503|7475059|FG000|STARTED|PET Imaging Sub-study||0
6552565|NCT01738503|7475060|FG001|STARTED|PET Imaging Sub-study||0
6552566|NCT01738503|7475061|FG002|STARTED|PET Imaging Sub-study||0
6552567|NCT01738503|7475062|FG003|STARTED|PET Imaging Sub-study||0
6552568|NCT01738503|7475063|FG004|STARTED|PET Imaging Sub-study||0
6552569|NCT01738503|7475064|FG005|STARTED|PET Imaging Sub-study||3
6552570|NCT01738503|7475065|FG006|STARTED|PET Imaging Sub-study||2
6552571|NCT01738503|7475059|FG000|COMPLETED|PET Imaging Sub-study||0
6552572|NCT01738503|7475060|FG001|COMPLETED|PET Imaging Sub-study||0
6552573|NCT01738503|7475061|FG002|COMPLETED|PET Imaging Sub-study||0
6552574|NCT01738503|7475062|FG003|COMPLETED|PET Imaging Sub-study||0
6552575|NCT01738503|7475063|FG004|COMPLETED|PET Imaging Sub-study||0
6552576|NCT01738503|7475064|FG005|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 12 injections plus all PET images|1
6552577|NCT01738503|7475065|FG006|COMPLETED|PET Imaging Sub-study|Completion defined as a total of 6 injections plus all PET images|1
6552578|NCT01738503|7475059|FG000|NOT COMPLETED|PET Imaging Sub-study||0
6652737|NCT02431754|7582458|FG001|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
6652738|NCT02431754|7582457|FG000|COMPLETED|Period 1 (8 Weeks)||79
6435490|NCT01071278|7350334|FG000|STARTED|Overall Study||2390
6435491|NCT01071278|7350334|FG000|COMPLETED|Overall Study||1677
6435492|NCT01071278|7350334|FG000|NOT COMPLETED|Overall Study||713
6435493|NCT01071317|7350342|FG000|STARTED|Overall Study||25
6435494|NCT01071317|7350343|FG001|STARTED|Overall Study||25
6435495|NCT01071317|7350342|FG000|COMPLETED|Overall Study||23
6435496|NCT01071317|7350343|FG001|COMPLETED|Overall Study||23
6435497|NCT01071317|7350342|FG000|NOT COMPLETED|Overall Study||2
6435498|NCT01071317|7350343|FG001|NOT COMPLETED|Overall Study||2
6435499|NCT01071356|7350351|FG000|STARTED|Overall Study||111
6435500|NCT01071356|7350352|FG001|STARTED|Overall Study||106
6435501|NCT01071356|7350351|FG000|COMPLETED|Overall Study||104
6435502|NCT01071356|7350352|FG001|COMPLETED|Overall Study||97
6435503|NCT01071356|7350351|FG000|NOT COMPLETED|Overall Study||7
6435504|NCT01071356|7350352|FG001|NOT COMPLETED|Overall Study||9
6435505|NCT01071395|7350360|FG000|STARTED|Overall Study||36
6435506|NCT01071395|7350361|FG001|STARTED|Overall Study||32
6435507|NCT01071395|7350360|FG000|COMPLETED|Overall Study||31
6435508|NCT01071395|7350361|FG001|COMPLETED|Overall Study||30
6435509|NCT01071395|7350360|FG000|NOT COMPLETED|Overall Study||5
6435510|NCT01071395|7350361|FG001|NOT COMPLETED|Overall Study||2
6435511|NCT01071512|7350367|FG000|STARTED|Overall Study||20
6435512|NCT01071512|7350367|FG000|COMPLETED|Overall Study||15
6435513|NCT01071512|7350367|FG000|NOT COMPLETED|Overall Study||5
6435514|NCT01071538|7350371|FG000|STARTED|Overall Study||15
6435515|NCT01071538|7350371|FG000|COMPLETED|Overall Study||13
6435516|NCT01071538|7350371|FG000|NOT COMPLETED|Overall Study||2
6435517|NCT01071798|7350375|FG000|STARTED|Participants Who Received One Cycle||1653
6435518|NCT01071798|7350375|FG000|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
6435519|NCT01071798|7350375|FG000|COMPLETED|Participants Who Received One Cycle||1588
6435520|NCT01071798|7350375|FG000|NOT COMPLETED|Participants Who Received One Cycle||65
6435521|NCT01071798|7350375|FG000|STARTED|Subpopulation Who Received Two Cycles||820
6435522|NCT01071798|7350375|FG000|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
6435523|NCT01071798|7350375|FG000|COMPLETED|Subpopulation Who Received Two Cycles||805
6435524|NCT01071798|7350375|FG000|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
6435525|NCT01071915|7350389|FG000|STARTED|Overall Study|Intention to Treat Analysis Set|157
6435526|NCT01071915|7350389|FG000|Full Analysis Set (FAS)|Overall Study||155
6435527|NCT01071915|7350389|FG000|Safety Analysis Set|Overall Study||156
6435528|NCT01071915|7350389|FG000|COMPLETED|Overall Study||148
6435529|NCT01071915|7350389|FG000|NOT COMPLETED|Overall Study||9
6435530|NCT01071954|7350393|FG000|STARTED|Overall Study||66
6435531|NCT01071954|7350393|FG000|Received Treatment|Overall Study||65
6435532|NCT01071954|7350393|FG000|COMPLETED|Overall Study||39
6435533|NCT01071954|7350393|FG000|NOT COMPLETED|Overall Study||27
6435534|NCT01072006|7350401|FG000|STARTED|Overall Study||14
6435535|NCT01072006|7350402|FG001|STARTED|Overall Study||5
6435536|NCT01072006|7350403|FG002|STARTED|Overall Study||0
6435537|NCT01072006|7350404|FG003|STARTED|Overall Study||11
6435538|NCT01072006|7350401|FG000|COMPLETED|Overall Study||14
6435539|NCT01072006|7350402|FG001|COMPLETED|Overall Study||5
6435540|NCT01072006|7350403|FG002|COMPLETED|Overall Study||0
6435541|NCT01072006|7350404|FG003|COMPLETED|Overall Study||11
6435542|NCT01072006|7350401|FG000|NOT COMPLETED|Overall Study||0
6435543|NCT01072006|7350402|FG001|NOT COMPLETED|Overall Study||0
6435544|NCT01072006|7350403|FG002|NOT COMPLETED|Overall Study||0
6435545|NCT01072006|7350404|FG003|NOT COMPLETED|Overall Study||0
6435546|NCT01072032|7350417|FG000|STARTED|Overall Study||13
6435547|NCT01072032|7350418|FG001|STARTED|Overall Study||14
6435548|NCT01072032|7350417|FG000|COMPLETED|Overall Study||5
6435549|NCT01072032|7350418|FG001|COMPLETED|Overall Study||5
6435550|NCT01072032|7350417|FG000|NOT COMPLETED|Overall Study||8
6435551|NCT01072032|7350418|FG001|NOT COMPLETED|Overall Study||9
6435552|NCT01072136|7350427|FG000|STARTED|Overall Study||44
6435553|NCT01072136|7350428|FG001|STARTED|Overall Study||43
6435554|NCT01072136|7350427|FG000|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
6435555|NCT01072136|7350428|FG001|Met All Enrollment Criteria|Overall Study||25
6435556|NCT01072136|7350427|FG000|COMPLETED|Overall Study||21
6435557|NCT01072136|7350428|FG001|COMPLETED|Overall Study||12
6435558|NCT01072136|7350427|FG000|NOT COMPLETED|Overall Study||23
6435559|NCT01072136|7350428|FG001|NOT COMPLETED|Overall Study||31
6435560|NCT01072149|7350437|FG000|STARTED|Treatment Period 1 (28 Days)||3
6552579|NCT01738503|7475060|FG001|NOT COMPLETED|PET Imaging Sub-study||0
6552580|NCT01738503|7475061|FG002|NOT COMPLETED|PET Imaging Sub-study||0
6552581|NCT01738503|7475062|FG003|NOT COMPLETED|PET Imaging Sub-study||0
6552582|NCT01738503|7475063|FG004|NOT COMPLETED|PET Imaging Sub-study||0
6552583|NCT01738503|7475064|FG005|NOT COMPLETED|PET Imaging Sub-study||2
6435561|NCT01072149|7350438|FG001|STARTED|Treatment Period 1 (28 Days)||3
6435562|NCT01072149|7350439|FG002|STARTED|Treatment Period 1 (28 Days)||3
6435563|NCT01072149|7350440|FG003|STARTED|Treatment Period 1 (28 Days)||3
6435564|NCT01072149|7350441|FG004|STARTED|Treatment Period 1 (28 Days)||3
6435565|NCT01072149|7350442|FG005|STARTED|Treatment Period 1 (28 Days)||3
6435566|NCT01072149|7350443|FG006|STARTED|Treatment Period 1 (28 Days)||3
6435567|NCT01072149|7350444|FG007|STARTED|Treatment Period 1 (28 Days)||3
6435568|NCT01072149|7350445|FG008|STARTED|Treatment Period 1 (28 Days)||3
6435569|NCT01072149|7350446|FG009|STARTED|Treatment Period 1 (28 Days)||3
6435570|NCT01072149|7350447|FG010|STARTED|Treatment Period 1 (28 Days)||3
6435571|NCT01072149|7350448|FG011|STARTED|Treatment Period 1 (28 Days)||3
6435572|NCT01072149|7350449|FG012|STARTED|Treatment Period 1 (28 Days)||3
6435573|NCT01072149|7350450|FG013|STARTED|Treatment Period 1 (28 Days)||3
6435574|NCT01072149|7350451|FG014|STARTED|Treatment Period 1 (28 Days)||3
6435575|NCT01072149|7350452|FG015|STARTED|Treatment Period 1 (28 Days)||3
6435576|NCT01072149|7350453|FG016|STARTED|Treatment Period 1 (28 Days)||3
6435577|NCT01072149|7350454|FG017|STARTED|Treatment Period 1 (28 Days)||3
6435578|NCT01072149|7350437|FG000|COMPLETED|Treatment Period 1 (28 Days)||3
6435579|NCT01072149|7350438|FG001|COMPLETED|Treatment Period 1 (28 Days)||3
6435580|NCT01072149|7350439|FG002|COMPLETED|Treatment Period 1 (28 Days)||2
6435581|NCT01072149|7350440|FG003|COMPLETED|Treatment Period 1 (28 Days)||3
6435582|NCT01072149|7350441|FG004|COMPLETED|Treatment Period 1 (28 Days)||3
6435583|NCT01072149|7350442|FG005|COMPLETED|Treatment Period 1 (28 Days)||3
6435584|NCT01072149|7350443|FG006|COMPLETED|Treatment Period 1 (28 Days)||3
6435585|NCT01072149|7350444|FG007|COMPLETED|Treatment Period 1 (28 Days)||3
6435586|NCT01072149|7350445|FG008|COMPLETED|Treatment Period 1 (28 Days)||3
6435587|NCT01072149|7350446|FG009|COMPLETED|Treatment Period 1 (28 Days)||3
6435588|NCT01072149|7350447|FG010|COMPLETED|Treatment Period 1 (28 Days)||2
6435589|NCT01072149|7350448|FG011|COMPLETED|Treatment Period 1 (28 Days)||3
6435590|NCT01072149|7350449|FG012|COMPLETED|Treatment Period 1 (28 Days)||3
6435591|NCT01072149|7350450|FG013|COMPLETED|Treatment Period 1 (28 Days)||3
6435592|NCT01072149|7350451|FG014|COMPLETED|Treatment Period 1 (28 Days)||3
6435593|NCT01072149|7350452|FG015|COMPLETED|Treatment Period 1 (28 Days)||3
6435594|NCT01072149|7350453|FG016|COMPLETED|Treatment Period 1 (28 Days)||3
6435595|NCT01072149|7350454|FG017|COMPLETED|Treatment Period 1 (28 Days)||2
6435596|NCT01072149|7350437|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435597|NCT01072149|7350438|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435598|NCT01072149|7350439|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6435599|NCT01072149|7350440|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435600|NCT01072149|7350441|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6552584|NCT01738503|7475065|FG006|NOT COMPLETED|PET Imaging Sub-study||1
6652739|NCT02431754|7582458|FG001|COMPLETED|Period 1 (8 Weeks)||82
6652740|NCT02431754|7582457|FG000|NOT COMPLETED|Period 1 (8 Weeks)||6
6652741|NCT02431754|7582458|FG001|NOT COMPLETED|Period 1 (8 Weeks)||4
6435601|NCT01072149|7350442|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435602|NCT01072149|7350443|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6552585|NCT01738581|7475089|FG000|STARTED|Overall Study||5
6552586|NCT01738581|7475090|FG001|STARTED|Overall Study||4
6552587|NCT01738581|7475089|FG000|COMPLETED|Overall Study||4
6552588|NCT01738581|7475090|FG001|COMPLETED|Overall Study||4
6552589|NCT01738581|7475089|FG000|NOT COMPLETED|Overall Study||1
6552590|NCT01738581|7475090|FG001|NOT COMPLETED|Overall Study||0
6552591|NCT01738594|7475099|FG000|STARTED|Registration and Treatment Start||0
6552592|NCT01738594|7475100|FG001|STARTED|Registration and Treatment Start||3
6552593|NCT01738594|7475101|FG002|STARTED|Registration and Treatment Start||0
6552594|NCT01738594|7475102|FG003|STARTED|Registration and Treatment Start||0
6552595|NCT01738594|7475103|FG004|STARTED|Registration and Treatment Start||1
6552596|NCT01738594|7475104|FG005|STARTED|Registration and Treatment Start||3
6552597|NCT01738594|7475105|FG006|STARTED|Registration and Treatment Start||0
6552598|NCT01738594|7475106|FG007|STARTED|Registration and Treatment Start||0
6552599|NCT01738594|7475099|FG000|Registered to Study|Registration and Treatment Start||0
6552600|NCT01738594|7475100|FG001|Registered to Study|Registration and Treatment Start||3
6552601|NCT01738594|7475101|FG002|Registered to Study|Registration and Treatment Start||0
6552602|NCT01738594|7475102|FG003|Registered to Study|Registration and Treatment Start||0
6552603|NCT01738594|7475103|FG004|Registered to Study|Registration and Treatment Start||1
6552604|NCT01738594|7475104|FG005|Registered to Study|Registration and Treatment Start||3
6552605|NCT01738594|7475105|FG006|Registered to Study|Registration and Treatment Start||0
6552606|NCT01738594|7475106|FG007|Registered to Study|Registration and Treatment Start||0
6552607|NCT01738594|7475099|FG000|Treatment Started|Registration and Treatment Start||0
6552608|NCT01738594|7475100|FG001|Treatment Started|Registration and Treatment Start||2
6552609|NCT01738594|7475101|FG002|Treatment Started|Registration and Treatment Start||0
6552610|NCT01738594|7475102|FG003|Treatment Started|Registration and Treatment Start||0
6552611|NCT01738594|7475103|FG004|Treatment Started|Registration and Treatment Start||1
6552612|NCT01738594|7475104|FG005|Treatment Started|Registration and Treatment Start||3
6552613|NCT01738594|7475105|FG006|Treatment Started|Registration and Treatment Start||0
6552614|NCT01738594|7475106|FG007|Treatment Started|Registration and Treatment Start||0
6652742|NCT02431754|7582457|FG000|STARTED|Wash-out Period (4 Weeks)||79
6552615|NCT01738594|7475099|FG000|COMPLETED|Registration and Treatment Start||0
6552616|NCT01738594|7475100|FG001|COMPLETED|Registration and Treatment Start||2
6435603|NCT01072149|7350444|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435604|NCT01072149|7350445|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435605|NCT01072149|7350446|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435606|NCT01072149|7350447|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6435607|NCT01072149|7350448|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435608|NCT01072149|7350449|FG012|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435609|NCT01072149|7350450|FG013|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435610|NCT01072149|7350451|FG014|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435611|NCT01072149|7350452|FG015|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435612|NCT01072149|7350453|FG016|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6435613|NCT01072149|7350454|FG017|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6435614|NCT01072149|7350437|FG000|STARTED|Washout Period 1 (14 Days)||3
6435615|NCT01072149|7350438|FG001|STARTED|Washout Period 1 (14 Days)||3
6435616|NCT01072149|7350439|FG002|STARTED|Washout Period 1 (14 Days)||2
6435617|NCT01072149|7350440|FG003|STARTED|Washout Period 1 (14 Days)||3
6435618|NCT01072149|7350441|FG004|STARTED|Washout Period 1 (14 Days)||3
6435619|NCT01072149|7350442|FG005|STARTED|Washout Period 1 (14 Days)||3
6435620|NCT01072149|7350443|FG006|STARTED|Washout Period 1 (14 Days)||3
6435621|NCT01072149|7350444|FG007|STARTED|Washout Period 1 (14 Days)||3
6435622|NCT01072149|7350445|FG008|STARTED|Washout Period 1 (14 Days)||3
6435623|NCT01072149|7350446|FG009|STARTED|Washout Period 1 (14 Days)||3
6435624|NCT01072149|7350447|FG010|STARTED|Washout Period 1 (14 Days)||2
6435625|NCT01072149|7350448|FG011|STARTED|Washout Period 1 (14 Days)||3
6435626|NCT01072149|7350449|FG012|STARTED|Washout Period 1 (14 Days)||3
6435627|NCT01072149|7350450|FG013|STARTED|Washout Period 1 (14 Days)||3
6435628|NCT01072149|7350451|FG014|STARTED|Washout Period 1 (14 Days)||3
6435629|NCT01072149|7350452|FG015|STARTED|Washout Period 1 (14 Days)||3
6435630|NCT01072149|7350453|FG016|STARTED|Washout Period 1 (14 Days)||3
6435631|NCT01072149|7350454|FG017|STARTED|Washout Period 1 (14 Days)||2
6435632|NCT01072149|7350437|FG000|COMPLETED|Washout Period 1 (14 Days)||3
6435633|NCT01072149|7350438|FG001|COMPLETED|Washout Period 1 (14 Days)||3
6435634|NCT01072149|7350439|FG002|COMPLETED|Washout Period 1 (14 Days)||2
6435635|NCT01072149|7350440|FG003|COMPLETED|Washout Period 1 (14 Days)||3
6435636|NCT01072149|7350441|FG004|COMPLETED|Washout Period 1 (14 Days)||3
6435637|NCT01072149|7350442|FG005|COMPLETED|Washout Period 1 (14 Days)||3
6435638|NCT01072149|7350443|FG006|COMPLETED|Washout Period 1 (14 Days)||3
6435639|NCT01072149|7350444|FG007|COMPLETED|Washout Period 1 (14 Days)||3
6435640|NCT01072149|7350445|FG008|COMPLETED|Washout Period 1 (14 Days)||3
6435641|NCT01072149|7350446|FG009|COMPLETED|Washout Period 1 (14 Days)||3
6435642|NCT01072149|7350447|FG010|COMPLETED|Washout Period 1 (14 Days)||2
6435643|NCT01072149|7350448|FG011|COMPLETED|Washout Period 1 (14 Days)||3
6435644|NCT01072149|7350449|FG012|COMPLETED|Washout Period 1 (14 Days)||3
6435645|NCT01072149|7350450|FG013|COMPLETED|Washout Period 1 (14 Days)||3
6435646|NCT01072149|7350451|FG014|COMPLETED|Washout Period 1 (14 Days)||3
6435647|NCT01072149|7350452|FG015|COMPLETED|Washout Period 1 (14 Days)||3
6435648|NCT01072149|7350453|FG016|COMPLETED|Washout Period 1 (14 Days)||3
6435649|NCT01072149|7350454|FG017|COMPLETED|Washout Period 1 (14 Days)||2
6435650|NCT01072149|7350437|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435651|NCT01072149|7350438|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435652|NCT01072149|7350439|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435653|NCT01072149|7350440|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435654|NCT01072149|7350441|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435655|NCT01072149|7350442|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
6552617|NCT01738594|7475101|FG002|COMPLETED|Registration and Treatment Start||0
6552618|NCT01738594|7475102|FG003|COMPLETED|Registration and Treatment Start||0
6552619|NCT01738594|7475103|FG004|COMPLETED|Registration and Treatment Start||1
6652743|NCT02431754|7582458|FG001|STARTED|Wash-out Period (4 Weeks)||82
6652744|NCT02431754|7582457|FG000|COMPLETED|Wash-out Period (4 Weeks)||75
6552620|NCT01738594|7475104|FG005|COMPLETED|Registration and Treatment Start||3
6552621|NCT01738594|7475105|FG006|COMPLETED|Registration and Treatment Start||0
6552622|NCT01738594|7475106|FG007|COMPLETED|Registration and Treatment Start||0
6552623|NCT01738594|7475099|FG000|NOT COMPLETED|Registration and Treatment Start||0
6552624|NCT01738594|7475100|FG001|NOT COMPLETED|Registration and Treatment Start||1
6552625|NCT01738594|7475101|FG002|NOT COMPLETED|Registration and Treatment Start||0
6552626|NCT01738594|7475102|FG003|NOT COMPLETED|Registration and Treatment Start||0
6552627|NCT01738594|7475103|FG004|NOT COMPLETED|Registration and Treatment Start||0
6552628|NCT01738594|7475104|FG005|NOT COMPLETED|Registration and Treatment Start||0
6552629|NCT01738594|7475105|FG006|NOT COMPLETED|Registration and Treatment Start||0
6552630|NCT01738594|7475106|FG007|NOT COMPLETED|Registration and Treatment Start||0
6552631|NCT01738594|7475099|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||0
6552632|NCT01738594|7475100|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||2
6552633|NCT01738594|7475101|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||0
6552634|NCT01738594|7475102|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||0
6552635|NCT01738594|7475103|FG004|STARTED|Completed 2 Cycles/Reached 1st Response||1
6552636|NCT01738594|7475104|FG005|STARTED|Completed 2 Cycles/Reached 1st Response||3
6435656|NCT01072149|7350443|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435657|NCT01072149|7350444|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435658|NCT01072149|7350445|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435659|NCT01072149|7350446|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435660|NCT01072149|7350447|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435661|NCT01072149|7350448|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435662|NCT01072149|7350449|FG012|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435663|NCT01072149|7350450|FG013|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435664|NCT01072149|7350451|FG014|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435665|NCT01072149|7350452|FG015|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435666|NCT01072149|7350453|FG016|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435667|NCT01072149|7350454|FG017|NOT COMPLETED|Washout Period 1 (14 Days)||0
6435668|NCT01072149|7350437|FG000|STARTED|Treatment Period 2 (28 Days)||3
6435669|NCT01072149|7350438|FG001|STARTED|Treatment Period 2 (28 Days)||3
6435670|NCT01072149|7350439|FG002|STARTED|Treatment Period 2 (28 Days)||2
6435671|NCT01072149|7350440|FG003|STARTED|Treatment Period 2 (28 Days)||3
6435672|NCT01072149|7350441|FG004|STARTED|Treatment Period 2 (28 Days)||3
6435673|NCT01072149|7350442|FG005|STARTED|Treatment Period 2 (28 Days)||3
6435674|NCT01072149|7350443|FG006|STARTED|Treatment Period 2 (28 Days)||3
6435675|NCT01072149|7350444|FG007|STARTED|Treatment Period 2 (28 Days)||3
6435676|NCT01072149|7350445|FG008|STARTED|Treatment Period 2 (28 Days)||3
6435677|NCT01072149|7350446|FG009|STARTED|Treatment Period 2 (28 Days)||3
6435678|NCT01072149|7350447|FG010|STARTED|Treatment Period 2 (28 Days)||2
6435679|NCT01072149|7350448|FG011|STARTED|Treatment Period 2 (28 Days)||3
6435680|NCT01072149|7350449|FG012|STARTED|Treatment Period 2 (28 Days)||3
6435681|NCT01072149|7350450|FG013|STARTED|Treatment Period 2 (28 Days)||3
6435682|NCT01072149|7350451|FG014|STARTED|Treatment Period 2 (28 Days)||3
6435683|NCT01072149|7350452|FG015|STARTED|Treatment Period 2 (28 Days)||3
6435684|NCT01072149|7350453|FG016|STARTED|Treatment Period 2 (28 Days)||3
6435685|NCT01072149|7350454|FG017|STARTED|Treatment Period 2 (28 Days)||2
6435686|NCT01072149|7350437|FG000|COMPLETED|Treatment Period 2 (28 Days)||3
6435687|NCT01072149|7350438|FG001|COMPLETED|Treatment Period 2 (28 Days)||2
6435688|NCT01072149|7350439|FG002|COMPLETED|Treatment Period 2 (28 Days)||1
6435689|NCT01072149|7350440|FG003|COMPLETED|Treatment Period 2 (28 Days)||3
6435690|NCT01072149|7350441|FG004|COMPLETED|Treatment Period 2 (28 Days)||3
6435691|NCT01072149|7350442|FG005|COMPLETED|Treatment Period 2 (28 Days)||3
6435692|NCT01072149|7350443|FG006|COMPLETED|Treatment Period 2 (28 Days)||3
6435693|NCT01072149|7350444|FG007|COMPLETED|Treatment Period 2 (28 Days)||2
6435694|NCT01072149|7350445|FG008|COMPLETED|Treatment Period 2 (28 Days)||3
6435695|NCT01072149|7350446|FG009|COMPLETED|Treatment Period 2 (28 Days)||3
6435696|NCT01072149|7350447|FG010|COMPLETED|Treatment Period 2 (28 Days)||2
6435697|NCT01072149|7350448|FG011|COMPLETED|Treatment Period 2 (28 Days)||3
6435698|NCT01072149|7350449|FG012|COMPLETED|Treatment Period 2 (28 Days)||3
6435699|NCT01072149|7350450|FG013|COMPLETED|Treatment Period 2 (28 Days)||3
6435700|NCT01072149|7350451|FG014|COMPLETED|Treatment Period 2 (28 Days)||3
6435701|NCT01072149|7350452|FG015|COMPLETED|Treatment Period 2 (28 Days)||3
6435702|NCT01072149|7350453|FG016|COMPLETED|Treatment Period 2 (28 Days)||3
6435703|NCT01072149|7350454|FG017|COMPLETED|Treatment Period 2 (28 Days)||2
6435704|NCT01072149|7350437|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435705|NCT01072149|7350438|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6435706|NCT01072149|7350439|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6435707|NCT01072149|7350440|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435708|NCT01072149|7350441|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435709|NCT01072149|7350442|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435710|NCT01072149|7350443|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435711|NCT01072149|7350444|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6435712|NCT01072149|7350445|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435713|NCT01072149|7350446|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435714|NCT01072149|7350447|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435715|NCT01072149|7350448|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435716|NCT01072149|7350449|FG012|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6552637|NCT01738594|7475105|FG006|STARTED|Completed 2 Cycles/Reached 1st Response||0
6552638|NCT01738594|7475106|FG007|STARTED|Completed 2 Cycles/Reached 1st Response||0
6552639|NCT01738594|7475099|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552640|NCT01738594|7475100|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
6552641|NCT01738594|7475101|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6652745|NCT02431754|7582458|FG001|COMPLETED|Wash-out Period (4 Weeks)||82
6652746|NCT02431754|7582457|FG000|NOT COMPLETED|Wash-out Period (4 Weeks)||4
6552642|NCT01738594|7475102|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552643|NCT01738594|7475103|FG004|COMPLETED|Completed 2 Cycles/Reached 1st Response||1
6552644|NCT01738594|7475104|FG005|COMPLETED|Completed 2 Cycles/Reached 1st Response||2
6552645|NCT01738594|7475105|FG006|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552646|NCT01738594|7475106|FG007|COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552647|NCT01738594|7475099|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552648|NCT01738594|7475100|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6652747|NCT02431754|7582458|FG001|NOT COMPLETED|Wash-out Period (4 Weeks)||0
6652748|NCT02431754|7582457|FG000|STARTED|Period 2 (8 Weeks)||75
6652749|NCT02431754|7582458|FG001|STARTED|Period 2 (8 Weeks)||82
6652750|NCT02431754|7582457|FG000|COMPLETED|Period 2 (8 Weeks)||74
6435717|NCT01072149|7350450|FG013|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435718|NCT01072149|7350451|FG014|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435719|NCT01072149|7350452|FG015|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435720|NCT01072149|7350453|FG016|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435721|NCT01072149|7350454|FG017|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6435722|NCT01072149|7350437|FG000|STARTED|Washout Period 2 (14 Days)||3
6435723|NCT01072149|7350438|FG001|STARTED|Washout Period 2 (14 Days)||2
6435724|NCT01072149|7350439|FG002|STARTED|Washout Period 2 (14 Days)||1
6435725|NCT01072149|7350440|FG003|STARTED|Washout Period 2 (14 Days)||3
6435726|NCT01072149|7350441|FG004|STARTED|Washout Period 2 (14 Days)||3
6435727|NCT01072149|7350442|FG005|STARTED|Washout Period 2 (14 Days)||3
6435728|NCT01072149|7350443|FG006|STARTED|Washout Period 2 (14 Days)||3
6435729|NCT01072149|7350444|FG007|STARTED|Washout Period 2 (14 Days)||2
6435730|NCT01072149|7350445|FG008|STARTED|Washout Period 2 (14 Days)||3
6435731|NCT01072149|7350446|FG009|STARTED|Washout Period 2 (14 Days)||3
6435732|NCT01072149|7350447|FG010|STARTED|Washout Period 2 (14 Days)||2
6435733|NCT01072149|7350448|FG011|STARTED|Washout Period 2 (14 Days)||3
6435734|NCT01072149|7350449|FG012|STARTED|Washout Period 2 (14 Days)||3
6435735|NCT01072149|7350450|FG013|STARTED|Washout Period 2 (14 Days)||3
6435736|NCT01072149|7350451|FG014|STARTED|Washout Period 2 (14 Days)||3
6435737|NCT01072149|7350452|FG015|STARTED|Washout Period 2 (14 Days)||3
6435738|NCT01072149|7350453|FG016|STARTED|Washout Period 2 (14 Days)||3
6435739|NCT01072149|7350454|FG017|STARTED|Washout Period 2 (14 Days)||2
6435740|NCT01072149|7350437|FG000|COMPLETED|Washout Period 2 (14 Days)||2
6435741|NCT01072149|7350438|FG001|COMPLETED|Washout Period 2 (14 Days)||2
6435742|NCT01072149|7350439|FG002|COMPLETED|Washout Period 2 (14 Days)||1
6435743|NCT01072149|7350440|FG003|COMPLETED|Washout Period 2 (14 Days)||3
6435744|NCT01072149|7350441|FG004|COMPLETED|Washout Period 2 (14 Days)||3
6435745|NCT01072149|7350442|FG005|COMPLETED|Washout Period 2 (14 Days)||3
6435746|NCT01072149|7350443|FG006|COMPLETED|Washout Period 2 (14 Days)||3
6435747|NCT01072149|7350444|FG007|COMPLETED|Washout Period 2 (14 Days)||2
6435748|NCT01072149|7350445|FG008|COMPLETED|Washout Period 2 (14 Days)||3
6435749|NCT01072149|7350446|FG009|COMPLETED|Washout Period 2 (14 Days)||3
6435750|NCT01072149|7350447|FG010|COMPLETED|Washout Period 2 (14 Days)||2
6435751|NCT01072149|7350448|FG011|COMPLETED|Washout Period 2 (14 Days)||3
6435752|NCT01072149|7350449|FG012|COMPLETED|Washout Period 2 (14 Days)||2
6435753|NCT01072149|7350450|FG013|COMPLETED|Washout Period 2 (14 Days)||3
6435754|NCT01072149|7350451|FG014|COMPLETED|Washout Period 2 (14 Days)||3
6435755|NCT01072149|7350452|FG015|COMPLETED|Washout Period 2 (14 Days)||1
6435756|NCT01072149|7350453|FG016|COMPLETED|Washout Period 2 (14 Days)||3
6435757|NCT01072149|7350454|FG017|COMPLETED|Washout Period 2 (14 Days)||2
6435758|NCT01072149|7350437|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||1
6435759|NCT01072149|7350438|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435760|NCT01072149|7350439|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435761|NCT01072149|7350440|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435762|NCT01072149|7350441|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435763|NCT01072149|7350442|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435764|NCT01072149|7350443|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435765|NCT01072149|7350444|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435766|NCT01072149|7350445|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435767|NCT01072149|7350446|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435768|NCT01072149|7350447|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435769|NCT01072149|7350448|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435770|NCT01072149|7350449|FG012|NOT COMPLETED|Washout Period 2 (14 Days)||1
6435771|NCT01072149|7350450|FG013|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435772|NCT01072149|7350451|FG014|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435773|NCT01072149|7350452|FG015|NOT COMPLETED|Washout Period 2 (14 Days)||2
6435774|NCT01072149|7350453|FG016|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435775|NCT01072149|7350454|FG017|NOT COMPLETED|Washout Period 2 (14 Days)||0
6435776|NCT01072149|7350437|FG000|STARTED|Treatment Period 3 (28 Days)||2
6435777|NCT01072149|7350438|FG001|STARTED|Treatment Period 3 (28 Days)||2
6435778|NCT01072149|7350439|FG002|STARTED|Treatment Period 3 (28 Days)||1
6435779|NCT01072149|7350440|FG003|STARTED|Treatment Period 3 (28 Days)||3
6435780|NCT01072149|7350441|FG004|STARTED|Treatment Period 3 (28 Days)||3
6435781|NCT01072149|7350442|FG005|STARTED|Treatment Period 3 (28 Days)||3
6435782|NCT01072149|7350443|FG006|STARTED|Treatment Period 3 (28 Days)||3
6435783|NCT01072149|7350444|FG007|STARTED|Treatment Period 3 (28 Days)||2
6435784|NCT01072149|7350445|FG008|STARTED|Treatment Period 3 (28 Days)||3
6435785|NCT01072149|7350446|FG009|STARTED|Treatment Period 3 (28 Days)||3
6435786|NCT01072149|7350447|FG010|STARTED|Treatment Period 3 (28 Days)||2
6435787|NCT01072149|7350448|FG011|STARTED|Treatment Period 3 (28 Days)||3
6435788|NCT01072149|7350449|FG012|STARTED|Treatment Period 3 (28 Days)||2
6435789|NCT01072149|7350450|FG013|STARTED|Treatment Period 3 (28 Days)||3
6435790|NCT01072149|7350451|FG014|STARTED|Treatment Period 3 (28 Days)||3
6435791|NCT01072149|7350452|FG015|STARTED|Treatment Period 3 (28 Days)||1
6435792|NCT01072149|7350453|FG016|STARTED|Treatment Period 3 (28 Days)||3
6435793|NCT01072149|7350454|FG017|STARTED|Treatment Period 3 (28 Days)||2
6435794|NCT01072149|7350437|FG000|COMPLETED|Treatment Period 3 (28 Days)||2
6435795|NCT01072149|7350438|FG001|COMPLETED|Treatment Period 3 (28 Days)||2
6435796|NCT01072149|7350439|FG002|COMPLETED|Treatment Period 3 (28 Days)||0
6435797|NCT01072149|7350440|FG003|COMPLETED|Treatment Period 3 (28 Days)||3
6435798|NCT01072149|7350441|FG004|COMPLETED|Treatment Period 3 (28 Days)||3
6435799|NCT01072149|7350442|FG005|COMPLETED|Treatment Period 3 (28 Days)||3
6435800|NCT01072149|7350443|FG006|COMPLETED|Treatment Period 3 (28 Days)||3
6435801|NCT01072149|7350444|FG007|COMPLETED|Treatment Period 3 (28 Days)||2
6435802|NCT01072149|7350445|FG008|COMPLETED|Treatment Period 3 (28 Days)||3
6435803|NCT01072149|7350446|FG009|COMPLETED|Treatment Period 3 (28 Days)||3
6435804|NCT01072149|7350447|FG010|COMPLETED|Treatment Period 3 (28 Days)||2
6435805|NCT01072149|7350448|FG011|COMPLETED|Treatment Period 3 (28 Days)||3
6435806|NCT01072149|7350449|FG012|COMPLETED|Treatment Period 3 (28 Days)||2
6435807|NCT01072149|7350450|FG013|COMPLETED|Treatment Period 3 (28 Days)||2
6435808|NCT01072149|7350451|FG014|COMPLETED|Treatment Period 3 (28 Days)||3
6435809|NCT01072149|7350452|FG015|COMPLETED|Treatment Period 3 (28 Days)||1
6435810|NCT01072149|7350453|FG016|COMPLETED|Treatment Period 3 (28 Days)||3
6435811|NCT01072149|7350454|FG017|COMPLETED|Treatment Period 3 (28 Days)||2
6435812|NCT01072149|7350437|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435813|NCT01072149|7350438|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435814|NCT01072149|7350439|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6435815|NCT01072149|7350440|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435816|NCT01072149|7350441|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435817|NCT01072149|7350442|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435818|NCT01072149|7350443|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435819|NCT01072149|7350444|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435820|NCT01072149|7350445|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435821|NCT01072149|7350446|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435822|NCT01072149|7350447|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435823|NCT01072149|7350448|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435824|NCT01072149|7350449|FG012|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435825|NCT01072149|7350450|FG013|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6435826|NCT01072149|7350451|FG014|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435827|NCT01072149|7350452|FG015|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435828|NCT01072149|7350453|FG016|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435829|NCT01072149|7350454|FG017|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6435830|NCT01072188|7350466|FG000|STARTED|Overall Study||22
6435831|NCT01072188|7350467|FG001|STARTED|Overall Study||23
6435832|NCT01072188|7350466|FG000|COMPLETED|Overall Study||22
6435833|NCT01072188|7350467|FG001|COMPLETED|Overall Study||23
6435834|NCT01072188|7350466|FG000|NOT COMPLETED|Overall Study||0
6435835|NCT01072188|7350467|FG001|NOT COMPLETED|Overall Study||0
6435836|NCT01072201|7350475|FG000|STARTED|Overall Study||30
6435837|NCT01072201|7350476|FG001|STARTED|Overall Study||30
6552649|NCT01738594|7475101|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552650|NCT01738594|7475102|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552651|NCT01738594|7475103|FG004|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552652|NCT01738594|7475104|FG005|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
6562784|NCT01803074|7485711|FG012|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6435838|NCT01072201|7350475|FG000|COMPLETED|Overall Study||30
6435839|NCT01072201|7350476|FG001|COMPLETED|Overall Study||29
6435840|NCT01072201|7350475|FG000|NOT COMPLETED|Overall Study||0
6435841|NCT01072201|7350476|FG001|NOT COMPLETED|Overall Study||1
6435842|NCT01072331|7350485|FG000|STARTED|Overall Study||34
6435843|NCT01072331|7350486|FG001|STARTED|Overall Study||33
6435844|NCT01072331|7350487|FG002|STARTED|Overall Study||32
6435845|NCT01072331|7350485|FG000|COMPLETED|Overall Study||34
6435846|NCT01072331|7350486|FG001|COMPLETED|Overall Study||33
6435847|NCT01072331|7350487|FG002|COMPLETED|Overall Study||32
6435848|NCT01072331|7350485|FG000|NOT COMPLETED|Overall Study||0
6435849|NCT01072331|7350486|FG001|NOT COMPLETED|Overall Study||0
6435850|NCT01072331|7350487|FG002|NOT COMPLETED|Overall Study||0
6435851|NCT01072344|7350497|FG000|STARTED|Overall Study||46
6435852|NCT01072344|7350498|FG001|STARTED|Overall Study||47
6435853|NCT01072344|7350497|FG000|COMPLETED|Overall Study||35
6435854|NCT01072344|7350498|FG001|COMPLETED|Overall Study||29
6435855|NCT01072344|7350497|FG000|NOT COMPLETED|Overall Study||11
6435856|NCT01072344|7350498|FG001|NOT COMPLETED|Overall Study||18
6435857|NCT01072357|7350506|FG000|STARTED|Overall Study||15
6435858|NCT01072357|7350507|FG001|STARTED|Overall Study||15
6435859|NCT01072357|7350506|FG000|COMPLETED|Overall Study||15
6435860|NCT01072357|7350507|FG001|COMPLETED|Overall Study||14
6435861|NCT01072357|7350506|FG000|NOT COMPLETED|Overall Study||0
6435862|NCT01072357|7350507|FG001|NOT COMPLETED|Overall Study||1
6435863|NCT01072396|7350515|FG000|STARTED|Period One||63
6435864|NCT01072396|7350516|FG001|STARTED|Period One||63
6435865|NCT01072396|7350515|FG000|COMPLETED|Period One||58
6435866|NCT01072396|7350516|FG001|COMPLETED|Period One||61
6435867|NCT01072396|7350515|FG000|NOT COMPLETED|Period One||5
6435868|NCT01072396|7350516|FG001|NOT COMPLETED|Period One||2
6435869|NCT01072396|7350515|FG000|STARTED|Washout Period||58
6435870|NCT01072396|7350516|FG001|STARTED|Washout Period||61
6435871|NCT01072396|7350515|FG000|COMPLETED|Washout Period||58
6435872|NCT01072396|7350516|FG001|COMPLETED|Washout Period||60
6435873|NCT01072396|7350515|FG000|NOT COMPLETED|Washout Period||0
6435874|NCT01072396|7350516|FG001|NOT COMPLETED|Washout Period||1
6435875|NCT01072396|7350515|FG000|STARTED|Period Two||58
6435876|NCT01072396|7350516|FG001|STARTED|Period Two||60
6435877|NCT01072396|7350515|FG000|COMPLETED|Period Two||57
6435878|NCT01072396|7350516|FG001|COMPLETED|Period Two||57
6435879|NCT01072396|7350515|FG000|NOT COMPLETED|Period Two||1
6435880|NCT01072396|7350516|FG001|NOT COMPLETED|Period Two||3
6435881|NCT01072409|7350522|FG000|STARTED|Overall Study||45
6435882|NCT01072409|7350522|FG000|COMPLETED|Overall Study||38
6435883|NCT01072409|7350522|FG000|NOT COMPLETED|Overall Study||7
6435884|NCT01072448|7350528|FG000|STARTED|Overall Study||163
6435885|NCT01072448|7350529|FG001|STARTED|Overall Study||160
6435886|NCT01072448|7350528|FG000|COMPLETED|Overall Study||144
6435887|NCT01072448|7350529|FG001|COMPLETED|Overall Study||130
6435888|NCT01072448|7350528|FG000|NOT COMPLETED|Overall Study||19
6435889|NCT01072448|7350529|FG001|NOT COMPLETED|Overall Study||30
6435890|NCT01072500|7350537|FG000|STARTED|Overall Study||818
6435891|NCT01072500|7350538|FG001|STARTED|Overall Study||817
6435892|NCT01072500|7350537|FG000|COMPLETED|Overall Study||794
6435893|NCT01072500|7350538|FG001|COMPLETED|Overall Study||803
6435894|NCT01072500|7350537|FG000|NOT COMPLETED|Overall Study||24
6435895|NCT01072500|7350538|FG001|NOT COMPLETED|Overall Study||14
6435896|NCT01072539|7350546|FG000|STARTED|Overall Study||3172
6435897|NCT01072539|7350546|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
6435898|NCT01072539|7350546|FG000|NOT COMPLETED|Overall Study||3
6435899|NCT01072617|7350550|FG000|STARTED|Overall Study||8
6435900|NCT01072617|7350550|FG000|COMPLETED|Overall Study||8
6435901|NCT01072617|7350550|FG000|NOT COMPLETED|Overall Study||0
6435902|NCT01072630|7350558|FG000|STARTED|Overall Study||230
6435903|NCT01072630|7350559|FG001|STARTED|Overall Study||232
6435904|NCT01072630|7350560|FG002|STARTED|Overall Study||30
6435905|NCT01072630|7350558|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
6435906|NCT01072630|7350559|FG001|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
6435907|NCT01072630|7350560|FG002|Safety Population|Overall Study|Treated participants.|30
6435908|NCT01072630|7350558|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
6435909|NCT01072630|7350559|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
6435910|NCT01072630|7350560|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
6435911|NCT01072630|7350558|FG000|COMPLETED|Overall Study||175
6435912|NCT01072630|7350559|FG001|COMPLETED|Overall Study||172
6435913|NCT01072630|7350560|FG002|COMPLETED|Overall Study||17
6435914|NCT01072630|7350558|FG000|NOT COMPLETED|Overall Study||55
6435915|NCT01072630|7350559|FG001|NOT COMPLETED|Overall Study||60
6435916|NCT01072630|7350560|FG002|NOT COMPLETED|Overall Study||13
6435917|NCT01072643|7350569|FG000|STARTED|Overall Study||4
6435918|NCT01072643|7350569|FG000|COMPLETED|Overall Study||4
6435919|NCT01072643|7350569|FG000|NOT COMPLETED|Overall Study||0
6435920|NCT01072656|7350594|FG000|STARTED|First Intervention||5
6435921|NCT01072656|7350595|FG001|STARTED|First Intervention||4
6435922|NCT01072656|7350594|FG000|COMPLETED|First Intervention||5
6435923|NCT01072656|7350595|FG001|COMPLETED|First Intervention||4
6435924|NCT01072656|7350594|FG000|NOT COMPLETED|First Intervention||0
6435925|NCT01072656|7350595|FG001|NOT COMPLETED|First Intervention||0
6435926|NCT01072656|7350594|FG000|STARTED|Second Intervention||5
6435927|NCT01072656|7350595|FG001|STARTED|Second Intervention||4
6652751|NCT02431754|7582458|FG001|COMPLETED|Period 2 (8 Weeks)||78
6652752|NCT02431754|7582457|FG000|NOT COMPLETED|Period 2 (8 Weeks)||1
6652753|NCT02431754|7582458|FG001|NOT COMPLETED|Period 2 (8 Weeks)||4
6652754|NCT02431793|7582469|FG000|STARTED|Overall Study||202
6652755|NCT02431793|7582470|FG001|STARTED|Overall Study||243
6652756|NCT02431793|7582471|FG002|STARTED|Overall Study||207
6652757|NCT02431793|7582469|FG000|Completed T1 (3-5 Days Post Enrollment)|Overall Study||136
6652758|NCT02431793|7582470|FG001|Completed T1 (3-5 Days Post Enrollment)|Overall Study||180
6652759|NCT02431793|7582471|FG002|Completed T1 (3-5 Days Post Enrollment)|Overall Study||143
6652760|NCT02431793|7582469|FG000|Completed T2 (7-14 Days Post Enrollment)|Overall Study||95
6652761|NCT02431793|7582470|FG001|Completed T2 (7-14 Days Post Enrollment)|Overall Study||141
6652762|NCT02431793|7582471|FG002|Completed T2 (7-14 Days Post Enrollment)|Overall Study||107
6652763|NCT02431793|7582469|FG000|Completed T3 (30 Days Post Enrollment)|Overall Study||85
6652764|NCT02431793|7582470|FG001|Completed T3 (30 Days Post Enrollment)|Overall Study||113
6652765|NCT02431793|7582471|FG002|Completed T3 (30 Days Post Enrollment)|Overall Study||93
6652766|NCT02431793|7582469|FG000|COMPLETED|Overall Study||83
6652767|NCT02431793|7582470|FG001|COMPLETED|Overall Study||109
6652768|NCT02431793|7582471|FG002|COMPLETED|Overall Study||90
6652769|NCT02431793|7582469|FG000|NOT COMPLETED|Overall Study||119
6652770|NCT02431793|7582470|FG001|NOT COMPLETED|Overall Study||134
6652771|NCT02431793|7582471|FG002|NOT COMPLETED|Overall Study||117
6652772|NCT02431806|7582483|FG000|STARTED|Double-blind Treatment Period||142
6652773|NCT02431806|7582484|FG001|STARTED|Double-blind Treatment Period||136
6652774|NCT02431806|7582485|FG002|STARTED|Double-blind Treatment Period||139
6652775|NCT02431806|7582486|FG003|STARTED|Double-blind Treatment Period||135
6652776|NCT02431806|7582483|FG000|Safety Population|Double-blind Treatment Period||141
6652777|NCT02431806|7582484|FG001|Safety Population|Double-blind Treatment Period||134
6435928|NCT01072656|7350594|FG000|COMPLETED|Second Intervention||5
6652778|NCT02431806|7582485|FG002|Safety Population|Double-blind Treatment Period||138
6652779|NCT02431806|7582486|FG003|Safety Population|Double-blind Treatment Period||134
6435929|NCT01072656|7350595|FG001|COMPLETED|Second Intervention||4
6435930|NCT01072656|7350594|FG000|NOT COMPLETED|Second Intervention||0
6435931|NCT01072656|7350595|FG001|NOT COMPLETED|Second Intervention||0
6435932|NCT01072669|7350604|FG000|STARTED|Overall Study||15
6435933|NCT01072669|7350605|FG001|STARTED|Overall Study||5
6435934|NCT01072669|7350604|FG000|COMPLETED|Overall Study||15
6435935|NCT01072669|7350605|FG001|COMPLETED|Overall Study||5
6435936|NCT01072669|7350604|FG000|NOT COMPLETED|Overall Study||0
6435937|NCT01072669|7350605|FG001|NOT COMPLETED|Overall Study||0
6435938|NCT01072773|7350611|FG000|STARTED|Overall Study||2
6435939|NCT01072773|7350611|FG000|COMPLETED|Overall Study||2
6435940|NCT01072773|7350611|FG000|NOT COMPLETED|Overall Study||0
6435941|NCT01072877|7350620|FG000|STARTED|Overall Study||56
6652780|NCT02431806|7582483|FG000|COMPLETED|Double-blind Treatment Period||117
6652781|NCT02431806|7582484|FG001|COMPLETED|Double-blind Treatment Period||115
6652782|NCT02431806|7582485|FG002|COMPLETED|Double-blind Treatment Period||107
6652783|NCT02431806|7582486|FG003|COMPLETED|Double-blind Treatment Period||109
6652784|NCT02431806|7582483|FG000|NOT COMPLETED|Double-blind Treatment Period||25
6652785|NCT02431806|7582484|FG001|NOT COMPLETED|Double-blind Treatment Period||21
6652786|NCT02431806|7582485|FG002|NOT COMPLETED|Double-blind Treatment Period||32
6652787|NCT02431806|7582486|FG003|NOT COMPLETED|Double-blind Treatment Period||26
6652788|NCT02431806|7582483|FG000|STARTED|Double-blind Down-taper Period||111
6652789|NCT02431806|7582484|FG001|STARTED|Double-blind Down-taper Period||109
6652790|NCT02431806|7582485|FG002|STARTED|Double-blind Down-taper Period||104
6652791|NCT02431806|7582486|FG003|STARTED|Double-blind Down-taper Period||107
6652792|NCT02431806|7582483|FG000|COMPLETED|Double-blind Down-taper Period||111
6652793|NCT02431806|7582484|FG001|COMPLETED|Double-blind Down-taper Period||109
6652794|NCT02431806|7582485|FG002|COMPLETED|Double-blind Down-taper Period||104
6652795|NCT02431806|7582486|FG003|COMPLETED|Double-blind Down-taper Period||107
6652796|NCT02431806|7582483|FG000|NOT COMPLETED|Double-blind Down-taper Period||0
6652797|NCT02431806|7582484|FG001|NOT COMPLETED|Double-blind Down-taper Period||0
6652798|NCT02431806|7582485|FG002|NOT COMPLETED|Double-blind Down-taper Period||0
6652799|NCT02431806|7582486|FG003|NOT COMPLETED|Double-blind Down-taper Period||0
6652800|NCT02432040|7582498|FG000|STARTED|Overall Study||14
6652801|NCT02432040|7582499|FG001|STARTED|Overall Study||14
6652802|NCT02432040|7582498|FG000|COMPLETED|Overall Study||6
6652803|NCT02432040|7582499|FG001|COMPLETED|Overall Study||8
6652804|NCT02432040|7582498|FG000|NOT COMPLETED|Overall Study||8
6652805|NCT02432040|7582499|FG001|NOT COMPLETED|Overall Study||6
6652806|NCT02432105|7582508|FG000|STARTED|Overall Study||164
6652807|NCT02432105|7582509|FG001|STARTED|Overall Study||110
6652808|NCT02432105|7582510|FG002|STARTED|Overall Study||111
6652809|NCT02432105|7582508|FG000|COMPLETED|Overall Study||162
6652810|NCT02432105|7582509|FG001|COMPLETED|Overall Study||108
6652811|NCT02432105|7582510|FG002|COMPLETED|Overall Study||108
6652812|NCT02432105|7582508|FG000|NOT COMPLETED|Overall Study||2
6652813|NCT02432105|7582509|FG001|NOT COMPLETED|Overall Study||2
6652814|NCT02432105|7582510|FG002|NOT COMPLETED|Overall Study||3
6652815|NCT02432144|7582519|FG000|STARTED|Overall Study||12
6652816|NCT02432144|7582519|FG000|COMPLETED|Overall Study||11
6652817|NCT02432144|7582519|FG000|NOT COMPLETED|Overall Study||1
6652818|NCT02432183|7582527|FG000|STARTED|Overall Study||44
6652819|NCT02432183|7582528|FG001|STARTED|Overall Study||47
6652820|NCT02432183|7582529|FG002|STARTED|Overall Study||26
6652821|NCT02432183|7582530|FG003|STARTED|Overall Study||17
6652822|NCT02432183|7582527|FG000|COMPLETED|Overall Study||44
6652823|NCT02432183|7582528|FG001|COMPLETED|Overall Study||47
6652824|NCT02432183|7582529|FG002|COMPLETED|Overall Study||26
6652825|NCT02432183|7582530|FG003|COMPLETED|Overall Study||17
6652826|NCT02432183|7582527|FG000|NOT COMPLETED|Overall Study||0
6652827|NCT02432183|7582528|FG001|NOT COMPLETED|Overall Study||0
6652828|NCT02432183|7582529|FG002|NOT COMPLETED|Overall Study||0
6652829|NCT02432183|7582530|FG003|NOT COMPLETED|Overall Study||0
6652830|NCT02432235|7582552|FG000|STARTED|Overall Study||2
6652831|NCT02432235|7582553|FG001|STARTED|Overall Study||2
6652832|NCT02432235|7582554|FG002|STARTED|Overall Study||2
6652833|NCT02432235|7582555|FG003|STARTED|Overall Study||3
6652834|NCT02432235|7582556|FG004|STARTED|Overall Study||2
6652835|NCT02432235|7582557|FG005|STARTED|Overall Study||20
6652836|NCT02432235|7582558|FG006|STARTED|Overall Study||41
6652837|NCT02432235|7582559|FG007|STARTED|Overall Study||29
6652838|NCT02432235|7582560|FG008|STARTED|Overall Study||26
6652839|NCT02432235|7582561|FG009|STARTED|Overall Study||3
6652840|NCT02432235|7582562|FG010|STARTED|Overall Study||2
6652841|NCT02432235|7582563|FG011|STARTED|Overall Study||1
6652842|NCT02432235|7582552|FG000|COMPLETED|Overall Study||1
6652843|NCT02432235|7582553|FG001|COMPLETED|Overall Study||0
6652844|NCT02432235|7582554|FG002|COMPLETED|Overall Study||0
6652845|NCT02432235|7582555|FG003|COMPLETED|Overall Study||1
6652846|NCT02432235|7582556|FG004|COMPLETED|Overall Study||0
6652847|NCT02432235|7582557|FG005|COMPLETED|Overall Study||8
6652848|NCT02432235|7582558|FG006|COMPLETED|Overall Study||23
6652849|NCT02432235|7582559|FG007|COMPLETED|Overall Study||9
6652850|NCT02432235|7582560|FG008|COMPLETED|Overall Study||5
6652851|NCT02432235|7582561|FG009|COMPLETED|Overall Study||0
6435942|NCT01072877|7350621|FG001|STARTED|Overall Study||57
6435943|NCT01072877|7350622|FG002|STARTED|Overall Study||51
6435944|NCT01072877|7350623|FG003|STARTED|Overall Study||52
6435945|NCT01072877|7350624|FG004|STARTED|Overall Study||63
6652852|NCT02432235|7582562|FG010|COMPLETED|Overall Study||1
6652853|NCT02432235|7582563|FG011|COMPLETED|Overall Study||0
6652854|NCT02432235|7582552|FG000|NOT COMPLETED|Overall Study||1
6435946|NCT01072877|7350620|FG000|COMPLETED|Overall Study||55
6435947|NCT01072877|7350621|FG001|COMPLETED|Overall Study||56
6435948|NCT01072877|7350622|FG002|COMPLETED|Overall Study||51
6435949|NCT01072877|7350623|FG003|COMPLETED|Overall Study||50
6435950|NCT01072877|7350624|FG004|COMPLETED|Overall Study||63
6435951|NCT01072877|7350620|FG000|NOT COMPLETED|Overall Study||1
6435952|NCT01072877|7350621|FG001|NOT COMPLETED|Overall Study||1
6435953|NCT01072877|7350622|FG002|NOT COMPLETED|Overall Study||0
6435954|NCT01072877|7350623|FG003|NOT COMPLETED|Overall Study||2
6435955|NCT01072877|7350624|FG004|NOT COMPLETED|Overall Study||0
6435956|NCT01072929|7350641|FG000|STARTED|Overall Study||199
6435957|NCT01072929|7350642|FG001|STARTED|Overall Study||201
6435958|NCT01072929|7350643|FG002|STARTED|Overall Study||33
6435959|NCT01072929|7350641|FG000|Safety Population|Overall Study|Treated participants|199
6435960|NCT01072929|7350642|FG001|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
6435961|NCT01072929|7350643|FG002|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
6435962|NCT01072929|7350641|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
6435963|NCT01072929|7350642|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
6435964|NCT01072929|7350643|FG002|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
6435965|NCT01072929|7350641|FG000|COMPLETED|Overall Study||155
6435966|NCT01072929|7350642|FG001|COMPLETED|Overall Study||150
6435967|NCT01072929|7350643|FG002|COMPLETED|Overall Study||24
6435968|NCT01072929|7350641|FG000|NOT COMPLETED|Overall Study||44
6435969|NCT01072929|7350642|FG001|NOT COMPLETED|Overall Study||51
6435970|NCT01072929|7350643|FG002|NOT COMPLETED|Overall Study||9
6435971|NCT01073020|7350656|FG000|STARTED|Overall Study||23
6435972|NCT01073020|7350657|FG001|STARTED|Overall Study||22
6435973|NCT01073020|7350658|FG002|STARTED|Overall Study||22
6435974|NCT01073020|7350659|FG003|STARTED|Overall Study||21
6435975|NCT01073020|7350656|FG000|COMPLETED|Overall Study||16
6435976|NCT01073020|7350657|FG001|COMPLETED|Overall Study||17
6435977|NCT01073020|7350658|FG002|COMPLETED|Overall Study||19
6435978|NCT01073020|7350659|FG003|COMPLETED|Overall Study||19
6435979|NCT01073020|7350656|FG000|NOT COMPLETED|Overall Study||7
6552653|NCT01738594|7475105|FG006|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6552654|NCT01738594|7475106|FG007|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6652855|NCT02432235|7582553|FG001|NOT COMPLETED|Overall Study||2
6435980|NCT01073020|7350657|FG001|NOT COMPLETED|Overall Study||5
6435981|NCT01073020|7350658|FG002|NOT COMPLETED|Overall Study||3
6435982|NCT01073020|7350659|FG003|NOT COMPLETED|Overall Study||2
6435983|NCT01073163|7350669|FG000|STARTED|Overall Study||54
6435984|NCT01073163|7350669|FG000|Enrolled But Not Treated|Overall Study||1
6435985|NCT01073163|7350669|FG000|Treated With <6 Cycles|Overall Study||4
6435986|NCT01073163|7350669|FG000|Treated With >=6 Cycles|Overall Study||49
6435987|NCT01073163|7350669|FG000|COMPLETED|Overall Study|Patients completed study|51
6435988|NCT01073163|7350669|FG000|NOT COMPLETED|Overall Study||3
6435989|NCT01073267|7350677|FG000|STARTED|Overall Study||4
6435990|NCT01073267|7350677|FG000|COMPLETED|Overall Study||1
6435991|NCT01073267|7350677|FG000|NOT COMPLETED|Overall Study||3
6435992|NCT01073293|7350683|FG000|STARTED|Overall Study||526
6435993|NCT01073293|7350684|FG001|STARTED|Overall Study||528
6435994|NCT01073293|7350683|FG000|COMPLETED|Overall Study||521
6435995|NCT01073293|7350684|FG001|COMPLETED|Overall Study||517
6435996|NCT01073293|7350683|FG000|NOT COMPLETED|Overall Study||5
6435997|NCT01073293|7350684|FG001|NOT COMPLETED|Overall Study||11
6435998|NCT01073449|7350690|FG000|STARTED|Overall Study||3362
6435999|NCT01073449|7350690|FG000|COMPLETED|Overall Study||3362
6436000|NCT01073449|7350690|FG000|NOT COMPLETED|Overall Study||0
6436001|NCT01073462|7350694|FG000|STARTED|Overall Study||67
6436002|NCT01073462|7350694|FG000|COMPLETED|Overall Study||26
6436003|NCT01073462|7350694|FG000|NOT COMPLETED|Overall Study||41
6436004|NCT01073566|7350700|FG000|STARTED|Period 1 (6 Weeks)||19
6552655|NCT01738594|7475099|FG000|STARTED|Completed 4 Cycles of Treatment||0
6652856|NCT02432235|7582554|FG002|NOT COMPLETED|Overall Study||2
6652857|NCT02432235|7582555|FG003|NOT COMPLETED|Overall Study||2
6652858|NCT02432235|7582556|FG004|NOT COMPLETED|Overall Study||2
6552656|NCT01738594|7475100|FG001|STARTED|Completed 4 Cycles of Treatment||2
6552657|NCT01738594|7475101|FG002|STARTED|Completed 4 Cycles of Treatment||0
6552658|NCT01738594|7475102|FG003|STARTED|Completed 4 Cycles of Treatment||0
6552659|NCT01738594|7475103|FG004|STARTED|Completed 4 Cycles of Treatment||1
6552660|NCT01738594|7475104|FG005|STARTED|Completed 4 Cycles of Treatment||2
6552661|NCT01738594|7475105|FG006|STARTED|Completed 4 Cycles of Treatment||0
6552662|NCT01738594|7475106|FG007|STARTED|Completed 4 Cycles of Treatment||0
6552663|NCT01738594|7475099|FG000|COMPLETED|Completed 4 Cycles of Treatment||0
6552664|NCT01738594|7475100|FG001|COMPLETED|Completed 4 Cycles of Treatment||0
6552665|NCT01738594|7475101|FG002|COMPLETED|Completed 4 Cycles of Treatment||0
6552666|NCT01738594|7475102|FG003|COMPLETED|Completed 4 Cycles of Treatment||0
6552667|NCT01738594|7475103|FG004|COMPLETED|Completed 4 Cycles of Treatment||1
6552668|NCT01738594|7475104|FG005|COMPLETED|Completed 4 Cycles of Treatment||1
6552669|NCT01738594|7475105|FG006|COMPLETED|Completed 4 Cycles of Treatment||0
6552670|NCT01738594|7475106|FG007|COMPLETED|Completed 4 Cycles of Treatment||0
6552671|NCT01738594|7475099|FG000|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6562785|NCT01803074|7485712|FG013|STARTED|Period 2: Part B (HIV-1 Clade B)||0
6436005|NCT01073566|7350701|FG001|STARTED|Period 1 (6 Weeks)||19
6436006|NCT01073566|7350700|FG000|COMPLETED|Period 1 (6 Weeks)||19
6436007|NCT01073566|7350701|FG001|COMPLETED|Period 1 (6 Weeks)||19
6436008|NCT01073566|7350700|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
6436009|NCT01073566|7350701|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
6436010|NCT01073566|7350700|FG000|STARTED|Period 2 (6 Weeks)||19
6436011|NCT01073566|7350701|FG001|STARTED|Period 2 (6 Weeks)||19
6436012|NCT01073566|7350700|FG000|COMPLETED|Period 2 (6 Weeks)||18
6436013|NCT01073566|7350701|FG001|COMPLETED|Period 2 (6 Weeks)||19
6436014|NCT01073566|7350700|FG000|NOT COMPLETED|Period 2 (6 Weeks)||1
6436015|NCT01073566|7350701|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
6436016|NCT01073605|7350710|FG000|STARTED|Overall Study||68
6436017|NCT01073605|7350711|FG001|STARTED|Overall Study||71
6436018|NCT01073605|7350712|FG002|STARTED|Overall Study||69
6436019|NCT01073605|7350710|FG000|Received Treatment|Overall Study||68
6436020|NCT01073605|7350711|FG001|Received Treatment|Overall Study||70
6436021|NCT01073605|7350712|FG002|Received Treatment|Overall Study||68
6436022|NCT01073605|7350710|FG000|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
6436023|NCT01073605|7350711|FG001|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
6436024|NCT01073605|7350712|FG002|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
6436025|NCT01073605|7350710|FG000|NOT COMPLETED|Overall Study||62
6436026|NCT01073605|7350711|FG001|NOT COMPLETED|Overall Study||67
6436027|NCT01073605|7350712|FG002|NOT COMPLETED|Overall Study||61
6436028|NCT01073618|7350720|FG000|STARTED|Overall Study||692
6436029|NCT01073618|7350720|FG000|COMPLETED|Overall Study||385
6436030|NCT01073618|7350720|FG000|NOT COMPLETED|Overall Study||307
6652859|NCT02432235|7582557|FG005|NOT COMPLETED|Overall Study||12
6652860|NCT02432235|7582558|FG006|NOT COMPLETED|Overall Study||18
6652861|NCT02432235|7582559|FG007|NOT COMPLETED|Overall Study||20
6652862|NCT02432235|7582560|FG008|NOT COMPLETED|Overall Study||21
6652863|NCT02432235|7582561|FG009|NOT COMPLETED|Overall Study||3
6652864|NCT02432235|7582562|FG010|NOT COMPLETED|Overall Study||1
6652865|NCT02432235|7582563|FG011|NOT COMPLETED|Overall Study||1
6652866|NCT02432274|7582599|FG000|STARTED|Overall Study||3
6652867|NCT02432274|7582600|FG001|STARTED|Overall Study||9
6652868|NCT02432274|7582601|FG002|STARTED|Overall Study||11
6652869|NCT02432274|7582602|FG003|STARTED|Overall Study||1
6652870|NCT02432274|7582603|FG004|STARTED|Overall Study||31
6652871|NCT02432274|7582604|FG005|STARTED|Overall Study||7
6652872|NCT02432274|7582605|FG006|STARTED|Overall Study||15
6652873|NCT02432274|7582606|FG007|STARTED|Overall Study||20
6652874|NCT02432274|7582599|FG000|Underwent Run-in Period|Overall Study||1
6652875|NCT02432274|7582600|FG001|Underwent Run-in Period|Overall Study||1
6652876|NCT02432274|7582601|FG002|Underwent Run-in Period|Overall Study||0
6652877|NCT02432274|7582602|FG003|Underwent Run-in Period|Overall Study||0
6652878|NCT02432274|7582603|FG004|Underwent Run-in Period|Overall Study||0
6652879|NCT02432274|7582604|FG005|Underwent Run-in Period|Overall Study||0
6652880|NCT02432274|7582605|FG006|Underwent Run-in Period|Overall Study||0
6652881|NCT02432274|7582606|FG007|Underwent Run-in Period|Overall Study||0
6652882|NCT02432274|7582599|FG000|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|5
6652883|NCT02432274|7582600|FG001|Treated (Safety Population)|Overall Study|2 participants assigned to lenvatinib17mg/m^2 actually received 14mg/m^2 (dose capped at 24 mg/day).|11
6652884|NCT02432274|7582601|FG002|Treated (Safety Population)|Overall Study||7
6652885|NCT02432274|7582602|FG003|Treated (Safety Population)|Overall Study||1
6652886|NCT02432274|7582603|FG004|Treated (Safety Population)|Overall Study||31
6652887|NCT02432274|7582604|FG005|Treated (Safety Population)|Overall Study|4 participants assigned to lenvatinib14mg/m^2 actually received 11mg/m^2 (dose capped at 24 mg/day).|11
6652888|NCT02432274|7582605|FG006|Treated (Safety Population)|Overall Study||11
6652889|NCT02432274|7582606|FG007|Treated (Safety Population)|Overall Study||20
6436031|NCT01073631|7350724|FG000|STARTED|Overall Study||543
6436032|NCT01073631|7350724|FG000|COMPLETED|Overall Study||374
6436033|NCT01073631|7350724|FG000|NOT COMPLETED|Overall Study||169
6436034|NCT01073657|7350730|FG000|STARTED|Overall Study||17
6436035|NCT01073657|7350731|FG001|STARTED|Overall Study||16
6436036|NCT01073657|7350730|FG000|COMPLETED|Overall Study||17
6436037|NCT01073657|7350731|FG001|COMPLETED|Overall Study||16
6436038|NCT01073657|7350730|FG000|NOT COMPLETED|Overall Study||0
6436039|NCT01073657|7350731|FG001|NOT COMPLETED|Overall Study||0
6436040|NCT01073865|7350739|FG000|STARTED|Overall Study|Number of patients randomised|109
6436041|NCT01073865|7350740|FG001|STARTED|Overall Study|Number of patients randomised|113
6436042|NCT01073865|7350739|FG000|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
6436043|NCT01073865|7350740|FG001|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
6652890|NCT02432274|7582599|FG000|COMPLETED|Overall Study||0
6652891|NCT02432274|7582600|FG001|COMPLETED|Overall Study||0
6652892|NCT02432274|7582601|FG002|COMPLETED|Overall Study||0
6652893|NCT02432274|7582602|FG003|COMPLETED|Overall Study||0
6652894|NCT02432274|7582603|FG004|COMPLETED|Overall Study||0
6652895|NCT02432274|7582604|FG005|COMPLETED|Overall Study||0
6652896|NCT02432274|7582605|FG006|COMPLETED|Overall Study||0
6652897|NCT02432274|7582606|FG007|COMPLETED|Overall Study||0
6652898|NCT02432274|7582599|FG000|NOT COMPLETED|Overall Study||3
6436044|NCT01073865|7350739|FG000|COMPLETED|Overall Study|Number of patients completed the study|81
6436045|NCT01073865|7350740|FG001|COMPLETED|Overall Study|Number of patients completed the study|74
6436046|NCT01073865|7350739|FG000|NOT COMPLETED|Overall Study||28
6436047|NCT01073865|7350740|FG001|NOT COMPLETED|Overall Study||39
6436048|NCT01073930|7350748|FG000|STARTED|Overall Study||307
6436049|NCT01073930|7350749|FG001|STARTED|Overall Study||301
6436050|NCT01073930|7350748|FG000|Safety Population (Treated)|Overall Study||305
6436051|NCT01073930|7350749|FG001|Safety Population (Treated)|Overall Study||298
6436052|NCT01073930|7350748|FG000|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
6436053|NCT01073930|7350749|FG001|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
6436054|NCT01073930|7350748|FG000|COMPLETED|Overall Study||304
6436055|NCT01073930|7350749|FG001|COMPLETED|Overall Study||295
6436056|NCT01073930|7350748|FG000|NOT COMPLETED|Overall Study||3
6436057|NCT01073930|7350749|FG001|NOT COMPLETED|Overall Study||6
6436058|NCT01073943|7350757|FG000|STARTED|Overall Study||300
6436059|NCT01073943|7350758|FG001|STARTED|Overall Study||303
6436060|NCT01073943|7350757|FG000|Safety Population (Treated)|Overall Study||296
6436061|NCT01073943|7350758|FG001|Safety Population (Treated)|Overall Study||302
6436062|NCT01073943|7350757|FG000|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
6436063|NCT01073943|7350758|FG001|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
6436064|NCT01073943|7350757|FG000|COMPLETED|Overall Study||287
6436065|NCT01073943|7350758|FG001|COMPLETED|Overall Study||295
6436066|NCT01073943|7350757|FG000|NOT COMPLETED|Overall Study||13
6436067|NCT01073943|7350758|FG001|NOT COMPLETED|Overall Study||8
6436068|NCT01074008|7350773|FG000|STARTED|Overall Study||8
6436069|NCT01074008|7350774|FG001|STARTED|Overall Study||8
6436070|NCT01074008|7350775|FG002|STARTED|Overall Study||8
6436071|NCT01074008|7350776|FG003|STARTED|Overall Study||8
6436072|NCT01074008|7350777|FG004|STARTED|Overall Study||8
6436073|NCT01074008|7350778|FG005|STARTED|Overall Study||7
6436074|NCT01074008|7350779|FG006|STARTED|Overall Study||8
6436075|NCT01074008|7350780|FG007|STARTED|Overall Study||8
6436076|NCT01074008|7350781|FG008|STARTED|Overall Study||11
6436077|NCT01074008|7350773|FG000|Completed Direct-acting Antiviral Agent|Overall Study||8
6436078|NCT01074008|7350774|FG001|Completed Direct-acting Antiviral Agent|Overall Study||7
6436079|NCT01074008|7350775|FG002|Completed Direct-acting Antiviral Agent|Overall Study||7
6436080|NCT01074008|7350776|FG003|Completed Direct-acting Antiviral Agent|Overall Study||8
6436081|NCT01074008|7350777|FG004|Completed Direct-acting Antiviral Agent|Overall Study||8
6436082|NCT01074008|7350778|FG005|Completed Direct-acting Antiviral Agent|Overall Study||5
6436083|NCT01074008|7350779|FG006|Completed Direct-acting Antiviral Agent|Overall Study||8
6436084|NCT01074008|7350780|FG007|Completed Direct-acting Antiviral Agent|Overall Study||7
6436085|NCT01074008|7350781|FG008|Completed Direct-acting Antiviral Agent|Overall Study||5
6436086|NCT01074008|7350773|FG000|COMPLETED|Overall Study||7
6436087|NCT01074008|7350774|FG001|COMPLETED|Overall Study||5
6436088|NCT01074008|7350775|FG002|COMPLETED|Overall Study||6
6436089|NCT01074008|7350776|FG003|COMPLETED|Overall Study||7
6436090|NCT01074008|7350777|FG004|COMPLETED|Overall Study||6
6436091|NCT01074008|7350778|FG005|COMPLETED|Overall Study||7
6436092|NCT01074008|7350779|FG006|COMPLETED|Overall Study||7
6436093|NCT01074008|7350780|FG007|COMPLETED|Overall Study||8
6436094|NCT01074008|7350781|FG008|COMPLETED|Overall Study||7
6436095|NCT01074008|7350773|FG000|NOT COMPLETED|Overall Study||1
6436096|NCT01074008|7350774|FG001|NOT COMPLETED|Overall Study||3
6436097|NCT01074008|7350775|FG002|NOT COMPLETED|Overall Study||2
6436098|NCT01074008|7350776|FG003|NOT COMPLETED|Overall Study||1
6436099|NCT01074008|7350777|FG004|NOT COMPLETED|Overall Study||2
6436100|NCT01074008|7350778|FG005|NOT COMPLETED|Overall Study||0
6436101|NCT01074008|7350779|FG006|NOT COMPLETED|Overall Study||1
6436102|NCT01074008|7350780|FG007|NOT COMPLETED|Overall Study||0
6436103|NCT01074008|7350781|FG008|NOT COMPLETED|Overall Study||4
6436104|NCT01074034|7350810|FG000|STARTED|Overall Study||211
6436105|NCT01074034|7350810|FG000|COMPLETED|Overall Study||205
6436106|NCT01074034|7350810|FG000|NOT COMPLETED|Overall Study||6
6436107|NCT01074047|7350817|FG000|STARTED|Treatment Phase||241
6436108|NCT01074047|7350818|FG001|STARTED|Treatment Phase||247
6436109|NCT01074047|7350817|FG000|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
6436110|NCT01074047|7350818|FG001|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
6436111|NCT01074047|7350817|FG000|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
6436112|NCT01074047|7350818|FG001|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
6436113|NCT01074047|7350817|FG000|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
6652899|NCT02432274|7582600|FG001|NOT COMPLETED|Overall Study||9
6652900|NCT02432274|7582601|FG002|NOT COMPLETED|Overall Study||11
6652901|NCT02432274|7582602|FG003|NOT COMPLETED|Overall Study||1
6652902|NCT02432274|7582603|FG004|NOT COMPLETED|Overall Study||31
6652903|NCT02432274|7582604|FG005|NOT COMPLETED|Overall Study||7
6652904|NCT02432274|7582605|FG006|NOT COMPLETED|Overall Study||15
6652905|NCT02432274|7582606|FG007|NOT COMPLETED|Overall Study||20
6652906|NCT02432287|7582638|FG000|STARTED|First Intervention||8
6652907|NCT02432287|7582639|FG001|STARTED|First Intervention||8
6652908|NCT02432287|7582638|FG000|COMPLETED|First Intervention||8
6652909|NCT02432287|7582639|FG001|COMPLETED|First Intervention||7
6652910|NCT02432287|7582638|FG000|NOT COMPLETED|First Intervention||0
6436114|NCT01074047|7350818|FG001|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
6436115|NCT01074047|7350817|FG000|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
6436116|NCT01074047|7350818|FG001|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
6436117|NCT01074047|7350817|FG000|NOT COMPLETED|Treatment Phase||217
6436118|NCT01074047|7350818|FG001|NOT COMPLETED|Treatment Phase||234
6436119|NCT01074047|7350817|FG000|STARTED|Survival Follow-Up Phase||140
6436120|NCT01074047|7350818|FG001|STARTED|Survival Follow-Up Phase||163
6436121|NCT01074047|7350817|FG000|COMPLETED|Survival Follow-Up Phase||16
6436122|NCT01074047|7350818|FG001|COMPLETED|Survival Follow-Up Phase||27
6552672|NCT01738594|7475100|FG001|NOT COMPLETED|Completed 4 Cycles of Treatment||2
6552673|NCT01738594|7475101|FG002|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6552674|NCT01738594|7475102|FG003|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6552675|NCT01738594|7475103|FG004|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6552676|NCT01738594|7475104|FG005|NOT COMPLETED|Completed 4 Cycles of Treatment||1
6552677|NCT01738594|7475105|FG006|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6552678|NCT01738594|7475106|FG007|NOT COMPLETED|Completed 4 Cycles of Treatment||0
6552679|NCT01738594|7475099|FG000|STARTED|Went on to Continue Treatment Cycle 5||0
6552680|NCT01738594|7475100|FG001|STARTED|Went on to Continue Treatment Cycle 5||0
6552681|NCT01738594|7475101|FG002|STARTED|Went on to Continue Treatment Cycle 5||0
6652911|NCT02432287|7582639|FG001|NOT COMPLETED|First Intervention||1
6652912|NCT02432287|7582638|FG000|STARTED|Washout Period||7
6652913|NCT02432287|7582639|FG001|STARTED|Washout Period||7
6652914|NCT02432287|7582638|FG000|COMPLETED|Washout Period||7
6652915|NCT02432287|7582639|FG001|COMPLETED|Washout Period||7
6652916|NCT02432287|7582638|FG000|NOT COMPLETED|Washout Period||0
6652917|NCT02432287|7582639|FG001|NOT COMPLETED|Washout Period||0
6652918|NCT02432287|7582638|FG000|STARTED|Second Intervention||7
6652919|NCT02432287|7582639|FG001|STARTED|Second Intervention||7
6652920|NCT02432287|7582638|FG000|COMPLETED|Second Intervention||7
6652921|NCT02432287|7582639|FG001|COMPLETED|Second Intervention||7
6652922|NCT02432287|7582638|FG000|NOT COMPLETED|Second Intervention||0
6652923|NCT02432287|7582639|FG001|NOT COMPLETED|Second Intervention||0
6652924|NCT02432300|7582647|FG000|STARTED|Overall Study||17
6652925|NCT02432300|7582647|FG000|COMPLETED|Overall Study||13
6652926|NCT02432300|7582647|FG000|NOT COMPLETED|Overall Study||4
6652927|NCT02432456|7582653|FG000|STARTED|Overall Study||75
6652928|NCT02432456|7582654|FG001|STARTED|Overall Study||75
6652929|NCT02432456|7582653|FG000|COMPLETED|Overall Study||75
6652930|NCT02432456|7582654|FG001|COMPLETED|Overall Study||75
6652931|NCT02432456|7582653|FG000|NOT COMPLETED|Overall Study||0
6652932|NCT02432456|7582654|FG001|NOT COMPLETED|Overall Study||0
6652933|NCT02432703|7582662|FG000|STARTED|Overall Study||75
6652934|NCT02432703|7582663|FG001|STARTED|Overall Study||74
6652935|NCT02432703|7582662|FG000|COMPLETED|Overall Study||53
6652936|NCT02432703|7582663|FG001|COMPLETED|Overall Study||56
6652937|NCT02432703|7582662|FG000|NOT COMPLETED|Overall Study||22
6652938|NCT02432703|7582663|FG001|NOT COMPLETED|Overall Study||18
6652939|NCT02432716|7582669|FG000|STARTED|Overall Study||6
6652940|NCT02432716|7582670|FG001|STARTED|Overall Study||6
6652941|NCT02432716|7582669|FG000|COMPLETED|Overall Study||6
6652942|NCT02432716|7582670|FG001|COMPLETED|Overall Study||6
6652943|NCT02432716|7582669|FG000|NOT COMPLETED|Overall Study||0
6652944|NCT02432716|7582670|FG001|NOT COMPLETED|Overall Study||0
6652945|NCT02432729|7582678|FG000|STARTED|Month 3 Visit||720
6652946|NCT02432729|7582678|FG000|COMPLETED|Month 3 Visit||718
6652947|NCT02432729|7582678|FG000|NOT COMPLETED|Month 3 Visit||2
6652948|NCT02432729|7582678|FG000|STARTED|Month 6 Visit||718
6652949|NCT02432729|7582678|FG000|COMPLETED|Month 6 Visit||632
6652950|NCT02432729|7582678|FG000|NOT COMPLETED|Month 6 Visit||86
6652951|NCT02432729|7582678|FG000|STARTED|Month 12 Visit||632
6652952|NCT02432729|7582678|FG000|COMPLETED|Month 12 Visit||436
6652953|NCT02432729|7582678|FG000|NOT COMPLETED|Month 12 Visit||196
6652954|NCT02432742|7582683|FG000|STARTED|Overall Study||100
6652955|NCT02432742|7582683|FG000|COMPLETED|Overall Study||95
6652956|NCT02432742|7582683|FG000|NOT COMPLETED|Overall Study||5
6652957|NCT02433080|7582690|FG000|STARTED|Overall Study||26
6652958|NCT02433080|7582691|FG001|STARTED|Overall Study||28
6436123|NCT01074047|7350817|FG000|NOT COMPLETED|Survival Follow-Up Phase||124
6552682|NCT01738594|7475102|FG003|STARTED|Went on to Continue Treatment Cycle 5||0
6652959|NCT02433080|7582690|FG000|8 Weeks|Overall Study||25
6652960|NCT02433080|7582691|FG001|8 Weeks|Overall Study||24
6652961|NCT02433080|7582690|FG000|COMPLETED|Overall Study||25
6652962|NCT02433080|7582691|FG001|COMPLETED|Overall Study||24
6652963|NCT02433080|7582690|FG000|NOT COMPLETED|Overall Study||1
6652964|NCT02433080|7582691|FG001|NOT COMPLETED|Overall Study||4
6652965|NCT02433288|7582700|FG000|STARTED|Overall Study||443
6652966|NCT02433288|7582701|FG001|STARTED|Overall Study||442
6652967|NCT02433288|7582700|FG000|COMPLETED|Overall Study||320
6652968|NCT02433288|7582701|FG001|COMPLETED|Overall Study||316
6652969|NCT02433288|7582700|FG000|NOT COMPLETED|Overall Study||123
6652970|NCT02433288|7582701|FG001|NOT COMPLETED|Overall Study||126
6652971|NCT02433340|7582711|FG000|STARTED|Overall Study||42
6652972|NCT02433340|7582712|FG001|STARTED|Overall Study||37
6652973|NCT02433340|7582713|FG002|STARTED|Overall Study||39
6652974|NCT02433340|7582714|FG003|STARTED|Overall Study||40
6652975|NCT02433340|7582711|FG000|COMPLETED|Overall Study||40
6652976|NCT02433340|7582712|FG001|COMPLETED|Overall Study||35
6436124|NCT01074047|7350818|FG001|NOT COMPLETED|Survival Follow-Up Phase||136
6436125|NCT01074047|7350817|FG000|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
6436126|NCT01074047|7350818|FG001|STARTED|Extension Phase||0
6436127|NCT01074047|7350817|FG000|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
6436128|NCT01074047|7350818|FG001|Safety Population|Extension Phase||0
6436129|NCT01074047|7350817|FG000|COMPLETED|Extension Phase||0
6436130|NCT01074047|7350818|FG001|COMPLETED|Extension Phase||0
6436131|NCT01074047|7350817|FG000|NOT COMPLETED|Extension Phase||22
6436132|NCT01074047|7350818|FG001|NOT COMPLETED|Extension Phase||0
6436133|NCT01074099|7350833|FG000|STARTED|Overall Study||2
6436134|NCT01074099|7350834|FG001|STARTED|Overall Study||3
6436135|NCT01074099|7350833|FG000|COMPLETED|Overall Study||2
6436136|NCT01074099|7350834|FG001|COMPLETED|Overall Study||3
6436137|NCT01074099|7350833|FG000|NOT COMPLETED|Overall Study||0
6436138|NCT01074099|7350834|FG001|NOT COMPLETED|Overall Study||0
6436139|NCT01074125|7350843|FG000|STARTED|Overall Study||51
6436140|NCT01074125|7350844|FG001|STARTED|Overall Study||52
6436141|NCT01074125|7350845|FG002|STARTED|Overall Study||48
6436142|NCT01074125|7350843|FG000|COMPLETED|Overall Study||39
6436143|NCT01074125|7350844|FG001|COMPLETED|Overall Study||47
6436144|NCT01074125|7350845|FG002|COMPLETED|Overall Study||36
6436145|NCT01074125|7350843|FG000|NOT COMPLETED|Overall Study||12
6436146|NCT01074125|7350844|FG001|NOT COMPLETED|Overall Study||5
6436147|NCT01074125|7350845|FG002|NOT COMPLETED|Overall Study||12
6436148|NCT01074164|7350858|FG000|STARTED|Overall Study||7
6436149|NCT01074164|7350859|FG001|STARTED|Overall Study||8
6436150|NCT01074164|7350858|FG000|COMPLETED|Overall Study||4
6436151|NCT01074164|7350859|FG001|COMPLETED|Overall Study||7
6436152|NCT01074164|7350858|FG000|NOT COMPLETED|Overall Study||3
6436153|NCT01074164|7350859|FG001|NOT COMPLETED|Overall Study||1
6436154|NCT01074177|7350865|FG000|STARTED|Overall Study||24
6436155|NCT01074177|7350865|FG000|COMPLETED|Overall Study||24
6436156|NCT01074177|7350865|FG000|NOT COMPLETED|Overall Study||0
6436157|NCT01074216|7350869|FG000|STARTED|Overall Study||54
6436158|NCT01074216|7350869|FG000|COMPLETED|Overall Study||41
6436159|NCT01074216|7350869|FG000|NOT COMPLETED|Overall Study||13
6436160|NCT01074229|7350876|FG000|STARTED|Overall Study||25
6436161|NCT01074229|7350877|FG001|STARTED|Overall Study||25
6436162|NCT01074229|7350878|FG002|STARTED|Overall Study||25
6436163|NCT01074229|7350876|FG000|COMPLETED|Overall Study||23
6436164|NCT01074229|7350877|FG001|COMPLETED|Overall Study||22
6436165|NCT01074229|7350878|FG002|COMPLETED|Overall Study||21
6436166|NCT01074229|7350876|FG000|NOT COMPLETED|Overall Study||2
6436167|NCT01074229|7350877|FG001|NOT COMPLETED|Overall Study||3
6436168|NCT01074229|7350878|FG002|NOT COMPLETED|Overall Study||4
6436169|NCT01074242|7350888|FG000|STARTED|Overall Study||3798
6436170|NCT01074242|7350888|FG000|Received at Least 1 Dose of Vaccine|Overall Study||3395
6436171|NCT01074242|7350888|FG000|COMPLETED|Overall Study||3395
6436172|NCT01074242|7350888|FG000|NOT COMPLETED|Overall Study||403
6436173|NCT01074255|7350892|FG000|STARTED|Overall Study||3141
6436174|NCT01074255|7350892|FG000|Treated|Overall Study||3139
6436175|NCT01074255|7350892|FG000|COMPLETED|Overall Study||3139
6436176|NCT01074255|7350892|FG000|NOT COMPLETED|Overall Study||2
6436177|NCT01074268|7350898|FG000|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
6436178|NCT01074268|7350899|FG001|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
6436179|NCT01074268|7350898|FG000|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
6436180|NCT01074268|7350899|FG001|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
6436181|NCT01074268|7350898|FG000|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
6436182|NCT01074268|7350899|FG001|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
6436183|NCT01074268|7350898|FG000|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
6436184|NCT01074268|7350899|FG001|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
6436185|NCT01074268|7350898|FG000|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
6436186|NCT01074268|7350899|FG001|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
6436187|NCT01074268|7350898|FG000|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
6436188|NCT01074268|7350899|FG001|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
6436189|NCT01074268|7350898|FG000|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
6436190|NCT01074268|7350899|FG001|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
6436191|NCT01074268|7350898|FG000|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
6436192|NCT01074268|7350899|FG001|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
6436193|NCT01074307|7350907|FG000|STARTED|Overall Study||66
6436194|NCT01074307|7350908|FG001|STARTED|Overall Study||114
6436195|NCT01074307|7350907|FG000|COMPLETED|Overall Study||44
6436196|NCT01074307|7350908|FG001|COMPLETED|Overall Study||102
6436197|NCT01074307|7350907|FG000|NOT COMPLETED|Overall Study||22
6436198|NCT01074307|7350908|FG001|NOT COMPLETED|Overall Study||12
6436199|NCT01074450|7350916|FG000|STARTED|First Intervention||12
6436200|NCT01074450|7350917|FG001|STARTED|First Intervention||12
6436201|NCT01074450|7350916|FG000|COMPLETED|First Intervention||12
6436202|NCT01074450|7350917|FG001|COMPLETED|First Intervention||10
6436203|NCT01074450|7350916|FG000|NOT COMPLETED|First Intervention||0
6436204|NCT01074450|7350917|FG001|NOT COMPLETED|First Intervention||2
6436205|NCT01074450|7350916|FG000|STARTED|Washout of 7 Days||12
6436206|NCT01074450|7350917|FG001|STARTED|Washout of 7 Days||10
6436207|NCT01074450|7350916|FG000|COMPLETED|Washout of 7 Days||12
6436208|NCT01074450|7350917|FG001|COMPLETED|Washout of 7 Days||10
6436209|NCT01074450|7350916|FG000|NOT COMPLETED|Washout of 7 Days||0
6436210|NCT01074450|7350917|FG001|NOT COMPLETED|Washout of 7 Days||0
6436211|NCT01074450|7350916|FG000|STARTED|Second Intervention||12
6436212|NCT01074450|7350917|FG001|STARTED|Second Intervention||10
6436213|NCT01074450|7350916|FG000|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
6436214|NCT01074450|7350917|FG001|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
6436215|NCT01074450|7350916|FG000|NOT COMPLETED|Second Intervention||1
6436216|NCT01074450|7350917|FG001|NOT COMPLETED|Second Intervention||1
6436217|NCT01074463|7350925|FG000|STARTED|First Intervention||12
6436218|NCT01074463|7350926|FG001|STARTED|First Intervention||12
6436219|NCT01074463|7350925|FG000|COMPLETED|First Intervention||12
6436220|NCT01074463|7350926|FG001|COMPLETED|First Intervention||12
6436221|NCT01074463|7350925|FG000|NOT COMPLETED|First Intervention||0
6436222|NCT01074463|7350926|FG001|NOT COMPLETED|First Intervention||0
6436223|NCT01074463|7350925|FG000|STARTED|Washout of 7 Days||12
6436224|NCT01074463|7350926|FG001|STARTED|Washout of 7 Days||12
6436225|NCT01074463|7350925|FG000|COMPLETED|Washout of 7 Days||12
6436226|NCT01074463|7350926|FG001|COMPLETED|Washout of 7 Days||12
6436227|NCT01074463|7350925|FG000|NOT COMPLETED|Washout of 7 Days||0
6436228|NCT01074463|7350926|FG001|NOT COMPLETED|Washout of 7 Days||0
6436229|NCT01074463|7350925|FG000|STARTED|Second Intervention||12
6436230|NCT01074463|7350926|FG001|STARTED|Second Intervention||12
6436231|NCT01074463|7350925|FG000|COMPLETED|Second Intervention||12
6436232|NCT01074463|7350926|FG001|COMPLETED|Second Intervention||12
6436233|NCT01074463|7350925|FG000|NOT COMPLETED|Second Intervention||0
6436234|NCT01074463|7350926|FG001|NOT COMPLETED|Second Intervention||0
6436235|NCT01074554|7350934|FG000|STARTED|Overall Study||14
6436236|NCT01074554|7350935|FG001|STARTED|Overall Study||15
6436237|NCT01074554|7350934|FG000|COMPLETED|Overall Study||11
6436238|NCT01074554|7350935|FG001|COMPLETED|Overall Study||11
6436239|NCT01074554|7350934|FG000|NOT COMPLETED|Overall Study||3
6436240|NCT01074554|7350935|FG001|NOT COMPLETED|Overall Study||4
6436241|NCT01074658|7350941|FG000|STARTED|Overall Study||1015
6436242|NCT01074658|7350941|FG000|Attempted Implant|Overall Study||996
6436243|NCT01074658|7350941|FG000|COMPLETED|Overall Study||996
6436244|NCT01074658|7350941|FG000|NOT COMPLETED|Overall Study||19
6436245|NCT01074931|7350945|FG000|STARTED|Overall Study||98
6436246|NCT01074931|7350945|FG000|COMPLETED|Overall Study||92
6436247|NCT01074931|7350945|FG000|NOT COMPLETED|Overall Study||6
6436248|NCT01074944|7350953|FG000|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
6436249|NCT01074944|7350954|FG001|STARTED|Lead-in Period (up to 78 Weeks)||0
6436250|NCT01074944|7350955|FG002|STARTED|Lead-in Period (up to 78 Weeks)||0
6436251|NCT01074944|7350956|FG003|STARTED|Lead-in Period (up to 78 Weeks)||0
6436252|NCT01074944|7350957|FG004|STARTED|Lead-in Period (up to 78 Weeks)||0
6436253|NCT01074944|7350953|FG000|COMPLETED|Lead-in Period (up to 78 Weeks)||157
6436254|NCT01074944|7350954|FG001|COMPLETED|Lead-in Period (up to 78 Weeks)||0
6436255|NCT01074944|7350955|FG002|COMPLETED|Lead-in Period (up to 78 Weeks)||0
6436256|NCT01074944|7350956|FG003|COMPLETED|Lead-in Period (up to 78 Weeks)||0
6436257|NCT01074944|7350957|FG004|COMPLETED|Lead-in Period (up to 78 Weeks)||0
6436258|NCT01074944|7350953|FG000|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
6436259|NCT01074944|7350954|FG001|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
6436260|NCT01074944|7350955|FG002|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
6436261|NCT01074944|7350956|FG003|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
6436262|NCT01074944|7350957|FG004|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
6436263|NCT01074944|7350953|FG000|STARTED|Primary Analysis Period (up to 52 Weeks)||0
6436264|NCT01074944|7350954|FG001|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
6436265|NCT01074944|7350955|FG002|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
6436266|NCT01074944|7350956|FG003|STARTED|Primary Analysis Period (up to 52 Weeks)||0
6436267|NCT01074944|7350957|FG004|STARTED|Primary Analysis Period (up to 52 Weeks)||0
6436268|NCT01074944|7350953|FG000|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6436269|NCT01074944|7350954|FG001|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
6436270|NCT01074944|7350955|FG002|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
6436271|NCT01074944|7350956|FG003|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6436272|NCT01074944|7350957|FG004|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6436273|NCT01074944|7350953|FG000|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6436274|NCT01074944|7350954|FG001|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
6436275|NCT01074944|7350955|FG002|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
6436276|NCT01074944|7350956|FG003|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6436277|NCT01074944|7350957|FG004|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
6436278|NCT01074944|7350953|FG000|STARTED|Long Term Treatment||0
6436279|NCT01074944|7350954|FG001|STARTED|Long Term Treatment||0
6436280|NCT01074944|7350955|FG002|STARTED|Long Term Treatment||0
6436281|NCT01074944|7350956|FG003|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
6436282|NCT01074944|7350957|FG004|STARTED|Long Term Treatment||0
6436283|NCT01074944|7350953|FG000|COMPLETED|Long Term Treatment||0
6436284|NCT01074944|7350954|FG001|COMPLETED|Long Term Treatment||0
6436285|NCT01074944|7350955|FG002|COMPLETED|Long Term Treatment||0
6436286|NCT01074944|7350956|FG003|COMPLETED|Long Term Treatment||95
6436287|NCT01074944|7350957|FG004|COMPLETED|Long Term Treatment||0
6436288|NCT01074944|7350953|FG000|NOT COMPLETED|Long Term Treatment||0
6436289|NCT01074944|7350954|FG001|NOT COMPLETED|Long Term Treatment||0
6436290|NCT01074944|7350955|FG002|NOT COMPLETED|Long Term Treatment||0
6436291|NCT01074944|7350956|FG003|NOT COMPLETED|Long Term Treatment||26
6436292|NCT01074944|7350957|FG004|NOT COMPLETED|Long Term Treatment||0
6436293|NCT01074944|7350953|FG000|STARTED|Extended Treatment (up to 42 Months)||0
6436294|NCT01074944|7350954|FG001|STARTED|Extended Treatment (up to 42 Months)||0
6436295|NCT01074944|7350955|FG002|STARTED|Extended Treatment (up to 42 Months)||0
6436296|NCT01074944|7350956|FG003|STARTED|Extended Treatment (up to 42 Months)||0
6436297|NCT01074944|7350957|FG004|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
6436298|NCT01074944|7350953|FG000|COMPLETED|Extended Treatment (up to 42 Months)||0
6436299|NCT01074944|7350954|FG001|COMPLETED|Extended Treatment (up to 42 Months)||0
6436300|NCT01074944|7350955|FG002|COMPLETED|Extended Treatment (up to 42 Months)||0
6436301|NCT01074944|7350956|FG003|COMPLETED|Extended Treatment (up to 42 Months)||0
6436302|NCT01074944|7350957|FG004|COMPLETED|Extended Treatment (up to 42 Months)||20
6436303|NCT01074944|7350953|FG000|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
6436304|NCT01074944|7350954|FG001|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
6436305|NCT01074944|7350955|FG002|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
6436306|NCT01074944|7350956|FG003|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
6436307|NCT01074944|7350957|FG004|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
6436308|NCT01075048|7350968|FG000|STARTED|Overall Study||9
6436309|NCT01075048|7350969|FG001|STARTED|Overall Study||60
6436310|NCT01075048|7350970|FG002|STARTED|Overall Study||62
6436311|NCT01075048|7350968|FG000|Did Not Receive Treatment|Overall Study||0
6436312|NCT01075048|7350969|FG001|Did Not Receive Treatment|Overall Study||1
6436313|NCT01075048|7350970|FG002|Did Not Receive Treatment|Overall Study||0
6436314|NCT01075048|7350968|FG000|COMPLETED|Overall Study||0
6436315|NCT01075048|7350969|FG001|COMPLETED|Overall Study||0
6436316|NCT01075048|7350970|FG002|COMPLETED|Overall Study||0
6436317|NCT01075048|7350968|FG000|NOT COMPLETED|Overall Study||9
6436318|NCT01075048|7350969|FG001|NOT COMPLETED|Overall Study||60
6436319|NCT01075048|7350970|FG002|NOT COMPLETED|Overall Study||62
6436320|NCT01075074|7350984|FG000|STARTED|Overall Study||25
6436321|NCT01075074|7350985|FG001|STARTED|Overall Study||25
6436322|NCT01075074|7350986|FG002|STARTED|Overall Study||25
6436323|NCT01075074|7350984|FG000|COMPLETED|Overall Study||24
6436324|NCT01075074|7350985|FG001|COMPLETED|Overall Study||23
6436325|NCT01075074|7350986|FG002|COMPLETED|Overall Study||23
6436326|NCT01075074|7350984|FG000|NOT COMPLETED|Overall Study||1
6436327|NCT01075074|7350985|FG001|NOT COMPLETED|Overall Study||2
6436328|NCT01075074|7350986|FG002|NOT COMPLETED|Overall Study||2
6436329|NCT01075087|7351000|FG000|STARTED|Overall Study||9
6436330|NCT01075087|7351001|FG001|STARTED|Overall Study||10
6436331|NCT01075087|7351000|FG000|COMPLETED|Overall Study||9
6436332|NCT01075087|7351001|FG001|COMPLETED|Overall Study||10
6436333|NCT01075087|7351000|FG000|NOT COMPLETED|Overall Study||0
6436334|NCT01075087|7351001|FG001|NOT COMPLETED|Overall Study||0
6436335|NCT01075100|7351009|FG000|STARTED|Overall Study||49
6436336|NCT01075100|7351010|FG001|STARTED|Overall Study||54
6436337|NCT01075100|7351009|FG000|COMPLETED|Overall Study||0
6436338|NCT01075100|7351010|FG001|COMPLETED|Overall Study||1
6436339|NCT01075100|7351009|FG000|NOT COMPLETED|Overall Study||49
6436340|NCT01075100|7351010|FG001|NOT COMPLETED|Overall Study||53
6436341|NCT01075152|7351020|FG000|STARTED|Overall Study|randomized|88
6436342|NCT01075152|7351021|FG001|STARTED|Overall Study|randomized|89
6436343|NCT01075152|7351020|FG000|COMPLETED|Overall Study||87
6436344|NCT01075152|7351021|FG001|COMPLETED|Overall Study||89
6436345|NCT01075152|7351020|FG000|NOT COMPLETED|Overall Study||1
6436346|NCT01075152|7351021|FG001|NOT COMPLETED|Overall Study||0
6436347|NCT01075178|7351031|FG000|STARTED|Subject Matching|eligible for matching|1148
6436348|NCT01075178|7351032|FG001|STARTED|Subject Matching|eligible for matching|1421
6436349|NCT01075178|7351031|FG000|COMPLETED|Subject Matching|subjects matched|1018
6436350|NCT01075178|7351032|FG001|COMPLETED|Subject Matching|subjects matched|1018
6436351|NCT01075178|7351031|FG000|NOT COMPLETED|Subject Matching||130
6436352|NCT01075178|7351032|FG001|NOT COMPLETED|Subject Matching||403
6436353|NCT01075178|7351031|FG000|STARTED|Subject Chart Review|subjects matched|1018
6436354|NCT01075178|7351032|FG001|STARTED|Subject Chart Review|subjects matched|1018
6436355|NCT01075178|7351031|FG000|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
6436356|NCT01075178|7351032|FG001|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
6436357|NCT01075178|7351031|FG000|NOT COMPLETED|Subject Chart Review||9
6436358|NCT01075178|7351032|FG001|NOT COMPLETED|Subject Chart Review||9
6436359|NCT01075191|7351038|FG000|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
6436360|NCT01075191|7351038|FG000|Discontinued Year 1|Overall Study||7
6436361|NCT01075191|7351038|FG000|Discontinued Year 2|Overall Study||6
6436362|NCT01075191|7351038|FG000|Discontinued Year 3|Overall Study||5
6436363|NCT01075191|7351038|FG000|COMPLETED|Overall Study||42
6436364|NCT01075191|7351038|FG000|NOT COMPLETED|Overall Study||18
6436365|NCT01075204|7351042|FG000|STARTED|Overall Study||335
6436366|NCT01075204|7351042|FG000|COMPLETED|Overall Study||335
6436367|NCT01075204|7351042|FG000|NOT COMPLETED|Overall Study||0
6499822|NCT01421342|7418576|FG000|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||149
6436368|NCT01075217|7351048|FG000|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
6436369|NCT01075217|7351049|FG001|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
6436370|NCT01075217|7351048|FG000|COMPLETED|Overall Study||82
6436371|NCT01075217|7351049|FG001|COMPLETED|Overall Study||84
6436372|NCT01075217|7351048|FG000|NOT COMPLETED|Overall Study||2
6436373|NCT01075217|7351049|FG001|NOT COMPLETED|Overall Study||1
6436374|NCT01075243|7351066|FG000|STARTED|Overall Study||163
6436375|NCT01075243|7351067|FG001|STARTED|Overall Study||158
6436376|NCT01075243|7351068|FG002|STARTED|Overall Study||80
6436377|NCT01075243|7351066|FG000|COMPLETED|Overall Study||157
6436378|NCT01075243|7351067|FG001|COMPLETED|Overall Study||155
6436379|NCT01075243|7351068|FG002|COMPLETED|Overall Study||80
6436380|NCT01075243|7351066|FG000|NOT COMPLETED|Overall Study||6
6436381|NCT01075243|7351067|FG001|NOT COMPLETED|Overall Study||3
6436382|NCT01075243|7351068|FG002|NOT COMPLETED|Overall Study||0
6436383|NCT01075256|7351081|FG000|STARTED|Overall Study||64
6436384|NCT01075256|7351082|FG001|STARTED|Overall Study||66
6436385|NCT01075256|7351083|FG002|STARTED|Overall Study||65
6436386|NCT01075256|7351081|FG000|COMPLETED|Overall Study||63
6436387|NCT01075256|7351082|FG001|COMPLETED|Overall Study||66
6436388|NCT01075256|7351083|FG002|COMPLETED|Overall Study||65
6436389|NCT01075256|7351081|FG000|NOT COMPLETED|Overall Study||1
6436390|NCT01075256|7351082|FG001|NOT COMPLETED|Overall Study||0
6436391|NCT01075256|7351083|FG002|NOT COMPLETED|Overall Study||0
6436392|NCT01075282|7351099|FG000|STARTED|Overall Study||273
6436393|NCT01075282|7351100|FG001|STARTED|Overall Study||272
6436394|NCT01075282|7351101|FG002|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
6436395|NCT01075282|7351099|FG000|Received at Least One Dose of Study Drug|Overall Study||273
6436396|NCT01075282|7351100|FG001|Received at Least One Dose of Study Drug|Overall Study||272
6436397|NCT01075282|7351101|FG002|Received at Least One Dose of Study Drug|Overall Study||262
6436398|NCT01075282|7351099|FG000|COMPLETED|Overall Study||242
6436399|NCT01075282|7351100|FG001|COMPLETED|Overall Study||243
6436400|NCT01075282|7351101|FG002|COMPLETED|Overall Study||238
6436401|NCT01075282|7351099|FG000|NOT COMPLETED|Overall Study||31
6436402|NCT01075282|7351100|FG001|NOT COMPLETED|Overall Study||29
6436403|NCT01075282|7351101|FG002|NOT COMPLETED|Overall Study||27
6436404|NCT01075321|7351110|FG000|STARTED|Overall Study||7
6436405|NCT01075321|7351111|FG001|STARTED|Overall Study||9
6436406|NCT01075321|7351112|FG002|STARTED|Overall Study||9
6436407|NCT01075321|7351113|FG003|STARTED|Overall Study||33
6436408|NCT01075321|7351110|FG000|COMPLETED|Overall Study||6
6436409|NCT01075321|7351111|FG001|COMPLETED|Overall Study||9
6436410|NCT01075321|7351112|FG002|COMPLETED|Overall Study||7
6436411|NCT01075321|7351113|FG003|COMPLETED|Overall Study||31
6436412|NCT01075321|7351110|FG000|NOT COMPLETED|Overall Study||1
6436413|NCT01075321|7351111|FG001|NOT COMPLETED|Overall Study||0
6436414|NCT01075321|7351112|FG002|NOT COMPLETED|Overall Study||2
6436415|NCT01075321|7351113|FG003|NOT COMPLETED|Overall Study||2
6436416|NCT01075347|7351127|FG000|STARTED|Overall Study||82
6436417|NCT01075347|7351128|FG001|STARTED|Overall Study||83
6652977|NCT02433340|7582713|FG002|COMPLETED|Overall Study||37
6652978|NCT02433340|7582714|FG003|COMPLETED|Overall Study||38
6552683|NCT01738594|7475103|FG004|STARTED|Went on to Continue Treatment Cycle 5||1
6552684|NCT01738594|7475104|FG005|STARTED|Went on to Continue Treatment Cycle 5||1
6552685|NCT01738594|7475105|FG006|STARTED|Went on to Continue Treatment Cycle 5||0
6436418|NCT01075347|7351127|FG000|COMPLETED|Overall Study||82
6436419|NCT01075347|7351128|FG001|COMPLETED|Overall Study||83
6436420|NCT01075347|7351127|FG000|NOT COMPLETED|Overall Study||0
6436421|NCT01075347|7351128|FG001|NOT COMPLETED|Overall Study||0
6436422|NCT01075399|7351134|FG000|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
6436423|NCT01075399|7351134|FG000|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
6436424|NCT01075399|7351134|FG000|NOT COMPLETED|Overall Study||8
6436425|NCT01075412|7351140|FG000|STARTED|Overall Study||4
6436426|NCT01075412|7351141|FG001|STARTED|Overall Study||2
6436427|NCT01075412|7351140|FG000|COMPLETED|Overall Study||4
6436428|NCT01075412|7351141|FG001|COMPLETED|Overall Study||1
6436429|NCT01075412|7351140|FG000|NOT COMPLETED|Overall Study||0
6436430|NCT01075412|7351141|FG001|NOT COMPLETED|Overall Study||1
6436431|NCT01075516|7351148|FG000|STARTED|Overall Study||107
6436432|NCT01075516|7351149|FG001|STARTED|Overall Study||102
6436433|NCT01075516|7351148|FG000|COMPLETED|Overall Study||89
6436434|NCT01075516|7351149|FG001|COMPLETED|Overall Study||86
6436435|NCT01075516|7351148|FG000|NOT COMPLETED|Overall Study||18
6436436|NCT01075516|7351149|FG001|NOT COMPLETED|Overall Study||16
6436437|NCT01075646|7351159|FG000|STARTED|Overall Study||33
6436438|NCT01075646|7351160|FG001|STARTED|Overall Study||34
6552686|NCT01738594|7475106|FG007|STARTED|Went on to Continue Treatment Cycle 5||0
6552687|NCT01738594|7475099|FG000|COMPLETED|Went on to Continue Treatment Cycle 5||0
6552688|NCT01738594|7475100|FG001|COMPLETED|Went on to Continue Treatment Cycle 5||0
6552689|NCT01738594|7475101|FG002|COMPLETED|Went on to Continue Treatment Cycle 5||0
6552690|NCT01738594|7475102|FG003|COMPLETED|Went on to Continue Treatment Cycle 5||0
6436439|NCT01075646|7351161|FG002|STARTED|Overall Study||53
6436440|NCT01075646|7351162|FG003|STARTED|Overall Study||46
6552691|NCT01738594|7475103|FG004|COMPLETED|Went on to Continue Treatment Cycle 5||0
6552692|NCT01738594|7475104|FG005|COMPLETED|Went on to Continue Treatment Cycle 5||0
6436441|NCT01075646|7351159|FG000|COMPLETED|Overall Study||29
6436442|NCT01075646|7351160|FG001|COMPLETED|Overall Study||31
6436443|NCT01075646|7351161|FG002|COMPLETED|Overall Study||52
6436444|NCT01075646|7351162|FG003|COMPLETED|Overall Study||44
6436445|NCT01075646|7351159|FG000|NOT COMPLETED|Overall Study||4
6436446|NCT01075646|7351160|FG001|NOT COMPLETED|Overall Study||3
6436447|NCT01075646|7351161|FG002|NOT COMPLETED|Overall Study||1
6436448|NCT01075646|7351162|FG003|NOT COMPLETED|Overall Study||2
6436449|NCT01075685|7351174|FG000|STARTED|Overall Study||743
6436450|NCT01075685|7351175|FG001|STARTED|Overall Study||414
6436451|NCT01075685|7351174|FG000|Met Inclusion Criteria|Overall Study||734
6436452|NCT01075685|7351175|FG001|Met Inclusion Criteria|Overall Study||413
6436453|NCT01075685|7351174|FG000|Completed Baseline Measures|Overall Study||225
6436454|NCT01075685|7351175|FG001|Completed Baseline Measures|Overall Study||263
6436455|NCT01075685|7351174|FG000|COMPLETED|Overall Study||151
6436456|NCT01075685|7351175|FG001|COMPLETED|Overall Study||188
6436457|NCT01075685|7351174|FG000|NOT COMPLETED|Overall Study||592
6436458|NCT01075685|7351175|FG001|NOT COMPLETED|Overall Study||226
6436459|NCT01075763|7351183|FG000|STARTED|Overall Study||23
6436460|NCT01075763|7351184|FG001|STARTED|Overall Study||19
6436461|NCT01075763|7351183|FG000|COMPLETED|Overall Study||19
6436462|NCT01075763|7351184|FG001|COMPLETED|Overall Study||15
6436463|NCT01075763|7351183|FG000|NOT COMPLETED|Overall Study||4
6436464|NCT01075763|7351184|FG001|NOT COMPLETED|Overall Study||4
6436465|NCT01075815|7351192|FG000|STARTED|Overall Study|Number of participants treated.|40
6436466|NCT01075815|7351193|FG001|STARTED|Overall Study|Number of participants treated.|35
6436467|NCT01075815|7351192|FG000|COMPLETED|Overall Study||30
6436468|NCT01075815|7351193|FG001|COMPLETED|Overall Study||31
6436469|NCT01075815|7351192|FG000|NOT COMPLETED|Overall Study||10
6436470|NCT01075815|7351193|FG001|NOT COMPLETED|Overall Study||4
6436471|NCT01075958|7351199|FG000|STARTED|Overall Study||283
6436472|NCT01075958|7351199|FG000|COMPLETED|Overall Study||239
6436473|NCT01075958|7351199|FG000|NOT COMPLETED|Overall Study||44
6436474|NCT01075971|7351203|FG000|STARTED|Overall Study||52
6436475|NCT01075971|7351203|FG000|COMPLETED|Overall Study||52
6436476|NCT01075971|7351203|FG000|NOT COMPLETED|Overall Study||0
6436477|NCT01075984|7351212|FG000|STARTED|Treatment Phase||10
6436478|NCT01075984|7351213|FG001|STARTED|Treatment Phase||11
6436479|NCT01075984|7351214|FG002|STARTED|Treatment Phase||21
6436480|NCT01075984|7351215|FG003|STARTED|Treatment Phase||24
6436481|NCT01075984|7351216|FG004|STARTED|Treatment Phase||213
6436482|NCT01075984|7351212|FG000|COMPLETED|Treatment Phase||10
6436483|NCT01075984|7351213|FG001|COMPLETED|Treatment Phase||10
6652979|NCT02433340|7582711|FG000|NOT COMPLETED|Overall Study||2
6652980|NCT02433340|7582712|FG001|NOT COMPLETED|Overall Study||2
6652981|NCT02433340|7582713|FG002|NOT COMPLETED|Overall Study||2
6652982|NCT02433340|7582714|FG003|NOT COMPLETED|Overall Study||2
6652983|NCT02433366|7582728|FG000|STARTED|Overall Study||411
6652984|NCT02433366|7582729|FG001|STARTED|Overall Study||802
6652985|NCT02433366|7582728|FG000|COMPLETED|Overall Study||411
6652986|NCT02433366|7582729|FG001|COMPLETED|Overall Study||802
6652987|NCT02433366|7582728|FG000|NOT COMPLETED|Overall Study||0
6652988|NCT02433366|7582729|FG001|NOT COMPLETED|Overall Study||0
6652989|NCT02433379|7582735|FG000|STARTED|Overall Study||1173
6652990|NCT02433379|7582735|FG000|COMPLETED|Overall Study||852
6652991|NCT02433379|7582735|FG000|NOT COMPLETED|Overall Study||321
6652992|NCT02433483|7582741|FG000|STARTED|Overall Study||2
6652993|NCT02433483|7582741|FG000|COMPLETED|Overall Study||0
6652994|NCT02433483|7582741|FG000|NOT COMPLETED|Overall Study||2
6652995|NCT02433496|7582748|FG000|STARTED|Overall Study|This includes patients (29956) and providers (34).|29990
6652996|NCT02433496|7582749|FG001|STARTED|Overall Study|This includes patients (13296) and providers (13).|13309
6652997|NCT02433496|7582750|FG002|STARTED|Overall Study|This includes patients (9813) and providers (20).|9833
6652998|NCT02433496|7582748|FG000|COMPLETED|Overall Study|This includes patients (29956) and providers (34).|29990
6652999|NCT02433496|7582749|FG001|COMPLETED|Overall Study|This includes patients (13296) and providers (13).|13309
6653000|NCT02433496|7582750|FG002|COMPLETED|Overall Study|This includes patients (9813) and providers (20).|9833
6653001|NCT02433496|7582748|FG000|NOT COMPLETED|Overall Study||0
6653002|NCT02433496|7582749|FG001|NOT COMPLETED|Overall Study||0
6653003|NCT02433496|7582750|FG002|NOT COMPLETED|Overall Study||0
6653004|NCT02433613|7582757|FG000|STARTED|Overall Study||1071
6653005|NCT02433613|7582757|FG000|COMPLETED|Overall Study||1054
6653006|NCT02433613|7582757|FG000|NOT COMPLETED|Overall Study||17
6653007|NCT02433665|7582763|FG000|STARTED|Overall Study||77
6653008|NCT02433665|7582764|FG001|STARTED|Overall Study||79
6653009|NCT02433665|7582763|FG000|COMPLETED|Overall Study||77
6653010|NCT02433665|7582764|FG001|COMPLETED|Overall Study||79
6436484|NCT01075984|7351214|FG002|COMPLETED|Treatment Phase||14
6436485|NCT01075984|7351215|FG003|COMPLETED|Treatment Phase||17
6436486|NCT01075984|7351216|FG004|COMPLETED|Treatment Phase||153
6653011|NCT02433665|7582763|FG000|NOT COMPLETED|Overall Study||0
6653012|NCT02433665|7582764|FG001|NOT COMPLETED|Overall Study||0
6436487|NCT01075984|7351212|FG000|NOT COMPLETED|Treatment Phase||0
6436488|NCT01075984|7351213|FG001|NOT COMPLETED|Treatment Phase||1
6436489|NCT01075984|7351214|FG002|NOT COMPLETED|Treatment Phase||7
6436490|NCT01075984|7351215|FG003|NOT COMPLETED|Treatment Phase||7
6436491|NCT01075984|7351216|FG004|NOT COMPLETED|Treatment Phase||60
6436492|NCT01075984|7351212|FG000|STARTED|Follow-up Phase||10
6436493|NCT01075984|7351213|FG001|STARTED|Follow-up Phase||10
6502073|NCT01432405|7420712|FG000|COMPLETED|Overall Study||11
6436494|NCT01075984|7351214|FG002|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
6436495|NCT01075984|7351215|FG003|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
6436496|NCT01075984|7351216|FG004|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
6436497|NCT01075984|7351212|FG000|COMPLETED|Follow-up Phase||10
6436498|NCT01075984|7351213|FG001|COMPLETED|Follow-up Phase||10
6436499|NCT01075984|7351214|FG002|COMPLETED|Follow-up Phase||19
6436500|NCT01075984|7351215|FG003|COMPLETED|Follow-up Phase||19
6552693|NCT01738594|7475105|FG006|COMPLETED|Went on to Continue Treatment Cycle 5||0
6552694|NCT01738594|7475106|FG007|COMPLETED|Went on to Continue Treatment Cycle 5||0
6552695|NCT01738594|7475099|FG000|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6653013|NCT02433678|7582772|FG000|STARTED|Overall Study||26
6653014|NCT02433678|7582773|FG001|STARTED|Overall Study||26
6653015|NCT02433678|7582772|FG000|COMPLETED|Overall Study||25
6436501|NCT01075984|7351216|FG004|COMPLETED|Follow-up Phase||165
6436502|NCT01075984|7351212|FG000|NOT COMPLETED|Follow-up Phase||0
6436503|NCT01075984|7351213|FG001|NOT COMPLETED|Follow-up Phase||0
6436504|NCT01075984|7351214|FG002|NOT COMPLETED|Follow-up Phase||1
6436505|NCT01075984|7351215|FG003|NOT COMPLETED|Follow-up Phase||2
6436506|NCT01075984|7351216|FG004|NOT COMPLETED|Follow-up Phase||47
6436507|NCT01076010|7351231|FG000|STARTED|Overall Study||161
6436508|NCT01076010|7351232|FG001|STARTED|Overall Study||88
6436509|NCT01076010|7351233|FG002|STARTED|Overall Study||28
6653016|NCT02433678|7582773|FG001|COMPLETED|Overall Study||24
6653017|NCT02433678|7582772|FG000|NOT COMPLETED|Overall Study||1
6653018|NCT02433678|7582773|FG001|NOT COMPLETED|Overall Study||2
6653019|NCT02433834|7582779|FG000|STARTED|Overall Study||248
6653020|NCT02433834|7582779|FG000|GP MDI 28.8 µg|Overall Study||112
6653021|NCT02433834|7582779|FG000|GP MDI 14.4 µg|Overall Study||230
6653022|NCT02433834|7582779|FG000|GP MDI 7.2 µg|Overall Study||228
6653023|NCT02433834|7582779|FG000|GP MDI 3.6 µg|Overall Study||118
6653024|NCT02433834|7582779|FG000|GP MDI 1.9 µg|Overall Study||107
6653025|NCT02433834|7582779|FG000|Placebo MDI|Overall Study||174
6653026|NCT02433834|7582779|FG000|SAL 50 µg|Overall Study||167
6653027|NCT02433834|7582779|FG000|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
6653028|NCT02433834|7582779|FG000|NOT COMPLETED|Overall Study||37
6653029|NCT02433977|7582795|FG000|STARTED|Overall Study||6
6653030|NCT02433977|7582795|FG000|COMPLETED|Overall Study||6
6653031|NCT02433977|7582795|FG000|NOT COMPLETED|Overall Study||0
6653032|NCT02434081|7582799|FG000|STARTED|Overall Study|Only patients enrolled after protocol amendments 1 (n=43) and 2 (n=36) were analysed (concurrent CRT+Nivo). Patients who received CRT and sequentially Nivo (enrolled under original protocol (n=12) or protocol amendment 1 (n=3)) were not included in the analysis population.|79
6653033|NCT02434081|7582799|FG000|COMPLETED|Overall Study||31
6653034|NCT02434081|7582799|FG000|NOT COMPLETED|Overall Study||48
6653035|NCT02434328|7582805|FG000|STARTED|Overall Study||372
6653036|NCT02434328|7582806|FG001|STARTED|Overall Study||371
6653037|NCT02434328|7582805|FG000|Randomized and Treated|Overall Study||370
6653038|NCT02434328|7582806|FG001|Randomized and Treated|Overall Study||369
6653039|NCT02434328|7582805|FG000|COMPLETED|Overall Study||342
6653040|NCT02434328|7582806|FG001|COMPLETED|Overall Study||329
6653041|NCT02434328|7582805|FG000|NOT COMPLETED|Overall Study||30
6653042|NCT02434328|7582806|FG001|NOT COMPLETED|Overall Study||42
6653043|NCT02434471|7582813|FG000|STARTED|Overall Study||34
6653044|NCT02434471|7582813|FG000|COMPLETED|Overall Study||25
6653045|NCT02434471|7582813|FG000|NOT COMPLETED|Overall Study||9
6653046|NCT02434497|7582818|FG000|STARTED|Overall Study||9
6653047|NCT02434497|7582818|FG000|COMPLETED|Overall Study||4
6653048|NCT02434497|7582818|FG000|NOT COMPLETED|Overall Study||5
6653049|NCT02434523|7582826|FG000|STARTED|Overall Study||15
6653050|NCT02434523|7582827|FG001|STARTED|Overall Study||15
6653051|NCT02434523|7582826|FG000|COMPLETED|Overall Study||10
6653052|NCT02434523|7582827|FG001|COMPLETED|Overall Study||9
6653053|NCT02434523|7582826|FG000|NOT COMPLETED|Overall Study||5
6653054|NCT02434523|7582827|FG001|NOT COMPLETED|Overall Study||6
6653055|NCT02434770|7582838|FG000|STARTED|Week 1 to Week 18||250
6653056|NCT02434770|7582839|FG001|STARTED|Week 1 to Week 18||250
6653057|NCT02434770|7582840|FG002|STARTED|Week 1 to Week 18||250
6436510|NCT01076010|7351231|FG000|COMPLETED|Overall Study||36
6552696|NCT01738594|7475100|FG001|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6552697|NCT01738594|7475101|FG002|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6552698|NCT01738594|7475102|FG003|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6552699|NCT01738594|7475103|FG004|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
6552700|NCT01738594|7475104|FG005|NOT COMPLETED|Went on to Continue Treatment Cycle 5||1
6552701|NCT01738594|7475105|FG006|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6552702|NCT01738594|7475106|FG007|NOT COMPLETED|Went on to Continue Treatment Cycle 5||0
6552703|NCT01738594|7475099|FG000|STARTED|Follow up for 1 Year||0
6552704|NCT01738594|7475100|FG001|STARTED|Follow up for 1 Year||2
6552705|NCT01738594|7475101|FG002|STARTED|Follow up for 1 Year||0
6552706|NCT01738594|7475102|FG003|STARTED|Follow up for 1 Year||0
6552707|NCT01738594|7475103|FG004|STARTED|Follow up for 1 Year||1
6552708|NCT01738594|7475104|FG005|STARTED|Follow up for 1 Year||3
6552709|NCT01738594|7475105|FG006|STARTED|Follow up for 1 Year||0
6552710|NCT01738594|7475106|FG007|STARTED|Follow up for 1 Year||0
6552711|NCT01738594|7475099|FG000|COMPLETED|Follow up for 1 Year||0
6552712|NCT01738594|7475100|FG001|COMPLETED|Follow up for 1 Year||2
6552713|NCT01738594|7475101|FG002|COMPLETED|Follow up for 1 Year||0
6653058|NCT02434770|7582838|FG000|Received at Least One Vaccination|Week 1 to Week 18||249
6653059|NCT02434770|7582839|FG001|Received at Least One Vaccination|Week 1 to Week 18||250
6436511|NCT01076010|7351232|FG001|COMPLETED|Overall Study||49
6436512|NCT01076010|7351233|FG002|COMPLETED|Overall Study||26
6436513|NCT01076010|7351231|FG000|NOT COMPLETED|Overall Study||125
6436514|NCT01076010|7351232|FG001|NOT COMPLETED|Overall Study||39
6436515|NCT01076010|7351233|FG002|NOT COMPLETED|Overall Study||2
6436516|NCT01076036|7351241|FG000|STARTED|Overall Study||10
6436517|NCT01076036|7351241|FG000|# of Procedures|Overall Study||8
6436518|NCT01076036|7351241|FG000|Complete CorPath Procedures|Overall Study||8
6436519|NCT01076036|7351241|FG000|COMPLETED|Overall Study||8
6436520|NCT01076036|7351241|FG000|NOT COMPLETED|Overall Study||2
6436521|NCT01076049|7351248|FG000|STARTED|Overall Study||52
6436522|NCT01076049|7351249|FG001|STARTED|Overall Study||55
6436523|NCT01076049|7351250|FG002|STARTED|Overall Study||1
6552714|NCT01738594|7475102|FG003|COMPLETED|Follow up for 1 Year||0
6653060|NCT02434770|7582840|FG002|Received at Least One Vaccination|Week 1 to Week 18||250
6653061|NCT02434770|7582838|FG000|COMPLETED|Week 1 to Week 18||235
6653062|NCT02434770|7582839|FG001|COMPLETED|Week 1 to Week 18||228
6653063|NCT02434770|7582840|FG002|COMPLETED|Week 1 to Week 18||233
6653064|NCT02434770|7582838|FG000|NOT COMPLETED|Week 1 to Week 18||15
6653065|NCT02434770|7582839|FG001|NOT COMPLETED|Week 1 to Week 18||22
6653066|NCT02434770|7582840|FG002|NOT COMPLETED|Week 1 to Week 18||17
6653067|NCT02434770|7582838|FG000|STARTED|Week 18 to Week||235
6653068|NCT02434770|7582839|FG001|STARTED|Week 18 to Week||228
6653069|NCT02434770|7582840|FG002|STARTED|Week 18 to Week||233
6653070|NCT02434770|7582838|FG000|COMPLETED|Week 18 to Week||227
6653071|NCT02434770|7582839|FG001|COMPLETED|Week 18 to Week||220
6653072|NCT02434770|7582840|FG002|COMPLETED|Week 18 to Week||227
6653073|NCT02434770|7582838|FG000|NOT COMPLETED|Week 18 to Week||8
6653074|NCT02434770|7582839|FG001|NOT COMPLETED|Week 18 to Week||8
6653075|NCT02434770|7582840|FG002|NOT COMPLETED|Week 18 to Week||6
6653076|NCT02434939|7582852|FG000|STARTED|Overall Study||120
6653077|NCT02434939|7582853|FG001|STARTED|Overall Study||120
6653078|NCT02434939|7582852|FG000|COMPLETED|Overall Study||83
6653079|NCT02434939|7582853|FG001|COMPLETED|Overall Study||71
6552715|NCT01738594|7475103|FG004|COMPLETED|Follow up for 1 Year||1
6552716|NCT01738594|7475104|FG005|COMPLETED|Follow up for 1 Year||0
6552717|NCT01738594|7475105|FG006|COMPLETED|Follow up for 1 Year||0
6552718|NCT01738594|7475106|FG007|COMPLETED|Follow up for 1 Year||0
6552719|NCT01738594|7475099|FG000|NOT COMPLETED|Follow up for 1 Year||0
6552720|NCT01738594|7475100|FG001|NOT COMPLETED|Follow up for 1 Year||0
6552721|NCT01738594|7475101|FG002|NOT COMPLETED|Follow up for 1 Year||0
6552722|NCT01738594|7475102|FG003|NOT COMPLETED|Follow up for 1 Year||0
6552723|NCT01738594|7475103|FG004|NOT COMPLETED|Follow up for 1 Year||0
6552724|NCT01738594|7475104|FG005|NOT COMPLETED|Follow up for 1 Year||3
6552725|NCT01738594|7475105|FG006|NOT COMPLETED|Follow up for 1 Year||0
6552726|NCT01738594|7475106|FG007|NOT COMPLETED|Follow up for 1 Year||0
6552727|NCT01738646|7475116|FG000|STARTED|Overall Study||40
6552728|NCT01738646|7475116|FG000|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
6552729|NCT01738646|7475116|FG000|NOT COMPLETED|Overall Study||2
6552730|NCT01738672|7475121|FG000|STARTED|Overall Study||16
6552731|NCT01738672|7475121|FG000|COMPLETED|Overall Study||11
6552732|NCT01738672|7475121|FG000|NOT COMPLETED|Overall Study||5
6552733|NCT01738737|7475130|FG000|STARTED|Overall Study||29
6552734|NCT01738737|7475131|FG001|STARTED|Overall Study||29
6552735|NCT01738737|7475132|FG002|STARTED|Overall Study||29
6552736|NCT01738737|7475133|FG003|STARTED|Overall Study||29
6552737|NCT01738737|7475134|FG004|STARTED|Overall Study||29
6552738|NCT01738737|7475130|FG000|COMPLETED|Overall Study||25
6552739|NCT01738737|7475131|FG001|COMPLETED|Overall Study||25
6552740|NCT01738737|7475132|FG002|COMPLETED|Overall Study||25
6552741|NCT01738737|7475133|FG003|COMPLETED|Overall Study||25
6552742|NCT01738737|7475134|FG004|COMPLETED|Overall Study||25
6552743|NCT01738737|7475130|FG000|NOT COMPLETED|Overall Study||4
6552744|NCT01738737|7475131|FG001|NOT COMPLETED|Overall Study||4
6552745|NCT01738737|7475132|FG002|NOT COMPLETED|Overall Study||4
6552746|NCT01738737|7475133|FG003|NOT COMPLETED|Overall Study||4
6552747|NCT01738737|7475134|FG004|NOT COMPLETED|Overall Study||4
6552748|NCT01738750|7475148|FG000|STARTED|Overall Study||49
6552749|NCT01738750|7475149|FG001|STARTED|Overall Study||51
6552750|NCT01738750|7475148|FG000|COMPLETED|Overall Study||49
6552751|NCT01738750|7475149|FG001|COMPLETED|Overall Study||51
6552752|NCT01738750|7475148|FG000|NOT COMPLETED|Overall Study||0
6552753|NCT01738750|7475149|FG001|NOT COMPLETED|Overall Study||0
6552754|NCT01738919|7475159|FG000|STARTED|Overall Study||15
6552755|NCT01738919|7475160|FG001|STARTED|Overall Study||17
6552756|NCT01738919|7475159|FG000|COMPLETED|Overall Study||14
6552757|NCT01738919|7475160|FG001|COMPLETED|Overall Study||14
6552758|NCT01738919|7475159|FG000|NOT COMPLETED|Overall Study||1
6552759|NCT01738919|7475160|FG001|NOT COMPLETED|Overall Study||3
6552760|NCT01738971|7475171|FG000|STARTED|Overall Study|54 participants recruited to this arm|54
6562908|NCT01803464|7485827|FG001|STARTED|Overall Study||4
6436524|NCT01076049|7351248|FG000|COMPLETED|Overall Study||45
6436525|NCT01076049|7351249|FG001|COMPLETED|Overall Study||52
6436526|NCT01076049|7351250|FG002|COMPLETED|Overall Study||1
6436527|NCT01076049|7351248|FG000|NOT COMPLETED|Overall Study||7
6436528|NCT01076049|7351249|FG001|NOT COMPLETED|Overall Study||3
6436529|NCT01076049|7351250|FG002|NOT COMPLETED|Overall Study||0
6436530|NCT01076075|7351262|FG000|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
6436531|NCT01076075|7351263|FG001|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
6436532|NCT01076075|7351262|FG000|Completed Phase A|Overall Study||199
6436533|NCT01076075|7351263|FG001|Completed Phase A|Overall Study||189
6653080|NCT02434939|7582852|FG000|NOT COMPLETED|Overall Study||37
6653081|NCT02434939|7582853|FG001|NOT COMPLETED|Overall Study||49
6653082|NCT02435069|7582860|FG000|STARTED|Preoperative Baseline Phase||5
6653083|NCT02435069|7582861|FG001|STARTED|Preoperative Baseline Phase||0
6653084|NCT02435069|7582862|FG002|STARTED|Preoperative Baseline Phase||0
6653085|NCT02435069|7582863|FG003|STARTED|Preoperative Baseline Phase||0
6653086|NCT02435069|7582864|FG004|STARTED|Preoperative Baseline Phase||0
6653087|NCT02435069|7582860|FG000|COMPLETED|Preoperative Baseline Phase||5
6653088|NCT02435069|7582861|FG001|COMPLETED|Preoperative Baseline Phase||0
6653089|NCT02435069|7582862|FG002|COMPLETED|Preoperative Baseline Phase||0
6653090|NCT02435069|7582863|FG003|COMPLETED|Preoperative Baseline Phase||0
6653091|NCT02435069|7582864|FG004|COMPLETED|Preoperative Baseline Phase||0
6653092|NCT02435069|7582860|FG000|NOT COMPLETED|Preoperative Baseline Phase||0
6653093|NCT02435069|7582861|FG001|NOT COMPLETED|Preoperative Baseline Phase||0
6653094|NCT02435069|7582862|FG002|NOT COMPLETED|Preoperative Baseline Phase||0
6653095|NCT02435069|7582863|FG003|NOT COMPLETED|Preoperative Baseline Phase||0
6653096|NCT02435069|7582864|FG004|NOT COMPLETED|Preoperative Baseline Phase||0
6653097|NCT02435069|7582860|FG000|STARTED|Dose Response - First Intervention||0
6653098|NCT02435069|7582861|FG001|STARTED|Dose Response - First Intervention||3
6653099|NCT02435069|7582862|FG002|STARTED|Dose Response - First Intervention||2
6653100|NCT02435069|7582863|FG003|STARTED|Dose Response - First Intervention||0
6653101|NCT02435069|7582864|FG004|STARTED|Dose Response - First Intervention||0
6653102|NCT02435069|7582860|FG000|COMPLETED|Dose Response - First Intervention||0
6653103|NCT02435069|7582861|FG001|COMPLETED|Dose Response - First Intervention||2
6653104|NCT02435069|7582862|FG002|COMPLETED|Dose Response - First Intervention||1
6653105|NCT02435069|7582863|FG003|COMPLETED|Dose Response - First Intervention||0
6653106|NCT02435069|7582864|FG004|COMPLETED|Dose Response - First Intervention||0
6653107|NCT02435069|7582860|FG000|NOT COMPLETED|Dose Response - First Intervention||0
6653108|NCT02435069|7582861|FG001|NOT COMPLETED|Dose Response - First Intervention||1
6653109|NCT02435069|7582862|FG002|NOT COMPLETED|Dose Response - First Intervention||1
6653110|NCT02435069|7582863|FG003|NOT COMPLETED|Dose Response - First Intervention||0
6653111|NCT02435069|7582864|FG004|NOT COMPLETED|Dose Response - First Intervention||0
6653112|NCT02435069|7582860|FG000|STARTED|Effectiveness - Second Intervention||0
6653113|NCT02435069|7582861|FG001|STARTED|Effectiveness - Second Intervention||0
6653114|NCT02435069|7582862|FG002|STARTED|Effectiveness - Second Intervention||0
6653115|NCT02435069|7582863|FG003|STARTED|Effectiveness - Second Intervention||1
6653116|NCT02435069|7582864|FG004|STARTED|Effectiveness - Second Intervention||1
6653117|NCT02435069|7582860|FG000|COMPLETED|Effectiveness - Second Intervention||0
6653118|NCT02435069|7582861|FG001|COMPLETED|Effectiveness - Second Intervention||0
6653119|NCT02435069|7582862|FG002|COMPLETED|Effectiveness - Second Intervention||0
6653120|NCT02435069|7582863|FG003|COMPLETED|Effectiveness - Second Intervention||1
6653121|NCT02435069|7582864|FG004|COMPLETED|Effectiveness - Second Intervention||0
6653122|NCT02435069|7582860|FG000|NOT COMPLETED|Effectiveness - Second Intervention||0
6653123|NCT02435069|7582861|FG001|NOT COMPLETED|Effectiveness - Second Intervention||0
6653124|NCT02435069|7582862|FG002|NOT COMPLETED|Effectiveness - Second Intervention||0
6653125|NCT02435069|7582863|FG003|NOT COMPLETED|Effectiveness - Second Intervention||0
6653126|NCT02435069|7582864|FG004|NOT COMPLETED|Effectiveness - Second Intervention||1
6653127|NCT02435147|7582884|FG000|STARTED|Overall Study||86
6653128|NCT02435147|7582884|FG000|COMPLETED|Overall Study||75
6653129|NCT02435147|7582884|FG000|NOT COMPLETED|Overall Study||11
6653130|NCT02435277|7582892|FG000|STARTED|Overall Study||12
6653131|NCT02435277|7582893|FG001|STARTED|Overall Study||16
6653132|NCT02435277|7582894|FG002|STARTED|Overall Study||11
6653133|NCT02435277|7582895|FG003|STARTED|Overall Study||11
6653134|NCT02435277|7582892|FG000|COMPLETED|Overall Study||10
6653135|NCT02435277|7582893|FG001|COMPLETED|Overall Study||15
6653136|NCT02435277|7582894|FG002|COMPLETED|Overall Study||11
6653137|NCT02435277|7582895|FG003|COMPLETED|Overall Study||11
6653138|NCT02435277|7582892|FG000|NOT COMPLETED|Overall Study||2
6653139|NCT02435277|7582893|FG001|NOT COMPLETED|Overall Study||1
6653140|NCT02435277|7582894|FG002|NOT COMPLETED|Overall Study||0
6653141|NCT02435277|7582895|FG003|NOT COMPLETED|Overall Study||0
6653142|NCT02435381|7582905|FG000|STARTED|Overall Study||5
6653143|NCT02435381|7582906|FG001|STARTED|Overall Study||6
6653144|NCT02435381|7582905|FG000|COMPLETED|Overall Study||3
6653145|NCT02435381|7582906|FG001|COMPLETED|Overall Study||5
6653146|NCT02435381|7582905|FG000|NOT COMPLETED|Overall Study||2
6653147|NCT02435381|7582906|FG001|NOT COMPLETED|Overall Study||1
6436534|NCT01076075|7351262|FG000|COMPLETED|Overall Study||172
6653148|NCT02435511|7582922|FG000|STARTED|Overall Study|Defined as enrolled and completed baseline|202
6653149|NCT02435511|7582923|FG001|STARTED|Overall Study|Defined as enrolled and completed baseline|209
6656178|NCT02458469|7586295|FG005|COMPLETED|Third Intervention (2 Weeks)||1
6436535|NCT01076075|7351263|FG001|COMPLETED|Overall Study||167
6436536|NCT01076075|7351262|FG000|NOT COMPLETED|Overall Study||41
6436537|NCT01076075|7351263|FG001|NOT COMPLETED|Overall Study||47
6436538|NCT01076088|7351278|FG000|STARTED|Overall Study||122
6552761|NCT01738971|7475172|FG001|STARTED|Overall Study|58 participants recruited to this arm|58
6552762|NCT01738971|7475173|FG002|STARTED|Overall Study|56 participants recruited to this arm|56
6552763|NCT01738971|7475171|FG000|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
6552764|NCT01738971|7475172|FG001|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
6552765|NCT01738971|7475173|FG002|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
6653150|NCT02435511|7582922|FG000|COMPLETED|Overall Study|Defined as completing the 3 month follow-up, not necessarily all time points|158
6653151|NCT02435511|7582923|FG001|COMPLETED|Overall Study|Defined as completing the 3 month follow-up; not necessarily all time points|174
6653152|NCT02435511|7582922|FG000|NOT COMPLETED|Overall Study||44
6653153|NCT02435511|7582923|FG001|NOT COMPLETED|Overall Study||35
6653154|NCT02435524|7582933|FG000|STARTED|Baseline Survey||1111
6653155|NCT02435524|7582934|FG001|STARTED|Baseline Survey||1177
6653156|NCT02435524|7582933|FG000|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1111
6653157|NCT02435524|7582934|FG001|COMPLETED|Baseline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1177
6653158|NCT02435524|7582933|FG000|NOT COMPLETED|Baseline Survey||0
6653159|NCT02435524|7582934|FG001|NOT COMPLETED|Baseline Survey||0
6653160|NCT02435524|7582933|FG000|STARTED|Endline Survey||1092
6653161|NCT02435524|7582934|FG001|STARTED|Endline Survey||1161
6653162|NCT02435524|7582933|FG000|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1092
6653163|NCT02435524|7582934|FG001|COMPLETED|Endline Survey|Design: 2 independent cross-sectional surveys; baseline & endline participants not same individuals|1161
6653164|NCT02435524|7582933|FG000|NOT COMPLETED|Endline Survey||0
6653165|NCT02435524|7582934|FG001|NOT COMPLETED|Endline Survey||0
6653166|NCT02435680|7582943|FG000|STARTED|Overall Study||21
6653167|NCT02435680|7582944|FG001|STARTED|Overall Study||13
6653168|NCT02435680|7582945|FG002|STARTED|Overall Study||16
6653169|NCT02435680|7582943|FG000|COMPLETED|Overall Study||0
6653170|NCT02435680|7582944|FG001|COMPLETED|Overall Study||0
6653171|NCT02435680|7582945|FG002|COMPLETED|Overall Study||0
6653172|NCT02435680|7582943|FG000|NOT COMPLETED|Overall Study||21
6653173|NCT02435680|7582944|FG001|NOT COMPLETED|Overall Study||13
6653174|NCT02435680|7582945|FG002|NOT COMPLETED|Overall Study||16
6653175|NCT02435706|7582959|FG000|STARTED|Overall Study||18
6653176|NCT02435706|7582960|FG001|STARTED|Overall Study||21
6653177|NCT02435706|7582959|FG000|COMPLETED|Overall Study||16
6653178|NCT02435706|7582960|FG001|COMPLETED|Overall Study||20
6653179|NCT02435706|7582959|FG000|NOT COMPLETED|Overall Study||2
6653180|NCT02435706|7582960|FG001|NOT COMPLETED|Overall Study||1
6653181|NCT02435836|7582966|FG000|STARTED|Overall Study||631
6653182|NCT02435836|7582966|FG000|COMPLETED|Overall Study||0
6653183|NCT02435836|7582966|FG000|NOT COMPLETED|Overall Study||631
6653184|NCT02435901|7582970|FG000|STARTED|Overall Study||29
6653185|NCT02435901|7582970|FG000|COMPLETED|Overall Study||29
6653186|NCT02435901|7582970|FG000|NOT COMPLETED|Overall Study||0
6653187|NCT02435914|7582979|FG000|STARTED|Overall Study||58
6653188|NCT02435914|7582980|FG001|STARTED|Overall Study||59
6653189|NCT02435914|7582981|FG002|STARTED|Overall Study||60
6653190|NCT02435914|7582982|FG003|STARTED|Overall Study||59
6653191|NCT02435914|7582979|FG000|COMPLETED|Overall Study||57
6653192|NCT02435914|7582980|FG001|COMPLETED|Overall Study||58
6653193|NCT02435914|7582981|FG002|COMPLETED|Overall Study||59
6653194|NCT02435914|7582982|FG003|COMPLETED|Overall Study||59
6653195|NCT02435914|7582979|FG000|NOT COMPLETED|Overall Study||1
6653196|NCT02435914|7582980|FG001|NOT COMPLETED|Overall Study||1
6653197|NCT02435914|7582981|FG002|NOT COMPLETED|Overall Study||1
6653198|NCT02435914|7582982|FG003|NOT COMPLETED|Overall Study||0
6653199|NCT02435966|7582995|FG000|STARTED|Overall Study||47
6653200|NCT02435966|7582996|FG001|STARTED|Overall Study||54
6653201|NCT02435966|7582997|FG002|STARTED|Overall Study||30
6653202|NCT02435966|7582995|FG000|First Intervention|Overall Study||47
6653203|NCT02435966|7582996|FG001|First Intervention|Overall Study||54
6653204|NCT02435966|7582997|FG002|First Intervention|Overall Study||30
6653205|NCT02435966|7582995|FG000|Second Intervention|Overall Study||47
6653206|NCT02435966|7582996|FG001|Second Intervention|Overall Study||53
6653207|NCT02435966|7582997|FG002|Second Intervention|Overall Study||30
6653208|NCT02435966|7582995|FG000|Follow-up|Overall Study||47
6653209|NCT02435966|7582996|FG001|Follow-up|Overall Study||53
6436539|NCT01076088|7351279|FG001|STARTED|Overall Study||125
6436540|NCT01076088|7351280|FG002|STARTED|Overall Study||126
6552766|NCT01738971|7475171|FG000|NOT COMPLETED|Overall Study||19
6436541|NCT01076088|7351281|FG003|STARTED|Overall Study||124
6552767|NCT01738971|7475172|FG001|NOT COMPLETED|Overall Study||30
6552768|NCT01738971|7475173|FG002|NOT COMPLETED|Overall Study||17
6552769|NCT01738984|7475183|FG000|STARTED|Overall Study||250
6653210|NCT02435966|7582997|FG002|Follow-up|Overall Study||30
6653211|NCT02435966|7582995|FG000|COMPLETED|Overall Study||47
6653212|NCT02435966|7582996|FG001|COMPLETED|Overall Study||53
6653213|NCT02435966|7582997|FG002|COMPLETED|Overall Study||30
6653214|NCT02435966|7582995|FG000|NOT COMPLETED|Overall Study||0
6653215|NCT02435966|7582996|FG001|NOT COMPLETED|Overall Study||1
6436542|NCT01076088|7351282|FG004|STARTED|Overall Study||120
6436543|NCT01076088|7351283|FG005|STARTED|Overall Study||127
6436544|NCT01076088|7351278|FG000|COMPLETED|Overall Study||111
6436545|NCT01076088|7351279|FG001|COMPLETED|Overall Study||107
6436546|NCT01076088|7351280|FG002|COMPLETED|Overall Study||109
6436547|NCT01076088|7351281|FG003|COMPLETED|Overall Study||109
6436548|NCT01076088|7351282|FG004|COMPLETED|Overall Study||104
6436549|NCT01076088|7351283|FG005|COMPLETED|Overall Study||104
6436550|NCT01076088|7351278|FG000|NOT COMPLETED|Overall Study||11
6653216|NCT02435966|7582997|FG002|NOT COMPLETED|Overall Study||0
6653217|NCT02435992|7583010|FG000|STARTED|Overall Study||429
6653218|NCT02435992|7583011|FG001|STARTED|Overall Study||216
6653219|NCT02435992|7583012|FG002|STARTED|Overall Study||367
6653220|NCT02435992|7583013|FG003|STARTED|Overall Study||0
6653221|NCT02435992|7583014|FG004|STARTED|Overall Study||0
6653222|NCT02435992|7583010|FG000|Transition to Maintenance Period|Overall Study||233
6653223|NCT02435992|7583011|FG001|Transition to Maintenance Period|Overall Study||69
6653224|NCT02435992|7583012|FG002|Transition to Maintenance Period|Overall Study||224
6653225|NCT02435992|7583013|FG003|Transition to Maintenance Period|Overall Study||0
6653226|NCT02435992|7583014|FG004|Transition to Maintenance Period|Overall Study||0
6653227|NCT02435992|7583010|FG000|Treated in Maintenance Period|Overall Study||0
6653228|NCT02435992|7583011|FG001|Treated in Maintenance Period|Overall Study||69
6653229|NCT02435992|7583012|FG002|Treated in Maintenance Period|Overall Study||0
6653230|NCT02435992|7583013|FG003|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|230
6653231|NCT02435992|7583014|FG004|Treated in Maintenance Period|Overall Study|Randomized from cohort 1 and 2 RCP1063 treatment|227
6653232|NCT02435992|7583010|FG000|COMPLETED|Overall Study||401
6653233|NCT02435992|7583011|FG001|COMPLETED|Overall Study||192
6653234|NCT02435992|7583012|FG002|COMPLETED|Overall Study||324
6653235|NCT02435992|7583013|FG003|COMPLETED|Overall Study||0
6653236|NCT02435992|7583014|FG004|COMPLETED|Overall Study||0
6653237|NCT02435992|7583010|FG000|NOT COMPLETED|Overall Study||28
6653238|NCT02435992|7583011|FG001|NOT COMPLETED|Overall Study||24
6653239|NCT02435992|7583012|FG002|NOT COMPLETED|Overall Study||43
6653240|NCT02435992|7583013|FG003|NOT COMPLETED|Overall Study||0
6653241|NCT02435992|7583014|FG004|NOT COMPLETED|Overall Study||0
6653242|NCT02436005|7583026|FG000|STARTED|First Intervention||12
6653243|NCT02436005|7583027|FG001|STARTED|First Intervention||13
6653244|NCT02436005|7583026|FG000|COMPLETED|First Intervention||12
6653245|NCT02436005|7583027|FG001|COMPLETED|First Intervention||13
6653246|NCT02436005|7583026|FG000|NOT COMPLETED|First Intervention||0
6653247|NCT02436005|7583027|FG001|NOT COMPLETED|First Intervention||0
6653248|NCT02436005|7583026|FG000|STARTED|Second Intervention||12
6653249|NCT02436005|7583027|FG001|STARTED|Second Intervention||13
6653250|NCT02436005|7583026|FG000|COMPLETED|Second Intervention||12
6653251|NCT02436005|7583027|FG001|COMPLETED|Second Intervention||12
6653252|NCT02436005|7583026|FG000|NOT COMPLETED|Second Intervention||0
6653253|NCT02436005|7583027|FG001|NOT COMPLETED|Second Intervention||1
6653254|NCT02436031|7583033|FG000|STARTED|First Study Night||8
6653255|NCT02436031|7583034|FG001|STARTED|First Study Night||8
6653256|NCT02436031|7583033|FG000|COMPLETED|First Study Night||8
6653257|NCT02436031|7583034|FG001|COMPLETED|First Study Night||8
6653258|NCT02436031|7583033|FG000|NOT COMPLETED|First Study Night||0
6653259|NCT02436031|7583034|FG001|NOT COMPLETED|First Study Night||0
6653260|NCT02436031|7583033|FG000|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
6653261|NCT02436031|7583034|FG001|STARTED|Second Study Night||8
6653262|NCT02436031|7583033|FG000|COMPLETED|Second Study Night||7
6653263|NCT02436031|7583034|FG001|COMPLETED|Second Study Night||8
6653264|NCT02436031|7583033|FG000|NOT COMPLETED|Second Study Night||0
6653265|NCT02436031|7583034|FG001|NOT COMPLETED|Second Study Night||0
6653266|NCT02436135|7583042|FG000|STARTED|Overall Study||6
6653267|NCT02436135|7583043|FG001|STARTED|Overall Study||4
6653268|NCT02436135|7583042|FG000|COMPLETED|Overall Study||0
6653269|NCT02436135|7583043|FG001|COMPLETED|Overall Study||0
6653270|NCT02436135|7583042|FG000|NOT COMPLETED|Overall Study||6
6653271|NCT02436135|7583043|FG001|NOT COMPLETED|Overall Study||4
6653272|NCT02436200|7583049|FG000|STARTED|Overall Study||21
6653273|NCT02436200|7583049|FG000|COMPLETED|Overall Study||20
6653274|NCT02436200|7583049|FG000|NOT COMPLETED|Overall Study||1
6653275|NCT02436239|7583057|FG000|STARTED|Open-Lable Treatment Period||122
6653276|NCT02436239|7583058|FG001|STARTED|Open-Lable Treatment Period||131
6653277|NCT02436239|7583059|FG002|STARTED|Open-Lable Treatment Period||65
6653278|NCT02436239|7583060|FG003|STARTED|Open-Lable Treatment Period||12
6653279|NCT02436239|7583057|FG000|COMPLETED|Open-Lable Treatment Period||89
6653280|NCT02436239|7583058|FG001|COMPLETED|Open-Lable Treatment Period||97
6653281|NCT02436239|7583059|FG002|COMPLETED|Open-Lable Treatment Period||38
6653282|NCT02436239|7583060|FG003|COMPLETED|Open-Lable Treatment Period||7
6653283|NCT02436239|7583057|FG000|NOT COMPLETED|Open-Lable Treatment Period||33
6653284|NCT02436239|7583058|FG001|NOT COMPLETED|Open-Lable Treatment Period||34
6653285|NCT02436239|7583059|FG002|NOT COMPLETED|Open-Lable Treatment Period||27
6653286|NCT02436239|7583060|FG003|NOT COMPLETED|Open-Lable Treatment Period||5
6656179|NCT02458469|7586290|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||0
6436551|NCT01076088|7351279|FG001|NOT COMPLETED|Overall Study||18
6436552|NCT01076088|7351280|FG002|NOT COMPLETED|Overall Study||17
6436553|NCT01076088|7351281|FG003|NOT COMPLETED|Overall Study||15
6436554|NCT01076088|7351282|FG004|NOT COMPLETED|Overall Study||16
6436555|NCT01076088|7351283|FG005|NOT COMPLETED|Overall Study||23
6436556|NCT01076153|7351298|FG000|STARTED|Overall Study||760
6436557|NCT01076153|7351298|FG000|COMPLETED|Overall Study||749
6436558|NCT01076153|7351298|FG000|NOT COMPLETED|Overall Study||11
6436559|NCT01076166|7351306|FG000|STARTED|Overall Study||337
6436560|NCT01076166|7351306|FG000|COMPLETED|Overall Study||328
6436561|NCT01076166|7351306|FG000|NOT COMPLETED|Overall Study||9
6436562|NCT01076179|7351313|FG000|STARTED|Overall Study||502
6436563|NCT01076179|7351313|FG000|COMPLETED|Overall Study||501
6436564|NCT01076179|7351313|FG000|NOT COMPLETED|Overall Study||1
6436565|NCT01076192|7351318|FG000|STARTED|Overall Study||547
6436566|NCT01076192|7351318|FG000|COMPLETED|Overall Study||350
6436567|NCT01076192|7351318|FG000|NOT COMPLETED|Overall Study||197
6436568|NCT01076205|7351323|FG000|STARTED|Overall Study||7229
6436569|NCT01076205|7351323|FG000|COMPLETED|Overall Study||1210
6436570|NCT01076205|7351323|FG000|NOT COMPLETED|Overall Study||6019
6436571|NCT01076231|7351343|FG000|STARTED|Overall Study||34
6436572|NCT01076231|7351343|FG000|COMPLETED|Overall Study||0
6436573|NCT01076231|7351343|FG000|NOT COMPLETED|Overall Study||34
6436574|NCT01076244|7351347|FG000|STARTED|Overall Study||46
6552770|NCT01738984|7475184|FG001|STARTED|Overall Study||249
6552771|NCT01738984|7475183|FG000|COMPLETED|Overall Study||186
6656240|NCT02459262|7586361|FG003|NOT COMPLETED|Overall Study||0
6436575|NCT01076244|7351347|FG000|COMPLETED|Overall Study||42
6436576|NCT01076244|7351347|FG000|NOT COMPLETED|Overall Study||4
6499823|NCT01421342|7418577|FG001|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||125
6499824|NCT01421342|7418578|FG002|NOT COMPLETED|Completed to Week 12 But Then Withdrawn||138
6499825|NCT01421342|7418576|FG000|STARTED|Continuation of Treatment (Week 12 - 36)||204
6499826|NCT01421342|7418577|FG001|STARTED|Continuation of Treatment (Week 12 - 36)||253
6499827|NCT01421342|7418578|FG002|STARTED|Continuation of Treatment (Week 12 - 36)||268
6499828|NCT01421342|7418576|FG000|COMPLETED|Continuation of Treatment (Week 12 - 36)||152
6499829|NCT01421342|7418577|FG001|COMPLETED|Continuation of Treatment (Week 12 - 36)||194
6499830|NCT01421342|7418578|FG002|COMPLETED|Continuation of Treatment (Week 12 - 36)||203
6499831|NCT01421342|7418576|FG000|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||52
6499832|NCT01421342|7418577|FG001|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||59
6499833|NCT01421342|7418578|FG002|NOT COMPLETED|Continuation of Treatment (Week 12 - 36)||65
6499834|NCT01421355|7418586|FG000|STARTED|Overall Study||21
6499835|NCT01421355|7418586|FG000|COMPLETED|Overall Study||15
6499836|NCT01421355|7418586|FG000|NOT COMPLETED|Overall Study||6
6499837|NCT01421459|7418592|FG000|STARTED|Overall Study||379
6499838|NCT01421459|7418593|FG001|STARTED|Overall Study||380
6499839|NCT01421459|7418592|FG000|Received at Least 1 Dose of Study Drug|Overall Study||376
6499840|NCT01421459|7418593|FG001|Received at Least 1 Dose of Study Drug|Overall Study||380
6499841|NCT01421459|7418592|FG000|COMPLETED|Overall Study||334
6499842|NCT01421459|7418593|FG001|COMPLETED|Overall Study||328
6499843|NCT01421459|7418592|FG000|NOT COMPLETED|Overall Study||45
6499844|NCT01421459|7418593|FG001|NOT COMPLETED|Overall Study||52
6499845|NCT01421472|7418603|FG000|STARTED|Overall Study||67
6499846|NCT01421472|7418604|FG001|STARTED|Overall Study||33
6499847|NCT01421472|7418605|FG002|STARTED|Overall Study||64
6499848|NCT01421472|7418606|FG003|STARTED|Overall Study||32
6499849|NCT01421472|7418603|FG000|COMPLETED|Overall Study||67
6499850|NCT01421472|7418604|FG001|COMPLETED|Overall Study||33
6499851|NCT01421472|7418605|FG002|COMPLETED|Overall Study||64
6499852|NCT01421472|7418606|FG003|COMPLETED|Overall Study||32
6499853|NCT01421472|7418603|FG000|NOT COMPLETED|Overall Study||0
6499854|NCT01421472|7418604|FG001|NOT COMPLETED|Overall Study||0
6499855|NCT01421472|7418605|FG002|NOT COMPLETED|Overall Study||0
6499856|NCT01421472|7418606|FG003|NOT COMPLETED|Overall Study||0
6499857|NCT01421498|7418618|FG000|STARTED|Overall Study||293
6499858|NCT01421498|7418619|FG001|STARTED|Overall Study||295
6499859|NCT01421498|7418618|FG000|COMPLETED|Overall Study||281
6499860|NCT01421498|7418619|FG001|COMPLETED|Overall Study||284
6499861|NCT01421498|7418618|FG000|NOT COMPLETED|Overall Study||12
6499862|NCT01421498|7418619|FG001|NOT COMPLETED|Overall Study||11
6499863|NCT01421511|7418627|FG000|STARTED|Overall Study||332
6499864|NCT01421511|7418628|FG001|STARTED|Overall Study||334
6499865|NCT01421511|7418627|FG000|COMPLETED|Overall Study||313
6499866|NCT01421511|7418628|FG001|COMPLETED|Overall Study||306
6499867|NCT01421511|7418627|FG000|NOT COMPLETED|Overall Study||19
6499868|NCT01421511|7418628|FG001|NOT COMPLETED|Overall Study||28
6499869|NCT01421589|7418635|FG000|STARTED|Overall Study||15
6499870|NCT01421589|7418635|FG000|COMPLETED|Overall Study||15
6499871|NCT01421589|7418635|FG000|NOT COMPLETED|Overall Study||0
6499872|NCT01421641|7418642|FG000|STARTED|Overall Study||37
6499873|NCT01421641|7418643|FG001|STARTED|Overall Study||37
6499874|NCT01421641|7418642|FG000|COMPLETED|Overall Study||35
6499875|NCT01421641|7418643|FG001|COMPLETED|Overall Study||35
6499876|NCT01421641|7418642|FG000|NOT COMPLETED|Overall Study||2
6499877|NCT01421641|7418643|FG001|NOT COMPLETED|Overall Study||2
6499878|NCT01421654|7418651|FG000|STARTED|Overall Study||11
6499879|NCT01421654|7418652|FG001|STARTED|Overall Study||9
6499880|NCT01421654|7418651|FG000|COMPLETED|Overall Study||11
6499881|NCT01421654|7418652|FG001|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
6499882|NCT01421654|7418651|FG000|NOT COMPLETED|Overall Study||0
6499883|NCT01421654|7418652|FG001|NOT COMPLETED|Overall Study||0
6499884|NCT01421667|7418662|FG000|STARTED|Overall Study||35
6552772|NCT01738984|7475184|FG001|COMPLETED|Overall Study||210
6436577|NCT01076270|7351351|FG000|STARTED|Overall Study||1
6436578|NCT01076270|7351351|FG000|COMPLETED|Overall Study||1
6436579|NCT01076270|7351351|FG000|NOT COMPLETED|Overall Study||0
6436580|NCT01076283|7351357|FG000|STARTED|Overall Study||7
6436581|NCT01076283|7351358|FG001|STARTED|Overall Study||7
6436582|NCT01076283|7351357|FG000|COMPLETED|Overall Study||6
6653287|NCT02436239|7583057|FG000|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|90
6653288|NCT02436239|7583058|FG001|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|103
6653289|NCT02436239|7583059|FG002|STARTED|Down-Taper Period|Enrollment permitted for participants who had not completed previous open-label treatment period.|44
6653290|NCT02436239|7583060|FG003|STARTED|Down-Taper Period|One participant who completed the open-label treatment period did not enter the down-taper period.|6
6653291|NCT02436239|7583057|FG000|COMPLETED|Down-Taper Period||86
6653292|NCT02436239|7583058|FG001|COMPLETED|Down-Taper Period||99
6653293|NCT02436239|7583059|FG002|COMPLETED|Down-Taper Period||43
6653294|NCT02436239|7583060|FG003|COMPLETED|Down-Taper Period||4
6653295|NCT02436239|7583057|FG000|NOT COMPLETED|Down-Taper Period||4
6653296|NCT02436239|7583058|FG001|NOT COMPLETED|Down-Taper Period||4
6653297|NCT02436239|7583059|FG002|NOT COMPLETED|Down-Taper Period||1
6744334|NCT03341533|7672376|FG000|STARTED|Overall Study||72
6744335|NCT03341533|7672377|FG001|STARTED|Overall Study||70
6744336|NCT03341533|7672376|FG000|COMPLETED|Overall Study||69
6744337|NCT03341533|7672377|FG001|COMPLETED|Overall Study||68
6744338|NCT03341533|7672376|FG000|NOT COMPLETED|Overall Study||3
6744339|NCT03341533|7672377|FG001|NOT COMPLETED|Overall Study||2
6744340|NCT03341546|7672383|FG000|STARTED|Overall Study||20
6744341|NCT03341546|7672383|FG000|COMPLETED|Overall Study||20
6744342|NCT03341546|7672383|FG000|NOT COMPLETED|Overall Study||0
6744343|NCT03341637|7672389|FG000|STARTED|Overall Study||100
6744344|NCT03341637|7672390|FG001|STARTED|Overall Study||300
6744345|NCT03341637|7672389|FG000|COMPLETED|Overall Study||95
6744346|NCT03341637|7672390|FG001|COMPLETED|Overall Study||296
6744347|NCT03341637|7672389|FG000|NOT COMPLETED|Overall Study||5
6744348|NCT03341637|7672390|FG001|NOT COMPLETED|Overall Study||4
6744349|NCT03341728|7672396|FG000|STARTED|Session 1||7
6744350|NCT03341728|7672397|FG001|STARTED|Session 1||7
6744351|NCT03341728|7672396|FG000|COMPLETED|Session 1||7
6744352|NCT03341728|7672397|FG001|COMPLETED|Session 1||7
6744353|NCT03341728|7672396|FG000|NOT COMPLETED|Session 1||0
6744354|NCT03341728|7672397|FG001|NOT COMPLETED|Session 1||0
6744355|NCT03341728|7672396|FG000|STARTED|Washout (1 Week)||7
6744356|NCT03341728|7672397|FG001|STARTED|Washout (1 Week)||7
6744357|NCT03341728|7672396|FG000|COMPLETED|Washout (1 Week)||7
6744358|NCT03341728|7672397|FG001|COMPLETED|Washout (1 Week)||7
6744359|NCT03341728|7672396|FG000|NOT COMPLETED|Washout (1 Week)||0
6744360|NCT03341728|7672397|FG001|NOT COMPLETED|Washout (1 Week)||0
6744361|NCT03341728|7672396|FG000|STARTED|Session 2||7
6744362|NCT03341728|7672397|FG001|STARTED|Session 2||7
6744363|NCT03341728|7672396|FG000|COMPLETED|Session 2||7
6744364|NCT03341728|7672397|FG001|COMPLETED|Session 2||7
6744365|NCT03341728|7672396|FG000|NOT COMPLETED|Session 2||0
6744366|NCT03341728|7672397|FG001|NOT COMPLETED|Session 2||0
6744367|NCT03341910|7672407|FG000|STARTED|Overall Study||54
6744368|NCT03341910|7672408|FG001|STARTED|Overall Study||49
6744369|NCT03341910|7672409|FG002|STARTED|Overall Study||26
6744370|NCT03341910|7672410|FG003|STARTED|Overall Study||26
6744371|NCT03341910|7672407|FG000|COMPLETED|Overall Study||54
6744372|NCT03341910|7672408|FG001|COMPLETED|Overall Study||49
6744373|NCT03341910|7672409|FG002|COMPLETED|Overall Study||26
6744374|NCT03341910|7672410|FG003|COMPLETED|Overall Study||26
6744375|NCT03341910|7672407|FG000|NOT COMPLETED|Overall Study||0
6744376|NCT03341910|7672408|FG001|NOT COMPLETED|Overall Study||0
6744377|NCT03341910|7672409|FG002|NOT COMPLETED|Overall Study||0
6744378|NCT03341910|7672410|FG003|NOT COMPLETED|Overall Study||0
6744379|NCT03341923|7672420|FG000|STARTED|Period 1, First 14 Days of Wear||67
6744380|NCT03341923|7672421|FG001|STARTED|Period 1, First 14 Days of Wear||67
6744381|NCT03341923|7672420|FG000|COMPLETED|Period 1, First 14 Days of Wear||67
6744382|NCT03341923|7672421|FG001|COMPLETED|Period 1, First 14 Days of Wear||67
6744383|NCT03341923|7672420|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
6744384|NCT03341923|7672421|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||0
6744385|NCT03341923|7672420|FG000|STARTED|Period 2, Second 14 Days of Wear||67
6744386|NCT03341923|7672421|FG001|STARTED|Period 2, Second 14 Days of Wear|Subject completed Period 1 but was discontinued before starting Period 2.|66
6436583|NCT01076283|7351358|FG001|COMPLETED|Overall Study||7
6436584|NCT01076283|7351357|FG000|NOT COMPLETED|Overall Study||1
6436585|NCT01076283|7351358|FG001|NOT COMPLETED|Overall Study||0
6436586|NCT01076296|7351364|FG000|STARTED|Overall Study||54
6436587|NCT01076296|7351365|FG001|STARTED|Overall Study||196
6744387|NCT03341923|7672420|FG000|COMPLETED|Period 2, Second 14 Days of Wear||67
6744388|NCT03341923|7672421|FG001|COMPLETED|Period 2, Second 14 Days of Wear||65
6744389|NCT03341923|7672420|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6744390|NCT03341923|7672421|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||1
6744391|NCT03341975|7672431|FG000|STARTED|Overall Study||44
6744392|NCT03341975|7672432|FG001|STARTED|Overall Study||47
6744393|NCT03341975|7672431|FG000|COMPLETED|Overall Study||44
6744394|NCT03341975|7672432|FG001|COMPLETED|Overall Study||47
6744395|NCT03341975|7672431|FG000|NOT COMPLETED|Overall Study||0
6744396|NCT03341975|7672432|FG001|NOT COMPLETED|Overall Study||0
6744397|NCT03342404|7672440|FG000|STARTED|Overall Study||96
6436588|NCT01076296|7351366|FG002|STARTED|Overall Study||51
6436589|NCT01076296|7351367|FG003|STARTED|Overall Study||199
6436590|NCT01076296|7351368|FG004|STARTED|Overall Study||59
6436591|NCT01076296|7351369|FG005|STARTED|Overall Study||191
6436592|NCT01076296|7351370|FG006|STARTED|Overall Study||51
6436593|NCT01076296|7351371|FG007|STARTED|Overall Study||199
6436594|NCT01076296|7351364|FG000|COMPLETED|Overall Study||54
6436595|NCT01076296|7351365|FG001|COMPLETED|Overall Study||196
6436596|NCT01076296|7351366|FG002|COMPLETED|Overall Study||51
6436597|NCT01076296|7351367|FG003|COMPLETED|Overall Study||199
6436598|NCT01076296|7351368|FG004|COMPLETED|Overall Study||59
6436599|NCT01076296|7351369|FG005|COMPLETED|Overall Study||191
6436600|NCT01076296|7351370|FG006|COMPLETED|Overall Study||51
6436601|NCT01076296|7351371|FG007|COMPLETED|Overall Study||199
6436602|NCT01076296|7351364|FG000|NOT COMPLETED|Overall Study||0
6436603|NCT01076296|7351365|FG001|NOT COMPLETED|Overall Study||0
6436604|NCT01076296|7351366|FG002|NOT COMPLETED|Overall Study||0
6436605|NCT01076296|7351367|FG003|NOT COMPLETED|Overall Study||0
6436606|NCT01076296|7351368|FG004|NOT COMPLETED|Overall Study||0
6436607|NCT01076296|7351369|FG005|NOT COMPLETED|Overall Study||0
6436608|NCT01076296|7351370|FG006|NOT COMPLETED|Overall Study||0
6436609|NCT01076296|7351371|FG007|NOT COMPLETED|Overall Study||0
6436610|NCT01076335|7351389|FG000|STARTED|Overall Study||40
6436611|NCT01076335|7351389|FG000|COMPLETED|Overall Study||36
6436612|NCT01076335|7351389|FG000|NOT COMPLETED|Overall Study||4
6436613|NCT01076348|7351393|FG000|STARTED|Overall Study||73
6436614|NCT01076348|7351393|FG000|COMPLETED|Overall Study||51
6436615|NCT01076348|7351393|FG000|NOT COMPLETED|Overall Study||22
6436616|NCT01076361|7351397|FG000|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
6436617|NCT01076361|7351397|FG000|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
6436618|NCT01076361|7351397|FG000|NOT COMPLETED|Overall Study||21
6436619|NCT01076400|7351401|FG000|STARTED|Overall Study||7
6436620|NCT01076400|7351402|FG001|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
6436621|NCT01076400|7351403|FG002|STARTED|Overall Study|No participants were enrolled in Part 2 of the study.|0
6436622|NCT01076400|7351401|FG000|COMPLETED|Overall Study||0
6436623|NCT01076400|7351402|FG001|COMPLETED|Overall Study||0
6436624|NCT01076400|7351403|FG002|COMPLETED|Overall Study||0
6436625|NCT01076400|7351401|FG000|NOT COMPLETED|Overall Study||7
6436626|NCT01076400|7351402|FG001|NOT COMPLETED|Overall Study||0
6436627|NCT01076400|7351403|FG002|NOT COMPLETED|Overall Study||0
6436628|NCT01076452|7351409|FG000|STARTED|Overall Study||147
6436629|NCT01076452|7351410|FG001|STARTED|Overall Study||152
6436630|NCT01076452|7351409|FG000|COMPLETED|Overall Study||123
6436631|NCT01076452|7351410|FG001|COMPLETED|Overall Study||138
6436632|NCT01076452|7351409|FG000|NOT COMPLETED|Overall Study||24
6436633|NCT01076452|7351410|FG001|NOT COMPLETED|Overall Study||14
6436634|NCT01076504|7351416|FG000|STARTED|Overall Study||80
6436635|NCT01076504|7351416|FG000|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
6436636|NCT01076504|7351416|FG000|NOT COMPLETED|Overall Study||80
6436637|NCT01076543|7351426|FG000|STARTED|Overall Study||8
6436638|NCT01076543|7351427|FG001|STARTED|Overall Study||3
6436639|NCT01076543|7351428|FG002|STARTED|Overall Study||6
6436640|NCT01076543|7351429|FG003|STARTED|Overall Study||39
6436641|NCT01076543|7351430|FG004|STARTED|Overall Study||15
6436642|NCT01076543|7351431|FG005|STARTED|Overall Study||39
6436643|NCT01076543|7351426|FG000|COMPLETED|Overall Study||6
6653298|NCT02436239|7583060|FG003|NOT COMPLETED|Down-Taper Period||2
6653299|NCT02436304|7583073|FG000|STARTED|Overall Study||153
6653300|NCT02436304|7583074|FG001|STARTED|Overall Study||102
6653301|NCT02436304|7583075|FG002|STARTED|Overall Study||101
6653302|NCT02436304|7583073|FG000|COMPLETED|Overall Study||153
6653303|NCT02436304|7583074|FG001|COMPLETED|Overall Study||100
6653304|NCT02436304|7583075|FG002|COMPLETED|Overall Study||100
6653305|NCT02436304|7583073|FG000|NOT COMPLETED|Overall Study||0
6653306|NCT02436304|7583074|FG001|NOT COMPLETED|Overall Study||2
6436644|NCT01076543|7351427|FG001|COMPLETED|Overall Study||3
6436645|NCT01076543|7351428|FG002|COMPLETED|Overall Study||6
6436646|NCT01076543|7351429|FG003|COMPLETED|Overall Study||39
6436647|NCT01076543|7351430|FG004|COMPLETED|Overall Study||15
6436648|NCT01076543|7351431|FG005|COMPLETED|Overall Study||39
6436649|NCT01076543|7351426|FG000|NOT COMPLETED|Overall Study||2
6436650|NCT01076543|7351427|FG001|NOT COMPLETED|Overall Study||0
6436651|NCT01076543|7351428|FG002|NOT COMPLETED|Overall Study||0
6436652|NCT01076543|7351429|FG003|NOT COMPLETED|Overall Study||0
6436653|NCT01076543|7351430|FG004|NOT COMPLETED|Overall Study||0
6436654|NCT01076543|7351431|FG005|NOT COMPLETED|Overall Study||0
6436655|NCT01076647|7351448|FG000|STARTED|Overall Study||233
6436656|NCT01076647|7351449|FG001|STARTED|Overall Study||234
6653307|NCT02436304|7583075|FG002|NOT COMPLETED|Overall Study||1
6436657|NCT01076647|7351448|FG000|COMPLETED|Overall Study||208
6436658|NCT01076647|7351449|FG001|COMPLETED|Overall Study||209
6436659|NCT01076647|7351448|FG000|NOT COMPLETED|Overall Study||25
6436660|NCT01076647|7351449|FG001|NOT COMPLETED|Overall Study||25
6436661|NCT01076686|7351459|FG000|STARTED|Overall Study||17
6436662|NCT01076686|7351460|FG001|STARTED|Overall Study||14
6436663|NCT01076686|7351461|FG002|STARTED|Overall Study||32
6436664|NCT01076686|7351462|FG003|STARTED|Overall Study||31
6436665|NCT01076686|7351459|FG000|COMPLETED|Overall Study||17
6436666|NCT01076686|7351460|FG001|COMPLETED|Overall Study||14
6436667|NCT01076686|7351461|FG002|COMPLETED|Overall Study||32
6436668|NCT01076686|7351462|FG003|COMPLETED|Overall Study||31
6436669|NCT01076686|7351459|FG000|NOT COMPLETED|Overall Study||0
6436670|NCT01076686|7351460|FG001|NOT COMPLETED|Overall Study||0
6436671|NCT01076686|7351461|FG002|NOT COMPLETED|Overall Study||0
6436672|NCT01076686|7351462|FG003|NOT COMPLETED|Overall Study||0
6436673|NCT01076959|7351472|FG000|STARTED|Overall Study||7740
6436674|NCT01076959|7351472|FG000|COMPLETED|Overall Study||5490
6436675|NCT01076959|7351472|FG000|NOT COMPLETED|Overall Study||2250
6436676|NCT01076972|7351489|FG000|STARTED|Overall Study||1184
6436677|NCT01076972|7351489|FG000|COMPLETED|Overall Study||1184
6436678|NCT01076972|7351489|FG000|NOT COMPLETED|Overall Study||0
6436679|NCT01076985|7351503|FG000|STARTED|Overall Study||24
6436680|NCT01076985|7351503|FG000|COMPLETED|Overall Study||24
6436681|NCT01076985|7351503|FG000|NOT COMPLETED|Overall Study||0
6436682|NCT01077024|7351511|FG000|STARTED|Overall Study||267
6436683|NCT01077024|7351512|FG001|STARTED|Overall Study||271
6436684|NCT01077024|7351511|FG000|COMPLETED|Overall Study||236
6436685|NCT01077024|7351512|FG001|COMPLETED|Overall Study||243
6436686|NCT01077024|7351511|FG000|NOT COMPLETED|Overall Study||31
6436687|NCT01077024|7351512|FG001|NOT COMPLETED|Overall Study||28
6436688|NCT01077050|7351518|FG000|STARTED|Overall Study||1951
6436689|NCT01077050|7351518|FG000|COMPLETED|Overall Study||1942
6436690|NCT01077050|7351518|FG000|NOT COMPLETED|Overall Study||9
6436691|NCT01077063|7351524|FG000|STARTED|Overall Study||4
6436692|NCT01077063|7351525|FG001|STARTED|Overall Study||3
6436693|NCT01077063|7351524|FG000|COMPLETED|Overall Study||0
6436694|NCT01077063|7351525|FG001|COMPLETED|Overall Study||0
6436695|NCT01077063|7351524|FG000|NOT COMPLETED|Overall Study||4
6436696|NCT01077063|7351525|FG001|NOT COMPLETED|Overall Study||3
6436697|NCT01077076|7351531|FG000|STARTED|First Intervention||5
6436698|NCT01077076|7351532|FG001|STARTED|First Intervention||5
6436699|NCT01077076|7351533|FG002|STARTED|First Intervention||5
6436700|NCT01077076|7351534|FG003|STARTED|First Intervention||5
6436701|NCT01077076|7351535|FG004|STARTED|First Intervention||5
6436702|NCT01077076|7351536|FG005|STARTED|First Intervention||5
6436703|NCT01077076|7351531|FG000|COMPLETED|First Intervention||4
6436704|NCT01077076|7351532|FG001|COMPLETED|First Intervention||5
6436705|NCT01077076|7351533|FG002|COMPLETED|First Intervention||5
6436706|NCT01077076|7351534|FG003|COMPLETED|First Intervention||5
6436707|NCT01077076|7351535|FG004|COMPLETED|First Intervention||5
6436708|NCT01077076|7351536|FG005|COMPLETED|First Intervention||5
6436709|NCT01077076|7351531|FG000|NOT COMPLETED|First Intervention||1
6436710|NCT01077076|7351532|FG001|NOT COMPLETED|First Intervention||0
6436711|NCT01077076|7351533|FG002|NOT COMPLETED|First Intervention||0
6436712|NCT01077076|7351534|FG003|NOT COMPLETED|First Intervention||0
6436713|NCT01077076|7351535|FG004|NOT COMPLETED|First Intervention||0
6436714|NCT01077076|7351536|FG005|NOT COMPLETED|First Intervention||0
6436715|NCT01077076|7351531|FG000|STARTED|Washout Period of 2 Weeks||4
6436716|NCT01077076|7351532|FG001|STARTED|Washout Period of 2 Weeks||5
6436717|NCT01077076|7351533|FG002|STARTED|Washout Period of 2 Weeks||5
6436718|NCT01077076|7351534|FG003|STARTED|Washout Period of 2 Weeks||5
6436719|NCT01077076|7351535|FG004|STARTED|Washout Period of 2 Weeks||5
6436720|NCT01077076|7351536|FG005|STARTED|Washout Period of 2 Weeks||5
6436721|NCT01077076|7351531|FG000|COMPLETED|Washout Period of 2 Weeks||4
6436722|NCT01077076|7351532|FG001|COMPLETED|Washout Period of 2 Weeks||5
6436723|NCT01077076|7351533|FG002|COMPLETED|Washout Period of 2 Weeks||5
6436724|NCT01077076|7351534|FG003|COMPLETED|Washout Period of 2 Weeks||5
6436725|NCT01077076|7351535|FG004|COMPLETED|Washout Period of 2 Weeks||5
6436726|NCT01077076|7351536|FG005|COMPLETED|Washout Period of 2 Weeks||5
6436727|NCT01077076|7351531|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6436728|NCT01077076|7351532|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6436729|NCT01077076|7351533|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
6436730|NCT01077076|7351534|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
6653308|NCT02436330|7583086|FG000|STARTED|Cohort 1||14
6653309|NCT02436330|7583087|FG001|STARTED|Cohort 1||4
6653310|NCT02436330|7583086|FG000|COMPLETED|Cohort 1||9
6653311|NCT02436330|7583087|FG001|COMPLETED|Cohort 1||1
6436731|NCT01077076|7351535|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
6436732|NCT01077076|7351536|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
6436733|NCT01077076|7351531|FG000|STARTED|Second Intervention||4
6436734|NCT01077076|7351532|FG001|STARTED|Second Intervention||5
6436735|NCT01077076|7351533|FG002|STARTED|Second Intervention||5
6436736|NCT01077076|7351534|FG003|STARTED|Second Intervention||5
6436737|NCT01077076|7351535|FG004|STARTED|Second Intervention||5
6436738|NCT01077076|7351536|FG005|STARTED|Second Intervention||5
6436739|NCT01077076|7351531|FG000|COMPLETED|Second Intervention||4
6436740|NCT01077076|7351532|FG001|COMPLETED|Second Intervention||5
6436741|NCT01077076|7351533|FG002|COMPLETED|Second Intervention||5
6436742|NCT01077076|7351534|FG003|COMPLETED|Second Intervention||5
6436743|NCT01077076|7351535|FG004|COMPLETED|Second Intervention||5
6436744|NCT01077076|7351536|FG005|COMPLETED|Second Intervention||5
6436745|NCT01077076|7351531|FG000|NOT COMPLETED|Second Intervention||0
6436746|NCT01077076|7351532|FG001|NOT COMPLETED|Second Intervention||0
6436747|NCT01077076|7351533|FG002|NOT COMPLETED|Second Intervention||0
6436748|NCT01077076|7351534|FG003|NOT COMPLETED|Second Intervention||0
6653312|NCT02436330|7583086|FG000|NOT COMPLETED|Cohort 1||5
6653313|NCT02436330|7583087|FG001|NOT COMPLETED|Cohort 1||3
6653314|NCT02436330|7583086|FG000|STARTED|Cohort 2||14
6653315|NCT02436330|7583087|FG001|STARTED|Cohort 2||10
6436749|NCT01077076|7351535|FG004|NOT COMPLETED|Second Intervention||0
6436750|NCT01077076|7351536|FG005|NOT COMPLETED|Second Intervention||0
6436751|NCT01077076|7351531|FG000|STARTED|Washout Period of 2 Weeks||4
6436752|NCT01077076|7351532|FG001|STARTED|Washout Period of 2 Weeks||5
6436753|NCT01077076|7351533|FG002|STARTED|Washout Period of 2 Weeks||5
6436754|NCT01077076|7351534|FG003|STARTED|Washout Period of 2 Weeks||5
6436755|NCT01077076|7351535|FG004|STARTED|Washout Period of 2 Weeks||5
6436756|NCT01077076|7351536|FG005|STARTED|Washout Period of 2 Weeks||5
6436757|NCT01077076|7351531|FG000|COMPLETED|Washout Period of 2 Weeks||4
6436758|NCT01077076|7351532|FG001|COMPLETED|Washout Period of 2 Weeks||5
6436759|NCT01077076|7351533|FG002|COMPLETED|Washout Period of 2 Weeks||5
6436760|NCT01077076|7351534|FG003|COMPLETED|Washout Period of 2 Weeks||5
6436761|NCT01077076|7351535|FG004|COMPLETED|Washout Period of 2 Weeks||5
6436762|NCT01077076|7351536|FG005|COMPLETED|Washout Period of 2 Weeks||5
6436763|NCT01077076|7351531|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6436764|NCT01077076|7351532|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6436765|NCT01077076|7351533|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
6436766|NCT01077076|7351534|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
6436767|NCT01077076|7351535|FG004|NOT COMPLETED|Washout Period of 2 Weeks||0
6436768|NCT01077076|7351536|FG005|NOT COMPLETED|Washout Period of 2 Weeks||0
6436769|NCT01077076|7351531|FG000|STARTED|Third Intervention||4
6436770|NCT01077076|7351532|FG001|STARTED|Third Intervention||5
6436771|NCT01077076|7351533|FG002|STARTED|Third Intervention||5
6436772|NCT01077076|7351534|FG003|STARTED|Third Intervention||5
6436773|NCT01077076|7351535|FG004|STARTED|Third Intervention||5
6436774|NCT01077076|7351536|FG005|STARTED|Third Intervention||5
6436775|NCT01077076|7351531|FG000|COMPLETED|Third Intervention||4
6436776|NCT01077076|7351532|FG001|COMPLETED|Third Intervention||5
6436777|NCT01077076|7351533|FG002|COMPLETED|Third Intervention||5
6436778|NCT01077076|7351534|FG003|COMPLETED|Third Intervention||5
6436779|NCT01077076|7351535|FG004|COMPLETED|Third Intervention||5
6436780|NCT01077076|7351536|FG005|COMPLETED|Third Intervention||4
6436781|NCT01077076|7351531|FG000|NOT COMPLETED|Third Intervention||0
6436782|NCT01077076|7351532|FG001|NOT COMPLETED|Third Intervention||0
6436783|NCT01077076|7351533|FG002|NOT COMPLETED|Third Intervention||0
6436784|NCT01077076|7351534|FG003|NOT COMPLETED|Third Intervention||0
6436785|NCT01077076|7351535|FG004|NOT COMPLETED|Third Intervention||0
6436786|NCT01077076|7351536|FG005|NOT COMPLETED|Third Intervention||1
6436787|NCT01077128|7351544|FG000|STARTED|Overall Study||500
6436788|NCT01077128|7351544|FG000|COMPLETED|Overall Study||433
6436789|NCT01077128|7351544|FG000|NOT COMPLETED|Overall Study||67
6436790|NCT01077154|7351600|FG000|STARTED|Overall Study||2253
6436791|NCT01077154|7351601|FG001|STARTED|Overall Study||2256
6436792|NCT01077154|7351600|FG000|Received Study Drug|Overall Study||2229
6436793|NCT01077154|7351601|FG001|Received Study Drug|Overall Study||2230
6436794|NCT01077154|7351600|FG000|COMPLETED|Overall Study||27
6436795|NCT01077154|7351601|FG001|COMPLETED|Overall Study||28
6436796|NCT01077154|7351600|FG000|NOT COMPLETED|Overall Study||2226
6436797|NCT01077154|7351601|FG001|NOT COMPLETED|Overall Study||2228
6436798|NCT01077193|7351607|FG000|STARTED|Overall Study||44
6436799|NCT01077193|7351607|FG000|COMPLETED|Overall Study||0
6436800|NCT01077193|7351607|FG000|NOT COMPLETED|Overall Study||44
6436801|NCT01077258|7351611|FG000|STARTED|Overall Study||4208
6436802|NCT01077258|7351611|FG000|COMPLETED|Overall Study||1640
6436803|NCT01077258|7351611|FG000|NOT COMPLETED|Overall Study||2568
6436804|NCT01077271|7351628|FG000|STARTED|Overall Study||124
6436805|NCT01077271|7351628|FG000|Participants Treated With Palivizumab|Overall Study||120
6436806|NCT01077271|7351628|FG000|Number of Participants Analyzed|Overall Study||120
6436807|NCT01077271|7351628|FG000|COMPLETED|Overall Study||102
6436808|NCT01077271|7351628|FG000|NOT COMPLETED|Overall Study||22
6436809|NCT01077284|7351643|FG000|STARTED|Overall Study||33
6436810|NCT01077284|7351644|FG001|STARTED|Overall Study||33
6436811|NCT01077284|7351645|FG002|STARTED|Overall Study||33
6436812|NCT01077284|7351643|FG000|COMPLETED|Overall Study||28
6436813|NCT01077284|7351644|FG001|COMPLETED|Overall Study||28
6436814|NCT01077284|7351645|FG002|COMPLETED|Overall Study||30
6436815|NCT01077284|7351643|FG000|NOT COMPLETED|Overall Study||5
6436816|NCT01077284|7351644|FG001|NOT COMPLETED|Overall Study||5
6436817|NCT01077284|7351645|FG002|NOT COMPLETED|Overall Study||3
6436818|NCT01077310|7351655|FG000|STARTED|Overall Study||67
6436819|NCT01077310|7351656|FG001|STARTED|Overall Study||33
6436820|NCT01077310|7351655|FG000|COMPLETED|Overall Study||67
6436821|NCT01077310|7351656|FG001|COMPLETED|Overall Study||33
6436822|NCT01077310|7351655|FG000|NOT COMPLETED|Overall Study||0
6436823|NCT01077310|7351656|FG001|NOT COMPLETED|Overall Study||0
6436824|NCT01077323|7351670|FG000|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
6436825|NCT01077323|7351671|FG001|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
6436826|NCT01077323|7351672|FG002|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
6436827|NCT01077323|7351670|FG000|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
6436828|NCT01077323|7351671|FG001|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
6436829|NCT01077323|7351672|FG002|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
6436830|NCT01077323|7351670|FG000|NOT COMPLETED|Overall Study||11378
6436831|NCT01077323|7351671|FG001|NOT COMPLETED|Overall Study||386263
6436832|NCT01077323|7351672|FG002|NOT COMPLETED|Overall Study||11912089
6436833|NCT01077362|7351683|FG000|STARTED|Overall Study||104
6436834|NCT01077362|7351684|FG001|STARTED|Overall Study||103
6436835|NCT01077362|7351685|FG002|STARTED|Overall Study||105
6436836|NCT01077362|7351683|FG000|COMPLETED|Overall Study||73
6436837|NCT01077362|7351684|FG001|COMPLETED|Overall Study||84
6436838|NCT01077362|7351685|FG002|COMPLETED|Overall Study||81
6436839|NCT01077362|7351683|FG000|NOT COMPLETED|Overall Study||31
6436840|NCT01077362|7351684|FG001|NOT COMPLETED|Overall Study||19
6436841|NCT01077362|7351685|FG002|NOT COMPLETED|Overall Study||24
6436842|NCT01077375|7351700|FG000|STARTED|Overall Study||21
6436843|NCT01077375|7351701|FG001|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
6436844|NCT01077375|7351700|FG000|COMPLETED|Overall Study||11
6436845|NCT01077375|7351701|FG001|COMPLETED|Overall Study||51
6436846|NCT01077375|7351700|FG000|NOT COMPLETED|Overall Study||10
6436847|NCT01077375|7351701|FG001|NOT COMPLETED|Overall Study||35
6436848|NCT01077401|7351711|FG000|STARTED|Overall Study||77
6436849|NCT01077401|7351712|FG001|STARTED|Overall Study||75
6436850|NCT01077401|7351711|FG000|COMPLETED|Overall Study||59
6436851|NCT01077401|7351712|FG001|COMPLETED|Overall Study||54
6436852|NCT01077401|7351711|FG000|NOT COMPLETED|Overall Study||18
6436853|NCT01077401|7351712|FG001|NOT COMPLETED|Overall Study||21
6436854|NCT01077518|7351720|FG000|STARTED|Treatment Phase - no Optional Ofa||173
6436855|NCT01077518|7351721|FG001|STARTED|Treatment Phase - no Optional Ofa||173
6436856|NCT01077518|7351722|FG002|STARTED|Treatment Phase - no Optional Ofa||0
6436857|NCT01077518|7351720|FG000|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
6436858|NCT01077518|7351721|FG001|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||64
6436859|NCT01077518|7351722|FG002|Completed 5-year Follow-up|Treatment Phase - no Optional Ofa||0
6436860|NCT01077518|7351720|FG000|Safety Population|Treatment Phase - no Optional Ofa||172
6436861|NCT01077518|7351721|FG001|Safety Population|Treatment Phase - no Optional Ofa||170
6436862|NCT01077518|7351722|FG002|Safety Population|Treatment Phase - no Optional Ofa||0
6436863|NCT01077518|7351720|FG000|COMPLETED|Treatment Phase - no Optional Ofa||95
6436864|NCT01077518|7351721|FG001|COMPLETED|Treatment Phase - no Optional Ofa||108
6436865|NCT01077518|7351722|FG002|COMPLETED|Treatment Phase - no Optional Ofa||0
6436866|NCT01077518|7351720|FG000|NOT COMPLETED|Treatment Phase - no Optional Ofa||78
6436867|NCT01077518|7351721|FG001|NOT COMPLETED|Treatment Phase - no Optional Ofa||65
6436868|NCT01077518|7351722|FG002|NOT COMPLETED|Treatment Phase - no Optional Ofa||0
6436869|NCT01077518|7351720|FG000|STARTED|Optional Ofa Phase||0
6436870|NCT01077518|7351721|FG001|STARTED|Optional Ofa Phase||0
6436871|NCT01077518|7351722|FG002|STARTED|Optional Ofa Phase||32
6436872|NCT01077518|7351720|FG000|Completed 5-year Follow-up|Optional Ofa Phase||0
6436873|NCT01077518|7351721|FG001|Completed 5-year Follow-up|Optional Ofa Phase||0
6436874|NCT01077518|7351722|FG002|Completed 5-year Follow-up|Optional Ofa Phase||12
6436875|NCT01077518|7351720|FG000|COMPLETED|Optional Ofa Phase||0
6436876|NCT01077518|7351721|FG001|COMPLETED|Optional Ofa Phase||0
6436877|NCT01077518|7351722|FG002|COMPLETED|Optional Ofa Phase||16
6436878|NCT01077518|7351720|FG000|NOT COMPLETED|Optional Ofa Phase||0
6436879|NCT01077518|7351721|FG001|NOT COMPLETED|Optional Ofa Phase||0
6436880|NCT01077518|7351722|FG002|NOT COMPLETED|Optional Ofa Phase||16
6436881|NCT01077544|7351733|FG000|STARTED|Overall Study||8
6436882|NCT01077544|7351734|FG001|STARTED|Overall Study||7
6436883|NCT01077544|7351733|FG000|COMPLETED|Overall Study||5
6436884|NCT01077544|7351734|FG001|COMPLETED|Overall Study||2
6436885|NCT01077544|7351733|FG000|NOT COMPLETED|Overall Study||3
6436886|NCT01077544|7351734|FG001|NOT COMPLETED|Overall Study||5
6436887|NCT01077596|7351752|FG000|STARTED|Overall Study||350
6436888|NCT01077596|7351753|FG001|STARTED|Overall Study||1050
6436889|NCT01077596|7351754|FG002|STARTED|Overall Study||457
6436890|NCT01077596|7351755|FG003|STARTED|Overall Study||1370
6436891|NCT01077596|7351756|FG004|STARTED|Overall Study||294
6436892|NCT01077596|7351757|FG005|STARTED|Overall Study||882
6436893|NCT01077596|7351758|FG006|STARTED|Overall Study||308
6436894|NCT01077596|7351759|FG007|STARTED|Overall Study||837
6436895|NCT01077596|7351760|FG008|STARTED|Overall Study||2842
6436896|NCT01077596|7351761|FG009|STARTED|Overall Study||28420
6436897|NCT01077596|7351762|FG010|STARTED|Overall Study||2215
6436898|NCT01077596|7351763|FG011|STARTED|Overall Study||22150
6436899|NCT01077596|7351752|FG000|COMPLETED|Overall Study||350
6436900|NCT01077596|7351753|FG001|COMPLETED|Overall Study||1050
6436901|NCT01077596|7351754|FG002|COMPLETED|Overall Study||457
6436902|NCT01077596|7351755|FG003|COMPLETED|Overall Study||1370
6436903|NCT01077596|7351756|FG004|COMPLETED|Overall Study||294
6436904|NCT01077596|7351757|FG005|COMPLETED|Overall Study||882
6436905|NCT01077596|7351758|FG006|COMPLETED|Overall Study||308
6436906|NCT01077596|7351759|FG007|COMPLETED|Overall Study||837
6436907|NCT01077596|7351760|FG008|COMPLETED|Overall Study||2842
6436908|NCT01077596|7351761|FG009|COMPLETED|Overall Study||28420
6436909|NCT01077596|7351762|FG010|COMPLETED|Overall Study||2215
6436910|NCT01077596|7351763|FG011|COMPLETED|Overall Study||22150
6436911|NCT01077596|7351752|FG000|NOT COMPLETED|Overall Study||0
6436912|NCT01077596|7351753|FG001|NOT COMPLETED|Overall Study||0
6436913|NCT01077596|7351754|FG002|NOT COMPLETED|Overall Study||0
6436914|NCT01077596|7351755|FG003|NOT COMPLETED|Overall Study||0
6436915|NCT01077596|7351756|FG004|NOT COMPLETED|Overall Study||0
6436916|NCT01077596|7351757|FG005|NOT COMPLETED|Overall Study||0
6436917|NCT01077596|7351758|FG006|NOT COMPLETED|Overall Study||0
6436918|NCT01077596|7351759|FG007|NOT COMPLETED|Overall Study||0
6436919|NCT01077596|7351760|FG008|NOT COMPLETED|Overall Study||0
6436920|NCT01077596|7351761|FG009|NOT COMPLETED|Overall Study||0
6436921|NCT01077596|7351762|FG010|NOT COMPLETED|Overall Study||0
6436922|NCT01077596|7351763|FG011|NOT COMPLETED|Overall Study||0
6436923|NCT01077622|7351784|FG000|STARTED|Overall Study||10
6436924|NCT01077622|7351784|FG000|COMPLETED|Overall Study||7
6436925|NCT01077622|7351784|FG000|NOT COMPLETED|Overall Study||3
6436926|NCT01077713|7351790|FG000|STARTED|Overall Study||44
6436927|NCT01077713|7351791|FG001|STARTED|Overall Study||42
6436928|NCT01077713|7351790|FG000|COMPLETED|Overall Study||8
6552773|NCT01738984|7475183|FG000|NOT COMPLETED|Overall Study||64
6436929|NCT01077713|7351791|FG001|COMPLETED|Overall Study||6
6436930|NCT01077713|7351790|FG000|NOT COMPLETED|Overall Study||36
6436931|NCT01077713|7351791|FG001|NOT COMPLETED|Overall Study||36
6436932|NCT01077739|7351799|FG000|STARTED|Overall Study||25
6436933|NCT01077739|7351800|FG001|STARTED|Overall Study||50
6436934|NCT01077739|7351799|FG000|COMPLETED|Overall Study||20
6436935|NCT01077739|7351800|FG001|COMPLETED|Overall Study||40
6436936|NCT01077739|7351799|FG000|NOT COMPLETED|Overall Study||5
6436937|NCT01077739|7351800|FG001|NOT COMPLETED|Overall Study||10
6436938|NCT01077804|7351806|FG000|STARTED|Overall Study||7585
6436939|NCT01077804|7351806|FG000|COMPLETED|Overall Study||7386
6436940|NCT01077804|7351806|FG000|NOT COMPLETED|Overall Study||199
6436941|NCT01077856|7351813|FG000|STARTED|Overall Study||22199
6436942|NCT01077856|7351814|FG001|STARTED|Overall Study||16604
6436943|NCT01077856|7351815|FG002|STARTED|Overall Study||15713
6436944|NCT01077856|7351813|FG000|COMPLETED|Overall Study||22199
6436945|NCT01077856|7351814|FG001|COMPLETED|Overall Study||16604
6436946|NCT01077856|7351815|FG002|COMPLETED|Overall Study||15713
6436947|NCT01077856|7351813|FG000|NOT COMPLETED|Overall Study||0
6436948|NCT01077856|7351814|FG001|NOT COMPLETED|Overall Study||0
6436949|NCT01077856|7351815|FG002|NOT COMPLETED|Overall Study||0
6436950|NCT01077921|7351857|FG000|STARTED|First Intervention||14
6436951|NCT01077921|7351858|FG001|STARTED|First Intervention||13
6436952|NCT01077921|7351857|FG000|COMPLETED|First Intervention||13
6436953|NCT01077921|7351858|FG001|COMPLETED|First Intervention||12
6436954|NCT01077921|7351857|FG000|NOT COMPLETED|First Intervention||1
6436955|NCT01077921|7351858|FG001|NOT COMPLETED|First Intervention||1
6436956|NCT01077921|7351857|FG000|STARTED|Washout||13
6436957|NCT01077921|7351858|FG001|STARTED|Washout||12
6436958|NCT01077921|7351857|FG000|COMPLETED|Washout||13
6436959|NCT01077921|7351858|FG001|COMPLETED|Washout||10
6436960|NCT01077921|7351857|FG000|NOT COMPLETED|Washout||0
6436961|NCT01077921|7351858|FG001|NOT COMPLETED|Washout||2
6436962|NCT01077921|7351857|FG000|STARTED|Second Intervention||13
6436963|NCT01077921|7351858|FG001|STARTED|Second Intervention||10
6436964|NCT01077921|7351857|FG000|COMPLETED|Second Intervention||13
6436965|NCT01077921|7351858|FG001|COMPLETED|Second Intervention||9
6436966|NCT01077921|7351857|FG000|NOT COMPLETED|Second Intervention||0
6436967|NCT01077921|7351858|FG001|NOT COMPLETED|Second Intervention||1
6436968|NCT01077960|7351865|FG000|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
6436969|NCT01077960|7351865|FG000|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
6436970|NCT01077960|7351865|FG000|NOT COMPLETED|Overall Study||16
6436971|NCT01077973|7351872|FG000|STARTED|Overall Study||41
6436972|NCT01077973|7351873|FG001|STARTED|Overall Study||79
6436973|NCT01077973|7351874|FG002|STARTED|Overall Study||80
6436974|NCT01077973|7351872|FG000|COMPLETED|Overall Study||41
6436975|NCT01077973|7351873|FG001|COMPLETED|Overall Study||79
6436976|NCT01077973|7351874|FG002|COMPLETED|Overall Study||80
6436977|NCT01077973|7351872|FG000|NOT COMPLETED|Overall Study||0
6436978|NCT01077973|7351873|FG001|NOT COMPLETED|Overall Study||0
6436979|NCT01077973|7351874|FG002|NOT COMPLETED|Overall Study||0
6436980|NCT01078090|7351884|FG000|STARTED|Overall Study||5745
6436981|NCT01078090|7351884|FG000|COMPLETED|Overall Study||1152
6436982|NCT01078090|7351884|FG000|NOT COMPLETED|Overall Study||4593
6436983|NCT01078116|7351902|FG000|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
6436984|NCT01078116|7351902|FG000|COMPLETED|Overall Study||76
6436985|NCT01078116|7351902|FG000|NOT COMPLETED|Overall Study||48
6436986|NCT01078155|7351906|FG000|STARTED|Overall Study||131
6436987|NCT01078155|7351906|FG000|COMPLETED|Overall Study||87
6436988|NCT01078155|7351906|FG000|NOT COMPLETED|Overall Study||44
6436989|NCT01078168|7351912|FG000|STARTED|Overall Study||11
6436990|NCT01078168|7351913|FG001|STARTED|Overall Study||11
6436991|NCT01078168|7351912|FG000|COMPLETED|Overall Study||11
6436992|NCT01078168|7351913|FG001|COMPLETED|Overall Study||10
6436993|NCT01078168|7351912|FG000|NOT COMPLETED|Overall Study||0
6436994|NCT01078168|7351913|FG001|NOT COMPLETED|Overall Study||1
6436995|NCT01078207|7351919|FG000|STARTED|Overall Study||100
6436996|NCT01078207|7351919|FG000|COMPLETED|Overall Study||100
6436997|NCT01078207|7351919|FG000|NOT COMPLETED|Overall Study||0
6436998|NCT01078220|7351923|FG000|STARTED|Overall Study||189629
6436999|NCT01078220|7351923|FG000|COMPLETED|Overall Study||189629
6437000|NCT01078220|7351923|FG000|NOT COMPLETED|Overall Study||0
6437001|NCT01078233|7351936|FG000|STARTED|Overall Study||656
6437002|NCT01078233|7351937|FG001|STARTED|Overall Study||296
6437003|NCT01078233|7351938|FG002|STARTED|Overall Study||1681
6437004|NCT01078233|7351939|FG003|STARTED|Overall Study||631
6437005|NCT01078233|7351940|FG004|STARTED|Overall Study||3199
6437006|NCT01078233|7351941|FG005|STARTED|Overall Study||154
6437007|NCT01078233|7351936|FG000|COMPLETED|Overall Study||656
6437008|NCT01078233|7351937|FG001|COMPLETED|Overall Study||296
6437009|NCT01078233|7351938|FG002|COMPLETED|Overall Study||1681
6437010|NCT01078233|7351939|FG003|COMPLETED|Overall Study||631
6437011|NCT01078233|7351940|FG004|COMPLETED|Overall Study||3199
6437012|NCT01078233|7351941|FG005|COMPLETED|Overall Study||154
6437013|NCT01078233|7351936|FG000|NOT COMPLETED|Overall Study||0
6437014|NCT01078233|7351937|FG001|NOT COMPLETED|Overall Study||0
6437015|NCT01078233|7351938|FG002|NOT COMPLETED|Overall Study||0
6437016|NCT01078233|7351939|FG003|NOT COMPLETED|Overall Study||0
6437017|NCT01078233|7351940|FG004|NOT COMPLETED|Overall Study||0
6437018|NCT01078233|7351941|FG005|NOT COMPLETED|Overall Study||0
6437019|NCT01078246|7351956|FG000|STARTED|Overall Study||1041
6437020|NCT01078246|7351957|FG001|STARTED|Overall Study||405
6437021|NCT01078246|7351958|FG002|STARTED|Overall Study||1963
6437022|NCT01078246|7351959|FG003|STARTED|Overall Study||152
6437023|NCT01078246|7351960|FG004|STARTED|Overall Study||3310
6437024|NCT01078246|7351961|FG005|STARTED|Overall Study||231
6437025|NCT01078246|7351962|FG006|STARTED|Overall Study||22
6437026|NCT01078246|7351956|FG000|COMPLETED|Overall Study||1041
6437027|NCT01078246|7351957|FG001|COMPLETED|Overall Study||405
6437028|NCT01078246|7351958|FG002|COMPLETED|Overall Study||1963
6437029|NCT01078246|7351959|FG003|COMPLETED|Overall Study||152
6437030|NCT01078246|7351960|FG004|COMPLETED|Overall Study||3310
6437031|NCT01078246|7351961|FG005|COMPLETED|Overall Study||231
6437032|NCT01078246|7351962|FG006|COMPLETED|Overall Study||22
6437033|NCT01078246|7351956|FG000|NOT COMPLETED|Overall Study||0
6437034|NCT01078246|7351957|FG001|NOT COMPLETED|Overall Study||0
6437035|NCT01078246|7351958|FG002|NOT COMPLETED|Overall Study||0
6437036|NCT01078246|7351959|FG003|NOT COMPLETED|Overall Study||0
6437037|NCT01078246|7351960|FG004|NOT COMPLETED|Overall Study||0
6437038|NCT01078246|7351961|FG005|NOT COMPLETED|Overall Study||0
6437039|NCT01078246|7351962|FG006|NOT COMPLETED|Overall Study||0
6437040|NCT01078298|7351972|FG000|STARTED|Overall Study||256
6437041|NCT01078298|7351973|FG001|STARTED|Overall Study||269
6437042|NCT01078298|7351972|FG000|COMPLETED|Overall Study||175
6437043|NCT01078298|7351973|FG001|COMPLETED|Overall Study||179
6437044|NCT01078298|7351972|FG000|NOT COMPLETED|Overall Study||81
6437045|NCT01078298|7351973|FG001|NOT COMPLETED|Overall Study||90
6437046|NCT01078363|7351981|FG000|STARTED|Overall Study||47
6437047|NCT01078363|7351982|FG001|STARTED|Overall Study||49
6437048|NCT01078363|7351981|FG000|COMPLETED|Overall Study||47
6437049|NCT01078363|7351982|FG001|COMPLETED|Overall Study||49
6437050|NCT01078363|7351981|FG000|NOT COMPLETED|Overall Study||0
6437051|NCT01078363|7351982|FG001|NOT COMPLETED|Overall Study||0
6437052|NCT01078376|7351994|FG000|STARTED|Overall Study||9
6437053|NCT01078376|7351995|FG001|STARTED|Overall Study||9
6437054|NCT01078376|7351996|FG002|STARTED|Overall Study||8
6437055|NCT01078376|7351997|FG003|STARTED|Overall Study||3
6437056|NCT01078376|7351994|FG000|COMPLETED|Overall Study||9
6437057|NCT01078376|7351995|FG001|COMPLETED|Overall Study||9
6437058|NCT01078376|7351996|FG002|COMPLETED|Overall Study||8
6437059|NCT01078376|7351997|FG003|COMPLETED|Overall Study||3
6437060|NCT01078376|7351994|FG000|NOT COMPLETED|Overall Study||0
6437061|NCT01078376|7351995|FG001|NOT COMPLETED|Overall Study||0
6437062|NCT01078376|7351996|FG002|NOT COMPLETED|Overall Study||0
6437063|NCT01078376|7351997|FG003|NOT COMPLETED|Overall Study||0
6437064|NCT01078389|7352012|FG000|STARTED|Overall Study||157
6437065|NCT01078389|7352013|FG001|STARTED|Overall Study||157
6437066|NCT01078389|7352012|FG000|COMPLETED|Overall Study||93
6437067|NCT01078389|7352013|FG001|COMPLETED|Overall Study||90
6437068|NCT01078389|7352012|FG000|NOT COMPLETED|Overall Study||64
6437069|NCT01078389|7352013|FG001|NOT COMPLETED|Overall Study||67
6437070|NCT01078402|7352022|FG000|STARTED|Overall Study||431
6437071|NCT01078402|7352023|FG001|STARTED|Overall Study||124
6437072|NCT01078402|7352024|FG002|STARTED|Overall Study||234
6437073|NCT01078402|7352022|FG000|COMPLETED|Overall Study||324
6437074|NCT01078402|7352023|FG001|COMPLETED|Overall Study||95
6437075|NCT01078402|7352024|FG002|COMPLETED|Overall Study||166
6437076|NCT01078402|7352022|FG000|NOT COMPLETED|Overall Study||107
6437077|NCT01078402|7352023|FG001|NOT COMPLETED|Overall Study||29
6437078|NCT01078402|7352024|FG002|NOT COMPLETED|Overall Study||68
6437079|NCT01078441|7352036|FG000|STARTED|Overall Study||2
6437080|NCT01078441|7352036|FG000|COMPLETED|Overall Study||1
6437081|NCT01078441|7352036|FG000|NOT COMPLETED|Overall Study||1
6437082|NCT01078545|7352040|FG000|STARTED|Overall Study||729
6437083|NCT01078545|7352040|FG000|Intent-to-treat Population|Overall Study||729
6437084|NCT01078545|7352040|FG000|Per Protocol Population|Overall Study||661
6437085|NCT01078545|7352040|FG000|COMPLETED|Overall Study||703
6437086|NCT01078545|7352040|FG000|NOT COMPLETED|Overall Study||26
6437087|NCT01078558|7352047|FG000|STARTED|Overall Study||2836
6437088|NCT01078558|7352048|FG001|STARTED|Overall Study||1127
6437089|NCT01078558|7352049|FG002|STARTED|Overall Study||1957
6437090|NCT01078558|7352047|FG000|Oligoarticular PsA|Overall Study||0
6437091|NCT01078558|7352048|FG001|Oligoarticular PsA|Overall Study||197
6437092|NCT01078558|7352049|FG002|Oligoarticular PsA|Overall Study||0
6437093|NCT01078558|7352047|FG000|COMPLETED|Overall Study||818
6437094|NCT01078558|7352048|FG001|COMPLETED|Overall Study||372
6437095|NCT01078558|7352049|FG002|COMPLETED|Overall Study||596
6437096|NCT01078558|7352047|FG000|NOT COMPLETED|Overall Study||2018
6437097|NCT01078558|7352048|FG001|NOT COMPLETED|Overall Study||755
6437098|NCT01078558|7352049|FG002|NOT COMPLETED|Overall Study||1361
6437099|NCT01078571|7352057|FG000|STARTED|Overall Study||705
6437100|NCT01078571|7352057|FG000|Safety Population|Overall Study||675
6437101|NCT01078571|7352057|FG000|Intent-to-treat (ITT) Population|Overall Study||591
6437102|NCT01078571|7352057|FG000|COMPLETED|Overall Study||590
6437103|NCT01078571|7352057|FG000|NOT COMPLETED|Overall Study||115
6437104|NCT01078584|7352066|FG000|STARTED|Overall Study||7993
6437105|NCT01078584|7352066|FG000|Participants Conducted Visit 2 (3-month)|Overall Study||7125
6552774|NCT01738984|7475184|FG001|NOT COMPLETED|Overall Study||39
6552775|NCT01739231|7475196|FG000|STARTED|Part A||24
6552776|NCT01739231|7475197|FG001|STARTED|Part A||24
6552777|NCT01739231|7475198|FG002|STARTED|Part A||12
6552778|NCT01739231|7475199|FG003|STARTED|Part A||0
6552779|NCT01739231|7475196|FG000|Received All 3 Vaccinations|Part A||21
6552780|NCT01739231|7475197|FG001|Received All 3 Vaccinations|Part A||20
6552781|NCT01739231|7475198|FG002|Received All 3 Vaccinations|Part A||12
6552782|NCT01739231|7475199|FG003|Received All 3 Vaccinations|Part A||0
6552783|NCT01739231|7475196|FG000|COMPLETED|Part A||20
6552784|NCT01739231|7475197|FG001|COMPLETED|Part A||17
6552785|NCT01739231|7475198|FG002|COMPLETED|Part A||12
6437106|NCT01078584|7352066|FG000|Participants Conducted Visit 3 (6-month)|Overall Study||5833
6437107|NCT01078584|7352066|FG000|Participants Conducted Visit 4(12-month)|Overall Study||4983
6437108|NCT01078584|7352066|FG000|COMPLETED|Overall Study||4983
6437109|NCT01078584|7352066|FG000|NOT COMPLETED|Overall Study||3010
6437110|NCT01078623|7352083|FG000|STARTED|Treatment Period 1||6
6437111|NCT01078623|7352084|FG001|STARTED|Treatment Period 1||6
6437112|NCT01078623|7352085|FG002|STARTED|Treatment Period 1||7
6437113|NCT01078623|7352086|FG003|STARTED|Treatment Period 1||6
6437114|NCT01078623|7352087|FG004|STARTED|Treatment Period 1||7
6437115|NCT01078623|7352088|FG005|STARTED|Treatment Period 1||6
6437116|NCT01078623|7352089|FG006|STARTED|Treatment Period 1||7
6437117|NCT01078623|7352090|FG007|STARTED|Treatment Period 1||7
6437118|NCT01078623|7352091|FG008|STARTED|Treatment Period 1||6
6437119|NCT01078623|7352092|FG009|STARTED|Treatment Period 1||7
6437120|NCT01078623|7352093|FG010|STARTED|Treatment Period 1||7
6437121|NCT01078623|7352094|FG011|STARTED|Treatment Period 1||7
6437122|NCT01078623|7352095|FG012|STARTED|Treatment Period 1||7
6437123|NCT01078623|7352096|FG013|STARTED|Treatment Period 1||7
6437124|NCT01078623|7352097|FG014|STARTED|Treatment Period 1||7
6437125|NCT01078623|7352098|FG015|STARTED|Treatment Period 1||7
6437126|NCT01078623|7352099|FG016|STARTED|Treatment Period 1||7
6437127|NCT01078623|7352100|FG017|STARTED|Treatment Period 1||7
6437128|NCT01078623|7352101|FG018|STARTED|Treatment Period 1||7
6437129|NCT01078623|7352102|FG019|STARTED|Treatment Period 1||7
6437130|NCT01078623|7352083|FG000|COMPLETED|Treatment Period 1||5
6437131|NCT01078623|7352084|FG001|COMPLETED|Treatment Period 1||5
6437132|NCT01078623|7352085|FG002|COMPLETED|Treatment Period 1||6
6437133|NCT01078623|7352086|FG003|COMPLETED|Treatment Period 1||6
6437134|NCT01078623|7352087|FG004|COMPLETED|Treatment Period 1||7
6437135|NCT01078623|7352088|FG005|COMPLETED|Treatment Period 1||5
6437136|NCT01078623|7352089|FG006|COMPLETED|Treatment Period 1||6
6437137|NCT01078623|7352090|FG007|COMPLETED|Treatment Period 1||6
6437138|NCT01078623|7352091|FG008|COMPLETED|Treatment Period 1||5
6437139|NCT01078623|7352092|FG009|COMPLETED|Treatment Period 1||6
6437140|NCT01078623|7352093|FG010|COMPLETED|Treatment Period 1||6
6437141|NCT01078623|7352094|FG011|COMPLETED|Treatment Period 1||7
6437142|NCT01078623|7352095|FG012|COMPLETED|Treatment Period 1||7
6437143|NCT01078623|7352096|FG013|COMPLETED|Treatment Period 1||7
6437144|NCT01078623|7352097|FG014|COMPLETED|Treatment Period 1||7
6437145|NCT01078623|7352098|FG015|COMPLETED|Treatment Period 1||7
6437146|NCT01078623|7352099|FG016|COMPLETED|Treatment Period 1||7
6437147|NCT01078623|7352100|FG017|COMPLETED|Treatment Period 1||7
6437148|NCT01078623|7352101|FG018|COMPLETED|Treatment Period 1||7
6437149|NCT01078623|7352102|FG019|COMPLETED|Treatment Period 1||7
6437150|NCT01078623|7352083|FG000|NOT COMPLETED|Treatment Period 1||1
6437151|NCT01078623|7352084|FG001|NOT COMPLETED|Treatment Period 1||1
6437152|NCT01078623|7352085|FG002|NOT COMPLETED|Treatment Period 1||1
6437153|NCT01078623|7352086|FG003|NOT COMPLETED|Treatment Period 1||0
6437154|NCT01078623|7352087|FG004|NOT COMPLETED|Treatment Period 1||0
6437155|NCT01078623|7352088|FG005|NOT COMPLETED|Treatment Period 1||1
6437156|NCT01078623|7352089|FG006|NOT COMPLETED|Treatment Period 1||1
6437157|NCT01078623|7352090|FG007|NOT COMPLETED|Treatment Period 1||1
6437158|NCT01078623|7352091|FG008|NOT COMPLETED|Treatment Period 1||1
6437159|NCT01078623|7352092|FG009|NOT COMPLETED|Treatment Period 1||1
6437160|NCT01078623|7352093|FG010|NOT COMPLETED|Treatment Period 1||1
6437161|NCT01078623|7352094|FG011|NOT COMPLETED|Treatment Period 1||0
6437162|NCT01078623|7352095|FG012|NOT COMPLETED|Treatment Period 1||0
6437163|NCT01078623|7352096|FG013|NOT COMPLETED|Treatment Period 1||0
6437164|NCT01078623|7352097|FG014|NOT COMPLETED|Treatment Period 1||0
6437165|NCT01078623|7352098|FG015|NOT COMPLETED|Treatment Period 1||0
6437166|NCT01078623|7352099|FG016|NOT COMPLETED|Treatment Period 1||0
6437167|NCT01078623|7352100|FG017|NOT COMPLETED|Treatment Period 1||0
6437168|NCT01078623|7352101|FG018|NOT COMPLETED|Treatment Period 1||0
6552786|NCT01739231|7475199|FG003|COMPLETED|Part A||0
6552787|NCT01739231|7475196|FG000|NOT COMPLETED|Part A||4
6552788|NCT01739231|7475197|FG001|NOT COMPLETED|Part A||7
6437169|NCT01078623|7352102|FG019|NOT COMPLETED|Treatment Period 1||0
6437170|NCT01078623|7352083|FG000|STARTED|Treatment Period 2||5
6437171|NCT01078623|7352084|FG001|STARTED|Treatment Period 2||5
6437172|NCT01078623|7352085|FG002|STARTED|Treatment Period 2||6
6437173|NCT01078623|7352086|FG003|STARTED|Treatment Period 2||6
6437174|NCT01078623|7352087|FG004|STARTED|Treatment Period 2||7
6552789|NCT01739231|7475198|FG002|NOT COMPLETED|Part A||0
6552790|NCT01739231|7475199|FG003|NOT COMPLETED|Part A||0
6552791|NCT01739231|7475196|FG000|STARTED|Part B||20
6552792|NCT01739231|7475197|FG001|STARTED|Part B||17
6437175|NCT01078623|7352088|FG005|STARTED|Treatment Period 2||5
6437176|NCT01078623|7352089|FG006|STARTED|Treatment Period 2||6
6437177|NCT01078623|7352090|FG007|STARTED|Treatment Period 2||6
6437178|NCT01078623|7352091|FG008|STARTED|Treatment Period 2||5
6437179|NCT01078623|7352092|FG009|STARTED|Treatment Period 2||6
6437180|NCT01078623|7352093|FG010|STARTED|Treatment Period 2||6
6437181|NCT01078623|7352094|FG011|STARTED|Treatment Period 2||7
6437182|NCT01078623|7352095|FG012|STARTED|Treatment Period 2||7
6437183|NCT01078623|7352096|FG013|STARTED|Treatment Period 2||7
6437184|NCT01078623|7352097|FG014|STARTED|Treatment Period 2||7
6437185|NCT01078623|7352098|FG015|STARTED|Treatment Period 2||7
6437186|NCT01078623|7352099|FG016|STARTED|Treatment Period 2||7
6437187|NCT01078623|7352100|FG017|STARTED|Treatment Period 2||7
6437188|NCT01078623|7352101|FG018|STARTED|Treatment Period 2||7
6437189|NCT01078623|7352102|FG019|STARTED|Treatment Period 2||7
6437190|NCT01078623|7352083|FG000|COMPLETED|Treatment Period 2||5
6437191|NCT01078623|7352084|FG001|COMPLETED|Treatment Period 2||5
6437192|NCT01078623|7352085|FG002|COMPLETED|Treatment Period 2||6
6437193|NCT01078623|7352086|FG003|COMPLETED|Treatment Period 2||6
6437194|NCT01078623|7352087|FG004|COMPLETED|Treatment Period 2||7
6437195|NCT01078623|7352088|FG005|COMPLETED|Treatment Period 2||4
6437196|NCT01078623|7352089|FG006|COMPLETED|Treatment Period 2||5
6437197|NCT01078623|7352090|FG007|COMPLETED|Treatment Period 2||6
6437198|NCT01078623|7352091|FG008|COMPLETED|Treatment Period 2||5
6437199|NCT01078623|7352092|FG009|COMPLETED|Treatment Period 2||6
6437200|NCT01078623|7352093|FG010|COMPLETED|Treatment Period 2||6
6437201|NCT01078623|7352094|FG011|COMPLETED|Treatment Period 2||7
6437202|NCT01078623|7352095|FG012|COMPLETED|Treatment Period 2||7
6437203|NCT01078623|7352096|FG013|COMPLETED|Treatment Period 2||7
6437204|NCT01078623|7352097|FG014|COMPLETED|Treatment Period 2||7
6437205|NCT01078623|7352098|FG015|COMPLETED|Treatment Period 2||7
6437206|NCT01078623|7352099|FG016|COMPLETED|Treatment Period 2||7
6437207|NCT01078623|7352100|FG017|COMPLETED|Treatment Period 2||7
6437208|NCT01078623|7352101|FG018|COMPLETED|Treatment Period 2||6
6437209|NCT01078623|7352102|FG019|COMPLETED|Treatment Period 2||7
6437210|NCT01078623|7352083|FG000|NOT COMPLETED|Treatment Period 2||0
6437211|NCT01078623|7352084|FG001|NOT COMPLETED|Treatment Period 2||0
6437212|NCT01078623|7352085|FG002|NOT COMPLETED|Treatment Period 2||0
6437213|NCT01078623|7352086|FG003|NOT COMPLETED|Treatment Period 2||0
6437214|NCT01078623|7352087|FG004|NOT COMPLETED|Treatment Period 2||0
6437215|NCT01078623|7352088|FG005|NOT COMPLETED|Treatment Period 2||1
6437216|NCT01078623|7352089|FG006|NOT COMPLETED|Treatment Period 2||1
6437217|NCT01078623|7352090|FG007|NOT COMPLETED|Treatment Period 2||0
6437218|NCT01078623|7352091|FG008|NOT COMPLETED|Treatment Period 2||0
6437219|NCT01078623|7352092|FG009|NOT COMPLETED|Treatment Period 2||0
6437220|NCT01078623|7352093|FG010|NOT COMPLETED|Treatment Period 2||0
6437221|NCT01078623|7352094|FG011|NOT COMPLETED|Treatment Period 2||0
6437222|NCT01078623|7352095|FG012|NOT COMPLETED|Treatment Period 2||0
6437223|NCT01078623|7352096|FG013|NOT COMPLETED|Treatment Period 2||0
6437224|NCT01078623|7352097|FG014|NOT COMPLETED|Treatment Period 2||0
6437225|NCT01078623|7352098|FG015|NOT COMPLETED|Treatment Period 2||0
6437226|NCT01078623|7352099|FG016|NOT COMPLETED|Treatment Period 2||0
6437227|NCT01078623|7352100|FG017|NOT COMPLETED|Treatment Period 2||0
6437228|NCT01078623|7352101|FG018|NOT COMPLETED|Treatment Period 2||1
6437229|NCT01078623|7352102|FG019|NOT COMPLETED|Treatment Period 2||0
6437230|NCT01078623|7352083|FG000|STARTED|Treatment Period 3||5
6437231|NCT01078623|7352084|FG001|STARTED|Treatment Period 3||5
6437232|NCT01078623|7352085|FG002|STARTED|Treatment Period 3||6
6437233|NCT01078623|7352086|FG003|STARTED|Treatment Period 3||6
6437234|NCT01078623|7352087|FG004|STARTED|Treatment Period 3||7
6437235|NCT01078623|7352088|FG005|STARTED|Treatment Period 3||4
6437236|NCT01078623|7352089|FG006|STARTED|Treatment Period 3||5
6437237|NCT01078623|7352090|FG007|STARTED|Treatment Period 3||6
6437238|NCT01078623|7352091|FG008|STARTED|Treatment Period 3||5
6437239|NCT01078623|7352092|FG009|STARTED|Treatment Period 3||6
6437240|NCT01078623|7352093|FG010|STARTED|Treatment Period 3||6
6437241|NCT01078623|7352094|FG011|STARTED|Treatment Period 3||7
6437242|NCT01078623|7352095|FG012|STARTED|Treatment Period 3||7
6437243|NCT01078623|7352096|FG013|STARTED|Treatment Period 3||7
6437244|NCT01078623|7352097|FG014|STARTED|Treatment Period 3||7
6437245|NCT01078623|7352098|FG015|STARTED|Treatment Period 3||7
6437246|NCT01078623|7352099|FG016|STARTED|Treatment Period 3||7
6437247|NCT01078623|7352100|FG017|STARTED|Treatment Period 3||7
6437248|NCT01078623|7352101|FG018|STARTED|Treatment Period 3||6
6437249|NCT01078623|7352102|FG019|STARTED|Treatment Period 3||7
6437250|NCT01078623|7352083|FG000|COMPLETED|Treatment Period 3||5
6437251|NCT01078623|7352084|FG001|COMPLETED|Treatment Period 3||5
6437252|NCT01078623|7352085|FG002|COMPLETED|Treatment Period 3||6
6437253|NCT01078623|7352086|FG003|COMPLETED|Treatment Period 3||6
6437254|NCT01078623|7352087|FG004|COMPLETED|Treatment Period 3||6
6437255|NCT01078623|7352088|FG005|COMPLETED|Treatment Period 3||4
6437256|NCT01078623|7352089|FG006|COMPLETED|Treatment Period 3||5
6437257|NCT01078623|7352090|FG007|COMPLETED|Treatment Period 3||6
6437258|NCT01078623|7352091|FG008|COMPLETED|Treatment Period 3||5
6437259|NCT01078623|7352092|FG009|COMPLETED|Treatment Period 3||6
6437260|NCT01078623|7352093|FG010|COMPLETED|Treatment Period 3||6
6552793|NCT01739231|7475198|FG002|STARTED|Part B||12
6437261|NCT01078623|7352094|FG011|COMPLETED|Treatment Period 3||7
6437262|NCT01078623|7352095|FG012|COMPLETED|Treatment Period 3||7
6437263|NCT01078623|7352096|FG013|COMPLETED|Treatment Period 3||6
6437264|NCT01078623|7352097|FG014|COMPLETED|Treatment Period 3||7
6437265|NCT01078623|7352098|FG015|COMPLETED|Treatment Period 3||7
6437266|NCT01078623|7352099|FG016|COMPLETED|Treatment Period 3||7
6437267|NCT01078623|7352100|FG017|COMPLETED|Treatment Period 3||7
6437268|NCT01078623|7352101|FG018|COMPLETED|Treatment Period 3||6
6437269|NCT01078623|7352102|FG019|COMPLETED|Treatment Period 3||7
6437270|NCT01078623|7352083|FG000|NOT COMPLETED|Treatment Period 3||0
6437271|NCT01078623|7352084|FG001|NOT COMPLETED|Treatment Period 3||0
6437272|NCT01078623|7352085|FG002|NOT COMPLETED|Treatment Period 3||0
6437273|NCT01078623|7352086|FG003|NOT COMPLETED|Treatment Period 3||0
6437274|NCT01078623|7352087|FG004|NOT COMPLETED|Treatment Period 3||1
6437275|NCT01078623|7352088|FG005|NOT COMPLETED|Treatment Period 3||0
6437276|NCT01078623|7352089|FG006|NOT COMPLETED|Treatment Period 3||0
6437277|NCT01078623|7352090|FG007|NOT COMPLETED|Treatment Period 3||0
6437278|NCT01078623|7352091|FG008|NOT COMPLETED|Treatment Period 3||0
6437279|NCT01078623|7352092|FG009|NOT COMPLETED|Treatment Period 3||0
6437280|NCT01078623|7352093|FG010|NOT COMPLETED|Treatment Period 3||0
6437281|NCT01078623|7352094|FG011|NOT COMPLETED|Treatment Period 3||0
6437282|NCT01078623|7352095|FG012|NOT COMPLETED|Treatment Period 3||0
6437283|NCT01078623|7352096|FG013|NOT COMPLETED|Treatment Period 3||1
6437284|NCT01078623|7352097|FG014|NOT COMPLETED|Treatment Period 3||0
6653316|NCT02436330|7583086|FG000|COMPLETED|Cohort 2||10
6653317|NCT02436330|7583087|FG001|COMPLETED|Cohort 2||7
6653318|NCT02436330|7583086|FG000|NOT COMPLETED|Cohort 2||4
6653319|NCT02436330|7583087|FG001|NOT COMPLETED|Cohort 2||3
6653320|NCT02436330|7583086|FG000|STARTED|Cohort 3||12
6653321|NCT02436330|7583087|FG001|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
6653322|NCT02436330|7583086|FG000|COMPLETED|Cohort 3||7
6653323|NCT02436330|7583087|FG001|COMPLETED|Cohort 3||0
6653324|NCT02436330|7583086|FG000|NOT COMPLETED|Cohort 3||5
6437285|NCT01078623|7352098|FG015|NOT COMPLETED|Treatment Period 3||0
6437286|NCT01078623|7352099|FG016|NOT COMPLETED|Treatment Period 3||0
6437287|NCT01078623|7352100|FG017|NOT COMPLETED|Treatment Period 3||0
6437288|NCT01078623|7352101|FG018|NOT COMPLETED|Treatment Period 3||0
6437289|NCT01078623|7352102|FG019|NOT COMPLETED|Treatment Period 3||0
6437290|NCT01078623|7352083|FG000|STARTED|Treatment Period 4||5
6653325|NCT02436330|7583087|FG001|NOT COMPLETED|Cohort 3||0
6653326|NCT02436330|7583086|FG000|STARTED|Cohort 4||6
6653327|NCT02436330|7583087|FG001|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
6653328|NCT02436330|7583086|FG000|COMPLETED|Cohort 4||4
6653329|NCT02436330|7583087|FG001|COMPLETED|Cohort 4||0
6653330|NCT02436330|7583086|FG000|NOT COMPLETED|Cohort 4||2
6653331|NCT02436330|7583087|FG001|NOT COMPLETED|Cohort 4||0
6653332|NCT02436330|7583086|FG000|STARTED|Cohort 5||10
6653333|NCT02436330|7583087|FG001|STARTED|Cohort 5||5
6653334|NCT02436330|7583086|FG000|COMPLETED|Cohort 5||4
6653335|NCT02436330|7583087|FG001|COMPLETED|Cohort 5||1
6437291|NCT01078623|7352084|FG001|STARTED|Treatment Period 4||5
6437292|NCT01078623|7352085|FG002|STARTED|Treatment Period 4||6
6437293|NCT01078623|7352086|FG003|STARTED|Treatment Period 4||6
6437294|NCT01078623|7352087|FG004|STARTED|Treatment Period 4||6
6437295|NCT01078623|7352088|FG005|STARTED|Treatment Period 4||4
6437296|NCT01078623|7352089|FG006|STARTED|Treatment Period 4||5
6437297|NCT01078623|7352090|FG007|STARTED|Treatment Period 4||6
6437298|NCT01078623|7352091|FG008|STARTED|Treatment Period 4||5
6437299|NCT01078623|7352092|FG009|STARTED|Treatment Period 4||6
6437300|NCT01078623|7352093|FG010|STARTED|Treatment Period 4||6
6437301|NCT01078623|7352094|FG011|STARTED|Treatment Period 4||7
6437302|NCT01078623|7352095|FG012|STARTED|Treatment Period 4||7
6437303|NCT01078623|7352096|FG013|STARTED|Treatment Period 4||6
6437304|NCT01078623|7352097|FG014|STARTED|Treatment Period 4||7
6437305|NCT01078623|7352098|FG015|STARTED|Treatment Period 4||7
6437306|NCT01078623|7352099|FG016|STARTED|Treatment Period 4||7
6437307|NCT01078623|7352100|FG017|STARTED|Treatment Period 4||7
6437308|NCT01078623|7352101|FG018|STARTED|Treatment Period 4||6
6437309|NCT01078623|7352102|FG019|STARTED|Treatment Period 4||7
6437310|NCT01078623|7352083|FG000|COMPLETED|Treatment Period 4||5
6437311|NCT01078623|7352084|FG001|COMPLETED|Treatment Period 4||5
6437312|NCT01078623|7352085|FG002|COMPLETED|Treatment Period 4||5
6437313|NCT01078623|7352086|FG003|COMPLETED|Treatment Period 4||6
6437314|NCT01078623|7352087|FG004|COMPLETED|Treatment Period 4||6
6437315|NCT01078623|7352088|FG005|COMPLETED|Treatment Period 4||4
6437316|NCT01078623|7352089|FG006|COMPLETED|Treatment Period 4||5
6437317|NCT01078623|7352090|FG007|COMPLETED|Treatment Period 4||6
6437318|NCT01078623|7352091|FG008|COMPLETED|Treatment Period 4||5
6437319|NCT01078623|7352092|FG009|COMPLETED|Treatment Period 4||6
6437320|NCT01078623|7352093|FG010|COMPLETED|Treatment Period 4||6
6437321|NCT01078623|7352094|FG011|COMPLETED|Treatment Period 4||7
6437322|NCT01078623|7352095|FG012|COMPLETED|Treatment Period 4||7
6437323|NCT01078623|7352096|FG013|COMPLETED|Treatment Period 4||6
6437324|NCT01078623|7352097|FG014|COMPLETED|Treatment Period 4||7
6437325|NCT01078623|7352098|FG015|COMPLETED|Treatment Period 4||6
6437326|NCT01078623|7352099|FG016|COMPLETED|Treatment Period 4||7
6653336|NCT02436330|7583086|FG000|NOT COMPLETED|Cohort 5||6
6653337|NCT02436330|7583087|FG001|NOT COMPLETED|Cohort 5||4
6437327|NCT01078623|7352100|FG017|COMPLETED|Treatment Period 4||7
6437328|NCT01078623|7352101|FG018|COMPLETED|Treatment Period 4||6
6437329|NCT01078623|7352102|FG019|COMPLETED|Treatment Period 4||7
6437330|NCT01078623|7352083|FG000|NOT COMPLETED|Treatment Period 4||0
6437331|NCT01078623|7352084|FG001|NOT COMPLETED|Treatment Period 4||0
6437332|NCT01078623|7352085|FG002|NOT COMPLETED|Treatment Period 4||1
6437333|NCT01078623|7352086|FG003|NOT COMPLETED|Treatment Period 4||0
6437334|NCT01078623|7352087|FG004|NOT COMPLETED|Treatment Period 4||0
6437335|NCT01078623|7352088|FG005|NOT COMPLETED|Treatment Period 4||0
6437336|NCT01078623|7352089|FG006|NOT COMPLETED|Treatment Period 4||0
6437337|NCT01078623|7352090|FG007|NOT COMPLETED|Treatment Period 4||0
6437338|NCT01078623|7352091|FG008|NOT COMPLETED|Treatment Period 4||0
6437339|NCT01078623|7352092|FG009|NOT COMPLETED|Treatment Period 4||0
6437340|NCT01078623|7352093|FG010|NOT COMPLETED|Treatment Period 4||0
6437341|NCT01078623|7352094|FG011|NOT COMPLETED|Treatment Period 4||0
6437342|NCT01078623|7352095|FG012|NOT COMPLETED|Treatment Period 4||0
6437343|NCT01078623|7352096|FG013|NOT COMPLETED|Treatment Period 4||0
6437344|NCT01078623|7352097|FG014|NOT COMPLETED|Treatment Period 4||0
6437345|NCT01078623|7352098|FG015|NOT COMPLETED|Treatment Period 4||1
6437346|NCT01078623|7352099|FG016|NOT COMPLETED|Treatment Period 4||0
6437347|NCT01078623|7352100|FG017|NOT COMPLETED|Treatment Period 4||0
6437348|NCT01078623|7352101|FG018|NOT COMPLETED|Treatment Period 4||0
6437349|NCT01078623|7352102|FG019|NOT COMPLETED|Treatment Period 4||0
6437350|NCT01078675|7352116|FG000|STARTED|Overall Study||250
6437351|NCT01078675|7352117|FG001|STARTED|Overall Study||65
6437352|NCT01078675|7352116|FG000|Patients Treated|Overall Study||198
6437353|NCT01078675|7352117|FG001|Patients Treated|Overall Study||0
6437354|NCT01078675|7352116|FG000|COMPLETED|Overall Study||182
6437355|NCT01078675|7352117|FG001|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
6437356|NCT01078675|7352116|FG000|NOT COMPLETED|Overall Study||68
6437357|NCT01078675|7352117|FG001|NOT COMPLETED|Overall Study||6
6437358|NCT01078753|7352125|FG000|STARTED|Treatment Period I||45
6437359|NCT01078753|7352126|FG001|STARTED|Treatment Period I||44
6437360|NCT01078753|7352125|FG000|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
6437361|NCT01078753|7352126|FG001|Full Analysis Set|Treatment Period I||44
6437362|NCT01078753|7352125|FG000|COMPLETED|Treatment Period I||45
6437363|NCT01078753|7352126|FG001|COMPLETED|Treatment Period I||44
6437364|NCT01078753|7352125|FG000|NOT COMPLETED|Treatment Period I||0
6437365|NCT01078753|7352126|FG001|NOT COMPLETED|Treatment Period I||0
6437366|NCT01078753|7352125|FG000|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
6437367|NCT01078753|7352126|FG001|STARTED|Treatment Period II||44
6437368|NCT01078753|7352125|FG000|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
6437369|NCT01078753|7352126|FG001|Full Analysis Set|Treatment Period II||44
6437370|NCT01078753|7352125|FG000|COMPLETED|Treatment Period II||45
6437371|NCT01078753|7352126|FG001|COMPLETED|Treatment Period II||44
6437372|NCT01078753|7352125|FG000|NOT COMPLETED|Treatment Period II||0
6437373|NCT01078753|7352126|FG001|NOT COMPLETED|Treatment Period II||0
6437374|NCT01078805|7352132|FG000|STARTED|Overall Study||4167
6437375|NCT01078805|7352132|FG000|Took at Least 1 Dose of Study Drug|Overall Study||4085
6437376|NCT01078805|7352132|FG000|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
6437377|NCT01078805|7352132|FG000|COMPLETED|Overall Study||2117
6437378|NCT01078805|7352132|FG000|NOT COMPLETED|Overall Study||2050
6437379|NCT01078909|7352141|FG000|STARTED|Overall Study||25
6437380|NCT01078909|7352142|FG001|STARTED|Overall Study||25
6437381|NCT01078909|7352143|FG002|STARTED|Overall Study||25
6437382|NCT01078909|7352144|FG003|STARTED|Overall Study||25
6437383|NCT01078909|7352145|FG004|STARTED|Overall Study||25
6437384|NCT01078909|7352141|FG000|COMPLETED|Overall Study||23
6437385|NCT01078909|7352142|FG001|COMPLETED|Overall Study||21
6437386|NCT01078909|7352143|FG002|COMPLETED|Overall Study||24
6437387|NCT01078909|7352144|FG003|COMPLETED|Overall Study||24
6437388|NCT01078909|7352145|FG004|COMPLETED|Overall Study||23
6437389|NCT01078909|7352141|FG000|NOT COMPLETED|Overall Study||2
6437390|NCT01078909|7352142|FG001|NOT COMPLETED|Overall Study||4
6437391|NCT01078909|7352143|FG002|NOT COMPLETED|Overall Study||1
6437392|NCT01078909|7352144|FG003|NOT COMPLETED|Overall Study||1
6437393|NCT01078909|7352145|FG004|NOT COMPLETED|Overall Study||2
6437394|NCT01078922|7352157|FG000|STARTED|Overall Study||11
6437395|NCT01078922|7352157|FG000|COMPLETED|Overall Study||10
6437396|NCT01078922|7352157|FG000|NOT COMPLETED|Overall Study||1
6437397|NCT01078974|7352162|FG000|STARTED|Overall Study||7
6437398|NCT01078974|7352162|FG000|COMPLETED|Overall Study||4
6552794|NCT01739231|7475199|FG003|STARTED|Part B||21
6552795|NCT01739231|7475196|FG000|Challenged|Part B||13
6552796|NCT01739231|7475197|FG001|Challenged|Part B||13
6552797|NCT01739231|7475198|FG002|Challenged|Part B||10
6437399|NCT01078974|7352162|FG000|NOT COMPLETED|Overall Study||3
6437400|NCT01079130|7352172|FG000|STARTED|Overall Study||85
6437401|NCT01079130|7352173|FG001|STARTED|Overall Study||85
6437402|NCT01079130|7352174|FG002|STARTED|Overall Study||84
6437403|NCT01079130|7352175|FG003|STARTED|Overall Study||86
6437404|NCT01079130|7352176|FG004|STARTED|Overall Study||86
6437405|NCT01079130|7352177|FG005|STARTED|Overall Study||85
6437406|NCT01079130|7352172|FG000|Safety Set: Received Study Drug|Overall Study||84
6552798|NCT01739231|7475199|FG003|Challenged|Part B||21
6437407|NCT01079130|7352173|FG001|Safety Set: Received Study Drug|Overall Study||81
6437408|NCT01079130|7352174|FG002|Safety Set: Received Study Drug|Overall Study||84
6437409|NCT01079130|7352175|FG003|Safety Set: Received Study Drug|Overall Study||85
6437410|NCT01079130|7352176|FG004|Safety Set: Received Study Drug|Overall Study||84
6437411|NCT01079130|7352177|FG005|Safety Set: Received Study Drug|Overall Study||84
6437412|NCT01079130|7352172|FG000|Full Analysis Set (FAS)|Overall Study||84
6437413|NCT01079130|7352173|FG001|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
6437414|NCT01079130|7352174|FG002|Full Analysis Set (FAS)|Overall Study||83
6437415|NCT01079130|7352175|FG003|Full Analysis Set (FAS)|Overall Study||85
6437416|NCT01079130|7352176|FG004|Full Analysis Set (FAS)|Overall Study||84
6437417|NCT01079130|7352177|FG005|Full Analysis Set (FAS)|Overall Study||84
6437418|NCT01079130|7352172|FG000|COMPLETED|Overall Study||83
6437419|NCT01079130|7352173|FG001|COMPLETED|Overall Study||78
6437420|NCT01079130|7352174|FG002|COMPLETED|Overall Study||83
6437421|NCT01079130|7352175|FG003|COMPLETED|Overall Study||81
6437422|NCT01079130|7352176|FG004|COMPLETED|Overall Study||78
6437423|NCT01079130|7352177|FG005|COMPLETED|Overall Study||80
6437424|NCT01079130|7352172|FG000|NOT COMPLETED|Overall Study||2
6437425|NCT01079130|7352173|FG001|NOT COMPLETED|Overall Study||7
6437426|NCT01079130|7352174|FG002|NOT COMPLETED|Overall Study||1
6437427|NCT01079130|7352175|FG003|NOT COMPLETED|Overall Study||5
6437428|NCT01079130|7352176|FG004|NOT COMPLETED|Overall Study||8
6437429|NCT01079130|7352177|FG005|NOT COMPLETED|Overall Study||5
6437430|NCT01079143|7352195|FG000|STARTED|Overall Study||36
6437431|NCT01079143|7352196|FG001|STARTED|Overall Study||60
6437432|NCT01079143|7352197|FG002|STARTED|Overall Study||39
6437433|NCT01079143|7352198|FG003|STARTED|Overall Study||59
6437434|NCT01079143|7352195|FG000|Exposed|Overall Study||36
6437435|NCT01079143|7352196|FG001|Exposed|Overall Study||60
6437436|NCT01079143|7352197|FG002|Exposed|Overall Study||39
6437437|NCT01079143|7352198|FG003|Exposed|Overall Study||59
6437438|NCT01079143|7352195|FG000|Month 3 (M3) Biopsies|Overall Study||36
6437439|NCT01079143|7352196|FG001|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
6437440|NCT01079143|7352197|FG002|Month 3 (M3) Biopsies|Overall Study||39
6437441|NCT01079143|7352198|FG003|Month 3 (M3) Biopsies|Overall Study||59
6437442|NCT01079143|7352195|FG000|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
6437443|NCT01079143|7352196|FG001|Month 12 (M12) Biopsies|Overall Study||43
6437444|NCT01079143|7352197|FG002|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
6437445|NCT01079143|7352198|FG003|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
6437446|NCT01079143|7352195|FG000|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
6437447|NCT01079143|7352196|FG001|M3 and M12 Biopsies|Overall Study||43
6437448|NCT01079143|7352197|FG002|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
6437449|NCT01079143|7352198|FG003|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
6437450|NCT01079143|7352195|FG000|COMPLETED|Overall Study||27
6437451|NCT01079143|7352196|FG001|COMPLETED|Overall Study||43
6437452|NCT01079143|7352197|FG002|COMPLETED|Overall Study||34
6437453|NCT01079143|7352198|FG003|COMPLETED|Overall Study||54
6437454|NCT01079143|7352195|FG000|NOT COMPLETED|Overall Study||9
6437455|NCT01079143|7352196|FG001|NOT COMPLETED|Overall Study||17
6437456|NCT01079143|7352197|FG002|NOT COMPLETED|Overall Study||5
6437457|NCT01079143|7352198|FG003|NOT COMPLETED|Overall Study||5
6437458|NCT01079182|7352212|FG000|STARTED|Overall Study||4681
6437459|NCT01079182|7352212|FG000|COMPLETED|Overall Study||1962
6437460|NCT01079182|7352212|FG000|NOT COMPLETED|Overall Study||2719
6744398|NCT03342404|7672441|FG001|STARTED|Overall Study||49
6744399|NCT03342404|7672440|FG000|COMPLETED|Overall Study||81
6744400|NCT03342404|7672441|FG001|COMPLETED|Overall Study||18
6744401|NCT03342404|7672440|FG000|NOT COMPLETED|Overall Study||15
6437461|NCT01079195|7352216|FG000|STARTED|Overall Study||15873
6437462|NCT01079195|7352216|FG000|COMPLETED|Overall Study||14442
6437463|NCT01079195|7352216|FG000|NOT COMPLETED|Overall Study||1431
6437464|NCT01079234|7352223|FG000|STARTED|Main: Week 0 to 26||164
6437465|NCT01079234|7352224|FG001|STARTED|Main: Week 0 to 26||165
6437466|NCT01079234|7352225|FG002|STARTED|Main: Week 0 to 26||164
6437467|NCT01079234|7352226|FG003|STARTED|Main: Week 0 to 26||0
6437468|NCT01079234|7352223|FG000|Exposed|Main: Week 0 to 26||164
6437469|NCT01079234|7352224|FG001|Exposed|Main: Week 0 to 26||165
6437470|NCT01079234|7352225|FG002|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
6437471|NCT01079234|7352226|FG003|Exposed|Main: Week 0 to 26||0
6437472|NCT01079234|7352223|FG000|COMPLETED|Main: Week 0 to 26||138
6437473|NCT01079234|7352224|FG001|COMPLETED|Main: Week 0 to 26||139
6437474|NCT01079234|7352225|FG002|COMPLETED|Main: Week 0 to 26||152
6437475|NCT01079234|7352226|FG003|COMPLETED|Main: Week 0 to 26||0
6437476|NCT01079234|7352223|FG000|NOT COMPLETED|Main: Week 0 to 26||26
6437477|NCT01079234|7352224|FG001|NOT COMPLETED|Main: Week 0 to 26||26
6437478|NCT01079234|7352225|FG002|NOT COMPLETED|Main: Week 0 to 26||12
6437479|NCT01079234|7352226|FG003|NOT COMPLETED|Main: Week 0 to 26||0
6437480|NCT01079234|7352223|FG000|STARTED|Extension: Week 27 to 52||0
6744402|NCT03342404|7672441|FG001|NOT COMPLETED|Overall Study||31
6437481|NCT01079234|7352224|FG001|STARTED|Extension: Week 27 to 52||0
6437482|NCT01079234|7352225|FG002|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
6437483|NCT01079234|7352226|FG003|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
6437484|NCT01079234|7352223|FG000|COMPLETED|Extension: Week 27 to 52||0
6437485|NCT01079234|7352224|FG001|COMPLETED|Extension: Week 27 to 52||0
6437486|NCT01079234|7352225|FG002|COMPLETED|Extension: Week 27 to 52||122
6437487|NCT01079234|7352226|FG003|COMPLETED|Extension: Week 27 to 52||223
6437488|NCT01079234|7352223|FG000|NOT COMPLETED|Extension: Week 27 to 52||0
6437489|NCT01079234|7352224|FG001|NOT COMPLETED|Extension: Week 27 to 52||0
6437490|NCT01079234|7352225|FG002|NOT COMPLETED|Extension: Week 27 to 52||11
6437491|NCT01079234|7352226|FG003|NOT COMPLETED|Extension: Week 27 to 52||16
6437492|NCT01079299|7352237|FG000|STARTED|Overall Study||27
6437493|NCT01079299|7352238|FG001|STARTED|Overall Study||25
6437494|NCT01079299|7352237|FG000|COMPLETED|Overall Study||27
6437495|NCT01079299|7352238|FG001|COMPLETED|Overall Study||25
6437496|NCT01079299|7352237|FG000|NOT COMPLETED|Overall Study||0
6437497|NCT01079299|7352238|FG001|NOT COMPLETED|Overall Study||0
6437498|NCT01079390|7352247|FG000|STARTED|Overall Study||15
6437499|NCT01079390|7352248|FG001|STARTED|Overall Study||15
6437500|NCT01079390|7352249|FG002|STARTED|Overall Study||14
6437501|NCT01079390|7352247|FG000|COMPLETED|Overall Study||10
6437502|NCT01079390|7352248|FG001|COMPLETED|Overall Study||10
6437503|NCT01079390|7352249|FG002|COMPLETED|Overall Study||10
6437504|NCT01079390|7352247|FG000|NOT COMPLETED|Overall Study||5
6437505|NCT01079390|7352248|FG001|NOT COMPLETED|Overall Study||5
6437506|NCT01079390|7352249|FG002|NOT COMPLETED|Overall Study||4
6437507|NCT01079663|7352261|FG000|STARTED|Overall Study||30
6552799|NCT01739231|7475196|FG000|COMPLETED|Part B||13
6552800|NCT01739231|7475197|FG001|COMPLETED|Part B||12
6552801|NCT01739231|7475198|FG002|COMPLETED|Part B||10
6552802|NCT01739231|7475199|FG003|COMPLETED|Part B||19
6437508|NCT01079663|7352262|FG001|STARTED|Overall Study||30
6437509|NCT01079663|7352261|FG000|COMPLETED|Overall Study||30
6437510|NCT01079663|7352262|FG001|COMPLETED|Overall Study||26
6437511|NCT01079663|7352261|FG000|NOT COMPLETED|Overall Study||0
6437512|NCT01079663|7352262|FG001|NOT COMPLETED|Overall Study||4
6437513|NCT01079741|7352273|FG000|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
6437514|NCT01079741|7352274|FG001|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437515|NCT01079741|7352275|FG002|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437516|NCT01079741|7352276|FG003|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437517|NCT01079741|7352277|FG004|STARTED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437518|NCT01079741|7352273|FG000|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||3
6437519|NCT01079741|7352274|FG001|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437520|NCT01079741|7352275|FG002|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437521|NCT01079741|7352276|FG003|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437522|NCT01079741|7352277|FG004|COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437523|NCT01079741|7352273|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437524|NCT01079741|7352274|FG001|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437525|NCT01079741|7352275|FG002|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437526|NCT01079741|7352276|FG003|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437527|NCT01079741|7352277|FG004|NOT COMPLETED|Cohort 1: Dose Level 1 (Weeks 1-12)||0
6437528|NCT01079741|7352273|FG000|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437529|NCT01079741|7352274|FG001|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||4
6437530|NCT01079741|7352275|FG002|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437531|NCT01079741|7352276|FG003|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437532|NCT01079741|7352277|FG004|STARTED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437533|NCT01079741|7352273|FG000|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437534|NCT01079741|7352274|FG001|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||3
6437535|NCT01079741|7352275|FG002|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437536|NCT01079741|7352276|FG003|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437537|NCT01079741|7352277|FG004|COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437538|NCT01079741|7352273|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437539|NCT01079741|7352274|FG001|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||1
6437540|NCT01079741|7352275|FG002|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437541|NCT01079741|7352276|FG003|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437542|NCT01079741|7352277|FG004|NOT COMPLETED|Cohort 2: Dose Level 2 (Weeks 13-24)||0
6437543|NCT01079741|7352273|FG000|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437544|NCT01079741|7352274|FG001|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437545|NCT01079741|7352275|FG002|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
6437546|NCT01079741|7352276|FG003|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437547|NCT01079741|7352277|FG004|STARTED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437548|NCT01079741|7352273|FG000|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437549|NCT01079741|7352274|FG001|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437550|NCT01079741|7352275|FG002|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437551|NCT01079741|7352276|FG003|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437552|NCT01079741|7352277|FG004|COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437553|NCT01079741|7352273|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437554|NCT01079741|7352274|FG001|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6552803|NCT01739231|7475196|FG000|NOT COMPLETED|Part B||7
6552804|NCT01739231|7475197|FG001|NOT COMPLETED|Part B||5
6437555|NCT01079741|7352275|FG002|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||3
6437556|NCT01079741|7352276|FG003|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437557|NCT01079741|7352277|FG004|NOT COMPLETED|Cohort 3: Dose Level 3 (Weeks 25-36)||0
6437558|NCT01079741|7352273|FG000|STARTED|Phase 2 (Weeks 37-48)||0
6437559|NCT01079741|7352274|FG001|STARTED|Phase 2 (Weeks 37-48)||0
6437560|NCT01079741|7352275|FG002|STARTED|Phase 2 (Weeks 37-48)||0
6437561|NCT01079741|7352276|FG003|STARTED|Phase 2 (Weeks 37-48)||12
6437562|NCT01079741|7352277|FG004|STARTED|Phase 2 (Weeks 37-48)||12
6437563|NCT01079741|7352273|FG000|COMPLETED|Phase 2 (Weeks 37-48)||0
6437564|NCT01079741|7352274|FG001|COMPLETED|Phase 2 (Weeks 37-48)||0
6437565|NCT01079741|7352275|FG002|COMPLETED|Phase 2 (Weeks 37-48)||0
6437566|NCT01079741|7352276|FG003|COMPLETED|Phase 2 (Weeks 37-48)||12
6437567|NCT01079741|7352277|FG004|COMPLETED|Phase 2 (Weeks 37-48)||9
6437568|NCT01079741|7352273|FG000|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
6437569|NCT01079741|7352274|FG001|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
6437570|NCT01079741|7352275|FG002|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
6437571|NCT01079741|7352276|FG003|NOT COMPLETED|Phase 2 (Weeks 37-48)||0
6437572|NCT01079741|7352277|FG004|NOT COMPLETED|Phase 2 (Weeks 37-48)||3
6437573|NCT01079806|7352291|FG000|STARTED|Day 1 to Week 96||120
6437574|NCT01079806|7352292|FG001|STARTED|Day 1 to Week 96||60
6437575|NCT01079806|7352291|FG000|Received Treatment|Day 1 to Week 96||120
6437576|NCT01079806|7352292|FG001|Received Treatment|Day 1 to Week 96||60
6437577|NCT01079806|7352291|FG000|Primary Endpoint Cohort|Day 1 to Week 96||82
6437578|NCT01079806|7352292|FG001|Primary Endpoint Cohort|Day 1 to Week 96||41
6437579|NCT01079806|7352291|FG000|COMPLETED|Day 1 to Week 96||113
6437580|NCT01079806|7352292|FG001|COMPLETED|Day 1 to Week 96||53
6437581|NCT01079806|7352291|FG000|NOT COMPLETED|Day 1 to Week 96||7
6437582|NCT01079806|7352292|FG001|NOT COMPLETED|Day 1 to Week 96||7
6437583|NCT01079806|7352291|FG000|STARTED|Long-term Follow-up: Day 1-End of Study||111
6437584|NCT01079806|7352292|FG001|STARTED|Long-term Follow-up: Day 1-End of Study||58
6437585|NCT01079806|7352291|FG000|COMPLETED|Long-term Follow-up: Day 1-End of Study||92
6437586|NCT01079806|7352292|FG001|COMPLETED|Long-term Follow-up: Day 1-End of Study||43
6437587|NCT01079806|7352291|FG000|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||19
6437588|NCT01079806|7352292|FG001|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||15
6437589|NCT01079832|7352300|FG000|STARTED|Overall Study||50
6437590|NCT01079832|7352300|FG000|COMPLETED|Overall Study||49
6437591|NCT01079832|7352300|FG000|NOT COMPLETED|Overall Study||1
6437592|NCT01079936|7352308|FG000|STARTED|Phase I: MTD||16
6437593|NCT01079936|7352309|FG001|STARTED|Phase I: MTD||0
6437594|NCT01079936|7352310|FG002|STARTED|Phase I: MTD||0
6437595|NCT01079936|7352311|FG003|STARTED|Phase I: MTD||0
6437596|NCT01079936|7352312|FG004|STARTED|Phase I: MTD||0
6437597|NCT01079936|7352308|FG000|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
6437598|NCT01079936|7352309|FG001|COMPLETED|Phase I: MTD||0
6437599|NCT01079936|7352310|FG002|COMPLETED|Phase I: MTD||0
6437600|NCT01079936|7352311|FG003|COMPLETED|Phase I: MTD||0
6437601|NCT01079936|7352312|FG004|COMPLETED|Phase I: MTD||0
6437602|NCT01079936|7352308|FG000|NOT COMPLETED|Phase I: MTD||4
6437603|NCT01079936|7352309|FG001|NOT COMPLETED|Phase I: MTD||0
6437604|NCT01079936|7352310|FG002|NOT COMPLETED|Phase I: MTD||0
6437605|NCT01079936|7352311|FG003|NOT COMPLETED|Phase I: MTD||0
6437606|NCT01079936|7352312|FG004|NOT COMPLETED|Phase I: MTD||0
6437607|NCT01079936|7352308|FG000|STARTED|Phase II||0
6437608|NCT01079936|7352309|FG001|STARTED|Phase II||3
6437609|NCT01079936|7352310|FG002|STARTED|Phase II||6
6437610|NCT01079936|7352311|FG003|STARTED|Phase II||24
6437611|NCT01079936|7352312|FG004|STARTED|Phase II||26
6437612|NCT01079936|7352308|FG000|COMPLETED|Phase II||0
6437613|NCT01079936|7352309|FG001|COMPLETED|Phase II||3
6437614|NCT01079936|7352310|FG002|COMPLETED|Phase II||5
6437615|NCT01079936|7352311|FG003|COMPLETED|Phase II||24
6437616|NCT01079936|7352312|FG004|COMPLETED|Phase II||25
6437617|NCT01079936|7352308|FG000|NOT COMPLETED|Phase II||0
6437618|NCT01079936|7352309|FG001|NOT COMPLETED|Phase II||0
6437619|NCT01079936|7352310|FG002|NOT COMPLETED|Phase II||1
6437620|NCT01079936|7352311|FG003|NOT COMPLETED|Phase II||0
6437621|NCT01079936|7352312|FG004|NOT COMPLETED|Phase II||1
6653338|NCT02436330|7583086|FG000|STARTED|Cohort 6||4
6653339|NCT02436330|7583087|FG001|STARTED|Cohort 6||5
6653340|NCT02436330|7583086|FG000|COMPLETED|Cohort 6||1
6653341|NCT02436330|7583087|FG001|COMPLETED|Cohort 6||4
6653342|NCT02436330|7583086|FG000|NOT COMPLETED|Cohort 6||3
6744403|NCT03342469|7672449|FG000|STARTED|Overall Study||9
6437622|NCT01079949|7352325|FG000|STARTED|Overall Study||46
6437623|NCT01079949|7352326|FG001|STARTED|Overall Study||47
6437624|NCT01079949|7352325|FG000|COMPLETED|Overall Study||31
6437625|NCT01079949|7352326|FG001|COMPLETED|Overall Study||34
6437626|NCT01079949|7352325|FG000|NOT COMPLETED|Overall Study||15
6437627|NCT01079949|7352326|FG001|NOT COMPLETED|Overall Study||13
6437628|NCT01079962|7352334|FG000|STARTED|Overall Study||105
6437629|NCT01079962|7352335|FG001|STARTED|Overall Study||104
6437630|NCT01079962|7352334|FG000|COMPLETED|Overall Study||90
6437631|NCT01079962|7352335|FG001|COMPLETED|Overall Study||89
6437632|NCT01079962|7352334|FG000|NOT COMPLETED|Overall Study||15
6437633|NCT01079962|7352335|FG001|NOT COMPLETED|Overall Study||15
6437634|NCT01079988|7352346|FG000|STARTED|Overall Study||10
6437635|NCT01079988|7352347|FG001|STARTED|Overall Study||1
6653343|NCT02436330|7583087|FG001|NOT COMPLETED|Cohort 6||1
6653344|NCT02436356|7583102|FG000|STARTED|Overall Study||33
6437636|NCT01079988|7352348|FG002|STARTED|Overall Study||8
6437637|NCT01079988|7352349|FG003|STARTED|Overall Study||20
6437638|NCT01079988|7352350|FG004|STARTED|Overall Study||2
6437639|NCT01079988|7352346|FG000|COMPLETED|Overall Study||9
6437640|NCT01079988|7352347|FG001|COMPLETED|Overall Study||1
6437641|NCT01079988|7352348|FG002|COMPLETED|Overall Study||8
6437642|NCT01079988|7352349|FG003|COMPLETED|Overall Study||17
6437643|NCT01079988|7352350|FG004|COMPLETED|Overall Study||1
6437644|NCT01079988|7352346|FG000|NOT COMPLETED|Overall Study||1
6437645|NCT01079988|7352347|FG001|NOT COMPLETED|Overall Study||0
6437646|NCT01079988|7352348|FG002|NOT COMPLETED|Overall Study||0
6437647|NCT01079988|7352349|FG003|NOT COMPLETED|Overall Study||3
6437648|NCT01079988|7352350|FG004|NOT COMPLETED|Overall Study||1
6437649|NCT01080118|7352364|FG000|STARTED|Overall Study||15
6437650|NCT01080118|7352365|FG001|STARTED|Overall Study||15
6437651|NCT01080118|7352366|FG002|STARTED|Overall Study||30
6437652|NCT01080118|7352367|FG003|STARTED|Overall Study||30
6437653|NCT01080118|7352364|FG000|COMPLETED|Overall Study||15
6437654|NCT01080118|7352365|FG001|COMPLETED|Overall Study||15
6437655|NCT01080118|7352366|FG002|COMPLETED|Overall Study||30
6437656|NCT01080118|7352367|FG003|COMPLETED|Overall Study||30
6437657|NCT01080118|7352364|FG000|NOT COMPLETED|Overall Study||0
6437658|NCT01080118|7352365|FG001|NOT COMPLETED|Overall Study||0
6437659|NCT01080118|7352366|FG002|NOT COMPLETED|Overall Study||0
6437660|NCT01080118|7352367|FG003|NOT COMPLETED|Overall Study||0
6437661|NCT01080131|7352375|FG000|STARTED|Core Study (0- 12 Weeks)||112
6437662|NCT01080131|7352376|FG001|STARTED|Core Study (0- 12 Weeks)||114
6437663|NCT01080131|7352375|FG000|COMPLETED|Core Study (0- 12 Weeks)||99
6437664|NCT01080131|7352376|FG001|COMPLETED|Core Study (0- 12 Weeks)||103
6437665|NCT01080131|7352375|FG000|NOT COMPLETED|Core Study (0- 12 Weeks)||13
6437666|NCT01080131|7352376|FG001|NOT COMPLETED|Core Study (0- 12 Weeks)||11
6437667|NCT01080131|7352375|FG000|STARTED|Extension Study 1 (12 -24 Weeks)||84
6437668|NCT01080131|7352376|FG001|STARTED|Extension Study 1 (12 -24 Weeks)||76
6437669|NCT01080131|7352375|FG000|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
6437670|NCT01080131|7352376|FG001|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
6437671|NCT01080131|7352375|FG000|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
6437672|NCT01080131|7352376|FG001|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
6437673|NCT01080131|7352375|FG000|STARTED|Extension Study 2 (25-72 Weeks)||72
6437674|NCT01080131|7352376|FG001|STARTED|Extension Study 2 (25-72 Weeks)||65
6437675|NCT01080131|7352375|FG000|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
6437676|NCT01080131|7352376|FG001|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
6437677|NCT01080131|7352375|FG000|COMPLETED|Extension Study 2 (25-72 Weeks)||64
6437678|NCT01080131|7352376|FG001|COMPLETED|Extension Study 2 (25-72 Weeks)||54
6437679|NCT01080131|7352375|FG000|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
6437680|NCT01080131|7352376|FG001|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
6437681|NCT01080196|7352402|FG000|STARTED|Overall Study||68
6437682|NCT01080196|7352403|FG001|STARTED|Overall Study||66
6437683|NCT01080196|7352402|FG000|COMPLETED|Overall Study||68
6437684|NCT01080196|7352403|FG001|COMPLETED|Overall Study||66
6437685|NCT01080196|7352402|FG000|NOT COMPLETED|Overall Study||0
6437686|NCT01080196|7352403|FG001|NOT COMPLETED|Overall Study||0
6437687|NCT01080209|7352418|FG000|STARTED|Overall Study||28
6437688|NCT01080209|7352419|FG001|STARTED|Overall Study||53
6437689|NCT01080209|7352420|FG002|STARTED|Overall Study||33
6437690|NCT01080209|7352421|FG003|STARTED|Overall Study||42
6437691|NCT01080209|7352422|FG004|STARTED|Overall Study||6
6437692|NCT01080209|7352423|FG005|STARTED|Overall Study||2
6437693|NCT01080209|7352424|FG006|STARTED|Overall Study||51
6437694|NCT01080209|7352418|FG000|COMPLETED|Overall Study||22
6437695|NCT01080209|7352419|FG001|COMPLETED|Overall Study||42
6437696|NCT01080209|7352420|FG002|COMPLETED|Overall Study||28
6437697|NCT01080209|7352421|FG003|COMPLETED|Overall Study||37
6552805|NCT01739231|7475198|FG002|NOT COMPLETED|Part B||2
6552806|NCT01739231|7475199|FG003|NOT COMPLETED|Part B||2
6552807|NCT01739309|7475217|FG000|STARTED|Overall Study||28
6552808|NCT01739309|7475217|FG000|Received at Least One Dose of Study Drug|Overall Study||28
6437698|NCT01080209|7352422|FG004|COMPLETED|Overall Study||6
6437699|NCT01080209|7352423|FG005|COMPLETED|Overall Study||2
6437700|NCT01080209|7352424|FG006|COMPLETED|Overall Study||44
6437701|NCT01080209|7352418|FG000|NOT COMPLETED|Overall Study||6
6437702|NCT01080209|7352419|FG001|NOT COMPLETED|Overall Study||11
6437703|NCT01080209|7352420|FG002|NOT COMPLETED|Overall Study||5
6437704|NCT01080209|7352421|FG003|NOT COMPLETED|Overall Study||5
6437705|NCT01080209|7352422|FG004|NOT COMPLETED|Overall Study||0
6437706|NCT01080209|7352423|FG005|NOT COMPLETED|Overall Study||0
6437707|NCT01080209|7352424|FG006|NOT COMPLETED|Overall Study||7
6437708|NCT01080248|7352440|FG000|STARTED|Overall Study||2
6437709|NCT01080248|7352440|FG000|COMPLETED|Overall Study||2
6552809|NCT01739309|7475217|FG000|Death Due to Any Cause|Overall Study||17
6437710|NCT01080248|7352440|FG000|NOT COMPLETED|Overall Study||0
6437711|NCT01080261|7352444|FG000|STARTED|Overall Study||60
6437712|NCT01080261|7352444|FG000|COMPLETED|Overall Study||60
6437713|NCT01080261|7352444|FG000|NOT COMPLETED|Overall Study||0
6437714|NCT01080300|7352450|FG000|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
6437715|NCT01080300|7352451|FG001|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
6437716|NCT01080300|7352450|FG000|COMPLETED|Overall Study||206
6437717|NCT01080300|7352451|FG001|COMPLETED|Overall Study||191
6437718|NCT01080300|7352450|FG000|NOT COMPLETED|Overall Study||94
6437719|NCT01080300|7352451|FG001|NOT COMPLETED|Overall Study||104
6437720|NCT01080326|7352459|FG000|STARTED|Overall Study||7
6437721|NCT01080326|7352459|FG000|COMPLETED|Overall Study||3
6437722|NCT01080326|7352459|FG000|NOT COMPLETED|Overall Study||4
6437723|NCT01080391|7352465|FG000|STARTED|Overall Study||396
6437724|NCT01080391|7352466|FG001|STARTED|Overall Study||396
6437725|NCT01080391|7352465|FG000|Treated|Overall Study||389
6437726|NCT01080391|7352466|FG001|Treated|Overall Study||392
6437727|NCT01080391|7352465|FG000|COMPLETED|Overall Study||389
6437728|NCT01080391|7352466|FG001|COMPLETED|Overall Study||392
6437729|NCT01080391|7352465|FG000|NOT COMPLETED|Overall Study||7
6437730|NCT01080391|7352466|FG001|NOT COMPLETED|Overall Study||4
6437731|NCT01080625|7352475|FG000|STARTED|Overall Study||31
6437732|NCT01080625|7352476|FG001|STARTED|Overall Study||33
6437733|NCT01080625|7352477|FG002|STARTED|Overall Study||32
6437734|NCT01080625|7352475|FG000|COMPLETED|Overall Study||31
6437735|NCT01080625|7352476|FG001|COMPLETED|Overall Study||31
6437736|NCT01080625|7352477|FG002|COMPLETED|Overall Study||31
6437737|NCT01080625|7352475|FG000|NOT COMPLETED|Overall Study||0
6437738|NCT01080625|7352476|FG001|NOT COMPLETED|Overall Study||2
6437739|NCT01080625|7352477|FG002|NOT COMPLETED|Overall Study||1
6437740|NCT01080677|7352488|FG000|STARTED|Overall Study||20
6437741|NCT01080677|7352489|FG001|STARTED|Overall Study||20
6437742|NCT01080677|7352490|FG002|STARTED|Overall Study||20
6437743|NCT01080677|7352488|FG000|COMPLETED|Overall Study||20
6437744|NCT01080677|7352489|FG001|COMPLETED|Overall Study||20
6437745|NCT01080677|7352490|FG002|COMPLETED|Overall Study||20
6437746|NCT01080677|7352488|FG000|NOT COMPLETED|Overall Study||0
6437747|NCT01080677|7352489|FG001|NOT COMPLETED|Overall Study||0
6437748|NCT01080677|7352490|FG002|NOT COMPLETED|Overall Study||0
6437749|NCT01080716|7352502|FG000|STARTED|Part 1||14
6437750|NCT01080716|7352503|FG001|STARTED|Part 1||6
6437751|NCT01080716|7352504|FG002|STARTED|Part 1||0
6437752|NCT01080716|7352505|FG003|STARTED|Part 1||0
6437753|NCT01080716|7352502|FG000|COMPLETED|Part 1||13
6437754|NCT01080716|7352503|FG001|COMPLETED|Part 1||6
6437755|NCT01080716|7352504|FG002|COMPLETED|Part 1||0
6437756|NCT01080716|7352505|FG003|COMPLETED|Part 1||0
6437757|NCT01080716|7352502|FG000|NOT COMPLETED|Part 1||1
6437758|NCT01080716|7352503|FG001|NOT COMPLETED|Part 1||0
6437759|NCT01080716|7352504|FG002|NOT COMPLETED|Part 1||0
6437760|NCT01080716|7352505|FG003|NOT COMPLETED|Part 1||0
6437761|NCT01080716|7352502|FG000|STARTED|Part 2||0
6437762|NCT01080716|7352503|FG001|STARTED|Part 2||0
6437763|NCT01080716|7352504|FG002|STARTED|Part 2||10
6437764|NCT01080716|7352505|FG003|STARTED|Part 2||10
6437765|NCT01080716|7352502|FG000|COMPLETED|Part 2||0
6437766|NCT01080716|7352503|FG001|COMPLETED|Part 2||0
6437767|NCT01080716|7352504|FG002|COMPLETED|Part 2||10
6437768|NCT01080716|7352505|FG003|COMPLETED|Part 2||10
6437769|NCT01080716|7352502|FG000|NOT COMPLETED|Part 2||0
6437770|NCT01080716|7352503|FG001|NOT COMPLETED|Part 2||0
6437771|NCT01080716|7352504|FG002|NOT COMPLETED|Part 2||0
6437772|NCT01080716|7352505|FG003|NOT COMPLETED|Part 2||0
6437773|NCT01080794|7352523|FG000|STARTED|Overall Study||20
6437774|NCT01080794|7352524|FG001|STARTED|Overall Study||14
6437775|NCT01080794|7352525|FG002|STARTED|Overall Study||12
6437776|NCT01080794|7352526|FG003|STARTED|Overall Study||15
6437777|NCT01080794|7352523|FG000|COMPLETED|Overall Study||15
6437778|NCT01080794|7352524|FG001|COMPLETED|Overall Study||12
6437779|NCT01080794|7352525|FG002|COMPLETED|Overall Study||10
6437780|NCT01080794|7352526|FG003|COMPLETED|Overall Study||13
6437781|NCT01080794|7352523|FG000|NOT COMPLETED|Overall Study||5
6437782|NCT01080794|7352524|FG001|NOT COMPLETED|Overall Study||2
6437783|NCT01080794|7352525|FG002|NOT COMPLETED|Overall Study||2
6437784|NCT01080794|7352526|FG003|NOT COMPLETED|Overall Study||2
6437785|NCT01080807|7352538|FG000|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
6437786|NCT01080807|7352539|FG001|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
6437787|NCT01080807|7352538|FG000|COMPLETED|Overall Study||158
6437788|NCT01080807|7352539|FG001|COMPLETED|Overall Study||167
6437789|NCT01080807|7352538|FG000|NOT COMPLETED|Overall Study||35
6437790|NCT01080807|7352539|FG001|NOT COMPLETED|Overall Study||23
6437791|NCT01080976|7352547|FG000|STARTED|Overall Study||5
6437792|NCT01080976|7352548|FG001|STARTED|Overall Study||5
6437793|NCT01080976|7352547|FG000|COMPLETED|Overall Study||5
6437794|NCT01080976|7352548|FG001|COMPLETED|Overall Study||5
6437795|NCT01080976|7352547|FG000|NOT COMPLETED|Overall Study||0
6437796|NCT01080976|7352548|FG001|NOT COMPLETED|Overall Study||0
6437797|NCT01081041|7352557|FG000|STARTED|Overall Study||33
6437798|NCT01081041|7352558|FG001|STARTED|Overall Study||81
6437799|NCT01081041|7352559|FG002|STARTED|Overall Study||73
6437800|NCT01081041|7352557|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
6437801|NCT01081041|7352558|FG001|Received at Least 1 Dose of Study Drug|Overall Study||77
6437802|NCT01081041|7352559|FG002|Received at Least 1 Dose of Study Drug|Overall Study||71
6437803|NCT01081041|7352557|FG000|COMPLETED|Overall Study||33
6437804|NCT01081041|7352558|FG001|COMPLETED|Overall Study||77
6437805|NCT01081041|7352559|FG002|COMPLETED|Overall Study||71
6437806|NCT01081041|7352557|FG000|NOT COMPLETED|Overall Study||0
6437807|NCT01081041|7352558|FG001|NOT COMPLETED|Overall Study||4
6437808|NCT01081041|7352559|FG002|NOT COMPLETED|Overall Study||2
6437809|NCT01081132|7352574|FG000|STARTED|Overall Study||157
6437810|NCT01081132|7352575|FG001|STARTED|Overall Study||157
6437811|NCT01081132|7352574|FG000|COMPLETED|Overall Study||102
6437812|NCT01081132|7352575|FG001|COMPLETED|Overall Study||105
6437813|NCT01081132|7352574|FG000|NOT COMPLETED|Overall Study||55
6437814|NCT01081132|7352575|FG001|NOT COMPLETED|Overall Study||52
6653345|NCT02436356|7583103|FG001|STARTED|Overall Study||11
6653346|NCT02436356|7583104|FG002|STARTED|Overall Study||4
6653347|NCT02436356|7583102|FG000|High Energy Fracture|Overall Study||14
6437815|NCT01081145|7352581|FG000|STARTED|Open-Label Phase||528
6437816|NCT01081145|7352582|FG001|STARTED|Open-Label Phase||0
6437817|NCT01081145|7352581|FG000|COMPLETED|Open-Label Phase||316
6437818|NCT01081145|7352582|FG001|COMPLETED|Open-Label Phase||0
6437819|NCT01081145|7352581|FG000|NOT COMPLETED|Open-Label Phase||212
6437820|NCT01081145|7352582|FG001|NOT COMPLETED|Open-Label Phase||0
6437821|NCT01081145|7352581|FG000|STARTED|Double-Blind Randomized-Withdrawal Phase||157
6437822|NCT01081145|7352582|FG001|STARTED|Double-Blind Randomized-Withdrawal Phase||159
6437823|NCT01081145|7352581|FG000|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
6437824|NCT01081145|7352582|FG001|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
6437825|NCT01081145|7352581|FG000|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
6437826|NCT01081145|7352582|FG001|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
6437827|NCT01081249|7352590|FG000|STARTED|Overall Study||11
6437828|NCT01081249|7352591|FG001|STARTED|Overall Study||7
6437829|NCT01081249|7352590|FG000|First Psychotherapy Appointment (1 Day)|Overall Study||11
6437830|NCT01081249|7352591|FG001|First Psychotherapy Appointment (1 Day)|Overall Study||6
6437831|NCT01081249|7352590|FG000|Washout (5-10 Days)|Overall Study||11
6437832|NCT01081249|7352591|FG001|Washout (5-10 Days)|Overall Study||6
6437833|NCT01081249|7352590|FG000|Second Psychotherapy Appointment (1 Day)|Overall Study||11
6437834|NCT01081249|7352591|FG001|Second Psychotherapy Appointment (1 Day)|Overall Study||6
6437835|NCT01081249|7352590|FG000|COMPLETED|Overall Study||11
6437836|NCT01081249|7352591|FG001|COMPLETED|Overall Study||6
6437837|NCT01081249|7352590|FG000|NOT COMPLETED|Overall Study||0
6437838|NCT01081249|7352591|FG001|NOT COMPLETED|Overall Study||1
6499885|NCT01421667|7418663|FG001|STARTED|Overall Study||68
6499886|NCT01421667|7418664|FG002|STARTED|Overall Study||53
6499887|NCT01421667|7418665|FG003|STARTED|Overall Study||16
6499888|NCT01421667|7418662|FG000|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
6499889|NCT01421667|7418663|FG001|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
6499890|NCT01421667|7418664|FG002|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
6499891|NCT01421667|7418665|FG003|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
6499892|NCT01421667|7418662|FG000|NOT COMPLETED|Overall Study||0
6499893|NCT01421667|7418663|FG001|NOT COMPLETED|Overall Study||2
6499894|NCT01421667|7418664|FG002|NOT COMPLETED|Overall Study||2
6499895|NCT01421667|7418665|FG003|NOT COMPLETED|Overall Study||1
6499896|NCT01421719|7418683|FG000|STARTED|Overall Study||20
6499897|NCT01421719|7418683|FG000|COMPLETED|Overall Study||16
6499898|NCT01421719|7418683|FG000|NOT COMPLETED|Overall Study||4
6499899|NCT01422070|7418690|FG000|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
6499900|NCT01422070|7418691|FG001|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
6499901|NCT01422070|7418690|FG000|COMPLETED|Overall Study||5031
6499902|NCT01422070|7418691|FG001|COMPLETED|Overall Study||803
6499903|NCT01422070|7418690|FG000|NOT COMPLETED|Overall Study||0
6499904|NCT01422070|7418691|FG001|NOT COMPLETED|Overall Study||0
6499905|NCT01422135|7418696|FG000|STARTED|Overall Study||4
6499906|NCT01422135|7418697|FG001|STARTED|Overall Study||4
6499907|NCT01422135|7418698|FG002|STARTED|Overall Study||4
6499908|NCT01422135|7418699|FG003|STARTED|Overall Study||4
6499909|NCT01422135|7418700|FG004|STARTED|Overall Study||4
6499910|NCT01422135|7418701|FG005|STARTED|Overall Study||4
6499911|NCT01422135|7418696|FG000|COMPLETED|Overall Study||4
6499912|NCT01422135|7418697|FG001|COMPLETED|Overall Study||4
6499913|NCT01422135|7418698|FG002|COMPLETED|Overall Study||3
6499914|NCT01422135|7418699|FG003|COMPLETED|Overall Study||4
6499915|NCT01422135|7418700|FG004|COMPLETED|Overall Study||4
6499916|NCT01422135|7418701|FG005|COMPLETED|Overall Study||3
6499917|NCT01422135|7418696|FG000|NOT COMPLETED|Overall Study||0
6499918|NCT01422135|7418697|FG001|NOT COMPLETED|Overall Study||0
6499919|NCT01422135|7418698|FG002|NOT COMPLETED|Overall Study||1
6499920|NCT01422135|7418699|FG003|NOT COMPLETED|Overall Study||0
6499921|NCT01422135|7418700|FG004|NOT COMPLETED|Overall Study||0
6499922|NCT01422135|7418701|FG005|NOT COMPLETED|Overall Study||1
6499923|NCT01422161|7418709|FG000|STARTED|Overall Study||10
6499924|NCT01422161|7418710|FG001|STARTED|Overall Study||6
6499925|NCT01422161|7418709|FG000|COMPLETED|Overall Study||10
6499926|NCT01422161|7418710|FG001|COMPLETED|Overall Study||6
6499927|NCT01422161|7418709|FG000|NOT COMPLETED|Overall Study||0
6499928|NCT01422161|7418710|FG001|NOT COMPLETED|Overall Study||0
6499929|NCT01422187|7418727|FG000|STARTED|Overall Study||8
6499930|NCT01422187|7418728|FG001|STARTED|Overall Study||9
6499931|NCT01422187|7418729|FG002|STARTED|Overall Study||2
6499932|NCT01422187|7418727|FG000|COMPLETED|Overall Study||7
6499933|NCT01422187|7418728|FG001|COMPLETED|Overall Study||8
6499934|NCT01422187|7418729|FG002|COMPLETED|Overall Study||2
6499935|NCT01422187|7418727|FG000|NOT COMPLETED|Overall Study||1
6653348|NCT02436356|7583103|FG001|High Energy Fracture|Overall Study||0
6437839|NCT01081301|7352597|FG000|STARTED|Overall Study||36
6437840|NCT01081301|7352597|FG000|COMPLETED|Overall Study||22
6437841|NCT01081301|7352597|FG000|NOT COMPLETED|Overall Study||14
6437842|NCT01081626|7352620|FG000|STARTED|Overall Study||155
6437843|NCT01081626|7352621|FG001|STARTED|Overall Study||155
6437844|NCT01081626|7352620|FG000|Assessed for Efficacy|Overall Study||122
6437845|NCT01081626|7352621|FG001|Assessed for Efficacy|Overall Study||125
6437846|NCT01081626|7352620|FG000|COMPLETED|Overall Study||95
6437847|NCT01081626|7352621|FG001|COMPLETED|Overall Study||94
6437848|NCT01081626|7352620|FG000|NOT COMPLETED|Overall Study||60
6437849|NCT01081626|7352621|FG001|NOT COMPLETED|Overall Study||61
6437850|NCT01081665|7352627|FG000|STARTED|Overall Study||237
6437851|NCT01081665|7352627|FG000|Full Analysis Set|Overall Study||237
6437852|NCT01081665|7352627|FG000|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
6437853|NCT01081665|7352627|FG000|COMPLETED|Overall Study||142
6437854|NCT01081665|7352627|FG000|NOT COMPLETED|Overall Study||95
6437855|NCT01081678|7352635|FG000|STARTED|Overall Study||89
6437856|NCT01081678|7352636|FG001|STARTED|Overall Study||60
6437857|NCT01081678|7352637|FG002|STARTED|Overall Study||93
6437858|NCT01081678|7352638|FG003|STARTED|Overall Study||90
6437859|NCT01081678|7352635|FG000|Received Study Drug|Overall Study||87
6437860|NCT01081678|7352636|FG001|Received Study Drug|Overall Study||60
6437861|NCT01081678|7352637|FG002|Received Study Drug|Overall Study||89
6437862|NCT01081678|7352638|FG003|Received Study Drug|Overall Study||89
6437863|NCT01081678|7352635|FG000|Completed 24 Weeks of Study|Overall Study||73
6437864|NCT01081678|7352636|FG001|Completed 24 Weeks of Study|Overall Study||50
6437865|NCT01081678|7352637|FG002|Completed 24 Weeks of Study|Overall Study||72
6437866|NCT01081678|7352638|FG003|Completed 24 Weeks of Study|Overall Study||68
6437867|NCT01081678|7352635|FG000|COMPLETED|Overall Study||62
6437868|NCT01081678|7352636|FG001|COMPLETED|Overall Study||44
6437869|NCT01081678|7352637|FG002|COMPLETED|Overall Study||62
6437870|NCT01081678|7352638|FG003|COMPLETED|Overall Study||61
6437871|NCT01081678|7352635|FG000|NOT COMPLETED|Overall Study||27
6437872|NCT01081678|7352636|FG001|NOT COMPLETED|Overall Study||16
6437873|NCT01081678|7352637|FG002|NOT COMPLETED|Overall Study||31
6437874|NCT01081678|7352638|FG003|NOT COMPLETED|Overall Study||29
6437875|NCT01081769|7352650|FG000|STARTED|Whole Intent-to-Treat||376
6437876|NCT01081769|7352651|FG001|STARTED|Whole Intent-to-Treat||388
6437877|NCT01081769|7352650|FG000|COMPLETED|Whole Intent-to-Treat||352
6437878|NCT01081769|7352651|FG001|COMPLETED|Whole Intent-to-Treat||363
6437879|NCT01081769|7352650|FG000|NOT COMPLETED|Whole Intent-to-Treat||24
6437880|NCT01081769|7352651|FG001|NOT COMPLETED|Whole Intent-to-Treat||25
6437881|NCT01081769|7352650|FG000|STARTED|CORE Intent-To-Treat||352
6437882|NCT01081769|7352651|FG001|STARTED|CORE Intent-To-Treat||363
6437883|NCT01081769|7352650|FG000|COMPLETED|CORE Intent-To-Treat||272
6437884|NCT01081769|7352651|FG001|COMPLETED|CORE Intent-To-Treat||266
6437885|NCT01081769|7352650|FG000|NOT COMPLETED|CORE Intent-To-Treat||80
6437886|NCT01081769|7352651|FG001|NOT COMPLETED|CORE Intent-To-Treat||97
6437887|NCT01081795|7352660|FG000|STARTED|Overall Study||130
6437888|NCT01081795|7352661|FG001|STARTED|Overall Study||130
6437889|NCT01081795|7352662|FG002|STARTED|Overall Study||127
6437890|NCT01081795|7352660|FG000|COMPLETED|Overall Study||97
6437891|NCT01081795|7352661|FG001|COMPLETED|Overall Study||95
6437892|NCT01081795|7352662|FG002|COMPLETED|Overall Study||97
6437893|NCT01081795|7352660|FG000|NOT COMPLETED|Overall Study||33
6437894|NCT01081795|7352661|FG001|NOT COMPLETED|Overall Study||35
6437895|NCT01081795|7352662|FG002|NOT COMPLETED|Overall Study||30
6437896|NCT01081834|7352675|FG000|STARTED|Core Period: Baseline to Week 26||192
6437897|NCT01081834|7352676|FG001|STARTED|Core Period: Baseline to Week 26||195
6437898|NCT01081834|7352677|FG002|STARTED|Core Period: Baseline to Week 26||197
6437899|NCT01081834|7352678|FG003|STARTED|Core Period: Baseline to Week 26||47
6437900|NCT01081834|7352679|FG004|STARTED|Core Period: Baseline to Week 26||44
6437901|NCT01081834|7352675|FG000|COMPLETED|Core Period: Baseline to Week 26||160
6437902|NCT01081834|7352676|FG001|COMPLETED|Core Period: Baseline to Week 26||172
6437903|NCT01081834|7352677|FG002|COMPLETED|Core Period: Baseline to Week 26||175
6437904|NCT01081834|7352678|FG003|COMPLETED|Core Period: Baseline to Week 26||40
6437905|NCT01081834|7352679|FG004|COMPLETED|Core Period: Baseline to Week 26||40
6437906|NCT01081834|7352675|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||32
6437907|NCT01081834|7352676|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||23
6437908|NCT01081834|7352677|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||22
6437909|NCT01081834|7352678|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||7
6437910|NCT01081834|7352679|FG004|NOT COMPLETED|Core Period: Baseline to Week 26||4
6437911|NCT01081834|7352675|FG000|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
6437912|NCT01081834|7352676|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
6437913|NCT01081834|7352677|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
6437914|NCT01081834|7352678|FG003|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
6437915|NCT01081834|7352679|FG004|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
6437916|NCT01081834|7352675|FG000|COMPLETED|Extension Period: Week 26 to Week 52||135
6437917|NCT01081834|7352676|FG001|COMPLETED|Extension Period: Week 26 to Week 52||152
6437918|NCT01081834|7352677|FG002|COMPLETED|Extension Period: Week 26 to Week 52||165
6437919|NCT01081834|7352678|FG003|COMPLETED|Extension Period: Week 26 to Week 52||0
6437920|NCT01081834|7352679|FG004|COMPLETED|Extension Period: Week 26 to Week 52||0
6437921|NCT01081834|7352675|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
6437922|NCT01081834|7352676|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
6437923|NCT01081834|7352677|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
6437924|NCT01081834|7352678|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
6437925|NCT01081834|7352679|FG004|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
6437926|NCT01081873|7352698|FG000|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
6437927|NCT01081873|7352698|FG000|COMPLETED|Overall Study||2416
6437928|NCT01081873|7352698|FG000|NOT COMPLETED|Overall Study||298
6437929|NCT01081912|7352727|FG000|STARTED|Conversion/Titration||510
6437930|NCT01081912|7352728|FG001|STARTED|Conversion/Titration||0
6437931|NCT01081912|7352729|FG002|STARTED|Conversion/Titration||0
6437932|NCT01081912|7352727|FG000|COMPLETED|Conversion/Titration||302
6437933|NCT01081912|7352728|FG001|COMPLETED|Conversion/Titration||0
6437934|NCT01081912|7352729|FG002|COMPLETED|Conversion/Titration||0
6437935|NCT01081912|7352727|FG000|NOT COMPLETED|Conversion/Titration||208
6437936|NCT01081912|7352728|FG001|NOT COMPLETED|Conversion/Titration||0
6437937|NCT01081912|7352729|FG002|NOT COMPLETED|Conversion/Titration||0
6437938|NCT01081912|7352727|FG000|STARTED|Maintenance Treatment||0
6437939|NCT01081912|7352728|FG001|STARTED|Maintenance Treatment||151
6437940|NCT01081912|7352729|FG002|STARTED|Maintenance Treatment||151
6437941|NCT01081912|7352727|FG000|COMPLETED|Maintenance Treatment||0
6437942|NCT01081912|7352728|FG001|COMPLETED|Maintenance Treatment||124
6437943|NCT01081912|7352729|FG002|COMPLETED|Maintenance Treatment||59
6437944|NCT01081912|7352727|FG000|NOT COMPLETED|Maintenance Treatment||0
6437945|NCT01081912|7352728|FG001|NOT COMPLETED|Maintenance Treatment||27
6437946|NCT01081912|7352729|FG002|NOT COMPLETED|Maintenance Treatment||92
6437947|NCT01082081|7352739|FG000|STARTED|Overall Study||121
6437948|NCT01082081|7352740|FG001|STARTED|Overall Study||119
6437949|NCT01082081|7352741|FG002|STARTED|Overall Study||60
6437950|NCT01082081|7352739|FG000|COMPLETED|Overall Study||121
6437951|NCT01082081|7352740|FG001|COMPLETED|Overall Study||118
6437952|NCT01082081|7352741|FG002|COMPLETED|Overall Study||58
6437953|NCT01082081|7352739|FG000|NOT COMPLETED|Overall Study||0
6437954|NCT01082081|7352740|FG001|NOT COMPLETED|Overall Study||1
6437955|NCT01082081|7352741|FG002|NOT COMPLETED|Overall Study||2
6437956|NCT01082159|7352749|FG000|STARTED|Overall Study||55
6437957|NCT01082159|7352749|FG000|COMPLETED|Overall Study||46
6437958|NCT01082159|7352749|FG000|NOT COMPLETED|Overall Study||9
6437959|NCT01082211|7352754|FG000|STARTED|Overall Study||65
6437960|NCT01082211|7352754|FG000|Has Baseline PT QOL Data|Overall Study||46
6437961|NCT01082211|7352754|FG000|Has Baseline MD QOL Data|Overall Study||44
6437962|NCT01082211|7352754|FG000|Has Baseline/12-month PT QOL Data|Overall Study||36
6437963|NCT01082211|7352754|FG000|Has Baseline/12-Month MD QOL Data|Overall Study||35
6437964|NCT01082211|7352754|FG000|Has Baseline/36-month PT QOL Data|Overall Study||32
6437965|NCT01082211|7352754|FG000|Has Baseline/36-Month MD QOL Data|Overall Study||27
6437966|NCT01082211|7352754|FG000|All Eligible Patients|Overall Study||58
6437967|NCT01082211|7352754|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
6437968|NCT01082211|7352754|FG000|NOT COMPLETED|Overall Study||7
6437969|NCT01082328|7352761|FG000|STARTED|Overall Study||59
6437970|NCT01082328|7352761|FG000|COMPLETED|Overall Study||58
6437971|NCT01082328|7352761|FG000|NOT COMPLETED|Overall Study||1
6437972|NCT01082367|7352767|FG000|STARTED|Double-blind Period||26
6437973|NCT01082367|7352768|FG001|STARTED|Double-blind Period||25
6437974|NCT01082367|7352767|FG000|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
6437975|NCT01082367|7352768|FG001|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
6437976|NCT01082367|7352767|FG000|Stage 2:no tx|Double-blind Period||0
6437977|NCT01082367|7352768|FG001|Stage 2:no tx|Double-blind Period||0
6437978|NCT01082367|7352767|FG000|Entered OL TOBI|Double-blind Period||4
6437979|NCT01082367|7352768|FG001|Entered OL TOBI|Double-blind Period||18
6437980|NCT01082367|7352767|FG000|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
6437981|NCT01082367|7352768|FG001|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
6437982|NCT01082367|7352767|FG000|Stage 3: Cross-over (co) tx|Double-blind Period||13
6437983|NCT01082367|7352768|FG001|Stage 3: Cross-over (co) tx|Double-blind Period||6
6437984|NCT01082367|7352767|FG000|Stage 4:no tx for Patients Not in co|Double-blind Period||0
6437985|NCT01082367|7352768|FG001|Stage 4:no tx for Patients Not in co|Double-blind Period||0
6437986|NCT01082367|7352767|FG000|COMPLETED|Double-blind Period||21
6437987|NCT01082367|7352768|FG001|COMPLETED|Double-blind Period||12
6437988|NCT01082367|7352767|FG000|NOT COMPLETED|Double-blind Period||5
6437989|NCT01082367|7352768|FG001|NOT COMPLETED|Double-blind Period||13
6437990|NCT01082367|7352767|FG000|STARTED|Follow-up (F-U) Period||19
6437991|NCT01082367|7352768|FG001|STARTED|Follow-up (F-U) Period||10
6437992|NCT01082367|7352767|FG000|Treated in F-U|Follow-up (F-U) Period||5
6437993|NCT01082367|7352768|FG001|Treated in F-U|Follow-up (F-U) Period||5
6437994|NCT01082367|7352767|FG000|COMPLETED|Follow-up (F-U) Period||17
6437995|NCT01082367|7352768|FG001|COMPLETED|Follow-up (F-U) Period||9
6437996|NCT01082367|7352767|FG000|NOT COMPLETED|Follow-up (F-U) Period||2
6437997|NCT01082367|7352768|FG001|NOT COMPLETED|Follow-up (F-U) Period||1
6437998|NCT01082380|7352778|FG000|STARTED|Overall Study||6
6437999|NCT01082380|7352778|FG000|COMPLETED|Overall Study||6
6438000|NCT01082380|7352778|FG000|NOT COMPLETED|Overall Study||0
6438001|NCT01082575|7352782|FG000|STARTED|Overall Study||100
6438002|NCT01082575|7352782|FG000|COMPLETED|Overall Study||100
6438003|NCT01082575|7352782|FG000|NOT COMPLETED|Overall Study||0
6438004|NCT01082588|7352788|FG000|STARTED|Overall Study||30
6438005|NCT01082588|7352789|FG001|STARTED|Overall Study||30
6438006|NCT01082588|7352788|FG000|COMPLETED|Overall Study||24
6438007|NCT01082588|7352789|FG001|COMPLETED|Overall Study||25
6438008|NCT01082588|7352788|FG000|NOT COMPLETED|Overall Study||6
6438009|NCT01082588|7352789|FG001|NOT COMPLETED|Overall Study||5
6438010|NCT01082614|7352797|FG000|STARTED|Overall Study||23
6438011|NCT01082614|7352798|FG001|STARTED|Overall Study||23
6438012|NCT01082614|7352797|FG000|COMPLETED|Overall Study||20
6438013|NCT01082614|7352798|FG001|COMPLETED|Overall Study||18
6438014|NCT01082614|7352797|FG000|NOT COMPLETED|Overall Study||3
6438015|NCT01082614|7352798|FG001|NOT COMPLETED|Overall Study||5
6438016|NCT01082640|7352807|FG000|STARTED|Overall Study||32
6438017|NCT01082640|7352808|FG001|STARTED|Overall Study||32
6438018|NCT01082640|7352809|FG002|STARTED|Overall Study||32
6438019|NCT01082640|7352807|FG000|COMPLETED|Overall Study||15
6438020|NCT01082640|7352808|FG001|COMPLETED|Overall Study||17
6438021|NCT01082640|7352809|FG002|COMPLETED|Overall Study||24
6438022|NCT01082640|7352807|FG000|NOT COMPLETED|Overall Study||17
6438023|NCT01082640|7352808|FG001|NOT COMPLETED|Overall Study||15
6438024|NCT01082640|7352809|FG002|NOT COMPLETED|Overall Study||8
6438025|NCT01082874|7352824|FG000|STARTED|Overall Study||2499
6438026|NCT01082874|7352825|FG001|STARTED|Overall Study||2510
6438027|NCT01082874|7352826|FG002|STARTED|Overall Study||2499
6438028|NCT01082874|7352827|FG003|STARTED|Overall Study||2502
6438029|NCT01082874|7352824|FG000|COMPLETED|Overall Study||2488
6438030|NCT01082874|7352825|FG001|COMPLETED|Overall Study||2498
6438031|NCT01082874|7352826|FG002|COMPLETED|Overall Study||2488
6438032|NCT01082874|7352827|FG003|COMPLETED|Overall Study||2489
6438033|NCT01082874|7352824|FG000|NOT COMPLETED|Overall Study||11
6438034|NCT01082874|7352825|FG001|NOT COMPLETED|Overall Study||12
6438035|NCT01082874|7352826|FG002|NOT COMPLETED|Overall Study||11
6438036|NCT01082874|7352827|FG003|NOT COMPLETED|Overall Study||13
6438037|NCT01082939|7352837|FG000|STARTED|Overall Study||80
6438038|NCT01082939|7352837|FG000|COMPLETED|Overall Study||80
6438039|NCT01082939|7352837|FG000|NOT COMPLETED|Overall Study||0
6438040|NCT01082952|7352843|FG000|STARTED|Overall Study||6
6438041|NCT01082952|7352844|FG001|STARTED|Overall Study||6
6438042|NCT01082952|7352843|FG000|COMPLETED|Overall Study||6
6438043|NCT01082952|7352844|FG001|COMPLETED|Overall Study||6
6438044|NCT01082952|7352843|FG000|NOT COMPLETED|Overall Study||0
6438045|NCT01082952|7352844|FG001|NOT COMPLETED|Overall Study||0
6438046|NCT01082965|7352852|FG000|STARTED|Overall Study||10
6438047|NCT01082965|7352853|FG001|STARTED|Overall Study||8
6438048|NCT01082965|7352852|FG000|COMPLETED|Overall Study||9
6438049|NCT01082965|7352853|FG001|COMPLETED|Overall Study||6
6438050|NCT01082965|7352852|FG000|NOT COMPLETED|Overall Study||1
6438051|NCT01082965|7352853|FG001|NOT COMPLETED|Overall Study||2
6438052|NCT01083121|7352859|FG000|STARTED|Overall Study|Participants who were enrolled in the study|1779
6438053|NCT01083121|7352859|FG000|COMPLETED|Overall Study|Participants included in the analysis|1698
6438054|NCT01083121|7352859|FG000|NOT COMPLETED|Overall Study||81
6438055|NCT01083160|7352867|FG000|STARTED|Overall Study||82
6438056|NCT01083160|7352867|FG000|Evaluable Population|Overall Study||71
6438057|NCT01083160|7352867|FG000|COMPLETED|Overall Study||81
6438058|NCT01083160|7352867|FG000|NOT COMPLETED|Overall Study||1
6438059|NCT01083173|7352871|FG000|STARTED|Main Surveillance: Safety Group||595
6438060|NCT01083173|7352872|FG001|STARTED|Main Surveillance: Safety Group||0
6438061|NCT01083173|7352871|FG000|COMPLETED|Main Surveillance: Safety Group||580
6438062|NCT01083173|7352872|FG001|COMPLETED|Main Surveillance: Safety Group||0
6438063|NCT01083173|7352871|FG000|NOT COMPLETED|Main Surveillance: Safety Group||15
6438064|NCT01083173|7352872|FG001|NOT COMPLETED|Main Surveillance: Safety Group||0
6438065|NCT01083173|7352871|FG000|STARTED|Main Surveillance: Effectiveness Group||580
6438066|NCT01083173|7352872|FG001|STARTED|Main Surveillance: Effectiveness Group||0
6438067|NCT01083173|7352871|FG000|COMPLETED|Main Surveillance: Effectiveness Group||198
6438068|NCT01083173|7352872|FG001|COMPLETED|Main Surveillance: Effectiveness Group||0
6438069|NCT01083173|7352871|FG000|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
6438070|NCT01083173|7352872|FG001|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
6438071|NCT01083173|7352871|FG000|STARTED|Long-term Surveillance: Safety Group||0
6438072|NCT01083173|7352872|FG001|STARTED|Long-term Surveillance: Safety Group||595
6438073|NCT01083173|7352871|FG000|COMPLETED|Long-term Surveillance: Safety Group||0
6438074|NCT01083173|7352872|FG001|COMPLETED|Long-term Surveillance: Safety Group||479
6438075|NCT01083173|7352871|FG000|NOT COMPLETED|Long-term Surveillance: Safety Group||0
6438076|NCT01083173|7352872|FG001|NOT COMPLETED|Long-term Surveillance: Safety Group||116
6438077|NCT01083173|7352871|FG000|STARTED|Long-term Surveillance: Effectiveness Gr||0
6438078|NCT01083173|7352872|FG001|STARTED|Long-term Surveillance: Effectiveness Gr||479
6438079|NCT01083173|7352871|FG000|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
6438080|NCT01083173|7352872|FG001|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
6438081|NCT01083173|7352871|FG000|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
6438082|NCT01083173|7352872|FG001|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
6438083|NCT01083186|7352881|FG000|STARTED|Overall Study||500
6438084|NCT01083186|7352881|FG000|COMPLETED|Overall Study||406
6438085|NCT01083186|7352881|FG000|NOT COMPLETED|Overall Study||94
6438086|NCT01083199|7352905|FG000|STARTED|Overall Study||10
6438087|NCT01083199|7352905|FG000|COMPLETED|Overall Study||10
6438088|NCT01083199|7352905|FG000|NOT COMPLETED|Overall Study||0
6438089|NCT01083316|7352910|FG000|STARTED|Overall Study||35
6438090|NCT01083316|7352910|FG000|COMPLETED|Overall Study||32
6438091|NCT01083316|7352910|FG000|NOT COMPLETED|Overall Study||3
6438092|NCT01083368|7352917|FG000|STARTED|Dose Escalation Weeks 1-4||0
6438093|NCT01083368|7352918|FG001|STARTED|Dose Escalation Weeks 1-4||0
6438094|NCT01083368|7352919|FG002|STARTED|Dose Escalation Weeks 1-4||4
6438095|NCT01083368|7352920|FG003|STARTED|Dose Escalation Weeks 1-4||0
6438096|NCT01083368|7352917|FG000|Disease Progression|Dose Escalation Weeks 1-4||0
6438097|NCT01083368|7352918|FG001|Disease Progression|Dose Escalation Weeks 1-4||0
6438098|NCT01083368|7352919|FG002|Disease Progression|Dose Escalation Weeks 1-4||1
6438099|NCT01083368|7352920|FG003|Disease Progression|Dose Escalation Weeks 1-4||0
6438100|NCT01083368|7352917|FG000|COMPLETED|Dose Escalation Weeks 1-4||0
6438101|NCT01083368|7352918|FG001|COMPLETED|Dose Escalation Weeks 1-4||0
6438102|NCT01083368|7352919|FG002|COMPLETED|Dose Escalation Weeks 1-4||4
6438103|NCT01083368|7352920|FG003|COMPLETED|Dose Escalation Weeks 1-4||0
6438104|NCT01083368|7352917|FG000|NOT COMPLETED|Dose Escalation Weeks 1-4||0
6438105|NCT01083368|7352918|FG001|NOT COMPLETED|Dose Escalation Weeks 1-4||0
6438106|NCT01083368|7352919|FG002|NOT COMPLETED|Dose Escalation Weeks 1-4||0
6438107|NCT01083368|7352920|FG003|NOT COMPLETED|Dose Escalation Weeks 1-4||0
6438108|NCT01083368|7352917|FG000|STARTED|Dose Escalation Weeks 5-9||0
6438109|NCT01083368|7352918|FG001|STARTED|Dose Escalation Weeks 5-9||0
6438110|NCT01083368|7352919|FG002|STARTED|Dose Escalation Weeks 5-9|Participant on DL1 did not move to dose level 2 because of disease progression.|1
6438111|NCT01083368|7352920|FG003|STARTED|Dose Escalation Weeks 5-9||6
6438112|NCT01083368|7352917|FG000|COMPLETED|Dose Escalation Weeks 5-9||0
6438113|NCT01083368|7352918|FG001|COMPLETED|Dose Escalation Weeks 5-9||0
6438114|NCT01083368|7352919|FG002|COMPLETED|Dose Escalation Weeks 5-9||1
6438115|NCT01083368|7352920|FG003|COMPLETED|Dose Escalation Weeks 5-9|3 participants on dose level 1 moved to dose level 2, 3 more new participants joined.|6
6438116|NCT01083368|7352917|FG000|NOT COMPLETED|Dose Escalation Weeks 5-9||0
6438117|NCT01083368|7352918|FG001|NOT COMPLETED|Dose Escalation Weeks 5-9||0
6438118|NCT01083368|7352919|FG002|NOT COMPLETED|Dose Escalation Weeks 5-9||0
6438119|NCT01083368|7352920|FG003|NOT COMPLETED|Dose Escalation Weeks 5-9||0
6438120|NCT01083368|7352917|FG000|STARTED|Phase II - Efficacy/Safety||0
6438121|NCT01083368|7352918|FG001|STARTED|Phase II - Efficacy/Safety||0
6438122|NCT01083368|7352919|FG002|STARTED|Phase II - Efficacy/Safety||0
6438123|NCT01083368|7352920|FG003|STARTED|Phase II - Efficacy/Safety||20
6438124|NCT01083368|7352917|FG000|COMPLETED|Phase II - Efficacy/Safety||0
6438125|NCT01083368|7352918|FG001|COMPLETED|Phase II - Efficacy/Safety||0
6438126|NCT01083368|7352919|FG002|COMPLETED|Phase II - Efficacy/Safety||0
6438127|NCT01083368|7352920|FG003|COMPLETED|Phase II - Efficacy/Safety|14 plus 6 participants from previous period|20
6438128|NCT01083368|7352917|FG000|NOT COMPLETED|Phase II - Efficacy/Safety||0
6438129|NCT01083368|7352918|FG001|NOT COMPLETED|Phase II - Efficacy/Safety||0
6438130|NCT01083368|7352919|FG002|NOT COMPLETED|Phase II - Efficacy/Safety||0
6438131|NCT01083368|7352920|FG003|NOT COMPLETED|Phase II - Efficacy/Safety||0
6438132|NCT01083485|7352930|FG000|STARTED|Overall Study||70
6438133|NCT01083485|7352931|FG001|STARTED|Overall Study||67
6438134|NCT01083485|7352930|FG000|COMPLETED|Overall Study||63
6438135|NCT01083485|7352931|FG001|COMPLETED|Overall Study||64
6438136|NCT01083485|7352930|FG000|NOT COMPLETED|Overall Study||7
6438137|NCT01083485|7352931|FG001|NOT COMPLETED|Overall Study||3
6438138|NCT01083576|7352941|FG000|STARTED|Overall Study||15
6438139|NCT01083576|7352942|FG001|STARTED|Overall Study||15
6438140|NCT01083576|7352941|FG000|COMPLETED|Overall Study||9
6438141|NCT01083576|7352942|FG001|COMPLETED|Overall Study||14
6438142|NCT01083576|7352941|FG000|NOT COMPLETED|Overall Study||6
6438143|NCT01083576|7352942|FG001|NOT COMPLETED|Overall Study||1
6438144|NCT01083602|7352949|FG000|STARTED|Overall Study||55
6438145|NCT01083602|7352949|FG000|COMPLETED|Overall Study||0
6438146|NCT01083602|7352949|FG000|NOT COMPLETED|Overall Study||55
6438147|NCT01083628|7352955|FG000|STARTED|Overall Study||45
6438148|NCT01083628|7352956|FG001|STARTED|Overall Study||40
6438149|NCT01083628|7352955|FG000|COMPLETED|Overall Study||45
6438150|NCT01083628|7352956|FG001|COMPLETED|Overall Study||40
6438151|NCT01083628|7352955|FG000|NOT COMPLETED|Overall Study||0
6438152|NCT01083628|7352956|FG001|NOT COMPLETED|Overall Study||0
6438153|NCT01083641|7352962|FG000|STARTED|Overall Study||17
6438154|NCT01083641|7352962|FG000|COMPLETED|Overall Study||15
6438155|NCT01083641|7352962|FG000|NOT COMPLETED|Overall Study||2
6438156|NCT01083654|7352968|FG000|STARTED|Overall Study||53
6438157|NCT01083654|7352969|FG001|STARTED|Overall Study||50
6438158|NCT01083654|7352968|FG000|COMPLETED|Overall Study||53
6438159|NCT01083654|7352969|FG001|COMPLETED|Overall Study||50
6438160|NCT01083654|7352968|FG000|NOT COMPLETED|Overall Study||0
6438161|NCT01083654|7352969|FG001|NOT COMPLETED|Overall Study||0
6438162|NCT01083667|7352975|FG000|STARTED|Overall Study|enrolled|32
6438163|NCT01083667|7352975|FG000|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
6438164|NCT01083667|7352975|FG000|NOT COMPLETED|Overall Study||10
6438165|NCT01083680|7352979|FG000|STARTED|Overall Study||4107
6438166|NCT01083680|7352979|FG000|Full Analysis Set (FAS), Efficacy|Overall Study||1621
6438167|NCT01083680|7352979|FG000|COMPLETED|Overall Study||263
6438168|NCT01083680|7352979|FG000|NOT COMPLETED|Overall Study||3844
6438169|NCT01083693|7352986|FG000|STARTED|Overall Study||93
6438170|NCT01083693|7352987|FG001|STARTED|Overall Study||28
6438171|NCT01083693|7352988|FG002|STARTED|Overall Study||40
6438172|NCT01083693|7352986|FG000|COMPLETED|Overall Study||73
6438173|NCT01083693|7352987|FG001|COMPLETED|Overall Study||22
6438174|NCT01083693|7352988|FG002|COMPLETED|Overall Study||33
6438175|NCT01083693|7352986|FG000|NOT COMPLETED|Overall Study||20
6438176|NCT01083693|7352987|FG001|NOT COMPLETED|Overall Study||6
6438177|NCT01083693|7352988|FG002|NOT COMPLETED|Overall Study||7
6438178|NCT01083706|7353000|FG000|STARTED|Overall Study||39
6438179|NCT01083706|7353000|FG000|COMPLETED|Overall Study||39
6438180|NCT01083706|7353000|FG000|NOT COMPLETED|Overall Study||0
6438181|NCT01083732|7353007|FG000|STARTED|Overall Study||6
6438182|NCT01083732|7353008|FG001|STARTED|Overall Study||9
6438183|NCT01083732|7353009|FG002|STARTED|Overall Study||3
6438184|NCT01083732|7353007|FG000|COMPLETED|Overall Study||6
6438185|NCT01083732|7353008|FG001|COMPLETED|Overall Study||9
6438186|NCT01083732|7353009|FG002|COMPLETED|Overall Study||3
6438187|NCT01083732|7353007|FG000|NOT COMPLETED|Overall Study||0
6438188|NCT01083732|7353008|FG001|NOT COMPLETED|Overall Study||0
6438189|NCT01083732|7353009|FG002|NOT COMPLETED|Overall Study||0
6438190|NCT01083758|7353020|FG000|STARTED|Overall Study||31
6438191|NCT01083758|7353020|FG000|COMPLETED|Overall Study||29
6438192|NCT01083758|7353020|FG000|NOT COMPLETED|Overall Study||2
6438193|NCT01083810|7353027|FG000|STARTED|Overall Study||137
6438194|NCT01083810|7353028|FG001|STARTED|Overall Study||92
6438195|NCT01083810|7353029|FG002|STARTED|Overall Study||55
6438196|NCT01083810|7353027|FG000|COMPLETED|Overall Study||72
6438197|NCT01083810|7353028|FG001|COMPLETED|Overall Study||47
6438198|NCT01083810|7353029|FG002|COMPLETED|Overall Study||35
6438199|NCT01083810|7353027|FG000|NOT COMPLETED|Overall Study||65
6438200|NCT01083810|7353028|FG001|NOT COMPLETED|Overall Study||45
6438201|NCT01083810|7353029|FG002|NOT COMPLETED|Overall Study||20
6438202|NCT01083849|7353037|FG000|STARTED|Overall Study||121
6438203|NCT01083849|7353038|FG001|STARTED|Overall Study||638
6438204|NCT01083849|7353037|FG000|COMPLETED|Overall Study||61
6438205|NCT01083849|7353038|FG001|COMPLETED|Overall Study||527
6438206|NCT01083849|7353037|FG000|NOT COMPLETED|Overall Study||60
6438207|NCT01083849|7353038|FG001|NOT COMPLETED|Overall Study||111
6438208|NCT01083901|7353050|FG000|STARTED|Overall Study||13
6552810|NCT01739309|7475217|FG000|Alive and on Study, Off Treatment|Overall Study||8
6552811|NCT01739309|7475217|FG000|COMPLETED|Overall Study||25
6552812|NCT01739309|7475217|FG000|NOT COMPLETED|Overall Study||3
6552813|NCT01739335|7475225|FG000|STARTED|Overall Study||41
6552814|NCT01739335|7475226|FG001|STARTED|Overall Study||40
6552815|NCT01739335|7475225|FG000|COMPLETED|Overall Study||34
6438209|NCT01083901|7353051|FG001|STARTED|Overall Study||8
6438210|NCT01083901|7353052|FG002|STARTED|Overall Study||13
6438211|NCT01083901|7353050|FG000|COMPLETED|Overall Study||12
6438212|NCT01083901|7353051|FG001|COMPLETED|Overall Study||6
6438213|NCT01083901|7353052|FG002|COMPLETED|Overall Study||11
6438214|NCT01083901|7353050|FG000|NOT COMPLETED|Overall Study||1
6438215|NCT01083901|7353051|FG001|NOT COMPLETED|Overall Study||2
6438216|NCT01083901|7353052|FG002|NOT COMPLETED|Overall Study||2
6438217|NCT01083979|7353060|FG000|STARTED|Overall Study||1
6438218|NCT01083979|7353060|FG000|COMPLETED|Overall Study||1
6438219|NCT01083979|7353060|FG000|NOT COMPLETED|Overall Study||0
6438220|NCT01084005|7353066|FG000|STARTED|Overall Study||79
6438221|NCT01084005|7353067|FG001|STARTED|Overall Study||162
6438222|NCT01084005|7353066|FG000|COMPLETED|Overall Study||74
6438223|NCT01084005|7353067|FG001|COMPLETED|Overall Study||146
6438224|NCT01084005|7353066|FG000|NOT COMPLETED|Overall Study||5
6438225|NCT01084005|7353067|FG001|NOT COMPLETED|Overall Study||16
6438226|NCT01084083|7353073|FG000|STARTED|Overall Study||90
6438227|NCT01084083|7353073|FG000|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
6438228|NCT01084083|7353073|FG000|Eligible|Overall Study||81
6438229|NCT01084083|7353073|FG000|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
6438230|NCT01084083|7353073|FG000|CR to Induction Therapy|Overall Study||56
6438231|NCT01084083|7353073|FG000|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
6438232|NCT01084083|7353073|FG000|COMPLETED|Overall Study||78
6438233|NCT01084083|7353073|FG000|NOT COMPLETED|Overall Study||12
6438234|NCT01084135|7353082|FG000|STARTED|12 Week||4
6438235|NCT01084135|7353083|FG001|STARTED|12 Week||4
6438236|NCT01084135|7353082|FG000|COMPLETED|12 Week||4
6552816|NCT01739335|7475226|FG001|COMPLETED|Overall Study||35
6438237|NCT01084135|7353083|FG001|COMPLETED|12 Week||4
6438238|NCT01084135|7353082|FG000|NOT COMPLETED|12 Week||0
6438239|NCT01084135|7353083|FG001|NOT COMPLETED|12 Week||0
6438240|NCT01084135|7353082|FG000|STARTED|20 Week||12
6438241|NCT01084135|7353083|FG001|STARTED|20 Week||11
6438242|NCT01084135|7353082|FG000|COMPLETED|20 Week||12
6438243|NCT01084135|7353083|FG001|COMPLETED|20 Week||10
6438244|NCT01084135|7353082|FG000|NOT COMPLETED|20 Week||0
6438245|NCT01084135|7353083|FG001|NOT COMPLETED|20 Week||1
6438246|NCT01084148|7353093|FG000|STARTED|Overall Study||118
6438247|NCT01084148|7353094|FG001|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
6438248|NCT01084148|7353093|FG000|Treated Patients|Overall Study||118
6438249|NCT01084148|7353094|FG001|Treated Patients|Overall Study|Patients who received test product at least once|117
6438250|NCT01084148|7353093|FG000|COMPLETED|Overall Study||88
6552817|NCT01739335|7475225|FG000|NOT COMPLETED|Overall Study||7
6438251|NCT01084148|7353094|FG001|COMPLETED|Overall Study||102
6438252|NCT01084148|7353093|FG000|NOT COMPLETED|Overall Study||30
6438253|NCT01084148|7353094|FG001|NOT COMPLETED|Overall Study||16
6438254|NCT01084174|7353104|FG000|STARTED|Overall Study||10
6438255|NCT01084174|7353105|FG001|STARTED|Overall Study||11
6438256|NCT01084174|7353104|FG000|COMPLETED|Overall Study||9
6438257|NCT01084174|7353105|FG001|COMPLETED|Overall Study||7
6438258|NCT01084174|7353104|FG000|NOT COMPLETED|Overall Study||1
6438259|NCT01084174|7353105|FG001|NOT COMPLETED|Overall Study||4
6438260|NCT01084239|7353113|FG000|STARTED|Randomization - Index Hospitalization||501
6438261|NCT01084239|7353114|FG001|STARTED|Randomization - Index Hospitalization||499
6438262|NCT01084239|7353113|FG000|COMPLETED|Randomization - Index Hospitalization||501
6438263|NCT01084239|7353114|FG001|COMPLETED|Randomization - Index Hospitalization||499
6438264|NCT01084239|7353113|FG000|NOT COMPLETED|Randomization - Index Hospitalization||0
6438265|NCT01084239|7353114|FG001|NOT COMPLETED|Randomization - Index Hospitalization||0
6438266|NCT01084239|7353113|FG000|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
6438267|NCT01084239|7353114|FG001|STARTED|28-Day Follow-up||499
6438268|NCT01084239|7353113|FG000|COMPLETED|28-Day Follow-up||497
6438269|NCT01084239|7353114|FG001|COMPLETED|28-Day Follow-up||490
6438270|NCT01084239|7353113|FG000|NOT COMPLETED|28-Day Follow-up||4
6438271|NCT01084239|7353114|FG001|NOT COMPLETED|28-Day Follow-up||9
6438272|NCT01084265|7353122|FG000|STARTED|Overall Study||31
6438273|NCT01084265|7353122|FG000|COMPLETED|Overall Study||31
6438274|NCT01084265|7353122|FG000|NOT COMPLETED|Overall Study||0
6438275|NCT01084278|7353131|FG000|STARTED|Overall Study||8
6438276|NCT01084278|7353132|FG001|STARTED|Overall Study||8
6438277|NCT01084278|7353133|FG002|STARTED|Overall Study||8
6438278|NCT01084278|7353134|FG003|STARTED|Overall Study||8
6438279|NCT01084278|7353135|FG004|STARTED|Overall Study||8
6438280|NCT01084278|7353131|FG000|COMPLETED|Overall Study||8
6438281|NCT01084278|7353132|FG001|COMPLETED|Overall Study||8
6438282|NCT01084278|7353133|FG002|COMPLETED|Overall Study||8
6438283|NCT01084278|7353134|FG003|COMPLETED|Overall Study||8
6438284|NCT01084278|7353135|FG004|COMPLETED|Overall Study||8
6438285|NCT01084278|7353131|FG000|NOT COMPLETED|Overall Study||0
6438286|NCT01084278|7353132|FG001|NOT COMPLETED|Overall Study||0
6438287|NCT01084278|7353133|FG002|NOT COMPLETED|Overall Study||0
6438288|NCT01084278|7353134|FG003|NOT COMPLETED|Overall Study||0
6438289|NCT01084278|7353135|FG004|NOT COMPLETED|Overall Study||0
6438290|NCT01084499|7353151|FG000|STARTED|Overall Study|First Intervention (Sequence 1) : Femara (1 Day)|13
6438291|NCT01084499|7353152|FG001|STARTED|Overall Study|First Intervention (Sequence 2) : Peratra (1 Day)|13
6438292|NCT01084499|7353151|FG000|Washout (5 Weeks)|Overall Study||13
6438293|NCT01084499|7353152|FG001|Washout (5 Weeks)|Overall Study||13
6438294|NCT01084499|7353151|FG000|COMPLETED|Overall Study|Second Intervention (Sequence 1) : Peratra (1 Day)|13
6438295|NCT01084499|7353152|FG001|COMPLETED|Overall Study|Second Intervention (Sequence 2) : Femara (1 Day)|13
6438296|NCT01084499|7353151|FG000|NOT COMPLETED|Overall Study||0
6438297|NCT01084499|7353152|FG001|NOT COMPLETED|Overall Study||0
6438298|NCT01084538|7353158|FG000|STARTED|Overall Study||181
6438299|NCT01084538|7353158|FG000|COMPLETED|Overall Study||113
6438300|NCT01084538|7353158|FG000|NOT COMPLETED|Overall Study||68
6438301|NCT01084551|7353165|FG000|STARTED|Overall Study||95
6438302|NCT01084551|7353166|FG001|STARTED|Overall Study||95
6438303|NCT01084551|7353167|FG002|STARTED|Overall Study||94
6438304|NCT01084551|7353165|FG000|COMPLETED|Overall Study||86
6438305|NCT01084551|7353166|FG001|COMPLETED|Overall Study||81
6438306|NCT01084551|7353167|FG002|COMPLETED|Overall Study||86
6438307|NCT01084551|7353165|FG000|NOT COMPLETED|Overall Study||9
6438308|NCT01084551|7353166|FG001|NOT COMPLETED|Overall Study||14
6438309|NCT01084551|7353167|FG002|NOT COMPLETED|Overall Study||8
6438310|NCT01084603|7353175|FG000|STARTED|Baseline||45
6438311|NCT01084603|7353175|FG000|COMPLETED|Baseline||43
6438312|NCT01084603|7353175|FG000|NOT COMPLETED|Baseline||2
6438313|NCT01084603|7353175|FG000|STARTED|NiQuitinTM Lozenge||43
6438314|NCT01084603|7353175|FG000|COMPLETED|NiQuitinTM Lozenge||42
6438315|NCT01084603|7353175|FG000|NOT COMPLETED|NiQuitinTM Lozenge||1
6438316|NCT01084603|7353175|FG000|STARTED|Washout Period 1||42
6438317|NCT01084603|7353175|FG000|COMPLETED|Washout Period 1||42
6438318|NCT01084603|7353175|FG000|NOT COMPLETED|Washout Period 1||0
6438319|NCT01084603|7353175|FG000|STARTED|Nicorette® Gum||42
6438320|NCT01084603|7353175|FG000|COMPLETED|Nicorette® Gum||41
6438321|NCT01084603|7353175|FG000|NOT COMPLETED|Nicorette® Gum||1
6438322|NCT01084603|7353175|FG000|STARTED|Washout Period 2||41
6438323|NCT01084603|7353175|FG000|COMPLETED|Washout Period 2||41
6438324|NCT01084603|7353175|FG000|NOT COMPLETED|Washout Period 2||0
6438325|NCT01084603|7353175|FG000|STARTED|Oral Nicotine 1||41
6438326|NCT01084603|7353175|FG000|COMPLETED|Oral Nicotine 1||40
6438327|NCT01084603|7353175|FG000|NOT COMPLETED|Oral Nicotine 1||1
6438328|NCT01084603|7353175|FG000|STARTED|Washout Period 3||40
6438329|NCT01084603|7353175|FG000|COMPLETED|Washout Period 3||40
6438330|NCT01084603|7353175|FG000|NOT COMPLETED|Washout Period 3||0
6438331|NCT01084603|7353175|FG000|STARTED|Oral Nicotine 2||40
6438332|NCT01084603|7353175|FG000|COMPLETED|Oral Nicotine 2||40
6438333|NCT01084603|7353175|FG000|NOT COMPLETED|Oral Nicotine 2||0
6438334|NCT01084603|7353175|FG000|STARTED|Washout Period 4||40
6438335|NCT01084603|7353175|FG000|COMPLETED|Washout Period 4||39
6438336|NCT01084603|7353175|FG000|NOT COMPLETED|Washout Period 4||1
6438337|NCT01084603|7353175|FG000|STARTED|Oral Nicotine 4||39
6438338|NCT01084603|7353175|FG000|COMPLETED|Oral Nicotine 4||39
6438339|NCT01084603|7353175|FG000|NOT COMPLETED|Oral Nicotine 4||0
6438340|NCT01084655|7353191|FG000|STARTED|Overall Study||6
6438341|NCT01084655|7353192|FG001|STARTED|Overall Study||8
6438342|NCT01084655|7353193|FG002|STARTED|Overall Study||24
6438343|NCT01084655|7353191|FG000|Treated|Overall Study||6
6438344|NCT01084655|7353192|FG001|Treated|Overall Study||8
6438345|NCT01084655|7353193|FG002|Treated|Overall Study||23
6438346|NCT01084655|7353191|FG000|COMPLETED|Overall Study||0
6438347|NCT01084655|7353192|FG001|COMPLETED|Overall Study||2
6438348|NCT01084655|7353193|FG002|COMPLETED|Overall Study||5
6438349|NCT01084655|7353191|FG000|NOT COMPLETED|Overall Study||6
6438350|NCT01084655|7353192|FG001|NOT COMPLETED|Overall Study||6
6438351|NCT01084655|7353193|FG002|NOT COMPLETED|Overall Study||19
6438352|NCT01084668|7353205|FG000|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
6438353|NCT01084668|7353205|FG000|COMPLETED|Overall Study||33
6438354|NCT01084668|7353205|FG000|NOT COMPLETED|Overall Study||9
6438355|NCT01084694|7353213|FG000|STARTED|Overall Study||50
6438356|NCT01084694|7353214|FG001|STARTED|Overall Study||50
6438357|NCT01084694|7353213|FG000|COMPLETED|Overall Study||44
6438358|NCT01084694|7353214|FG001|COMPLETED|Overall Study||30
6438359|NCT01084694|7353213|FG000|NOT COMPLETED|Overall Study||6
6438360|NCT01084694|7353214|FG001|NOT COMPLETED|Overall Study||20
6438361|NCT01084707|7353228|FG000|STARTED|Overall Study||40
6438362|NCT01084707|7353228|FG000|COMPLETED|Overall Study||34
6438363|NCT01084707|7353228|FG000|NOT COMPLETED|Overall Study||6
6438364|NCT01084759|7353240|FG000|STARTED|Overall Study||16
6438365|NCT01084759|7353240|FG000|COMPLETED|Overall Study||14
6438366|NCT01084759|7353240|FG000|NOT COMPLETED|Overall Study||2
6438367|NCT01084772|7353246|FG000|STARTED|Baseline||68
6552818|NCT01739335|7475226|FG001|NOT COMPLETED|Overall Study||5
6552819|NCT01739348|7475240|FG000|STARTED|Part I (Base Study)||703
6552820|NCT01739348|7475241|FG001|STARTED|Part I (Base Study)||700
6552821|NCT01739348|7475242|FG002|STARTED|Part I (Base Study)||103
6552822|NCT01739348|7475243|FG003|STARTED|Part I (Base Study)||705
6552823|NCT01739348|7475240|FG000|Treated|Part I (Base Study)||702
6552824|NCT01739348|7475241|FG001|Treated|Part I (Base Study)||700
6552825|NCT01739348|7475242|FG002|Treated|Part I (Base Study)||103
6552826|NCT01739348|7475243|FG003|Treated|Part I (Base Study)||705
6552827|NCT01739348|7475240|FG000|COMPLETED|Part I (Base Study)||501
6552828|NCT01739348|7475241|FG001|COMPLETED|Part I (Base Study)||497
6552829|NCT01739348|7475242|FG002|COMPLETED|Part I (Base Study)||77
6552830|NCT01739348|7475243|FG003|COMPLETED|Part I (Base Study)||516
6552831|NCT01739348|7475240|FG000|NOT COMPLETED|Part I (Base Study)||202
6438368|NCT01084772|7353247|FG001|STARTED|Baseline||66
6438369|NCT01084772|7353246|FG000|COMPLETED|Baseline||61
6438370|NCT01084772|7353247|FG001|COMPLETED|Baseline||60
6438371|NCT01084772|7353246|FG000|NOT COMPLETED|Baseline||7
6438372|NCT01084772|7353247|FG001|NOT COMPLETED|Baseline||6
6438373|NCT01084772|7353246|FG000|STARTED|3 Months||61
6438374|NCT01084772|7353247|FG001|STARTED|3 Months||60
6438375|NCT01084772|7353246|FG000|COMPLETED|3 Months||58
6438376|NCT01084772|7353247|FG001|COMPLETED|3 Months||58
6438377|NCT01084772|7353246|FG000|NOT COMPLETED|3 Months||3
6438378|NCT01084772|7353247|FG001|NOT COMPLETED|3 Months||2
6438379|NCT01084772|7353246|FG000|STARTED|1 Year||58
6438380|NCT01084772|7353247|FG001|STARTED|1 Year||58
6438381|NCT01084772|7353246|FG000|COMPLETED|1 Year||55
6438382|NCT01084772|7353247|FG001|COMPLETED|1 Year||50
6438383|NCT01084772|7353246|FG000|NOT COMPLETED|1 Year||3
6438384|NCT01084772|7353247|FG001|NOT COMPLETED|1 Year||8
6438385|NCT01084772|7353246|FG000|STARTED|2 Years||55
6438386|NCT01084772|7353247|FG001|STARTED|2 Years||50
6438387|NCT01084772|7353246|FG000|COMPLETED|2 Years||46
6438388|NCT01084772|7353247|FG001|COMPLETED|2 Years||46
6438389|NCT01084772|7353246|FG000|NOT COMPLETED|2 Years||9
6438390|NCT01084772|7353247|FG001|NOT COMPLETED|2 Years||4
6438391|NCT01085006|7353255|FG000|STARTED|Overall Study||50
6438392|NCT01085006|7353256|FG001|STARTED|Overall Study||50
6438393|NCT01085006|7353255|FG000|COMPLETED|Overall Study||50
6438394|NCT01085006|7353256|FG001|COMPLETED|Overall Study||50
6438395|NCT01085006|7353255|FG000|NOT COMPLETED|Overall Study||0
6438396|NCT01085006|7353256|FG001|NOT COMPLETED|Overall Study||0
6438397|NCT01085045|7353262|FG000|STARTED|Part A||122
6438398|NCT01085045|7353262|FG000|GFF MDI 72/9.6mcg|Part A||40
6438399|NCT01085045|7353262|FG000|GFF MDI 36/9.6 µg (PT003)|Part A||42
6438400|NCT01085045|7353262|FG000|GP MDI 36 µg (PT001)|Part A||40
6438401|NCT01085045|7353262|FG000|Spiriva 18 µg|Part A||58
6438402|NCT01085045|7353262|FG000|FF MDI 9.6 µg (PT005)|Part A||20
6438403|NCT01085045|7353262|FG000|FF MDI 7.2 µg (PT005)|Part A||21
6438404|NCT01085045|7353262|FG000|Placebo MDI|Part A||5
6438405|NCT01085045|7353262|FG000|Foradil 12 µg|Part A||14
6438406|NCT01085045|7353262|FG000|COMPLETED|Part A||104
6552832|NCT01739348|7475241|FG001|NOT COMPLETED|Part I (Base Study)||203
6438407|NCT01085045|7353262|FG000|NOT COMPLETED|Part A||18
6438408|NCT01085045|7353262|FG000|STARTED|Part B||104
6438409|NCT01085045|7353262|FG000|GFF MDI 72/9.6mcg (PT003)|Part B||0
6438410|NCT01085045|7353262|FG000|GFF MDI 36/9.6 µg|Part B||0
6438411|NCT01085045|7353262|FG000|Spiriva 18 µg|Part B||0
6438412|NCT01085045|7353262|FG000|FF MDI 9.6 µg (PT005)|Part B||43
6438413|NCT01085045|7353262|FG000|FF MDI 7.2 µg (PT005)|Part B||43
6438414|NCT01085045|7353262|FG000|Placebo MDI|Part B||47
6438415|NCT01085045|7353262|FG000|Foradil 12 µg|Part B||41
6552833|NCT01739348|7475242|FG002|NOT COMPLETED|Part I (Base Study)||26
6438416|NCT01085045|7353262|FG000|GP MDI 36 µg (PT001)|Part B||0
6438417|NCT01085045|7353262|FG000|COMPLETED|Part B||89
6438418|NCT01085045|7353262|FG000|NOT COMPLETED|Part B||15
6438419|NCT01085136|7353282|FG000|STARTED|Part A||1154
6438420|NCT01085136|7353283|FG001|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
6438421|NCT01085136|7353284|FG002|STARTED|Part A||0
6438422|NCT01085136|7353282|FG000|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
6438423|NCT01085136|7353283|FG001|Randomized to Part B|Part A||0
6438424|NCT01085136|7353284|FG002|Randomized to Part B|Part A||0
6438425|NCT01085136|7353282|FG000|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
6438426|NCT01085136|7353283|FG001|COMPLETED|Part A||0
6438427|NCT01085136|7353284|FG002|COMPLETED|Part A||0
6438428|NCT01085136|7353282|FG000|NOT COMPLETED|Part A||323
6438429|NCT01085136|7353283|FG001|NOT COMPLETED|Part A||0
6438430|NCT01085136|7353284|FG002|NOT COMPLETED|Part A||0
6438431|NCT01085136|7353282|FG000|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
6438432|NCT01085136|7353283|FG001|STARTED|Part B||138
6438433|NCT01085136|7353284|FG002|STARTED|Part B||68
6438434|NCT01085136|7353282|FG000|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
6438435|NCT01085136|7353283|FG001|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
6438436|NCT01085136|7353284|FG002|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
6438437|NCT01085136|7353282|FG000|NOT COMPLETED|Part B||0
6438438|NCT01085136|7353283|FG001|NOT COMPLETED|Part B||51
6438439|NCT01085136|7353284|FG002|NOT COMPLETED|Part B||26
6438440|NCT01085201|7353299|FG000|STARTED|Overall Study||18
6438441|NCT01085201|7353300|FG001|STARTED|Overall Study||7
6438442|NCT01085201|7353301|FG002|STARTED|Overall Study||5
6438443|NCT01085201|7353302|FG003|STARTED|Overall Study||6
6438444|NCT01085201|7353303|FG004|STARTED|Overall Study||3
6438445|NCT01085201|7353299|FG000|COMPLETED|Overall Study||15
6438446|NCT01085201|7353300|FG001|COMPLETED|Overall Study||6
6438447|NCT01085201|7353301|FG002|COMPLETED|Overall Study||3
6438448|NCT01085201|7353302|FG003|COMPLETED|Overall Study||6
6438449|NCT01085201|7353303|FG004|COMPLETED|Overall Study||3
6438450|NCT01085201|7353299|FG000|NOT COMPLETED|Overall Study||3
6438451|NCT01085201|7353300|FG001|NOT COMPLETED|Overall Study||1
6438452|NCT01085201|7353301|FG002|NOT COMPLETED|Overall Study||2
6438453|NCT01085201|7353302|FG003|NOT COMPLETED|Overall Study||0
6552834|NCT01739348|7475243|FG003|NOT COMPLETED|Part I (Base Study)||189
6552835|NCT01739348|7475240|FG000|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|379
6438454|NCT01085201|7353303|FG004|NOT COMPLETED|Overall Study||0
6438455|NCT01085214|7353320|FG000|STARTED|Overall Study||37
6438456|NCT01085214|7353320|FG000|COMPLETED|Overall Study||36
6438457|NCT01085214|7353320|FG000|NOT COMPLETED|Overall Study||1
6438458|NCT01085318|7353326|FG000|STARTED|Overall Study||23
6438459|NCT01085318|7353327|FG001|STARTED|Overall Study||15
6438460|NCT01085318|7353326|FG000|COMPLETED|Overall Study||21
6438461|NCT01085318|7353327|FG001|COMPLETED|Overall Study||15
6438462|NCT01085318|7353326|FG000|NOT COMPLETED|Overall Study||2
6438463|NCT01085318|7353327|FG001|NOT COMPLETED|Overall Study||0
6438464|NCT01085331|7353335|FG000|STARTED|Overall Study||10
6438465|NCT01085331|7353336|FG001|STARTED|Overall Study||6
6438466|NCT01085331|7353335|FG000|COMPLETED|Overall Study||10
6438467|NCT01085331|7353336|FG001|COMPLETED|Overall Study||6
6438468|NCT01085331|7353335|FG000|NOT COMPLETED|Overall Study||0
6438469|NCT01085331|7353336|FG001|NOT COMPLETED|Overall Study||0
6438470|NCT01085344|7353346|FG000|STARTED|Overall Study||56
6438471|NCT01085344|7353346|FG000|COMPLETED|Overall Study||50
6438472|NCT01085344|7353346|FG000|NOT COMPLETED|Overall Study||6
6438473|NCT01085357|7353352|FG000|STARTED|Overall Study||374
6438474|NCT01085357|7353353|FG001|STARTED|Overall Study||131
6438475|NCT01085357|7353352|FG000|COMPLETED|Overall Study||355
6438476|NCT01085357|7353353|FG001|COMPLETED|Overall Study||125
6438477|NCT01085357|7353352|FG000|NOT COMPLETED|Overall Study||19
6438478|NCT01085357|7353353|FG001|NOT COMPLETED|Overall Study||6
6438479|NCT01085500|7353361|FG000|STARTED|Overall Study||26
6438480|NCT01085500|7353362|FG001|STARTED|Overall Study||24
6438481|NCT01085500|7353361|FG000|COMPLETED|Overall Study||26
6438482|NCT01085500|7353362|FG001|COMPLETED|Overall Study||24
6438483|NCT01085500|7353361|FG000|NOT COMPLETED|Overall Study||0
6438484|NCT01085500|7353362|FG001|NOT COMPLETED|Overall Study||0
6438485|NCT01085513|7353370|FG000|STARTED|Phase I - Development Phase||54
6438486|NCT01085513|7353371|FG001|STARTED|Phase I - Development Phase||52
6438487|NCT01085513|7353370|FG000|COMPLETED|Phase I - Development Phase|recruitment was premature terminated|54
6438488|NCT01085513|7353371|FG001|COMPLETED|Phase I - Development Phase||52
6438489|NCT01085513|7353370|FG000|NOT COMPLETED|Phase I - Development Phase||0
6438490|NCT01085513|7353371|FG001|NOT COMPLETED|Phase I - Development Phase||0
6438491|NCT01085513|7353370|FG000|STARTED|Phase II - Validation Phase||21
6438492|NCT01085513|7353371|FG001|STARTED|Phase II - Validation Phase||16
6438493|NCT01085513|7353370|FG000|COMPLETED|Phase II - Validation Phase||21
6438494|NCT01085513|7353371|FG001|COMPLETED|Phase II - Validation Phase||16
6438495|NCT01085513|7353370|FG000|NOT COMPLETED|Phase II - Validation Phase||0
6438496|NCT01085513|7353371|FG001|NOT COMPLETED|Phase II - Validation Phase||0
6438497|NCT01085539|7353377|FG000|STARTED|Sat Secs Off--No Alarm Evaluation||50
6438498|NCT01085539|7353377|FG000|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
6438499|NCT01085539|7353377|FG000|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
6438500|NCT01085539|7353377|FG000|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
6438501|NCT01085539|7353377|FG000|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
6438502|NCT01085539|7353377|FG000|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
6438503|NCT01085539|7353377|FG000|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
6438504|NCT01085539|7353377|FG000|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
6438505|NCT01085539|7353377|FG000|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
6438506|NCT01085539|7353377|FG000|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
6438507|NCT01085539|7353377|FG000|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
6438508|NCT01085539|7353377|FG000|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
6438509|NCT01085539|7353377|FG000|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
6438510|NCT01085539|7353377|FG000|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
6438511|NCT01085539|7353377|FG000|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
6438512|NCT01085591|7353384|FG000|STARTED|Overall Study||69
6438513|NCT01085591|7353385|FG001|STARTED|Overall Study||71
6552836|NCT01739348|7475241|FG001|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|366
6552837|NCT01739348|7475242|FG002|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|61
6552838|NCT01739348|7475243|FG003|STARTED|Part II (Extension Study)|Number started refers only to participants completing Part I, volunteering to continue to Part II.|396
6552839|NCT01739348|7475240|FG000|Treated|Part II (Extension Study)||379
6552840|NCT01739348|7475241|FG001|Treated|Part II (Extension Study)||365
6552841|NCT01739348|7475242|FG002|Treated|Part II (Extension Study)||61
6438514|NCT01085591|7353386|FG002|STARTED|Overall Study||70
6438515|NCT01085591|7353384|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
6438516|NCT01085591|7353385|FG001|Received at Least 1 Dose of Study Drug|Overall Study||69
6438517|NCT01085591|7353386|FG002|Received at Least 1 Dose of Study Drug|Overall Study||70
6438518|NCT01085591|7353384|FG000|COMPLETED|Overall Study||66
6438519|NCT01085591|7353385|FG001|COMPLETED|Overall Study||65
6438520|NCT01085591|7353386|FG002|COMPLETED|Overall Study||63
6438521|NCT01085591|7353384|FG000|NOT COMPLETED|Overall Study||3
6438522|NCT01085591|7353385|FG001|NOT COMPLETED|Overall Study||6
6438523|NCT01085591|7353386|FG002|NOT COMPLETED|Overall Study||7
6438524|NCT01085630|7353397|FG000|STARTED|Overall Study||26
6438525|NCT01085630|7353398|FG001|STARTED|Overall Study||27
6438526|NCT01085630|7353397|FG000|COMPLETED|Overall Study||22
6438527|NCT01085630|7353398|FG001|COMPLETED|Overall Study||27
6438528|NCT01085630|7353397|FG000|NOT COMPLETED|Overall Study||4
6438529|NCT01085630|7353398|FG001|NOT COMPLETED|Overall Study||0
6438530|NCT01085682|7353406|FG000|STARTED|Overall Study||31
6438531|NCT01085682|7353407|FG001|STARTED|Overall Study||28
6438532|NCT01085682|7353406|FG000|COMPLETED|Overall Study||6
6438533|NCT01085682|7353407|FG001|COMPLETED|Overall Study||3
6438534|NCT01085682|7353406|FG000|NOT COMPLETED|Overall Study||25
6438535|NCT01085682|7353407|FG001|NOT COMPLETED|Overall Study||25
6438536|NCT01085734|7353415|FG000|STARTED|Overall Study||15
6438537|NCT01085734|7353416|FG001|STARTED|Overall Study||15
6438538|NCT01085734|7353415|FG000|COMPLETED|Overall Study||14
6438539|NCT01085734|7353416|FG001|COMPLETED|Overall Study||11
6438540|NCT01085734|7353415|FG000|NOT COMPLETED|Overall Study||1
6438541|NCT01085734|7353416|FG001|NOT COMPLETED|Overall Study||4
6438542|NCT01085760|7353427|FG000|STARTED|Overall Study||8
6438543|NCT01085760|7353428|FG001|STARTED|Overall Study||9
6438544|NCT01085760|7353429|FG002|STARTED|Overall Study||9
6438545|NCT01085760|7353430|FG003|STARTED|Overall Study||9
6438546|NCT01085760|7353427|FG000|COMPLETED|Overall Study||7
6438547|NCT01085760|7353428|FG001|COMPLETED|Overall Study||8
6438548|NCT01085760|7353429|FG002|COMPLETED|Overall Study||7
6438549|NCT01085760|7353430|FG003|COMPLETED|Overall Study||6
6438550|NCT01085760|7353427|FG000|NOT COMPLETED|Overall Study||1
6438551|NCT01085760|7353428|FG001|NOT COMPLETED|Overall Study||1
6438552|NCT01085760|7353429|FG002|NOT COMPLETED|Overall Study||2
6438553|NCT01085760|7353430|FG003|NOT COMPLETED|Overall Study||3
6438554|NCT01085786|7353442|FG000|STARTED|Overall Study||123
6438555|NCT01085786|7353443|FG001|STARTED|Overall Study||117
6438556|NCT01085786|7353442|FG000|COMPLETED|Overall Study||123
6438557|NCT01085786|7353443|FG001|COMPLETED|Overall Study||117
6438558|NCT01085786|7353442|FG000|NOT COMPLETED|Overall Study||0
6552842|NCT01739348|7475243|FG003|Treated|Part II (Extension Study)||394
6552843|NCT01739348|7475240|FG000|COMPLETED|Part II (Extension Study)||0
6552844|NCT01739348|7475241|FG001|COMPLETED|Part II (Extension Study)||0
6552845|NCT01739348|7475242|FG002|COMPLETED|Part II (Extension Study)||0
6552846|NCT01739348|7475243|FG003|COMPLETED|Part II (Extension Study)||0
6438559|NCT01085786|7353443|FG001|NOT COMPLETED|Overall Study||0
6438560|NCT01085812|7353449|FG000|STARTED|Open-Label Period||0
6438561|NCT01085812|7353450|FG001|STARTED|Open-Label Period||734
6438562|NCT01085812|7353449|FG000|COMPLETED|Open-Label Period||0
6438563|NCT01085812|7353450|FG001|COMPLETED|Open-Label Period||494
6438564|NCT01085812|7353449|FG000|NOT COMPLETED|Open-Label Period||0
6438565|NCT01085812|7353450|FG001|NOT COMPLETED|Open-Label Period||240
6438566|NCT01085812|7353449|FG000|STARTED|Double-Blind Period||113
6438567|NCT01085812|7353450|FG001|STARTED|Double-Blind Period||235
6438568|NCT01085812|7353449|FG000|COMPLETED|Double-Blind Period||92
6438569|NCT01085812|7353450|FG001|COMPLETED|Double-Blind Period||177
6438570|NCT01085812|7353449|FG000|NOT COMPLETED|Double-Blind Period||21
6438571|NCT01085812|7353450|FG001|NOT COMPLETED|Double-Blind Period||58
6438572|NCT01085812|7353449|FG000|STARTED|Double-blind Intent-to-treat Population||112
6438573|NCT01085812|7353450|FG001|STARTED|Double-blind Intent-to-treat Population||230
6438574|NCT01085812|7353449|FG000|COMPLETED|Double-blind Intent-to-treat Population||92
6438575|NCT01085812|7353450|FG001|COMPLETED|Double-blind Intent-to-treat Population||174
6438576|NCT01085812|7353449|FG000|NOT COMPLETED|Double-blind Intent-to-treat Population||20
6438577|NCT01085812|7353450|FG001|NOT COMPLETED|Double-blind Intent-to-treat Population||56
6438578|NCT01085825|7353459|FG000|STARTED|Overall Study|1st participant enrolled|252
6438579|NCT01085825|7353460|FG001|STARTED|Overall Study||248
6438580|NCT01085825|7353459|FG000|COMPLETED|Overall Study||251
6438581|NCT01085825|7353460|FG001|COMPLETED|Overall Study||247
6438582|NCT01085825|7353459|FG000|NOT COMPLETED|Overall Study||1
6438583|NCT01085825|7353460|FG001|NOT COMPLETED|Overall Study||1
6438584|NCT01085903|7353468|FG000|STARTED|Overall Study||21
6438585|NCT01085903|7353469|FG001|STARTED|Overall Study||4
6438586|NCT01085903|7353470|FG002|STARTED|Overall Study||3
6438587|NCT01085903|7353468|FG000|COMPLETED|Overall Study||21
6438588|NCT01085903|7353469|FG001|COMPLETED|Overall Study||4
6438589|NCT01085903|7353470|FG002|COMPLETED|Overall Study||3
6438590|NCT01085903|7353468|FG000|NOT COMPLETED|Overall Study||0
6438591|NCT01085903|7353469|FG001|NOT COMPLETED|Overall Study||0
6438592|NCT01085903|7353470|FG002|NOT COMPLETED|Overall Study||0
6438593|NCT01085968|7353491|FG000|STARTED|Overall Study||29
6438594|NCT01085968|7353492|FG001|STARTED|Overall Study||25
6438595|NCT01085968|7353491|FG000|COMPLETED|Overall Study||19
6438596|NCT01085968|7353492|FG001|COMPLETED|Overall Study||21
6438597|NCT01085968|7353491|FG000|NOT COMPLETED|Overall Study||10
6438598|NCT01085968|7353492|FG001|NOT COMPLETED|Overall Study||4
6438599|NCT01086033|7353498|FG000|STARTED|Overall Study||566
6438600|NCT01086033|7353498|FG000|COMPLETED|Overall Study||262
6438601|NCT01086033|7353498|FG000|NOT COMPLETED|Overall Study||304
6438602|NCT01086150|7353508|FG000|STARTED|Overall Study||11
6438603|NCT01086150|7353509|FG001|STARTED|Overall Study||27
6438604|NCT01086150|7353510|FG002|STARTED|Overall Study||13
6438605|NCT01086150|7353508|FG000|COMPLETED|Overall Study||11
6438606|NCT01086150|7353509|FG001|COMPLETED|Overall Study||21
6438607|NCT01086150|7353510|FG002|COMPLETED|Overall Study||12
6438608|NCT01086150|7353508|FG000|NOT COMPLETED|Overall Study||0
6438609|NCT01086150|7353509|FG001|NOT COMPLETED|Overall Study||6
6438610|NCT01086150|7353510|FG002|NOT COMPLETED|Overall Study||1
6438611|NCT01086215|7353522|FG000|STARTED|Overall Study||212
6438612|NCT01086215|7353523|FG001|STARTED|Overall Study||201
6438613|NCT01086215|7353524|FG002|STARTED|Overall Study||73
6438614|NCT01086215|7353525|FG003|STARTED|Overall Study||14
6653349|NCT02436356|7583104|FG002|High Energy Fracture|Overall Study||4
6744404|NCT03342469|7672450|FG001|STARTED|Overall Study||9
6744405|NCT03342469|7672451|FG002|STARTED|Overall Study||3
6438615|NCT01086215|7353522|FG000|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
6438616|NCT01086215|7353523|FG001|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
6438617|NCT01086215|7353524|FG002|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
6438618|NCT01086215|7353525|FG003|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
6438619|NCT01086215|7353522|FG000|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
6438620|NCT01086215|7353523|FG001|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
6438621|NCT01086215|7353524|FG002|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
6438622|NCT01086215|7353525|FG003|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
6438623|NCT01086215|7353522|FG000|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
6438624|NCT01086215|7353523|FG001|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
6438625|NCT01086215|7353524|FG002|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
6438626|NCT01086215|7353525|FG003|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
6438627|NCT01086215|7353522|FG000|COMPLETED|Overall Study||176
6438628|NCT01086215|7353523|FG001|COMPLETED|Overall Study||154
6438629|NCT01086215|7353524|FG002|COMPLETED|Overall Study||47
6438630|NCT01086215|7353525|FG003|COMPLETED|Overall Study||11
6438631|NCT01086215|7353522|FG000|NOT COMPLETED|Overall Study||36
6438632|NCT01086215|7353523|FG001|NOT COMPLETED|Overall Study||47
6438633|NCT01086215|7353524|FG002|NOT COMPLETED|Overall Study||26
6438634|NCT01086215|7353525|FG003|NOT COMPLETED|Overall Study||3
6438635|NCT01086228|7353535|FG000|STARTED|8 Month Follow-up|Analysis population|2009
6438636|NCT01086228|7353535|FG000|COMPLETED|8 Month Follow-up||1938
6438637|NCT01086228|7353535|FG000|NOT COMPLETED|8 Month Follow-up||71
6438638|NCT01086228|7353535|FG000|STARTED|1-year Follow-up||1938
6438639|NCT01086228|7353535|FG000|COMPLETED|1-year Follow-up||1894
6438640|NCT01086228|7353535|FG000|NOT COMPLETED|1-year Follow-up||44
6438641|NCT01086228|7353535|FG000|STARTED|2-year Follow-up||1894
6438642|NCT01086228|7353535|FG000|COMPLETED|2-year Follow-up||1834
6438643|NCT01086228|7353535|FG000|NOT COMPLETED|2-year Follow-up||60
6438644|NCT01086228|7353535|FG000|STARTED|3-year Follow-up||1834
6438645|NCT01086228|7353535|FG000|COMPLETED|3-year Follow-up||1767
6438646|NCT01086228|7353535|FG000|NOT COMPLETED|3-year Follow-up||67
6438647|NCT01086228|7353535|FG000|STARTED|4-year Follow-up||1767
6438648|NCT01086228|7353535|FG000|COMPLETED|4-year Follow-up||1664
6438649|NCT01086228|7353535|FG000|NOT COMPLETED|4-year Follow-up||103
6438650|NCT01086228|7353535|FG000|STARTED|5-year Follow-up||1664
6438651|NCT01086228|7353535|FG000|COMPLETED|5-year Follow-up||1012
6438652|NCT01086228|7353535|FG000|NOT COMPLETED|5-year Follow-up||652
6438653|NCT01086358|7353539|FG000|STARTED|First Intervention|30 subjects enrolled.|30
6653350|NCT02436356|7583102|FG000|Low Energy Fracture|Overall Study||19
6438654|NCT01086358|7353540|FG001|STARTED|First Intervention|30 subjects enrolled, 1 withdrew before randomization|29
6438655|NCT01086358|7353539|FG000|COMPLETED|First Intervention||21
6438656|NCT01086358|7353540|FG001|COMPLETED|First Intervention||24
6438657|NCT01086358|7353539|FG000|NOT COMPLETED|First Intervention||9
6438658|NCT01086358|7353540|FG001|NOT COMPLETED|First Intervention||5
6438659|NCT01086358|7353539|FG000|STARTED|Second Intervention||21
6438660|NCT01086358|7353540|FG001|STARTED|Second Intervention||24
6438661|NCT01086358|7353539|FG000|COMPLETED|Second Intervention||17
6438662|NCT01086358|7353540|FG001|COMPLETED|Second Intervention||20
6438663|NCT01086358|7353539|FG000|NOT COMPLETED|Second Intervention||4
6438664|NCT01086358|7353540|FG001|NOT COMPLETED|Second Intervention||4
6438665|NCT01086384|7353548|FG000|STARTED|2-week Run-in Period||2183
6438666|NCT01086384|7353549|FG001|STARTED|2-week Run-in Period||0
6438667|NCT01086384|7353550|FG002|STARTED|2-week Run-in Period||0
6438668|NCT01086384|7353548|FG000|COMPLETED|2-week Run-in Period||2020
6438669|NCT01086384|7353549|FG001|COMPLETED|2-week Run-in Period||0
6438670|NCT01086384|7353550|FG002|COMPLETED|2-week Run-in Period||0
6438671|NCT01086384|7353548|FG000|NOT COMPLETED|2-week Run-in Period||163
6438672|NCT01086384|7353549|FG001|NOT COMPLETED|2-week Run-in Period||0
6438673|NCT01086384|7353550|FG002|NOT COMPLETED|2-week Run-in Period||0
6438674|NCT01086384|7353548|FG000|STARTED|Treatment Period||0
6438675|NCT01086384|7353549|FG001|STARTED|Treatment Period||1011
6438676|NCT01086384|7353550|FG002|STARTED|Treatment Period||1009
6438677|NCT01086384|7353548|FG000|COMPLETED|Treatment Period||0
6438678|NCT01086384|7353549|FG001|COMPLETED|Treatment Period||863
6438679|NCT01086384|7353550|FG002|COMPLETED|Treatment Period||885
6438680|NCT01086384|7353548|FG000|NOT COMPLETED|Treatment Period||0
6438681|NCT01086384|7353549|FG001|NOT COMPLETED|Treatment Period||148
6438682|NCT01086384|7353550|FG002|NOT COMPLETED|Treatment Period||124
6438683|NCT01086410|7353560|FG000|STARTED|Overall Study||58
6438684|NCT01086410|7353561|FG001|STARTED|Overall Study||56
6438685|NCT01086410|7353562|FG002|STARTED|Overall Study||56
6438686|NCT01086410|7353563|FG003|STARTED|Overall Study||15
6438687|NCT01086410|7353560|FG000|COMPLETED|Overall Study||55
6438688|NCT01086410|7353561|FG001|COMPLETED|Overall Study||54
6438689|NCT01086410|7353562|FG002|COMPLETED|Overall Study||55
6438690|NCT01086410|7353563|FG003|COMPLETED|Overall Study||13
6438691|NCT01086410|7353560|FG000|NOT COMPLETED|Overall Study||3
6438692|NCT01086410|7353561|FG001|NOT COMPLETED|Overall Study||2
6438693|NCT01086410|7353562|FG002|NOT COMPLETED|Overall Study||1
6438694|NCT01086410|7353563|FG003|NOT COMPLETED|Overall Study||2
6438695|NCT01086423|7353576|FG000|STARTED|Overall Study||330
6438696|NCT01086423|7353577|FG001|STARTED|Overall Study||324
6438697|NCT01086423|7353578|FG002|STARTED|Overall Study||330
6438698|NCT01086423|7353576|FG000|COMPLETED|Overall Study||320
6438699|NCT01086423|7353577|FG001|COMPLETED|Overall Study||321
6438700|NCT01086423|7353578|FG002|COMPLETED|Overall Study||321
6438701|NCT01086423|7353576|FG000|NOT COMPLETED|Overall Study||10
6438702|NCT01086423|7353577|FG001|NOT COMPLETED|Overall Study||3
6438703|NCT01086423|7353578|FG002|NOT COMPLETED|Overall Study||9
6438704|NCT01086475|7353588|FG000|STARTED|Overall Study||34
6438705|NCT01086475|7353589|FG001|STARTED|Overall Study||33
6438706|NCT01086475|7353588|FG000|COMPLETED|Overall Study||34
6438707|NCT01086475|7353589|FG001|COMPLETED|Overall Study||33
6438708|NCT01086475|7353588|FG000|NOT COMPLETED|Overall Study||0
6438709|NCT01086475|7353589|FG001|NOT COMPLETED|Overall Study||0
6438710|NCT01086540|7353597|FG000|STARTED|Overall Study||29
6438711|NCT01086540|7353598|FG001|STARTED|Overall Study||28
6438712|NCT01086540|7353597|FG000|COMPLETED|Overall Study||23
6438713|NCT01086540|7353598|FG001|COMPLETED|Overall Study||26
6438714|NCT01086540|7353597|FG000|NOT COMPLETED|Overall Study||6
6438715|NCT01086540|7353598|FG001|NOT COMPLETED|Overall Study||2
6438716|NCT01086605|7353606|FG000|STARTED|Overall Study||24
6438717|NCT01086605|7353607|FG001|STARTED|Overall Study||22
6438718|NCT01086605|7353606|FG000|COMPLETED|Overall Study||24
6438719|NCT01086605|7353607|FG001|COMPLETED|Overall Study||22
6438720|NCT01086605|7353606|FG000|NOT COMPLETED|Overall Study||0
6438721|NCT01086605|7353607|FG001|NOT COMPLETED|Overall Study||0
6438722|NCT01086761|7353619|FG000|STARTED|Overall Study||9
6438723|NCT01086761|7353620|FG001|STARTED|Overall Study||7
6438724|NCT01086761|7353621|FG002|STARTED|Overall Study||6
6438725|NCT01086761|7353622|FG003|STARTED|Overall Study||6
6438726|NCT01086761|7353623|FG004|STARTED|Overall Study||4
6438727|NCT01086761|7353624|FG005|STARTED|Overall Study||0
6438728|NCT01086761|7353619|FG000|COMPLETED|Overall Study||9
6438729|NCT01086761|7353620|FG001|COMPLETED|Overall Study||7
6438730|NCT01086761|7353621|FG002|COMPLETED|Overall Study||6
6438731|NCT01086761|7353622|FG003|COMPLETED|Overall Study||6
6438732|NCT01086761|7353623|FG004|COMPLETED|Overall Study||4
6438733|NCT01086761|7353624|FG005|COMPLETED|Overall Study||0
6438734|NCT01086761|7353619|FG000|NOT COMPLETED|Overall Study||0
6438735|NCT01086761|7353620|FG001|NOT COMPLETED|Overall Study||0
6438736|NCT01086761|7353621|FG002|NOT COMPLETED|Overall Study||0
6438737|NCT01086761|7353622|FG003|NOT COMPLETED|Overall Study||0
6438738|NCT01086761|7353623|FG004|NOT COMPLETED|Overall Study||0
6438739|NCT01086761|7353624|FG005|NOT COMPLETED|Overall Study||0
6438740|NCT01086852|7353637|FG000|STARTED|Overall Study||4
6438741|NCT01086852|7353637|FG000|COMPLETED|Overall Study||4
6438742|NCT01086852|7353637|FG000|NOT COMPLETED|Overall Study||0
6438743|NCT01086969|7353645|FG000|STARTED|Overall Study||100
6438744|NCT01086969|7353646|FG001|STARTED|Overall Study||100
6438745|NCT01086969|7353647|FG002|STARTED|Overall Study||100
6438746|NCT01086969|7353645|FG000|COMPLETED|Overall Study||99
6438747|NCT01086969|7353646|FG001|COMPLETED|Overall Study||98
6438748|NCT01086969|7353647|FG002|COMPLETED|Overall Study||100
6438749|NCT01086969|7353645|FG000|NOT COMPLETED|Overall Study||1
6438750|NCT01086969|7353646|FG001|NOT COMPLETED|Overall Study||2
6438751|NCT01086969|7353647|FG002|NOT COMPLETED|Overall Study||0
6499936|NCT01422187|7418728|FG001|NOT COMPLETED|Overall Study||1
6499937|NCT01422187|7418729|FG002|NOT COMPLETED|Overall Study||0
6499938|NCT01422200|7418739|FG000|STARTED|Overall Study||11
6499939|NCT01422200|7418740|FG001|STARTED|Overall Study||11
6499940|NCT01422200|7418739|FG000|COMPLETED|Overall Study||11
6499941|NCT01422200|7418740|FG001|COMPLETED|Overall Study||11
6499942|NCT01422200|7418739|FG000|NOT COMPLETED|Overall Study||0
6499943|NCT01422200|7418740|FG001|NOT COMPLETED|Overall Study||0
6499944|NCT01422213|7418751|FG000|STARTED|Overall Study||196
6499945|NCT01422213|7418752|FG001|STARTED|Overall Study||195
6499946|NCT01422213|7418753|FG002|STARTED|Overall Study||207
6499947|NCT01422213|7418751|FG000|COMPLETED|Overall Study||163
6499948|NCT01422213|7418752|FG001|COMPLETED|Overall Study||173
6499949|NCT01422213|7418753|FG002|COMPLETED|Overall Study||178
6499950|NCT01422213|7418751|FG000|NOT COMPLETED|Overall Study||33
6499951|NCT01422213|7418752|FG001|NOT COMPLETED|Overall Study||22
6499952|NCT01422213|7418753|FG002|NOT COMPLETED|Overall Study||29
6499953|NCT01422226|7418763|FG000|STARTED|Overall Study||1
6499954|NCT01422226|7418764|FG001|STARTED|Overall Study||2
6499955|NCT01422226|7418763|FG000|COMPLETED|Overall Study||1
6499956|NCT01422226|7418764|FG001|COMPLETED|Overall Study||2
6499957|NCT01422226|7418763|FG000|NOT COMPLETED|Overall Study||0
6499958|NCT01422226|7418764|FG001|NOT COMPLETED|Overall Study||0
6499959|NCT01422239|7418772|FG000|STARTED|Overall Study||14
6499960|NCT01422239|7418773|FG001|STARTED|Overall Study||6
6499961|NCT01422239|7418772|FG000|COMPLETED|Overall Study||10
6499962|NCT01422239|7418773|FG001|COMPLETED|Overall Study||3
6499963|NCT01422239|7418772|FG000|NOT COMPLETED|Overall Study||4
6499964|NCT01422239|7418773|FG001|NOT COMPLETED|Overall Study||3
6499965|NCT01422304|7418781|FG000|STARTED|Overall Study|Randomized|598
6499966|NCT01422304|7418782|FG001|STARTED|Overall Study|Randomized|600
6499967|NCT01422304|7418781|FG000|Treated|Overall Study||595
6499968|NCT01422304|7418782|FG001|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
6499969|NCT01422304|7418781|FG000|COMPLETED|Overall Study||574
6499970|NCT01422304|7418782|FG001|COMPLETED|Overall Study||563
6499971|NCT01422304|7418781|FG000|NOT COMPLETED|Overall Study||24
6499972|NCT01422304|7418782|FG001|NOT COMPLETED|Overall Study||37
6499973|NCT01422356|7418788|FG000|STARTED|Overall Study||200
6499974|NCT01422356|7418788|FG000|COMPLETED|Overall Study||169
6499975|NCT01422356|7418788|FG000|NOT COMPLETED|Overall Study||31
6499976|NCT01422369|7418792|FG000|STARTED|NK-104 4mg QD||28
6499977|NCT01422369|7418792|FG000|COMPLETED|NK-104 4mg QD||28
6499978|NCT01422369|7418792|FG000|NOT COMPLETED|NK-104 4mg QD||0
6499979|NCT01422369|7418792|FG000|STARTED|Prezista 800mg/100mg QD||28
6499980|NCT01422369|7418792|FG000|COMPLETED|Prezista 800mg/100mg QD||28
6499981|NCT01422369|7418792|FG000|NOT COMPLETED|Prezista 800mg/100mg QD||0
6499982|NCT01422369|7418792|FG000|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
6499983|NCT01422369|7418792|FG000|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
6499984|NCT01422369|7418792|FG000|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
6499985|NCT01422382|7418797|FG000|STARTED|NK-104 4mg Once Daily (QD)||28
6499986|NCT01422382|7418797|FG000|COMPLETED|NK-104 4mg Once Daily (QD)||28
6499987|NCT01422382|7418797|FG000|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
6499988|NCT01422382|7418797|FG000|STARTED|Diltiazem 240 mg QD||28
6499989|NCT01422382|7418797|FG000|COMPLETED|Diltiazem 240 mg QD||28
6499990|NCT01422382|7418797|FG000|NOT COMPLETED|Diltiazem 240 mg QD||0
6499991|NCT01422382|7418797|FG000|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
6499992|NCT01422382|7418797|FG000|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
6499993|NCT01422382|7418797|FG000|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
6499994|NCT01422408|7418801|FG000|STARTED|Overall Study||34
6499995|NCT01422408|7418801|FG000|COMPLETED|Overall Study||30
6499996|NCT01422408|7418801|FG000|NOT COMPLETED|Overall Study||4
6499997|NCT01422434|7418808|FG000|STARTED|Overall Study||227
6499998|NCT01422434|7418809|FG001|STARTED|Overall Study||226
6499999|NCT01422434|7418810|FG002|STARTED|Overall Study||223
6500000|NCT01422434|7418808|FG000|COMPLETED|Overall Study||216
6500001|NCT01422434|7418809|FG001|COMPLETED|Overall Study||221
6500002|NCT01422434|7418810|FG002|COMPLETED|Overall Study||217
6500003|NCT01422434|7418808|FG000|NOT COMPLETED|Overall Study||11
6500004|NCT01422434|7418809|FG001|NOT COMPLETED|Overall Study||5
6500005|NCT01422434|7418810|FG002|NOT COMPLETED|Overall Study||6
6500006|NCT01422538|7418821|FG000|STARTED|Overall Study||10
6500007|NCT01422538|7418822|FG001|STARTED|Overall Study||10
6500008|NCT01422538|7418823|FG002|STARTED|Overall Study||10
6500009|NCT01422538|7418821|FG000|COMPLETED|Overall Study||10
6500010|NCT01422538|7418822|FG001|COMPLETED|Overall Study||8
6500011|NCT01422538|7418823|FG002|COMPLETED|Overall Study||8
6500012|NCT01422538|7418821|FG000|NOT COMPLETED|Overall Study||0
6500013|NCT01422538|7418822|FG001|NOT COMPLETED|Overall Study||2
6500014|NCT01422538|7418823|FG002|NOT COMPLETED|Overall Study||2
6500015|NCT01422720|7418832|FG000|STARTED|Overall Study||72
6500016|NCT01422720|7418832|FG000|Safety Set|Overall Study||72
6500017|NCT01422720|7418832|FG000|Full Analysis Set (FAS)|Overall Study||71
6438752|NCT01087489|7353655|FG000|STARTED|Overall Study||19
6438753|NCT01087489|7353656|FG001|STARTED|Overall Study||34
6438754|NCT01087489|7353655|FG000|COMPLETED|Overall Study||19
6438755|NCT01087489|7353656|FG001|COMPLETED|Overall Study||31
6438756|NCT01087489|7353655|FG000|NOT COMPLETED|Overall Study||0
6438757|NCT01087489|7353656|FG001|NOT COMPLETED|Overall Study||3
6438758|NCT01087502|7353664|FG000|STARTED|Up to Interim Analysis (Week 12)||123
6438759|NCT01087502|7353665|FG001|STARTED|Up to Interim Analysis (Week 12)||118
6438760|NCT01087502|7353664|FG000|COMPLETED|Up to Interim Analysis (Week 12)||114
6438761|NCT01087502|7353665|FG001|COMPLETED|Up to Interim Analysis (Week 12)||110
6438762|NCT01087502|7353664|FG000|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
6438763|NCT01087502|7353665|FG001|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
6438764|NCT01087502|7353664|FG000|STARTED|Up to Final Analysis (Week 52)||123
6438765|NCT01087502|7353665|FG001|STARTED|Up to Final Analysis (Week 52)||118
6438766|NCT01087502|7353664|FG000|COMPLETED|Up to Final Analysis (Week 52)||90
6438767|NCT01087502|7353665|FG001|COMPLETED|Up to Final Analysis (Week 52)||95
6438768|NCT01087502|7353664|FG000|NOT COMPLETED|Up to Final Analysis (Week 52)||33
6438769|NCT01087502|7353665|FG001|NOT COMPLETED|Up to Final Analysis (Week 52)||23
6438770|NCT01087528|7353673|FG000|STARTED|Overall Study||51
6438771|NCT01087528|7353673|FG000|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
6438772|NCT01087528|7353673|FG000|NOT COMPLETED|Overall Study||7
6438773|NCT01087541|7353681|FG000|STARTED|Overall Study||3307
6438774|NCT01087541|7353682|FG001|STARTED|Overall Study||3523
6438775|NCT01087541|7353681|FG000|COMPLETED|Overall Study||3307
6438776|NCT01087541|7353682|FG001|COMPLETED|Overall Study||3523
6438777|NCT01087541|7353681|FG000|NOT COMPLETED|Overall Study||0
6438778|NCT01087541|7353682|FG001|NOT COMPLETED|Overall Study||0
6438779|NCT01087723|7353690|FG000|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
6438780|NCT01087723|7353691|FG001|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
6438781|NCT01087723|7353690|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
6438782|NCT01087723|7353691|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
6438783|NCT01087723|7353690|FG000|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
6438784|NCT01087723|7353691|FG001|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
6438785|NCT01087723|7353690|FG000|NOT COMPLETED|Overall Study||14
6438786|NCT01087723|7353691|FG001|NOT COMPLETED|Overall Study||20
6438787|NCT01087736|7353699|FG000|STARTED|Overall Study||14
6438788|NCT01087736|7353700|FG001|STARTED|Overall Study||16
6438789|NCT01087736|7353699|FG000|COMPLETED|Overall Study||13
6438790|NCT01087736|7353700|FG001|COMPLETED|Overall Study||14
6438791|NCT01087736|7353699|FG000|NOT COMPLETED|Overall Study||1
6438792|NCT01087736|7353700|FG001|NOT COMPLETED|Overall Study||2
6438793|NCT01087762|7353709|FG000|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
6438794|NCT01087762|7353710|FG001|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
6438795|NCT01087762|7353711|FG002|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
6438796|NCT01087762|7353712|FG003|STARTED|Double Blind Period (Weeks 0-24)||0
6438797|NCT01087762|7353713|FG004|STARTED|Double Blind Period (Weeks 0-24)||0
6438798|NCT01087762|7353709|FG000|COMPLETED|Double Blind Period (Weeks 0-24)||95
6552847|NCT01739348|7475240|FG000|NOT COMPLETED|Part II (Extension Study)||379
6552848|NCT01739348|7475241|FG001|NOT COMPLETED|Part II (Extension Study)||366
6552849|NCT01739348|7475242|FG002|NOT COMPLETED|Part II (Extension Study)||61
6552850|NCT01739348|7475243|FG003|NOT COMPLETED|Part II (Extension Study)||396
6552851|NCT01739361|7475259|FG000|STARTED|Overall Study||21
6552852|NCT01739361|7475260|FG001|STARTED|Overall Study||23
6438799|NCT01087762|7353710|FG001|COMPLETED|Double Blind Period (Weeks 0-24)||105
6438800|NCT01087762|7353711|FG002|COMPLETED|Double Blind Period (Weeks 0-24)||98
6438801|NCT01087762|7353712|FG003|COMPLETED|Double Blind Period (Weeks 0-24)||0
6438802|NCT01087762|7353713|FG004|COMPLETED|Double Blind Period (Weeks 0-24)||0
6438803|NCT01087762|7353709|FG000|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
6438804|NCT01087762|7353710|FG001|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
6552853|NCT01739361|7475259|FG000|COMPLETED|Overall Study||18
6552854|NCT01739361|7475260|FG001|COMPLETED|Overall Study||22
6552855|NCT01739361|7475259|FG000|NOT COMPLETED|Overall Study||3
6438805|NCT01087762|7353711|FG002|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
6438806|NCT01087762|7353712|FG003|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
6438807|NCT01087762|7353713|FG004|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
6438808|NCT01087762|7353709|FG000|STARTED|Open-Label Period (Weeks 48-204)||0
6438809|NCT01087762|7353710|FG001|STARTED|Open-Label Period (Weeks 48-204)||0
6438810|NCT01087762|7353711|FG002|STARTED|Open-Label Period (Weeks 48-204)||0
6438811|NCT01087762|7353712|FG003|STARTED|Open-Label Period (Weeks 48-204)||158
6438812|NCT01087762|7353713|FG004|STARTED|Open-Label Period (Weeks 48-204)||157
6438813|NCT01087762|7353709|FG000|COMPLETED|Open-Label Period (Weeks 48-204)||0
6438814|NCT01087762|7353710|FG001|COMPLETED|Open-Label Period (Weeks 48-204)||0
6438815|NCT01087762|7353711|FG002|COMPLETED|Open-Label Period (Weeks 48-204)||0
6438816|NCT01087762|7353712|FG003|COMPLETED|Open-Label Period (Weeks 48-204)||99
6552856|NCT01739361|7475260|FG001|NOT COMPLETED|Overall Study||1
6552857|NCT01739400|7475268|FG000|STARTED|Overall Study||109
6552858|NCT01739400|7475269|FG001|STARTED|Overall Study||108
6438817|NCT01087762|7353713|FG004|COMPLETED|Open-Label Period (Weeks 48-204)||100
6438818|NCT01087762|7353709|FG000|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
6438819|NCT01087762|7353710|FG001|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
6438820|NCT01087762|7353711|FG002|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
6438821|NCT01087762|7353712|FG003|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
6438822|NCT01087762|7353713|FG004|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
6438823|NCT01087775|7353723|FG000|STARTED|Overall Study||25
6438824|NCT01087775|7353723|FG000|COMPLETED|Overall Study|2 subjects were found to be ineligible for the study|23
6438825|NCT01087775|7353723|FG000|NOT COMPLETED|Overall Study||2
6438826|NCT01087788|7353731|FG000|STARTED|24-weeks Double-blind Period||136
6438827|NCT01087788|7353732|FG001|STARTED|24-weeks Double-blind Period||138
6438828|NCT01087788|7353733|FG002|STARTED|24-weeks Double-blind Period||135
6438829|NCT01087788|7353731|FG000|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
6438830|NCT01087788|7353732|FG001|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
6438831|NCT01087788|7353733|FG002|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
6438832|NCT01087788|7353731|FG000|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
6438833|NCT01087788|7353732|FG001|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
6438834|NCT01087788|7353733|FG002|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
6438835|NCT01087788|7353731|FG000|COMPLETED|24-weeks Double-blind Period||120
6438836|NCT01087788|7353732|FG001|COMPLETED|24-weeks Double-blind Period||128
6438837|NCT01087788|7353733|FG002|COMPLETED|24-weeks Double-blind Period||120
6438838|NCT01087788|7353731|FG000|NOT COMPLETED|24-weeks Double-blind Period||16
6438839|NCT01087788|7353732|FG001|NOT COMPLETED|24-weeks Double-blind Period||10
6438840|NCT01087788|7353733|FG002|NOT COMPLETED|24-weeks Double-blind Period||15
6438841|NCT01087788|7353731|FG000|STARTED|24-weeks Dose-blind Period||120
6438842|NCT01087788|7353732|FG001|STARTED|24-weeks Dose-blind Period||128
6438843|NCT01087788|7353733|FG002|STARTED|24-weeks Dose-blind Period||120
6438844|NCT01087788|7353731|FG000|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
6438845|NCT01087788|7353732|FG001|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
6438846|NCT01087788|7353733|FG002|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
6438847|NCT01087788|7353731|FG000|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
6438848|NCT01087788|7353732|FG001|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
6438849|NCT01087788|7353733|FG002|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
6438850|NCT01087788|7353731|FG000|COMPLETED|24-weeks Dose-blind Period||113
6438851|NCT01087788|7353732|FG001|COMPLETED|24-weeks Dose-blind Period||123
6438852|NCT01087788|7353733|FG002|COMPLETED|24-weeks Dose-blind Period||114
6438853|NCT01087788|7353731|FG000|NOT COMPLETED|24-weeks Dose-blind Period||7
6438854|NCT01087788|7353732|FG001|NOT COMPLETED|24-weeks Dose-blind Period||5
6438855|NCT01087788|7353733|FG002|NOT COMPLETED|24-weeks Dose-blind Period||6
6438856|NCT01087788|7353731|FG000|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
6438857|NCT01087788|7353732|FG001|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
6438858|NCT01087788|7353733|FG002|STARTED|Open-Label Period (OL-P)||114
6438859|NCT01087788|7353731|FG000|COMPLETED|Open-Label Period (OL-P)||81
6438860|NCT01087788|7353732|FG001|COMPLETED|Open-Label Period (OL-P)||97
6438861|NCT01087788|7353733|FG002|COMPLETED|Open-Label Period (OL-P)||86
6438862|NCT01087788|7353731|FG000|NOT COMPLETED|Open-Label Period (OL-P)||30
6438863|NCT01087788|7353732|FG001|NOT COMPLETED|Open-Label Period (OL-P)||24
6438864|NCT01087788|7353733|FG002|NOT COMPLETED|Open-Label Period (OL-P)||28
6438865|NCT01087801|7353744|FG000|STARTED|Overall Study||30
6438866|NCT01087801|7353745|FG001|STARTED|Overall Study||34
6438867|NCT01087801|7353744|FG000|COMPLETED|Overall Study||26
6438868|NCT01087801|7353745|FG001|COMPLETED|Overall Study||29
6438869|NCT01087801|7353744|FG000|NOT COMPLETED|Overall Study||4
6438870|NCT01087801|7353745|FG001|NOT COMPLETED|Overall Study||5
6438871|NCT01087814|7353753|FG000|STARTED|First Intervention (5 Days)||8
6438872|NCT01087814|7353754|FG001|STARTED|First Intervention (5 Days)||7
6438873|NCT01087814|7353753|FG000|COMPLETED|First Intervention (5 Days)||5
6438874|NCT01087814|7353754|FG001|COMPLETED|First Intervention (5 Days)||6
6438875|NCT01087814|7353753|FG000|NOT COMPLETED|First Intervention (5 Days)||3
6438876|NCT01087814|7353754|FG001|NOT COMPLETED|First Intervention (5 Days)||1
6438877|NCT01087814|7353753|FG000|STARTED|Second Intervention (5 Days)||5
6438878|NCT01087814|7353754|FG001|STARTED|Second Intervention (5 Days)||6
6438879|NCT01087814|7353753|FG000|COMPLETED|Second Intervention (5 Days)||4
6438880|NCT01087814|7353754|FG001|COMPLETED|Second Intervention (5 Days)||6
6438881|NCT01087814|7353753|FG000|NOT COMPLETED|Second Intervention (5 Days)||1
6438882|NCT01087814|7353754|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
6438883|NCT01087905|7353768|FG000|STARTED|Overall Study||119
6438884|NCT01087905|7353769|FG001|STARTED|Overall Study||126
6438885|NCT01087905|7353770|FG002|STARTED|Overall Study||123
6438886|NCT01087905|7353771|FG003|STARTED|Overall Study||122
6438887|NCT01087905|7353772|FG004|STARTED|Overall Study||122
6438888|NCT01087905|7353773|FG005|STARTED|Overall Study||127
6438889|NCT01087905|7353774|FG006|STARTED|Overall Study||121
6438890|NCT01087905|7353775|FG007|STARTED|Overall Study||127
6438891|NCT01087905|7353768|FG000|COMPLETED|Overall Study||90
6438892|NCT01087905|7353769|FG001|COMPLETED|Overall Study||94
6438893|NCT01087905|7353770|FG002|COMPLETED|Overall Study||101
6438894|NCT01087905|7353771|FG003|COMPLETED|Overall Study||86
6438895|NCT01087905|7353772|FG004|COMPLETED|Overall Study||91
6438896|NCT01087905|7353773|FG005|COMPLETED|Overall Study||99
6438897|NCT01087905|7353774|FG006|COMPLETED|Overall Study||98
6438898|NCT01087905|7353775|FG007|COMPLETED|Overall Study||98
6438899|NCT01087905|7353768|FG000|NOT COMPLETED|Overall Study||29
6438900|NCT01087905|7353769|FG001|NOT COMPLETED|Overall Study||32
6438901|NCT01087905|7353770|FG002|NOT COMPLETED|Overall Study||22
6438902|NCT01087905|7353771|FG003|NOT COMPLETED|Overall Study||36
6438903|NCT01087905|7353772|FG004|NOT COMPLETED|Overall Study||31
6438904|NCT01087905|7353773|FG005|NOT COMPLETED|Overall Study||28
6438905|NCT01087905|7353774|FG006|NOT COMPLETED|Overall Study||23
6438906|NCT01087905|7353775|FG007|NOT COMPLETED|Overall Study||29
6438907|NCT01087918|7353793|FG000|STARTED|Overall Study||5
6438908|NCT01087918|7353794|FG001|STARTED|Overall Study||4
6438909|NCT01087918|7353793|FG000|COMPLETED|Overall Study||5
6438910|NCT01087918|7353794|FG001|COMPLETED|Overall Study||4
6438911|NCT01087918|7353793|FG000|NOT COMPLETED|Overall Study||0
6438912|NCT01087918|7353794|FG001|NOT COMPLETED|Overall Study||0
6438913|NCT01087931|7353806|FG000|STARTED|Overall Study||20
6438914|NCT01087931|7353807|FG001|STARTED|Overall Study||20
6438915|NCT01087931|7353806|FG000|1st Follow up|Overall Study||20
6438916|NCT01087931|7353807|FG001|1st Follow up|Overall Study||19
6438917|NCT01087931|7353806|FG000|Final Follow up|Overall Study||19
6438918|NCT01087931|7353807|FG001|Final Follow up|Overall Study||17
6438919|NCT01087931|7353806|FG000|COMPLETED|Overall Study||20
6438920|NCT01087931|7353807|FG001|COMPLETED|Overall Study||20
6438921|NCT01087931|7353806|FG000|NOT COMPLETED|Overall Study||0
6438922|NCT01087931|7353807|FG001|NOT COMPLETED|Overall Study||0
6438923|NCT01087944|7353813|FG000|STARTED|Period 1 (Week 1-3)||30
6438924|NCT01087944|7353814|FG001|STARTED|Period 1 (Week 1-3)||30
6438925|NCT01087944|7353813|FG000|COMPLETED|Period 1 (Week 1-3)||29
6438926|NCT01087944|7353814|FG001|COMPLETED|Period 1 (Week 1-3)||30
6438927|NCT01087944|7353813|FG000|NOT COMPLETED|Period 1 (Week 1-3)||1
6438928|NCT01087944|7353814|FG001|NOT COMPLETED|Period 1 (Week 1-3)||0
6438929|NCT01087944|7353813|FG000|STARTED|Period 2 (Week 4-6)||29
6438930|NCT01087944|7353814|FG001|STARTED|Period 2 (Week 4-6)||30
6438931|NCT01087944|7353813|FG000|COMPLETED|Period 2 (Week 4-6)||29
6438932|NCT01087944|7353814|FG001|COMPLETED|Period 2 (Week 4-6)||28
6438933|NCT01087944|7353813|FG000|NOT COMPLETED|Period 2 (Week 4-6)||0
6438934|NCT01087944|7353814|FG001|NOT COMPLETED|Period 2 (Week 4-6)||2
6438935|NCT01087957|7353822|FG000|STARTED|Overall Study||253
6438936|NCT01087957|7353823|FG001|STARTED|Overall Study||242
6438937|NCT01087957|7353822|FG000|COMPLETED|Overall Study||212
6438938|NCT01087957|7353823|FG001|COMPLETED|Overall Study||187
6438939|NCT01087957|7353822|FG000|NOT COMPLETED|Overall Study||41
6438940|NCT01087957|7353823|FG001|NOT COMPLETED|Overall Study||55
6438941|NCT01087970|7353829|FG000|STARTED|Overall Study||69
6438942|NCT01087970|7353829|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||69
6438943|NCT01087970|7353829|FG000|Completed 6 Cycles|Overall Study||69
6438944|NCT01087970|7353829|FG000|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
6438945|NCT01087970|7353829|FG000|Received Carboplatin|Overall Study||63
6438946|NCT01087970|7353829|FG000|COMPLETED|Overall Study||67
6438947|NCT01087970|7353829|FG000|NOT COMPLETED|Overall Study||2
6438948|NCT01087996|7353836|FG000|STARTED|Overall Study||15
6438949|NCT01087996|7353837|FG001|STARTED|Overall Study||15
6438950|NCT01087996|7353836|FG000|COMPLETED|Overall Study||15
6438951|NCT01087996|7353837|FG001|COMPLETED|Overall Study||15
6438952|NCT01087996|7353836|FG000|NOT COMPLETED|Overall Study||0
6438953|NCT01087996|7353837|FG001|NOT COMPLETED|Overall Study||0
6438954|NCT01088048|7353853|FG000|STARTED|Overall Study||51
6438955|NCT01088048|7353854|FG001|STARTED|Overall Study||51
6438956|NCT01088048|7353855|FG002|STARTED|Overall Study||18
6438957|NCT01088048|7353856|FG003|STARTED|Overall Study||18
6438958|NCT01088048|7353857|FG004|STARTED|Overall Study||33
6438959|NCT01088048|7353858|FG005|STARTED|Overall Study||21
6438960|NCT01088048|7353859|FG006|STARTED|Overall Study||12
6438961|NCT01088048|7353860|FG007|STARTED|Overall Study||15
6438962|NCT01088048|7353861|FG008|STARTED|Overall Study||15
6438963|NCT01088048|7353862|FG009|STARTED|Overall Study||7
6438964|NCT01088048|7353853|FG000|Participants With CLL|Overall Study||19
6438965|NCT01088048|7353854|FG001|Participants With CLL|Overall Study||18
6438966|NCT01088048|7353855|FG002|Participants With CLL|Overall Study||0
6438967|NCT01088048|7353856|FG003|Participants With CLL|Overall Study||0
6438968|NCT01088048|7353857|FG004|Participants With CLL|Overall Study||15
6438969|NCT01088048|7353858|FG005|Participants With CLL|Overall Study||21
6438970|NCT01088048|7353859|FG006|Participants With CLL|Overall Study||12
6438971|NCT01088048|7353860|FG007|Participants With CLL|Overall Study||15
6438972|NCT01088048|7353861|FG008|Participants With CLL|Overall Study||14
6438973|NCT01088048|7353862|FG009|Participants With CLL|Overall Study||1
6438974|NCT01088048|7353853|FG000|Participants With Indolent NHL|Overall Study||32
6438975|NCT01088048|7353854|FG001|Participants With Indolent NHL|Overall Study||33
6438976|NCT01088048|7353855|FG002|Participants With Indolent NHL|Overall Study||0
6438977|NCT01088048|7353856|FG003|Participants With Indolent NHL|Overall Study||0
6438978|NCT01088048|7353857|FG004|Participants With Indolent NHL|Overall Study||14
6438979|NCT01088048|7353858|FG005|Participants With Indolent NHL|Overall Study||0
6438980|NCT01088048|7353859|FG006|Participants With Indolent NHL|Overall Study||0
6438981|NCT01088048|7353860|FG007|Participants With Indolent NHL|Overall Study||0
6438982|NCT01088048|7353861|FG008|Participants With Indolent NHL|Overall Study||1
6438983|NCT01088048|7353862|FG009|Participants With Indolent NHL|Overall Study||6
6438984|NCT01088048|7353853|FG000|Participants With MCL|Overall Study||0
6438985|NCT01088048|7353854|FG001|Participants With MCL|Overall Study||0
6438986|NCT01088048|7353855|FG002|Participants With MCL|Overall Study||18
6438987|NCT01088048|7353856|FG003|Participants With MCL|Overall Study||18
6438988|NCT01088048|7353857|FG004|Participants With MCL|Overall Study||4
6438989|NCT01088048|7353858|FG005|Participants With MCL|Overall Study||0
6438990|NCT01088048|7353859|FG006|Participants With MCL|Overall Study||0
6438991|NCT01088048|7353860|FG007|Participants With MCL|Overall Study||0
6438992|NCT01088048|7353861|FG008|Participants With MCL|Overall Study||0
6438993|NCT01088048|7353862|FG009|Participants With MCL|Overall Study||0
6438994|NCT01088048|7353853|FG000|COMPLETED|Overall Study||29
6438995|NCT01088048|7353854|FG001|COMPLETED|Overall Study||24
6438996|NCT01088048|7353855|FG002|COMPLETED|Overall Study||4
6438997|NCT01088048|7353856|FG003|COMPLETED|Overall Study||4
6438998|NCT01088048|7353857|FG004|COMPLETED|Overall Study||16
6438999|NCT01088048|7353858|FG005|COMPLETED|Overall Study||10
6439000|NCT01088048|7353859|FG006|COMPLETED|Overall Study||6
6439001|NCT01088048|7353860|FG007|COMPLETED|Overall Study||10
6439002|NCT01088048|7353861|FG008|COMPLETED|Overall Study||8
6439003|NCT01088048|7353862|FG009|COMPLETED|Overall Study||3
6439004|NCT01088048|7353853|FG000|NOT COMPLETED|Overall Study||22
6439005|NCT01088048|7353854|FG001|NOT COMPLETED|Overall Study||27
6439006|NCT01088048|7353855|FG002|NOT COMPLETED|Overall Study||14
6439007|NCT01088048|7353856|FG003|NOT COMPLETED|Overall Study||14
6439008|NCT01088048|7353857|FG004|NOT COMPLETED|Overall Study||17
6439009|NCT01088048|7353858|FG005|NOT COMPLETED|Overall Study||11
6439010|NCT01088048|7353859|FG006|NOT COMPLETED|Overall Study||6
6439011|NCT01088048|7353860|FG007|NOT COMPLETED|Overall Study||5
6439012|NCT01088048|7353861|FG008|NOT COMPLETED|Overall Study||7
6439013|NCT01088048|7353862|FG009|NOT COMPLETED|Overall Study||4
6439014|NCT01088243|7353897|FG000|STARTED|Overall Study||13
6439015|NCT01088243|7353898|FG001|STARTED|Overall Study||5
6439016|NCT01088243|7353897|FG000|COMPLETED|Overall Study||12
6439017|NCT01088243|7353898|FG001|COMPLETED|Overall Study||5
6439018|NCT01088243|7353897|FG000|NOT COMPLETED|Overall Study||1
6439019|NCT01088243|7353898|FG001|NOT COMPLETED|Overall Study||0
6439020|NCT01088295|7353904|FG000|STARTED|Overall Study||36
6439021|NCT01088295|7353904|FG000|COMPLETED|Overall Study||35
6439022|NCT01088295|7353904|FG000|NOT COMPLETED|Overall Study||1
6439023|NCT01088399|7353911|FG000|STARTED|Overall Study||8716
6439024|NCT01088399|7353912|FG001|STARTED|Overall Study||1655
6439025|NCT01088399|7353913|FG002|STARTED|Overall Study||302
6439026|NCT01088399|7353911|FG000|COMPLETED|Overall Study||1595
6439027|NCT01088399|7353912|FG001|COMPLETED|Overall Study||308
6439028|NCT01088399|7353913|FG002|COMPLETED|Overall Study||21
6439029|NCT01088399|7353911|FG000|NOT COMPLETED|Overall Study||7121
6439030|NCT01088399|7353912|FG001|NOT COMPLETED|Overall Study||1347
6439031|NCT01088399|7353913|FG002|NOT COMPLETED|Overall Study||281
6439032|NCT01088412|7353924|FG000|STARTED|Overall Study||22311
6439033|NCT01088412|7353925|FG001|STARTED|Overall Study||457
6439034|NCT01088412|7353926|FG002|STARTED|Overall Study||77
6439035|NCT01088412|7353924|FG000|Safety Modified Evaluable (SME)|Overall Study||22294
6439036|NCT01088412|7353925|FG001|Safety Modified Evaluable (SME)|Overall Study||456
6439037|NCT01088412|7353926|FG002|Safety Modified Evaluable (SME)|Overall Study||0
6439038|NCT01088412|7353924|FG000|SME With at Least 1 Follow Up (FU)|Overall Study||21178
6439039|NCT01088412|7353925|FG001|SME With at Least 1 Follow Up (FU)|Overall Study||306
6439040|NCT01088412|7353926|FG002|SME With at Least 1 Follow Up (FU)|Overall Study||0
6439041|NCT01088412|7353924|FG000|SME+ >= 1 FU and Unknown Arm|Overall Study||21177
6439042|NCT01088412|7353925|FG001|SME+ >= 1 FU and Unknown Arm|Overall Study||306
6439043|NCT01088412|7353926|FG002|SME+ >= 1 FU and Unknown Arm|Overall Study||40
6439044|NCT01088412|7353924|FG000|SME+ >= 1 FU and No Previous Cancer|Overall Study||20556
6439045|NCT01088412|7353925|FG001|SME+ >= 1 FU and No Previous Cancer|Overall Study||192
6439046|NCT01088412|7353926|FG002|SME+ >= 1 FU and No Previous Cancer|Overall Study||0
6439047|NCT01088412|7353924|FG000|SME+ >= 1 FU and Previous Cancer|Overall Study||622
6439048|NCT01088412|7353925|FG001|SME+ >= 1 FU and Previous Cancer|Overall Study||114
6439049|NCT01088412|7353926|FG002|SME+ >= 1 FU and Previous Cancer|Overall Study||0
6439050|NCT01088412|7353924|FG000|COMPLETED|Overall Study||4294
6552859|NCT01739400|7475268|FG000|Treated With 10 mg Macitentan|Overall Study||109
6552860|NCT01739400|7475269|FG001|Treated With 10 mg Macitentan|Overall Study||108
6552861|NCT01739400|7475268|FG000|COMPLETED|Overall Study||92
6552862|NCT01739400|7475269|FG001|COMPLETED|Overall Study||99
6439051|NCT01088412|7353925|FG001|COMPLETED|Overall Study||21
6439052|NCT01088412|7353926|FG002|COMPLETED|Overall Study||5
6439053|NCT01088412|7353924|FG000|NOT COMPLETED|Overall Study||18017
6439054|NCT01088412|7353925|FG001|NOT COMPLETED|Overall Study||436
6552863|NCT01739400|7475268|FG000|NOT COMPLETED|Overall Study||17
6439055|NCT01088412|7353926|FG002|NOT COMPLETED|Overall Study||72
6439056|NCT01088438|7353939|FG000|STARTED|Overall Study||94
6439057|NCT01088438|7353940|FG001|STARTED|Overall Study||95
6439058|NCT01088438|7353939|FG000|COMPLETED|Overall Study||65
6439059|NCT01088438|7353940|FG001|COMPLETED|Overall Study||59
6439060|NCT01088438|7353939|FG000|NOT COMPLETED|Overall Study||29
6439061|NCT01088438|7353940|FG001|NOT COMPLETED|Overall Study||36
6439062|NCT01088464|7353949|FG000|STARTED|Overall Study||3
6439063|NCT01088464|7353950|FG001|STARTED|Overall Study||6
6439064|NCT01088464|7353951|FG002|STARTED|Overall Study||6
6439065|NCT01088464|7353949|FG000|Received Any Quantity of Study Drug|Overall Study||3
6439066|NCT01088464|7353950|FG001|Received Any Quantity of Study Drug|Overall Study||6
6439067|NCT01088464|7353951|FG002|Received Any Quantity of Study Drug|Overall Study||6
6439068|NCT01088464|7353949|FG000|COMPLETED|Overall Study||3
6439069|NCT01088464|7353950|FG001|COMPLETED|Overall Study||6
6439070|NCT01088464|7353951|FG002|COMPLETED|Overall Study||6
6439071|NCT01088464|7353949|FG000|NOT COMPLETED|Overall Study||0
6439072|NCT01088464|7353950|FG001|NOT COMPLETED|Overall Study||0
6439073|NCT01088464|7353951|FG002|NOT COMPLETED|Overall Study||0
6439074|NCT01088503|7353962|FG000|STARTED|Overall Study||3123
6439075|NCT01088503|7353963|FG001|STARTED|Overall Study||8846
6439076|NCT01088503|7353964|FG002|STARTED|Overall Study||258
6439077|NCT01088503|7353962|FG000|COMPLETED|Overall Study||2941
6439078|NCT01088503|7353963|FG001|COMPLETED|Overall Study||8161
6439079|NCT01088503|7353964|FG002|COMPLETED|Overall Study||241
6439080|NCT01088503|7353962|FG000|NOT COMPLETED|Overall Study||182
6439081|NCT01088503|7353963|FG001|NOT COMPLETED|Overall Study||685
6439082|NCT01088503|7353964|FG002|NOT COMPLETED|Overall Study||17
6439083|NCT01088529|7353972|FG000|STARTED|Overall Study||44
6439084|NCT01088529|7353973|FG001|STARTED|Overall Study||22
6439085|NCT01088529|7353972|FG000|Received Treatment|Overall Study||44
6439086|NCT01088529|7353973|FG001|Received Treatment|Overall Study||21
6439087|NCT01088529|7353972|FG000|COMPLETED|Overall Study||44
6439088|NCT01088529|7353973|FG001|COMPLETED|Overall Study||21
6439089|NCT01088529|7353972|FG000|NOT COMPLETED|Overall Study||0
6439090|NCT01088529|7353973|FG001|NOT COMPLETED|Overall Study||1
6439091|NCT01088646|7353979|FG000|STARTED|Overall Study||25
6439092|NCT01088646|7353979|FG000|COMPLETED|Overall Study||25
6439093|NCT01088646|7353979|FG000|NOT COMPLETED|Overall Study||0
6439094|NCT01088672|7353984|FG000|STARTED|Overall Study||60
6439095|NCT01088672|7353984|FG000|COMPLETED|Overall Study||60
6439096|NCT01088672|7353984|FG000|NOT COMPLETED|Overall Study||0
6439097|NCT01088711|7353992|FG000|STARTED|Overall Study||18
6439098|NCT01088711|7353993|FG001|STARTED|Overall Study||6
6439099|NCT01088711|7353994|FG002|STARTED|Overall Study||6
6439100|NCT01088711|7353995|FG003|STARTED|Overall Study||2
6439101|NCT01088711|7353992|FG000|COMPLETED|Overall Study||18
6439102|NCT01088711|7353993|FG001|COMPLETED|Overall Study||6
6439103|NCT01088711|7353994|FG002|COMPLETED|Overall Study||6
6439104|NCT01088711|7353995|FG003|COMPLETED|Overall Study||2
6439105|NCT01088711|7353992|FG000|NOT COMPLETED|Overall Study||0
6439106|NCT01088711|7353993|FG001|NOT COMPLETED|Overall Study||0
6439107|NCT01088711|7353994|FG002|NOT COMPLETED|Overall Study||0
6439108|NCT01088711|7353995|FG003|NOT COMPLETED|Overall Study||0
6439109|NCT01088984|7354009|FG000|STARTED|Phase 1||5
6439110|NCT01088984|7354010|FG001|STARTED|Phase 1||6
6439111|NCT01088984|7354009|FG000|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
6439112|NCT01088984|7354010|FG001|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
6439113|NCT01088984|7354009|FG000|NOT COMPLETED|Phase 1||5
6439114|NCT01088984|7354010|FG001|NOT COMPLETED|Phase 1||6
6439115|NCT01088984|7354009|FG000|STARTED|Phase 2||0
6439116|NCT01088984|7354010|FG001|STARTED|Phase 2||32
6439117|NCT01088984|7354009|FG000|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
6439118|NCT01088984|7354010|FG001|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
6439119|NCT01088984|7354009|FG000|NOT COMPLETED|Phase 2||0
6439120|NCT01088984|7354010|FG001|NOT COMPLETED|Phase 2||32
6439121|NCT01088997|7354021|FG000|STARTED|Overall Study||7
6439122|NCT01088997|7354022|FG001|STARTED|Overall Study||5
6439123|NCT01088997|7354021|FG000|COMPLETED|Overall Study||4
6439124|NCT01088997|7354022|FG001|COMPLETED|Overall Study||2
6439125|NCT01088997|7354021|FG000|NOT COMPLETED|Overall Study||3
6439126|NCT01088997|7354022|FG001|NOT COMPLETED|Overall Study||3
6439127|NCT01089023|7354031|FG000|STARTED|Overall Study||95
6439128|NCT01089023|7354031|FG000|COMPLETED|Overall Study||88
6552864|NCT01739400|7475269|FG001|NOT COMPLETED|Overall Study||9
6552865|NCT01739595|7475277|FG000|STARTED|Overall Study||112
6552866|NCT01739595|7475278|FG001|STARTED|Overall Study||22
6439129|NCT01089023|7354031|FG000|NOT COMPLETED|Overall Study||7
6439130|NCT01089062|7354041|FG000|STARTED|Visit 2 (Randomization)||4
6439131|NCT01089062|7354042|FG001|STARTED|Visit 2 (Randomization)||4
6439132|NCT01089062|7354043|FG002|STARTED|Visit 2 (Randomization)||4
6439133|NCT01089062|7354044|FG003|STARTED|Visit 2 (Randomization)||4
6439134|NCT01089062|7354045|FG004|STARTED|Visit 2 (Randomization)||4
6439135|NCT01089062|7354046|FG005|STARTED|Visit 2 (Randomization)||4
6439136|NCT01089062|7354041|FG000|COMPLETED|Visit 2 (Randomization)||3
6439137|NCT01089062|7354042|FG001|COMPLETED|Visit 2 (Randomization)||3
6439138|NCT01089062|7354043|FG002|COMPLETED|Visit 2 (Randomization)||3
6439139|NCT01089062|7354044|FG003|COMPLETED|Visit 2 (Randomization)||4
6439140|NCT01089062|7354045|FG004|COMPLETED|Visit 2 (Randomization)||3
6439141|NCT01089062|7354046|FG005|COMPLETED|Visit 2 (Randomization)||3
6439142|NCT01089062|7354041|FG000|NOT COMPLETED|Visit 2 (Randomization)||1
6439143|NCT01089062|7354042|FG001|NOT COMPLETED|Visit 2 (Randomization)||1
6439144|NCT01089062|7354043|FG002|NOT COMPLETED|Visit 2 (Randomization)||1
6439145|NCT01089062|7354044|FG003|NOT COMPLETED|Visit 2 (Randomization)||0
6439146|NCT01089062|7354045|FG004|NOT COMPLETED|Visit 2 (Randomization)||1
6439147|NCT01089062|7354046|FG005|NOT COMPLETED|Visit 2 (Randomization)||1
6439148|NCT01089062|7354041|FG000|STARTED|Visit 3||3
6439149|NCT01089062|7354042|FG001|STARTED|Visit 3||3
6439150|NCT01089062|7354043|FG002|STARTED|Visit 3||3
6439151|NCT01089062|7354044|FG003|STARTED|Visit 3||4
6439152|NCT01089062|7354045|FG004|STARTED|Visit 3||3
6439153|NCT01089062|7354046|FG005|STARTED|Visit 3||3
6439154|NCT01089062|7354041|FG000|COMPLETED|Visit 3||3
6439155|NCT01089062|7354042|FG001|COMPLETED|Visit 3||3
6439156|NCT01089062|7354043|FG002|COMPLETED|Visit 3||3
6439157|NCT01089062|7354044|FG003|COMPLETED|Visit 3||3
6439158|NCT01089062|7354045|FG004|COMPLETED|Visit 3||3
6439159|NCT01089062|7354046|FG005|COMPLETED|Visit 3||3
6439160|NCT01089062|7354041|FG000|NOT COMPLETED|Visit 3||0
6439161|NCT01089062|7354042|FG001|NOT COMPLETED|Visit 3||0
6439162|NCT01089062|7354043|FG002|NOT COMPLETED|Visit 3||0
6439163|NCT01089062|7354044|FG003|NOT COMPLETED|Visit 3||1
6439164|NCT01089062|7354045|FG004|NOT COMPLETED|Visit 3||0
6439165|NCT01089062|7354046|FG005|NOT COMPLETED|Visit 3||0
6439166|NCT01089062|7354041|FG000|STARTED|Visit 4||3
6439167|NCT01089062|7354042|FG001|STARTED|Visit 4||3
6439168|NCT01089062|7354043|FG002|STARTED|Visit 4||3
6439169|NCT01089062|7354044|FG003|STARTED|Visit 4||3
6439170|NCT01089062|7354045|FG004|STARTED|Visit 4||3
6439171|NCT01089062|7354046|FG005|STARTED|Visit 4||3
6439172|NCT01089062|7354041|FG000|COMPLETED|Visit 4||3
6439173|NCT01089062|7354042|FG001|COMPLETED|Visit 4||3
6439174|NCT01089062|7354043|FG002|COMPLETED|Visit 4||3
6439175|NCT01089062|7354044|FG003|COMPLETED|Visit 4||3
6439176|NCT01089062|7354045|FG004|COMPLETED|Visit 4||3
6439177|NCT01089062|7354046|FG005|COMPLETED|Visit 4||3
6439178|NCT01089062|7354041|FG000|NOT COMPLETED|Visit 4||0
6439179|NCT01089062|7354042|FG001|NOT COMPLETED|Visit 4||0
6439180|NCT01089062|7354043|FG002|NOT COMPLETED|Visit 4||0
6439181|NCT01089062|7354044|FG003|NOT COMPLETED|Visit 4||0
6439182|NCT01089062|7354045|FG004|NOT COMPLETED|Visit 4||0
6439183|NCT01089062|7354046|FG005|NOT COMPLETED|Visit 4||0
6439184|NCT01089062|7354041|FG000|STARTED|Follow-up Visit (Final Visit)||3
6439185|NCT01089062|7354042|FG001|STARTED|Follow-up Visit (Final Visit)||3
6439186|NCT01089062|7354043|FG002|STARTED|Follow-up Visit (Final Visit)||3
6439187|NCT01089062|7354044|FG003|STARTED|Follow-up Visit (Final Visit)||3
6439188|NCT01089062|7354045|FG004|STARTED|Follow-up Visit (Final Visit)||3
6439189|NCT01089062|7354046|FG005|STARTED|Follow-up Visit (Final Visit)||3
6439190|NCT01089062|7354041|FG000|COMPLETED|Follow-up Visit (Final Visit)||3
6439191|NCT01089062|7354042|FG001|COMPLETED|Follow-up Visit (Final Visit)||3
6439192|NCT01089062|7354043|FG002|COMPLETED|Follow-up Visit (Final Visit)||3
6439193|NCT01089062|7354044|FG003|COMPLETED|Follow-up Visit (Final Visit)||3
6439194|NCT01089062|7354045|FG004|COMPLETED|Follow-up Visit (Final Visit)||3
6439195|NCT01089062|7354046|FG005|COMPLETED|Follow-up Visit (Final Visit)||3
6439196|NCT01089062|7354041|FG000|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6439197|NCT01089062|7354042|FG001|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6439198|NCT01089062|7354043|FG002|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6439199|NCT01089062|7354044|FG003|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6439200|NCT01089062|7354045|FG004|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6439201|NCT01089062|7354046|FG005|NOT COMPLETED|Follow-up Visit (Final Visit)||0
6439202|NCT01089127|7354061|FG000|STARTED|Overall Study||92
6439203|NCT01089127|7354062|FG001|STARTED|Overall Study||91
6439204|NCT01089127|7354063|FG002|STARTED|Overall Study||94
6439205|NCT01089127|7354064|FG003|STARTED|Overall Study||92
6439206|NCT01089127|7354065|FG004|STARTED|Overall Study||92
6439207|NCT01089127|7354066|FG005|STARTED|Overall Study||91
6439208|NCT01089127|7354061|FG000|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
6439209|NCT01089127|7354062|FG001|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
6439210|NCT01089127|7354063|FG002|Exposed to Study Drug|Overall Study||94
6439211|NCT01089127|7354064|FG003|Exposed to Study Drug|Overall Study||92
6439212|NCT01089127|7354065|FG004|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
6439213|NCT01089127|7354066|FG005|Exposed to Study Drug|Overall Study||91
6439214|NCT01089127|7354061|FG000|COMPLETED|Overall Study||84
6439215|NCT01089127|7354062|FG001|COMPLETED|Overall Study||86
6439216|NCT01089127|7354063|FG002|COMPLETED|Overall Study||92
6439217|NCT01089127|7354064|FG003|COMPLETED|Overall Study||91
6439218|NCT01089127|7354065|FG004|COMPLETED|Overall Study||90
6439219|NCT01089127|7354066|FG005|COMPLETED|Overall Study||88
6439220|NCT01089127|7354061|FG000|NOT COMPLETED|Overall Study||8
6439221|NCT01089127|7354062|FG001|NOT COMPLETED|Overall Study||5
6439222|NCT01089127|7354063|FG002|NOT COMPLETED|Overall Study||2
6439223|NCT01089127|7354064|FG003|NOT COMPLETED|Overall Study||1
6439224|NCT01089127|7354065|FG004|NOT COMPLETED|Overall Study||2
6439225|NCT01089127|7354066|FG005|NOT COMPLETED|Overall Study||3
6439226|NCT01089231|7354084|FG000|STARTED|Overall Study||10
6439227|NCT01089231|7354085|FG001|STARTED|Overall Study||10
6439228|NCT01089231|7354086|FG002|STARTED|Overall Study||10
6439229|NCT01089231|7354087|FG003|STARTED|Overall Study||10
6500018|NCT01422720|7418832|FG000|Per-Protocol Set (PPS)|Overall Study||55
6439230|NCT01089231|7354084|FG000|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
6439231|NCT01089231|7354085|FG001|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
6439232|NCT01089231|7354086|FG002|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
6439233|NCT01089231|7354087|FG003|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
6439234|NCT01089231|7354084|FG000|NOT COMPLETED|Overall Study||4
6439235|NCT01089231|7354085|FG001|NOT COMPLETED|Overall Study||2
6439236|NCT01089231|7354086|FG002|NOT COMPLETED|Overall Study||2
6439237|NCT01089231|7354087|FG003|NOT COMPLETED|Overall Study||1
6439238|NCT01089361|7354099|FG000|STARTED|Overall Study||9
6439239|NCT01089361|7354100|FG001|STARTED|Overall Study||10
6439240|NCT01089361|7354099|FG000|COMPLETED|Overall Study||8
6439241|NCT01089361|7354100|FG001|COMPLETED|Overall Study||10
6439242|NCT01089361|7354099|FG000|NOT COMPLETED|Overall Study||1
6439243|NCT01089361|7354100|FG001|NOT COMPLETED|Overall Study||0
6439244|NCT01089413|7354111|FG000|STARTED|Overall Study||201
6439245|NCT01089413|7354111|FG000|Received Bevacizumab in First Line|Overall Study||199
6439246|NCT01089413|7354111|FG000|COMPLETED|Overall Study||0
6439247|NCT01089413|7354111|FG000|NOT COMPLETED|Overall Study||201
6439248|NCT01089504|7354123|FG000|STARTED|Overall Study||8
6439249|NCT01089504|7354124|FG001|STARTED|Overall Study||5
6439250|NCT01089504|7354123|FG000|COMPLETED|Overall Study||5
6439251|NCT01089504|7354124|FG001|COMPLETED|Overall Study||4
6439252|NCT01089504|7354123|FG000|NOT COMPLETED|Overall Study||3
6439253|NCT01089504|7354124|FG001|NOT COMPLETED|Overall Study||1
6439254|NCT01089517|7354133|FG000|STARTED|Overall Study||148
6439255|NCT01089517|7354134|FG001|STARTED|Overall Study||149
6439256|NCT01089517|7354135|FG002|STARTED|Overall Study||152
6439257|NCT01089517|7354133|FG000|COMPLETED|Overall Study||144
6439258|NCT01089517|7354134|FG001|COMPLETED|Overall Study||144
6439259|NCT01089517|7354135|FG002|COMPLETED|Overall Study||147
6439260|NCT01089517|7354133|FG000|NOT COMPLETED|Overall Study||4
6439261|NCT01089517|7354134|FG001|NOT COMPLETED|Overall Study||5
6439262|NCT01089517|7354135|FG002|NOT COMPLETED|Overall Study||5
6439263|NCT01089543|7354147|FG000|STARTED|Overall Study||84
6439264|NCT01089543|7354148|FG001|STARTED|Overall Study||85
6439265|NCT01089543|7354149|FG002|STARTED|Overall Study||84
6439266|NCT01089543|7354150|FG003|STARTED|Overall Study||85
6439267|NCT01089543|7354147|FG000|COMPLETED|Overall Study||81
6439268|NCT01089543|7354148|FG001|COMPLETED|Overall Study||81
6439269|NCT01089543|7354149|FG002|COMPLETED|Overall Study||81
6439270|NCT01089543|7354150|FG003|COMPLETED|Overall Study||83
6439271|NCT01089543|7354147|FG000|NOT COMPLETED|Overall Study||3
6439272|NCT01089543|7354148|FG001|NOT COMPLETED|Overall Study||4
6439273|NCT01089543|7354149|FG002|NOT COMPLETED|Overall Study||3
6439274|NCT01089543|7354150|FG003|NOT COMPLETED|Overall Study||2
6439275|NCT01089556|7354162|FG000|STARTED|Study Period II (Weeks 1-8)||404
6439276|NCT01089556|7354163|FG001|STARTED|Study Period II (Weeks 1-8)||407
6439277|NCT01089556|7354164|FG002|STARTED|Study Period II (Weeks 1-8)||0
6439278|NCT01089556|7354165|FG003|STARTED|Study Period II (Weeks 1-8)||0
6439279|NCT01089556|7354166|FG004|STARTED|Study Period II (Weeks 1-8)||0
6439280|NCT01089556|7354167|FG005|STARTED|Study Period II (Weeks 1-8)||0
6439281|NCT01089556|7354162|FG000|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
6439282|NCT01089556|7354163|FG001|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
6439283|NCT01089556|7354164|FG002|Safety Population|Study Period II (Weeks 1-8)||0
6439284|NCT01089556|7354165|FG003|Safety Population|Study Period II (Weeks 1-8)||0
6439285|NCT01089556|7354166|FG004|Safety Population|Study Period II (Weeks 1-8)||0
6439286|NCT01089556|7354167|FG005|Safety Population|Study Period II (Weeks 1-8)||0
6439287|NCT01089556|7354162|FG000|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
6439288|NCT01089556|7354163|FG001|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
6439289|NCT01089556|7354164|FG002|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
6439290|NCT01089556|7354165|FG003|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
6439291|NCT01089556|7354166|FG004|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
6439292|NCT01089556|7354167|FG005|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
6439293|NCT01089556|7354162|FG000|COMPLETED|Study Period II (Weeks 1-8)||333
6439294|NCT01089556|7354163|FG001|COMPLETED|Study Period II (Weeks 1-8)||333
6439295|NCT01089556|7354164|FG002|COMPLETED|Study Period II (Weeks 1-8)||0
6439296|NCT01089556|7354165|FG003|COMPLETED|Study Period II (Weeks 1-8)||0
6439297|NCT01089556|7354166|FG004|COMPLETED|Study Period II (Weeks 1-8)||0
6439298|NCT01089556|7354167|FG005|COMPLETED|Study Period II (Weeks 1-8)||0
6439299|NCT01089556|7354162|FG000|NOT COMPLETED|Study Period II (Weeks 1-8)||71
6439300|NCT01089556|7354163|FG001|NOT COMPLETED|Study Period II (Weeks 1-8)||74
6439301|NCT01089556|7354164|FG002|NOT COMPLETED|Study Period II (Weeks 1-8)||0
6439302|NCT01089556|7354165|FG003|NOT COMPLETED|Study Period II (Weeks 1-8)||0
6439303|NCT01089556|7354166|FG004|NOT COMPLETED|Study Period II (Weeks 1-8)||0
6439304|NCT01089556|7354167|FG005|NOT COMPLETED|Study Period II (Weeks 1-8)||0
6439305|NCT01089556|7354162|FG000|STARTED|Study Period III (Weeks 9-16)||0
6439306|NCT01089556|7354163|FG001|STARTED|Study Period III (Weeks 9-16)||0
6439307|NCT01089556|7354164|FG002|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
6500019|NCT01422720|7418832|FG000|COMPLETED|Overall Study||50
6500020|NCT01422720|7418832|FG000|NOT COMPLETED|Overall Study||22
6439308|NCT01089556|7354165|FG003|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
6439309|NCT01089556|7354166|FG004|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
6439310|NCT01089556|7354167|FG005|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
6439311|NCT01089556|7354162|FG000|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
6439312|NCT01089556|7354163|FG001|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
6439313|NCT01089556|7354164|FG002|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
6439314|NCT01089556|7354165|FG003|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
6439315|NCT01089556|7354166|FG004|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
6439316|NCT01089556|7354167|FG005|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
6439317|NCT01089556|7354162|FG000|COMPLETED|Study Period III (Weeks 9-16)||0
6439318|NCT01089556|7354163|FG001|COMPLETED|Study Period III (Weeks 9-16)||0
6439319|NCT01089556|7354164|FG002|COMPLETED|Study Period III (Weeks 9-16)||60
6439320|NCT01089556|7354165|FG003|COMPLETED|Study Period III (Weeks 9-16)||66
6439321|NCT01089556|7354166|FG004|COMPLETED|Study Period III (Weeks 9-16)||83
6439322|NCT01089556|7354167|FG005|COMPLETED|Study Period III (Weeks 9-16)||92
6439323|NCT01089556|7354162|FG000|NOT COMPLETED|Study Period III (Weeks 9-16)||0
6439324|NCT01089556|7354163|FG001|NOT COMPLETED|Study Period III (Weeks 9-16)||0
6439325|NCT01089556|7354164|FG002|NOT COMPLETED|Study Period III (Weeks 9-16)||14
6439326|NCT01089556|7354165|FG003|NOT COMPLETED|Study Period III (Weeks 9-16)||9
6439327|NCT01089556|7354166|FG004|NOT COMPLETED|Study Period III (Weeks 9-16)||12
6439328|NCT01089556|7354167|FG005|NOT COMPLETED|Study Period III (Weeks 9-16)||7
6439329|NCT01089569|7354182|FG000|STARTED|Overall Study||20
6439330|NCT01089569|7354183|FG001|STARTED|Overall Study||20
6439331|NCT01089569|7354184|FG002|STARTED|Overall Study||20
6439332|NCT01089569|7354182|FG000|COMPLETED|Overall Study||16
6439333|NCT01089569|7354183|FG001|COMPLETED|Overall Study||17
6439334|NCT01089569|7354184|FG002|COMPLETED|Overall Study||16
6439335|NCT01089569|7354182|FG000|NOT COMPLETED|Overall Study||4
6439336|NCT01089569|7354183|FG001|NOT COMPLETED|Overall Study||3
6439337|NCT01089569|7354184|FG002|NOT COMPLETED|Overall Study||4
6439338|NCT01089582|7354192|FG000|STARTED|Overall Study||603
6439339|NCT01089582|7354192|FG000|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
6439340|NCT01089582|7354192|FG000|NOT COMPLETED|Overall Study||30
6439341|NCT01089595|7354198|FG000|STARTED|Overall Study||2
6439342|NCT01089595|7354199|FG001|STARTED|Overall Study||3
6439343|NCT01089595|7354198|FG000|COMPLETED|Overall Study||2
6439344|NCT01089595|7354199|FG001|COMPLETED|Overall Study||3
6439345|NCT01089595|7354198|FG000|NOT COMPLETED|Overall Study||0
6439346|NCT01089595|7354199|FG001|NOT COMPLETED|Overall Study||0
6439347|NCT01089608|7354209|FG000|STARTED|Overall Study||43
6439348|NCT01089608|7354210|FG001|STARTED|Overall Study||50
6439349|NCT01089608|7354209|FG000|COMPLETED|Overall Study||43
6439350|NCT01089608|7354210|FG001|COMPLETED|Overall Study||44
6439351|NCT01089608|7354209|FG000|NOT COMPLETED|Overall Study||0
6439352|NCT01089608|7354210|FG001|NOT COMPLETED|Overall Study||6
6439353|NCT01089647|7354218|FG000|STARTED|Overall Study||17
6439354|NCT01089647|7354219|FG001|STARTED|Overall Study||17
6439355|NCT01089647|7354218|FG000|COMPLETED|Overall Study||13
6439356|NCT01089647|7354219|FG001|COMPLETED|Overall Study||13
6439357|NCT01089647|7354218|FG000|NOT COMPLETED|Overall Study||4
6439358|NCT01089647|7354219|FG001|NOT COMPLETED|Overall Study||4
6439359|NCT01089725|7354230|FG000|STARTED|Overall Study||72
6439360|NCT01089725|7354231|FG001|STARTED|Overall Study||75
6439361|NCT01089725|7354232|FG002|STARTED|Overall Study||65
6439362|NCT01089725|7354233|FG003|STARTED|Overall Study||87
6439363|NCT01089725|7354234|FG004|STARTED|Overall Study||86
6439364|NCT01089725|7354230|FG000|Treated|Overall Study||72
6439365|NCT01089725|7354231|FG001|Treated|Overall Study||74
6439366|NCT01089725|7354232|FG002|Treated|Overall Study||63
6439367|NCT01089725|7354233|FG003|Treated|Overall Study||86
6439368|NCT01089725|7354234|FG004|Treated|Overall Study||84
6439369|NCT01089725|7354230|FG000|COMPLETED|Overall Study||6
6439370|NCT01089725|7354231|FG001|COMPLETED|Overall Study||7
6439371|NCT01089725|7354232|FG002|COMPLETED|Overall Study||4
6439372|NCT01089725|7354233|FG003|COMPLETED|Overall Study||8
6439373|NCT01089725|7354234|FG004|COMPLETED|Overall Study||6
6439374|NCT01089725|7354230|FG000|NOT COMPLETED|Overall Study||66
6439375|NCT01089725|7354231|FG001|NOT COMPLETED|Overall Study||68
6439376|NCT01089725|7354232|FG002|NOT COMPLETED|Overall Study||61
6439377|NCT01089725|7354233|FG003|NOT COMPLETED|Overall Study||79
6439378|NCT01089725|7354234|FG004|NOT COMPLETED|Overall Study||80
6439379|NCT01089751|7354252|FG000|STARTED|Overall Study||163
6439380|NCT01089751|7354253|FG001|STARTED|Overall Study||159
6439381|NCT01089751|7354252|FG000|COMPLETED|Overall Study||129
6439382|NCT01089751|7354253|FG001|COMPLETED|Overall Study||132
6439383|NCT01089751|7354252|FG000|NOT COMPLETED|Overall Study||34
6439384|NCT01089751|7354253|FG001|NOT COMPLETED|Overall Study||27
6439385|NCT01090011|7354259|FG000|STARTED|Overall Study||171
6439386|NCT01090011|7354259|FG000|COMPLETED|Overall Study||0
6439387|NCT01090011|7354259|FG000|NOT COMPLETED|Overall Study||171
6439388|NCT01090050|7354273|FG000|STARTED|Overall Study||16
6439389|NCT01090050|7354274|FG001|STARTED|Overall Study||12
6439390|NCT01090050|7354273|FG000|COMPLETED|Overall Study||15
6439391|NCT01090050|7354274|FG001|COMPLETED|Overall Study||5
6439392|NCT01090050|7354273|FG000|NOT COMPLETED|Overall Study||1
6439393|NCT01090050|7354274|FG001|NOT COMPLETED|Overall Study||7
6439394|NCT01090063|7354284|FG000|STARTED|Screen||28
6439395|NCT01090063|7354284|FG000|COMPLETED|Screen||24
6439396|NCT01090063|7354284|FG000|NOT COMPLETED|Screen||4
6439397|NCT01090063|7354284|FG000|STARTED|Treatment||24
6439398|NCT01090063|7354284|FG000|COMPLETED|Treatment||20
6439399|NCT01090063|7354284|FG000|NOT COMPLETED|Treatment||4
6439400|NCT01090076|7354300|FG000|STARTED|Overall Study||12
6439401|NCT01090076|7354301|FG001|STARTED|Overall Study||14
6439402|NCT01090076|7354300|FG000|COMPLETED|Overall Study||11
6439403|NCT01090076|7354301|FG001|COMPLETED|Overall Study||12
6439404|NCT01090076|7354300|FG000|NOT COMPLETED|Overall Study||1
6439405|NCT01090076|7354301|FG001|NOT COMPLETED|Overall Study||2
6439406|NCT01090102|7354311|FG000|STARTED|First 12 Weeks||15
6439407|NCT01090102|7354312|FG001|STARTED|First 12 Weeks||18
6439408|NCT01090102|7354311|FG000|COMPLETED|First 12 Weeks||11
6439409|NCT01090102|7354312|FG001|COMPLETED|First 12 Weeks||16
6439410|NCT01090102|7354311|FG000|NOT COMPLETED|First 12 Weeks||4
6439411|NCT01090102|7354312|FG001|NOT COMPLETED|First 12 Weeks||2
6439412|NCT01090102|7354311|FG000|STARTED|Second 12 Weeks||11
6439413|NCT01090102|7354312|FG001|STARTED|Second 12 Weeks||16
6439414|NCT01090102|7354311|FG000|COMPLETED|Second 12 Weeks||11
6439415|NCT01090102|7354312|FG001|COMPLETED|Second 12 Weeks||15
6439416|NCT01090102|7354311|FG000|NOT COMPLETED|Second 12 Weeks||0
6439417|NCT01090102|7354312|FG001|NOT COMPLETED|Second 12 Weeks||1
6439418|NCT01090180|7354320|FG000|STARTED|Overall Study||33
6439419|NCT01090180|7354321|FG001|STARTED|Overall Study||29
6439420|NCT01090180|7354320|FG000|COMPLETED|Overall Study||22
6439421|NCT01090180|7354321|FG001|COMPLETED|Overall Study||21
6439422|NCT01090180|7354320|FG000|NOT COMPLETED|Overall Study||11
6439423|NCT01090180|7354321|FG001|NOT COMPLETED|Overall Study||8
6439424|NCT01090310|7354331|FG000|STARTED|Core Study||29
6439425|NCT01090310|7354332|FG001|STARTED|Core Study||31
6439426|NCT01090310|7354333|FG002|STARTED|Core Study||31
6439427|NCT01090310|7354334|FG003|STARTED|Core Study||34
6439428|NCT01090310|7354331|FG000|COMPLETED|Core Study||21
6439429|NCT01090310|7354332|FG001|COMPLETED|Core Study||20
6439430|NCT01090310|7354333|FG002|COMPLETED|Core Study||24
6439431|NCT01090310|7354334|FG003|COMPLETED|Core Study||27
6439432|NCT01090310|7354331|FG000|NOT COMPLETED|Core Study||8
6439433|NCT01090310|7354332|FG001|NOT COMPLETED|Core Study||11
6439434|NCT01090310|7354333|FG002|NOT COMPLETED|Core Study||7
6439435|NCT01090310|7354334|FG003|NOT COMPLETED|Core Study||7
6439436|NCT01090310|7354331|FG000|STARTED|Extension Study||17
6439437|NCT01090310|7354332|FG001|STARTED|Extension Study||16
6439438|NCT01090310|7354333|FG002|STARTED|Extension Study||16
6439439|NCT01090310|7354334|FG003|STARTED|Extension Study||21
6439440|NCT01090310|7354331|FG000|COMPLETED|Extension Study||3
6439441|NCT01090310|7354332|FG001|COMPLETED|Extension Study||0
6439442|NCT01090310|7354333|FG002|COMPLETED|Extension Study||1
6439443|NCT01090310|7354334|FG003|COMPLETED|Extension Study||1
6439444|NCT01090310|7354331|FG000|NOT COMPLETED|Extension Study||14
6439445|NCT01090310|7354332|FG001|NOT COMPLETED|Extension Study||16
6439446|NCT01090310|7354333|FG002|NOT COMPLETED|Extension Study||15
6439447|NCT01090310|7354334|FG003|NOT COMPLETED|Extension Study||20
6439448|NCT01090323|7354346|FG000|STARTED|Overall Study||132
6439449|NCT01090323|7354347|FG001|STARTED|Overall Study||53
6439450|NCT01090323|7354346|FG000|COMPLETED|Overall Study||43
6439451|NCT01090323|7354347|FG001|COMPLETED|Overall Study||19
6439452|NCT01090323|7354346|FG000|NOT COMPLETED|Overall Study||89
6439453|NCT01090323|7354347|FG001|NOT COMPLETED|Overall Study||34
6439454|NCT01090414|7354357|FG000|STARTED|Parent Studies||191
6439455|NCT01090414|7354358|FG001|STARTED|Parent Studies||241
6439456|NCT01090414|7354359|FG002|STARTED|Parent Studies||64
6439457|NCT01090414|7354360|FG003|STARTED|Parent Studies||18
6439458|NCT01090414|7354357|FG000|COMPLETED|Parent Studies||50
6439459|NCT01090414|7354358|FG001|COMPLETED|Parent Studies||114
6439460|NCT01090414|7354359|FG002|COMPLETED|Parent Studies||43
6439461|NCT01090414|7354360|FG003|COMPLETED|Parent Studies||5
6439462|NCT01090414|7354357|FG000|NOT COMPLETED|Parent Studies||141
6439463|NCT01090414|7354358|FG001|NOT COMPLETED|Parent Studies||127
6439464|NCT01090414|7354359|FG002|NOT COMPLETED|Parent Studies||21
6439465|NCT01090414|7354360|FG003|NOT COMPLETED|Parent Studies||13
6439466|NCT01090414|7354357|FG000|STARTED|Study 101-99|50 participants completed the parent study, but only 48 participants enrolled into Study 101-99.|48
6439467|NCT01090414|7354358|FG001|STARTED|Study 101-99|114 participants completed the parent study, but only 108 participants enrolled into Study 101-99.|108
6439468|NCT01090414|7354359|FG002|STARTED|Study 101-99|43 participants completed the parent study, but only 41 participants enrolled into Study 101-99.|41
6439469|NCT01090414|7354360|FG003|STARTED|Study 101-99||5
6439470|NCT01090414|7354357|FG000|COMPLETED|Study 101-99||0
6439471|NCT01090414|7354358|FG001|COMPLETED|Study 101-99||0
6439472|NCT01090414|7354359|FG002|COMPLETED|Study 101-99||0
6439473|NCT01090414|7354360|FG003|COMPLETED|Study 101-99||0
6439474|NCT01090414|7354357|FG000|NOT COMPLETED|Study 101-99||48
6439475|NCT01090414|7354358|FG001|NOT COMPLETED|Study 101-99||108
6439476|NCT01090414|7354359|FG002|NOT COMPLETED|Study 101-99||41
6439477|NCT01090414|7354360|FG003|NOT COMPLETED|Study 101-99||5
6439478|NCT01090427|7354385|FG000|STARTED|Controlled Period||37
6439479|NCT01090427|7354386|FG001|STARTED|Controlled Period||37
6439480|NCT01090427|7354387|FG002|STARTED|Controlled Period||36
6439481|NCT01090427|7354388|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6439482|NCT01090427|7354389|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6439483|NCT01090427|7354390|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6439484|NCT01090427|7354391|FG006|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6439485|NCT01090427|7354385|FG000|COMPLETED|Controlled Period||37
6439486|NCT01090427|7354386|FG001|COMPLETED|Controlled Period||37
6439487|NCT01090427|7354387|FG002|COMPLETED|Controlled Period||36
6439488|NCT01090427|7354388|FG003|COMPLETED|Controlled Period||0
6439489|NCT01090427|7354389|FG004|COMPLETED|Controlled Period||0
6439490|NCT01090427|7354390|FG005|COMPLETED|Controlled Period||0
6439491|NCT01090427|7354391|FG006|COMPLETED|Controlled Period||0
6439492|NCT01090427|7354385|FG000|NOT COMPLETED|Controlled Period||0
6439493|NCT01090427|7354386|FG001|NOT COMPLETED|Controlled Period||0
6439494|NCT01090427|7354387|FG002|NOT COMPLETED|Controlled Period||0
6439495|NCT01090427|7354388|FG003|NOT COMPLETED|Controlled Period||0
6439496|NCT01090427|7354389|FG004|NOT COMPLETED|Controlled Period||0
6439497|NCT01090427|7354390|FG005|NOT COMPLETED|Controlled Period||0
6439498|NCT01090427|7354391|FG006|NOT COMPLETED|Controlled Period||0
6439499|NCT01090427|7354385|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6439500|NCT01090427|7354386|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6439501|NCT01090427|7354387|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6439502|NCT01090427|7354388|FG003|STARTED|After Controlled Period||19
6439503|NCT01090427|7354389|FG004|STARTED|After Controlled Period||18
6439504|NCT01090427|7354390|FG005|STARTED|After Controlled Period||37
6439505|NCT01090427|7354391|FG006|STARTED|After Controlled Period||36
6439506|NCT01090427|7354385|FG000|COMPLETED|After Controlled Period||0
6439507|NCT01090427|7354386|FG001|COMPLETED|After Controlled Period||0
6439508|NCT01090427|7354387|FG002|COMPLETED|After Controlled Period||0
6439509|NCT01090427|7354388|FG003|COMPLETED|After Controlled Period||17
6439510|NCT01090427|7354389|FG004|COMPLETED|After Controlled Period||18
6439511|NCT01090427|7354390|FG005|COMPLETED|After Controlled Period||32
6439512|NCT01090427|7354391|FG006|COMPLETED|After Controlled Period||34
6439513|NCT01090427|7354385|FG000|NOT COMPLETED|After Controlled Period||0
6439514|NCT01090427|7354386|FG001|NOT COMPLETED|After Controlled Period||0
6439515|NCT01090427|7354387|FG002|NOT COMPLETED|After Controlled Period||0
6439516|NCT01090427|7354388|FG003|NOT COMPLETED|After Controlled Period||2
6439517|NCT01090427|7354389|FG004|NOT COMPLETED|After Controlled Period||0
6439518|NCT01090427|7354390|FG005|NOT COMPLETED|After Controlled Period||5
6439519|NCT01090427|7354391|FG006|NOT COMPLETED|After Controlled Period||2
6439520|NCT01090453|7354405|FG000|STARTED|Overall Study||238
6439521|NCT01090453|7354406|FG001|STARTED|Overall Study||242
6439522|NCT01090453|7354405|FG000|COMPLETED|Overall Study||225
6439523|NCT01090453|7354406|FG001|COMPLETED|Overall Study||228
6439524|NCT01090453|7354405|FG000|NOT COMPLETED|Overall Study||13
6439525|NCT01090453|7354406|FG001|NOT COMPLETED|Overall Study||14
6439526|NCT01090479|7354414|FG000|STARTED|Overall Study||50
6439527|NCT01090479|7354415|FG001|STARTED|Overall Study||50
6439528|NCT01090479|7354414|FG000|COMPLETED|Overall Study||50
6439529|NCT01090479|7354415|FG001|COMPLETED|Overall Study||50
6439530|NCT01090479|7354414|FG000|NOT COMPLETED|Overall Study||0
6439531|NCT01090479|7354415|FG001|NOT COMPLETED|Overall Study||0
6439532|NCT01090492|7354429|FG000|STARTED|First Intervention Period (4 Weeks)||27
6439533|NCT01090492|7354430|FG001|STARTED|First Intervention Period (4 Weeks)||29
6439534|NCT01090492|7354431|FG002|STARTED|First Intervention Period (4 Weeks)||29
6439535|NCT01090492|7354432|FG003|STARTED|First Intervention Period (4 Weeks)||28
6439536|NCT01090492|7354433|FG004|STARTED|First Intervention Period (4 Weeks)||33
6439537|NCT01090492|7354434|FG005|STARTED|First Intervention Period (4 Weeks)||32
6439538|NCT01090492|7354435|FG006|STARTED|First Intervention Period (4 Weeks)||32
6439539|NCT01090492|7354436|FG007|STARTED|First Intervention Period (4 Weeks)||33
6439540|NCT01090492|7354429|FG000|COMPLETED|First Intervention Period (4 Weeks)||26
6439541|NCT01090492|7354430|FG001|COMPLETED|First Intervention Period (4 Weeks)||24
6439542|NCT01090492|7354431|FG002|COMPLETED|First Intervention Period (4 Weeks)||26
6439543|NCT01090492|7354432|FG003|COMPLETED|First Intervention Period (4 Weeks)||22
6439544|NCT01090492|7354433|FG004|COMPLETED|First Intervention Period (4 Weeks)||29
6439545|NCT01090492|7354434|FG005|COMPLETED|First Intervention Period (4 Weeks)||30
6439546|NCT01090492|7354435|FG006|COMPLETED|First Intervention Period (4 Weeks)||31
6439547|NCT01090492|7354436|FG007|COMPLETED|First Intervention Period (4 Weeks)||27
6439548|NCT01090492|7354429|FG000|NOT COMPLETED|First Intervention Period (4 Weeks)||1
6439549|NCT01090492|7354430|FG001|NOT COMPLETED|First Intervention Period (4 Weeks)||5
6439550|NCT01090492|7354431|FG002|NOT COMPLETED|First Intervention Period (4 Weeks)||3
6439551|NCT01090492|7354432|FG003|NOT COMPLETED|First Intervention Period (4 Weeks)||6
6439552|NCT01090492|7354433|FG004|NOT COMPLETED|First Intervention Period (4 Weeks)||4
6439553|NCT01090492|7354434|FG005|NOT COMPLETED|First Intervention Period (4 Weeks)||2
6439554|NCT01090492|7354435|FG006|NOT COMPLETED|First Intervention Period (4 Weeks)||1
6439555|NCT01090492|7354436|FG007|NOT COMPLETED|First Intervention Period (4 Weeks)||6
6439556|NCT01090492|7354429|FG000|STARTED|Placebo Washout Period ( 2 Weeks)||26
6439557|NCT01090492|7354430|FG001|STARTED|Placebo Washout Period ( 2 Weeks)||24
6439558|NCT01090492|7354431|FG002|STARTED|Placebo Washout Period ( 2 Weeks)||26
6439559|NCT01090492|7354432|FG003|STARTED|Placebo Washout Period ( 2 Weeks)||22
6439560|NCT01090492|7354433|FG004|STARTED|Placebo Washout Period ( 2 Weeks)||29
6439561|NCT01090492|7354434|FG005|STARTED|Placebo Washout Period ( 2 Weeks)||30
6439562|NCT01090492|7354435|FG006|STARTED|Placebo Washout Period ( 2 Weeks)||31
6439563|NCT01090492|7354436|FG007|STARTED|Placebo Washout Period ( 2 Weeks)||27
6439564|NCT01090492|7354429|FG000|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
6439565|NCT01090492|7354430|FG001|COMPLETED|Placebo Washout Period ( 2 Weeks)||24
6439566|NCT01090492|7354431|FG002|COMPLETED|Placebo Washout Period ( 2 Weeks)||26
6439567|NCT01090492|7354432|FG003|COMPLETED|Placebo Washout Period ( 2 Weeks)||22
6439568|NCT01090492|7354433|FG004|COMPLETED|Placebo Washout Period ( 2 Weeks)||29
6439569|NCT01090492|7354434|FG005|COMPLETED|Placebo Washout Period ( 2 Weeks)||30
6439570|NCT01090492|7354435|FG006|COMPLETED|Placebo Washout Period ( 2 Weeks)||31
6439571|NCT01090492|7354436|FG007|COMPLETED|Placebo Washout Period ( 2 Weeks)||27
6439572|NCT01090492|7354429|FG000|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6439573|NCT01090492|7354430|FG001|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6439574|NCT01090492|7354431|FG002|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6439575|NCT01090492|7354432|FG003|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6439576|NCT01090492|7354433|FG004|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6439577|NCT01090492|7354434|FG005|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6439578|NCT01090492|7354435|FG006|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6439579|NCT01090492|7354436|FG007|NOT COMPLETED|Placebo Washout Period ( 2 Weeks)||0
6439580|NCT01090492|7354429|FG000|STARTED|Second Intervention Period (4 Weeks)||26
6439581|NCT01090492|7354430|FG001|STARTED|Second Intervention Period (4 Weeks)||24
6439582|NCT01090492|7354431|FG002|STARTED|Second Intervention Period (4 Weeks)||26
6439583|NCT01090492|7354432|FG003|STARTED|Second Intervention Period (4 Weeks)||22
6439584|NCT01090492|7354433|FG004|STARTED|Second Intervention Period (4 Weeks)||29
6439585|NCT01090492|7354434|FG005|STARTED|Second Intervention Period (4 Weeks)||30
6439586|NCT01090492|7354435|FG006|STARTED|Second Intervention Period (4 Weeks)||31
6439587|NCT01090492|7354436|FG007|STARTED|Second Intervention Period (4 Weeks)||27
6439588|NCT01090492|7354429|FG000|COMPLETED|Second Intervention Period (4 Weeks)||25
6439589|NCT01090492|7354430|FG001|COMPLETED|Second Intervention Period (4 Weeks)||22
6439590|NCT01090492|7354431|FG002|COMPLETED|Second Intervention Period (4 Weeks)||24
6439591|NCT01090492|7354432|FG003|COMPLETED|Second Intervention Period (4 Weeks)||22
6439592|NCT01090492|7354433|FG004|COMPLETED|Second Intervention Period (4 Weeks)||27
6439593|NCT01090492|7354434|FG005|COMPLETED|Second Intervention Period (4 Weeks)||29
6439594|NCT01090492|7354435|FG006|COMPLETED|Second Intervention Period (4 Weeks)||22
6439595|NCT01090492|7354436|FG007|COMPLETED|Second Intervention Period (4 Weeks)||25
6439596|NCT01090492|7354429|FG000|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
6439597|NCT01090492|7354430|FG001|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
6439598|NCT01090492|7354431|FG002|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
6439599|NCT01090492|7354432|FG003|NOT COMPLETED|Second Intervention Period (4 Weeks)||0
6439600|NCT01090492|7354433|FG004|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
6439601|NCT01090492|7354434|FG005|NOT COMPLETED|Second Intervention Period (4 Weeks)||1
6439602|NCT01090492|7354435|FG006|NOT COMPLETED|Second Intervention Period (4 Weeks)||9
6439603|NCT01090492|7354436|FG007|NOT COMPLETED|Second Intervention Period (4 Weeks)||2
6439604|NCT01090739|7354455|FG000|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
6439605|NCT01090739|7354455|FG000|COMPLETED|Enrollment||152
6439606|NCT01090739|7354455|FG000|NOT COMPLETED|Enrollment||55
6439607|NCT01090739|7354455|FG000|STARTED|12 Month Follow-up||152
6439608|NCT01090739|7354455|FG000|COMPLETED|12 Month Follow-up||147
6439609|NCT01090739|7354455|FG000|NOT COMPLETED|12 Month Follow-up||5
6439610|NCT01090739|7354455|FG000|STARTED|24 Month Follow-up||147
6439611|NCT01090739|7354455|FG000|COMPLETED|24 Month Follow-up||138
6439612|NCT01090739|7354455|FG000|NOT COMPLETED|24 Month Follow-up||9
6439613|NCT01090739|7354455|FG000|STARTED|36 Month Follow-up||138
6439614|NCT01090739|7354455|FG000|COMPLETED|36 Month Follow-up||115
6439615|NCT01090739|7354455|FG000|NOT COMPLETED|36 Month Follow-up||23
6439616|NCT01090752|7354462|FG000|STARTED|Overall Study||8
6439617|NCT01090752|7354463|FG001|STARTED|Overall Study||8
6439618|NCT01090752|7354462|FG000|COMPLETED|Overall Study||8
6439619|NCT01090752|7354463|FG001|COMPLETED|Overall Study||8
6439620|NCT01090752|7354462|FG000|NOT COMPLETED|Overall Study||0
6439621|NCT01090752|7354463|FG001|NOT COMPLETED|Overall Study||0
6439622|NCT01090765|7354475|FG000|STARTED|Overall Study||3
6439623|NCT01090765|7354476|FG001|STARTED|Overall Study||3
6439624|NCT01090765|7354477|FG002|STARTED|Overall Study||3
6439625|NCT01090765|7354478|FG003|STARTED|Overall Study||2
6439626|NCT01090765|7354479|FG004|STARTED|Overall Study||6
6439627|NCT01090765|7354480|FG005|STARTED|Overall Study||4
6439628|NCT01090765|7354475|FG000|COMPLETED|Overall Study||3
6439629|NCT01090765|7354476|FG001|COMPLETED|Overall Study||3
6439630|NCT01090765|7354477|FG002|COMPLETED|Overall Study||3
6439631|NCT01090765|7354478|FG003|COMPLETED|Overall Study||1
6439632|NCT01090765|7354479|FG004|COMPLETED|Overall Study||4
6439633|NCT01090765|7354480|FG005|COMPLETED|Overall Study||3
6439634|NCT01090765|7354475|FG000|NOT COMPLETED|Overall Study||0
6439635|NCT01090765|7354476|FG001|NOT COMPLETED|Overall Study||0
6439636|NCT01090765|7354477|FG002|NOT COMPLETED|Overall Study||0
6439637|NCT01090765|7354478|FG003|NOT COMPLETED|Overall Study||1
6439638|NCT01090765|7354479|FG004|NOT COMPLETED|Overall Study||2
6439639|NCT01090765|7354480|FG005|NOT COMPLETED|Overall Study||1
6439640|NCT01090921|7354495|FG000|STARTED|Overall Study||50
6439641|NCT01090921|7354495|FG000|COMPLETED|Overall Study||23
6439642|NCT01090921|7354495|FG000|NOT COMPLETED|Overall Study||27
6439643|NCT01090973|7354499|FG000|STARTED|Overall Study||1
6439644|NCT01090973|7354499|FG000|COMPLETED|Overall Study||0
6439645|NCT01090973|7354499|FG000|NOT COMPLETED|Overall Study||1
6439646|NCT01091103|7354503|FG000|STARTED|Overall Study||60
6439647|NCT01091103|7354503|FG000|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
6439648|NCT01091103|7354503|FG000|NOT COMPLETED|Overall Study||4
6439649|NCT01091116|7354514|FG000|STARTED|Overall Study||83
6439650|NCT01091116|7354515|FG001|STARTED|Overall Study||88
6439651|NCT01091116|7354516|FG002|STARTED|Overall Study||84
6439652|NCT01091116|7354517|FG003|STARTED|Overall Study||84
6439653|NCT01091116|7354518|FG004|STARTED|Overall Study||84
6439654|NCT01091116|7354514|FG000|COMPLETED|Overall Study||77
6439655|NCT01091116|7354515|FG001|COMPLETED|Overall Study||80
6439656|NCT01091116|7354516|FG002|COMPLETED|Overall Study||73
6439657|NCT01091116|7354517|FG003|COMPLETED|Overall Study||80
6439658|NCT01091116|7354518|FG004|COMPLETED|Overall Study||73
6439659|NCT01091116|7354514|FG000|NOT COMPLETED|Overall Study||6
6439660|NCT01091116|7354515|FG001|NOT COMPLETED|Overall Study||8
6439661|NCT01091116|7354516|FG002|NOT COMPLETED|Overall Study||11
6439662|NCT01091116|7354517|FG003|NOT COMPLETED|Overall Study||4
6439663|NCT01091116|7354518|FG004|NOT COMPLETED|Overall Study||11
6439664|NCT01091155|7354530|FG000|STARTED|Overall Study||288
6439665|NCT01091155|7354530|FG000|COMPLETED|Overall Study||279
6439666|NCT01091155|7354530|FG000|NOT COMPLETED|Overall Study||9
6439667|NCT01091168|7354536|FG000|STARTED|Overall Study||298
6439668|NCT01091168|7354537|FG001|STARTED|Overall Study||296
6439669|NCT01091168|7354536|FG000|COMPLETED|Overall Study||0
6439670|NCT01091168|7354537|FG001|COMPLETED|Overall Study||0
6439671|NCT01091168|7354536|FG000|NOT COMPLETED|Overall Study||298
6439672|NCT01091168|7354537|FG001|NOT COMPLETED|Overall Study||296
6439673|NCT01091246|7354546|FG000|STARTED|Overall Study||1385
6439674|NCT01091246|7354547|FG001|STARTED|Overall Study||464
6439675|NCT01091246|7354548|FG002|STARTED|Overall Study||463
6439676|NCT01091246|7354546|FG000|COMPLETED|Overall Study||1350
6439677|NCT01091246|7354547|FG001|COMPLETED|Overall Study||448
6439678|NCT01091246|7354548|FG002|COMPLETED|Overall Study||450
6439679|NCT01091246|7354546|FG000|NOT COMPLETED|Overall Study||35
6439680|NCT01091246|7354547|FG001|NOT COMPLETED|Overall Study||16
6439681|NCT01091246|7354548|FG002|NOT COMPLETED|Overall Study||13
6439682|NCT01091259|7354558|FG000|STARTED|Overall Study||29
6439683|NCT01091259|7354558|FG000|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
6439684|NCT01091259|7354558|FG000|NOT COMPLETED|Overall Study||5
6439685|NCT01091363|7354564|FG000|STARTED|Overall Study||55
6439686|NCT01091363|7354565|FG001|STARTED|Overall Study||54
6439687|NCT01091363|7354564|FG000|COMPLETED|Overall Study||42
6439688|NCT01091363|7354565|FG001|COMPLETED|Overall Study||37
6439689|NCT01091363|7354564|FG000|NOT COMPLETED|Overall Study||13
6439690|NCT01091363|7354565|FG001|NOT COMPLETED|Overall Study||17
6439691|NCT01091428|7354575|FG000|STARTED|Phase 1||38
6439692|NCT01091428|7354576|FG001|STARTED|Phase 1||11
6439693|NCT01091428|7354577|FG002|STARTED|Phase 1||0
6439694|NCT01091428|7354578|FG003|STARTED|Phase 1||0
6439695|NCT01091428|7354575|FG000|COMPLETED|Phase 1|Completed = participants who completed the treatment.|0
6439696|NCT01091428|7354576|FG001|COMPLETED|Phase 1||0
6439697|NCT01091428|7354577|FG002|COMPLETED|Phase 1||0
6439698|NCT01091428|7354578|FG003|COMPLETED|Phase 1||0
6439699|NCT01091428|7354575|FG000|NOT COMPLETED|Phase 1||38
6439700|NCT01091428|7354576|FG001|NOT COMPLETED|Phase 1||11
6439701|NCT01091428|7354577|FG002|NOT COMPLETED|Phase 1||0
6439702|NCT01091428|7354578|FG003|NOT COMPLETED|Phase 1||0
6439703|NCT01091428|7354575|FG000|STARTED|Phase 2||0
6439704|NCT01091428|7354576|FG001|STARTED|Phase 2||0
6439705|NCT01091428|7354577|FG002|STARTED|Phase 2||73
6439706|NCT01091428|7354578|FG003|STARTED|Phase 2||69
6439707|NCT01091428|7354575|FG000|COMPLETED|Phase 2||0
6439708|NCT01091428|7354576|FG001|COMPLETED|Phase 2||0
6552867|NCT01739595|7475279|FG002|STARTED|Overall Study||47
6552868|NCT01739595|7475277|FG000|COMPLETED|Overall Study||99
6552869|NCT01739595|7475278|FG001|COMPLETED|Overall Study||21
6552870|NCT01739595|7475279|FG002|COMPLETED|Overall Study||45
6552871|NCT01739595|7475277|FG000|NOT COMPLETED|Overall Study||13
6552872|NCT01739595|7475278|FG001|NOT COMPLETED|Overall Study||1
6552873|NCT01739595|7475279|FG002|NOT COMPLETED|Overall Study||2
6439709|NCT01091428|7354577|FG002|COMPLETED|Phase 2||0
6439710|NCT01091428|7354578|FG003|COMPLETED|Phase 2||0
6439711|NCT01091428|7354575|FG000|NOT COMPLETED|Phase 2||0
6439712|NCT01091428|7354576|FG001|NOT COMPLETED|Phase 2||0
6439713|NCT01091428|7354577|FG002|NOT COMPLETED|Phase 2||73
6439714|NCT01091428|7354578|FG003|NOT COMPLETED|Phase 2||69
6439715|NCT01091454|7354597|FG000|STARTED|Overall Study||48
6439716|NCT01091454|7354597|FG000|COMPLETED|Overall Study||47
6439717|NCT01091454|7354597|FG000|NOT COMPLETED|Overall Study||1
6439718|NCT01091519|7354603|FG000|STARTED|Overall Study||346
6439719|NCT01091519|7354604|FG001|STARTED|Overall Study||435
6439720|NCT01091519|7354603|FG000|Treated|Overall Study||342
6439721|NCT01091519|7354604|FG001|Treated|Overall Study||431
6552874|NCT01739699|7475288|FG000|STARTED|Overall Study||70
6552875|NCT01739699|7475289|FG001|STARTED|Overall Study||70
6552876|NCT01739699|7475288|FG000|COMPLETED|Overall Study||66
6552877|NCT01739699|7475289|FG001|COMPLETED|Overall Study||65
6552878|NCT01739699|7475288|FG000|NOT COMPLETED|Overall Study||4
6552879|NCT01739699|7475289|FG001|NOT COMPLETED|Overall Study||5
6552880|NCT01739764|7475298|FG000|STARTED|Overall Study||29
6552881|NCT01739764|7475299|FG001|STARTED|Overall Study||40
6552882|NCT01739764|7475300|FG002|STARTED|Overall Study||146
6552883|NCT01739764|7475298|FG000|COMPLETED|Overall Study||3
6552884|NCT01739764|7475299|FG001|COMPLETED|Overall Study||4
6552885|NCT01739764|7475300|FG002|COMPLETED|Overall Study||20
6552886|NCT01739764|7475298|FG000|NOT COMPLETED|Overall Study||26
6552887|NCT01739764|7475299|FG001|NOT COMPLETED|Overall Study||36
6552888|NCT01739764|7475300|FG002|NOT COMPLETED|Overall Study||126
6552889|NCT01739790|7475310|FG000|STARTED|Overall Study||24
6552890|NCT01739790|7475311|FG001|STARTED|Overall Study||27
6552891|NCT01739790|7475310|FG000|COMPLETED|Overall Study||22
6552892|NCT01739790|7475311|FG001|COMPLETED|Overall Study||23
6552893|NCT01739790|7475310|FG000|NOT COMPLETED|Overall Study||2
6552894|NCT01739790|7475311|FG001|NOT COMPLETED|Overall Study||4
6552895|NCT01739803|7475319|FG000|STARTED|Overall Study||76
6552896|NCT01739803|7475320|FG001|STARTED|Overall Study||74
6552897|NCT01739803|7475319|FG000|COMPLETED|Overall Study||67
6552898|NCT01739803|7475320|FG001|COMPLETED|Overall Study||68
6552899|NCT01739803|7475319|FG000|NOT COMPLETED|Overall Study||9
6552900|NCT01739803|7475320|FG001|NOT COMPLETED|Overall Study||6
6552901|NCT01739933|7475328|FG000|STARTED|Overall Study|Underwent randomization and received study drug|214
6552902|NCT01739933|7475329|FG001|STARTED|Overall Study|Underwent randomization and received study drug|208
6552903|NCT01739933|7475328|FG000|Discharged From Hospital and Eligible for Follow-up|Overall Study||140
6552904|NCT01739933|7475329|FG001|Discharged From Hospital and Eligible for Follow-up|Overall Study||147
6552905|NCT01739933|7475328|FG000|COMPLETED|Overall Study|97% of those eligible (alive and who did not withdraw)|108
6552906|NCT01739933|7475329|FG001|COMPLETED|Overall Study|91% of those eligible (alive and who did not withdraw)|101
6653351|NCT02436356|7583103|FG001|Low Energy Fracture|Overall Study||0
6653352|NCT02436356|7583104|FG002|Low Energy Fracture|Overall Study||0
6653353|NCT02436356|7583102|FG000|COMPLETED|Overall Study||28
6439722|NCT01091519|7354603|FG000|COMPLETED|Overall Study||291
6439723|NCT01091519|7354604|FG001|COMPLETED|Overall Study||362
6439724|NCT01091519|7354603|FG000|NOT COMPLETED|Overall Study||55
6439725|NCT01091519|7354604|FG001|NOT COMPLETED|Overall Study||73
6439726|NCT01091662|7354612|FG000|STARTED|Overall Study||58
6439727|NCT01091662|7354613|FG001|STARTED|Overall Study||114
6653354|NCT02436356|7583103|FG001|COMPLETED|Overall Study||10
6653355|NCT02436356|7583104|FG002|COMPLETED|Overall Study||2
6653356|NCT02436356|7583102|FG000|NOT COMPLETED|Overall Study||5
6653357|NCT02436356|7583103|FG001|NOT COMPLETED|Overall Study||1
6653358|NCT02436356|7583104|FG002|NOT COMPLETED|Overall Study||2
6653359|NCT02436408|7583117|FG000|STARTED|Overall Study||35
6653360|NCT02436408|7583117|FG000|COMPLETED|Overall Study||34
6653361|NCT02436408|7583117|FG000|NOT COMPLETED|Overall Study||1
6653362|NCT02436577|7583127|FG000|STARTED|Overall Study||7
6653363|NCT02436577|7583128|FG001|STARTED|Overall Study||7
6653364|NCT02436577|7583129|FG002|STARTED|Overall Study||7
6653365|NCT02436577|7583130|FG003|STARTED|Overall Study||7
6439728|NCT01091662|7354612|FG000|COMPLETED|Overall Study||41
6439729|NCT01091662|7354613|FG001|COMPLETED|Overall Study||80
6439730|NCT01091662|7354612|FG000|NOT COMPLETED|Overall Study||17
6439731|NCT01091662|7354613|FG001|NOT COMPLETED|Overall Study||34
6439732|NCT01091675|7354624|FG000|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
6439733|NCT01091675|7354624|FG000|COMPLETED|Overall Study||23
6439734|NCT01091675|7354624|FG000|NOT COMPLETED|Overall Study||34
6439735|NCT01091948|7354630|FG000|STARTED|Overall Study||37
6439736|NCT01091948|7354631|FG001|STARTED|Overall Study||38
6439737|NCT01091948|7354630|FG000|COMPLETED|Overall Study||37
6439738|NCT01091948|7354631|FG001|COMPLETED|Overall Study||38
6439739|NCT01091948|7354630|FG000|NOT COMPLETED|Overall Study||0
6439740|NCT01091948|7354631|FG001|NOT COMPLETED|Overall Study||0
6439741|NCT01091974|7354642|FG000|STARTED|Overall Study||24
6439742|NCT01091974|7354643|FG001|STARTED|Overall Study||23
6439743|NCT01091974|7354644|FG002|STARTED|Overall Study||25
6439744|NCT01091974|7354645|FG003|STARTED|Overall Study||24
6439745|NCT01091974|7354642|FG000|COMPLETED|Overall Study||19
6439746|NCT01091974|7354643|FG001|COMPLETED|Overall Study||18
6439747|NCT01091974|7354644|FG002|COMPLETED|Overall Study||19
6439748|NCT01091974|7354645|FG003|COMPLETED|Overall Study||17
6439749|NCT01091974|7354642|FG000|NOT COMPLETED|Overall Study||5
6439750|NCT01091974|7354643|FG001|NOT COMPLETED|Overall Study||5
6439751|NCT01091974|7354644|FG002|NOT COMPLETED|Overall Study||6
6653366|NCT02436577|7583131|FG004|STARTED|Overall Study||7
6653367|NCT02436577|7583132|FG005|STARTED|Overall Study||7
6653368|NCT02436577|7583127|FG000|COMPLETED|Overall Study||7
6653369|NCT02436577|7583128|FG001|COMPLETED|Overall Study||6
6653370|NCT02436577|7583129|FG002|COMPLETED|Overall Study||7
6439752|NCT01091974|7354645|FG003|NOT COMPLETED|Overall Study||7
6439753|NCT01092182|7354658|FG000|STARTED|Overall Study||15
6653371|NCT02436577|7583130|FG003|COMPLETED|Overall Study||7
6439754|NCT01092182|7354659|FG001|STARTED|Overall Study||98
6439755|NCT01092182|7354660|FG002|STARTED|Overall Study||81
6439756|NCT01092182|7354658|FG000|COMPLETED|Overall Study||14
6439757|NCT01092182|7354659|FG001|COMPLETED|Overall Study||80
6439758|NCT01092182|7354660|FG002|COMPLETED|Overall Study||53
6439759|NCT01092182|7354658|FG000|NOT COMPLETED|Overall Study||1
6439760|NCT01092182|7354659|FG001|NOT COMPLETED|Overall Study||18
6439761|NCT01092182|7354660|FG002|NOT COMPLETED|Overall Study||28
6439762|NCT01092195|7354671|FG000|STARTED|Overall Study||23
6439763|NCT01092195|7354672|FG001|STARTED|Overall Study||21
6439764|NCT01092195|7354673|FG002|STARTED|Overall Study||20
6439765|NCT01092195|7354671|FG000|COMPLETED|Overall Study||23
6439766|NCT01092195|7354672|FG001|COMPLETED|Overall Study||21
6439767|NCT01092195|7354673|FG002|COMPLETED|Overall Study||20
6439768|NCT01092195|7354671|FG000|NOT COMPLETED|Overall Study||0
6439769|NCT01092195|7354672|FG001|NOT COMPLETED|Overall Study||0
6439770|NCT01092195|7354673|FG002|NOT COMPLETED|Overall Study||0
6439771|NCT01092338|7354683|FG000|STARTED|Overall Study||22
6439772|NCT01092338|7354684|FG001|STARTED|Overall Study||22
6439773|NCT01092338|7354683|FG000|COMPLETED|Overall Study||21
6439774|NCT01092338|7354684|FG001|COMPLETED|Overall Study||21
6439775|NCT01092338|7354683|FG000|NOT COMPLETED|Overall Study||1
6439776|NCT01092338|7354684|FG001|NOT COMPLETED|Overall Study||1
6439777|NCT01092364|7354693|FG000|STARTED|Overall Study||122
6439778|NCT01092364|7354694|FG001|STARTED|Overall Study||120
6439779|NCT01092364|7354695|FG002|STARTED|Overall Study||123
6439780|NCT01092364|7354693|FG000|COMPLETED|Overall Study||104
6439781|NCT01092364|7354694|FG001|COMPLETED|Overall Study||104
6439782|NCT01092364|7354695|FG002|COMPLETED|Overall Study||105
6439783|NCT01092364|7354693|FG000|NOT COMPLETED|Overall Study||18
6439784|NCT01092364|7354694|FG001|NOT COMPLETED|Overall Study||16
6439785|NCT01092364|7354695|FG002|NOT COMPLETED|Overall Study||18
6439786|NCT01092416|7354703|FG000|STARTED|Enrollment||443
6439787|NCT01092416|7354703|FG000|COMPLETED|Enrollment||440
6439788|NCT01092416|7354703|FG000|NOT COMPLETED|Enrollment||3
6439789|NCT01092416|7354703|FG000|STARTED|30-Day Follow-up||440
6439790|NCT01092416|7354703|FG000|COMPLETED|30-Day Follow-up||430
6439791|NCT01092416|7354703|FG000|NOT COMPLETED|30-Day Follow-up||10
6439792|NCT01092416|7354703|FG000|STARTED|12-Month Follow-up||438
6439793|NCT01092416|7354703|FG000|COMPLETED|12-Month Follow-up||413
6439794|NCT01092416|7354703|FG000|NOT COMPLETED|12-Month Follow-up||25
6439795|NCT01092442|7354712|FG000|STARTED|Overall Study||80
6439796|NCT01092442|7354713|FG001|STARTED|Overall Study||60
6439797|NCT01092442|7354712|FG000|COMPLETED|Overall Study||80
6439798|NCT01092442|7354713|FG001|COMPLETED|Overall Study||60
6439799|NCT01092442|7354712|FG000|NOT COMPLETED|Overall Study||0
6439800|NCT01092442|7354713|FG001|NOT COMPLETED|Overall Study||0
6439801|NCT01092507|7354726|FG000|STARTED|Overall Study||149
6439802|NCT01092507|7354727|FG001|STARTED|Overall Study||150
6439803|NCT01092507|7354726|FG000|COMPLETED|Overall Study||147
6439804|NCT01092507|7354727|FG001|COMPLETED|Overall Study||150
6439805|NCT01092507|7354726|FG000|NOT COMPLETED|Overall Study||2
6439806|NCT01092507|7354727|FG001|NOT COMPLETED|Overall Study||0
6439807|NCT01092546|7354733|FG000|STARTED|Overall Study||16
6439808|NCT01092546|7354733|FG000|COMPLETED|Overall Study||12
6439809|NCT01092546|7354733|FG000|NOT COMPLETED|Overall Study||4
6439810|NCT01092559|7354737|FG000|STARTED|Overall Study||10
6439811|NCT01092559|7354737|FG000|COMPLETED|Overall Study||10
6439812|NCT01092559|7354737|FG000|NOT COMPLETED|Overall Study||0
6439813|NCT01092637|7354743|FG000|STARTED|Overall Study||145
6439814|NCT01092637|7354744|FG001|STARTED|Overall Study||135
6439815|NCT01092637|7354743|FG000|COMPLETED|Overall Study||98
6439816|NCT01092637|7354744|FG001|COMPLETED|Overall Study||86
6439817|NCT01092637|7354743|FG000|NOT COMPLETED|Overall Study||47
6439818|NCT01092637|7354744|FG001|NOT COMPLETED|Overall Study||49
6439819|NCT01092663|7354753|FG000|STARTED|Overall Study||31
6439820|NCT01092663|7354754|FG001|STARTED|Overall Study||30
6439821|NCT01092663|7354753|FG000|COMPLETED|Overall Study||24
6439822|NCT01092663|7354754|FG001|COMPLETED|Overall Study||26
6439823|NCT01092663|7354753|FG000|NOT COMPLETED|Overall Study||7
6439824|NCT01092663|7354754|FG001|NOT COMPLETED|Overall Study||4
6439825|NCT01092676|7354767|FG000|STARTED|Overall Study||50
6439826|NCT01092676|7354768|FG001|STARTED|Overall Study||49
6439827|NCT01092676|7354767|FG000|COMPLETED|Overall Study||50
6439828|NCT01092676|7354768|FG001|COMPLETED|Overall Study||49
6439829|NCT01092676|7354767|FG000|NOT COMPLETED|Overall Study||0
6439830|NCT01092676|7354768|FG001|NOT COMPLETED|Overall Study||0
6439831|NCT01092702|7354774|FG000|STARTED|Overall Study||32
6439832|NCT01092702|7354774|FG000|COMPLETED|Overall Study||23
6439833|NCT01092702|7354774|FG000|NOT COMPLETED|Overall Study||9
6439834|NCT01092728|7354780|FG000|STARTED|Overall Study||4
6439835|NCT01092728|7354781|FG001|STARTED|Overall Study||14
6439836|NCT01092728|7354780|FG000|COMPLETED|Overall Study||0
6439837|NCT01092728|7354781|FG001|COMPLETED|Overall Study||0
6439838|NCT01092728|7354780|FG000|NOT COMPLETED|Overall Study||4
6439839|NCT01092728|7354781|FG001|NOT COMPLETED|Overall Study||14
6439840|NCT01092767|7354787|FG000|STARTED|Overall Study||50
6439841|NCT01092767|7354787|FG000|COMPLETED|Overall Study||45
6439842|NCT01092767|7354787|FG000|NOT COMPLETED|Overall Study||5
6439843|NCT01092780|7354791|FG000|STARTED|Treatment Period 1||14
6439844|NCT01092780|7354792|FG001|STARTED|Treatment Period 1||15
6439845|NCT01092780|7354793|FG002|STARTED|Treatment Period 1||14
6439846|NCT01092780|7354794|FG003|STARTED|Treatment Period 1||13
6439847|NCT01092780|7354791|FG000|COMPLETED|Treatment Period 1||14
6439848|NCT01092780|7354792|FG001|COMPLETED|Treatment Period 1||15
6439849|NCT01092780|7354793|FG002|COMPLETED|Treatment Period 1||14
6439850|NCT01092780|7354794|FG003|COMPLETED|Treatment Period 1||13
6439851|NCT01092780|7354791|FG000|NOT COMPLETED|Treatment Period 1||0
6439852|NCT01092780|7354792|FG001|NOT COMPLETED|Treatment Period 1||0
6439853|NCT01092780|7354793|FG002|NOT COMPLETED|Treatment Period 1||0
6439854|NCT01092780|7354794|FG003|NOT COMPLETED|Treatment Period 1||0
6439855|NCT01092780|7354791|FG000|STARTED|Washout Period 1||14
6439856|NCT01092780|7354792|FG001|STARTED|Washout Period 1||15
6439857|NCT01092780|7354793|FG002|STARTED|Washout Period 1||14
6439858|NCT01092780|7354794|FG003|STARTED|Washout Period 1||13
6439859|NCT01092780|7354791|FG000|COMPLETED|Washout Period 1||13
6439860|NCT01092780|7354792|FG001|COMPLETED|Washout Period 1||14
6439861|NCT01092780|7354793|FG002|COMPLETED|Washout Period 1||14
6439862|NCT01092780|7354794|FG003|COMPLETED|Washout Period 1||13
6439863|NCT01092780|7354791|FG000|NOT COMPLETED|Washout Period 1||1
6439864|NCT01092780|7354792|FG001|NOT COMPLETED|Washout Period 1||1
6439865|NCT01092780|7354793|FG002|NOT COMPLETED|Washout Period 1||0
6439866|NCT01092780|7354794|FG003|NOT COMPLETED|Washout Period 1||0
6439867|NCT01092780|7354791|FG000|STARTED|Treatment Period 2||13
6439868|NCT01092780|7354792|FG001|STARTED|Treatment Period 2||14
6439869|NCT01092780|7354793|FG002|STARTED|Treatment Period 2||14
6439870|NCT01092780|7354794|FG003|STARTED|Treatment Period 2||13
6439871|NCT01092780|7354791|FG000|COMPLETED|Treatment Period 2||13
6439872|NCT01092780|7354792|FG001|COMPLETED|Treatment Period 2||14
6439873|NCT01092780|7354793|FG002|COMPLETED|Treatment Period 2||14
6439874|NCT01092780|7354794|FG003|COMPLETED|Treatment Period 2||13
6439875|NCT01092780|7354791|FG000|NOT COMPLETED|Treatment Period 2||0
6439876|NCT01092780|7354792|FG001|NOT COMPLETED|Treatment Period 2||0
6439877|NCT01092780|7354793|FG002|NOT COMPLETED|Treatment Period 2||0
6439878|NCT01092780|7354794|FG003|NOT COMPLETED|Treatment Period 2||0
6439879|NCT01092780|7354791|FG000|STARTED|Washout Period 2||13
6653372|NCT02436577|7583131|FG004|COMPLETED|Overall Study||7
6653373|NCT02436577|7583132|FG005|COMPLETED|Overall Study||7
6653374|NCT02436577|7583127|FG000|NOT COMPLETED|Overall Study||0
6653375|NCT02436577|7583128|FG001|NOT COMPLETED|Overall Study||1
6439880|NCT01092780|7354792|FG001|STARTED|Washout Period 2||14
6439881|NCT01092780|7354793|FG002|STARTED|Washout Period 2||14
6439882|NCT01092780|7354794|FG003|STARTED|Washout Period 2||13
6439883|NCT01092780|7354791|FG000|COMPLETED|Washout Period 2||13
6439884|NCT01092780|7354792|FG001|COMPLETED|Washout Period 2||13
6439885|NCT01092780|7354793|FG002|COMPLETED|Washout Period 2||13
6439886|NCT01092780|7354794|FG003|COMPLETED|Washout Period 2||13
6439887|NCT01092780|7354791|FG000|NOT COMPLETED|Washout Period 2||0
6439888|NCT01092780|7354792|FG001|NOT COMPLETED|Washout Period 2||1
6439889|NCT01092780|7354793|FG002|NOT COMPLETED|Washout Period 2||1
6439890|NCT01092780|7354794|FG003|NOT COMPLETED|Washout Period 2||0
6439891|NCT01092780|7354791|FG000|STARTED|Treatment Period 3||13
6439892|NCT01092780|7354792|FG001|STARTED|Treatment Period 3||13
6439893|NCT01092780|7354793|FG002|STARTED|Treatment Period 3||13
6439894|NCT01092780|7354794|FG003|STARTED|Treatment Period 3||13
6439895|NCT01092780|7354791|FG000|COMPLETED|Treatment Period 3||13
6439896|NCT01092780|7354792|FG001|COMPLETED|Treatment Period 3||13
6552907|NCT01739933|7475328|FG000|NOT COMPLETED|Overall Study||106
6552908|NCT01739933|7475329|FG001|NOT COMPLETED|Overall Study||107
6552909|NCT01740089|7475338|FG000|STARTED|First 12 Weeks of Treatment||50
6552910|NCT01740089|7475339|FG001|STARTED|First 12 Weeks of Treatment||50
6552911|NCT01740089|7475340|FG002|STARTED|First 12 Weeks of Treatment||50
6552912|NCT01740089|7475338|FG000|COMPLETED|First 12 Weeks of Treatment||50
6439897|NCT01092780|7354793|FG002|COMPLETED|Treatment Period 3||13
6439898|NCT01092780|7354794|FG003|COMPLETED|Treatment Period 3||13
6439899|NCT01092780|7354791|FG000|NOT COMPLETED|Treatment Period 3||0
6439900|NCT01092780|7354792|FG001|NOT COMPLETED|Treatment Period 3||0
6439901|NCT01092780|7354793|FG002|NOT COMPLETED|Treatment Period 3||0
6439902|NCT01092780|7354794|FG003|NOT COMPLETED|Treatment Period 3||0
6439903|NCT01092780|7354791|FG000|STARTED|Washout Period 3||13
6439904|NCT01092780|7354792|FG001|STARTED|Washout Period 3||13
6439905|NCT01092780|7354793|FG002|STARTED|Washout Period 3||13
6439906|NCT01092780|7354794|FG003|STARTED|Washout Period 3||13
6439907|NCT01092780|7354791|FG000|COMPLETED|Washout Period 3||13
6439908|NCT01092780|7354792|FG001|COMPLETED|Washout Period 3||13
6439909|NCT01092780|7354793|FG002|COMPLETED|Washout Period 3||13
6439910|NCT01092780|7354794|FG003|COMPLETED|Washout Period 3||13
6439911|NCT01092780|7354791|FG000|NOT COMPLETED|Washout Period 3||0
6439912|NCT01092780|7354792|FG001|NOT COMPLETED|Washout Period 3||0
6439913|NCT01092780|7354793|FG002|NOT COMPLETED|Washout Period 3||0
6439914|NCT01092780|7354794|FG003|NOT COMPLETED|Washout Period 3||0
6439915|NCT01092780|7354791|FG000|STARTED|Treatment Period 4||13
6552913|NCT01740089|7475339|FG001|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
6439916|NCT01092780|7354792|FG001|STARTED|Treatment Period 4||13
6439917|NCT01092780|7354793|FG002|STARTED|Treatment Period 4||13
6439918|NCT01092780|7354794|FG003|STARTED|Treatment Period 4||13
6439919|NCT01092780|7354791|FG000|COMPLETED|Treatment Period 4||13
6439920|NCT01092780|7354792|FG001|COMPLETED|Treatment Period 4||13
6439921|NCT01092780|7354793|FG002|COMPLETED|Treatment Period 4||13
6552914|NCT01740089|7475340|FG002|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:~AE before W12 (n=2)"|48
6552915|NCT01740089|7475338|FG000|NOT COMPLETED|First 12 Weeks of Treatment||0
6653376|NCT02436577|7583129|FG002|NOT COMPLETED|Overall Study||0
6653377|NCT02436577|7583130|FG003|NOT COMPLETED|Overall Study||0
6439922|NCT01092780|7354794|FG003|COMPLETED|Treatment Period 4||13
6439923|NCT01092780|7354791|FG000|NOT COMPLETED|Treatment Period 4||0
6439924|NCT01092780|7354792|FG001|NOT COMPLETED|Treatment Period 4||0
6439925|NCT01092780|7354793|FG002|NOT COMPLETED|Treatment Period 4||0
6439926|NCT01092780|7354794|FG003|NOT COMPLETED|Treatment Period 4||0
6439927|NCT01092832|7354806|FG000|STARTED|Overall Study||14
6439928|NCT01092832|7354807|FG001|STARTED|Overall Study||8
6439929|NCT01092832|7354806|FG000|COMPLETED|Overall Study||13
6439930|NCT01092832|7354807|FG001|COMPLETED|Overall Study||8
6439931|NCT01092832|7354806|FG000|NOT COMPLETED|Overall Study||1
6439932|NCT01092832|7354807|FG001|NOT COMPLETED|Overall Study||0
6439933|NCT01092910|7354813|FG000|STARTED|Overall Study||57
6439934|NCT01092910|7354813|FG000|4 Month Follow-up|Overall Study||54
6439935|NCT01092910|7354813|FG000|10 Month Follow-up|Overall Study||52
6439936|NCT01092910|7354813|FG000|COMPLETED|Overall Study||52
6439937|NCT01092910|7354813|FG000|NOT COMPLETED|Overall Study||5
6439938|NCT01092923|7354820|FG000|STARTED|Overall Study||10
6439939|NCT01092923|7354821|FG001|STARTED|Overall Study||10
6439940|NCT01092923|7354820|FG000|COMPLETED|Overall Study||10
6439941|NCT01092923|7354821|FG001|COMPLETED|Overall Study||10
6439942|NCT01092923|7354820|FG000|NOT COMPLETED|Overall Study||0
6439943|NCT01092923|7354821|FG001|NOT COMPLETED|Overall Study||0
6500021|NCT01422824|7418840|FG000|STARTED|Overall Study||185
6500022|NCT01422824|7418840|FG000|Treated|Overall Study||184
6500023|NCT01422824|7418840|FG000|COMPLETED|Overall Study||147
6500024|NCT01422824|7418840|FG000|NOT COMPLETED|Overall Study||38
6500025|NCT01422850|7418844|FG000|STARTED|Overall Study||21
6500026|NCT01422850|7418844|FG000|Week 4 - First Treatment|Overall Study||21
6500027|NCT01422850|7418844|FG000|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
6500028|NCT01422850|7418844|FG000|Week 9 - Second Treatment|Overall Study||20
6500029|NCT01422850|7418844|FG000|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
6500030|NCT01422850|7418844|FG000|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
6500031|NCT01422850|7418844|FG000|COMPLETED|Overall Study||18
6500032|NCT01422850|7418844|FG000|NOT COMPLETED|Overall Study||3
6500033|NCT01422876|7418860|FG000|STARTED|Week 24||137
6500034|NCT01422876|7418861|FG001|STARTED|Week 24||136
6500035|NCT01422876|7418862|FG002|STARTED|Week 24||141
6500036|NCT01422876|7418863|FG003|STARTED|Week 24||140
6500037|NCT01422876|7418864|FG004|STARTED|Week 24||132
6500038|NCT01422876|7418865|FG005|STARTED|Week 24||137
6552916|NCT01740089|7475339|FG001|NOT COMPLETED|First 12 Weeks of Treatment||2
6552917|NCT01740089|7475340|FG002|NOT COMPLETED|First 12 Weeks of Treatment||2
6552918|NCT01740089|7475338|FG000|STARTED|After 12 Weeks||50
6552919|NCT01740089|7475339|FG001|STARTED|After 12 Weeks||48
6552920|NCT01740089|7475340|FG002|STARTED|After 12 Weeks||48
6552921|NCT01740089|7475338|FG000|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
6552922|NCT01740089|7475339|FG001|COMPLETED|After 12 Weeks|"Withdrawn due to:~Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
6552923|NCT01740089|7475340|FG002|COMPLETED|After 12 Weeks|"Withdrawn due to:~No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
6552924|NCT01740089|7475338|FG000|NOT COMPLETED|After 12 Weeks||7
6552925|NCT01740089|7475339|FG001|NOT COMPLETED|After 12 Weeks||3
6500039|NCT01422876|7418866|FG006|STARTED|Week 24||136
6500040|NCT01422876|7418867|FG007|STARTED|Week 24||135
6500041|NCT01422876|7418868|FG008|STARTED|Week 24||134
6500042|NCT01422876|7418869|FG009|STARTED|Week 24||135
6500043|NCT01422876|7418860|FG000|COMPLETED|Week 24||131
6500044|NCT01422876|7418861|FG001|COMPLETED|Week 24||133
6500045|NCT01422876|7418862|FG002|COMPLETED|Week 24||136
6500046|NCT01422876|7418863|FG003|COMPLETED|Week 24||132
6500047|NCT01422876|7418864|FG004|COMPLETED|Week 24||125
6500048|NCT01422876|7418865|FG005|COMPLETED|Week 24||131
6500049|NCT01422876|7418866|FG006|COMPLETED|Week 24||130
6500050|NCT01422876|7418867|FG007|COMPLETED|Week 24||128
6500051|NCT01422876|7418868|FG008|COMPLETED|Week 24||128
6500052|NCT01422876|7418869|FG009|COMPLETED|Week 24||125
6500053|NCT01422876|7418860|FG000|NOT COMPLETED|Week 24||6
6500054|NCT01422876|7418861|FG001|NOT COMPLETED|Week 24||3
6500055|NCT01422876|7418862|FG002|NOT COMPLETED|Week 24||5
6500056|NCT01422876|7418863|FG003|NOT COMPLETED|Week 24||8
6500057|NCT01422876|7418864|FG004|NOT COMPLETED|Week 24||7
6500058|NCT01422876|7418865|FG005|NOT COMPLETED|Week 24||6
6500059|NCT01422876|7418866|FG006|NOT COMPLETED|Week 24||6
6500060|NCT01422876|7418867|FG007|NOT COMPLETED|Week 24||7
6500061|NCT01422876|7418868|FG008|NOT COMPLETED|Week 24||6
6500062|NCT01422876|7418869|FG009|NOT COMPLETED|Week 24||10
6500063|NCT01422876|7418860|FG000|STARTED|Week 52||137
6500064|NCT01422876|7418861|FG001|STARTED|Week 52||136
6500065|NCT01422876|7418862|FG002|STARTED|Week 52||141
6500066|NCT01422876|7418863|FG003|STARTED|Week 52||140
6500067|NCT01422876|7418864|FG004|STARTED|Week 52||132
6500068|NCT01422876|7418865|FG005|STARTED|Week 52||137
6500069|NCT01422876|7418866|FG006|STARTED|Week 52||136
6500070|NCT01422876|7418867|FG007|STARTED|Week 52||135
6500071|NCT01422876|7418868|FG008|STARTED|Week 52||134
6500072|NCT01422876|7418869|FG009|STARTED|Week 52||135
6500073|NCT01422876|7418860|FG000|COMPLETED|Week 52||125
6500074|NCT01422876|7418861|FG001|COMPLETED|Week 52||126
6500075|NCT01422876|7418862|FG002|COMPLETED|Week 52||128
6500076|NCT01422876|7418863|FG003|COMPLETED|Week 52||122
6500077|NCT01422876|7418864|FG004|COMPLETED|Week 52||117
6500078|NCT01422876|7418865|FG005|COMPLETED|Week 52||120
6552926|NCT01740089|7475340|FG002|NOT COMPLETED|After 12 Weeks||11
6439944|NCT01093014|7354831|FG000|STARTED|Overall Study||12
6439945|NCT01093014|7354832|FG001|STARTED|Overall Study||9
6439946|NCT01093014|7354833|FG002|STARTED|Overall Study||12
6439947|NCT01093014|7354831|FG000|COMPLETED|Overall Study||12
6439948|NCT01093014|7354832|FG001|COMPLETED|Overall Study||9
6439949|NCT01093014|7354833|FG002|COMPLETED|Overall Study||12
6439950|NCT01093014|7354831|FG000|NOT COMPLETED|Overall Study||0
6439951|NCT01093014|7354832|FG001|NOT COMPLETED|Overall Study||0
6439952|NCT01093014|7354833|FG002|NOT COMPLETED|Overall Study||0
6439953|NCT01093027|7354846|FG000|STARTED|Visit 1||10
6439954|NCT01093027|7354847|FG001|STARTED|Visit 1||10
6439955|NCT01093027|7354846|FG000|COMPLETED|Visit 1||10
6439956|NCT01093027|7354847|FG001|COMPLETED|Visit 1||10
6439957|NCT01093027|7354846|FG000|NOT COMPLETED|Visit 1||0
6439958|NCT01093027|7354847|FG001|NOT COMPLETED|Visit 1||0
6439959|NCT01093027|7354846|FG000|STARTED|Visit 2||10
6439960|NCT01093027|7354847|FG001|STARTED|Visit 2||10
6439961|NCT01093027|7354846|FG000|COMPLETED|Visit 2||10
6439962|NCT01093027|7354847|FG001|COMPLETED|Visit 2||10
6439963|NCT01093027|7354846|FG000|NOT COMPLETED|Visit 2||0
6439964|NCT01093027|7354847|FG001|NOT COMPLETED|Visit 2||0
6439965|NCT01093183|7354853|FG000|STARTED|Overall Study||19
6439966|NCT01093183|7354854|FG001|STARTED|Overall Study||6
6439967|NCT01093183|7354853|FG000|COMPLETED|Overall Study||18
6439968|NCT01093183|7354854|FG001|COMPLETED|Overall Study||4
6439969|NCT01093183|7354853|FG000|NOT COMPLETED|Overall Study||1
6439970|NCT01093183|7354854|FG001|NOT COMPLETED|Overall Study||2
6439971|NCT01093222|7354858|FG000|STARTED|Overall Study||40
6439972|NCT01093222|7354858|FG000|Eligible and Began Protocol Therapy|Overall Study||34
6439973|NCT01093222|7354858|FG000|COMPLETED|Overall Study||0
6439974|NCT01093222|7354858|FG000|NOT COMPLETED|Overall Study||40
6439975|NCT01093417|7354864|FG000|STARTED|Overall Study||15
6439976|NCT01093417|7354865|FG001|STARTED|Overall Study||30
6439977|NCT01093417|7354864|FG000|COMPLETED|Overall Study||15
6439978|NCT01093417|7354865|FG001|COMPLETED|Overall Study||29
6439979|NCT01093417|7354864|FG000|NOT COMPLETED|Overall Study||0
6439980|NCT01093417|7354865|FG001|NOT COMPLETED|Overall Study||1
6439981|NCT01093469|7354874|FG000|STARTED|Overall Study||13
6439982|NCT01093469|7354875|FG001|STARTED|Overall Study||13
6439983|NCT01093469|7354876|FG002|STARTED|Overall Study||13
6439984|NCT01093469|7354874|FG000|COMPLETED|Overall Study||13
6439985|NCT01093469|7354875|FG001|COMPLETED|Overall Study||13
6439986|NCT01093469|7354876|FG002|COMPLETED|Overall Study||12
6439987|NCT01093469|7354874|FG000|NOT COMPLETED|Overall Study||0
6439988|NCT01093469|7354875|FG001|NOT COMPLETED|Overall Study||0
6439989|NCT01093469|7354876|FG002|NOT COMPLETED|Overall Study||1
6439990|NCT01093482|7354884|FG000|STARTED|Overall Study||8151
6439991|NCT01093482|7354884|FG000|COMPLETED|Overall Study||8151
6439992|NCT01093482|7354884|FG000|NOT COMPLETED|Overall Study||0
6439993|NCT01093521|7354888|FG000|STARTED|Overall Study||20
6439994|NCT01093521|7354888|FG000|COMPLETED|Overall Study||20
6439995|NCT01093521|7354888|FG000|NOT COMPLETED|Overall Study||0
6439996|NCT01093534|7354897|FG000|STARTED|Overall Study||186
6439997|NCT01093534|7354898|FG001|STARTED|Overall Study||183
6439998|NCT01093534|7354899|FG002|STARTED|Overall Study||178
6439999|NCT01093534|7354897|FG000|Received Study Treatment|Overall Study||186
6440000|NCT01093534|7354898|FG001|Received Study Treatment|Overall Study||182
6440001|NCT01093534|7354899|FG002|Received Study Treatment|Overall Study||175
6440002|NCT01093534|7354897|FG000|COMPLETED|Overall Study||176
6440003|NCT01093534|7354898|FG001|COMPLETED|Overall Study||167
6440004|NCT01093534|7354899|FG002|COMPLETED|Overall Study||169
6440005|NCT01093534|7354897|FG000|NOT COMPLETED|Overall Study||10
6440006|NCT01093534|7354898|FG001|NOT COMPLETED|Overall Study||16
6440007|NCT01093534|7354899|FG002|NOT COMPLETED|Overall Study||9
6440008|NCT01093573|7354911|FG000|STARTED|Overall Study||3
6440009|NCT01093573|7354912|FG001|STARTED|Overall Study||3
6440010|NCT01093573|7354913|FG002|STARTED|Overall Study||28
6440011|NCT01093573|7354911|FG000|COMPLETED|Overall Study||3
6440012|NCT01093573|7354912|FG001|COMPLETED|Overall Study||3
6440013|NCT01093573|7354913|FG002|COMPLETED|Overall Study||26
6440014|NCT01093573|7354911|FG000|NOT COMPLETED|Overall Study||0
6440015|NCT01093573|7354912|FG001|NOT COMPLETED|Overall Study||0
6440016|NCT01093573|7354913|FG002|NOT COMPLETED|Overall Study||2
6440017|NCT01093586|7354924|FG000|STARTED|Overall Study||14
6440018|NCT01093586|7354924|FG000|COMPLETED|Overall Study||11
6440019|NCT01093586|7354924|FG000|NOT COMPLETED|Overall Study||3
6440020|NCT01093599|7354930|FG000|STARTED|Overall Study||91
6440021|NCT01093599|7354931|FG001|STARTED|Overall Study||105
6440022|NCT01093599|7354930|FG000|COMPLETED|Overall Study||59
6440023|NCT01093599|7354931|FG001|COMPLETED|Overall Study||59
6440024|NCT01093599|7354930|FG000|NOT COMPLETED|Overall Study||32
6440025|NCT01093599|7354931|FG001|NOT COMPLETED|Overall Study||46
6440026|NCT01093625|7354939|FG000|STARTED|Baseline and Dispensed||49
6440027|NCT01093625|7354940|FG001|STARTED|Baseline and Dispensed||49
6440028|NCT01093625|7354939|FG000|COMPLETED|Baseline and Dispensed||47
6440029|NCT01093625|7354940|FG001|COMPLETED|Baseline and Dispensed||49
6440030|NCT01093625|7354939|FG000|NOT COMPLETED|Baseline and Dispensed||2
6440031|NCT01093625|7354940|FG001|NOT COMPLETED|Baseline and Dispensed||0
6440032|NCT01093625|7354939|FG000|STARTED|2-Week Visit||47
6440033|NCT01093625|7354940|FG001|STARTED|2-Week Visit||49
6440034|NCT01093625|7354939|FG000|COMPLETED|2-Week Visit||46
6440035|NCT01093625|7354940|FG001|COMPLETED|2-Week Visit||49
6440036|NCT01093625|7354939|FG000|NOT COMPLETED|2-Week Visit||1
6440037|NCT01093625|7354940|FG001|NOT COMPLETED|2-Week Visit||0
6440038|NCT01093625|7354939|FG000|STARTED|1-Month Visit||46
6440039|NCT01093625|7354940|FG001|STARTED|1-Month Visit||49
6440040|NCT01093625|7354939|FG000|COMPLETED|1-Month Visit||44
6440041|NCT01093625|7354940|FG001|COMPLETED|1-Month Visit||49
6440042|NCT01093625|7354939|FG000|NOT COMPLETED|1-Month Visit||2
6440043|NCT01093625|7354940|FG001|NOT COMPLETED|1-Month Visit||0
6440044|NCT01093625|7354939|FG000|STARTED|3-Month Visit||44
6440045|NCT01093625|7354940|FG001|STARTED|3-Month Visit||49
6440046|NCT01093625|7354939|FG000|COMPLETED|3-Month Visit||42
6440047|NCT01093625|7354940|FG001|COMPLETED|3-Month Visit||49
6440048|NCT01093625|7354939|FG000|NOT COMPLETED|3-Month Visit||2
6440049|NCT01093625|7354940|FG001|NOT COMPLETED|3-Month Visit||0
6440050|NCT01093625|7354939|FG000|STARTED|6-Month Visit||42
6440051|NCT01093625|7354940|FG001|STARTED|6-Month Visit||49
6440052|NCT01093625|7354939|FG000|COMPLETED|6-Month Visit||34
6440053|NCT01093625|7354940|FG001|COMPLETED|6-Month Visit||40
6440054|NCT01093625|7354939|FG000|NOT COMPLETED|6-Month Visit||8
6440055|NCT01093625|7354940|FG001|NOT COMPLETED|6-Month Visit||9
6440056|NCT01093625|7354939|FG000|STARTED|1-Year Visit||34
6440057|NCT01093625|7354940|FG001|STARTED|1-Year Visit||40
6440058|NCT01093625|7354939|FG000|COMPLETED|1-Year Visit||29
6440059|NCT01093625|7354940|FG001|COMPLETED|1-Year Visit||37
6440060|NCT01093625|7354939|FG000|NOT COMPLETED|1-Year Visit||5
6440061|NCT01093625|7354940|FG001|NOT COMPLETED|1-Year Visit||3
6440062|NCT01093651|7354948|FG000|STARTED|Overall Study||10
6440063|NCT01093651|7354949|FG001|STARTED|Overall Study||10
6440064|NCT01093651|7354948|FG000|COMPLETED|Overall Study||10
6440065|NCT01093651|7354949|FG001|COMPLETED|Overall Study||10
6440066|NCT01093651|7354948|FG000|NOT COMPLETED|Overall Study||0
6440067|NCT01093651|7354949|FG001|NOT COMPLETED|Overall Study||0
6440068|NCT01093690|7354957|FG000|STARTED|Overall Study||83
6440069|NCT01093690|7354958|FG001|STARTED|Overall Study||79
6440070|NCT01093690|7354957|FG000|COMPLETED|Overall Study||83
6440071|NCT01093690|7354958|FG001|COMPLETED|Overall Study||79
6440072|NCT01093690|7354957|FG000|NOT COMPLETED|Overall Study||0
6440073|NCT01093690|7354958|FG001|NOT COMPLETED|Overall Study||0
6440074|NCT01093755|7354966|FG000|STARTED|Overall Study||16
6440075|NCT01093755|7354967|FG001|STARTED|Overall Study||14
6440076|NCT01093755|7354966|FG000|COMPLETED|Overall Study||13
6440077|NCT01093755|7354967|FG001|COMPLETED|Overall Study||10
6440078|NCT01093755|7354966|FG000|NOT COMPLETED|Overall Study||3
6440079|NCT01093755|7354967|FG001|NOT COMPLETED|Overall Study||4
6440080|NCT01093794|7354973|FG000|STARTED|Treatment Period 1||7
6440081|NCT01093794|7354974|FG001|STARTED|Treatment Period 1||7
6440082|NCT01093794|7354975|FG002|STARTED|Treatment Period 1||7
6440083|NCT01093794|7354976|FG003|STARTED|Treatment Period 1||7
6440084|NCT01093794|7354973|FG000|COMPLETED|Treatment Period 1||7
6440085|NCT01093794|7354974|FG001|COMPLETED|Treatment Period 1||7
6440086|NCT01093794|7354975|FG002|COMPLETED|Treatment Period 1||7
6440087|NCT01093794|7354976|FG003|COMPLETED|Treatment Period 1||7
6440088|NCT01093794|7354973|FG000|NOT COMPLETED|Treatment Period 1||0
6440089|NCT01093794|7354974|FG001|NOT COMPLETED|Treatment Period 1||0
6440090|NCT01093794|7354975|FG002|NOT COMPLETED|Treatment Period 1||0
6440091|NCT01093794|7354976|FG003|NOT COMPLETED|Treatment Period 1||0
6440092|NCT01093794|7354973|FG000|STARTED|Treatment Period 2||7
6440093|NCT01093794|7354974|FG001|STARTED|Treatment Period 2||7
6440094|NCT01093794|7354975|FG002|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
6440095|NCT01093794|7354976|FG003|STARTED|Treatment Period 2||7
6552927|NCT01740128|7475351|FG000|STARTED|Overall Study||10
6552928|NCT01740128|7475352|FG001|STARTED|Overall Study||11
6552929|NCT01740128|7475351|FG000|COMPLETED|Overall Study||4
6552930|NCT01740128|7475352|FG001|COMPLETED|Overall Study||4
6552931|NCT01740128|7475351|FG000|NOT COMPLETED|Overall Study||6
6552932|NCT01740128|7475352|FG001|NOT COMPLETED|Overall Study||7
6440096|NCT01093794|7354973|FG000|COMPLETED|Treatment Period 2||7
6440097|NCT01093794|7354974|FG001|COMPLETED|Treatment Period 2||7
6440098|NCT01093794|7354975|FG002|COMPLETED|Treatment Period 2||6
6440099|NCT01093794|7354976|FG003|COMPLETED|Treatment Period 2||7
6440100|NCT01093794|7354973|FG000|NOT COMPLETED|Treatment Period 2||0
6440101|NCT01093794|7354974|FG001|NOT COMPLETED|Treatment Period 2||0
6440102|NCT01093794|7354975|FG002|NOT COMPLETED|Treatment Period 2||0
6440103|NCT01093794|7354976|FG003|NOT COMPLETED|Treatment Period 2||0
6440104|NCT01093794|7354973|FG000|STARTED|Treatment Period 3||7
6440105|NCT01093794|7354974|FG001|STARTED|Treatment Period 3||7
6440106|NCT01093794|7354975|FG002|STARTED|Treatment Period 3||6
6440107|NCT01093794|7354976|FG003|STARTED|Treatment Period 3||7
6440108|NCT01093794|7354973|FG000|COMPLETED|Treatment Period 3||7
6440109|NCT01093794|7354974|FG001|COMPLETED|Treatment Period 3||7
6440110|NCT01093794|7354975|FG002|COMPLETED|Treatment Period 3||6
6440111|NCT01093794|7354976|FG003|COMPLETED|Treatment Period 3||7
6440112|NCT01093794|7354973|FG000|NOT COMPLETED|Treatment Period 3||0
6440113|NCT01093794|7354974|FG001|NOT COMPLETED|Treatment Period 3||0
6440114|NCT01093794|7354975|FG002|NOT COMPLETED|Treatment Period 3||0
6440115|NCT01093794|7354976|FG003|NOT COMPLETED|Treatment Period 3||0
6440116|NCT01093794|7354973|FG000|STARTED|Treatment Period 4||7
6440117|NCT01093794|7354974|FG001|STARTED|Treatment Period 4||7
6440118|NCT01093794|7354975|FG002|STARTED|Treatment Period 4||6
6552933|NCT01740206|7475360|FG000|STARTED|Overall Study||14
6552934|NCT01740206|7475361|FG001|STARTED|Overall Study||34
6440119|NCT01093794|7354976|FG003|STARTED|Treatment Period 4||7
6440120|NCT01093794|7354973|FG000|COMPLETED|Treatment Period 4||7
6440121|NCT01093794|7354974|FG001|COMPLETED|Treatment Period 4||7
6440122|NCT01093794|7354975|FG002|COMPLETED|Treatment Period 4||6
6440123|NCT01093794|7354976|FG003|COMPLETED|Treatment Period 4||7
6440124|NCT01093794|7354973|FG000|NOT COMPLETED|Treatment Period 4||0
6440125|NCT01093794|7354974|FG001|NOT COMPLETED|Treatment Period 4||0
6440126|NCT01093794|7354975|FG002|NOT COMPLETED|Treatment Period 4||0
6440127|NCT01093794|7354976|FG003|NOT COMPLETED|Treatment Period 4||0
6440128|NCT01093885|7354986|FG000|STARTED|Overall Study||15
6440129|NCT01093885|7354986|FG000|COMPLETED|Overall Study||10
6440130|NCT01093885|7354986|FG000|NOT COMPLETED|Overall Study||5
6440131|NCT01093976|7354991|FG000|STARTED|Overall Study||14
6440132|NCT01093976|7354991|FG000|COMPLETED|Overall Study||14
6440133|NCT01093976|7354991|FG000|NOT COMPLETED|Overall Study||0
6440134|NCT01094106|7354997|FG000|STARTED|Overall Study||33
6440135|NCT01094106|7354998|FG001|STARTED|Overall Study||34
6440136|NCT01094106|7354997|FG000|COMPLETED|Overall Study||33
6440137|NCT01094106|7354998|FG001|COMPLETED|Overall Study||34
6440138|NCT01094106|7354997|FG000|NOT COMPLETED|Overall Study||0
6440139|NCT01094106|7354998|FG001|NOT COMPLETED|Overall Study||0
6440140|NCT01094119|7355006|FG000|STARTED|Overall Study||34
6440141|NCT01094119|7355007|FG001|STARTED|Overall Study||36
6440142|NCT01094119|7355006|FG000|COMPLETED|Overall Study||32
6440143|NCT01094119|7355007|FG001|COMPLETED|Overall Study||32
6440144|NCT01094119|7355006|FG000|NOT COMPLETED|Overall Study||2
6440145|NCT01094119|7355007|FG001|NOT COMPLETED|Overall Study||4
6440146|NCT01094171|7355013|FG000|STARTED|Overall Study||400
6440147|NCT01094171|7355013|FG000|COMPLETED|Overall Study||390
6440148|NCT01094171|7355013|FG000|NOT COMPLETED|Overall Study||10
6440149|NCT01094184|7355019|FG000|STARTED|Overall Study||36
6440150|NCT01094184|7355020|FG001|STARTED|Overall Study||13
6440151|NCT01094184|7355019|FG000|COMPLETED|Overall Study||1
6440152|NCT01094184|7355020|FG001|COMPLETED|Overall Study||2
6440153|NCT01094184|7355019|FG000|NOT COMPLETED|Overall Study||35
6440154|NCT01094184|7355020|FG001|NOT COMPLETED|Overall Study||11
6440155|NCT01094288|7355034|FG000|STARTED|Overall Study||6
6440156|NCT01094288|7355035|FG001|STARTED|Overall Study||15
6440157|NCT01094288|7355036|FG002|STARTED|Overall Study||5
6440158|NCT01094288|7355037|FG003|STARTED|Overall Study||3
6440159|NCT01094288|7355038|FG004|STARTED|Overall Study||2
6440160|NCT01094288|7355039|FG005|STARTED|Overall Study||4
6440161|NCT01094288|7355040|FG006|STARTED|Overall Study||2
6440162|NCT01094288|7355041|FG007|STARTED|Overall Study||4
6440163|NCT01094288|7355034|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|4
6440164|NCT01094288|7355035|FG001|COMPLETED|Overall Study||5
6440165|NCT01094288|7355036|FG002|COMPLETED|Overall Study||1
6440166|NCT01094288|7355037|FG003|COMPLETED|Overall Study||1
6440167|NCT01094288|7355038|FG004|COMPLETED|Overall Study||2
6552935|NCT01740206|7475360|FG000|COMPLETED|Overall Study||14
6552936|NCT01740206|7475361|FG001|COMPLETED|Overall Study||34
6552937|NCT01740206|7475360|FG000|NOT COMPLETED|Overall Study||0
6552938|NCT01740206|7475361|FG001|NOT COMPLETED|Overall Study||0
6552939|NCT01740258|7475367|FG000|STARTED|Overall Study||68
6552940|NCT01740258|7475367|FG000|Entered Part A|Overall Study||68
6440168|NCT01094288|7355039|FG005|COMPLETED|Overall Study||4
6440169|NCT01094288|7355040|FG006|COMPLETED|Overall Study||2
6440170|NCT01094288|7355041|FG007|COMPLETED|Overall Study||2
6440171|NCT01094288|7355034|FG000|NOT COMPLETED|Overall Study||2
6440172|NCT01094288|7355035|FG001|NOT COMPLETED|Overall Study||10
6440173|NCT01094288|7355036|FG002|NOT COMPLETED|Overall Study||4
6440174|NCT01094288|7355037|FG003|NOT COMPLETED|Overall Study||2
6440175|NCT01094288|7355038|FG004|NOT COMPLETED|Overall Study||0
6440176|NCT01094288|7355039|FG005|NOT COMPLETED|Overall Study||0
6440177|NCT01094288|7355040|FG006|NOT COMPLETED|Overall Study||0
6440178|NCT01094288|7355041|FG007|NOT COMPLETED|Overall Study||2
6440179|NCT01094301|7355063|FG000|STARTED|Trial Stage||28
6440180|NCT01094301|7355063|FG000|Subjects Who Received Smartpatch Lead|Trial Stage||28
6552941|NCT01740258|7475367|FG000|Entered Part B|Overall Study||62
6552942|NCT01740258|7475367|FG000|Entered Part C|Overall Study||20
6440181|NCT01094301|7355063|FG000|COMPLETED|Trial Stage||27
6440182|NCT01094301|7355063|FG000|NOT COMPLETED|Trial Stage||1
6440183|NCT01094301|7355063|FG000|STARTED|Implant Stage||13
6440184|NCT01094301|7355063|FG000|Met Criteria for Implant Stage|Implant Stage||7
6440185|NCT01094301|7355063|FG000|Subjects Who Received SPR IPG|Implant Stage||5
6440186|NCT01094301|7355063|FG000|COMPLETED|Implant Stage||5
6440187|NCT01094301|7355063|FG000|NOT COMPLETED|Implant Stage||8
6440188|NCT01094522|7355071|FG000|STARTED|Overall Study||20
6440189|NCT01094522|7355072|FG001|STARTED|Overall Study||20
6440190|NCT01094522|7355071|FG000|COMPLETED|Overall Study||20
6440191|NCT01094522|7355072|FG001|COMPLETED|Overall Study||20
6440192|NCT01094522|7355071|FG000|NOT COMPLETED|Overall Study||0
6440193|NCT01094522|7355072|FG001|NOT COMPLETED|Overall Study||0
6440194|NCT01094548|7355081|FG000|STARTED|Overall Study||17
6440195|NCT01094548|7355082|FG001|STARTED|Overall Study||17
6440196|NCT01094548|7355081|FG000|COMPLETED|Overall Study||17
6440197|NCT01094548|7355082|FG001|COMPLETED|Overall Study||17
6440198|NCT01094548|7355081|FG000|NOT COMPLETED|Overall Study||0
6440199|NCT01094548|7355082|FG001|NOT COMPLETED|Overall Study||0
6440200|NCT01094574|7355096|FG000|STARTED|Overall Study||1
6440201|NCT01094574|7355097|FG001|STARTED|Overall Study||1
6440202|NCT01094574|7355098|FG002|STARTED|Overall Study||2
6440203|NCT01094574|7355099|FG003|STARTED|Overall Study||2
6440204|NCT01094574|7355100|FG004|STARTED|Overall Study||2
6440205|NCT01094574|7355101|FG005|STARTED|Overall Study||2
6440206|NCT01094574|7355096|FG000|COMPLETED|Overall Study||1
6440207|NCT01094574|7355097|FG001|COMPLETED|Overall Study||1
6440208|NCT01094574|7355098|FG002|COMPLETED|Overall Study||2
6440209|NCT01094574|7355099|FG003|COMPLETED|Overall Study||2
6440210|NCT01094574|7355100|FG004|COMPLETED|Overall Study||2
6440211|NCT01094574|7355101|FG005|COMPLETED|Overall Study||2
6440212|NCT01094574|7355096|FG000|NOT COMPLETED|Overall Study||0
6440213|NCT01094574|7355097|FG001|NOT COMPLETED|Overall Study||0
6440214|NCT01094574|7355098|FG002|NOT COMPLETED|Overall Study||0
6440215|NCT01094574|7355099|FG003|NOT COMPLETED|Overall Study||0
6440216|NCT01094574|7355100|FG004|NOT COMPLETED|Overall Study||0
6440217|NCT01094574|7355101|FG005|NOT COMPLETED|Overall Study||0
6440218|NCT01094704|7355114|FG000|STARTED|Overall Study||8
6440219|NCT01094704|7355115|FG001|STARTED|Overall Study||8
6440220|NCT01094704|7355114|FG000|COMPLETED|Overall Study||8
6440221|NCT01094704|7355115|FG001|COMPLETED|Overall Study||8
6440222|NCT01094704|7355114|FG000|NOT COMPLETED|Overall Study||0
6440223|NCT01094704|7355115|FG001|NOT COMPLETED|Overall Study||0
6440224|NCT01094717|7355123|FG000|STARTED|Overall Study||3
6440225|NCT01094717|7355124|FG001|STARTED|Overall Study||10
6440226|NCT01094717|7355123|FG000|COMPLETED|Overall Study||3
6440227|NCT01094717|7355124|FG001|COMPLETED|Overall Study||10
6440228|NCT01094717|7355123|FG000|NOT COMPLETED|Overall Study||0
6440229|NCT01094717|7355124|FG001|NOT COMPLETED|Overall Study||0
6440230|NCT01094730|7355140|FG000|STARTED|Period 1 (14 Days)||92
6440231|NCT01094730|7355141|FG001|STARTED|Period 1 (14 Days)||88
6440232|NCT01094730|7355140|FG000|COMPLETED|Period 1 (14 Days)||90
6440233|NCT01094730|7355141|FG001|COMPLETED|Period 1 (14 Days)||86
6440234|NCT01094730|7355140|FG000|NOT COMPLETED|Period 1 (14 Days)||2
6440235|NCT01094730|7355141|FG001|NOT COMPLETED|Period 1 (14 Days)||2
6440236|NCT01094730|7355140|FG000|STARTED|Period 2 (14 Days)||90
6440237|NCT01094730|7355141|FG001|STARTED|Period 2 (14 Days)||86
6440238|NCT01094730|7355140|FG000|COMPLETED|Period 2 (14 Days)||87
6440239|NCT01094730|7355141|FG001|COMPLETED|Period 2 (14 Days)||84
6440240|NCT01094730|7355140|FG000|NOT COMPLETED|Period 2 (14 Days)||3
6440241|NCT01094730|7355141|FG001|NOT COMPLETED|Period 2 (14 Days)||2
6440242|NCT01094743|7355148|FG000|STARTED|Period 1||52
6440243|NCT01094743|7355148|FG000|COMPLETED|Period 1||50
6440244|NCT01094743|7355148|FG000|NOT COMPLETED|Period 1||2
6440245|NCT01094743|7355148|FG000|STARTED|Period 2||50
6440246|NCT01094743|7355148|FG000|COMPLETED|Period 2||50
6440247|NCT01094743|7355148|FG000|NOT COMPLETED|Period 2||0
6440248|NCT01094782|7355159|FG000|STARTED|Overall Study||39
6440249|NCT01094782|7355160|FG001|STARTED|Overall Study||39
6440250|NCT01094782|7355161|FG002|STARTED|Overall Study||34
6440251|NCT01094782|7355162|FG003|STARTED|Overall Study||56
6440252|NCT01094782|7355163|FG004|STARTED|Overall Study||42
6440253|NCT01094782|7355164|FG005|STARTED|Overall Study||38
6440254|NCT01094782|7355159|FG000|COMPLETED|Overall Study||31
6440255|NCT01094782|7355160|FG001|COMPLETED|Overall Study||29
6440256|NCT01094782|7355161|FG002|COMPLETED|Overall Study||31
6440257|NCT01094782|7355162|FG003|COMPLETED|Overall Study||45
6440258|NCT01094782|7355163|FG004|COMPLETED|Overall Study||31
6440259|NCT01094782|7355164|FG005|COMPLETED|Overall Study||30
6440260|NCT01094782|7355159|FG000|NOT COMPLETED|Overall Study||8
6440261|NCT01094782|7355160|FG001|NOT COMPLETED|Overall Study||10
6440262|NCT01094782|7355161|FG002|NOT COMPLETED|Overall Study||3
6440263|NCT01094782|7355162|FG003|NOT COMPLETED|Overall Study||11
6440264|NCT01094782|7355163|FG004|NOT COMPLETED|Overall Study||11
6440265|NCT01094782|7355164|FG005|NOT COMPLETED|Overall Study||8
6440266|NCT01094808|7355181|FG000|STARTED|Overall Study||21
6440267|NCT01094808|7355182|FG001|STARTED|Overall Study||20
6440268|NCT01094808|7355183|FG002|STARTED|Overall Study||21
6440269|NCT01094808|7355181|FG000|COMPLETED|Overall Study||20
6440270|NCT01094808|7355182|FG001|COMPLETED|Overall Study||19
6440271|NCT01094808|7355183|FG002|COMPLETED|Overall Study||21
6440272|NCT01094808|7355181|FG000|NOT COMPLETED|Overall Study||1
6440273|NCT01094808|7355182|FG001|NOT COMPLETED|Overall Study||1
6440274|NCT01094808|7355183|FG002|NOT COMPLETED|Overall Study||0
6440275|NCT01094886|7355191|FG000|STARTED|Overall Study||53
6440276|NCT01094886|7355191|FG000|COMPLETED|Overall Study||46
6440277|NCT01094886|7355191|FG000|NOT COMPLETED|Overall Study||7
6440284|NCT01095094|7355206|FG000|STARTED|Overall Study||19
6440285|NCT01095094|7355206|FG000|COMPLETED|Overall Study||16
6440286|NCT01095094|7355206|FG000|NOT COMPLETED|Overall Study||3
6440287|NCT01095497|7355212|FG000|STARTED|Intravenous CINRYZE||14
6440288|NCT01095497|7355213|FG001|STARTED|Intravenous CINRYZE||12
6440289|NCT01095497|7355212|FG000|COMPLETED|Intravenous CINRYZE||13
6440290|NCT01095497|7355213|FG001|COMPLETED|Intravenous CINRYZE||12
6440291|NCT01095497|7355212|FG000|NOT COMPLETED|Intravenous CINRYZE||1
6440292|NCT01095497|7355213|FG001|NOT COMPLETED|Intravenous CINRYZE||0
6440293|NCT01095497|7355212|FG000|STARTED|Subcutaneous CINRYZE||13
6440294|NCT01095497|7355213|FG001|STARTED|Subcutaneous CINRYZE||12
6440295|NCT01095497|7355212|FG000|COMPLETED|Subcutaneous CINRYZE||12
6440296|NCT01095497|7355213|FG001|COMPLETED|Subcutaneous CINRYZE||12
6440297|NCT01095497|7355212|FG000|NOT COMPLETED|Subcutaneous CINRYZE||1
6440298|NCT01095497|7355213|FG001|NOT COMPLETED|Subcutaneous CINRYZE||0
6440299|NCT01095510|7355227|FG000|STARTED|Overall Study||3
6440300|NCT01095510|7355228|FG001|STARTED|Overall Study||0
6440301|NCT01095510|7355229|FG002|STARTED|Overall Study||3
6440302|NCT01095510|7355230|FG003|STARTED|Overall Study||3
6440303|NCT01095510|7355227|FG000|COMPLETED|Overall Study||3
6440304|NCT01095510|7355228|FG001|COMPLETED|Overall Study||0
6440305|NCT01095510|7355229|FG002|COMPLETED|Overall Study||3
6440306|NCT01095510|7355230|FG003|COMPLETED|Overall Study||3
6440307|NCT01095510|7355227|FG000|NOT COMPLETED|Overall Study||0
6440308|NCT01095510|7355228|FG001|NOT COMPLETED|Overall Study||0
6440309|NCT01095510|7355229|FG002|NOT COMPLETED|Overall Study||0
6440310|NCT01095510|7355230|FG003|NOT COMPLETED|Overall Study||0
6440311|NCT01095653|7355241|FG000|STARTED|Overall Study||132
6440312|NCT01095653|7355242|FG001|STARTED|Overall Study||128
6440313|NCT01095653|7355243|FG002|STARTED|Overall Study||133
6440314|NCT01095653|7355241|FG000|COMPLETED|Overall Study||113
6440315|NCT01095653|7355242|FG001|COMPLETED|Overall Study||113
6440316|NCT01095653|7355243|FG002|COMPLETED|Overall Study||117
6440317|NCT01095653|7355241|FG000|NOT COMPLETED|Overall Study||19
6440318|NCT01095653|7355242|FG001|NOT COMPLETED|Overall Study||15
6440319|NCT01095653|7355243|FG002|NOT COMPLETED|Overall Study||16
6440320|NCT01095666|7355254|FG000|STARTED|Overall Study||145
6440321|NCT01095666|7355255|FG001|STARTED|Overall Study||147
6440322|NCT01095666|7355256|FG002|STARTED|Overall Study||152
6440323|NCT01095666|7355254|FG000|COMPLETED|Overall Study||128
6440324|NCT01095666|7355255|FG001|COMPLETED|Overall Study||136
6440325|NCT01095666|7355256|FG002|COMPLETED|Overall Study||145
6440326|NCT01095666|7355254|FG000|NOT COMPLETED|Overall Study||17
6440327|NCT01095666|7355255|FG001|NOT COMPLETED|Overall Study||11
6440328|NCT01095666|7355256|FG002|NOT COMPLETED|Overall Study||7
6440329|NCT01095757|7355264|FG000|STARTED|Overall Study||45
6440330|NCT01095757|7355264|FG000|COMPLETED|Overall Study||45
6440331|NCT01095757|7355264|FG000|NOT COMPLETED|Overall Study||0
6440332|NCT01095796|7355271|FG000|STARTED|Overall Study||353
6440333|NCT01095796|7355272|FG001|STARTED|Overall Study||354
6440334|NCT01095796|7355271|FG000|COMPLETED|Overall Study||58
6440335|NCT01095796|7355272|FG001|COMPLETED|Overall Study||65
6440336|NCT01095796|7355271|FG000|NOT COMPLETED|Overall Study||295
6440337|NCT01095796|7355272|FG001|NOT COMPLETED|Overall Study||289
6440338|NCT01095835|7355281|FG000|STARTED|Overall Study||51
6440339|NCT01095835|7355282|FG001|STARTED|Overall Study||52
6440340|NCT01095835|7355283|FG002|STARTED|Overall Study||25
6440341|NCT01095835|7355281|FG000|COMPLETED|Overall Study||41
6440342|NCT01095835|7355282|FG001|COMPLETED|Overall Study||40
6440343|NCT01095835|7355283|FG002|COMPLETED|Overall Study||17
6440344|NCT01095835|7355281|FG000|NOT COMPLETED|Overall Study||10
6440345|NCT01095835|7355282|FG001|NOT COMPLETED|Overall Study||12
6440346|NCT01095835|7355283|FG002|NOT COMPLETED|Overall Study||8
6440347|NCT01095887|7355292|FG000|STARTED|Overall Study||6
6440348|NCT01095887|7355292|FG000|COMPLETED|Overall Study||6
6440349|NCT01095887|7355292|FG000|NOT COMPLETED|Overall Study||0
6440350|NCT01095978|7355296|FG000|STARTED|Overall Study||2822
6440351|NCT01095978|7355296|FG000|COMPLETED|Overall Study||2819
6440352|NCT01095978|7355296|FG000|NOT COMPLETED|Overall Study||3
6440353|NCT01096017|7355302|FG000|STARTED|Treatment Period 1||12
6440354|NCT01096017|7355303|FG001|STARTED|Treatment Period 1||12
6440355|NCT01096017|7355302|FG000|COMPLETED|Treatment Period 1||12
6440356|NCT01096017|7355303|FG001|COMPLETED|Treatment Period 1||12
6440357|NCT01096017|7355302|FG000|NOT COMPLETED|Treatment Period 1||0
6440358|NCT01096017|7355303|FG001|NOT COMPLETED|Treatment Period 1||0
6440359|NCT01096017|7355302|FG000|STARTED|Washout 1 - 14 Days||12
6440360|NCT01096017|7355303|FG001|STARTED|Washout 1 - 14 Days||12
6440361|NCT01096017|7355302|FG000|COMPLETED|Washout 1 - 14 Days||12
6440362|NCT01096017|7355303|FG001|COMPLETED|Washout 1 - 14 Days||12
6440363|NCT01096017|7355302|FG000|NOT COMPLETED|Washout 1 - 14 Days||0
6440364|NCT01096017|7355303|FG001|NOT COMPLETED|Washout 1 - 14 Days||0
6440365|NCT01096017|7355302|FG000|STARTED|Treatment Period 2||12
6440366|NCT01096017|7355303|FG001|STARTED|Treatment Period 2||12
6440367|NCT01096017|7355302|FG000|COMPLETED|Treatment Period 2||11
6440368|NCT01096017|7355303|FG001|COMPLETED|Treatment Period 2||11
6440369|NCT01096017|7355302|FG000|NOT COMPLETED|Treatment Period 2||1
6440370|NCT01096017|7355303|FG001|NOT COMPLETED|Treatment Period 2||1
6440371|NCT01096056|7355311|FG000|STARTED|Overall Study||20
6440372|NCT01096056|7355312|FG001|STARTED|Overall Study||20
6440373|NCT01096056|7355311|FG000|Completed at Day 42|Overall Study||20
6440374|NCT01096056|7355312|FG001|Completed at Day 42|Overall Study||20
6440375|NCT01096056|7355311|FG000|COMPLETED|Overall Study||20
6440376|NCT01096056|7355312|FG001|COMPLETED|Overall Study||19
6440377|NCT01096056|7355311|FG000|NOT COMPLETED|Overall Study||0
6440378|NCT01096056|7355312|FG001|NOT COMPLETED|Overall Study||1
6440379|NCT01096160|7355328|FG000|STARTED|Overall Study||6
6440380|NCT01096160|7355329|FG001|STARTED|Overall Study||2
6440381|NCT01096160|7355330|FG002|STARTED|Overall Study||6
6440382|NCT01096160|7355331|FG003|STARTED|Overall Study||2
6440383|NCT01096160|7355332|FG004|STARTED|Overall Study||6
6440384|NCT01096160|7355333|FG005|STARTED|Overall Study||2
6440385|NCT01096160|7355334|FG006|STARTED|Overall Study||6
6440386|NCT01096160|7355335|FG007|STARTED|Overall Study||2
6440387|NCT01096160|7355336|FG008|STARTED|Overall Study||6
6440388|NCT01096160|7355337|FG009|STARTED|Overall Study||2
6440389|NCT01096160|7355328|FG000|COMPLETED|Overall Study||6
6440390|NCT01096160|7355329|FG001|COMPLETED|Overall Study||2
6440391|NCT01096160|7355330|FG002|COMPLETED|Overall Study||5
6440392|NCT01096160|7355331|FG003|COMPLETED|Overall Study||2
6440393|NCT01096160|7355332|FG004|COMPLETED|Overall Study||5
6440394|NCT01096160|7355333|FG005|COMPLETED|Overall Study||2
6440395|NCT01096160|7355334|FG006|COMPLETED|Overall Study||4
6440396|NCT01096160|7355335|FG007|COMPLETED|Overall Study||2
6440397|NCT01096160|7355336|FG008|COMPLETED|Overall Study||4
6440398|NCT01096160|7355337|FG009|COMPLETED|Overall Study||1
6440399|NCT01096160|7355328|FG000|NOT COMPLETED|Overall Study||0
6440400|NCT01096160|7355329|FG001|NOT COMPLETED|Overall Study||0
6440401|NCT01096160|7355330|FG002|NOT COMPLETED|Overall Study||1
6440402|NCT01096160|7355331|FG003|NOT COMPLETED|Overall Study||0
6440403|NCT01096160|7355332|FG004|NOT COMPLETED|Overall Study||1
6440404|NCT01096160|7355333|FG005|NOT COMPLETED|Overall Study||0
6440405|NCT01096160|7355334|FG006|NOT COMPLETED|Overall Study||2
6440406|NCT01096160|7355335|FG007|NOT COMPLETED|Overall Study||0
6440407|NCT01096160|7355336|FG008|NOT COMPLETED|Overall Study||2
6440408|NCT01096160|7355337|FG009|NOT COMPLETED|Overall Study||1
6440409|NCT01096186|7355372|FG000|STARTED|Overall Study||617
6440410|NCT01096186|7355372|FG000|COMPLETED|Overall Study||567
6440411|NCT01096186|7355372|FG000|NOT COMPLETED|Overall Study||50
6440412|NCT01096290|7355378|FG000|STARTED|Overall Study||9
6440413|NCT01096290|7355379|FG001|STARTED|Overall Study||14
6440414|NCT01096290|7355378|FG000|COMPLETED|Overall Study||9
6440415|NCT01096290|7355379|FG001|COMPLETED|Overall Study||14
6440416|NCT01096290|7355378|FG000|NOT COMPLETED|Overall Study||0
6440417|NCT01096290|7355379|FG001|NOT COMPLETED|Overall Study||0
6440418|NCT01096316|7355387|FG000|STARTED|Overall Study||102
6440419|NCT01096316|7355388|FG001|STARTED|Overall Study||103
6440420|NCT01096316|7355387|FG000|COMPLETED|Overall Study||87
6440421|NCT01096316|7355388|FG001|COMPLETED|Overall Study||94
6440422|NCT01096316|7355387|FG000|NOT COMPLETED|Overall Study||15
6440423|NCT01096316|7355388|FG001|NOT COMPLETED|Overall Study||9
6440424|NCT01096342|7355394|FG000|STARTED|Overall Study||16
6440425|NCT01096342|7355394|FG000|COMPLETED|Overall Study||15
6440426|NCT01096342|7355394|FG000|NOT COMPLETED|Overall Study||1
6440427|NCT01096446|7355400|FG000|STARTED|Overall Study||12
6440428|NCT01096446|7355401|FG001|STARTED|Overall Study||10
6440429|NCT01096446|7355400|FG000|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
6440430|NCT01096446|7355401|FG001|COMPLETED|Overall Study||10
6440431|NCT01096446|7355400|FG000|NOT COMPLETED|Overall Study||3
6440432|NCT01096446|7355401|FG001|NOT COMPLETED|Overall Study||0
6440433|NCT01096550|7355408|FG000|STARTED|Overall Study||170
6440434|NCT01096550|7355409|FG001|STARTED|Overall Study||175
6440435|NCT01096550|7355408|FG000|COMPLETED|Overall Study||133
6440436|NCT01096550|7355409|FG001|COMPLETED|Overall Study||146
6440437|NCT01096550|7355408|FG000|NOT COMPLETED|Overall Study||37
6440438|NCT01096550|7355409|FG001|NOT COMPLETED|Overall Study||29
6440439|NCT01096589|7355419|FG000|STARTED|Overall Study||22
6440440|NCT01096589|7355420|FG001|STARTED|Overall Study||20
6440441|NCT01096589|7355421|FG002|STARTED|Overall Study||22
6440442|NCT01096589|7355422|FG003|STARTED|Overall Study||18
6440443|NCT01096589|7355419|FG000|COMPLETED|Overall Study||18
6440444|NCT01096589|7355420|FG001|COMPLETED|Overall Study||18
6440445|NCT01096589|7355421|FG002|COMPLETED|Overall Study||18
6440446|NCT01096589|7355422|FG003|COMPLETED|Overall Study||15
6440447|NCT01096589|7355419|FG000|NOT COMPLETED|Overall Study||4
6440448|NCT01096589|7355420|FG001|NOT COMPLETED|Overall Study||2
6440449|NCT01096589|7355421|FG002|NOT COMPLETED|Overall Study||4
6440450|NCT01096589|7355422|FG003|NOT COMPLETED|Overall Study||3
6440451|NCT01096667|7355441|FG000|STARTED|Overall Study||39
6440452|NCT01096667|7355442|FG001|STARTED|Overall Study||39
6440453|NCT01096667|7355443|FG002|STARTED|Overall Study||38
6440454|NCT01096667|7355444|FG003|STARTED|Overall Study||39
6440455|NCT01096667|7355445|FG004|STARTED|Overall Study||39
6440456|NCT01096667|7355441|FG000|Treated|Overall Study||38
6440457|NCT01096667|7355442|FG001|Treated|Overall Study||39
6440458|NCT01096667|7355443|FG002|Treated|Overall Study||38
6440459|NCT01096667|7355444|FG003|Treated|Overall Study||39
6440460|NCT01096667|7355445|FG004|Treated|Overall Study||39
6440461|NCT01096667|7355441|FG000|COMPLETED|Overall Study||36
6440462|NCT01096667|7355442|FG001|COMPLETED|Overall Study||37
6440463|NCT01096667|7355443|FG002|COMPLETED|Overall Study||36
6440464|NCT01096667|7355444|FG003|COMPLETED|Overall Study||36
6440465|NCT01096667|7355445|FG004|COMPLETED|Overall Study||39
6440466|NCT01096667|7355441|FG000|NOT COMPLETED|Overall Study||3
6440467|NCT01096667|7355442|FG001|NOT COMPLETED|Overall Study||2
6440468|NCT01096667|7355443|FG002|NOT COMPLETED|Overall Study||2
6440469|NCT01096667|7355444|FG003|NOT COMPLETED|Overall Study||3
6440470|NCT01096667|7355445|FG004|NOT COMPLETED|Overall Study||0
6440471|NCT01096680|7355463|FG000|STARTED|Overall Study||27
6440472|NCT01096680|7355464|FG001|STARTED|Overall Study||27
6440473|NCT01096680|7355465|FG002|STARTED|Overall Study||27
6440474|NCT01096680|7355466|FG003|STARTED|Overall Study||27
6440475|NCT01096680|7355467|FG004|STARTED|Overall Study||27
6440476|NCT01096680|7355463|FG000|COMPLETED|Overall Study||27
6440477|NCT01096680|7355464|FG001|COMPLETED|Overall Study||27
6440478|NCT01096680|7355465|FG002|COMPLETED|Overall Study||27
6440479|NCT01096680|7355466|FG003|COMPLETED|Overall Study||27
6440480|NCT01096680|7355467|FG004|COMPLETED|Overall Study||27
6440481|NCT01096680|7355463|FG000|NOT COMPLETED|Overall Study||0
6440482|NCT01096680|7355464|FG001|NOT COMPLETED|Overall Study||0
6440483|NCT01096680|7355465|FG002|NOT COMPLETED|Overall Study||0
6440484|NCT01096680|7355466|FG003|NOT COMPLETED|Overall Study||0
6440485|NCT01096680|7355467|FG004|NOT COMPLETED|Overall Study||0
6440486|NCT01096771|7355481|FG000|STARTED|Overall Study||7
6440487|NCT01096771|7355482|FG001|STARTED|Overall Study||7
6440488|NCT01096771|7355481|FG000|COMPLETED|Overall Study||7
6440489|NCT01096771|7355482|FG001|COMPLETED|Overall Study||7
6440490|NCT01096771|7355481|FG000|NOT COMPLETED|Overall Study||0
6440491|NCT01096771|7355482|FG001|NOT COMPLETED|Overall Study||0
6440492|NCT01096784|7355490|FG000|STARTED|Overall Study||61
6440493|NCT01096784|7355491|FG001|STARTED|Overall Study||60
6440494|NCT01096784|7355490|FG000|COMPLETED|Overall Study||46
6440495|NCT01096784|7355491|FG001|COMPLETED|Overall Study||46
6440496|NCT01096784|7355490|FG000|NOT COMPLETED|Overall Study||15
6440497|NCT01096784|7355491|FG001|NOT COMPLETED|Overall Study||14
6440498|NCT01096810|7355499|FG000|STARTED|Overall Study||20
6440499|NCT01096810|7355499|FG000|COMPLETED|Overall Study||20
6440500|NCT01096810|7355499|FG000|NOT COMPLETED|Overall Study||0
6440501|NCT01096823|7355505|FG000|STARTED|Overall Study||14
6440502|NCT01096823|7355506|FG001|STARTED|Overall Study||16
6440503|NCT01096823|7355505|FG000|COMPLETED|Overall Study||11
6440504|NCT01096823|7355506|FG001|COMPLETED|Overall Study||15
6440505|NCT01096823|7355505|FG000|NOT COMPLETED|Overall Study||3
6440506|NCT01096823|7355506|FG001|NOT COMPLETED|Overall Study||1
6440507|NCT01096849|7355515|FG000|STARTED|Overall Study||22
6440508|NCT01096849|7355516|FG001|STARTED|Overall Study||76
6440509|NCT01096849|7355517|FG002|STARTED|Overall Study||47
6440510|NCT01096849|7355515|FG000|COMPLETED|Overall Study||20
6440511|NCT01096849|7355516|FG001|COMPLETED|Overall Study||64
6440512|NCT01096849|7355517|FG002|COMPLETED|Overall Study||41
6440513|NCT01096849|7355515|FG000|NOT COMPLETED|Overall Study||2
6440514|NCT01096849|7355516|FG001|NOT COMPLETED|Overall Study||12
6440515|NCT01096849|7355517|FG002|NOT COMPLETED|Overall Study||6
6440516|NCT01096875|7355527|FG000|STARTED|Overall Study||30
6440517|NCT01096875|7355528|FG001|STARTED|Overall Study||30
6440518|NCT01096875|7355527|FG000|COMPLETED|Overall Study||30
6440519|NCT01096875|7355528|FG001|COMPLETED|Overall Study||29
6440520|NCT01096875|7355527|FG000|NOT COMPLETED|Overall Study||0
6440521|NCT01096875|7355528|FG001|NOT COMPLETED|Overall Study||1
6440522|NCT01096992|7355541|FG000|STARTED|Overall Study||6
6440523|NCT01096992|7355542|FG001|STARTED|Overall Study||3
6440524|NCT01096992|7355543|FG002|STARTED|Overall Study||6
6440525|NCT01096992|7355544|FG003|STARTED|Overall Study||6
6440526|NCT01096992|7355545|FG004|STARTED|Overall Study||30
6440527|NCT01096992|7355541|FG000|COMPLETED|Overall Study||6
6440528|NCT01096992|7355542|FG001|COMPLETED|Overall Study||3
6440529|NCT01096992|7355543|FG002|COMPLETED|Overall Study||6
6440530|NCT01096992|7355544|FG003|COMPLETED|Overall Study||6
6440531|NCT01096992|7355545|FG004|COMPLETED|Overall Study||30
6440532|NCT01096992|7355541|FG000|NOT COMPLETED|Overall Study||0
6440533|NCT01096992|7355542|FG001|NOT COMPLETED|Overall Study||0
6440534|NCT01096992|7355543|FG002|NOT COMPLETED|Overall Study||0
6440535|NCT01096992|7355544|FG003|NOT COMPLETED|Overall Study||0
6440536|NCT01096992|7355545|FG004|NOT COMPLETED|Overall Study||0
6440537|NCT01097044|7355560|FG000|STARTED|Overall Study||39
6440538|NCT01097044|7355561|FG001|STARTED|Overall Study||38
6440539|NCT01097044|7355560|FG000|COMPLETED|Overall Study||34
6440540|NCT01097044|7355561|FG001|COMPLETED|Overall Study||33
6440541|NCT01097044|7355560|FG000|NOT COMPLETED|Overall Study||5
6440542|NCT01097044|7355561|FG001|NOT COMPLETED|Overall Study||5
6440543|NCT01097057|7355569|FG000|STARTED|Overall Study||20
6440544|NCT01097057|7355569|FG000|COMPLETED|Overall Study||17
6440545|NCT01097057|7355569|FG000|NOT COMPLETED|Overall Study||3
6440546|NCT01097304|7355573|FG000|STARTED|Overall Study||36
6440547|NCT01097304|7355573|FG000|COMPLETED|Overall Study||29
6440548|NCT01097304|7355573|FG000|NOT COMPLETED|Overall Study||7
6440549|NCT01097330|7355580|FG000|STARTED|Overall Study||7
6440550|NCT01097330|7355581|FG001|STARTED|Overall Study||5
6440551|NCT01097330|7355580|FG000|COMPLETED|Overall Study||0
6440552|NCT01097330|7355581|FG001|COMPLETED|Overall Study||0
6440553|NCT01097330|7355580|FG000|NOT COMPLETED|Overall Study||7
6440554|NCT01097330|7355581|FG001|NOT COMPLETED|Overall Study||5
6440555|NCT01097343|7355587|FG000|STARTED|First Intervention- 30 Days||25
6440556|NCT01097343|7355588|FG001|STARTED|First Intervention- 30 Days||25
6440557|NCT01097343|7355587|FG000|COMPLETED|First Intervention- 30 Days||25
6440558|NCT01097343|7355588|FG001|COMPLETED|First Intervention- 30 Days||25
6440559|NCT01097343|7355587|FG000|NOT COMPLETED|First Intervention- 30 Days||0
6440560|NCT01097343|7355588|FG001|NOT COMPLETED|First Intervention- 30 Days||0
6440561|NCT01097343|7355587|FG000|STARTED|Second Intervention- 30 Days||25
6440562|NCT01097343|7355588|FG001|STARTED|Second Intervention- 30 Days||25
6440563|NCT01097343|7355587|FG000|COMPLETED|Second Intervention- 30 Days||25
6440564|NCT01097343|7355588|FG001|COMPLETED|Second Intervention- 30 Days||25
6440565|NCT01097343|7355587|FG000|NOT COMPLETED|Second Intervention- 30 Days||0
6440566|NCT01097343|7355588|FG001|NOT COMPLETED|Second Intervention- 30 Days||0
6440567|NCT01097395|7355596|FG000|STARTED|Overall Study||17
6440568|NCT01097395|7355597|FG001|STARTED|Overall Study||18
6440569|NCT01097395|7355596|FG000|COMPLETED|Overall Study||14
6440570|NCT01097395|7355597|FG001|COMPLETED|Overall Study||14
6440571|NCT01097395|7355596|FG000|NOT COMPLETED|Overall Study||3
6440572|NCT01097395|7355597|FG001|NOT COMPLETED|Overall Study||4
6440573|NCT01097421|7355603|FG000|STARTED|Overall Study||328
6440574|NCT01097421|7355603|FG000|COMPLETED|Overall Study||314
6440575|NCT01097421|7355603|FG000|NOT COMPLETED|Overall Study||14
6440576|NCT01097460|7355607|FG000|STARTED|Overall Study||16
6440577|NCT01097460|7355607|FG000|COMPLETED|Overall Study||16
6440578|NCT01097460|7355607|FG000|NOT COMPLETED|Overall Study||0
6440579|NCT01097577|7355613|FG000|STARTED|Overall Study||67
6440580|NCT01097577|7355614|FG001|STARTED|Overall Study||63
6440581|NCT01097577|7355613|FG000|COMPLETED|Overall Study||67
6440582|NCT01097577|7355614|FG001|COMPLETED|Overall Study||62
6440583|NCT01097577|7355613|FG000|NOT COMPLETED|Overall Study||0
6440584|NCT01097577|7355614|FG001|NOT COMPLETED|Overall Study||1
6440585|NCT01097616|7355623|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
6440586|NCT01097616|7355624|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
6440587|NCT01097616|7355625|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
6440588|NCT01097616|7355626|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440589|NCT01097616|7355627|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440590|NCT01097616|7355628|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440591|NCT01097616|7355629|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440592|NCT01097616|7355630|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440593|NCT01097616|7355623|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
6440594|NCT01097616|7355624|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
6440595|NCT01097616|7355625|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
6440596|NCT01097616|7355626|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440597|NCT01097616|7355627|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440598|NCT01097616|7355628|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440599|NCT01097616|7355629|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440600|NCT01097616|7355630|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440601|NCT01097616|7355623|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
6440602|NCT01097616|7355624|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
6440603|NCT01097616|7355625|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
6440604|NCT01097616|7355626|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440605|NCT01097616|7355627|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440606|NCT01097616|7355628|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440607|NCT01097616|7355629|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440608|NCT01097616|7355630|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440609|NCT01097616|7355623|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
6440610|NCT01097616|7355624|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
6440611|NCT01097616|7355625|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
6440612|NCT01097616|7355626|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440613|NCT01097616|7355627|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440614|NCT01097616|7355628|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440615|NCT01097616|7355629|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440616|NCT01097616|7355630|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440617|NCT01097616|7355623|FG000|STARTED|Optional DB EXT Phase||100
6440618|NCT01097616|7355624|FG001|STARTED|Optional DB EXT Phase||172
6440619|NCT01097616|7355625|FG002|STARTED|Optional DB EXT Phase||151
6440620|NCT01097616|7355626|FG003|STARTED|Optional DB EXT Phase||0
6440621|NCT01097616|7355627|FG004|STARTED|Optional DB EXT Phase||0
6440622|NCT01097616|7355628|FG005|STARTED|Optional DB EXT Phase||0
6440623|NCT01097616|7355629|FG006|STARTED|Optional DB EXT Phase||0
6440624|NCT01097616|7355630|FG007|STARTED|Optional DB EXT Phase||0
6552943|NCT01740258|7475367|FG000|Entered Part D|Overall Study||42
6552944|NCT01740258|7475367|FG000|COMPLETED|Overall Study||68
6552945|NCT01740258|7475367|FG000|NOT COMPLETED|Overall Study||0
6552946|NCT01740323|7475373|FG000|STARTED|Overall Study||15
6552947|NCT01740323|7475374|FG001|STARTED|Overall Study||15
6552948|NCT01740323|7475373|FG000|COMPLETED|Overall Study||13
6440625|NCT01097616|7355623|FG000|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
6440626|NCT01097616|7355624|FG001|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
6440627|NCT01097616|7355625|FG002|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
6440628|NCT01097616|7355626|FG003|COMPLETED|Optional DB EXT Phase||0
6440629|NCT01097616|7355627|FG004|COMPLETED|Optional DB EXT Phase||0
6440630|NCT01097616|7355628|FG005|COMPLETED|Optional DB EXT Phase||0
6440631|NCT01097616|7355629|FG006|COMPLETED|Optional DB EXT Phase||0
6440632|NCT01097616|7355630|FG007|COMPLETED|Optional DB EXT Phase||0
6440633|NCT01097616|7355623|FG000|NOT COMPLETED|Optional DB EXT Phase||15
6440634|NCT01097616|7355624|FG001|NOT COMPLETED|Optional DB EXT Phase||21
6440635|NCT01097616|7355625|FG002|NOT COMPLETED|Optional DB EXT Phase||10
6440636|NCT01097616|7355626|FG003|NOT COMPLETED|Optional DB EXT Phase||0
6440637|NCT01097616|7355627|FG004|NOT COMPLETED|Optional DB EXT Phase||0
6440638|NCT01097616|7355628|FG005|NOT COMPLETED|Optional DB EXT Phase||0
6440639|NCT01097616|7355629|FG006|NOT COMPLETED|Optional DB EXT Phase||0
6440640|NCT01097616|7355630|FG007|NOT COMPLETED|Optional DB EXT Phase||0
6440641|NCT01097616|7355623|FG000|STARTED|DB RO Phase||0
6552949|NCT01740323|7475374|FG001|COMPLETED|Overall Study||15
6440642|NCT01097616|7355624|FG001|STARTED|DB RO Phase||0
6440643|NCT01097616|7355625|FG002|STARTED|DB RO Phase||0
6440644|NCT01097616|7355626|FG003|STARTED|DB RO Phase||101
6552950|NCT01740323|7475373|FG000|NOT COMPLETED|Overall Study||2
6552951|NCT01740323|7475374|FG001|NOT COMPLETED|Overall Study||0
6552952|NCT01740362|7475384|FG000|STARTED|Overall Study||6
6440645|NCT01097616|7355627|FG004|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
6440646|NCT01097616|7355628|FG005|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
6440647|NCT01097616|7355629|FG006|STARTED|DB RO Phase||162
6440648|NCT01097616|7355630|FG007|STARTED|DB RO Phase||327
6440649|NCT01097616|7355623|FG000|COMPLETED|DB RO Phase||0
6440650|NCT01097616|7355624|FG001|COMPLETED|DB RO Phase||0
6440651|NCT01097616|7355625|FG002|COMPLETED|DB RO Phase||0
6440652|NCT01097616|7355626|FG003|COMPLETED|DB RO Phase||100
6440653|NCT01097616|7355627|FG004|COMPLETED|DB RO Phase||111
6440654|NCT01097616|7355628|FG005|COMPLETED|DB RO Phase||159
6440655|NCT01097616|7355629|FG006|COMPLETED|DB RO Phase||161
6440656|NCT01097616|7355630|FG007|COMPLETED|DB RO Phase||326
6440657|NCT01097616|7355623|FG000|NOT COMPLETED|DB RO Phase||0
6440658|NCT01097616|7355624|FG001|NOT COMPLETED|DB RO Phase||0
6440659|NCT01097616|7355625|FG002|NOT COMPLETED|DB RO Phase||0
6440660|NCT01097616|7355626|FG003|NOT COMPLETED|DB RO Phase||1
6440661|NCT01097616|7355627|FG004|NOT COMPLETED|DB RO Phase||1
6440662|NCT01097616|7355628|FG005|NOT COMPLETED|DB RO Phase||2
6440663|NCT01097616|7355629|FG006|NOT COMPLETED|DB RO Phase||1
6440664|NCT01097616|7355630|FG007|NOT COMPLETED|DB RO Phase||1
6440665|NCT01097629|7355659|FG000|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
6440666|NCT01097629|7355660|FG001|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
6440667|NCT01097629|7355661|FG002|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
6440668|NCT01097629|7355662|FG003|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440669|NCT01097629|7355663|FG004|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440670|NCT01097629|7355664|FG005|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440671|NCT01097629|7355665|FG006|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440672|NCT01097629|7355666|FG007|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
6440673|NCT01097629|7355659|FG000|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
6440674|NCT01097629|7355660|FG001|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
6440675|NCT01097629|7355661|FG002|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
6440676|NCT01097629|7355662|FG003|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440677|NCT01097629|7355663|FG004|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440678|NCT01097629|7355664|FG005|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440679|NCT01097629|7355665|FG006|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440680|NCT01097629|7355666|FG007|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
6440681|NCT01097629|7355659|FG000|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
6440682|NCT01097629|7355660|FG001|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
6440683|NCT01097629|7355661|FG002|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
6440684|NCT01097629|7355662|FG003|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440685|NCT01097629|7355663|FG004|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440686|NCT01097629|7355664|FG005|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440687|NCT01097629|7355665|FG006|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440688|NCT01097629|7355666|FG007|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440689|NCT01097629|7355659|FG000|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
6440690|NCT01097629|7355660|FG001|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
6440691|NCT01097629|7355661|FG002|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
6440692|NCT01097629|7355662|FG003|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440693|NCT01097629|7355663|FG004|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440694|NCT01097629|7355664|FG005|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440695|NCT01097629|7355665|FG006|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440696|NCT01097629|7355666|FG007|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
6440697|NCT01097629|7355659|FG000|STARTED|DB RO Phase||0
6440698|NCT01097629|7355660|FG001|STARTED|DB RO Phase||0
6440699|NCT01097629|7355661|FG002|STARTED|DB RO Phase||0
6440700|NCT01097629|7355662|FG003|STARTED|DB RO Phase||97
6440701|NCT01097629|7355663|FG004|STARTED|DB RO Phase||108
6440702|NCT01097629|7355664|FG005|STARTED|DB RO Phase||173
6440703|NCT01097629|7355665|FG006|STARTED|DB RO Phase||171
6440704|NCT01097629|7355666|FG007|STARTED|DB RO Phase||327
6440705|NCT01097629|7355659|FG000|COMPLETED|DB RO Phase||0
6440706|NCT01097629|7355660|FG001|COMPLETED|DB RO Phase||0
6440707|NCT01097629|7355661|FG002|COMPLETED|DB RO Phase||0
6440708|NCT01097629|7355662|FG003|COMPLETED|DB RO Phase||96
6440709|NCT01097629|7355663|FG004|COMPLETED|DB RO Phase||108
6440710|NCT01097629|7355664|FG005|COMPLETED|DB RO Phase||172
6440711|NCT01097629|7355665|FG006|COMPLETED|DB RO Phase||168
6440712|NCT01097629|7355666|FG007|COMPLETED|DB RO Phase||326
6440713|NCT01097629|7355659|FG000|NOT COMPLETED|DB RO Phase||0
6440714|NCT01097629|7355660|FG001|NOT COMPLETED|DB RO Phase||0
6440715|NCT01097629|7355661|FG002|NOT COMPLETED|DB RO Phase||0
6440716|NCT01097629|7355662|FG003|NOT COMPLETED|DB RO Phase||1
6440717|NCT01097629|7355663|FG004|NOT COMPLETED|DB RO Phase||0
6440718|NCT01097629|7355664|FG005|NOT COMPLETED|DB RO Phase||1
6552953|NCT01740362|7475385|FG001|STARTED|Overall Study||6
6552954|NCT01740362|7475386|FG002|STARTED|Overall Study||6
6552955|NCT01740362|7475387|FG003|STARTED|Overall Study||6
6552956|NCT01740362|7475384|FG000|COMPLETED|Overall Study||6
6440719|NCT01097629|7355665|FG006|NOT COMPLETED|DB RO Phase||3
6440720|NCT01097629|7355666|FG007|NOT COMPLETED|DB RO Phase||1
6440721|NCT01097642|7355691|FG000|STARTED|Overall Study||15
6440722|NCT01097642|7355692|FG001|STARTED|Overall Study||25
6440723|NCT01097642|7355691|FG000|COMPLETED|Overall Study||15
6440724|NCT01097642|7355692|FG001|COMPLETED|Overall Study||25
6440725|NCT01097642|7355691|FG000|NOT COMPLETED|Overall Study||0
6440726|NCT01097642|7355692|FG001|NOT COMPLETED|Overall Study||0
6440727|NCT01097655|7355698|FG000|STARTED|Overall Study||3049
6440728|NCT01097655|7355698|FG000|COMPLETED|Overall Study|participants included for analysis|3039
6440729|NCT01097655|7355698|FG000|NOT COMPLETED|Overall Study||10
6440730|NCT01097668|7355704|FG000|STARTED|Overall Study||21
6440731|NCT01097668|7355705|FG001|STARTED|Overall Study||22
6440732|NCT01097668|7355704|FG000|Week 20|Overall Study|Patient evaluability time point = week 20|21
6440733|NCT01097668|7355705|FG001|Week 20|Overall Study|Patient evaluability time point = week 20|22
6440734|NCT01097668|7355704|FG000|Week 48|Overall Study||19
6440735|NCT01097668|7355705|FG001|Week 48|Overall Study||20
6440736|NCT01097668|7355704|FG000|COMPLETED|Overall Study||19
6440737|NCT01097668|7355705|FG001|COMPLETED|Overall Study||20
6440738|NCT01097668|7355704|FG000|NOT COMPLETED|Overall Study||2
6440739|NCT01097668|7355705|FG001|NOT COMPLETED|Overall Study||2
6440740|NCT01097694|7355717|FG000|STARTED|Overall Study||32
6440741|NCT01097694|7355718|FG001|STARTED|Overall Study||30
6440742|NCT01097694|7355717|FG000|COMPLETED|Overall Study||24
6440743|NCT01097694|7355718|FG001|COMPLETED|Overall Study||26
6440744|NCT01097694|7355717|FG000|NOT COMPLETED|Overall Study||8
6440745|NCT01097694|7355718|FG001|NOT COMPLETED|Overall Study||4
6440746|NCT01097707|7355729|FG000|STARTED|Overall Study||83
6440747|NCT01097707|7355730|FG001|STARTED|Overall Study||80
6440748|NCT01097707|7355731|FG002|STARTED|Overall Study||82
6440749|NCT01097707|7355732|FG003|STARTED|Overall Study||84
6440750|NCT01097707|7355733|FG004|STARTED|Overall Study||85
6440751|NCT01097707|7355729|FG000|COMPLETED|Overall Study||39
6440752|NCT01097707|7355730|FG001|COMPLETED|Overall Study||37
6440753|NCT01097707|7355731|FG002|COMPLETED|Overall Study||37
6440754|NCT01097707|7355732|FG003|COMPLETED|Overall Study||40
6440755|NCT01097707|7355733|FG004|COMPLETED|Overall Study||35
6440756|NCT01097707|7355729|FG000|NOT COMPLETED|Overall Study||44
6440757|NCT01097707|7355730|FG001|NOT COMPLETED|Overall Study||43
6440758|NCT01097707|7355731|FG002|NOT COMPLETED|Overall Study||45
6440759|NCT01097707|7355732|FG003|NOT COMPLETED|Overall Study||44
6440760|NCT01097707|7355733|FG004|NOT COMPLETED|Overall Study||50
6440761|NCT01097785|7355747|FG000|STARTED|Cycle 1 (30 Days)||6
6440762|NCT01097785|7355748|FG001|STARTED|Cycle 1 (30 Days)||6
6440763|NCT01097785|7355747|FG000|COMPLETED|Cycle 1 (30 Days)||6
6440764|NCT01097785|7355748|FG001|COMPLETED|Cycle 1 (30 Days)||6
6440765|NCT01097785|7355747|FG000|NOT COMPLETED|Cycle 1 (30 Days)||0
6440766|NCT01097785|7355748|FG001|NOT COMPLETED|Cycle 1 (30 Days)||0
6440767|NCT01097785|7355747|FG000|STARTED|Washout (2 Weeks)||6
6440768|NCT01097785|7355748|FG001|STARTED|Washout (2 Weeks)||6
6440769|NCT01097785|7355747|FG000|COMPLETED|Washout (2 Weeks)||6
6440770|NCT01097785|7355748|FG001|COMPLETED|Washout (2 Weeks)||6
6440771|NCT01097785|7355747|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6440772|NCT01097785|7355748|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6440773|NCT01097785|7355747|FG000|STARTED|Cycle 3 (30 Days)||6
6440774|NCT01097785|7355748|FG001|STARTED|Cycle 3 (30 Days)||6
6440775|NCT01097785|7355747|FG000|COMPLETED|Cycle 3 (30 Days)||6
6440776|NCT01097785|7355748|FG001|COMPLETED|Cycle 3 (30 Days)||6
6440777|NCT01097785|7355747|FG000|NOT COMPLETED|Cycle 3 (30 Days)||0
6440778|NCT01097785|7355748|FG001|NOT COMPLETED|Cycle 3 (30 Days)||0
6440779|NCT01097863|7355758|FG000|STARTED|Overall Study||90
6440780|NCT01097863|7355759|FG001|STARTED|Overall Study||98
6440781|NCT01097863|7355760|FG002|STARTED|Overall Study||91
6440782|NCT01097863|7355758|FG000|COMPLETED|Overall Study||89
6440783|NCT01097863|7355759|FG001|COMPLETED|Overall Study||98
6440784|NCT01097863|7355760|FG002|COMPLETED|Overall Study||89
6440785|NCT01097863|7355758|FG000|NOT COMPLETED|Overall Study||1
6440786|NCT01097863|7355759|FG001|NOT COMPLETED|Overall Study||0
6440787|NCT01097863|7355760|FG002|NOT COMPLETED|Overall Study||2
6440788|NCT01097915|7355771|FG000|STARTED|Overall Study||50
6440789|NCT01097915|7355772|FG001|STARTED|Overall Study||70
6440790|NCT01097915|7355773|FG002|STARTED|Overall Study||50
6440791|NCT01097915|7355771|FG000|COMPLETED|Overall Study||27
6440792|NCT01097915|7355772|FG001|COMPLETED|Overall Study||28
6440793|NCT01097915|7355773|FG002|COMPLETED|Overall Study||20
6440794|NCT01097915|7355771|FG000|NOT COMPLETED|Overall Study||23
6440795|NCT01097915|7355772|FG001|NOT COMPLETED|Overall Study||42
6440796|NCT01097915|7355773|FG002|NOT COMPLETED|Overall Study||30
6440797|NCT01098006|7355792|FG000|STARTED|Overall Study||7
6440798|NCT01098006|7355793|FG001|STARTED|Overall Study||11
6440799|NCT01098006|7355794|FG002|STARTED|Overall Study||60
6440800|NCT01098006|7355795|FG003|STARTED|Overall Study||21
6440801|NCT01098006|7355792|FG000|COMPLETED|Overall Study||7
6440802|NCT01098006|7355793|FG001|COMPLETED|Overall Study||11
6440803|NCT01098006|7355794|FG002|COMPLETED|Overall Study||60
6440804|NCT01098006|7355795|FG003|COMPLETED|Overall Study||21
6440805|NCT01098006|7355792|FG000|NOT COMPLETED|Overall Study||0
6440806|NCT01098006|7355793|FG001|NOT COMPLETED|Overall Study||0
6440807|NCT01098006|7355794|FG002|NOT COMPLETED|Overall Study||0
6440808|NCT01098006|7355795|FG003|NOT COMPLETED|Overall Study||0
6440809|NCT01098097|7355805|FG000|STARTED|Overall Study||963
6440810|NCT01098097|7355805|FG000|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
6440811|NCT01098097|7355805|FG000|NOT COMPLETED|Overall Study||82
6440812|NCT01098162|7355809|FG000|STARTED|Overall Study||573
6440813|NCT01098162|7355809|FG000|COMPLETED|Overall Study||461
6440814|NCT01098162|7355809|FG000|NOT COMPLETED|Overall Study||112
6440815|NCT01098240|7355813|FG000|STARTED|Open-Label Phase||297
6440816|NCT01098240|7355814|FG001|STARTED|Open-Label Phase||0
6440817|NCT01098240|7355815|FG002|STARTED|Open-Label Phase||0
6440818|NCT01098240|7355813|FG000|COMPLETED|Open-Label Phase||162
6440819|NCT01098240|7355814|FG001|COMPLETED|Open-Label Phase||0
6440820|NCT01098240|7355815|FG002|COMPLETED|Open-Label Phase||0
6440821|NCT01098240|7355813|FG000|NOT COMPLETED|Open-Label Phase||135
6440822|NCT01098240|7355814|FG001|NOT COMPLETED|Open-Label Phase||0
6440823|NCT01098240|7355815|FG002|NOT COMPLETED|Open-Label Phase||0
6440824|NCT01098240|7355813|FG000|STARTED|Double-Blind Phase||0
6440825|NCT01098240|7355814|FG001|STARTED|Double-Blind Phase||77
6440826|NCT01098240|7355815|FG002|STARTED|Double-Blind Phase||85
6440827|NCT01098240|7355813|FG000|COMPLETED|Double-Blind Phase||0
6440828|NCT01098240|7355814|FG001|COMPLETED|Double-Blind Phase||60
6440829|NCT01098240|7355815|FG002|COMPLETED|Double-Blind Phase||63
6440830|NCT01098240|7355813|FG000|NOT COMPLETED|Double-Blind Phase||0
6440831|NCT01098240|7355814|FG001|NOT COMPLETED|Double-Blind Phase||17
6440832|NCT01098240|7355815|FG002|NOT COMPLETED|Double-Blind Phase||22
6440833|NCT01098253|7355824|FG000|STARTED|Overall Study||94
6440834|NCT01098253|7355825|FG001|STARTED|Overall Study||88
6440835|NCT01098253|7355824|FG000|COMPLETED|Overall Study||92
6440836|NCT01098253|7355825|FG001|COMPLETED|Overall Study||88
6440837|NCT01098253|7355824|FG000|NOT COMPLETED|Overall Study||2
6440838|NCT01098253|7355825|FG001|NOT COMPLETED|Overall Study||0
6440839|NCT01098266|7355833|FG000|STARTED|Overall Study||200
6440840|NCT01098266|7355834|FG001|STARTED|Overall Study||200
6440841|NCT01098266|7355833|FG000|COMPLETED|Overall Study||193
6440842|NCT01098266|7355834|FG001|COMPLETED|Overall Study||193
6440843|NCT01098266|7355833|FG000|NOT COMPLETED|Overall Study||7
6440844|NCT01098266|7355834|FG001|NOT COMPLETED|Overall Study||7
6440845|NCT01098305|7355842|FG000|STARTED|Overall Study||119
6440846|NCT01098305|7355843|FG001|STARTED|Overall Study||118
6440847|NCT01098305|7355842|FG000|COMPLETED|Overall Study||88
6440848|NCT01098305|7355843|FG001|COMPLETED|Overall Study||85
6440849|NCT01098305|7355842|FG000|NOT COMPLETED|Overall Study||31
6440850|NCT01098305|7355843|FG001|NOT COMPLETED|Overall Study||33
6440851|NCT01098318|7355852|FG000|STARTED|Overall Study||20
6440852|NCT01098318|7355853|FG001|STARTED|Overall Study||19
6440853|NCT01098318|7355854|FG002|STARTED|Overall Study||18
6440854|NCT01098318|7355852|FG000|COMPLETED|Overall Study||17
6440855|NCT01098318|7355853|FG001|COMPLETED|Overall Study||12
6440856|NCT01098318|7355854|FG002|COMPLETED|Overall Study||15
6440857|NCT01098318|7355852|FG000|NOT COMPLETED|Overall Study||3
6440858|NCT01098318|7355853|FG001|NOT COMPLETED|Overall Study||7
6440859|NCT01098318|7355854|FG002|NOT COMPLETED|Overall Study||3
6440860|NCT01098422|7355862|FG000|STARTED|Overall Study||10
6440861|NCT01098422|7355862|FG000|COMPLETED|Overall Study||9
6440862|NCT01098422|7355862|FG000|NOT COMPLETED|Overall Study||1
6440863|NCT01098461|7355870|FG000|STARTED|Treatment Period (TP) (16 Weeks)||53
6440864|NCT01098461|7355871|FG001|STARTED|Treatment Period (TP) (16 Weeks)||52
6440865|NCT01098461|7355872|FG002|STARTED|Treatment Period (TP) (16 Weeks)||54
6440866|NCT01098461|7355873|FG003|STARTED|Treatment Period (TP) (16 Weeks)||53
6440867|NCT01098461|7355870|FG000|COMPLETED|Treatment Period (TP) (16 Weeks)||41
6440868|NCT01098461|7355871|FG001|COMPLETED|Treatment Period (TP) (16 Weeks)||45
6440869|NCT01098461|7355872|FG002|COMPLETED|Treatment Period (TP) (16 Weeks)||53
6440870|NCT01098461|7355873|FG003|COMPLETED|Treatment Period (TP) (16 Weeks)||50
6440871|NCT01098461|7355870|FG000|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
6440872|NCT01098461|7355871|FG001|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
6440873|NCT01098461|7355872|FG002|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
6440874|NCT01098461|7355873|FG003|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
6440875|NCT01098461|7355870|FG000|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
6440876|NCT01098461|7355871|FG001|STARTED|Follow-up (FU) Period (8 Weeks)||52
6440877|NCT01098461|7355872|FG002|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
6440878|NCT01098461|7355873|FG003|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
6440879|NCT01098461|7355870|FG000|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
6440880|NCT01098461|7355871|FG001|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
6440881|NCT01098461|7355872|FG002|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
6440882|NCT01098461|7355873|FG003|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
6440883|NCT01098461|7355870|FG000|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
6440884|NCT01098461|7355871|FG001|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
6440885|NCT01098461|7355872|FG002|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
6440886|NCT01098461|7355873|FG003|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
6440887|NCT01098474|7355890|FG000|STARTED|Active Phase||50
6440888|NCT01098474|7355891|FG001|STARTED|Active Phase||50
6440889|NCT01098474|7355892|FG002|STARTED|Active Phase||50
6440890|NCT01098474|7355893|FG003|STARTED|Active Phase||49
6440891|NCT01098474|7355894|FG004|STARTED|Active Phase||52
6440892|NCT01098474|7355895|FG005|STARTED|Active Phase||49
6440893|NCT01098474|7355890|FG000|COMPLETED|Active Phase||48
6440894|NCT01098474|7355891|FG001|COMPLETED|Active Phase||49
6440895|NCT01098474|7355892|FG002|COMPLETED|Active Phase||45
6440896|NCT01098474|7355893|FG003|COMPLETED|Active Phase||49
6440897|NCT01098474|7355894|FG004|COMPLETED|Active Phase||52
6440898|NCT01098474|7355895|FG005|COMPLETED|Active Phase||49
6440899|NCT01098474|7355890|FG000|NOT COMPLETED|Active Phase||2
6440900|NCT01098474|7355891|FG001|NOT COMPLETED|Active Phase||1
6440901|NCT01098474|7355892|FG002|NOT COMPLETED|Active Phase||5
6440902|NCT01098474|7355893|FG003|NOT COMPLETED|Active Phase||0
6440903|NCT01098474|7355894|FG004|NOT COMPLETED|Active Phase||0
6440904|NCT01098474|7355895|FG005|NOT COMPLETED|Active Phase||0
6440905|NCT01098474|7355890|FG000|STARTED|Follow Up Phase||48
6440906|NCT01098474|7355891|FG001|STARTED|Follow Up Phase||49
6440907|NCT01098474|7355892|FG002|STARTED|Follow Up Phase||45
6440908|NCT01098474|7355893|FG003|STARTED|Follow Up Phase||49
6440909|NCT01098474|7355894|FG004|STARTED|Follow Up Phase||52
6440910|NCT01098474|7355895|FG005|STARTED|Follow Up Phase||49
6440911|NCT01098474|7355890|FG000|COMPLETED|Follow Up Phase||48
6440912|NCT01098474|7355891|FG001|COMPLETED|Follow Up Phase||49
6440913|NCT01098474|7355892|FG002|COMPLETED|Follow Up Phase||45
6440914|NCT01098474|7355893|FG003|COMPLETED|Follow Up Phase||47
6440915|NCT01098474|7355894|FG004|COMPLETED|Follow Up Phase||50
6440916|NCT01098474|7355895|FG005|COMPLETED|Follow Up Phase||44
6440917|NCT01098474|7355890|FG000|NOT COMPLETED|Follow Up Phase||0
6440918|NCT01098474|7355891|FG001|NOT COMPLETED|Follow Up Phase||0
6440919|NCT01098474|7355892|FG002|NOT COMPLETED|Follow Up Phase||0
6440920|NCT01098474|7355893|FG003|NOT COMPLETED|Follow Up Phase||2
6440921|NCT01098474|7355894|FG004|NOT COMPLETED|Follow Up Phase||2
6440922|NCT01098474|7355895|FG005|NOT COMPLETED|Follow Up Phase||5
6440923|NCT01098487|7355919|FG000|STARTED|Overall Study||162
6440924|NCT01098487|7355919|FG000|COMPLETED|Overall Study||118
6440925|NCT01098487|7355919|FG000|NOT COMPLETED|Overall Study||44
6440926|NCT01098500|7355923|FG000|STARTED|Overall Study||3800
6440927|NCT01098500|7355923|FG000|COMPLETED|Overall Study||3800
6440928|NCT01098500|7355923|FG000|NOT COMPLETED|Overall Study||0
6440929|NCT01098539|7355929|FG000|STARTED|Overall Study||249
6440930|NCT01098539|7355930|FG001|STARTED|Overall Study||246
6440931|NCT01098539|7355929|FG000|COMPLETED|Overall Study||198
6440932|NCT01098539|7355930|FG001|COMPLETED|Overall Study||178
6440933|NCT01098539|7355929|FG000|NOT COMPLETED|Overall Study||51
6440934|NCT01098539|7355930|FG001|NOT COMPLETED|Overall Study||68
6440935|NCT01098578|7355936|FG000|STARTED|Overall Study||20
6440936|NCT01098578|7355936|FG000|COMPLETED|Overall Study||20
6440937|NCT01098578|7355936|FG000|NOT COMPLETED|Overall Study||0
6440938|NCT01098747|7355946|FG000|STARTED|Overall Study||48
6440939|NCT01098747|7355947|FG001|STARTED|Overall Study||95
6440940|NCT01098747|7355948|FG002|STARTED|Overall Study||86
6440941|NCT01098747|7355949|FG003|STARTED|Overall Study||87
6440942|NCT01098747|7355946|FG000|COMPLETED|Overall Study||48
6440943|NCT01098747|7355947|FG001|COMPLETED|Overall Study||95
6440944|NCT01098747|7355948|FG002|COMPLETED|Overall Study||86
6653378|NCT02436577|7583131|FG004|NOT COMPLETED|Overall Study||0
6653379|NCT02436577|7583132|FG005|NOT COMPLETED|Overall Study||0
6653380|NCT02436668|7583142|FG000|STARTED|Overall Study||213
6653381|NCT02436668|7583143|FG001|STARTED|Overall Study||211
6653382|NCT02436668|7583142|FG000|COMPLETED|Overall Study||212
6653383|NCT02436668|7583143|FG001|COMPLETED|Overall Study||207
6653384|NCT02436668|7583142|FG000|NOT COMPLETED|Overall Study||1
6653385|NCT02436668|7583143|FG001|NOT COMPLETED|Overall Study||4
6653386|NCT02436681|7583152|FG000|STARTED|Overall Study||41
6653387|NCT02436681|7583152|FG000|COMPLETED|Overall Study||27
6653388|NCT02436681|7583152|FG000|NOT COMPLETED|Overall Study||14
6653389|NCT02436759|7583158|FG000|STARTED|Overall Study||94
6653390|NCT02436759|7583159|FG001|STARTED|Overall Study||46
6440945|NCT01098747|7355949|FG003|COMPLETED|Overall Study||87
6440946|NCT01098747|7355946|FG000|NOT COMPLETED|Overall Study||0
6440947|NCT01098747|7355947|FG001|NOT COMPLETED|Overall Study||0
6440948|NCT01098747|7355948|FG002|NOT COMPLETED|Overall Study||0
6440949|NCT01098747|7355949|FG003|NOT COMPLETED|Overall Study||0
6500079|NCT01422876|7418866|FG006|COMPLETED|Week 52||120
6500080|NCT01422876|7418867|FG007|COMPLETED|Week 52||112
6500081|NCT01422876|7418868|FG008|COMPLETED|Week 52||113
6500082|NCT01422876|7418869|FG009|COMPLETED|Week 52||118
6500083|NCT01422876|7418860|FG000|NOT COMPLETED|Week 52||12
6500084|NCT01422876|7418861|FG001|NOT COMPLETED|Week 52||10
6500085|NCT01422876|7418862|FG002|NOT COMPLETED|Week 52||13
6500086|NCT01422876|7418863|FG003|NOT COMPLETED|Week 52||18
6500087|NCT01422876|7418864|FG004|NOT COMPLETED|Week 52||15
6500088|NCT01422876|7418865|FG005|NOT COMPLETED|Week 52||17
6500089|NCT01422876|7418866|FG006|NOT COMPLETED|Week 52||16
6500090|NCT01422876|7418867|FG007|NOT COMPLETED|Week 52||23
6500091|NCT01422876|7418868|FG008|NOT COMPLETED|Week 52||21
6500092|NCT01422876|7418869|FG009|NOT COMPLETED|Week 52||17
6500093|NCT01422889|7418887|FG000|STARTED|Overall Study||1120
6500094|NCT01422889|7418887|FG000|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
6500095|NCT01422889|7418887|FG000|NOT COMPLETED|Overall Study||9
6500096|NCT01422915|7418891|FG000|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
6500097|NCT01422915|7418891|FG000|COMPLETED|Overall Study||3
6500098|NCT01422915|7418891|FG000|NOT COMPLETED|Overall Study||1
6653391|NCT02436759|7583158|FG000|Subjects Randomized|Overall Study||94
6653392|NCT02436759|7583159|FG001|Subjects Randomized|Overall Study||46
6653393|NCT02436759|7583158|FG000|Subjects Treated|Overall Study||94
6440950|NCT01098812|7355961|FG000|STARTED|Overall Study||95
6440951|NCT01098812|7355962|FG001|STARTED|Overall Study||102
6440952|NCT01098812|7355963|FG002|STARTED|Overall Study||72
6440953|NCT01098812|7355961|FG000|COMPLETED|Overall Study||93
6440954|NCT01098812|7355962|FG001|COMPLETED|Overall Study||101
6440955|NCT01098812|7355963|FG002|COMPLETED|Overall Study||71
6440956|NCT01098812|7355961|FG000|NOT COMPLETED|Overall Study||2
6440957|NCT01098812|7355962|FG001|NOT COMPLETED|Overall Study||1
6440958|NCT01098812|7355963|FG002|NOT COMPLETED|Overall Study||1
6440959|NCT01098851|7355972|FG000|STARTED|Overall Study||11
6440960|NCT01098851|7355973|FG001|STARTED|Overall Study||10
6440961|NCT01098851|7355972|FG000|COMPLETED|Overall Study||10
6440962|NCT01098851|7355973|FG001|COMPLETED|Overall Study||10
6440963|NCT01098851|7355972|FG000|NOT COMPLETED|Overall Study||1
6440964|NCT01098851|7355973|FG001|NOT COMPLETED|Overall Study||0
6440965|NCT01099111|7355984|FG000|STARTED|Overall Study||50
6440966|NCT01099111|7355985|FG001|STARTED|Overall Study||50
6552957|NCT01740362|7475385|FG001|COMPLETED|Overall Study||6
6552958|NCT01740362|7475386|FG002|COMPLETED|Overall Study||6
6440967|NCT01099111|7355986|FG002|STARTED|Overall Study||46
6440968|NCT01099111|7355987|FG003|STARTED|Overall Study||29
6440969|NCT01099111|7355988|FG004|STARTED|Overall Study||50
6440970|NCT01099111|7355984|FG000|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
6440971|NCT01099111|7355985|FG001|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
6440972|NCT01099111|7355986|FG002|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
6440973|NCT01099111|7355987|FG003|COMPLETED|Overall Study||29
6440974|NCT01099111|7355988|FG004|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
6440975|NCT01099111|7355984|FG000|NOT COMPLETED|Overall Study||0
6440976|NCT01099111|7355985|FG001|NOT COMPLETED|Overall Study||0
6440977|NCT01099111|7355986|FG002|NOT COMPLETED|Overall Study||0
6440978|NCT01099111|7355987|FG003|NOT COMPLETED|Overall Study||0
6440979|NCT01099111|7355988|FG004|NOT COMPLETED|Overall Study||0
6440980|NCT01099202|7356002|FG000|STARTED|Overall Study||55
6440981|NCT01099202|7356003|FG001|STARTED|Overall Study||54
6440982|NCT01099202|7356002|FG000|COMPLETED|Overall Study||55
6440983|NCT01099202|7356003|FG001|COMPLETED|Overall Study||54
6440984|NCT01099202|7356002|FG000|NOT COMPLETED|Overall Study||0
6440985|NCT01099202|7356003|FG001|NOT COMPLETED|Overall Study||0
6440986|NCT01099215|7356012|FG000|STARTED|Overall Study||11
6440987|NCT01099215|7356013|FG001|STARTED|Overall Study||10
6440988|NCT01099215|7356012|FG000|COMPLETED|Overall Study||10
6440989|NCT01099215|7356013|FG001|COMPLETED|Overall Study||9
6440990|NCT01099215|7356012|FG000|NOT COMPLETED|Overall Study||1
6440991|NCT01099215|7356013|FG001|NOT COMPLETED|Overall Study||1
6440992|NCT01099267|7356019|FG000|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
6440993|NCT01099267|7356019|FG000|COMPLETED|MDS-003 Study||24
6440994|NCT01099267|7356019|FG000|NOT COMPLETED|MDS-003 Study||124
6440995|NCT01099267|7356019|FG000|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
6440996|NCT01099267|7356019|FG000|Informed Consent Given|MDS-009 Extension Follow-up||33
6440997|NCT01099267|7356019|FG000|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
6440998|NCT01099267|7356019|FG000|COMPLETED|MDS-009 Extension Follow-up||54
6440999|NCT01099267|7356019|FG000|NOT COMPLETED|MDS-009 Extension Follow-up||0
6441000|NCT01099358|7356023|FG000|STARTED|Overall Study||4
6441001|NCT01099358|7356024|FG001|STARTED|Overall Study||6
6441002|NCT01099358|7356025|FG002|STARTED|Overall Study||21
6441003|NCT01099358|7356026|FG003|STARTED|Overall Study||16
6441004|NCT01099358|7356023|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6441005|NCT01099358|7356024|FG001|Received at Least One Dose of Study Drug|Overall Study||6
6441006|NCT01099358|7356025|FG002|Received at Least One Dose of Study Drug|Overall Study||20
6441007|NCT01099358|7356026|FG003|Received at Least One Dose of Study Drug|Overall Study||15
6441008|NCT01099358|7356023|FG000|COMPLETED|Overall Study||1
6441009|NCT01099358|7356024|FG001|COMPLETED|Overall Study||5
6441010|NCT01099358|7356025|FG002|COMPLETED|Overall Study||13
6441011|NCT01099358|7356026|FG003|COMPLETED|Overall Study||12
6552959|NCT01740362|7475387|FG003|COMPLETED|Overall Study||6
6441012|NCT01099358|7356023|FG000|NOT COMPLETED|Overall Study||3
6441013|NCT01099358|7356024|FG001|NOT COMPLETED|Overall Study||1
6441014|NCT01099358|7356025|FG002|NOT COMPLETED|Overall Study||8
6441015|NCT01099358|7356026|FG003|NOT COMPLETED|Overall Study||4
6441016|NCT01099397|7356037|FG000|STARTED|Overall Study||39
6441017|NCT01099397|7356037|FG000|COMPLETED|Overall Study||26
6441018|NCT01099397|7356037|FG000|NOT COMPLETED|Overall Study||13
6441019|NCT01099449|7356045|FG000|STARTED|Overall Study||118
6441020|NCT01099449|7356046|FG001|STARTED|Overall Study||119
6441021|NCT01099449|7356047|FG002|STARTED|Overall Study||116
6441022|NCT01099449|7356045|FG000|COMPLETED|Overall Study||118
6441023|NCT01099449|7356046|FG001|COMPLETED|Overall Study||119
6441024|NCT01099449|7356047|FG002|COMPLETED|Overall Study||116
6441025|NCT01099449|7356045|FG000|NOT COMPLETED|Overall Study||0
6441026|NCT01099449|7356046|FG001|NOT COMPLETED|Overall Study||0
6441027|NCT01099449|7356047|FG002|NOT COMPLETED|Overall Study||0
6441028|NCT01099475|7356070|FG000|STARTED|Overall Study||10
6441029|NCT01099475|7356071|FG001|STARTED|Overall Study||10
6441030|NCT01099475|7356070|FG000|COMPLETED|Overall Study||10
6441031|NCT01099475|7356071|FG001|COMPLETED|Overall Study||10
6441032|NCT01099475|7356070|FG000|NOT COMPLETED|Overall Study||0
6441033|NCT01099475|7356071|FG001|NOT COMPLETED|Overall Study||0
6441034|NCT01099579|7356080|FG000|STARTED|Stage 1 (ATV Powder Formulation)||21
6441035|NCT01099579|7356081|FG001|STARTED|Stage 1 (ATV Powder Formulation)||19
6441036|NCT01099579|7356082|FG002|STARTED|Stage 1 (ATV Powder Formulation)||16
6441037|NCT01099579|7356080|FG000|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
6441038|NCT01099579|7356081|FG001|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
6441039|NCT01099579|7356082|FG002|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
6441040|NCT01099579|7356080|FG000|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
6441041|NCT01099579|7356081|FG001|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
6441042|NCT01099579|7356082|FG002|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
6441043|NCT01099579|7356080|FG000|STARTED|Stage 2 (ATV Capsule)||16
6441044|NCT01099579|7356081|FG001|STARTED|Stage 2 (ATV Capsule)||14
6441045|NCT01099579|7356082|FG002|STARTED|Stage 2 (ATV Capsule)||15
6441046|NCT01099579|7356080|FG000|COMPLETED|Stage 2 (ATV Capsule)||10
6441047|NCT01099579|7356081|FG001|COMPLETED|Stage 2 (ATV Capsule)||9
6441048|NCT01099579|7356082|FG002|COMPLETED|Stage 2 (ATV Capsule)||9
6441049|NCT01099579|7356080|FG000|NOT COMPLETED|Stage 2 (ATV Capsule)||6
6441050|NCT01099579|7356081|FG001|NOT COMPLETED|Stage 2 (ATV Capsule)||5
6441051|NCT01099579|7356082|FG002|NOT COMPLETED|Stage 2 (ATV Capsule)||6
6441052|NCT01099618|7356095|FG000|STARTED|Overall Study||17
6441053|NCT01099618|7356096|FG001|STARTED|Overall Study||16
6441054|NCT01099618|7356097|FG002|STARTED|Overall Study||15
6441055|NCT01099618|7356095|FG000|COMPLETED|Overall Study||17
6441056|NCT01099618|7356096|FG001|COMPLETED|Overall Study||16
6441057|NCT01099618|7356097|FG002|COMPLETED|Overall Study||15
6441058|NCT01099618|7356095|FG000|NOT COMPLETED|Overall Study||0
6441059|NCT01099618|7356096|FG001|NOT COMPLETED|Overall Study||0
6441060|NCT01099618|7356097|FG002|NOT COMPLETED|Overall Study||0
6441061|NCT01099631|7356111|FG000|STARTED|Overall Study||6
6441062|NCT01099631|7356112|FG001|STARTED|Overall Study||3
6441063|NCT01099631|7356113|FG002|STARTED|Overall Study||3
6441064|NCT01099631|7356114|FG003|STARTED|Overall Study||3
6441065|NCT01099631|7356115|FG004|STARTED|Overall Study||3
6441066|NCT01099631|7356116|FG005|STARTED|Overall Study||4
6441067|NCT01099631|7356111|FG000|COMPLETED|Overall Study||6
6441068|NCT01099631|7356112|FG001|COMPLETED|Overall Study||3
6441069|NCT01099631|7356113|FG002|COMPLETED|Overall Study||3
6441070|NCT01099631|7356114|FG003|COMPLETED|Overall Study||3
6441071|NCT01099631|7356115|FG004|COMPLETED|Overall Study||3
6441072|NCT01099631|7356116|FG005|COMPLETED|Overall Study||4
6441073|NCT01099631|7356111|FG000|NOT COMPLETED|Overall Study||0
6441074|NCT01099631|7356112|FG001|NOT COMPLETED|Overall Study||0
6441075|NCT01099631|7356113|FG002|NOT COMPLETED|Overall Study||0
6441076|NCT01099631|7356114|FG003|NOT COMPLETED|Overall Study||0
6441077|NCT01099631|7356115|FG004|NOT COMPLETED|Overall Study||0
6441078|NCT01099631|7356116|FG005|NOT COMPLETED|Overall Study||0
6441079|NCT01099709|7356136|FG000|STARTED|Period 1||42
6441080|NCT01099709|7356137|FG001|STARTED|Period 1||43
6441081|NCT01099709|7356136|FG000|COMPLETED|Period 1||41
6441082|NCT01099709|7356137|FG001|COMPLETED|Period 1||41
6441083|NCT01099709|7356136|FG000|NOT COMPLETED|Period 1||1
6441084|NCT01099709|7356137|FG001|NOT COMPLETED|Period 1||2
6441085|NCT01099709|7356136|FG000|STARTED|Period 2||41
6441086|NCT01099709|7356137|FG001|STARTED|Period 2||41
6441087|NCT01099709|7356136|FG000|COMPLETED|Period 2||41
6441088|NCT01099709|7356137|FG001|COMPLETED|Period 2||41
6441089|NCT01099709|7356136|FG000|NOT COMPLETED|Period 2||0
6441090|NCT01099709|7356137|FG001|NOT COMPLETED|Period 2||0
6441091|NCT01099761|7356148|FG000|STARTED|Overall Study||9
6441092|NCT01099761|7356149|FG001|STARTED|Overall Study||9
6441093|NCT01099761|7356150|FG002|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
6441094|NCT01099761|7356151|FG003|STARTED|Overall Study||6
6441095|NCT01099761|7356148|FG000|COMPLETED|Overall Study||9
6441096|NCT01099761|7356149|FG001|COMPLETED|Overall Study||9
6441097|NCT01099761|7356150|FG002|COMPLETED|Overall Study||0
6441098|NCT01099761|7356151|FG003|COMPLETED|Overall Study||6
6441099|NCT01099761|7356148|FG000|NOT COMPLETED|Overall Study||0
6441100|NCT01099761|7356149|FG001|NOT COMPLETED|Overall Study||0
6441101|NCT01099761|7356150|FG002|NOT COMPLETED|Overall Study||0
6441102|NCT01099761|7356151|FG003|NOT COMPLETED|Overall Study||0
6441103|NCT01099774|7356162|FG000|STARTED|Overall Study||302
6441104|NCT01099774|7356163|FG001|STARTED|Overall Study||295
6441105|NCT01099774|7356162|FG000|COMPLETED|Overall Study||296
6441106|NCT01099774|7356163|FG001|COMPLETED|Overall Study||289
6441107|NCT01099774|7356162|FG000|NOT COMPLETED|Overall Study||6
6441108|NCT01099774|7356163|FG001|NOT COMPLETED|Overall Study||6
6441109|NCT01099917|7356169|FG000|STARTED|Overall Study||45
6441110|NCT01099917|7356169|FG000|COMPLETED|Overall Study||18
6441111|NCT01099917|7356169|FG000|NOT COMPLETED|Overall Study||27
6441112|NCT01099969|7356177|FG000|STARTED|Overall Study||15
6441113|NCT01099969|7356178|FG001|STARTED|Overall Study||15
6441114|NCT01099969|7356179|FG002|STARTED|Overall Study||15
6441115|NCT01099969|7356180|FG003|STARTED|Overall Study||15
6441116|NCT01099969|7356177|FG000|COMPLETED|Overall Study||15
6441117|NCT01099969|7356178|FG001|COMPLETED|Overall Study||15
6441118|NCT01099969|7356179|FG002|COMPLETED|Overall Study||15
6441119|NCT01099969|7356180|FG003|COMPLETED|Overall Study||15
6441120|NCT01099969|7356177|FG000|NOT COMPLETED|Overall Study||0
6441121|NCT01099969|7356178|FG001|NOT COMPLETED|Overall Study||0
6441122|NCT01099969|7356179|FG002|NOT COMPLETED|Overall Study||0
6441123|NCT01099969|7356180|FG003|NOT COMPLETED|Overall Study||0
6441124|NCT01100034|7356190|FG000|STARTED|Overall Study||72
6441125|NCT01100034|7356190|FG000|COMPLETED|Overall Study||29
6441126|NCT01100034|7356190|FG000|NOT COMPLETED|Overall Study||43
6441127|NCT01100073|7356194|FG000|STARTED|Overall Study|Baseline (Visit 1)|1699
6441128|NCT01100073|7356194|FG000|COMPLETED|Overall Study|End of study (Visit 3)|1599
6441129|NCT01100073|7356194|FG000|NOT COMPLETED|Overall Study||100
6441130|NCT01100086|7356198|FG000|STARTED|Period 1||43
6441131|NCT01100086|7356199|FG001|STARTED|Period 1||41
6441132|NCT01100086|7356198|FG000|COMPLETED|Period 1||42
6441133|NCT01100086|7356199|FG001|COMPLETED|Period 1||41
6441134|NCT01100086|7356198|FG000|NOT COMPLETED|Period 1||1
6441135|NCT01100086|7356199|FG001|NOT COMPLETED|Period 1||0
6441136|NCT01100086|7356198|FG000|STARTED|Period 2||42
6441137|NCT01100086|7356199|FG001|STARTED|Period 2||41
6441138|NCT01100086|7356198|FG000|COMPLETED|Period 2||42
6441139|NCT01100086|7356199|FG001|COMPLETED|Period 2||41
6441140|NCT01100086|7356198|FG000|NOT COMPLETED|Period 2||0
6441141|NCT01100086|7356199|FG001|NOT COMPLETED|Period 2||0
6441142|NCT01100112|7356205|FG000|STARTED|Overall Study||60
6441143|NCT01100112|7356205|FG000|COMPLETED|Overall Study||52
6441144|NCT01100112|7356205|FG000|NOT COMPLETED|Overall Study||8
6441145|NCT01100242|7356209|FG000|STARTED|Overall Study||17
6441146|NCT01100242|7356209|FG000|COMPLETED|Overall Study||17
6441147|NCT01100242|7356209|FG000|NOT COMPLETED|Overall Study||0
6441148|NCT01100255|7356215|FG000|STARTED|Overall Study||8
6441149|NCT01100255|7356216|FG001|STARTED|Overall Study||7
6441150|NCT01100255|7356215|FG000|COMPLETED|Overall Study||8
6441151|NCT01100255|7356216|FG001|COMPLETED|Overall Study||7
6441152|NCT01100255|7356215|FG000|NOT COMPLETED|Overall Study||0
6441153|NCT01100255|7356216|FG001|NOT COMPLETED|Overall Study||0
6441154|NCT01100268|7356222|FG000|STARTED|Overall Study||4
6441155|NCT01100268|7356222|FG000|COMPLETED|Overall Study||4
6441156|NCT01100268|7356222|FG000|NOT COMPLETED|Overall Study||0
6441157|NCT01100307|7356228|FG000|STARTED|Double Masked Phase (Up to Week 24)||123
6441158|NCT01100307|7356229|FG001|STARTED|Double Masked Phase (Up to Week 24)||120
6441159|NCT01100307|7356228|FG000|COMPLETED|Double Masked Phase (Up to Week 24)||117
6441160|NCT01100307|7356229|FG001|COMPLETED|Double Masked Phase (Up to Week 24)||116
6441161|NCT01100307|7356228|FG000|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
6441162|NCT01100307|7356229|FG001|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
6441163|NCT01100307|7356228|FG000|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
6441164|NCT01100307|7356229|FG001|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
6441165|NCT01100307|7356228|FG000|COMPLETED|Open Phase (Week 24 up to Week 54)||110
6441166|NCT01100307|7356229|FG001|COMPLETED|Open Phase (Week 24 up to Week 54)||99
6441167|NCT01100307|7356228|FG000|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
6441168|NCT01100307|7356229|FG001|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
6441169|NCT01100320|7356237|FG000|STARTED|Period 1||43
6441170|NCT01100320|7356238|FG001|STARTED|Period 1||45
6441171|NCT01100320|7356237|FG000|COMPLETED|Period 1||38
6441172|NCT01100320|7356238|FG001|COMPLETED|Period 1||38
6441173|NCT01100320|7356237|FG000|NOT COMPLETED|Period 1||5
6441174|NCT01100320|7356238|FG001|NOT COMPLETED|Period 1||7
6441175|NCT01100320|7356237|FG000|STARTED|Period 2||38
6441176|NCT01100320|7356238|FG001|STARTED|Period 2||38
6441177|NCT01100320|7356237|FG000|COMPLETED|Period 2||37
6441178|NCT01100320|7356238|FG001|COMPLETED|Period 2||37
6441179|NCT01100320|7356237|FG000|NOT COMPLETED|Period 2||1
6441180|NCT01100320|7356238|FG001|NOT COMPLETED|Period 2||1
6441181|NCT01100437|7356244|FG000|STARTED|Screening||4
6441182|NCT01100437|7356245|FG001|STARTED|Screening||2
6441183|NCT01100437|7356246|FG002|STARTED|Screening||8
6441184|NCT01100437|7356244|FG000|COMPLETED|Screening||4
6441185|NCT01100437|7356245|FG001|COMPLETED|Screening||2
6441186|NCT01100437|7356246|FG002|COMPLETED|Screening||8
6441187|NCT01100437|7356244|FG000|NOT COMPLETED|Screening||0
6441188|NCT01100437|7356245|FG001|NOT COMPLETED|Screening||0
6441189|NCT01100437|7356246|FG002|NOT COMPLETED|Screening||0
6441190|NCT01100437|7356244|FG000|STARTED|Titration/Stabilization||4
6441191|NCT01100437|7356245|FG001|STARTED|Titration/Stabilization||2
6441192|NCT01100437|7356246|FG002|STARTED|Titration/Stabilization||8
6441193|NCT01100437|7356244|FG000|COMPLETED|Titration/Stabilization||4
6441194|NCT01100437|7356245|FG001|COMPLETED|Titration/Stabilization||2
6441195|NCT01100437|7356246|FG002|COMPLETED|Titration/Stabilization||2
6441196|NCT01100437|7356244|FG000|NOT COMPLETED|Titration/Stabilization||0
6441197|NCT01100437|7356245|FG001|NOT COMPLETED|Titration/Stabilization||0
6441198|NCT01100437|7356246|FG002|NOT COMPLETED|Titration/Stabilization||6
6441199|NCT01100437|7356244|FG000|STARTED|Maintenance||4
6441200|NCT01100437|7356245|FG001|STARTED|Maintenance||2
6441201|NCT01100437|7356246|FG002|STARTED|Maintenance||2
6441202|NCT01100437|7356244|FG000|COMPLETED|Maintenance||4
6441203|NCT01100437|7356245|FG001|COMPLETED|Maintenance||2
6441204|NCT01100437|7356246|FG002|COMPLETED|Maintenance||0
6441205|NCT01100437|7356244|FG000|NOT COMPLETED|Maintenance||0
6441206|NCT01100437|7356245|FG001|NOT COMPLETED|Maintenance||0
6441207|NCT01100437|7356246|FG002|NOT COMPLETED|Maintenance||2
6441208|NCT01100437|7356244|FG000|STARTED|Treatment 1||4
6441209|NCT01100437|7356245|FG001|STARTED|Treatment 1||2
6441210|NCT01100437|7356246|FG002|STARTED|Treatment 1||0
6441211|NCT01100437|7356244|FG000|COMPLETED|Treatment 1||4
6441212|NCT01100437|7356245|FG001|COMPLETED|Treatment 1||2
6441213|NCT01100437|7356246|FG002|COMPLETED|Treatment 1||0
6441214|NCT01100437|7356244|FG000|NOT COMPLETED|Treatment 1||0
6441215|NCT01100437|7356245|FG001|NOT COMPLETED|Treatment 1||0
6441216|NCT01100437|7356246|FG002|NOT COMPLETED|Treatment 1||0
6441217|NCT01100437|7356244|FG000|STARTED|Washout (4 Days)||4
6441218|NCT01100437|7356245|FG001|STARTED|Washout (4 Days)||2
6441219|NCT01100437|7356246|FG002|STARTED|Washout (4 Days)||0
6441220|NCT01100437|7356244|FG000|COMPLETED|Washout (4 Days)||4
6441221|NCT01100437|7356245|FG001|COMPLETED|Washout (4 Days)||2
6441222|NCT01100437|7356246|FG002|COMPLETED|Washout (4 Days)||0
6441223|NCT01100437|7356244|FG000|NOT COMPLETED|Washout (4 Days)||0
6441224|NCT01100437|7356245|FG001|NOT COMPLETED|Washout (4 Days)||0
6441225|NCT01100437|7356246|FG002|NOT COMPLETED|Washout (4 Days)||0
6441226|NCT01100437|7356244|FG000|STARTED|Treatment 2||4
6441227|NCT01100437|7356245|FG001|STARTED|Treatment 2||2
6441228|NCT01100437|7356246|FG002|STARTED|Treatment 2||0
6441229|NCT01100437|7356244|FG000|COMPLETED|Treatment 2||4
6441230|NCT01100437|7356245|FG001|COMPLETED|Treatment 2||2
6441231|NCT01100437|7356246|FG002|COMPLETED|Treatment 2||0
6441232|NCT01100437|7356244|FG000|NOT COMPLETED|Treatment 2||0
6441233|NCT01100437|7356245|FG001|NOT COMPLETED|Treatment 2||0
6441234|NCT01100437|7356246|FG002|NOT COMPLETED|Treatment 2||0
6441235|NCT01100502|7356257|FG000|STARTED|Overall Study||165
6441236|NCT01100502|7356258|FG001|STARTED|Overall Study||164
6441237|NCT01100502|7356257|FG000|COMPLETED|Overall Study|Completed due to study closure by sponsor|89
6441238|NCT01100502|7356258|FG001|COMPLETED|Overall Study|Completed due to study closure by sponsor|70
6441239|NCT01100502|7356257|FG000|NOT COMPLETED|Overall Study||76
6441240|NCT01100502|7356258|FG001|NOT COMPLETED|Overall Study||94
6441241|NCT01100528|7356264|FG000|STARTED|Overall Study||38
6441242|NCT01100528|7356264|FG000|COMPLETED|Overall Study||35
6441243|NCT01100528|7356264|FG000|NOT COMPLETED|Overall Study||3
6653394|NCT02436759|7583159|FG001|Subjects Treated|Overall Study||46
6653395|NCT02436759|7583158|FG000|COMPLETED|Overall Study||90
6653396|NCT02436759|7583159|FG001|COMPLETED|Overall Study||45
6653397|NCT02436759|7583158|FG000|NOT COMPLETED|Overall Study||4
6653398|NCT02436759|7583159|FG001|NOT COMPLETED|Overall Study||1
6653399|NCT02436811|7583168|FG000|STARTED|Overall Study||60
6653400|NCT02436811|7583169|FG001|STARTED|Overall Study||60
6653401|NCT02436811|7583170|FG002|STARTED|Overall Study||60
6653402|NCT02436811|7583168|FG000|COMPLETED|Overall Study||58
6653403|NCT02436811|7583169|FG001|COMPLETED|Overall Study||51
6653404|NCT02436811|7583170|FG002|COMPLETED|Overall Study||53
6653405|NCT02436811|7583168|FG000|NOT COMPLETED|Overall Study||2
6441244|NCT01100567|7356270|FG000|STARTED|Overall Study||50
6441245|NCT01100567|7356271|FG001|STARTED|Overall Study||51
6441246|NCT01100567|7356270|FG000|COMPLETED|Overall Study||38
6441247|NCT01100567|7356271|FG001|COMPLETED|Overall Study||35
6441248|NCT01100567|7356270|FG000|NOT COMPLETED|Overall Study||12
6441249|NCT01100567|7356271|FG001|NOT COMPLETED|Overall Study||16
6441250|NCT01100606|7356277|FG000|STARTED|First Treatment Period||8
6441251|NCT01100606|7356278|FG001|STARTED|First Treatment Period||7
6441252|NCT01100606|7356277|FG000|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
6441253|NCT01100606|7356278|FG001|COMPLETED|First Treatment Period||7
6441254|NCT01100606|7356277|FG000|NOT COMPLETED|First Treatment Period||0
6441255|NCT01100606|7356278|FG001|NOT COMPLETED|First Treatment Period||0
6441256|NCT01100606|7356277|FG000|STARTED|Second Treatment Period||8
6441257|NCT01100606|7356278|FG001|STARTED|Second Treatment Period||7
6441258|NCT01100606|7356277|FG000|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
6441259|NCT01100606|7356278|FG001|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
6441260|NCT01100606|7356277|FG000|NOT COMPLETED|Second Treatment Period||0
6441261|NCT01100606|7356278|FG001|NOT COMPLETED|Second Treatment Period||0
6441262|NCT01100723|7356288|FG000|STARTED|Overall Study||92
6441263|NCT01100723|7356288|FG000|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
6441264|NCT01100723|7356288|FG000|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
6441265|NCT01100723|7356288|FG000|NOT COMPLETED|Overall Study||14
6441266|NCT01100762|7356293|FG000|STARTED|Overall Study||10
6441267|NCT01100762|7356293|FG000|COMPLETED|Overall Study||10
6441268|NCT01100762|7356293|FG000|NOT COMPLETED|Overall Study||0
6441269|NCT01100853|7356301|FG000|STARTED|Overall Study||51
6441270|NCT01100853|7356302|FG001|STARTED|Overall Study||49
6653406|NCT02436811|7583169|FG001|NOT COMPLETED|Overall Study||9
6441271|NCT01100853|7356301|FG000|COMPLETED|Overall Study||24
6441272|NCT01100853|7356302|FG001|COMPLETED|Overall Study||26
6441273|NCT01100853|7356301|FG000|NOT COMPLETED|Overall Study||27
6441274|NCT01100853|7356302|FG001|NOT COMPLETED|Overall Study||23
6653407|NCT02436811|7583170|FG002|NOT COMPLETED|Overall Study||7
6441275|NCT01100931|7356310|FG000|STARTED|Phase I||22
6441276|NCT01100931|7356311|FG001|STARTED|Phase I||0
6441277|NCT01100931|7356310|FG000|COMPLETED|Phase I||22
6441278|NCT01100931|7356311|FG001|COMPLETED|Phase I||0
6441279|NCT01100931|7356310|FG000|NOT COMPLETED|Phase I||0
6653408|NCT02436876|7583182|FG000|STARTED|Overall Study||6
6653409|NCT02436876|7583183|FG001|STARTED|Overall Study||9
6441280|NCT01100931|7356311|FG001|NOT COMPLETED|Phase I||0
6441281|NCT01100931|7356310|FG000|STARTED|Phase II||0
6441282|NCT01100931|7356311|FG001|STARTED|Phase II||19
6441283|NCT01100931|7356310|FG000|COMPLETED|Phase II||0
6441284|NCT01100931|7356311|FG001|COMPLETED|Phase II||19
6441285|NCT01100931|7356310|FG000|NOT COMPLETED|Phase II||0
6441286|NCT01100931|7356311|FG001|NOT COMPLETED|Phase II||0
6441287|NCT01100944|7356318|FG000|STARTED|Dose Escalation Phase 1 Dose Level 1||6
6441288|NCT01100944|7356319|FG001|STARTED|Dose Escalation Phase 1 Dose Level 1||0
6441289|NCT01100944|7356320|FG002|STARTED|Dose Escalation Phase 1 Dose Level 1||0
6441290|NCT01100944|7356318|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
6441291|NCT01100944|7356319|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
6441292|NCT01100944|7356320|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
6441293|NCT01100944|7356318|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
6441294|NCT01100944|7356319|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
6441295|NCT01100944|7356320|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
6441296|NCT01100944|7356318|FG000|STARTED|Dose Escalation Phase 1 Dose Level 2||0
6441297|NCT01100944|7356319|FG001|STARTED|Dose Escalation Phase 1 Dose Level 2||2
6441298|NCT01100944|7356320|FG002|STARTED|Dose Escalation Phase 1 Dose Level 2||0
6441299|NCT01100944|7356318|FG000|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6441300|NCT01100944|7356319|FG001|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6441301|NCT01100944|7356320|FG002|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6441302|NCT01100944|7356318|FG000|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6441303|NCT01100944|7356319|FG001|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
6441304|NCT01100944|7356320|FG002|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
6441305|NCT01100944|7356318|FG000|STARTED|Expansion Phase - Phase 2||0
6441306|NCT01100944|7356319|FG001|STARTED|Expansion Phase - Phase 2||0
6441307|NCT01100944|7356320|FG002|STARTED|Expansion Phase - Phase 2||18
6441308|NCT01100944|7356318|FG000|COMPLETED|Expansion Phase - Phase 2||0
6441309|NCT01100944|7356319|FG001|COMPLETED|Expansion Phase - Phase 2||0
6441310|NCT01100944|7356320|FG002|COMPLETED|Expansion Phase - Phase 2||18
6441311|NCT01100944|7356318|FG000|NOT COMPLETED|Expansion Phase - Phase 2||0
6441312|NCT01100944|7356319|FG001|NOT COMPLETED|Expansion Phase - Phase 2||0
6441313|NCT01100944|7356320|FG002|NOT COMPLETED|Expansion Phase - Phase 2||0
6441314|NCT01101022|7356343|FG000|STARTED|Overall Study||79
6441315|NCT01101022|7356344|FG001|STARTED|Overall Study||80
6441316|NCT01101022|7356343|FG000|COMPLETED|Overall Study||62
6441317|NCT01101022|7356344|FG001|COMPLETED|Overall Study||53
6441318|NCT01101022|7356343|FG000|NOT COMPLETED|Overall Study||17
6441319|NCT01101022|7356344|FG001|NOT COMPLETED|Overall Study||27
6441320|NCT01101035|7356352|FG000|STARTED|Overall Study||3101
6441321|NCT01101035|7356353|FG001|STARTED|Overall Study||3097
6441322|NCT01101035|7356352|FG000|COMPLETED|Overall Study||1704
6441323|NCT01101035|7356353|FG001|COMPLETED|Overall Study||1706
6441324|NCT01101035|7356352|FG000|NOT COMPLETED|Overall Study||1397
6441325|NCT01101035|7356353|FG001|NOT COMPLETED|Overall Study||1391
6441326|NCT01101061|7356365|FG000|STARTED|Overall Study||6
6441327|NCT01101061|7356366|FG001|STARTED|Overall Study||6
6441328|NCT01101061|7356367|FG002|STARTED|Overall Study||7
6441329|NCT01101061|7356368|FG003|STARTED|Overall Study||6
6441330|NCT01101061|7356369|FG004|STARTED|Overall Study||2
6441331|NCT01101061|7356370|FG005|STARTED|Overall Study||4
6441332|NCT01101061|7356365|FG000|Received Study Drug|Overall Study||6
6441333|NCT01101061|7356366|FG001|Received Study Drug|Overall Study||6
6441334|NCT01101061|7356367|FG002|Received Study Drug|Overall Study||6
6441335|NCT01101061|7356368|FG003|Received Study Drug|Overall Study||6
6441336|NCT01101061|7356369|FG004|Received Study Drug|Overall Study||2
6441337|NCT01101061|7356370|FG005|Received Study Drug|Overall Study||4
6441338|NCT01101061|7356365|FG000|COMPLETED|Overall Study||6
6441339|NCT01101061|7356366|FG001|COMPLETED|Overall Study||6
6441340|NCT01101061|7356367|FG002|COMPLETED|Overall Study||6
6441341|NCT01101061|7356368|FG003|COMPLETED|Overall Study||6
6441342|NCT01101061|7356369|FG004|COMPLETED|Overall Study||2
6441343|NCT01101061|7356370|FG005|COMPLETED|Overall Study||4
6441344|NCT01101061|7356365|FG000|NOT COMPLETED|Overall Study||0
6441345|NCT01101061|7356366|FG001|NOT COMPLETED|Overall Study||0
6441346|NCT01101061|7356367|FG002|NOT COMPLETED|Overall Study||1
6441347|NCT01101061|7356368|FG003|NOT COMPLETED|Overall Study||0
6441348|NCT01101061|7356369|FG004|NOT COMPLETED|Overall Study||0
6441349|NCT01101061|7356370|FG005|NOT COMPLETED|Overall Study||0
6441350|NCT01101100|7356388|FG000|STARTED|Overall Study||181
6441351|NCT01101100|7356388|FG000|COMPLETED|Overall Study||126
6441352|NCT01101100|7356388|FG000|NOT COMPLETED|Overall Study||55
6441353|NCT01101165|7356393|FG000|STARTED|Period 1||47
6441354|NCT01101165|7356394|FG001|STARTED|Period 1||45
6441355|NCT01101165|7356393|FG000|COMPLETED|Period 1||45
6441356|NCT01101165|7356394|FG001|COMPLETED|Period 1||40
6441357|NCT01101165|7356393|FG000|NOT COMPLETED|Period 1||2
6441358|NCT01101165|7356394|FG001|NOT COMPLETED|Period 1||5
6441359|NCT01101165|7356393|FG000|STARTED|Period 2||45
6441360|NCT01101165|7356394|FG001|STARTED|Period 2||40
6441361|NCT01101165|7356393|FG000|COMPLETED|Period 2||41
6441362|NCT01101165|7356394|FG001|COMPLETED|Period 2||39
6441363|NCT01101165|7356393|FG000|NOT COMPLETED|Period 2||4
6441364|NCT01101165|7356394|FG001|NOT COMPLETED|Period 2||1
6441365|NCT01101178|7356400|FG000|STARTED|Period 1||40
6441366|NCT01101178|7356401|FG001|STARTED|Period 1||39
6441367|NCT01101178|7356400|FG000|COMPLETED|Period 1||36
6441368|NCT01101178|7356401|FG001|COMPLETED|Period 1||35
6441369|NCT01101178|7356400|FG000|NOT COMPLETED|Period 1||4
6441370|NCT01101178|7356401|FG001|NOT COMPLETED|Period 1||4
6441371|NCT01101178|7356400|FG000|STARTED|Period 2||36
6441372|NCT01101178|7356401|FG001|STARTED|Period 2||35
6441373|NCT01101178|7356400|FG000|COMPLETED|Period 2||36
6441374|NCT01101178|7356401|FG001|COMPLETED|Period 2||34
6441375|NCT01101178|7356400|FG000|NOT COMPLETED|Period 2||0
6441376|NCT01101178|7356401|FG001|NOT COMPLETED|Period 2||1
6441377|NCT01101191|7356408|FG000|STARTED|Period 1||42
6441378|NCT01101191|7356409|FG001|STARTED|Period 1||42
6441379|NCT01101191|7356408|FG000|COMPLETED|Period 1||40
6441380|NCT01101191|7356409|FG001|COMPLETED|Period 1||40
6441381|NCT01101191|7356408|FG000|NOT COMPLETED|Period 1||2
6441382|NCT01101191|7356409|FG001|NOT COMPLETED|Period 1||2
6441383|NCT01101191|7356408|FG000|STARTED|Period 2||40
6441384|NCT01101191|7356409|FG001|STARTED|Period 2||40
6441385|NCT01101191|7356408|FG000|COMPLETED|Period 2||40
6441386|NCT01101191|7356409|FG001|COMPLETED|Period 2||40
6441387|NCT01101191|7356408|FG000|NOT COMPLETED|Period 2||0
6441388|NCT01101191|7356409|FG001|NOT COMPLETED|Period 2||0
6441389|NCT01101308|7356416|FG000|STARTED|Period 1||27
6441390|NCT01101308|7356417|FG001|STARTED|Period 1||28
6441391|NCT01101308|7356416|FG000|COMPLETED|Period 1||24
6441392|NCT01101308|7356417|FG001|COMPLETED|Period 1||27
6441393|NCT01101308|7356416|FG000|NOT COMPLETED|Period 1||3
6441394|NCT01101308|7356417|FG001|NOT COMPLETED|Period 1||1
6441395|NCT01101308|7356416|FG000|STARTED|Period 2||24
6441396|NCT01101308|7356417|FG001|STARTED|Period 2||27
6441397|NCT01101308|7356416|FG000|COMPLETED|Period 2||24
6441398|NCT01101308|7356417|FG001|COMPLETED|Period 2||27
6441399|NCT01101308|7356416|FG000|NOT COMPLETED|Period 2||0
6441400|NCT01101308|7356417|FG001|NOT COMPLETED|Period 2||0
6441401|NCT01101321|7356424|FG000|STARTED|Period 1||30
6441402|NCT01101321|7356425|FG001|STARTED|Period 1||28
6441403|NCT01101321|7356424|FG000|COMPLETED|Period 1||26
6441404|NCT01101321|7356425|FG001|COMPLETED|Period 1||24
6441405|NCT01101321|7356424|FG000|NOT COMPLETED|Period 1||4
6441406|NCT01101321|7356425|FG001|NOT COMPLETED|Period 1||4
6441407|NCT01101321|7356424|FG000|STARTED|Period 2||26
6441408|NCT01101321|7356425|FG001|STARTED|Period 2||24
6441409|NCT01101321|7356424|FG000|COMPLETED|Period 2||26
6441410|NCT01101321|7356425|FG001|COMPLETED|Period 2||24
6441411|NCT01101321|7356424|FG000|NOT COMPLETED|Period 2||0
6441412|NCT01101321|7356425|FG001|NOT COMPLETED|Period 2||0
6441413|NCT01101334|7356433|FG000|STARTED|Overall Study||45
6441414|NCT01101334|7356434|FG001|STARTED|Overall Study||45
6441415|NCT01101334|7356433|FG000|Received Study Treatment|Overall Study||44
6441416|NCT01101334|7356434|FG001|Received Study Treatment|Overall Study||45
6441417|NCT01101334|7356433|FG000|COMPLETED|Overall Study||0
6441418|NCT01101334|7356434|FG001|COMPLETED|Overall Study||0
6441419|NCT01101334|7356433|FG000|NOT COMPLETED|Overall Study||45
6441420|NCT01101334|7356434|FG001|NOT COMPLETED|Overall Study||45
6441421|NCT01101477|7356443|FG000|STARTED|Overall Study||49
6441422|NCT01101477|7356444|FG001|STARTED|Overall Study||49
6441423|NCT01101477|7356445|FG002|STARTED|Overall Study||46
6441424|NCT01101477|7356443|FG000|COMPLETED|Overall Study||44
6441425|NCT01101477|7356444|FG001|COMPLETED|Overall Study||46
6441426|NCT01101477|7356445|FG002|COMPLETED|Overall Study||45
6441427|NCT01101477|7356443|FG000|NOT COMPLETED|Overall Study||5
6441428|NCT01101477|7356444|FG001|NOT COMPLETED|Overall Study||3
6441429|NCT01101477|7356445|FG002|NOT COMPLETED|Overall Study||1
6441430|NCT01101542|7356453|FG000|STARTED|Year 3 Surveillance Period||105
6441431|NCT01101542|7356453|FG000|COMPLETED|Year 3 Surveillance Period||94
6441432|NCT01101542|7356453|FG000|NOT COMPLETED|Year 3 Surveillance Period||11
6441433|NCT01101542|7356453|FG000|STARTED|Year 4 Surveillance Period||569
6441434|NCT01101542|7356453|FG000|COMPLETED|Year 4 Surveillance Period||282
6441435|NCT01101542|7356453|FG000|NOT COMPLETED|Year 4 Surveillance Period||287
6441436|NCT01101542|7356453|FG000|STARTED|Year 5 Surveillance Period||809
6441437|NCT01101542|7356453|FG000|COMPLETED|Year 5 Surveillance Period||668
6441438|NCT01101542|7356453|FG000|NOT COMPLETED|Year 5 Surveillance Period||141
6441439|NCT01101542|7356453|FG000|STARTED|Year 6 Surveillance Period||3091
6441440|NCT01101542|7356453|FG000|COMPLETED|Year 6 Surveillance Period||2100
6441441|NCT01101542|7356453|FG000|NOT COMPLETED|Year 6 Surveillance Period||991
6441442|NCT01101750|7356457|FG000|STARTED|Overall Study||25
6441443|NCT01101750|7356457|FG000|COMPLETED|Overall Study||9
6441444|NCT01101750|7356457|FG000|NOT COMPLETED|Overall Study||16
6441445|NCT01101841|7356463|FG000|STARTED|Overall Study||285
6441446|NCT01101841|7356464|FG001|STARTED|Overall Study||285
6441447|NCT01101841|7356463|FG000|COMPLETED|Overall Study||235
6441448|NCT01101841|7356464|FG001|COMPLETED|Overall Study||218
6441449|NCT01101841|7356463|FG000|NOT COMPLETED|Overall Study||50
6441450|NCT01101841|7356464|FG001|NOT COMPLETED|Overall Study||67
6441451|NCT01101867|7356473|FG000|STARTED|Overall Study||63
6441452|NCT01101867|7356474|FG001|STARTED|Overall Study||63
6441453|NCT01101867|7356473|FG000|COMPLETED|Overall Study||62
6441454|NCT01101867|7356474|FG001|COMPLETED|Overall Study||59
6441455|NCT01101867|7356473|FG000|NOT COMPLETED|Overall Study||1
6441456|NCT01101867|7356474|FG001|NOT COMPLETED|Overall Study||4
6441457|NCT01101880|7356484|FG000|STARTED|Overall Study||50
6441458|NCT01101880|7356484|FG000|COMPLETED|Overall Study||50
6441459|NCT01101880|7356484|FG000|NOT COMPLETED|Overall Study||0
6441460|NCT01101958|7356490|FG000|STARTED|Overall Study||62
6441461|NCT01101958|7356491|FG001|STARTED|Overall Study||34
6441462|NCT01101958|7356490|FG000|COMPLETED|Overall Study||51
6441463|NCT01101958|7356491|FG001|COMPLETED|Overall Study||29
6441464|NCT01101958|7356490|FG000|NOT COMPLETED|Overall Study||11
6441465|NCT01101958|7356491|FG001|NOT COMPLETED|Overall Study||5
6441466|NCT01101971|7356497|FG000|STARTED|Overall Study||45
6441467|NCT01101971|7356497|FG000|COMPLETED|Overall Study||45
6441468|NCT01101971|7356497|FG000|NOT COMPLETED|Overall Study||0
6441469|NCT01101997|7356501|FG000|STARTED|Overall Study||60
6441470|NCT01101997|7356501|FG000|COMPLETED|Overall Study||58
6441471|NCT01101997|7356501|FG000|NOT COMPLETED|Overall Study||2
6441472|NCT01102218|7356509|FG000|STARTED|Overall Study||24
6441473|NCT01102218|7356510|FG001|STARTED|Overall Study||24
6441474|NCT01102218|7356509|FG000|COMPLETED|Overall Study||13
6441475|NCT01102218|7356510|FG001|COMPLETED|Overall Study||14
6441476|NCT01102218|7356509|FG000|NOT COMPLETED|Overall Study||11
6441477|NCT01102218|7356510|FG001|NOT COMPLETED|Overall Study||10
6441478|NCT01102231|7356516|FG000|STARTED|Overall Study||106
6441479|NCT01102231|7356516|FG000|COMPLETED|Overall Study||91
6441480|NCT01102231|7356516|FG000|NOT COMPLETED|Overall Study||15
6441481|NCT01102257|7356523|FG000|STARTED|Overall Study||9
6441482|NCT01102257|7356524|FG001|STARTED|Overall Study||9
6441483|NCT01102257|7356523|FG000|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
6441484|NCT01102257|7356524|FG001|COMPLETED|Overall Study||9
6441485|NCT01102257|7356523|FG000|NOT COMPLETED|Overall Study||2
6441486|NCT01102257|7356524|FG001|NOT COMPLETED|Overall Study||0
6441487|NCT01102270|7356530|FG000|STARTED|Overall Study||8
6441488|NCT01102270|7356531|FG001|STARTED|Overall Study||9
6441489|NCT01102270|7356530|FG000|COMPLETED|Overall Study||8
6441490|NCT01102270|7356531|FG001|COMPLETED|Overall Study||9
6441491|NCT01102270|7356530|FG000|NOT COMPLETED|Overall Study||0
6441492|NCT01102270|7356531|FG001|NOT COMPLETED|Overall Study||0
6441493|NCT01102374|7356539|FG000|STARTED|Overall Study||55
6441494|NCT01102374|7356540|FG001|STARTED|Overall Study||52
6441495|NCT01102374|7356539|FG000|COMPLETED|Overall Study||39
6441496|NCT01102374|7356540|FG001|COMPLETED|Overall Study||33
6441497|NCT01102374|7356539|FG000|NOT COMPLETED|Overall Study||16
6441498|NCT01102374|7356540|FG001|NOT COMPLETED|Overall Study||19
6441499|NCT01102413|7356548|FG000|STARTED|Overall Study||233
6441500|NCT01102413|7356549|FG001|STARTED|Overall Study||118
6441501|NCT01102413|7356548|FG000|COMPLETED|Overall Study||208
6441502|NCT01102413|7356549|FG001|COMPLETED|Overall Study||106
6441503|NCT01102413|7356548|FG000|NOT COMPLETED|Overall Study||25
6441504|NCT01102413|7356549|FG001|NOT COMPLETED|Overall Study||12
6441505|NCT01102426|7356557|FG000|STARTED|Overall Study||171
6441506|NCT01102426|7356558|FG001|STARTED|Overall Study||84
6441507|NCT01102426|7356557|FG000|COMPLETED|Overall Study||6
6441508|NCT01102426|7356558|FG001|COMPLETED|Overall Study||3
6441509|NCT01102426|7356557|FG000|NOT COMPLETED|Overall Study||165
6441510|NCT01102426|7356558|FG001|NOT COMPLETED|Overall Study||81
6441511|NCT01102491|7356566|FG000|STARTED|Overall Study||71
6441512|NCT01102491|7356567|FG001|STARTED|Overall Study||71
6441513|NCT01102491|7356566|FG000|COMPLETED|Overall Study|11 patient excluded|60
6441514|NCT01102491|7356567|FG001|COMPLETED|Overall Study|12 patients were excluded|59
6441515|NCT01102491|7356566|FG000|NOT COMPLETED|Overall Study||11
6441516|NCT01102491|7356567|FG001|NOT COMPLETED|Overall Study||12
6441517|NCT01102738|7356573|FG000|STARTED|Overall Study||369
6441518|NCT01102738|7356573|FG000|COMPLETED|Overall Study||369
6441519|NCT01102738|7356573|FG000|NOT COMPLETED|Overall Study||0
6441520|NCT01102764|7356579|FG000|STARTED|Overall Study||64
6441521|NCT01102764|7356580|FG001|STARTED|Overall Study||68
6441522|NCT01102764|7356579|FG000|COMPLETED|Overall Study||43
6441523|NCT01102764|7356580|FG001|COMPLETED|Overall Study||55
6441524|NCT01102764|7356579|FG000|NOT COMPLETED|Overall Study||21
6441525|NCT01102764|7356580|FG001|NOT COMPLETED|Overall Study||13
6441526|NCT01102777|7356588|FG000|STARTED|Overall Study||84
6441527|NCT01102777|7356589|FG001|STARTED|Overall Study||155
6441528|NCT01102777|7356588|FG000|COMPLETED|Overall Study||75
6441529|NCT01102777|7356589|FG001|COMPLETED|Overall Study||139
6441530|NCT01102777|7356588|FG000|NOT COMPLETED|Overall Study||9
6441531|NCT01102777|7356589|FG001|NOT COMPLETED|Overall Study||16
6441532|NCT01102803|7356598|FG000|STARTED|Baseline to Post-Treatment||14
6441533|NCT01102803|7356599|FG001|STARTED|Baseline to Post-Treatment||15
6441534|NCT01102803|7356598|FG000|COMPLETED|Baseline to Post-Treatment||11
6441535|NCT01102803|7356599|FG001|COMPLETED|Baseline to Post-Treatment||15
6441536|NCT01102803|7356598|FG000|NOT COMPLETED|Baseline to Post-Treatment||3
6441537|NCT01102803|7356599|FG001|NOT COMPLETED|Baseline to Post-Treatment||0
6441538|NCT01102803|7356598|FG000|STARTED|Post to Follow-Up||11
6441539|NCT01102803|7356599|FG001|STARTED|Post to Follow-Up||15
6441540|NCT01102803|7356598|FG000|COMPLETED|Post to Follow-Up||10
6441541|NCT01102803|7356599|FG001|COMPLETED|Post to Follow-Up||12
6441542|NCT01102803|7356598|FG000|NOT COMPLETED|Post to Follow-Up||1
6441543|NCT01102803|7356599|FG001|NOT COMPLETED|Post to Follow-Up||3
6441544|NCT01102894|7356607|FG000|STARTED|Overall Study||10
6441545|NCT01102894|7356607|FG000|COMPLETED|Overall Study||10
6441546|NCT01102894|7356607|FG000|NOT COMPLETED|Overall Study||0
6441547|NCT01102972|7356615|FG000|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|199
6441548|NCT01102972|7356616|FG001|STARTED|Overall Study|"297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn't start the study."|97
6441549|NCT01102972|7356615|FG000|Completed Week 24|Overall Study||180
6441550|NCT01102972|7356616|FG001|Completed Week 24|Overall Study||88
6441551|NCT01102972|7356615|FG000|COMPLETED|Overall Study|These participants completed Study Week 48.|170
6653410|NCT02436876|7583184|FG002|STARTED|Overall Study||7
6653411|NCT02436876|7583185|FG003|STARTED|Overall Study||7
6653412|NCT02436876|7583182|FG000|Treated|Overall Study||6
6653413|NCT02436876|7583183|FG001|Treated|Overall Study||6
6653414|NCT02436876|7583184|FG002|Treated|Overall Study||6
6653415|NCT02436876|7583185|FG003|Treated|Overall Study||7
6653416|NCT02436876|7583182|FG000|COMPLETED|Overall Study||5
6653417|NCT02436876|7583183|FG001|COMPLETED|Overall Study||5
6653418|NCT02436876|7583184|FG002|COMPLETED|Overall Study||5
6441552|NCT01102972|7356616|FG001|COMPLETED|Overall Study|These participants completed Study Week 48.|83
6441553|NCT01102972|7356615|FG000|NOT COMPLETED|Overall Study||29
6441554|NCT01102972|7356616|FG001|NOT COMPLETED|Overall Study||14
6441555|NCT01103063|7356624|FG000|STARTED|Overall Study||1446
6441556|NCT01103063|7356625|FG001|STARTED|Overall Study||1445
6441557|NCT01103063|7356624|FG000|COMPLETED|Overall Study||969
6441558|NCT01103063|7356625|FG001|COMPLETED|Overall Study||1024
6441559|NCT01103063|7356624|FG000|NOT COMPLETED|Overall Study||477
6441560|NCT01103063|7356625|FG001|NOT COMPLETED|Overall Study||421
6441561|NCT01103141|7356635|FG000|STARTED|Overall Study||67
6441562|NCT01103141|7356636|FG001|STARTED|Overall Study||76
6441563|NCT01103141|7356635|FG000|COMPLETED|Overall Study||65
6441564|NCT01103141|7356636|FG001|COMPLETED|Overall Study||74
6441565|NCT01103141|7356635|FG000|NOT COMPLETED|Overall Study||2
6441566|NCT01103141|7356636|FG001|NOT COMPLETED|Overall Study||2
6441567|NCT01103232|7356644|FG000|STARTED|Overall Study||13
6441568|NCT01103232|7356645|FG001|STARTED|Overall Study||13
6441569|NCT01103232|7356644|FG000|COMPLETED|Overall Study||12
6441570|NCT01103232|7356645|FG001|COMPLETED|Overall Study||11
6441571|NCT01103232|7356644|FG000|NOT COMPLETED|Overall Study||1
6441572|NCT01103232|7356645|FG001|NOT COMPLETED|Overall Study||2
6441573|NCT01103245|7356655|FG000|STARTED|Overall Study||13
6441574|NCT01103245|7356656|FG001|STARTED|Overall Study||7
6441575|NCT01103245|7356657|FG002|STARTED|Overall Study||12
6441576|NCT01103245|7356658|FG003|STARTED|Overall Study||6
6441577|NCT01103245|7356655|FG000|COMPLETED|Overall Study||10
6441578|NCT01103245|7356656|FG001|COMPLETED|Overall Study||5
6441579|NCT01103245|7356657|FG002|COMPLETED|Overall Study||8
6441580|NCT01103245|7356658|FG003|COMPLETED|Overall Study||6
6441581|NCT01103245|7356655|FG000|NOT COMPLETED|Overall Study||3
6441582|NCT01103245|7356656|FG001|NOT COMPLETED|Overall Study||2
6441583|NCT01103245|7356657|FG002|NOT COMPLETED|Overall Study||4
6441584|NCT01103245|7356658|FG003|NOT COMPLETED|Overall Study||0
6441585|NCT01103271|7356670|FG000|STARTED|Overall Study||11
6441586|NCT01103271|7356671|FG001|STARTED|Overall Study||9
6653419|NCT02436876|7583185|FG003|COMPLETED|Overall Study||5
6653420|NCT02436876|7583182|FG000|NOT COMPLETED|Overall Study||1
6653421|NCT02436876|7583183|FG001|NOT COMPLETED|Overall Study||4
6653422|NCT02436876|7583184|FG002|NOT COMPLETED|Overall Study||2
6653423|NCT02436876|7583185|FG003|NOT COMPLETED|Overall Study||2
6653424|NCT02436889|7583202|FG000|STARTED|Overall Study||12
6653425|NCT02436889|7583203|FG001|STARTED|Overall Study||11
6441587|NCT01103271|7356670|FG000|COMPLETED|Overall Study||10
6441588|NCT01103271|7356671|FG001|COMPLETED|Overall Study||5
6441589|NCT01103271|7356670|FG000|NOT COMPLETED|Overall Study||1
6441590|NCT01103271|7356671|FG001|NOT COMPLETED|Overall Study||4
6441591|NCT01103284|7356680|FG000|STARTED|Overall Study||236
6441592|NCT01103284|7356681|FG001|STARTED|Overall Study||239
6441593|NCT01103284|7356680|FG000|Treated|Overall Study||236
6441594|NCT01103284|7356681|FG001|Treated|Overall Study||238
6441595|NCT01103284|7356680|FG000|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
6441596|NCT01103284|7356681|FG001|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
6441597|NCT01103284|7356680|FG000|COMPLETED|Overall Study||194
6441598|NCT01103284|7356681|FG001|COMPLETED|Overall Study||195
6441599|NCT01103284|7356680|FG000|NOT COMPLETED|Overall Study||42
6441600|NCT01103284|7356681|FG001|NOT COMPLETED|Overall Study||44
6441601|NCT01103323|7356689|FG000|STARTED|Without/Before Drug Switch||505
6441602|NCT01103323|7356690|FG001|STARTED|Without/Before Drug Switch||255
6441603|NCT01103323|7356689|FG000|Participants Received Treatment|Without/Before Drug Switch||500
6441604|NCT01103323|7356690|FG001|Participants Received Treatment|Without/Before Drug Switch||253
6441605|NCT01103323|7356689|FG000|COMPLETED|Without/Before Drug Switch||429
6441606|NCT01103323|7356690|FG001|COMPLETED|Without/Before Drug Switch||237
6441607|NCT01103323|7356689|FG000|NOT COMPLETED|Without/Before Drug Switch||76
6441608|NCT01103323|7356690|FG001|NOT COMPLETED|Without/Before Drug Switch||18
6441609|NCT01103323|7356689|FG000|STARTED|Switched From Placebo to Regorafenib||0
6441610|NCT01103323|7356690|FG001|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
6441611|NCT01103323|7356689|FG000|COMPLETED|Switched From Placebo to Regorafenib||0
6441612|NCT01103323|7356690|FG001|COMPLETED|Switched From Placebo to Regorafenib||3
6441613|NCT01103323|7356689|FG000|NOT COMPLETED|Switched From Placebo to Regorafenib||0
6441614|NCT01103323|7356690|FG001|NOT COMPLETED|Switched From Placebo to Regorafenib||1
6441615|NCT01103362|7356697|FG000|STARTED|Overall Study||596
6441616|NCT01103362|7356697|FG000|COMPLETED|Overall Study||0
6653426|NCT02436889|7583202|FG000|COMPLETED|Overall Study||11
6653427|NCT02436889|7583203|FG001|COMPLETED|Overall Study||10
6441617|NCT01103362|7356697|FG000|NOT COMPLETED|Overall Study||596
6441618|NCT01103414|7356706|FG000|STARTED|Overall Study||72
6441619|NCT01103414|7356707|FG001|STARTED|Overall Study||71
6441620|NCT01103414|7356708|FG002|STARTED|Overall Study||71
6441621|NCT01103414|7356709|FG003|STARTED|Overall Study||71
6441622|NCT01103414|7356710|FG004|STARTED|Overall Study||71
6441623|NCT01103414|7356706|FG000|COMPLETED|Overall Study||59
6441624|NCT01103414|7356707|FG001|COMPLETED|Overall Study||62
6441625|NCT01103414|7356708|FG002|COMPLETED|Overall Study||56
6441626|NCT01103414|7356709|FG003|COMPLETED|Overall Study||64
6441627|NCT01103414|7356710|FG004|COMPLETED|Overall Study||56
6441628|NCT01103414|7356706|FG000|NOT COMPLETED|Overall Study||13
6441629|NCT01103414|7356707|FG001|NOT COMPLETED|Overall Study||9
6441630|NCT01103414|7356708|FG002|NOT COMPLETED|Overall Study||15
6441631|NCT01103414|7356709|FG003|NOT COMPLETED|Overall Study||7
6441632|NCT01103414|7356710|FG004|NOT COMPLETED|Overall Study||15
6441633|NCT01103440|7356724|FG000|STARTED|Overall Study||18
6441634|NCT01103440|7356725|FG001|STARTED|Overall Study||18
6441635|NCT01103440|7356724|FG000|COMPLETED|Overall Study||18
6441636|NCT01103440|7356725|FG001|COMPLETED|Overall Study||18
6441637|NCT01103440|7356724|FG000|NOT COMPLETED|Overall Study||0
6441638|NCT01103440|7356725|FG001|NOT COMPLETED|Overall Study||0
6441639|NCT01103466|7356731|FG000|STARTED|First Period (14 +/- 3 Days)||12
6441640|NCT01103466|7356732|FG001|STARTED|First Period (14 +/- 3 Days)||12
6441641|NCT01103466|7356733|FG002|STARTED|First Period (14 +/- 3 Days)||13
6441642|NCT01103466|7356731|FG000|COMPLETED|First Period (14 +/- 3 Days)||10
6441643|NCT01103466|7356732|FG001|COMPLETED|First Period (14 +/- 3 Days)||12
6441644|NCT01103466|7356733|FG002|COMPLETED|First Period (14 +/- 3 Days)||13
6441645|NCT01103466|7356731|FG000|NOT COMPLETED|First Period (14 +/- 3 Days)||2
6441646|NCT01103466|7356732|FG001|NOT COMPLETED|First Period (14 +/- 3 Days)||0
6441647|NCT01103466|7356733|FG002|NOT COMPLETED|First Period (14 +/- 3 Days)||0
6441648|NCT01103466|7356731|FG000|STARTED|Second Period (14 +/- 3 Days)||15
6441649|NCT01103466|7356732|FG001|STARTED|Second Period (14 +/- 3 Days)||13
6441650|NCT01103466|7356733|FG002|STARTED|Second Period (14 +/- 3 Days)||7
6441651|NCT01103466|7356731|FG000|COMPLETED|Second Period (14 +/- 3 Days)||13
6441652|NCT01103466|7356732|FG001|COMPLETED|Second Period (14 +/- 3 Days)||11
6441653|NCT01103466|7356733|FG002|COMPLETED|Second Period (14 +/- 3 Days)||6
6441654|NCT01103466|7356731|FG000|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
6441655|NCT01103466|7356732|FG001|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
6441656|NCT01103466|7356733|FG002|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
6441657|NCT01103466|7356731|FG000|STARTED|Third Period (14 +/- 3 Days)||8
6441658|NCT01103466|7356732|FG001|STARTED|Third Period (14 +/- 3 Days)||8
6441659|NCT01103466|7356733|FG002|STARTED|Third Period (14 +/- 3 Days)||14
6441660|NCT01103466|7356731|FG000|COMPLETED|Third Period (14 +/- 3 Days)||6
6441661|NCT01103466|7356732|FG001|COMPLETED|Third Period (14 +/- 3 Days)||8
6441662|NCT01103466|7356733|FG002|COMPLETED|Third Period (14 +/- 3 Days)||13
6441663|NCT01103466|7356731|FG000|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
6441664|NCT01103466|7356732|FG001|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
6441665|NCT01103466|7356733|FG002|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
6441666|NCT01103479|7356744|FG000|STARTED|Overall Study||168
6441667|NCT01103479|7356745|FG001|STARTED|Overall Study||210
6441668|NCT01103479|7356746|FG002|STARTED|Overall Study||188
6441669|NCT01103479|7356744|FG000|COMPLETED|Overall Study||163
6441670|NCT01103479|7356745|FG001|COMPLETED|Overall Study||201
6441671|NCT01103479|7356746|FG002|COMPLETED|Overall Study||174
6441672|NCT01103479|7356744|FG000|NOT COMPLETED|Overall Study||5
6441673|NCT01103479|7356745|FG001|NOT COMPLETED|Overall Study||9
6441674|NCT01103479|7356746|FG002|NOT COMPLETED|Overall Study||14
6441675|NCT01103492|7356755|FG000|STARTED|Overall Study||1
6441676|NCT01103492|7356755|FG000|COMPLETED|Overall Study||1
6441677|NCT01103492|7356755|FG000|NOT COMPLETED|Overall Study||0
6441678|NCT01103505|7356761|FG000|STARTED|Overall Study||763
6441679|NCT01103505|7356762|FG001|STARTED|Overall Study||757
6441680|NCT01103505|7356761|FG000|COMPLETED|Overall Study||739
6441681|NCT01103505|7356762|FG001|COMPLETED|Overall Study||737
6441682|NCT01103505|7356761|FG000|NOT COMPLETED|Overall Study||24
6441683|NCT01103505|7356762|FG001|NOT COMPLETED|Overall Study||20
6441684|NCT01103713|7356776|FG000|STARTED|Overall Study||168
6441685|NCT01103713|7356776|FG000|COMPLETED|Overall Study||155
6441686|NCT01103713|7356776|FG000|NOT COMPLETED|Overall Study||13
6441687|NCT01103778|7356783|FG000|STARTED|Overall Study||11
6441688|NCT01103778|7356783|FG000|COMPLETED|Overall Study||8
6441689|NCT01103778|7356783|FG000|NOT COMPLETED|Overall Study||3
6441690|NCT01103934|7356791|FG000|STARTED|Overall Study||17
6441691|NCT01103934|7356792|FG001|STARTED|Overall Study||18
6441692|NCT01103934|7356791|FG000|COMPLETED|Overall Study||17
6441693|NCT01103934|7356792|FG001|COMPLETED|Overall Study||18
6441694|NCT01103934|7356791|FG000|NOT COMPLETED|Overall Study||0
6441695|NCT01103934|7356792|FG001|NOT COMPLETED|Overall Study||0
6441696|NCT01103960|7356800|FG000|STARTED|Overall Study|Randomised and treated.|164
6441697|NCT01103960|7356801|FG001|STARTED|Overall Study|Randomised and treated.|160
6441698|NCT01103960|7356800|FG000|COMPLETED|Overall Study|Completed study medication.|159
6441699|NCT01103960|7356801|FG001|COMPLETED|Overall Study|Completed study medication.|158
6441700|NCT01103960|7356800|FG000|NOT COMPLETED|Overall Study||5
6441701|NCT01103960|7356801|FG001|NOT COMPLETED|Overall Study||2
6441702|NCT01103973|7356809|FG000|STARTED|Overall Study||51
6441703|NCT01103973|7356810|FG001|STARTED|Overall Study||46
6441704|NCT01103973|7356809|FG000|COMPLETED|Overall Study||51
6441705|NCT01103973|7356810|FG001|COMPLETED|Overall Study||46
6441706|NCT01103973|7356809|FG000|NOT COMPLETED|Overall Study||0
6441707|NCT01103973|7356810|FG001|NOT COMPLETED|Overall Study||0
6441708|NCT01104025|7356816|FG000|STARTED|Treatment Period||31
6441709|NCT01104025|7356816|FG000|COMPLETED|Treatment Period||25
6441710|NCT01104025|7356816|FG000|NOT COMPLETED|Treatment Period||6
6441711|NCT01104025|7356816|FG000|STARTED|Follow up Until BMT OR 6 Months||25
6441712|NCT01104025|7356816|FG000|COMPLETED|Follow up Until BMT OR 6 Months||22
6441713|NCT01104025|7356816|FG000|NOT COMPLETED|Follow up Until BMT OR 6 Months||3
6441714|NCT01104025|7356816|FG000|STARTED|Follow up Until Day 100 Post BMT|only 11 participants proceeded to BMT; 14 did not|11
6441715|NCT01104025|7356816|FG000|COMPLETED|Follow up Until Day 100 Post BMT||9
6441716|NCT01104025|7356816|FG000|NOT COMPLETED|Follow up Until Day 100 Post BMT||2
6441717|NCT01104090|7356822|FG000|STARTED|Overall Study||25
6441718|NCT01104090|7356823|FG001|STARTED|Overall Study||25
6441719|NCT01104090|7356822|FG000|COMPLETED|Overall Study||25
6441720|NCT01104090|7356823|FG001|COMPLETED|Overall Study||25
6441721|NCT01104090|7356822|FG000|NOT COMPLETED|Overall Study||0
6441722|NCT01104090|7356823|FG001|NOT COMPLETED|Overall Study||0
6441723|NCT01104103|7356833|FG000|STARTED|Overall Study||243
6441724|NCT01104103|7356834|FG001|STARTED|Overall Study||224
6441725|NCT01104103|7356833|FG000|COMPLETED|Overall Study||243
6441726|NCT01104103|7356834|FG001|COMPLETED|Overall Study||224
6441727|NCT01104103|7356833|FG000|NOT COMPLETED|Overall Study||0
6441728|NCT01104103|7356834|FG001|NOT COMPLETED|Overall Study||0
6441729|NCT01104155|7356842|FG000|STARTED|Overall Study||63
6441730|NCT01104155|7356843|FG001|STARTED|Overall Study||60
6441731|NCT01104155|7356842|FG000|COMPLETED|Overall Study||38
6441732|NCT01104155|7356843|FG001|COMPLETED|Overall Study||42
6441733|NCT01104155|7356842|FG000|NOT COMPLETED|Overall Study||25
6441734|NCT01104155|7356843|FG001|NOT COMPLETED|Overall Study||18
6441735|NCT01104207|7356851|FG000|STARTED|Overall Study||35
6441736|NCT01104207|7356852|FG001|STARTED|Overall Study||35
6441737|NCT01104207|7356851|FG000|COMPLETED|Overall Study||32
6441738|NCT01104207|7356852|FG001|COMPLETED|Overall Study||32
6441739|NCT01104207|7356851|FG000|NOT COMPLETED|Overall Study||3
6441740|NCT01104207|7356852|FG001|NOT COMPLETED|Overall Study||3
6441741|NCT01104246|7356858|FG000|STARTED|Overall Study||40
6441742|NCT01104246|7356858|FG000|Baseline Characteristics Measured|Overall Study||35
6441743|NCT01104246|7356858|FG000|COMPLETED|Overall Study||35
6441744|NCT01104246|7356858|FG000|NOT COMPLETED|Overall Study||5
6441745|NCT01104285|7356864|FG000|STARTED|Overall Study||112
6441746|NCT01104285|7356865|FG001|STARTED|Overall Study||86
6441747|NCT01104285|7356864|FG000|COMPLETED|Overall Study||112
6441748|NCT01104285|7356865|FG001|COMPLETED|Overall Study||86
6441749|NCT01104285|7356864|FG000|NOT COMPLETED|Overall Study||0
6441750|NCT01104285|7356865|FG001|NOT COMPLETED|Overall Study||0
6441751|NCT01104311|7356873|FG000|STARTED|Overall Study||66
6441752|NCT01104311|7356874|FG001|STARTED|Overall Study||66
6441753|NCT01104311|7356873|FG000|COMPLETED|Overall Study||56
6441754|NCT01104311|7356874|FG001|COMPLETED|Overall Study||54
6441755|NCT01104311|7356873|FG000|NOT COMPLETED|Overall Study||10
6441756|NCT01104311|7356874|FG001|NOT COMPLETED|Overall Study||12
6441757|NCT01104376|7356884|FG000|STARTED|Overall Study||89
6441758|NCT01104376|7356884|FG000|COMPLETED|Overall Study||61
6441759|NCT01104376|7356884|FG000|NOT COMPLETED|Overall Study||28
6441760|NCT01104402|7356890|FG000|STARTED|Overall Study||132
6441761|NCT01104402|7356891|FG001|STARTED|Overall Study||135
6441762|NCT01104402|7356890|FG000|COMPLETED|Overall Study||111
6441763|NCT01104402|7356891|FG001|COMPLETED|Overall Study||102
6441764|NCT01104402|7356890|FG000|NOT COMPLETED|Overall Study||21
6441765|NCT01104402|7356891|FG001|NOT COMPLETED|Overall Study||33
6441766|NCT01104415|7356897|FG000|STARTED|Core Phase||15
6441767|NCT01104415|7356898|FG001|STARTED|Core Phase||0
6441768|NCT01104415|7356897|FG000|COMPLETED|Core Phase||14
6441769|NCT01104415|7356898|FG001|COMPLETED|Core Phase||0
6441770|NCT01104415|7356897|FG000|NOT COMPLETED|Core Phase||1
6441771|NCT01104415|7356898|FG001|NOT COMPLETED|Core Phase||0
6441772|NCT01104415|7356897|FG000|STARTED|Extension Period||0
6441773|NCT01104415|7356898|FG001|STARTED|Extension Period|Out of 14 participants who completed Core Phase, 3 were not eligible to enter the Extension Period.|11
6441774|NCT01104415|7356897|FG000|COMPLETED|Extension Period||0
6441775|NCT01104415|7356898|FG001|COMPLETED|Extension Period||0
6441776|NCT01104415|7356897|FG000|NOT COMPLETED|Extension Period||0
6441777|NCT01104415|7356898|FG001|NOT COMPLETED|Extension Period||11
6500099|NCT01423084|7418898|FG000|STARTED|Overall Study||170
6500100|NCT01423084|7418899|FG001|STARTED|Overall Study||174
6500101|NCT01423084|7418898|FG000|COMPLETED|Overall Study||168
6500102|NCT01423084|7418899|FG001|COMPLETED|Overall Study||170
6500103|NCT01423084|7418898|FG000|NOT COMPLETED|Overall Study||2
6500104|NCT01423084|7418899|FG001|NOT COMPLETED|Overall Study||4
6500105|NCT01423162|7418908|FG000|STARTED|Overall Study||11
6500106|NCT01423162|7418909|FG001|STARTED|Overall Study||9
6500107|NCT01423162|7418908|FG000|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
6500108|NCT01423162|7418909|FG001|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
6500109|NCT01423162|7418908|FG000|NOT COMPLETED|Overall Study||0
6500110|NCT01423162|7418909|FG001|NOT COMPLETED|Overall Study||0
6500111|NCT01423253|7418915|FG000|STARTED|Overall Study||48
6500112|NCT01423253|7418915|FG000|COMPLETED|Overall Study||39
6500113|NCT01423253|7418915|FG000|NOT COMPLETED|Overall Study||9
6441778|NCT01104493|7356907|FG000|STARTED|Overall Study||240
6552960|NCT01740362|7475384|FG000|NOT COMPLETED|Overall Study||0
6552961|NCT01740362|7475385|FG001|NOT COMPLETED|Overall Study||0
6441779|NCT01104493|7356908|FG001|STARTED|Overall Study||60
6441780|NCT01104493|7356907|FG000|COMPLETED|Overall Study||240
6441781|NCT01104493|7356908|FG001|COMPLETED|Overall Study||58
6441782|NCT01104493|7356907|FG000|NOT COMPLETED|Overall Study||0
6441783|NCT01104493|7356908|FG001|NOT COMPLETED|Overall Study||2
6441784|NCT01104545|7356917|FG000|STARTED|Overall Study||8
6441785|NCT01104545|7356918|FG001|STARTED|Overall Study||8
6441786|NCT01104545|7356919|FG002|STARTED|Overall Study|1 participant received 0.50 mg of MK-3614 or placebo in Periods 3 and 4 instead of planned 0.75 mg|8
6441787|NCT01104545|7356917|FG000|COMPLETED|Overall Study||8
6441788|NCT01104545|7356918|FG001|COMPLETED|Overall Study|Participant discontinued after receiving 0.75 mg MK-3614 in Period 1|7
6441789|NCT01104545|7356919|FG002|COMPLETED|Overall Study|Participants discontinued after receiving MK-3614 0.75 mg (Period 1)and placebo (Period 2)|6
6441790|NCT01104545|7356917|FG000|NOT COMPLETED|Overall Study||0
6441791|NCT01104545|7356918|FG001|NOT COMPLETED|Overall Study||1
6441792|NCT01104545|7356919|FG002|NOT COMPLETED|Overall Study||2
6441793|NCT01104558|7356964|FG000|STARTED|Overall Study||100
6441794|NCT01104558|7356964|FG000|COMPLETED|Overall Study||83
6441795|NCT01104558|7356964|FG000|NOT COMPLETED|Overall Study||17
6441796|NCT01104584|7356968|FG000|STARTED|Overall Study|screened and enrolled|460
6441797|NCT01104584|7356968|FG000|Received Treatment|Overall Study|treatment started|439
6441798|NCT01104584|7356968|FG000|Fulfilled Requirements of FAS Population|Overall Study||397
6441799|NCT01104584|7356968|FG000|COMPLETED|Overall Study|study course completed|437
6441800|NCT01104584|7356968|FG000|NOT COMPLETED|Overall Study||23
6441801|NCT01104636|7356990|FG000|STARTED|Overall Study||1177
6441802|NCT01104636|7356990|FG000|COMPLETED|Overall Study||999
6441803|NCT01104636|7356990|FG000|NOT COMPLETED|Overall Study||178
6441804|NCT01104662|7357002|FG000|STARTED|Overall Study||20
6441805|NCT01104662|7357003|FG001|STARTED|Overall Study||21
6441806|NCT01104662|7357004|FG002|STARTED|Overall Study||5
6441807|NCT01104662|7357005|FG003|STARTED|Overall Study||4
6441808|NCT01104662|7357006|FG004|STARTED|Overall Study||15
6441809|NCT01104662|7357007|FG005|STARTED|Overall Study||16
6441810|NCT01104662|7357008|FG006|STARTED|Overall Study||5
6441811|NCT01104662|7357009|FG007|STARTED|Overall Study||6
6441812|NCT01104662|7357002|FG000|Received at Least 1 Dose of Study Drug|Overall Study||17
6441813|NCT01104662|7357003|FG001|Received at Least 1 Dose of Study Drug|Overall Study||17
6441814|NCT01104662|7357004|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
6441815|NCT01104662|7357005|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
6441816|NCT01104662|7357006|FG004|Received at Least 1 Dose of Study Drug|Overall Study||15
6441817|NCT01104662|7357007|FG005|Received at Least 1 Dose of Study Drug|Overall Study||15
6441818|NCT01104662|7357008|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
6441819|NCT01104662|7357009|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
6441820|NCT01104662|7357002|FG000|COMPLETED|Overall Study||10
6441821|NCT01104662|7357003|FG001|COMPLETED|Overall Study||11
6441822|NCT01104662|7357004|FG002|COMPLETED|Overall Study||4
6441823|NCT01104662|7357005|FG003|COMPLETED|Overall Study||3
6441824|NCT01104662|7357006|FG004|COMPLETED|Overall Study||14
6441825|NCT01104662|7357007|FG005|COMPLETED|Overall Study||12
6441826|NCT01104662|7357008|FG006|COMPLETED|Overall Study||5
6441827|NCT01104662|7357009|FG007|COMPLETED|Overall Study||6
6441828|NCT01104662|7357002|FG000|NOT COMPLETED|Overall Study||10
6441829|NCT01104662|7357003|FG001|NOT COMPLETED|Overall Study||10
6441830|NCT01104662|7357004|FG002|NOT COMPLETED|Overall Study||1
6441831|NCT01104662|7357005|FG003|NOT COMPLETED|Overall Study||1
6441832|NCT01104662|7357006|FG004|NOT COMPLETED|Overall Study||1
6441833|NCT01104662|7357007|FG005|NOT COMPLETED|Overall Study||4
6441834|NCT01104662|7357008|FG006|NOT COMPLETED|Overall Study||0
6441835|NCT01104662|7357009|FG007|NOT COMPLETED|Overall Study||0
6441836|NCT01104701|7357032|FG000|STARTED|Overall Study||30
6441837|NCT01104701|7357033|FG001|STARTED|Overall Study||30
6441838|NCT01104701|7357034|FG002|STARTED|Overall Study||31
6441839|NCT01104701|7357035|FG003|STARTED|Overall Study||30
6441840|NCT01104701|7357032|FG000|COMPLETED|Overall Study||30
6441841|NCT01104701|7357033|FG001|COMPLETED|Overall Study||27
6441842|NCT01104701|7357034|FG002|COMPLETED|Overall Study||29
6441843|NCT01104701|7357035|FG003|COMPLETED|Overall Study||28
6441844|NCT01104701|7357032|FG000|NOT COMPLETED|Overall Study||0
6441845|NCT01104701|7357033|FG001|NOT COMPLETED|Overall Study||3
6441846|NCT01104701|7357034|FG002|NOT COMPLETED|Overall Study||2
6441847|NCT01104701|7357035|FG003|NOT COMPLETED|Overall Study||2
6441848|NCT01104766|7357049|FG000|STARTED|Overall Study||153
6441849|NCT01104766|7357050|FG001|STARTED|Overall Study||155
6441850|NCT01104766|7357051|FG002|STARTED|Overall Study||157
6441851|NCT01104766|7357052|FG003|STARTED|Overall Study||152
6441852|NCT01104766|7357049|FG000|COMPLETED|Overall Study||95
6441853|NCT01104766|7357050|FG001|COMPLETED|Overall Study||104
6441854|NCT01104766|7357051|FG002|COMPLETED|Overall Study||97
6441855|NCT01104766|7357052|FG003|COMPLETED|Overall Study||114
6441856|NCT01104766|7357049|FG000|NOT COMPLETED|Overall Study||58
6441857|NCT01104766|7357050|FG001|NOT COMPLETED|Overall Study||51
6441858|NCT01104766|7357051|FG002|NOT COMPLETED|Overall Study||60
6552962|NCT01740362|7475386|FG002|NOT COMPLETED|Overall Study||0
6552963|NCT01740362|7475387|FG003|NOT COMPLETED|Overall Study||0
6552964|NCT01740388|7475399|FG000|STARTED|Overall Study||64
6441859|NCT01104766|7357052|FG003|NOT COMPLETED|Overall Study||38
6441860|NCT01104779|7357065|FG000|STARTED|Overall Study||147
6441861|NCT01104779|7357066|FG001|STARTED|Overall Study||151
6441862|NCT01104779|7357067|FG002|STARTED|Overall Study||148
6441863|NCT01104779|7357065|FG000|COMPLETED|Overall Study||88
6441864|NCT01104779|7357066|FG001|COMPLETED|Overall Study||96
6441865|NCT01104779|7357067|FG002|COMPLETED|Overall Study||86
6441866|NCT01104779|7357065|FG000|NOT COMPLETED|Overall Study||59
6441867|NCT01104779|7357066|FG001|NOT COMPLETED|Overall Study||55
6441868|NCT01104779|7357067|FG002|NOT COMPLETED|Overall Study||62
6441869|NCT01104792|7357075|FG000|STARTED|Overall Study||752
6441870|NCT01104792|7357075|FG000|COMPLETED|Overall Study||226
6441871|NCT01104792|7357075|FG000|NOT COMPLETED|Overall Study||526
6441872|NCT01104870|7357082|FG000|STARTED|Overall Study||11
6441873|NCT01104870|7357083|FG001|STARTED|Overall Study||19
6441874|NCT01104870|7357084|FG002|STARTED|Overall Study||20
6441875|NCT01104870|7357082|FG000|COMPLETED|Overall Study||10
6441876|NCT01104870|7357083|FG001|COMPLETED|Overall Study||18
6441877|NCT01104870|7357084|FG002|COMPLETED|Overall Study||18
6441878|NCT01104870|7357082|FG000|NOT COMPLETED|Overall Study||1
6441879|NCT01104870|7357083|FG001|NOT COMPLETED|Overall Study||1
6441880|NCT01104870|7357084|FG002|NOT COMPLETED|Overall Study||2
6441881|NCT01105065|7357092|FG000|STARTED|Overall Study||23
6441882|NCT01105065|7357092|FG000|COMPLETED|Overall Study||17
6441883|NCT01105065|7357092|FG000|NOT COMPLETED|Overall Study||6
6441884|NCT01105091|7357100|FG000|STARTED|Overall Study||20
6441885|NCT01105091|7357101|FG001|STARTED|Overall Study||10
6441886|NCT01105091|7357100|FG000|COMPLETED|Overall Study||18
6441887|NCT01105091|7357101|FG001|COMPLETED|Overall Study||10
6441888|NCT01105091|7357100|FG000|NOT COMPLETED|Overall Study||2
6441889|NCT01105091|7357101|FG001|NOT COMPLETED|Overall Study||0
6441890|NCT01105117|7357111|FG000|STARTED|Overall Study||1
6441891|NCT01105117|7357112|FG001|STARTED|Overall Study||1
6441892|NCT01105117|7357111|FG000|COMPLETED|Overall Study||1
6441893|NCT01105117|7357112|FG001|COMPLETED|Overall Study||1
6441894|NCT01105117|7357111|FG000|NOT COMPLETED|Overall Study||0
6441895|NCT01105117|7357112|FG001|NOT COMPLETED|Overall Study||0
6441896|NCT01105130|7357121|FG000|STARTED|Overall Study||48
6441897|NCT01105130|7357122|FG001|STARTED|Overall Study||45
6441898|NCT01105130|7357123|FG002|STARTED|Overall Study||47
6441899|NCT01105130|7357121|FG000|COMPLETED|Overall Study||38
6441900|NCT01105130|7357122|FG001|COMPLETED|Overall Study||34
6441901|NCT01105130|7357123|FG002|COMPLETED|Overall Study||37
6441902|NCT01105130|7357121|FG000|NOT COMPLETED|Overall Study||10
6441903|NCT01105130|7357122|FG001|NOT COMPLETED|Overall Study||11
6441904|NCT01105130|7357123|FG002|NOT COMPLETED|Overall Study||10
6441905|NCT01105247|7357133|FG000|STARTED|Overall Study||116
6441906|NCT01105247|7357134|FG001|STARTED|Overall Study||16
6441907|NCT01105247|7357133|FG000|COMPLETED|Overall Study||79
6441908|NCT01105247|7357134|FG001|COMPLETED|Overall Study||16
6441909|NCT01105247|7357133|FG000|NOT COMPLETED|Overall Study||37
6441910|NCT01105247|7357134|FG001|NOT COMPLETED|Overall Study||0
6441911|NCT01105312|7357148|FG000|STARTED|Overall Study||16
6441912|NCT01105312|7357149|FG001|STARTED|Overall Study||6
6441913|NCT01105312|7357150|FG002|STARTED|Overall Study||6
6441914|NCT01105312|7357148|FG000|COMPLETED|Overall Study||13
6441915|NCT01105312|7357149|FG001|COMPLETED|Overall Study||6
6441916|NCT01105312|7357150|FG002|COMPLETED|Overall Study||6
6441917|NCT01105312|7357148|FG000|NOT COMPLETED|Overall Study||3
6441918|NCT01105312|7357149|FG001|NOT COMPLETED|Overall Study||0
6441919|NCT01105312|7357150|FG002|NOT COMPLETED|Overall Study||0
6441920|NCT01105377|7357160|FG000|STARTED|Overall Study||24
6441921|NCT01105377|7357161|FG001|STARTED|Overall Study||23
6441922|NCT01105377|7357160|FG000|COMPLETED|Overall Study||24
6441923|NCT01105377|7357161|FG001|COMPLETED|Overall Study||22
6441924|NCT01105377|7357160|FG000|NOT COMPLETED|Overall Study||0
6441925|NCT01105377|7357161|FG001|NOT COMPLETED|Overall Study||1
6441926|NCT01105533|7357167|FG000|STARTED|Overall Study||1
6441927|NCT01105533|7357168|FG001|STARTED|Overall Study||1
6441928|NCT01105533|7357169|FG002|STARTED|Overall Study||3
6441929|NCT01105533|7357170|FG003|STARTED|Overall Study||3
6441930|NCT01105533|7357171|FG004|STARTED|Overall Study||7
6441931|NCT01105533|7357172|FG005|STARTED|Overall Study||7
6441932|NCT01105533|7357173|FG006|STARTED|Overall Study||8
6441933|NCT01105533|7357174|FG007|STARTED|Overall Study||4
6441934|NCT01105533|7357175|FG008|STARTED|Overall Study||12
6441935|NCT01105533|7357167|FG000|COMPLETED|Overall Study||0
6441936|NCT01105533|7357168|FG001|COMPLETED|Overall Study||0
6441937|NCT01105533|7357169|FG002|COMPLETED|Overall Study||0
6441938|NCT01105533|7357170|FG003|COMPLETED|Overall Study||0
6441939|NCT01105533|7357171|FG004|COMPLETED|Overall Study||0
6441940|NCT01105533|7357172|FG005|COMPLETED|Overall Study||0
6441941|NCT01105533|7357173|FG006|COMPLETED|Overall Study||0
6441942|NCT01105533|7357174|FG007|COMPLETED|Overall Study||0
6441943|NCT01105533|7357175|FG008|COMPLETED|Overall Study||0
6441944|NCT01105533|7357167|FG000|NOT COMPLETED|Overall Study||1
6441945|NCT01105533|7357168|FG001|NOT COMPLETED|Overall Study||1
6441946|NCT01105533|7357169|FG002|NOT COMPLETED|Overall Study||3
6441947|NCT01105533|7357170|FG003|NOT COMPLETED|Overall Study||3
6441948|NCT01105533|7357171|FG004|NOT COMPLETED|Overall Study||7
6441949|NCT01105533|7357172|FG005|NOT COMPLETED|Overall Study||7
6441950|NCT01105533|7357173|FG006|NOT COMPLETED|Overall Study||8
6441951|NCT01105533|7357174|FG007|NOT COMPLETED|Overall Study||4
6441952|NCT01105533|7357175|FG008|NOT COMPLETED|Overall Study||12
6441953|NCT01105650|7357191|FG000|STARTED|Overall Study||3
6441954|NCT01105650|7357192|FG001|STARTED|Overall Study||3
6441955|NCT01105650|7357193|FG002|STARTED|Overall Study||7
6441956|NCT01105650|7357194|FG003|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
6441957|NCT01105650|7357191|FG000|COMPLETED|Overall Study||3
6441958|NCT01105650|7357192|FG001|COMPLETED|Overall Study||3
6441959|NCT01105650|7357193|FG002|COMPLETED|Overall Study||7
6441960|NCT01105650|7357194|FG003|COMPLETED|Overall Study||0
6441961|NCT01105650|7357191|FG000|NOT COMPLETED|Overall Study||0
6552965|NCT01740388|7475400|FG001|STARTED|Overall Study||72
6552966|NCT01740388|7475399|FG000|COMPLETED|Overall Study||18
6552967|NCT01740388|7475400|FG001|COMPLETED|Overall Study||28
6552968|NCT01740388|7475399|FG000|NOT COMPLETED|Overall Study||46
6552969|NCT01740388|7475400|FG001|NOT COMPLETED|Overall Study||44
6552970|NCT01740401|7475406|FG000|STARTED|Overall Study||10
6552971|NCT01740401|7475406|FG000|COMPLETED|Overall Study||0
6552972|NCT01740401|7475406|FG000|NOT COMPLETED|Overall Study||10
6552973|NCT01740414|7475412|FG000|STARTED|Overall Study||12
6552974|NCT01740414|7475413|FG001|STARTED|Overall Study||16
6552975|NCT01740414|7475412|FG000|COMPLETED|Overall Study||3
6552976|NCT01740414|7475413|FG001|COMPLETED|Overall Study||8
6552977|NCT01740414|7475412|FG000|NOT COMPLETED|Overall Study||9
6552978|NCT01740414|7475413|FG001|NOT COMPLETED|Overall Study||8
6441962|NCT01105650|7357192|FG001|NOT COMPLETED|Overall Study||0
6441963|NCT01105650|7357193|FG002|NOT COMPLETED|Overall Study||0
6441964|NCT01105650|7357194|FG003|NOT COMPLETED|Overall Study||0
6441965|NCT01105702|7357202|FG000|STARTED|Overall Study||28
6441966|NCT01105702|7357202|FG000|COMPLETED|Overall Study||10
6441967|NCT01105702|7357202|FG000|NOT COMPLETED|Overall Study||18
6441968|NCT01105754|7357210|FG000|STARTED|Overall Study||319
6441969|NCT01105754|7357211|FG001|STARTED|Overall Study||319
6441970|NCT01105754|7357210|FG000|COMPLETED|Overall Study||304
6441971|NCT01105754|7357211|FG001|COMPLETED|Overall Study||307
6441972|NCT01105754|7357210|FG000|NOT COMPLETED|Overall Study||15
6441973|NCT01105754|7357211|FG001|NOT COMPLETED|Overall Study||12
6441974|NCT01105767|7357220|FG000|STARTED|Overall Study||9315
6441975|NCT01105767|7357221|FG001|STARTED|Overall Study||10864
6441976|NCT01105767|7357222|FG002|STARTED|Overall Study||10030
6441977|NCT01105767|7357220|FG000|COMPLETED|Overall Study||8155
6441978|NCT01105767|7357221|FG001|COMPLETED|Overall Study||9250
6441979|NCT01105767|7357222|FG002|COMPLETED|Overall Study||8846
6441980|NCT01105767|7357220|FG000|NOT COMPLETED|Overall Study||1160
6441981|NCT01105767|7357221|FG001|NOT COMPLETED|Overall Study||1614
6441982|NCT01105767|7357222|FG002|NOT COMPLETED|Overall Study||1184
6441983|NCT01105936|7357230|FG000|STARTED|Period 1||8
6441984|NCT01105936|7357231|FG001|STARTED|Period 1||8
6441985|NCT01105936|7357232|FG002|STARTED|Period 1||7
6441986|NCT01105936|7357233|FG003|STARTED|Period 1||8
6441987|NCT01105936|7357230|FG000|COMPLETED|Period 1||8
6441988|NCT01105936|7357231|FG001|COMPLETED|Period 1||8
6441989|NCT01105936|7357232|FG002|COMPLETED|Period 1||7
6441990|NCT01105936|7357233|FG003|COMPLETED|Period 1||7
6441991|NCT01105936|7357230|FG000|NOT COMPLETED|Period 1||0
6441992|NCT01105936|7357231|FG001|NOT COMPLETED|Period 1||0
6441993|NCT01105936|7357232|FG002|NOT COMPLETED|Period 1||0
6441994|NCT01105936|7357233|FG003|NOT COMPLETED|Period 1||1
6441995|NCT01105936|7357230|FG000|STARTED|Wash-out Period 1||8
6441996|NCT01105936|7357231|FG001|STARTED|Wash-out Period 1||8
6441997|NCT01105936|7357232|FG002|STARTED|Wash-out Period 1||7
6441998|NCT01105936|7357233|FG003|STARTED|Wash-out Period 1||7
6441999|NCT01105936|7357230|FG000|COMPLETED|Wash-out Period 1||8
6442000|NCT01105936|7357231|FG001|COMPLETED|Wash-out Period 1||8
6442001|NCT01105936|7357232|FG002|COMPLETED|Wash-out Period 1||7
6442002|NCT01105936|7357233|FG003|COMPLETED|Wash-out Period 1||7
6442003|NCT01105936|7357230|FG000|NOT COMPLETED|Wash-out Period 1||0
6442004|NCT01105936|7357231|FG001|NOT COMPLETED|Wash-out Period 1||0
6442005|NCT01105936|7357232|FG002|NOT COMPLETED|Wash-out Period 1||0
6442006|NCT01105936|7357233|FG003|NOT COMPLETED|Wash-out Period 1||0
6442007|NCT01105936|7357230|FG000|STARTED|Period 2||8
6442008|NCT01105936|7357231|FG001|STARTED|Period 2||8
6442009|NCT01105936|7357232|FG002|STARTED|Period 2||7
6442010|NCT01105936|7357233|FG003|STARTED|Period 2||7
6442011|NCT01105936|7357230|FG000|COMPLETED|Period 2||7
6442012|NCT01105936|7357231|FG001|COMPLETED|Period 2||8
6442013|NCT01105936|7357232|FG002|COMPLETED|Period 2||7
6442014|NCT01105936|7357233|FG003|COMPLETED|Period 2||7
6442015|NCT01105936|7357230|FG000|NOT COMPLETED|Period 2||1
6442016|NCT01105936|7357231|FG001|NOT COMPLETED|Period 2||0
6442017|NCT01105936|7357232|FG002|NOT COMPLETED|Period 2||0
6442018|NCT01105936|7357233|FG003|NOT COMPLETED|Period 2||0
6442019|NCT01105936|7357230|FG000|STARTED|Wash-out Period 2||7
6442020|NCT01105936|7357231|FG001|STARTED|Wash-out Period 2||8
6442021|NCT01105936|7357232|FG002|STARTED|Wash-out Period 2||7
6442022|NCT01105936|7357233|FG003|STARTED|Wash-out Period 2||7
6442023|NCT01105936|7357230|FG000|COMPLETED|Wash-out Period 2||7
6442024|NCT01105936|7357231|FG001|COMPLETED|Wash-out Period 2||8
6442025|NCT01105936|7357232|FG002|COMPLETED|Wash-out Period 2||7
6442026|NCT01105936|7357233|FG003|COMPLETED|Wash-out Period 2||7
6442027|NCT01105936|7357230|FG000|NOT COMPLETED|Wash-out Period 2||0
6442028|NCT01105936|7357231|FG001|NOT COMPLETED|Wash-out Period 2||0
6442029|NCT01105936|7357232|FG002|NOT COMPLETED|Wash-out Period 2||0
6442030|NCT01105936|7357233|FG003|NOT COMPLETED|Wash-out Period 2||0
6442031|NCT01105936|7357230|FG000|STARTED|Period 3||7
6442032|NCT01105936|7357231|FG001|STARTED|Period 3||8
6442033|NCT01105936|7357232|FG002|STARTED|Period 3||7
6442034|NCT01105936|7357233|FG003|STARTED|Period 3||7
6442035|NCT01105936|7357230|FG000|COMPLETED|Period 3||7
6442036|NCT01105936|7357231|FG001|COMPLETED|Period 3||6
6442037|NCT01105936|7357232|FG002|COMPLETED|Period 3||7
6442038|NCT01105936|7357233|FG003|COMPLETED|Period 3||7
6442039|NCT01105936|7357230|FG000|NOT COMPLETED|Period 3||0
6442040|NCT01105936|7357231|FG001|NOT COMPLETED|Period 3||2
6442041|NCT01105936|7357232|FG002|NOT COMPLETED|Period 3||0
6442042|NCT01105936|7357233|FG003|NOT COMPLETED|Period 3||0
6442043|NCT01105975|7357252|FG000|STARTED|Overall Study||40
6442044|NCT01105975|7357253|FG001|STARTED|Overall Study||39
6442045|NCT01105975|7357254|FG002|STARTED|Overall Study||42
6442046|NCT01105975|7357255|FG003|STARTED|Overall Study||38
6442047|NCT01105975|7357256|FG004|STARTED|Overall Study||41
6442048|NCT01105975|7357257|FG005|STARTED|Overall Study||35
6442049|NCT01105975|7357258|FG006|STARTED|Overall Study||42
6442050|NCT01105975|7357259|FG007|STARTED|Overall Study||40
6442051|NCT01105975|7357260|FG008|STARTED|Overall Study||40
6442052|NCT01105975|7357261|FG009|STARTED|Overall Study||41
6442053|NCT01105975|7357252|FG000|Took at Least One Dose of Study Drug|Overall Study||40
6442054|NCT01105975|7357253|FG001|Took at Least One Dose of Study Drug|Overall Study||38
6442055|NCT01105975|7357254|FG002|Took at Least One Dose of Study Drug|Overall Study||40
6442056|NCT01105975|7357255|FG003|Took at Least One Dose of Study Drug|Overall Study||38
6442057|NCT01105975|7357256|FG004|Took at Least One Dose of Study Drug|Overall Study||41
6442058|NCT01105975|7357257|FG005|Took at Least One Dose of Study Drug|Overall Study||35
6442059|NCT01105975|7357258|FG006|Took at Least One Dose of Study Drug|Overall Study||41
6442060|NCT01105975|7357259|FG007|Took at Least One Dose of Study Drug|Overall Study||40
6442061|NCT01105975|7357260|FG008|Took at Least One Dose of Study Drug|Overall Study||39
6442062|NCT01105975|7357261|FG009|Took at Least One Dose of Study Drug|Overall Study||41
6442063|NCT01105975|7357252|FG000|COMPLETED|Overall Study||35
6442064|NCT01105975|7357253|FG001|COMPLETED|Overall Study||34
6442065|NCT01105975|7357254|FG002|COMPLETED|Overall Study||32
6442066|NCT01105975|7357255|FG003|COMPLETED|Overall Study||36
6442067|NCT01105975|7357256|FG004|COMPLETED|Overall Study||35
6442068|NCT01105975|7357257|FG005|COMPLETED|Overall Study||30
6442069|NCT01105975|7357258|FG006|COMPLETED|Overall Study||34
6442070|NCT01105975|7357259|FG007|COMPLETED|Overall Study||33
6442071|NCT01105975|7357260|FG008|COMPLETED|Overall Study||34
6442072|NCT01105975|7357261|FG009|COMPLETED|Overall Study||32
6442073|NCT01105975|7357252|FG000|NOT COMPLETED|Overall Study||5
6442074|NCT01105975|7357253|FG001|NOT COMPLETED|Overall Study||5
6442075|NCT01105975|7357254|FG002|NOT COMPLETED|Overall Study||10
6442076|NCT01105975|7357255|FG003|NOT COMPLETED|Overall Study||2
6442077|NCT01105975|7357256|FG004|NOT COMPLETED|Overall Study||6
6442078|NCT01105975|7357257|FG005|NOT COMPLETED|Overall Study||5
6442079|NCT01105975|7357258|FG006|NOT COMPLETED|Overall Study||8
6442080|NCT01105975|7357259|FG007|NOT COMPLETED|Overall Study||7
6442081|NCT01105975|7357260|FG008|NOT COMPLETED|Overall Study||6
6442082|NCT01105975|7357261|FG009|NOT COMPLETED|Overall Study||9
6442083|NCT01106014|7357304|FG000|STARTED|Overall Study||574
6442084|NCT01106014|7357305|FG001|STARTED|Overall Study||582
6442085|NCT01106014|7357304|FG000|COMPLETED|Overall Study||289
6442086|NCT01106014|7357305|FG001|COMPLETED|Overall Study||252
6442087|NCT01106014|7357304|FG000|NOT COMPLETED|Overall Study||285
6442088|NCT01106014|7357305|FG001|NOT COMPLETED|Overall Study||330
6442089|NCT01106027|7357311|FG000|STARTED|Overall Study||2
6442090|NCT01106027|7357311|FG000|COMPLETED|Overall Study||1
6442091|NCT01106027|7357311|FG000|NOT COMPLETED|Overall Study||1
6442092|NCT01106040|7357315|FG000|STARTED|Overall Study||163
6442093|NCT01106040|7357315|FG000|COMPLETED|Overall Study||152
6442094|NCT01106040|7357315|FG000|NOT COMPLETED|Overall Study||11
6442095|NCT01106092|7357324|FG000|STARTED|Overall Study||78
6442096|NCT01106092|7357325|FG001|STARTED|Overall Study||78
6442097|NCT01106092|7357326|FG002|STARTED|Overall Study||78
6442098|NCT01106092|7357327|FG003|STARTED|Overall Study||78
6442099|NCT01106092|7357324|FG000|COMPLETED|Overall Study||78
6442100|NCT01106092|7357325|FG001|COMPLETED|Overall Study||78
6442101|NCT01106092|7357326|FG002|COMPLETED|Overall Study||78
6442102|NCT01106092|7357327|FG003|COMPLETED|Overall Study||77
6442103|NCT01106092|7357324|FG000|NOT COMPLETED|Overall Study||0
6442104|NCT01106092|7357325|FG001|NOT COMPLETED|Overall Study||0
6442105|NCT01106092|7357326|FG002|NOT COMPLETED|Overall Study||0
6442106|NCT01106092|7357327|FG003|NOT COMPLETED|Overall Study||1
6442107|NCT01106157|7357339|FG000|STARTED|Overall Study||17
6442108|NCT01106157|7357340|FG001|STARTED|Overall Study||8
6442109|NCT01106157|7357339|FG000|COMPLETED|Overall Study||16
6442110|NCT01106157|7357340|FG001|COMPLETED|Overall Study||8
6442111|NCT01106157|7357339|FG000|NOT COMPLETED|Overall Study||1
6442112|NCT01106157|7357340|FG001|NOT COMPLETED|Overall Study||0
6442113|NCT01106248|7357346|FG000|STARTED|Overall Study||26
6442114|NCT01106248|7357346|FG000|COMPLETED|Overall Study||23
6442115|NCT01106248|7357346|FG000|NOT COMPLETED|Overall Study||3
6442116|NCT01106287|7357354|FG000|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
6442117|NCT01106287|7357355|FG001|STARTED|Overall Study||3
6442118|NCT01106287|7357356|FG002|STARTED|Overall Study||3
6442119|NCT01106287|7357357|FG003|STARTED|Overall Study||3
6442120|NCT01106287|7357354|FG000|COMPLETED|Overall Study||3
6442121|NCT01106287|7357355|FG001|COMPLETED|Overall Study||3
6442122|NCT01106287|7357356|FG002|COMPLETED|Overall Study||3
6442123|NCT01106287|7357357|FG003|COMPLETED|Overall Study||3
6442124|NCT01106287|7357354|FG000|NOT COMPLETED|Overall Study||1
6442125|NCT01106287|7357355|FG001|NOT COMPLETED|Overall Study||0
6442126|NCT01106287|7357356|FG002|NOT COMPLETED|Overall Study||0
6442127|NCT01106287|7357357|FG003|NOT COMPLETED|Overall Study||0
6442128|NCT01106326|7357371|FG000|STARTED|Overall Study||30
6442129|NCT01106326|7357371|FG000|COMPLETED|Overall Study||28
6442130|NCT01106326|7357371|FG000|NOT COMPLETED|Overall Study||2
6442131|NCT01106352|7357382|FG000|STARTED|Overall Study||7
6442132|NCT01106352|7357383|FG001|STARTED|Overall Study||3
6442133|NCT01106352|7357384|FG002|STARTED|Overall Study||7
6442134|NCT01106352|7357385|FG003|STARTED|Overall Study||36
6442135|NCT01106352|7357386|FG004|STARTED|Overall Study||17
6442136|NCT01106352|7357382|FG000|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
6442137|NCT01106352|7357383|FG001|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
6442138|NCT01106352|7357384|FG002|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
6442139|NCT01106352|7357385|FG003|Started Dose Escalation|Overall Study||0
6442140|NCT01106352|7357386|FG004|Started Dose Escalation|Overall Study||0
6442141|NCT01106352|7357382|FG000|Completed Dose Escalation|Overall Study||6
6442142|NCT01106352|7357383|FG001|Completed Dose Escalation|Overall Study||3
6442143|NCT01106352|7357384|FG002|Completed Dose Escalation|Overall Study||5
6442144|NCT01106352|7357385|FG003|Completed Dose Escalation|Overall Study||0
6442145|NCT01106352|7357386|FG004|Completed Dose Escalation|Overall Study||0
6442146|NCT01106352|7357382|FG000|Started Safety Cohort|Overall Study||0
6442147|NCT01106352|7357383|FG001|Started Safety Cohort|Overall Study||0
6442148|NCT01106352|7357384|FG002|Started Safety Cohort|Overall Study||0
6442149|NCT01106352|7357385|FG003|Started Safety Cohort|Overall Study||36
6442150|NCT01106352|7357386|FG004|Started Safety Cohort|Overall Study||17
6442151|NCT01106352|7357382|FG000|Treated Safety Cohort|Overall Study||0
6442152|NCT01106352|7357383|FG001|Treated Safety Cohort|Overall Study||0
6442153|NCT01106352|7357384|FG002|Treated Safety Cohort|Overall Study||0
6442154|NCT01106352|7357385|FG003|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
6442155|NCT01106352|7357386|FG004|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
6442156|NCT01106352|7357382|FG000|Completed Safety Cohort|Overall Study||0
6442157|NCT01106352|7357383|FG001|Completed Safety Cohort|Overall Study||0
6442158|NCT01106352|7357384|FG002|Completed Safety Cohort|Overall Study||0
6442159|NCT01106352|7357385|FG003|Completed Safety Cohort|Overall Study||23
6442160|NCT01106352|7357386|FG004|Completed Safety Cohort|Overall Study||9
6442161|NCT01106352|7357382|FG000|COMPLETED|Overall Study||6
6442162|NCT01106352|7357383|FG001|COMPLETED|Overall Study||3
6442163|NCT01106352|7357384|FG002|COMPLETED|Overall Study||5
6442164|NCT01106352|7357385|FG003|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
6442165|NCT01106352|7357386|FG004|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
6442166|NCT01106352|7357382|FG000|NOT COMPLETED|Overall Study||1
6442167|NCT01106352|7357383|FG001|NOT COMPLETED|Overall Study||0
6442168|NCT01106352|7357384|FG002|NOT COMPLETED|Overall Study||2
6442169|NCT01106352|7357385|FG003|NOT COMPLETED|Overall Study||13
6442170|NCT01106352|7357386|FG004|NOT COMPLETED|Overall Study||8
6442171|NCT01106391|7357402|FG000|STARTED|Overall Study||60
6442172|NCT01106391|7357402|FG000|COMPLETED|Overall Study||60
6442173|NCT01106391|7357402|FG000|NOT COMPLETED|Overall Study||0
6442174|NCT01106404|7357408|FG000|STARTED|Period I (First 6 Weeks)||36
6442175|NCT01106404|7357409|FG001|STARTED|Period I (First 6 Weeks)||40
6442176|NCT01106404|7357408|FG000|COMPLETED|Period I (First 6 Weeks)||33
6442177|NCT01106404|7357409|FG001|COMPLETED|Period I (First 6 Weeks)||38
6442178|NCT01106404|7357408|FG000|NOT COMPLETED|Period I (First 6 Weeks)||3
6442179|NCT01106404|7357409|FG001|NOT COMPLETED|Period I (First 6 Weeks)||2
6442180|NCT01106404|7357408|FG000|STARTED|Period II (Second 6 Weeks)||33
6442181|NCT01106404|7357409|FG001|STARTED|Period II (Second 6 Weeks)||38
6442182|NCT01106404|7357408|FG000|COMPLETED|Period II (Second 6 Weeks)||33
6442183|NCT01106404|7357409|FG001|COMPLETED|Period II (Second 6 Weeks)||38
6442184|NCT01106404|7357408|FG000|NOT COMPLETED|Period II (Second 6 Weeks)||0
6442185|NCT01106404|7357409|FG001|NOT COMPLETED|Period II (Second 6 Weeks)||0
6442186|NCT01106430|7357423|FG000|STARTED|Overall Study||133
6442187|NCT01106430|7357424|FG001|STARTED|Overall Study||134
6442188|NCT01106430|7357423|FG000|COMPLETED|Overall Study||100
6442189|NCT01106430|7357424|FG001|COMPLETED|Overall Study||101
6442190|NCT01106430|7357423|FG000|NOT COMPLETED|Overall Study||33
6442191|NCT01106430|7357424|FG001|NOT COMPLETED|Overall Study||33
6442192|NCT01106456|7357432|FG000|STARTED|Overall Study||243
6442193|NCT01106456|7357433|FG001|STARTED|Overall Study||220
6442194|NCT01106456|7357432|FG000|COMPLETED|Overall Study||140
6442195|NCT01106456|7357433|FG001|COMPLETED|Overall Study||96
6442196|NCT01106456|7357432|FG000|NOT COMPLETED|Overall Study||103
6442197|NCT01106456|7357433|FG001|NOT COMPLETED|Overall Study||124
6442198|NCT01106586|7357441|FG000|STARTED|Overall Study||353
6442199|NCT01106586|7357442|FG001|STARTED|Overall Study||355
6442200|NCT01106586|7357441|FG000|COMPLETED|Overall Study||68
6442201|NCT01106586|7357442|FG001|COMPLETED|Overall Study||70
6442202|NCT01106586|7357441|FG000|NOT COMPLETED|Overall Study||285
6442203|NCT01106586|7357442|FG001|NOT COMPLETED|Overall Study||285
6442204|NCT01106625|7357451|FG000|STARTED|Core Period: Baseline to Week 26||156
6442205|NCT01106625|7357452|FG001|STARTED|Core Period: Baseline to Week 26||157
6442206|NCT01106625|7357453|FG002|STARTED|Core Period: Baseline to Week 26||156
6442207|NCT01106625|7357451|FG000|COMPLETED|Core Period: Baseline to Week 26||123
6442208|NCT01106625|7357452|FG001|COMPLETED|Core Period: Baseline to Week 26||129
6442209|NCT01106625|7357453|FG002|COMPLETED|Core Period: Baseline to Week 26||129
6442210|NCT01106625|7357451|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||33
6442211|NCT01106625|7357452|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||28
6442212|NCT01106625|7357453|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||27
6442213|NCT01106625|7357451|FG000|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
6442214|NCT01106625|7357452|FG001|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
6442215|NCT01106625|7357453|FG002|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
6442216|NCT01106625|7357451|FG000|COMPLETED|Extension Period: Week 26 to Week 52||90
6442217|NCT01106625|7357452|FG001|COMPLETED|Extension Period: Week 26 to Week 52||109
6442218|NCT01106625|7357453|FG002|COMPLETED|Extension Period: Week 26 to Week 52||111
6442219|NCT01106625|7357451|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
6442220|NCT01106625|7357452|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
6442221|NCT01106625|7357453|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
6442222|NCT01106651|7357467|FG000|STARTED|Overall Study||237
6442223|NCT01106651|7357468|FG001|STARTED|Overall Study||241
6442224|NCT01106651|7357469|FG002|STARTED|Overall Study||236
6442225|NCT01106651|7357467|FG000|COMPLETED|Overall Study||158
6442226|NCT01106651|7357468|FG001|COMPLETED|Overall Study||184
6442227|NCT01106651|7357469|FG002|COMPLETED|Overall Study||178
6442228|NCT01106651|7357467|FG000|NOT COMPLETED|Overall Study||79
6442229|NCT01106651|7357468|FG001|NOT COMPLETED|Overall Study||57
6442230|NCT01106651|7357469|FG002|NOT COMPLETED|Overall Study||58
6442231|NCT01106677|7357484|FG000|STARTED|Core Period: Baseline to Week 26||183
6442232|NCT01106677|7357485|FG001|STARTED|Core Period: Baseline to Week 26||368
6442233|NCT01106677|7357486|FG002|STARTED|Core Period: Baseline to Week 26||367
6442234|NCT01106677|7357487|FG003|STARTED|Core Period: Baseline to Week 26||366
6442235|NCT01106677|7357484|FG000|COMPLETED|Core Period: Baseline to Week 26||155
6442236|NCT01106677|7357485|FG001|COMPLETED|Core Period: Baseline to Week 26||322
6442237|NCT01106677|7357486|FG002|COMPLETED|Core Period: Baseline to Week 26||323
6442238|NCT01106677|7357487|FG003|COMPLETED|Core Period: Baseline to Week 26||319
6442239|NCT01106677|7357484|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||28
6442240|NCT01106677|7357485|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||46
6442241|NCT01106677|7357486|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||44
6442242|NCT01106677|7357487|FG003|NOT COMPLETED|Core Period: Baseline to Week 26||47
6442243|NCT01106677|7357484|FG000|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
6442244|NCT01106677|7357485|FG001|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
6442245|NCT01106677|7357486|FG002|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
6442246|NCT01106677|7357487|FG003|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
6442247|NCT01106677|7357484|FG000|COMPLETED|Extension Period: Week 26 to Week 52||138
6442248|NCT01106677|7357485|FG001|COMPLETED|Extension Period: Week 26 to Week 52||298
6442249|NCT01106677|7357486|FG002|COMPLETED|Extension Period: Week 26 to Week 52||299
6442250|NCT01106677|7357487|FG003|COMPLETED|Extension Period: Week 26 to Week 52||285
6442251|NCT01106677|7357484|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
6442252|NCT01106677|7357485|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
6442253|NCT01106677|7357486|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
6442254|NCT01106677|7357487|FG003|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
6442255|NCT01106690|7357507|FG000|STARTED|Core Period: Baseline to Week 26||115
6442256|NCT01106690|7357508|FG001|STARTED|Core Period: Baseline to Week 26||113
6442257|NCT01106690|7357509|FG002|STARTED|Core Period: Baseline to Week 26||114
6442258|NCT01106690|7357507|FG000|COMPLETED|Core Period: Baseline to Week 26||91
6552979|NCT01740440|7475424|FG000|STARTED|Overall Study||30
6552980|NCT01740440|7475424|FG000|COMPLETED|Overall Study||27
6552981|NCT01740440|7475424|FG000|NOT COMPLETED|Overall Study||3
6552982|NCT01740713|7475432|FG000|STARTED|Overall Study||6
6552983|NCT01740713|7475433|FG001|STARTED|Overall Study||8
6552984|NCT01740713|7475434|FG002|STARTED|Overall Study||7
6552985|NCT01740713|7475432|FG000|COMPLETED|Overall Study||6
6552986|NCT01740713|7475433|FG001|COMPLETED|Overall Study||6
6552987|NCT01740713|7475434|FG002|COMPLETED|Overall Study||6
6552988|NCT01740713|7475432|FG000|NOT COMPLETED|Overall Study||0
6552989|NCT01740713|7475433|FG001|NOT COMPLETED|Overall Study||2
6552990|NCT01740713|7475434|FG002|NOT COMPLETED|Overall Study||1
6552991|NCT01740726|7475446|FG000|STARTED|Overall Study||0
6552992|NCT01740726|7475447|FG001|STARTED|Overall Study||1
6552993|NCT01740726|7475446|FG000|COMPLETED|Overall Study||0
6552994|NCT01740726|7475447|FG001|COMPLETED|Overall Study||1
6552995|NCT01740726|7475446|FG000|NOT COMPLETED|Overall Study||0
6552996|NCT01740726|7475447|FG001|NOT COMPLETED|Overall Study||0
6562786|NCT01803074|7485699|FG000|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562787|NCT01803074|7485700|FG001|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562788|NCT01803074|7485701|FG002|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6442259|NCT01106690|7357508|FG001|COMPLETED|Core Period: Baseline to Week 26||104
6442260|NCT01106690|7357509|FG002|COMPLETED|Core Period: Baseline to Week 26||101
6442261|NCT01106690|7357507|FG000|NOT COMPLETED|Core Period: Baseline to Week 26||24
6442262|NCT01106690|7357508|FG001|NOT COMPLETED|Core Period: Baseline to Week 26||9
6442263|NCT01106690|7357509|FG002|NOT COMPLETED|Core Period: Baseline to Week 26||13
6442264|NCT01106690|7357507|FG000|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
6442265|NCT01106690|7357508|FG001|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
6442266|NCT01106690|7357509|FG002|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
6442267|NCT01106690|7357507|FG000|COMPLETED|Extension Period: Week 26 to Week 52||78
6442268|NCT01106690|7357508|FG001|COMPLETED|Extension Period: Week 26 to Week 52||96
6442269|NCT01106690|7357509|FG002|COMPLETED|Extension Period: Week 26 to Week 52||89
6442270|NCT01106690|7357507|FG000|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
6442271|NCT01106690|7357508|FG001|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
6442272|NCT01106690|7357509|FG002|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
6442273|NCT01106833|7357522|FG000|STARTED|Overall Study||74
6442274|NCT01106833|7357523|FG001|STARTED|Overall Study||77
6442275|NCT01106833|7357522|FG000|COMPLETED|Overall Study||74
6442276|NCT01106833|7357523|FG001|COMPLETED|Overall Study||77
6442277|NCT01106833|7357522|FG000|NOT COMPLETED|Overall Study||0
6442278|NCT01106833|7357523|FG001|NOT COMPLETED|Overall Study||0
6442279|NCT01106846|7357531|FG000|STARTED|Overall Study||12
6442280|NCT01106846|7357532|FG001|STARTED|Overall Study||10
6442281|NCT01106846|7357531|FG000|COMPLETED|Overall Study||12
6442282|NCT01106846|7357532|FG001|COMPLETED|Overall Study||9
6442283|NCT01106846|7357531|FG000|NOT COMPLETED|Overall Study||0
6442284|NCT01106846|7357532|FG001|NOT COMPLETED|Overall Study||1
6442285|NCT01106859|7357538|FG000|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
6442286|NCT01106859|7357538|FG000|COMPLETED|Overall Study||40
6442287|NCT01106859|7357538|FG000|NOT COMPLETED|Overall Study||0
6442288|NCT01106898|7357549|FG000|STARTED|Overall Study||100
6442289|NCT01106898|7357549|FG000|COMPLETED|Overall Study||94
6442290|NCT01106898|7357549|FG000|NOT COMPLETED|Overall Study||6
6442291|NCT01106911|7357553|FG000|STARTED|Overall Study||1085
6442292|NCT01106911|7357553|FG000|COMPLETED|Overall Study||1080
6442293|NCT01106911|7357553|FG000|NOT COMPLETED|Overall Study||5
6442294|NCT01106950|7357557|FG000|STARTED|Overall Study||15
6442295|NCT01106950|7357557|FG000|COMPLETED|Overall Study||15
6442296|NCT01106950|7357557|FG000|NOT COMPLETED|Overall Study||0
6442297|NCT01106976|7357563|FG000|STARTED|Overall Study||67
6442298|NCT01106976|7357563|FG000|COMPLETED|Overall Study||59
6442299|NCT01106976|7357563|FG000|NOT COMPLETED|Overall Study||8
6442300|NCT01107015|7357571|FG000|STARTED|Overall Study||62
6653428|NCT02436889|7583202|FG000|NOT COMPLETED|Overall Study||1
6653429|NCT02436889|7583203|FG001|NOT COMPLETED|Overall Study||1
6653430|NCT02436915|7583211|FG000|STARTED|Overall Study||9
6653431|NCT02436915|7583212|FG001|STARTED|Overall Study||10
6653432|NCT02436915|7583211|FG000|COMPLETED|Overall Study||9
6653433|NCT02436915|7583212|FG001|COMPLETED|Overall Study||9
6653434|NCT02436915|7583211|FG000|NOT COMPLETED|Overall Study||0
6653435|NCT02436915|7583212|FG001|NOT COMPLETED|Overall Study||1
6653436|NCT02437084|7583220|FG000|STARTED|Overall Study||75
6653437|NCT02437084|7583220|FG000|COMPLETED|Overall Study||72
6653438|NCT02437084|7583220|FG000|NOT COMPLETED|Overall Study||3
6653439|NCT02437162|7583227|FG000|STARTED|Overall Study||116
6653440|NCT02437162|7583228|FG001|STARTED|Overall Study||116
6653441|NCT02437162|7583229|FG002|STARTED|Overall Study||115
6653442|NCT02437162|7583227|FG000|Treated|Overall Study||116
6653443|NCT02437162|7583228|FG001|Treated|Overall Study||116
6653444|NCT02437162|7583229|FG002|Treated|Overall Study||114
6653445|NCT02437162|7583227|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|26
6442301|NCT01107015|7357572|FG001|STARTED|Overall Study||38
6442302|NCT01107015|7357573|FG002|STARTED|Overall Study||33
6442303|NCT01107015|7357574|FG003|STARTED|Overall Study||80
6442304|NCT01107015|7357571|FG000|COMPLETED|Overall Study||56
6442305|NCT01107015|7357572|FG001|COMPLETED|Overall Study||23
6442306|NCT01107015|7357573|FG002|COMPLETED|Overall Study||22
6442307|NCT01107015|7357574|FG003|COMPLETED|Overall Study||62
6442308|NCT01107015|7357571|FG000|NOT COMPLETED|Overall Study||6
6442309|NCT01107015|7357572|FG001|NOT COMPLETED|Overall Study||15
6442310|NCT01107015|7357573|FG002|NOT COMPLETED|Overall Study||11
6442311|NCT01107015|7357574|FG003|NOT COMPLETED|Overall Study||18
6442312|NCT01107197|7357586|FG000|STARTED|Overall Study||99
6442313|NCT01107197|7357587|FG001|STARTED|Overall Study||101
6442314|NCT01107197|7357586|FG000|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
6442315|NCT01107197|7357587|FG001|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
6442316|NCT01107197|7357586|FG000|NOT COMPLETED|Overall Study||20
6442317|NCT01107197|7357587|FG001|NOT COMPLETED|Overall Study||23
6442318|NCT01107353|7357595|FG000|STARTED|Overall Study||20
6442319|NCT01107353|7357596|FG001|STARTED|Overall Study||20
6442320|NCT01107353|7357595|FG000|COMPLETED|Overall Study||19
6442321|NCT01107353|7357596|FG001|COMPLETED|Overall Study||20
6442322|NCT01107353|7357595|FG000|NOT COMPLETED|Overall Study||1
6656241|NCT02459262|7586362|FG004|NOT COMPLETED|Overall Study||0
6442323|NCT01107353|7357596|FG001|NOT COMPLETED|Overall Study||0
6442324|NCT01107379|7357602|FG000|STARTED|Overall Study||203
6442325|NCT01107379|7357602|FG000|COMPLETED|Overall Study||182
6442326|NCT01107379|7357602|FG000|NOT COMPLETED|Overall Study||21
6442327|NCT01107392|7357608|FG000|STARTED|Overall Study||158
6442328|NCT01107392|7357609|FG001|STARTED|Overall Study||157
6442329|NCT01107392|7357608|FG000|COMPLETED|Overall Study||153
6442330|NCT01107392|7357609|FG001|COMPLETED|Overall Study||154
6442331|NCT01107392|7357608|FG000|NOT COMPLETED|Overall Study||5
6442332|NCT01107392|7357609|FG001|NOT COMPLETED|Overall Study||3
6442333|NCT01107405|7357620|FG000|STARTED|Overall Study||21
6442334|NCT01107405|7357621|FG001|STARTED|Overall Study||20
6442335|NCT01107405|7357622|FG002|STARTED|Overall Study||20
6442336|NCT01107405|7357623|FG003|STARTED|Overall Study||20
6442337|NCT01107405|7357624|FG004|STARTED|Overall Study||20
6442338|NCT01107405|7357620|FG000|COMPLETED|Overall Study||19
6442339|NCT01107405|7357621|FG001|COMPLETED|Overall Study||19
6442340|NCT01107405|7357622|FG002|COMPLETED|Overall Study||18
6442341|NCT01107405|7357623|FG003|COMPLETED|Overall Study||17
6442342|NCT01107405|7357624|FG004|COMPLETED|Overall Study||17
6442343|NCT01107405|7357620|FG000|NOT COMPLETED|Overall Study||2
6442344|NCT01107405|7357621|FG001|NOT COMPLETED|Overall Study||1
6442345|NCT01107405|7357622|FG002|NOT COMPLETED|Overall Study||2
6442346|NCT01107405|7357623|FG003|NOT COMPLETED|Overall Study||3
6442347|NCT01107405|7357624|FG004|NOT COMPLETED|Overall Study||3
6442348|NCT01107418|7357640|FG000|STARTED|Overall Study||52
6442349|NCT01107418|7357640|FG000|COMPLETED|Overall Study||0
6442350|NCT01107418|7357640|FG000|NOT COMPLETED|Overall Study||52
6442351|NCT01107444|7357657|FG000|STARTED|Overall Study||120
6442352|NCT01107444|7357658|FG001|STARTED|Overall Study||60
6442353|NCT01107444|7357657|FG000|Received At Least 1 Dose of Study Drug|Overall Study||114
6442354|NCT01107444|7357658|FG001|Received At Least 1 Dose of Study Drug|Overall Study||48
6442355|NCT01107444|7357657|FG000|COMPLETED|Overall Study||112
6442356|NCT01107444|7357658|FG001|COMPLETED|Overall Study||47
6442357|NCT01107444|7357657|FG000|NOT COMPLETED|Overall Study||8
6442358|NCT01107444|7357658|FG001|NOT COMPLETED|Overall Study||13
6442359|NCT01107457|7357672|FG000|STARTED|Part A||27
6442360|NCT01107457|7357673|FG001|STARTED|Part A||28
6442361|NCT01107457|7357674|FG002|STARTED|Part A||30
6442362|NCT01107457|7357675|FG003|STARTED|Part A||29
6442363|NCT01107457|7357676|FG004|STARTED|Part A||28
6442364|NCT01107457|7357677|FG005|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
6442365|NCT01107457|7357672|FG000|Received at Least 1 Dose of Study Drug|Part A||27
6442366|NCT01107457|7357673|FG001|Received at Least 1 Dose of Study Drug|Part A||28
6442367|NCT01107457|7357674|FG002|Received at Least 1 Dose of Study Drug|Part A||30
6442368|NCT01107457|7357675|FG003|Received at Least 1 Dose of Study Drug|Part A||29
6442369|NCT01107457|7357676|FG004|Received at Least 1 Dose of Study Drug|Part A||28
6442370|NCT01107457|7357677|FG005|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
6442371|NCT01107457|7357672|FG000|COMPLETED|Part A||22
6442372|NCT01107457|7357673|FG001|COMPLETED|Part A||21
6442373|NCT01107457|7357674|FG002|COMPLETED|Part A||29
6442374|NCT01107457|7357675|FG003|COMPLETED|Part A||26
6442375|NCT01107457|7357676|FG004|COMPLETED|Part A||27
6442376|NCT01107457|7357677|FG005|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
6442377|NCT01107457|7357672|FG000|NOT COMPLETED|Part A||5
6442378|NCT01107457|7357673|FG001|NOT COMPLETED|Part A||7
6442379|NCT01107457|7357674|FG002|NOT COMPLETED|Part A||1
6442380|NCT01107457|7357675|FG003|NOT COMPLETED|Part A||3
6442381|NCT01107457|7357676|FG004|NOT COMPLETED|Part A||1
6442382|NCT01107457|7357677|FG005|NOT COMPLETED|Part A||0
6442383|NCT01107457|7357672|FG000|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6442384|NCT01107457|7357673|FG001|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6442385|NCT01107457|7357674|FG002|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6442386|NCT01107457|7357675|FG003|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6442387|NCT01107457|7357676|FG004|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
6442388|NCT01107457|7357677|FG005|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
6442389|NCT01107457|7357672|FG000|Completed Part B (Week 240)|Part B and C||0
6442390|NCT01107457|7357673|FG001|Completed Part B (Week 240)|Part B and C||0
6442391|NCT01107457|7357674|FG002|Completed Part B (Week 240)|Part B and C||0
6442392|NCT01107457|7357675|FG003|Completed Part B (Week 240)|Part B and C||0
6442393|NCT01107457|7357676|FG004|Completed Part B (Week 240)|Part B and C||0
6442394|NCT01107457|7357677|FG005|Completed Part B (Week 240)|Part B and C||74
6442395|NCT01107457|7357672|FG000|Completed Part C|Part B and C||0
6442396|NCT01107457|7357673|FG001|Completed Part C|Part B and C||0
6442397|NCT01107457|7357674|FG002|Completed Part C|Part B and C||0
6442398|NCT01107457|7357675|FG003|Completed Part C|Part B and C||0
6442399|NCT01107457|7357676|FG004|Completed Part C|Part B and C||0
6442400|NCT01107457|7357677|FG005|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
6442401|NCT01107457|7357672|FG000|Post Treatment Safety Visits|Part B and C||0
6442402|NCT01107457|7357673|FG001|Post Treatment Safety Visits|Part B and C||0
6442403|NCT01107457|7357674|FG002|Post Treatment Safety Visits|Part B and C||0
6442404|NCT01107457|7357675|FG003|Post Treatment Safety Visits|Part B and C||0
6442405|NCT01107457|7357676|FG004|Post Treatment Safety Visits|Part B and C||0
6442406|NCT01107457|7357677|FG005|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
6442407|NCT01107457|7357672|FG000|COMPLETED|Part B and C||0
6442408|NCT01107457|7357673|FG001|COMPLETED|Part B and C||0
6442409|NCT01107457|7357674|FG002|COMPLETED|Part B and C||0
6442410|NCT01107457|7357675|FG003|COMPLETED|Part B and C||0
6442411|NCT01107457|7357676|FG004|COMPLETED|Part B and C||0
6442412|NCT01107457|7357677|FG005|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
6442413|NCT01107457|7357672|FG000|NOT COMPLETED|Part B and C||0
6442414|NCT01107457|7357673|FG001|NOT COMPLETED|Part B and C||0
6442415|NCT01107457|7357674|FG002|NOT COMPLETED|Part B and C||0
6442416|NCT01107457|7357675|FG003|NOT COMPLETED|Part B and C||0
6442417|NCT01107457|7357676|FG004|NOT COMPLETED|Part B and C||0
6442418|NCT01107457|7357677|FG005|NOT COMPLETED|Part B and C||120
6442419|NCT01107535|7357695|FG000|STARTED|Overall Study||82
6442420|NCT01107535|7357695|FG000|Number of Participants Analyzed|Overall Study||82
6442421|NCT01107535|7357695|FG000|COMPLETED|Overall Study||77
6442422|NCT01107535|7357695|FG000|NOT COMPLETED|Overall Study||5
6442423|NCT01107626|7357703|FG000|STARTED|Step 1: Induction Therapy||642
6442424|NCT01107626|7357704|FG001|STARTED|Step 1: Induction Therapy||287
6442425|NCT01107626|7357705|FG002|STARTED|Step 1: Induction Therapy||294
6442426|NCT01107626|7357706|FG003|STARTED|Step 1: Induction Therapy||293
6442427|NCT01107626|7357703|FG000|COMPLETED|Step 1: Induction Therapy||65
6442428|NCT01107626|7357704|FG001|COMPLETED|Step 1: Induction Therapy||287
6442429|NCT01107626|7357705|FG002|COMPLETED|Step 1: Induction Therapy||294
6442430|NCT01107626|7357706|FG003|COMPLETED|Step 1: Induction Therapy||293
6442431|NCT01107626|7357703|FG000|NOT COMPLETED|Step 1: Induction Therapy||577
6442432|NCT01107626|7357704|FG001|NOT COMPLETED|Step 1: Induction Therapy||0
6442433|NCT01107626|7357705|FG002|NOT COMPLETED|Step 1: Induction Therapy||0
6442434|NCT01107626|7357706|FG003|NOT COMPLETED|Step 1: Induction Therapy||0
6442435|NCT01107626|7357703|FG000|STARTED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
6442436|NCT01107626|7357704|FG001|STARTED|Step 2: Maintenance Therapy||287
6442437|NCT01107626|7357705|FG002|STARTED|Step 2: Maintenance Therapy||294
6442438|NCT01107626|7357706|FG003|STARTED|Step 2: Maintenance Therapy||293
6442439|NCT01107626|7357703|FG000|COMPLETED|Step 2: Maintenance Therapy|Patients without complete/partial response or stable disease post induction phase weren't randomized|0
6442440|NCT01107626|7357704|FG001|COMPLETED|Step 2: Maintenance Therapy||1
6442441|NCT01107626|7357705|FG002|COMPLETED|Step 2: Maintenance Therapy||0
6442442|NCT01107626|7357706|FG003|COMPLETED|Step 2: Maintenance Therapy||1
6442443|NCT01107626|7357703|FG000|NOT COMPLETED|Step 2: Maintenance Therapy||0
6442444|NCT01107626|7357704|FG001|NOT COMPLETED|Step 2: Maintenance Therapy||286
6442445|NCT01107626|7357705|FG002|NOT COMPLETED|Step 2: Maintenance Therapy||294
6442446|NCT01107626|7357706|FG003|NOT COMPLETED|Step 2: Maintenance Therapy||292
6442447|NCT01107665|7357715|FG000|STARTED|Overall Study||60
6442448|NCT01107665|7357715|FG000|COMPLETED|Overall Study||11
6442449|NCT01107665|7357715|FG000|NOT COMPLETED|Overall Study||49
6442450|NCT01107730|7357724|FG000|STARTED|Overall Study||11
6442451|NCT01107730|7357725|FG001|STARTED|Overall Study||11
6442452|NCT01107730|7357726|FG002|STARTED|Overall Study||11
6442453|NCT01107730|7357724|FG000|COMPLETED|Overall Study||11
6442454|NCT01107730|7357725|FG001|COMPLETED|Overall Study||11
6442455|NCT01107730|7357726|FG002|COMPLETED|Overall Study||11
6442456|NCT01107730|7357724|FG000|NOT COMPLETED|Overall Study||0
6442457|NCT01107730|7357725|FG001|NOT COMPLETED|Overall Study||0
6442458|NCT01107730|7357726|FG002|NOT COMPLETED|Overall Study||0
6442459|NCT01107743|7357734|FG000|STARTED|Overall Study||1291
6442460|NCT01107743|7357734|FG000|COMPLETED|Overall Study||1245
6442461|NCT01107743|7357734|FG000|NOT COMPLETED|Overall Study||46
6442462|NCT01107834|7357785|FG000|STARTED|Overall Study||30
6442463|NCT01107834|7357786|FG001|STARTED|Overall Study||30
6442464|NCT01107834|7357785|FG000|COMPLETED|Overall Study||30
6442465|NCT01107834|7357786|FG001|COMPLETED|Overall Study||30
6442466|NCT01107834|7357785|FG000|NOT COMPLETED|Overall Study||0
6442467|NCT01107834|7357786|FG001|NOT COMPLETED|Overall Study||0
6442468|NCT01107886|7357794|FG000|STARTED|Overall Study|Randomized subjects|8280
6442469|NCT01107886|7357795|FG001|STARTED|Overall Study|Randomized subjects|8212
6442470|NCT01107886|7357794|FG000|COMPLETED|Overall Study|Completed subjects|8078
6442471|NCT01107886|7357795|FG001|COMPLETED|Overall Study|Completed subjects|7998
6442472|NCT01107886|7357794|FG000|NOT COMPLETED|Overall Study||202
6442473|NCT01107886|7357795|FG001|NOT COMPLETED|Overall Study||214
6442474|NCT01107899|7357804|FG000|STARTED|Overall Study||10
6442475|NCT01107899|7357805|FG001|STARTED|Overall Study||10
6442476|NCT01107899|7357806|FG002|STARTED|Overall Study||9
6442477|NCT01107899|7357804|FG000|Received at Least One Dose of Study Drug|Overall Study||10
6442478|NCT01107899|7357805|FG001|Received at Least One Dose of Study Drug|Overall Study||10
6442479|NCT01107899|7357806|FG002|Received at Least One Dose of Study Drug|Overall Study||8
6552997|NCT01740791|7475459|FG000|STARTED|Overall Study||22
6552998|NCT01740791|7475460|FG001|STARTED|Overall Study||7
6552999|NCT01740791|7475461|FG002|STARTED|Overall Study||17
6553000|NCT01740791|7475462|FG003|STARTED|Overall Study||14
6553001|NCT01740791|7475463|FG004|STARTED|Overall Study||9
6500114|NCT01423604|7418922|FG000|STARTED|Safety Run-In||9
6553002|NCT01740791|7475464|FG005|STARTED|Overall Study||34
6553003|NCT01740791|7475459|FG000|COMPLETED|Overall Study||10
6442480|NCT01107899|7357804|FG000|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
6442481|NCT01107899|7357805|FG001|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
6442482|NCT01107899|7357806|FG002|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
6442483|NCT01107899|7357804|FG000|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
6442484|NCT01107899|7357805|FG001|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
6442485|NCT01107899|7357806|FG002|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
6442486|NCT01107899|7357804|FG000|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
6442487|NCT01107899|7357805|FG001|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
6442488|NCT01107899|7357806|FG002|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
6442489|NCT01107899|7357804|FG000|COMPLETED|Overall Study||5
6442490|NCT01107899|7357805|FG001|COMPLETED|Overall Study||10
6442491|NCT01107899|7357806|FG002|COMPLETED|Overall Study||5
6442492|NCT01107899|7357804|FG000|NOT COMPLETED|Overall Study||5
6442493|NCT01107899|7357805|FG001|NOT COMPLETED|Overall Study||0
6442494|NCT01107899|7357806|FG002|NOT COMPLETED|Overall Study||4
6442495|NCT01107912|7357821|FG000|STARTED|Period 1||73
6442496|NCT01107912|7357822|FG001|STARTED|Period 1||0
6442497|NCT01107912|7357823|FG002|STARTED|Period 1||0
6442498|NCT01107912|7357824|FG003|STARTED|Period 1||0
6442499|NCT01107912|7357825|FG004|STARTED|Period 1||82
6442500|NCT01107912|7357826|FG005|STARTED|Period 1||0
6442501|NCT01107912|7357821|FG000|Received at Least 1 Dose of Study Drug|Period 1||73
6442502|NCT01107912|7357822|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
6442503|NCT01107912|7357823|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
6442504|NCT01107912|7357824|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
6442505|NCT01107912|7357825|FG004|Received at Least 1 Dose of Study Drug|Period 1||82
6442506|NCT01107912|7357826|FG005|Received at Least 1 Dose of Study Drug|Period 1||0
6442507|NCT01107912|7357821|FG000|COMPLETED|Period 1||72
6442508|NCT01107912|7357822|FG001|COMPLETED|Period 1||0
6442509|NCT01107912|7357823|FG002|COMPLETED|Period 1||0
6442510|NCT01107912|7357824|FG003|COMPLETED|Period 1||0
6442511|NCT01107912|7357825|FG004|COMPLETED|Period 1||79
6442512|NCT01107912|7357826|FG005|COMPLETED|Period 1||0
6442513|NCT01107912|7357821|FG000|NOT COMPLETED|Period 1||1
6442514|NCT01107912|7357822|FG001|NOT COMPLETED|Period 1||0
6442515|NCT01107912|7357823|FG002|NOT COMPLETED|Period 1||0
6442516|NCT01107912|7357824|FG003|NOT COMPLETED|Period 1||0
6442517|NCT01107912|7357825|FG004|NOT COMPLETED|Period 1||3
6442518|NCT01107912|7357826|FG005|NOT COMPLETED|Period 1||0
6442519|NCT01107912|7357821|FG000|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
6442520|NCT01107912|7357822|FG001|STARTED|Period 2||36
6442521|NCT01107912|7357823|FG002|STARTED|Period 2||36
6442522|NCT01107912|7357824|FG003|STARTED|Period 2||41
6442523|NCT01107912|7357825|FG004|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
6442524|NCT01107912|7357826|FG005|STARTED|Period 2||38
6442525|NCT01107912|7357821|FG000|COMPLETED|Period 2||0
6442526|NCT01107912|7357822|FG001|COMPLETED|Period 2||36
6442527|NCT01107912|7357823|FG002|COMPLETED|Period 2||35
6442528|NCT01107912|7357824|FG003|COMPLETED|Period 2||41
6442529|NCT01107912|7357825|FG004|COMPLETED|Period 2||0
6442530|NCT01107912|7357826|FG005|COMPLETED|Period 2||38
6442531|NCT01107912|7357821|FG000|NOT COMPLETED|Period 2||0
6442532|NCT01107912|7357822|FG001|NOT COMPLETED|Period 2||0
6442533|NCT01107912|7357823|FG002|NOT COMPLETED|Period 2||1
6442534|NCT01107912|7357824|FG003|NOT COMPLETED|Period 2||0
6442535|NCT01107912|7357825|FG004|NOT COMPLETED|Period 2||0
6442536|NCT01107912|7357826|FG005|NOT COMPLETED|Period 2||0
6442537|NCT01107912|7357821|FG000|STARTED|Period 3||0
6442538|NCT01107912|7357822|FG001|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
6442539|NCT01107912|7357823|FG002|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
6442540|NCT01107912|7357824|FG003|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
6442541|NCT01107912|7357825|FG004|STARTED|Period 3||0
6442542|NCT01107912|7357826|FG005|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
6442543|NCT01107912|7357821|FG000|COMPLETED|Period 3||0
6442544|NCT01107912|7357822|FG001|COMPLETED|Period 3||34
6442545|NCT01107912|7357823|FG002|COMPLETED|Period 3||35
6442546|NCT01107912|7357824|FG003|COMPLETED|Period 3||37
6442547|NCT01107912|7357825|FG004|COMPLETED|Period 3||0
6442548|NCT01107912|7357826|FG005|COMPLETED|Period 3||41
6442549|NCT01107912|7357821|FG000|NOT COMPLETED|Period 3||0
6442550|NCT01107912|7357822|FG001|NOT COMPLETED|Period 3||1
6442551|NCT01107912|7357823|FG002|NOT COMPLETED|Period 3||1
6442552|NCT01107912|7357824|FG003|NOT COMPLETED|Period 3||1
6442553|NCT01107912|7357825|FG004|NOT COMPLETED|Period 3||0
6442554|NCT01107912|7357826|FG005|NOT COMPLETED|Period 3||0
6442555|NCT01107925|7357845|FG000|STARTED|Period 1-Randomization up Through Day 12||34
6442556|NCT01107925|7357846|FG001|STARTED|Period 1-Randomization up Through Day 12||0
6442557|NCT01107925|7357847|FG002|STARTED|Period 1-Randomization up Through Day 12||0
6442558|NCT01107925|7357848|FG003|STARTED|Period 1-Randomization up Through Day 12||0
6442559|NCT01107925|7357849|FG004|STARTED|Period 1-Randomization up Through Day 12||38
6442560|NCT01107925|7357850|FG005|STARTED|Period 1-Randomization up Through Day 12||0
6442561|NCT01107925|7357845|FG000|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
6442562|NCT01107925|7357846|FG001|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
6442563|NCT01107925|7357847|FG002|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
6442564|NCT01107925|7357848|FG003|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
6442565|NCT01107925|7357849|FG004|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
6442566|NCT01107925|7357850|FG005|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
6442567|NCT01107925|7357845|FG000|COMPLETED|Period 1-Randomization up Through Day 12||33
6442568|NCT01107925|7357846|FG001|COMPLETED|Period 1-Randomization up Through Day 12||0
6442569|NCT01107925|7357847|FG002|COMPLETED|Period 1-Randomization up Through Day 12||0
6442570|NCT01107925|7357848|FG003|COMPLETED|Period 1-Randomization up Through Day 12||0
6442571|NCT01107925|7357849|FG004|COMPLETED|Period 1-Randomization up Through Day 12||37
6442572|NCT01107925|7357850|FG005|COMPLETED|Period 1-Randomization up Through Day 12||0
6442573|NCT01107925|7357845|FG000|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
6442574|NCT01107925|7357846|FG001|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
6442575|NCT01107925|7357847|FG002|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
6442576|NCT01107925|7357848|FG003|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
6442577|NCT01107925|7357849|FG004|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
6442578|NCT01107925|7357850|FG005|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
6442579|NCT01107925|7357845|FG000|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
6442580|NCT01107925|7357846|FG001|STARTED|Period 2||16
6442581|NCT01107925|7357847|FG002|STARTED|Period 2||17
6442582|NCT01107925|7357848|FG003|STARTED|Period 2||20
6442583|NCT01107925|7357849|FG004|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
6442584|NCT01107925|7357850|FG005|STARTED|Period 2||17
6442585|NCT01107925|7357845|FG000|Took at Least 1 Dose of Study Drug|Period 2||0
6442586|NCT01107925|7357846|FG001|Took at Least 1 Dose of Study Drug|Period 2||16
6442587|NCT01107925|7357847|FG002|Took at Least 1 Dose of Study Drug|Period 2||17
6442588|NCT01107925|7357848|FG003|Took at Least 1 Dose of Study Drug|Period 2||20
6442589|NCT01107925|7357849|FG004|Took at Least 1 Dose of Study Drug|Period 2||0
6442590|NCT01107925|7357850|FG005|Took at Least 1 Dose of Study Drug|Period 2||17
6442591|NCT01107925|7357845|FG000|COMPLETED|Period 2||0
6442592|NCT01107925|7357846|FG001|COMPLETED|Period 2||15
6442593|NCT01107925|7357847|FG002|COMPLETED|Period 2||17
6442594|NCT01107925|7357848|FG003|COMPLETED|Period 2||20
6442595|NCT01107925|7357849|FG004|COMPLETED|Period 2||0
6442596|NCT01107925|7357850|FG005|COMPLETED|Period 2||16
6442597|NCT01107925|7357845|FG000|NOT COMPLETED|Period 2||0
6442598|NCT01107925|7357846|FG001|NOT COMPLETED|Period 2||1
6442599|NCT01107925|7357847|FG002|NOT COMPLETED|Period 2||0
6442600|NCT01107925|7357848|FG003|NOT COMPLETED|Period 2||0
6442601|NCT01107925|7357849|FG004|NOT COMPLETED|Period 2||0
6442602|NCT01107925|7357850|FG005|NOT COMPLETED|Period 2||1
6442603|NCT01107925|7357845|FG000|STARTED|Period 3||0
6442604|NCT01107925|7357846|FG001|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
6442605|NCT01107925|7357847|FG002|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
6442606|NCT01107925|7357848|FG003|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
6442607|NCT01107925|7357849|FG004|STARTED|Period 3||0
6442608|NCT01107925|7357850|FG005|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
6442609|NCT01107925|7357845|FG000|Took at Least 1 Dose of Study Drug|Period 3||0
6442610|NCT01107925|7357846|FG001|Took at Least 1 Dose of Study Drug|Period 3||17
6442611|NCT01107925|7357847|FG002|Took at Least 1 Dose of Study Drug|Period 3||15
6442612|NCT01107925|7357848|FG003|Took at Least 1 Dose of Study Drug|Period 3||16
6442613|NCT01107925|7357849|FG004|Took at Least 1 Dose of Study Drug|Period 3||0
6442614|NCT01107925|7357850|FG005|Took at Least 1 Dose of Study Drug|Period 3||20
6442615|NCT01107925|7357845|FG000|COMPLETED|Period 3||0
6442616|NCT01107925|7357846|FG001|COMPLETED|Period 3||17
6442617|NCT01107925|7357847|FG002|COMPLETED|Period 3||15
6442618|NCT01107925|7357848|FG003|COMPLETED|Period 3||16
6442619|NCT01107925|7357849|FG004|COMPLETED|Period 3||0
6442620|NCT01107925|7357850|FG005|COMPLETED|Period 3||20
6553004|NCT01740791|7475460|FG001|COMPLETED|Overall Study||4
6553005|NCT01740791|7475461|FG002|COMPLETED|Overall Study||11
6553006|NCT01740791|7475462|FG003|COMPLETED|Overall Study||7
6553007|NCT01740791|7475463|FG004|COMPLETED|Overall Study||6
6553008|NCT01740791|7475464|FG005|COMPLETED|Overall Study||23
6553009|NCT01740791|7475459|FG000|NOT COMPLETED|Overall Study||12
6442621|NCT01107925|7357845|FG000|NOT COMPLETED|Period 3||0
6442622|NCT01107925|7357846|FG001|NOT COMPLETED|Period 3||0
6442623|NCT01107925|7357847|FG002|NOT COMPLETED|Period 3||0
6553010|NCT01740791|7475460|FG001|NOT COMPLETED|Overall Study||3
6653446|NCT02437162|7583228|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
6442624|NCT01107925|7357848|FG003|NOT COMPLETED|Period 3||0
6442625|NCT01107925|7357849|FG004|NOT COMPLETED|Period 3||0
6442626|NCT01107925|7357850|FG005|NOT COMPLETED|Period 3||0
6442627|NCT01107964|7357880|FG000|STARTED|Overall Study||13
6442628|NCT01107964|7357881|FG001|STARTED|Overall Study||14
6442629|NCT01107964|7357880|FG000|COMPLETED|Overall Study||12
6442630|NCT01107964|7357881|FG001|COMPLETED|Overall Study||13
6442631|NCT01107964|7357880|FG000|NOT COMPLETED|Overall Study||1
6442632|NCT01107964|7357881|FG001|NOT COMPLETED|Overall Study||1
6442633|NCT01108003|7357889|FG000|STARTED|Overall Study||4
6442634|NCT01108003|7357890|FG001|STARTED|Overall Study||3
6442635|NCT01108003|7357889|FG000|COMPLETED|Overall Study||4
6442636|NCT01108003|7357890|FG001|COMPLETED|Overall Study||3
6442637|NCT01108003|7357889|FG000|NOT COMPLETED|Overall Study||0
6442638|NCT01108003|7357890|FG001|NOT COMPLETED|Overall Study||0
6442639|NCT01108068|7357898|FG000|STARTED|Overall Study||10
6442640|NCT01108068|7357899|FG001|STARTED|Overall Study||16
6442641|NCT01108068|7357898|FG000|COMPLETED|Overall Study|Only 5 individuals were recruited into the Lithium treatment arm|4
6442642|NCT01108068|7357899|FG001|COMPLETED|Overall Study||16
6442643|NCT01108068|7357898|FG000|NOT COMPLETED|Overall Study||6
6442644|NCT01108068|7357899|FG001|NOT COMPLETED|Overall Study||0
6442645|NCT01108081|7357910|FG000|STARTED|Overall Study||46
6553011|NCT01740791|7475461|FG002|NOT COMPLETED|Overall Study||6
6553012|NCT01740791|7475462|FG003|NOT COMPLETED|Overall Study||7
6553013|NCT01740791|7475463|FG004|NOT COMPLETED|Overall Study||3
6553014|NCT01740791|7475464|FG005|NOT COMPLETED|Overall Study||11
6553015|NCT01740817|7475519|FG000|STARTED|First Intervention (48 h)||8
6553016|NCT01740817|7475520|FG001|STARTED|First Intervention (48 h)||4
6553017|NCT01740817|7475519|FG000|COMPLETED|First Intervention (48 h)||8
6553018|NCT01740817|7475520|FG001|COMPLETED|First Intervention (48 h)||4
6653447|NCT02437162|7583229|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|14
6653448|NCT02437162|7583227|FG000|Cross Over at Week 24|Overall Study|Out of 87: crossed over to Ustekinumab 45 mg (n=44) and Ustekinumab 90 mg (n=43)|87
6653449|NCT02437162|7583228|FG001|Cross Over at Week 24|Overall Study||0
6653450|NCT02437162|7583229|FG002|Cross Over at Week 24|Overall Study||0
6653451|NCT02437162|7583227|FG000|COMPLETED|Overall Study||9
6653452|NCT02437162|7583228|FG001|COMPLETED|Overall Study||8
6653453|NCT02437162|7583229|FG002|COMPLETED|Overall Study||6
6653454|NCT02437162|7583227|FG000|NOT COMPLETED|Overall Study||107
6653455|NCT02437162|7583228|FG001|NOT COMPLETED|Overall Study||108
6653456|NCT02437162|7583229|FG002|NOT COMPLETED|Overall Study||109
6653457|NCT02437188|7583244|FG000|STARTED|Overall Study||44
6653458|NCT02437188|7583245|FG001|STARTED|Overall Study||44
6653459|NCT02437188|7583244|FG000|COMPLETED|Overall Study||40
6653460|NCT02437188|7583245|FG001|COMPLETED|Overall Study||35
6653461|NCT02437188|7583244|FG000|NOT COMPLETED|Overall Study||4
6653462|NCT02437188|7583245|FG001|NOT COMPLETED|Overall Study||9
6653463|NCT02437253|7583256|FG000|STARTED|Overall Study||1
6653464|NCT02437253|7583257|FG001|STARTED|Overall Study||1
6653465|NCT02437253|7583256|FG000|COMPLETED|Overall Study||1
6653466|NCT02437253|7583257|FG001|COMPLETED|Overall Study||1
6653467|NCT02437253|7583256|FG000|NOT COMPLETED|Overall Study||0
6653468|NCT02437253|7583257|FG001|NOT COMPLETED|Overall Study||0
6653469|NCT02437305|7583267|FG000|STARTED|Overall Study||50
6442646|NCT01108081|7357911|FG001|STARTED|Overall Study||42
6442647|NCT01108081|7357912|FG002|STARTED|Overall Study||38
6442648|NCT01108081|7357913|FG003|STARTED|Overall Study||43
6442649|NCT01108081|7357910|FG000|COMPLETED|Overall Study||44
6442650|NCT01108081|7357911|FG001|COMPLETED|Overall Study||40
6442651|NCT01108081|7357912|FG002|COMPLETED|Overall Study||38
6442652|NCT01108081|7357913|FG003|COMPLETED|Overall Study||39
6442653|NCT01108081|7357910|FG000|NOT COMPLETED|Overall Study||2
6442654|NCT01108081|7357911|FG001|NOT COMPLETED|Overall Study||2
6442655|NCT01108081|7357912|FG002|NOT COMPLETED|Overall Study||0
6442656|NCT01108081|7357913|FG003|NOT COMPLETED|Overall Study||4
6442657|NCT01108094|7357927|FG000|STARTED|Overall Study||12
6442658|NCT01108094|7357928|FG001|STARTED|Overall Study||3
6442659|NCT01108094|7357929|FG002|STARTED|Overall Study||4
6442660|NCT01108094|7357930|FG003|STARTED|Overall Study||10
6442661|NCT01108094|7357927|FG000|COMPLETED|Overall Study||9
6442662|NCT01108094|7357928|FG001|COMPLETED|Overall Study||3
6442663|NCT01108094|7357929|FG002|COMPLETED|Overall Study||4
6442664|NCT01108094|7357930|FG003|COMPLETED|Overall Study||10
6442665|NCT01108094|7357927|FG000|NOT COMPLETED|Overall Study||3
6442666|NCT01108094|7357928|FG001|NOT COMPLETED|Overall Study||0
6553019|NCT01740817|7475519|FG000|NOT COMPLETED|First Intervention (48 h)||0
6653470|NCT02437305|7583268|FG001|STARTED|Overall Study||50
6653471|NCT02437305|7583267|FG000|COMPLETED|Overall Study||32
6653472|NCT02437305|7583268|FG001|COMPLETED|Overall Study||38
6653473|NCT02437305|7583267|FG000|NOT COMPLETED|Overall Study||18
6653474|NCT02437305|7583268|FG001|NOT COMPLETED|Overall Study||12
6653475|NCT02437344|7583274|FG000|STARTED|Overall Study||16
6442667|NCT01108094|7357929|FG002|NOT COMPLETED|Overall Study||0
6442668|NCT01108094|7357930|FG003|NOT COMPLETED|Overall Study||0
6442669|NCT01108185|7357943|FG000|STARTED|Overall Study||3181
6442670|NCT01108185|7357943|FG000|Per Protocol Population|Overall Study||3181
6442671|NCT01108185|7357943|FG000|COMPLETED|Overall Study||3154
6442672|NCT01108185|7357943|FG000|NOT COMPLETED|Overall Study||27
6442673|NCT01108237|7357949|FG000|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
6442674|NCT01108237|7357950|FG001|STARTED|Overall Study||101
6442675|NCT01108237|7357949|FG000|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
6442676|NCT01108237|7357950|FG001|COMPLETED|Overall Study||84
6442677|NCT01108237|7357949|FG000|NOT COMPLETED|Overall Study||9
6442678|NCT01108237|7357950|FG001|NOT COMPLETED|Overall Study||17
6442679|NCT01108263|7357958|FG000|STARTED|Overall Study||2
6442680|NCT01108263|7357959|FG001|STARTED|Overall Study||3
6442681|NCT01108263|7357958|FG000|COMPLETED|Overall Study||2
6442682|NCT01108263|7357959|FG001|COMPLETED|Overall Study||2
6442683|NCT01108263|7357958|FG000|NOT COMPLETED|Overall Study||0
6442684|NCT01108263|7357959|FG001|NOT COMPLETED|Overall Study||1
6442685|NCT01108341|7357965|FG000|STARTED|Overall Study||50
6442686|NCT01108341|7357965|FG000|Safety Set (Enrolled and Treated)|Overall Study||49
6442687|NCT01108341|7357965|FG000|COMPLETED|Overall Study||45
6442688|NCT01108341|7357965|FG000|NOT COMPLETED|Overall Study||5
6442689|NCT01108406|7357969|FG000|STARTED|Overall Study||22
6442690|NCT01108406|7357969|FG000|COMPLETED|Overall Study||22
6442691|NCT01108406|7357969|FG000|NOT COMPLETED|Overall Study||0
6442692|NCT01108445|7357977|FG000|STARTED|Overall Study||57
6442693|NCT01108445|7357978|FG001|STARTED|Overall Study||51
6442694|NCT01108445|7357977|FG000|COMPLETED|Overall Study||1
6442695|NCT01108445|7357978|FG001|COMPLETED|Overall Study||2
6442696|NCT01108445|7357977|FG000|NOT COMPLETED|Overall Study||56
6442697|NCT01108445|7357978|FG001|NOT COMPLETED|Overall Study||49
6442698|NCT01108458|7357984|FG000|STARTED|Overall Study||1
6442699|NCT01108458|7357984|FG000|COMPLETED|Overall Study||0
6442700|NCT01108458|7357984|FG000|NOT COMPLETED|Overall Study||1
6442701|NCT01108510|7357990|FG000|STARTED|Overall Study||349
6442702|NCT01108510|7357991|FG001|STARTED|Overall Study||349
6442703|NCT01108510|7357990|FG000|COMPLETED|Overall Study||70
6442704|NCT01108510|7357991|FG001|COMPLETED|Overall Study||81
6442705|NCT01108510|7357990|FG000|NOT COMPLETED|Overall Study||279
6442706|NCT01108510|7357991|FG001|NOT COMPLETED|Overall Study||268
6442707|NCT01108718|7357999|FG000|STARTED|Received First Intervention (2 Months)||5
6442708|NCT01108718|7358000|FG001|STARTED|Received First Intervention (2 Months)||7
6442709|NCT01108718|7357999|FG000|COMPLETED|Received First Intervention (2 Months)||5
6442710|NCT01108718|7358000|FG001|COMPLETED|Received First Intervention (2 Months)||7
6442711|NCT01108718|7357999|FG000|NOT COMPLETED|Received First Intervention (2 Months)||0
6442712|NCT01108718|7358000|FG001|NOT COMPLETED|Received First Intervention (2 Months)||0
6442713|NCT01108718|7357999|FG000|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
6442714|NCT01108718|7358000|FG001|STARTED|Received Second Intervention (2 Months)||7
6442715|NCT01108718|7357999|FG000|COMPLETED|Received Second Intervention (2 Months)||4
6442716|NCT01108718|7358000|FG001|COMPLETED|Received Second Intervention (2 Months)||7
6442717|NCT01108718|7357999|FG000|NOT COMPLETED|Received Second Intervention (2 Months)||1
6442718|NCT01108718|7358000|FG001|NOT COMPLETED|Received Second Intervention (2 Months)||0
6442719|NCT01108731|7358007|FG000|STARTED|Overall Study||17
6442720|NCT01108731|7358008|FG001|STARTED|Overall Study||17
6442721|NCT01108731|7358007|FG000|COMPLETED|Overall Study||13
6442722|NCT01108731|7358008|FG001|COMPLETED|Overall Study||13
6442723|NCT01108731|7358007|FG000|NOT COMPLETED|Overall Study||4
6442724|NCT01108731|7358008|FG001|NOT COMPLETED|Overall Study||4
6442725|NCT01108757|7358016|FG000|STARTED|Overall Study||26
6442726|NCT01108757|7358017|FG001|STARTED|Overall Study||26
6442727|NCT01108757|7358016|FG000|COMPLETED|Overall Study||26
6442728|NCT01108757|7358017|FG001|COMPLETED|Overall Study||26
6442729|NCT01108757|7358016|FG000|NOT COMPLETED|Overall Study||0
6442730|NCT01108757|7358017|FG001|NOT COMPLETED|Overall Study||0
6442731|NCT01108796|7358027|FG000|STARTED|Overall Study||774
6442732|NCT01108796|7358028|FG001|STARTED|Overall Study||1067
6442733|NCT01108796|7358027|FG000|COMPLETED|Overall Study||767
6442734|NCT01108796|7358028|FG001|COMPLETED|Overall Study||1060
6442735|NCT01108796|7358027|FG000|NOT COMPLETED|Overall Study||7
6442736|NCT01108796|7358028|FG001|NOT COMPLETED|Overall Study||7
6442737|NCT01108809|7358036|FG000|STARTED|Overall Study||295
6442738|NCT01108809|7358036|FG000|COMPLETED|Overall Study||291
6442739|NCT01108809|7358036|FG000|NOT COMPLETED|Overall Study||4
6442740|NCT01108835|7358043|FG000|STARTED|Overall Study||90
6442741|NCT01108835|7358044|FG001|STARTED|Overall Study||90
6442742|NCT01108835|7358043|FG000|COMPLETED|Overall Study||73
6442743|NCT01108835|7358044|FG001|COMPLETED|Overall Study||69
6442744|NCT01108835|7358043|FG000|NOT COMPLETED|Overall Study||17
6442745|NCT01108835|7358044|FG001|NOT COMPLETED|Overall Study||21
6553020|NCT01740817|7475520|FG001|NOT COMPLETED|First Intervention (48 h)||0
6553021|NCT01740817|7475519|FG000|STARTED|Washout (4-6 Weeks)||8
6553022|NCT01740817|7475520|FG001|STARTED|Washout (4-6 Weeks)||4
6553023|NCT01740817|7475519|FG000|COMPLETED|Washout (4-6 Weeks)||8
6442746|NCT01109056|7358053|FG000|STARTED|Overall Study||57
6442747|NCT01109056|7358054|FG001|STARTED|Overall Study||58
6442748|NCT01109056|7358053|FG000|COMPLETED|Overall Study||50
6442749|NCT01109056|7358054|FG001|COMPLETED|Overall Study||53
6442750|NCT01109056|7358053|FG000|NOT COMPLETED|Overall Study||7
6442751|NCT01109056|7358054|FG001|NOT COMPLETED|Overall Study||5
6442752|NCT01109069|7358060|FG000|STARTED|Overall Study||199
6442753|NCT01109069|7358060|FG000|COMPLETED|Overall Study||106
6442754|NCT01109069|7358060|FG000|NOT COMPLETED|Overall Study||93
6442755|NCT01109108|7358067|FG000|STARTED|Overall Study||4035
6442756|NCT01109108|7358068|FG001|STARTED|Overall Study||4755
6553024|NCT01740817|7475520|FG001|COMPLETED|Washout (4-6 Weeks)||4
6442757|NCT01109108|7358067|FG000|COMPLETED|Overall Study||4035
6442758|NCT01109108|7358068|FG001|COMPLETED|Overall Study||4755
6442759|NCT01109108|7358067|FG000|NOT COMPLETED|Overall Study||0
6442760|NCT01109108|7358068|FG001|NOT COMPLETED|Overall Study||0
6442761|NCT01109147|7358077|FG000|STARTED|Overall Study||17
6442762|NCT01109147|7358078|FG001|STARTED|Overall Study||14
6442763|NCT01109147|7358079|FG002|STARTED|Overall Study||36
6442764|NCT01109147|7358077|FG000|COMPLETED|Overall Study|2 have been excluded of the results|15
6442765|NCT01109147|7358078|FG001|COMPLETED|Overall Study|3 have been excluded of the results|11
6442766|NCT01109147|7358079|FG002|COMPLETED|Overall Study|10 have been excluded of the results|26
6442767|NCT01109147|7358077|FG000|NOT COMPLETED|Overall Study||2
6442768|NCT01109147|7358078|FG001|NOT COMPLETED|Overall Study||3
6442769|NCT01109147|7358079|FG002|NOT COMPLETED|Overall Study||10
6442770|NCT01109173|7358091|FG000|STARTED|Overall Study||851
6442771|NCT01109173|7358092|FG001|STARTED|Overall Study||845
6442772|NCT01109173|7358093|FG002|STARTED|Overall Study||211
6442773|NCT01109173|7358094|FG003|STARTED|Overall Study||213
6442774|NCT01109173|7358091|FG000|COMPLETED|Overall Study||763
6442775|NCT01109173|7358092|FG001|COMPLETED|Overall Study||759
6442776|NCT01109173|7358093|FG002|COMPLETED|Overall Study||110
6442777|NCT01109173|7358094|FG003|COMPLETED|Overall Study||120
6442778|NCT01109173|7358091|FG000|NOT COMPLETED|Overall Study||88
6442779|NCT01109173|7358092|FG001|NOT COMPLETED|Overall Study||86
6442780|NCT01109173|7358093|FG002|NOT COMPLETED|Overall Study||101
6442781|NCT01109173|7358094|FG003|NOT COMPLETED|Overall Study||93
6442782|NCT01109316|7358110|FG000|STARTED|Study Period 1||22
6442783|NCT01109316|7358111|FG001|STARTED|Study Period 1||22
6553025|NCT01740817|7475519|FG000|NOT COMPLETED|Washout (4-6 Weeks)||0
6553026|NCT01740817|7475520|FG001|NOT COMPLETED|Washout (4-6 Weeks)||0
6553027|NCT01740817|7475519|FG000|STARTED|Second Intervention (48 h)||8
6553028|NCT01740817|7475520|FG001|STARTED|Second Intervention (48 h)||4
6553029|NCT01740817|7475519|FG000|COMPLETED|Second Intervention (48 h)||8
6553030|NCT01740817|7475520|FG001|COMPLETED|Second Intervention (48 h)||4
6553031|NCT01740817|7475519|FG000|NOT COMPLETED|Second Intervention (48 h)||0
6553032|NCT01740817|7475520|FG001|NOT COMPLETED|Second Intervention (48 h)||0
6442784|NCT01109316|7358112|FG002|STARTED|Study Period 1||22
6442785|NCT01109316|7358113|FG003|STARTED|Study Period 1||22
6442786|NCT01109316|7358114|FG004|STARTED|Study Period 1||22
6442787|NCT01109316|7358115|FG005|STARTED|Study Period 1||22
6442788|NCT01109316|7358110|FG000|Received at Least One Dose of Study Drug|Study Period 1||22
6442789|NCT01109316|7358111|FG001|Received at Least One Dose of Study Drug|Study Period 1||22
6442790|NCT01109316|7358112|FG002|Received at Least One Dose of Study Drug|Study Period 1||22
6442791|NCT01109316|7358113|FG003|Received at Least One Dose of Study Drug|Study Period 1||22
6442792|NCT01109316|7358114|FG004|Received at Least One Dose of Study Drug|Study Period 1||22
6442793|NCT01109316|7358115|FG005|Received at Least One Dose of Study Drug|Study Period 1||20
6442794|NCT01109316|7358110|FG000|COMPLETED|Study Period 1||22
6442795|NCT01109316|7358111|FG001|COMPLETED|Study Period 1||22
6442796|NCT01109316|7358112|FG002|COMPLETED|Study Period 1||19
6442797|NCT01109316|7358113|FG003|COMPLETED|Study Period 1||21
6442798|NCT01109316|7358114|FG004|COMPLETED|Study Period 1||20
6442799|NCT01109316|7358115|FG005|COMPLETED|Study Period 1||20
6442800|NCT01109316|7358110|FG000|NOT COMPLETED|Study Period 1||0
6442801|NCT01109316|7358111|FG001|NOT COMPLETED|Study Period 1||0
6442802|NCT01109316|7358112|FG002|NOT COMPLETED|Study Period 1||3
6442803|NCT01109316|7358113|FG003|NOT COMPLETED|Study Period 1||1
6442804|NCT01109316|7358114|FG004|NOT COMPLETED|Study Period 1||2
6442805|NCT01109316|7358115|FG005|NOT COMPLETED|Study Period 1||2
6442806|NCT01109316|7358110|FG000|STARTED|Study Period 2||22
6442807|NCT01109316|7358111|FG001|STARTED|Study Period 2||22
6442808|NCT01109316|7358112|FG002|STARTED|Study Period 2||19
6442809|NCT01109316|7358113|FG003|STARTED|Study Period 2||21
6442810|NCT01109316|7358114|FG004|STARTED|Study Period 2||20
6442811|NCT01109316|7358115|FG005|STARTED|Study Period 2||20
6442812|NCT01109316|7358110|FG000|COMPLETED|Study Period 2||21
6442813|NCT01109316|7358111|FG001|COMPLETED|Study Period 2||21
6442814|NCT01109316|7358112|FG002|COMPLETED|Study Period 2||18
6442815|NCT01109316|7358113|FG003|COMPLETED|Study Period 2||20
6442816|NCT01109316|7358114|FG004|COMPLETED|Study Period 2||20
6442817|NCT01109316|7358115|FG005|COMPLETED|Study Period 2||19
6442818|NCT01109316|7358110|FG000|NOT COMPLETED|Study Period 2||1
6442819|NCT01109316|7358111|FG001|NOT COMPLETED|Study Period 2||1
6442820|NCT01109316|7358112|FG002|NOT COMPLETED|Study Period 2||1
6442821|NCT01109316|7358113|FG003|NOT COMPLETED|Study Period 2||1
6442822|NCT01109316|7358114|FG004|NOT COMPLETED|Study Period 2||0
6442823|NCT01109316|7358115|FG005|NOT COMPLETED|Study Period 2||1
6442824|NCT01109316|7358110|FG000|STARTED|Study Period 3||21
6442825|NCT01109316|7358111|FG001|STARTED|Study Period 3||21
6442826|NCT01109316|7358112|FG002|STARTED|Study Period 3||18
6442827|NCT01109316|7358113|FG003|STARTED|Study Period 3||20
6442828|NCT01109316|7358114|FG004|STARTED|Study Period 3||20
6442829|NCT01109316|7358115|FG005|STARTED|Study Period 3||19
6442830|NCT01109316|7358110|FG000|COMPLETED|Study Period 3||20
6442831|NCT01109316|7358111|FG001|COMPLETED|Study Period 3||21
6442832|NCT01109316|7358112|FG002|COMPLETED|Study Period 3||18
6442833|NCT01109316|7358113|FG003|COMPLETED|Study Period 3||20
6442834|NCT01109316|7358114|FG004|COMPLETED|Study Period 3||18
6442835|NCT01109316|7358115|FG005|COMPLETED|Study Period 3||19
6442836|NCT01109316|7358110|FG000|NOT COMPLETED|Study Period 3||1
6442837|NCT01109316|7358111|FG001|NOT COMPLETED|Study Period 3||0
6442838|NCT01109316|7358112|FG002|NOT COMPLETED|Study Period 3||0
6442839|NCT01109316|7358113|FG003|NOT COMPLETED|Study Period 3||0
6442840|NCT01109316|7358114|FG004|NOT COMPLETED|Study Period 3||2
6442841|NCT01109316|7358115|FG005|NOT COMPLETED|Study Period 3||0
6442842|NCT01109381|7358123|FG000|STARTED|Overall Study||33
6442843|NCT01109381|7358123|FG000|COMPLETED|Overall Study||31
6442844|NCT01109381|7358123|FG000|NOT COMPLETED|Overall Study||2
6442845|NCT01109524|7358129|FG000|STARTED|Overall Study||60
6442846|NCT01109524|7358129|FG000|COMPLETED|Overall Study||3
6442847|NCT01109524|7358129|FG000|NOT COMPLETED|Overall Study||57
6442848|NCT01109576|7358133|FG000|STARTED|Overall Study||13
6442849|NCT01109576|7358133|FG000|COMPLETED|Overall Study||12
6442850|NCT01109576|7358133|FG000|NOT COMPLETED|Overall Study||1
6442851|NCT01109602|7358140|FG000|STARTED|Overall Study||14
6442852|NCT01109602|7358141|FG001|STARTED|Overall Study||23
6442853|NCT01109602|7358142|FG002|STARTED|Overall Study||10
6442854|NCT01109602|7358140|FG000|COMPLETED|Overall Study||13
6442855|NCT01109602|7358141|FG001|COMPLETED|Overall Study||21
6442856|NCT01109602|7358142|FG002|COMPLETED|Overall Study||9
6442857|NCT01109602|7358140|FG000|NOT COMPLETED|Overall Study||1
6442858|NCT01109602|7358141|FG001|NOT COMPLETED|Overall Study||2
6442859|NCT01109602|7358142|FG002|NOT COMPLETED|Overall Study||1
6442860|NCT01109849|7358151|FG000|STARTED|Initial Randomization: ADHD Treatment||50
6442861|NCT01109849|7358152|FG001|STARTED|Initial Randomization: ADHD Treatment||180
6442862|NCT01109849|7358153|FG002|STARTED|Initial Randomization: ADHD Treatment||0
6442863|NCT01109849|7358154|FG003|STARTED|Initial Randomization: ADHD Treatment||0
6442864|NCT01109849|7358155|FG004|STARTED|Initial Randomization: ADHD Treatment||0
6442865|NCT01109849|7358151|FG000|COMPLETED|Initial Randomization: ADHD Treatment||32
6442866|NCT01109849|7358152|FG001|COMPLETED|Initial Randomization: ADHD Treatment||131
6442867|NCT01109849|7358153|FG002|COMPLETED|Initial Randomization: ADHD Treatment||0
6442868|NCT01109849|7358154|FG003|COMPLETED|Initial Randomization: ADHD Treatment||0
6442869|NCT01109849|7358155|FG004|COMPLETED|Initial Randomization: ADHD Treatment||0
6442870|NCT01109849|7358151|FG000|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
6442871|NCT01109849|7358152|FG001|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
6442872|NCT01109849|7358153|FG002|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
6442873|NCT01109849|7358154|FG003|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
6442874|NCT01109849|7358155|FG004|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
6442875|NCT01109849|7358151|FG000|STARTED|Adaptive Randomization: Weight Recovery||0
6442876|NCT01109849|7358152|FG001|STARTED|Adaptive Randomization: Weight Recovery||0
6442877|NCT01109849|7358153|FG002|STARTED|Adaptive Randomization: Weight Recovery||24
6442878|NCT01109849|7358154|FG003|STARTED|Adaptive Randomization: Weight Recovery||23
6442879|NCT01109849|7358155|FG004|STARTED|Adaptive Randomization: Weight Recovery||25
6442880|NCT01109849|7358151|FG000|COMPLETED|Adaptive Randomization: Weight Recovery||0
6442881|NCT01109849|7358152|FG001|COMPLETED|Adaptive Randomization: Weight Recovery||0
6442882|NCT01109849|7358153|FG002|COMPLETED|Adaptive Randomization: Weight Recovery||23
6442883|NCT01109849|7358154|FG003|COMPLETED|Adaptive Randomization: Weight Recovery||20
6442884|NCT01109849|7358155|FG004|COMPLETED|Adaptive Randomization: Weight Recovery||24
6442885|NCT01109849|7358151|FG000|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
6442886|NCT01109849|7358152|FG001|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
6442887|NCT01109849|7358153|FG002|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
6442888|NCT01109849|7358154|FG003|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
6442889|NCT01109849|7358155|FG004|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
6442890|NCT01109940|7358179|FG000|STARTED|Overall Study||21
6442891|NCT01109940|7358180|FG001|STARTED|Overall Study||8
6442892|NCT01109940|7358181|FG002|STARTED|Overall Study||7
6442893|NCT01109940|7358182|FG003|STARTED|Overall Study||3
6442894|NCT01109940|7358179|FG000|COMPLETED|Overall Study||13
6442895|NCT01109940|7358180|FG001|COMPLETED|Overall Study||6
6442896|NCT01109940|7358181|FG002|COMPLETED|Overall Study||6
6442897|NCT01109940|7358182|FG003|COMPLETED|Overall Study||3
6442898|NCT01109940|7358179|FG000|NOT COMPLETED|Overall Study||8
6442899|NCT01109940|7358180|FG001|NOT COMPLETED|Overall Study||2
6442900|NCT01109940|7358181|FG002|NOT COMPLETED|Overall Study||1
6442901|NCT01109940|7358182|FG003|NOT COMPLETED|Overall Study||0
6500115|NCT01423604|7418923|FG001|STARTED|Safety Run-In||0
6500116|NCT01423604|7418922|FG000|COMPLETED|Safety Run-In||0
6500117|NCT01423604|7418923|FG001|COMPLETED|Safety Run-In||0
6500118|NCT01423604|7418922|FG000|NOT COMPLETED|Safety Run-In||9
6500119|NCT01423604|7418923|FG001|NOT COMPLETED|Safety Run-In||0
6500120|NCT01423604|7418922|FG000|STARTED|Randomized||64
6500121|NCT01423604|7418923|FG001|STARTED|Randomized||63
6500122|NCT01423604|7418922|FG000|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
6500123|NCT01423604|7418923|FG001|COMPLETED|Randomized||0
6500124|NCT01423604|7418922|FG000|NOT COMPLETED|Randomized||63
6500125|NCT01423604|7418923|FG001|NOT COMPLETED|Randomized||63
6500126|NCT01423617|7418932|FG000|STARTED|Overall Study||46
6500127|NCT01423617|7418933|FG001|STARTED|Overall Study||46
6653476|NCT02437344|7583274|FG000|COMPLETED|Overall Study||15
6653477|NCT02437344|7583274|FG000|NOT COMPLETED|Overall Study||1
6653478|NCT02437383|7583280|FG000|STARTED|Overall Study||100
6500128|NCT01423617|7418932|FG000|COMPLETED|Overall Study||46
6500129|NCT01423617|7418933|FG001|COMPLETED|Overall Study||45
6653479|NCT02437383|7583281|FG001|STARTED|Overall Study||100
6653480|NCT02437383|7583280|FG000|COMPLETED|Overall Study||87
6553033|NCT01741012|7475526|FG000|STARTED|Overall Study||37
6653481|NCT02437383|7583281|FG001|COMPLETED|Overall Study||87
6442902|NCT01109979|7358194|FG000|STARTED|Overall Study||12
6442903|NCT01109979|7358195|FG001|STARTED|Overall Study||12
6442904|NCT01109979|7358194|FG000|COMPLETED|Overall Study||10
6442905|NCT01109979|7358195|FG001|COMPLETED|Overall Study||11
6442906|NCT01109979|7358194|FG000|NOT COMPLETED|Overall Study||2
6442907|NCT01109979|7358195|FG001|NOT COMPLETED|Overall Study||1
6442908|NCT01109992|7358203|FG000|STARTED|Overall Study||11
6442909|NCT01109992|7358204|FG001|STARTED|Overall Study||32
6553034|NCT01741012|7475526|FG000|COMPLETED|Overall Study||34
6442910|NCT01109992|7358203|FG000|Subjects Enrolled|Overall Study||11
6442911|NCT01109992|7358204|FG001|Subjects Enrolled|Overall Study||32
6442912|NCT01109992|7358203|FG000|COMPLETED|Overall Study||11
6442913|NCT01109992|7358204|FG001|COMPLETED|Overall Study||30
6442914|NCT01109992|7358203|FG000|NOT COMPLETED|Overall Study||0
6442915|NCT01109992|7358204|FG001|NOT COMPLETED|Overall Study||2
6442916|NCT01110005|7358215|FG000|STARTED|Overall Study||157
6442917|NCT01110005|7358216|FG001|STARTED|Overall Study||161
6442918|NCT01110005|7358215|FG000|COMPLETED|Overall Study||153
6442919|NCT01110005|7358216|FG001|COMPLETED|Overall Study||156
6442920|NCT01110005|7358215|FG000|NOT COMPLETED|Overall Study||4
6442921|NCT01110005|7358216|FG001|NOT COMPLETED|Overall Study||5
6442922|NCT01110135|7358222|FG000|STARTED|Overall Study||43
6442923|NCT01110135|7358222|FG000|COMPLETED|Overall Study||34
6442924|NCT01110135|7358222|FG000|NOT COMPLETED|Overall Study||9
6442925|NCT01110187|7358228|FG000|STARTED|Overall Study||7
6442926|NCT01110187|7358229|FG001|STARTED|Overall Study||4
6442927|NCT01110187|7358228|FG000|COMPLETED|Overall Study|completed 7 day treatment|7
6442928|NCT01110187|7358229|FG001|COMPLETED|Overall Study|completed 7 day treatment|4
6442929|NCT01110187|7358228|FG000|NOT COMPLETED|Overall Study||0
6442930|NCT01110187|7358229|FG001|NOT COMPLETED|Overall Study||0
6442931|NCT01110200|7358239|FG000|STARTED|Overall Study||314
6442932|NCT01110200|7358240|FG001|STARTED|Overall Study||325
6442933|NCT01110200|7358239|FG000|COMPLETED|Overall Study||208
6442934|NCT01110200|7358240|FG001|COMPLETED|Overall Study||204
6442935|NCT01110200|7358239|FG000|NOT COMPLETED|Overall Study||106
6442936|NCT01110200|7358240|FG001|NOT COMPLETED|Overall Study||121
6442937|NCT01110239|7358250|FG000|STARTED|Sham Preconditioning||7
6442938|NCT01110239|7358251|FG001|STARTED|Sham Preconditioning||14
6442939|NCT01110239|7358252|FG002|STARTED|Sham Preconditioning||7
6442940|NCT01110239|7358253|FG003|STARTED|Sham Preconditioning||6
6442941|NCT01110239|7358250|FG000|COMPLETED|Sham Preconditioning||7
6442942|NCT01110239|7358251|FG001|COMPLETED|Sham Preconditioning||14
6442943|NCT01110239|7358252|FG002|COMPLETED|Sham Preconditioning||6
6442944|NCT01110239|7358253|FG003|COMPLETED|Sham Preconditioning||6
6442945|NCT01110239|7358250|FG000|NOT COMPLETED|Sham Preconditioning||0
6442946|NCT01110239|7358251|FG001|NOT COMPLETED|Sham Preconditioning||0
6442947|NCT01110239|7358252|FG002|NOT COMPLETED|Sham Preconditioning||1
6442948|NCT01110239|7358253|FG003|NOT COMPLETED|Sham Preconditioning||0
6442949|NCT01110239|7358250|FG000|STARTED|5 Min Ischemia||0
6442950|NCT01110239|7358251|FG001|STARTED|5 Min Ischemia||14
6442951|NCT01110239|7358252|FG002|STARTED|5 Min Ischemia||0
6442952|NCT01110239|7358253|FG003|STARTED|5 Min Ischemia||0
6442953|NCT01110239|7358250|FG000|COMPLETED|5 Min Ischemia||0
6442954|NCT01110239|7358251|FG001|COMPLETED|5 Min Ischemia||0
6442955|NCT01110239|7358252|FG002|COMPLETED|5 Min Ischemia||0
6442956|NCT01110239|7358253|FG003|COMPLETED|5 Min Ischemia||0
6442957|NCT01110239|7358250|FG000|NOT COMPLETED|5 Min Ischemia||0
6442958|NCT01110239|7358251|FG001|NOT COMPLETED|5 Min Ischemia||14
6442959|NCT01110239|7358252|FG002|NOT COMPLETED|5 Min Ischemia||0
6442960|NCT01110239|7358253|FG003|NOT COMPLETED|5 Min Ischemia||0
6442961|NCT01110239|7358250|FG000|STARTED|7.5 Min Ischemia||0
6442962|NCT01110239|7358251|FG001|STARTED|7.5 Min Ischemia||0
6442963|NCT01110239|7358252|FG002|STARTED|7.5 Min Ischemia||7
6442964|NCT01110239|7358253|FG003|STARTED|7.5 Min Ischemia||0
6442965|NCT01110239|7358250|FG000|COMPLETED|7.5 Min Ischemia||0
6442966|NCT01110239|7358251|FG001|COMPLETED|7.5 Min Ischemia||0
6442967|NCT01110239|7358252|FG002|COMPLETED|7.5 Min Ischemia||6
6442968|NCT01110239|7358253|FG003|COMPLETED|7.5 Min Ischemia||0
6442969|NCT01110239|7358250|FG000|NOT COMPLETED|7.5 Min Ischemia||0
6442970|NCT01110239|7358251|FG001|NOT COMPLETED|7.5 Min Ischemia||0
6442971|NCT01110239|7358252|FG002|NOT COMPLETED|7.5 Min Ischemia||1
6442972|NCT01110239|7358253|FG003|NOT COMPLETED|7.5 Min Ischemia||0
6442973|NCT01110239|7358250|FG000|STARTED|10 Min Ischemia||0
6442974|NCT01110239|7358251|FG001|STARTED|10 Min Ischemia||0
6442975|NCT01110239|7358252|FG002|STARTED|10 Min Ischemia||0
6442976|NCT01110239|7358253|FG003|STARTED|10 Min Ischemia||6
6442977|NCT01110239|7358250|FG000|COMPLETED|10 Min Ischemia||0
6553035|NCT01741012|7475526|FG000|NOT COMPLETED|Overall Study||3
6553036|NCT01741259|7475533|FG000|STARTED|Overall Study||133
6553037|NCT01741259|7475534|FG001|STARTED|Overall Study||135
6553038|NCT01741259|7475533|FG000|COMPLETED|Overall Study||127
6442978|NCT01110239|7358251|FG001|COMPLETED|10 Min Ischemia||0
6442979|NCT01110239|7358252|FG002|COMPLETED|10 Min Ischemia||0
6442980|NCT01110239|7358253|FG003|COMPLETED|10 Min Ischemia||6
6442981|NCT01110239|7358250|FG000|NOT COMPLETED|10 Min Ischemia||0
6442982|NCT01110239|7358251|FG001|NOT COMPLETED|10 Min Ischemia||0
6442983|NCT01110239|7358252|FG002|NOT COMPLETED|10 Min Ischemia||0
6442984|NCT01110239|7358253|FG003|NOT COMPLETED|10 Min Ischemia||0
6442985|NCT01110252|7358264|FG000|STARTED|Pre-procedure (Stem Cells Infusion)||4
6442986|NCT01110252|7358264|FG000|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
6442987|NCT01110252|7358264|FG000|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
6442988|NCT01110252|7358264|FG000|STARTED|Post-procedure (Stem Cells Infusion)||4
6442989|NCT01110252|7358264|FG000|COMPLETED|Post-procedure (Stem Cells Infusion)||4
6442990|NCT01110252|7358264|FG000|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
6442991|NCT01110330|7358272|FG000|STARTED|Overall Study||119
6442992|NCT01110330|7358273|FG001|STARTED|Overall Study||230
6442993|NCT01110330|7358274|FG002|STARTED|Overall Study||234
6442994|NCT01110330|7358272|FG000|Positive Baseline Culture Set|Overall Study||56
6442995|NCT01110330|7358273|FG001|Positive Baseline Culture Set|Overall Study||111
6442996|NCT01110330|7358274|FG002|Positive Baseline Culture Set|Overall Study||114
6442997|NCT01110330|7358272|FG000|COMPLETED|Overall Study||104
6442998|NCT01110330|7358273|FG001|COMPLETED|Overall Study||207
6442999|NCT01110330|7358274|FG002|COMPLETED|Overall Study||208
6443000|NCT01110330|7358272|FG000|NOT COMPLETED|Overall Study||15
6443001|NCT01110330|7358273|FG001|NOT COMPLETED|Overall Study||23
6443002|NCT01110330|7358274|FG002|NOT COMPLETED|Overall Study||26
6443003|NCT01110382|7358284|FG000|STARTED|Overall Study||31
6443004|NCT01110382|7358285|FG001|STARTED|Overall Study||10
6443005|NCT01110382|7358284|FG000|COMPLETED|Overall Study||31
6443006|NCT01110382|7358285|FG001|COMPLETED|Overall Study||8
6443007|NCT01110382|7358284|FG000|NOT COMPLETED|Overall Study||0
6443008|NCT01110382|7358285|FG001|NOT COMPLETED|Overall Study||2
6443009|NCT01110395|7358291|FG000|STARTED|Overall Study||15
6443010|NCT01110395|7358291|FG000|COMPLETED|Overall Study||15
6443011|NCT01110395|7358291|FG000|NOT COMPLETED|Overall Study||0
6443012|NCT01110408|7358297|FG000|STARTED|Overall Study||31
6443013|NCT01110408|7358298|FG001|STARTED|Overall Study||10
6443014|NCT01110408|7358297|FG000|COMPLETED|Overall Study||30
6443015|NCT01110408|7358298|FG001|COMPLETED|Overall Study||10
6443016|NCT01110408|7358297|FG000|NOT COMPLETED|Overall Study||1
6443017|NCT01110408|7358298|FG001|NOT COMPLETED|Overall Study||0
6443018|NCT01110421|7358306|FG000|STARTED|Overall Study||5
6443019|NCT01110421|7358307|FG001|STARTED|Overall Study||2
6443020|NCT01110421|7358306|FG000|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
6443021|NCT01110421|7358307|FG001|COMPLETED|Overall Study||2
6443022|NCT01110421|7358306|FG000|NOT COMPLETED|Overall Study||0
6443023|NCT01110421|7358307|FG001|NOT COMPLETED|Overall Study||0
6443024|NCT01110434|7358315|FG000|STARTED|Overall Study||40
6443025|NCT01110434|7358316|FG001|STARTED|Overall Study||26
6443026|NCT01110434|7358315|FG000|COMPLETED|Overall Study||29
6443027|NCT01110434|7358316|FG001|COMPLETED|Overall Study||20
6443028|NCT01110434|7358315|FG000|NOT COMPLETED|Overall Study||11
6443029|NCT01110434|7358316|FG001|NOT COMPLETED|Overall Study||6
6443030|NCT01110499|7358330|FG000|STARTED|Overall Study||14
6443031|NCT01110499|7358331|FG001|STARTED|Overall Study||14
6443032|NCT01110499|7358332|FG002|STARTED|Overall Study||14
6443033|NCT01110499|7358333|FG003|STARTED|Overall Study||14
6443034|NCT01110499|7358334|FG004|STARTED|Overall Study||14
6443035|NCT01110499|7358335|FG005|STARTED|Overall Study||14
6443036|NCT01110499|7358336|FG006|STARTED|Overall Study||39
6443037|NCT01110499|7358337|FG007|STARTED|Overall Study||40
6443038|NCT01110499|7358330|FG000|COMPLETED|Overall Study||14
6443039|NCT01110499|7358331|FG001|COMPLETED|Overall Study||14
6443040|NCT01110499|7358332|FG002|COMPLETED|Overall Study||14
6443041|NCT01110499|7358333|FG003|COMPLETED|Overall Study||14
6443042|NCT01110499|7358334|FG004|COMPLETED|Overall Study||14
6443043|NCT01110499|7358335|FG005|COMPLETED|Overall Study||14
6443044|NCT01110499|7358336|FG006|COMPLETED|Overall Study||39
6443045|NCT01110499|7358337|FG007|COMPLETED|Overall Study||40
6443046|NCT01110499|7358330|FG000|NOT COMPLETED|Overall Study||0
6443047|NCT01110499|7358331|FG001|NOT COMPLETED|Overall Study||0
6443048|NCT01110499|7358332|FG002|NOT COMPLETED|Overall Study||0
6443049|NCT01110499|7358333|FG003|NOT COMPLETED|Overall Study||0
6443050|NCT01110499|7358334|FG004|NOT COMPLETED|Overall Study||0
6443051|NCT01110499|7358335|FG005|NOT COMPLETED|Overall Study||0
6443052|NCT01110499|7358336|FG006|NOT COMPLETED|Overall Study||0
6443053|NCT01110499|7358337|FG007|NOT COMPLETED|Overall Study||0
6443054|NCT01110681|7358357|FG000|STARTED|Overall Study||115
6443055|NCT01110681|7358357|FG000|COMPLETED|Overall Study||83
6443056|NCT01110681|7358357|FG000|NOT COMPLETED|Overall Study||32
6443057|NCT01110707|7358363|FG000|STARTED|Overall Study||63
6443058|NCT01110707|7358364|FG001|STARTED|Overall Study||68
6443059|NCT01110707|7358363|FG000|COMPLETED|Overall Study||63
6443060|NCT01110707|7358364|FG001|COMPLETED|Overall Study||65
6443061|NCT01110707|7358363|FG000|NOT COMPLETED|Overall Study||0
6443062|NCT01110707|7358364|FG001|NOT COMPLETED|Overall Study||3
6443063|NCT01110876|7358373|FG000|STARTED|Overall Study|One received 400 mg Erlotinib dose as result of enzyme inducing anticonvulsants (EIACs)|13
6553039|NCT01741259|7475534|FG001|COMPLETED|Overall Study||129
6553040|NCT01741259|7475533|FG000|NOT COMPLETED|Overall Study||6
6553041|NCT01741259|7475534|FG001|NOT COMPLETED|Overall Study||6
6553042|NCT01741272|7475542|FG000|STARTED|Overall Study||92
6443064|NCT01110876|7358374|FG001|STARTED|Overall Study||5
6443065|NCT01110876|7358373|FG000|COMPLETED|Overall Study||13
6443066|NCT01110876|7358374|FG001|COMPLETED|Overall Study||5
6553043|NCT01741272|7475543|FG001|STARTED|Overall Study||97
6553044|NCT01741272|7475542|FG000|COMPLETED|Overall Study||92
6553045|NCT01741272|7475543|FG001|COMPLETED|Overall Study||97
6553046|NCT01741272|7475542|FG000|NOT COMPLETED|Overall Study||0
6653482|NCT02437383|7583280|FG000|NOT COMPLETED|Overall Study||13
6443067|NCT01110876|7358373|FG000|NOT COMPLETED|Overall Study||0
6443068|NCT01110876|7358374|FG001|NOT COMPLETED|Overall Study||0
6443069|NCT01110915|7358383|FG000|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
6443070|NCT01110915|7358384|FG001|STARTED|Overall Study|Subjects being randomized to the Control group.|86
6443071|NCT01110915|7358383|FG000|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
6443072|NCT01110915|7358384|FG001|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
6443073|NCT01110915|7358383|FG000|NOT COMPLETED|Overall Study||10
6443074|NCT01110915|7358384|FG001|NOT COMPLETED|Overall Study||2
6443075|NCT01110967|7358391|FG000|STARTED|Overall Study||40
6443076|NCT01110967|7358391|FG000|Surgery|Overall Study||40
6443077|NCT01110967|7358391|FG000|1 Month Follow up|Overall Study||26
6443078|NCT01110967|7358391|FG000|3 Months Follow up|Overall Study||28
6443079|NCT01110967|7358391|FG000|6 Months Follow up|Overall Study||24
6443080|NCT01110967|7358391|FG000|12 Months Follow up|Overall Study||31
6443081|NCT01110967|7358391|FG000|COMPLETED|Overall Study||31
6443082|NCT01110967|7358391|FG000|NOT COMPLETED|Overall Study||9
6443083|NCT01111058|7358397|FG000|STARTED|Overall Study||28
6443084|NCT01111058|7358398|FG001|STARTED|Overall Study||24
6443085|NCT01111058|7358397|FG000|COMPLETED|Overall Study||28
6443086|NCT01111058|7358398|FG001|COMPLETED|Overall Study||24
6443087|NCT01111058|7358397|FG000|NOT COMPLETED|Overall Study||0
6443088|NCT01111058|7358398|FG001|NOT COMPLETED|Overall Study||0
6443089|NCT01111123|7358406|FG000|STARTED|Open- Label Phase||55
6443090|NCT01111123|7358407|FG001|STARTED|Open- Label Phase||0
6443091|NCT01111123|7358406|FG000|COMPLETED|Open- Label Phase||41
6443092|NCT01111123|7358407|FG001|COMPLETED|Open- Label Phase||0
6443093|NCT01111123|7358406|FG000|NOT COMPLETED|Open- Label Phase||14
6443094|NCT01111123|7358407|FG001|NOT COMPLETED|Open- Label Phase||0
6443095|NCT01111123|7358406|FG000|STARTED|Maintenance Phase||21
6443096|NCT01111123|7358407|FG001|STARTED|Maintenance Phase||20
6443097|NCT01111123|7358406|FG000|COMPLETED|Maintenance Phase||21
6443098|NCT01111123|7358407|FG001|COMPLETED|Maintenance Phase||18
6443099|NCT01111123|7358406|FG000|NOT COMPLETED|Maintenance Phase||0
6443100|NCT01111123|7358407|FG001|NOT COMPLETED|Maintenance Phase||2
6443101|NCT01111149|7358418|FG000|STARTED|Overall Study||9
6443102|NCT01111149|7358419|FG001|STARTED|Overall Study||6
6443103|NCT01111149|7358420|FG002|STARTED|Overall Study||9
6443104|NCT01111149|7358418|FG000|COMPLETED|Overall Study||7
6443105|NCT01111149|7358419|FG001|COMPLETED|Overall Study||5
6443106|NCT01111149|7358420|FG002|COMPLETED|Overall Study||5
6443107|NCT01111149|7358418|FG000|NOT COMPLETED|Overall Study||2
6443108|NCT01111149|7358419|FG001|NOT COMPLETED|Overall Study||1
6443109|NCT01111149|7358420|FG002|NOT COMPLETED|Overall Study||4
6443110|NCT01111162|7358428|FG000|STARTED|Overall Study||120
6443111|NCT01111162|7358428|FG000|COMPLETED|Overall Study||120
6443112|NCT01111162|7358428|FG000|NOT COMPLETED|Overall Study||0
6443113|NCT01111240|7358433|FG000|STARTED|Overall Study||4635
6443114|NCT01111240|7358433|FG000|COMPLETED|Overall Study||3569
6443115|NCT01111240|7358433|FG000|NOT COMPLETED|Overall Study||1066
6443116|NCT01111292|7358439|FG000|STARTED|Randomization||3
6443117|NCT01111292|7358440|FG001|STARTED|Randomization||2
6443118|NCT01111292|7358439|FG000|COMPLETED|Randomization||3
6443119|NCT01111292|7358440|FG001|COMPLETED|Randomization||2
6443120|NCT01111292|7358439|FG000|NOT COMPLETED|Randomization||0
6443121|NCT01111292|7358440|FG001|NOT COMPLETED|Randomization||0
6443122|NCT01111292|7358439|FG000|STARTED|Treatment||3
6443123|NCT01111292|7358440|FG001|STARTED|Treatment||2
6443124|NCT01111292|7358439|FG000|COMPLETED|Treatment||2
6443125|NCT01111292|7358440|FG001|COMPLETED|Treatment||1
6443126|NCT01111292|7358439|FG000|NOT COMPLETED|Treatment||1
6443127|NCT01111292|7358440|FG001|NOT COMPLETED|Treatment||1
6443128|NCT01111292|7358439|FG000|STARTED|Post Treatment Biopsy||2
6443129|NCT01111292|7358440|FG001|STARTED|Post Treatment Biopsy||1
6443130|NCT01111292|7358439|FG000|COMPLETED|Post Treatment Biopsy||2
6443131|NCT01111292|7358440|FG001|COMPLETED|Post Treatment Biopsy||1
6443132|NCT01111292|7358439|FG000|NOT COMPLETED|Post Treatment Biopsy||0
6653483|NCT02437383|7583281|FG001|NOT COMPLETED|Overall Study||13
6653484|NCT02437409|7583287|FG000|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
6653485|NCT02437409|7583287|FG000|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
6653486|NCT02437409|7583287|FG000|NOT COMPLETED|Overall Study||15
6443133|NCT01111292|7358440|FG001|NOT COMPLETED|Post Treatment Biopsy||0
6443134|NCT01111292|7358439|FG000|STARTED|Follow-Up||2
6443135|NCT01111292|7358440|FG001|STARTED|Follow-Up||1
6443136|NCT01111292|7358439|FG000|COMPLETED|Follow-Up||2
6443137|NCT01111292|7358440|FG001|COMPLETED|Follow-Up||1
6443138|NCT01111292|7358439|FG000|NOT COMPLETED|Follow-Up||0
6443139|NCT01111292|7358440|FG001|NOT COMPLETED|Follow-Up||0
6443140|NCT01111318|7358450|FG000|STARTED|Overall Study||12
6443141|NCT01111318|7358451|FG001|STARTED|Overall Study||8
6443142|NCT01111318|7358452|FG002|STARTED|Overall Study||8
6443143|NCT01111318|7358453|FG003|STARTED|Overall Study||8
6443144|NCT01111318|7358450|FG000|COMPLETED|Overall Study||12
6443145|NCT01111318|7358451|FG001|COMPLETED|Overall Study||8
6443146|NCT01111318|7358452|FG002|COMPLETED|Overall Study||8
6653487|NCT02437487|7583294|FG000|STARTED|Overall Study||59
6653488|NCT02437487|7583295|FG001|STARTED|Overall Study||30
6653489|NCT02437487|7583294|FG000|Actual Treatment Received|Overall Study||60
6443147|NCT01111318|7358453|FG003|COMPLETED|Overall Study||8
6443148|NCT01111318|7358450|FG000|NOT COMPLETED|Overall Study||0
6443149|NCT01111318|7358451|FG001|NOT COMPLETED|Overall Study||0
6443150|NCT01111318|7358452|FG002|NOT COMPLETED|Overall Study||0
6443151|NCT01111318|7358453|FG003|NOT COMPLETED|Overall Study||0
6443152|NCT01111331|7358463|FG000|STARTED|Overall Study||9
6443153|NCT01111331|7358464|FG001|STARTED|Overall Study||9
6443154|NCT01111331|7358463|FG000|COMPLETED|Overall Study||9
6443155|NCT01111331|7358464|FG001|COMPLETED|Overall Study||9
6443156|NCT01111331|7358463|FG000|NOT COMPLETED|Overall Study||0
6443157|NCT01111331|7358464|FG001|NOT COMPLETED|Overall Study||0
6443158|NCT01111370|7358474|FG000|STARTED|Overall Study||60
6443159|NCT01111370|7358474|FG000|COMPLETED|Overall Study||58
6443160|NCT01111370|7358474|FG000|NOT COMPLETED|Overall Study||2
6443161|NCT01111461|7358478|FG000|STARTED|Overall Study||133
6443162|NCT01111461|7358478|FG000|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
6443163|NCT01111461|7358478|FG000|NOT COMPLETED|Overall Study||51
6443164|NCT01111474|7358482|FG000|STARTED|Overall Study|593 teeth from 74 participants: 296 teeth treated with cyanoacrylate and 297 teeth with LILT|74
6443165|NCT01111474|7358482|FG000|COMPLETED|Overall Study|434 teeth from 62 participants: 218 teeth teated with cyanoacrylate and 216 teeth with LILT|62
6443166|NCT01111474|7358482|FG000|NOT COMPLETED|Overall Study||12
6443167|NCT01111526|7358488|FG000|STARTED|Overall Study||4
6443168|NCT01111526|7358489|FG001|STARTED|Overall Study||8
6443169|NCT01111526|7358490|FG002|STARTED|Overall Study||10
6443170|NCT01111526|7358488|FG000|COMPLETED|Overall Study||4
6443171|NCT01111526|7358489|FG001|COMPLETED|Overall Study||7
6443172|NCT01111526|7358490|FG002|COMPLETED|Overall Study||8
6443173|NCT01111526|7358488|FG000|NOT COMPLETED|Overall Study||0
6443174|NCT01111526|7358489|FG001|NOT COMPLETED|Overall Study||1
6443175|NCT01111526|7358490|FG002|NOT COMPLETED|Overall Study||2
6443176|NCT01111539|7358494|FG000|STARTED|Phase B (Day 1 to Week 8)||211
6443177|NCT01111539|7358495|FG001|STARTED|Phase B (Day 1 to Week 8)||0
6443178|NCT01111539|7358496|FG002|STARTED|Phase B (Day 1 to Week 8)||0
6443179|NCT01111539|7358497|FG003|STARTED|Phase B (Day 1 to Week 8)||0
6443180|NCT01111539|7358498|FG004|STARTED|Phase B (Day 1 to Week 8)||0
6443181|NCT01111539|7358494|FG000|COMPLETED|Phase B (Day 1 to Week 8)||129
6443182|NCT01111539|7358495|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
6443183|NCT01111539|7358496|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
6443184|NCT01111539|7358497|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
6443185|NCT01111539|7358498|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
6443186|NCT01111539|7358494|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||82
6443187|NCT01111539|7358495|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
6443188|NCT01111539|7358496|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
6443189|NCT01111539|7358497|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
6443190|NCT01111539|7358498|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
6443191|NCT01111539|7358494|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
6443192|NCT01111539|7358495|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||45
6443193|NCT01111539|7358496|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
6443194|NCT01111539|7358497|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
6443195|NCT01111539|7358498|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||28
6443196|NCT01111539|7358494|FG000|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
6443197|NCT01111539|7358495|FG001|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
6443198|NCT01111539|7358496|FG002|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
6443199|NCT01111539|7358497|FG003|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
6443200|NCT01111539|7358498|FG004|Intent-to-treat (ITT) Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
6443201|NCT01111539|7358494|FG000|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||0
6443202|NCT01111539|7358495|FG001|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||45
6443203|NCT01111539|7358496|FG002|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
6443204|NCT01111539|7358497|FG003|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||27
6443205|NCT01111539|7358498|FG004|Safety Sample|Phase B+ and Phase C (Weeks 9 to 14)||28
6443206|NCT01111539|7358494|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
6443207|NCT01111539|7358495|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||38
6443208|NCT01111539|7358496|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||22
6443209|NCT01111539|7358497|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||20
6443210|NCT01111539|7358498|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
6443211|NCT01111539|7358494|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
6443212|NCT01111539|7358495|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||7
6443213|NCT01111539|7358496|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||6
6443214|NCT01111539|7358497|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||8
6443215|NCT01111539|7358498|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||10
6443216|NCT01111552|7358508|FG000|STARTED|Phase B (Day 1 to Week 8)||237
6443217|NCT01111552|7358509|FG001|STARTED|Phase B (Day 1 to Week 8)||0
6443218|NCT01111552|7358510|FG002|STARTED|Phase B (Day 1 to Week 8)||0
6443219|NCT01111552|7358511|FG003|STARTED|Phase B (Day 1 to Week 8)||0
6443220|NCT01111552|7358512|FG004|STARTED|Phase B (Day 1 to Week 8)||0
6443221|NCT01111552|7358508|FG000|COMPLETED|Phase B (Day 1 to Week 8)||120
6443222|NCT01111552|7358509|FG001|COMPLETED|Phase B (Day 1 to Week 8)||0
6443223|NCT01111552|7358510|FG002|COMPLETED|Phase B (Day 1 to Week 8)||0
6443224|NCT01111552|7358511|FG003|COMPLETED|Phase B (Day 1 to Week 8)||0
6443225|NCT01111552|7358512|FG004|COMPLETED|Phase B (Day 1 to Week 8)||0
6443226|NCT01111552|7358508|FG000|NOT COMPLETED|Phase B (Day 1 to Week 8)||117
6443227|NCT01111552|7358509|FG001|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
6443228|NCT01111552|7358510|FG002|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
6443229|NCT01111552|7358511|FG003|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
6443230|NCT01111552|7358512|FG004|NOT COMPLETED|Phase B (Day 1 to Week 8)||0
6443231|NCT01111552|7358508|FG000|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||0
6443232|NCT01111552|7358509|FG001|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||54
6443233|NCT01111552|7358510|FG002|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||22
6443234|NCT01111552|7358511|FG003|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||21
6443235|NCT01111552|7358512|FG004|STARTED|Phase B+ and Phase C (Weeks 9 to 14)||23
6443236|NCT01111552|7358508|FG000|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
6443237|NCT01111552|7358509|FG001|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||45
6443238|NCT01111552|7358510|FG002|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
6443239|NCT01111552|7358511|FG003|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||17
6443240|NCT01111552|7358512|FG004|COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||18
6443241|NCT01111552|7358508|FG000|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||0
6443242|NCT01111552|7358509|FG001|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||9
6443243|NCT01111552|7358510|FG002|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
6443244|NCT01111552|7358511|FG003|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||4
6443245|NCT01111552|7358512|FG004|NOT COMPLETED|Phase B+ and Phase C (Weeks 9 to 14)||5
6443246|NCT01111604|7358525|FG000|STARTED|Overall Study||54
6443247|NCT01111604|7358526|FG001|STARTED|Overall Study||52
6443248|NCT01111604|7358527|FG002|STARTED|Overall Study||52
6443249|NCT01111604|7358525|FG000|Received at Least One Dose of Study Drug|Overall Study||49
6443250|NCT01111604|7358526|FG001|Received at Least One Dose of Study Drug|Overall Study||52
6443251|NCT01111604|7358527|FG002|Received at Least One Dose of Study Drug|Overall Study||52
6443252|NCT01111604|7358525|FG000|COMPLETED|Overall Study||46
6443253|NCT01111604|7358526|FG001|COMPLETED|Overall Study||52
6443254|NCT01111604|7358527|FG002|COMPLETED|Overall Study||49
6443255|NCT01111604|7358525|FG000|NOT COMPLETED|Overall Study||8
6443256|NCT01111604|7358526|FG001|NOT COMPLETED|Overall Study||0
6443257|NCT01111604|7358527|FG002|NOT COMPLETED|Overall Study||3
6443258|NCT01111825|7358557|FG000|STARTED|Overall Study||8
6443259|NCT01111825|7358558|FG001|STARTED|Overall Study||6
6443260|NCT01111825|7358559|FG002|STARTED|Overall Study||37
6443261|NCT01111825|7358560|FG003|STARTED|Overall Study||48
6443262|NCT01111825|7358557|FG000|COMPLETED|Overall Study||5
6443263|NCT01111825|7358558|FG001|COMPLETED|Overall Study||5
6443264|NCT01111825|7358559|FG002|COMPLETED|Overall Study||29
6443265|NCT01111825|7358560|FG003|COMPLETED|Overall Study||27
6443266|NCT01111825|7358557|FG000|NOT COMPLETED|Overall Study||3
6443267|NCT01111825|7358558|FG001|NOT COMPLETED|Overall Study||1
6443268|NCT01111825|7358559|FG002|NOT COMPLETED|Overall Study||8
6443269|NCT01111825|7358560|FG003|NOT COMPLETED|Overall Study||21
6443270|NCT01111838|7358570|FG000|STARTED|Overall Study||22
6443271|NCT01111838|7358570|FG000|COMPLETED|Overall Study||15
6443272|NCT01111838|7358570|FG000|NOT COMPLETED|Overall Study||7
6443273|NCT01111851|7358576|FG000|STARTED|Overall Study||8
6443274|NCT01111851|7358577|FG001|STARTED|Overall Study||8
6443275|NCT01111851|7358576|FG000|COMPLETED|Overall Study||6
6443276|NCT01111851|7358577|FG001|COMPLETED|Overall Study||8
6443277|NCT01111851|7358576|FG000|NOT COMPLETED|Overall Study||2
6443278|NCT01111851|7358577|FG001|NOT COMPLETED|Overall Study||0
6443279|NCT01112059|7358585|FG000|STARTED|Overall Study||20
6443280|NCT01112059|7358586|FG001|STARTED|Overall Study||20
6443281|NCT01112059|7358585|FG000|COMPLETED|Overall Study||19
6443282|NCT01112059|7358586|FG001|COMPLETED|Overall Study||20
6443283|NCT01112059|7358585|FG000|NOT COMPLETED|Overall Study||1
6443284|NCT01112059|7358586|FG001|NOT COMPLETED|Overall Study||0
6443285|NCT01112228|7358595|FG000|STARTED|Overall Study||600
6443286|NCT01112228|7358595|FG000|COMPLETED|Overall Study||600
6443287|NCT01112228|7358595|FG000|NOT COMPLETED|Overall Study||0
6443288|NCT01112241|7358601|FG000|STARTED|Overall Study||17
6443289|NCT01112241|7358601|FG000|COMPLETED|Overall Study||17
6443290|NCT01112241|7358601|FG000|NOT COMPLETED|Overall Study||0
6443291|NCT01112267|7358607|FG000|STARTED|Overall Study||126
6443292|NCT01112267|7358608|FG001|STARTED|Overall Study||122
6443293|NCT01112267|7358607|FG000|Treated|Overall Study||125
6443294|NCT01112267|7358608|FG001|Treated|Overall Study||120
6443295|NCT01112267|7358607|FG000|COMPLETED|Overall Study||92
6443296|NCT01112267|7358608|FG001|COMPLETED|Overall Study||104
6443297|NCT01112267|7358607|FG000|NOT COMPLETED|Overall Study||34
6443298|NCT01112267|7358608|FG001|NOT COMPLETED|Overall Study||18
6443299|NCT01112293|7358614|FG000|STARTED|Overall Study||14
6443300|NCT01112293|7358614|FG000|COMPLETED|Overall Study||14
6443301|NCT01112293|7358614|FG000|NOT COMPLETED|Overall Study||0
6443302|NCT01112358|7358620|FG000|STARTED|Overall Study||25
6443303|NCT01112358|7358621|FG001|STARTED|Overall Study||33
6443304|NCT01112358|7358620|FG000|COMPLETED|Overall Study||25
6443305|NCT01112358|7358621|FG001|COMPLETED|Overall Study||33
6443306|NCT01112358|7358620|FG000|NOT COMPLETED|Overall Study||0
6443307|NCT01112358|7358621|FG001|NOT COMPLETED|Overall Study||0
6443308|NCT01112514|7358627|FG000|STARTED|Overall Study||4
6443309|NCT01112514|7358627|FG000|COMPLETED|Overall Study||3
6443310|NCT01112514|7358627|FG000|NOT COMPLETED|Overall Study||1
6443311|NCT01112579|7358633|FG000|STARTED|Overall Study||42
6443312|NCT01112579|7358634|FG001|STARTED|Overall Study||24
6443313|NCT01112579|7358633|FG000|COMPLETED|Overall Study||41
6443314|NCT01112579|7358634|FG001|COMPLETED|Overall Study||21
6443315|NCT01112579|7358633|FG000|NOT COMPLETED|Overall Study||1
6443316|NCT01112579|7358634|FG001|NOT COMPLETED|Overall Study||3
6443317|NCT01112670|7358640|FG000|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
6443318|NCT01112670|7358641|FG001|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443319|NCT01112670|7358642|FG002|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
6443320|NCT01112670|7358643|FG003|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443321|NCT01112670|7358644|FG004|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
6443322|NCT01112670|7358645|FG005|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443323|NCT01112670|7358640|FG000|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
6443324|NCT01112670|7358641|FG001|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443325|NCT01112670|7358642|FG002|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
6443326|NCT01112670|7358643|FG003|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443327|NCT01112670|7358644|FG004|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
6443328|NCT01112670|7358645|FG005|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443329|NCT01112670|7358640|FG000|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
6443330|NCT01112670|7358641|FG001|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443331|NCT01112670|7358642|FG002|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
6443332|NCT01112670|7358643|FG003|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443333|NCT01112670|7358644|FG004|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
6443334|NCT01112670|7358645|FG005|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
6443335|NCT01112670|7358640|FG000|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443336|NCT01112670|7358641|FG001|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
6443337|NCT01112670|7358642|FG002|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443338|NCT01112670|7358643|FG003|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
6443339|NCT01112670|7358644|FG004|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443340|NCT01112670|7358645|FG005|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
6443341|NCT01112670|7358640|FG000|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443342|NCT01112670|7358641|FG001|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
6443343|NCT01112670|7358642|FG002|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443344|NCT01112670|7358643|FG003|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
6443345|NCT01112670|7358644|FG004|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443346|NCT01112670|7358645|FG005|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
6443347|NCT01112670|7358640|FG000|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443348|NCT01112670|7358641|FG001|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443349|NCT01112670|7358642|FG002|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443350|NCT01112670|7358643|FG003|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443351|NCT01112670|7358644|FG004|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443352|NCT01112670|7358645|FG005|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
6443353|NCT01112683|7358654|FG000|STARTED|Overall Study||19
6443354|NCT01112683|7358655|FG001|STARTED|Overall Study||20
6443355|NCT01112683|7358654|FG000|COMPLETED|Overall Study||18
6443356|NCT01112683|7358655|FG001|COMPLETED|Overall Study||19
6443357|NCT01112683|7358654|FG000|NOT COMPLETED|Overall Study||1
6443358|NCT01112683|7358655|FG001|NOT COMPLETED|Overall Study||1
6443359|NCT01112696|7358661|FG000|STARTED|Overall Study||100
6443360|NCT01112696|7358661|FG000|COMPLETED|Overall Study||98
6443361|NCT01112696|7358661|FG000|NOT COMPLETED|Overall Study||2
6443362|NCT01112735|7358668|FG000|STARTED|Overall Study||20
6443363|NCT01112735|7358669|FG001|STARTED|Overall Study||20
6443364|NCT01112735|7358668|FG000|COMPLETED|Overall Study||20
6443365|NCT01112735|7358669|FG001|COMPLETED|Overall Study||20
6443366|NCT01112735|7358668|FG000|NOT COMPLETED|Overall Study||0
6443367|NCT01112735|7358669|FG001|NOT COMPLETED|Overall Study||0
6443368|NCT01112865|7358675|FG000|STARTED|First Intervention||59
6443369|NCT01112865|7358676|FG001|STARTED|First Intervention||61
6443370|NCT01112865|7358675|FG000|COMPLETED|First Intervention||59
6443371|NCT01112865|7358676|FG001|COMPLETED|First Intervention||61
6443372|NCT01112865|7358675|FG000|NOT COMPLETED|First Intervention||0
6443373|NCT01112865|7358676|FG001|NOT COMPLETED|First Intervention||0
6443374|NCT01112865|7358675|FG000|STARTED|Second Intervention||59
6553047|NCT01741272|7475543|FG001|NOT COMPLETED|Overall Study||0
6443375|NCT01112865|7358676|FG001|STARTED|Second Intervention||61
6443376|NCT01112865|7358675|FG000|COMPLETED|Second Intervention||59
6443377|NCT01112865|7358676|FG001|COMPLETED|Second Intervention||61
6443378|NCT01112865|7358675|FG000|NOT COMPLETED|Second Intervention||0
6443379|NCT01112865|7358676|FG001|NOT COMPLETED|Second Intervention||0
6443380|NCT01112917|7358682|FG000|STARTED|Overall Study||96
6443381|NCT01112917|7358683|FG001|STARTED|Overall Study||53
6443382|NCT01112917|7358682|FG000|COMPLETED|Overall Study||89
6443383|NCT01112917|7358683|FG001|COMPLETED|Overall Study||38
6443384|NCT01112917|7358682|FG000|NOT COMPLETED|Overall Study||7
6443385|NCT01112917|7358683|FG001|NOT COMPLETED|Overall Study||15
6443386|NCT01112982|7358687|FG000|STARTED|Overall Study||74
6443387|NCT01112982|7358687|FG000|COMPLETED|Overall Study||72
6443388|NCT01112982|7358687|FG000|NOT COMPLETED|Overall Study||2
6443389|NCT01113008|7358696|FG000|STARTED|Overall Study||133
6443390|NCT01113008|7358697|FG001|STARTED|Overall Study||133
6553048|NCT01741350|7475551|FG000|STARTED|Study Intervention||149
6653490|NCT02437487|7583295|FG001|Actual Treatment Received|Overall Study||29
6653491|NCT02437487|7583294|FG000|Intention-to-Treat Population|Overall Study||59
6443391|NCT01113008|7358696|FG000|COMPLETED|Overall Study||133
6553049|NCT01741350|7475552|FG001|STARTED|Study Intervention||155
6653492|NCT02437487|7583295|FG001|Intention-to-Treat Population|Overall Study||30
6653493|NCT02437487|7583294|FG000|COMPLETED|Overall Study||32
6653494|NCT02437487|7583295|FG001|COMPLETED|Overall Study||16
6653495|NCT02437487|7583294|FG000|NOT COMPLETED|Overall Study||27
6653496|NCT02437487|7583295|FG001|NOT COMPLETED|Overall Study||14
6443392|NCT01113008|7358697|FG001|COMPLETED|Overall Study||133
6443393|NCT01113008|7358696|FG000|NOT COMPLETED|Overall Study||0
6443394|NCT01113008|7358697|FG001|NOT COMPLETED|Overall Study||0
6443395|NCT01113385|7358703|FG000|STARTED|Overall Study||7
6443396|NCT01113385|7358703|FG000|COMPLETED|Overall Study||7
6443397|NCT01113385|7358703|FG000|NOT COMPLETED|Overall Study||0
6443398|NCT01113398|7358707|FG000|STARTED|Overall Study||36
6443399|NCT01113398|7358707|FG000|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
6443400|NCT01113398|7358707|FG000|NOT COMPLETED|Overall Study||0
6443401|NCT01113463|7358711|FG000|STARTED|Overall Study||17
6443402|NCT01113463|7358711|FG000|COMPLETED|Overall Study||12
6443403|NCT01113463|7358711|FG000|NOT COMPLETED|Overall Study||5
6443404|NCT01113502|7358720|FG000|STARTED|Overall Study||4
6443405|NCT01113502|7358721|FG001|STARTED|Overall Study||3
6443406|NCT01113502|7358722|FG002|STARTED|Overall Study||7
6443407|NCT01113502|7358723|FG003|STARTED|Overall Study||9
6443408|NCT01113502|7358724|FG004|STARTED|Overall Study||21
6443409|NCT01113502|7358720|FG000|COMPLETED|Overall Study||3
6443410|NCT01113502|7358721|FG001|COMPLETED|Overall Study||3
6443411|NCT01113502|7358722|FG002|COMPLETED|Overall Study||3
6443412|NCT01113502|7358723|FG003|COMPLETED|Overall Study||6
6443413|NCT01113502|7358724|FG004|COMPLETED|Overall Study||21
6443414|NCT01113502|7358720|FG000|NOT COMPLETED|Overall Study||1
6443415|NCT01113502|7358721|FG001|NOT COMPLETED|Overall Study||0
6443416|NCT01113502|7358722|FG002|NOT COMPLETED|Overall Study||4
6443417|NCT01113502|7358723|FG003|NOT COMPLETED|Overall Study||3
6443418|NCT01113502|7358724|FG004|NOT COMPLETED|Overall Study||0
6443419|NCT01113541|7358737|FG000|STARTED|Overall Study||13
6443420|NCT01113541|7358737|FG000|COMPLETED|Overall Study||0
6443421|NCT01113541|7358737|FG000|NOT COMPLETED|Overall Study||13
6443422|NCT01113580|7358743|FG000|STARTED|Overall Study||60
6443423|NCT01113580|7358744|FG001|STARTED|Overall Study||60
6443424|NCT01113580|7358743|FG000|COMPLETED|Overall Study||59
6553050|NCT01741350|7475551|FG000|COMPLETED|Study Intervention||149
6553051|NCT01741350|7475552|FG001|COMPLETED|Study Intervention||155
6553052|NCT01741350|7475551|FG000|NOT COMPLETED|Study Intervention||0
6553053|NCT01741350|7475552|FG001|NOT COMPLETED|Study Intervention||0
6443425|NCT01113580|7358744|FG001|COMPLETED|Overall Study||60
6443426|NCT01113580|7358743|FG000|NOT COMPLETED|Overall Study||1
6443427|NCT01113580|7358744|FG001|NOT COMPLETED|Overall Study||0
6443428|NCT01113632|7358752|FG000|STARTED|Overall Study||33
6443429|NCT01113632|7358753|FG001|STARTED|Overall Study||44
6443430|NCT01113632|7358752|FG000|COMPLETED|Overall Study||2
6443431|NCT01113632|7358753|FG001|COMPLETED|Overall Study||19
6443432|NCT01113632|7358752|FG000|NOT COMPLETED|Overall Study||31
6443433|NCT01113632|7358753|FG001|NOT COMPLETED|Overall Study||25
6443434|NCT01113710|7358759|FG000|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
6443435|NCT01113710|7358759|FG000|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
6443436|NCT01113710|7358759|FG000|NOT COMPLETED|Overall Study||269
6443437|NCT01113723|7358765|FG000|STARTED|Overall Study||70
6443438|NCT01113723|7358766|FG001|STARTED|Overall Study||70
6443439|NCT01113723|7358765|FG000|COMPLETED|Overall Study||70
6443440|NCT01113723|7358766|FG001|COMPLETED|Overall Study||70
6443441|NCT01113723|7358765|FG000|NOT COMPLETED|Overall Study||0
6443442|NCT01113723|7358766|FG001|NOT COMPLETED|Overall Study||0
6443443|NCT01113749|7358776|FG000|STARTED|Overall Study||127
6443444|NCT01113749|7358777|FG001|STARTED|Overall Study||129
6443445|NCT01113749|7358776|FG000|COMPLETED|Overall Study||126
6443446|NCT01113749|7358777|FG001|COMPLETED|Overall Study||127
6443447|NCT01113749|7358776|FG000|NOT COMPLETED|Overall Study||1
6443448|NCT01113749|7358777|FG001|NOT COMPLETED|Overall Study||2
6443449|NCT01113801|7358787|FG000|STARTED|Overall Study||103
6443450|NCT01113801|7358788|FG001|STARTED|Overall Study||105
6443451|NCT01113801|7358789|FG002|STARTED|Overall Study||103
6443452|NCT01113801|7358790|FG003|STARTED|Overall Study||106
6443453|NCT01113801|7358787|FG000|Received at Least One Dose of Drug|Overall Study||103
6443454|NCT01113801|7358788|FG001|Received at Least One Dose of Drug|Overall Study||105
6443455|NCT01113801|7358789|FG002|Received at Least One Dose of Drug|Overall Study||103
6443456|NCT01113801|7358790|FG003|Received at Least One Dose of Drug|Overall Study||105
6443457|NCT01113801|7358787|FG000|COMPLETED|Overall Study||62
6443458|NCT01113801|7358788|FG001|COMPLETED|Overall Study||65
6443459|NCT01113801|7358789|FG002|COMPLETED|Overall Study||66
6443460|NCT01113801|7358790|FG003|COMPLETED|Overall Study||65
6443461|NCT01113801|7358787|FG000|NOT COMPLETED|Overall Study||41
6443462|NCT01113801|7358788|FG001|NOT COMPLETED|Overall Study||40
6443463|NCT01113801|7358789|FG002|NOT COMPLETED|Overall Study||37
6553054|NCT01741350|7475551|FG000|STARTED|Post Intervention Assessment (at Week 4)||149
6553055|NCT01741350|7475552|FG001|STARTED|Post Intervention Assessment (at Week 4)||155
6553056|NCT01741350|7475551|FG000|COMPLETED|Post Intervention Assessment (at Week 4)||135
6553057|NCT01741350|7475552|FG001|COMPLETED|Post Intervention Assessment (at Week 4)||141
6653497|NCT02437513|7583301|FG000|STARTED|Overall Study||2
6443464|NCT01113801|7358790|FG003|NOT COMPLETED|Overall Study||41
6443465|NCT01113879|7358802|FG000|STARTED|Period 1: Block 1||7
6443466|NCT01113879|7358803|FG001|STARTED|Period 1: Block 1||2
6443467|NCT01113879|7358802|FG000|COMPLETED|Period 1: Block 1||5
6443468|NCT01113879|7358803|FG001|COMPLETED|Period 1: Block 1||2
6443469|NCT01113879|7358802|FG000|NOT COMPLETED|Period 1: Block 1||2
6443470|NCT01113879|7358803|FG001|NOT COMPLETED|Period 1: Block 1||0
6443471|NCT01113879|7358802|FG000|STARTED|Period 2: Block 2||5
6443472|NCT01113879|7358803|FG001|STARTED|Period 2: Block 2||2
6443473|NCT01113879|7358802|FG000|COMPLETED|Period 2: Block 2||5
6443474|NCT01113879|7358803|FG001|COMPLETED|Period 2: Block 2||2
6443475|NCT01113879|7358802|FG000|NOT COMPLETED|Period 2: Block 2||0
6443476|NCT01113879|7358803|FG001|NOT COMPLETED|Period 2: Block 2||0
6443477|NCT01113892|7358813|FG000|STARTED|Overall Study||101
6443478|NCT01113892|7358814|FG001|STARTED|Overall Study||106
6443479|NCT01113892|7358813|FG000|COMPLETED|Overall Study||87
6443480|NCT01113892|7358814|FG001|COMPLETED|Overall Study||90
6443481|NCT01113892|7358813|FG000|NOT COMPLETED|Overall Study||14
6443482|NCT01113892|7358814|FG001|NOT COMPLETED|Overall Study||16
6443483|NCT01113931|7358822|FG000|STARTED|Overall Study||247
6443484|NCT01113931|7358823|FG001|STARTED|Overall Study||248
6443485|NCT01113931|7358822|FG000|Safety Population|Overall Study|1 subject did not take any study medication|246
6443486|NCT01113931|7358823|FG001|Safety Population|Overall Study||248
6443487|NCT01113931|7358822|FG000|mITT Population|Overall Study||188
6443488|NCT01113931|7358823|FG001|mITT Population|Overall Study||190
6443489|NCT01113931|7358822|FG000|COMPLETED|Overall Study||228
6443490|NCT01113931|7358823|FG001|COMPLETED|Overall Study||231
6443491|NCT01113931|7358822|FG000|NOT COMPLETED|Overall Study||19
6443492|NCT01113931|7358823|FG001|NOT COMPLETED|Overall Study||17
6443493|NCT01113983|7358831|FG000|STARTED|Overall Study||37
6443494|NCT01113983|7358832|FG001|STARTED|Overall Study||27
6443495|NCT01113983|7358831|FG000|COMPLETED|Overall Study||12
6443496|NCT01113983|7358832|FG001|COMPLETED|Overall Study||10
6443497|NCT01113983|7358831|FG000|NOT COMPLETED|Overall Study||25
6443498|NCT01113983|7358832|FG001|NOT COMPLETED|Overall Study||17
6443499|NCT01114334|7358840|FG000|STARTED|Overall Study||88
6443500|NCT01114334|7358841|FG001|STARTED|Overall Study||80
6443501|NCT01114334|7358840|FG000|COMPLETED|Overall Study||67
6443502|NCT01114334|7358841|FG001|COMPLETED|Overall Study||58
6443503|NCT01114334|7358840|FG000|NOT COMPLETED|Overall Study||21
6443504|NCT01114334|7358841|FG001|NOT COMPLETED|Overall Study||22
6443505|NCT01114360|7358848|FG000|STARTED|Intervention 1 (4 Weeks)||18
6443506|NCT01114360|7358849|FG001|STARTED|Intervention 1 (4 Weeks)||19
6443507|NCT01114360|7358848|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
6443508|NCT01114360|7358849|FG001|COMPLETED|Intervention 1 (4 Weeks)||18
6443509|NCT01114360|7358848|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||0
6443510|NCT01114360|7358849|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||1
6443511|NCT01114360|7358848|FG000|STARTED|Intervention 2 (4 Weeks)||18
6443512|NCT01114360|7358849|FG001|STARTED|Intervention 2 (4 Weeks)||18
6443513|NCT01114360|7358848|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
6443514|NCT01114360|7358849|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
6443515|NCT01114360|7358848|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
6653498|NCT02437513|7583301|FG000|COMPLETED|Overall Study||0
6653499|NCT02437513|7583301|FG000|NOT COMPLETED|Overall Study||2
6653500|NCT02437669|7583305|FG000|STARTED|Overall Study||35
6653501|NCT02437669|7583305|FG000|COMPLETED|Overall Study||35
6653502|NCT02437669|7583305|FG000|NOT COMPLETED|Overall Study||0
6653503|NCT02437864|7583312|FG000|STARTED|Overall Study||200
6653504|NCT02437864|7583313|FG001|STARTED|Overall Study||160
6653505|NCT02437864|7583312|FG000|COMPLETED|Overall Study||196
6653506|NCT02437864|7583313|FG001|COMPLETED|Overall Study||160
6653507|NCT02437864|7583312|FG000|NOT COMPLETED|Overall Study||4
6653508|NCT02437864|7583313|FG001|NOT COMPLETED|Overall Study||0
6653509|NCT02437890|7583324|FG000|STARTED|Overall Study||62
6653510|NCT02437890|7583325|FG001|STARTED|Overall Study||64
6653511|NCT02437890|7583326|FG002|STARTED|Overall Study||62
6653512|NCT02437890|7583327|FG003|STARTED|Overall Study||62
6443516|NCT01114360|7358849|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||0
6443517|NCT01114373|7358869|FG000|STARTED|Intervention 1 (4 Weeks)||21
6443518|NCT01114373|7358870|FG001|STARTED|Intervention 1 (4 Weeks)||19
6443519|NCT01114373|7358869|FG000|COMPLETED|Intervention 1 (4 Weeks)||18
6443520|NCT01114373|7358870|FG001|COMPLETED|Intervention 1 (4 Weeks)||19
6443521|NCT01114373|7358869|FG000|NOT COMPLETED|Intervention 1 (4 Weeks)||3
6443522|NCT01114373|7358870|FG001|NOT COMPLETED|Intervention 1 (4 Weeks)||0
6443523|NCT01114373|7358869|FG000|STARTED|Intervention 2 (4 Weeks)||18
6443524|NCT01114373|7358870|FG001|STARTED|Intervention 2 (4 Weeks)||19
6653513|NCT02437890|7583328|FG004|STARTED|Overall Study||62
6443525|NCT01114373|7358869|FG000|COMPLETED|Intervention 2 (4 Weeks)||18
6653514|NCT02437890|7583324|FG000|COMPLETED|Overall Study||54
6443526|NCT01114373|7358870|FG001|COMPLETED|Intervention 2 (4 Weeks)||18
6443527|NCT01114373|7358869|FG000|NOT COMPLETED|Intervention 2 (4 Weeks)||0
6443528|NCT01114373|7358870|FG001|NOT COMPLETED|Intervention 2 (4 Weeks)||1
6443529|NCT01114438|7358880|FG000|STARTED|Overall Study||45
6443530|NCT01114438|7358880|FG000|COMPLETED|Overall Study||31
6443531|NCT01114438|7358880|FG000|NOT COMPLETED|Overall Study||14
6443532|NCT01114503|7358889|FG000|STARTED|Overall Study||2
6653515|NCT02437890|7583325|FG001|COMPLETED|Overall Study||48
6653516|NCT02437890|7583326|FG002|COMPLETED|Overall Study||47
6653517|NCT02437890|7583327|FG003|COMPLETED|Overall Study||40
6653518|NCT02437890|7583328|FG004|COMPLETED|Overall Study||46
6443533|NCT01114503|7358889|FG000|COMPLETED|Overall Study||2
6653519|NCT02437890|7583324|FG000|NOT COMPLETED|Overall Study||8
6443534|NCT01114503|7358889|FG000|NOT COMPLETED|Overall Study||0
6443535|NCT01114516|7358895|FG000|STARTED|Overall Study||26
6443536|NCT01114516|7358896|FG001|STARTED|Overall Study||27
6443537|NCT01114516|7358895|FG000|COMPLETED|Overall Study||24
6443538|NCT01114516|7358896|FG001|COMPLETED|Overall Study||26
6443539|NCT01114516|7358895|FG000|NOT COMPLETED|Overall Study||2
6443540|NCT01114516|7358896|FG001|NOT COMPLETED|Overall Study||1
6443541|NCT01114529|7358905|FG000|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
6443542|NCT01114529|7358906|FG001|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
6443543|NCT01114529|7358907|FG002|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
6443544|NCT01114529|7358905|FG000|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
6443545|NCT01114529|7358906|FG001|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
6443546|NCT01114529|7358907|FG002|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
6443547|NCT01114529|7358905|FG000|NOT COMPLETED|Completed Study Medication at Month 24||124
6443548|NCT01114529|7358906|FG001|NOT COMPLETED|Completed Study Medication at Month 24||41
6443549|NCT01114529|7358907|FG002|NOT COMPLETED|Completed Study Medication at Month 24||32
6443550|NCT01114529|7358905|FG000|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
6443551|NCT01114529|7358906|FG001|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
6443552|NCT01114529|7358907|FG002|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
6443553|NCT01114529|7358905|FG000|COMPLETED|Completed Study Phase at Month 24|at month 24|313
6443554|NCT01114529|7358906|FG001|COMPLETED|Completed Study Phase at Month 24|at month 24|215
6443555|NCT01114529|7358907|FG002|COMPLETED|Completed Study Phase at Month 24|at month 24|111
6443556|NCT01114529|7358905|FG000|NOT COMPLETED|Completed Study Phase at Month 24||40
6443557|NCT01114529|7358906|FG001|NOT COMPLETED|Completed Study Phase at Month 24||16
6443558|NCT01114529|7358907|FG002|NOT COMPLETED|Completed Study Phase at Month 24||14
6443559|NCT01114555|7358917|FG000|STARTED|Overall Study||34
6443560|NCT01114555|7358917|FG000|COMPLETED|Overall Study||34
6443561|NCT01114555|7358917|FG000|NOT COMPLETED|Overall Study||0
6443562|NCT01114581|7358923|FG000|STARTED|Overall Study||19
6443563|NCT01114581|7358924|FG001|STARTED|Overall Study||19
6443564|NCT01114581|7358923|FG000|COMPLETED|Overall Study||19
6443565|NCT01114581|7358924|FG001|COMPLETED|Overall Study||19
6443566|NCT01114581|7358923|FG000|NOT COMPLETED|Overall Study||0
6443567|NCT01114581|7358924|FG001|NOT COMPLETED|Overall Study||0
6443568|NCT01114620|7358930|FG000|STARTED|Overall Study||50
6443569|NCT01114620|7358930|FG000|COMPLETED|Overall Study||50
6443570|NCT01114620|7358930|FG000|NOT COMPLETED|Overall Study||0
6443571|NCT01114646|7358936|FG000|STARTED|Overall Study||66
6443572|NCT01114646|7358937|FG001|STARTED|Overall Study||64
6443573|NCT01114646|7358936|FG000|COMPLETED|Overall Study||63
6443574|NCT01114646|7358937|FG001|COMPLETED|Overall Study||62
6553058|NCT01741350|7475551|FG000|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
6443575|NCT01114646|7358936|FG000|NOT COMPLETED|Overall Study||3
6443576|NCT01114646|7358937|FG001|NOT COMPLETED|Overall Study||2
6443577|NCT01114672|7358945|FG000|STARTED|Overall Study||25
6443578|NCT01114672|7358946|FG001|STARTED|Overall Study||25
6443579|NCT01114672|7358945|FG000|COMPLETED|Overall Study||21
6443580|NCT01114672|7358946|FG001|COMPLETED|Overall Study||23
6443581|NCT01114672|7358945|FG000|NOT COMPLETED|Overall Study||4
6443582|NCT01114672|7358946|FG001|NOT COMPLETED|Overall Study||2
6443583|NCT01114724|7358952|FG000|STARTED|Overall Study||50
6443584|NCT01114724|7358952|FG000|COMPLETED|Overall Study||40
6443585|NCT01114724|7358952|FG000|NOT COMPLETED|Overall Study||10
6443586|NCT01114737|7358959|FG000|STARTED|Randomized Treatment Period||108
6443587|NCT01114737|7358960|FG001|STARTED|Randomized Treatment Period||98
6443588|NCT01114737|7358959|FG000|COMPLETED|Randomized Treatment Period||105
6443589|NCT01114737|7358960|FG001|COMPLETED|Randomized Treatment Period||97
6443590|NCT01114737|7358959|FG000|NOT COMPLETED|Randomized Treatment Period||3
6443591|NCT01114737|7358960|FG001|NOT COMPLETED|Randomized Treatment Period||1
6443592|NCT01114737|7358959|FG000|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
6443593|NCT01114737|7358960|FG001|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
6443594|NCT01114737|7358959|FG000|COMPLETED|Open-Label Treatment Period||100
6443595|NCT01114737|7358960|FG001|COMPLETED|Open-Label Treatment Period||95
6443596|NCT01114737|7358959|FG000|NOT COMPLETED|Open-Label Treatment Period||5
6443597|NCT01114737|7358960|FG001|NOT COMPLETED|Open-Label Treatment Period||2
6443598|NCT01114828|7358979|FG000|STARTED|Overall Study||19
6443599|NCT01114828|7358980|FG001|STARTED|Overall Study||21
6443600|NCT01114828|7358979|FG000|COMPLETED|Overall Study||16
6443601|NCT01114828|7358980|FG001|COMPLETED|Overall Study||17
6443602|NCT01114828|7358979|FG000|NOT COMPLETED|Overall Study||3
6443603|NCT01114828|7358980|FG001|NOT COMPLETED|Overall Study||4
6443604|NCT01114880|7358988|FG000|STARTED|Period 1 (Week 0 to Week 12)||229
6443605|NCT01114880|7358989|FG001|STARTED|Period 1 (Week 0 to Week 12)||115
6443606|NCT01114880|7358988|FG000|COMPLETED|Period 1 (Week 0 to Week 12)||224
6443607|NCT01114880|7358989|FG001|COMPLETED|Period 1 (Week 0 to Week 12)||113
6443608|NCT01114880|7358988|FG000|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
6443609|NCT01114880|7358989|FG001|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
6443610|NCT01114880|7358988|FG000|STARTED|Period 2 (Week 12 to Week 24)||224
6443611|NCT01114880|7358989|FG001|STARTED|Period 2 (Week 12 to Week 24)||113
6443612|NCT01114880|7358988|FG000|COMPLETED|Period 2 (Week 12 to Week 24)||221
6443613|NCT01114880|7358989|FG001|COMPLETED|Period 2 (Week 12 to Week 24)||111
6443614|NCT01114880|7358988|FG000|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
6443615|NCT01114880|7358989|FG001|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
6443616|NCT01114893|7359002|FG000|STARTED|Overall Study||14
6443617|NCT01114893|7359003|FG001|STARTED|Overall Study||14
6443618|NCT01114893|7359004|FG002|STARTED|Overall Study||14
6443619|NCT01114893|7359005|FG003|STARTED|Overall Study||13
6443620|NCT01114893|7359006|FG004|STARTED|Overall Study||12
6443621|NCT01114893|7359002|FG000|COMPLETED|Overall Study||14
6443622|NCT01114893|7359003|FG001|COMPLETED|Overall Study||14
6443623|NCT01114893|7359004|FG002|COMPLETED|Overall Study||14
6443624|NCT01114893|7359005|FG003|COMPLETED|Overall Study||13
6443625|NCT01114893|7359006|FG004|COMPLETED|Overall Study||12
6443626|NCT01114893|7359002|FG000|NOT COMPLETED|Overall Study||0
6443627|NCT01114893|7359003|FG001|NOT COMPLETED|Overall Study||0
6443628|NCT01114893|7359004|FG002|NOT COMPLETED|Overall Study||0
6443629|NCT01114893|7359005|FG003|NOT COMPLETED|Overall Study||0
6443630|NCT01114893|7359006|FG004|NOT COMPLETED|Overall Study||0
6443631|NCT01114945|7359022|FG000|STARTED|Overall Study||30
6443632|NCT01114945|7359023|FG001|STARTED|Overall Study||30
6443633|NCT01114945|7359024|FG002|STARTED|Overall Study||30
6443634|NCT01114945|7359025|FG003|STARTED|Overall Study||31
6443635|NCT01114945|7359022|FG000|COMPLETED|Overall Study||30
6443636|NCT01114945|7359023|FG001|COMPLETED|Overall Study||30
6443637|NCT01114945|7359024|FG002|COMPLETED|Overall Study||30
6443638|NCT01114945|7359025|FG003|COMPLETED|Overall Study||31
6443639|NCT01114945|7359022|FG000|NOT COMPLETED|Overall Study||0
6443640|NCT01114945|7359023|FG001|NOT COMPLETED|Overall Study||0
6443641|NCT01114945|7359024|FG002|NOT COMPLETED|Overall Study||0
6443642|NCT01114945|7359025|FG003|NOT COMPLETED|Overall Study||0
6443643|NCT01114971|7359039|FG000|STARTED|Overall Study||25
6443644|NCT01114971|7359040|FG001|STARTED|Overall Study||25
6443645|NCT01114971|7359041|FG002|STARTED|Overall Study||25
6443646|NCT01114971|7359039|FG000|COMPLETED|Overall Study||25
6443647|NCT01114971|7359040|FG001|COMPLETED|Overall Study||25
6443648|NCT01114971|7359041|FG002|COMPLETED|Overall Study||25
6443649|NCT01114971|7359039|FG000|NOT COMPLETED|Overall Study||0
6443650|NCT01114971|7359040|FG001|NOT COMPLETED|Overall Study||0
6443651|NCT01114971|7359041|FG002|NOT COMPLETED|Overall Study||0
6443652|NCT01114997|7359052|FG000|STARTED|Overall Study||11
6443653|NCT01114997|7359053|FG001|STARTED|Overall Study||10
6443654|NCT01114997|7359054|FG002|STARTED|Overall Study||11
6443655|NCT01114997|7359052|FG000|COMPLETED|Overall Study||11
6443656|NCT01114997|7359053|FG001|COMPLETED|Overall Study||10
6443657|NCT01114997|7359054|FG002|COMPLETED|Overall Study||11
6443658|NCT01114997|7359052|FG000|NOT COMPLETED|Overall Study||0
6443659|NCT01114997|7359053|FG001|NOT COMPLETED|Overall Study||0
6443660|NCT01114997|7359054|FG002|NOT COMPLETED|Overall Study||0
6443661|NCT01115101|7359065|FG000|STARTED|Overall Study||113
6443662|NCT01115101|7359066|FG001|STARTED|Overall Study||126
6443663|NCT01115101|7359065|FG000|COMPLETED|Overall Study||113
6443664|NCT01115101|7359066|FG001|COMPLETED|Overall Study||126
6443665|NCT01115101|7359065|FG000|NOT COMPLETED|Overall Study||0
6443666|NCT01115101|7359066|FG001|NOT COMPLETED|Overall Study||0
6443667|NCT01115166|7359072|FG000|STARTED|Overall Study||10
6443668|NCT01115166|7359072|FG000|COMPLETED|Overall Study||10
6443669|NCT01115166|7359072|FG000|NOT COMPLETED|Overall Study||0
6443670|NCT01115231|7359078|FG000|STARTED|Overall Study||133
6443671|NCT01115231|7359079|FG001|STARTED|Overall Study||90
6443672|NCT01115231|7359078|FG000|COMPLETED|Overall Study||133
6443673|NCT01115231|7359079|FG001|COMPLETED|Overall Study||90
6443674|NCT01115231|7359078|FG000|NOT COMPLETED|Overall Study||0
6443675|NCT01115231|7359079|FG001|NOT COMPLETED|Overall Study||0
6443676|NCT01115309|7359086|FG000|STARTED|Procedure Safety (1-Month)||175
6443677|NCT01115309|7359086|FG000|COMPLETED|Procedure Safety (1-Month)||172
6443678|NCT01115309|7359086|FG000|NOT COMPLETED|Procedure Safety (1-Month)||3
6443679|NCT01115309|7359086|FG000|STARTED|Long-term Follow-up||50
6443680|NCT01115309|7359086|FG000|6-Month Follow-up|Long-term Follow-up||46
6443681|NCT01115309|7359086|FG000|12-Month Follow-up|Long-term Follow-up||44
6443682|NCT01115309|7359086|FG000|COMPLETED|Long-term Follow-up||44
6443683|NCT01115309|7359086|FG000|NOT COMPLETED|Long-term Follow-up||6
6443684|NCT01115452|7359091|FG000|STARTED|Overall Study||32
6443685|NCT01115452|7359091|FG000|COMPLETED|Overall Study||32
6443686|NCT01115452|7359091|FG000|NOT COMPLETED|Overall Study||0
6443687|NCT01115491|7359099|FG000|STARTED|Overall Study||32
6443688|NCT01115491|7359099|FG000|COMPLETED|Overall Study||2
6443689|NCT01115491|7359099|FG000|NOT COMPLETED|Overall Study||30
6443690|NCT01115517|7359105|FG000|STARTED|Overall Study||18
6443691|NCT01115517|7359106|FG001|STARTED|Overall Study||21
6443692|NCT01115517|7359105|FG000|COMPLETED|Overall Study||14
6443693|NCT01115517|7359106|FG001|COMPLETED|Overall Study||16
6443694|NCT01115517|7359105|FG000|NOT COMPLETED|Overall Study||4
6443695|NCT01115517|7359106|FG001|NOT COMPLETED|Overall Study||5
6443696|NCT01115556|7359114|FG000|STARTED|Overall Study||7
6443697|NCT01115556|7359115|FG001|STARTED|Overall Study||2
6443698|NCT01115556|7359114|FG000|COMPLETED|Overall Study||7
6443699|NCT01115556|7359115|FG001|COMPLETED|Overall Study||2
6443700|NCT01115556|7359114|FG000|NOT COMPLETED|Overall Study||0
6443701|NCT01115556|7359115|FG001|NOT COMPLETED|Overall Study||0
6443702|NCT01115569|7359123|FG000|STARTED|Conversion/Titration Phase||638
6443703|NCT01115569|7359124|FG001|STARTED|Conversion/Titration Phase||0
6443704|NCT01115569|7359123|FG000|COMPLETED|Conversion/Titration Phase||424
6443705|NCT01115569|7359124|FG001|COMPLETED|Conversion/Titration Phase||0
6443706|NCT01115569|7359123|FG000|NOT COMPLETED|Conversion/Titration Phase||214
6443707|NCT01115569|7359124|FG001|NOT COMPLETED|Conversion/Titration Phase||0
6443708|NCT01115569|7359123|FG000|STARTED|Maintenance Phase||0
6443709|NCT01115569|7359124|FG001|STARTED|Maintenance Phase||424
6443710|NCT01115569|7359123|FG000|COMPLETED|Maintenance Phase||0
6443711|NCT01115569|7359124|FG001|COMPLETED|Maintenance Phase||285
6443712|NCT01115569|7359123|FG000|NOT COMPLETED|Maintenance Phase||0
6443713|NCT01115569|7359124|FG001|NOT COMPLETED|Maintenance Phase||139
6443714|NCT01115582|7359129|FG000|STARTED|Overall Study||16
6443715|NCT01115582|7359129|FG000|COMPLETED|Overall Study||16
6443716|NCT01115582|7359129|FG000|NOT COMPLETED|Overall Study||0
6443717|NCT01115660|7359135|FG000|STARTED|Overall Study||20
6443718|NCT01115660|7359136|FG001|STARTED|Overall Study||10
6443719|NCT01115660|7359135|FG000|COMPLETED|Overall Study||19
6443720|NCT01115660|7359136|FG001|COMPLETED|Overall Study||10
6443721|NCT01115660|7359135|FG000|NOT COMPLETED|Overall Study||1
6443722|NCT01115660|7359136|FG001|NOT COMPLETED|Overall Study||0
6500130|NCT01423617|7418932|FG000|NOT COMPLETED|Overall Study||0
6500131|NCT01423617|7418933|FG001|NOT COMPLETED|Overall Study||1
6500132|NCT01423760|7418941|FG000|STARTED|Overall Study||14
6500133|NCT01423760|7418942|FG001|STARTED|Overall Study||13
6500134|NCT01423760|7418941|FG000|Number of Tecemotide Subjects|Overall Study||12
6500135|NCT01423760|7418942|FG001|Number of Tecemotide Subjects|Overall Study||8
6500136|NCT01423760|7418941|FG000|Number of Non-treatment Subjects|Overall Study||2
6500137|NCT01423760|7418942|FG001|Number of Non-treatment Subjects|Overall Study||5
6500138|NCT01423760|7418941|FG000|Safety Analysis Set|Overall Study||12
6500139|NCT01423760|7418942|FG001|Safety Analysis Set|Overall Study||8
6500140|NCT01423760|7418941|FG000|COMPLETED|Overall Study||14
6500141|NCT01423760|7418942|FG001|COMPLETED|Overall Study||13
6500142|NCT01423760|7418941|FG000|NOT COMPLETED|Overall Study||0
6500143|NCT01423760|7418942|FG001|NOT COMPLETED|Overall Study||0
6500144|NCT01423773|7418948|FG000|STARTED|Period One, 2 Days||10
6500145|NCT01423773|7418949|FG001|STARTED|Period One, 2 Days||10
6500146|NCT01423773|7418948|FG000|COMPLETED|Period One, 2 Days||10
6500147|NCT01423773|7418949|FG001|COMPLETED|Period One, 2 Days||10
6500148|NCT01423773|7418948|FG000|NOT COMPLETED|Period One, 2 Days||0
6500149|NCT01423773|7418949|FG001|NOT COMPLETED|Period One, 2 Days||0
6500150|NCT01423773|7418948|FG000|STARTED|Period 2, 2 Days||10
6500151|NCT01423773|7418949|FG001|STARTED|Period 2, 2 Days||10
6500152|NCT01423773|7418948|FG000|COMPLETED|Period 2, 2 Days||10
6500153|NCT01423773|7418949|FG001|COMPLETED|Period 2, 2 Days||10
6500154|NCT01423773|7418948|FG000|NOT COMPLETED|Period 2, 2 Days||0
6500155|NCT01423773|7418949|FG001|NOT COMPLETED|Period 2, 2 Days||0
6500156|NCT01423812|7418957|FG000|STARTED|Overall Study||30
6500157|NCT01423812|7418958|FG001|STARTED|Overall Study||30
6500158|NCT01423812|7418957|FG000|COMPLETED|Overall Study||27
6500159|NCT01423812|7418958|FG001|COMPLETED|Overall Study||26
6500160|NCT01423812|7418957|FG000|NOT COMPLETED|Overall Study||3
6500161|NCT01423812|7418958|FG001|NOT COMPLETED|Overall Study||4
6500162|NCT01423916|7418969|FG000|STARTED|Overall Study||74
6500163|NCT01423916|7418970|FG001|STARTED|Overall Study||73
6500164|NCT01423916|7418971|FG002|STARTED|Overall Study||71
6500165|NCT01423916|7418969|FG000|COMPLETED|Overall Study||63
6500166|NCT01423916|7418970|FG001|COMPLETED|Overall Study||53
6500167|NCT01423916|7418971|FG002|COMPLETED|Overall Study||64
6500168|NCT01423916|7418969|FG000|NOT COMPLETED|Overall Study||11
6500169|NCT01423916|7418970|FG001|NOT COMPLETED|Overall Study||20
6500170|NCT01423916|7418971|FG002|NOT COMPLETED|Overall Study||7
6500171|NCT01424033|7418990|FG000|STARTED|Overall Study||5
6500172|NCT01424033|7418990|FG000|COMPLETED|Overall Study||0
6500173|NCT01424033|7418990|FG000|NOT COMPLETED|Overall Study||5
6500174|NCT01424072|7418997|FG000|STARTED|Overall Study||27
6500175|NCT01424072|7418998|FG001|STARTED|Overall Study||26
6500176|NCT01424072|7418999|FG002|STARTED|Overall Study||22
6500177|NCT01424072|7418997|FG000|COMPLETED|Overall Study||27
6500178|NCT01424072|7418998|FG001|COMPLETED|Overall Study||26
6500179|NCT01424072|7418999|FG002|COMPLETED|Overall Study||22
6500180|NCT01424072|7418997|FG000|NOT COMPLETED|Overall Study||0
6500181|NCT01424072|7418998|FG001|NOT COMPLETED|Overall Study||0
6500182|NCT01424072|7418999|FG002|NOT COMPLETED|Overall Study||0
6500183|NCT01424189|7419009|FG000|STARTED|Overall Study||386
6500184|NCT01424189|7419010|FG001|STARTED|Overall Study||188
6500185|NCT01424189|7419009|FG000|COMPLETED|Overall Study||373
6500186|NCT01424189|7419010|FG001|COMPLETED|Overall Study||182
6500187|NCT01424189|7419009|FG000|NOT COMPLETED|Overall Study||13
6500188|NCT01424189|7419010|FG001|NOT COMPLETED|Overall Study||6
6500189|NCT01424215|7419018|FG000|STARTED|Overall Study||50
6500190|NCT01424215|7419019|FG001|STARTED|Overall Study||50
6500191|NCT01424215|7419018|FG000|COMPLETED|Overall Study||50
6500192|NCT01424215|7419019|FG001|COMPLETED|Overall Study||50
6500193|NCT01424215|7419018|FG000|NOT COMPLETED|Overall Study||0
6500194|NCT01424215|7419019|FG001|NOT COMPLETED|Overall Study||0
6500195|NCT01424228|7419027|FG000|STARTED|Overall Study||182
6500196|NCT01424228|7419028|FG001|STARTED|Overall Study||182
6500197|NCT01424228|7419027|FG000|COMPLETED|Overall Study||126
6500198|NCT01424228|7419028|FG001|COMPLETED|Overall Study||135
6500199|NCT01424228|7419027|FG000|NOT COMPLETED|Overall Study||56
6500200|NCT01424228|7419028|FG001|NOT COMPLETED|Overall Study||47
6443723|NCT01115673|7359145|FG000|STARTED|Overall Study||239
6443724|NCT01115673|7359146|FG001|STARTED|Overall Study||241
6443725|NCT01115673|7359147|FG002|STARTED|Overall Study||60
6443726|NCT01115673|7359145|FG000|COMPLETED|Overall Study||239
6443727|NCT01115673|7359146|FG001|COMPLETED|Overall Study||241
6443728|NCT01115673|7359147|FG002|COMPLETED|Overall Study||60
6443729|NCT01115673|7359145|FG000|NOT COMPLETED|Overall Study||0
6443730|NCT01115673|7359146|FG001|NOT COMPLETED|Overall Study||0
6443731|NCT01115673|7359147|FG002|NOT COMPLETED|Overall Study||0
6443732|NCT01115738|7359158|FG000|STARTED|Overall Study||110
6443733|NCT01115738|7359159|FG001|STARTED|Overall Study||83
6443734|NCT01115738|7359160|FG002|STARTED|Overall Study||89
6443735|NCT01115738|7359158|FG000|Received Any Treatment|Overall Study||109
6443736|NCT01115738|7359159|FG001|Received Any Treatment|Overall Study||79
6443737|NCT01115738|7359160|FG002|Received Any Treatment|Overall Study||88
6443738|NCT01115738|7359158|FG000|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
6443739|NCT01115738|7359159|FG001|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
6443740|NCT01115738|7359160|FG002|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
6443741|NCT01115738|7359158|FG000|COMPLETED|Overall Study||85
6443742|NCT01115738|7359159|FG001|COMPLETED|Overall Study||62
6443743|NCT01115738|7359160|FG002|COMPLETED|Overall Study||62
6443744|NCT01115738|7359158|FG000|NOT COMPLETED|Overall Study||25
6443745|NCT01115738|7359159|FG001|NOT COMPLETED|Overall Study||21
6443746|NCT01115738|7359160|FG002|NOT COMPLETED|Overall Study||27
6443747|NCT01115803|7359183|FG000|STARTED|Overall Study||4
6443748|NCT01115803|7359184|FG001|STARTED|Overall Study||5
6443749|NCT01115803|7359185|FG002|STARTED|Overall Study||3
6443750|NCT01115803|7359186|FG003|STARTED|Overall Study||5
6443751|NCT01115803|7359187|FG004|STARTED|Overall Study||3
6443752|NCT01115803|7359188|FG005|STARTED|Overall Study||3
6443753|NCT01115803|7359189|FG006|STARTED|Overall Study||6
6443754|NCT01115803|7359183|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
6443755|NCT01115803|7359184|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
6443756|NCT01115803|7359185|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6443757|NCT01115803|7359186|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
6443758|NCT01115803|7359187|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
6443759|NCT01115803|7359188|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
6443760|NCT01115803|7359189|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
6443761|NCT01115803|7359183|FG000|COMPLETED|Overall Study||4
6443762|NCT01115803|7359184|FG001|COMPLETED|Overall Study||5
6443763|NCT01115803|7359185|FG002|COMPLETED|Overall Study||2
6443764|NCT01115803|7359186|FG003|COMPLETED|Overall Study||5
6443765|NCT01115803|7359187|FG004|COMPLETED|Overall Study||3
6443766|NCT01115803|7359188|FG005|COMPLETED|Overall Study||3
6443767|NCT01115803|7359189|FG006|COMPLETED|Overall Study||4
6443768|NCT01115803|7359183|FG000|NOT COMPLETED|Overall Study||0
6553059|NCT01741350|7475552|FG001|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
6553060|NCT01741350|7475551|FG000|STARTED|3-Month Follow-up Assessment||135
6443769|NCT01115803|7359184|FG001|NOT COMPLETED|Overall Study||0
6443770|NCT01115803|7359185|FG002|NOT COMPLETED|Overall Study||1
6443771|NCT01115803|7359186|FG003|NOT COMPLETED|Overall Study||0
6443772|NCT01115803|7359187|FG004|NOT COMPLETED|Overall Study||0
6443773|NCT01115803|7359188|FG005|NOT COMPLETED|Overall Study||0
6443774|NCT01115803|7359189|FG006|NOT COMPLETED|Overall Study||2
6443775|NCT01115855|7359212|FG000|STARTED|Overall Study||111
6443776|NCT01115855|7359213|FG001|STARTED|Overall Study||110
6443777|NCT01115855|7359212|FG000|COMPLETED|Overall Study||75
6443778|NCT01115855|7359213|FG001|COMPLETED|Overall Study||74
6443779|NCT01115855|7359212|FG000|NOT COMPLETED|Overall Study||36
6443780|NCT01115855|7359213|FG001|NOT COMPLETED|Overall Study||36
6443781|NCT01115933|7359219|FG000|STARTED|Overall Study||65
6443782|NCT01115933|7359219|FG000|COMPLETED|Overall Study||64
6443783|NCT01115933|7359219|FG000|NOT COMPLETED|Overall Study||1
6443784|NCT01115998|7359278|FG000|STARTED|Overall Study||17
6443785|NCT01115998|7359279|FG001|STARTED|Overall Study||17
6443786|NCT01115998|7359278|FG000|COMPLETED|Overall Study||11
6443787|NCT01115998|7359279|FG001|COMPLETED|Overall Study||11
6443788|NCT01115998|7359278|FG000|NOT COMPLETED|Overall Study||6
6443789|NCT01115998|7359279|FG001|NOT COMPLETED|Overall Study||6
6443790|NCT01116024|7359285|FG000|STARTED|Overall Study|148 subjects left operating room with the device implanted and were included in the analysis.|148
6443791|NCT01116024|7359285|FG000|COMPLETED|Overall Study|Patient Enrollment stop date|96
6443792|NCT01116024|7359285|FG000|NOT COMPLETED|Overall Study||52
6443793|NCT01116037|7359311|FG000|STARTED|Overall Study||26
6443794|NCT01116037|7359311|FG000|COMPLETED|Overall Study||1
6443795|NCT01116037|7359311|FG000|NOT COMPLETED|Overall Study||25
6443796|NCT01116102|7359323|FG000|STARTED|Overall Study||2
6443797|NCT01116102|7359324|FG001|STARTED|Overall Study||3
6443798|NCT01116102|7359325|FG002|STARTED|Overall Study||3
6443799|NCT01116102|7359326|FG003|STARTED|Overall Study||3
6443800|NCT01116102|7359327|FG004|STARTED|Overall Study||2
6553061|NCT01741350|7475552|FG001|STARTED|3-Month Follow-up Assessment||141
6443801|NCT01116102|7359328|FG005|STARTED|Overall Study||2
6443802|NCT01116102|7359329|FG006|STARTED|Overall Study||2
6443803|NCT01116102|7359330|FG007|STARTED|Overall Study||3
6443804|NCT01116102|7359323|FG000|COMPLETED|Overall Study||2
6443805|NCT01116102|7359324|FG001|COMPLETED|Overall Study||3
6443806|NCT01116102|7359325|FG002|COMPLETED|Overall Study||3
6443807|NCT01116102|7359326|FG003|COMPLETED|Overall Study||3
6443808|NCT01116102|7359327|FG004|COMPLETED|Overall Study||2
6443809|NCT01116102|7359328|FG005|COMPLETED|Overall Study||2
6443810|NCT01116102|7359329|FG006|COMPLETED|Overall Study||2
6443811|NCT01116102|7359330|FG007|COMPLETED|Overall Study||3
6443812|NCT01116102|7359323|FG000|NOT COMPLETED|Overall Study||0
6443813|NCT01116102|7359324|FG001|NOT COMPLETED|Overall Study||0
6443814|NCT01116102|7359325|FG002|NOT COMPLETED|Overall Study||0
6443815|NCT01116102|7359326|FG003|NOT COMPLETED|Overall Study||0
6443816|NCT01116102|7359327|FG004|NOT COMPLETED|Overall Study||0
6443817|NCT01116102|7359328|FG005|NOT COMPLETED|Overall Study||0
6443818|NCT01116102|7359329|FG006|NOT COMPLETED|Overall Study||0
6443819|NCT01116102|7359330|FG007|NOT COMPLETED|Overall Study||0
6443820|NCT01116401|7359348|FG000|STARTED|Overall Study||29
6443821|NCT01116401|7359348|FG000|COMPLETED|Overall Study||29
6443822|NCT01116401|7359348|FG000|NOT COMPLETED|Overall Study||0
6443823|NCT01116427|7359354|FG000|STARTED|Core Phase||44
6443824|NCT01116427|7359355|FG001|STARTED|Core Phase||21
6443825|NCT01116427|7359354|FG000|COMPLETED|Core Phase||39
6443826|NCT01116427|7359355|FG001|COMPLETED|Core Phase||20
6443827|NCT01116427|7359354|FG000|NOT COMPLETED|Core Phase||5
6443828|NCT01116427|7359355|FG001|NOT COMPLETED|Core Phase||1
6443829|NCT01116427|7359354|FG000|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
6443830|NCT01116427|7359355|FG001|STARTED|Extension Phase||20
6443831|NCT01116427|7359354|FG000|COMPLETED|Extension Phase||29
6443832|NCT01116427|7359355|FG001|COMPLETED|Extension Phase||18
6443833|NCT01116427|7359354|FG000|NOT COMPLETED|Extension Phase||9
6443834|NCT01116427|7359355|FG001|NOT COMPLETED|Extension Phase||2
6443835|NCT01116440|7359367|FG000|STARTED|Treatment||11
6443836|NCT01116440|7359368|FG001|STARTED|Treatment||16
6443837|NCT01116440|7359367|FG000|COMPLETED|Treatment||8
6443838|NCT01116440|7359368|FG001|COMPLETED|Treatment||9
6443839|NCT01116440|7359367|FG000|NOT COMPLETED|Treatment||3
6443840|NCT01116440|7359368|FG001|NOT COMPLETED|Treatment||7
6443841|NCT01116440|7359367|FG000|STARTED|Withdrawal||8
6443842|NCT01116440|7359368|FG001|STARTED|Withdrawal||9
6443843|NCT01116440|7359367|FG000|COMPLETED|Withdrawal||8
6443844|NCT01116440|7359368|FG001|COMPLETED|Withdrawal||7
6443845|NCT01116440|7359367|FG000|NOT COMPLETED|Withdrawal||0
6443846|NCT01116440|7359368|FG001|NOT COMPLETED|Withdrawal||2
6443847|NCT01116440|7359367|FG000|STARTED|Follow-up||8
6443848|NCT01116440|7359368|FG001|STARTED|Follow-up||7
6443849|NCT01116440|7359367|FG000|COMPLETED|Follow-up||8
6443850|NCT01116440|7359368|FG001|COMPLETED|Follow-up||5
6443851|NCT01116440|7359367|FG000|NOT COMPLETED|Follow-up||0
6443852|NCT01116440|7359368|FG001|NOT COMPLETED|Follow-up||2
6443853|NCT01116466|7359376|FG000|STARTED|Overall Study||5
6443854|NCT01116466|7359376|FG000|COMPLETED|Overall Study||5
6443855|NCT01116466|7359376|FG000|NOT COMPLETED|Overall Study||0
6443856|NCT01116544|7359383|FG000|STARTED|Overall Study||23
6443857|NCT01116544|7359384|FG001|STARTED|Overall Study||23
6443858|NCT01116544|7359383|FG000|COMPLETED|Overall Study||21
6443859|NCT01116544|7359384|FG001|COMPLETED|Overall Study||22
6443860|NCT01116544|7359383|FG000|NOT COMPLETED|Overall Study||2
6443861|NCT01116544|7359384|FG001|NOT COMPLETED|Overall Study||1
6443862|NCT01116661|7359390|FG000|STARTED|Overall Study||199
6443863|NCT01116661|7359390|FG000|COMPLETED|Overall Study||197
6443864|NCT01116661|7359390|FG000|NOT COMPLETED|Overall Study||2
6443865|NCT01116687|7359394|FG000|STARTED|Overall Study||37
6443866|NCT01116687|7359394|FG000|COMPLETED|Overall Study||33
6443867|NCT01116687|7359394|FG000|NOT COMPLETED|Overall Study||4
6443868|NCT01116739|7359400|FG000|STARTED|Overall Study||1056
6443869|NCT01116739|7359401|FG001|STARTED|Overall Study||1004
6443870|NCT01116739|7359400|FG000|COMPLETED|Overall Study||926
6443871|NCT01116739|7359401|FG001|COMPLETED|Overall Study||868
6443872|NCT01116739|7359400|FG000|NOT COMPLETED|Overall Study||130
6443873|NCT01116739|7359401|FG001|NOT COMPLETED|Overall Study||136
6443874|NCT01116882|7359409|FG000|STARTED|30-day||2774
6443875|NCT01116882|7359410|FG001|STARTED|30-day||917
6443876|NCT01116882|7359409|FG000|COMPLETED|30-day||2706
6443877|NCT01116882|7359410|FG001|COMPLETED|30-day||886
6443878|NCT01116882|7359409|FG000|NOT COMPLETED|30-day||68
6443879|NCT01116882|7359410|FG001|NOT COMPLETED|30-day||31
6443880|NCT01116882|7359409|FG000|STARTED|12-month||2706
6443881|NCT01116882|7359410|FG001|STARTED|12-month||886
6443882|NCT01116882|7359409|FG000|COMPLETED|12-month||2439
6443883|NCT01116882|7359410|FG001|COMPLETED|12-month||787
6443884|NCT01116882|7359409|FG000|NOT COMPLETED|12-month||267
6443885|NCT01116882|7359410|FG001|NOT COMPLETED|12-month||99
6443886|NCT01116895|7359423|FG000|STARTED|Overall Study||16
6443887|NCT01116895|7359424|FG001|STARTED|Overall Study||15
6443888|NCT01116895|7359425|FG002|STARTED|Overall Study||18
6443889|NCT01116895|7359426|FG003|STARTED|Overall Study||14
6443890|NCT01116895|7359423|FG000|COMPLETED|Overall Study||12
6443891|NCT01116895|7359424|FG001|COMPLETED|Overall Study||8
6443892|NCT01116895|7359425|FG002|COMPLETED|Overall Study||14
6443893|NCT01116895|7359426|FG003|COMPLETED|Overall Study||11
6443894|NCT01116895|7359423|FG000|NOT COMPLETED|Overall Study||4
6443895|NCT01116895|7359424|FG001|NOT COMPLETED|Overall Study||7
6443896|NCT01116895|7359425|FG002|NOT COMPLETED|Overall Study||4
6443897|NCT01116895|7359426|FG003|NOT COMPLETED|Overall Study||3
6443898|NCT01116921|7359438|FG000|STARTED|Overall Study||53
6443899|NCT01116921|7359439|FG001|STARTED|Overall Study||50
6443900|NCT01116921|7359438|FG000|COMPLETED|Overall Study||53
6443901|NCT01116921|7359439|FG001|COMPLETED|Overall Study||50
6443902|NCT01116921|7359438|FG000|NOT COMPLETED|Overall Study||0
6443903|NCT01116921|7359439|FG001|NOT COMPLETED|Overall Study||0
6443904|NCT01116934|7359447|FG000|STARTED|Overall Study||8
6443905|NCT01116934|7359448|FG001|STARTED|Overall Study||9
6443906|NCT01116934|7359447|FG000|COMPLETED|Overall Study||8
6443907|NCT01116934|7359448|FG001|COMPLETED|Overall Study||9
6443908|NCT01116934|7359447|FG000|NOT COMPLETED|Overall Study||0
6443909|NCT01116934|7359448|FG001|NOT COMPLETED|Overall Study||0
6443910|NCT01116986|7359486|FG000|STARTED|Overall Study||24
6443911|NCT01116986|7359487|FG001|STARTED|Overall Study||19
6443912|NCT01116986|7359488|FG002|STARTED|Overall Study||18
6443913|NCT01116986|7359489|FG003|STARTED|Overall Study||22
6443914|NCT01116986|7359490|FG004|STARTED|Overall Study||24
6443915|NCT01116986|7359491|FG005|STARTED|Overall Study||22
6443916|NCT01116986|7359492|FG006|STARTED|Overall Study||22
6443917|NCT01116986|7359493|FG007|STARTED|Overall Study||22
6443918|NCT01116986|7359494|FG008|STARTED|Overall Study||20
6443919|NCT01116986|7359495|FG009|STARTED|Overall Study||23
6443920|NCT01116986|7359496|FG010|STARTED|Overall Study||19
6443921|NCT01116986|7359497|FG011|STARTED|Overall Study||20
6443922|NCT01116986|7359498|FG012|STARTED|Overall Study||17
6443923|NCT01116986|7359499|FG013|STARTED|Overall Study||19
6443924|NCT01116986|7359500|FG014|STARTED|Overall Study||17
6553062|NCT01741350|7475551|FG000|COMPLETED|3-Month Follow-up Assessment||129
6553063|NCT01741350|7475552|FG001|COMPLETED|3-Month Follow-up Assessment||119
6553064|NCT01741350|7475551|FG000|NOT COMPLETED|3-Month Follow-up Assessment||6
6443925|NCT01116986|7359501|FG015|STARTED|Overall Study||21
6443926|NCT01116986|7359502|FG016|STARTED|Overall Study||16
6443927|NCT01116986|7359503|FG017|STARTED|Overall Study||24
6443928|NCT01116986|7359504|FG018|STARTED|Overall Study||23
6443929|NCT01116986|7359505|FG019|STARTED|Overall Study||15
6443930|NCT01116986|7359506|FG020|STARTED|Overall Study||24
6443931|NCT01116986|7359507|FG021|STARTED|Overall Study||20
6443932|NCT01116986|7359508|FG022|STARTED|Overall Study||23
6443933|NCT01116986|7359509|FG023|STARTED|Overall Study||21
6443934|NCT01116986|7359510|FG024|STARTED|Overall Study||18
6443935|NCT01116986|7359511|FG025|STARTED|Overall Study||19
6443936|NCT01116986|7359512|FG026|STARTED|Overall Study||18
6443937|NCT01116986|7359513|FG027|STARTED|Overall Study||19
6443938|NCT01116986|7359514|FG028|STARTED|Overall Study||17
6443939|NCT01116986|7359515|FG029|STARTED|Overall Study||17
6443940|NCT01116986|7359516|FG030|STARTED|Overall Study||17
6443941|NCT01116986|7359517|FG031|STARTED|Overall Study||17
6443942|NCT01116986|7359486|FG000|COMPLETED|Overall Study||22
6443943|NCT01116986|7359487|FG001|COMPLETED|Overall Study||16
6443944|NCT01116986|7359488|FG002|COMPLETED|Overall Study||16
6443945|NCT01116986|7359489|FG003|COMPLETED|Overall Study||20
6443946|NCT01116986|7359490|FG004|COMPLETED|Overall Study||20
6443947|NCT01116986|7359491|FG005|COMPLETED|Overall Study||20
6443948|NCT01116986|7359492|FG006|COMPLETED|Overall Study||20
6443949|NCT01116986|7359493|FG007|COMPLETED|Overall Study||20
6443950|NCT01116986|7359494|FG008|COMPLETED|Overall Study||19
6443951|NCT01116986|7359495|FG009|COMPLETED|Overall Study||19
6443952|NCT01116986|7359496|FG010|COMPLETED|Overall Study||18
6443953|NCT01116986|7359497|FG011|COMPLETED|Overall Study||20
6443954|NCT01116986|7359498|FG012|COMPLETED|Overall Study||16
6553065|NCT01741350|7475552|FG001|NOT COMPLETED|3-Month Follow-up Assessment||22
6553066|NCT01741350|7475551|FG000|STARTED|6-Month Follow-up Assessment||129
6553067|NCT01741350|7475552|FG001|STARTED|6-Month Follow-up Assessment||119
6653520|NCT02437890|7583325|FG001|NOT COMPLETED|Overall Study||16
6653521|NCT02437890|7583326|FG002|NOT COMPLETED|Overall Study||15
6653522|NCT02437890|7583327|FG003|NOT COMPLETED|Overall Study||22
6653523|NCT02437890|7583328|FG004|NOT COMPLETED|Overall Study||16
6653524|NCT02437903|7583344|FG000|STARTED|Overall Study||30
6653525|NCT02437903|7583344|FG000|COMPLETED|Overall Study||25
6653526|NCT02437903|7583344|FG000|NOT COMPLETED|Overall Study||5
6653527|NCT02438137|7583351|FG000|STARTED|Overall Study||44
6653528|NCT02438137|7583352|FG001|STARTED|Overall Study||21
6653529|NCT02438137|7583351|FG000|COMPLETED|Overall Study||36
6653530|NCT02438137|7583352|FG001|COMPLETED|Overall Study||15
6653531|NCT02438137|7583351|FG000|NOT COMPLETED|Overall Study||8
6553068|NCT01741350|7475551|FG000|COMPLETED|6-Month Follow-up Assessment||114
6553069|NCT01741350|7475552|FG001|COMPLETED|6-Month Follow-up Assessment||111
6553070|NCT01741350|7475551|FG000|NOT COMPLETED|6-Month Follow-up Assessment||15
6553071|NCT01741350|7475552|FG001|NOT COMPLETED|6-Month Follow-up Assessment||8
6653532|NCT02438137|7583352|FG001|NOT COMPLETED|Overall Study||6
6443955|NCT01116986|7359499|FG013|COMPLETED|Overall Study||16
6443956|NCT01116986|7359500|FG014|COMPLETED|Overall Study||17
6443957|NCT01116986|7359501|FG015|COMPLETED|Overall Study||15
6553072|NCT01741350|7475551|FG000|STARTED|12-Month Follow-up Assessment||114
6553073|NCT01741350|7475552|FG001|STARTED|12-Month Follow-up Assessment||111
6653533|NCT02438280|7583362|FG000|STARTED|Overall Study||14
6653534|NCT02438280|7583363|FG001|STARTED|Overall Study||13
6653535|NCT02438280|7583362|FG000|COMPLETED|Overall Study||13
6443958|NCT01116986|7359502|FG016|COMPLETED|Overall Study||13
6443959|NCT01116986|7359503|FG017|COMPLETED|Overall Study||19
6443960|NCT01116986|7359504|FG018|COMPLETED|Overall Study||20
6443961|NCT01116986|7359505|FG019|COMPLETED|Overall Study||13
6443962|NCT01116986|7359506|FG020|COMPLETED|Overall Study||22
6443963|NCT01116986|7359507|FG021|COMPLETED|Overall Study||18
6443964|NCT01116986|7359508|FG022|COMPLETED|Overall Study||19
6443965|NCT01116986|7359509|FG023|COMPLETED|Overall Study||19
6443966|NCT01116986|7359510|FG024|COMPLETED|Overall Study||15
6443967|NCT01116986|7359511|FG025|COMPLETED|Overall Study||19
6443968|NCT01116986|7359512|FG026|COMPLETED|Overall Study||14
6443969|NCT01116986|7359513|FG027|COMPLETED|Overall Study||18
6443970|NCT01116986|7359514|FG028|COMPLETED|Overall Study||17
6443971|NCT01116986|7359515|FG029|COMPLETED|Overall Study||17
6443972|NCT01116986|7359516|FG030|COMPLETED|Overall Study||16
6443973|NCT01116986|7359517|FG031|COMPLETED|Overall Study||14
6443974|NCT01116986|7359486|FG000|NOT COMPLETED|Overall Study||2
6443975|NCT01116986|7359487|FG001|NOT COMPLETED|Overall Study||3
6443976|NCT01116986|7359488|FG002|NOT COMPLETED|Overall Study||2
6443977|NCT01116986|7359489|FG003|NOT COMPLETED|Overall Study||2
6443978|NCT01116986|7359490|FG004|NOT COMPLETED|Overall Study||4
6443979|NCT01116986|7359491|FG005|NOT COMPLETED|Overall Study||2
6443980|NCT01116986|7359492|FG006|NOT COMPLETED|Overall Study||2
6443981|NCT01116986|7359493|FG007|NOT COMPLETED|Overall Study||2
6443982|NCT01116986|7359494|FG008|NOT COMPLETED|Overall Study||1
6443983|NCT01116986|7359495|FG009|NOT COMPLETED|Overall Study||4
6443984|NCT01116986|7359496|FG010|NOT COMPLETED|Overall Study||1
6443985|NCT01116986|7359497|FG011|NOT COMPLETED|Overall Study||0
6443986|NCT01116986|7359498|FG012|NOT COMPLETED|Overall Study||1
6443987|NCT01116986|7359499|FG013|NOT COMPLETED|Overall Study||3
6443988|NCT01116986|7359500|FG014|NOT COMPLETED|Overall Study||0
6443989|NCT01116986|7359501|FG015|NOT COMPLETED|Overall Study||6
6443990|NCT01116986|7359502|FG016|NOT COMPLETED|Overall Study||3
6443991|NCT01116986|7359503|FG017|NOT COMPLETED|Overall Study||5
6443992|NCT01116986|7359504|FG018|NOT COMPLETED|Overall Study||3
6443993|NCT01116986|7359505|FG019|NOT COMPLETED|Overall Study||2
6443994|NCT01116986|7359506|FG020|NOT COMPLETED|Overall Study||2
6443995|NCT01116986|7359507|FG021|NOT COMPLETED|Overall Study||2
6443996|NCT01116986|7359508|FG022|NOT COMPLETED|Overall Study||4
6443997|NCT01116986|7359509|FG023|NOT COMPLETED|Overall Study||2
6443998|NCT01116986|7359510|FG024|NOT COMPLETED|Overall Study||3
6443999|NCT01116986|7359511|FG025|NOT COMPLETED|Overall Study||0
6444000|NCT01116986|7359512|FG026|NOT COMPLETED|Overall Study||4
6444001|NCT01116986|7359513|FG027|NOT COMPLETED|Overall Study||1
6444002|NCT01116986|7359514|FG028|NOT COMPLETED|Overall Study||0
6444003|NCT01116986|7359515|FG029|NOT COMPLETED|Overall Study||0
6444004|NCT01116986|7359516|FG030|NOT COMPLETED|Overall Study||1
6444005|NCT01116986|7359517|FG031|NOT COMPLETED|Overall Study||3
6444006|NCT01117012|7359539|FG000|STARTED|Overall Study||89
6444007|NCT01117012|7359540|FG001|STARTED|Overall Study||103
6444008|NCT01117012|7359539|FG000|COMPLETED|Overall Study||81
6444009|NCT01117012|7359540|FG001|COMPLETED|Overall Study||98
6444010|NCT01117012|7359539|FG000|NOT COMPLETED|Overall Study||8
6444011|NCT01117012|7359540|FG001|NOT COMPLETED|Overall Study||5
6444012|NCT01117051|7359548|FG000|STARTED|Overall Study||86
6444013|NCT01117051|7359549|FG001|STARTED|Overall Study||88
6444014|NCT01117051|7359548|FG000|COMPLETED|Overall Study||73
6444015|NCT01117051|7359549|FG001|COMPLETED|Overall Study||77
6444016|NCT01117051|7359548|FG000|NOT COMPLETED|Overall Study||13
6444017|NCT01117051|7359549|FG001|NOT COMPLETED|Overall Study||11
6444018|NCT01117090|7359556|FG000|STARTED|Overall Study||47
6444019|NCT01117090|7359556|FG000|COMPLETED|Overall Study||47
6444020|NCT01117090|7359556|FG000|NOT COMPLETED|Overall Study||0
6444021|NCT01117181|7359569|FG000|STARTED|Overall Study||29
6444022|NCT01117181|7359570|FG001|STARTED|Overall Study||31
6444023|NCT01117181|7359569|FG000|COMPLETED|Overall Study||28
6444024|NCT01117181|7359570|FG001|COMPLETED|Overall Study||29
6444025|NCT01117181|7359569|FG000|NOT COMPLETED|Overall Study||1
6444026|NCT01117181|7359570|FG001|NOT COMPLETED|Overall Study||2
6444027|NCT01117311|7359578|FG000|STARTED|Lead-in Mixed Meal 1||3
6444028|NCT01117311|7359579|FG001|STARTED|Lead-in Mixed Meal 1||4
6444029|NCT01117311|7359578|FG000|COMPLETED|Lead-in Mixed Meal 1||3
6444030|NCT01117311|7359579|FG001|COMPLETED|Lead-in Mixed Meal 1||4
6444031|NCT01117311|7359578|FG000|NOT COMPLETED|Lead-in Mixed Meal 1||0
6444032|NCT01117311|7359579|FG001|NOT COMPLETED|Lead-in Mixed Meal 1||0
6444033|NCT01117311|7359578|FG000|STARTED|First Intervention - Mixed Meal 2||3
6444034|NCT01117311|7359579|FG001|STARTED|First Intervention - Mixed Meal 2||4
6444035|NCT01117311|7359578|FG000|COMPLETED|First Intervention - Mixed Meal 2||3
6444036|NCT01117311|7359579|FG001|COMPLETED|First Intervention - Mixed Meal 2||4
6444037|NCT01117311|7359578|FG000|NOT COMPLETED|First Intervention - Mixed Meal 2||0
6444038|NCT01117311|7359579|FG001|NOT COMPLETED|First Intervention - Mixed Meal 2||0
6444039|NCT01117311|7359578|FG000|STARTED|Second Intervention - Mixed Meal 3||3
6444040|NCT01117311|7359579|FG001|STARTED|Second Intervention - Mixed Meal 3||4
6444041|NCT01117311|7359578|FG000|COMPLETED|Second Intervention - Mixed Meal 3||3
6444042|NCT01117311|7359579|FG001|COMPLETED|Second Intervention - Mixed Meal 3||4
6444043|NCT01117311|7359578|FG000|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
6444044|NCT01117311|7359579|FG001|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
6444045|NCT01117337|7359587|FG000|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
6444046|NCT01117337|7359588|FG001|STARTED|Overall Study||52
6444047|NCT01117337|7359587|FG000|Underwent Surgery|Overall Study|52 patients underwent surgery|52
6444048|NCT01117337|7359588|FG001|Underwent Surgery|Overall Study||52
6444049|NCT01117337|7359587|FG000|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
6444050|NCT01117337|7359588|FG001|COMPLETED|Overall Study||52
6444051|NCT01117337|7359587|FG000|NOT COMPLETED|Overall Study||4
6444052|NCT01117337|7359588|FG001|NOT COMPLETED|Overall Study||0
6444053|NCT01117350|7359596|FG000|STARTED|Comparative Period|STARTED: randomized|489
6444054|NCT01117350|7359597|FG001|STARTED|Comparative Period||489
6444055|NCT01117350|7359596|FG000|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
6444056|NCT01117350|7359597|FG001|TREATED = Safety Population|Comparative Period||481
6444057|NCT01117350|7359596|FG000|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
6444058|NCT01117350|7359597|FG001|mITT Population|Comparative Period||470
6444059|NCT01117350|7359596|FG000|COMPLETED|Comparative Period||447
6444060|NCT01117350|7359597|FG001|COMPLETED|Comparative Period||414
6444061|NCT01117350|7359596|FG000|NOT COMPLETED|Comparative Period||42
6444062|NCT01117350|7359597|FG001|NOT COMPLETED|Comparative Period||75
6444063|NCT01117350|7359596|FG000|STARTED|Extension Period||0
6444064|NCT01117350|7359597|FG001|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
6444065|NCT01117350|7359596|FG000|TREATED = Safety Population (Extension)|Extension Period||0
6444066|NCT01117350|7359597|FG001|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
6444067|NCT01117350|7359596|FG000|mITT Population (Extension)|Extension Period||0
6444068|NCT01117350|7359597|FG001|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
6444069|NCT01117350|7359596|FG000|COMPLETED|Extension Period||0
6444070|NCT01117350|7359597|FG001|COMPLETED|Extension Period||147
6444071|NCT01117350|7359596|FG000|NOT COMPLETED|Extension Period||0
6444072|NCT01117350|7359597|FG001|NOT COMPLETED|Extension Period||63
6444073|NCT01117428|7359612|FG000|STARTED|Overall Study|"0.4 mg/kg=1~0.75 mg/kg=1~1.5 mg/kg=3~3 mg/kg=3~6 mg/kg=3~9 mg/kg=6~12 mg/kg=3"|20
6444074|NCT01117428|7359613|FG001|STARTED|Overall Study||29
6444075|NCT01117428|7359614|FG002|STARTED|Overall Study||13
6444076|NCT01117428|7359615|FG003|STARTED|Overall Study||12
6444077|NCT01117428|7359616|FG004|STARTED|Overall Study||17
6444078|NCT01117428|7359617|FG005|STARTED|Overall Study||20
6444079|NCT01117428|7359612|FG000|COMPLETED|Overall Study||0
6444080|NCT01117428|7359613|FG001|COMPLETED|Overall Study||0
6444081|NCT01117428|7359614|FG002|COMPLETED|Overall Study||0
6444082|NCT01117428|7359615|FG003|COMPLETED|Overall Study||0
6444083|NCT01117428|7359616|FG004|COMPLETED|Overall Study||0
6444084|NCT01117428|7359617|FG005|COMPLETED|Overall Study||0
6444085|NCT01117428|7359612|FG000|NOT COMPLETED|Overall Study||20
6444086|NCT01117428|7359613|FG001|NOT COMPLETED|Overall Study||29
6444087|NCT01117428|7359614|FG002|NOT COMPLETED|Overall Study||13
6444088|NCT01117428|7359615|FG003|NOT COMPLETED|Overall Study||12
6444089|NCT01117428|7359616|FG004|NOT COMPLETED|Overall Study||17
6444090|NCT01117428|7359617|FG005|NOT COMPLETED|Overall Study||20
6444091|NCT01117454|7359635|FG000|STARTED|Overall Study||6
6444092|NCT01117454|7359636|FG001|STARTED|Overall Study||8
6444093|NCT01117454|7359635|FG000|COMPLETED|Overall Study||6
6444094|NCT01117454|7359636|FG001|COMPLETED|Overall Study||7
6444095|NCT01117454|7359635|FG000|NOT COMPLETED|Overall Study||0
6444096|NCT01117454|7359636|FG001|NOT COMPLETED|Overall Study||1
6444097|NCT01117480|7359642|FG000|STARTED|Overall Study||1013
6444098|NCT01117480|7359642|FG000|COMPLETED|Overall Study||985
6444099|NCT01117480|7359642|FG000|NOT COMPLETED|Overall Study||28
6444100|NCT01117623|7359654|FG000|STARTED|Overall Study||3
6444101|NCT01117623|7359655|FG001|STARTED|Overall Study||8
6444102|NCT01117623|7359656|FG002|STARTED|Overall Study||11
6444103|NCT01117623|7359657|FG003|STARTED|Overall Study||6
6444104|NCT01117623|7359658|FG004|STARTED|Overall Study||10
6444105|NCT01117623|7359659|FG005|STARTED|Overall Study||16
6444106|NCT01117623|7359660|FG006|STARTED|Overall Study||6
6444107|NCT01117623|7359661|FG007|STARTED|Overall Study||26
6553074|NCT01741350|7475551|FG000|COMPLETED|12-Month Follow-up Assessment||111
6553075|NCT01741350|7475552|FG001|COMPLETED|12-Month Follow-up Assessment||109
6553076|NCT01741350|7475551|FG000|NOT COMPLETED|12-Month Follow-up Assessment||3
6553077|NCT01741350|7475552|FG001|NOT COMPLETED|12-Month Follow-up Assessment||2
6553078|NCT01741454|7475562|FG000|STARTED|Overall Study||49
6553079|NCT01741454|7475563|FG001|STARTED|Overall Study||50
6553080|NCT01741454|7475564|FG002|STARTED|Overall Study||39
6444108|NCT01117623|7359654|FG000|ITT Efficacy Analysis Population|Overall Study||3
6444109|NCT01117623|7359655|FG001|ITT Efficacy Analysis Population|Overall Study||8
6444110|NCT01117623|7359656|FG002|ITT Efficacy Analysis Population|Overall Study||11
6444111|NCT01117623|7359657|FG003|ITT Efficacy Analysis Population|Overall Study||5
6444112|NCT01117623|7359658|FG004|ITT Efficacy Analysis Population|Overall Study||10
6444113|NCT01117623|7359659|FG005|ITT Efficacy Analysis Population|Overall Study||16
6444114|NCT01117623|7359660|FG006|ITT Efficacy Analysis Population|Overall Study||6
6444115|NCT01117623|7359661|FG007|ITT Efficacy Analysis Population|Overall Study||22
6444116|NCT01117623|7359654|FG000|PK Population|Overall Study||3
6553081|NCT01741454|7475565|FG003|STARTED|Overall Study||43
6444117|NCT01117623|7359655|FG001|PK Population|Overall Study||8
6444118|NCT01117623|7359656|FG002|PK Population|Overall Study||10
6444119|NCT01117623|7359657|FG003|PK Population|Overall Study||6
6444120|NCT01117623|7359658|FG004|PK Population|Overall Study||10
6444121|NCT01117623|7359659|FG005|PK Population|Overall Study||14
6444122|NCT01117623|7359660|FG006|PK Population|Overall Study||6
6444123|NCT01117623|7359661|FG007|PK Population|Overall Study||24
6444124|NCT01117623|7359654|FG000|COMPLETED|Overall Study||0
6444125|NCT01117623|7359655|FG001|COMPLETED|Overall Study||0
6444126|NCT01117623|7359656|FG002|COMPLETED|Overall Study||0
6444127|NCT01117623|7359657|FG003|COMPLETED|Overall Study||0
6444128|NCT01117623|7359658|FG004|COMPLETED|Overall Study||0
6444129|NCT01117623|7359659|FG005|COMPLETED|Overall Study||0
6444130|NCT01117623|7359660|FG006|COMPLETED|Overall Study||0
6444131|NCT01117623|7359661|FG007|COMPLETED|Overall Study||0
6444132|NCT01117623|7359654|FG000|NOT COMPLETED|Overall Study||3
6444133|NCT01117623|7359655|FG001|NOT COMPLETED|Overall Study||8
6444134|NCT01117623|7359656|FG002|NOT COMPLETED|Overall Study||11
6444135|NCT01117623|7359657|FG003|NOT COMPLETED|Overall Study||6
6444136|NCT01117623|7359658|FG004|NOT COMPLETED|Overall Study||10
6444137|NCT01117623|7359659|FG005|NOT COMPLETED|Overall Study||16
6444138|NCT01117623|7359660|FG006|NOT COMPLETED|Overall Study||6
6444139|NCT01117623|7359661|FG007|NOT COMPLETED|Overall Study||26
6444140|NCT01117727|7359681|FG000|STARTED|Overall Study||1
6444141|NCT01117727|7359681|FG000|COMPLETED|Overall Study||1
6444142|NCT01117727|7359681|FG000|NOT COMPLETED|Overall Study||0
6444143|NCT01117766|7359686|FG000|STARTED|First Intervention||14
6444144|NCT01117766|7359687|FG001|STARTED|First Intervention||17
6444145|NCT01117766|7359686|FG000|Received Treatment|First Intervention||14
6444146|NCT01117766|7359687|FG001|Received Treatment|First Intervention||17
6444147|NCT01117766|7359686|FG000|COMPLETED|First Intervention||13
6444148|NCT01117766|7359687|FG001|COMPLETED|First Intervention||16
6444149|NCT01117766|7359686|FG000|NOT COMPLETED|First Intervention||1
6444150|NCT01117766|7359687|FG001|NOT COMPLETED|First Intervention||1
6444151|NCT01117766|7359686|FG000|STARTED|Washout Period||13
6444152|NCT01117766|7359687|FG001|STARTED|Washout Period||16
6444153|NCT01117766|7359686|FG000|COMPLETED|Washout Period||13
6444154|NCT01117766|7359687|FG001|COMPLETED|Washout Period||14
6444155|NCT01117766|7359686|FG000|NOT COMPLETED|Washout Period||0
6444156|NCT01117766|7359687|FG001|NOT COMPLETED|Washout Period||2
6444157|NCT01117766|7359686|FG000|STARTED|Second Intervention||13
6444158|NCT01117766|7359687|FG001|STARTED|Second Intervention||14
6444159|NCT01117766|7359686|FG000|COMPLETED|Second Intervention||11
6444160|NCT01117766|7359687|FG001|COMPLETED|Second Intervention||9
6444161|NCT01117766|7359686|FG000|NOT COMPLETED|Second Intervention||2
6444162|NCT01117766|7359687|FG001|NOT COMPLETED|Second Intervention||5
6444163|NCT01117792|7359693|FG000|STARTED|Overall Study||55
6444164|NCT01117792|7359693|FG000|COMPLETED|Overall Study||51
6444165|NCT01117792|7359693|FG000|NOT COMPLETED|Overall Study||4
6444166|NCT01117857|7359697|FG000|STARTED|Overall Study||22
6444167|NCT01117857|7359697|FG000|COMPLETED|Overall Study||13
6444168|NCT01117857|7359697|FG000|NOT COMPLETED|Overall Study||9
6444169|NCT01117870|7359703|FG000|STARTED|Overall Study||15
6444170|NCT01117870|7359704|FG001|STARTED|Overall Study||16
6444171|NCT01117870|7359703|FG000|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
6444172|NCT01117870|7359704|FG001|COMPLETED|Overall Study||16
6444173|NCT01117870|7359703|FG000|NOT COMPLETED|Overall Study||1
6444174|NCT01117870|7359704|FG001|NOT COMPLETED|Overall Study||0
6444175|NCT01117948|7359716|FG000|STARTED|Double Blind||111
6444176|NCT01117948|7359717|FG001|STARTED|Double Blind||108
6444177|NCT01117948|7359716|FG000|COMPLETED|Double Blind||93
6444178|NCT01117948|7359717|FG001|COMPLETED|Double Blind||98
6444179|NCT01117948|7359716|FG000|NOT COMPLETED|Double Blind||18
6444180|NCT01117948|7359717|FG001|NOT COMPLETED|Double Blind||10
6444181|NCT01117948|7359716|FG000|STARTED|Open Label||93
6444182|NCT01117948|7359717|FG001|STARTED|Open Label||98
6444183|NCT01117948|7359716|FG000|COMPLETED|Open Label||41
6444184|NCT01117948|7359717|FG001|COMPLETED|Open Label||51
6444185|NCT01117948|7359716|FG000|NOT COMPLETED|Open Label||52
6444186|NCT01117948|7359717|FG001|NOT COMPLETED|Open Label||47
6444187|NCT01117987|7359725|FG000|STARTED|Overall Study||66
6444188|NCT01117987|7359726|FG001|STARTED|Overall Study||78
6444189|NCT01117987|7359725|FG000|COMPLETED|Overall Study||5
6444190|NCT01117987|7359726|FG001|COMPLETED|Overall Study||4
6444191|NCT01117987|7359725|FG000|NOT COMPLETED|Overall Study||61
6444192|NCT01117987|7359726|FG001|NOT COMPLETED|Overall Study||74
6444193|NCT01118052|7359732|FG000|STARTED|Overall Study||22
6444194|NCT01118052|7359732|FG000|COMPLETED|Overall Study||20
6444195|NCT01118052|7359732|FG000|NOT COMPLETED|Overall Study||2
6444196|NCT01118091|7359744|FG000|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
6444197|NCT01118091|7359745|FG001|STARTED|Overall Study||5
6444198|NCT01118091|7359744|FG000|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
6444199|NCT01118091|7359745|FG001|COMPLETED|Overall Study||5
6444200|NCT01118091|7359744|FG000|NOT COMPLETED|Overall Study||0
6444201|NCT01118091|7359745|FG001|NOT COMPLETED|Overall Study||0
6444202|NCT01118117|7359753|FG000|STARTED|Overall Study||261
6444203|NCT01118117|7359754|FG001|STARTED|Overall Study||15
6444204|NCT01118117|7359753|FG000|COMPLETED|Overall Study||240
6444205|NCT01118117|7359754|FG001|COMPLETED|Overall Study||15
6444206|NCT01118117|7359753|FG000|NOT COMPLETED|Overall Study||21
6444207|NCT01118117|7359754|FG001|NOT COMPLETED|Overall Study||0
6444208|NCT01118143|7359762|FG000|STARTED|Overall Study||64
6444209|NCT01118143|7359763|FG001|STARTED|Overall Study||69
6444210|NCT01118143|7359762|FG000|COMPLETED|Overall Study||62
6444211|NCT01118143|7359763|FG001|COMPLETED|Overall Study||64
6444212|NCT01118143|7359762|FG000|NOT COMPLETED|Overall Study||2
6444213|NCT01118143|7359763|FG001|NOT COMPLETED|Overall Study||5
6444214|NCT01118221|7359773|FG000|STARTED|Overall Study||14
6444215|NCT01118221|7359774|FG001|STARTED|Overall Study||11
6444216|NCT01118221|7359773|FG000|COMPLETED|Overall Study||11
6444217|NCT01118221|7359774|FG001|COMPLETED|Overall Study||10
6444218|NCT01118221|7359773|FG000|NOT COMPLETED|Overall Study||3
6444219|NCT01118221|7359774|FG001|NOT COMPLETED|Overall Study||1
6444220|NCT01118273|7359790|FG000|STARTED|Overall Study||27
6444221|NCT01118273|7359791|FG001|STARTED|Overall Study||27
6444222|NCT01118273|7359792|FG002|STARTED|Overall Study||27
6444223|NCT01118273|7359793|FG003|STARTED|Overall Study||27
6444224|NCT01118273|7359794|FG004|STARTED|Overall Study||27
6444225|NCT01118273|7359795|FG005|STARTED|Overall Study||27
6444226|NCT01118273|7359790|FG000|COMPLETED|Overall Study||27
6444227|NCT01118273|7359791|FG001|COMPLETED|Overall Study||27
6444228|NCT01118273|7359792|FG002|COMPLETED|Overall Study||27
6305705|NCT01927419|7209054|FG001|COMPLETED|Pre-Treatment Period||46
6305706|NCT01927419|7209053|FG000|NOT COMPLETED|Pre-Treatment Period||1
6305707|NCT01927419|7209054|FG001|NOT COMPLETED|Pre-Treatment Period||1
6444229|NCT01118273|7359793|FG003|COMPLETED|Overall Study||27
6444230|NCT01118273|7359794|FG004|COMPLETED|Overall Study||27
6444231|NCT01118273|7359795|FG005|COMPLETED|Overall Study||27
6444232|NCT01118273|7359790|FG000|NOT COMPLETED|Overall Study||0
6444233|NCT01118273|7359791|FG001|NOT COMPLETED|Overall Study||0
6444234|NCT01118273|7359792|FG002|NOT COMPLETED|Overall Study||0
6444235|NCT01118273|7359793|FG003|NOT COMPLETED|Overall Study||0
6444236|NCT01118273|7359794|FG004|NOT COMPLETED|Overall Study||0
6444237|NCT01118273|7359795|FG005|NOT COMPLETED|Overall Study||0
6444238|NCT01118299|7359811|FG000|STARTED|Overall Study||68
6444239|NCT01118299|7359812|FG001|STARTED|Overall Study||29
6444240|NCT01118299|7359811|FG000|COMPLETED|Overall Study||45
6444241|NCT01118299|7359812|FG001|COMPLETED|Overall Study||0
6444242|NCT01118299|7359811|FG000|NOT COMPLETED|Overall Study||23
6444243|NCT01118299|7359812|FG001|NOT COMPLETED|Overall Study||29
6444244|NCT01118312|7359819|FG000|STARTED|Overall Study||189
6444245|NCT01118312|7359820|FG001|STARTED|Overall Study||199
6444246|NCT01118312|7359819|FG000|COMPLETED|Overall Study||155
6444247|NCT01118312|7359820|FG001|COMPLETED|Overall Study||164
6444248|NCT01118312|7359819|FG000|NOT COMPLETED|Overall Study||34
6444249|NCT01118312|7359820|FG001|NOT COMPLETED|Overall Study||35
6444250|NCT01118325|7359829|FG000|STARTED|Overall Study||50
6444251|NCT01118325|7359830|FG001|STARTED|Overall Study||43
6444252|NCT01118325|7359831|FG002|STARTED|Overall Study||46
6444253|NCT01118325|7359829|FG000|COMPLETED|Overall Study||49
6444254|NCT01118325|7359830|FG001|COMPLETED|Overall Study||43
6444255|NCT01118325|7359831|FG002|COMPLETED|Overall Study||45
6444256|NCT01118325|7359829|FG000|NOT COMPLETED|Overall Study||1
6444257|NCT01118325|7359830|FG001|NOT COMPLETED|Overall Study||0
6444258|NCT01118325|7359831|FG002|NOT COMPLETED|Overall Study||1
6444259|NCT01118338|7359854|FG000|STARTED|Overall Study||185
6444260|NCT01118338|7359855|FG001|STARTED|Overall Study||183
6444261|NCT01118338|7359854|FG000|COMPLETED|Overall Study||182
6444262|NCT01118338|7359855|FG001|COMPLETED|Overall Study||174
6444263|NCT01118338|7359854|FG000|NOT COMPLETED|Overall Study||3
6444264|NCT01118338|7359855|FG001|NOT COMPLETED|Overall Study||9
6444265|NCT01118351|7359861|FG000|STARTED|Overall Study||19
6444266|NCT01118351|7359861|FG000|COMPLETED|Overall Study||15
6444267|NCT01118351|7359861|FG000|NOT COMPLETED|Overall Study||4
6444268|NCT01118377|7359865|FG000|STARTED|Overall Study||45
6444269|NCT01118377|7359865|FG000|COMPLETED|Overall Study||3
6444270|NCT01118377|7359865|FG000|NOT COMPLETED|Overall Study||42
6444271|NCT01118455|7359871|FG000|STARTED|Baseline [Visits 1 & 2]||66
6444272|NCT01118455|7359872|FG001|STARTED|Baseline [Visits 1 & 2]||69
6444273|NCT01118455|7359871|FG000|Actual Patients Treated|Baseline [Visits 1 & 2]||65
6444274|NCT01118455|7359872|FG001|Actual Patients Treated|Baseline [Visits 1 & 2]||69
6444275|NCT01118455|7359871|FG000|COMPLETED|Baseline [Visits 1 & 2]||65
6444276|NCT01118455|7359872|FG001|COMPLETED|Baseline [Visits 1 & 2]||69
6444277|NCT01118455|7359871|FG000|NOT COMPLETED|Baseline [Visits 1 & 2]||1
6444278|NCT01118455|7359872|FG001|NOT COMPLETED|Baseline [Visits 1 & 2]||0
6444279|NCT01118455|7359871|FG000|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
6444280|NCT01118455|7359872|FG001|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
6553082|NCT01741454|7475562|FG000|COMPLETED|Overall Study||36
6553083|NCT01741454|7475563|FG001|COMPLETED|Overall Study||44
6553084|NCT01741454|7475564|FG002|COMPLETED|Overall Study||22
6553085|NCT01741454|7475565|FG003|COMPLETED|Overall Study||21
6553086|NCT01741454|7475562|FG000|NOT COMPLETED|Overall Study||13
6553087|NCT01741454|7475563|FG001|NOT COMPLETED|Overall Study||6
6444281|NCT01118455|7359871|FG000|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
6444282|NCT01118455|7359872|FG001|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
6444283|NCT01118455|7359871|FG000|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
6444284|NCT01118455|7359872|FG001|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
6444285|NCT01118520|7359889|FG000|STARTED|Overall Study||73
6444286|NCT01118520|7359890|FG001|STARTED|Overall Study||72
6444287|NCT01118520|7359891|FG002|STARTED|Overall Study||79
6444288|NCT01118520|7359889|FG000|COMPLETED|Overall Study||53
6553088|NCT01741454|7475564|FG002|NOT COMPLETED|Overall Study||17
6553089|NCT01741454|7475565|FG003|NOT COMPLETED|Overall Study||22
6444289|NCT01118520|7359890|FG001|COMPLETED|Overall Study||49
6444290|NCT01118520|7359891|FG002|COMPLETED|Overall Study||59
6444291|NCT01118520|7359889|FG000|NOT COMPLETED|Overall Study||20
6444292|NCT01118520|7359890|FG001|NOT COMPLETED|Overall Study||23
6444293|NCT01118520|7359891|FG002|NOT COMPLETED|Overall Study||20
6444294|NCT01118624|7359899|FG000|STARTED|Overall Study||22
6444295|NCT01118624|7359899|FG000|COMPLETED|Overall Study||0
6444296|NCT01118624|7359899|FG000|NOT COMPLETED|Overall Study||22
6444297|NCT01118663|7359905|FG000|STARTED|Overall Study||7
6444298|NCT01118663|7359906|FG001|STARTED|Overall Study||10
6444299|NCT01118663|7359905|FG000|COMPLETED|Overall Study||5
6444300|NCT01118663|7359906|FG001|COMPLETED|Overall Study||8
6444301|NCT01118663|7359905|FG000|NOT COMPLETED|Overall Study||2
6444302|NCT01118663|7359906|FG001|NOT COMPLETED|Overall Study||2
6444303|NCT01118715|7359914|FG000|STARTED|Overall Study||68
6444304|NCT01118715|7359915|FG001|STARTED|Overall Study||60
6444305|NCT01118715|7359914|FG000|COMPLETED|Overall Study||68
6444306|NCT01118715|7359915|FG001|COMPLETED|Overall Study||60
6444307|NCT01118715|7359914|FG000|NOT COMPLETED|Overall Study||0
6444308|NCT01118715|7359915|FG001|NOT COMPLETED|Overall Study||0
6444309|NCT01118728|7359942|FG000|STARTED|Overall Study||223
6444310|NCT01118728|7359942|FG000|COMPLETED|Overall Study||0
6444311|NCT01118728|7359942|FG000|NOT COMPLETED|Overall Study||223
6444312|NCT01118741|7359948|FG000|STARTED|Overall Study||9
6444313|NCT01118741|7359949|FG001|STARTED|Overall Study||10
6444314|NCT01118741|7359948|FG000|COMPLETED|Overall Study||9
6444315|NCT01118741|7359949|FG001|COMPLETED|Overall Study||10
6444316|NCT01118741|7359948|FG000|NOT COMPLETED|Overall Study||0
6444317|NCT01118741|7359949|FG001|NOT COMPLETED|Overall Study||0
6444318|NCT01118780|7359959|FG000|STARTED|Overall Study||151
6444319|NCT01118780|7359960|FG001|STARTED|Overall Study||140
6444320|NCT01118780|7359959|FG000|COMPLETED|Overall Study||115
6444321|NCT01118780|7359960|FG001|COMPLETED|Overall Study||105
6444322|NCT01118780|7359959|FG000|NOT COMPLETED|Overall Study||36
6444323|NCT01118780|7359960|FG001|NOT COMPLETED|Overall Study||35
6444324|NCT01118845|7359969|FG000|STARTED|Overall Study||59
6444325|NCT01118845|7359969|FG000|COMPLETED|Overall Study||17
6444326|NCT01118845|7359969|FG000|NOT COMPLETED|Overall Study||42
6444327|NCT01118949|7359973|FG000|STARTED|Overall Study||49
6444328|NCT01118949|7359973|FG000|COMPLETED|Overall Study||40
6444329|NCT01118949|7359973|FG000|NOT COMPLETED|Overall Study||9
6444330|NCT01118962|7359977|FG000|STARTED|Overall Study||39
6553090|NCT01741480|7475581|FG000|STARTED|Overall Study||285
6553091|NCT01741480|7475582|FG001|STARTED|Overall Study||286
6444331|NCT01118962|7359977|FG000|COMPLETED|Overall Study||29
6444332|NCT01118962|7359977|FG000|NOT COMPLETED|Overall Study||10
6444333|NCT01118975|7359983|FG000|STARTED|Overall Study||9
6444334|NCT01118975|7359984|FG001|STARTED|Overall Study||3
6444335|NCT01118975|7359983|FG000|COMPLETED|Overall Study||9
6444336|NCT01118975|7359984|FG001|COMPLETED|Overall Study||2
6444337|NCT01118975|7359983|FG000|NOT COMPLETED|Overall Study||0
6444338|NCT01118975|7359984|FG001|NOT COMPLETED|Overall Study||1
6444339|NCT01118988|7359993|FG000|STARTED|Overall Study||16
6444340|NCT01118988|7359994|FG001|STARTED|Overall Study||4
6444341|NCT01118988|7359995|FG002|STARTED|Overall Study||7
6444342|NCT01118988|7359993|FG000|COMPLETED|Overall Study||11
6444343|NCT01118988|7359994|FG001|COMPLETED|Overall Study||3
6444344|NCT01118988|7359995|FG002|COMPLETED|Overall Study||3
6444345|NCT01118988|7359993|FG000|NOT COMPLETED|Overall Study||5
6444346|NCT01118988|7359994|FG001|NOT COMPLETED|Overall Study||1
6444347|NCT01118988|7359995|FG002|NOT COMPLETED|Overall Study||4
6444348|NCT01119001|7360002|FG000|STARTED|Overall Study||13
6444349|NCT01119001|7360002|FG000|COMPLETED|Overall Study||11
6444350|NCT01119001|7360002|FG000|NOT COMPLETED|Overall Study||2
6444351|NCT01119040|7360008|FG000|STARTED|Overall Study||1
6444352|NCT01119040|7360008|FG000|COMPLETED|Overall Study||0
6444353|NCT01119040|7360008|FG000|NOT COMPLETED|Overall Study||1
6444354|NCT01119105|7360015|FG000|STARTED|Overall Study||70
6444355|NCT01119105|7360016|FG001|STARTED|Overall Study||72
6444356|NCT01119105|7360017|FG002|STARTED|Overall Study||68
6444357|NCT01119105|7360015|FG000|COMPLETED|Overall Study||66
6444358|NCT01119105|7360016|FG001|COMPLETED|Overall Study||66
6444359|NCT01119105|7360017|FG002|COMPLETED|Overall Study||60
6444360|NCT01119105|7360015|FG000|NOT COMPLETED|Overall Study||4
6444361|NCT01119105|7360016|FG001|NOT COMPLETED|Overall Study||6
6444362|NCT01119105|7360017|FG002|NOT COMPLETED|Overall Study||8
6444363|NCT01119118|7360025|FG000|STARTED|Overall Study||6
6444364|NCT01119118|7360025|FG000|COMPLETED|Overall Study||5
6444365|NCT01119118|7360025|FG000|NOT COMPLETED|Overall Study||1
6444366|NCT01119131|7360032|FG000|STARTED|Overall Study||10
6444367|NCT01119131|7360033|FG001|STARTED|Overall Study||28
6444368|NCT01119131|7360034|FG002|STARTED|Overall Study||30
6444369|NCT01119131|7360032|FG000|COMPLETED|Overall Study||8
6444370|NCT01119131|7360033|FG001|COMPLETED|Overall Study||27
6444371|NCT01119131|7360034|FG002|COMPLETED|Overall Study||24
6444372|NCT01119131|7360032|FG000|NOT COMPLETED|Overall Study||2
6444373|NCT01119131|7360033|FG001|NOT COMPLETED|Overall Study||1
6444374|NCT01119131|7360034|FG002|NOT COMPLETED|Overall Study||6
6444375|NCT01119222|7360042|FG000|STARTED|Overall Study||5
6444376|NCT01119222|7360043|FG001|STARTED|Overall Study||5
6444377|NCT01119222|7360044|FG002|STARTED|Overall Study||5
6444378|NCT01119222|7360045|FG003|STARTED|Overall Study||4
6444379|NCT01119222|7360042|FG000|COMPLETED|Overall Study||5
6444380|NCT01119222|7360043|FG001|COMPLETED|Overall Study||5
6444381|NCT01119222|7360044|FG002|COMPLETED|Overall Study||5
6444382|NCT01119222|7360045|FG003|COMPLETED|Overall Study||4
6444383|NCT01119222|7360042|FG000|NOT COMPLETED|Overall Study||0
6444384|NCT01119222|7360043|FG001|NOT COMPLETED|Overall Study||0
6444385|NCT01119222|7360044|FG002|NOT COMPLETED|Overall Study||0
6444386|NCT01119222|7360045|FG003|NOT COMPLETED|Overall Study||0
6444387|NCT01119248|7360058|FG000|STARTED|Overall Study||120
6444388|NCT01119248|7360058|FG000|COMPLETED|Overall Study||115
6444389|NCT01119248|7360058|FG000|NOT COMPLETED|Overall Study||5
6444390|NCT01119287|7360069|FG000|STARTED|Overall Study||26
6444391|NCT01119287|7360070|FG001|STARTED|Overall Study||24
6444392|NCT01119287|7360071|FG002|STARTED|Overall Study||26
6444393|NCT01119287|7360072|FG003|STARTED|Overall Study||31
6444394|NCT01119287|7360073|FG004|STARTED|Overall Study||31
6444395|NCT01119287|7360074|FG005|STARTED|Overall Study||32
6444396|NCT01119287|7360069|FG000|COMPLETED|Overall Study||26
6444397|NCT01119287|7360070|FG001|COMPLETED|Overall Study||24
6444398|NCT01119287|7360071|FG002|COMPLETED|Overall Study||24
6444399|NCT01119287|7360072|FG003|COMPLETED|Overall Study||29
6444400|NCT01119287|7360073|FG004|COMPLETED|Overall Study||30
6444401|NCT01119287|7360074|FG005|COMPLETED|Overall Study||32
6444402|NCT01119287|7360069|FG000|NOT COMPLETED|Overall Study||0
6444403|NCT01119287|7360070|FG001|NOT COMPLETED|Overall Study||0
6444404|NCT01119287|7360071|FG002|NOT COMPLETED|Overall Study||2
6444405|NCT01119287|7360072|FG003|NOT COMPLETED|Overall Study||2
6444406|NCT01119287|7360073|FG004|NOT COMPLETED|Overall Study||1
6444407|NCT01119287|7360074|FG005|NOT COMPLETED|Overall Study||0
6444408|NCT01119443|7360088|FG000|STARTED|Up-titration Period (10 Days)||14
6444409|NCT01119443|7360089|FG001|STARTED|Up-titration Period (10 Days)||14
6444410|NCT01119443|7360088|FG000|COMPLETED|Up-titration Period (10 Days)||14
6444411|NCT01119443|7360089|FG001|COMPLETED|Up-titration Period (10 Days)||14
6444412|NCT01119443|7360088|FG000|NOT COMPLETED|Up-titration Period (10 Days)||0
6444413|NCT01119443|7360089|FG001|NOT COMPLETED|Up-titration Period (10 Days)||0
6444414|NCT01119443|7360088|FG000|STARTED|Crossover Period 1 (5 Days)||14
6444415|NCT01119443|7360089|FG001|STARTED|Crossover Period 1 (5 Days)||14
6444416|NCT01119443|7360088|FG000|COMPLETED|Crossover Period 1 (5 Days)||14
6444417|NCT01119443|7360089|FG001|COMPLETED|Crossover Period 1 (5 Days)||13
6444418|NCT01119443|7360088|FG000|NOT COMPLETED|Crossover Period 1 (5 Days)||0
6444419|NCT01119443|7360089|FG001|NOT COMPLETED|Crossover Period 1 (5 Days)||1
6444420|NCT01119443|7360088|FG000|STARTED|Crossover Period 2 (5 Days)||14
6444421|NCT01119443|7360089|FG001|STARTED|Crossover Period 2 (5 Days)||13
6444422|NCT01119443|7360088|FG000|COMPLETED|Crossover Period 2 (5 Days)||14
6444423|NCT01119443|7360089|FG001|COMPLETED|Crossover Period 2 (5 Days)||13
6444424|NCT01119443|7360088|FG000|NOT COMPLETED|Crossover Period 2 (5 Days)||0
6444425|NCT01119443|7360089|FG001|NOT COMPLETED|Crossover Period 2 (5 Days)||0
6444426|NCT01119443|7360088|FG000|STARTED|Crossover Period 3 (5 Days)||14
6444427|NCT01119443|7360089|FG001|STARTED|Crossover Period 3 (5 Days)||13
6444428|NCT01119443|7360088|FG000|COMPLETED|Crossover Period 3 (5 Days)||14
6444429|NCT01119443|7360089|FG001|COMPLETED|Crossover Period 3 (5 Days)||13
6444430|NCT01119443|7360088|FG000|NOT COMPLETED|Crossover Period 3 (5 Days)||0
6444431|NCT01119443|7360089|FG001|NOT COMPLETED|Crossover Period 3 (5 Days)||0
6444432|NCT01119443|7360088|FG000|STARTED|Crossover Period 4 (5 Days)||14
6444433|NCT01119443|7360089|FG001|STARTED|Crossover Period 4 (5 Days)||13
6444434|NCT01119443|7360088|FG000|COMPLETED|Crossover Period 4 (5 Days)||14
6444435|NCT01119443|7360089|FG001|COMPLETED|Crossover Period 4 (5 Days)||13
6444436|NCT01119443|7360088|FG000|NOT COMPLETED|Crossover Period 4 (5 Days)||0
6444437|NCT01119443|7360089|FG001|NOT COMPLETED|Crossover Period 4 (5 Days)||0
6444438|NCT01119443|7360088|FG000|STARTED|Down-titration Period (1 Day)||14
6444439|NCT01119443|7360089|FG001|STARTED|Down-titration Period (1 Day)||13
6444440|NCT01119443|7360088|FG000|COMPLETED|Down-titration Period (1 Day)||14
6444441|NCT01119443|7360089|FG001|COMPLETED|Down-titration Period (1 Day)||13
6444442|NCT01119443|7360088|FG000|NOT COMPLETED|Down-titration Period (1 Day)||0
6444443|NCT01119443|7360089|FG001|NOT COMPLETED|Down-titration Period (1 Day)||0
6444444|NCT01119443|7360088|FG000|STARTED|End of Study (All Patients)||14
6444445|NCT01119443|7360089|FG001|STARTED|End of Study (All Patients)||14
6444446|NCT01119443|7360088|FG000|COMPLETED|End of Study (All Patients)||14
6444447|NCT01119443|7360089|FG001|COMPLETED|End of Study (All Patients)||14
6444448|NCT01119443|7360088|FG000|NOT COMPLETED|End of Study (All Patients)||0
6444449|NCT01119443|7360089|FG001|NOT COMPLETED|End of Study (All Patients)||0
6444450|NCT01119456|7360106|FG000|STARTED|Overall Study||7
6444451|NCT01119456|7360107|FG001|STARTED|Overall Study||3
6444452|NCT01119456|7360108|FG002|STARTED|Overall Study||3
6444453|NCT01119456|7360109|FG003|STARTED|Overall Study||13
6444454|NCT01119456|7360110|FG004|STARTED|Overall Study||4
6444455|NCT01119456|7360111|FG005|STARTED|Overall Study||3
6444456|NCT01119456|7360112|FG006|STARTED|Overall Study||3
6444457|NCT01119456|7360113|FG007|STARTED|Overall Study||3
6444458|NCT01119456|7360106|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
6444459|NCT01119456|7360107|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6444460|NCT01119456|7360108|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6444461|NCT01119456|7360109|FG003|Received at Least 1 Dose of Study Drug|Overall Study||13
6444462|NCT01119456|7360110|FG004|Received at Least 1 Dose of Study Drug|Overall Study||4
6444463|NCT01119456|7360111|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
6444464|NCT01119456|7360112|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
6444465|NCT01119456|7360113|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
6444466|NCT01119456|7360106|FG000|COMPLETED|Overall Study||7
6444467|NCT01119456|7360107|FG001|COMPLETED|Overall Study||3
6444468|NCT01119456|7360108|FG002|COMPLETED|Overall Study||3
6444469|NCT01119456|7360109|FG003|COMPLETED|Overall Study||13
6444470|NCT01119456|7360110|FG004|COMPLETED|Overall Study||4
6444471|NCT01119456|7360111|FG005|COMPLETED|Overall Study||3
6444472|NCT01119456|7360112|FG006|COMPLETED|Overall Study||3
6444473|NCT01119456|7360113|FG007|COMPLETED|Overall Study||3
6444474|NCT01119456|7360106|FG000|NOT COMPLETED|Overall Study||0
6444475|NCT01119456|7360107|FG001|NOT COMPLETED|Overall Study||0
6444476|NCT01119456|7360108|FG002|NOT COMPLETED|Overall Study||0
6444477|NCT01119456|7360109|FG003|NOT COMPLETED|Overall Study||0
6444478|NCT01119456|7360110|FG004|NOT COMPLETED|Overall Study||0
6444479|NCT01119456|7360111|FG005|NOT COMPLETED|Overall Study||0
6444480|NCT01119456|7360112|FG006|NOT COMPLETED|Overall Study||0
6444481|NCT01119456|7360113|FG007|NOT COMPLETED|Overall Study||0
6444482|NCT01119508|7360138|FG000|STARTED|Overall Study||64
6444483|NCT01119508|7360138|FG000|Received Four Induction Doses|Overall Study||45
6444484|NCT01119508|7360138|FG000|Received Fifth Consolidation Dose week12|Overall Study||32
6444485|NCT01119508|7360138|FG000|COMPLETED|Overall Study||5
6444486|NCT01119508|7360138|FG000|NOT COMPLETED|Overall Study||59
6444487|NCT01119625|7360144|FG000|STARTED|Overall Study||118
6444488|NCT01119625|7360145|FG001|STARTED|Overall Study||120
6444489|NCT01119625|7360144|FG000|COMPLETED|Overall Study||115
6444490|NCT01119625|7360145|FG001|COMPLETED|Overall Study||116
6444491|NCT01119625|7360144|FG000|NOT COMPLETED|Overall Study||3
6444492|NCT01119625|7360145|FG001|NOT COMPLETED|Overall Study||4
6444493|NCT01119703|7360153|FG000|STARTED|Overall Study||30
6444494|NCT01119703|7360154|FG001|STARTED|Overall Study||144
6444495|NCT01119703|7360153|FG000|COMPLETED|Overall Study||30
6444496|NCT01119703|7360154|FG001|COMPLETED|Overall Study||143
6444497|NCT01119703|7360153|FG000|NOT COMPLETED|Overall Study||0
6444498|NCT01119703|7360154|FG001|NOT COMPLETED|Overall Study||1
6444499|NCT01119716|7360159|FG000|STARTED|Overall Study||4658
6444500|NCT01119716|7360159|FG000|COMPLETED|Overall Study||4658
6444501|NCT01119716|7360159|FG000|NOT COMPLETED|Overall Study||0
6444502|NCT01119755|7360167|FG000|STARTED|Overall Study||80
6444503|NCT01119755|7360167|FG000|COMPLETED|Overall Study||80
6444504|NCT01119755|7360167|FG000|NOT COMPLETED|Overall Study||0
6444505|NCT01119768|7360173|FG000|STARTED|Treatment Period||154
6444506|NCT01119768|7360174|FG001|STARTED|Treatment Period||151
6444507|NCT01119768|7360173|FG000|COMPLETED|Treatment Period||136
6444508|NCT01119768|7360174|FG001|COMPLETED|Treatment Period||126
6444509|NCT01119768|7360173|FG000|NOT COMPLETED|Treatment Period||18
6444510|NCT01119768|7360174|FG001|NOT COMPLETED|Treatment Period||25
6444511|NCT01119768|7360173|FG000|STARTED|Follow-up||136
6444512|NCT01119768|7360174|FG001|STARTED|Follow-up||124
6444513|NCT01119768|7360173|FG000|COMPLETED|Follow-up||135
6444514|NCT01119768|7360174|FG001|COMPLETED|Follow-up||122
6444515|NCT01119768|7360173|FG000|NOT COMPLETED|Follow-up||1
6444516|NCT01119768|7360174|FG001|NOT COMPLETED|Follow-up||2
6444517|NCT01119794|7360180|FG000|STARTED|Overall Study||10
6444518|NCT01119794|7360180|FG000|COMPLETED|Overall Study||10
6444519|NCT01119794|7360180|FG000|NOT COMPLETED|Overall Study||0
6444520|NCT01119846|7360187|FG000|STARTED|Overall Study||13
6444521|NCT01119846|7360188|FG001|STARTED|Overall Study||4
6444522|NCT01119846|7360189|FG002|STARTED|Overall Study||83
6444523|NCT01119846|7360187|FG000|COMPLETED|Overall Study||11
6444524|NCT01119846|7360188|FG001|COMPLETED|Overall Study||4
6444525|NCT01119846|7360189|FG002|COMPLETED|Overall Study||72
6444526|NCT01119846|7360187|FG000|NOT COMPLETED|Overall Study||2
6444527|NCT01119846|7360188|FG001|NOT COMPLETED|Overall Study||0
6444528|NCT01119846|7360189|FG002|NOT COMPLETED|Overall Study||11
6444529|NCT01119859|7360226|FG000|STARTED|Overall Study||163
6444530|NCT01119859|7360227|FG001|STARTED|Overall Study||163
6444531|NCT01119859|7360226|FG000|COMPLETED|Overall Study||139
6444532|NCT01119859|7360227|FG001|COMPLETED|Overall Study||133
6444533|NCT01119859|7360226|FG000|NOT COMPLETED|Overall Study||24
6444534|NCT01119859|7360227|FG001|NOT COMPLETED|Overall Study||30
6444535|NCT01119898|7360235|FG000|STARTED|Overall Study||131
6553092|NCT01741480|7475581|FG000|COMPLETED|Overall Study||285
6553093|NCT01741480|7475582|FG001|COMPLETED|Overall Study||286
6553094|NCT01741480|7475581|FG000|NOT COMPLETED|Overall Study||0
6553095|NCT01741480|7475582|FG001|NOT COMPLETED|Overall Study||0
6444536|NCT01119898|7360236|FG001|STARTED|Overall Study||129
6444537|NCT01119898|7360235|FG000|Received Study Drug (mITT)|Overall Study||130
6444538|NCT01119898|7360236|FG001|Received Study Drug (mITT)|Overall Study||129
6444539|NCT01119898|7360235|FG000|COMPLETED|Overall Study||123
6444540|NCT01119898|7360236|FG001|COMPLETED|Overall Study||117
6444541|NCT01119898|7360235|FG000|NOT COMPLETED|Overall Study||8
6444542|NCT01119898|7360236|FG001|NOT COMPLETED|Overall Study||12
6444543|NCT01119937|7360244|FG000|STARTED|Overall Study||123
6553096|NCT01741532|7475590|FG000|STARTED|Overall Study||59
6444544|NCT01119937|7360245|FG001|STARTED|Overall Study||40
6444545|NCT01119937|7360244|FG000|COMPLETED|Overall Study||104
6444546|NCT01119937|7360245|FG001|COMPLETED|Overall Study||33
6444547|NCT01119937|7360244|FG000|NOT COMPLETED|Overall Study||19
6444548|NCT01119937|7360245|FG001|NOT COMPLETED|Overall Study||7
6444549|NCT01119950|7360251|FG000|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
6444550|NCT01119950|7360251|FG000|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
6444551|NCT01119950|7360251|FG000|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
6444552|NCT01119950|7360251|FG000|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
6444553|NCT01119950|7360251|FG000|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
6444554|NCT01119950|7360251|FG000|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
6444555|NCT01119950|7360251|FG000|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
6444556|NCT01119950|7360251|FG000|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
6444557|NCT01119950|7360251|FG000|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
6444558|NCT01119950|7360251|FG000|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
6444559|NCT01119950|7360251|FG000|NOT COMPLETED|Overall Study||47
6444560|NCT01119963|7360279|FG000|STARTED|Overall Study||74
6444561|NCT01119963|7360280|FG001|STARTED|Overall Study||78
6444562|NCT01119963|7360279|FG000|COMPLETED|Overall Study||73
6444563|NCT01119963|7360280|FG001|COMPLETED|Overall Study||77
6444564|NCT01119963|7360279|FG000|NOT COMPLETED|Overall Study||1
6444565|NCT01119963|7360280|FG001|NOT COMPLETED|Overall Study||1
6444566|NCT01120028|7360292|FG000|STARTED|Period 1: Alemtuzumab or Basiliximab||426
6444567|NCT01120028|7360293|FG001|STARTED|Period 1: Alemtuzumab or Basiliximab||426
6444568|NCT01120028|7360294|FG002|STARTED|Period 1: Alemtuzumab or Basiliximab||0
6444569|NCT01120028|7360295|FG003|STARTED|Period 1: Alemtuzumab or Basiliximab||0
6444570|NCT01120028|7360292|FG000|COMPLETED|Period 1: Alemtuzumab or Basiliximab||412
6444571|NCT01120028|7360293|FG001|COMPLETED|Period 1: Alemtuzumab or Basiliximab||403
6444572|NCT01120028|7360294|FG002|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
6444573|NCT01120028|7360295|FG003|COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
6444574|NCT01120028|7360292|FG000|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||14
6444575|NCT01120028|7360293|FG001|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||23
6444576|NCT01120028|7360294|FG002|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
6444577|NCT01120028|7360295|FG003|NOT COMPLETED|Period 1: Alemtuzumab or Basiliximab||0
6444578|NCT01120028|7360292|FG000|STARTED|Period 2: Tacrolimus or Sirolimus||0
6444579|NCT01120028|7360293|FG001|STARTED|Period 2: Tacrolimus or Sirolimus||0
6444580|NCT01120028|7360294|FG002|STARTED|Period 2: Tacrolimus or Sirolimus||197
6444581|NCT01120028|7360295|FG003|STARTED|Period 2: Tacrolimus or Sirolimus||197
6444582|NCT01120028|7360292|FG000|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6444583|NCT01120028|7360293|FG001|COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6444584|NCT01120028|7360294|FG002|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
6444585|NCT01120028|7360295|FG003|COMPLETED|Period 2: Tacrolimus or Sirolimus||197
6444586|NCT01120028|7360292|FG000|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6444587|NCT01120028|7360293|FG001|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6444588|NCT01120028|7360294|FG002|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6444589|NCT01120028|7360295|FG003|NOT COMPLETED|Period 2: Tacrolimus or Sirolimus||0
6444590|NCT01120067|7360308|FG000|STARTED|Overall Study||12
6444591|NCT01120067|7360309|FG001|STARTED|Overall Study||11
6444592|NCT01120067|7360308|FG000|COMPLETED|Overall Study||7
6444593|NCT01120067|7360309|FG001|COMPLETED|Overall Study||10
6444594|NCT01120067|7360308|FG000|NOT COMPLETED|Overall Study||5
6444595|NCT01120067|7360309|FG001|NOT COMPLETED|Overall Study||1
6444596|NCT01120093|7360315|FG000|STARTED|Treatment Period 1||18
6444597|NCT01120093|7360316|FG001|STARTED|Treatment Period 1||14
6444598|NCT01120093|7360317|FG002|STARTED|Treatment Period 1||17
6444599|NCT01120093|7360318|FG003|STARTED|Treatment Period 1||14
6444600|NCT01120093|7360319|FG004|STARTED|Treatment Period 1||16
6444601|NCT01120093|7360315|FG000|COMPLETED|Treatment Period 1||18
6444602|NCT01120093|7360316|FG001|COMPLETED|Treatment Period 1||13
6444603|NCT01120093|7360317|FG002|COMPLETED|Treatment Period 1||16
6444604|NCT01120093|7360318|FG003|COMPLETED|Treatment Period 1||14
6444605|NCT01120093|7360319|FG004|COMPLETED|Treatment Period 1||15
6444606|NCT01120093|7360315|FG000|NOT COMPLETED|Treatment Period 1||0
6444607|NCT01120093|7360316|FG001|NOT COMPLETED|Treatment Period 1||1
6444608|NCT01120093|7360317|FG002|NOT COMPLETED|Treatment Period 1||1
6444609|NCT01120093|7360318|FG003|NOT COMPLETED|Treatment Period 1||0
6444610|NCT01120093|7360319|FG004|NOT COMPLETED|Treatment Period 1||1
6444611|NCT01120093|7360315|FG000|STARTED|Treatment Period 2||18
6444612|NCT01120093|7360316|FG001|STARTED|Treatment Period 2||13
6444613|NCT01120093|7360317|FG002|STARTED|Treatment Period 2||16
6444614|NCT01120093|7360318|FG003|STARTED|Treatment Period 2||14
6444615|NCT01120093|7360319|FG004|STARTED|Treatment Period 2||15
6444616|NCT01120093|7360315|FG000|COMPLETED|Treatment Period 2||18
6444617|NCT01120093|7360316|FG001|COMPLETED|Treatment Period 2||13
6444618|NCT01120093|7360317|FG002|COMPLETED|Treatment Period 2||16
6444619|NCT01120093|7360318|FG003|COMPLETED|Treatment Period 2||13
6444620|NCT01120093|7360319|FG004|COMPLETED|Treatment Period 2||14
6444621|NCT01120093|7360315|FG000|NOT COMPLETED|Treatment Period 2||0
6444622|NCT01120093|7360316|FG001|NOT COMPLETED|Treatment Period 2||0
6444623|NCT01120093|7360317|FG002|NOT COMPLETED|Treatment Period 2||0
6444624|NCT01120093|7360318|FG003|NOT COMPLETED|Treatment Period 2||1
6444625|NCT01120093|7360319|FG004|NOT COMPLETED|Treatment Period 2||1
6444626|NCT01120093|7360315|FG000|STARTED|Treatment Period 3||18
6444627|NCT01120093|7360316|FG001|STARTED|Treatment Period 3||13
6444628|NCT01120093|7360317|FG002|STARTED|Treatment Period 3||16
6444629|NCT01120093|7360318|FG003|STARTED|Treatment Period 3||13
6444630|NCT01120093|7360319|FG004|STARTED|Treatment Period 3||14
6444631|NCT01120093|7360315|FG000|COMPLETED|Treatment Period 3||18
6444632|NCT01120093|7360316|FG001|COMPLETED|Treatment Period 3||13
6444633|NCT01120093|7360317|FG002|COMPLETED|Treatment Period 3||15
6444634|NCT01120093|7360318|FG003|COMPLETED|Treatment Period 3||12
6444635|NCT01120093|7360319|FG004|COMPLETED|Treatment Period 3||13
6444636|NCT01120093|7360315|FG000|NOT COMPLETED|Treatment Period 3||0
6444637|NCT01120093|7360316|FG001|NOT COMPLETED|Treatment Period 3||0
6444638|NCT01120093|7360317|FG002|NOT COMPLETED|Treatment Period 3||1
6444639|NCT01120093|7360318|FG003|NOT COMPLETED|Treatment Period 3||1
6444640|NCT01120093|7360319|FG004|NOT COMPLETED|Treatment Period 3||1
6444641|NCT01120093|7360315|FG000|STARTED|Treatment Period 4||18
6444642|NCT01120093|7360316|FG001|STARTED|Treatment Period 4||13
6444643|NCT01120093|7360317|FG002|STARTED|Treatment Period 4||15
6444644|NCT01120093|7360318|FG003|STARTED|Treatment Period 4||12
6444645|NCT01120093|7360319|FG004|STARTED|Treatment Period 4||13
6444646|NCT01120093|7360315|FG000|COMPLETED|Treatment Period 4||17
6444647|NCT01120093|7360316|FG001|COMPLETED|Treatment Period 4||13
6444648|NCT01120093|7360317|FG002|COMPLETED|Treatment Period 4||15
6444649|NCT01120093|7360318|FG003|COMPLETED|Treatment Period 4||12
6444650|NCT01120093|7360319|FG004|COMPLETED|Treatment Period 4||13
6444651|NCT01120093|7360315|FG000|NOT COMPLETED|Treatment Period 4||1
6444652|NCT01120093|7360316|FG001|NOT COMPLETED|Treatment Period 4||0
6444653|NCT01120093|7360317|FG002|NOT COMPLETED|Treatment Period 4||0
6444654|NCT01120093|7360318|FG003|NOT COMPLETED|Treatment Period 4||0
6444655|NCT01120093|7360319|FG004|NOT COMPLETED|Treatment Period 4||0
6444656|NCT01120093|7360315|FG000|STARTED|Treatment Period 5||17
6444657|NCT01120093|7360316|FG001|STARTED|Treatment Period 5||13
6444658|NCT01120093|7360317|FG002|STARTED|Treatment Period 5||15
6444659|NCT01120093|7360318|FG003|STARTED|Treatment Period 5||12
6444660|NCT01120093|7360319|FG004|STARTED|Treatment Period 5||13
6444661|NCT01120093|7360315|FG000|COMPLETED|Treatment Period 5||17
6444662|NCT01120093|7360316|FG001|COMPLETED|Treatment Period 5||12
6444663|NCT01120093|7360317|FG002|COMPLETED|Treatment Period 5||15
6444664|NCT01120093|7360318|FG003|COMPLETED|Treatment Period 5||11
6444665|NCT01120093|7360319|FG004|COMPLETED|Treatment Period 5||13
6444666|NCT01120093|7360315|FG000|NOT COMPLETED|Treatment Period 5||0
6444667|NCT01120093|7360316|FG001|NOT COMPLETED|Treatment Period 5||1
6444668|NCT01120093|7360317|FG002|NOT COMPLETED|Treatment Period 5||0
6444669|NCT01120093|7360318|FG003|NOT COMPLETED|Treatment Period 5||1
6444670|NCT01120093|7360319|FG004|NOT COMPLETED|Treatment Period 5||0
6444671|NCT01120184|7360334|FG000|STARTED|Overall Study||365
6444672|NCT01120184|7360335|FG001|STARTED|Overall Study||367
6444673|NCT01120184|7360336|FG002|STARTED|Overall Study||363
6444674|NCT01120184|7360334|FG000|Treated|Overall Study||355
6444675|NCT01120184|7360335|FG001|Treated|Overall Study||365
6444676|NCT01120184|7360336|FG002|Treated|Overall Study||360
6444677|NCT01120184|7360334|FG000|COMPLETED|Overall Study||0
6444678|NCT01120184|7360335|FG001|COMPLETED|Overall Study||0
6444679|NCT01120184|7360336|FG002|COMPLETED|Overall Study||0
6444680|NCT01120184|7360334|FG000|NOT COMPLETED|Overall Study||365
6444681|NCT01120184|7360335|FG001|NOT COMPLETED|Overall Study||367
6444682|NCT01120184|7360336|FG002|NOT COMPLETED|Overall Study||363
6444683|NCT01120197|7360346|FG000|STARTED|Overall Study||47
6444684|NCT01120197|7360347|FG001|STARTED|Overall Study||42
6444685|NCT01120197|7360346|FG000|COMPLETED|Overall Study||38
6444686|NCT01120197|7360347|FG001|COMPLETED|Overall Study||32
6444687|NCT01120197|7360346|FG000|NOT COMPLETED|Overall Study||9
6444688|NCT01120197|7360347|FG001|NOT COMPLETED|Overall Study||10
6444689|NCT01120210|7360356|FG000|STARTED|MAIN INFUSION||16
6444690|NCT01120210|7360357|FG001|STARTED|MAIN INFUSION||46
6444691|NCT01120210|7360356|FG000|COMPLETED|MAIN INFUSION||15
6444692|NCT01120210|7360357|FG001|COMPLETED|MAIN INFUSION||45
6444693|NCT01120210|7360356|FG000|NOT COMPLETED|MAIN INFUSION||1
6444694|NCT01120210|7360357|FG001|NOT COMPLETED|MAIN INFUSION||1
6444695|NCT01120210|7360356|FG000|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
6444696|NCT01120210|7360357|FG001|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
6444697|NCT01120210|7360356|FG000|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
6444698|NCT01120210|7360357|FG001|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
6444699|NCT01120210|7360356|FG000|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
6444700|NCT01120210|7360357|FG001|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
6444701|NCT01120223|7360363|FG000|STARTED|Overall Study||78
6444702|NCT01120223|7360363|FG000|COMPLETED|Overall Study||74
6444703|NCT01120223|7360363|FG000|NOT COMPLETED|Overall Study||4
6444704|NCT01120236|7360369|FG000|STARTED|Overall Study||105
6444705|NCT01120236|7360370|FG001|STARTED|Overall Study||106
6444706|NCT01120236|7360369|FG000|Ineligble|Overall Study||0
6444707|NCT01120236|7360370|FG001|Ineligble|Overall Study|Patient ineligible due to no demonstable radiographic metastasis and is excluded from all analyses.|1
6444708|NCT01120236|7360369|FG000|COMPLETED|Overall Study||105
6444709|NCT01120236|7360370|FG001|COMPLETED|Overall Study||105
6444710|NCT01120236|7360369|FG000|NOT COMPLETED|Overall Study||0
6444711|NCT01120236|7360370|FG001|NOT COMPLETED|Overall Study||1
6444712|NCT01120275|7360384|FG000|STARTED|Overall Study||36
6444713|NCT01120275|7360384|FG000|Eligible and Treated|Overall Study||32
6444714|NCT01120275|7360384|FG000|COMPLETED|Overall Study||0
6444715|NCT01120275|7360384|FG000|NOT COMPLETED|Overall Study||36
6444716|NCT01120379|7360389|FG000|STARTED|One Year Timepoint||5020
6444717|NCT01120379|7360389|FG000|COMPLETED|One Year Timepoint||4742
6444718|NCT01120379|7360389|FG000|NOT COMPLETED|One Year Timepoint||278
6444719|NCT01120379|7360389|FG000|STARTED|Two Year Timepoint||4742
6444720|NCT01120379|7360389|FG000|COMPLETED|Two Year Timepoint||4505
6444721|NCT01120379|7360389|FG000|NOT COMPLETED|Two Year Timepoint||237
6444722|NCT01120379|7360389|FG000|STARTED|Three Year Timepoint||4505
6444723|NCT01120379|7360389|FG000|COMPLETED|Three Year Timepoint||4291
6444724|NCT01120379|7360389|FG000|NOT COMPLETED|Three Year Timepoint||214
6444725|NCT01120379|7360389|FG000|STARTED|Four Year Timepoint||4291
6444726|NCT01120379|7360389|FG000|COMPLETED|Four Year Timepoint||3923
6444727|NCT01120379|7360389|FG000|NOT COMPLETED|Four Year Timepoint||368
6444728|NCT01120405|7360395|FG000|STARTED|Overall Study||298
6444729|NCT01120405|7360396|FG001|STARTED|Overall Study||302
6444730|NCT01120405|7360395|FG000|COMPLETED|Overall Study||271
6444731|NCT01120405|7360396|FG001|COMPLETED|Overall Study||269
6444732|NCT01120405|7360395|FG000|NOT COMPLETED|Overall Study||27
6444733|NCT01120405|7360396|FG001|NOT COMPLETED|Overall Study||33
6444734|NCT01120600|7360406|FG000|STARTED|Overall Study||147
6444735|NCT01120600|7360407|FG001|STARTED|Overall Study||147
6444736|NCT01120600|7360406|FG000|Treated|Overall Study||146
6444737|NCT01120600|7360407|FG001|Treated|Overall Study||146
6444738|NCT01120600|7360406|FG000|COMPLETED|Overall Study||128
6444739|NCT01120600|7360407|FG001|COMPLETED|Overall Study||115
6444740|NCT01120600|7360406|FG000|NOT COMPLETED|Overall Study||19
6444741|NCT01120600|7360407|FG001|NOT COMPLETED|Overall Study||32
6500201|NCT01424293|7419034|FG000|STARTED|Overall Study||7
6553097|NCT01741532|7475591|FG001|STARTED|Overall Study||30
6553098|NCT01741532|7475590|FG000|Exposed|Overall Study||58
6553099|NCT01741532|7475591|FG001|Exposed|Overall Study||30
6553100|NCT01741532|7475590|FG000|Provided Post-baseline Efficacy Data|Overall Study||58
6553101|NCT01741532|7475591|FG001|Provided Post-baseline Efficacy Data|Overall Study||28
6553102|NCT01741532|7475590|FG000|COMPLETED|Overall Study||49
6553103|NCT01741532|7475591|FG001|COMPLETED|Overall Study||27
6553104|NCT01741532|7475590|FG000|NOT COMPLETED|Overall Study||10
6553105|NCT01741532|7475591|FG001|NOT COMPLETED|Overall Study||3
6500202|NCT01424293|7419034|FG000|COMPLETED|Overall Study||7
6500203|NCT01424293|7419034|FG000|NOT COMPLETED|Overall Study||0
6500204|NCT01424306|7419038|FG000|STARTED|Overall Study||4
6500205|NCT01424306|7419039|FG001|STARTED|Overall Study||4
6500206|NCT01424306|7419040|FG002|STARTED|Overall Study||3
6500207|NCT01424306|7419041|FG003|STARTED|Overall Study||3
6500208|NCT01424306|7419042|FG004|STARTED|Overall Study||5
6500209|NCT01424306|7419043|FG005|STARTED|Overall Study||6
6500210|NCT01424306|7419038|FG000|COMPLETED|Overall Study||4
6500211|NCT01424306|7419039|FG001|COMPLETED|Overall Study||4
6500212|NCT01424306|7419040|FG002|COMPLETED|Overall Study||3
6500213|NCT01424306|7419041|FG003|COMPLETED|Overall Study||3
6500214|NCT01424306|7419042|FG004|COMPLETED|Overall Study||4
6500215|NCT01424306|7419043|FG005|COMPLETED|Overall Study||6
6500216|NCT01424306|7419038|FG000|NOT COMPLETED|Overall Study||0
6500217|NCT01424306|7419039|FG001|NOT COMPLETED|Overall Study||0
6500218|NCT01424306|7419040|FG002|NOT COMPLETED|Overall Study||0
6500219|NCT01424306|7419041|FG003|NOT COMPLETED|Overall Study||0
6500220|NCT01424306|7419042|FG004|NOT COMPLETED|Overall Study||1
6500221|NCT01424306|7419043|FG005|NOT COMPLETED|Overall Study||0
6500222|NCT01424397|7419087|FG000|STARTED|Period-1 (8 Days)||7
6500223|NCT01424397|7419088|FG001|STARTED|Period-1 (8 Days)||8
6500224|NCT01424397|7419089|FG002|STARTED|Period-1 (8 Days)||8
6500225|NCT01424397|7419090|FG003|STARTED|Period-1 (8 Days)||8
6500226|NCT01424397|7419091|FG004|STARTED|Period-1 (8 Days)||8
6500227|NCT01424397|7419092|FG005|STARTED|Period-1 (8 Days)||8
6500228|NCT01424397|7419093|FG006|STARTED|Period-1 (8 Days)||4
6500229|NCT01424397|7419094|FG007|STARTED|Period-1 (8 Days)||4
6500230|NCT01424397|7419095|FG008|STARTED|Period-1 (8 Days)||4
6500231|NCT01424397|7419096|FG009|STARTED|Period-1 (8 Days)||3
6500232|NCT01424397|7419097|FG010|STARTED|Period-1 (8 Days)||4
6500233|NCT01424397|7419098|FG011|STARTED|Period-1 (8 Days)||4
6500234|NCT01424397|7419087|FG000|COMPLETED|Period-1 (8 Days)||7
6500235|NCT01424397|7419088|FG001|COMPLETED|Period-1 (8 Days)||8
6500236|NCT01424397|7419089|FG002|COMPLETED|Period-1 (8 Days)||8
6500237|NCT01424397|7419090|FG003|COMPLETED|Period-1 (8 Days)||8
6500238|NCT01424397|7419091|FG004|COMPLETED|Period-1 (8 Days)||8
6500239|NCT01424397|7419092|FG005|COMPLETED|Period-1 (8 Days)||8
6500240|NCT01424397|7419093|FG006|COMPLETED|Period-1 (8 Days)||4
6500241|NCT01424397|7419094|FG007|COMPLETED|Period-1 (8 Days)||4
6500242|NCT01424397|7419095|FG008|COMPLETED|Period-1 (8 Days)||4
6500243|NCT01424397|7419096|FG009|COMPLETED|Period-1 (8 Days)||3
6553106|NCT01741545|7475603|FG000|STARTED|Treatment Period||12
6553107|NCT01741545|7475604|FG001|STARTED|Treatment Period||39
6553108|NCT01741545|7475603|FG000|COMPLETED|Treatment Period||11
6553109|NCT01741545|7475604|FG001|COMPLETED|Treatment Period||35
6500244|NCT01424397|7419097|FG010|COMPLETED|Period-1 (8 Days)||4
6500245|NCT01424397|7419098|FG011|COMPLETED|Period-1 (8 Days)||4
6500246|NCT01424397|7419087|FG000|NOT COMPLETED|Period-1 (8 Days)||0
6500247|NCT01424397|7419088|FG001|NOT COMPLETED|Period-1 (8 Days)||0
6500248|NCT01424397|7419089|FG002|NOT COMPLETED|Period-1 (8 Days)||0
6500249|NCT01424397|7419090|FG003|NOT COMPLETED|Period-1 (8 Days)||0
6500250|NCT01424397|7419091|FG004|NOT COMPLETED|Period-1 (8 Days)||0
6500251|NCT01424397|7419092|FG005|NOT COMPLETED|Period-1 (8 Days)||0
6500252|NCT01424397|7419093|FG006|NOT COMPLETED|Period-1 (8 Days)||0
6444742|NCT01120626|7360415|FG000|STARTED|Overall Study||20
6444743|NCT01120626|7360416|FG001|STARTED|Overall Study||22
6444744|NCT01120626|7360415|FG000|COMPLETED|Overall Study||19
6444745|NCT01120626|7360416|FG001|COMPLETED|Overall Study||22
6444746|NCT01120626|7360415|FG000|NOT COMPLETED|Overall Study||1
6444747|NCT01120626|7360416|FG001|NOT COMPLETED|Overall Study||0
6444748|NCT01120639|7360426|FG000|STARTED|Overall Study||6
6444749|NCT01120639|7360427|FG001|STARTED|Overall Study||6
6444750|NCT01120639|7360428|FG002|STARTED|Overall Study||6
6444751|NCT01120639|7360429|FG003|STARTED|Overall Study||12
6444752|NCT01120639|7360426|FG000|COMPLETED|Overall Study||6
6444753|NCT01120639|7360427|FG001|COMPLETED|Overall Study||6
6444754|NCT01120639|7360428|FG002|COMPLETED|Overall Study||6
6444755|NCT01120639|7360429|FG003|COMPLETED|Overall Study||12
6444756|NCT01120639|7360426|FG000|NOT COMPLETED|Overall Study||0
6444757|NCT01120639|7360427|FG001|NOT COMPLETED|Overall Study||0
6444758|NCT01120639|7360428|FG002|NOT COMPLETED|Overall Study||0
6444759|NCT01120639|7360429|FG003|NOT COMPLETED|Overall Study||0
6444760|NCT01120691|7360442|FG000|STARTED|Overall Study||741
6444761|NCT01120691|7360443|FG001|STARTED|Overall Study||741
6444762|NCT01120691|7360444|FG002|STARTED|Overall Study||742
6444763|NCT01120691|7360442|FG000|Full Analysis Set (FAS)|Overall Study||736
6444764|NCT01120691|7360443|FG001|Full Analysis Set (FAS)|Overall Study||739
6444765|NCT01120691|7360444|FG002|Full Analysis Set (FAS)|Overall Study||739
6444766|NCT01120691|7360442|FG000|Safety Set (SAF)|Overall Study||736
6444767|NCT01120691|7360443|FG001|Safety Set (SAF)|Overall Study||740
6444768|NCT01120691|7360444|FG002|Safety Set (SAF)|Overall Study||739
6444769|NCT01120691|7360442|FG000|Modified Safety Set (mSAF)|Overall Study||729
6444770|NCT01120691|7360443|FG001|Modified Safety Set (mSAF)|Overall Study||740
6444771|NCT01120691|7360444|FG002|Modified Safety Set (mSAF)|Overall Study||737
6444772|NCT01120691|7360442|FG000|Modified Full Analysis Set (mFAS)|Overall Study||729
6444773|NCT01120691|7360443|FG001|Modified Full Analysis Set (mFAS)|Overall Study||739
6444774|NCT01120691|7360444|FG002|Modified Full Analysis Set (mFAS)|Overall Study||737
6444775|NCT01120691|7360442|FG000|COMPLETED|Overall Study||570
6444776|NCT01120691|7360443|FG001|COMPLETED|Overall Study||538
6444777|NCT01120691|7360444|FG002|COMPLETED|Overall Study||559
6444778|NCT01120691|7360442|FG000|NOT COMPLETED|Overall Study||171
6444779|NCT01120691|7360443|FG001|NOT COMPLETED|Overall Study||203
6444780|NCT01120691|7360444|FG002|NOT COMPLETED|Overall Study||183
6444781|NCT01120704|7360488|FG000|STARTED|Overall Study||13
6444782|NCT01120704|7360489|FG001|STARTED|Overall Study||17
6444783|NCT01120704|7360490|FG002|STARTED|Overall Study||14
6444784|NCT01120704|7360491|FG003|STARTED|Overall Study||19
6444785|NCT01120704|7360492|FG004|STARTED|Overall Study||16
6444786|NCT01120704|7360493|FG005|STARTED|Overall Study||19
6444787|NCT01120704|7360494|FG006|STARTED|Overall Study||15
6444788|NCT01120704|7360495|FG007|STARTED|Overall Study||15
6444789|NCT01120704|7360496|FG008|STARTED|Overall Study||22
6444790|NCT01120704|7360497|FG009|STARTED|Overall Study||20
6444791|NCT01120704|7360498|FG010|STARTED|Overall Study||17
6444792|NCT01120704|7360499|FG011|STARTED|Overall Study||16
6444793|NCT01120704|7360500|FG012|STARTED|Overall Study||17
6444794|NCT01120704|7360501|FG013|STARTED|Overall Study||19
6444795|NCT01120704|7360502|FG014|STARTED|Overall Study||18
6444796|NCT01120704|7360503|FG015|STARTED|Overall Study||18
6444797|NCT01120704|7360504|FG016|STARTED|Overall Study||14
6444798|NCT01120704|7360505|FG017|STARTED|Overall Study||16
6444799|NCT01120704|7360506|FG018|STARTED|Overall Study||17
6444800|NCT01120704|7360507|FG019|STARTED|Overall Study||18
6444801|NCT01120704|7360508|FG020|STARTED|Overall Study||17
6444802|NCT01120704|7360509|FG021|STARTED|Overall Study||16
6444803|NCT01120704|7360510|FG022|STARTED|Overall Study||21
6444804|NCT01120704|7360511|FG023|STARTED|Overall Study||16
6444805|NCT01120704|7360512|FG024|STARTED|Overall Study||18
6444806|NCT01120704|7360513|FG025|STARTED|Overall Study||14
6444807|NCT01120704|7360514|FG026|STARTED|Overall Study||18
6444808|NCT01120704|7360515|FG027|STARTED|Overall Study||18
6444809|NCT01120704|7360516|FG028|STARTED|Overall Study||19
6444810|NCT01120704|7360517|FG029|STARTED|Overall Study||15
6444811|NCT01120704|7360518|FG030|STARTED|Overall Study||14
6444812|NCT01120704|7360519|FG031|STARTED|Overall Study||18
6444813|NCT01120704|7360488|FG000|COMPLETED|Overall Study||10
6444814|NCT01120704|7360489|FG001|COMPLETED|Overall Study||13
6444815|NCT01120704|7360490|FG002|COMPLETED|Overall Study||13
6444816|NCT01120704|7360491|FG003|COMPLETED|Overall Study||15
6444817|NCT01120704|7360492|FG004|COMPLETED|Overall Study||14
6444818|NCT01120704|7360493|FG005|COMPLETED|Overall Study||18
6444819|NCT01120704|7360494|FG006|COMPLETED|Overall Study||12
6444820|NCT01120704|7360495|FG007|COMPLETED|Overall Study||13
6444821|NCT01120704|7360496|FG008|COMPLETED|Overall Study||19
6444822|NCT01120704|7360497|FG009|COMPLETED|Overall Study||19
6444823|NCT01120704|7360498|FG010|COMPLETED|Overall Study||16
6444824|NCT01120704|7360499|FG011|COMPLETED|Overall Study||14
6444825|NCT01120704|7360500|FG012|COMPLETED|Overall Study||14
6444826|NCT01120704|7360501|FG013|COMPLETED|Overall Study||15
6444827|NCT01120704|7360502|FG014|COMPLETED|Overall Study||17
6444828|NCT01120704|7360503|FG015|COMPLETED|Overall Study||16
6444829|NCT01120704|7360504|FG016|COMPLETED|Overall Study||13
6444830|NCT01120704|7360505|FG017|COMPLETED|Overall Study||16
6444831|NCT01120704|7360506|FG018|COMPLETED|Overall Study||15
6444832|NCT01120704|7360507|FG019|COMPLETED|Overall Study||15
6444833|NCT01120704|7360508|FG020|COMPLETED|Overall Study||14
6444834|NCT01120704|7360509|FG021|COMPLETED|Overall Study||16
6444835|NCT01120704|7360510|FG022|COMPLETED|Overall Study||17
6444836|NCT01120704|7360511|FG023|COMPLETED|Overall Study||13
6444837|NCT01120704|7360512|FG024|COMPLETED|Overall Study||16
6444838|NCT01120704|7360513|FG025|COMPLETED|Overall Study||14
6444839|NCT01120704|7360514|FG026|COMPLETED|Overall Study||15
6444840|NCT01120704|7360515|FG027|COMPLETED|Overall Study||16
6444841|NCT01120704|7360516|FG028|COMPLETED|Overall Study||14
6444842|NCT01120704|7360517|FG029|COMPLETED|Overall Study||12
6444843|NCT01120704|7360518|FG030|COMPLETED|Overall Study||12
6444844|NCT01120704|7360519|FG031|COMPLETED|Overall Study||17
6444845|NCT01120704|7360488|FG000|NOT COMPLETED|Overall Study||3
6444846|NCT01120704|7360489|FG001|NOT COMPLETED|Overall Study||4
6444847|NCT01120704|7360490|FG002|NOT COMPLETED|Overall Study||1
6444848|NCT01120704|7360491|FG003|NOT COMPLETED|Overall Study||4
6444849|NCT01120704|7360492|FG004|NOT COMPLETED|Overall Study||2
6444850|NCT01120704|7360493|FG005|NOT COMPLETED|Overall Study||1
6444851|NCT01120704|7360494|FG006|NOT COMPLETED|Overall Study||3
6444852|NCT01120704|7360495|FG007|NOT COMPLETED|Overall Study||2
6444853|NCT01120704|7360496|FG008|NOT COMPLETED|Overall Study||3
6444854|NCT01120704|7360497|FG009|NOT COMPLETED|Overall Study||1
6444855|NCT01120704|7360498|FG010|NOT COMPLETED|Overall Study||1
6444856|NCT01120704|7360499|FG011|NOT COMPLETED|Overall Study||2
6444857|NCT01120704|7360500|FG012|NOT COMPLETED|Overall Study||3
6444858|NCT01120704|7360501|FG013|NOT COMPLETED|Overall Study||4
6444859|NCT01120704|7360502|FG014|NOT COMPLETED|Overall Study||1
6444860|NCT01120704|7360503|FG015|NOT COMPLETED|Overall Study||2
6444861|NCT01120704|7360504|FG016|NOT COMPLETED|Overall Study||1
6444862|NCT01120704|7360505|FG017|NOT COMPLETED|Overall Study||0
6444863|NCT01120704|7360506|FG018|NOT COMPLETED|Overall Study||2
6444864|NCT01120704|7360507|FG019|NOT COMPLETED|Overall Study||3
6444865|NCT01120704|7360508|FG020|NOT COMPLETED|Overall Study||3
6444866|NCT01120704|7360509|FG021|NOT COMPLETED|Overall Study||0
6444867|NCT01120704|7360510|FG022|NOT COMPLETED|Overall Study||4
6444868|NCT01120704|7360511|FG023|NOT COMPLETED|Overall Study||3
6444869|NCT01120704|7360512|FG024|NOT COMPLETED|Overall Study||2
6444870|NCT01120704|7360513|FG025|NOT COMPLETED|Overall Study||0
6444871|NCT01120704|7360514|FG026|NOT COMPLETED|Overall Study||3
6444872|NCT01120704|7360515|FG027|NOT COMPLETED|Overall Study||2
6444873|NCT01120704|7360516|FG028|NOT COMPLETED|Overall Study||5
6444874|NCT01120704|7360517|FG029|NOT COMPLETED|Overall Study||3
6444875|NCT01120704|7360518|FG030|NOT COMPLETED|Overall Study||2
6444876|NCT01120704|7360519|FG031|NOT COMPLETED|Overall Study||1
6444877|NCT01120717|7360535|FG000|STARTED|Overall Study||226
6444878|NCT01120717|7360536|FG001|STARTED|Overall Study||113
6444879|NCT01120717|7360535|FG000|Safety Population: Received Study Drug|Overall Study||225
6444880|NCT01120717|7360536|FG001|Safety Population: Received Study Drug|Overall Study||113
6444881|NCT01120717|7360535|FG000|COMPLETED|Overall Study||194
6444882|NCT01120717|7360536|FG001|COMPLETED|Overall Study||89
6444883|NCT01120717|7360535|FG000|NOT COMPLETED|Overall Study||32
6444884|NCT01120717|7360536|FG001|NOT COMPLETED|Overall Study||24
6444885|NCT01120756|7360544|FG000|STARTED|Overall Study||21
6444886|NCT01120756|7360545|FG001|STARTED|Overall Study||14
6444887|NCT01120756|7360544|FG000|COMPLETED|Overall Study||20
6444888|NCT01120756|7360545|FG001|COMPLETED|Overall Study||13
6444889|NCT01120756|7360544|FG000|NOT COMPLETED|Overall Study||1
6444890|NCT01120756|7360545|FG001|NOT COMPLETED|Overall Study||1
6444891|NCT01120782|7360551|FG000|STARTED|Overall Study||45
6444892|NCT01120782|7360551|FG000|COMPLETED|Overall Study||34
6444893|NCT01120782|7360551|FG000|NOT COMPLETED|Overall Study||11
6444894|NCT01120808|7360555|FG000|STARTED|Overall Study||136
6444895|NCT01120808|7360555|FG000|COMPLETED|Overall Study||90
6444896|NCT01120808|7360555|FG000|NOT COMPLETED|Overall Study||46
6444897|NCT01120834|7360559|FG000|STARTED|Overall Study||18
6444898|NCT01120834|7360559|FG000|COMPLETED|Overall Study||18
6444899|NCT01120834|7360559|FG000|NOT COMPLETED|Overall Study||0
6444900|NCT01120899|7360563|FG000|STARTED|Overall Study||6
6444901|NCT01120899|7360563|FG000|Month 6|Overall Study||5
6444902|NCT01120899|7360563|FG000|Month 12|Overall Study||3
6444903|NCT01120899|7360563|FG000|Month 18|Overall Study||3
6444904|NCT01120899|7360563|FG000|COMPLETED|Overall Study||3
6444905|NCT01120899|7360563|FG000|NOT COMPLETED|Overall Study||3
6444906|NCT01120990|7360567|FG000|STARTED|Overall Study||51
6444907|NCT01120990|7360567|FG000|COMPLETED|Overall Study||51
6444908|NCT01120990|7360567|FG000|NOT COMPLETED|Overall Study||0
6444909|NCT01121146|7360573|FG000|STARTED|Overall Study||116
6444910|NCT01121146|7360574|FG001|STARTED|Overall Study||114
6444911|NCT01121146|7360573|FG000|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
6444912|NCT01121146|7360574|FG001|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
6444913|NCT01121146|7360573|FG000|NOT COMPLETED|Overall Study||26
6444914|NCT01121146|7360574|FG001|NOT COMPLETED|Overall Study||42
6444915|NCT01121172|7360583|FG000|STARTED|Overall Study||90
6444916|NCT01121172|7360584|FG001|STARTED|Overall Study||90
6444917|NCT01121172|7360583|FG000|COMPLETED|Overall Study||90
6444918|NCT01121172|7360584|FG001|COMPLETED|Overall Study||90
6444919|NCT01121172|7360583|FG000|NOT COMPLETED|Overall Study||0
6444920|NCT01121172|7360584|FG001|NOT COMPLETED|Overall Study||0
6444921|NCT01121185|7360593|FG000|STARTED|Overall Study||7
6444922|NCT01121185|7360594|FG001|STARTED|Overall Study||6
6444923|NCT01121185|7360593|FG000|Infused|Overall Study||7
6500253|NCT01424397|7419094|FG007|NOT COMPLETED|Period-1 (8 Days)||0
6444924|NCT01121185|7360594|FG001|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
6444925|NCT01121185|7360593|FG000|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
6444926|NCT01121185|7360594|FG001|Transplanted|Overall Study||5
6444927|NCT01121185|7360593|FG000|COMPLETED|Overall Study||6
6444928|NCT01121185|7360594|FG001|COMPLETED|Overall Study||5
6444929|NCT01121185|7360593|FG000|NOT COMPLETED|Overall Study||1
6444930|NCT01121185|7360594|FG001|NOT COMPLETED|Overall Study||1
6444931|NCT01121211|7360602|FG000|STARTED|Overall Study||43
6444932|NCT01121211|7360603|FG001|STARTED|Overall Study||47
6444933|NCT01121211|7360602|FG000|COMPLETED|Overall Study||32
6444934|NCT01121211|7360603|FG001|COMPLETED|Overall Study||35
6444935|NCT01121211|7360602|FG000|NOT COMPLETED|Overall Study||11
6444936|NCT01121211|7360603|FG001|NOT COMPLETED|Overall Study||12
6444937|NCT01121224|7360611|FG000|STARTED|Overall Study||305
6444938|NCT01121224|7360612|FG001|STARTED|Overall Study||292
6444939|NCT01121224|7360611|FG000|COMPLETED|Overall Study||280
6444940|NCT01121224|7360612|FG001|COMPLETED|Overall Study||275
6444941|NCT01121224|7360611|FG000|NOT COMPLETED|Overall Study||25
6444942|NCT01121224|7360612|FG001|NOT COMPLETED|Overall Study||17
6444943|NCT01121250|7360623|FG000|STARTED|Overall Study||76
6444944|NCT01121250|7360624|FG001|STARTED|Overall Study||76
6444945|NCT01121250|7360625|FG002|STARTED|Overall Study||76
6444946|NCT01121250|7360623|FG000|COMPLETED|Overall Study||76
6444947|NCT01121250|7360624|FG001|COMPLETED|Overall Study||76
6444948|NCT01121250|7360625|FG002|COMPLETED|Overall Study||75
6444949|NCT01121250|7360623|FG000|NOT COMPLETED|Overall Study||0
6444950|NCT01121250|7360624|FG001|NOT COMPLETED|Overall Study||0
6444951|NCT01121250|7360625|FG002|NOT COMPLETED|Overall Study||1
6553110|NCT01741545|7475603|FG000|NOT COMPLETED|Treatment Period||1
6444952|NCT01121263|7360635|FG000|STARTED|Overall Study||200
6444953|NCT01121263|7360636|FG001|STARTED|Overall Study||98
6444954|NCT01121263|7360635|FG000|COMPLETED|Overall Study||175
6444955|NCT01121263|7360636|FG001|COMPLETED|Overall Study||83
6444956|NCT01121263|7360635|FG000|NOT COMPLETED|Overall Study||25
6444957|NCT01121263|7360636|FG001|NOT COMPLETED|Overall Study||15
6444958|NCT01121393|7360646|FG000|STARTED|Overall Study|Randomised|242
6444959|NCT01121393|7360647|FG001|STARTED|Overall Study|Randomised|122
6444960|NCT01121393|7360646|FG000|Treated|Overall Study|Treated|239
6444961|NCT01121393|7360647|FG001|Treated|Overall Study|Treated|113
6444962|NCT01121393|7360646|FG000|COMPLETED|Overall Study|At the time of data cut-off for last-patient out (07 December 2017)|0
6444963|NCT01121393|7360647|FG001|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
6444964|NCT01121393|7360646|FG000|NOT COMPLETED|Overall Study||242
6444965|NCT01121393|7360647|FG001|NOT COMPLETED|Overall Study||84
6444966|NCT01121406|7360661|FG000|STARTED|Overall Study||55
6444967|NCT01121406|7360662|FG001|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
6444968|NCT01121406|7360661|FG000|COMPLETED|Overall Study||0
6444969|NCT01121406|7360662|FG001|COMPLETED|Overall Study||0
6444970|NCT01121406|7360661|FG000|NOT COMPLETED|Overall Study||55
6444971|NCT01121406|7360662|FG001|NOT COMPLETED|Overall Study||55
6444972|NCT01121484|7360673|FG000|STARTED|Overall Study||218
6444973|NCT01121484|7360674|FG001|STARTED|Overall Study||221
6444974|NCT01121484|7360673|FG000|Treated|Overall Study||217
6444975|NCT01121484|7360674|FG001|Treated|Overall Study||217
6444976|NCT01121484|7360673|FG000|COMPLETED|Overall Study||185
6444977|NCT01121484|7360674|FG001|COMPLETED|Overall Study||178
6444978|NCT01121484|7360673|FG000|NOT COMPLETED|Overall Study||33
6444979|NCT01121484|7360674|FG001|NOT COMPLETED|Overall Study||43
6444980|NCT01121536|7360680|FG000|STARTED|Overall Study||867
6444981|NCT01121536|7360680|FG000|Safety Population|Overall Study|Participants treated|863
6444982|NCT01121536|7360680|FG000|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
6444983|NCT01121536|7360680|FG000|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
6444984|NCT01121536|7360680|FG000|NOT COMPLETED|Overall Study||361
6444985|NCT01121549|7360684|FG000|STARTED|Overall Study||378
6444986|NCT01121549|7360684|FG000|COMPLETED|Overall Study||31
6444987|NCT01121549|7360684|FG000|NOT COMPLETED|Overall Study||347
6444988|NCT01121562|7360688|FG000|STARTED|Overall Study||12
6444989|NCT01121562|7360688|FG000|COMPLETED|Overall Study||0
6444990|NCT01121562|7360688|FG000|NOT COMPLETED|Overall Study||12
6444991|NCT01121575|7360698|FG000|STARTED|Overall Study||14
6444992|NCT01121575|7360699|FG001|STARTED|Overall Study||6
6444993|NCT01121575|7360700|FG002|STARTED|Overall Study||7
6444994|NCT01121575|7360701|FG003|STARTED|Overall Study||6
6444995|NCT01121575|7360702|FG004|STARTED|Overall Study||25
6444996|NCT01121575|7360703|FG005|STARTED|Overall Study||12
6444997|NCT01121575|7360698|FG000|Treated|Overall Study||14
6444998|NCT01121575|7360699|FG001|Treated|Overall Study||6
6444999|NCT01121575|7360700|FG002|Treated|Overall Study||7
6445000|NCT01121575|7360701|FG003|Treated|Overall Study||6
6445001|NCT01121575|7360702|FG004|Treated|Overall Study||25
6445002|NCT01121575|7360703|FG005|Treated|Overall Study||12
6445003|NCT01121575|7360698|FG000|COMPLETED|Overall Study||0
6445004|NCT01121575|7360699|FG001|COMPLETED|Overall Study||0
6445005|NCT01121575|7360700|FG002|COMPLETED|Overall Study||0
6445006|NCT01121575|7360701|FG003|COMPLETED|Overall Study||0
6445007|NCT01121575|7360702|FG004|COMPLETED|Overall Study||0
6445008|NCT01121575|7360703|FG005|COMPLETED|Overall Study||0
6445009|NCT01121575|7360698|FG000|NOT COMPLETED|Overall Study||14
6445010|NCT01121575|7360699|FG001|NOT COMPLETED|Overall Study||6
6445011|NCT01121575|7360700|FG002|NOT COMPLETED|Overall Study||7
6445012|NCT01121575|7360701|FG003|NOT COMPLETED|Overall Study||6
6445013|NCT01121575|7360702|FG004|NOT COMPLETED|Overall Study||25
6445014|NCT01121575|7360703|FG005|NOT COMPLETED|Overall Study||12
6445015|NCT01121666|7360724|FG000|STARTED|Overall Study||249
6553111|NCT01741545|7475604|FG001|NOT COMPLETED|Treatment Period||4
6553112|NCT01741545|7475603|FG000|STARTED|Follow-up Period (24 Weeks)|1 participant re-joined Cohort A in follow-up period.|12
6553113|NCT01741545|7475604|FG001|STARTED|Follow-up Period (24 Weeks)|4 participants re-joined Cohort B in follow-up period.|39
6553114|NCT01741545|7475603|FG000|COMPLETED|Follow-up Period (24 Weeks)||11
6553115|NCT01741545|7475604|FG001|COMPLETED|Follow-up Period (24 Weeks)||37
6553116|NCT01741545|7475603|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
6553117|NCT01741545|7475604|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||2
6445016|NCT01121666|7360725|FG001|STARTED|Overall Study||123
6445017|NCT01121666|7360724|FG000|COMPLETED|Overall Study||220
6445018|NCT01121666|7360725|FG001|COMPLETED|Overall Study||113
6445019|NCT01121666|7360724|FG000|NOT COMPLETED|Overall Study||29
6445020|NCT01121666|7360725|FG001|NOT COMPLETED|Overall Study||10
6445021|NCT01121757|7360733|FG000|STARTED|First Drug||6
6445022|NCT01121757|7360734|FG001|STARTED|First Drug||3
6653536|NCT02438280|7583363|FG001|COMPLETED|Overall Study||13
6653537|NCT02438280|7583362|FG000|NOT COMPLETED|Overall Study||1
6653538|NCT02438280|7583363|FG001|NOT COMPLETED|Overall Study||0
6653539|NCT02438371|7583372|FG000|STARTED|Overall Study||24
6653540|NCT02438371|7583373|FG001|STARTED|Overall Study||25
6653541|NCT02438371|7583372|FG000|Received Intervention|Overall Study||24
6653542|NCT02438371|7583373|FG001|Received Intervention|Overall Study||25
6445023|NCT01121757|7360733|FG000|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
6445024|NCT01121757|7360734|FG001|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
6445025|NCT01121757|7360733|FG000|NOT COMPLETED|First Drug||1
6445026|NCT01121757|7360734|FG001|NOT COMPLETED|First Drug||2
6445027|NCT01121757|7360733|FG000|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
6445028|NCT01121757|7360734|FG001|STARTED|Second Drug||1
6445029|NCT01121757|7360733|FG000|COMPLETED|Second Drug||4
6445030|NCT01121757|7360734|FG001|COMPLETED|Second Drug||1
6445031|NCT01121757|7360733|FG000|NOT COMPLETED|Second Drug||0
6445032|NCT01121757|7360734|FG001|NOT COMPLETED|Second Drug||0
6445033|NCT01121757|7360733|FG000|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
6445034|NCT01121757|7360734|FG001|STARTED|Combination||1
6445035|NCT01121757|7360733|FG000|COMPLETED|Combination||0
6445036|NCT01121757|7360734|FG001|COMPLETED|Combination||0
6445037|NCT01121757|7360733|FG000|NOT COMPLETED|Combination||2
6445038|NCT01121757|7360734|FG001|NOT COMPLETED|Combination||1
6445039|NCT01121900|7360742|FG000|STARTED|First Intervention Period||13
6445040|NCT01121900|7360743|FG001|STARTED|First Intervention Period||13
6445041|NCT01121900|7360742|FG000|COMPLETED|First Intervention Period||12
6445042|NCT01121900|7360743|FG001|COMPLETED|First Intervention Period||12
6445043|NCT01121900|7360742|FG000|NOT COMPLETED|First Intervention Period||1
6445044|NCT01121900|7360743|FG001|NOT COMPLETED|First Intervention Period||1
6445045|NCT01121900|7360742|FG000|STARTED|Washout Period of 7 Days||12
6445046|NCT01121900|7360743|FG001|STARTED|Washout Period of 7 Days||12
6445047|NCT01121900|7360742|FG000|COMPLETED|Washout Period of 7 Days||12
6445048|NCT01121900|7360743|FG001|COMPLETED|Washout Period of 7 Days||11
6445049|NCT01121900|7360742|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6445050|NCT01121900|7360743|FG001|NOT COMPLETED|Washout Period of 7 Days||1
6445051|NCT01121900|7360742|FG000|STARTED|Second Intervention Period||12
6445052|NCT01121900|7360743|FG001|STARTED|Second Intervention Period||11
6445053|NCT01121900|7360742|FG000|COMPLETED|Second Intervention Period||12
6445054|NCT01121900|7360743|FG001|COMPLETED|Second Intervention Period||11
6445055|NCT01121900|7360742|FG000|NOT COMPLETED|Second Intervention Period||0
6445056|NCT01121900|7360743|FG001|NOT COMPLETED|Second Intervention Period||0
6445057|NCT01121913|7360749|FG000|STARTED|First Intervention Period||6
6445058|NCT01121913|7360750|FG001|STARTED|First Intervention Period||6
6445059|NCT01121913|7360751|FG002|STARTED|First Intervention Period||6
6445060|NCT01121913|7360752|FG003|STARTED|First Intervention Period||6
6445061|NCT01121913|7360749|FG000|COMPLETED|First Intervention Period||6
6445062|NCT01121913|7360750|FG001|COMPLETED|First Intervention Period||6
6445063|NCT01121913|7360751|FG002|COMPLETED|First Intervention Period||5
6445064|NCT01121913|7360752|FG003|COMPLETED|First Intervention Period||6
6445065|NCT01121913|7360749|FG000|NOT COMPLETED|First Intervention Period||0
6445066|NCT01121913|7360750|FG001|NOT COMPLETED|First Intervention Period||0
6445067|NCT01121913|7360751|FG002|NOT COMPLETED|First Intervention Period||1
6445068|NCT01121913|7360752|FG003|NOT COMPLETED|First Intervention Period||0
6445069|NCT01121913|7360749|FG000|STARTED|First Washout Period||6
6445070|NCT01121913|7360750|FG001|STARTED|First Washout Period||6
6445071|NCT01121913|7360751|FG002|STARTED|First Washout Period||5
6445072|NCT01121913|7360752|FG003|STARTED|First Washout Period||6
6445073|NCT01121913|7360749|FG000|COMPLETED|First Washout Period||5
6445074|NCT01121913|7360750|FG001|COMPLETED|First Washout Period||6
6553118|NCT01741688|7475610|FG000|STARTED|Overall Study||16
6445075|NCT01121913|7360751|FG002|COMPLETED|First Washout Period||5
6445076|NCT01121913|7360752|FG003|COMPLETED|First Washout Period||6
6553119|NCT01741688|7475610|FG000|COMPLETED|Overall Study||13
6553120|NCT01741688|7475610|FG000|NOT COMPLETED|Overall Study||3
6445077|NCT01121913|7360749|FG000|NOT COMPLETED|First Washout Period||1
6445078|NCT01121913|7360750|FG001|NOT COMPLETED|First Washout Period||0
6445079|NCT01121913|7360751|FG002|NOT COMPLETED|First Washout Period||0
6445080|NCT01121913|7360752|FG003|NOT COMPLETED|First Washout Period||0
6445081|NCT01121913|7360749|FG000|STARTED|Second Intervention Period||5
6445082|NCT01121913|7360750|FG001|STARTED|Second Intervention Period||6
6445083|NCT01121913|7360751|FG002|STARTED|Second Intervention Period||5
6445084|NCT01121913|7360752|FG003|STARTED|Second Intervention Period||6
6445085|NCT01121913|7360749|FG000|COMPLETED|Second Intervention Period||5
6445086|NCT01121913|7360750|FG001|COMPLETED|Second Intervention Period||6
6445087|NCT01121913|7360751|FG002|COMPLETED|Second Intervention Period||4
6445088|NCT01121913|7360752|FG003|COMPLETED|Second Intervention Period||6
6445089|NCT01121913|7360749|FG000|NOT COMPLETED|Second Intervention Period||0
6445090|NCT01121913|7360750|FG001|NOT COMPLETED|Second Intervention Period||0
6445091|NCT01121913|7360751|FG002|NOT COMPLETED|Second Intervention Period||1
6445092|NCT01121913|7360752|FG003|NOT COMPLETED|Second Intervention Period||0
6445093|NCT01121913|7360749|FG000|STARTED|Second Washout Period||5
6445094|NCT01121913|7360750|FG001|STARTED|Second Washout Period||6
6445095|NCT01121913|7360751|FG002|STARTED|Second Washout Period||4
6445096|NCT01121913|7360752|FG003|STARTED|Second Washout Period||6
6445097|NCT01121913|7360749|FG000|COMPLETED|Second Washout Period||5
6445098|NCT01121913|7360750|FG001|COMPLETED|Second Washout Period||6
6445099|NCT01121913|7360751|FG002|COMPLETED|Second Washout Period||3
6445100|NCT01121913|7360752|FG003|COMPLETED|Second Washout Period||6
6445101|NCT01121913|7360749|FG000|NOT COMPLETED|Second Washout Period||0
6445102|NCT01121913|7360750|FG001|NOT COMPLETED|Second Washout Period||0
6445103|NCT01121913|7360751|FG002|NOT COMPLETED|Second Washout Period||1
6445104|NCT01121913|7360752|FG003|NOT COMPLETED|Second Washout Period||0
6445105|NCT01121913|7360749|FG000|STARTED|Third Intervention Period||5
6445106|NCT01121913|7360750|FG001|STARTED|Third Intervention Period||6
6445107|NCT01121913|7360751|FG002|STARTED|Third Intervention Period||3
6445108|NCT01121913|7360752|FG003|STARTED|Third Intervention Period||6
6445109|NCT01121913|7360749|FG000|COMPLETED|Third Intervention Period||5
6445110|NCT01121913|7360750|FG001|COMPLETED|Third Intervention Period||6
6445111|NCT01121913|7360751|FG002|COMPLETED|Third Intervention Period||3
6445112|NCT01121913|7360752|FG003|COMPLETED|Third Intervention Period||6
6445113|NCT01121913|7360749|FG000|NOT COMPLETED|Third Intervention Period||0
6445114|NCT01121913|7360750|FG001|NOT COMPLETED|Third Intervention Period||0
6445115|NCT01121913|7360751|FG002|NOT COMPLETED|Third Intervention Period||0
6445116|NCT01121913|7360752|FG003|NOT COMPLETED|Third Intervention Period||0
6445117|NCT01121913|7360749|FG000|STARTED|Third Washout Period||5
6445118|NCT01121913|7360750|FG001|STARTED|Third Washout Period||6
6445119|NCT01121913|7360751|FG002|STARTED|Third Washout Period||3
6445120|NCT01121913|7360752|FG003|STARTED|Third Washout Period||6
6445121|NCT01121913|7360749|FG000|COMPLETED|Third Washout Period||4
6445122|NCT01121913|7360750|FG001|COMPLETED|Third Washout Period||6
6445123|NCT01121913|7360751|FG002|COMPLETED|Third Washout Period||3
6445124|NCT01121913|7360752|FG003|COMPLETED|Third Washout Period||6
6445125|NCT01121913|7360749|FG000|NOT COMPLETED|Third Washout Period||1
6445126|NCT01121913|7360750|FG001|NOT COMPLETED|Third Washout Period||0
6445127|NCT01121913|7360751|FG002|NOT COMPLETED|Third Washout Period||0
6445128|NCT01121913|7360752|FG003|NOT COMPLETED|Third Washout Period||0
6445129|NCT01121913|7360749|FG000|STARTED|Fourth Intervention Period||4
6445130|NCT01121913|7360750|FG001|STARTED|Fourth Intervention Period||6
6445131|NCT01121913|7360751|FG002|STARTED|Fourth Intervention Period||3
6445132|NCT01121913|7360752|FG003|STARTED|Fourth Intervention Period||6
6445133|NCT01121913|7360749|FG000|COMPLETED|Fourth Intervention Period||4
6445134|NCT01121913|7360750|FG001|COMPLETED|Fourth Intervention Period||6
6445135|NCT01121913|7360751|FG002|COMPLETED|Fourth Intervention Period||3
6445136|NCT01121913|7360752|FG003|COMPLETED|Fourth Intervention Period||6
6445137|NCT01121913|7360749|FG000|NOT COMPLETED|Fourth Intervention Period||0
6445138|NCT01121913|7360750|FG001|NOT COMPLETED|Fourth Intervention Period||0
6445139|NCT01121913|7360751|FG002|NOT COMPLETED|Fourth Intervention Period||0
6445140|NCT01121913|7360752|FG003|NOT COMPLETED|Fourth Intervention Period||0
6445141|NCT01121926|7360762|FG000|STARTED|First Intervention Period||15
6445142|NCT01121926|7360763|FG001|STARTED|First Intervention Period||15
6445143|NCT01121926|7360762|FG000|COMPLETED|First Intervention Period||14
6445144|NCT01121926|7360763|FG001|COMPLETED|First Intervention Period||15
6445145|NCT01121926|7360762|FG000|NOT COMPLETED|First Intervention Period||1
6445146|NCT01121926|7360763|FG001|NOT COMPLETED|First Intervention Period||0
6445147|NCT01121926|7360762|FG000|STARTED|Washout Period||14
6445148|NCT01121926|7360763|FG001|STARTED|Washout Period||15
6445149|NCT01121926|7360762|FG000|COMPLETED|Washout Period||14
6445150|NCT01121926|7360763|FG001|COMPLETED|Washout Period||13
6445151|NCT01121926|7360762|FG000|NOT COMPLETED|Washout Period||0
6445152|NCT01121926|7360763|FG001|NOT COMPLETED|Washout Period||2
6445153|NCT01121926|7360762|FG000|STARTED|Second Intervention Period||14
6445154|NCT01121926|7360763|FG001|STARTED|Second Intervention Period||13
6445155|NCT01121926|7360762|FG000|COMPLETED|Second Intervention Period||14
6445156|NCT01121926|7360763|FG001|COMPLETED|Second Intervention Period||13
6445157|NCT01121926|7360762|FG000|NOT COMPLETED|Second Intervention Period||0
6445158|NCT01121926|7360763|FG001|NOT COMPLETED|Second Intervention Period||0
6445159|NCT01121939|7360769|FG000|STARTED|Overall Study||43
6445160|NCT01121939|7360769|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
6445161|NCT01121939|7360769|FG000|NOT COMPLETED|Overall Study||43
6445162|NCT01121991|7360776|FG000|STARTED|Overall Study|Number of participants treated|52
6445163|NCT01121991|7360776|FG000|COMPLETED|Overall Study||46
6445164|NCT01121991|7360776|FG000|NOT COMPLETED|Overall Study||6
6445165|NCT01122030|7360787|FG000|STARTED|Overall Study||18
6445166|NCT01122030|7360788|FG001|STARTED|Overall Study||9
6445167|NCT01122030|7360789|FG002|STARTED|Overall Study||9
6445168|NCT01122030|7360790|FG003|STARTED|Overall Study||9
6445169|NCT01122030|7360791|FG004|STARTED|Overall Study||9
6445170|NCT01122030|7360792|FG005|STARTED|Overall Study||9
6445171|NCT01122030|7360793|FG006|STARTED|Overall Study||9
6445172|NCT01122030|7360787|FG000|Received Treatment|Overall Study||18
6445173|NCT01122030|7360788|FG001|Received Treatment|Overall Study||9
6445174|NCT01122030|7360789|FG002|Received Treatment|Overall Study||9
6445175|NCT01122030|7360790|FG003|Received Treatment|Overall Study||9
6445176|NCT01122030|7360791|FG004|Received Treatment|Overall Study||9
6445177|NCT01122030|7360792|FG005|Received Treatment|Overall Study||9
6445178|NCT01122030|7360793|FG006|Received Treatment|Overall Study||9
6553121|NCT01741701|7475617|FG000|STARTED|Overall Study||18
6553122|NCT01741701|7475618|FG001|STARTED|Overall Study||15
6553123|NCT01741701|7475617|FG000|COMPLETED|Overall Study||13
6445179|NCT01122030|7360787|FG000|COMPLETED|Overall Study||18
6445180|NCT01122030|7360788|FG001|COMPLETED|Overall Study||9
6445181|NCT01122030|7360789|FG002|COMPLETED|Overall Study||9
6445182|NCT01122030|7360790|FG003|COMPLETED|Overall Study||9
6445183|NCT01122030|7360791|FG004|COMPLETED|Overall Study||9
6445184|NCT01122030|7360792|FG005|COMPLETED|Overall Study||9
6445185|NCT01122030|7360793|FG006|COMPLETED|Overall Study||9
6445186|NCT01122030|7360787|FG000|NOT COMPLETED|Overall Study||0
6445187|NCT01122030|7360788|FG001|NOT COMPLETED|Overall Study||0
6445188|NCT01122030|7360789|FG002|NOT COMPLETED|Overall Study||0
6445189|NCT01122030|7360790|FG003|NOT COMPLETED|Overall Study||0
6445190|NCT01122030|7360791|FG004|NOT COMPLETED|Overall Study||0
6445191|NCT01122030|7360792|FG005|NOT COMPLETED|Overall Study||0
6445192|NCT01122030|7360793|FG006|NOT COMPLETED|Overall Study||0
6445193|NCT01122108|7360815|FG000|STARTED|Overall Study||21
6445194|NCT01122108|7360816|FG001|STARTED|Overall Study||21
6445195|NCT01122108|7360815|FG000|COMPLETED|Overall Study||21
6445196|NCT01122108|7360816|FG001|COMPLETED|Overall Study||21
6445197|NCT01122108|7360815|FG000|NOT COMPLETED|Overall Study||0
6445198|NCT01122108|7360816|FG001|NOT COMPLETED|Overall Study||0
6445199|NCT01122160|7360824|FG000|STARTED|First Intervention (7 Days)||6
6445200|NCT01122160|7360825|FG001|STARTED|First Intervention (7 Days)||5
6445201|NCT01122160|7360824|FG000|COMPLETED|First Intervention (7 Days)||6
6445202|NCT01122160|7360825|FG001|COMPLETED|First Intervention (7 Days)||5
6445203|NCT01122160|7360824|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6445204|NCT01122160|7360825|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6445205|NCT01122160|7360824|FG000|STARTED|Washout (7-14 Days)||6
6445206|NCT01122160|7360825|FG001|STARTED|Washout (7-14 Days)||5
6445207|NCT01122160|7360824|FG000|COMPLETED|Washout (7-14 Days)||6
6445208|NCT01122160|7360825|FG001|COMPLETED|Washout (7-14 Days)||5
6445209|NCT01122160|7360824|FG000|NOT COMPLETED|Washout (7-14 Days)||0
6445210|NCT01122160|7360825|FG001|NOT COMPLETED|Washout (7-14 Days)||0
6445211|NCT01122160|7360824|FG000|STARTED|Second Intervention (7 Days)||6
6445212|NCT01122160|7360825|FG001|STARTED|Second Intervention (7 Days)||5
6445213|NCT01122160|7360824|FG000|COMPLETED|Second Intervention (7 Days)||6
6445214|NCT01122160|7360825|FG001|COMPLETED|Second Intervention (7 Days)||5
6445215|NCT01122160|7360824|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6445216|NCT01122160|7360825|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6445217|NCT01122173|7360831|FG000|STARTED|Overall Study||150
6445218|NCT01122173|7360831|FG000|COMPLETED|Overall Study||141
6445219|NCT01122173|7360831|FG000|NOT COMPLETED|Overall Study||9
6445220|NCT01122238|7360852|FG000|STARTED|Overall Study||30
6445221|NCT01122238|7360853|FG001|STARTED|Overall Study||37
6445222|NCT01122238|7360854|FG002|STARTED|Overall Study||33
6445223|NCT01122238|7360855|FG003|STARTED|Overall Study||33
6445224|NCT01122238|7360856|FG004|STARTED|Overall Study||33
6445225|NCT01122238|7360857|FG005|STARTED|Overall Study||32
6445226|NCT01122238|7360858|FG006|STARTED|Overall Study||35
6445227|NCT01122238|7360859|FG007|STARTED|Overall Study||32
6445228|NCT01122238|7360860|FG008|STARTED|Overall Study||32
6445229|NCT01122238|7360861|FG009|STARTED|Overall Study||34
6445230|NCT01122238|7360862|FG010|STARTED|Overall Study||32
6445231|NCT01122238|7360863|FG011|STARTED|Overall Study||33
6445232|NCT01122238|7360864|FG012|STARTED|Overall Study||30
6445233|NCT01122238|7360865|FG013|STARTED|Overall Study||32
6445234|NCT01122238|7360866|FG014|STARTED|Overall Study||28
6445235|NCT01122238|7360867|FG015|STARTED|Overall Study||31
6445236|NCT01122238|7360852|FG000|COMPLETED|Overall Study||28
6445237|NCT01122238|7360853|FG001|COMPLETED|Overall Study||36
6445238|NCT01122238|7360854|FG002|COMPLETED|Overall Study||28
6553124|NCT01741701|7475618|FG001|COMPLETED|Overall Study||13
6553125|NCT01741701|7475617|FG000|NOT COMPLETED|Overall Study||5
6553126|NCT01741701|7475618|FG001|NOT COMPLETED|Overall Study||2
6445239|NCT01122238|7360855|FG003|COMPLETED|Overall Study||33
6445240|NCT01122238|7360856|FG004|COMPLETED|Overall Study||33
6445241|NCT01122238|7360857|FG005|COMPLETED|Overall Study||31
6445242|NCT01122238|7360858|FG006|COMPLETED|Overall Study||34
6445243|NCT01122238|7360859|FG007|COMPLETED|Overall Study||32
6445244|NCT01122238|7360860|FG008|COMPLETED|Overall Study||31
6445245|NCT01122238|7360861|FG009|COMPLETED|Overall Study||33
6445246|NCT01122238|7360862|FG010|COMPLETED|Overall Study||32
6445247|NCT01122238|7360863|FG011|COMPLETED|Overall Study||31
6445248|NCT01122238|7360864|FG012|COMPLETED|Overall Study||28
6445249|NCT01122238|7360865|FG013|COMPLETED|Overall Study||31
6445250|NCT01122238|7360866|FG014|COMPLETED|Overall Study||28
6445251|NCT01122238|7360867|FG015|COMPLETED|Overall Study||31
6445252|NCT01122238|7360852|FG000|NOT COMPLETED|Overall Study||2
6445253|NCT01122238|7360853|FG001|NOT COMPLETED|Overall Study||1
6445254|NCT01122238|7360854|FG002|NOT COMPLETED|Overall Study||5
6445255|NCT01122238|7360855|FG003|NOT COMPLETED|Overall Study||0
6445256|NCT01122238|7360856|FG004|NOT COMPLETED|Overall Study||0
6445257|NCT01122238|7360857|FG005|NOT COMPLETED|Overall Study||1
6445258|NCT01122238|7360858|FG006|NOT COMPLETED|Overall Study||1
6445259|NCT01122238|7360859|FG007|NOT COMPLETED|Overall Study||0
6445260|NCT01122238|7360860|FG008|NOT COMPLETED|Overall Study||1
6445261|NCT01122238|7360861|FG009|NOT COMPLETED|Overall Study||1
6445262|NCT01122238|7360862|FG010|NOT COMPLETED|Overall Study||0
6445263|NCT01122238|7360863|FG011|NOT COMPLETED|Overall Study||2
6445264|NCT01122238|7360864|FG012|NOT COMPLETED|Overall Study||2
6445265|NCT01122238|7360865|FG013|NOT COMPLETED|Overall Study||1
6445266|NCT01122238|7360866|FG014|NOT COMPLETED|Overall Study||0
6445267|NCT01122238|7360867|FG015|NOT COMPLETED|Overall Study||0
6445268|NCT01122264|7360884|FG000|STARTED|Overall Study||252
6445269|NCT01122264|7360885|FG001|STARTED|Overall Study||257
6445270|NCT01122264|7360886|FG002|STARTED|Overall Study||261
6445271|NCT01122264|7360884|FG000|Received at Least 1 Dose of Study Drug|Overall Study||250
6445272|NCT01122264|7360885|FG001|Received at Least 1 Dose of Study Drug|Overall Study||257
6445273|NCT01122264|7360886|FG002|Received at Least 1 Dose of Study Drug|Overall Study||260
6445274|NCT01122264|7360884|FG000|COMPLETED|Overall Study||220
6445275|NCT01122264|7360885|FG001|COMPLETED|Overall Study||228
6445276|NCT01122264|7360886|FG002|COMPLETED|Overall Study||214
6445277|NCT01122264|7360884|FG000|NOT COMPLETED|Overall Study||32
6445278|NCT01122264|7360885|FG001|NOT COMPLETED|Overall Study||29
6445279|NCT01122264|7360886|FG002|NOT COMPLETED|Overall Study||47
6445280|NCT01122316|7360898|FG000|STARTED|Overall Study||10
6445281|NCT01122316|7360898|FG000|COMPLETED|Overall Study||8
6445282|NCT01122316|7360898|FG000|NOT COMPLETED|Overall Study||2
6445283|NCT01122394|7360904|FG000|STARTED|Overall Study||66
6445284|NCT01122394|7360905|FG001|STARTED|Overall Study||74
6445285|NCT01122394|7360904|FG000|COMPLETED|Overall Study||63
6445286|NCT01122394|7360905|FG001|COMPLETED|Overall Study||70
6445287|NCT01122394|7360904|FG000|NOT COMPLETED|Overall Study||3
6445288|NCT01122394|7360905|FG001|NOT COMPLETED|Overall Study||4
6445289|NCT01122446|7360915|FG000|STARTED|Overall Study||25
6445290|NCT01122446|7360916|FG001|STARTED|Overall Study||25
6445291|NCT01122446|7360915|FG000|COMPLETED|Overall Study||25
6445292|NCT01122446|7360916|FG001|COMPLETED|Overall Study||25
6445293|NCT01122446|7360915|FG000|NOT COMPLETED|Overall Study||0
6445294|NCT01122446|7360916|FG001|NOT COMPLETED|Overall Study||0
6445295|NCT01122576|7360925|FG000|STARTED|Pre-Cataract Surgery||26
6445296|NCT01122576|7360926|FG001|STARTED|Pre-Cataract Surgery||26
6445297|NCT01122576|7360927|FG002|STARTED|Pre-Cataract Surgery||26
6445298|NCT01122576|7360925|FG000|COMPLETED|Pre-Cataract Surgery||26
6445299|NCT01122576|7360926|FG001|COMPLETED|Pre-Cataract Surgery||25
6445300|NCT01122576|7360927|FG002|COMPLETED|Pre-Cataract Surgery||24
6445301|NCT01122576|7360925|FG000|NOT COMPLETED|Pre-Cataract Surgery||0
6445302|NCT01122576|7360926|FG001|NOT COMPLETED|Pre-Cataract Surgery||1
6445303|NCT01122576|7360927|FG002|NOT COMPLETED|Pre-Cataract Surgery||2
6445304|NCT01122576|7360925|FG000|STARTED|Post-Cataract Surgery||26
6445305|NCT01122576|7360926|FG001|STARTED|Post-Cataract Surgery||25
6445306|NCT01122576|7360927|FG002|STARTED|Post-Cataract Surgery||24
6445307|NCT01122576|7360925|FG000|COMPLETED|Post-Cataract Surgery||26
6445308|NCT01122576|7360926|FG001|COMPLETED|Post-Cataract Surgery||25
6445309|NCT01122576|7360927|FG002|COMPLETED|Post-Cataract Surgery||22
6445310|NCT01122576|7360925|FG000|NOT COMPLETED|Post-Cataract Surgery||0
6445311|NCT01122576|7360926|FG001|NOT COMPLETED|Post-Cataract Surgery||0
6445312|NCT01122576|7360927|FG002|NOT COMPLETED|Post-Cataract Surgery||2
6445313|NCT01122680|7360938|FG000|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
6445314|NCT01122680|7360939|FG001|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
6445315|NCT01122680|7360940|FG002|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
6445316|NCT01122680|7360941|FG003|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
6445317|NCT01122680|7360938|FG000|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
6445318|NCT01122680|7360939|FG001|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
6445319|NCT01122680|7360940|FG002|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
6445320|NCT01122680|7360941|FG003|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
6445321|NCT01122680|7360938|FG000|NOT COMPLETED|Period 1 (4 Weeks)||3
6445322|NCT01122680|7360939|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
6445323|NCT01122680|7360940|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
6445324|NCT01122680|7360941|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
6445325|NCT01122680|7360938|FG000|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
6445326|NCT01122680|7360939|FG001|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
6445327|NCT01122680|7360940|FG002|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
6445328|NCT01122680|7360941|FG003|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
6445329|NCT01122680|7360938|FG000|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
6445330|NCT01122680|7360939|FG001|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
6445331|NCT01122680|7360940|FG002|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
6445332|NCT01122680|7360941|FG003|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
6445333|NCT01122680|7360938|FG000|NOT COMPLETED|Period 2 (4 Weeks)||1
6445334|NCT01122680|7360939|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
6445335|NCT01122680|7360940|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
6445336|NCT01122680|7360941|FG003|NOT COMPLETED|Period 2 (4 Weeks)||1
6445337|NCT01122680|7360938|FG000|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
6445338|NCT01122680|7360939|FG001|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
6445339|NCT01122680|7360940|FG002|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
6445340|NCT01122680|7360941|FG003|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
6445341|NCT01122680|7360938|FG000|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
6445342|NCT01122680|7360939|FG001|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
6445343|NCT01122680|7360940|FG002|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
6445344|NCT01122680|7360941|FG003|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
6445345|NCT01122680|7360938|FG000|NOT COMPLETED|Period 3 (4 Weeks)||1
6445346|NCT01122680|7360939|FG001|NOT COMPLETED|Period 3 (4 Weeks)||1
6445347|NCT01122680|7360940|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
6445348|NCT01122680|7360941|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
6445349|NCT01122849|7360954|FG000|STARTED|Overall Study||20
6445350|NCT01122849|7360955|FG001|STARTED|Overall Study||21
6445351|NCT01122849|7360956|FG002|STARTED|Overall Study||20
6445352|NCT01122849|7360954|FG000|COMPLETED|Overall Study||20
6445353|NCT01122849|7360955|FG001|COMPLETED|Overall Study||21
6445354|NCT01122849|7360956|FG002|COMPLETED|Overall Study||20
6445355|NCT01122849|7360954|FG000|NOT COMPLETED|Overall Study||0
6445356|NCT01122849|7360955|FG001|NOT COMPLETED|Overall Study||0
6445357|NCT01122849|7360956|FG002|NOT COMPLETED|Overall Study||0
6445358|NCT01122862|7360974|FG000|STARTED|Period 1||8
6445359|NCT01122862|7360975|FG001|STARTED|Period 1||8
6445360|NCT01122862|7360976|FG002|STARTED|Period 1||7
6445361|NCT01122862|7360974|FG000|COMPLETED|Period 1||8
6445362|NCT01122862|7360975|FG001|COMPLETED|Period 1||7
6445363|NCT01122862|7360976|FG002|COMPLETED|Period 1||7
6445364|NCT01122862|7360974|FG000|NOT COMPLETED|Period 1||0
6445365|NCT01122862|7360975|FG001|NOT COMPLETED|Period 1||1
6445366|NCT01122862|7360976|FG002|NOT COMPLETED|Period 1||0
6445367|NCT01122862|7360974|FG000|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
6445368|NCT01122862|7360975|FG001|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
6445369|NCT01122862|7360976|FG002|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
6445370|NCT01122862|7360974|FG000|COMPLETED|Period 2||8
6445371|NCT01122862|7360975|FG001|COMPLETED|Period 2||7
6445372|NCT01122862|7360976|FG002|COMPLETED|Period 2||6
6445373|NCT01122862|7360974|FG000|NOT COMPLETED|Period 2||0
6445374|NCT01122862|7360975|FG001|NOT COMPLETED|Period 2||0
6445375|NCT01122862|7360976|FG002|NOT COMPLETED|Period 2||1
6445376|NCT01122862|7360974|FG000|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
6445377|NCT01122862|7360975|FG001|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
6445378|NCT01122862|7360976|FG002|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
6445379|NCT01122862|7360974|FG000|COMPLETED|Period 3||6
6445380|NCT01122862|7360975|FG001|COMPLETED|Period 3||7
6445381|NCT01122862|7360976|FG002|COMPLETED|Period 3||8
6445382|NCT01122862|7360974|FG000|NOT COMPLETED|Period 3||0
6445383|NCT01122862|7360975|FG001|NOT COMPLETED|Period 3||0
6445384|NCT01122862|7360976|FG002|NOT COMPLETED|Period 3||0
6445385|NCT01122901|7360987|FG000|STARTED|Overall Study||40
6445386|NCT01122901|7360988|FG001|STARTED|Overall Study||7
6445387|NCT01122901|7360987|FG000|COMPLETED|Overall Study||40
6445388|NCT01122901|7360988|FG001|COMPLETED|Overall Study||7
6445389|NCT01122901|7360987|FG000|NOT COMPLETED|Overall Study||0
6445390|NCT01122901|7360988|FG001|NOT COMPLETED|Overall Study||0
6445391|NCT01122927|7360999|FG000|STARTED|Period 1 - Conversion Phase||297
6445392|NCT01122927|7361000|FG001|STARTED|Period 1 - Conversion Phase||0
6445393|NCT01122927|7360999|FG000|COMPLETED|Period 1 - Conversion Phase||283
6445394|NCT01122927|7361000|FG001|COMPLETED|Period 1 - Conversion Phase||0
6445395|NCT01122927|7360999|FG000|NOT COMPLETED|Period 1 - Conversion Phase||14
6445396|NCT01122927|7361000|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
6445397|NCT01122927|7360999|FG000|STARTED|Period 2- Open-label Treatment Phase||0
6445398|NCT01122927|7361000|FG001|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
6445399|NCT01122927|7360999|FG000|COMPLETED|Period 2- Open-label Treatment Phase||0
6553127|NCT01741792|7475627|FG000|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
6553128|NCT01741792|7475628|FG001|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
6553129|NCT01741792|7475629|FG002|STARTED|Overall Study||14
6553130|NCT01741792|7475627|FG000|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
6445400|NCT01122927|7361000|FG001|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
6445401|NCT01122927|7360999|FG000|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
6445402|NCT01122927|7361000|FG001|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
6445403|NCT01123070|7361014|FG000|STARTED|Part A Cohort 1 Open Label Period||3
6445404|NCT01123070|7361015|FG001|STARTED|Part A Cohort 1 Open Label Period||0
6445405|NCT01123070|7361016|FG002|STARTED|Part A Cohort 1 Open Label Period||0
6445406|NCT01123070|7361017|FG003|STARTED|Part A Cohort 1 Open Label Period||0
6445407|NCT01123070|7361014|FG000|COMPLETED|Part A Cohort 1 Open Label Period||3
6445408|NCT01123070|7361015|FG001|COMPLETED|Part A Cohort 1 Open Label Period||0
6445409|NCT01123070|7361016|FG002|COMPLETED|Part A Cohort 1 Open Label Period||0
6445410|NCT01123070|7361017|FG003|COMPLETED|Part A Cohort 1 Open Label Period||0
6445411|NCT01123070|7361014|FG000|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
6445412|NCT01123070|7361015|FG001|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
6445413|NCT01123070|7361016|FG002|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
6445414|NCT01123070|7361017|FG003|NOT COMPLETED|Part A Cohort 1 Open Label Period||0
6445415|NCT01123070|7361014|FG000|STARTED|Part A Cohort 2 Open Label Period||0
6445416|NCT01123070|7361015|FG001|STARTED|Part A Cohort 2 Open Label Period||3
6445417|NCT01123070|7361016|FG002|STARTED|Part A Cohort 2 Open Label Period||0
6445418|NCT01123070|7361017|FG003|STARTED|Part A Cohort 2 Open Label Period||0
6445419|NCT01123070|7361014|FG000|COMPLETED|Part A Cohort 2 Open Label Period||0
6445420|NCT01123070|7361015|FG001|COMPLETED|Part A Cohort 2 Open Label Period||3
6445421|NCT01123070|7361016|FG002|COMPLETED|Part A Cohort 2 Open Label Period||0
6445422|NCT01123070|7361017|FG003|COMPLETED|Part A Cohort 2 Open Label Period||0
6445423|NCT01123070|7361014|FG000|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
6445424|NCT01123070|7361015|FG001|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
6445425|NCT01123070|7361016|FG002|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
6445426|NCT01123070|7361017|FG003|NOT COMPLETED|Part A Cohort 2 Open Label Period||0
6445427|NCT01123070|7361014|FG000|STARTED|Part B Double Blind Period||0
6445428|NCT01123070|7361015|FG001|STARTED|Part B Double Blind Period||0
6445429|NCT01123070|7361016|FG002|STARTED|Part B Double Blind Period||25
6445430|NCT01123070|7361017|FG003|STARTED|Part B Double Blind Period||23
6445431|NCT01123070|7361014|FG000|COMPLETED|Part B Double Blind Period||0
6445432|NCT01123070|7361015|FG001|COMPLETED|Part B Double Blind Period||0
6445433|NCT01123070|7361016|FG002|COMPLETED|Part B Double Blind Period||21
6445434|NCT01123070|7361017|FG003|COMPLETED|Part B Double Blind Period||20
6445435|NCT01123070|7361014|FG000|NOT COMPLETED|Part B Double Blind Period||0
6445436|NCT01123070|7361015|FG001|NOT COMPLETED|Part B Double Blind Period||0
6445437|NCT01123070|7361016|FG002|NOT COMPLETED|Part B Double Blind Period||4
6445438|NCT01123070|7361017|FG003|NOT COMPLETED|Part B Double Blind Period||3
6445439|NCT01123083|7361030|FG000|STARTED|Overall Study||61
6445440|NCT01123083|7361031|FG001|STARTED|Overall Study||118
6445441|NCT01123083|7361030|FG000|COMPLETED|Overall Study||50
6445442|NCT01123083|7361031|FG001|COMPLETED|Overall Study||103
6445443|NCT01123083|7361030|FG000|NOT COMPLETED|Overall Study||11
6445444|NCT01123083|7361031|FG001|NOT COMPLETED|Overall Study||15
6445445|NCT01123148|7361037|FG000|STARTED|Overall Study||14
6445446|NCT01123148|7361037|FG000|BCI Calibration >50% Accuracy|Overall Study||13
6445447|NCT01123148|7361037|FG000|COMPLETED|Overall Study||12
6445448|NCT01123148|7361037|FG000|NOT COMPLETED|Overall Study||2
6445449|NCT01123161|7361043|FG000|STARTED|Overall Study||57
6445450|NCT01123161|7361044|FG001|STARTED|Overall Study||63
6445451|NCT01123161|7361043|FG000|COMPLETED|Overall Study||55
6445452|NCT01123161|7361044|FG001|COMPLETED|Overall Study||63
6445453|NCT01123161|7361043|FG000|NOT COMPLETED|Overall Study||2
6445454|NCT01123161|7361044|FG001|NOT COMPLETED|Overall Study||0
6445455|NCT01123200|7361053|FG000|STARTED|Overall Study||1
6445456|NCT01123200|7361053|FG000|COMPLETED|Overall Study||0
6445457|NCT01123200|7361053|FG000|NOT COMPLETED|Overall Study||1
6445458|NCT01123356|7361057|FG000|STARTED|Overall Study||21
6445459|NCT01123356|7361057|FG000|COMPLETED|Overall Study||14
6445460|NCT01123356|7361057|FG000|NOT COMPLETED|Overall Study||7
6445461|NCT01123382|7361064|FG000|STARTED|Overall Study||13
6445462|NCT01123382|7361065|FG001|STARTED|Overall Study||12
6445463|NCT01123382|7361064|FG000|Received Intervention|Overall Study||12
6445464|NCT01123382|7361065|FG001|Received Intervention|Overall Study||10
6445465|NCT01123382|7361064|FG000|COMPLETED|Overall Study||11
6445466|NCT01123382|7361065|FG001|COMPLETED|Overall Study||6
6445467|NCT01123382|7361064|FG000|NOT COMPLETED|Overall Study||2
6445468|NCT01123382|7361065|FG001|NOT COMPLETED|Overall Study||6
6445469|NCT01123395|7361071|FG000|STARTED|Period 1||8
6445470|NCT01123395|7361072|FG001|STARTED|Period 1||8
6445471|NCT01123395|7361071|FG000|COMPLETED|Period 1||8
6445472|NCT01123395|7361072|FG001|COMPLETED|Period 1||8
6445473|NCT01123395|7361071|FG000|NOT COMPLETED|Period 1||0
6445474|NCT01123395|7361072|FG001|NOT COMPLETED|Period 1||0
6445475|NCT01123395|7361071|FG000|STARTED|Washout Period of 14 Days||8
6445476|NCT01123395|7361072|FG001|STARTED|Washout Period of 14 Days||8
6445477|NCT01123395|7361071|FG000|COMPLETED|Washout Period of 14 Days||8
6445478|NCT01123395|7361072|FG001|COMPLETED|Washout Period of 14 Days||7
6445479|NCT01123395|7361071|FG000|NOT COMPLETED|Washout Period of 14 Days||0
6445480|NCT01123395|7361072|FG001|NOT COMPLETED|Washout Period of 14 Days||1
6445481|NCT01123395|7361071|FG000|STARTED|Period 2||8
6445482|NCT01123395|7361072|FG001|STARTED|Period 2||7
6445483|NCT01123395|7361071|FG000|COMPLETED|Period 2||8
6445484|NCT01123395|7361072|FG001|COMPLETED|Period 2||7
6445485|NCT01123395|7361071|FG000|NOT COMPLETED|Period 2||0
6445486|NCT01123395|7361072|FG001|NOT COMPLETED|Period 2||0
6445487|NCT01123512|7361080|FG000|STARTED|Overall Study||153
6445488|NCT01123512|7361081|FG001|STARTED|Overall Study||147
6445489|NCT01123512|7361080|FG000|COMPLETED|Overall Study||127
6445490|NCT01123512|7361081|FG001|COMPLETED|Overall Study||126
6445491|NCT01123512|7361080|FG000|NOT COMPLETED|Overall Study||26
6445492|NCT01123512|7361081|FG001|NOT COMPLETED|Overall Study||21
6445493|NCT01123642|7361087|FG000|STARTED|Overall Study||345
6445494|NCT01123642|7361087|FG000|COMPLETED|Overall Study||277
6445495|NCT01123642|7361087|FG000|NOT COMPLETED|Overall Study||68
6445496|NCT01123655|7361094|FG000|STARTED|Overall Study||10
6445497|NCT01123655|7361095|FG001|STARTED|Overall Study||4
6445498|NCT01123655|7361096|FG002|STARTED|Overall Study||8
6445499|NCT01123655|7361094|FG000|COMPLETED|Overall Study||9
6445500|NCT01123655|7361095|FG001|COMPLETED|Overall Study||3
6445501|NCT01123655|7361096|FG002|COMPLETED|Overall Study||7
6445502|NCT01123655|7361094|FG000|NOT COMPLETED|Overall Study||1
6445503|NCT01123655|7361095|FG001|NOT COMPLETED|Overall Study||1
6445504|NCT01123655|7361096|FG002|NOT COMPLETED|Overall Study||1
6445505|NCT01123889|7361104|FG000|STARTED|Overall Study||5
6445506|NCT01123889|7361105|FG001|STARTED|Overall Study||7
6445507|NCT01123889|7361104|FG000|COMPLETED|Overall Study||2
6445508|NCT01123889|7361105|FG001|COMPLETED|Overall Study||6
6445509|NCT01123889|7361104|FG000|NOT COMPLETED|Overall Study||3
6445510|NCT01123889|7361105|FG001|NOT COMPLETED|Overall Study||1
6445511|NCT01123928|7361113|FG000|STARTED|Overall Study||212
6445512|NCT01123928|7361114|FG001|STARTED|Overall Study||222
6445513|NCT01123928|7361113|FG000|COMPLETED|Overall Study||212
6445514|NCT01123928|7361114|FG001|COMPLETED|Overall Study||222
6445515|NCT01123928|7361113|FG000|NOT COMPLETED|Overall Study||0
6445516|NCT01123928|7361114|FG001|NOT COMPLETED|Overall Study||0
6445517|NCT01123941|7361122|FG000|STARTED|Overall Study||25
6445518|NCT01123941|7361123|FG001|STARTED|Overall Study||25
6445519|NCT01123941|7361122|FG000|COMPLETED|Overall Study||23
6445520|NCT01123941|7361123|FG001|COMPLETED|Overall Study||24
6445521|NCT01123941|7361122|FG000|NOT COMPLETED|Overall Study||2
6445522|NCT01123941|7361123|FG001|NOT COMPLETED|Overall Study||1
6445523|NCT01123980|7361131|FG000|STARTED|Overall Study||261
6445524|NCT01123980|7361132|FG001|STARTED|Overall Study||260
6445525|NCT01123980|7361131|FG000|COMPLETED|Overall Study||242
6445526|NCT01123980|7361132|FG001|COMPLETED|Overall Study||236
6445527|NCT01123980|7361131|FG000|NOT COMPLETED|Overall Study||19
6445528|NCT01123980|7361132|FG001|NOT COMPLETED|Overall Study||24
6445529|NCT01124006|7361141|FG000|STARTED|Overall Study||10
6445530|NCT01124006|7361142|FG001|STARTED|Overall Study||10
6445531|NCT01124006|7361143|FG002|STARTED|Overall Study||4
6445532|NCT01124006|7361141|FG000|COMPLETED|Overall Study||7
6445533|NCT01124006|7361142|FG001|COMPLETED|Overall Study||8
6445534|NCT01124006|7361143|FG002|COMPLETED|Overall Study||2
6445535|NCT01124006|7361141|FG000|NOT COMPLETED|Overall Study||3
6445536|NCT01124006|7361142|FG001|NOT COMPLETED|Overall Study||2
6445537|NCT01124006|7361143|FG002|NOT COMPLETED|Overall Study||2
6445538|NCT01124045|7361153|FG000|STARTED|Overall Study||39
6445539|NCT01124045|7361154|FG001|STARTED|Overall Study||40
6445540|NCT01124045|7361153|FG000|COMPLETED|Overall Study||39
6445541|NCT01124045|7361154|FG001|COMPLETED|Overall Study||37
6445542|NCT01124045|7361153|FG000|NOT COMPLETED|Overall Study||0
6445543|NCT01124045|7361154|FG001|NOT COMPLETED|Overall Study||3
6445544|NCT01124097|7361164|FG000|STARTED|Overall Study||60
6445545|NCT01124097|7361165|FG001|STARTED|Overall Study||60
6445546|NCT01124097|7361166|FG002|STARTED|Overall Study||60
6553131|NCT01741792|7475628|FG001|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
6553132|NCT01741792|7475629|FG002|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
6553133|NCT01741792|7475627|FG000|COMPLETED|Overall Study||3
6553134|NCT01741792|7475628|FG001|COMPLETED|Overall Study||1
6445547|NCT01124097|7361167|FG003|STARTED|Overall Study||60
6445548|NCT01124097|7361164|FG000|Safety Population|Overall Study||60
6445549|NCT01124097|7361165|FG001|Safety Population|Overall Study||60
6445550|NCT01124097|7361166|FG002|Safety Population|Overall Study||60
6445551|NCT01124097|7361167|FG003|Safety Population|Overall Study||60
6445552|NCT01124097|7361164|FG000|Efficacy Population|Overall Study||52
6445553|NCT01124097|7361165|FG001|Efficacy Population|Overall Study||53
6445554|NCT01124097|7361166|FG002|Efficacy Population|Overall Study||53
6445555|NCT01124097|7361167|FG003|Efficacy Population|Overall Study||51
6445556|NCT01124097|7361164|FG000|COMPLETED|Overall Study||26
6445557|NCT01124097|7361165|FG001|COMPLETED|Overall Study||38
6445558|NCT01124097|7361166|FG002|COMPLETED|Overall Study||40
6445559|NCT01124097|7361167|FG003|COMPLETED|Overall Study||46
6445560|NCT01124097|7361164|FG000|NOT COMPLETED|Overall Study||34
6445561|NCT01124097|7361165|FG001|NOT COMPLETED|Overall Study||22
6445562|NCT01124097|7361166|FG002|NOT COMPLETED|Overall Study||20
6445563|NCT01124097|7361167|FG003|NOT COMPLETED|Overall Study||14
6445564|NCT01124149|7361177|FG000|STARTED|Acute Phase||722
6445565|NCT01124149|7361177|FG000|COMPLETED|Acute Phase||639
6445566|NCT01124149|7361177|FG000|NOT COMPLETED|Acute Phase||83
6445567|NCT01124149|7361177|FG000|STARTED|Maintenance Phase||469
6445568|NCT01124149|7361177|FG000|COMPLETED|Maintenance Phase||373
6445569|NCT01124149|7361177|FG000|NOT COMPLETED|Maintenance Phase||96
6445570|NCT01124162|7361186|FG000|STARTED|First Intervention||40
6445571|NCT01124162|7361187|FG001|STARTED|First Intervention||40
6445572|NCT01124162|7361186|FG000|COMPLETED|First Intervention||38
6445573|NCT01124162|7361187|FG001|COMPLETED|First Intervention||40
6445574|NCT01124162|7361186|FG000|NOT COMPLETED|First Intervention||2
6445575|NCT01124162|7361187|FG001|NOT COMPLETED|First Intervention||0
6445576|NCT01124162|7361186|FG000|STARTED|Washout of 7 Days||38
6445577|NCT01124162|7361187|FG001|STARTED|Washout of 7 Days||40
6445578|NCT01124162|7361186|FG000|COMPLETED|Washout of 7 Days||37
6445579|NCT01124162|7361187|FG001|COMPLETED|Washout of 7 Days||40
6445580|NCT01124162|7361186|FG000|NOT COMPLETED|Washout of 7 Days||1
6445581|NCT01124162|7361187|FG001|NOT COMPLETED|Washout of 7 Days||0
6445582|NCT01124162|7361186|FG000|STARTED|Second Intervention||37
6445583|NCT01124162|7361187|FG001|STARTED|Second Intervention||40
6445584|NCT01124162|7361186|FG000|COMPLETED|Second Intervention||37
6445585|NCT01124162|7361187|FG001|COMPLETED|Second Intervention||40
6445586|NCT01124162|7361186|FG000|NOT COMPLETED|Second Intervention||0
6445587|NCT01124162|7361187|FG001|NOT COMPLETED|Second Intervention||0
6445588|NCT01124175|7361195|FG000|STARTED|First Intervention||40
6445589|NCT01124175|7361196|FG001|STARTED|First Intervention||40
6445590|NCT01124175|7361195|FG000|COMPLETED|First Intervention||40
6445591|NCT01124175|7361196|FG001|COMPLETED|First Intervention||40
6445592|NCT01124175|7361195|FG000|NOT COMPLETED|First Intervention||0
6445593|NCT01124175|7361196|FG001|NOT COMPLETED|First Intervention||0
6445594|NCT01124175|7361195|FG000|STARTED|Washout of 7 Days||40
6445595|NCT01124175|7361196|FG001|STARTED|Washout of 7 Days||40
6445596|NCT01124175|7361195|FG000|COMPLETED|Washout of 7 Days||40
6445597|NCT01124175|7361196|FG001|COMPLETED|Washout of 7 Days||38
6445598|NCT01124175|7361195|FG000|NOT COMPLETED|Washout of 7 Days||0
6445599|NCT01124175|7361196|FG001|NOT COMPLETED|Washout of 7 Days||2
6445600|NCT01124175|7361195|FG000|STARTED|Second Intervention||40
6445601|NCT01124175|7361196|FG001|STARTED|Second Intervention||38
6445602|NCT01124175|7361195|FG000|COMPLETED|Second Intervention||40
6445603|NCT01124175|7361196|FG001|COMPLETED|Second Intervention||38
6445604|NCT01124175|7361195|FG000|NOT COMPLETED|Second Intervention||0
6445605|NCT01124175|7361196|FG001|NOT COMPLETED|Second Intervention||0
6445606|NCT01124188|7361204|FG000|STARTED|Overall Study||68
6445607|NCT01124188|7361205|FG001|STARTED|Overall Study||71
6445608|NCT01124188|7361204|FG000|COMPLETED|Overall Study||60
6445609|NCT01124188|7361205|FG001|COMPLETED|Overall Study||65
6445610|NCT01124188|7361204|FG000|NOT COMPLETED|Overall Study||8
6445611|NCT01124188|7361205|FG001|NOT COMPLETED|Overall Study||6
6445612|NCT01124292|7361214|FG000|STARTED|Overall Study||16
6445613|NCT01124292|7361215|FG001|STARTED|Overall Study||24
6445614|NCT01124292|7361216|FG002|STARTED|Overall Study||21
6445615|NCT01124292|7361214|FG000|COMPLETED|Overall Study||14
6445616|NCT01124292|7361215|FG001|COMPLETED|Overall Study||9
6445617|NCT01124292|7361216|FG002|COMPLETED|Overall Study||11
6445618|NCT01124292|7361214|FG000|NOT COMPLETED|Overall Study||2
6445619|NCT01124292|7361215|FG001|NOT COMPLETED|Overall Study||15
6445620|NCT01124292|7361216|FG002|NOT COMPLETED|Overall Study||10
6445621|NCT01124305|7361229|FG000|STARTED|Overall Study||34
6445622|NCT01124305|7361230|FG001|STARTED|Overall Study||36
6445623|NCT01124305|7361229|FG000|COMPLETED|Overall Study||26
6445624|NCT01124305|7361230|FG001|COMPLETED|Overall Study||26
6445625|NCT01124305|7361229|FG000|NOT COMPLETED|Overall Study||8
6445626|NCT01124305|7361230|FG001|NOT COMPLETED|Overall Study||10
6445627|NCT01124370|7361236|FG000|STARTED|Overall Study|Underwent implant attempt|57
6445628|NCT01124370|7361236|FG000|Successfully Implanted|Overall Study||50
6445629|NCT01124370|7361236|FG000|Therapy Initiated|Overall Study||48
6445630|NCT01124370|7361236|FG000|3 Month Visit|Overall Study|Defines evaluable population|47
6445631|NCT01124370|7361236|FG000|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
6445632|NCT01124370|7361236|FG000|NOT COMPLETED|Overall Study||20
6445633|NCT01124422|7361242|FG000|STARTED|4-Week Open-label Run-in Phase||338
6445634|NCT01124422|7361243|FG001|STARTED|4-Week Open-label Run-in Phase||0
6445635|NCT01124422|7361244|FG002|STARTED|4-Week Open-label Run-in Phase||0
6445636|NCT01124422|7361242|FG000|COMPLETED|4-Week Open-label Run-in Phase||255
6445637|NCT01124422|7361243|FG001|COMPLETED|4-Week Open-label Run-in Phase||0
6445638|NCT01124422|7361244|FG002|COMPLETED|4-Week Open-label Run-in Phase||0
6445639|NCT01124422|7361242|FG000|NOT COMPLETED|4-Week Open-label Run-in Phase||83
6445640|NCT01124422|7361243|FG001|NOT COMPLETED|4-Week Open-label Run-in Phase||0
6445641|NCT01124422|7361244|FG002|NOT COMPLETED|4-Week Open-label Run-in Phase||0
6445642|NCT01124422|7361242|FG000|STARTED|4-Week Double-blind Treatment Phase||0
6445643|NCT01124422|7361243|FG001|STARTED|4-Week Double-blind Treatment Phase||131
6653543|NCT02438371|7583372|FG000|COMPLETED|Overall Study||20
6445644|NCT01124422|7361244|FG002|STARTED|4-Week Double-blind Treatment Phase||124
6445645|NCT01124422|7361242|FG000|COMPLETED|4-Week Double-blind Treatment Phase||0
6445646|NCT01124422|7361243|FG001|COMPLETED|4-Week Double-blind Treatment Phase||120
6445647|NCT01124422|7361244|FG002|COMPLETED|4-Week Double-blind Treatment Phase||115
6445648|NCT01124422|7361242|FG000|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
6445649|NCT01124422|7361243|FG001|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
6445650|NCT01124422|7361244|FG002|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
6445651|NCT01124448|7361253|FG000|STARTED|Overall Study||25
6445652|NCT01124448|7361254|FG001|STARTED|Overall Study||15
6445653|NCT01124448|7361253|FG000|COMPLETED|Overall Study||23
6445654|NCT01124448|7361254|FG001|COMPLETED|Overall Study||12
6445655|NCT01124448|7361253|FG000|NOT COMPLETED|Overall Study||2
6653544|NCT02438371|7583373|FG001|COMPLETED|Overall Study||22
6445656|NCT01124448|7361254|FG001|NOT COMPLETED|Overall Study||3
6445657|NCT01124604|7361262|FG000|STARTED|Overall Study||60
6445658|NCT01124604|7361263|FG001|STARTED|Overall Study||31
6445659|NCT01124604|7361262|FG000|COMPLETED|Overall Study||45
6445660|NCT01124604|7361263|FG001|COMPLETED|Overall Study||29
6445661|NCT01124604|7361262|FG000|NOT COMPLETED|Overall Study||15
6445662|NCT01124604|7361263|FG001|NOT COMPLETED|Overall Study||2
6445663|NCT01124617|7361271|FG000|STARTED|Overall Study||60
6445664|NCT01124617|7361272|FG001|STARTED|Overall Study||31
6445665|NCT01124617|7361271|FG000|COMPLETED|Overall Study||41
6445666|NCT01124617|7361272|FG001|COMPLETED|Overall Study||25
6445667|NCT01124617|7361271|FG000|NOT COMPLETED|Overall Study||19
6445668|NCT01124617|7361272|FG001|NOT COMPLETED|Overall Study||6
6445669|NCT01124643|7361278|FG000|STARTED|Overall Study||35
6445670|NCT01124643|7361278|FG000|COMPLETED|Overall Study||34
6445671|NCT01124643|7361278|FG000|NOT COMPLETED|Overall Study||1
6445672|NCT01124734|7361282|FG000|STARTED|Overall Study||17
6445673|NCT01124734|7361282|FG000|Completion of Course 1 Cycle 1|Overall Study|All 17 participants successfully completed Course 1 Cycle 1|17
6445674|NCT01124734|7361282|FG000|Initiation of Course 1 Cycle 2|Overall Study||17
6445675|NCT01124734|7361282|FG000|COMPLETED|Overall Study|Closed to accrual|0
6445676|NCT01124734|7361282|FG000|NOT COMPLETED|Overall Study||17
6445677|NCT01124786|7361293|FG000|STARTED|Overall Study||182
6445678|NCT01124786|7361294|FG001|STARTED|Overall Study||185
6445679|NCT01124786|7361293|FG000|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
6445680|NCT01124786|7361294|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
6445681|NCT01124786|7361293|FG000|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
6445682|NCT01124786|7361294|FG001|Safety Population|Overall Study||181
6445683|NCT01124786|7361293|FG000|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
6445684|NCT01124786|7361294|FG001|Tumor Evaluable Population|Overall Study||180
6445685|NCT01124786|7361293|FG000|COMPLETED|Overall Study||178
6445686|NCT01124786|7361294|FG001|COMPLETED|Overall Study||180
6445687|NCT01124786|7361293|FG000|NOT COMPLETED|Overall Study||4
6445688|NCT01124786|7361294|FG001|NOT COMPLETED|Overall Study||5
6445689|NCT01124838|7361302|FG000|STARTED|Overall Study||130
6445690|NCT01124838|7361303|FG001|STARTED|Overall Study||131
6445691|NCT01124838|7361302|FG000|Enrolled in Main Study|Overall Study||114
6445692|NCT01124838|7361303|FG001|Enrolled in Main Study|Overall Study||115
6445693|NCT01124838|7361302|FG000|Enrolled in Japan Sub-study|Overall Study||16
6445694|NCT01124838|7361303|FG001|Enrolled in Japan Sub-study|Overall Study||16
6445695|NCT01124838|7361302|FG000|COMPLETED|Overall Study||112
6445696|NCT01124838|7361303|FG001|COMPLETED|Overall Study||116
6445697|NCT01124838|7361302|FG000|NOT COMPLETED|Overall Study||18
6445698|NCT01124838|7361303|FG001|NOT COMPLETED|Overall Study||15
6445699|NCT01124864|7361317|FG000|STARTED|Overall Study||28
6445700|NCT01124864|7361318|FG001|STARTED|Overall Study||35
6445701|NCT01124864|7361319|FG002|STARTED|Overall Study||34
6445702|NCT01124864|7361320|FG003|STARTED|Overall Study||22
6445703|NCT01124864|7361321|FG004|STARTED|Overall Study||31
6445704|NCT01124864|7361322|FG005|STARTED|Overall Study||3
6445705|NCT01124864|7361317|FG000|COMPLETED|Overall Study||0
6445706|NCT01124864|7361318|FG001|COMPLETED|Overall Study||0
6445707|NCT01124864|7361319|FG002|COMPLETED|Overall Study||0
6445708|NCT01124864|7361320|FG003|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
6445709|NCT01124864|7361321|FG004|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
6445710|NCT01124864|7361322|FG005|COMPLETED|Overall Study||0
6445711|NCT01124864|7361317|FG000|NOT COMPLETED|Overall Study||28
6445712|NCT01124864|7361318|FG001|NOT COMPLETED|Overall Study||35
6445713|NCT01124864|7361319|FG002|NOT COMPLETED|Overall Study||34
6445714|NCT01124864|7361320|FG003|NOT COMPLETED|Overall Study||21
6445715|NCT01124864|7361321|FG004|NOT COMPLETED|Overall Study||30
6445716|NCT01124864|7361322|FG005|NOT COMPLETED|Overall Study||3
6445717|NCT01124916|7361340|FG000|STARTED|Overall Study||38
6445718|NCT01124916|7361341|FG001|STARTED|Overall Study||40
6445719|NCT01124916|7361340|FG000|COMPLETED|Overall Study||35
6445720|NCT01124916|7361341|FG001|COMPLETED|Overall Study||38
6445721|NCT01124916|7361340|FG000|NOT COMPLETED|Overall Study||3
6445722|NCT01124916|7361341|FG001|NOT COMPLETED|Overall Study||2
6445723|NCT01124955|7361349|FG000|STARTED|Overall Study||40
6445724|NCT01124955|7361350|FG001|STARTED|Overall Study||40
6445725|NCT01124955|7361349|FG000|COMPLETED|Overall Study||40
6445726|NCT01124955|7361350|FG001|COMPLETED|Overall Study||40
6445727|NCT01124955|7361349|FG000|NOT COMPLETED|Overall Study||0
6445728|NCT01124955|7361350|FG001|NOT COMPLETED|Overall Study||0
6445729|NCT01125046|7361356|FG000|STARTED|First 6 Months of Treatment||50
6445730|NCT01125046|7361356|FG000|COMPLETED|First 6 Months of Treatment||36
6445731|NCT01125046|7361356|FG000|NOT COMPLETED|First 6 Months of Treatment||14
6445732|NCT01125046|7361356|FG000|STARTED|Continued Treatment After 6 Months||36
6445733|NCT01125046|7361356|FG000|COMPLETED|Continued Treatment After 6 Months||33
6445734|NCT01125046|7361356|FG000|NOT COMPLETED|Continued Treatment After 6 Months||3
6445735|NCT01125046|7361356|FG000|STARTED|Follow-up/Data Cut Off Point||49
6445736|NCT01125046|7361356|FG000|COMPLETED|Follow-up/Data Cut Off Point||16
6445737|NCT01125046|7361356|FG000|NOT COMPLETED|Follow-up/Data Cut Off Point||33
6445738|NCT01125098|7361362|FG000|STARTED|Overall Study||91
6445739|NCT01125098|7361363|FG001|STARTED|Overall Study||90
6445740|NCT01125098|7361362|FG000|COMPLETED|Overall Study||88
6445741|NCT01125098|7361363|FG001|COMPLETED|Overall Study||90
6445742|NCT01125098|7361362|FG000|NOT COMPLETED|Overall Study||3
6445743|NCT01125098|7361363|FG001|NOT COMPLETED|Overall Study||0
6445744|NCT01125163|7361371|FG000|STARTED|Overall Study||76
6445745|NCT01125163|7361372|FG001|STARTED|Overall Study||74
6445746|NCT01125163|7361371|FG000|COMPLETED|Overall Study||76
6445747|NCT01125163|7361372|FG001|COMPLETED|Overall Study||74
6445748|NCT01125163|7361371|FG000|NOT COMPLETED|Overall Study||0
6445749|NCT01125163|7361372|FG001|NOT COMPLETED|Overall Study||0
6445750|NCT01125189|7361382|FG000|STARTED|Treatment Period||159
6445751|NCT01125189|7361383|FG001|STARTED|Treatment Period||158
6445752|NCT01125189|7361384|FG002|STARTED|Treatment Period||78
6445753|NCT01125189|7361382|FG000|COMPLETED|Treatment Period||128
6445754|NCT01125189|7361383|FG001|COMPLETED|Treatment Period||123
6445755|NCT01125189|7361384|FG002|COMPLETED|Treatment Period||37
6445756|NCT01125189|7361382|FG000|NOT COMPLETED|Treatment Period||31
6445757|NCT01125189|7361383|FG001|NOT COMPLETED|Treatment Period||35
6445758|NCT01125189|7361384|FG002|NOT COMPLETED|Treatment Period||41
6445759|NCT01125189|7361382|FG000|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
6445760|NCT01125189|7361383|FG001|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
6445761|NCT01125189|7361384|FG002|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
6445762|NCT01125189|7361382|FG000|COMPLETED|Follow up Period||132
6445763|NCT01125189|7361383|FG001|COMPLETED|Follow up Period||138
6445764|NCT01125189|7361384|FG002|COMPLETED|Follow up Period||58
6445765|NCT01125189|7361382|FG000|NOT COMPLETED|Follow up Period||20
6445766|NCT01125189|7361383|FG001|NOT COMPLETED|Follow up Period||15
6445767|NCT01125189|7361384|FG002|NOT COMPLETED|Follow up Period||16
6445768|NCT01125202|7361397|FG000|STARTED|Overall Study||93
6445769|NCT01125202|7361398|FG001|STARTED|Overall Study||86
6445770|NCT01125202|7361397|FG000|COMPLETED|Overall Study||81
6445771|NCT01125202|7361398|FG001|COMPLETED|Overall Study||79
6445772|NCT01125202|7361397|FG000|NOT COMPLETED|Overall Study||12
6445773|NCT01125202|7361398|FG001|NOT COMPLETED|Overall Study||7
6445774|NCT01125293|7361410|FG000|STARTED|Overall Study||3
6445775|NCT01125293|7361411|FG001|STARTED|Overall Study||3
6445776|NCT01125293|7361412|FG002|STARTED|Overall Study||4
6445777|NCT01125293|7361413|FG003|STARTED|Overall Study||3
6445778|NCT01125293|7361414|FG004|STARTED|Overall Study|Per protocol, a 10 patient expansion cohort is used to confirm the MTD determined in Stage B .|10
6445779|NCT01125293|7361415|FG005|STARTED|Overall Study||23
6445780|NCT01125293|7361410|FG000|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
6553135|NCT01741792|7475629|FG002|COMPLETED|Overall Study||2
6553136|NCT01741792|7475627|FG000|NOT COMPLETED|Overall Study||6
6553137|NCT01741792|7475628|FG001|NOT COMPLETED|Overall Study||1
6553138|NCT01741792|7475629|FG002|NOT COMPLETED|Overall Study||12
6445781|NCT01125293|7361411|FG001|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
6445782|NCT01125293|7361412|FG002|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
6445783|NCT01125293|7361413|FG003|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study||3
6445784|NCT01125293|7361414|FG004|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase I dose expansion cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
6445785|NCT01125293|7361415|FG005|Evaluable for Phase I Dose-Limiting Toxicity|Overall Study|The Phase II cohort was not evaluated for cycle 1 dose-limiting toxicity.|0
6445786|NCT01125293|7361410|FG000|COMPLETED|Overall Study||0
6445787|NCT01125293|7361411|FG001|COMPLETED|Overall Study||0
6445788|NCT01125293|7361412|FG002|COMPLETED|Overall Study||0
6445789|NCT01125293|7361413|FG003|COMPLETED|Overall Study||0
6445790|NCT01125293|7361414|FG004|COMPLETED|Overall Study||0
6445791|NCT01125293|7361415|FG005|COMPLETED|Overall Study||0
6445792|NCT01125293|7361410|FG000|NOT COMPLETED|Overall Study||3
6445793|NCT01125293|7361411|FG001|NOT COMPLETED|Overall Study||3
6445794|NCT01125293|7361412|FG002|NOT COMPLETED|Overall Study||4
6445795|NCT01125293|7361413|FG003|NOT COMPLETED|Overall Study||3
6445796|NCT01125293|7361414|FG004|NOT COMPLETED|Overall Study||10
6445797|NCT01125293|7361415|FG005|NOT COMPLETED|Overall Study||23
6445798|NCT01125358|7361436|FG000|STARTED|Overall Study||21
6445799|NCT01125358|7361437|FG001|STARTED|Overall Study||21
6445800|NCT01125358|7361438|FG002|STARTED|Overall Study||20
6445801|NCT01125358|7361439|FG003|STARTED|Overall Study||20
6445802|NCT01125358|7361436|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
6445803|NCT01125358|7361437|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
6445804|NCT01125358|7361438|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
6445805|NCT01125358|7361439|FG003|Received at Least 1 Dose of Study Drug|Overall Study||20
6445806|NCT01125358|7361436|FG000|Placebo Responder|Overall Study||1
6445807|NCT01125358|7361437|FG001|Placebo Responder|Overall Study||0
6445808|NCT01125358|7361438|FG002|Placebo Responder|Overall Study||0
6445809|NCT01125358|7361439|FG003|Placebo Responder|Overall Study||0
6445810|NCT01125358|7361436|FG000|COMPLETED|Overall Study||9
6445811|NCT01125358|7361437|FG001|COMPLETED|Overall Study||17
6445812|NCT01125358|7361438|FG002|COMPLETED|Overall Study||11
6445813|NCT01125358|7361439|FG003|COMPLETED|Overall Study||12
6445814|NCT01125358|7361436|FG000|NOT COMPLETED|Overall Study||12
6445815|NCT01125358|7361437|FG001|NOT COMPLETED|Overall Study||4
6445816|NCT01125358|7361438|FG002|NOT COMPLETED|Overall Study||9
6445817|NCT01125358|7361439|FG003|NOT COMPLETED|Overall Study||8
6553139|NCT01742065|7475645|FG000|STARTED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
6445818|NCT04733664|7361449|FG000|STARTED|Overall Study||10
6653545|NCT02438371|7583372|FG000|NOT COMPLETED|Overall Study||4
6653546|NCT02438371|7583373|FG001|NOT COMPLETED|Overall Study||3
6656180|NCT02458469|7586291|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||0
6445819|NCT04733664|7361449|FG000|COMPLETED|Overall Study||10
6445820|NCT04733664|7361449|FG000|NOT COMPLETED|Overall Study||0
6656181|NCT02458469|7586292|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
6656182|NCT02458469|7586293|FG003|NOT COMPLETED|Third Intervention (2 Weeks)||0
6656183|NCT02458469|7586294|FG004|NOT COMPLETED|Third Intervention (2 Weeks)||0
6656184|NCT02458469|7586295|FG005|NOT COMPLETED|Third Intervention (2 Weeks)||0
6656185|NCT02458638|7586303|FG000|STARTED|Overall Study||474
6656186|NCT02458638|7586303|FG000|COMPLETED|Overall Study||15
6445861|NCT03884270|7361505|FG000|STARTED|Overall Study||23
6445862|NCT03884270|7361505|FG000|COMPLETED|Overall Study||22
6445863|NCT03884270|7361505|FG000|NOT COMPLETED|Overall Study||1
6656187|NCT02458638|7586303|FG000|NOT COMPLETED|Overall Study||459
6656188|NCT02458690|7586309|FG000|STARTED|Overall Study||107
6445864|NCT03621696|7361513|FG000|STARTED|Overall Study||21
6445865|NCT03621696|7361514|FG001|STARTED|Overall Study||31
6445866|NCT03621696|7361515|FG002|STARTED|Overall Study||6
6445867|NCT03621696|7361516|FG003|STARTED|Overall Study||5
6445868|NCT03621696|7361513|FG000|COMPLETED|Overall Study||20
6445869|NCT03621696|7361514|FG001|COMPLETED|Overall Study||30
6445870|NCT03621696|7361515|FG002|COMPLETED|Overall Study||4
6445871|NCT03621696|7361516|FG003|COMPLETED|Overall Study||0
6445872|NCT03621696|7361513|FG000|NOT COMPLETED|Overall Study||1
6445873|NCT03621696|7361514|FG001|NOT COMPLETED|Overall Study||1
6445874|NCT03621696|7361515|FG002|NOT COMPLETED|Overall Study||2
6445875|NCT03621696|7361516|FG003|NOT COMPLETED|Overall Study||5
6445876|NCT03544268|7361526|FG000|STARTED|Overall Study||5
6445877|NCT03544268|7361527|FG001|STARTED|Overall Study||15
6445878|NCT03544268|7361526|FG000|COMPLETED|Overall Study||3
6445879|NCT03544268|7361527|FG001|COMPLETED|Overall Study||15
6445880|NCT03544268|7361526|FG000|NOT COMPLETED|Overall Study||2
6445881|NCT03544268|7361527|FG001|NOT COMPLETED|Overall Study||0
6445882|NCT03530995|7361535|FG000|STARTED|Part 1 Period 1; Part 2 Period 1||35
6445883|NCT03530995|7361536|FG001|STARTED|Part 1 Period 1; Part 2 Period 1||38
6445884|NCT03530995|7361535|FG000|COMPLETED|Part 1 Period 1; Part 2 Period 1||35
6445885|NCT03530995|7361536|FG001|COMPLETED|Part 1 Period 1; Part 2 Period 1||38
6445886|NCT03530995|7361535|FG000|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
6445887|NCT03530995|7361536|FG001|NOT COMPLETED|Part 1 Period 1; Part 2 Period 1||0
6445888|NCT03530995|7361535|FG000|STARTED|Part 1 Period 2; Part 2 Period 2||35
6445889|NCT03530995|7361536|FG001|STARTED|Part 1 Period 2; Part 2 Period 2||38
6445890|NCT03530995|7361535|FG000|COMPLETED|Part 1 Period 2; Part 2 Period 2||35
6445891|NCT03530995|7361536|FG001|COMPLETED|Part 1 Period 2; Part 2 Period 2||38
6445892|NCT03530995|7361535|FG000|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
6445893|NCT03530995|7361536|FG001|NOT COMPLETED|Part 1 Period 2; Part 2 Period 2||0
6445894|NCT03530995|7361535|FG000|STARTED|Part 1 Period 3||35
6445895|NCT03530995|7361536|FG001|STARTED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
6445896|NCT03530995|7361535|FG000|COMPLETED|Part 1 Period 3||32
6445897|NCT03530995|7361536|FG001|COMPLETED|Part 1 Period 3|Period 3 is not applicable to part 2 of the study.|0
6445898|NCT03530995|7361535|FG000|NOT COMPLETED|Part 1 Period 3||3
6445899|NCT03530995|7361536|FG001|NOT COMPLETED|Part 1 Period 3||0
6445900|NCT03530995|7361535|FG000|STARTED|Part 1 Period 4||32
6445901|NCT03530995|7361536|FG001|STARTED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
6445902|NCT03530995|7361535|FG000|COMPLETED|Part 1 Period 4||30
6445903|NCT03530995|7361536|FG001|COMPLETED|Part 1 Period 4|Period 4 is not applicable to part 2 of the study.|0
6445904|NCT03530995|7361535|FG000|NOT COMPLETED|Part 1 Period 4||2
6445905|NCT03530995|7361536|FG001|NOT COMPLETED|Part 1 Period 4||0
6445906|NCT03421197|7361562|FG000|STARTED|Overall Study||105
6445907|NCT03421197|7361563|FG001|STARTED|Overall Study||107
6445908|NCT03421197|7361564|FG002|STARTED|Overall Study||107
6445909|NCT03421197|7361565|FG003|STARTED|Overall Study||107
6445910|NCT03421197|7361562|FG000|COMPLETED|Overall Study||67
6445911|NCT03421197|7361563|FG001|COMPLETED|Overall Study||68
6445912|NCT03421197|7361564|FG002|COMPLETED|Overall Study||56
6445913|NCT03421197|7361565|FG003|COMPLETED|Overall Study||62
6445914|NCT03421197|7361562|FG000|NOT COMPLETED|Overall Study||38
6445915|NCT03421197|7361563|FG001|NOT COMPLETED|Overall Study||39
6445916|NCT03421197|7361564|FG002|NOT COMPLETED|Overall Study||51
6445917|NCT03421197|7361565|FG003|NOT COMPLETED|Overall Study||45
6445918|NCT03371108|7361577|FG000|STARTED|Safety Analysis Set||284
6445919|NCT03371108|7361578|FG001|STARTED|Safety Analysis Set||283
6445920|NCT03371108|7361577|FG000|COMPLETED|Safety Analysis Set||281
6445921|NCT03371108|7361578|FG001|COMPLETED|Safety Analysis Set||282
6445922|NCT03371108|7361577|FG000|NOT COMPLETED|Safety Analysis Set||3
6445923|NCT03371108|7361578|FG001|NOT COMPLETED|Safety Analysis Set||1
6445924|NCT03371108|7361577|FG000|STARTED|Completers||281
6445925|NCT03371108|7361578|FG001|STARTED|Completers||282
6445926|NCT03371108|7361577|FG000|COMPLETED|Completers||259
6656189|NCT02458690|7586310|FG001|STARTED|Overall Study||109
6656190|NCT02458690|7586309|FG000|COMPLETED|Overall Study||99
6445927|NCT03371108|7361578|FG001|COMPLETED|Completers||256
6445928|NCT03371108|7361577|FG000|NOT COMPLETED|Completers||22
6445929|NCT03371108|7361578|FG001|NOT COMPLETED|Completers||26
6445930|NCT03112993|7361586|FG000|STARTED|Overall Study||19
6445931|NCT03112993|7361587|FG001|STARTED|Overall Study||21
6445821|NCT04573322|7361457|FG000|STARTED|Overall Study||6
6445822|NCT04573322|7361458|FG001|STARTED|Overall Study||6
6445823|NCT04573322|7361459|FG002|STARTED|Overall Study||7
6445824|NCT04573322|7361460|FG003|STARTED|Overall Study||6
6445825|NCT04573322|7361457|FG000|COMPLETED|Overall Study||5
6445826|NCT04573322|7361458|FG001|COMPLETED|Overall Study||4
6445827|NCT04573322|7361459|FG002|COMPLETED|Overall Study||5
6445828|NCT04573322|7361460|FG003|COMPLETED|Overall Study||3
6445829|NCT04573322|7361457|FG000|NOT COMPLETED|Overall Study||1
6445830|NCT04573322|7361458|FG001|NOT COMPLETED|Overall Study||2
6653547|NCT02438384|7583382|FG000|STARTED|Overall Study||25
6653548|NCT02438384|7583383|FG001|STARTED|Overall Study||25
6653549|NCT02438384|7583384|FG002|STARTED|Overall Study||25
6653550|NCT02438384|7583382|FG000|COMPLETED|Overall Study||17
6653551|NCT02438384|7583383|FG001|COMPLETED|Overall Study||19
6653552|NCT02438384|7583384|FG002|COMPLETED|Overall Study||21
6653553|NCT02438384|7583382|FG000|NOT COMPLETED|Overall Study||8
6653554|NCT02438384|7583383|FG001|NOT COMPLETED|Overall Study||6
6653555|NCT02438384|7583384|FG002|NOT COMPLETED|Overall Study||4
6445831|NCT04573322|7361459|FG002|NOT COMPLETED|Overall Study||2
6445832|NCT04573322|7361460|FG003|NOT COMPLETED|Overall Study||3
6445833|NCT04516746|7361472|FG000|STARTED|Overall Study||21635
6445834|NCT04516746|7361473|FG001|STARTED|Overall Study||10816
6445835|NCT04516746|7361472|FG000|Participants Who Received First Dose|Overall Study||21583
6445836|NCT04516746|7361473|FG001|Participants Who Received First Dose|Overall Study||10796
6445837|NCT04516746|7361472|FG000|Participants Who Received Second Dose|Overall Study||20769
6445838|NCT04516746|7361473|FG001|Participants Who Received Second Dose|Overall Study||9951
6445839|NCT04516746|7361472|FG000|COMPLETED|Overall Study||0
6445840|NCT04516746|7361473|FG001|COMPLETED|Overall Study||0
6445841|NCT04516746|7361472|FG000|NOT COMPLETED|Overall Study||21635
6445842|NCT04516746|7361473|FG001|NOT COMPLETED|Overall Study||10816
6445843|NCT04374565|7361479|FG000|STARTED|Overall Study||29
6445844|NCT04374565|7361479|FG000|COMPLETED|Overall Study||29
6445845|NCT04374565|7361479|FG000|NOT COMPLETED|Overall Study||0
6445846|NCT04364737|7361485|FG000|STARTED|Overall Study||468
6445847|NCT04364737|7361486|FG001|STARTED|Overall Study||473
6445848|NCT04364737|7361485|FG000|COMPLETED|Overall Study||463
6445849|NCT04364737|7361486|FG001|COMPLETED|Overall Study||463
6445850|NCT04364737|7361485|FG000|NOT COMPLETED|Overall Study||5
6445851|NCT04364737|7361486|FG001|NOT COMPLETED|Overall Study||10
6445852|NCT04354155|7361492|FG000|STARTED|Overall Study||40
6445853|NCT04354155|7361492|FG000|COMPLETED|Overall Study||38
6445854|NCT04354155|7361492|FG000|NOT COMPLETED|Overall Study||2
6445855|NCT04085367|7361498|FG000|STARTED|Overall Study||364
6445856|NCT04085367|7361499|FG001|STARTED|Overall Study||193
6445857|NCT04085367|7361498|FG000|COMPLETED|Overall Study||344
6445858|NCT04085367|7361499|FG001|COMPLETED|Overall Study||185
6445859|NCT04085367|7361498|FG000|NOT COMPLETED|Overall Study||20
6445860|NCT04085367|7361499|FG001|NOT COMPLETED|Overall Study||8
6445932|NCT03112993|7361586|FG000|COMPLETED|Overall Study||19
6445933|NCT03112993|7361587|FG001|COMPLETED|Overall Study||21
6445934|NCT03112993|7361586|FG000|NOT COMPLETED|Overall Study||0
6445935|NCT03112993|7361587|FG001|NOT COMPLETED|Overall Study||0
6445936|NCT03088137|7361597|FG000|STARTED|Overall Study||55
6445937|NCT03088137|7361598|FG001|STARTED|Overall Study||55
6445938|NCT03088137|7361597|FG000|COMPLETED|Overall Study||55
6445939|NCT03088137|7361598|FG001|COMPLETED|Overall Study||55
6445940|NCT03088137|7361597|FG000|NOT COMPLETED|Overall Study||0
6445941|NCT03088137|7361598|FG001|NOT COMPLETED|Overall Study||0
6445942|NCT03038438|7361604|FG000|STARTED|Overall Study||200
6445943|NCT03038438|7361604|FG000|30-Day Follow-Up|Overall Study||198
6445944|NCT03038438|7361604|FG000|6-Month Follow-up|Overall Study||193
6445945|NCT03038438|7361604|FG000|12-Month Follow-up|Overall Study||191
6445946|NCT03038438|7361604|FG000|24-Month Follow-up|Overall Study||148
6445947|NCT03038438|7361604|FG000|COMPLETED|Overall Study||148
6445948|NCT03038438|7361604|FG000|NOT COMPLETED|Overall Study||52
6445949|NCT02951481|7361610|FG000|STARTED|Overall Study||231
6445950|NCT02951481|7361611|FG001|STARTED|Overall Study||172
6445951|NCT02951481|7361610|FG000|COMPLETED|Overall Study||231
6445952|NCT02951481|7361611|FG001|COMPLETED|Overall Study||172
6445953|NCT02951481|7361610|FG000|NOT COMPLETED|Overall Study||0
6445954|NCT02951481|7361611|FG001|NOT COMPLETED|Overall Study||0
6445955|NCT02574481|7361621|FG000|STARTED|Overall Study||309
6445956|NCT02574481|7361622|FG001|STARTED|Overall Study||156
6445957|NCT02574481|7361623|FG002|STARTED|Overall Study||50
6445958|NCT02574481|7361624|FG003|STARTED|Overall Study||13
6445959|NCT02574481|7361621|FG000|COMPLETED|Overall Study||282
6445960|NCT02574481|7361622|FG001|COMPLETED|Overall Study||142
6445961|NCT02574481|7361623|FG002|COMPLETED|Overall Study||47
6445962|NCT02574481|7361624|FG003|COMPLETED|Overall Study||13
6445963|NCT02574481|7361621|FG000|NOT COMPLETED|Overall Study||27
6445964|NCT02574481|7361622|FG001|NOT COMPLETED|Overall Study||14
6445965|NCT02574481|7361623|FG002|NOT COMPLETED|Overall Study||3
6445966|NCT02574481|7361624|FG003|NOT COMPLETED|Overall Study||0
6445967|NCT02557139|7361640|FG000|STARTED|Overall Study||8
6445968|NCT02557139|7361641|FG001|STARTED|Overall Study||8
6445969|NCT02557139|7361642|FG002|STARTED|Overall Study||7
6445970|NCT02557139|7361640|FG000|COMPLETED|Overall Study||6
6653556|NCT02438423|7583396|FG000|STARTED|Overall Study||25
6445971|NCT02557139|7361641|FG001|COMPLETED|Overall Study||8
6445972|NCT02557139|7361642|FG002|COMPLETED|Overall Study||5
6653557|NCT02438423|7583397|FG001|STARTED|Overall Study||25
6445973|NCT02557139|7361640|FG000|NOT COMPLETED|Overall Study||2
6445974|NCT02557139|7361641|FG001|NOT COMPLETED|Overall Study||0
6445975|NCT02557139|7361642|FG002|NOT COMPLETED|Overall Study||2
6445976|NCT02451943|7361661|FG000|STARTED|Overall Study||258
6445977|NCT02451943|7361662|FG001|STARTED|Overall Study||251
6445978|NCT02451943|7361661|FG000|Received at Least One Dose of Study Drug|Overall Study||257
6445979|NCT02451943|7361662|FG001|Received at Least One Dose of Study Drug|Overall Study||249
6445980|NCT02451943|7361661|FG000|Leiomyosarcoma (LMS) Population|Overall Study||119
6445981|NCT02451943|7361662|FG001|Leiomyosarcoma (LMS) Population|Overall Study||115
6445982|NCT02451943|7361661|FG000|COMPLETED|Overall Study||238
6445983|NCT02451943|7361662|FG001|COMPLETED|Overall Study||227
6445984|NCT02451943|7361661|FG000|NOT COMPLETED|Overall Study||20
6445985|NCT02451943|7361662|FG001|NOT COMPLETED|Overall Study||24
6445986|NCT02312258|7361670|FG000|STARTED|Overall Study||281
6445987|NCT02312258|7361671|FG001|STARTED|Overall Study||425
6445988|NCT02312258|7361670|FG000|COMPLETED|Overall Study||30
6445989|NCT02312258|7361671|FG001|COMPLETED|Overall Study||66
6445990|NCT02312258|7361670|FG000|NOT COMPLETED|Overall Study||251
6445991|NCT02312258|7361671|FG001|NOT COMPLETED|Overall Study||359
6445992|NCT02242942|7361680|FG000|STARTED|Overall Study||216
6553140|NCT01742065|7475646|FG001|STARTED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
6553141|NCT01742065|7475645|FG000|COMPLETED|Overall Study|20059 patients were analyzed in 13 clinics.|20059
6553142|NCT01742065|7475646|FG001|COMPLETED|Overall Study|21134 patients were analyzed in 13 clinics.|21134
6445993|NCT02242942|7361681|FG001|STARTED|Overall Study||216
6445994|NCT02242942|7361682|FG002|STARTED|Overall Study||13
6445995|NCT02242942|7361680|FG000|Treated|Overall Study||214
6445996|NCT02242942|7361681|FG001|Treated|Overall Study||212
6445997|NCT02242942|7361682|FG002|Treated|Overall Study||13
6445998|NCT02242942|7361680|FG000|COMPLETED|Overall Study||0
6445999|NCT02242942|7361681|FG001|COMPLETED|Overall Study||0
6446000|NCT02242942|7361682|FG002|COMPLETED|Overall Study||0
6446001|NCT02242942|7361680|FG000|NOT COMPLETED|Overall Study||216
6446002|NCT02242942|7361681|FG001|NOT COMPLETED|Overall Study||216
6446003|NCT02242942|7361682|FG002|NOT COMPLETED|Overall Study||13
6500254|NCT01424397|7419095|FG008|NOT COMPLETED|Period-1 (8 Days)||0
6500255|NCT01424397|7419096|FG009|NOT COMPLETED|Period-1 (8 Days)||0
6500256|NCT01424397|7419097|FG010|NOT COMPLETED|Period-1 (8 Days)||0
6500257|NCT01424397|7419098|FG011|NOT COMPLETED|Period-1 (8 Days)||0
6500258|NCT01424397|7419087|FG000|STARTED|Washout Period-1 (14-20 Days)||7
6500259|NCT01424397|7419088|FG001|STARTED|Washout Period-1 (14-20 Days)||8
6500260|NCT01424397|7419089|FG002|STARTED|Washout Period-1 (14-20 Days)||8
6500261|NCT01424397|7419090|FG003|STARTED|Washout Period-1 (14-20 Days)||8
6500262|NCT01424397|7419091|FG004|STARTED|Washout Period-1 (14-20 Days)||8
6500263|NCT01424397|7419092|FG005|STARTED|Washout Period-1 (14-20 Days)||8
6500264|NCT01424397|7419093|FG006|STARTED|Washout Period-1 (14-20 Days)||4
6500265|NCT01424397|7419094|FG007|STARTED|Washout Period-1 (14-20 Days)||4
6500266|NCT01424397|7419095|FG008|STARTED|Washout Period-1 (14-20 Days)||4
6500267|NCT01424397|7419096|FG009|STARTED|Washout Period-1 (14-20 Days)||3
6500268|NCT01424397|7419097|FG010|STARTED|Washout Period-1 (14-20 Days)||4
6500269|NCT01424397|7419098|FG011|STARTED|Washout Period-1 (14-20 Days)||4
6500270|NCT01424397|7419087|FG000|COMPLETED|Washout Period-1 (14-20 Days)||7
6500271|NCT01424397|7419088|FG001|COMPLETED|Washout Period-1 (14-20 Days)||8
6500272|NCT01424397|7419089|FG002|COMPLETED|Washout Period-1 (14-20 Days)||8
6500273|NCT01424397|7419090|FG003|COMPLETED|Washout Period-1 (14-20 Days)||8
6500274|NCT01424397|7419091|FG004|COMPLETED|Washout Period-1 (14-20 Days)||8
6500275|NCT01424397|7419092|FG005|COMPLETED|Washout Period-1 (14-20 Days)||8
6500276|NCT01424397|7419093|FG006|COMPLETED|Washout Period-1 (14-20 Days)||4
6500277|NCT01424397|7419094|FG007|COMPLETED|Washout Period-1 (14-20 Days)||4
6500278|NCT01424397|7419095|FG008|COMPLETED|Washout Period-1 (14-20 Days)||4
6500279|NCT01424397|7419096|FG009|COMPLETED|Washout Period-1 (14-20 Days)||3
6500280|NCT01424397|7419097|FG010|COMPLETED|Washout Period-1 (14-20 Days)||4
6500281|NCT01424397|7419098|FG011|COMPLETED|Washout Period-1 (14-20 Days)||4
6500282|NCT01424397|7419087|FG000|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500283|NCT01424397|7419088|FG001|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500284|NCT01424397|7419089|FG002|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500285|NCT01424397|7419090|FG003|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500286|NCT01424397|7419091|FG004|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500287|NCT01424397|7419092|FG005|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500288|NCT01424397|7419093|FG006|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500289|NCT01424397|7419094|FG007|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500290|NCT01424397|7419095|FG008|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500291|NCT01424397|7419096|FG009|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500292|NCT01424397|7419097|FG010|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500293|NCT01424397|7419098|FG011|NOT COMPLETED|Washout Period-1 (14-20 Days)||0
6500294|NCT01424397|7419087|FG000|STARTED|Period-2 (8 Days)||7
6553143|NCT01742065|7475645|FG000|NOT COMPLETED|Overall Study||0
6553144|NCT01742065|7475646|FG001|NOT COMPLETED|Overall Study||0
6553145|NCT01742078|7475661|FG000|STARTED|Overall Study||6
6553146|NCT01742078|7475662|FG001|STARTED|Overall Study||6
6553147|NCT01742078|7475663|FG002|STARTED|Overall Study||6
6553148|NCT01742078|7475664|FG003|STARTED|Overall Study||6
6500295|NCT01424397|7419088|FG001|STARTED|Period-2 (8 Days)||8
6500296|NCT01424397|7419089|FG002|STARTED|Period-2 (8 Days)||8
6553149|NCT01742078|7475665|FG004|STARTED|Overall Study||6
6446004|NCT02198794|7361692|FG000|STARTED|Part A: Open-Label (158 Weeks)||337
6446005|NCT02198794|7361693|FG001|STARTED|Part A: Open-Label (158 Weeks)||0
6446006|NCT02198794|7361694|FG002|STARTED|Part A: Open-Label (158 Weeks)||0
6446007|NCT02198794|7361695|FG003|STARTED|Part A: Open-Label (158 Weeks)||0
6446008|NCT02198794|7361692|FG000|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||337
6446009|NCT02198794|7361693|FG001|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
6446010|NCT02198794|7361694|FG002|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
6446011|NCT02198794|7361695|FG003|Received at Least 1 Dose of Study Drug|Part A: Open-Label (158 Weeks)||0
6446012|NCT02198794|7361692|FG000|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||337
6446013|NCT02198794|7361693|FG001|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
6446014|NCT02198794|7361694|FG002|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
6446015|NCT02198794|7361695|FG003|Intent-to-Treat (ITT) Population|Part A: Open-Label (158 Weeks)||0
6446016|NCT02198794|7361692|FG000|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||195
6446017|NCT02198794|7361693|FG001|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
6446018|NCT02198794|7361694|FG002|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
6446019|NCT02198794|7361695|FG003|Participants Who Participated in Part A But Not in Part B|Part A: Open-Label (158 Weeks)||0
6446020|NCT02198794|7361692|FG000|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||142
6446021|NCT02198794|7361693|FG001|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
6446022|NCT02198794|7361694|FG002|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
6446023|NCT02198794|7361695|FG003|Participants Who Agreed to Continue in Part B|Part A: Open-Label (158 Weeks)||0
6446024|NCT02198794|7361692|FG000|COMPLETED|Part A: Open-Label (158 Weeks)||32
6446025|NCT02198794|7361693|FG001|COMPLETED|Part A: Open-Label (158 Weeks)||0
6446026|NCT02198794|7361694|FG002|COMPLETED|Part A: Open-Label (158 Weeks)||0
6446027|NCT02198794|7361695|FG003|COMPLETED|Part A: Open-Label (158 Weeks)||0
6446028|NCT02198794|7361692|FG000|NOT COMPLETED|Part A: Open-Label (158 Weeks)||305
6446029|NCT02198794|7361693|FG001|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
6446030|NCT02198794|7361694|FG002|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
6446031|NCT02198794|7361695|FG003|NOT COMPLETED|Part A: Open-Label (158 Weeks)||0
6446032|NCT02198794|7361692|FG000|STARTED|Part B: Randomized (13 Weeks)||0
6446033|NCT02198794|7361693|FG001|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
6446034|NCT02198794|7361694|FG002|STARTED|Part B: Randomized (13 Weeks)|Participants of Part A who agreed to participate in Part B|71
6446035|NCT02198794|7361695|FG003|STARTED|Part B: Randomized (13 Weeks)||0
6446036|NCT02198794|7361692|FG000|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
6446037|NCT02198794|7361693|FG001|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||63
6446038|NCT02198794|7361694|FG002|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||65
6446039|NCT02198794|7361695|FG003|Randomized Withdrawal mITT Population|Part B: Randomized (13 Weeks)||0
6446040|NCT02198794|7361692|FG000|COMPLETED|Part B: Randomized (13 Weeks)||0
6446041|NCT02198794|7361693|FG001|COMPLETED|Part B: Randomized (13 Weeks)||66
6446042|NCT02198794|7361694|FG002|COMPLETED|Part B: Randomized (13 Weeks)||68
6446043|NCT02198794|7361695|FG003|COMPLETED|Part B: Randomized (13 Weeks)||0
6446044|NCT02198794|7361692|FG000|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
6446045|NCT02198794|7361693|FG001|NOT COMPLETED|Part B: Randomized (13 Weeks)||5
6446046|NCT02198794|7361694|FG002|NOT COMPLETED|Part B: Randomized (13 Weeks)||3
6446047|NCT02198794|7361695|FG003|NOT COMPLETED|Part B: Randomized (13 Weeks)||0
6446048|NCT02198794|7361692|FG000|STARTED|Part C: Safety Assessment (52 Weeks)||0
6446049|NCT02198794|7361693|FG001|STARTED|Part C: Safety Assessment (52 Weeks)||0
6446050|NCT02198794|7361694|FG002|STARTED|Part C: Safety Assessment (52 Weeks)||0
6446051|NCT02198794|7361695|FG003|STARTED|Part C: Safety Assessment (52 Weeks)||80
6446052|NCT02198794|7361692|FG000|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
6446053|NCT02198794|7361693|FG001|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
6446054|NCT02198794|7361694|FG002|COMPLETED|Part C: Safety Assessment (52 Weeks)||0
6446055|NCT02198794|7361695|FG003|COMPLETED|Part C: Safety Assessment (52 Weeks)||73
6446056|NCT02198794|7361692|FG000|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
6446057|NCT02198794|7361693|FG001|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
6446058|NCT02198794|7361694|FG002|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||0
6446059|NCT02198794|7361695|FG003|NOT COMPLETED|Part C: Safety Assessment (52 Weeks)||7
6446060|NCT01877655|7361706|FG000|STARTED|Overall Study||263
6446061|NCT01877655|7361707|FG001|STARTED|Overall Study||251
6446062|NCT01877655|7361706|FG000|Received Treatment|Overall Study||255
6446063|NCT01877655|7361707|FG001|Received Treatment|Overall Study||246
6446064|NCT01877655|7361706|FG000|COMPLETED|Overall Study||165
6446065|NCT01877655|7361707|FG001|COMPLETED|Overall Study||154
6446066|NCT01877655|7361706|FG000|NOT COMPLETED|Overall Study||98
6446067|NCT01877655|7361707|FG001|NOT COMPLETED|Overall Study||97
6446068|NCT00308685|7361715|FG000|STARTED|Overall Study||50
6446069|NCT00308685|7361716|FG001|STARTED|Overall Study||45
6446070|NCT00308685|7361715|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
6446071|NCT00308685|7361716|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
6446072|NCT00308685|7361715|FG000|COMPLETED|Overall Study||47
6446073|NCT00308685|7361716|FG001|COMPLETED|Overall Study||40
6446074|NCT00308685|7361715|FG000|NOT COMPLETED|Overall Study||3
6446075|NCT00308685|7361716|FG001|NOT COMPLETED|Overall Study||5
6446076|NCT01125514|7361722|FG000|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
6446077|NCT01125514|7361722|FG000|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
6446078|NCT01125514|7361722|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
6446079|NCT01125514|7361722|FG000|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
6446080|NCT01125514|7361722|FG000|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
6446081|NCT01125514|7361722|FG000|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
6446082|NCT01125514|7361722|FG000|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
6446083|NCT01125514|7361722|FG000|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
6446084|NCT01125514|7361722|FG000|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
6446085|NCT01125514|7361722|FG000|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
6446086|NCT01125514|7361722|FG000|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
6446087|NCT01125566|7361738|FG000|STARTED|Patients Before the Switch (26Apr2013)||339
6446088|NCT01125566|7361739|FG001|STARTED|Patients Before the Switch (26Apr2013)||169
6446089|NCT01125566|7361740|FG002|STARTED|Patients Before the Switch (26Apr2013)||0
6446090|NCT01125566|7361738|FG000|Treated|Patients Before the Switch (26Apr2013)||337
6446091|NCT01125566|7361739|FG001|Treated|Patients Before the Switch (26Apr2013)||169
6446092|NCT01125566|7361740|FG002|Treated|Patients Before the Switch (26Apr2013)||0
6446093|NCT01125566|7361738|FG000|COMPLETED|Patients Before the Switch (26Apr2013)||74
6446094|NCT01125566|7361739|FG001|COMPLETED|Patients Before the Switch (26Apr2013)||0
6446095|NCT01125566|7361740|FG002|COMPLETED|Patients Before the Switch (26Apr2013)||0
6446096|NCT01125566|7361738|FG000|NOT COMPLETED|Patients Before the Switch (26Apr2013)||265
6446097|NCT01125566|7361739|FG001|NOT COMPLETED|Patients Before the Switch (26Apr2013)||169
6446098|NCT01125566|7361740|FG002|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
6446099|NCT01125566|7361738|FG000|STARTED|Patients Who Switched From AV to TV||0
6446100|NCT01125566|7361739|FG001|STARTED|Patients Who Switched From AV to TV||0
6446101|NCT01125566|7361740|FG002|STARTED|Patients Who Switched From AV to TV||75
6446102|NCT01125566|7361738|FG000|COMPLETED|Patients Who Switched From AV to TV||0
6446103|NCT01125566|7361739|FG001|COMPLETED|Patients Who Switched From AV to TV||0
6446104|NCT01125566|7361740|FG002|COMPLETED|Patients Who Switched From AV to TV||2
6446105|NCT01125566|7361738|FG000|NOT COMPLETED|Patients Who Switched From AV to TV||0
6446106|NCT01125566|7361739|FG001|NOT COMPLETED|Patients Who Switched From AV to TV||0
6446107|NCT01125566|7361740|FG002|NOT COMPLETED|Patients Who Switched From AV to TV||73
6446108|NCT01125605|7361747|FG000|STARTED|Overall Study|started = had baseline values|325
6446109|NCT01125605|7361747|FG000|Safety|Overall Study|1 patient was only analysed for safety|326
6446110|NCT01125605|7361747|FG000|COMPLETED|Overall Study||325
6446111|NCT01125605|7361747|FG000|NOT COMPLETED|Overall Study||0
6446112|NCT01125722|7361766|FG000|STARTED|Overall Study||37
6446113|NCT01125722|7361767|FG001|STARTED|Overall Study||37
6446114|NCT01125722|7361766|FG000|COMPLETED|Overall Study||34
6446115|NCT01125722|7361767|FG001|COMPLETED|Overall Study||36
6446116|NCT01125722|7361766|FG000|NOT COMPLETED|Overall Study||3
6446117|NCT01125722|7361767|FG001|NOT COMPLETED|Overall Study||1
6446118|NCT01125748|7361775|FG000|STARTED|Overall Study||88
6446119|NCT01125748|7361776|FG001|STARTED|Overall Study||88
6446120|NCT01125748|7361775|FG000|COMPLETED|Overall Study||78
6446121|NCT01125748|7361776|FG001|COMPLETED|Overall Study||74
6446122|NCT01125748|7361775|FG000|NOT COMPLETED|Overall Study||10
6446123|NCT01125748|7361776|FG001|NOT COMPLETED|Overall Study||14
6446124|NCT01125774|7361784|FG000|STARTED|Overall Study|Randomized|3018
6446125|NCT01125774|7361785|FG001|STARTED|Overall Study|Randomized|1502
6446126|NCT01125774|7361786|FG002|STARTED|Overall Study|Unique participants randomized|22
6446127|NCT01125774|7361787|FG003|STARTED|Overall Study|Unique participants randomized|6
6446128|NCT01125774|7361784|FG000|Treated|Overall Study||2638
6446129|NCT01125774|7361785|FG001|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
6446130|NCT01125774|7361786|FG002|Treated|Overall Study|Received telcagepant|21
6446131|NCT01125774|7361787|FG003|Treated|Overall Study||5
6446132|NCT01125774|7361784|FG000|COMPLETED|Overall Study||1893
6446133|NCT01125774|7361785|FG001|COMPLETED|Overall Study||948
6446134|NCT01125774|7361786|FG002|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
6446135|NCT01125774|7361787|FG003|COMPLETED|Overall Study|Completed study at least once|3
6446136|NCT01125774|7361784|FG000|NOT COMPLETED|Overall Study||1125
6446137|NCT01125774|7361785|FG001|NOT COMPLETED|Overall Study||554
6446138|NCT01125774|7361786|FG002|NOT COMPLETED|Overall Study||9
6446139|NCT01125774|7361787|FG003|NOT COMPLETED|Overall Study||3
6446140|NCT01125800|7361798|FG000|STARTED|Phase I||11
6446141|NCT01125800|7361799|FG001|STARTED|Phase I||16
6446142|NCT01125800|7361800|FG002|STARTED|Phase I||11
6446143|NCT01125800|7361801|FG003|STARTED|Phase I||21
6446144|NCT01125800|7361802|FG004|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
6446145|NCT01125800|7361798|FG000|COMPLETED|Phase I||3
6446146|NCT01125800|7361799|FG001|COMPLETED|Phase I||7
6446147|NCT01125800|7361800|FG002|COMPLETED|Phase I||7
6446148|NCT01125800|7361801|FG003|COMPLETED|Phase I||10
6446149|NCT01125800|7361802|FG004|COMPLETED|Phase I||0
6446150|NCT01125800|7361798|FG000|NOT COMPLETED|Phase I||8
6446151|NCT01125800|7361799|FG001|NOT COMPLETED|Phase I||9
6446152|NCT01125800|7361800|FG002|NOT COMPLETED|Phase I||4
6446153|NCT01125800|7361801|FG003|NOT COMPLETED|Phase I||11
6446154|NCT01125800|7361802|FG004|NOT COMPLETED|Phase I||0
6446155|NCT01125800|7361798|FG000|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
6446156|NCT01125800|7361799|FG001|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
6446157|NCT01125800|7361800|FG002|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
6446158|NCT01125800|7361801|FG003|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
6446159|NCT01125800|7361802|FG004|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
6446160|NCT01125800|7361798|FG000|COMPLETED|Phase II||0
6446161|NCT01125800|7361799|FG001|COMPLETED|Phase II||0
6446162|NCT01125800|7361800|FG002|COMPLETED|Phase II||0
6446163|NCT01125800|7361801|FG003|COMPLETED|Phase II||0
6446164|NCT01125800|7361802|FG004|COMPLETED|Phase II||5
6446165|NCT01125800|7361798|FG000|NOT COMPLETED|Phase II||0
6446166|NCT01125800|7361799|FG001|NOT COMPLETED|Phase II||0
6446167|NCT01125800|7361800|FG002|NOT COMPLETED|Phase II||0
6446168|NCT01125800|7361801|FG003|NOT COMPLETED|Phase II||1
6446169|NCT01125800|7361802|FG004|NOT COMPLETED|Phase II||11
6446170|NCT01125813|7361817|FG000|STARTED|Overall Study||36
6446171|NCT01125813|7361817|FG000|COMPLETED|Overall Study||30
6446172|NCT01125813|7361817|FG000|NOT COMPLETED|Overall Study||6
6446173|NCT01125917|7361821|FG000|STARTED|Overall Study||354
6446174|NCT01125917|7361821|FG000|COMPLETED|Overall Study||15
6446175|NCT01125917|7361821|FG000|NOT COMPLETED|Overall Study||339
6446176|NCT01125930|7361827|FG000|STARTED|Overall Study||22
6446177|NCT01125930|7361828|FG001|STARTED|Overall Study||46
6446178|NCT01125930|7361827|FG000|COMPLETED|Overall Study||21
6446179|NCT01125930|7361828|FG001|COMPLETED|Overall Study||36
6446180|NCT01125930|7361827|FG000|NOT COMPLETED|Overall Study||1
6446181|NCT01125930|7361828|FG001|NOT COMPLETED|Overall Study||10
6446182|NCT01126060|7361852|FG000|STARTED|Overall Study||40
6446183|NCT01126060|7361853|FG001|STARTED|Overall Study||40
6446184|NCT01126060|7361852|FG000|COMPLETED|Overall Study||40
6446185|NCT01126060|7361853|FG001|COMPLETED|Overall Study||38
6446186|NCT01126060|7361852|FG000|NOT COMPLETED|Overall Study||0
6446187|NCT01126060|7361853|FG001|NOT COMPLETED|Overall Study||2
6446188|NCT01126099|7361861|FG000|STARTED|Double Blind Phase||11
6446189|NCT01126099|7361862|FG001|STARTED|Double Blind Phase||9
6446190|NCT01126099|7361861|FG000|COMPLETED|Double Blind Phase||7
6446191|NCT01126099|7361862|FG001|COMPLETED|Double Blind Phase||7
6446192|NCT01126099|7361861|FG000|NOT COMPLETED|Double Blind Phase||4
6446193|NCT01126099|7361862|FG001|NOT COMPLETED|Double Blind Phase||2
6446194|NCT01126099|7361861|FG000|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
6446195|NCT01126099|7361862|FG001|STARTED|Open-label Extension||7
6446196|NCT01126099|7361861|FG000|COMPLETED|Open-label Extension||4
6446197|NCT01126099|7361862|FG001|COMPLETED|Open-label Extension||6
6446198|NCT01126099|7361861|FG000|NOT COMPLETED|Open-label Extension||1
6446199|NCT01126099|7361862|FG001|NOT COMPLETED|Open-label Extension||1
6446200|NCT01126268|7361868|FG000|STARTED|Overall Study||38
6446201|NCT01126268|7361868|FG000|COMPLETED|Overall Study||37
6446202|NCT01126268|7361868|FG000|NOT COMPLETED|Overall Study||1
6653558|NCT02438423|7583398|FG002|STARTED|Overall Study||25
6446203|NCT01126359|7361872|FG000|STARTED|First Intervention (20-minutes)||5
6446204|NCT01126359|7361873|FG001|STARTED|First Intervention (20-minutes)||6
6446205|NCT01126359|7361872|FG000|COMPLETED|First Intervention (20-minutes)||5
6446206|NCT01126359|7361873|FG001|COMPLETED|First Intervention (20-minutes)||5
6446207|NCT01126359|7361872|FG000|NOT COMPLETED|First Intervention (20-minutes)||0
6446208|NCT01126359|7361873|FG001|NOT COMPLETED|First Intervention (20-minutes)||1
6446209|NCT01126359|7361872|FG000|STARTED|Dressing Replacement/Healing (48-hours)||5
6446210|NCT01126359|7361873|FG001|STARTED|Dressing Replacement/Healing (48-hours)||5
6446211|NCT01126359|7361872|FG000|COMPLETED|Dressing Replacement/Healing (48-hours)||5
6446212|NCT01126359|7361873|FG001|COMPLETED|Dressing Replacement/Healing (48-hours)||5
6446213|NCT01126359|7361872|FG000|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
6446214|NCT01126359|7361873|FG001|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
6446215|NCT01126359|7361872|FG000|STARTED|Second Intervention (20-minutes)||5
6446216|NCT01126359|7361873|FG001|STARTED|Second Intervention (20-minutes)||5
6446217|NCT01126359|7361872|FG000|COMPLETED|Second Intervention (20-minutes)||5
6446218|NCT01126359|7361873|FG001|COMPLETED|Second Intervention (20-minutes)||5
6446219|NCT01126359|7361872|FG000|NOT COMPLETED|Second Intervention (20-minutes)||0
6446220|NCT01126359|7361873|FG001|NOT COMPLETED|Second Intervention (20-minutes)||0
6446221|NCT01126424|7361889|FG000|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
6446222|NCT01126424|7361890|FG001|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
6446223|NCT01126424|7361891|FG002|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
6446224|NCT01126424|7361892|FG003|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
6446225|NCT01126424|7361893|FG004|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
6446226|NCT01126424|7361894|FG005|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
6446227|NCT01126424|7361889|FG000|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
6446228|NCT01126424|7361890|FG001|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6553150|NCT01742078|7475666|FG005|STARTED|Overall Study||6
6446229|NCT01126424|7361891|FG002|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6446230|NCT01126424|7361892|FG003|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6446231|NCT01126424|7361893|FG004|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6446232|NCT01126424|7361894|FG005|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
6446233|NCT01126424|7361889|FG000|COMPLETED|Overall Study||3
6446234|NCT01126424|7361890|FG001|COMPLETED|Overall Study||4
6446235|NCT01126424|7361891|FG002|COMPLETED|Overall Study||4
6446236|NCT01126424|7361892|FG003|COMPLETED|Overall Study||3
6446237|NCT01126424|7361893|FG004|COMPLETED|Overall Study||2
6446238|NCT01126424|7361894|FG005|COMPLETED|Overall Study||4
6446239|NCT01126424|7361889|FG000|NOT COMPLETED|Overall Study||0
6446240|NCT01126424|7361890|FG001|NOT COMPLETED|Overall Study||0
6446241|NCT01126424|7361891|FG002|NOT COMPLETED|Overall Study||1
6446242|NCT01126424|7361892|FG003|NOT COMPLETED|Overall Study||3
6446243|NCT01126424|7361893|FG004|NOT COMPLETED|Overall Study||2
6446244|NCT01126424|7361894|FG005|NOT COMPLETED|Overall Study||0
6446245|NCT01126437|7361905|FG000|STARTED|Overall Study||5741
6446246|NCT01126437|7361906|FG001|STARTED|Overall Study||5729
6446247|NCT01126437|7361907|FG002|STARTED|Overall Study||5713
6446248|NCT01126437|7361905|FG000|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
6446249|NCT01126437|7361906|FG001|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
6446250|NCT01126437|7361907|FG002|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
6446251|NCT01126437|7361905|FG000|NOT COMPLETED|Overall Study||1341
6446252|NCT01126437|7361906|FG001|NOT COMPLETED|Overall Study||1330
6446253|NCT01126437|7361907|FG002|NOT COMPLETED|Overall Study||1313
6446254|NCT01126541|7361918|FG000|STARTED|Overall Study||70
6446255|NCT01126541|7361919|FG001|STARTED|Overall Study||73
6446256|NCT01126541|7361920|FG002|STARTED|Overall Study||81
6446257|NCT01126541|7361918|FG000|COMPLETED|Overall Study||60
6446258|NCT01126541|7361919|FG001|COMPLETED|Overall Study||61
6446259|NCT01126541|7361920|FG002|COMPLETED|Overall Study||55
6446260|NCT01126541|7361918|FG000|NOT COMPLETED|Overall Study||10
6446261|NCT01126541|7361919|FG001|NOT COMPLETED|Overall Study||12
6446262|NCT01126541|7361920|FG002|NOT COMPLETED|Overall Study||26
6446263|NCT01126580|7361933|FG000|STARTED|Overall Study||269
6446264|NCT01126580|7361934|FG001|STARTED|Overall Study||270
6446265|NCT01126580|7361935|FG002|STARTED|Overall Study||268
6446266|NCT01126580|7361933|FG000|Received at Least 1 Dose of Study Drug|Overall Study||269
6446267|NCT01126580|7361934|FG001|Received at Least 1 Dose of Study Drug|Overall Study||270
6446268|NCT01126580|7361935|FG002|Received at Least 1 Dose of Study Drug|Overall Study||268
6446269|NCT01126580|7361933|FG000|Completed 26 Weeks|Overall Study||233
6446270|NCT01126580|7361934|FG001|Completed 26 Weeks|Overall Study||242
6446271|NCT01126580|7361935|FG002|Completed 26 Weeks|Overall Study||226
6446272|NCT01126580|7361933|FG000|COMPLETED|Overall Study||220
6446273|NCT01126580|7361934|FG001|COMPLETED|Overall Study||218
6446274|NCT01126580|7361935|FG002|COMPLETED|Overall Study||213
6446275|NCT01126580|7361933|FG000|NOT COMPLETED|Overall Study||49
6446276|NCT01126580|7361934|FG001|NOT COMPLETED|Overall Study||52
6446277|NCT01126580|7361935|FG002|NOT COMPLETED|Overall Study||55
6446278|NCT01126593|7361947|FG000|STARTED|Overall Study||33
6446279|NCT01126593|7361948|FG001|STARTED|Overall Study||29
6446280|NCT01126593|7361949|FG002|STARTED|Overall Study||34
6446281|NCT01126593|7361947|FG000|COMPLETED|Overall Study||29
6446282|NCT01126593|7361948|FG001|COMPLETED|Overall Study||27
6446283|NCT01126593|7361949|FG002|COMPLETED|Overall Study||32
6446284|NCT01126593|7361947|FG000|NOT COMPLETED|Overall Study||4
6446285|NCT01126593|7361948|FG001|NOT COMPLETED|Overall Study||2
6446286|NCT01126593|7361949|FG002|NOT COMPLETED|Overall Study||2
6446287|NCT01126619|7361957|FG000|STARTED|Overall Study||103
6446288|NCT01126619|7361957|FG000|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
6446289|NCT01126619|7361957|FG000|NOT COMPLETED|Overall Study||17
6446290|NCT01126671|7361965|FG000|STARTED|Overall Study||26
6446291|NCT01126671|7361966|FG001|STARTED|Overall Study||30
6446292|NCT01126671|7361965|FG000|COMPLETED|Overall Study||24
6446293|NCT01126671|7361966|FG001|COMPLETED|Overall Study||29
6446294|NCT01126671|7361965|FG000|NOT COMPLETED|Overall Study||2
6446295|NCT01126671|7361966|FG001|NOT COMPLETED|Overall Study||1
6446296|NCT01126723|7361976|FG000|STARTED|Overall Study||35
6446297|NCT01126723|7361977|FG001|STARTED|Overall Study||31
6446298|NCT01126723|7361976|FG000|COMPLETED|Overall Study||29
6446299|NCT01126723|7361977|FG001|COMPLETED|Overall Study||28
6446300|NCT01126723|7361976|FG000|NOT COMPLETED|Overall Study||6
6446301|NCT01126723|7361977|FG001|NOT COMPLETED|Overall Study||3
6446302|NCT01127061|7361985|FG000|STARTED|Overall Study||67
6446303|NCT01127061|7361986|FG001|STARTED|Overall Study||69
6446304|NCT01127061|7361985|FG000|COMPLETED|Overall Study||57
6446305|NCT01127061|7361986|FG001|COMPLETED|Overall Study||56
6446306|NCT01127061|7361985|FG000|NOT COMPLETED|Overall Study||10
6446307|NCT01127061|7361986|FG001|NOT COMPLETED|Overall Study||13
6446308|NCT01127087|7361994|FG000|STARTED|Overall Study||8
6446309|NCT01127087|7361995|FG001|STARTED|Overall Study||2
6446310|NCT01127087|7361994|FG000|COMPLETED|Overall Study||8
6446311|NCT01127087|7361995|FG001|COMPLETED|Overall Study||2
6446312|NCT01127087|7361994|FG000|NOT COMPLETED|Overall Study||0
6446313|NCT01127087|7361995|FG001|NOT COMPLETED|Overall Study||0
6446314|NCT01127139|7362003|FG000|STARTED|Overall Study||3828
6446315|NCT01127139|7362003|FG000|Number of Participants Analyzed|Overall Study||3828
6446316|NCT01127139|7362003|FG000|COMPLETED|Overall Study||3771
6446317|NCT01127139|7362003|FG000|NOT COMPLETED|Overall Study||57
6446318|NCT01127165|7362012|FG000|STARTED|Overall Study||65
6446319|NCT01127165|7362013|FG001|STARTED|Overall Study||60
6446320|NCT01127165|7362012|FG000|COMPLETED|Overall Study||49
6446321|NCT01127165|7362013|FG001|COMPLETED|Overall Study||41
6446322|NCT01127165|7362012|FG000|NOT COMPLETED|Overall Study||16
6446323|NCT01127165|7362013|FG001|NOT COMPLETED|Overall Study||19
6446324|NCT01127321|7362024|FG000|STARTED|Overall Study||3
6446325|NCT01127321|7362025|FG001|STARTED|Overall Study||1
6446326|NCT01127321|7362026|FG002|STARTED|Overall Study||1
6446327|NCT01127321|7362027|FG003|STARTED|Overall Study||7
6446328|NCT01127321|7362028|FG004|STARTED|Overall Study||5
6446329|NCT01127321|7362024|FG000|COMPLETED|Overall Study||3
6446330|NCT01127321|7362025|FG001|COMPLETED|Overall Study||1
6446331|NCT01127321|7362026|FG002|COMPLETED|Overall Study||1
6446332|NCT01127321|7362027|FG003|COMPLETED|Overall Study||7
6446333|NCT01127321|7362028|FG004|COMPLETED|Overall Study||5
6446334|NCT01127321|7362024|FG000|NOT COMPLETED|Overall Study||0
6446335|NCT01127321|7362025|FG001|NOT COMPLETED|Overall Study||0
6446336|NCT01127321|7362026|FG002|NOT COMPLETED|Overall Study||0
6446337|NCT01127321|7362027|FG003|NOT COMPLETED|Overall Study||0
6446338|NCT01127321|7362028|FG004|NOT COMPLETED|Overall Study||0
6446339|NCT01127373|7362040|FG000|STARTED|Overall Study||116
6446340|NCT01127373|7362040|FG000|COMPLETED|Overall Study||104
6446341|NCT01127373|7362040|FG000|NOT COMPLETED|Overall Study||12
6446342|NCT01127438|7362050|FG000|STARTED|Overall Study||25
6446343|NCT01127438|7362051|FG001|STARTED|Overall Study||25
6446344|NCT01127438|7362052|FG002|STARTED|Overall Study||26
6553151|NCT01742078|7475667|FG006|STARTED|Overall Study||6
6553152|NCT01742078|7475668|FG007|STARTED|Overall Study||6
6553153|NCT01742078|7475669|FG008|STARTED|Overall Study||12
6553154|NCT01742078|7475661|FG000|RECEIVED STUDY DRUG|Overall Study||6
6553155|NCT01742078|7475662|FG001|RECEIVED STUDY DRUG|Overall Study||6
6553156|NCT01742078|7475663|FG002|RECEIVED STUDY DRUG|Overall Study||6
6553157|NCT01742078|7475664|FG003|RECEIVED STUDY DRUG|Overall Study||6
6553158|NCT01742078|7475665|FG004|RECEIVED STUDY DRUG|Overall Study||6
6653559|NCT02438423|7583399|FG003|STARTED|Overall Study||25
6653560|NCT02438423|7583396|FG000|COMPLETED|Overall Study||25
6653561|NCT02438423|7583397|FG001|COMPLETED|Overall Study||25
6653562|NCT02438423|7583398|FG002|COMPLETED|Overall Study||25
6446345|NCT01127438|7362053|FG003|STARTED|Overall Study||24
6446346|NCT01127438|7362054|FG004|STARTED|Overall Study||28
6446347|NCT01127438|7362055|FG005|STARTED|Overall Study||25
6446348|NCT01127438|7362050|FG000|COMPLETED|Overall Study||25
6446349|NCT01127438|7362051|FG001|COMPLETED|Overall Study||25
6446350|NCT01127438|7362052|FG002|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
6446351|NCT01127438|7362053|FG003|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
6446352|NCT01127438|7362054|FG004|COMPLETED|Overall Study||28
6446353|NCT01127438|7362055|FG005|COMPLETED|Overall Study||25
6446354|NCT01127438|7362050|FG000|NOT COMPLETED|Overall Study||0
6446355|NCT01127438|7362051|FG001|NOT COMPLETED|Overall Study||0
6446356|NCT01127438|7362052|FG002|NOT COMPLETED|Overall Study||0
6446357|NCT01127438|7362053|FG003|NOT COMPLETED|Overall Study||0
6446358|NCT01127438|7362054|FG004|NOT COMPLETED|Overall Study||0
6446359|NCT01127438|7362055|FG005|NOT COMPLETED|Overall Study||0
6446360|NCT01127581|7362067|FG000|STARTED|Overall Study||678
6446361|NCT01127581|7362068|FG001|STARTED|Overall Study||680
6446362|NCT01127581|7362067|FG000|COMPLETED|Overall Study||678
6446363|NCT01127581|7362068|FG001|COMPLETED|Overall Study||680
6553159|NCT01742078|7475666|FG005|RECEIVED STUDY DRUG|Overall Study||6
6653563|NCT02438423|7583399|FG003|COMPLETED|Overall Study||25
6653564|NCT02438423|7583396|FG000|NOT COMPLETED|Overall Study||0
6653565|NCT02438423|7583397|FG001|NOT COMPLETED|Overall Study||0
6653566|NCT02438423|7583398|FG002|NOT COMPLETED|Overall Study||0
6653567|NCT02438423|7583399|FG003|NOT COMPLETED|Overall Study||0
6653568|NCT02438475|7583413|FG000|STARTED|Overall Study||104
6653569|NCT02438475|7583414|FG001|STARTED|Overall Study||104
6653570|NCT02438475|7583413|FG000|COMPLETED|Overall Study||102
6653571|NCT02438475|7583414|FG001|COMPLETED|Overall Study||104
6653572|NCT02438475|7583413|FG000|NOT COMPLETED|Overall Study||2
6653573|NCT02438475|7583414|FG001|NOT COMPLETED|Overall Study||0
6446364|NCT01127581|7362067|FG000|NOT COMPLETED|Overall Study||0
6446365|NCT01127581|7362068|FG001|NOT COMPLETED|Overall Study||0
6446366|NCT01127607|7362076|FG000|STARTED|Phase I (Within Subjects)||14
6446367|NCT01127607|7362077|FG001|STARTED|Phase I (Within Subjects)||13
6446368|NCT01127607|7362076|FG000|COMPLETED|Phase I (Within Subjects)||14
6446369|NCT01127607|7362077|FG001|COMPLETED|Phase I (Within Subjects)||13
6553160|NCT01742078|7475667|FG006|RECEIVED STUDY DRUG|Overall Study||6
6553161|NCT01742078|7475668|FG007|RECEIVED STUDY DRUG|Overall Study||6
6446370|NCT01127607|7362076|FG000|NOT COMPLETED|Phase I (Within Subjects)||0
6446371|NCT01127607|7362077|FG001|NOT COMPLETED|Phase I (Within Subjects)||0
6446372|NCT01127607|7362076|FG000|STARTED|Phase II (Between Subjects)||14
6446373|NCT01127607|7362077|FG001|STARTED|Phase II (Between Subjects)||13
6446374|NCT01127607|7362076|FG000|COMPLETED|Phase II (Between Subjects)||13
6446375|NCT01127607|7362077|FG001|COMPLETED|Phase II (Between Subjects)||11
6446376|NCT01127607|7362076|FG000|NOT COMPLETED|Phase II (Between Subjects)||1
6446377|NCT01127607|7362077|FG001|NOT COMPLETED|Phase II (Between Subjects)||2
6446378|NCT01127633|7362102|FG000|STARTED|Overall Study||723
6446379|NCT01127633|7362103|FG001|STARTED|Overall Study||734
6446380|NCT01127633|7362102|FG000|Received at Least 1 Dose of Study Drug|Overall Study||723
6446381|NCT01127633|7362103|FG001|Received at Least 1 Dose of Study Drug|Overall Study||734
6446382|NCT01127633|7362102|FG000|COMPLETED|Overall Study||70
6446383|NCT01127633|7362103|FG001|COMPLETED|Overall Study||61
6446384|NCT01127633|7362102|FG000|NOT COMPLETED|Overall Study||653
6446385|NCT01127633|7362103|FG001|NOT COMPLETED|Overall Study||673
6446386|NCT01127646|7362111|FG000|STARTED|Overall Study||15
6446387|NCT01127646|7362112|FG001|STARTED|Overall Study||8
6446388|NCT01127646|7362111|FG000|COMPLETED|Overall Study||14
6446389|NCT01127646|7362112|FG001|COMPLETED|Overall Study||7
6446390|NCT01127646|7362111|FG000|NOT COMPLETED|Overall Study||1
6446391|NCT01127646|7362112|FG001|NOT COMPLETED|Overall Study||1
6446392|NCT01127659|7362126|FG000|STARTED|Overall Study||22
6446393|NCT01127659|7362127|FG001|STARTED|Overall Study||22
6446394|NCT01127659|7362128|FG002|STARTED|Overall Study||12
6446395|NCT01127659|7362129|FG003|STARTED|Overall Study||10
6446396|NCT01127659|7362130|FG004|STARTED|Overall Study||50
6446397|NCT01127659|7362131|FG005|STARTED|Overall Study||21
6446398|NCT01127659|7362126|FG000|COMPLETED|Overall Study||20
6446399|NCT01127659|7362127|FG001|COMPLETED|Overall Study||14
6446400|NCT01127659|7362128|FG002|COMPLETED|Overall Study||10
6446401|NCT01127659|7362129|FG003|COMPLETED|Overall Study||6
6446402|NCT01127659|7362130|FG004|COMPLETED|Overall Study||50
6446403|NCT01127659|7362131|FG005|COMPLETED|Overall Study||21
6446404|NCT01127659|7362126|FG000|NOT COMPLETED|Overall Study||2
6446405|NCT01127659|7362127|FG001|NOT COMPLETED|Overall Study||8
6446406|NCT01127659|7362128|FG002|NOT COMPLETED|Overall Study||2
6446407|NCT01127659|7362129|FG003|NOT COMPLETED|Overall Study||4
6446408|NCT01127659|7362130|FG004|NOT COMPLETED|Overall Study||0
6446409|NCT01127659|7362131|FG005|NOT COMPLETED|Overall Study||0
6446410|NCT01127737|7362147|FG000|STARTED|Overall Study||37
6446411|NCT01127737|7362148|FG001|STARTED|Overall Study||38
6446412|NCT01127737|7362147|FG000|COMPLETED|Overall Study||37
6446413|NCT01127737|7362148|FG001|COMPLETED|Overall Study||38
6446414|NCT01127737|7362147|FG000|NOT COMPLETED|Overall Study||0
6446415|NCT01127737|7362148|FG001|NOT COMPLETED|Overall Study||0
6446416|NCT01127763|7362154|FG000|STARTED|Overall Study||25
6446417|NCT01127763|7362154|FG000|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
6446418|NCT01127763|7362154|FG000|NOT COMPLETED|Overall Study||5
6446419|NCT01127893|7362162|FG000|STARTED|Overall Study||1
6446420|NCT01127893|7362162|FG000|COMPLETED|Overall Study||0
6446421|NCT01127893|7362162|FG000|NOT COMPLETED|Overall Study||1
6446422|NCT01128049|7362169|FG000|STARTED|Overall Study||5
6446423|NCT01128049|7362170|FG001|STARTED|Overall Study||5
6446424|NCT01128049|7362171|FG002|STARTED|Overall Study||5
6446425|NCT01128049|7362169|FG000|COMPLETED|Overall Study||5
6446426|NCT01128049|7362170|FG001|COMPLETED|Overall Study||5
6446427|NCT01128049|7362171|FG002|COMPLETED|Overall Study||5
6446428|NCT01128049|7362169|FG000|NOT COMPLETED|Overall Study||0
6446429|NCT01128049|7362170|FG001|NOT COMPLETED|Overall Study||0
6446430|NCT01128049|7362171|FG002|NOT COMPLETED|Overall Study||0
6446431|NCT01128153|7362181|FG000|STARTED|Overall Study|Randomised|129
6446432|NCT01128153|7362182|FG001|STARTED|Overall Study|Randomised|128
6446433|NCT01128153|7362181|FG000|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
6446434|NCT01128153|7362182|FG001|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
6446435|NCT01128153|7362181|FG000|COMPLETED|Overall Study|Completed 24 weeks|113
6446436|NCT01128153|7362182|FG001|COMPLETED|Overall Study|Completed 24 weeks|113
6446437|NCT01128153|7362181|FG000|NOT COMPLETED|Overall Study||16
6446438|NCT01128153|7362182|FG001|NOT COMPLETED|Overall Study||15
6446439|NCT01128179|7362190|FG000|STARTED|Overall Study||23
6446440|NCT01128179|7362191|FG001|STARTED|Overall Study||12
6446441|NCT01128179|7362190|FG000|COMPLETED|Overall Study||21
6553162|NCT01742078|7475669|FG008|RECEIVED STUDY DRUG|Overall Study||12
6553163|NCT01742078|7475661|FG000|COMPLETED|Overall Study||6
6553164|NCT01742078|7475662|FG001|COMPLETED|Overall Study||6
6446442|NCT01128179|7362191|FG001|COMPLETED|Overall Study||12
6446443|NCT01128179|7362190|FG000|NOT COMPLETED|Overall Study||2
6446444|NCT01128179|7362191|FG001|NOT COMPLETED|Overall Study||0
6446445|NCT01128192|7362199|FG000|STARTED|Overall Study||19
6446446|NCT01128192|7362200|FG001|STARTED|Overall Study||19
6446447|NCT01128192|7362201|FG002|STARTED|Overall Study||7
6446448|NCT01128192|7362199|FG000|COMPLETED|Overall Study||19
6446449|NCT01128192|7362200|FG001|COMPLETED|Overall Study||19
6446450|NCT01128192|7362201|FG002|COMPLETED|Overall Study||7
6446451|NCT01128192|7362199|FG000|NOT COMPLETED|Overall Study||0
6446452|NCT01128192|7362200|FG001|NOT COMPLETED|Overall Study||0
6446453|NCT01128192|7362201|FG002|NOT COMPLETED|Overall Study||0
6446454|NCT01128244|7362212|FG000|STARTED|Overall Study||13
6446455|NCT01128244|7362212|FG000|COMPLETED|Overall Study||10
6446456|NCT01128244|7362212|FG000|NOT COMPLETED|Overall Study||3
6446457|NCT01128270|7362220|FG000|STARTED|Environment Chloral Hydrate and DCA (1A)||7
6446458|NCT01128270|7362220|FG000|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
6446459|NCT01128270|7362220|FG000|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
6446460|NCT01128270|7362220|FG000|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
6446461|NCT01128270|7362220|FG000|COMPLETED|Environmental Chloral Hydrate (1B)||8
6446462|NCT01128270|7362220|FG000|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
6446463|NCT01128270|7362220|FG000|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
6446464|NCT01128270|7362220|FG000|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
6446465|NCT01128270|7362220|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
6446466|NCT01128270|7362220|FG000|STARTED|Therapeutic Chloral Hydrate (2B)||8
6446467|NCT01128270|7362220|FG000|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
6446468|NCT01128270|7362220|FG000|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
6446469|NCT01128296|7362232|FG000|STARTED|Overall Study||1
6446470|NCT01128296|7362233|FG001|STARTED|Overall Study||1
6446471|NCT01128296|7362234|FG002|STARTED|Overall Study||1
6446472|NCT01128296|7362235|FG003|STARTED|Overall Study||1
6446473|NCT01128296|7362236|FG004|STARTED|Overall Study||1
6446474|NCT01128296|7362237|FG005|STARTED|Overall Study||26
6446475|NCT01128296|7362232|FG000|COMPLETED|Overall Study||1
6446476|NCT01128296|7362233|FG001|COMPLETED|Overall Study||1
6446477|NCT01128296|7362234|FG002|COMPLETED|Overall Study||1
6446478|NCT01128296|7362235|FG003|COMPLETED|Overall Study||1
6446479|NCT01128296|7362236|FG004|COMPLETED|Overall Study||1
6446480|NCT01128296|7362237|FG005|COMPLETED|Overall Study||21
6446481|NCT01128296|7362232|FG000|NOT COMPLETED|Overall Study||0
6446482|NCT01128296|7362233|FG001|NOT COMPLETED|Overall Study||0
6446483|NCT01128296|7362234|FG002|NOT COMPLETED|Overall Study||0
6446484|NCT01128296|7362235|FG003|NOT COMPLETED|Overall Study||0
6446485|NCT01128296|7362236|FG004|NOT COMPLETED|Overall Study||0
6446486|NCT01128296|7362237|FG005|NOT COMPLETED|Overall Study||5
6446487|NCT01128361|7362250|FG000|STARTED|Overall Study||39
6446488|NCT01128361|7362251|FG001|STARTED|Overall Study||37
6446489|NCT01128361|7362250|FG000|COMPLETED|Overall Study||34
6446490|NCT01128361|7362251|FG001|COMPLETED|Overall Study||34
6446491|NCT01128361|7362250|FG000|NOT COMPLETED|Overall Study||5
6446492|NCT01128361|7362251|FG001|NOT COMPLETED|Overall Study||3
6446493|NCT01128387|7362259|FG000|STARTED|Overall Study||5
6446494|NCT01128387|7362260|FG001|STARTED|Overall Study||6
6446495|NCT01128387|7362259|FG000|COMPLETED|Overall Study||5
6446496|NCT01128387|7362260|FG001|COMPLETED|Overall Study||5
6446497|NCT01128387|7362259|FG000|NOT COMPLETED|Overall Study||0
6446498|NCT01128387|7362260|FG001|NOT COMPLETED|Overall Study||1
6446499|NCT01128400|7362269|FG000|STARTED|Overall Study||8
6446500|NCT01128400|7362270|FG001|STARTED|Overall Study||9
6446501|NCT01128400|7362271|FG002|STARTED|Overall Study||23
6446502|NCT01128400|7362269|FG000|COMPLETED|Overall Study||6
6446503|NCT01128400|7362270|FG001|COMPLETED|Overall Study||8
6446504|NCT01128400|7362271|FG002|COMPLETED|Overall Study||7
6446505|NCT01128400|7362269|FG000|NOT COMPLETED|Overall Study||2
6446506|NCT01128400|7362270|FG001|NOT COMPLETED|Overall Study||1
6446507|NCT01128400|7362271|FG002|NOT COMPLETED|Overall Study||16
6446508|NCT01128413|7362281|FG000|STARTED|Overall Study||11
6446509|NCT01128413|7362282|FG001|STARTED|Overall Study||11
6446510|NCT01128413|7362281|FG000|COMPLETED|Overall Study||7
6446511|NCT01128413|7362282|FG001|COMPLETED|Overall Study||10
6446512|NCT01128413|7362281|FG000|NOT COMPLETED|Overall Study||4
6446513|NCT01128413|7362282|FG001|NOT COMPLETED|Overall Study||1
6446514|NCT01128426|7362288|FG000|STARTED|Overall Study||53902
6446515|NCT01128426|7362288|FG000|COMPLETED|Overall Study||53902
6446516|NCT01128426|7362288|FG000|NOT COMPLETED|Overall Study||0
6446517|NCT01128543|7362294|FG000|STARTED|Overall Study||29
6446518|NCT01128543|7362294|FG000|COMPLETED|Overall Study||25
6446519|NCT01128543|7362294|FG000|NOT COMPLETED|Overall Study||4
6446520|NCT01128569|7362298|FG000|STARTED|Treatment Period 1||9
6446521|NCT01128569|7362299|FG001|STARTED|Treatment Period 1||8
6446522|NCT01128569|7362300|FG002|STARTED|Treatment Period 1||9
6446523|NCT01128569|7362301|FG003|STARTED|Treatment Period 1||8
6446524|NCT01128569|7362302|FG004|STARTED|Treatment Period 1||9
6446525|NCT01128569|7362303|FG005|STARTED|Treatment Period 1||9
6446526|NCT01128569|7362298|FG000|COMPLETED|Treatment Period 1||9
6446527|NCT01128569|7362299|FG001|COMPLETED|Treatment Period 1||8
6446528|NCT01128569|7362300|FG002|COMPLETED|Treatment Period 1||9
6446529|NCT01128569|7362301|FG003|COMPLETED|Treatment Period 1||8
6446530|NCT01128569|7362302|FG004|COMPLETED|Treatment Period 1||9
6446531|NCT01128569|7362303|FG005|COMPLETED|Treatment Period 1||9
6446532|NCT01128569|7362298|FG000|NOT COMPLETED|Treatment Period 1||0
6446533|NCT01128569|7362299|FG001|NOT COMPLETED|Treatment Period 1||0
6446534|NCT01128569|7362300|FG002|NOT COMPLETED|Treatment Period 1||0
6446535|NCT01128569|7362301|FG003|NOT COMPLETED|Treatment Period 1||0
6446536|NCT01128569|7362302|FG004|NOT COMPLETED|Treatment Period 1||0
6446537|NCT01128569|7362303|FG005|NOT COMPLETED|Treatment Period 1||0
6446538|NCT01128569|7362298|FG000|STARTED|Washout Period 1||9
6446539|NCT01128569|7362299|FG001|STARTED|Washout Period 1||8
6446540|NCT01128569|7362300|FG002|STARTED|Washout Period 1||9
6446541|NCT01128569|7362301|FG003|STARTED|Washout Period 1||8
6446542|NCT01128569|7362302|FG004|STARTED|Washout Period 1||9
6446543|NCT01128569|7362303|FG005|STARTED|Washout Period 1||9
6446544|NCT01128569|7362298|FG000|COMPLETED|Washout Period 1||9
6446545|NCT01128569|7362299|FG001|COMPLETED|Washout Period 1||8
6446546|NCT01128569|7362300|FG002|COMPLETED|Washout Period 1||8
6446547|NCT01128569|7362301|FG003|COMPLETED|Washout Period 1||8
6446548|NCT01128569|7362302|FG004|COMPLETED|Washout Period 1||9
6446549|NCT01128569|7362303|FG005|COMPLETED|Washout Period 1||9
6446550|NCT01128569|7362298|FG000|NOT COMPLETED|Washout Period 1||0
6446551|NCT01128569|7362299|FG001|NOT COMPLETED|Washout Period 1||0
6446552|NCT01128569|7362300|FG002|NOT COMPLETED|Washout Period 1||1
6446553|NCT01128569|7362301|FG003|NOT COMPLETED|Washout Period 1||0
6446554|NCT01128569|7362302|FG004|NOT COMPLETED|Washout Period 1||0
6446555|NCT01128569|7362303|FG005|NOT COMPLETED|Washout Period 1||0
6446556|NCT01128569|7362298|FG000|STARTED|Treatment Period 2||9
6446557|NCT01128569|7362299|FG001|STARTED|Treatment Period 2||8
6446558|NCT01128569|7362300|FG002|STARTED|Treatment Period 2||8
6446559|NCT01128569|7362301|FG003|STARTED|Treatment Period 2||8
6446560|NCT01128569|7362302|FG004|STARTED|Treatment Period 2||9
6446561|NCT01128569|7362303|FG005|STARTED|Treatment Period 2||9
6446562|NCT01128569|7362298|FG000|COMPLETED|Treatment Period 2||9
6446563|NCT01128569|7362299|FG001|COMPLETED|Treatment Period 2||7
6446564|NCT01128569|7362300|FG002|COMPLETED|Treatment Period 2||8
6446565|NCT01128569|7362301|FG003|COMPLETED|Treatment Period 2||8
6446566|NCT01128569|7362302|FG004|COMPLETED|Treatment Period 2||9
6446567|NCT01128569|7362303|FG005|COMPLETED|Treatment Period 2||9
6446568|NCT01128569|7362298|FG000|NOT COMPLETED|Treatment Period 2||0
6446569|NCT01128569|7362299|FG001|NOT COMPLETED|Treatment Period 2||1
6446570|NCT01128569|7362300|FG002|NOT COMPLETED|Treatment Period 2||0
6446571|NCT01128569|7362301|FG003|NOT COMPLETED|Treatment Period 2||0
6446572|NCT01128569|7362302|FG004|NOT COMPLETED|Treatment Period 2||0
6446573|NCT01128569|7362303|FG005|NOT COMPLETED|Treatment Period 2||0
6446574|NCT01128569|7362298|FG000|STARTED|Washout Period 2||9
6446575|NCT01128569|7362299|FG001|STARTED|Washout Period 2||7
6446576|NCT01128569|7362300|FG002|STARTED|Washout Period 2||8
6446577|NCT01128569|7362301|FG003|STARTED|Washout Period 2||8
6446578|NCT01128569|7362302|FG004|STARTED|Washout Period 2||9
6446579|NCT01128569|7362303|FG005|STARTED|Washout Period 2||9
6446580|NCT01128569|7362298|FG000|COMPLETED|Washout Period 2||9
6446581|NCT01128569|7362299|FG001|COMPLETED|Washout Period 2||7
6446582|NCT01128569|7362300|FG002|COMPLETED|Washout Period 2||8
6446583|NCT01128569|7362301|FG003|COMPLETED|Washout Period 2||8
6446584|NCT01128569|7362302|FG004|COMPLETED|Washout Period 2||9
6446585|NCT01128569|7362303|FG005|COMPLETED|Washout Period 2||9
6446586|NCT01128569|7362298|FG000|NOT COMPLETED|Washout Period 2||0
6446587|NCT01128569|7362299|FG001|NOT COMPLETED|Washout Period 2||0
6446588|NCT01128569|7362300|FG002|NOT COMPLETED|Washout Period 2||0
6446589|NCT01128569|7362301|FG003|NOT COMPLETED|Washout Period 2||0
6446590|NCT01128569|7362302|FG004|NOT COMPLETED|Washout Period 2||0
6446591|NCT01128569|7362303|FG005|NOT COMPLETED|Washout Period 2||0
6446592|NCT01128569|7362298|FG000|STARTED|Treatment Period 3||9
6446593|NCT01128569|7362299|FG001|STARTED|Treatment Period 3||7
6446594|NCT01128569|7362300|FG002|STARTED|Treatment Period 3||8
6446595|NCT01128569|7362301|FG003|STARTED|Treatment Period 3||8
6446596|NCT01128569|7362302|FG004|STARTED|Treatment Period 3||9
6446597|NCT01128569|7362303|FG005|STARTED|Treatment Period 3||9
6446598|NCT01128569|7362298|FG000|COMPLETED|Treatment Period 3||9
6446599|NCT01128569|7362299|FG001|COMPLETED|Treatment Period 3||7
6446600|NCT01128569|7362300|FG002|COMPLETED|Treatment Period 3||8
6446601|NCT01128569|7362301|FG003|COMPLETED|Treatment Period 3||8
6446602|NCT01128569|7362302|FG004|COMPLETED|Treatment Period 3||9
6446603|NCT01128569|7362303|FG005|COMPLETED|Treatment Period 3||9
6446604|NCT01128569|7362298|FG000|NOT COMPLETED|Treatment Period 3||0
6446605|NCT01128569|7362299|FG001|NOT COMPLETED|Treatment Period 3||0
6446606|NCT01128569|7362300|FG002|NOT COMPLETED|Treatment Period 3||0
6446607|NCT01128569|7362301|FG003|NOT COMPLETED|Treatment Period 3||0
6446608|NCT01128569|7362302|FG004|NOT COMPLETED|Treatment Period 3||0
6446609|NCT01128569|7362303|FG005|NOT COMPLETED|Treatment Period 3||0
6446610|NCT01128595|7362311|FG000|STARTED|Treatment Period 1||7
6446611|NCT01128595|7362312|FG001|STARTED|Treatment Period 1||6
6446612|NCT01128595|7362313|FG002|STARTED|Treatment Period 1||7
6446613|NCT01128595|7362314|FG003|STARTED|Treatment Period 1||7
6446614|NCT01128595|7362311|FG000|COMPLETED|Treatment Period 1||7
6446615|NCT01128595|7362312|FG001|COMPLETED|Treatment Period 1||6
6446616|NCT01128595|7362313|FG002|COMPLETED|Treatment Period 1||7
6446617|NCT01128595|7362314|FG003|COMPLETED|Treatment Period 1||7
6446618|NCT01128595|7362311|FG000|NOT COMPLETED|Treatment Period 1||0
6446619|NCT01128595|7362312|FG001|NOT COMPLETED|Treatment Period 1||0
6446620|NCT01128595|7362313|FG002|NOT COMPLETED|Treatment Period 1||0
6446621|NCT01128595|7362314|FG003|NOT COMPLETED|Treatment Period 1||0
6446622|NCT01128595|7362311|FG000|STARTED|Washout Period 1||7
6446623|NCT01128595|7362312|FG001|STARTED|Washout Period 1||6
6446624|NCT01128595|7362313|FG002|STARTED|Washout Period 1||7
6446625|NCT01128595|7362314|FG003|STARTED|Washout Period 1||7
6446626|NCT01128595|7362311|FG000|COMPLETED|Washout Period 1||7
6446627|NCT01128595|7362312|FG001|COMPLETED|Washout Period 1||6
6446628|NCT01128595|7362313|FG002|COMPLETED|Washout Period 1||7
6446629|NCT01128595|7362314|FG003|COMPLETED|Washout Period 1||7
6446630|NCT01128595|7362311|FG000|NOT COMPLETED|Washout Period 1||0
6446631|NCT01128595|7362312|FG001|NOT COMPLETED|Washout Period 1||0
6446632|NCT01128595|7362313|FG002|NOT COMPLETED|Washout Period 1||0
6446633|NCT01128595|7362314|FG003|NOT COMPLETED|Washout Period 1||0
6446634|NCT01128595|7362311|FG000|STARTED|Treatment Period 2||7
6446635|NCT01128595|7362312|FG001|STARTED|Treatment Period 2||6
6446636|NCT01128595|7362313|FG002|STARTED|Treatment Period 2||7
6446637|NCT01128595|7362314|FG003|STARTED|Treatment Period 2||7
6446638|NCT01128595|7362311|FG000|COMPLETED|Treatment Period 2||7
6446639|NCT01128595|7362312|FG001|COMPLETED|Treatment Period 2||6
6653574|NCT02438540|7583422|FG000|STARTED|Overall Study||19
6653575|NCT02438540|7583423|FG001|STARTED|Overall Study||20
6653576|NCT02438540|7583422|FG000|COMPLETED|Overall Study||19
6653577|NCT02438540|7583423|FG001|COMPLETED|Overall Study||20
6653578|NCT02438540|7583422|FG000|NOT COMPLETED|Overall Study||0
6653579|NCT02438540|7583423|FG001|NOT COMPLETED|Overall Study||0
6446640|NCT01128595|7362313|FG002|COMPLETED|Treatment Period 2||7
6446641|NCT01128595|7362314|FG003|COMPLETED|Treatment Period 2||7
6446642|NCT01128595|7362311|FG000|NOT COMPLETED|Treatment Period 2||0
6446643|NCT01128595|7362312|FG001|NOT COMPLETED|Treatment Period 2||0
6446644|NCT01128595|7362313|FG002|NOT COMPLETED|Treatment Period 2||0
6446645|NCT01128595|7362314|FG003|NOT COMPLETED|Treatment Period 2||0
6446646|NCT01128595|7362311|FG000|STARTED|Washout Period 2||7
6446647|NCT01128595|7362312|FG001|STARTED|Washout Period 2||6
6446648|NCT01128595|7362313|FG002|STARTED|Washout Period 2||7
6446649|NCT01128595|7362314|FG003|STARTED|Washout Period 2||7
6446650|NCT01128595|7362311|FG000|COMPLETED|Washout Period 2||7
6446651|NCT01128595|7362312|FG001|COMPLETED|Washout Period 2||6
6446652|NCT01128595|7362313|FG002|COMPLETED|Washout Period 2||7
6446653|NCT01128595|7362314|FG003|COMPLETED|Washout Period 2||7
6446654|NCT01128595|7362311|FG000|NOT COMPLETED|Washout Period 2||0
6446655|NCT01128595|7362312|FG001|NOT COMPLETED|Washout Period 2||0
6446656|NCT01128595|7362313|FG002|NOT COMPLETED|Washout Period 2||0
6446657|NCT01128595|7362314|FG003|NOT COMPLETED|Washout Period 2||0
6446658|NCT01128595|7362311|FG000|STARTED|Treatment Period 3||7
6446659|NCT01128595|7362312|FG001|STARTED|Treatment Period 3||6
6446660|NCT01128595|7362313|FG002|STARTED|Treatment Period 3||7
6446661|NCT01128595|7362314|FG003|STARTED|Treatment Period 3||7
6446662|NCT01128595|7362311|FG000|COMPLETED|Treatment Period 3||7
6446663|NCT01128595|7362312|FG001|COMPLETED|Treatment Period 3||5
6446664|NCT01128595|7362313|FG002|COMPLETED|Treatment Period 3||7
6446665|NCT01128595|7362314|FG003|COMPLETED|Treatment Period 3||7
6446666|NCT01128595|7362311|FG000|NOT COMPLETED|Treatment Period 3||0
6446667|NCT01128595|7362312|FG001|NOT COMPLETED|Treatment Period 3||1
6446668|NCT01128595|7362313|FG002|NOT COMPLETED|Treatment Period 3||0
6446669|NCT01128595|7362314|FG003|NOT COMPLETED|Treatment Period 3||0
6446670|NCT01128595|7362311|FG000|STARTED|Washout Period 3||7
6446671|NCT01128595|7362312|FG001|STARTED|Washout Period 3||5
6446672|NCT01128595|7362313|FG002|STARTED|Washout Period 3||7
6446673|NCT01128595|7362314|FG003|STARTED|Washout Period 3||7
6446674|NCT01128595|7362311|FG000|COMPLETED|Washout Period 3||7
6446675|NCT01128595|7362312|FG001|COMPLETED|Washout Period 3||5
6446676|NCT01128595|7362313|FG002|COMPLETED|Washout Period 3||7
6446677|NCT01128595|7362314|FG003|COMPLETED|Washout Period 3||7
6446678|NCT01128595|7362311|FG000|NOT COMPLETED|Washout Period 3||0
6446679|NCT01128595|7362312|FG001|NOT COMPLETED|Washout Period 3||0
6446680|NCT01128595|7362313|FG002|NOT COMPLETED|Washout Period 3||0
6446681|NCT01128595|7362314|FG003|NOT COMPLETED|Washout Period 3||0
6446682|NCT01128595|7362311|FG000|STARTED|Treatment Period 4||7
6446683|NCT01128595|7362312|FG001|STARTED|Treatment Period 4||5
6446684|NCT01128595|7362313|FG002|STARTED|Treatment Period 4||7
6446685|NCT01128595|7362314|FG003|STARTED|Treatment Period 4||7
6446686|NCT01128595|7362311|FG000|COMPLETED|Treatment Period 4||7
6446687|NCT01128595|7362312|FG001|COMPLETED|Treatment Period 4||5
6446688|NCT01128595|7362313|FG002|COMPLETED|Treatment Period 4||7
6446689|NCT01128595|7362314|FG003|COMPLETED|Treatment Period 4||7
6446690|NCT01128595|7362311|FG000|NOT COMPLETED|Treatment Period 4||0
6446691|NCT01128595|7362312|FG001|NOT COMPLETED|Treatment Period 4||0
6446692|NCT01128595|7362313|FG002|NOT COMPLETED|Treatment Period 4||0
6446693|NCT01128595|7362314|FG003|NOT COMPLETED|Treatment Period 4||0
6446694|NCT01128621|7362327|FG000|STARTED|Part A: GSK1292263 300 mg||6
6446695|NCT01128621|7362328|FG001|STARTED|Part A: GSK1292263 300 mg||0
6446696|NCT01128621|7362327|FG000|COMPLETED|Part A: GSK1292263 300 mg||6
6446697|NCT01128621|7362328|FG001|COMPLETED|Part A: GSK1292263 300 mg||0
6446698|NCT01128621|7362327|FG000|NOT COMPLETED|Part A: GSK1292263 300 mg||0
6446699|NCT01128621|7362328|FG001|NOT COMPLETED|Part A: GSK1292263 300 mg||0
6446700|NCT01128621|7362327|FG000|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
6446701|NCT01128621|7362328|FG001|STARTED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||67
6446702|NCT01128621|7362327|FG000|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
6446703|NCT01128621|7362328|FG001|COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||65
6446704|NCT01128621|7362327|FG000|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||0
6446705|NCT01128621|7362328|FG001|NOT COMPLETED|Part B: GSK1292263 75 mg/300 mg/ 600 mg||2
6446706|NCT01128738|7362352|FG000|STARTED|First Treatment Phase (TP)||78
6446707|NCT01128738|7362353|FG001|STARTED|First Treatment Phase (TP)||74
6653580|NCT02438722|7583432|FG000|STARTED|Overall Study||83
6446708|NCT01128738|7362352|FG000|COMPLETED|First Treatment Phase (TP)||74
6446709|NCT01128738|7362353|FG001|COMPLETED|First Treatment Phase (TP)||73
6446710|NCT01128738|7362352|FG000|NOT COMPLETED|First Treatment Phase (TP)||4
6446711|NCT01128738|7362353|FG001|NOT COMPLETED|First Treatment Phase (TP)||1
6446712|NCT01128738|7362352|FG000|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
6446713|NCT01128738|7362353|FG001|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
6446714|NCT01128738|7362352|FG000|COMPLETED|Second TP||34
6446715|NCT01128738|7362353|FG001|COMPLETED|Second TP||63
6446716|NCT01128738|7362352|FG000|NOT COMPLETED|Second TP||0
6446717|NCT01128738|7362353|FG001|NOT COMPLETED|Second TP||3
6446718|NCT01128829|7362360|FG000|STARTED|Overall Study||6
6446719|NCT01128829|7362361|FG001|STARTED|Overall Study||11
6446720|NCT01128829|7362360|FG000|COMPLETED|Overall Study||6
6446721|NCT01128829|7362361|FG001|COMPLETED|Overall Study||11
6446722|NCT01128829|7362360|FG000|NOT COMPLETED|Overall Study||0
6446723|NCT01128829|7362361|FG001|NOT COMPLETED|Overall Study||0
6446724|NCT01128842|7362365|FG000|STARTED|Overall Study||7
6446725|NCT01128842|7362365|FG000|COMPLETED|Overall Study||0
6446726|NCT01128842|7362365|FG000|NOT COMPLETED|Overall Study||7
6446727|NCT01128894|7362372|FG000|STARTED|Overall Study||404
6446728|NCT01128894|7362373|FG001|STARTED|Overall Study||408
6446729|NCT01128894|7362372|FG000|COMPLETED|Overall Study||346
6446730|NCT01128894|7362373|FG001|COMPLETED|Overall Study||340
6446731|NCT01128894|7362372|FG000|NOT COMPLETED|Overall Study||58
6446732|NCT01128894|7362373|FG001|NOT COMPLETED|Overall Study||68
6446733|NCT01128946|7362379|FG000|STARTED|Period I||20
6446734|NCT01128946|7362380|FG001|STARTED|Period I||21
6446735|NCT01128946|7362381|FG002|STARTED|Period I||21
6446736|NCT01128946|7362382|FG003|STARTED|Period I||21
6446737|NCT01128946|7362379|FG000|COMPLETED|Period I||20
6446738|NCT01128946|7362380|FG001|COMPLETED|Period I||20
6446739|NCT01128946|7362381|FG002|COMPLETED|Period I||20
6446740|NCT01128946|7362382|FG003|COMPLETED|Period I||20
6446741|NCT01128946|7362379|FG000|NOT COMPLETED|Period I||0
6446742|NCT01128946|7362380|FG001|NOT COMPLETED|Period I||1
6446743|NCT01128946|7362381|FG002|NOT COMPLETED|Period I||1
6446744|NCT01128946|7362382|FG003|NOT COMPLETED|Period I||1
6446745|NCT01128946|7362379|FG000|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
6446746|NCT01128946|7362380|FG001|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
6446747|NCT01128946|7362381|FG002|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
6446748|NCT01128946|7362382|FG003|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
6446749|NCT01128946|7362379|FG000|COMPLETED|Period II||20
6446750|NCT01128946|7362380|FG001|COMPLETED|Period II||19
6446751|NCT01128946|7362381|FG002|COMPLETED|Period II||20
6446752|NCT01128946|7362382|FG003|COMPLETED|Period II||19
6446753|NCT01128946|7362379|FG000|NOT COMPLETED|Period II||0
6446754|NCT01128946|7362380|FG001|NOT COMPLETED|Period II||1
6446755|NCT01128946|7362381|FG002|NOT COMPLETED|Period II||0
6446756|NCT01128946|7362382|FG003|NOT COMPLETED|Period II||1
6446757|NCT01128946|7362379|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
6446758|NCT01128946|7362380|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
6446759|NCT01128946|7362381|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
6446760|NCT01128946|7362382|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
6446761|NCT01128946|7362379|FG000|COMPLETED|Period III||19
6446762|NCT01128946|7362380|FG001|COMPLETED|Period III||19
6446763|NCT01128946|7362381|FG002|COMPLETED|Period III||20
6446764|NCT01128946|7362382|FG003|COMPLETED|Period III||19
6446765|NCT01128946|7362379|FG000|NOT COMPLETED|Period III||1
6446766|NCT01128946|7362380|FG001|NOT COMPLETED|Period III||0
6446767|NCT01128946|7362381|FG002|NOT COMPLETED|Period III||0
6446768|NCT01128946|7362382|FG003|NOT COMPLETED|Period III||0
6446769|NCT01128946|7362379|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
6446770|NCT01128946|7362380|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
6446771|NCT01128946|7362381|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
6446772|NCT01128946|7362382|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
6446773|NCT01128946|7362379|FG000|COMPLETED|Period IV||19
6446774|NCT01128946|7362380|FG001|COMPLETED|Period IV||20
6446775|NCT01128946|7362381|FG002|COMPLETED|Period IV||19
6446776|NCT01128946|7362382|FG003|COMPLETED|Period IV||19
6446777|NCT01128946|7362379|FG000|NOT COMPLETED|Period IV||0
6446778|NCT01128946|7362380|FG001|NOT COMPLETED|Period IV||0
6446779|NCT01128946|7362381|FG002|NOT COMPLETED|Period IV||0
6446780|NCT01128946|7362382|FG003|NOT COMPLETED|Period IV||0
6446781|NCT01128959|7362393|FG000|STARTED|Lead in Period||108
6446782|NCT01128959|7362393|FG000|COMPLETED|Lead in Period||105
6446783|NCT01128959|7362393|FG000|NOT COMPLETED|Lead in Period||3
6446784|NCT01128959|7362393|FG000|STARTED|Treatment Period||105
6446785|NCT01128959|7362393|FG000|COMPLETED|Treatment Period||101
6446786|NCT01128959|7362393|FG000|NOT COMPLETED|Treatment Period||4
6446787|NCT01128972|7362399|FG000|STARTED|Period I||7
6446788|NCT01128972|7362400|FG001|STARTED|Period I||7
6446789|NCT01128972|7362401|FG002|STARTED|Period I||7
6446790|NCT01128972|7362402|FG003|STARTED|Period I||7
6446791|NCT01128972|7362403|FG004|STARTED|Period I||8
6446792|NCT01128972|7362399|FG000|COMPLETED|Period I||7
6446793|NCT01128972|7362400|FG001|COMPLETED|Period I||7
6446794|NCT01128972|7362401|FG002|COMPLETED|Period I||7
6446795|NCT01128972|7362402|FG003|COMPLETED|Period I||7
6446796|NCT01128972|7362403|FG004|COMPLETED|Period I||8
6446797|NCT01128972|7362399|FG000|NOT COMPLETED|Period I||0
6446798|NCT01128972|7362400|FG001|NOT COMPLETED|Period I||0
6446799|NCT01128972|7362401|FG002|NOT COMPLETED|Period I||0
6446800|NCT01128972|7362402|FG003|NOT COMPLETED|Period I||0
6446801|NCT01128972|7362403|FG004|NOT COMPLETED|Period I||0
6446802|NCT01128972|7362399|FG000|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
6446803|NCT01128972|7362400|FG001|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
6446804|NCT01128972|7362401|FG002|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
6446805|NCT01128972|7362402|FG003|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
6446806|NCT01128972|7362403|FG004|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
6446807|NCT01128972|7362399|FG000|COMPLETED|Period II||7
6446808|NCT01128972|7362400|FG001|COMPLETED|Period II||7
6446809|NCT01128972|7362401|FG002|COMPLETED|Period II||7
6446810|NCT01128972|7362402|FG003|COMPLETED|Period II||8
6446811|NCT01128972|7362403|FG004|COMPLETED|Period II||7
6446812|NCT01128972|7362399|FG000|NOT COMPLETED|Period II||0
6446813|NCT01128972|7362400|FG001|NOT COMPLETED|Period II||0
6446814|NCT01128972|7362401|FG002|NOT COMPLETED|Period II||0
6446815|NCT01128972|7362402|FG003|NOT COMPLETED|Period II||0
6446816|NCT01128972|7362403|FG004|NOT COMPLETED|Period II||0
6446817|NCT01128972|7362399|FG000|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
6446818|NCT01128972|7362400|FG001|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
6446819|NCT01128972|7362401|FG002|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
6446820|NCT01128972|7362402|FG003|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
6446821|NCT01128972|7362403|FG004|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
6446822|NCT01128972|7362399|FG000|COMPLETED|Period III||7
6446823|NCT01128972|7362400|FG001|COMPLETED|Period III||7
6446824|NCT01128972|7362401|FG002|COMPLETED|Period III||8
6446825|NCT01128972|7362402|FG003|COMPLETED|Period III||7
6446826|NCT01128972|7362403|FG004|COMPLETED|Period III||7
6446827|NCT01128972|7362399|FG000|NOT COMPLETED|Period III||0
6446828|NCT01128972|7362400|FG001|NOT COMPLETED|Period III||0
6446829|NCT01128972|7362401|FG002|NOT COMPLETED|Period III||0
6446830|NCT01128972|7362402|FG003|NOT COMPLETED|Period III||0
6446831|NCT01128972|7362403|FG004|NOT COMPLETED|Period III||0
6446832|NCT01128972|7362399|FG000|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
6446833|NCT01128972|7362400|FG001|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
6446834|NCT01128972|7362401|FG002|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
6446835|NCT01128972|7362402|FG003|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
6446836|NCT01128972|7362403|FG004|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
6446837|NCT01128972|7362399|FG000|COMPLETED|Period IV||7
6446838|NCT01128972|7362400|FG001|COMPLETED|Period IV||8
6446839|NCT01128972|7362401|FG002|COMPLETED|Period IV||7
6446840|NCT01128972|7362402|FG003|COMPLETED|Period IV||7
6446841|NCT01128972|7362403|FG004|COMPLETED|Period IV||7
6446842|NCT01128972|7362399|FG000|NOT COMPLETED|Period IV||0
6446843|NCT01128972|7362400|FG001|NOT COMPLETED|Period IV||0
6446844|NCT01128972|7362401|FG002|NOT COMPLETED|Period IV||0
6653581|NCT02438722|7583433|FG001|STARTED|Overall Study||85
6653582|NCT02438722|7583432|FG000|Participants Evaluable for Adverse Events|Overall Study||78
6653583|NCT02438722|7583433|FG001|Participants Evaluable for Adverse Events|Overall Study||85
6653584|NCT02438722|7583432|FG000|COMPLETED|Overall Study||0
6653585|NCT02438722|7583433|FG001|COMPLETED|Overall Study||0
6653586|NCT02438722|7583432|FG000|NOT COMPLETED|Overall Study||83
6653587|NCT02438722|7583433|FG001|NOT COMPLETED|Overall Study||85
6653588|NCT02438787|7583442|FG000|STARTED|Overall Study||104
6653589|NCT02438787|7583443|FG001|STARTED|Overall Study||106
6653590|NCT02438787|7583444|FG002|STARTED|Overall Study||105
6653591|NCT02438787|7583442|FG000|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
6653592|NCT02438787|7583443|FG001|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|21
6653593|NCT02438787|7583444|FG002|Early Escape at Week 16|Overall Study|Study discontinuation/completion reported under randomization group|20
6653594|NCT02438787|7583442|FG000|Cross Over at Week 24|Overall Study|Out of 43: crossed over to Ustekinumab 45 mg (n=21) and Ustekinumab 90 mg (n=22)|43
6653595|NCT02438787|7583443|FG001|Cross Over at Week 24|Overall Study||0
6653596|NCT02438787|7583444|FG002|Cross Over at Week 24|Overall Study||0
6653597|NCT02438787|7583442|FG000|COMPLETED|Overall Study||23
6653598|NCT02438787|7583443|FG001|COMPLETED|Overall Study||23
6653599|NCT02438787|7583444|FG002|COMPLETED|Overall Study||22
6653600|NCT02438787|7583442|FG000|NOT COMPLETED|Overall Study||81
6653601|NCT02438787|7583443|FG001|NOT COMPLETED|Overall Study||83
6653602|NCT02438787|7583444|FG002|NOT COMPLETED|Overall Study||83
6653603|NCT02438813|7583457|FG000|STARTED|Overall Study||1029
6653604|NCT02438813|7583457|FG000|Received Treatment for SMF|Overall Study||676
6653605|NCT02438813|7583457|FG000|Did Not ReceiveTreatment for SMF|Overall Study||353
6653606|NCT02438813|7583457|FG000|COMPLETED|Overall Study||504
6653607|NCT02438813|7583457|FG000|NOT COMPLETED|Overall Study||525
6446845|NCT01128972|7362402|FG003|NOT COMPLETED|Period IV||0
6446846|NCT01128972|7362403|FG004|NOT COMPLETED|Period IV||0
6446847|NCT01128972|7362399|FG000|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
6446848|NCT01128972|7362400|FG001|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
6446849|NCT01128972|7362401|FG002|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
6446850|NCT01128972|7362402|FG003|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
6446851|NCT01128972|7362403|FG004|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
6446852|NCT01128972|7362399|FG000|COMPLETED|Period V||8
6446853|NCT01128972|7362400|FG001|COMPLETED|Period V||7
6446854|NCT01128972|7362401|FG002|COMPLETED|Period V||7
6446855|NCT01128972|7362402|FG003|COMPLETED|Period V||7
6446856|NCT01128972|7362403|FG004|COMPLETED|Period V||7
6446857|NCT01128972|7362399|FG000|NOT COMPLETED|Period V||0
6446858|NCT01128972|7362400|FG001|NOT COMPLETED|Period V||0
6446859|NCT01128972|7362401|FG002|NOT COMPLETED|Period V||0
6446860|NCT01128972|7362402|FG003|NOT COMPLETED|Period V||0
6446861|NCT01128972|7362403|FG004|NOT COMPLETED|Period V||0
6446862|NCT01129011|7362423|FG000|STARTED|Overall Study|Safety, Intent-to-Treat population|210
6446863|NCT01129011|7362424|FG001|STARTED|Overall Study|Safety, Intent-to-Treat population|210
6446864|NCT01129011|7362423|FG000|COMPLETED|Overall Study||151
6446865|NCT01129011|7362424|FG001|COMPLETED|Overall Study||153
6446866|NCT01129011|7362423|FG000|NOT COMPLETED|Overall Study||59
6446867|NCT01129011|7362424|FG001|NOT COMPLETED|Overall Study||57
6446868|NCT01129024|7362430|FG000|STARTED|Overall Study||19
6446869|NCT01129024|7362430|FG000|COMPLETED|Overall Study||0
6446870|NCT01129024|7362430|FG000|NOT COMPLETED|Overall Study||19
6446871|NCT01129102|7362437|FG000|STARTED|Overall Study||110
6446872|NCT01129102|7362438|FG001|STARTED|Overall Study||50
6446873|NCT01129102|7362439|FG002|STARTED|Overall Study||55
6446874|NCT01129102|7362437|FG000|COMPLETED|Overall Study||102
6446875|NCT01129102|7362438|FG001|COMPLETED|Overall Study||44
6446876|NCT01129102|7362439|FG002|COMPLETED|Overall Study||48
6446877|NCT01129102|7362437|FG000|NOT COMPLETED|Overall Study||8
6446878|NCT01129102|7362438|FG001|NOT COMPLETED|Overall Study||6
6446879|NCT01129102|7362439|FG002|NOT COMPLETED|Overall Study||7
6446880|NCT01129115|7362450|FG000|STARTED|Overall Study||25
6446881|NCT01129115|7362451|FG001|STARTED|Overall Study||25
6446882|NCT01129115|7362452|FG002|STARTED|Overall Study||27
6446883|NCT01129115|7362453|FG003|STARTED|Overall Study||24
6446884|NCT01129115|7362450|FG000|COMPLETED|Overall Study||23
6446885|NCT01129115|7362451|FG001|COMPLETED|Overall Study||18
6446886|NCT01129115|7362452|FG002|COMPLETED|Overall Study||21
6446887|NCT01129115|7362453|FG003|COMPLETED|Overall Study||15
6446888|NCT01129115|7362450|FG000|NOT COMPLETED|Overall Study||2
6446889|NCT01129115|7362451|FG001|NOT COMPLETED|Overall Study||7
6446890|NCT01129115|7362452|FG002|NOT COMPLETED|Overall Study||6
6446891|NCT01129115|7362453|FG003|NOT COMPLETED|Overall Study||9
6446892|NCT01129128|7362466|FG000|STARTED|Overall Study||22
6446893|NCT01129128|7362467|FG001|STARTED|Overall Study||22
6446894|NCT01129128|7362468|FG002|STARTED|Overall Study||23
6446895|NCT01129128|7362466|FG000|COMPLETED|Overall Study||19
6446896|NCT01129128|7362467|FG001|COMPLETED|Overall Study||18
6446897|NCT01129128|7362468|FG002|COMPLETED|Overall Study||19
6446898|NCT01129128|7362466|FG000|NOT COMPLETED|Overall Study||3
6446899|NCT01129128|7362467|FG001|NOT COMPLETED|Overall Study||4
6446900|NCT01129128|7362468|FG002|NOT COMPLETED|Overall Study||4
6446901|NCT01129141|7362478|FG000|STARTED|Overall Study||101
6446902|NCT01129141|7362479|FG001|STARTED|Overall Study||104
6446903|NCT01129141|7362478|FG000|COMPLETED|Overall Study||86
6446904|NCT01129141|7362479|FG001|COMPLETED|Overall Study||91
6446905|NCT01129141|7362478|FG000|NOT COMPLETED|Overall Study||15
6446906|NCT01129141|7362479|FG001|NOT COMPLETED|Overall Study||13
6446907|NCT01129206|7362485|FG000|STARTED|Overall Study||6
6446908|NCT01129206|7362485|FG000|COMPLETED|Overall Study||6
6446909|NCT01129206|7362485|FG000|NOT COMPLETED|Overall Study||0
6446910|NCT01129245|7362494|FG000|STARTED|Control Cycle (no Celecoxib or Placebo)||10
6446911|NCT01129245|7362495|FG001|STARTED|Control Cycle (no Celecoxib or Placebo)||10
6446912|NCT01129245|7362494|FG000|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
6446913|NCT01129245|7362495|FG001|COMPLETED|Control Cycle (no Celecoxib or Placebo)||10
6446914|NCT01129245|7362494|FG000|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
6446915|NCT01129245|7362495|FG001|NOT COMPLETED|Control Cycle (no Celecoxib or Placebo)||0
6446916|NCT01129245|7362494|FG000|STARTED|Treatment Cycle 1||10
6446917|NCT01129245|7362495|FG001|STARTED|Treatment Cycle 1||10
6446918|NCT01129245|7362494|FG000|COMPLETED|Treatment Cycle 1||10
6446919|NCT01129245|7362495|FG001|COMPLETED|Treatment Cycle 1||10
6446920|NCT01129245|7362494|FG000|NOT COMPLETED|Treatment Cycle 1||0
6446921|NCT01129245|7362495|FG001|NOT COMPLETED|Treatment Cycle 1||0
6446922|NCT01129245|7362494|FG000|STARTED|Washout Cycle||10
6446923|NCT01129245|7362495|FG001|STARTED|Washout Cycle||10
6446924|NCT01129245|7362494|FG000|COMPLETED|Washout Cycle||10
6446925|NCT01129245|7362495|FG001|COMPLETED|Washout Cycle||10
6446926|NCT01129245|7362494|FG000|NOT COMPLETED|Washout Cycle||0
6446927|NCT01129245|7362495|FG001|NOT COMPLETED|Washout Cycle||0
6446928|NCT01129245|7362494|FG000|STARTED|Treatment Cycle 2||10
6446929|NCT01129245|7362495|FG001|STARTED|Treatment Cycle 2||10
6446930|NCT01129245|7362494|FG000|COMPLETED|Treatment Cycle 2||10
6446931|NCT01129245|7362495|FG001|COMPLETED|Treatment Cycle 2||10
6446932|NCT01129245|7362494|FG000|NOT COMPLETED|Treatment Cycle 2||0
6446933|NCT01129245|7362495|FG001|NOT COMPLETED|Treatment Cycle 2||0
6446934|NCT01129284|7362507|FG000|STARTED|Overall Study||5
6446935|NCT01129284|7362508|FG001|STARTED|Overall Study||5
6446936|NCT01129284|7362509|FG002|STARTED|Overall Study||5
6446937|NCT01129284|7362507|FG000|COMPLETED|Overall Study||3
6446938|NCT01129284|7362508|FG001|COMPLETED|Overall Study||5
6446939|NCT01129284|7362509|FG002|COMPLETED|Overall Study||4
6446940|NCT01129284|7362507|FG000|NOT COMPLETED|Overall Study||2
6446941|NCT01129284|7362508|FG001|NOT COMPLETED|Overall Study||0
6446942|NCT01129284|7362509|FG002|NOT COMPLETED|Overall Study||1
6446943|NCT01129336|7362519|FG000|STARTED|Overall Study||15
6446944|NCT01129336|7362520|FG001|STARTED|Overall Study||29
6446945|NCT01129336|7362519|FG000|Completed Treatment|Overall Study||1
6446946|NCT01129336|7362520|FG001|Completed Treatment|Overall Study||3
6446947|NCT01129336|7362519|FG000|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
6446948|NCT01129336|7362520|FG001|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
6446949|NCT01129336|7362519|FG000|NOT COMPLETED|Overall Study||12
6446950|NCT01129336|7362520|FG001|NOT COMPLETED|Overall Study||16
6446951|NCT01129440|7362528|FG000|STARTED|Overall Study||297
6446952|NCT01129440|7362529|FG001|STARTED|Overall Study||300
6446953|NCT01129440|7362528|FG000|12 Month Follow-up|Overall Study||249
6446954|NCT01129440|7362529|FG001|12 Month Follow-up|Overall Study||256
6446955|NCT01129440|7362528|FG000|24 Month Follow-up|Overall Study||239
6446956|NCT01129440|7362529|FG001|24 Month Follow-up|Overall Study||258
6446957|NCT01129440|7362528|FG000|COMPLETED|Overall Study||246
6446958|NCT01129440|7362529|FG001|COMPLETED|Overall Study||258
6446959|NCT01129440|7362528|FG000|NOT COMPLETED|Overall Study||51
6446960|NCT01129440|7362529|FG001|NOT COMPLETED|Overall Study||42
6500297|NCT01424397|7419090|FG003|STARTED|Period-2 (8 Days)||8
6500298|NCT01424397|7419091|FG004|STARTED|Period-2 (8 Days)||8
6500299|NCT01424397|7419092|FG005|STARTED|Period-2 (8 Days)||8
6500300|NCT01424397|7419093|FG006|STARTED|Period-2 (8 Days)||4
6500301|NCT01424397|7419094|FG007|STARTED|Period-2 (8 Days)||4
6500302|NCT01424397|7419095|FG008|STARTED|Period-2 (8 Days)||4
6500303|NCT01424397|7419096|FG009|STARTED|Period-2 (8 Days)||3
6500304|NCT01424397|7419097|FG010|STARTED|Period-2 (8 Days)||4
6500305|NCT01424397|7419098|FG011|STARTED|Period-2 (8 Days)||4
6500306|NCT01424397|7419087|FG000|COMPLETED|Period-2 (8 Days)||7
6500307|NCT01424397|7419088|FG001|COMPLETED|Period-2 (8 Days)||8
6500308|NCT01424397|7419089|FG002|COMPLETED|Period-2 (8 Days)||7
6500309|NCT01424397|7419090|FG003|COMPLETED|Period-2 (8 Days)||8
6500310|NCT01424397|7419091|FG004|COMPLETED|Period-2 (8 Days)||8
6500311|NCT01424397|7419092|FG005|COMPLETED|Period-2 (8 Days)||8
6653608|NCT02438826|7583473|FG000|STARTED|Double-Blind Treatment Phase||123
6653609|NCT02438826|7583474|FG001|STARTED|Double-Blind Treatment Phase||117
6653610|NCT02438826|7583475|FG002|STARTED|Double-Blind Treatment Phase||0
6653611|NCT02438826|7583476|FG003|STARTED|Double-Blind Treatment Phase||0
6653612|NCT02438826|7583473|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||120
6653613|NCT02438826|7583474|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||117
6653614|NCT02438826|7583475|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
6653615|NCT02438826|7583476|FG003|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||0
6653616|NCT02438826|7583473|FG000|COMPLETED|Double-Blind Treatment Phase||117
6653617|NCT02438826|7583474|FG001|COMPLETED|Double-Blind Treatment Phase||113
6653618|NCT02438826|7583475|FG002|COMPLETED|Double-Blind Treatment Phase||0
6653619|NCT02438826|7583476|FG003|COMPLETED|Double-Blind Treatment Phase||0
6653620|NCT02438826|7583473|FG000|NOT COMPLETED|Double-Blind Treatment Phase||6
6653621|NCT02438826|7583474|FG001|NOT COMPLETED|Double-Blind Treatment Phase||4
6653622|NCT02438826|7583475|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
6653623|NCT02438826|7583476|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
6653624|NCT02438826|7583473|FG000|STARTED|Open-Label Treatment Phase|This period is optional phase, one participant chose not to enter the open-label phase.|116
6653625|NCT02438826|7583474|FG001|STARTED|Open-Label Treatment Phase||113
6653626|NCT02438826|7583475|FG002|STARTED|Open-Label Treatment Phase||0
6653627|NCT02438826|7583476|FG003|STARTED|Open-Label Treatment Phase||0
6653628|NCT02438826|7583473|FG000|COMPLETED|Open-Label Treatment Phase||72
6653629|NCT02438826|7583474|FG001|COMPLETED|Open-Label Treatment Phase||80
6653630|NCT02438826|7583475|FG002|COMPLETED|Open-Label Treatment Phase||0
6653631|NCT02438826|7583476|FG003|COMPLETED|Open-Label Treatment Phase||0
6653632|NCT02438826|7583473|FG000|NOT COMPLETED|Open-Label Treatment Phase||44
6500312|NCT01424397|7419093|FG006|COMPLETED|Period-2 (8 Days)||4
6653633|NCT02438826|7583474|FG001|NOT COMPLETED|Open-Label Treatment Phase||33
6653634|NCT02438826|7583475|FG002|NOT COMPLETED|Open-Label Treatment Phase||0
6653635|NCT02438826|7583476|FG003|NOT COMPLETED|Open-Label Treatment Phase||0
6500313|NCT01424397|7419094|FG007|COMPLETED|Period-2 (8 Days)||4
6500314|NCT01424397|7419095|FG008|COMPLETED|Period-2 (8 Days)||4
6500315|NCT01424397|7419096|FG009|COMPLETED|Period-2 (8 Days)||3
6500316|NCT01424397|7419097|FG010|COMPLETED|Period-2 (8 Days)||4
6500317|NCT01424397|7419098|FG011|COMPLETED|Period-2 (8 Days)||4
6500318|NCT01424397|7419087|FG000|NOT COMPLETED|Period-2 (8 Days)||0
6500319|NCT01424397|7419088|FG001|NOT COMPLETED|Period-2 (8 Days)||0
6500320|NCT01424397|7419089|FG002|NOT COMPLETED|Period-2 (8 Days)||1
6500321|NCT01424397|7419090|FG003|NOT COMPLETED|Period-2 (8 Days)||0
6500322|NCT01424397|7419091|FG004|NOT COMPLETED|Period-2 (8 Days)||0
6446961|NCT01129531|7362539|FG000|STARTED|Treatment Cycle 1||84
6446962|NCT01129531|7362540|FG001|STARTED|Treatment Cycle 1||84
6446963|NCT01129531|7362541|FG002|STARTED|Treatment Cycle 1||126
6446964|NCT01129531|7362539|FG000|COMPLETED|Treatment Cycle 1||80
6446965|NCT01129531|7362540|FG001|COMPLETED|Treatment Cycle 1||78
6446966|NCT01129531|7362541|FG002|COMPLETED|Treatment Cycle 1||110
6446967|NCT01129531|7362539|FG000|NOT COMPLETED|Treatment Cycle 1||4
6446968|NCT01129531|7362540|FG001|NOT COMPLETED|Treatment Cycle 1||6
6446969|NCT01129531|7362541|FG002|NOT COMPLETED|Treatment Cycle 1||16
6446970|NCT01129531|7362539|FG000|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
6446971|NCT01129531|7362540|FG001|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
6446972|NCT01129531|7362541|FG002|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
6446973|NCT01129531|7362539|FG000|COMPLETED|Treatment Cycle 2||88
6446974|NCT01129531|7362540|FG001|COMPLETED|Treatment Cycle 2||92
6446975|NCT01129531|7362541|FG002|COMPLETED|Treatment Cycle 2||74
6446976|NCT01129531|7362539|FG000|NOT COMPLETED|Treatment Cycle 2||6
6446977|NCT01129531|7362540|FG001|NOT COMPLETED|Treatment Cycle 2||3
6446978|NCT01129531|7362541|FG002|NOT COMPLETED|Treatment Cycle 2||5
6446979|NCT01129557|7362556|FG000|STARTED|Overall Study||15
6446980|NCT01129557|7362557|FG001|STARTED|Overall Study||17
6446981|NCT01129557|7362558|FG002|STARTED|Overall Study||14
6446982|NCT01129557|7362556|FG000|COMPLETED|Overall Study||11
6446983|NCT01129557|7362557|FG001|COMPLETED|Overall Study||12
6446984|NCT01129557|7362558|FG002|COMPLETED|Overall Study||10
6446985|NCT01129557|7362556|FG000|NOT COMPLETED|Overall Study||4
6446986|NCT01129557|7362557|FG001|NOT COMPLETED|Overall Study||5
6446987|NCT01129557|7362558|FG002|NOT COMPLETED|Overall Study||4
6446988|NCT01129583|7362579|FG000|STARTED|Overall Study||9
6446989|NCT01129583|7362580|FG001|STARTED|Overall Study||9
6446990|NCT01129583|7362579|FG000|COMPLETED|Overall Study||6
6446991|NCT01129583|7362580|FG001|COMPLETED|Overall Study||7
6446992|NCT01129583|7362579|FG000|NOT COMPLETED|Overall Study||3
6446993|NCT01129583|7362580|FG001|NOT COMPLETED|Overall Study||2
6446994|NCT01129609|7362586|FG000|STARTED|Overall Study||20
6446995|NCT01129609|7362586|FG000|COMPLETED|Overall Study||18
6446996|NCT01129609|7362586|FG000|NOT COMPLETED|Overall Study||2
6446997|NCT01129622|7362590|FG000|STARTED|Overall Study||16
6446998|NCT01129622|7362590|FG000|COMPLETED|Overall Study||14
6446999|NCT01129622|7362590|FG000|NOT COMPLETED|Overall Study||2
6447000|NCT01129765|7362595|FG000|STARTED|Overall Study||30
6447001|NCT01129765|7362595|FG000|COMPLETED|Overall Study||30
6447002|NCT01129765|7362595|FG000|NOT COMPLETED|Overall Study||0
6447003|NCT01129778|7362599|FG000|STARTED|Overall Study||22
6447004|NCT01129778|7362599|FG000|COMPLETED|Overall Study||15
6447005|NCT01129778|7362599|FG000|NOT COMPLETED|Overall Study||7
6447006|NCT01129804|7362605|FG000|STARTED|Overall Study||96
6447007|NCT01129804|7362606|FG001|STARTED|Overall Study||97
6447008|NCT01129804|7362605|FG000|COMPLETED|Overall Study||64
6447009|NCT01129804|7362606|FG001|COMPLETED|Overall Study||66
6447010|NCT01129804|7362605|FG000|NOT COMPLETED|Overall Study||32
6447011|NCT01129804|7362606|FG001|NOT COMPLETED|Overall Study||31
6447012|NCT01129882|7362612|FG000|STARTED|Overall Study||709
6447013|NCT01129882|7362612|FG000|Received at Least 1 Dose of Study Drug|Overall Study||709
6447014|NCT01129882|7362612|FG000|COMPLETED|Overall Study||431
6447015|NCT01129882|7362612|FG000|NOT COMPLETED|Overall Study||278
6447016|NCT01129921|7362618|FG000|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
6447017|NCT01129921|7362619|FG001|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
6447018|NCT01129921|7362618|FG000|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
6447019|NCT01129921|7362619|FG001|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
6447020|NCT01129921|7362618|FG000|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
6653636|NCT02438826|7583473|FG000|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
6653637|NCT02438826|7583474|FG001|STARTED|Post-Treatment Phase|Participants who discontinued Open-Label Treatment also had the option to enter Post-Treatment Phase|93
6653638|NCT02438826|7583475|FG002|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|2
6653639|NCT02438826|7583476|FG003|STARTED|Post-Treatment Phase|Participants entered from Double-Blind Treatment Phase.|4
6653640|NCT02438826|7583473|FG000|COMPLETED|Post-Treatment Phase||84
6653641|NCT02438826|7583474|FG001|COMPLETED|Post-Treatment Phase||92
6653642|NCT02438826|7583475|FG002|COMPLETED|Post-Treatment Phase||2
6653643|NCT02438826|7583476|FG003|COMPLETED|Post-Treatment Phase||4
6653644|NCT02438826|7583473|FG000|NOT COMPLETED|Post-Treatment Phase||9
6653645|NCT02438826|7583474|FG001|NOT COMPLETED|Post-Treatment Phase||1
6653646|NCT02438826|7583475|FG002|NOT COMPLETED|Post-Treatment Phase||0
6653647|NCT02438826|7583476|FG003|NOT COMPLETED|Post-Treatment Phase||0
6653648|NCT02439138|7583491|FG000|STARTED|Overall Study||5
6653649|NCT02439138|7583491|FG000|COMPLETED|Overall Study||2
6653650|NCT02439138|7583491|FG000|NOT COMPLETED|Overall Study||3
6653651|NCT02439164|7583497|FG000|STARTED|Overall Study||18
6653652|NCT02439164|7583498|FG001|STARTED|Overall Study||18
6653653|NCT02439164|7583497|FG000|COMPLETED|Overall Study||18
6447021|NCT01129921|7362619|FG001|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
6447022|NCT01129921|7362618|FG000|STARTED|After Sham Cross-over to Mild, One Year||20
6447023|NCT01129921|7362619|FG001|STARTED|After Sham Cross-over to Mild, One Year||20
6500323|NCT01424397|7419092|FG005|NOT COMPLETED|Period-2 (8 Days)||0
6653654|NCT02439164|7583498|FG001|COMPLETED|Overall Study||18
6447024|NCT01129921|7362618|FG000|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
6447025|NCT01129921|7362619|FG001|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
6447026|NCT01129921|7362618|FG000|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
6447027|NCT01129921|7362619|FG001|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
6447028|NCT01129960|7362633|FG000|STARTED|Overall Study||84
6447029|NCT01129960|7362634|FG001|STARTED|Overall Study||83
6447030|NCT01129960|7362635|FG002|STARTED|Overall Study||82
6447031|NCT01129960|7362636|FG003|STARTED|Overall Study||83
6447032|NCT01129960|7362633|FG000|Safety|Overall Study||84
6447033|NCT01129960|7362634|FG001|Safety|Overall Study||83
6447034|NCT01129960|7362635|FG002|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
6447035|NCT01129960|7362636|FG003|Safety|Overall Study||82
6447036|NCT01129960|7362633|FG000|Intent-to-Treat|Overall Study||84
6447037|NCT01129960|7362634|FG001|Intent-to-Treat|Overall Study||83
6447038|NCT01129960|7362635|FG002|Intent-to-Treat|Overall Study||82
6447039|NCT01129960|7362636|FG003|Intent-to-Treat|Overall Study||83
6447040|NCT01129960|7362633|FG000|Per-Protocol|Overall Study||34
6447041|NCT01129960|7362634|FG001|Per-Protocol|Overall Study||52
6447042|NCT01129960|7362635|FG002|Per-Protocol|Overall Study||49
6447043|NCT01129960|7362636|FG003|Per-Protocol|Overall Study||55
6447044|NCT01129960|7362633|FG000|Full Analysis Set (FAS|Overall Study||71
6447045|NCT01129960|7362634|FG001|Full Analysis Set (FAS|Overall Study||67
6447046|NCT01129960|7362635|FG002|Full Analysis Set (FAS|Overall Study||68
6447047|NCT01129960|7362636|FG003|Full Analysis Set (FAS|Overall Study||71
6447048|NCT01129960|7362633|FG000|COMPLETED|Overall Study||54
6447049|NCT01129960|7362634|FG001|COMPLETED|Overall Study||61
6447050|NCT01129960|7362635|FG002|COMPLETED|Overall Study||56
6447051|NCT01129960|7362636|FG003|COMPLETED|Overall Study||70
6447052|NCT01129960|7362633|FG000|NOT COMPLETED|Overall Study||30
6447053|NCT01129960|7362634|FG001|NOT COMPLETED|Overall Study||22
6447054|NCT01129960|7362635|FG002|NOT COMPLETED|Overall Study||26
6447055|NCT01129960|7362636|FG003|NOT COMPLETED|Overall Study||13
6447056|NCT01130051|7362646|FG000|STARTED|Period 1||8
6447057|NCT01130051|7362647|FG001|STARTED|Period 1||8
6447058|NCT01130051|7362646|FG000|COMPLETED|Period 1||8
6447059|NCT01130051|7362647|FG001|COMPLETED|Period 1||8
6447060|NCT01130051|7362646|FG000|NOT COMPLETED|Period 1||0
6447061|NCT01130051|7362647|FG001|NOT COMPLETED|Period 1||0
6447062|NCT01130051|7362646|FG000|STARTED|Washout Period of 14 Days||8
6447063|NCT01130051|7362647|FG001|STARTED|Washout Period of 14 Days||8
6447064|NCT01130051|7362646|FG000|COMPLETED|Washout Period of 14 Days||7
6447065|NCT01130051|7362647|FG001|COMPLETED|Washout Period of 14 Days||6
6447066|NCT01130051|7362646|FG000|NOT COMPLETED|Washout Period of 14 Days||1
6447067|NCT01130051|7362647|FG001|NOT COMPLETED|Washout Period of 14 Days||2
6447068|NCT01130051|7362646|FG000|STARTED|Period 2||7
6447069|NCT01130051|7362647|FG001|STARTED|Period 2||6
6447070|NCT01130051|7362646|FG000|COMPLETED|Period 2||7
6447071|NCT01130051|7362647|FG001|COMPLETED|Period 2||6
6447072|NCT01130051|7362646|FG000|NOT COMPLETED|Period 2||0
6447073|NCT01130051|7362647|FG001|NOT COMPLETED|Period 2||0
6447074|NCT01130103|7362655|FG000|STARTED|Randomized Treatment||19
6447075|NCT01130103|7362656|FG001|STARTED|Randomized Treatment||18
6447076|NCT01130103|7362655|FG000|COMPLETED|Randomized Treatment||13
6447077|NCT01130103|7362656|FG001|COMPLETED|Randomized Treatment||13
6447078|NCT01130103|7362655|FG000|NOT COMPLETED|Randomized Treatment||6
6447079|NCT01130103|7362656|FG001|NOT COMPLETED|Randomized Treatment||5
6447080|NCT01130103|7362655|FG000|STARTED|Maintenance Treatment||13
6447081|NCT01130103|7362656|FG001|STARTED|Maintenance Treatment||13
6447082|NCT01130103|7362655|FG000|COMPLETED|Maintenance Treatment||11
6447083|NCT01130103|7362656|FG001|COMPLETED|Maintenance Treatment||11
6447084|NCT01130103|7362655|FG000|NOT COMPLETED|Maintenance Treatment||2
6447085|NCT01130103|7362656|FG001|NOT COMPLETED|Maintenance Treatment||2
6447086|NCT01130168|7362662|FG000|STARTED|Period 1||6
6447087|NCT01130168|7362663|FG001|STARTED|Period 1||7
6447088|NCT01130168|7362664|FG002|STARTED|Period 1||6
6447089|NCT01130168|7362665|FG003|STARTED|Period 1||8
6447090|NCT01130168|7362666|FG004|STARTED|Period 1||5
6447091|NCT01130168|7362667|FG005|STARTED|Period 1||6
6447092|NCT01130168|7362662|FG000|COMPLETED|Period 1||6
6447093|NCT01130168|7362663|FG001|COMPLETED|Period 1||6
6447094|NCT01130168|7362664|FG002|COMPLETED|Period 1||5
6447095|NCT01130168|7362665|FG003|COMPLETED|Period 1||5
6447096|NCT01130168|7362666|FG004|COMPLETED|Period 1||5
6447097|NCT01130168|7362667|FG005|COMPLETED|Period 1||6
6447098|NCT01130168|7362662|FG000|NOT COMPLETED|Period 1||0
6447099|NCT01130168|7362663|FG001|NOT COMPLETED|Period 1||1
6447100|NCT01130168|7362664|FG002|NOT COMPLETED|Period 1||1
6447101|NCT01130168|7362665|FG003|NOT COMPLETED|Period 1||3
6447102|NCT01130168|7362666|FG004|NOT COMPLETED|Period 1||0
6447103|NCT01130168|7362667|FG005|NOT COMPLETED|Period 1||0
6447104|NCT01130168|7362662|FG000|STARTED|Period 2||6
6447105|NCT01130168|7362663|FG001|STARTED|Period 2||6
6447106|NCT01130168|7362664|FG002|STARTED|Period 2||5
6447107|NCT01130168|7362665|FG003|STARTED|Period 2||5
6447108|NCT01130168|7362666|FG004|STARTED|Period 2||5
6447109|NCT01130168|7362667|FG005|STARTED|Period 2||6
6447110|NCT01130168|7362662|FG000|COMPLETED|Period 2||6
6447111|NCT01130168|7362663|FG001|COMPLETED|Period 2||6
6447112|NCT01130168|7362664|FG002|COMPLETED|Period 2||5
6447113|NCT01130168|7362665|FG003|COMPLETED|Period 2||5
6447114|NCT01130168|7362666|FG004|COMPLETED|Period 2||5
6447115|NCT01130168|7362667|FG005|COMPLETED|Period 2||6
6447116|NCT01130168|7362662|FG000|NOT COMPLETED|Period 2||0
6447117|NCT01130168|7362663|FG001|NOT COMPLETED|Period 2||0
6447118|NCT01130168|7362664|FG002|NOT COMPLETED|Period 2||0
6447119|NCT01130168|7362665|FG003|NOT COMPLETED|Period 2||0
6447120|NCT01130168|7362666|FG004|NOT COMPLETED|Period 2||0
6447121|NCT01130168|7362667|FG005|NOT COMPLETED|Period 2||0
6447122|NCT01130168|7362662|FG000|STARTED|Period 3||6
6447123|NCT01130168|7362663|FG001|STARTED|Period 3||6
6447124|NCT01130168|7362664|FG002|STARTED|Period 3||5
6447125|NCT01130168|7362665|FG003|STARTED|Period 3||5
6447126|NCT01130168|7362666|FG004|STARTED|Period 3||5
6447127|NCT01130168|7362667|FG005|STARTED|Period 3||6
6447128|NCT01130168|7362662|FG000|COMPLETED|Period 3||6
6447129|NCT01130168|7362663|FG001|COMPLETED|Period 3||6
6447130|NCT01130168|7362664|FG002|COMPLETED|Period 3||5
6447131|NCT01130168|7362665|FG003|COMPLETED|Period 3||5
6447132|NCT01130168|7362666|FG004|COMPLETED|Period 3||5
6447133|NCT01130168|7362667|FG005|COMPLETED|Period 3||6
6447134|NCT01130168|7362662|FG000|NOT COMPLETED|Period 3||0
6447135|NCT01130168|7362663|FG001|NOT COMPLETED|Period 3||0
6447136|NCT01130168|7362664|FG002|NOT COMPLETED|Period 3||0
6447137|NCT01130168|7362665|FG003|NOT COMPLETED|Period 3||0
6447138|NCT01130168|7362666|FG004|NOT COMPLETED|Period 3||0
6447139|NCT01130168|7362667|FG005|NOT COMPLETED|Period 3||0
6447140|NCT01130272|7362681|FG000|STARTED|Overall Study||107
6447141|NCT01130272|7362682|FG001|STARTED|Overall Study||173
6447142|NCT01130272|7362683|FG002|STARTED|Overall Study||169
6447143|NCT01130272|7362684|FG003|STARTED|Overall Study||171
6447144|NCT01130272|7362685|FG004|STARTED|Overall Study||169
6447145|NCT01130272|7362681|FG000|Safety Analysis Set: as Randomized|Overall Study||105
6447146|NCT01130272|7362682|FG001|Safety Analysis Set: as Randomized|Overall Study||171
6447147|NCT01130272|7362683|FG002|Safety Analysis Set: as Randomized|Overall Study||166
6447148|NCT01130272|7362684|FG003|Safety Analysis Set: as Randomized|Overall Study||167
6447149|NCT01130272|7362685|FG004|Safety Analysis Set: as Randomized|Overall Study||162
6447150|NCT01130272|7362681|FG000|Safety Analysis Set: Highest Dose Level|Overall Study|105 total represents 1 patient in from Placebo arm; 1 patient out to 200 mg arm.|105
6447151|NCT01130272|7362682|FG001|Safety Analysis Set: Highest Dose Level|Overall Study|170 total represents 2 patients in from Placebo arm; 3 patients out to 200 mg arm.|170
6447152|NCT01130272|7362683|FG002|Safety Analysis Set: Highest Dose Level|Overall Study|165 total represents 1 patient out to 200 mg arm.|165
6447153|NCT01130272|7362684|FG003|Safety Analysis Set: Highest Dose Level|Overall Study|172 total represents 1 patient in from 5 mg; 3 patients in from 25 mg;1 patient in from 100 mg arms.|172
6447154|NCT01130272|7362685|FG004|Safety Analysis Set: Highest Dose Level|Overall Study|159 total represents 2 patients out to 25 mg arm; 1 patient out to 5 mg arm.|159
6447155|NCT01130272|7362681|FG000|COMPLETED|Overall Study||48
6447156|NCT01130272|7362682|FG001|COMPLETED|Overall Study||131
6447157|NCT01130272|7362683|FG002|COMPLETED|Overall Study||121
6447158|NCT01130272|7362684|FG003|COMPLETED|Overall Study||103
6447159|NCT01130272|7362685|FG004|COMPLETED|Overall Study||117
6447160|NCT01130272|7362681|FG000|NOT COMPLETED|Overall Study||59
6447161|NCT01130272|7362682|FG001|NOT COMPLETED|Overall Study||42
6447162|NCT01130272|7362683|FG002|NOT COMPLETED|Overall Study||48
6447163|NCT01130272|7362684|FG003|NOT COMPLETED|Overall Study||68
6447164|NCT01130272|7362685|FG004|NOT COMPLETED|Overall Study||52
6447165|NCT01130337|7362697|FG000|STARTED|Overall Study||36
6447166|NCT01130337|7362697|FG000|COMPLETED|Overall Study||22
6447167|NCT01130337|7362697|FG000|NOT COMPLETED|Overall Study||14
6447168|NCT01130493|7362701|FG000|STARTED|Open-label Dose Conversion to IPX066|During the open-label dose conversion to IPX066, all subjects received IPX066|110
6447169|NCT01130493|7362702|FG001|STARTED|Open-label Dose Conversion to IPX066||0
6447170|NCT01130493|7362703|FG002|STARTED|Open-label Dose Conversion to IPX066||0
6447171|NCT01130493|7362701|FG000|COMPLETED|Open-label Dose Conversion to IPX066||91
6447172|NCT01130493|7362702|FG001|COMPLETED|Open-label Dose Conversion to IPX066||0
6447173|NCT01130493|7362703|FG002|COMPLETED|Open-label Dose Conversion to IPX066||0
6447174|NCT01130493|7362701|FG000|NOT COMPLETED|Open-label Dose Conversion to IPX066||19
6447175|NCT01130493|7362702|FG001|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
6447176|NCT01130493|7362703|FG002|NOT COMPLETED|Open-label Dose Conversion to IPX066||0
6447177|NCT01130493|7362701|FG000|STARTED|Part 1: Double-blind Treatment Period 1|91 subjects completed IPX066 dose conversion and were then randomized to the two treatment sequences|0
6447178|NCT01130493|7362702|FG001|STARTED|Part 1: Double-blind Treatment Period 1|48 were randomized to IPX066-CLE double-blind treatment sequence|48
6447179|NCT01130493|7362703|FG002|STARTED|Part 1: Double-blind Treatment Period 1|43 were randomized to CLE-IPX066 double-blind treatment sequence|43
6447180|NCT01130493|7362701|FG000|COMPLETED|Part 1: Double-blind Treatment Period 1||0
6447181|NCT01130493|7362702|FG001|COMPLETED|Part 1: Double-blind Treatment Period 1||46
6447182|NCT01130493|7362703|FG002|COMPLETED|Part 1: Double-blind Treatment Period 1||43
6447183|NCT01130493|7362701|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
6447184|NCT01130493|7362702|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||2
6447185|NCT01130493|7362703|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 1||0
6447186|NCT01130493|7362701|FG000|STARTED|Part 1: Open-Label IPX066 Washout||0
6447187|NCT01130493|7362702|FG001|STARTED|Part 1: Open-Label IPX066 Washout||46
6447188|NCT01130493|7362703|FG002|STARTED|Part 1: Open-Label IPX066 Washout||43
6553165|NCT01742078|7475663|FG002|COMPLETED|Overall Study||6
6553166|NCT01742078|7475664|FG003|COMPLETED|Overall Study||5
6553167|NCT01742078|7475665|FG004|COMPLETED|Overall Study||6
6553168|NCT01742078|7475666|FG005|COMPLETED|Overall Study||6
6553169|NCT01742078|7475667|FG006|COMPLETED|Overall Study||6
6553170|NCT01742078|7475668|FG007|COMPLETED|Overall Study||6
6447189|NCT01130493|7362701|FG000|COMPLETED|Part 1: Open-Label IPX066 Washout||0
6447190|NCT01130493|7362702|FG001|COMPLETED|Part 1: Open-Label IPX066 Washout||45
6447191|NCT01130493|7362703|FG002|COMPLETED|Part 1: Open-Label IPX066 Washout||41
6447192|NCT01130493|7362701|FG000|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||0
6447193|NCT01130493|7362702|FG001|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||1
6447194|NCT01130493|7362703|FG002|NOT COMPLETED|Part 1: Open-Label IPX066 Washout||2
6447195|NCT01130493|7362701|FG000|STARTED|Part 1: Double-blind Treatment Period 2||0
6447196|NCT01130493|7362702|FG001|STARTED|Part 1: Double-blind Treatment Period 2||45
6447197|NCT01130493|7362703|FG002|STARTED|Part 1: Double-blind Treatment Period 2||41
6447198|NCT01130493|7362701|FG000|COMPLETED|Part 1: Double-blind Treatment Period 2||0
6447199|NCT01130493|7362702|FG001|COMPLETED|Part 1: Double-blind Treatment Period 2||45
6447200|NCT01130493|7362703|FG002|COMPLETED|Part 1: Double-blind Treatment Period 2||39
6447201|NCT01130493|7362701|FG000|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
6447202|NCT01130493|7362702|FG001|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||0
6447203|NCT01130493|7362703|FG002|NOT COMPLETED|Part 1: Double-blind Treatment Period 2||2
6447204|NCT01130493|7362701|FG000|STARTED|Part 2: OLE||0
6447205|NCT01130493|7362702|FG001|STARTED|Part 2: OLE|All subjects received IPX066 during OLE|39
6447206|NCT01130493|7362703|FG002|STARTED|Part 2: OLE|No subjects received CLE during OLE|35
6447207|NCT01130493|7362701|FG000|COMPLETED|Part 2: OLE||0
6447208|NCT01130493|7362702|FG001|COMPLETED|Part 2: OLE||36
6447209|NCT01130493|7362703|FG002|COMPLETED|Part 2: OLE||30
6447210|NCT01130493|7362701|FG000|NOT COMPLETED|Part 2: OLE||0
6447211|NCT01130493|7362702|FG001|NOT COMPLETED|Part 2: OLE||3
6447212|NCT01130493|7362703|FG002|NOT COMPLETED|Part 2: OLE||5
6447213|NCT01130532|7362717|FG000|STARTED|Period III (Weeks 0-12)||207
6447214|NCT01130532|7362718|FG001|STARTED|Period III (Weeks 0-12)||207
6447215|NCT01130532|7362719|FG002|STARTED|Period III (Weeks 0-12)||209
6447216|NCT01130532|7362720|FG003|STARTED|Period III (Weeks 0-12)||0
6447217|NCT01130532|7362717|FG000|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
6447218|NCT01130532|7362718|FG001|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
6447219|NCT01130532|7362719|FG002|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
6447220|NCT01130532|7362720|FG003|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
6447221|NCT01130532|7362717|FG000|COMPLETED|Period III (Weeks 0-12)||186
6447222|NCT01130532|7362718|FG001|COMPLETED|Period III (Weeks 0-12)||189
6447223|NCT01130532|7362719|FG002|COMPLETED|Period III (Weeks 0-12)||190
6447224|NCT01130532|7362720|FG003|COMPLETED|Period III (Weeks 0-12)||0
6447225|NCT01130532|7362717|FG000|NOT COMPLETED|Period III (Weeks 0-12)||21
6447226|NCT01130532|7362718|FG001|NOT COMPLETED|Period III (Weeks 0-12)||18
6447227|NCT01130532|7362719|FG002|NOT COMPLETED|Period III (Weeks 0-12)||19
6447228|NCT01130532|7362720|FG003|NOT COMPLETED|Period III (Weeks 0-12)||0
6447229|NCT01130532|7362717|FG000|STARTED|Period IV (Weeks 13-16)||0
6447230|NCT01130532|7362718|FG001|STARTED|Period IV (Weeks 13-16)||0
6447231|NCT01130532|7362719|FG002|STARTED|Period IV (Weeks 13-16)||0
6447232|NCT01130532|7362720|FG003|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
6447233|NCT01130532|7362717|FG000|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
6447234|NCT01130532|7362718|FG001|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
6447235|NCT01130532|7362719|FG002|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
6447236|NCT01130532|7362720|FG003|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
6447237|NCT01130532|7362717|FG000|COMPLETED|Period IV (Weeks 13-16)||0
6447238|NCT01130532|7362718|FG001|COMPLETED|Period IV (Weeks 13-16)||0
6447239|NCT01130532|7362719|FG002|COMPLETED|Period IV (Weeks 13-16)||0
6447240|NCT01130532|7362720|FG003|COMPLETED|Period IV (Weeks 13-16)||552
6447241|NCT01130532|7362717|FG000|NOT COMPLETED|Period IV (Weeks 13-16)||0
6447242|NCT01130532|7362718|FG001|NOT COMPLETED|Period IV (Weeks 13-16)||0
6447243|NCT01130532|7362719|FG002|NOT COMPLETED|Period IV (Weeks 13-16)||0
6447244|NCT01130532|7362720|FG003|NOT COMPLETED|Period IV (Weeks 13-16)||10
6447245|NCT01130597|7362732|FG000|STARTED|Overall Study||63
6447246|NCT01130597|7362732|FG000|COMPLETED|Overall Study||56
6447247|NCT01130597|7362732|FG000|NOT COMPLETED|Overall Study||7
6447248|NCT01130740|7362738|FG000|STARTED|Overall Study||149
6447249|NCT01130740|7362739|FG001|STARTED|Overall Study||151
6447250|NCT01130740|7362738|FG000|COMPLETED|Overall Study||137
6447251|NCT01130740|7362739|FG001|COMPLETED|Overall Study||136
6447252|NCT01130740|7362738|FG000|NOT COMPLETED|Overall Study||12
6447253|NCT01130740|7362739|FG001|NOT COMPLETED|Overall Study||15
6447254|NCT01130831|7362745|FG000|STARTED|Overall Study||66
6447255|NCT01130831|7362745|FG000|COMPLETED|Overall Study||52
6447256|NCT01130831|7362745|FG000|NOT COMPLETED|Overall Study||14
6447257|NCT01130844|7362764|FG000|STARTED|Overall Study||21
6447258|NCT01130844|7362765|FG001|STARTED|Overall Study||22
6447259|NCT01130844|7362766|FG002|STARTED|Overall Study||9
6447260|NCT01130844|7362764|FG000|COMPLETED|Overall Study||21
6447261|NCT01130844|7362765|FG001|COMPLETED|Overall Study||22
6447262|NCT01130844|7362766|FG002|COMPLETED|Overall Study||9
6447263|NCT01130844|7362764|FG000|NOT COMPLETED|Overall Study||0
6447264|NCT01130844|7362765|FG001|NOT COMPLETED|Overall Study||0
6447265|NCT01130844|7362766|FG002|NOT COMPLETED|Overall Study||0
6553171|NCT01742078|7475669|FG008|COMPLETED|Overall Study||12
6447266|NCT01130883|7362777|FG000|STARTED|Overall Study||3130
6447267|NCT01130883|7362777|FG000|Participants Analyzed|Overall Study||3128
6653655|NCT02439164|7583497|FG000|NOT COMPLETED|Overall Study||0
6653656|NCT02439164|7583498|FG001|NOT COMPLETED|Overall Study||0
6653657|NCT02439281|7583507|FG000|STARTED|Overall Study||24
6653658|NCT02439281|7583508|FG001|STARTED|Overall Study||26
6653659|NCT02439281|7583507|FG000|COMPLETED|Overall Study||24
6447268|NCT01130883|7362777|FG000|COMPLETED|Overall Study||3120
6447269|NCT01130883|7362777|FG000|NOT COMPLETED|Overall Study||10
6447270|NCT01130896|7362781|FG000|STARTED|Overall Study||1509
6447271|NCT01130896|7362781|FG000|COMPLETED|Overall Study||1509
6447272|NCT01130896|7362781|FG000|NOT COMPLETED|Overall Study||0
6447273|NCT01130974|7362787|FG000|STARTED|Overall Study||100
6447274|NCT01130974|7362788|FG001|STARTED|Overall Study||100
6447275|NCT01130974|7362787|FG000|COMPLETED|Overall Study||85
6447276|NCT01130974|7362788|FG001|COMPLETED|Overall Study||87
6447277|NCT01130974|7362787|FG000|NOT COMPLETED|Overall Study||15
6447278|NCT01130974|7362788|FG001|NOT COMPLETED|Overall Study||13
6447279|NCT01131052|7362797|FG000|STARTED|Overall Study||75
6447280|NCT01131052|7362798|FG001|STARTED|Overall Study||75
6447281|NCT01131052|7362797|FG000|COMPLETED|Overall Study||75
6447282|NCT01131052|7362798|FG001|COMPLETED|Overall Study||75
6447283|NCT01131052|7362797|FG000|NOT COMPLETED|Overall Study||0
6447284|NCT01131052|7362798|FG001|NOT COMPLETED|Overall Study||0
6447285|NCT01131065|7362804|FG000|STARTED|Overall Study||15
6447286|NCT01131065|7362804|FG000|COMPLETED|Overall Study||15
6447287|NCT01131065|7362804|FG000|NOT COMPLETED|Overall Study||0
6447288|NCT01131078|7362811|FG000|STARTED|Overall Study||101
6447289|NCT01131078|7362812|FG001|STARTED|Overall Study||102
6553172|NCT01742078|7475661|FG000|NOT COMPLETED|Overall Study||0
6553173|NCT01742078|7475662|FG001|NOT COMPLETED|Overall Study||0
6553174|NCT01742078|7475663|FG002|NOT COMPLETED|Overall Study||0
6553175|NCT01742078|7475664|FG003|NOT COMPLETED|Overall Study||1
6553176|NCT01742078|7475665|FG004|NOT COMPLETED|Overall Study||0
6553177|NCT01742078|7475666|FG005|NOT COMPLETED|Overall Study||0
6553178|NCT01742078|7475667|FG006|NOT COMPLETED|Overall Study||0
6553179|NCT01742078|7475668|FG007|NOT COMPLETED|Overall Study||0
6553180|NCT01742078|7475669|FG008|NOT COMPLETED|Overall Study||0
6553181|NCT01742091|7475697|FG000|STARTED|Overall Study||9
6553182|NCT01742091|7475698|FG001|STARTED|Overall Study||11
6553183|NCT01742091|7475699|FG002|STARTED|Overall Study||10
6447290|NCT01131078|7362813|FG002|STARTED|Overall Study||103
6447291|NCT01131078|7362811|FG000|COMPLETED|Overall Study||0
6447292|NCT01131078|7362812|FG001|COMPLETED|Overall Study||1
6447293|NCT01131078|7362813|FG002|COMPLETED|Overall Study||1
6447294|NCT01131078|7362811|FG000|NOT COMPLETED|Overall Study||101
6447295|NCT01131078|7362812|FG001|NOT COMPLETED|Overall Study||101
6447296|NCT01131078|7362813|FG002|NOT COMPLETED|Overall Study||102
6447297|NCT01131104|7362823|FG000|STARTED|Overall Study||345
6447298|NCT01131104|7362823|FG000|Study Set|Overall Study||344
6447299|NCT01131104|7362823|FG000|Adjudication-Confirmed NAION Set|Overall Study||279
6447300|NCT01131104|7362823|FG000|30-Day Analysis Set|Overall Study||24
6447301|NCT01131104|7362823|FG000|42-Day Analysis Set|Overall Study||28
6447302|NCT01131104|7362823|FG000|12-Month Analysis Set|Overall Study||26
6447303|NCT01131104|7362823|FG000|COMPLETED|Overall Study||332
6447304|NCT01131104|7362823|FG000|NOT COMPLETED|Overall Study||13
6447305|NCT01131130|7362827|FG000|STARTED|Period 1 - Baseline||118
6553184|NCT01742091|7475700|FG003|STARTED|Overall Study||9
6553185|NCT01742091|7475701|FG004|STARTED|Overall Study||8
6447306|NCT01131130|7362827|FG000|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
6447307|NCT01131130|7362827|FG000|NOT COMPLETED|Period 1 - Baseline||1
6447308|NCT01131130|7362827|FG000|STARTED|Period 2 - Crossover||117
6447309|NCT01131130|7362827|FG000|COMPLETED|Period 2 - Crossover||117
6447310|NCT01131130|7362827|FG000|NOT COMPLETED|Period 2 - Crossover||0
6447311|NCT01131130|7362827|FG000|STARTED|Period 3- Crossover||117
6447312|NCT01131130|7362827|FG000|COMPLETED|Period 3- Crossover||116
6447313|NCT01131130|7362827|FG000|NOT COMPLETED|Period 3- Crossover||1
6447314|NCT01131182|7362837|FG000|STARTED|Overall Study||529
6447315|NCT01131182|7362838|FG001|STARTED|Overall Study||537
6447316|NCT01131182|7362837|FG000|COMPLETED|Overall Study||513
6447317|NCT01131182|7362838|FG001|COMPLETED|Overall Study||521
6447318|NCT01131182|7362837|FG000|NOT COMPLETED|Overall Study||16
6447319|NCT01131182|7362838|FG001|NOT COMPLETED|Overall Study||16
6447320|NCT01131260|7362846|FG000|STARTED|Overall Study||5532
6447321|NCT01131260|7362847|FG001|STARTED|Overall Study||5576
6447322|NCT01131260|7362846|FG000|COMPLETED|Overall Study||5488
6553186|NCT01742091|7475702|FG005|STARTED|Overall Study||12
6553187|NCT01742091|7475697|FG000|RECEIVED STUDY DRUG|Overall Study||9
6653660|NCT02439281|7583508|FG001|COMPLETED|Overall Study||26
6744406|NCT03342469|7672452|FG003|STARTED|Overall Study||8
6447323|NCT01131260|7362847|FG001|COMPLETED|Overall Study||5529
6447324|NCT01131260|7362846|FG000|NOT COMPLETED|Overall Study||44
6447325|NCT01131260|7362847|FG001|NOT COMPLETED|Overall Study||47
6447326|NCT01131299|7362855|FG000|STARTED|Overall Study||42
6447327|NCT01131299|7362856|FG001|STARTED|Overall Study||44
6447328|NCT01131299|7362855|FG000|COMPLETED|Overall Study||38
6447329|NCT01131299|7362856|FG001|COMPLETED|Overall Study||37
6447330|NCT01131299|7362855|FG000|NOT COMPLETED|Overall Study||4
6447331|NCT01131299|7362856|FG001|NOT COMPLETED|Overall Study||7
6553188|NCT01742091|7475698|FG001|RECEIVED STUDY DRUG|Overall Study||11
6744407|NCT03342469|7672449|FG000|COMPLETED|Overall Study||9
6447332|NCT01131312|7362864|FG000|STARTED|Overall Study||1839
6447333|NCT01131312|7362865|FG001|STARTED|Overall Study||1385
6447334|NCT01131312|7362866|FG002|STARTED|Overall Study||1836
6447335|NCT01131312|7362864|FG000|COMPLETED|Overall Study||1414
6447336|NCT01131312|7362865|FG001|COMPLETED|Overall Study||1156
6447337|NCT01131312|7362866|FG002|COMPLETED|Overall Study||1485
6447338|NCT01131312|7362864|FG000|NOT COMPLETED|Overall Study||425
6447339|NCT01131312|7362865|FG001|NOT COMPLETED|Overall Study||229
6447340|NCT01131312|7362866|FG002|NOT COMPLETED|Overall Study||351
6447341|NCT01131325|7362874|FG000|STARTED|Overall Study||3
6447342|NCT01131325|7362874|FG000|COMPLETED|Overall Study||0
6447343|NCT01131325|7362874|FG000|NOT COMPLETED|Overall Study||3
6447344|NCT01131351|7362880|FG000|STARTED|Overall Study||5
6447345|NCT01131351|7362881|FG001|STARTED|Overall Study||5
6447346|NCT01131351|7362880|FG000|COMPLETED|Overall Study||5
6447347|NCT01131351|7362881|FG001|COMPLETED|Overall Study||2
6447348|NCT01131351|7362880|FG000|NOT COMPLETED|Overall Study||0
6447349|NCT01131351|7362881|FG001|NOT COMPLETED|Overall Study||3
6447350|NCT01131494|7362887|FG000|STARTED|Overall Study||17
6447351|NCT01131494|7362887|FG000|COMPLETED|Overall Study||15
6447352|NCT01131494|7362887|FG000|NOT COMPLETED|Overall Study||2
6447353|NCT01131507|7362892|FG000|STARTED|Overall Study||15
6447354|NCT01131507|7362892|FG000|COMPLETED|Overall Study||12
6447355|NCT01131507|7362892|FG000|NOT COMPLETED|Overall Study||3
6447356|NCT01131520|7362898|FG000|STARTED|Overall Study||180
6447357|NCT01131520|7362899|FG001|STARTED|Overall Study||180
6447358|NCT01131520|7362898|FG000|COMPLETED|Overall Study||179
6447359|NCT01131520|7362899|FG001|COMPLETED|Overall Study||176
6447360|NCT01131520|7362898|FG000|NOT COMPLETED|Overall Study||1
6447361|NCT01131520|7362899|FG001|NOT COMPLETED|Overall Study||4
6447362|NCT01131585|7362907|FG000|STARTED|Overall Study||85
6447363|NCT01131585|7362908|FG001|STARTED|Overall Study||43
6447364|NCT01131585|7362907|FG000|COMPLETED|Overall Study||0
6447365|NCT01131585|7362908|FG001|COMPLETED|Overall Study||0
6447366|NCT01131585|7362907|FG000|NOT COMPLETED|Overall Study||85
6447367|NCT01131585|7362908|FG001|NOT COMPLETED|Overall Study||43
6447368|NCT01131676|7362917|FG000|STARTED|Discontinuation From Treatment|Randomised|2337
6447369|NCT01131676|7362918|FG001|STARTED|Discontinuation From Treatment|Randomised|2347
6447370|NCT01131676|7362919|FG002|STARTED|Discontinuation From Treatment|Randomised|2344
6447371|NCT01131676|7362917|FG000|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
6447372|NCT01131676|7362918|FG001|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
6447373|NCT01131676|7362919|FG002|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
6447374|NCT01131676|7362917|FG000|NOT COMPLETED|Discontinuation From Treatment||687
6447375|NCT01131676|7362918|FG001|NOT COMPLETED|Discontinuation From Treatment||557
6447376|NCT01131676|7362919|FG002|NOT COMPLETED|Discontinuation From Treatment||544
6447377|NCT01131676|7362917|FG000|STARTED|Discontinuation From Study (Treated Set)||2333
6447378|NCT01131676|7362918|FG001|STARTED|Discontinuation From Study (Treated Set)||2345
6447379|NCT01131676|7362919|FG002|STARTED|Discontinuation From Study (Treated Set)||2342
6447380|NCT01131676|7362917|FG000|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
6447381|NCT01131676|7362918|FG001|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
6447382|NCT01131676|7362919|FG002|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
6447383|NCT01131676|7362917|FG000|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
6447384|NCT01131676|7362918|FG001|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
6447385|NCT01131676|7362919|FG002|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
6447386|NCT01131676|7362917|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
6447387|NCT01131676|7362918|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
6447388|NCT01131676|7362919|FG002|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
6447389|NCT01132118|7362930|FG000|STARTED|First Intervention (8 Weeks)||15
6447390|NCT01132118|7362931|FG001|STARTED|First Intervention (8 Weeks)||15
6447391|NCT01132118|7362930|FG000|COMPLETED|First Intervention (8 Weeks)||12
6447392|NCT01132118|7362931|FG001|COMPLETED|First Intervention (8 Weeks)||12
6447393|NCT01132118|7362930|FG000|NOT COMPLETED|First Intervention (8 Weeks)||3
6447394|NCT01132118|7362931|FG001|NOT COMPLETED|First Intervention (8 Weeks)||3
6553189|NCT01742091|7475699|FG002|RECEIVED STUDY DRUG|Overall Study||10
6553190|NCT01742091|7475700|FG003|RECEIVED STUDY DRUG|Overall Study||9
6553191|NCT01742091|7475701|FG004|RECEIVED STUDY DRUG|Overall Study||8
6553192|NCT01742091|7475702|FG005|RECEIVED STUDY DRUG|Overall Study||12
6553193|NCT01742091|7475697|FG000|COMPLETED|Overall Study||9
6553194|NCT01742091|7475698|FG001|COMPLETED|Overall Study||11
6447395|NCT01132118|7362930|FG000|STARTED|Second Intervention (8 Weeks)||12
6447396|NCT01132118|7362931|FG001|STARTED|Second Intervention (8 Weeks)||12
6447397|NCT01132118|7362930|FG000|COMPLETED|Second Intervention (8 Weeks)||12
6447398|NCT01132118|7362931|FG001|COMPLETED|Second Intervention (8 Weeks)||11
6447399|NCT01132118|7362930|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
6447400|NCT01132118|7362931|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||1
6447401|NCT01132144|7362939|FG000|STARTED|Overall Study||79
6553195|NCT01742091|7475699|FG002|COMPLETED|Overall Study||10
6553196|NCT01742091|7475700|FG003|COMPLETED|Overall Study||8
6553197|NCT01742091|7475701|FG004|COMPLETED|Overall Study||7
6553198|NCT01742091|7475702|FG005|COMPLETED|Overall Study||10
6553199|NCT01742091|7475697|FG000|NOT COMPLETED|Overall Study||0
6447402|NCT01132144|7362940|FG001|STARTED|Overall Study||79
6447403|NCT01132144|7362939|FG000|COMPLETED|Overall Study||79
6447404|NCT01132144|7362940|FG001|COMPLETED|Overall Study||79
6447405|NCT01132144|7362939|FG000|NOT COMPLETED|Overall Study||0
6447406|NCT01132144|7362940|FG001|NOT COMPLETED|Overall Study||0
6447407|NCT01132313|7362960|FG000|STARTED|Overall Study||17
6447408|NCT01132313|7362961|FG001|STARTED|Overall Study||17
6447409|NCT01132313|7362962|FG002|STARTED|Overall Study||81
6447410|NCT01132313|7362963|FG003|STARTED|Overall Study||80
6447411|NCT01132313|7362964|FG004|STARTED|Overall Study||79
6447412|NCT01132313|7362965|FG005|STARTED|Overall Study||79
6447413|NCT01132313|7362966|FG006|STARTED|Overall Study||49
6447414|NCT01132313|7362967|FG007|STARTED|Overall Study||32
6447415|NCT01132313|7362968|FG008|STARTED|Overall Study||26
6447416|NCT01132313|7362969|FG009|STARTED|Overall Study||25
6447417|NCT01132313|7362970|FG010|STARTED|Overall Study||1
6447418|NCT01132313|7362971|FG011|STARTED|Overall Study||2
6447419|NCT01132313|7362960|FG000|COMPLETED|Overall Study||14
6447420|NCT01132313|7362961|FG001|COMPLETED|Overall Study||17
6447421|NCT01132313|7362962|FG002|COMPLETED|Overall Study||61
6447422|NCT01132313|7362963|FG003|COMPLETED|Overall Study||48
6447423|NCT01132313|7362964|FG004|COMPLETED|Overall Study||34
6447424|NCT01132313|7362965|FG005|COMPLETED|Overall Study||54
6447425|NCT01132313|7362966|FG006|COMPLETED|Overall Study||19
6447426|NCT01132313|7362967|FG007|COMPLETED|Overall Study||24
6447427|NCT01132313|7362968|FG008|COMPLETED|Overall Study||5
6447428|NCT01132313|7362969|FG009|COMPLETED|Overall Study||5
6447429|NCT01132313|7362970|FG010|COMPLETED|Overall Study||0
6447430|NCT01132313|7362971|FG011|COMPLETED|Overall Study||2
6447431|NCT01132313|7362960|FG000|NOT COMPLETED|Overall Study||3
6447432|NCT01132313|7362961|FG001|NOT COMPLETED|Overall Study||0
6447433|NCT01132313|7362962|FG002|NOT COMPLETED|Overall Study||20
6447434|NCT01132313|7362963|FG003|NOT COMPLETED|Overall Study||32
6447435|NCT01132313|7362964|FG004|NOT COMPLETED|Overall Study||45
6447436|NCT01132313|7362965|FG005|NOT COMPLETED|Overall Study||25
6447437|NCT01132313|7362966|FG006|NOT COMPLETED|Overall Study||30
6447438|NCT01132313|7362967|FG007|NOT COMPLETED|Overall Study||8
6447439|NCT01132313|7362968|FG008|NOT COMPLETED|Overall Study||21
6447440|NCT01132313|7362969|FG009|NOT COMPLETED|Overall Study||20
6447441|NCT01132313|7362970|FG010|NOT COMPLETED|Overall Study||1
6447442|NCT01132313|7362971|FG011|NOT COMPLETED|Overall Study||0
6447443|NCT01132326|7363002|FG000|STARTED|Overall Study||350
6447444|NCT01132326|7363002|FG000|COMPLETED|Overall Study||132
6447445|NCT01132326|7363002|FG000|NOT COMPLETED|Overall Study||218
6447446|NCT01132378|7363006|FG000|STARTED|Overall Study||40
6447447|NCT01132378|7363006|FG000|COMPLETED|Overall Study||40
6447448|NCT01132378|7363006|FG000|NOT COMPLETED|Overall Study||0
6447449|NCT01132482|7363013|FG000|STARTED|Overall Study||13
6447450|NCT01132482|7363014|FG001|STARTED|Overall Study||6
6447451|NCT01132482|7363013|FG000|COMPLETED|Overall Study||12
6447452|NCT01132482|7363014|FG001|COMPLETED|Overall Study||6
6447453|NCT01132482|7363013|FG000|NOT COMPLETED|Overall Study||1
6447454|NCT01132482|7363014|FG001|NOT COMPLETED|Overall Study||0
6447455|NCT01132495|7363024|FG000|STARTED|Overall Study||447
6447456|NCT01132495|7363025|FG001|STARTED|Overall Study||441
6447457|NCT01132495|7363026|FG002|STARTED|Overall Study||166
6447458|NCT01132495|7363027|FG003|STARTED|Overall Study||116
6447459|NCT01132495|7363024|FG000|COMPLETED|Overall Study||407
6447460|NCT01132495|7363025|FG001|COMPLETED|Overall Study||403
6447461|NCT01132495|7363026|FG002|COMPLETED|Overall Study||146
6447462|NCT01132495|7363027|FG003|COMPLETED|Overall Study||104
6447463|NCT01132495|7363024|FG000|NOT COMPLETED|Overall Study||40
6447464|NCT01132495|7363025|FG001|NOT COMPLETED|Overall Study||38
6447465|NCT01132495|7363026|FG002|NOT COMPLETED|Overall Study||20
6447466|NCT01132495|7363027|FG003|NOT COMPLETED|Overall Study||12
6447467|NCT01132508|7363038|FG000|STARTED|Overall Study||33
6447468|NCT01132508|7363038|FG000|Treated at Baseline|Overall Study||33
6447469|NCT01132508|7363038|FG000|6 Weeks|Overall Study||33
6447470|NCT01132508|7363038|FG000|12 Weeks|Overall Study||33
6447471|NCT01132508|7363038|FG000|26 Weeks|Overall Study||33
6447472|NCT01132508|7363038|FG000|52 Weeks|Overall Study||30
6447473|NCT01132508|7363038|FG000|78 Weeks|Overall Study||28
6447474|NCT01132508|7363038|FG000|104 Weeks|Overall Study||27
6447475|NCT01132508|7363038|FG000|COMPLETED|Overall Study||24
6447476|NCT01132508|7363038|FG000|NOT COMPLETED|Overall Study||9
6447477|NCT01132547|7363044|FG000|STARTED|Overall Study||9
6447478|NCT01132547|7363045|FG001|STARTED|Overall Study||13
6447479|NCT01132547|7363044|FG000|COMPLETED|Overall Study||5
6447480|NCT01132547|7363045|FG001|COMPLETED|Overall Study||12
6447481|NCT01132547|7363044|FG000|NOT COMPLETED|Overall Study||4
6447482|NCT01132547|7363045|FG001|NOT COMPLETED|Overall Study||1
6447483|NCT01132612|7363054|FG000|STARTED|Overall Study||46
6447484|NCT01132612|7363055|FG001|STARTED|Overall Study||42
6447485|NCT01132612|7363056|FG002|STARTED|Overall Study||187
6447486|NCT01132612|7363054|FG000|COMPLETED|Overall Study||6
6447487|NCT01132612|7363055|FG001|COMPLETED|Overall Study||7
6447488|NCT01132612|7363056|FG002|COMPLETED|Overall Study||17
6447489|NCT01132612|7363054|FG000|NOT COMPLETED|Overall Study||40
6447490|NCT01132612|7363055|FG001|NOT COMPLETED|Overall Study||35
6447491|NCT01132612|7363056|FG002|NOT COMPLETED|Overall Study||170
6447492|NCT01132651|7363066|FG000|STARTED|Overall Study||4
6447493|NCT01132651|7363067|FG001|STARTED|Overall Study||5
6447494|NCT01132651|7363066|FG000|COMPLETED|Overall Study||3
6447495|NCT01132651|7363067|FG001|COMPLETED|Overall Study||4
6447496|NCT01132651|7363066|FG000|NOT COMPLETED|Overall Study||1
6447497|NCT01132651|7363067|FG001|NOT COMPLETED|Overall Study||1
6447498|NCT01132664|7363078|FG000|STARTED|Phase lb||5
6447499|NCT01132664|7363079|FG001|STARTED|Phase lb||12
6447500|NCT01132664|7363080|FG002|STARTED|Phase lb||0
6447501|NCT01132664|7363081|FG003|STARTED|Phase lb||0
6447502|NCT01132664|7363082|FG004|STARTED|Phase lb||0
6447503|NCT01132664|7363078|FG000|COMPLETED|Phase lb||0
6447504|NCT01132664|7363079|FG001|COMPLETED|Phase lb||0
6447505|NCT01132664|7363080|FG002|COMPLETED|Phase lb||0
6447506|NCT01132664|7363081|FG003|COMPLETED|Phase lb||0
6447507|NCT01132664|7363082|FG004|COMPLETED|Phase lb||0
6447508|NCT01132664|7363078|FG000|NOT COMPLETED|Phase lb||5
6447509|NCT01132664|7363079|FG001|NOT COMPLETED|Phase lb||12
6447510|NCT01132664|7363080|FG002|NOT COMPLETED|Phase lb||0
6447511|NCT01132664|7363081|FG003|NOT COMPLETED|Phase lb||0
6447512|NCT01132664|7363082|FG004|NOT COMPLETED|Phase lb||0
6447513|NCT01132664|7363078|FG000|STARTED|Phase ll||0
6447514|NCT01132664|7363079|FG001|STARTED|Phase ll||0
6447515|NCT01132664|7363080|FG002|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
6447516|NCT01132664|7363081|FG003|STARTED|Phase ll||0
6447517|NCT01132664|7363082|FG004|STARTED|Phase ll||0
6447518|NCT01132664|7363078|FG000|COMPLETED|Phase ll||0
6447519|NCT01132664|7363079|FG001|COMPLETED|Phase ll||0
6447520|NCT01132664|7363080|FG002|COMPLETED|Phase ll||0
6447521|NCT01132664|7363081|FG003|COMPLETED|Phase ll||0
6447522|NCT01132664|7363082|FG004|COMPLETED|Phase ll||0
6447523|NCT01132664|7363078|FG000|NOT COMPLETED|Phase ll||0
6447524|NCT01132664|7363079|FG001|NOT COMPLETED|Phase ll||0
6447525|NCT01132664|7363080|FG002|NOT COMPLETED|Phase ll||50
6447526|NCT01132664|7363081|FG003|NOT COMPLETED|Phase ll||0
6447527|NCT01132664|7363082|FG004|NOT COMPLETED|Phase ll||0
6447528|NCT01132664|7363078|FG000|STARTED|BM Cohort||0
6447529|NCT01132664|7363079|FG001|STARTED|BM Cohort||0
6447530|NCT01132664|7363080|FG002|STARTED|BM Cohort||0
6447531|NCT01132664|7363081|FG003|STARTED|BM Cohort||3
6447532|NCT01132664|7363082|FG004|STARTED|BM Cohort||6
6447533|NCT01132664|7363078|FG000|COMPLETED|BM Cohort||0
6447534|NCT01132664|7363079|FG001|COMPLETED|BM Cohort||0
6447535|NCT01132664|7363080|FG002|COMPLETED|BM Cohort||0
6447536|NCT01132664|7363081|FG003|COMPLETED|BM Cohort||0
6447537|NCT01132664|7363082|FG004|COMPLETED|BM Cohort||0
6447538|NCT01132664|7363078|FG000|NOT COMPLETED|BM Cohort||0
6447539|NCT01132664|7363079|FG001|NOT COMPLETED|BM Cohort||0
6447540|NCT01132664|7363080|FG002|NOT COMPLETED|BM Cohort||0
6447541|NCT01132664|7363081|FG003|NOT COMPLETED|BM Cohort||3
6447542|NCT01132664|7363082|FG004|NOT COMPLETED|BM Cohort||6
6447543|NCT01132690|7363096|FG000|STARTED|Overall Study||6
6447544|NCT01132690|7363097|FG001|STARTED|Overall Study||5
6447545|NCT01132690|7363096|FG000|COMPLETED|Overall Study||6
6447546|NCT01132690|7363097|FG001|COMPLETED|Overall Study||5
6447547|NCT01132690|7363096|FG000|NOT COMPLETED|Overall Study||0
6447548|NCT01132690|7363097|FG001|NOT COMPLETED|Overall Study||0
6447549|NCT01132755|7363103|FG000|STARTED|Overall Study||112
6447550|NCT01132755|7363103|FG000|COMPLETED|Overall Study||70
6447551|NCT01132755|7363103|FG000|NOT COMPLETED|Overall Study||42
6447552|NCT01132807|7363107|FG000|STARTED|Initial ABVD Treatment (2 Cycles)||15
6447553|NCT01132807|7363108|FG001|STARTED|Initial ABVD Treatment (2 Cycles)||135
6447554|NCT01132807|7363109|FG002|STARTED|Initial ABVD Treatment (2 Cycles)||14
6447555|NCT01132807|7363107|FG000|COMPLETED|Initial ABVD Treatment (2 Cycles)||0
6447556|NCT01132807|7363108|FG001|COMPLETED|Initial ABVD Treatment (2 Cycles)||135
6447557|NCT01132807|7363109|FG002|COMPLETED|Initial ABVD Treatment (2 Cycles)||14
6447558|NCT01132807|7363107|FG000|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||15
6447559|NCT01132807|7363108|FG001|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
6447560|NCT01132807|7363109|FG002|NOT COMPLETED|Initial ABVD Treatment (2 Cycles)||0
6447561|NCT01132807|7363107|FG000|STARTED|Post-Cycle 2 PET Assessment||0
6447562|NCT01132807|7363108|FG001|STARTED|Post-Cycle 2 PET Assessment||135
6447563|NCT01132807|7363109|FG002|STARTED|Post-Cycle 2 PET Assessment||14
6447564|NCT01132807|7363107|FG000|COMPLETED|Post-Cycle 2 PET Assessment||0
6447565|NCT01132807|7363108|FG001|COMPLETED|Post-Cycle 2 PET Assessment||135
6447566|NCT01132807|7363109|FG002|COMPLETED|Post-Cycle 2 PET Assessment||14
6447567|NCT01132807|7363107|FG000|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
6447568|NCT01132807|7363108|FG001|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
6447569|NCT01132807|7363109|FG002|NOT COMPLETED|Post-Cycle 2 PET Assessment||0
6447570|NCT01132820|7363117|FG000|STARTED|Overall Study||53
6447571|NCT01132820|7363117|FG000|COMPLETED|Overall Study||48
6447572|NCT01132820|7363117|FG000|NOT COMPLETED|Overall Study||5
6447573|NCT01132846|7363124|FG000|STARTED|Overall Study||122
6447574|NCT01132846|7363125|FG001|STARTED|Overall Study||119
6447575|NCT01132846|7363126|FG002|STARTED|Overall Study||119
6447576|NCT01132846|7363124|FG000|COMPLETED|Overall Study||106
6447577|NCT01132846|7363125|FG001|COMPLETED|Overall Study||101
6447578|NCT01132846|7363126|FG002|COMPLETED|Overall Study||108
6447579|NCT01132846|7363124|FG000|NOT COMPLETED|Overall Study||16
6447580|NCT01132846|7363125|FG001|NOT COMPLETED|Overall Study||18
6447581|NCT01132846|7363126|FG002|NOT COMPLETED|Overall Study||11
6447582|NCT01133067|7363136|FG000|STARTED|Overall Study||200
6447583|NCT01133067|7363136|FG000|COMPLETED|Overall Study||61
6447584|NCT01133067|7363136|FG000|NOT COMPLETED|Overall Study||139
6447585|NCT01133158|7363140|FG000|STARTED|Overall Study||60
6447586|NCT01133158|7363140|FG000|COMPLETED|Overall Study||43
6447587|NCT01133158|7363140|FG000|NOT COMPLETED|Overall Study||17
6553200|NCT01742091|7475698|FG001|NOT COMPLETED|Overall Study||0
6553201|NCT01742091|7475699|FG002|NOT COMPLETED|Overall Study||0
6653661|NCT02439281|7583507|FG000|NOT COMPLETED|Overall Study||0
6447588|NCT01133171|7363149|FG000|STARTED|Overall Study||25
6447589|NCT01133171|7363150|FG001|STARTED|Overall Study||27
6447590|NCT01133171|7363151|FG002|STARTED|Overall Study||25
6447591|NCT01133171|7363149|FG000|COMPLETED|Overall Study||24
6447592|NCT01133171|7363150|FG001|COMPLETED|Overall Study||25
6447593|NCT01133171|7363151|FG002|COMPLETED|Overall Study||25
6653662|NCT02439281|7583508|FG001|NOT COMPLETED|Overall Study||0
6653663|NCT02439320|7583519|FG000|STARTED|Overall Study||744
6653664|NCT02439320|7583520|FG001|STARTED|Overall Study||745
6653665|NCT02439320|7583521|FG002|STARTED|Overall Study||742
6653666|NCT02439320|7583519|FG000|Confirmed Eligibility|Overall Study||710
6653667|NCT02439320|7583520|FG001|Confirmed Eligibility|Overall Study||695
6653668|NCT02439320|7583521|FG002|Confirmed Eligibility|Overall Study||705
6653669|NCT02439320|7583519|FG000|1st Dose (by 4 Hours Migraine Onset)|Overall Study||630
6653670|NCT02439320|7583520|FG001|1st Dose (by 4 Hours Migraine Onset)|Overall Study||609
6447594|NCT01133171|7363149|FG000|NOT COMPLETED|Overall Study||1
6447595|NCT01133171|7363150|FG001|NOT COMPLETED|Overall Study||2
6447596|NCT01133171|7363151|FG002|NOT COMPLETED|Overall Study||0
6447597|NCT01133275|7363159|FG000|STARTED|Overall Study||28
6447598|NCT01133275|7363159|FG000|COMPLETED|Overall Study||26
6447599|NCT01133275|7363159|FG000|NOT COMPLETED|Overall Study||2
6447600|NCT01133379|7363166|FG000|STARTED|Overall Study||58
6447601|NCT01133379|7363167|FG001|STARTED|Overall Study||58
6447602|NCT01133379|7363168|FG002|STARTED|Overall Study||58
6447603|NCT01133379|7363166|FG000|COMPLETED|Overall Study||57
6447604|NCT01133379|7363167|FG001|COMPLETED|Overall Study||56
6447605|NCT01133379|7363168|FG002|COMPLETED|Overall Study||56
6447606|NCT01133379|7363166|FG000|NOT COMPLETED|Overall Study||1
6447607|NCT01133379|7363167|FG001|NOT COMPLETED|Overall Study||2
6447608|NCT01133379|7363168|FG002|NOT COMPLETED|Overall Study||2
6447609|NCT01133392|7363178|FG000|STARTED|First Intervention (1 Day )||20
6447610|NCT01133392|7363179|FG001|STARTED|First Intervention (1 Day )||18
6447611|NCT01133392|7363178|FG000|COMPLETED|First Intervention (1 Day )||20
6447612|NCT01133392|7363179|FG001|COMPLETED|First Intervention (1 Day )||18
6447613|NCT01133392|7363178|FG000|NOT COMPLETED|First Intervention (1 Day )||0
6447614|NCT01133392|7363179|FG001|NOT COMPLETED|First Intervention (1 Day )||0
6447615|NCT01133392|7363178|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
6447616|NCT01133392|7363179|FG001|STARTED|Interval Between Dosing (4-7 Days)||18
6447617|NCT01133392|7363178|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
6447618|NCT01133392|7363179|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
6447619|NCT01133392|7363178|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
6447620|NCT01133392|7363179|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
6447621|NCT01133392|7363178|FG000|STARTED|Second Intervention (1 Day)||20
6447622|NCT01133392|7363179|FG001|STARTED|Second Intervention (1 Day)||17
6447623|NCT01133392|7363178|FG000|COMPLETED|Second Intervention (1 Day)||20
6447624|NCT01133392|7363179|FG001|COMPLETED|Second Intervention (1 Day)||17
6447625|NCT01133392|7363178|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6447626|NCT01133392|7363179|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6653671|NCT02439320|7583521|FG002|1st Dose (by 4 Hours Migraine Onset)|Overall Study||617
6653672|NCT02439320|7583519|FG000|2nd Dose (After 2 Hour Assessment)|Overall Study||289
6653673|NCT02439320|7583520|FG001|2nd Dose (After 2 Hour Assessment)|Overall Study||238
6653674|NCT02439320|7583521|FG002|2nd Dose (After 2 Hour Assessment)|Overall Study||401
6653675|NCT02439320|7583519|FG000|COMPLETED|Overall Study||648
6653676|NCT02439320|7583520|FG001|COMPLETED|Overall Study||631
6653677|NCT02439320|7583521|FG002|COMPLETED|Overall Study||643
6653678|NCT02439320|7583519|FG000|NOT COMPLETED|Overall Study||96
6653679|NCT02439320|7583520|FG001|NOT COMPLETED|Overall Study||114
6653680|NCT02439320|7583521|FG002|NOT COMPLETED|Overall Study||99
6653681|NCT02439710|7583535|FG000|STARTED|Overall Study||656
6653682|NCT02439710|7583535|FG000|COMPLETED|Overall Study||656
6653683|NCT02439710|7583535|FG000|NOT COMPLETED|Overall Study||0
6653684|NCT02439749|7583541|FG000|STARTED|Overall Study||182
6653685|NCT02439749|7583542|FG001|STARTED|Overall Study||184
6653686|NCT02439749|7583541|FG000|COMPLETED|Overall Study||153
6447627|NCT01133392|7363178|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
6447628|NCT01133392|7363179|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
6447629|NCT01133392|7363178|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
6447630|NCT01133392|7363179|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||17
6447631|NCT01133392|7363178|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
6553202|NCT01742091|7475700|FG003|NOT COMPLETED|Overall Study||1
6553203|NCT01742091|7475701|FG004|NOT COMPLETED|Overall Study||1
6553204|NCT01742091|7475702|FG005|NOT COMPLETED|Overall Study||2
6553205|NCT01742117|7475718|FG000|STARTED|Overall Study||2641
6553206|NCT01742117|7475719|FG001|STARTED|Overall Study||2635
6447632|NCT01133392|7363179|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
6447633|NCT01133392|7363178|FG000|STARTED|Third Intervention (1 Day)||20
6447634|NCT01133392|7363179|FG001|STARTED|Third Intervention (1 Day)||17
6447635|NCT01133392|7363178|FG000|COMPLETED|Third Intervention (1 Day)||20
6553207|NCT01742117|7475718|FG000|COMPLETED|Overall Study||2641
6553208|NCT01742117|7475719|FG001|COMPLETED|Overall Study||2635
6553209|NCT01742117|7475718|FG000|NOT COMPLETED|Overall Study||0
6653687|NCT02439749|7583542|FG001|COMPLETED|Overall Study||147
6653688|NCT02439749|7583541|FG000|NOT COMPLETED|Overall Study||29
6447636|NCT01133392|7363179|FG001|COMPLETED|Third Intervention (1 Day)||17
6447637|NCT01133392|7363178|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6447638|NCT01133392|7363179|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6447639|NCT01133392|7363178|FG000|STARTED|Interval Between Dosing (4-7 Days)||20
6447640|NCT01133392|7363179|FG001|STARTED|Interval Between Dosing (4-7 Days)||17
6447641|NCT01133392|7363178|FG000|COMPLETED|Interval Between Dosing (4-7 Days)||20
6447642|NCT01133392|7363179|FG001|COMPLETED|Interval Between Dosing (4-7 Days)||16
6447643|NCT01133392|7363178|FG000|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
6447644|NCT01133392|7363179|FG001|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
6447645|NCT01133392|7363178|FG000|STARTED|Fourth Intervention (1 Day)||20
6447646|NCT01133392|7363179|FG001|STARTED|Fourth Intervention (1 Day)||16
6447647|NCT01133392|7363178|FG000|COMPLETED|Fourth Intervention (1 Day)||20
6447648|NCT01133392|7363179|FG001|COMPLETED|Fourth Intervention (1 Day)||16
6447649|NCT01133392|7363178|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
6447650|NCT01133392|7363179|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
6447651|NCT01133405|7363195|FG000|STARTED|Period 1||3
6447652|NCT01133405|7363196|FG001|STARTED|Period 1||6
6447653|NCT01133405|7363197|FG002|STARTED|Period 1||5
6447654|NCT01133405|7363198|FG003|STARTED|Period 1||5
6447655|NCT01133405|7363199|FG004|STARTED|Period 1||3
6447656|NCT01133405|7363200|FG005|STARTED|Period 1||5
6447657|NCT01133405|7363201|FG006|STARTED|Period 1||5
6553210|NCT01742117|7475719|FG001|NOT COMPLETED|Overall Study||0
6553211|NCT01742208|7475728|FG000|STARTED|Overall Study||3
6553212|NCT01742208|7475729|FG001|STARTED|Overall Study||17
6553213|NCT01742208|7475730|FG002|STARTED|Overall Study||16
6553214|NCT01742208|7475728|FG000|COMPLETED|Overall Study||3
6553215|NCT01742208|7475729|FG001|COMPLETED|Overall Study||17
6447658|NCT01133405|7363202|FG007|STARTED|Period 1||2
6447659|NCT01133405|7363203|FG008|STARTED|Period 1||4
6447660|NCT01133405|7363204|FG009|STARTED|Period 1||2
6447661|NCT01133405|7363195|FG000|Safety Analysis Population|Period 1|One discontinued from study after randomization but before any study procedures.|2
6447662|NCT01133405|7363196|FG001|Safety Analysis Population|Period 1||6
6447663|NCT01133405|7363197|FG002|Safety Analysis Population|Period 1||5
6447664|NCT01133405|7363198|FG003|Safety Analysis Population|Period 1||5
6447665|NCT01133405|7363199|FG004|Safety Analysis Population|Period 1||3
6447666|NCT01133405|7363200|FG005|Safety Analysis Population|Period 1||5
6447667|NCT01133405|7363201|FG006|Safety Analysis Population|Period 1||5
6447668|NCT01133405|7363202|FG007|Safety Analysis Population|Period 1||2
6447669|NCT01133405|7363203|FG008|Safety Analysis Population|Period 1||4
6447670|NCT01133405|7363204|FG009|Safety Analysis Population|Period 1||2
6447671|NCT01133405|7363195|FG000|Received at Least 1 Dose of Drug|Period 1||2
6447672|NCT01133405|7363196|FG001|Received at Least 1 Dose of Drug|Period 1||4
6447673|NCT01133405|7363197|FG002|Received at Least 1 Dose of Drug|Period 1||4
6447674|NCT01133405|7363198|FG003|Received at Least 1 Dose of Drug|Period 1||3
6447675|NCT01133405|7363199|FG004|Received at Least 1 Dose of Drug|Period 1||3
6447676|NCT01133405|7363200|FG005|Received at Least 1 Dose of Drug|Period 1||4
6447677|NCT01133405|7363201|FG006|Received at Least 1 Dose of Drug|Period 1||4
6447678|NCT01133405|7363202|FG007|Received at Least 1 Dose of Drug|Period 1||2
6447679|NCT01133405|7363203|FG008|Received at Least 1 Dose of Drug|Period 1||4
6447680|NCT01133405|7363204|FG009|Received at Least 1 Dose of Drug|Period 1||2
6447681|NCT01133405|7363195|FG000|COMPLETED|Period 1||2
6447682|NCT01133405|7363196|FG001|COMPLETED|Period 1||3
6447683|NCT01133405|7363197|FG002|COMPLETED|Period 1||4
6447684|NCT01133405|7363198|FG003|COMPLETED|Period 1||1
6447685|NCT01133405|7363199|FG004|COMPLETED|Period 1||3
6447686|NCT01133405|7363200|FG005|COMPLETED|Period 1||3
6447687|NCT01133405|7363201|FG006|COMPLETED|Period 1||4
6447688|NCT01133405|7363202|FG007|COMPLETED|Period 1||2
6447689|NCT01133405|7363203|FG008|COMPLETED|Period 1||4
6447690|NCT01133405|7363204|FG009|COMPLETED|Period 1||2
6447691|NCT01133405|7363195|FG000|NOT COMPLETED|Period 1||1
6447692|NCT01133405|7363196|FG001|NOT COMPLETED|Period 1||3
6447693|NCT01133405|7363197|FG002|NOT COMPLETED|Period 1||1
6447694|NCT01133405|7363198|FG003|NOT COMPLETED|Period 1||4
6447695|NCT01133405|7363199|FG004|NOT COMPLETED|Period 1||0
6447696|NCT01133405|7363200|FG005|NOT COMPLETED|Period 1||2
6553216|NCT01742208|7475730|FG002|COMPLETED|Overall Study||16
6553217|NCT01742208|7475728|FG000|NOT COMPLETED|Overall Study||0
6553218|NCT01742208|7475729|FG001|NOT COMPLETED|Overall Study||0
6553219|NCT01742208|7475730|FG002|NOT COMPLETED|Overall Study||0
6653689|NCT02439749|7583542|FG001|NOT COMPLETED|Overall Study||37
6653690|NCT02439814|7583550|FG000|STARTED|Overall Study||11
6653691|NCT02439814|7583551|FG001|STARTED|Overall Study||10
6653692|NCT02439814|7583550|FG000|COMPLETED|Overall Study||11
6447697|NCT01133405|7363201|FG006|NOT COMPLETED|Period 1||1
6447698|NCT01133405|7363202|FG007|NOT COMPLETED|Period 1||0
6447699|NCT01133405|7363203|FG008|NOT COMPLETED|Period 1||0
6447700|NCT01133405|7363204|FG009|NOT COMPLETED|Period 1||0
6447701|NCT01133405|7363195|FG000|STARTED|Period 2||2
6447702|NCT01133405|7363196|FG001|STARTED|Period 2|One participant started and received 15 mg LY2886721 only in period 2.|4
6447703|NCT01133405|7363197|FG002|STARTED|Period 2||4
6553220|NCT01742286|7475747|FG000|STARTED|Escalation Phase||5
6553221|NCT01742286|7475748|FG001|STARTED|Escalation Phase||12
6653693|NCT02439814|7583551|FG001|COMPLETED|Overall Study||10
6653694|NCT02439814|7583550|FG000|NOT COMPLETED|Overall Study||0
6653695|NCT02439814|7583551|FG001|NOT COMPLETED|Overall Study||0
6653696|NCT02439879|7583559|FG000|STARTED|Overall Study||16
6447704|NCT01133405|7363198|FG003|STARTED|Period 2|Two participants started and received 25 mg LY2886721 only in period 2.|3
6447705|NCT01133405|7363199|FG004|STARTED|Period 2||3
6447706|NCT01133405|7363200|FG005|STARTED|Period 2|One participant started and received 25 mg LY2886721 only in period 2.|4
6447707|NCT01133405|7363201|FG006|STARTED|Period 2|Cohort C was planned only for single period.|0
6447708|NCT01133405|7363202|FG007|STARTED|Period 2|Cohort C was planned only for single period.|0
6447709|NCT01133405|7363203|FG008|STARTED|Period 2|Cohort D was planned only for single period.|0
6447710|NCT01133405|7363204|FG009|STARTED|Period 2|Cohort D was planned only for single period.|0
6447711|NCT01133405|7363195|FG000|Received at Least 1 Dose of Study Drug|Period 2||2
6447712|NCT01133405|7363196|FG001|Received at Least 1 Dose of Study Drug|Period 2||4
6447713|NCT01133405|7363197|FG002|Received at Least 1 Dose of Study Drug|Period 2||4
6447714|NCT01133405|7363198|FG003|Received at Least 1 Dose of Study Drug|Period 2||3
6447715|NCT01133405|7363199|FG004|Received at Least 1 Dose of Study Drug|Period 2||3
6447716|NCT01133405|7363200|FG005|Received at Least 1 Dose of Study Drug|Period 2||4
6447717|NCT01133405|7363201|FG006|Received at Least 1 Dose of Study Drug|Period 2||0
6447718|NCT01133405|7363202|FG007|Received at Least 1 Dose of Study Drug|Period 2||0
6447719|NCT01133405|7363203|FG008|Received at Least 1 Dose of Study Drug|Period 2||0
6447720|NCT01133405|7363204|FG009|Received at Least 1 Dose of Study Drug|Period 2||0
6447721|NCT01133405|7363195|FG000|COMPLETED|Period 2||2
6447722|NCT01133405|7363196|FG001|COMPLETED|Period 2||3
6447723|NCT01133405|7363197|FG002|COMPLETED|Period 2||3
6447724|NCT01133405|7363198|FG003|COMPLETED|Period 2||2
6447725|NCT01133405|7363199|FG004|COMPLETED|Period 2||3
6447726|NCT01133405|7363200|FG005|COMPLETED|Period 2||2
6447727|NCT01133405|7363201|FG006|COMPLETED|Period 2||0
6447728|NCT01133405|7363202|FG007|COMPLETED|Period 2||0
6447729|NCT01133405|7363203|FG008|COMPLETED|Period 2||0
6447730|NCT01133405|7363204|FG009|COMPLETED|Period 2||0
6447731|NCT01133405|7363195|FG000|NOT COMPLETED|Period 2||0
6447732|NCT01133405|7363196|FG001|NOT COMPLETED|Period 2||1
6447733|NCT01133405|7363197|FG002|NOT COMPLETED|Period 2||1
6447734|NCT01133405|7363198|FG003|NOT COMPLETED|Period 2||1
6447735|NCT01133405|7363199|FG004|NOT COMPLETED|Period 2||0
6447736|NCT01133405|7363200|FG005|NOT COMPLETED|Period 2||2
6447737|NCT01133405|7363201|FG006|NOT COMPLETED|Period 2||0
6447738|NCT01133405|7363202|FG007|NOT COMPLETED|Period 2||0
6447739|NCT01133405|7363203|FG008|NOT COMPLETED|Period 2||0
6447740|NCT01133405|7363204|FG009|NOT COMPLETED|Period 2||0
6447741|NCT01133405|7363195|FG000|STARTED|Period 3||2
6447742|NCT01133405|7363196|FG001|STARTED|Period 3|One participant started and received placebo only in period 3.|4
6447743|NCT01133405|7363197|FG002|STARTED|Period 3|One participant started and received 35 mg LY2886721 only in period 3.|4
6447744|NCT01133405|7363198|FG003|STARTED|Period 3||2
6447745|NCT01133405|7363199|FG004|STARTED|Period 3||3
6447746|NCT01133405|7363200|FG005|STARTED|Period 3||2
6447747|NCT01133405|7363201|FG006|STARTED|Period 3||0
6447748|NCT01133405|7363202|FG007|STARTED|Period 3||0
6447749|NCT01133405|7363203|FG008|STARTED|Period 3||0
6447750|NCT01133405|7363204|FG009|STARTED|Period 3||0
6447751|NCT01133405|7363195|FG000|Received at Least 1 Dose of Study Drug|Period 3||2
6447752|NCT01133405|7363196|FG001|Received at Least 1 Dose of Study Drug|Period 3||4
6447753|NCT01133405|7363197|FG002|Received at Least 1 Dose of Study Drug|Period 3||4
6447754|NCT01133405|7363198|FG003|Received at Least 1 Dose of Study Drug|Period 3||2
6447755|NCT01133405|7363199|FG004|Received at Least 1 Dose of Study Drug|Period 3||3
6447756|NCT01133405|7363200|FG005|Received at Least 1 Dose of Study Drug|Period 3||2
6447757|NCT01133405|7363201|FG006|Received at Least 1 Dose of Study Drug|Period 3||0
6447758|NCT01133405|7363202|FG007|Received at Least 1 Dose of Study Drug|Period 3||0
6447759|NCT01133405|7363203|FG008|Received at Least 1 Dose of Study Drug|Period 3||0
6447760|NCT01133405|7363204|FG009|Received at Least 1 Dose of Study Drug|Period 3||0
6447761|NCT01133405|7363195|FG000|COMPLETED|Period 3||2
6447762|NCT01133405|7363196|FG001|COMPLETED|Period 3||4
6447763|NCT01133405|7363197|FG002|COMPLETED|Period 3||4
6447764|NCT01133405|7363198|FG003|COMPLETED|Period 3||2
6447765|NCT01133405|7363199|FG004|COMPLETED|Period 3||3
6447766|NCT01133405|7363200|FG005|COMPLETED|Period 3||2
6447767|NCT01133405|7363201|FG006|COMPLETED|Period 3||0
6447768|NCT01133405|7363202|FG007|COMPLETED|Period 3||0
6447769|NCT01133405|7363203|FG008|COMPLETED|Period 3||0
6447770|NCT01133405|7363204|FG009|COMPLETED|Period 3||0
6447771|NCT01133405|7363195|FG000|NOT COMPLETED|Period 3||0
6447772|NCT01133405|7363196|FG001|NOT COMPLETED|Period 3||0
6447773|NCT01133405|7363197|FG002|NOT COMPLETED|Period 3||0
6447774|NCT01133405|7363198|FG003|NOT COMPLETED|Period 3||0
6447775|NCT01133405|7363199|FG004|NOT COMPLETED|Period 3||0
6447776|NCT01133405|7363200|FG005|NOT COMPLETED|Period 3||0
6447777|NCT01133405|7363201|FG006|NOT COMPLETED|Period 3||0
6447778|NCT01133405|7363202|FG007|NOT COMPLETED|Period 3||0
6447779|NCT01133405|7363203|FG008|NOT COMPLETED|Period 3||0
6447780|NCT01133405|7363204|FG009|NOT COMPLETED|Period 3||0
6447781|NCT01133418|7363236|FG000|STARTED|Overall Study||34
6447782|NCT01133418|7363237|FG001|STARTED|Overall Study||38
6447783|NCT01133418|7363236|FG000|COMPLETED|Overall Study||29
6447784|NCT01133418|7363237|FG001|COMPLETED|Overall Study||32
6447785|NCT01133418|7363236|FG000|NOT COMPLETED|Overall Study||5
6447786|NCT01133418|7363237|FG001|NOT COMPLETED|Overall Study||6
6447787|NCT01133522|7363253|FG000|STARTED|Overall Study||10
6447788|NCT01133522|7363254|FG001|STARTED|Overall Study||7
6447789|NCT01133522|7363255|FG002|STARTED|Overall Study||6
6447790|NCT01133522|7363256|FG003|STARTED|Overall Study||7
6447791|NCT01133522|7363257|FG004|STARTED|Overall Study||7
6447792|NCT01133522|7363258|FG005|STARTED|Overall Study||6
6447793|NCT01133522|7363259|FG006|STARTED|Overall Study||2
6447794|NCT01133522|7363260|FG007|STARTED|Overall Study||9
6447795|NCT01133522|7363261|FG008|STARTED|Overall Study||2
6447796|NCT01133522|7363262|FG009|STARTED|Overall Study||4
6447797|NCT01133522|7363253|FG000|Received Treatment|Overall Study||10
6447798|NCT01133522|7363254|FG001|Received Treatment|Overall Study||6
6447799|NCT01133522|7363255|FG002|Received Treatment|Overall Study||6
6447800|NCT01133522|7363256|FG003|Received Treatment|Overall Study||6
6447801|NCT01133522|7363257|FG004|Received Treatment|Overall Study||6
6447802|NCT01133522|7363258|FG005|Received Treatment|Overall Study||6
6447803|NCT01133522|7363259|FG006|Received Treatment|Overall Study||2
6447804|NCT01133522|7363260|FG007|Received Treatment|Overall Study||9
6447805|NCT01133522|7363261|FG008|Received Treatment|Overall Study||2
6447806|NCT01133522|7363262|FG009|Received Treatment|Overall Study||4
6447807|NCT01133522|7363253|FG000|COMPLETED|Overall Study||10
6447808|NCT01133522|7363254|FG001|COMPLETED|Overall Study||6
6447809|NCT01133522|7363255|FG002|COMPLETED|Overall Study||6
6447810|NCT01133522|7363256|FG003|COMPLETED|Overall Study||6
6447811|NCT01133522|7363257|FG004|COMPLETED|Overall Study||6
6447812|NCT01133522|7363258|FG005|COMPLETED|Overall Study||6
6447813|NCT01133522|7363259|FG006|COMPLETED|Overall Study||2
6447814|NCT01133522|7363260|FG007|COMPLETED|Overall Study||9
6447815|NCT01133522|7363261|FG008|COMPLETED|Overall Study||2
6447816|NCT01133522|7363262|FG009|COMPLETED|Overall Study||4
6447817|NCT01133522|7363253|FG000|NOT COMPLETED|Overall Study||0
6653697|NCT02439879|7583560|FG001|STARTED|Overall Study||17
6653698|NCT02439879|7583559|FG000|COMPLETED|Overall Study||16
6653699|NCT02439879|7583560|FG001|COMPLETED|Overall Study||17
6653700|NCT02439879|7583559|FG000|NOT COMPLETED|Overall Study||0
6653701|NCT02439879|7583560|FG001|NOT COMPLETED|Overall Study||0
6653702|NCT02440022|7583568|FG000|STARTED|Overall Study||141
6653703|NCT02440022|7583569|FG001|STARTED|Overall Study||144
6653704|NCT02440022|7583568|FG000|COMPLETED|Overall Study||114
6653705|NCT02440022|7583569|FG001|COMPLETED|Overall Study||131
6653706|NCT02440022|7583568|FG000|NOT COMPLETED|Overall Study||27
6653707|NCT02440022|7583569|FG001|NOT COMPLETED|Overall Study||13
6653708|NCT02440139|7583575|FG000|STARTED|Overall Study|12 radiologists read 324 CT cases|12
6653709|NCT02440139|7583575|FG000|COMPLETED|Overall Study|12 radiologists read 324 CT cases|12
6653710|NCT02440139|7583575|FG000|NOT COMPLETED|Overall Study||0
6653711|NCT02440178|7583583|FG000|STARTED|Overall Study||66
6447818|NCT01133522|7363254|FG001|NOT COMPLETED|Overall Study||1
6447819|NCT01133522|7363255|FG002|NOT COMPLETED|Overall Study||0
6447820|NCT01133522|7363256|FG003|NOT COMPLETED|Overall Study||1
6447821|NCT01133522|7363257|FG004|NOT COMPLETED|Overall Study||1
6447822|NCT01133522|7363258|FG005|NOT COMPLETED|Overall Study||0
6447823|NCT01133522|7363259|FG006|NOT COMPLETED|Overall Study||0
6447824|NCT01133522|7363260|FG007|NOT COMPLETED|Overall Study||0
6447825|NCT01133522|7363261|FG008|NOT COMPLETED|Overall Study||0
6447826|NCT01133522|7363262|FG009|NOT COMPLETED|Overall Study||0
6447827|NCT01133626|7363294|FG000|STARTED|Overall Study||50
6447828|NCT01133626|7363295|FG001|STARTED|Overall Study||46
6447829|NCT01133626|7363296|FG002|STARTED|Overall Study||11
6447830|NCT01133626|7363294|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
6447831|NCT01133626|7363295|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
6447832|NCT01133626|7363296|FG002|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
6447833|NCT01133626|7363294|FG000|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
6653712|NCT02440178|7583583|FG000|COMPLETED|Overall Study||46
6653713|NCT02440178|7583583|FG000|NOT COMPLETED|Overall Study||20
6653714|NCT02440204|7583592|FG000|STARTED|Overall Study||22
6653715|NCT02440204|7583593|FG001|STARTED|Overall Study||24
6653716|NCT02440204|7583594|FG002|STARTED|Overall Study||22
6653717|NCT02440204|7583592|FG000|COMPLETED|Overall Study||22
6653718|NCT02440204|7583593|FG001|COMPLETED|Overall Study||24
6653719|NCT02440204|7583594|FG002|COMPLETED|Overall Study||22
6653720|NCT02440204|7583592|FG000|NOT COMPLETED|Overall Study||0
6653721|NCT02440204|7583593|FG001|NOT COMPLETED|Overall Study||0
6653722|NCT02440204|7583594|FG002|NOT COMPLETED|Overall Study||0
6447834|NCT01133626|7363295|FG001|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
6447835|NCT01133626|7363296|FG002|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
6447836|NCT01133626|7363294|FG000|COMPLETED|Overall Study||49
6447837|NCT01133626|7363295|FG001|COMPLETED|Overall Study||41
6447838|NCT01133626|7363296|FG002|COMPLETED|Overall Study||9
6447839|NCT01133626|7363294|FG000|NOT COMPLETED|Overall Study||1
6447840|NCT01133626|7363295|FG001|NOT COMPLETED|Overall Study||5
6447841|NCT01133626|7363296|FG002|NOT COMPLETED|Overall Study||2
6447842|NCT01133665|7363304|FG000|STARTED|Overall Study||42
6447843|NCT01133665|7363304|FG000|COMPLETED|Overall Study||40
6447844|NCT01133665|7363304|FG000|NOT COMPLETED|Overall Study||2
6447845|NCT01133678|7363310|FG000|STARTED|Overall Study||25
6447846|NCT01133678|7363311|FG001|STARTED|Overall Study||25
6653723|NCT02440308|7583602|FG000|STARTED|Overall Study||10
6653724|NCT02440308|7583602|FG000|COMPLETED|Overall Study||10
6653725|NCT02440308|7583602|FG000|NOT COMPLETED|Overall Study||0
6447847|NCT01133678|7363310|FG000|COMPLETED|Overall Study||24
6447848|NCT01133678|7363311|FG001|COMPLETED|Overall Study||24
6447849|NCT01133678|7363310|FG000|NOT COMPLETED|Overall Study||1
6447850|NCT01133678|7363311|FG001|NOT COMPLETED|Overall Study||1
6447851|NCT01133704|7363319|FG000|STARTED|Overall Study||65
6447852|NCT01133704|7363320|FG001|STARTED|Overall Study||33
6447853|NCT01133704|7363319|FG000|COMPLETED|Overall Study|(including 3 year follow-up)|16
6447854|NCT01133704|7363320|FG001|COMPLETED|Overall Study|(including 3 year follow-up)|7
6447855|NCT01133704|7363319|FG000|NOT COMPLETED|Overall Study||49
6447856|NCT01133704|7363320|FG001|NOT COMPLETED|Overall Study||26
6447857|NCT01133756|7363329|FG000|STARTED|Overall Study||2
6447858|NCT01133756|7363330|FG001|STARTED|Overall Study||3
6447859|NCT01133756|7363331|FG002|STARTED|Overall Study||2
6447860|NCT01133756|7363329|FG000|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
6447861|NCT01133756|7363330|FG001|Completed 6 Cycles|Overall Study||0
6447862|NCT01133756|7363331|FG002|Completed 6 Cycles|Overall Study||0
6447863|NCT01133756|7363329|FG000|COMPLETED|Overall Study||0
6447864|NCT01133756|7363330|FG001|COMPLETED|Overall Study||0
6447865|NCT01133756|7363331|FG002|COMPLETED|Overall Study||0
6447866|NCT01133756|7363329|FG000|NOT COMPLETED|Overall Study||2
6447867|NCT01133756|7363330|FG001|NOT COMPLETED|Overall Study||3
6447868|NCT01133756|7363331|FG002|NOT COMPLETED|Overall Study||2
6447869|NCT01133821|7363341|FG000|STARTED|Overall Study||45
6447870|NCT01133821|7363342|FG001|STARTED|Overall Study||47
6447871|NCT01133821|7363341|FG000|COMPLETED|Overall Study||27
6447872|NCT01133821|7363342|FG001|COMPLETED|Overall Study||28
6447873|NCT01133821|7363341|FG000|NOT COMPLETED|Overall Study||18
6447874|NCT01133821|7363342|FG001|NOT COMPLETED|Overall Study||19
6447875|NCT01133847|7363351|FG000|STARTED|Active Treatment Phase (Weeks 1-16)||78
6447876|NCT01133847|7363352|FG001|STARTED|Active Treatment Phase (Weeks 1-16)||74
6447877|NCT01133847|7363353|FG002|STARTED|Active Treatment Phase (Weeks 1-16)||70
6447878|NCT01133847|7363351|FG000|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
6447879|NCT01133847|7363352|FG001|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
6447880|NCT01133847|7363353|FG002|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
6447881|NCT01133847|7363351|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
6447882|NCT01133847|7363352|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
6447883|NCT01133847|7363353|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
6447884|NCT01133847|7363351|FG000|STARTED|Follow-Up Phase||73
6447885|NCT01133847|7363352|FG001|STARTED|Follow-Up Phase||73
6553222|NCT01742286|7475749|FG002|STARTED|Escalation Phase||6
6553223|NCT01742286|7475750|FG003|STARTED|Escalation Phase||2
6553224|NCT01742286|7475751|FG004|STARTED|Escalation Phase||4
6553225|NCT01742286|7475752|FG005|STARTED|Escalation Phase||5
6653726|NCT02440334|7583606|FG000|STARTED|Overall Study||53
6653727|NCT02440334|7583606|FG000|COMPLETED|Overall Study||53
6653728|NCT02440334|7583606|FG000|NOT COMPLETED|Overall Study||0
6653729|NCT02440451|7583610|FG000|STARTED|Overall Study||15
6653730|NCT02440451|7583610|FG000|COMPLETED|Overall Study||15
6653731|NCT02440451|7583610|FG000|NOT COMPLETED|Overall Study||0
6653732|NCT02440568|7583618|FG000|STARTED|Overall Study||5
6653733|NCT02440568|7583619|FG001|STARTED|Overall Study||4
6653734|NCT02440568|7583620|FG002|STARTED|Overall Study||10
6653735|NCT02440568|7583621|FG003|STARTED|Overall Study||3
6653736|NCT02440568|7583618|FG000|COMPLETED|Overall Study||1
6653737|NCT02440568|7583619|FG001|COMPLETED|Overall Study||1
6653738|NCT02440568|7583620|FG002|COMPLETED|Overall Study||5
6653739|NCT02440568|7583621|FG003|COMPLETED|Overall Study||1
6653740|NCT02440568|7583618|FG000|NOT COMPLETED|Overall Study||4
6653741|NCT02440568|7583619|FG001|NOT COMPLETED|Overall Study||3
6653742|NCT02440568|7583620|FG002|NOT COMPLETED|Overall Study||5
6653743|NCT02440568|7583621|FG003|NOT COMPLETED|Overall Study||2
6653744|NCT02440594|7583640|FG000|STARTED|Overall Study||509
6653745|NCT02440594|7583641|FG001|STARTED|Overall Study||509
6653746|NCT02440594|7583642|FG002|STARTED|Overall Study||436
6653747|NCT02440594|7583643|FG003|STARTED|Overall Study||429
6653748|NCT02440594|7583644|FG004|STARTED|Overall Study||55
6653749|NCT02440594|7583645|FG005|STARTED|Overall Study||54
6653750|NCT02440594|7583646|FG006|STARTED|Overall Study||150
6653751|NCT02440594|7583647|FG007|STARTED|Overall Study||290
6653752|NCT02440594|7583640|FG000|COMPLETED|Overall Study||377
6447886|NCT01133847|7363353|FG002|STARTED|Follow-Up Phase||67
6447887|NCT01133847|7363351|FG000|COMPLETED|Follow-Up Phase||72
6447888|NCT01133847|7363352|FG001|COMPLETED|Follow-Up Phase||70
6553226|NCT01742286|7475753|FG006|STARTED|Escalation Phase||6
6553227|NCT01742286|7475747|FG000|Ended Treatment = Not Completed)|Escalation Phase||5
6553228|NCT01742286|7475748|FG001|Ended Treatment = Not Completed)|Escalation Phase||12
6553229|NCT01742286|7475749|FG002|Ended Treatment = Not Completed)|Escalation Phase||6
6553230|NCT01742286|7475750|FG003|Ended Treatment = Not Completed)|Escalation Phase||2
6553231|NCT01742286|7475751|FG004|Ended Treatment = Not Completed)|Escalation Phase||4
6653753|NCT02440594|7583641|FG001|COMPLETED|Overall Study||401
6653754|NCT02440594|7583642|FG002|COMPLETED|Overall Study||319
6653755|NCT02440594|7583643|FG003|COMPLETED|Overall Study||340
6653756|NCT02440594|7583644|FG004|COMPLETED|Overall Study||46
6653757|NCT02440594|7583645|FG005|COMPLETED|Overall Study||47
6653758|NCT02440594|7583646|FG006|COMPLETED|Overall Study||113
6653759|NCT02440594|7583647|FG007|COMPLETED|Overall Study||234
6653760|NCT02440594|7583640|FG000|NOT COMPLETED|Overall Study||132
6447889|NCT01133847|7363353|FG002|COMPLETED|Follow-Up Phase||60
6447890|NCT01133847|7363351|FG000|NOT COMPLETED|Follow-Up Phase||1
6447891|NCT01133847|7363352|FG001|NOT COMPLETED|Follow-Up Phase||3
6447892|NCT01133847|7363353|FG002|NOT COMPLETED|Follow-Up Phase||7
6447893|NCT01133860|7363362|FG000|STARTED|Overall Study||12
6447894|NCT01133860|7363362|FG000|COMPLETED|Overall Study||12
6447895|NCT01133860|7363362|FG000|NOT COMPLETED|Overall Study||0
6447896|NCT01133977|7363372|FG000|STARTED|Overall Study|Treated|3
6447897|NCT01133977|7363373|FG001|STARTED|Overall Study|Treated|7
6447898|NCT01133977|7363374|FG002|STARTED|Overall Study|Treated|6
6447899|NCT01133977|7363375|FG003|STARTED|Overall Study|Treated|42
6447900|NCT01133977|7363376|FG004|STARTED|Overall Study|Treated|39
6447901|NCT01133977|7363372|FG000|COMPLETED|Overall Study||0
6447902|NCT01133977|7363373|FG001|COMPLETED|Overall Study||0
6447903|NCT01133977|7363374|FG002|COMPLETED|Overall Study||0
6447904|NCT01133977|7363375|FG003|COMPLETED|Overall Study||3
6447905|NCT01133977|7363376|FG004|COMPLETED|Overall Study||1
6447906|NCT01133977|7363372|FG000|NOT COMPLETED|Overall Study||3
6447907|NCT01133977|7363373|FG001|NOT COMPLETED|Overall Study||7
6447908|NCT01133977|7363374|FG002|NOT COMPLETED|Overall Study||6
6447909|NCT01133977|7363375|FG003|NOT COMPLETED|Overall Study||39
6447910|NCT01133977|7363376|FG004|NOT COMPLETED|Overall Study||38
6447911|NCT01134016|7363391|FG000|STARTED|Overall Study||13
6447912|NCT01134016|7363391|FG000|COMPLETED|Overall Study||10
6447913|NCT01134016|7363391|FG000|NOT COMPLETED|Overall Study||3
6447914|NCT01134042|7363427|FG000|STARTED|Overall Study||194
6447915|NCT01134042|7363428|FG001|STARTED|Overall Study||197
6447916|NCT01134042|7363429|FG002|STARTED|Overall Study||195
6447917|NCT01134042|7363427|FG000|COMPLETED|Overall Study||146
6447918|NCT01134042|7363428|FG001|COMPLETED|Overall Study||169
6447919|NCT01134042|7363429|FG002|COMPLETED|Overall Study||161
6653761|NCT02440594|7583641|FG001|NOT COMPLETED|Overall Study||108
6653762|NCT02440594|7583642|FG002|NOT COMPLETED|Overall Study||117
6653763|NCT02440594|7583643|FG003|NOT COMPLETED|Overall Study||89
6653764|NCT02440594|7583644|FG004|NOT COMPLETED|Overall Study||9
6653765|NCT02440594|7583645|FG005|NOT COMPLETED|Overall Study||7
6653766|NCT02440594|7583646|FG006|NOT COMPLETED|Overall Study||37
6653767|NCT02440594|7583647|FG007|NOT COMPLETED|Overall Study||56
6653768|NCT02440633|7583672|FG000|STARTED|Overall Study||8
6447920|NCT01134042|7363427|FG000|NOT COMPLETED|Overall Study||48
6447921|NCT01134042|7363428|FG001|NOT COMPLETED|Overall Study||28
6447922|NCT01134042|7363429|FG002|NOT COMPLETED|Overall Study||34
6447923|NCT01134055|7363445|FG000|STARTED|Overall Study||73
6447924|NCT01134055|7363446|FG001|STARTED|Overall Study||72
6447925|NCT01134055|7363447|FG002|STARTED|Overall Study||74
6447926|NCT01134055|7363448|FG003|STARTED|Overall Study||73
6447927|NCT01134055|7363449|FG004|STARTED|Overall Study||73
6447928|NCT01134055|7363450|FG005|STARTED|Overall Study||72
6447929|NCT01134055|7363451|FG006|STARTED|Overall Study||73
6447930|NCT01134055|7363445|FG000|COMPLETED|Overall Study||65
6447931|NCT01134055|7363446|FG001|COMPLETED|Overall Study||66
6447932|NCT01134055|7363447|FG002|COMPLETED|Overall Study||71
6447933|NCT01134055|7363448|FG003|COMPLETED|Overall Study||67
6447934|NCT01134055|7363449|FG004|COMPLETED|Overall Study||67
6447935|NCT01134055|7363450|FG005|COMPLETED|Overall Study||65
6447936|NCT01134055|7363451|FG006|COMPLETED|Overall Study||62
6447937|NCT01134055|7363445|FG000|NOT COMPLETED|Overall Study||8
6447938|NCT01134055|7363446|FG001|NOT COMPLETED|Overall Study||6
6447939|NCT01134055|7363447|FG002|NOT COMPLETED|Overall Study||3
6447940|NCT01134055|7363448|FG003|NOT COMPLETED|Overall Study||6
6553232|NCT01742286|7475752|FG005|Ended Treatment = Not Completed)|Escalation Phase||5
6553233|NCT01742286|7475753|FG006|Ended Treatment = Not Completed)|Escalation Phase||6
6553234|NCT01742286|7475747|FG000|COMPLETED|Escalation Phase||0
6553235|NCT01742286|7475748|FG001|COMPLETED|Escalation Phase||0
6553236|NCT01742286|7475749|FG002|COMPLETED|Escalation Phase||0
6653769|NCT02440633|7583672|FG000|COMPLETED|Overall Study||8
6653770|NCT02440633|7583672|FG000|NOT COMPLETED|Overall Study||0
6653771|NCT02440659|7583682|FG000|STARTED|Overall Study||1997
6653772|NCT02440659|7583683|FG001|STARTED|Overall Study||949
6653773|NCT02440659|7583682|FG000|COMPLETED|Overall Study||1346
6653774|NCT02440659|7583683|FG001|COMPLETED|Overall Study||614
6653775|NCT02440659|7583682|FG000|NOT COMPLETED|Overall Study||651
6653776|NCT02440659|7583683|FG001|NOT COMPLETED|Overall Study||335
6653777|NCT02440789|7583689|FG000|STARTED|Overall Study||32
6447941|NCT01134055|7363449|FG004|NOT COMPLETED|Overall Study||6
6447942|NCT01134055|7363450|FG005|NOT COMPLETED|Overall Study||7
6447943|NCT01134055|7363451|FG006|NOT COMPLETED|Overall Study||11
6447944|NCT01134081|7363473|FG000|STARTED|Overall Study||44
6447945|NCT01134081|7363473|FG000|COMPLETED|Overall Study||44
6447946|NCT01134081|7363473|FG000|NOT COMPLETED|Overall Study||0
6447947|NCT01134107|7363483|FG000|STARTED|Period 1-First Treatment Intervention||67
6447948|NCT01134107|7363484|FG001|STARTED|Period 1-First Treatment Intervention||66
6447949|NCT01134107|7363483|FG000|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
6553237|NCT01742286|7475750|FG003|COMPLETED|Escalation Phase||0
6553238|NCT01742286|7475751|FG004|COMPLETED|Escalation Phase||0
6553239|NCT01742286|7475752|FG005|COMPLETED|Escalation Phase||0
6553240|NCT01742286|7475753|FG006|COMPLETED|Escalation Phase||0
6553241|NCT01742286|7475747|FG000|NOT COMPLETED|Escalation Phase||5
6553242|NCT01742286|7475748|FG001|NOT COMPLETED|Escalation Phase||12
6553243|NCT01742286|7475749|FG002|NOT COMPLETED|Escalation Phase||6
6500324|NCT01424397|7419093|FG006|NOT COMPLETED|Period-2 (8 Days)||0
6553244|NCT01742286|7475750|FG003|NOT COMPLETED|Escalation Phase||2
6447950|NCT01134107|7363484|FG001|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
6447951|NCT01134107|7363483|FG000|COMPLETED|Period 1-First Treatment Intervention||61
6447952|NCT01134107|7363484|FG001|COMPLETED|Period 1-First Treatment Intervention||61
6447953|NCT01134107|7363483|FG000|NOT COMPLETED|Period 1-First Treatment Intervention||6
6447954|NCT01134107|7363484|FG001|NOT COMPLETED|Period 1-First Treatment Intervention||5
6447955|NCT01134107|7363483|FG000|STARTED|Period 2-Second Treatment Intervention||61
6447956|NCT01134107|7363484|FG001|STARTED|Period 2-Second Treatment Intervention||61
6447957|NCT01134107|7363483|FG000|COMPLETED|Period 2-Second Treatment Intervention||57
6447958|NCT01134107|7363484|FG001|COMPLETED|Period 2-Second Treatment Intervention||61
6447959|NCT01134107|7363483|FG000|NOT COMPLETED|Period 2-Second Treatment Intervention||4
6447960|NCT01134107|7363484|FG001|NOT COMPLETED|Period 2-Second Treatment Intervention||0
6447961|NCT01134198|7363492|FG000|STARTED|Phase 1||16
6447962|NCT01134198|7363493|FG001|STARTED|Phase 1||13
6447963|NCT01134198|7363492|FG000|COMPLETED|Phase 1||9
6447964|NCT01134198|7363493|FG001|COMPLETED|Phase 1||11
6447965|NCT01134198|7363492|FG000|NOT COMPLETED|Phase 1||7
6447966|NCT01134198|7363493|FG001|NOT COMPLETED|Phase 1||2
6447967|NCT01134198|7363492|FG000|STARTED|Phase 2||9
6447968|NCT01134198|7363493|FG001|STARTED|Phase 2||11
6447969|NCT01134198|7363492|FG000|COMPLETED|Phase 2||9
6447970|NCT01134198|7363493|FG001|COMPLETED|Phase 2||7
6447971|NCT01134198|7363492|FG000|NOT COMPLETED|Phase 2||0
6447972|NCT01134198|7363493|FG001|NOT COMPLETED|Phase 2||4
6447973|NCT01134263|7363504|FG000|STARTED|Overall Study||164
6447974|NCT01134263|7363505|FG001|STARTED|Overall Study||163
6447975|NCT01134263|7363506|FG002|STARTED|Overall Study||163
6447976|NCT01134263|7363507|FG003|STARTED|Overall Study||168
6447977|NCT01134263|7363508|FG004|STARTED|Overall Study||57
6447978|NCT01134263|7363504|FG000|Received Vaccination 1|Overall Study||163
6447979|NCT01134263|7363505|FG001|Received Vaccination 1|Overall Study||162
6447980|NCT01134263|7363506|FG002|Received Vaccination 1|Overall Study||163
6653778|NCT02440789|7583689|FG000|Initiated Sirolimus|Overall Study||30
6653779|NCT02440789|7583689|FG000|Completed 20 Weeks of Sirolimus|Overall Study||16
6653780|NCT02440789|7583689|FG000|COMPLETED|Overall Study||28
6653781|NCT02440789|7583689|FG000|NOT COMPLETED|Overall Study||4
6653782|NCT02441062|7583693|FG000|STARTED|Overall Study||122
6653783|NCT02441062|7583693|FG000|COMPLETED|Overall Study||122
6653784|NCT02441062|7583693|FG000|NOT COMPLETED|Overall Study||0
6653785|NCT02441114|7583697|FG000|STARTED|Period1||10
6653786|NCT02441114|7583697|FG000|COMPLETED|Period1||10
6653787|NCT02441114|7583697|FG000|NOT COMPLETED|Period1||0
6653788|NCT02441114|7583697|FG000|STARTED|Washout1||10
6653789|NCT02441114|7583697|FG000|COMPLETED|Washout1||10
6653790|NCT02441114|7583697|FG000|NOT COMPLETED|Washout1||0
6653791|NCT02441114|7583697|FG000|STARTED|Period2||10
6653792|NCT02441114|7583697|FG000|COMPLETED|Period2||10
6653793|NCT02441114|7583697|FG000|NOT COMPLETED|Period2||0
6653794|NCT02441114|7583697|FG000|STARTED|Washout2||10
6653795|NCT02441114|7583697|FG000|COMPLETED|Washout2||6
6653796|NCT02441114|7583697|FG000|NOT COMPLETED|Washout2||4
6653797|NCT02441114|7583697|FG000|STARTED|Period3||6
6653798|NCT02441114|7583697|FG000|COMPLETED|Period3||6
6653799|NCT02441114|7583697|FG000|NOT COMPLETED|Period3||0
6653800|NCT02441179|7583703|FG000|STARTED|Overall Study||18
6653801|NCT02441179|7583704|FG001|STARTED|Overall Study||17
6653802|NCT02441179|7583703|FG000|COMPLETED|Overall Study||17
6653803|NCT02441179|7583704|FG001|COMPLETED|Overall Study||16
6653804|NCT02441179|7583703|FG000|NOT COMPLETED|Overall Study||1
6653805|NCT02441179|7583704|FG001|NOT COMPLETED|Overall Study||1
6653806|NCT02441218|7583713|FG000|STARTED|Overall Study||3241
6653807|NCT02441218|7583714|FG001|STARTED|Overall Study||3264
6653808|NCT02441218|7583713|FG000|COMPLETED|Overall Study||2663
6653809|NCT02441218|7583714|FG001|COMPLETED|Overall Study||2652
6653810|NCT02441218|7583713|FG000|NOT COMPLETED|Overall Study||578
6653811|NCT02441218|7583714|FG001|NOT COMPLETED|Overall Study||612
6653812|NCT02441283|7583720|FG000|STARTED|Overall Study||377
6653813|NCT02441283|7583720|FG000|COMPLETED|Overall Study||287
6653814|NCT02441283|7583720|FG000|NOT COMPLETED|Overall Study||90
6653815|NCT02441309|7583727|FG000|STARTED|Overall Study||3
6653816|NCT02441309|7583728|FG001|STARTED|Overall Study||2
6653817|NCT02441309|7583729|FG002|STARTED|Overall Study||3
6653818|NCT02441309|7583727|FG000|Received Allocated Intervention|Overall Study||1
6653819|NCT02441309|7583728|FG001|Received Allocated Intervention|Overall Study||2
6653820|NCT02441309|7583729|FG002|Received Allocated Intervention|Overall Study||3
6653821|NCT02441309|7583727|FG000|COMPLETED|Overall Study||0
6653822|NCT02441309|7583728|FG001|COMPLETED|Overall Study||0
6653823|NCT02441309|7583729|FG002|COMPLETED|Overall Study||0
6653824|NCT02441309|7583727|FG000|NOT COMPLETED|Overall Study||3
6447981|NCT01134263|7363507|FG003|Received Vaccination 1|Overall Study||167
6447982|NCT01134263|7363508|FG004|Received Vaccination 1|Overall Study||57
6447983|NCT01134263|7363504|FG000|Received Vaccination 2|Overall Study||151
6653825|NCT02441309|7583728|FG001|NOT COMPLETED|Overall Study||2
6447984|NCT01134263|7363505|FG001|Received Vaccination 2|Overall Study||152
6447985|NCT01134263|7363506|FG002|Received Vaccination 2|Overall Study||139
6653826|NCT02441309|7583729|FG002|NOT COMPLETED|Overall Study||3
6653827|NCT02441517|7583740|FG000|STARTED|Overall Study||4
6653828|NCT02441517|7583740|FG000|Received Treatment|Overall Study||4
6653829|NCT02441517|7583740|FG000|COMPLETED|Overall Study||0
6653830|NCT02441517|7583740|FG000|NOT COMPLETED|Overall Study||4
6653831|NCT02441946|7583747|FG000|STARTED|Cycle 1 Period 1 (2 Weeks)||74
6447986|NCT01134263|7363507|FG003|Received Vaccination 2|Overall Study||154
6447987|NCT01134263|7363508|FG004|Received Vaccination 2|Overall Study||53
6447988|NCT01134263|7363504|FG000|Received Vaccination 3|Overall Study||140
6447989|NCT01134263|7363505|FG001|Received Vaccination 3|Overall Study||145
6447990|NCT01134263|7363506|FG002|Received Vaccination 3|Overall Study||134
6447991|NCT01134263|7363507|FG003|Received Vaccination 3|Overall Study||151
6447992|NCT01134263|7363508|FG004|Received Vaccination 3|Overall Study||49
6447993|NCT01134263|7363504|FG000|Safety Population|Overall Study||163
6447994|NCT01134263|7363505|FG001|Safety Population|Overall Study||161
6447995|NCT01134263|7363506|FG002|Safety Population|Overall Study|1 participant randomized to the Phase III Lot 2 group, received Phase III Lot 3 vaccination.|164
6447996|NCT01134263|7363507|FG003|Safety Population|Overall Study||167
6447997|NCT01134263|7363508|FG004|Safety Population|Overall Study||57
6447998|NCT01134263|7363504|FG000|COMPLETED|Overall Study||140
6447999|NCT01134263|7363505|FG001|COMPLETED|Overall Study||143
6448000|NCT01134263|7363506|FG002|COMPLETED|Overall Study||134
6448001|NCT01134263|7363507|FG003|COMPLETED|Overall Study||149
6448002|NCT01134263|7363508|FG004|COMPLETED|Overall Study||48
6448003|NCT01134263|7363504|FG000|NOT COMPLETED|Overall Study||24
6448004|NCT01134263|7363505|FG001|NOT COMPLETED|Overall Study||20
6448005|NCT01134263|7363506|FG002|NOT COMPLETED|Overall Study||29
6448006|NCT01134263|7363507|FG003|NOT COMPLETED|Overall Study||19
6448007|NCT01134263|7363508|FG004|NOT COMPLETED|Overall Study||9
6448008|NCT01134276|7363528|FG000|STARTED|Overall Study||104
6448009|NCT01134276|7363529|FG001|STARTED|Overall Study||107
6448010|NCT01134276|7363528|FG000|COMPLETED|Overall Study||104
6448011|NCT01134276|7363529|FG001|COMPLETED|Overall Study||107
6448012|NCT01134276|7363528|FG000|NOT COMPLETED|Overall Study||0
6448013|NCT01134276|7363529|FG001|NOT COMPLETED|Overall Study||0
6448014|NCT01134315|7363540|FG000|STARTED|Overall Study||21
6448015|NCT01134315|7363541|FG001|STARTED|Overall Study||40
6448016|NCT01134315|7363540|FG000|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
6448017|NCT01134315|7363541|FG001|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
6448018|NCT01134315|7363540|FG000|NOT COMPLETED|Overall Study||9
6448019|NCT01134315|7363541|FG001|NOT COMPLETED|Overall Study||19
6448020|NCT01134328|7363551|FG000|STARTED|Overall Study||21
6448021|NCT01134328|7363552|FG001|STARTED|Overall Study||21
6448022|NCT01134328|7363553|FG002|STARTED|Overall Study||20
6448023|NCT01134328|7363554|FG003|STARTED|Overall Study||21
6448024|NCT01134328|7363551|FG000|COMPLETED|Overall Study||19
6448025|NCT01134328|7363552|FG001|COMPLETED|Overall Study||18
6448026|NCT01134328|7363553|FG002|COMPLETED|Overall Study||17
6448027|NCT01134328|7363554|FG003|COMPLETED|Overall Study||17
6448028|NCT01134328|7363551|FG000|NOT COMPLETED|Overall Study||2
6448029|NCT01134328|7363552|FG001|NOT COMPLETED|Overall Study||3
6448030|NCT01134328|7363553|FG002|NOT COMPLETED|Overall Study||3
6448031|NCT01134328|7363554|FG003|NOT COMPLETED|Overall Study||4
6448032|NCT01134393|7363564|FG000|STARTED|Overall Study|Entered and treated.|501
6553245|NCT01742286|7475751|FG004|NOT COMPLETED|Escalation Phase||4
6553246|NCT01742286|7475752|FG005|NOT COMPLETED|Escalation Phase||5
6553247|NCT01742286|7475753|FG006|NOT COMPLETED|Escalation Phase||6
6653832|NCT02441946|7583748|FG001|STARTED|Cycle 1 Period 1 (2 Weeks)||76
6653833|NCT02441946|7583749|FG002|STARTED|Cycle 1 Period 1 (2 Weeks)||74
6653834|NCT02441946|7583747|FG000|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
6653835|NCT02441946|7583748|FG001|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)|1 participant did not receive drug due to an error in randomization.|75
6653836|NCT02441946|7583749|FG002|Received at Least One Dose of Study Drug|Cycle 1 Period 1 (2 Weeks)||74
6653837|NCT02441946|7583747|FG000|COMPLETED|Cycle 1 Period 1 (2 Weeks)||72
6653838|NCT02441946|7583748|FG001|COMPLETED|Cycle 1 Period 1 (2 Weeks)||71
6653839|NCT02441946|7583749|FG002|COMPLETED|Cycle 1 Period 1 (2 Weeks)||74
6653840|NCT02441946|7583747|FG000|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||2
6653841|NCT02441946|7583748|FG001|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
6653842|NCT02441946|7583749|FG002|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
6653843|NCT02441946|7583747|FG000|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned to abemaciclib + anastrozole post cycle 1.|217
6744408|NCT03342469|7672450|FG001|COMPLETED|Overall Study||8
6744409|NCT03342469|7672451|FG002|COMPLETED|Overall Study||3
6448033|NCT01134393|7363564|FG000|COMPLETED|Overall Study|Completed trial medication.|449
6448034|NCT01134393|7363564|FG000|NOT COMPLETED|Overall Study||52
6448035|NCT01134510|7363571|FG000|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
6448036|NCT01134510|7363572|FG001|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
6448037|NCT01134510|7363571|FG000|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
6553248|NCT01742286|7475747|FG000|STARTED|Expansion Phase||0
6553249|NCT01742286|7475748|FG001|STARTED|Expansion Phase||0
6553250|NCT01742286|7475749|FG002|STARTED|Expansion Phase||7
6553251|NCT01742286|7475750|FG003|STARTED|Expansion Phase||0
6553252|NCT01742286|7475751|FG004|STARTED|Expansion Phase||0
6553253|NCT01742286|7475752|FG005|STARTED|Expansion Phase||0
6553254|NCT01742286|7475753|FG006|STARTED|Expansion Phase||36
6553255|NCT01742286|7475747|FG000|End of Treatment = Not Ccompleted|Expansion Phase||0
6553256|NCT01742286|7475748|FG001|End of Treatment = Not Ccompleted|Expansion Phase||0
6553257|NCT01742286|7475749|FG002|End of Treatment = Not Ccompleted|Expansion Phase||7
6553258|NCT01742286|7475750|FG003|End of Treatment = Not Ccompleted|Expansion Phase||0
6448038|NCT01134510|7363572|FG001|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
6448039|NCT01134510|7363571|FG000|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
6448040|NCT01134510|7363572|FG001|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
6448041|NCT01134510|7363571|FG000|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
6448042|NCT01134510|7363572|FG001|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
6448043|NCT01134510|7363571|FG000|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
6448044|NCT01134510|7363572|FG001|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
6448045|NCT01134510|7363571|FG000|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
6448046|NCT01134510|7363572|FG001|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
6448047|NCT01134510|7363571|FG000|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
6448048|NCT01134510|7363572|FG001|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
6448049|NCT01134510|7363571|FG000|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
6448050|NCT01134510|7363572|FG001|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
6448051|NCT01134510|7363571|FG000|Month 1|Overall Study||10
6448052|NCT01134510|7363572|FG001|Month 1|Overall Study||10
6448053|NCT01134510|7363571|FG000|Month 3|Overall Study||10
6448054|NCT01134510|7363572|FG001|Month 3|Overall Study||9
6448055|NCT01134510|7363571|FG000|COMPLETED|Overall Study||10
6448056|NCT01134510|7363572|FG001|COMPLETED|Overall Study||9
6448057|NCT01134510|7363571|FG000|NOT COMPLETED|Overall Study||0
6448058|NCT01134510|7363572|FG001|NOT COMPLETED|Overall Study||1
6448059|NCT01134549|7363586|FG000|STARTED|Overall Study||8
6448060|NCT01134549|7363587|FG001|STARTED|Overall Study||6
6448061|NCT01134549|7363588|FG002|STARTED|Overall Study||6
6448062|NCT01134549|7363589|FG003|STARTED|Overall Study||6
6448063|NCT01134549|7363590|FG004|STARTED|Overall Study||6
6448064|NCT01134549|7363586|FG000|COMPLETED|Overall Study||8
6448065|NCT01134549|7363587|FG001|COMPLETED|Overall Study||6
6448066|NCT01134549|7363588|FG002|COMPLETED|Overall Study||6
6448067|NCT01134549|7363589|FG003|COMPLETED|Overall Study||6
6448068|NCT01134549|7363590|FG004|COMPLETED|Overall Study||6
6448069|NCT01134549|7363586|FG000|NOT COMPLETED|Overall Study||0
6448070|NCT01134549|7363587|FG001|NOT COMPLETED|Overall Study||0
6448071|NCT01134549|7363588|FG002|NOT COMPLETED|Overall Study||0
6448072|NCT01134549|7363589|FG003|NOT COMPLETED|Overall Study||0
6448073|NCT01134549|7363590|FG004|NOT COMPLETED|Overall Study||0
6448074|NCT01134562|7363612|FG000|STARTED|Overall Study||4
6448075|NCT01134562|7363613|FG001|STARTED|Overall Study||4
6448076|NCT01134562|7363614|FG002|STARTED|Overall Study||4
6448077|NCT01134562|7363615|FG003|STARTED|Overall Study||8
6448078|NCT01134562|7363616|FG004|STARTED|Overall Study||8
6448079|NCT01134562|7363612|FG000|COMPLETED|Overall Study||4
6448080|NCT01134562|7363613|FG001|COMPLETED|Overall Study||3
6448081|NCT01134562|7363614|FG002|COMPLETED|Overall Study||4
6448082|NCT01134562|7363615|FG003|COMPLETED|Overall Study||8
6448083|NCT01134562|7363616|FG004|COMPLETED|Overall Study||8
6448084|NCT01134562|7363612|FG000|NOT COMPLETED|Overall Study||0
6448085|NCT01134562|7363613|FG001|NOT COMPLETED|Overall Study||1
6448086|NCT01134562|7363614|FG002|NOT COMPLETED|Overall Study||0
6448087|NCT01134562|7363615|FG003|NOT COMPLETED|Overall Study||0
6448088|NCT01134562|7363616|FG004|NOT COMPLETED|Overall Study||0
6448089|NCT01134575|7363639|FG000|STARTED|Overall Study||3
6448090|NCT01134575|7363640|FG001|STARTED|Overall Study||45
6448091|NCT01134575|7363641|FG002|STARTED|Overall Study||42
6448092|NCT01134575|7363639|FG000|COMPLETED|Overall Study||3
6448093|NCT01134575|7363640|FG001|COMPLETED|Overall Study||45
6448094|NCT01134575|7363641|FG002|COMPLETED|Overall Study||42
6448095|NCT01134575|7363639|FG000|NOT COMPLETED|Overall Study||0
6448096|NCT01134575|7363640|FG001|NOT COMPLETED|Overall Study||0
6448097|NCT01134575|7363641|FG002|NOT COMPLETED|Overall Study||0
6448108|NCT01134627|7363660|FG000|STARTED|Overall Study|Number of participants treated.|149
6448109|NCT01134627|7363661|FG001|STARTED|Overall Study|Number of participants treated.|155
6448110|NCT01134627|7363660|FG000|COMPLETED|Overall Study||80
6448111|NCT01134627|7363661|FG001|COMPLETED|Overall Study||88
6448112|NCT01134627|7363660|FG000|NOT COMPLETED|Overall Study||69
6448113|NCT01134627|7363661|FG001|NOT COMPLETED|Overall Study||67
6448114|NCT01134705|7363669|FG000|STARTED|Overall Study||236
6448115|NCT01134705|7363670|FG001|STARTED|Overall Study||238
6448116|NCT01134705|7363669|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
6448117|NCT01134705|7363670|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
6448118|NCT01134705|7363669|FG000|COMPLETED|Overall Study||221
6448119|NCT01134705|7363670|FG001|COMPLETED|Overall Study||216
6448120|NCT01134705|7363669|FG000|NOT COMPLETED|Overall Study||15
6448121|NCT01134705|7363670|FG001|NOT COMPLETED|Overall Study||22
6448122|NCT01134731|7363679|FG000|STARTED|Overall Study||23
6448123|NCT01134731|7363680|FG001|STARTED|Overall Study||21
6448124|NCT01134731|7363681|FG002|STARTED|Overall Study||10
6448125|NCT01134731|7363679|FG000|COMPLETED|Overall Study||10
6448126|NCT01134731|7363680|FG001|COMPLETED|Overall Study||10
6448127|NCT01134731|7363681|FG002|COMPLETED|Overall Study||2
6448128|NCT01134731|7363679|FG000|NOT COMPLETED|Overall Study||13
6448129|NCT01134731|7363680|FG001|NOT COMPLETED|Overall Study||11
6448130|NCT01134731|7363681|FG002|NOT COMPLETED|Overall Study||8
6448131|NCT01134783|7363692|FG000|STARTED|Overall Study||224
6448132|NCT01134783|7363693|FG001|STARTED|Overall Study||217
6448133|NCT01134783|7363692|FG000|COMPLETED|Overall Study||188
6448134|NCT01134783|7363693|FG001|COMPLETED|Overall Study||180
6448135|NCT01134783|7363692|FG000|NOT COMPLETED|Overall Study||36
6448136|NCT01134783|7363693|FG001|NOT COMPLETED|Overall Study||37
6653844|NCT02441946|7583748|FG001|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
6653845|NCT02441946|7583749|FG002|STARTED|Cycle 2-5 Period 2 (14 Weeks)|All 217 participants were assigned abemaciclib + anastrozole post cycle 1.|0
6653846|NCT02441946|7583747|FG000|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||217
6653847|NCT02441946|7583748|FG001|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
6653848|NCT02441946|7583749|FG002|Received at Least One Dose of Study Drug|Cycle 2-5 Period 2 (14 Weeks)||0
6653849|NCT02441946|7583747|FG000|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||5
6653850|NCT02441946|7583748|FG001|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
6653851|NCT02441946|7583749|FG002|Progressive Disease|Cycle 2-5 Period 2 (14 Weeks)||0
6653852|NCT02441946|7583747|FG000|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||190
6653853|NCT02441946|7583748|FG001|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
6653854|NCT02441946|7583749|FG002|COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
6653855|NCT02441946|7583747|FG000|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||27
6653856|NCT02441946|7583748|FG001|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
6653857|NCT02441946|7583749|FG002|NOT COMPLETED|Cycle 2-5 Period 2 (14 Weeks)||0
6653858|NCT02441946|7583747|FG000|STARTED|Extension Period (8 Weeks)|All participants who did not discontinue continued to the extension period.|42
6653859|NCT02441946|7583748|FG001|STARTED|Extension Period (8 Weeks)||0
6653860|NCT02441946|7583749|FG002|STARTED|Extension Period (8 Weeks)||0
6653861|NCT02441946|7583747|FG000|COMPLETED|Extension Period (8 Weeks)||40
6653862|NCT02441946|7583748|FG001|COMPLETED|Extension Period (8 Weeks)||0
6653863|NCT02441946|7583749|FG002|COMPLETED|Extension Period (8 Weeks)||0
6653864|NCT02441946|7583747|FG000|NOT COMPLETED|Extension Period (8 Weeks)||2
6653865|NCT02441946|7583748|FG001|NOT COMPLETED|Extension Period (8 Weeks)||0
6653866|NCT02441946|7583749|FG002|NOT COMPLETED|Extension Period (8 Weeks)||0
6653867|NCT02442206|7583762|FG000|STARTED|Period 1||30
6653868|NCT02442206|7583763|FG001|STARTED|Period 1||32
6653869|NCT02442206|7583762|FG000|COMPLETED|Period 1||29
6653870|NCT02442206|7583763|FG001|COMPLETED|Period 1||29
6653871|NCT02442206|7583762|FG000|NOT COMPLETED|Period 1||1
6653872|NCT02442206|7583763|FG001|NOT COMPLETED|Period 1||3
6653873|NCT02442206|7583762|FG000|STARTED|Period 2||29
6653874|NCT02442206|7583763|FG001|STARTED|Period 2||29
6653875|NCT02442206|7583762|FG000|COMPLETED|Period 2||28
6653876|NCT02442206|7583763|FG001|COMPLETED|Period 2||29
6653877|NCT02442206|7583762|FG000|NOT COMPLETED|Period 2||1
6653878|NCT02442206|7583763|FG001|NOT COMPLETED|Period 2||0
6653879|NCT02442271|7583770|FG000|STARTED|Overall Study||222
6653880|NCT02442271|7583770|FG000|COMPLETED|Overall Study||218
6653881|NCT02442271|7583770|FG000|NOT COMPLETED|Overall Study||4
6653882|NCT02442284|7583788|FG000|STARTED|Overall Study||99
6653883|NCT02442284|7583788|FG000|COMPLETED|Overall Study||92
6653884|NCT02442284|7583788|FG000|NOT COMPLETED|Overall Study||7
6653885|NCT02442310|7583792|FG000|STARTED|Overall Study||20
6653886|NCT02442310|7583792|FG000|COMPLETED|Overall Study||17
6653887|NCT02442310|7583792|FG000|NOT COMPLETED|Overall Study||3
6653888|NCT02442336|7583802|FG000|STARTED|Overall Study||80
6653889|NCT02442336|7583802|FG000|Developmental Phase|Overall Study||6
6653890|NCT02442336|7583802|FG000|Evaluation Phase|Overall Study||74
6653891|NCT02442336|7583802|FG000|Provided Access to Intervention|Overall Study||55
6653892|NCT02442336|7583802|FG000|COMPLETED|Overall Study||44
6653893|NCT02442336|7583802|FG000|NOT COMPLETED|Overall Study||36
6653894|NCT02442622|7583808|FG000|STARTED|Overall Study||15
6653895|NCT02442622|7583809|FG001|STARTED|Overall Study||17
6653896|NCT02442622|7583808|FG000|COMPLETED|Overall Study||12
6653897|NCT02442622|7583809|FG001|COMPLETED|Overall Study||16
6653898|NCT02442622|7583808|FG000|NOT COMPLETED|Overall Study||3
6653899|NCT02442622|7583809|FG001|NOT COMPLETED|Overall Study||1
6653900|NCT02442687|7583818|FG000|STARTED|Overall Study||21
6653901|NCT02442687|7583819|FG001|STARTED|Overall Study||22
6448137|NCT01134887|7363707|FG000|STARTED|Overall Study||9
6448138|NCT01134887|7363708|FG001|STARTED|Overall Study||11
6448139|NCT01134887|7363709|FG002|STARTED|Overall Study||5
6448140|NCT01134887|7363710|FG003|STARTED|Overall Study||5
6448141|NCT01134887|7363707|FG000|COMPLETED|Overall Study||9
6653902|NCT02442687|7583820|FG002|STARTED|Overall Study||22
6653903|NCT02442687|7583818|FG000|COMPLETED|Overall Study||13
6653904|NCT02442687|7583819|FG001|COMPLETED|Overall Study||11
6653905|NCT02442687|7583820|FG002|COMPLETED|Overall Study||19
6653906|NCT02442687|7583818|FG000|NOT COMPLETED|Overall Study||8
6653907|NCT02442687|7583819|FG001|NOT COMPLETED|Overall Study||11
6653908|NCT02442687|7583820|FG002|NOT COMPLETED|Overall Study||3
6653909|NCT02442700|7583831|FG000|STARTED|First 12 Weeks||12
6653910|NCT02442700|7583832|FG001|STARTED|First 12 Weeks||12
6653911|NCT02442700|7583831|FG000|COMPLETED|First 12 Weeks||12
6653912|NCT02442700|7583832|FG001|COMPLETED|First 12 Weeks||12
6653913|NCT02442700|7583831|FG000|NOT COMPLETED|First 12 Weeks||0
6653914|NCT02442700|7583832|FG001|NOT COMPLETED|First 12 Weeks||0
6653915|NCT02442700|7583831|FG000|STARTED|Later 12 Weeks||12
6448142|NCT01134887|7363708|FG001|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
6448143|NCT01134887|7363709|FG002|COMPLETED|Overall Study||5
6448144|NCT01134887|7363710|FG003|COMPLETED|Overall Study||5
6448145|NCT01134887|7363707|FG000|NOT COMPLETED|Overall Study||0
6448146|NCT01134887|7363708|FG001|NOT COMPLETED|Overall Study||4
6448147|NCT01134887|7363709|FG002|NOT COMPLETED|Overall Study||0
6448148|NCT01134887|7363710|FG003|NOT COMPLETED|Overall Study||0
6448149|NCT01134900|7363720|FG000|STARTED|Overall Study||200
6448150|NCT01134900|7363721|FG001|STARTED|Overall Study||196
6448151|NCT01134900|7363720|FG000|COMPLETED|Overall Study||200
6448152|NCT01134900|7363721|FG001|COMPLETED|Overall Study||196
6448153|NCT01134900|7363720|FG000|NOT COMPLETED|Overall Study||0
6448154|NCT01134900|7363721|FG001|NOT COMPLETED|Overall Study||0
6448155|NCT01134939|7363735|FG000|STARTED|Overall Study||59
6448156|NCT01134939|7363736|FG001|STARTED|Overall Study||42
6448157|NCT01134939|7363737|FG002|STARTED|Overall Study||51
6448158|NCT01134939|7363738|FG003|STARTED|Overall Study||46
6448159|NCT01134939|7363739|FG004|STARTED|Overall Study||33
6448160|NCT01134939|7363740|FG005|STARTED|Overall Study||14
6448161|NCT01134939|7363741|FG006|STARTED|Overall Study||19
6448162|NCT01134939|7363742|FG007|STARTED|Overall Study||1
6448163|NCT01134939|7363735|FG000|COMPLETED|Overall Study||42
6653916|NCT02442700|7583832|FG001|STARTED|Later 12 Weeks||12
6653917|NCT02442700|7583831|FG000|COMPLETED|Later 12 Weeks||12
6653918|NCT02442700|7583832|FG001|COMPLETED|Later 12 Weeks||12
6653919|NCT02442700|7583831|FG000|NOT COMPLETED|Later 12 Weeks||0
6653920|NCT02442700|7583832|FG001|NOT COMPLETED|Later 12 Weeks||0
6653921|NCT02442804|7583840|FG000|STARTED|Overall Study||8
6653922|NCT02442804|7583841|FG001|STARTED|Overall Study||8
6653923|NCT02442804|7583840|FG000|COMPLETED|Overall Study||7
6653924|NCT02442804|7583841|FG001|COMPLETED|Overall Study||7
6653925|NCT02442804|7583840|FG000|NOT COMPLETED|Overall Study||1
6653926|NCT02442804|7583841|FG001|NOT COMPLETED|Overall Study||1
6653927|NCT02442830|7583849|FG000|STARTED|Overall Study||42
6653928|NCT02442830|7583850|FG001|STARTED|Overall Study||45
6653929|NCT02442830|7583849|FG000|COMPLETED|Overall Study||42
6653930|NCT02442830|7583850|FG001|COMPLETED|Overall Study||44
6653931|NCT02442830|7583849|FG000|NOT COMPLETED|Overall Study||0
6653932|NCT02442830|7583850|FG001|NOT COMPLETED|Overall Study||1
6653933|NCT02442856|7583857|FG000|STARTED|Overall Study||21
6653934|NCT02442856|7583857|FG000|COMPLETED|Overall Study||21
6653935|NCT02442856|7583857|FG000|NOT COMPLETED|Overall Study||0
6653936|NCT02442869|7583867|FG000|STARTED|Overall Study||18
6653937|NCT02442869|7583868|FG001|STARTED|Overall Study||29
6653938|NCT02442869|7583869|FG002|STARTED|Overall Study||6
6653939|NCT02442869|7583870|FG003|STARTED|Overall Study||2
6653940|NCT02442869|7583871|FG004|STARTED|Overall Study||5
6653941|NCT02442869|7583872|FG005|STARTED|Overall Study||2
6653942|NCT02442869|7583867|FG000|COMPLETED|Overall Study||13
6653943|NCT02442869|7583868|FG001|COMPLETED|Overall Study||20
6653944|NCT02442869|7583869|FG002|COMPLETED|Overall Study||6
6653945|NCT02442869|7583870|FG003|COMPLETED|Overall Study||1
6653946|NCT02442869|7583871|FG004|COMPLETED|Overall Study||3
6653947|NCT02442869|7583872|FG005|COMPLETED|Overall Study||2
6653948|NCT02442869|7583867|FG000|NOT COMPLETED|Overall Study||5
6653949|NCT02442869|7583868|FG001|NOT COMPLETED|Overall Study||9
6653950|NCT02442869|7583869|FG002|NOT COMPLETED|Overall Study||0
6653951|NCT02442869|7583870|FG003|NOT COMPLETED|Overall Study||1
6653952|NCT02442869|7583871|FG004|NOT COMPLETED|Overall Study||2
6653953|NCT02442869|7583872|FG005|NOT COMPLETED|Overall Study||0
6653954|NCT02443103|7583896|FG000|STARTED|Overall Study||4
6653955|NCT02443103|7583896|FG000|COMPLETED|Overall Study||1
6653956|NCT02443103|7583896|FG000|NOT COMPLETED|Overall Study||3
6653957|NCT02443155|7583904|FG000|STARTED|Overall Study||77
6653958|NCT02443155|7583905|FG001|STARTED|Overall Study||77
6653959|NCT02443155|7583906|FG002|STARTED|Overall Study||76
6653960|NCT02443155|7583907|FG003|STARTED|Overall Study||77
6448164|NCT01134939|7363736|FG001|COMPLETED|Overall Study||24
6448165|NCT01134939|7363737|FG002|COMPLETED|Overall Study||41
6448166|NCT01134939|7363738|FG003|COMPLETED|Overall Study||32
6448167|NCT01134939|7363739|FG004|COMPLETED|Overall Study||23
6448168|NCT01134939|7363740|FG005|COMPLETED|Overall Study||5
6448169|NCT01134939|7363741|FG006|COMPLETED|Overall Study||10
6653961|NCT02443155|7583904|FG000|Full Analysis Set|Overall Study||77
6653962|NCT02443155|7583905|FG001|Full Analysis Set|Overall Study||77
6653963|NCT02443155|7583906|FG002|Full Analysis Set|Overall Study||76
6653964|NCT02443155|7583907|FG003|Full Analysis Set|Overall Study||77
6653965|NCT02443155|7583904|FG000|PK Analysis Set|Overall Study||21
6653966|NCT02443155|7583905|FG001|PK Analysis Set|Overall Study||21
6653967|NCT02443155|7583906|FG002|PK Analysis Set|Overall Study||22
6653968|NCT02443155|7583907|FG003|PK Analysis Set|Overall Study||20
6653969|NCT02443155|7583904|FG000|Safety Analysis Set|Overall Study||77
6653970|NCT02443155|7583905|FG001|Safety Analysis Set|Overall Study||77
6653971|NCT02443155|7583906|FG002|Safety Analysis Set|Overall Study||76
6448170|NCT01134939|7363742|FG007|COMPLETED|Overall Study||1
6448171|NCT01134939|7363735|FG000|NOT COMPLETED|Overall Study||17
6448172|NCT01134939|7363736|FG001|NOT COMPLETED|Overall Study||18
6448173|NCT01134939|7363737|FG002|NOT COMPLETED|Overall Study||10
6448174|NCT01134939|7363738|FG003|NOT COMPLETED|Overall Study||14
6448175|NCT01134939|7363739|FG004|NOT COMPLETED|Overall Study||10
6448176|NCT01134939|7363740|FG005|NOT COMPLETED|Overall Study||9
6448177|NCT01134939|7363741|FG006|NOT COMPLETED|Overall Study||9
6448178|NCT01134939|7363742|FG007|NOT COMPLETED|Overall Study||0
6448179|NCT01134952|7363756|FG000|STARTED|Overall Study||11
6448180|NCT01134952|7363756|FG000|COMPLETED|Overall Study||11
6448181|NCT01134952|7363756|FG000|NOT COMPLETED|Overall Study||0
6500325|NCT01424397|7419094|FG007|NOT COMPLETED|Period-2 (8 Days)||0
6500326|NCT01424397|7419095|FG008|NOT COMPLETED|Period-2 (8 Days)||0
6500327|NCT01424397|7419096|FG009|NOT COMPLETED|Period-2 (8 Days)||0
6500328|NCT01424397|7419097|FG010|NOT COMPLETED|Period-2 (8 Days)||0
6500329|NCT01424397|7419098|FG011|NOT COMPLETED|Period-2 (8 Days)||0
6500330|NCT01424397|7419087|FG000|STARTED|Washout Period-2 (14-20 Days)||7
6500331|NCT01424397|7419088|FG001|STARTED|Washout Period-2 (14-20 Days)||8
6500332|NCT01424397|7419089|FG002|STARTED|Washout Period-2 (14-20 Days)||7
6500333|NCT01424397|7419090|FG003|STARTED|Washout Period-2 (14-20 Days)||8
6500334|NCT01424397|7419091|FG004|STARTED|Washout Period-2 (14-20 Days)||8
6500335|NCT01424397|7419092|FG005|STARTED|Washout Period-2 (14-20 Days)||8
6500336|NCT01424397|7419093|FG006|STARTED|Washout Period-2 (14-20 Days)||4
6500337|NCT01424397|7419094|FG007|STARTED|Washout Period-2 (14-20 Days)||4
6500338|NCT01424397|7419095|FG008|STARTED|Washout Period-2 (14-20 Days)||4
6500339|NCT01424397|7419096|FG009|STARTED|Washout Period-2 (14-20 Days)||3
6500340|NCT01424397|7419097|FG010|STARTED|Washout Period-2 (14-20 Days)||4
6500341|NCT01424397|7419098|FG011|STARTED|Washout Period-2 (14-20 Days)||4
6500342|NCT01424397|7419087|FG000|COMPLETED|Washout Period-2 (14-20 Days)||7
6500343|NCT01424397|7419088|FG001|COMPLETED|Washout Period-2 (14-20 Days)||8
6500344|NCT01424397|7419089|FG002|COMPLETED|Washout Period-2 (14-20 Days)||7
6500345|NCT01424397|7419090|FG003|COMPLETED|Washout Period-2 (14-20 Days)||8
6500346|NCT01424397|7419091|FG004|COMPLETED|Washout Period-2 (14-20 Days)||8
6500347|NCT01424397|7419092|FG005|COMPLETED|Washout Period-2 (14-20 Days)||8
6500348|NCT01424397|7419093|FG006|COMPLETED|Washout Period-2 (14-20 Days)||4
6500349|NCT01424397|7419094|FG007|COMPLETED|Washout Period-2 (14-20 Days)||4
6500350|NCT01424397|7419095|FG008|COMPLETED|Washout Period-2 (14-20 Days)||4
6500351|NCT01424397|7419096|FG009|COMPLETED|Washout Period-2 (14-20 Days)||3
6500352|NCT01424397|7419097|FG010|COMPLETED|Washout Period-2 (14-20 Days)||4
6500353|NCT01424397|7419098|FG011|COMPLETED|Washout Period-2 (14-20 Days)||4
6553259|NCT01742286|7475751|FG004|End of Treatment = Not Ccompleted|Expansion Phase||0
6553260|NCT01742286|7475752|FG005|End of Treatment = Not Ccompleted|Expansion Phase||0
6653972|NCT02443155|7583907|FG003|Safety Analysis Set|Overall Study||77
6653973|NCT02443155|7583904|FG000|COMPLETED|Overall Study||65
6653974|NCT02443155|7583905|FG001|COMPLETED|Overall Study||63
6653975|NCT02443155|7583906|FG002|COMPLETED|Overall Study||67
6653976|NCT02443155|7583907|FG003|COMPLETED|Overall Study||61
6653977|NCT02443155|7583904|FG000|NOT COMPLETED|Overall Study||12
6653978|NCT02443155|7583905|FG001|NOT COMPLETED|Overall Study||14
6653979|NCT02443155|7583906|FG002|NOT COMPLETED|Overall Study||9
6653980|NCT02443155|7583907|FG003|NOT COMPLETED|Overall Study||16
6653981|NCT02443298|7583920|FG000|STARTED|Overall Study||105
6653982|NCT02443298|7583921|FG001|STARTED|Overall Study||109
6653983|NCT02443298|7583920|FG000|COMPLETED|Overall Study||101
6653984|NCT02443298|7583921|FG001|COMPLETED|Overall Study||104
6653985|NCT02443298|7583920|FG000|NOT COMPLETED|Overall Study||4
6653986|NCT02443298|7583921|FG001|NOT COMPLETED|Overall Study||5
6653987|NCT02443337|7583929|FG000|STARTED|Overall Study||15
6653988|NCT02443337|7583930|FG001|STARTED|Overall Study||16
6653989|NCT02443337|7583929|FG000|Received at Least One Dose of Study Drug|Overall Study||15
6653990|NCT02443337|7583930|FG001|Received at Least One Dose of Study Drug|Overall Study||16
6653991|NCT02443337|7583929|FG000|COMPLETED|Overall Study||10
6653992|NCT02443337|7583930|FG001|COMPLETED|Overall Study||14
6653993|NCT02443337|7583929|FG000|NOT COMPLETED|Overall Study||5
6653994|NCT02443337|7583930|FG001|NOT COMPLETED|Overall Study||2
6653995|NCT02443402|7583943|FG000|STARTED|Overall Study||36
6653996|NCT02443402|7583944|FG001|STARTED|Overall Study||31
6653997|NCT02443402|7583943|FG000|COMPLETED|Overall Study||32
6653998|NCT02443402|7583944|FG001|COMPLETED|Overall Study||28
6653999|NCT02443402|7583943|FG000|NOT COMPLETED|Overall Study||4
6500354|NCT01424397|7419087|FG000|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500355|NCT01424397|7419088|FG001|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500356|NCT01424397|7419089|FG002|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500357|NCT01424397|7419090|FG003|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500358|NCT01424397|7419091|FG004|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500359|NCT01424397|7419092|FG005|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500360|NCT01424397|7419093|FG006|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6553261|NCT01742286|7475753|FG006|End of Treatment = Not Ccompleted|Expansion Phase||36
6553262|NCT01742286|7475747|FG000|COMPLETED|Expansion Phase||0
6553263|NCT01742286|7475748|FG001|COMPLETED|Expansion Phase||0
6553264|NCT01742286|7475749|FG002|COMPLETED|Expansion Phase||0
6553265|NCT01742286|7475750|FG003|COMPLETED|Expansion Phase||0
6553266|NCT01742286|7475751|FG004|COMPLETED|Expansion Phase||0
6553267|NCT01742286|7475752|FG005|COMPLETED|Expansion Phase||0
6553268|NCT01742286|7475753|FG006|COMPLETED|Expansion Phase||0
6448182|NCT01135017|7363766|FG000|STARTED|Overall Study||55
6448183|NCT01135017|7363767|FG001|STARTED|Overall Study||57
6448184|NCT01135017|7363766|FG000|Treated|Overall Study||55
6448185|NCT01135017|7363767|FG001|Treated|Overall Study||57
6448186|NCT01135017|7363766|FG000|Evaluable for Efficacy|Overall Study||55
6448187|NCT01135017|7363767|FG001|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
6448188|NCT01135017|7363766|FG000|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
6448189|NCT01135017|7363767|FG001|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
6448190|NCT01135017|7363766|FG000|NOT COMPLETED|Overall Study||6
6448191|NCT01135017|7363767|FG001|NOT COMPLETED|Overall Study||12
6448192|NCT01135069|7363776|FG000|STARTED|Overall Study||205
6448193|NCT01135069|7363777|FG001|STARTED|Overall Study||209
6448194|NCT01135069|7363778|FG002|STARTED|Overall Study||66
6448195|NCT01135069|7363776|FG000|COMPLETED|Overall Study||169
6448196|NCT01135069|7363777|FG001|COMPLETED|Overall Study||177
6448197|NCT01135069|7363778|FG002|COMPLETED|Overall Study||56
6448198|NCT01135069|7363776|FG000|NOT COMPLETED|Overall Study||36
6448199|NCT01135069|7363777|FG001|NOT COMPLETED|Overall Study||32
6448200|NCT01135069|7363778|FG002|NOT COMPLETED|Overall Study||10
6448201|NCT01135095|7363786|FG000|STARTED|Overall Study||101
6448202|NCT01135095|7363786|FG000|COMPLETED|Overall Study||101
6448203|NCT01135095|7363786|FG000|NOT COMPLETED|Overall Study||0
6448204|NCT01135186|7363790|FG000|STARTED|Overall Study||9
6553269|NCT01742286|7475747|FG000|NOT COMPLETED|Expansion Phase||0
6553270|NCT01742286|7475748|FG001|NOT COMPLETED|Expansion Phase||0
6553271|NCT01742286|7475749|FG002|NOT COMPLETED|Expansion Phase||7
6553272|NCT01742286|7475750|FG003|NOT COMPLETED|Expansion Phase||0
6553273|NCT01742286|7475751|FG004|NOT COMPLETED|Expansion Phase||0
6654000|NCT02443402|7583944|FG001|NOT COMPLETED|Overall Study||3
6448205|NCT01135186|7363790|FG000|COMPLETED|Overall Study||9
6448206|NCT01135186|7363790|FG000|NOT COMPLETED|Overall Study||0
6448207|NCT01135329|7363796|FG000|STARTED|Overall Study||15
6448208|NCT01135329|7363796|FG000|COMPLETED|Overall Study||15
6448209|NCT01135329|7363796|FG000|NOT COMPLETED|Overall Study||0
6448210|NCT01135368|7363801|FG000|STARTED|Overall Study||506
6448211|NCT01135368|7363801|FG000|COMPLETED|Overall Study||255
6448212|NCT01135368|7363801|FG000|NOT COMPLETED|Overall Study||251
6448213|NCT01135381|7363843|FG000|STARTED|Overall Study||189
6448214|NCT01135381|7363844|FG001|STARTED|Overall Study||185
6448215|NCT01135381|7363845|FG002|STARTED|Overall Study||69
6448216|NCT01135381|7363846|FG003|STARTED|Overall Study||68
6448217|NCT01135381|7363843|FG000|COMPLETED|Overall Study||168
6448218|NCT01135381|7363844|FG001|COMPLETED|Overall Study||178
6448219|NCT01135381|7363845|FG002|COMPLETED|Overall Study||65
6448220|NCT01135381|7363846|FG003|COMPLETED|Overall Study||67
6448221|NCT01135381|7363843|FG000|NOT COMPLETED|Overall Study||21
6654001|NCT02443519|7583952|FG000|STARTED|Overall Study||31
6448222|NCT01135381|7363844|FG001|NOT COMPLETED|Overall Study||7
6448223|NCT01135381|7363845|FG002|NOT COMPLETED|Overall Study||4
6448224|NCT01135381|7363846|FG003|NOT COMPLETED|Overall Study||1
6448225|NCT01135394|7363856|FG000|STARTED|Screening||114
6553274|NCT01742286|7475752|FG005|NOT COMPLETED|Expansion Phase||0
6553275|NCT01742286|7475753|FG006|NOT COMPLETED|Expansion Phase||36
6553276|NCT01742364|7475780|FG000|STARTED|Overall Study||33
6553277|NCT01742364|7475781|FG001|STARTED|Overall Study||33
6553278|NCT01742364|7475782|FG002|STARTED|Overall Study||15
6553279|NCT01742364|7475783|FG003|STARTED|Overall Study||15
6553280|NCT01742364|7475780|FG000|COMPLETED|Overall Study||33
6553281|NCT01742364|7475781|FG001|COMPLETED|Overall Study||33
6553282|NCT01742364|7475782|FG002|COMPLETED|Overall Study||15
6553283|NCT01742364|7475783|FG003|COMPLETED|Overall Study||15
6553284|NCT01742364|7475780|FG000|NOT COMPLETED|Overall Study||0
6553285|NCT01742364|7475781|FG001|NOT COMPLETED|Overall Study||0
6553286|NCT01742364|7475782|FG002|NOT COMPLETED|Overall Study||0
6553287|NCT01742364|7475783|FG003|NOT COMPLETED|Overall Study||0
6553288|NCT01742832|7475796|FG000|STARTED|Overall Study||20
6553289|NCT01742832|7475797|FG001|STARTED|Overall Study||28
6553290|NCT01742832|7475796|FG000|COMPLETED|Overall Study||19
6553291|NCT01742832|7475797|FG001|COMPLETED|Overall Study||23
6553292|NCT01742832|7475796|FG000|NOT COMPLETED|Overall Study||1
6553293|NCT01742832|7475797|FG001|NOT COMPLETED|Overall Study||5
6553294|NCT01742897|7475803|FG000|STARTED|Overall Study||35
6553295|NCT01742897|7475803|FG000|Treated|Overall Study||33
6553296|NCT01742897|7475803|FG000|COMPLETED|Overall Study||30
6553297|NCT01742897|7475803|FG000|NOT COMPLETED|Overall Study||5
6553298|NCT01742936|7475809|FG000|STARTED|Overall Study||50
6553299|NCT01742936|7475810|FG001|STARTED|Overall Study||50
6553300|NCT01742936|7475809|FG000|COMPLETED|Overall Study||50
6553301|NCT01742936|7475810|FG001|COMPLETED|Overall Study||50
6553302|NCT01742936|7475809|FG000|NOT COMPLETED|Overall Study||0
6553303|NCT01742936|7475810|FG001|NOT COMPLETED|Overall Study||0
6553304|NCT01742949|7475816|FG000|STARTED|Overall Study||20
6553305|NCT01742949|7475817|FG001|STARTED|Overall Study||20
6553306|NCT01742949|7475816|FG000|COMPLETED|Overall Study||20
6553307|NCT01742949|7475817|FG001|COMPLETED|Overall Study||20
6553308|NCT01742949|7475816|FG000|NOT COMPLETED|Overall Study||0
6553309|NCT01742949|7475817|FG001|NOT COMPLETED|Overall Study||0
6553310|NCT01743001|7475828|FG000|STARTED|Overall Study||114
6448226|NCT01135394|7363856|FG000|COMPLETED|Screening||81
6448227|NCT01135394|7363856|FG000|NOT COMPLETED|Screening||33
6448228|NCT01135394|7363856|FG000|STARTED|Baseline Assessment||81
6448229|NCT01135394|7363856|FG000|COMPLETED|Baseline Assessment||66
6448230|NCT01135394|7363856|FG000|NOT COMPLETED|Baseline Assessment||15
6448231|NCT01135394|7363856|FG000|STARTED|Study Treatment||66
6448232|NCT01135394|7363856|FG000|COMPLETED|Study Treatment||62
6448233|NCT01135394|7363856|FG000|NOT COMPLETED|Study Treatment||4
6448234|NCT01135420|7363862|FG000|STARTED|Overall Study||199
6448235|NCT01135420|7363863|FG001|STARTED|Overall Study||207
6448236|NCT01135420|7363862|FG000|COMPLETED|Overall Study||155
6448237|NCT01135420|7363863|FG001|COMPLETED|Overall Study||175
6448238|NCT01135420|7363862|FG000|NOT COMPLETED|Overall Study||44
6448239|NCT01135420|7363863|FG001|NOT COMPLETED|Overall Study||32
6448240|NCT01135498|7363869|FG000|STARTED|Overall Study||90
6448241|NCT01135498|7363869|FG000|COMPLETED|Overall Study||0
6448242|NCT01135498|7363869|FG000|NOT COMPLETED|Overall Study||90
6448243|NCT01135511|7363883|FG000|STARTED|Overall Study||41
6448244|NCT01135511|7363884|FG001|STARTED|Overall Study||42
6448245|NCT01135511|7363885|FG002|STARTED|Overall Study||41
6448246|NCT01135511|7363886|FG003|STARTED|Overall Study||40
6448247|NCT01135511|7363887|FG004|STARTED|Overall Study||39
6448248|NCT01135511|7363888|FG005|STARTED|Overall Study||21
6448249|NCT01135511|7363889|FG006|STARTED|Overall Study||19
6448250|NCT01135511|7363890|FG007|STARTED|Overall Study||21
6448251|NCT01135511|7363891|FG008|STARTED|Overall Study||21
6448252|NCT01135511|7363883|FG000|COMPLETED|Overall Study||41
6448253|NCT01135511|7363884|FG001|COMPLETED|Overall Study||39
6448254|NCT01135511|7363885|FG002|COMPLETED|Overall Study||33
6448255|NCT01135511|7363886|FG003|COMPLETED|Overall Study||37
6448256|NCT01135511|7363887|FG004|COMPLETED|Overall Study||38
6448257|NCT01135511|7363888|FG005|COMPLETED|Overall Study||20
6448258|NCT01135511|7363889|FG006|COMPLETED|Overall Study||18
6448259|NCT01135511|7363890|FG007|COMPLETED|Overall Study||20
6448260|NCT01135511|7363891|FG008|COMPLETED|Overall Study||20
6448261|NCT01135511|7363883|FG000|NOT COMPLETED|Overall Study||0
6448262|NCT01135511|7363884|FG001|NOT COMPLETED|Overall Study||3
6448263|NCT01135511|7363885|FG002|NOT COMPLETED|Overall Study||8
6448264|NCT01135511|7363886|FG003|NOT COMPLETED|Overall Study||3
6448265|NCT01135511|7363887|FG004|NOT COMPLETED|Overall Study||1
6448266|NCT01135511|7363888|FG005|NOT COMPLETED|Overall Study||1
6448267|NCT01135511|7363889|FG006|NOT COMPLETED|Overall Study||1
6448268|NCT01135511|7363890|FG007|NOT COMPLETED|Overall Study||1
6448269|NCT01135511|7363891|FG008|NOT COMPLETED|Overall Study||1
6448270|NCT01135524|7363911|FG000|STARTED|Overall Study||196
6448271|NCT01135524|7363911|FG000|COMPLETED|Overall Study||0
6448272|NCT01135524|7363911|FG000|NOT COMPLETED|Overall Study||196
6448273|NCT01135537|7363915|FG000|STARTED|Overall Study||30
6448274|NCT01135537|7363915|FG000|COMPLETED|Overall Study||17
6448275|NCT01135537|7363915|FG000|NOT COMPLETED|Overall Study||13
6500361|NCT01424397|7419094|FG007|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500362|NCT01424397|7419095|FG008|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500363|NCT01424397|7419096|FG009|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500364|NCT01424397|7419097|FG010|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500365|NCT01424397|7419098|FG011|NOT COMPLETED|Washout Period-2 (14-20 Days)||0
6500366|NCT01424397|7419087|FG000|STARTED|Period-3 (8 Days)||7
6500367|NCT01424397|7419088|FG001|STARTED|Period-3 (8 Days)||8
6500368|NCT01424397|7419089|FG002|STARTED|Period-3 (8 Days)||7
6500369|NCT01424397|7419090|FG003|STARTED|Period-3 (8 Days)||8
6500370|NCT01424397|7419091|FG004|STARTED|Period-3 (8 Days)||8
6500371|NCT01424397|7419092|FG005|STARTED|Period-3 (8 Days)||8
6500372|NCT01424397|7419093|FG006|STARTED|Period-3 (8 Days)||4
6500373|NCT01424397|7419094|FG007|STARTED|Period-3 (8 Days)||4
6500374|NCT01424397|7419095|FG008|STARTED|Period-3 (8 Days)||4
6500375|NCT01424397|7419096|FG009|STARTED|Period-3 (8 Days)||3
6500376|NCT01424397|7419097|FG010|STARTED|Period-3 (8 Days)||4
6500377|NCT01424397|7419098|FG011|STARTED|Period-3 (8 Days)||4
6500378|NCT01424397|7419087|FG000|COMPLETED|Period-3 (8 Days)||7
6500379|NCT01424397|7419088|FG001|COMPLETED|Period-3 (8 Days)||8
6500380|NCT01424397|7419089|FG002|COMPLETED|Period-3 (8 Days)||7
6500381|NCT01424397|7419090|FG003|COMPLETED|Period-3 (8 Days)||8
6500382|NCT01424397|7419091|FG004|COMPLETED|Period-3 (8 Days)||8
6500383|NCT01424397|7419092|FG005|COMPLETED|Period-3 (8 Days)||8
6500384|NCT01424397|7419093|FG006|COMPLETED|Period-3 (8 Days)||4
6500385|NCT01424397|7419094|FG007|COMPLETED|Period-3 (8 Days)||4
6500386|NCT01424397|7419095|FG008|COMPLETED|Period-3 (8 Days)||4
6500387|NCT01424397|7419096|FG009|COMPLETED|Period-3 (8 Days)||3
6500388|NCT01424397|7419097|FG010|COMPLETED|Period-3 (8 Days)||4
6500389|NCT01424397|7419098|FG011|COMPLETED|Period-3 (8 Days)||4
6500390|NCT01424397|7419087|FG000|NOT COMPLETED|Period-3 (8 Days)||0
6500391|NCT01424397|7419088|FG001|NOT COMPLETED|Period-3 (8 Days)||0
6500392|NCT01424397|7419089|FG002|NOT COMPLETED|Period-3 (8 Days)||0
6500393|NCT01424397|7419090|FG003|NOT COMPLETED|Period-3 (8 Days)||0
6500394|NCT01424397|7419091|FG004|NOT COMPLETED|Period-3 (8 Days)||0
6500395|NCT01424397|7419092|FG005|NOT COMPLETED|Period-3 (8 Days)||0
6500396|NCT01424397|7419093|FG006|NOT COMPLETED|Period-3 (8 Days)||0
6500397|NCT01424397|7419094|FG007|NOT COMPLETED|Period-3 (8 Days)||0
6500398|NCT01424397|7419095|FG008|NOT COMPLETED|Period-3 (8 Days)||0
6500399|NCT01424397|7419096|FG009|NOT COMPLETED|Period-3 (8 Days)||0
6500400|NCT01424397|7419097|FG010|NOT COMPLETED|Period-3 (8 Days)||0
6500401|NCT01424397|7419098|FG011|NOT COMPLETED|Period-3 (8 Days)||0
6448276|NCT01135914|7363922|FG000|STARTED|Overall Study||78
6448277|NCT01135914|7363923|FG001|STARTED|Overall Study||80
6448278|NCT01135914|7363924|FG002|STARTED|Overall Study||81
6448279|NCT01135914|7363922|FG000|Intent to Treat (ITT) Population|Overall Study||73
6448280|NCT01135914|7363923|FG001|Intent to Treat (ITT) Population|Overall Study||75
6448281|NCT01135914|7363924|FG002|Intent to Treat (ITT) Population|Overall Study||72
6448282|NCT01135914|7363922|FG000|Safety Population|Overall Study||73
6448283|NCT01135914|7363923|FG001|Safety Population|Overall Study||75
6448284|NCT01135914|7363924|FG002|Safety Population|Overall Study||74
6448285|NCT01135914|7363922|FG000|COMPLETED|Overall Study||74
6448286|NCT01135914|7363923|FG001|COMPLETED|Overall Study||75
6448287|NCT01135914|7363924|FG002|COMPLETED|Overall Study||59
6448288|NCT01135914|7363922|FG000|NOT COMPLETED|Overall Study||4
6448289|NCT01135914|7363923|FG001|NOT COMPLETED|Overall Study||5
6448290|NCT01135914|7363924|FG002|NOT COMPLETED|Overall Study||22
6448291|NCT01135992|7363932|FG000|STARTED|Overall Study||143
6448292|NCT01135992|7363932|FG000|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
6448293|NCT01135992|7363932|FG000|Full Analysis Set|Overall Study||129
6448294|NCT01135992|7363932|FG000|COMPLETED|Overall Study||122
6448295|NCT01135992|7363932|FG000|NOT COMPLETED|Overall Study||21
6448296|NCT01136174|7363940|FG000|STARTED|Overall Study||12
6654002|NCT02443519|7583953|FG001|STARTED|Overall Study||29
6654003|NCT02443519|7583952|FG000|COMPLETED|Overall Study||29
6654004|NCT02443519|7583953|FG001|COMPLETED|Overall Study||26
6654005|NCT02443519|7583952|FG000|NOT COMPLETED|Overall Study||2
6654006|NCT02443519|7583953|FG001|NOT COMPLETED|Overall Study||3
6654007|NCT02443571|7583962|FG000|STARTED|Overall Study||596
6654008|NCT02443571|7583963|FG001|STARTED|Overall Study||95
6654009|NCT02443571|7583964|FG002|STARTED|Overall Study||23
6654010|NCT02443571|7583962|FG000|COMPLETED|Overall Study||596
6654011|NCT02443571|7583963|FG001|COMPLETED|Overall Study||95
6654012|NCT02443571|7583964|FG002|COMPLETED|Overall Study||23
6654013|NCT02443571|7583962|FG000|NOT COMPLETED|Overall Study||0
6654014|NCT02443571|7583963|FG001|NOT COMPLETED|Overall Study||0
6654015|NCT02443571|7583964|FG002|NOT COMPLETED|Overall Study||0
6654016|NCT02443688|7583975|FG000|STARTED|Overall Study||66
6654017|NCT02443688|7583976|FG001|STARTED|Overall Study||67
6654018|NCT02443688|7583977|FG002|STARTED|Overall Study||67
6654019|NCT02443688|7583975|FG000|COMPLETED|Overall Study||54
6654020|NCT02443688|7583976|FG001|COMPLETED|Overall Study||58
6654021|NCT02443688|7583977|FG002|COMPLETED|Overall Study||55
6654022|NCT02443688|7583975|FG000|NOT COMPLETED|Overall Study||12
6654023|NCT02443688|7583976|FG001|NOT COMPLETED|Overall Study||9
6654024|NCT02443688|7583977|FG002|NOT COMPLETED|Overall Study||12
6654025|NCT02443740|7583993|FG000|STARTED|Intervention Period 1 (3 Days)||2
6654026|NCT02443740|7583994|FG001|STARTED|Intervention Period 1 (3 Days)||2
6654027|NCT02443740|7583995|FG002|STARTED|Intervention Period 1 (3 Days)||2
6654028|NCT02443740|7583996|FG003|STARTED|Intervention Period 1 (3 Days)||3
6654029|NCT02443740|7583997|FG004|STARTED|Intervention Period 1 (3 Days)||2
6654030|NCT02443740|7583998|FG005|STARTED|Intervention Period 1 (3 Days)||4
6654031|NCT02443740|7583999|FG006|STARTED|Intervention Period 1 (3 Days)||3
6654032|NCT02443740|7584000|FG007|STARTED|Intervention Period 1 (3 Days)||2
6654033|NCT02443740|7584001|FG008|STARTED|Intervention Period 1 (3 Days)||6
6654034|NCT02443740|7584002|FG009|STARTED|Intervention Period 1 (3 Days)||3
6654035|NCT02443740|7584003|FG010|STARTED|Intervention Period 1 (3 Days)||3
6654036|NCT02443740|7583993|FG000|COMPLETED|Intervention Period 1 (3 Days)||1
6654037|NCT02443740|7583994|FG001|COMPLETED|Intervention Period 1 (3 Days)||2
6654038|NCT02443740|7583995|FG002|COMPLETED|Intervention Period 1 (3 Days)||2
6654039|NCT02443740|7583996|FG003|COMPLETED|Intervention Period 1 (3 Days)||3
6654040|NCT02443740|7583997|FG004|COMPLETED|Intervention Period 1 (3 Days)||2
6654041|NCT02443740|7583998|FG005|COMPLETED|Intervention Period 1 (3 Days)||2
6654042|NCT02443740|7583999|FG006|COMPLETED|Intervention Period 1 (3 Days)||2
6654043|NCT02443740|7584000|FG007|COMPLETED|Intervention Period 1 (3 Days)||2
6654044|NCT02443740|7584001|FG008|COMPLETED|Intervention Period 1 (3 Days)||6
6654045|NCT02443740|7584002|FG009|COMPLETED|Intervention Period 1 (3 Days)||3
6654046|NCT02443740|7584003|FG010|COMPLETED|Intervention Period 1 (3 Days)||3
6654047|NCT02443740|7583993|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||1
6654048|NCT02443740|7583994|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6654049|NCT02443740|7583995|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6654050|NCT02443740|7583996|FG003|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6654051|NCT02443740|7583997|FG004|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6654052|NCT02443740|7583998|FG005|NOT COMPLETED|Intervention Period 1 (3 Days)||2
6654053|NCT02443740|7583999|FG006|NOT COMPLETED|Intervention Period 1 (3 Days)||1
6654054|NCT02443740|7584000|FG007|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6654055|NCT02443740|7584001|FG008|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6654056|NCT02443740|7584002|FG009|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6654057|NCT02443740|7584003|FG010|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6654058|NCT02443740|7583993|FG000|STARTED|Washout Period 1 (7 Days)||1
6654059|NCT02443740|7583994|FG001|STARTED|Washout Period 1 (7 Days)||2
6448297|NCT01136174|7363941|FG001|STARTED|Overall Study||6
6448298|NCT01136174|7363942|FG002|STARTED|Overall Study||8
6654060|NCT02443740|7583995|FG002|STARTED|Washout Period 1 (7 Days)||2
6654061|NCT02443740|7583996|FG003|STARTED|Washout Period 1 (7 Days)||3
6654062|NCT02443740|7583997|FG004|STARTED|Washout Period 1 (7 Days)||2
6654063|NCT02443740|7583998|FG005|STARTED|Washout Period 1 (7 Days)||2
6448299|NCT01136174|7363943|FG003|STARTED|Overall Study||24
6448300|NCT01136174|7363940|FG000|COMPLETED|Overall Study||12
6448301|NCT01136174|7363941|FG001|COMPLETED|Overall Study||6
6448302|NCT01136174|7363942|FG002|COMPLETED|Overall Study||8
6448303|NCT01136174|7363943|FG003|COMPLETED|Overall Study||20
6448304|NCT01136174|7363940|FG000|NOT COMPLETED|Overall Study||0
6448305|NCT01136174|7363941|FG001|NOT COMPLETED|Overall Study||0
6448306|NCT01136174|7363942|FG002|NOT COMPLETED|Overall Study||0
6448307|NCT01136174|7363943|FG003|NOT COMPLETED|Overall Study||4
6448308|NCT01136226|7363962|FG000|STARTED|Overall Study||42
6448309|NCT01136226|7363962|FG000|COMPLETED|Overall Study||29
6448310|NCT01136226|7363962|FG000|NOT COMPLETED|Overall Study||13
6448311|NCT01136291|7363969|FG000|STARTED|Overall Study||40
6448312|NCT01136291|7363970|FG001|STARTED|Overall Study||42
6448313|NCT01136291|7363969|FG000|Follow|Overall Study||40
6448314|NCT01136291|7363970|FG001|Follow|Overall Study||42
6448315|NCT01136291|7363969|FG000|COMPLETED|Overall Study||39
6448316|NCT01136291|7363970|FG001|COMPLETED|Overall Study||41
6448317|NCT01136291|7363969|FG000|NOT COMPLETED|Overall Study||1
6448318|NCT01136291|7363970|FG001|NOT COMPLETED|Overall Study||1
6448319|NCT01136356|7363976|FG000|STARTED|First Intervention||6
6448320|NCT01136356|7363977|FG001|STARTED|First Intervention||6
6448321|NCT01136356|7363976|FG000|COMPLETED|First Intervention||6
6448322|NCT01136356|7363977|FG001|COMPLETED|First Intervention||6
6448323|NCT01136356|7363976|FG000|NOT COMPLETED|First Intervention||0
6448324|NCT01136356|7363977|FG001|NOT COMPLETED|First Intervention||0
6448325|NCT01136356|7363976|FG000|STARTED|First 18-day Withdrawal||6
6448326|NCT01136356|7363977|FG001|STARTED|First 18-day Withdrawal||6
6448327|NCT01136356|7363976|FG000|COMPLETED|First 18-day Withdrawal||2
6448328|NCT01136356|7363977|FG001|COMPLETED|First 18-day Withdrawal||6
6448329|NCT01136356|7363976|FG000|NOT COMPLETED|First 18-day Withdrawal||4
6448330|NCT01136356|7363977|FG001|NOT COMPLETED|First 18-day Withdrawal||0
6448331|NCT01136356|7363976|FG000|STARTED|Second Intervention||2
6448332|NCT01136356|7363977|FG001|STARTED|Second Intervention||6
6448333|NCT01136356|7363976|FG000|COMPLETED|Second Intervention||2
6448334|NCT01136356|7363977|FG001|COMPLETED|Second Intervention||6
6448335|NCT01136356|7363976|FG000|NOT COMPLETED|Second Intervention||0
6448336|NCT01136356|7363977|FG001|NOT COMPLETED|Second Intervention||0
6448337|NCT01136356|7363976|FG000|STARTED|Second 18-day Withdrawal||2
6448338|NCT01136356|7363977|FG001|STARTED|Second 18-day Withdrawal||6
6448339|NCT01136356|7363976|FG000|COMPLETED|Second 18-day Withdrawal||2
6448340|NCT01136356|7363977|FG001|COMPLETED|Second 18-day Withdrawal||5
6448341|NCT01136356|7363976|FG000|NOT COMPLETED|Second 18-day Withdrawal||0
6448342|NCT01136356|7363977|FG001|NOT COMPLETED|Second 18-day Withdrawal||1
6448343|NCT01136382|7363984|FG000|STARTED|Overall Study||152
6448344|NCT01136382|7363985|FG001|STARTED|Overall Study||152
6448345|NCT01136382|7363984|FG000|COMPLETED|Overall Study||92
6448346|NCT01136382|7363985|FG001|COMPLETED|Overall Study||121
6448347|NCT01136382|7363984|FG000|NOT COMPLETED|Overall Study||60
6448348|NCT01136382|7363985|FG001|NOT COMPLETED|Overall Study||31
6448349|NCT01136408|7363994|FG000|STARTED|Overall Study||46
6448350|NCT01136408|7363995|FG001|STARTED|Overall Study||58
6448351|NCT01136408|7363996|FG002|STARTED|Overall Study||62
6448352|NCT01136408|7363994|FG000|COMPLETED|Overall Study||41
6448353|NCT01136408|7363995|FG001|COMPLETED|Overall Study||49
6448354|NCT01136408|7363996|FG002|COMPLETED|Overall Study||57
6448355|NCT01136408|7363994|FG000|NOT COMPLETED|Overall Study||5
6448356|NCT01136408|7363995|FG001|NOT COMPLETED|Overall Study||9
6448357|NCT01136408|7363996|FG002|NOT COMPLETED|Overall Study||5
6448358|NCT01136486|7364008|FG000|STARTED|Overall Study||56
6448359|NCT01136486|7364008|FG000|COMPLETED|Overall Study||56
6448360|NCT01136486|7364008|FG000|NOT COMPLETED|Overall Study||0
6448361|NCT01136655|7364012|FG000|STARTED|BUD 160/FM 2.25 (1 Dose)||54
6448362|NCT01136655|7364012|FG000|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
6448363|NCT01136655|7364012|FG000|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
6448364|NCT01136655|7364012|FG000|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
6448365|NCT01136655|7364012|FG000|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
6448366|NCT01136655|7364012|FG000|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
6448367|NCT01136655|7364012|FG000|STARTED|BUD 160/FM 4.5 (1 Dose)||53
6448368|NCT01136655|7364012|FG000|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
6448369|NCT01136655|7364012|FG000|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
6448370|NCT01136655|7364012|FG000|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
6448371|NCT01136655|7364012|FG000|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
6448372|NCT01136655|7364012|FG000|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
6448373|NCT01136655|7364012|FG000|STARTED|BUD 160/FM 9.0 (1 Dose)||53
6448374|NCT01136655|7364012|FG000|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
6448375|NCT01136655|7364012|FG000|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
6448376|NCT01136655|7364012|FG000|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
6448377|NCT01136655|7364012|FG000|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
6448378|NCT01136655|7364012|FG000|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
6448379|NCT01136655|7364012|FG000|STARTED|BUD 160 (1 Dose)||51
6448380|NCT01136655|7364012|FG000|COMPLETED|BUD 160 (1 Dose)||51
6448381|NCT01136655|7364012|FG000|NOT COMPLETED|BUD 160 (1 Dose)||0
6448382|NCT01136655|7364012|FG000|STARTED|Washout After BUD 160 (7 Days)||51
6448383|NCT01136655|7364012|FG000|COMPLETED|Washout After BUD 160 (7 Days)||51
6448384|NCT01136655|7364012|FG000|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
6448385|NCT01136655|7364012|FG000|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
6448386|NCT01136655|7364012|FG000|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
6448387|NCT01136655|7364012|FG000|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
6448388|NCT01136655|7364012|FG000|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
6448389|NCT01136655|7364012|FG000|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
6448390|NCT01136655|7364012|FG000|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
6448391|NCT01136733|7364032|FG000|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|7
6448392|NCT01136733|7364033|FG001|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|11
6448393|NCT01136733|7364034|FG002|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|2
6448394|NCT01136733|7364035|FG003|STARTED|Phase 1b|Participants in Phase 1b did not advance to Phase 2.|0
6448395|NCT01136733|7364036|FG004|STARTED|Phase 1b||0
6448396|NCT01136733|7364037|FG005|STARTED|Phase 1b||0
6448397|NCT01136733|7364038|FG006|STARTED|Phase 1b||0
6448398|NCT01136733|7364032|FG000|COMPLETED|Phase 1b||6
6448399|NCT01136733|7364033|FG001|COMPLETED|Phase 1b||6
6448400|NCT01136733|7364034|FG002|COMPLETED|Phase 1b||0
6448401|NCT01136733|7364035|FG003|COMPLETED|Phase 1b||0
6448402|NCT01136733|7364036|FG004|COMPLETED|Phase 1b||0
6448403|NCT01136733|7364037|FG005|COMPLETED|Phase 1b||0
6448404|NCT01136733|7364038|FG006|COMPLETED|Phase 1b||0
6448405|NCT01136733|7364032|FG000|NOT COMPLETED|Phase 1b||1
6448406|NCT01136733|7364033|FG001|NOT COMPLETED|Phase 1b||5
6448407|NCT01136733|7364034|FG002|NOT COMPLETED|Phase 1b||2
6448408|NCT01136733|7364035|FG003|NOT COMPLETED|Phase 1b||0
6448409|NCT01136733|7364036|FG004|NOT COMPLETED|Phase 1b||0
6448410|NCT01136733|7364037|FG005|NOT COMPLETED|Phase 1b||0
6448411|NCT01136733|7364038|FG006|NOT COMPLETED|Phase 1b||0
6448412|NCT01136733|7364032|FG000|STARTED|Phase 2||0
6448413|NCT01136733|7364033|FG001|STARTED|Phase 2||0
6448414|NCT01136733|7364034|FG002|STARTED|Phase 2||0
6448415|NCT01136733|7364035|FG003|STARTED|Phase 2||0
6448416|NCT01136733|7364036|FG004|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|51
6448417|NCT01136733|7364037|FG005|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|52
6448418|NCT01136733|7364038|FG006|STARTED|Phase 2|Participants in Phase 2 did not participate in Phase 1b.|50
6448419|NCT01136733|7364032|FG000|COMPLETED|Phase 2||0
6448420|NCT01136733|7364033|FG001|COMPLETED|Phase 2||0
6448421|NCT01136733|7364034|FG002|COMPLETED|Phase 2||0
6448422|NCT01136733|7364035|FG003|COMPLETED|Phase 2||0
6448423|NCT01136733|7364036|FG004|COMPLETED|Phase 2||0
6448424|NCT01136733|7364037|FG005|COMPLETED|Phase 2||0
6654064|NCT02443740|7583999|FG006|STARTED|Washout Period 1 (7 Days)||2
6654065|NCT02443740|7584000|FG007|STARTED|Washout Period 1 (7 Days)||2
6654066|NCT02443740|7584001|FG008|STARTED|Washout Period 1 (7 Days)||0
6654067|NCT02443740|7584002|FG009|STARTED|Washout Period 1 (7 Days)||3
6654068|NCT02443740|7584003|FG010|STARTED|Washout Period 1 (7 Days)||3
6654069|NCT02443740|7583993|FG000|COMPLETED|Washout Period 1 (7 Days)||1
6654070|NCT02443740|7583994|FG001|COMPLETED|Washout Period 1 (7 Days)||2
6654071|NCT02443740|7583995|FG002|COMPLETED|Washout Period 1 (7 Days)||2
6654072|NCT02443740|7583996|FG003|COMPLETED|Washout Period 1 (7 Days)||3
6654073|NCT02443740|7583997|FG004|COMPLETED|Washout Period 1 (7 Days)||2
6654074|NCT02443740|7583998|FG005|COMPLETED|Washout Period 1 (7 Days)||2
6654075|NCT02443740|7583999|FG006|COMPLETED|Washout Period 1 (7 Days)||2
6654076|NCT02443740|7584000|FG007|COMPLETED|Washout Period 1 (7 Days)||2
6654077|NCT02443740|7584001|FG008|COMPLETED|Washout Period 1 (7 Days)||0
6654078|NCT02443740|7584002|FG009|COMPLETED|Washout Period 1 (7 Days)||3
6654079|NCT02443740|7584003|FG010|COMPLETED|Washout Period 1 (7 Days)||3
6654080|NCT02443740|7583993|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654081|NCT02443740|7583994|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654082|NCT02443740|7583995|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654083|NCT02443740|7583996|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654084|NCT02443740|7583997|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654085|NCT02443740|7583998|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654086|NCT02443740|7583999|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654087|NCT02443740|7584000|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654088|NCT02443740|7584001|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654089|NCT02443740|7584002|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654090|NCT02443740|7584003|FG010|NOT COMPLETED|Washout Period 1 (7 Days)||0
6654091|NCT02443740|7583993|FG000|STARTED|Intervention Period 2 (3 Days)||1
6654092|NCT02443740|7583994|FG001|STARTED|Intervention Period 2 (3 Days)||2
6654093|NCT02443740|7583995|FG002|STARTED|Intervention Period 2 (3 Days)||2
6654094|NCT02443740|7583996|FG003|STARTED|Intervention Period 2 (3 Days)||3
6654095|NCT02443740|7583997|FG004|STARTED|Intervention Period 2 (3 Days)||2
6654096|NCT02443740|7583998|FG005|STARTED|Intervention Period 2 (3 Days)||2
6654097|NCT02443740|7583999|FG006|STARTED|Intervention Period 2 (3 Days)||2
6654098|NCT02443740|7584000|FG007|STARTED|Intervention Period 2 (3 Days)||2
6654099|NCT02443740|7584001|FG008|STARTED|Intervention Period 2 (3 Days)||0
6654100|NCT02443740|7584002|FG009|STARTED|Intervention Period 2 (3 Days)||3
6448425|NCT01136733|7364038|FG006|COMPLETED|Phase 2||0
6448426|NCT01136733|7364032|FG000|NOT COMPLETED|Phase 2||0
6448427|NCT01136733|7364033|FG001|NOT COMPLETED|Phase 2||0
6448428|NCT01136733|7364034|FG002|NOT COMPLETED|Phase 2||0
6448429|NCT01136733|7364035|FG003|NOT COMPLETED|Phase 2||0
6448430|NCT01136733|7364036|FG004|NOT COMPLETED|Phase 2||51
6448431|NCT01136733|7364037|FG005|NOT COMPLETED|Phase 2||52
6654101|NCT02443740|7584003|FG010|STARTED|Intervention Period 2 (3 Days)||3
6654102|NCT02443740|7583993|FG000|COMPLETED|Intervention Period 2 (3 Days)||1
6448432|NCT01136733|7364038|FG006|NOT COMPLETED|Phase 2||50
6448433|NCT01136746|7364070|FG000|STARTED|Overall Study||9
6448434|NCT01136746|7364071|FG001|STARTED|Overall Study||7
6448435|NCT01136746|7364070|FG000|COMPLETED|Overall Study||6
6448436|NCT01136746|7364071|FG001|COMPLETED|Overall Study||4
6448437|NCT01136746|7364070|FG000|NOT COMPLETED|Overall Study||3
6448438|NCT01136746|7364071|FG001|NOT COMPLETED|Overall Study||3
6448439|NCT01136772|7364079|FG000|STARTED|Overall Study||157
6448440|NCT01136772|7364080|FG001|STARTED|Overall Study||154
6448441|NCT01136772|7364079|FG000|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
6448442|NCT01136772|7364080|FG001|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
6448443|NCT01136772|7364079|FG000|COMPLETED|Overall Study||41
6448444|NCT01136772|7364080|FG001|COMPLETED|Overall Study||44
6448445|NCT01136772|7364079|FG000|NOT COMPLETED|Overall Study||116
6448446|NCT01136772|7364080|FG001|NOT COMPLETED|Overall Study||110
6448447|NCT01136785|7364088|FG000|STARTED|Overall Study||15
6448448|NCT01136785|7364089|FG001|STARTED|Overall Study||7
6448449|NCT01136785|7364088|FG000|COMPLETED|Overall Study||13
6448450|NCT01136785|7364089|FG001|COMPLETED|Overall Study||6
6448451|NCT01136785|7364088|FG000|NOT COMPLETED|Overall Study||2
6448452|NCT01136785|7364089|FG001|NOT COMPLETED|Overall Study||1
6448453|NCT01136798|7364101|FG000|STARTED|Overall Study||10
6448454|NCT01136798|7364102|FG001|STARTED|Overall Study||8
6448455|NCT01136798|7364101|FG000|COMPLETED|Overall Study||10
6448456|NCT01136798|7364102|FG001|COMPLETED|Overall Study||8
6448457|NCT01136798|7364101|FG000|NOT COMPLETED|Overall Study||0
6448458|NCT01136798|7364102|FG001|NOT COMPLETED|Overall Study||0
6448459|NCT01136876|7364110|FG000|STARTED|Overall Study||28
6448460|NCT01136876|7364111|FG001|STARTED|Overall Study||29
6448461|NCT01136876|7364110|FG000|COMPLETED|Overall Study||23
6448462|NCT01136876|7364111|FG001|COMPLETED|Overall Study||18
6448463|NCT01136876|7364110|FG000|NOT COMPLETED|Overall Study||5
6448464|NCT01136876|7364111|FG001|NOT COMPLETED|Overall Study||11
6448465|NCT01136915|7364121|FG000|STARTED|Overall Study||8
6448466|NCT01136915|7364122|FG001|STARTED|Overall Study||7
6448467|NCT01136915|7364121|FG000|COMPLETED|Overall Study||6
6448468|NCT01136915|7364122|FG001|COMPLETED|Overall Study||6
6448469|NCT01136915|7364121|FG000|NOT COMPLETED|Overall Study||2
6448470|NCT01136915|7364122|FG001|NOT COMPLETED|Overall Study||1
6448471|NCT01136954|7364132|FG000|STARTED|Overall Study||72
6448472|NCT01136954|7364133|FG001|STARTED|Overall Study||72
6448473|NCT01136954|7364132|FG000|COMPLETED|Overall Study||48
6448474|NCT01136954|7364133|FG001|COMPLETED|Overall Study||51
6448475|NCT01136954|7364132|FG000|NOT COMPLETED|Overall Study||24
6654103|NCT02443740|7583994|FG001|COMPLETED|Intervention Period 2 (3 Days)||2
6654104|NCT02443740|7583995|FG002|COMPLETED|Intervention Period 2 (3 Days)||2
6654105|NCT02443740|7583996|FG003|COMPLETED|Intervention Period 2 (3 Days)||3
6654106|NCT02443740|7583997|FG004|COMPLETED|Intervention Period 2 (3 Days)||2
6654107|NCT02443740|7583998|FG005|COMPLETED|Intervention Period 2 (3 Days)||2
6654108|NCT02443740|7583999|FG006|COMPLETED|Intervention Period 2 (3 Days)||2
6654109|NCT02443740|7584000|FG007|COMPLETED|Intervention Period 2 (3 Days)||2
6654110|NCT02443740|7584001|FG008|COMPLETED|Intervention Period 2 (3 Days)||0
6654111|NCT02443740|7584002|FG009|COMPLETED|Intervention Period 2 (3 Days)||3
6654112|NCT02443740|7584003|FG010|COMPLETED|Intervention Period 2 (3 Days)||3
6654113|NCT02443740|7583993|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654114|NCT02443740|7583994|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654115|NCT02443740|7583995|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654116|NCT02443740|7583996|FG003|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654117|NCT02443740|7583997|FG004|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654118|NCT02443740|7583998|FG005|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654119|NCT02443740|7583999|FG006|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654120|NCT02443740|7584000|FG007|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654121|NCT02443740|7584001|FG008|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654122|NCT02443740|7584002|FG009|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654123|NCT02443740|7584003|FG010|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6654124|NCT02443740|7583993|FG000|STARTED|Washout Period 2 (7 Days)||1
6654125|NCT02443740|7583994|FG001|STARTED|Washout Period 2 (7 Days)||2
6654126|NCT02443740|7583995|FG002|STARTED|Washout Period 2 (7 Days)||2
6654127|NCT02443740|7583996|FG003|STARTED|Washout Period 2 (7 Days)||3
6654128|NCT02443740|7583997|FG004|STARTED|Washout Period 2 (7 Days)||2
6654129|NCT02443740|7583998|FG005|STARTED|Washout Period 2 (7 Days)||2
6654130|NCT02443740|7583999|FG006|STARTED|Washout Period 2 (7 Days)||2
6654131|NCT02443740|7584000|FG007|STARTED|Washout Period 2 (7 Days)||2
6654132|NCT02443740|7584001|FG008|STARTED|Washout Period 2 (7 Days)||0
6654133|NCT02443740|7584002|FG009|STARTED|Washout Period 2 (7 Days)||0
6654134|NCT02443740|7584003|FG010|STARTED|Washout Period 2 (7 Days)||0
6654135|NCT02443740|7583993|FG000|COMPLETED|Washout Period 2 (7 Days)||1
6654136|NCT02443740|7583994|FG001|COMPLETED|Washout Period 2 (7 Days)||2
6448476|NCT01136954|7364133|FG001|NOT COMPLETED|Overall Study||21
6448477|NCT01137006|7364147|FG000|STARTED|Overall Study||3
6448478|NCT01137006|7364148|FG001|STARTED|Overall Study||3
6448479|NCT01137006|7364149|FG002|STARTED|Overall Study||8
6448480|NCT01137006|7364150|FG003|STARTED|Overall Study||3
6448481|NCT01137006|7364151|FG004|STARTED|Overall Study||3
6448482|NCT01137006|7364152|FG005|STARTED|Overall Study||4
6448483|NCT01137006|7364153|FG006|STARTED|Overall Study||3
6448484|NCT01137006|7364147|FG000|Completed at Least 1 Treatment Cycle|Overall Study||3
6448485|NCT01137006|7364148|FG001|Completed at Least 1 Treatment Cycle|Overall Study||3
6448486|NCT01137006|7364149|FG002|Completed at Least 1 Treatment Cycle|Overall Study||8
6448487|NCT01137006|7364150|FG003|Completed at Least 1 Treatment Cycle|Overall Study||3
6448488|NCT01137006|7364151|FG004|Completed at Least 1 Treatment Cycle|Overall Study||3
6448489|NCT01137006|7364152|FG005|Completed at Least 1 Treatment Cycle|Overall Study||4
6448490|NCT01137006|7364153|FG006|Completed at Least 1 Treatment Cycle|Overall Study||3
6448491|NCT01137006|7364147|FG000|COMPLETED|Overall Study||3
6553311|NCT01743001|7475829|FG001|STARTED|Overall Study||112
6553312|NCT01743001|7475828|FG000|COMPLETED|Overall Study||111
6553313|NCT01743001|7475829|FG001|COMPLETED|Overall Study||112
6553314|NCT01743001|7475828|FG000|NOT COMPLETED|Overall Study||3
6654137|NCT02443740|7583995|FG002|COMPLETED|Washout Period 2 (7 Days)||2
6654138|NCT02443740|7583996|FG003|COMPLETED|Washout Period 2 (7 Days)||3
6448492|NCT01137006|7364148|FG001|COMPLETED|Overall Study||3
6448493|NCT01137006|7364149|FG002|COMPLETED|Overall Study||8
6448494|NCT01137006|7364150|FG003|COMPLETED|Overall Study||3
6448495|NCT01137006|7364151|FG004|COMPLETED|Overall Study||3
6448496|NCT01137006|7364152|FG005|COMPLETED|Overall Study||4
6448497|NCT01137006|7364153|FG006|COMPLETED|Overall Study||3
6448498|NCT01137006|7364147|FG000|NOT COMPLETED|Overall Study||0
6448499|NCT01137006|7364148|FG001|NOT COMPLETED|Overall Study||0
6448500|NCT01137006|7364149|FG002|NOT COMPLETED|Overall Study||0
6448501|NCT01137006|7364150|FG003|NOT COMPLETED|Overall Study||0
6448502|NCT01137006|7364151|FG004|NOT COMPLETED|Overall Study||0
6448503|NCT01137006|7364152|FG005|NOT COMPLETED|Overall Study||0
6448504|NCT01137006|7364153|FG006|NOT COMPLETED|Overall Study||0
6448505|NCT01137032|7364170|FG000|STARTED|Overall Study||19
6448506|NCT01137032|7364170|FG000|COMPLETED|Overall Study||19
6448507|NCT01137032|7364170|FG000|NOT COMPLETED|Overall Study||0
6654139|NCT02443740|7583997|FG004|COMPLETED|Washout Period 2 (7 Days)||2
6654140|NCT02443740|7583998|FG005|COMPLETED|Washout Period 2 (7 Days)||2
6654141|NCT02443740|7583999|FG006|COMPLETED|Washout Period 2 (7 Days)||2
6654142|NCT02443740|7584000|FG007|COMPLETED|Washout Period 2 (7 Days)||2
6654143|NCT02443740|7584001|FG008|COMPLETED|Washout Period 2 (7 Days)||0
6654144|NCT02443740|7584002|FG009|COMPLETED|Washout Period 2 (7 Days)||0
6654145|NCT02443740|7584003|FG010|COMPLETED|Washout Period 2 (7 Days)||0
6654146|NCT02443740|7583993|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654147|NCT02443740|7583994|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654148|NCT02443740|7583995|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654149|NCT02443740|7583996|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654150|NCT02443740|7583997|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654151|NCT02443740|7583998|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654152|NCT02443740|7583999|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654153|NCT02443740|7584000|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654154|NCT02443740|7584001|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654155|NCT02443740|7584002|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654156|NCT02443740|7584003|FG010|NOT COMPLETED|Washout Period 2 (7 Days)||0
6654157|NCT02443740|7583993|FG000|STARTED|Intervention Period 3 (3 Days)||1
6654158|NCT02443740|7583994|FG001|STARTED|Intervention Period 3 (3 Days)||2
6654159|NCT02443740|7583995|FG002|STARTED|Intervention Period 3 (3 Days)||2
6654160|NCT02443740|7583996|FG003|STARTED|Intervention Period 3 (3 Days)||3
6654161|NCT02443740|7583997|FG004|STARTED|Intervention Period 3 (3 Days)||2
6654162|NCT02443740|7583998|FG005|STARTED|Intervention Period 3 (3 Days)||2
6654163|NCT02443740|7583999|FG006|STARTED|Intervention Period 3 (3 Days)||2
6654164|NCT02443740|7584000|FG007|STARTED|Intervention Period 3 (3 Days)||2
6654165|NCT02443740|7584001|FG008|STARTED|Intervention Period 3 (3 Days)||0
6654166|NCT02443740|7584002|FG009|STARTED|Intervention Period 3 (3 Days)||0
6744410|NCT03342469|7672452|FG003|COMPLETED|Overall Study||8
6744411|NCT03342469|7672449|FG000|NOT COMPLETED|Overall Study||0
6744412|NCT03342469|7672450|FG001|NOT COMPLETED|Overall Study||1
6744413|NCT03342469|7672451|FG002|NOT COMPLETED|Overall Study||0
6744414|NCT03342469|7672452|FG003|NOT COMPLETED|Overall Study||0
6744415|NCT03342560|7672463|FG000|STARTED|Overall Study||30
6744416|NCT03342560|7672463|FG000|COMPLETED|Overall Study||28
6744417|NCT03342560|7672463|FG000|NOT COMPLETED|Overall Study||2
6744418|NCT03342690|7672471|FG000|STARTED|Overall Study||1164
6744419|NCT03342690|7672471|FG000|COMPLETED|Overall Study||1139
6744420|NCT03342690|7672471|FG000|NOT COMPLETED|Overall Study||25
6744421|NCT03342898|7672478|FG000|STARTED|Overall Study||300
6744422|NCT03342898|7672479|FG001|STARTED|Overall Study||300
6744423|NCT03342898|7672480|FG002|STARTED|Overall Study||300
6744424|NCT03342898|7672478|FG000|COMPLETED|Overall Study||246
6553315|NCT01743001|7475829|FG001|NOT COMPLETED|Overall Study||0
6553316|NCT01743027|7475839|FG000|STARTED|Overall Study||98
6553317|NCT01743027|7475840|FG001|STARTED|Overall Study||99
6553318|NCT01743027|7475841|FG002|STARTED|Overall Study||99
6553319|NCT01743027|7475842|FG003|STARTED|Overall Study||49
6553320|NCT01743027|7475839|FG000|COMPLETED|Overall Study||93
6553321|NCT01743027|7475840|FG001|COMPLETED|Overall Study||94
6553322|NCT01743027|7475841|FG002|COMPLETED|Overall Study||90
6553323|NCT01743027|7475842|FG003|COMPLETED|Overall Study||48
6553324|NCT01743027|7475839|FG000|NOT COMPLETED|Overall Study||5
6553325|NCT01743027|7475840|FG001|NOT COMPLETED|Overall Study||5
6553326|NCT01743027|7475841|FG002|NOT COMPLETED|Overall Study||9
6744425|NCT03342898|7672479|FG001|COMPLETED|Overall Study||247
6448508|NCT01137071|7364174|FG000|STARTED|Overall Study|all patients considered eligible were included on the study|29
6448509|NCT01137071|7364174|FG000|COMPLETED|Overall Study|Of the eligible patients|15
6448510|NCT01137071|7364174|FG000|NOT COMPLETED|Overall Study||14
6448511|NCT01137110|7364185|FG000|STARTED|Overall Study||35
6448512|NCT01137110|7364186|FG001|STARTED|Overall Study||49
6448513|NCT01137110|7364185|FG000|COMPLETED|Overall Study||34
6448514|NCT01137110|7364186|FG001|COMPLETED|Overall Study||49
6448515|NCT01137110|7364185|FG000|NOT COMPLETED|Overall Study||1
6448516|NCT01137110|7364186|FG001|NOT COMPLETED|Overall Study||0
6448517|NCT01137292|7364192|FG000|STARTED|Overall Study||177
6448518|NCT01137292|7364192|FG000|COMPLETED|Overall Study||123
6448519|NCT01137292|7364192|FG000|NOT COMPLETED|Overall Study||54
6448520|NCT01137370|7364198|FG000|STARTED|Overall Study||116
6448521|NCT01137370|7364199|FG001|STARTED|Overall Study||87
6448522|NCT01137370|7364198|FG000|COMPLETED|Overall Study||116
6448523|NCT01137370|7364199|FG001|COMPLETED|Overall Study||87
6448524|NCT01137370|7364198|FG000|NOT COMPLETED|Overall Study||0
6448525|NCT01137370|7364199|FG001|NOT COMPLETED|Overall Study||0
6448526|NCT01137396|7364207|FG000|STARTED|Overall Study||30
6448527|NCT01137396|7364208|FG001|STARTED|Overall Study||27
6448528|NCT01137396|7364207|FG000|COMPLETED|Overall Study||22
6448529|NCT01137396|7364208|FG001|COMPLETED|Overall Study||25
6448530|NCT01137396|7364207|FG000|NOT COMPLETED|Overall Study||8
6448531|NCT01137396|7364208|FG001|NOT COMPLETED|Overall Study||2
6448535|NCT01137474|7364222|FG000|STARTED|Overall Study||311
6448536|NCT01137474|7364223|FG001|STARTED|Overall Study||166
6448537|NCT01137474|7364224|FG002|STARTED|Overall Study||165
6448538|NCT01137474|7364225|FG003|STARTED|Overall Study||302
6448539|NCT01137474|7364222|FG000|Received Treatment|Overall Study||311
6448540|NCT01137474|7364223|FG001|Received Treatment|Overall Study||166
6448541|NCT01137474|7364224|FG002|Received Treatment|Overall Study||165
6448542|NCT01137474|7364225|FG003|Received Treatment|Overall Study||302
6448543|NCT01137474|7364222|FG000|COMPLETED|Overall Study||287
6448544|NCT01137474|7364223|FG001|COMPLETED|Overall Study||154
6448545|NCT01137474|7364224|FG002|COMPLETED|Overall Study||158
6448546|NCT01137474|7364225|FG003|COMPLETED|Overall Study||281
6448547|NCT01137474|7364222|FG000|NOT COMPLETED|Overall Study||24
6654167|NCT02443740|7584003|FG010|STARTED|Intervention Period 3 (3 Days)||0
6654168|NCT02443740|7583993|FG000|COMPLETED|Intervention Period 3 (3 Days)||1
6654169|NCT02443740|7583994|FG001|COMPLETED|Intervention Period 3 (3 Days)||2
6654170|NCT02443740|7583995|FG002|COMPLETED|Intervention Period 3 (3 Days)||2
6654171|NCT02443740|7583996|FG003|COMPLETED|Intervention Period 3 (3 Days)||3
6654172|NCT02443740|7583997|FG004|COMPLETED|Intervention Period 3 (3 Days)||2
6654173|NCT02443740|7583998|FG005|COMPLETED|Intervention Period 3 (3 Days)||2
6654174|NCT02443740|7583999|FG006|COMPLETED|Intervention Period 3 (3 Days)||2
6654175|NCT02443740|7584000|FG007|COMPLETED|Intervention Period 3 (3 Days)||2
6654176|NCT02443740|7584001|FG008|COMPLETED|Intervention Period 3 (3 Days)||0
6654177|NCT02443740|7584002|FG009|COMPLETED|Intervention Period 3 (3 Days)||0
6654178|NCT02443740|7584003|FG010|COMPLETED|Intervention Period 3 (3 Days)||0
6654179|NCT02443740|7583993|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654180|NCT02443740|7583994|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654181|NCT02443740|7583995|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654182|NCT02443740|7583996|FG003|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654183|NCT02443740|7583997|FG004|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654184|NCT02443740|7583998|FG005|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654185|NCT02443740|7583999|FG006|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654186|NCT02443740|7584000|FG007|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654187|NCT02443740|7584001|FG008|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654188|NCT02443740|7584002|FG009|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654189|NCT02443740|7584003|FG010|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6654190|NCT02443740|7583993|FG000|STARTED|Washout Period 3 (7 Days)||1
6654191|NCT02443740|7583994|FG001|STARTED|Washout Period 3 (7 Days)||2
6654192|NCT02443740|7583995|FG002|STARTED|Washout Period 3 (7 Days)||2
6654193|NCT02443740|7583996|FG003|STARTED|Washout Period 3 (7 Days)||3
6654194|NCT02443740|7583997|FG004|STARTED|Washout Period 3 (7 Days)||2
6654195|NCT02443740|7583998|FG005|STARTED|Washout Period 3 (7 Days)||2
6654196|NCT02443740|7583999|FG006|STARTED|Washout Period 3 (7 Days)||2
6654197|NCT02443740|7584000|FG007|STARTED|Washout Period 3 (7 Days)||2
6654198|NCT02443740|7584001|FG008|STARTED|Washout Period 3 (7 Days)||0
6654199|NCT02443740|7584002|FG009|STARTED|Washout Period 3 (7 Days)||0
6654200|NCT02443740|7584003|FG010|STARTED|Washout Period 3 (7 Days)||0
6654201|NCT02443740|7583993|FG000|COMPLETED|Washout Period 3 (7 Days)||1
6654202|NCT02443740|7583994|FG001|COMPLETED|Washout Period 3 (7 Days)||2
6654203|NCT02443740|7583995|FG002|COMPLETED|Washout Period 3 (7 Days)||2
6654204|NCT02443740|7583996|FG003|COMPLETED|Washout Period 3 (7 Days)||3
6654205|NCT02443740|7583997|FG004|COMPLETED|Washout Period 3 (7 Days)||2
6654206|NCT02443740|7583998|FG005|COMPLETED|Washout Period 3 (7 Days)||2
6654207|NCT02443740|7583999|FG006|COMPLETED|Washout Period 3 (7 Days)||2
6654208|NCT02443740|7584000|FG007|COMPLETED|Washout Period 3 (7 Days)||2
6448548|NCT01137474|7364223|FG001|NOT COMPLETED|Overall Study||12
6448549|NCT01137474|7364224|FG002|NOT COMPLETED|Overall Study||7
6448550|NCT01137474|7364225|FG003|NOT COMPLETED|Overall Study||21
6448551|NCT01137539|7364235|FG000|STARTED|Overall Study||50
6448552|NCT01137539|7364235|FG000|COMPLETED|Overall Study||50
6448553|NCT01137539|7364235|FG000|NOT COMPLETED|Overall Study||0
6448554|NCT01137578|7364239|FG000|STARTED|Overall Study||77
6448555|NCT01137578|7364240|FG001|STARTED|Overall Study||14
6448556|NCT01137578|7364241|FG002|STARTED|Overall Study||43
6448557|NCT01137578|7364239|FG000|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
6448558|NCT01137578|7364240|FG001|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
6448559|NCT01137578|7364241|FG002|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
6448560|NCT01137578|7364239|FG000|NOT COMPLETED|Overall Study||16
6448561|NCT01137578|7364240|FG001|NOT COMPLETED|Overall Study||2
6448562|NCT01137578|7364241|FG002|NOT COMPLETED|Overall Study||6
6448563|NCT01137604|7364273|FG000|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
6448564|NCT01137604|7364274|FG001|STARTED|Overall Study||42
6448565|NCT01137604|7364275|FG002|STARTED|Overall Study||39
6448566|NCT01137604|7364276|FG003|STARTED|Overall Study||32
6448567|NCT01137604|7364273|FG000|Disease Progression|Overall Study||34
6448568|NCT01137604|7364274|FG001|Disease Progression|Overall Study||29
6448569|NCT01137604|7364275|FG002|Disease Progression|Overall Study||25
6448570|NCT01137604|7364276|FG003|Disease Progression|Overall Study||21
6448571|NCT01137604|7364273|FG000|Treatment Ongoing at Data Cutoff|Overall Study||2
6448572|NCT01137604|7364274|FG001|Treatment Ongoing at Data Cutoff|Overall Study||3
6448573|NCT01137604|7364275|FG002|Treatment Ongoing at Data Cutoff|Overall Study||1
6448574|NCT01137604|7364276|FG003|Treatment Ongoing at Data Cutoff|Overall Study||0
6448575|NCT01137604|7364273|FG000|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
6448576|NCT01137604|7364274|FG001|COMPLETED|Overall Study||32
6448577|NCT01137604|7364275|FG002|COMPLETED|Overall Study||26
6448578|NCT01137604|7364276|FG003|COMPLETED|Overall Study||21
6448579|NCT01137604|7364273|FG000|NOT COMPLETED|Overall Study||2
6448580|NCT01137604|7364274|FG001|NOT COMPLETED|Overall Study||10
6448581|NCT01137604|7364275|FG002|NOT COMPLETED|Overall Study||13
6448582|NCT01137604|7364276|FG003|NOT COMPLETED|Overall Study||11
6448583|NCT01137682|7364289|FG000|STARTED|Overall Study||65
6448584|NCT01137682|7364290|FG001|STARTED|Overall Study||65
6448585|NCT01137682|7364291|FG002|STARTED|Overall Study||68
6448586|NCT01137682|7364289|FG000|Not Treated|Overall Study||2
6448587|NCT01137682|7364290|FG001|Not Treated|Overall Study||2
6654209|NCT02443740|7584001|FG008|COMPLETED|Washout Period 3 (7 Days)||0
6654210|NCT02443740|7584002|FG009|COMPLETED|Washout Period 3 (7 Days)||0
6654211|NCT02443740|7584003|FG010|COMPLETED|Washout Period 3 (7 Days)||0
6654212|NCT02443740|7583993|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654213|NCT02443740|7583994|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654214|NCT02443740|7583995|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654215|NCT02443740|7583996|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654216|NCT02443740|7583997|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654217|NCT02443740|7583998|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654218|NCT02443740|7583999|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654219|NCT02443740|7584000|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654220|NCT02443740|7584001|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654221|NCT02443740|7584002|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654222|NCT02443740|7584003|FG010|NOT COMPLETED|Washout Period 3 (7 Days)||0
6654223|NCT02443740|7583993|FG000|STARTED|Intervention Period 4 (3 Days)||1
6654224|NCT02443740|7583994|FG001|STARTED|Intervention Period 4 (3 Days)||2
6654225|NCT02443740|7583995|FG002|STARTED|Intervention Period 4 (3 Days)||2
6654226|NCT02443740|7583996|FG003|STARTED|Intervention Period 4 (3 Days)||3
6654227|NCT02443740|7583997|FG004|STARTED|Intervention Period 4 (3 Days)||2
6654228|NCT02443740|7583998|FG005|STARTED|Intervention Period 4 (3 Days)||2
6654229|NCT02443740|7583999|FG006|STARTED|Intervention Period 4 (3 Days)||2
6654230|NCT02443740|7584000|FG007|STARTED|Intervention Period 4 (3 Days)||2
6654231|NCT02443740|7584001|FG008|STARTED|Intervention Period 4 (3 Days)||0
6654232|NCT02443740|7584002|FG009|STARTED|Intervention Period 4 (3 Days)||0
6654233|NCT02443740|7584003|FG010|STARTED|Intervention Period 4 (3 Days)||0
6654234|NCT02443740|7583993|FG000|COMPLETED|Intervention Period 4 (3 Days)||1
6654235|NCT02443740|7583994|FG001|COMPLETED|Intervention Period 4 (3 Days)||2
6654236|NCT02443740|7583995|FG002|COMPLETED|Intervention Period 4 (3 Days)||2
6654237|NCT02443740|7583996|FG003|COMPLETED|Intervention Period 4 (3 Days)||3
6654238|NCT02443740|7583997|FG004|COMPLETED|Intervention Period 4 (3 Days)||2
6654239|NCT02443740|7583998|FG005|COMPLETED|Intervention Period 4 (3 Days)||2
6654240|NCT02443740|7583999|FG006|COMPLETED|Intervention Period 4 (3 Days)||2
6654241|NCT02443740|7584000|FG007|COMPLETED|Intervention Period 4 (3 Days)||2
6654242|NCT02443740|7584001|FG008|COMPLETED|Intervention Period 4 (3 Days)||0
6654243|NCT02443740|7584002|FG009|COMPLETED|Intervention Period 4 (3 Days)||0
6654244|NCT02443740|7584003|FG010|COMPLETED|Intervention Period 4 (3 Days)||0
6448588|NCT01137682|7364291|FG002|Not Treated|Overall Study||1
6448589|NCT01137682|7364289|FG000|Treated|Overall Study||63
6448590|NCT01137682|7364290|FG001|Treated|Overall Study||63
6448591|NCT01137682|7364291|FG002|Treated|Overall Study||67
6448592|NCT01137682|7364289|FG000|Completed 24-Week Core Phase|Overall Study||59
6448593|NCT01137682|7364290|FG001|Completed 24-Week Core Phase|Overall Study||57
6448594|NCT01137682|7364291|FG002|Completed 24-Week Core Phase|Overall Study||65
6654245|NCT02443740|7583993|FG000|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6656191|NCT02458690|7586310|FG001|COMPLETED|Overall Study||100
6448595|NCT01137682|7364289|FG000|Not Continuing Into Extension|Overall Study||2
6448596|NCT01137682|7364290|FG001|Not Continuing Into Extension|Overall Study||3
6448597|NCT01137682|7364291|FG002|Not Continuing Into Extension|Overall Study||2
6448598|NCT01137682|7364289|FG000|Continuing Into Extension|Overall Study||57
6448599|NCT01137682|7364290|FG001|Continuing Into Extension|Overall Study||54
6448600|NCT01137682|7364291|FG002|Continuing Into Extension|Overall Study||63
6448601|NCT01137682|7364289|FG000|Safety Set - CORE|Overall Study|2 patients never received drug.|63
6448602|NCT01137682|7364290|FG001|Safety Set - CORE|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
6448603|NCT01137682|7364291|FG002|Safety Set - CORE|Overall Study|2 patients never received drug.|66
6448604|NCT01137682|7364289|FG000|Safety Set - Extension|Overall Study||57
6448605|NCT01137682|7364290|FG001|Safety Set - Extension|Overall Study||54
6448606|NCT01137682|7364291|FG002|Safety Set - Extension|Overall Study|1 patient did not receive study treatment|62
6448607|NCT01137682|7364289|FG000|COMPLETED|Overall Study||28
6448608|NCT01137682|7364290|FG001|COMPLETED|Overall Study||25
6448609|NCT01137682|7364291|FG002|COMPLETED|Overall Study||34
6448610|NCT01137682|7364289|FG000|NOT COMPLETED|Overall Study||37
6448611|NCT01137682|7364290|FG001|NOT COMPLETED|Overall Study||40
6448612|NCT01137682|7364291|FG002|NOT COMPLETED|Overall Study||34
6448613|NCT01137786|7364305|FG000|STARTED|Overall Study||25
6448614|NCT01137786|7364306|FG001|STARTED|Overall Study||24
6448615|NCT01137786|7364305|FG000|COMPLETED|Overall Study||24
6448616|NCT01137786|7364306|FG001|COMPLETED|Overall Study||21
6448617|NCT01137786|7364305|FG000|NOT COMPLETED|Overall Study||1
6448618|NCT01137786|7364306|FG001|NOT COMPLETED|Overall Study||3
6448619|NCT01137812|7364316|FG000|STARTED|Overall Study||377
6448620|NCT01137812|7364317|FG001|STARTED|Overall Study||378
6448621|NCT01137812|7364316|FG000|COMPLETED|Overall Study||254
6448622|NCT01137812|7364317|FG001|COMPLETED|Overall Study||210
6448623|NCT01137812|7364316|FG000|NOT COMPLETED|Overall Study||123
6448624|NCT01137812|7364317|FG001|NOT COMPLETED|Overall Study||168
6448625|NCT01137890|7364325|FG000|STARTED|Overall Study||14
6448626|NCT01137890|7364326|FG001|STARTED|Overall Study||5
6448627|NCT01137890|7364325|FG000|COMPLETED|Overall Study||8
6448628|NCT01137890|7364326|FG001|COMPLETED|Overall Study||2
6448629|NCT01137890|7364325|FG000|NOT COMPLETED|Overall Study||6
6448630|NCT01137890|7364326|FG001|NOT COMPLETED|Overall Study||3
6448631|NCT01138007|7364381|FG000|STARTED|Overall Study||187
6448632|NCT01138007|7364382|FG001|STARTED|Overall Study||190
6448633|NCT01138007|7364383|FG002|STARTED|Overall Study||192
6448634|NCT01138007|7364381|FG000|COMPLETED|Overall Study||165
6448635|NCT01138007|7364382|FG001|COMPLETED|Overall Study||160
6448636|NCT01138007|7364383|FG002|COMPLETED|Overall Study||144
6448637|NCT01138007|7364381|FG000|NOT COMPLETED|Overall Study||22
6448638|NCT01138007|7364382|FG001|NOT COMPLETED|Overall Study||30
6448639|NCT01138007|7364383|FG002|NOT COMPLETED|Overall Study||48
6448640|NCT01138046|7364393|FG000|STARTED|Overall Study||12
6448641|NCT01138046|7364393|FG000|COMPLETED|Overall Study||6
6448642|NCT01138046|7364393|FG000|NOT COMPLETED|Overall Study||6
6448643|NCT01138098|7364399|FG000|STARTED|Overall Study||95
6448644|NCT01138098|7364400|FG001|STARTED|Overall Study||90
6448645|NCT01138098|7364399|FG000|COMPLETED|Overall Study||95
6448646|NCT01138098|7364400|FG001|COMPLETED|Overall Study||90
6448647|NCT01138098|7364399|FG000|NOT COMPLETED|Overall Study||0
6448648|NCT01138098|7364400|FG001|NOT COMPLETED|Overall Study||0
6448649|NCT01138111|7364406|FG000|STARTED|Overall Study||45
6448650|NCT01138111|7364406|FG000|COMPLETED|Overall Study||36
6448651|NCT01138111|7364406|FG000|NOT COMPLETED|Overall Study||9
6448652|NCT01138124|7364439|FG000|STARTED|Overall Study||3149
6448653|NCT01138124|7364440|FG001|STARTED|Overall Study||30026
6448654|NCT01138124|7364441|FG002|STARTED|Overall Study||1981
6448655|NCT01138124|7364442|FG003|STARTED|Overall Study||19046
6448656|NCT01138124|7364439|FG000|COMPLETED|Overall Study||3149
6448657|NCT01138124|7364440|FG001|COMPLETED|Overall Study||30026
6448658|NCT01138124|7364441|FG002|COMPLETED|Overall Study||1981
6448659|NCT01138124|7364442|FG003|COMPLETED|Overall Study||19046
6448660|NCT01138124|7364439|FG000|NOT COMPLETED|Overall Study||0
6448661|NCT01138124|7364440|FG001|NOT COMPLETED|Overall Study||0
6448662|NCT01138124|7364441|FG002|NOT COMPLETED|Overall Study||0
6448663|NCT01138124|7364442|FG003|NOT COMPLETED|Overall Study||0
6448664|NCT01138150|7364452|FG000|STARTED|Overall Study||18
6448665|NCT01138150|7364453|FG001|STARTED|Overall Study||18
6448666|NCT01138150|7364452|FG000|COMPLETED|Overall Study||17
6448667|NCT01138150|7364453|FG001|COMPLETED|Overall Study||17
6448668|NCT01138150|7364452|FG000|NOT COMPLETED|Overall Study||1
6448669|NCT01138150|7364453|FG001|NOT COMPLETED|Overall Study||1
6448670|NCT01138475|7364472|FG000|STARTED|Overall Study||16
6448671|NCT01138475|7364473|FG001|STARTED|Overall Study||16
6654246|NCT02443740|7583994|FG001|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654247|NCT02443740|7583995|FG002|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654248|NCT02443740|7583996|FG003|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654249|NCT02443740|7583997|FG004|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6448672|NCT01138475|7364474|FG002|STARTED|Overall Study||17
6448673|NCT01138475|7364472|FG000|COMPLETED|Overall Study||16
6448674|NCT01138475|7364473|FG001|COMPLETED|Overall Study||16
6448675|NCT01138475|7364474|FG002|COMPLETED|Overall Study||17
6448676|NCT01138475|7364472|FG000|NOT COMPLETED|Overall Study||0
6448677|NCT01138475|7364473|FG001|NOT COMPLETED|Overall Study||0
6448678|NCT01138475|7364474|FG002|NOT COMPLETED|Overall Study||0
6448679|NCT01138501|7364488|FG000|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
6448680|NCT01138501|7364488|FG000|Exposed|Overall Study||63
6448681|NCT01138501|7364488|FG000|COMPLETED|Overall Study||60
6448682|NCT01138501|7364488|FG000|NOT COMPLETED|Overall Study||5
6448683|NCT01138514|7364495|FG000|STARTED|Overall Study||522
6448684|NCT01138514|7364496|FG001|STARTED|Overall Study||516
6448685|NCT01138514|7364497|FG002|STARTED|Overall Study||517
6448686|NCT01138514|7364495|FG000|COMPLETED|Overall Study||474
6448687|NCT01138514|7364496|FG001|COMPLETED|Overall Study||463
6448688|NCT01138514|7364497|FG002|COMPLETED|Overall Study||424
6448689|NCT01138514|7364495|FG000|NOT COMPLETED|Overall Study||48
6448690|NCT01138514|7364496|FG001|NOT COMPLETED|Overall Study||53
6448691|NCT01138514|7364497|FG002|NOT COMPLETED|Overall Study||93
6448692|NCT01138657|7364508|FG000|STARTED|Overall Study||120
6448693|NCT01138657|7364509|FG001|STARTED|Overall Study||119
6448694|NCT01138657|7364508|FG000|Enrolled in Main Study|Overall Study||112
6448695|NCT01138657|7364509|FG001|Enrolled in Main Study|Overall Study||111
6448696|NCT01138657|7364508|FG000|Enrolled in Japan Sub-study|Overall Study||8
6654250|NCT02443740|7583998|FG005|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654251|NCT02443740|7583999|FG006|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654252|NCT02443740|7584000|FG007|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654253|NCT02443740|7584001|FG008|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654254|NCT02443740|7584002|FG009|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654255|NCT02443740|7584003|FG010|NOT COMPLETED|Intervention Period 4 (3 Days)||0
6654256|NCT02443792|7584035|FG000|STARTED|Overall Study||50
6654257|NCT02443792|7584036|FG001|STARTED|Overall Study||25
6654258|NCT02443792|7584035|FG000|COMPLETED|Overall Study||43
6654259|NCT02443792|7584036|FG001|COMPLETED|Overall Study||23
6654260|NCT02443792|7584035|FG000|NOT COMPLETED|Overall Study||7
6654261|NCT02443792|7584036|FG001|NOT COMPLETED|Overall Study||2
6654262|NCT02443805|7584044|FG000|STARTED|Overall Study||802
6654263|NCT02443805|7584045|FG001|STARTED|Overall Study||805
6654264|NCT02443805|7584044|FG000|COMPLETED|Overall Study||589
6654265|NCT02443805|7584045|FG001|COMPLETED|Overall Study||678
6654266|NCT02443805|7584044|FG000|NOT COMPLETED|Overall Study||213
6654267|NCT02443805|7584045|FG001|NOT COMPLETED|Overall Study||127
6654268|NCT02443883|7584055|FG000|STARTED|Overall Study||40
6654269|NCT02443883|7584056|FG001|STARTED|Overall Study||42
6654270|NCT02443883|7584057|FG002|STARTED|Overall Study||41
6654271|NCT02443883|7584058|FG003|STARTED|Overall Study||41
6654272|NCT02443883|7584055|FG000|Received at Least One Dose of Study Drug|Overall Study||38
6654273|NCT02443883|7584056|FG001|Received at Least One Dose of Study Drug|Overall Study||42
6654274|NCT02443883|7584057|FG002|Received at Least One Dose of Study Drug|Overall Study||41
6654275|NCT02443883|7584058|FG003|Received at Least One Dose of Study Drug|Overall Study||40
6654276|NCT02443883|7584055|FG000|COMPLETED|Overall Study||34
6654277|NCT02443883|7584056|FG001|COMPLETED|Overall Study||38
6654278|NCT02443883|7584057|FG002|COMPLETED|Overall Study||40
6654279|NCT02443883|7584058|FG003|COMPLETED|Overall Study||36
6654280|NCT02443883|7584055|FG000|NOT COMPLETED|Overall Study||6
6654281|NCT02443883|7584056|FG001|NOT COMPLETED|Overall Study||4
6654282|NCT02443883|7584057|FG002|NOT COMPLETED|Overall Study||1
6654283|NCT02443883|7584058|FG003|NOT COMPLETED|Overall Study||5
6654284|NCT02444143|7584070|FG000|STARTED|Overall Study||10
6654285|NCT02444143|7584071|FG001|STARTED|Overall Study||10
6654286|NCT02444143|7584070|FG000|COMPLETED|Overall Study||10
6654287|NCT02444143|7584071|FG001|COMPLETED|Overall Study|1 patient withdrawal|9
6654288|NCT02444143|7584070|FG000|NOT COMPLETED|Overall Study||0
6654289|NCT02444143|7584071|FG001|NOT COMPLETED|Overall Study||1
6654290|NCT02444182|7584081|FG000|STARTED|Overall Study||54
6654291|NCT02444182|7584082|FG001|STARTED|Overall Study||54
6654292|NCT02444182|7584081|FG000|COMPLETED|Overall Study||52
6654293|NCT02444182|7584082|FG001|COMPLETED|Overall Study||49
6654294|NCT02444182|7584081|FG000|NOT COMPLETED|Overall Study||2
6654295|NCT02444182|7584082|FG001|NOT COMPLETED|Overall Study||5
6654296|NCT02444234|7584088|FG000|STARTED|First Intervention (3 Days)||6
6654297|NCT02444234|7584089|FG001|STARTED|First Intervention (3 Days)||5
6654298|NCT02444234|7584088|FG000|COMPLETED|First Intervention (3 Days)||6
6654299|NCT02444234|7584089|FG001|COMPLETED|First Intervention (3 Days)||5
6654300|NCT02444234|7584088|FG000|NOT COMPLETED|First Intervention (3 Days)||0
6654301|NCT02444234|7584089|FG001|NOT COMPLETED|First Intervention (3 Days)||0
6654302|NCT02444234|7584088|FG000|STARTED|Washout (2 Day Minimum)||6
6654303|NCT02444234|7584089|FG001|STARTED|Washout (2 Day Minimum)||5
6654304|NCT02444234|7584088|FG000|COMPLETED|Washout (2 Day Minimum)||6
6654305|NCT02444234|7584089|FG001|COMPLETED|Washout (2 Day Minimum)||5
6654306|NCT02444234|7584088|FG000|NOT COMPLETED|Washout (2 Day Minimum)||0
6654307|NCT02444234|7584089|FG001|NOT COMPLETED|Washout (2 Day Minimum)||0
6654308|NCT02444234|7584088|FG000|STARTED|Second Intervention (3 Days)||6
6654309|NCT02444234|7584089|FG001|STARTED|Second Intervention (3 Days)||5
6654310|NCT02444234|7584088|FG000|COMPLETED|Second Intervention (3 Days)||6
6654311|NCT02444234|7584089|FG001|COMPLETED|Second Intervention (3 Days)||5
6448697|NCT01138657|7364509|FG001|Enrolled in Japan Sub-study|Overall Study||8
6654312|NCT02444234|7584088|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
6654313|NCT02444234|7584089|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
6654314|NCT02444533|7584099|FG000|STARTED|Overall Study||17
6654315|NCT02444533|7584100|FG001|STARTED|Overall Study||22
6654316|NCT02444533|7584099|FG000|COMPLETED|Overall Study||15
6448698|NCT01138657|7364508|FG000|COMPLETED|Overall Study||112
6448699|NCT01138657|7364509|FG001|COMPLETED|Overall Study||101
6448700|NCT01138657|7364508|FG000|NOT COMPLETED|Overall Study||8
6448701|NCT01138657|7364509|FG001|NOT COMPLETED|Overall Study||18
6448702|NCT01138735|7364519|FG000|STARTED|Overall Study||142
6448703|NCT01138735|7364520|FG001|STARTED|Overall Study||143
6448704|NCT01138735|7364519|FG000|COMPLETED|Overall Study||134
6448705|NCT01138735|7364520|FG001|COMPLETED|Overall Study||126
6448706|NCT01138735|7364519|FG000|NOT COMPLETED|Overall Study||8
6448707|NCT01138735|7364520|FG001|NOT COMPLETED|Overall Study||17
6448708|NCT01138826|7364526|FG000|STARTED|First Intervention Period||3
6448709|NCT01138826|7364527|FG001|STARTED|First Intervention Period||3
6654317|NCT02444533|7584100|FG001|COMPLETED|Overall Study||18
6654318|NCT02444533|7584099|FG000|NOT COMPLETED|Overall Study||2
6654319|NCT02444533|7584100|FG001|NOT COMPLETED|Overall Study||4
6654320|NCT02444663|7584106|FG000|STARTED|Clinician Valgus||9
6654321|NCT02444663|7584106|FG000|COMPLETED|Clinician Valgus||9
6654322|NCT02444663|7584106|FG000|NOT COMPLETED|Clinician Valgus||0
6654323|NCT02444663|7584106|FG000|STARTED|Clinician Varus||9
6654324|NCT02444663|7584106|FG000|COMPLETED|Clinician Varus||9
6654325|NCT02444663|7584106|FG000|NOT COMPLETED|Clinician Varus||0
6654326|NCT02444663|7584106|FG000|STARTED|Device Valgus 0N||9
6654327|NCT02444663|7584106|FG000|COMPLETED|Device Valgus 0N||9
6654328|NCT02444663|7584106|FG000|NOT COMPLETED|Device Valgus 0N||0
6654329|NCT02444663|7584106|FG000|STARTED|Device Valgus 10N||9
6654330|NCT02444663|7584106|FG000|COMPLETED|Device Valgus 10N||9
6654331|NCT02444663|7584106|FG000|NOT COMPLETED|Device Valgus 10N||0
6654332|NCT02444663|7584106|FG000|STARTED|Device Valgus 20N||9
6654333|NCT02444663|7584106|FG000|COMPLETED|Device Valgus 20N||9
6654334|NCT02444663|7584106|FG000|NOT COMPLETED|Device Valgus 20N||0
6654335|NCT02444663|7584106|FG000|STARTED|Device Valgus 30N||9
6654336|NCT02444663|7584106|FG000|COMPLETED|Device Valgus 30N||9
6654337|NCT02444663|7584106|FG000|NOT COMPLETED|Device Valgus 30N||0
6654338|NCT02444663|7584106|FG000|STARTED|Device Varus 0N||9
6654339|NCT02444663|7584106|FG000|COMPLETED|Device Varus 0N||9
6654340|NCT02444663|7584106|FG000|NOT COMPLETED|Device Varus 0N||0
6744426|NCT03342898|7672480|FG002|COMPLETED|Overall Study||246
6744427|NCT03342898|7672478|FG000|NOT COMPLETED|Overall Study||54
6744428|NCT03342898|7672479|FG001|NOT COMPLETED|Overall Study||53
6744429|NCT03342898|7672480|FG002|NOT COMPLETED|Overall Study||54
6744430|NCT03342963|7672492|FG000|STARTED|Overall Study||27
6744431|NCT03342963|7672493|FG001|STARTED|Overall Study||27
6744432|NCT03342963|7672494|FG002|STARTED|Overall Study||10
6744433|NCT03342963|7672495|FG003|STARTED|Overall Study||10
6744434|NCT03342963|7672492|FG000|COMPLETED|Overall Study||25
6744435|NCT03342963|7672493|FG001|COMPLETED|Overall Study||25
6744436|NCT03342963|7672494|FG002|COMPLETED|Overall Study||10
6744437|NCT03342963|7672495|FG003|COMPLETED|Overall Study||10
6744438|NCT03342963|7672492|FG000|NOT COMPLETED|Overall Study||2
6744439|NCT03342963|7672493|FG001|NOT COMPLETED|Overall Study||2
6744440|NCT03342963|7672494|FG002|NOT COMPLETED|Overall Study||0
6744441|NCT03342963|7672495|FG003|NOT COMPLETED|Overall Study||0
6744442|NCT03343067|7672508|FG000|STARTED|Open Label Period: Day 1 to Month 3||7
6744443|NCT03343067|7672509|FG001|STARTED|Open Label Period: Day 1 to Month 3||3
6744444|NCT03343067|7672510|FG002|STARTED|Open Label Period: Day 1 to Month 3||1
6744445|NCT03343067|7672508|FG000|COMPLETED|Open Label Period: Day 1 to Month 3||0
6744446|NCT03343067|7672509|FG001|COMPLETED|Open Label Period: Day 1 to Month 3||3
6744447|NCT03343067|7672510|FG002|COMPLETED|Open Label Period: Day 1 to Month 3||1
6744448|NCT03343067|7672508|FG000|NOT COMPLETED|Open Label Period: Day 1 to Month 3||7
6744449|NCT03343067|7672509|FG001|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
6744450|NCT03343067|7672510|FG002|NOT COMPLETED|Open Label Period: Day 1 to Month 3||0
6744451|NCT03343067|7672508|FG000|STARTED|Double Blind Period: Month 3 to Month 6||0
6744452|NCT03343067|7672509|FG001|STARTED|Double Blind Period: Month 3 to Month 6||3
6744453|NCT03343067|7672510|FG002|STARTED|Double Blind Period: Month 3 to Month 6||1
6744454|NCT03343067|7672508|FG000|COMPLETED|Double Blind Period: Month 3 to Month 6||0
6744455|NCT03343067|7672509|FG001|COMPLETED|Double Blind Period: Month 3 to Month 6||0
6744456|NCT03343067|7672510|FG002|COMPLETED|Double Blind Period: Month 3 to Month 6||0
6744457|NCT03343067|7672508|FG000|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||0
6744458|NCT03343067|7672509|FG001|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||3
6744459|NCT03343067|7672510|FG002|NOT COMPLETED|Double Blind Period: Month 3 to Month 6||1
6744460|NCT03343080|7672520|FG000|STARTED|Overall Study||14
6744461|NCT03343080|7672521|FG001|STARTED|Overall Study||18
6744462|NCT03343080|7672520|FG000|COMPLETED|Overall Study||14
6744463|NCT03343080|7672521|FG001|COMPLETED|Overall Study||18
6744464|NCT03343080|7672520|FG000|NOT COMPLETED|Overall Study||0
6744465|NCT03343080|7672521|FG001|NOT COMPLETED|Overall Study||0
6744466|NCT03343639|7672529|FG000|STARTED|Overall Study||102
6744467|NCT03343639|7672530|FG001|STARTED|Overall Study||102
6744468|NCT03343639|7672529|FG000|COMPLETED|Overall Study||88
6744469|NCT03343639|7672530|FG001|COMPLETED|Overall Study||90
6744470|NCT03343639|7672529|FG000|NOT COMPLETED|Overall Study||14
6448710|NCT01138826|7364528|FG002|STARTED|First Intervention Period||3
6448711|NCT01138826|7364529|FG003|STARTED|First Intervention Period||3
6654341|NCT02444663|7584106|FG000|STARTED|Device Varus 10N||9
6654342|NCT02444663|7584106|FG000|COMPLETED|Device Varus 10N||9
6654343|NCT02444663|7584106|FG000|NOT COMPLETED|Device Varus 10N||0
6744471|NCT03343639|7672530|FG001|NOT COMPLETED|Overall Study||12
6654344|NCT02444663|7584106|FG000|STARTED|Device Varus 20N||9
6448712|NCT01138826|7364530|FG004|STARTED|First Intervention Period||3
6448713|NCT01138826|7364531|FG005|STARTED|First Intervention Period||3
6448714|NCT01138826|7364526|FG000|COMPLETED|First Intervention Period||3
6448715|NCT01138826|7364527|FG001|COMPLETED|First Intervention Period||3
6448716|NCT01138826|7364528|FG002|COMPLETED|First Intervention Period||3
6448717|NCT01138826|7364529|FG003|COMPLETED|First Intervention Period||3
6448718|NCT01138826|7364530|FG004|COMPLETED|First Intervention Period||3
6448719|NCT01138826|7364531|FG005|COMPLETED|First Intervention Period||3
6448720|NCT01138826|7364526|FG000|NOT COMPLETED|First Intervention Period||0
6448721|NCT01138826|7364527|FG001|NOT COMPLETED|First Intervention Period||0
6448722|NCT01138826|7364528|FG002|NOT COMPLETED|First Intervention Period||0
6448723|NCT01138826|7364529|FG003|NOT COMPLETED|First Intervention Period||0
6448724|NCT01138826|7364530|FG004|NOT COMPLETED|First Intervention Period||0
6448725|NCT01138826|7364531|FG005|NOT COMPLETED|First Intervention Period||0
6448726|NCT01138826|7364526|FG000|STARTED|Washout Period I (of 16 Days)||3
6448727|NCT01138826|7364527|FG001|STARTED|Washout Period I (of 16 Days)||3
6448728|NCT01138826|7364528|FG002|STARTED|Washout Period I (of 16 Days)||3
6448729|NCT01138826|7364529|FG003|STARTED|Washout Period I (of 16 Days)||3
6448730|NCT01138826|7364530|FG004|STARTED|Washout Period I (of 16 Days)||3
6448731|NCT01138826|7364531|FG005|STARTED|Washout Period I (of 16 Days)||3
6448732|NCT01138826|7364526|FG000|COMPLETED|Washout Period I (of 16 Days)||2
6448733|NCT01138826|7364527|FG001|COMPLETED|Washout Period I (of 16 Days)||2
6448734|NCT01138826|7364528|FG002|COMPLETED|Washout Period I (of 16 Days)||3
6448735|NCT01138826|7364529|FG003|COMPLETED|Washout Period I (of 16 Days)||3
6448736|NCT01138826|7364530|FG004|COMPLETED|Washout Period I (of 16 Days)||2
6448737|NCT01138826|7364531|FG005|COMPLETED|Washout Period I (of 16 Days)||3
6448738|NCT01138826|7364526|FG000|NOT COMPLETED|Washout Period I (of 16 Days)||1
6448739|NCT01138826|7364527|FG001|NOT COMPLETED|Washout Period I (of 16 Days)||1
6448740|NCT01138826|7364528|FG002|NOT COMPLETED|Washout Period I (of 16 Days)||0
6448741|NCT01138826|7364529|FG003|NOT COMPLETED|Washout Period I (of 16 Days)||0
6448742|NCT01138826|7364530|FG004|NOT COMPLETED|Washout Period I (of 16 Days)||1
6448743|NCT01138826|7364531|FG005|NOT COMPLETED|Washout Period I (of 16 Days)||0
6448744|NCT01138826|7364526|FG000|STARTED|Second Intervention Period||2
6448745|NCT01138826|7364527|FG001|STARTED|Second Intervention Period||2
6448746|NCT01138826|7364528|FG002|STARTED|Second Intervention Period||3
6448747|NCT01138826|7364529|FG003|STARTED|Second Intervention Period||3
6448748|NCT01138826|7364530|FG004|STARTED|Second Intervention Period||2
6448749|NCT01138826|7364531|FG005|STARTED|Second Intervention Period||3
6448750|NCT01138826|7364526|FG000|COMPLETED|Second Intervention Period||2
6448751|NCT01138826|7364527|FG001|COMPLETED|Second Intervention Period||2
6448752|NCT01138826|7364528|FG002|COMPLETED|Second Intervention Period||3
6448753|NCT01138826|7364529|FG003|COMPLETED|Second Intervention Period||3
6744472|NCT03343704|7672538|FG000|STARTED|Overall Study||13
6744473|NCT03343704|7672539|FG001|STARTED|Overall Study||6
6744474|NCT03343704|7672538|FG000|COMPLETED|Overall Study||12
6744475|NCT03343704|7672539|FG001|COMPLETED|Overall Study||4
6744476|NCT03343704|7672538|FG000|NOT COMPLETED|Overall Study||1
6744477|NCT03343704|7672539|FG001|NOT COMPLETED|Overall Study||2
6744478|NCT03344172|7672549|FG000|STARTED|Overall Study||16
6744479|NCT03344172|7672550|FG001|STARTED|Overall Study||16
6744480|NCT03344172|7672549|FG000|COMPLETED|Overall Study||15
6744481|NCT03344172|7672550|FG001|COMPLETED|Overall Study||16
6744482|NCT03344172|7672549|FG000|NOT COMPLETED|Overall Study||1
6744483|NCT03344172|7672550|FG001|NOT COMPLETED|Overall Study||0
6744484|NCT03344510|7672556|FG000|STARTED|First Injection (5 Minutes)||21
6744485|NCT03344510|7672557|FG001|STARTED|First Injection (5 Minutes)||26
6744486|NCT03344510|7672556|FG000|Received Injection|First Injection (5 Minutes)||21
6744487|NCT03344510|7672557|FG001|Received Injection|First Injection (5 Minutes)||26
6744488|NCT03344510|7672556|FG000|COMPLETED|First Injection (5 Minutes)||21
6744489|NCT03344510|7672557|FG001|COMPLETED|First Injection (5 Minutes)||26
6744490|NCT03344510|7672556|FG000|NOT COMPLETED|First Injection (5 Minutes)||0
6744491|NCT03344510|7672557|FG001|NOT COMPLETED|First Injection (5 Minutes)||0
6744492|NCT03344510|7672556|FG000|STARTED|Wash Out (10 Minutes||21
6744493|NCT03344510|7672557|FG001|STARTED|Wash Out (10 Minutes||26
6744494|NCT03344510|7672556|FG000|COMPLETED|Wash Out (10 Minutes||21
6744495|NCT03344510|7672557|FG001|COMPLETED|Wash Out (10 Minutes||26
6744496|NCT03344510|7672556|FG000|NOT COMPLETED|Wash Out (10 Minutes||0
6744497|NCT03344510|7672557|FG001|NOT COMPLETED|Wash Out (10 Minutes||0
6744498|NCT03344510|7672556|FG000|STARTED|Second Injection (5 Minutes)||21
6744499|NCT03344510|7672557|FG001|STARTED|Second Injection (5 Minutes)||26
6744500|NCT03344510|7672556|FG000|Received Injection|Second Injection (5 Minutes)||21
6744501|NCT03344510|7672557|FG001|Received Injection|Second Injection (5 Minutes)||26
6744502|NCT03344510|7672556|FG000|COMPLETED|Second Injection (5 Minutes)||21
6744503|NCT03344510|7672557|FG001|COMPLETED|Second Injection (5 Minutes)||26
6744504|NCT03344510|7672556|FG000|NOT COMPLETED|Second Injection (5 Minutes)||0
6744505|NCT03344510|7672557|FG001|NOT COMPLETED|Second Injection (5 Minutes)||0
6744506|NCT03344640|7672566|FG000|STARTED|Overall Study||49
6744507|NCT03344640|7672567|FG001|STARTED|Overall Study||47
6744508|NCT03344640|7672566|FG000|COMPLETED|Overall Study||46
6744509|NCT03344640|7672567|FG001|COMPLETED|Overall Study||44
6744510|NCT03344640|7672566|FG000|NOT COMPLETED|Overall Study||3
6744511|NCT03344640|7672567|FG001|NOT COMPLETED|Overall Study||3
6744512|NCT03344640|7672566|FG000|STARTED|Follow-up Epoch||46
6448754|NCT01138826|7364530|FG004|COMPLETED|Second Intervention Period||2
6448755|NCT01138826|7364531|FG005|COMPLETED|Second Intervention Period||3
6448756|NCT01138826|7364526|FG000|NOT COMPLETED|Second Intervention Period||0
6448757|NCT01138826|7364527|FG001|NOT COMPLETED|Second Intervention Period||0
6448758|NCT01138826|7364528|FG002|NOT COMPLETED|Second Intervention Period||0
6448759|NCT01138826|7364529|FG003|NOT COMPLETED|Second Intervention Period||0
6448760|NCT01138826|7364530|FG004|NOT COMPLETED|Second Intervention Period||0
6448761|NCT01138826|7364531|FG005|NOT COMPLETED|Second Intervention Period||0
6448762|NCT01138826|7364526|FG000|STARTED|Washout Period II (of 16 Days)||2
6448763|NCT01138826|7364527|FG001|STARTED|Washout Period II (of 16 Days)||2
6448764|NCT01138826|7364528|FG002|STARTED|Washout Period II (of 16 Days)||3
6448765|NCT01138826|7364529|FG003|STARTED|Washout Period II (of 16 Days)||3
6448766|NCT01138826|7364530|FG004|STARTED|Washout Period II (of 16 Days)||2
6448767|NCT01138826|7364531|FG005|STARTED|Washout Period II (of 16 Days)||3
6448768|NCT01138826|7364526|FG000|COMPLETED|Washout Period II (of 16 Days)||2
6448769|NCT01138826|7364527|FG001|COMPLETED|Washout Period II (of 16 Days)||2
6448770|NCT01138826|7364528|FG002|COMPLETED|Washout Period II (of 16 Days)||3
6448771|NCT01138826|7364529|FG003|COMPLETED|Washout Period II (of 16 Days)||3
6448772|NCT01138826|7364530|FG004|COMPLETED|Washout Period II (of 16 Days)||2
6448773|NCT01138826|7364531|FG005|COMPLETED|Washout Period II (of 16 Days)||3
6448774|NCT01138826|7364526|FG000|NOT COMPLETED|Washout Period II (of 16 Days)||0
6448775|NCT01138826|7364527|FG001|NOT COMPLETED|Washout Period II (of 16 Days)||0
6448776|NCT01138826|7364528|FG002|NOT COMPLETED|Washout Period II (of 16 Days)||0
6448777|NCT01138826|7364529|FG003|NOT COMPLETED|Washout Period II (of 16 Days)||0
6448778|NCT01138826|7364530|FG004|NOT COMPLETED|Washout Period II (of 16 Days)||0
6448779|NCT01138826|7364531|FG005|NOT COMPLETED|Washout Period II (of 16 Days)||0
6448780|NCT01138826|7364526|FG000|STARTED|Third Intervention Period||2
6448781|NCT01138826|7364527|FG001|STARTED|Third Intervention Period||2
6448782|NCT01138826|7364528|FG002|STARTED|Third Intervention Period||3
6744513|NCT03344640|7672567|FG001|STARTED|Follow-up Epoch||44
6744514|NCT03344640|7672566|FG000|COMPLETED|Follow-up Epoch||46
6744515|NCT03344640|7672567|FG001|COMPLETED|Follow-up Epoch||42
6744516|NCT03344640|7672566|FG000|NOT COMPLETED|Follow-up Epoch||0
6744517|NCT03344640|7672567|FG001|NOT COMPLETED|Follow-up Epoch||2
6744518|NCT03344861|7672573|FG000|STARTED|Overall Study||10
6744519|NCT03344861|7672573|FG000|COMPLETED|Overall Study||10
6744520|NCT03344861|7672573|FG000|NOT COMPLETED|Overall Study||0
6744521|NCT03345108|7672577|FG000|STARTED|Period-1||8
6744522|NCT03345108|7672578|FG001|STARTED|Period-1||8
6744523|NCT03345108|7672579|FG002|STARTED|Period-1||8
6744524|NCT03345108|7672580|FG003|STARTED|Period-1||8
6744525|NCT03345108|7672581|FG004|STARTED|Period-1||8
6744526|NCT03345108|7672582|FG005|STARTED|Period-1||8
6744527|NCT03345108|7672577|FG000|COMPLETED|Period-1||8
6744528|NCT03345108|7672578|FG001|COMPLETED|Period-1||8
6744529|NCT03345108|7672579|FG002|COMPLETED|Period-1||8
6744530|NCT03345108|7672580|FG003|COMPLETED|Period-1||8
6744531|NCT03345108|7672581|FG004|COMPLETED|Period-1||8
6744532|NCT03345108|7672582|FG005|COMPLETED|Period-1||8
6744533|NCT03345108|7672577|FG000|NOT COMPLETED|Period-1||0
6744534|NCT03345108|7672578|FG001|NOT COMPLETED|Period-1||0
6744535|NCT03345108|7672579|FG002|NOT COMPLETED|Period-1||0
6744536|NCT03345108|7672580|FG003|NOT COMPLETED|Period-1||0
6744537|NCT03345108|7672581|FG004|NOT COMPLETED|Period-1||0
6744538|NCT03345108|7672582|FG005|NOT COMPLETED|Period-1||0
6744539|NCT03345108|7672577|FG000|STARTED|Period-2||8
6744540|NCT03345108|7672578|FG001|STARTED|Period-2||8
6744541|NCT03345108|7672579|FG002|STARTED|Period-2||8
6744542|NCT03345108|7672580|FG003|STARTED|Period-2||8
6744543|NCT03345108|7672581|FG004|STARTED|Period-2||8
6744544|NCT03345108|7672582|FG005|STARTED|Period-2||8
6744545|NCT03345108|7672577|FG000|COMPLETED|Period-2||8
6744546|NCT03345108|7672578|FG001|COMPLETED|Period-2||8
6744547|NCT03345108|7672579|FG002|COMPLETED|Period-2||8
6744548|NCT03345108|7672580|FG003|COMPLETED|Period-2||8
6744549|NCT03345108|7672581|FG004|COMPLETED|Period-2||8
6744550|NCT03345108|7672582|FG005|COMPLETED|Period-2||8
6744551|NCT03345108|7672577|FG000|NOT COMPLETED|Period-2||0
6744552|NCT03345108|7672578|FG001|NOT COMPLETED|Period-2||0
6744553|NCT03345108|7672579|FG002|NOT COMPLETED|Period-2||0
6744554|NCT03345108|7672580|FG003|NOT COMPLETED|Period-2||0
6744555|NCT03345108|7672581|FG004|NOT COMPLETED|Period-2||0
6744556|NCT03345108|7672582|FG005|NOT COMPLETED|Period-2||0
6744557|NCT03345108|7672577|FG000|STARTED|Period-3||7
6744558|NCT03345108|7672578|FG001|STARTED|Period-3||8
6744559|NCT03345108|7672579|FG002|STARTED|Period-3||8
6744560|NCT03345108|7672580|FG003|STARTED|Period-3||8
6744561|NCT03345108|7672581|FG004|STARTED|Period-3||8
6744562|NCT03345108|7672582|FG005|STARTED|Period-3||8
6744563|NCT03345108|7672577|FG000|COMPLETED|Period-3||7
6744564|NCT03345108|7672578|FG001|COMPLETED|Period-3||8
6744565|NCT03345108|7672579|FG002|COMPLETED|Period-3||8
6744566|NCT03345108|7672580|FG003|COMPLETED|Period-3||8
6744567|NCT03345108|7672581|FG004|COMPLETED|Period-3||8
6744568|NCT03345108|7672582|FG005|COMPLETED|Period-3||8
6744569|NCT03345108|7672577|FG000|NOT COMPLETED|Period-3||0
6744570|NCT03345108|7672578|FG001|NOT COMPLETED|Period-3||0
6744571|NCT03345108|7672579|FG002|NOT COMPLETED|Period-3||0
6744572|NCT03345108|7672580|FG003|NOT COMPLETED|Period-3||0
6744573|NCT03345108|7672581|FG004|NOT COMPLETED|Period-3||0
6744574|NCT03345108|7672582|FG005|NOT COMPLETED|Period-3||0
6744575|NCT03345160|7672590|FG000|STARTED|Overall Study||7
6448783|NCT01138826|7364529|FG003|STARTED|Third Intervention Period||3
6448784|NCT01138826|7364530|FG004|STARTED|Third Intervention Period||2
6448785|NCT01138826|7364531|FG005|STARTED|Third Intervention Period||3
6448786|NCT01138826|7364526|FG000|COMPLETED|Third Intervention Period||2
6448787|NCT01138826|7364527|FG001|COMPLETED|Third Intervention Period||2
6448788|NCT01138826|7364528|FG002|COMPLETED|Third Intervention Period||3
6448789|NCT01138826|7364529|FG003|COMPLETED|Third Intervention Period||3
6448790|NCT01138826|7364530|FG004|COMPLETED|Third Intervention Period||2
6448791|NCT01138826|7364531|FG005|COMPLETED|Third Intervention Period||3
6448792|NCT01138826|7364526|FG000|NOT COMPLETED|Third Intervention Period||0
6448793|NCT01138826|7364527|FG001|NOT COMPLETED|Third Intervention Period||0
6448794|NCT01138826|7364528|FG002|NOT COMPLETED|Third Intervention Period||0
6448795|NCT01138826|7364529|FG003|NOT COMPLETED|Third Intervention Period||0
6744576|NCT03345160|7672590|FG000|COMPLETED|Overall Study||7
6744577|NCT03345160|7672590|FG000|NOT COMPLETED|Overall Study||0
6744578|NCT03345394|7672596|FG000|STARTED|Overall Study||48
6744579|NCT03345394|7672597|FG001|STARTED|Overall Study||50
6744580|NCT03345394|7672596|FG000|COMPLETED|Overall Study||48
6744581|NCT03345394|7672597|FG001|COMPLETED|Overall Study||50
6744582|NCT03345394|7672596|FG000|NOT COMPLETED|Overall Study||0
6744583|NCT03345394|7672597|FG001|NOT COMPLETED|Overall Study||0
6744584|NCT03345407|7672610|FG000|STARTED|Overall Study||276
6744585|NCT03345407|7672611|FG001|STARTED|Overall Study||22
6744586|NCT03345407|7672612|FG002|STARTED|Overall Study||91
6744587|NCT03345407|7672613|FG003|STARTED|Overall Study||92
6744588|NCT03345407|7672614|FG004|STARTED|Overall Study||90
6744589|NCT03345407|7672615|FG005|STARTED|Overall Study||89
6744590|NCT03345407|7672616|FG006|STARTED|Overall Study||278
6744591|NCT03345407|7672610|FG000|COMPLETED|Overall Study||244
6744592|NCT03345407|7672611|FG001|COMPLETED|Overall Study||19
6744593|NCT03345407|7672612|FG002|COMPLETED|Overall Study||79
6744594|NCT03345407|7672613|FG003|COMPLETED|Overall Study||81
6744595|NCT03345407|7672614|FG004|COMPLETED|Overall Study||75
6744596|NCT03345407|7672615|FG005|COMPLETED|Overall Study||73
6744597|NCT03345407|7672616|FG006|COMPLETED|Overall Study||233
6744598|NCT03345407|7672610|FG000|NOT COMPLETED|Overall Study||32
6744599|NCT03345407|7672611|FG001|NOT COMPLETED|Overall Study||3
6744600|NCT03345407|7672612|FG002|NOT COMPLETED|Overall Study||12
6744601|NCT03345407|7672613|FG003|NOT COMPLETED|Overall Study||11
6744602|NCT03345407|7672614|FG004|NOT COMPLETED|Overall Study||15
6744603|NCT03345407|7672615|FG005|NOT COMPLETED|Overall Study||16
6744604|NCT03345407|7672616|FG006|NOT COMPLETED|Overall Study||45
6744605|NCT03345472|7672638|FG000|STARTED|Implant to 3 Months||103
6744606|NCT03345472|7672638|FG000|COMPLETED|Implant to 3 Months||99
6744607|NCT03345472|7672638|FG000|NOT COMPLETED|Implant to 3 Months||4
6744608|NCT03345472|7672638|FG000|STARTED|3 Months to 12 Months||99
6744609|NCT03345472|7672638|FG000|COMPLETED|3 Months to 12 Months||91
6744610|NCT03345472|7672638|FG000|NOT COMPLETED|3 Months to 12 Months||8
6744611|NCT03345914|7672645|FG000|STARTED|Overall Study||123
6744612|NCT03345914|7672646|FG001|STARTED|Overall Study||122
6744613|NCT03345914|7672647|FG002|STARTED|Overall Study||122
6744614|NCT03345914|7672645|FG000|Completed Week 16 Study Treatment|Overall Study||114
6744615|NCT03345914|7672646|FG001|Completed Week 16 Study Treatment|Overall Study||118
6744616|NCT03345914|7672647|FG002|Completed Week 16 Study Treatment|Overall Study||119
6744617|NCT03345914|7672645|FG000|Completed Week 28 End of Study|Overall Study||0
6744618|NCT03345914|7672646|FG001|Completed Week 28 End of Study|Overall Study||0
6744619|NCT03345914|7672647|FG002|Completed Week 28 End of Study|Overall Study||0
6744620|NCT03345914|7672645|FG000|COMPLETED|Overall Study||0
6744621|NCT03345914|7672646|FG001|COMPLETED|Overall Study||0
6744622|NCT03345914|7672647|FG002|COMPLETED|Overall Study||0
6744623|NCT03345914|7672645|FG000|NOT COMPLETED|Overall Study||123
6744624|NCT03345914|7672646|FG001|NOT COMPLETED|Overall Study||122
6744625|NCT03345914|7672647|FG002|NOT COMPLETED|Overall Study||122
6744626|NCT03345979|7672657|FG000|STARTED|Overall Study||99
6744627|NCT03345979|7672658|FG001|STARTED|Overall Study||101
6744628|NCT03345979|7672657|FG000|COMPLETED|Overall Study||56
6744629|NCT03345979|7672658|FG001|COMPLETED|Overall Study||43
6744630|NCT03345979|7672657|FG000|NOT COMPLETED|Overall Study||43
6744631|NCT03345979|7672658|FG001|NOT COMPLETED|Overall Study||58
6744632|NCT03346057|7672668|FG000|STARTED|Overall Study||111
6744633|NCT03346057|7672669|FG001|STARTED|Overall Study||112
6744634|NCT03346057|7672670|FG002|STARTED|Overall Study||68
6744635|NCT03346057|7672671|FG003|STARTED|Overall Study||53
6744636|NCT03346057|7672668|FG000|Treated|Overall Study||105
6744637|NCT03346057|7672669|FG001|Treated|Overall Study||107
6744638|NCT03346057|7672670|FG002|Treated|Overall Study||68
6744639|NCT03346057|7672671|FG003|Treated|Overall Study||51
6744640|NCT03346057|7672668|FG000|COMPLETED|Overall Study||104
6448796|NCT01138826|7364530|FG004|NOT COMPLETED|Third Intervention Period||0
6448797|NCT01138826|7364531|FG005|NOT COMPLETED|Third Intervention Period||0
6448798|NCT01138917|7364539|FG000|STARTED|Overall Study||101
6744641|NCT03346057|7672669|FG001|COMPLETED|Overall Study||104
6744642|NCT03346057|7672670|FG002|COMPLETED|Overall Study||67
6744643|NCT03346057|7672671|FG003|COMPLETED|Overall Study||51
6744644|NCT03346057|7672668|FG000|NOT COMPLETED|Overall Study||7
6744645|NCT03346057|7672669|FG001|NOT COMPLETED|Overall Study||8
6744646|NCT03346057|7672670|FG002|NOT COMPLETED|Overall Study||1
6744647|NCT03346057|7672671|FG003|NOT COMPLETED|Overall Study||2
6744648|NCT03346070|7672686|FG000|STARTED|Overall Study||41
6744649|NCT03346070|7672687|FG001|STARTED|Overall Study||41
6448799|NCT01138917|7364539|FG000|COMPLETED|Overall Study||77
6448800|NCT01138917|7364539|FG000|NOT COMPLETED|Overall Study||24
6448801|NCT01138969|7364549|FG000|STARTED|Overall Study||83
6448802|NCT01138969|7364550|FG001|STARTED|Overall Study||82
6448803|NCT01138969|7364549|FG000|COMPLETED|Overall Study||83
6448804|NCT01138969|7364550|FG001|COMPLETED|Overall Study||82
6448805|NCT01138969|7364549|FG000|NOT COMPLETED|Overall Study||0
6448806|NCT01138969|7364550|FG001|NOT COMPLETED|Overall Study||0
6448807|NCT01138995|7364558|FG000|STARTED|Overall Study||98
6448808|NCT01138995|7364559|FG001|STARTED|Overall Study||99
6448809|NCT01138995|7364558|FG000|COMPLETED|Overall Study||88
6448810|NCT01138995|7364559|FG001|COMPLETED|Overall Study||74
6448811|NCT01138995|7364558|FG000|NOT COMPLETED|Overall Study||10
6448812|NCT01138995|7364559|FG001|NOT COMPLETED|Overall Study||25
6448813|NCT01139008|7364566|FG000|STARTED|Overall Study||80
6448814|NCT01139008|7364566|FG000|COMPLETED|Overall Study||74
6448815|NCT01139008|7364566|FG000|NOT COMPLETED|Overall Study||6
6448816|NCT01139021|7364579|FG000|STARTED|Overall Study||152
6448817|NCT01139021|7364580|FG001|STARTED|Overall Study||153
6448818|NCT01139021|7364581|FG002|STARTED|Overall Study||67
6448819|NCT01139021|7364582|FG003|STARTED|Overall Study||19
6448820|NCT01139021|7364583|FG004|STARTED|Overall Study||116
6448821|NCT01139021|7364584|FG005|STARTED|Overall Study||1
6448822|NCT01139021|7364579|FG000|COMPLETED|Overall Study||151
6448823|NCT01139021|7364580|FG001|COMPLETED|Overall Study||153
6448824|NCT01139021|7364581|FG002|COMPLETED|Overall Study||67
6448825|NCT01139021|7364582|FG003|COMPLETED|Overall Study||18
6448826|NCT01139021|7364583|FG004|COMPLETED|Overall Study||107
6448827|NCT01139021|7364584|FG005|COMPLETED|Overall Study||1
6448828|NCT01139021|7364579|FG000|NOT COMPLETED|Overall Study||1
6448829|NCT01139021|7364580|FG001|NOT COMPLETED|Overall Study||0
6553327|NCT01743027|7475842|FG003|NOT COMPLETED|Overall Study||1
6553328|NCT01743040|7475852|FG000|STARTED|Overall Study||1014
6553329|NCT01743040|7475852|FG000|CADence Testing|Overall Study||1013
6553330|NCT01743040|7475852|FG000|Nuclear Stress Test|Overall Study||992
6553331|NCT01743040|7475852|FG000|CT and/or Standard Angiogram|Overall Study||785
6553332|NCT01743040|7475852|FG000|COMPLETED|Overall Study||785
6553333|NCT01743040|7475852|FG000|NOT COMPLETED|Overall Study||229
6553334|NCT01743092|7475858|FG000|STARTED|Overall Study||33
6553335|NCT01743092|7475859|FG001|STARTED|Overall Study||26
6553336|NCT01743092|7475858|FG000|COMPLETED|Overall Study||19
6553337|NCT01743092|7475859|FG001|COMPLETED|Overall Study||11
6553338|NCT01743092|7475858|FG000|NOT COMPLETED|Overall Study||14
6553339|NCT01743092|7475859|FG001|NOT COMPLETED|Overall Study||15
6553340|NCT01743131|7475869|FG000|STARTED|Overall Study||73
6553341|NCT01743131|7475870|FG001|STARTED|Overall Study||69
6553342|NCT01743131|7475871|FG002|STARTED|Overall Study||43
6553343|NCT01743131|7475872|FG003|STARTED|Overall Study||1
6553344|NCT01743131|7475873|FG004|STARTED|Overall Study||127
6553345|NCT01743131|7475869|FG000|Not Included in Analysis|Overall Study||0
6553346|NCT01743131|7475870|FG001|Not Included in Analysis|Overall Study||0
6553347|NCT01743131|7475871|FG002|Not Included in Analysis|Overall Study||0
6553348|NCT01743131|7475872|FG003|Not Included in Analysis|Overall Study||1
6448830|NCT01139021|7364581|FG002|NOT COMPLETED|Overall Study||0
6448831|NCT01139021|7364582|FG003|NOT COMPLETED|Overall Study||1
6448832|NCT01139021|7364583|FG004|NOT COMPLETED|Overall Study||9
6448833|NCT01139021|7364584|FG005|NOT COMPLETED|Overall Study||0
6448834|NCT01139047|7364599|FG000|STARTED|Overall Study||77
6448835|NCT01139047|7364599|FG000|COMPLETED|Overall Study||76
6448836|NCT01139047|7364599|FG000|NOT COMPLETED|Overall Study||1
6448837|NCT01139164|7364609|FG000|STARTED|Overall Study||4
6448838|NCT01139164|7364610|FG001|STARTED|Overall Study||67
6448839|NCT01139164|7364611|FG002|STARTED|Overall Study||7
6448840|NCT01139164|7364609|FG000|COMPLETED|Overall Study||4
6448841|NCT01139164|7364610|FG001|COMPLETED|Overall Study||65
6448842|NCT01139164|7364611|FG002|COMPLETED|Overall Study||7
6448843|NCT01139164|7364609|FG000|NOT COMPLETED|Overall Study||0
6448844|NCT01139164|7364610|FG001|NOT COMPLETED|Overall Study||2
6448845|NCT01139164|7364611|FG002|NOT COMPLETED|Overall Study||0
6448846|NCT01139190|7364621|FG000|STARTED|Overall Study||38
6448847|NCT01139190|7364622|FG001|STARTED|Overall Study||39
6448848|NCT01139190|7364621|FG000|COMPLETED|Overall Study||38
6448849|NCT01139190|7364622|FG001|COMPLETED|Overall Study||38
6448850|NCT01139190|7364621|FG000|NOT COMPLETED|Overall Study||0
6448851|NCT01139190|7364622|FG001|NOT COMPLETED|Overall Study||1
6448852|NCT01139411|7364630|FG000|STARTED|Overall Study||26
6553349|NCT01743131|7475873|FG004|Not Included in Analysis|Overall Study||0
6553350|NCT01743131|7475869|FG000|COMPLETED|Overall Study||73
6553351|NCT01743131|7475870|FG001|COMPLETED|Overall Study||69
6448853|NCT01139411|7364631|FG001|STARTED|Overall Study||23
6448854|NCT01139411|7364630|FG000|COMPLETED|Overall Study||24
6448855|NCT01139411|7364631|FG001|COMPLETED|Overall Study||19
6448856|NCT01139411|7364630|FG000|NOT COMPLETED|Overall Study||2
6448857|NCT01139411|7364631|FG001|NOT COMPLETED|Overall Study||4
6448858|NCT01139450|7364642|FG000|STARTED|Overall Study||302
6448859|NCT01139450|7364643|FG001|STARTED|Overall Study||297
6448860|NCT01139450|7364644|FG002|STARTED|Overall Study||300
6448861|NCT01139450|7364642|FG000|COMPLETED|Overall Study||275
6448862|NCT01139450|7364643|FG001|COMPLETED|Overall Study||272
6448863|NCT01139450|7364644|FG002|COMPLETED|Overall Study||262
6448864|NCT01139450|7364642|FG000|NOT COMPLETED|Overall Study||27
6448865|NCT01139450|7364643|FG001|NOT COMPLETED|Overall Study||25
6744650|NCT03346070|7672688|FG002|STARTED|Overall Study||41
6744651|NCT03346070|7672689|FG003|STARTED|Overall Study||42
6744652|NCT03346070|7672690|FG004|STARTED|Overall Study||42
6744653|NCT03346070|7672686|FG000|Treated|Overall Study||38
6448866|NCT01139450|7364644|FG002|NOT COMPLETED|Overall Study||38
6448867|NCT01139515|7364652|FG000|STARTED|First Intervention Period||4
6448868|NCT01139515|7364653|FG001|STARTED|First Intervention Period||4
6448869|NCT01139515|7364654|FG002|STARTED|First Intervention Period||4
6448870|NCT01139515|7364655|FG003|STARTED|First Intervention Period||4
6448871|NCT01139515|7364652|FG000|COMPLETED|First Intervention Period||4
6448872|NCT01139515|7364653|FG001|COMPLETED|First Intervention Period||4
6448873|NCT01139515|7364654|FG002|COMPLETED|First Intervention Period||4
6448874|NCT01139515|7364655|FG003|COMPLETED|First Intervention Period||4
6744654|NCT03346070|7672687|FG001|Treated|Overall Study||38
6744655|NCT03346070|7672688|FG002|Treated|Overall Study||38
6744656|NCT03346070|7672689|FG003|Treated|Overall Study||36
6744657|NCT03346070|7672690|FG004|Treated|Overall Study||38
6744658|NCT03346070|7672686|FG000|COMPLETED|Overall Study||38
6744659|NCT03346070|7672687|FG001|COMPLETED|Overall Study||37
6744660|NCT03346070|7672688|FG002|COMPLETED|Overall Study||37
6744661|NCT03346070|7672689|FG003|COMPLETED|Overall Study||36
6744662|NCT03346070|7672690|FG004|COMPLETED|Overall Study||37
6744663|NCT03346070|7672686|FG000|NOT COMPLETED|Overall Study||3
6744664|NCT03346070|7672687|FG001|NOT COMPLETED|Overall Study||4
6744665|NCT03346070|7672688|FG002|NOT COMPLETED|Overall Study||4
6744666|NCT03346070|7672689|FG003|NOT COMPLETED|Overall Study||6
6744667|NCT03346070|7672690|FG004|NOT COMPLETED|Overall Study||5
6744668|NCT03346161|7672706|FG000|STARTED|Overall Study||60
6744669|NCT03346161|7672707|FG001|STARTED|Overall Study||60
6744670|NCT03346161|7672706|FG000|COMPLETED|Overall Study||60
6744671|NCT03346161|7672707|FG001|COMPLETED|Overall Study||60
6744672|NCT03346161|7672706|FG000|NOT COMPLETED|Overall Study||0
6744673|NCT03346161|7672707|FG001|NOT COMPLETED|Overall Study||0
6744674|NCT03346759|7672715|FG000|STARTED|Enrollment to Baseline Data Collected||15
6744675|NCT03346759|7672716|FG001|STARTED|Enrollment to Baseline Data Collected||13
6744676|NCT03346759|7672715|FG000|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon A First arm who provided at least one vaginal microbiota sample.|13
6744677|NCT03346759|7672716|FG001|COMPLETED|Enrollment to Baseline Data Collected|Participants assigned to the Tampon B First arm who provided at least one vaginal microbiota sample.|10
6744678|NCT03346759|7672715|FG000|NOT COMPLETED|Enrollment to Baseline Data Collected||2
6744679|NCT03346759|7672716|FG001|NOT COMPLETED|Enrollment to Baseline Data Collected||3
6744680|NCT03346759|7672715|FG000|STARTED|First Menstrual Cycle||13
6744681|NCT03346759|7672716|FG001|STARTED|First Menstrual Cycle||10
6744682|NCT03346759|7672715|FG000|COMPLETED|First Menstrual Cycle||12
6744683|NCT03346759|7672716|FG001|COMPLETED|First Menstrual Cycle||10
6744684|NCT03346759|7672715|FG000|NOT COMPLETED|First Menstrual Cycle||1
6744685|NCT03346759|7672716|FG001|NOT COMPLETED|First Menstrual Cycle||0
6744686|NCT03346759|7672715|FG000|STARTED|Second Menstrual Cycle||12
6744687|NCT03346759|7672716|FG001|STARTED|Second Menstrual Cycle||10
6744688|NCT03346759|7672715|FG000|COMPLETED|Second Menstrual Cycle||11
6744689|NCT03346759|7672716|FG001|COMPLETED|Second Menstrual Cycle||10
6744690|NCT03346759|7672715|FG000|NOT COMPLETED|Second Menstrual Cycle||1
6744691|NCT03346759|7672716|FG001|NOT COMPLETED|Second Menstrual Cycle||0
6744692|NCT03346759|7672715|FG000|STARTED|Third Menstrual Cycle||11
6744693|NCT03346759|7672716|FG001|STARTED|Third Menstrual Cycle||10
6744694|NCT03346759|7672715|FG000|COMPLETED|Third Menstrual Cycle||11
6744695|NCT03346759|7672716|FG001|COMPLETED|Third Menstrual Cycle||10
6744696|NCT03346759|7672715|FG000|NOT COMPLETED|Third Menstrual Cycle||0
6744697|NCT03346759|7672716|FG001|NOT COMPLETED|Third Menstrual Cycle||0
6744698|NCT03346850|7672725|FG000|STARTED|Overall Study||20
6744699|NCT03346850|7672726|FG001|STARTED|Overall Study||20
6744700|NCT03346850|7672725|FG000|COMPLETED|Overall Study||18
6744701|NCT03346850|7672726|FG001|COMPLETED|Overall Study||17
6744702|NCT03346850|7672725|FG000|NOT COMPLETED|Overall Study||2
6744703|NCT03346850|7672726|FG001|NOT COMPLETED|Overall Study||3
6744704|NCT03346902|7672734|FG000|STARTED|Overall Study||4
6744705|NCT03346902|7672735|FG001|STARTED|Overall Study||8
6744706|NCT03346902|7672734|FG000|COMPLETED|Overall Study||4
6744707|NCT03346902|7672735|FG001|COMPLETED|Overall Study||8
6744708|NCT03346902|7672734|FG000|NOT COMPLETED|Overall Study||0
6744709|NCT03346902|7672735|FG001|NOT COMPLETED|Overall Study||0
6744710|NCT03347188|7672743|FG000|STARTED|Double-blind (DB) Period (12 Weeks)||44
6744711|NCT03347188|7672744|FG001|STARTED|Double-blind (DB) Period (12 Weeks)||43
6744712|NCT03347188|7672743|FG000|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
6744713|NCT03347188|7672744|FG001|Received at Least 1 Dose of Study Drug|Double-blind (DB) Period (12 Weeks)||43
6744714|NCT03347188|7672743|FG000|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||42
6744715|NCT03347188|7672744|FG001|Full Analysis Set (FAS)|Double-blind (DB) Period (12 Weeks)||43
6744716|NCT03347188|7672743|FG000|COMPLETED|Double-blind (DB) Period (12 Weeks)||29
6448875|NCT01139515|7364652|FG000|NOT COMPLETED|First Intervention Period||0
6448876|NCT01139515|7364653|FG001|NOT COMPLETED|First Intervention Period||0
6744717|NCT03347188|7672744|FG001|COMPLETED|Double-blind (DB) Period (12 Weeks)||26
6744718|NCT03347188|7672743|FG000|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||15
6744719|NCT03347188|7672744|FG001|NOT COMPLETED|Double-blind (DB) Period (12 Weeks)||17
6744720|NCT03347188|7672743|FG000|STARTED|Open-label (OL) Period (12 Weeks)||35
6744721|NCT03347188|7672744|FG001|STARTED|Open-label (OL) Period (12 Weeks)||35
6448877|NCT01139515|7364654|FG002|NOT COMPLETED|First Intervention Period||0
6448878|NCT01139515|7364655|FG003|NOT COMPLETED|First Intervention Period||0
6448879|NCT01139515|7364652|FG000|STARTED|Washout Period I (46hrs)||4
6448880|NCT01139515|7364653|FG001|STARTED|Washout Period I (46hrs)||4
6448881|NCT01139515|7364654|FG002|STARTED|Washout Period I (46hrs)||4
6448882|NCT01139515|7364655|FG003|STARTED|Washout Period I (46hrs)||4
6448883|NCT01139515|7364652|FG000|COMPLETED|Washout Period I (46hrs)||4
6448884|NCT01139515|7364653|FG001|COMPLETED|Washout Period I (46hrs)||4
6448885|NCT01139515|7364654|FG002|COMPLETED|Washout Period I (46hrs)||4
6448886|NCT01139515|7364655|FG003|COMPLETED|Washout Period I (46hrs)||4
6448887|NCT01139515|7364652|FG000|NOT COMPLETED|Washout Period I (46hrs)||0
6448888|NCT01139515|7364653|FG001|NOT COMPLETED|Washout Period I (46hrs)||0
6448889|NCT01139515|7364654|FG002|NOT COMPLETED|Washout Period I (46hrs)||0
6448890|NCT01139515|7364655|FG003|NOT COMPLETED|Washout Period I (46hrs)||0
6744722|NCT03347188|7672743|FG000|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||26
6744723|NCT03347188|7672744|FG001|Entered in OL Period for Anti-drug Antibody (ADA) Only|Open-label (OL) Period (12 Weeks)||28
6744724|NCT03347188|7672743|FG000|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||9
6744725|NCT03347188|7672744|FG001|Received at Least 1 Dose of Study Drug|Open-label (OL) Period (12 Weeks)||7
6744726|NCT03347188|7672743|FG000|COMPLETED|Open-label (OL) Period (12 Weeks)||8
6744727|NCT03347188|7672744|FG001|COMPLETED|Open-label (OL) Period (12 Weeks)||6
6744728|NCT03347188|7672743|FG000|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||27
6744729|NCT03347188|7672744|FG001|NOT COMPLETED|Open-label (OL) Period (12 Weeks)||29
6744730|NCT03347279|7672752|FG000|STARTED|Overall Study||529
6744731|NCT03347279|7672753|FG001|STARTED|Overall Study||532
6744732|NCT03347279|7672752|FG000|Received Treatment|Overall Study||528
6744733|NCT03347279|7672753|FG001|Received Treatment|Overall Study||531
6744734|NCT03347279|7672752|FG000|COMPLETED|Overall Study||513
6744735|NCT03347279|7672753|FG001|COMPLETED|Overall Study||509
6744736|NCT03347279|7672752|FG000|NOT COMPLETED|Overall Study||16
6744737|NCT03347279|7672753|FG001|NOT COMPLETED|Overall Study||23
6744738|NCT03347695|7672761|FG000|STARTED|Overall Study||20
6744739|NCT03347695|7672762|FG001|STARTED|Overall Study||120
6744740|NCT03347695|7672761|FG000|COMPLETED|Overall Study||20
6744741|NCT03347695|7672762|FG001|COMPLETED|Overall Study||115
6744742|NCT03347695|7672761|FG000|NOT COMPLETED|Overall Study||0
6744743|NCT03347695|7672762|FG001|NOT COMPLETED|Overall Study||5
6744744|NCT03348683|7672772|FG000|STARTED|Overall Study||121
6744745|NCT03348683|7672773|FG001|STARTED|Overall Study||119
6744746|NCT03348683|7672772|FG000|COMPLETED|Overall Study||121
6744747|NCT03348683|7672773|FG001|COMPLETED|Overall Study||119
6744748|NCT03348683|7672772|FG000|NOT COMPLETED|Overall Study||0
6744749|NCT03348683|7672773|FG001|NOT COMPLETED|Overall Study||0
6744750|NCT03349034|7672781|FG000|STARTED|Overall Study||12
6744751|NCT03349034|7672782|FG001|STARTED|Overall Study||12
6744752|NCT03349034|7672781|FG000|COMPLETED|Overall Study||8
6744753|NCT03349034|7672782|FG001|COMPLETED|Overall Study||10
6744754|NCT03349034|7672781|FG000|NOT COMPLETED|Overall Study||4
6744755|NCT03349034|7672782|FG001|NOT COMPLETED|Overall Study||2
6744756|NCT03349060|7672793|FG000|STARTED|Overall Study||156
6744757|NCT03349060|7672794|FG001|STARTED|Overall Study||154
6744758|NCT03349060|7672795|FG002|STARTED|Overall Study||77
6744759|NCT03349060|7672793|FG000|COMPLETED|Overall Study||135
6744760|NCT03349060|7672794|FG001|COMPLETED|Overall Study||137
6744761|NCT03349060|7672795|FG002|COMPLETED|Overall Study||61
6744762|NCT03349060|7672793|FG000|NOT COMPLETED|Overall Study||21
6744763|NCT03349060|7672794|FG001|NOT COMPLETED|Overall Study||17
6744764|NCT03349060|7672795|FG002|NOT COMPLETED|Overall Study||16
6744765|NCT03349099|7672805|FG000|STARTED|Overall Study||48
6744766|NCT03349099|7672806|FG001|STARTED|Overall Study||47
6744767|NCT03349099|7672805|FG000|COMPLETED|Overall Study||44
6744768|NCT03349099|7672806|FG001|COMPLETED|Overall Study||43
6744769|NCT03349099|7672805|FG000|NOT COMPLETED|Overall Study||4
6744770|NCT03349099|7672806|FG001|NOT COMPLETED|Overall Study||4
6744771|NCT03349333|7672812|FG000|STARTED|Overall Study||71
6744772|NCT03349333|7672812|FG000|COMPLETED|Overall Study||0
6744773|NCT03349333|7672812|FG000|NOT COMPLETED|Overall Study||71
6744774|NCT03349437|7672816|FG000|STARTED|Screening||25
6744775|NCT03349437|7672817|FG001|STARTED|Screening||0
6744776|NCT03349437|7672818|FG002|STARTED|Screening||0
6744777|NCT03349437|7672816|FG000|COMPLETED|Screening||20
6744778|NCT03349437|7672817|FG001|COMPLETED|Screening||0
6744779|NCT03349437|7672818|FG002|COMPLETED|Screening||0
6744780|NCT03349437|7672816|FG000|NOT COMPLETED|Screening||5
6744781|NCT03349437|7672817|FG001|NOT COMPLETED|Screening||0
6744782|NCT03349437|7672818|FG002|NOT COMPLETED|Screening||0
6744783|NCT03349437|7672816|FG000|STARTED|Intervention||0
6744784|NCT03349437|7672817|FG001|STARTED|Intervention||10
6744785|NCT03349437|7672818|FG002|STARTED|Intervention||10
6744786|NCT03349437|7672816|FG000|COMPLETED|Intervention||0
6744787|NCT03349437|7672817|FG001|COMPLETED|Intervention||10
6744788|NCT03349437|7672818|FG002|COMPLETED|Intervention||10
6744789|NCT03349437|7672816|FG000|NOT COMPLETED|Intervention||0
6448891|NCT01139515|7364652|FG000|STARTED|Second Intervention Period||4
6448892|NCT01139515|7364653|FG001|STARTED|Second Intervention Period||4
6744790|NCT03349437|7672817|FG001|NOT COMPLETED|Intervention||0
6744791|NCT03349437|7672818|FG002|NOT COMPLETED|Intervention||0
6744792|NCT03349515|7672827|FG000|STARTED|Overall Study||55
6744793|NCT03349515|7672828|FG001|STARTED|Overall Study||51
6744794|NCT03349515|7672827|FG000|COMPLETED|Overall Study||50
6448893|NCT01139515|7364654|FG002|STARTED|Second Intervention Period||4
6448894|NCT01139515|7364655|FG003|STARTED|Second Intervention Period||4
6448895|NCT01139515|7364652|FG000|COMPLETED|Second Intervention Period||4
6448896|NCT01139515|7364653|FG001|COMPLETED|Second Intervention Period||4
6448897|NCT01139515|7364654|FG002|COMPLETED|Second Intervention Period||4
6448898|NCT01139515|7364655|FG003|COMPLETED|Second Intervention Period||4
6448899|NCT01139515|7364652|FG000|NOT COMPLETED|Second Intervention Period||0
6448900|NCT01139515|7364653|FG001|NOT COMPLETED|Second Intervention Period||0
6448901|NCT01139515|7364654|FG002|NOT COMPLETED|Second Intervention Period||0
6448902|NCT01139515|7364655|FG003|NOT COMPLETED|Second Intervention Period||0
6448903|NCT01139515|7364652|FG000|STARTED|Washout Period 2 (46 Hrs)||4
6553352|NCT01743131|7475871|FG002|COMPLETED|Overall Study||43
6553353|NCT01743131|7475872|FG003|COMPLETED|Overall Study||1
6553354|NCT01743131|7475873|FG004|COMPLETED|Overall Study||127
6744795|NCT03349515|7672828|FG001|COMPLETED|Overall Study||50
6744796|NCT03349515|7672827|FG000|NOT COMPLETED|Overall Study||5
6744797|NCT03349515|7672828|FG001|NOT COMPLETED|Overall Study||1
6744798|NCT03349567|7672838|FG000|STARTED|Overall Study||2
6744799|NCT03349567|7672839|FG001|STARTED|Overall Study||2
6744800|NCT03349567|7672838|FG000|COMPLETED|Overall Study||2
6744801|NCT03349567|7672839|FG001|COMPLETED|Overall Study||2
6744802|NCT03349567|7672838|FG000|NOT COMPLETED|Overall Study||0
6744803|NCT03349567|7672839|FG001|NOT COMPLETED|Overall Study||0
6744804|NCT03349632|7672847|FG000|STARTED|Period 1, First Week of Wear||11
6744805|NCT03349632|7672848|FG001|STARTED|Period 1, First Week of Wear||11
6744806|NCT03349632|7672849|FG002|STARTED|Period 1, First Week of Wear||11
6744807|NCT03349632|7672850|FG003|STARTED|Period 1, First Week of Wear||11
6744808|NCT03349632|7672851|FG004|STARTED|Period 1, First Week of Wear||11
6744809|NCT03349632|7672852|FG005|STARTED|Period 1, First Week of Wear||11
6553355|NCT01743131|7475869|FG000|NOT COMPLETED|Overall Study||0
6553356|NCT01743131|7475870|FG001|NOT COMPLETED|Overall Study||0
6553357|NCT01743131|7475871|FG002|NOT COMPLETED|Overall Study||0
6553358|NCT01743131|7475872|FG003|NOT COMPLETED|Overall Study||0
6553359|NCT01743131|7475873|FG004|NOT COMPLETED|Overall Study||0
6553360|NCT01743469|7475886|FG000|STARTED|Active Treatment Phase||53
6553361|NCT01743469|7475887|FG001|STARTED|Active Treatment Phase||55
6553362|NCT01743469|7475888|FG002|STARTED|Active Treatment Phase||38
6553363|NCT01743469|7475889|FG003|STARTED|Active Treatment Phase||21
6744810|NCT03349632|7672847|FG000|COMPLETED|Period 1, First Week of Wear||11
6744811|NCT03349632|7672848|FG001|COMPLETED|Period 1, First Week of Wear||11
6744812|NCT03349632|7672849|FG002|COMPLETED|Period 1, First Week of Wear||11
6744813|NCT03349632|7672850|FG003|COMPLETED|Period 1, First Week of Wear||11
6744814|NCT03349632|7672851|FG004|COMPLETED|Period 1, First Week of Wear||11
6744815|NCT03349632|7672852|FG005|COMPLETED|Period 1, First Week of Wear||11
6744816|NCT03349632|7672847|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
6744817|NCT03349632|7672848|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
6744818|NCT03349632|7672849|FG002|NOT COMPLETED|Period 1, First Week of Wear||0
6744819|NCT03349632|7672850|FG003|NOT COMPLETED|Period 1, First Week of Wear||0
6744820|NCT03349632|7672851|FG004|NOT COMPLETED|Period 1, First Week of Wear||0
6744821|NCT03349632|7672852|FG005|NOT COMPLETED|Period 1, First Week of Wear||0
6744822|NCT03349632|7672847|FG000|STARTED|Period 2, Second Week of Wear||11
6744823|NCT03349632|7672848|FG001|STARTED|Period 2, Second Week of Wear||11
6744824|NCT03349632|7672849|FG002|STARTED|Period 2, Second Week of Wear||11
6744825|NCT03349632|7672850|FG003|STARTED|Period 2, Second Week of Wear||11
6744826|NCT03349632|7672851|FG004|STARTED|Period 2, Second Week of Wear||11
6744827|NCT03349632|7672852|FG005|STARTED|Period 2, Second Week of Wear||11
6744828|NCT03349632|7672847|FG000|COMPLETED|Period 2, Second Week of Wear||11
6744829|NCT03349632|7672848|FG001|COMPLETED|Period 2, Second Week of Wear||11
6744830|NCT03349632|7672849|FG002|COMPLETED|Period 2, Second Week of Wear||11
6744831|NCT03349632|7672850|FG003|COMPLETED|Period 2, Second Week of Wear||11
6744832|NCT03349632|7672851|FG004|COMPLETED|Period 2, Second Week of Wear||11
6744833|NCT03349632|7672852|FG005|COMPLETED|Period 2, Second Week of Wear||11
6744834|NCT03349632|7672847|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
6744835|NCT03349632|7672848|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
6744836|NCT03349632|7672849|FG002|NOT COMPLETED|Period 2, Second Week of Wear||0
6744837|NCT03349632|7672850|FG003|NOT COMPLETED|Period 2, Second Week of Wear||0
6744838|NCT03349632|7672851|FG004|NOT COMPLETED|Period 2, Second Week of Wear||0
6744839|NCT03349632|7672852|FG005|NOT COMPLETED|Period 2, Second Week of Wear||0
6744840|NCT03349710|7672870|FG000|STARTED|Randomized||12
6744841|NCT03349710|7672871|FG001|STARTED|Randomized||10
6744842|NCT03349710|7672872|FG002|STARTED|Randomized||27
6744843|NCT03349710|7672873|FG003|STARTED|Randomized||25
6744844|NCT03349710|7672870|FG000|COMPLETED|Randomized||12
6744845|NCT03349710|7672871|FG001|COMPLETED|Randomized||10
6744846|NCT03349710|7672872|FG002|COMPLETED|Randomized||27
6744847|NCT03349710|7672873|FG003|COMPLETED|Randomized||24
6744848|NCT03349710|7672870|FG000|NOT COMPLETED|Randomized||0
6744849|NCT03349710|7672871|FG001|NOT COMPLETED|Randomized||0
6744850|NCT03349710|7672872|FG002|NOT COMPLETED|Randomized||0
6744851|NCT03349710|7672873|FG003|NOT COMPLETED|Randomized||1
6744852|NCT03349710|7672870|FG000|STARTED|Treatment Period||12
6448904|NCT01139515|7364653|FG001|STARTED|Washout Period 2 (46 Hrs)||4
6744853|NCT03349710|7672871|FG001|STARTED|Treatment Period||10
6744854|NCT03349710|7672872|FG002|STARTED|Treatment Period||27
6744855|NCT03349710|7672873|FG003|STARTED|Treatment Period||24
6448905|NCT01139515|7364654|FG002|STARTED|Washout Period 2 (46 Hrs)||4
6448906|NCT01139515|7364655|FG003|STARTED|Washout Period 2 (46 Hrs)||4
6448907|NCT01139515|7364652|FG000|COMPLETED|Washout Period 2 (46 Hrs)||4
6448908|NCT01139515|7364653|FG001|COMPLETED|Washout Period 2 (46 Hrs)||4
6448909|NCT01139515|7364654|FG002|COMPLETED|Washout Period 2 (46 Hrs)||4
6448910|NCT01139515|7364655|FG003|COMPLETED|Washout Period 2 (46 Hrs)||4
6744856|NCT03349710|7672870|FG000|COMPLETED|Treatment Period||0
6744857|NCT03349710|7672871|FG001|COMPLETED|Treatment Period||0
6744858|NCT03349710|7672872|FG002|COMPLETED|Treatment Period||0
6744859|NCT03349710|7672873|FG003|COMPLETED|Treatment Period||0
6744860|NCT03349710|7672870|FG000|NOT COMPLETED|Treatment Period||12
6744861|NCT03349710|7672871|FG001|NOT COMPLETED|Treatment Period||10
6744862|NCT03349710|7672872|FG002|NOT COMPLETED|Treatment Period||27
6744863|NCT03349710|7672873|FG003|NOT COMPLETED|Treatment Period||24
6744864|NCT03349892|7672883|FG000|STARTED|Overall Study||1
6744865|NCT03349892|7672883|FG000|COMPLETED|Overall Study||1
6744866|NCT03349892|7672883|FG000|NOT COMPLETED|Overall Study||0
6744867|NCT03350217|7672889|FG000|STARTED|Overall Study||79
6744868|NCT03350217|7672890|FG001|STARTED|Overall Study||81
6744869|NCT03350217|7672889|FG000|COMPLETED|Overall Study||77
6744870|NCT03350217|7672890|FG001|COMPLETED|Overall Study||81
6744871|NCT03350217|7672889|FG000|NOT COMPLETED|Overall Study||2
6744872|NCT03350217|7672890|FG001|NOT COMPLETED|Overall Study||0
6744873|NCT03350256|7672896|FG000|STARTED|Overall Study||60
6744874|NCT03350256|7672896|FG000|Spinal Cord Stimulation Trial|Overall Study|Subject that underwent SCS trial|50
6744875|NCT03350256|7672896|FG000|Permanent Implant|Overall Study|subjects that underwent permanent SCS implant|35
6744876|NCT03350256|7672896|FG000|1 Month Follow up|Overall Study||30
6744877|NCT03350256|7672896|FG000|3 Month Follow up|Overall Study||27
6744878|NCT03350256|7672896|FG000|6 Month Follow up|Overall Study||24
6744879|NCT03350256|7672896|FG000|COMPLETED|Overall Study||24
6744880|NCT03350256|7672896|FG000|NOT COMPLETED|Overall Study||36
6744881|NCT03350542|7672900|FG000|STARTED|Overall Study||100
6744882|NCT03350542|7672900|FG000|Completed 12-Month Clinical F/U|Overall Study||96
6744883|NCT03350542|7672900|FG000|Death With no 12-month F/U|Overall Study||4
6744884|NCT03350542|7672900|FG000|COMPLETED|Overall Study||96
6744885|NCT03350542|7672900|FG000|NOT COMPLETED|Overall Study||4
6744886|NCT03350672|7672907|FG000|STARTED|Overall Study||17
6744887|NCT03350672|7672908|FG001|STARTED|Overall Study||10
6744888|NCT03350672|7672909|FG002|STARTED|Overall Study||10
6744889|NCT03350672|7672907|FG000|COMPLETED|Overall Study||10
6744890|NCT03350672|7672908|FG001|COMPLETED|Overall Study||10
6744891|NCT03350672|7672909|FG002|COMPLETED|Overall Study||10
6744892|NCT03350672|7672907|FG000|NOT COMPLETED|Overall Study||7
6744893|NCT03350672|7672908|FG001|NOT COMPLETED|Overall Study||0
6744894|NCT03350672|7672909|FG002|NOT COMPLETED|Overall Study||0
6779658|NCT03724981|7707859|FG001|STARTED|First Device||156
6779659|NCT03724981|7707858|FG000|COMPLETED|First Device||155
6779660|NCT03724981|7707859|FG001|COMPLETED|First Device||155
6779661|NCT03724981|7707858|FG000|NOT COMPLETED|First Device||1
6779662|NCT03724981|7707859|FG001|NOT COMPLETED|First Device||1
6779663|NCT03724981|7707858|FG000|STARTED|Second Device||155
6779664|NCT03724981|7707859|FG001|STARTED|Second Device||155
6779665|NCT03724981|7707858|FG000|COMPLETED|Second Device||155
6779666|NCT03724981|7707859|FG001|COMPLETED|Second Device||155
6779667|NCT03724981|7707858|FG000|NOT COMPLETED|Second Device||0
6779668|NCT03724981|7707859|FG001|NOT COMPLETED|Second Device||0
6779669|NCT03724968|7707869|FG000|STARTED|Overall Study||0
6779670|NCT03724968|7707870|FG001|STARTED|Overall Study||2
6779671|NCT03724968|7707869|FG000|COMPLETED|Overall Study||0
6779672|NCT03724968|7707870|FG001|COMPLETED|Overall Study||0
6779673|NCT03724968|7707869|FG000|NOT COMPLETED|Overall Study||0
6779674|NCT03724968|7707870|FG001|NOT COMPLETED|Overall Study||2
6779675|NCT03724877|7707878|FG000|STARTED|Overall Study||6921
6779676|NCT03724877|7707879|FG001|STARTED|Overall Study||1932
6779677|NCT03724877|7707878|FG000|COMPLETED|Overall Study||6921
6779678|NCT03724877|7707879|FG001|COMPLETED|Overall Study||1932
6779679|NCT03724877|7707878|FG000|NOT COMPLETED|Overall Study||0
6779680|NCT03724877|7707879|FG001|NOT COMPLETED|Overall Study||0
6779681|NCT03724253|7707890|FG000|STARTED|Overall Study||5
6779682|NCT03724253|7707891|FG001|STARTED|Overall Study||5
6779683|NCT03724253|7707892|FG002|STARTED|Overall Study||5
6779684|NCT03724253|7707893|FG003|STARTED|Overall Study||3
6779685|NCT03724253|7707894|FG004|STARTED|Overall Study||1
6779686|NCT03724253|7707890|FG000|COMPLETED|Overall Study||5
6779687|NCT03724253|7707891|FG001|COMPLETED|Overall Study||5
6779688|NCT03724253|7707892|FG002|COMPLETED|Overall Study||5
6779689|NCT03724253|7707893|FG003|COMPLETED|Overall Study||3
6779690|NCT03724253|7707894|FG004|COMPLETED|Overall Study||1
6779691|NCT03724253|7707890|FG000|NOT COMPLETED|Overall Study||0
6779692|NCT03724253|7707891|FG001|NOT COMPLETED|Overall Study||0
6779693|NCT03724253|7707892|FG002|NOT COMPLETED|Overall Study||0
6779694|NCT03724253|7707893|FG003|NOT COMPLETED|Overall Study||0
6779695|NCT03724253|7707894|FG004|NOT COMPLETED|Overall Study||0
6779696|NCT03723980|7707908|FG000|STARTED|Overall Study||40
6448911|NCT01139515|7364652|FG000|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
6779697|NCT03723980|7707909|FG001|STARTED|Overall Study||40
6779698|NCT03723980|7707908|FG000|COMPLETED|Overall Study||33
6779699|NCT03723980|7707909|FG001|COMPLETED|Overall Study||35
6779700|NCT03723980|7707908|FG000|NOT COMPLETED|Overall Study||7
6779701|NCT03723980|7707909|FG001|NOT COMPLETED|Overall Study||5
6448912|NCT01139515|7364653|FG001|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
6448913|NCT01139515|7364654|FG002|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
6448914|NCT01139515|7364655|FG003|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
6448915|NCT01139515|7364652|FG000|STARTED|Third Intervention Period||4
6448916|NCT01139515|7364653|FG001|STARTED|Third Intervention Period||4
6448917|NCT01139515|7364654|FG002|STARTED|Third Intervention Period||4
6448918|NCT01139515|7364655|FG003|STARTED|Third Intervention Period||4
6744895|NCT03350724|7672919|FG000|STARTED|Overall Study||17
6744896|NCT03350724|7672920|FG001|STARTED|Overall Study||17
6744897|NCT03350724|7672919|FG000|COMPLETED|Overall Study||17
6744898|NCT03350724|7672920|FG001|COMPLETED|Overall Study||17
6744899|NCT03350724|7672919|FG000|NOT COMPLETED|Overall Study||0
6744900|NCT03350724|7672920|FG001|NOT COMPLETED|Overall Study||0
6744901|NCT03350919|7672928|FG000|STARTED|Overall Study||25
6744902|NCT03350919|7672929|FG001|STARTED|Overall Study||23
6744903|NCT03350919|7672928|FG000|COMPLETED|Overall Study||23
6744904|NCT03350919|7672929|FG001|COMPLETED|Overall Study||23
6744905|NCT03350919|7672928|FG000|NOT COMPLETED|Overall Study||2
6744906|NCT03350919|7672929|FG001|NOT COMPLETED|Overall Study||0
6744907|NCT03351101|7672939|FG000|STARTED|Overall Study||136
6744908|NCT03351101|7672940|FG001|STARTED|Overall Study||132
6744909|NCT03351101|7672939|FG000|COMPLETED|Overall Study||135
6744910|NCT03351101|7672940|FG001|COMPLETED|Overall Study||129
6744911|NCT03351101|7672939|FG000|NOT COMPLETED|Overall Study||1
6744912|NCT03351101|7672940|FG001|NOT COMPLETED|Overall Study||3
6744913|NCT03351114|7672946|FG000|STARTED|Overall Study||8
6744914|NCT03351114|7672946|FG000|COMPLETED|Overall Study||7
6744915|NCT03351114|7672946|FG000|NOT COMPLETED|Overall Study||1
6744916|NCT03351231|7672950|FG000|STARTED|Combination Therapy Period|Started = initiated and completed monotherapy, then initiated combination therapy|5
6744917|NCT03351231|7672950|FG000|COMPLETED|Combination Therapy Period|Completed = finished combination therapy|0
6744918|NCT03351231|7672950|FG000|NOT COMPLETED|Combination Therapy Period||5
6744919|NCT03351231|7672950|FG000|STARTED|Safety Follow-Up Period|Started = Initiated Safety Follow-up|3
6744920|NCT03351231|7672950|FG000|COMPLETED|Safety Follow-Up Period|Completed = Finishing safety follow-up and continuing in study|0
6744921|NCT03351231|7672950|FG000|NOT COMPLETED|Safety Follow-Up Period||3
6744922|NCT03351335|7672957|FG000|STARTED|Overall Study||21
6744923|NCT03351335|7672958|FG001|STARTED|Overall Study||19
6744924|NCT03351335|7672959|FG002|STARTED|Overall Study||20
6744925|NCT03351335|7672957|FG000|COMPLETED|Overall Study||21
6744926|NCT03351335|7672958|FG001|COMPLETED|Overall Study||19
6744927|NCT03351335|7672959|FG002|COMPLETED|Overall Study||16
6744928|NCT03351335|7672957|FG000|NOT COMPLETED|Overall Study||0
6744929|NCT03351335|7672958|FG001|NOT COMPLETED|Overall Study||0
6744930|NCT03351335|7672959|FG002|NOT COMPLETED|Overall Study||4
6744931|NCT03351478|7672970|FG000|STARTED|Overall Study||307
6744932|NCT03351478|7672971|FG001|STARTED|Overall Study||309
6744933|NCT03351478|7672972|FG002|STARTED|Overall Study||154
6744934|NCT03351478|7672970|FG000|COMPLETED|Overall Study||293
6744935|NCT03351478|7672971|FG001|COMPLETED|Overall Study||292
6744936|NCT03351478|7672972|FG002|COMPLETED|Overall Study||147
6744937|NCT03351478|7672970|FG000|NOT COMPLETED|Overall Study||14
6744938|NCT03351478|7672971|FG001|NOT COMPLETED|Overall Study||17
6744939|NCT03351478|7672972|FG002|NOT COMPLETED|Overall Study||7
6744940|NCT03351608|7672985|FG000|STARTED|Overall Study||19
6744941|NCT03351608|7672986|FG001|STARTED|Overall Study||23
6744942|NCT03351608|7672987|FG002|STARTED|Overall Study||35
6744943|NCT03351608|7672988|FG003|STARTED|Overall Study||176
6744944|NCT03351608|7672989|FG004|STARTED|Overall Study||35
6744945|NCT03351608|7672985|FG000|Treated|Overall Study||18
6744946|NCT03351608|7672986|FG001|Treated|Overall Study||22
6744947|NCT03351608|7672987|FG002|Treated|Overall Study||33
6744948|NCT03351608|7672988|FG003|Treated|Overall Study||169
6744949|NCT03351608|7672989|FG004|Treated|Overall Study||34
6744950|NCT03351608|7672985|FG000|COMPLETED|Overall Study||18
6744951|NCT03351608|7672986|FG001|COMPLETED|Overall Study||21
6744952|NCT03351608|7672987|FG002|COMPLETED|Overall Study||32
6744953|NCT03351608|7672988|FG003|COMPLETED|Overall Study||168
6744954|NCT03351608|7672989|FG004|COMPLETED|Overall Study||33
6744955|NCT03351608|7672985|FG000|NOT COMPLETED|Overall Study||1
6744956|NCT03351608|7672986|FG001|NOT COMPLETED|Overall Study||2
6744957|NCT03351608|7672987|FG002|NOT COMPLETED|Overall Study||3
6744958|NCT03351608|7672988|FG003|NOT COMPLETED|Overall Study||8
6744959|NCT03351608|7672989|FG004|NOT COMPLETED|Overall Study||2
6744960|NCT03351699|7673017|FG000|STARTED|Overall Study||6
6744961|NCT03351699|7673018|FG001|STARTED|Overall Study||6
6744962|NCT03351699|7673019|FG002|STARTED|Overall Study||6
6744963|NCT03351699|7673020|FG003|STARTED|Overall Study||6
6744964|NCT03351699|7673021|FG004|STARTED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
6744965|NCT03351699|7673017|FG000|COMPLETED|Overall Study||6
6744966|NCT03351699|7673018|FG001|COMPLETED|Overall Study||6
6744967|NCT03351699|7673019|FG002|COMPLETED|Overall Study||6
6744968|NCT03351699|7673020|FG003|COMPLETED|Overall Study||6
6744969|NCT03351699|7673021|FG004|COMPLETED|Overall Study|Panel F did not enroll, following evaluation of earlier Panel data.|0
6744970|NCT03351699|7673017|FG000|NOT COMPLETED|Overall Study||0
6744971|NCT03351699|7673018|FG001|NOT COMPLETED|Overall Study||0
6744972|NCT03351699|7673019|FG002|NOT COMPLETED|Overall Study||0
6744973|NCT03351699|7673020|FG003|NOT COMPLETED|Overall Study||0
6744974|NCT03351699|7673021|FG004|NOT COMPLETED|Overall Study||0
6744975|NCT03351738|7673045|FG000|STARTED|Overall Study||23
6448919|NCT01139515|7364652|FG000|COMPLETED|Third Intervention Period||4
6448920|NCT01139515|7364653|FG001|COMPLETED|Third Intervention Period||4
6448921|NCT01139515|7364654|FG002|COMPLETED|Third Intervention Period||4
6448922|NCT01139515|7364655|FG003|COMPLETED|Third Intervention Period||4
6448923|NCT01139515|7364652|FG000|NOT COMPLETED|Third Intervention Period||0
6448924|NCT01139515|7364653|FG001|NOT COMPLETED|Third Intervention Period||0
6448925|NCT01139515|7364654|FG002|NOT COMPLETED|Third Intervention Period||0
6448926|NCT01139515|7364655|FG003|NOT COMPLETED|Third Intervention Period||0
6448927|NCT01139515|7364652|FG000|STARTED|Washout Period 3 (46 Hrs)||4
6448928|NCT01139515|7364653|FG001|STARTED|Washout Period 3 (46 Hrs)||4
6448929|NCT01139515|7364654|FG002|STARTED|Washout Period 3 (46 Hrs)||4
6448930|NCT01139515|7364655|FG003|STARTED|Washout Period 3 (46 Hrs)||4
6448931|NCT01139515|7364652|FG000|COMPLETED|Washout Period 3 (46 Hrs)||4
6448932|NCT01139515|7364653|FG001|COMPLETED|Washout Period 3 (46 Hrs)||4
6448933|NCT01139515|7364654|FG002|COMPLETED|Washout Period 3 (46 Hrs)||4
6448934|NCT01139515|7364655|FG003|COMPLETED|Washout Period 3 (46 Hrs)||4
6448935|NCT01139515|7364652|FG000|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
6448936|NCT01139515|7364653|FG001|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
6448937|NCT01139515|7364654|FG002|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
6448938|NCT01139515|7364655|FG003|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
6448939|NCT01139515|7364652|FG000|STARTED|Fourth Intervention Period||4
6448940|NCT01139515|7364653|FG001|STARTED|Fourth Intervention Period||4
6448941|NCT01139515|7364654|FG002|STARTED|Fourth Intervention Period||4
6448942|NCT01139515|7364655|FG003|STARTED|Fourth Intervention Period||4
6448943|NCT01139515|7364652|FG000|COMPLETED|Fourth Intervention Period||4
6448944|NCT01139515|7364653|FG001|COMPLETED|Fourth Intervention Period||4
6448945|NCT01139515|7364654|FG002|COMPLETED|Fourth Intervention Period||4
6448946|NCT01139515|7364655|FG003|COMPLETED|Fourth Intervention Period||4
6448947|NCT01139515|7364652|FG000|NOT COMPLETED|Fourth Intervention Period||0
6448948|NCT01139515|7364653|FG001|NOT COMPLETED|Fourth Intervention Period||0
6448949|NCT01139515|7364654|FG002|NOT COMPLETED|Fourth Intervention Period||0
6448950|NCT01139515|7364655|FG003|NOT COMPLETED|Fourth Intervention Period||0
6448951|NCT01139580|7364667|FG000|STARTED|Overall Study||181
6553364|NCT01743469|7475886|FG000|COMPLETED|Active Treatment Phase||0
6553365|NCT01743469|7475887|FG001|COMPLETED|Active Treatment Phase||0
6448952|NCT01139580|7364668|FG001|STARTED|Overall Study||182
6448953|NCT01139580|7364667|FG000|COMPLETED|Overall Study||158
6448954|NCT01139580|7364668|FG001|COMPLETED|Overall Study||164
6448955|NCT01139580|7364667|FG000|NOT COMPLETED|Overall Study||23
6448956|NCT01139580|7364668|FG001|NOT COMPLETED|Overall Study||18
6448957|NCT01139658|7364676|FG000|STARTED|Overall Study||747
6448958|NCT01139658|7364677|FG001|STARTED|Overall Study||929
6448959|NCT01139658|7364676|FG000|COMPLETED|Overall Study||691
6448960|NCT01139658|7364677|FG001|COMPLETED|Overall Study||816
6448961|NCT01139658|7364676|FG000|NOT COMPLETED|Overall Study||56
6448962|NCT01139658|7364677|FG001|NOT COMPLETED|Overall Study||113
6448963|NCT01139762|7364685|FG000|STARTED|Washout and Placebo Lead-In Period||1070
6448964|NCT01139762|7364686|FG001|STARTED|Washout and Placebo Lead-In Period||0
6448965|NCT01139762|7364687|FG002|STARTED|Washout and Placebo Lead-In Period||0
6448966|NCT01139762|7364685|FG000|COMPLETED|Washout and Placebo Lead-In Period||696
6448967|NCT01139762|7364686|FG001|COMPLETED|Washout and Placebo Lead-In Period||0
6448968|NCT01139762|7364687|FG002|COMPLETED|Washout and Placebo Lead-In Period||0
6448969|NCT01139762|7364685|FG000|NOT COMPLETED|Washout and Placebo Lead-In Period||374
6448970|NCT01139762|7364686|FG001|NOT COMPLETED|Washout and Placebo Lead-In Period||0
6448971|NCT01139762|7364687|FG002|NOT COMPLETED|Washout and Placebo Lead-In Period||0
6448972|NCT01139762|7364685|FG000|STARTED|Double-Blind Randomized Active Treatment||0
6448973|NCT01139762|7364686|FG001|STARTED|Double-Blind Randomized Active Treatment||346
6448974|NCT01139762|7364687|FG002|STARTED|Double-Blind Randomized Active Treatment||350
6448975|NCT01139762|7364685|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
6448976|NCT01139762|7364686|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
6448977|NCT01139762|7364687|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
6448978|NCT01139762|7364685|FG000|COMPLETED|Double-Blind Randomized Active Treatment||0
6448979|NCT01139762|7364686|FG001|COMPLETED|Double-Blind Randomized Active Treatment||306
6448980|NCT01139762|7364687|FG002|COMPLETED|Double-Blind Randomized Active Treatment||286
6448981|NCT01139762|7364685|FG000|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
6448982|NCT01139762|7364686|FG001|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
6448983|NCT01139762|7364687|FG002|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
6448984|NCT01139775|7364697|FG000|STARTED|Overall Study||14
6448985|NCT01139775|7364698|FG001|STARTED|Overall Study||39
6448986|NCT01139775|7364699|FG002|STARTED|Overall Study||23
6448987|NCT01139775|7364697|FG000|Received at Least 1 Dose of Study Drug|Overall Study||14
6448988|NCT01139775|7364698|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
6448989|NCT01139775|7364699|FG002|Received at Least 1 Dose of Study Drug|Overall Study||22
6448990|NCT01139775|7364697|FG000|COMPLETED|Overall Study||13
6448991|NCT01139775|7364698|FG001|COMPLETED|Overall Study||26
6448992|NCT01139775|7364699|FG002|COMPLETED|Overall Study||17
6448993|NCT01139775|7364697|FG000|NOT COMPLETED|Overall Study||1
6448994|NCT01139775|7364698|FG001|NOT COMPLETED|Overall Study||13
6448995|NCT01139775|7364699|FG002|NOT COMPLETED|Overall Study||6
6448996|NCT01139801|7364711|FG000|STARTED|Overall Study||25
6448997|NCT01139801|7364712|FG001|STARTED|Overall Study||25
6448998|NCT01139801|7364711|FG000|COMPLETED|Overall Study||25
6448999|NCT01139801|7364712|FG001|COMPLETED|Overall Study||25
6449000|NCT01139801|7364711|FG000|NOT COMPLETED|Overall Study||0
6449001|NCT01139801|7364712|FG001|NOT COMPLETED|Overall Study||0
6449002|NCT01139814|7364718|FG000|STARTED|Overall Study||181
6449003|NCT01139814|7364718|FG000|COMPLETED|Overall Study||181
6449004|NCT01139814|7364718|FG000|NOT COMPLETED|Overall Study||0
6449005|NCT01139879|7364723|FG000|STARTED|Overall Study||10
6449006|NCT01139879|7364723|FG000|COMPLETED|Overall Study||10
6449007|NCT01139879|7364723|FG000|NOT COMPLETED|Overall Study||0
6449008|NCT01140061|7364739|FG000|STARTED|Part I|Includes 1 replacement participant|7
6449009|NCT01140061|7364740|FG001|STARTED|Part I||2
6449010|NCT01140061|7364741|FG002|STARTED|Part I||0
6449011|NCT01140061|7364742|FG003|STARTED|Part I||0
6449012|NCT01140061|7364743|FG004|STARTED|Part I||0
6449013|NCT01140061|7364744|FG005|STARTED|Part I||0
6449014|NCT01140061|7364745|FG006|STARTED|Part I||0
6449015|NCT01140061|7364746|FG007|STARTED|Part I||0
6449016|NCT01140061|7364747|FG008|STARTED|Part I||0
6449017|NCT01140061|7364748|FG009|STARTED|Part I||0
6449018|NCT01140061|7364739|FG000|COMPLETED|Part I||6
6449019|NCT01140061|7364740|FG001|COMPLETED|Part I||2
6449020|NCT01140061|7364741|FG002|COMPLETED|Part I||0
6449021|NCT01140061|7364742|FG003|COMPLETED|Part I||0
6449022|NCT01140061|7364743|FG004|COMPLETED|Part I||0
6449023|NCT01140061|7364744|FG005|COMPLETED|Part I||0
6449024|NCT01140061|7364745|FG006|COMPLETED|Part I||0
6449025|NCT01140061|7364746|FG007|COMPLETED|Part I||0
6449026|NCT01140061|7364747|FG008|COMPLETED|Part I||0
6449027|NCT01140061|7364748|FG009|COMPLETED|Part I||0
6449028|NCT01140061|7364739|FG000|NOT COMPLETED|Part I||1
6449029|NCT01140061|7364740|FG001|NOT COMPLETED|Part I||0
6449030|NCT01140061|7364741|FG002|NOT COMPLETED|Part I||0
6449031|NCT01140061|7364742|FG003|NOT COMPLETED|Part I||0
6449032|NCT01140061|7364743|FG004|NOT COMPLETED|Part I||0
6449033|NCT01140061|7364744|FG005|NOT COMPLETED|Part I||0
6449034|NCT01140061|7364745|FG006|NOT COMPLETED|Part I||0
6449035|NCT01140061|7364746|FG007|NOT COMPLETED|Part I||0
6449036|NCT01140061|7364747|FG008|NOT COMPLETED|Part I||0
6449037|NCT01140061|7364748|FG009|NOT COMPLETED|Part I||0
6449038|NCT01140061|7364739|FG000|STARTED|Part II||0
6449039|NCT01140061|7364740|FG001|STARTED|Part II||0
6449040|NCT01140061|7364741|FG002|STARTED|Part II||6
6449041|NCT01140061|7364742|FG003|STARTED|Part II||2
6449042|NCT01140061|7364743|FG004|STARTED|Part II||6
6449043|NCT01140061|7364744|FG005|STARTED|Part II||2
6449044|NCT01140061|7364745|FG006|STARTED|Part II||6
6449045|NCT01140061|7364746|FG007|STARTED|Part II||2
6449046|NCT01140061|7364747|FG008|STARTED|Part II||0
6449047|NCT01140061|7364748|FG009|STARTED|Part II||0
6449048|NCT01140061|7364739|FG000|COMPLETED|Part II||0
6449049|NCT01140061|7364740|FG001|COMPLETED|Part II||0
6449050|NCT01140061|7364741|FG002|COMPLETED|Part II||6
6449051|NCT01140061|7364742|FG003|COMPLETED|Part II||2
6449052|NCT01140061|7364743|FG004|COMPLETED|Part II||6
6449053|NCT01140061|7364744|FG005|COMPLETED|Part II||2
6449054|NCT01140061|7364745|FG006|COMPLETED|Part II||6
6449055|NCT01140061|7364746|FG007|COMPLETED|Part II||2
6449056|NCT01140061|7364747|FG008|COMPLETED|Part II||0
6449057|NCT01140061|7364748|FG009|COMPLETED|Part II||0
6449058|NCT01140061|7364739|FG000|NOT COMPLETED|Part II||0
6449059|NCT01140061|7364740|FG001|NOT COMPLETED|Part II||0
6449060|NCT01140061|7364741|FG002|NOT COMPLETED|Part II||0
6449061|NCT01140061|7364742|FG003|NOT COMPLETED|Part II||0
6449062|NCT01140061|7364743|FG004|NOT COMPLETED|Part II||0
6449063|NCT01140061|7364744|FG005|NOT COMPLETED|Part II||0
6449064|NCT01140061|7364745|FG006|NOT COMPLETED|Part II||0
6449065|NCT01140061|7364746|FG007|NOT COMPLETED|Part II||0
6449066|NCT01140061|7364747|FG008|NOT COMPLETED|Part II||0
6449067|NCT01140061|7364748|FG009|NOT COMPLETED|Part II||0
6449068|NCT01140061|7364739|FG000|STARTED|Part III||0
6449069|NCT01140061|7364740|FG001|STARTED|Part III||0
6449070|NCT01140061|7364741|FG002|STARTED|Part III||0
6449071|NCT01140061|7364742|FG003|STARTED|Part III||0
6449072|NCT01140061|7364743|FG004|STARTED|Part III||0
6449073|NCT01140061|7364744|FG005|STARTED|Part III||0
6449074|NCT01140061|7364745|FG006|STARTED|Part III||0
6449075|NCT01140061|7364746|FG007|STARTED|Part III||0
6449076|NCT01140061|7364747|FG008|STARTED|Part III||7
6449077|NCT01140061|7364748|FG009|STARTED|Part III|Includes 1 replacement participant|2
6449078|NCT01140061|7364739|FG000|COMPLETED|Part III||0
6449079|NCT01140061|7364740|FG001|COMPLETED|Part III||0
6449080|NCT01140061|7364741|FG002|COMPLETED|Part III||0
6449081|NCT01140061|7364742|FG003|COMPLETED|Part III||0
6449082|NCT01140061|7364743|FG004|COMPLETED|Part III||0
6449083|NCT01140061|7364744|FG005|COMPLETED|Part III||0
6449084|NCT01140061|7364745|FG006|COMPLETED|Part III||0
6449085|NCT01140061|7364746|FG007|COMPLETED|Part III||0
6449086|NCT01140061|7364747|FG008|COMPLETED|Part III||7
6449087|NCT01140061|7364748|FG009|COMPLETED|Part III||2
6449088|NCT01140061|7364739|FG000|NOT COMPLETED|Part III||0
6449089|NCT01140061|7364740|FG001|NOT COMPLETED|Part III||0
6449090|NCT01140061|7364741|FG002|NOT COMPLETED|Part III||0
6449091|NCT01140061|7364742|FG003|NOT COMPLETED|Part III||0
6449092|NCT01140061|7364743|FG004|NOT COMPLETED|Part III||0
6449093|NCT01140061|7364744|FG005|NOT COMPLETED|Part III||0
6449094|NCT01140061|7364745|FG006|NOT COMPLETED|Part III||0
6449095|NCT01140061|7364746|FG007|NOT COMPLETED|Part III||0
6449096|NCT01140061|7364747|FG008|NOT COMPLETED|Part III||0
6449097|NCT01140061|7364748|FG009|NOT COMPLETED|Part III||0
6449098|NCT01140061|7364739|FG000|STARTED|Extension||0
6449099|NCT01140061|7364740|FG001|STARTED|Extension||0
6449100|NCT01140061|7364741|FG002|STARTED|Extension||0
6449101|NCT01140061|7364742|FG003|STARTED|Extension||0
6449102|NCT01140061|7364743|FG004|STARTED|Extension||0
6449103|NCT01140061|7364744|FG005|STARTED|Extension||0
6449104|NCT01140061|7364745|FG006|STARTED|Extension||0
6449105|NCT01140061|7364746|FG007|STARTED|Extension||0
6449106|NCT01140061|7364747|FG008|STARTED|Extension||7
6449107|NCT01140061|7364748|FG009|STARTED|Extension||2
6449108|NCT01140061|7364739|FG000|COMPLETED|Extension||0
6449109|NCT01140061|7364740|FG001|COMPLETED|Extension||0
6449110|NCT01140061|7364741|FG002|COMPLETED|Extension||0
6449111|NCT01140061|7364742|FG003|COMPLETED|Extension||0
6449112|NCT01140061|7364743|FG004|COMPLETED|Extension||0
6449113|NCT01140061|7364744|FG005|COMPLETED|Extension||0
6449114|NCT01140061|7364745|FG006|COMPLETED|Extension||0
6449115|NCT01140061|7364746|FG007|COMPLETED|Extension||0
6449116|NCT01140061|7364747|FG008|COMPLETED|Extension||7
6449117|NCT01140061|7364748|FG009|COMPLETED|Extension||1
6449118|NCT01140061|7364739|FG000|NOT COMPLETED|Extension||0
6449119|NCT01140061|7364740|FG001|NOT COMPLETED|Extension||0
6449120|NCT01140061|7364741|FG002|NOT COMPLETED|Extension||0
6449121|NCT01140061|7364742|FG003|NOT COMPLETED|Extension||0
6449122|NCT01140061|7364743|FG004|NOT COMPLETED|Extension||0
6449123|NCT01140061|7364744|FG005|NOT COMPLETED|Extension||0
6449124|NCT01140061|7364745|FG006|NOT COMPLETED|Extension||0
6449125|NCT01140061|7364746|FG007|NOT COMPLETED|Extension||0
6449126|NCT01140061|7364747|FG008|NOT COMPLETED|Extension||0
6449127|NCT01140061|7364748|FG009|NOT COMPLETED|Extension||1
6449128|NCT01140191|7364763|FG000|STARTED|Overall Study||1
6449129|NCT01140191|7364763|FG000|COMPLETED|Overall Study||1
6449130|NCT01140191|7364763|FG000|NOT COMPLETED|Overall Study||0
6449131|NCT01140295|7364769|FG000|STARTED|Overall Study||17
6449132|NCT01140295|7364770|FG001|STARTED|Overall Study||16
6449133|NCT01140295|7364769|FG000|COMPLETED|Overall Study||16
6449134|NCT01140295|7364770|FG001|COMPLETED|Overall Study||14
6449135|NCT01140295|7364769|FG000|NOT COMPLETED|Overall Study||1
6449136|NCT01140295|7364770|FG001|NOT COMPLETED|Overall Study||2
6449137|NCT01140347|7364780|FG000|STARTED|Overall Study||283
6449138|NCT01140347|7364781|FG001|STARTED|Overall Study||282
6449139|NCT01140347|7364780|FG000|Received at Least 1 Dose of Study Drug|Overall Study||277
6449140|NCT01140347|7364781|FG001|Received at Least 1 Dose of Study Drug|Overall Study||276
6449141|NCT01140347|7364780|FG000|COMPLETED|Overall Study||265
6449142|NCT01140347|7364781|FG001|COMPLETED|Overall Study||268
6449143|NCT01140347|7364780|FG000|NOT COMPLETED|Overall Study||18
6449144|NCT01140347|7364781|FG001|NOT COMPLETED|Overall Study||14
6449145|NCT01140360|7364787|FG000|STARTED|Overall Study||21
6553366|NCT01743469|7475888|FG002|COMPLETED|Active Treatment Phase||0
6553367|NCT01743469|7475889|FG003|COMPLETED|Active Treatment Phase||0
6449146|NCT01140360|7364787|FG000|COMPLETED|Overall Study||15
6449147|NCT01140360|7364787|FG000|NOT COMPLETED|Overall Study||6
6449148|NCT01140477|7364793|FG000|STARTED|Overall Study||153
6449149|NCT01140477|7364794|FG001|STARTED|Overall Study||76
6449150|NCT01140477|7364793|FG000|COMPLETED|Overall Study||145
6449151|NCT01140477|7364794|FG001|COMPLETED|Overall Study||70
6449152|NCT01140477|7364793|FG000|NOT COMPLETED|Overall Study||8
6449153|NCT01140477|7364794|FG001|NOT COMPLETED|Overall Study||6
6449154|NCT01140503|7364800|FG000|STARTED|Overall Study||5
6449155|NCT01140503|7364800|FG000|COMPLETED|Overall Study||4
6449156|NCT01140503|7364800|FG000|NOT COMPLETED|Overall Study||1
6449157|NCT01140568|7364804|FG000|STARTED|Overall Study||38
6449158|NCT01140568|7364804|FG000|Screen Fail|Overall Study||4
6449159|NCT01140568|7364804|FG000|Treated With Study Drug|Overall Study||34
6449160|NCT01140568|7364804|FG000|COMPLETED|Overall Study||2
6449161|NCT01140568|7364804|FG000|NOT COMPLETED|Overall Study||36
6449162|NCT01140646|7364808|FG000|STARTED|Overall Study||43
6449163|NCT01140646|7364808|FG000|COMPLETED|Overall Study||34
6449164|NCT01140646|7364808|FG000|NOT COMPLETED|Overall Study||9
6449165|NCT01140815|7364814|FG000|STARTED|Overall Study||25
6449166|NCT01140815|7364815|FG001|STARTED|Overall Study||25
6449167|NCT01140815|7364814|FG000|COMPLETED|Overall Study||25
6449168|NCT01140815|7364815|FG001|COMPLETED|Overall Study||25
6449169|NCT01140815|7364814|FG000|NOT COMPLETED|Overall Study||0
6449170|NCT01140815|7364815|FG001|NOT COMPLETED|Overall Study||0
6449171|NCT01140880|7364825|FG000|STARTED|Overall Study||70
6449172|NCT01140880|7364826|FG001|STARTED|Overall Study||100
6449173|NCT01140880|7364825|FG000|COMPLETED|Overall Study||56
6449174|NCT01140880|7364826|FG001|COMPLETED|Overall Study||56
6449175|NCT01140880|7364825|FG000|NOT COMPLETED|Overall Study||14
6449176|NCT01140880|7364826|FG001|NOT COMPLETED|Overall Study||44
6449177|NCT01140906|7364836|FG000|STARTED|Overall Study||158
6449178|NCT01140906|7364837|FG001|STARTED|Overall Study||151
6449179|NCT01140906|7364838|FG002|STARTED|Overall Study||151
6449180|NCT01140906|7364839|FG003|STARTED|Overall Study||147
6449181|NCT01140906|7364836|FG000|COMPLETED|Overall Study||133
6449182|NCT01140906|7364837|FG001|COMPLETED|Overall Study||117
6449183|NCT01140906|7364838|FG002|COMPLETED|Overall Study||125
6449184|NCT01140906|7364839|FG003|COMPLETED|Overall Study||131
6449185|NCT01140906|7364836|FG000|NOT COMPLETED|Overall Study||25
6449186|NCT01140906|7364837|FG001|NOT COMPLETED|Overall Study||34
6449187|NCT01140906|7364838|FG002|NOT COMPLETED|Overall Study||26
6449188|NCT01140906|7364839|FG003|NOT COMPLETED|Overall Study||16
6449189|NCT01141049|7364851|FG000|STARTED|Overall Study||19
6449190|NCT01141049|7364852|FG001|STARTED|Overall Study||21
6449191|NCT01141049|7364851|FG000|COMPLETED|Overall Study||14
6449192|NCT01141049|7364852|FG001|COMPLETED|Overall Study||13
6449193|NCT01141049|7364851|FG000|NOT COMPLETED|Overall Study||5
6449194|NCT01141049|7364852|FG001|NOT COMPLETED|Overall Study||8
6449195|NCT01141075|7364858|FG000|STARTED|Cycle 1||11
6449196|NCT01141075|7364858|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||11
6449197|NCT01141075|7364858|FG000|COMPLETED|Cycle 1||11
6449198|NCT01141075|7364858|FG000|NOT COMPLETED|Cycle 1||0
6449199|NCT01141075|7364858|FG000|STARTED|Cycle 2||11
6449200|NCT01141075|7364858|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||11
6449201|NCT01141075|7364858|FG000|COMPLETED|Cycle 2||11
6449202|NCT01141075|7364858|FG000|NOT COMPLETED|Cycle 2||0
6449203|NCT01141205|7364864|FG000|STARTED|Overall Study||18
6449204|NCT01141205|7364865|FG001|STARTED|Overall Study||5
6449205|NCT01141205|7364864|FG000|COMPLETED|Overall Study||15
6449206|NCT01141205|7364865|FG001|COMPLETED|Overall Study||3
6449207|NCT01141205|7364864|FG000|NOT COMPLETED|Overall Study||3
6449208|NCT01141205|7364865|FG001|NOT COMPLETED|Overall Study||2
6449209|NCT01141283|7364875|FG000|STARTED|Overall Study||290
6449210|NCT01141283|7364875|FG000|COMPLETED|Overall Study||202
6449211|NCT01141283|7364875|FG000|NOT COMPLETED|Overall Study||88
6449212|NCT01141374|7364882|FG000|STARTED|Overall Study||26
6449213|NCT01141374|7364883|FG001|STARTED|Overall Study||27
6449214|NCT01141374|7364884|FG002|STARTED|Overall Study||22
6449215|NCT01141374|7364882|FG000|COMPLETED|Overall Study||26
6449216|NCT01141374|7364883|FG001|COMPLETED|Overall Study||27
6449217|NCT01141374|7364884|FG002|COMPLETED|Overall Study||22
6449218|NCT01141374|7364882|FG000|NOT COMPLETED|Overall Study||0
6449219|NCT01141374|7364883|FG001|NOT COMPLETED|Overall Study||0
6449220|NCT01141374|7364884|FG002|NOT COMPLETED|Overall Study||0
6449221|NCT01141478|7364896|FG000|STARTED|Overall Study||4
6449222|NCT01141478|7364897|FG001|STARTED|Overall Study||4
6449223|NCT01141478|7364896|FG000|COMPLETED|Overall Study||3
6449224|NCT01141478|7364897|FG001|COMPLETED|Overall Study||3
6449225|NCT01141478|7364896|FG000|NOT COMPLETED|Overall Study||1
6449226|NCT01141478|7364897|FG001|NOT COMPLETED|Overall Study||1
6449227|NCT01141491|7364905|FG000|STARTED|Overall Study||68
6449228|NCT01141491|7364906|FG001|STARTED|Overall Study||68
6449229|NCT01141491|7364905|FG000|COMPLETED|Overall Study||20
6449230|NCT01141491|7364906|FG001|COMPLETED|Overall Study||21
6449231|NCT01141491|7364905|FG000|NOT COMPLETED|Overall Study||48
6449232|NCT01141491|7364906|FG001|NOT COMPLETED|Overall Study||47
6449233|NCT01141569|7364912|FG000|STARTED|Overall Study||12
6449234|NCT01141569|7364912|FG000|COMPLETED|Overall Study||12
6449235|NCT01141569|7364912|FG000|NOT COMPLETED|Overall Study||0
6449236|NCT01141595|7364916|FG000|STARTED|Overall Study||10
6449237|NCT01141595|7364916|FG000|COMPLETED|Overall Study||8
6449238|NCT01141595|7364916|FG000|NOT COMPLETED|Overall Study||2
6449239|NCT01141608|7364922|FG000|STARTED|Overall Study||152
6449240|NCT01141608|7364923|FG001|STARTED|Overall Study||150
6449241|NCT01141608|7364922|FG000|COMPLETED|Overall Study||152
6449242|NCT01141608|7364923|FG001|COMPLETED|Overall Study||150
6449243|NCT01141608|7364922|FG000|NOT COMPLETED|Overall Study||0
6449244|NCT01141608|7364923|FG001|NOT COMPLETED|Overall Study||0
6449245|NCT01141647|7364929|FG000|STARTED|Overall Study||213
6449246|NCT01141647|7364929|FG000|COMPLETED|Overall Study||167
6449247|NCT01141647|7364929|FG000|NOT COMPLETED|Overall Study||46
6500402|NCT01424501|7419118|FG000|STARTED|Overall Study||7
6500403|NCT01424501|7419119|FG001|STARTED|Overall Study||6
6500404|NCT01424501|7419120|FG002|STARTED|Overall Study||24
6500405|NCT01424501|7419121|FG003|STARTED|Overall Study||25
6500406|NCT01424501|7419122|FG004|STARTED|Overall Study||40
6500407|NCT01424501|7419123|FG005|STARTED|Overall Study||40
6500408|NCT01424501|7419118|FG000|COMPLETED|Overall Study||6
6500409|NCT01424501|7419119|FG001|COMPLETED|Overall Study||5
6500410|NCT01424501|7419120|FG002|COMPLETED|Overall Study||22
6500411|NCT01424501|7419121|FG003|COMPLETED|Overall Study||25
6500412|NCT01424501|7419122|FG004|COMPLETED|Overall Study||40
6500413|NCT01424501|7419123|FG005|COMPLETED|Overall Study||40
6500414|NCT01424501|7419118|FG000|NOT COMPLETED|Overall Study||1
6500415|NCT01424501|7419119|FG001|NOT COMPLETED|Overall Study||1
6500416|NCT01424501|7419120|FG002|NOT COMPLETED|Overall Study||2
6500417|NCT01424501|7419121|FG003|NOT COMPLETED|Overall Study||0
6500418|NCT01424501|7419122|FG004|NOT COMPLETED|Overall Study||0
6500419|NCT01424501|7419123|FG005|NOT COMPLETED|Overall Study||0
6500420|NCT01424514|7419138|FG000|STARTED|Period 1:Intervention Period 1 (14 Days)||20
6500421|NCT01424514|7419139|FG001|STARTED|Period 1:Intervention Period 1 (14 Days)||20
6500422|NCT01424514|7419138|FG000|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
6500423|NCT01424514|7419139|FG001|COMPLETED|Period 1:Intervention Period 1 (14 Days)||19
6500424|NCT01424514|7419138|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
6500425|NCT01424514|7419139|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (14 Days)||1
6500426|NCT01424514|7419138|FG000|STARTED|Period 2:Washout Period (4 Weeks)||19
6500427|NCT01424514|7419139|FG001|STARTED|Period 2:Washout Period (4 Weeks)||19
6500428|NCT01424514|7419138|FG000|COMPLETED|Period 2:Washout Period (4 Weeks)||19
6500429|NCT01424514|7419139|FG001|COMPLETED|Period 2:Washout Period (4 Weeks)||19
6500430|NCT01424514|7419138|FG000|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
6500431|NCT01424514|7419139|FG001|NOT COMPLETED|Period 2:Washout Period (4 Weeks)||0
6500432|NCT01424514|7419138|FG000|STARTED|Period 3:Intervention Period 2 (14 Days)||19
6449248|NCT01141660|7364940|FG000|STARTED|Overall Study||71
6449249|NCT01141660|7364941|FG001|STARTED|Overall Study||60
6449250|NCT01141660|7364940|FG000|COMPLETED|Overall Study||71
6449251|NCT01141660|7364941|FG001|COMPLETED|Overall Study||48
6553368|NCT01743469|7475886|FG000|NOT COMPLETED|Active Treatment Phase||53
6553369|NCT01743469|7475887|FG001|NOT COMPLETED|Active Treatment Phase||55
6553370|NCT01743469|7475888|FG002|NOT COMPLETED|Active Treatment Phase||38
6553371|NCT01743469|7475889|FG003|NOT COMPLETED|Active Treatment Phase||21
6553372|NCT01743469|7475886|FG000|STARTED|Follow-up Period - Post-Treatment||51
6553373|NCT01743469|7475887|FG001|STARTED|Follow-up Period - Post-Treatment||53
6553374|NCT01743469|7475888|FG002|STARTED|Follow-up Period - Post-Treatment||37
6553375|NCT01743469|7475889|FG003|STARTED|Follow-up Period - Post-Treatment||21
6449252|NCT01141660|7364940|FG000|NOT COMPLETED|Overall Study||0
6449253|NCT01141660|7364941|FG001|NOT COMPLETED|Overall Study||12
6449254|NCT01141725|7364947|FG000|STARTED|Overall Study||3
6449255|NCT01141725|7364948|FG001|STARTED|Overall Study||33
6449256|NCT01141725|7364949|FG002|STARTED|Overall Study||3
6449257|NCT01141725|7364947|FG000|COMPLETED|Overall Study||3
6449258|NCT01141725|7364948|FG001|COMPLETED|Overall Study||33
6449259|NCT01141725|7364949|FG002|COMPLETED|Overall Study||3
6449260|NCT01141725|7364947|FG000|NOT COMPLETED|Overall Study||0
6449261|NCT01141725|7364948|FG001|NOT COMPLETED|Overall Study||0
6449262|NCT01141725|7364949|FG002|NOT COMPLETED|Overall Study||0
6449263|NCT01141907|7364958|FG000|STARTED|Overall Study||6
6449264|NCT01141907|7364959|FG001|STARTED|Overall Study||5
6449265|NCT01141907|7364958|FG000|COMPLETED|Overall Study||6
6449266|NCT01141907|7364959|FG001|COMPLETED|Overall Study||5
6449267|NCT01141907|7364958|FG000|NOT COMPLETED|Overall Study||0
6449268|NCT01141907|7364959|FG001|NOT COMPLETED|Overall Study||0
6449269|NCT01142089|7364967|FG000|STARTED|Overall Study||65
6449270|NCT01142089|7364968|FG001|STARTED|Overall Study||199
6449271|NCT01142089|7364967|FG000|COMPLETED|Overall Study||53
6449272|NCT01142089|7364968|FG001|COMPLETED|Overall Study||178
6449273|NCT01142089|7364967|FG000|NOT COMPLETED|Overall Study||12
6449274|NCT01142089|7364968|FG001|NOT COMPLETED|Overall Study||21
6449275|NCT01142115|7364974|FG000|STARTED|First Intervention||21
6449276|NCT01142115|7364975|FG001|STARTED|First Intervention||20
6449277|NCT01142115|7364974|FG000|COMPLETED|First Intervention||19
6449278|NCT01142115|7364975|FG001|COMPLETED|First Intervention||19
6449279|NCT01142115|7364974|FG000|NOT COMPLETED|First Intervention||2
6449280|NCT01142115|7364975|FG001|NOT COMPLETED|First Intervention||1
6449281|NCT01142115|7364974|FG000|STARTED|Second Intervention||19
6449282|NCT01142115|7364975|FG001|STARTED|Second Intervention||19
6449283|NCT01142115|7364974|FG000|COMPLETED|Second Intervention||19
6449284|NCT01142115|7364975|FG001|COMPLETED|Second Intervention||19
6449285|NCT01142115|7364974|FG000|NOT COMPLETED|Second Intervention||0
6449286|NCT01142115|7364975|FG001|NOT COMPLETED|Second Intervention||0
6449287|NCT01142193|7364982|FG000|STARTED|Overall Study||124
6449288|NCT01142193|7364983|FG001|STARTED|Overall Study||125
6449289|NCT01142193|7364982|FG000|COMPLETED|Overall Study||103
6449290|NCT01142193|7364983|FG001|COMPLETED|Overall Study||114
6449291|NCT01142193|7364982|FG000|NOT COMPLETED|Overall Study||21
6449292|NCT01142193|7364983|FG001|NOT COMPLETED|Overall Study||11
6449293|NCT01142232|7364994|FG000|STARTED|Overall Study||3
6449294|NCT01142232|7364995|FG001|STARTED|Overall Study||4
6449295|NCT01142232|7364996|FG002|STARTED|Overall Study||3
6449296|NCT01142232|7364997|FG003|STARTED|Overall Study||6
6449297|NCT01142232|7364998|FG004|STARTED|Overall Study||44
6449298|NCT01142232|7364994|FG000|COMPLETED|Overall Study||0
6449299|NCT01142232|7364995|FG001|COMPLETED|Overall Study||0
6449300|NCT01142232|7364996|FG002|COMPLETED|Overall Study||0
6449301|NCT01142232|7364997|FG003|COMPLETED|Overall Study||1
6449302|NCT01142232|7364998|FG004|COMPLETED|Overall Study||10
6449303|NCT01142232|7364994|FG000|NOT COMPLETED|Overall Study||3
6449304|NCT01142232|7364995|FG001|NOT COMPLETED|Overall Study||4
6449305|NCT01142232|7364996|FG002|NOT COMPLETED|Overall Study||3
6449306|NCT01142232|7364997|FG003|NOT COMPLETED|Overall Study||5
6449307|NCT01142232|7364998|FG004|NOT COMPLETED|Overall Study||34
6449308|NCT01142297|7365010|FG000|STARTED|Overall Study||24
6449309|NCT01142297|7365010|FG000|COMPLETED|Overall Study||18
6449310|NCT01142297|7365010|FG000|NOT COMPLETED|Overall Study||6
6449311|NCT01142310|7365019|FG000|STARTED|Overall Study||26
6449312|NCT01142310|7365020|FG001|STARTED|Overall Study||28
6449313|NCT01142310|7365019|FG000|COMPLETED|Overall Study||17
6449314|NCT01142310|7365020|FG001|COMPLETED|Overall Study||16
6449315|NCT01142310|7365019|FG000|NOT COMPLETED|Overall Study||9
6449316|NCT01142310|7365020|FG001|NOT COMPLETED|Overall Study||12
6449317|NCT01142323|7365026|FG000|STARTED|Overall Study||8
6449318|NCT01142323|7365026|FG000|COMPLETED|Overall Study||8
6449319|NCT01142323|7365026|FG000|NOT COMPLETED|Overall Study||0
6449320|NCT01142336|7365034|FG000|STARTED|Overall Study||26
6449321|NCT01142336|7365035|FG001|STARTED|Overall Study||23
6449322|NCT01142336|7365034|FG000|COMPLETED|Overall Study||25
6553376|NCT01743469|7475886|FG000|COMPLETED|Follow-up Period - Post-Treatment||6
6449323|NCT01142336|7365035|FG001|COMPLETED|Overall Study||21
6449324|NCT01142336|7365034|FG000|NOT COMPLETED|Overall Study||1
6449325|NCT01142336|7365035|FG001|NOT COMPLETED|Overall Study||2
6449326|NCT01142466|7365046|FG000|STARTED|Overall Study||15
6449327|NCT01142466|7365047|FG001|STARTED|Overall Study||15
6449328|NCT01142466|7365046|FG000|COMPLETED|Overall Study||12
6449329|NCT01142466|7365047|FG001|COMPLETED|Overall Study||13
6449330|NCT01142466|7365046|FG000|NOT COMPLETED|Overall Study||3
6449331|NCT01142466|7365047|FG001|NOT COMPLETED|Overall Study||2
6449332|NCT01142661|7365053|FG000|STARTED|Overall Study||9
6449333|NCT01142661|7365053|FG000|COMPLETED|Overall Study||5
6449334|NCT01142661|7365053|FG000|NOT COMPLETED|Overall Study||4
6449335|NCT01142726|7365060|FG000|STARTED|Treatment Phase: Day 1 Through Month 12||119
6449336|NCT01142726|7365061|FG001|STARTED|Treatment Phase: Day 1 Through Month 12||116
6449337|NCT01142726|7365062|FG002|STARTED|Treatment Phase: Day 1 Through Month 12||116
6449338|NCT01142726|7365060|FG000|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
6449339|NCT01142726|7365061|FG001|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
6449340|NCT01142726|7365062|FG002|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
6449341|NCT01142726|7365060|FG000|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
6449342|NCT01142726|7365061|FG001|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
6449343|NCT01142726|7365062|FG002|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
6449344|NCT01142726|7365060|FG000|STARTED|Withdrawal Phase: Months 12 up to 24||84
6449345|NCT01142726|7365061|FG001|STARTED|Withdrawal Phase: Months 12 up to 24||66
6449346|NCT01142726|7365062|FG002|STARTED|Withdrawal Phase: Months 12 up to 24||75
6449347|NCT01142726|7365060|FG000|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
6449348|NCT01142726|7365061|FG001|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
6449349|NCT01142726|7365062|FG002|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
6449350|NCT01142726|7365060|FG000|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
6449351|NCT01142726|7365061|FG001|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
6449352|NCT01142726|7365062|FG002|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
6449353|NCT01142726|7365060|FG000|STARTED|Re-Exposure Phase: Months 24 up to 30||55
6449354|NCT01142726|7365061|FG001|STARTED|Re-Exposure Phase: Months 24 up to 30||48
6449355|NCT01142726|7365062|FG002|STARTED|Re-Exposure Phase: Months 24 up to 30||43
6449356|NCT01142726|7365060|FG000|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
6449357|NCT01142726|7365061|FG001|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
6449358|NCT01142726|7365062|FG002|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
6449359|NCT01142726|7365060|FG000|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
6449360|NCT01142726|7365061|FG001|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
6449361|NCT01142726|7365062|FG002|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
6449362|NCT01142791|7365078|FG000|STARTED|Overall Study||115
6449363|NCT01142791|7365079|FG001|STARTED|Overall Study|6 participants receiving only 1 sonication were included only in adverse events reporting.|6
6449364|NCT01142791|7365078|FG000|Safety|Overall Study||115
6449365|NCT01142791|7365079|FG001|Safety|Overall Study|Safety data only was reported for 6 participants receiving only 1 sonication.|6
6449366|NCT01142791|7365078|FG000|COMPLETED|Overall Study||108
6449367|NCT01142791|7365079|FG001|COMPLETED|Overall Study||0
6449368|NCT01142791|7365078|FG000|NOT COMPLETED|Overall Study||7
6449369|NCT01142791|7365079|FG001|NOT COMPLETED|Overall Study||6
6449370|NCT01142908|7365085|FG000|STARTED|Overall Study||215
6449371|NCT01142908|7365086|FG001|STARTED|Overall Study||213
6449372|NCT01142908|7365085|FG000|6 Month f/u|Overall Study||188
6449373|NCT01142908|7365086|FG001|6 Month f/u|Overall Study||196
6449374|NCT01142908|7365085|FG000|COMPLETED|Overall Study||183
6449375|NCT01142908|7365086|FG001|COMPLETED|Overall Study||191
6449376|NCT01142908|7365085|FG000|NOT COMPLETED|Overall Study||32
6449377|NCT01142908|7365086|FG001|NOT COMPLETED|Overall Study||22
6449378|NCT01142947|7365092|FG000|STARTED|Overall Study||362
6449379|NCT01142947|7365092|FG000|COMPLETED|Overall Study||244
6449380|NCT01142947|7365092|FG000|NOT COMPLETED|Overall Study||118
6449381|NCT01143038|7365096|FG000|STARTED|Overall Study||75
6449382|NCT01143038|7365096|FG000|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
6449383|NCT01143038|7365096|FG000|NOT COMPLETED|Overall Study||16
6449384|NCT01143051|7365106|FG000|STARTED|Visit 1||4
6449385|NCT01143051|7365107|FG001|STARTED|Visit 1||4
6449386|NCT01143051|7365108|FG002|STARTED|Visit 1||4
6449387|NCT01143051|7365109|FG003|STARTED|Visit 1||4
6449388|NCT01143051|7365110|FG004|STARTED|Visit 1||4
6449389|NCT01143051|7365111|FG005|STARTED|Visit 1||4
6449390|NCT01143051|7365106|FG000|COMPLETED|Visit 1||4
6449391|NCT01143051|7365107|FG001|COMPLETED|Visit 1||4
6449392|NCT01143051|7365108|FG002|COMPLETED|Visit 1||4
6449393|NCT01143051|7365109|FG003|COMPLETED|Visit 1||4
6449394|NCT01143051|7365110|FG004|COMPLETED|Visit 1||4
6449395|NCT01143051|7365111|FG005|COMPLETED|Visit 1||4
6449396|NCT01143051|7365106|FG000|NOT COMPLETED|Visit 1||0
6449397|NCT01143051|7365107|FG001|NOT COMPLETED|Visit 1||0
6449398|NCT01143051|7365108|FG002|NOT COMPLETED|Visit 1||0
6449399|NCT01143051|7365109|FG003|NOT COMPLETED|Visit 1||0
6449400|NCT01143051|7365110|FG004|NOT COMPLETED|Visit 1||0
6449401|NCT01143051|7365111|FG005|NOT COMPLETED|Visit 1||0
6449402|NCT01143051|7365106|FG000|STARTED|3-14 Day Washout||4
6449403|NCT01143051|7365107|FG001|STARTED|3-14 Day Washout||4
6449404|NCT01143051|7365108|FG002|STARTED|3-14 Day Washout||4
6449405|NCT01143051|7365109|FG003|STARTED|3-14 Day Washout||4
6449406|NCT01143051|7365110|FG004|STARTED|3-14 Day Washout||4
6449407|NCT01143051|7365111|FG005|STARTED|3-14 Day Washout||4
6449408|NCT01143051|7365106|FG000|COMPLETED|3-14 Day Washout||4
6449409|NCT01143051|7365107|FG001|COMPLETED|3-14 Day Washout||4
6449410|NCT01143051|7365108|FG002|COMPLETED|3-14 Day Washout||3
6449411|NCT01143051|7365109|FG003|COMPLETED|3-14 Day Washout||4
6449412|NCT01143051|7365110|FG004|COMPLETED|3-14 Day Washout||4
6449413|NCT01143051|7365111|FG005|COMPLETED|3-14 Day Washout||4
6449414|NCT01143051|7365106|FG000|NOT COMPLETED|3-14 Day Washout||0
6449415|NCT01143051|7365107|FG001|NOT COMPLETED|3-14 Day Washout||0
6449416|NCT01143051|7365108|FG002|NOT COMPLETED|3-14 Day Washout||1
6449417|NCT01143051|7365109|FG003|NOT COMPLETED|3-14 Day Washout||0
6449418|NCT01143051|7365110|FG004|NOT COMPLETED|3-14 Day Washout||0
6449419|NCT01143051|7365111|FG005|NOT COMPLETED|3-14 Day Washout||0
6449420|NCT01143051|7365106|FG000|STARTED|Visit 2||4
6449421|NCT01143051|7365107|FG001|STARTED|Visit 2||4
6449422|NCT01143051|7365108|FG002|STARTED|Visit 2||3
6449423|NCT01143051|7365109|FG003|STARTED|Visit 2||4
6449424|NCT01143051|7365110|FG004|STARTED|Visit 2||4
6449425|NCT01143051|7365111|FG005|STARTED|Visit 2||4
6449426|NCT01143051|7365106|FG000|COMPLETED|Visit 2||4
6449427|NCT01143051|7365107|FG001|COMPLETED|Visit 2||4
6449428|NCT01143051|7365108|FG002|COMPLETED|Visit 2||3
6449429|NCT01143051|7365109|FG003|COMPLETED|Visit 2||4
6449430|NCT01143051|7365110|FG004|COMPLETED|Visit 2||4
6449431|NCT01143051|7365111|FG005|COMPLETED|Visit 2||4
6449432|NCT01143051|7365106|FG000|NOT COMPLETED|Visit 2||0
6449433|NCT01143051|7365107|FG001|NOT COMPLETED|Visit 2||0
6449434|NCT01143051|7365108|FG002|NOT COMPLETED|Visit 2||0
6449435|NCT01143051|7365109|FG003|NOT COMPLETED|Visit 2||0
6449436|NCT01143051|7365110|FG004|NOT COMPLETED|Visit 2||0
6449437|NCT01143051|7365111|FG005|NOT COMPLETED|Visit 2||0
6449438|NCT01143051|7365106|FG000|STARTED|3-14 Day Washout||4
6449439|NCT01143051|7365107|FG001|STARTED|3-14 Day Washout||4
6449440|NCT01143051|7365108|FG002|STARTED|3-14 Day Washout||3
6449441|NCT01143051|7365109|FG003|STARTED|3-14 Day Washout||4
6449442|NCT01143051|7365110|FG004|STARTED|3-14 Day Washout||4
6449443|NCT01143051|7365111|FG005|STARTED|3-14 Day Washout||4
6449444|NCT01143051|7365106|FG000|COMPLETED|3-14 Day Washout||4
6449445|NCT01143051|7365107|FG001|COMPLETED|3-14 Day Washout||4
6449446|NCT01143051|7365108|FG002|COMPLETED|3-14 Day Washout||3
6449447|NCT01143051|7365109|FG003|COMPLETED|3-14 Day Washout||4
6449448|NCT01143051|7365110|FG004|COMPLETED|3-14 Day Washout||4
6449449|NCT01143051|7365111|FG005|COMPLETED|3-14 Day Washout||3
6449450|NCT01143051|7365106|FG000|NOT COMPLETED|3-14 Day Washout||0
6449451|NCT01143051|7365107|FG001|NOT COMPLETED|3-14 Day Washout||0
6449452|NCT01143051|7365108|FG002|NOT COMPLETED|3-14 Day Washout||0
6449453|NCT01143051|7365109|FG003|NOT COMPLETED|3-14 Day Washout||0
6449454|NCT01143051|7365110|FG004|NOT COMPLETED|3-14 Day Washout||0
6449455|NCT01143051|7365111|FG005|NOT COMPLETED|3-14 Day Washout||1
6449456|NCT01143051|7365106|FG000|STARTED|Visit 3||4
6449457|NCT01143051|7365107|FG001|STARTED|Visit 3||4
6744976|NCT03351738|7673046|FG001|STARTED|Overall Study||20
6744977|NCT03351738|7673047|FG002|STARTED|Overall Study||24
6744978|NCT03351738|7673048|FG003|STARTED|Overall Study||22
6744979|NCT03351738|7673049|FG004|STARTED|Overall Study||21
6744980|NCT03351738|7673050|FG005|STARTED|Overall Study||22
6449458|NCT01143051|7365108|FG002|STARTED|Visit 3||3
6449459|NCT01143051|7365109|FG003|STARTED|Visit 3||4
6449460|NCT01143051|7365110|FG004|STARTED|Visit 3||4
6449461|NCT01143051|7365111|FG005|STARTED|Visit 3||3
6449462|NCT01143051|7365106|FG000|COMPLETED|Visit 3||4
6449463|NCT01143051|7365107|FG001|COMPLETED|Visit 3||4
6449464|NCT01143051|7365108|FG002|COMPLETED|Visit 3||3
6449465|NCT01143051|7365109|FG003|COMPLETED|Visit 3||4
6449466|NCT01143051|7365110|FG004|COMPLETED|Visit 3||4
6449467|NCT01143051|7365111|FG005|COMPLETED|Visit 3||3
6449468|NCT01143051|7365106|FG000|NOT COMPLETED|Visit 3||0
6449469|NCT01143051|7365107|FG001|NOT COMPLETED|Visit 3||0
6449470|NCT01143051|7365108|FG002|NOT COMPLETED|Visit 3||0
6449471|NCT01143051|7365109|FG003|NOT COMPLETED|Visit 3||0
6449472|NCT01143051|7365110|FG004|NOT COMPLETED|Visit 3||0
6449473|NCT01143051|7365111|FG005|NOT COMPLETED|Visit 3||0
6449474|NCT01143077|7365124|FG000|STARTED|Overall Study||74
6449475|NCT01143077|7365125|FG001|STARTED|Overall Study||88
6449476|NCT01143077|7365126|FG002|STARTED|Overall Study||82
6449477|NCT01143077|7365124|FG000|COMPLETED|Overall Study||58
6449478|NCT01143077|7365125|FG001|COMPLETED|Overall Study||73
6449479|NCT01143077|7365126|FG002|COMPLETED|Overall Study||67
6449480|NCT01143077|7365124|FG000|NOT COMPLETED|Overall Study||16
6449481|NCT01143077|7365125|FG001|NOT COMPLETED|Overall Study||15
6449482|NCT01143077|7365126|FG002|NOT COMPLETED|Overall Study||15
6449483|NCT01143090|7365134|FG000|STARTED|Overall Study||149
6449484|NCT01143090|7365134|FG000|COMPLETED|Overall Study||98
6449485|NCT01143090|7365134|FG000|NOT COMPLETED|Overall Study||51
6449486|NCT01143142|7365140|FG000|STARTED|Overall Study||36
6449487|NCT01143142|7365141|FG001|STARTED|Overall Study||34
6449488|NCT01143142|7365140|FG000|COMPLETED|Overall Study||36
6449489|NCT01143142|7365141|FG001|COMPLETED|Overall Study||34
6449490|NCT01143142|7365140|FG000|NOT COMPLETED|Overall Study||0
6449491|NCT01143142|7365141|FG001|NOT COMPLETED|Overall Study||0
6449492|NCT01143181|7365151|FG000|STARTED|Overall Study||30
6449493|NCT01143181|7365152|FG001|STARTED|Overall Study||38
6449494|NCT01143181|7365153|FG002|STARTED|Overall Study||102
6449495|NCT01143181|7365154|FG003|STARTED|Overall Study||40
6449496|NCT01143181|7365151|FG000|COMPLETED|Overall Study||14
6449497|NCT01143181|7365152|FG001|COMPLETED|Overall Study||22
6449498|NCT01143181|7365153|FG002|COMPLETED|Overall Study||58
6449499|NCT01143181|7365154|FG003|COMPLETED|Overall Study||17
6449500|NCT01143181|7365151|FG000|NOT COMPLETED|Overall Study||16
6449501|NCT01143181|7365152|FG001|NOT COMPLETED|Overall Study||16
6449502|NCT01143181|7365153|FG002|NOT COMPLETED|Overall Study||44
6449503|NCT01143181|7365154|FG003|NOT COMPLETED|Overall Study||23
6449504|NCT01143207|7365164|FG000|STARTED|Overall Study||26
6449505|NCT01143207|7365164|FG000|COMPLETED|Overall Study||24
6744981|NCT03351738|7673045|FG000|COMPLETED|Overall Study||23
6744982|NCT03351738|7673046|FG001|COMPLETED|Overall Study||19
6553377|NCT01743469|7475887|FG001|COMPLETED|Follow-up Period - Post-Treatment||5
6553378|NCT01743469|7475888|FG002|COMPLETED|Follow-up Period - Post-Treatment||14
6553379|NCT01743469|7475889|FG003|COMPLETED|Follow-up Period - Post-Treatment||5
6449506|NCT01143207|7365164|FG000|NOT COMPLETED|Overall Study||2
6449507|NCT01143259|7365170|FG000|STARTED|Overall Study||136
6449508|NCT01143259|7365171|FG001|STARTED|Overall Study||138
6449509|NCT01143259|7365170|FG000|COMPLETED|Overall Study||113
6449510|NCT01143259|7365171|FG001|COMPLETED|Overall Study||118
6449511|NCT01143259|7365170|FG000|NOT COMPLETED|Overall Study||23
6449512|NCT01143259|7365171|FG001|NOT COMPLETED|Overall Study||20
6449513|NCT01143272|7365179|FG000|STARTED|Overall Study||246
6449514|NCT01143272|7365180|FG001|STARTED|Overall Study||231
6449515|NCT01143272|7365179|FG000|COMPLETED|Overall Study||246
6449516|NCT01143272|7365180|FG001|COMPLETED|Overall Study||231
6449517|NCT01143272|7365179|FG000|NOT COMPLETED|Overall Study||0
6449518|NCT01143272|7365180|FG001|NOT COMPLETED|Overall Study||0
6449519|NCT01143324|7365186|FG000|STARTED|Overall Study||252
6449520|NCT01143324|7365186|FG000|COMPLETED|Overall Study||233
6449521|NCT01143324|7365186|FG000|NOT COMPLETED|Overall Study||19
6449522|NCT01143337|7365192|FG000|STARTED|Overall Study||49
6449523|NCT01143337|7365193|FG001|STARTED|Overall Study||50
6449524|NCT01143337|7365194|FG002|STARTED|Overall Study||13
6449525|NCT01143337|7365192|FG000|COMPLETED|Overall Study||39
6449526|NCT01143337|7365193|FG001|COMPLETED|Overall Study||39
6449527|NCT01143337|7365194|FG002|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
6449528|NCT01143337|7365192|FG000|NOT COMPLETED|Overall Study||10
6449529|NCT01143337|7365193|FG001|NOT COMPLETED|Overall Study||11
6449530|NCT01143337|7365194|FG002|NOT COMPLETED|Overall Study||12
6449531|NCT01143389|7365202|FG000|STARTED|Overall Study||253
6449532|NCT01143389|7365203|FG001|STARTED|Overall Study||257
6449533|NCT01143389|7365202|FG000|COMPLETED|Overall Study||227
6449534|NCT01143389|7365203|FG001|COMPLETED|Overall Study||232
6449535|NCT01143389|7365202|FG000|NOT COMPLETED|Overall Study||26
6449536|NCT01143389|7365203|FG001|NOT COMPLETED|Overall Study||25
6449537|NCT01143402|7365212|FG000|STARTED|Overall Study||51
6449538|NCT01143402|7365213|FG001|STARTED|Overall Study||50
6449539|NCT01143402|7365214|FG002|STARTED|Overall Study||19
6449540|NCT01143402|7365212|FG000|COMPLETED|Overall Study||50
6449541|NCT01143402|7365213|FG001|COMPLETED|Overall Study||49
6449542|NCT01143402|7365214|FG002|COMPLETED|Overall Study||18
6449543|NCT01143402|7365212|FG000|NOT COMPLETED|Overall Study||1
6449544|NCT01143402|7365213|FG001|NOT COMPLETED|Overall Study||1
6449545|NCT01143402|7365214|FG002|NOT COMPLETED|Overall Study||1
6449546|NCT01143610|7365223|FG000|STARTED|Overall Study||7
6449547|NCT01143610|7365224|FG001|STARTED|Overall Study||8
6449548|NCT01143610|7365223|FG000|COMPLETED|Overall Study||7
6449549|NCT01143610|7365224|FG001|COMPLETED|Overall Study||8
6449550|NCT01143610|7365223|FG000|NOT COMPLETED|Overall Study||0
6449551|NCT01143610|7365224|FG001|NOT COMPLETED|Overall Study||0
6449552|NCT01143636|7365233|FG000|STARTED|Overall Study||6
6449553|NCT01143636|7365234|FG001|STARTED|Overall Study||5
6449554|NCT01143636|7365235|FG002|STARTED|Overall Study||8
6449555|NCT01143636|7365236|FG003|STARTED|Overall Study||7
6449556|NCT01143636|7365233|FG000|COMPLETED|Overall Study||5
6449557|NCT01143636|7365234|FG001|COMPLETED|Overall Study||4
6449558|NCT01143636|7365235|FG002|COMPLETED|Overall Study||8
6449559|NCT01143636|7365236|FG003|COMPLETED|Overall Study||7
6449560|NCT01143636|7365233|FG000|NOT COMPLETED|Overall Study||1
6449561|NCT01143636|7365234|FG001|NOT COMPLETED|Overall Study||1
6449562|NCT01143636|7365235|FG002|NOT COMPLETED|Overall Study||0
6449563|NCT01143636|7365236|FG003|NOT COMPLETED|Overall Study||0
6449564|NCT01143649|7365251|FG000|STARTED|Overall Study||7
6449565|NCT01143649|7365252|FG001|STARTED|Overall Study||7
6449566|NCT01143649|7365253|FG002|STARTED|Overall Study||10
6449567|NCT01143649|7365254|FG003|STARTED|Overall Study||10
6449568|NCT01143649|7365255|FG004|STARTED|Overall Study||5
6449569|NCT01143649|7365256|FG005|STARTED|Overall Study||5
6449570|NCT01143649|7365251|FG000|COMPLETED|Overall Study||7
6449571|NCT01143649|7365252|FG001|COMPLETED|Overall Study||7
6744983|NCT03351738|7673047|FG002|COMPLETED|Overall Study||24
6744984|NCT03351738|7673048|FG003|COMPLETED|Overall Study||21
6744985|NCT03351738|7673049|FG004|COMPLETED|Overall Study||21
6744986|NCT03351738|7673050|FG005|COMPLETED|Overall Study||22
6744987|NCT03351738|7673045|FG000|NOT COMPLETED|Overall Study||0
6744988|NCT03351738|7673046|FG001|NOT COMPLETED|Overall Study||1
6744989|NCT03351738|7673047|FG002|NOT COMPLETED|Overall Study||0
6449572|NCT01143649|7365253|FG002|COMPLETED|Overall Study||10
6449573|NCT01143649|7365254|FG003|COMPLETED|Overall Study||10
6449574|NCT01143649|7365255|FG004|COMPLETED|Overall Study||4
6744990|NCT03351738|7673048|FG003|NOT COMPLETED|Overall Study||1
6449575|NCT01143649|7365256|FG005|COMPLETED|Overall Study||3
6449576|NCT01143649|7365251|FG000|NOT COMPLETED|Overall Study||0
6449577|NCT01143649|7365252|FG001|NOT COMPLETED|Overall Study||0
6449578|NCT01143649|7365253|FG002|NOT COMPLETED|Overall Study||0
6449579|NCT01143649|7365254|FG003|NOT COMPLETED|Overall Study||0
6449580|NCT01143649|7365255|FG004|NOT COMPLETED|Overall Study||1
6449581|NCT01143649|7365256|FG005|NOT COMPLETED|Overall Study||2
6449582|NCT01143688|7365270|FG000|STARTED|Overall Study||39
6449583|NCT01143688|7365270|FG000|COMPLETED|Overall Study||39
6449584|NCT01143688|7365270|FG000|NOT COMPLETED|Overall Study||0
6449585|NCT01143701|7365282|FG000|STARTED|Overall Study||258
6449586|NCT01143701|7365283|FG001|STARTED|Overall Study||319
6449587|NCT01143701|7365282|FG000|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
6449588|NCT01143701|7365283|FG001|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
6449589|NCT01143701|7365282|FG000|NOT COMPLETED|Overall Study||23
6449590|NCT01143701|7365283|FG001|NOT COMPLETED|Overall Study||32
6449591|NCT01143714|7365291|FG000|STARTED|Overall Study||29
6449592|NCT01143714|7365292|FG001|STARTED|Overall Study||28
6449593|NCT01143714|7365291|FG000|COMPLETED|Overall Study||22
6449594|NCT01143714|7365292|FG001|COMPLETED|Overall Study||25
6449595|NCT01143714|7365291|FG000|NOT COMPLETED|Overall Study||7
6449596|NCT01143714|7365292|FG001|NOT COMPLETED|Overall Study||3
6449597|NCT01143727|7365300|FG000|STARTED|Overall Study||9
6449598|NCT01143727|7365301|FG001|STARTED|Overall Study||8
6449599|NCT01143727|7365300|FG000|COMPLETED|Overall Study||9
6449600|NCT01143727|7365301|FG001|COMPLETED|Overall Study||8
6449601|NCT01143727|7365300|FG000|NOT COMPLETED|Overall Study||0
6449602|NCT01143727|7365301|FG001|NOT COMPLETED|Overall Study||0
6449603|NCT01143766|7365309|FG000|STARTED|Overall Study||25
6449604|NCT01143766|7365310|FG001|STARTED|Overall Study||31
6449605|NCT01143766|7365309|FG000|COMPLETED|Overall Study||25
6449606|NCT01143766|7365310|FG001|COMPLETED|Overall Study||31
6449607|NCT01143766|7365309|FG000|NOT COMPLETED|Overall Study||0
6449608|NCT01143766|7365310|FG001|NOT COMPLETED|Overall Study||0
6449609|NCT01143792|7365321|FG000|STARTED|Overall Study||93
6449610|NCT01143792|7365322|FG001|STARTED|Overall Study||86
6449611|NCT01143792|7365323|FG002|STARTED|Overall Study||91
6449612|NCT01143792|7365321|FG000|COMPLETED|Overall Study||93
6449613|NCT01143792|7365322|FG001|COMPLETED|Overall Study||86
6449614|NCT01143792|7365323|FG002|COMPLETED|Overall Study||91
6449615|NCT01143792|7365321|FG000|NOT COMPLETED|Overall Study||0
6449616|NCT01143792|7365322|FG001|NOT COMPLETED|Overall Study||0
6449617|NCT01143792|7365323|FG002|NOT COMPLETED|Overall Study||0
6449618|NCT01143818|7365342|FG000|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
6449619|NCT01143818|7365342|FG000|COMPLETED|Overall Study||799
6449620|NCT01143818|7365342|FG000|NOT COMPLETED|Overall Study||250
6449621|NCT01143870|7365349|FG000|STARTED|Overall Study||58
6449622|NCT01143870|7365350|FG001|STARTED|Overall Study||58
6449623|NCT01143870|7365351|FG002|STARTED|Overall Study||61
6449624|NCT01143870|7365349|FG000|Post-intervention Survey|Overall Study||53
6449625|NCT01143870|7365350|FG001|Post-intervention Survey|Overall Study||50
6449626|NCT01143870|7365351|FG002|Post-intervention Survey|Overall Study||61
6449627|NCT01143870|7365349|FG000|Had Available 6-month A1C|Overall Study||27
6449628|NCT01143870|7365350|FG001|Had Available 6-month A1C|Overall Study||29
6449629|NCT01143870|7365351|FG002|Had Available 6-month A1C|Overall Study||31
6449630|NCT01143870|7365349|FG000|A1C Imputed|Overall Study||31
6449631|NCT01143870|7365350|FG001|A1C Imputed|Overall Study||29
6449632|NCT01143870|7365351|FG002|A1C Imputed|Overall Study||30
6449633|NCT01143870|7365349|FG000|COMPLETED|Overall Study||58
6449634|NCT01143870|7365350|FG001|COMPLETED|Overall Study||58
6449635|NCT01143870|7365351|FG002|COMPLETED|Overall Study||61
6449636|NCT01143870|7365349|FG000|NOT COMPLETED|Overall Study||0
6449637|NCT01143870|7365350|FG001|NOT COMPLETED|Overall Study||0
6449638|NCT01143870|7365351|FG002|NOT COMPLETED|Overall Study||0
6449639|NCT01143883|7365361|FG000|STARTED|Overall Study||55
6449640|NCT01143883|7365362|FG001|STARTED|Overall Study||55
6449641|NCT01143883|7365361|FG000|COMPLETED|Overall Study||55
6449642|NCT01143883|7365362|FG001|COMPLETED|Overall Study||55
6449643|NCT01143883|7365361|FG000|NOT COMPLETED|Overall Study||0
6449644|NCT01143883|7365362|FG001|NOT COMPLETED|Overall Study||0
6449645|NCT01143896|7365370|FG000|STARTED|Overall Study||156
6449646|NCT01143896|7365371|FG001|STARTED|Overall Study||153
6449647|NCT01143896|7365370|FG000|COMPLETED|Overall Study||114
6449648|NCT01143896|7365371|FG001|COMPLETED|Overall Study||128
6449649|NCT01143896|7365370|FG000|NOT COMPLETED|Overall Study||42
6449650|NCT01143896|7365371|FG001|NOT COMPLETED|Overall Study||25
6449651|NCT01144026|7365380|FG000|STARTED|Overall Study||10
6449652|NCT01144026|7365381|FG001|STARTED|Overall Study||5
6449653|NCT01144026|7365380|FG000|COMPLETED|Overall Study||10
6449654|NCT01144026|7365381|FG001|COMPLETED|Overall Study||5
6449655|NCT01144026|7365380|FG000|NOT COMPLETED|Overall Study||0
6449656|NCT01144026|7365381|FG001|NOT COMPLETED|Overall Study||0
6449657|NCT01144052|7365389|FG000|STARTED|Overall Study||10
6449658|NCT01144052|7365390|FG001|STARTED|Overall Study||9
6449659|NCT01144052|7365389|FG000|COMPLETED|Overall Study||9
6449660|NCT01144052|7365390|FG001|COMPLETED|Overall Study||8
6449661|NCT01144052|7365389|FG000|NOT COMPLETED|Overall Study||1
6449662|NCT01144052|7365390|FG001|NOT COMPLETED|Overall Study||1
6449663|NCT01144143|7365401|FG000|STARTED|Overall Study||8
6449664|NCT01144143|7365402|FG001|STARTED|Overall Study||4
6449665|NCT01144143|7365403|FG002|STARTED|Overall Study||4
6449666|NCT01144143|7365401|FG000|COMPLETED|Overall Study||8
6449667|NCT01144143|7365402|FG001|COMPLETED|Overall Study||4
6449668|NCT01144143|7365403|FG002|COMPLETED|Overall Study||4
6449669|NCT01144143|7365401|FG000|NOT COMPLETED|Overall Study||0
6449670|NCT01144143|7365402|FG001|NOT COMPLETED|Overall Study||0
6449671|NCT01144143|7365403|FG002|NOT COMPLETED|Overall Study||0
6449672|NCT01144182|7365417|FG000|STARTED|Overall Study||68
6449673|NCT01144182|7365418|FG001|STARTED|Overall Study||68
6449674|NCT01144182|7365417|FG000|COMPLETED|Overall Study||51
6449675|NCT01144182|7365418|FG001|COMPLETED|Overall Study||47
6449676|NCT01144182|7365417|FG000|NOT COMPLETED|Overall Study||17
6449677|NCT01144182|7365418|FG001|NOT COMPLETED|Overall Study||21
6449678|NCT01144286|7365429|FG000|STARTED|Overall Study||57
6449679|NCT01144286|7365430|FG001|STARTED|Overall Study||58
6449680|NCT01144286|7365431|FG002|STARTED|Overall Study||58
6449681|NCT01144286|7365432|FG003|STARTED|Overall Study||56
6449682|NCT01144286|7365429|FG000|COMPLETED|Overall Study||57
6449683|NCT01144286|7365430|FG001|COMPLETED|Overall Study||58
6449684|NCT01144286|7365431|FG002|COMPLETED|Overall Study||58
6449685|NCT01144286|7365432|FG003|COMPLETED|Overall Study||56
6449686|NCT01144286|7365429|FG000|NOT COMPLETED|Overall Study||0
6449687|NCT01144286|7365430|FG001|NOT COMPLETED|Overall Study||0
6449688|NCT01144286|7365431|FG002|NOT COMPLETED|Overall Study||0
6449689|NCT01144286|7365432|FG003|NOT COMPLETED|Overall Study||0
6449690|NCT01144299|7365444|FG000|STARTED|Overall Study||60
6449691|NCT01144299|7365445|FG001|STARTED|Overall Study||54
6449692|NCT01144299|7365444|FG000|COMPLETED|Overall Study||58
6449693|NCT01144299|7365445|FG001|COMPLETED|Overall Study||54
6449694|NCT01144299|7365444|FG000|NOT COMPLETED|Overall Study||2
6449695|NCT01144299|7365445|FG001|NOT COMPLETED|Overall Study||0
6449696|NCT01144338|7365453|FG000|STARTED|Overall Study||7396
6449697|NCT01144338|7365454|FG001|STARTED|Overall Study||7356
6449698|NCT01144338|7365453|FG000|COMPLETED|Overall Study||7093
6449699|NCT01144338|7365454|FG001|COMPLETED|Overall Study||7094
6449700|NCT01144338|7365453|FG000|NOT COMPLETED|Overall Study||303
6449701|NCT01144338|7365454|FG001|NOT COMPLETED|Overall Study||262
6449702|NCT01144364|7365462|FG000|STARTED|Induction Phase||234
6449703|NCT01144364|7365463|FG001|STARTED|Induction Phase||0
6449704|NCT01144364|7365464|FG002|STARTED|Induction Phase||0
6449705|NCT01144364|7365462|FG000|COMPLETED|Induction Phase||202
6449706|NCT01144364|7365463|FG001|COMPLETED|Induction Phase||0
6449707|NCT01144364|7365464|FG002|COMPLETED|Induction Phase||0
6449708|NCT01144364|7365462|FG000|NOT COMPLETED|Induction Phase||32
6449709|NCT01144364|7365463|FG001|NOT COMPLETED|Induction Phase||0
6553380|NCT01743469|7475886|FG000|NOT COMPLETED|Follow-up Period - Post-Treatment||45
6553381|NCT01743469|7475887|FG001|NOT COMPLETED|Follow-up Period - Post-Treatment||48
6553382|NCT01743469|7475888|FG002|NOT COMPLETED|Follow-up Period - Post-Treatment||23
6553383|NCT01743469|7475889|FG003|NOT COMPLETED|Follow-up Period - Post-Treatment||16
6553384|NCT01743521|7475903|FG000|STARTED|Overall Study||7
6553385|NCT01743521|7475904|FG001|STARTED|Overall Study||3
6553386|NCT01743521|7475905|FG002|STARTED|Overall Study||2
6553387|NCT01743521|7475906|FG003|STARTED|Overall Study||2
6553388|NCT01743521|7475903|FG000|COMPLETED|Overall Study||7
6553389|NCT01743521|7475904|FG001|COMPLETED|Overall Study||3
6553390|NCT01743521|7475905|FG002|COMPLETED|Overall Study||2
6449710|NCT01144364|7365464|FG002|NOT COMPLETED|Induction Phase||0
6449711|NCT01144364|7365462|FG000|STARTED|Follow-Up/Maintenance Phase||0
6449712|NCT01144364|7365463|FG001|STARTED|Follow-Up/Maintenance Phase||101
6449713|NCT01144364|7365464|FG002|STARTED|Follow-Up/Maintenance Phase||101
6449714|NCT01144364|7365462|FG000|COMPLETED|Follow-Up/Maintenance Phase||0
6449715|NCT01144364|7365463|FG001|COMPLETED|Follow-Up/Maintenance Phase||66
6449716|NCT01144364|7365464|FG002|COMPLETED|Follow-Up/Maintenance Phase||60
6449717|NCT01144364|7365462|FG000|NOT COMPLETED|Follow-Up/Maintenance Phase||0
6449718|NCT01144364|7365463|FG001|NOT COMPLETED|Follow-Up/Maintenance Phase||35
6449719|NCT01144364|7365464|FG002|NOT COMPLETED|Follow-Up/Maintenance Phase||41
6449720|NCT01144377|7365479|FG000|STARTED|52 Week Treatment Period||31
6449721|NCT01144377|7365480|FG001|STARTED|52 Week Treatment Period||30
6449722|NCT01144377|7365481|FG002|STARTED|52 Week Treatment Period||30
6449723|NCT01144377|7365482|FG003|STARTED|52 Week Treatment Period||26
6449724|NCT01144377|7365483|FG004|STARTED|52 Week Treatment Period||37
6449725|NCT01144377|7365479|FG000|Received at Least One Dose of Study Drug|52 Week Treatment Period||31
6449726|NCT01144377|7365480|FG001|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
6449727|NCT01144377|7365481|FG002|Received at Least One Dose of Study Drug|52 Week Treatment Period||30
6449728|NCT01144377|7365482|FG003|Received at Least One Dose of Study Drug|52 Week Treatment Period||25
6449729|NCT01144377|7365483|FG004|Received at Least One Dose of Study Drug|52 Week Treatment Period||37
6449730|NCT01144377|7365479|FG000|COMPLETED|52 Week Treatment Period||26
6449731|NCT01144377|7365480|FG001|COMPLETED|52 Week Treatment Period||29
6449732|NCT01144377|7365481|FG002|COMPLETED|52 Week Treatment Period||25
6449733|NCT01144377|7365482|FG003|COMPLETED|52 Week Treatment Period||22
6449734|NCT01144377|7365483|FG004|COMPLETED|52 Week Treatment Period||34
6449735|NCT01144377|7365479|FG000|NOT COMPLETED|52 Week Treatment Period||5
6449736|NCT01144377|7365480|FG001|NOT COMPLETED|52 Week Treatment Period||1
6449737|NCT01144377|7365481|FG002|NOT COMPLETED|52 Week Treatment Period||5
6449738|NCT01144377|7365482|FG003|NOT COMPLETED|52 Week Treatment Period||4
6449739|NCT01144377|7365483|FG004|NOT COMPLETED|52 Week Treatment Period||3
6449740|NCT01144377|7365479|FG000|STARTED|12 Week Safety Follow-up Period||26
6449741|NCT01144377|7365480|FG001|STARTED|12 Week Safety Follow-up Period||29
6449742|NCT01144377|7365481|FG002|STARTED|12 Week Safety Follow-up Period||25
6449743|NCT01144377|7365482|FG003|STARTED|12 Week Safety Follow-up Period||22
6553391|NCT01743521|7475906|FG003|COMPLETED|Overall Study||2
6449744|NCT01144377|7365483|FG004|STARTED|12 Week Safety Follow-up Period||34
6449745|NCT01144377|7365479|FG000|COMPLETED|12 Week Safety Follow-up Period|Of the 26 participants who completed this Period, 22 continued to the Optional 40 Week follow-up.|26
6449746|NCT01144377|7365480|FG001|COMPLETED|12 Week Safety Follow-up Period|Of the 29 participants who completed this Period, 25 continued to the Optional 40 Week follow-up.|29
6500433|NCT01424514|7419139|FG001|STARTED|Period 3:Intervention Period 2 (14 Days)||19
6449747|NCT01144377|7365481|FG002|COMPLETED|12 Week Safety Follow-up Period|Of the 25 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|25
6449748|NCT01144377|7365482|FG003|COMPLETED|12 Week Safety Follow-up Period|Of the 22 participants who completed this Period, 3 continued to the Optional 40 Week follow-up.|22
6449749|NCT01144377|7365483|FG004|COMPLETED|12 Week Safety Follow-up Period|Of the 34 participants who completed this Period, 23 continued to the Optional 40 Week follow-up.|34
6449750|NCT01144377|7365479|FG000|NOT COMPLETED|12 Week Safety Follow-up Period||0
6449751|NCT01144377|7365480|FG001|NOT COMPLETED|12 Week Safety Follow-up Period||0
6449752|NCT01144377|7365481|FG002|NOT COMPLETED|12 Week Safety Follow-up Period||0
6449753|NCT01144377|7365482|FG003|NOT COMPLETED|12 Week Safety Follow-up Period||0
6449754|NCT01144377|7365483|FG004|NOT COMPLETED|12 Week Safety Follow-up Period||0
6449755|NCT01144377|7365479|FG000|STARTED|Optional 40 Week Safety Follow-up Period||22
6449756|NCT01144377|7365480|FG001|STARTED|Optional 40 Week Safety Follow-up Period||25
6449757|NCT01144377|7365481|FG002|STARTED|Optional 40 Week Safety Follow-up Period||23
6449758|NCT01144377|7365482|FG003|STARTED|Optional 40 Week Safety Follow-up Period||3
6449759|NCT01144377|7365483|FG004|STARTED|Optional 40 Week Safety Follow-up Period||23
6449760|NCT01144377|7365479|FG000|COMPLETED|Optional 40 Week Safety Follow-up Period||21
6449761|NCT01144377|7365480|FG001|COMPLETED|Optional 40 Week Safety Follow-up Period||24
6449762|NCT01144377|7365481|FG002|COMPLETED|Optional 40 Week Safety Follow-up Period||23
6449763|NCT01144377|7365482|FG003|COMPLETED|Optional 40 Week Safety Follow-up Period||3
6449764|NCT01144377|7365483|FG004|COMPLETED|Optional 40 Week Safety Follow-up Period||21
6449765|NCT01144377|7365479|FG000|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
6449766|NCT01144377|7365480|FG001|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||1
6449767|NCT01144377|7365481|FG002|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
6449768|NCT01144377|7365482|FG003|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||0
6449769|NCT01144377|7365483|FG004|NOT COMPLETED|Optional 40 Week Safety Follow-up Period||2
6449770|NCT01144403|7365497|FG000|STARTED|Overall Study||8
6449771|NCT01144403|7365497|FG000|COMPLETED|Overall Study||3
6449772|NCT01144403|7365497|FG000|NOT COMPLETED|Overall Study||5
6449773|NCT01144442|7365502|FG000|STARTED|Overall Study||10
6449774|NCT01144442|7365502|FG000|COMPLETED|Overall Study||10
6449775|NCT01144442|7365502|FG000|NOT COMPLETED|Overall Study||0
6449776|NCT01144455|7365509|FG000|STARTED|Overall Study||69
6449777|NCT01144455|7365510|FG001|STARTED|Overall Study||71
6449778|NCT01144455|7365511|FG002|STARTED|Overall Study||74
6449779|NCT01144455|7365509|FG000|COMPLETED|Overall Study||19
6449780|NCT01144455|7365510|FG001|COMPLETED|Overall Study||29
6449781|NCT01144455|7365511|FG002|COMPLETED|Overall Study||38
6449782|NCT01144455|7365509|FG000|NOT COMPLETED|Overall Study||50
6449783|NCT01144455|7365510|FG001|NOT COMPLETED|Overall Study||42
6449784|NCT01144455|7365511|FG002|NOT COMPLETED|Overall Study||36
6449785|NCT01144494|7365519|FG000|STARTED|Overall Study||15
6449786|NCT01144494|7365520|FG001|STARTED|Overall Study||18
6449787|NCT01144494|7365519|FG000|COMPLETED|Overall Study||15
6449788|NCT01144494|7365520|FG001|COMPLETED|Overall Study||14
6449789|NCT01144494|7365519|FG000|NOT COMPLETED|Overall Study||0
6449790|NCT01144494|7365520|FG001|NOT COMPLETED|Overall Study||4
6449791|NCT01144598|7365531|FG000|STARTED|Overall Study||356
6449792|NCT01144598|7365531|FG000|Analysis Population|Overall Study||356
6449793|NCT01144598|7365531|FG000|COMPLETED|Overall Study||356
6449794|NCT01144598|7365531|FG000|NOT COMPLETED|Overall Study||0
6449795|NCT01144624|7365538|FG000|STARTED|Overall Study||7
6449796|NCT01144624|7365539|FG001|STARTED|Overall Study||7
6449797|NCT01144624|7365540|FG002|STARTED|Overall Study||6
6449798|NCT01144624|7365538|FG000|Received Treatment|Overall Study||7
6553392|NCT01743521|7475903|FG000|NOT COMPLETED|Overall Study||0
6553393|NCT01743521|7475904|FG001|NOT COMPLETED|Overall Study||0
6744991|NCT03351738|7673049|FG004|NOT COMPLETED|Overall Study||0
6744992|NCT03351738|7673050|FG005|NOT COMPLETED|Overall Study||0
6449799|NCT01144624|7365539|FG001|Received Treatment|Overall Study||7
6449800|NCT01144624|7365540|FG002|Received Treatment|Overall Study||6
6449801|NCT01144624|7365538|FG000|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
6449802|NCT01144624|7365539|FG001|Completed Treatment|Overall Study||7
6449803|NCT01144624|7365540|FG002|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
6449804|NCT01144624|7365538|FG000|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
6449805|NCT01144624|7365539|FG001|COMPLETED|Overall Study||7
6449806|NCT01144624|7365540|FG002|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
6449807|NCT01144624|7365538|FG000|NOT COMPLETED|Overall Study||0
6449808|NCT01144624|7365539|FG001|NOT COMPLETED|Overall Study||0
6449809|NCT01144624|7365540|FG002|NOT COMPLETED|Overall Study||0
6449810|NCT01144637|7365552|FG000|STARTED|Overall Study||999
6449811|NCT01144637|7365553|FG001|STARTED|Overall Study||1005
6449812|NCT01144637|7365554|FG002|STARTED|Overall Study||999
6449813|NCT01144637|7365555|FG003|STARTED|Overall Study||1002
6449814|NCT01144637|7365552|FG000|COMPLETED|Overall Study||925
6449815|NCT01144637|7365553|FG001|COMPLETED|Overall Study||929
6449816|NCT01144637|7365554|FG002|COMPLETED|Overall Study||939
6449817|NCT01144637|7365555|FG003|COMPLETED|Overall Study||946
6449818|NCT01144637|7365552|FG000|NOT COMPLETED|Overall Study||74
6449819|NCT01144637|7365553|FG001|NOT COMPLETED|Overall Study||76
6744993|NCT03351933|7673069|FG000|STARTED|Overall Study||28
6449820|NCT01144637|7365554|FG002|NOT COMPLETED|Overall Study||60
6449821|NCT01144637|7365555|FG003|NOT COMPLETED|Overall Study||56
6449822|NCT01144663|7365569|FG000|STARTED|Primary Vaccination Phase||528
6449823|NCT01144663|7365570|FG001|STARTED|Primary Vaccination Phase||524
6449824|NCT01144663|7365571|FG002|STARTED|Primary Vaccination Phase||516
6449825|NCT01144663|7365572|FG003|STARTED|Primary Vaccination Phase||527
6449826|NCT01144663|7365569|FG000|COMPLETED|Primary Vaccination Phase||508
6449827|NCT01144663|7365570|FG001|COMPLETED|Primary Vaccination Phase||517
6449828|NCT01144663|7365571|FG002|COMPLETED|Primary Vaccination Phase||508
6449829|NCT01144663|7365572|FG003|COMPLETED|Primary Vaccination Phase||509
6449830|NCT01144663|7365569|FG000|NOT COMPLETED|Primary Vaccination Phase||20
6449831|NCT01144663|7365570|FG001|NOT COMPLETED|Primary Vaccination Phase||7
6449832|NCT01144663|7365571|FG002|NOT COMPLETED|Primary Vaccination Phase||8
6449833|NCT01144663|7365572|FG003|NOT COMPLETED|Primary Vaccination Phase||18
6449834|NCT01144663|7365569|FG000|STARTED|Booster Vaccination Phase||497
6449835|NCT01144663|7365570|FG001|STARTED|Booster Vaccination Phase||511
6449836|NCT01144663|7365571|FG002|STARTED|Booster Vaccination Phase||503
6449837|NCT01144663|7365572|FG003|STARTED|Booster Vaccination Phase||506
6449838|NCT01144663|7365569|FG000|COMPLETED|Booster Vaccination Phase||494
6449839|NCT01144663|7365570|FG001|COMPLETED|Booster Vaccination Phase||509
6449840|NCT01144663|7365571|FG002|COMPLETED|Booster Vaccination Phase||498
6449841|NCT01144663|7365572|FG003|COMPLETED|Booster Vaccination Phase||505
6449842|NCT01144663|7365569|FG000|NOT COMPLETED|Booster Vaccination Phase||3
6449843|NCT01144663|7365570|FG001|NOT COMPLETED|Booster Vaccination Phase||2
6449844|NCT01144663|7365571|FG002|NOT COMPLETED|Booster Vaccination Phase||5
6449845|NCT01144663|7365572|FG003|NOT COMPLETED|Booster Vaccination Phase||1
6449846|NCT01144663|7365569|FG000|STARTED|Extended Safety Follow-Up (ESFU)||497
6449847|NCT01144663|7365570|FG001|STARTED|Extended Safety Follow-Up (ESFU)||511
6449848|NCT01144663|7365571|FG002|STARTED|Extended Safety Follow-Up (ESFU)||503
6449849|NCT01144663|7365572|FG003|STARTED|Extended Safety Follow-Up (ESFU)||506
6449850|NCT01144663|7365569|FG000|COMPLETED|Extended Safety Follow-Up (ESFU)||492
6449851|NCT01144663|7365570|FG001|COMPLETED|Extended Safety Follow-Up (ESFU)||502
6449852|NCT01144663|7365571|FG002|COMPLETED|Extended Safety Follow-Up (ESFU)||496
6449853|NCT01144663|7365572|FG003|COMPLETED|Extended Safety Follow-Up (ESFU)||505
6449854|NCT01144663|7365569|FG000|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||5
6449855|NCT01144663|7365570|FG001|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||9
6449856|NCT01144663|7365571|FG002|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||7
6449857|NCT01144663|7365572|FG003|NOT COMPLETED|Extended Safety Follow-Up (ESFU)||1
6449858|NCT01144715|7365584|FG000|STARTED|Overall Study||51
6449859|NCT01144715|7365585|FG001|STARTED|Overall Study||48
6449860|NCT01144715|7365584|FG000|COMPLETED|Overall Study||47
6449861|NCT01144715|7365585|FG001|COMPLETED|Overall Study||45
6449862|NCT01144715|7365584|FG000|NOT COMPLETED|Overall Study||4
6553394|NCT01743521|7475905|FG002|NOT COMPLETED|Overall Study||0
6553395|NCT01743521|7475906|FG003|NOT COMPLETED|Overall Study||0
6744994|NCT03351933|7673069|FG000|COMPLETED|Overall Study||26
6744995|NCT03351933|7673069|FG000|NOT COMPLETED|Overall Study||2
6744996|NCT03352245|7673075|FG000|STARTED|Overall Study||20
6744997|NCT03352245|7673076|FG001|STARTED|Overall Study||20
6744998|NCT03352245|7673075|FG000|COMPLETED|Overall Study||20
6744999|NCT03352245|7673076|FG001|COMPLETED|Overall Study||19
6745000|NCT03352245|7673075|FG000|NOT COMPLETED|Overall Study||0
6449863|NCT01144715|7365585|FG001|NOT COMPLETED|Overall Study||3
6449864|NCT01144949|7365593|FG000|STARTED|Overall Study||119
6449865|NCT01144949|7365594|FG001|STARTED|Overall Study||120
6449866|NCT01144949|7365593|FG000|COMPLETED|Overall Study||108
6449867|NCT01144949|7365594|FG001|COMPLETED|Overall Study||106
6449868|NCT01144949|7365593|FG000|NOT COMPLETED|Overall Study||11
6449869|NCT01144949|7365594|FG001|NOT COMPLETED|Overall Study||14
6449870|NCT01145001|7365604|FG000|STARTED|Overall Study||36
6449871|NCT01145001|7365605|FG001|STARTED|Overall Study||37
6449872|NCT01145001|7365606|FG002|STARTED|Overall Study||44
6449873|NCT01145001|7365607|FG003|STARTED|Overall Study||37
6449874|NCT01145001|7365604|FG000|COMPLETED|Overall Study||28
6449875|NCT01145001|7365605|FG001|COMPLETED|Overall Study||31
6449876|NCT01145001|7365606|FG002|COMPLETED|Overall Study||39
6449877|NCT01145001|7365607|FG003|COMPLETED|Overall Study||31
6449878|NCT01145001|7365604|FG000|NOT COMPLETED|Overall Study||8
6449879|NCT01145001|7365605|FG001|NOT COMPLETED|Overall Study||6
6449880|NCT01145001|7365606|FG002|NOT COMPLETED|Overall Study||5
6449881|NCT01145001|7365607|FG003|NOT COMPLETED|Overall Study||6
6449882|NCT01145053|7365617|FG000|STARTED|Overall Study||341
6745001|NCT03352245|7673076|FG001|NOT COMPLETED|Overall Study||1
6745002|NCT03352323|7673082|FG000|STARTED|Overall Study||50
6745003|NCT03352323|7673082|FG000|COMPLETED|Overall Study||49
6449883|NCT01145053|7365617|FG000|COMPLETED|Overall Study||248
6449884|NCT01145053|7365617|FG000|NOT COMPLETED|Overall Study||93
6449885|NCT01145066|7365624|FG000|STARTED|Overall Study||26
6449886|NCT01145066|7365625|FG001|STARTED|Overall Study||20
6449887|NCT01145066|7365626|FG002|STARTED|Overall Study||25
6449888|NCT01145066|7365624|FG000|COMPLETED|Overall Study||22
6449889|NCT01145066|7365625|FG001|COMPLETED|Overall Study||16
6449890|NCT01145066|7365626|FG002|COMPLETED|Overall Study||21
6449891|NCT01145066|7365624|FG000|NOT COMPLETED|Overall Study||4
6449892|NCT01145066|7365625|FG001|NOT COMPLETED|Overall Study||4
6745004|NCT03352323|7673082|FG000|NOT COMPLETED|Overall Study||1
6745005|NCT03352414|7673088|FG000|STARTED|Overall Study||42
6745006|NCT03352414|7673089|FG001|STARTED|Overall Study||42
6553396|NCT01743560|7475914|FG000|STARTED|Overall Study||52
6553397|NCT01743560|7475914|FG000|Full Analysis Set (FAS)|Overall Study|≥ 1 dose study drug|49
6449893|NCT01145066|7365626|FG002|NOT COMPLETED|Overall Study||4
6449894|NCT01145183|7365638|FG000|STARTED|Overall Study||21
6449895|NCT01145183|7365639|FG001|STARTED|Overall Study||26
6449896|NCT01145183|7365640|FG002|STARTED|Overall Study||19
6449897|NCT01145183|7365641|FG003|STARTED|Overall Study||10
6449898|NCT01145183|7365638|FG000|COMPLETED|Overall Study||21
6449899|NCT01145183|7365639|FG001|COMPLETED|Overall Study||26
6449900|NCT01145183|7365640|FG002|COMPLETED|Overall Study||19
6449901|NCT01145183|7365641|FG003|COMPLETED|Overall Study||10
6449902|NCT01145183|7365638|FG000|NOT COMPLETED|Overall Study||0
6449903|NCT01145183|7365639|FG001|NOT COMPLETED|Overall Study||0
6449904|NCT01145183|7365640|FG002|NOT COMPLETED|Overall Study||0
6449905|NCT01145183|7365641|FG003|NOT COMPLETED|Overall Study||0
6449906|NCT01145222|7365655|FG000|STARTED|Overall Study||40
6449907|NCT01145222|7365656|FG001|STARTED|Overall Study||40
6449908|NCT01145222|7365657|FG002|STARTED|Overall Study||41
6449909|NCT01145222|7365658|FG003|STARTED|Overall Study||41
6449910|NCT01145222|7365655|FG000|Safety Population|Overall Study||40
6449911|NCT01145222|7365656|FG001|Safety Population|Overall Study||40
6449912|NCT01145222|7365657|FG002|Safety Population|Overall Study||40
6449913|NCT01145222|7365658|FG003|Safety Population|Overall Study||41
6449914|NCT01145222|7365655|FG000|Intention to Treat (ITT) Population|Overall Study||40
6449915|NCT01145222|7365656|FG001|Intention to Treat (ITT) Population|Overall Study||40
6449916|NCT01145222|7365657|FG002|Intention to Treat (ITT) Population|Overall Study||40
6449917|NCT01145222|7365658|FG003|Intention to Treat (ITT) Population|Overall Study||40
6449918|NCT01145222|7365655|FG000|COMPLETED|Overall Study||40
6449919|NCT01145222|7365656|FG001|COMPLETED|Overall Study||40
6449920|NCT01145222|7365657|FG002|COMPLETED|Overall Study||40
6449921|NCT01145222|7365658|FG003|COMPLETED|Overall Study||40
6449922|NCT01145222|7365655|FG000|NOT COMPLETED|Overall Study||0
6449923|NCT01145222|7365656|FG001|NOT COMPLETED|Overall Study||0
6449924|NCT01145222|7365657|FG002|NOT COMPLETED|Overall Study||1
6449925|NCT01145222|7365658|FG003|NOT COMPLETED|Overall Study||1
6449926|NCT01145352|7365668|FG000|STARTED|Overall Study||113
6449927|NCT01145352|7365668|FG000|COMPLETED|Overall Study||102
6449928|NCT01145352|7365668|FG000|NOT COMPLETED|Overall Study||11
6449929|NCT01145391|7365674|FG000|STARTED|Overall Study||293
6449930|NCT01145391|7365675|FG001|STARTED|Overall Study||298
6449931|NCT01145391|7365674|FG000|9 Months Post-randomization|Overall Study||293
6449932|NCT01145391|7365675|FG001|9 Months Post-randomization|Overall Study||298
6449933|NCT01145391|7365674|FG000|COMPLETED|Overall Study||293
6449934|NCT01145391|7365675|FG001|COMPLETED|Overall Study||298
6449935|NCT01145391|7365674|FG000|NOT COMPLETED|Overall Study||0
6449936|NCT01145391|7365675|FG001|NOT COMPLETED|Overall Study||0
6449937|NCT01145417|7365685|FG000|STARTED|Overall Study||108
6553398|NCT01743560|7475914|FG000|Safety Analysis Set (SAF)|Overall Study|≥ 1 dose study drug +1 post baseline safety assessment|49
6553399|NCT01743560|7475914|FG000|COMPLETED|Overall Study||9
6553400|NCT01743560|7475914|FG000|NOT COMPLETED|Overall Study||43
6449938|NCT01145417|7365686|FG001|STARTED|Overall Study||109
6449939|NCT01145417|7365685|FG000|COMPLETED|Overall Study||67
6449940|NCT01145417|7365686|FG001|COMPLETED|Overall Study||62
6449941|NCT01145417|7365685|FG000|NOT COMPLETED|Overall Study||41
6449942|NCT01145417|7365686|FG001|NOT COMPLETED|Overall Study||47
6449943|NCT01145482|7365694|FG000|STARTED|First Intervention (1 Day)||6
6449944|NCT01145482|7365695|FG001|STARTED|First Intervention (1 Day)||6
6449945|NCT01145482|7365694|FG000|COMPLETED|First Intervention (1 Day)||6
6449946|NCT01145482|7365695|FG001|COMPLETED|First Intervention (1 Day)||5
6449947|NCT01145482|7365694|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6449948|NCT01145482|7365695|FG001|NOT COMPLETED|First Intervention (1 Day)||1
6449949|NCT01145482|7365694|FG000|STARTED|Second Intervention (1 Day)||5
6449950|NCT01145482|7365695|FG001|STARTED|Second Intervention (1 Day)||6
6449951|NCT01145482|7365694|FG000|COMPLETED|Second Intervention (1 Day)||5
6449952|NCT01145482|7365695|FG001|COMPLETED|Second Intervention (1 Day)||6
6449953|NCT01145482|7365694|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6449954|NCT01145482|7365695|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6449955|NCT01145508|7365703|FG000|STARTED|Overall Study||7
6449956|NCT01145508|7365704|FG001|STARTED|Overall Study||3
6449957|NCT01145508|7365703|FG000|Treated|Overall Study||6
6449958|NCT01145508|7365704|FG001|Treated|Overall Study||2
6449959|NCT01145508|7365703|FG000|COMPLETED|Overall Study||2
6449960|NCT01145508|7365704|FG001|COMPLETED|Overall Study||1
6449961|NCT01145508|7365703|FG000|NOT COMPLETED|Overall Study||5
6449962|NCT01145508|7365704|FG001|NOT COMPLETED|Overall Study||2
6449963|NCT01145547|7365710|FG000|STARTED|Overall Study||4
6449964|NCT01145547|7365711|FG001|STARTED|Overall Study||3
6449965|NCT01145547|7365710|FG000|COMPLETED|Overall Study||4
6449966|NCT01145547|7365711|FG001|COMPLETED|Overall Study||3
6449967|NCT01145547|7365710|FG000|NOT COMPLETED|Overall Study||0
6449968|NCT01145547|7365711|FG001|NOT COMPLETED|Overall Study||0
6449969|NCT01145560|7365720|FG000|STARTED|Overall Study||100
6449970|NCT01145560|7365721|FG001|STARTED|Overall Study||100
6449971|NCT01145560|7365722|FG002|STARTED|Overall Study||100
6449972|NCT01145560|7365720|FG000|Received Treatment|Overall Study||99
6553401|NCT01743677|7475927|FG000|STARTED|First Intervention Period||10
6449973|NCT01145560|7365721|FG001|Received Treatment|Overall Study||98
6449974|NCT01145560|7365722|FG002|Received Treatment|Overall Study||99
6500434|NCT01424514|7419138|FG000|COMPLETED|Period 3:Intervention Period 2 (14 Days)||18
6449975|NCT01145560|7365720|FG000|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
6449976|NCT01145560|7365721|FG001|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
6449977|NCT01145560|7365722|FG002|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
6449978|NCT01145560|7365720|FG000|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
6449979|NCT01145560|7365721|FG001|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
6449980|NCT01145560|7365722|FG002|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
6449981|NCT01145560|7365720|FG000|NOT COMPLETED|Overall Study||4
6449982|NCT01145560|7365721|FG001|NOT COMPLETED|Overall Study||4
6449983|NCT01145560|7365722|FG002|NOT COMPLETED|Overall Study||2
6449984|NCT01145625|7365732|FG000|STARTED|Overall Study||161
6449985|NCT01145625|7365733|FG001|STARTED|Overall Study||161
6449986|NCT01145625|7365732|FG000|COMPLETED|Overall Study||137
6449987|NCT01145625|7365733|FG001|COMPLETED|Overall Study||130
6449988|NCT01145625|7365732|FG000|NOT COMPLETED|Overall Study||24
6449989|NCT01145625|7365733|FG001|NOT COMPLETED|Overall Study||31
6449990|NCT01145638|7365741|FG000|STARTED|Overall Study||231
6449991|NCT01145638|7365742|FG001|STARTED|Overall Study||119
6449992|NCT01145638|7365741|FG000|COMPLETED|Overall Study||141
6449993|NCT01145638|7365742|FG001|COMPLETED|Overall Study||62
6449994|NCT01145638|7365741|FG000|NOT COMPLETED|Overall Study||90
6449995|NCT01145638|7365742|FG001|NOT COMPLETED|Overall Study||57
6449996|NCT01145755|7365751|FG000|STARTED|Overall Study||40
6449997|NCT01145755|7365752|FG001|STARTED|Overall Study||47
6449998|NCT01145755|7365753|FG002|STARTED|Overall Study||44
6449999|NCT01145755|7365751|FG000|COMPLETED|Overall Study||20
6450000|NCT01145755|7365752|FG001|COMPLETED|Overall Study||19
6450001|NCT01145755|7365753|FG002|COMPLETED|Overall Study||19
6450002|NCT01145755|7365751|FG000|NOT COMPLETED|Overall Study||20
6450003|NCT01145755|7365752|FG001|NOT COMPLETED|Overall Study||28
6450004|NCT01145755|7365753|FG002|NOT COMPLETED|Overall Study||25
6450005|NCT01145833|7365763|FG000|STARTED|Overall Study||25
6450006|NCT01145833|7365764|FG001|STARTED|Overall Study||25
6450007|NCT01145833|7365763|FG000|COMPLETED|Overall Study||22
6450008|NCT01145833|7365764|FG001|COMPLETED|Overall Study||25
6450009|NCT01145833|7365763|FG000|NOT COMPLETED|Overall Study||3
6450010|NCT01145833|7365764|FG001|NOT COMPLETED|Overall Study||0
6450011|NCT01145885|7365770|FG000|STARTED|Overall Study||7
6450012|NCT01145885|7365770|FG000|COMPLETED|Overall Study||0
6450013|NCT01145885|7365770|FG000|NOT COMPLETED|Overall Study||7
6450014|NCT01145898|7365782|FG000|STARTED|6-month Treatment||12
6450015|NCT01145898|7365783|FG001|STARTED|6-month Treatment||44
6450016|NCT01145898|7365782|FG000|COMPLETED|6-month Treatment||12
6450017|NCT01145898|7365783|FG001|COMPLETED|6-month Treatment||44
6450018|NCT01145898|7365782|FG000|NOT COMPLETED|6-month Treatment||0
6450019|NCT01145898|7365783|FG001|NOT COMPLETED|6-month Treatment||0
6450020|NCT01145898|7365782|FG000|STARTED|3-year Treatment||12
6450021|NCT01145898|7365783|FG001|STARTED|3-year Treatment||44
6450022|NCT01145898|7365782|FG000|COMPLETED|3-year Treatment||9
6450023|NCT01145898|7365783|FG001|COMPLETED|3-year Treatment||28
6450024|NCT01145898|7365782|FG000|NOT COMPLETED|3-year Treatment||3
6450025|NCT01145898|7365783|FG001|NOT COMPLETED|3-year Treatment||16
6450026|NCT01146054|7365788|FG000|STARTED|Overall Study||59
6450027|NCT01146054|7365788|FG000|COMPLETED|Overall Study||49
6450028|NCT01146054|7365788|FG000|NOT COMPLETED|Overall Study||10
6450029|NCT01146275|7365792|FG000|STARTED|Overall Study||6
6450030|NCT01146275|7365792|FG000|COMPLETED|Overall Study||6
6450031|NCT01146275|7365792|FG000|NOT COMPLETED|Overall Study||0
6450032|NCT01146288|7365799|FG000|STARTED|First Intervention(1 Day)||7
6450033|NCT01146288|7365800|FG001|STARTED|First Intervention(1 Day)||6
6450034|NCT01146288|7365799|FG000|COMPLETED|First Intervention(1 Day)||7
6450035|NCT01146288|7365800|FG001|COMPLETED|First Intervention(1 Day)||5
6450036|NCT01146288|7365799|FG000|NOT COMPLETED|First Intervention(1 Day)||0
6450037|NCT01146288|7365800|FG001|NOT COMPLETED|First Intervention(1 Day)||1
6450038|NCT01146288|7365799|FG000|STARTED|Second Intervention (1 Day)||7
6450039|NCT01146288|7365800|FG001|STARTED|Second Intervention (1 Day)||5
6450040|NCT01146288|7365799|FG000|COMPLETED|Second Intervention (1 Day)||7
6450041|NCT01146288|7365800|FG001|COMPLETED|Second Intervention (1 Day)||5
6450042|NCT01146288|7365799|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6450043|NCT01146288|7365800|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6450044|NCT01146379|7365811|FG000|STARTED|Overall Study||21
6450045|NCT01146379|7365812|FG001|STARTED|Overall Study||22
6450046|NCT01146379|7365813|FG002|STARTED|Overall Study||21
6450047|NCT01146379|7365814|FG003|STARTED|Overall Study||21
6450048|NCT01146379|7365811|FG000|COMPLETED|Overall Study||20
6450049|NCT01146379|7365812|FG001|COMPLETED|Overall Study||21
6450050|NCT01146379|7365813|FG002|COMPLETED|Overall Study||21
6450051|NCT01146379|7365814|FG003|COMPLETED|Overall Study||20
6450052|NCT01146379|7365811|FG000|NOT COMPLETED|Overall Study||1
6450053|NCT01146379|7365812|FG001|NOT COMPLETED|Overall Study||1
6305708|NCT01927419|7209053|FG000|STARTED|Treatment Period||94
6305709|NCT01927419|7209054|FG001|STARTED|Treatment Period||46
6305710|NCT01927419|7209053|FG000|COMPLETED|Treatment Period||0
6305711|NCT01927419|7209054|FG001|COMPLETED|Treatment Period||0
6305712|NCT01927419|7209053|FG000|NOT COMPLETED|Treatment Period||94
6305713|NCT01927419|7209054|FG001|NOT COMPLETED|Treatment Period||46
6450054|NCT01146379|7365813|FG002|NOT COMPLETED|Overall Study||0
6450055|NCT01146379|7365814|FG003|NOT COMPLETED|Overall Study||1
6450056|NCT01146457|7365829|FG000|STARTED|Overall Study||19
6450057|NCT01146457|7365830|FG001|STARTED|Overall Study||17
6450058|NCT01146457|7365831|FG002|STARTED|Overall Study||21
6450059|NCT01146457|7365832|FG003|STARTED|Overall Study||13
6450060|NCT01146457|7365833|FG004|STARTED|Overall Study||13
6450061|NCT01146457|7365829|FG000|COMPLETED|Overall Study||19
6450062|NCT01146457|7365830|FG001|COMPLETED|Overall Study||17
6450063|NCT01146457|7365831|FG002|COMPLETED|Overall Study||20
6450064|NCT01146457|7365832|FG003|COMPLETED|Overall Study||13
6450065|NCT01146457|7365833|FG004|COMPLETED|Overall Study||13
6450066|NCT01146457|7365829|FG000|NOT COMPLETED|Overall Study||0
6450067|NCT01146457|7365830|FG001|NOT COMPLETED|Overall Study||0
6450068|NCT01146457|7365831|FG002|NOT COMPLETED|Overall Study||1
6450069|NCT01146457|7365832|FG003|NOT COMPLETED|Overall Study||0
6450070|NCT01146457|7365833|FG004|NOT COMPLETED|Overall Study||0
6450071|NCT01146496|7365847|FG000|STARTED|Overall Study||114168
6450072|NCT01146496|7365848|FG001|STARTED|Overall Study||109693
6450073|NCT01146496|7365847|FG000|COMPLETED|Overall Study||114168
6450074|NCT01146496|7365848|FG001|COMPLETED|Overall Study||109693
6450075|NCT01146496|7365847|FG000|NOT COMPLETED|Overall Study||0
6450076|NCT01146496|7365848|FG001|NOT COMPLETED|Overall Study||0
6450077|NCT01146561|7365855|FG000|STARTED|Overall Study||2
6450078|NCT01146561|7365855|FG000|COMPLETED|Overall Study||0
6450079|NCT01146561|7365855|FG000|NOT COMPLETED|Overall Study||2
6450080|NCT01146600|7365861|FG000|STARTED|Period 1 (Weeks 1 & 2)||13
6450081|NCT01146600|7365862|FG001|STARTED|Period 1 (Weeks 1 & 2)||10
6450082|NCT01146600|7365861|FG000|COMPLETED|Period 1 (Weeks 1 & 2)||10
6450083|NCT01146600|7365862|FG001|COMPLETED|Period 1 (Weeks 1 & 2)||10
6450084|NCT01146600|7365861|FG000|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
6450085|NCT01146600|7365862|FG001|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
6450086|NCT01146600|7365861|FG000|STARTED|Washout (Week 3)||10
6450087|NCT01146600|7365862|FG001|STARTED|Washout (Week 3)||10
6450088|NCT01146600|7365861|FG000|COMPLETED|Washout (Week 3)||10
6450089|NCT01146600|7365862|FG001|COMPLETED|Washout (Week 3)||10
6450090|NCT01146600|7365861|FG000|NOT COMPLETED|Washout (Week 3)||0
6450091|NCT01146600|7365862|FG001|NOT COMPLETED|Washout (Week 3)||0
6450092|NCT01146600|7365861|FG000|STARTED|Period 2 (Weeks 4 & 5)||10
6450093|NCT01146600|7365862|FG001|STARTED|Period 2 (Weeks 4 & 5)||10
6450094|NCT01146600|7365861|FG000|COMPLETED|Period 2 (Weeks 4 & 5)||10
6450095|NCT01146600|7365862|FG001|COMPLETED|Period 2 (Weeks 4 & 5)||10
6450096|NCT01146600|7365861|FG000|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
6450097|NCT01146600|7365862|FG001|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
6450098|NCT01146613|7365871|FG000|STARTED|Overall Study||99
6450099|NCT01146613|7365872|FG001|STARTED|Overall Study||101
6450100|NCT01146613|7365871|FG000|COMPLETED|Overall Study||92
6450101|NCT01146613|7365872|FG001|COMPLETED|Overall Study||89
6450102|NCT01146613|7365871|FG000|NOT COMPLETED|Overall Study||7
6450103|NCT01146613|7365872|FG001|NOT COMPLETED|Overall Study||12
6450104|NCT01146665|7365880|FG000|STARTED|Overall Study||18
6450105|NCT01146665|7365881|FG001|STARTED|Overall Study||26
6450106|NCT01146665|7365880|FG000|1-month Post-ED Discharge (Follow-up)|Overall Study||9
6450107|NCT01146665|7365881|FG001|1-month Post-ED Discharge (Follow-up)|Overall Study||12
6450108|NCT01146665|7365880|FG000|3-month Post-ED Discharge (Follow-up)|Overall Study||8
6450109|NCT01146665|7365881|FG001|3-month Post-ED Discharge (Follow-up)|Overall Study||10
6450110|NCT01146665|7365880|FG000|COMPLETED|Overall Study||8
6450111|NCT01146665|7365881|FG001|COMPLETED|Overall Study||10
6450112|NCT01146665|7365880|FG000|NOT COMPLETED|Overall Study||10
6450113|NCT01146665|7365881|FG001|NOT COMPLETED|Overall Study||16
6450114|NCT01146704|7365898|FG000|STARTED|Overall Study||16
6450115|NCT01146704|7365899|FG001|STARTED|Overall Study||15
6450116|NCT01146704|7365898|FG000|COMPLETED|Overall Study||16
6450117|NCT01146704|7365899|FG001|COMPLETED|Overall Study||15
6450118|NCT01146704|7365898|FG000|NOT COMPLETED|Overall Study||0
6450119|NCT01146704|7365899|FG001|NOT COMPLETED|Overall Study||0
6450120|NCT01146782|7365905|FG000|STARTED|Screening Cohort||367
6450121|NCT01146782|7365905|FG000|COMPLETED|Screening Cohort||146
6450122|NCT01146782|7365905|FG000|NOT COMPLETED|Screening Cohort||221
6450123|NCT01146782|7365905|FG000|STARTED|Safety Cohort||146
6450124|NCT01146782|7365905|FG000|COMPLETED|Safety Cohort||63
6450125|NCT01146782|7365905|FG000|NOT COMPLETED|Safety Cohort||83
6450126|NCT01146782|7365905|FG000|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
6450127|NCT01146782|7365905|FG000|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
6450128|NCT01146782|7365905|FG000|NOT COMPLETED|Primary Endpoint Cohort||6
6450129|NCT01146795|7365910|FG000|STARTED|Overall Study||32
6450130|NCT01146795|7365910|FG000|COMPLETED|Overall Study||12
6450131|NCT01146795|7365910|FG000|NOT COMPLETED|Overall Study||20
6450132|NCT01146808|7365914|FG000|STARTED|Overall Study||16
6450133|NCT01146808|7365914|FG000|COMPLETED|Overall Study||16
6450134|NCT01146808|7365914|FG000|NOT COMPLETED|Overall Study||0
6450135|NCT01146834|7365923|FG000|STARTED|Overall Study||20
6450136|NCT01146834|7365924|FG001|STARTED|Overall Study||4
6450137|NCT01146834|7365925|FG002|STARTED|Overall Study||23
6450138|NCT01146834|7365926|FG003|STARTED|Overall Study||0
6450139|NCT01146834|7365927|FG004|STARTED|Overall Study||0
6450140|NCT01146834|7365923|FG000|COMPLETED|Overall Study||17
6450141|NCT01146834|7365924|FG001|COMPLETED|Overall Study||4
6450142|NCT01146834|7365925|FG002|COMPLETED|Overall Study||21
6450143|NCT01146834|7365926|FG003|COMPLETED|Overall Study||0
6450144|NCT01146834|7365927|FG004|COMPLETED|Overall Study||0
6450145|NCT01146834|7365923|FG000|NOT COMPLETED|Overall Study||3
6450146|NCT01146834|7365924|FG001|NOT COMPLETED|Overall Study||0
6450147|NCT01146834|7365925|FG002|NOT COMPLETED|Overall Study||2
6450148|NCT01146834|7365926|FG003|NOT COMPLETED|Overall Study||0
6450149|NCT01146834|7365927|FG004|NOT COMPLETED|Overall Study||0
6450150|NCT01146860|7365941|FG000|STARTED|Overall Study||194
6450151|NCT01146860|7365942|FG001|STARTED|Overall Study||192
6450152|NCT01146860|7365941|FG000|COMPLETED|Overall Study||194
6450153|NCT01146860|7365942|FG001|COMPLETED|Overall Study||191
6450154|NCT01146860|7365941|FG000|NOT COMPLETED|Overall Study||0
6450155|NCT01146860|7365942|FG001|NOT COMPLETED|Overall Study||1
6450156|NCT01146873|7365950|FG000|STARTED|Overall Study||148
6450157|NCT01146873|7365951|FG001|STARTED|Overall Study||150
6450158|NCT01146873|7365950|FG000|COMPLETED|Overall Study||148
6450159|NCT01146873|7365951|FG001|COMPLETED|Overall Study||144
6450160|NCT01146873|7365950|FG000|NOT COMPLETED|Overall Study||0
6450161|NCT01146873|7365951|FG001|NOT COMPLETED|Overall Study||6
6450162|NCT01146912|7365964|FG000|STARTED|Overall Study||4607
6450163|NCT01146912|7365965|FG001|STARTED|Overall Study||4606
6450164|NCT01146912|7365966|FG002|STARTED|Overall Study||593
6450165|NCT01146912|7365967|FG003|STARTED|Overall Study||594
6450166|NCT01146912|7365968|FG004|STARTED|Overall Study||1821
6450167|NCT01146912|7365969|FG005|STARTED|Overall Study||1821
6450168|NCT01146912|7365970|FG006|STARTED|Overall Study||1820
6450169|NCT01146912|7365971|FG007|STARTED|Overall Study||14675
6450170|NCT01146912|7365964|FG000|COMPLETED|Overall Study||3790
6450171|NCT01146912|7365965|FG001|COMPLETED|Overall Study||3784
6450172|NCT01146912|7365966|FG002|COMPLETED|Overall Study||576
6450173|NCT01146912|7365967|FG003|COMPLETED|Overall Study||577
6450174|NCT01146912|7365968|FG004|COMPLETED|Overall Study||1780
6450175|NCT01146912|7365969|FG005|COMPLETED|Overall Study||1760
6450176|NCT01146912|7365970|FG006|COMPLETED|Overall Study||1764
6450177|NCT01146912|7365971|FG007|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
6450178|NCT01146912|7365964|FG000|NOT COMPLETED|Overall Study||817
6450179|NCT01146912|7365965|FG001|NOT COMPLETED|Overall Study||822
6450180|NCT01146912|7365966|FG002|NOT COMPLETED|Overall Study||17
6450181|NCT01146912|7365967|FG003|NOT COMPLETED|Overall Study||17
6450182|NCT01146912|7365968|FG004|NOT COMPLETED|Overall Study||41
6450183|NCT01146912|7365969|FG005|NOT COMPLETED|Overall Study||61
6450184|NCT01146912|7365970|FG006|NOT COMPLETED|Overall Study||56
6450185|NCT01146912|7365971|FG007|NOT COMPLETED|Overall Study||0
6450186|NCT01146951|7365992|FG000|STARTED|Overall Study||29
6450187|NCT01146951|7365993|FG001|STARTED|Overall Study||30
6450188|NCT01146951|7365992|FG000|COMPLETED|Overall Study||25
6450189|NCT01146951|7365993|FG001|COMPLETED|Overall Study||29
6450190|NCT01146951|7365992|FG000|NOT COMPLETED|Overall Study||4
6450191|NCT01146951|7365993|FG001|NOT COMPLETED|Overall Study||1
6450192|NCT01147055|7365999|FG000|STARTED|First Intervention Period||15
6450193|NCT01147055|7366000|FG001|STARTED|First Intervention Period||0
6450194|NCT01147055|7365999|FG000|COMPLETED|First Intervention Period||14
6450195|NCT01147055|7366000|FG001|COMPLETED|First Intervention Period||0
6450196|NCT01147055|7365999|FG000|NOT COMPLETED|First Intervention Period||1
6450197|NCT01147055|7366000|FG001|NOT COMPLETED|First Intervention Period||0
6450198|NCT01147055|7365999|FG000|STARTED|Washout Period (at Least 14 Days)||14
6450199|NCT01147055|7366000|FG001|STARTED|Washout Period (at Least 14 Days)||0
6450200|NCT01147055|7365999|FG000|COMPLETED|Washout Period (at Least 14 Days)||14
6450201|NCT01147055|7366000|FG001|COMPLETED|Washout Period (at Least 14 Days)||0
6450202|NCT01147055|7365999|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6450203|NCT01147055|7366000|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6450204|NCT01147055|7365999|FG000|STARTED|Second Intervention Period||0
6450205|NCT01147055|7366000|FG001|STARTED|Second Intervention Period||14
6450206|NCT01147055|7365999|FG000|COMPLETED|Second Intervention Period||0
6450207|NCT01147055|7366000|FG001|COMPLETED|Second Intervention Period||14
6450208|NCT01147055|7365999|FG000|NOT COMPLETED|Second Intervention Period||0
6450209|NCT01147055|7366000|FG001|NOT COMPLETED|Second Intervention Period||0
6500435|NCT01424514|7419139|FG001|COMPLETED|Period 3:Intervention Period 2 (14 Days)||19
6500436|NCT01424514|7419138|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||1
6500437|NCT01424514|7419139|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (14 Days)||0
6500438|NCT01424566|7419150|FG000|STARTED|Single-blind Treatment||406
6500439|NCT01424566|7419151|FG001|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
6500440|NCT01424566|7419152|FG002|STARTED|Single-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|0
6500441|NCT01424566|7419150|FG000|Received at Least 1 Dose of Study Drug|Single-blind Treatment|Two participants did not administer any study drug.|404
6500442|NCT01424566|7419151|FG001|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
6500443|NCT01424566|7419152|FG002|Received at Least 1 Dose of Study Drug|Single-blind Treatment||0
6500444|NCT01424566|7419150|FG000|Single-blind Safety Population|Single-blind Treatment||404
6500445|NCT01424566|7419151|FG001|Single-blind Safety Population|Single-blind Treatment||0
6500446|NCT01424566|7419152|FG002|Single-blind Safety Population|Single-blind Treatment||0
6500447|NCT01424566|7419150|FG000|Met Randomization Criteria|Single-blind Treatment||206
6500448|NCT01424566|7419151|FG001|Met Randomization Criteria|Single-blind Treatment||0
6500449|NCT01424566|7419152|FG002|Met Randomization Criteria|Single-blind Treatment||0
6450210|NCT01147068|7366013|FG000|STARTED|Subjects That Received 1st Dose||60
6450211|NCT01147068|7366014|FG001|STARTED|Subjects That Received 1st Dose||57
6450212|NCT01147068|7366015|FG002|STARTED|Subjects That Received 1st Dose||55
6450213|NCT01147068|7366016|FG003|STARTED|Subjects That Received 1st Dose||56
6450214|NCT01147068|7366017|FG004|STARTED|Subjects That Received 1st Dose||56
6450215|NCT01147068|7366018|FG005|STARTED|Subjects That Received 1st Dose||53
6450216|NCT01147068|7366019|FG006|STARTED|Subjects That Received 1st Dose||55
6450217|NCT01147068|7366013|FG000|COMPLETED|Subjects That Received 1st Dose||60
6450218|NCT01147068|7366014|FG001|COMPLETED|Subjects That Received 1st Dose||57
6450219|NCT01147068|7366015|FG002|COMPLETED|Subjects That Received 1st Dose||55
6450220|NCT01147068|7366016|FG003|COMPLETED|Subjects That Received 1st Dose||56
6450221|NCT01147068|7366017|FG004|COMPLETED|Subjects That Received 1st Dose||56
6450222|NCT01147068|7366018|FG005|COMPLETED|Subjects That Received 1st Dose||53
6450223|NCT01147068|7366019|FG006|COMPLETED|Subjects That Received 1st Dose||55
6450224|NCT01147068|7366013|FG000|NOT COMPLETED|Subjects That Received 1st Dose||0
6450225|NCT01147068|7366014|FG001|NOT COMPLETED|Subjects That Received 1st Dose||0
6450226|NCT01147068|7366015|FG002|NOT COMPLETED|Subjects That Received 1st Dose||0
6450227|NCT01147068|7366016|FG003|NOT COMPLETED|Subjects That Received 1st Dose||0
6450228|NCT01147068|7366017|FG004|NOT COMPLETED|Subjects That Received 1st Dose||0
6450229|NCT01147068|7366018|FG005|NOT COMPLETED|Subjects That Received 1st Dose||0
6450230|NCT01147068|7366019|FG006|NOT COMPLETED|Subjects That Received 1st Dose||0
6450231|NCT01147068|7366013|FG000|STARTED|Subjects That Received 2nd Dose||60
6450232|NCT01147068|7366014|FG001|STARTED|Subjects That Received 2nd Dose||57
6450233|NCT01147068|7366015|FG002|STARTED|Subjects That Received 2nd Dose||55
6450234|NCT01147068|7366016|FG003|STARTED|Subjects That Received 2nd Dose||56
6745007|NCT03352414|7673088|FG000|Allocated|Overall Study||30
6745008|NCT03352414|7673089|FG001|Allocated|Overall Study||32
6745009|NCT03352414|7673088|FG000|COMPLETED|Overall Study||30
6450235|NCT01147068|7366017|FG004|STARTED|Subjects That Received 2nd Dose||56
6450236|NCT01147068|7366018|FG005|STARTED|Subjects That Received 2nd Dose||53
6450237|NCT01147068|7366019|FG006|STARTED|Subjects That Received 2nd Dose||55
6450238|NCT01147068|7366013|FG000|COMPLETED|Subjects That Received 2nd Dose||59
6450239|NCT01147068|7366014|FG001|COMPLETED|Subjects That Received 2nd Dose||52
6450240|NCT01147068|7366015|FG002|COMPLETED|Subjects That Received 2nd Dose||52
6450241|NCT01147068|7366016|FG003|COMPLETED|Subjects That Received 2nd Dose||56
6450242|NCT01147068|7366017|FG004|COMPLETED|Subjects That Received 2nd Dose||55
6450243|NCT01147068|7366018|FG005|COMPLETED|Subjects That Received 2nd Dose||51
6450244|NCT01147068|7366019|FG006|COMPLETED|Subjects That Received 2nd Dose||55
6450245|NCT01147068|7366013|FG000|NOT COMPLETED|Subjects That Received 2nd Dose||1
6450246|NCT01147068|7366014|FG001|NOT COMPLETED|Subjects That Received 2nd Dose||5
6450247|NCT01147068|7366015|FG002|NOT COMPLETED|Subjects That Received 2nd Dose||3
6450248|NCT01147068|7366016|FG003|NOT COMPLETED|Subjects That Received 2nd Dose||0
6450249|NCT01147068|7366017|FG004|NOT COMPLETED|Subjects That Received 2nd Dose||1
6450250|NCT01147068|7366018|FG005|NOT COMPLETED|Subjects That Received 2nd Dose||2
6450251|NCT01147068|7366019|FG006|NOT COMPLETED|Subjects That Received 2nd Dose||0
6450252|NCT01147068|7366013|FG000|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
6450253|NCT01147068|7366014|FG001|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
6450254|NCT01147068|7366015|FG002|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
6450255|NCT01147068|7366016|FG003|STARTED|Subjects That Completed Safety Follow-up||56
6450256|NCT01147068|7366017|FG004|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
6450257|NCT01147068|7366018|FG005|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
6450258|NCT01147068|7366019|FG006|STARTED|Subjects That Completed Safety Follow-up||55
6450259|NCT01147068|7366013|FG000|COMPLETED|Subjects That Completed Safety Follow-up||59
6450260|NCT01147068|7366014|FG001|COMPLETED|Subjects That Completed Safety Follow-up||56
6450261|NCT01147068|7366015|FG002|COMPLETED|Subjects That Completed Safety Follow-up||55
6450262|NCT01147068|7366016|FG003|COMPLETED|Subjects That Completed Safety Follow-up||54
6450263|NCT01147068|7366017|FG004|COMPLETED|Subjects That Completed Safety Follow-up||56
6450264|NCT01147068|7366018|FG005|COMPLETED|Subjects That Completed Safety Follow-up||52
6450265|NCT01147068|7366019|FG006|COMPLETED|Subjects That Completed Safety Follow-up||54
6450266|NCT01147068|7366013|FG000|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
6450267|NCT01147068|7366014|FG001|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
6450268|NCT01147068|7366015|FG002|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
6450269|NCT01147068|7366016|FG003|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
6450270|NCT01147068|7366017|FG004|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
6450271|NCT01147068|7366018|FG005|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
6450272|NCT01147068|7366019|FG006|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
6450273|NCT01147107|7366037|FG000|STARTED|Overall Study||39
6450274|NCT01147107|7366038|FG001|STARTED|Overall Study||41
6450275|NCT01147107|7366037|FG000|COMPLETED|Overall Study||33
6450276|NCT01147107|7366038|FG001|COMPLETED|Overall Study||40
6450277|NCT01147107|7366037|FG000|NOT COMPLETED|Overall Study||6
6450278|NCT01147107|7366038|FG001|NOT COMPLETED|Overall Study||1
6450279|NCT01147172|7366044|FG000|STARTED|Overall Study||100
6450280|NCT01147172|7366044|FG000|COMPLETED|Overall Study||96
6450281|NCT01147172|7366044|FG000|NOT COMPLETED|Overall Study||4
6450282|NCT01147250|7366052|FG000|STARTED|Overall Study||3034
6450283|NCT01147250|7366053|FG001|STARTED|Overall Study||3034
6450284|NCT01147250|7366052|FG000|Treated|Overall Study||3032
6450285|NCT01147250|7366053|FG001|Treated|Overall Study||3031
6450286|NCT01147250|7366052|FG000|COMPLETED|Overall Study||2924
6450287|NCT01147250|7366053|FG001|COMPLETED|Overall Study||2929
6450288|NCT01147250|7366052|FG000|NOT COMPLETED|Overall Study||110
6450289|NCT01147250|7366053|FG001|NOT COMPLETED|Overall Study||105
6450290|NCT01147302|7366061|FG000|STARTED|Overall Study||9
6450291|NCT01147302|7366062|FG001|STARTED|Overall Study||9
6450292|NCT01147302|7366061|FG000|COMPLETED|Overall Study||9
6450293|NCT01147302|7366062|FG001|COMPLETED|Overall Study||9
6450294|NCT01147302|7366061|FG000|NOT COMPLETED|Overall Study||0
6450295|NCT01147302|7366062|FG001|NOT COMPLETED|Overall Study||0
6450296|NCT01147341|7366070|FG000|STARTED|Double Blind Period||27
6450297|NCT01147341|7366071|FG001|STARTED|Double Blind Period||10
6450298|NCT01147341|7366070|FG000|COMPLETED|Double Blind Period||26
6450299|NCT01147341|7366071|FG001|COMPLETED|Double Blind Period||8
6450300|NCT01147341|7366070|FG000|NOT COMPLETED|Double Blind Period||1
6450301|NCT01147341|7366071|FG001|NOT COMPLETED|Double Blind Period||2
6450302|NCT01147341|7366070|FG000|STARTED|Open Label Period||26
6450303|NCT01147341|7366071|FG001|STARTED|Open Label Period||8
6450304|NCT01147341|7366070|FG000|COMPLETED|Open Label Period||22
6450305|NCT01147341|7366071|FG001|COMPLETED|Open Label Period||8
6450306|NCT01147341|7366070|FG000|NOT COMPLETED|Open Label Period||4
6450307|NCT01147341|7366071|FG001|NOT COMPLETED|Open Label Period||0
6450308|NCT01147380|7366079|FG000|STARTED|Overall Study||6
6450309|NCT01147380|7366080|FG001|STARTED|Overall Study||12
6450310|NCT01147380|7366079|FG000|COMPLETED|Overall Study||6
6450311|NCT01147380|7366080|FG001|COMPLETED|Overall Study||12
6450312|NCT01147380|7366079|FG000|NOT COMPLETED|Overall Study||0
6450313|NCT01147380|7366080|FG001|NOT COMPLETED|Overall Study||0
6450314|NCT01147406|7366094|FG000|STARTED|Overall Study||6
6450315|NCT01147406|7366095|FG001|STARTED|Overall Study||12
6450316|NCT01147406|7366096|FG002|STARTED|Overall Study||1
6450317|NCT01147406|7366097|FG003|STARTED|Overall Study||6
6450318|NCT01147406|7366098|FG004|STARTED|Overall Study||6
6450319|NCT01147406|7366099|FG005|STARTED|Overall Study||10
6450320|NCT01147406|7366094|FG000|COMPLETED|Overall Study||6
6450321|NCT01147406|7366095|FG001|COMPLETED|Overall Study||12
6450322|NCT01147406|7366096|FG002|COMPLETED|Overall Study||1
6450323|NCT01147406|7366097|FG003|COMPLETED|Overall Study||6
6450324|NCT01147406|7366098|FG004|COMPLETED|Overall Study||6
6450325|NCT01147406|7366099|FG005|COMPLETED|Overall Study||10
6450326|NCT01147406|7366094|FG000|NOT COMPLETED|Overall Study||0
6450327|NCT01147406|7366095|FG001|NOT COMPLETED|Overall Study||0
6450328|NCT01147406|7366096|FG002|NOT COMPLETED|Overall Study||0
6450329|NCT01147406|7366097|FG003|NOT COMPLETED|Overall Study||0
6450330|NCT01147406|7366098|FG004|NOT COMPLETED|Overall Study||0
6450331|NCT01147406|7366099|FG005|NOT COMPLETED|Overall Study||0
6450332|NCT01147458|7366114|FG000|STARTED|First Intervention||48
6450333|NCT01147458|7366115|FG001|STARTED|First Intervention||47
6450334|NCT01147458|7366116|FG002|STARTED|First Intervention||47
6450335|NCT01147458|7366117|FG003|STARTED|First Intervention||48
6450336|NCT01147458|7366114|FG000|COMPLETED|First Intervention||34
6450337|NCT01147458|7366115|FG001|COMPLETED|First Intervention||31
6450338|NCT01147458|7366116|FG002|COMPLETED|First Intervention||35
6450339|NCT01147458|7366117|FG003|COMPLETED|First Intervention||34
6450340|NCT01147458|7366114|FG000|NOT COMPLETED|First Intervention||14
6450341|NCT01147458|7366115|FG001|NOT COMPLETED|First Intervention||16
6450342|NCT01147458|7366116|FG002|NOT COMPLETED|First Intervention||12
6450343|NCT01147458|7366117|FG003|NOT COMPLETED|First Intervention||14
6450344|NCT01147458|7366114|FG000|STARTED|Washout Period of 2 Weeks||34
6450345|NCT01147458|7366115|FG001|STARTED|Washout Period of 2 Weeks||31
6450346|NCT01147458|7366116|FG002|STARTED|Washout Period of 2 Weeks||35
6450347|NCT01147458|7366117|FG003|STARTED|Washout Period of 2 Weeks||34
6450348|NCT01147458|7366114|FG000|COMPLETED|Washout Period of 2 Weeks||34
6450349|NCT01147458|7366115|FG001|COMPLETED|Washout Period of 2 Weeks||31
6450350|NCT01147458|7366116|FG002|COMPLETED|Washout Period of 2 Weeks||35
6450351|NCT01147458|7366117|FG003|COMPLETED|Washout Period of 2 Weeks||34
6450352|NCT01147458|7366114|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6450353|NCT01147458|7366115|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6450354|NCT01147458|7366116|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
6450355|NCT01147458|7366117|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
6450356|NCT01147458|7366114|FG000|STARTED|Second Intervention||34
6450357|NCT01147458|7366115|FG001|STARTED|Second Intervention||31
6450358|NCT01147458|7366116|FG002|STARTED|Second Intervention||35
6450359|NCT01147458|7366117|FG003|STARTED|Second Intervention||34
6450360|NCT01147458|7366114|FG000|COMPLETED|Second Intervention||25
6450361|NCT01147458|7366115|FG001|COMPLETED|Second Intervention||24
6450362|NCT01147458|7366116|FG002|COMPLETED|Second Intervention||27
6450363|NCT01147458|7366117|FG003|COMPLETED|Second Intervention||30
6450364|NCT01147458|7366114|FG000|NOT COMPLETED|Second Intervention||9
6450365|NCT01147458|7366115|FG001|NOT COMPLETED|Second Intervention||7
6450366|NCT01147458|7366116|FG002|NOT COMPLETED|Second Intervention||8
6450367|NCT01147458|7366117|FG003|NOT COMPLETED|Second Intervention||4
6450368|NCT01147471|7366131|FG000|STARTED|Through Initial Hospital Discharge||13
6450369|NCT01147471|7366132|FG001|STARTED|Through Initial Hospital Discharge||11
6450370|NCT01147471|7366131|FG000|COMPLETED|Through Initial Hospital Discharge||13
6553402|NCT01743677|7475928|FG001|STARTED|First Intervention Period||10
6553403|NCT01743677|7475929|FG002|STARTED|First Intervention Period||10
6553404|NCT01743677|7475930|FG003|STARTED|First Intervention Period||10
6553405|NCT01743677|7475931|FG004|STARTED|First Intervention Period||10
6553406|NCT01743677|7475932|FG005|STARTED|First Intervention Period||10
6553407|NCT01743677|7475927|FG000|COMPLETED|First Intervention Period||10
6553408|NCT01743677|7475928|FG001|COMPLETED|First Intervention Period||10
6553409|NCT01743677|7475929|FG002|COMPLETED|First Intervention Period||10
6553410|NCT01743677|7475930|FG003|COMPLETED|First Intervention Period||10
6553411|NCT01743677|7475931|FG004|COMPLETED|First Intervention Period||10
6553412|NCT01743677|7475932|FG005|COMPLETED|First Intervention Period||10
6553413|NCT01743677|7475927|FG000|NOT COMPLETED|First Intervention Period||0
6553414|NCT01743677|7475928|FG001|NOT COMPLETED|First Intervention Period||0
6450371|NCT01147471|7366132|FG001|COMPLETED|Through Initial Hospital Discharge||11
6450372|NCT01147471|7366131|FG000|NOT COMPLETED|Through Initial Hospital Discharge||0
6450373|NCT01147471|7366132|FG001|NOT COMPLETED|Through Initial Hospital Discharge||0
6450374|NCT01147471|7366131|FG000|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
6450375|NCT01147471|7366132|FG001|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
6450376|NCT01147471|7366131|FG000|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
6450377|NCT01147471|7366132|FG001|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
6450378|NCT01147471|7366131|FG000|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
6450379|NCT01147471|7366132|FG001|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
6450380|NCT01147471|7366131|FG000|STARTED|3 Month Follow Up||13
6450381|NCT01147471|7366132|FG001|STARTED|3 Month Follow Up||8
6450382|NCT01147471|7366131|FG000|COMPLETED|3 Month Follow Up||12
6450383|NCT01147471|7366132|FG001|COMPLETED|3 Month Follow Up||6
6450384|NCT01147471|7366131|FG000|NOT COMPLETED|3 Month Follow Up||1
6450385|NCT01147471|7366132|FG001|NOT COMPLETED|3 Month Follow Up||2
6450386|NCT01147471|7366131|FG000|STARTED|6 Month Follow Up||12
6450387|NCT01147471|7366132|FG001|STARTED|6 Month Follow Up||6
6450388|NCT01147471|7366131|FG000|COMPLETED|6 Month Follow Up||8
6450389|NCT01147471|7366132|FG001|COMPLETED|6 Month Follow Up||4
6450390|NCT01147471|7366131|FG000|NOT COMPLETED|6 Month Follow Up||4
6450391|NCT01147471|7366132|FG001|NOT COMPLETED|6 Month Follow Up||2
6450392|NCT01147497|7366140|FG000|STARTED|Overall Study||37
6450393|NCT01147497|7366141|FG001|STARTED|Overall Study||36
6450394|NCT01147497|7366140|FG000|COMPLETED|Overall Study||35
6450395|NCT01147497|7366141|FG001|COMPLETED|Overall Study||36
6450396|NCT01147497|7366140|FG000|NOT COMPLETED|Overall Study||2
6450397|NCT01147497|7366141|FG001|NOT COMPLETED|Overall Study||0
6450398|NCT01147601|7366149|FG000|STARTED|Overall Study||5
6450399|NCT01147601|7366150|FG001|STARTED|Overall Study||1
6450400|NCT01147601|7366149|FG000|COMPLETED|Overall Study||2
6450401|NCT01147601|7366150|FG001|COMPLETED|Overall Study||1
6450402|NCT01147601|7366149|FG000|NOT COMPLETED|Overall Study||3
6450403|NCT01147601|7366150|FG001|NOT COMPLETED|Overall Study||0
6450404|NCT01147627|7366159|FG000|STARTED|Overall Study||142
6450405|NCT01147627|7366160|FG001|STARTED|Overall Study||138
6450406|NCT01147627|7366161|FG002|STARTED|Overall Study||136
6450407|NCT01147627|7366159|FG000|COMPLETED|Overall Study||110
6450408|NCT01147627|7366160|FG001|COMPLETED|Overall Study||114
6450409|NCT01147627|7366161|FG002|COMPLETED|Overall Study||118
6450410|NCT01147627|7366159|FG000|NOT COMPLETED|Overall Study||32
6450411|NCT01147627|7366160|FG001|NOT COMPLETED|Overall Study||24
6450412|NCT01147627|7366161|FG002|NOT COMPLETED|Overall Study||18
6450413|NCT01147640|7366171|FG000|STARTED|Overall Study||83
6450414|NCT01147640|7366172|FG001|STARTED|Overall Study||39
6450415|NCT01147640|7366171|FG000|COMPLETED|Overall Study||78
6450416|NCT01147640|7366172|FG001|COMPLETED|Overall Study||38
6450417|NCT01147640|7366171|FG000|NOT COMPLETED|Overall Study||5
6450418|NCT01147640|7366172|FG001|NOT COMPLETED|Overall Study||1
6450419|NCT01147744|7366185|FG000|STARTED|Overall Study||100
6450420|NCT01147744|7366186|FG001|STARTED|Overall Study||99
6450421|NCT01147744|7366187|FG002|STARTED|Overall Study||100
6450422|NCT01147744|7366188|FG003|STARTED|Overall Study||100
6450423|NCT01147744|7366189|FG004|STARTED|Overall Study||101
6450424|NCT01147744|7366190|FG005|STARTED|Overall Study||103
6450425|NCT01147744|7366191|FG006|STARTED|Overall Study||97
6450426|NCT01147744|7366185|FG000|COMPLETED|Overall Study||71
6450427|NCT01147744|7366186|FG001|COMPLETED|Overall Study||76
6450428|NCT01147744|7366187|FG002|COMPLETED|Overall Study||82
6450429|NCT01147744|7366188|FG003|COMPLETED|Overall Study||82
6450430|NCT01147744|7366189|FG004|COMPLETED|Overall Study||76
6450431|NCT01147744|7366190|FG005|COMPLETED|Overall Study||83
6450432|NCT01147744|7366191|FG006|COMPLETED|Overall Study||78
6450433|NCT01147744|7366185|FG000|NOT COMPLETED|Overall Study||29
6450434|NCT01147744|7366186|FG001|NOT COMPLETED|Overall Study||23
6450435|NCT01147744|7366187|FG002|NOT COMPLETED|Overall Study||18
6553415|NCT01743677|7475929|FG002|NOT COMPLETED|First Intervention Period||0
6553416|NCT01743677|7475930|FG003|NOT COMPLETED|First Intervention Period||0
6553417|NCT01743677|7475931|FG004|NOT COMPLETED|First Intervention Period||0
6553418|NCT01743677|7475932|FG005|NOT COMPLETED|First Intervention Period||0
6450436|NCT01147744|7366188|FG003|NOT COMPLETED|Overall Study||18
6450437|NCT01147744|7366189|FG004|NOT COMPLETED|Overall Study||25
6450438|NCT01147744|7366190|FG005|NOT COMPLETED|Overall Study||20
6450439|NCT01147744|7366191|FG006|NOT COMPLETED|Overall Study||19
6450440|NCT01147809|7366219|FG000|STARTED|Phase I (168 Days)||3
6450441|NCT01147809|7366220|FG001|STARTED|Phase I (168 Days)||9
6450442|NCT01147809|7366221|FG002|STARTED|Phase I (168 Days)||4
6450443|NCT01147809|7366222|FG003|STARTED|Phase I (168 Days)||10
6450444|NCT01147809|7366223|FG004|STARTED|Phase I (168 Days)||0
6450445|NCT01147809|7366224|FG005|STARTED|Phase I (168 Days)||0
6450446|NCT01147809|7366219|FG000|COMPLETED|Phase I (168 Days)||2
6450447|NCT01147809|7366220|FG001|COMPLETED|Phase I (168 Days)||8
6450448|NCT01147809|7366221|FG002|COMPLETED|Phase I (168 Days)||2
6450449|NCT01147809|7366222|FG003|COMPLETED|Phase I (168 Days)||5
6450450|NCT01147809|7366223|FG004|COMPLETED|Phase I (168 Days)||0
6450451|NCT01147809|7366224|FG005|COMPLETED|Phase I (168 Days)||0
6450452|NCT01147809|7366219|FG000|NOT COMPLETED|Phase I (168 Days)||1
6450453|NCT01147809|7366220|FG001|NOT COMPLETED|Phase I (168 Days)||1
6450454|NCT01147809|7366221|FG002|NOT COMPLETED|Phase I (168 Days)||2
6450455|NCT01147809|7366222|FG003|NOT COMPLETED|Phase I (168 Days)||5
6450456|NCT01147809|7366223|FG004|NOT COMPLETED|Phase I (168 Days)||0
6450457|NCT01147809|7366224|FG005|NOT COMPLETED|Phase I (168 Days)||0
6450458|NCT01147809|7366219|FG000|STARTED|Phase II (168 Days)||0
6450459|NCT01147809|7366220|FG001|STARTED|Phase II (168 Days)||0
6450460|NCT01147809|7366221|FG002|STARTED|Phase II (168 Days)||0
6450461|NCT01147809|7366222|FG003|STARTED|Phase II (168 Days)||0
6450462|NCT01147809|7366223|FG004|STARTED|Phase II (168 Days)||23
6450463|NCT01147809|7366224|FG005|STARTED|Phase II (168 Days)||52
6450464|NCT01147809|7366219|FG000|Ongoing|Phase II (168 Days)||0
6450465|NCT01147809|7366220|FG001|Ongoing|Phase II (168 Days)||0
6450466|NCT01147809|7366221|FG002|Ongoing|Phase II (168 Days)||0
6450467|NCT01147809|7366222|FG003|Ongoing|Phase II (168 Days)||0
6450468|NCT01147809|7366223|FG004|Ongoing|Phase II (168 Days)||1
6450469|NCT01147809|7366224|FG005|Ongoing|Phase II (168 Days)||0
6450470|NCT01147809|7366219|FG000|COMPLETED|Phase II (168 Days)||0
6450471|NCT01147809|7366220|FG001|COMPLETED|Phase II (168 Days)||0
6450472|NCT01147809|7366221|FG002|COMPLETED|Phase II (168 Days)||0
6450473|NCT01147809|7366222|FG003|COMPLETED|Phase II (168 Days)||0
6450474|NCT01147809|7366223|FG004|COMPLETED|Phase II (168 Days)||7
6450475|NCT01147809|7366224|FG005|COMPLETED|Phase II (168 Days)||19
6450476|NCT01147809|7366219|FG000|NOT COMPLETED|Phase II (168 Days)||0
6450477|NCT01147809|7366220|FG001|NOT COMPLETED|Phase II (168 Days)||0
6450478|NCT01147809|7366221|FG002|NOT COMPLETED|Phase II (168 Days)||0
6450479|NCT01147809|7366222|FG003|NOT COMPLETED|Phase II (168 Days)||0
6450480|NCT01147809|7366223|FG004|NOT COMPLETED|Phase II (168 Days)||16
6450481|NCT01147809|7366224|FG005|NOT COMPLETED|Phase II (168 Days)||33
6450482|NCT01147848|7366241|FG000|STARTED|Run-in Period||1564
6450483|NCT01147848|7366242|FG001|STARTED|Run-in Period||0
6450484|NCT01147848|7366243|FG002|STARTED|Run-in Period||0
6450485|NCT01147848|7366241|FG000|COMPLETED|Run-in Period||806
6450486|NCT01147848|7366242|FG001|COMPLETED|Run-in Period||0
6450487|NCT01147848|7366243|FG002|COMPLETED|Run-in Period||0
6450488|NCT01147848|7366241|FG000|NOT COMPLETED|Run-in Period||758
6450489|NCT01147848|7366242|FG001|NOT COMPLETED|Run-in Period||0
6450490|NCT01147848|7366243|FG002|NOT COMPLETED|Run-in Period||0
6450491|NCT01147848|7366241|FG000|STARTED|Randomized Phase||0
6450492|NCT01147848|7366242|FG001|STARTED|Randomized Phase||403
6450493|NCT01147848|7366243|FG002|STARTED|Randomized Phase||403
6450494|NCT01147848|7366241|FG000|COMPLETED|Randomized Phase||0
6450495|NCT01147848|7366242|FG001|COMPLETED|Randomized Phase||358
6450496|NCT01147848|7366243|FG002|COMPLETED|Randomized Phase||357
6450497|NCT01147848|7366241|FG000|NOT COMPLETED|Randomized Phase||0
6450498|NCT01147848|7366242|FG001|NOT COMPLETED|Randomized Phase||45
6450499|NCT01147848|7366243|FG002|NOT COMPLETED|Randomized Phase||46
6450500|NCT01147874|7366250|FG000|STARTED|Overall Study||1013
6450501|NCT01147874|7366250|FG000|COMPLETED|Overall Study||946
6450502|NCT01147874|7366250|FG000|NOT COMPLETED|Overall Study||67
6450503|NCT01147900|7366257|FG000|STARTED|At Year 8.5||54
6450504|NCT01147900|7366258|FG001|STARTED|At Year 8.5||60
6450505|NCT01147900|7366259|FG002|STARTED|At Year 8.5||66
6450506|NCT01147900|7366257|FG000|COMPLETED|At Year 8.5||54
6450507|NCT01147900|7366258|FG001|COMPLETED|At Year 8.5||60
6450508|NCT01147900|7366259|FG002|COMPLETED|At Year 8.5||66
6450509|NCT01147900|7366257|FG000|NOT COMPLETED|At Year 8.5||0
6450510|NCT01147900|7366258|FG001|NOT COMPLETED|At Year 8.5||0
6450511|NCT01147900|7366259|FG002|NOT COMPLETED|At Year 8.5||0
6450512|NCT01147900|7366257|FG000|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
6450513|NCT01147900|7366258|FG001|STARTED|At Year 10||60
6450514|NCT01147900|7366259|FG002|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
6450515|NCT01147900|7366257|FG000|COMPLETED|At Year 10||55
6450516|NCT01147900|7366258|FG001|COMPLETED|At Year 10||59
6450517|NCT01147900|7366259|FG002|COMPLETED|At Year 10||62
6450518|NCT01147900|7366257|FG000|NOT COMPLETED|At Year 10||0
6450519|NCT01147900|7366258|FG001|NOT COMPLETED|At Year 10||1
6450520|NCT01147900|7366259|FG002|NOT COMPLETED|At Year 10||0
6450521|NCT01147926|7366269|FG000|STARTED|Overall Study||187
6450522|NCT01147926|7366270|FG001|STARTED|Overall Study||187
6450523|NCT01147926|7366269|FG000|COMPLETED|Overall Study||160
6450524|NCT01147926|7366270|FG001|COMPLETED|Overall Study||158
6450525|NCT01147926|7366269|FG000|NOT COMPLETED|Overall Study||27
6450526|NCT01147926|7366270|FG001|NOT COMPLETED|Overall Study||29
6450527|NCT01148017|7366280|FG000|STARTED|Overall Study||214
6450528|NCT01148017|7366281|FG001|STARTED|Overall Study||121
6450529|NCT01148017|7366282|FG002|STARTED|Overall Study||53
6450530|NCT01148017|7366283|FG003|STARTED|Overall Study||45
6450531|NCT01148017|7366280|FG000|COMPLETED|Overall Study||134
6450532|NCT01148017|7366281|FG001|COMPLETED|Overall Study||87
6450533|NCT01148017|7366282|FG002|COMPLETED|Overall Study||53
6450534|NCT01148017|7366283|FG003|COMPLETED|Overall Study||45
6450535|NCT01148017|7366280|FG000|NOT COMPLETED|Overall Study||80
6450536|NCT01148017|7366281|FG001|NOT COMPLETED|Overall Study||34
6450537|NCT01148017|7366282|FG002|NOT COMPLETED|Overall Study||0
6450538|NCT01148017|7366283|FG003|NOT COMPLETED|Overall Study||0
6450539|NCT01148225|7366294|FG000|STARTED|Overall Study||424
6450540|NCT01148225|7366294|FG000|COMPLETED|Overall Study||239
6450541|NCT01148225|7366294|FG000|NOT COMPLETED|Overall Study||185
6450542|NCT01148420|7366301|FG000|STARTED|Overall Study||48
6450543|NCT01148420|7366301|FG000|COMPLETED|Overall Study||48
6450544|NCT01148420|7366301|FG000|NOT COMPLETED|Overall Study||0
6450545|NCT01148459|7366308|FG000|STARTED|Overall Study||99
6450546|NCT01148459|7366309|FG001|STARTED|Overall Study||101
6450547|NCT01148459|7366308|FG000|COMPLETED|Overall Study||87
6450548|NCT01148459|7366309|FG001|COMPLETED|Overall Study||90
6450549|NCT01148459|7366308|FG000|NOT COMPLETED|Overall Study||12
6450550|NCT01148459|7366309|FG001|NOT COMPLETED|Overall Study||11
6450551|NCT01148511|7366317|FG000|STARTED|Exposed to Study Drug||99
6450552|NCT01148511|7366318|FG001|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
6450553|NCT01148511|7366319|FG002|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
6450554|NCT01148511|7366317|FG000|COMPLETED|Exposed to Study Drug||93
6450555|NCT01148511|7366318|FG001|COMPLETED|Exposed to Study Drug||0
6450556|NCT01148511|7366319|FG002|COMPLETED|Exposed to Study Drug||0
6450557|NCT01148511|7366317|FG000|NOT COMPLETED|Exposed to Study Drug||6
6450558|NCT01148511|7366318|FG001|NOT COMPLETED|Exposed to Study Drug||0
6450559|NCT01148511|7366319|FG002|NOT COMPLETED|Exposed to Study Drug||0
6450560|NCT01148511|7366317|FG000|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
6450561|NCT01148511|7366318|FG001|STARTED|Randomized||48
6450562|NCT01148511|7366319|FG002|STARTED|Randomized||45
6450563|NCT01148511|7366317|FG000|COMPLETED|Randomized||0
6450564|NCT01148511|7366318|FG001|COMPLETED|Randomized||38
6450565|NCT01148511|7366319|FG002|COMPLETED|Randomized||39
6450566|NCT01148511|7366317|FG000|NOT COMPLETED|Randomized||0
6450567|NCT01148511|7366318|FG001|NOT COMPLETED|Randomized||10
6450568|NCT01148511|7366319|FG002|NOT COMPLETED|Randomized||6
6450569|NCT01148524|7366335|FG000|STARTED|Overall Study||49
6450570|NCT01148524|7366336|FG001|STARTED|Overall Study||95
6450571|NCT01148524|7366337|FG002|STARTED|Overall Study||53
6450572|NCT01148524|7366338|FG003|STARTED|Overall Study||102
6450573|NCT01148524|7366339|FG004|STARTED|Overall Study||57
6450574|NCT01148524|7366340|FG005|STARTED|Overall Study||106
6450575|NCT01148524|7366341|FG006|STARTED|Overall Study||153
6450576|NCT01148524|7366342|FG007|STARTED|Overall Study||51
6450577|NCT01148524|7366343|FG008|STARTED|Overall Study||151
6450578|NCT01148524|7366335|FG000|COMPLETED|Overall Study||49
6450579|NCT01148524|7366336|FG001|COMPLETED|Overall Study||95
6450580|NCT01148524|7366337|FG002|COMPLETED|Overall Study||53
6450581|NCT01148524|7366338|FG003|COMPLETED|Overall Study||102
6450582|NCT01148524|7366339|FG004|COMPLETED|Overall Study||57
6450583|NCT01148524|7366340|FG005|COMPLETED|Overall Study||106
6450584|NCT01148524|7366341|FG006|COMPLETED|Overall Study||153
6450585|NCT01148524|7366342|FG007|COMPLETED|Overall Study||51
6450586|NCT01148524|7366343|FG008|COMPLETED|Overall Study||151
6450587|NCT01148524|7366335|FG000|NOT COMPLETED|Overall Study||0
6450588|NCT01148524|7366336|FG001|NOT COMPLETED|Overall Study||0
6450589|NCT01148524|7366337|FG002|NOT COMPLETED|Overall Study||0
6450590|NCT01148524|7366338|FG003|NOT COMPLETED|Overall Study||0
6450591|NCT01148524|7366339|FG004|NOT COMPLETED|Overall Study||0
6450592|NCT01148524|7366340|FG005|NOT COMPLETED|Overall Study||0
6450593|NCT01148524|7366341|FG006|NOT COMPLETED|Overall Study||0
6450594|NCT01148524|7366342|FG007|NOT COMPLETED|Overall Study||0
6450595|NCT01148524|7366343|FG008|NOT COMPLETED|Overall Study||0
6450596|NCT01148537|7366366|FG000|STARTED|Overall Study||44
6450597|NCT01148537|7366367|FG001|STARTED|Overall Study||44
6450598|NCT01148537|7366368|FG002|STARTED|Overall Study||44
6450599|NCT01148537|7366366|FG000|COMPLETED|Overall Study||41
6450600|NCT01148537|7366367|FG001|COMPLETED|Overall Study||44
6450601|NCT01148537|7366368|FG002|COMPLETED|Overall Study||41
6450602|NCT01148537|7366366|FG000|NOT COMPLETED|Overall Study||3
6450603|NCT01148537|7366367|FG001|NOT COMPLETED|Overall Study||0
6450604|NCT01148537|7366368|FG002|NOT COMPLETED|Overall Study||3
6450605|NCT01148563|7366379|FG000|STARTED|Overall Study||69
6450606|NCT01148563|7366380|FG001|STARTED|Overall Study||67
6450607|NCT01148563|7366379|FG000|COMPLETED|Overall Study||40
6450608|NCT01148563|7366380|FG001|COMPLETED|Overall Study||37
6450609|NCT01148563|7366379|FG000|NOT COMPLETED|Overall Study||29
6450610|NCT01148563|7366380|FG001|NOT COMPLETED|Overall Study||30
6450611|NCT01148693|7366389|FG000|STARTED|Overall Study||70
6450612|NCT01148693|7366390|FG001|STARTED|Overall Study||67
6450613|NCT01148693|7366389|FG000|COMPLETED|Overall Study||57
6450614|NCT01148693|7366390|FG001|COMPLETED|Overall Study||57
6450615|NCT01148693|7366389|FG000|NOT COMPLETED|Overall Study||13
6450616|NCT01148693|7366390|FG001|NOT COMPLETED|Overall Study||10
6450617|NCT01148745|7366396|FG000|STARTED|Overall Study||15
6450618|NCT01148745|7366396|FG000|COMPLETED|Overall Study||15
6450619|NCT01148745|7366396|FG000|NOT COMPLETED|Overall Study||0
6450620|NCT01148771|7366404|FG000|STARTED|First Intervention||6
6450621|NCT01148771|7366405|FG001|STARTED|First Intervention||6
6450622|NCT01148771|7366404|FG000|COMPLETED|First Intervention||6
6450623|NCT01148771|7366405|FG001|COMPLETED|First Intervention||6
6450624|NCT01148771|7366404|FG000|NOT COMPLETED|First Intervention||0
6450625|NCT01148771|7366405|FG001|NOT COMPLETED|First Intervention||0
6450626|NCT01148771|7366404|FG000|STARTED|Washout Period||6
6450627|NCT01148771|7366405|FG001|STARTED|Washout Period||6
6450628|NCT01148771|7366404|FG000|COMPLETED|Washout Period||6
6450629|NCT01148771|7366405|FG001|COMPLETED|Washout Period||5
6450630|NCT01148771|7366404|FG000|NOT COMPLETED|Washout Period||0
6450631|NCT01148771|7366405|FG001|NOT COMPLETED|Washout Period||1
6450632|NCT01148771|7366404|FG000|STARTED|Second Intervention||6
6450633|NCT01148771|7366405|FG001|STARTED|Second Intervention||5
6450634|NCT01148771|7366404|FG000|COMPLETED|Second Intervention||6
6450635|NCT01148771|7366405|FG001|COMPLETED|Second Intervention||5
6450636|NCT01148771|7366404|FG000|NOT COMPLETED|Second Intervention||0
6450637|NCT01148771|7366405|FG001|NOT COMPLETED|Second Intervention||0
6450638|NCT01148810|7366417|FG000|STARTED|Overall Study||8
6450639|NCT01148810|7366418|FG001|STARTED|Overall Study||10
6450640|NCT01148810|7366417|FG000|COMPLETED|Overall Study||7
6450641|NCT01148810|7366418|FG001|COMPLETED|Overall Study||5
6450642|NCT01148810|7366417|FG000|NOT COMPLETED|Overall Study||1
6450643|NCT01148810|7366418|FG001|NOT COMPLETED|Overall Study||5
6450644|NCT01148836|7366427|FG000|STARTED|Overall Study|Enrollment completed|8
6450645|NCT01148836|7366428|FG001|STARTED|Overall Study||10
6450646|NCT01148836|7366427|FG000|COMPLETED|Overall Study|Enrollment completed|7
6450647|NCT01148836|7366428|FG001|COMPLETED|Overall Study||8
6450648|NCT01148836|7366427|FG000|NOT COMPLETED|Overall Study||1
6450649|NCT01148836|7366428|FG001|NOT COMPLETED|Overall Study||2
6450650|NCT01148862|7366434|FG000|STARTED|First Intervention||25
6450651|NCT01148862|7366435|FG001|STARTED|First Intervention||25
6450652|NCT01148862|7366434|FG000|COMPLETED|First Intervention||25
6450653|NCT01148862|7366435|FG001|COMPLETED|First Intervention||25
6450654|NCT01148862|7366434|FG000|NOT COMPLETED|First Intervention||0
6450655|NCT01148862|7366435|FG001|NOT COMPLETED|First Intervention||0
6450656|NCT01148862|7366434|FG000|STARTED|Washout Period of 2 Weeks||25
6450657|NCT01148862|7366435|FG001|STARTED|Washout Period of 2 Weeks||25
6745010|NCT03352414|7673089|FG001|COMPLETED|Overall Study||32
6745011|NCT03352414|7673088|FG000|NOT COMPLETED|Overall Study||12
6450658|NCT01148862|7366434|FG000|COMPLETED|Washout Period of 2 Weeks||25
6553419|NCT01743677|7475927|FG000|STARTED|Washout Period 1 (at Least 7 Days)||10
6553420|NCT01743677|7475928|FG001|STARTED|Washout Period 1 (at Least 7 Days)||10
6553421|NCT01743677|7475929|FG002|STARTED|Washout Period 1 (at Least 7 Days)||10
6553422|NCT01743677|7475930|FG003|STARTED|Washout Period 1 (at Least 7 Days)||10
6450659|NCT01148862|7366435|FG001|COMPLETED|Washout Period of 2 Weeks||25
6450660|NCT01148862|7366434|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6450661|NCT01148862|7366435|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6450662|NCT01148862|7366434|FG000|STARTED|Second Intervention||25
6450663|NCT01148862|7366435|FG001|STARTED|Second Intervention||25
6450664|NCT01148862|7366434|FG000|COMPLETED|Second Intervention||25
6450665|NCT01148862|7366435|FG001|COMPLETED|Second Intervention||23
6450666|NCT01148862|7366434|FG000|NOT COMPLETED|Second Intervention||0
6450667|NCT01148862|7366435|FG001|NOT COMPLETED|Second Intervention||2
6450668|NCT01148940|7366443|FG000|STARTED|Overall Study||7
6450669|NCT01148940|7366444|FG001|STARTED|Overall Study||27
6450670|NCT01148940|7366445|FG002|STARTED|Overall Study||0
6450671|NCT01148940|7366443|FG000|COMPLETED|Overall Study||7
6450672|NCT01148940|7366444|FG001|COMPLETED|Overall Study||27
6450673|NCT01148940|7366445|FG002|COMPLETED|Overall Study||0
6450674|NCT01148940|7366443|FG000|NOT COMPLETED|Overall Study||0
6450675|NCT01148940|7366444|FG001|NOT COMPLETED|Overall Study||0
6450676|NCT01148940|7366445|FG002|NOT COMPLETED|Overall Study||0
6450677|NCT01148979|7366455|FG000|STARTED|Overall Study||13
6450678|NCT01148979|7366456|FG001|STARTED|Overall Study||16
6450679|NCT01148979|7366455|FG000|COMPLETED|Overall Study||13
6450680|NCT01148979|7366456|FG001|COMPLETED|Overall Study||15
6450681|NCT01148979|7366455|FG000|NOT COMPLETED|Overall Study||0
6450682|NCT01148979|7366456|FG001|NOT COMPLETED|Overall Study||1
6450683|NCT01149057|7366462|FG000|STARTED|Overall Study||145
6450684|NCT01149057|7366462|FG000|COMPLETED|Overall Study||88
6450685|NCT01149057|7366462|FG000|NOT COMPLETED|Overall Study||57
6450686|NCT01149096|7366468|FG000|STARTED|Overall Study||6
6450687|NCT01149096|7366469|FG001|STARTED|Overall Study||7
6450688|NCT01149096|7366468|FG000|COMPLETED|Overall Study||6
6450689|NCT01149096|7366469|FG001|COMPLETED|Overall Study||6
6450690|NCT01149096|7366468|FG000|NOT COMPLETED|Overall Study||0
6450691|NCT01149096|7366469|FG001|NOT COMPLETED|Overall Study||1
6450692|NCT01149148|7366478|FG000|STARTED|Overall Study||12
6450693|NCT01149148|7366479|FG001|STARTED|Overall Study||13
6450694|NCT01149148|7366478|FG000|COMPLETED|Overall Study||10
6450695|NCT01149148|7366479|FG001|COMPLETED|Overall Study||11
6450696|NCT01149148|7366478|FG000|NOT COMPLETED|Overall Study||2
6450697|NCT01149148|7366479|FG001|NOT COMPLETED|Overall Study||2
6450698|NCT01149343|7366490|FG000|STARTED|Overall Study||20
6450699|NCT01149343|7366491|FG001|STARTED|Overall Study||24
6450700|NCT01149343|7366492|FG002|STARTED|Overall Study||22
6450701|NCT01149343|7366493|FG003|STARTED|Overall Study||40
6553423|NCT01743677|7475931|FG004|STARTED|Washout Period 1 (at Least 7 Days)||10
6745012|NCT03352414|7673089|FG001|NOT COMPLETED|Overall Study||10
6450702|NCT01149343|7366490|FG000|COMPLETED|Overall Study||0
6450703|NCT01149343|7366491|FG001|COMPLETED|Overall Study||0
6450704|NCT01149343|7366492|FG002|COMPLETED|Overall Study||0
6450705|NCT01149343|7366493|FG003|COMPLETED|Overall Study||0
6450706|NCT01149343|7366490|FG000|NOT COMPLETED|Overall Study||20
6450707|NCT01149343|7366491|FG001|NOT COMPLETED|Overall Study||24
6450708|NCT01149343|7366492|FG002|NOT COMPLETED|Overall Study||22
6450709|NCT01149343|7366493|FG003|NOT COMPLETED|Overall Study||40
6450710|NCT01149369|7366509|FG000|STARTED|Overall Study||63
6450711|NCT01149369|7366510|FG001|STARTED|Overall Study||63
6450712|NCT01149369|7366509|FG000|COMPLETED|Overall Study||57
6450713|NCT01149369|7366510|FG001|COMPLETED|Overall Study||60
6450714|NCT01149369|7366509|FG000|NOT COMPLETED|Overall Study||6
6450715|NCT01149369|7366510|FG001|NOT COMPLETED|Overall Study||3
6450716|NCT01149421|7366519|FG000|STARTED|Overall Study||251
6450717|NCT01149421|7366520|FG001|STARTED|Overall Study||254
6450718|NCT01149421|7366521|FG002|STARTED|Overall Study||250
6450719|NCT01149421|7366519|FG000|Received at Least One Dose of Study Drug|Overall Study||251
6450720|NCT01149421|7366520|FG001|Received at Least One Dose of Study Drug|Overall Study||254
6450721|NCT01149421|7366521|FG002|Received at Least One Dose of Study Drug|Overall Study||250
6450722|NCT01149421|7366519|FG000|COMPLETED|Overall Study||199
6450723|NCT01149421|7366520|FG001|COMPLETED|Overall Study||225
6450724|NCT01149421|7366521|FG002|COMPLETED|Overall Study||206
6450725|NCT01149421|7366519|FG000|NOT COMPLETED|Overall Study||52
6450726|NCT01149421|7366520|FG001|NOT COMPLETED|Overall Study||29
6450727|NCT01149421|7366521|FG002|NOT COMPLETED|Overall Study||44
6450728|NCT01149434|7366531|FG000|STARTED|Overall Study||4
6450729|NCT01149434|7366532|FG001|STARTED|Overall Study||15
6450730|NCT01149434|7366531|FG000|COMPLETED|Overall Study||4
6450731|NCT01149434|7366532|FG001|COMPLETED|Overall Study||10
6450732|NCT01149434|7366531|FG000|NOT COMPLETED|Overall Study||0
6450733|NCT01149434|7366532|FG001|NOT COMPLETED|Overall Study||5
6450734|NCT01149460|7366541|FG000|STARTED|Overall Study||18
6450735|NCT01149460|7366542|FG001|STARTED|Overall Study||18
6450736|NCT01149460|7366541|FG000|COMPLETED|Overall Study||18
6450737|NCT01149460|7366542|FG001|COMPLETED|Overall Study||16
6450738|NCT01149460|7366541|FG000|NOT COMPLETED|Overall Study||0
6450739|NCT01149460|7366542|FG001|NOT COMPLETED|Overall Study||2
6450740|NCT01149473|7366550|FG000|STARTED|First Intervention||40
6450741|NCT01149473|7366551|FG001|STARTED|First Intervention||40
6450742|NCT01149473|7366550|FG000|COMPLETED|First Intervention||39
6450743|NCT01149473|7366551|FG001|COMPLETED|First Intervention||39
6450744|NCT01149473|7366550|FG000|NOT COMPLETED|First Intervention||1
6450745|NCT01149473|7366551|FG001|NOT COMPLETED|First Intervention||1
6450746|NCT01149473|7366550|FG000|STARTED|Washout of 7 Days||39
6450747|NCT01149473|7366551|FG001|STARTED|Washout of 7 Days||39
6450748|NCT01149473|7366550|FG000|COMPLETED|Washout of 7 Days||38
6450749|NCT01149473|7366551|FG001|COMPLETED|Washout of 7 Days||38
6450750|NCT01149473|7366550|FG000|NOT COMPLETED|Washout of 7 Days||1
6450751|NCT01149473|7366551|FG001|NOT COMPLETED|Washout of 7 Days||1
6450752|NCT01149473|7366550|FG000|STARTED|Second Intervention||38
6450753|NCT01149473|7366551|FG001|STARTED|Second Intervention||38
6745013|NCT03352453|7673099|FG000|STARTED|Overall Study||66
6745014|NCT03352453|7673100|FG001|STARTED|Overall Study||72
6745015|NCT03352453|7673099|FG000|COMPLETED|Overall Study||44
6745016|NCT03352453|7673100|FG001|COMPLETED|Overall Study||40
6745017|NCT03352453|7673099|FG000|NOT COMPLETED|Overall Study||22
6745018|NCT03352453|7673100|FG001|NOT COMPLETED|Overall Study||32
6745019|NCT03352609|7673108|FG000|STARTED|Overall Study||2
6745020|NCT03352609|7673109|FG001|STARTED|Overall Study||3
6745021|NCT03352609|7673108|FG000|COMPLETED|Overall Study||2
6745022|NCT03352609|7673109|FG001|COMPLETED|Overall Study||3
6745023|NCT03352609|7673108|FG000|NOT COMPLETED|Overall Study||0
6745024|NCT03352609|7673109|FG001|NOT COMPLETED|Overall Study||0
6745025|NCT03352713|7673115|FG000|STARTED|Overall Study||185
6745026|NCT03352713|7673115|FG000|COMPLETED|Overall Study|Participants who completed at least 1 EMA for inclusion in data analysis|159
6745027|NCT03352713|7673115|FG000|NOT COMPLETED|Overall Study||26
6745028|NCT03353220|7673119|FG000|STARTED|First Intervention (7 Days) - Phase 1||14
6745029|NCT03353220|7673120|FG001|STARTED|First Intervention (7 Days) - Phase 1||16
6745030|NCT03353220|7673119|FG000|COMPLETED|First Intervention (7 Days) - Phase 1||14
6745031|NCT03353220|7673120|FG001|COMPLETED|First Intervention (7 Days) - Phase 1||16
6745032|NCT03353220|7673119|FG000|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
6745033|NCT03353220|7673120|FG001|NOT COMPLETED|First Intervention (7 Days) - Phase 1||0
6745034|NCT03353220|7673119|FG000|STARTED|Washout (3 Weeks) - Phase 1||14
6745035|NCT03353220|7673120|FG001|STARTED|Washout (3 Weeks) - Phase 1||16
6745036|NCT03353220|7673119|FG000|COMPLETED|Washout (3 Weeks) - Phase 1||14
6745037|NCT03353220|7673120|FG001|COMPLETED|Washout (3 Weeks) - Phase 1||16
6745038|NCT03353220|7673119|FG000|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
6745039|NCT03353220|7673120|FG001|NOT COMPLETED|Washout (3 Weeks) - Phase 1||0
6450754|NCT01149473|7366550|FG000|COMPLETED|Second Intervention||38
6450755|NCT01149473|7366551|FG001|COMPLETED|Second Intervention||38
6745040|NCT03353220|7673119|FG000|STARTED|Second Intervention (7 Days) - Phase 1||14
6745041|NCT03353220|7673120|FG001|STARTED|Second Intervention (7 Days) - Phase 1||16
6745042|NCT03353220|7673119|FG000|COMPLETED|Second Intervention (7 Days) - Phase 1||14
6745043|NCT03353220|7673120|FG001|COMPLETED|Second Intervention (7 Days) - Phase 1||16
6745044|NCT03353220|7673119|FG000|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
6745045|NCT03353220|7673120|FG001|NOT COMPLETED|Second Intervention (7 Days) - Phase 1||0
6745046|NCT03353220|7673119|FG000|STARTED|Third Intervention (6 Months) - Phase 2||14
6450756|NCT01149473|7366550|FG000|NOT COMPLETED|Second Intervention||0
6450757|NCT01149473|7366551|FG001|NOT COMPLETED|Second Intervention||0
6450758|NCT01149486|7366559|FG000|STARTED|First Intervention||10
6450759|NCT01149486|7366560|FG001|STARTED|First Intervention||10
6450760|NCT01149486|7366559|FG000|COMPLETED|First Intervention||10
6450761|NCT01149486|7366560|FG001|COMPLETED|First Intervention||9
6450762|NCT01149486|7366559|FG000|NOT COMPLETED|First Intervention||0
6450763|NCT01149486|7366560|FG001|NOT COMPLETED|First Intervention||1
6450764|NCT01149486|7366559|FG000|STARTED|Washout of 7 Days||10
6450765|NCT01149486|7366560|FG001|STARTED|Washout of 7 Days||9
6450766|NCT01149486|7366559|FG000|COMPLETED|Washout of 7 Days||10
6450767|NCT01149486|7366560|FG001|COMPLETED|Washout of 7 Days||9
6450768|NCT01149486|7366559|FG000|NOT COMPLETED|Washout of 7 Days||0
6450769|NCT01149486|7366560|FG001|NOT COMPLETED|Washout of 7 Days||0
6450770|NCT01149486|7366559|FG000|STARTED|Second Intervention||10
6450771|NCT01149486|7366560|FG001|STARTED|Second Intervention||9
6450772|NCT01149486|7366559|FG000|COMPLETED|Second Intervention||10
6450773|NCT01149486|7366560|FG001|COMPLETED|Second Intervention||9
6450774|NCT01149486|7366559|FG000|NOT COMPLETED|Second Intervention||0
6450775|NCT01149486|7366560|FG001|NOT COMPLETED|Second Intervention||0
6450776|NCT01149512|7366566|FG000|STARTED|Overall Study||178
6450777|NCT01149512|7366566|FG000|COMPLETED|Overall Study||178
6450778|NCT01149512|7366566|FG000|NOT COMPLETED|Overall Study||0
6450779|NCT01149538|7366572|FG000|STARTED|Overall Study||31
6450780|NCT01149538|7366573|FG001|STARTED|Overall Study||29
6450781|NCT01149538|7366572|FG000|COMPLETED|Overall Study||26
6450782|NCT01149538|7366573|FG001|COMPLETED|Overall Study||25
6450783|NCT01149538|7366572|FG000|NOT COMPLETED|Overall Study||5
6450784|NCT01149538|7366573|FG001|NOT COMPLETED|Overall Study||4
6450785|NCT01149616|7366581|FG000|STARTED|Overall Study||41
6450786|NCT01149616|7366582|FG001|STARTED|Overall Study||41
6450787|NCT01149616|7366581|FG000|COMPLETED|Overall Study||41
6450788|NCT01149616|7366582|FG001|COMPLETED|Overall Study||41
6450789|NCT01149616|7366581|FG000|NOT COMPLETED|Overall Study||0
6450790|NCT01149616|7366582|FG001|NOT COMPLETED|Overall Study||0
6450791|NCT01149655|7366592|FG000|STARTED|Period 1 - Conversion Phase||186
6450792|NCT01149655|7366593|FG001|STARTED|Period 1 - Conversion Phase||0
6450793|NCT01149655|7366594|FG002|STARTED|Period 1 - Conversion Phase||0
6450794|NCT01149655|7366595|FG003|STARTED|Period 1 - Conversion Phase||0
6450795|NCT01149655|7366592|FG000|COMPLETED|Period 1 - Conversion Phase||168
6450796|NCT01149655|7366593|FG001|COMPLETED|Period 1 - Conversion Phase||0
6450797|NCT01149655|7366594|FG002|COMPLETED|Period 1 - Conversion Phase||0
6450798|NCT01149655|7366595|FG003|COMPLETED|Period 1 - Conversion Phase||0
6450799|NCT01149655|7366592|FG000|NOT COMPLETED|Period 1 - Conversion Phase||18
6450800|NCT01149655|7366593|FG001|NOT COMPLETED|Period 1 - Conversion Phase||0
6450801|NCT01149655|7366594|FG002|NOT COMPLETED|Period 1 - Conversion Phase||0
6450802|NCT01149655|7366595|FG003|NOT COMPLETED|Period 1 - Conversion Phase||0
6450803|NCT01149655|7366592|FG000|STARTED|Period 2-Stabilization Phase||0
6450804|NCT01149655|7366593|FG001|STARTED|Period 2-Stabilization Phase||183
6450805|NCT01149655|7366594|FG002|STARTED|Period 2-Stabilization Phase||0
6450806|NCT01149655|7366595|FG003|STARTED|Period 2-Stabilization Phase||0
6450807|NCT01149655|7366592|FG000|COMPLETED|Period 2-Stabilization Phase||0
6450808|NCT01149655|7366593|FG001|COMPLETED|Period 2-Stabilization Phase||146
6450809|NCT01149655|7366594|FG002|COMPLETED|Period 2-Stabilization Phase||0
6450810|NCT01149655|7366595|FG003|COMPLETED|Period 2-Stabilization Phase||0
6450811|NCT01149655|7366592|FG000|NOT COMPLETED|Period 2-Stabilization Phase||0
6450812|NCT01149655|7366593|FG001|NOT COMPLETED|Period 2-Stabilization Phase||37
6450813|NCT01149655|7366594|FG002|NOT COMPLETED|Period 2-Stabilization Phase||0
6450814|NCT01149655|7366595|FG003|NOT COMPLETED|Period 2-Stabilization Phase||0
6450815|NCT01149655|7366592|FG000|STARTED|Period 3-DB Maintenance Phase||0
6450816|NCT01149655|7366593|FG001|STARTED|Period 3-DB Maintenance Phase||0
6450817|NCT01149655|7366594|FG002|STARTED|Period 3-DB Maintenance Phase||98
6450818|NCT01149655|7366595|FG003|STARTED|Period 3-DB Maintenance Phase||48
6450819|NCT01149655|7366592|FG000|COMPLETED|Period 3-DB Maintenance Phase||0
6450820|NCT01149655|7366593|FG001|COMPLETED|Period 3-DB Maintenance Phase||0
6450821|NCT01149655|7366594|FG002|COMPLETED|Period 3-DB Maintenance Phase||15
6450822|NCT01149655|7366595|FG003|COMPLETED|Period 3-DB Maintenance Phase||6
6450823|NCT01149655|7366592|FG000|NOT COMPLETED|Period 3-DB Maintenance Phase||0
6450824|NCT01149655|7366593|FG001|NOT COMPLETED|Period 3-DB Maintenance Phase||0
6450825|NCT01149655|7366594|FG002|NOT COMPLETED|Period 3-DB Maintenance Phase||83
6450826|NCT01149655|7366595|FG003|NOT COMPLETED|Period 3-DB Maintenance Phase||42
6450827|NCT01149681|7366603|FG000|STARTED|Overall Study||12
6450828|NCT01149681|7366603|FG000|COMPLETED|Overall Study||0
6450829|NCT01149681|7366603|FG000|NOT COMPLETED|Overall Study||12
6450830|NCT01149733|7366610|FG000|STARTED|Overall Study||16
6450831|NCT01149733|7366611|FG001|STARTED|Overall Study||16
6450832|NCT01149733|7366610|FG000|COMPLETED|Overall Study||16
6450833|NCT01149733|7366611|FG001|COMPLETED|Overall Study||16
6450834|NCT01149733|7366610|FG000|NOT COMPLETED|Overall Study||0
6450835|NCT01149733|7366611|FG001|NOT COMPLETED|Overall Study||0
6450836|NCT01149759|7366617|FG000|STARTED|Overall Study||9
6450837|NCT01149759|7366617|FG000|COMPLETED|Overall Study||9
6450838|NCT01149759|7366617|FG000|NOT COMPLETED|Overall Study||0
6450839|NCT01149772|7366623|FG000|STARTED|Overall Study||180
6450840|NCT01149772|7366624|FG001|STARTED|Overall Study||122
6450841|NCT01149772|7366623|FG000|COMPLETED|Overall Study||132
6450842|NCT01149772|7366624|FG001|COMPLETED|Overall Study||101
6450843|NCT01149772|7366623|FG000|NOT COMPLETED|Overall Study||48
6553424|NCT01743677|7475932|FG005|STARTED|Washout Period 1 (at Least 7 Days)||10
6553425|NCT01743677|7475927|FG000|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6553426|NCT01743677|7475928|FG001|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6553427|NCT01743677|7475929|FG002|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6553428|NCT01743677|7475930|FG003|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6553429|NCT01743677|7475931|FG004|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6553430|NCT01743677|7475932|FG005|COMPLETED|Washout Period 1 (at Least 7 Days)||10
6553431|NCT01743677|7475927|FG000|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6553432|NCT01743677|7475928|FG001|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6553433|NCT01743677|7475929|FG002|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6450844|NCT01149772|7366624|FG001|NOT COMPLETED|Overall Study||21
6450845|NCT01149785|7366632|FG000|STARTED|First Intervention||15
6450846|NCT01149785|7366633|FG001|STARTED|First Intervention||0
6450847|NCT01149785|7366632|FG000|COMPLETED|First Intervention||15
6450848|NCT01149785|7366633|FG001|COMPLETED|First Intervention||0
6450849|NCT01149785|7366632|FG000|NOT COMPLETED|First Intervention||0
6450850|NCT01149785|7366633|FG001|NOT COMPLETED|First Intervention||0
6450851|NCT01149785|7366632|FG000|STARTED|Washout Period of at Least 14 Days||15
6450852|NCT01149785|7366633|FG001|STARTED|Washout Period of at Least 14 Days||0
6553434|NCT01743677|7475930|FG003|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6553435|NCT01743677|7475931|FG004|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6553436|NCT01743677|7475932|FG005|NOT COMPLETED|Washout Period 1 (at Least 7 Days)||0
6553437|NCT01743677|7475927|FG000|STARTED|Second Intervention Period||10
6553438|NCT01743677|7475928|FG001|STARTED|Second Intervention Period||10
6553439|NCT01743677|7475929|FG002|STARTED|Second Intervention Period||10
6450853|NCT01149785|7366632|FG000|COMPLETED|Washout Period of at Least 14 Days||15
6450854|NCT01149785|7366633|FG001|COMPLETED|Washout Period of at Least 14 Days||0
6450855|NCT01149785|7366632|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
6450856|NCT01149785|7366633|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
6450857|NCT01149785|7366632|FG000|STARTED|Second Intervention||0
6450858|NCT01149785|7366633|FG001|STARTED|Second Intervention||15
6450859|NCT01149785|7366632|FG000|COMPLETED|Second Intervention||0
6450860|NCT01149785|7366633|FG001|COMPLETED|Second Intervention||15
6450861|NCT01149785|7366632|FG000|NOT COMPLETED|Second Intervention||0
6450862|NCT01149785|7366633|FG001|NOT COMPLETED|Second Intervention||0
6450863|NCT01149863|7366639|FG000|STARTED|Overall Study||34
6450864|NCT01149863|7366639|FG000|COMPLETED|Overall Study||31
6450865|NCT01149863|7366639|FG000|NOT COMPLETED|Overall Study||3
6450866|NCT01149876|7366647|FG000|STARTED|Overall Study||21
6450867|NCT01149876|7366648|FG001|STARTED|Overall Study||20
6450868|NCT01149876|7366649|FG002|STARTED|Overall Study||21
6450869|NCT01149876|7366650|FG003|STARTED|Overall Study||18
6450870|NCT01149876|7366647|FG000|COMPLETED|Overall Study||20
6450871|NCT01149876|7366648|FG001|COMPLETED|Overall Study||20
6450872|NCT01149876|7366649|FG002|COMPLETED|Overall Study||20
6450873|NCT01149876|7366650|FG003|COMPLETED|Overall Study||18
6450874|NCT01149876|7366647|FG000|NOT COMPLETED|Overall Study||1
6450875|NCT01149876|7366648|FG001|NOT COMPLETED|Overall Study||0
6450876|NCT01149876|7366649|FG002|NOT COMPLETED|Overall Study||1
6450877|NCT01149876|7366650|FG003|NOT COMPLETED|Overall Study||0
6450878|NCT01150097|7366664|FG000|STARTED|Months 24 to 36 Post-transplantation||106
6450879|NCT01150097|7366665|FG001|STARTED|Months 24 to 36 Post-transplantation||51
6450880|NCT01150097|7366666|FG002|STARTED|Months 24 to 36 Post-transplantation||125
6450881|NCT01150097|7366664|FG000|COMPLETED|Months 24 to 36 Post-transplantation||96
6450882|NCT01150097|7366665|FG001|COMPLETED|Months 24 to 36 Post-transplantation||49
6450883|NCT01150097|7366666|FG002|COMPLETED|Months 24 to 36 Post-transplantation||117
6450884|NCT01150097|7366664|FG000|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
6450885|NCT01150097|7366665|FG001|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
6450886|NCT01150097|7366666|FG002|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
6450887|NCT01150097|7366664|FG000|STARTED|Months 24 to 48 Post-transplantation||106
6450888|NCT01150097|7366665|FG001|STARTED|Months 24 to 48 Post-transplantation||51
6450889|NCT01150097|7366666|FG002|STARTED|Months 24 to 48 Post-transplantation||0
6450890|NCT01150097|7366664|FG000|COMPLETED|Months 24 to 48 Post-transplantation||95
6450891|NCT01150097|7366665|FG001|COMPLETED|Months 24 to 48 Post-transplantation||47
6450892|NCT01150097|7366666|FG002|COMPLETED|Months 24 to 48 Post-transplantation||0
6450893|NCT01150097|7366664|FG000|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
6450894|NCT01150097|7366665|FG001|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
6450895|NCT01150097|7366666|FG002|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
6450896|NCT01150123|7366694|FG000|STARTED|Overall Study||40
6450897|NCT01150123|7366695|FG001|STARTED|Overall Study||40
6450898|NCT01150123|7366696|FG002|STARTED|Overall Study||39
6450899|NCT01150123|7366697|FG003|STARTED|Overall Study||40
6450900|NCT01150123|7366698|FG004|STARTED|Overall Study||40
6450901|NCT01150123|7366699|FG005|STARTED|Overall Study||40
6450902|NCT01150123|7366700|FG006|STARTED|Overall Study||39
6450903|NCT01150123|7366701|FG007|STARTED|Overall Study||40
6450904|NCT01150123|7366702|FG008|STARTED|Overall Study||20
6450905|NCT01150123|7366703|FG009|STARTED|Overall Study||40
6450906|NCT01150123|7366704|FG010|STARTED|Overall Study||40
6450907|NCT01150123|7366705|FG011|STARTED|Overall Study||40
6450908|NCT01150123|7366706|FG012|STARTED|Overall Study||40
6450909|NCT01150123|7366707|FG013|STARTED|Overall Study||40
6450910|NCT01150123|7366708|FG014|STARTED|Overall Study||40
6450911|NCT01150123|7366709|FG015|STARTED|Overall Study||40
6450912|NCT01150123|7366710|FG016|STARTED|Overall Study||40
6450913|NCT01150123|7366711|FG017|STARTED|Overall Study||20
6450914|NCT01150123|7366694|FG000|COMPLETED|Overall Study||37
6745047|NCT03353220|7673120|FG001|STARTED|Third Intervention (6 Months) - Phase 2||16
6745048|NCT03353220|7673119|FG000|COMPLETED|Third Intervention (6 Months) - Phase 2||10
6745049|NCT03353220|7673120|FG001|COMPLETED|Third Intervention (6 Months) - Phase 2||9
6745050|NCT03353220|7673119|FG000|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||4
6745051|NCT03353220|7673120|FG001|NOT COMPLETED|Third Intervention (6 Months) - Phase 2||7
6745052|NCT03353246|7673126|FG000|STARTED|Overall Study||500
6450915|NCT01150123|7366695|FG001|COMPLETED|Overall Study||38
6450916|NCT01150123|7366696|FG002|COMPLETED|Overall Study||35
6450917|NCT01150123|7366697|FG003|COMPLETED|Overall Study||37
6450918|NCT01150123|7366698|FG004|COMPLETED|Overall Study||37
6450919|NCT01150123|7366699|FG005|COMPLETED|Overall Study||34
6450920|NCT01150123|7366700|FG006|COMPLETED|Overall Study||39
6450921|NCT01150123|7366701|FG007|COMPLETED|Overall Study||37
6450922|NCT01150123|7366702|FG008|COMPLETED|Overall Study||15
6450923|NCT01150123|7366703|FG009|COMPLETED|Overall Study||39
6450924|NCT01150123|7366704|FG010|COMPLETED|Overall Study||38
6450925|NCT01150123|7366705|FG011|COMPLETED|Overall Study||39
6450926|NCT01150123|7366706|FG012|COMPLETED|Overall Study||37
6450927|NCT01150123|7366707|FG013|COMPLETED|Overall Study||40
6450928|NCT01150123|7366708|FG014|COMPLETED|Overall Study||40
6450929|NCT01150123|7366709|FG015|COMPLETED|Overall Study||39
6450930|NCT01150123|7366710|FG016|COMPLETED|Overall Study||40
6450931|NCT01150123|7366711|FG017|COMPLETED|Overall Study||19
6450932|NCT01150123|7366694|FG000|NOT COMPLETED|Overall Study||3
6450933|NCT01150123|7366695|FG001|NOT COMPLETED|Overall Study||2
6450934|NCT01150123|7366696|FG002|NOT COMPLETED|Overall Study||4
6450935|NCT01150123|7366697|FG003|NOT COMPLETED|Overall Study||3
6450936|NCT01150123|7366698|FG004|NOT COMPLETED|Overall Study||3
6450937|NCT01150123|7366699|FG005|NOT COMPLETED|Overall Study||6
6450938|NCT01150123|7366700|FG006|NOT COMPLETED|Overall Study||0
6450939|NCT01150123|7366701|FG007|NOT COMPLETED|Overall Study||3
6450940|NCT01150123|7366702|FG008|NOT COMPLETED|Overall Study||5
6450941|NCT01150123|7366703|FG009|NOT COMPLETED|Overall Study||1
6450942|NCT01150123|7366704|FG010|NOT COMPLETED|Overall Study||2
6450943|NCT01150123|7366705|FG011|NOT COMPLETED|Overall Study||1
6450944|NCT01150123|7366706|FG012|NOT COMPLETED|Overall Study||3
6450945|NCT01150123|7366707|FG013|NOT COMPLETED|Overall Study||0
6450946|NCT01150123|7366708|FG014|NOT COMPLETED|Overall Study||0
6450947|NCT01150123|7366709|FG015|NOT COMPLETED|Overall Study||1
6450948|NCT01150123|7366710|FG016|NOT COMPLETED|Overall Study||0
6450949|NCT01150123|7366711|FG017|NOT COMPLETED|Overall Study||1
6450950|NCT01150357|7366771|FG000|STARTED|Dose Response Phase (Phase 1)||108
6450951|NCT01150357|7366772|FG001|STARTED|Dose Response Phase (Phase 1)||54
6450952|NCT01150357|7366773|FG002|STARTED|Dose Response Phase (Phase 1)||105
6450953|NCT01150357|7366771|FG000|COMPLETED|Dose Response Phase (Phase 1)||107
6450954|NCT01150357|7366772|FG001|COMPLETED|Dose Response Phase (Phase 1)||51
6450955|NCT01150357|7366773|FG002|COMPLETED|Dose Response Phase (Phase 1)||102
6450956|NCT01150357|7366771|FG000|NOT COMPLETED|Dose Response Phase (Phase 1)||1
6450957|NCT01150357|7366772|FG001|NOT COMPLETED|Dose Response Phase (Phase 1)||3
6450958|NCT01150357|7366773|FG002|NOT COMPLETED|Dose Response Phase (Phase 1)||3
6450959|NCT01150357|7366771|FG000|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
6450960|NCT01150357|7366772|FG001|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
6450961|NCT01150357|7366773|FG002|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
6450962|NCT01150357|7366771|FG000|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
6450963|NCT01150357|7366772|FG001|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
6450964|NCT01150357|7366773|FG002|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
6450965|NCT01150357|7366771|FG000|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
6450966|NCT01150357|7366772|FG001|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
6450967|NCT01150357|7366773|FG002|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
6450968|NCT01150357|7366771|FG000|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
6450969|NCT01150357|7366772|FG001|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
6450970|NCT01150357|7366773|FG002|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
6450971|NCT01150357|7366771|FG000|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
6450972|NCT01150357|7366772|FG001|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
6450973|NCT01150357|7366773|FG002|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
6450974|NCT01150357|7366771|FG000|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
6450975|NCT01150357|7366772|FG001|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
6450976|NCT01150357|7366773|FG002|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
6450977|NCT01150357|7366771|FG000|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
6450978|NCT01150357|7366772|FG001|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
6450979|NCT01150357|7366773|FG002|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
6450980|NCT01150461|7366795|FG000|STARTED|Overall Study||11
6450981|NCT01150461|7366796|FG001|STARTED|Overall Study||9
6450982|NCT01150461|7366795|FG000|COMPLETED|Overall Study||11
6450983|NCT01150461|7366796|FG001|COMPLETED|Overall Study||9
6450984|NCT01150461|7366795|FG000|NOT COMPLETED|Overall Study||0
6450985|NCT01150461|7366796|FG001|NOT COMPLETED|Overall Study||0
6450986|NCT01150474|7366804|FG000|STARTED|Overall Study||51
6450987|NCT01150474|7366805|FG001|STARTED|Overall Study||52
6450988|NCT01150474|7366804|FG000|COMPLETED|Overall Study||41
6450989|NCT01150474|7366805|FG001|COMPLETED|Overall Study||49
6450990|NCT01150474|7366804|FG000|NOT COMPLETED|Overall Study||10
6450991|NCT01150474|7366805|FG001|NOT COMPLETED|Overall Study||3
6450992|NCT01150500|7366811|FG000|STARTED|Overall Study||65
6450993|NCT01150500|7366811|FG000|COMPLETED|Overall Study||0
6450994|NCT01150500|7366811|FG000|NOT COMPLETED|Overall Study||65
6450995|NCT01150760|7366817|FG000|STARTED|Overall Study||3525
6450996|NCT01150760|7366818|FG001|STARTED|Overall Study||3525
6450997|NCT01150760|7366817|FG000|COMPLETED|Overall Study||3525
6450998|NCT01150760|7366818|FG001|COMPLETED|Overall Study||3525
6450999|NCT01150760|7366817|FG000|NOT COMPLETED|Overall Study||0
6451000|NCT01150760|7366818|FG001|NOT COMPLETED|Overall Study||0
6451001|NCT01150838|7366829|FG000|STARTED|Overall Study||19
6451002|NCT01150838|7366830|FG001|STARTED|Overall Study||26
6451003|NCT01150838|7366831|FG002|STARTED|Overall Study||24
6451004|NCT01150838|7366832|FG003|STARTED|Overall Study||15
6451005|NCT01150838|7366833|FG004|STARTED|Overall Study||16
6451006|NCT01150838|7366834|FG005|STARTED|Overall Study||2
6451007|NCT01150838|7366829|FG000|COMPLETED|Overall Study||19
6451008|NCT01150838|7366830|FG001|COMPLETED|Overall Study||26
6451009|NCT01150838|7366831|FG002|COMPLETED|Overall Study||24
6451010|NCT01150838|7366832|FG003|COMPLETED|Overall Study||15
6451011|NCT01150838|7366833|FG004|COMPLETED|Overall Study||16
6451012|NCT01150838|7366834|FG005|COMPLETED|Overall Study||2
6451013|NCT01150838|7366829|FG000|NOT COMPLETED|Overall Study||0
6451014|NCT01150838|7366830|FG001|NOT COMPLETED|Overall Study||0
6451015|NCT01150838|7366831|FG002|NOT COMPLETED|Overall Study||0
6451016|NCT01150838|7366832|FG003|NOT COMPLETED|Overall Study||0
6451017|NCT01150838|7366833|FG004|NOT COMPLETED|Overall Study||0
6451018|NCT01150838|7366834|FG005|NOT COMPLETED|Overall Study||0
6451019|NCT01150903|7366844|FG000|STARTED|Overall Study||24708
6451020|NCT01150903|7366845|FG001|STARTED|Overall Study||74124
6451021|NCT01150903|7366844|FG000|COMPLETED|Overall Study||24708
6451022|NCT01150903|7366845|FG001|COMPLETED|Overall Study||74124
6451023|NCT01150903|7366844|FG000|NOT COMPLETED|Overall Study||0
6451024|NCT01150903|7366845|FG001|NOT COMPLETED|Overall Study||0
6451025|NCT01150981|7366853|FG000|STARTED|Overall Study||20
6451026|NCT01150981|7366854|FG001|STARTED|Overall Study||15
6451027|NCT01150981|7366853|FG000|COMPLETED|Overall Study||16
6451028|NCT01150981|7366854|FG001|COMPLETED|Overall Study||13
6451029|NCT01150981|7366853|FG000|NOT COMPLETED|Overall Study||4
6451030|NCT01150981|7366854|FG001|NOT COMPLETED|Overall Study||2
6451031|NCT01151020|7366860|FG000|STARTED|Overall Study||110
6451032|NCT01151020|7366860|FG000|30-day|Overall Study||110
6451033|NCT01151020|7366860|FG000|COMPLETED|Overall Study||56
6451034|NCT01151020|7366860|FG000|NOT COMPLETED|Overall Study||54
6451035|NCT01151046|7366866|FG000|STARTED|Overall Study||59
6451036|NCT01151046|7366867|FG001|STARTED|Overall Study||59
6451037|NCT01151046|7366866|FG000|COMPLETED|Overall Study||56
6451038|NCT01151046|7366867|FG001|COMPLETED|Overall Study||59
6451039|NCT01151046|7366866|FG000|NOT COMPLETED|Overall Study||3
6451040|NCT01151046|7366867|FG001|NOT COMPLETED|Overall Study||0
6451041|NCT01151085|7366877|FG000|STARTED|Overall Study||1002
6451042|NCT01151085|7366877|FG000|COMPLETED|Overall Study||946
6451043|NCT01151085|7366877|FG000|NOT COMPLETED|Overall Study||56
6451044|NCT01151098|7366888|FG000|STARTED|Overall Study|Extension Safety Population|189
6451045|NCT01151098|7366888|FG000|COMPLETED|Overall Study||72
6451046|NCT01151098|7366888|FG000|NOT COMPLETED|Overall Study||117
6451047|NCT01151137|7366894|FG000|STARTED|Overall Study||1617
6451048|NCT01151137|7366895|FG001|STARTED|Overall Study||1619
6451049|NCT01151137|7366894|FG000|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
6451050|NCT01151137|7366895|FG001|Treated|Overall Study||1613
6451051|NCT01151137|7366894|FG000|Discontinued Treatment|Overall Study||171
6451052|NCT01151137|7366895|FG001|Discontinued Treatment|Overall Study||342
6451053|NCT01151137|7366894|FG000|COMPLETED|Overall Study||1601
6451054|NCT01151137|7366895|FG001|COMPLETED|Overall Study||1591
6451055|NCT01151137|7366894|FG000|NOT COMPLETED|Overall Study||16
6451056|NCT01151137|7366895|FG001|NOT COMPLETED|Overall Study||28
6451057|NCT01151189|7366903|FG000|STARTED|Overall Study||326
6451058|NCT01151189|7366904|FG001|STARTED|Overall Study||324
6451059|NCT01151189|7366903|FG000|Received Vaccine|Overall Study||325
6451060|NCT01151189|7366904|FG001|Received Vaccine|Overall Study||324
6451061|NCT01151189|7366903|FG000|COMPLETED|Overall Study||311
6451062|NCT01151189|7366904|FG001|COMPLETED|Overall Study||314
6451063|NCT01151189|7366903|FG000|NOT COMPLETED|Overall Study||15
6451064|NCT01151189|7366904|FG001|NOT COMPLETED|Overall Study||10
6451065|NCT01151215|7366913|FG000|STARTED|Overall Study||120
6451066|NCT01151215|7366914|FG001|STARTED|Overall Study||118
6451067|NCT01151215|7366915|FG002|STARTED|Overall Study||121
6451068|NCT01151215|7366913|FG000|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
6451069|NCT01151215|7366914|FG001|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
6451070|NCT01151215|7366915|FG002|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
6451071|NCT01151215|7366913|FG000|NOT COMPLETED|Overall Study||20
6451072|NCT01151215|7366914|FG001|NOT COMPLETED|Overall Study||23
6451073|NCT01151215|7366915|FG002|NOT COMPLETED|Overall Study||19
6451074|NCT01151280|7366923|FG000|STARTED|Overall Study||10
6451075|NCT01151280|7366923|FG000|COMPLETED|Overall Study||6
6451076|NCT01151280|7366923|FG000|NOT COMPLETED|Overall Study||4
6451077|NCT01151345|7366927|FG000|STARTED|First Intervention Period||13
6451078|NCT01151345|7366928|FG001|STARTED|First Intervention Period||13
6451079|NCT01151345|7366927|FG000|Treated|First Intervention Period||13
6451080|NCT01151345|7366928|FG001|Treated|First Intervention Period||12
6451081|NCT01151345|7366927|FG000|COMPLETED|First Intervention Period||13
6451082|NCT01151345|7366928|FG001|COMPLETED|First Intervention Period||12
6451083|NCT01151345|7366927|FG000|NOT COMPLETED|First Intervention Period||0
6451084|NCT01151345|7366928|FG001|NOT COMPLETED|First Intervention Period||1
6451085|NCT01151345|7366927|FG000|STARTED|Wash-out Period (7 Days)||13
6451086|NCT01151345|7366928|FG001|STARTED|Wash-out Period (7 Days)||12
6451087|NCT01151345|7366927|FG000|COMPLETED|Wash-out Period (7 Days)||13
6451088|NCT01151345|7366928|FG001|COMPLETED|Wash-out Period (7 Days)||12
6451089|NCT01151345|7366927|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
6451090|NCT01151345|7366928|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
6451091|NCT01151345|7366927|FG000|STARTED|Second Intervention Period||13
6451092|NCT01151345|7366928|FG001|STARTED|Second Intervention Period||12
6451093|NCT01151345|7366927|FG000|COMPLETED|Second Intervention Period||13
6451094|NCT01151345|7366928|FG001|COMPLETED|Second Intervention Period||12
6451095|NCT01151345|7366927|FG000|NOT COMPLETED|Second Intervention Period||0
6451096|NCT01151345|7366928|FG001|NOT COMPLETED|Second Intervention Period||0
6451097|NCT01151371|7366937|FG000|STARTED|Overall Study||149
6451098|NCT01151371|7366938|FG001|STARTED|Overall Study||150
6451099|NCT01151371|7366939|FG002|STARTED|Overall Study||153
6451100|NCT01151371|7366937|FG000|COMPLETED|Overall Study||144
6451101|NCT01151371|7366938|FG001|COMPLETED|Overall Study||149
6451102|NCT01151371|7366939|FG002|COMPLETED|Overall Study||146
6451103|NCT01151371|7366937|FG000|NOT COMPLETED|Overall Study||5
6451104|NCT01151371|7366938|FG001|NOT COMPLETED|Overall Study||1
6451105|NCT01151371|7366939|FG002|NOT COMPLETED|Overall Study||7
6451106|NCT01151410|7366949|FG000|STARTED|Overall Study||104
6451107|NCT01151410|7366950|FG001|STARTED|Overall Study||104
6451108|NCT01151410|7366949|FG000|Safety Set (SAF)|Overall Study||105
6451109|NCT01151410|7366950|FG001|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
6451110|NCT01151410|7366949|FG000|COMPLETED|Overall Study||93
6451111|NCT01151410|7366950|FG001|COMPLETED|Overall Study||89
6451112|NCT01151410|7366949|FG000|NOT COMPLETED|Overall Study||11
6451113|NCT01151410|7366950|FG001|NOT COMPLETED|Overall Study||15
6451114|NCT01151423|7366958|FG000|STARTED|Overall Study||36
6451115|NCT01151423|7366959|FG001|STARTED|Overall Study||39
6451116|NCT01151423|7366958|FG000|Received Study Drug|Overall Study||35
6451117|NCT01151423|7366959|FG001|Received Study Drug|Overall Study||37
6451118|NCT01151423|7366958|FG000|COMPLETED|Overall Study||20
6451119|NCT01151423|7366959|FG001|COMPLETED|Overall Study||21
6451120|NCT01151423|7366958|FG000|NOT COMPLETED|Overall Study||16
6451121|NCT01151423|7366959|FG001|NOT COMPLETED|Overall Study||18
6451122|NCT01151436|7366965|FG000|STARTED|Overall Study||77
6451123|NCT01151436|7366965|FG000|COMPLETED|Overall Study||76
6451124|NCT01151436|7366965|FG000|NOT COMPLETED|Overall Study||1
6451125|NCT01151449|7366969|FG000|STARTED|Overall Study||6
6451126|NCT01151449|7366969|FG000|COMPLETED|Overall Study||6
6451127|NCT01151449|7366969|FG000|NOT COMPLETED|Overall Study||0
6451128|NCT01151540|7366973|FG000|STARTED|Overall Study||54
6451129|NCT01151540|7366973|FG000|COMPLETED|Overall Study||41
6451130|NCT01151540|7366973|FG000|NOT COMPLETED|Overall Study||13
6451131|NCT01151579|7366979|FG000|STARTED|Overall Study||58
6451132|NCT01151579|7366980|FG001|STARTED|Overall Study||31
6451133|NCT01151579|7366979|FG000|COMPLETED|Overall Study||46
6451134|NCT01151579|7366980|FG001|COMPLETED|Overall Study||24
6451135|NCT01151579|7366979|FG000|NOT COMPLETED|Overall Study||12
6451136|NCT01151579|7366980|FG001|NOT COMPLETED|Overall Study||7
6451137|NCT01151618|7366986|FG000|STARTED|Overall Study||22
6451138|NCT01151618|7366986|FG000|COMPLETED|Overall Study||13
6451139|NCT01151618|7366986|FG000|NOT COMPLETED|Overall Study||9
6451140|NCT01151761|7366990|FG000|STARTED|Overall Study||2
6451141|NCT01151761|7366990|FG000|COMPLETED|Overall Study||2
6451142|NCT01151761|7366990|FG000|NOT COMPLETED|Overall Study||0
6451143|NCT01151813|7366994|FG000|STARTED|Period 1||8
6451144|NCT01151813|7366995|FG001|STARTED|Period 1||7
6451145|NCT01151813|7366994|FG000|COMPLETED|Period 1||8
6451146|NCT01151813|7366995|FG001|COMPLETED|Period 1||7
6451147|NCT01151813|7366994|FG000|NOT COMPLETED|Period 1||0
6451148|NCT01151813|7366995|FG001|NOT COMPLETED|Period 1||0
6451149|NCT01151813|7366994|FG000|STARTED|Period 2||8
6451150|NCT01151813|7366995|FG001|STARTED|Period 2||7
6451151|NCT01151813|7366994|FG000|COMPLETED|Period 2||8
6451152|NCT01151813|7366995|FG001|COMPLETED|Period 2||7
6451153|NCT01151813|7366994|FG000|NOT COMPLETED|Period 2||0
6451154|NCT01151813|7366995|FG001|NOT COMPLETED|Period 2||0
6451155|NCT01151852|7367004|FG000|STARTED|Overall Study||41
6451156|NCT01151852|7367005|FG001|STARTED|Overall Study||40
6451157|NCT01151852|7367004|FG000|COMPLETED|Overall Study||41
6451158|NCT01151852|7367005|FG001|COMPLETED|Overall Study||40
6451159|NCT01151852|7367004|FG000|NOT COMPLETED|Overall Study||0
6451160|NCT01151852|7367005|FG001|NOT COMPLETED|Overall Study||0
6451161|NCT01152021|7367013|FG000|STARTED|Overall Study||8
6451162|NCT01152021|7367014|FG001|STARTED|Overall Study||7
6451163|NCT01152021|7367013|FG000|COMPLETED|Overall Study||2
6451164|NCT01152021|7367014|FG001|COMPLETED|Overall Study||1
6451165|NCT01152021|7367013|FG000|NOT COMPLETED|Overall Study||6
6451166|NCT01152021|7367014|FG001|NOT COMPLETED|Overall Study||6
6451167|NCT01152112|7367024|FG000|STARTED|Overall Study||42
6451168|NCT01152112|7367025|FG001|STARTED|Overall Study||32
6451169|NCT01152112|7367024|FG000|COMPLETED|Overall Study||42
6451170|NCT01152112|7367025|FG001|COMPLETED|Overall Study||32
6451171|NCT01152112|7367024|FG000|NOT COMPLETED|Overall Study||0
6451172|NCT01152112|7367025|FG001|NOT COMPLETED|Overall Study||0
6451173|NCT01152190|7367033|FG000|STARTED|Overall Study||50
6451174|NCT01152190|7367034|FG001|STARTED|Overall Study||47
6451175|NCT01152190|7367033|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
6451176|NCT01152190|7367034|FG001|Received at Least 1 Dose of Study Drug|Overall Study||47
6451177|NCT01152190|7367033|FG000|COMPLETED|Overall Study||45
6451178|NCT01152190|7367034|FG001|COMPLETED|Overall Study||39
6451179|NCT01152190|7367033|FG000|NOT COMPLETED|Overall Study||5
6451180|NCT01152190|7367034|FG001|NOT COMPLETED|Overall Study||8
6451181|NCT01152294|7367042|FG000|STARTED|Overall Study||213
6451182|NCT01152294|7367043|FG001|STARTED|Overall Study||188
6451183|NCT01152294|7367042|FG000|COMPLETED|Overall Study||213
6451184|NCT01152294|7367043|FG001|COMPLETED|Overall Study||188
6451185|NCT01152294|7367042|FG000|NOT COMPLETED|Overall Study||0
6451186|NCT01152294|7367043|FG001|NOT COMPLETED|Overall Study||0
6451187|NCT01152307|7367051|FG000|STARTED|Overall Study||191
6451188|NCT01152307|7367052|FG001|STARTED|Overall Study||214
6451189|NCT01152307|7367051|FG000|COMPLETED|Overall Study||191
6451190|NCT01152307|7367052|FG001|COMPLETED|Overall Study||214
6451191|NCT01152307|7367051|FG000|NOT COMPLETED|Overall Study||0
6451192|NCT01152307|7367052|FG001|NOT COMPLETED|Overall Study||0
6451193|NCT01152359|7367060|FG000|STARTED|Overall Study||105
6451194|NCT01152359|7367061|FG001|STARTED|Overall Study||102
6451195|NCT01152359|7367060|FG000|COMPLETED|Overall Study||81
6451196|NCT01152359|7367061|FG001|COMPLETED|Overall Study||80
6451197|NCT01152359|7367060|FG000|NOT COMPLETED|Overall Study||24
6451198|NCT01152359|7367061|FG001|NOT COMPLETED|Overall Study||22
6451199|NCT01152385|7367071|FG000|STARTED|Overall Study||55
6451200|NCT01152385|7367072|FG001|STARTED|Overall Study||58
6451201|NCT01152385|7367073|FG002|STARTED|Overall Study||56
6451202|NCT01152385|7367074|FG003|STARTED|Overall Study||55
6451203|NCT01152385|7367071|FG000|COMPLETED|Overall Study||46
6451204|NCT01152385|7367072|FG001|COMPLETED|Overall Study||52
6451205|NCT01152385|7367073|FG002|COMPLETED|Overall Study||51
6451206|NCT01152385|7367074|FG003|COMPLETED|Overall Study||50
6451207|NCT01152385|7367071|FG000|NOT COMPLETED|Overall Study||9
6451208|NCT01152385|7367072|FG001|NOT COMPLETED|Overall Study||6
6451209|NCT01152385|7367073|FG002|NOT COMPLETED|Overall Study||5
6451210|NCT01152385|7367074|FG003|NOT COMPLETED|Overall Study||5
6451211|NCT01152437|7367091|FG000|STARTED|Overall Study|randomised|36
6451212|NCT01152437|7367092|FG001|STARTED|Overall Study|randomised|15
6451213|NCT01152437|7367093|FG002|STARTED|Overall Study|entered|43
6451214|NCT01152437|7367091|FG000|COMPLETED|Overall Study||0
6451215|NCT01152437|7367092|FG001|COMPLETED|Overall Study||0
6451216|NCT01152437|7367093|FG002|COMPLETED|Overall Study||0
6451217|NCT01152437|7367091|FG000|NOT COMPLETED|Overall Study||36
6451218|NCT01152437|7367092|FG001|NOT COMPLETED|Overall Study||15
6451219|NCT01152437|7367093|FG002|NOT COMPLETED|Overall Study||43
6451220|NCT01152450|7367103|FG000|STARTED|Period 1 (4 Weeks)||15
6451221|NCT01152450|7367104|FG001|STARTED|Period 1 (4 Weeks)||16
6451222|NCT01152450|7367105|FG002|STARTED|Period 1 (4 Weeks)||17
6451223|NCT01152450|7367106|FG003|STARTED|Period 1 (4 Weeks)||15
6451224|NCT01152450|7367107|FG004|STARTED|Period 1 (4 Weeks)||18
6451225|NCT01152450|7367108|FG005|STARTED|Period 1 (4 Weeks)||13
6451226|NCT01152450|7367103|FG000|COMPLETED|Period 1 (4 Weeks)||15
6451227|NCT01152450|7367104|FG001|COMPLETED|Period 1 (4 Weeks)||15
6451228|NCT01152450|7367105|FG002|COMPLETED|Period 1 (4 Weeks)||16
6451229|NCT01152450|7367106|FG003|COMPLETED|Period 1 (4 Weeks)||15
6451230|NCT01152450|7367107|FG004|COMPLETED|Period 1 (4 Weeks)||16
6451231|NCT01152450|7367108|FG005|COMPLETED|Period 1 (4 Weeks)||12
6451232|NCT01152450|7367103|FG000|NOT COMPLETED|Period 1 (4 Weeks)||0
6451233|NCT01152450|7367104|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
6451234|NCT01152450|7367105|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
6451235|NCT01152450|7367106|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
6451236|NCT01152450|7367107|FG004|NOT COMPLETED|Period 1 (4 Weeks)||2
6451237|NCT01152450|7367108|FG005|NOT COMPLETED|Period 1 (4 Weeks)||1
6553440|NCT01743677|7475930|FG003|STARTED|Second Intervention Period||10
6553441|NCT01743677|7475931|FG004|STARTED|Second Intervention Period||10
6451238|NCT01152450|7367103|FG000|STARTED|Period 2 (4 Weeks)||15
6451239|NCT01152450|7367104|FG001|STARTED|Period 2 (4 Weeks)||15
6451240|NCT01152450|7367105|FG002|STARTED|Period 2 (4 Weeks)||16
6451241|NCT01152450|7367106|FG003|STARTED|Period 2 (4 Weeks)||15
6553442|NCT01743677|7475932|FG005|STARTED|Second Intervention Period||10
6451242|NCT01152450|7367107|FG004|STARTED|Period 2 (4 Weeks)||16
6451243|NCT01152450|7367108|FG005|STARTED|Period 2 (4 Weeks)||12
6451244|NCT01152450|7367103|FG000|COMPLETED|Period 2 (4 Weeks)||15
6451245|NCT01152450|7367104|FG001|COMPLETED|Period 2 (4 Weeks)||15
6451246|NCT01152450|7367105|FG002|COMPLETED|Period 2 (4 Weeks)||16
6451247|NCT01152450|7367106|FG003|COMPLETED|Period 2 (4 Weeks)||15
6451248|NCT01152450|7367107|FG004|COMPLETED|Period 2 (4 Weeks)||16
6451249|NCT01152450|7367108|FG005|COMPLETED|Period 2 (4 Weeks)||12
6451250|NCT01152450|7367103|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
6451251|NCT01152450|7367104|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
6451252|NCT01152450|7367105|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
6451253|NCT01152450|7367106|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
6451254|NCT01152450|7367107|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
6451255|NCT01152450|7367108|FG005|NOT COMPLETED|Period 2 (4 Weeks)||0
6451256|NCT01152450|7367103|FG000|STARTED|Period 3 (4 Weeks)||15
6451257|NCT01152450|7367104|FG001|STARTED|Period 3 (4 Weeks)||15
6451258|NCT01152450|7367105|FG002|STARTED|Period 3 (4 Weeks)||16
6451259|NCT01152450|7367106|FG003|STARTED|Period 3 (4 Weeks)||15
6451260|NCT01152450|7367107|FG004|STARTED|Period 3 (4 Weeks)||16
6451261|NCT01152450|7367108|FG005|STARTED|Period 3 (4 Weeks)||12
6451262|NCT01152450|7367103|FG000|COMPLETED|Period 3 (4 Weeks)||15
6451263|NCT01152450|7367104|FG001|COMPLETED|Period 3 (4 Weeks)||15
6553443|NCT01743677|7475927|FG000|COMPLETED|Second Intervention Period||10
6553444|NCT01743677|7475928|FG001|COMPLETED|Second Intervention Period||10
6553445|NCT01743677|7475929|FG002|COMPLETED|Second Intervention Period||10
6553446|NCT01743677|7475930|FG003|COMPLETED|Second Intervention Period||10
6553447|NCT01743677|7475931|FG004|COMPLETED|Second Intervention Period||10
6451264|NCT01152450|7367105|FG002|COMPLETED|Period 3 (4 Weeks)||16
6451265|NCT01152450|7367106|FG003|COMPLETED|Period 3 (4 Weeks)||15
6451266|NCT01152450|7367107|FG004|COMPLETED|Period 3 (4 Weeks)||16
6451267|NCT01152450|7367108|FG005|COMPLETED|Period 3 (4 Weeks)||12
6451268|NCT01152450|7367103|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
6451269|NCT01152450|7367104|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
6451270|NCT01152450|7367105|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
6451271|NCT01152450|7367106|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
6451272|NCT01152450|7367107|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
6451273|NCT01152450|7367108|FG005|NOT COMPLETED|Period 3 (4 Weeks)||0
6451274|NCT01152515|7367118|FG000|STARTED|Overall Study||25
6451275|NCT01152515|7367119|FG001|STARTED|Overall Study||25
6451276|NCT01152515|7367118|FG000|COMPLETED|Overall Study||25
6451277|NCT01152515|7367119|FG001|COMPLETED|Overall Study||25
6451278|NCT01152515|7367118|FG000|NOT COMPLETED|Overall Study||0
6451279|NCT01152515|7367119|FG001|NOT COMPLETED|Overall Study||0
6451280|NCT01152554|7367127|FG000|STARTED|Overall Study||610
6451281|NCT01152554|7367128|FG001|STARTED|Overall Study||203
6451282|NCT01152554|7367127|FG000|Received Treatment|Overall Study||607
6451283|NCT01152554|7367128|FG001|Received Treatment|Overall Study||201
6451284|NCT01152554|7367127|FG000|COMPLETED|Overall Study||276
6451285|NCT01152554|7367128|FG001|COMPLETED|Overall Study||92
6451286|NCT01152554|7367127|FG000|NOT COMPLETED|Overall Study||334
6451287|NCT01152554|7367128|FG001|NOT COMPLETED|Overall Study||111
6451288|NCT01152580|7367136|FG000|STARTED|Overall Study||5
6451289|NCT01152580|7367137|FG001|STARTED|Overall Study||14
6451290|NCT01152580|7367136|FG000|COMPLETED|Overall Study||5
6451291|NCT01152580|7367137|FG001|COMPLETED|Overall Study||13
6451292|NCT01152580|7367136|FG000|NOT COMPLETED|Overall Study||0
6451293|NCT01152580|7367137|FG001|NOT COMPLETED|Overall Study||1
6451294|NCT01152697|7367143|FG000|STARTED|Overall Study||30
6451295|NCT01152697|7367143|FG000|COMPLETED|Overall Study||11
6451296|NCT01152697|7367143|FG000|NOT COMPLETED|Overall Study||19
6500450|NCT01424566|7419150|FG000|COMPLETED|Single-blind Treatment||206
6500451|NCT01424566|7419151|FG001|COMPLETED|Single-blind Treatment||0
6500452|NCT01424566|7419152|FG002|COMPLETED|Single-blind Treatment||0
6500453|NCT01424566|7419150|FG000|NOT COMPLETED|Single-blind Treatment||200
6500454|NCT01424566|7419151|FG001|NOT COMPLETED|Single-blind Treatment||0
6500455|NCT01424566|7419152|FG002|NOT COMPLETED|Single-blind Treatment||0
6500456|NCT01424566|7419150|FG000|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the double-blind period.|0
6500457|NCT01424566|7419151|FG001|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
6500458|NCT01424566|7419152|FG002|STARTED|Double-blind Treatment|Participants were not enrolled in this arm in the single-blind period.|103
6500459|NCT01424566|7419150|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment||0
6500460|NCT01424566|7419151|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
6500461|NCT01424566|7419152|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment||103
6500462|NCT01424566|7419150|FG000|Randomized Safety Population|Double-blind Treatment||0
6500463|NCT01424566|7419151|FG001|Randomized Safety Population|Double-blind Treatment||103
6500464|NCT01424566|7419152|FG002|Randomized Safety Population|Double-blind Treatment||103
6500465|NCT01424566|7419150|FG000|ITT Population|Double-blind Treatment||0
6500466|NCT01424566|7419151|FG001|ITT Population|Double-blind Treatment||103
6500467|NCT01424566|7419152|FG002|ITT Population|Double-blind Treatment||103
6500468|NCT01424566|7419150|FG000|COMPLETED|Double-blind Treatment||0
6500469|NCT01424566|7419151|FG001|COMPLETED|Double-blind Treatment||78
6500470|NCT01424566|7419152|FG002|COMPLETED|Double-blind Treatment||88
6500471|NCT01424566|7419150|FG000|NOT COMPLETED|Double-blind Treatment||0
6500472|NCT01424566|7419151|FG001|NOT COMPLETED|Double-blind Treatment||25
6500473|NCT01424566|7419152|FG002|NOT COMPLETED|Double-blind Treatment||15
6500474|NCT01424644|7419161|FG000|STARTED|Overall Study||402
6500475|NCT01424644|7419162|FG001|STARTED|Overall Study||399
6500476|NCT01424644|7419161|FG000|COMPLETED|Overall Study||369
6500477|NCT01424644|7419162|FG001|COMPLETED|Overall Study||372
6500478|NCT01424644|7419161|FG000|NOT COMPLETED|Overall Study||33
6500479|NCT01424644|7419162|FG001|NOT COMPLETED|Overall Study||27
6500480|NCT01424670|7419170|FG000|STARTED|6-Month Intensive Period (182 Days)||341
6500481|NCT01424670|7419171|FG001|STARTED|6-Month Intensive Period (182 Days)||170
6451297|NCT01152788|7367149|FG000|STARTED|Overall Study||32
6451298|NCT01152788|7367150|FG001|STARTED|Overall Study||32
6451299|NCT01152788|7367149|FG000|COMPLETED|Overall Study||32
6451300|NCT01152788|7367150|FG001|COMPLETED|Overall Study||28
6451301|NCT01152788|7367149|FG000|NOT COMPLETED|Overall Study||0
6451302|NCT01152788|7367150|FG001|NOT COMPLETED|Overall Study||4
6451303|NCT01152814|7367156|FG000|STARTED|Overall Study||64
6451304|NCT01152814|7367156|FG000|COMPLETED|Overall Study||62
6451305|NCT01152814|7367156|FG000|NOT COMPLETED|Overall Study||2
6451306|NCT01152996|7367160|FG000|STARTED|Overall Study||1075
6451307|NCT01152996|7367160|FG000|Treated|Overall Study||1073
6451308|NCT01152996|7367160|FG000|COMPLETED|Overall Study||538
6451309|NCT01152996|7367160|FG000|NOT COMPLETED|Overall Study||537
6451310|NCT01153009|7367168|FG000|STARTED|Overall Study||161
6451311|NCT01153009|7367169|FG001|STARTED|Overall Study||147
6451312|NCT01153009|7367170|FG002|STARTED|Overall Study||154
6451313|NCT01153009|7367171|FG003|STARTED|Overall Study||152
6451314|NCT01153009|7367168|FG000|Treated|Overall Study||159
6451315|NCT01153009|7367169|FG001|Treated|Overall Study||147
6451316|NCT01153009|7367170|FG002|Treated|Overall Study||154
6451317|NCT01153009|7367171|FG003|Treated|Overall Study||150
6451318|NCT01153009|7367168|FG000|COMPLETED|Overall Study||129
6451319|NCT01153009|7367169|FG001|COMPLETED|Overall Study||113
6451320|NCT01153009|7367170|FG002|COMPLETED|Overall Study||113
6451321|NCT01153009|7367171|FG003|COMPLETED|Overall Study||115
6451322|NCT01153009|7367168|FG000|NOT COMPLETED|Overall Study||32
6451323|NCT01153009|7367169|FG001|NOT COMPLETED|Overall Study||34
6451324|NCT01153009|7367170|FG002|NOT COMPLETED|Overall Study||41
6451325|NCT01153009|7367171|FG003|NOT COMPLETED|Overall Study||37
6451326|NCT01153269|7367181|FG000|STARTED|Overall Study||33
6451327|NCT01153269|7367181|FG000|Participants Analyzed|Overall Study||33
6451328|NCT01153269|7367181|FG000|COMPLETED|Overall Study||31
6451329|NCT01153269|7367181|FG000|NOT COMPLETED|Overall Study||2
6451330|NCT01153321|7367190|FG000|STARTED|Overall Study||22
6451331|NCT01153321|7367191|FG001|STARTED|Overall Study||22
6451332|NCT01153321|7367190|FG000|COMPLETED|Overall Study||21
6451333|NCT01153321|7367191|FG001|COMPLETED|Overall Study||19
6451334|NCT01153321|7367190|FG000|NOT COMPLETED|Overall Study||1
6451335|NCT01153321|7367191|FG001|NOT COMPLETED|Overall Study||3
6451336|NCT01153347|7367201|FG000|STARTED|Overall Study||160
6451337|NCT01153347|7367202|FG001|STARTED|Overall Study||160
6451338|NCT01153347|7367203|FG002|STARTED|Overall Study||160
6553448|NCT01743677|7475932|FG005|COMPLETED|Second Intervention Period||10
6451339|NCT01153347|7367204|FG003|STARTED|Overall Study||161
6451340|NCT01153347|7367201|FG000|Received Treatment|Overall Study||160
6451341|NCT01153347|7367202|FG001|Received Treatment|Overall Study||158
6451342|NCT01153347|7367203|FG002|Received Treatment|Overall Study||158
6451343|NCT01153347|7367204|FG003|Received Treatment|Overall Study||160
6451344|NCT01153347|7367201|FG000|COMPLETED|Overall Study||127
6451345|NCT01153347|7367202|FG001|COMPLETED|Overall Study||116
6451346|NCT01153347|7367203|FG002|COMPLETED|Overall Study||110
6451347|NCT01153347|7367204|FG003|COMPLETED|Overall Study||129
6451348|NCT01153347|7367201|FG000|NOT COMPLETED|Overall Study||33
6451349|NCT01153347|7367202|FG001|NOT COMPLETED|Overall Study||44
6451350|NCT01153347|7367203|FG002|NOT COMPLETED|Overall Study||50
6451351|NCT01153347|7367204|FG003|NOT COMPLETED|Overall Study||32
6451352|NCT01153425|7367216|FG000|STARTED|Overall Study||16
6451353|NCT01153425|7367217|FG001|STARTED|Overall Study||17
6451354|NCT01153425|7367216|FG000|COMPLETED|Overall Study||13
6451355|NCT01153425|7367217|FG001|COMPLETED|Overall Study||14
6451356|NCT01153425|7367216|FG000|NOT COMPLETED|Overall Study||3
6451357|NCT01153425|7367217|FG001|NOT COMPLETED|Overall Study||3
6451358|NCT01153503|7367227|FG000|STARTED|Overall Study||25
6451359|NCT01153503|7367228|FG001|STARTED|Overall Study||25
6451360|NCT01153503|7367229|FG002|STARTED|Overall Study||25
6451361|NCT01153503|7367227|FG000|COMPLETED|Overall Study||25
6451362|NCT01153503|7367228|FG001|COMPLETED|Overall Study||24
6451363|NCT01153503|7367229|FG002|COMPLETED|Overall Study||25
6451364|NCT01153503|7367227|FG000|NOT COMPLETED|Overall Study||0
6451365|NCT01153503|7367228|FG001|NOT COMPLETED|Overall Study||1
6451366|NCT01153503|7367229|FG002|NOT COMPLETED|Overall Study||0
6451367|NCT01153516|7367239|FG000|STARTED|Overall Study||12
6451368|NCT01153516|7367240|FG001|STARTED|Overall Study||10
6451369|NCT01153516|7367239|FG000|COMPLETED|Overall Study||10
6451370|NCT01153516|7367240|FG001|COMPLETED|Overall Study||10
6451371|NCT01153516|7367239|FG000|NOT COMPLETED|Overall Study||2
6451372|NCT01153516|7367240|FG001|NOT COMPLETED|Overall Study||0
6451373|NCT01153581|7367246|FG000|STARTED|Overall Study||109
6451374|NCT01153581|7367246|FG000|COMPLETED|Overall Study||109
6451375|NCT01153581|7367246|FG000|NOT COMPLETED|Overall Study||0
6451376|NCT01153620|7367258|FG000|STARTED|Overall Study||30
6451377|NCT01153620|7367259|FG001|STARTED|Overall Study|30 patients (31 wounds)|30
6451378|NCT01153620|7367258|FG000|COMPLETED|Overall Study||30
6451379|NCT01153620|7367259|FG001|COMPLETED|Overall Study|30 patients (31 wounds)|30
6451380|NCT01153620|7367258|FG000|NOT COMPLETED|Overall Study||0
6451381|NCT01153620|7367259|FG001|NOT COMPLETED|Overall Study||0
6451382|NCT01153633|7367267|FG000|STARTED|Overall Study||17
6451383|NCT01153633|7367268|FG001|STARTED|Overall Study||17
6451384|NCT01153633|7367267|FG000|COMPLETED|Overall Study||13
6451385|NCT01153633|7367268|FG001|COMPLETED|Overall Study||13
6451386|NCT01153633|7367267|FG000|NOT COMPLETED|Overall Study||4
6451387|NCT01153633|7367268|FG001|NOT COMPLETED|Overall Study||4
6451388|NCT01153672|7367276|FG000|STARTED|Overall Study||8
6451389|NCT01153672|7367276|FG000|COMPLETED|Overall Study||6
6451390|NCT01153672|7367276|FG000|NOT COMPLETED|Overall Study||2
6451391|NCT01153685|7367282|FG000|STARTED|Overall Study||50
6451392|NCT01153685|7367283|FG001|STARTED|Overall Study||70
6451393|NCT01153685|7367282|FG000|COMPLETED|Overall Study||50
6451394|NCT01153685|7367283|FG001|COMPLETED|Overall Study||70
6451395|NCT01153685|7367282|FG000|NOT COMPLETED|Overall Study||0
6451396|NCT01153685|7367283|FG001|NOT COMPLETED|Overall Study||0
6451397|NCT01153698|7367289|FG000|STARTED|Overall Study|Entered and treated.|168
6451398|NCT01153698|7367289|FG000|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
6451399|NCT01153698|7367289|FG000|NOT COMPLETED|Overall Study||29
6451400|NCT01153711|7367294|FG000|STARTED|Overall Study||32
6451401|NCT01153711|7367294|FG000|COMPLETED|Overall Study||32
6451402|NCT01153711|7367294|FG000|NOT COMPLETED|Overall Study||0
6451403|NCT01153724|7367300|FG000|STARTED|Treatment Period 1||35
6451404|NCT01153724|7367300|FG000|COMPLETED|Treatment Period 1||34
6451405|NCT01153724|7367300|FG000|NOT COMPLETED|Treatment Period 1||1
6451406|NCT01153724|7367300|FG000|STARTED|Treatment Period 2||34
6451407|NCT01153724|7367300|FG000|COMPLETED|Treatment Period 2||32
6451408|NCT01153724|7367300|FG000|NOT COMPLETED|Treatment Period 2||2
6451409|NCT01153763|7367306|FG000|STARTED|Overall Study||92
6451410|NCT01153763|7367306|FG000|COMPLETED|Overall Study||71
6451411|NCT01153763|7367306|FG000|NOT COMPLETED|Overall Study||21
6451412|NCT01153815|7367312|FG000|STARTED|Overall Study||83
6745053|NCT03353246|7673126|FG000|COMPLETED|Overall Study||500
6745054|NCT03353246|7673126|FG000|NOT COMPLETED|Overall Study||0
6745055|NCT03353740|7673130|FG000|STARTED|Overall Study||346
6745056|NCT03353740|7673130|FG000|COMPLETED|Overall Study||294
6745057|NCT03353740|7673130|FG000|NOT COMPLETED|Overall Study||52
6745058|NCT03353753|7673136|FG000|STARTED|Overall Study||85
6745059|NCT03353753|7673137|FG001|STARTED|Overall Study|1 patient was randomized but not dosed|44
6451413|NCT01153815|7367313|FG001|STARTED|Overall Study||87
6451414|NCT01153815|7367312|FG000|COMPLETED|Overall Study||74
6451415|NCT01153815|7367313|FG001|COMPLETED|Overall Study||82
6451416|NCT01153815|7367312|FG000|NOT COMPLETED|Overall Study||9
6451417|NCT01153815|7367313|FG001|NOT COMPLETED|Overall Study||5
6451418|NCT01153841|7367321|FG000|STARTED|Overall Study||199
6451419|NCT01153841|7367322|FG001|STARTED|Overall Study||99
6451420|NCT01153841|7367321|FG000|COMPLETED|Overall Study||193
6451421|NCT01153841|7367322|FG001|COMPLETED|Overall Study||99
6451422|NCT01153841|7367321|FG000|NOT COMPLETED|Overall Study||6
6451423|NCT01153841|7367322|FG001|NOT COMPLETED|Overall Study||0
6451424|NCT01153893|7367330|FG000|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
6451425|NCT01153893|7367331|FG001|STARTED|Overall Study||36
6451426|NCT01153893|7367330|FG000|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
6451427|NCT01153893|7367331|FG001|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
6451428|NCT01153893|7367330|FG000|NOT COMPLETED|Overall Study||1
6451429|NCT01153893|7367331|FG001|NOT COMPLETED|Overall Study||0
6451430|NCT01153958|7367339|FG000|STARTED|Overall Study||66
6451431|NCT01153958|7367340|FG001|STARTED|Overall Study||67
6451432|NCT01153958|7367339|FG000|COMPLETED|Overall Study||30
6451433|NCT01153958|7367340|FG001|COMPLETED|Overall Study||35
6451434|NCT01153958|7367339|FG000|NOT COMPLETED|Overall Study||36
6451435|NCT01153958|7367340|FG001|NOT COMPLETED|Overall Study||32
6451436|NCT01153971|7367346|FG000|STARTED|Induction Phase (Months 1 to 7 of Study)||47
6451437|NCT01153971|7367346|FG000|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
6451438|NCT01153971|7367346|FG000|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
6451439|NCT01153971|7367346|FG000|STARTED|Maintenance Phase (Months 8-16 of Study)||44
6451440|NCT01153971|7367346|FG000|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
6451441|NCT01153971|7367346|FG000|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
6451442|NCT01153971|7367346|FG000|STARTED|Follow-up (Months 17-40 of Study)||41
6451443|NCT01153971|7367346|FG000|COMPLETED|Follow-up (Months 17-40 of Study)||37
6451444|NCT01153971|7367346|FG000|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
6451445|NCT01153984|7367350|FG000|STARTED|Overall Study||23
6451446|NCT01153984|7367350|FG000|COMPLETED|Overall Study||21
6451447|NCT01153984|7367350|FG000|NOT COMPLETED|Overall Study||2
6451448|NCT01154010|7367356|FG000|STARTED|Overall Study||9
6451449|NCT01154010|7367357|FG001|STARTED|Overall Study||9
6451450|NCT01154010|7367356|FG000|COMPLETED|Overall Study||9
6451451|NCT01154010|7367357|FG001|COMPLETED|Overall Study||8
6451452|NCT01154010|7367356|FG000|NOT COMPLETED|Overall Study||0
6451453|NCT01154010|7367357|FG001|NOT COMPLETED|Overall Study||1
6451454|NCT01154088|7367366|FG000|STARTED|Overall Study||390
6451455|NCT01154088|7367367|FG001|STARTED|Overall Study||390
6451456|NCT01154088|7367368|FG002|STARTED|Overall Study||390
6451457|NCT01154088|7367366|FG000|COMPLETED|Overall Study||386
6451458|NCT01154088|7367367|FG001|COMPLETED|Overall Study||384
6451459|NCT01154088|7367368|FG002|COMPLETED|Overall Study||383
6451460|NCT01154088|7367366|FG000|NOT COMPLETED|Overall Study||4
6451461|NCT01154088|7367367|FG001|NOT COMPLETED|Overall Study||6
6745060|NCT03353753|7673136|FG000|COMPLETED|Overall Study||46
6745061|NCT03353753|7673137|FG001|COMPLETED|Overall Study||35
6745062|NCT03353753|7673136|FG000|NOT COMPLETED|Overall Study||39
6451462|NCT01154088|7367368|FG002|NOT COMPLETED|Overall Study||7
6451463|NCT01154101|7367382|FG000|STARTED|Overall Study||7
6451464|NCT01154101|7367383|FG001|STARTED|Overall Study||9
6451465|NCT01154101|7367384|FG002|STARTED|Overall Study||12
6451466|NCT01154101|7367385|FG003|STARTED|Overall Study||11
6451467|NCT01154101|7367386|FG004|STARTED|Overall Study||1
6451468|NCT01154101|7367382|FG000|COMPLETED|Overall Study||7
6451469|NCT01154101|7367383|FG001|COMPLETED|Overall Study||5
6451470|NCT01154101|7367384|FG002|COMPLETED|Overall Study||9
6451471|NCT01154101|7367385|FG003|COMPLETED|Overall Study||9
6451472|NCT01154101|7367386|FG004|COMPLETED|Overall Study||0
6451473|NCT01154101|7367382|FG000|NOT COMPLETED|Overall Study||0
6451474|NCT01154101|7367383|FG001|NOT COMPLETED|Overall Study||4
6451475|NCT01154101|7367384|FG002|NOT COMPLETED|Overall Study||3
6451476|NCT01154101|7367385|FG003|NOT COMPLETED|Overall Study||2
6451477|NCT01154101|7367386|FG004|NOT COMPLETED|Overall Study||1
6451478|NCT01154127|7367405|FG000|STARTED|Period 1 (21 Days)||55
6451479|NCT01154127|7367406|FG001|STARTED|Period 1 (21 Days)||53
6451480|NCT01154127|7367405|FG000|COMPLETED|Period 1 (21 Days)||52
6451481|NCT01154127|7367406|FG001|COMPLETED|Period 1 (21 Days)||47
6451482|NCT01154127|7367405|FG000|NOT COMPLETED|Period 1 (21 Days)||3
6451483|NCT01154127|7367406|FG001|NOT COMPLETED|Period 1 (21 Days)||6
6451484|NCT01154127|7367405|FG000|STARTED|Washout (14 - 28 Days)||52
6451485|NCT01154127|7367406|FG001|STARTED|Washout (14 - 28 Days)||47
6451486|NCT01154127|7367405|FG000|COMPLETED|Washout (14 - 28 Days)||49
6451487|NCT01154127|7367406|FG001|COMPLETED|Washout (14 - 28 Days)||47
6451488|NCT01154127|7367405|FG000|NOT COMPLETED|Washout (14 - 28 Days)||3
6451489|NCT01154127|7367406|FG001|NOT COMPLETED|Washout (14 - 28 Days)||0
6451490|NCT01154127|7367405|FG000|STARTED|Period 2 (21 Days)||49
6451491|NCT01154127|7367406|FG001|STARTED|Period 2 (21 Days)||47
6451492|NCT01154127|7367405|FG000|COMPLETED|Period 2 (21 Days)||49
6451493|NCT01154127|7367406|FG001|COMPLETED|Period 2 (21 Days)||46
6451494|NCT01154127|7367405|FG000|NOT COMPLETED|Period 2 (21 Days)||0
6451495|NCT01154127|7367406|FG001|NOT COMPLETED|Period 2 (21 Days)||1
6451496|NCT01154140|7367414|FG000|STARTED|Overall Study||172
6451497|NCT01154140|7367415|FG001|STARTED|Overall Study||171
6451498|NCT01154140|7367414|FG000|Treated|Overall Study||171
6451499|NCT01154140|7367415|FG001|Treated|Overall Study||169
6451500|NCT01154140|7367414|FG000|COMPLETED|Overall Study||81
6451501|NCT01154140|7367415|FG001|COMPLETED|Overall Study||69
6451502|NCT01154140|7367414|FG000|NOT COMPLETED|Overall Study||91
6451503|NCT01154140|7367415|FG001|NOT COMPLETED|Overall Study||102
6451504|NCT01154153|7367423|FG000|STARTED|Overall Study||71
6451505|NCT01154153|7367424|FG001|STARTED|Overall Study||69
6451506|NCT01154153|7367423|FG000|COMPLETED|Overall Study||66
6451507|NCT01154153|7367424|FG001|COMPLETED|Overall Study||66
6451508|NCT01154153|7367423|FG000|NOT COMPLETED|Overall Study||5
6451509|NCT01154153|7367424|FG001|NOT COMPLETED|Overall Study||3
6451510|NCT01154166|7367432|FG000|STARTED|Overall Study||169
6451511|NCT01154166|7367433|FG001|STARTED|Overall Study||175
6451512|NCT01154166|7367432|FG000|COMPLETED|Overall Study||135
6451513|NCT01154166|7367433|FG001|COMPLETED|Overall Study||163
6451514|NCT01154166|7367432|FG000|NOT COMPLETED|Overall Study||34
6451515|NCT01154166|7367433|FG001|NOT COMPLETED|Overall Study||12
6451516|NCT01154192|7367442|FG000|STARTED|Overall Study||14
6451517|NCT01154192|7367443|FG001|STARTED|Overall Study||10
6451518|NCT01154192|7367444|FG002|STARTED|Overall Study||0
6451519|NCT01154192|7367442|FG000|COMPLETED|Overall Study||14
6451520|NCT01154192|7367443|FG001|COMPLETED|Overall Study||10
6451521|NCT01154192|7367444|FG002|COMPLETED|Overall Study||0
6451522|NCT01154192|7367442|FG000|NOT COMPLETED|Overall Study||0
6451523|NCT01154192|7367443|FG001|NOT COMPLETED|Overall Study||0
6451524|NCT01154192|7367444|FG002|NOT COMPLETED|Overall Study||0
6451525|NCT01154218|7367453|FG000|STARTED|First Intervention Period||9
6451526|NCT01154218|7367454|FG001|STARTED|First Intervention Period||9
6451527|NCT01154218|7367455|FG002|STARTED|First Intervention Period||9
6451528|NCT01154218|7367456|FG003|STARTED|First Intervention Period||9
6451529|NCT01154218|7367453|FG000|COMPLETED|First Intervention Period||9
6451530|NCT01154218|7367454|FG001|COMPLETED|First Intervention Period||9
6451531|NCT01154218|7367455|FG002|COMPLETED|First Intervention Period||9
6451532|NCT01154218|7367456|FG003|COMPLETED|First Intervention Period||9
6451533|NCT01154218|7367453|FG000|NOT COMPLETED|First Intervention Period||0
6451534|NCT01154218|7367454|FG001|NOT COMPLETED|First Intervention Period||0
6451535|NCT01154218|7367455|FG002|NOT COMPLETED|First Intervention Period||0
6451536|NCT01154218|7367456|FG003|NOT COMPLETED|First Intervention Period||0
6451537|NCT01154218|7367453|FG000|STARTED|Washout Period (at Least 14 Days)||9
6451538|NCT01154218|7367454|FG001|STARTED|Washout Period (at Least 14 Days)||9
6451539|NCT01154218|7367455|FG002|STARTED|Washout Period (at Least 14 Days)||9
6451540|NCT01154218|7367456|FG003|STARTED|Washout Period (at Least 14 Days)||9
6451541|NCT01154218|7367453|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
6451542|NCT01154218|7367454|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
6451543|NCT01154218|7367455|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
6451544|NCT01154218|7367456|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
6451545|NCT01154218|7367453|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451546|NCT01154218|7367454|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451547|NCT01154218|7367455|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451548|NCT01154218|7367456|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451549|NCT01154218|7367453|FG000|STARTED|Second Intervention Period||9
6451550|NCT01154218|7367454|FG001|STARTED|Second Intervention Period||9
6451551|NCT01154218|7367455|FG002|STARTED|Second Intervention Period||9
6451552|NCT01154218|7367456|FG003|STARTED|Second Intervention Period||9
6451553|NCT01154218|7367453|FG000|COMPLETED|Second Intervention Period||9
6451554|NCT01154218|7367454|FG001|COMPLETED|Second Intervention Period||9
6451555|NCT01154218|7367455|FG002|COMPLETED|Second Intervention Period||9
6451556|NCT01154218|7367456|FG003|COMPLETED|Second Intervention Period||9
6451557|NCT01154218|7367453|FG000|NOT COMPLETED|Second Intervention Period||0
6451558|NCT01154218|7367454|FG001|NOT COMPLETED|Second Intervention Period||0
6451559|NCT01154218|7367455|FG002|NOT COMPLETED|Second Intervention Period||0
6451560|NCT01154218|7367456|FG003|NOT COMPLETED|Second Intervention Period||0
6451561|NCT01154218|7367453|FG000|STARTED|Washout Period (at Least 14 Days)||9
6451562|NCT01154218|7367454|FG001|STARTED|Washout Period (at Least 14 Days)||9
6451563|NCT01154218|7367455|FG002|STARTED|Washout Period (at Least 14 Days)||9
6451564|NCT01154218|7367456|FG003|STARTED|Washout Period (at Least 14 Days)||9
6451565|NCT01154218|7367453|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
6451566|NCT01154218|7367454|FG001|COMPLETED|Washout Period (at Least 14 Days)||9
6451567|NCT01154218|7367455|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
6451568|NCT01154218|7367456|FG003|COMPLETED|Washout Period (at Least 14 Days)||9
6451569|NCT01154218|7367453|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451570|NCT01154218|7367454|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451571|NCT01154218|7367455|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451572|NCT01154218|7367456|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451573|NCT01154218|7367453|FG000|STARTED|Third Intervention Period||9
6451574|NCT01154218|7367454|FG001|STARTED|Third Intervention Period||9
6451575|NCT01154218|7367455|FG002|STARTED|Third Intervention Period||9
6451576|NCT01154218|7367456|FG003|STARTED|Third Intervention Period||9
6451577|NCT01154218|7367453|FG000|COMPLETED|Third Intervention Period||9
6451578|NCT01154218|7367454|FG001|COMPLETED|Third Intervention Period||8
6451579|NCT01154218|7367455|FG002|COMPLETED|Third Intervention Period||9
6451580|NCT01154218|7367456|FG003|COMPLETED|Third Intervention Period||9
6451581|NCT01154218|7367453|FG000|NOT COMPLETED|Third Intervention Period||0
6451582|NCT01154218|7367454|FG001|NOT COMPLETED|Third Intervention Period||1
6451583|NCT01154218|7367455|FG002|NOT COMPLETED|Third Intervention Period||0
6451584|NCT01154218|7367456|FG003|NOT COMPLETED|Third Intervention Period||0
6451585|NCT01154218|7367453|FG000|STARTED|Washout Period (at Least 14 Days)||9
6451586|NCT01154218|7367454|FG001|STARTED|Washout Period (at Least 14 Days)||8
6451587|NCT01154218|7367455|FG002|STARTED|Washout Period (at Least 14 Days)||9
6451588|NCT01154218|7367456|FG003|STARTED|Washout Period (at Least 14 Days)||9
6451589|NCT01154218|7367453|FG000|COMPLETED|Washout Period (at Least 14 Days)||9
6451590|NCT01154218|7367454|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
6451591|NCT01154218|7367455|FG002|COMPLETED|Washout Period (at Least 14 Days)||9
6451592|NCT01154218|7367456|FG003|COMPLETED|Washout Period (at Least 14 Days)||8
6451593|NCT01154218|7367453|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451594|NCT01154218|7367454|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451595|NCT01154218|7367455|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6451596|NCT01154218|7367456|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||1
6451597|NCT01154218|7367453|FG000|STARTED|Fourth Intervention Period||9
6451598|NCT01154218|7367454|FG001|STARTED|Fourth Intervention Period||8
6451599|NCT01154218|7367455|FG002|STARTED|Fourth Intervention Period||9
6451600|NCT01154218|7367456|FG003|STARTED|Fourth Intervention Period||8
6451601|NCT01154218|7367453|FG000|COMPLETED|Fourth Intervention Period||8
6451602|NCT01154218|7367454|FG001|COMPLETED|Fourth Intervention Period||8
6451603|NCT01154218|7367455|FG002|COMPLETED|Fourth Intervention Period||9
6451604|NCT01154218|7367456|FG003|COMPLETED|Fourth Intervention Period||8
6451605|NCT01154218|7367453|FG000|NOT COMPLETED|Fourth Intervention Period||1
6451606|NCT01154218|7367454|FG001|NOT COMPLETED|Fourth Intervention Period||0
6451607|NCT01154218|7367455|FG002|NOT COMPLETED|Fourth Intervention Period||0
6451608|NCT01154218|7367456|FG003|NOT COMPLETED|Fourth Intervention Period||0
6451609|NCT01154231|7367466|FG000|STARTED|Overall Study||314
6451610|NCT01154231|7367466|FG000|COMPLETED|Overall Study||312
6451611|NCT01154231|7367466|FG000|NOT COMPLETED|Overall Study||2
6451612|NCT01154283|7367472|FG000|STARTED|0-6 Weeks||14
6451613|NCT01154283|7367473|FG001|STARTED|0-6 Weeks||14
6451614|NCT01154283|7367472|FG000|COMPLETED|0-6 Weeks||7
6451615|NCT01154283|7367473|FG001|COMPLETED|0-6 Weeks||11
6451616|NCT01154283|7367472|FG000|NOT COMPLETED|0-6 Weeks||7
6451617|NCT01154283|7367473|FG001|NOT COMPLETED|0-6 Weeks||3
6451618|NCT01154283|7367472|FG000|STARTED|7-12 Weeks||7
6451619|NCT01154283|7367473|FG001|STARTED|7-12 Weeks||11
6451620|NCT01154283|7367472|FG000|COMPLETED|7-12 Weeks||6
6451621|NCT01154283|7367473|FG001|COMPLETED|7-12 Weeks||10
6451622|NCT01154283|7367472|FG000|NOT COMPLETED|7-12 Weeks||1
6451623|NCT01154283|7367473|FG001|NOT COMPLETED|7-12 Weeks||1
6451624|NCT01154296|7367481|FG000|STARTED|Randomization and Intervention||2505
6451625|NCT01154296|7367482|FG001|STARTED|Randomization and Intervention||2507
6451626|NCT01154296|7367481|FG000|COMPLETED|Randomization and Intervention||2500
6451627|NCT01154296|7367482|FG001|COMPLETED|Randomization and Intervention||2505
6451628|NCT01154296|7367481|FG000|NOT COMPLETED|Randomization and Intervention||5
6451629|NCT01154296|7367482|FG001|NOT COMPLETED|Randomization and Intervention||2
6451630|NCT01154296|7367481|FG000|STARTED|6-month Follow-up||2505
6451631|NCT01154296|7367482|FG001|STARTED|6-month Follow-up||2507
6451632|NCT01154296|7367481|FG000|COMPLETED|6-month Follow-up||2177
6451633|NCT01154296|7367482|FG001|COMPLETED|6-month Follow-up||2179
6451634|NCT01154296|7367481|FG000|NOT COMPLETED|6-month Follow-up||328
6451635|NCT01154296|7367482|FG001|NOT COMPLETED|6-month Follow-up||328
6451636|NCT01154322|7367488|FG000|STARTED|Overall Study||16
6451637|NCT01154322|7367488|FG000|COMPLETED|Overall Study||14
6451638|NCT01154322|7367488|FG000|NOT COMPLETED|Overall Study||2
6451639|NCT01154335|7367496|FG000|STARTED|Overall Study||7
6451640|NCT01154335|7367497|FG001|STARTED|Overall Study||6
6451641|NCT01154335|7367498|FG002|STARTED|Overall Study||5
6451642|NCT01154335|7367496|FG000|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
6451643|NCT01154335|7367497|FG001|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
6451644|NCT01154335|7367498|FG002|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
6451645|NCT01154335|7367496|FG000|NOT COMPLETED|Overall Study||7
6451646|NCT01154335|7367497|FG001|NOT COMPLETED|Overall Study||6
6451647|NCT01154335|7367498|FG002|NOT COMPLETED|Overall Study||5
6451648|NCT01154452|7367509|FG000|STARTED|Phase Ib||6
6451649|NCT01154452|7367510|FG001|STARTED|Phase Ib||4
6451650|NCT01154452|7367511|FG002|STARTED|Phase Ib||0
6451651|NCT01154452|7367512|FG003|STARTED|Phase Ib||0
6451652|NCT01154452|7367509|FG000|COMPLETED|Phase Ib||3
6451653|NCT01154452|7367510|FG001|COMPLETED|Phase Ib||3
6451654|NCT01154452|7367511|FG002|COMPLETED|Phase Ib||0
6451655|NCT01154452|7367512|FG003|COMPLETED|Phase Ib||0
6451656|NCT01154452|7367509|FG000|NOT COMPLETED|Phase Ib||3
6451657|NCT01154452|7367510|FG001|NOT COMPLETED|Phase Ib||1
6451658|NCT01154452|7367511|FG002|NOT COMPLETED|Phase Ib||0
6451659|NCT01154452|7367512|FG003|NOT COMPLETED|Phase Ib||0
6451660|NCT01154452|7367509|FG000|STARTED|Phase II||0
6451661|NCT01154452|7367510|FG001|STARTED|Phase II||0
6451662|NCT01154452|7367511|FG002|STARTED|Phase II||35
6451663|NCT01154452|7367512|FG003|STARTED|Phase II||33
6451664|NCT01154452|7367509|FG000|COMPLETED|Phase II||0
6451665|NCT01154452|7367510|FG001|COMPLETED|Phase II||0
6451666|NCT01154452|7367511|FG002|COMPLETED|Phase II||30
6451667|NCT01154452|7367512|FG003|COMPLETED|Phase II||27
6451668|NCT01154452|7367509|FG000|NOT COMPLETED|Phase II||0
6451669|NCT01154452|7367510|FG001|NOT COMPLETED|Phase II||0
6451670|NCT01154452|7367511|FG002|NOT COMPLETED|Phase II||5
6451671|NCT01154452|7367512|FG003|NOT COMPLETED|Phase II||6
6654345|NCT02444663|7584106|FG000|COMPLETED|Device Varus 20N||9
6654346|NCT02444663|7584106|FG000|NOT COMPLETED|Device Varus 20N||0
6654347|NCT02444663|7584106|FG000|STARTED|Device Varus 30N||9
6654348|NCT02444663|7584106|FG000|COMPLETED|Device Varus 30N||9
6451672|NCT01154634|7367529|FG000|STARTED|Period 1 - First Intervention||4
6451673|NCT01154634|7367530|FG001|STARTED|Period 1 - First Intervention||7
6451674|NCT01154634|7367531|FG002|STARTED|Period 1 - First Intervention||4
6451675|NCT01154634|7367532|FG003|STARTED|Period 1 - First Intervention||5
6451676|NCT01154634|7367529|FG000|COMPLETED|Period 1 - First Intervention||4
6451677|NCT01154634|7367530|FG001|COMPLETED|Period 1 - First Intervention||7
6451678|NCT01154634|7367531|FG002|COMPLETED|Period 1 - First Intervention||4
6451679|NCT01154634|7367532|FG003|COMPLETED|Period 1 - First Intervention||5
6451680|NCT01154634|7367529|FG000|NOT COMPLETED|Period 1 - First Intervention||0
6451681|NCT01154634|7367530|FG001|NOT COMPLETED|Period 1 - First Intervention||0
6451682|NCT01154634|7367531|FG002|NOT COMPLETED|Period 1 - First Intervention||0
6451683|NCT01154634|7367532|FG003|NOT COMPLETED|Period 1 - First Intervention||0
6451684|NCT01154634|7367529|FG000|STARTED|Period 2 - Washout||4
6451685|NCT01154634|7367530|FG001|STARTED|Period 2 - Washout||7
6451686|NCT01154634|7367531|FG002|STARTED|Period 2 - Washout||4
6451687|NCT01154634|7367532|FG003|STARTED|Period 2 - Washout||5
6451688|NCT01154634|7367529|FG000|COMPLETED|Period 2 - Washout||4
6451689|NCT01154634|7367530|FG001|COMPLETED|Period 2 - Washout||7
6451690|NCT01154634|7367531|FG002|COMPLETED|Period 2 - Washout||4
6451691|NCT01154634|7367532|FG003|COMPLETED|Period 2 - Washout||5
6451692|NCT01154634|7367529|FG000|NOT COMPLETED|Period 2 - Washout||0
6451693|NCT01154634|7367530|FG001|NOT COMPLETED|Period 2 - Washout||0
6451694|NCT01154634|7367531|FG002|NOT COMPLETED|Period 2 - Washout||0
6451695|NCT01154634|7367532|FG003|NOT COMPLETED|Period 2 - Washout||0
6451696|NCT01154634|7367529|FG000|STARTED|Period 3- Second Intervention||4
6451697|NCT01154634|7367530|FG001|STARTED|Period 3- Second Intervention||7
6451698|NCT01154634|7367531|FG002|STARTED|Period 3- Second Intervention||4
6451699|NCT01154634|7367532|FG003|STARTED|Period 3- Second Intervention||5
6451700|NCT01154634|7367529|FG000|COMPLETED|Period 3- Second Intervention||4
6451701|NCT01154634|7367530|FG001|COMPLETED|Period 3- Second Intervention||7
6451702|NCT01154634|7367531|FG002|COMPLETED|Period 3- Second Intervention||4
6451703|NCT01154634|7367532|FG003|COMPLETED|Period 3- Second Intervention||5
6451704|NCT01154634|7367529|FG000|NOT COMPLETED|Period 3- Second Intervention||0
6451705|NCT01154634|7367530|FG001|NOT COMPLETED|Period 3- Second Intervention||0
6451706|NCT01154634|7367531|FG002|NOT COMPLETED|Period 3- Second Intervention||0
6451707|NCT01154634|7367532|FG003|NOT COMPLETED|Period 3- Second Intervention||0
6451708|NCT01154634|7367529|FG000|STARTED|Period 4 - Washout||4
6451709|NCT01154634|7367530|FG001|STARTED|Period 4 - Washout||7
6451710|NCT01154634|7367531|FG002|STARTED|Period 4 - Washout||4
6654349|NCT02444663|7584106|FG000|NOT COMPLETED|Device Varus 30N||0
6654350|NCT02444715|7584130|FG000|STARTED|Overall Study||46
6451711|NCT01154634|7367532|FG003|STARTED|Period 4 - Washout||5
6451712|NCT01154634|7367529|FG000|COMPLETED|Period 4 - Washout||4
6451713|NCT01154634|7367530|FG001|COMPLETED|Period 4 - Washout||7
6451714|NCT01154634|7367531|FG002|COMPLETED|Period 4 - Washout||4
6451715|NCT01154634|7367532|FG003|COMPLETED|Period 4 - Washout||5
6451716|NCT01154634|7367529|FG000|NOT COMPLETED|Period 4 - Washout||0
6451717|NCT01154634|7367530|FG001|NOT COMPLETED|Period 4 - Washout||0
6451718|NCT01154634|7367531|FG002|NOT COMPLETED|Period 4 - Washout||0
6451719|NCT01154634|7367532|FG003|NOT COMPLETED|Period 4 - Washout||0
6451720|NCT01154634|7367529|FG000|STARTED|Period 5 - Third Intervention||4
6451721|NCT01154634|7367530|FG001|STARTED|Period 5 - Third Intervention||7
6451722|NCT01154634|7367531|FG002|STARTED|Period 5 - Third Intervention||4
6451723|NCT01154634|7367532|FG003|STARTED|Period 5 - Third Intervention||5
6451724|NCT01154634|7367529|FG000|COMPLETED|Period 5 - Third Intervention||4
6451725|NCT01154634|7367530|FG001|COMPLETED|Period 5 - Third Intervention||7
6451726|NCT01154634|7367531|FG002|COMPLETED|Period 5 - Third Intervention||4
6451727|NCT01154634|7367532|FG003|COMPLETED|Period 5 - Third Intervention||5
6451728|NCT01154634|7367529|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
6451729|NCT01154634|7367530|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
6451730|NCT01154634|7367531|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
6451731|NCT01154634|7367532|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
6451732|NCT01154634|7367529|FG000|STARTED|Period 6 - Washout||4
6451733|NCT01154634|7367530|FG001|STARTED|Period 6 - Washout||7
6451734|NCT01154634|7367531|FG002|STARTED|Period 6 - Washout||4
6451735|NCT01154634|7367532|FG003|STARTED|Period 6 - Washout||5
6451736|NCT01154634|7367529|FG000|COMPLETED|Period 6 - Washout||4
6451737|NCT01154634|7367530|FG001|COMPLETED|Period 6 - Washout||7
6451738|NCT01154634|7367531|FG002|COMPLETED|Period 6 - Washout||4
6451739|NCT01154634|7367532|FG003|COMPLETED|Period 6 - Washout||5
6451740|NCT01154634|7367529|FG000|NOT COMPLETED|Period 6 - Washout||0
6451741|NCT01154634|7367530|FG001|NOT COMPLETED|Period 6 - Washout||0
6451742|NCT01154634|7367531|FG002|NOT COMPLETED|Period 6 - Washout||0
6451743|NCT01154634|7367532|FG003|NOT COMPLETED|Period 6 - Washout||0
6451744|NCT01154634|7367529|FG000|STARTED|Period 7 - Fourth Intervention||4
6451745|NCT01154634|7367530|FG001|STARTED|Period 7 - Fourth Intervention||7
6451746|NCT01154634|7367531|FG002|STARTED|Period 7 - Fourth Intervention||4
6451747|NCT01154634|7367532|FG003|STARTED|Period 7 - Fourth Intervention||5
6451748|NCT01154634|7367529|FG000|COMPLETED|Period 7 - Fourth Intervention||4
6451749|NCT01154634|7367530|FG001|COMPLETED|Period 7 - Fourth Intervention||7
6451750|NCT01154634|7367531|FG002|COMPLETED|Period 7 - Fourth Intervention||4
6451751|NCT01154634|7367532|FG003|COMPLETED|Period 7 - Fourth Intervention||5
6451752|NCT01154634|7367529|FG000|NOT COMPLETED|Period 7 - Fourth Intervention||0
6451753|NCT01154634|7367530|FG001|NOT COMPLETED|Period 7 - Fourth Intervention||0
6451754|NCT01154634|7367531|FG002|NOT COMPLETED|Period 7 - Fourth Intervention||0
6451755|NCT01154634|7367532|FG003|NOT COMPLETED|Period 7 - Fourth Intervention||0
6451756|NCT01154673|7367544|FG000|STARTED|Overall Study||16
6451757|NCT01154673|7367545|FG001|STARTED|Overall Study||16
6451758|NCT01154673|7367544|FG000|COMPLETED|Overall Study||14
6451759|NCT01154673|7367545|FG001|COMPLETED|Overall Study||16
6451760|NCT01154673|7367544|FG000|NOT COMPLETED|Overall Study||2
6451761|NCT01154673|7367545|FG001|NOT COMPLETED|Overall Study||0
6451762|NCT01154699|7367553|FG000|STARTED|First Intervention (4 Weeks)||13
6451763|NCT01154699|7367554|FG001|STARTED|First Intervention (4 Weeks)||8
6451764|NCT01154699|7367553|FG000|Subjects With Asthma Only|First Intervention (4 Weeks)||7
6451765|NCT01154699|7367554|FG001|Subjects With Asthma Only|First Intervention (4 Weeks)||6
6451766|NCT01154699|7367553|FG000|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
6451767|NCT01154699|7367554|FG001|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
6451768|NCT01154699|7367553|FG000|COMPLETED|First Intervention (4 Weeks)||13
6451769|NCT01154699|7367554|FG001|COMPLETED|First Intervention (4 Weeks)||8
6451770|NCT01154699|7367553|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6451771|NCT01154699|7367554|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6451772|NCT01154699|7367553|FG000|STARTED|Washout Period (4 Weeks)||13
6451773|NCT01154699|7367554|FG001|STARTED|Washout Period (4 Weeks)||8
6451774|NCT01154699|7367553|FG000|Subjects With Asthma Only|Washout Period (4 Weeks)||7
6451775|NCT01154699|7367554|FG001|Subjects With Asthma Only|Washout Period (4 Weeks)||6
6451776|NCT01154699|7367553|FG000|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
6451777|NCT01154699|7367554|FG001|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
6451778|NCT01154699|7367553|FG000|COMPLETED|Washout Period (4 Weeks)||13
6451779|NCT01154699|7367554|FG001|COMPLETED|Washout Period (4 Weeks)||8
6451780|NCT01154699|7367553|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
6451781|NCT01154699|7367554|FG001|NOT COMPLETED|Washout Period (4 Weeks)||0
6451782|NCT01154699|7367553|FG000|STARTED|Second Intervention||13
6451783|NCT01154699|7367554|FG001|STARTED|Second Intervention||8
6451784|NCT01154699|7367553|FG000|Subjects With Asthma Only|Second Intervention||7
6451785|NCT01154699|7367554|FG001|Subjects With Asthma Only|Second Intervention||6
6451786|NCT01154699|7367553|FG000|Subjects With Asthma + OSA|Second Intervention||6
6451787|NCT01154699|7367554|FG001|Subjects With Asthma + OSA|Second Intervention||2
6451788|NCT01154699|7367553|FG000|COMPLETED|Second Intervention||13
6451789|NCT01154699|7367554|FG001|COMPLETED|Second Intervention||8
6451790|NCT01154699|7367553|FG000|NOT COMPLETED|Second Intervention||0
6451791|NCT01154699|7367554|FG001|NOT COMPLETED|Second Intervention||0
6451792|NCT01154751|7367562|FG000|STARTED|6-month Follow-up||109
6451793|NCT01154751|7367562|FG000|COMPLETED|6-month Follow-up||98
6451794|NCT01154751|7367562|FG000|NOT COMPLETED|6-month Follow-up||11
6451795|NCT01154751|7367562|FG000|STARTED|1-year Follow-up||98
6451796|NCT01154751|7367562|FG000|COMPLETED|1-year Follow-up||93
6451797|NCT01154751|7367562|FG000|NOT COMPLETED|1-year Follow-up||5
6451798|NCT01154751|7367562|FG000|STARTED|2-year Follow-up||93
6451799|NCT01154751|7367562|FG000|COMPLETED|2-year Follow-up||83
6451800|NCT01154751|7367562|FG000|NOT COMPLETED|2-year Follow-up||10
6451801|NCT01154751|7367562|FG000|STARTED|3-year Follow-up||83
6451802|NCT01154751|7367562|FG000|COMPLETED|3-year Follow-up||34
6451803|NCT01154751|7367562|FG000|NOT COMPLETED|3-year Follow-up||49
6451804|NCT01154816|7367578|FG000|STARTED|Overall Study||20
6451805|NCT01154816|7367579|FG001|STARTED|Overall Study||12
6451806|NCT01154816|7367580|FG002|STARTED|Overall Study||10
6451807|NCT01154816|7367581|FG003|STARTED|Overall Study||10
6451808|NCT01154816|7367582|FG004|STARTED|Overall Study||10
6451809|NCT01154816|7367583|FG005|STARTED|Overall Study||8
6451810|NCT01154816|7367584|FG006|STARTED|Overall Study||6
6451811|NCT01154816|7367585|FG007|STARTED|Overall Study||7
6451812|NCT01154816|7367586|FG008|STARTED|Overall Study||10
6451813|NCT01154816|7367587|FG009|STARTED|Overall Study||10
6451814|NCT01154816|7367588|FG010|STARTED|Overall Study||11
6451815|NCT01154816|7367589|FG011|STARTED|Overall Study||4
6451816|NCT01154816|7367578|FG000|COMPLETED|Overall Study||0
6451817|NCT01154816|7367579|FG001|COMPLETED|Overall Study||2
6451818|NCT01154816|7367580|FG002|COMPLETED|Overall Study||0
6451819|NCT01154816|7367581|FG003|COMPLETED|Overall Study||0
6451820|NCT01154816|7367582|FG004|COMPLETED|Overall Study||0
6451821|NCT01154816|7367583|FG005|COMPLETED|Overall Study||0
6451822|NCT01154816|7367584|FG006|COMPLETED|Overall Study||0
6451823|NCT01154816|7367585|FG007|COMPLETED|Overall Study||0
6451824|NCT01154816|7367586|FG008|COMPLETED|Overall Study||1
6451825|NCT01154816|7367587|FG009|COMPLETED|Overall Study||0
6451826|NCT01154816|7367588|FG010|COMPLETED|Overall Study||0
6451827|NCT01154816|7367589|FG011|COMPLETED|Overall Study||0
6451828|NCT01154816|7367578|FG000|NOT COMPLETED|Overall Study||20
6451829|NCT01154816|7367579|FG001|NOT COMPLETED|Overall Study||10
6451830|NCT01154816|7367580|FG002|NOT COMPLETED|Overall Study||10
6451831|NCT01154816|7367581|FG003|NOT COMPLETED|Overall Study||10
6451832|NCT01154816|7367582|FG004|NOT COMPLETED|Overall Study||10
6451833|NCT01154816|7367583|FG005|NOT COMPLETED|Overall Study||8
6451834|NCT01154816|7367584|FG006|NOT COMPLETED|Overall Study||6
6451835|NCT01154816|7367585|FG007|NOT COMPLETED|Overall Study||7
6451836|NCT01154816|7367586|FG008|NOT COMPLETED|Overall Study||9
6451837|NCT01154816|7367587|FG009|NOT COMPLETED|Overall Study||10
6451838|NCT01154816|7367588|FG010|NOT COMPLETED|Overall Study||11
6451839|NCT01154816|7367589|FG011|NOT COMPLETED|Overall Study||4
6451840|NCT01154985|7367620|FG000|STARTED|Overall Study|Randomized|75
6451841|NCT01154985|7367621|FG001|STARTED|Overall Study|Randomized|82
6451842|NCT01154985|7367622|FG002|STARTED|Overall Study|Randomized|86
6451843|NCT01154985|7367620|FG000|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
6451844|NCT01154985|7367621|FG001|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
6451845|NCT01154985|7367622|FG002|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
6451846|NCT01154985|7367620|FG000|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
6451847|NCT01154985|7367621|FG001|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
6451848|NCT01154985|7367622|FG002|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
6451849|NCT01154985|7367620|FG000|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
6451850|NCT01154985|7367621|FG001|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
6451851|NCT01154985|7367622|FG002|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
6451852|NCT01154985|7367620|FG000|COMPLETED|Overall Study||58
6451853|NCT01154985|7367621|FG001|COMPLETED|Overall Study||55
6451854|NCT01154985|7367622|FG002|COMPLETED|Overall Study||68
6451855|NCT01154985|7367620|FG000|NOT COMPLETED|Overall Study||17
6451856|NCT01154985|7367621|FG001|NOT COMPLETED|Overall Study||27
6451857|NCT01154985|7367622|FG002|NOT COMPLETED|Overall Study||18
6451858|NCT01155011|7367632|FG000|STARTED|Baseline to 6 Months||151
6451859|NCT01155011|7367633|FG001|STARTED|Baseline to 6 Months||156
6451860|NCT01155011|7367632|FG000|COMPLETED|Baseline to 6 Months||129
6451861|NCT01155011|7367633|FG001|COMPLETED|Baseline to 6 Months||131
6451862|NCT01155011|7367632|FG000|NOT COMPLETED|Baseline to 6 Months||22
6451863|NCT01155011|7367633|FG001|NOT COMPLETED|Baseline to 6 Months||25
6451864|NCT01155011|7367632|FG000|STARTED|6 to 12 Months||129
6451865|NCT01155011|7367633|FG001|STARTED|6 to 12 Months||131
6451866|NCT01155011|7367632|FG000|COMPLETED|6 to 12 Months||120
6451867|NCT01155011|7367633|FG001|COMPLETED|6 to 12 Months||121
6451868|NCT01155011|7367632|FG000|NOT COMPLETED|6 to 12 Months||9
6451869|NCT01155011|7367633|FG001|NOT COMPLETED|6 to 12 Months||10
6451870|NCT01155024|7367643|FG000|STARTED|First Socket Intervention Fitting||5
6451871|NCT01155024|7367644|FG001|STARTED|First Socket Intervention Fitting||5
6451872|NCT01155024|7367643|FG000|COMPLETED|First Socket Intervention Fitting||5
6451873|NCT01155024|7367644|FG001|COMPLETED|First Socket Intervention Fitting||5
6451874|NCT01155024|7367643|FG000|NOT COMPLETED|First Socket Intervention Fitting||0
6451875|NCT01155024|7367644|FG001|NOT COMPLETED|First Socket Intervention Fitting||0
6451876|NCT01155024|7367643|FG000|STARTED|Second Socket Intervention Fitting||5
6451877|NCT01155024|7367644|FG001|STARTED|Second Socket Intervention Fitting||5
6451878|NCT01155024|7367643|FG000|COMPLETED|Second Socket Intervention Fitting||5
6451879|NCT01155024|7367644|FG001|COMPLETED|Second Socket Intervention Fitting||5
6451880|NCT01155024|7367643|FG000|NOT COMPLETED|Second Socket Intervention Fitting||0
6451881|NCT01155024|7367644|FG001|NOT COMPLETED|Second Socket Intervention Fitting||0
6451882|NCT01155024|7367643|FG000|STARTED|Direct Manufactured Socket 3 Month Trial||0
6451883|NCT01155024|7367644|FG001|STARTED|Direct Manufactured Socket 3 Month Trial||10
6451884|NCT01155024|7367643|FG000|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
6451885|NCT01155024|7367644|FG001|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
6451886|NCT01155024|7367643|FG000|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
6451887|NCT01155024|7367644|FG001|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
6451888|NCT01155050|7367655|FG000|STARTED|Overall Study||50
6451889|NCT01155050|7367656|FG001|STARTED|Overall Study||51
6451890|NCT01155050|7367657|FG002|STARTED|Overall Study||52
6451891|NCT01155050|7367658|FG003|STARTED|Overall Study||49
6451892|NCT01155050|7367655|FG000|COMPLETED|Overall Study||35
6451893|NCT01155050|7367656|FG001|COMPLETED|Overall Study||31
6451894|NCT01155050|7367657|FG002|COMPLETED|Overall Study||33
6451895|NCT01155050|7367658|FG003|COMPLETED|Overall Study||27
6451896|NCT01155050|7367655|FG000|NOT COMPLETED|Overall Study||15
6451897|NCT01155050|7367656|FG001|NOT COMPLETED|Overall Study||20
6451898|NCT01155050|7367657|FG002|NOT COMPLETED|Overall Study||19
6451899|NCT01155050|7367658|FG003|NOT COMPLETED|Overall Study||22
6451900|NCT01155063|7367668|FG000|STARTED|Overall Study||89
6451901|NCT01155063|7367668|FG000|COMPLETED|Overall Study||0
6451902|NCT01155063|7367668|FG000|NOT COMPLETED|Overall Study||89
6451903|NCT01155141|7367672|FG000|STARTED|Overall Study||16
6451904|NCT01155141|7367672|FG000|COMPLETED|Overall Study||14
6451905|NCT01155141|7367672|FG000|NOT COMPLETED|Overall Study||2
6451906|NCT01155154|7367679|FG000|STARTED|Overall Study||25
6451907|NCT01155154|7367680|FG001|STARTED|Overall Study||24
6745063|NCT03353753|7673137|FG001|NOT COMPLETED|Overall Study||9
6745064|NCT03354325|7673145|FG000|STARTED|Overall Study||151
6745065|NCT03354325|7673146|FG001|STARTED|Overall Study||153
6745066|NCT03354325|7673145|FG000|COMPLETED|Overall Study||131
6745067|NCT03354325|7673146|FG001|COMPLETED|Overall Study||138
6745068|NCT03354325|7673145|FG000|NOT COMPLETED|Overall Study||20
6745069|NCT03354325|7673146|FG001|NOT COMPLETED|Overall Study||15
6745070|NCT03354429|7673154|FG000|STARTED|Overall Study||5523
6745071|NCT03354429|7673155|FG001|STARTED|Overall Study||5493
6451908|NCT01155154|7367681|FG002|STARTED|Overall Study||24
6451909|NCT01155154|7367679|FG000|COMPLETED|Overall Study||25
6451910|NCT01155154|7367680|FG001|COMPLETED|Overall Study||24
6451911|NCT01155154|7367681|FG002|COMPLETED|Overall Study||24
6451912|NCT01155154|7367679|FG000|NOT COMPLETED|Overall Study||0
6451913|NCT01155154|7367680|FG001|NOT COMPLETED|Overall Study||0
6451914|NCT01155154|7367681|FG002|NOT COMPLETED|Overall Study||0
6451915|NCT01155167|7367691|FG000|STARTED|Overall Study||43
6451916|NCT01155167|7367692|FG001|STARTED|Overall Study||43
6451917|NCT01155167|7367691|FG000|COMPLETED|Overall Study||40
6451918|NCT01155167|7367692|FG001|COMPLETED|Overall Study||43
6451919|NCT01155167|7367691|FG000|NOT COMPLETED|Overall Study||3
6451920|NCT01155167|7367692|FG001|NOT COMPLETED|Overall Study||0
6451921|NCT01155180|7367700|FG000|STARTED|Overall Study||18
6451922|NCT01155180|7367701|FG001|STARTED|Overall Study||6
6451923|NCT01155180|7367700|FG000|COMPLETED|Overall Study||18
6451924|NCT01155180|7367701|FG001|COMPLETED|Overall Study||6
6451925|NCT01155180|7367700|FG000|NOT COMPLETED|Overall Study||0
6451926|NCT01155180|7367701|FG001|NOT COMPLETED|Overall Study||0
6451927|NCT01155193|7367711|FG000|STARTED|Overall Study||10924
6451928|NCT01155193|7367712|FG001|STARTED|Overall Study||3818
6451929|NCT01155193|7367713|FG002|STARTED|Overall Study||2260
6451930|NCT01155193|7367714|FG003|STARTED|Overall Study||13802
6451931|NCT01155193|7367711|FG000|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|10686
6451932|NCT01155193|7367712|FG001|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|3805
6451933|NCT01155193|7367713|FG002|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|2248
6451934|NCT01155193|7367714|FG003|COMPLETED|Overall Study|Evaluable population (participants treated between 01 September and 01 May of the following year)|13711
6451935|NCT01155193|7367711|FG000|NOT COMPLETED|Overall Study||238
6451936|NCT01155193|7367712|FG001|NOT COMPLETED|Overall Study||13
6451937|NCT01155193|7367713|FG002|NOT COMPLETED|Overall Study||12
6451938|NCT01155193|7367714|FG003|NOT COMPLETED|Overall Study||91
6451939|NCT01155219|7367731|FG000|STARTED|Overall Study||77
6451940|NCT01155219|7367732|FG001|STARTED|Overall Study||73
6451941|NCT01155219|7367731|FG000|COMPLETED|Overall Study||73
6451942|NCT01155219|7367732|FG001|COMPLETED|Overall Study||70
6451943|NCT01155219|7367731|FG000|NOT COMPLETED|Overall Study||4
6451944|NCT01155219|7367732|FG001|NOT COMPLETED|Overall Study||3
6451945|NCT01155284|7367740|FG000|STARTED|Overall Study||47
6451946|NCT01155284|7367741|FG001|STARTED|Overall Study||23
6451947|NCT01155284|7367740|FG000|COMPLETED|Overall Study||40
6451948|NCT01155284|7367741|FG001|COMPLETED|Overall Study||18
6451949|NCT01155284|7367740|FG000|NOT COMPLETED|Overall Study||7
6745072|NCT03354429|7673154|FG000|COMPLETED|Overall Study||5514
6745073|NCT03354429|7673155|FG001|COMPLETED|Overall Study||5486
6745074|NCT03354429|7673154|FG000|NOT COMPLETED|Overall Study||9
6451950|NCT01155284|7367741|FG001|NOT COMPLETED|Overall Study||5
6451951|NCT01155323|7367749|FG000|STARTED|First Intervention||60
6451952|NCT01155323|7367750|FG001|STARTED|First Intervention||58
6451953|NCT01155323|7367749|FG000|COMPLETED|First Intervention||59
6451954|NCT01155323|7367750|FG001|COMPLETED|First Intervention||57
6451955|NCT01155323|7367749|FG000|NOT COMPLETED|First Intervention||1
6451956|NCT01155323|7367750|FG001|NOT COMPLETED|First Intervention||1
6451957|NCT01155323|7367749|FG000|STARTED|Second Intervention||59
6451958|NCT01155323|7367750|FG001|STARTED|Second Intervention||57
6451959|NCT01155323|7367749|FG000|COMPLETED|Second Intervention||58
6451960|NCT01155323|7367750|FG001|COMPLETED|Second Intervention||56
6451961|NCT01155323|7367749|FG000|NOT COMPLETED|Second Intervention||1
6451962|NCT01155323|7367750|FG001|NOT COMPLETED|Second Intervention||1
6451963|NCT01155336|7367758|FG000|STARTED|Overall Study|We did not complete the study.|0
6451964|NCT01155336|7367759|FG001|STARTED|Overall Study|We did not complete the study.|4
6451965|NCT01155336|7367758|FG000|COMPLETED|Overall Study|We did not complete the study.|0
6451966|NCT01155336|7367759|FG001|COMPLETED|Overall Study|We did not complete the study.|4
6451967|NCT01155336|7367758|FG000|NOT COMPLETED|Overall Study||0
6451968|NCT01155336|7367759|FG001|NOT COMPLETED|Overall Study||0
6451969|NCT01155466|7367770|FG000|STARTED|Overall Study||156
6451970|NCT01155466|7367771|FG001|STARTED|Overall Study||155
6451971|NCT01155466|7367772|FG002|STARTED|Overall Study||156
6451972|NCT01155466|7367773|FG003|STARTED|Overall Study||155
6451973|NCT01155466|7367774|FG004|STARTED|Overall Study||156
6451974|NCT01155466|7367770|FG000|Treated|Overall Study||154
6451975|NCT01155466|7367771|FG001|Treated|Overall Study||153
6451976|NCT01155466|7367772|FG002|Treated|Overall Study||153
6451977|NCT01155466|7367773|FG003|Treated|Overall Study||155
6451978|NCT01155466|7367774|FG004|Treated|Overall Study||154
6451979|NCT01155466|7367770|FG000|COMPLETED|Overall Study|Completed treatment phase|134
6451980|NCT01155466|7367771|FG001|COMPLETED|Overall Study|Completed treatment phase|130
6451981|NCT01155466|7367772|FG002|COMPLETED|Overall Study|Completed treatment phase|136
6451982|NCT01155466|7367773|FG003|COMPLETED|Overall Study|Completed treatment phase|134
6451983|NCT01155466|7367774|FG004|COMPLETED|Overall Study|Completed treatment phase|129
6451984|NCT01155466|7367770|FG000|NOT COMPLETED|Overall Study||22
6451985|NCT01155466|7367771|FG001|NOT COMPLETED|Overall Study||25
6451986|NCT01155466|7367772|FG002|NOT COMPLETED|Overall Study||20
6451987|NCT01155466|7367773|FG003|NOT COMPLETED|Overall Study||21
6451988|NCT01155466|7367774|FG004|NOT COMPLETED|Overall Study||27
6451989|NCT01155479|7367791|FG000|STARTED|Part I||204
6745075|NCT03354429|7673155|FG001|NOT COMPLETED|Overall Study||7
6745076|NCT03354598|7673163|FG000|STARTED|Overall Study||835
6451990|NCT01155479|7367792|FG001|STARTED|Part I||204
6451991|NCT01155479|7367793|FG002|STARTED|Part I||206
6451992|NCT01155479|7367794|FG003|STARTED|Part I||204
6451993|NCT01155479|7367795|FG004|STARTED|Part I||204
6451994|NCT01155479|7367791|FG000|Treated|Part I||200
6451995|NCT01155479|7367792|FG001|Treated|Part I||202
6451996|NCT01155479|7367793|FG002|Treated|Part I||204
6451997|NCT01155479|7367794|FG003|Treated|Part I||198
6451998|NCT01155479|7367795|FG004|Treated|Part I||203
6451999|NCT01155479|7367791|FG000|COMPLETED|Part I||166
6452000|NCT01155479|7367792|FG001|COMPLETED|Part I||177
6452001|NCT01155479|7367793|FG002|COMPLETED|Part I||167
6452002|NCT01155479|7367794|FG003|COMPLETED|Part I||177
6452003|NCT01155479|7367795|FG004|COMPLETED|Part I||181
6452004|NCT01155479|7367791|FG000|NOT COMPLETED|Part I||38
6452005|NCT01155479|7367792|FG001|NOT COMPLETED|Part I||27
6452006|NCT01155479|7367793|FG002|NOT COMPLETED|Part I||39
6452007|NCT01155479|7367794|FG003|NOT COMPLETED|Part I||27
6452008|NCT01155479|7367795|FG004|NOT COMPLETED|Part I||23
6452009|NCT01155479|7367791|FG000|STARTED|Part II||166
6452010|NCT01155479|7367792|FG001|STARTED|Part II||177
6452011|NCT01155479|7367793|FG002|STARTED|Part II||167
6452012|NCT01155479|7367794|FG003|STARTED|Part II||177
6452013|NCT01155479|7367795|FG004|STARTED|Part II||181
6452014|NCT01155479|7367791|FG000|COMPLETED|Part II||107
6452015|NCT01155479|7367792|FG001|COMPLETED|Part II||116
6452016|NCT01155479|7367793|FG002|COMPLETED|Part II||109
6452017|NCT01155479|7367794|FG003|COMPLETED|Part II||127
6452018|NCT01155479|7367795|FG004|COMPLETED|Part II||126
6452019|NCT01155479|7367791|FG000|NOT COMPLETED|Part II||59
6452020|NCT01155479|7367792|FG001|NOT COMPLETED|Part II||61
6452021|NCT01155479|7367793|FG002|NOT COMPLETED|Part II||58
6452022|NCT01155479|7367794|FG003|NOT COMPLETED|Part II||50
6452023|NCT01155479|7367795|FG004|NOT COMPLETED|Part II||55
6452024|NCT01155531|7367827|FG000|STARTED|Overall Study||10
6452025|NCT01155531|7367828|FG001|STARTED|Overall Study||10
6452026|NCT01155531|7367829|FG002|STARTED|Overall Study||10
6452027|NCT01155531|7367830|FG003|STARTED|Overall Study||10
6452028|NCT01155531|7367827|FG000|COMPLETED|Overall Study||9
6452029|NCT01155531|7367828|FG001|COMPLETED|Overall Study||10
6452030|NCT01155531|7367829|FG002|COMPLETED|Overall Study||8
6452031|NCT01155531|7367830|FG003|COMPLETED|Overall Study||9
6452032|NCT01155531|7367827|FG000|NOT COMPLETED|Overall Study||1
6452033|NCT01155531|7367828|FG001|NOT COMPLETED|Overall Study||0
6452034|NCT01155531|7367829|FG002|NOT COMPLETED|Overall Study||2
6452035|NCT01155531|7367830|FG003|NOT COMPLETED|Overall Study||1
6452036|NCT01155570|7367840|FG000|STARTED|Overall Study|Safety Analysis Population|734
6452037|NCT01155570|7367840|FG000|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
6452038|NCT01155570|7367840|FG000|COMPLETED|Overall Study||592
6452039|NCT01155570|7367840|FG000|NOT COMPLETED|Overall Study||142
6745077|NCT03354598|7673164|FG001|STARTED|Overall Study||836
6452040|NCT01155583|7367855|FG000|STARTED|Phase I||3
6452041|NCT01155583|7367856|FG001|STARTED|Phase I||3
6452042|NCT01155583|7367857|FG002|STARTED|Phase I||4
6452043|NCT01155583|7367858|FG003|STARTED|Phase I||6
6452044|NCT01155583|7367859|FG004|STARTED|Phase I||7
6452045|NCT01155583|7367860|FG005|STARTED|Phase I||0
6452046|NCT01155583|7367861|FG006|STARTED|Phase I||3
6452047|NCT01155583|7367862|FG007|STARTED|Phase I||8
6452048|NCT01155583|7367863|FG008|STARTED|Phase I||0
6452049|NCT01155583|7367855|FG000|COMPLETED|Phase I||3
6452050|NCT01155583|7367856|FG001|COMPLETED|Phase I||3
6452051|NCT01155583|7367857|FG002|COMPLETED|Phase I||4
6452052|NCT01155583|7367858|FG003|COMPLETED|Phase I||6
6452053|NCT01155583|7367859|FG004|COMPLETED|Phase I||6
6452054|NCT01155583|7367860|FG005|COMPLETED|Phase I||0
6452055|NCT01155583|7367861|FG006|COMPLETED|Phase I||3
6452056|NCT01155583|7367862|FG007|COMPLETED|Phase I||5
6452057|NCT01155583|7367863|FG008|COMPLETED|Phase I||0
6452058|NCT01155583|7367855|FG000|NOT COMPLETED|Phase I||0
6452059|NCT01155583|7367856|FG001|NOT COMPLETED|Phase I||0
6452060|NCT01155583|7367857|FG002|NOT COMPLETED|Phase I||0
6452061|NCT01155583|7367858|FG003|NOT COMPLETED|Phase I||0
6452062|NCT01155583|7367859|FG004|NOT COMPLETED|Phase I||1
6452063|NCT01155583|7367860|FG005|NOT COMPLETED|Phase I||0
6452064|NCT01155583|7367861|FG006|NOT COMPLETED|Phase I||0
6452065|NCT01155583|7367862|FG007|NOT COMPLETED|Phase I||3
6452066|NCT01155583|7367863|FG008|NOT COMPLETED|Phase I||0
6452067|NCT01155583|7367855|FG000|STARTED|Phase II - Expansion Phase||0
6452068|NCT01155583|7367856|FG001|STARTED|Phase II - Expansion Phase||0
6452069|NCT01155583|7367857|FG002|STARTED|Phase II - Expansion Phase||0
6452070|NCT01155583|7367858|FG003|STARTED|Phase II - Expansion Phase||0
6452071|NCT01155583|7367859|FG004|STARTED|Phase II - Expansion Phase||0
6452072|NCT01155583|7367860|FG005|STARTED|Phase II - Expansion Phase||0
6452073|NCT01155583|7367861|FG006|STARTED|Phase II - Expansion Phase||0
6452074|NCT01155583|7367862|FG007|STARTED|Phase II - Expansion Phase||0
6452075|NCT01155583|7367863|FG008|STARTED|Phase II - Expansion Phase||11
6452076|NCT01155583|7367855|FG000|COMPLETED|Phase II - Expansion Phase||0
6452077|NCT01155583|7367856|FG001|COMPLETED|Phase II - Expansion Phase||0
6452078|NCT01155583|7367857|FG002|COMPLETED|Phase II - Expansion Phase||0
6452079|NCT01155583|7367858|FG003|COMPLETED|Phase II - Expansion Phase||0
6452080|NCT01155583|7367859|FG004|COMPLETED|Phase II - Expansion Phase||0
6452081|NCT01155583|7367860|FG005|COMPLETED|Phase II - Expansion Phase||0
6452082|NCT01155583|7367861|FG006|COMPLETED|Phase II - Expansion Phase||0
6452083|NCT01155583|7367862|FG007|COMPLETED|Phase II - Expansion Phase||0
6452084|NCT01155583|7367863|FG008|COMPLETED|Phase II - Expansion Phase||11
6452085|NCT01155583|7367855|FG000|NOT COMPLETED|Phase II - Expansion Phase||0
6452086|NCT01155583|7367856|FG001|NOT COMPLETED|Phase II - Expansion Phase||0
6452087|NCT01155583|7367857|FG002|NOT COMPLETED|Phase II - Expansion Phase||0
6452088|NCT01155583|7367858|FG003|NOT COMPLETED|Phase II - Expansion Phase||0
6452089|NCT01155583|7367859|FG004|NOT COMPLETED|Phase II - Expansion Phase||0
6452090|NCT01155583|7367860|FG005|NOT COMPLETED|Phase II - Expansion Phase||0
6452091|NCT01155583|7367861|FG006|NOT COMPLETED|Phase II - Expansion Phase||0
6452092|NCT01155583|7367862|FG007|NOT COMPLETED|Phase II - Expansion Phase||0
6452093|NCT01155583|7367863|FG008|NOT COMPLETED|Phase II - Expansion Phase||0
6452094|NCT01155661|7367879|FG000|STARTED|Overall Study||608
6452095|NCT01155661|7367879|FG000|COMPLETED|Overall Study||328
6452096|NCT01155661|7367879|FG000|NOT COMPLETED|Overall Study||280
6452097|NCT01155726|7367885|FG000|STARTED|Period 1, 3 Days (Masked)||24
6452098|NCT01155726|7367886|FG001|STARTED|Period 1, 3 Days (Masked)||20
6452099|NCT01155726|7367887|FG002|STARTED|Period 1, 3 Days (Masked)||30
6452100|NCT01155726|7367888|FG003|STARTED|Period 1, 3 Days (Masked)||25
6452101|NCT01155726|7367885|FG000|COMPLETED|Period 1, 3 Days (Masked)||23
6452102|NCT01155726|7367886|FG001|COMPLETED|Period 1, 3 Days (Masked)||20
6452103|NCT01155726|7367887|FG002|COMPLETED|Period 1, 3 Days (Masked)||28
6452104|NCT01155726|7367888|FG003|COMPLETED|Period 1, 3 Days (Masked)||25
6452105|NCT01155726|7367885|FG000|NOT COMPLETED|Period 1, 3 Days (Masked)||1
6452106|NCT01155726|7367886|FG001|NOT COMPLETED|Period 1, 3 Days (Masked)||0
6452107|NCT01155726|7367887|FG002|NOT COMPLETED|Period 1, 3 Days (Masked)||2
6452108|NCT01155726|7367888|FG003|NOT COMPLETED|Period 1, 3 Days (Masked)||0
6452109|NCT01155726|7367885|FG000|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
6452110|NCT01155726|7367886|FG001|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
6452111|NCT01155726|7367887|FG002|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
6452112|NCT01155726|7367888|FG003|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
6452113|NCT01155726|7367885|FG000|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
6452114|NCT01155726|7367886|FG001|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
6452115|NCT01155726|7367887|FG002|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
6452116|NCT01155726|7367888|FG003|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
6452117|NCT01155726|7367885|FG000|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
6452118|NCT01155726|7367886|FG001|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
6452119|NCT01155726|7367887|FG002|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
6452120|NCT01155726|7367888|FG003|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
6452121|NCT01155778|7367913|FG000|STARTED|Overall Study||4
6452122|NCT01155778|7367914|FG001|STARTED|Overall Study||4
6452123|NCT01155778|7367915|FG002|STARTED|Overall Study||4
6452124|NCT01155778|7367913|FG000|COMPLETED|Overall Study||4
6452125|NCT01155778|7367914|FG001|COMPLETED|Overall Study||4
6452126|NCT01155778|7367915|FG002|COMPLETED|Overall Study||4
6452127|NCT01155778|7367913|FG000|NOT COMPLETED|Overall Study||0
6452128|NCT01155778|7367914|FG001|NOT COMPLETED|Overall Study||0
6452129|NCT01155778|7367915|FG002|NOT COMPLETED|Overall Study||0
6452130|NCT01155830|7367926|FG000|STARTED|Overall Study||0
6452131|NCT01155830|7367927|FG001|STARTED|Overall Study||0
6452132|NCT01155830|7367928|FG002|STARTED|Overall Study||21
6452133|NCT01155830|7367926|FG000|COMPLETED|Overall Study||0
6452134|NCT01155830|7367927|FG001|COMPLETED|Overall Study||0
6452135|NCT01155830|7367928|FG002|COMPLETED|Overall Study||21
6452136|NCT01155830|7367926|FG000|NOT COMPLETED|Overall Study||0
6452137|NCT01155830|7367927|FG001|NOT COMPLETED|Overall Study||0
6452138|NCT01155830|7367928|FG002|NOT COMPLETED|Overall Study||0
6452139|NCT01155869|7367938|FG000|STARTED|Overall Study||3
6452140|NCT01155869|7367939|FG001|STARTED|Overall Study||4
6452141|NCT01155869|7367938|FG000|COMPLETED|Overall Study||0
6452142|NCT01155869|7367939|FG001|COMPLETED|Overall Study||3
6452143|NCT01155869|7367938|FG000|NOT COMPLETED|Overall Study||3
6452144|NCT01155869|7367939|FG001|NOT COMPLETED|Overall Study||1
6452145|NCT01155999|7367947|FG000|STARTED|Overall Study||146
6452146|NCT01155999|7367948|FG001|STARTED|Overall Study||140
6452147|NCT01155999|7367947|FG000|COMPLETED|Overall Study||139
6452148|NCT01155999|7367948|FG001|COMPLETED|Overall Study||136
6452149|NCT01155999|7367947|FG000|NOT COMPLETED|Overall Study||7
6452150|NCT01155999|7367948|FG001|NOT COMPLETED|Overall Study||4
6452151|NCT01156012|7367956|FG000|STARTED|Overall Study||213
6452152|NCT01156012|7367957|FG001|STARTED|Overall Study||189
6452153|NCT01156012|7367956|FG000|COMPLETED|Overall Study||206
6452154|NCT01156012|7367957|FG001|COMPLETED|Overall Study||186
6452155|NCT01156012|7367956|FG000|NOT COMPLETED|Overall Study||7
6452156|NCT01156012|7367957|FG001|NOT COMPLETED|Overall Study||3
6452157|NCT01156051|7367965|FG000|STARTED|Overall Study||12
6452158|NCT01156051|7367966|FG001|STARTED|Overall Study||17
6452159|NCT01156051|7367965|FG000|COMPLETED|Overall Study||11
6452160|NCT01156051|7367966|FG001|COMPLETED|Overall Study||16
6452161|NCT01156051|7367965|FG000|NOT COMPLETED|Overall Study||1
6452162|NCT01156051|7367966|FG001|NOT COMPLETED|Overall Study||1
6452163|NCT01156116|7367974|FG000|STARTED|Overall Study||26
6452164|NCT01156116|7367975|FG001|STARTED|Overall Study||13
6452165|NCT01156116|7367974|FG000|COMPLETED|Overall Study||21
6452166|NCT01156116|7367975|FG001|COMPLETED|Overall Study||12
6452167|NCT01156116|7367974|FG000|NOT COMPLETED|Overall Study||5
6452168|NCT01156116|7367975|FG001|NOT COMPLETED|Overall Study||1
6452169|NCT01156142|7367983|FG000|STARTED|Overall Study||77
6452170|NCT01156142|7367984|FG001|STARTED|Overall Study||78
6452171|NCT01156142|7367983|FG000|COMPLETED|Overall Study||69
6452172|NCT01156142|7367984|FG001|COMPLETED|Overall Study||71
6452173|NCT01156142|7367983|FG000|NOT COMPLETED|Overall Study||8
6452174|NCT01156142|7367984|FG001|NOT COMPLETED|Overall Study||7
6452175|NCT01156311|7367992|FG000|STARTED|2-Month Monotherapy Period||59
6452176|NCT01156311|7367993|FG001|STARTED|2-Month Monotherapy Period||49
6452177|NCT01156311|7367994|FG002|STARTED|2-Month Monotherapy Period||0
6452178|NCT01156311|7367995|FG003|STARTED|2-Month Monotherapy Period||0
6452179|NCT01156311|7367992|FG000|COMPLETED|2-Month Monotherapy Period||57
6452180|NCT01156311|7367993|FG001|COMPLETED|2-Month Monotherapy Period||47
6452181|NCT01156311|7367994|FG002|COMPLETED|2-Month Monotherapy Period||0
6452182|NCT01156311|7367995|FG003|COMPLETED|2-Month Monotherapy Period||0
6452183|NCT01156311|7367992|FG000|NOT COMPLETED|2-Month Monotherapy Period||2
6452184|NCT01156311|7367993|FG001|NOT COMPLETED|2-Month Monotherapy Period||2
6452185|NCT01156311|7367994|FG002|NOT COMPLETED|2-Month Monotherapy Period||0
6452186|NCT01156311|7367995|FG003|NOT COMPLETED|2-Month Monotherapy Period||0
6452187|NCT01156311|7367992|FG000|STARTED|6-month Add-on Therapy Period||0
6452188|NCT01156311|7367993|FG001|STARTED|6-month Add-on Therapy Period||0
6452189|NCT01156311|7367994|FG002|STARTED|6-month Add-on Therapy Period||57
6452190|NCT01156311|7367995|FG003|STARTED|6-month Add-on Therapy Period||47
6452191|NCT01156311|7367992|FG000|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
6452192|NCT01156311|7367993|FG001|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
6452193|NCT01156311|7367994|FG002|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
6452194|NCT01156311|7367995|FG003|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
6452195|NCT01156311|7367992|FG000|COMPLETED|6-month Add-on Therapy Period||0
6452196|NCT01156311|7367993|FG001|COMPLETED|6-month Add-on Therapy Period||0
6452197|NCT01156311|7367994|FG002|COMPLETED|6-month Add-on Therapy Period||45
6452198|NCT01156311|7367995|FG003|COMPLETED|6-month Add-on Therapy Period||37
6452199|NCT01156311|7367992|FG000|NOT COMPLETED|6-month Add-on Therapy Period||0
6452200|NCT01156311|7367993|FG001|NOT COMPLETED|6-month Add-on Therapy Period||0
6452201|NCT01156311|7367994|FG002|NOT COMPLETED|6-month Add-on Therapy Period||12
6452202|NCT01156311|7367995|FG003|NOT COMPLETED|6-month Add-on Therapy Period||10
6452203|NCT01156363|7368006|FG000|STARTED|Overall Study||86
6452204|NCT01156363|7368006|FG000|COMPLETED|Overall Study||64
6452205|NCT01156363|7368006|FG000|NOT COMPLETED|Overall Study||22
6452206|NCT01156376|7368020|FG000|STARTED|Overall Study||27
6452207|NCT01156376|7368021|FG001|STARTED|Overall Study||26
6452208|NCT01156376|7368022|FG002|STARTED|Overall Study||27
6452209|NCT01156376|7368020|FG000|COMPLETED|Overall Study||26
6452210|NCT01156376|7368021|FG001|COMPLETED|Overall Study||26
6452211|NCT01156376|7368022|FG002|COMPLETED|Overall Study||23
6452212|NCT01156376|7368020|FG000|NOT COMPLETED|Overall Study||1
6452213|NCT01156376|7368021|FG001|NOT COMPLETED|Overall Study||0
6452214|NCT01156376|7368022|FG002|NOT COMPLETED|Overall Study||4
6452215|NCT01156480|7368032|FG000|STARTED|Overall Study||0
6452216|NCT01156480|7368033|FG001|STARTED|Overall Study||2
6452217|NCT01156480|7368032|FG000|COMPLETED|Overall Study||0
6452218|NCT01156480|7368033|FG001|COMPLETED|Overall Study||1
6452219|NCT01156480|7368032|FG000|NOT COMPLETED|Overall Study||0
6452220|NCT01156480|7368033|FG001|NOT COMPLETED|Overall Study||1
6452221|NCT01156532|7368041|FG000|STARTED|Overall Study||30
6452222|NCT01156532|7368041|FG000|COMPLETED|Overall Study||28
6452223|NCT01156532|7368041|FG000|NOT COMPLETED|Overall Study||2
6452224|NCT01156571|7368047|FG000|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
6452225|NCT01156571|7368048|FG001|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
6452226|NCT01156571|7368047|FG000|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
6452227|NCT01156571|7368048|FG001|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
6452228|NCT01156571|7368047|FG000|NOT COMPLETED|Overall Study||17
6452229|NCT01156571|7368048|FG001|NOT COMPLETED|Overall Study||19
6452230|NCT01156597|7368056|FG000|STARTED|Overall Study||16
6452231|NCT01156597|7368057|FG001|STARTED|Overall Study||14
6452232|NCT01156597|7368056|FG000|COMPLETED|Overall Study||13
6452233|NCT01156597|7368057|FG001|COMPLETED|Overall Study||13
6452234|NCT01156597|7368056|FG000|NOT COMPLETED|Overall Study||3
6452235|NCT01156597|7368057|FG001|NOT COMPLETED|Overall Study||1
6452236|NCT01156675|7368067|FG000|STARTED|Overall Study||107
6452237|NCT01156675|7368068|FG001|STARTED|Overall Study||106
6452238|NCT01156675|7368069|FG002|STARTED|Overall Study||2
6452239|NCT01156675|7368067|FG000|COMPLETED|Overall Study||73
6452240|NCT01156675|7368068|FG001|COMPLETED|Overall Study||81
6452241|NCT01156675|7368069|FG002|COMPLETED|Overall Study||0
6745078|NCT03354598|7673163|FG000|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||147
6452242|NCT01156675|7368067|FG000|NOT COMPLETED|Overall Study||34
6452243|NCT01156675|7368068|FG001|NOT COMPLETED|Overall Study||25
6452244|NCT01156675|7368069|FG002|NOT COMPLETED|Overall Study||2
6452245|NCT01156701|7368078|FG000|STARTED|Overall Study||257
6452246|NCT01156701|7368079|FG001|STARTED|Overall Study||1007
6452247|NCT01156701|7368080|FG002|STARTED|Overall Study||163716
6452248|NCT01156701|7368081|FG003|STARTED|Overall Study||6725
6452249|NCT01156701|7368078|FG000|COMPLETED|Overall Study||257
6452250|NCT01156701|7368079|FG001|COMPLETED|Overall Study||1007
6452251|NCT01156701|7368080|FG002|COMPLETED|Overall Study||163716
6452252|NCT01156701|7368081|FG003|COMPLETED|Overall Study||6725
6452253|NCT01156701|7368078|FG000|NOT COMPLETED|Overall Study||0
6452254|NCT01156701|7368079|FG001|NOT COMPLETED|Overall Study||0
6452255|NCT01156701|7368080|FG002|NOT COMPLETED|Overall Study||0
6452256|NCT01156701|7368081|FG003|NOT COMPLETED|Overall Study||0
6452257|NCT01156714|7368094|FG000|STARTED|Overall Study||20
6452258|NCT01156714|7368095|FG001|STARTED|Overall Study||19
6452259|NCT01156714|7368096|FG002|STARTED|Overall Study||20
6452260|NCT01156714|7368094|FG000|COMPLETED|Overall Study||11
6452261|NCT01156714|7368095|FG001|COMPLETED|Overall Study||15
6452262|NCT01156714|7368096|FG002|COMPLETED|Overall Study||17
6452263|NCT01156714|7368094|FG000|NOT COMPLETED|Overall Study||9
6452264|NCT01156714|7368095|FG001|NOT COMPLETED|Overall Study||4
6452265|NCT01156714|7368096|FG002|NOT COMPLETED|Overall Study||3
6452266|NCT01156792|7368107|FG000|STARTED|Overall Study||162
6452267|NCT01156792|7368107|FG000|COMPLETED|Overall Study||93
6452268|NCT01156792|7368107|FG000|NOT COMPLETED|Overall Study||69
6452269|NCT01156805|7368124|FG000|STARTED|Overall Study||237
6452270|NCT01156805|7368125|FG001|STARTED|Overall Study||272
6452271|NCT01156805|7368124|FG000|COMPLETED|Overall Study||181
6452272|NCT01156805|7368125|FG001|COMPLETED|Overall Study||216
6452273|NCT01156805|7368124|FG000|NOT COMPLETED|Overall Study||56
6452274|NCT01156805|7368125|FG001|NOT COMPLETED|Overall Study||56
6452275|NCT01156844|7368135|FG000|STARTED|Overall Study|Randomized participants.|48
6452276|NCT01156844|7368136|FG001|STARTED|Overall Study||48
6452277|NCT01156844|7368137|FG002|STARTED|Overall Study||48
6452278|NCT01156844|7368138|FG003|STARTED|Overall Study||47
6452279|NCT01156844|7368135|FG000|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
6452280|NCT01156844|7368136|FG001|PD & Safety Sets: Received Study Drug|Overall Study||47
6452281|NCT01156844|7368137|FG002|PD & Safety Sets: Received Study Drug|Overall Study||48
6452282|NCT01156844|7368138|FG003|PD & Safety Sets: Received Study Drug|Overall Study||46
6452283|NCT01156844|7368135|FG000|COMPLETED|Overall Study||46
6452284|NCT01156844|7368136|FG001|COMPLETED|Overall Study||46
6452285|NCT01156844|7368137|FG002|COMPLETED|Overall Study||42
6452286|NCT01156844|7368138|FG003|COMPLETED|Overall Study||41
6452287|NCT01156844|7368135|FG000|NOT COMPLETED|Overall Study||2
6452288|NCT01156844|7368136|FG001|NOT COMPLETED|Overall Study||2
6452289|NCT01156844|7368137|FG002|NOT COMPLETED|Overall Study||6
6452290|NCT01156844|7368138|FG003|NOT COMPLETED|Overall Study||6
6452291|NCT01156987|7368153|FG000|STARTED|Overall Study||8
6452292|NCT01156987|7368154|FG001|STARTED|Overall Study||23
6452293|NCT01156987|7368153|FG000|COMPLETED|Overall Study||8
6452294|NCT01156987|7368154|FG001|COMPLETED|Overall Study||12
6452295|NCT01156987|7368153|FG000|NOT COMPLETED|Overall Study||0
6452296|NCT01156987|7368154|FG001|NOT COMPLETED|Overall Study||11
6452297|NCT01157065|7368162|FG000|STARTED|Overall Study||38
6452298|NCT01157065|7368163|FG001|STARTED|Overall Study||11
6452299|NCT01157065|7368162|FG000|COMPLETED|Overall Study||38
6452300|NCT01157065|7368163|FG001|COMPLETED|Overall Study||10
6452301|NCT01157065|7368162|FG000|NOT COMPLETED|Overall Study||0
6452302|NCT01157065|7368163|FG001|NOT COMPLETED|Overall Study||1
6452303|NCT01157078|7368171|FG000|STARTED|Overall Study||159
6452304|NCT01157078|7368172|FG001|STARTED|Overall Study||160
6452305|NCT01157078|7368171|FG000|Received Treatment|Overall Study||157
6452306|NCT01157078|7368172|FG001|Received Treatment|Overall Study||159
6452307|NCT01157078|7368171|FG000|COMPLETED|Overall Study||124
6452308|NCT01157078|7368172|FG001|COMPLETED|Overall Study||124
6452309|NCT01157078|7368171|FG000|NOT COMPLETED|Overall Study||35
6452310|NCT01157078|7368172|FG001|NOT COMPLETED|Overall Study||36
6452311|NCT01157117|7368181|FG000|STARTED|Overall Study||28
6452312|NCT01157117|7368182|FG001|STARTED|Overall Study||29
6452313|NCT01157117|7368183|FG002|STARTED|Overall Study||20
6452314|NCT01157117|7368181|FG000|Began Omalizumab or Placebo Dosing|Overall Study||27
6452315|NCT01157117|7368182|FG001|Began Omalizumab or Placebo Dosing|Overall Study||28
6452316|NCT01157117|7368183|FG002|Began Omalizumab or Placebo Dosing|Overall Study||0
6452317|NCT01157117|7368181|FG000|Began Milk OIT Dosing at Month 4|Overall Study||27
6452318|NCT01157117|7368182|FG001|Began Milk OIT Dosing at Month 4|Overall Study||28
6452319|NCT01157117|7368183|FG002|Began Milk OIT Dosing at Month 4|Overall Study||0
6452320|NCT01157117|7368181|FG000|Reached Milk OIT Maintenance Dosing|Overall Study||26
6452321|NCT01157117|7368182|FG001|Reached Milk OIT Maintenance Dosing|Overall Study||26
6452322|NCT01157117|7368183|FG002|Reached Milk OIT Maintenance Dosing|Overall Study||0
6452323|NCT01157117|7368181|FG000|Unblinded at Month 16|Overall Study||26
6452324|NCT01157117|7368182|FG001|Unblinded at Month 16|Overall Study||26
6452325|NCT01157117|7368183|FG002|Unblinded at Month 16|Overall Study||0
6452326|NCT01157117|7368181|FG000|Completed Month 28 Desensitization OFC|Overall Study||26
6452327|NCT01157117|7368182|FG001|Completed Month 28 Desensitization OFC|Overall Study||24
6452328|NCT01157117|7368183|FG002|Completed Month 28 Desensitization OFC|Overall Study||0
6452329|NCT01157117|7368181|FG000|Discontinued Milk OIT at Month 30|Overall Study||24
6452330|NCT01157117|7368182|FG001|Discontinued Milk OIT at Month 30|Overall Study||20
6452331|NCT01157117|7368183|FG002|Discontinued Milk OIT at Month 30|Overall Study||0
6452332|NCT01157117|7368181|FG000|Completed Month 32 Tolerance OFC|Overall Study||24
6452333|NCT01157117|7368182|FG001|Completed Month 32 Tolerance OFC|Overall Study||20
6452334|NCT01157117|7368183|FG002|Completed Month 32 Tolerance OFC|Overall Study||0
6452335|NCT01157117|7368181|FG000|Completed Final Month 38 Study Visit|Overall Study||19
6452336|NCT01157117|7368182|FG001|Completed Final Month 38 Study Visit|Overall Study||18
6452337|NCT01157117|7368183|FG002|Completed Final Month 38 Study Visit|Overall Study||3
6452338|NCT01157117|7368181|FG000|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
6452339|NCT01157117|7368182|FG001|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
6452340|NCT01157117|7368183|FG002|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
6452341|NCT01157117|7368181|FG000|NOT COMPLETED|Overall Study||9
6452342|NCT01157117|7368182|FG001|NOT COMPLETED|Overall Study||11
6452343|NCT01157117|7368183|FG002|NOT COMPLETED|Overall Study||15
6452344|NCT01157169|7368193|FG000|STARTED|First Intervention||20
6452345|NCT01157169|7368194|FG001|STARTED|First Intervention||20
6452346|NCT01157169|7368193|FG000|COMPLETED|First Intervention||16
6452347|NCT01157169|7368194|FG001|COMPLETED|First Intervention||18
6452348|NCT01157169|7368193|FG000|NOT COMPLETED|First Intervention||4
6452349|NCT01157169|7368194|FG001|NOT COMPLETED|First Intervention||2
6452350|NCT01157169|7368193|FG000|STARTED|Washout of 10 Days||16
6452351|NCT01157169|7368194|FG001|STARTED|Washout of 10 Days||18
6452352|NCT01157169|7368193|FG000|COMPLETED|Washout of 10 Days||16
6452353|NCT01157169|7368194|FG001|COMPLETED|Washout of 10 Days||18
6452354|NCT01157169|7368193|FG000|NOT COMPLETED|Washout of 10 Days||0
6452355|NCT01157169|7368194|FG001|NOT COMPLETED|Washout of 10 Days||0
6452356|NCT01157169|7368193|FG000|STARTED|Second Intervention||16
6452357|NCT01157169|7368194|FG001|STARTED|Second Intervention||18
6452358|NCT01157169|7368193|FG000|COMPLETED|Second Intervention||16
6452359|NCT01157169|7368194|FG001|COMPLETED|Second Intervention||17
6452360|NCT01157169|7368193|FG000|NOT COMPLETED|Second Intervention||0
6452361|NCT01157169|7368194|FG001|NOT COMPLETED|Second Intervention||1
6452362|NCT01157182|7368202|FG000|STARTED|First Intervention||18
6452363|NCT01157182|7368203|FG001|STARTED|First Intervention||18
6452364|NCT01157182|7368202|FG000|COMPLETED|First Intervention||18
6452365|NCT01157182|7368203|FG001|COMPLETED|First Intervention||18
6452366|NCT01157182|7368202|FG000|NOT COMPLETED|First Intervention||0
6452367|NCT01157182|7368203|FG001|NOT COMPLETED|First Intervention||0
6452368|NCT01157182|7368202|FG000|STARTED|Washout of 28 Days||18
6452369|NCT01157182|7368203|FG001|STARTED|Washout of 28 Days||18
6452370|NCT01157182|7368202|FG000|COMPLETED|Washout of 28 Days||16
6452371|NCT01157182|7368203|FG001|COMPLETED|Washout of 28 Days||18
6452372|NCT01157182|7368202|FG000|NOT COMPLETED|Washout of 28 Days||2
6452373|NCT01157182|7368203|FG001|NOT COMPLETED|Washout of 28 Days||0
6452374|NCT01157182|7368202|FG000|STARTED|Second Intervention||16
6452375|NCT01157182|7368203|FG001|STARTED|Second Intervention||18
6452376|NCT01157182|7368202|FG000|COMPLETED|Second Intervention||16
6452377|NCT01157182|7368203|FG001|COMPLETED|Second Intervention||18
6452378|NCT01157182|7368202|FG000|NOT COMPLETED|Second Intervention||0
6452379|NCT01157182|7368203|FG001|NOT COMPLETED|Second Intervention||0
6452380|NCT01157234|7368211|FG000|STARTED|Overall Study||15
6452381|NCT01157234|7368212|FG001|STARTED|Overall Study||15
6452382|NCT01157234|7368211|FG000|COMPLETED|Overall Study||14
6452383|NCT01157234|7368212|FG001|COMPLETED|Overall Study||15
6452384|NCT01157234|7368211|FG000|NOT COMPLETED|Overall Study||1
6452385|NCT01157234|7368212|FG001|NOT COMPLETED|Overall Study||0
6452386|NCT01157351|7368227|FG000|STARTED|Overall Study||230
6452387|NCT01157351|7368228|FG001|STARTED|Overall Study||220
6452388|NCT01157351|7368227|FG000|Treated|Overall Study||226
6452389|NCT01157351|7368228|FG001|Treated|Overall Study||218
6452390|NCT01157351|7368227|FG000|COMPLETED|Overall Study||93
6452391|NCT01157351|7368228|FG001|COMPLETED|Overall Study||88
6452392|NCT01157351|7368227|FG000|NOT COMPLETED|Overall Study||137
6452393|NCT01157351|7368228|FG001|NOT COMPLETED|Overall Study||132
6452394|NCT01157364|7368240|FG000|STARTED|Overall Study||15
6452395|NCT01157364|7368241|FG001|STARTED|Overall Study||21
6452396|NCT01157364|7368242|FG002|STARTED|Overall Study||21
6452397|NCT01157364|7368243|FG003|STARTED|Overall Study||18
6452398|NCT01157364|7368244|FG004|STARTED|Overall Study||11
6452399|NCT01157364|7368245|FG005|STARTED|Overall Study||23
6452400|NCT01157364|7368240|FG000|COMPLETED|Overall Study||13
6452401|NCT01157364|7368241|FG001|COMPLETED|Overall Study||17
6452402|NCT01157364|7368242|FG002|COMPLETED|Overall Study||17
6452403|NCT01157364|7368243|FG003|COMPLETED|Overall Study||16
6452404|NCT01157364|7368244|FG004|COMPLETED|Overall Study||9
6452405|NCT01157364|7368245|FG005|COMPLETED|Overall Study||22
6452406|NCT01157364|7368240|FG000|NOT COMPLETED|Overall Study||2
6452407|NCT01157364|7368241|FG001|NOT COMPLETED|Overall Study||4
6452408|NCT01157364|7368242|FG002|NOT COMPLETED|Overall Study||4
6452409|NCT01157364|7368243|FG003|NOT COMPLETED|Overall Study||2
6452410|NCT01157364|7368244|FG004|NOT COMPLETED|Overall Study||2
6452411|NCT01157364|7368245|FG005|NOT COMPLETED|Overall Study||1
6452412|NCT01157377|7368266|FG000|STARTED|Overall Study||23
6452413|NCT01157377|7368267|FG001|STARTED|Overall Study||23
6452414|NCT01157377|7368268|FG002|STARTED|Overall Study||27
6452415|NCT01157377|7368269|FG003|STARTED|Overall Study||15
6452416|NCT01157377|7368270|FG004|STARTED|Overall Study||20
6745079|NCT03354598|7673164|FG001|Microbiologic Modified Intent to Treat Resistant (Micro-MITTR) Participants|Overall Study||139
6745080|NCT03354598|7673163|FG000|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||370
6745081|NCT03354598|7673164|FG001|Microbiologic Modified Intent to Treat Susceptible (Micro-MITTS) Participants|Overall Study||415
6452417|NCT01157377|7368271|FG005|STARTED|Overall Study||19
6452418|NCT01157377|7368272|FG006|STARTED|Overall Study||29
6452419|NCT01157377|7368266|FG000|COMPLETED|Overall Study||21
6452420|NCT01157377|7368267|FG001|COMPLETED|Overall Study||20
6452421|NCT01157377|7368268|FG002|COMPLETED|Overall Study||26
6452422|NCT01157377|7368269|FG003|COMPLETED|Overall Study||14
6452423|NCT01157377|7368270|FG004|COMPLETED|Overall Study||18
6452424|NCT01157377|7368271|FG005|COMPLETED|Overall Study||16
6452425|NCT01157377|7368272|FG006|COMPLETED|Overall Study||27
6452426|NCT01157377|7368266|FG000|NOT COMPLETED|Overall Study||2
6452427|NCT01157377|7368267|FG001|NOT COMPLETED|Overall Study||3
6452428|NCT01157377|7368268|FG002|NOT COMPLETED|Overall Study||1
6452429|NCT01157377|7368269|FG003|NOT COMPLETED|Overall Study||1
6452430|NCT01157377|7368270|FG004|NOT COMPLETED|Overall Study||2
6452431|NCT01157377|7368271|FG005|NOT COMPLETED|Overall Study||3
6452432|NCT01157377|7368272|FG006|NOT COMPLETED|Overall Study||2
6452433|NCT01157416|7368290|FG000|STARTED|Overall Study||17
6452434|NCT01157416|7368291|FG001|STARTED|Overall Study||16
6452435|NCT01157416|7368290|FG000|COMPLETED|Overall Study||15
6452436|NCT01157416|7368291|FG001|COMPLETED|Overall Study||16
6452437|NCT01157416|7368290|FG000|NOT COMPLETED|Overall Study||2
6452438|NCT01157416|7368291|FG001|NOT COMPLETED|Overall Study||0
6452439|NCT01157429|7368299|FG000|STARTED|Overall Study||12
6452440|NCT01157429|7368300|FG001|STARTED|Overall Study||12
6452441|NCT01157429|7368299|FG000|COMPLETED|Overall Study||8
6452442|NCT01157429|7368300|FG001|COMPLETED|Overall Study||8
6452443|NCT01157429|7368299|FG000|NOT COMPLETED|Overall Study||4
6452444|NCT01157429|7368300|FG001|NOT COMPLETED|Overall Study||4
6452445|NCT01157676|7368308|FG000|STARTED|Enrollment||174
6452446|NCT01157676|7368309|FG001|STARTED|Enrollment||176
6452447|NCT01157676|7368308|FG000|COMPLETED|Enrollment||174
6452448|NCT01157676|7368309|FG001|COMPLETED|Enrollment||176
6452449|NCT01157676|7368308|FG000|NOT COMPLETED|Enrollment||0
6452450|NCT01157676|7368309|FG001|NOT COMPLETED|Enrollment||0
6452451|NCT01157676|7368308|FG000|STARTED|Randomization||174
6452452|NCT01157676|7368309|FG001|STARTED|Randomization||176
6452453|NCT01157676|7368308|FG000|COMPLETED|Randomization||153
6452454|NCT01157676|7368309|FG001|COMPLETED|Randomization||159
6452455|NCT01157676|7368308|FG000|NOT COMPLETED|Randomization||21
6452456|NCT01157676|7368309|FG001|NOT COMPLETED|Randomization||17
6452457|NCT01157676|7368308|FG000|STARTED|Surgery||153
6452458|NCT01157676|7368309|FG001|STARTED|Surgery||159
6452459|NCT01157676|7368308|FG000|COMPLETED|Surgery||152
6452460|NCT01157676|7368309|FG001|COMPLETED|Surgery|advanced disease=2, inadequate visualization=1, inability to tolerate position=1, colonic mass=1.|150
6452461|NCT01157676|7368308|FG000|NOT COMPLETED|Surgery||1
6452462|NCT01157676|7368309|FG001|NOT COMPLETED|Surgery||9
6500482|NCT01424670|7419170|FG000|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||341
6500483|NCT01424670|7419171|FG001|Received at Least 1 Dose of Study Drug|6-Month Intensive Period (182 Days)||170
6500484|NCT01424670|7419170|FG000|COMPLETED|6-Month Intensive Period (182 Days)||322
6500485|NCT01424670|7419171|FG001|COMPLETED|6-Month Intensive Period (182 Days)||156
6500486|NCT01424670|7419170|FG000|NOT COMPLETED|6-Month Intensive Period (182 Days)||19
6500487|NCT01424670|7419171|FG001|NOT COMPLETED|6-Month Intensive Period (182 Days)||14
6500488|NCT01424670|7419170|FG000|STARTED|Continuation Period||322
6500489|NCT01424670|7419171|FG001|STARTED|Continuation Period||156
6500490|NCT01424670|7419170|FG000|COMPLETED|Continuation Period||288
6452463|NCT01157845|7368321|FG000|STARTED|Overall Study||165
6452464|NCT01157845|7368321|FG000|COMPLETED|Overall Study||130
6452465|NCT01157845|7368321|FG000|NOT COMPLETED|Overall Study||35
6452466|NCT01157897|7368329|FG000|STARTED|Overall Study||10
6452467|NCT01157897|7368330|FG001|STARTED|Overall Study||10
6452468|NCT01157897|7368331|FG002|STARTED|Overall Study||10
6452469|NCT01157897|7368332|FG003|STARTED|Overall Study||6
6452470|NCT01157897|7368329|FG000|COMPLETED|Overall Study||8
6452471|NCT01157897|7368330|FG001|COMPLETED|Overall Study||8
6452472|NCT01157897|7368331|FG002|COMPLETED|Overall Study||10
6452473|NCT01157897|7368332|FG003|COMPLETED|Overall Study||5
6452474|NCT01157897|7368329|FG000|NOT COMPLETED|Overall Study||2
6452475|NCT01157897|7368330|FG001|NOT COMPLETED|Overall Study||2
6452476|NCT01157897|7368331|FG002|NOT COMPLETED|Overall Study||0
6452477|NCT01157897|7368332|FG003|NOT COMPLETED|Overall Study||1
6452478|NCT01158118|7368344|FG000|STARTED|Overall Study||24
6452479|NCT01158118|7368345|FG001|STARTED|Overall Study||24
6452480|NCT01158118|7368344|FG000|COMPLETED|Overall Study||23
6452481|NCT01158118|7368345|FG001|COMPLETED|Overall Study||21
6452482|NCT01158118|7368344|FG000|NOT COMPLETED|Overall Study||1
6452483|NCT01158118|7368345|FG001|NOT COMPLETED|Overall Study||3
6452484|NCT01158157|7368351|FG000|STARTED|Overall Study|61 subjects screened; 25 subjects were vaccinated; 36 subjects were not eligible.|25
6452485|NCT01158157|7368351|FG000|COMPLETED|Overall Study||25
6452486|NCT01158157|7368351|FG000|NOT COMPLETED|Overall Study||0
6452487|NCT01158222|7368355|FG000|STARTED|Overall Study||37
6452488|NCT01158222|7368355|FG000|COMPLETED|Overall Study||20
6452489|NCT01158222|7368355|FG000|NOT COMPLETED|Overall Study||17
6452490|NCT01158261|7368359|FG000|STARTED|Overall Study||300
6452491|NCT01158261|7368359|FG000|COMPLETED|Overall Study||283
6452492|NCT01158261|7368359|FG000|NOT COMPLETED|Overall Study||17
6452493|NCT01158378|7368365|FG000|STARTED|Overall Study||124
6452494|NCT01158378|7368366|FG001|STARTED|Overall Study||126
6452495|NCT01158378|7368365|FG000|COMPLETED|Overall Study||114
6452496|NCT01158378|7368366|FG001|COMPLETED|Overall Study||117
6452497|NCT01158378|7368365|FG000|NOT COMPLETED|Overall Study||10
6452498|NCT01158378|7368366|FG001|NOT COMPLETED|Overall Study||9
6452499|NCT01158404|7368381|FG000|STARTED|Overall Study||3
6452500|NCT01158404|7368382|FG001|STARTED|Overall Study||4
6452501|NCT01158404|7368383|FG002|STARTED|Overall Study||3
6452502|NCT01158404|7368384|FG003|STARTED|Overall Study||3
6452503|NCT01158404|7368385|FG004|STARTED|Overall Study||6
6452504|NCT01158404|7368386|FG005|STARTED|Overall Study||5
6452505|NCT01158404|7368387|FG006|STARTED|Overall Study||3
6452506|NCT01158404|7368388|FG007|STARTED|Overall Study||8
6452507|NCT01158404|7368381|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6452508|NCT01158404|7368382|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
6452509|NCT01158404|7368383|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6452510|NCT01158404|7368384|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6452511|NCT01158404|7368385|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
6452512|NCT01158404|7368386|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
6452513|NCT01158404|7368387|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
6452514|NCT01158404|7368388|FG007|Received at Least 1 Dose of Study Drug|Overall Study||8
6452515|NCT01158404|7368381|FG000|COMPLETED|Overall Study||3
6452516|NCT01158404|7368382|FG001|COMPLETED|Overall Study||3
6452517|NCT01158404|7368383|FG002|COMPLETED|Overall Study||3
6452518|NCT01158404|7368384|FG003|COMPLETED|Overall Study||3
6452519|NCT01158404|7368385|FG004|COMPLETED|Overall Study||3
6452520|NCT01158404|7368386|FG005|COMPLETED|Overall Study||4
6452521|NCT01158404|7368387|FG006|COMPLETED|Overall Study||2
6452522|NCT01158404|7368388|FG007|COMPLETED|Overall Study||6
6452523|NCT01158404|7368381|FG000|NOT COMPLETED|Overall Study||0
6452524|NCT01158404|7368382|FG001|NOT COMPLETED|Overall Study||1
6452525|NCT01158404|7368383|FG002|NOT COMPLETED|Overall Study||0
6452526|NCT01158404|7368384|FG003|NOT COMPLETED|Overall Study||0
6452527|NCT01158404|7368385|FG004|NOT COMPLETED|Overall Study||3
6452528|NCT01158404|7368386|FG005|NOT COMPLETED|Overall Study||1
6452529|NCT01158404|7368387|FG006|NOT COMPLETED|Overall Study||1
6452530|NCT01158404|7368388|FG007|NOT COMPLETED|Overall Study||2
6452531|NCT01158521|7368408|FG000|STARTED|Overall Study||25
6452532|NCT01158521|7368408|FG000|COMPLETED|Overall Study||25
6452533|NCT01158521|7368408|FG000|NOT COMPLETED|Overall Study||0
6452534|NCT01158534|7368414|FG000|STARTED|Overall Study||17
6452535|NCT01158534|7368414|FG000|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
6452536|NCT01158534|7368414|FG000|NOT COMPLETED|Overall Study||3
6452537|NCT01158573|7368422|FG000|STARTED|Overall Study|Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only|30
6452538|NCT01158573|7368423|FG001|STARTED|Overall Study||30
6452539|NCT01158573|7368424|FG002|STARTED|Overall Study||29
6452540|NCT01158573|7368425|FG003|STARTED|Overall Study||28
6452541|NCT01158573|7368422|FG000|COMPLETED|Overall Study|Study completed at 117 subjects.|30
6452542|NCT01158573|7368423|FG001|COMPLETED|Overall Study||30
6452543|NCT01158573|7368424|FG002|COMPLETED|Overall Study||29
6452544|NCT01158573|7368425|FG003|COMPLETED|Overall Study||28
6452545|NCT01158573|7368422|FG000|NOT COMPLETED|Overall Study||0
6452546|NCT01158573|7368423|FG001|NOT COMPLETED|Overall Study||0
6452547|NCT01158573|7368424|FG002|NOT COMPLETED|Overall Study||0
6452548|NCT01158573|7368425|FG003|NOT COMPLETED|Overall Study||0
6452549|NCT01158651|7368435|FG000|STARTED|Overall Study||23
6452550|NCT01158651|7368435|FG000|COMPLETED|Overall Study||22
6452551|NCT01158651|7368435|FG000|NOT COMPLETED|Overall Study||1
6452552|NCT01158703|7368441|FG000|STARTED|Overall Study||12
6452553|NCT01158703|7368442|FG001|STARTED|Overall Study||8
6452554|NCT01158703|7368441|FG000|COMPLETED|Overall Study||12
6452555|NCT01158703|7368442|FG001|COMPLETED|Overall Study||8
6452556|NCT01158703|7368441|FG000|NOT COMPLETED|Overall Study||0
6452557|NCT01158703|7368442|FG001|NOT COMPLETED|Overall Study||0
6452558|NCT01158716|7368450|FG000|STARTED|Overall Study||48
6452559|NCT01158716|7368451|FG001|STARTED|Overall Study||48
6452560|NCT01158716|7368450|FG000|COMPLETED|Overall Study||47
6452561|NCT01158716|7368451|FG001|COMPLETED|Overall Study||47
6452562|NCT01158716|7368450|FG000|NOT COMPLETED|Overall Study||1
6452563|NCT01158716|7368451|FG001|NOT COMPLETED|Overall Study||1
6452564|NCT01158820|7368459|FG000|STARTED|Overall Study||25
6452565|NCT01158820|7368460|FG001|STARTED|Overall Study||25
6452566|NCT01158820|7368459|FG000|COMPLETED|Overall Study||25
6452567|NCT01158820|7368460|FG001|COMPLETED|Overall Study||25
6452568|NCT01158820|7368459|FG000|NOT COMPLETED|Overall Study||0
6452569|NCT01158820|7368460|FG001|NOT COMPLETED|Overall Study||0
6452570|NCT01158885|7368467|FG000|STARTED|Treatment Course 1||2
6452571|NCT01158885|7368467|FG000|COMPLETED|Treatment Course 1||2
6452572|NCT01158885|7368467|FG000|NOT COMPLETED|Treatment Course 1||0
6452573|NCT01158885|7368467|FG000|STARTED|Treatment Course 2|Neither of the patients that were treated on Treatment Course 1 were eligible to proceed to Course 2|0
6452574|NCT01158885|7368467|FG000|COMPLETED|Treatment Course 2||0
6452575|NCT01158885|7368467|FG000|NOT COMPLETED|Treatment Course 2||0
6452576|NCT01158924|7368473|FG000|STARTED|Overall Study||14
6452577|NCT01158924|7368474|FG001|STARTED|Overall Study||26
6452578|NCT01158924|7368473|FG000|COMPLETED|Overall Study||13
6452579|NCT01158924|7368474|FG001|COMPLETED|Overall Study||23
6452580|NCT01158924|7368473|FG000|NOT COMPLETED|Overall Study||1
6452581|NCT01158924|7368474|FG001|NOT COMPLETED|Overall Study||3
6452582|NCT01158950|7368480|FG000|STARTED|1st Intervention (1 Day)||13
6452583|NCT01158950|7368481|FG001|STARTED|1st Intervention (1 Day)||13
6452584|NCT01158950|7368480|FG000|Data Collected|1st Intervention (1 Day)||12
6452585|NCT01158950|7368481|FG001|Data Collected|1st Intervention (1 Day)||11
6452586|NCT01158950|7368480|FG000|COMPLETED|1st Intervention (1 Day)||12
6452587|NCT01158950|7368481|FG001|COMPLETED|1st Intervention (1 Day)||11
6452588|NCT01158950|7368480|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
6452589|NCT01158950|7368481|FG001|NOT COMPLETED|1st Intervention (1 Day)||2
6452590|NCT01158950|7368480|FG000|STARTED|Washout (1 Week)||12
6452591|NCT01158950|7368481|FG001|STARTED|Washout (1 Week)||11
6452592|NCT01158950|7368480|FG000|COMPLETED|Washout (1 Week)||12
6452593|NCT01158950|7368481|FG001|COMPLETED|Washout (1 Week)||11
6452594|NCT01158950|7368480|FG000|NOT COMPLETED|Washout (1 Week)||0
6452595|NCT01158950|7368481|FG001|NOT COMPLETED|Washout (1 Week)||0
6452596|NCT01158950|7368480|FG000|STARTED|2nd Intervention (1 Day)||12
6452597|NCT01158950|7368481|FG001|STARTED|2nd Intervention (1 Day)||11
6452598|NCT01158950|7368480|FG000|COMPLETED|2nd Intervention (1 Day)||12
6452599|NCT01158950|7368481|FG001|COMPLETED|2nd Intervention (1 Day)||11
6452600|NCT01158950|7368480|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
6452601|NCT01158950|7368481|FG001|NOT COMPLETED|2nd Intervention (1 Day)||0
6452602|NCT01158976|7368488|FG000|STARTED|Overall Study||43
6452603|NCT01158976|7368489|FG001|STARTED|Overall Study||21
6452604|NCT01158976|7368488|FG000|COMPLETED|Overall Study||34
6452605|NCT01158976|7368489|FG001|COMPLETED|Overall Study||17
6452606|NCT01158976|7368488|FG000|NOT COMPLETED|Overall Study||9
6452607|NCT01158976|7368489|FG001|NOT COMPLETED|Overall Study||4
6452608|NCT01159015|7368497|FG000|STARTED|Overall Study||357
6452609|NCT01159015|7368498|FG001|STARTED|Overall Study||177
6452610|NCT01159015|7368497|FG000|COMPLETED|Overall Study||339
6452611|NCT01159015|7368498|FG001|COMPLETED|Overall Study||170
6452612|NCT01159015|7368497|FG000|NOT COMPLETED|Overall Study||18
6452613|NCT01159015|7368498|FG001|NOT COMPLETED|Overall Study||7
6452614|NCT01159054|7368504|FG000|STARTED|Overall Study||22
6452615|NCT01159054|7368504|FG000|COMPLETED|Overall Study||2
6452616|NCT01159054|7368504|FG000|NOT COMPLETED|Overall Study||20
6452617|NCT01159067|7368508|FG000|STARTED|Overall Study||1
6452618|NCT01159067|7368508|FG000|COMPLETED|Overall Study||1
6452619|NCT01159067|7368508|FG000|NOT COMPLETED|Overall Study||0
6452620|NCT01159171|7368512|FG000|STARTED|Overall Study||50
6452621|NCT01159171|7368512|FG000|COMPLETED|Overall Study||0
6452622|NCT01159171|7368512|FG000|NOT COMPLETED|Overall Study||50
6452623|NCT01159262|7368520|FG000|STARTED|Overall Study||14
6452624|NCT01159262|7368521|FG001|STARTED|Overall Study||14
6452625|NCT01159262|7368522|FG002|STARTED|Overall Study||8
6452626|NCT01159262|7368520|FG000|COMPLETED|Overall Study||14
6452627|NCT01159262|7368521|FG001|COMPLETED|Overall Study||14
6452628|NCT01159262|7368522|FG002|COMPLETED|Overall Study||8
6452629|NCT01159262|7368520|FG000|NOT COMPLETED|Overall Study||0
6452630|NCT01159262|7368521|FG001|NOT COMPLETED|Overall Study||0
6452631|NCT01159262|7368522|FG002|NOT COMPLETED|Overall Study||0
6452632|NCT01159431|7368532|FG000|STARTED|Overall Study||25
6452633|NCT01159431|7368533|FG001|STARTED|Overall Study||25
6452634|NCT01159431|7368532|FG000|COMPLETED|Overall Study||23
6452635|NCT01159431|7368533|FG001|COMPLETED|Overall Study||19
6452636|NCT01159431|7368532|FG000|NOT COMPLETED|Overall Study||2
6452637|NCT01159431|7368533|FG001|NOT COMPLETED|Overall Study||6
6452638|NCT01159535|7368549|FG000|STARTED|Overall Study||103
6452639|NCT01159535|7368550|FG001|STARTED|Overall Study||88
6452640|NCT01159535|7368551|FG002|STARTED|Overall Study||95
6553449|NCT01743677|7475927|FG000|NOT COMPLETED|Second Intervention Period||0
6553450|NCT01743677|7475928|FG001|NOT COMPLETED|Second Intervention Period||0
6553451|NCT01743677|7475929|FG002|NOT COMPLETED|Second Intervention Period||0
6553452|NCT01743677|7475930|FG003|NOT COMPLETED|Second Intervention Period||0
6553453|NCT01743677|7475931|FG004|NOT COMPLETED|Second Intervention Period||0
6553454|NCT01743677|7475932|FG005|NOT COMPLETED|Second Intervention Period||0
6553455|NCT01743677|7475927|FG000|STARTED|Washout Period 2 (at Least 7 Days)||10
6553456|NCT01743677|7475928|FG001|STARTED|Washout Period 2 (at Least 7 Days)||10
6553457|NCT01743677|7475929|FG002|STARTED|Washout Period 2 (at Least 7 Days)||10
6553458|NCT01743677|7475930|FG003|STARTED|Washout Period 2 (at Least 7 Days)||10
6553459|NCT01743677|7475931|FG004|STARTED|Washout Period 2 (at Least 7 Days)||10
6553460|NCT01743677|7475932|FG005|STARTED|Washout Period 2 (at Least 7 Days)||10
6553461|NCT01743677|7475927|FG000|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6553462|NCT01743677|7475928|FG001|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6553463|NCT01743677|7475929|FG002|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6553464|NCT01743677|7475930|FG003|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6553465|NCT01743677|7475931|FG004|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6553466|NCT01743677|7475932|FG005|COMPLETED|Washout Period 2 (at Least 7 Days)||10
6553467|NCT01743677|7475927|FG000|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6553468|NCT01743677|7475928|FG001|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6553469|NCT01743677|7475929|FG002|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6553470|NCT01743677|7475930|FG003|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6553471|NCT01743677|7475931|FG004|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6553472|NCT01743677|7475932|FG005|NOT COMPLETED|Washout Period 2 (at Least 7 Days)||0
6553473|NCT01743677|7475927|FG000|STARTED|Third Intervention Period||10
6553474|NCT01743677|7475928|FG001|STARTED|Third Intervention Period||10
6553475|NCT01743677|7475929|FG002|STARTED|Third Intervention Period||10
6553476|NCT01743677|7475930|FG003|STARTED|Third Intervention Period||10
6553477|NCT01743677|7475931|FG004|STARTED|Third Intervention Period||10
6553478|NCT01743677|7475932|FG005|STARTED|Third Intervention Period||10
6452641|NCT01159535|7368549|FG000|COMPLETED|Overall Study||79
6452642|NCT01159535|7368550|FG001|COMPLETED|Overall Study||64
6452643|NCT01159535|7368551|FG002|COMPLETED|Overall Study||64
6452644|NCT01159535|7368549|FG000|NOT COMPLETED|Overall Study||24
6452645|NCT01159535|7368550|FG001|NOT COMPLETED|Overall Study||24
6452646|NCT01159535|7368551|FG002|NOT COMPLETED|Overall Study||31
6452647|NCT01159574|7368559|FG000|STARTED|Treatment Phase||121
6452648|NCT01159574|7368559|FG000|COMPLETED|Treatment Phase||100
6452649|NCT01159574|7368559|FG000|NOT COMPLETED|Treatment Phase||21
6452650|NCT01159574|7368559|FG000|STARTED|Follow Up Phase||112
6452651|NCT01159574|7368559|FG000|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
6452652|NCT01159574|7368559|FG000|NOT COMPLETED|Follow Up Phase||20
6452653|NCT01159600|7368571|FG000|STARTED|Overall Study||207
6452654|NCT01159600|7368572|FG001|STARTED|Overall Study||217
6452655|NCT01159600|7368573|FG002|STARTED|Overall Study||214
6452656|NCT01159600|7368574|FG003|STARTED|Overall Study||69
6452657|NCT01159600|7368575|FG004|STARTED|Overall Study||225
6452658|NCT01159600|7368576|FG005|STARTED|Overall Study||226
6452659|NCT01159600|7368577|FG006|STARTED|Overall Study||218
6452660|NCT01159600|7368578|FG007|STARTED|Overall Study||103
6452661|NCT01159600|7368571|FG000|COMPLETED|Overall Study||186
6452662|NCT01159600|7368572|FG001|COMPLETED|Overall Study||209
6452663|NCT01159600|7368573|FG002|COMPLETED|Overall Study||196
6452664|NCT01159600|7368574|FG003|COMPLETED|Overall Study||58
6452665|NCT01159600|7368575|FG004|COMPLETED|Overall Study||201
6452666|NCT01159600|7368576|FG005|COMPLETED|Overall Study||208
6452667|NCT01159600|7368577|FG006|COMPLETED|Overall Study||199
6452668|NCT01159600|7368578|FG007|COMPLETED|Overall Study||85
6452669|NCT01159600|7368571|FG000|NOT COMPLETED|Overall Study||21
6452670|NCT01159600|7368572|FG001|NOT COMPLETED|Overall Study||8
6452671|NCT01159600|7368573|FG002|NOT COMPLETED|Overall Study||18
6452672|NCT01159600|7368574|FG003|NOT COMPLETED|Overall Study||11
6452673|NCT01159600|7368575|FG004|NOT COMPLETED|Overall Study||24
6452674|NCT01159600|7368576|FG005|NOT COMPLETED|Overall Study||18
6553479|NCT01743677|7475927|FG000|COMPLETED|Third Intervention Period||10
6553480|NCT01743677|7475928|FG001|COMPLETED|Third Intervention Period||10
6553481|NCT01743677|7475929|FG002|COMPLETED|Third Intervention Period||10
6452675|NCT01159600|7368577|FG006|NOT COMPLETED|Overall Study||19
6452676|NCT01159600|7368578|FG007|NOT COMPLETED|Overall Study||18
6452677|NCT01159665|7368603|FG000|STARTED|Overall Study||9
6452678|NCT01159665|7368604|FG001|STARTED|Overall Study||9
6452679|NCT01159665|7368605|FG002|STARTED|Overall Study||8
6452680|NCT01159665|7368606|FG003|STARTED|Overall Study||4
6452681|NCT01159665|7368607|FG004|STARTED|Overall Study||4
6452682|NCT01159665|7368608|FG005|STARTED|Overall Study||4
6452683|NCT01159665|7368603|FG000|COMPLETED|Overall Study||9
6452684|NCT01159665|7368604|FG001|COMPLETED|Overall Study||8
6452685|NCT01159665|7368605|FG002|COMPLETED|Overall Study||8
6452686|NCT01159665|7368606|FG003|COMPLETED|Overall Study||4
6452687|NCT01159665|7368607|FG004|COMPLETED|Overall Study||4
6452688|NCT01159665|7368608|FG005|COMPLETED|Overall Study||4
6452689|NCT01159665|7368603|FG000|NOT COMPLETED|Overall Study||0
6452690|NCT01159665|7368604|FG001|NOT COMPLETED|Overall Study||1
6452691|NCT01159665|7368605|FG002|NOT COMPLETED|Overall Study||0
6452692|NCT01159665|7368606|FG003|NOT COMPLETED|Overall Study||0
6452693|NCT01159665|7368607|FG004|NOT COMPLETED|Overall Study||0
6452694|NCT01159665|7368608|FG005|NOT COMPLETED|Overall Study||0
6452695|NCT01159691|7368622|FG000|STARTED|Overall Study||76
6452696|NCT01159691|7368622|FG000|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
6452697|NCT01159691|7368622|FG000|NOT COMPLETED|Overall Study||22
6452698|NCT01159743|7368628|FG000|STARTED|Overall Study||237
6452699|NCT01159743|7368629|FG001|STARTED|Overall Study||109
6452700|NCT01159743|7368628|FG000|COMPLETED|Overall Study||237
6452701|NCT01159743|7368629|FG001|COMPLETED|Overall Study||109
6452702|NCT01159743|7368628|FG000|NOT COMPLETED|Overall Study||0
6452703|NCT01159743|7368629|FG001|NOT COMPLETED|Overall Study||0
6452704|NCT01159769|7368635|FG000|STARTED|Overall Study||215
6452705|NCT01159769|7368635|FG000|COMPLETED|Overall Study||214
6452706|NCT01159769|7368635|FG000|NOT COMPLETED|Overall Study||1
6452707|NCT01159912|7368642|FG000|STARTED|Overall Study||115
6452708|NCT01159912|7368643|FG001|STARTED|Overall Study||114
6452709|NCT01159912|7368644|FG002|STARTED|Overall Study||114
6553482|NCT01743677|7475930|FG003|COMPLETED|Third Intervention Period||10
6553483|NCT01743677|7475931|FG004|COMPLETED|Third Intervention Period||10
6553484|NCT01743677|7475932|FG005|COMPLETED|Third Intervention Period||10
6553485|NCT01743677|7475927|FG000|NOT COMPLETED|Third Intervention Period||0
6553486|NCT01743677|7475928|FG001|NOT COMPLETED|Third Intervention Period||0
6553487|NCT01743677|7475929|FG002|NOT COMPLETED|Third Intervention Period||0
6452710|NCT01159912|7368642|FG000|COMPLETED|Overall Study||75
6452711|NCT01159912|7368643|FG001|COMPLETED|Overall Study||92
6452712|NCT01159912|7368644|FG002|COMPLETED|Overall Study||88
6452713|NCT01159912|7368642|FG000|NOT COMPLETED|Overall Study||40
6452714|NCT01159912|7368643|FG001|NOT COMPLETED|Overall Study||22
6745082|NCT03354598|7673163|FG000|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||517
6745083|NCT03354598|7673164|FG001|Microbiologic Modified Intent to Treat (Micro-MITT) Participants|Overall Study||554
6745084|NCT03354598|7673163|FG000|Modified Intent to Treat (MITT) Participants|Overall Study||785
6745085|NCT03354598|7673164|FG001|Modified Intent to Treat (MITT) Participants|Overall Study||794
6745086|NCT03354598|7673163|FG000|Intent to Treat (ITT) Participants|Overall Study||787
6745087|NCT03354598|7673164|FG001|Intent to Treat (ITT) Participants|Overall Study||803
6745088|NCT03354598|7673163|FG000|Safety Participants|Overall Study||833
6745089|NCT03354598|7673164|FG001|Safety Participants|Overall Study||827
6745090|NCT03354598|7673163|FG000|COMPLETED|Overall Study||755
6745091|NCT03354598|7673164|FG001|COMPLETED|Overall Study||761
6452715|NCT01159912|7368644|FG002|NOT COMPLETED|Overall Study||26
6452716|NCT01159938|7368655|FG000|STARTED|First Study Period||26
6452717|NCT01159938|7368656|FG001|STARTED|First Study Period||11
6452718|NCT01159938|7368657|FG002|STARTED|First Study Period||11
6452719|NCT01159938|7368658|FG003|STARTED|First Study Period||12
6452720|NCT01159938|7368659|FG004|STARTED|First Study Period||12
6452721|NCT01159938|7368655|FG000|Received at Least 1 Dose of Study Drug|First Study Period||0
6452722|NCT01159938|7368656|FG001|Received at Least 1 Dose of Study Drug|First Study Period||11
6452723|NCT01159938|7368657|FG002|Received at Least 1 Dose of Study Drug|First Study Period||11
6452724|NCT01159938|7368658|FG003|Received at Least 1 Dose of Study Drug|First Study Period||12
6452725|NCT01159938|7368659|FG004|Received at Least 1 Dose of Study Drug|First Study Period||12
6452726|NCT01159938|7368655|FG000|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
6452727|NCT01159938|7368656|FG001|Safety and Efficacy Analysis Population|First Study Period||11
6452728|NCT01159938|7368657|FG002|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
6452729|NCT01159938|7368658|FG003|Safety and Efficacy Analysis Population|First Study Period||12
6452730|NCT01159938|7368659|FG004|Safety and Efficacy Analysis Population|First Study Period||12
6452731|NCT01159938|7368655|FG000|COMPLETED|First Study Period||26
6452732|NCT01159938|7368656|FG001|COMPLETED|First Study Period||11
6452733|NCT01159938|7368657|FG002|COMPLETED|First Study Period||10
6452734|NCT01159938|7368658|FG003|COMPLETED|First Study Period||12
6452735|NCT01159938|7368659|FG004|COMPLETED|First Study Period||12
6452736|NCT01159938|7368655|FG000|NOT COMPLETED|First Study Period||0
6452737|NCT01159938|7368656|FG001|NOT COMPLETED|First Study Period||0
6452738|NCT01159938|7368657|FG002|NOT COMPLETED|First Study Period||1
6452739|NCT01159938|7368658|FG003|NOT COMPLETED|First Study Period||0
6452740|NCT01159938|7368659|FG004|NOT COMPLETED|First Study Period||0
6452741|NCT01159938|7368655|FG000|STARTED|Second Study Period||0
6452742|NCT01159938|7368656|FG001|STARTED|Second Study Period||11
6452743|NCT01159938|7368657|FG002|STARTED|Second Study Period||10
6452744|NCT01159938|7368658|FG003|STARTED|Second Study Period||12
6452745|NCT01159938|7368659|FG004|STARTED|Second Study Period||12
6452746|NCT01159938|7368655|FG000|COMPLETED|Second Study Period||0
6452747|NCT01159938|7368656|FG001|COMPLETED|Second Study Period||11
6452748|NCT01159938|7368657|FG002|COMPLETED|Second Study Period||10
6452749|NCT01159938|7368658|FG003|COMPLETED|Second Study Period||12
6452750|NCT01159938|7368659|FG004|COMPLETED|Second Study Period||12
6452751|NCT01159938|7368655|FG000|NOT COMPLETED|Second Study Period||0
6452752|NCT01159938|7368656|FG001|NOT COMPLETED|Second Study Period||0
6553488|NCT01743677|7475930|FG003|NOT COMPLETED|Third Intervention Period||0
6553489|NCT01743677|7475931|FG004|NOT COMPLETED|Third Intervention Period||0
6745092|NCT03354598|7673163|FG000|NOT COMPLETED|Overall Study||80
6452753|NCT01159938|7368657|FG002|NOT COMPLETED|Second Study Period||0
6452754|NCT01159938|7368658|FG003|NOT COMPLETED|Second Study Period||0
6452755|NCT01159938|7368659|FG004|NOT COMPLETED|Second Study Period||0
6452756|NCT01160198|7368683|FG000|STARTED|Overall Study||89
6452757|NCT01160198|7368684|FG001|STARTED|Overall Study||91
6452758|NCT01160198|7368685|FG002|STARTED|Overall Study||90
6452759|NCT01160198|7368683|FG000|COMPLETED|Overall Study||87
6452760|NCT01160198|7368684|FG001|COMPLETED|Overall Study||88
6452761|NCT01160198|7368685|FG002|COMPLETED|Overall Study||89
6452762|NCT01160198|7368683|FG000|NOT COMPLETED|Overall Study||2
6452763|NCT01160198|7368684|FG001|NOT COMPLETED|Overall Study||3
6452764|NCT01160198|7368685|FG002|NOT COMPLETED|Overall Study||1
6452765|NCT01160211|7368696|FG000|STARTED|Overall Study||120
6452766|NCT01160211|7368697|FG001|STARTED|Overall Study||118
6452767|NCT01160211|7368698|FG002|STARTED|Overall Study||117
6452768|NCT01160211|7368696|FG000|Ongoing|Overall Study||90
6452769|NCT01160211|7368697|FG001|Ongoing|Overall Study||75
6452770|NCT01160211|7368698|FG002|Ongoing|Overall Study||79
6452771|NCT01160211|7368696|FG000|COMPLETED|Overall Study||21
6452772|NCT01160211|7368697|FG001|COMPLETED|Overall Study||31
6452773|NCT01160211|7368698|FG002|COMPLETED|Overall Study||30
6452774|NCT01160211|7368696|FG000|NOT COMPLETED|Overall Study||99
6452775|NCT01160211|7368697|FG001|NOT COMPLETED|Overall Study||87
6452776|NCT01160211|7368698|FG002|NOT COMPLETED|Overall Study||87
6452777|NCT01160237|7368710|FG000|STARTED|Overall Study||4
6452778|NCT01160237|7368711|FG001|STARTED|Overall Study||3
6452779|NCT01160237|7368712|FG002|STARTED|Overall Study||0
6452780|NCT01160237|7368710|FG000|COMPLETED|Overall Study||4
6452781|NCT01160237|7368711|FG001|COMPLETED|Overall Study||3
6452782|NCT01160237|7368712|FG002|COMPLETED|Overall Study||0
6452783|NCT01160237|7368710|FG000|NOT COMPLETED|Overall Study||0
6452784|NCT01160237|7368711|FG001|NOT COMPLETED|Overall Study||0
6452785|NCT01160237|7368712|FG002|NOT COMPLETED|Overall Study||0
6452786|NCT01160289|7368725|FG000|STARTED|Screening, Washout, and Lead-In Period||894
6452787|NCT01160289|7368726|FG001|STARTED|Screening, Washout, and Lead-In Period||0
6452788|NCT01160289|7368727|FG002|STARTED|Screening, Washout, and Lead-In Period||0
6452789|NCT01160289|7368728|FG003|STARTED|Screening, Washout, and Lead-In Period||0
6452790|NCT01160289|7368729|FG004|STARTED|Screening, Washout, and Lead-In Period||0
6452791|NCT01160289|7368730|FG005|STARTED|Screening, Washout, and Lead-In Period||0
6452792|NCT01160289|7368725|FG000|COMPLETED|Screening, Washout, and Lead-In Period||410
6452793|NCT01160289|7368726|FG001|COMPLETED|Screening, Washout, and Lead-In Period||0
6452794|NCT01160289|7368727|FG002|COMPLETED|Screening, Washout, and Lead-In Period||0
6452795|NCT01160289|7368728|FG003|COMPLETED|Screening, Washout, and Lead-In Period||0
6452796|NCT01160289|7368729|FG004|COMPLETED|Screening, Washout, and Lead-In Period||0
6452797|NCT01160289|7368730|FG005|COMPLETED|Screening, Washout, and Lead-In Period||0
6452798|NCT01160289|7368725|FG000|NOT COMPLETED|Screening, Washout, and Lead-In Period||484
6452799|NCT01160289|7368726|FG001|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6452800|NCT01160289|7368727|FG002|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6452801|NCT01160289|7368728|FG003|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6452802|NCT01160289|7368729|FG004|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6452803|NCT01160289|7368730|FG005|NOT COMPLETED|Screening, Washout, and Lead-In Period||0
6452804|NCT01160289|7368725|FG000|STARTED|Post-Randomization Period||0
6452805|NCT01160289|7368726|FG001|STARTED|Post-Randomization Period||85
6452806|NCT01160289|7368727|FG002|STARTED|Post-Randomization Period||97
6452807|NCT01160289|7368728|FG003|STARTED|Post-Randomization Period||52
6452808|NCT01160289|7368729|FG004|STARTED|Post-Randomization Period||89
6452809|NCT01160289|7368730|FG005|STARTED|Post-Randomization Period||87
6452810|NCT01160289|7368725|FG000|Received at Least 1 Dose of Study Drug|Post-Randomization Period||0
6452811|NCT01160289|7368726|FG001|Received at Least 1 Dose of Study Drug|Post-Randomization Period||85
6452812|NCT01160289|7368727|FG002|Received at Least 1 Dose of Study Drug|Post-Randomization Period||97
6452813|NCT01160289|7368728|FG003|Received at Least 1 Dose of Study Drug|Post-Randomization Period||52
6452814|NCT01160289|7368729|FG004|Received at Least 1 Dose of Study Drug|Post-Randomization Period||89
6452815|NCT01160289|7368730|FG005|Received at Least 1 Dose of Study Drug|Post-Randomization Period||87
6452816|NCT01160289|7368725|FG000|COMPLETED|Post-Randomization Period||0
6452817|NCT01160289|7368726|FG001|COMPLETED|Post-Randomization Period||65
6452818|NCT01160289|7368727|FG002|COMPLETED|Post-Randomization Period||73
6452819|NCT01160289|7368728|FG003|COMPLETED|Post-Randomization Period||31
6452820|NCT01160289|7368729|FG004|COMPLETED|Post-Randomization Period||80
6452821|NCT01160289|7368730|FG005|COMPLETED|Post-Randomization Period||73
6452822|NCT01160289|7368725|FG000|NOT COMPLETED|Post-Randomization Period||0
6452823|NCT01160289|7368726|FG001|NOT COMPLETED|Post-Randomization Period||20
6452824|NCT01160289|7368727|FG002|NOT COMPLETED|Post-Randomization Period||24
6452825|NCT01160289|7368728|FG003|NOT COMPLETED|Post-Randomization Period||21
6452826|NCT01160289|7368729|FG004|NOT COMPLETED|Post-Randomization Period||9
6452827|NCT01160289|7368730|FG005|NOT COMPLETED|Post-Randomization Period||14
6452828|NCT01160354|7368746|FG000|STARTED|Overall Study||3
6452829|NCT01160354|7368747|FG001|STARTED|Overall Study||4
6452830|NCT01160354|7368748|FG002|STARTED|Overall Study||15
6452831|NCT01160354|7368746|FG000|COMPLETED|Overall Study||3
6452832|NCT01160354|7368747|FG001|COMPLETED|Overall Study||3
6452833|NCT01160354|7368748|FG002|COMPLETED|Overall Study||14
6452834|NCT01160354|7368746|FG000|NOT COMPLETED|Overall Study||0
6452835|NCT01160354|7368747|FG001|NOT COMPLETED|Overall Study||1
6452836|NCT01160354|7368748|FG002|NOT COMPLETED|Overall Study||1
6452837|NCT01160380|7368758|FG000|STARTED|Overall Study||25
6452838|NCT01160380|7368759|FG001|STARTED|Overall Study||25
6452839|NCT01160380|7368758|FG000|COMPLETED|Overall Study||17
6745093|NCT03354598|7673164|FG001|NOT COMPLETED|Overall Study||75
6745094|NCT03354637|7673173|FG000|STARTED|Double-blind Period||43
6745095|NCT03354637|7673174|FG001|STARTED|Double-blind Period||44
6452840|NCT01160380|7368759|FG001|COMPLETED|Overall Study||20
6452841|NCT01160380|7368758|FG000|NOT COMPLETED|Overall Study||8
6452842|NCT01160380|7368759|FG001|NOT COMPLETED|Overall Study||5
6452843|NCT01160445|7368767|FG000|STARTED|Overall Study||7
6452844|NCT01160445|7368768|FG001|STARTED|Overall Study||2
6452845|NCT01160445|7368767|FG000|COMPLETED|Overall Study||7
6452846|NCT01160445|7368768|FG001|COMPLETED|Overall Study||2
6452847|NCT01160445|7368767|FG000|NOT COMPLETED|Overall Study||0
6452848|NCT01160445|7368768|FG001|NOT COMPLETED|Overall Study||0
6452849|NCT01160458|7368774|FG000|STARTED|Overall Study||20
6452850|NCT01160458|7368774|FG000|COMPLETED|Overall Study||20
6452851|NCT01160458|7368774|FG000|NOT COMPLETED|Overall Study||0
6452852|NCT01160484|7368778|FG000|STARTED|Overall Study||40
6452853|NCT01160484|7368778|FG000|COMPLETED|Overall Study||22
6452854|NCT01160484|7368778|FG000|NOT COMPLETED|Overall Study||18
6452855|NCT01160614|7368784|FG000|STARTED|Overall Study||5
6452856|NCT01160614|7368785|FG001|STARTED|Overall Study||25
6452857|NCT01160614|7368784|FG000|COMPLETED|Overall Study||5
6452858|NCT01160614|7368785|FG001|COMPLETED|Overall Study||23
6452859|NCT01160614|7368784|FG000|NOT COMPLETED|Overall Study||0
6452860|NCT01160614|7368785|FG001|NOT COMPLETED|Overall Study||2
6452861|NCT01160640|7368811|FG000|STARTED|Overall Study||117
6452862|NCT01160640|7368812|FG001|STARTED|Overall Study||116
6452863|NCT01160640|7368811|FG000|COMPLETED|Overall Study||113
6452864|NCT01160640|7368812|FG001|COMPLETED|Overall Study||110
6452865|NCT01160640|7368811|FG000|NOT COMPLETED|Overall Study||4
6452866|NCT01160640|7368812|FG001|NOT COMPLETED|Overall Study||6
6452867|NCT01160744|7368824|FG000|STARTED|Overall Study||71
6452868|NCT01160744|7368825|FG001|STARTED|Overall Study||69
6452869|NCT01160744|7368826|FG002|STARTED|Overall Study||69
6452870|NCT01160744|7368827|FG003|STARTED|Overall Study||71
6452871|NCT01160744|7368824|FG000|Received Study Drug|Overall Study||69
6452872|NCT01160744|7368825|FG001|Received Study Drug|Overall Study||67
6452873|NCT01160744|7368826|FG002|Received Study Drug|Overall Study||63
6452874|NCT01160744|7368827|FG003|Received Study Drug|Overall Study||71
6452875|NCT01160744|7368824|FG000|COMPLETED|Overall Study||60
6745096|NCT03354637|7673175|FG002|STARTED|Double-blind Period||42
6745097|NCT03354637|7673173|FG000|COMPLETED|Double-blind Period||26
6745098|NCT03354637|7673174|FG001|COMPLETED|Double-blind Period||31
6745099|NCT03354637|7673175|FG002|COMPLETED|Double-blind Period||35
6745100|NCT03354637|7673173|FG000|NOT COMPLETED|Double-blind Period||17
6745101|NCT03354637|7673174|FG001|NOT COMPLETED|Double-blind Period||13
6745102|NCT03354637|7673175|FG002|NOT COMPLETED|Double-blind Period||7
6745103|NCT03354637|7673173|FG000|STARTED|Open Label Extension||0
6745104|NCT03354637|7673174|FG001|STARTED|Open Label Extension||0
6745105|NCT03354637|7673175|FG002|STARTED|Open Label Extension||61
6452876|NCT01160744|7368825|FG001|COMPLETED|Overall Study||64
6452877|NCT01160744|7368826|FG002|COMPLETED|Overall Study||62
6452878|NCT01160744|7368827|FG003|COMPLETED|Overall Study||67
6452879|NCT01160744|7368824|FG000|NOT COMPLETED|Overall Study||11
6452880|NCT01160744|7368825|FG001|NOT COMPLETED|Overall Study||5
6452881|NCT01160744|7368826|FG002|NOT COMPLETED|Overall Study||7
6452882|NCT01160744|7368827|FG003|NOT COMPLETED|Overall Study||4
6452883|NCT01160770|7368839|FG000|STARTED|Overall Study||267
6452884|NCT01160770|7368839|FG000|COMPLETED|Overall Study||188
6452885|NCT01160770|7368839|FG000|NOT COMPLETED|Overall Study||79
6452886|NCT01160822|7368850|FG000|STARTED|Overall Study||6
6452887|NCT01160822|7368851|FG001|STARTED|Overall Study||7
6452888|NCT01160822|7368852|FG002|STARTED|Overall Study||6
6452889|NCT01160822|7368853|FG003|STARTED|Overall Study||5
6452890|NCT01160822|7368854|FG004|STARTED|Overall Study||45
6452891|NCT01160822|7368855|FG005|STARTED|Overall Study||47
6452892|NCT01160822|7368856|FG006|STARTED|Overall Study||53
6452893|NCT01160822|7368850|FG000|COMPLETED|Overall Study||6
6452894|NCT01160822|7368851|FG001|COMPLETED|Overall Study||7
6452895|NCT01160822|7368852|FG002|COMPLETED|Overall Study||6
6452896|NCT01160822|7368853|FG003|COMPLETED|Overall Study||5
6452897|NCT01160822|7368854|FG004|COMPLETED|Overall Study||36
6452898|NCT01160822|7368855|FG005|COMPLETED|Overall Study||40
6452899|NCT01160822|7368856|FG006|COMPLETED|Overall Study||44
6745106|NCT03354637|7673173|FG000|COMPLETED|Open Label Extension||0
6745107|NCT03354637|7673174|FG001|COMPLETED|Open Label Extension||0
6745108|NCT03354637|7673175|FG002|COMPLETED|Open Label Extension||33
6452900|NCT01160822|7368850|FG000|NOT COMPLETED|Overall Study||0
6452901|NCT01160822|7368851|FG001|NOT COMPLETED|Overall Study||0
6452902|NCT01160822|7368852|FG002|NOT COMPLETED|Overall Study||0
6452903|NCT01160822|7368853|FG003|NOT COMPLETED|Overall Study||0
6452904|NCT01160822|7368854|FG004|NOT COMPLETED|Overall Study||9
6452905|NCT01160822|7368855|FG005|NOT COMPLETED|Overall Study||7
6452906|NCT01160822|7368856|FG006|NOT COMPLETED|Overall Study||9
6452907|NCT01160848|7368875|FG000|STARTED|Overall Study||12
6452908|NCT01160848|7368876|FG001|STARTED|Overall Study||8
6452909|NCT01160848|7368875|FG000|COMPLETED|Overall Study||12
6452910|NCT01160848|7368876|FG001|COMPLETED|Overall Study||8
6452911|NCT01160848|7368875|FG000|NOT COMPLETED|Overall Study||0
6452912|NCT01160848|7368876|FG001|NOT COMPLETED|Overall Study||0
6452913|NCT01161043|7368886|FG000|STARTED|Overall Study||83
6452914|NCT01161043|7368886|FG000|COMPLETED|Overall Study||80
6452915|NCT01161043|7368886|FG000|NOT COMPLETED|Overall Study||3
6452916|NCT01161121|7368890|FG000|STARTED|Overall Study||46
6452917|NCT01161121|7368890|FG000|COMPLETED|Overall Study||46
6452918|NCT01161121|7368890|FG000|NOT COMPLETED|Overall Study||0
6452919|NCT01161160|7368901|FG000|STARTED|Overall Study||76
6452920|NCT01161160|7368902|FG001|STARTED|Overall Study||75
6452921|NCT01161160|7368903|FG002|STARTED|Overall Study||58
6452922|NCT01161160|7368901|FG000|COMPLETED|Overall Study||76
6452923|NCT01161160|7368902|FG001|COMPLETED|Overall Study||75
6452924|NCT01161160|7368903|FG002|COMPLETED|Overall Study||58
6452925|NCT01161160|7368901|FG000|NOT COMPLETED|Overall Study||0
6452926|NCT01161160|7368902|FG001|NOT COMPLETED|Overall Study||0
6452927|NCT01161160|7368903|FG002|NOT COMPLETED|Overall Study||0
6452928|NCT01161173|7368911|FG000|STARTED|Overall Study||347
6452929|NCT01161173|7368911|FG000|COMPLETED|Overall Study||0
6452930|NCT01161173|7368911|FG000|NOT COMPLETED|Overall Study||347
6452931|NCT01161225|7368918|FG000|STARTED|Overall Study||59
6452932|NCT01161225|7368919|FG001|STARTED|Overall Study||53
6452933|NCT01161225|7368920|FG002|STARTED|Overall Study||14
6452934|NCT01161225|7368918|FG000|COMPLETED|Overall Study||45
6452935|NCT01161225|7368919|FG001|COMPLETED|Overall Study||44
6452936|NCT01161225|7368920|FG002|COMPLETED|Overall Study||12
6452937|NCT01161225|7368918|FG000|NOT COMPLETED|Overall Study||14
6452938|NCT01161225|7368919|FG001|NOT COMPLETED|Overall Study||9
6452939|NCT01161225|7368920|FG002|NOT COMPLETED|Overall Study||2
6452940|NCT01161329|7368934|FG000|STARTED|Overall Study||33
6452941|NCT01161329|7368935|FG001|STARTED|Overall Study||34
6452942|NCT01161329|7368934|FG000|COMPLETED|Overall Study||29
6452943|NCT01161329|7368935|FG001|COMPLETED|Overall Study||24
6452944|NCT01161329|7368934|FG000|NOT COMPLETED|Overall Study||4
6452945|NCT01161329|7368935|FG001|NOT COMPLETED|Overall Study||10
6452946|NCT01161407|7368944|FG000|STARTED|Overall Study||6
6452947|NCT01161407|7368945|FG001|STARTED|Overall Study||6
6452948|NCT01161407|7368944|FG000|COMPLETED|Overall Study||3
6553490|NCT01743677|7475932|FG005|NOT COMPLETED|Third Intervention Period||0
6553491|NCT01743729|7475944|FG000|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
6553492|NCT01743729|7475945|FG001|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
6553493|NCT01743729|7475944|FG000|COMPLETED|Overall Study||321
6553494|NCT01743729|7475945|FG001|COMPLETED|Overall Study||348
6553495|NCT01743729|7475944|FG000|NOT COMPLETED|Overall Study||37
6553496|NCT01743729|7475945|FG001|NOT COMPLETED|Overall Study||12
6553497|NCT01743859|7475951|FG000|STARTED|Overall Study||37
6553498|NCT01743859|7475951|FG000|COMPLETED|Overall Study||28
6553499|NCT01743859|7475951|FG000|NOT COMPLETED|Overall Study||9
6553500|NCT01743963|7475957|FG000|STARTED|Overall Study||21
6452949|NCT01161407|7368945|FG001|COMPLETED|Overall Study||5
6452950|NCT01161407|7368944|FG000|NOT COMPLETED|Overall Study||3
6452951|NCT01161407|7368945|FG001|NOT COMPLETED|Overall Study||1
6452952|NCT01161420|7368951|FG000|STARTED|Inspire Therapy||126
6452953|NCT01161420|7368951|FG000|COMPLETED|Inspire Therapy||124
6452954|NCT01161420|7368951|FG000|NOT COMPLETED|Inspire Therapy||2
6452955|NCT01161420|7368951|FG000|STARTED|Withdrawal Study - Maintenance||23
6452956|NCT01161420|7368951|FG000|COMPLETED|Withdrawal Study - Maintenance||23
6452957|NCT01161420|7368951|FG000|NOT COMPLETED|Withdrawal Study - Maintenance||0
6452958|NCT01161420|7368951|FG000|STARTED|Withdrawal Study - Withdrawal||23
6452959|NCT01161420|7368951|FG000|COMPLETED|Withdrawal Study - Withdrawal||23
6452960|NCT01161420|7368951|FG000|NOT COMPLETED|Withdrawal Study - Withdrawal||0
6452961|NCT01161446|7368963|FG000|STARTED|Overall Study||116
6452962|NCT01161446|7368964|FG001|STARTED|Overall Study||114
6452963|NCT01161446|7368963|FG000|COMPLETED|Overall Study||98
6452964|NCT01161446|7368964|FG001|COMPLETED|Overall Study||99
6452965|NCT01161446|7368963|FG000|NOT COMPLETED|Overall Study||18
6452966|NCT01161446|7368964|FG001|NOT COMPLETED|Overall Study||15
6452967|NCT01161472|7368970|FG000|STARTED|First Intervention Period||5
6452968|NCT01161472|7368971|FG001|STARTED|First Intervention Period||5
6452969|NCT01161472|7368972|FG002|STARTED|First Intervention Period||5
6452970|NCT01161472|7368973|FG003|STARTED|First Intervention Period||5
6452971|NCT01161472|7368970|FG000|Treated|First Intervention Period||5
6452972|NCT01161472|7368971|FG001|Treated|First Intervention Period||5
6452973|NCT01161472|7368972|FG002|Treated|First Intervention Period||5
6452974|NCT01161472|7368973|FG003|Treated|First Intervention Period||5
6452975|NCT01161472|7368970|FG000|COMPLETED|First Intervention Period||5
6452976|NCT01161472|7368971|FG001|COMPLETED|First Intervention Period||5
6452977|NCT01161472|7368972|FG002|COMPLETED|First Intervention Period||5
6452978|NCT01161472|7368973|FG003|COMPLETED|First Intervention Period||5
6452979|NCT01161472|7368970|FG000|NOT COMPLETED|First Intervention Period||0
6452980|NCT01161472|7368971|FG001|NOT COMPLETED|First Intervention Period||0
6452981|NCT01161472|7368972|FG002|NOT COMPLETED|First Intervention Period||0
6452982|NCT01161472|7368973|FG003|NOT COMPLETED|First Intervention Period||0
6452983|NCT01161472|7368970|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
6452984|NCT01161472|7368971|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
6452985|NCT01161472|7368972|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
6553501|NCT01743963|7475958|FG001|STARTED|Overall Study||17
6553502|NCT01743963|7475957|FG000|COMPLETED|Overall Study||21
6452986|NCT01161472|7368973|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
6452987|NCT01161472|7368970|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6452988|NCT01161472|7368971|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6452989|NCT01161472|7368972|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6452990|NCT01161472|7368973|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6452991|NCT01161472|7368970|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6452992|NCT01161472|7368971|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6452993|NCT01161472|7368972|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6452994|NCT01161472|7368973|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6452995|NCT01161472|7368970|FG000|STARTED|Second Intervention Period||5
6452996|NCT01161472|7368971|FG001|STARTED|Second Intervention Period||5
6452997|NCT01161472|7368972|FG002|STARTED|Second Intervention Period||5
6452998|NCT01161472|7368973|FG003|STARTED|Second Intervention Period||5
6452999|NCT01161472|7368970|FG000|COMPLETED|Second Intervention Period||5
6453000|NCT01161472|7368971|FG001|COMPLETED|Second Intervention Period||5
6453001|NCT01161472|7368972|FG002|COMPLETED|Second Intervention Period||5
6453002|NCT01161472|7368973|FG003|COMPLETED|Second Intervention Period||5
6453003|NCT01161472|7368970|FG000|NOT COMPLETED|Second Intervention Period||0
6453004|NCT01161472|7368971|FG001|NOT COMPLETED|Second Intervention Period||0
6453005|NCT01161472|7368972|FG002|NOT COMPLETED|Second Intervention Period||0
6453006|NCT01161472|7368973|FG003|NOT COMPLETED|Second Intervention Period||0
6453007|NCT01161472|7368970|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||5
6453008|NCT01161472|7368971|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
6453009|NCT01161472|7368972|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
6453010|NCT01161472|7368973|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
6453011|NCT01161472|7368970|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
6453012|NCT01161472|7368971|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6453013|NCT01161472|7368972|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6453014|NCT01161472|7368973|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6453015|NCT01161472|7368970|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
6453016|NCT01161472|7368971|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6453017|NCT01161472|7368972|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6453018|NCT01161472|7368973|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6453019|NCT01161472|7368970|FG000|STARTED|Third Intervention Period||4
6453020|NCT01161472|7368971|FG001|STARTED|Third Intervention Period||5
6553503|NCT01743963|7475958|FG001|COMPLETED|Overall Study||17
6553504|NCT01743963|7475957|FG000|NOT COMPLETED|Overall Study||0
6553505|NCT01743963|7475958|FG001|NOT COMPLETED|Overall Study||0
6553506|NCT01743976|7475966|FG000|STARTED|Overall Study||2
6553507|NCT01743976|7475967|FG001|STARTED|Overall Study||3
6453021|NCT01161472|7368972|FG002|STARTED|Third Intervention Period||5
6453022|NCT01161472|7368973|FG003|STARTED|Third Intervention Period||5
6453023|NCT01161472|7368970|FG000|COMPLETED|Third Intervention Period||4
6453024|NCT01161472|7368971|FG001|COMPLETED|Third Intervention Period||5
6453025|NCT01161472|7368972|FG002|COMPLETED|Third Intervention Period||5
6453026|NCT01161472|7368973|FG003|COMPLETED|Third Intervention Period||5
6453027|NCT01161472|7368970|FG000|NOT COMPLETED|Third Intervention Period||0
6453028|NCT01161472|7368971|FG001|NOT COMPLETED|Third Intervention Period||0
6453029|NCT01161472|7368972|FG002|NOT COMPLETED|Third Intervention Period||0
6453030|NCT01161472|7368973|FG003|NOT COMPLETED|Third Intervention Period||0
6453031|NCT01161472|7368970|FG000|STARTED|Washout Period (At Least 3 to 6 Days)||4
6453032|NCT01161472|7368971|FG001|STARTED|Washout Period (At Least 3 to 6 Days)||5
6453033|NCT01161472|7368972|FG002|STARTED|Washout Period (At Least 3 to 6 Days)||5
6453034|NCT01161472|7368973|FG003|STARTED|Washout Period (At Least 3 to 6 Days)||5
6453035|NCT01161472|7368970|FG000|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
6453036|NCT01161472|7368971|FG001|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6453037|NCT01161472|7368972|FG002|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6453038|NCT01161472|7368973|FG003|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
6453039|NCT01161472|7368970|FG000|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6453040|NCT01161472|7368971|FG001|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6453041|NCT01161472|7368972|FG002|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6453042|NCT01161472|7368973|FG003|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
6453043|NCT01161472|7368970|FG000|STARTED|Fourth Intervention Period||4
6453044|NCT01161472|7368971|FG001|STARTED|Fourth Intervention Period||5
6453045|NCT01161472|7368972|FG002|STARTED|Fourth Intervention Period||5
6453046|NCT01161472|7368973|FG003|STARTED|Fourth Intervention Period||5
6453047|NCT01161472|7368970|FG000|COMPLETED|Fourth Intervention Period||4
6453048|NCT01161472|7368971|FG001|COMPLETED|Fourth Intervention Period||5
6453049|NCT01161472|7368972|FG002|COMPLETED|Fourth Intervention Period||5
6453050|NCT01161472|7368973|FG003|COMPLETED|Fourth Intervention Period||5
6453051|NCT01161472|7368970|FG000|NOT COMPLETED|Fourth Intervention Period||0
6453052|NCT01161472|7368971|FG001|NOT COMPLETED|Fourth Intervention Period||0
6453053|NCT01161472|7368972|FG002|NOT COMPLETED|Fourth Intervention Period||0
6453054|NCT01161472|7368973|FG003|NOT COMPLETED|Fourth Intervention Period||0
6453055|NCT01161498|7368985|FG000|STARTED|Overall Study||3
6453056|NCT01161498|7368986|FG001|STARTED|Overall Study||2
6453057|NCT01161498|7368985|FG000|COMPLETED|Overall Study||3
6453058|NCT01161498|7368986|FG001|COMPLETED|Overall Study||1
6453059|NCT01161498|7368985|FG000|NOT COMPLETED|Overall Study||0
6453060|NCT01161498|7368986|FG001|NOT COMPLETED|Overall Study||1
6453061|NCT01161524|7368994|FG000|STARTED|Core Study (23 Weeks)||85
6453062|NCT01161524|7368995|FG001|STARTED|Core Study (23 Weeks)||48
6553508|NCT01743976|7475966|FG000|COMPLETED|Overall Study||2
6453063|NCT01161524|7368996|FG002|STARTED|Core Study (23 Weeks)||0
6453064|NCT01161524|7368994|FG000|COMPLETED|Core Study (23 Weeks)||76
6453065|NCT01161524|7368995|FG001|COMPLETED|Core Study (23 Weeks)||43
6453066|NCT01161524|7368996|FG002|COMPLETED|Core Study (23 Weeks)||0
6453067|NCT01161524|7368994|FG000|NOT COMPLETED|Core Study (23 Weeks)||9
6453068|NCT01161524|7368995|FG001|NOT COMPLETED|Core Study (23 Weeks)||5
6453069|NCT01161524|7368996|FG002|NOT COMPLETED|Core Study (23 Weeks)||0
6453070|NCT01161524|7368994|FG000|STARTED|Extension Phase (Approximately 83 Weeks)||0
6453071|NCT01161524|7368995|FG001|STARTED|Extension Phase (Approximately 83 Weeks)||0
6453072|NCT01161524|7368996|FG002|STARTED|Extension Phase (Approximately 83 Weeks)||114
6453073|NCT01161524|7368994|FG000|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
6453074|NCT01161524|7368995|FG001|COMPLETED|Extension Phase (Approximately 83 Weeks)||0
6453075|NCT01161524|7368996|FG002|COMPLETED|Extension Phase (Approximately 83 Weeks)||90
6453076|NCT01161524|7368994|FG000|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
6453077|NCT01161524|7368995|FG001|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||0
6453078|NCT01161524|7368996|FG002|NOT COMPLETED|Extension Phase (Approximately 83 Weeks)||24
6453079|NCT01161537|7369005|FG000|STARTED|Part A||8
6453080|NCT01161537|7369005|FG000|COMPLETED|Part A||8
6453081|NCT01161537|7369005|FG000|NOT COMPLETED|Part A||0
6453082|NCT01161537|7369005|FG000|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
6453083|NCT01161537|7369005|FG000|COMPLETED|Part B||7
6453084|NCT01161537|7369005|FG000|NOT COMPLETED|Part B||2
6453085|NCT01161563|7369016|FG000|STARTED|Overall Study||63
6453086|NCT01161563|7369017|FG001|STARTED|Overall Study||55
6453087|NCT01161563|7369016|FG000|COMPLETED|Overall Study||58
6453088|NCT01161563|7369017|FG001|COMPLETED|Overall Study||49
6453089|NCT01161563|7369016|FG000|NOT COMPLETED|Overall Study||5
6453090|NCT01161563|7369017|FG001|NOT COMPLETED|Overall Study||6
6453091|NCT01161628|7369023|FG000|STARTED|Overall Study||25
6453092|NCT01161628|7369023|FG000|COMPLETED|Overall Study||17
6453093|NCT01161628|7369023|FG000|NOT COMPLETED|Overall Study||8
6453094|NCT01161771|7369027|FG000|STARTED|Overall Study||32
6453095|NCT01161771|7369027|FG000|COMPLETED|Overall Study||32
6453096|NCT01161771|7369027|FG000|NOT COMPLETED|Overall Study||0
6453097|NCT01161862|7369033|FG000|STARTED|Overall Study||12
6453098|NCT01161862|7369034|FG001|STARTED|Overall Study||12
6453099|NCT01161862|7369033|FG000|COMPLETED|Overall Study||12
6453100|NCT01161862|7369034|FG001|COMPLETED|Overall Study||12
6453101|NCT01161862|7369033|FG000|NOT COMPLETED|Overall Study||0
6453102|NCT01161862|7369034|FG001|NOT COMPLETED|Overall Study||0
6453103|NCT01162005|7369045|FG000|STARTED|Overall Study||44
6453104|NCT01162005|7369046|FG001|STARTED|Overall Study||33
6453105|NCT01162005|7369045|FG000|COMPLETED|Overall Study||44
6453106|NCT01162005|7369046|FG001|COMPLETED|Overall Study||33
6453107|NCT01162005|7369045|FG000|NOT COMPLETED|Overall Study||0
6453108|NCT01162005|7369046|FG001|NOT COMPLETED|Overall Study||0
6453109|NCT01162096|7369054|FG000|STARTED|Overall Study||34
6453110|NCT01162096|7369054|FG000|COMPLETED|Overall Study||34
6453111|NCT01162096|7369054|FG000|NOT COMPLETED|Overall Study||0
6453112|NCT01162122|7369061|FG000|STARTED|Overall Study||3552
6453113|NCT01162122|7369062|FG001|STARTED|Overall Study||3552
6453114|NCT01162122|7369061|FG000|Vaccinated|Overall Study||3541
6453115|NCT01162122|7369062|FG001|Vaccinated|Overall Study||3541
6453116|NCT01162122|7369061|FG000|COMPLETED|Overall Study||3361
6453117|NCT01162122|7369062|FG001|COMPLETED|Overall Study||3356
6453118|NCT01162122|7369061|FG000|NOT COMPLETED|Overall Study||191
6453119|NCT01162122|7369062|FG001|NOT COMPLETED|Overall Study||196
6453120|NCT01162135|7369071|FG000|STARTED|Overall Study||16
6453121|NCT01162135|7369071|FG000|COMPLETED|Overall Study||13
6453122|NCT01162135|7369071|FG000|NOT COMPLETED|Overall Study||3
6453123|NCT01162239|7369079|FG000|STARTED|Treatment Phase||55
6453124|NCT01162239|7369080|FG001|STARTED|Treatment Phase||54
6453125|NCT01162239|7369081|FG002|STARTED|Treatment Phase||52
6453126|NCT01162239|7369082|FG003|STARTED|Treatment Phase||55
6453127|NCT01162239|7369079|FG000|Week 12|Treatment Phase||50
6453128|NCT01162239|7369080|FG001|Week 12|Treatment Phase||51
6453129|NCT01162239|7369081|FG002|Week 12|Treatment Phase||49
6453130|NCT01162239|7369082|FG003|Week 12|Treatment Phase||53
6453131|NCT01162239|7369079|FG000|Week 24|Treatment Phase||51
6453132|NCT01162239|7369080|FG001|Week 24|Treatment Phase||48
6453133|NCT01162239|7369081|FG002|Week 24|Treatment Phase||48
6453134|NCT01162239|7369082|FG003|Week 24|Treatment Phase||50
6453135|NCT01162239|7369079|FG000|Week 52|Treatment Phase||49
6453136|NCT01162239|7369080|FG001|Week 52|Treatment Phase||47
6453137|NCT01162239|7369081|FG002|Week 52|Treatment Phase||48
6453138|NCT01162239|7369082|FG003|Week 52|Treatment Phase||50
6453139|NCT01162239|7369079|FG000|COMPLETED|Treatment Phase||49
6453140|NCT01162239|7369080|FG001|COMPLETED|Treatment Phase||47
6453141|NCT01162239|7369081|FG002|COMPLETED|Treatment Phase||48
6453142|NCT01162239|7369082|FG003|COMPLETED|Treatment Phase||50
6453143|NCT01162239|7369079|FG000|NOT COMPLETED|Treatment Phase||6
6453144|NCT01162239|7369080|FG001|NOT COMPLETED|Treatment Phase||7
6453145|NCT01162239|7369081|FG002|NOT COMPLETED|Treatment Phase||4
6453146|NCT01162239|7369082|FG003|NOT COMPLETED|Treatment Phase||5
6453147|NCT01162239|7369079|FG000|STARTED|Extended Follow-up||47
6453148|NCT01162239|7369080|FG001|STARTED|Extended Follow-up||45
6453149|NCT01162239|7369081|FG002|STARTED|Extended Follow-up||45
6453150|NCT01162239|7369082|FG003|STARTED|Extended Follow-up||47
6453151|NCT01162239|7369079|FG000|COMPLETED|Extended Follow-up||39
6453152|NCT01162239|7369080|FG001|COMPLETED|Extended Follow-up||32
6453153|NCT01162239|7369081|FG002|COMPLETED|Extended Follow-up||37
6453154|NCT01162239|7369082|FG003|COMPLETED|Extended Follow-up||41
6453155|NCT01162239|7369079|FG000|NOT COMPLETED|Extended Follow-up||8
6453156|NCT01162239|7369080|FG001|NOT COMPLETED|Extended Follow-up||13
6453157|NCT01162239|7369081|FG002|NOT COMPLETED|Extended Follow-up||8
6453158|NCT01162239|7369082|FG003|NOT COMPLETED|Extended Follow-up||6
6453159|NCT01162317|7369095|FG000|STARTED|Overall Study||30
6453160|NCT01162317|7369096|FG001|STARTED|Overall Study||30
6453161|NCT01162317|7369095|FG000|COMPLETED|Overall Study||27
6453162|NCT01162317|7369096|FG001|COMPLETED|Overall Study||28
6453163|NCT01162317|7369095|FG000|NOT COMPLETED|Overall Study||3
6453164|NCT01162317|7369096|FG001|NOT COMPLETED|Overall Study||2
6453165|NCT01162343|7369102|FG000|STARTED|Overall Study||498
6453166|NCT01162343|7369102|FG000|COMPLETED|Overall Study||406
6453167|NCT01162343|7369102|FG000|NOT COMPLETED|Overall Study||92
6453168|NCT01162421|7369108|FG000|STARTED|Overall Study||37
6453169|NCT01162421|7369109|FG001|STARTED|Overall Study||40
6453170|NCT01162421|7369108|FG000|COMPLETED|Overall Study||29
6453171|NCT01162421|7369109|FG001|COMPLETED|Overall Study||27
6453172|NCT01162421|7369108|FG000|NOT COMPLETED|Overall Study||8
6453173|NCT01162421|7369109|FG001|NOT COMPLETED|Overall Study||13
6453174|NCT01162473|7369117|FG000|STARTED|Overall Study||8
6453175|NCT01162473|7369118|FG001|STARTED|Overall Study||17
6453176|NCT01162473|7369117|FG000|COMPLETED|Overall Study||6
6453177|NCT01162473|7369118|FG001|COMPLETED|Overall Study||12
6453178|NCT01162473|7369117|FG000|NOT COMPLETED|Overall Study||2
6453179|NCT01162473|7369118|FG001|NOT COMPLETED|Overall Study||5
6453180|NCT01162486|7369129|FG000|STARTED|Overall Study||8
6453181|NCT01162486|7369130|FG001|STARTED|Overall Study||6
6453182|NCT01162486|7369131|FG002|STARTED|Overall Study||6
6453183|NCT01162486|7369132|FG003|STARTED|Overall Study||7
6553509|NCT01743976|7475967|FG001|COMPLETED|Overall Study||3
6553510|NCT01743976|7475966|FG000|NOT COMPLETED|Overall Study||0
6553511|NCT01743976|7475967|FG001|NOT COMPLETED|Overall Study||0
6453184|NCT01162486|7369133|FG004|STARTED|Overall Study||6
6453185|NCT01162486|7369129|FG000|Took at Least One Dose Study Drug|Overall Study||8
6453186|NCT01162486|7369130|FG001|Took at Least One Dose Study Drug|Overall Study||6
6453187|NCT01162486|7369131|FG002|Took at Least One Dose Study Drug|Overall Study||6
6453188|NCT01162486|7369132|FG003|Took at Least One Dose Study Drug|Overall Study||7
6453189|NCT01162486|7369133|FG004|Took at Least One Dose Study Drug|Overall Study||6
6453190|NCT01162486|7369129|FG000|COMPLETED|Overall Study||6
6453191|NCT01162486|7369130|FG001|COMPLETED|Overall Study||6
6453192|NCT01162486|7369131|FG002|COMPLETED|Overall Study||5
6453193|NCT01162486|7369132|FG003|COMPLETED|Overall Study||6
6453194|NCT01162486|7369133|FG004|COMPLETED|Overall Study||6
6453195|NCT01162486|7369129|FG000|NOT COMPLETED|Overall Study||2
6453196|NCT01162486|7369130|FG001|NOT COMPLETED|Overall Study||0
6453197|NCT01162486|7369131|FG002|NOT COMPLETED|Overall Study||1
6453198|NCT01162486|7369132|FG003|NOT COMPLETED|Overall Study||1
6453199|NCT01162486|7369133|FG004|NOT COMPLETED|Overall Study||0
6453200|NCT01162499|7369149|FG000|STARTED|Intervention 1 (4 Hours)||3
6453201|NCT01162499|7369150|FG001|STARTED|Intervention 1 (4 Hours)||4
6453202|NCT01162499|7369149|FG000|Received Intervention|Intervention 1 (4 Hours)||3
6453203|NCT01162499|7369150|FG001|Received Intervention|Intervention 1 (4 Hours)||3
6453204|NCT01162499|7369149|FG000|COMPLETED|Intervention 1 (4 Hours)||3
6453205|NCT01162499|7369150|FG001|COMPLETED|Intervention 1 (4 Hours)||3
6453206|NCT01162499|7369149|FG000|NOT COMPLETED|Intervention 1 (4 Hours)||0
6453207|NCT01162499|7369150|FG001|NOT COMPLETED|Intervention 1 (4 Hours)||1
6453208|NCT01162499|7369149|FG000|STARTED|Intervention 2 (4 Hours)||3
6453209|NCT01162499|7369150|FG001|STARTED|Intervention 2 (4 Hours)||3
6453210|NCT01162499|7369149|FG000|COMPLETED|Intervention 2 (4 Hours)||3
6453211|NCT01162499|7369150|FG001|COMPLETED|Intervention 2 (4 Hours)||3
6453212|NCT01162499|7369149|FG000|NOT COMPLETED|Intervention 2 (4 Hours)||0
6453213|NCT01162499|7369150|FG001|NOT COMPLETED|Intervention 2 (4 Hours)||0
6453214|NCT01162551|7369158|FG000|STARTED|Overall Study|2 subjects were enrolled but withdrew before receiving any study treatment|3
6453215|NCT01162551|7369158|FG000|COMPLETED|Overall Study||3
6453216|NCT01162551|7369158|FG000|NOT COMPLETED|Overall Study||0
6453217|NCT01162733|7369164|FG000|STARTED|Overall Study||49
6453218|NCT01162733|7369165|FG001|STARTED|Overall Study||50
6453219|NCT01162733|7369164|FG000|COMPLETED|Overall Study||22
6453220|NCT01162733|7369165|FG001|COMPLETED|Overall Study||25
6453221|NCT01162733|7369164|FG000|NOT COMPLETED|Overall Study||27
6553512|NCT01743989|7475976|FG000|STARTED|Treatment Phase||120
6553513|NCT01743989|7475977|FG001|STARTED|Treatment Phase||119
6553514|NCT01743989|7475978|FG002|STARTED|Treatment Phase||381
6553515|NCT01743989|7475976|FG000|Participants Who Signed Informed Consent|Treatment Phase||120
6453222|NCT01162733|7369165|FG001|NOT COMPLETED|Overall Study||25
6453223|NCT01162863|7369174|FG000|STARTED|Overall Study||18
6453224|NCT01162863|7369175|FG001|STARTED|Overall Study||17
6453225|NCT01162863|7369176|FG002|STARTED|Overall Study||17
6453226|NCT01162863|7369174|FG000|COMPLETED|Overall Study||17
6453227|NCT01162863|7369175|FG001|COMPLETED|Overall Study||16
6553516|NCT01743989|7475977|FG001|Participants Who Signed Informed Consent|Treatment Phase||118
6553517|NCT01743989|7475978|FG002|Participants Who Signed Informed Consent|Treatment Phase||381
6453228|NCT01162863|7369176|FG002|COMPLETED|Overall Study||17
6453229|NCT01162863|7369174|FG000|NOT COMPLETED|Overall Study||1
6453230|NCT01162863|7369175|FG001|NOT COMPLETED|Overall Study||1
6453231|NCT01162863|7369176|FG002|NOT COMPLETED|Overall Study||0
6453232|NCT01163032|7369187|FG000|STARTED|Randomization Phase||42
6453233|NCT01163032|7369188|FG001|STARTED|Randomization Phase||42
6453234|NCT01163032|7369189|FG002|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
6453235|NCT01163032|7369187|FG000|COMPLETED|Randomization Phase||32
6453236|NCT01163032|7369188|FG001|COMPLETED|Randomization Phase||30
6453237|NCT01163032|7369189|FG002|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
6453238|NCT01163032|7369187|FG000|NOT COMPLETED|Randomization Phase||10
6453239|NCT01163032|7369188|FG001|NOT COMPLETED|Randomization Phase||12
6453240|NCT01163032|7369189|FG002|NOT COMPLETED|Randomization Phase||0
6453241|NCT01163032|7369187|FG000|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
6453242|NCT01163032|7369188|FG001|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
6453243|NCT01163032|7369189|FG002|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
6453244|NCT01163032|7369187|FG000|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
6453245|NCT01163032|7369188|FG001|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
6453246|NCT01163032|7369189|FG002|COMPLETED|Open Label Extension Phase||39
6453247|NCT01163032|7369187|FG000|NOT COMPLETED|Open Label Extension Phase||0
6453248|NCT01163032|7369188|FG001|NOT COMPLETED|Open Label Extension Phase||0
6453249|NCT01163032|7369189|FG002|NOT COMPLETED|Open Label Extension Phase||16
6453250|NCT01163097|7369200|FG000|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
6453251|NCT01163097|7369201|FG001|STARTED|Overall Study||16
6453252|NCT01163097|7369202|FG002|STARTED|Overall Study||8
6453253|NCT01163097|7369200|FG000|COMPLETED|Overall Study||14
6453254|NCT01163097|7369201|FG001|COMPLETED|Overall Study||16
6453255|NCT01163097|7369202|FG002|COMPLETED|Overall Study||8
6453256|NCT01163097|7369200|FG000|NOT COMPLETED|Overall Study||6
6453257|NCT01163097|7369201|FG001|NOT COMPLETED|Overall Study||0
6453258|NCT01163097|7369202|FG002|NOT COMPLETED|Overall Study||0
6453259|NCT01163149|7369215|FG000|STARTED|Primary Treatment Period||7
6453260|NCT01163149|7369216|FG001|STARTED|Primary Treatment Period||6
6453261|NCT01163149|7369217|FG002|STARTED|Primary Treatment Period||6
6453262|NCT01163149|7369215|FG000|COMPLETED|Primary Treatment Period||7
6453263|NCT01163149|7369216|FG001|COMPLETED|Primary Treatment Period||6
6453264|NCT01163149|7369217|FG002|COMPLETED|Primary Treatment Period||6
6453265|NCT01163149|7369215|FG000|NOT COMPLETED|Primary Treatment Period||0
6453266|NCT01163149|7369216|FG001|NOT COMPLETED|Primary Treatment Period||0
6453267|NCT01163149|7369217|FG002|NOT COMPLETED|Primary Treatment Period||0
6453268|NCT01163149|7369215|FG000|STARTED|Extension Treatment Period||7
6453269|NCT01163149|7369216|FG001|STARTED|Extension Treatment Period||6
6453270|NCT01163149|7369217|FG002|STARTED|Extension Treatment Period||6
6453271|NCT01163149|7369215|FG000|COMPLETED|Extension Treatment Period||5
6453272|NCT01163149|7369216|FG001|COMPLETED|Extension Treatment Period||5
6453273|NCT01163149|7369217|FG002|COMPLETED|Extension Treatment Period||4
6453274|NCT01163149|7369215|FG000|NOT COMPLETED|Extension Treatment Period||2
6453275|NCT01163149|7369216|FG001|NOT COMPLETED|Extension Treatment Period||1
6453276|NCT01163149|7369217|FG002|NOT COMPLETED|Extension Treatment Period||2
6453277|NCT01163162|7369239|FG000|STARTED|Overall Study||16
6453278|NCT01163162|7369239|FG000|COMPLETED|Overall Study||16
6453279|NCT01163162|7369239|FG000|NOT COMPLETED|Overall Study||0
6453280|NCT01163214|7369245|FG000|STARTED|Overall Study||79
6453281|NCT01163214|7369246|FG001|STARTED|Overall Study||81
6453282|NCT01163214|7369245|FG000|COMPLETED|Overall Study||79
6453283|NCT01163214|7369246|FG001|COMPLETED|Overall Study||81
6453284|NCT01163214|7369245|FG000|NOT COMPLETED|Overall Study||0
6453285|NCT01163214|7369246|FG001|NOT COMPLETED|Overall Study||0
6453286|NCT01163253|7369254|FG000|STARTED|Overall Study||2281
6453287|NCT01163253|7369255|FG001|STARTED|Overall Study||586
6453288|NCT01163253|7369254|FG000|COMPLETED|Overall Study||0
6453289|NCT01163253|7369255|FG001|COMPLETED|Overall Study||0
6453290|NCT01163253|7369254|FG000|NOT COMPLETED|Overall Study||2281
6453291|NCT01163253|7369255|FG001|NOT COMPLETED|Overall Study||586
6453292|NCT01163266|7369264|FG000|STARTED|Overall Study||157
6453293|NCT01163266|7369265|FG001|STARTED|Overall Study||155
6453294|NCT01163266|7369266|FG002|STARTED|Overall Study||150
6453295|NCT01163266|7369264|FG000|Treated|Overall Study||157
6453296|NCT01163266|7369265|FG001|Treated|Overall Study||155
6453297|NCT01163266|7369266|FG002|Treated|Overall Study||150
6453298|NCT01163266|7369264|FG000|COMPLETED|Overall Study||139
6453299|NCT01163266|7369265|FG001|COMPLETED|Overall Study||124
6453300|NCT01163266|7369266|FG002|COMPLETED|Overall Study||122
6453301|NCT01163266|7369264|FG000|NOT COMPLETED|Overall Study||18
6453302|NCT01163266|7369265|FG001|NOT COMPLETED|Overall Study||31
6453303|NCT01163266|7369266|FG002|NOT COMPLETED|Overall Study||28
6453304|NCT01163279|7369276|FG000|STARTED|Overall Study||10
6453305|NCT01163279|7369277|FG001|STARTED|Overall Study||9
6453306|NCT01163279|7369276|FG000|COMPLETED|Overall Study||8
6453307|NCT01163279|7369277|FG001|COMPLETED|Overall Study||9
6453308|NCT01163279|7369276|FG000|NOT COMPLETED|Overall Study||2
6453309|NCT01163279|7369277|FG001|NOT COMPLETED|Overall Study||0
6453310|NCT01163292|7369286|FG000|STARTED|Overall Study||106
6453311|NCT01163292|7369287|FG001|STARTED|Overall Study||114
6453312|NCT01163292|7369286|FG000|COMPLETED|Overall Study||65
6453313|NCT01163292|7369287|FG001|COMPLETED|Overall Study||92
6453314|NCT01163292|7369286|FG000|NOT COMPLETED|Overall Study||41
6453315|NCT01163292|7369287|FG001|NOT COMPLETED|Overall Study||22
6453316|NCT01163318|7369293|FG000|STARTED|Overall Study||552
6453317|NCT01163318|7369293|FG000|COMPLETED|Overall Study||284
6453318|NCT01163318|7369293|FG000|NOT COMPLETED|Overall Study||268
6453319|NCT01163461|7369297|FG000|STARTED|Overall Study||14
6453320|NCT01163461|7369298|FG001|STARTED|Overall Study||14
6453321|NCT01163461|7369297|FG000|COMPLETED|Overall Study||14
6453322|NCT01163461|7369298|FG001|COMPLETED|Overall Study||14
6453323|NCT01163461|7369297|FG000|NOT COMPLETED|Overall Study||0
6453324|NCT01163461|7369298|FG001|NOT COMPLETED|Overall Study||0
6453325|NCT01163474|7369302|FG000|STARTED|Overall Study||40
6453326|NCT01163474|7369302|FG000|COMPLETED|Overall Study||24
6453327|NCT01163474|7369302|FG000|NOT COMPLETED|Overall Study||16
6453328|NCT01163604|7369311|FG000|STARTED|Overall Study|August 2010|58
6453329|NCT01163604|7369312|FG001|STARTED|Overall Study|August 2010|56
6453330|NCT01163604|7369311|FG000|COMPLETED|Overall Study|August 2011|58
6453331|NCT01163604|7369312|FG001|COMPLETED|Overall Study|August 2011|56
6453332|NCT01163604|7369311|FG000|NOT COMPLETED|Overall Study||0
6453333|NCT01163604|7369312|FG001|NOT COMPLETED|Overall Study||0
6453334|NCT01163617|7369318|FG000|STARTED|Phase A (User Experience), Weeks 0 and 2||19
6453335|NCT01163617|7369319|FG001|STARTED|Phase A (User Experience), Weeks 0 and 2||23
6453336|NCT01163617|7369320|FG002|STARTED|Phase A (User Experience), Weeks 0 and 2||21
6453337|NCT01163617|7369321|FG003|STARTED|Phase A (User Experience), Weeks 0 and 2||21
6453338|NCT01163617|7369322|FG004|STARTED|Phase A (User Experience), Weeks 0 and 2||0
6453339|NCT01163617|7369323|FG005|STARTED|Phase A (User Experience), Weeks 0 and 2||0
6453340|NCT01163617|7369324|FG006|STARTED|Phase A (User Experience), Weeks 0 and 2||0
6453341|NCT01163617|7369325|FG007|STARTED|Phase A (User Experience), Weeks 0 and 2||0
6453342|NCT01163617|7369318|FG000|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
6453343|NCT01163617|7369319|FG001|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
6453344|NCT01163617|7369320|FG002|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
6453345|NCT01163617|7369321|FG003|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
6453346|NCT01163617|7369322|FG004|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453347|NCT01163617|7369323|FG005|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453348|NCT01163617|7369324|FG006|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453349|NCT01163617|7369325|FG007|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453350|NCT01163617|7369318|FG000|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453351|NCT01163617|7369319|FG001|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
6453352|NCT01163617|7369320|FG002|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
6453353|NCT01163617|7369321|FG003|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453354|NCT01163617|7369322|FG004|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453355|NCT01163617|7369323|FG005|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453356|NCT01163617|7369324|FG006|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453357|NCT01163617|7369325|FG007|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
6453358|NCT01163617|7369318|FG000|STARTED|Phase B (Injection Time), Week 4||0
6453359|NCT01163617|7369319|FG001|STARTED|Phase B (Injection Time), Week 4||0
6453360|NCT01163617|7369320|FG002|STARTED|Phase B (Injection Time), Week 4||0
6453361|NCT01163617|7369321|FG003|STARTED|Phase B (Injection Time), Week 4||0
6453362|NCT01163617|7369322|FG004|STARTED|Phase B (Injection Time), Week 4||18
6453363|NCT01163617|7369323|FG005|STARTED|Phase B (Injection Time), Week 4||27
6453364|NCT01163617|7369324|FG006|STARTED|Phase B (Injection Time), Week 4||16
6453365|NCT01163617|7369325|FG007|STARTED|Phase B (Injection Time), Week 4||20
6453366|NCT01163617|7369318|FG000|COMPLETED|Phase B (Injection Time), Week 4||0
6453367|NCT01163617|7369319|FG001|COMPLETED|Phase B (Injection Time), Week 4||0
6453368|NCT01163617|7369320|FG002|COMPLETED|Phase B (Injection Time), Week 4||0
6453369|NCT01163617|7369321|FG003|COMPLETED|Phase B (Injection Time), Week 4||0
6453370|NCT01163617|7369322|FG004|COMPLETED|Phase B (Injection Time), Week 4||18
6453371|NCT01163617|7369323|FG005|COMPLETED|Phase B (Injection Time), Week 4||27
6453372|NCT01163617|7369324|FG006|COMPLETED|Phase B (Injection Time), Week 4||16
6453373|NCT01163617|7369325|FG007|COMPLETED|Phase B (Injection Time), Week 4||20
6453374|NCT01163617|7369318|FG000|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6453375|NCT01163617|7369319|FG001|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6745109|NCT03354637|7673173|FG000|NOT COMPLETED|Open Label Extension||0
6745110|NCT03354637|7673174|FG001|NOT COMPLETED|Open Label Extension||0
6745111|NCT03354637|7673175|FG002|NOT COMPLETED|Open Label Extension||28
6745112|NCT03354663|7673184|FG000|STARTED|Enrollment to Catheter Insertion||156
6745113|NCT03354663|7673184|FG000|COMPLETED|Enrollment to Catheter Insertion||151
6745114|NCT03354663|7673184|FG000|NOT COMPLETED|Enrollment to Catheter Insertion||5
6745115|NCT03354663|7673184|FG000|STARTED|Completed 30-day Visit||151
6453376|NCT01163617|7369320|FG002|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6453377|NCT01163617|7369321|FG003|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6453378|NCT01163617|7369322|FG004|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6453379|NCT01163617|7369323|FG005|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6745116|NCT03354663|7673184|FG000|COMPLETED|Completed 30-day Visit||149
6745117|NCT03354663|7673184|FG000|NOT COMPLETED|Completed 30-day Visit||2
6453380|NCT01163617|7369324|FG006|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6453381|NCT01163617|7369325|FG007|NOT COMPLETED|Phase B (Injection Time), Week 4||0
6453382|NCT01163643|7369351|FG000|STARTED|Overall Study||68
6453383|NCT01163643|7369352|FG001|STARTED|Overall Study||37
6453384|NCT01163643|7369353|FG002|STARTED|Overall Study||35
6453385|NCT01163643|7369354|FG003|STARTED|Overall Study||74
6453386|NCT01163643|7369355|FG004|STARTED|Overall Study||69
6453387|NCT01163643|7369356|FG005|STARTED|Overall Study||73
6453388|NCT01163643|7369351|FG000|COMPLETED|Overall Study||62
6453389|NCT01163643|7369352|FG001|COMPLETED|Overall Study||35
6453390|NCT01163643|7369353|FG002|COMPLETED|Overall Study||33
6453391|NCT01163643|7369354|FG003|COMPLETED|Overall Study||69
6453392|NCT01163643|7369355|FG004|COMPLETED|Overall Study||61
6453393|NCT01163643|7369356|FG005|COMPLETED|Overall Study||66
6453394|NCT01163643|7369351|FG000|NOT COMPLETED|Overall Study||6
6453395|NCT01163643|7369352|FG001|NOT COMPLETED|Overall Study||2
6453396|NCT01163643|7369353|FG002|NOT COMPLETED|Overall Study||2
6453397|NCT01163643|7369354|FG003|NOT COMPLETED|Overall Study||5
6453398|NCT01163643|7369355|FG004|NOT COMPLETED|Overall Study||8
6453399|NCT01163643|7369356|FG005|NOT COMPLETED|Overall Study||7
6453400|NCT01163656|7369372|FG000|STARTED|Overall Study||33
6453401|NCT01163656|7369373|FG001|STARTED|Overall Study||33
6453402|NCT01163656|7369372|FG000|COMPLETED|Overall Study||30
6453403|NCT01163656|7369373|FG001|COMPLETED|Overall Study||30
6453404|NCT01163656|7369372|FG000|NOT COMPLETED|Overall Study||3
6453405|NCT01163656|7369373|FG001|NOT COMPLETED|Overall Study||3
6453406|NCT01163721|7369381|FG000|STARTED|Overall Study||39
6453407|NCT01163721|7369382|FG001|STARTED|Overall Study||41
6453408|NCT01163721|7369381|FG000|COMPLETED|Overall Study||31
6453409|NCT01163721|7369382|FG001|COMPLETED|Overall Study||29
6453410|NCT01163721|7369381|FG000|NOT COMPLETED|Overall Study||8
6453411|NCT01163721|7369382|FG001|NOT COMPLETED|Overall Study||12
6453412|NCT01163747|7369390|FG000|STARTED|Overall Study||31
6453413|NCT01163747|7369391|FG001|STARTED|Overall Study||60
6453414|NCT01163747|7369390|FG000|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
6453415|NCT01163747|7369391|FG001|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
6453416|NCT01163747|7369390|FG000|COMPLETED|Overall Study||25
6453417|NCT01163747|7369391|FG001|COMPLETED|Overall Study||49
6453418|NCT01163747|7369390|FG000|NOT COMPLETED|Overall Study||6
6453419|NCT01163747|7369391|FG001|NOT COMPLETED|Overall Study||11
6453420|NCT01163760|7369397|FG000|STARTED|Period 1 (Fit)||12
6453421|NCT01163760|7369398|FG001|STARTED|Period 1 (Fit)||13
6453422|NCT01163760|7369399|FG002|STARTED|Period 1 (Fit)||13
6453423|NCT01163760|7369400|FG003|STARTED|Period 1 (Fit)||12
6453424|NCT01163760|7369397|FG000|COMPLETED|Period 1 (Fit)||12
6453425|NCT01163760|7369398|FG001|COMPLETED|Period 1 (Fit)||13
6453426|NCT01163760|7369399|FG002|COMPLETED|Period 1 (Fit)||13
6453427|NCT01163760|7369400|FG003|COMPLETED|Period 1 (Fit)||12
6453428|NCT01163760|7369397|FG000|NOT COMPLETED|Period 1 (Fit)||0
6453429|NCT01163760|7369398|FG001|NOT COMPLETED|Period 1 (Fit)||0
6453430|NCT01163760|7369399|FG002|NOT COMPLETED|Period 1 (Fit)||0
6453431|NCT01163760|7369400|FG003|NOT COMPLETED|Period 1 (Fit)||0
6453432|NCT01163760|7369397|FG000|STARTED|Period 2 (Follow-up)||12
6453433|NCT01163760|7369398|FG001|STARTED|Period 2 (Follow-up)||13
6453434|NCT01163760|7369399|FG002|STARTED|Period 2 (Follow-up)||13
6453435|NCT01163760|7369400|FG003|STARTED|Period 2 (Follow-up)||12
6453436|NCT01163760|7369397|FG000|COMPLETED|Period 2 (Follow-up)||12
6453437|NCT01163760|7369398|FG001|COMPLETED|Period 2 (Follow-up)||13
6453438|NCT01163760|7369399|FG002|COMPLETED|Period 2 (Follow-up)||13
6453439|NCT01163760|7369400|FG003|COMPLETED|Period 2 (Follow-up)||12
6453440|NCT01163760|7369397|FG000|NOT COMPLETED|Period 2 (Follow-up)||0
6453441|NCT01163760|7369398|FG001|NOT COMPLETED|Period 2 (Follow-up)||0
6453442|NCT01163760|7369399|FG002|NOT COMPLETED|Period 2 (Follow-up)||0
6453443|NCT01163760|7369400|FG003|NOT COMPLETED|Period 2 (Follow-up)||0
6453444|NCT01163760|7369397|FG000|STARTED|Period 3 (Fit)||12
6453445|NCT01163760|7369398|FG001|STARTED|Period 3 (Fit)||13
6453446|NCT01163760|7369399|FG002|STARTED|Period 3 (Fit)||13
6453447|NCT01163760|7369400|FG003|STARTED|Period 3 (Fit)||12
6453448|NCT01163760|7369397|FG000|COMPLETED|Period 3 (Fit)||12
6453449|NCT01163760|7369398|FG001|COMPLETED|Period 3 (Fit)||13
6453450|NCT01163760|7369399|FG002|COMPLETED|Period 3 (Fit)||13
6453451|NCT01163760|7369400|FG003|COMPLETED|Period 3 (Fit)||12
6453452|NCT01163760|7369397|FG000|NOT COMPLETED|Period 3 (Fit)||0
6453453|NCT01163760|7369398|FG001|NOT COMPLETED|Period 3 (Fit)||0
6453454|NCT01163760|7369399|FG002|NOT COMPLETED|Period 3 (Fit)||0
6453455|NCT01163760|7369400|FG003|NOT COMPLETED|Period 3 (Fit)||0
6453456|NCT01163760|7369397|FG000|STARTED|Period 4 (Follow-up)||12
6453457|NCT01163760|7369398|FG001|STARTED|Period 4 (Follow-up)||13
6453458|NCT01163760|7369399|FG002|STARTED|Period 4 (Follow-up)||13
6453459|NCT01163760|7369400|FG003|STARTED|Period 4 (Follow-up)||12
6453460|NCT01163760|7369397|FG000|COMPLETED|Period 4 (Follow-up)||12
6453461|NCT01163760|7369398|FG001|COMPLETED|Period 4 (Follow-up)||13
6453462|NCT01163760|7369399|FG002|COMPLETED|Period 4 (Follow-up)||13
6453463|NCT01163760|7369400|FG003|COMPLETED|Period 4 (Follow-up)||12
6453464|NCT01163760|7369397|FG000|NOT COMPLETED|Period 4 (Follow-up)||0
6453465|NCT01163760|7369398|FG001|NOT COMPLETED|Period 4 (Follow-up)||0
6453466|NCT01163760|7369399|FG002|NOT COMPLETED|Period 4 (Follow-up)||0
6453467|NCT01163760|7369400|FG003|NOT COMPLETED|Period 4 (Follow-up)||0
6453468|NCT01163786|7369408|FG000|STARTED|Treatment With Bortezomib||17
6453469|NCT01163786|7369408|FG000|Completed 1st Cycle|Treatment With Bortezomib||17
6453470|NCT01163786|7369408|FG000|Completed 2nd Cycle|Treatment With Bortezomib|One patient completed cycle 2 but missed one dose of Bortezomib.|14
6453471|NCT01163786|7369408|FG000|COMPLETED|Treatment With Bortezomib||14
6453472|NCT01163786|7369408|FG000|NOT COMPLETED|Treatment With Bortezomib||3
6453473|NCT01163786|7369408|FG000|STARTED|Completed Follow up (Visit 9 and 10)||14
6453474|NCT01163786|7369408|FG000|Completed Week 12 Follow up (Visit 9)|Completed Follow up (Visit 9 and 10)||14
6453475|NCT01163786|7369408|FG000|Completed Week 18 Follow up (Visit 10)|Completed Follow up (Visit 9 and 10)||13
6453476|NCT01163786|7369408|FG000|COMPLETED|Completed Follow up (Visit 9 and 10)||13
6453477|NCT01163786|7369408|FG000|NOT COMPLETED|Completed Follow up (Visit 9 and 10)||1
6500491|NCT01424670|7419171|FG001|COMPLETED|Continuation Period||142
6500492|NCT01424670|7419170|FG000|NOT COMPLETED|Continuation Period||34
6500493|NCT01424670|7419171|FG001|NOT COMPLETED|Continuation Period||14
6500494|NCT01424722|7419179|FG000|STARTED|Overall Study||2258
6500495|NCT01424722|7419179|FG000|COMPLETED|Overall Study||0
6500496|NCT01424722|7419179|FG000|NOT COMPLETED|Overall Study||2258
6500497|NCT01424813|7419185|FG000|STARTED|Overall Study||79
6500498|NCT01424813|7419186|FG001|STARTED|Overall Study||79
6500499|NCT01424813|7419185|FG000|Treated|Overall Study|Safety set and full analysis set|79
6500500|NCT01424813|7419186|FG001|Treated|Overall Study|Safety set and full analysis set|78
6500501|NCT01424813|7419185|FG000|COMPLETED|Overall Study||74
6500502|NCT01424813|7419186|FG001|COMPLETED|Overall Study||77
6500503|NCT01424813|7419185|FG000|NOT COMPLETED|Overall Study||5
6500504|NCT01424813|7419186|FG001|NOT COMPLETED|Overall Study||2
6500505|NCT01424930|7419194|FG000|STARTED|Overall Study||7
6500506|NCT01424930|7419195|FG001|STARTED|Overall Study||18
6500507|NCT01424930|7419194|FG000|Completed Food Safety Evaluation|Overall Study||6
6500508|NCT01424930|7419195|FG001|Completed Food Safety Evaluation|Overall Study||18
6500509|NCT01424930|7419194|FG000|COMPLETED|Overall Study||3
6500510|NCT01424930|7419195|FG001|COMPLETED|Overall Study||4
6500511|NCT01424930|7419194|FG000|NOT COMPLETED|Overall Study||4
6500512|NCT01424930|7419195|FG001|NOT COMPLETED|Overall Study||14
6500513|NCT01424943|7419203|FG000|STARTED|Overall Study||25
6500514|NCT01424943|7419204|FG001|STARTED|Overall Study||24
6500515|NCT01424943|7419203|FG000|COMPLETED|Overall Study||12
6500516|NCT01424943|7419204|FG001|COMPLETED|Overall Study||23
6500517|NCT01424943|7419203|FG000|NOT COMPLETED|Overall Study||13
6500518|NCT01424943|7419204|FG001|NOT COMPLETED|Overall Study||1
6500519|NCT01425190|7419213|FG000|STARTED|Overall Study||16
6500520|NCT01425190|7419214|FG001|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
6500521|NCT01425190|7419215|FG002|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
6500522|NCT01425190|7419213|FG000|COMPLETED|Overall Study||15
6500523|NCT01425190|7419214|FG001|COMPLETED|Overall Study||0
6500524|NCT01425190|7419215|FG002|COMPLETED|Overall Study||0
6500525|NCT01425190|7419213|FG000|NOT COMPLETED|Overall Study||1
6500526|NCT01425190|7419214|FG001|NOT COMPLETED|Overall Study||0
6500527|NCT01425190|7419215|FG002|NOT COMPLETED|Overall Study||0
6500528|NCT01425203|7419225|FG000|STARTED|Treatment Phase||159
6500529|NCT01425203|7419226|FG001|STARTED|Treatment Phase||79
6500530|NCT01425203|7419227|FG002|STARTED|Treatment Phase||0
6500531|NCT01425203|7419225|FG000|Treated (FAS)|Treatment Phase||159
6500532|NCT01425203|7419226|FG001|Treated (FAS)|Treatment Phase||78
6500533|NCT01425203|7419227|FG002|Treated (FAS)|Treatment Phase||0
6500534|NCT01425203|7419225|FG000|COMPLETED|Treatment Phase||132
6500535|NCT01425203|7419226|FG001|COMPLETED|Treatment Phase||42
6500536|NCT01425203|7419227|FG002|COMPLETED|Treatment Phase||0
6500537|NCT01425203|7419225|FG000|NOT COMPLETED|Treatment Phase||27
6500538|NCT01425203|7419226|FG001|NOT COMPLETED|Treatment Phase||37
6500539|NCT01425203|7419227|FG002|NOT COMPLETED|Treatment Phase||0
6500540|NCT01425203|7419225|FG000|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
6500541|NCT01425203|7419226|FG001|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
6500542|NCT01425203|7419227|FG002|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
6500543|NCT01425203|7419225|FG000|COMPLETED|Crossover Phase||0
6500544|NCT01425203|7419226|FG001|COMPLETED|Crossover Phase||0
6500545|NCT01425203|7419227|FG002|COMPLETED|Crossover Phase||21
6500546|NCT01425203|7419225|FG000|NOT COMPLETED|Crossover Phase||0
6500547|NCT01425203|7419226|FG001|NOT COMPLETED|Crossover Phase||0
6500548|NCT01425203|7419227|FG002|NOT COMPLETED|Crossover Phase||6
6500549|NCT01425203|7419225|FG000|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
6500550|NCT01425203|7419226|FG001|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
6500551|NCT01425203|7419227|FG002|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
6500552|NCT01425203|7419225|FG000|COMPLETED|Follow-up Phase||153
6500553|NCT01425203|7419226|FG001|COMPLETED|Follow-up Phase||49
6500554|NCT01425203|7419227|FG002|COMPLETED|Follow-up Phase||27
6500555|NCT01425203|7419225|FG000|NOT COMPLETED|Follow-up Phase||0
6500556|NCT01425203|7419226|FG001|NOT COMPLETED|Follow-up Phase||0
6500557|NCT01425203|7419227|FG002|NOT COMPLETED|Follow-up Phase||0
6500558|NCT01425229|7419235|FG000|STARTED|Bosentan Single Dose||16
6500559|NCT01425229|7419235|FG000|COMPLETED|Bosentan Single Dose||16
6500560|NCT01425229|7419235|FG000|NOT COMPLETED|Bosentan Single Dose||0
6500561|NCT01425229|7419235|FG000|STARTED|Bosentan Steady-state||16
6500562|NCT01425229|7419235|FG000|COMPLETED|Bosentan Steady-state||16
6500563|NCT01425229|7419235|FG000|NOT COMPLETED|Bosentan Steady-state||0
6500564|NCT01425229|7419235|FG000|STARTED|Bosentan During Clarithromycin||16
6500565|NCT01425229|7419235|FG000|COMPLETED|Bosentan During Clarithromycin||16
6500566|NCT01425229|7419235|FG000|NOT COMPLETED|Bosentan During Clarithromycin||0
6745118|NCT03354754|7673194|FG000|STARTED|Overall Study||2
6745119|NCT03354754|7673195|FG001|STARTED|Overall Study||1
6745120|NCT03354754|7673194|FG000|COMPLETED|Overall Study||2
6745121|NCT03354754|7673195|FG001|COMPLETED|Overall Study||1
6745122|NCT03354754|7673194|FG000|NOT COMPLETED|Overall Study||0
6453478|NCT01163851|7369414|FG000|STARTED|Overall Study||13
6453479|NCT01163851|7369415|FG001|STARTED|Overall Study||12
6453480|NCT01163851|7369414|FG000|Treated|Overall Study||12
6453481|NCT01163851|7369415|FG001|Treated|Overall Study||12
6453482|NCT01163851|7369414|FG000|COMPLETED|Overall Study||12
6453483|NCT01163851|7369415|FG001|COMPLETED|Overall Study||11
6453484|NCT01163851|7369414|FG000|NOT COMPLETED|Overall Study||1
6453485|NCT01163851|7369415|FG001|NOT COMPLETED|Overall Study||1
6453486|NCT01163916|7369424|FG000|STARTED|Overall Study||126
6453487|NCT01163916|7369425|FG001|STARTED|Overall Study||35
6453488|NCT01163916|7369426|FG002|STARTED|Overall Study||91
6453489|NCT01163916|7369424|FG000|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
6453490|NCT01163916|7369425|FG001|Safety Population|Overall Study||35
6453491|NCT01163916|7369426|FG002|Safety Population|Overall Study||91
6453492|NCT01163916|7369424|FG000|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
6453493|NCT01163916|7369425|FG001|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
6453494|NCT01163916|7369426|FG002|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
6453495|NCT01163916|7369424|FG000|NOT COMPLETED|Overall Study||30
6453496|NCT01163916|7369425|FG001|NOT COMPLETED|Overall Study||4
6453497|NCT01163916|7369426|FG002|NOT COMPLETED|Overall Study||20
6453498|NCT01163955|7369441|FG000|STARTED|Overall Study||26
6453499|NCT01163955|7369442|FG001|STARTED|Overall Study||30
6453500|NCT01163955|7369441|FG000|COMPLETED|Overall Study||26
6453501|NCT01163955|7369442|FG001|COMPLETED|Overall Study||26
6453502|NCT01163955|7369441|FG000|NOT COMPLETED|Overall Study||0
6453503|NCT01163955|7369442|FG001|NOT COMPLETED|Overall Study||4
6453504|NCT01164007|7369448|FG000|STARTED|Overall Study||40
6453505|NCT01164007|7369448|FG000|Treated|Overall Study||37
6453506|NCT01164007|7369448|FG000|COMPLETED|Overall Study||0
6453507|NCT01164007|7369448|FG000|NOT COMPLETED|Overall Study||40
6453508|NCT01164098|7369454|FG000|STARTED|Overall Study||15
6453509|NCT01164098|7369455|FG001|STARTED|Overall Study||15
6453510|NCT01164098|7369454|FG000|COMPLETED|Overall Study||15
6453511|NCT01164098|7369455|FG001|COMPLETED|Overall Study||15
6453512|NCT01164098|7369454|FG000|NOT COMPLETED|Overall Study||0
6453513|NCT01164098|7369455|FG001|NOT COMPLETED|Overall Study||0
6453514|NCT01164137|7369463|FG000|STARTED|Overall Study||80
6453515|NCT01164137|7369464|FG001|STARTED|Overall Study||76
6453516|NCT01164137|7369463|FG000|COMPLETED|Overall Study||77
6453517|NCT01164137|7369464|FG001|COMPLETED|Overall Study||76
6453518|NCT01164137|7369463|FG000|NOT COMPLETED|Overall Study||3
6453519|NCT01164137|7369464|FG001|NOT COMPLETED|Overall Study||0
6453520|NCT01164475|7369472|FG000|STARTED|Overall Study||30
6453521|NCT01164475|7369473|FG001|STARTED|Overall Study||31
6453522|NCT01164475|7369472|FG000|COMPLETED|Overall Study||28
6453523|NCT01164475|7369473|FG001|COMPLETED|Overall Study||29
6453524|NCT01164475|7369472|FG000|NOT COMPLETED|Overall Study||2
6453525|NCT01164475|7369473|FG001|NOT COMPLETED|Overall Study||2
6453526|NCT01164501|7369482|FG000|STARTED|Overall Study||321
6453527|NCT01164501|7369483|FG001|STARTED|Overall Study||98
6453528|NCT01164501|7369484|FG002|STARTED|Overall Study||322
6453529|NCT01164501|7369482|FG000|COMPLETED|Overall Study||278
6453530|NCT01164501|7369483|FG001|COMPLETED|Overall Study||88
6453531|NCT01164501|7369484|FG002|COMPLETED|Overall Study||280
6453532|NCT01164501|7369482|FG000|NOT COMPLETED|Overall Study||43
6453533|NCT01164501|7369483|FG001|NOT COMPLETED|Overall Study||10
6453534|NCT01164501|7369484|FG002|NOT COMPLETED|Overall Study||42
6453535|NCT01164579|7369497|FG000|STARTED|Overall Study||36
6453536|NCT01164579|7369498|FG001|STARTED|Overall Study||36
6453537|NCT01164579|7369499|FG002|STARTED|Overall Study||37
6453538|NCT01164579|7369497|FG000|COMPLETED|Overall Study||28
6453539|NCT01164579|7369498|FG001|COMPLETED|Overall Study||27
6453540|NCT01164579|7369499|FG002|COMPLETED|Overall Study||21
6453541|NCT01164579|7369497|FG000|NOT COMPLETED|Overall Study||8
6453542|NCT01164579|7369498|FG001|NOT COMPLETED|Overall Study||9
6453543|NCT01164579|7369499|FG002|NOT COMPLETED|Overall Study||16
6453544|NCT01164644|7369510|FG000|STARTED|Overall Study||12
6453545|NCT01164644|7369511|FG001|STARTED|Overall Study||14
6745123|NCT03354754|7673195|FG001|NOT COMPLETED|Overall Study||0
6453546|NCT01164644|7369510|FG000|COMPLETED|Overall Study||9
6453547|NCT01164644|7369511|FG001|COMPLETED|Overall Study||13
6453548|NCT01164644|7369510|FG000|NOT COMPLETED|Overall Study||3
6453549|NCT01164644|7369511|FG001|NOT COMPLETED|Overall Study||1
6453550|NCT01164722|7369519|FG000|STARTED|Overall Study||60
6453551|NCT01164722|7369520|FG001|STARTED|Overall Study||60
6453552|NCT01164722|7369519|FG000|COMPLETED|Overall Study||42
6453553|NCT01164722|7369520|FG001|COMPLETED|Overall Study||45
6453554|NCT01164722|7369519|FG000|NOT COMPLETED|Overall Study||18
6453555|NCT01164722|7369520|FG001|NOT COMPLETED|Overall Study||15
6453556|NCT01164865|7369528|FG000|STARTED|Overall Study||39
6453557|NCT01164865|7369529|FG001|STARTED|Overall Study||39
6453558|NCT01164865|7369528|FG000|COMPLETED|Overall Study||37
6453559|NCT01164865|7369529|FG001|COMPLETED|Overall Study||38
6453560|NCT01164865|7369528|FG000|NOT COMPLETED|Overall Study||2
6453561|NCT01164865|7369529|FG001|NOT COMPLETED|Overall Study||1
6745124|NCT03355326|7673203|FG000|STARTED|Overall Study||9
6453562|NCT01164891|7369535|FG000|STARTED|Overall Study||7
6453563|NCT01164891|7369535|FG000|COMPLETED|Overall Study||1
6453564|NCT01164891|7369535|FG000|NOT COMPLETED|Overall Study||6
6453565|NCT01164956|7369540|FG000|STARTED|Overall Study||1
6453566|NCT01164956|7369541|FG001|STARTED|Overall Study||1
6453567|NCT01164956|7369542|FG002|STARTED|Overall Study||1
6453568|NCT01164956|7369540|FG000|Evaluable for pedsFACIT-F Score Change|Overall Study||0
6453569|NCT01164956|7369541|FG001|Evaluable for pedsFACIT-F Score Change|Overall Study||1
6453570|NCT01164956|7369542|FG002|Evaluable for pedsFACIT-F Score Change|Overall Study||0
6453571|NCT01164956|7369540|FG000|COMPLETED|Overall Study||0
6453572|NCT01164956|7369541|FG001|COMPLETED|Overall Study||1
6453573|NCT01164956|7369542|FG002|COMPLETED|Overall Study||0
6453574|NCT01164956|7369540|FG000|NOT COMPLETED|Overall Study||1
6453575|NCT01164956|7369541|FG001|NOT COMPLETED|Overall Study||0
6453576|NCT01164956|7369542|FG002|NOT COMPLETED|Overall Study||1
6453577|NCT01165021|7369550|FG000|STARTED|Overall Study||19
6453578|NCT01165021|7369550|FG000|≥1 Dose Chemo|Overall Study||19
6453579|NCT01165021|7369550|FG000|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
6453580|NCT01165021|7369550|FG000|3 Cycles of Chemo, Then Surgery|Overall Study||15
6453581|NCT01165021|7369550|FG000|COMPLETED|Overall Study||18
6453582|NCT01165021|7369550|FG000|NOT COMPLETED|Overall Study||1
6453583|NCT01165047|7369554|FG000|STARTED|Overall Study||10
6453584|NCT01165047|7369554|FG000|COMPLETED|Overall Study||10
6453585|NCT01165047|7369554|FG000|NOT COMPLETED|Overall Study||0
6453586|NCT01165112|7369558|FG000|STARTED|Overall Study||48
6453587|NCT01165112|7369558|FG000|COMPLETED|Overall Study||48
6453588|NCT01165112|7369558|FG000|NOT COMPLETED|Overall Study||0
6453589|NCT01165138|7369565|FG000|STARTED|Overall Study||0
6453590|NCT01165138|7369566|FG001|STARTED|Overall Study||203
6453591|NCT01165138|7369567|FG002|STARTED|Overall Study||205
6453592|NCT01165138|7369568|FG003|STARTED|Overall Study||201
6453593|NCT01165138|7369565|FG000|COMPLETED|Overall Study||0
6453594|NCT01165138|7369566|FG001|COMPLETED|Overall Study||151
6453595|NCT01165138|7369567|FG002|COMPLETED|Overall Study||185
6453596|NCT01165138|7369568|FG003|COMPLETED|Overall Study||179
6453597|NCT01165138|7369565|FG000|NOT COMPLETED|Overall Study||0
6453598|NCT01165138|7369566|FG001|NOT COMPLETED|Overall Study||52
6453599|NCT01165138|7369567|FG002|NOT COMPLETED|Overall Study||20
6453600|NCT01165138|7369568|FG003|NOT COMPLETED|Overall Study||22
6453601|NCT01165177|7369578|FG000|STARTED|Overall Study||7695
6453602|NCT01165177|7369579|FG001|STARTED|Overall Study||7710
6453603|NCT01165177|7369578|FG000|COMPLETED|Overall Study||6773
6453604|NCT01165177|7369579|FG001|COMPLETED|Overall Study||6808
6453605|NCT01165177|7369578|FG000|NOT COMPLETED|Overall Study||922
6453606|NCT01165177|7369579|FG001|NOT COMPLETED|Overall Study||902
6453607|NCT01165203|7369595|FG000|STARTED|Active Phase||74
6453608|NCT01165203|7369596|FG001|STARTED|Active Phase||49
6453609|NCT01165203|7369595|FG000|COMPLETED|Active Phase||69
6453610|NCT01165203|7369596|FG001|COMPLETED|Active Phase||47
6453611|NCT01165203|7369595|FG000|NOT COMPLETED|Active Phase||5
6453612|NCT01165203|7369596|FG001|NOT COMPLETED|Active Phase||2
6453613|NCT01165203|7369595|FG000|STARTED|Extended Safety Follow-up Phase||74
6453614|NCT01165203|7369596|FG001|STARTED|Extended Safety Follow-up Phase||49
6453615|NCT01165203|7369595|FG000|COMPLETED|Extended Safety Follow-up Phase||67
6453616|NCT01165203|7369596|FG001|COMPLETED|Extended Safety Follow-up Phase||45
6453617|NCT01165203|7369595|FG000|NOT COMPLETED|Extended Safety Follow-up Phase||7
6453618|NCT01165203|7369596|FG001|NOT COMPLETED|Extended Safety Follow-up Phase||4
6453619|NCT01165216|7369611|FG000|STARTED|Overall Study|Participants who received any study drug|8
6453620|NCT01165216|7369612|FG001|STARTED|Overall Study|Participants who received any study drug|7
6453621|NCT01165216|7369611|FG000|Received at Least 1 Dose of Ipilimumab|Overall Study||6
6453622|NCT01165216|7369612|FG001|Received at Least 1 Dose of Ipilimumab|Overall Study||6
6453623|NCT01165216|7369611|FG000|COMPLETED|Overall Study|Completed=still on study drug|0
6453624|NCT01165216|7369612|FG001|COMPLETED|Overall Study|Completed=still on study drug|0
6453625|NCT01165216|7369611|FG000|NOT COMPLETED|Overall Study||8
6453626|NCT01165216|7369612|FG001|NOT COMPLETED|Overall Study||7
6453627|NCT01165229|7369622|FG000|STARTED|Overall Study||6950
6453628|NCT01165229|7369623|FG001|STARTED|Overall Study||6950
6453629|NCT01165229|7369622|FG000|COMPLETED|Overall Study||5770
6453630|NCT01165229|7369623|FG001|COMPLETED|Overall Study||5760
6453631|NCT01165229|7369622|FG000|NOT COMPLETED|Overall Study||1180
6453632|NCT01165229|7369623|FG001|NOT COMPLETED|Overall Study||1190
6453633|NCT01165242|7369662|FG000|STARTED|Overall Study||337
6453634|NCT01165242|7369663|FG001|STARTED|Overall Study||336
6453635|NCT01165242|7369664|FG002|STARTED|Overall Study||338
6453636|NCT01165242|7369662|FG000|COMPLETED|Overall Study||327
6453637|NCT01165242|7369663|FG001|COMPLETED|Overall Study||326
6453638|NCT01165242|7369664|FG002|COMPLETED|Overall Study||324
6453639|NCT01165242|7369662|FG000|NOT COMPLETED|Overall Study||10
6453640|NCT01165242|7369663|FG001|NOT COMPLETED|Overall Study||10
6453641|NCT01165242|7369664|FG002|NOT COMPLETED|Overall Study||14
6453642|NCT01165281|7369676|FG000|STARTED|Overall Study||168
6453643|NCT01165281|7369677|FG001|STARTED|Overall Study||172
6453644|NCT01165281|7369676|FG000|COMPLETED|Overall Study||110
6453645|NCT01165281|7369677|FG001|COMPLETED|Overall Study||121
6453646|NCT01165281|7369676|FG000|NOT COMPLETED|Overall Study||58
6453647|NCT01165281|7369677|FG001|NOT COMPLETED|Overall Study||51
6453648|NCT01165307|7369685|FG000|STARTED|Overall Study||33
6453649|NCT01165307|7369686|FG001|STARTED|Overall Study||34
6453650|NCT01165307|7369685|FG000|COMPLETED|Overall Study||19
6453651|NCT01165307|7369686|FG001|COMPLETED|Overall Study||31
6453652|NCT01165307|7369685|FG000|NOT COMPLETED|Overall Study||14
6453653|NCT01165307|7369686|FG001|NOT COMPLETED|Overall Study||3
6453654|NCT01165320|7369694|FG000|STARTED|Overall Study||12
6453655|NCT01165320|7369695|FG001|STARTED|Overall Study||8
6453656|NCT01165320|7369696|FG002|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
6453657|NCT01165320|7369694|FG000|COMPLETED|Overall Study||9
6453658|NCT01165320|7369695|FG001|COMPLETED|Overall Study||4
6453659|NCT01165320|7369696|FG002|COMPLETED|Overall Study||0
6453660|NCT01165320|7369694|FG000|NOT COMPLETED|Overall Study||3
6453661|NCT01165320|7369695|FG001|NOT COMPLETED|Overall Study||4
6453662|NCT01165320|7369696|FG002|NOT COMPLETED|Overall Study||0
6453663|NCT01165541|7369702|FG000|STARTED|Quetiapine XR Monotherapy||20
6453664|NCT01165541|7369702|FG000|COMPLETED|Quetiapine XR Monotherapy||16
6453665|NCT01165541|7369702|FG000|NOT COMPLETED|Quetiapine XR Monotherapy||4
6453666|NCT01165541|7369702|FG000|STARTED|Quetiapine XR and Mirtazepine||16
6453667|NCT01165541|7369702|FG000|COMPLETED|Quetiapine XR and Mirtazepine||11
6453668|NCT01165541|7369702|FG000|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
6453669|NCT01165554|7369708|FG000|STARTED|Overall Study|This was the number of subjects that started the study.|203
6453670|NCT01165554|7369708|FG000|COMPLETED|Overall Study||180
6453671|NCT01165554|7369708|FG000|NOT COMPLETED|Overall Study||23
6453672|NCT01165684|7369717|FG000|STARTED|Overall Study||201
6453673|NCT01165684|7369718|FG001|STARTED|Overall Study||200
6453674|NCT01165684|7369717|FG000|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
6453675|NCT01165684|7369718|FG001|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
6453676|NCT01165684|7369717|FG000|COMPLETED|Overall Study||173
6453677|NCT01165684|7369718|FG001|COMPLETED|Overall Study||148
6453678|NCT01165684|7369717|FG000|NOT COMPLETED|Overall Study||28
6453679|NCT01165684|7369718|FG001|NOT COMPLETED|Overall Study||52
6453680|NCT01165775|7369724|FG000|STARTED|Overall Study||17
6453681|NCT01165775|7369724|FG000|COMPLETED|Overall Study||15
6453682|NCT01165775|7369724|FG000|NOT COMPLETED|Overall Study||2
6453683|NCT01165840|7369732|FG000|STARTED|Overall Study||36
6453684|NCT01165840|7369732|FG000|COMPLETED|Overall Study||36
6453685|NCT01165840|7369732|FG000|NOT COMPLETED|Overall Study||0
6453686|NCT01165983|7369738|FG000|STARTED|Overall Study||51
6453687|NCT01165983|7369739|FG001|STARTED|Overall Study||49
6453688|NCT01165983|7369738|FG000|COMPLETED|Overall Study||46
6453689|NCT01165983|7369739|FG001|COMPLETED|Overall Study||42
6453690|NCT01165983|7369738|FG000|NOT COMPLETED|Overall Study||5
6453691|NCT01165983|7369739|FG001|NOT COMPLETED|Overall Study||7
6453692|NCT01165996|7369747|FG000|STARTED|Overall Study||25
6453693|NCT01165996|7369747|FG000|Induction Phase|Overall Study||25
6453694|NCT01165996|7369747|FG000|Maintenance Phase|Overall Study||23
6453695|NCT01165996|7369747|FG000|COMPLETED|Overall Study||23
6453696|NCT01165996|7369747|FG000|NOT COMPLETED|Overall Study||2
6453697|NCT01166126|7369752|FG000|STARTED|Overall Study||4
6453698|NCT01166126|7369752|FG000|COMPLETED|Overall Study||4
6453699|NCT01166126|7369752|FG000|NOT COMPLETED|Overall Study||0
6453700|NCT01166139|7369756|FG000|STARTED|Overall Study||10
6453701|NCT01166139|7369756|FG000|COMPLETED|Overall Study||7
6453702|NCT01166139|7369756|FG000|NOT COMPLETED|Overall Study||3
6453703|NCT01166230|7369762|FG000|STARTED|Overall Study||280
6453704|NCT01166230|7369763|FG001|STARTED|Overall Study||271
6453705|NCT01166230|7369762|FG000|COMPLETED|Overall Study||261
6453706|NCT01166230|7369763|FG001|COMPLETED|Overall Study||255
6453707|NCT01166230|7369762|FG000|NOT COMPLETED|Overall Study||19
6453708|NCT01166230|7369763|FG001|NOT COMPLETED|Overall Study||16
6453709|NCT01166282|7369771|FG000|STARTED|Double-blind Period||15
6453710|NCT01166282|7369772|FG001|STARTED|Double-blind Period||31
6453711|NCT01166282|7369773|FG002|STARTED|Double-blind Period||0
6453712|NCT01166282|7369771|FG000|COMPLETED|Double-blind Period||15
6453713|NCT01166282|7369772|FG001|COMPLETED|Double-blind Period||31
6553518|NCT01743989|7475976|FG000|COMPLETED|Treatment Phase||119
6553519|NCT01743989|7475977|FG001|COMPLETED|Treatment Phase||104
6553520|NCT01743989|7475978|FG002|COMPLETED|Treatment Phase||0
6553521|NCT01743989|7475976|FG000|NOT COMPLETED|Treatment Phase||1
6553522|NCT01743989|7475977|FG001|NOT COMPLETED|Treatment Phase||15
6553523|NCT01743989|7475978|FG002|NOT COMPLETED|Treatment Phase||381
6453714|NCT01166282|7369773|FG002|COMPLETED|Double-blind Period||0
6453715|NCT01166282|7369771|FG000|NOT COMPLETED|Double-blind Period||0
6453716|NCT01166282|7369772|FG001|NOT COMPLETED|Double-blind Period||0
6453717|NCT01166282|7369773|FG002|NOT COMPLETED|Double-blind Period||0
6453718|NCT01166282|7369771|FG000|STARTED|Open-label Period||0
6553524|NCT01743989|7475976|FG000|STARTED|TFR Phase||119
6553525|NCT01743989|7475977|FG001|STARTED|TFR Phase||104
6453719|NCT01166282|7369772|FG001|STARTED|Open-label Period||0
6453720|NCT01166282|7369773|FG002|STARTED|Open-label Period||46
6453721|NCT01166282|7369771|FG000|COMPLETED|Open-label Period||0
6453722|NCT01166282|7369772|FG001|COMPLETED|Open-label Period||0
6453723|NCT01166282|7369773|FG002|COMPLETED|Open-label Period||29
6453724|NCT01166282|7369771|FG000|NOT COMPLETED|Open-label Period||0
6453725|NCT01166282|7369772|FG001|NOT COMPLETED|Open-label Period||0
6453726|NCT01166282|7369773|FG002|NOT COMPLETED|Open-label Period||17
6453727|NCT01166347|7369783|FG000|STARTED|Overall Study||297
6453728|NCT01166347|7369784|FG001|STARTED|Overall Study||149
6453729|NCT01166347|7369783|FG000|COMPLETED|Overall Study||295
6453730|NCT01166347|7369784|FG001|COMPLETED|Overall Study||148
6553526|NCT01743989|7475978|FG002|STARTED|TFR Phase||0
6453731|NCT01166347|7369783|FG000|NOT COMPLETED|Overall Study||2
6453732|NCT01166347|7369784|FG001|NOT COMPLETED|Overall Study||1
6453733|NCT01166373|7369794|FG000|STARTED|Overall Study||95
6453734|NCT01166373|7369795|FG001|STARTED|Overall Study||91
6453735|NCT01166373|7369796|FG002|STARTED|Overall Study||91
6453736|NCT01166373|7369797|FG003|STARTED|Overall Study||97
6453737|NCT01166373|7369794|FG000|Completed OPTIMAL Year 2 Visit|Overall Study||81
6453738|NCT01166373|7369795|FG001|Completed OPTIMAL Year 2 Visit|Overall Study||80
6453739|NCT01166373|7369796|FG002|Completed OPTIMAL Year 2 Visit|Overall Study||79
6453740|NCT01166373|7369797|FG003|Completed OPTIMAL Year 2 Visit|Overall Study||87
6453741|NCT01166373|7369794|FG000|Randomized to Video|Overall Study||32
6453742|NCT01166373|7369795|FG001|Randomized to Video|Overall Study||43
6453743|NCT01166373|7369796|FG002|Randomized to Video|Overall Study||38
6453744|NCT01166373|7369797|FG003|Randomized to Video|Overall Study||40
6453745|NCT01166373|7369794|FG000|Randomized to No Video|Overall Study||45
6453746|NCT01166373|7369795|FG001|Randomized to No Video|Overall Study||30
6453747|NCT01166373|7369796|FG002|Randomized to No Video|Overall Study||34
6453748|NCT01166373|7369797|FG003|Randomized to No Video|Overall Study||42
6453749|NCT01166373|7369794|FG000|Consented to Participate E-OPTIMAL|Overall Study||72
6453750|NCT01166373|7369795|FG001|Consented to Participate E-OPTIMAL|Overall Study||66
6453751|NCT01166373|7369796|FG002|Consented to Participate E-OPTIMAL|Overall Study||69
6453752|NCT01166373|7369797|FG003|Consented to Participate E-OPTIMAL|Overall Study||78
6453753|NCT01166373|7369794|FG000|Completed E-OPTIMAL Year 3 Visit|Overall Study||70
6453754|NCT01166373|7369795|FG001|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
6453755|NCT01166373|7369796|FG002|Completed E-OPTIMAL Year 3 Visit|Overall Study||66
6453756|NCT01166373|7369797|FG003|Completed E-OPTIMAL Year 3 Visit|Overall Study||77
6453757|NCT01166373|7369794|FG000|Completed E-OPTIMAL Year 4 Visit|Overall Study||67
6453758|NCT01166373|7369795|FG001|Completed E-OPTIMAL Year 4 Visit|Overall Study||61
6453759|NCT01166373|7369796|FG002|Completed E-OPTIMAL Year 4 Visit|Overall Study||63
6453760|NCT01166373|7369797|FG003|Completed E-OPTIMAL Year 4 Visit|Overall Study||68
6453761|NCT01166373|7369794|FG000|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
6453762|NCT01166373|7369795|FG001|Completed E-OPTIMAL Year 5 Visit|Overall Study||56
6453763|NCT01166373|7369796|FG002|Completed E-OPTIMAL Year 5 Visit|Overall Study||62
6453764|NCT01166373|7369797|FG003|Completed E-OPTIMAL Year 5 Visit|Overall Study||64
6453765|NCT01166373|7369794|FG000|COMPLETED|Overall Study||90
6453766|NCT01166373|7369795|FG001|COMPLETED|Overall Study||87
6453767|NCT01166373|7369796|FG002|COMPLETED|Overall Study||87
6453768|NCT01166373|7369797|FG003|COMPLETED|Overall Study||92
6453769|NCT01166373|7369794|FG000|NOT COMPLETED|Overall Study||5
6453770|NCT01166373|7369795|FG001|NOT COMPLETED|Overall Study||4
6453771|NCT01166373|7369796|FG002|NOT COMPLETED|Overall Study||4
6453772|NCT01166373|7369797|FG003|NOT COMPLETED|Overall Study||5
6453773|NCT01166438|7369811|FG000|STARTED|Double-blind Phase: 1st 6 Months||122
6453774|NCT01166438|7369812|FG001|STARTED|Double-blind Phase: 1st 6 Months||127
6453775|NCT01166438|7369811|FG000|Treated|Double-blind Phase: 1st 6 Months||121
6453776|NCT01166438|7369812|FG001|Treated|Double-blind Phase: 1st 6 Months||126
6453777|NCT01166438|7369811|FG000|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|113
6453778|NCT01166438|7369812|FG001|COMPLETED|Double-blind Phase: 1st 6 Months|Completion of 12 month follow-up visit|118
6453779|NCT01166438|7369811|FG000|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
6453780|NCT01166438|7369812|FG001|NOT COMPLETED|Double-blind Phase: 1st 6 Months||9
6453781|NCT01166438|7369811|FG000|STARTED|Off Treatment Follow-up Phase||85
6453782|NCT01166438|7369812|FG001|STARTED|Off Treatment Follow-up Phase||89
6453783|NCT01166438|7369811|FG000|COMPLETED|Off Treatment Follow-up Phase||51
6453784|NCT01166438|7369812|FG001|COMPLETED|Off Treatment Follow-up Phase||33
6453785|NCT01166438|7369811|FG000|NOT COMPLETED|Off Treatment Follow-up Phase||34
6453786|NCT01166438|7369812|FG001|NOT COMPLETED|Off Treatment Follow-up Phase||56
6453787|NCT01166568|7369822|FG000|STARTED|Deferred Implantation- Randomized||0
6453788|NCT01166568|7369823|FG001|STARTED|Deferred Implantation- Randomized||0
6453789|NCT01166568|7369824|FG002|STARTED|Deferred Implantation- Randomized||16
6453790|NCT01166568|7369822|FG000|COMPLETED|Deferred Implantation- Randomized||0
6453791|NCT01166568|7369823|FG001|COMPLETED|Deferred Implantation- Randomized||0
6453792|NCT01166568|7369824|FG002|COMPLETED|Deferred Implantation- Randomized|From the randomized sub-study control group (n=16), 1 subject withdrew during the observation phase|15
6453793|NCT01166568|7369822|FG000|NOT COMPLETED|Deferred Implantation- Randomized||0
6453794|NCT01166568|7369823|FG001|NOT COMPLETED|Deferred Implantation- Randomized||0
6453795|NCT01166568|7369824|FG002|NOT COMPLETED|Deferred Implantation- Randomized||1
6453796|NCT01166568|7369822|FG000|STARTED|Implantation- Nonrandomized & Randomized||288
6453797|NCT01166568|7369823|FG001|STARTED|Implantation- Nonrandomized & Randomized||33
6453798|NCT01166568|7369824|FG002|STARTED|Implantation- Nonrandomized & Randomized|15 subjects completed the observation phase and 9 subjects (17 eyes) proceeded with implantation.|9
6453799|NCT01166568|7369822|FG000|COMPLETED|Implantation- Nonrandomized & Randomized||274
6453800|NCT01166568|7369823|FG001|COMPLETED|Implantation- Nonrandomized & Randomized||32
6453801|NCT01166568|7369824|FG002|COMPLETED|Implantation- Nonrandomized & Randomized|(1) Primary eye implanted only subject withdrew consent after implantation of the device.|8
6453802|NCT01166568|7369822|FG000|NOT COMPLETED|Implantation- Nonrandomized & Randomized||14
6453803|NCT01166568|7369823|FG001|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
6453804|NCT01166568|7369824|FG002|NOT COMPLETED|Implantation- Nonrandomized & Randomized||1
6453805|NCT01166646|7369832|FG000|STARTED|Overall Study||21
6453806|NCT01166646|7369833|FG001|STARTED|Overall Study||22
6453807|NCT01166646|7369832|FG000|COMPLETED|Overall Study||20
6453808|NCT01166646|7369833|FG001|COMPLETED|Overall Study||21
6453809|NCT01166646|7369832|FG000|NOT COMPLETED|Overall Study||1
6453810|NCT01166646|7369833|FG001|NOT COMPLETED|Overall Study||1
6453811|NCT01166659|7369839|FG000|STARTED|Overall Study||48
6453812|NCT01166659|7369839|FG000|COMPLETED|Overall Study||35
6453813|NCT01166659|7369839|FG000|NOT COMPLETED|Overall Study||13
6453814|NCT01166750|7369846|FG000|STARTED|Overall Study||10
6453815|NCT01166750|7369847|FG001|STARTED|Overall Study||13
6453816|NCT01166750|7369846|FG000|COMPLETED|Overall Study||9
6453817|NCT01166750|7369847|FG001|COMPLETED|Overall Study||13
6453818|NCT01166750|7369846|FG000|NOT COMPLETED|Overall Study||1
6453819|NCT01166750|7369847|FG001|NOT COMPLETED|Overall Study||0
6453820|NCT01166763|7369853|FG000|STARTED|Overall Study||30
6453821|NCT01166763|7369853|FG000|COMPLETED|Overall Study||27
6453822|NCT01166763|7369853|FG000|NOT COMPLETED|Overall Study||3
6453823|NCT01166945|7369859|FG000|STARTED|Randomized||51
6453824|NCT01166945|7369860|FG001|STARTED|Randomized||47
6453825|NCT01166945|7369859|FG000|COMPLETED|Randomized||47
6453826|NCT01166945|7369860|FG001|COMPLETED|Randomized||43
6453827|NCT01166945|7369859|FG000|NOT COMPLETED|Randomized||4
6453828|NCT01166945|7369860|FG001|NOT COMPLETED|Randomized||4
6453829|NCT01166945|7369859|FG000|STARTED|Day 5||47
6453830|NCT01166945|7369860|FG001|STARTED|Day 5||43
6453831|NCT01166945|7369859|FG000|COMPLETED|Day 5||47
6453832|NCT01166945|7369860|FG001|COMPLETED|Day 5||43
6453833|NCT01166945|7369859|FG000|NOT COMPLETED|Day 5||0
6453834|NCT01166945|7369860|FG001|NOT COMPLETED|Day 5||0
6453835|NCT01166945|7369859|FG000|STARTED|Day 10||47
6453836|NCT01166945|7369860|FG001|STARTED|Day 10||43
6453837|NCT01166945|7369859|FG000|COMPLETED|Day 10||44
6453838|NCT01166945|7369860|FG001|COMPLETED|Day 10||41
6453839|NCT01166945|7369859|FG000|NOT COMPLETED|Day 10||3
6453840|NCT01166945|7369860|FG001|NOT COMPLETED|Day 10||2
6453841|NCT01166945|7369859|FG000|STARTED|Day 15||44
6453842|NCT01166945|7369860|FG001|STARTED|Day 15||41
6453843|NCT01166945|7369859|FG000|COMPLETED|Day 15||42
6453844|NCT01166945|7369860|FG001|COMPLETED|Day 15||40
6453845|NCT01166945|7369859|FG000|NOT COMPLETED|Day 15||2
6453846|NCT01166945|7369860|FG001|NOT COMPLETED|Day 15||1
6453847|NCT01166945|7369859|FG000|STARTED|Day 20||42
6453848|NCT01166945|7369860|FG001|STARTED|Day 20||40
6453849|NCT01166945|7369859|FG000|COMPLETED|Day 20||42
6453850|NCT01166945|7369860|FG001|COMPLETED|Day 20||40
6453851|NCT01166945|7369859|FG000|NOT COMPLETED|Day 20||0
6453852|NCT01166945|7369860|FG001|NOT COMPLETED|Day 20||0
6453853|NCT01166945|7369859|FG000|STARTED|Day 30||42
6453854|NCT01166945|7369860|FG001|STARTED|Day 30||40
6453855|NCT01166945|7369859|FG000|COMPLETED|Day 30||38
6453856|NCT01166945|7369860|FG001|COMPLETED|Day 30||37
6453857|NCT01166945|7369859|FG000|NOT COMPLETED|Day 30||4
6453858|NCT01166945|7369860|FG001|NOT COMPLETED|Day 30||3
6453859|NCT01166958|7369870|FG000|STARTED|Overall Study||13
6453860|NCT01166958|7369871|FG001|STARTED|Overall Study||13
6453861|NCT01166958|7369870|FG000|COMPLETED|Overall Study||12
6453862|NCT01166958|7369871|FG001|COMPLETED|Overall Study||13
6453863|NCT01166958|7369870|FG000|NOT COMPLETED|Overall Study||1
6453864|NCT01166958|7369871|FG001|NOT COMPLETED|Overall Study||0
6453865|NCT01166971|7369879|FG000|STARTED|Overall Study||33
6453866|NCT01166971|7369880|FG001|STARTED|Overall Study||31
6453867|NCT01166971|7369879|FG000|COMPLETED|Overall Study||32
6453868|NCT01166971|7369880|FG001|COMPLETED|Overall Study||30
6453869|NCT01166971|7369879|FG000|NOT COMPLETED|Overall Study||1
6453870|NCT01166971|7369880|FG001|NOT COMPLETED|Overall Study||1
6453871|NCT01166984|7369891|FG000|STARTED|Overall Study||5
6453872|NCT01166984|7369892|FG001|STARTED|Overall Study||5
6453873|NCT01166984|7369893|FG002|STARTED|Overall Study||5
6453874|NCT01166984|7369894|FG003|STARTED|Overall Study||5
6453875|NCT01166984|7369895|FG004|STARTED|Overall Study||5
6453876|NCT01166984|7369891|FG000|COMPLETED|Overall Study||5
6453877|NCT01166984|7369892|FG001|COMPLETED|Overall Study||5
6453878|NCT01166984|7369893|FG002|COMPLETED|Overall Study||5
6453879|NCT01166984|7369894|FG003|COMPLETED|Overall Study||5
6453880|NCT01166984|7369895|FG004|COMPLETED|Overall Study||5
6453881|NCT01166984|7369891|FG000|NOT COMPLETED|Overall Study||0
6453882|NCT01166984|7369892|FG001|NOT COMPLETED|Overall Study||0
6453883|NCT01166984|7369893|FG002|NOT COMPLETED|Overall Study||0
6453884|NCT01166984|7369894|FG003|NOT COMPLETED|Overall Study||0
6453885|NCT01166984|7369895|FG004|NOT COMPLETED|Overall Study||0
6453886|NCT01166997|7369919|FG000|STARTED|Overall Study||29
6453887|NCT01166997|7369920|FG001|STARTED|Overall Study||30
6453888|NCT01166997|7369919|FG000|COMPLETED|Overall Study||27
6453889|NCT01166997|7369920|FG001|COMPLETED|Overall Study||30
6453890|NCT01166997|7369919|FG000|NOT COMPLETED|Overall Study||2
6453891|NCT01166997|7369920|FG001|NOT COMPLETED|Overall Study||0
6453892|NCT01167023|7369930|FG000|STARTED|Overall Study||0
6453893|NCT01167023|7369931|FG001|STARTED|Overall Study||21
6453894|NCT01167023|7369932|FG002|STARTED|Overall Study||41
6453895|NCT01167023|7369930|FG000|Received at Least 1 Dose of Study Drug|Overall Study||0
6453896|NCT01167023|7369931|FG001|Received at Least 1 Dose of Study Drug|Overall Study||19
6453897|NCT01167023|7369932|FG002|Received at Least 1 Dose of Study Drug|Overall Study||41
6453898|NCT01167023|7369930|FG000|COMPLETED|Overall Study||0
6453899|NCT01167023|7369931|FG001|COMPLETED|Overall Study||18
6453900|NCT01167023|7369932|FG002|COMPLETED|Overall Study||39
6453901|NCT01167023|7369930|FG000|NOT COMPLETED|Overall Study||0
6453902|NCT01167023|7369931|FG001|NOT COMPLETED|Overall Study||3
6453903|NCT01167023|7369932|FG002|NOT COMPLETED|Overall Study||2
6453904|NCT01167140|7369938|FG000|STARTED|Overall Study||42
6453905|NCT01167140|7369938|FG000|COMPLETED|Overall Study||41
6453906|NCT01167140|7369938|FG000|NOT COMPLETED|Overall Study||1
6453907|NCT01167153|7369944|FG000|STARTED|Overall Study||282
6453908|NCT01167153|7369945|FG001|STARTED|Overall Study||282
6453909|NCT01167153|7369944|FG000|Intention to Treat (ITT)|Overall Study||272
6453910|NCT01167153|7369945|FG001|Intention to Treat (ITT)|Overall Study||268
6453911|NCT01167153|7369944|FG000|COMPLETED|Overall Study||264
6453912|NCT01167153|7369945|FG001|COMPLETED|Overall Study||249
6453913|NCT01167153|7369944|FG000|NOT COMPLETED|Overall Study||18
6453914|NCT01167153|7369945|FG001|NOT COMPLETED|Overall Study||33
6453915|NCT01167179|7369953|FG000|STARTED|Overall Study||80
6453916|NCT01167179|7369954|FG001|STARTED|Overall Study||80
6453917|NCT01167179|7369953|FG000|COMPLETED|Overall Study||65
6453918|NCT01167179|7369954|FG001|COMPLETED|Overall Study||59
6453919|NCT01167179|7369953|FG000|NOT COMPLETED|Overall Study||15
6453920|NCT01167179|7369954|FG001|NOT COMPLETED|Overall Study||21
6453921|NCT01167192|7369960|FG000|STARTED|Overall Study||10
6453922|NCT01167192|7369960|FG000|COMPLETED|Overall Study||6
6453923|NCT01167192|7369960|FG000|NOT COMPLETED|Overall Study||4
6453924|NCT01167257|7369966|FG000|STARTED|Overall Study||31
6453925|NCT01167257|7369967|FG001|STARTED|Overall Study||31
6453926|NCT01167257|7369966|FG000|COMPLETED|Overall Study||28
6453927|NCT01167257|7369967|FG001|COMPLETED|Overall Study||28
6453928|NCT01167257|7369966|FG000|NOT COMPLETED|Overall Study||3
6453929|NCT01167257|7369967|FG001|NOT COMPLETED|Overall Study||3
6453930|NCT01167426|7369977|FG000|STARTED|Overall Study||148
6453931|NCT01167426|7369977|FG000|COMPLETED|Overall Study||138
6453932|NCT01167426|7369977|FG000|NOT COMPLETED|Overall Study||10
6453933|NCT01167452|7369982|FG000|STARTED|Overall Study||36
6453934|NCT01167452|7369982|FG000|COMPLETED|Overall Study||36
6453935|NCT01167452|7369982|FG000|NOT COMPLETED|Overall Study||0
6453936|NCT01167504|7369987|FG000|STARTED|Overall Study||15
6453937|NCT01167504|7369987|FG000|COMPLETED|Overall Study||12
6453938|NCT01167504|7369987|FG000|NOT COMPLETED|Overall Study||3
6453939|NCT01167569|7369993|FG000|STARTED|Overall Study||28
6453940|NCT01167569|7369994|FG001|STARTED|Overall Study||29
6453941|NCT01167569|7369993|FG000|COMPLETED|Overall Study||27
6453942|NCT01167569|7369994|FG001|COMPLETED|Overall Study||27
6453943|NCT01167569|7369993|FG000|NOT COMPLETED|Overall Study||1
6453944|NCT01167569|7369994|FG001|NOT COMPLETED|Overall Study||2
6453945|NCT01167582|7370004|FG000|STARTED|Overall Study||55
6453946|NCT01167582|7370005|FG001|STARTED|Overall Study||55
6453947|NCT01167582|7370004|FG000|COMPLETED|Overall Study||55
6453948|NCT01167582|7370005|FG001|COMPLETED|Overall Study||54
6453949|NCT01167582|7370004|FG000|NOT COMPLETED|Overall Study||0
6453950|NCT01167582|7370005|FG001|NOT COMPLETED|Overall Study||1
6453951|NCT01167595|7370013|FG000|STARTED|Overall Study||522
6453952|NCT01167595|7370014|FG001|STARTED|Overall Study||537
6453953|NCT01167595|7370013|FG000|COMPLETED|Overall Study||522
6453954|NCT01167595|7370014|FG001|COMPLETED|Overall Study||537
6453955|NCT01167595|7370013|FG000|NOT COMPLETED|Overall Study||0
6453956|NCT01167595|7370014|FG001|NOT COMPLETED|Overall Study||0
6453957|NCT01167608|7370020|FG000|STARTED|Overall Study||883
6453958|NCT01167608|7370020|FG000|COMPLETED|Overall Study||769
6453959|NCT01167608|7370020|FG000|NOT COMPLETED|Overall Study||114
6453960|NCT01167634|7370029|FG000|STARTED|Overall Study||33
6453961|NCT01167634|7370030|FG001|STARTED|Overall Study||33
6453962|NCT01167634|7370031|FG002|STARTED|Overall Study||33
6745125|NCT03355326|7673204|FG001|STARTED|Overall Study||7
6745126|NCT03355326|7673203|FG000|COMPLETED|Overall Study||6
6745127|NCT03355326|7673204|FG001|COMPLETED|Overall Study||4
6453963|NCT01167634|7370032|FG003|STARTED|Overall Study||33
6453964|NCT01167634|7370029|FG000|COMPLETED|Overall Study||31
6453965|NCT01167634|7370030|FG001|COMPLETED|Overall Study||29
6453966|NCT01167634|7370031|FG002|COMPLETED|Overall Study||30
6453967|NCT01167634|7370032|FG003|COMPLETED|Overall Study||29
6453968|NCT01167634|7370029|FG000|NOT COMPLETED|Overall Study||2
6453969|NCT01167634|7370030|FG001|NOT COMPLETED|Overall Study||4
6453970|NCT01167634|7370031|FG002|NOT COMPLETED|Overall Study||3
6453971|NCT01167634|7370032|FG003|NOT COMPLETED|Overall Study||4
6453972|NCT01167712|7370044|FG000|STARTED|Overall Study||346
6453973|NCT01167712|7370045|FG001|STARTED|Overall Study||346
6453974|NCT01167712|7370044|FG000|COMPLETED|Overall Study||346
6453975|NCT01167712|7370045|FG001|COMPLETED|Overall Study||346
6453976|NCT01167712|7370044|FG000|NOT COMPLETED|Overall Study||0
6453977|NCT01167712|7370045|FG001|NOT COMPLETED|Overall Study||0
6453978|NCT01167829|7370051|FG000|STARTED|Overall Study||12
6453979|NCT01167829|7370051|FG000|COMPLETED|Overall Study||12
6745128|NCT03355326|7673203|FG000|NOT COMPLETED|Overall Study||3
6745129|NCT03355326|7673204|FG001|NOT COMPLETED|Overall Study||3
6453980|NCT01167829|7370051|FG000|NOT COMPLETED|Overall Study||0
6453981|NCT01167881|7370059|FG000|STARTED|Overall Study||769
6453982|NCT01167881|7370060|FG001|STARTED|Overall Study||780
6453983|NCT01167881|7370059|FG000|Completed After 2 Years Treatment|Overall Study||95
6453984|NCT01167881|7370060|FG001|Completed After 2 Years Treatment|Overall Study||127
6453985|NCT01167881|7370059|FG000|Completed After 4 Years Treatment|Overall Study||515
6453986|NCT01167881|7370060|FG001|Completed After 4 Years Treatment|Overall Study||462
6453987|NCT01167881|7370059|FG000|COMPLETED|Overall Study||610
6453988|NCT01167881|7370060|FG001|COMPLETED|Overall Study||589
6453989|NCT01167881|7370059|FG000|NOT COMPLETED|Overall Study||159
6453990|NCT01167881|7370060|FG001|NOT COMPLETED|Overall Study||191
6453991|NCT01167907|7370068|FG000|STARTED|Overall Study||17
6453992|NCT01167907|7370069|FG001|STARTED|Overall Study||15
6453993|NCT01167907|7370068|FG000|COMPLETED|Overall Study||15
6453994|NCT01167907|7370069|FG001|COMPLETED|Overall Study||14
6453995|NCT01167907|7370068|FG000|NOT COMPLETED|Overall Study||2
6453996|NCT01167907|7370069|FG001|NOT COMPLETED|Overall Study||1
6453997|NCT01168024|7370077|FG000|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
6453998|NCT01168024|7370078|FG001|STARTED|Overall Study||3
6453999|NCT01168024|7370077|FG000|COMPLETED|Overall Study||13
6454000|NCT01168024|7370078|FG001|COMPLETED|Overall Study||3
6454001|NCT01168024|7370077|FG000|NOT COMPLETED|Overall Study||0
6454002|NCT01168024|7370078|FG001|NOT COMPLETED|Overall Study||0
6454003|NCT01168232|7370084|FG000|STARTED|Overall Study||42
6454004|NCT01168232|7370084|FG000|COMPLETED|Overall Study|Eligible and treated patients|34
6454005|NCT01168232|7370084|FG000|NOT COMPLETED|Overall Study||8
6454006|NCT01168349|7370088|FG000|STARTED|Overall Study||1055
6454007|NCT01168349|7370088|FG000|COMPLETED|Overall Study||754
6454008|NCT01168349|7370088|FG000|NOT COMPLETED|Overall Study||301
6454009|NCT01168401|7370119|FG000|STARTED|Overall Study||10
6454010|NCT01168401|7370120|FG001|STARTED|Overall Study||10
6454011|NCT01168401|7370121|FG002|STARTED|Overall Study||10
6454012|NCT01168401|7370122|FG003|STARTED|Overall Study||9
6454013|NCT01168401|7370123|FG004|STARTED|Overall Study||9
6454014|NCT01168401|7370124|FG005|STARTED|Overall Study||9
6454015|NCT01168401|7370125|FG006|STARTED|Overall Study||10
6454016|NCT01168401|7370126|FG007|STARTED|Overall Study||10
6454017|NCT01168401|7370127|FG008|STARTED|Overall Study||9
6454018|NCT01168401|7370128|FG009|STARTED|Overall Study||8
6454019|NCT01168401|7370129|FG010|STARTED|Overall Study||8
6454020|NCT01168401|7370119|FG000|COMPLETED|Overall Study||9
6454021|NCT01168401|7370120|FG001|COMPLETED|Overall Study||9
6454022|NCT01168401|7370121|FG002|COMPLETED|Overall Study||8
6454023|NCT01168401|7370122|FG003|COMPLETED|Overall Study||7
6454024|NCT01168401|7370123|FG004|COMPLETED|Overall Study||9
6454025|NCT01168401|7370124|FG005|COMPLETED|Overall Study||9
6454026|NCT01168401|7370125|FG006|COMPLETED|Overall Study||10
6454027|NCT01168401|7370126|FG007|COMPLETED|Overall Study||10
6454028|NCT01168401|7370127|FG008|COMPLETED|Overall Study||9
6454029|NCT01168401|7370128|FG009|COMPLETED|Overall Study||8
6454030|NCT01168401|7370129|FG010|COMPLETED|Overall Study||8
6454031|NCT01168401|7370119|FG000|NOT COMPLETED|Overall Study||1
6454032|NCT01168401|7370120|FG001|NOT COMPLETED|Overall Study||1
6454033|NCT01168401|7370121|FG002|NOT COMPLETED|Overall Study||2
6454034|NCT01168401|7370122|FG003|NOT COMPLETED|Overall Study||2
6454035|NCT01168401|7370123|FG004|NOT COMPLETED|Overall Study||0
6454036|NCT01168401|7370124|FG005|NOT COMPLETED|Overall Study||0
6454037|NCT01168401|7370125|FG006|NOT COMPLETED|Overall Study||0
6454038|NCT01168401|7370126|FG007|NOT COMPLETED|Overall Study||0
6454039|NCT01168401|7370127|FG008|NOT COMPLETED|Overall Study||0
6454040|NCT01168401|7370128|FG009|NOT COMPLETED|Overall Study||0
6454041|NCT01168401|7370129|FG010|NOT COMPLETED|Overall Study||0
6454042|NCT01168427|7370153|FG000|STARTED|Overall Study||66
6454043|NCT01168427|7370153|FG000|COMPLETED|Overall Study||65
6454044|NCT01168427|7370153|FG000|NOT COMPLETED|Overall Study||1
6454045|NCT01168596|7370159|FG000|STARTED|Overall Study||16
6454046|NCT01168596|7370160|FG001|STARTED|Overall Study||14
6454047|NCT01168596|7370159|FG000|COMPLETED|Overall Study||13
6454048|NCT01168596|7370160|FG001|COMPLETED|Overall Study||13
6454049|NCT01168596|7370159|FG000|NOT COMPLETED|Overall Study||3
6454050|NCT01168596|7370160|FG001|NOT COMPLETED|Overall Study||1
6454051|NCT01168674|7370166|FG000|STARTED|Overall Study||25
6454052|NCT01168674|7370167|FG001|STARTED|Overall Study||24
6454053|NCT01168674|7370166|FG000|COMPLETED|Overall Study||25
6454054|NCT01168674|7370167|FG001|COMPLETED|Overall Study||24
6454055|NCT01168674|7370166|FG000|NOT COMPLETED|Overall Study||0
6454056|NCT01168674|7370167|FG001|NOT COMPLETED|Overall Study||0
6454057|NCT01168687|7370176|FG000|STARTED|Overall Study||23
6454058|NCT01168687|7370177|FG001|STARTED|Overall Study||23
6454059|NCT01168687|7370176|FG000|COMPLETED|Overall Study||23
6454060|NCT01168687|7370177|FG001|COMPLETED|Overall Study||23
6454061|NCT01168687|7370176|FG000|NOT COMPLETED|Overall Study||0
6454062|NCT01168687|7370177|FG001|NOT COMPLETED|Overall Study||0
6454063|NCT01168726|7370186|FG000|STARTED|Overall Study||111
6454064|NCT01168726|7370187|FG001|STARTED|Overall Study||121
6454065|NCT01168726|7370188|FG002|STARTED|Overall Study||133
6454066|NCT01168726|7370186|FG000|COMPLETED|Overall Study||103
6454067|NCT01168726|7370187|FG001|COMPLETED|Overall Study||112
6454068|NCT01168726|7370188|FG002|COMPLETED|Overall Study||128
6454069|NCT01168726|7370186|FG000|NOT COMPLETED|Overall Study||8
6454070|NCT01168726|7370187|FG001|NOT COMPLETED|Overall Study||9
6454071|NCT01168726|7370188|FG002|NOT COMPLETED|Overall Study||5
6454072|NCT01168856|7370198|FG000|STARTED|Overall Study||176
6454073|NCT01168856|7370199|FG001|STARTED|Overall Study||558
6454074|NCT01168856|7370198|FG000|COMPLETED|Overall Study||158
6454075|NCT01168856|7370199|FG001|COMPLETED|Overall Study||215
6454076|NCT01168856|7370198|FG000|NOT COMPLETED|Overall Study||18
6454077|NCT01168856|7370199|FG001|NOT COMPLETED|Overall Study||343
6454078|NCT01168908|7370212|FG000|STARTED|Double Blind, Placebo Controlled||10
6454079|NCT01168908|7370213|FG001|STARTED|Double Blind, Placebo Controlled||10
6454080|NCT01168908|7370212|FG000|COMPLETED|Double Blind, Placebo Controlled||7
6454081|NCT01168908|7370213|FG001|COMPLETED|Double Blind, Placebo Controlled||8
6454082|NCT01168908|7370212|FG000|NOT COMPLETED|Double Blind, Placebo Controlled||3
6454083|NCT01168908|7370213|FG001|NOT COMPLETED|Double Blind, Placebo Controlled||2
6454084|NCT01168908|7370212|FG000|STARTED|Open Label||7
6454085|NCT01168908|7370213|FG001|STARTED|Open Label||8
6454086|NCT01168908|7370212|FG000|COMPLETED|Open Label||6
6454087|NCT01168908|7370213|FG001|COMPLETED|Open Label||7
6454088|NCT01168908|7370212|FG000|NOT COMPLETED|Open Label||1
6454089|NCT01168908|7370213|FG001|NOT COMPLETED|Open Label||1
6454090|NCT01168934|7370219|FG000|STARTED|First Intervention Period||7
6454091|NCT01168934|7370220|FG001|STARTED|First Intervention Period||7
6454092|NCT01168934|7370219|FG000|COMPLETED|First Intervention Period||7
6454093|NCT01168934|7370220|FG001|COMPLETED|First Intervention Period||7
6454094|NCT01168934|7370219|FG000|NOT COMPLETED|First Intervention Period||0
6454095|NCT01168934|7370220|FG001|NOT COMPLETED|First Intervention Period||0
6454096|NCT01168934|7370219|FG000|STARTED|Washout Period (at Least 14 Days)||7
6454097|NCT01168934|7370220|FG001|STARTED|Washout Period (at Least 14 Days)||7
6454098|NCT01168934|7370219|FG000|COMPLETED|Washout Period (at Least 14 Days)||7
6454099|NCT01168934|7370220|FG001|COMPLETED|Washout Period (at Least 14 Days)||7
6454100|NCT01168934|7370219|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6454101|NCT01168934|7370220|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6454102|NCT01168934|7370219|FG000|STARTED|Second Intervention Period||7
6454103|NCT01168934|7370220|FG001|STARTED|Second Intervention Period||7
6454104|NCT01168934|7370219|FG000|COMPLETED|Second Intervention Period||7
6454105|NCT01168934|7370220|FG001|COMPLETED|Second Intervention Period||7
6454106|NCT01168934|7370219|FG000|NOT COMPLETED|Second Intervention Period||0
6454107|NCT01168934|7370220|FG001|NOT COMPLETED|Second Intervention Period||0
6454108|NCT01168973|7370229|FG000|STARTED|Overall Study||628
6454109|NCT01168973|7370230|FG001|STARTED|Overall Study||625
6454110|NCT01168973|7370229|FG000|Received Any Quantity of Any Study Drug|Overall Study||624
6454111|NCT01168973|7370230|FG001|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
6454112|NCT01168973|7370229|FG000|COMPLETED|Overall Study||15
6454113|NCT01168973|7370230|FG001|COMPLETED|Overall Study||14
6454114|NCT01168973|7370229|FG000|NOT COMPLETED|Overall Study||613
6454115|NCT01168973|7370230|FG001|NOT COMPLETED|Overall Study||611
6454116|NCT01168986|7370239|FG000|STARTED|Overall Study||20
6454117|NCT01168986|7370240|FG001|STARTED|Overall Study||21
6454118|NCT01168986|7370241|FG002|STARTED|Overall Study||21
6454119|NCT01168986|7370239|FG000|COMPLETED|Overall Study||18
6454120|NCT01168986|7370240|FG001|COMPLETED|Overall Study||20
6454121|NCT01168986|7370241|FG002|COMPLETED|Overall Study||21
6454122|NCT01168986|7370239|FG000|NOT COMPLETED|Overall Study||2
6454123|NCT01168986|7370240|FG001|NOT COMPLETED|Overall Study||1
6454124|NCT01168986|7370241|FG002|NOT COMPLETED|Overall Study||0
6454125|NCT01168999|7370253|FG000|STARTED|Overall Study||28
6454126|NCT01168999|7370254|FG001|STARTED|Overall Study||27
6454127|NCT01168999|7370255|FG002|STARTED|Overall Study||27
6454128|NCT01168999|7370256|FG003|STARTED|Overall Study||28
6454129|NCT01168999|7370253|FG000|COMPLETED|Overall Study||26
6454130|NCT01168999|7370254|FG001|COMPLETED|Overall Study||26
6454131|NCT01168999|7370255|FG002|COMPLETED|Overall Study||27
6454132|NCT01168999|7370256|FG003|COMPLETED|Overall Study||28
6454133|NCT01168999|7370253|FG000|NOT COMPLETED|Overall Study||2
6454134|NCT01168999|7370254|FG001|NOT COMPLETED|Overall Study||1
6454135|NCT01168999|7370255|FG002|NOT COMPLETED|Overall Study||0
6454136|NCT01168999|7370256|FG003|NOT COMPLETED|Overall Study||0
6454137|NCT01169038|7370266|FG000|STARTED|Overall Study||15
6454138|NCT01169038|7370266|FG000|COMPLETED|Overall Study||8
6454139|NCT01169038|7370266|FG000|NOT COMPLETED|Overall Study||7
6454140|NCT01169064|7370272|FG000|STARTED|Overall Study||239
6454141|NCT01169064|7370273|FG001|STARTED|Overall Study||236
6454142|NCT01169064|7370272|FG000|COMPLETED|Overall Study||239
6454143|NCT01169064|7370273|FG001|COMPLETED|Overall Study||236
6454144|NCT01169064|7370272|FG000|NOT COMPLETED|Overall Study||0
6454145|NCT01169064|7370273|FG001|NOT COMPLETED|Overall Study||0
6454146|NCT01169103|7370283|FG000|STARTED|Overall Study||11
6454147|NCT01169103|7370284|FG001|STARTED|Overall Study||11
6454148|NCT01169103|7370283|FG000|COMPLETED|Overall Study||5
6454149|NCT01169103|7370284|FG001|COMPLETED|Overall Study||7
6553527|NCT01743989|7475976|FG000|COMPLETED|TFR Phase||37
6553528|NCT01743989|7475977|FG001|COMPLETED|TFR Phase||36
6454150|NCT01169103|7370283|FG000|NOT COMPLETED|Overall Study||6
6454151|NCT01169103|7370284|FG001|NOT COMPLETED|Overall Study||4
6454152|NCT01169311|7370290|FG000|STARTED|Overall Study||27
6454153|NCT01169311|7370290|FG000|COMPLETED|Overall Study||27
6454154|NCT01169311|7370290|FG000|NOT COMPLETED|Overall Study||0
6553529|NCT01743989|7475978|FG002|COMPLETED|TFR Phase||0
6553530|NCT01743989|7475976|FG000|NOT COMPLETED|TFR Phase||82
6454155|NCT01169337|7370298|FG000|STARTED|Overall Study||44
6454156|NCT01169337|7370299|FG001|STARTED|Overall Study||90
6454157|NCT01169337|7370300|FG002|STARTED|Overall Study||92
6454158|NCT01169337|7370298|FG000|Received Treatment/Observation|Overall Study||44
6454159|NCT01169337|7370299|FG001|Received Treatment/Observation|Overall Study||88
6454160|NCT01169337|7370300|FG002|Received Treatment/Observation|Overall Study||86
6454161|NCT01169337|7370298|FG000|COMPLETED|Overall Study||0
6454162|NCT01169337|7370299|FG001|COMPLETED|Overall Study||0
6454163|NCT01169337|7370300|FG002|COMPLETED|Overall Study||86
6454164|NCT01169337|7370298|FG000|NOT COMPLETED|Overall Study||44
6454165|NCT01169337|7370299|FG001|NOT COMPLETED|Overall Study||90
6454166|NCT01169337|7370300|FG002|NOT COMPLETED|Overall Study||6
6454167|NCT01169350|7370308|FG000|STARTED|Overall Study||8
6454168|NCT01169350|7370308|FG000|COMPLETED|Overall Study||3
6454169|NCT01169350|7370308|FG000|NOT COMPLETED|Overall Study||5
6454170|NCT01169467|7370314|FG000|STARTED|Overall Study||44
6454171|NCT01169467|7370315|FG001|STARTED|Overall Study||40
6454172|NCT01169467|7370314|FG000|COMPLETED|Overall Study||37
6454173|NCT01169467|7370315|FG001|COMPLETED|Overall Study||36
6454174|NCT01169467|7370314|FG000|NOT COMPLETED|Overall Study||7
6454175|NCT01169467|7370315|FG001|NOT COMPLETED|Overall Study||4
6454176|NCT01169493|7370327|FG000|STARTED|Period 1 (6 Months)||2
6454177|NCT01169493|7370328|FG001|STARTED|Period 1 (6 Months)||4
6454178|NCT01169493|7370329|FG002|STARTED|Period 1 (6 Months)||5
6454179|NCT01169493|7370330|FG003|STARTED|Period 1 (6 Months)||0
6454180|NCT01169493|7370331|FG004|STARTED|Period 1 (6 Months)||0
6454181|NCT01169493|7370332|FG005|STARTED|Period 1 (6 Months)||5
6454182|NCT01169493|7370327|FG000|COMPLETED|Period 1 (6 Months)||2
6454183|NCT01169493|7370328|FG001|COMPLETED|Period 1 (6 Months)||3
6454184|NCT01169493|7370329|FG002|COMPLETED|Period 1 (6 Months)||3
6454185|NCT01169493|7370330|FG003|COMPLETED|Period 1 (6 Months)||0
6454186|NCT01169493|7370331|FG004|COMPLETED|Period 1 (6 Months)||0
6454187|NCT01169493|7370332|FG005|COMPLETED|Period 1 (6 Months)||2
6454188|NCT01169493|7370327|FG000|NOT COMPLETED|Period 1 (6 Months)||0
6454189|NCT01169493|7370328|FG001|NOT COMPLETED|Period 1 (6 Months)||1
6454190|NCT01169493|7370329|FG002|NOT COMPLETED|Period 1 (6 Months)||2
6454191|NCT01169493|7370330|FG003|NOT COMPLETED|Period 1 (6 Months)||0
6454192|NCT01169493|7370331|FG004|NOT COMPLETED|Period 1 (6 Months)||0
6454193|NCT01169493|7370332|FG005|NOT COMPLETED|Period 1 (6 Months)||3
6454194|NCT01169493|7370327|FG000|STARTED|Period 2 (6 Months)||2
6454195|NCT01169493|7370328|FG001|STARTED|Period 2 (6 Months)||3
6454196|NCT01169493|7370329|FG002|STARTED|Period 2 (6 Months)||3
6454197|NCT01169493|7370330|FG003|STARTED|Period 2 (6 Months)||0
6454198|NCT01169493|7370331|FG004|STARTED|Period 2 (6 Months)||0
6454199|NCT01169493|7370332|FG005|STARTED|Period 2 (6 Months)||2
6454200|NCT01169493|7370327|FG000|COMPLETED|Period 2 (6 Months)||2
6454201|NCT01169493|7370328|FG001|COMPLETED|Period 2 (6 Months)||3
6454202|NCT01169493|7370329|FG002|COMPLETED|Period 2 (6 Months)||3
6454203|NCT01169493|7370330|FG003|COMPLETED|Period 2 (6 Months)||0
6454204|NCT01169493|7370331|FG004|COMPLETED|Period 2 (6 Months)||0
6454205|NCT01169493|7370332|FG005|COMPLETED|Period 2 (6 Months)||2
6454206|NCT01169493|7370327|FG000|NOT COMPLETED|Period 2 (6 Months)||0
6454207|NCT01169493|7370328|FG001|NOT COMPLETED|Period 2 (6 Months)||0
6454208|NCT01169493|7370329|FG002|NOT COMPLETED|Period 2 (6 Months)||0
6454209|NCT01169493|7370330|FG003|NOT COMPLETED|Period 2 (6 Months)||0
6454210|NCT01169493|7370331|FG004|NOT COMPLETED|Period 2 (6 Months)||0
6454211|NCT01169493|7370332|FG005|NOT COMPLETED|Period 2 (6 Months)||0
6454212|NCT01169493|7370327|FG000|STARTED|Period 3 (6 Months)||2
6454213|NCT01169493|7370328|FG001|STARTED|Period 3 (6 Months)||3
6454214|NCT01169493|7370329|FG002|STARTED|Period 3 (6 Months)||3
6454215|NCT01169493|7370330|FG003|STARTED|Period 3 (6 Months)||0
6454216|NCT01169493|7370331|FG004|STARTED|Period 3 (6 Months)||0
6454217|NCT01169493|7370332|FG005|STARTED|Period 3 (6 Months)||2
6454218|NCT01169493|7370327|FG000|COMPLETED|Period 3 (6 Months)||2
6454219|NCT01169493|7370328|FG001|COMPLETED|Period 3 (6 Months)||1
6454220|NCT01169493|7370329|FG002|COMPLETED|Period 3 (6 Months)||2
6454221|NCT01169493|7370330|FG003|COMPLETED|Period 3 (6 Months)||0
6454222|NCT01169493|7370331|FG004|COMPLETED|Period 3 (6 Months)||0
6454223|NCT01169493|7370332|FG005|COMPLETED|Period 3 (6 Months)||2
6454224|NCT01169493|7370327|FG000|NOT COMPLETED|Period 3 (6 Months)||0
6454225|NCT01169493|7370328|FG001|NOT COMPLETED|Period 3 (6 Months)||2
6454226|NCT01169493|7370329|FG002|NOT COMPLETED|Period 3 (6 Months)||1
6454227|NCT01169493|7370330|FG003|NOT COMPLETED|Period 3 (6 Months)||0
6454228|NCT01169493|7370331|FG004|NOT COMPLETED|Period 3 (6 Months)||0
6454229|NCT01169493|7370332|FG005|NOT COMPLETED|Period 3 (6 Months)||0
6454230|NCT01169519|7370340|FG000|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
6454231|NCT01169519|7370340|FG000|COMPLETED|Overall Study||21
6454232|NCT01169519|7370340|FG000|NOT COMPLETED|Overall Study||0
6454233|NCT01169532|7370352|FG000|STARTED|Overall Study||16
6454234|NCT01169532|7370352|FG000|COMPLETED|Overall Study||15
6454235|NCT01169532|7370352|FG000|NOT COMPLETED|Overall Study||1
6454236|NCT01169558|7370356|FG000|STARTED|Overall Study||162
6454237|NCT01169558|7370356|FG000|COMPLETED|Overall Study||6
6454238|NCT01169558|7370356|FG000|NOT COMPLETED|Overall Study||156
6454239|NCT01169636|7370365|FG000|STARTED|Overall Study||3
6454240|NCT01169636|7370366|FG001|STARTED|Overall Study||6
6454241|NCT01169636|7370367|FG002|STARTED|Overall Study||20
6454242|NCT01169636|7370368|FG003|STARTED|Overall Study||13
6454243|NCT01169636|7370369|FG004|STARTED|Overall Study||14
6454244|NCT01169636|7370365|FG000|COMPLETED|Overall Study||3
6454245|NCT01169636|7370366|FG001|COMPLETED|Overall Study||6
6454246|NCT01169636|7370367|FG002|COMPLETED|Overall Study||17
6454247|NCT01169636|7370368|FG003|COMPLETED|Overall Study||12
6454248|NCT01169636|7370369|FG004|COMPLETED|Overall Study||11
6454249|NCT01169636|7370365|FG000|NOT COMPLETED|Overall Study||0
6454250|NCT01169636|7370366|FG001|NOT COMPLETED|Overall Study||0
6454251|NCT01169636|7370367|FG002|NOT COMPLETED|Overall Study||3
6454252|NCT01169636|7370368|FG003|NOT COMPLETED|Overall Study||1
6454253|NCT01169636|7370369|FG004|NOT COMPLETED|Overall Study||3
6454254|NCT01169649|7370379|FG000|STARTED|Overall Study||11
6454255|NCT01169649|7370379|FG000|COMPLETED|Overall Study||8
6454256|NCT01169649|7370379|FG000|NOT COMPLETED|Overall Study||3
6454257|NCT01169675|7370388|FG000|STARTED|Overall Study||20
6454258|NCT01169675|7370389|FG001|STARTED|Overall Study||3
6454259|NCT01169675|7370390|FG002|STARTED|Overall Study||7
6454260|NCT01169675|7370391|FG003|STARTED|Overall Study||17
6454261|NCT01169675|7370392|FG004|STARTED|Overall Study||6
6454262|NCT01169675|7370388|FG000|COMPLETED|Overall Study||0
6454263|NCT01169675|7370389|FG001|COMPLETED|Overall Study||0
6454264|NCT01169675|7370390|FG002|COMPLETED|Overall Study||0
6454265|NCT01169675|7370391|FG003|COMPLETED|Overall Study||0
6454266|NCT01169675|7370392|FG004|COMPLETED|Overall Study||0
6454267|NCT01169675|7370388|FG000|NOT COMPLETED|Overall Study||20
6454268|NCT01169675|7370389|FG001|NOT COMPLETED|Overall Study||3
6454269|NCT01169675|7370390|FG002|NOT COMPLETED|Overall Study||7
6454270|NCT01169675|7370391|FG003|NOT COMPLETED|Overall Study||17
6454271|NCT01169675|7370392|FG004|NOT COMPLETED|Overall Study||6
6454272|NCT01169701|7370406|FG000|STARTED|Overall Study||36
6454273|NCT01169701|7370407|FG001|STARTED|Overall Study||35
6454274|NCT01169701|7370406|FG000|Safety Set|Overall Study||36
6454275|NCT01169701|7370407|FG001|Safety Set|Overall Study||35
6454276|NCT01169701|7370406|FG000|Intent to Treat (ITT) Set|Overall Study||32
6454277|NCT01169701|7370407|FG001|Intent to Treat (ITT) Set|Overall Study||28
6454278|NCT01169701|7370406|FG000|COMPLETED|Overall Study||31
6454279|NCT01169701|7370407|FG001|COMPLETED|Overall Study||25
6454280|NCT01169701|7370406|FG000|NOT COMPLETED|Overall Study||5
6454281|NCT01169701|7370407|FG001|NOT COMPLETED|Overall Study||10
6454282|NCT01169779|7370415|FG000|STARTED|Overall Study|Randomized.|195
6454283|NCT01169779|7370416|FG001|STARTED|Overall Study||196
6454284|NCT01169779|7370415|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
6454285|NCT01169779|7370416|FG001|Treated/Safety Population|Overall Study||196
6454286|NCT01169779|7370415|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
6454287|NCT01169779|7370416|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||195
6454288|NCT01169779|7370415|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
6454289|NCT01169779|7370416|FG001|Subgroup for Standardized Meal Test|Overall Study||121
6454290|NCT01169779|7370415|FG000|COMPLETED|Overall Study||184
6454291|NCT01169779|7370416|FG001|COMPLETED|Overall Study||179
6454292|NCT01169779|7370415|FG000|NOT COMPLETED|Overall Study||11
6553531|NCT01743989|7475977|FG001|NOT COMPLETED|TFR Phase||68
6553532|NCT01743989|7475978|FG002|NOT COMPLETED|TFR Phase||0
6553533|NCT01743989|7475976|FG000|STARTED|Re-treatment Phase||74
6553534|NCT01743989|7475977|FG001|STARTED|Re-treatment Phase||55
6553535|NCT01743989|7475978|FG002|STARTED|Re-treatment Phase||0
6454293|NCT01169779|7370416|FG001|NOT COMPLETED|Overall Study||17
6454294|NCT01169844|7370424|FG000|STARTED|Overall Study||19
6454295|NCT01169844|7370425|FG001|STARTED|Overall Study||9
6454296|NCT01169844|7370424|FG000|COMPLETED|Overall Study||14
6454297|NCT01169844|7370425|FG001|COMPLETED|Overall Study||8
6454298|NCT01169844|7370424|FG000|NOT COMPLETED|Overall Study||5
6454299|NCT01169844|7370425|FG001|NOT COMPLETED|Overall Study||1
6500567|NCT01425268|7419245|FG000|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
6500568|NCT01425268|7419246|FG001|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
6500569|NCT01425268|7419245|FG000|COMPLETED|Overall Study||98
6500570|NCT01425268|7419246|FG001|COMPLETED|Overall Study||52
6500571|NCT01425268|7419245|FG000|NOT COMPLETED|Overall Study||8
6745130|NCT03355742|7673210|FG000|STARTED|Overall Study||963
6745131|NCT03355742|7673210|FG000|COMPLETED|Overall Study||864
6745132|NCT03355742|7673210|FG000|NOT COMPLETED|Overall Study||99
6500572|NCT01425268|7419246|FG001|NOT COMPLETED|Overall Study||0
6500573|NCT01425281|7419254|FG000|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|335
6500574|NCT01425281|7419255|FG001|STARTED|At 30-day Clinical Follow-up|Intent-to-Treat (ITT) Population|166
6500575|NCT01425281|7419254|FG000|COMPLETED|At 30-day Clinical Follow-up||334
6500576|NCT01425281|7419255|FG001|COMPLETED|At 30-day Clinical Follow-up||166
6500577|NCT01425281|7419254|FG000|NOT COMPLETED|At 30-day Clinical Follow-up||1
6500578|NCT01425281|7419255|FG001|NOT COMPLETED|At 30-day Clinical Follow-up||0
6553536|NCT01743989|7475976|FG000|COMPLETED|Re-treatment Phase||58
6553537|NCT01743989|7475977|FG001|COMPLETED|Re-treatment Phase||46
6553538|NCT01743989|7475978|FG002|COMPLETED|Re-treatment Phase||0
6745133|NCT03355820|7673214|FG000|STARTED|Overall Study||227
6745134|NCT03355820|7673214|FG000|COMPLETED|Overall Study||227
6745135|NCT03355820|7673214|FG000|NOT COMPLETED|Overall Study||0
6745136|NCT03356145|7673220|FG000|STARTED|Overall Study||48
6454300|NCT01169987|7370431|FG000|STARTED|Overall Study||191
6454301|NCT01169987|7370431|FG000|COMPLETED|Overall Study||160
6454302|NCT01169987|7370431|FG000|NOT COMPLETED|Overall Study||31
6454303|NCT01170039|7370443|FG000|STARTED|Overall Study||37
6454304|NCT01170039|7370444|FG001|STARTED|Overall Study||39
6454305|NCT01170039|7370443|FG000|COMPLETED|Overall Study||29
6454306|NCT01170039|7370444|FG001|COMPLETED|Overall Study||33
6454307|NCT01170039|7370443|FG000|NOT COMPLETED|Overall Study||8
6454308|NCT01170039|7370444|FG001|NOT COMPLETED|Overall Study||6
6454309|NCT01170065|7370453|FG000|STARTED|Overall Study||37
6454310|NCT01170065|7370454|FG001|STARTED|Overall Study||126
6454311|NCT01170065|7370455|FG002|STARTED|Overall Study||35
6454312|NCT01170065|7370453|FG000|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
6454313|NCT01170065|7370454|FG001|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|34
6454314|NCT01170065|7370455|FG002|COMPLETED|Overall Study|Planned observation time is from first trial drug intake to follow-up visit|9
6454315|NCT01170065|7370453|FG000|NOT COMPLETED|Overall Study||28
6454316|NCT01170065|7370454|FG001|NOT COMPLETED|Overall Study||92
6454317|NCT01170065|7370455|FG002|NOT COMPLETED|Overall Study||26
6454318|NCT01170091|7370463|FG000|STARTED|Overall Study||651
6454319|NCT01170091|7370463|FG000|COMPLETED|Overall Study||627
6454320|NCT01170091|7370463|FG000|NOT COMPLETED|Overall Study||24
6454321|NCT01170117|7370469|FG000|STARTED|Overall Study||77
6454322|NCT01170117|7370470|FG001|STARTED|Overall Study||75
6454323|NCT01170117|7370469|FG000|COMPLETED|Overall Study||47
6454324|NCT01170117|7370470|FG001|COMPLETED|Overall Study||55
6454325|NCT01170117|7370469|FG000|NOT COMPLETED|Overall Study||30
6454326|NCT01170117|7370470|FG001|NOT COMPLETED|Overall Study||20
6454327|NCT01170208|7370479|FG000|STARTED|Overall Study||20
6454328|NCT01170208|7370480|FG001|STARTED|Overall Study||20
6454329|NCT01170208|7370481|FG002|STARTED|Overall Study||6
6454330|NCT01170208|7370479|FG000|COMPLETED|Overall Study||14
6454331|NCT01170208|7370480|FG001|COMPLETED|Overall Study||20
6454332|NCT01170208|7370481|FG002|COMPLETED|Overall Study||4
6454333|NCT01170208|7370479|FG000|NOT COMPLETED|Overall Study||6
6454334|NCT01170208|7370480|FG001|NOT COMPLETED|Overall Study||0
6454335|NCT01170208|7370481|FG002|NOT COMPLETED|Overall Study||2
6454336|NCT01170221|7370494|FG000|STARTED|Overall Study||332
6454337|NCT01170221|7370495|FG001|STARTED|Overall Study||335
6454338|NCT01170221|7370494|FG000|COMPLETED|Overall Study||299
6454339|NCT01170221|7370495|FG001|COMPLETED|Overall Study||307
6454340|NCT01170221|7370494|FG000|NOT COMPLETED|Overall Study||33
6454341|NCT01170221|7370495|FG001|NOT COMPLETED|Overall Study||28
6454342|NCT01170247|7370503|FG000|STARTED|Overall Study||2
6454343|NCT01170247|7370504|FG001|STARTED|Overall Study||1
6454344|NCT01170247|7370503|FG000|COMPLETED|Overall Study||2
6454345|NCT01170247|7370504|FG001|COMPLETED|Overall Study||1
6454346|NCT01170247|7370503|FG000|NOT COMPLETED|Overall Study||0
6454347|NCT01170247|7370504|FG001|NOT COMPLETED|Overall Study||0
6454348|NCT01170273|7370512|FG000|STARTED|Overall Study||64
6745137|NCT03356145|7673221|FG001|STARTED|Overall Study||48
6745138|NCT03356145|7673220|FG000|Received Allocated Intervention|Overall Study||45
6745139|NCT03356145|7673221|FG001|Received Allocated Intervention|Overall Study||47
6745140|NCT03356145|7673220|FG000|COMPLETED|Overall Study||45
6745141|NCT03356145|7673221|FG001|COMPLETED|Overall Study||47
6745142|NCT03356145|7673220|FG000|NOT COMPLETED|Overall Study||3
6745143|NCT03356145|7673221|FG001|NOT COMPLETED|Overall Study||1
6745144|NCT03356977|7673227|FG000|STARTED|Overall Study||137
6745145|NCT03356977|7673227|FG000|COMPLETED|Overall Study||132
6745146|NCT03356977|7673227|FG000|NOT COMPLETED|Overall Study||5
6745147|NCT03357341|7673233|FG000|STARTED|Overall Study||96
6745148|NCT03357341|7673234|FG001|STARTED|Overall Study||98
6745149|NCT03357341|7673233|FG000|COMPLETED|Overall Study||89
6745150|NCT03357341|7673234|FG001|COMPLETED|Overall Study||86
6745151|NCT03357341|7673233|FG000|NOT COMPLETED|Overall Study||7
6745152|NCT03357341|7673234|FG001|NOT COMPLETED|Overall Study||12
6454349|NCT01170273|7370513|FG001|STARTED|Overall Study||66
6454350|NCT01170273|7370512|FG000|COMPLETED|Overall Study||56
6454351|NCT01170273|7370513|FG001|COMPLETED|Overall Study||57
6454352|NCT01170273|7370512|FG000|NOT COMPLETED|Overall Study||8
6454353|NCT01170273|7370513|FG001|NOT COMPLETED|Overall Study||9
6454354|NCT01170364|7370521|FG000|STARTED|Overall Study||8
6454355|NCT01170364|7370522|FG001|STARTED|Overall Study||6
6454356|NCT01170364|7370521|FG000|COMPLETED|Overall Study||4
6454357|NCT01170364|7370522|FG001|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
6454358|NCT01170364|7370521|FG000|NOT COMPLETED|Overall Study||4
6454359|NCT01170364|7370522|FG001|NOT COMPLETED|Overall Study||1
6454360|NCT01170390|7370530|FG000|STARTED|Oral Contraceptives||32
6454361|NCT01170390|7370531|FG001|STARTED|Oral Contraceptives||0
6454362|NCT01170390|7370532|FG002|STARTED|Oral Contraceptives||0
6454363|NCT01170390|7370530|FG000|COMPLETED|Oral Contraceptives||31
6454364|NCT01170390|7370531|FG001|COMPLETED|Oral Contraceptives||0
6745153|NCT03357393|7673244|FG000|STARTED|Overall Study||50
6454365|NCT01170390|7370532|FG002|COMPLETED|Oral Contraceptives||0
6454366|NCT01170390|7370530|FG000|NOT COMPLETED|Oral Contraceptives||1
6745154|NCT03357393|7673245|FG001|STARTED|Overall Study||50
6745155|NCT03357393|7673246|FG002|STARTED|Overall Study||50
6745156|NCT03357393|7673244|FG000|COMPLETED|Overall Study||50
6745157|NCT03357393|7673245|FG001|COMPLETED|Overall Study||50
6745158|NCT03357393|7673246|FG002|COMPLETED|Overall Study||50
6454367|NCT01170390|7370531|FG001|NOT COMPLETED|Oral Contraceptives||0
6454368|NCT01170390|7370532|FG002|NOT COMPLETED|Oral Contraceptives||0
6454369|NCT01170390|7370530|FG000|STARTED|Randomized Treatment||0
6454370|NCT01170390|7370531|FG001|STARTED|Randomized Treatment||17
6454371|NCT01170390|7370532|FG002|STARTED|Randomized Treatment||15
6454372|NCT01170390|7370530|FG000|COMPLETED|Randomized Treatment||0
6454373|NCT01170390|7370531|FG001|COMPLETED|Randomized Treatment||16
6454374|NCT01170390|7370532|FG002|COMPLETED|Randomized Treatment||15
6454375|NCT01170390|7370530|FG000|NOT COMPLETED|Randomized Treatment||0
6454376|NCT01170390|7370531|FG001|NOT COMPLETED|Randomized Treatment||1
6454377|NCT01170390|7370532|FG002|NOT COMPLETED|Randomized Treatment||0
6745159|NCT03357393|7673244|FG000|NOT COMPLETED|Overall Study||0
6745160|NCT03357393|7673245|FG001|NOT COMPLETED|Overall Study||0
6745161|NCT03357393|7673246|FG002|NOT COMPLETED|Overall Study||0
6745162|NCT03357471|7673256|FG000|STARTED|Overall Study||35
6745163|NCT03357471|7673257|FG001|STARTED|Overall Study||32
6454378|NCT01170533|7370540|FG000|STARTED|Omeprazole Cross-over||20
6454379|NCT01170533|7370541|FG001|STARTED|Omeprazole Cross-over||0
6454380|NCT01170533|7370540|FG000|COMPLETED|Omeprazole Cross-over||20
6454381|NCT01170533|7370541|FG001|COMPLETED|Omeprazole Cross-over||0
6454382|NCT01170533|7370540|FG000|NOT COMPLETED|Omeprazole Cross-over||0
6454383|NCT01170533|7370541|FG001|NOT COMPLETED|Omeprazole Cross-over||0
6454384|NCT01170533|7370540|FG000|STARTED|Pantoprazole Cross-over||0
6454385|NCT01170533|7370541|FG001|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
6454386|NCT01170533|7370540|FG000|COMPLETED|Pantoprazole Cross-over||0
6454387|NCT01170533|7370541|FG001|COMPLETED|Pantoprazole Cross-over||20
6454388|NCT01170533|7370540|FG000|NOT COMPLETED|Pantoprazole Cross-over||0
6454389|NCT01170533|7370541|FG001|NOT COMPLETED|Pantoprazole Cross-over||0
6454390|NCT01170546|7370555|FG000|STARTED|Overall Study||7
6454391|NCT01170546|7370556|FG001|STARTED|Overall Study||7
6454392|NCT01170546|7370557|FG002|STARTED|Overall Study||6
6454393|NCT01170546|7370558|FG003|STARTED|Overall Study||8
6454394|NCT01170546|7370555|FG000|COMPLETED|Overall Study||7
6454395|NCT01170546|7370556|FG001|COMPLETED|Overall Study||7
6454396|NCT01170546|7370557|FG002|COMPLETED|Overall Study||6
6454397|NCT01170546|7370558|FG003|COMPLETED|Overall Study||8
6454398|NCT01170546|7370555|FG000|NOT COMPLETED|Overall Study||0
6454399|NCT01170546|7370556|FG001|NOT COMPLETED|Overall Study||0
6454400|NCT01170546|7370557|FG002|NOT COMPLETED|Overall Study||0
6454401|NCT01170546|7370558|FG003|NOT COMPLETED|Overall Study||0
6454402|NCT01170598|7370568|FG000|STARTED|Overall Study||35
6454403|NCT01170598|7370568|FG000|COMPLETED|Overall Study||29
6454404|NCT01170598|7370568|FG000|NOT COMPLETED|Overall Study||6
6454405|NCT01170663|7370574|FG000|STARTED|Overall Study|Participant was included in ramucirumab (IMC-1121B)/paclitaxel treatment arm (safety population).|330
6454406|NCT01170663|7370575|FG001|STARTED|Overall Study|Participant was included in the placebo/paclitaxel treatment arm (intent-to-treat (ITT) population).|335
6454407|NCT01170663|7370574|FG000|Received Any Treatment (Safety Pop)|Overall Study||327
6454408|NCT01170663|7370575|FG001|Received Any Treatment (Safety Pop)|Overall Study||329
6454409|NCT01170663|7370574|FG000|COMPLETED|Overall Study||316
6454410|NCT01170663|7370575|FG001|COMPLETED|Overall Study||315
6454411|NCT01170663|7370574|FG000|NOT COMPLETED|Overall Study||14
6454412|NCT01170663|7370575|FG001|NOT COMPLETED|Overall Study||20
6454413|NCT01170715|7370581|FG000|STARTED|Overall Study||21
6454414|NCT01170715|7370581|FG000|COMPLETED|Overall Study||14
6454415|NCT01170715|7370581|FG000|NOT COMPLETED|Overall Study||7
6454416|NCT01170754|7370587|FG000|STARTED|Overall Study||66
6454417|NCT01170754|7370588|FG001|STARTED|Overall Study||70
6454418|NCT01170754|7370587|FG000|COMPLETED|Overall Study||66
6454419|NCT01170754|7370588|FG001|COMPLETED|Overall Study||70
6454420|NCT01170754|7370587|FG000|NOT COMPLETED|Overall Study||0
6454421|NCT01170754|7370588|FG001|NOT COMPLETED|Overall Study||0
6454422|NCT01170884|7370598|FG000|STARTED|Overall Study||59
6454423|NCT01170884|7370599|FG001|STARTED|Overall Study||62
6454424|NCT01170884|7370598|FG000|COMPLETED|Overall Study||54
6454425|NCT01170884|7370599|FG001|COMPLETED|Overall Study||60
6454426|NCT01170884|7370598|FG000|NOT COMPLETED|Overall Study||5
6454427|NCT01170884|7370599|FG001|NOT COMPLETED|Overall Study||2
6454428|NCT01170949|7370607|FG000|STARTED|Overall Study||50
6454429|NCT01170949|7370608|FG001|STARTED|Overall Study||26
6454430|NCT01170949|7370607|FG000|COMPLETED|Overall Study||43
6454431|NCT01170949|7370608|FG001|COMPLETED|Overall Study||22
6454432|NCT01170949|7370607|FG000|NOT COMPLETED|Overall Study||7
6454433|NCT01170949|7370608|FG001|NOT COMPLETED|Overall Study||4
6454434|NCT01170962|7370617|FG000|STARTED|Treatment Period||203
6454435|NCT01170962|7370618|FG001|STARTED|Treatment Period||199
6454436|NCT01170962|7370619|FG002|STARTED|Treatment Period||17
6454437|NCT01170962|7370617|FG000|No PDR|Treatment Period||145
6454438|NCT01170962|7370618|FG001|No PDR|Treatment Period||127
6454439|NCT01170962|7370619|FG002|No PDR|Treatment Period||17
6454440|NCT01170962|7370617|FG000|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||30
6454441|NCT01170962|7370618|FG001|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||36
6454442|NCT01170962|7370619|FG002|PDR -Randomized to 24 Weeks pegIFNα--2a|Treatment Period||0
6454443|NCT01170962|7370617|FG000|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||28
6454444|NCT01170962|7370618|FG001|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||36
6454445|NCT01170962|7370619|FG002|PDR -Randomized to 48 Weeks Follow--up|Treatment Period||0
6745164|NCT03357471|7673256|FG000|COMPLETED|Overall Study||33
6454446|NCT01170962|7370617|FG000|COMPLETED|Treatment Period||76
6454447|NCT01170962|7370618|FG001|COMPLETED|Treatment Period||88
6454448|NCT01170962|7370619|FG002|COMPLETED|Treatment Period||5
6454449|NCT01170962|7370617|FG000|NOT COMPLETED|Treatment Period||127
6454450|NCT01170962|7370618|FG001|NOT COMPLETED|Treatment Period||111
6454451|NCT01170962|7370619|FG002|NOT COMPLETED|Treatment Period||12
6454452|NCT01170962|7370617|FG000|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
6454453|NCT01170962|7370618|FG001|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
6454454|NCT01170962|7370619|FG002|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
6454455|NCT01170962|7370617|FG000|COMPLETED|Follow up Period||159
6454456|NCT01170962|7370618|FG001|COMPLETED|Follow up Period||165
6454457|NCT01170962|7370619|FG002|COMPLETED|Follow up Period||9
6553539|NCT01743989|7475976|FG000|NOT COMPLETED|Re-treatment Phase||16
6553540|NCT01743989|7475977|FG001|NOT COMPLETED|Re-treatment Phase||9
6553541|NCT01743989|7475978|FG002|NOT COMPLETED|Re-treatment Phase||0
6454458|NCT01170962|7370617|FG000|NOT COMPLETED|Follow up Period||39
6454459|NCT01170962|7370618|FG001|NOT COMPLETED|Follow up Period||27
6454460|NCT01170962|7370619|FG002|NOT COMPLETED|Follow up Period||6
6454461|NCT01171118|7370636|FG000|STARTED|Overall Study||10
6454462|NCT01171118|7370636|FG000|COMPLETED|Overall Study||10
6454463|NCT01171118|7370636|FG000|NOT COMPLETED|Overall Study||0
6454464|NCT01171183|7370648|FG000|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
6454465|NCT01171183|7370649|FG001|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
6454466|NCT01171183|7370648|FG000|COMPLETED|Residential Facility (Weeks 1-2)||13
6454467|NCT01171183|7370649|FG001|COMPLETED|Residential Facility (Weeks 1-2)||10
6454468|NCT01171183|7370648|FG000|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
6454469|NCT01171183|7370649|FG001|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
6454470|NCT01171183|7370648|FG000|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
6454471|NCT01171183|7370649|FG001|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
6454472|NCT01171183|7370648|FG000|COMPLETED|Outpatient Participation (Weeks 3-10)||2
6454473|NCT01171183|7370649|FG001|COMPLETED|Outpatient Participation (Weeks 3-10)||4
6454474|NCT01171183|7370648|FG000|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
6454475|NCT01171183|7370649|FG001|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
6454476|NCT01171521|7370655|FG000|STARTED|Overall Study||6
6454477|NCT01171521|7370655|FG000|COMPLETED|Overall Study||0
6454478|NCT01171521|7370655|FG000|NOT COMPLETED|Overall Study||6
6454479|NCT01171612|7370659|FG000|STARTED|Overall Study||483
6454480|NCT01171612|7370659|FG000|COMPLETED|Overall Study||432
6454481|NCT01171612|7370659|FG000|NOT COMPLETED|Overall Study||51
6454482|NCT01171625|7370666|FG000|STARTED|Overall Study||283
6454483|NCT01171625|7370666|FG000|Subjects Implanted With Device|Overall Study||258
6454484|NCT01171625|7370666|FG000|COMPLETED|Overall Study||103
6454485|NCT01171625|7370666|FG000|NOT COMPLETED|Overall Study||180
6454486|NCT01171677|7370680|FG000|STARTED|Overall Study||17
6454487|NCT01171677|7370681|FG001|STARTED|Overall Study||15
6454488|NCT01171677|7370680|FG000|COMPLETED|Overall Study||11
6454489|NCT01171677|7370681|FG001|COMPLETED|Overall Study||12
6454490|NCT01171677|7370680|FG000|NOT COMPLETED|Overall Study||6
6454491|NCT01171677|7370681|FG001|NOT COMPLETED|Overall Study||3
6454492|NCT01171690|7370689|FG000|STARTED|Overall Study||5
6454493|NCT01171690|7370690|FG001|STARTED|Overall Study||5
6454494|NCT01171690|7370689|FG000|COMPLETED|Overall Study||5
6454495|NCT01171690|7370690|FG001|COMPLETED|Overall Study||5
6454496|NCT01171690|7370689|FG000|NOT COMPLETED|Overall Study||0
6454497|NCT01171690|7370690|FG001|NOT COMPLETED|Overall Study||0
6454498|NCT01171794|7370698|FG000|STARTED|Overall Study||47
6454499|NCT01171794|7370699|FG001|STARTED|Overall Study||42
6454500|NCT01171794|7370698|FG000|COMPLETED|Overall Study||44
6454501|NCT01171794|7370699|FG001|COMPLETED|Overall Study||42
6454502|NCT01171794|7370698|FG000|NOT COMPLETED|Overall Study||3
6454503|NCT01171794|7370699|FG001|NOT COMPLETED|Overall Study||0
6454504|NCT01171820|7370707|FG000|STARTED|Overall Study||106
6454505|NCT01171820|7370708|FG001|STARTED|Overall Study||218
6454506|NCT01171820|7370707|FG000|COMPLETED|Overall Study||100
6454507|NCT01171820|7370708|FG001|COMPLETED|Overall Study||212
6454508|NCT01171820|7370707|FG000|NOT COMPLETED|Overall Study||6
6454509|NCT01171820|7370708|FG001|NOT COMPLETED|Overall Study||6
6553542|NCT01744197|7475991|FG000|STARTED|Overall Study||32
6454510|NCT01171924|7370716|FG000|STARTED|Overall Study||23
6454511|NCT01171924|7370717|FG001|STARTED|Overall Study||23
6454512|NCT01171924|7370716|FG000|COMPLETED|Overall Study||0
6454513|NCT01171924|7370717|FG001|COMPLETED|Overall Study||0
6454514|NCT01171924|7370716|FG000|NOT COMPLETED|Overall Study||23
6454515|NCT01171924|7370717|FG001|NOT COMPLETED|Overall Study||23
6454516|NCT01171963|7370725|FG000|STARTED|Overall Study||1666
6454517|NCT01171963|7370726|FG001|STARTED|Overall Study||1667
6454518|NCT01171963|7370725|FG000|COMPLETED|Overall Study||1518
6454519|NCT01171963|7370726|FG001|COMPLETED|Overall Study||1499
6454520|NCT01171963|7370725|FG000|NOT COMPLETED|Overall Study||148
6454521|NCT01171963|7370726|FG001|NOT COMPLETED|Overall Study||168
6454522|NCT01171976|7370738|FG000|STARTED|Overall Study||121
6553543|NCT01744197|7475992|FG001|STARTED|Overall Study||29
6454523|NCT01171976|7370739|FG001|STARTED|Overall Study||128
6454524|NCT01171976|7370740|FG002|STARTED|Overall Study||123
6454525|NCT01171976|7370738|FG000|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
6454526|NCT01171976|7370739|FG001|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
6454527|NCT01171976|7370740|FG002|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
6454528|NCT01171976|7370738|FG000|COMPLETED|Overall Study||107
6454529|NCT01171976|7370739|FG001|COMPLETED|Overall Study||117
6454530|NCT01171976|7370740|FG002|COMPLETED|Overall Study||108
6454531|NCT01171976|7370738|FG000|NOT COMPLETED|Overall Study||14
6454532|NCT01171976|7370739|FG001|NOT COMPLETED|Overall Study||11
6454533|NCT01171976|7370740|FG002|NOT COMPLETED|Overall Study||15
6454534|NCT01171989|7370751|FG000|STARTED|Overall Study||137
6454535|NCT01171989|7370752|FG001|STARTED|Overall Study||133
6454536|NCT01171989|7370753|FG002|STARTED|Overall Study||121
6454537|NCT01171989|7370751|FG000|COMPLETED|Overall Study||137
6454538|NCT01171989|7370752|FG001|COMPLETED|Overall Study||133
6454539|NCT01171989|7370753|FG002|COMPLETED|Overall Study||120
6454540|NCT01171989|7370751|FG000|NOT COMPLETED|Overall Study||0
6454541|NCT01171989|7370752|FG001|NOT COMPLETED|Overall Study||0
6454542|NCT01171989|7370753|FG002|NOT COMPLETED|Overall Study||1
6454543|NCT01172067|7370763|FG000|STARTED|Overall Study||200
6454544|NCT01172067|7370764|FG001|STARTED|Overall Study||200
6454545|NCT01172067|7370763|FG000|COMPLETED|Overall Study||153
6454546|NCT01172067|7370764|FG001|COMPLETED|Overall Study||163
6454547|NCT01172067|7370763|FG000|NOT COMPLETED|Overall Study||47
6454548|NCT01172067|7370764|FG001|NOT COMPLETED|Overall Study||37
6454549|NCT01172145|7370772|FG000|STARTED|Overall Study||11
6454550|NCT01172145|7370773|FG001|STARTED|Overall Study||11
6454551|NCT01172145|7370772|FG000|COMPLETED|Overall Study||11
6454552|NCT01172145|7370773|FG001|COMPLETED|Overall Study||11
6454553|NCT01172145|7370772|FG000|NOT COMPLETED|Overall Study||0
6454554|NCT01172145|7370773|FG001|NOT COMPLETED|Overall Study||0
6454555|NCT01172184|7370779|FG000|STARTED|Overall Study||111
6454556|NCT01172184|7370779|FG000|COMPLETED|Overall Study||111
6454557|NCT01172184|7370779|FG000|NOT COMPLETED|Overall Study||0
6454558|NCT01172197|7370785|FG000|STARTED|Overall Study||7
6454559|NCT01172197|7370786|FG001|STARTED|Overall Study||7
6454560|NCT01172197|7370785|FG000|COMPLETED|Overall Study||7
6454561|NCT01172197|7370786|FG001|COMPLETED|Overall Study||7
6454562|NCT01172197|7370785|FG000|NOT COMPLETED|Overall Study||0
6454563|NCT01172197|7370786|FG001|NOT COMPLETED|Overall Study||0
6454564|NCT01172275|7370794|FG000|STARTED|Overall Study||5
6454565|NCT01172275|7370795|FG001|STARTED|Overall Study||6
6454566|NCT01172275|7370794|FG000|COMPLETED|Overall Study||3
6454567|NCT01172275|7370795|FG001|COMPLETED|Overall Study||6
6454568|NCT01172275|7370794|FG000|NOT COMPLETED|Overall Study||2
6454569|NCT01172275|7370795|FG001|NOT COMPLETED|Overall Study||0
6454570|NCT01172288|7370803|FG000|STARTED|Overall Study||17
6454571|NCT01172288|7370804|FG001|STARTED|Overall Study||14
6454572|NCT01172288|7370803|FG000|COMPLETED|Overall Study||16
6454573|NCT01172288|7370804|FG001|COMPLETED|Overall Study||13
6454574|NCT01172288|7370803|FG000|NOT COMPLETED|Overall Study||1
6454575|NCT01172288|7370804|FG001|NOT COMPLETED|Overall Study||1
6454576|NCT01172353|7370812|FG000|STARTED|Overall Study||150
6454577|NCT01172353|7370813|FG001|STARTED|Overall Study||151
6454578|NCT01172353|7370812|FG000|COMPLETED|Overall Study||150
6454579|NCT01172353|7370813|FG001|COMPLETED|Overall Study||151
6454580|NCT01172353|7370812|FG000|NOT COMPLETED|Overall Study||0
6454581|NCT01172353|7370813|FG001|NOT COMPLETED|Overall Study||0
6454582|NCT01172418|7370821|FG000|STARTED|Overall Study||100
6454583|NCT01172418|7370822|FG001|STARTED|Overall Study||100
6454584|NCT01172418|7370821|FG000|COMPLETED|Overall Study||100
6454585|NCT01172418|7370822|FG001|COMPLETED|Overall Study||100
6454586|NCT01172418|7370821|FG000|NOT COMPLETED|Overall Study||0
6454587|NCT01172418|7370822|FG001|NOT COMPLETED|Overall Study||0
6454588|NCT01172522|7370832|FG000|STARTED|Overall Study||15
6454589|NCT01172522|7370833|FG001|STARTED|Overall Study||15
6454590|NCT01172522|7370832|FG000|COMPLETED|Overall Study||15
6454591|NCT01172522|7370833|FG001|COMPLETED|Overall Study||15
6454592|NCT01172522|7370832|FG000|NOT COMPLETED|Overall Study||0
6454593|NCT01172522|7370833|FG001|NOT COMPLETED|Overall Study||0
6454594|NCT01172535|7370838|FG000|STARTED|Overall Study||97
6454595|NCT01172535|7370838|FG000|COMPLETED|Overall Study||89
6454596|NCT01172535|7370838|FG000|NOT COMPLETED|Overall Study||8
6454597|NCT01172600|7370847|FG000|STARTED|Overall Study||39
6454598|NCT01172600|7370848|FG001|STARTED|Overall Study||39
6454599|NCT01172600|7370847|FG000|COMPLETED|Overall Study||39
6454600|NCT01172600|7370848|FG001|COMPLETED|Overall Study||39
6454601|NCT01172600|7370847|FG000|NOT COMPLETED|Overall Study||0
6454602|NCT01172600|7370848|FG001|NOT COMPLETED|Overall Study||0
6454603|NCT01172639|7370859|FG000|STARTED|Overall Study||98
6454604|NCT01172639|7370860|FG001|STARTED|Overall Study||98
6454605|NCT01172639|7370861|FG002|STARTED|Overall Study||93
6454606|NCT01172639|7370862|FG003|STARTED|Overall Study||43
6454607|NCT01172639|7370863|FG004|STARTED|Overall Study||47
6454608|NCT01172639|7370859|FG000|Week 16|Overall Study||94
6454609|NCT01172639|7370860|FG001|Week 16|Overall Study||96
6454610|NCT01172639|7370861|FG002|Week 16|Overall Study||91
6454611|NCT01172639|7370862|FG003|Week 16|Overall Study||39
6454612|NCT01172639|7370863|FG004|Week 16|Overall Study||47
6454613|NCT01172639|7370859|FG000|Week 52|Overall Study||89
6745165|NCT03357471|7673257|FG001|COMPLETED|Overall Study||32
6745166|NCT03357471|7673256|FG000|NOT COMPLETED|Overall Study||2
6745167|NCT03357471|7673257|FG001|NOT COMPLETED|Overall Study||0
6745168|NCT03357614|7673265|FG000|STARTED|Overall Study||697
6745169|NCT03357614|7673266|FG001|STARTED|Overall Study||698
6745170|NCT03357614|7673265|FG000|COMPLETED|Overall Study||672
6745171|NCT03357614|7673266|FG001|COMPLETED|Overall Study||670
6454614|NCT01172639|7370860|FG001|Week 52|Overall Study||89
6454615|NCT01172639|7370861|FG002|Week 52|Overall Study||88
6454616|NCT01172639|7370862|FG003|Week 52|Overall Study||38
6454617|NCT01172639|7370863|FG004|Week 52|Overall Study||45
6454618|NCT01172639|7370859|FG000|COMPLETED|Overall Study||85
6454619|NCT01172639|7370860|FG001|COMPLETED|Overall Study||87
6454620|NCT01172639|7370861|FG002|COMPLETED|Overall Study||77
6454621|NCT01172639|7370862|FG003|COMPLETED|Overall Study||32
6454622|NCT01172639|7370863|FG004|COMPLETED|Overall Study||41
6454623|NCT01172639|7370859|FG000|NOT COMPLETED|Overall Study||13
6454624|NCT01172639|7370860|FG001|NOT COMPLETED|Overall Study||11
6454625|NCT01172639|7370861|FG002|NOT COMPLETED|Overall Study||16
6454626|NCT01172639|7370862|FG003|NOT COMPLETED|Overall Study||11
6454627|NCT01172639|7370863|FG004|NOT COMPLETED|Overall Study||6
6454628|NCT01172808|7370879|FG000|STARTED|Overall Study|Entered and Treated|269
6454629|NCT01172808|7370880|FG001|STARTED|Overall Study|Entered and Treated|262
6454630|NCT01172808|7370881|FG002|STARTED|Overall Study|Entered and Treated|264
6454631|NCT01172808|7370882|FG003|STARTED|Overall Study|Entered and Treated|275
6454632|NCT01172808|7370879|FG000|COMPLETED|Overall Study||248
6454633|NCT01172808|7370880|FG001|COMPLETED|Overall Study||249
6454634|NCT01172808|7370881|FG002|COMPLETED|Overall Study||241
6454635|NCT01172808|7370882|FG003|COMPLETED|Overall Study||260
6454636|NCT01172808|7370879|FG000|NOT COMPLETED|Overall Study||21
6454637|NCT01172808|7370880|FG001|NOT COMPLETED|Overall Study||13
6454638|NCT01172808|7370881|FG002|NOT COMPLETED|Overall Study||23
6454639|NCT01172808|7370882|FG003|NOT COMPLETED|Overall Study||15
6454640|NCT01172821|7370896|FG000|STARTED|Overall Study|Entered and Treated|254
6454641|NCT01172821|7370897|FG001|STARTED|Overall Study|Entered and Treated|257
6454642|NCT01172821|7370898|FG002|STARTED|Overall Study|Entered and Treated|253
6454643|NCT01172821|7370899|FG003|STARTED|Overall Study|Entered and Treated|266
6454644|NCT01172821|7370896|FG000|COMPLETED|Overall Study||240
6454645|NCT01172821|7370897|FG001|COMPLETED|Overall Study||245
6454646|NCT01172821|7370898|FG002|COMPLETED|Overall Study||240
6454647|NCT01172821|7370899|FG003|COMPLETED|Overall Study||249
6454648|NCT01172821|7370896|FG000|NOT COMPLETED|Overall Study||14
6454649|NCT01172821|7370897|FG001|NOT COMPLETED|Overall Study||12
6454650|NCT01172821|7370898|FG002|NOT COMPLETED|Overall Study||13
6454651|NCT01172821|7370899|FG003|NOT COMPLETED|Overall Study||17
6454652|NCT01172847|7370909|FG000|STARTED|Overall Study||24
6454653|NCT01172847|7370909|FG000|Oseltamivir|Overall Study||24
6454654|NCT01172847|7370909|FG000|Rimantadine|Overall Study||22
6454655|NCT01172847|7370909|FG000|Oseltamivir + Rimantadine|Overall Study||21
6454656|NCT01172847|7370909|FG000|COMPLETED|Overall Study||21
6454657|NCT01172847|7370909|FG000|NOT COMPLETED|Overall Study||3
6454658|NCT01172873|7370921|FG000|STARTED|Overall Study||11
6454659|NCT01172873|7370922|FG001|STARTED|Overall Study||5
6745172|NCT03357614|7673265|FG000|NOT COMPLETED|Overall Study||25
6745173|NCT03357614|7673266|FG001|NOT COMPLETED|Overall Study||28
6454660|NCT01172873|7370921|FG000|COMPLETED|Overall Study||8
6454661|NCT01172873|7370922|FG001|COMPLETED|Overall Study||3
6454662|NCT01172873|7370921|FG000|NOT COMPLETED|Overall Study||3
6454663|NCT01172873|7370922|FG001|NOT COMPLETED|Overall Study||2
6454664|NCT01172938|7370931|FG000|STARTED|Placebo-controlled Phase (Week 0-24)||168
6454665|NCT01172938|7370932|FG001|STARTED|Placebo-controlled Phase (Week 0-24)||168
6454666|NCT01172938|7370933|FG002|STARTED|Placebo-controlled Phase (Week 0-24)||168
6454667|NCT01172938|7370934|FG003|STARTED|Placebo-controlled Phase (Week 0-24)||0
6454668|NCT01172938|7370935|FG004|STARTED|Placebo-controlled Phase (Week 0-24)||0
6454669|NCT01172938|7370936|FG005|STARTED|Placebo-controlled Phase (Week 0-24)||0
6454670|NCT01172938|7370937|FG006|STARTED|Placebo-controlled Phase (Week 0-24)||0
6454671|NCT01172938|7370938|FG007|STARTED|Placebo-controlled Phase (Week 0-24)||0
6454672|NCT01172938|7370939|FG008|STARTED|Placebo-controlled Phase (Week 0-24)||0
6454673|NCT01172938|7370931|FG000|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
6454674|NCT01172938|7370932|FG001|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
6454675|NCT01172938|7370933|FG002|Received Treatment|Placebo-controlled Phase (Week 0-24)||168
6454676|NCT01172938|7370934|FG003|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6454677|NCT01172938|7370935|FG004|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6454678|NCT01172938|7370936|FG005|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6454679|NCT01172938|7370937|FG006|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6454680|NCT01172938|7370938|FG007|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6454681|NCT01172938|7370939|FG008|Received Treatment|Placebo-controlled Phase (Week 0-24)||0
6454682|NCT01172938|7370931|FG000|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
6454683|NCT01172938|7370932|FG001|Completed Week 16|Placebo-controlled Phase (Week 0-24)||158
6745174|NCT03357731|7673272|FG000|STARTED|Overall Study||8
6745175|NCT03357731|7673273|FG001|STARTED|Overall Study||7
6745176|NCT03357731|7673274|FG002|STARTED|Overall Study||7
6454684|NCT01172938|7370933|FG002|Completed Week 16|Placebo-controlled Phase (Week 0-24)||154
6454685|NCT01172938|7370934|FG003|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6745177|NCT03357731|7673275|FG003|STARTED|Overall Study||7
6454686|NCT01172938|7370935|FG004|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6454687|NCT01172938|7370936|FG005|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6454688|NCT01172938|7370937|FG006|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6454689|NCT01172938|7370938|FG007|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6454690|NCT01172938|7370939|FG008|Completed Week 16|Placebo-controlled Phase (Week 0-24)||0
6454691|NCT01172938|7370931|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Five participants who escaped early did not complete Week 24|107
6454692|NCT01172938|7370932|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)|Six participants who escaped early did not complete Week 24|78
6454693|NCT01172938|7370933|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||58
6454694|NCT01172938|7370934|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6454695|NCT01172938|7370935|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6454696|NCT01172938|7370936|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6454697|NCT01172938|7370937|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6454698|NCT01172938|7370938|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6454699|NCT01172938|7370939|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0-24)||0
6454700|NCT01172938|7370931|FG000|COMPLETED|Placebo-controlled Phase (Week 0-24)|One participant who completed Week 24 did not enter the active treatment phase|150
6454701|NCT01172938|7370932|FG001|COMPLETED|Placebo-controlled Phase (Week 0-24)||146
6454702|NCT01172938|7370933|FG002|COMPLETED|Placebo-controlled Phase (Week 0-24)||148
6454703|NCT01172938|7370934|FG003|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454704|NCT01172938|7370935|FG004|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454705|NCT01172938|7370936|FG005|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454706|NCT01172938|7370937|FG006|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454707|NCT01172938|7370938|FG007|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454708|NCT01172938|7370939|FG008|COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454709|NCT01172938|7370931|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||18
6454710|NCT01172938|7370932|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||22
6454711|NCT01172938|7370933|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||20
6454712|NCT01172938|7370934|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454713|NCT01172938|7370935|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454714|NCT01172938|7370936|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454715|NCT01172938|7370937|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454716|NCT01172938|7370938|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454717|NCT01172938|7370939|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0-24)||0
6454718|NCT01172938|7370931|FG000|STARTED|Active Treatment Phase (Weeks 25-52)||0
6454719|NCT01172938|7370932|FG001|STARTED|Active Treatment Phase (Weeks 25-52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
6454720|NCT01172938|7370933|FG002|STARTED|Active Treatment Phase (Weeks 25-52)|Three participants who completed Week 24 did not enter the active treatment phase|145
6454721|NCT01172938|7370934|FG003|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
6454722|NCT01172938|7370935|FG004|STARTED|Active Treatment Phase (Weeks 25-52)||23
6454723|NCT01172938|7370936|FG005|STARTED|Active Treatment Phase (Weeks 25-52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
6454724|NCT01172938|7370937|FG006|STARTED|Active Treatment Phase (Weeks 25-52)||24
6454725|NCT01172938|7370938|FG007|STARTED|Active Treatment Phase (Weeks 25-52)||0
6454726|NCT01172938|7370939|FG008|STARTED|Active Treatment Phase (Weeks 25-52)||0
6454727|NCT01172938|7370931|FG000|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6454728|NCT01172938|7370932|FG001|COMPLETED|Active Treatment Phase (Weeks 25-52)||124
6454729|NCT01172938|7370933|FG002|COMPLETED|Active Treatment Phase (Weeks 25-52)||130
6454730|NCT01172938|7370934|FG003|COMPLETED|Active Treatment Phase (Weeks 25-52)||44
6454731|NCT01172938|7370935|FG004|COMPLETED|Active Treatment Phase (Weeks 25-52)||19
6454732|NCT01172938|7370936|FG005|COMPLETED|Active Treatment Phase (Weeks 25-52)||34
6745178|NCT03357731|7673276|FG004|STARTED|Overall Study||8
6745179|NCT03357731|7673277|FG005|STARTED|Overall Study||8
6745180|NCT03357731|7673272|FG000|Completed Period 1 (P1)|Overall Study|1 withdrew post-P1 completion/prior to P2 therapy due to acute cholecystitis, but returned for P2/P3|8
6745181|NCT03357731|7673273|FG001|Completed Period 1 (P1)|Overall Study||7
6745182|NCT03357731|7673274|FG002|Completed Period 1 (P1)|Overall Study||7
6745183|NCT03357731|7673275|FG003|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to acute bradycardia and hypotension|6
6745184|NCT03357731|7673276|FG004|Completed Period 1 (P1)|Overall Study|1 discontinued P1 due to hypotension but resumed P2/P3|7
6745185|NCT03357731|7673277|FG005|Completed Period 1 (P1)|Overall Study||8
6745186|NCT03357731|7673272|FG000|Completed Period 2 (P2)|Overall Study||8
6745187|NCT03357731|7673273|FG001|Completed Period 2 (P2)|Overall Study||7
6745188|NCT03357731|7673274|FG002|Completed Period 2 (P2)|Overall Study||7
6745189|NCT03357731|7673275|FG003|Completed Period 2 (P2)|Overall Study|"1 completed P1, did not proceed to P2/P3 (lost to follow-up);~1 discontinued P2 due to hypotension"|4
6745190|NCT03357731|7673276|FG004|Completed Period 2 (P2)|Overall Study|1 only completed P1, did not continue to P2/P3 (withdrew consent due to personal reasons)|7
6745191|NCT03357731|7673277|FG005|Completed Period 2 (P2)|Overall Study|1 discontinued P2 due to an Adverse Event (AE)|7
6745192|NCT03357731|7673272|FG000|COMPLETED|Overall Study||8
6745193|NCT03357731|7673273|FG001|COMPLETED|Overall Study||7
6745194|NCT03357731|7673274|FG002|COMPLETED|Overall Study|1 discontinuation due to hypotension|6
6454733|NCT01172938|7370937|FG006|COMPLETED|Active Treatment Phase (Weeks 25-52)||22
6454734|NCT01172938|7370938|FG007|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6454735|NCT01172938|7370939|FG008|COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6454736|NCT01172938|7370931|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6454737|NCT01172938|7370932|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||12
6454738|NCT01172938|7370933|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
6454739|NCT01172938|7370934|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||7
6454740|NCT01172938|7370935|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||4
6454741|NCT01172938|7370936|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||15
6454742|NCT01172938|7370937|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||2
6454743|NCT01172938|7370938|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6454744|NCT01172938|7370939|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25-52)||0
6454745|NCT01172938|7370931|FG000|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6454746|NCT01172938|7370932|FG001|STARTED|Active-Treatment Phase (Weeks 52-104)|Six participants who completed Week 52 did not enter the next year of active treatment phase|118
6454747|NCT01172938|7370933|FG002|STARTED|Active-Treatment Phase (Weeks 52-104)|Nine participants who completed Week 52 did not enter the next year of active treatment phase|121
6454748|NCT01172938|7370934|FG003|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6454749|NCT01172938|7370935|FG004|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6454750|NCT01172938|7370936|FG005|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6454751|NCT01172938|7370937|FG006|STARTED|Active-Treatment Phase (Weeks 52-104)||0
6454752|NCT01172938|7370938|FG007|STARTED|Active-Treatment Phase (Weeks 52-104)||61
6454753|NCT01172938|7370939|FG008|STARTED|Active-Treatment Phase (Weeks 52-104)||49
6454754|NCT01172938|7370931|FG000|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454755|NCT01172938|7370932|FG001|COMPLETED|Active-Treatment Phase (Weeks 52-104)||95
6454756|NCT01172938|7370933|FG002|COMPLETED|Active-Treatment Phase (Weeks 52-104)||100
6454757|NCT01172938|7370934|FG003|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454758|NCT01172938|7370935|FG004|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454759|NCT01172938|7370936|FG005|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454760|NCT01172938|7370937|FG006|COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454761|NCT01172938|7370938|FG007|COMPLETED|Active-Treatment Phase (Weeks 52-104)||46
6454762|NCT01172938|7370939|FG008|COMPLETED|Active-Treatment Phase (Weeks 52-104)||45
6454763|NCT01172938|7370931|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454764|NCT01172938|7370932|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||23
6454765|NCT01172938|7370933|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||21
6454766|NCT01172938|7370934|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454767|NCT01172938|7370935|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454768|NCT01172938|7370936|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454769|NCT01172938|7370937|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||0
6454770|NCT01172938|7370938|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||15
6454771|NCT01172938|7370939|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 52-104)||4
6454772|NCT01172938|7370931|FG000|STARTED|Active-Treatment Phase Weeks (104-156)||0
6454773|NCT01172938|7370932|FG001|STARTED|Active-Treatment Phase Weeks (104-156)||95
6454774|NCT01172938|7370933|FG002|STARTED|Active-Treatment Phase Weeks (104-156)||100
6454775|NCT01172938|7370934|FG003|STARTED|Active-Treatment Phase Weeks (104-156)||0
6454776|NCT01172938|7370935|FG004|STARTED|Active-Treatment Phase Weeks (104-156)||0
6553544|NCT01744197|7475991|FG000|COMPLETED|Overall Study||28
6553545|NCT01744197|7475992|FG001|COMPLETED|Overall Study||26
6553546|NCT01744197|7475991|FG000|NOT COMPLETED|Overall Study||4
6553547|NCT01744197|7475992|FG001|NOT COMPLETED|Overall Study||3
6454777|NCT01172938|7370936|FG005|STARTED|Active-Treatment Phase Weeks (104-156)||0
6454778|NCT01172938|7370937|FG006|STARTED|Active-Treatment Phase Weeks (104-156)||0
6454779|NCT01172938|7370938|FG007|STARTED|Active-Treatment Phase Weeks (104-156)||46
6454780|NCT01172938|7370939|FG008|STARTED|Active-Treatment Phase Weeks (104-156)||45
6454781|NCT01172938|7370931|FG000|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454782|NCT01172938|7370932|FG001|COMPLETED|Active-Treatment Phase Weeks (104-156)||84
6454783|NCT01172938|7370933|FG002|COMPLETED|Active-Treatment Phase Weeks (104-156)||93
6454784|NCT01172938|7370934|FG003|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454785|NCT01172938|7370935|FG004|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454786|NCT01172938|7370936|FG005|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454787|NCT01172938|7370937|FG006|COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454788|NCT01172938|7370938|FG007|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
6454789|NCT01172938|7370939|FG008|COMPLETED|Active-Treatment Phase Weeks (104-156)||41
6454790|NCT01172938|7370931|FG000|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454791|NCT01172938|7370932|FG001|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||11
6454792|NCT01172938|7370933|FG002|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||7
6454793|NCT01172938|7370934|FG003|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454794|NCT01172938|7370935|FG004|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454795|NCT01172938|7370936|FG005|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454796|NCT01172938|7370937|FG006|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||0
6454797|NCT01172938|7370938|FG007|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||5
6454798|NCT01172938|7370939|FG008|NOT COMPLETED|Active-Treatment Phase Weeks (104-156)||4
6553548|NCT01744340|7476000|FG000|STARTED|Overall Study||8
6553549|NCT01744340|7476001|FG001|STARTED|Overall Study||15
6454799|NCT01172938|7370931|FG000|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6454800|NCT01172938|7370932|FG001|STARTED|Active-Treatment Phase (Weeks 156-208)||84
6454801|NCT01172938|7370933|FG002|STARTED|Active-Treatment Phase (Weeks 156-208)||93
6454802|NCT01172938|7370934|FG003|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6454803|NCT01172938|7370935|FG004|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6454804|NCT01172938|7370936|FG005|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6454805|NCT01172938|7370937|FG006|STARTED|Active-Treatment Phase (Weeks 156-208)||0
6454806|NCT01172938|7370938|FG007|STARTED|Active-Treatment Phase (Weeks 156-208)||41
6454807|NCT01172938|7370939|FG008|STARTED|Active-Treatment Phase (Weeks 156-208)||41
6454808|NCT01172938|7370931|FG000|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454809|NCT01172938|7370932|FG001|COMPLETED|Active-Treatment Phase (Weeks 156-208)||75
6454810|NCT01172938|7370933|FG002|COMPLETED|Active-Treatment Phase (Weeks 156-208)||88
6454811|NCT01172938|7370934|FG003|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454812|NCT01172938|7370935|FG004|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454813|NCT01172938|7370936|FG005|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454814|NCT01172938|7370937|FG006|COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454815|NCT01172938|7370938|FG007|COMPLETED|Active-Treatment Phase (Weeks 156-208)||32
6454816|NCT01172938|7370939|FG008|COMPLETED|Active-Treatment Phase (Weeks 156-208)||34
6454817|NCT01172938|7370931|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454818|NCT01172938|7370932|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
6454819|NCT01172938|7370933|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||5
6454820|NCT01172938|7370934|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454821|NCT01172938|7370935|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454822|NCT01172938|7370936|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454823|NCT01172938|7370937|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||0
6454824|NCT01172938|7370938|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||9
6454825|NCT01172938|7370939|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 156-208)||7
6454826|NCT01172938|7370931|FG000|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6454827|NCT01172938|7370932|FG001|STARTED|Active-Treatment Phase (Weeks 208-260)||75
6454828|NCT01172938|7370933|FG002|STARTED|Active-Treatment Phase (Weeks 208-260)||88
6454829|NCT01172938|7370934|FG003|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6454830|NCT01172938|7370935|FG004|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6454831|NCT01172938|7370936|FG005|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6454832|NCT01172938|7370937|FG006|STARTED|Active-Treatment Phase (Weeks 208-260)||0
6454833|NCT01172938|7370938|FG007|STARTED|Active-Treatment Phase (Weeks 208-260)||32
6454834|NCT01172938|7370939|FG008|STARTED|Active-Treatment Phase (Weeks 208-260)||34
6454835|NCT01172938|7370931|FG000|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6454836|NCT01172938|7370932|FG001|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6454837|NCT01172938|7370933|FG002|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6454838|NCT01172938|7370934|FG003|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6454839|NCT01172938|7370935|FG004|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6454840|NCT01172938|7370936|FG005|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6454841|NCT01172938|7370937|FG006|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6454842|NCT01172938|7370938|FG007|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||25
6454843|NCT01172938|7370939|FG008|Switched From 20 mg to 30 mg BID|Active-Treatment Phase (Weeks 208-260)||0
6454844|NCT01172938|7370931|FG000|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454845|NCT01172938|7370932|FG001|COMPLETED|Active-Treatment Phase (Weeks 208-260)||72
6454846|NCT01172938|7370933|FG002|COMPLETED|Active-Treatment Phase (Weeks 208-260)||80
6454847|NCT01172938|7370934|FG003|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454848|NCT01172938|7370935|FG004|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454849|NCT01172938|7370936|FG005|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454850|NCT01172938|7370937|FG006|COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454851|NCT01172938|7370938|FG007|COMPLETED|Active-Treatment Phase (Weeks 208-260)||29
6454852|NCT01172938|7370939|FG008|COMPLETED|Active-Treatment Phase (Weeks 208-260)||32
6454853|NCT01172938|7370931|FG000|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454854|NCT01172938|7370932|FG001|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
6454855|NCT01172938|7370933|FG002|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||8
6454856|NCT01172938|7370934|FG003|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454857|NCT01172938|7370935|FG004|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454858|NCT01172938|7370936|FG005|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454859|NCT01172938|7370937|FG006|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||0
6454860|NCT01172938|7370938|FG007|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||3
6454861|NCT01172938|7370939|FG008|NOT COMPLETED|Active-Treatment Phase (Weeks 208-260)||2
6454862|NCT01173016|7370957|FG000|STARTED|Overall Study||11
6454863|NCT01173016|7370957|FG000|COMPLETED|Overall Study||10
6654351|NCT02444715|7584131|FG001|STARTED|Overall Study||48
6654352|NCT02444715|7584130|FG000|COMPLETED|Overall Study||36
6745195|NCT03357731|7673275|FG003|COMPLETED|Overall Study||4
6654353|NCT02444715|7584131|FG001|COMPLETED|Overall Study||32
6654354|NCT02444715|7584130|FG000|NOT COMPLETED|Overall Study||10
6654355|NCT02444715|7584131|FG001|NOT COMPLETED|Overall Study||16
6654356|NCT02444793|7584142|FG000|STARTED|Overall Study||11
6654357|NCT02444793|7584143|FG001|STARTED|Overall Study||6
6654358|NCT02444793|7584144|FG002|STARTED|Overall Study||4
6745196|NCT03357731|7673276|FG004|COMPLETED|Overall Study||7
6745197|NCT03357731|7673277|FG005|COMPLETED|Overall Study||7
6745198|NCT03357731|7673272|FG000|NOT COMPLETED|Overall Study||0
6745199|NCT03357731|7673273|FG001|NOT COMPLETED|Overall Study||0
6745200|NCT03357731|7673274|FG002|NOT COMPLETED|Overall Study||1
6745201|NCT03357731|7673275|FG003|NOT COMPLETED|Overall Study||3
6745202|NCT03357731|7673276|FG004|NOT COMPLETED|Overall Study||1
6745203|NCT03357731|7673277|FG005|NOT COMPLETED|Overall Study||1
6745204|NCT03358147|7673290|FG000|STARTED|Overall Study||235
6745205|NCT03358147|7673291|FG001|STARTED|Overall Study||240
6745206|NCT03358147|7673292|FG002|STARTED|Overall Study||240
6654359|NCT02444793|7584145|FG003|STARTED|Overall Study||3
6654360|NCT02444793|7584142|FG000|COMPLETED|Overall Study||0
6654361|NCT02444793|7584143|FG001|COMPLETED|Overall Study||0
6654362|NCT02444793|7584144|FG002|COMPLETED|Overall Study||0
6654363|NCT02444793|7584145|FG003|COMPLETED|Overall Study||0
6654364|NCT02444793|7584142|FG000|NOT COMPLETED|Overall Study||11
6654365|NCT02444793|7584143|FG001|NOT COMPLETED|Overall Study||6
6654366|NCT02444793|7584144|FG002|NOT COMPLETED|Overall Study||4
6654367|NCT02444793|7584145|FG003|NOT COMPLETED|Overall Study||3
6654368|NCT02444936|7584158|FG000|STARTED|Overall Study||10
6654369|NCT02444936|7584159|FG001|STARTED|Overall Study||12
6654370|NCT02444936|7584158|FG000|COMPLETED|Overall Study||10
6654371|NCT02444936|7584159|FG001|COMPLETED|Overall Study||12
6454864|NCT01173016|7370957|FG000|NOT COMPLETED|Overall Study||1
6454865|NCT01173029|7370963|FG000|STARTED|Overall Study||61
6454866|NCT01173029|7370964|FG001|STARTED|Overall Study||31
6454867|NCT01173029|7370963|FG000|COMPLETED|Overall Study||61
6454868|NCT01173029|7370964|FG001|COMPLETED|Overall Study||31
6454869|NCT01173029|7370963|FG000|NOT COMPLETED|Overall Study||0
6454870|NCT01173029|7370964|FG001|NOT COMPLETED|Overall Study||0
6454871|NCT01173055|7370981|FG000|STARTED|Period 1 - Day 1 to 49||10
6454872|NCT01173055|7370982|FG001|STARTED|Period 1 - Day 1 to 49||12
6454873|NCT01173055|7370981|FG000|COMPLETED|Period 1 - Day 1 to 49||8
6454874|NCT01173055|7370982|FG001|COMPLETED|Period 1 - Day 1 to 49||10
6454875|NCT01173055|7370981|FG000|NOT COMPLETED|Period 1 - Day 1 to 49||2
6454876|NCT01173055|7370982|FG001|NOT COMPLETED|Period 1 - Day 1 to 49||2
6454877|NCT01173055|7370981|FG000|STARTED|Placebo Washout Period - Day 50 to 63||8
6454878|NCT01173055|7370982|FG001|STARTED|Placebo Washout Period - Day 50 to 63||10
6454879|NCT01173055|7370981|FG000|COMPLETED|Placebo Washout Period - Day 50 to 63||8
6454880|NCT01173055|7370982|FG001|COMPLETED|Placebo Washout Period - Day 50 to 63||10
6454881|NCT01173055|7370981|FG000|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
6454882|NCT01173055|7370982|FG001|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
6454883|NCT01173055|7370981|FG000|STARTED|Period 2 - Day 64 to 112||8
6454884|NCT01173055|7370982|FG001|STARTED|Period 2 - Day 64 to 112||10
6454885|NCT01173055|7370981|FG000|COMPLETED|Period 2 - Day 64 to 112||8
6454886|NCT01173055|7370982|FG001|COMPLETED|Period 2 - Day 64 to 112||9
6454887|NCT01173055|7370981|FG000|NOT COMPLETED|Period 2 - Day 64 to 112||0
6454888|NCT01173055|7370982|FG001|NOT COMPLETED|Period 2 - Day 64 to 112||1
6454889|NCT01173120|7370988|FG000|STARTED|Overall Study||62
6454890|NCT01173120|7370988|FG000|Switched Back to Main Study|Overall Study||57
6454891|NCT01173120|7370988|FG000|Discontinued ACP Substudy and Main Study|Overall Study||5
6454892|NCT01173120|7370988|FG000|COMPLETED|Overall Study||0
6454893|NCT01173120|7370988|FG000|NOT COMPLETED|Overall Study||62
6454894|NCT01173159|7370994|FG000|STARTED|Overall Study||10
6454895|NCT01173159|7370994|FG000|COMPLETED|Overall Study||10
6454896|NCT01173159|7370994|FG000|NOT COMPLETED|Overall Study||0
6454897|NCT01173211|7371004|FG000|STARTED|Overall Study||48
6454898|NCT01173211|7371005|FG001|STARTED|Overall Study||45
6454899|NCT01173211|7371006|FG002|STARTED|Overall Study||46
6454900|NCT01173211|7371007|FG003|STARTED|Overall Study||15
6454901|NCT01173211|7371008|FG004|STARTED|Overall Study||16
6454902|NCT01173211|7371009|FG005|STARTED|Overall Study||13
6454903|NCT01173211|7371004|FG000|COMPLETED|Overall Study||46
6454904|NCT01173211|7371005|FG001|COMPLETED|Overall Study||44
6454905|NCT01173211|7371006|FG002|COMPLETED|Overall Study||44
6454906|NCT01173211|7371007|FG003|COMPLETED|Overall Study||15
6454907|NCT01173211|7371008|FG004|COMPLETED|Overall Study||16
6454908|NCT01173211|7371009|FG005|COMPLETED|Overall Study||13
6454909|NCT01173211|7371004|FG000|NOT COMPLETED|Overall Study||2
6454910|NCT01173211|7371005|FG001|NOT COMPLETED|Overall Study||1
6454911|NCT01173211|7371006|FG002|NOT COMPLETED|Overall Study||2
6454912|NCT01173211|7371007|FG003|NOT COMPLETED|Overall Study||0
6454913|NCT01173211|7371008|FG004|NOT COMPLETED|Overall Study||0
6454914|NCT01173211|7371009|FG005|NOT COMPLETED|Overall Study||0
6454915|NCT01173471|7371027|FG000|STARTED|Overall Study|Randomized|6
6454916|NCT01173471|7371028|FG001|STARTED|Overall Study|Randomized|7
6454917|NCT01173471|7371029|FG002|STARTED|Overall Study|Randomized|18
6454918|NCT01173471|7371030|FG003|STARTED|Overall Study|Randomized|19
6454919|NCT01173471|7371027|FG000|Received Treatment|Overall Study||6
6654372|NCT02444936|7584158|FG000|NOT COMPLETED|Overall Study||0
6654373|NCT02444936|7584159|FG001|NOT COMPLETED|Overall Study||0
6745207|NCT03358147|7673293|FG003|STARTED|Overall Study||237
6654374|NCT02444988|7584167|FG000|STARTED|Overall Study||2646
6745208|NCT03358147|7673294|FG004|STARTED|Overall Study||119
6745209|NCT03358147|7673290|FG000|COMPLETED|Overall Study||201
6454920|NCT01173471|7371028|FG001|Received Treatment|Overall Study||7
6454921|NCT01173471|7371029|FG002|Received Treatment|Overall Study||18
6454922|NCT01173471|7371030|FG003|Received Treatment|Overall Study||19
6454923|NCT01173471|7371027|FG000|Completed Treatment|Overall Study||4
6454924|NCT01173471|7371028|FG001|Completed Treatment|Overall Study||7
6454925|NCT01173471|7371029|FG002|Completed Treatment|Overall Study||15
6454926|NCT01173471|7371030|FG003|Completed Treatment|Overall Study||18
6454927|NCT01173471|7371027|FG000|COMPLETED|Overall Study|Completed study|4
6454928|NCT01173471|7371028|FG001|COMPLETED|Overall Study|Completed study|7
6454929|NCT01173471|7371029|FG002|COMPLETED|Overall Study|Completed study|15
6454930|NCT01173471|7371030|FG003|COMPLETED|Overall Study|Completed study|18
6454931|NCT01173471|7371027|FG000|NOT COMPLETED|Overall Study||2
6454932|NCT01173471|7371028|FG001|NOT COMPLETED|Overall Study||0
6454933|NCT01173471|7371029|FG002|NOT COMPLETED|Overall Study||3
6454934|NCT01173471|7371030|FG003|NOT COMPLETED|Overall Study||1
6454935|NCT01173523|7371042|FG000|STARTED|Overall Study||13
6454936|NCT01173523|7371043|FG001|STARTED|Overall Study||12
6454937|NCT01173523|7371042|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6454938|NCT01173523|7371043|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6454939|NCT01173523|7371042|FG000|NOT COMPLETED|Overall Study||13
6454940|NCT01173523|7371043|FG001|NOT COMPLETED|Overall Study||12
6454941|NCT01173601|7371053|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1416
6454942|NCT01173601|7371054|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6454943|NCT01173601|7371055|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6454944|NCT01173601|7371056|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6454945|NCT01173601|7371057|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6454946|NCT01173601|7371053|FG000|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase had the option to enter the DC phase.|21
6454947|NCT01173601|7371054|FG001|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
6454948|NCT01173601|7371055|FG002|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
6454949|NCT01173601|7371056|FG003|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
6454950|NCT01173601|7371057|FG004|Entered Discontinuation Phase|Confirmation (CF) Phase, 3 Weeks||0
6454951|NCT01173601|7371053|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the AT Phase.|1328
6454952|NCT01173601|7371054|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6454953|NCT01173601|7371055|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6454954|NCT01173601|7371056|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6454955|NCT01173601|7371057|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6454956|NCT01173601|7371053|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
6454957|NCT01173601|7371054|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6454958|NCT01173601|7371055|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6454959|NCT01173601|7371056|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6454960|NCT01173601|7371057|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6454961|NCT01173601|7371053|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6454962|NCT01173601|7371054|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
6454963|NCT01173601|7371055|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
6454964|NCT01173601|7371056|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||240
6454965|NCT01173601|7371057|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||627
6454966|NCT01173601|7371053|FG000|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6454967|NCT01173601|7371054|FG001|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|100
6454968|NCT01173601|7371055|FG002|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the taper DC Phase.|107
6454969|NCT01173601|7371056|FG003|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6454970|NCT01173601|7371057|FG004|Entered Taper Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6454971|NCT01173601|7371053|FG000|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6454972|NCT01173601|7371054|FG001|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|100
6454973|NCT01173601|7371055|FG002|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|108
6454974|NCT01173601|7371056|FG003|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|221
6454975|NCT01173601|7371057|FG004|Entered Abrupt Discontinuation Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early entered the abrupt DC Phase.|586
6454976|NCT01173601|7371053|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6454977|NCT01173601|7371054|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
6454978|NCT01173601|7371055|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||197
6454979|NCT01173601|7371056|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||210
6454980|NCT01173601|7371057|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||559
6454981|NCT01173601|7371053|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6454982|NCT01173601|7371054|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
6454983|NCT01173601|7371055|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
6454984|NCT01173601|7371056|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||30
6454985|NCT01173601|7371057|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||68
6454986|NCT01173653|7371077|FG000|STARTED|Overall Study||109
6454987|NCT01173653|7371078|FG001|STARTED|Overall Study||90
6454988|NCT01173653|7371077|FG000|COMPLETED|Overall Study||56
6454989|NCT01173653|7371078|FG001|COMPLETED|Overall Study||49
6454990|NCT01173653|7371077|FG000|NOT COMPLETED|Overall Study||53
6454991|NCT01173653|7371078|FG001|NOT COMPLETED|Overall Study||41
6454992|NCT01173679|7371084|FG000|STARTED|Overall Study||10
6454993|NCT01173679|7371084|FG000|COMPLETED|Overall Study||9
6454994|NCT01173679|7371084|FG000|NOT COMPLETED|Overall Study||1
6454995|NCT01173692|7371091|FG000|STARTED|Overall Study||22
6454996|NCT01173692|7371092|FG001|STARTED|Overall Study||25
6454997|NCT01173692|7371091|FG000|COMPLETED|Overall Study||20
6454998|NCT01173692|7371092|FG001|COMPLETED|Overall Study||20
6454999|NCT01173692|7371091|FG000|NOT COMPLETED|Overall Study||2
6455000|NCT01173692|7371092|FG001|NOT COMPLETED|Overall Study||5
6455001|NCT01173718|7371098|FG000|STARTED|Overall Study||138
6455002|NCT01173718|7371098|FG000|COMPLETED|Overall Study||94
6455003|NCT01173718|7371098|FG000|NOT COMPLETED|Overall Study||44
6455004|NCT01173848|7371104|FG000|STARTED|Overall Study||8
6455005|NCT01173848|7371105|FG001|STARTED|Overall Study||11
6455006|NCT01173848|7371104|FG000|COMPLETED|Overall Study||4
6455007|NCT01173848|7371105|FG001|COMPLETED|Overall Study||3
6455008|NCT01173848|7371104|FG000|NOT COMPLETED|Overall Study||4
6553550|NCT01744340|7476000|FG000|COMPLETED|Overall Study||8
6553551|NCT01744340|7476001|FG001|COMPLETED|Overall Study||15
6553552|NCT01744340|7476000|FG000|NOT COMPLETED|Overall Study||0
6455009|NCT01173848|7371105|FG001|NOT COMPLETED|Overall Study||8
6455010|NCT01173874|7371112|FG000|STARTED|Overall Study||56
6455011|NCT01173874|7371113|FG001|STARTED|Overall Study||64
6455012|NCT01173874|7371112|FG000|COMPLETED|Overall Study||33
6455013|NCT01173874|7371113|FG001|COMPLETED|Overall Study||41
6455014|NCT01173874|7371112|FG000|NOT COMPLETED|Overall Study||23
6455015|NCT01173874|7371113|FG001|NOT COMPLETED|Overall Study||23
6455016|NCT01174004|7371121|FG000|STARTED|Overall Study||94
6455017|NCT01174004|7371122|FG001|STARTED|Overall Study||105
6455018|NCT01174004|7371121|FG000|COMPLETED|Overall Study||87
6455019|NCT01174004|7371122|FG001|COMPLETED|Overall Study||89
6455020|NCT01174004|7371121|FG000|NOT COMPLETED|Overall Study||7
6455021|NCT01174004|7371122|FG001|NOT COMPLETED|Overall Study||16
6455022|NCT01174030|7371133|FG000|STARTED|Overall Study||53
6455023|NCT01174030|7371134|FG001|STARTED|Overall Study||54
6455024|NCT01174030|7371135|FG002|STARTED|Overall Study||54
6455025|NCT01174030|7371136|FG003|STARTED|Overall Study||55
6455026|NCT01174030|7371137|FG004|STARTED|Overall Study||53
6455027|NCT01174030|7371133|FG000|COMPLETED|Overall Study||51
6455028|NCT01174030|7371134|FG001|COMPLETED|Overall Study||52
6455029|NCT01174030|7371135|FG002|COMPLETED|Overall Study||52
6455030|NCT01174030|7371136|FG003|COMPLETED|Overall Study||53
6455031|NCT01174030|7371137|FG004|COMPLETED|Overall Study||52
6455032|NCT01174030|7371133|FG000|NOT COMPLETED|Overall Study||2
6455033|NCT01174030|7371134|FG001|NOT COMPLETED|Overall Study||2
6455034|NCT01174030|7371135|FG002|NOT COMPLETED|Overall Study||2
6455035|NCT01174030|7371136|FG003|NOT COMPLETED|Overall Study||2
6455036|NCT01174030|7371137|FG004|NOT COMPLETED|Overall Study||1
6455037|NCT01174043|7371149|FG000|STARTED|Overall Study||11
6455038|NCT01174043|7371149|FG000|COMPLETED|Overall Study||0
6455039|NCT01174043|7371149|FG000|NOT COMPLETED|Overall Study||11
6455040|NCT01174082|7371155|FG000|STARTED|Overall Study||1
6455041|NCT01174082|7371156|FG001|STARTED|Overall Study||1
6455042|NCT01174082|7371155|FG000|COMPLETED|Overall Study||1
6455043|NCT01174082|7371156|FG001|COMPLETED|Overall Study||1
6455044|NCT01174082|7371155|FG000|NOT COMPLETED|Overall Study||0
6455045|NCT01174082|7371156|FG001|NOT COMPLETED|Overall Study||0
6455046|NCT01174160|7371164|FG000|STARTED|Overall Study||61
6455047|NCT01174160|7371165|FG001|STARTED|Overall Study||62
6455048|NCT01174160|7371164|FG000|Discontinued Pre Dose|Overall Study||6
6455049|NCT01174160|7371165|FG001|Discontinued Pre Dose|Overall Study||6
6455050|NCT01174160|7371164|FG000|Dosed|Overall Study||55
6455051|NCT01174160|7371165|FG001|Dosed|Overall Study||56
6455052|NCT01174160|7371164|FG000|Discontinued Post Dose|Overall Study||2
6455053|NCT01174160|7371165|FG001|Discontinued Post Dose|Overall Study||0
6455054|NCT01174160|7371164|FG000|COMPLETED|Overall Study||53
6455055|NCT01174160|7371165|FG001|COMPLETED|Overall Study||56
6455056|NCT01174160|7371164|FG000|NOT COMPLETED|Overall Study||8
6455057|NCT01174160|7371165|FG001|NOT COMPLETED|Overall Study||6
6455058|NCT01174173|7371171|FG000|STARTED|Overall Study||11
6455059|NCT01174173|7371171|FG000|COMPLETED|Overall Study||10
6455060|NCT01174173|7371171|FG000|NOT COMPLETED|Overall Study||1
6455061|NCT01174186|7371178|FG000|STARTED|Overall Study|Patients were included over three years|15
6455062|NCT01174186|7371179|FG001|STARTED|Overall Study||15
6455063|NCT01174186|7371178|FG000|COMPLETED|Overall Study||15
6455064|NCT01174186|7371179|FG001|COMPLETED|Overall Study||12
6553553|NCT01744340|7476001|FG001|NOT COMPLETED|Overall Study||0
6455065|NCT01174186|7371178|FG000|NOT COMPLETED|Overall Study||0
6455066|NCT01174186|7371179|FG001|NOT COMPLETED|Overall Study||3
6455067|NCT01174238|7371185|FG000|STARTED|Overall Study||38
6455068|NCT01174238|7371185|FG000|Participants That Underwent FLT-PET Scan|Overall Study||6
6455069|NCT01174238|7371185|FG000|COMPLETED|Overall Study||36
6455070|NCT01174238|7371185|FG000|NOT COMPLETED|Overall Study||2
6455071|NCT01174264|7371195|FG000|STARTED|Single Dose Pharmacokinetics||23
6455072|NCT01174264|7371196|FG001|STARTED|Single Dose Pharmacokinetics||20
6455073|NCT01174264|7371197|FG002|STARTED|Single Dose Pharmacokinetics||20
6553554|NCT01744353|7476010|FG000|STARTED|Overall Study||6
6455074|NCT01174264|7371195|FG000|COMPLETED|Single Dose Pharmacokinetics||22
6455075|NCT01174264|7371196|FG001|COMPLETED|Single Dose Pharmacokinetics||20
6455076|NCT01174264|7371197|FG002|COMPLETED|Single Dose Pharmacokinetics||18
6455077|NCT01174264|7371195|FG000|NOT COMPLETED|Single Dose Pharmacokinetics||1
6455078|NCT01174264|7371196|FG001|NOT COMPLETED|Single Dose Pharmacokinetics||0
6455079|NCT01174264|7371197|FG002|NOT COMPLETED|Single Dose Pharmacokinetics||2
6455080|NCT01174264|7371195|FG000|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
6455081|NCT01174264|7371196|FG001|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
6455082|NCT01174264|7371197|FG002|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
6455083|NCT01174264|7371195|FG000|COMPLETED|Steady-state Pharmacokinetics||25
6455084|NCT01174264|7371196|FG001|COMPLETED|Steady-state Pharmacokinetics||0
6455085|NCT01174264|7371197|FG002|COMPLETED|Steady-state Pharmacokinetics||27
6455086|NCT01174264|7371195|FG000|NOT COMPLETED|Steady-state Pharmacokinetics||6
6455087|NCT01174264|7371196|FG001|NOT COMPLETED|Steady-state Pharmacokinetics||0
6455088|NCT01174264|7371197|FG002|NOT COMPLETED|Steady-state Pharmacokinetics||2
6455089|NCT01174342|7371205|FG000|STARTED|Overall Study||30
6455090|NCT01174342|7371205|FG000|COMPLETED|Overall Study||26
6455091|NCT01174342|7371205|FG000|NOT COMPLETED|Overall Study||4
6455092|NCT01174446|7371209|FG000|STARTED|Part 1 -Pharmacokinetic Crossover||14
6455093|NCT01174446|7371210|FG001|STARTED|Part 1 -Pharmacokinetic Crossover||14
6455094|NCT01174446|7371211|FG002|STARTED|Part 1 -Pharmacokinetic Crossover||0
6455095|NCT01174446|7371212|FG003|STARTED|Part 1 -Pharmacokinetic Crossover||0
6455096|NCT01174446|7371209|FG000|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
6455097|NCT01174446|7371210|FG001|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
6455098|NCT01174446|7371211|FG002|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6455099|NCT01174446|7371212|FG003|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6455100|NCT01174446|7371209|FG000|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6455101|NCT01174446|7371210|FG001|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6455102|NCT01174446|7371211|FG002|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6455103|NCT01174446|7371212|FG003|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
6455104|NCT01174446|7371209|FG000|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
6455105|NCT01174446|7371210|FG001|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
6455106|NCT01174446|7371211|FG002|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
6455107|NCT01174446|7371212|FG003|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
6455108|NCT01174446|7371209|FG000|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
6455109|NCT01174446|7371210|FG001|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
6455110|NCT01174446|7371211|FG002|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
6455111|NCT01174446|7371212|FG003|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
6455112|NCT01174446|7371209|FG000|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
6455113|NCT01174446|7371210|FG001|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
6455114|NCT01174446|7371211|FG002|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
6455115|NCT01174446|7371212|FG003|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
6553555|NCT01744353|7476011|FG001|STARTED|Overall Study||26
6553556|NCT01744353|7476012|FG002|STARTED|Overall Study||3
6553557|NCT01744353|7476010|FG000|COMPLETED|Overall Study||6
6553558|NCT01744353|7476011|FG001|COMPLETED|Overall Study||26
6553559|NCT01744353|7476012|FG002|COMPLETED|Overall Study||3
6553560|NCT01744353|7476010|FG000|NOT COMPLETED|Overall Study||0
6553561|NCT01744353|7476011|FG001|NOT COMPLETED|Overall Study||0
6455116|NCT01174446|7371209|FG000|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
6455117|NCT01174446|7371210|FG001|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
6455118|NCT01174446|7371211|FG002|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
6455119|NCT01174446|7371212|FG003|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
6455120|NCT01174446|7371209|FG000|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
6455121|NCT01174446|7371210|FG001|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
6455122|NCT01174446|7371211|FG002|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
6455123|NCT01174446|7371212|FG003|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
6455124|NCT01174446|7371209|FG000|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
6455125|NCT01174446|7371210|FG001|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
6455126|NCT01174446|7371211|FG002|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
6455127|NCT01174446|7371212|FG003|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
6455128|NCT01174459|7371259|FG000|STARTED|Overall Study|Registered patients|571
6455129|NCT01174459|7371259|FG000|COMPLETED|Overall Study|Case report form (CRF) collected|566
6455130|NCT01174459|7371259|FG000|NOT COMPLETED|Overall Study||5
6455131|NCT01174550|7371265|FG000|STARTED|Overall Study||5007
6455132|NCT01174550|7371266|FG001|STARTED|Overall Study||4996
6455133|NCT01174550|7371265|FG000|COMPLETED|Overall Study||3737
6455134|NCT01174550|7371266|FG001|COMPLETED|Overall Study||4123
6455135|NCT01174550|7371265|FG000|NOT COMPLETED|Overall Study||1270
6455136|NCT01174550|7371266|FG001|NOT COMPLETED|Overall Study||873
6500579|NCT01425281|7419254|FG000|STARTED|At 180-day Clinical Follow-up||334
6553562|NCT01744353|7476012|FG002|NOT COMPLETED|Overall Study||0
6553563|NCT01744392|7476018|FG000|STARTED|Overall Study||23
6455137|NCT01174576|7371272|FG000|STARTED|Overall Study|All participants received all interventions without exception.|16
6455138|NCT01174576|7371272|FG000|COMPLETED|Overall Study||16
6455139|NCT01174576|7371272|FG000|NOT COMPLETED|Overall Study||0
6455140|NCT01174784|7371285|FG000|STARTED|Overall Study||88
6455141|NCT01174784|7371285|FG000|COMPLETED|Overall Study|While 88 subjects did complete the procedure, 4 were considered screen failures post-procedure.|84
6455142|NCT01174784|7371285|FG000|NOT COMPLETED|Overall Study||4
6455143|NCT01174823|7371292|FG000|STARTED|Overall Study||122
6455144|NCT01174823|7371293|FG001|STARTED|Overall Study||123
6455145|NCT01174823|7371292|FG000|COMPLETED|Overall Study||115
6455146|NCT01174823|7371293|FG001|COMPLETED|Overall Study||119
6455147|NCT01174823|7371292|FG000|NOT COMPLETED|Overall Study||7
6455148|NCT01174823|7371293|FG001|NOT COMPLETED|Overall Study||4
6455149|NCT01175005|7371299|FG000|STARTED|Overall Study||62
6455150|NCT01175005|7371299|FG000|COMPLETED|Overall Study||62
6455151|NCT01175005|7371299|FG000|NOT COMPLETED|Overall Study||0
6455152|NCT01175018|7371306|FG000|STARTED|Overall Study||15
6455153|NCT01175018|7371307|FG001|STARTED|Overall Study||15
6455154|NCT01175018|7371306|FG000|COMPLETED|Overall Study||12
6455155|NCT01175018|7371307|FG001|COMPLETED|Overall Study||14
6455156|NCT01175018|7371306|FG000|NOT COMPLETED|Overall Study||3
6455157|NCT01175018|7371307|FG001|NOT COMPLETED|Overall Study||1
6455158|NCT01175031|7371315|FG000|STARTED|Overall Study||45
6455159|NCT01175031|7371315|FG000|COMPLETED|Overall Study||45
6455160|NCT01175031|7371315|FG000|NOT COMPLETED|Overall Study||0
6455161|NCT01175083|7371329|FG000|STARTED|Primary Epoch||50
6455162|NCT01175083|7371330|FG001|STARTED|Primary Epoch||50
6455163|NCT01175083|7371331|FG002|STARTED|Primary Epoch||50
6455164|NCT01175083|7371332|FG003|STARTED|Primary Epoch||50
6455165|NCT01175083|7371333|FG004|STARTED|Primary Epoch||50
6455166|NCT01175083|7371334|FG005|STARTED|Primary Epoch||50
6455167|NCT01175083|7371329|FG000|COMPLETED|Primary Epoch||50
6455168|NCT01175083|7371330|FG001|COMPLETED|Primary Epoch||50
6455169|NCT01175083|7371331|FG002|COMPLETED|Primary Epoch||50
6455170|NCT01175083|7371332|FG003|COMPLETED|Primary Epoch||50
6455171|NCT01175083|7371333|FG004|COMPLETED|Primary Epoch||50
6455172|NCT01175083|7371334|FG005|COMPLETED|Primary Epoch||47
6455173|NCT01175083|7371329|FG000|NOT COMPLETED|Primary Epoch||0
6455174|NCT01175083|7371330|FG001|NOT COMPLETED|Primary Epoch||0
6553564|NCT01744392|7476018|FG000|COMPLETED|Overall Study||22
6553565|NCT01744392|7476018|FG000|NOT COMPLETED|Overall Study||1
6553566|NCT01744483|7476026|FG000|STARTED|Overall Study||44
6553567|NCT01744483|7476027|FG001|STARTED|Overall Study||35
6553568|NCT01744483|7476028|FG002|STARTED|Overall Study||38
6553569|NCT01744483|7476026|FG000|COMPLETED|Overall Study||15
6553570|NCT01744483|7476027|FG001|COMPLETED|Overall Study||13
6553571|NCT01744483|7476028|FG002|COMPLETED|Overall Study||10
6553572|NCT01744483|7476026|FG000|NOT COMPLETED|Overall Study||29
6553573|NCT01744483|7476027|FG001|NOT COMPLETED|Overall Study||22
6553574|NCT01744483|7476028|FG002|NOT COMPLETED|Overall Study||28
6553575|NCT01744496|7476038|FG000|STARTED|Titration Period||33
6553576|NCT01744496|7476039|FG001|STARTED|Titration Period||35
6553577|NCT01744496|7476038|FG000|COMPLETED|Titration Period||31
6553578|NCT01744496|7476039|FG001|COMPLETED|Titration Period||33
6553579|NCT01744496|7476038|FG000|NOT COMPLETED|Titration Period||2
6553580|NCT01744496|7476039|FG001|NOT COMPLETED|Titration Period||2
6553581|NCT01744496|7476038|FG000|STARTED|Maintenance Period||31
6553582|NCT01744496|7476039|FG001|STARTED|Maintenance Period||33
6553583|NCT01744496|7476038|FG000|COMPLETED|Maintenance Period||27
6553584|NCT01744496|7476039|FG001|COMPLETED|Maintenance Period||29
6553585|NCT01744496|7476038|FG000|NOT COMPLETED|Maintenance Period||4
6553586|NCT01744496|7476039|FG001|NOT COMPLETED|Maintenance Period||4
6553587|NCT01744574|7476049|FG000|STARTED|Overall Study||57
6455175|NCT01175083|7371331|FG002|NOT COMPLETED|Primary Epoch||0
6553588|NCT01744574|7476050|FG001|STARTED|Overall Study||56
6553589|NCT01744574|7476051|FG002|STARTED|Overall Study||52
6553590|NCT01744574|7476052|FG003|STARTED|Overall Study||51
6553591|NCT01744574|7476049|FG000|COMPLETED|Overall Study||33
6553592|NCT01744574|7476050|FG001|COMPLETED|Overall Study||31
6553593|NCT01744574|7476051|FG002|COMPLETED|Overall Study||32
6553594|NCT01744574|7476052|FG003|COMPLETED|Overall Study||40
6553595|NCT01744574|7476049|FG000|NOT COMPLETED|Overall Study||24
6553596|NCT01744574|7476050|FG001|NOT COMPLETED|Overall Study||25
6553597|NCT01744574|7476051|FG002|NOT COMPLETED|Overall Study||20
6553598|NCT01744574|7476052|FG003|NOT COMPLETED|Overall Study||11
6553599|NCT01744665|7476062|FG000|STARTED|Monitoring Phase||59
6553600|NCT01744665|7476062|FG000|COMPLETED|Monitoring Phase||41
6455176|NCT01175083|7371332|FG003|NOT COMPLETED|Primary Epoch||0
6455177|NCT01175083|7371333|FG004|NOT COMPLETED|Primary Epoch||0
6455178|NCT01175083|7371334|FG005|NOT COMPLETED|Primary Epoch||3
6455179|NCT01175083|7371329|FG000|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
6455180|NCT01175083|7371330|FG001|STARTED|Booster Epoch|One subject died between both Epochs and hence did not participate in the Booster Epoch.|49
6455181|NCT01175083|7371331|FG002|STARTED|Booster Epoch||50
6455182|NCT01175083|7371332|FG003|STARTED|Booster Epoch||50
6455183|NCT01175083|7371333|FG004|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
6553601|NCT01744665|7476062|FG000|NOT COMPLETED|Monitoring Phase||18
6553602|NCT01744665|7476062|FG000|STARTED|Consolidation Phase||41
6553603|NCT01744665|7476062|FG000|COMPLETED|Consolidation Phase||22
6553604|NCT01744665|7476062|FG000|NOT COMPLETED|Consolidation Phase||19
6455184|NCT01175083|7371334|FG005|STARTED|Booster Epoch|No subjects participated in the Booster Epoch, as no booster dose was planned per protocol.|0
6455185|NCT01175083|7371329|FG000|COMPLETED|Booster Epoch||49
6553605|NCT01744665|7476062|FG000|STARTED|Treatment Free Remission Phase||32
6553606|NCT01744665|7476062|FG000|COMPLETED|Treatment Free Remission Phase||32
6553607|NCT01744665|7476062|FG000|NOT COMPLETED|Treatment Free Remission Phase||0
6553608|NCT01744665|7476062|FG000|STARTED|Re-initiation Phase||17
6553609|NCT01744665|7476062|FG000|COMPLETED|Re-initiation Phase||4
6553610|NCT01744665|7476062|FG000|NOT COMPLETED|Re-initiation Phase||13
6455186|NCT01175083|7371330|FG001|COMPLETED|Booster Epoch||49
6455187|NCT01175083|7371331|FG002|COMPLETED|Booster Epoch||49
6455188|NCT01175083|7371332|FG003|COMPLETED|Booster Epoch||49
6455189|NCT01175083|7371333|FG004|COMPLETED|Booster Epoch||0
6455190|NCT01175083|7371334|FG005|COMPLETED|Booster Epoch||0
6455191|NCT01175083|7371329|FG000|NOT COMPLETED|Booster Epoch||0
6455192|NCT01175083|7371330|FG001|NOT COMPLETED|Booster Epoch||0
6455193|NCT01175083|7371331|FG002|NOT COMPLETED|Booster Epoch||1
6455194|NCT01175083|7371332|FG003|NOT COMPLETED|Booster Epoch||1
6455195|NCT01175083|7371333|FG004|NOT COMPLETED|Booster Epoch||0
6455196|NCT01175083|7371334|FG005|NOT COMPLETED|Booster Epoch||0
6455197|NCT01175135|7371356|FG000|STARTED|Overall Study||74
6455198|NCT01175135|7371357|FG001|STARTED|Overall Study||74
6455199|NCT01175135|7371358|FG002|STARTED|Overall Study||37
6455200|NCT01175135|7371359|FG003|STARTED|Overall Study||74
6455201|NCT01175135|7371356|FG000|Treated|Overall Study||74
6455202|NCT01175135|7371357|FG001|Treated|Overall Study||74
6455203|NCT01175135|7371358|FG002|Treated|Overall Study||36
6455204|NCT01175135|7371359|FG003|Treated|Overall Study||74
6455205|NCT01175135|7371356|FG000|Analyzed for Efficacy|Overall Study||74
6455206|NCT01175135|7371357|FG001|Analyzed for Efficacy|Overall Study||73
6455207|NCT01175135|7371358|FG002|Analyzed for Efficacy|Overall Study||34
6455208|NCT01175135|7371359|FG003|Analyzed for Efficacy|Overall Study||73
6455209|NCT01175135|7371356|FG000|COMPLETED|Overall Study||58
6455210|NCT01175135|7371357|FG001|COMPLETED|Overall Study||52
6455211|NCT01175135|7371358|FG002|COMPLETED|Overall Study||25
6455212|NCT01175135|7371359|FG003|COMPLETED|Overall Study||60
6455213|NCT01175135|7371356|FG000|NOT COMPLETED|Overall Study||16
6455214|NCT01175135|7371357|FG001|NOT COMPLETED|Overall Study||22
6455215|NCT01175135|7371358|FG002|NOT COMPLETED|Overall Study||12
6455216|NCT01175135|7371359|FG003|NOT COMPLETED|Overall Study||14
6455217|NCT01175148|7371371|FG000|STARTED|Overall Study||30
6455218|NCT01175148|7371372|FG001|STARTED|Overall Study||30
6455219|NCT01175148|7371371|FG000|COMPLETED|Overall Study||30
6455220|NCT01175148|7371372|FG001|COMPLETED|Overall Study||30
6455221|NCT01175148|7371371|FG000|NOT COMPLETED|Overall Study||0
6455222|NCT01175148|7371372|FG001|NOT COMPLETED|Overall Study||0
6455223|NCT01175213|7371381|FG000|STARTED|IGSC, 10%/rHuPH20||63
6455224|NCT01175213|7371382|FG001|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
6455225|NCT01175213|7371381|FG000|COMPLETED|IGSC, 10%/rHuPH20||48
6455226|NCT01175213|7371382|FG001|COMPLETED|IGSC, 10%/rHuPH20||3
6455227|NCT01175213|7371381|FG000|NOT COMPLETED|IGSC, 10%/rHuPH20||15
6455228|NCT01175213|7371382|FG001|NOT COMPLETED|IGSC, 10%/rHuPH20||0
6455229|NCT01175213|7371381|FG000|STARTED|Safety Follow-up||48
6455230|NCT01175213|7371382|FG001|STARTED|Safety Follow-up||3
6455231|NCT01175213|7371381|FG000|COMPLETED|Safety Follow-up||47
6455232|NCT01175213|7371382|FG001|COMPLETED|Safety Follow-up||3
6455233|NCT01175213|7371381|FG000|NOT COMPLETED|Safety Follow-up||1
6455234|NCT01175213|7371382|FG001|NOT COMPLETED|Safety Follow-up||0
6455235|NCT01175226|7371393|FG000|STARTED|Overall Study||155
6455236|NCT01175226|7371394|FG001|STARTED|Overall Study||145
6455237|NCT01175226|7371393|FG000|COMPLETED|Overall Study||144
6455238|NCT01175226|7371394|FG001|COMPLETED|Overall Study||140
6455239|NCT01175226|7371393|FG000|NOT COMPLETED|Overall Study||11
6455240|NCT01175226|7371394|FG001|NOT COMPLETED|Overall Study||5
6455241|NCT01175317|7371402|FG000|STARTED|Overall Study||27
6455242|NCT01175317|7371403|FG001|STARTED|Overall Study||31
6455243|NCT01175317|7371402|FG000|COMPLETED|Overall Study||27
6455244|NCT01175317|7371403|FG001|COMPLETED|Overall Study||31
6455245|NCT01175317|7371402|FG000|NOT COMPLETED|Overall Study||0
6455246|NCT01175317|7371403|FG001|NOT COMPLETED|Overall Study||0
6455247|NCT01175343|7371409|FG000|STARTED|Overall Study||44
6455248|NCT01175343|7371409|FG000|COMPLETED|Overall Study||44
6455249|NCT01175343|7371409|FG000|NOT COMPLETED|Overall Study||0
6455250|NCT01175369|7371415|FG000|STARTED|Overall Study||265
6455251|NCT01175369|7371416|FG001|STARTED|Overall Study||265
6455252|NCT01175369|7371415|FG000|COMPLETED|Overall Study||263
6455253|NCT01175369|7371416|FG001|COMPLETED|Overall Study||260
6455254|NCT01175369|7371415|FG000|NOT COMPLETED|Overall Study||2
6455255|NCT01175369|7371416|FG001|NOT COMPLETED|Overall Study||5
6455256|NCT01175382|7371425|FG000|STARTED|Overall Study||71
6455257|NCT01175382|7371426|FG001|STARTED|Overall Study||68
6455258|NCT01175382|7371427|FG002|STARTED|Overall Study||65
6455259|NCT01175382|7371425|FG000|COMPLETED|Overall Study||63
6455260|NCT01175382|7371426|FG001|COMPLETED|Overall Study||61
6455261|NCT01175382|7371427|FG002|COMPLETED|Overall Study||59
6455262|NCT01175382|7371425|FG000|NOT COMPLETED|Overall Study||8
6455263|NCT01175382|7371426|FG001|NOT COMPLETED|Overall Study||7
6553611|NCT01744691|7476069|FG000|STARTED|Overall Study|Participants who received study treatment|144
6455264|NCT01175382|7371427|FG002|NOT COMPLETED|Overall Study||6
6455265|NCT01175395|7371435|FG000|STARTED|Overall Study||10
6455266|NCT01175395|7371435|FG000|COMPLETED|Overall Study||10
6455267|NCT01175395|7371435|FG000|NOT COMPLETED|Overall Study||0
6455268|NCT01175434|7371441|FG000|STARTED|Overall Study||48
6455269|NCT01175434|7371442|FG001|STARTED|Overall Study||51
6455270|NCT01175434|7371441|FG000|COMPLETED|Overall Study||48
6455271|NCT01175434|7371442|FG001|COMPLETED|Overall Study||51
6455272|NCT01175434|7371441|FG000|NOT COMPLETED|Overall Study||0
6455273|NCT01175434|7371442|FG001|NOT COMPLETED|Overall Study||0
6455274|NCT01175473|7371450|FG000|STARTED|Overall Study|Randomized and treated.|77
6455275|NCT01175473|7371451|FG001|STARTED|Overall Study||71
6455276|NCT01175473|7371450|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
6455277|NCT01175473|7371451|FG001|Safety Population|Overall Study||71
6455278|NCT01175473|7371450|FG000|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
6455279|NCT01175473|7371451|FG001|Pharmacodynamic (PD) Population|Overall Study||68
6455280|NCT01175473|7371450|FG000|COMPLETED|Overall Study||75
6455281|NCT01175473|7371451|FG001|COMPLETED|Overall Study||69
6455282|NCT01175473|7371450|FG000|NOT COMPLETED|Overall Study||2
6455283|NCT01175473|7371451|FG001|NOT COMPLETED|Overall Study||2
6455284|NCT01175590|7371459|FG000|STARTED|Overall Study||347
6455285|NCT01175590|7371460|FG001|STARTED|Overall Study||171
6455286|NCT01175590|7371459|FG000|Modified Intent to Treat Population|Overall Study||212
6455287|NCT01175590|7371460|FG001|Modified Intent to Treat Population|Overall Study||87
6455288|NCT01175590|7371459|FG000|Safety Population|Overall Study||344
6455289|NCT01175590|7371460|FG001|Safety Population|Overall Study||170
6455290|NCT01175590|7371459|FG000|COMPLETED|Overall Study||335
6455291|NCT01175590|7371460|FG001|COMPLETED|Overall Study||161
6455292|NCT01175590|7371459|FG000|NOT COMPLETED|Overall Study||12
6455293|NCT01175590|7371460|FG001|NOT COMPLETED|Overall Study||10
6455294|NCT01175668|7371469|FG000|STARTED|Overall Study||34
6455295|NCT01175668|7371470|FG001|STARTED|Overall Study||34
6455296|NCT01175668|7371469|FG000|COMPLETED|Overall Study||32
6455297|NCT01175668|7371470|FG001|COMPLETED|Overall Study||34
6455298|NCT01175668|7371469|FG000|NOT COMPLETED|Overall Study||2
6455299|NCT01175668|7371470|FG001|NOT COMPLETED|Overall Study||0
6455300|NCT01175707|7371478|FG000|STARTED|Overall Study||40
6455301|NCT01175707|7371479|FG001|STARTED|Overall Study||40
6455302|NCT01175707|7371478|FG000|COMPLETED|Overall Study||36
6455303|NCT01175707|7371479|FG001|COMPLETED|Overall Study||34
6455304|NCT01175707|7371478|FG000|NOT COMPLETED|Overall Study||4
6455305|NCT01175707|7371479|FG001|NOT COMPLETED|Overall Study||6
6455306|NCT01175798|7371488|FG000|STARTED|Overall Study||34
6455307|NCT01175798|7371489|FG001|STARTED|Overall Study||62
6455308|NCT01175798|7371488|FG000|COMPLETED|Overall Study||27
6455309|NCT01175798|7371489|FG001|COMPLETED|Overall Study||41
6455310|NCT01175798|7371488|FG000|NOT COMPLETED|Overall Study||7
6455311|NCT01175798|7371489|FG001|NOT COMPLETED|Overall Study||21
6500580|NCT01425281|7419255|FG001|STARTED|At 180-day Clinical Follow-up||166
6500581|NCT01425281|7419254|FG000|COMPLETED|At 180-day Clinical Follow-up||331
6500582|NCT01425281|7419255|FG001|COMPLETED|At 180-day Clinical Follow-up||165
6500583|NCT01425281|7419254|FG000|NOT COMPLETED|At 180-day Clinical Follow-up||3
6500584|NCT01425281|7419255|FG001|NOT COMPLETED|At 180-day Clinical Follow-up||1
6500585|NCT01425281|7419254|FG000|STARTED|At 1-year Clinical Follow-up||331
6500586|NCT01425281|7419255|FG001|STARTED|At 1-year Clinical Follow-up||165
6500587|NCT01425281|7419254|FG000|COMPLETED|At 1-year Clinical Follow-up||329
6500588|NCT01425281|7419255|FG001|COMPLETED|At 1-year Clinical Follow-up||164
6500589|NCT01425281|7419254|FG000|NOT COMPLETED|At 1-year Clinical Follow-up||2
6500590|NCT01425281|7419255|FG001|NOT COMPLETED|At 1-year Clinical Follow-up||1
6500591|NCT01425281|7419254|FG000|STARTED|At 2-year Clinical Follow-up||329
6500592|NCT01425281|7419255|FG001|STARTED|At 2-year Clinical Follow-up||164
6500593|NCT01425281|7419254|FG000|COMPLETED|At 2-year Clinical Follow-up||323
6500594|NCT01425281|7419255|FG001|COMPLETED|At 2-year Clinical Follow-up||163
6500595|NCT01425281|7419254|FG000|NOT COMPLETED|At 2-year Clinical Follow-up||6
6500596|NCT01425281|7419255|FG001|NOT COMPLETED|At 2-year Clinical Follow-up||1
6500597|NCT01425281|7419254|FG000|STARTED|At 3-year Clinical Follow-up||323
6500598|NCT01425281|7419255|FG001|STARTED|At 3-year Clinical Follow-up||163
6500599|NCT01425281|7419254|FG000|COMPLETED|At 3-year Clinical Follow-up||318
6500600|NCT01425281|7419255|FG001|COMPLETED|At 3-year Clinical Follow-up||157
6500601|NCT01425281|7419254|FG000|NOT COMPLETED|At 3-year Clinical Follow-up||5
6500602|NCT01425281|7419255|FG001|NOT COMPLETED|At 3-year Clinical Follow-up||6
6500603|NCT01425281|7419254|FG000|STARTED|At 4-year Clinical Follow-up||318
6500604|NCT01425281|7419255|FG001|STARTED|At 4-year Clinical Follow-up||157
6500605|NCT01425281|7419254|FG000|COMPLETED|At 4-year Clinical Follow-up||288
6500606|NCT01425281|7419255|FG001|COMPLETED|At 4-year Clinical Follow-up||136
6500607|NCT01425281|7419254|FG000|NOT COMPLETED|At 4-year Clinical Follow-up||30
6500608|NCT01425281|7419255|FG001|NOT COMPLETED|At 4-year Clinical Follow-up||21
6500609|NCT01425281|7419254|FG000|STARTED|At 5-year Clinical Follow-up||288
6500610|NCT01425281|7419255|FG001|STARTED|At 5-year Clinical Follow-up||136
6500611|NCT01425281|7419254|FG000|COMPLETED|At 5-year Clinical Follow-up||256
6500612|NCT01425281|7419255|FG001|COMPLETED|At 5-year Clinical Follow-up||125
6500613|NCT01425281|7419254|FG000|NOT COMPLETED|At 5-year Clinical Follow-up||32
6500614|NCT01425281|7419255|FG001|NOT COMPLETED|At 5-year Clinical Follow-up||11
6500615|NCT01425307|7419264|FG000|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
6455312|NCT01175811|7371497|FG000|STARTED|Overall Study||199
6455313|NCT01175811|7371498|FG001|STARTED|Overall Study||203
6455314|NCT01175811|7371497|FG000|Received at Least 1 Dose of Study Drug|Overall Study||197
6455315|NCT01175811|7371498|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
6455316|NCT01175811|7371497|FG000|COMPLETED|Overall Study||183
6455317|NCT01175811|7371498|FG001|COMPLETED|Overall Study||189
6455318|NCT01175811|7371497|FG000|NOT COMPLETED|Overall Study||16
6455319|NCT01175811|7371498|FG001|NOT COMPLETED|Overall Study||14
6455320|NCT01175824|7371506|FG000|STARTED|Overall Study||236
6455321|NCT01175824|7371507|FG001|STARTED|Overall Study||242
6455322|NCT01175824|7371506|FG000|Received at Least 1 Dose of Study Drug|Overall Study||236
6455323|NCT01175824|7371507|FG001|Received at Least 1 Dose of Study Drug|Overall Study||240
6455324|NCT01175824|7371506|FG000|COMPLETED|Overall Study||220
6455325|NCT01175824|7371507|FG001|COMPLETED|Overall Study||220
6455326|NCT01175824|7371506|FG000|NOT COMPLETED|Overall Study||16
6455327|NCT01175824|7371507|FG001|NOT COMPLETED|Overall Study||22
6455328|NCT01175850|7371515|FG000|STARTED|IN.PACT SFA I Phase||99
6455329|NCT01175850|7371516|FG001|STARTED|IN.PACT SFA I Phase||51
6455330|NCT01175850|7371515|FG000|COMPLETED|IN.PACT SFA I Phase||88
6455331|NCT01175850|7371516|FG001|COMPLETED|IN.PACT SFA I Phase||49
6455332|NCT01175850|7371515|FG000|NOT COMPLETED|IN.PACT SFA I Phase||11
6455333|NCT01175850|7371516|FG001|NOT COMPLETED|IN.PACT SFA I Phase||2
6455334|NCT01175850|7371515|FG000|STARTED|IN.PACT SFA II Phase||121
6455335|NCT01175850|7371516|FG001|STARTED|IN.PACT SFA II Phase||60
6455336|NCT01175850|7371515|FG000|COMPLETED|IN.PACT SFA II Phase||109
6455337|NCT01175850|7371516|FG001|COMPLETED|IN.PACT SFA II Phase||55
6455338|NCT01175850|7371515|FG000|NOT COMPLETED|IN.PACT SFA II Phase||12
6455339|NCT01175850|7371516|FG001|NOT COMPLETED|IN.PACT SFA II Phase||5
6455340|NCT01175902|7371525|FG000|STARTED|Overall Study||22
6455341|NCT01175902|7371526|FG001|STARTED|Overall Study||22
6455342|NCT01175902|7371525|FG000|COMPLETED|Overall Study||22
6455343|NCT01175902|7371526|FG001|COMPLETED|Overall Study||22
6455344|NCT01175902|7371525|FG000|NOT COMPLETED|Overall Study||0
6455345|NCT01175902|7371526|FG001|NOT COMPLETED|Overall Study||0
6455346|NCT01175980|7371534|FG000|STARTED|Overall Study||30
6455347|NCT01175980|7371534|FG000|COMPLETED|Overall Study||30
6455348|NCT01175980|7371534|FG000|NOT COMPLETED|Overall Study||0
6455349|NCT01176032|7371540|FG000|STARTED|Overall Study|"Started indicates randomized and safety population"|37
6455350|NCT01176032|7371541|FG001|STARTED|Overall Study||37
6455351|NCT01176032|7371540|FG000|Intention-to-treat (ITT) Population|Overall Study||32
6455352|NCT01176032|7371541|FG001|Intention-to-treat (ITT) Population|Overall Study||37
6455353|NCT01176032|7371540|FG000|COMPLETED|Overall Study||31
6455354|NCT01176032|7371541|FG001|COMPLETED|Overall Study||36
6455355|NCT01176032|7371540|FG000|NOT COMPLETED|Overall Study||6
6455356|NCT01176032|7371541|FG001|NOT COMPLETED|Overall Study||1
6455357|NCT01176058|7371554|FG000|STARTED|Overall Study||9
6455358|NCT01176058|7371555|FG001|STARTED|Overall Study||8
6455359|NCT01176058|7371554|FG000|COMPLETED|Overall Study||5
6455360|NCT01176058|7371555|FG001|COMPLETED|Overall Study||5
6455361|NCT01176058|7371554|FG000|NOT COMPLETED|Overall Study||4
6455362|NCT01176058|7371555|FG001|NOT COMPLETED|Overall Study||3
6455363|NCT01176240|7371565|FG000|STARTED|Study 306A||24
6455364|NCT01176240|7371566|FG001|STARTED|Study 306A||27
6455365|NCT01176240|7371565|FG000|COMPLETED|Study 306A||21
6455366|NCT01176240|7371566|FG001|COMPLETED|Study 306A||24
6455367|NCT01176240|7371565|FG000|NOT COMPLETED|Study 306A||3
6455368|NCT01176240|7371566|FG001|NOT COMPLETED|Study 306A||3
6455369|NCT01176240|7371565|FG000|STARTED|Study 306B||89
6455370|NCT01176240|7371566|FG001|STARTED|Study 306B||85
6455371|NCT01176240|7371565|FG000|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
6455372|NCT01176240|7371566|FG001|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
6455373|NCT01176240|7371565|FG000|1 wk of Stable Dosing and Visit 4|Study 306B||69
6455374|NCT01176240|7371566|FG001|1 wk of Stable Dosing and Visit 4|Study 306B||78
6455375|NCT01176240|7371565|FG000|2 wk of Stable Dosing and Visit 5|Study 306B||68
6455376|NCT01176240|7371566|FG001|2 wk of Stable Dosing and Visit 5|Study 306B||75
6455377|NCT01176240|7371565|FG000|4 wk of Stable Dosing and Visit 6|Study 306B||67
6455378|NCT01176240|7371566|FG001|4 wk of Stable Dosing and Visit 6|Study 306B||73
6455379|NCT01176240|7371565|FG000|COMPLETED|Study 306B||63
6455380|NCT01176240|7371566|FG001|COMPLETED|Study 306B||68
6455381|NCT01176240|7371565|FG000|NOT COMPLETED|Study 306B||26
6455382|NCT01176240|7371566|FG001|NOT COMPLETED|Study 306B||17
6455383|NCT01176266|7371572|FG000|STARTED|Overall Study||69
6455384|NCT01176266|7371572|FG000|COMPLETED|Overall Study||60
6455385|NCT01176266|7371572|FG000|NOT COMPLETED|Overall Study||9
6455386|NCT01176292|7371582|FG000|STARTED|Overall Study||71
6455387|NCT01176292|7371583|FG001|STARTED|Overall Study||71
6455388|NCT01176292|7371582|FG000|COMPLETED|Overall Study||66
6455389|NCT01176292|7371583|FG001|COMPLETED|Overall Study||62
6455390|NCT01176292|7371582|FG000|NOT COMPLETED|Overall Study||5
6455391|NCT01176292|7371583|FG001|NOT COMPLETED|Overall Study||9
6455392|NCT01176435|7371592|FG000|STARTED|Overall Study||15
6455393|NCT01176435|7371593|FG001|STARTED|Overall Study||15
6455394|NCT01176435|7371594|FG002|STARTED|Overall Study||15
6455395|NCT01176435|7371592|FG000|COMPLETED|Overall Study||15
6455396|NCT01176435|7371593|FG001|COMPLETED|Overall Study||15
6455397|NCT01176435|7371594|FG002|COMPLETED|Overall Study||15
6455398|NCT01176435|7371592|FG000|NOT COMPLETED|Overall Study||0
6455399|NCT01176435|7371593|FG001|NOT COMPLETED|Overall Study||0
6455400|NCT01176435|7371594|FG002|NOT COMPLETED|Overall Study||0
6455401|NCT01176448|7371602|FG000|STARTED|Overall Study||6
6455402|NCT01176448|7371602|FG000|COMPLETED|Overall Study||6
6455403|NCT01176448|7371602|FG000|NOT COMPLETED|Overall Study||0
6455404|NCT01176565|7371612|FG000|STARTED|Overall Study||500
6455405|NCT01176565|7371613|FG001|STARTED|Overall Study||500
6455406|NCT01176565|7371612|FG000|COMPLETED|Overall Study||480
6455407|NCT01176565|7371613|FG001|COMPLETED|Overall Study||481
6455408|NCT01176565|7371612|FG000|NOT COMPLETED|Overall Study||20
6455409|NCT01176565|7371613|FG001|NOT COMPLETED|Overall Study||19
6455410|NCT01176591|7371621|FG000|STARTED|Session 1||10
6455411|NCT01176591|7371622|FG001|STARTED|Session 1||3
6455412|NCT01176591|7371621|FG000|COMPLETED|Session 1||10
6455413|NCT01176591|7371622|FG001|COMPLETED|Session 1||3
6455414|NCT01176591|7371621|FG000|NOT COMPLETED|Session 1||0
6455415|NCT01176591|7371622|FG001|NOT COMPLETED|Session 1||0
6455416|NCT01176591|7371621|FG000|STARTED|Session 2||10
6455417|NCT01176591|7371622|FG001|STARTED|Session 2||3
6455418|NCT01176591|7371621|FG000|COMPLETED|Session 2||10
6455419|NCT01176591|7371622|FG001|COMPLETED|Session 2||3
6455420|NCT01176591|7371621|FG000|NOT COMPLETED|Session 2||0
6455421|NCT01176591|7371622|FG001|NOT COMPLETED|Session 2||0
6455422|NCT01176617|7371632|FG000|STARTED|1 - 6 Months (Ron-randomized)||0
6455423|NCT01176617|7371633|FG001|STARTED|1 - 6 Months (Ron-randomized)||0
6455424|NCT01176617|7371634|FG002|STARTED|1 - 6 Months (Ron-randomized)||38
6455425|NCT01176617|7371632|FG000|COMPLETED|1 - 6 Months (Ron-randomized)||0
6455426|NCT01176617|7371633|FG001|COMPLETED|1 - 6 Months (Ron-randomized)||0
6455427|NCT01176617|7371634|FG002|COMPLETED|1 - 6 Months (Ron-randomized)||38
6455428|NCT01176617|7371632|FG000|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
6455429|NCT01176617|7371633|FG001|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
6455430|NCT01176617|7371634|FG002|NOT COMPLETED|1 - 6 Months (Ron-randomized)||0
6455431|NCT01176617|7371632|FG000|STARTED|6 - 12 Months (Randomized)||18
6455432|NCT01176617|7371633|FG001|STARTED|6 - 12 Months (Randomized)||20
6455433|NCT01176617|7371634|FG002|STARTED|6 - 12 Months (Randomized)||0
6455434|NCT01176617|7371632|FG000|COMPLETED|6 - 12 Months (Randomized)||13
6455435|NCT01176617|7371633|FG001|COMPLETED|6 - 12 Months (Randomized)||20
6455436|NCT01176617|7371634|FG002|COMPLETED|6 - 12 Months (Randomized)||0
6455437|NCT01176617|7371632|FG000|NOT COMPLETED|6 - 12 Months (Randomized)||5
6455438|NCT01176617|7371633|FG001|NOT COMPLETED|6 - 12 Months (Randomized)||0
6455439|NCT01176617|7371634|FG002|NOT COMPLETED|6 - 12 Months (Randomized)||0
6455440|NCT01176773|7371642|FG000|STARTED|Overall Study||62
6455441|NCT01176773|7371642|FG000|COMPLETED|Overall Study||59
6455442|NCT01176773|7371642|FG000|NOT COMPLETED|Overall Study||3
6455443|NCT01176877|7371647|FG000|STARTED|Overall Study||40
6455444|NCT01176877|7371647|FG000|COMPLETED|Overall Study||31
6455445|NCT01176877|7371647|FG000|NOT COMPLETED|Overall Study||9
6455446|NCT01176916|7371652|FG000|STARTED|Overall Study||564
6455447|NCT01176916|7371652|FG000|Treated|Overall Study||558
6455448|NCT01176916|7371652|FG000|Assigne But Not Treated|Overall Study||6
6455449|NCT01176916|7371652|FG000|COMPLETED|Overall Study||397
6455450|NCT01176916|7371652|FG000|NOT COMPLETED|Overall Study||167
6455451|NCT01176955|7371658|FG000|STARTED|Overall Study||10
6455452|NCT01176955|7371659|FG001|STARTED|Overall Study||10
6455453|NCT01176955|7371658|FG000|COMPLETED|Overall Study||7
6455454|NCT01176955|7371659|FG001|COMPLETED|Overall Study||8
6455455|NCT01176955|7371658|FG000|NOT COMPLETED|Overall Study||3
6455456|NCT01176955|7371659|FG001|NOT COMPLETED|Overall Study||2
6455457|NCT01176968|7371670|FG000|STARTED|Overall Study||506
6455458|NCT01176968|7371671|FG001|STARTED|Overall Study||506
6455459|NCT01176968|7371670|FG000|Treated|Overall Study||505
6455460|NCT01176968|7371671|FG001|Treated|Overall Study||505
6455461|NCT01176968|7371670|FG000|COMPLETED|Overall Study||422
6455462|NCT01176968|7371671|FG001|COMPLETED|Overall Study||424
6455463|NCT01176968|7371670|FG000|NOT COMPLETED|Overall Study||84
6455464|NCT01176968|7371671|FG001|NOT COMPLETED|Overall Study||82
6455465|NCT01176981|7371677|FG000|STARTED|Overall Study||6
6455466|NCT01176981|7371677|FG000|COMPLETED|Overall Study||6
6455467|NCT01176981|7371677|FG000|NOT COMPLETED|Overall Study||0
6455468|NCT01177007|7371681|FG000|STARTED|Overall Study||50
6455469|NCT01177007|7371681|FG000|Completed First Y90 Treatment|Overall Study||50
6455470|NCT01177007|7371681|FG000|Completed First Clinical and Imaging|Overall Study||43
6455471|NCT01177007|7371681|FG000|COMPLETED|Overall Study||12
6455472|NCT01177007|7371681|FG000|NOT COMPLETED|Overall Study||38
6455473|NCT01177059|7371687|FG000|STARTED|Overall Study||68
6455474|NCT01177059|7371687|FG000|COMPLETED|Overall Study||18
6455475|NCT01177059|7371687|FG000|NOT COMPLETED|Overall Study||50
6455476|NCT01177098|7371693|FG000|STARTED|Overall Study||278
6455477|NCT01177098|7371694|FG001|STARTED|Overall Study||283
6455478|NCT01177098|7371693|FG000|COMPLETED|Overall Study||269
6455479|NCT01177098|7371694|FG001|COMPLETED|Overall Study||271
6455480|NCT01177098|7371693|FG000|NOT COMPLETED|Overall Study||9
6455481|NCT01177098|7371694|FG001|NOT COMPLETED|Overall Study||12
6455482|NCT01177137|7371703|FG000|STARTED|Overall Study||51
6455483|NCT01177137|7371704|FG001|STARTED|Overall Study||51
6455484|NCT01177137|7371705|FG002|STARTED|Overall Study||49
6455485|NCT01177137|7371703|FG000|COMPLETED|Overall Study||41
6455486|NCT01177137|7371704|FG001|COMPLETED|Overall Study||41
6455487|NCT01177137|7371705|FG002|COMPLETED|Overall Study||47
6455488|NCT01177137|7371703|FG000|NOT COMPLETED|Overall Study||10
6455489|NCT01177137|7371704|FG001|NOT COMPLETED|Overall Study||10
6455490|NCT01177137|7371705|FG002|NOT COMPLETED|Overall Study||2
6455491|NCT01177189|7371718|FG000|STARTED|Overall Study||42
6455492|NCT01177189|7371719|FG001|STARTED|Overall Study||45
6455493|NCT01177189|7371718|FG000|COMPLETED|Overall Study||42
6455494|NCT01177189|7371719|FG001|COMPLETED|Overall Study||45
6455495|NCT01177189|7371718|FG000|NOT COMPLETED|Overall Study||0
6455496|NCT01177189|7371719|FG001|NOT COMPLETED|Overall Study||0
6455497|NCT01177228|7371729|FG000|STARTED|Overall Study||9
6455498|NCT01177228|7371730|FG001|STARTED|Overall Study||13
6455499|NCT01177228|7371731|FG002|STARTED|Overall Study||14
6455500|NCT01177228|7371732|FG003|STARTED|Overall Study||11
6455501|NCT01177228|7371729|FG000|Received Treatment|Overall Study||9
6455502|NCT01177228|7371730|FG001|Received Treatment|Overall Study||12
6455503|NCT01177228|7371731|FG002|Received Treatment|Overall Study||14
6455504|NCT01177228|7371732|FG003|Received Treatment|Overall Study||11
6455505|NCT01177228|7371729|FG000|COMPLETED|Overall Study||8
6455506|NCT01177228|7371730|FG001|COMPLETED|Overall Study||11
6455507|NCT01177228|7371731|FG002|COMPLETED|Overall Study||14
6455508|NCT01177228|7371732|FG003|COMPLETED|Overall Study||11
6455509|NCT01177228|7371729|FG000|NOT COMPLETED|Overall Study||1
6455510|NCT01177228|7371730|FG001|NOT COMPLETED|Overall Study||2
6455511|NCT01177228|7371731|FG002|NOT COMPLETED|Overall Study||0
6455512|NCT01177228|7371732|FG003|NOT COMPLETED|Overall Study||0
6455513|NCT01177293|7371747|FG000|STARTED|First Intervention Period||7
6455514|NCT01177293|7371748|FG001|STARTED|First Intervention Period||7
6455515|NCT01177293|7371747|FG000|COMPLETED|First Intervention Period||7
6455516|NCT01177293|7371748|FG001|COMPLETED|First Intervention Period||7
6455517|NCT01177293|7371747|FG000|NOT COMPLETED|First Intervention Period||0
6455518|NCT01177293|7371748|FG001|NOT COMPLETED|First Intervention Period||0
6455519|NCT01177293|7371747|FG000|STARTED|Washout Period (of 14 Days)||7
6455520|NCT01177293|7371748|FG001|STARTED|Washout Period (of 14 Days)||7
6455521|NCT01177293|7371747|FG000|COMPLETED|Washout Period (of 14 Days)||7
6455522|NCT01177293|7371748|FG001|COMPLETED|Washout Period (of 14 Days)||6
6455523|NCT01177293|7371747|FG000|NOT COMPLETED|Washout Period (of 14 Days)||0
6455524|NCT01177293|7371748|FG001|NOT COMPLETED|Washout Period (of 14 Days)||1
6455525|NCT01177293|7371747|FG000|STARTED|Second Intervention Period||7
6455526|NCT01177293|7371748|FG001|STARTED|Second Intervention Period||6
6455527|NCT01177293|7371747|FG000|COMPLETED|Second Intervention Period||7
6455528|NCT01177293|7371748|FG001|COMPLETED|Second Intervention Period||6
6455529|NCT01177293|7371747|FG000|NOT COMPLETED|Second Intervention Period||0
6455530|NCT01177293|7371748|FG001|NOT COMPLETED|Second Intervention Period||0
6455531|NCT01177384|7371756|FG000|STARTED|Overall Study||191
6455532|NCT01177384|7371757|FG001|STARTED|Overall Study|Includes the second randomization of a participant|190
6455533|NCT01177384|7371756|FG000|COMPLETED|Overall Study||177
6455534|NCT01177384|7371757|FG001|COMPLETED|Overall Study||164
6455535|NCT01177384|7371756|FG000|NOT COMPLETED|Overall Study||14
6455536|NCT01177384|7371757|FG001|NOT COMPLETED|Overall Study||26
6455537|NCT01177410|7371766|FG000|STARTED|Overall Study||51
6455538|NCT01177410|7371767|FG001|STARTED|Overall Study||47
6455539|NCT01177410|7371768|FG002|STARTED|Overall Study||50
6455540|NCT01177410|7371766|FG000|COMPLETED|Overall Study||50
6455541|NCT01177410|7371767|FG001|COMPLETED|Overall Study||40
6455542|NCT01177410|7371768|FG002|COMPLETED|Overall Study||45
6455543|NCT01177410|7371766|FG000|NOT COMPLETED|Overall Study||1
6455544|NCT01177410|7371767|FG001|NOT COMPLETED|Overall Study||7
6455545|NCT01177410|7371768|FG002|NOT COMPLETED|Overall Study||5
6455546|NCT01177553|7371778|FG000|STARTED|Overall Study||3
6455547|NCT01177553|7371779|FG001|STARTED|Overall Study||2
6455548|NCT01177553|7371778|FG000|COMPLETED|Overall Study|data as of March 2009|2
6455549|NCT01177553|7371779|FG001|COMPLETED|Overall Study|data as of March 2009|2
6455550|NCT01177553|7371778|FG000|NOT COMPLETED|Overall Study||1
6455551|NCT01177553|7371779|FG001|NOT COMPLETED|Overall Study||0
6455552|NCT01177670|7371785|FG000|STARTED|Overall Study||169
6455553|NCT01177670|7371785|FG000|COMPLETED|Overall Study||0
6455554|NCT01177670|7371785|FG000|NOT COMPLETED|Overall Study||169
6455555|NCT01177709|7371789|FG000|STARTED|Overall Study||12
6455556|NCT01177709|7371789|FG000|COMPLETED|Overall Study||12
6455557|NCT01177709|7371789|FG000|NOT COMPLETED|Overall Study||0
6455558|NCT01177722|7371797|FG000|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
6455559|NCT01177722|7371798|FG001|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
6455560|NCT01177722|7371799|FG002|STARTED|Overall Study||342
6455561|NCT01177722|7371800|FG003|STARTED|Overall Study||345
6455562|NCT01177722|7371797|FG000|COMPLETED|Overall Study||331
6455563|NCT01177722|7371798|FG001|COMPLETED|Overall Study||334
6455564|NCT01177722|7371799|FG002|COMPLETED|Overall Study||333
6455565|NCT01177722|7371800|FG003|COMPLETED|Overall Study||338
6455566|NCT01177722|7371797|FG000|NOT COMPLETED|Overall Study||13
6455567|NCT01177722|7371798|FG001|NOT COMPLETED|Overall Study||10
6455568|NCT01177722|7371799|FG002|NOT COMPLETED|Overall Study||9
6455569|NCT01177722|7371800|FG003|NOT COMPLETED|Overall Study||7
6455570|NCT01177735|7371811|FG000|STARTED|Overall Study||71
6455571|NCT01177735|7371811|FG000|COMPLETED|Overall Study||0
6455572|NCT01177735|7371811|FG000|NOT COMPLETED|Overall Study||71
6455573|NCT01177787|7371815|FG000|STARTED|Clinical Efficacy of Cryolipolysis||28
6455574|NCT01177787|7371815|FG000|COMPLETED|Clinical Efficacy of Cryolipolysis||28
6455575|NCT01177787|7371815|FG000|NOT COMPLETED|Clinical Efficacy of Cryolipolysis||0
6455576|NCT01177787|7371815|FG000|STARTED|Cryolipolysis on Thigh||28
6455577|NCT01177787|7371815|FG000|COMPLETED|Cryolipolysis on Thigh||14
6455578|NCT01177787|7371815|FG000|NOT COMPLETED|Cryolipolysis on Thigh||14
6455579|NCT01177800|7371829|FG000|STARTED|Overall Study||84
6455580|NCT01177800|7371830|FG001|STARTED|Overall Study||45
6455581|NCT01177800|7371829|FG000|COMPLETED|Overall Study||74
6455582|NCT01177800|7371830|FG001|COMPLETED|Overall Study||40
6455583|NCT01177800|7371829|FG000|NOT COMPLETED|Overall Study||10
6455584|NCT01177800|7371830|FG001|NOT COMPLETED|Overall Study||5
6455585|NCT01177813|7371841|FG000|STARTED|Overall Study||228
6455586|NCT01177813|7371842|FG001|STARTED|Overall Study||224
6745210|NCT03358147|7673291|FG001|COMPLETED|Overall Study||201
6745211|NCT03358147|7673292|FG002|COMPLETED|Overall Study||206
6745212|NCT03358147|7673293|FG003|COMPLETED|Overall Study||201
6745213|NCT03358147|7673294|FG004|COMPLETED|Overall Study||105
6745214|NCT03358147|7673290|FG000|NOT COMPLETED|Overall Study||34
6745215|NCT03358147|7673291|FG001|NOT COMPLETED|Overall Study||39
6745216|NCT03358147|7673292|FG002|NOT COMPLETED|Overall Study||34
6745217|NCT03358147|7673293|FG003|NOT COMPLETED|Overall Study||36
6455587|NCT01177813|7371843|FG002|STARTED|Overall Study||224
6455588|NCT01177813|7371844|FG003|STARTED|Overall Study||223
6455589|NCT01177813|7371845|FG004|STARTED|Overall Study||87
6455590|NCT01177813|7371841|FG000|COMPLETED|Overall Study||187
6455591|NCT01177813|7371842|FG001|COMPLETED|Overall Study||206
6455592|NCT01177813|7371843|FG002|COMPLETED|Overall Study||204
6455593|NCT01177813|7371844|FG003|COMPLETED|Overall Study||206
6455594|NCT01177813|7371845|FG004|COMPLETED|Overall Study||78
6455595|NCT01177813|7371841|FG000|NOT COMPLETED|Overall Study||41
6455596|NCT01177813|7371842|FG001|NOT COMPLETED|Overall Study||18
6455597|NCT01177813|7371843|FG002|NOT COMPLETED|Overall Study||20
6455598|NCT01177813|7371844|FG003|NOT COMPLETED|Overall Study||17
6455599|NCT01177813|7371845|FG004|NOT COMPLETED|Overall Study||9
6455600|NCT01177943|7371859|FG000|STARTED|First Intervention||21
6455601|NCT01177943|7371860|FG001|STARTED|First Intervention||21
6455602|NCT01177943|7371859|FG000|COMPLETED|First Intervention||19
6455603|NCT01177943|7371860|FG001|COMPLETED|First Intervention||21
6455604|NCT01177943|7371859|FG000|NOT COMPLETED|First Intervention||2
6455605|NCT01177943|7371860|FG001|NOT COMPLETED|First Intervention||0
6455606|NCT01177943|7371859|FG000|STARTED|Second Intervention||19
6455607|NCT01177943|7371860|FG001|STARTED|Second Intervention||21
6455608|NCT01177943|7371859|FG000|COMPLETED|Second Intervention||19
6455609|NCT01177943|7371860|FG001|COMPLETED|Second Intervention||21
6455610|NCT01177943|7371859|FG000|NOT COMPLETED|Second Intervention||0
6455611|NCT01177943|7371860|FG001|NOT COMPLETED|Second Intervention||0
6455612|NCT01177956|7371866|FG000|STARTED|Overall Study||68
6455613|NCT01177956|7371866|FG000|COMPLETED|Overall Study||68
6455614|NCT01177956|7371866|FG000|NOT COMPLETED|Overall Study||0
6455615|NCT01177969|7371873|FG000|STARTED|Overall Study||19
6455616|NCT01177969|7371874|FG001|STARTED|Overall Study||14
6455617|NCT01177969|7371873|FG000|COMPLETED|Overall Study||16
6455618|NCT01177969|7371874|FG001|COMPLETED|Overall Study||11
6455619|NCT01177969|7371873|FG000|NOT COMPLETED|Overall Study||3
6455620|NCT01177969|7371874|FG001|NOT COMPLETED|Overall Study||3
6455621|NCT01178073|7371883|FG000|STARTED|Overall Study||302
6455622|NCT01178073|7371884|FG001|STARTED|Overall Study||152
6455623|NCT01178073|7371885|FG002|STARTED|Overall Study||151
6455624|NCT01178073|7371883|FG000|COMPLETED|Overall Study||240
6455625|NCT01178073|7371884|FG001|COMPLETED|Overall Study||108
6455626|NCT01178073|7371885|FG002|COMPLETED|Overall Study||105
6455627|NCT01178073|7371883|FG000|NOT COMPLETED|Overall Study||62
6553612|NCT01744691|7476069|FG000|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
6553613|NCT01744691|7476069|FG000|NOT COMPLETED|Overall Study||43
6553614|NCT01744704|7476085|FG000|STARTED|Overall Study||3
6553615|NCT01744704|7476086|FG001|STARTED|Overall Study||3
6553616|NCT01744704|7476087|FG002|STARTED|Overall Study||3
6553617|NCT01744704|7476088|FG003|STARTED|Overall Study||6
6553618|NCT01744704|7476089|FG004|STARTED|Overall Study||6
6553619|NCT01744704|7476090|FG005|STARTED|Overall Study||7
6553620|NCT01744704|7476091|FG006|STARTED|Overall Study||6
6553621|NCT01744704|7476092|FG007|STARTED|Overall Study||9
6553622|NCT01744704|7476093|FG008|STARTED|Overall Study||3
6553623|NCT01744704|7476094|FG009|STARTED|Overall Study||9
6553624|NCT01744704|7476095|FG010|STARTED|Overall Study||9
6553625|NCT01744704|7476096|FG011|STARTED|Overall Study||10
6553626|NCT01744704|7476085|FG000|COMPLETED|Overall Study||3
6455628|NCT01178073|7371884|FG001|NOT COMPLETED|Overall Study||44
6455629|NCT01178073|7371885|FG002|NOT COMPLETED|Overall Study||46
6455630|NCT01178086|7371896|FG000|STARTED|Overall Study|Safety analysis set: participants who received at least one dose of rituximab.|681
6553627|NCT01744704|7476086|FG001|COMPLETED|Overall Study||3
6455631|NCT01178086|7371896|FG000|Effectiveness Analysis Set (EAS)|Overall Study|who received at least 1 dose of rituximab and had data from baseline and at least 1 follow-up visit.|661
6455632|NCT01178086|7371896|FG000|COMPLETED|Overall Study||349
6455633|NCT01178086|7371896|FG000|NOT COMPLETED|Overall Study||332
6553628|NCT01744704|7476087|FG002|COMPLETED|Overall Study||3
6553629|NCT01744704|7476088|FG003|COMPLETED|Overall Study||6
6553630|NCT01744704|7476089|FG004|COMPLETED|Overall Study||6
6745218|NCT03358147|7673294|FG004|NOT COMPLETED|Overall Study||14
6745219|NCT03358238|7673308|FG000|STARTED|Overall Study||23
6455634|NCT01178099|7371906|FG000|STARTED|Overall Study||13
6455635|NCT01178099|7371907|FG001|STARTED|Overall Study||13
6455636|NCT01178099|7371906|FG000|COMPLETED|Overall Study||13
6455637|NCT01178099|7371907|FG001|COMPLETED|Overall Study||12
6455638|NCT01178099|7371906|FG000|NOT COMPLETED|Overall Study||0
6455639|NCT01178099|7371907|FG001|NOT COMPLETED|Overall Study||1
6455640|NCT01178125|7371917|FG000|STARTED|Overall Study|Number enrolled.|2858
6455641|NCT01178125|7371917|FG000|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
6455642|NCT01178125|7371917|FG000|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
6455643|NCT01178125|7371917|FG000|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
6455644|NCT01178125|7371917|FG000|COMPLETED|Overall Study||1680
6455645|NCT01178125|7371917|FG000|NOT COMPLETED|Overall Study||1178
6455646|NCT01178138|7371926|FG000|STARTED|Overall Study||24
6455647|NCT01178138|7371926|FG000|Completed 6 Sessions|Overall Study||1
6455648|NCT01178138|7371926|FG000|Completed 5 Sessions|Overall Study||1
6455649|NCT01178138|7371926|FG000|Completed 3 Sessions|Overall Study||1
6455650|NCT01178138|7371926|FG000|COMPLETED|Overall Study||1
6455651|NCT01178138|7371926|FG000|NOT COMPLETED|Overall Study||23
6455652|NCT01178216|7371935|FG000|STARTED|Overall Study||41
6455653|NCT01178216|7371935|FG000|COMPLETED|Overall Study||39
6455654|NCT01178216|7371935|FG000|NOT COMPLETED|Overall Study||2
6455655|NCT01178268|7371941|FG000|STARTED|Overall Study||367
6455656|NCT01178268|7371942|FG001|STARTED|Overall Study||121
6455657|NCT01178268|7371941|FG000|COMPLETED|Overall Study||360
6455658|NCT01178268|7371942|FG001|COMPLETED|Overall Study||120
6455659|NCT01178268|7371941|FG000|NOT COMPLETED|Overall Study||7
6455660|NCT01178268|7371942|FG001|NOT COMPLETED|Overall Study||1
6455661|NCT01178281|7371951|FG000|STARTED|Overall Study||168
6455662|NCT01178281|7371952|FG001|STARTED|Overall Study||84
6455663|NCT01178281|7371953|FG002|STARTED|Overall Study||15
6455664|NCT01178281|7371951|FG000|Received Study Drug|Overall Study||167
6455665|NCT01178281|7371952|FG001|Received Study Drug|Overall Study||83
6455666|NCT01178281|7371953|FG002|Received Study Drug|Overall Study||15
6455667|NCT01178281|7371951|FG000|COMPLETED|Overall Study||168
6455668|NCT01178281|7371952|FG001|COMPLETED|Overall Study||84
6455669|NCT01178281|7371953|FG002|COMPLETED|Overall Study||15
6455670|NCT01178281|7371951|FG000|NOT COMPLETED|Overall Study||0
6455671|NCT01178281|7371952|FG001|NOT COMPLETED|Overall Study||0
6455672|NCT01178281|7371953|FG002|NOT COMPLETED|Overall Study||0
6455673|NCT01178294|7371963|FG000|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
6455674|NCT01178294|7371963|FG000|COMPLETED|Overall Study||18
6455675|NCT01178294|7371963|FG000|NOT COMPLETED|Overall Study||11
6455676|NCT01178333|7371970|FG000|STARTED|Overall Study||71
6455677|NCT01178333|7371971|FG001|STARTED|Overall Study||284
6455678|NCT01178333|7371972|FG002|STARTED|Overall Study||87
6455679|NCT01178333|7371970|FG000|COMPLETED|Overall Study||71
6455680|NCT01178333|7371971|FG001|COMPLETED|Overall Study||284
6455681|NCT01178333|7371972|FG002|COMPLETED|Overall Study||87
6455682|NCT01178333|7371970|FG000|NOT COMPLETED|Overall Study||0
6455683|NCT01178333|7371971|FG001|NOT COMPLETED|Overall Study||0
6455684|NCT01178333|7371972|FG002|NOT COMPLETED|Overall Study||0
6455685|NCT01178385|7371984|FG000|STARTED|Overall Study||24
6455686|NCT01178385|7371985|FG001|STARTED|Overall Study||21
6455687|NCT01178385|7371984|FG000|COMPLETED|Overall Study||22
6455688|NCT01178385|7371985|FG001|COMPLETED|Overall Study||21
6455689|NCT01178385|7371984|FG000|NOT COMPLETED|Overall Study||2
6455690|NCT01178385|7371985|FG001|NOT COMPLETED|Overall Study||0
6455691|NCT01178411|7371991|FG000|STARTED|Overall Study||60
6455692|NCT01178411|7371991|FG000|COMPLETED|Overall Study||0
6455693|NCT01178411|7371991|FG000|NOT COMPLETED|Overall Study||60
6455694|NCT01178528|7371998|FG000|STARTED|Overall Study||41
6455695|NCT01178528|7371999|FG001|STARTED|Overall Study||38
6455696|NCT01178528|7372000|FG002|STARTED|Overall Study||42
6455697|NCT01178528|7371998|FG000|COMPLETED|Overall Study||41
6455698|NCT01178528|7371999|FG001|COMPLETED|Overall Study||38
6455699|NCT01178528|7372000|FG002|COMPLETED|Overall Study||42
6455700|NCT01178528|7371998|FG000|NOT COMPLETED|Overall Study||0
6455701|NCT01178528|7371999|FG001|NOT COMPLETED|Overall Study||0
6455702|NCT01178528|7372000|FG002|NOT COMPLETED|Overall Study||0
6455703|NCT01178671|7372011|FG000|STARTED|Overall Study||18
6455704|NCT01178671|7372012|FG001|STARTED|Overall Study||18
6455705|NCT01178671|7372011|FG000|COMPLETED|Overall Study||6
6455706|NCT01178671|7372012|FG001|COMPLETED|Overall Study||3
6455707|NCT01178671|7372011|FG000|NOT COMPLETED|Overall Study||12
6455708|NCT01178671|7372012|FG001|NOT COMPLETED|Overall Study||15
6455709|NCT01178762|7372018|FG000|STARTED|Overall Study||42
6455710|NCT01178762|7372018|FG000|COMPLETED|Overall Study||27
6455711|NCT01178762|7372018|FG000|NOT COMPLETED|Overall Study||15
6455712|NCT01178827|7372025|FG000|STARTED|Overall Study||6
6455713|NCT01178827|7372026|FG001|STARTED|Overall Study||10
6455714|NCT01178827|7372027|FG002|STARTED|Overall Study||4
6455715|NCT01178827|7372025|FG000|COMPLETED|Overall Study||6
6455716|NCT01178827|7372026|FG001|COMPLETED|Overall Study||10
6455717|NCT01178827|7372027|FG002|COMPLETED|Overall Study||4
6455718|NCT01178827|7372025|FG000|NOT COMPLETED|Overall Study||0
6455719|NCT01178827|7372026|FG001|NOT COMPLETED|Overall Study||0
6455720|NCT01178827|7372027|FG002|NOT COMPLETED|Overall Study||0
6455721|NCT01178853|7372037|FG000|STARTED|Period 1 (Warfarin Titration)||24
6455722|NCT01178853|7372038|FG001|STARTED|Period 1 (Warfarin Titration)||24
6455723|NCT01178853|7372037|FG000|COMPLETED|Period 1 (Warfarin Titration)||23
6455724|NCT01178853|7372038|FG001|COMPLETED|Period 1 (Warfarin Titration)||22
6455725|NCT01178853|7372037|FG000|NOT COMPLETED|Period 1 (Warfarin Titration)||1
6455726|NCT01178853|7372038|FG001|NOT COMPLETED|Period 1 (Warfarin Titration)||2
6455727|NCT01178853|7372037|FG000|STARTED|Period 2 (Warfarin + Study Drug)||23
6455728|NCT01178853|7372038|FG001|STARTED|Period 2 (Warfarin + Study Drug)||22
6455729|NCT01178853|7372037|FG000|COMPLETED|Period 2 (Warfarin + Study Drug)||22
6455730|NCT01178853|7372038|FG001|COMPLETED|Period 2 (Warfarin + Study Drug)||22
6455731|NCT01178853|7372037|FG000|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
6455732|NCT01178853|7372038|FG001|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
6455733|NCT01178853|7372037|FG000|STARTED|Period 3 (Warfarin Titration)||22
6455734|NCT01178853|7372038|FG001|STARTED|Period 3 (Warfarin Titration)||22
6455735|NCT01178853|7372037|FG000|COMPLETED|Period 3 (Warfarin Titration)||21
6455736|NCT01178853|7372038|FG001|COMPLETED|Period 3 (Warfarin Titration)||22
6455737|NCT01178853|7372037|FG000|NOT COMPLETED|Period 3 (Warfarin Titration)||1
6455738|NCT01178853|7372038|FG001|NOT COMPLETED|Period 3 (Warfarin Titration)||0
6455739|NCT01178853|7372037|FG000|STARTED|Period 4 (Warfarin + Study Drug)||21
6455740|NCT01178853|7372038|FG001|STARTED|Period 4 (Warfarin + Study Drug)||22
6455741|NCT01178853|7372037|FG000|COMPLETED|Period 4 (Warfarin + Study Drug)||21
6455742|NCT01178853|7372038|FG001|COMPLETED|Period 4 (Warfarin + Study Drug)||19
6455743|NCT01178853|7372037|FG000|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
6654375|NCT02444988|7584168|FG001|STARTED|Overall Study||2735
6654376|NCT02444988|7584167|FG000|COMPLETED|Overall Study||2646
6654377|NCT02444988|7584168|FG001|COMPLETED|Overall Study||2735
6654378|NCT02444988|7584167|FG000|NOT COMPLETED|Overall Study||0
6654379|NCT02444988|7584168|FG001|NOT COMPLETED|Overall Study||0
6654380|NCT02445014|7584174|FG000|STARTED|Overall Study||3
6654381|NCT02445014|7584174|FG000|COMPLETED|Overall Study||3
6654382|NCT02445014|7584174|FG000|NOT COMPLETED|Overall Study||0
6654383|NCT02445027|7584178|FG000|STARTED|Overall Study||60
6654384|NCT02445027|7584178|FG000|COMPLETED|Overall Study||45
6654385|NCT02445027|7584178|FG000|NOT COMPLETED|Overall Study||15
6654386|NCT02445196|7584184|FG000|STARTED|Overall Study||62
6654387|NCT02445196|7584185|FG001|STARTED|Overall Study||58
6654388|NCT02445196|7584184|FG000|COMPLETED|Overall Study||51
6455744|NCT01178853|7372038|FG001|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
6455745|NCT01178944|7372044|FG000|STARTED|Overall Study||35
6455746|NCT01178944|7372044|FG000|COMPLETED|Overall Study||35
6455747|NCT01178944|7372044|FG000|NOT COMPLETED|Overall Study||0
6455748|NCT01179048|7372050|FG000|STARTED|Overall Study||4668
6455749|NCT01179048|7372051|FG001|STARTED|Overall Study||4672
6455750|NCT01179048|7372050|FG000|COMPLETED|Overall Study||4529
6455751|NCT01179048|7372051|FG001|COMPLETED|Overall Study||4513
6455752|NCT01179048|7372050|FG000|NOT COMPLETED|Overall Study||139
6455753|NCT01179048|7372051|FG001|NOT COMPLETED|Overall Study||159
6455754|NCT01179113|7372059|FG000|STARTED|Overall Study||17
6455755|NCT01179113|7372060|FG001|STARTED|Overall Study||16
6455756|NCT01179113|7372059|FG000|COMPLETED|Overall Study||17
6455757|NCT01179113|7372060|FG001|COMPLETED|Overall Study||16
6455758|NCT01179113|7372059|FG000|NOT COMPLETED|Overall Study||0
6455759|NCT01179113|7372060|FG001|NOT COMPLETED|Overall Study||0
6455760|NCT01179191|7372066|FG000|STARTED|Titration Phase (up to 6 Weeks)||684
6455761|NCT01179191|7372066|FG000|COMPLETED|Titration Phase (up to 6 Weeks)||351
6455762|NCT01179191|7372066|FG000|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
6455763|NCT01179191|7372066|FG000|STARTED|Maintenance Phase (8 Weeks)||351
6455764|NCT01179191|7372066|FG000|COMPLETED|Maintenance Phase (8 Weeks)||234
6455765|NCT01179191|7372066|FG000|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
6455766|NCT01179217|7372072|FG000|STARTED|Overall Study||152
6455767|NCT01179217|7372073|FG001|STARTED|Overall Study||78
6455768|NCT01179217|7372072|FG000|COMPLETED|Overall Study||97
6455769|NCT01179217|7372073|FG001|COMPLETED|Overall Study||59
6455770|NCT01179217|7372072|FG000|NOT COMPLETED|Overall Study||55
6455771|NCT01179217|7372073|FG001|NOT COMPLETED|Overall Study||19
6455772|NCT01179334|7372083|FG000|STARTED|Treatment Period||12
6455773|NCT01179334|7372084|FG001|STARTED|Treatment Period||6
6455774|NCT01179334|7372083|FG000|Participants Received Treatment|Treatment Period||12
6455775|NCT01179334|7372084|FG001|Participants Received Treatment|Treatment Period||6
6455776|NCT01179334|7372083|FG000|COMPLETED|Treatment Period||11
6455777|NCT01179334|7372084|FG001|COMPLETED|Treatment Period||6
6455778|NCT01179334|7372083|FG000|NOT COMPLETED|Treatment Period||1
6455779|NCT01179334|7372084|FG001|NOT COMPLETED|Treatment Period||0
6455780|NCT01179334|7372083|FG000|STARTED|Long-term Extension (LTE) Period||11
6455781|NCT01179334|7372084|FG001|STARTED|Long-term Extension (LTE) Period||6
6455782|NCT01179334|7372083|FG000|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
6455783|NCT01179334|7372084|FG001|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
6455784|NCT01179334|7372083|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||11
6455785|NCT01179334|7372084|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||6
6455786|NCT01179347|7372092|FG000|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
6455787|NCT01179347|7372093|FG001|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
6455788|NCT01179347|7372092|FG000|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
6455789|NCT01179347|7372093|FG001|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
6455790|NCT01179347|7372092|FG000|NOT COMPLETED|Double-blind Period (12 Weeks)||8
6455791|NCT01179347|7372093|FG001|NOT COMPLETED|Double-blind Period (12 Weeks)||14
6654389|NCT02445196|7584185|FG001|COMPLETED|Overall Study||52
6455792|NCT01179347|7372092|FG000|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
6455793|NCT01179347|7372093|FG001|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
6455794|NCT01179347|7372092|FG000|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
6455795|NCT01179347|7372093|FG001|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
6455796|NCT01179347|7372092|FG000|NOT COMPLETED|Open-label Period (12 Weeks)||15
6455797|NCT01179347|7372093|FG001|NOT COMPLETED|Open-label Period (12 Weeks)||16
6455798|NCT01179477|7372101|FG000|STARTED|Overall Study||1930
6455799|NCT01179477|7372101|FG000|COMPLETED|Overall Study||843
6455800|NCT01179477|7372101|FG000|NOT COMPLETED|Overall Study||1087
6455801|NCT01179490|7372105|FG000|STARTED|Overall Study||5
6455802|NCT01179490|7372105|FG000|COMPLETED|Overall Study||5
6455803|NCT01179490|7372105|FG000|NOT COMPLETED|Overall Study||0
6455804|NCT01179516|7372112|FG000|STARTED|Overall Study||160
6455805|NCT01179516|7372113|FG001|STARTED|Overall Study||157
6455806|NCT01179516|7372114|FG002|STARTED|Overall Study||152
6455807|NCT01179516|7372112|FG000|Treated|Overall Study||160
6455808|NCT01179516|7372113|FG001|Treated|Overall Study||154
6455809|NCT01179516|7372114|FG002|Treated|Overall Study||151
6455810|NCT01179516|7372112|FG000|COMPLETED|Overall Study||133
6455811|NCT01179516|7372113|FG001|COMPLETED|Overall Study||131
6455812|NCT01179516|7372114|FG002|COMPLETED|Overall Study||121
6455813|NCT01179516|7372112|FG000|NOT COMPLETED|Overall Study||27
6455814|NCT01179516|7372113|FG001|NOT COMPLETED|Overall Study||26
6553631|NCT01744704|7476090|FG005|COMPLETED|Overall Study||7
6553632|NCT01744704|7476091|FG006|COMPLETED|Overall Study||6
6455815|NCT01179516|7372114|FG002|NOT COMPLETED|Overall Study||31
6455816|NCT01179568|7372126|FG000|STARTED|Overall Study||101
6455817|NCT01179568|7372127|FG001|STARTED|Overall Study||99
6455818|NCT01179568|7372128|FG002|STARTED|Overall Study||99
6455819|NCT01179568|7372129|FG003|STARTED|Overall Study||96
6455820|NCT01179568|7372126|FG000|Completed Week 12 Assessment|Overall Study||69
6455821|NCT01179568|7372127|FG001|Completed Week 12 Assessment|Overall Study||69
6455822|NCT01179568|7372128|FG002|Completed Week 12 Assessment|Overall Study||76
6455823|NCT01179568|7372129|FG003|Completed Week 12 Assessment|Overall Study||75
6455824|NCT01179568|7372126|FG000|COMPLETED|Overall Study||73
6455825|NCT01179568|7372127|FG001|COMPLETED|Overall Study||61
6455826|NCT01179568|7372128|FG002|COMPLETED|Overall Study||76
6455827|NCT01179568|7372129|FG003|COMPLETED|Overall Study||76
6455828|NCT01179568|7372126|FG000|NOT COMPLETED|Overall Study||28
6455829|NCT01179568|7372127|FG001|NOT COMPLETED|Overall Study||38
6455830|NCT01179568|7372128|FG002|NOT COMPLETED|Overall Study||23
6455831|NCT01179568|7372129|FG003|NOT COMPLETED|Overall Study||20
6455832|NCT01179672|7372144|FG000|STARTED|Overall Study||203
6455833|NCT01179672|7372145|FG001|STARTED|Overall Study||202
6455834|NCT01179672|7372144|FG000|Received at Least 1 Dose of Study Drug|Overall Study||202
6455835|NCT01179672|7372145|FG001|Received at Least 1 Dose of Study Drug|Overall Study||202
6455836|NCT01179672|7372144|FG000|Entered Taper|Overall Study||181
6455837|NCT01179672|7372145|FG001|Entered Taper|Overall Study||177
6455838|NCT01179672|7372144|FG000|COMPLETED|Overall Study||173
6455839|NCT01179672|7372145|FG001|COMPLETED|Overall Study||176
6455840|NCT01179672|7372144|FG000|NOT COMPLETED|Overall Study||30
6455841|NCT01179672|7372145|FG001|NOT COMPLETED|Overall Study||26
6455842|NCT01179919|7372155|FG000|STARTED|Overall Study||21
6455843|NCT01179919|7372155|FG000|COMPLETED|Overall Study||19
6455844|NCT01179919|7372155|FG000|NOT COMPLETED|Overall Study||2
6455845|NCT01179984|7372159|FG000|STARTED|Overall Study||76
6455846|NCT01179984|7372159|FG000|COMPLETED|Overall Study||58
6455847|NCT01179984|7372159|FG000|NOT COMPLETED|Overall Study||18
6455848|NCT01180036|7372166|FG000|STARTED|Overall Study||65
6455849|NCT01180036|7372167|FG001|STARTED|Overall Study||65
6455850|NCT01180036|7372166|FG000|COMPLETED|Overall Study||65
6455851|NCT01180036|7372167|FG001|COMPLETED|Overall Study||65
6455852|NCT01180036|7372166|FG000|NOT COMPLETED|Overall Study||0
6455853|NCT01180036|7372167|FG001|NOT COMPLETED|Overall Study||0
6455854|NCT01180049|7372177|FG000|STARTED|Overall Study||53
6455855|NCT01180049|7372178|FG001|STARTED|Overall Study||48
6455856|NCT01180049|7372177|FG000|COMPLETED|Overall Study||0
6455857|NCT01180049|7372178|FG001|COMPLETED|Overall Study||0
6455858|NCT01180049|7372177|FG000|NOT COMPLETED|Overall Study||53
6455859|NCT01180049|7372178|FG001|NOT COMPLETED|Overall Study||48
6455860|NCT01180127|7372188|FG000|STARTED|Overall Study||10
6455861|NCT01180127|7372189|FG001|STARTED|Overall Study||11
6455862|NCT01180127|7372190|FG002|STARTED|Overall Study||10
6455863|NCT01180127|7372191|FG003|STARTED|Overall Study||10
6455864|NCT01180127|7372188|FG000|COMPLETED|Overall Study||8
6455865|NCT01180127|7372189|FG001|COMPLETED|Overall Study||11
6455866|NCT01180127|7372190|FG002|COMPLETED|Overall Study||9
6455867|NCT01180127|7372191|FG003|COMPLETED|Overall Study||9
6455868|NCT01180127|7372188|FG000|NOT COMPLETED|Overall Study||2
6455869|NCT01180127|7372189|FG001|NOT COMPLETED|Overall Study||0
6455870|NCT01180127|7372190|FG002|NOT COMPLETED|Overall Study||1
6455871|NCT01180127|7372191|FG003|NOT COMPLETED|Overall Study||1
6455872|NCT01180244|7372207|FG000|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
6455873|NCT01180244|7372208|FG001|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
6455874|NCT01180244|7372207|FG000|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
6500616|NCT01425307|7419265|FG001|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
6455875|NCT01180244|7372208|FG001|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
6455876|NCT01180244|7372207|FG000|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
6455877|NCT01180244|7372208|FG001|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
6455878|NCT01180244|7372207|FG000|NOT COMPLETED|Overall Study||6
6455879|NCT01180244|7372208|FG001|NOT COMPLETED|Overall Study||8
6455880|NCT01180296|7372216|FG000|STARTED|Overall Study||20
6455881|NCT01180296|7372217|FG001|STARTED|Overall Study||16
6455882|NCT01180296|7372216|FG000|COMPLETED|Overall Study||19
6455883|NCT01180296|7372217|FG001|COMPLETED|Overall Study||14
6455884|NCT01180296|7372216|FG000|NOT COMPLETED|Overall Study||1
6455885|NCT01180296|7372217|FG001|NOT COMPLETED|Overall Study||2
6455886|NCT01180400|7372227|FG000|STARTED|Overall Study||147
6455887|NCT01180400|7372228|FG001|STARTED|Overall Study||148
6455888|NCT01180400|7372227|FG000|Received Treatment|Overall Study||147
6455889|NCT01180400|7372228|FG001|Received Treatment|Overall Study||146
6455890|NCT01180400|7372227|FG000|COMPLETED|Overall Study||122
6455891|NCT01180400|7372228|FG001|COMPLETED|Overall Study||121
6455892|NCT01180400|7372227|FG000|NOT COMPLETED|Overall Study||25
6455893|NCT01180400|7372228|FG001|NOT COMPLETED|Overall Study||27
6455894|NCT01180478|7372236|FG000|STARTED|Overall Study||484
6455895|NCT01180478|7372237|FG001|STARTED|Overall Study||481
6455896|NCT01180478|7372236|FG000|COMPLETED|Overall Study||303
6455897|NCT01180478|7372237|FG001|COMPLETED|Overall Study||293
6455898|NCT01180478|7372236|FG000|NOT COMPLETED|Overall Study||181
6455899|NCT01180478|7372237|FG001|NOT COMPLETED|Overall Study||188
6455900|NCT01180647|7372247|FG000|STARTED|Overall Study||17
6455901|NCT01180647|7372248|FG001|STARTED|Overall Study||17
6455902|NCT01180647|7372247|FG000|COMPLETED|Overall Study||12
6455903|NCT01180647|7372248|FG001|COMPLETED|Overall Study||11
6455904|NCT01180647|7372247|FG000|NOT COMPLETED|Overall Study||5
6455905|NCT01180647|7372248|FG001|NOT COMPLETED|Overall Study||6
6455906|NCT01180660|7372256|FG000|STARTED|Overall Study||25
6455907|NCT01180660|7372257|FG001|STARTED|Overall Study||26
6455908|NCT01180660|7372256|FG000|COMPLETED|Overall Study||24
6455909|NCT01180660|7372257|FG001|COMPLETED|Overall Study||26
6455910|NCT01180660|7372256|FG000|NOT COMPLETED|Overall Study||1
6455911|NCT01180660|7372257|FG001|NOT COMPLETED|Overall Study||0
6455912|NCT01180777|7372263|FG000|STARTED|Overall Study||92
6455913|NCT01180777|7372263|FG000|COMPLETED|Overall Study||80
6455914|NCT01180777|7372263|FG000|NOT COMPLETED|Overall Study||12
6455915|NCT01180790|7372276|FG000|STARTED|Overall Study||16
6455916|NCT01180790|7372277|FG001|STARTED|Overall Study||16
6455917|NCT01180790|7372278|FG002|STARTED|Overall Study||17
6455918|NCT01180790|7372279|FG003|STARTED|Overall Study||15
6455919|NCT01180790|7372280|FG004|STARTED|Overall Study||19
6455920|NCT01180790|7372281|FG005|STARTED|Overall Study||20
6455921|NCT01180790|7372282|FG006|STARTED|Overall Study||19
6455922|NCT01180790|7372276|FG000|COMPLETED|Overall Study||7
6455923|NCT01180790|7372277|FG001|COMPLETED|Overall Study||11
6455924|NCT01180790|7372278|FG002|COMPLETED|Overall Study||4
6455925|NCT01180790|7372279|FG003|COMPLETED|Overall Study||6
6455926|NCT01180790|7372280|FG004|COMPLETED|Overall Study||14
6455927|NCT01180790|7372281|FG005|COMPLETED|Overall Study||13
6455928|NCT01180790|7372282|FG006|COMPLETED|Overall Study||18
6455929|NCT01180790|7372276|FG000|NOT COMPLETED|Overall Study||9
6455930|NCT01180790|7372277|FG001|NOT COMPLETED|Overall Study||5
6455931|NCT01180790|7372278|FG002|NOT COMPLETED|Overall Study||13
6455932|NCT01180790|7372279|FG003|NOT COMPLETED|Overall Study||9
6455933|NCT01180790|7372280|FG004|NOT COMPLETED|Overall Study||5
6455934|NCT01180790|7372281|FG005|NOT COMPLETED|Overall Study||7
6455935|NCT01180790|7372282|FG006|NOT COMPLETED|Overall Study||1
6455936|NCT01180894|7372328|FG000|STARTED|Overall Study||75
6455937|NCT01180894|7372329|FG001|STARTED|Overall Study||75
6455938|NCT01180894|7372328|FG000|COMPLETED|Overall Study||75
6455939|NCT01180894|7372329|FG001|COMPLETED|Overall Study||75
6455940|NCT01180894|7372328|FG000|NOT COMPLETED|Overall Study||0
6455941|NCT01180894|7372329|FG001|NOT COMPLETED|Overall Study||0
6455942|NCT01180985|7372337|FG000|STARTED|Period 1 (7 +/- Days)||27
6455943|NCT01180985|7372338|FG001|STARTED|Period 1 (7 +/- Days)||26
6455944|NCT01180985|7372337|FG000|COMPLETED|Period 1 (7 +/- Days)||27
6455945|NCT01180985|7372338|FG001|COMPLETED|Period 1 (7 +/- Days)||26
6455946|NCT01180985|7372337|FG000|NOT COMPLETED|Period 1 (7 +/- Days)||0
6455947|NCT01180985|7372338|FG001|NOT COMPLETED|Period 1 (7 +/- Days)||0
6455948|NCT01180985|7372337|FG000|STARTED|Period 2 (7 +/- 1 Days)||27
6455949|NCT01180985|7372338|FG001|STARTED|Period 2 (7 +/- 1 Days)||26
6455950|NCT01180985|7372337|FG000|COMPLETED|Period 2 (7 +/- 1 Days)||26
6455951|NCT01180985|7372338|FG001|COMPLETED|Period 2 (7 +/- 1 Days)||26
6455952|NCT01180985|7372337|FG000|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
6455953|NCT01180985|7372338|FG001|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
6455954|NCT01180998|7372348|FG000|STARTED|Overall Study||67
6455955|NCT01180998|7372349|FG001|STARTED|Overall Study||72
6455956|NCT01180998|7372350|FG002|STARTED|Overall Study||61
6455957|NCT01180998|7372348|FG000|COMPLETED|Overall Study||63
6455958|NCT01180998|7372349|FG001|COMPLETED|Overall Study||68
6455959|NCT01180998|7372350|FG002|COMPLETED|Overall Study||51
6455960|NCT01180998|7372348|FG000|NOT COMPLETED|Overall Study||4
6455961|NCT01180998|7372349|FG001|NOT COMPLETED|Overall Study||4
6455962|NCT01180998|7372350|FG002|NOT COMPLETED|Overall Study||10
6455963|NCT01181011|7372359|FG000|STARTED|Overall Study||28
6455964|NCT01181011|7372359|FG000|Received Telmisartan 80mg|Overall Study||27
6455965|NCT01181011|7372359|FG000|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
6455966|NCT01181011|7372359|FG000|Received Amlodipine 5mg|Overall Study||26
6455967|NCT01181011|7372359|FG000|COMPLETED|Overall Study||25
6455968|NCT01181011|7372359|FG000|NOT COMPLETED|Overall Study||3
6455969|NCT01181050|7372370|FG000|STARTED|Overall Study||41
6455970|NCT01181050|7372371|FG001|STARTED|Overall Study||22
6455971|NCT01181050|7372370|FG000|COMPLETED|Overall Study||41
6455972|NCT01181050|7372371|FG001|COMPLETED|Overall Study||22
6455973|NCT01181050|7372370|FG000|NOT COMPLETED|Overall Study||0
6455974|NCT01181050|7372371|FG001|NOT COMPLETED|Overall Study||0
6455975|NCT01181076|7372379|FG000|STARTED|Overall Study||59
6455976|NCT01181076|7372380|FG001|STARTED|Overall Study||60
6455977|NCT01181076|7372379|FG000|COMPLETED|Overall Study||40
6455978|NCT01181076|7372380|FG001|COMPLETED|Overall Study|As determined|48
6455979|NCT01181076|7372379|FG000|NOT COMPLETED|Overall Study||19
6455980|NCT01181076|7372380|FG001|NOT COMPLETED|Overall Study||12
6455981|NCT01181102|7372388|FG000|STARTED|Overall Study||360
6553633|NCT01744704|7476092|FG007|COMPLETED|Overall Study||9
6553634|NCT01744704|7476093|FG008|COMPLETED|Overall Study||3
6553635|NCT01744704|7476094|FG009|COMPLETED|Overall Study||9
6553636|NCT01744704|7476095|FG010|COMPLETED|Overall Study||9
6455982|NCT01181102|7372389|FG001|STARTED|Overall Study||356
6455983|NCT01181102|7372388|FG000|Safety Analysis Set|Overall Study||354
6455984|NCT01181102|7372389|FG001|Safety Analysis Set|Overall Study||349
6455985|NCT01181102|7372388|FG000|Efficacy Analysis Population|Overall Study||299
6455986|NCT01181102|7372389|FG001|Efficacy Analysis Population|Overall Study||295
6455987|NCT01181102|7372388|FG000|COMPLETED|Overall Study||309
6455988|NCT01181102|7372389|FG001|COMPLETED|Overall Study||310
6455989|NCT01181102|7372388|FG000|NOT COMPLETED|Overall Study||51
6455990|NCT01181102|7372389|FG001|NOT COMPLETED|Overall Study||46
6455991|NCT01181128|7372398|FG000|STARTED|Overall Study||118
6455992|NCT01181128|7372399|FG001|STARTED|Overall Study||24
6455993|NCT01181128|7372400|FG002|STARTED|Overall Study||23
6455994|NCT01181128|7372398|FG000|Pharmacokinetic (PK) Subgroup|Overall Study||30
6455995|NCT01181128|7372399|FG001|Pharmacokinetic (PK) Subgroup|Overall Study||0
6455996|NCT01181128|7372400|FG002|Pharmacokinetic (PK) Subgroup|Overall Study||0
6455997|NCT01181128|7372398|FG000|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
6455998|NCT01181128|7372399|FG001|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
6455999|NCT01181128|7372400|FG002|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
6456000|NCT01181128|7372398|FG000|COMPLETED|Overall Study||112
6456001|NCT01181128|7372399|FG001|COMPLETED|Overall Study||19
6456002|NCT01181128|7372400|FG002|COMPLETED|Overall Study||22
6456003|NCT01181128|7372398|FG000|NOT COMPLETED|Overall Study||6
6456004|NCT01181128|7372399|FG001|NOT COMPLETED|Overall Study||5
6456005|NCT01181128|7372400|FG002|NOT COMPLETED|Overall Study||1
6456006|NCT01181141|7372422|FG000|STARTED|Overall Study||62
6456007|NCT01181141|7372423|FG001|STARTED|Overall Study||30
6456008|NCT01181141|7372422|FG000|Safety Analysis Population|Overall Study||59
6456009|NCT01181141|7372423|FG001|Safety Analysis Population|Overall Study||29
6456010|NCT01181141|7372422|FG000|COMPLETED|Overall Study||50
6456011|NCT01181141|7372423|FG001|COMPLETED|Overall Study||26
6456012|NCT01181141|7372422|FG000|NOT COMPLETED|Overall Study||12
6456013|NCT01181141|7372423|FG001|NOT COMPLETED|Overall Study||4
6456014|NCT01181167|7372431|FG000|STARTED|Overall Study||307
6456015|NCT01181167|7372432|FG001|STARTED|Overall Study||303
6456016|NCT01181167|7372431|FG000|Efficacy Analysis Population|Overall Study||255
6456017|NCT01181167|7372432|FG001|Efficacy Analysis Population|Overall Study||248
6456018|NCT01181167|7372431|FG000|COMPLETED|Overall Study||284
6456019|NCT01181167|7372432|FG001|COMPLETED|Overall Study||271
6456020|NCT01181167|7372431|FG000|NOT COMPLETED|Overall Study||23
6456021|NCT01181167|7372432|FG001|NOT COMPLETED|Overall Study||32
6456022|NCT01181258|7372438|FG000|STARTED|Overall Study||16
6456023|NCT01181258|7372438|FG000|COMPLETED|Overall Study||16
6456024|NCT01181258|7372438|FG000|NOT COMPLETED|Overall Study||0
6456025|NCT01181271|7372442|FG000|STARTED|Autologous Transplant||42
6456026|NCT01181271|7372442|FG000|COMPLETED|Autologous Transplant||42
6456027|NCT01181271|7372442|FG000|NOT COMPLETED|Autologous Transplant||0
6456028|NCT01181271|7372442|FG000|STARTED|Evaluation for Allogeneic Transplant||42
6456029|NCT01181271|7372442|FG000|COMPLETED|Evaluation for Allogeneic Transplant||29
6456030|NCT01181271|7372442|FG000|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
6456031|NCT01181271|7372442|FG000|STARTED|Allogeneic Transplant||29
6456032|NCT01181271|7372442|FG000|COMPLETED|Allogeneic Transplant||29
6456033|NCT01181271|7372442|FG000|NOT COMPLETED|Allogeneic Transplant||0
6456034|NCT01181323|7372450|FG000|STARTED|Overall Study||124
6456035|NCT01181323|7372451|FG001|STARTED|Overall Study||124
6456036|NCT01181323|7372452|FG002|STARTED|Overall Study||124
6456037|NCT01181323|7372453|FG003|STARTED|Overall Study||125
6456038|NCT01181323|7372450|FG000|COMPLETED|Overall Study||123
6456039|NCT01181323|7372451|FG001|COMPLETED|Overall Study||121
6456040|NCT01181323|7372452|FG002|COMPLETED|Overall Study||123
6456041|NCT01181323|7372453|FG003|COMPLETED|Overall Study||122
6456042|NCT01181323|7372450|FG000|NOT COMPLETED|Overall Study||1
6456043|NCT01181323|7372451|FG001|NOT COMPLETED|Overall Study||3
6456044|NCT01181323|7372452|FG002|NOT COMPLETED|Overall Study||1
6456045|NCT01181323|7372453|FG003|NOT COMPLETED|Overall Study||3
6553637|NCT01744704|7476096|FG011|COMPLETED|Overall Study||10
6456046|NCT01181349|7372475|FG000|STARTED|Overall Study||350
6456047|NCT01181349|7372475|FG000|COMPLETED|Overall Study||350
6456048|NCT01181349|7372475|FG000|NOT COMPLETED|Overall Study||0
6456049|NCT01181479|7372483|FG000|STARTED|Subjects Receive AG200-15 or Lessina||1129
6745220|NCT03358238|7673309|FG001|STARTED|Overall Study||25
6745221|NCT03358238|7673308|FG000|COMPLETED|Overall Study||23
6745222|NCT03358238|7673309|FG001|COMPLETED|Overall Study||24
6745223|NCT03358238|7673308|FG000|NOT COMPLETED|Overall Study||0
6745224|NCT03358238|7673309|FG001|NOT COMPLETED|Overall Study||1
6745225|NCT03358251|7673319|FG000|STARTED|Overall Study||34
6745226|NCT03358251|7673319|FG000|COMPLETED|Overall Study||34
6745227|NCT03358251|7673319|FG000|NOT COMPLETED|Overall Study||0
6745228|NCT03358290|7673331|FG000|STARTED|Overall Study||2
6745229|NCT03358290|7673332|FG001|STARTED|Overall Study||3
6456050|NCT01181479|7372484|FG001|STARTED|Subjects Receive AG200-15 or Lessina||375
6456051|NCT01181479|7372485|FG002|STARTED|Subjects Receive AG200-15 or Lessina|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|0
6456052|NCT01181479|7372483|FG000|COMPLETED|Subjects Receive AG200-15 or Lessina||485
6456053|NCT01181479|7372484|FG001|COMPLETED|Subjects Receive AG200-15 or Lessina||249
6456054|NCT01181479|7372485|FG002|COMPLETED|Subjects Receive AG200-15 or Lessina||0
6456055|NCT01181479|7372483|FG000|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||644
6456056|NCT01181479|7372484|FG001|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||126
6456057|NCT01181479|7372485|FG002|NOT COMPLETED|Subjects Receive AG200-15 or Lessina||0
6456058|NCT01181479|7372483|FG000|STARTED|Crossover Subjects Recieve AG200-15||0
6456059|NCT01181479|7372484|FG001|STARTED|Crossover Subjects Recieve AG200-15||0
6456060|NCT01181479|7372485|FG002|STARTED|Crossover Subjects Recieve AG200-15|"This column is a subset of the Lessina completers in the Lessina (Cycles 1-6) column."|249
6456061|NCT01181479|7372483|FG000|COMPLETED|Crossover Subjects Recieve AG200-15||0
6456062|NCT01181479|7372484|FG001|COMPLETED|Crossover Subjects Recieve AG200-15||0
6456063|NCT01181479|7372485|FG002|COMPLETED|Crossover Subjects Recieve AG200-15||150
6456064|NCT01181479|7372483|FG000|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
6456065|NCT01181479|7372484|FG001|NOT COMPLETED|Crossover Subjects Recieve AG200-15||0
6456066|NCT01181479|7372485|FG002|NOT COMPLETED|Crossover Subjects Recieve AG200-15||99
6456067|NCT01181492|7372500|FG000|STARTED|Overall Study||103
6456068|NCT01181492|7372501|FG001|STARTED|Overall Study||66
6456069|NCT01181492|7372502|FG002|STARTED|Overall Study||7
6456070|NCT01181492|7372500|FG000|COMPLETED|Overall Study||103
6456071|NCT01181492|7372501|FG001|COMPLETED|Overall Study||66
6456072|NCT01181492|7372502|FG002|COMPLETED|Overall Study||7
6456073|NCT01181492|7372500|FG000|NOT COMPLETED|Overall Study||0
6456074|NCT01181492|7372501|FG001|NOT COMPLETED|Overall Study||0
6456075|NCT01181492|7372502|FG002|NOT COMPLETED|Overall Study||0
6456076|NCT01181531|7372512|FG000|STARTED|Overall Study|Subjects are randomized after washout.|157
6456077|NCT01181531|7372513|FG001|STARTED|Overall Study|Subjects are randomized after washout.|155
6456078|NCT01181531|7372512|FG000|Received Investigational Product|Overall Study||155
6456079|NCT01181531|7372513|FG001|Received Investigational Product|Overall Study||153
6456080|NCT01181531|7372512|FG000|COMPLETED|Overall Study||96
6456081|NCT01181531|7372513|FG001|COMPLETED|Overall Study||102
6456082|NCT01181531|7372512|FG000|NOT COMPLETED|Overall Study||61
6456083|NCT01181531|7372513|FG001|NOT COMPLETED|Overall Study||53
6500617|NCT01425307|7419264|FG000|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
6500618|NCT01425307|7419265|FG001|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
6500619|NCT01425307|7419264|FG000|NOT COMPLETED|Overall Study||19
6500620|NCT01425307|7419265|FG001|NOT COMPLETED|Overall Study||19
6500621|NCT01425359|7419275|FG000|STARTED|Overall Study||476
6500622|NCT01425359|7419276|FG001|STARTED|Overall Study||473
6500623|NCT01425359|7419275|FG000|COMPLETED|Overall Study||457
6500624|NCT01425359|7419276|FG001|COMPLETED|Overall Study||451
6500625|NCT01425359|7419275|FG000|NOT COMPLETED|Overall Study||19
6500626|NCT01425359|7419276|FG001|NOT COMPLETED|Overall Study||22
6500627|NCT01425463|7419285|FG000|STARTED|Overall Study||130
6500628|NCT01425463|7419286|FG001|STARTED|Overall Study||126
6500629|NCT01425463|7419285|FG000|Safety Set|Overall Study||126
6500630|NCT01425463|7419286|FG001|Safety Set|Overall Study||122
6500631|NCT01425463|7419285|FG000|Full Analysis Set|Overall Study||122
6500632|NCT01425463|7419286|FG001|Full Analysis Set|Overall Study||116
6500633|NCT01425463|7419285|FG000|COMPLETED|Overall Study||106
6500634|NCT01425463|7419286|FG001|COMPLETED|Overall Study||102
6500635|NCT01425463|7419285|FG000|NOT COMPLETED|Overall Study||24
6500636|NCT01425463|7419286|FG001|NOT COMPLETED|Overall Study||24
6745230|NCT03358290|7673333|FG002|STARTED|Overall Study||3
6745231|NCT03358290|7673334|FG003|STARTED|Overall Study||3
6500637|NCT01425528|7419294|FG000|STARTED|Overall Study||6
6500638|NCT01425528|7419295|FG001|STARTED|Overall Study||6
6500639|NCT01425528|7419294|FG000|COMPLETED|Overall Study||5
6500640|NCT01425528|7419295|FG001|COMPLETED|Overall Study||5
6500641|NCT01425528|7419294|FG000|NOT COMPLETED|Overall Study||1
6500642|NCT01425528|7419295|FG001|NOT COMPLETED|Overall Study||1
6502074|NCT01432405|7420713|FG001|COMPLETED|Overall Study||10
6502075|NCT01432405|7420712|FG000|NOT COMPLETED|Overall Study||1
6502076|NCT01432405|7420713|FG001|NOT COMPLETED|Overall Study||2
6502077|NCT01432444|7420719|FG000|STARTED|Tolerability/Cross-titration Phase||325
6502078|NCT01432444|7420720|FG001|STARTED|Tolerability/Cross-titration Phase||0
6502079|NCT01432444|7420721|FG002|STARTED|Tolerability/Cross-titration Phase||0
6502080|NCT01432444|7420719|FG000|COMPLETED|Tolerability/Cross-titration Phase||265
6553638|NCT01744704|7476085|FG000|NOT COMPLETED|Overall Study||0
6553639|NCT01744704|7476086|FG001|NOT COMPLETED|Overall Study||0
6553640|NCT01744704|7476087|FG002|NOT COMPLETED|Overall Study||0
6456084|NCT01181596|7372519|FG000|STARTED|Overall Study||31
6456085|NCT01181596|7372519|FG000|COMPLETED|Overall Study||31
6456086|NCT01181596|7372519|FG000|NOT COMPLETED|Overall Study||0
6456087|NCT01181609|7372524|FG000|STARTED|Overall Study||54
6456088|NCT01181609|7372524|FG000|COMPLETED|Overall Study||1
6456089|NCT01181609|7372524|FG000|NOT COMPLETED|Overall Study||53
6456090|NCT01181674|7372531|FG000|STARTED|Overall Study||28
6456091|NCT01181674|7372532|FG001|STARTED|Overall Study||27
6456092|NCT01181674|7372533|FG002|STARTED|Overall Study||28
6456093|NCT01181674|7372531|FG000|COMPLETED|Overall Study||28
6456094|NCT01181674|7372532|FG001|COMPLETED|Overall Study||27
6456095|NCT01181674|7372533|FG002|COMPLETED|Overall Study|28 included in analyses|26
6456096|NCT01181674|7372531|FG000|NOT COMPLETED|Overall Study||0
6456097|NCT01181674|7372532|FG001|NOT COMPLETED|Overall Study||0
6456098|NCT01181674|7372533|FG002|NOT COMPLETED|Overall Study||2
6456099|NCT01181726|7372543|FG000|STARTED|First Intervention||20
6456100|NCT01181726|7372544|FG001|STARTED|First Intervention||20
6456101|NCT01181726|7372543|FG000|COMPLETED|First Intervention||19
6456102|NCT01181726|7372544|FG001|COMPLETED|First Intervention||20
6456103|NCT01181726|7372543|FG000|NOT COMPLETED|First Intervention||1
6456104|NCT01181726|7372544|FG001|NOT COMPLETED|First Intervention||0
6456105|NCT01181726|7372543|FG000|STARTED|Washout of 28 Days||19
6456106|NCT01181726|7372544|FG001|STARTED|Washout of 28 Days||20
6456107|NCT01181726|7372543|FG000|COMPLETED|Washout of 28 Days||19
6456108|NCT01181726|7372544|FG001|COMPLETED|Washout of 28 Days||20
6456109|NCT01181726|7372543|FG000|NOT COMPLETED|Washout of 28 Days||0
6456110|NCT01181726|7372544|FG001|NOT COMPLETED|Washout of 28 Days||0
6456111|NCT01181726|7372543|FG000|STARTED|Second Intervention||19
6456112|NCT01181726|7372544|FG001|STARTED|Second Intervention||20
6456113|NCT01181726|7372543|FG000|COMPLETED|Second Intervention||19
6456114|NCT01181726|7372544|FG001|COMPLETED|Second Intervention||20
6456115|NCT01181726|7372543|FG000|NOT COMPLETED|Second Intervention||0
6456116|NCT01181726|7372544|FG001|NOT COMPLETED|Second Intervention||0
6456117|NCT01181804|7372554|FG000|STARTED|Period 1, Fed (Part 1)||30
6456118|NCT01181804|7372555|FG001|STARTED|Period 1, Fed (Part 1)||30
6456119|NCT01181804|7372556|FG002|STARTED|Period 1, Fed (Part 1)||0
6456120|NCT01181804|7372557|FG003|STARTED|Period 1, Fed (Part 1)||0
6456121|NCT01181804|7372554|FG000|COMPLETED|Period 1, Fed (Part 1)||30
6456122|NCT01181804|7372555|FG001|COMPLETED|Period 1, Fed (Part 1)||30
6456123|NCT01181804|7372556|FG002|COMPLETED|Period 1, Fed (Part 1)||0
6456124|NCT01181804|7372557|FG003|COMPLETED|Period 1, Fed (Part 1)||0
6456125|NCT01181804|7372554|FG000|NOT COMPLETED|Period 1, Fed (Part 1)||0
6456126|NCT01181804|7372555|FG001|NOT COMPLETED|Period 1, Fed (Part 1)||0
6456127|NCT01181804|7372556|FG002|NOT COMPLETED|Period 1, Fed (Part 1)||0
6456128|NCT01181804|7372557|FG003|NOT COMPLETED|Period 1, Fed (Part 1)||0
6456129|NCT01181804|7372554|FG000|STARTED|Period 2, Fed (Part 1)||30
6456130|NCT01181804|7372555|FG001|STARTED|Period 2, Fed (Part 1)||30
6456131|NCT01181804|7372556|FG002|STARTED|Period 2, Fed (Part 1)||0
6456132|NCT01181804|7372557|FG003|STARTED|Period 2, Fed (Part 1)||0
6456133|NCT01181804|7372554|FG000|COMPLETED|Period 2, Fed (Part 1)||30
6456134|NCT01181804|7372555|FG001|COMPLETED|Period 2, Fed (Part 1)||30
6456135|NCT01181804|7372556|FG002|COMPLETED|Period 2, Fed (Part 1)||0
6456136|NCT01181804|7372557|FG003|COMPLETED|Period 2, Fed (Part 1)||0
6456137|NCT01181804|7372554|FG000|NOT COMPLETED|Period 2, Fed (Part 1)||0
6456138|NCT01181804|7372555|FG001|NOT COMPLETED|Period 2, Fed (Part 1)||0
6456139|NCT01181804|7372556|FG002|NOT COMPLETED|Period 2, Fed (Part 1)||0
6456140|NCT01181804|7372557|FG003|NOT COMPLETED|Period 2, Fed (Part 1)||0
6456141|NCT01181804|7372554|FG000|STARTED|Period 3, Fasted (Part 2)||0
6456142|NCT01181804|7372555|FG001|STARTED|Period 3, Fasted (Part 2)||0
6456143|NCT01181804|7372556|FG002|STARTED|Period 3, Fasted (Part 2)||59
6456144|NCT01181804|7372557|FG003|STARTED|Period 3, Fasted (Part 2)||58
6456145|NCT01181804|7372554|FG000|COMPLETED|Period 3, Fasted (Part 2)||0
6456146|NCT01181804|7372555|FG001|COMPLETED|Period 3, Fasted (Part 2)||0
6456147|NCT01181804|7372556|FG002|COMPLETED|Period 3, Fasted (Part 2)||59
6456148|NCT01181804|7372557|FG003|COMPLETED|Period 3, Fasted (Part 2)||58
6456149|NCT01181804|7372554|FG000|NOT COMPLETED|Period 3, Fasted (Part 2)||0
6456150|NCT01181804|7372555|FG001|NOT COMPLETED|Period 3, Fasted (Part 2)||0
6456151|NCT01181804|7372556|FG002|NOT COMPLETED|Period 3, Fasted (Part 2)||0
6456152|NCT01181804|7372557|FG003|NOT COMPLETED|Period 3, Fasted (Part 2)||0
6456153|NCT01181804|7372554|FG000|STARTED|Period 4, Fasted (Part 2)||0
6456154|NCT01181804|7372555|FG001|STARTED|Period 4, Fasted (Part 2)||0
6456155|NCT01181804|7372556|FG002|STARTED|Period 4, Fasted (Part 2)||59
6456156|NCT01181804|7372557|FG003|STARTED|Period 4, Fasted (Part 2)||58
6456157|NCT01181804|7372554|FG000|COMPLETED|Period 4, Fasted (Part 2)||0
6456158|NCT01181804|7372555|FG001|COMPLETED|Period 4, Fasted (Part 2)||0
6456159|NCT01181804|7372556|FG002|COMPLETED|Period 4, Fasted (Part 2)||58
6456160|NCT01181804|7372557|FG003|COMPLETED|Period 4, Fasted (Part 2)||58
6456161|NCT01181804|7372554|FG000|NOT COMPLETED|Period 4, Fasted (Part 2)||0
6456162|NCT01181804|7372555|FG001|NOT COMPLETED|Period 4, Fasted (Part 2)||0
6553641|NCT01744704|7476088|FG003|NOT COMPLETED|Overall Study||0
6456163|NCT01181804|7372556|FG002|NOT COMPLETED|Period 4, Fasted (Part 2)||1
6456164|NCT01181804|7372557|FG003|NOT COMPLETED|Period 4, Fasted (Part 2)||0
6456165|NCT01181895|7372570|FG000|STARTED|Overall Study||116
6456166|NCT01181895|7372571|FG001|STARTED|Overall Study||115
6456167|NCT01181895|7372572|FG002|STARTED|Overall Study||116
6456168|NCT01181895|7372570|FG000|COMPLETED|Overall Study||99
6456169|NCT01181895|7372571|FG001|COMPLETED|Overall Study||101
6456170|NCT01181895|7372572|FG002|COMPLETED|Overall Study||98
6456171|NCT01181895|7372570|FG000|NOT COMPLETED|Overall Study||17
6456172|NCT01181895|7372571|FG001|NOT COMPLETED|Overall Study||14
6456173|NCT01181895|7372572|FG002|NOT COMPLETED|Overall Study||18
6456174|NCT01181947|7372580|FG000|STARTED|Overall Study||100
6456175|NCT01181947|7372580|FG000|COMPLETED|Overall Study||100
6456176|NCT01181947|7372580|FG000|NOT COMPLETED|Overall Study||0
6456177|NCT01181986|7372587|FG000|STARTED|Phase 1||19
6456178|NCT01181986|7372588|FG001|STARTED|Phase 1||23
6456179|NCT01181986|7372589|FG002|STARTED|Phase 1||34
6456180|NCT01181986|7372587|FG000|Saline+Exenatide|Phase 1|N/A for this arm|0
6456181|NCT01181986|7372588|FG001|Saline+Exenatide|Phase 1|N/A for this arm|0
6456182|NCT01181986|7372589|FG002|Saline+Exenatide|Phase 1||32
6456183|NCT01181986|7372587|FG000|Saline+Placebo|Phase 1|N/A for this arm|0
6456184|NCT01181986|7372588|FG001|Saline+Placebo|Phase 1|N/A for this arm|0
6456185|NCT01181986|7372589|FG002|Saline+Placebo|Phase 1||33
6456186|NCT01181986|7372587|FG000|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
6456187|NCT01181986|7372588|FG001|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
6456188|NCT01181986|7372589|FG002|Exendin-9+Exenatide|Phase 1||33
6456189|NCT01181986|7372587|FG000|COMPLETED|Phase 1||18
6456190|NCT01181986|7372588|FG001|COMPLETED|Phase 1||22
6456191|NCT01181986|7372589|FG002|COMPLETED|Phase 1||32
6456192|NCT01181986|7372587|FG000|NOT COMPLETED|Phase 1||1
6456193|NCT01181986|7372588|FG001|NOT COMPLETED|Phase 1||1
6456194|NCT01181986|7372589|FG002|NOT COMPLETED|Phase 1||2
6456195|NCT01181986|7372587|FG000|STARTED|Phase 2||18
6456196|NCT01181986|7372588|FG001|STARTED|Phase 2||22
6456197|NCT01181986|7372589|FG002|STARTED|Phase 2|N/A for Sub-study 2|0
6456198|NCT01181986|7372587|FG000|COMPLETED|Phase 2||18
6456199|NCT01181986|7372588|FG001|COMPLETED|Phase 2||18
6456200|NCT01181986|7372589|FG002|COMPLETED|Phase 2||0
6456201|NCT01181986|7372587|FG000|NOT COMPLETED|Phase 2||0
6456202|NCT01181986|7372588|FG001|NOT COMPLETED|Phase 2||4
6456203|NCT01181986|7372589|FG002|NOT COMPLETED|Phase 2||0
6456204|NCT01182103|7372605|FG000|STARTED|Overall Study||48
6456205|NCT01182103|7372606|FG001|STARTED|Overall Study||62
6456206|NCT01182103|7372605|FG000|COMPLETED|Overall Study||48
6456207|NCT01182103|7372606|FG001|COMPLETED|Overall Study||62
6456208|NCT01182103|7372605|FG000|NOT COMPLETED|Overall Study||0
6456209|NCT01182103|7372606|FG001|NOT COMPLETED|Overall Study||0
6456210|NCT01182181|7372617|FG000|STARTED|First Intervention||11
6456211|NCT01182181|7372618|FG001|STARTED|First Intervention||11
6456212|NCT01182181|7372617|FG000|COMPLETED|First Intervention||10
6456213|NCT01182181|7372618|FG001|COMPLETED|First Intervention||11
6456214|NCT01182181|7372617|FG000|NOT COMPLETED|First Intervention||1
6456215|NCT01182181|7372618|FG001|NOT COMPLETED|First Intervention||0
6456216|NCT01182181|7372617|FG000|STARTED|Washout of 21 Days||10
6456217|NCT01182181|7372618|FG001|STARTED|Washout of 21 Days||11
6456218|NCT01182181|7372617|FG000|COMPLETED|Washout of 21 Days||10
6456219|NCT01182181|7372618|FG001|COMPLETED|Washout of 21 Days||10
6456220|NCT01182181|7372617|FG000|NOT COMPLETED|Washout of 21 Days||0
6456221|NCT01182181|7372618|FG001|NOT COMPLETED|Washout of 21 Days||1
6456222|NCT01182181|7372617|FG000|STARTED|Second Intervention||10
6456223|NCT01182181|7372618|FG001|STARTED|Second Intervention||10
6456224|NCT01182181|7372617|FG000|COMPLETED|Second Intervention||10
6456225|NCT01182181|7372618|FG001|COMPLETED|Second Intervention||10
6456226|NCT01182181|7372617|FG000|NOT COMPLETED|Second Intervention||0
6456227|NCT01182181|7372618|FG001|NOT COMPLETED|Second Intervention||0
6456228|NCT01182194|7372626|FG000|STARTED|First Intervention||16
6456229|NCT01182194|7372627|FG001|STARTED|First Intervention||16
6553642|NCT01744704|7476089|FG004|NOT COMPLETED|Overall Study||0
6553643|NCT01744704|7476090|FG005|NOT COMPLETED|Overall Study||0
6553644|NCT01744704|7476091|FG006|NOT COMPLETED|Overall Study||0
6553645|NCT01744704|7476092|FG007|NOT COMPLETED|Overall Study||0
6553646|NCT01744704|7476093|FG008|NOT COMPLETED|Overall Study||0
6553647|NCT01744704|7476094|FG009|NOT COMPLETED|Overall Study||0
6553648|NCT01744704|7476095|FG010|NOT COMPLETED|Overall Study||0
6456230|NCT01182194|7372626|FG000|COMPLETED|First Intervention||16
6456231|NCT01182194|7372627|FG001|COMPLETED|First Intervention||16
6456232|NCT01182194|7372626|FG000|NOT COMPLETED|First Intervention||0
6456233|NCT01182194|7372627|FG001|NOT COMPLETED|First Intervention||0
6456234|NCT01182194|7372626|FG000|STARTED|Washout of 28 Days||16
6553649|NCT01744704|7476096|FG011|NOT COMPLETED|Overall Study||0
6553650|NCT01744730|7476128|FG000|STARTED|Overall Study||4
6553651|NCT01744730|7476129|FG001|STARTED|Overall Study||3
6553652|NCT01744730|7476130|FG002|STARTED|Overall Study||4
6456235|NCT01182194|7372627|FG001|STARTED|Washout of 28 Days||16
6456236|NCT01182194|7372626|FG000|COMPLETED|Washout of 28 Days||15
6456237|NCT01182194|7372627|FG001|COMPLETED|Washout of 28 Days||16
6456238|NCT01182194|7372626|FG000|NOT COMPLETED|Washout of 28 Days||1
6456239|NCT01182194|7372627|FG001|NOT COMPLETED|Washout of 28 Days||0
6456240|NCT01182194|7372626|FG000|STARTED|Second Intervention||15
6456241|NCT01182194|7372627|FG001|STARTED|Second Intervention||16
6456242|NCT01182194|7372626|FG000|COMPLETED|Second Intervention||15
6456243|NCT01182194|7372627|FG001|COMPLETED|Second Intervention||16
6456244|NCT01182194|7372626|FG000|NOT COMPLETED|Second Intervention||0
6456245|NCT01182194|7372627|FG001|NOT COMPLETED|Second Intervention||0
6456246|NCT01182207|7372635|FG000|STARTED|First Intervention||18
6456247|NCT01182207|7372636|FG001|STARTED|First Intervention||15
6456248|NCT01182207|7372635|FG000|COMPLETED|First Intervention||18
6456249|NCT01182207|7372636|FG001|COMPLETED|First Intervention||14
6456250|NCT01182207|7372635|FG000|NOT COMPLETED|First Intervention||0
6456251|NCT01182207|7372636|FG001|NOT COMPLETED|First Intervention||1
6456252|NCT01182207|7372635|FG000|STARTED|Washout of 28 Days||18
6456253|NCT01182207|7372636|FG001|STARTED|Washout of 28 Days||14
6456254|NCT01182207|7372635|FG000|COMPLETED|Washout of 28 Days||18
6456255|NCT01182207|7372636|FG001|COMPLETED|Washout of 28 Days||14
6456256|NCT01182207|7372635|FG000|NOT COMPLETED|Washout of 28 Days||0
6456257|NCT01182207|7372636|FG001|NOT COMPLETED|Washout of 28 Days||0
6456258|NCT01182207|7372635|FG000|STARTED|Second Intervention||18
6456259|NCT01182207|7372636|FG001|STARTED|Second Intervention||14
6456260|NCT01182207|7372635|FG000|COMPLETED|Second Intervention||17
6456261|NCT01182207|7372636|FG001|COMPLETED|Second Intervention||14
6456262|NCT01182207|7372635|FG000|NOT COMPLETED|Second Intervention||1
6456263|NCT01182207|7372636|FG001|NOT COMPLETED|Second Intervention||0
6456264|NCT01182285|7372642|FG000|STARTED|First Intervention Week 1-10||13
6456265|NCT01182285|7372643|FG001|STARTED|First Intervention Week 1-10||0
6456266|NCT01182285|7372644|FG002|STARTED|First Intervention Week 1-10||0
6456267|NCT01182285|7372642|FG000|COMPLETED|First Intervention Week 1-10||10
6456268|NCT01182285|7372643|FG001|COMPLETED|First Intervention Week 1-10||0
6456269|NCT01182285|7372644|FG002|COMPLETED|First Intervention Week 1-10||0
6456270|NCT01182285|7372642|FG000|NOT COMPLETED|First Intervention Week 1-10||3
6456271|NCT01182285|7372643|FG001|NOT COMPLETED|First Intervention Week 1-10||0
6456272|NCT01182285|7372644|FG002|NOT COMPLETED|First Intervention Week 1-10||0
6456273|NCT01182285|7372642|FG000|STARTED|Second Intervention Week 11-17||0
6456274|NCT01182285|7372643|FG001|STARTED|Second Intervention Week 11-17||0
6456275|NCT01182285|7372644|FG002|STARTED|Second Intervention Week 11-17||0
6456276|NCT01182285|7372642|FG000|COMPLETED|Second Intervention Week 11-17||0
6456277|NCT01182285|7372643|FG001|COMPLETED|Second Intervention Week 11-17||0
6456278|NCT01182285|7372644|FG002|COMPLETED|Second Intervention Week 11-17||0
6456279|NCT01182285|7372642|FG000|NOT COMPLETED|Second Intervention Week 11-17||0
6456280|NCT01182285|7372643|FG001|NOT COMPLETED|Second Intervention Week 11-17||0
6456281|NCT01182285|7372644|FG002|NOT COMPLETED|Second Intervention Week 11-17||0
6456282|NCT01182285|7372642|FG000|STARTED|Third Intervention Week 11-52||0
6456283|NCT01182285|7372643|FG001|STARTED|Third Intervention Week 11-52||0
6456284|NCT01182285|7372644|FG002|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
6456285|NCT01182285|7372642|FG000|COMPLETED|Third Intervention Week 11-52||0
6456286|NCT01182285|7372643|FG001|COMPLETED|Third Intervention Week 11-52||0
6456287|NCT01182285|7372644|FG002|COMPLETED|Third Intervention Week 11-52||0
6456288|NCT01182285|7372642|FG000|NOT COMPLETED|Third Intervention Week 11-52||0
6456289|NCT01182285|7372643|FG001|NOT COMPLETED|Third Intervention Week 11-52||0
6456290|NCT01182285|7372644|FG002|NOT COMPLETED|Third Intervention Week 11-52||8
6456291|NCT01182298|7372651|FG000|STARTED|Overall Study||10
6456292|NCT01182298|7372651|FG000|COMPLETED|Overall Study||4
6456293|NCT01182298|7372651|FG000|NOT COMPLETED|Overall Study||6
6456294|NCT01182337|7372657|FG000|STARTED|Overall Study||22
6456295|NCT01182337|7372658|FG001|STARTED|Overall Study||9
6456296|NCT01182337|7372657|FG000|COMPLETED|Overall Study||19
6456297|NCT01182337|7372658|FG001|COMPLETED|Overall Study||7
6456298|NCT01182337|7372657|FG000|NOT COMPLETED|Overall Study||3
6456299|NCT01182337|7372658|FG001|NOT COMPLETED|Overall Study||2
6456300|NCT01182350|7372665|FG000|STARTED|Overall Study||30
6456301|NCT01182350|7372666|FG001|STARTED|Overall Study||14
6456302|NCT01182350|7372667|FG002|STARTED|Overall Study||3
6456303|NCT01182350|7372668|FG003|STARTED|Overall Study||3
6456304|NCT01182350|7372669|FG004|STARTED|Overall Study||3
6456305|NCT01182350|7372665|FG000|Underwent Stereotactic Biopsy|Overall Study||30
6456306|NCT01182350|7372666|FG001|Underwent Stereotactic Biopsy|Overall Study||14
6456307|NCT01182350|7372667|FG002|Underwent Stereotactic Biopsy|Overall Study||3
6456308|NCT01182350|7372668|FG003|Underwent Stereotactic Biopsy|Overall Study||3
6456309|NCT01182350|7372669|FG004|Underwent Stereotactic Biopsy|Overall Study||0
6456310|NCT01182350|7372665|FG000|Started Assigned Chemoradiation|Overall Study||27
6456311|NCT01182350|7372666|FG001|Started Assigned Chemoradiation|Overall Study||14
6456312|NCT01182350|7372667|FG002|Started Assigned Chemoradiation|Overall Study||2
6456313|NCT01182350|7372668|FG003|Started Assigned Chemoradiation|Overall Study||2
6456314|NCT01182350|7372669|FG004|Started Assigned Chemoradiation|Overall Study||0
6456315|NCT01182350|7372665|FG000|COMPLETED|Overall Study||3
6456316|NCT01182350|7372666|FG001|COMPLETED|Overall Study||0
6456317|NCT01182350|7372667|FG002|COMPLETED|Overall Study||0
6456318|NCT01182350|7372668|FG003|COMPLETED|Overall Study||0
6456319|NCT01182350|7372669|FG004|COMPLETED|Overall Study||0
6456320|NCT01182350|7372665|FG000|NOT COMPLETED|Overall Study||27
6456321|NCT01182350|7372666|FG001|NOT COMPLETED|Overall Study||14
6456322|NCT01182350|7372667|FG002|NOT COMPLETED|Overall Study||3
6456323|NCT01182350|7372668|FG003|NOT COMPLETED|Overall Study||3
6456324|NCT01182350|7372669|FG004|NOT COMPLETED|Overall Study||3
6456325|NCT01182376|7372687|FG000|STARTED|Overall Study||15
6456326|NCT01182376|7372688|FG001|STARTED|Overall Study||18
6456327|NCT01182376|7372687|FG000|COMPLETED|Overall Study||4
6456328|NCT01182376|7372688|FG001|COMPLETED|Overall Study||13
6456329|NCT01182376|7372687|FG000|NOT COMPLETED|Overall Study||11
6456330|NCT01182376|7372688|FG001|NOT COMPLETED|Overall Study||5
6456331|NCT01182415|7372694|FG000|STARTED|Overall Study||30
6456332|NCT01182415|7372694|FG000|COMPLETED|Overall Study||29
6456333|NCT01182415|7372694|FG000|NOT COMPLETED|Overall Study||1
6745232|NCT03358290|7673335|FG004|STARTED|Overall Study||2
6745233|NCT03358290|7673331|FG000|COMPLETED|Overall Study||2
6745234|NCT03358290|7673332|FG001|COMPLETED|Overall Study||2
6745235|NCT03358290|7673333|FG002|COMPLETED|Overall Study||1
6745236|NCT03358290|7673334|FG003|COMPLETED|Overall Study||1
6745237|NCT03358290|7673335|FG004|COMPLETED|Overall Study||1
6745238|NCT03358290|7673331|FG000|NOT COMPLETED|Overall Study||0
6745239|NCT03358290|7673332|FG001|NOT COMPLETED|Overall Study||1
6745240|NCT03358290|7673333|FG002|NOT COMPLETED|Overall Study||2
6745241|NCT03358290|7673334|FG003|NOT COMPLETED|Overall Study||2
6745242|NCT03358290|7673335|FG004|NOT COMPLETED|Overall Study||1
6745243|NCT03358329|7673347|FG000|STARTED|Overall Study||50
6745244|NCT03358329|7673347|FG000|COMPLETED|Overall Study||46
6745245|NCT03358329|7673347|FG000|NOT COMPLETED|Overall Study||4
6745246|NCT03358355|7673353|FG000|STARTED|Overall Study||9
6745247|NCT03358355|7673353|FG000|COMPLETED|Overall Study||9
6745248|NCT03358355|7673353|FG000|NOT COMPLETED|Overall Study||0
6745249|NCT03358407|7673372|FG000|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745250|NCT03358407|7673373|FG001|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745251|NCT03358407|7673374|FG002|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745252|NCT03358407|7673375|FG003|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745253|NCT03358407|7673376|FG004|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745254|NCT03358407|7673377|FG005|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745255|NCT03358407|7673378|FG006|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745256|NCT03358407|7673379|FG007|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745257|NCT03358407|7673380|FG008|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745258|NCT03358407|7673381|FG009|STARTED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745259|NCT03358407|7673372|FG000|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745260|NCT03358407|7673373|FG001|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745261|NCT03358407|7673374|FG002|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745262|NCT03358407|7673375|FG003|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745263|NCT03358407|7673376|FG004|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||2
6745264|NCT03358407|7673377|FG005|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745265|NCT03358407|7673378|FG006|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745266|NCT03358407|7673379|FG007|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745267|NCT03358407|7673380|FG008|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745268|NCT03358407|7673381|FG009|COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745269|NCT03358407|7673372|FG000|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745270|NCT03358407|7673373|FG001|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745271|NCT03358407|7673374|FG002|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745272|NCT03358407|7673375|FG003|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745273|NCT03358407|7673376|FG004|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745274|NCT03358407|7673377|FG005|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745275|NCT03358407|7673378|FG006|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745276|NCT03358407|7673379|FG007|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6456334|NCT01182428|7372700|FG000|STARTED|Overall Study||304
6456335|NCT01182428|7372701|FG001|STARTED|Overall Study||151
6456336|NCT01182428|7372700|FG000|COMPLETED|Overall Study||293
6456337|NCT01182428|7372701|FG001|COMPLETED|Overall Study||150
6456338|NCT01182428|7372700|FG000|NOT COMPLETED|Overall Study||11
6456339|NCT01182428|7372701|FG001|NOT COMPLETED|Overall Study||1
6456340|NCT01182441|7372709|FG000|STARTED|Overall Study||269
6456341|NCT01182441|7372710|FG001|STARTED|Overall Study||138
6456342|NCT01182441|7372709|FG000|COMPLETED|Overall Study||49
6456343|NCT01182441|7372710|FG001|COMPLETED|Overall Study||19
6456344|NCT01182441|7372709|FG000|NOT COMPLETED|Overall Study||220
6456345|NCT01182441|7372710|FG001|NOT COMPLETED|Overall Study||119
6456346|NCT01182480|7372716|FG000|STARTED|Overall Study||47
6456347|NCT01182480|7372716|FG000|COMPLETED|Overall Study||47
6456348|NCT01182480|7372716|FG000|NOT COMPLETED|Overall Study||0
6456349|NCT01182493|7372722|FG000|STARTED|Overall Study||168
6456350|NCT01182493|7372723|FG001|STARTED|Overall Study||163
6456351|NCT01182493|7372722|FG000|COMPLETED|Overall Study||152
6456352|NCT01182493|7372723|FG001|COMPLETED|Overall Study||156
6456353|NCT01182493|7372722|FG000|NOT COMPLETED|Overall Study||16
6456354|NCT01182493|7372723|FG001|NOT COMPLETED|Overall Study||7
6456355|NCT01182675|7372731|FG000|STARTED|Overall Study||7
6456356|NCT01182675|7372732|FG001|STARTED|Overall Study||0
6745277|NCT03358407|7673380|FG008|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745278|NCT03358407|7673381|FG009|NOT COMPLETED|P1:PartA-Cohort1(4days)+Washout(48hours)||0
6745279|NCT03358407|7673372|FG000|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6745280|NCT03358407|7673373|FG001|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6456357|NCT01182675|7372731|FG000|COMPLETED|Overall Study||7
6456358|NCT01182675|7372732|FG001|COMPLETED|Overall Study||0
6456359|NCT01182675|7372731|FG000|NOT COMPLETED|Overall Study||0
6456360|NCT01182675|7372732|FG001|NOT COMPLETED|Overall Study||0
6456361|NCT01182805|7372740|FG000|STARTED|Overall Study||50
6456362|NCT01182805|7372740|FG000|COMPLETED|Overall Study||50
6456363|NCT01182805|7372740|FG000|NOT COMPLETED|Overall Study||0
6456364|NCT01182844|7372748|FG000|STARTED|Overall Study||15
6456365|NCT01182844|7372749|FG001|STARTED|Overall Study||15
6456366|NCT01182844|7372748|FG000|COMPLETED|Overall Study||15
6456367|NCT01182844|7372749|FG001|COMPLETED|Overall Study||13
6456368|NCT01182844|7372748|FG000|NOT COMPLETED|Overall Study||0
6456369|NCT01182844|7372749|FG001|NOT COMPLETED|Overall Study||2
6456370|NCT01183013|7372762|FG000|STARTED|Overall Study||131
6456371|NCT01183013|7372763|FG001|STARTED|Overall Study||140
6456372|NCT01183013|7372764|FG002|STARTED|Overall Study||138
6456373|NCT01183013|7372765|FG003|STARTED|Overall Study||135
6456374|NCT01183013|7372766|FG004|STARTED|Overall Study||126
6456375|NCT01183013|7372767|FG005|STARTED|Overall Study||133
6456376|NCT01183013|7372768|FG006|STARTED|Overall Study||133
6456377|NCT01183013|7372762|FG000|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
6456378|NCT01183013|7372763|FG001|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
6456379|NCT01183013|7372764|FG002|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
6456380|NCT01183013|7372765|FG003|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
6456381|NCT01183013|7372766|FG004|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
6456382|NCT01183013|7372767|FG005|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
6456383|NCT01183013|7372768|FG006|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
6456384|NCT01183013|7372762|FG000|NOT COMPLETED|Overall Study||45
6456385|NCT01183013|7372763|FG001|NOT COMPLETED|Overall Study||39
6456386|NCT01183013|7372764|FG002|NOT COMPLETED|Overall Study||41
6456387|NCT01183013|7372765|FG003|NOT COMPLETED|Overall Study||30
6456388|NCT01183013|7372766|FG004|NOT COMPLETED|Overall Study||36
6456389|NCT01183013|7372767|FG005|NOT COMPLETED|Overall Study||45
6456390|NCT01183013|7372768|FG006|NOT COMPLETED|Overall Study||37
6456391|NCT01183065|7372785|FG000|STARTED|Overall Study||13
6456392|NCT01183065|7372785|FG000|COMPLETED|Overall Study||12
6456393|NCT01183065|7372785|FG000|NOT COMPLETED|Overall Study||1
6456394|NCT01183104|7372791|FG000|STARTED|Overall Study||153
6456395|NCT01183104|7372792|FG001|STARTED|Overall Study||152
6456396|NCT01183104|7372791|FG000|Received Study Drug|Overall Study||148
6456397|NCT01183104|7372792|FG001|Received Study Drug|Overall Study||143
6456398|NCT01183104|7372791|FG000|Continued Treatment for 12 Weeks|Overall Study||143
6456399|NCT01183104|7372792|FG001|Continued Treatment for 12 Weeks|Overall Study||129
6456400|NCT01183104|7372791|FG000|Completed 52-week Treatment|Overall Study||119
6456401|NCT01183104|7372792|FG001|Completed 52-week Treatment|Overall Study||111
6456402|NCT01183104|7372791|FG000|Enrolled in Extension Study|Overall Study||80
6456403|NCT01183104|7372792|FG001|Enrolled in Extension Study|Overall Study||61
6456404|NCT01183104|7372791|FG000|COMPLETED|Overall Study||76
6456405|NCT01183104|7372792|FG001|COMPLETED|Overall Study||60
6456406|NCT01183104|7372791|FG000|NOT COMPLETED|Overall Study||77
6456407|NCT01183104|7372792|FG001|NOT COMPLETED|Overall Study||92
6456408|NCT01183143|7372798|FG000|STARTED|Overall Study||215
6456409|NCT01183143|7372798|FG000|Intention to Treat (ITT) Population|Overall Study|ITT=Subjects who received at least 1 dose of the investigational medicinal product (IMP).|204
6456410|NCT01183143|7372798|FG000|COMPLETED|Overall Study||65
6456411|NCT01183143|7372798|FG000|NOT COMPLETED|Overall Study||150
6553653|NCT01744730|7476131|FG003|STARTED|Overall Study||11
6553654|NCT01744730|7476132|FG004|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
6553655|NCT01744730|7476128|FG000|COMPLETED|Overall Study||4
6553656|NCT01744730|7476129|FG001|COMPLETED|Overall Study||3
6553657|NCT01744730|7476130|FG002|COMPLETED|Overall Study||4
6553658|NCT01744730|7476131|FG003|COMPLETED|Overall Study||11
6553659|NCT01744730|7476132|FG004|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
6553660|NCT01744730|7476128|FG000|NOT COMPLETED|Overall Study||0
6553661|NCT01744730|7476129|FG001|NOT COMPLETED|Overall Study||0
6553662|NCT01744730|7476130|FG002|NOT COMPLETED|Overall Study||0
6553663|NCT01744730|7476131|FG003|NOT COMPLETED|Overall Study||0
6553664|NCT01744730|7476132|FG004|NOT COMPLETED|Overall Study||0
6553665|NCT01744782|7476145|FG000|STARTED|Overall Study||17
6553666|NCT01744782|7476145|FG000|COMPLETED|Overall Study||16
6553667|NCT01744782|7476145|FG000|NOT COMPLETED|Overall Study||1
6553668|NCT01744821|7476153|FG000|STARTED|Overall Study||1
6553669|NCT01744821|7476154|FG001|STARTED|Overall Study||3
6553670|NCT01744821|7476155|FG002|STARTED|Overall Study||2
6553671|NCT01744821|7476156|FG003|STARTED|Overall Study||1
6553672|NCT01744821|7476153|FG000|COMPLETED|Overall Study||1
6456412|NCT01183169|7372806|FG000|STARTED|Main Phase||121
6553673|NCT01744821|7476154|FG001|COMPLETED|Overall Study||3
6553674|NCT01744821|7476155|FG002|COMPLETED|Overall Study||2
6553675|NCT01744821|7476156|FG003|COMPLETED|Overall Study||1
6553676|NCT01744821|7476153|FG000|NOT COMPLETED|Overall Study||0
6553677|NCT01744821|7476154|FG001|NOT COMPLETED|Overall Study||0
6553678|NCT01744821|7476155|FG002|NOT COMPLETED|Overall Study||0
6553679|NCT01744821|7476156|FG003|NOT COMPLETED|Overall Study||0
6553680|NCT01744860|7476166|FG000|STARTED|Overall Study||420
6553681|NCT01744860|7476166|FG000|COMPLETED|Overall Study||420
6456413|NCT01183169|7372807|FG001|STARTED|Main Phase||115
6456414|NCT01183169|7372808|FG002|STARTED|Main Phase||59
6456415|NCT01183169|7372809|FG003|STARTED|Main Phase||55
6456416|NCT01183169|7372810|FG004|STARTED|Main Phase||109
6456417|NCT01183169|7372811|FG005|STARTED|Main Phase||0
6456418|NCT01183169|7372812|FG006|STARTED|Main Phase||0
6456419|NCT01183169|7372806|FG000|Completed Treatment|Main Phase||72
6456420|NCT01183169|7372807|FG001|Completed Treatment|Main Phase||78
6456421|NCT01183169|7372808|FG002|Completed Treatment|Main Phase||17
6456422|NCT01183169|7372809|FG003|Completed Treatment|Main Phase||17
6456423|NCT01183169|7372810|FG004|Completed Treatment|Main Phase||77
6456424|NCT01183169|7372811|FG005|Completed Treatment|Main Phase||0
6456425|NCT01183169|7372812|FG006|Completed Treatment|Main Phase||0
6456426|NCT01183169|7372806|FG000|Switched to ALV|Main Phase||0
6456427|NCT01183169|7372807|FG001|Switched to ALV|Main Phase||0
6456428|NCT01183169|7372808|FG002|Switched to ALV|Main Phase||35
6456429|NCT01183169|7372809|FG003|Switched to ALV|Main Phase||30
6456430|NCT01183169|7372810|FG004|Switched to ALV|Main Phase||0
6456431|NCT01183169|7372811|FG005|Switched to ALV|Main Phase||0
6456432|NCT01183169|7372812|FG006|Switched to ALV|Main Phase||0
6456433|NCT01183169|7372806|FG000|COMPLETED|Main Phase||94
6456434|NCT01183169|7372807|FG001|COMPLETED|Main Phase||93
6456435|NCT01183169|7372808|FG002|COMPLETED|Main Phase||18
6456436|NCT01183169|7372809|FG003|COMPLETED|Main Phase||18
6456437|NCT01183169|7372810|FG004|COMPLETED|Main Phase||83
6456438|NCT01183169|7372811|FG005|COMPLETED|Main Phase||0
6456439|NCT01183169|7372812|FG006|COMPLETED|Main Phase||0
6456440|NCT01183169|7372806|FG000|NOT COMPLETED|Main Phase||27
6456441|NCT01183169|7372807|FG001|NOT COMPLETED|Main Phase||22
6456442|NCT01183169|7372808|FG002|NOT COMPLETED|Main Phase||41
6456443|NCT01183169|7372809|FG003|NOT COMPLETED|Main Phase||37
6456444|NCT01183169|7372810|FG004|NOT COMPLETED|Main Phase||26
6456445|NCT01183169|7372811|FG005|NOT COMPLETED|Main Phase||0
6456446|NCT01183169|7372812|FG006|NOT COMPLETED|Main Phase||0
6456447|NCT01183169|7372806|FG000|STARTED|Post-switch Phase|Not a post-switch group|0
6456448|NCT01183169|7372807|FG001|STARTED|Post-switch Phase|Not a post-switch group|0
6456449|NCT01183169|7372808|FG002|STARTED|Post-switch Phase|Not a post-switch group|0
6456450|NCT01183169|7372809|FG003|STARTED|Post-switch Phase|Not a post-switch group|0
6456451|NCT01183169|7372810|FG004|STARTED|Post-switch Phase|Not a post-switch group|0
6456452|NCT01183169|7372811|FG005|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
6456453|NCT01183169|7372812|FG006|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
6456454|NCT01183169|7372806|FG000|Completed Treatment|Post-switch Phase||0
6456455|NCT01183169|7372807|FG001|Completed Treatment|Post-switch Phase||0
6456456|NCT01183169|7372808|FG002|Completed Treatment|Post-switch Phase||0
6456457|NCT01183169|7372809|FG003|Completed Treatment|Post-switch Phase||0
6456458|NCT01183169|7372810|FG004|Completed Treatment|Post-switch Phase||0
6456459|NCT01183169|7372811|FG005|Completed Treatment|Post-switch Phase||12
6456460|NCT01183169|7372812|FG006|Completed Treatment|Post-switch Phase||13
6456461|NCT01183169|7372806|FG000|COMPLETED|Post-switch Phase||0
6456462|NCT01183169|7372807|FG001|COMPLETED|Post-switch Phase||0
6456463|NCT01183169|7372808|FG002|COMPLETED|Post-switch Phase||0
6456464|NCT01183169|7372809|FG003|COMPLETED|Post-switch Phase||0
6456465|NCT01183169|7372810|FG004|COMPLETED|Post-switch Phase||0
6456466|NCT01183169|7372811|FG005|COMPLETED|Post-switch Phase||21
6456467|NCT01183169|7372812|FG006|COMPLETED|Post-switch Phase||21
6456468|NCT01183169|7372806|FG000|NOT COMPLETED|Post-switch Phase||0
6456469|NCT01183169|7372807|FG001|NOT COMPLETED|Post-switch Phase||0
6456470|NCT01183169|7372808|FG002|NOT COMPLETED|Post-switch Phase||0
6456471|NCT01183169|7372809|FG003|NOT COMPLETED|Post-switch Phase||0
6456472|NCT01183169|7372810|FG004|NOT COMPLETED|Post-switch Phase||0
6456473|NCT01183169|7372811|FG005|NOT COMPLETED|Post-switch Phase||14
6456474|NCT01183169|7372812|FG006|NOT COMPLETED|Post-switch Phase||9
6456475|NCT01183234|7372832|FG000|STARTED|First Intervention||14
6456476|NCT01183234|7372833|FG001|STARTED|First Intervention||14
6456477|NCT01183234|7372832|FG000|COMPLETED|First Intervention||13
6456478|NCT01183234|7372833|FG001|COMPLETED|First Intervention||14
6456479|NCT01183234|7372832|FG000|NOT COMPLETED|First Intervention||1
6456480|NCT01183234|7372833|FG001|NOT COMPLETED|First Intervention||0
6456481|NCT01183234|7372832|FG000|STARTED|Washout||13
6456482|NCT01183234|7372833|FG001|STARTED|Washout||14
6456483|NCT01183234|7372832|FG000|COMPLETED|Washout||13
6456484|NCT01183234|7372833|FG001|COMPLETED|Washout||14
6456485|NCT01183234|7372832|FG000|NOT COMPLETED|Washout||0
6456486|NCT01183234|7372833|FG001|NOT COMPLETED|Washout||0
6456487|NCT01183234|7372832|FG000|STARTED|Second Intervention||13
6456488|NCT01183234|7372833|FG001|STARTED|Second Intervention||14
6456489|NCT01183234|7372832|FG000|COMPLETED|Second Intervention||13
6456490|NCT01183234|7372833|FG001|COMPLETED|Second Intervention||14
6456491|NCT01183234|7372832|FG000|NOT COMPLETED|Second Intervention||0
6456492|NCT01183234|7372833|FG001|NOT COMPLETED|Second Intervention||0
6456493|NCT01183260|7372841|FG000|STARTED|Overall Study||14
6456494|NCT01183260|7372842|FG001|STARTED|Overall Study||11
6456495|NCT01183260|7372841|FG000|COMPLETED|Overall Study||10
6456496|NCT01183260|7372842|FG001|COMPLETED|Overall Study||9
6456497|NCT01183260|7372841|FG000|NOT COMPLETED|Overall Study||4
6456498|NCT01183260|7372842|FG001|NOT COMPLETED|Overall Study||2
6456499|NCT01183312|7372850|FG000|STARTED|First Intervention Day||5
6456500|NCT01183312|7372851|FG001|STARTED|First Intervention Day||5
6456501|NCT01183312|7372850|FG000|COMPLETED|First Intervention Day||5
6456502|NCT01183312|7372851|FG001|COMPLETED|First Intervention Day||5
6456503|NCT01183312|7372850|FG000|NOT COMPLETED|First Intervention Day||0
6456504|NCT01183312|7372851|FG001|NOT COMPLETED|First Intervention Day||0
6456505|NCT01183312|7372850|FG000|STARTED|Washout Period of at Least 1 Week||5
6456506|NCT01183312|7372851|FG001|STARTED|Washout Period of at Least 1 Week||5
6456507|NCT01183312|7372850|FG000|COMPLETED|Washout Period of at Least 1 Week||5
6456508|NCT01183312|7372851|FG001|COMPLETED|Washout Period of at Least 1 Week||5
6456509|NCT01183312|7372850|FG000|NOT COMPLETED|Washout Period of at Least 1 Week||0
6456510|NCT01183312|7372851|FG001|NOT COMPLETED|Washout Period of at Least 1 Week||0
6456511|NCT01183312|7372850|FG000|STARTED|Second Intervention Day||5
6456512|NCT01183312|7372851|FG001|STARTED|Second Intervention Day||5
6456513|NCT01183312|7372850|FG000|COMPLETED|Second Intervention Day||5
6456514|NCT01183312|7372851|FG001|COMPLETED|Second Intervention Day||5
6456515|NCT01183312|7372850|FG000|NOT COMPLETED|Second Intervention Day||0
6456516|NCT01183312|7372851|FG001|NOT COMPLETED|Second Intervention Day||0
6456517|NCT01183390|7372859|FG000|STARTED|First Intervention||11
6456518|NCT01183390|7372860|FG001|STARTED|First Intervention||11
6456519|NCT01183390|7372859|FG000|COMPLETED|First Intervention||11
6456520|NCT01183390|7372860|FG001|COMPLETED|First Intervention||10
6456521|NCT01183390|7372859|FG000|NOT COMPLETED|First Intervention||0
6456522|NCT01183390|7372860|FG001|NOT COMPLETED|First Intervention||1
6456523|NCT01183390|7372859|FG000|STARTED|Washout of 21 Days||11
6456524|NCT01183390|7372860|FG001|STARTED|Washout of 21 Days||10
6456525|NCT01183390|7372859|FG000|COMPLETED|Washout of 21 Days||11
6456526|NCT01183390|7372860|FG001|COMPLETED|Washout of 21 Days||10
6456527|NCT01183390|7372859|FG000|NOT COMPLETED|Washout of 21 Days||0
6456528|NCT01183390|7372860|FG001|NOT COMPLETED|Washout of 21 Days||0
6456529|NCT01183390|7372859|FG000|STARTED|Second Intervention||11
6456530|NCT01183390|7372860|FG001|STARTED|Second Intervention||10
6456531|NCT01183390|7372859|FG000|COMPLETED|Second Intervention||11
6456532|NCT01183390|7372860|FG001|COMPLETED|Second Intervention||10
6456533|NCT01183390|7372859|FG000|NOT COMPLETED|Second Intervention||0
6456534|NCT01183390|7372860|FG001|NOT COMPLETED|Second Intervention||0
6456535|NCT01183481|7372866|FG000|STARTED|Overall Study||19
6456536|NCT01183481|7372866|FG000|COMPLETED|Overall Study||19
6456537|NCT01183481|7372866|FG000|NOT COMPLETED|Overall Study||0
6456538|NCT01183533|7372871|FG000|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
6456539|NCT01183533|7372871|FG000|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
6456540|NCT01183533|7372871|FG000|NOT COMPLETED|Overall Study||0
6456541|NCT01183546|7372875|FG000|STARTED|Overall Study||53
6456542|NCT01183546|7372875|FG000|COMPLETED|Overall Study||53
6456543|NCT01183546|7372875|FG000|NOT COMPLETED|Overall Study||0
6456544|NCT01183559|7372880|FG000|STARTED|Overall Study||9
6456545|NCT01183559|7372880|FG000|COMPLETED|Overall Study||9
6456546|NCT01183559|7372880|FG000|NOT COMPLETED|Overall Study||0
6456547|NCT01183650|7372887|FG000|STARTED|Overall Study||12
6456548|NCT01183650|7372888|FG001|STARTED|Overall Study||12
6456549|NCT01183650|7372887|FG000|COMPLETED|Overall Study||12
6456550|NCT01183650|7372888|FG001|COMPLETED|Overall Study||12
6456551|NCT01183650|7372887|FG000|NOT COMPLETED|Overall Study||0
6456552|NCT01183650|7372888|FG001|NOT COMPLETED|Overall Study||0
6456553|NCT01183689|7372897|FG000|STARTED|Overall Study||202
6456554|NCT01183689|7372898|FG001|STARTED|Overall Study||200
6456555|NCT01183689|7372899|FG002|STARTED|Overall Study||197
6456556|NCT01183689|7372897|FG000|Month 4 Visit|Overall Study||197
6456557|NCT01183689|7372898|FG001|Month 4 Visit|Overall Study||192
6456558|NCT01183689|7372899|FG002|Month 4 Visit|Overall Study||187
6456559|NCT01183689|7372897|FG000|Year 1 Visit|Overall Study||187
6456560|NCT01183689|7372898|FG001|Year 1 Visit|Overall Study||172
6456561|NCT01183689|7372899|FG002|Year 1 Visit|Overall Study||183
6456562|NCT01183689|7372897|FG000|Year 2 Visit|Overall Study||178
6456563|NCT01183689|7372898|FG001|Year 2 Visit|Overall Study||172
6456564|NCT01183689|7372899|FG002|Year 2 Visit|Overall Study||174
6456565|NCT01183689|7372897|FG000|Year 3 Visit|Overall Study||139
6456566|NCT01183689|7372898|FG001|Year 3 Visit|Overall Study||125
6456567|NCT01183689|7372899|FG002|Year 3 Visit|Overall Study||126
6456568|NCT01183689|7372897|FG000|Year 4 Visit|Overall Study||38
6553682|NCT01744860|7476166|FG000|NOT COMPLETED|Overall Study||0
6553683|NCT01744977|7476180|FG000|STARTED|Overall Study||120
6553684|NCT01744977|7476181|FG001|STARTED|Overall Study||120
6553685|NCT01744977|7476180|FG000|6 Month Completed|Overall Study||113
6553686|NCT01744977|7476181|FG001|6 Month Completed|Overall Study||115
6553687|NCT01744977|7476180|FG000|COMPLETED|Overall Study||109
6553688|NCT01744977|7476181|FG001|COMPLETED|Overall Study||115
6553689|NCT01744977|7476180|FG000|NOT COMPLETED|Overall Study||11
6553690|NCT01744977|7476181|FG001|NOT COMPLETED|Overall Study||5
6553691|NCT01745055|7476187|FG000|STARTED|Overall Study||12
6553692|NCT01745055|7476187|FG000|COMPLETED|Overall Study||12
6553693|NCT01745055|7476187|FG000|NOT COMPLETED|Overall Study||0
6553694|NCT01745094|7476200|FG000|STARTED|Overall Study||35
6553695|NCT01745094|7476201|FG001|STARTED|Overall Study||37
6456569|NCT01183689|7372898|FG001|Year 4 Visit|Overall Study||33
6456570|NCT01183689|7372899|FG002|Year 4 Visit|Overall Study||30
6456571|NCT01183689|7372897|FG000|COMPLETED|Overall Study||202
6456572|NCT01183689|7372898|FG001|COMPLETED|Overall Study||200
6456573|NCT01183689|7372899|FG002|COMPLETED|Overall Study||197
6456574|NCT01183689|7372897|FG000|NOT COMPLETED|Overall Study||0
6456575|NCT01183689|7372898|FG001|NOT COMPLETED|Overall Study||0
6456576|NCT01183689|7372899|FG002|NOT COMPLETED|Overall Study||0
6553696|NCT01745094|7476202|FG002|STARTED|Overall Study||58
6456577|NCT01183728|7372909|FG000|STARTED|Overall Study||12
6456578|NCT01183728|7372909|FG000|COMPLETED|Overall Study||12
6456579|NCT01183728|7372909|FG000|NOT COMPLETED|Overall Study||0
6456580|NCT01183780|7372915|FG000|STARTED|Overall Study||536
6456581|NCT01183780|7372916|FG001|STARTED|Overall Study||536
6456582|NCT01183780|7372915|FG000|Received at Least 1 Dose of Study Drug|Overall Study||528
6456583|NCT01183780|7372916|FG001|Received at Least 1 Dose of Study Drug|Overall Study||529
6456584|NCT01183780|7372915|FG000|COMPLETED|Overall Study||505
6456585|NCT01183780|7372916|FG001|COMPLETED|Overall Study||511
6456586|NCT01183780|7372915|FG000|NOT COMPLETED|Overall Study||31
6456587|NCT01183780|7372916|FG001|NOT COMPLETED|Overall Study||25
6456588|NCT01183858|7372924|FG000|STARTED|Overall Study||154
6456589|NCT01183858|7372925|FG001|STARTED|Overall Study||159
6456590|NCT01183858|7372924|FG000|Safety Population|Overall Study||154
6456591|NCT01183858|7372925|FG001|Safety Population|Overall Study||158
6456592|NCT01183858|7372924|FG000|COMPLETED|Overall Study||1
6456593|NCT01183858|7372925|FG001|COMPLETED|Overall Study||3
6456594|NCT01183858|7372924|FG000|NOT COMPLETED|Overall Study||153
6456595|NCT01183858|7372925|FG001|NOT COMPLETED|Overall Study||156
6456596|NCT01183923|7372931|FG000|STARTED|Intervention 1 (7 Days)||1
6456597|NCT01183923|7372932|FG001|STARTED|Intervention 1 (7 Days)||0
6456598|NCT01183923|7372931|FG000|COMPLETED|Intervention 1 (7 Days)||1
6456599|NCT01183923|7372932|FG001|COMPLETED|Intervention 1 (7 Days)||0
6456600|NCT01183923|7372931|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
6456601|NCT01183923|7372932|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
6456602|NCT01183923|7372931|FG000|STARTED|Washout (14 Days)||1
6456603|NCT01183923|7372932|FG001|STARTED|Washout (14 Days)||0
6654390|NCT02445196|7584184|FG000|NOT COMPLETED|Overall Study||11
6654391|NCT02445196|7584185|FG001|NOT COMPLETED|Overall Study||6
6654392|NCT02445287|7584193|FG000|STARTED|Overall Study||35
6456604|NCT01183923|7372931|FG000|COMPLETED|Washout (14 Days)||1
6456605|NCT01183923|7372932|FG001|COMPLETED|Washout (14 Days)||0
6456606|NCT01183923|7372931|FG000|NOT COMPLETED|Washout (14 Days)||0
6456607|NCT01183923|7372932|FG001|NOT COMPLETED|Washout (14 Days)||0
6456608|NCT01183923|7372931|FG000|STARTED|Intervention 2 (7 Days)||1
6456609|NCT01183923|7372932|FG001|STARTED|Intervention 2 (7 Days)||0
6456610|NCT01183923|7372931|FG000|COMPLETED|Intervention 2 (7 Days)||1
6456611|NCT01183923|7372932|FG001|COMPLETED|Intervention 2 (7 Days)||0
6456612|NCT01183923|7372931|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
6456613|NCT01183923|7372932|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
6456614|NCT01183975|7372937|FG000|STARTED|Overall Study||517
6456615|NCT01183975|7372937|FG000|COMPLETED|Overall Study||444
6456616|NCT01183975|7372937|FG000|NOT COMPLETED|Overall Study||73
6456617|NCT01184014|7372943|FG000|STARTED|Overall Study||35
6456618|NCT01184014|7372944|FG001|STARTED|Overall Study||37
6456619|NCT01184014|7372943|FG000|COMPLETED|Overall Study||30
6456620|NCT01184014|7372944|FG001|COMPLETED|Overall Study||31
6456621|NCT01184014|7372943|FG000|NOT COMPLETED|Overall Study||5
6456622|NCT01184014|7372944|FG001|NOT COMPLETED|Overall Study||6
6456623|NCT01184053|7372950|FG000|STARTED|Overall Study||3
6456624|NCT01184053|7372950|FG000|COMPLETED|Overall Study||0
6456625|NCT01184053|7372950|FG000|NOT COMPLETED|Overall Study||3
6456626|NCT01184079|7372957|FG000|STARTED|Overall Study||111
6456627|NCT01184079|7372958|FG001|STARTED|Overall Study||109
6456628|NCT01184079|7372957|FG000|Dose 2|Overall Study||110
6456629|NCT01184079|7372958|FG001|Dose 2|Overall Study||108
6456630|NCT01184079|7372957|FG000|Dose 3|Overall Study||101
6456631|NCT01184079|7372958|FG001|Dose 3|Overall Study||107
6456632|NCT01184079|7372957|FG000|Final Blood Draw|Overall Study||97
6456633|NCT01184079|7372958|FG001|Final Blood Draw|Overall Study||107
6456634|NCT01184079|7372957|FG000|COMPLETED|Overall Study||97
6456635|NCT01184079|7372958|FG001|COMPLETED|Overall Study||107
6456636|NCT01184079|7372957|FG000|NOT COMPLETED|Overall Study||14
6456637|NCT01184079|7372958|FG001|NOT COMPLETED|Overall Study||2
6456638|NCT01184118|7372966|FG000|STARTED|Overall Study||36
6456639|NCT01184118|7372966|FG000|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
6456640|NCT01184118|7372966|FG000|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
6456641|NCT01184118|7372966|FG000|FP MDI as Indicated (2 Weeks)|Overall Study||18
6456642|NCT01184118|7372966|FG000|COMPLETED|Overall Study||18
6456643|NCT01184118|7372966|FG000|NOT COMPLETED|Overall Study||18
6456644|NCT01184326|7372973|FG000|STARTED|Overall Study||3
6456645|NCT01184326|7372974|FG001|STARTED|Overall Study||6
6456646|NCT01184326|7372975|FG002|STARTED|Overall Study||14
6456647|NCT01184326|7372973|FG000|COMPLETED|Overall Study||0
6456648|NCT01184326|7372974|FG001|COMPLETED|Overall Study||0
6456649|NCT01184326|7372975|FG002|COMPLETED|Overall Study||0
6456650|NCT01184326|7372973|FG000|NOT COMPLETED|Overall Study||3
6456651|NCT01184326|7372974|FG001|NOT COMPLETED|Overall Study||6
6456652|NCT01184326|7372975|FG002|NOT COMPLETED|Overall Study||14
6456653|NCT01184417|7372988|FG000|STARTED|Overall Study||51
6456654|NCT01184417|7372989|FG001|STARTED|Overall Study||51
6456655|NCT01184417|7372988|FG000|COMPLETED|Overall Study||51
6456656|NCT01184417|7372989|FG001|COMPLETED|Overall Study||51
6456657|NCT01184417|7372988|FG000|NOT COMPLETED|Overall Study||0
6456658|NCT01184417|7372989|FG001|NOT COMPLETED|Overall Study||0
6456659|NCT01184508|7372997|FG000|STARTED|Overall Study||45
6456660|NCT01184508|7372998|FG001|STARTED|Overall Study||42
6456661|NCT01184508|7372997|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
6456662|NCT01184508|7372998|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
6654393|NCT02445287|7584194|FG001|STARTED|Overall Study||13
6456663|NCT01184508|7372997|FG000|COMPLETED|Overall Study||29
6456664|NCT01184508|7372998|FG001|COMPLETED|Overall Study||27
6456665|NCT01184508|7372997|FG000|NOT COMPLETED|Overall Study||16
6456666|NCT01184508|7372998|FG001|NOT COMPLETED|Overall Study||15
6456667|NCT01184755|7373008|FG000|STARTED|Overall Study||126
6456668|NCT01184755|7373009|FG001|STARTED|Overall Study||65
6456669|NCT01184755|7373010|FG002|STARTED|Overall Study||62
6456670|NCT01184755|7373008|FG000|COMPLETED|Overall Study||101
6456671|NCT01184755|7373009|FG001|COMPLETED|Overall Study||54
6456672|NCT01184755|7373010|FG002|COMPLETED|Overall Study||56
6456673|NCT01184755|7373008|FG000|NOT COMPLETED|Overall Study||25
6456674|NCT01184755|7373009|FG001|NOT COMPLETED|Overall Study||11
6456675|NCT01184755|7373010|FG002|NOT COMPLETED|Overall Study||6
6456676|NCT01184846|7373018|FG000|STARTED|Overall Study||28
6456677|NCT01184846|7373018|FG000|COMPLETED|Overall Study||25
6456678|NCT01184846|7373018|FG000|NOT COMPLETED|Overall Study||3
6456679|NCT01184859|7373029|FG000|STARTED|Period 1: Single Dose||23
6456680|NCT01184859|7373030|FG001|STARTED|Period 1: Single Dose||25
6456681|NCT01184859|7373031|FG002|STARTED|Period 1: Single Dose||22
6456682|NCT01184859|7373032|FG003|STARTED|Period 1: Single Dose||22
6456683|NCT01184859|7373033|FG004|STARTED|Period 1: Single Dose||24
6456684|NCT01184859|7373029|FG000|Full Analysis Set (FAS)|Period 1: Single Dose||23
6456685|NCT01184859|7373030|FG001|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
6456686|NCT01184859|7373031|FG002|Full Analysis Set (FAS)|Period 1: Single Dose||22
6456687|NCT01184859|7373032|FG003|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
6456688|NCT01184859|7373033|FG004|Full Analysis Set (FAS)|Period 1: Single Dose||24
6456689|NCT01184859|7373029|FG000|Per Protocol (PP)|Period 1: Single Dose||23
6456690|NCT01184859|7373030|FG001|Per Protocol (PP)|Period 1: Single Dose||23
6456691|NCT01184859|7373031|FG002|Per Protocol (PP)|Period 1: Single Dose||22
6456692|NCT01184859|7373032|FG003|Per Protocol (PP)|Period 1: Single Dose||21
6456693|NCT01184859|7373033|FG004|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
6456694|NCT01184859|7373029|FG000|COMPLETED|Period 1: Single Dose||23
6456695|NCT01184859|7373030|FG001|COMPLETED|Period 1: Single Dose||23
6456696|NCT01184859|7373031|FG002|COMPLETED|Period 1: Single Dose||22
6456697|NCT01184859|7373032|FG003|COMPLETED|Period 1: Single Dose||22
6456698|NCT01184859|7373033|FG004|COMPLETED|Period 1: Single Dose||23
6456699|NCT01184859|7373029|FG000|NOT COMPLETED|Period 1: Single Dose||0
6456700|NCT01184859|7373030|FG001|NOT COMPLETED|Period 1: Single Dose||2
6456701|NCT01184859|7373031|FG002|NOT COMPLETED|Period 1: Single Dose||0
6456702|NCT01184859|7373032|FG003|NOT COMPLETED|Period 1: Single Dose||0
6456703|NCT01184859|7373033|FG004|NOT COMPLETED|Period 1: Single Dose||1
6456704|NCT01184859|7373029|FG000|STARTED|Washout Period||23
6456705|NCT01184859|7373030|FG001|STARTED|Washout Period||23
6456706|NCT01184859|7373031|FG002|STARTED|Washout Period||22
6456707|NCT01184859|7373032|FG003|STARTED|Washout Period||22
6456708|NCT01184859|7373033|FG004|STARTED|Washout Period||23
6456709|NCT01184859|7373029|FG000|COMPLETED|Washout Period||23
6456710|NCT01184859|7373030|FG001|COMPLETED|Washout Period||23
6456711|NCT01184859|7373031|FG002|COMPLETED|Washout Period||22
6456712|NCT01184859|7373032|FG003|COMPLETED|Washout Period||22
6456713|NCT01184859|7373033|FG004|COMPLETED|Washout Period||23
6456714|NCT01184859|7373029|FG000|NOT COMPLETED|Washout Period||0
6456715|NCT01184859|7373030|FG001|NOT COMPLETED|Washout Period||0
6456716|NCT01184859|7373031|FG002|NOT COMPLETED|Washout Period||0
6456717|NCT01184859|7373032|FG003|NOT COMPLETED|Washout Period||0
6456718|NCT01184859|7373033|FG004|NOT COMPLETED|Washout Period||0
6456719|NCT01184859|7373029|FG000|STARTED|Period 2: Daily Dose for 28 Days||23
6456720|NCT01184859|7373030|FG001|STARTED|Period 2: Daily Dose for 28 Days||23
6456721|NCT01184859|7373031|FG002|STARTED|Period 2: Daily Dose for 28 Days||22
6456722|NCT01184859|7373032|FG003|STARTED|Period 2: Daily Dose for 28 Days||22
6553697|NCT01745094|7476203|FG003|STARTED|Overall Study||93
6553698|NCT01745094|7476200|FG000|COMPLETED|Overall Study||30
6456723|NCT01184859|7373033|FG004|STARTED|Period 2: Daily Dose for 28 Days||23
6456724|NCT01184859|7373029|FG000|COMPLETED|Period 2: Daily Dose for 28 Days||22
6456725|NCT01184859|7373030|FG001|COMPLETED|Period 2: Daily Dose for 28 Days||23
6456726|NCT01184859|7373031|FG002|COMPLETED|Period 2: Daily Dose for 28 Days||22
6456727|NCT01184859|7373032|FG003|COMPLETED|Period 2: Daily Dose for 28 Days||22
6456728|NCT01184859|7373033|FG004|COMPLETED|Period 2: Daily Dose for 28 Days||22
6456729|NCT01184859|7373029|FG000|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
6456730|NCT01184859|7373030|FG001|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
6456731|NCT01184859|7373031|FG002|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
6456732|NCT01184859|7373032|FG003|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
6456733|NCT01184859|7373033|FG004|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
6553699|NCT01745094|7476201|FG001|COMPLETED|Overall Study||37
6456734|NCT01184872|7373052|FG000|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
6456735|NCT01184872|7373053|FG001|STARTED|Overall Study||39
6456736|NCT01184872|7373052|FG000|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
6456737|NCT01184872|7373053|FG001|Safety Set|Overall Study||40
6456738|NCT01184872|7373052|FG000|Clinical Evaluable Set (CES)|Overall Study||73
6456739|NCT01184872|7373053|FG001|Clinical Evaluable Set (CES)|Overall Study||30
6456740|NCT01184872|7373052|FG000|Microbiologically Evaluable Set (MES)|Overall Study||65
6456741|NCT01184872|7373053|FG001|Microbiologically Evaluable Set (MES)|Overall Study||27
6456742|NCT01184872|7373052|FG000|COMPLETED|Overall Study||71
6456743|NCT01184872|7373053|FG001|COMPLETED|Overall Study||31
6456744|NCT01184872|7373052|FG000|NOT COMPLETED|Overall Study||10
6456745|NCT01184872|7373053|FG001|NOT COMPLETED|Overall Study||8
6456746|NCT01184885|7373059|FG000|STARTED|Overall Study||7
6456747|NCT01184885|7373059|FG000|COMPLETED|Overall Study||7
6456748|NCT01184885|7373059|FG000|NOT COMPLETED|Overall Study||0
6456749|NCT01184898|7373064|FG000|STARTED|Overall Study||36
6456750|NCT01184898|7373064|FG000|COMPLETED|Overall Study||36
6456751|NCT01184898|7373064|FG000|NOT COMPLETED|Overall Study||0
6456752|NCT01184989|7373068|FG000|STARTED|Overall Study|Treated Patients|112
6456753|NCT01184989|7373068|FG000|COMPLETED|Overall Study||100
6456754|NCT01184989|7373068|FG000|NOT COMPLETED|Overall Study||12
6456755|NCT01185028|7373072|FG000|STARTED|Overall Study||8
6456756|NCT01185028|7373072|FG000|COMPLETED|Overall Study||4
6456757|NCT01185028|7373072|FG000|NOT COMPLETED|Overall Study||4
6456758|NCT01185080|7373079|FG000|STARTED|Overall Study||50
6456759|NCT01185080|7373080|FG001|STARTED|Overall Study||16
6456760|NCT01185080|7373081|FG002|STARTED|Overall Study||17
6456761|NCT01185080|7373079|FG000|COMPLETED|Overall Study||49
6456762|NCT01185080|7373080|FG001|COMPLETED|Overall Study||15
6456763|NCT01185080|7373081|FG002|COMPLETED|Overall Study||16
6456764|NCT01185080|7373079|FG000|NOT COMPLETED|Overall Study||1
6456765|NCT01185080|7373080|FG001|NOT COMPLETED|Overall Study||1
6456766|NCT01185080|7373081|FG002|NOT COMPLETED|Overall Study||1
6456767|NCT01185171|7373089|FG000|STARTED|Induction Chemotherapy||59
6456768|NCT01185171|7373089|FG000|COMPLETED|Induction Chemotherapy||57
6456769|NCT01185171|7373089|FG000|NOT COMPLETED|Induction Chemotherapy||2
6456770|NCT01185171|7373089|FG000|STARTED|Concurrent Chemo and Radiation Treatment||69
6456771|NCT01185171|7373089|FG000|COMPLETED|Concurrent Chemo and Radiation Treatment||66
6456772|NCT01185171|7373089|FG000|NOT COMPLETED|Concurrent Chemo and Radiation Treatment||3
6456773|NCT01185171|7373089|FG000|STARTED|Maintenance||60
6456774|NCT01185171|7373089|FG000|COMPLETED|Maintenance||48
6456775|NCT01185171|7373089|FG000|NOT COMPLETED|Maintenance||12
6456776|NCT01185249|7373093|FG000|STARTED|Overall Study|Total number of patients consented to participate.|66
6456777|NCT01185249|7373093|FG000|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
6456778|NCT01185249|7373093|FG000|NOT COMPLETED|Overall Study||42
6456779|NCT01185288|7373100|FG000|STARTED|Overall Study||154
6456780|NCT01185288|7373101|FG001|STARTED|Overall Study||155
6456781|NCT01185288|7373100|FG000|COMPLETED|Overall Study||135
6456782|NCT01185288|7373101|FG001|COMPLETED|Overall Study||139
6456783|NCT01185288|7373100|FG000|NOT COMPLETED|Overall Study||19
6456784|NCT01185288|7373101|FG001|NOT COMPLETED|Overall Study||16
6456785|NCT01185301|7373111|FG000|STARTED|Overall Study||98
6456786|NCT01185301|7373112|FG001|STARTED|Overall Study||100
6456787|NCT01185301|7373113|FG002|STARTED|Overall Study||99
6456788|NCT01185301|7373114|FG003|STARTED|Overall Study||98
6456789|NCT01185301|7373111|FG000|COMPLETED|Overall Study||83
6456790|NCT01185301|7373112|FG001|COMPLETED|Overall Study||93
6456791|NCT01185301|7373113|FG002|COMPLETED|Overall Study||93
6456792|NCT01185301|7373114|FG003|COMPLETED|Overall Study||89
6456793|NCT01185301|7373111|FG000|NOT COMPLETED|Overall Study||15
6456794|NCT01185301|7373112|FG001|NOT COMPLETED|Overall Study||7
6456795|NCT01185301|7373113|FG002|NOT COMPLETED|Overall Study||6
6456796|NCT01185301|7373114|FG003|NOT COMPLETED|Overall Study||9
6456797|NCT01185340|7373127|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1056
6456798|NCT01185340|7373128|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6456799|NCT01185340|7373129|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6456800|NCT01185340|7373130|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6456801|NCT01185340|7373127|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|18
6456802|NCT01185340|7373128|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6456803|NCT01185340|7373129|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6456804|NCT01185340|7373130|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6745281|NCT03358407|7673374|FG002|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6745282|NCT03358407|7673375|FG003|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6745283|NCT03358407|7673376|FG004|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6745284|NCT03358407|7673377|FG005|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745285|NCT03358407|7673378|FG006|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745286|NCT03358407|7673379|FG007|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745287|NCT03358407|7673380|FG008|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745288|NCT03358407|7673381|FG009|STARTED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6456805|NCT01185340|7373127|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|968
6456806|NCT01185340|7373128|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6456807|NCT01185340|7373129|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6456808|NCT01185340|7373130|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6456809|NCT01185340|7373127|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||88
6456810|NCT01185340|7373128|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6456811|NCT01185340|7373129|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6745289|NCT03358407|7673372|FG000|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6745290|NCT03358407|7673373|FG001|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6745291|NCT03358407|7673374|FG002|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
6456812|NCT01185340|7373130|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6456813|NCT01185340|7373127|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6456814|NCT01185340|7373128|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||230
6456815|NCT01185340|7373129|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||219
6456816|NCT01185340|7373130|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||519
6456817|NCT01185340|7373127|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6456818|NCT01185340|7373128|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|206
6456819|NCT01185340|7373129|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|204
6456820|NCT01185340|7373130|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|483
6456821|NCT01185340|7373127|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6456822|NCT01185340|7373128|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||195
6456823|NCT01185340|7373129|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||186
6456824|NCT01185340|7373130|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||458
6456825|NCT01185340|7373127|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6456826|NCT01185340|7373128|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
6456827|NCT01185340|7373129|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||33
6456828|NCT01185340|7373130|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||61
6456829|NCT01185353|7373147|FG000|STARTED|Part A (Weeks 0 Through 12)||49
6456830|NCT01185353|7373148|FG001|STARTED|Part A (Weeks 0 Through 12)||52
6456831|NCT01185353|7373149|FG002|STARTED|Part A (Weeks 0 Through 12)||52
6456832|NCT01185353|7373150|FG003|STARTED|Part A (Weeks 0 Through 12)||50
6456833|NCT01185353|7373151|FG004|STARTED|Part A (Weeks 0 Through 12)||98
6456834|NCT01185353|7373152|FG005|STARTED|Part A (Weeks 0 Through 12)||0
6456835|NCT01185353|7373153|FG006|STARTED|Part A (Weeks 0 Through 12)||0
6456836|NCT01185353|7373154|FG007|STARTED|Part A (Weeks 0 Through 12)||0
6456837|NCT01185353|7373155|FG008|STARTED|Part A (Weeks 0 Through 12)||0
6456838|NCT01185353|7373156|FG009|STARTED|Part A (Weeks 0 Through 12)||0
6456839|NCT01185353|7373147|FG000|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
6456840|NCT01185353|7373148|FG001|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
6456841|NCT01185353|7373149|FG002|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
6456842|NCT01185353|7373150|FG003|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
6456843|NCT01185353|7373151|FG004|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
6456844|NCT01185353|7373152|FG005|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6456845|NCT01185353|7373153|FG006|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6456846|NCT01185353|7373154|FG007|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6456847|NCT01185353|7373155|FG008|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6456848|NCT01185353|7373156|FG009|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
6456849|NCT01185353|7373147|FG000|COMPLETED|Part A (Weeks 0 Through 12)||44
6456850|NCT01185353|7373148|FG001|COMPLETED|Part A (Weeks 0 Through 12)||51
6456851|NCT01185353|7373149|FG002|COMPLETED|Part A (Weeks 0 Through 12)||50
6456852|NCT01185353|7373150|FG003|COMPLETED|Part A (Weeks 0 Through 12)||49
6456853|NCT01185353|7373151|FG004|COMPLETED|Part A (Weeks 0 Through 12)||82
6456854|NCT01185353|7373152|FG005|COMPLETED|Part A (Weeks 0 Through 12)||0
6456855|NCT01185353|7373153|FG006|COMPLETED|Part A (Weeks 0 Through 12)||0
6456856|NCT01185353|7373154|FG007|COMPLETED|Part A (Weeks 0 Through 12)||0
6456857|NCT01185353|7373155|FG008|COMPLETED|Part A (Weeks 0 Through 12)||0
6456858|NCT01185353|7373156|FG009|COMPLETED|Part A (Weeks 0 Through 12)||0
6456859|NCT01185353|7373147|FG000|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
6456860|NCT01185353|7373148|FG001|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
6456861|NCT01185353|7373149|FG002|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
6456862|NCT01185353|7373150|FG003|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
6456863|NCT01185353|7373151|FG004|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
6456864|NCT01185353|7373152|FG005|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6456865|NCT01185353|7373153|FG006|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6456866|NCT01185353|7373154|FG007|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6456867|NCT01185353|7373155|FG008|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6456868|NCT01185353|7373156|FG009|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
6456869|NCT01185353|7373147|FG000|STARTED|Part B (Weeks 12 Through 24)||0
6456870|NCT01185353|7373148|FG001|STARTED|Part B (Weeks 12 Through 24)||51
6456871|NCT01185353|7373149|FG002|STARTED|Part B (Weeks 12 Through 24)||50
6456872|NCT01185353|7373150|FG003|STARTED|Part B (Weeks 12 Through 24)||49
6456873|NCT01185353|7373151|FG004|STARTED|Part B (Weeks 12 Through 24)||0
6456874|NCT01185353|7373152|FG005|STARTED|Part B (Weeks 12 Through 24)||63
6456875|NCT01185353|7373153|FG006|STARTED|Part B (Weeks 12 Through 24)||63
6456876|NCT01185353|7373154|FG007|STARTED|Part B (Weeks 12 Through 24)||0
6456877|NCT01185353|7373155|FG008|STARTED|Part B (Weeks 12 Through 24)||0
6456878|NCT01185353|7373156|FG009|STARTED|Part B (Weeks 12 Through 24)||0
6456879|NCT01185353|7373147|FG000|COMPLETED|Part B (Weeks 12 Through 24)||0
6456880|NCT01185353|7373148|FG001|COMPLETED|Part B (Weeks 12 Through 24)||50
6456881|NCT01185353|7373149|FG002|COMPLETED|Part B (Weeks 12 Through 24)||48
6456882|NCT01185353|7373150|FG003|COMPLETED|Part B (Weeks 12 Through 24)||45
6456883|NCT01185353|7373151|FG004|COMPLETED|Part B (Weeks 12 Through 24)||0
6456884|NCT01185353|7373152|FG005|COMPLETED|Part B (Weeks 12 Through 24)||59
6456885|NCT01185353|7373153|FG006|COMPLETED|Part B (Weeks 12 Through 24)||57
6456886|NCT01185353|7373154|FG007|COMPLETED|Part B (Weeks 12 Through 24)||0
6456887|NCT01185353|7373155|FG008|COMPLETED|Part B (Weeks 12 Through 24)||0
6456888|NCT01185353|7373156|FG009|COMPLETED|Part B (Weeks 12 Through 24)||0
6456889|NCT01185353|7373147|FG000|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6456890|NCT01185353|7373148|FG001|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
6456891|NCT01185353|7373149|FG002|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
6456892|NCT01185353|7373150|FG003|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
6456893|NCT01185353|7373151|FG004|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6456894|NCT01185353|7373152|FG005|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
6456895|NCT01185353|7373153|FG006|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
6456896|NCT01185353|7373154|FG007|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6456897|NCT01185353|7373155|FG008|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6456898|NCT01185353|7373156|FG009|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
6456899|NCT01185353|7373147|FG000|STARTED|Part C (Weeks 24 Through 76)||0
6456900|NCT01185353|7373148|FG001|STARTED|Part C (Weeks 24 Through 76)||0
6456901|NCT01185353|7373149|FG002|STARTED|Part C (Weeks 24 Through 76)||0
6456902|NCT01185353|7373150|FG003|STARTED|Part C (Weeks 24 Through 76)||0
6456903|NCT01185353|7373151|FG004|STARTED|Part C (Weeks 24 Through 76)||0
6456904|NCT01185353|7373152|FG005|STARTED|Part C (Weeks 24 Through 76)||0
6456905|NCT01185353|7373153|FG006|STARTED|Part C (Weeks 24 Through 76)||0
6456906|NCT01185353|7373154|FG007|STARTED|Part C (Weeks 24 Through 76)||108
6456907|NCT01185353|7373155|FG008|STARTED|Part C (Weeks 24 Through 76)||61
6456908|NCT01185353|7373156|FG009|STARTED|Part C (Weeks 24 Through 76)||32
6456909|NCT01185353|7373147|FG000|COMPLETED|Part C (Weeks 24 Through 76)||0
6456910|NCT01185353|7373148|FG001|COMPLETED|Part C (Weeks 24 Through 76)||0
6456911|NCT01185353|7373149|FG002|COMPLETED|Part C (Weeks 24 Through 76)||0
6456912|NCT01185353|7373150|FG003|COMPLETED|Part C (Weeks 24 Through 76)||0
6456913|NCT01185353|7373151|FG004|COMPLETED|Part C (Weeks 24 Through 76)||0
6456914|NCT01185353|7373152|FG005|COMPLETED|Part C (Weeks 24 Through 76)||0
6456915|NCT01185353|7373153|FG006|COMPLETED|Part C (Weeks 24 Through 76)||0
6456916|NCT01185353|7373154|FG007|COMPLETED|Part C (Weeks 24 Through 76)||92
6456917|NCT01185353|7373155|FG008|COMPLETED|Part C (Weeks 24 Through 76)||53
6456918|NCT01185353|7373156|FG009|COMPLETED|Part C (Weeks 24 Through 76)||24
6456919|NCT01185353|7373147|FG000|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6456920|NCT01185353|7373148|FG001|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6456921|NCT01185353|7373149|FG002|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6456922|NCT01185353|7373150|FG003|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6456923|NCT01185353|7373151|FG004|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6456924|NCT01185353|7373152|FG005|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6456925|NCT01185353|7373153|FG006|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
6456926|NCT01185353|7373154|FG007|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
6456927|NCT01185353|7373155|FG008|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
6456928|NCT01185353|7373156|FG009|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
6456929|NCT01185353|7373147|FG000|STARTED|Part D (Weeks 76 Through 128)||0
6456930|NCT01185353|7373148|FG001|STARTED|Part D (Weeks 76 Through 128)||0
6456931|NCT01185353|7373149|FG002|STARTED|Part D (Weeks 76 Through 128)||0
6456932|NCT01185353|7373150|FG003|STARTED|Part D (Weeks 76 Through 128)||0
6456933|NCT01185353|7373151|FG004|STARTED|Part D (Weeks 76 Through 128)||0
6456934|NCT01185353|7373152|FG005|STARTED|Part D (Weeks 76 Through 128)||0
6456935|NCT01185353|7373153|FG006|STARTED|Part D (Weeks 76 Through 128)||0
6456936|NCT01185353|7373154|FG007|STARTED|Part D (Weeks 76 Through 128)||79
6456937|NCT01185353|7373155|FG008|STARTED|Part D (Weeks 76 Through 128)||47
6456938|NCT01185353|7373156|FG009|STARTED|Part D (Weeks 76 Through 128)||18
6456939|NCT01185353|7373147|FG000|COMPLETED|Part D (Weeks 76 Through 128)||0
6456940|NCT01185353|7373148|FG001|COMPLETED|Part D (Weeks 76 Through 128)||0
6456941|NCT01185353|7373149|FG002|COMPLETED|Part D (Weeks 76 Through 128)||0
6456942|NCT01185353|7373150|FG003|COMPLETED|Part D (Weeks 76 Through 128)||0
6456943|NCT01185353|7373151|FG004|COMPLETED|Part D (Weeks 76 Through 128)||0
6456944|NCT01185353|7373152|FG005|COMPLETED|Part D (Weeks 76 Through 128)||0
6456945|NCT01185353|7373153|FG006|COMPLETED|Part D (Weeks 76 Through 128)||0
6456946|NCT01185353|7373154|FG007|COMPLETED|Part D (Weeks 76 Through 128)||76
6456947|NCT01185353|7373155|FG008|COMPLETED|Part D (Weeks 76 Through 128)||40
6456948|NCT01185353|7373156|FG009|COMPLETED|Part D (Weeks 76 Through 128)||17
6456949|NCT01185353|7373147|FG000|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6456950|NCT01185353|7373148|FG001|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6456951|NCT01185353|7373149|FG002|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6456952|NCT01185353|7373150|FG003|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6456953|NCT01185353|7373151|FG004|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6456954|NCT01185353|7373152|FG005|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6456955|NCT01185353|7373153|FG006|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
6456956|NCT01185353|7373154|FG007|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
6456957|NCT01185353|7373155|FG008|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
6456958|NCT01185353|7373156|FG009|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
6456959|NCT01185366|7373197|FG000|STARTED|First Line Therapy||38
6456960|NCT01185366|7373198|FG001|STARTED|First Line Therapy||34
6456961|NCT01185366|7373197|FG000|Received 1st Drug|First Line Therapy||36
6456962|NCT01185366|7373198|FG001|Received 1st Drug|First Line Therapy||33
6456963|NCT01185366|7373197|FG000|COMPLETED|First Line Therapy||35
6456964|NCT01185366|7373198|FG001|COMPLETED|First Line Therapy||33
6456965|NCT01185366|7373197|FG000|NOT COMPLETED|First Line Therapy||3
6456966|NCT01185366|7373198|FG001|NOT COMPLETED|First Line Therapy||1
6456967|NCT01185366|7373197|FG000|STARTED|Crossover to Second Line Therapy||35
6456968|NCT01185366|7373198|FG001|STARTED|Crossover to Second Line Therapy||33
6456969|NCT01185366|7373197|FG000|Received Crossover Drug|Crossover to Second Line Therapy||21
6456970|NCT01185366|7373198|FG001|Received Crossover Drug|Crossover to Second Line Therapy||23
6456971|NCT01185366|7373197|FG000|COMPLETED|Crossover to Second Line Therapy||21
6456972|NCT01185366|7373198|FG001|COMPLETED|Crossover to Second Line Therapy||23
6456973|NCT01185366|7373197|FG000|NOT COMPLETED|Crossover to Second Line Therapy||14
6456974|NCT01185366|7373198|FG001|NOT COMPLETED|Crossover to Second Line Therapy||10
6456975|NCT01185509|7373208|FG000|STARTED|Overall Study||11
6456976|NCT01185509|7373209|FG001|STARTED|Overall Study||20
6456977|NCT01185509|7373208|FG000|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6456978|NCT01185509|7373209|FG001|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
6456979|NCT01185509|7373208|FG000|NOT COMPLETED|Overall Study||11
6456980|NCT01185509|7373209|FG001|NOT COMPLETED|Overall Study||20
6456981|NCT01185522|7373216|FG000|STARTED|Overall Study||693
6456982|NCT01185522|7373216|FG000|COMPLETED|Overall Study||585
6456983|NCT01185522|7373216|FG000|NOT COMPLETED|Overall Study||108
6456984|NCT01185548|7373221|FG000|STARTED|Period 1 : Tolbutamide||4
6456985|NCT01185548|7373221|FG000|COMPLETED|Period 1 : Tolbutamide||4
6456986|NCT01185548|7373221|FG000|NOT COMPLETED|Period 1 : Tolbutamide||0
6456987|NCT01185548|7373221|FG000|STARTED|Period 2: Tasisulam and Tolbutamide||4
6456988|NCT01185548|7373221|FG000|COMPLETED|Period 2: Tasisulam and Tolbutamide||2
6456989|NCT01185548|7373221|FG000|NOT COMPLETED|Period 2: Tasisulam and Tolbutamide||2
6456990|NCT01185548|7373221|FG000|STARTED|Period 3: Tasisulam and Tolbutamide||2
6456991|NCT01185548|7373221|FG000|COMPLETED|Period 3: Tasisulam and Tolbutamide||2
6456992|NCT01185548|7373221|FG000|NOT COMPLETED|Period 3: Tasisulam and Tolbutamide||0
6456993|NCT01185561|7373236|FG000|STARTED|Overall Study||36
6456994|NCT01185561|7373237|FG001|STARTED|Overall Study||38
6456995|NCT01185561|7373236|FG000|COMPLETED|Overall Study||34
6456996|NCT01185561|7373237|FG001|COMPLETED|Overall Study||26
6456997|NCT01185561|7373236|FG000|NOT COMPLETED|Overall Study||2
6456998|NCT01185561|7373237|FG001|NOT COMPLETED|Overall Study||12
6456999|NCT01185600|7373245|FG000|STARTED|Overall Study||73
6457000|NCT01185600|7373246|FG001|STARTED|Overall Study||104
6457001|NCT01185600|7373245|FG000|COMPLETED|Overall Study||41
6457002|NCT01185600|7373246|FG001|COMPLETED|Overall Study||59
6457003|NCT01185600|7373245|FG000|NOT COMPLETED|Overall Study||32
6457004|NCT01185600|7373246|FG001|NOT COMPLETED|Overall Study||45
6457005|NCT01185639|7373255|FG000|STARTED|Overall Study||29
6457006|NCT01185639|7373255|FG000|COMPLETED|Overall Study||27
6457007|NCT01185639|7373255|FG000|NOT COMPLETED|Overall Study||2
6457008|NCT01185704|7373261|FG000|STARTED|Overall Study||68
6457009|NCT01185704|7373262|FG001|STARTED|Overall Study||68
6457010|NCT01185704|7373261|FG000|Treated|Overall Study||65
6457011|NCT01185704|7373262|FG001|Treated|Overall Study||65
6457012|NCT01185704|7373261|FG000|COMPLETED|Overall Study||55
6457013|NCT01185704|7373262|FG001|COMPLETED|Overall Study||60
6457014|NCT01185704|7373261|FG000|NOT COMPLETED|Overall Study||13
6457015|NCT01185704|7373262|FG001|NOT COMPLETED|Overall Study||8
6457016|NCT01185782|7373270|FG000|STARTED|Overall Study||129
6457017|NCT01185782|7373271|FG001|STARTED|Overall Study||136
6457018|NCT01185782|7373270|FG000|Treated|Overall Study||129
6457019|NCT01185782|7373271|FG001|Treated|Overall Study||132
6457020|NCT01185782|7373270|FG000|COMPLETED|Overall Study||123
6457021|NCT01185782|7373271|FG001|COMPLETED|Overall Study||125
6457022|NCT01185782|7373270|FG000|NOT COMPLETED|Overall Study||6
6457023|NCT01185782|7373271|FG001|NOT COMPLETED|Overall Study||11
6457024|NCT01185821|7373282|FG000|STARTED|Overall Study||33
6457025|NCT01185821|7373283|FG001|STARTED|Overall Study||29
6457026|NCT01185821|7373284|FG002|STARTED|Overall Study||43
6457027|NCT01185821|7373285|FG003|STARTED|Overall Study||29
6457028|NCT01185821|7373286|FG004|STARTED|Overall Study||50
6457029|NCT01185821|7373282|FG000|Patients With Washout|Overall Study||33
6457030|NCT01185821|7373283|FG001|Patients With Washout|Overall Study||29
6457031|NCT01185821|7373284|FG002|Patients With Washout|Overall Study||39
6457032|NCT01185821|7373285|FG003|Patients With Washout|Overall Study||29
6457033|NCT01185821|7373286|FG004|Patients With Washout|Overall Study||33
6457034|NCT01185821|7373282|FG000|Patients Without Washout|Overall Study||0
6457035|NCT01185821|7373283|FG001|Patients Without Washout|Overall Study||0
6457036|NCT01185821|7373284|FG002|Patients Without Washout|Overall Study||4
6457037|NCT01185821|7373285|FG003|Patients Without Washout|Overall Study||0
6457038|NCT01185821|7373286|FG004|Patients Without Washout|Overall Study||17
6457039|NCT01185821|7373282|FG000|Patients on Placebo in Core|Overall Study||8
6457040|NCT01185821|7373283|FG001|Patients on Placebo in Core|Overall Study||7
6457041|NCT01185821|7373284|FG002|Patients on Placebo in Core|Overall Study||9
6457042|NCT01185821|7373285|FG003|Patients on Placebo in Core|Overall Study||8
6457043|NCT01185821|7373286|FG004|Patients on Placebo in Core|Overall Study||2
6457044|NCT01185821|7373282|FG000|COMPLETED|Overall Study||26
6457045|NCT01185821|7373283|FG001|COMPLETED|Overall Study||20
6457046|NCT01185821|7373284|FG002|COMPLETED|Overall Study||33
6457047|NCT01185821|7373285|FG003|COMPLETED|Overall Study||23
6457048|NCT01185821|7373286|FG004|COMPLETED|Overall Study||26
6457049|NCT01185821|7373282|FG000|NOT COMPLETED|Overall Study||7
6457050|NCT01185821|7373283|FG001|NOT COMPLETED|Overall Study||9
6457051|NCT01185821|7373284|FG002|NOT COMPLETED|Overall Study||10
6457052|NCT01185821|7373285|FG003|NOT COMPLETED|Overall Study||6
6457053|NCT01185821|7373286|FG004|NOT COMPLETED|Overall Study||24
6457054|NCT01185834|7373300|FG000|STARTED|Overall Study||118
6457055|NCT01185834|7373300|FG000|COMPLETED|Overall Study||104
6457056|NCT01185834|7373300|FG000|NOT COMPLETED|Overall Study||14
6457057|NCT01185964|7373307|FG000|STARTED|Phase 1b and Phase 2||15
6457058|NCT01185964|7373308|FG001|STARTED|Phase 1b and Phase 2||66
6457059|NCT01185964|7373309|FG002|STARTED|Phase 1b and Phase 2||67
6457060|NCT01185964|7373310|FG003|STARTED|Phase 1b and Phase 2||0
6457061|NCT01185964|7373307|FG000|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
6457062|NCT01185964|7373308|FG001|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
6457063|NCT01185964|7373309|FG002|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
6457064|NCT01185964|7373310|FG003|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
6457065|NCT01185964|7373307|FG000|COMPLETED|Phase 1b and Phase 2||13
6457066|NCT01185964|7373308|FG001|COMPLETED|Phase 1b and Phase 2||56
6457067|NCT01185964|7373309|FG002|COMPLETED|Phase 1b and Phase 2||58
6457068|NCT01185964|7373310|FG003|COMPLETED|Phase 1b and Phase 2||0
6457069|NCT01185964|7373307|FG000|NOT COMPLETED|Phase 1b and Phase 2||2
6457070|NCT01185964|7373308|FG001|NOT COMPLETED|Phase 1b and Phase 2||10
6457071|NCT01185964|7373309|FG002|NOT COMPLETED|Phase 1b and Phase 2||9
6457072|NCT01185964|7373310|FG003|NOT COMPLETED|Phase 1b and Phase 2||0
6457073|NCT01185964|7373307|FG000|STARTED|Optional Olaratumab Monotherapy on Dox||0
6457074|NCT01185964|7373308|FG001|STARTED|Optional Olaratumab Monotherapy on Dox||0
6457075|NCT01185964|7373309|FG002|STARTED|Optional Olaratumab Monotherapy on Dox||0
6457076|NCT01185964|7373310|FG003|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
6457077|NCT01185964|7373307|FG000|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6457078|NCT01185964|7373308|FG001|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6457079|NCT01185964|7373309|FG002|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6457080|NCT01185964|7373310|FG003|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
6457081|NCT01185964|7373307|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6457082|NCT01185964|7373308|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6457083|NCT01185964|7373309|FG002|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
6457084|NCT01185964|7373310|FG003|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
6457085|NCT01186250|7373328|FG000|STARTED|Overall Study||9
6457086|NCT01186250|7373329|FG001|STARTED|Overall Study||9
6457087|NCT01186250|7373328|FG000|COMPLETED|Overall Study||8
6457088|NCT01186250|7373329|FG001|COMPLETED|Overall Study||9
6457089|NCT01186250|7373328|FG000|NOT COMPLETED|Overall Study||1
6457090|NCT01186250|7373329|FG001|NOT COMPLETED|Overall Study||0
6457091|NCT01186328|7373335|FG000|STARTED|Overall Study||6
6457092|NCT01186328|7373336|FG001|STARTED|Overall Study||0
6457093|NCT01186328|7373337|FG002|STARTED|Overall Study||0
6457094|NCT01186328|7373335|FG000|COMPLETED|Overall Study||5
6457095|NCT01186328|7373336|FG001|COMPLETED|Overall Study||0
6457096|NCT01186328|7373337|FG002|COMPLETED|Overall Study||0
6457097|NCT01186328|7373335|FG000|NOT COMPLETED|Overall Study||1
6457098|NCT01186328|7373336|FG001|NOT COMPLETED|Overall Study||0
6457099|NCT01186328|7373337|FG002|NOT COMPLETED|Overall Study||0
6457100|NCT01186406|7373342|FG000|STARTED|Overall Study||41
6457101|NCT01186406|7373342|FG000|COMPLETED|Overall Study||41
6457102|NCT01186406|7373342|FG000|NOT COMPLETED|Overall Study||0
6457103|NCT01186419|7373348|FG000|STARTED|Overall Study||24
6457104|NCT01186419|7373349|FG001|STARTED|Overall Study||27
6457105|NCT01186419|7373348|FG000|COMPLETED|Overall Study||17
6457106|NCT01186419|7373349|FG001|COMPLETED|Overall Study||18
6457107|NCT01186419|7373348|FG000|NOT COMPLETED|Overall Study||7
6457108|NCT01186419|7373349|FG001|NOT COMPLETED|Overall Study||9
6457109|NCT01186458|7373354|FG000|STARTED|Overall Study||4
6457110|NCT01186458|7373354|FG000|COMPLETED|Overall Study||3
6457111|NCT01186458|7373354|FG000|NOT COMPLETED|Overall Study||1
6457112|NCT01186562|7373360|FG000|STARTED|Overall Study||54
6457113|NCT01186562|7373361|FG001|STARTED|Overall Study||29
6457114|NCT01186562|7373360|FG000|COMPLETED|Overall Study||50
6457115|NCT01186562|7373361|FG001|COMPLETED|Overall Study||27
6457116|NCT01186562|7373360|FG000|NOT COMPLETED|Overall Study||4
6457117|NCT01186562|7373361|FG001|NOT COMPLETED|Overall Study||2
6457118|NCT01186692|7373367|FG000|STARTED|Overall Study||131
6457119|NCT01186692|7373367|FG000|COMPLETED|Overall Study||99
6457120|NCT01186692|7373367|FG000|NOT COMPLETED|Overall Study||32
6457121|NCT01186705|7373375|FG000|STARTED|Overall Study||1
6457122|NCT01186705|7373375|FG000|COMPLETED|Overall Study||1
6457123|NCT01186705|7373375|FG000|NOT COMPLETED|Overall Study||0
6457124|NCT01186744|7373385|FG000|STARTED|Overall Study||218
6457125|NCT01186744|7373386|FG001|STARTED|Overall Study||157
6457126|NCT01186744|7373387|FG002|STARTED|Overall Study||31
6457127|NCT01186744|7373388|FG003|STARTED|Overall Study||82
6457128|NCT01186744|7373389|FG004|STARTED|Overall Study||45
6457129|NCT01186744|7373390|FG005|STARTED|Overall Study||133
6457130|NCT01186744|7373385|FG000|COMPLETED|Overall Study||10
6457131|NCT01186744|7373386|FG001|COMPLETED|Overall Study||5
6457132|NCT01186744|7373387|FG002|COMPLETED|Overall Study||25
6457133|NCT01186744|7373388|FG003|COMPLETED|Overall Study||70
6457134|NCT01186744|7373389|FG004|COMPLETED|Overall Study||39
6457135|NCT01186744|7373390|FG005|COMPLETED|Overall Study||107
6457136|NCT01186744|7373385|FG000|NOT COMPLETED|Overall Study||208
6457137|NCT01186744|7373386|FG001|NOT COMPLETED|Overall Study||152
6457138|NCT01186744|7373387|FG002|NOT COMPLETED|Overall Study||6
6457139|NCT01186744|7373388|FG003|NOT COMPLETED|Overall Study||12
6457140|NCT01186744|7373389|FG004|NOT COMPLETED|Overall Study||6
6457141|NCT01186744|7373390|FG005|NOT COMPLETED|Overall Study||26
6457142|NCT01186770|7373429|FG000|STARTED|Overall Study||201
6457143|NCT01186770|7373430|FG001|STARTED|Overall Study||202
6457144|NCT01186770|7373431|FG002|STARTED|Overall Study||200
6457145|NCT01186770|7373432|FG003|STARTED|Overall Study||201
6457146|NCT01186770|7373429|FG000|Intent-to-treat (ITT Population)|Overall Study||201
6457147|NCT01186770|7373430|FG001|Intent-to-treat (ITT Population)|Overall Study||201
6457148|NCT01186770|7373431|FG002|Intent-to-treat (ITT Population)|Overall Study||200
6457149|NCT01186770|7373432|FG003|Intent-to-treat (ITT Population)|Overall Study||201
6457150|NCT01186770|7373429|FG000|COMPLETED|Overall Study||160
6457151|NCT01186770|7373430|FG001|COMPLETED|Overall Study||156
6457152|NCT01186770|7373431|FG002|COMPLETED|Overall Study||148
6457153|NCT01186770|7373432|FG003|COMPLETED|Overall Study||143
6457154|NCT01186770|7373429|FG000|NOT COMPLETED|Overall Study||41
6457155|NCT01186770|7373430|FG001|NOT COMPLETED|Overall Study||46
6457156|NCT01186770|7373431|FG002|NOT COMPLETED|Overall Study||52
6457157|NCT01186770|7373432|FG003|NOT COMPLETED|Overall Study||58
6457158|NCT01186796|7373444|FG000|STARTED|Overall Study||14
6457159|NCT01186796|7373445|FG001|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
6457160|NCT01186796|7373444|FG000|COMPLETED|Overall Study||10
6457161|NCT01186796|7373445|FG001|COMPLETED|Overall Study||14
6457162|NCT01186796|7373444|FG000|NOT COMPLETED|Overall Study||4
6457163|NCT01186796|7373445|FG001|NOT COMPLETED|Overall Study||2
6457164|NCT01186809|7373451|FG000|STARTED|Overall Study||73
6457165|NCT01186809|7373451|FG000|COMPLETED|Overall Study||43
6457166|NCT01186809|7373451|FG000|NOT COMPLETED|Overall Study||30
6457167|NCT01186939|7373455|FG000|STARTED|Overall Study||40
6457168|NCT01186939|7373455|FG000|COMPLETED|Overall Study||0
6457169|NCT01186939|7373455|FG000|NOT COMPLETED|Overall Study||40
6457170|NCT01186978|7373459|FG000|STARTED|Overall Study||63
6457171|NCT01186978|7373459|FG000|COMPLETED|Overall Study||62
6457172|NCT01186978|7373459|FG000|NOT COMPLETED|Overall Study||1
6457173|NCT01187004|7373465|FG000|STARTED|Overall Study||20
6457174|NCT01187004|7373466|FG001|STARTED|Overall Study||144
6457175|NCT01187004|7373465|FG000|COMPLETED|Overall Study||20
6457176|NCT01187004|7373466|FG001|COMPLETED|Overall Study||144
6457177|NCT01187004|7373465|FG000|NOT COMPLETED|Overall Study||0
6457178|NCT01187004|7373466|FG001|NOT COMPLETED|Overall Study||0
6457179|NCT01187017|7373473|FG000|STARTED|Overall Study||1
6457180|NCT01187017|7373473|FG000|COMPLETED|Overall Study||1
6457181|NCT01187017|7373473|FG000|NOT COMPLETED|Overall Study||0
6457182|NCT01187043|7373484|FG000|STARTED|Overall Study||12
6457183|NCT01187043|7373485|FG001|STARTED|Overall Study||10
6457184|NCT01187043|7373486|FG002|STARTED|Overall Study||12
6457185|NCT01187043|7373487|FG003|STARTED|Overall Study||12
6457186|NCT01187043|7373488|FG004|STARTED|Overall Study||12
6457187|NCT01187043|7373484|FG000|COMPLETED|Overall Study||11
6457188|NCT01187043|7373485|FG001|COMPLETED|Overall Study||10
6457189|NCT01187043|7373486|FG002|COMPLETED|Overall Study||8
6457190|NCT01187043|7373487|FG003|COMPLETED|Overall Study||12
6457191|NCT01187043|7373488|FG004|COMPLETED|Overall Study||10
6457192|NCT01187043|7373484|FG000|NOT COMPLETED|Overall Study||1
6457193|NCT01187043|7373485|FG001|NOT COMPLETED|Overall Study||0
6457194|NCT01187043|7373486|FG002|NOT COMPLETED|Overall Study||4
6457195|NCT01187043|7373487|FG003|NOT COMPLETED|Overall Study||0
6457196|NCT01187043|7373488|FG004|NOT COMPLETED|Overall Study||2
6457197|NCT01187095|7373502|FG000|STARTED|Overall Study||153
6457198|NCT01187095|7373503|FG001|STARTED|Overall Study||142
6457199|NCT01187095|7373502|FG000|COMPLETED|Overall Study||108
6457200|NCT01187095|7373503|FG001|COMPLETED|Overall Study||108
6457201|NCT01187095|7373502|FG000|NOT COMPLETED|Overall Study||45
6457202|NCT01187095|7373503|FG001|NOT COMPLETED|Overall Study||34
6457203|NCT01187329|7373511|FG000|STARTED|Overall Study||50
6457204|NCT01187329|7373512|FG001|STARTED|Overall Study||50
6457205|NCT01187329|7373511|FG000|COMPLETED|Overall Study||49
6457206|NCT01187329|7373512|FG001|COMPLETED|Overall Study||48
6457207|NCT01187329|7373511|FG000|NOT COMPLETED|Overall Study||1
6457208|NCT01187329|7373512|FG001|NOT COMPLETED|Overall Study||2
6457209|NCT01187355|7373520|FG000|STARTED|Overall Study||294
6457210|NCT01187355|7373521|FG001|STARTED|Overall Study||297
6457211|NCT01187355|7373520|FG000|COMPLETED|Overall Study||276
6457212|NCT01187355|7373521|FG001|COMPLETED|Overall Study||277
6457213|NCT01187355|7373520|FG000|NOT COMPLETED|Overall Study||18
6457214|NCT01187355|7373521|FG001|NOT COMPLETED|Overall Study||20
6457215|NCT01187381|7373527|FG000|STARTED|Overall Study||250
6457216|NCT01187381|7373527|FG000|COMPLETED|Overall Study|A participant completed study when the trastuzumab treatment was discontinued.|250
6457217|NCT01187381|7373527|FG000|NOT COMPLETED|Overall Study||0
6500643|NCT01425632|7419304|FG000|STARTED|Overall Study||161
6500644|NCT01425632|7419305|FG001|STARTED|Overall Study||166
6500645|NCT01425632|7419306|FG002|STARTED|Overall Study||163
6500646|NCT01425632|7419304|FG000|COMPLETED|Overall Study||160
6457218|NCT01187407|7373535|FG000|STARTED|Confirmation (CF) Phase, 3 Weeks||1480
6457219|NCT01187407|7373536|FG001|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6457220|NCT01187407|7373537|FG002|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6457221|NCT01187407|7373538|FG003|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6457222|NCT01187407|7373539|FG004|STARTED|Confirmation (CF) Phase, 3 Weeks||0
6457223|NCT01187407|7373535|FG000|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks|Participants who discontinued the CF Phase early had the option to enter the DC Phase.|25
6457224|NCT01187407|7373536|FG001|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6457225|NCT01187407|7373537|FG002|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6457226|NCT01187407|7373538|FG003|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6457227|NCT01187407|7373539|FG004|Entered Discontinuation (DC) Phase|Confirmation (CF) Phase, 3 Weeks||0
6457228|NCT01187407|7373535|FG000|COMPLETED|Confirmation (CF) Phase, 3 Weeks|Participants who completed the CF Phase entered the Adjunctive Treatment (AT) Phase.|1390
6457229|NCT01187407|7373536|FG001|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6457230|NCT01187407|7373537|FG002|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6457231|NCT01187407|7373538|FG003|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6457232|NCT01187407|7373539|FG004|COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6457233|NCT01187407|7373535|FG000|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||90
6457234|NCT01187407|7373536|FG001|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6457235|NCT01187407|7373537|FG002|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6457236|NCT01187407|7373538|FG003|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6457237|NCT01187407|7373539|FG004|NOT COMPLETED|Confirmation (CF) Phase, 3 Weeks||0
6457238|NCT01187407|7373535|FG000|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6457239|NCT01187407|7373536|FG001|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||232
6457240|NCT01187407|7373537|FG002|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||226
6457241|NCT01187407|7373538|FG003|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||231
6457242|NCT01187407|7373539|FG004|STARTED|Adjunctive Treatment (AT) Phase, 8 Weeks||701
6457243|NCT01187407|7373535|FG000|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6457244|NCT01187407|7373536|FG001|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|212
6457245|NCT01187407|7373537|FG002|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|215
6457246|NCT01187407|7373538|FG003|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|220
6457247|NCT01187407|7373539|FG004|Entered Discontinuation (DC) Phase|Adjunctive Treatment (AT) Phase, 8 Weeks|Participants who completed the AT Phase or discontinued early had the option to enter the DC Phase.|660
6457248|NCT01187407|7373535|FG000|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6457249|NCT01187407|7373536|FG001|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||196
6457250|NCT01187407|7373537|FG002|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||191
6457251|NCT01187407|7373538|FG003|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||202
6457252|NCT01187407|7373539|FG004|COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||626
6457253|NCT01187407|7373535|FG000|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||0
6457254|NCT01187407|7373536|FG001|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||36
6457255|NCT01187407|7373537|FG002|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||35
6457256|NCT01187407|7373538|FG003|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||29
6457257|NCT01187407|7373539|FG004|NOT COMPLETED|Adjunctive Treatment (AT) Phase, 8 Weeks||75
6457258|NCT01187446|7373558|FG000|STARTED|Overall Study||14
6457259|NCT01187446|7373559|FG001|STARTED|Overall Study||14
6457260|NCT01187446|7373558|FG000|COMPLETED|Overall Study||14
6457261|NCT01187446|7373559|FG001|COMPLETED|Overall Study||13
6457262|NCT01187446|7373558|FG000|NOT COMPLETED|Overall Study||0
6457263|NCT01187446|7373559|FG001|NOT COMPLETED|Overall Study||1
6457264|NCT01187498|7373567|FG000|STARTED|Overall Study||73
6457265|NCT01187498|7373568|FG001|STARTED|Overall Study||70
6457266|NCT01187498|7373567|FG000|COMPLETED|Overall Study||64
6457267|NCT01187498|7373568|FG001|COMPLETED|Overall Study||60
6457268|NCT01187498|7373567|FG000|NOT COMPLETED|Overall Study||9
6457269|NCT01187498|7373568|FG001|NOT COMPLETED|Overall Study||10
6457270|NCT01187511|7373576|FG000|STARTED|Overall Study||22
6457271|NCT01187511|7373577|FG001|STARTED|Overall Study||22
6457272|NCT01187511|7373576|FG000|COMPLETED|Overall Study||14
6457273|NCT01187511|7373577|FG001|COMPLETED|Overall Study||21
6457274|NCT01187511|7373576|FG000|NOT COMPLETED|Overall Study||8
6457275|NCT01187511|7373577|FG001|NOT COMPLETED|Overall Study||1
6457276|NCT01187550|7373585|FG000|STARTED|Overall Study||183
6457277|NCT01187550|7373586|FG001|STARTED|Overall Study||30
6457278|NCT01187550|7373585|FG000|Treated|Overall Study||175
6457279|NCT01187550|7373586|FG001|Treated|Overall Study||30
6457280|NCT01187550|7373585|FG000|COMPLETED|Overall Study||169
6457281|NCT01187550|7373586|FG001|COMPLETED|Overall Study||29
6553700|NCT01745094|7476202|FG002|COMPLETED|Overall Study||46
6553701|NCT01745094|7476203|FG003|COMPLETED|Overall Study||90
6553702|NCT01745094|7476200|FG000|NOT COMPLETED|Overall Study||5
6553703|NCT01745094|7476201|FG001|NOT COMPLETED|Overall Study||0
6553704|NCT01745094|7476202|FG002|NOT COMPLETED|Overall Study||12
6553705|NCT01745094|7476203|FG003|NOT COMPLETED|Overall Study||3
6553706|NCT01745120|7476218|FG000|STARTED|Overall Study||11
6553707|NCT01745120|7476219|FG001|STARTED|Overall Study||8
6779702|NCT03723603|7707921|FG000|STARTED|Overall Study||8
6457282|NCT01187550|7373585|FG000|NOT COMPLETED|Overall Study||14
6457283|NCT01187550|7373586|FG001|NOT COMPLETED|Overall Study||1
6457284|NCT01187771|7373594|FG000|STARTED|Overall Study||28
6457285|NCT01187771|7373595|FG001|STARTED|Overall Study||21
6457286|NCT01187771|7373594|FG000|COMPLETED|Overall Study||25
6457287|NCT01187771|7373595|FG001|COMPLETED|Overall Study||18
6457288|NCT01187771|7373594|FG000|NOT COMPLETED|Overall Study||3
6457289|NCT01187771|7373595|FG001|NOT COMPLETED|Overall Study||3
6457290|NCT01187901|7373605|FG000|STARTED|Overall Study||46
6457291|NCT01187901|7373606|FG001|STARTED|Overall Study||46
6457292|NCT01187901|7373605|FG000|COMPLETED|Overall Study||37
6457293|NCT01187901|7373606|FG001|COMPLETED|Overall Study||36
6457294|NCT01187901|7373605|FG000|NOT COMPLETED|Overall Study||9
6457295|NCT01187901|7373606|FG001|NOT COMPLETED|Overall Study||10
6457296|NCT01187914|7373612|FG000|STARTED|Overall Study||40
6457297|NCT01187914|7373612|FG000|COMPLETED|Overall Study||40
6457298|NCT01187914|7373612|FG000|NOT COMPLETED|Overall Study||0
6457299|NCT01187953|7373618|FG000|STARTED|Overall Study||268
6457300|NCT01187953|7373619|FG001|STARTED|Overall Study||275
6457301|NCT01187953|7373618|FG000|Dosed|Overall Study||266
6457302|NCT01187953|7373619|FG001|Dosed|Overall Study||271
6457303|NCT01187953|7373618|FG000|COMPLETED|Overall Study||253
6457304|NCT01187953|7373619|FG001|COMPLETED|Overall Study||254
6457305|NCT01187953|7373618|FG000|NOT COMPLETED|Overall Study||15
6457306|NCT01187953|7373619|FG001|NOT COMPLETED|Overall Study||21
6457307|NCT01188109|7373625|FG000|STARTED|Overall Study||22
6457308|NCT01188109|7373625|FG000|COMPLETED|Overall Study||22
6457309|NCT01188109|7373625|FG000|NOT COMPLETED|Overall Study||0
6457310|NCT01188226|7373629|FG000|STARTED|Overall Study||10
6457311|NCT01188226|7373629|FG000|COMPLETED|Overall Study||6
6457312|NCT01188226|7373629|FG000|NOT COMPLETED|Overall Study||4
6457313|NCT01188343|7373646|FG000|STARTED|Overall Study||102
6457314|NCT01188343|7373647|FG001|STARTED|Overall Study||219
6457315|NCT01188343|7373648|FG002|STARTED|Overall Study||221
6457316|NCT01188343|7373646|FG000|COMPLETED|Overall Study||101
6457317|NCT01188343|7373647|FG001|COMPLETED|Overall Study||193
6457318|NCT01188343|7373648|FG002|COMPLETED|Overall Study||220
6457319|NCT01188343|7373646|FG000|NOT COMPLETED|Overall Study||1
6457320|NCT01188343|7373647|FG001|NOT COMPLETED|Overall Study||26
6457321|NCT01188343|7373648|FG002|NOT COMPLETED|Overall Study||1
6457322|NCT01188369|7373661|FG000|STARTED|Overall Study||10
6457323|NCT01188369|7373662|FG001|STARTED|Overall Study||10
6457324|NCT01188369|7373661|FG000|COMPLETED|Overall Study||10
6457325|NCT01188369|7373662|FG001|COMPLETED|Overall Study||10
6457326|NCT01188369|7373661|FG000|NOT COMPLETED|Overall Study||0
6457327|NCT01188369|7373662|FG001|NOT COMPLETED|Overall Study||0
6457328|NCT01188421|7373671|FG000|STARTED|Overall Study||31
6457329|NCT01188421|7373672|FG001|STARTED|Overall Study||36
6457330|NCT01188421|7373673|FG002|STARTED|Overall Study||36
6457331|NCT01188421|7373671|FG000|COMPLETED|Overall Study||28
6457332|NCT01188421|7373672|FG001|COMPLETED|Overall Study||26
6457333|NCT01188421|7373673|FG002|COMPLETED|Overall Study||22
6457334|NCT01188421|7373671|FG000|NOT COMPLETED|Overall Study||3
6457335|NCT01188421|7373672|FG001|NOT COMPLETED|Overall Study||10
6457336|NCT01188421|7373673|FG002|NOT COMPLETED|Overall Study||14
6457337|NCT01188447|7373681|FG000|STARTED|Overall Study||4034
6457338|NCT01188447|7373681|FG000|COMPLETED|Overall Study||4034
6457339|NCT01188447|7373681|FG000|NOT COMPLETED|Overall Study||0
6457340|NCT01188460|7373688|FG000|STARTED|Overall Study||25
6457341|NCT01188460|7373689|FG001|STARTED|Overall Study||23
6457342|NCT01188460|7373688|FG000|COMPLETED|Overall Study||25
6457343|NCT01188460|7373689|FG001|COMPLETED|Overall Study||23
6457344|NCT01188460|7373688|FG000|NOT COMPLETED|Overall Study||0
6457345|NCT01188460|7373689|FG001|NOT COMPLETED|Overall Study||0
6457346|NCT01188499|7373700|FG000|STARTED|Overall Study||24
6457347|NCT01188499|7373701|FG001|STARTED|Overall Study||83
6457348|NCT01188499|7373702|FG002|STARTED|Overall Study||33
6457349|NCT01188499|7373703|FG003|STARTED|Overall Study||18
6457350|NCT01188499|7373704|FG004|STARTED|Overall Study||18
6457351|NCT01188499|7373700|FG000|COMPLETED|Overall Study||24
6457352|NCT01188499|7373701|FG001|COMPLETED|Overall Study||83
6457353|NCT01188499|7373702|FG002|COMPLETED|Overall Study||33
6457354|NCT01188499|7373703|FG003|COMPLETED|Overall Study||18
6457355|NCT01188499|7373704|FG004|COMPLETED|Overall Study||18
6457356|NCT01188499|7373700|FG000|NOT COMPLETED|Overall Study||0
6457357|NCT01188499|7373701|FG001|NOT COMPLETED|Overall Study||0
6457358|NCT01188499|7373702|FG002|NOT COMPLETED|Overall Study||0
6457359|NCT01188499|7373703|FG003|NOT COMPLETED|Overall Study||0
6457360|NCT01188499|7373704|FG004|NOT COMPLETED|Overall Study||0
6457361|NCT01188538|7373718|FG000|STARTED|Overall Study||20
6457362|NCT01188538|7373719|FG001|STARTED|Overall Study||20
6457363|NCT01188538|7373718|FG000|COMPLETED|Overall Study||20
6457364|NCT01188538|7373719|FG001|COMPLETED|Overall Study||19
6457365|NCT01188538|7373718|FG000|NOT COMPLETED|Overall Study||0
6457366|NCT01188538|7373719|FG001|NOT COMPLETED|Overall Study||1
6457367|NCT01188551|7373731|FG000|STARTED|Overall Study||25
6457368|NCT01188551|7373732|FG001|STARTED|Overall Study||25
6457369|NCT01188551|7373733|FG002|STARTED|Overall Study||25
6457370|NCT01188551|7373734|FG003|STARTED|Overall Study||25
6457371|NCT01188551|7373731|FG000|COMPLETED|Overall Study||24
6457372|NCT01188551|7373732|FG001|COMPLETED|Overall Study||25
6457373|NCT01188551|7373733|FG002|COMPLETED|Overall Study||25
6457374|NCT01188551|7373734|FG003|COMPLETED|Overall Study||25
6457375|NCT01188551|7373731|FG000|NOT COMPLETED|Overall Study||1
6457376|NCT01188551|7373732|FG001|NOT COMPLETED|Overall Study||0
6457377|NCT01188551|7373733|FG002|NOT COMPLETED|Overall Study||0
6457378|NCT01188551|7373734|FG003|NOT COMPLETED|Overall Study||0
6457379|NCT01188564|7373746|FG000|STARTED|Double-blind Phase||44
6457380|NCT01188564|7373747|FG001|STARTED|Double-blind Phase||31
6457381|NCT01188564|7373746|FG000|COMPLETED|Double-blind Phase||43
6457382|NCT01188564|7373747|FG001|COMPLETED|Double-blind Phase||31
6457383|NCT01188564|7373746|FG000|NOT COMPLETED|Double-blind Phase||1
6457384|NCT01188564|7373747|FG001|NOT COMPLETED|Double-blind Phase||0
6457385|NCT01188564|7373746|FG000|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
6457386|NCT01188564|7373747|FG001|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
6457387|NCT01188564|7373746|FG000|COMPLETED|Open Label Phase||24
6457388|NCT01188564|7373747|FG001|COMPLETED|Open Label Phase||20
6457389|NCT01188564|7373746|FG000|NOT COMPLETED|Open Label Phase||0
6457390|NCT01188564|7373747|FG001|NOT COMPLETED|Open Label Phase||0
6457391|NCT01188577|7373755|FG000|STARTED|Visit 1||11
6457392|NCT01188577|7373756|FG001|STARTED|Visit 1||12
6457393|NCT01188577|7373755|FG000|COMPLETED|Visit 1||11
6457394|NCT01188577|7373756|FG001|COMPLETED|Visit 1||12
6457395|NCT01188577|7373755|FG000|NOT COMPLETED|Visit 1||0
6457396|NCT01188577|7373756|FG001|NOT COMPLETED|Visit 1||0
6457397|NCT01188577|7373755|FG000|STARTED|3-14 Day Washout||11
6457398|NCT01188577|7373756|FG001|STARTED|3-14 Day Washout||12
6457399|NCT01188577|7373755|FG000|COMPLETED|3-14 Day Washout||11
6457400|NCT01188577|7373756|FG001|COMPLETED|3-14 Day Washout||12
6457401|NCT01188577|7373755|FG000|NOT COMPLETED|3-14 Day Washout||0
6457402|NCT01188577|7373756|FG001|NOT COMPLETED|3-14 Day Washout||0
6457403|NCT01188577|7373755|FG000|STARTED|Visit 2||11
6457404|NCT01188577|7373756|FG001|STARTED|Visit 2||12
6457405|NCT01188577|7373755|FG000|COMPLETED|Visit 2||11
6457406|NCT01188577|7373756|FG001|COMPLETED|Visit 2||12
6457407|NCT01188577|7373755|FG000|NOT COMPLETED|Visit 2||0
6457408|NCT01188577|7373756|FG001|NOT COMPLETED|Visit 2||0
6457409|NCT01188603|7373762|FG000|STARTED|Overall Study||24
6457410|NCT01188603|7373762|FG000|COMPLETED|Overall Study||24
6457411|NCT01188603|7373762|FG000|NOT COMPLETED|Overall Study||0
6457412|NCT01188655|7373766|FG000|STARTED|Overall Study||89
6457413|NCT01188655|7373766|FG000|COMPLETED|Overall Study||76
6457414|NCT01188655|7373766|FG000|NOT COMPLETED|Overall Study||13
6457415|NCT01188668|7373770|FG000|STARTED|Period 1: ARIP Alone||38
6457416|NCT01188668|7373770|FG000|COMPLETED|Period 1: ARIP Alone||36
6457417|NCT01188668|7373770|FG000|NOT COMPLETED|Period 1: ARIP Alone||2
6457418|NCT01188668|7373770|FG000|STARTED|Period 2: Coadministration ARIP + DVS SR||36
6457419|NCT01188668|7373770|FG000|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
6457420|NCT01188668|7373770|FG000|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
6457421|NCT01188681|7373781|FG000|STARTED|Overall Study||6
6457422|NCT01188681|7373782|FG001|STARTED|Overall Study||6
6457423|NCT01188681|7373783|FG002|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
6457424|NCT01188681|7373784|FG003|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
6457425|NCT01188681|7373781|FG000|COMPLETED|Overall Study||6
6457426|NCT01188681|7373782|FG001|COMPLETED|Overall Study||6
6457427|NCT01188681|7373783|FG002|COMPLETED|Overall Study||32
6457428|NCT01188681|7373784|FG003|COMPLETED|Overall Study||33
6457429|NCT01188681|7373781|FG000|NOT COMPLETED|Overall Study||0
6457430|NCT01188681|7373782|FG001|NOT COMPLETED|Overall Study||0
6457431|NCT01188681|7373783|FG002|NOT COMPLETED|Overall Study||1
6457432|NCT01188681|7373784|FG003|NOT COMPLETED|Overall Study||1
6457433|NCT01188694|7373801|FG000|STARTED|Overall Study||15
6457434|NCT01188694|7373802|FG001|STARTED|Overall Study||16
6457435|NCT01188694|7373803|FG002|STARTED|Overall Study||11
6457436|NCT01188694|7373801|FG000|COMPLETED|Overall Study||10
6457437|NCT01188694|7373802|FG001|COMPLETED|Overall Study||15
6457438|NCT01188694|7373803|FG002|COMPLETED|Overall Study||10
6457439|NCT01188694|7373801|FG000|NOT COMPLETED|Overall Study||5
6457440|NCT01188694|7373802|FG001|NOT COMPLETED|Overall Study||1
6457441|NCT01188694|7373803|FG002|NOT COMPLETED|Overall Study||1
6457442|NCT01188772|7373815|FG000|STARTED|Overall Study||48
6457443|NCT01188772|7373816|FG001|STARTED|Overall Study||48
6457444|NCT01188772|7373817|FG002|STARTED|Overall Study||26
6457445|NCT01188772|7373818|FG003|STARTED|Overall Study||25
6457446|NCT01188772|7373815|FG000|Randomized and Treated|Overall Study||48
6457447|NCT01188772|7373816|FG001|Randomized and Treated|Overall Study||47
6457448|NCT01188772|7373817|FG002|Randomized and Treated|Overall Study||26
6457449|NCT01188772|7373818|FG003|Randomized and Treated|Overall Study||25
6457450|NCT01188772|7373815|FG000|COMPLETED|Overall Study||43
6457451|NCT01188772|7373816|FG001|COMPLETED|Overall Study||45
6457452|NCT01188772|7373817|FG002|COMPLETED|Overall Study||15
6457453|NCT01188772|7373818|FG003|COMPLETED|Overall Study||24
6457454|NCT01188772|7373815|FG000|NOT COMPLETED|Overall Study||5
6457455|NCT01188772|7373816|FG001|NOT COMPLETED|Overall Study||3
6457456|NCT01188772|7373817|FG002|NOT COMPLETED|Overall Study||11
6457457|NCT01188772|7373818|FG003|NOT COMPLETED|Overall Study||1
6457458|NCT01188811|7373833|FG000|STARTED|Overall Study||28
6457459|NCT01188811|7373834|FG001|STARTED|Overall Study||26
6457460|NCT01188811|7373833|FG000|COMPLETED|Overall Study||22
6457461|NCT01188811|7373834|FG001|COMPLETED|Overall Study||24
6457462|NCT01188811|7373833|FG000|NOT COMPLETED|Overall Study||6
6457463|NCT01188811|7373834|FG001|NOT COMPLETED|Overall Study||2
6457464|NCT01188876|7373840|FG000|STARTED|Overall Study||50
6457465|NCT01188876|7373840|FG000|COMPLETED|Overall Study||50
6457466|NCT01188876|7373840|FG000|NOT COMPLETED|Overall Study||0
6457467|NCT01188928|7373848|FG000|STARTED|Overall Study||482
6457468|NCT01188928|7373849|FG001|STARTED|Overall Study||479
6457469|NCT01188928|7373850|FG002|STARTED|Overall Study||96
6457470|NCT01188928|7373851|FG003|STARTED|Overall Study||95
6457471|NCT01188928|7373848|FG000|COMPLETED|Overall Study||444
6457472|NCT01188928|7373849|FG001|COMPLETED|Overall Study||417
6457473|NCT01188928|7373850|FG002|COMPLETED|Overall Study||82
6457474|NCT01188928|7373851|FG003|COMPLETED|Overall Study||77
6457475|NCT01188928|7373848|FG000|NOT COMPLETED|Overall Study||38
6457476|NCT01188928|7373849|FG001|NOT COMPLETED|Overall Study||62
6457477|NCT01188928|7373850|FG002|NOT COMPLETED|Overall Study||14
6457478|NCT01188928|7373851|FG003|NOT COMPLETED|Overall Study||18
6457479|NCT01188967|7373863|FG000|STARTED|Overall Study||10
6457480|NCT01188967|7373864|FG001|STARTED|Overall Study||8
6457481|NCT01188967|7373863|FG000|COMPLETED|Overall Study||5
6457482|NCT01188967|7373864|FG001|COMPLETED|Overall Study||4
6457483|NCT01188967|7373863|FG000|NOT COMPLETED|Overall Study||5
6457484|NCT01188967|7373864|FG001|NOT COMPLETED|Overall Study||4
6457485|NCT01189032|7373875|FG000|STARTED|Overall Study||94
6457486|NCT01189032|7373876|FG001|STARTED|Overall Study||96
6457487|NCT01189032|7373877|FG002|STARTED|Overall Study||96
6457488|NCT01189032|7373875|FG000|COMPLETED|Overall Study||89
6457489|NCT01189032|7373876|FG001|COMPLETED|Overall Study||89
6457490|NCT01189032|7373877|FG002|COMPLETED|Overall Study||90
6457491|NCT01189032|7373875|FG000|NOT COMPLETED|Overall Study||5
6457492|NCT01189032|7373876|FG001|NOT COMPLETED|Overall Study||7
6457493|NCT01189032|7373877|FG002|NOT COMPLETED|Overall Study||6
6457494|NCT01189110|7373887|FG000|STARTED|Overall Study|September, 2010|64
6457495|NCT01189110|7373888|FG001|STARTED|Overall Study||61
6457496|NCT01189110|7373887|FG000|COMPLETED|Overall Study|February, 2011|64
6457497|NCT01189110|7373888|FG001|COMPLETED|Overall Study||61
6457498|NCT01189110|7373887|FG000|NOT COMPLETED|Overall Study||0
6457499|NCT01189110|7373888|FG001|NOT COMPLETED|Overall Study||0
6457500|NCT01189123|7373896|FG000|STARTED|Overall Study||52
6457501|NCT01189123|7373897|FG001|STARTED|Overall Study||53
6457502|NCT01189123|7373896|FG000|COMPLETED|Overall Study||50
6457503|NCT01189123|7373897|FG001|COMPLETED|Overall Study||47
6457504|NCT01189123|7373896|FG000|NOT COMPLETED|Overall Study||2
6457505|NCT01189123|7373897|FG001|NOT COMPLETED|Overall Study||6
6457506|NCT01189136|7373905|FG000|STARTED|Overall Study||42
6457507|NCT01189136|7373906|FG001|STARTED|Overall Study||42
6457508|NCT01189136|7373905|FG000|COMPLETED|Overall Study||42
6457509|NCT01189136|7373906|FG001|COMPLETED|Overall Study||42
6457510|NCT01189136|7373905|FG000|NOT COMPLETED|Overall Study||0
6457511|NCT01189136|7373906|FG001|NOT COMPLETED|Overall Study||0
6457512|NCT01189201|7373912|FG000|STARTED|Overall Study||42
6457513|NCT01189201|7373912|FG000|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
6457514|NCT01189201|7373912|FG000|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
6457515|NCT01189201|7373912|FG000|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
6457516|NCT01189201|7373912|FG000|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
6457517|NCT01189201|7373912|FG000|COMPLETED|Overall Study||41
6457518|NCT01189201|7373912|FG000|NOT COMPLETED|Overall Study||1
6457519|NCT01189240|7373927|FG000|STARTED|Overall Study||4
6457520|NCT01189240|7373928|FG001|STARTED|Overall Study||6
6457521|NCT01189240|7373929|FG002|STARTED|Overall Study||3
6457522|NCT01189240|7373927|FG000|COMPLETED|Overall Study||4
6457523|NCT01189240|7373928|FG001|COMPLETED|Overall Study||6
6457524|NCT01189240|7373929|FG002|COMPLETED|Overall Study||3
6457525|NCT01189240|7373927|FG000|NOT COMPLETED|Overall Study||0
6457526|NCT01189240|7373928|FG001|NOT COMPLETED|Overall Study||0
6457527|NCT01189240|7373929|FG002|NOT COMPLETED|Overall Study||0
6457528|NCT01189266|7373942|FG000|STARTED|Overall Study||6
6457529|NCT01189266|7373943|FG001|STARTED|Overall Study||6
6457530|NCT01189266|7373944|FG002|STARTED|Overall Study||67
6457531|NCT01189266|7373942|FG000|COMPLETED|Overall Study||0
6457532|NCT01189266|7373943|FG001|COMPLETED|Overall Study||0
6457533|NCT01189266|7373944|FG002|COMPLETED|Overall Study||2
6457534|NCT01189266|7373942|FG000|NOT COMPLETED|Overall Study||6
6457535|NCT01189266|7373943|FG001|NOT COMPLETED|Overall Study||6
6457536|NCT01189266|7373944|FG002|NOT COMPLETED|Overall Study||65
6457537|NCT01189279|7373956|FG000|STARTED|Overall Study||14
6457538|NCT01189279|7373957|FG001|STARTED|Overall Study||14
6457539|NCT01189279|7373958|FG002|STARTED|Overall Study||14
6457540|NCT01189279|7373956|FG000|COMPLETED|Overall Study||13
6457541|NCT01189279|7373957|FG001|COMPLETED|Overall Study||14
6457542|NCT01189279|7373958|FG002|COMPLETED|Overall Study||13
6457543|NCT01189279|7373956|FG000|NOT COMPLETED|Overall Study||1
6457544|NCT01189279|7373957|FG001|NOT COMPLETED|Overall Study||0
6457545|NCT01189279|7373958|FG002|NOT COMPLETED|Overall Study||1
6457546|NCT01189292|7373968|FG000|STARTED|Intention to Treat Analysis||76
6457547|NCT01189292|7373969|FG001|STARTED|Intention to Treat Analysis||76
6457548|NCT01189292|7373968|FG000|COMPLETED|Intention to Treat Analysis||76
6457549|NCT01189292|7373969|FG001|COMPLETED|Intention to Treat Analysis||76
6457550|NCT01189292|7373968|FG000|NOT COMPLETED|Intention to Treat Analysis||0
6457551|NCT01189292|7373969|FG001|NOT COMPLETED|Intention to Treat Analysis||0
6457552|NCT01189292|7373968|FG000|STARTED|Per Protocol Analysis||76
6457553|NCT01189292|7373969|FG001|STARTED|Per Protocol Analysis||76
6457554|NCT01189292|7373968|FG000|COMPLETED|Per Protocol Analysis||65
6457555|NCT01189292|7373969|FG001|COMPLETED|Per Protocol Analysis||60
6457556|NCT01189292|7373968|FG000|NOT COMPLETED|Per Protocol Analysis||11
6457557|NCT01189292|7373969|FG001|NOT COMPLETED|Per Protocol Analysis||16
6457558|NCT01189370|7373975|FG000|STARTED|Dose Level 1||25
6457559|NCT01189370|7373976|FG001|STARTED|Dose Level 1||0
6457560|NCT01189370|7373977|FG002|STARTED|Dose Level 1||0
6457561|NCT01189370|7373975|FG000|COMPLETED|Dose Level 1||16
6457562|NCT01189370|7373976|FG001|COMPLETED|Dose Level 1||0
6457563|NCT01189370|7373977|FG002|COMPLETED|Dose Level 1||0
6457564|NCT01189370|7373975|FG000|NOT COMPLETED|Dose Level 1||9
6457565|NCT01189370|7373976|FG001|NOT COMPLETED|Dose Level 1||0
6457566|NCT01189370|7373977|FG002|NOT COMPLETED|Dose Level 1||0
6457567|NCT01189370|7373975|FG000|STARTED|Dose Level 2||0
6457568|NCT01189370|7373976|FG001|STARTED|Dose Level 2||16
6457569|NCT01189370|7373977|FG002|STARTED|Dose Level 2||0
6457570|NCT01189370|7373975|FG000|COMPLETED|Dose Level 2||0
6457571|NCT01189370|7373976|FG001|COMPLETED|Dose Level 2||12
6457572|NCT01189370|7373977|FG002|COMPLETED|Dose Level 2||0
6457573|NCT01189370|7373975|FG000|NOT COMPLETED|Dose Level 2||0
6457574|NCT01189370|7373976|FG001|NOT COMPLETED|Dose Level 2||4
6457575|NCT01189370|7373977|FG002|NOT COMPLETED|Dose Level 2||0
6457576|NCT01189370|7373975|FG000|STARTED|Dose Level 3||0
6457577|NCT01189370|7373976|FG001|STARTED|Dose Level 3||0
6457578|NCT01189370|7373977|FG002|STARTED|Dose Level 3||12
6457579|NCT01189370|7373975|FG000|COMPLETED|Dose Level 3||0
6457580|NCT01189370|7373976|FG001|COMPLETED|Dose Level 3||0
6457581|NCT01189370|7373977|FG002|COMPLETED|Dose Level 3||6
6457582|NCT01189370|7373975|FG000|NOT COMPLETED|Dose Level 3||0
6457583|NCT01189370|7373976|FG001|NOT COMPLETED|Dose Level 3||0
6457584|NCT01189370|7373977|FG002|NOT COMPLETED|Dose Level 3||6
6457585|NCT01189409|7373986|FG000|STARTED|First 3 Weeks||37
6457586|NCT01189409|7373987|FG001|STARTED|First 3 Weeks||33
6457587|NCT01189409|7373986|FG000|COMPLETED|First 3 Weeks||19
6457588|NCT01189409|7373987|FG001|COMPLETED|First 3 Weeks||23
6457589|NCT01189409|7373986|FG000|NOT COMPLETED|First 3 Weeks||18
6457590|NCT01189409|7373987|FG001|NOT COMPLETED|First 3 Weeks||10
6457591|NCT01189409|7373986|FG000|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||19
6457592|NCT01189409|7373987|FG001|STARTED|Second 3 Weeks (Switch to 2nd Treatment)||23
6457593|NCT01189409|7373986|FG000|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||13
6457594|NCT01189409|7373987|FG001|COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||15
6457595|NCT01189409|7373986|FG000|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||6
6457596|NCT01189409|7373987|FG001|NOT COMPLETED|Second 3 Weeks (Switch to 2nd Treatment)||8
6457597|NCT01189461|7374000|FG000|STARTED|Overall Study||46
6457598|NCT01189461|7374000|FG000|COMPLETED|Overall Study||12
6457599|NCT01189461|7374000|FG000|NOT COMPLETED|Overall Study||34
6553708|NCT01745120|7476218|FG000|COMPLETED|Overall Study||10
6553709|NCT01745120|7476219|FG001|COMPLETED|Overall Study||8
6553710|NCT01745120|7476218|FG000|NOT COMPLETED|Overall Study||1
6553711|NCT01745120|7476219|FG001|NOT COMPLETED|Overall Study||0
6553712|NCT01745133|7476231|FG000|STARTED|Overall Study||19
6553713|NCT01745133|7476232|FG001|STARTED|Overall Study||20
6553714|NCT01745133|7476233|FG002|STARTED|Overall Study||19
6553715|NCT01745133|7476231|FG000|COMPLETED|Overall Study||13
6553716|NCT01745133|7476232|FG001|COMPLETED|Overall Study||16
6553717|NCT01745133|7476233|FG002|COMPLETED|Overall Study||15
6553718|NCT01745133|7476231|FG000|NOT COMPLETED|Overall Study||6
6553719|NCT01745133|7476232|FG001|NOT COMPLETED|Overall Study||4
6553720|NCT01745133|7476233|FG002|NOT COMPLETED|Overall Study||4
6553721|NCT01745146|7476243|FG000|STARTED|Overall Study||30
6457600|NCT01189487|7374004|FG000|STARTED|Overall Study|Treated participants|47
6457601|NCT01189487|7374004|FG000|COMPLETED|Overall Study||44
6457602|NCT01189487|7374004|FG000|NOT COMPLETED|Overall Study||3
6457603|NCT01189500|7374008|FG000|STARTED|Period 1: TAMOX Alone||30
6457604|NCT01189500|7374008|FG000|COMPLETED|Period 1: TAMOX Alone||29
6457605|NCT01189500|7374008|FG000|NOT COMPLETED|Period 1: TAMOX Alone||1
6457606|NCT01189500|7374008|FG000|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
6457607|NCT01189500|7374008|FG000|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
6457608|NCT01189500|7374008|FG000|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
6457609|NCT01189604|7374022|FG000|STARTED|Overall Study||21
6457610|NCT01189604|7374023|FG001|STARTED|Overall Study||21
6457611|NCT01189604|7374024|FG002|STARTED|Overall Study||20
6457612|NCT01189604|7374025|FG003|STARTED|Overall Study||20
6457613|NCT01189604|7374026|FG004|STARTED|Overall Study||20
6457614|NCT01189604|7374027|FG005|STARTED|Overall Study||11
6457615|NCT01189604|7374028|FG006|STARTED|Overall Study||10
6457616|NCT01189604|7374022|FG000|Administered Study Drug|Overall Study||20
6553722|NCT01745146|7476244|FG001|STARTED|Overall Study||60
6457617|NCT01189604|7374023|FG001|Administered Study Drug|Overall Study||20
6457618|NCT01189604|7374024|FG002|Administered Study Drug|Overall Study||20
6457619|NCT01189604|7374025|FG003|Administered Study Drug|Overall Study||20
6457620|NCT01189604|7374026|FG004|Administered Study Drug|Overall Study||20
6457621|NCT01189604|7374027|FG005|Administered Study Drug|Overall Study||10
6457622|NCT01189604|7374028|FG006|Administered Study Drug|Overall Study||10
6457623|NCT01189604|7374022|FG000|COMPLETED|Overall Study||20
6457624|NCT01189604|7374023|FG001|COMPLETED|Overall Study||20
6457625|NCT01189604|7374024|FG002|COMPLETED|Overall Study||20
6457626|NCT01189604|7374025|FG003|COMPLETED|Overall Study||20
6457627|NCT01189604|7374026|FG004|COMPLETED|Overall Study||18
6553723|NCT01745146|7476243|FG000|Allocation to Intervention|Overall Study||30
6457628|NCT01189604|7374027|FG005|COMPLETED|Overall Study||10
6457629|NCT01189604|7374028|FG006|COMPLETED|Overall Study||9
6457630|NCT01189604|7374022|FG000|NOT COMPLETED|Overall Study||1
6457631|NCT01189604|7374023|FG001|NOT COMPLETED|Overall Study||1
6457632|NCT01189604|7374024|FG002|NOT COMPLETED|Overall Study||0
6457633|NCT01189604|7374025|FG003|NOT COMPLETED|Overall Study||0
6457634|NCT01189604|7374026|FG004|NOT COMPLETED|Overall Study||2
6457635|NCT01189604|7374027|FG005|NOT COMPLETED|Overall Study||1
6553724|NCT01745146|7476244|FG001|Allocation to Intervention|Overall Study||60
6553725|NCT01745146|7476243|FG000|Primary Outcome Assessment|Overall Study||27
6553726|NCT01745146|7476244|FG001|Primary Outcome Assessment|Overall Study||57
6553727|NCT01745146|7476243|FG000|Analysis|Overall Study||27
6553728|NCT01745146|7476244|FG001|Analysis|Overall Study||57
6457636|NCT01189604|7374028|FG006|NOT COMPLETED|Overall Study||1
6457637|NCT01189617|7374046|FG000|STARTED|Overall Study||35
6457638|NCT01189617|7374047|FG001|STARTED|Overall Study||35
6457639|NCT01189617|7374046|FG000|COMPLETED|Overall Study||35
6457640|NCT01189617|7374047|FG001|COMPLETED|Overall Study||35
6457641|NCT01189617|7374046|FG000|NOT COMPLETED|Overall Study||0
6457642|NCT01189617|7374047|FG001|NOT COMPLETED|Overall Study||0
6457643|NCT01189747|7374055|FG000|STARTED|Overall Study||222
6457644|NCT01189747|7374056|FG001|STARTED|Overall Study||224
6457645|NCT01189747|7374055|FG000|COMPLETED|Overall Study||210
6457646|NCT01189747|7374056|FG001|COMPLETED|Overall Study||206
6457647|NCT01189747|7374055|FG000|NOT COMPLETED|Overall Study||12
6457648|NCT01189747|7374056|FG001|NOT COMPLETED|Overall Study||18
6457649|NCT01189760|7374065|FG000|STARTED|Overall Study||305
6457650|NCT01189760|7374066|FG001|STARTED|Overall Study||306
6457651|NCT01189760|7374067|FG002|STARTED|Overall Study||306
6457652|NCT01189760|7374065|FG000|COMPLETED|Overall Study||291
6457653|NCT01189760|7374066|FG001|COMPLETED|Overall Study||283
6457654|NCT01189760|7374067|FG002|COMPLETED|Overall Study||255
6457655|NCT01189760|7374065|FG000|NOT COMPLETED|Overall Study||14
6457656|NCT01189760|7374066|FG001|NOT COMPLETED|Overall Study||23
6457657|NCT01189760|7374067|FG002|NOT COMPLETED|Overall Study||51
6457658|NCT01189812|7374077|FG000|STARTED|Overall Study||40
6457659|NCT01189812|7374078|FG001|STARTED|Overall Study||40
6457660|NCT01189812|7374077|FG000|COMPLETED|Overall Study||32
6457661|NCT01189812|7374078|FG001|COMPLETED|Overall Study||32
6457662|NCT01189812|7374077|FG000|NOT COMPLETED|Overall Study||8
6457663|NCT01189812|7374078|FG001|NOT COMPLETED|Overall Study||8
6457664|NCT01189890|7374086|FG000|STARTED|Overall Study||241
6457665|NCT01189890|7374087|FG001|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
6457666|NCT01189890|7374086|FG000|COMPLETED|Overall Study||204
6457667|NCT01189890|7374087|FG001|COMPLETED|Overall Study||200
6457668|NCT01189890|7374086|FG000|NOT COMPLETED|Overall Study||37
6457669|NCT01189890|7374087|FG001|NOT COMPLETED|Overall Study||39
6457670|NCT01190007|7374093|FG000|STARTED|Overall Study|Treated|159
6457671|NCT01190007|7374093|FG000|COMPLETED|Overall Study||145
6457672|NCT01190007|7374093|FG000|NOT COMPLETED|Overall Study||14
6457673|NCT01190020|7374099|FG000|STARTED|Overall Study||29
6457674|NCT01190020|7374100|FG001|STARTED|Overall Study||12
6457675|NCT01190020|7374099|FG000|COMPLETED|Overall Study||22
6457676|NCT01190020|7374100|FG001|COMPLETED|Overall Study||12
6457677|NCT01190020|7374099|FG000|NOT COMPLETED|Overall Study||7
6457678|NCT01190020|7374100|FG001|NOT COMPLETED|Overall Study||0
6457679|NCT01190085|7374109|FG000|STARTED|Overall Study||13
6457680|NCT01190085|7374110|FG001|STARTED|Overall Study||14
6457681|NCT01190085|7374111|FG002|STARTED|Overall Study||18
6457682|NCT01190085|7374109|FG000|COMPLETED|Overall Study||13
6457683|NCT01190085|7374110|FG001|COMPLETED|Overall Study||14
6457684|NCT01190085|7374111|FG002|COMPLETED|Overall Study||18
6457685|NCT01190085|7374109|FG000|NOT COMPLETED|Overall Study||0
6457686|NCT01190085|7374110|FG001|NOT COMPLETED|Overall Study||0
6457687|NCT01190085|7374111|FG002|NOT COMPLETED|Overall Study||0
6457688|NCT01190098|7374121|FG000|STARTED|Overall Study||42
6457689|NCT01190098|7374122|FG001|STARTED|Overall Study||10
6457690|NCT01190098|7374121|FG000|COMPLETED|Overall Study||39
6457691|NCT01190098|7374122|FG001|COMPLETED|Overall Study||8
6457692|NCT01190098|7374121|FG000|NOT COMPLETED|Overall Study||3
6457693|NCT01190098|7374122|FG001|NOT COMPLETED|Overall Study||2
6457694|NCT01190124|7374131|FG000|STARTED|Overall Study||107
6457695|NCT01190124|7374132|FG001|STARTED|Overall Study||24
6457696|NCT01190124|7374133|FG002|STARTED|Overall Study||20
6457697|NCT01190124|7374131|FG000|COMPLETED|Overall Study||90
6457698|NCT01190124|7374132|FG001|COMPLETED|Overall Study||24
6457699|NCT01190124|7374133|FG002|COMPLETED|Overall Study||19
6457700|NCT01190124|7374131|FG000|NOT COMPLETED|Overall Study||17
6457701|NCT01190124|7374132|FG001|NOT COMPLETED|Overall Study||0
6457702|NCT01190124|7374133|FG002|NOT COMPLETED|Overall Study||1
6457703|NCT01190150|7374146|FG000|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
6457704|NCT01190150|7374147|FG001|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
6457705|NCT01190150|7374146|FG000|COMPLETED|First Treatment||10
6457706|NCT01190150|7374147|FG001|COMPLETED|First Treatment||9
6457707|NCT01190150|7374146|FG000|NOT COMPLETED|First Treatment||1
6457708|NCT01190150|7374147|FG001|NOT COMPLETED|First Treatment||0
6457709|NCT01190150|7374146|FG000|STARTED|Washout||10
6457710|NCT01190150|7374147|FG001|STARTED|Washout||9
6457711|NCT01190150|7374146|FG000|COMPLETED|Washout||10
6457712|NCT01190150|7374147|FG001|COMPLETED|Washout||7
6457713|NCT01190150|7374146|FG000|NOT COMPLETED|Washout||0
6457714|NCT01190150|7374147|FG001|NOT COMPLETED|Washout||2
6457715|NCT01190150|7374146|FG000|STARTED|Second Treatment||10
6457716|NCT01190150|7374147|FG001|STARTED|Second Treatment||7
6457717|NCT01190150|7374146|FG000|COMPLETED|Second Treatment||10
6457718|NCT01190150|7374147|FG001|COMPLETED|Second Treatment||7
6457719|NCT01190150|7374146|FG000|NOT COMPLETED|Second Treatment||0
6457720|NCT01190150|7374147|FG001|NOT COMPLETED|Second Treatment||0
6457721|NCT01190176|7374153|FG000|STARTED|Overall Study||32
6457722|NCT01190176|7374153|FG000|COMPLETED|Overall Study||30
6457723|NCT01190176|7374153|FG000|NOT COMPLETED|Overall Study||2
6457724|NCT01190189|7374157|FG000|STARTED|Overall Study||137
6457725|NCT01190189|7374157|FG000|COMPLETED|Overall Study||131
6457726|NCT01190189|7374157|FG000|NOT COMPLETED|Overall Study||6
6457727|NCT01190215|7374163|FG000|STARTED|Up to Day 28||38
6457728|NCT01190215|7374164|FG001|STARTED|Up to Day 28||39
6457729|NCT01190215|7374163|FG000|COMPLETED|Up to Day 28||38
6457730|NCT01190215|7374164|FG001|COMPLETED|Up to Day 28||39
6457731|NCT01190215|7374163|FG000|NOT COMPLETED|Up to Day 28||0
6457732|NCT01190215|7374164|FG001|NOT COMPLETED|Up to Day 28||0
6457733|NCT01190215|7374163|FG000|STARTED|Up to Month 6||38
6457734|NCT01190215|7374164|FG001|STARTED|Up to Month 6||39
6457735|NCT01190215|7374163|FG000|COMPLETED|Up to Month 6||36
6457736|NCT01190215|7374164|FG001|COMPLETED|Up to Month 6||39
6457737|NCT01190215|7374163|FG000|NOT COMPLETED|Up to Month 6||2
6457738|NCT01190215|7374164|FG001|NOT COMPLETED|Up to Month 6||0
6457739|NCT01190410|7374172|FG000|STARTED|Overall Study||4
6457740|NCT01190410|7374173|FG001|STARTED|Overall Study||12
6457741|NCT01190410|7374172|FG000|Re-Induction|Overall Study||0
6457742|NCT01190410|7374173|FG001|Re-Induction|Overall Study||2
6457743|NCT01190410|7374172|FG000|COMPLETED|Overall Study||3
6457744|NCT01190410|7374173|FG001|COMPLETED|Overall Study||3
6457745|NCT01190410|7374172|FG000|NOT COMPLETED|Overall Study||1
6457746|NCT01190410|7374173|FG001|NOT COMPLETED|Overall Study||9
6457747|NCT01190436|7374185|FG000|STARTED|Overall Study||125
6457748|NCT01190436|7374185|FG000|COMPLETED|Overall Study||86
6457749|NCT01190436|7374185|FG000|NOT COMPLETED|Overall Study||39
6457750|NCT01190449|7374192|FG000|STARTED|Overall Study||15
6457751|NCT01190449|7374193|FG001|STARTED|Overall Study||36
6457752|NCT01190449|7374192|FG000|COMPLETED|Overall Study||15
6457753|NCT01190449|7374193|FG001|COMPLETED|Overall Study||32
6457754|NCT01190449|7374192|FG000|NOT COMPLETED|Overall Study||0
6457755|NCT01190449|7374193|FG001|NOT COMPLETED|Overall Study||4
6457756|NCT01190475|7374202|FG000|STARTED|Overall Study||2
6457757|NCT01190475|7374203|FG001|STARTED|Overall Study||2
6457758|NCT01190475|7374204|FG002|STARTED|Overall Study||2
6457759|NCT01190475|7374202|FG000|COMPLETED|Overall Study||2
6457760|NCT01190475|7374203|FG001|COMPLETED|Overall Study||2
6457761|NCT01190475|7374204|FG002|COMPLETED|Overall Study||1
6457762|NCT01190475|7374202|FG000|NOT COMPLETED|Overall Study||0
6457763|NCT01190475|7374203|FG001|NOT COMPLETED|Overall Study||0
6457764|NCT01190475|7374204|FG002|NOT COMPLETED|Overall Study||1
6457765|NCT01190514|7374214|FG000|STARTED|First Intervention (Period 1)||11
6457766|NCT01190514|7374215|FG001|STARTED|First Intervention (Period 1)||10
6457767|NCT01190514|7374216|FG002|STARTED|First Intervention (Period 1)||10
6457768|NCT01190514|7374217|FG003|STARTED|First Intervention (Period 1)||10
6457769|NCT01190514|7374214|FG000|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
6457770|NCT01190514|7374215|FG001|COMPLETED|First Intervention (Period 1)||10
6457771|NCT01190514|7374216|FG002|COMPLETED|First Intervention (Period 1)||10
6457772|NCT01190514|7374217|FG003|COMPLETED|First Intervention (Period 1)||10
6457773|NCT01190514|7374214|FG000|NOT COMPLETED|First Intervention (Period 1)||1
6457774|NCT01190514|7374215|FG001|NOT COMPLETED|First Intervention (Period 1)||0
6457775|NCT01190514|7374216|FG002|NOT COMPLETED|First Intervention (Period 1)||0
6457776|NCT01190514|7374217|FG003|NOT COMPLETED|First Intervention (Period 1)||0
6457777|NCT01190514|7374214|FG000|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
6457778|NCT01190514|7374215|FG001|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
6457779|NCT01190514|7374216|FG002|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
6457780|NCT01190514|7374217|FG003|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
6457781|NCT01190514|7374214|FG000|COMPLETED|Second Intervention (Period 2)||10
6457782|NCT01190514|7374215|FG001|COMPLETED|Second Intervention (Period 2)||10
6457783|NCT01190514|7374216|FG002|COMPLETED|Second Intervention (Period 2)||10
6457784|NCT01190514|7374217|FG003|COMPLETED|Second Intervention (Period 2)||10
6457785|NCT01190514|7374214|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
6457786|NCT01190514|7374215|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
6457787|NCT01190514|7374216|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
6457788|NCT01190514|7374217|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
6457789|NCT01190514|7374214|FG000|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
6457790|NCT01190514|7374215|FG001|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
6457791|NCT01190514|7374216|FG002|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
6457792|NCT01190514|7374217|FG003|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
6457793|NCT01190514|7374214|FG000|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
6457794|NCT01190514|7374215|FG001|COMPLETED|Third Intervention (Period 3)||10
6457795|NCT01190514|7374216|FG002|COMPLETED|Third Intervention (Period 3)||10
6457796|NCT01190514|7374217|FG003|COMPLETED|Third Intervention (Period 3)||10
6457797|NCT01190514|7374214|FG000|NOT COMPLETED|Third Intervention (Period 3)||1
6457798|NCT01190514|7374215|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
6457799|NCT01190514|7374216|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
6457800|NCT01190514|7374217|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
6457801|NCT01190514|7374214|FG000|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
6457802|NCT01190514|7374215|FG001|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
6457803|NCT01190514|7374216|FG002|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
6457804|NCT01190514|7374217|FG003|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
6457805|NCT01190514|7374214|FG000|COMPLETED|Fourth Intervention (Period 4)||9
6457806|NCT01190514|7374215|FG001|COMPLETED|Fourth Intervention (Period 4)||10
6457807|NCT01190514|7374216|FG002|COMPLETED|Fourth Intervention (Period 4)||10
6457808|NCT01190514|7374217|FG003|COMPLETED|Fourth Intervention (Period 4)||10
6457809|NCT01190514|7374214|FG000|NOT COMPLETED|Fourth Intervention (Period 4)||0
6457810|NCT01190514|7374215|FG001|NOT COMPLETED|Fourth Intervention (Period 4)||0
6553729|NCT01745146|7476243|FG000|COMPLETED|Overall Study||27
6553730|NCT01745146|7476244|FG001|COMPLETED|Overall Study||57
6553731|NCT01745146|7476243|FG000|NOT COMPLETED|Overall Study||3
6553732|NCT01745146|7476244|FG001|NOT COMPLETED|Overall Study||3
6457811|NCT01190514|7374216|FG002|NOT COMPLETED|Fourth Intervention (Period 4)||0
6457812|NCT01190514|7374217|FG003|NOT COMPLETED|Fourth Intervention (Period 4)||0
6457813|NCT01190527|7374227|FG000|STARTED|Overall Study||42
6457814|NCT01190527|7374227|FG000|COMPLETED|Overall Study||42
6457815|NCT01190527|7374227|FG000|NOT COMPLETED|Overall Study||0
6457816|NCT01190566|7374233|FG000|STARTED|Overall Study||6
6457817|NCT01190566|7374234|FG001|STARTED|Overall Study||42
6457818|NCT01190566|7374233|FG000|COMPLETED|Overall Study||6
6457819|NCT01190566|7374234|FG001|COMPLETED|Overall Study||42
6457820|NCT01190566|7374233|FG000|NOT COMPLETED|Overall Study||0
6457821|NCT01190566|7374234|FG001|NOT COMPLETED|Overall Study||0
6457822|NCT01190813|7374243|FG000|STARTED|Overall Study||90
6457823|NCT01190813|7374244|FG001|STARTED|Overall Study||49
6457824|NCT01190813|7374243|FG000|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
6457825|NCT01190813|7374244|FG001|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
6457826|NCT01190813|7374243|FG000|4-week Visit|Overall Study|0 missed, 1 dropped|88
6457827|NCT01190813|7374244|FG001|4-week Visit|Overall Study|1 missed, 1 dropped|47
6457828|NCT01190813|7374243|FG000|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
6457829|NCT01190813|7374244|FG001|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
6457830|NCT01190813|7374243|FG000|10-week Visit|Overall Study|0 missed, 0 dropped|88
6457831|NCT01190813|7374244|FG001|10-week Visit|Overall Study|0 dropped, 0 missed|48
6457832|NCT01190813|7374243|FG000|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
6457833|NCT01190813|7374244|FG001|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
6457834|NCT01190813|7374243|FG000|16-week Visit|Overall Study|1 dropped|87
6457835|NCT01190813|7374244|FG001|16-week Visit|Overall Study|2 dropped|46
6457836|NCT01190813|7374243|FG000|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
6457837|NCT01190813|7374244|FG001|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
6457838|NCT01190813|7374243|FG000|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
6457839|NCT01190813|7374244|FG001|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
6457840|NCT01190813|7374243|FG000|26-week Visit|Overall Study|0 missed, 0 dropped|86
6457841|NCT01190813|7374244|FG001|26-week Visit|Overall Study|0 missed, 0 dropped|45
6457842|NCT01190813|7374243|FG000|COMPLETED|Overall Study||86
6457843|NCT01190813|7374244|FG001|COMPLETED|Overall Study||45
6457844|NCT01190813|7374243|FG000|NOT COMPLETED|Overall Study||4
6457845|NCT01190813|7374244|FG001|NOT COMPLETED|Overall Study||4
6457846|NCT01190839|7374252|FG000|STARTED|Overall Study||150
6457847|NCT01190839|7374253|FG001|STARTED|Overall Study||147
6457848|NCT01190839|7374252|FG000|Treated|Overall Study||148
6457849|NCT01190839|7374253|FG001|Treated|Overall Study||143
6457850|NCT01190839|7374252|FG000|COMPLETED|Overall Study||0
6457851|NCT01190839|7374253|FG001|COMPLETED|Overall Study||0
6457852|NCT01190839|7374252|FG000|NOT COMPLETED|Overall Study||150
6457853|NCT01190839|7374253|FG001|NOT COMPLETED|Overall Study||147
6457854|NCT01190865|7374261|FG000|STARTED|Overall Study||28
6457855|NCT01190865|7374261|FG000|COMPLETED|Overall Study||25
6457856|NCT01190865|7374261|FG000|NOT COMPLETED|Overall Study||3
6457857|NCT01190878|7374269|FG000|STARTED|Overall Study||40
6457858|NCT01190878|7374270|FG001|STARTED|Overall Study||45
6457859|NCT01190878|7374271|FG002|STARTED|Overall Study||42
6457860|NCT01190878|7374272|FG003|STARTED|Overall Study||42
6457861|NCT01190878|7374269|FG000|COMPLETED|Overall Study||37
6457862|NCT01190878|7374270|FG001|COMPLETED|Overall Study||42
6457863|NCT01190878|7374271|FG002|COMPLETED|Overall Study||37
6457864|NCT01190878|7374272|FG003|COMPLETED|Overall Study||22
6457865|NCT01190878|7374269|FG000|NOT COMPLETED|Overall Study||3
6457866|NCT01190878|7374270|FG001|NOT COMPLETED|Overall Study||3
6457867|NCT01190878|7374271|FG002|NOT COMPLETED|Overall Study||5
6457868|NCT01190878|7374272|FG003|NOT COMPLETED|Overall Study||20
6457869|NCT01190891|7374284|FG000|STARTED|Overall Study||52
6457870|NCT01190891|7374285|FG001|STARTED|Overall Study||52
6457871|NCT01190891|7374284|FG000|COMPLETED|Overall Study||46
6457872|NCT01190891|7374285|FG001|COMPLETED|Overall Study||52
6457873|NCT01190891|7374284|FG000|NOT COMPLETED|Overall Study||6
6553733|NCT01745211|7476251|FG000|STARTED|Overall Study||45
6553734|NCT01745211|7476251|FG000|COMPLETED|Overall Study||27
6457874|NCT01190891|7374285|FG001|NOT COMPLETED|Overall Study||0
6457875|NCT01190930|7374293|FG000|STARTED|Induction||9298
6457876|NCT01190930|7374294|FG001|STARTED|Induction||52
6457877|NCT01190930|7374295|FG002|STARTED|Induction||0
6457878|NCT01190930|7374296|FG003|STARTED|Induction||0
6457879|NCT01190930|7374297|FG004|STARTED|Induction||0
6457880|NCT01190930|7374298|FG005|STARTED|Induction||0
6457881|NCT01190930|7374299|FG006|STARTED|Induction||0
6457882|NCT01190930|7374300|FG007|STARTED|Induction||0
6457883|NCT01190930|7374301|FG008|STARTED|Induction||0
6457884|NCT01190930|7374302|FG009|STARTED|Induction||0
6457885|NCT01190930|7374293|FG000|COMPLETED|Induction||3949
6457886|NCT01190930|7374294|FG001|COMPLETED|Induction||43
6457887|NCT01190930|7374295|FG002|COMPLETED|Induction||0
6457888|NCT01190930|7374296|FG003|COMPLETED|Induction||0
6457889|NCT01190930|7374297|FG004|COMPLETED|Induction||0
6457890|NCT01190930|7374298|FG005|COMPLETED|Induction||0
6457891|NCT01190930|7374299|FG006|COMPLETED|Induction||0
6457892|NCT01190930|7374300|FG007|COMPLETED|Induction||0
6457893|NCT01190930|7374301|FG008|COMPLETED|Induction||0
6457894|NCT01190930|7374302|FG009|COMPLETED|Induction||0
6457895|NCT01190930|7374293|FG000|NOT COMPLETED|Induction||5349
6457896|NCT01190930|7374294|FG001|NOT COMPLETED|Induction||9
6457897|NCT01190930|7374295|FG002|NOT COMPLETED|Induction||0
6457898|NCT01190930|7374296|FG003|NOT COMPLETED|Induction||0
6457899|NCT01190930|7374297|FG004|NOT COMPLETED|Induction||0
6457900|NCT01190930|7374298|FG005|NOT COMPLETED|Induction||0
6457901|NCT01190930|7374299|FG006|NOT COMPLETED|Induction||0
6457902|NCT01190930|7374300|FG007|NOT COMPLETED|Induction||0
6457903|NCT01190930|7374301|FG008|NOT COMPLETED|Induction||0
6457904|NCT01190930|7374302|FG009|NOT COMPLETED|Induction||0
6457905|NCT01190930|7374293|FG000|STARTED|Post Induction Pre-Maintenance||0
6457906|NCT01190930|7374294|FG001|STARTED|Post Induction Pre-Maintenance||43
6457907|NCT01190930|7374295|FG002|STARTED|Post Induction Pre-Maintenance||3122
6457908|NCT01190930|7374296|FG003|STARTED|Post Induction Pre-Maintenance||224
6457909|NCT01190930|7374297|FG004|STARTED|Post Induction Pre-Maintenance||301
6457910|NCT01190930|7374298|FG005|STARTED|Post Induction Pre-Maintenance||302
6457911|NCT01190930|7374299|FG006|STARTED|Post Induction Pre-Maintenance||0
6457912|NCT01190930|7374300|FG007|STARTED|Post Induction Pre-Maintenance||0
6457913|NCT01190930|7374301|FG008|STARTED|Post Induction Pre-Maintenance||0
6457914|NCT01190930|7374302|FG009|STARTED|Post Induction Pre-Maintenance||0
6457915|NCT01190930|7374293|FG000|COMPLETED|Post Induction Pre-Maintenance||0
6457916|NCT01190930|7374294|FG001|COMPLETED|Post Induction Pre-Maintenance||37
6457917|NCT01190930|7374295|FG002|COMPLETED|Post Induction Pre-Maintenance||2364
6457918|NCT01190930|7374296|FG003|COMPLETED|Post Induction Pre-Maintenance||207
6457919|NCT01190930|7374297|FG004|COMPLETED|Post Induction Pre-Maintenance||296
6457920|NCT01190930|7374298|FG005|COMPLETED|Post Induction Pre-Maintenance||296
6457921|NCT01190930|7374299|FG006|COMPLETED|Post Induction Pre-Maintenance||0
6457922|NCT01190930|7374300|FG007|COMPLETED|Post Induction Pre-Maintenance||0
6457923|NCT01190930|7374301|FG008|COMPLETED|Post Induction Pre-Maintenance||0
6457924|NCT01190930|7374302|FG009|COMPLETED|Post Induction Pre-Maintenance||0
6457925|NCT01190930|7374293|FG000|NOT COMPLETED|Post Induction Pre-Maintenance||0
6457926|NCT01190930|7374294|FG001|NOT COMPLETED|Post Induction Pre-Maintenance||6
6457927|NCT01190930|7374295|FG002|NOT COMPLETED|Post Induction Pre-Maintenance||758
6457928|NCT01190930|7374296|FG003|NOT COMPLETED|Post Induction Pre-Maintenance||17
6457929|NCT01190930|7374297|FG004|NOT COMPLETED|Post Induction Pre-Maintenance||5
6457930|NCT01190930|7374298|FG005|NOT COMPLETED|Post Induction Pre-Maintenance||6
6457931|NCT01190930|7374299|FG006|NOT COMPLETED|Post Induction Pre-Maintenance||0
6457932|NCT01190930|7374300|FG007|NOT COMPLETED|Post Induction Pre-Maintenance||0
6457933|NCT01190930|7374301|FG008|NOT COMPLETED|Post Induction Pre-Maintenance||0
6457934|NCT01190930|7374302|FG009|NOT COMPLETED|Post Induction Pre-Maintenance||0
6457935|NCT01190930|7374293|FG000|STARTED|Maintenance||0
6457936|NCT01190930|7374294|FG001|STARTED|Maintenance||37
6457937|NCT01190930|7374295|FG002|STARTED|Maintenance||0
6457938|NCT01190930|7374296|FG003|STARTED|Maintenance||207
6457939|NCT01190930|7374297|FG004|STARTED|Maintenance||296
6457940|NCT01190930|7374298|FG005|STARTED|Maintenance||296
6457941|NCT01190930|7374299|FG006|STARTED|Maintenance||600
6457942|NCT01190930|7374300|FG007|STARTED|Maintenance||586
6457943|NCT01190930|7374301|FG008|STARTED|Maintenance||586
6457944|NCT01190930|7374302|FG009|STARTED|Maintenance||592
6457945|NCT01190930|7374293|FG000|COMPLETED|Maintenance||0
6457946|NCT01190930|7374294|FG001|COMPLETED|Maintenance||27
6457947|NCT01190930|7374295|FG002|COMPLETED|Maintenance||0
6457948|NCT01190930|7374296|FG003|COMPLETED|Maintenance||167
6457949|NCT01190930|7374297|FG004|COMPLETED|Maintenance||287
6457950|NCT01190930|7374298|FG005|COMPLETED|Maintenance||284
6457951|NCT01190930|7374299|FG006|COMPLETED|Maintenance||574
6457952|NCT01190930|7374300|FG007|COMPLETED|Maintenance||540
6457953|NCT01190930|7374301|FG008|COMPLETED|Maintenance||540
6457954|NCT01190930|7374302|FG009|COMPLETED|Maintenance||555
6457955|NCT01190930|7374293|FG000|NOT COMPLETED|Maintenance||0
6457956|NCT01190930|7374294|FG001|NOT COMPLETED|Maintenance||10
6457957|NCT01190930|7374295|FG002|NOT COMPLETED|Maintenance||0
6457958|NCT01190930|7374296|FG003|NOT COMPLETED|Maintenance||40
6457959|NCT01190930|7374297|FG004|NOT COMPLETED|Maintenance||9
6457960|NCT01190930|7374298|FG005|NOT COMPLETED|Maintenance||12
6457961|NCT01190930|7374299|FG006|NOT COMPLETED|Maintenance||26
6457962|NCT01190930|7374300|FG007|NOT COMPLETED|Maintenance||46
6457963|NCT01190930|7374301|FG008|NOT COMPLETED|Maintenance||46
6457964|NCT01190930|7374302|FG009|NOT COMPLETED|Maintenance||37
6457965|NCT01191008|7374326|FG000|STARTED|Overall Study||633
6457966|NCT01191008|7374326|FG000|COMPLETED|Overall Study||618
6457967|NCT01191008|7374326|FG000|NOT COMPLETED|Overall Study||15
6457968|NCT01191086|7374330|FG000|STARTED|Overall Study||210
6457969|NCT01191086|7374330|FG000|COMPLETED|Overall Study||148
6457970|NCT01191086|7374330|FG000|NOT COMPLETED|Overall Study||62
6457971|NCT01191190|7374334|FG000|STARTED|Overall Study||21
6457972|NCT01191190|7374334|FG000|COMPLETED|Overall Study||20
6457973|NCT01191190|7374334|FG000|NOT COMPLETED|Overall Study||1
6457974|NCT01191242|7374338|FG000|STARTED|Overall Study||31
6457975|NCT01191242|7374338|FG000|COMPLETED|Overall Study||31
6457976|NCT01191242|7374338|FG000|NOT COMPLETED|Overall Study||0
6457977|NCT01191255|7374346|FG000|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
6457978|NCT01191255|7374347|FG001|STARTED|Safety Assessment Period||292
6457979|NCT01191255|7374348|FG002|STARTED|Safety Assessment Period||0
6457980|NCT01191255|7374349|FG003|STARTED|Safety Assessment Period||0
6457981|NCT01191255|7374346|FG000|Safety Population|Safety Assessment Period||149
6457982|NCT01191255|7374347|FG001|Safety Population|Safety Assessment Period||289
6457983|NCT01191255|7374348|FG002|Safety Population|Safety Assessment Period||0
6457984|NCT01191255|7374349|FG003|Safety Population|Safety Assessment Period||0
6457985|NCT01191255|7374346|FG000|COMPLETED|Safety Assessment Period||111
6457986|NCT01191255|7374347|FG001|COMPLETED|Safety Assessment Period||193
6457987|NCT01191255|7374348|FG002|COMPLETED|Safety Assessment Period||0
6457988|NCT01191255|7374349|FG003|COMPLETED|Safety Assessment Period||0
6457989|NCT01191255|7374346|FG000|NOT COMPLETED|Safety Assessment Period||38
6457990|NCT01191255|7374347|FG001|NOT COMPLETED|Safety Assessment Period||99
6457991|NCT01191255|7374348|FG002|NOT COMPLETED|Safety Assessment Period||0
6457992|NCT01191255|7374349|FG003|NOT COMPLETED|Safety Assessment Period||0
6457993|NCT01191255|7374346|FG000|STARTED|Efficacy Assessment Period||0
6457994|NCT01191255|7374347|FG001|STARTED|Efficacy Assessment Period||0
6457995|NCT01191255|7374348|FG002|STARTED|Efficacy Assessment Period||96
6457996|NCT01191255|7374349|FG003|STARTED|Efficacy Assessment Period||96
6457997|NCT01191255|7374346|FG000|COMPLETED|Efficacy Assessment Period||0
6457998|NCT01191255|7374347|FG001|COMPLETED|Efficacy Assessment Period||0
6457999|NCT01191255|7374348|FG002|COMPLETED|Efficacy Assessment Period||70
6458000|NCT01191255|7374349|FG003|COMPLETED|Efficacy Assessment Period||90
6458001|NCT01191255|7374346|FG000|NOT COMPLETED|Efficacy Assessment Period||0
6458002|NCT01191255|7374347|FG001|NOT COMPLETED|Efficacy Assessment Period||0
6458003|NCT01191255|7374348|FG002|NOT COMPLETED|Efficacy Assessment Period||26
6458004|NCT01191255|7374349|FG003|NOT COMPLETED|Efficacy Assessment Period||6
6458005|NCT01191268|7374362|FG000|STARTED|Overall Study||295
6458006|NCT01191268|7374363|FG001|STARTED|Overall Study||293
6458007|NCT01191268|7374364|FG002|STARTED|Overall Study||296
6458008|NCT01191268|7374362|FG000|Received at Least One Dose of Study Drug|Overall Study||295
6458009|NCT01191268|7374363|FG001|Received at Least One Dose of Study Drug|Overall Study||293
6458010|NCT01191268|7374364|FG002|Received at Least One Dose of Study Drug|Overall Study||296
6458011|NCT01191268|7374362|FG000|COMPLETED|Overall Study||237
6458012|NCT01191268|7374363|FG001|COMPLETED|Overall Study||238
6458013|NCT01191268|7374364|FG002|COMPLETED|Overall Study||244
6458014|NCT01191268|7374362|FG000|NOT COMPLETED|Overall Study||58
6458015|NCT01191268|7374363|FG001|NOT COMPLETED|Overall Study||55
6458016|NCT01191268|7374364|FG002|NOT COMPLETED|Overall Study||52
6458017|NCT01191320|7374376|FG000|STARTED|Overall Study||43
6458018|NCT01191320|7374377|FG001|STARTED|Overall Study||38
6458019|NCT01191320|7374378|FG002|STARTED|Overall Study||38
6458020|NCT01191320|7374376|FG000|COMPLETED|Overall Study||36
6458021|NCT01191320|7374377|FG001|COMPLETED|Overall Study||32
6458022|NCT01191320|7374378|FG002|COMPLETED|Overall Study||31
6458023|NCT01191320|7374376|FG000|NOT COMPLETED|Overall Study||7
6458024|NCT01191320|7374377|FG001|NOT COMPLETED|Overall Study||6
6458025|NCT01191320|7374378|FG002|NOT COMPLETED|Overall Study||7
6458026|NCT01191333|7374388|FG000|STARTED|Overall Study||81
6458027|NCT01191333|7374389|FG001|STARTED|Overall Study||83
6458028|NCT01191333|7374388|FG000|COMPLETED|Overall Study||60
6458029|NCT01191333|7374389|FG001|COMPLETED|Overall Study||65
6458030|NCT01191333|7374388|FG000|NOT COMPLETED|Overall Study||21
6458031|NCT01191333|7374389|FG001|NOT COMPLETED|Overall Study||18
6458032|NCT01191398|7374398|FG000|STARTED|Overall Study||17
6458033|NCT01191398|7374399|FG001|STARTED|Overall Study||17
6458034|NCT01191398|7374400|FG002|STARTED|Overall Study||18
6458035|NCT01191398|7374398|FG000|COMPLETED|Overall Study||17
6458036|NCT01191398|7374399|FG001|COMPLETED|Overall Study||17
6458037|NCT01191398|7374400|FG002|COMPLETED|Overall Study||18
6458038|NCT01191398|7374398|FG000|NOT COMPLETED|Overall Study||0
6458039|NCT01191398|7374399|FG001|NOT COMPLETED|Overall Study||0
6458040|NCT01191398|7374400|FG002|NOT COMPLETED|Overall Study||0
6553735|NCT01745211|7476251|FG000|NOT COMPLETED|Overall Study||18
6458041|NCT01191411|7374411|FG000|STARTED|Overall Study||1593
6458042|NCT01191411|7374412|FG001|STARTED|Overall Study||479
6458043|NCT01191411|7374413|FG002|STARTED|Overall Study||3898
6458044|NCT01191411|7374411|FG000|COMPLETED|Overall Study||648
6458045|NCT01191411|7374412|FG001|COMPLETED|Overall Study||118
6458046|NCT01191411|7374413|FG002|COMPLETED|Overall Study||471
6458047|NCT01191411|7374411|FG000|NOT COMPLETED|Overall Study||945
6458048|NCT01191411|7374412|FG001|NOT COMPLETED|Overall Study||361
6458049|NCT01191411|7374413|FG002|NOT COMPLETED|Overall Study||3427
6553736|NCT01745367|7476257|FG000|STARTED|Overall Study||8
6458050|NCT01191476|7374424|FG000|STARTED|Overall Study||112
6458051|NCT01191476|7374425|FG001|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
6458052|NCT01191476|7374426|FG002|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
6458053|NCT01191476|7374424|FG000|COMPLETED|Overall Study||109
6458054|NCT01191476|7374425|FG001|COMPLETED|Overall Study||107
6458055|NCT01191476|7374426|FG002|COMPLETED|Overall Study||111
6458056|NCT01191476|7374424|FG000|NOT COMPLETED|Overall Study||3
6458057|NCT01191476|7374425|FG001|NOT COMPLETED|Overall Study||4
6458058|NCT01191476|7374426|FG002|NOT COMPLETED|Overall Study||0
6458059|NCT01191541|7374438|FG000|STARTED|All the Patients||30
6458060|NCT01191541|7374439|FG001|STARTED|All the Patients||35
6458061|NCT01191541|7374438|FG000|COMPLETED|All the Patients||30
6458062|NCT01191541|7374439|FG001|COMPLETED|All the Patients||35
6458063|NCT01191541|7374438|FG000|NOT COMPLETED|All the Patients||0
6458064|NCT01191541|7374439|FG001|NOT COMPLETED|All the Patients||0
6458065|NCT01191541|7374438|FG000|STARTED|the Randomized Patients||30
6458066|NCT01191541|7374439|FG001|STARTED|the Randomized Patients||35
6458067|NCT01191541|7374438|FG000|COMPLETED|the Randomized Patients||30
6458068|NCT01191541|7374439|FG001|COMPLETED|the Randomized Patients||35
6458069|NCT01191541|7374438|FG000|NOT COMPLETED|the Randomized Patients||0
6458070|NCT01191541|7374439|FG001|NOT COMPLETED|the Randomized Patients||0
6458071|NCT01191723|7374455|FG000|STARTED|Overall Study||9
6458072|NCT01191723|7374456|FG001|STARTED|Overall Study||9
6458073|NCT01191723|7374457|FG002|STARTED|Overall Study||9
6553737|NCT01745367|7476258|FG001|STARTED|Overall Study||22
6553738|NCT01745367|7476257|FG000|Treated|Overall Study||8
6553739|NCT01745367|7476258|FG001|Treated|Overall Study||21
6553740|NCT01745367|7476257|FG000|COMPLETED|Overall Study||0
6553741|NCT01745367|7476258|FG001|COMPLETED|Overall Study||0
6553742|NCT01745367|7476257|FG000|NOT COMPLETED|Overall Study||8
6553743|NCT01745367|7476258|FG001|NOT COMPLETED|Overall Study||22
6553744|NCT01745380|7476266|FG000|STARTED|Overall Study||100
6553745|NCT01745380|7476267|FG001|STARTED|Overall Study||50
6553746|NCT01745380|7476266|FG000|COMPLETED|Overall Study||99
6654394|NCT02445287|7584193|FG000|COMPLETED|Overall Study||35
6458074|NCT01191723|7374458|FG003|STARTED|Overall Study||9
6458075|NCT01191723|7374459|FG004|STARTED|Overall Study||9
6458076|NCT01191723|7374460|FG005|STARTED|Overall Study||9
6458077|NCT01191723|7374455|FG000|COMPLETED|Overall Study||9
6458078|NCT01191723|7374456|FG001|COMPLETED|Overall Study||9
6458079|NCT01191723|7374457|FG002|COMPLETED|Overall Study||9
6458080|NCT01191723|7374458|FG003|COMPLETED|Overall Study||9
6458081|NCT01191723|7374459|FG004|COMPLETED|Overall Study||9
6458082|NCT01191723|7374460|FG005|COMPLETED|Overall Study||9
6458083|NCT01191723|7374455|FG000|NOT COMPLETED|Overall Study||0
6458084|NCT01191723|7374456|FG001|NOT COMPLETED|Overall Study||0
6458085|NCT01191723|7374457|FG002|NOT COMPLETED|Overall Study||0
6458086|NCT01191723|7374458|FG003|NOT COMPLETED|Overall Study||0
6458087|NCT01191723|7374459|FG004|NOT COMPLETED|Overall Study||0
6458088|NCT01191723|7374460|FG005|NOT COMPLETED|Overall Study||0
6458089|NCT01191736|7374476|FG000|STARTED|Overall Study||51
6458090|NCT01191736|7374477|FG001|STARTED|Overall Study||47
6458091|NCT01191736|7374478|FG002|STARTED|Overall Study||49
6458092|NCT01191736|7374479|FG003|STARTED|Overall Study||46
6458093|NCT01191736|7374480|FG004|STARTED|Overall Study||48
6458094|NCT01191736|7374481|FG005|STARTED|Overall Study||50
6458095|NCT01191736|7374482|FG006|STARTED|Overall Study||45
6458096|NCT01191736|7374476|FG000|COMPLETED|Overall Study||51
6458097|NCT01191736|7374477|FG001|COMPLETED|Overall Study||47
6458098|NCT01191736|7374478|FG002|COMPLETED|Overall Study||49
6654395|NCT02445287|7584194|FG001|COMPLETED|Overall Study||13
6654396|NCT02445287|7584193|FG000|NOT COMPLETED|Overall Study||0
6654397|NCT02445287|7584194|FG001|NOT COMPLETED|Overall Study||0
6654398|NCT02445326|7584207|FG000|STARTED|Overall Study||35
6654399|NCT02445326|7584208|FG001|STARTED|Overall Study||38
6654400|NCT02445326|7584207|FG000|COMPLETED|Overall Study||33
6654401|NCT02445326|7584208|FG001|COMPLETED|Overall Study||37
6654402|NCT02445326|7584207|FG000|NOT COMPLETED|Overall Study||2
6654403|NCT02445326|7584208|FG001|NOT COMPLETED|Overall Study||1
6654404|NCT02445573|7584216|FG000|STARTED|Overall Study||40
6654405|NCT02445573|7584217|FG001|STARTED|Overall Study||40
6458099|NCT01191736|7374479|FG003|COMPLETED|Overall Study||46
6458100|NCT01191736|7374480|FG004|COMPLETED|Overall Study||48
6458101|NCT01191736|7374481|FG005|COMPLETED|Overall Study||50
6458102|NCT01191736|7374482|FG006|COMPLETED|Overall Study||45
6458103|NCT01191736|7374476|FG000|NOT COMPLETED|Overall Study||0
6458104|NCT01191736|7374477|FG001|NOT COMPLETED|Overall Study||0
6458105|NCT01191736|7374478|FG002|NOT COMPLETED|Overall Study||0
6458106|NCT01191736|7374479|FG003|NOT COMPLETED|Overall Study||0
6458107|NCT01191736|7374480|FG004|NOT COMPLETED|Overall Study||0
6458108|NCT01191736|7374481|FG005|NOT COMPLETED|Overall Study||0
6458109|NCT01191736|7374482|FG006|NOT COMPLETED|Overall Study||0
6458110|NCT01191749|7374498|FG000|STARTED|Overall Study||7
6458111|NCT01191749|7374498|FG000|COMPLETED|Overall Study||7
6458112|NCT01191749|7374498|FG000|NOT COMPLETED|Overall Study||0
6458113|NCT01191762|7374504|FG000|STARTED|Overall Study||15
6458114|NCT01191762|7374505|FG001|STARTED|Overall Study||15
6458115|NCT01191762|7374504|FG000|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
6458116|NCT01191762|7374505|FG001|COMPLETED|Overall Study||15
6553747|NCT01745380|7476267|FG001|COMPLETED|Overall Study||49
6458117|NCT01191762|7374504|FG000|NOT COMPLETED|Overall Study||1
6458118|NCT01191762|7374505|FG001|NOT COMPLETED|Overall Study||0
6458119|NCT01191788|7374513|FG000|STARTED|Overall Study||140
6458120|NCT01191788|7374514|FG001|STARTED|Overall Study||159
6458121|NCT01191788|7374513|FG000|COMPLETED|Overall Study|Completed 3-month followup|119
6458122|NCT01191788|7374514|FG001|COMPLETED|Overall Study|Completed 3-month followup|137
6458123|NCT01191788|7374513|FG000|NOT COMPLETED|Overall Study||21
6458124|NCT01191788|7374514|FG001|NOT COMPLETED|Overall Study||22
6458125|NCT01191801|7374523|FG000|STARTED|Overall Study||356
6458126|NCT01191801|7374524|FG001|STARTED|Overall Study||355
6458127|NCT01191801|7374523|FG000|COMPLETED|Overall Study||40
6458128|NCT01191801|7374524|FG001|COMPLETED|Overall Study||18
6458129|NCT01191801|7374523|FG000|NOT COMPLETED|Overall Study||316
6458130|NCT01191801|7374524|FG001|NOT COMPLETED|Overall Study||337
6458131|NCT01191827|7374532|FG000|STARTED|Overall Study||20
6458132|NCT01191827|7374533|FG001|STARTED|Overall Study||20
6458133|NCT01191827|7374532|FG000|COMPLETED|Overall Study||20
6458134|NCT01191827|7374533|FG001|COMPLETED|Overall Study||20
6458135|NCT01191827|7374532|FG000|NOT COMPLETED|Overall Study||0
6458136|NCT01191827|7374533|FG001|NOT COMPLETED|Overall Study||0
6458137|NCT01191840|7374541|FG000|STARTED|Overall Study||254
6458138|NCT01191840|7374542|FG001|STARTED|Overall Study||255
6458139|NCT01191840|7374541|FG000|COMPLETED|Overall Study||240
6458140|NCT01191840|7374542|FG001|COMPLETED|Overall Study||240
6458141|NCT01191840|7374541|FG000|NOT COMPLETED|Overall Study||14
6458142|NCT01191840|7374542|FG001|NOT COMPLETED|Overall Study||15
6458143|NCT01191944|7374550|FG000|STARTED|Overall Study|Treated titration/maintenance|234
6458144|NCT01191944|7374551|FG001|STARTED|Overall Study|Treated titration/maintenance|239
6458145|NCT01191944|7374550|FG000|COMPLETED|Overall Study|Completed titration/maintenance|217
6458146|NCT01191944|7374551|FG001|COMPLETED|Overall Study|Completed titration/maintenance|220
6458147|NCT01191944|7374550|FG000|NOT COMPLETED|Overall Study||17
6458148|NCT01191944|7374551|FG001|NOT COMPLETED|Overall Study||19
6458149|NCT01192022|7374561|FG000|STARTED|Overall Study||114
6458150|NCT01192022|7374562|FG001|STARTED|Overall Study||110
6458151|NCT01192022|7374563|FG002|STARTED|Overall Study||8
6458152|NCT01192022|7374564|FG003|STARTED|Overall Study||9
6458153|NCT01192022|7374565|FG004|STARTED|Overall Study||12
6458154|NCT01192022|7374561|FG000|Safety Population-Received Treatment|Overall Study||114
6458155|NCT01192022|7374562|FG001|Safety Population-Received Treatment|Overall Study||109
6458156|NCT01192022|7374563|FG002|Safety Population-Received Treatment|Overall Study||8
6458157|NCT01192022|7374564|FG003|Safety Population-Received Treatment|Overall Study||9
6458158|NCT01192022|7374565|FG004|Safety Population-Received Treatment|Overall Study||12
6458159|NCT01192022|7374561|FG000|COMPLETED|Overall Study||101
6458160|NCT01192022|7374562|FG001|COMPLETED|Overall Study||99
6458161|NCT01192022|7374563|FG002|COMPLETED|Overall Study||7
6458162|NCT01192022|7374564|FG003|COMPLETED|Overall Study||7
6458163|NCT01192022|7374565|FG004|COMPLETED|Overall Study||11
6458164|NCT01192022|7374561|FG000|NOT COMPLETED|Overall Study||13
6458165|NCT01192022|7374562|FG001|NOT COMPLETED|Overall Study||11
6458166|NCT01192022|7374563|FG002|NOT COMPLETED|Overall Study||1
6458167|NCT01192022|7374564|FG003|NOT COMPLETED|Overall Study||2
6458168|NCT01192022|7374565|FG004|NOT COMPLETED|Overall Study||1
6458169|NCT01192100|7374576|FG000|STARTED|Overall Study||6
6458170|NCT01192100|7374577|FG001|STARTED|Overall Study||4
6458171|NCT01192100|7374578|FG002|STARTED|Overall Study||3
6458172|NCT01192100|7374579|FG003|STARTED|Overall Study||4
6458173|NCT01192100|7374580|FG004|STARTED|Overall Study||3
6458174|NCT01192100|7374581|FG005|STARTED|Overall Study||2
6458175|NCT01192100|7374576|FG000|Began 1st Intervention Week|Overall Study||6
6458176|NCT01192100|7374577|FG001|Began 1st Intervention Week|Overall Study||4
6745292|NCT03358407|7673375|FG003|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6745293|NCT03358407|7673376|FG004|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||2
6745294|NCT03358407|7673377|FG005|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745295|NCT03358407|7673378|FG006|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6458177|NCT01192100|7374578|FG002|Began 1st Intervention Week|Overall Study||3
6458178|NCT01192100|7374579|FG003|Began 1st Intervention Week|Overall Study||4
6458179|NCT01192100|7374580|FG004|Began 1st Intervention Week|Overall Study||3
6458180|NCT01192100|7374581|FG005|Began 1st Intervention Week|Overall Study||2
6458181|NCT01192100|7374576|FG000|Began 2nd Intervention Week|Overall Study||6
6458182|NCT01192100|7374577|FG001|Began 2nd Intervention Week|Overall Study||4
6458183|NCT01192100|7374578|FG002|Began 2nd Intervention Week|Overall Study||3
6458184|NCT01192100|7374579|FG003|Began 2nd Intervention Week|Overall Study||3
6458185|NCT01192100|7374580|FG004|Began 2nd Intervention Week|Overall Study||2
6458186|NCT01192100|7374581|FG005|Began 2nd Intervention Week|Overall Study||2
6458187|NCT01192100|7374576|FG000|Began 3rd Intervention Week|Overall Study||6
6458188|NCT01192100|7374577|FG001|Began 3rd Intervention Week|Overall Study||4
6458189|NCT01192100|7374578|FG002|Began 3rd Intervention Week|Overall Study||3
6458190|NCT01192100|7374579|FG003|Began 3rd Intervention Week|Overall Study||3
6458191|NCT01192100|7374580|FG004|Began 3rd Intervention Week|Overall Study||2
6458192|NCT01192100|7374581|FG005|Began 3rd Intervention Week|Overall Study||2
6458193|NCT01192100|7374576|FG000|COMPLETED|Overall Study||6
6458194|NCT01192100|7374577|FG001|COMPLETED|Overall Study||4
6458195|NCT01192100|7374578|FG002|COMPLETED|Overall Study||3
6745296|NCT03358407|7673379|FG007|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745297|NCT03358407|7673380|FG008|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6458196|NCT01192100|7374579|FG003|COMPLETED|Overall Study||3
6458197|NCT01192100|7374580|FG004|COMPLETED|Overall Study||2
6458198|NCT01192100|7374581|FG005|COMPLETED|Overall Study||2
6458199|NCT01192100|7374576|FG000|NOT COMPLETED|Overall Study||0
6458200|NCT01192100|7374577|FG001|NOT COMPLETED|Overall Study||0
6458201|NCT01192100|7374578|FG002|NOT COMPLETED|Overall Study||0
6458202|NCT01192100|7374579|FG003|NOT COMPLETED|Overall Study||1
6458203|NCT01192100|7374580|FG004|NOT COMPLETED|Overall Study||1
6458204|NCT01192100|7374581|FG005|NOT COMPLETED|Overall Study||0
6458205|NCT01192126|7374591|FG000|STARTED|First Intervention (1 Week)||51
6458206|NCT01192126|7374592|FG001|STARTED|First Intervention (1 Week)||51
6458207|NCT01192126|7374591|FG000|COMPLETED|First Intervention (1 Week)||49
6458208|NCT01192126|7374592|FG001|COMPLETED|First Intervention (1 Week)||50
6458209|NCT01192126|7374591|FG000|NOT COMPLETED|First Intervention (1 Week)||2
6458210|NCT01192126|7374592|FG001|NOT COMPLETED|First Intervention (1 Week)||1
6458211|NCT01192126|7374591|FG000|STARTED|Second Intervention (1 Week)||49
6458212|NCT01192126|7374592|FG001|STARTED|Second Intervention (1 Week)||50
6458213|NCT01192126|7374591|FG000|COMPLETED|Second Intervention (1 Week)||49
6458214|NCT01192126|7374592|FG001|COMPLETED|Second Intervention (1 Week)||50
6458215|NCT01192126|7374591|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6458216|NCT01192126|7374592|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6458217|NCT01192139|7374598|FG000|STARTED|Period 1||5
6458218|NCT01192139|7374599|FG001|STARTED|Period 1||5
6458219|NCT01192139|7374600|FG002|STARTED|Period 1||5
6458220|NCT01192139|7374601|FG003|STARTED|Period 1||5
6458221|NCT01192139|7374602|FG004|STARTED|Period 1||5
6458222|NCT01192139|7374603|FG005|STARTED|Period 1||5
6458223|NCT01192139|7374598|FG000|COMPLETED|Period 1||5
6458224|NCT01192139|7374599|FG001|COMPLETED|Period 1||5
6458225|NCT01192139|7374600|FG002|COMPLETED|Period 1||5
6458226|NCT01192139|7374601|FG003|COMPLETED|Period 1||5
6458227|NCT01192139|7374602|FG004|COMPLETED|Period 1||5
6458228|NCT01192139|7374603|FG005|COMPLETED|Period 1||5
6458229|NCT01192139|7374598|FG000|NOT COMPLETED|Period 1||0
6458230|NCT01192139|7374599|FG001|NOT COMPLETED|Period 1||0
6458231|NCT01192139|7374600|FG002|NOT COMPLETED|Period 1||0
6458232|NCT01192139|7374601|FG003|NOT COMPLETED|Period 1||0
6458233|NCT01192139|7374602|FG004|NOT COMPLETED|Period 1||0
6458234|NCT01192139|7374603|FG005|NOT COMPLETED|Period 1||0
6458235|NCT01192139|7374598|FG000|STARTED|Period 2||5
6458236|NCT01192139|7374599|FG001|STARTED|Period 2||5
6458237|NCT01192139|7374600|FG002|STARTED|Period 2||5
6458238|NCT01192139|7374601|FG003|STARTED|Period 2||5
6458239|NCT01192139|7374602|FG004|STARTED|Period 2||5
6458240|NCT01192139|7374603|FG005|STARTED|Period 2||5
6458241|NCT01192139|7374598|FG000|COMPLETED|Period 2||5
6458242|NCT01192139|7374599|FG001|COMPLETED|Period 2||5
6458243|NCT01192139|7374600|FG002|COMPLETED|Period 2||5
6458244|NCT01192139|7374601|FG003|COMPLETED|Period 2||5
6458245|NCT01192139|7374602|FG004|COMPLETED|Period 2||5
6458246|NCT01192139|7374603|FG005|COMPLETED|Period 2||5
6458247|NCT01192139|7374598|FG000|NOT COMPLETED|Period 2||0
6458248|NCT01192139|7374599|FG001|NOT COMPLETED|Period 2||0
6458249|NCT01192139|7374600|FG002|NOT COMPLETED|Period 2||0
6458250|NCT01192139|7374601|FG003|NOT COMPLETED|Period 2||0
6458251|NCT01192139|7374602|FG004|NOT COMPLETED|Period 2||0
6458252|NCT01192139|7374603|FG005|NOT COMPLETED|Period 2||0
6458253|NCT01192139|7374598|FG000|STARTED|Period 3||5
6458254|NCT01192139|7374599|FG001|STARTED|Period 3||5
6458255|NCT01192139|7374600|FG002|STARTED|Period 3||5
6458256|NCT01192139|7374601|FG003|STARTED|Period 3||5
6458257|NCT01192139|7374602|FG004|STARTED|Period 3||5
6458258|NCT01192139|7374603|FG005|STARTED|Period 3||5
6458259|NCT01192139|7374598|FG000|COMPLETED|Period 3||5
6458260|NCT01192139|7374599|FG001|COMPLETED|Period 3||5
6458261|NCT01192139|7374600|FG002|COMPLETED|Period 3||5
6458262|NCT01192139|7374601|FG003|COMPLETED|Period 3||5
6553748|NCT01745380|7476266|FG000|NOT COMPLETED|Overall Study||1
6553749|NCT01745380|7476267|FG001|NOT COMPLETED|Overall Study||1
6553750|NCT01745393|7476275|FG000|STARTED|Treatment to End-of-treatment Assessment||163
6553751|NCT01745393|7476276|FG001|STARTED|Treatment to End-of-treatment Assessment||164
6553752|NCT01745393|7476275|FG000|Received Treatment|Treatment to End-of-treatment Assessment|Behavioral counseling = TSE-reduction and cessation counseling via telephone|147
6458263|NCT01192139|7374602|FG004|COMPLETED|Period 3||5
6458264|NCT01192139|7374603|FG005|COMPLETED|Period 3||5
6458265|NCT01192139|7374598|FG000|NOT COMPLETED|Period 3||0
6458266|NCT01192139|7374599|FG001|NOT COMPLETED|Period 3||0
6458267|NCT01192139|7374600|FG002|NOT COMPLETED|Period 3||0
6458268|NCT01192139|7374601|FG003|NOT COMPLETED|Period 3||0
6458269|NCT01192139|7374602|FG004|NOT COMPLETED|Period 3||0
6458270|NCT01192139|7374603|FG005|NOT COMPLETED|Period 3||0
6458271|NCT01192152|7374611|FG000|STARTED|Period 1||15
6458272|NCT01192152|7374612|FG001|STARTED|Period 1||15
6458273|NCT01192152|7374611|FG000|COMPLETED|Period 1||15
6458274|NCT01192152|7374612|FG001|COMPLETED|Period 1||14
6458275|NCT01192152|7374611|FG000|NOT COMPLETED|Period 1||0
6458276|NCT01192152|7374612|FG001|NOT COMPLETED|Period 1||1
6458277|NCT01192152|7374611|FG000|STARTED|Period 2||15
6458278|NCT01192152|7374612|FG001|STARTED|Period 2||14
6458279|NCT01192152|7374611|FG000|COMPLETED|Period 2||15
6458280|NCT01192152|7374612|FG001|COMPLETED|Period 2||14
6458281|NCT01192152|7374611|FG000|NOT COMPLETED|Period 2||0
6458282|NCT01192152|7374612|FG001|NOT COMPLETED|Period 2||0
6458283|NCT01192152|7374611|FG000|STARTED|Period 3||15
6458284|NCT01192152|7374612|FG001|STARTED|Period 3||0
6553753|NCT01745393|7476276|FG001|Received Treatment|Treatment to End-of-treatment Assessment|Attention control = nutrition education via telephone|144
6553754|NCT01745393|7476275|FG000|COMPLETED|Treatment to End-of-treatment Assessment||142
6553755|NCT01745393|7476276|FG001|COMPLETED|Treatment to End-of-treatment Assessment||156
6553756|NCT01745393|7476275|FG000|NOT COMPLETED|Treatment to End-of-treatment Assessment||21
6745298|NCT03358407|7673381|FG009|COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745299|NCT03358407|7673372|FG000|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6458285|NCT01192152|7374611|FG000|COMPLETED|Period 3||14
6458286|NCT01192152|7374612|FG001|COMPLETED|Period 3||0
6458287|NCT01192152|7374611|FG000|NOT COMPLETED|Period 3||1
6458288|NCT01192152|7374612|FG001|NOT COMPLETED|Period 3||0
6458289|NCT01192178|7374622|FG000|STARTED|Overall Study||171
6458290|NCT01192178|7374623|FG001|STARTED|Overall Study||168
6458291|NCT01192178|7374622|FG000|COMPLETED|Overall Study||147
6458292|NCT01192178|7374623|FG001|COMPLETED|Overall Study||145
6458293|NCT01192178|7374622|FG000|NOT COMPLETED|Overall Study||24
6458294|NCT01192178|7374623|FG001|NOT COMPLETED|Overall Study||23
6500647|NCT01425632|7419305|FG001|COMPLETED|Overall Study||165
6500648|NCT01425632|7419306|FG002|COMPLETED|Overall Study||159
6500649|NCT01425632|7419304|FG000|NOT COMPLETED|Overall Study||1
6500650|NCT01425632|7419305|FG001|NOT COMPLETED|Overall Study||1
6500651|NCT01425632|7419306|FG002|NOT COMPLETED|Overall Study||4
6500652|NCT01425723|7419316|FG000|STARTED|Overall Study|13 participants in <6 Years Old Age Cohort and 14 participants in 6 to <12 Years Old Age Cohort.|27
6500653|NCT01425723|7419317|FG001|STARTED|Overall Study||93
6500654|NCT01425723|7419316|FG000|Weekly Prophylaxis|Overall Study||23
6500655|NCT01425723|7419317|FG001|Weekly Prophylaxis|Overall Study||51
6745300|NCT03358407|7673373|FG001|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745301|NCT03358407|7673374|FG002|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||1
6745302|NCT03358407|7673375|FG003|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745303|NCT03358407|7673376|FG004|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745304|NCT03358407|7673377|FG005|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745305|NCT03358407|7673378|FG006|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745306|NCT03358407|7673379|FG007|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745307|NCT03358407|7673380|FG008|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745308|NCT03358407|7673381|FG009|NOT COMPLETED|P2:PartA-Cohort1(4days)+Washout(48hours)||0
6745309|NCT03358407|7673372|FG000|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745310|NCT03358407|7673373|FG001|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745311|NCT03358407|7673374|FG002|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/Placebo/GSK 30mg/GSK 100mg arm|2
6745312|NCT03358407|7673375|FG003|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745313|NCT03358407|7673376|FG004|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745314|NCT03358407|7673377|FG005|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745315|NCT03358407|7673378|FG006|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745316|NCT03358407|7673379|FG007|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745317|NCT03358407|7673380|FG008|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745318|NCT03358407|7673381|FG009|STARTED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745319|NCT03358407|7673372|FG000|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745320|NCT03358407|7673373|FG001|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745321|NCT03358407|7673374|FG002|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745322|NCT03358407|7673375|FG003|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745323|NCT03358407|7673376|FG004|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||2
6745324|NCT03358407|7673377|FG005|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6500656|NCT01425723|7419316|FG000|Individualized Prophylaxis|Overall Study||5
6500657|NCT01425723|7419317|FG001|Individualized Prophylaxis|Overall Study||31
6500658|NCT01425723|7419316|FG000|Personalized Prophylaxis|Overall Study||2
6500659|NCT01425723|7419317|FG001|Personalized Prophylaxis|Overall Study||17
6500660|NCT01425723|7419316|FG000|Episodic|Overall Study||0
6500661|NCT01425723|7419317|FG001|Episodic|Overall Study||15
6500662|NCT01425723|7419316|FG000|Surgery Subgroup|Overall Study||1
6500663|NCT01425723|7419317|FG001|Surgery Subgroup|Overall Study||15
6500664|NCT01425723|7419316|FG000|COMPLETED|Overall Study||23
6500665|NCT01425723|7419317|FG001|COMPLETED|Overall Study||75
6500666|NCT01425723|7419316|FG000|NOT COMPLETED|Overall Study||4
6500667|NCT01425723|7419317|FG001|NOT COMPLETED|Overall Study||18
6500668|NCT01425749|7419334|FG000|STARTED|Overall Study||13
6500669|NCT01425749|7419335|FG001|STARTED|Overall Study||12
6500670|NCT01425749|7419334|FG000|COMPLETED|Overall Study||13
6500671|NCT01425749|7419335|FG001|COMPLETED|Overall Study||11
6500672|NCT01425749|7419334|FG000|NOT COMPLETED|Overall Study||0
6500673|NCT01425749|7419335|FG001|NOT COMPLETED|Overall Study||1
6500674|NCT01425801|7419344|FG000|STARTED|Period 1||9
6500675|NCT01425801|7419345|FG001|STARTED|Period 1||9
6500676|NCT01425801|7419346|FG002|STARTED|Period 1||9
6500677|NCT01425801|7419347|FG003|STARTED|Period 1||12
6500678|NCT01425801|7419348|FG004|STARTED|Period 1||13
6500679|NCT01425801|7419349|FG005|STARTED|Period 1||10
6500680|NCT01425801|7419344|FG000|COMPLETED|Period 1||9
6500681|NCT01425801|7419345|FG001|COMPLETED|Period 1||9
6500682|NCT01425801|7419346|FG002|COMPLETED|Period 1||9
6500683|NCT01425801|7419347|FG003|COMPLETED|Period 1||12
6500684|NCT01425801|7419348|FG004|COMPLETED|Period 1||12
6500685|NCT01425801|7419349|FG005|COMPLETED|Period 1||10
6500686|NCT01425801|7419344|FG000|NOT COMPLETED|Period 1||0
6458295|NCT01192191|7374633|FG000|STARTED|Overall Study||60
6458296|NCT01192191|7374634|FG001|STARTED|Overall Study||127
6458297|NCT01192191|7374633|FG000|COMPLETED|Overall Study||49
6458298|NCT01192191|7374634|FG001|COMPLETED|Overall Study||106
6458299|NCT01192191|7374633|FG000|NOT COMPLETED|Overall Study||11
6458300|NCT01192191|7374634|FG001|NOT COMPLETED|Overall Study||21
6458301|NCT01192204|7374642|FG000|STARTED|Overall Study||23
6458302|NCT01192204|7374643|FG001|STARTED|Overall Study||18
6458303|NCT01192204|7374642|FG000|COMPLETED|Overall Study||22
6458304|NCT01192204|7374643|FG001|COMPLETED|Overall Study||18
6458305|NCT01192204|7374642|FG000|NOT COMPLETED|Overall Study||1
6458306|NCT01192204|7374643|FG001|NOT COMPLETED|Overall Study||0
6458307|NCT01192282|7374653|FG000|STARTED|Overall Study||156
6458308|NCT01192282|7374653|FG000|COMPLETED|Overall Study||156
6458309|NCT01192282|7374653|FG000|NOT COMPLETED|Overall Study||0
6458310|NCT01192295|7374668|FG000|STARTED|Overall Study||27
6458311|NCT01192295|7374669|FG001|STARTED|Overall Study||128
6458312|NCT01192295|7374668|FG000|COMPLETED|Overall Study||17
6458313|NCT01192295|7374669|FG001|COMPLETED|Overall Study||105
6458314|NCT01192295|7374668|FG000|NOT COMPLETED|Overall Study||10
6458315|NCT01192295|7374669|FG001|NOT COMPLETED|Overall Study||23
6458316|NCT01192347|7374677|FG000|STARTED|Overall Study||175
6458317|NCT01192347|7374677|FG000|COMPLETED|Overall Study||163
6458318|NCT01192347|7374677|FG000|NOT COMPLETED|Overall Study||12
6458319|NCT01192399|7374681|FG000|STARTED|Overall Study||29
6458320|NCT01192399|7374681|FG000|COMPLETED|Overall Study||27
6458321|NCT01192399|7374681|FG000|NOT COMPLETED|Overall Study||2
6458322|NCT01192412|7374687|FG000|STARTED|Overall Study||497
6458323|NCT01192412|7374688|FG001|STARTED|Overall Study||490
6458324|NCT01192412|7374687|FG000|COMPLETED|Overall Study||493
6458325|NCT01192412|7374688|FG001|COMPLETED|Overall Study||488
6458326|NCT01192412|7374687|FG000|NOT COMPLETED|Overall Study||4
6458327|NCT01192412|7374688|FG001|NOT COMPLETED|Overall Study||2
6458328|NCT01192516|7374697|FG000|STARTED|Overall Study|Indicates number of people initially randomized to group|66
6458329|NCT01192516|7374698|FG001|STARTED|Overall Study|Indicates number of people initially randomized to group|66
6458330|NCT01192516|7374699|FG002|STARTED|Overall Study|Indicates number of people initially randomized to group|63
6458331|NCT01192516|7374697|FG000|COMPLETED|Overall Study||46
6458332|NCT01192516|7374698|FG001|COMPLETED|Overall Study||49
6458333|NCT01192516|7374699|FG002|COMPLETED|Overall Study||55
6458334|NCT01192516|7374697|FG000|NOT COMPLETED|Overall Study||20
6458335|NCT01192516|7374698|FG001|NOT COMPLETED|Overall Study||17
6458336|NCT01192516|7374699|FG002|NOT COMPLETED|Overall Study||8
6458337|NCT01192542|7374711|FG000|STARTED|Period 1||18
6458338|NCT01192542|7374712|FG001|STARTED|Period 1||20
6458339|NCT01192542|7374711|FG000|COMPLETED|Period 1||18
6458340|NCT01192542|7374712|FG001|COMPLETED|Period 1||20
6458341|NCT01192542|7374711|FG000|NOT COMPLETED|Period 1||0
6458342|NCT01192542|7374712|FG001|NOT COMPLETED|Period 1||0
6458343|NCT01192542|7374711|FG000|STARTED|Period 2||18
6458344|NCT01192542|7374712|FG001|STARTED|Period 2||20
6458345|NCT01192542|7374711|FG000|COMPLETED|Period 2||18
6458346|NCT01192542|7374712|FG001|COMPLETED|Period 2||20
6458347|NCT01192542|7374711|FG000|NOT COMPLETED|Period 2||0
6458348|NCT01192542|7374712|FG001|NOT COMPLETED|Period 2||0
6458349|NCT01192815|7374720|FG000|STARTED|Overall Study||2
6458350|NCT01192815|7374720|FG000|COMPLETED|Overall Study||0
6458351|NCT01192815|7374720|FG000|NOT COMPLETED|Overall Study||2
6458352|NCT01192828|7374724|FG000|STARTED|Overall Study||14
6458353|NCT01192828|7374724|FG000|COMPLETED|Overall Study||14
6458354|NCT01192828|7374724|FG000|NOT COMPLETED|Overall Study||0
6458355|NCT01193010|7374732|FG000|STARTED|Overall Study||20
6458356|NCT01193010|7374733|FG001|STARTED|Overall Study||20
6458357|NCT01193010|7374732|FG000|COMPLETED|Overall Study||17
6458358|NCT01193010|7374733|FG001|COMPLETED|Overall Study||20
6458359|NCT01193010|7374732|FG000|NOT COMPLETED|Overall Study||3
6458360|NCT01193010|7374733|FG001|NOT COMPLETED|Overall Study||0
6458361|NCT01193049|7374739|FG000|STARTED|Period 1: Placebo Run-In||5
6458362|NCT01193049|7374740|FG001|STARTED|Period 1: Placebo Run-In||6
6458363|NCT01193049|7374739|FG000|COMPLETED|Period 1: Placebo Run-In||5
6458364|NCT01193049|7374740|FG001|COMPLETED|Period 1: Placebo Run-In||6
6553757|NCT01745393|7476276|FG001|NOT COMPLETED|Treatment to End-of-treatment Assessment||8
6553758|NCT01745393|7476275|FG000|STARTED|12-month Follow-up||142
6553759|NCT01745393|7476276|FG001|STARTED|12-month Follow-up||156
6553760|NCT01745393|7476275|FG000|COMPLETED|12-month Follow-up||136
6553761|NCT01745393|7476276|FG001|COMPLETED|12-month Follow-up||151
6458365|NCT01193049|7374739|FG000|NOT COMPLETED|Period 1: Placebo Run-In||0
6458366|NCT01193049|7374740|FG001|NOT COMPLETED|Period 1: Placebo Run-In||0
6458367|NCT01193049|7374739|FG000|STARTED|Washout 1 : 21 Day Washout||5
6458368|NCT01193049|7374740|FG001|STARTED|Washout 1 : 21 Day Washout||6
6458369|NCT01193049|7374739|FG000|COMPLETED|Washout 1 : 21 Day Washout||5
6553762|NCT01745393|7476275|FG000|NOT COMPLETED|12-month Follow-up||6
6458370|NCT01193049|7374740|FG001|COMPLETED|Washout 1 : 21 Day Washout||6
6458371|NCT01193049|7374739|FG000|NOT COMPLETED|Washout 1 : 21 Day Washout||0
6458372|NCT01193049|7374740|FG001|NOT COMPLETED|Washout 1 : 21 Day Washout||0
6458373|NCT01193049|7374739|FG000|STARTED|Period 2 : Double Blind Crossover||5
6458374|NCT01193049|7374740|FG001|STARTED|Period 2 : Double Blind Crossover||6
6458375|NCT01193049|7374739|FG000|COMPLETED|Period 2 : Double Blind Crossover||5
6500687|NCT01425801|7419345|FG001|NOT COMPLETED|Period 1||0
6553763|NCT01745393|7476276|FG001|NOT COMPLETED|12-month Follow-up||5
6458376|NCT01193049|7374740|FG001|COMPLETED|Period 2 : Double Blind Crossover||6
6458377|NCT01193049|7374739|FG000|NOT COMPLETED|Period 2 : Double Blind Crossover||0
6458378|NCT01193049|7374740|FG001|NOT COMPLETED|Period 2 : Double Blind Crossover||0
6458379|NCT01193049|7374739|FG000|STARTED|Washout 2 : 21 Day Washout||5
6458380|NCT01193049|7374740|FG001|STARTED|Washout 2 : 21 Day Washout||6
6458381|NCT01193049|7374739|FG000|COMPLETED|Washout 2 : 21 Day Washout||5
6458382|NCT01193049|7374740|FG001|COMPLETED|Washout 2 : 21 Day Washout||6
6458383|NCT01193049|7374739|FG000|NOT COMPLETED|Washout 2 : 21 Day Washout||0
6458384|NCT01193049|7374740|FG001|NOT COMPLETED|Washout 2 : 21 Day Washout||0
6458385|NCT01193049|7374739|FG000|STARTED|Period 3 : Double Blind Crossover||5
6458386|NCT01193049|7374740|FG001|STARTED|Period 3 : Double Blind Crossover||6
6458387|NCT01193049|7374739|FG000|COMPLETED|Period 3 : Double Blind Crossover||5
6458388|NCT01193049|7374740|FG001|COMPLETED|Period 3 : Double Blind Crossover||6
6458389|NCT01193049|7374739|FG000|NOT COMPLETED|Period 3 : Double Blind Crossover||0
6458390|NCT01193049|7374740|FG001|NOT COMPLETED|Period 3 : Double Blind Crossover||0
6458391|NCT01193101|7374750|FG000|STARTED|Overall Study||100
6458392|NCT01193101|7374751|FG001|STARTED|Overall Study||101
6458393|NCT01193101|7374752|FG002|STARTED|Overall Study||96
6458394|NCT01193101|7374753|FG003|STARTED|Overall Study||92
6458395|NCT01193101|7374750|FG000|Full Analysis Set|Overall Study||100
6458396|NCT01193101|7374751|FG001|Full Analysis Set|Overall Study||101
6458397|NCT01193101|7374752|FG002|Full Analysis Set|Overall Study||96
6458398|NCT01193101|7374753|FG003|Full Analysis Set|Overall Study||92
6458399|NCT01193101|7374750|FG000|Placebo Withdrawal Set|Overall Study||95
6458400|NCT01193101|7374751|FG001|Placebo Withdrawal Set|Overall Study||94
6458401|NCT01193101|7374752|FG002|Placebo Withdrawal Set|Overall Study||93
6458402|NCT01193101|7374753|FG003|Placebo Withdrawal Set|Overall Study||80
6458403|NCT01193101|7374750|FG000|COMPLETED|Overall Study||95
6458404|NCT01193101|7374751|FG001|COMPLETED|Overall Study||94
6458405|NCT01193101|7374752|FG002|COMPLETED|Overall Study||93
6458406|NCT01193101|7374753|FG003|COMPLETED|Overall Study||80
6458407|NCT01193101|7374750|FG000|NOT COMPLETED|Overall Study||5
6458408|NCT01193101|7374751|FG001|NOT COMPLETED|Overall Study||7
6458409|NCT01193101|7374752|FG002|NOT COMPLETED|Overall Study||3
6458410|NCT01193101|7374753|FG003|NOT COMPLETED|Overall Study||12
6458411|NCT01193114|7374765|FG000|STARTED|Overall Study||30
6458412|NCT01193114|7374766|FG001|STARTED|Overall Study||30
6458413|NCT01193114|7374765|FG000|COMPLETED|Overall Study||30
6458414|NCT01193114|7374766|FG001|COMPLETED|Overall Study||30
6458415|NCT01193114|7374765|FG000|NOT COMPLETED|Overall Study||0
6458416|NCT01193114|7374766|FG001|NOT COMPLETED|Overall Study||0
6458417|NCT01193127|7374776|FG000|STARTED|Randomized||57
6458418|NCT01193127|7374777|FG001|STARTED|Randomized||54
6458419|NCT01193127|7374778|FG002|STARTED|Randomized||55
6458420|NCT01193127|7374779|FG003|STARTED|Randomized||57
6458421|NCT01193127|7374776|FG000|COMPLETED|Randomized||57
6458422|NCT01193127|7374777|FG001|COMPLETED|Randomized||54
6458423|NCT01193127|7374778|FG002|COMPLETED|Randomized||55
6458424|NCT01193127|7374779|FG003|COMPLETED|Randomized||56
6458425|NCT01193127|7374776|FG000|NOT COMPLETED|Randomized||0
6458426|NCT01193127|7374777|FG001|NOT COMPLETED|Randomized||0
6458427|NCT01193127|7374778|FG002|NOT COMPLETED|Randomized||0
6458428|NCT01193127|7374779|FG003|NOT COMPLETED|Randomized||1
6458429|NCT01193127|7374776|FG000|STARTED|Treated||57
6458430|NCT01193127|7374777|FG001|STARTED|Treated||54
6458431|NCT01193127|7374778|FG002|STARTED|Treated||55
6458432|NCT01193127|7374779|FG003|STARTED|Treated||56
6458433|NCT01193127|7374776|FG000|COMPLETED|Treated||57
6458434|NCT01193127|7374777|FG001|COMPLETED|Treated||54
6458435|NCT01193127|7374778|FG002|COMPLETED|Treated||55
6458436|NCT01193127|7374779|FG003|COMPLETED|Treated||55
6458437|NCT01193127|7374776|FG000|NOT COMPLETED|Treated||0
6458438|NCT01193127|7374777|FG001|NOT COMPLETED|Treated||0
6458439|NCT01193127|7374778|FG002|NOT COMPLETED|Treated||0
6458440|NCT01193127|7374779|FG003|NOT COMPLETED|Treated||1
6458441|NCT01193153|7374791|FG000|STARTED|Open-label Lead in Period||667
6458442|NCT01193153|7374792|FG001|STARTED|Open-label Lead in Period||0
6458443|NCT01193153|7374791|FG000|COMPLETED|Open-label Lead in Period||432
6458444|NCT01193153|7374792|FG001|COMPLETED|Open-label Lead in Period||0
6458445|NCT01193153|7374791|FG000|NOT COMPLETED|Open-label Lead in Period||235
6458446|NCT01193153|7374792|FG001|NOT COMPLETED|Open-label Lead in Period||0
6458447|NCT01193153|7374791|FG000|STARTED|Open-label Stabilization Period||432
6458448|NCT01193153|7374792|FG001|STARTED|Open-label Stabilization Period||0
6458449|NCT01193153|7374791|FG000|COMPLETED|Open-label Stabilization Period||334
6458450|NCT01193153|7374792|FG001|COMPLETED|Open-label Stabilization Period||0
6458451|NCT01193153|7374791|FG000|NOT COMPLETED|Open-label Stabilization Period||98
6458452|NCT01193153|7374792|FG001|NOT COMPLETED|Open-label Stabilization Period||0
6458453|NCT01193153|7374791|FG000|STARTED|Double Blind Relapse Prevention Period||164
6458454|NCT01193153|7374792|FG001|STARTED|Double Blind Relapse Prevention Period||170
6458455|NCT01193153|7374791|FG000|COMPLETED|Double Blind Relapse Prevention Period||100
6458456|NCT01193153|7374792|FG001|COMPLETED|Double Blind Relapse Prevention Period||65
6458457|NCT01193153|7374791|FG000|NOT COMPLETED|Double Blind Relapse Prevention Period||64
6458458|NCT01193153|7374792|FG001|NOT COMPLETED|Double Blind Relapse Prevention Period||105
6458459|NCT01193218|7374806|FG000|STARTED|0-12 Weeks|It is actually placebo group|109
6458460|NCT01193218|7374807|FG001|STARTED|0-12 Weeks|It is actually N/A|0
6458461|NCT01193218|7374808|FG002|STARTED|0-12 Weeks|It is actually empa 5mg group|110
6458462|NCT01193218|7374809|FG003|STARTED|0-12 Weeks|It is actually N/A|0
6458463|NCT01193218|7374810|FG004|STARTED|0-12 Weeks||109
6458464|NCT01193218|7374811|FG005|STARTED|0-12 Weeks||109
6458465|NCT01193218|7374812|FG006|STARTED|0-12 Weeks|It is actually empa 50mg group|110
6458466|NCT01193218|7374813|FG007|STARTED|0-12 Weeks|It is actually N/A|0
6458467|NCT01193218|7374806|FG000|COMPLETED|0-12 Weeks||100
6553764|NCT01745627|7476282|FG000|STARTED|Overall Study||42
6458468|NCT01193218|7374807|FG001|COMPLETED|0-12 Weeks||0
6458469|NCT01193218|7374808|FG002|COMPLETED|0-12 Weeks||107
6458470|NCT01193218|7374809|FG003|COMPLETED|0-12 Weeks||0
6458471|NCT01193218|7374810|FG004|COMPLETED|0-12 Weeks||108
6458472|NCT01193218|7374811|FG005|COMPLETED|0-12 Weeks||106
6458473|NCT01193218|7374812|FG006|COMPLETED|0-12 Weeks||107
6458474|NCT01193218|7374813|FG007|COMPLETED|0-12 Weeks||0
6458475|NCT01193218|7374806|FG000|NOT COMPLETED|0-12 Weeks||9
6458476|NCT01193218|7374807|FG001|NOT COMPLETED|0-12 Weeks||0
6458477|NCT01193218|7374808|FG002|NOT COMPLETED|0-12 Weeks||3
6458478|NCT01193218|7374809|FG003|NOT COMPLETED|0-12 Weeks||0
6458479|NCT01193218|7374810|FG004|NOT COMPLETED|0-12 Weeks||1
6458480|NCT01193218|7374811|FG005|NOT COMPLETED|0-12 Weeks||3
6458481|NCT01193218|7374812|FG006|NOT COMPLETED|0-12 Weeks||3
6458482|NCT01193218|7374813|FG007|NOT COMPLETED|0-12 Weeks||0
6458483|NCT01193218|7374806|FG000|STARTED|12-52 Weeks||50
6458484|NCT01193218|7374807|FG001|STARTED|12-52 Weeks||50
6458485|NCT01193218|7374808|FG002|STARTED|12-52 Weeks||54
6458486|NCT01193218|7374809|FG003|STARTED|12-52 Weeks||53
6458487|NCT01193218|7374810|FG004|STARTED|12-52 Weeks||108
6458488|NCT01193218|7374811|FG005|STARTED|12-52 Weeks||106
6458489|NCT01193218|7374812|FG006|STARTED|12-52 Weeks||54
6458490|NCT01193218|7374813|FG007|STARTED|12-52 Weeks||53
6458491|NCT01193218|7374806|FG000|COMPLETED|12-52 Weeks||45
6458492|NCT01193218|7374807|FG001|COMPLETED|12-52 Weeks||50
6458493|NCT01193218|7374808|FG002|COMPLETED|12-52 Weeks||50
6458494|NCT01193218|7374809|FG003|COMPLETED|12-52 Weeks||50
6458495|NCT01193218|7374810|FG004|COMPLETED|12-52 Weeks||104
6458496|NCT01193218|7374811|FG005|COMPLETED|12-52 Weeks||101
6458497|NCT01193218|7374812|FG006|COMPLETED|12-52 Weeks||51
6458498|NCT01193218|7374813|FG007|COMPLETED|12-52 Weeks||49
6458499|NCT01193218|7374806|FG000|NOT COMPLETED|12-52 Weeks||5
6458500|NCT01193218|7374807|FG001|NOT COMPLETED|12-52 Weeks||0
6458501|NCT01193218|7374808|FG002|NOT COMPLETED|12-52 Weeks||4
6458502|NCT01193218|7374809|FG003|NOT COMPLETED|12-52 Weeks||3
6458503|NCT01193218|7374810|FG004|NOT COMPLETED|12-52 Weeks||4
6458504|NCT01193218|7374811|FG005|NOT COMPLETED|12-52 Weeks||5
6458505|NCT01193218|7374812|FG006|NOT COMPLETED|12-52 Weeks||3
6458506|NCT01193218|7374813|FG007|NOT COMPLETED|12-52 Weeks||4
6458507|NCT01193244|7374831|FG000|STARTED|Overall Study||779
6458508|NCT01193244|7374832|FG001|STARTED|Overall Study||781
6458509|NCT01193244|7374831|FG000|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
6458510|NCT01193244|7374832|FG001|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
6458511|NCT01193244|7374831|FG000|COMPLETED|Overall Study||391
6458512|NCT01193244|7374832|FG001|COMPLETED|Overall Study||391
6458513|NCT01193244|7374831|FG000|NOT COMPLETED|Overall Study||388
6458514|NCT01193244|7374832|FG001|NOT COMPLETED|Overall Study||390
6458515|NCT01193257|7374840|FG000|STARTED|Overall Study||365
6458516|NCT01193257|7374841|FG001|STARTED|Overall Study||734
6458517|NCT01193257|7374840|FG000|Treated|Overall Study||363
6458518|NCT01193257|7374841|FG001|Treated|Overall Study||732
6458519|NCT01193257|7374840|FG000|COMPLETED|Overall Study||0
6458520|NCT01193257|7374841|FG001|COMPLETED|Overall Study||0
6458521|NCT01193257|7374840|FG000|NOT COMPLETED|Overall Study||365
6458522|NCT01193257|7374841|FG001|NOT COMPLETED|Overall Study||734
6458523|NCT01193283|7374847|FG000|STARTED|Overall Study||22
6458524|NCT01193283|7374847|FG000|COMPLETED|Overall Study||21
6458525|NCT01193283|7374847|FG000|NOT COMPLETED|Overall Study||1
6458526|NCT01193335|7374853|FG000|STARTED|Infant Series||100
6458527|NCT01193335|7374854|FG001|STARTED|Infant Series||100
6458528|NCT01193335|7374853|FG000|COMPLETED|Infant Series||100
6458529|NCT01193335|7374854|FG001|COMPLETED|Infant Series||100
6458530|NCT01193335|7374853|FG000|NOT COMPLETED|Infant Series||0
6458531|NCT01193335|7374854|FG001|NOT COMPLETED|Infant Series||0
6458532|NCT01193335|7374853|FG000|STARTED|After Infant Series||100
6458533|NCT01193335|7374854|FG001|STARTED|After Infant Series||100
6458534|NCT01193335|7374853|FG000|COMPLETED|After Infant Series||99
6458535|NCT01193335|7374854|FG001|COMPLETED|After Infant Series||97
6458536|NCT01193335|7374853|FG000|NOT COMPLETED|After Infant Series||1
6458537|NCT01193335|7374854|FG001|NOT COMPLETED|After Infant Series||3
6458538|NCT01193335|7374853|FG000|STARTED|Toddler Dose||99
6458539|NCT01193335|7374854|FG001|STARTED|Toddler Dose||97
6458540|NCT01193335|7374853|FG000|COMPLETED|Toddler Dose||99
6458541|NCT01193335|7374854|FG001|COMPLETED|Toddler Dose||97
6458542|NCT01193335|7374853|FG000|NOT COMPLETED|Toddler Dose||0
6458543|NCT01193335|7374854|FG001|NOT COMPLETED|Toddler Dose||0
6553765|NCT01745627|7476282|FG000|COMPLETED|Overall Study||20
6458544|NCT01193335|7374853|FG000|STARTED|1-Year Follow-up||99
6458545|NCT01193335|7374854|FG001|STARTED|1-Year Follow-up||97
6458546|NCT01193335|7374853|FG000|COMPLETED|1-Year Follow-up||88
6458547|NCT01193335|7374854|FG001|COMPLETED|1-Year Follow-up||88
6458548|NCT01193335|7374853|FG000|NOT COMPLETED|1-Year Follow-up||11
6458549|NCT01193335|7374854|FG001|NOT COMPLETED|1-Year Follow-up||9
6458550|NCT01193335|7374853|FG000|STARTED|2-Year Follow-up||88
6458551|NCT01193335|7374854|FG001|STARTED|2-Year Follow-up||88
6458552|NCT01193335|7374853|FG000|COMPLETED|2-Year Follow-up||81
6458553|NCT01193335|7374854|FG001|COMPLETED|2-Year Follow-up||80
6458554|NCT01193335|7374853|FG000|NOT COMPLETED|2-Year Follow-up||7
6458555|NCT01193335|7374854|FG001|NOT COMPLETED|2-Year Follow-up||8
6458556|NCT01193348|7374876|FG000|STARTED|Screening Period||27
6458557|NCT01193348|7374876|FG000|COMPLETED|Screening Period||22
6458558|NCT01193348|7374876|FG000|NOT COMPLETED|Screening Period||5
6458559|NCT01193348|7374876|FG000|STARTED|Treatment Period (26 Weeks)||22
6458560|NCT01193348|7374876|FG000|COMPLETED|Treatment Period (26 Weeks)||19
6458561|NCT01193348|7374876|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||3
6458562|NCT01193348|7374876|FG000|STARTED|Extension Treatment Period||17
6458563|NCT01193348|7374876|FG000|COMPLETED|Extension Treatment Period||16
6458564|NCT01193348|7374876|FG000|NOT COMPLETED|Extension Treatment Period||1
6458565|NCT01193348|7374876|FG000|STARTED|Post Treatment Period (Patients Who Disc||10
6458566|NCT01193348|7374876|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||8
6458567|NCT01193348|7374876|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
6458568|NCT01193517|7374888|FG000|STARTED|Overall Study||3
6458569|NCT01193517|7374889|FG001|STARTED|Overall Study||12
6458570|NCT01193517|7374890|FG002|STARTED|Overall Study||11
6458571|NCT01193517|7374888|FG000|COMPLETED|Overall Study||2
6458572|NCT01193517|7374889|FG001|COMPLETED|Overall Study||12
6458573|NCT01193517|7374890|FG002|COMPLETED|Overall Study||11
6458574|NCT01193517|7374888|FG000|NOT COMPLETED|Overall Study||1
6458575|NCT01193517|7374889|FG001|NOT COMPLETED|Overall Study||0
6458576|NCT01193517|7374890|FG002|NOT COMPLETED|Overall Study||0
6458577|NCT01193582|7374903|FG000|STARTED|Vaccination Series||100
6458578|NCT01193582|7374904|FG001|STARTED|Vaccination Series||101
6458579|NCT01193582|7374905|FG002|STARTED|Vaccination Series||125
6458580|NCT01193582|7374906|FG003|STARTED|Vaccination Series||180
6458581|NCT01193582|7374903|FG000|Vaccinated Dose 1|Vaccination Series||100
6458582|NCT01193582|7374904|FG001|Vaccinated Dose 1|Vaccination Series||100
6458583|NCT01193582|7374905|FG002|Vaccinated Dose 1|Vaccination Series||125
6458584|NCT01193582|7374906|FG003|Vaccinated Dose 1|Vaccination Series||180
6458585|NCT01193582|7374903|FG000|Vaccinated Dose 2|Vaccination Series||92
6458586|NCT01193582|7374904|FG001|Vaccinated Dose 2|Vaccination Series||91
6458587|NCT01193582|7374905|FG002|Vaccinated Dose 2|Vaccination Series||118
6458588|NCT01193582|7374906|FG003|Vaccinated Dose 2|Vaccination Series||0
6458589|NCT01193582|7374903|FG000|Vaccinated Dose 3|Vaccination Series||90
6458590|NCT01193582|7374904|FG001|Vaccinated Dose 3|Vaccination Series||89
6458591|NCT01193582|7374905|FG002|Vaccinated Dose 3|Vaccination Series||0
6458592|NCT01193582|7374906|FG003|Vaccinated Dose 3|Vaccination Series||0
6458593|NCT01193582|7374903|FG000|Vaccinated Dose 4|Vaccination Series||90
6458594|NCT01193582|7374904|FG001|Vaccinated Dose 4|Vaccination Series||0
6458595|NCT01193582|7374905|FG002|Vaccinated Dose 4|Vaccination Series||0
6458596|NCT01193582|7374906|FG003|Vaccinated Dose 4|Vaccination Series||0
6458597|NCT01193582|7374903|FG000|COMPLETED|Vaccination Series||89
6458598|NCT01193582|7374904|FG001|COMPLETED|Vaccination Series||88
6458599|NCT01193582|7374905|FG002|COMPLETED|Vaccination Series||117
6458600|NCT01193582|7374906|FG003|COMPLETED|Vaccination Series||177
6458601|NCT01193582|7374903|FG000|NOT COMPLETED|Vaccination Series||11
6458602|NCT01193582|7374904|FG001|NOT COMPLETED|Vaccination Series||13
6458603|NCT01193582|7374905|FG002|NOT COMPLETED|Vaccination Series||8
6458604|NCT01193582|7374906|FG003|NOT COMPLETED|Vaccination Series||3
6458605|NCT01193582|7374903|FG000|STARTED|12 Month Follow-up||89
6458606|NCT01193582|7374904|FG001|STARTED|12 Month Follow-up||88
6458607|NCT01193582|7374905|FG002|STARTED|12 Month Follow-up||117
6458608|NCT01193582|7374906|FG003|STARTED|12 Month Follow-up||177
6458609|NCT01193582|7374903|FG000|COMPLETED|12 Month Follow-up||83
6458610|NCT01193582|7374904|FG001|COMPLETED|12 Month Follow-up||88
6458611|NCT01193582|7374905|FG002|COMPLETED|12 Month Follow-up||113
6458612|NCT01193582|7374906|FG003|COMPLETED|12 Month Follow-up||166
6458613|NCT01193582|7374903|FG000|NOT COMPLETED|12 Month Follow-up||6
6458614|NCT01193582|7374904|FG001|NOT COMPLETED|12 Month Follow-up||0
6458615|NCT01193582|7374905|FG002|NOT COMPLETED|12 Month Follow-up||4
6458616|NCT01193582|7374906|FG003|NOT COMPLETED|12 Month Follow-up||11
6458617|NCT01193608|7374924|FG000|STARTED|Overall Study||6
6458618|NCT01193608|7374925|FG001|STARTED|Overall Study||6
6458619|NCT01193608|7374926|FG002|STARTED|Overall Study||16
6458620|NCT01193608|7374927|FG003|STARTED|Overall Study||17
6458621|NCT01193608|7374928|FG004|STARTED|Overall Study||24
6458622|NCT01193608|7374929|FG005|STARTED|Overall Study||19
6458623|NCT01193608|7374924|FG000|COMPLETED|Overall Study||6
6458624|NCT01193608|7374925|FG001|COMPLETED|Overall Study||4
6458625|NCT01193608|7374926|FG002|COMPLETED|Overall Study||14
6458626|NCT01193608|7374927|FG003|COMPLETED|Overall Study||14
6458627|NCT01193608|7374928|FG004|COMPLETED|Overall Study||19
6458628|NCT01193608|7374929|FG005|COMPLETED|Overall Study||17
6458629|NCT01193608|7374924|FG000|NOT COMPLETED|Overall Study||0
6458630|NCT01193608|7374925|FG001|NOT COMPLETED|Overall Study||2
6458631|NCT01193608|7374926|FG002|NOT COMPLETED|Overall Study||2
6458632|NCT01193608|7374927|FG003|NOT COMPLETED|Overall Study||3
6458633|NCT01193608|7374928|FG004|NOT COMPLETED|Overall Study||5
6458634|NCT01193608|7374929|FG005|NOT COMPLETED|Overall Study||2
6458635|NCT01193660|7374951|FG000|STARTED|Overall Study||35
6458636|NCT01193660|7374952|FG001|STARTED|Overall Study||36
6458637|NCT01193660|7374953|FG002|STARTED|Overall Study||34
6458638|NCT01193660|7374951|FG000|COMPLETED|Overall Study||31
6458639|NCT01193660|7374952|FG001|COMPLETED|Overall Study||33
6458640|NCT01193660|7374953|FG002|COMPLETED|Overall Study||32
6458641|NCT01193660|7374951|FG000|NOT COMPLETED|Overall Study||4
6458642|NCT01193660|7374952|FG001|NOT COMPLETED|Overall Study||3
6458643|NCT01193660|7374953|FG002|NOT COMPLETED|Overall Study||2
6458644|NCT01193686|7374963|FG000|STARTED|Overall Study||15
6458645|NCT01193686|7374964|FG001|STARTED|Overall Study||9
6458646|NCT01193686|7374963|FG000|Completed Baseline Assessment|Overall Study||15
6458647|NCT01193686|7374964|FG001|Completed Baseline Assessment|Overall Study||9
6458648|NCT01193686|7374963|FG000|Completed Mentor Training|Overall Study||9
6458649|NCT01193686|7374964|FG001|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
6458650|NCT01193686|7374963|FG000|Completed Visits and Final Assessment|Overall Study||8
6458651|NCT01193686|7374964|FG001|Completed Visits and Final Assessment|Overall Study||8
6458652|NCT01193686|7374963|FG000|COMPLETED|Overall Study||8
6458653|NCT01193686|7374964|FG001|COMPLETED|Overall Study||8
6458654|NCT01193686|7374963|FG000|NOT COMPLETED|Overall Study||7
6458655|NCT01193686|7374964|FG001|NOT COMPLETED|Overall Study||1
6458656|NCT01193868|7374971|FG000|STARTED|Overall Study||6
6458657|NCT01193868|7374971|FG000|COMPLETED|Overall Study||6
6458658|NCT01193868|7374971|FG000|NOT COMPLETED|Overall Study||0
6458659|NCT01193907|7374979|FG000|STARTED|Overall Study||22
6458660|NCT01193907|7374980|FG001|STARTED|Overall Study||22
6458661|NCT01193907|7374981|FG002|STARTED|Overall Study||22
6458662|NCT01193907|7374982|FG003|STARTED|Overall Study||22
6458663|NCT01193907|7374979|FG000|COMPLETED|Overall Study||21
6458664|NCT01193907|7374980|FG001|COMPLETED|Overall Study||22
6458665|NCT01193907|7374981|FG002|COMPLETED|Overall Study||22
6458666|NCT01193907|7374982|FG003|COMPLETED|Overall Study||21
6458667|NCT01193907|7374979|FG000|NOT COMPLETED|Overall Study||1
6458668|NCT01193907|7374980|FG001|NOT COMPLETED|Overall Study||0
6458669|NCT01193907|7374981|FG002|NOT COMPLETED|Overall Study||0
6458670|NCT01193907|7374982|FG003|NOT COMPLETED|Overall Study||1
6458671|NCT01193920|7375002|FG000|STARTED|Overall Study||40
6458672|NCT01193920|7375003|FG001|STARTED|Overall Study||20
6458673|NCT01193920|7375004|FG002|STARTED|Overall Study||80
6458674|NCT01193920|7375005|FG003|STARTED|Overall Study||80
6458675|NCT01193920|7375006|FG004|STARTED|Overall Study||80
6458676|NCT01193920|7375007|FG005|STARTED|Overall Study||80
6458677|NCT01193920|7375008|FG006|STARTED|Overall Study||80
6458678|NCT01193920|7375009|FG007|STARTED|Overall Study||80
6458679|NCT01193920|7375010|FG008|STARTED|Overall Study||76
6458680|NCT01193920|7375011|FG009|STARTED|Overall Study||81
6458681|NCT01193920|7375002|FG000|COMPLETED|Overall Study||37
6458682|NCT01193920|7375003|FG001|COMPLETED|Overall Study||20
6458683|NCT01193920|7375004|FG002|COMPLETED|Overall Study||74
6458684|NCT01193920|7375005|FG003|COMPLETED|Overall Study||76
6458685|NCT01193920|7375006|FG004|COMPLETED|Overall Study||74
6458686|NCT01193920|7375007|FG005|COMPLETED|Overall Study||76
6458687|NCT01193920|7375008|FG006|COMPLETED|Overall Study||74
6458688|NCT01193920|7375009|FG007|COMPLETED|Overall Study||76
6458689|NCT01193920|7375010|FG008|COMPLETED|Overall Study||71
6458690|NCT01193920|7375011|FG009|COMPLETED|Overall Study||74
6458691|NCT01193920|7375002|FG000|NOT COMPLETED|Overall Study||3
6458692|NCT01193920|7375003|FG001|NOT COMPLETED|Overall Study||0
6458693|NCT01193920|7375004|FG002|NOT COMPLETED|Overall Study||6
6458694|NCT01193920|7375005|FG003|NOT COMPLETED|Overall Study||4
6458695|NCT01193920|7375006|FG004|NOT COMPLETED|Overall Study||6
6458696|NCT01193920|7375007|FG005|NOT COMPLETED|Overall Study||4
6458697|NCT01193920|7375008|FG006|NOT COMPLETED|Overall Study||6
6458698|NCT01193920|7375009|FG007|NOT COMPLETED|Overall Study||4
6458699|NCT01193920|7375010|FG008|NOT COMPLETED|Overall Study||5
6458700|NCT01193920|7375011|FG009|NOT COMPLETED|Overall Study||7
6458701|NCT01194089|7375036|FG000|STARTED|Overall Study||42
6458702|NCT01194089|7375037|FG001|STARTED|Overall Study||47
6458703|NCT01194089|7375036|FG000|COMPLETED|Overall Study||42
6458704|NCT01194089|7375037|FG001|COMPLETED|Overall Study||47
6458705|NCT01194089|7375036|FG000|NOT COMPLETED|Overall Study||0
6458706|NCT01194089|7375037|FG001|NOT COMPLETED|Overall Study||0
6458707|NCT01194154|7375045|FG000|STARTED|Overall Study||117
6458708|NCT01194154|7375046|FG001|STARTED|Overall Study||124
6458709|NCT01194154|7375045|FG000|Full Analysis Set|Overall Study||115
6458710|NCT01194154|7375046|FG001|Full Analysis Set|Overall Study||120
6458711|NCT01194154|7375045|FG000|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
6458712|NCT01194154|7375046|FG001|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
6458713|NCT01194154|7375045|FG000|COMPLETED|Overall Study||68
6458714|NCT01194154|7375046|FG001|COMPLETED|Overall Study||91
6458715|NCT01194154|7375045|FG000|NOT COMPLETED|Overall Study||49
6458716|NCT01194154|7375046|FG001|NOT COMPLETED|Overall Study||33
6458717|NCT01194245|7375059|FG000|STARTED|Titration Period (4 to 6 Weeks)||135
6458718|NCT01194245|7375060|FG001|STARTED|Titration Period (4 to 6 Weeks)||0
6458719|NCT01194245|7375061|FG002|STARTED|Titration Period (4 to 6 Weeks)||0
6458720|NCT01194245|7375062|FG003|STARTED|Titration Period (4 to 6 Weeks)||0
6458721|NCT01194245|7375063|FG004|STARTED|Titration Period (4 to 6 Weeks)||0
6458722|NCT01194245|7375059|FG000|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
6458723|NCT01194245|7375060|FG001|COMPLETED|Titration Period (4 to 6 Weeks)||0
6458724|NCT01194245|7375061|FG002|COMPLETED|Titration Period (4 to 6 Weeks)||0
6458725|NCT01194245|7375062|FG003|COMPLETED|Titration Period (4 to 6 Weeks)||0
6458726|NCT01194245|7375063|FG004|COMPLETED|Titration Period (4 to 6 Weeks)||0
6458727|NCT01194245|7375059|FG000|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
6458728|NCT01194245|7375060|FG001|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
6458729|NCT01194245|7375061|FG002|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
6458730|NCT01194245|7375062|FG003|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
6458731|NCT01194245|7375063|FG004|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
6458732|NCT01194245|7375059|FG000|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
6458733|NCT01194245|7375060|FG001|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
6458734|NCT01194245|7375061|FG002|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
6458735|NCT01194245|7375062|FG003|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
6458736|NCT01194245|7375063|FG004|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
6458737|NCT01194245|7375059|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
6458738|NCT01194245|7375060|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
6458739|NCT01194245|7375061|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
6458740|NCT01194245|7375062|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
6745325|NCT03358407|7673378|FG006|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745326|NCT03358407|7673379|FG007|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745327|NCT03358407|7673380|FG008|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6458741|NCT01194245|7375063|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
6458742|NCT01194245|7375059|FG000|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
6458743|NCT01194245|7375060|FG001|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
6458744|NCT01194245|7375061|FG002|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
6458745|NCT01194245|7375062|FG003|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
6458746|NCT01194245|7375063|FG004|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
6458747|NCT01194245|7375059|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
6458748|NCT01194245|7375060|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
6458749|NCT01194245|7375061|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
6458750|NCT01194245|7375062|FG003|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
6458751|NCT01194245|7375063|FG004|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
6458752|NCT01194245|7375059|FG000|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
6458753|NCT01194245|7375060|FG001|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
6458754|NCT01194245|7375061|FG002|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
6458755|NCT01194245|7375062|FG003|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
6458756|NCT01194245|7375063|FG004|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
6458757|NCT01194245|7375059|FG000|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6458758|NCT01194245|7375060|FG001|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
6458759|NCT01194245|7375061|FG002|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
6458760|NCT01194245|7375062|FG003|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
6458761|NCT01194245|7375063|FG004|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
6458762|NCT01194245|7375059|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6458763|NCT01194245|7375060|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6458764|NCT01194245|7375061|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6458765|NCT01194245|7375062|FG003|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6458766|NCT01194245|7375063|FG004|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
6458767|NCT01194258|7375072|FG000|STARTED|Titration Period||132
6458768|NCT01194258|7375073|FG001|STARTED|Titration Period||0
6458769|NCT01194258|7375074|FG002|STARTED|Titration Period||0
6458770|NCT01194258|7375075|FG003|STARTED|Titration Period||0
6458771|NCT01194258|7375076|FG004|STARTED|Titration Period||0
6458772|NCT01194258|7375072|FG000|COMPLETED|Titration Period||121
6458773|NCT01194258|7375073|FG001|COMPLETED|Titration Period||0
6458774|NCT01194258|7375074|FG002|COMPLETED|Titration Period||0
6458775|NCT01194258|7375075|FG003|COMPLETED|Titration Period||0
6458776|NCT01194258|7375076|FG004|COMPLETED|Titration Period||0
6458777|NCT01194258|7375072|FG000|NOT COMPLETED|Titration Period||11
6458778|NCT01194258|7375073|FG001|NOT COMPLETED|Titration Period||0
6458779|NCT01194258|7375074|FG002|NOT COMPLETED|Titration Period||0
6458780|NCT01194258|7375075|FG003|NOT COMPLETED|Titration Period||0
6458781|NCT01194258|7375076|FG004|NOT COMPLETED|Titration Period||0
6458782|NCT01194258|7375072|FG000|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
6458783|NCT01194258|7375073|FG001|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
6458784|NCT01194258|7375074|FG002|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
6458785|NCT01194258|7375075|FG003|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
6458786|NCT01194258|7375076|FG004|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
6458787|NCT01194258|7375072|FG000|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
6458788|NCT01194258|7375073|FG001|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
6458789|NCT01194258|7375074|FG002|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
6458790|NCT01194258|7375075|FG003|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
6458791|NCT01194258|7375076|FG004|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
6458792|NCT01194258|7375072|FG000|COMPLETED|Period 1 (12 Weeks)||0
6458793|NCT01194258|7375073|FG001|COMPLETED|Period 1 (12 Weeks)||29
6745328|NCT03358407|7673381|FG009|COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6553766|NCT01745627|7476282|FG000|NOT COMPLETED|Overall Study||22
6553767|NCT01745822|7476288|FG000|STARTED|Overall Study|168 mothers and 163 infants|331
6553768|NCT01745822|7476289|FG001|STARTED|Overall Study|163 mothers and 160 infants|323
6458794|NCT01194258|7375074|FG002|COMPLETED|Period 1 (12 Weeks)||30
6458795|NCT01194258|7375075|FG003|COMPLETED|Period 1 (12 Weeks)||29
6458796|NCT01194258|7375076|FG004|COMPLETED|Period 1 (12 Weeks)||32
6458797|NCT01194258|7375072|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
6458798|NCT01194258|7375073|FG001|NOT COMPLETED|Period 1 (12 Weeks)||0
6458799|NCT01194258|7375074|FG002|NOT COMPLETED|Period 1 (12 Weeks)||0
6458800|NCT01194258|7375075|FG003|NOT COMPLETED|Period 1 (12 Weeks)||0
6458801|NCT01194258|7375076|FG004|NOT COMPLETED|Period 1 (12 Weeks)||1
6458802|NCT01194258|7375072|FG000|STARTED|Period 2 (12 Weeks)||0
6458803|NCT01194258|7375073|FG001|STARTED|Period 2 (12 Weeks)||29
6458804|NCT01194258|7375074|FG002|STARTED|Period 2 (12 Weeks)||30
6458805|NCT01194258|7375075|FG003|STARTED|Period 2 (12 Weeks)||29
6458806|NCT01194258|7375076|FG004|STARTED|Period 2 (12 Weeks)||32
6458807|NCT01194258|7375072|FG000|COMPLETED|Period 2 (12 Weeks)||0
6458808|NCT01194258|7375073|FG001|COMPLETED|Period 2 (12 Weeks)||27
6654406|NCT02445573|7584216|FG000|COMPLETED|Overall Study||39
6654407|NCT02445573|7584217|FG001|COMPLETED|Overall Study||38
6654408|NCT02445573|7584216|FG000|NOT COMPLETED|Overall Study||1
6654409|NCT02445573|7584217|FG001|NOT COMPLETED|Overall Study||2
6654410|NCT02445586|7584223|FG000|STARTED|Overall Study||52
6654411|NCT02445586|7584223|FG000|Received at Least One Dose of Study Drug|Overall Study||52
6654412|NCT02445586|7584223|FG000|COMPLETED|Overall Study||13
6654413|NCT02445586|7584223|FG000|NOT COMPLETED|Overall Study||39
6654414|NCT02445625|7584227|FG000|STARTED|Overall Study||15
6654415|NCT02445625|7584227|FG000|COMPLETED|Overall Study||15
6654416|NCT02445625|7584227|FG000|NOT COMPLETED|Overall Study||0
6654417|NCT02445755|7584232|FG000|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
6654418|NCT02445755|7584232|FG000|COMPLETED|Overall Study||100
6654419|NCT02445755|7584232|FG000|NOT COMPLETED|Overall Study||13
6654420|NCT02445794|7584243|FG000|STARTED|Overall Study||6
6654421|NCT02445794|7584244|FG001|STARTED|Overall Study||3
6654422|NCT02445794|7584245|FG002|STARTED|Overall Study||7
6654423|NCT02445794|7584246|FG003|STARTED|Overall Study||3
6654424|NCT02445794|7584243|FG000|COMPLETED|Overall Study||6
6654425|NCT02445794|7584244|FG001|COMPLETED|Overall Study||3
6654426|NCT02445794|7584245|FG002|COMPLETED|Overall Study||5
6654427|NCT02445794|7584246|FG003|COMPLETED|Overall Study||3
6654428|NCT02445794|7584243|FG000|NOT COMPLETED|Overall Study||0
6654429|NCT02445794|7584244|FG001|NOT COMPLETED|Overall Study||0
6654430|NCT02445794|7584245|FG002|NOT COMPLETED|Overall Study||2
6654431|NCT02445794|7584246|FG003|NOT COMPLETED|Overall Study||0
6654432|NCT02445807|7584263|FG000|STARTED|Overall Study||176
6654433|NCT02445807|7584264|FG001|STARTED|Overall Study||89
6654434|NCT02445807|7584263|FG000|COMPLETED|Overall Study||176
6458809|NCT01194258|7375074|FG002|COMPLETED|Period 2 (12 Weeks)||29
6458810|NCT01194258|7375075|FG003|COMPLETED|Period 2 (12 Weeks)||29
6458811|NCT01194258|7375076|FG004|COMPLETED|Period 2 (12 Weeks)||30
6458812|NCT01194258|7375072|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
6458813|NCT01194258|7375073|FG001|NOT COMPLETED|Period 2 (12 Weeks)||2
6458814|NCT01194258|7375074|FG002|NOT COMPLETED|Period 2 (12 Weeks)||1
6458815|NCT01194258|7375075|FG003|NOT COMPLETED|Period 2 (12 Weeks)||0
6458816|NCT01194258|7375076|FG004|NOT COMPLETED|Period 2 (12 Weeks)||2
6458817|NCT01194271|7375087|FG000|STARTED|Overall Study||19
6458818|NCT01194271|7375087|FG000|COMPLETED|Overall Study||16
6458819|NCT01194271|7375087|FG000|NOT COMPLETED|Overall Study||3
6458820|NCT01194297|7375093|FG000|STARTED|Overall Study||2
6458821|NCT01194297|7375094|FG001|STARTED|Overall Study||1
6458822|NCT01194297|7375093|FG000|COMPLETED|Overall Study||2
6458823|NCT01194297|7375094|FG001|COMPLETED|Overall Study||1
6458824|NCT01194297|7375093|FG000|NOT COMPLETED|Overall Study||0
6458825|NCT01194297|7375094|FG001|NOT COMPLETED|Overall Study||0
6458826|NCT01194414|7375102|FG000|STARTED|24 Weeks Double Blind Period||631
6458827|NCT01194414|7375103|FG001|STARTED|24 Weeks Double Blind Period||631
6458828|NCT01194414|7375104|FG002|STARTED|24 Weeks Double Blind Period||0
6458829|NCT01194414|7375105|FG003|STARTED|24 Weeks Double Blind Period||0
6458830|NCT01194414|7375102|FG000|Per Protocol Population|24 Weeks Double Blind Period||558
6458831|NCT01194414|7375103|FG001|Per Protocol Population|24 Weeks Double Blind Period||537
6458832|NCT01194414|7375104|FG002|Per Protocol Population|24 Weeks Double Blind Period||0
6458833|NCT01194414|7375105|FG003|Per Protocol Population|24 Weeks Double Blind Period||0
6458834|NCT01194414|7375102|FG000|COMPLETED|24 Weeks Double Blind Period||572
6458835|NCT01194414|7375103|FG001|COMPLETED|24 Weeks Double Blind Period||564
6553769|NCT01745822|7476288|FG000|COMPLETED|Overall Study||331
6553770|NCT01745822|7476289|FG001|COMPLETED|Overall Study||323
6458836|NCT01194414|7375104|FG002|COMPLETED|24 Weeks Double Blind Period||0
6458837|NCT01194414|7375105|FG003|COMPLETED|24 Weeks Double Blind Period||0
6458838|NCT01194414|7375102|FG000|NOT COMPLETED|24 Weeks Double Blind Period||59
6458839|NCT01194414|7375103|FG001|NOT COMPLETED|24 Weeks Double Blind Period||67
6553771|NCT01745822|7476288|FG000|NOT COMPLETED|Overall Study||0
6553772|NCT01745822|7476289|FG001|NOT COMPLETED|Overall Study||0
6553773|NCT01745848|7476295|FG000|STARTED|Overall Study||26
6553774|NCT01745848|7476295|FG000|COMPLETED|Overall Study||20
6553775|NCT01745848|7476295|FG000|NOT COMPLETED|Overall Study||6
6553776|NCT01745952|7476299|FG000|STARTED|Overall Study||4
6553777|NCT01745952|7476300|FG001|STARTED|Overall Study||4
6458840|NCT01194414|7375104|FG002|NOT COMPLETED|24 Weeks Double Blind Period||0
6458841|NCT01194414|7375105|FG003|NOT COMPLETED|24 Weeks Double Blind Period||0
6458842|NCT01194414|7375102|FG000|STARTED|72 Weeks Open Label Extension||524
6458843|NCT01194414|7375103|FG001|STARTED|72 Weeks Open Label Extension||377
6458844|NCT01194414|7375104|FG002|STARTED|72 Weeks Open Label Extension||48
6458845|NCT01194414|7375105|FG003|STARTED|72 Weeks Open Label Extension||186
6458846|NCT01194414|7375102|FG000|COMPLETED|72 Weeks Open Label Extension||445
6458847|NCT01194414|7375103|FG001|COMPLETED|72 Weeks Open Label Extension||311
6458848|NCT01194414|7375104|FG002|COMPLETED|72 Weeks Open Label Extension||40
6458849|NCT01194414|7375105|FG003|COMPLETED|72 Weeks Open Label Extension||160
6458850|NCT01194414|7375102|FG000|NOT COMPLETED|72 Weeks Open Label Extension||79
6458851|NCT01194414|7375103|FG001|NOT COMPLETED|72 Weeks Open Label Extension||66
6458852|NCT01194414|7375104|FG002|NOT COMPLETED|72 Weeks Open Label Extension||8
6458853|NCT01194414|7375105|FG003|NOT COMPLETED|72 Weeks Open Label Extension||26
6458854|NCT01194440|7375117|FG000|STARTED|Baseline (First Dose)||59
6458855|NCT01194440|7375117|FG000|COMPLETED|Baseline (First Dose)||52
6458856|NCT01194440|7375117|FG000|NOT COMPLETED|Baseline (First Dose)||7
6458857|NCT01194440|7375117|FG000|STARTED|6-months (2nd Dose)||52
6458858|NCT01194440|7375117|FG000|COMPLETED|6-months (2nd Dose)||48
6458859|NCT01194440|7375117|FG000|NOT COMPLETED|6-months (2nd Dose)||4
6458860|NCT01194453|7375124|FG000|STARTED|Overall Study||144
6458861|NCT01194453|7375125|FG001|STARTED|Overall Study||144
6458862|NCT01194453|7375124|FG000|COMPLETED|Overall Study||127
6458863|NCT01194453|7375125|FG001|COMPLETED|Overall Study||127
6458864|NCT01194453|7375124|FG000|NOT COMPLETED|Overall Study||17
6458865|NCT01194453|7375125|FG001|NOT COMPLETED|Overall Study||17
6458866|NCT01194466|7375131|FG000|STARTED|Overall Study||14
6458867|NCT01194466|7375132|FG001|STARTED|Overall Study||14
6458868|NCT01194466|7375133|FG002|STARTED|Overall Study||13
6458869|NCT01194466|7375131|FG000|COMPLETED|Overall Study||14
6458870|NCT01194466|7375132|FG001|COMPLETED|Overall Study||14
6458871|NCT01194466|7375133|FG002|COMPLETED|Overall Study||13
6458872|NCT01194466|7375131|FG000|NOT COMPLETED|Overall Study||0
6458873|NCT01194466|7375132|FG001|NOT COMPLETED|Overall Study||0
6458874|NCT01194466|7375133|FG002|NOT COMPLETED|Overall Study||0
6458875|NCT01194479|7375143|FG000|STARTED|Overall Study||3
6458876|NCT01194479|7375144|FG001|STARTED|Overall Study||4
6458877|NCT01194479|7375145|FG002|STARTED|Overall Study||2
6458878|NCT01194479|7375146|FG003|STARTED|Overall Study||5
6458879|NCT01194479|7375143|FG000|Cross-over at Second Visit|Overall Study||3
6458880|NCT01194479|7375144|FG001|Cross-over at Second Visit|Overall Study||4
6458881|NCT01194479|7375145|FG002|Cross-over at Second Visit|Overall Study||2
6458882|NCT01194479|7375146|FG003|Cross-over at Second Visit|Overall Study||5
6458883|NCT01194479|7375143|FG000|COMPLETED|Overall Study||3
6458884|NCT01194479|7375144|FG001|COMPLETED|Overall Study||4
6458885|NCT01194479|7375145|FG002|COMPLETED|Overall Study||2
6458886|NCT01194479|7375146|FG003|COMPLETED|Overall Study||5
6458887|NCT01194479|7375143|FG000|NOT COMPLETED|Overall Study||0
6458888|NCT01194479|7375144|FG001|NOT COMPLETED|Overall Study||0
6458889|NCT01194479|7375145|FG002|NOT COMPLETED|Overall Study||0
6458890|NCT01194479|7375146|FG003|NOT COMPLETED|Overall Study||0
6458891|NCT01194531|7375158|FG000|STARTED|Overall Study||29
6458892|NCT01194531|7375159|FG001|STARTED|Overall Study||30
6458893|NCT01194531|7375158|FG000|COMPLETED|Overall Study||24
6458894|NCT01194531|7375159|FG001|COMPLETED|Overall Study||27
6458895|NCT01194531|7375158|FG000|NOT COMPLETED|Overall Study||5
6458896|NCT01194531|7375159|FG001|NOT COMPLETED|Overall Study||3
6458897|NCT01194674|7375165|FG000|STARTED|Overall Study||2
6458898|NCT01194674|7375165|FG000|COMPLETED|Overall Study||2
6458899|NCT01194674|7375165|FG000|NOT COMPLETED|Overall Study||0
6458900|NCT01194804|7375170|FG000|STARTED|Overall Study||27
6458901|NCT01194804|7375170|FG000|COMPLETED|Overall Study||26
6458902|NCT01194804|7375170|FG000|NOT COMPLETED|Overall Study||1
6458903|NCT01194830|7375176|FG000|STARTED|Overall Study||124
6458904|NCT01194830|7375177|FG001|STARTED|Overall Study||110
6458905|NCT01194830|7375176|FG000|COMPLETED|Overall Study||88
6458906|NCT01194830|7375177|FG001|COMPLETED|Overall Study||83
6458907|NCT01194830|7375176|FG000|NOT COMPLETED|Overall Study||36
6458908|NCT01194830|7375177|FG001|NOT COMPLETED|Overall Study||27
6458909|NCT01194869|7375183|FG000|STARTED|Overall Study||25
6458910|NCT01194869|7375183|FG000|COMPLETED|Overall Study||21
6458911|NCT01194869|7375183|FG000|NOT COMPLETED|Overall Study||4
6458912|NCT01194973|7375187|FG000|STARTED|Screening Period||44
6458913|NCT01194973|7375187|FG000|COMPLETED|Screening Period||41
6458914|NCT01194973|7375187|FG000|NOT COMPLETED|Screening Period||3
6458915|NCT01194973|7375187|FG000|STARTED|26 Week Treatment Period||41
6458916|NCT01194973|7375187|FG000|COMPLETED|26 Week Treatment Period||38
6458917|NCT01194973|7375187|FG000|NOT COMPLETED|26 Week Treatment Period||3
6458918|NCT01194999|7375191|FG000|STARTED|Overall Study||132
6458919|NCT01194999|7375191|FG000|COMPLETED|Overall Study||115
6458920|NCT01194999|7375191|FG000|NOT COMPLETED|Overall Study||17
6458921|NCT01195025|7375195|FG000|STARTED|First Intervention A||2
6458922|NCT01195025|7375196|FG001|STARTED|First Intervention A||3
6458923|NCT01195025|7375197|FG002|STARTED|First Intervention A||2
6458924|NCT01195025|7375198|FG003|STARTED|First Intervention A||2
6458925|NCT01195025|7375199|FG004|STARTED|First Intervention A||1
6458926|NCT01195025|7375195|FG000|COMPLETED|First Intervention A||2
6458927|NCT01195025|7375196|FG001|COMPLETED|First Intervention A||3
6458928|NCT01195025|7375197|FG002|COMPLETED|First Intervention A||2
6458929|NCT01195025|7375198|FG003|COMPLETED|First Intervention A||2
6458930|NCT01195025|7375199|FG004|COMPLETED|First Intervention A||1
6458931|NCT01195025|7375195|FG000|NOT COMPLETED|First Intervention A||0
6458932|NCT01195025|7375196|FG001|NOT COMPLETED|First Intervention A||0
6458933|NCT01195025|7375197|FG002|NOT COMPLETED|First Intervention A||0
6458934|NCT01195025|7375198|FG003|NOT COMPLETED|First Intervention A||0
6458935|NCT01195025|7375199|FG004|NOT COMPLETED|First Intervention A||0
6458936|NCT01195025|7375195|FG000|STARTED|Second Intervention B||2
6458937|NCT01195025|7375196|FG001|STARTED|Second Intervention B||3
6458938|NCT01195025|7375197|FG002|STARTED|Second Intervention B||2
6458939|NCT01195025|7375198|FG003|STARTED|Second Intervention B||2
6458940|NCT01195025|7375199|FG004|STARTED|Second Intervention B||1
6458941|NCT01195025|7375195|FG000|COMPLETED|Second Intervention B||2
6458942|NCT01195025|7375196|FG001|COMPLETED|Second Intervention B||3
6458943|NCT01195025|7375197|FG002|COMPLETED|Second Intervention B||2
6553778|NCT01745952|7476301|FG002|STARTED|Overall Study||3
6553779|NCT01745952|7476299|FG000|COMPLETED|Overall Study||3
6553780|NCT01745952|7476300|FG001|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
6458944|NCT01195025|7375198|FG003|COMPLETED|Second Intervention B||2
6458945|NCT01195025|7375199|FG004|COMPLETED|Second Intervention B||1
6458946|NCT01195025|7375195|FG000|NOT COMPLETED|Second Intervention B||0
6458947|NCT01195025|7375196|FG001|NOT COMPLETED|Second Intervention B||0
6458948|NCT01195025|7375197|FG002|NOT COMPLETED|Second Intervention B||0
6458949|NCT01195025|7375198|FG003|NOT COMPLETED|Second Intervention B||0
6458950|NCT01195025|7375199|FG004|NOT COMPLETED|Second Intervention B||0
6458951|NCT01195025|7375195|FG000|STARTED|Third Intervention C||2
6458952|NCT01195025|7375196|FG001|STARTED|Third Intervention C||3
6458953|NCT01195025|7375197|FG002|STARTED|Third Intervention C||2
6458954|NCT01195025|7375198|FG003|STARTED|Third Intervention C||2
6458955|NCT01195025|7375199|FG004|STARTED|Third Intervention C||1
6458956|NCT01195025|7375195|FG000|COMPLETED|Third Intervention C||2
6458957|NCT01195025|7375196|FG001|COMPLETED|Third Intervention C||3
6458958|NCT01195025|7375197|FG002|COMPLETED|Third Intervention C||2
6458959|NCT01195025|7375198|FG003|COMPLETED|Third Intervention C||2
6458960|NCT01195025|7375199|FG004|COMPLETED|Third Intervention C||1
6458961|NCT01195025|7375195|FG000|NOT COMPLETED|Third Intervention C||0
6458962|NCT01195025|7375196|FG001|NOT COMPLETED|Third Intervention C||0
6458963|NCT01195025|7375197|FG002|NOT COMPLETED|Third Intervention C||0
6553781|NCT01745952|7476301|FG002|COMPLETED|Overall Study||3
6458964|NCT01195025|7375198|FG003|NOT COMPLETED|Third Intervention C||0
6458965|NCT01195025|7375199|FG004|NOT COMPLETED|Third Intervention C||0
6458966|NCT01195090|7375207|FG000|STARTED|Overall Study||60
6458967|NCT01195090|7375208|FG001|STARTED|Overall Study||60
6458968|NCT01195090|7375207|FG000|COMPLETED|Overall Study||54
6458969|NCT01195090|7375208|FG001|COMPLETED|Overall Study||52
6458970|NCT01195090|7375207|FG000|NOT COMPLETED|Overall Study||6
6458971|NCT01195090|7375208|FG001|NOT COMPLETED|Overall Study||8
6458972|NCT01195103|7375217|FG000|STARTED|Overall Study||6
6458973|NCT01195103|7375218|FG001|STARTED|Overall Study||2
6458974|NCT01195103|7375219|FG002|STARTED|Overall Study||5
6458975|NCT01195103|7375217|FG000|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
6458976|NCT01195103|7375218|FG001|COMPLETED|Overall Study||2
6458977|NCT01195103|7375219|FG002|COMPLETED|Overall Study||5
6458978|NCT01195103|7375217|FG000|NOT COMPLETED|Overall Study||1
6458979|NCT01195103|7375218|FG001|NOT COMPLETED|Overall Study||0
6458980|NCT01195103|7375219|FG002|NOT COMPLETED|Overall Study||0
6458981|NCT01195116|7375229|FG000|STARTED|Overall Study||21
6458982|NCT01195116|7375230|FG001|STARTED|Overall Study||20
6458983|NCT01195116|7375229|FG000|COMPLETED|Overall Study||21
6458984|NCT01195116|7375230|FG001|COMPLETED|Overall Study||20
6458985|NCT01195116|7375229|FG000|NOT COMPLETED|Overall Study||0
6458986|NCT01195116|7375230|FG001|NOT COMPLETED|Overall Study||0
6458987|NCT01195272|7375236|FG000|STARTED|Overall Study||21
6458988|NCT01195272|7375236|FG000|COMPLETED|Overall Study||17
6458989|NCT01195272|7375236|FG000|NOT COMPLETED|Overall Study||4
6458990|NCT01195363|7375242|FG000|STARTED|Overall Study||15
6458991|NCT01195363|7375243|FG001|STARTED|Overall Study||13
6458992|NCT01195363|7375242|FG000|COMPLETED|Overall Study||4
6458993|NCT01195363|7375243|FG001|COMPLETED|Overall Study||4
6458994|NCT01195363|7375242|FG000|NOT COMPLETED|Overall Study||11
6458995|NCT01195363|7375243|FG001|NOT COMPLETED|Overall Study||9
6458996|NCT01195415|7375249|FG000|STARTED|Overall Study||25
6458997|NCT01195415|7375249|FG000|COMPLETED|Overall Study||23
6553782|NCT01745952|7476299|FG000|NOT COMPLETED|Overall Study||1
6553783|NCT01745952|7476300|FG001|NOT COMPLETED|Overall Study||1
6553784|NCT01745952|7476301|FG002|NOT COMPLETED|Overall Study||0
6553785|NCT01746017|7476326|FG000|STARTED|Period 1||2
6553786|NCT01746017|7476327|FG001|STARTED|Period 1||2
6553787|NCT01746017|7476328|FG002|STARTED|Period 1||2
6553788|NCT01746017|7476329|FG003|STARTED|Period 1||2
6553789|NCT01746017|7476330|FG004|STARTED|Period 1||2
6553790|NCT01746017|7476331|FG005|STARTED|Period 1||2
6553791|NCT01746017|7476332|FG006|STARTED|Period 1||3
6553792|NCT01746017|7476333|FG007|STARTED|Period 1||2
6553793|NCT01746017|7476334|FG008|STARTED|Period 1||3
6553794|NCT01746017|7476335|FG009|STARTED|Period 1||3
6458998|NCT01195415|7375249|FG000|NOT COMPLETED|Overall Study||2
6458999|NCT01195467|7375253|FG000|STARTED|Overall Study||40
6459000|NCT01195467|7375253|FG000|COMPLETED|Overall Study||30
6459001|NCT01195467|7375253|FG000|NOT COMPLETED|Overall Study||10
6459002|NCT01195545|7375257|FG000|STARTED|Overall Study||20
6459003|NCT01195545|7375257|FG000|COMPLETED|Overall Study||16
6459004|NCT01195545|7375257|FG000|NOT COMPLETED|Overall Study||4
6459005|NCT01195584|7375264|FG000|STARTED|Overall Study||20
6459006|NCT01195584|7375265|FG001|STARTED|Overall Study||25
6459007|NCT01195584|7375266|FG002|STARTED|Overall Study||27
6459008|NCT01195584|7375264|FG000|COMPLETED|Overall Study||20
6459009|NCT01195584|7375265|FG001|COMPLETED|Overall Study||25
6459010|NCT01195584|7375266|FG002|COMPLETED|Overall Study||27
6459011|NCT01195584|7375264|FG000|NOT COMPLETED|Overall Study||0
6459012|NCT01195584|7375265|FG001|NOT COMPLETED|Overall Study||0
6459013|NCT01195584|7375266|FG002|NOT COMPLETED|Overall Study||0
6459014|NCT01195597|7375276|FG000|STARTED|Overall Study||40
6459015|NCT01195597|7375276|FG000|COMPLETED|Overall Study||27
6459016|NCT01195597|7375276|FG000|NOT COMPLETED|Overall Study||13
6459017|NCT01195623|7375282|FG000|STARTED|Overall Study|166 legs total operated|148
6459018|NCT01195623|7375283|FG001|STARTED|Overall Study|177 legs total operated|145
6459019|NCT01195623|7375282|FG000|COMPLETED|Overall Study|127 legs|113
6459020|NCT01195623|7375283|FG001|COMPLETED|Overall Study|129 legs|108
6459021|NCT01195623|7375282|FG000|NOT COMPLETED|Overall Study||35
6459022|NCT01195623|7375283|FG001|NOT COMPLETED|Overall Study||37
6459023|NCT01195636|7375291|FG000|STARTED|First Intervention (3 Weeks)||35
6459024|NCT01195636|7375292|FG001|STARTED|First Intervention (3 Weeks)||35
6459025|NCT01195636|7375291|FG000|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
6459026|NCT01195636|7375292|FG001|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
6459027|NCT01195636|7375291|FG000|COMPLETED|First Intervention (3 Weeks)||30
6459028|NCT01195636|7375292|FG001|COMPLETED|First Intervention (3 Weeks)||32
6459029|NCT01195636|7375291|FG000|NOT COMPLETED|First Intervention (3 Weeks)||5
6459030|NCT01195636|7375292|FG001|NOT COMPLETED|First Intervention (3 Weeks)||3
6459031|NCT01195636|7375291|FG000|STARTED|Washout Period (2 Weeks)||30
6459032|NCT01195636|7375292|FG001|STARTED|Washout Period (2 Weeks)||32
6459033|NCT01195636|7375291|FG000|COMPLETED|Washout Period (2 Weeks)||28
6459034|NCT01195636|7375292|FG001|COMPLETED|Washout Period (2 Weeks)||29
6459035|NCT01195636|7375291|FG000|NOT COMPLETED|Washout Period (2 Weeks)||2
6459036|NCT01195636|7375292|FG001|NOT COMPLETED|Washout Period (2 Weeks)||3
6459037|NCT01195636|7375291|FG000|STARTED|Second Intervention (3 Weeks)||28
6459038|NCT01195636|7375292|FG001|STARTED|Second Intervention (3 Weeks)||29
6459039|NCT01195636|7375291|FG000|COMPLETED|Second Intervention (3 Weeks)||27
6459040|NCT01195636|7375292|FG001|COMPLETED|Second Intervention (3 Weeks)||27
6459041|NCT01195636|7375291|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
6459042|NCT01195636|7375292|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||2
6459043|NCT01195662|7375301|FG000|STARTED|Double Blind Treatment Period||224
6459044|NCT01195662|7375302|FG001|STARTED|Double Blind Treatment Period||225
6459045|NCT01195662|7375303|FG002|STARTED|Double Blind Treatment Period||133
6459046|NCT01195662|7375301|FG000|COMPLETED|Double Blind Treatment Period||202
6459047|NCT01195662|7375302|FG001|COMPLETED|Double Blind Treatment Period||211
6459048|NCT01195662|7375303|FG002|COMPLETED|Double Blind Treatment Period||119
6459049|NCT01195662|7375301|FG000|NOT COMPLETED|Double Blind Treatment Period||22
6459050|NCT01195662|7375302|FG001|NOT COMPLETED|Double Blind Treatment Period||14
6553795|NCT01746017|7476336|FG010|STARTED|Period 1||3
6553796|NCT01746017|7476326|FG000|Received at Least 1 Dose of Study Drug|Period 1||2
6553797|NCT01746017|7476327|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
6459051|NCT01195662|7375303|FG002|NOT COMPLETED|Double Blind Treatment Period||14
6459052|NCT01195662|7375301|FG000|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
6459053|NCT01195662|7375302|FG001|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
6459054|NCT01195662|7375303|FG002|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
6459055|NCT01195662|7375301|FG000|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
6459056|NCT01195662|7375302|FG001|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
6459057|NCT01195662|7375303|FG002|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
6459058|NCT01195662|7375301|FG000|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
6459059|NCT01195662|7375302|FG001|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
6459060|NCT01195662|7375303|FG002|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
6459061|NCT01195675|7375312|FG000|STARTED|Overall Study||30
6459062|NCT01195675|7375312|FG000|Received Empa 25mg|Overall Study||28
6459063|NCT01195675|7375312|FG000|Received Empa 200mg|Overall Study||30
6459064|NCT01195675|7375312|FG000|Received Moxifloxacin|Overall Study||29
6459065|NCT01195675|7375312|FG000|Received Placebo 1|Overall Study||29
6459066|NCT01195675|7375312|FG000|Received Placebo 2|Overall Study||28
6459067|NCT01195675|7375312|FG000|COMPLETED|Overall Study||27
6459068|NCT01195675|7375312|FG000|NOT COMPLETED|Overall Study||3
6459069|NCT01195701|7375329|FG000|STARTED|Overall Study||10
6459070|NCT01195701|7375330|FG001|STARTED|Overall Study||25
6459071|NCT01195701|7375329|FG000|COMPLETED|Overall Study||10
6459072|NCT01195701|7375330|FG001|COMPLETED|Overall Study||20
6459073|NCT01195701|7375329|FG000|NOT COMPLETED|Overall Study||0
6459074|NCT01195701|7375330|FG001|NOT COMPLETED|Overall Study||5
6459075|NCT01195779|7375350|FG000|STARTED|Overall Study||0
6459076|NCT01195779|7375351|FG001|STARTED|Overall Study||0
6459077|NCT01195779|7375352|FG002|STARTED|Overall Study||0
6459078|NCT01195779|7375353|FG003|STARTED|Overall Study||0
6459079|NCT01195779|7375354|FG004|STARTED|Overall Study||1
6459080|NCT01195779|7375355|FG005|STARTED|Overall Study||0
6459081|NCT01195779|7375356|FG006|STARTED|Overall Study||0
6459082|NCT01195779|7375357|FG007|STARTED|Overall Study||1
6459083|NCT01195779|7375358|FG008|STARTED|Overall Study||0
6459084|NCT01195779|7375359|FG009|STARTED|Overall Study||0
6459085|NCT01195779|7375360|FG010|STARTED|Overall Study||0
6459086|NCT01195779|7375361|FG011|STARTED|Overall Study||1
6459087|NCT01195779|7375362|FG012|STARTED|Overall Study||0
6459088|NCT01195779|7375363|FG013|STARTED|Overall Study||1
6459089|NCT01195779|7375350|FG000|COMPLETED|Overall Study||0
6459090|NCT01195779|7375351|FG001|COMPLETED|Overall Study||0
6459091|NCT01195779|7375352|FG002|COMPLETED|Overall Study||0
6459092|NCT01195779|7375353|FG003|COMPLETED|Overall Study||0
6459093|NCT01195779|7375354|FG004|COMPLETED|Overall Study||1
6459094|NCT01195779|7375355|FG005|COMPLETED|Overall Study||0
6459095|NCT01195779|7375356|FG006|COMPLETED|Overall Study||0
6459096|NCT01195779|7375357|FG007|COMPLETED|Overall Study||1
6459097|NCT01195779|7375358|FG008|COMPLETED|Overall Study||0
6459098|NCT01195779|7375359|FG009|COMPLETED|Overall Study||0
6459099|NCT01195779|7375360|FG010|COMPLETED|Overall Study||0
6459100|NCT01195779|7375361|FG011|COMPLETED|Overall Study||1
6459101|NCT01195779|7375362|FG012|COMPLETED|Overall Study||0
6459102|NCT01195779|7375363|FG013|COMPLETED|Overall Study||1
6459103|NCT01195779|7375350|FG000|NOT COMPLETED|Overall Study||0
6459104|NCT01195779|7375351|FG001|NOT COMPLETED|Overall Study||0
6459105|NCT01195779|7375352|FG002|NOT COMPLETED|Overall Study||0
6459106|NCT01195779|7375353|FG003|NOT COMPLETED|Overall Study||0
6459107|NCT01195779|7375354|FG004|NOT COMPLETED|Overall Study||0
6459108|NCT01195779|7375355|FG005|NOT COMPLETED|Overall Study||0
6459109|NCT01195779|7375356|FG006|NOT COMPLETED|Overall Study||0
6459110|NCT01195779|7375357|FG007|NOT COMPLETED|Overall Study||0
6459111|NCT01195779|7375358|FG008|NOT COMPLETED|Overall Study||0
6459112|NCT01195779|7375359|FG009|NOT COMPLETED|Overall Study||0
6459113|NCT01195779|7375360|FG010|NOT COMPLETED|Overall Study||0
6459114|NCT01195779|7375361|FG011|NOT COMPLETED|Overall Study||0
6459115|NCT01195779|7375362|FG012|NOT COMPLETED|Overall Study||0
6459116|NCT01195779|7375363|FG013|NOT COMPLETED|Overall Study||0
6459117|NCT01195831|7375395|FG000|STARTED|Overall Study||120
6459118|NCT01195831|7375396|FG001|STARTED|Overall Study||124
6459119|NCT01195831|7375395|FG000|COMPLETED|Overall Study||112
6459120|NCT01195831|7375396|FG001|COMPLETED|Overall Study||114
6459121|NCT01195831|7375395|FG000|NOT COMPLETED|Overall Study||8
6459122|NCT01195831|7375396|FG001|NOT COMPLETED|Overall Study||10
6459123|NCT01195844|7375402|FG000|STARTED|Overall Study||230
6459124|NCT01195844|7375402|FG000|COMPLETED|Overall Study||190
6459125|NCT01195844|7375402|FG000|NOT COMPLETED|Overall Study||40
6459126|NCT01195883|7375418|FG000|STARTED|Overall Study||553
6459127|NCT01195883|7375419|FG001|STARTED|Overall Study||549
6459128|NCT01195883|7375418|FG000|COMPLETED|Overall Study||534
6459129|NCT01195883|7375419|FG001|COMPLETED|Overall Study||523
6459130|NCT01195883|7375418|FG000|NOT COMPLETED|Overall Study||19
6459131|NCT01195883|7375419|FG001|NOT COMPLETED|Overall Study||26
6459132|NCT01195922|7375425|FG000|STARTED|Overall Study||16
6459133|NCT01195922|7375425|FG000|COMPLETED|Overall Study||16
6459134|NCT01195922|7375425|FG000|NOT COMPLETED|Overall Study||0
6459135|NCT01195948|7375432|FG000|STARTED|Overall Study||10
6459136|NCT01195948|7375433|FG001|STARTED|Overall Study||10
6459137|NCT01195948|7375434|FG002|STARTED|Overall Study||11
6459138|NCT01195948|7375432|FG000|Week 24|Overall Study||10
6459139|NCT01195948|7375433|FG001|Week 24|Overall Study||10
6459140|NCT01195948|7375434|FG002|Week 24|Overall Study||10
6459141|NCT01195948|7375432|FG000|COMPLETED|Overall Study||10
6459142|NCT01195948|7375433|FG001|COMPLETED|Overall Study||9
6459143|NCT01195948|7375434|FG002|COMPLETED|Overall Study||9
6459144|NCT01195948|7375432|FG000|NOT COMPLETED|Overall Study||0
6459145|NCT01195948|7375433|FG001|NOT COMPLETED|Overall Study||1
6745329|NCT03358407|7673372|FG000|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745330|NCT03358407|7673373|FG001|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745331|NCT03358407|7673374|FG002|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745332|NCT03358407|7673375|FG003|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745333|NCT03358407|7673376|FG004|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745334|NCT03358407|7673377|FG005|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745335|NCT03358407|7673378|FG006|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745336|NCT03358407|7673379|FG007|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745337|NCT03358407|7673380|FG008|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745338|NCT03358407|7673381|FG009|NOT COMPLETED|P3:PartA-Cohort1(4days)+Washout(48hours)||0
6745339|NCT03358407|7673372|FG000|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6745340|NCT03358407|7673373|FG001|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6745341|NCT03358407|7673374|FG002|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6459146|NCT01195948|7375434|FG002|NOT COMPLETED|Overall Study||2
6459147|NCT01196026|7375451|FG000|STARTED|Overall Study||10
6459148|NCT01196026|7375452|FG001|STARTED|Overall Study||44
6459149|NCT01196026|7375453|FG002|STARTED|Overall Study||23
6459150|NCT01196026|7375454|FG003|STARTED|Overall Study||10
6745342|NCT03358407|7673375|FG003|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6459151|NCT01196026|7375455|FG004|STARTED|Overall Study||43
6459152|NCT01196026|7375456|FG005|STARTED|Overall Study||24
6459153|NCT01196026|7375451|FG000|Completed at Day 28|Overall Study||9
6459154|NCT01196026|7375452|FG001|Completed at Day 28|Overall Study||41
6459155|NCT01196026|7375453|FG002|Completed at Day 28|Overall Study||23
6459156|NCT01196026|7375454|FG003|Completed at Day 28|Overall Study||10
6459157|NCT01196026|7375455|FG004|Completed at Day 28|Overall Study||42
6459158|NCT01196026|7375456|FG005|Completed at Day 28|Overall Study||24
6459159|NCT01196026|7375451|FG000|COMPLETED|Overall Study||9
6459160|NCT01196026|7375452|FG001|COMPLETED|Overall Study||36
6459161|NCT01196026|7375453|FG002|COMPLETED|Overall Study||23
6459162|NCT01196026|7375454|FG003|COMPLETED|Overall Study||10
6459163|NCT01196026|7375455|FG004|COMPLETED|Overall Study||42
6459164|NCT01196026|7375456|FG005|COMPLETED|Overall Study||24
6459165|NCT01196026|7375451|FG000|NOT COMPLETED|Overall Study||1
6459166|NCT01196026|7375452|FG001|NOT COMPLETED|Overall Study||8
6459167|NCT01196026|7375453|FG002|NOT COMPLETED|Overall Study||0
6459168|NCT01196026|7375454|FG003|NOT COMPLETED|Overall Study||0
6459169|NCT01196026|7375455|FG004|NOT COMPLETED|Overall Study||1
6459170|NCT01196026|7375456|FG005|NOT COMPLETED|Overall Study||0
6459171|NCT01196052|7375472|FG000|STARTED|Overall Study||153
6459172|NCT01196052|7375472|FG000|Received Trastuzumab Emtansine|Overall Study||148
6459173|NCT01196052|7375472|FG000|COMPLETED|Overall Study||130
6459174|NCT01196052|7375472|FG000|NOT COMPLETED|Overall Study||23
6459175|NCT01196078|7375478|FG000|STARTED|Overall Study||57
6459176|NCT01196078|7375479|FG001|STARTED|Overall Study||57
6459177|NCT01196078|7375478|FG000|COMPLETED|Overall Study||24
6459178|NCT01196078|7375479|FG001|COMPLETED|Overall Study||20
6459179|NCT01196078|7375478|FG000|NOT COMPLETED|Overall Study||33
6553798|NCT01746017|7476328|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
6553799|NCT01746017|7476329|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
6553800|NCT01746017|7476330|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
6553801|NCT01746017|7476331|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
6459180|NCT01196078|7375479|FG001|NOT COMPLETED|Overall Study||37
6459181|NCT01196091|7375488|FG000|STARTED|Overall Study||387
6459182|NCT01196091|7375489|FG001|STARTED|Overall Study||389
6459183|NCT01196091|7375490|FG002|STARTED|Overall Study||388
6459184|NCT01196091|7375488|FG000|Received at Least 1 Dose of Study Drug|Overall Study||386
6459185|NCT01196091|7375489|FG001|Received at Least 1 Dose of Study Drug|Overall Study||389
6459186|NCT01196091|7375490|FG002|Received at Least 1 Dose of Study Drug|Overall Study||387
6459187|NCT01196091|7375488|FG000|ITT-Received Drug and Excluded Sites|Overall Study||381
6459188|NCT01196091|7375489|FG001|ITT-Received Drug and Excluded Sites|Overall Study||378
6459189|NCT01196091|7375490|FG002|ITT-Received Drug and Excluded Sites|Overall Study||379
6459190|NCT01196091|7375488|FG000|Follow-Up|Overall Study||103
6459191|NCT01196091|7375489|FG001|Follow-Up|Overall Study||105
6459192|NCT01196091|7375490|FG002|Follow-Up|Overall Study||128
6459193|NCT01196091|7375488|FG000|COMPLETED|Overall Study||299
6459194|NCT01196091|7375489|FG001|COMPLETED|Overall Study||291
6459195|NCT01196091|7375490|FG002|COMPLETED|Overall Study||284
6459196|NCT01196091|7375488|FG000|NOT COMPLETED|Overall Study||88
6459197|NCT01196091|7375489|FG001|NOT COMPLETED|Overall Study||98
6459198|NCT01196091|7375490|FG002|NOT COMPLETED|Overall Study||104
6459199|NCT01196104|7375505|FG000|STARTED|Overall Study||19
6459200|NCT01196104|7375506|FG001|STARTED|Overall Study||20
6459201|NCT01196104|7375505|FG000|COMPLETED|Overall Study||15
6459202|NCT01196104|7375506|FG001|COMPLETED|Overall Study||15
6459203|NCT01196104|7375505|FG000|NOT COMPLETED|Overall Study||4
6459204|NCT01196104|7375506|FG001|NOT COMPLETED|Overall Study||5
6459205|NCT01196117|7375514|FG000|STARTED|Placebo, Then CPAP||18
6459206|NCT01196117|7375515|FG001|STARTED|Placebo, Then CPAP||0
6459207|NCT01196117|7375514|FG000|COMPLETED|Placebo, Then CPAP||18
6459208|NCT01196117|7375515|FG001|COMPLETED|Placebo, Then CPAP||0
6459209|NCT01196117|7375514|FG000|NOT COMPLETED|Placebo, Then CPAP||0
6459210|NCT01196117|7375515|FG001|NOT COMPLETED|Placebo, Then CPAP||0
6459211|NCT01196117|7375514|FG000|STARTED|CPAP||0
6459212|NCT01196117|7375515|FG001|STARTED|CPAP||18
6459213|NCT01196117|7375514|FG000|COMPLETED|CPAP||0
6459214|NCT01196117|7375515|FG001|COMPLETED|CPAP||18
6459215|NCT01196117|7375514|FG000|NOT COMPLETED|CPAP||0
6459216|NCT01196117|7375515|FG001|NOT COMPLETED|CPAP||0
6459217|NCT01196377|7375529|FG000|STARTED|Overall Study||4
6459218|NCT01196377|7375530|FG001|STARTED|Overall Study||4
6459219|NCT01196377|7375531|FG002|STARTED|Overall Study||4
6459220|NCT01196377|7375532|FG003|STARTED|Overall Study||4
6459221|NCT01196377|7375529|FG000|COMPLETED|Overall Study||4
6459222|NCT01196377|7375530|FG001|COMPLETED|Overall Study||4
6459223|NCT01196377|7375531|FG002|COMPLETED|Overall Study||4
6459224|NCT01196377|7375532|FG003|COMPLETED|Overall Study||4
6459225|NCT01196377|7375529|FG000|NOT COMPLETED|Overall Study||0
6459226|NCT01196377|7375530|FG001|NOT COMPLETED|Overall Study||0
6459227|NCT01196377|7375531|FG002|NOT COMPLETED|Overall Study||0
6459228|NCT01196377|7375532|FG003|NOT COMPLETED|Overall Study||0
6459229|NCT01196416|7375542|FG000|STARTED|Overall Study||14
6459230|NCT01196416|7375542|FG000|COMPLETED|Overall Study||12
6459231|NCT01196416|7375542|FG000|NOT COMPLETED|Overall Study||2
6459232|NCT01196429|7375548|FG000|STARTED|Overall Study||45
6459233|NCT01196429|7375549|FG001|STARTED|Overall Study||45
6459234|NCT01196429|7375548|FG000|COMPLETED|Overall Study||42
6459235|NCT01196429|7375549|FG001|COMPLETED|Overall Study||45
6459236|NCT01196429|7375548|FG000|NOT COMPLETED|Overall Study||3
6459237|NCT01196429|7375549|FG001|NOT COMPLETED|Overall Study||0
6459238|NCT01196442|7375557|FG000|STARTED|Overall Study||39
6459239|NCT01196442|7375557|FG000|COMPLETED|Overall Study||39
6459240|NCT01196442|7375557|FG000|NOT COMPLETED|Overall Study||0
6459241|NCT01196533|7375562|FG000|STARTED|Overall Study||94
6459242|NCT01196533|7375562|FG000|COMPLETED|Overall Study||94
6459243|NCT01196533|7375562|FG000|NOT COMPLETED|Overall Study||0
6459244|NCT01196741|7375568|FG000|STARTED|Overall Study||71
6459245|NCT01196741|7375569|FG001|STARTED|Overall Study||36
6459246|NCT01196741|7375568|FG000|COMPLETED|Overall Study||11
6459247|NCT01196741|7375569|FG001|COMPLETED|Overall Study||8
6459248|NCT01196741|7375568|FG000|NOT COMPLETED|Overall Study||60
6459249|NCT01196741|7375569|FG001|NOT COMPLETED|Overall Study||28
6459250|NCT01196793|7375575|FG000|STARTED|Overall Study||108
6459251|NCT01196793|7375575|FG000|COMPLETED|Overall Study||108
6459252|NCT01196793|7375575|FG000|NOT COMPLETED|Overall Study||0
6459253|NCT01196819|7375581|FG000|STARTED|Overall Study||231
6459254|NCT01196819|7375582|FG001|STARTED|Overall Study||227
6459255|NCT01196819|7375581|FG000|COMPLETED|Overall Study||225
6459256|NCT01196819|7375582|FG001|COMPLETED|Overall Study||227
6553802|NCT01746017|7476332|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
6553803|NCT01746017|7476333|FG007|Received at Least 1 Dose of Study Drug|Period 1||2
6553804|NCT01746017|7476334|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
6553805|NCT01746017|7476335|FG009|Received at Least 1 Dose of Study Drug|Period 1||3
6553806|NCT01746017|7476336|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
6553807|NCT01746017|7476326|FG000|COMPLETED|Period 1||2
6553808|NCT01746017|7476327|FG001|COMPLETED|Period 1||2
6553809|NCT01746017|7476328|FG002|COMPLETED|Period 1||2
6553810|NCT01746017|7476329|FG003|COMPLETED|Period 1||2
6459257|NCT01196819|7375581|FG000|NOT COMPLETED|Overall Study||6
6459258|NCT01196819|7375582|FG001|NOT COMPLETED|Overall Study||0
6459259|NCT01196871|7375594|FG000|STARTED|Stage 1: Period 1||5
6459260|NCT01196871|7375595|FG001|STARTED|Stage 1: Period 1||3
6459261|NCT01196871|7375596|FG002|STARTED|Stage 1: Period 1||4
6459262|NCT01196871|7375597|FG003|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
6459263|NCT01196871|7375598|FG004|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
6459264|NCT01196871|7375599|FG005|STARTED|Stage 1: Period 1|Zero participants noted since these participants started in Stage 2|0
6459265|NCT01196871|7375594|FG000|PK Population|Stage 1: Period 1||5
6459266|NCT01196871|7375595|FG001|PK Population|Stage 1: Period 1||3
6459267|NCT01196871|7375596|FG002|PK Population|Stage 1: Period 1||4
6459268|NCT01196871|7375597|FG003|PK Population|Stage 1: Period 1||0
6459269|NCT01196871|7375598|FG004|PK Population|Stage 1: Period 1||0
6459270|NCT01196871|7375599|FG005|PK Population|Stage 1: Period 1||0
6459271|NCT01196871|7375594|FG000|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||5
6459272|NCT01196871|7375595|FG001|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||3
6459273|NCT01196871|7375596|FG002|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||4
6459274|NCT01196871|7375597|FG003|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
6459275|NCT01196871|7375598|FG004|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
6459276|NCT01196871|7375599|FG005|Received at Least 1 Dose of Study Drug|Stage 1: Period 1||0
6459277|NCT01196871|7375594|FG000|COMPLETED|Stage 1: Period 1||5
6459278|NCT01196871|7375595|FG001|COMPLETED|Stage 1: Period 1||3
6459279|NCT01196871|7375596|FG002|COMPLETED|Stage 1: Period 1||4
6459280|NCT01196871|7375597|FG003|COMPLETED|Stage 1: Period 1||0
6459281|NCT01196871|7375598|FG004|COMPLETED|Stage 1: Period 1||0
6459282|NCT01196871|7375599|FG005|COMPLETED|Stage 1: Period 1||0
6459283|NCT01196871|7375594|FG000|NOT COMPLETED|Stage 1: Period 1||0
6459284|NCT01196871|7375595|FG001|NOT COMPLETED|Stage 1: Period 1||0
6459285|NCT01196871|7375596|FG002|NOT COMPLETED|Stage 1: Period 1||0
6459286|NCT01196871|7375597|FG003|NOT COMPLETED|Stage 1: Period 1||0
6459287|NCT01196871|7375598|FG004|NOT COMPLETED|Stage 1: Period 1||0
6459288|NCT01196871|7375599|FG005|NOT COMPLETED|Stage 1: Period 1||0
6459289|NCT01196871|7375594|FG000|STARTED|Stage 1: Period 2||5
6459290|NCT01196871|7375595|FG001|STARTED|Stage 1: Period 2||3
6459291|NCT01196871|7375596|FG002|STARTED|Stage 1: Period 2||4
6459292|NCT01196871|7375597|FG003|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
6459293|NCT01196871|7375598|FG004|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
6459294|NCT01196871|7375599|FG005|STARTED|Stage 1: Period 2|Zero participants noted since these participants started in Stage 2|0
6459295|NCT01196871|7375594|FG000|PK Population|Stage 1: Period 2||5
6553811|NCT01746017|7476330|FG004|COMPLETED|Period 1||2
6459296|NCT01196871|7375595|FG001|PK Population|Stage 1: Period 2||3
6459297|NCT01196871|7375596|FG002|PK Population|Stage 1: Period 2||4
6459298|NCT01196871|7375597|FG003|PK Population|Stage 1: Period 2||0
6459299|NCT01196871|7375598|FG004|PK Population|Stage 1: Period 2||0
6459300|NCT01196871|7375599|FG005|PK Population|Stage 1: Period 2||0
6459301|NCT01196871|7375594|FG000|COMPLETED|Stage 1: Period 2||5
6459302|NCT01196871|7375595|FG001|COMPLETED|Stage 1: Period 2||3
6553812|NCT01746017|7476331|FG005|COMPLETED|Period 1||2
6459303|NCT01196871|7375596|FG002|COMPLETED|Stage 1: Period 2||4
6459304|NCT01196871|7375597|FG003|COMPLETED|Stage 1: Period 2||0
6459305|NCT01196871|7375598|FG004|COMPLETED|Stage 1: Period 2||0
6553813|NCT01746017|7476332|FG006|COMPLETED|Period 1||2
6553814|NCT01746017|7476333|FG007|COMPLETED|Period 1||2
6459306|NCT01196871|7375599|FG005|COMPLETED|Stage 1: Period 2||0
6459307|NCT01196871|7375594|FG000|NOT COMPLETED|Stage 1: Period 2||0
6459308|NCT01196871|7375595|FG001|NOT COMPLETED|Stage 1: Period 2||0
6459309|NCT01196871|7375596|FG002|NOT COMPLETED|Stage 1: Period 2||0
6459310|NCT01196871|7375597|FG003|NOT COMPLETED|Stage 1: Period 2||0
6459311|NCT01196871|7375598|FG004|NOT COMPLETED|Stage 1: Period 2||0
6459312|NCT01196871|7375599|FG005|NOT COMPLETED|Stage 1: Period 2||0
6459313|NCT01196871|7375594|FG000|STARTED|Stage 1: Period 3||5
6459314|NCT01196871|7375595|FG001|STARTED|Stage 1: Period 3||3
6459315|NCT01196871|7375596|FG002|STARTED|Stage 1: Period 3||4
6459316|NCT01196871|7375597|FG003|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
6459317|NCT01196871|7375598|FG004|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
6459318|NCT01196871|7375599|FG005|STARTED|Stage 1: Period 3|Zero participants noted since these participants started in Stage 2|0
6459319|NCT01196871|7375594|FG000|COMPLETED|Stage 1: Period 3||5
6459320|NCT01196871|7375595|FG001|COMPLETED|Stage 1: Period 3||3
6459321|NCT01196871|7375596|FG002|COMPLETED|Stage 1: Period 3||4
6459322|NCT01196871|7375597|FG003|COMPLETED|Stage 1: Period 3||0
6459323|NCT01196871|7375598|FG004|COMPLETED|Stage 1: Period 3||0
6459324|NCT01196871|7375599|FG005|COMPLETED|Stage 1: Period 3||0
6459325|NCT01196871|7375594|FG000|NOT COMPLETED|Stage 1: Period 3||0
6459326|NCT01196871|7375595|FG001|NOT COMPLETED|Stage 1: Period 3||0
6459327|NCT01196871|7375596|FG002|NOT COMPLETED|Stage 1: Period 3||0
6459328|NCT01196871|7375597|FG003|NOT COMPLETED|Stage 1: Period 3||0
6459329|NCT01196871|7375598|FG004|NOT COMPLETED|Stage 1: Period 3||0
6459330|NCT01196871|7375599|FG005|NOT COMPLETED|Stage 1: Period 3||0
6459331|NCT01196871|7375594|FG000|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
6459332|NCT01196871|7375595|FG001|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
6459333|NCT01196871|7375596|FG002|STARTED|Stage 2: Period 1|Zero participants noted because participants had completed Stage 1|0
6459334|NCT01196871|7375597|FG003|STARTED|Stage 2: Period 1|Both participants re-enrolled into Stage 2 after completing Stage 1|2
6459335|NCT01196871|7375598|FG004|STARTED|Stage 2: Period 1|One participant re-enrolled into Stage 2 after completing Stage 1|5
6459336|NCT01196871|7375599|FG005|STARTED|Stage 2: Period 1||4
6459337|NCT01196871|7375594|FG000|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
6459338|NCT01196871|7375595|FG001|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
6459339|NCT01196871|7375596|FG002|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||0
6459340|NCT01196871|7375597|FG003|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||2
6459341|NCT01196871|7375598|FG004|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||5
6459342|NCT01196871|7375599|FG005|Received at Least 1 Dose of Study Drug|Stage 2: Period 1||4
6459343|NCT01196871|7375594|FG000|PK Population|Stage 2: Period 1||0
6459344|NCT01196871|7375595|FG001|PK Population|Stage 2: Period 1||0
6459345|NCT01196871|7375596|FG002|PK Population|Stage 2: Period 1||0
6459346|NCT01196871|7375597|FG003|PK Population|Stage 2: Period 1||1
6459347|NCT01196871|7375598|FG004|PK Population|Stage 2: Period 1||5
6459348|NCT01196871|7375599|FG005|PK Population|Stage 2: Period 1||4
6459349|NCT01196871|7375594|FG000|COMPLETED|Stage 2: Period 1||0
6459350|NCT01196871|7375595|FG001|COMPLETED|Stage 2: Period 1||0
6459351|NCT01196871|7375596|FG002|COMPLETED|Stage 2: Period 1||0
6459352|NCT01196871|7375597|FG003|COMPLETED|Stage 2: Period 1||2
6459353|NCT01196871|7375598|FG004|COMPLETED|Stage 2: Period 1||5
6459354|NCT01196871|7375599|FG005|COMPLETED|Stage 2: Period 1||4
6459355|NCT01196871|7375594|FG000|NOT COMPLETED|Stage 2: Period 1||0
6459356|NCT01196871|7375595|FG001|NOT COMPLETED|Stage 2: Period 1||0
6459357|NCT01196871|7375596|FG002|NOT COMPLETED|Stage 2: Period 1||0
6459358|NCT01196871|7375597|FG003|NOT COMPLETED|Stage 2: Period 1||0
6459359|NCT01196871|7375598|FG004|NOT COMPLETED|Stage 2: Period 1||0
6459360|NCT01196871|7375599|FG005|NOT COMPLETED|Stage 2: Period 1||0
6459361|NCT01196871|7375594|FG000|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
6459362|NCT01196871|7375595|FG001|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
6459363|NCT01196871|7375596|FG002|STARTED|Stage 2: Period 2|Zero participants noted because participants had completed Stage 1|0
6459364|NCT01196871|7375597|FG003|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|1
6459365|NCT01196871|7375598|FG004|STARTED|Stage 2: Period 2|One participant switched agalsidase dose from 0.5 mg/kg in Period 1 to 1.0 mg/kg in Period 2|6
6459366|NCT01196871|7375599|FG005|STARTED|Stage 2: Period 2||4
6459367|NCT01196871|7375594|FG000|PK Population|Stage 2: Period 2||0
6459368|NCT01196871|7375595|FG001|PK Population|Stage 2: Period 2||0
6459369|NCT01196871|7375596|FG002|PK Population|Stage 2: Period 2||0
6459370|NCT01196871|7375597|FG003|PK Population|Stage 2: Period 2||1
6459371|NCT01196871|7375598|FG004|PK Population|Stage 2: Period 2||6
6459372|NCT01196871|7375599|FG005|PK Population|Stage 2: Period 2||4
6459373|NCT01196871|7375594|FG000|COMPLETED|Stage 2: Period 2||0
6459374|NCT01196871|7375595|FG001|COMPLETED|Stage 2: Period 2||0
6459375|NCT01196871|7375596|FG002|COMPLETED|Stage 2: Period 2||0
6459376|NCT01196871|7375597|FG003|COMPLETED|Stage 2: Period 2||1
6459377|NCT01196871|7375598|FG004|COMPLETED|Stage 2: Period 2||6
6553815|NCT01746017|7476334|FG008|COMPLETED|Period 1||3
6553816|NCT01746017|7476335|FG009|COMPLETED|Period 1||3
6553817|NCT01746017|7476336|FG010|COMPLETED|Period 1||3
6553818|NCT01746017|7476326|FG000|NOT COMPLETED|Period 1||0
6745343|NCT03358407|7673376|FG004|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6745344|NCT03358407|7673377|FG005|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6459378|NCT01196871|7375599|FG005|COMPLETED|Stage 2: Period 2||4
6459379|NCT01196871|7375594|FG000|NOT COMPLETED|Stage 2: Period 2||0
6459380|NCT01196871|7375595|FG001|NOT COMPLETED|Stage 2: Period 2||0
6459381|NCT01196871|7375596|FG002|NOT COMPLETED|Stage 2: Period 2||0
6459382|NCT01196871|7375597|FG003|NOT COMPLETED|Stage 2: Period 2||0
6459383|NCT01196871|7375598|FG004|NOT COMPLETED|Stage 2: Period 2||0
6459384|NCT01196871|7375599|FG005|NOT COMPLETED|Stage 2: Period 2||0
6459385|NCT01196923|7375622|FG000|STARTED|Overall Study||20
6459386|NCT01196923|7375622|FG000|COMPLETED|Overall Study||20
6459387|NCT01196923|7375622|FG000|NOT COMPLETED|Overall Study||0
6459388|NCT01196975|7375631|FG000|STARTED|Overall Study||423
6459389|NCT01196975|7375632|FG001|STARTED|Overall Study||424
6459390|NCT01196975|7375633|FG002|STARTED|Overall Study||425
6459391|NCT01196975|7375634|FG003|STARTED|Overall Study||213
6459392|NCT01196975|7375635|FG004|STARTED|Overall Study||218
6459393|NCT01196975|7375631|FG000|COMPLETED|Overall Study||408
6459394|NCT01196975|7375632|FG001|COMPLETED|Overall Study||415
6459395|NCT01196975|7375633|FG002|COMPLETED|Overall Study||420
6459396|NCT01196975|7375634|FG003|COMPLETED|Overall Study||207
6459397|NCT01196975|7375635|FG004|COMPLETED|Overall Study||205
6459398|NCT01196975|7375631|FG000|NOT COMPLETED|Overall Study||15
6745345|NCT03358407|7673378|FG006|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745346|NCT03358407|7673379|FG007|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6459399|NCT01196975|7375632|FG001|NOT COMPLETED|Overall Study||9
6459400|NCT01196975|7375633|FG002|NOT COMPLETED|Overall Study||5
6459401|NCT01196975|7375634|FG003|NOT COMPLETED|Overall Study||6
6459402|NCT01196975|7375635|FG004|NOT COMPLETED|Overall Study||13
6459403|NCT01196988|7375674|FG000|STARTED|Overall Study||915
6459404|NCT01196988|7375675|FG001|STARTED|Overall Study||912
6459405|NCT01196988|7375676|FG002|STARTED|Overall Study||911
6459406|NCT01196988|7375677|FG003|STARTED|Overall Study||277
6459407|NCT01196988|7375674|FG000|COMPLETED|Overall Study||891
6459408|NCT01196988|7375675|FG001|COMPLETED|Overall Study||880
6459409|NCT01196988|7375676|FG002|COMPLETED|Overall Study||886
6459410|NCT01196988|7375677|FG003|COMPLETED|Overall Study||276
6459411|NCT01196988|7375674|FG000|NOT COMPLETED|Overall Study||24
6459412|NCT01196988|7375675|FG001|NOT COMPLETED|Overall Study||32
6459413|NCT01196988|7375676|FG002|NOT COMPLETED|Overall Study||25
6459414|NCT01196988|7375677|FG003|NOT COMPLETED|Overall Study||1
6459415|NCT01197300|7375690|FG000|STARTED|Overall Study||10
6459416|NCT01197300|7375691|FG001|STARTED|Overall Study||15
6459417|NCT01197300|7375690|FG000|COMPLETED|Overall Study||10
6459418|NCT01197300|7375691|FG001|COMPLETED|Overall Study||13
6459419|NCT01197300|7375690|FG000|NOT COMPLETED|Overall Study||0
6459420|NCT01197300|7375691|FG001|NOT COMPLETED|Overall Study||2
6459421|NCT01197326|7375699|FG000|STARTED|Overall Study||205
6459422|NCT01197326|7375700|FG001|STARTED|Overall Study||209
6459423|NCT01197326|7375699|FG000|COMPLETED|Overall Study||205
6459424|NCT01197326|7375700|FG001|COMPLETED|Overall Study||209
6459425|NCT01197326|7375699|FG000|NOT COMPLETED|Overall Study||0
6459426|NCT01197326|7375700|FG001|NOT COMPLETED|Overall Study||0
6459427|NCT01197378|7375708|FG000|STARTED|Overall Study||60
6459428|NCT01197378|7375708|FG000|Received Treatment|Overall Study||59
6459429|NCT01197378|7375708|FG000|COMPLETED|Overall Study||53
6459430|NCT01197378|7375708|FG000|NOT COMPLETED|Overall Study||7
6459431|NCT01197417|7375714|FG000|STARTED|Overall Study||104
6459432|NCT01197417|7375715|FG001|STARTED|Overall Study||104
6459433|NCT01197417|7375714|FG000|Received Study Drug|Overall Study||101
6459434|NCT01197417|7375715|FG001|Received Study Drug|Overall Study||103
6459435|NCT01197417|7375714|FG000|COMPLETED|Overall Study||96
6459436|NCT01197417|7375715|FG001|COMPLETED|Overall Study||86
6459437|NCT01197417|7375714|FG000|NOT COMPLETED|Overall Study||8
6459438|NCT01197417|7375715|FG001|NOT COMPLETED|Overall Study||18
6459439|NCT01197456|7375723|FG000|STARTED|Overall Study||171
6459440|NCT01197456|7375724|FG001|STARTED|Overall Study||61
6459441|NCT01197456|7375723|FG000|COMPLETED|Overall Study||171
6459442|NCT01197456|7375724|FG001|COMPLETED|Overall Study||61
6459443|NCT01197456|7375723|FG000|NOT COMPLETED|Overall Study||0
6459444|NCT01197456|7375724|FG001|NOT COMPLETED|Overall Study||0
6459445|NCT01197495|7375732|FG000|STARTED|Overall Study||157
6459446|NCT01197495|7375733|FG001|STARTED|Overall Study||56
6459447|NCT01197495|7375732|FG000|COMPLETED|Overall Study||144
6459448|NCT01197495|7375733|FG001|COMPLETED|Overall Study||49
6459449|NCT01197495|7375732|FG000|NOT COMPLETED|Overall Study||13
6459450|NCT01197495|7375733|FG001|NOT COMPLETED|Overall Study||7
6459451|NCT01197508|7375743|FG000|STARTED|Overall Study||174
6459452|NCT01197508|7375744|FG001|STARTED|Overall Study||174
6459453|NCT01197508|7375745|FG002|STARTED|Overall Study||174
6459454|NCT01197508|7375746|FG003|STARTED|Overall Study||174
6459455|NCT01197508|7375743|FG000|Received Treatment|Overall Study||174
6459456|NCT01197508|7375744|FG001|Received Treatment|Overall Study||174
6459457|NCT01197508|7375745|FG002|Received Treatment|Overall Study||171
6459458|NCT01197508|7375746|FG003|Received Treatment|Overall Study||174
6459459|NCT01197508|7375743|FG000|COMPLETED|Overall Study||151
6459460|NCT01197508|7375744|FG001|COMPLETED|Overall Study||144
6459461|NCT01197508|7375745|FG002|COMPLETED|Overall Study||125
6459462|NCT01197508|7375746|FG003|COMPLETED|Overall Study||158
6459463|NCT01197508|7375743|FG000|NOT COMPLETED|Overall Study||23
6459464|NCT01197508|7375744|FG001|NOT COMPLETED|Overall Study||30
6459465|NCT01197508|7375745|FG002|NOT COMPLETED|Overall Study||49
6459466|NCT01197508|7375746|FG003|NOT COMPLETED|Overall Study||16
6459467|NCT01197521|7375759|FG000|STARTED|Overall Study|Patients who received treatment|310
6459468|NCT01197521|7375760|FG001|STARTED|Overall Study|Patients who received treatment|304
6459469|NCT01197521|7375761|FG002|STARTED|Overall Study|Patients who received treatment|304
6459470|NCT01197521|7375759|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
6459471|NCT01197521|7375760|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
6459472|NCT01197521|7375761|FG002|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
6459473|NCT01197521|7375759|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
6459474|NCT01197521|7375760|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
6459475|NCT01197521|7375761|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
6459476|NCT01197521|7375759|FG000|NOT COMPLETED|Overall Study||103
6459477|NCT01197521|7375760|FG001|NOT COMPLETED|Overall Study||113
6459478|NCT01197521|7375761|FG002|NOT COMPLETED|Overall Study||143
6459479|NCT01197534|7375775|FG000|STARTED|Overall Study|Patients who received treatment|308
6459480|NCT01197534|7375776|FG001|STARTED|Overall Study|Patients who received treatment|298
6459481|NCT01197534|7375777|FG002|STARTED|Overall Study|Patients who received treatment|302
6459482|NCT01197534|7375775|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
6459483|NCT01197534|7375776|FG001|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
6459484|NCT01197534|7375777|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
6459485|NCT01197534|7375775|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
6459486|NCT01197534|7375776|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
6459487|NCT01197534|7375777|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
6459488|NCT01197534|7375775|FG000|NOT COMPLETED|Overall Study||134
6459489|NCT01197534|7375776|FG001|NOT COMPLETED|Overall Study||130
6459490|NCT01197534|7375777|FG002|NOT COMPLETED|Overall Study||173
6459491|NCT01197547|7375788|FG000|STARTED|Overall Study||1014
6459492|NCT01197547|7375788|FG000|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
6459493|NCT01197547|7375788|FG000|NOT COMPLETED|Overall Study||22
6459494|NCT01197560|7375794|FG000|STARTED|Overall Study|This is the intent to treat population|54
6459495|NCT01197560|7375795|FG001|STARTED|Overall Study|This is the intent to treat population|57
6459496|NCT01197560|7375794|FG000|Received ≥ One Dose Study Drug|Overall Study||54
6459497|NCT01197560|7375795|FG001|Received ≥ One Dose Study Drug|Overall Study||55
6459498|NCT01197560|7375794|FG000|Lenalidomide Crossover|Overall Study||0
6459499|NCT01197560|7375795|FG001|Lenalidomide Crossover|Overall Study||29
6459500|NCT01197560|7375794|FG000|Discontinued Treatment After ≥ 6 Cycles|Overall Study||14
6459501|NCT01197560|7375795|FG001|Discontinued Treatment After ≥ 6 Cycles|Overall Study||0
6459502|NCT01197560|7375794|FG000|COMPLETED|Overall Study||0
6459503|NCT01197560|7375795|FG001|COMPLETED|Overall Study||4
6459504|NCT01197560|7375794|FG000|NOT COMPLETED|Overall Study||54
6459505|NCT01197560|7375795|FG001|NOT COMPLETED|Overall Study||53
6500688|NCT01425801|7419346|FG002|NOT COMPLETED|Period 1||0
6500689|NCT01425801|7419347|FG003|NOT COMPLETED|Period 1||0
6500690|NCT01425801|7419348|FG004|NOT COMPLETED|Period 1||1
6500691|NCT01425801|7419349|FG005|NOT COMPLETED|Period 1||0
6500692|NCT01425801|7419344|FG000|STARTED|Period 2||9
6500693|NCT01425801|7419345|FG001|STARTED|Period 2||9
6500694|NCT01425801|7419346|FG002|STARTED|Period 2||9
6500695|NCT01425801|7419347|FG003|STARTED|Period 2||12
6500696|NCT01425801|7419348|FG004|STARTED|Period 2||12
6500697|NCT01425801|7419349|FG005|STARTED|Period 2||10
6500698|NCT01425801|7419344|FG000|COMPLETED|Period 2||9
6500699|NCT01425801|7419345|FG001|COMPLETED|Period 2||9
6500700|NCT01425801|7419346|FG002|COMPLETED|Period 2||9
6500701|NCT01425801|7419347|FG003|COMPLETED|Period 2||12
6500702|NCT01425801|7419348|FG004|COMPLETED|Period 2||11
6500703|NCT01425801|7419349|FG005|COMPLETED|Period 2||10
6500704|NCT01425801|7419344|FG000|NOT COMPLETED|Period 2||0
6500705|NCT01425801|7419345|FG001|NOT COMPLETED|Period 2||0
6500706|NCT01425801|7419346|FG002|NOT COMPLETED|Period 2||0
6500707|NCT01425801|7419347|FG003|NOT COMPLETED|Period 2||0
6500708|NCT01425801|7419348|FG004|NOT COMPLETED|Period 2||1
6500709|NCT01425801|7419349|FG005|NOT COMPLETED|Period 2||0
6500710|NCT01425801|7419344|FG000|STARTED|Period 3||9
6500711|NCT01425801|7419345|FG001|STARTED|Period 3||9
6500712|NCT01425801|7419346|FG002|STARTED|Period 3||9
6500713|NCT01425801|7419347|FG003|STARTED|Period 3||12
6500714|NCT01425801|7419348|FG004|STARTED|Period 3||11
6500715|NCT01425801|7419349|FG005|STARTED|Period 3||10
6500716|NCT01425801|7419344|FG000|COMPLETED|Period 3||9
6500717|NCT01425801|7419345|FG001|COMPLETED|Period 3||9
6500718|NCT01425801|7419346|FG002|COMPLETED|Period 3||8
6500719|NCT01425801|7419347|FG003|COMPLETED|Period 3||12
6500720|NCT01425801|7419348|FG004|COMPLETED|Period 3||11
6500721|NCT01425801|7419349|FG005|COMPLETED|Period 3||10
6500722|NCT01425801|7419344|FG000|NOT COMPLETED|Period 3||0
6500723|NCT01425801|7419345|FG001|NOT COMPLETED|Period 3||0
6500724|NCT01425801|7419346|FG002|NOT COMPLETED|Period 3||1
6500725|NCT01425801|7419347|FG003|NOT COMPLETED|Period 3||0
6500726|NCT01425801|7419348|FG004|NOT COMPLETED|Period 3||0
6500727|NCT01425801|7419349|FG005|NOT COMPLETED|Period 3||0
6500728|NCT01425801|7419344|FG000|STARTED|Period 4||9
6500729|NCT01425801|7419345|FG001|STARTED|Period 4||9
6500730|NCT01425801|7419346|FG002|STARTED|Period 4||8
6500731|NCT01425801|7419347|FG003|STARTED|Period 4||12
6500732|NCT01425801|7419348|FG004|STARTED|Period 4||11
6500733|NCT01425801|7419349|FG005|STARTED|Period 4||10
6459506|NCT01197573|7375806|FG000|STARTED|Overall Study||33
6459507|NCT01197573|7375807|FG001|STARTED|Overall Study||46
6459508|NCT01197573|7375808|FG002|STARTED|Overall Study||12
6459509|NCT01197573|7375809|FG003|STARTED|Overall Study||12
6459510|NCT01197573|7375806|FG000|COMPLETED|Overall Study||33
6459511|NCT01197573|7375807|FG001|COMPLETED|Overall Study||46
6459512|NCT01197573|7375808|FG002|COMPLETED|Overall Study||12
6459513|NCT01197573|7375809|FG003|COMPLETED|Overall Study||12
6459514|NCT01197573|7375806|FG000|NOT COMPLETED|Overall Study||0
6459515|NCT01197573|7375807|FG001|NOT COMPLETED|Overall Study||0
6459516|NCT01197573|7375808|FG002|NOT COMPLETED|Overall Study||0
6459517|NCT01197573|7375809|FG003|NOT COMPLETED|Overall Study||0
6459518|NCT01197612|7375819|FG000|STARTED|Overall Study||18
6459519|NCT01197612|7375819|FG000|Week 3|Overall Study||16
6459520|NCT01197612|7375819|FG000|Returned for Week 24|Overall Study||6
6459521|NCT01197612|7375819|FG000|COMPLETED|Overall Study||6
6459522|NCT01197612|7375819|FG000|NOT COMPLETED|Overall Study||12
6459523|NCT01197755|7375829|FG000|STARTED|Overall Study|Patients who received treatment|105
6459524|NCT01197755|7375830|FG001|STARTED|Overall Study|Patients who received treatment|108
6459525|NCT01197755|7375831|FG002|STARTED|Overall Study|Patients who received treatment|109
6459526|NCT01197755|7375829|FG000|Randomised But Did Not Receive Treatment|Overall Study||0
6459527|NCT01197755|7375830|FG001|Randomised But Did Not Receive Treatment|Overall Study||0
6459528|NCT01197755|7375831|FG002|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
6459529|NCT01197755|7375829|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
6459530|NCT01197755|7375830|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
6459531|NCT01197755|7375831|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
6459532|NCT01197755|7375829|FG000|NOT COMPLETED|Overall Study||38
6459533|NCT01197755|7375830|FG001|NOT COMPLETED|Overall Study||43
6459534|NCT01197755|7375831|FG002|NOT COMPLETED|Overall Study||54
6459535|NCT01197794|7375848|FG000|STARTED|Overall Study||164
6459536|NCT01197794|7375849|FG001|STARTED|Overall Study|Two participants did not receive study treatment|161
6459537|NCT01197794|7375850|FG002|STARTED|Overall Study|Two participants did not receive study treatment|166
6459538|NCT01197794|7375851|FG003|STARTED|Overall Study||164
6459539|NCT01197794|7375852|FG004|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
6459540|NCT01197794|7375853|FG005|STARTED|Overall Study||163
6459541|NCT01197794|7375854|FG006|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
6459542|NCT01197794|7375848|FG000|COMPLETED|Overall Study||148
6459543|NCT01197794|7375849|FG001|COMPLETED|Overall Study||146
6459544|NCT01197794|7375850|FG002|COMPLETED|Overall Study||153
6459545|NCT01197794|7375851|FG003|COMPLETED|Overall Study||152
6459546|NCT01197794|7375852|FG004|COMPLETED|Overall Study||149
6459547|NCT01197794|7375853|FG005|COMPLETED|Overall Study||144
6459548|NCT01197794|7375854|FG006|COMPLETED|Overall Study||142
6459549|NCT01197794|7375848|FG000|NOT COMPLETED|Overall Study||16
6459550|NCT01197794|7375849|FG001|NOT COMPLETED|Overall Study||15
6459551|NCT01197794|7375850|FG002|NOT COMPLETED|Overall Study||13
6459552|NCT01197794|7375851|FG003|NOT COMPLETED|Overall Study||12
6459553|NCT01197794|7375852|FG004|NOT COMPLETED|Overall Study||14
6459554|NCT01197794|7375853|FG005|NOT COMPLETED|Overall Study||19
6459555|NCT01197794|7375854|FG006|NOT COMPLETED|Overall Study||21
6459556|NCT01197833|7375874|FG000|STARTED|Overall Study||38
6459557|NCT01197833|7375875|FG001|STARTED|Overall Study||39
6459558|NCT01197833|7375876|FG002|STARTED|Overall Study||40
6459559|NCT01197833|7375874|FG000|COMPLETED|Overall Study||38
6459560|NCT01197833|7375875|FG001|COMPLETED|Overall Study||39
6459561|NCT01197833|7375876|FG002|COMPLETED|Overall Study||40
6459562|NCT01197833|7375874|FG000|NOT COMPLETED|Overall Study||0
6459563|NCT01197833|7375875|FG001|NOT COMPLETED|Overall Study||0
6459564|NCT01197833|7375876|FG002|NOT COMPLETED|Overall Study||0
6459565|NCT01197898|7375886|FG000|STARTED|Overall Study||5
6459566|NCT01197898|7375887|FG001|STARTED|Overall Study||5
6459567|NCT01197898|7375886|FG000|COMPLETED|Overall Study||5
6459568|NCT01197898|7375887|FG001|COMPLETED|Overall Study||5
6459569|NCT01197898|7375886|FG000|NOT COMPLETED|Overall Study||0
6459570|NCT01197898|7375887|FG001|NOT COMPLETED|Overall Study||0
6459571|NCT01197911|7375896|FG000|STARTED|Overall Study||18
6459572|NCT01197911|7375897|FG001|STARTED|Overall Study||10
6553819|NCT01746017|7476327|FG001|NOT COMPLETED|Period 1||0
6553820|NCT01746017|7476328|FG002|NOT COMPLETED|Period 1||0
6553821|NCT01746017|7476329|FG003|NOT COMPLETED|Period 1||0
6553822|NCT01746017|7476330|FG004|NOT COMPLETED|Period 1||0
6553823|NCT01746017|7476331|FG005|NOT COMPLETED|Period 1||0
6553824|NCT01746017|7476332|FG006|NOT COMPLETED|Period 1||1
6553825|NCT01746017|7476333|FG007|NOT COMPLETED|Period 1||0
6553826|NCT01746017|7476334|FG008|NOT COMPLETED|Period 1||0
6553827|NCT01746017|7476335|FG009|NOT COMPLETED|Period 1||0
6553828|NCT01746017|7476336|FG010|NOT COMPLETED|Period 1||0
6553829|NCT01746017|7476326|FG000|STARTED|Period 2||2
6459573|NCT01197911|7375898|FG002|STARTED|Overall Study||10
6459574|NCT01197911|7375896|FG000|COMPLETED|Overall Study||18
6459575|NCT01197911|7375897|FG001|COMPLETED|Overall Study||10
6459576|NCT01197911|7375898|FG002|COMPLETED|Overall Study||9
6459577|NCT01197911|7375896|FG000|NOT COMPLETED|Overall Study||0
6459578|NCT01197911|7375897|FG001|NOT COMPLETED|Overall Study||0
6553830|NCT01746017|7476327|FG001|STARTED|Period 2||2
6553831|NCT01746017|7476328|FG002|STARTED|Period 2||2
6553832|NCT01746017|7476329|FG003|STARTED|Period 2||2
6459579|NCT01197911|7375898|FG002|NOT COMPLETED|Overall Study||1
6459580|NCT01198002|7375910|FG000|STARTED|Treatment Period 1 (Weeks 0-52)||345
6459581|NCT01198002|7375911|FG001|STARTED|Treatment Period 1 (Weeks 0-52)||347
6459582|NCT01198002|7375912|FG002|STARTED|Treatment Period 1 (Weeks 0-52)||349
6459583|NCT01198002|7375910|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
6459584|NCT01198002|7375911|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||345
6459585|NCT01198002|7375912|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0-52)||348
6459586|NCT01198002|7375910|FG000|Week 16 NR|Treatment Period 1 (Weeks 0-52)||58
6459587|NCT01198002|7375911|FG001|Week 16 NR|Treatment Period 1 (Weeks 0-52)||62
6459588|NCT01198002|7375912|FG002|Week 16 NR|Treatment Period 1 (Weeks 0-52)||90
6459589|NCT01198002|7375910|FG000|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||293
6459590|NCT01198002|7375911|FG001|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||303
6459591|NCT01198002|7375912|FG002|Post-Treatment Follow-Up Population|Treatment Period 1 (Weeks 0-52)||307
6459592|NCT01198002|7375910|FG000|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|70
6459593|NCT01198002|7375911|FG001|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|73
6459594|NCT01198002|7375912|FG002|COMPLETED|Treatment Period 1 (Weeks 0-52)|Those who completed 52-week Treatment Period 1 including both Week 16 responders and NR.|80
6459595|NCT01198002|7375910|FG000|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||275
6459596|NCT01198002|7375911|FG001|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||274
6459597|NCT01198002|7375912|FG002|NOT COMPLETED|Treatment Period 1 (Weeks 0-52)||269
6459598|NCT01198002|7375910|FG000|STARTED|Treatment Period 2 (Weeks 52-100)||70
6459599|NCT01198002|7375911|FG001|STARTED|Treatment Period 2 (Weeks 52-100)||73
6459600|NCT01198002|7375912|FG002|STARTED|Treatment Period 2 (Weeks 52-100)||80
6459601|NCT01198002|7375910|FG000|COMPLETED|Treatment Period 2 (Weeks 52-100)||1
6459602|NCT01198002|7375911|FG001|COMPLETED|Treatment Period 2 (Weeks 52-100)||0
6459603|NCT01198002|7375912|FG002|COMPLETED|Treatment Period 2 (Weeks 52-100)||2
6459604|NCT01198002|7375910|FG000|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||69
6459605|NCT01198002|7375911|FG001|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||73
6459606|NCT01198002|7375912|FG002|NOT COMPLETED|Treatment Period 2 (Weeks 52-100)||78
6459607|NCT01198028|7375942|FG000|STARTED|Overall Study||39
6459608|NCT01198028|7375942|FG000|COMPLETED|Overall Study||29
6553833|NCT01746017|7476330|FG004|STARTED|Period 2||2
6553834|NCT01746017|7476331|FG005|STARTED|Period 2||2
6459609|NCT01198028|7375942|FG000|NOT COMPLETED|Overall Study||10
6459610|NCT01198132|7375948|FG000|STARTED|Overall Study||63
6459611|NCT01198132|7375949|FG001|STARTED|Overall Study||66
6459612|NCT01198132|7375948|FG000|COMPLETED|Overall Study||45
6459613|NCT01198132|7375949|FG001|COMPLETED|Overall Study||45
6459614|NCT01198132|7375948|FG000|NOT COMPLETED|Overall Study||18
6459615|NCT01198132|7375949|FG001|NOT COMPLETED|Overall Study||21
6459616|NCT01198145|7375959|FG000|STARTED|Overall Study||44
6459617|NCT01198145|7375960|FG001|STARTED|Overall Study||43
6459618|NCT01198145|7375959|FG000|COMPLETED|Overall Study||43
6459619|NCT01198145|7375960|FG001|COMPLETED|Overall Study||42
6459620|NCT01198145|7375959|FG000|NOT COMPLETED|Overall Study||1
6459621|NCT01198145|7375960|FG001|NOT COMPLETED|Overall Study||1
6459622|NCT01198158|7375969|FG000|STARTED|Overall Study||41
6459623|NCT01198158|7375970|FG001|STARTED|Overall Study||36
6459624|NCT01198158|7375969|FG000|COMPLETED|Overall Study||41
6459625|NCT01198158|7375970|FG001|COMPLETED|Overall Study||36
6459626|NCT01198158|7375969|FG000|NOT COMPLETED|Overall Study||0
6459627|NCT01198158|7375970|FG001|NOT COMPLETED|Overall Study||0
6459628|NCT01198275|7375978|FG000|STARTED|Overall Study||100
6459629|NCT01198275|7375979|FG001|STARTED|Overall Study||99
6459630|NCT01198275|7375978|FG000|COMPLETED|Overall Study||94
6459631|NCT01198275|7375979|FG001|COMPLETED|Overall Study||94
6459632|NCT01198275|7375978|FG000|NOT COMPLETED|Overall Study||6
6459633|NCT01198275|7375979|FG001|NOT COMPLETED|Overall Study||5
6459634|NCT01198327|7375985|FG000|STARTED|Overall Study||66
6459635|NCT01198327|7375985|FG000|COMPLETED|Overall Study||56
6459636|NCT01198327|7375985|FG000|NOT COMPLETED|Overall Study||10
6459637|NCT01198366|7375998|FG000|STARTED|Overall Study||52
6459638|NCT01198366|7375999|FG001|STARTED|Overall Study||51
6459639|NCT01198366|7376000|FG002|STARTED|Overall Study||51
6459640|NCT01198366|7376001|FG003|STARTED|Overall Study||52
6459641|NCT01198366|7376002|FG004|STARTED|Overall Study||140
6459642|NCT01198366|7376003|FG005|STARTED|Overall Study||141
6459643|NCT01198366|7375998|FG000|COMPLETED|Overall Study||40
6459644|NCT01198366|7375999|FG001|COMPLETED|Overall Study||44
6459645|NCT01198366|7376000|FG002|COMPLETED|Overall Study||43
6459646|NCT01198366|7376001|FG003|COMPLETED|Overall Study||47
6459647|NCT01198366|7376002|FG004|COMPLETED|Overall Study||125
6459648|NCT01198366|7376003|FG005|COMPLETED|Overall Study||128
6459649|NCT01198366|7375998|FG000|NOT COMPLETED|Overall Study||12
6459650|NCT01198366|7375999|FG001|NOT COMPLETED|Overall Study||7
6553835|NCT01746017|7476332|FG006|STARTED|Period 2||2
6459651|NCT01198366|7376000|FG002|NOT COMPLETED|Overall Study||8
6459652|NCT01198366|7376001|FG003|NOT COMPLETED|Overall Study||5
6459653|NCT01198366|7376002|FG004|NOT COMPLETED|Overall Study||15
6459654|NCT01198366|7376003|FG005|NOT COMPLETED|Overall Study||13
6553836|NCT01746017|7476333|FG007|STARTED|Period 2||2
6553837|NCT01746017|7476334|FG008|STARTED|Period 2||3
6459655|NCT01198470|7376017|FG000|STARTED|Overall Study||20
6459656|NCT01198470|7376017|FG000|COMPLETED|Overall Study||18
6459657|NCT01198470|7376017|FG000|NOT COMPLETED|Overall Study||2
6553838|NCT01746017|7476335|FG009|STARTED|Period 2||3
6553839|NCT01746017|7476336|FG010|STARTED|Period 2||3
6553840|NCT01746017|7476326|FG000|COMPLETED|Period 2||2
6553841|NCT01746017|7476327|FG001|COMPLETED|Period 2||2
6553842|NCT01746017|7476328|FG002|COMPLETED|Period 2||2
6553843|NCT01746017|7476329|FG003|COMPLETED|Period 2||2
6459658|NCT01198509|7376027|FG000|STARTED|Overall Study||5
6459659|NCT01198509|7376028|FG001|STARTED|Overall Study||10
6459660|NCT01198509|7376029|FG002|STARTED|Overall Study||19
6459661|NCT01198509|7376030|FG003|STARTED|Overall Study||66
6553844|NCT01746017|7476330|FG004|COMPLETED|Period 2||2
6553845|NCT01746017|7476331|FG005|COMPLETED|Period 2||2
6553846|NCT01746017|7476332|FG006|COMPLETED|Period 2||2
6553847|NCT01746017|7476333|FG007|COMPLETED|Period 2||2
6553848|NCT01746017|7476334|FG008|COMPLETED|Period 2||3
6553849|NCT01746017|7476335|FG009|COMPLETED|Period 2||3
6459662|NCT01198509|7376031|FG004|STARTED|Overall Study||20
6459663|NCT01198509|7376032|FG005|STARTED|Overall Study||58
6459664|NCT01198509|7376027|FG000|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
6459665|NCT01198509|7376028|FG001|COMPLETED|Overall Study||10
6459666|NCT01198509|7376029|FG002|COMPLETED|Overall Study||19
6459667|NCT01198509|7376030|FG003|COMPLETED|Overall Study||66
6459668|NCT01198509|7376031|FG004|COMPLETED|Overall Study||20
6459669|NCT01198509|7376032|FG005|COMPLETED|Overall Study||58
6459670|NCT01198509|7376027|FG000|NOT COMPLETED|Overall Study||1
6459671|NCT01198509|7376028|FG001|NOT COMPLETED|Overall Study||0
6459672|NCT01198509|7376029|FG002|NOT COMPLETED|Overall Study||0
6459673|NCT01198509|7376030|FG003|NOT COMPLETED|Overall Study||0
6459674|NCT01198509|7376031|FG004|NOT COMPLETED|Overall Study||0
6459675|NCT01198509|7376032|FG005|NOT COMPLETED|Overall Study||0
6459676|NCT01198574|7376048|FG000|STARTED|Overall Study||98
6459677|NCT01198574|7376049|FG001|STARTED|Overall Study||102
6459678|NCT01198574|7376050|FG002|STARTED|Overall Study||100
6459679|NCT01198574|7376051|FG003|STARTED|Overall Study||102
6459680|NCT01198574|7376048|FG000|COMPLETED|Overall Study||94
6459681|NCT01198574|7376049|FG001|COMPLETED|Overall Study||101
6459682|NCT01198574|7376050|FG002|COMPLETED|Overall Study||99
6459683|NCT01198574|7376051|FG003|COMPLETED|Overall Study||98
6459684|NCT01198574|7376048|FG000|NOT COMPLETED|Overall Study||4
6459685|NCT01198574|7376049|FG001|NOT COMPLETED|Overall Study||1
6459686|NCT01198574|7376050|FG002|NOT COMPLETED|Overall Study||1
6459687|NCT01198574|7376051|FG003|NOT COMPLETED|Overall Study||4
6459688|NCT01198587|7376065|FG000|STARTED|Overall Study||31
6459689|NCT01198587|7376066|FG001|STARTED|Overall Study||5
6459690|NCT01198587|7376067|FG002|STARTED|Overall Study||30
6459691|NCT01198587|7376068|FG003|STARTED|Overall Study||5
6459692|NCT01198587|7376065|FG000|COMPLETED|Overall Study||23
6459693|NCT01198587|7376066|FG001|COMPLETED|Overall Study||5
6459694|NCT01198587|7376067|FG002|COMPLETED|Overall Study||21
6459695|NCT01198587|7376068|FG003|COMPLETED|Overall Study||5
6459696|NCT01198587|7376065|FG000|NOT COMPLETED|Overall Study||8
6459697|NCT01198587|7376066|FG001|NOT COMPLETED|Overall Study||0
6459698|NCT01198587|7376067|FG002|NOT COMPLETED|Overall Study||9
6459699|NCT01198587|7376068|FG003|NOT COMPLETED|Overall Study||0
6459700|NCT01198600|7376083|FG000|STARTED|Phase 1: Period One, 30 Days of Wear||35
6459701|NCT01198600|7376084|FG001|STARTED|Phase 1: Period One, 30 Days of Wear||37
6459702|NCT01198600|7376085|FG002|STARTED|Phase 1: Period One, 30 Days of Wear||0
6459703|NCT01198600|7376086|FG003|STARTED|Phase 1: Period One, 30 Days of Wear||0
6459704|NCT01198600|7376083|FG000|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
6459705|NCT01198600|7376084|FG001|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
6459706|NCT01198600|7376085|FG002|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
6459707|NCT01198600|7376086|FG003|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
6459708|NCT01198600|7376083|FG000|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
6459709|NCT01198600|7376084|FG001|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
6459710|NCT01198600|7376085|FG002|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
6459711|NCT01198600|7376086|FG003|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
6459712|NCT01198600|7376083|FG000|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
6459713|NCT01198600|7376084|FG001|STARTED|Phase 1: Period Two, 30 Days of Wear||36
6459714|NCT01198600|7376085|FG002|STARTED|Phase 1: Period Two, 30 Days of Wear||0
6459715|NCT01198600|7376086|FG003|STARTED|Phase 1: Period Two, 30 Days of Wear||0
6459716|NCT01198600|7376083|FG000|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
6459717|NCT01198600|7376084|FG001|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
6459718|NCT01198600|7376085|FG002|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6459719|NCT01198600|7376086|FG003|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6459720|NCT01198600|7376083|FG000|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6459721|NCT01198600|7376084|FG001|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
6459722|NCT01198600|7376085|FG002|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6553850|NCT01746017|7476336|FG010|COMPLETED|Period 2||3
6553851|NCT01746017|7476326|FG000|NOT COMPLETED|Period 2||0
6459723|NCT01198600|7376086|FG003|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
6459724|NCT01198600|7376083|FG000|STARTED|Phase 2: 56 Days of Wear||0
6459725|NCT01198600|7376084|FG001|STARTED|Phase 2: 56 Days of Wear||0
6459726|NCT01198600|7376085|FG002|STARTED|Phase 2: 56 Days of Wear||67
6459727|NCT01198600|7376086|FG003|STARTED|Phase 2: 56 Days of Wear||0
6459728|NCT01198600|7376083|FG000|COMPLETED|Phase 2: 56 Days of Wear||0
6459729|NCT01198600|7376084|FG001|COMPLETED|Phase 2: 56 Days of Wear||0
6459730|NCT01198600|7376085|FG002|COMPLETED|Phase 2: 56 Days of Wear||62
6459731|NCT01198600|7376086|FG003|COMPLETED|Phase 2: 56 Days of Wear||0
6459732|NCT01198600|7376083|FG000|NOT COMPLETED|Phase 2: 56 Days of Wear||0
6459733|NCT01198600|7376084|FG001|NOT COMPLETED|Phase 2: 56 Days of Wear||0
6459734|NCT01198600|7376085|FG002|NOT COMPLETED|Phase 2: 56 Days of Wear||5
6459735|NCT01198600|7376086|FG003|NOT COMPLETED|Phase 2: 56 Days of Wear||0
6459736|NCT01198600|7376083|FG000|STARTED|Phase 3: 43 Days of Wear||0
6459737|NCT01198600|7376084|FG001|STARTED|Phase 3: 43 Days of Wear||0
6459738|NCT01198600|7376085|FG002|STARTED|Phase 3: 43 Days of Wear||0
6459739|NCT01198600|7376086|FG003|STARTED|Phase 3: 43 Days of Wear||38
6459740|NCT01198600|7376083|FG000|COMPLETED|Phase 3: 43 Days of Wear||0
6459741|NCT01198600|7376084|FG001|COMPLETED|Phase 3: 43 Days of Wear||0
6459742|NCT01198600|7376085|FG002|COMPLETED|Phase 3: 43 Days of Wear||0
6459743|NCT01198600|7376086|FG003|COMPLETED|Phase 3: 43 Days of Wear||38
6459744|NCT01198600|7376083|FG000|NOT COMPLETED|Phase 3: 43 Days of Wear||0
6459745|NCT01198600|7376084|FG001|NOT COMPLETED|Phase 3: 43 Days of Wear||0
6459746|NCT01198600|7376085|FG002|NOT COMPLETED|Phase 3: 43 Days of Wear||0
6459747|NCT01198600|7376086|FG003|NOT COMPLETED|Phase 3: 43 Days of Wear||0
6459748|NCT01198691|7376096|FG000|STARTED|Completed Surgery -Received Intervention||50
6459749|NCT01198691|7376097|FG001|STARTED|Completed Surgery -Received Intervention||50
6459750|NCT01198691|7376096|FG000|COMPLETED|Completed Surgery -Received Intervention||50
6459751|NCT01198691|7376097|FG001|COMPLETED|Completed Surgery -Received Intervention||50
6459752|NCT01198691|7376096|FG000|NOT COMPLETED|Completed Surgery -Received Intervention||0
6459753|NCT01198691|7376097|FG001|NOT COMPLETED|Completed Surgery -Received Intervention||0
6459754|NCT01198691|7376096|FG000|STARTED|Completed VAS Score Postop Day 1||50
6459755|NCT01198691|7376097|FG001|STARTED|Completed VAS Score Postop Day 1||50
6459756|NCT01198691|7376096|FG000|COMPLETED|Completed VAS Score Postop Day 1||47
6459757|NCT01198691|7376097|FG001|COMPLETED|Completed VAS Score Postop Day 1||46
6459758|NCT01198691|7376096|FG000|NOT COMPLETED|Completed VAS Score Postop Day 1||3
6459759|NCT01198691|7376097|FG001|NOT COMPLETED|Completed VAS Score Postop Day 1||4
6459760|NCT01198691|7376096|FG000|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
6459761|NCT01198691|7376097|FG001|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
6459762|NCT01198691|7376096|FG000|COMPLETED|Completed VAS Score at Discharge||45
6459763|NCT01198691|7376097|FG001|COMPLETED|Completed VAS Score at Discharge||44
6459764|NCT01198691|7376096|FG000|NOT COMPLETED|Completed VAS Score at Discharge||5
6459765|NCT01198691|7376097|FG001|NOT COMPLETED|Completed VAS Score at Discharge||6
6459766|NCT01198691|7376096|FG000|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
6459767|NCT01198691|7376097|FG001|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
6459768|NCT01198691|7376096|FG000|COMPLETED|Survey Prior to Discharge||18
6459769|NCT01198691|7376097|FG001|COMPLETED|Survey Prior to Discharge||17
6459770|NCT01198691|7376096|FG000|NOT COMPLETED|Survey Prior to Discharge||32
6459771|NCT01198691|7376097|FG001|NOT COMPLETED|Survey Prior to Discharge||33
6459772|NCT01198691|7376096|FG000|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
6459773|NCT01198691|7376097|FG001|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
6459774|NCT01198691|7376096|FG000|COMPLETED|6 Week Post-partum Survey||21
6459775|NCT01198691|7376097|FG001|COMPLETED|6 Week Post-partum Survey||26
6459776|NCT01198691|7376096|FG000|NOT COMPLETED|6 Week Post-partum Survey||29
6459777|NCT01198691|7376097|FG001|NOT COMPLETED|6 Week Post-partum Survey||24
6459778|NCT01198756|7376107|FG000|STARTED|Overall Study||932
6459779|NCT01198756|7376108|FG001|STARTED|Overall Study||929
6459780|NCT01198756|7376109|FG002|STARTED|Overall Study||932
6459781|NCT01198756|7376110|FG003|STARTED|Overall Study||301
6459782|NCT01198756|7376107|FG000|COMPLETED|Overall Study||894
6459783|NCT01198756|7376108|FG001|COMPLETED|Overall Study||889
6459784|NCT01198756|7376109|FG002|COMPLETED|Overall Study||902
6459785|NCT01198756|7376110|FG003|COMPLETED|Overall Study||275
6459786|NCT01198756|7376107|FG000|NOT COMPLETED|Overall Study||38
6459787|NCT01198756|7376108|FG001|NOT COMPLETED|Overall Study||40
6459788|NCT01198756|7376109|FG002|NOT COMPLETED|Overall Study||30
6459789|NCT01198756|7376110|FG003|NOT COMPLETED|Overall Study||26
6459790|NCT01198769|7376127|FG000|STARTED|Overall Study||15
6459791|NCT01198769|7376127|FG000|COMPLETED|Overall Study||15
6459792|NCT01198769|7376127|FG000|NOT COMPLETED|Overall Study||0
6459793|NCT01198795|7376131|FG000|STARTED|Overall Study||162
6459794|NCT01198795|7376131|FG000|COMPLETED|Overall Study||80
6459795|NCT01198795|7376131|FG000|NOT COMPLETED|Overall Study||82
6459796|NCT01198873|7376137|FG000|STARTED|Overall Study||41
6459797|NCT01198873|7376138|FG001|STARTED|Overall Study||35
6459798|NCT01198873|7376137|FG000|Treated|Overall Study||41
6459799|NCT01198873|7376138|FG001|Treated|Overall Study||35
6459800|NCT01198873|7376137|FG000|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
6500734|NCT01425801|7419344|FG000|COMPLETED|Period 4||9
6459801|NCT01198873|7376138|FG001|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
6459802|NCT01198873|7376137|FG000|COMPLETED|Overall Study||4
6459803|NCT01198873|7376138|FG001|COMPLETED|Overall Study||3
6459804|NCT01198873|7376137|FG000|NOT COMPLETED|Overall Study||37
6459805|NCT01198873|7376138|FG001|NOT COMPLETED|Overall Study||32
6459806|NCT01198977|7376146|FG000|STARTED|Overall Study||31
6459807|NCT01198977|7376147|FG001|STARTED|Overall Study||33
6459808|NCT01198977|7376146|FG000|COMPLETED|Overall Study||30
6459809|NCT01198977|7376147|FG001|COMPLETED|Overall Study||33
6459810|NCT01198977|7376146|FG000|NOT COMPLETED|Overall Study||1
6459811|NCT01198977|7376147|FG001|NOT COMPLETED|Overall Study||0
6459812|NCT01199016|7376155|FG000|STARTED|Overall Study||239
6459813|NCT01199016|7376155|FG000|Treated|Overall Study||236
6459814|NCT01199016|7376155|FG000|COMPLETED|Overall Study||162
6459815|NCT01199016|7376155|FG000|NOT COMPLETED|Overall Study||77
6459816|NCT01199042|7376159|FG000|STARTED|Sleep Laboratory (3 Nights)||29
6459817|NCT01199042|7376159|FG000|COMPLETED|Sleep Laboratory (3 Nights)||27
6459818|NCT01199042|7376159|FG000|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
6459819|NCT01199042|7376159|FG000|STARTED|At Home (3 Months)||27
6459820|NCT01199042|7376159|FG000|COMPLETED|At Home (3 Months)||26
6459821|NCT01199042|7376159|FG000|NOT COMPLETED|At Home (3 Months)||1
6459822|NCT01199055|7376171|FG000|STARTED|Overall Study||3
6459823|NCT01199055|7376172|FG001|STARTED|Overall Study||4
6459824|NCT01199055|7376173|FG002|STARTED|Overall Study||9
6459825|NCT01199055|7376171|FG000|COMPLETED|Overall Study||1
6459826|NCT01199055|7376172|FG001|COMPLETED|Overall Study||1
6459827|NCT01199055|7376173|FG002|COMPLETED|Overall Study||5
6459828|NCT01199055|7376171|FG000|NOT COMPLETED|Overall Study||2
6459829|NCT01199055|7376172|FG001|NOT COMPLETED|Overall Study||3
6459830|NCT01199055|7376173|FG002|NOT COMPLETED|Overall Study||4
6459831|NCT01199068|7376186|FG000|STARTED|Overall Study||3
6459832|NCT01199068|7376187|FG001|STARTED|Overall Study||3
6459833|NCT01199068|7376188|FG002|STARTED|Overall Study||9
6459834|NCT01199068|7376186|FG000|Received Treatment|Overall Study||3
6459835|NCT01199068|7376187|FG001|Received Treatment|Overall Study||3
6459836|NCT01199068|7376188|FG002|Received Treatment|Overall Study||8
6459837|NCT01199068|7376186|FG000|COMPLETED|Overall Study||0
6459838|NCT01199068|7376187|FG001|COMPLETED|Overall Study||0
6459839|NCT01199068|7376188|FG002|COMPLETED|Overall Study||0
6459840|NCT01199068|7376186|FG000|NOT COMPLETED|Overall Study||3
6459841|NCT01199068|7376187|FG001|NOT COMPLETED|Overall Study||3
6459842|NCT01199068|7376188|FG002|NOT COMPLETED|Overall Study||9
6459843|NCT01199146|7376203|FG000|STARTED|Overall Study||42
6459844|NCT01199146|7376203|FG000|COMPLETED|Overall Study||39
6459845|NCT01199146|7376203|FG000|NOT COMPLETED|Overall Study||3
6459846|NCT01199198|7376209|FG000|STARTED|Overall Study||24
6459847|NCT01199198|7376210|FG001|STARTED|Overall Study||24
6459848|NCT01199198|7376209|FG000|COMPLETED|Overall Study||17
6459849|NCT01199198|7376210|FG001|COMPLETED|Overall Study||13
6459850|NCT01199198|7376209|FG000|NOT COMPLETED|Overall Study||7
6459851|NCT01199198|7376210|FG001|NOT COMPLETED|Overall Study||11
6459852|NCT01199237|7376218|FG000|STARTED|Overall Study||41
6459853|NCT01199237|7376219|FG001|STARTED|Overall Study||40
6459854|NCT01199237|7376218|FG000|COMPLETED|Overall Study||41
6459855|NCT01199237|7376219|FG001|COMPLETED|Overall Study||40
6459856|NCT01199237|7376218|FG000|NOT COMPLETED|Overall Study||0
6459857|NCT01199237|7376219|FG001|NOT COMPLETED|Overall Study||0
6459858|NCT01199263|7376229|FG000|STARTED|Overall Study||54
6459859|NCT01199263|7376230|FG001|STARTED|Overall Study||54
6459860|NCT01199263|7376229|FG000|COMPLETED|Overall Study||48
6459861|NCT01199263|7376230|FG001|COMPLETED|Overall Study||52
6459862|NCT01199263|7376229|FG000|NOT COMPLETED|Overall Study||6
6459863|NCT01199263|7376230|FG001|NOT COMPLETED|Overall Study||2
6459864|NCT01199289|7376242|FG000|STARTED|Overall Study||77
6459865|NCT01199289|7376243|FG001|STARTED|Overall Study||75
6459866|NCT01199289|7376244|FG002|STARTED|Overall Study||76
6459867|NCT01199289|7376245|FG003|STARTED|Overall Study||77
6459868|NCT01199289|7376242|FG000|Participants Who Received Study Treatment|Overall Study||76
6459869|NCT01199289|7376243|FG001|Participants Who Received Study Treatment|Overall Study||74
6459870|NCT01199289|7376244|FG002|Participants Who Received Study Treatment|Overall Study||76
6459871|NCT01199289|7376245|FG003|Participants Who Received Study Treatment|Overall Study||76
6459872|NCT01199289|7376242|FG000|COMPLETED|Overall Study||68
6459873|NCT01199289|7376243|FG001|COMPLETED|Overall Study||68
6459874|NCT01199289|7376244|FG002|COMPLETED|Overall Study||71
6459875|NCT01199289|7376245|FG003|COMPLETED|Overall Study||65
6459876|NCT01199289|7376242|FG000|NOT COMPLETED|Overall Study||9
6459877|NCT01199289|7376243|FG001|NOT COMPLETED|Overall Study||7
6459878|NCT01199289|7376244|FG002|NOT COMPLETED|Overall Study||5
6459879|NCT01199289|7376245|FG003|NOT COMPLETED|Overall Study||12
6459880|NCT01199380|7376260|FG000|STARTED|Overall Study||88
6459881|NCT01199380|7376261|FG001|STARTED|Overall Study||96
6459882|NCT01199380|7376260|FG000|COMPLETED|Overall Study||78
6459883|NCT01199380|7376261|FG001|COMPLETED|Overall Study||81
6459884|NCT01199380|7376260|FG000|NOT COMPLETED|Overall Study||10
6459885|NCT01199380|7376261|FG001|NOT COMPLETED|Overall Study||15
6459886|NCT01199471|7376267|FG000|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
6459887|NCT01199471|7376267|FG000|COMPLETED|Overall Study||3994
6459888|NCT01199471|7376267|FG000|NOT COMPLETED|Overall Study||6
6459889|NCT01199575|7376272|FG000|STARTED|Overall Study||30
6459890|NCT01199575|7376272|FG000|COMPLETED|Overall Study||25
6459891|NCT01199575|7376272|FG000|NOT COMPLETED|Overall Study||5
6459892|NCT01199601|7376279|FG000|STARTED|Overall Study|Control Group|422
6459893|NCT01199601|7376280|FG001|STARTED|Overall Study|Intervention Group|422
6459894|NCT01199601|7376279|FG000|COMPLETED|Overall Study||353
6459895|NCT01199601|7376280|FG001|COMPLETED|Overall Study||344
6459896|NCT01199601|7376279|FG000|NOT COMPLETED|Overall Study||69
6459897|NCT01199601|7376280|FG001|NOT COMPLETED|Overall Study||78
6459898|NCT01199705|7376286|FG000|STARTED|IVIG Treatment||25
6459899|NCT01199705|7376286|FG000|COMPLETED|IVIG Treatment||25
6459900|NCT01199705|7376286|FG000|NOT COMPLETED|IVIG Treatment||0
6459901|NCT01199705|7376286|FG000|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
6459902|NCT01199705|7376286|FG000|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
6459903|NCT01199705|7376286|FG000|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
6459904|NCT01199705|7376286|FG000|STARTED|SCIG Treatment (Efficacy)||24
6459905|NCT01199705|7376286|FG000|COMPLETED|SCIG Treatment (Efficacy)||24
6459906|NCT01199705|7376286|FG000|NOT COMPLETED|SCIG Treatment (Efficacy)||0
6459907|NCT01199731|7376304|FG000|STARTED|Overall Study||9
6459908|NCT01199731|7376305|FG001|STARTED|Overall Study||11
6459909|NCT01199731|7376306|FG002|STARTED|Overall Study||10
6459910|NCT01199731|7376304|FG000|COMPLETED|Overall Study||0
6459911|NCT01199731|7376305|FG001|COMPLETED|Overall Study||0
6459912|NCT01199731|7376306|FG002|COMPLETED|Overall Study||0
6459913|NCT01199731|7376304|FG000|NOT COMPLETED|Overall Study||9
6459914|NCT01199731|7376305|FG001|NOT COMPLETED|Overall Study||11
6459915|NCT01199731|7376306|FG002|NOT COMPLETED|Overall Study||10
6459916|NCT01199744|7376314|FG000|STARTED|Overall Study||1575
6459917|NCT01199744|7376314|FG000|COMPLETED|Overall Study||1575
6459918|NCT01199744|7376314|FG000|NOT COMPLETED|Overall Study||0
6459919|NCT01199822|7376321|FG000|STARTED|Overall Study||3
6459920|NCT01199822|7376322|FG001|STARTED|Overall Study||7
6459921|NCT01199822|7376323|FG002|STARTED|Overall Study||6
6459922|NCT01199822|7376321|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6459923|NCT01199822|7376322|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
6459924|NCT01199822|7376323|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6459925|NCT01199822|7376321|FG000|COMPLETED|Overall Study||3
6459926|NCT01199822|7376322|FG001|COMPLETED|Overall Study||6
6459927|NCT01199822|7376323|FG002|COMPLETED|Overall Study||6
6459928|NCT01199822|7376321|FG000|NOT COMPLETED|Overall Study||0
6459929|NCT01199822|7376322|FG001|NOT COMPLETED|Overall Study||1
6459930|NCT01199822|7376323|FG002|NOT COMPLETED|Overall Study||0
6459931|NCT01199848|7376338|FG000|STARTED|Placebo Arm||29
6459932|NCT01199848|7376338|FG000|COMPLETED|Placebo Arm||21
6459933|NCT01199848|7376338|FG000|NOT COMPLETED|Placebo Arm||8
6459934|NCT01199848|7376338|FG000|STARTED|10g STR Arm||21
6459935|NCT01199848|7376338|FG000|COMPLETED|10g STR Arm||21
6459936|NCT01199848|7376338|FG000|NOT COMPLETED|10g STR Arm||0
6459937|NCT01199848|7376338|FG000|STARTED|20G STRB Arm||21
6459938|NCT01199848|7376338|FG000|COMPLETED|20G STRB Arm||21
6459939|NCT01199848|7376338|FG000|NOT COMPLETED|20G STRB Arm||0
6459940|NCT01199848|7376338|FG000|STARTED|40G STRB Arm||21
6459941|NCT01199848|7376338|FG000|COMPLETED|40G STRB Arm||21
6459942|NCT01199848|7376338|FG000|NOT COMPLETED|40G STRB Arm||0
6459943|NCT01199861|7376350|FG000|STARTED|Overall Study||95
6459944|NCT01199861|7376351|FG001|STARTED|Overall Study||43
6459945|NCT01199861|7376350|FG000|COMPLETED|Overall Study||93
6459946|NCT01199861|7376351|FG001|COMPLETED|Overall Study||43
6459947|NCT01199861|7376350|FG000|NOT COMPLETED|Overall Study||2
6459948|NCT01199861|7376351|FG001|NOT COMPLETED|Overall Study||0
6459949|NCT01199926|7376359|FG000|STARTED|Overall Study||17
6459950|NCT01199926|7376360|FG001|STARTED|Overall Study||17
6459951|NCT01199926|7376359|FG000|COMPLETED|Overall Study||10
6459952|NCT01199926|7376360|FG001|COMPLETED|Overall Study||13
6459953|NCT01199926|7376359|FG000|NOT COMPLETED|Overall Study||7
6459954|NCT01199926|7376360|FG001|NOT COMPLETED|Overall Study||4
6459955|NCT01199939|7376366|FG000|STARTED|Overall Study|Number of enrolled participants|54
6459956|NCT01199939|7376366|FG000|COMPLETED|Overall Study||41
6459957|NCT01199939|7376366|FG000|NOT COMPLETED|Overall Study||13
6459958|NCT01199952|7376372|FG000|STARTED|Overall Study||103
6459959|NCT01199952|7376373|FG001|STARTED|Overall Study||104
6459960|NCT01199952|7376372|FG000|COMPLETED|Overall Study||51
6459961|NCT01199952|7376373|FG001|COMPLETED|Overall Study||59
6459962|NCT01199952|7376372|FG000|NOT COMPLETED|Overall Study||52
6459963|NCT01199952|7376373|FG001|NOT COMPLETED|Overall Study||45
6459964|NCT01199965|7376382|FG000|STARTED|Overall Study||23
6459965|NCT01199965|7376383|FG001|STARTED|Overall Study||24
6459966|NCT01199965|7376382|FG000|COMPLETED|Overall Study||22
6459967|NCT01199965|7376383|FG001|COMPLETED|Overall Study||24
6459968|NCT01199965|7376382|FG000|NOT COMPLETED|Overall Study||1
6459969|NCT01199965|7376383|FG001|NOT COMPLETED|Overall Study||0
6459970|NCT01200030|7376400|FG000|STARTED|Overall Study||12
6459971|NCT01200030|7376401|FG001|STARTED|Overall Study||13
6459972|NCT01200030|7376402|FG002|STARTED|Overall Study||12
6459973|NCT01200030|7376400|FG000|COMPLETED|Overall Study||12
6459974|NCT01200030|7376401|FG001|COMPLETED|Overall Study||13
6459975|NCT01200030|7376402|FG002|COMPLETED|Overall Study||12
6459976|NCT01200030|7376400|FG000|NOT COMPLETED|Overall Study||0
6459977|NCT01200030|7376401|FG001|NOT COMPLETED|Overall Study||0
6459978|NCT01200030|7376402|FG002|NOT COMPLETED|Overall Study||0
6459979|NCT01200069|7376412|FG000|STARTED|Overall Study||8
6459980|NCT01200069|7376413|FG001|STARTED|Overall Study||6
6459981|NCT01200069|7376412|FG000|COMPLETED|Overall Study||8
6459982|NCT01200069|7376413|FG001|COMPLETED|Overall Study||5
6459983|NCT01200069|7376412|FG000|NOT COMPLETED|Overall Study||0
6459984|NCT01200069|7376413|FG001|NOT COMPLETED|Overall Study||1
6459985|NCT01200160|7376462|FG000|STARTED|Overall Study||128
6459986|NCT01200160|7376462|FG000|COMPLETED|Overall Study||66
6459987|NCT01200160|7376462|FG000|NOT COMPLETED|Overall Study||62
6459988|NCT01200238|7376468|FG000|STARTED|Overall Study||7
6459989|NCT01200238|7376469|FG001|STARTED|Overall Study||10
6459990|NCT01200238|7376468|FG000|COMPLETED|Overall Study||0
6459991|NCT01200238|7376469|FG001|COMPLETED|Overall Study||0
6459992|NCT01200238|7376468|FG000|NOT COMPLETED|Overall Study||7
6459993|NCT01200238|7376469|FG001|NOT COMPLETED|Overall Study||10
6459994|NCT01200290|7376475|FG000|STARTED|Treatment Period||18
6459995|NCT01200290|7376475|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||18
6459996|NCT01200290|7376475|FG000|COMPLETED|Treatment Period||17
6459997|NCT01200290|7376475|FG000|NOT COMPLETED|Treatment Period||1
6459998|NCT01200290|7376475|FG000|STARTED|Post-Treatment Follow-Up Period|Participant who discontinued treatment was included in the post-treatment follow-up period.|18
6459999|NCT01200290|7376475|FG000|COMPLETED|Post-Treatment Follow-Up Period||16
6460000|NCT01200290|7376475|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
6460001|NCT01200329|7376479|FG000|STARTED|Overall Study||81
6460002|NCT01200329|7376479|FG000|COMPLETED|Overall Study||78
6460003|NCT01200329|7376479|FG000|NOT COMPLETED|Overall Study||3
6460004|NCT01200342|7376483|FG000|STARTED|Overall Study||7
6460005|NCT01200342|7376483|FG000|COMPLETED|Overall Study||6
6460006|NCT01200342|7376483|FG000|NOT COMPLETED|Overall Study||1
6460007|NCT01200355|7376489|FG000|STARTED|Overall Study||58
6460008|NCT01200355|7376490|FG001|STARTED|Overall Study||55
6460009|NCT01200355|7376489|FG000|COMPLETED|Overall Study||51
6460010|NCT01200355|7376490|FG001|COMPLETED|Overall Study||53
6460011|NCT01200355|7376489|FG000|NOT COMPLETED|Overall Study||7
6460012|NCT01200355|7376490|FG001|NOT COMPLETED|Overall Study||2
6460013|NCT01200368|7376499|FG000|STARTED|Infant Series||183
6460014|NCT01200368|7376500|FG001|STARTED|Infant Series||184
6460015|NCT01200368|7376501|FG002|STARTED|Infant Series||184
6460016|NCT01200368|7376499|FG000|Vaccinated Dose 1|Infant Series||183
6460017|NCT01200368|7376500|FG001|Vaccinated Dose 1|Infant Series||183
6460018|NCT01200368|7376501|FG002|Vaccinated Dose 1|Infant Series||183
6460019|NCT01200368|7376499|FG000|Vaccinated Dose 2|Infant Series||183
6460020|NCT01200368|7376500|FG001|Vaccinated Dose 2|Infant Series||182
6460021|NCT01200368|7376501|FG002|Vaccinated Dose 2|Infant Series||183
6460022|NCT01200368|7376499|FG000|Vaccinated Dose 3|Infant Series||181
6460023|NCT01200368|7376500|FG001|Vaccinated Dose 3|Infant Series||178
6460024|NCT01200368|7376501|FG002|Vaccinated Dose 3|Infant Series||182
6460025|NCT01200368|7376499|FG000|COMPLETED|Infant Series||180
6460026|NCT01200368|7376500|FG001|COMPLETED|Infant Series||178
6460027|NCT01200368|7376501|FG002|COMPLETED|Infant Series||178
6460028|NCT01200368|7376499|FG000|NOT COMPLETED|Infant Series||3
6460029|NCT01200368|7376500|FG001|NOT COMPLETED|Infant Series||6
6460030|NCT01200368|7376501|FG002|NOT COMPLETED|Infant Series||6
6460031|NCT01200368|7376499|FG000|STARTED|After Infant Series||180
6460032|NCT01200368|7376500|FG001|STARTED|After Infant Series||178
6460033|NCT01200368|7376501|FG002|STARTED|After Infant Series||178
6460034|NCT01200368|7376499|FG000|COMPLETED|After Infant Series||162
6460035|NCT01200368|7376500|FG001|COMPLETED|After Infant Series||162
6460036|NCT01200368|7376501|FG002|COMPLETED|After Infant Series||169
6460037|NCT01200368|7376499|FG000|NOT COMPLETED|After Infant Series||18
6460038|NCT01200368|7376500|FG001|NOT COMPLETED|After Infant Series||16
6460039|NCT01200368|7376501|FG002|NOT COMPLETED|After Infant Series||9
6460040|NCT01200368|7376499|FG000|STARTED|Toddler Dose||162
6460041|NCT01200368|7376500|FG001|STARTED|Toddler Dose||162
6460042|NCT01200368|7376501|FG002|STARTED|Toddler Dose||169
6460043|NCT01200368|7376499|FG000|COMPLETED|Toddler Dose||162
6460044|NCT01200368|7376500|FG001|COMPLETED|Toddler Dose||159
6460045|NCT01200368|7376501|FG002|COMPLETED|Toddler Dose||168
6460046|NCT01200368|7376499|FG000|NOT COMPLETED|Toddler Dose||0
6460047|NCT01200368|7376500|FG001|NOT COMPLETED|Toddler Dose||3
6460048|NCT01200368|7376501|FG002|NOT COMPLETED|Toddler Dose||1
6460049|NCT01200394|7376518|FG000|STARTED|Overall Study||64
6460050|NCT01200394|7376519|FG001|STARTED|Overall Study||192
6460051|NCT01200394|7376518|FG000|COMPLETED|Overall Study||62
6460052|NCT01200394|7376519|FG001|COMPLETED|Overall Study||164
6460053|NCT01200394|7376518|FG000|NOT COMPLETED|Overall Study||2
6460054|NCT01200394|7376519|FG001|NOT COMPLETED|Overall Study||28
6460055|NCT01200407|7376526|FG000|STARTED|Overall Study||615
6460056|NCT01200407|7376526|FG000|COMPLETED|Overall Study||533
6460057|NCT01200407|7376526|FG000|NOT COMPLETED|Overall Study||82
6460058|NCT01200433|7376532|FG000|STARTED|Overall Study||21
6460059|NCT01200433|7376533|FG001|STARTED|Overall Study||23
6460060|NCT01200433|7376532|FG000|COMPLETED|Overall Study||21
6460061|NCT01200433|7376533|FG001|COMPLETED|Overall Study||23
6460062|NCT01200433|7376532|FG000|NOT COMPLETED|Overall Study||0
6460063|NCT01200433|7376533|FG001|NOT COMPLETED|Overall Study||0
6460064|NCT01200485|7376539|FG000|STARTED|Cycle 1: Rasburicase Alone Delivery|Of 55 participants screened, only 52 treated.|55
6460065|NCT01200485|7376540|FG001|STARTED|Cycle 1: Rasburicase Alone Delivery||0
6460066|NCT01200485|7376541|FG002|STARTED|Cycle 1: Rasburicase Alone Delivery||0
6460067|NCT01200485|7376539|FG000|COMPLETED|Cycle 1: Rasburicase Alone Delivery||52
6460068|NCT01200485|7376540|FG001|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
6745347|NCT03358407|7673380|FG008|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6460069|NCT01200485|7376541|FG002|COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
6460070|NCT01200485|7376539|FG000|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||3
6460071|NCT01200485|7376540|FG001|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
6460072|NCT01200485|7376541|FG002|NOT COMPLETED|Cycle 1: Rasburicase Alone Delivery||0
6460073|NCT01200485|7376539|FG000|STARTED|Cycle 2: Randomization|Of 55 enrolled on study, 52 participants were treated in Cycle 1, only 46 randomized to Cycle 2|0
6460074|NCT01200485|7376540|FG001|STARTED|Cycle 2: Randomization|Six not randomized: Methemoglobinemia-1, Kidney failure-2, Chemotherapy changed-2, Not evaluable-1|21
6460075|NCT01200485|7376541|FG002|STARTED|Cycle 2: Randomization||25
6460076|NCT01200485|7376539|FG000|COMPLETED|Cycle 2: Randomization||0
6460077|NCT01200485|7376540|FG001|COMPLETED|Cycle 2: Randomization||21
6460078|NCT01200485|7376541|FG002|COMPLETED|Cycle 2: Randomization||25
6460079|NCT01200485|7376539|FG000|NOT COMPLETED|Cycle 2: Randomization||0
6460080|NCT01200485|7376540|FG001|NOT COMPLETED|Cycle 2: Randomization||0
6460081|NCT01200485|7376541|FG002|NOT COMPLETED|Cycle 2: Randomization||0
6460082|NCT01200498|7376548|FG000|STARTED|Overall Study||22
6460083|NCT01200498|7376548|FG000|COMPLETED|Overall Study||22
6460084|NCT01200498|7376548|FG000|NOT COMPLETED|Overall Study||0
6460085|NCT01200511|7376552|FG000|STARTED|Overall Study||49
6460086|NCT01200511|7376552|FG000|COMPLETED|Overall Study||44
6460087|NCT01200511|7376552|FG000|NOT COMPLETED|Overall Study||5
6460088|NCT01200524|7376561|FG000|STARTED|Overall Study||41
6460089|NCT01200524|7376562|FG001|STARTED|Overall Study||48
6460090|NCT01200524|7376563|FG002|STARTED|Overall Study||44
6460091|NCT01200524|7376561|FG000|COMPLETED|Overall Study||39
6460092|NCT01200524|7376562|FG001|COMPLETED|Overall Study||47
6460093|NCT01200524|7376563|FG002|COMPLETED|Overall Study||40
6460094|NCT01200524|7376561|FG000|NOT COMPLETED|Overall Study||2
6460095|NCT01200524|7376562|FG001|NOT COMPLETED|Overall Study||1
6460096|NCT01200524|7376563|FG002|NOT COMPLETED|Overall Study||4
6460097|NCT01200589|7376573|FG000|STARTED|Overall Study||219
6460098|NCT01200589|7376574|FG001|STARTED|Overall Study||219
6460099|NCT01200589|7376573|FG000|Intent-to-treat (ITT) Analysis Set|Overall Study||219
6460100|NCT01200589|7376574|FG001|Intent-to-treat (ITT) Analysis Set|Overall Study||219
6460101|NCT01200589|7376573|FG000|Safety Set|Overall Study||217
6460102|NCT01200589|7376574|FG001|Safety Set|Overall Study||218
6460103|NCT01200589|7376573|FG000|COMPLETED|Overall Study||29
6460104|NCT01200589|7376574|FG001|COMPLETED|Overall Study||30
6460105|NCT01200589|7376573|FG000|NOT COMPLETED|Overall Study||190
6460106|NCT01200589|7376574|FG001|NOT COMPLETED|Overall Study||189
6460107|NCT01200758|7376582|FG000|STARTED|Stage I||64
6745348|NCT03358407|7673381|FG009|STARTED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745349|NCT03358407|7673372|FG000|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6745350|NCT03358407|7673373|FG001|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6460108|NCT01200758|7376583|FG001|STARTED|Stage I||63
6460109|NCT01200758|7376584|FG002|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
6460110|NCT01200758|7376585|FG003|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
6460111|NCT01200758|7376582|FG000|COMPLETED|Stage I|Participants completed treatment period.|46
6460112|NCT01200758|7376583|FG001|COMPLETED|Stage I|Participants completed treatment period.|46
6460113|NCT01200758|7376584|FG002|COMPLETED|Stage I||0
6460114|NCT01200758|7376585|FG003|COMPLETED|Stage I||0
6745351|NCT03358407|7673374|FG002|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6745352|NCT03358407|7673375|FG003|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||2
6745353|NCT03358407|7673376|FG004|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
6745354|NCT03358407|7673377|FG005|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745355|NCT03358407|7673378|FG006|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745356|NCT03358407|7673379|FG007|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745357|NCT03358407|7673380|FG008|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745358|NCT03358407|7673381|FG009|COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745359|NCT03358407|7673372|FG000|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745360|NCT03358407|7673373|FG001|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745361|NCT03358407|7673374|FG002|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745362|NCT03358407|7673375|FG003|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745363|NCT03358407|7673376|FG004|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||1
6745364|NCT03358407|7673377|FG005|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745365|NCT03358407|7673378|FG006|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745366|NCT03358407|7673379|FG007|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745367|NCT03358407|7673380|FG008|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745368|NCT03358407|7673381|FG009|NOT COMPLETED|P4:PartA-Cohort1(4days)+Washout(48hours)||0
6745369|NCT03358407|7673372|FG000|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6745370|NCT03358407|7673373|FG001|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6745371|NCT03358407|7673374|FG002|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6745372|NCT03358407|7673375|FG003|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6745373|NCT03358407|7673376|FG004|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)|1 participant was added to Part A-Cohort 1: GSK 2mg/GSK 4mg/GSK 10mg/GSK 30mg/Placebo arm|2
6745374|NCT03358407|7673377|FG005|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6460115|NCT01200758|7376582|FG000|NOT COMPLETED|Stage I||18
6745375|NCT03358407|7673378|FG006|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6553852|NCT01746017|7476327|FG001|NOT COMPLETED|Period 2||0
6553853|NCT01746017|7476328|FG002|NOT COMPLETED|Period 2||0
6553854|NCT01746017|7476329|FG003|NOT COMPLETED|Period 2||0
6553855|NCT01746017|7476330|FG004|NOT COMPLETED|Period 2||0
6553856|NCT01746017|7476331|FG005|NOT COMPLETED|Period 2||0
6553857|NCT01746017|7476332|FG006|NOT COMPLETED|Period 2||0
6553858|NCT01746017|7476333|FG007|NOT COMPLETED|Period 2||0
6553859|NCT01746017|7476334|FG008|NOT COMPLETED|Period 2||0
6553860|NCT01746017|7476335|FG009|NOT COMPLETED|Period 2||0
6553861|NCT01746017|7476336|FG010|NOT COMPLETED|Period 2||0
6553862|NCT01746017|7476326|FG000|STARTED|Period 3||2
6553863|NCT01746017|7476327|FG001|STARTED|Period 3||2
6553864|NCT01746017|7476328|FG002|STARTED|Period 3||2
6553865|NCT01746017|7476329|FG003|STARTED|Period 3||2
6553866|NCT01746017|7476330|FG004|STARTED|Period 3||2
6553867|NCT01746017|7476331|FG005|STARTED|Period 3||2
6553868|NCT01746017|7476332|FG006|STARTED|Period 3||2
6553869|NCT01746017|7476333|FG007|STARTED|Period 3||2
6553870|NCT01746017|7476334|FG008|STARTED|Period 3||3
6553871|NCT01746017|7476335|FG009|STARTED|Period 3||3
6553872|NCT01746017|7476336|FG010|STARTED|Period 3||3
6553873|NCT01746017|7476326|FG000|COMPLETED|Period 3||2
6553874|NCT01746017|7476327|FG001|COMPLETED|Period 3||2
6553875|NCT01746017|7476328|FG002|COMPLETED|Period 3||2
6553876|NCT01746017|7476329|FG003|COMPLETED|Period 3||2
6553877|NCT01746017|7476330|FG004|COMPLETED|Period 3||2
6553878|NCT01746017|7476331|FG005|COMPLETED|Period 3||1
6553879|NCT01746017|7476332|FG006|COMPLETED|Period 3||2
6553880|NCT01746017|7476333|FG007|COMPLETED|Period 3||2
6553881|NCT01746017|7476334|FG008|COMPLETED|Period 3||3
6553882|NCT01746017|7476335|FG009|COMPLETED|Period 3||3
6553883|NCT01746017|7476336|FG010|COMPLETED|Period 3||3
6553884|NCT01746017|7476326|FG000|NOT COMPLETED|Period 3||0
6553885|NCT01746017|7476327|FG001|NOT COMPLETED|Period 3||0
6553886|NCT01746017|7476328|FG002|NOT COMPLETED|Period 3||0
6553887|NCT01746017|7476329|FG003|NOT COMPLETED|Period 3||0
6553888|NCT01746017|7476330|FG004|NOT COMPLETED|Period 3||0
6553889|NCT01746017|7476331|FG005|NOT COMPLETED|Period 3||1
6553890|NCT01746017|7476332|FG006|NOT COMPLETED|Period 3||0
6553891|NCT01746017|7476333|FG007|NOT COMPLETED|Period 3||0
6553892|NCT01746017|7476334|FG008|NOT COMPLETED|Period 3||0
6553893|NCT01746017|7476335|FG009|NOT COMPLETED|Period 3||0
6553894|NCT01746017|7476336|FG010|NOT COMPLETED|Period 3||0
6553895|NCT01746017|7476326|FG000|STARTED|Period 4||2
6553896|NCT01746017|7476327|FG001|STARTED|Period 4||2
6553897|NCT01746017|7476328|FG002|STARTED|Period 4||2
6553898|NCT01746017|7476329|FG003|STARTED|Period 4||2
6553899|NCT01746017|7476330|FG004|STARTED|Period 4||2
6553900|NCT01746017|7476331|FG005|STARTED|Period 4||1
6553901|NCT01746017|7476332|FG006|STARTED|Period 4||2
6553902|NCT01746017|7476333|FG007|STARTED|Period 4||2
6553903|NCT01746017|7476334|FG008|STARTED|Period 4|Part B occurred only for 3 periods.|0
6553904|NCT01746017|7476335|FG009|STARTED|Period 4|Part B occurred only for 3 periods.|0
6553905|NCT01746017|7476336|FG010|STARTED|Period 4|Part B occurred only for 3 periods.|0
6553906|NCT01746017|7476326|FG000|COMPLETED|Period 4||2
6553907|NCT01746017|7476327|FG001|COMPLETED|Period 4||2
6460116|NCT01200758|7376583|FG001|NOT COMPLETED|Stage I||17
6460117|NCT01200758|7376584|FG002|NOT COMPLETED|Stage I||0
6460118|NCT01200758|7376585|FG003|NOT COMPLETED|Stage I||0
6460119|NCT01200758|7376582|FG000|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
6460120|NCT01200758|7376583|FG001|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
6460121|NCT01200758|7376584|FG002|STARTED|Stage 2||141
6460122|NCT01200758|7376585|FG003|STARTED|Stage 2||142
6460123|NCT01200758|7376582|FG000|COMPLETED|Stage 2||0
6460124|NCT01200758|7376583|FG001|COMPLETED|Stage 2||0
6460125|NCT01200758|7376584|FG002|COMPLETED|Stage 2|Participants completed treatment period.|100
6460126|NCT01200758|7376585|FG003|COMPLETED|Stage 2|Participants completed treatment period.|92
6460127|NCT01200758|7376582|FG000|NOT COMPLETED|Stage 2||0
6460128|NCT01200758|7376583|FG001|NOT COMPLETED|Stage 2||0
6460129|NCT01200758|7376584|FG002|NOT COMPLETED|Stage 2||41
6460130|NCT01200758|7376585|FG003|NOT COMPLETED|Stage 2||50
6460131|NCT01200797|7376597|FG000|STARTED|Overall Study||19
6460132|NCT01200797|7376597|FG000|COMPLETED|Overall Study||0
6460133|NCT01200797|7376597|FG000|NOT COMPLETED|Overall Study||19
6460134|NCT01200810|7376604|FG000|STARTED|Overall Study||5
6460135|NCT01200810|7376605|FG001|STARTED|Overall Study||5
6460136|NCT01200810|7376604|FG000|COMPLETED|Overall Study||0
6460137|NCT01200810|7376605|FG001|COMPLETED|Overall Study||0
6460138|NCT01200810|7376604|FG000|NOT COMPLETED|Overall Study||5
6460139|NCT01200810|7376605|FG001|NOT COMPLETED|Overall Study||5
6460140|NCT01200875|7376611|FG000|STARTED|Overall Study||25
6460141|NCT01200875|7376611|FG000|COMPLETED|Overall Study||25
6553908|NCT01746017|7476328|FG002|COMPLETED|Period 4||2
6553909|NCT01746017|7476329|FG003|COMPLETED|Period 4||2
6553910|NCT01746017|7476330|FG004|COMPLETED|Period 4||2
6553911|NCT01746017|7476331|FG005|COMPLETED|Period 4||1
6553912|NCT01746017|7476332|FG006|COMPLETED|Period 4||2
6553913|NCT01746017|7476333|FG007|COMPLETED|Period 4||2
6553914|NCT01746017|7476334|FG008|COMPLETED|Period 4||0
6553915|NCT01746017|7476335|FG009|COMPLETED|Period 4||0
6553916|NCT01746017|7476336|FG010|COMPLETED|Period 4||0
6553917|NCT01746017|7476326|FG000|NOT COMPLETED|Period 4||0
6553918|NCT01746017|7476327|FG001|NOT COMPLETED|Period 4||0
6553919|NCT01746017|7476328|FG002|NOT COMPLETED|Period 4||0
6553920|NCT01746017|7476329|FG003|NOT COMPLETED|Period 4||0
6460142|NCT01200875|7376611|FG000|NOT COMPLETED|Overall Study||0
6460143|NCT01200992|7376617|FG000|STARTED|Overall Study||39
6460144|NCT01200992|7376618|FG001|STARTED|Overall Study||45
6460145|NCT01200992|7376617|FG000|COMPLETED|Overall Study||2
6460146|NCT01200992|7376618|FG001|COMPLETED|Overall Study||4
6460147|NCT01200992|7376617|FG000|NOT COMPLETED|Overall Study||37
6460148|NCT01200992|7376618|FG001|NOT COMPLETED|Overall Study||41
6460149|NCT01201057|7376630|FG000|STARTED|Overall Study||34
6460150|NCT01201057|7376631|FG001|STARTED|Overall Study||33
6460151|NCT01201057|7376632|FG002|STARTED|Overall Study||32
6460152|NCT01201057|7376633|FG003|STARTED|Overall Study||33
6460153|NCT01201057|7376630|FG000|COMPLETED|Overall Study||32
6460154|NCT01201057|7376631|FG001|COMPLETED|Overall Study||29
6460155|NCT01201057|7376632|FG002|COMPLETED|Overall Study||27
6460156|NCT01201057|7376633|FG003|COMPLETED|Overall Study||29
6460157|NCT01201057|7376630|FG000|NOT COMPLETED|Overall Study||2
6460158|NCT01201057|7376631|FG001|NOT COMPLETED|Overall Study||4
6460159|NCT01201057|7376632|FG002|NOT COMPLETED|Overall Study||5
6460160|NCT01201057|7376633|FG003|NOT COMPLETED|Overall Study||4
6460161|NCT01201265|7376643|FG000|STARTED|Overall Study||40
6460162|NCT01201265|7376643|FG000|COMPLETED|Overall Study||2
6460163|NCT01201265|7376643|FG000|NOT COMPLETED|Overall Study||38
6460164|NCT01201317|7376650|FG000|STARTED|Overall Study||48
6460165|NCT01201317|7376651|FG001|STARTED|Overall Study||45
6460166|NCT01201317|7376652|FG002|STARTED|Overall Study||41
6460167|NCT01201317|7376650|FG000|COMPLETED|Overall Study||39
6460168|NCT01201317|7376651|FG001|COMPLETED|Overall Study||38
6460169|NCT01201317|7376652|FG002|COMPLETED|Overall Study||33
6460170|NCT01201317|7376650|FG000|NOT COMPLETED|Overall Study||9
6460171|NCT01201317|7376651|FG001|NOT COMPLETED|Overall Study||7
6460172|NCT01201317|7376652|FG002|NOT COMPLETED|Overall Study||8
6460173|NCT01201343|7376660|FG000|STARTED|Overall Study||79
6460174|NCT01201343|7376660|FG000|Treated|Overall Study||76
6460175|NCT01201343|7376660|FG000|COMPLETED|Overall Study||60
6460176|NCT01201343|7376660|FG000|NOT COMPLETED|Overall Study||19
6460177|NCT01201356|7376664|FG000|STARTED|Overall Study||4125
6460178|NCT01201356|7376664|FG000|Safety Set|Overall Study||4083
6460179|NCT01201356|7376664|FG000|Fingolimod Full Analysis Set|Overall Study||4046
6460180|NCT01201356|7376664|FG000|COMPLETED|Overall Study||3481
6460181|NCT01201356|7376664|FG000|NOT COMPLETED|Overall Study||644
6460182|NCT01201486|7376668|FG000|STARTED|Overall Study||6781
6460183|NCT01201486|7376668|FG000|COMPLETED|Overall Study||6781
6460184|NCT01201486|7376668|FG000|NOT COMPLETED|Overall Study||0
6460185|NCT01201629|7376674|FG000|STARTED|Overall Study||8
6460186|NCT01201629|7376675|FG001|STARTED|Overall Study||8
6460187|NCT01201629|7376674|FG000|COMPLETED|Overall Study||8
6460188|NCT01201629|7376675|FG001|COMPLETED|Overall Study||8
6460189|NCT01201629|7376674|FG000|NOT COMPLETED|Overall Study||0
6460190|NCT01201629|7376675|FG001|NOT COMPLETED|Overall Study||0
6460191|NCT01201759|7376683|FG000|STARTED|Visit 1 Wash-in ( Untreated)||10
6460192|NCT01201759|7376684|FG001|STARTED|Visit 1 Wash-in ( Untreated)||8
6460193|NCT01201759|7376683|FG000|COMPLETED|Visit 1 Wash-in ( Untreated)||8
6460194|NCT01201759|7376684|FG001|COMPLETED|Visit 1 Wash-in ( Untreated)||7
6460195|NCT01201759|7376683|FG000|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
6460196|NCT01201759|7376684|FG001|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
6460197|NCT01201759|7376683|FG000|STARTED|Visit 2||8
6460198|NCT01201759|7376684|FG001|STARTED|Visit 2||7
6460199|NCT01201759|7376683|FG000|COMPLETED|Visit 2||8
6460200|NCT01201759|7376684|FG001|COMPLETED|Visit 2||7
6460201|NCT01201759|7376683|FG000|NOT COMPLETED|Visit 2||0
6460202|NCT01201759|7376684|FG001|NOT COMPLETED|Visit 2||0
6460203|NCT01201759|7376683|FG000|STARTED|Visit 3 - Washout||8
6460204|NCT01201759|7376684|FG001|STARTED|Visit 3 - Washout||7
6460205|NCT01201759|7376683|FG000|COMPLETED|Visit 3 - Washout||7
6460206|NCT01201759|7376684|FG001|COMPLETED|Visit 3 - Washout||4
6460207|NCT01201759|7376683|FG000|NOT COMPLETED|Visit 3 - Washout||1
6460208|NCT01201759|7376684|FG001|NOT COMPLETED|Visit 3 - Washout||3
6460209|NCT01201759|7376683|FG000|STARTED|Visit 4 Crossover||7
6460210|NCT01201759|7376684|FG001|STARTED|Visit 4 Crossover||4
6460211|NCT01201759|7376683|FG000|COMPLETED|Visit 4 Crossover||7
6460212|NCT01201759|7376684|FG001|COMPLETED|Visit 4 Crossover||3
6460213|NCT01201759|7376683|FG000|NOT COMPLETED|Visit 4 Crossover||0
6460214|NCT01201759|7376684|FG001|NOT COMPLETED|Visit 4 Crossover||1
6460215|NCT01201759|7376683|FG000|STARTED|Visit 5||7
6460216|NCT01201759|7376684|FG001|STARTED|Visit 5||3
6460217|NCT01201759|7376683|FG000|COMPLETED|Visit 5||7
6460218|NCT01201759|7376684|FG001|COMPLETED|Visit 5||3
6460219|NCT01201759|7376683|FG000|NOT COMPLETED|Visit 5||0
6460220|NCT01201759|7376684|FG001|NOT COMPLETED|Visit 5||0
6460221|NCT01201772|7376695|FG000|STARTED|Overall Study||23
6460222|NCT01201772|7376696|FG001|STARTED|Overall Study||21
6460223|NCT01201772|7376697|FG002|STARTED|Overall Study||21
6460224|NCT01201772|7376695|FG000|COMPLETED|Overall Study||22
6460225|NCT01201772|7376696|FG001|COMPLETED|Overall Study||21
6460226|NCT01201772|7376697|FG002|COMPLETED|Overall Study||21
6460227|NCT01201772|7376695|FG000|NOT COMPLETED|Overall Study||1
6460228|NCT01201772|7376696|FG001|NOT COMPLETED|Overall Study||0
6460229|NCT01201772|7376697|FG002|NOT COMPLETED|Overall Study||0
6460230|NCT01201785|7376703|FG000|STARTED|Overall Study||36
6460231|NCT01201785|7376703|FG000|COMPLETED|Overall Study||20
6460232|NCT01201785|7376703|FG000|NOT COMPLETED|Overall Study||16
6460233|NCT01201798|7376709|FG000|STARTED|Overall Study||56
6460234|NCT01201798|7376710|FG001|STARTED|Overall Study||54
6460235|NCT01201798|7376709|FG000|COMPLETED|Overall Study||47
6460236|NCT01201798|7376710|FG001|COMPLETED|Overall Study||39
6460237|NCT01201798|7376709|FG000|NOT COMPLETED|Overall Study||9
6460238|NCT01201798|7376710|FG001|NOT COMPLETED|Overall Study||15
6460239|NCT01201811|7376716|FG000|STARTED|Overall Study||44
6460240|NCT01201811|7376716|FG000|COMPLETED|Overall Study||25
6460241|NCT01201811|7376716|FG000|NOT COMPLETED|Overall Study||19
6460242|NCT01201850|7376720|FG000|STARTED|Overall Study||7
6460243|NCT01201850|7376720|FG000|COMPLETED|Overall Study||3
6460244|NCT01201850|7376720|FG000|NOT COMPLETED|Overall Study||4
6460245|NCT01201863|7376727|FG000|STARTED|Overall Study||12
6460246|NCT01201863|7376728|FG001|STARTED|Overall Study||10
6460247|NCT01201863|7376729|FG002|STARTED|Overall Study||24
6460248|NCT01201863|7376727|FG000|COMPLETED|Overall Study||11
6460249|NCT01201863|7376728|FG001|COMPLETED|Overall Study||6
6460250|NCT01201863|7376729|FG002|COMPLETED|Overall Study||18
6460251|NCT01201863|7376727|FG000|NOT COMPLETED|Overall Study||1
6460252|NCT01201863|7376728|FG001|NOT COMPLETED|Overall Study||4
6460253|NCT01201863|7376729|FG002|NOT COMPLETED|Overall Study||6
6460254|NCT01201915|7376740|FG000|STARTED|Overall Study||24
6460255|NCT01201915|7376741|FG001|STARTED|Overall Study||25
6460256|NCT01201915|7376742|FG002|STARTED|Overall Study||25
6460257|NCT01201915|7376740|FG000|COMPLETED|Overall Study||16
6460258|NCT01201915|7376741|FG001|COMPLETED|Overall Study||14
6460259|NCT01201915|7376742|FG002|COMPLETED|Overall Study||19
6460260|NCT01201915|7376740|FG000|NOT COMPLETED|Overall Study||8
6460261|NCT01201915|7376741|FG001|NOT COMPLETED|Overall Study||11
6460262|NCT01201915|7376742|FG002|NOT COMPLETED|Overall Study||6
6460263|NCT01201967|7376752|FG000|STARTED|Overall Study||92
6460264|NCT01201967|7376753|FG001|STARTED|Overall Study||91
6460265|NCT01201967|7376752|FG000|COMPLETED|Overall Study||86
6460266|NCT01201967|7376753|FG001|COMPLETED|Overall Study||86
6460267|NCT01201967|7376752|FG000|NOT COMPLETED|Overall Study||6
6460268|NCT01201967|7376753|FG001|NOT COMPLETED|Overall Study||5
6460269|NCT01202071|7376760|FG000|STARTED|Overall Study||6
6460270|NCT01202071|7376761|FG001|STARTED|Overall Study||6
6460271|NCT01202071|7376762|FG002|STARTED|Overall Study||6
6460272|NCT01202071|7376763|FG003|STARTED|Overall Study||6
6460273|NCT01202071|7376760|FG000|COMPLETED|Overall Study||6
6460274|NCT01202071|7376761|FG001|COMPLETED|Overall Study||6
6460275|NCT01202071|7376762|FG002|COMPLETED|Overall Study||6
6460276|NCT01202071|7376763|FG003|COMPLETED|Overall Study||6
6460277|NCT01202071|7376760|FG000|NOT COMPLETED|Overall Study||0
6460278|NCT01202071|7376761|FG001|NOT COMPLETED|Overall Study||0
6460279|NCT01202071|7376762|FG002|NOT COMPLETED|Overall Study||0
6460280|NCT01202071|7376763|FG003|NOT COMPLETED|Overall Study||0
6460281|NCT01202162|7376775|FG000|STARTED|Overall Study||43
6460282|NCT01202162|7376776|FG001|STARTED|Overall Study||42
6460283|NCT01202162|7376775|FG000|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
6460284|NCT01202162|7376776|FG001|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
6460285|NCT01202162|7376775|FG000|NOT COMPLETED|Overall Study||3
6460286|NCT01202162|7376776|FG001|NOT COMPLETED|Overall Study||2
6460287|NCT01202175|7376784|FG000|STARTED|Overall Study||50
6460288|NCT01202175|7376784|FG000|Nebivolol|Overall Study||25
6460289|NCT01202175|7376784|FG000|Pacebo|Overall Study||25
6460290|NCT01202175|7376784|FG000|COMPLETED|Overall Study||45
6460291|NCT01202175|7376784|FG000|NOT COMPLETED|Overall Study||5
6460292|NCT01202188|7376794|FG000|STARTED|Overall Study||475
6460293|NCT01202188|7376795|FG001|STARTED|Overall Study||477
6460294|NCT01202188|7376796|FG002|STARTED|Overall Study||475
6460295|NCT01202188|7376797|FG003|STARTED|Overall Study||483
6460296|NCT01202188|7376798|FG004|STARTED|Overall Study||234
6460297|NCT01202188|7376794|FG000|Safety Set; Received Study Drug|Overall Study||474
6460298|NCT01202188|7376795|FG001|Safety Set; Received Study Drug|Overall Study||476
6460299|NCT01202188|7376796|FG002|Safety Set; Received Study Drug|Overall Study||473
6460300|NCT01202188|7376797|FG003|Safety Set; Received Study Drug|Overall Study||480
6460301|NCT01202188|7376798|FG004|Safety Set; Received Study Drug|Overall Study||232
6460302|NCT01202188|7376794|FG000|COMPLETED|Overall Study||437
6460303|NCT01202188|7376795|FG001|COMPLETED|Overall Study||421
6460304|NCT01202188|7376796|FG002|COMPLETED|Overall Study||422
6460305|NCT01202188|7376797|FG003|COMPLETED|Overall Study||441
6460306|NCT01202188|7376798|FG004|COMPLETED|Overall Study||189
6460307|NCT01202188|7376794|FG000|NOT COMPLETED|Overall Study||38
6460308|NCT01202188|7376795|FG001|NOT COMPLETED|Overall Study||56
6460309|NCT01202188|7376796|FG002|NOT COMPLETED|Overall Study||53
6460310|NCT01202188|7376797|FG003|NOT COMPLETED|Overall Study||42
6460311|NCT01202188|7376798|FG004|NOT COMPLETED|Overall Study||45
6460312|NCT01202227|7376816|FG000|STARTED|Overall Study|Treated|103
6460313|NCT01202227|7376816|FG000|COMPLETED|Overall Study||84
6460314|NCT01202227|7376816|FG000|NOT COMPLETED|Overall Study||19
6460315|NCT01202253|7376820|FG000|STARTED|Overall Study||50
6460316|NCT01202253|7376820|FG000|COMPLETED|Overall Study||50
6460317|NCT01202253|7376820|FG000|NOT COMPLETED|Overall Study||0
6460318|NCT01202279|7376826|FG000|STARTED|Overall Study||591
6460319|NCT01202279|7376827|FG001|STARTED|Overall Study||588
6460320|NCT01202279|7376826|FG000|COMPLETED|Overall Study||554
6460321|NCT01202279|7376827|FG001|COMPLETED|Overall Study||561
6460322|NCT01202279|7376826|FG000|NOT COMPLETED|Overall Study||37
6460323|NCT01202279|7376827|FG001|NOT COMPLETED|Overall Study||27
6460324|NCT01202409|7376833|FG000|STARTED|Overall Study||19
6460325|NCT01202409|7376833|FG000|COMPLETED|Overall Study||11
6460326|NCT01202409|7376833|FG000|NOT COMPLETED|Overall Study||8
6460327|NCT01202565|7376837|FG000|STARTED|Overall Study||506
6460328|NCT01202565|7376837|FG000|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
6460329|NCT01202565|7376837|FG000|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
6460330|NCT01202565|7376837|FG000|NOT COMPLETED|Overall Study||67
6460331|NCT01202578|7376841|FG000|STARTED|Overall Study||53
6460332|NCT01202578|7376841|FG000|COMPLETED|Overall Study||53
6460333|NCT01202578|7376841|FG000|NOT COMPLETED|Overall Study||0
6460334|NCT01202591|7376851|FG000|STARTED|Overall Study||5
6460335|NCT01202591|7376852|FG001|STARTED|Overall Study||5
6460336|NCT01202591|7376853|FG002|STARTED|Overall Study||12
6460337|NCT01202591|7376854|FG003|STARTED|Overall Study||9
6460338|NCT01202591|7376855|FG004|STARTED|Overall Study||5
6460339|NCT01202591|7376856|FG005|STARTED|Overall Study||4
6460340|NCT01202591|7376851|FG000|COMPLETED|Overall Study||0
6460341|NCT01202591|7376852|FG001|COMPLETED|Overall Study||0
6460342|NCT01202591|7376853|FG002|COMPLETED|Overall Study||1
6460343|NCT01202591|7376854|FG003|COMPLETED|Overall Study||2
6460344|NCT01202591|7376855|FG004|COMPLETED|Overall Study||0
6460345|NCT01202591|7376856|FG005|COMPLETED|Overall Study||0
6460346|NCT01202591|7376851|FG000|NOT COMPLETED|Overall Study||5
6460347|NCT01202591|7376852|FG001|NOT COMPLETED|Overall Study||5
6460348|NCT01202591|7376853|FG002|NOT COMPLETED|Overall Study||11
6460349|NCT01202591|7376854|FG003|NOT COMPLETED|Overall Study||7
6460350|NCT01202591|7376855|FG004|NOT COMPLETED|Overall Study||5
6460351|NCT01202591|7376856|FG005|NOT COMPLETED|Overall Study||4
6460352|NCT01202643|7376872|FG000|STARTED|Period 1||6
6460353|NCT01202643|7376873|FG001|STARTED|Period 1||6
6460354|NCT01202643|7376872|FG000|COMPLETED|Period 1||6
6460355|NCT01202643|7376873|FG001|COMPLETED|Period 1||6
6460356|NCT01202643|7376872|FG000|NOT COMPLETED|Period 1||0
6460357|NCT01202643|7376873|FG001|NOT COMPLETED|Period 1||0
6460358|NCT01202643|7376872|FG000|STARTED|Crossover Cycle|One patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
6460359|NCT01202643|7376873|FG001|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
6460360|NCT01202643|7376872|FG000|COMPLETED|Crossover Cycle||1
6460361|NCT01202643|7376873|FG001|COMPLETED|Crossover Cycle||2
6460362|NCT01202643|7376872|FG000|NOT COMPLETED|Crossover Cycle||0
6460363|NCT01202643|7376873|FG001|NOT COMPLETED|Crossover Cycle||0
6460364|NCT01202656|7376881|FG000|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
6460365|NCT01202656|7376882|FG001|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
6460366|NCT01202656|7376881|FG000|COMPLETED|Cycle 1||67
6460367|NCT01202656|7376882|FG001|COMPLETED|Cycle 1||62
6460368|NCT01202656|7376881|FG000|NOT COMPLETED|Cycle 1||0
6460369|NCT01202656|7376882|FG001|NOT COMPLETED|Cycle 1||0
6460370|NCT01202656|7376881|FG000|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
6460371|NCT01202656|7376882|FG001|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
6460372|NCT01202656|7376881|FG000|COMPLETED|CrossoverCycle||18
6460373|NCT01202656|7376882|FG001|COMPLETED|CrossoverCycle||14
6460374|NCT01202656|7376881|FG000|NOT COMPLETED|CrossoverCycle||0
6460375|NCT01202656|7376882|FG001|NOT COMPLETED|CrossoverCycle||0
6500735|NCT01425801|7419345|FG001|COMPLETED|Period 4||9
6500736|NCT01425801|7419346|FG002|COMPLETED|Period 4||7
6500737|NCT01425801|7419347|FG003|COMPLETED|Period 4||12
6500738|NCT01425801|7419348|FG004|COMPLETED|Period 4||11
6500739|NCT01425801|7419349|FG005|COMPLETED|Period 4||10
6500740|NCT01425801|7419344|FG000|NOT COMPLETED|Period 4||0
6500741|NCT01425801|7419345|FG001|NOT COMPLETED|Period 4||0
6500742|NCT01425801|7419346|FG002|NOT COMPLETED|Period 4||1
6500743|NCT01425801|7419347|FG003|NOT COMPLETED|Period 4||0
6500744|NCT01425801|7419348|FG004|NOT COMPLETED|Period 4||0
6500745|NCT01425801|7419349|FG005|NOT COMPLETED|Period 4||0
6500746|NCT01425801|7419344|FG000|STARTED|Period 5||9
6500747|NCT01425801|7419345|FG001|STARTED|Period 5||9
6500748|NCT01425801|7419346|FG002|STARTED|Period 5||7
6500749|NCT01425801|7419347|FG003|STARTED|Period 5||12
6500750|NCT01425801|7419348|FG004|STARTED|Period 5||11
6500751|NCT01425801|7419349|FG005|STARTED|Period 5||10
6500752|NCT01425801|7419344|FG000|COMPLETED|Period 5||9
6500753|NCT01425801|7419345|FG001|COMPLETED|Period 5||9
6500754|NCT01425801|7419346|FG002|COMPLETED|Period 5||7
6500755|NCT01425801|7419347|FG003|COMPLETED|Period 5||12
6500756|NCT01425801|7419348|FG004|COMPLETED|Period 5||11
6500757|NCT01425801|7419349|FG005|COMPLETED|Period 5||10
6500758|NCT01425801|7419344|FG000|NOT COMPLETED|Period 5||0
6500759|NCT01425801|7419345|FG001|NOT COMPLETED|Period 5||0
6500760|NCT01425801|7419346|FG002|NOT COMPLETED|Period 5||0
6500761|NCT01425801|7419347|FG003|NOT COMPLETED|Period 5||0
6500762|NCT01425801|7419348|FG004|NOT COMPLETED|Period 5||0
6500763|NCT01425801|7419349|FG005|NOT COMPLETED|Period 5||0
6500764|NCT01425801|7419344|FG000|STARTED|Period 6||9
6500765|NCT01425801|7419345|FG001|STARTED|Period 6||9
6500766|NCT01425801|7419346|FG002|STARTED|Period 6||7
6500767|NCT01425801|7419347|FG003|STARTED|Period 6||12
6500768|NCT01425801|7419348|FG004|STARTED|Period 6||11
6500769|NCT01425801|7419349|FG005|STARTED|Period 6||10
6500770|NCT01425801|7419344|FG000|COMPLETED|Period 6||9
6500771|NCT01425801|7419345|FG001|COMPLETED|Period 6||9
6500772|NCT01425801|7419346|FG002|COMPLETED|Period 6||7
6500773|NCT01425801|7419347|FG003|COMPLETED|Period 6||12
6460376|NCT01202721|7376892|FG000|STARTED|Overall Study||18
6460377|NCT01202721|7376893|FG001|STARTED|Overall Study||26
6460378|NCT01202721|7376894|FG002|STARTED|Overall Study||14
6460379|NCT01202721|7376895|FG003|STARTED|Overall Study||27
6460380|NCT01202721|7376892|FG000|COMPLETED|Overall Study||18
6460381|NCT01202721|7376893|FG001|COMPLETED|Overall Study||26
6460382|NCT01202721|7376894|FG002|COMPLETED|Overall Study||14
6553921|NCT01746017|7476330|FG004|NOT COMPLETED|Period 4||0
6553922|NCT01746017|7476331|FG005|NOT COMPLETED|Period 4||0
6745376|NCT03358407|7673379|FG007|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6460383|NCT01202721|7376895|FG003|COMPLETED|Overall Study||27
6460384|NCT01202721|7376892|FG000|NOT COMPLETED|Overall Study||0
6460385|NCT01202721|7376893|FG001|NOT COMPLETED|Overall Study||0
6460386|NCT01202721|7376894|FG002|NOT COMPLETED|Overall Study||0
6460387|NCT01202721|7376895|FG003|NOT COMPLETED|Overall Study||0
6460388|NCT01202747|7376907|FG000|STARTED|Overall Study||50
6460389|NCT01202747|7376907|FG000|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
6460390|NCT01202747|7376907|FG000|NOT COMPLETED|Overall Study||1
6460391|NCT01202760|7376914|FG000|STARTED|Overall Study||379
6460392|NCT01202760|7376915|FG001|STARTED|Overall Study||374
6460393|NCT01202760|7376916|FG002|STARTED|Overall Study||251
6460394|NCT01202760|7376914|FG000|Received at Least One Dose of Study Drug|Overall Study||379
6460395|NCT01202760|7376915|FG001|Received at Least One Dose of Study Drug|Overall Study||371
6460396|NCT01202760|7376916|FG002|Received at Least One Dose of Study Drug|Overall Study||250
6460397|NCT01202760|7376914|FG000|COMPLETED|Overall Study||332
6460398|NCT01202760|7376915|FG001|COMPLETED|Overall Study||322
6460399|NCT01202760|7376916|FG002|COMPLETED|Overall Study||216
6460400|NCT01202760|7376914|FG000|NOT COMPLETED|Overall Study||47
6460401|NCT01202760|7376915|FG001|NOT COMPLETED|Overall Study||52
6460402|NCT01202760|7376916|FG002|NOT COMPLETED|Overall Study||35
6460403|NCT01202773|7376939|FG000|STARTED|Overall Study||153
6553923|NCT01746017|7476332|FG006|NOT COMPLETED|Period 4||0
6553924|NCT01746017|7476333|FG007|NOT COMPLETED|Period 4||0
6745377|NCT03358407|7673380|FG008|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6460404|NCT01202773|7376940|FG001|STARTED|Overall Study||148
6460405|NCT01202773|7376941|FG002|STARTED|Overall Study||155
6460406|NCT01202773|7376939|FG000|Received at Least 1 Dose of Study Drug|Overall Study||153
6460407|NCT01202773|7376940|FG001|Received at Least 1 Dose of Study Drug|Overall Study||147
6460408|NCT01202773|7376941|FG002|Received at Least 1 Dose of Study Drug|Overall Study||154
6460409|NCT01202773|7376939|FG000|Week 16 NR|Overall Study||23
6460410|NCT01202773|7376940|FG001|Week 16 NR|Overall Study||33
6460411|NCT01202773|7376941|FG002|Week 16 NR|Overall Study||37
6460412|NCT01202773|7376939|FG000|Post-Treatment Follow-Up Population|Overall Study||46
6460413|NCT01202773|7376940|FG001|Post-Treatment Follow-Up Population|Overall Study||36
6460414|NCT01202773|7376941|FG002|Post-Treatment Follow-Up Population|Overall Study||51
6460415|NCT01202773|7376939|FG000|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|96
6460416|NCT01202773|7376940|FG001|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|105
6460417|NCT01202773|7376941|FG002|COMPLETED|Overall Study|Those who completed 24-week treatment period including both Week 16 responders and NR.|100
6460418|NCT01202773|7376939|FG000|NOT COMPLETED|Overall Study||57
6460419|NCT01202773|7376940|FG001|NOT COMPLETED|Overall Study||43
6460420|NCT01202773|7376941|FG002|NOT COMPLETED|Overall Study||55
6460421|NCT01202877|7376962|FG000|STARTED|Overall Study||6
6745378|NCT03358407|7673381|FG009|STARTED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745379|NCT03358407|7673372|FG000|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6745380|NCT03358407|7673373|FG001|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6745381|NCT03358407|7673374|FG002|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6745382|NCT03358407|7673375|FG003|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6460422|NCT01202877|7376963|FG001|STARTED|Overall Study||8
6460423|NCT01202877|7376964|FG002|STARTED|Overall Study||40
6460424|NCT01202877|7376962|FG000|COMPLETED|Overall Study||6
6460425|NCT01202877|7376963|FG001|COMPLETED|Overall Study||7
6460426|NCT01202877|7376964|FG002|COMPLETED|Overall Study||34
6460427|NCT01202877|7376962|FG000|NOT COMPLETED|Overall Study||0
6460428|NCT01202877|7376963|FG001|NOT COMPLETED|Overall Study||1
6460429|NCT01202877|7376964|FG002|NOT COMPLETED|Overall Study||6
6460430|NCT01202903|7376974|FG000|STARTED|Overall Study||308
6460431|NCT01202903|7376975|FG001|STARTED|Overall Study||308
6460432|NCT01202903|7376974|FG000|Full Analysis Set|Overall Study||306
6460433|NCT01202903|7376975|FG001|Full Analysis Set|Overall Study||302
6460434|NCT01202903|7376974|FG000|Safety Set*|Overall Study||310
6460435|NCT01202903|7376975|FG001|Safety Set*|Overall Study||299
6460436|NCT01202903|7376974|FG000|COMPLETED|Overall Study||297
6460437|NCT01202903|7376975|FG001|COMPLETED|Overall Study||292
6460438|NCT01202903|7376974|FG000|NOT COMPLETED|Overall Study||11
6460439|NCT01202903|7376975|FG001|NOT COMPLETED|Overall Study||16
6460440|NCT01202955|7376983|FG000|STARTED|Period 1: 10 Days||9
6460441|NCT01202955|7376984|FG001|STARTED|Period 1: 10 Days||10
6745383|NCT03358407|7673376|FG004|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||2
6745384|NCT03358407|7673377|FG005|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6460442|NCT01202955|7376983|FG000|COMPLETED|Period 1: 10 Days||9
6460443|NCT01202955|7376984|FG001|COMPLETED|Period 1: 10 Days||8
6460444|NCT01202955|7376983|FG000|NOT COMPLETED|Period 1: 10 Days||0
6460445|NCT01202955|7376984|FG001|NOT COMPLETED|Period 1: 10 Days||2
6553925|NCT01746017|7476334|FG008|NOT COMPLETED|Period 4||0
6460446|NCT01202955|7376983|FG000|STARTED|Period 2: 7 Days (Wash-Out)||9
6460447|NCT01202955|7376984|FG001|STARTED|Period 2: 7 Days (Wash-Out)||8
6460448|NCT01202955|7376983|FG000|COMPLETED|Period 2: 7 Days (Wash-Out)||9
6460449|NCT01202955|7376984|FG001|COMPLETED|Period 2: 7 Days (Wash-Out)||8
6460450|NCT01202955|7376983|FG000|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
6460451|NCT01202955|7376984|FG001|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
6460452|NCT01202955|7376983|FG000|STARTED|Period 3: 10 Days||9
6460453|NCT01202955|7376984|FG001|STARTED|Period 3: 10 Days||8
6460454|NCT01202955|7376983|FG000|COMPLETED|Period 3: 10 Days||9
6460455|NCT01202955|7376984|FG001|COMPLETED|Period 3: 10 Days||8
6460456|NCT01202955|7376983|FG000|NOT COMPLETED|Period 3: 10 Days||0
6460457|NCT01202955|7376984|FG001|NOT COMPLETED|Period 3: 10 Days||0
6460458|NCT01202994|7376990|FG000|STARTED|Overall Study||27
6460459|NCT01202994|7376990|FG000|COMPLETED|Overall Study||27
6460460|NCT01202994|7376990|FG000|NOT COMPLETED|Overall Study||0
6460461|NCT01203046|7376997|FG000|STARTED|Overall Study||28
6460462|NCT01203046|7376998|FG001|STARTED|Overall Study||28
6460463|NCT01203046|7376997|FG000|COMPLETED|Overall Study||28
6460464|NCT01203046|7376998|FG001|COMPLETED|Overall Study||28
6460465|NCT01203046|7376997|FG000|NOT COMPLETED|Overall Study||0
6460466|NCT01203046|7376998|FG001|NOT COMPLETED|Overall Study||0
6460467|NCT01203072|7377011|FG000|STARTED|Overall Study||105
6460468|NCT01203072|7377012|FG001|STARTED|Overall Study||106
6460469|NCT01203072|7377013|FG002|STARTED|Overall Study||104
6460470|NCT01203072|7377014|FG003|STARTED|Overall Study||106
6460471|NCT01203072|7377015|FG004|STARTED|Overall Study||102
6460472|NCT01203072|7377011|FG000|COMPLETED|Overall Study||95
6460473|NCT01203072|7377012|FG001|COMPLETED|Overall Study||100
6460474|NCT01203072|7377013|FG002|COMPLETED|Overall Study||101
6460475|NCT01203072|7377014|FG003|COMPLETED|Overall Study||100
6460476|NCT01203072|7377015|FG004|COMPLETED|Overall Study||96
6460477|NCT01203072|7377011|FG000|NOT COMPLETED|Overall Study||10
6460478|NCT01203072|7377012|FG001|NOT COMPLETED|Overall Study||6
6460479|NCT01203072|7377013|FG002|NOT COMPLETED|Overall Study||3
6460480|NCT01203072|7377014|FG003|NOT COMPLETED|Overall Study||6
6460481|NCT01203072|7377015|FG004|NOT COMPLETED|Overall Study||6
6460482|NCT01203098|7377030|FG000|STARTED|Overall Study||89
6460483|NCT01203098|7377031|FG001|STARTED|Overall Study||86
6460484|NCT01203098|7377032|FG002|STARTED|Overall Study||89
6460485|NCT01203098|7377030|FG000|Safety Analysis Dataset|Overall Study||89
6460486|NCT01203098|7377031|FG001|Safety Analysis Dataset|Overall Study||85
6460487|NCT01203098|7377032|FG002|Safety Analysis Dataset|Overall Study||87
6460488|NCT01203098|7377030|FG000|COMPLETED|Overall Study||83
6460489|NCT01203098|7377031|FG001|COMPLETED|Overall Study||82
6460490|NCT01203098|7377032|FG002|COMPLETED|Overall Study||78
6460491|NCT01203098|7377030|FG000|NOT COMPLETED|Overall Study||6
6460492|NCT01203098|7377031|FG001|NOT COMPLETED|Overall Study||4
6460493|NCT01203098|7377032|FG002|NOT COMPLETED|Overall Study||11
6460494|NCT01203189|7377043|FG000|STARTED|First 4 Weeks Treatment||10
6460495|NCT01203189|7377044|FG001|STARTED|First 4 Weeks Treatment||10
6460496|NCT01203189|7377045|FG002|STARTED|First 4 Weeks Treatment||3
6460497|NCT01203189|7377043|FG000|COMPLETED|First 4 Weeks Treatment||8
6460498|NCT01203189|7377044|FG001|COMPLETED|First 4 Weeks Treatment||8
6460499|NCT01203189|7377045|FG002|COMPLETED|First 4 Weeks Treatment||3
6460500|NCT01203189|7377043|FG000|NOT COMPLETED|First 4 Weeks Treatment||2
6460501|NCT01203189|7377044|FG001|NOT COMPLETED|First 4 Weeks Treatment||2
6460502|NCT01203189|7377045|FG002|NOT COMPLETED|First 4 Weeks Treatment||0
6460503|NCT01203189|7377043|FG000|STARTED|Cross Over Period 4 Weeks Treatment||0
6460504|NCT01203189|7377044|FG001|STARTED|Cross Over Period 4 Weeks Treatment||0
6460505|NCT01203189|7377045|FG002|STARTED|Cross Over Period 4 Weeks Treatment||3
6460506|NCT01203189|7377043|FG000|COMPLETED|Cross Over Period 4 Weeks Treatment||0
6460507|NCT01203189|7377044|FG001|COMPLETED|Cross Over Period 4 Weeks Treatment||0
6460508|NCT01203189|7377045|FG002|COMPLETED|Cross Over Period 4 Weeks Treatment||3
6460509|NCT01203189|7377043|FG000|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
6460510|NCT01203189|7377044|FG001|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
6460511|NCT01203189|7377045|FG002|NOT COMPLETED|Cross Over Period 4 Weeks Treatment||0
6460512|NCT01203319|7377056|FG000|STARTED|Overall Study||434
6460513|NCT01203319|7377057|FG001|STARTED|Overall Study||435
6460514|NCT01203319|7377058|FG002|STARTED|Overall Study||222
6460515|NCT01203319|7377056|FG000|COMPLETED|Overall Study||428
6460516|NCT01203319|7377057|FG001|COMPLETED|Overall Study||426
6460517|NCT01203319|7377058|FG002|COMPLETED|Overall Study||217
6460518|NCT01203319|7377056|FG000|NOT COMPLETED|Overall Study||6
6460519|NCT01203319|7377057|FG001|NOT COMPLETED|Overall Study||9
6460520|NCT01203319|7377058|FG002|NOT COMPLETED|Overall Study||5
6745385|NCT03358407|7673378|FG006|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745386|NCT03358407|7673379|FG007|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6460521|NCT01203644|7377068|FG000|STARTED|Overall Study||26
6460522|NCT01203644|7377069|FG001|STARTED|Overall Study||50
6460523|NCT01203644|7377068|FG000|COMPLETED|Overall Study||26
6460524|NCT01203644|7377069|FG001|COMPLETED|Overall Study||50
6460525|NCT01203644|7377068|FG000|NOT COMPLETED|Overall Study||0
6460526|NCT01203644|7377069|FG001|NOT COMPLETED|Overall Study||0
6460527|NCT01203774|7377078|FG000|STARTED|Overall Study||21
6745387|NCT03358407|7673380|FG008|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6460528|NCT01203774|7377079|FG001|STARTED|Overall Study||10
6460529|NCT01203774|7377078|FG000|COMPLETED|Overall Study||21
6460530|NCT01203774|7377079|FG001|COMPLETED|Overall Study||10
6460531|NCT01203774|7377078|FG000|NOT COMPLETED|Overall Study||0
6460532|NCT01203774|7377079|FG001|NOT COMPLETED|Overall Study||0
6460533|NCT01203787|7377087|FG000|STARTED|Overall Study||63
6460534|NCT01203787|7377088|FG001|STARTED|Overall Study||57
6460535|NCT01203787|7377087|FG000|COMPLETED|Overall Study||32
6460536|NCT01203787|7377088|FG001|COMPLETED|Overall Study||30
6460537|NCT01203787|7377087|FG000|NOT COMPLETED|Overall Study||31
6460538|NCT01203787|7377088|FG001|NOT COMPLETED|Overall Study||27
6460539|NCT01203826|7377098|FG000|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
6460540|NCT01203826|7377099|FG001|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
6460541|NCT01203826|7377098|FG000|COMPLETED|Overall Study||6
6460542|NCT01203826|7377099|FG001|COMPLETED|Overall Study||6
6460543|NCT01203826|7377098|FG000|NOT COMPLETED|Overall Study||0
6460544|NCT01203826|7377099|FG001|NOT COMPLETED|Overall Study||0
6460545|NCT01203852|7377105|FG000|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
6460546|NCT01203852|7377105|FG000|COMPLETED|Metoprolol 8 Weeks||369
6460547|NCT01203852|7377105|FG000|NOT COMPLETED|Metoprolol 8 Weeks||470
6460548|NCT01203852|7377105|FG000|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
6460549|NCT01203852|7377105|FG000|COMPLETED|Washout 2 Weeks||282
6460550|NCT01203852|7377105|FG000|NOT COMPLETED|Washout 2 Weeks||46
6460551|NCT01203852|7377105|FG000|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
6460552|NCT01203852|7377105|FG000|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
6460553|NCT01203852|7377105|FG000|COMPLETED|Chlorthalidone 8 Weeks||328
6460554|NCT01203852|7377105|FG000|NOT COMPLETED|Chlorthalidone 8 Weeks||0
6460555|NCT01203878|7377115|FG000|STARTED|Overall Study||9
6460556|NCT01203878|7377116|FG001|STARTED|Overall Study||9
6460557|NCT01203878|7377117|FG002|STARTED|Overall Study||3
6460558|NCT01203878|7377115|FG000|COMPLETED|Overall Study||9
6460559|NCT01203878|7377116|FG001|COMPLETED|Overall Study||9
6460560|NCT01203878|7377117|FG002|COMPLETED|Overall Study||0
6460561|NCT01203878|7377115|FG000|NOT COMPLETED|Overall Study||0
6460562|NCT01203878|7377116|FG001|NOT COMPLETED|Overall Study||0
6460563|NCT01203878|7377117|FG002|NOT COMPLETED|Overall Study||3
6460564|NCT01203917|7377124|FG000|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
6460565|NCT01203917|7377124|FG000|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
6460566|NCT01203917|7377124|FG000|NOT COMPLETED|Overall Study||36
6460567|NCT01203930|7377130|FG000|STARTED|Overall Study||64
6460568|NCT01203930|7377131|FG001|STARTED|Overall Study||41
6460569|NCT01203930|7377130|FG000|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
6460570|NCT01203930|7377131|FG001|COMPLETED|Overall Study||0
6460571|NCT01203930|7377130|FG000|NOT COMPLETED|Overall Study||21
6460572|NCT01203930|7377131|FG001|NOT COMPLETED|Overall Study||41
6460573|NCT01203956|7377139|FG000|STARTED|First Two-week Period||15
6460574|NCT01203956|7377140|FG001|STARTED|First Two-week Period||13
6460575|NCT01203956|7377139|FG000|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
6460576|NCT01203956|7377140|FG001|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
6460577|NCT01203956|7377139|FG000|NOT COMPLETED|First Two-week Period||0
6460578|NCT01203956|7377140|FG001|NOT COMPLETED|First Two-week Period||0
6460579|NCT01203956|7377139|FG000|STARTED|Second Two-week Period||15
6460580|NCT01203956|7377140|FG001|STARTED|Second Two-week Period||13
6460581|NCT01203956|7377139|FG000|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
6460582|NCT01203956|7377140|FG001|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
6460583|NCT01203956|7377139|FG000|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
6460584|NCT01203956|7377140|FG001|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
6460585|NCT01203956|7377139|FG000|NOT COMPLETED|Second Two-week Period||5
6460586|NCT01203956|7377140|FG001|NOT COMPLETED|Second Two-week Period||6
6460587|NCT01204203|7377147|FG000|STARTED|Overall Study||8
6460588|NCT01204203|7377147|FG000|COMPLETED|Overall Study||8
6460589|NCT01204203|7377147|FG000|NOT COMPLETED|Overall Study||0
6460590|NCT01204255|7377151|FG000|STARTED|Overall Study||11
6460591|NCT01204255|7377151|FG000|COMPLETED|Overall Study||10
6460592|NCT01204255|7377151|FG000|NOT COMPLETED|Overall Study||1
6460593|NCT01204294|7377162|FG000|STARTED|Overall Study||82
6460594|NCT01204294|7377163|FG001|STARTED|Overall Study||66
6460595|NCT01204294|7377164|FG002|STARTED|Overall Study||74
6460596|NCT01204294|7377165|FG003|STARTED|Overall Study||143
6460597|NCT01204294|7377166|FG004|STARTED|Overall Study||85
6460598|NCT01204294|7377167|FG005|STARTED|Overall Study||63
6460599|NCT01204294|7377168|FG006|STARTED|Overall Study||61
6460600|NCT01204294|7377162|FG000|COMPLETED|Overall Study||79
6460601|NCT01204294|7377163|FG001|COMPLETED|Overall Study||58
6553926|NCT01746017|7476335|FG009|NOT COMPLETED|Period 4||0
6553927|NCT01746017|7476336|FG010|NOT COMPLETED|Period 4||0
6553928|NCT01746043|7476379|FG000|STARTED|Overall Study||5
6553929|NCT01746043|7476380|FG001|STARTED|Overall Study||4
6460602|NCT01204294|7377164|FG002|COMPLETED|Overall Study||69
6305714|NCT01924533|7209062|FG000|STARTED|Overall Study||263
6305715|NCT01924533|7209063|FG001|STARTED|Overall Study||262
6305716|NCT01924533|7209062|FG000|COMPLETED|Overall Study||74
6460603|NCT01204294|7377165|FG003|COMPLETED|Overall Study||132
6460604|NCT01204294|7377166|FG004|COMPLETED|Overall Study||83
6460605|NCT01204294|7377167|FG005|COMPLETED|Overall Study||58
6460606|NCT01204294|7377168|FG006|COMPLETED|Overall Study||59
6460607|NCT01204294|7377162|FG000|NOT COMPLETED|Overall Study||3
6460608|NCT01204294|7377163|FG001|NOT COMPLETED|Overall Study||8
6460609|NCT01204294|7377164|FG002|NOT COMPLETED|Overall Study||5
6460610|NCT01204294|7377165|FG003|NOT COMPLETED|Overall Study||11
6460611|NCT01204294|7377166|FG004|NOT COMPLETED|Overall Study||2
6460612|NCT01204294|7377167|FG005|NOT COMPLETED|Overall Study||5
6460613|NCT01204294|7377168|FG006|NOT COMPLETED|Overall Study||2
6460614|NCT01204398|7377184|FG000|STARTED|Overall Study|Entered and treated.|27
6460615|NCT01204398|7377184|FG000|COMPLETED|Overall Study|Completed trial medication.|26
6460616|NCT01204398|7377184|FG000|NOT COMPLETED|Overall Study||1
6460617|NCT01204658|7377192|FG000|STARTED|Primary Phase||146
6460618|NCT01204658|7377193|FG001|STARTED|Primary Phase||142
6460619|NCT01204658|7377194|FG002|STARTED|Primary Phase||145
6460620|NCT01204658|7377195|FG003|STARTED|Primary Phase||142
6460621|NCT01204658|7377192|FG000|COMPLETED|Primary Phase||146
6460622|NCT01204658|7377193|FG001|COMPLETED|Primary Phase||142
6460623|NCT01204658|7377194|FG002|COMPLETED|Primary Phase||144
6460624|NCT01204658|7377195|FG003|COMPLETED|Primary Phase||142
6460625|NCT01204658|7377192|FG000|NOT COMPLETED|Primary Phase||0
6460626|NCT01204658|7377193|FG001|NOT COMPLETED|Primary Phase||0
6460627|NCT01204658|7377194|FG002|NOT COMPLETED|Primary Phase||1
6460628|NCT01204658|7377195|FG003|NOT COMPLETED|Primary Phase||0
6460629|NCT01204658|7377192|FG000|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
6460630|NCT01204658|7377193|FG001|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
6460631|NCT01204658|7377194|FG002|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
6460632|NCT01204658|7377195|FG003|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
6460633|NCT01204658|7377192|FG000|COMPLETED|Booster Phase||144
6460634|NCT01204658|7377193|FG001|COMPLETED|Booster Phase||140
6460635|NCT01204658|7377194|FG002|COMPLETED|Booster Phase||140
6460636|NCT01204658|7377195|FG003|COMPLETED|Booster Phase||140
6460637|NCT01204658|7377192|FG000|NOT COMPLETED|Booster Phase||0
6460638|NCT01204658|7377193|FG001|NOT COMPLETED|Booster Phase||0
6460639|NCT01204658|7377194|FG002|NOT COMPLETED|Booster Phase||0
6460640|NCT01204658|7377195|FG003|NOT COMPLETED|Booster Phase||0
6460641|NCT01204671|7377213|FG000|STARTED|Overall Study||1012
6460642|NCT01204671|7377214|FG001|STARTED|Overall Study||1013
6460643|NCT01204671|7377215|FG002|STARTED|Overall Study||1011
6460644|NCT01204671|7377216|FG003|STARTED|Overall Study||1010
6460645|NCT01204671|7377217|FG004|STARTED|Overall Study||610
6460646|NCT01204671|7377213|FG000|COMPLETED|Overall Study||998
6460647|NCT01204671|7377214|FG001|COMPLETED|Overall Study||998
6460648|NCT01204671|7377215|FG002|COMPLETED|Overall Study||998
6460649|NCT01204671|7377216|FG003|COMPLETED|Overall Study||997
6460650|NCT01204671|7377217|FG004|COMPLETED|Overall Study||606
6460651|NCT01204671|7377213|FG000|NOT COMPLETED|Overall Study||14
6460652|NCT01204671|7377214|FG001|NOT COMPLETED|Overall Study||15
6460653|NCT01204671|7377215|FG002|NOT COMPLETED|Overall Study||13
6460654|NCT01204671|7377216|FG003|NOT COMPLETED|Overall Study||13
6460655|NCT01204671|7377217|FG004|NOT COMPLETED|Overall Study||4
6460656|NCT01204697|7377235|FG000|STARTED|Overall Study||36
6460657|NCT01204697|7377236|FG001|STARTED|Overall Study||38
6460658|NCT01204697|7377235|FG000|Treated|Overall Study||36
6460659|NCT01204697|7377236|FG001|Treated|Overall Study||37
6460660|NCT01204697|7377235|FG000|COMPLETED|Overall Study||5
6460661|NCT01204697|7377236|FG001|COMPLETED|Overall Study||2
6460662|NCT01204697|7377235|FG000|NOT COMPLETED|Overall Study||31
6460663|NCT01204697|7377236|FG001|NOT COMPLETED|Overall Study||36
6460664|NCT01204710|7377244|FG000|STARTED|Randomization Treatment||63
6460665|NCT01204710|7377245|FG001|STARTED|Randomization Treatment||60
6460666|NCT01204710|7377244|FG000|Received ≥1 Dose of Study Drug|Randomization Treatment||62
6745388|NCT03358407|7673381|FG009|COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745389|NCT03358407|7673372|FG000|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745390|NCT03358407|7673373|FG001|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745391|NCT03358407|7673374|FG002|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745392|NCT03358407|7673375|FG003|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745393|NCT03358407|7673376|FG004|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745394|NCT03358407|7673377|FG005|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745395|NCT03358407|7673378|FG006|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6460667|NCT01204710|7377245|FG001|Received ≥1 Dose of Study Drug|Randomization Treatment||59
6460668|NCT01204710|7377244|FG000|COMPLETED|Randomization Treatment||49
6460669|NCT01204710|7377245|FG001|COMPLETED|Randomization Treatment||47
6460670|NCT01204710|7377244|FG000|NOT COMPLETED|Randomization Treatment||14
6460671|NCT01204710|7377245|FG001|NOT COMPLETED|Randomization Treatment||13
6460672|NCT01204710|7377244|FG000|STARTED|Optional Olaratumab Monotherapy|Olaratumab follow-on treatment was optional for participants in mitoxantrone group only who had PD.|0
6460673|NCT01204710|7377245|FG001|STARTED|Optional Olaratumab Monotherapy|Among 43 participants who experienced PD, 19 received olaratumab monotherapy.|19
6460674|NCT01204710|7377244|FG000|COMPLETED|Optional Olaratumab Monotherapy||0
6460675|NCT01204710|7377245|FG001|COMPLETED|Optional Olaratumab Monotherapy||16
6460676|NCT01204710|7377244|FG000|NOT COMPLETED|Optional Olaratumab Monotherapy||0
6460677|NCT01204710|7377245|FG001|NOT COMPLETED|Optional Olaratumab Monotherapy||3
6460678|NCT01204736|7377262|FG000|STARTED|Overall Study||4
6460679|NCT01204736|7377263|FG001|STARTED|Overall Study||5
6460680|NCT01204736|7377264|FG002|STARTED|Overall Study||3
6460681|NCT01204736|7377265|FG003|STARTED|Overall Study||2
6460682|NCT01204736|7377262|FG000|COMPLETED|Overall Study||4
6460683|NCT01204736|7377263|FG001|COMPLETED|Overall Study||5
6460684|NCT01204736|7377264|FG002|COMPLETED|Overall Study||3
6460685|NCT01204736|7377265|FG003|COMPLETED|Overall Study||2
6460686|NCT01204736|7377262|FG000|NOT COMPLETED|Overall Study||0
6460687|NCT01204736|7377263|FG001|NOT COMPLETED|Overall Study||0
6460688|NCT01204736|7377264|FG002|NOT COMPLETED|Overall Study||0
6460689|NCT01204736|7377265|FG003|NOT COMPLETED|Overall Study||0
6460690|NCT01204775|7377277|FG000|STARTED|Overall Study||4
6460691|NCT01204775|7377278|FG001|STARTED|Overall Study||4
6460692|NCT01204775|7377277|FG000|Double-blind Treatment Period|Overall Study||4
6460693|NCT01204775|7377278|FG001|Double-blind Treatment Period|Overall Study||4
6460694|NCT01204775|7377277|FG000|COMPLETED|Overall Study||3
6460695|NCT01204775|7377278|FG001|COMPLETED|Overall Study||3
6460696|NCT01204775|7377277|FG000|NOT COMPLETED|Overall Study||1
6460697|NCT01204775|7377278|FG001|NOT COMPLETED|Overall Study||1
6460698|NCT01204853|7377284|FG000|STARTED|Overall Study||2
6460699|NCT01204853|7377284|FG000|COMPLETED|Overall Study||2
6460700|NCT01204853|7377284|FG000|NOT COMPLETED|Overall Study||0
6460701|NCT01204905|7377288|FG000|STARTED|Overall Study||7
6460702|NCT01204905|7377288|FG000|COMPLETED|Overall Study||5
6460703|NCT01204905|7377288|FG000|NOT COMPLETED|Overall Study||2
6460704|NCT01204918|7377295|FG000|STARTED|Overall Study||25
6460705|NCT01204918|7377296|FG001|STARTED|Overall Study||39
6460706|NCT01204918|7377297|FG002|STARTED|Overall Study||40
6460707|NCT01204918|7377295|FG000|Stage 1 Begin|Overall Study||25
6460708|NCT01204918|7377296|FG001|Stage 1 Begin|Overall Study||39
6460709|NCT01204918|7377297|FG002|Stage 1 Begin|Overall Study||40
6460710|NCT01204918|7377295|FG000|Stage 1 End|Overall Study||22
6460711|NCT01204918|7377296|FG001|Stage 1 End|Overall Study||35
6460712|NCT01204918|7377297|FG002|Stage 1 End|Overall Study||36
6460713|NCT01204918|7377295|FG000|Stage 2 Begin|Overall Study||22
6460714|NCT01204918|7377296|FG001|Stage 2 Begin|Overall Study||35
6460715|NCT01204918|7377297|FG002|Stage 2 Begin|Overall Study||36
6460716|NCT01204918|7377295|FG000|Stage 2 End|Overall Study||21
6460717|NCT01204918|7377296|FG001|Stage 2 End|Overall Study||29
6460718|NCT01204918|7377297|FG002|Stage 2 End|Overall Study||35
6460719|NCT01204918|7377295|FG000|COMPLETED|Overall Study||21
6460720|NCT01204918|7377296|FG001|COMPLETED|Overall Study||29
6460721|NCT01204918|7377297|FG002|COMPLETED|Overall Study||35
6460722|NCT01204918|7377295|FG000|NOT COMPLETED|Overall Study||4
6460723|NCT01204918|7377296|FG001|NOT COMPLETED|Overall Study||10
6460724|NCT01204918|7377297|FG002|NOT COMPLETED|Overall Study||5
6460725|NCT01205035|7377307|FG000|STARTED|Overall Study||3
6460726|NCT01205035|7377308|FG001|STARTED|Overall Study||3
6460727|NCT01205035|7377307|FG000|COMPLETED|Overall Study||1
6460728|NCT01205035|7377308|FG001|COMPLETED|Overall Study||3
6460729|NCT01205035|7377307|FG000|NOT COMPLETED|Overall Study||2
6460730|NCT01205035|7377308|FG001|NOT COMPLETED|Overall Study||0
6460731|NCT01205126|7377316|FG000|STARTED|Titration Phase||130
6460732|NCT01205126|7377317|FG001|STARTED|Titration Phase||130
6460733|NCT01205126|7377316|FG000|COMPLETED|Titration Phase||107
6460734|NCT01205126|7377317|FG001|COMPLETED|Titration Phase||111
6460735|NCT01205126|7377316|FG000|NOT COMPLETED|Titration Phase||23
6460736|NCT01205126|7377317|FG001|NOT COMPLETED|Titration Phase||19
6460737|NCT01205126|7377316|FG000|STARTED|Between Titration & Maintenance Phase||107
6460738|NCT01205126|7377317|FG001|STARTED|Between Titration & Maintenance Phase||111
6460739|NCT01205126|7377316|FG000|COMPLETED|Between Titration & Maintenance Phase||107
6460740|NCT01205126|7377317|FG001|COMPLETED|Between Titration & Maintenance Phase||107
6460741|NCT01205126|7377316|FG000|NOT COMPLETED|Between Titration & Maintenance Phase||0
6460742|NCT01205126|7377317|FG001|NOT COMPLETED|Between Titration & Maintenance Phase||4
6460743|NCT01205126|7377316|FG000|STARTED|Maintenance Phase||107
6460744|NCT01205126|7377317|FG001|STARTED|Maintenance Phase||107
6460745|NCT01205126|7377316|FG000|COMPLETED|Maintenance Phase||70
6460746|NCT01205126|7377317|FG001|COMPLETED|Maintenance Phase||67
6460747|NCT01205126|7377316|FG000|NOT COMPLETED|Maintenance Phase||37
6460748|NCT01205126|7377317|FG001|NOT COMPLETED|Maintenance Phase||40
6460749|NCT01205152|7377323|FG000|STARTED|Overall Study||10
6460750|NCT01205152|7377323|FG000|COMPLETED|Overall Study||9
6460751|NCT01205152|7377323|FG000|NOT COMPLETED|Overall Study||1
6460752|NCT01205165|7377329|FG000|STARTED|Overall Study||104
6460753|NCT01205165|7377329|FG000|COMPLETED|Overall Study||102
6460754|NCT01205165|7377329|FG000|NOT COMPLETED|Overall Study||2
6460755|NCT01205230|7377336|FG000|STARTED|Overall Study||21
6460756|NCT01205230|7377337|FG001|STARTED|Overall Study||13
6460757|NCT01205230|7377336|FG000|Combination Therapy|Overall Study||21
6460758|NCT01205230|7377337|FG001|Combination Therapy|Overall Study||13
6460759|NCT01205230|7377336|FG000|COMPLETED|Overall Study||16
6460760|NCT01205230|7377337|FG001|COMPLETED|Overall Study||13
6460761|NCT01205230|7377336|FG000|NOT COMPLETED|Overall Study||5
6460762|NCT01205230|7377337|FG001|NOT COMPLETED|Overall Study||0
6460763|NCT01205269|7377348|FG000|STARTED|Period 1 - First Intervention||4
6460764|NCT01205269|7377349|FG001|STARTED|Period 1 - First Intervention||4
6460765|NCT01205269|7377350|FG002|STARTED|Period 1 - First Intervention||4
6460766|NCT01205269|7377351|FG003|STARTED|Period 1 - First Intervention||6
6460767|NCT01205269|7377352|FG004|STARTED|Period 1 - First Intervention||5
6460768|NCT01205269|7377353|FG005|STARTED|Period 1 - First Intervention||5
6460769|NCT01205269|7377348|FG000|COMPLETED|Period 1 - First Intervention||4
6460770|NCT01205269|7377349|FG001|COMPLETED|Period 1 - First Intervention||4
6460771|NCT01205269|7377350|FG002|COMPLETED|Period 1 - First Intervention||4
6460772|NCT01205269|7377351|FG003|COMPLETED|Period 1 - First Intervention||6
6460773|NCT01205269|7377352|FG004|COMPLETED|Period 1 - First Intervention||5
6460774|NCT01205269|7377353|FG005|COMPLETED|Period 1 - First Intervention||5
6460775|NCT01205269|7377348|FG000|NOT COMPLETED|Period 1 - First Intervention||0
6460776|NCT01205269|7377349|FG001|NOT COMPLETED|Period 1 - First Intervention||0
6460777|NCT01205269|7377350|FG002|NOT COMPLETED|Period 1 - First Intervention||0
6460778|NCT01205269|7377351|FG003|NOT COMPLETED|Period 1 - First Intervention||0
6460779|NCT01205269|7377352|FG004|NOT COMPLETED|Period 1 - First Intervention||0
6460780|NCT01205269|7377353|FG005|NOT COMPLETED|Period 1 - First Intervention||0
6460781|NCT01205269|7377348|FG000|STARTED|Period 2 - Washout||4
6460782|NCT01205269|7377349|FG001|STARTED|Period 2 - Washout||4
6460783|NCT01205269|7377350|FG002|STARTED|Period 2 - Washout||4
6460784|NCT01205269|7377351|FG003|STARTED|Period 2 - Washout||6
6460785|NCT01205269|7377352|FG004|STARTED|Period 2 - Washout||5
6460786|NCT01205269|7377353|FG005|STARTED|Period 2 - Washout||5
6460787|NCT01205269|7377348|FG000|COMPLETED|Period 2 - Washout||4
6460788|NCT01205269|7377349|FG001|COMPLETED|Period 2 - Washout||4
6460789|NCT01205269|7377350|FG002|COMPLETED|Period 2 - Washout||4
6460790|NCT01205269|7377351|FG003|COMPLETED|Period 2 - Washout||6
6460791|NCT01205269|7377352|FG004|COMPLETED|Period 2 - Washout||5
6460792|NCT01205269|7377353|FG005|COMPLETED|Period 2 - Washout||5
6460793|NCT01205269|7377348|FG000|NOT COMPLETED|Period 2 - Washout||0
6460794|NCT01205269|7377349|FG001|NOT COMPLETED|Period 2 - Washout||0
6460795|NCT01205269|7377350|FG002|NOT COMPLETED|Period 2 - Washout||0
6460796|NCT01205269|7377351|FG003|NOT COMPLETED|Period 2 - Washout||0
6460797|NCT01205269|7377352|FG004|NOT COMPLETED|Period 2 - Washout||0
6460798|NCT01205269|7377353|FG005|NOT COMPLETED|Period 2 - Washout||0
6460799|NCT01205269|7377348|FG000|STARTED|Period 3 - Second Intervention||4
6460800|NCT01205269|7377349|FG001|STARTED|Period 3 - Second Intervention||4
6460801|NCT01205269|7377350|FG002|STARTED|Period 3 - Second Intervention||4
6460802|NCT01205269|7377351|FG003|STARTED|Period 3 - Second Intervention||6
6460803|NCT01205269|7377352|FG004|STARTED|Period 3 - Second Intervention||5
6460804|NCT01205269|7377353|FG005|STARTED|Period 3 - Second Intervention||5
6460805|NCT01205269|7377348|FG000|COMPLETED|Period 3 - Second Intervention||4
6460806|NCT01205269|7377349|FG001|COMPLETED|Period 3 - Second Intervention||4
6460807|NCT01205269|7377350|FG002|COMPLETED|Period 3 - Second Intervention||4
6460808|NCT01205269|7377351|FG003|COMPLETED|Period 3 - Second Intervention||6
6460809|NCT01205269|7377352|FG004|COMPLETED|Period 3 - Second Intervention||5
6460810|NCT01205269|7377353|FG005|COMPLETED|Period 3 - Second Intervention||5
6553930|NCT01746043|7476381|FG002|STARTED|Overall Study||5
6553931|NCT01746043|7476382|FG003|STARTED|Overall Study||5
6553932|NCT01746043|7476379|FG000|COMPLETED|Overall Study||5
6745396|NCT03358407|7673379|FG007|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745397|NCT03358407|7673380|FG008|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745398|NCT03358407|7673381|FG009|NOT COMPLETED|P5:PartA-Cohort1(4days)+Followup(14days)||0
6745399|NCT03358407|7673372|FG000|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745400|NCT03358407|7673373|FG001|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745401|NCT03358407|7673374|FG002|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745402|NCT03358407|7673375|FG003|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745403|NCT03358407|7673376|FG004|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745404|NCT03358407|7673377|FG005|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6745405|NCT03358407|7673378|FG006|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6745406|NCT03358407|7673379|FG007|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||6
6745407|NCT03358407|7673380|FG008|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745408|NCT03358407|7673381|FG009|STARTED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745409|NCT03358407|7673372|FG000|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745410|NCT03358407|7673373|FG001|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745411|NCT03358407|7673374|FG002|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745412|NCT03358407|7673375|FG003|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745413|NCT03358407|7673376|FG004|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745414|NCT03358407|7673377|FG005|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745415|NCT03358407|7673378|FG006|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||2
6745416|NCT03358407|7673379|FG007|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6745417|NCT03358407|7673380|FG008|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745418|NCT03358407|7673381|FG009|COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745419|NCT03358407|7673372|FG000|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745420|NCT03358407|7673373|FG001|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745421|NCT03358407|7673374|FG002|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745422|NCT03358407|7673375|FG003|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745423|NCT03358407|7673376|FG004|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745424|NCT03358407|7673377|FG005|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6745425|NCT03358407|7673378|FG006|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||1
6500774|NCT01425801|7419348|FG004|COMPLETED|Period 6||11
6460811|NCT01205269|7377348|FG000|NOT COMPLETED|Period 3 - Second Intervention||0
6460812|NCT01205269|7377349|FG001|NOT COMPLETED|Period 3 - Second Intervention||0
6460813|NCT01205269|7377350|FG002|NOT COMPLETED|Period 3 - Second Intervention||0
6460814|NCT01205269|7377351|FG003|NOT COMPLETED|Period 3 - Second Intervention||0
6460815|NCT01205269|7377352|FG004|NOT COMPLETED|Period 3 - Second Intervention||0
6460816|NCT01205269|7377353|FG005|NOT COMPLETED|Period 3 - Second Intervention||0
6460817|NCT01205269|7377348|FG000|STARTED|Period 4 - Washout||4
6460818|NCT01205269|7377349|FG001|STARTED|Period 4 - Washout||4
6460819|NCT01205269|7377350|FG002|STARTED|Period 4 - Washout||4
6460820|NCT01205269|7377351|FG003|STARTED|Period 4 - Washout||6
6460821|NCT01205269|7377352|FG004|STARTED|Period 4 - Washout||5
6460822|NCT01205269|7377353|FG005|STARTED|Period 4 - Washout||5
6460823|NCT01205269|7377348|FG000|COMPLETED|Period 4 - Washout||4
6460824|NCT01205269|7377349|FG001|COMPLETED|Period 4 - Washout||4
6460825|NCT01205269|7377350|FG002|COMPLETED|Period 4 - Washout||4
6460826|NCT01205269|7377351|FG003|COMPLETED|Period 4 - Washout||5
6460827|NCT01205269|7377352|FG004|COMPLETED|Period 4 - Washout||5
6460828|NCT01205269|7377353|FG005|COMPLETED|Period 4 - Washout||5
6460829|NCT01205269|7377348|FG000|NOT COMPLETED|Period 4 - Washout||0
6460830|NCT01205269|7377349|FG001|NOT COMPLETED|Period 4 - Washout||0
6460831|NCT01205269|7377350|FG002|NOT COMPLETED|Period 4 - Washout||0
6460832|NCT01205269|7377351|FG003|NOT COMPLETED|Period 4 - Washout||1
6460833|NCT01205269|7377352|FG004|NOT COMPLETED|Period 4 - Washout||0
6460834|NCT01205269|7377353|FG005|NOT COMPLETED|Period 4 - Washout||0
6460835|NCT01205269|7377348|FG000|STARTED|Period 5 - Third Intervention||4
6460836|NCT01205269|7377349|FG001|STARTED|Period 5 - Third Intervention||4
6460837|NCT01205269|7377350|FG002|STARTED|Period 5 - Third Intervention||4
6460838|NCT01205269|7377351|FG003|STARTED|Period 5 - Third Intervention||5
6460839|NCT01205269|7377352|FG004|STARTED|Period 5 - Third Intervention||5
6460840|NCT01205269|7377353|FG005|STARTED|Period 5 - Third Intervention||5
6460841|NCT01205269|7377348|FG000|COMPLETED|Period 5 - Third Intervention||4
6460842|NCT01205269|7377349|FG001|COMPLETED|Period 5 - Third Intervention||4
6460843|NCT01205269|7377350|FG002|COMPLETED|Period 5 - Third Intervention||4
6460844|NCT01205269|7377351|FG003|COMPLETED|Period 5 - Third Intervention||5
6460845|NCT01205269|7377352|FG004|COMPLETED|Period 5 - Third Intervention||5
6460846|NCT01205269|7377353|FG005|COMPLETED|Period 5 - Third Intervention||5
6460847|NCT01205269|7377348|FG000|NOT COMPLETED|Period 5 - Third Intervention||0
6460848|NCT01205269|7377349|FG001|NOT COMPLETED|Period 5 - Third Intervention||0
6460849|NCT01205269|7377350|FG002|NOT COMPLETED|Period 5 - Third Intervention||0
6460850|NCT01205269|7377351|FG003|NOT COMPLETED|Period 5 - Third Intervention||0
6460851|NCT01205269|7377352|FG004|NOT COMPLETED|Period 5 - Third Intervention||0
6460852|NCT01205269|7377353|FG005|NOT COMPLETED|Period 5 - Third Intervention||0
6460853|NCT01205399|7377361|FG000|STARTED|Overall Study||78
6745426|NCT03358407|7673379|FG007|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||3
6745427|NCT03358407|7673380|FG008|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745428|NCT03358407|7673381|FG009|NOT COMPLETED|P1:PartA-Cohort2(4days)+Washout(48hours)||0
6745429|NCT03358407|7673372|FG000|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745430|NCT03358407|7673373|FG001|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745431|NCT03358407|7673374|FG002|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745432|NCT03358407|7673375|FG003|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745433|NCT03358407|7673376|FG004|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745434|NCT03358407|7673377|FG005|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: Placebo/GSK 400mg arm|3
6745435|NCT03358407|7673378|FG006|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|1 participant was added to Part A-Cohort 2: GSK 200mg/ Placebo arm|3
6745436|NCT03358407|7673379|FG007|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)|3 participants were added to Part A-Cohort 2: GSK 200mg/GSK 400mg arm|6
6745437|NCT03358407|7673380|FG008|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745438|NCT03358407|7673381|FG009|STARTED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745439|NCT03358407|7673372|FG000|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745440|NCT03358407|7673373|FG001|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745441|NCT03358407|7673374|FG002|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745442|NCT03358407|7673375|FG003|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745443|NCT03358407|7673376|FG004|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745444|NCT03358407|7673377|FG005|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745445|NCT03358407|7673378|FG006|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745446|NCT03358407|7673379|FG007|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745447|NCT03358407|7673380|FG008|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745448|NCT03358407|7673381|FG009|COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745449|NCT03358407|7673372|FG000|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745450|NCT03358407|7673373|FG001|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745451|NCT03358407|7673374|FG002|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745452|NCT03358407|7673375|FG003|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745453|NCT03358407|7673376|FG004|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745454|NCT03358407|7673377|FG005|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
6460854|NCT01205399|7377361|FG000|COMPLETED|Overall Study||78
6460855|NCT01205399|7377361|FG000|NOT COMPLETED|Overall Study||0
6460856|NCT01205438|7377368|FG000|STARTED|Overall Study||372
6460857|NCT01205438|7377369|FG001|STARTED|Overall Study||376
6460858|NCT01205438|7377370|FG002|STARTED|Overall Study||376
6460859|NCT01205438|7377368|FG000|Received At Least One Dose of Study Drug|Overall Study||371
6460860|NCT01205438|7377369|FG001|Received At Least One Dose of Study Drug|Overall Study||374
6460861|NCT01205438|7377370|FG002|Received At Least One Dose of Study Drug|Overall Study||376
6460862|NCT01205438|7377368|FG000|Participated in Follow Up|Overall Study||72
6460863|NCT01205438|7377369|FG001|Participated in Follow Up|Overall Study||78
6460864|NCT01205438|7377370|FG002|Participated in Follow Up|Overall Study||66
6460865|NCT01205438|7377368|FG000|COMPLETED|Overall Study||295
6460866|NCT01205438|7377369|FG001|COMPLETED|Overall Study||289
6460867|NCT01205438|7377370|FG002|COMPLETED|Overall Study||288
6460868|NCT01205438|7377368|FG000|NOT COMPLETED|Overall Study||77
6460869|NCT01205438|7377369|FG001|NOT COMPLETED|Overall Study||87
6460870|NCT01205438|7377370|FG002|NOT COMPLETED|Overall Study||88
6460871|NCT01205451|7377383|FG000|STARTED|Overall Study||53
6460872|NCT01205451|7377384|FG001|STARTED|Overall Study||56
6460873|NCT01205451|7377383|FG000|COMPLETED|Overall Study||47
6460874|NCT01205451|7377384|FG001|COMPLETED|Overall Study||46
6460875|NCT01205451|7377383|FG000|NOT COMPLETED|Overall Study||6
6460876|NCT01205451|7377384|FG001|NOT COMPLETED|Overall Study||10
6460877|NCT01205503|7377392|FG000|STARTED|First Intervention (1st Cycle)||16
6460878|NCT01205503|7377393|FG001|STARTED|First Intervention (1st Cycle)||16
6460879|NCT01205503|7377392|FG000|COMPLETED|First Intervention (1st Cycle)||16
6460880|NCT01205503|7377393|FG001|COMPLETED|First Intervention (1st Cycle)||16
6460881|NCT01205503|7377392|FG000|NOT COMPLETED|First Intervention (1st Cycle)||0
6460882|NCT01205503|7377393|FG001|NOT COMPLETED|First Intervention (1st Cycle)||0
6460883|NCT01205503|7377392|FG000|STARTED|Second Intervention (2nd Cycle)||16
6460884|NCT01205503|7377393|FG001|STARTED|Second Intervention (2nd Cycle)||16
6460885|NCT01205503|7377392|FG000|COMPLETED|Second Intervention (2nd Cycle)||16
6460886|NCT01205503|7377393|FG001|COMPLETED|Second Intervention (2nd Cycle)||16
6460887|NCT01205503|7377392|FG000|NOT COMPLETED|Second Intervention (2nd Cycle)||0
6460888|NCT01205503|7377393|FG001|NOT COMPLETED|Second Intervention (2nd Cycle)||0
6460889|NCT01205529|7377399|FG000|STARTED|Overall Study||161
6460890|NCT01205529|7377399|FG000|COMPLETED|Overall Study||106
6460891|NCT01205529|7377399|FG000|NOT COMPLETED|Overall Study||55
6460892|NCT01205568|7377403|FG000|STARTED|Overall Study|26 patients received only CB therapy, 39 patients received both CB and HPB therapy.|65
6460893|NCT01205568|7377404|FG001|STARTED|Overall Study|8 patients received only HPB therapy, 39 patients received both CB and HPB therapy.|47
6460894|NCT01205568|7377403|FG000|COMPLETED|Overall Study||65
6460895|NCT01205568|7377404|FG001|COMPLETED|Overall Study||47
6460896|NCT01205568|7377403|FG000|NOT COMPLETED|Overall Study||0
6460897|NCT01205568|7377404|FG001|NOT COMPLETED|Overall Study||0
6460898|NCT01205581|7377414|FG000|STARTED|Overall Study||14
6460899|NCT01205581|7377415|FG001|STARTED|Overall Study||13
6460900|NCT01205581|7377416|FG002|STARTED|Overall Study||8
6460901|NCT01205581|7377417|FG003|STARTED|Overall Study||9
6460902|NCT01205581|7377418|FG004|STARTED|Overall Study||20
6460903|NCT01205581|7377419|FG005|STARTED|Overall Study||20
6460904|NCT01205581|7377414|FG000|COMPLETED|Overall Study||13
6460905|NCT01205581|7377415|FG001|COMPLETED|Overall Study||13
6460906|NCT01205581|7377416|FG002|COMPLETED|Overall Study||8
6460907|NCT01205581|7377417|FG003|COMPLETED|Overall Study||9
6460908|NCT01205581|7377418|FG004|COMPLETED|Overall Study||20
6460909|NCT01205581|7377419|FG005|COMPLETED|Overall Study||20
6460910|NCT01205581|7377414|FG000|NOT COMPLETED|Overall Study||1
6460911|NCT01205581|7377415|FG001|NOT COMPLETED|Overall Study||0
6460912|NCT01205581|7377416|FG002|NOT COMPLETED|Overall Study||0
6460913|NCT01205581|7377417|FG003|NOT COMPLETED|Overall Study||0
6460914|NCT01205581|7377418|FG004|NOT COMPLETED|Overall Study||0
6460915|NCT01205581|7377419|FG005|NOT COMPLETED|Overall Study||0
6460916|NCT01205646|7377450|FG000|STARTED|Overall Study||11
6460917|NCT01205646|7377450|FG000|COMPLETED|Overall Study||11
6460918|NCT01205646|7377450|FG000|NOT COMPLETED|Overall Study||0
6460919|NCT01205685|7377454|FG000|STARTED|Overall Study||11
6460920|NCT01205685|7377454|FG000|COMPLETED|Overall Study||0
6460921|NCT01205685|7377454|FG000|NOT COMPLETED|Overall Study||11
6745455|NCT03358407|7673378|FG006|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||3
6745456|NCT03358407|7673379|FG007|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||6
6745457|NCT03358407|7673380|FG008|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745458|NCT03358407|7673381|FG009|NOT COMPLETED|P2:PartA-Cohort2(4days)+Followup(14days)||0
6745459|NCT03358407|7673372|FG000|STARTED|Part B: Overall Period (11 Weeks)||0
6745460|NCT03358407|7673373|FG001|STARTED|Part B: Overall Period (11 Weeks)||0
6745461|NCT03358407|7673374|FG002|STARTED|Part B: Overall Period (11 Weeks)||0
6745462|NCT03358407|7673375|FG003|STARTED|Part B: Overall Period (11 Weeks)||0
6745463|NCT03358407|7673376|FG004|STARTED|Part B: Overall Period (11 Weeks)||0
6745464|NCT03358407|7673377|FG005|STARTED|Part B: Overall Period (11 Weeks)||0
6745465|NCT03358407|7673378|FG006|STARTED|Part B: Overall Period (11 Weeks)||0
6745466|NCT03358407|7673379|FG007|STARTED|Part B: Overall Period (11 Weeks)||0
6745467|NCT03358407|7673380|FG008|STARTED|Part B: Overall Period (11 Weeks)||0
6745468|NCT03358407|7673381|FG009|STARTED|Part B: Overall Period (11 Weeks)||0
6745469|NCT03358407|7673372|FG000|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745470|NCT03358407|7673373|FG001|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745471|NCT03358407|7673374|FG002|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745472|NCT03358407|7673375|FG003|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745473|NCT03358407|7673376|FG004|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745474|NCT03358407|7673377|FG005|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745475|NCT03358407|7673378|FG006|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745476|NCT03358407|7673379|FG007|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745477|NCT03358407|7673380|FG008|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745478|NCT03358407|7673381|FG009|COMPLETED|Part B: Overall Period (11 Weeks)||0
6745479|NCT03358407|7673372|FG000|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745480|NCT03358407|7673373|FG001|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745481|NCT03358407|7673374|FG002|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745482|NCT03358407|7673375|FG003|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745483|NCT03358407|7673376|FG004|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745484|NCT03358407|7673377|FG005|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745485|NCT03358407|7673378|FG006|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745486|NCT03358407|7673379|FG007|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745487|NCT03358407|7673380|FG008|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745488|NCT03358407|7673381|FG009|NOT COMPLETED|Part B: Overall Period (11 Weeks)||0
6745489|NCT03358472|7673412|FG000|STARTED|Overall Study||35
6745490|NCT03358472|7673413|FG001|STARTED|Overall Study||19
6745491|NCT03358472|7673414|FG002|STARTED|Overall Study||35
6745492|NCT03358472|7673412|FG000|Intention-to-Treat (ITT)|Overall Study||35
6745493|NCT03358472|7673413|FG001|Intention-to-Treat (ITT)|Overall Study||19
6745494|NCT03358472|7673414|FG002|Intention-to-Treat (ITT)|Overall Study||35
6745495|NCT03358472|7673412|FG000|All Participants as Treated (APaT)|Overall Study||34
6745496|NCT03358472|7673413|FG001|All Participants as Treated (APaT)|Overall Study||19
6745497|NCT03358472|7673414|FG002|All Participants as Treated (APaT)|Overall Study||34
6745498|NCT03358472|7673412|FG000|COMPLETED|Overall Study||20
6745499|NCT03358472|7673413|FG001|COMPLETED|Overall Study||9
6745500|NCT03358472|7673414|FG002|COMPLETED|Overall Study||19
6745501|NCT03358472|7673412|FG000|NOT COMPLETED|Overall Study||15
6745502|NCT03358472|7673413|FG001|NOT COMPLETED|Overall Study||10
6745503|NCT03358472|7673414|FG002|NOT COMPLETED|Overall Study||16
6745504|NCT03358576|7673424|FG000|STARTED|Overall Study||338
6745505|NCT03358576|7673425|FG001|STARTED|Overall Study||336
6745506|NCT03358576|7673424|FG000|COMPLETED|Overall Study||312
6745507|NCT03358576|7673425|FG001|COMPLETED|Overall Study||311
6745508|NCT03358576|7673424|FG000|NOT COMPLETED|Overall Study||26
6745509|NCT03358576|7673425|FG001|NOT COMPLETED|Overall Study||25
6745510|NCT03359395|7673433|FG000|STARTED|First Intervention A / B||49
6745511|NCT03359395|7673434|FG001|STARTED|First Intervention A / B||50
6745512|NCT03359395|7673433|FG000|COMPLETED|First Intervention A / B||46
6745513|NCT03359395|7673434|FG001|COMPLETED|First Intervention A / B||47
6745514|NCT03359395|7673433|FG000|NOT COMPLETED|First Intervention A / B||3
6745515|NCT03359395|7673434|FG001|NOT COMPLETED|First Intervention A / B||3
6460922|NCT01205776|7377460|FG000|STARTED|Overall Study||948
6460923|NCT01205776|7377461|FG001|STARTED|Overall Study||957
6460924|NCT01205776|7377460|FG000|COMPLETED|Overall Study||884
6460925|NCT01205776|7377461|FG001|COMPLETED|Overall Study||862
6460926|NCT01205776|7377460|FG000|NOT COMPLETED|Overall Study||64
6460927|NCT01205776|7377461|FG001|NOT COMPLETED|Overall Study||95
6460928|NCT01205828|7377467|FG000|STARTED|Overall Study||16
6460929|NCT01205828|7377467|FG000|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
6460930|NCT01205828|7377467|FG000|NOT COMPLETED|Overall Study||0
6460931|NCT01206062|7377474|FG000|STARTED|Overall Study||4678
6460932|NCT01206062|7377475|FG001|STARTED|Overall Study||4683
6460933|NCT01206062|7377474|FG000|COMPLETED|Overall Study||4678
6460934|NCT01206062|7377475|FG001|COMPLETED|Overall Study||4683
6460935|NCT01206062|7377474|FG000|NOT COMPLETED|Overall Study||0
6460936|NCT01206062|7377475|FG001|NOT COMPLETED|Overall Study||0
6460937|NCT01206140|7377485|FG000|STARTED|Overall Study||35
6460938|NCT01206140|7377486|FG001|STARTED|Overall Study||35
6460939|NCT01206140|7377485|FG000|COMPLETED|Overall Study||34
6460940|NCT01206140|7377486|FG001|COMPLETED|Overall Study||35
6460941|NCT01206140|7377485|FG000|NOT COMPLETED|Overall Study||1
6460942|NCT01206140|7377486|FG001|NOT COMPLETED|Overall Study||0
6460943|NCT01206166|7377494|FG000|STARTED|Overall Study||73
6460944|NCT01206166|7377495|FG001|STARTED|Overall Study||52
6460945|NCT01206166|7377494|FG000|COMPLETED|Overall Study||71
6460946|NCT01206166|7377495|FG001|COMPLETED|Overall Study||49
6460947|NCT01206166|7377494|FG000|NOT COMPLETED|Overall Study||2
6460948|NCT01206166|7377495|FG001|NOT COMPLETED|Overall Study||3
6460949|NCT01206322|7377506|FG000|STARTED|Overall Study||4
6460950|NCT01206322|7377507|FG001|STARTED|Overall Study||11
6460951|NCT01206322|7377508|FG002|STARTED|Overall Study||9
6460952|NCT01206322|7377509|FG003|STARTED|Overall Study||6
6460953|NCT01206322|7377506|FG000|COMPLETED|Overall Study||4
6460954|NCT01206322|7377507|FG001|COMPLETED|Overall Study||11
6460955|NCT01206322|7377508|FG002|COMPLETED|Overall Study||9
6745516|NCT03359395|7673433|FG000|STARTED|Second Intervention B/A||46
6745517|NCT03359395|7673434|FG001|STARTED|Second Intervention B/A||47
6745518|NCT03359395|7673433|FG000|COMPLETED|Second Intervention B/A||43
6745519|NCT03359395|7673434|FG001|COMPLETED|Second Intervention B/A||44
6745520|NCT03359395|7673433|FG000|NOT COMPLETED|Second Intervention B/A||3
6745521|NCT03359395|7673434|FG001|NOT COMPLETED|Second Intervention B/A||3
6745522|NCT03359473|7673444|FG000|STARTED|Overall Study||23
6460956|NCT01206322|7377509|FG003|COMPLETED|Overall Study||5
6460957|NCT01206322|7377506|FG000|NOT COMPLETED|Overall Study||0
6460958|NCT01206322|7377507|FG001|NOT COMPLETED|Overall Study||0
6460959|NCT01206322|7377508|FG002|NOT COMPLETED|Overall Study||0
6460960|NCT01206322|7377509|FG003|NOT COMPLETED|Overall Study||1
6460961|NCT01206387|7377521|FG000|STARTED|Overall Study||60
6460962|NCT01206387|7377522|FG001|STARTED|Overall Study||60
6460963|NCT01206387|7377521|FG000|COMPLETED|Overall Study||59
6460964|NCT01206387|7377522|FG001|COMPLETED|Overall Study||60
6460965|NCT01206387|7377521|FG000|NOT COMPLETED|Overall Study||1
6460966|NCT01206387|7377522|FG001|NOT COMPLETED|Overall Study||0
6460967|NCT01206452|7377530|FG000|STARTED|Overall Study||30
6460968|NCT01206452|7377531|FG001|STARTED|Overall Study||30
6460969|NCT01206452|7377530|FG000|COMPLETED|Overall Study||30
6460970|NCT01206452|7377531|FG001|COMPLETED|Overall Study||30
6460971|NCT01206452|7377530|FG000|NOT COMPLETED|Overall Study||0
6460972|NCT01206452|7377531|FG001|NOT COMPLETED|Overall Study||0
6460973|NCT01206465|7377537|FG000|STARTED|Overall Study||3
6460974|NCT01206465|7377538|FG001|STARTED|Overall Study||6
6460975|NCT01206465|7377539|FG002|STARTED|Overall Study||6
6460976|NCT01206465|7377540|FG003|STARTED|Overall Study||6
6460977|NCT01206465|7377541|FG004|STARTED|Overall Study||6
6460978|NCT01206465|7377537|FG000|COMPLETED|Overall Study||3
6460979|NCT01206465|7377538|FG001|COMPLETED|Overall Study||6
6460980|NCT01206465|7377539|FG002|COMPLETED|Overall Study||6
6460981|NCT01206465|7377540|FG003|COMPLETED|Overall Study||6
6460982|NCT01206465|7377541|FG004|COMPLETED|Overall Study||6
6460983|NCT01206465|7377537|FG000|NOT COMPLETED|Overall Study||0
6460984|NCT01206465|7377538|FG001|NOT COMPLETED|Overall Study||0
6460985|NCT01206465|7377539|FG002|NOT COMPLETED|Overall Study||0
6460986|NCT01206465|7377540|FG003|NOT COMPLETED|Overall Study||0
6460987|NCT01206465|7377541|FG004|NOT COMPLETED|Overall Study||0
6460988|NCT01206478|7377559|FG000|STARTED|Overall Study||9
6460989|NCT01206478|7377560|FG001|STARTED|Overall Study||12
6460990|NCT01206478|7377559|FG000|COMPLETED|Overall Study||7
6460991|NCT01206478|7377560|FG001|COMPLETED|Overall Study||7
6460992|NCT01206478|7377559|FG000|NOT COMPLETED|Overall Study||2
6460993|NCT01206478|7377560|FG001|NOT COMPLETED|Overall Study||5
6460994|NCT01206582|7377568|FG000|STARTED|Overall Study||11
6460995|NCT01206582|7377569|FG001|STARTED|Overall Study||9
6460996|NCT01206582|7377568|FG000|COMPLETED|Overall Study||9
6460997|NCT01206582|7377569|FG001|COMPLETED|Overall Study||7
6460998|NCT01206582|7377568|FG000|NOT COMPLETED|Overall Study||2
6460999|NCT01206582|7377569|FG001|NOT COMPLETED|Overall Study||2
6461000|NCT01206595|7377577|FG000|STARTED|Overall Study||38
6461001|NCT01206595|7377578|FG001|STARTED|Overall Study||20
6461002|NCT01206595|7377577|FG000|COMPLETED|Overall Study||38
6461003|NCT01206595|7377578|FG001|COMPLETED|Overall Study||20
6461004|NCT01206595|7377577|FG000|NOT COMPLETED|Overall Study||0
6461005|NCT01206595|7377578|FG001|NOT COMPLETED|Overall Study||0
6461006|NCT01206608|7377588|FG000|STARTED|Overall Study||20
6745523|NCT03359473|7673445|FG001|STARTED|Overall Study||24
6745524|NCT03359473|7673446|FG002|STARTED|Overall Study||24
6745525|NCT03359473|7673447|FG003|STARTED|Overall Study||25
6745526|NCT03359473|7673444|FG000|COMPLETED|Overall Study||21
6745527|NCT03359473|7673445|FG001|COMPLETED|Overall Study||18
6745528|NCT03359473|7673446|FG002|COMPLETED|Overall Study||18
6745529|NCT03359473|7673447|FG003|COMPLETED|Overall Study||20
6745530|NCT03359473|7673444|FG000|NOT COMPLETED|Overall Study||2
6745531|NCT03359473|7673445|FG001|NOT COMPLETED|Overall Study||6
6745532|NCT03359473|7673446|FG002|NOT COMPLETED|Overall Study||6
6745533|NCT03359473|7673447|FG003|NOT COMPLETED|Overall Study||5
6745534|NCT03359590|7673460|FG000|STARTED|First Intervention||10
6745535|NCT03359590|7673461|FG001|STARTED|First Intervention||10
6745536|NCT03359590|7673460|FG000|Exposed|First Intervention||9
6745537|NCT03359590|7673461|FG001|Exposed|First Intervention||10
6745538|NCT03359590|7673460|FG000|Discontinued|First Intervention||1
6745539|NCT03359590|7673461|FG001|Discontinued|First Intervention||2
6745540|NCT03359590|7673460|FG000|COMPLETED|First Intervention||9
6745541|NCT03359590|7673461|FG001|COMPLETED|First Intervention||8
6745542|NCT03359590|7673460|FG000|NOT COMPLETED|First Intervention||1
6745543|NCT03359590|7673461|FG001|NOT COMPLETED|First Intervention||2
6745544|NCT03359590|7673460|FG000|STARTED|Second Intervention||9
6745545|NCT03359590|7673461|FG001|STARTED|Second Intervention||8
6745546|NCT03359590|7673460|FG000|Exposed|Second Intervention||9
6745547|NCT03359590|7673461|FG001|Exposed|Second Intervention||8
6745548|NCT03359590|7673460|FG000|Discontinued|Second Intervention||0
6745549|NCT03359590|7673461|FG001|Discontinued|Second Intervention||0
6745550|NCT03359590|7673460|FG000|COMPLETED|Second Intervention||9
6745551|NCT03359590|7673461|FG001|COMPLETED|Second Intervention||8
6745552|NCT03359590|7673460|FG000|NOT COMPLETED|Second Intervention||0
6745553|NCT03359590|7673461|FG001|NOT COMPLETED|Second Intervention||0
6745554|NCT03359629|7673469|FG000|STARTED|Overall Study||200
6745555|NCT03359629|7673470|FG001|STARTED|Overall Study||10
6461007|NCT01206608|7377589|FG001|STARTED|Overall Study||20
6461008|NCT01206608|7377588|FG000|COMPLETED|Overall Study||20
6461009|NCT01206608|7377589|FG001|COMPLETED|Overall Study||20
6461010|NCT01206608|7377588|FG000|NOT COMPLETED|Overall Study||0
6461011|NCT01206608|7377589|FG001|NOT COMPLETED|Overall Study||0
6461012|NCT01206660|7377597|FG000|STARTED|Overall Study||60
6461013|NCT01206660|7377598|FG001|STARTED|Overall Study||60
6461014|NCT01206660|7377597|FG000|COMPLETED|Overall Study||60
6461015|NCT01206660|7377598|FG001|COMPLETED|Overall Study||60
6461016|NCT01206660|7377597|FG000|NOT COMPLETED|Overall Study||0
6461017|NCT01206660|7377598|FG001|NOT COMPLETED|Overall Study||0
6461018|NCT01206738|7377607|FG000|STARTED|Overall Study||63
6461019|NCT01206738|7377608|FG001|STARTED|Overall Study||74
6461020|NCT01206738|7377609|FG002|STARTED|Overall Study||61
6461021|NCT01206738|7377607|FG000|COMPLETED|Overall Study||40
6461022|NCT01206738|7377608|FG001|COMPLETED|Overall Study||49
6461023|NCT01206738|7377609|FG002|COMPLETED|Overall Study||42
6461024|NCT01206738|7377607|FG000|NOT COMPLETED|Overall Study||23
6461025|NCT01206738|7377608|FG001|NOT COMPLETED|Overall Study||25
6461026|NCT01206738|7377609|FG002|NOT COMPLETED|Overall Study||19
6461027|NCT01206764|7377619|FG000|STARTED|Overall Study||142
6461028|NCT01206764|7377619|FG000|COMPLETED|Overall Study||4
6461029|NCT01206764|7377619|FG000|NOT COMPLETED|Overall Study||138
6461030|NCT01206777|7377623|FG000|STARTED|Overall Study||52
6553933|NCT01746043|7476380|FG001|COMPLETED|Overall Study||4
6553934|NCT01746043|7476381|FG002|COMPLETED|Overall Study||5
6745556|NCT03359629|7673469|FG000|COMPLETED|Overall Study||200
6461031|NCT01206777|7377623|FG000|Discontinued Trial and Deemed Ineligible|Overall Study||2
6461032|NCT01206777|7377623|FG000|COMPLETED|Overall Study||50
6461033|NCT01206777|7377623|FG000|NOT COMPLETED|Overall Study||2
6461034|NCT01206816|7377634|FG000|STARTED|Overall Study|Started=Treated|3
6461035|NCT01206816|7377635|FG001|STARTED|Overall Study|Started=Treated|3
6461036|NCT01206816|7377636|FG002|STARTED|Overall Study|Started=Treated|20
6461037|NCT01206816|7377637|FG003|STARTED|Overall Study|Started=Treated|3
6461038|NCT01206816|7377638|FG004|STARTED|Overall Study|Started=Treated|3
6461039|NCT01206816|7377639|FG005|STARTED|Overall Study|Started=Treated|19
6461040|NCT01206816|7377640|FG006|STARTED|Overall Study|Started=Treated|6
6461041|NCT01206816|7377634|FG000|COMPLETED|Overall Study||0
6461042|NCT01206816|7377635|FG001|COMPLETED|Overall Study||0
6461043|NCT01206816|7377636|FG002|COMPLETED|Overall Study|1pt dist.due to 'Other AE' for vol& since 'other' from aftb.1pt 'PD' for vol& since,'DLT' from aftb|0
6461044|NCT01206816|7377637|FG003|COMPLETED|Overall Study|1pt discontinue (dist.)due to 'PD' for vol.& since, 'Other AE' from aftb|0
6461045|NCT01206816|7377638|FG004|COMPLETED|Overall Study||0
6461046|NCT01206816|7377639|FG005|COMPLETED|Overall Study|1pt dist. due to 'PD' for vol & since, 'Other AE' from aftb|0
6461047|NCT01206816|7377640|FG006|COMPLETED|Overall Study|1pt dist. due to 'other AE' & 1pt 'other' for vol & since,'PD' from aftb.|0
6461048|NCT01206816|7377634|FG000|NOT COMPLETED|Overall Study||3
6461049|NCT01206816|7377635|FG001|NOT COMPLETED|Overall Study||3
6461050|NCT01206816|7377636|FG002|NOT COMPLETED|Overall Study||20
6461051|NCT01206816|7377637|FG003|NOT COMPLETED|Overall Study||3
6461052|NCT01206816|7377638|FG004|NOT COMPLETED|Overall Study||3
6461053|NCT01206816|7377639|FG005|NOT COMPLETED|Overall Study||19
6461054|NCT01206816|7377640|FG006|NOT COMPLETED|Overall Study||6
6461055|NCT01207219|7377663|FG000|STARTED|Overall Study||45
6461056|NCT01207219|7377664|FG001|STARTED|Overall Study||40
6461057|NCT01207219|7377665|FG002|STARTED|Overall Study||39
6461058|NCT01207219|7377663|FG000|Included in ITT Analysis|Overall Study||40
6461059|NCT01207219|7377664|FG001|Included in ITT Analysis|Overall Study||37
6461060|NCT01207219|7377665|FG002|Included in ITT Analysis|Overall Study||38
6461061|NCT01207219|7377663|FG000|COMPLETED|Overall Study||34
6461062|NCT01207219|7377664|FG001|COMPLETED|Overall Study||29
6461063|NCT01207219|7377665|FG002|COMPLETED|Overall Study||32
6461064|NCT01207219|7377663|FG000|NOT COMPLETED|Overall Study||11
6461065|NCT01207219|7377664|FG001|NOT COMPLETED|Overall Study||11
6461066|NCT01207219|7377665|FG002|NOT COMPLETED|Overall Study||7
6461067|NCT01207388|7377673|FG000|STARTED|Overall Study||116
6461068|NCT01207388|7377673|FG000|COMPLETED|Overall Study||48
6461069|NCT01207388|7377673|FG000|NOT COMPLETED|Overall Study||68
6461070|NCT01207401|7377687|FG000|STARTED|Overall Study||26
6461071|NCT01207401|7377688|FG001|STARTED|Overall Study||24
6461072|NCT01207401|7377687|FG000|COMPLETED|Overall Study||26
6461073|NCT01207401|7377688|FG001|COMPLETED|Overall Study||24
6461074|NCT01207401|7377687|FG000|NOT COMPLETED|Overall Study||0
6461075|NCT01207401|7377688|FG001|NOT COMPLETED|Overall Study||0
6461076|NCT01207414|7377696|FG000|STARTED|Overall Study|Includes 1 patient randomized in error.|241
6461077|NCT01207414|7377697|FG001|STARTED|Overall Study||260
6553935|NCT01746043|7476382|FG003|COMPLETED|Overall Study||5
6745557|NCT03359629|7673470|FG001|COMPLETED|Overall Study||10
6745558|NCT03359629|7673469|FG000|NOT COMPLETED|Overall Study||0
6745559|NCT03359629|7673470|FG001|NOT COMPLETED|Overall Study||0
6745560|NCT03359850|7673478|FG000|STARTED|PK Phase (Up to Day 8)||9
6745561|NCT03359850|7673479|FG001|STARTED|PK Phase (Up to Day 8)||8
6461078|NCT01207414|7377696|FG000|Safety Population: Received Study Drug|Overall Study||240
6461079|NCT01207414|7377697|FG001|Safety Population: Received Study Drug|Overall Study||260
6461080|NCT01207414|7377696|FG000|COMPLETED|Overall Study||168
6461081|NCT01207414|7377697|FG001|COMPLETED|Overall Study||178
6553936|NCT01746043|7476379|FG000|NOT COMPLETED|Overall Study||0
6745562|NCT03359850|7673478|FG000|COMPLETED|PK Phase (Up to Day 8)||8
6745563|NCT03359850|7673479|FG001|COMPLETED|PK Phase (Up to Day 8)||7
6745564|NCT03359850|7673478|FG000|NOT COMPLETED|PK Phase (Up to Day 8)||1
6745565|NCT03359850|7673479|FG001|NOT COMPLETED|PK Phase (Up to Day 8)||1
6745566|NCT03359850|7673478|FG000|STARTED|Extension Phase (Up to 28 Months)||8
6745567|NCT03359850|7673479|FG001|STARTED|Extension Phase (Up to 28 Months)||7
6745568|NCT03359850|7673478|FG000|COMPLETED|Extension Phase (Up to 28 Months)||0
6745569|NCT03359850|7673479|FG001|COMPLETED|Extension Phase (Up to 28 Months)||1
6745570|NCT03359850|7673478|FG000|NOT COMPLETED|Extension Phase (Up to 28 Months)||8
6745571|NCT03359850|7673479|FG001|NOT COMPLETED|Extension Phase (Up to 28 Months)||6
6745572|NCT03359889|7673487|FG000|STARTED|Overall Study||5
6745573|NCT03359889|7673487|FG000|COMPLETED|Overall Study||5
6745574|NCT03359889|7673487|FG000|NOT COMPLETED|Overall Study||0
6745575|NCT03360071|7673493|FG000|STARTED|Overall Study||17
6745576|NCT03360071|7673494|FG001|STARTED|Overall Study||14
6745577|NCT03360071|7673493|FG000|COMPLETED|Overall Study||16
6745578|NCT03360071|7673494|FG001|COMPLETED|Overall Study||14
6745579|NCT03360071|7673493|FG000|NOT COMPLETED|Overall Study||1
6745580|NCT03360071|7673494|FG001|NOT COMPLETED|Overall Study||0
6745581|NCT03360110|7673500|FG000|STARTED|First Intervention||27
6745582|NCT03360110|7673501|FG001|STARTED|First Intervention||26
6745583|NCT03360110|7673500|FG000|COMPLETED|First Intervention||27
6461082|NCT01207414|7377696|FG000|NOT COMPLETED|Overall Study||73
6461083|NCT01207414|7377697|FG001|NOT COMPLETED|Overall Study||82
6461084|NCT01207427|7377706|FG000|STARTED|Run-in Placebo Period||43
6461085|NCT01207427|7377707|FG001|STARTED|Run-in Placebo Period||45
6461086|NCT01207427|7377708|FG002|STARTED|Run-in Placebo Period||43
6461087|NCT01207427|7377706|FG000|COMPLETED|Run-in Placebo Period||43
6553937|NCT01746043|7476380|FG001|NOT COMPLETED|Overall Study||0
6553938|NCT01746043|7476381|FG002|NOT COMPLETED|Overall Study||0
6553939|NCT01746043|7476382|FG003|NOT COMPLETED|Overall Study||0
6553940|NCT01746095|7476396|FG000|STARTED|Overall Study||20
6553941|NCT01746095|7476397|FG001|STARTED|Overall Study||20
6745584|NCT03360110|7673501|FG001|COMPLETED|First Intervention||26
6461088|NCT01207427|7377707|FG001|COMPLETED|Run-in Placebo Period||45
6461089|NCT01207427|7377708|FG002|COMPLETED|Run-in Placebo Period||43
6461090|NCT01207427|7377706|FG000|NOT COMPLETED|Run-in Placebo Period||0
6461091|NCT01207427|7377707|FG001|NOT COMPLETED|Run-in Placebo Period||0
6461092|NCT01207427|7377708|FG002|NOT COMPLETED|Run-in Placebo Period||0
6461093|NCT01207427|7377706|FG000|STARTED|Double-blind Treatment Period||43
6461094|NCT01207427|7377707|FG001|STARTED|Double-blind Treatment Period||45
6461095|NCT01207427|7377708|FG002|STARTED|Double-blind Treatment Period||43
6461096|NCT01207427|7377706|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
6461097|NCT01207427|7377707|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
6461098|NCT01207427|7377708|FG002|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
6461099|NCT01207427|7377706|FG000|COMPLETED|Double-blind Treatment Period||40
6461100|NCT01207427|7377707|FG001|COMPLETED|Double-blind Treatment Period||43
6461101|NCT01207427|7377708|FG002|COMPLETED|Double-blind Treatment Period||41
6461102|NCT01207427|7377706|FG000|NOT COMPLETED|Double-blind Treatment Period||3
6461103|NCT01207427|7377707|FG001|NOT COMPLETED|Double-blind Treatment Period||2
6745585|NCT03360110|7673500|FG000|NOT COMPLETED|First Intervention||0
6745586|NCT03360110|7673501|FG001|NOT COMPLETED|First Intervention||0
6745587|NCT03360110|7673500|FG000|STARTED|Second Intervention||27
6745588|NCT03360110|7673501|FG001|STARTED|Second Intervention||26
6745589|NCT03360110|7673500|FG000|COMPLETED|Second Intervention||27
6745590|NCT03360110|7673501|FG001|COMPLETED|Second Intervention||26
6745591|NCT03360110|7673500|FG000|NOT COMPLETED|Second Intervention||0
6745592|NCT03360110|7673501|FG001|NOT COMPLETED|Second Intervention||0
6745593|NCT03360344|7673522|FG000|STARTED|Overall Study||15
6745594|NCT03360344|7673523|FG001|STARTED|Overall Study||16
6461104|NCT01207427|7377708|FG002|NOT COMPLETED|Double-blind Treatment Period||2
6461105|NCT01207427|7377706|FG000|STARTED|Run-out Placebo Period||40
6461106|NCT01207427|7377707|FG001|STARTED|Run-out Placebo Period||43
6461107|NCT01207427|7377708|FG002|STARTED|Run-out Placebo Period||41
6461108|NCT01207427|7377706|FG000|COMPLETED|Run-out Placebo Period||40
6461109|NCT01207427|7377707|FG001|COMPLETED|Run-out Placebo Period||43
6461110|NCT01207427|7377708|FG002|COMPLETED|Run-out Placebo Period||41
6461111|NCT01207427|7377706|FG000|NOT COMPLETED|Run-out Placebo Period||0
6461112|NCT01207427|7377707|FG001|NOT COMPLETED|Run-out Placebo Period||0
6461113|NCT01207427|7377708|FG002|NOT COMPLETED|Run-out Placebo Period||0
6461114|NCT01207440|7377723|FG000|STARTED|Overall Study||203
6461115|NCT01207440|7377724|FG001|STARTED|Overall Study||64
6553942|NCT01746095|7476398|FG002|STARTED|Overall Study||24
6553943|NCT01746095|7476399|FG003|STARTED|Overall Study||23
6553944|NCT01746095|7476396|FG000|COMPLETED|Overall Study||16
6745595|NCT03360344|7673524|FG002|STARTED|Overall Study||13
6745596|NCT03360344|7673522|FG000|COMPLETED|Overall Study||15
6745597|NCT03360344|7673523|FG001|COMPLETED|Overall Study||15
6745598|NCT03360344|7673524|FG002|COMPLETED|Overall Study||12
6745599|NCT03360344|7673522|FG000|NOT COMPLETED|Overall Study||0
6745600|NCT03360344|7673523|FG001|NOT COMPLETED|Overall Study||1
6553945|NCT01746095|7476397|FG001|COMPLETED|Overall Study||16
6745601|NCT03360344|7673524|FG002|NOT COMPLETED|Overall Study||1
6745602|NCT03360747|7673532|FG000|STARTED|Overall Study||3
6745603|NCT03360747|7673532|FG000|COMPLETED|Overall Study||2
6745604|NCT03360747|7673532|FG000|NOT COMPLETED|Overall Study||1
6745605|NCT03361137|7673541|FG000|STARTED|Overall Study||1
6745606|NCT03361137|7673542|FG001|STARTED|Overall Study||9
6745607|NCT03361137|7673543|FG002|STARTED|Overall Study||1
6461116|NCT01207440|7377725|FG002|STARTED|Overall Study||65
6461117|NCT01207440|7377726|FG003|STARTED|Overall Study||18
6461118|NCT01207440|7377727|FG004|STARTED|Overall Study||48
6461119|NCT01207440|7377728|FG005|STARTED|Overall Study||46
6461120|NCT01207440|7377729|FG006|STARTED|Overall Study||5
6461121|NCT01207440|7377723|FG000|COMPLETED|Overall Study||0
6461122|NCT01207440|7377724|FG001|COMPLETED|Overall Study||0
6461123|NCT01207440|7377725|FG002|COMPLETED|Overall Study||0
6461124|NCT01207440|7377726|FG003|COMPLETED|Overall Study||0
6461125|NCT01207440|7377727|FG004|COMPLETED|Overall Study||0
6461126|NCT01207440|7377728|FG005|COMPLETED|Overall Study||0
6461127|NCT01207440|7377729|FG006|COMPLETED|Overall Study||0
6461128|NCT01207440|7377723|FG000|NOT COMPLETED|Overall Study||203
6461129|NCT01207440|7377724|FG001|NOT COMPLETED|Overall Study||64
6461130|NCT01207440|7377725|FG002|NOT COMPLETED|Overall Study||65
6461131|NCT01207440|7377726|FG003|NOT COMPLETED|Overall Study||18
6461132|NCT01207440|7377727|FG004|NOT COMPLETED|Overall Study||48
6461133|NCT01207440|7377728|FG005|NOT COMPLETED|Overall Study||46
6461134|NCT01207440|7377729|FG006|NOT COMPLETED|Overall Study||5
6461135|NCT01207453|7377753|FG000|STARTED|First Intervention||23
6461136|NCT01207453|7377754|FG001|STARTED|First Intervention||18
6461137|NCT01207453|7377753|FG000|COMPLETED|First Intervention||21
6461138|NCT01207453|7377754|FG001|COMPLETED|First Intervention||17
6461139|NCT01207453|7377753|FG000|NOT COMPLETED|First Intervention||2
6461140|NCT01207453|7377754|FG001|NOT COMPLETED|First Intervention||1
6461141|NCT01207453|7377753|FG000|STARTED|Washout||21
6461142|NCT01207453|7377754|FG001|STARTED|Washout||17
6461143|NCT01207453|7377753|FG000|COMPLETED|Washout||19
6461144|NCT01207453|7377754|FG001|COMPLETED|Washout||17
6461145|NCT01207453|7377753|FG000|NOT COMPLETED|Washout||2
6461146|NCT01207453|7377754|FG001|NOT COMPLETED|Washout||0
6461147|NCT01207453|7377753|FG000|STARTED|2nd Intervention||19
6461148|NCT01207453|7377754|FG001|STARTED|2nd Intervention||17
6461149|NCT01207453|7377753|FG000|COMPLETED|2nd Intervention||17
6461150|NCT01207453|7377754|FG001|COMPLETED|2nd Intervention||15
6461151|NCT01207453|7377753|FG000|NOT COMPLETED|2nd Intervention||2
6461152|NCT01207453|7377754|FG001|NOT COMPLETED|2nd Intervention||2
6461153|NCT01207466|7377763|FG000|STARTED|Period 1, One Week of Wear||46
6461154|NCT01207466|7377764|FG001|STARTED|Period 1, One Week of Wear||48
6461155|NCT01207466|7377763|FG000|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
6461156|NCT01207466|7377764|FG001|COMPLETED|Period 1, One Week of Wear||48
6461157|NCT01207466|7377763|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
6461158|NCT01207466|7377764|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
6461159|NCT01207466|7377763|FG000|STARTED|Period 2, One Week of Wear||45
6461160|NCT01207466|7377764|FG001|STARTED|Period 2, One Week of Wear||48
6461161|NCT01207466|7377763|FG000|COMPLETED|Period 2, One Week of Wear||45
6461162|NCT01207466|7377764|FG001|COMPLETED|Period 2, One Week of Wear||48
6461163|NCT01207466|7377763|FG000|NOT COMPLETED|Period 2, One Week of Wear||0
6461164|NCT01207466|7377764|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
6461165|NCT01207570|7377772|FG000|STARTED|The First Stage (Before Crossover)||23
6461166|NCT01207570|7377773|FG001|STARTED|The First Stage (Before Crossover)||31
6461167|NCT01207570|7377772|FG000|COMPLETED|The First Stage (Before Crossover)||23
6461168|NCT01207570|7377773|FG001|COMPLETED|The First Stage (Before Crossover)||31
6461169|NCT01207570|7377772|FG000|NOT COMPLETED|The First Stage (Before Crossover)||0
6461170|NCT01207570|7377773|FG001|NOT COMPLETED|The First Stage (Before Crossover)||0
6461171|NCT01207570|7377772|FG000|STARTED|The Second Stage (After Crossover)||31
6461172|NCT01207570|7377773|FG001|STARTED|The Second Stage (After Crossover)||23
6461173|NCT01207570|7377772|FG000|COMPLETED|The Second Stage (After Crossover)||31
6461174|NCT01207570|7377773|FG001|COMPLETED|The Second Stage (After Crossover)||23
6461175|NCT01207570|7377772|FG000|NOT COMPLETED|The Second Stage (After Crossover)||0
6461176|NCT01207570|7377773|FG001|NOT COMPLETED|The Second Stage (After Crossover)||0
6461177|NCT01207583|7377784|FG000|STARTED|Overall Study||14
6461178|NCT01207583|7377785|FG001|STARTED|Overall Study||31
6461179|NCT01207583|7377786|FG002|STARTED|Overall Study||55
6461180|NCT01207583|7377784|FG000|Dose 1|Overall Study||14
6461181|NCT01207583|7377785|FG001|Dose 1|Overall Study||31
6461182|NCT01207583|7377786|FG002|Dose 1|Overall Study||55
6461183|NCT01207583|7377784|FG000|Dose 2|Overall Study||13
6461184|NCT01207583|7377785|FG001|Dose 2|Overall Study||29
6461185|NCT01207583|7377786|FG002|Dose 2|Overall Study||54
6461186|NCT01207583|7377784|FG000|Dose 3|Overall Study||13
6461187|NCT01207583|7377785|FG001|Dose 3|Overall Study||27
6461188|NCT01207583|7377786|FG002|Dose 3|Overall Study||0
6461189|NCT01207583|7377784|FG000|Dose 4|Overall Study||7
6461190|NCT01207583|7377785|FG001|Dose 4|Overall Study||0
6461191|NCT01207583|7377786|FG002|Dose 4|Overall Study||0
6461192|NCT01207583|7377784|FG000|COMPLETED|Overall Study||13
6461193|NCT01207583|7377785|FG001|COMPLETED|Overall Study||26
6461194|NCT01207583|7377786|FG002|COMPLETED|Overall Study||54
6461195|NCT01207583|7377784|FG000|NOT COMPLETED|Overall Study||1
6461196|NCT01207583|7377785|FG001|NOT COMPLETED|Overall Study||5
6461197|NCT01207583|7377786|FG002|NOT COMPLETED|Overall Study||1
6461198|NCT01207596|7377807|FG000|STARTED|Overall Study||30
6461199|NCT01207596|7377807|FG000|COMPLETED|Overall Study||21
6461200|NCT01207596|7377807|FG000|NOT COMPLETED|Overall Study||9
6461201|NCT01207648|7377811|FG000|STARTED|Overall Study||307
6461202|NCT01207648|7377811|FG000|COMPLETED|Overall Study||307
6461203|NCT01207648|7377811|FG000|NOT COMPLETED|Overall Study||0
6461204|NCT01207687|7377815|FG000|STARTED|Overall Study||14
6461205|NCT01207687|7377815|FG000|COMPLETED|Overall Study||12
6461206|NCT01207687|7377815|FG000|NOT COMPLETED|Overall Study||2
6461207|NCT01207752|7377827|FG000|STARTED|Overall Study||35
6553946|NCT01746095|7476398|FG002|COMPLETED|Overall Study||11
6553947|NCT01746095|7476399|FG003|COMPLETED|Overall Study||15
6553948|NCT01746095|7476396|FG000|NOT COMPLETED|Overall Study||4
6553949|NCT01746095|7476397|FG001|NOT COMPLETED|Overall Study||4
6745608|NCT03361137|7673544|FG003|STARTED|Overall Study||2
6745609|NCT03361137|7673545|FG004|STARTED|Overall Study||1
6461208|NCT01207752|7377828|FG001|STARTED|Overall Study||34
6461209|NCT01207752|7377827|FG000|COMPLETED|Overall Study||33
6461210|NCT01207752|7377828|FG001|COMPLETED|Overall Study||27
6461211|NCT01207752|7377827|FG000|NOT COMPLETED|Overall Study||2
6461212|NCT01207752|7377828|FG001|NOT COMPLETED|Overall Study||7
6461213|NCT01207765|7377834|FG000|STARTED|Overall Study||8
6461214|NCT01207765|7377834|FG000|COMPLETED|Overall Study||8
6461215|NCT01207765|7377834|FG000|NOT COMPLETED|Overall Study||0
6461216|NCT01207908|7377840|FG000|STARTED|Overall Study||22
6461217|NCT01207908|7377841|FG001|STARTED|Overall Study||22
6461218|NCT01207908|7377840|FG000|COMPLETED|Overall Study||17
6461219|NCT01207908|7377841|FG001|COMPLETED|Overall Study||21
6461220|NCT01207908|7377840|FG000|NOT COMPLETED|Overall Study||5
6461221|NCT01207908|7377841|FG001|NOT COMPLETED|Overall Study||1
6461222|NCT01207934|7377850|FG000|STARTED|Overall Study||6
6461223|NCT01207934|7377851|FG001|STARTED|Overall Study||6
6461224|NCT01207934|7377852|FG002|STARTED|Overall Study||6
6461225|NCT01207934|7377850|FG000|COMPLETED|Overall Study||6
6461226|NCT01207934|7377851|FG001|COMPLETED|Overall Study||6
6461227|NCT01207934|7377852|FG002|COMPLETED|Overall Study||6
6461228|NCT01207934|7377850|FG000|NOT COMPLETED|Overall Study||0
6461229|NCT01207934|7377851|FG001|NOT COMPLETED|Overall Study||0
6461230|NCT01207934|7377852|FG002|NOT COMPLETED|Overall Study||0
6461231|NCT01208038|7377860|FG000|STARTED|Overall Study||22
6461232|NCT01208038|7377860|FG000|COMPLETED|Overall Study|Patient withdrew before commencing study drug|21
6461233|NCT01208038|7377860|FG000|NOT COMPLETED|Overall Study||1
6461234|NCT01208051|7377869|FG000|STARTED|Total Enrollment||4
6461235|NCT01208051|7377870|FG001|STARTED|Total Enrollment||7
6461236|NCT01208051|7377871|FG002|STARTED|Total Enrollment||6
6461237|NCT01208051|7377872|FG003|STARTED|Total Enrollment||39
6461238|NCT01208051|7377873|FG004|STARTED|Total Enrollment||71
6461239|NCT01208051|7377869|FG000|COMPLETED|Total Enrollment||4
6461240|NCT01208051|7377870|FG001|COMPLETED|Total Enrollment||6
6461241|NCT01208051|7377871|FG002|COMPLETED|Total Enrollment||5
6461242|NCT01208051|7377872|FG003|COMPLETED|Total Enrollment||39
6461243|NCT01208051|7377873|FG004|COMPLETED|Total Enrollment||69
6461244|NCT01208051|7377869|FG000|NOT COMPLETED|Total Enrollment||0
6461245|NCT01208051|7377870|FG001|NOT COMPLETED|Total Enrollment||1
6461246|NCT01208051|7377871|FG002|NOT COMPLETED|Total Enrollment||1
6461247|NCT01208051|7377872|FG003|NOT COMPLETED|Total Enrollment||0
6461248|NCT01208051|7377873|FG004|NOT COMPLETED|Total Enrollment||2
6461249|NCT01208051|7377869|FG000|STARTED|Interim Futility Analysis||0
6461250|NCT01208051|7377870|FG001|STARTED|Interim Futility Analysis||0
6461251|NCT01208051|7377871|FG002|STARTED|Interim Futility Analysis||0
6553950|NCT01746095|7476398|FG002|NOT COMPLETED|Overall Study||13
6745610|NCT03361137|7673541|FG000|COMPLETED|Overall Study||0
6745611|NCT03361137|7673542|FG001|COMPLETED|Overall Study||9
6745612|NCT03361137|7673543|FG002|COMPLETED|Overall Study||1
6745613|NCT03361137|7673544|FG003|COMPLETED|Overall Study||2
6745614|NCT03361137|7673545|FG004|COMPLETED|Overall Study||1
6745615|NCT03361137|7673541|FG000|NOT COMPLETED|Overall Study||1
6745616|NCT03361137|7673542|FG001|NOT COMPLETED|Overall Study||0
6745617|NCT03361137|7673543|FG002|NOT COMPLETED|Overall Study||0
6745618|NCT03361137|7673544|FG003|NOT COMPLETED|Overall Study||0
6745619|NCT03361137|7673545|FG004|NOT COMPLETED|Overall Study||0
6745620|NCT03361176|7673561|FG000|STARTED|Overall Study||10
6745621|NCT03361176|7673562|FG001|STARTED|Overall Study||20
6745622|NCT03361176|7673561|FG000|COMPLETED|Overall Study||9
6745623|NCT03361176|7673562|FG001|COMPLETED|Overall Study||15
6745624|NCT03361176|7673561|FG000|NOT COMPLETED|Overall Study||1
6745625|NCT03361176|7673562|FG001|NOT COMPLETED|Overall Study||5
6745626|NCT03361293|7673570|FG000|STARTED|Overall Study||20
6745627|NCT03361293|7673571|FG001|STARTED|Overall Study||24
6745628|NCT03361293|7673570|FG000|COMPLETED|Overall Study||19
6745629|NCT03361293|7673571|FG001|COMPLETED|Overall Study||19
6745630|NCT03361293|7673570|FG000|NOT COMPLETED|Overall Study||1
6745631|NCT03361293|7673571|FG001|NOT COMPLETED|Overall Study||5
6745632|NCT03361423|7673579|FG000|STARTED|Overall Study||126
6745633|NCT03361423|7673580|FG001|STARTED|Overall Study||126
6745634|NCT03361423|7673579|FG000|COMPLETED|Overall Study||99
6745635|NCT03361423|7673580|FG001|COMPLETED|Overall Study||103
6461252|NCT01208051|7377872|FG003|STARTED|Interim Futility Analysis||39
6553951|NCT01746095|7476399|FG003|NOT COMPLETED|Overall Study||8
6745636|NCT03361423|7673579|FG000|NOT COMPLETED|Overall Study||27
6745637|NCT03361423|7673580|FG001|NOT COMPLETED|Overall Study||23
6461253|NCT01208051|7377873|FG004|STARTED|Interim Futility Analysis||68
6461254|NCT01208051|7377869|FG000|COMPLETED|Interim Futility Analysis||0
6461255|NCT01208051|7377870|FG001|COMPLETED|Interim Futility Analysis||0
6461256|NCT01208051|7377871|FG002|COMPLETED|Interim Futility Analysis||0
6461257|NCT01208051|7377872|FG003|COMPLETED|Interim Futility Analysis||39
6461258|NCT01208051|7377873|FG004|COMPLETED|Interim Futility Analysis||68
6461259|NCT01208051|7377869|FG000|NOT COMPLETED|Interim Futility Analysis||0
6461260|NCT01208051|7377870|FG001|NOT COMPLETED|Interim Futility Analysis||0
6461261|NCT01208051|7377871|FG002|NOT COMPLETED|Interim Futility Analysis||0
6461262|NCT01208051|7377872|FG003|NOT COMPLETED|Interim Futility Analysis||0
6461263|NCT01208051|7377873|FG004|NOT COMPLETED|Interim Futility Analysis||0
6461264|NCT01208051|7377869|FG000|STARTED|After Crossover to Cediranib Only||0
6461265|NCT01208051|7377870|FG001|STARTED|After Crossover to Cediranib Only||0
6461266|NCT01208051|7377871|FG002|STARTED|After Crossover to Cediranib Only||0
6461267|NCT01208051|7377872|FG003|STARTED|After Crossover to Cediranib Only||39
6461268|NCT01208051|7377873|FG004|STARTED|After Crossover to Cediranib Only|One patient entered while futility analysis was ongoing.|69
6461269|NCT01208051|7377869|FG000|COMPLETED|After Crossover to Cediranib Only||0
6461270|NCT01208051|7377870|FG001|COMPLETED|After Crossover to Cediranib Only||0
6461271|NCT01208051|7377871|FG002|COMPLETED|After Crossover to Cediranib Only||0
6461272|NCT01208051|7377872|FG003|COMPLETED|After Crossover to Cediranib Only||39
6461273|NCT01208051|7377873|FG004|COMPLETED|After Crossover to Cediranib Only||69
6461274|NCT01208051|7377869|FG000|NOT COMPLETED|After Crossover to Cediranib Only||0
6461275|NCT01208051|7377870|FG001|NOT COMPLETED|After Crossover to Cediranib Only||0
6461276|NCT01208051|7377871|FG002|NOT COMPLETED|After Crossover to Cediranib Only||0
6461277|NCT01208051|7377872|FG003|NOT COMPLETED|After Crossover to Cediranib Only||0
6461278|NCT01208051|7377873|FG004|NOT COMPLETED|After Crossover to Cediranib Only||0
6461279|NCT01208103|7377889|FG000|STARTED|Overall Study||30
6461280|NCT01208103|7377889|FG000|COMPLETED|Overall Study||28
6461281|NCT01208103|7377889|FG000|NOT COMPLETED|Overall Study||2
6461282|NCT01208220|7377896|FG000|STARTED|Overall Study||1
6461283|NCT01208220|7377897|FG001|STARTED|Overall Study||1
6461284|NCT01208220|7377896|FG000|COMPLETED|Overall Study||1
6461285|NCT01208220|7377897|FG001|COMPLETED|Overall Study||1
6461286|NCT01208220|7377896|FG000|NOT COMPLETED|Overall Study||0
6461287|NCT01208220|7377897|FG001|NOT COMPLETED|Overall Study||0
6461288|NCT01208233|7377909|FG000|STARTED|Overall Study||11
6461289|NCT01208233|7377910|FG001|STARTED|Overall Study||9
6461290|NCT01208233|7377911|FG002|STARTED|Overall Study||11
6461291|NCT01208233|7377912|FG003|STARTED|Overall Study||10
6461292|NCT01208233|7377913|FG004|STARTED|Overall Study||70
6461293|NCT01208233|7377914|FG005|STARTED|Overall Study||67
6461294|NCT01208233|7377909|FG000|COMPLETED|Overall Study||6
6461295|NCT01208233|7377910|FG001|COMPLETED|Overall Study||6
6461296|NCT01208233|7377911|FG002|COMPLETED|Overall Study||7
6461297|NCT01208233|7377912|FG003|COMPLETED|Overall Study||9
6461298|NCT01208233|7377913|FG004|COMPLETED|Overall Study||46
6461299|NCT01208233|7377914|FG005|COMPLETED|Overall Study||46
6461300|NCT01208233|7377909|FG000|NOT COMPLETED|Overall Study||5
6461301|NCT01208233|7377910|FG001|NOT COMPLETED|Overall Study||3
6461302|NCT01208233|7377911|FG002|NOT COMPLETED|Overall Study||4
6461303|NCT01208233|7377912|FG003|NOT COMPLETED|Overall Study||1
6461304|NCT01208233|7377913|FG004|NOT COMPLETED|Overall Study||24
6461305|NCT01208233|7377914|FG005|NOT COMPLETED|Overall Study||21
6461306|NCT01208324|7377938|FG000|STARTED|Pre-randomization of Patch||14
6461307|NCT01208324|7377939|FG001|STARTED|Pre-randomization of Patch||15
6461308|NCT01208324|7377940|FG002|STARTED|Pre-randomization of Patch||10
6461309|NCT01208324|7377941|FG003|STARTED|Pre-randomization of Patch||8
6461310|NCT01208324|7377938|FG000|Test Day 1|Pre-randomization of Patch||14
6461311|NCT01208324|7377939|FG001|Test Day 1|Pre-randomization of Patch||15
6461312|NCT01208324|7377940|FG002|Test Day 1|Pre-randomization of Patch||10
6461313|NCT01208324|7377941|FG003|Test Day 1|Pre-randomization of Patch||8
6461314|NCT01208324|7377938|FG000|Test Day 2|Pre-randomization of Patch||14
6461315|NCT01208324|7377939|FG001|Test Day 2|Pre-randomization of Patch||15
6461316|NCT01208324|7377940|FG002|Test Day 2|Pre-randomization of Patch||8
6461317|NCT01208324|7377941|FG003|Test Day 2|Pre-randomization of Patch||5
6461318|NCT01208324|7377938|FG000|COMPLETED|Pre-randomization of Patch||14
6461319|NCT01208324|7377939|FG001|COMPLETED|Pre-randomization of Patch||15
6461320|NCT01208324|7377940|FG002|COMPLETED|Pre-randomization of Patch||8
6461321|NCT01208324|7377941|FG003|COMPLETED|Pre-randomization of Patch||5
6461322|NCT01208324|7377938|FG000|NOT COMPLETED|Pre-randomization of Patch||0
6461323|NCT01208324|7377939|FG001|NOT COMPLETED|Pre-randomization of Patch||0
6461324|NCT01208324|7377940|FG002|NOT COMPLETED|Pre-randomization of Patch||2
6461325|NCT01208324|7377941|FG003|NOT COMPLETED|Pre-randomization of Patch||3
6461326|NCT01208324|7377938|FG000|STARTED|Post-randomization of Patch||14
6461327|NCT01208324|7377939|FG001|STARTED|Post-randomization of Patch||15
6461328|NCT01208324|7377940|FG002|STARTED|Post-randomization of Patch||8
6461329|NCT01208324|7377941|FG003|STARTED|Post-randomization of Patch||5
6461330|NCT01208324|7377938|FG000|Test Day 3|Post-randomization of Patch||13
6461331|NCT01208324|7377939|FG001|Test Day 3|Post-randomization of Patch||15
6461332|NCT01208324|7377940|FG002|Test Day 3|Post-randomization of Patch||8
6461333|NCT01208324|7377941|FG003|Test Day 3|Post-randomization of Patch||5
6461334|NCT01208324|7377938|FG000|Test Day 4|Post-randomization of Patch||13
6461335|NCT01208324|7377939|FG001|Test Day 4|Post-randomization of Patch||15
6461336|NCT01208324|7377940|FG002|Test Day 4|Post-randomization of Patch||8
6461337|NCT01208324|7377941|FG003|Test Day 4|Post-randomization of Patch||5
6461338|NCT01208324|7377938|FG000|COMPLETED|Post-randomization of Patch||13
6461339|NCT01208324|7377939|FG001|COMPLETED|Post-randomization of Patch||15
6461340|NCT01208324|7377940|FG002|COMPLETED|Post-randomization of Patch||8
6461341|NCT01208324|7377941|FG003|COMPLETED|Post-randomization of Patch||5
6461342|NCT01208324|7377938|FG000|NOT COMPLETED|Post-randomization of Patch||1
6461343|NCT01208324|7377939|FG001|NOT COMPLETED|Post-randomization of Patch||0
6461344|NCT01208324|7377940|FG002|NOT COMPLETED|Post-randomization of Patch||0
6461345|NCT01208324|7377941|FG003|NOT COMPLETED|Post-randomization of Patch||0
6461346|NCT01208337|7377951|FG000|STARTED|Overall Study||23
6461347|NCT01208337|7377951|FG000|One-year Follow-up|Overall Study||23
6461348|NCT01208337|7377951|FG000|Five-year Follow-up|Overall Study||20
6461349|NCT01208337|7377951|FG000|COMPLETED|Overall Study||20
6461350|NCT01208337|7377951|FG000|NOT COMPLETED|Overall Study||3
6461351|NCT01208402|7377957|FG000|STARTED|Overall Study||31
6461352|NCT01208402|7377958|FG001|STARTED|Overall Study||28
6461353|NCT01208402|7377957|FG000|COMPLETED|Overall Study||30
6461354|NCT01208402|7377958|FG001|COMPLETED|Overall Study||28
6461355|NCT01208402|7377957|FG000|NOT COMPLETED|Overall Study||1
6461356|NCT01208402|7377958|FG001|NOT COMPLETED|Overall Study||0
6461357|NCT01208415|7377964|FG000|STARTED|Overall Study||40
6461358|NCT01208415|7377964|FG000|6 Months|Overall Study||37
6461359|NCT01208415|7377964|FG000|COMPLETED|Overall Study||0
6461360|NCT01208415|7377964|FG000|NOT COMPLETED|Overall Study||40
6461361|NCT01208870|7377970|FG000|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013|46
6461362|NCT01208870|7377971|FG001|STARTED|Overall Study|The same group was run as Pilot 1 Spring 2012 and Pilot 2 Summer 2013.|44
6461363|NCT01208870|7377970|FG000|Pilot 1|Overall Study||20
6461364|NCT01208870|7377971|FG001|Pilot 1|Overall Study||22
6461365|NCT01208870|7377970|FG000|Pilot 2|Overall Study||26
6461366|NCT01208870|7377971|FG001|Pilot 2|Overall Study||22
6461367|NCT01208870|7377970|FG000|COMPLETED|Overall Study||44
6461368|NCT01208870|7377971|FG001|COMPLETED|Overall Study||36
6461369|NCT01208870|7377970|FG000|NOT COMPLETED|Overall Study||2
6461370|NCT01208870|7377971|FG001|NOT COMPLETED|Overall Study||8
6461371|NCT01208922|7377981|FG000|STARTED|Overall Study||420
6461372|NCT01208922|7377982|FG001|STARTED|Overall Study||415
6461373|NCT01208922|7377981|FG000|COMPLETED|Overall Study||409
6461374|NCT01208922|7377982|FG001|COMPLETED|Overall Study||405
6461375|NCT01208922|7377981|FG000|NOT COMPLETED|Overall Study||11
6461376|NCT01208922|7377982|FG001|NOT COMPLETED|Overall Study||10
6461377|NCT01208961|7377988|FG000|STARTED|Low-Fat Period I||27
6461378|NCT01208961|7377989|FG001|STARTED|Low-Fat Period I||27
6461379|NCT01208961|7377988|FG000|COMPLETED|Low-Fat Period I||27
6461380|NCT01208961|7377989|FG001|COMPLETED|Low-Fat Period I||27
6461381|NCT01208961|7377988|FG000|NOT COMPLETED|Low-Fat Period I||0
6461382|NCT01208961|7377989|FG001|NOT COMPLETED|Low-Fat Period I||0
6461383|NCT01208961|7377988|FG000|STARTED|Low-Fat Period II||26
6461384|NCT01208961|7377989|FG001|STARTED|Low-Fat Period II||27
6461385|NCT01208961|7377988|FG000|COMPLETED|Low-Fat Period II||26
6461386|NCT01208961|7377989|FG001|COMPLETED|Low-Fat Period II||27
6461387|NCT01208961|7377988|FG000|NOT COMPLETED|Low-Fat Period II||0
6461388|NCT01208961|7377989|FG001|NOT COMPLETED|Low-Fat Period II||0
6461389|NCT01208961|7377988|FG000|STARTED|High-Fat Period III||26
6461390|NCT01208961|7377989|FG001|STARTED|High-Fat Period III||26
6461391|NCT01208961|7377988|FG000|COMPLETED|High-Fat Period III||25
6461392|NCT01208961|7377989|FG001|COMPLETED|High-Fat Period III||26
6461393|NCT01208961|7377988|FG000|NOT COMPLETED|High-Fat Period III||1
6461394|NCT01208961|7377989|FG001|NOT COMPLETED|High-Fat Period III||0
6461395|NCT01208961|7377988|FG000|STARTED|High-Fat Period IV||25
6461396|NCT01208961|7377989|FG001|STARTED|High-Fat Period IV||26
6461397|NCT01208961|7377988|FG000|COMPLETED|High-Fat Period IV||25
6461398|NCT01208961|7377989|FG001|COMPLETED|High-Fat Period IV||26
6461399|NCT01208961|7377988|FG000|NOT COMPLETED|High-Fat Period IV||0
6461400|NCT01208961|7377989|FG001|NOT COMPLETED|High-Fat Period IV||0
6461401|NCT01209078|7377996|FG000|STARTED|Overall Study||57
6461402|NCT01209078|7377997|FG001|STARTED|Overall Study||27
6461403|NCT01209078|7377996|FG000|COMPLETED|Overall Study||41
6461404|NCT01209078|7377997|FG001|COMPLETED|Overall Study||24
6461405|NCT01209078|7377996|FG000|NOT COMPLETED|Overall Study||16
6461406|NCT01209078|7377997|FG001|NOT COMPLETED|Overall Study||3
6461407|NCT01209143|7378007|FG000|STARTED|Overall Study||24
6461408|NCT01209143|7378008|FG001|STARTED|Overall Study||28
6461409|NCT01209143|7378007|FG000|COMPLETED|Overall Study||5
6461410|NCT01209143|7378008|FG001|COMPLETED|Overall Study||8
6461411|NCT01209143|7378007|FG000|NOT COMPLETED|Overall Study||19
6461412|NCT01209143|7378008|FG001|NOT COMPLETED|Overall Study||20
6461413|NCT01209195|7378016|FG000|STARTED|Overall Study||7
6461414|NCT01209195|7378017|FG001|STARTED|Overall Study||3
6461415|NCT01209195|7378018|FG002|STARTED|Overall Study||6
6461416|NCT01209195|7378019|FG003|STARTED|Overall Study||6
6461417|NCT01209195|7378020|FG004|STARTED|Overall Study||6
6461418|NCT01209195|7378021|FG005|STARTED|Overall Study||13
6461419|NCT01209195|7378016|FG000|COMPLETED|Overall Study||7
6461420|NCT01209195|7378017|FG001|COMPLETED|Overall Study||3
6461421|NCT01209195|7378018|FG002|COMPLETED|Overall Study||6
6461422|NCT01209195|7378019|FG003|COMPLETED|Overall Study||6
6461423|NCT01209195|7378020|FG004|COMPLETED|Overall Study||6
6461424|NCT01209195|7378021|FG005|COMPLETED|Overall Study||13
6461425|NCT01209195|7378016|FG000|NOT COMPLETED|Overall Study||0
6461426|NCT01209195|7378017|FG001|NOT COMPLETED|Overall Study||0
6461427|NCT01209195|7378018|FG002|NOT COMPLETED|Overall Study||0
6461428|NCT01209195|7378019|FG003|NOT COMPLETED|Overall Study||0
6461429|NCT01209195|7378020|FG004|NOT COMPLETED|Overall Study||0
6461430|NCT01209195|7378021|FG005|NOT COMPLETED|Overall Study||0
6500775|NCT01425801|7419349|FG005|COMPLETED|Period 6||10
6461431|NCT01209234|7378039|FG000|STARTED|Overall Study||1070
6461432|NCT01209234|7378040|FG001|STARTED|Overall Study||1070
6461433|NCT01209234|7378039|FG000|COMPLETED|Overall Study||1058
6461434|NCT01209234|7378040|FG001|COMPLETED|Overall Study||1063
6461435|NCT01209234|7378039|FG000|NOT COMPLETED|Overall Study||12
6461436|NCT01209234|7378040|FG001|NOT COMPLETED|Overall Study||7
6461437|NCT01209260|7378048|FG000|STARTED|Overall Study||36
6461438|NCT01209260|7378049|FG001|STARTED|Overall Study||36
6461439|NCT01209260|7378048|FG000|COMPLETED|Overall Study||36
6461440|NCT01209260|7378049|FG001|COMPLETED|Overall Study||36
6461441|NCT01209260|7378048|FG000|NOT COMPLETED|Overall Study||0
6461442|NCT01209260|7378049|FG001|NOT COMPLETED|Overall Study||0
6461443|NCT01209286|7378060|FG000|STARTED|Overall Study||7
6461444|NCT01209286|7378061|FG001|STARTED|Overall Study||23
6461445|NCT01209286|7378062|FG002|STARTED|Overall Study||6
6461446|NCT01209286|7378060|FG000|COMPLETED|Overall Study||2
6461447|NCT01209286|7378061|FG001|COMPLETED|Overall Study||13
6461448|NCT01209286|7378062|FG002|COMPLETED|Overall Study||3
6461449|NCT01209286|7378060|FG000|NOT COMPLETED|Overall Study||5
6461450|NCT01209286|7378061|FG001|NOT COMPLETED|Overall Study||10
6461451|NCT01209286|7378062|FG002|NOT COMPLETED|Overall Study||3
6461452|NCT01209325|7378079|FG000|STARTED|Overall Study||149
6461453|NCT01209325|7378079|FG000|Eligible|Overall Study||145
6461454|NCT01209325|7378079|FG000|Received First Vaccine Injection|Overall Study||144
6461455|NCT01209325|7378079|FG000|Received Second Vaccine Injection|Overall Study||141
6461456|NCT01209325|7378079|FG000|Received Third Vaccine Infjection|Overall Study||138
6461457|NCT01209325|7378079|FG000|Returned After Week 28|Overall Study||124
6461458|NCT01209325|7378079|FG000|COMPLETED|Overall Study||106
6461459|NCT01209325|7378079|FG000|NOT COMPLETED|Overall Study||43
6461460|NCT01209442|7378105|FG000|STARTED|Overall Study||30
6461461|NCT01209442|7378105|FG000|COMPLETED|Overall Study||30
6461462|NCT01209442|7378105|FG000|NOT COMPLETED|Overall Study||0
6461463|NCT01209598|7378111|FG000|STARTED|Overall Study||30
6461464|NCT01209598|7378112|FG001|STARTED|Overall Study||60
6461465|NCT01209598|7378111|FG000|COMPLETED|Overall Study||29
6461466|NCT01209598|7378112|FG001|COMPLETED|Overall Study||60
6461467|NCT01209598|7378111|FG000|NOT COMPLETED|Overall Study||1
6461468|NCT01209598|7378112|FG001|NOT COMPLETED|Overall Study||0
6461469|NCT01209624|7378119|FG000|STARTED|Overall Study||902
6461470|NCT01209624|7378119|FG000|Per Protocol Population|Overall Study||469
6461471|NCT01209624|7378119|FG000|COMPLETED|Overall Study||576
6461472|NCT01209624|7378119|FG000|NOT COMPLETED|Overall Study||326
6461473|NCT01209689|7378125|FG000|STARTED|Overall Study||91
6461474|NCT01209689|7378126|FG001|STARTED|Overall Study||22
6461475|NCT01209689|7378125|FG000|COMPLETED|Overall Study||0
6461476|NCT01209689|7378126|FG001|COMPLETED|Overall Study||0
6461477|NCT01209689|7378125|FG000|NOT COMPLETED|Overall Study||91
6461478|NCT01209689|7378126|FG001|NOT COMPLETED|Overall Study||22
6461479|NCT01209702|7378134|FG000|STARTED|Overall Study||51
6461480|NCT01209702|7378135|FG001|STARTED|Overall Study||51
6461481|NCT01209702|7378136|FG002|STARTED|Overall Study||51
6461482|NCT01209702|7378137|FG003|STARTED|Overall Study||153
6461483|NCT01209702|7378134|FG000|Treated|Overall Study||51
6461484|NCT01209702|7378135|FG001|Treated|Overall Study||51
6745638|NCT03361605|7673586|FG000|STARTED|Overall Study||29
6745639|NCT03361605|7673586|FG000|COMPLETED|Overall Study||26
6745640|NCT03361605|7673586|FG000|NOT COMPLETED|Overall Study||3
6745641|NCT03361917|7673592|FG000|STARTED|Overall Study||99
6745642|NCT03361917|7673593|FG001|STARTED|Overall Study||101
6745643|NCT03361917|7673592|FG000|COMPLETED|Overall Study||99
6745644|NCT03361917|7673593|FG001|COMPLETED|Overall Study||101
6745645|NCT03361917|7673592|FG000|NOT COMPLETED|Overall Study||0
6745646|NCT03361917|7673593|FG001|NOT COMPLETED|Overall Study||0
6745647|NCT03362879|7673599|FG000|STARTED|Overall Study||409
6745648|NCT03362879|7673599|FG000|COMPLETED|Overall Study||409
6745649|NCT03362879|7673599|FG000|NOT COMPLETED|Overall Study||0
6745650|NCT03362944|7673604|FG000|STARTED|First Intervention||8
6745651|NCT03362944|7673605|FG001|STARTED|First Intervention||8
6745652|NCT03362944|7673604|FG000|COMPLETED|First Intervention||8
6745653|NCT03362944|7673605|FG001|COMPLETED|First Intervention||8
6745654|NCT03362944|7673604|FG000|NOT COMPLETED|First Intervention||0
6745655|NCT03362944|7673605|FG001|NOT COMPLETED|First Intervention||0
6745656|NCT03362944|7673604|FG000|STARTED|Single Week Washout Period||8
6745657|NCT03362944|7673605|FG001|STARTED|Single Week Washout Period||8
6745658|NCT03362944|7673604|FG000|COMPLETED|Single Week Washout Period||8
6745659|NCT03362944|7673605|FG001|COMPLETED|Single Week Washout Period||8
6745660|NCT03362944|7673604|FG000|NOT COMPLETED|Single Week Washout Period||0
6745661|NCT03362944|7673605|FG001|NOT COMPLETED|Single Week Washout Period||0
6745662|NCT03362944|7673604|FG000|STARTED|Second Intervention||8
6745663|NCT03362944|7673605|FG001|STARTED|Second Intervention||8
6745664|NCT03362944|7673604|FG000|COMPLETED|Second Intervention||8
6461485|NCT01209702|7378136|FG002|Treated|Overall Study||51
6461486|NCT01209702|7378137|FG003|Treated|Overall Study||152
6461487|NCT01209702|7378134|FG000|Escape or Switched to Tocilizumab|Overall Study||51
6461488|NCT01209702|7378135|FG001|Escape or Switched to Tocilizumab|Overall Study||0
6461489|NCT01209702|7378136|FG002|Escape or Switched to Tocilizumab|Overall Study||6
6461490|NCT01209702|7378137|FG003|Escape or Switched to Tocilizumab|Overall Study||0
6461491|NCT01209702|7378134|FG000|Completed 12 Weeks Treatment|Overall Study||50
6461492|NCT01209702|7378135|FG001|Completed 12 Weeks Treatment|Overall Study||48
6461493|NCT01209702|7378136|FG002|Completed 12 Weeks Treatment|Overall Study||12
6461494|NCT01209702|7378137|FG003|Completed 12 Weeks Treatment|Overall Study||59
6461495|NCT01209702|7378134|FG000|Completed 24 Weeks Treatment|Overall Study||19
6461496|NCT01209702|7378135|FG001|Completed 24 Weeks Treatment|Overall Study||28
6461497|NCT01209702|7378136|FG002|Completed 24 Weeks Treatment|Overall Study||3
6461498|NCT01209702|7378137|FG003|Completed 24 Weeks Treatment|Overall Study||10
6461499|NCT01209702|7378134|FG000|COMPLETED|Overall Study||0
6745665|NCT03362944|7673605|FG001|COMPLETED|Second Intervention||8
6745666|NCT03362944|7673604|FG000|NOT COMPLETED|Second Intervention||0
6745667|NCT03362944|7673605|FG001|NOT COMPLETED|Second Intervention||0
6745668|NCT03362957|7673613|FG000|STARTED|Overall Study||14
6745669|NCT03362957|7673614|FG001|STARTED|Overall Study||7
6745670|NCT03362957|7673613|FG000|Crossover to Receive GAE Procedure|Overall Study||0
6745671|NCT03362957|7673614|FG001|Crossover to Receive GAE Procedure|Overall Study||7
6745672|NCT03362957|7673613|FG000|COMPLETED|Overall Study||14
6745673|NCT03362957|7673614|FG001|COMPLETED|Overall Study||7
6461500|NCT01209702|7378135|FG001|COMPLETED|Overall Study||0
6461501|NCT01209702|7378136|FG002|COMPLETED|Overall Study||0
6461502|NCT01209702|7378137|FG003|COMPLETED|Overall Study||0
6461503|NCT01209702|7378134|FG000|NOT COMPLETED|Overall Study||51
6461504|NCT01209702|7378135|FG001|NOT COMPLETED|Overall Study||51
6461505|NCT01209702|7378136|FG002|NOT COMPLETED|Overall Study||51
6461506|NCT01209702|7378137|FG003|NOT COMPLETED|Overall Study||153
6461507|NCT01209780|7378160|FG000|STARTED|Overall Study||1042
6461508|NCT01209780|7378161|FG001|STARTED|Overall Study||485
6461509|NCT01209780|7378162|FG002|STARTED|Overall Study||48
6461510|NCT01209780|7378163|FG003|STARTED|Overall Study||817
6461511|NCT01209780|7378164|FG004|STARTED|Overall Study||412
6461512|NCT01209780|7378160|FG000|COMPLETED|Overall Study||1016
6461513|NCT01209780|7378161|FG001|COMPLETED|Overall Study||467
6461514|NCT01209780|7378162|FG002|COMPLETED|Overall Study||44
6461515|NCT01209780|7378163|FG003|COMPLETED|Overall Study||807
6461516|NCT01209780|7378164|FG004|COMPLETED|Overall Study||407
6461517|NCT01209780|7378160|FG000|NOT COMPLETED|Overall Study||26
6461518|NCT01209780|7378161|FG001|NOT COMPLETED|Overall Study||18
6461519|NCT01209780|7378162|FG002|NOT COMPLETED|Overall Study||4
6461520|NCT01209780|7378163|FG003|NOT COMPLETED|Overall Study||10
6461521|NCT01209780|7378164|FG004|NOT COMPLETED|Overall Study||5
6461522|NCT01209832|7378177|FG000|STARTED|Period 1||11
6461523|NCT01209832|7378177|FG000|Received At Least 1 Dose of Study Drug|Period 1||10
6461524|NCT01209832|7378177|FG000|COMPLETED|Period 1||10
6461525|NCT01209832|7378177|FG000|NOT COMPLETED|Period 1||1
6461526|NCT01209832|7378177|FG000|STARTED|Period 2||10
6461527|NCT01209832|7378177|FG000|COMPLETED|Period 2||9
6461528|NCT01209832|7378177|FG000|NOT COMPLETED|Period 2||1
6461529|NCT01209832|7378177|FG000|STARTED|Maintenance Period 1 (M1)|Five participants who completed Period 2 did not enroll into Maintenance Period.|4
6461530|NCT01209832|7378177|FG000|COMPLETED|Maintenance Period 1 (M1)||4
6461531|NCT01209832|7378177|FG000|NOT COMPLETED|Maintenance Period 1 (M1)||0
6461532|NCT01209832|7378177|FG000|STARTED|Maintenance Period 2 (M1)|One participant who completed maintenance period 1 did not enter maintenance period 2.|3
6461533|NCT01209832|7378177|FG000|COMPLETED|Maintenance Period 2 (M1)||3
6461534|NCT01209832|7378177|FG000|NOT COMPLETED|Maintenance Period 2 (M1)||0
6461535|NCT01209949|7378188|FG000|STARTED|Overall Study||30
6745674|NCT03362957|7673613|FG000|NOT COMPLETED|Overall Study||0
6745675|NCT03362957|7673614|FG001|NOT COMPLETED|Overall Study||0
6745676|NCT03363321|7673627|FG000|STARTED|Overall Study||5
6745677|NCT03363321|7673628|FG001|STARTED|Overall Study||4
6745678|NCT03363321|7673629|FG002|STARTED|Overall Study||4
6745679|NCT03363321|7673630|FG003|STARTED|Overall Study||5
6745680|NCT03363321|7673631|FG004|STARTED|Overall Study||2
6745681|NCT03363321|7673627|FG000|COMPLETED|Overall Study||5
6745682|NCT03363321|7673628|FG001|COMPLETED|Overall Study||3
6745683|NCT03363321|7673629|FG002|COMPLETED|Overall Study||4
6745684|NCT03363321|7673630|FG003|COMPLETED|Overall Study||4
6745685|NCT03363321|7673631|FG004|COMPLETED|Overall Study||2
6745686|NCT03363321|7673627|FG000|NOT COMPLETED|Overall Study||0
6745687|NCT03363321|7673628|FG001|NOT COMPLETED|Overall Study||1
6745688|NCT03363321|7673629|FG002|NOT COMPLETED|Overall Study||0
6745689|NCT03363321|7673630|FG003|NOT COMPLETED|Overall Study||1
6745690|NCT03363321|7673631|FG004|NOT COMPLETED|Overall Study||0
6745691|NCT03363776|7673647|FG000|STARTED|Overall Study||4
6745692|NCT03363776|7673648|FG001|STARTED|Overall Study||3
6745693|NCT03363776|7673649|FG002|STARTED|Overall Study||3
6745694|NCT03363776|7673647|FG000|COMPLETED|Overall Study||1
6745695|NCT03363776|7673648|FG001|COMPLETED|Overall Study||0
6745696|NCT03363776|7673649|FG002|COMPLETED|Overall Study||1
6745697|NCT03363776|7673647|FG000|NOT COMPLETED|Overall Study||3
6745698|NCT03363776|7673648|FG001|NOT COMPLETED|Overall Study||3
6461536|NCT01209949|7378188|FG000|COMPLETED|Overall Study||27
6461537|NCT01209949|7378188|FG000|NOT COMPLETED|Overall Study||3
6461538|NCT01210001|7378195|FG000|STARTED|Overall Study||166
6461539|NCT01210001|7378196|FG001|STARTED|Overall Study||165
6461540|NCT01210001|7378197|FG002|STARTED|Overall Study||168
6461541|NCT01210001|7378195|FG000|COMPLETED|Overall Study||147
6461542|NCT01210001|7378196|FG001|COMPLETED|Overall Study||154
6461543|NCT01210001|7378197|FG002|COMPLETED|Overall Study||156
6461544|NCT01210001|7378195|FG000|NOT COMPLETED|Overall Study||19
6461545|NCT01210001|7378196|FG001|NOT COMPLETED|Overall Study||11
6461546|NCT01210001|7378197|FG002|NOT COMPLETED|Overall Study||12
6745699|NCT03363776|7673649|FG002|NOT COMPLETED|Overall Study||2
6461547|NCT01210079|7378207|FG000|STARTED|Overall Study||10
6461548|NCT01210079|7378208|FG001|STARTED|Overall Study||16
6461549|NCT01210079|7378207|FG000|COMPLETED|Overall Study||10
6461550|NCT01210079|7378208|FG001|COMPLETED|Overall Study||16
6461551|NCT01210079|7378207|FG000|NOT COMPLETED|Overall Study||0
6461552|NCT01210079|7378208|FG001|NOT COMPLETED|Overall Study||0
6461553|NCT01210118|7378216|FG000|STARTED|Overall Study||45
6461554|NCT01210118|7378217|FG001|STARTED|Overall Study||47
6461555|NCT01210118|7378216|FG000|COMPLETED|Overall Study||42
6461556|NCT01210118|7378217|FG001|COMPLETED|Overall Study||42
6461557|NCT01210118|7378216|FG000|NOT COMPLETED|Overall Study||3
6461558|NCT01210118|7378217|FG001|NOT COMPLETED|Overall Study||5
6461559|NCT01210144|7378228|FG000|STARTED|Overall Study||13
6461560|NCT01210144|7378229|FG001|STARTED|Overall Study||11
6461561|NCT01210144|7378228|FG000|COMPLETED|Overall Study||10
6461562|NCT01210144|7378229|FG001|COMPLETED|Overall Study||11
6461563|NCT01210144|7378228|FG000|NOT COMPLETED|Overall Study||3
6461564|NCT01210144|7378229|FG001|NOT COMPLETED|Overall Study||0
6461565|NCT01210170|7378236|FG000|STARTED|Overall Study||22
6461566|NCT01210170|7378236|FG000|COMPLETED|Overall Study||15
6461567|NCT01210170|7378236|FG000|NOT COMPLETED|Overall Study||7
6461568|NCT01210222|7378257|FG000|STARTED|Overall Study||35
6461569|NCT01210222|7378257|FG000|COMPLETED|Overall Study||32
6461570|NCT01210222|7378257|FG000|NOT COMPLETED|Overall Study||3
6461571|NCT01210352|7378276|FG000|STARTED|Overall Study||6
6461572|NCT01210352|7378277|FG001|STARTED|Overall Study||6
6461573|NCT01210352|7378278|FG002|STARTED|Overall Study||7
6461574|NCT01210352|7378279|FG003|STARTED|Overall Study||7
6461575|NCT01210352|7378280|FG004|STARTED|Overall Study||6
6461576|NCT01210352|7378281|FG005|STARTED|Overall Study||6
6461577|NCT01210352|7378282|FG006|STARTED|Overall Study||7
6461578|NCT01210352|7378283|FG007|STARTED|Overall Study||10
6461579|NCT01210352|7378284|FG008|STARTED|Overall Study||6
6461580|NCT01210352|7378276|FG000|COMPLETED|Overall Study||6
6461581|NCT01210352|7378277|FG001|COMPLETED|Overall Study||6
6461582|NCT01210352|7378278|FG002|COMPLETED|Overall Study||5
6461583|NCT01210352|7378279|FG003|COMPLETED|Overall Study||7
6461584|NCT01210352|7378280|FG004|COMPLETED|Overall Study||6
6461585|NCT01210352|7378281|FG005|COMPLETED|Overall Study||6
6461586|NCT01210352|7378282|FG006|COMPLETED|Overall Study||5
6461587|NCT01210352|7378283|FG007|COMPLETED|Overall Study||7
6461588|NCT01210352|7378284|FG008|COMPLETED|Overall Study||2
6461589|NCT01210352|7378276|FG000|NOT COMPLETED|Overall Study||0
6461590|NCT01210352|7378277|FG001|NOT COMPLETED|Overall Study||0
6461591|NCT01210352|7378278|FG002|NOT COMPLETED|Overall Study||2
6461592|NCT01210352|7378279|FG003|NOT COMPLETED|Overall Study||0
6461593|NCT01210352|7378280|FG004|NOT COMPLETED|Overall Study||0
6461594|NCT01210352|7378281|FG005|NOT COMPLETED|Overall Study||0
6461595|NCT01210352|7378282|FG006|NOT COMPLETED|Overall Study||2
6461596|NCT01210352|7378283|FG007|NOT COMPLETED|Overall Study||3
6461597|NCT01210352|7378284|FG008|NOT COMPLETED|Overall Study||4
6461598|NCT01210443|7378389|FG000|STARTED|Overall Study||2
6461599|NCT01210443|7378389|FG000|COMPLETED|Overall Study||0
6461600|NCT01210443|7378389|FG000|NOT COMPLETED|Overall Study||2
6461601|NCT01210495|7378397|FG000|STARTED|Overall Study||15
6461602|NCT01210495|7378398|FG001|STARTED|Overall Study||7
6461603|NCT01210495|7378399|FG002|STARTED|Overall Study||134
6461604|NCT01210495|7378400|FG003|STARTED|Overall Study||68
6461605|NCT01210495|7378397|FG000|COMPLETED|Overall Study||0
6461606|NCT01210495|7378398|FG001|COMPLETED|Overall Study||0
6461607|NCT01210495|7378399|FG002|COMPLETED|Overall Study||0
6553952|NCT01746108|7476412|FG000|STARTED|Overall Study||18
6553953|NCT01746108|7476413|FG001|STARTED|Overall Study||28
6553954|NCT01746108|7476414|FG002|STARTED|Overall Study||6
6553955|NCT01746108|7476412|FG000|COMPLETED|Overall Study||18
6553956|NCT01746108|7476413|FG001|COMPLETED|Overall Study||24
6553957|NCT01746108|7476414|FG002|COMPLETED|Overall Study||6
6553958|NCT01746108|7476412|FG000|NOT COMPLETED|Overall Study||0
6553959|NCT01746108|7476413|FG001|NOT COMPLETED|Overall Study||4
6553960|NCT01746108|7476414|FG002|NOT COMPLETED|Overall Study||0
6553961|NCT01746173|7476430|FG000|STARTED|Overall Study||5
6553962|NCT01746173|7476430|FG000|COMPLETED|Overall Study||3
6553963|NCT01746173|7476430|FG000|NOT COMPLETED|Overall Study||2
6553964|NCT01746225|7476437|FG000|STARTED|Overall Study||83
6553965|NCT01746225|7476438|FG001|STARTED|Overall Study||86
6553966|NCT01746225|7476439|FG002|STARTED|Overall Study||86
6553967|NCT01746225|7476437|FG000|COMPLETED|Overall Study||43
6553968|NCT01746225|7476438|FG001|COMPLETED|Overall Study||40
6553969|NCT01746225|7476439|FG002|COMPLETED|Overall Study||43
6553970|NCT01746225|7476437|FG000|NOT COMPLETED|Overall Study||40
6553971|NCT01746225|7476438|FG001|NOT COMPLETED|Overall Study||46
6461608|NCT01210495|7378400|FG003|COMPLETED|Overall Study||0
6553972|NCT01746225|7476439|FG002|NOT COMPLETED|Overall Study||43
6461609|NCT01210495|7378397|FG000|NOT COMPLETED|Overall Study||15
6553973|NCT01746264|7476447|FG000|STARTED|Overall Study||19
6553974|NCT01746264|7476447|FG000|COMPLETED|Overall Study||19
6461610|NCT01210495|7378398|FG001|NOT COMPLETED|Overall Study||7
6461611|NCT01210495|7378399|FG002|NOT COMPLETED|Overall Study||134
6461612|NCT01210495|7378400|FG003|NOT COMPLETED|Overall Study||68
6461613|NCT01210560|7378412|FG000|STARTED|Intervention 1 (7 Days)||2
6461614|NCT01210560|7378413|FG001|STARTED|Intervention 1 (7 Days)||2
6461615|NCT01210560|7378414|FG002|STARTED|Intervention 1 (7 Days)||2
6461616|NCT01210560|7378415|FG003|STARTED|Intervention 1 (7 Days)||2
6461617|NCT01210560|7378416|FG004|STARTED|Intervention 1 (7 Days)||2
6553975|NCT01746264|7476447|FG000|NOT COMPLETED|Overall Study||0
6553976|NCT01746368|7476453|FG000|STARTED|Overall Study||33
6553977|NCT01746368|7476454|FG001|STARTED|Overall Study||17
6553978|NCT01746368|7476453|FG000|Recieved Allocated Intervention|Overall Study||31
6553979|NCT01746368|7476454|FG001|Recieved Allocated Intervention|Overall Study||8
6553980|NCT01746368|7476453|FG000|Assessment Completed|Overall Study||31
6553981|NCT01746368|7476454|FG001|Assessment Completed|Overall Study||16
6553982|NCT01746368|7476453|FG000|Analyzed for AD Completion Rate|Overall Study||32
6553983|NCT01746368|7476454|FG001|Analyzed for AD Completion Rate|Overall Study||17
6553984|NCT01746368|7476453|FG000|Analyzed for Satisfaction|Overall Study||30
6553985|NCT01746368|7476454|FG001|Analyzed for Satisfaction|Overall Study||16
6553986|NCT01746368|7476453|FG000|COMPLETED|Overall Study||31
6553987|NCT01746368|7476454|FG001|COMPLETED|Overall Study||16
6553988|NCT01746368|7476453|FG000|NOT COMPLETED|Overall Study||2
6553989|NCT01746368|7476454|FG001|NOT COMPLETED|Overall Study||1
6553990|NCT01746420|7476465|FG000|STARTED|Overall Study||20
6553991|NCT01746420|7476466|FG001|STARTED|Overall Study||20
6553992|NCT01746420|7476467|FG002|STARTED|Overall Study||20
6553993|NCT01746420|7476468|FG003|STARTED|Overall Study||20
6553994|NCT01746420|7476469|FG004|STARTED|Overall Study||20
6553995|NCT01746420|7476465|FG000|COMPLETED|Overall Study||17
6553996|NCT01746420|7476466|FG001|COMPLETED|Overall Study||18
6553997|NCT01746420|7476467|FG002|COMPLETED|Overall Study||17
6553998|NCT01746420|7476468|FG003|COMPLETED|Overall Study||20
6745700|NCT03363854|7673659|FG000|STARTED|Initial Treatment Period||253
6745701|NCT03363854|7673660|FG001|STARTED|Initial Treatment Period||127
6745702|NCT03363854|7673661|FG002|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
6745703|NCT03363854|7673662|FG003|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
6745704|NCT03363854|7673663|FG004|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
6745705|NCT03363854|7673664|FG005|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
6745706|NCT03363854|7673665|FG006|STARTED|Initial Treatment Period|This treatment group applies to the continuation treatment period (see below).|0
6745707|NCT03363854|7673666|FG007|STARTED|Initial Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
6745708|NCT03363854|7673659|FG000|COMPLETED|Initial Treatment Period||235
6745709|NCT03363854|7673660|FG001|COMPLETED|Initial Treatment Period||120
6745710|NCT03363854|7673661|FG002|COMPLETED|Initial Treatment Period||0
6745711|NCT03363854|7673662|FG003|COMPLETED|Initial Treatment Period||0
6745712|NCT03363854|7673663|FG004|COMPLETED|Initial Treatment Period||0
6745713|NCT03363854|7673664|FG005|COMPLETED|Initial Treatment Period||0
6745714|NCT03363854|7673665|FG006|COMPLETED|Initial Treatment Period||0
6745715|NCT03363854|7673666|FG007|COMPLETED|Initial Treatment Period||0
6745716|NCT03363854|7673659|FG000|NOT COMPLETED|Initial Treatment Period||18
6745717|NCT03363854|7673660|FG001|NOT COMPLETED|Initial Treatment Period||7
6745718|NCT03363854|7673661|FG002|NOT COMPLETED|Initial Treatment Period||0
6745719|NCT03363854|7673662|FG003|NOT COMPLETED|Initial Treatment Period||0
6745720|NCT03363854|7673663|FG004|NOT COMPLETED|Initial Treatment Period||0
6745721|NCT03363854|7673664|FG005|NOT COMPLETED|Initial Treatment Period||0
6745722|NCT03363854|7673665|FG006|NOT COMPLETED|Initial Treatment Period||0
6745723|NCT03363854|7673666|FG007|NOT COMPLETED|Initial Treatment Period||0
6745724|NCT03363854|7673659|FG000|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
6745725|NCT03363854|7673660|FG001|STARTED|Continuation Treatment Period|This treatment group applies to the initial treatment period (see above).|0
6745726|NCT03363854|7673661|FG002|STARTED|Continuation Treatment Period||69
6745727|NCT03363854|7673662|FG003|STARTED|Continuation Treatment Period||69
6745728|NCT03363854|7673663|FG004|STARTED|Continuation Treatment Period||95
6745729|NCT03363854|7673664|FG005|STARTED|Continuation Treatment Period||79
6745730|NCT03363854|7673665|FG006|STARTED|Continuation Treatment Period||41
6745731|NCT03363854|7673666|FG007|STARTED|Continuation Treatment Period|This treatment group applies to the safety follow-up period (see below).|0
6745732|NCT03363854|7673659|FG000|COMPLETED|Continuation Treatment Period||0
6745733|NCT03363854|7673660|FG001|COMPLETED|Continuation Treatment Period||0
6745734|NCT03363854|7673661|FG002|COMPLETED|Continuation Treatment Period||68
6745735|NCT03363854|7673662|FG003|COMPLETED|Continuation Treatment Period||65
6745736|NCT03363854|7673663|FG004|COMPLETED|Continuation Treatment Period||87
6745737|NCT03363854|7673664|FG005|COMPLETED|Continuation Treatment Period||72
6745738|NCT03363854|7673665|FG006|COMPLETED|Continuation Treatment Period||38
6745739|NCT03363854|7673666|FG007|COMPLETED|Continuation Treatment Period||0
6745740|NCT03363854|7673659|FG000|NOT COMPLETED|Continuation Treatment Period||0
6745741|NCT03363854|7673660|FG001|NOT COMPLETED|Continuation Treatment Period||0
6745742|NCT03363854|7673661|FG002|NOT COMPLETED|Continuation Treatment Period||1
6745743|NCT03363854|7673662|FG003|NOT COMPLETED|Continuation Treatment Period||4
6745744|NCT03363854|7673663|FG004|NOT COMPLETED|Continuation Treatment Period||8
6745745|NCT03363854|7673664|FG005|NOT COMPLETED|Continuation Treatment Period||7
6745746|NCT03363854|7673665|FG006|NOT COMPLETED|Continuation Treatment Period||3
6745747|NCT03363854|7673666|FG007|NOT COMPLETED|Continuation Treatment Period||0
6745748|NCT03363854|7673659|FG000|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
6745749|NCT03363854|7673660|FG001|STARTED|Safety Follow-up Period|This treatment group applies to the initial treatment period (see above).|0
6553999|NCT01746420|7476469|FG004|COMPLETED|Overall Study||20
6554000|NCT01746420|7476465|FG000|NOT COMPLETED|Overall Study||3
6554001|NCT01746420|7476466|FG001|NOT COMPLETED|Overall Study||2
6554002|NCT01746420|7476467|FG002|NOT COMPLETED|Overall Study||3
6554003|NCT01746420|7476468|FG003|NOT COMPLETED|Overall Study||0
6554004|NCT01746420|7476469|FG004|NOT COMPLETED|Overall Study||0
6745750|NCT03363854|7673661|FG002|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
6745751|NCT03363854|7673662|FG003|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
6461618|NCT01210560|7378417|FG005|STARTED|Intervention 1 (7 Days)||2
6461619|NCT01210560|7378418|FG006|STARTED|Intervention 1 (7 Days)||4
6461620|NCT01210560|7378419|FG007|STARTED|Intervention 1 (7 Days)||4
6461621|NCT01210560|7378420|FG008|STARTED|Intervention 1 (7 Days)||5
6461622|NCT01210560|7378412|FG000|COMPLETED|Intervention 1 (7 Days)||2
6461623|NCT01210560|7378413|FG001|COMPLETED|Intervention 1 (7 Days)||2
6461624|NCT01210560|7378414|FG002|COMPLETED|Intervention 1 (7 Days)||2
6461625|NCT01210560|7378415|FG003|COMPLETED|Intervention 1 (7 Days)||2
6461626|NCT01210560|7378416|FG004|COMPLETED|Intervention 1 (7 Days)||2
6461627|NCT01210560|7378417|FG005|COMPLETED|Intervention 1 (7 Days)||2
6461628|NCT01210560|7378418|FG006|COMPLETED|Intervention 1 (7 Days)||4
6461629|NCT01210560|7378419|FG007|COMPLETED|Intervention 1 (7 Days)||4
6461630|NCT01210560|7378420|FG008|COMPLETED|Intervention 1 (7 Days)||5
6461631|NCT01210560|7378412|FG000|NOT COMPLETED|Intervention 1 (7 Days)||0
6461632|NCT01210560|7378413|FG001|NOT COMPLETED|Intervention 1 (7 Days)||0
6461633|NCT01210560|7378414|FG002|NOT COMPLETED|Intervention 1 (7 Days)||0
6461634|NCT01210560|7378415|FG003|NOT COMPLETED|Intervention 1 (7 Days)||0
6461635|NCT01210560|7378416|FG004|NOT COMPLETED|Intervention 1 (7 Days)||0
6461636|NCT01210560|7378417|FG005|NOT COMPLETED|Intervention 1 (7 Days)||0
6461637|NCT01210560|7378418|FG006|NOT COMPLETED|Intervention 1 (7 Days)||0
6461638|NCT01210560|7378419|FG007|NOT COMPLETED|Intervention 1 (7 Days)||0
6461639|NCT01210560|7378420|FG008|NOT COMPLETED|Intervention 1 (7 Days)||0
6461640|NCT01210560|7378412|FG000|STARTED|Intervention 2 (7 Days)||2
6461641|NCT01210560|7378413|FG001|STARTED|Intervention 2 (7 Days)||2
6461642|NCT01210560|7378414|FG002|STARTED|Intervention 2 (7 Days)||2
6461643|NCT01210560|7378415|FG003|STARTED|Intervention 2 (7 Days)||2
6461644|NCT01210560|7378416|FG004|STARTED|Intervention 2 (7 Days)||2
6461645|NCT01210560|7378417|FG005|STARTED|Intervention 2 (7 Days)||2
6461646|NCT01210560|7378418|FG006|STARTED|Intervention 2 (7 Days)||4
6461647|NCT01210560|7378419|FG007|STARTED|Intervention 2 (7 Days)||4
6461648|NCT01210560|7378420|FG008|STARTED|Intervention 2 (7 Days)||5
6461649|NCT01210560|7378412|FG000|COMPLETED|Intervention 2 (7 Days)||2
6461650|NCT01210560|7378413|FG001|COMPLETED|Intervention 2 (7 Days)||2
6461651|NCT01210560|7378414|FG002|COMPLETED|Intervention 2 (7 Days)||2
6461652|NCT01210560|7378415|FG003|COMPLETED|Intervention 2 (7 Days)||2
6461653|NCT01210560|7378416|FG004|COMPLETED|Intervention 2 (7 Days)||2
6461654|NCT01210560|7378417|FG005|COMPLETED|Intervention 2 (7 Days)||2
6461655|NCT01210560|7378418|FG006|COMPLETED|Intervention 2 (7 Days)||4
6461656|NCT01210560|7378419|FG007|COMPLETED|Intervention 2 (7 Days)||4
6461657|NCT01210560|7378420|FG008|COMPLETED|Intervention 2 (7 Days)||5
6461658|NCT01210560|7378412|FG000|NOT COMPLETED|Intervention 2 (7 Days)||0
6554005|NCT01746511|7476484|FG000|STARTED|Overall Study||40
6554006|NCT01746511|7476485|FG001|STARTED|Overall Study||39
6745752|NCT03363854|7673663|FG004|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
6745753|NCT03363854|7673664|FG005|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
6745754|NCT03363854|7673665|FG006|STARTED|Safety Follow-up Period|This treatment group applies to the continuation treatment period (see above).|0
6745755|NCT03363854|7673666|FG007|STARTED|Safety Follow-up Period||278
6745756|NCT03363854|7673659|FG000|COMPLETED|Safety Follow-up Period||0
6745757|NCT03363854|7673660|FG001|COMPLETED|Safety Follow-up Period||0
6745758|NCT03363854|7673661|FG002|COMPLETED|Safety Follow-up Period||0
6745759|NCT03363854|7673662|FG003|COMPLETED|Safety Follow-up Period||0
6745760|NCT03363854|7673663|FG004|COMPLETED|Safety Follow-up Period||0
6745761|NCT03363854|7673664|FG005|COMPLETED|Safety Follow-up Period||0
6745762|NCT03363854|7673665|FG006|COMPLETED|Safety Follow-up Period||0
6745763|NCT03363854|7673666|FG007|COMPLETED|Safety Follow-up Period||62
6745764|NCT03363854|7673659|FG000|NOT COMPLETED|Safety Follow-up Period||0
6745765|NCT03363854|7673660|FG001|NOT COMPLETED|Safety Follow-up Period||0
6745766|NCT03363854|7673661|FG002|NOT COMPLETED|Safety Follow-up Period||0
6745767|NCT03363854|7673662|FG003|NOT COMPLETED|Safety Follow-up Period||0
6745768|NCT03363854|7673663|FG004|NOT COMPLETED|Safety Follow-up Period||0
6745769|NCT03363854|7673664|FG005|NOT COMPLETED|Safety Follow-up Period||0
6745770|NCT03363854|7673665|FG006|NOT COMPLETED|Safety Follow-up Period||0
6745771|NCT03363854|7673666|FG007|NOT COMPLETED|Safety Follow-up Period||216
6461659|NCT01210560|7378413|FG001|NOT COMPLETED|Intervention 2 (7 Days)||0
6461660|NCT01210560|7378414|FG002|NOT COMPLETED|Intervention 2 (7 Days)||0
6461661|NCT01210560|7378415|FG003|NOT COMPLETED|Intervention 2 (7 Days)||0
6461662|NCT01210560|7378416|FG004|NOT COMPLETED|Intervention 2 (7 Days)||0
6461663|NCT01210560|7378417|FG005|NOT COMPLETED|Intervention 2 (7 Days)||0
6461664|NCT01210560|7378418|FG006|NOT COMPLETED|Intervention 2 (7 Days)||0
6461665|NCT01210560|7378419|FG007|NOT COMPLETED|Intervention 2 (7 Days)||0
6554007|NCT01746511|7476484|FG000|COMPLETED|Overall Study||40
6554008|NCT01746511|7476485|FG001|COMPLETED|Overall Study||39
6554009|NCT01746511|7476484|FG000|NOT COMPLETED|Overall Study||0
6554010|NCT01746511|7476485|FG001|NOT COMPLETED|Overall Study||0
6554011|NCT01746732|7476491|FG000|STARTED|Lead-In Period||23
6461666|NCT01210560|7378420|FG008|NOT COMPLETED|Intervention 2 (7 Days)||0
6461667|NCT01210560|7378412|FG000|STARTED|Intervention 3 (7 Days)||2
6461668|NCT01210560|7378413|FG001|STARTED|Intervention 3 (7 Days)||2
6461669|NCT01210560|7378414|FG002|STARTED|Intervention 3 (7 Days)||2
6461670|NCT01210560|7378415|FG003|STARTED|Intervention 3 (7 Days)||2
6461671|NCT01210560|7378416|FG004|STARTED|Intervention 3 (7 Days)||2
6461672|NCT01210560|7378417|FG005|STARTED|Intervention 3 (7 Days)||2
6461673|NCT01210560|7378418|FG006|STARTED|Intervention 3 (7 Days)||4
6461674|NCT01210560|7378419|FG007|STARTED|Intervention 3 (7 Days)||4
6461675|NCT01210560|7378420|FG008|STARTED|Intervention 3 (7 Days)||5
6461676|NCT01210560|7378412|FG000|COMPLETED|Intervention 3 (7 Days)||2
6461677|NCT01210560|7378413|FG001|COMPLETED|Intervention 3 (7 Days)||2
6461678|NCT01210560|7378414|FG002|COMPLETED|Intervention 3 (7 Days)||2
6461679|NCT01210560|7378415|FG003|COMPLETED|Intervention 3 (7 Days)||2
6461680|NCT01210560|7378416|FG004|COMPLETED|Intervention 3 (7 Days)||2
6461681|NCT01210560|7378417|FG005|COMPLETED|Intervention 3 (7 Days)||2
6461682|NCT01210560|7378418|FG006|COMPLETED|Intervention 3 (7 Days)||4
6461683|NCT01210560|7378419|FG007|COMPLETED|Intervention 3 (7 Days)||4
6461684|NCT01210560|7378420|FG008|COMPLETED|Intervention 3 (7 Days)||5
6461685|NCT01210560|7378412|FG000|NOT COMPLETED|Intervention 3 (7 Days)||0
6461686|NCT01210560|7378413|FG001|NOT COMPLETED|Intervention 3 (7 Days)||0
6461687|NCT01210560|7378414|FG002|NOT COMPLETED|Intervention 3 (7 Days)||0
6461688|NCT01210560|7378415|FG003|NOT COMPLETED|Intervention 3 (7 Days)||0
6461689|NCT01210560|7378416|FG004|NOT COMPLETED|Intervention 3 (7 Days)||0
6461690|NCT01210560|7378417|FG005|NOT COMPLETED|Intervention 3 (7 Days)||0
6745772|NCT03363906|7673689|FG000|STARTED|Period 1 (Reference or Test)||15
6745773|NCT03363906|7673690|FG001|STARTED|Period 1 (Reference or Test)||12
6745774|NCT03363906|7673689|FG000|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||15
6745775|NCT03363906|7673690|FG001|Received at Least One Dose of Study Drug|Period 1 (Reference or Test)||11
6745776|NCT03363906|7673689|FG000|COMPLETED|Period 1 (Reference or Test)||14
6745777|NCT03363906|7673690|FG001|COMPLETED|Period 1 (Reference or Test)||10
6745778|NCT03363906|7673689|FG000|NOT COMPLETED|Period 1 (Reference or Test)||1
6745779|NCT03363906|7673690|FG001|NOT COMPLETED|Period 1 (Reference or Test)||2
6745780|NCT03363906|7673689|FG000|STARTED|Period 2 (Test or Reference)||14
6745781|NCT03363906|7673690|FG001|STARTED|Period 2 (Test or Reference)||10
6745782|NCT03363906|7673689|FG000|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||12
6745783|NCT03363906|7673690|FG001|Received at Least One Dose of Study Drug|Period 2 (Test or Reference)||9
6745784|NCT03363906|7673689|FG000|COMPLETED|Period 2 (Test or Reference)||10
6745785|NCT03363906|7673690|FG001|COMPLETED|Period 2 (Test or Reference)||9
6745786|NCT03363906|7673689|FG000|NOT COMPLETED|Period 2 (Test or Reference)||4
6745787|NCT03363906|7673690|FG001|NOT COMPLETED|Period 2 (Test or Reference)||1
6745788|NCT03364023|7673696|FG000|STARTED|Overall Study||183
6745789|NCT03364023|7673696|FG000|COMPLETED|Overall Study||166
6745790|NCT03364023|7673696|FG000|NOT COMPLETED|Overall Study||17
6745791|NCT03364049|7673704|FG000|STARTED|Overall Study||6
6745792|NCT03364049|7673705|FG001|STARTED|Overall Study||6
6745793|NCT03364049|7673706|FG002|STARTED|Overall Study||6
6745794|NCT03364049|7673707|FG003|STARTED|Overall Study||15
6745795|NCT03364049|7673704|FG000|COMPLETED|Overall Study||0
6745796|NCT03364049|7673705|FG001|COMPLETED|Overall Study||0
6745797|NCT03364049|7673706|FG002|COMPLETED|Overall Study||0
6745798|NCT03364049|7673707|FG003|COMPLETED|Overall Study||0
6745799|NCT03364049|7673704|FG000|NOT COMPLETED|Overall Study||6
6745800|NCT03364049|7673705|FG001|NOT COMPLETED|Overall Study||6
6745801|NCT03364049|7673706|FG002|NOT COMPLETED|Overall Study||6
6745802|NCT03364049|7673707|FG003|NOT COMPLETED|Overall Study||15
6745803|NCT03364192|7673717|FG000|STARTED|Overall Study||28
6745804|NCT03364192|7673717|FG000|COMPLETED|Overall Study||12
6745805|NCT03364192|7673717|FG000|NOT COMPLETED|Overall Study||16
6745806|NCT03364309|7673725|FG000|STARTED|Induction Period||88
6745807|NCT03364309|7673726|FG001|STARTED|Induction Period||174
6745808|NCT03364309|7673727|FG002|STARTED|Induction Period||176
6745809|NCT03364309|7673728|FG003|STARTED|Induction Period||0
6745810|NCT03364309|7673729|FG004|STARTED|Induction Period||0
6745811|NCT03364309|7673730|FG005|STARTED|Induction Period||0
6745812|NCT03364309|7673731|FG006|STARTED|Induction Period||0
6745813|NCT03364309|7673732|FG007|STARTED|Induction Period||0
6745814|NCT03364309|7673733|FG008|STARTED|Induction Period||0
6745815|NCT03364309|7673734|FG009|STARTED|Induction Period||0
6745816|NCT03364309|7673735|FG010|STARTED|Induction Period||0
6745817|NCT03364309|7673736|FG011|STARTED|Induction Period||0
6745818|NCT03364309|7673737|FG012|STARTED|Induction Period||0
6745819|NCT03364309|7673738|FG013|STARTED|Induction Period||0
6745820|NCT03364309|7673739|FG014|STARTED|Induction Period||0
6745821|NCT03364309|7673740|FG015|STARTED|Induction Period||0
6461691|NCT01210560|7378418|FG006|NOT COMPLETED|Intervention 3 (7 Days)||0
6745822|NCT03364309|7673741|FG016|STARTED|Induction Period||0
6745823|NCT03364309|7673742|FG017|STARTED|Induction Period||0
6745824|NCT03364309|7673743|FG018|STARTED|Induction Period||0
6461692|NCT01210560|7378419|FG007|NOT COMPLETED|Intervention 3 (7 Days)||0
6461693|NCT01210560|7378420|FG008|NOT COMPLETED|Intervention 3 (7 Days)||0
6461694|NCT01210651|7378435|FG000|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
6500776|NCT01425801|7419344|FG000|NOT COMPLETED|Period 6||0
6500777|NCT01425801|7419345|FG001|NOT COMPLETED|Period 6||0
6461695|NCT01210651|7378436|FG001|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
6461696|NCT01210651|7378435|FG000|Number Attending 1st Assigned Session|Overall Study||18
6461697|NCT01210651|7378436|FG001|Number Attending 1st Assigned Session|Overall Study||12
6461698|NCT01210651|7378435|FG000|COMPLETED|Overall Study||15
6461699|NCT01210651|7378436|FG001|COMPLETED|Overall Study||10
6461700|NCT01210651|7378435|FG000|NOT COMPLETED|Overall Study||5
6461701|NCT01210651|7378436|FG001|NOT COMPLETED|Overall Study||8
6461702|NCT01210664|7378446|FG000|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
6461703|NCT01210664|7378447|FG001|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461704|NCT01210664|7378448|FG002|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461705|NCT01210664|7378449|FG003|STARTED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461706|NCT01210664|7378446|FG000|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
6461707|NCT01210664|7378447|FG001|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461708|NCT01210664|7378448|FG002|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461709|NCT01210664|7378449|FG003|Received Study Treatment|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461710|NCT01210664|7378446|FG000|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||3
6461711|NCT01210664|7378447|FG001|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461712|NCT01210664|7378448|FG002|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461713|NCT01210664|7378449|FG003|COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461714|NCT01210664|7378446|FG000|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461715|NCT01210664|7378447|FG001|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461716|NCT01210664|7378448|FG002|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461717|NCT01210664|7378449|FG003|NOT COMPLETED|Cohort 1: PolyTregs 0.05 x 10^8 Cells||0
6461718|NCT01210664|7378446|FG000|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461719|NCT01210664|7378447|FG001|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
6461720|NCT01210664|7378448|FG002|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461721|NCT01210664|7378449|FG003|STARTED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461722|NCT01210664|7378446|FG000|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461723|NCT01210664|7378447|FG001|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
6461724|NCT01210664|7378448|FG002|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461725|NCT01210664|7378449|FG003|Received Study Treatment|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461726|NCT01210664|7378446|FG000|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461727|NCT01210664|7378447|FG001|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||3
6461728|NCT01210664|7378448|FG002|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461729|NCT01210664|7378449|FG003|COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461730|NCT01210664|7378446|FG000|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461731|NCT01210664|7378447|FG001|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461732|NCT01210664|7378448|FG002|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461733|NCT01210664|7378449|FG003|NOT COMPLETED|Cohort 2: PolyTregs 0.4 x 10^8 Cells||0
6461734|NCT01210664|7378446|FG000|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461735|NCT01210664|7378447|FG001|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461736|NCT01210664|7378448|FG002|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||5
6461737|NCT01210664|7378449|FG003|STARTED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461738|NCT01210664|7378446|FG000|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461739|NCT01210664|7378447|FG001|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461740|NCT01210664|7378448|FG002|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||4
6461741|NCT01210664|7378449|FG003|Received Study Treatment|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461742|NCT01210664|7378446|FG000|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461743|NCT01210664|7378447|FG001|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461744|NCT01210664|7378448|FG002|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||3
6461745|NCT01210664|7378449|FG003|COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461746|NCT01210664|7378446|FG000|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461747|NCT01210664|7378447|FG001|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461748|NCT01210664|7378448|FG002|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||2
6461749|NCT01210664|7378449|FG003|NOT COMPLETED|Cohort 3: PolyTregs 3.2 x 10^8 Cells||0
6461750|NCT01210664|7378446|FG000|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461751|NCT01210664|7378447|FG001|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461752|NCT01210664|7378448|FG002|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461753|NCT01210664|7378449|FG003|STARTED|Cohort 4: PolyTregs 26 x 10^8 Cells||5
6461754|NCT01210664|7378446|FG000|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461755|NCT01210664|7378447|FG001|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461756|NCT01210664|7378448|FG002|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461757|NCT01210664|7378449|FG003|Received Study Treatment|Cohort 4: PolyTregs 26 x 10^8 Cells||4
6461758|NCT01210664|7378446|FG000|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461759|NCT01210664|7378447|FG001|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6554012|NCT01746732|7476492|FG001|STARTED|Lead-In Period||0
6554013|NCT01746732|7476493|FG002|STARTED|Lead-In Period||0
6554014|NCT01746732|7476491|FG000|Participants Received at Least 1 Dose|Lead-In Period||22
6554015|NCT01746732|7476492|FG001|Participants Received at Least 1 Dose|Lead-In Period||0
6554016|NCT01746732|7476493|FG002|Participants Received at Least 1 Dose|Lead-In Period||0
6554017|NCT01746732|7476491|FG000|COMPLETED|Lead-In Period||22
6554018|NCT01746732|7476492|FG001|COMPLETED|Lead-In Period||0
6554019|NCT01746732|7476493|FG002|COMPLETED|Lead-In Period||0
6554020|NCT01746732|7476491|FG000|NOT COMPLETED|Lead-In Period||1
6554021|NCT01746732|7476492|FG001|NOT COMPLETED|Lead-In Period||0
6461760|NCT01210664|7378448|FG002|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461761|NCT01210664|7378449|FG003|COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||4
6461762|NCT01210664|7378446|FG000|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461763|NCT01210664|7378447|FG001|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461764|NCT01210664|7378448|FG002|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||0
6461765|NCT01210664|7378449|FG003|NOT COMPLETED|Cohort 4: PolyTregs 26 x 10^8 Cells||1
6461766|NCT01210690|7378459|FG000|STARTED|Overall Study||101
6461767|NCT01210690|7378459|FG000|COMPLETED|Overall Study||75
6461768|NCT01210690|7378459|FG000|NOT COMPLETED|Overall Study||26
6461769|NCT01210716|7378464|FG000|STARTED|First TPE Procedure||20
6461770|NCT01210716|7378465|FG001|STARTED|First TPE Procedure||17
6461771|NCT01210716|7378464|FG000|COMPLETED|First TPE Procedure||18
6461772|NCT01210716|7378465|FG001|COMPLETED|First TPE Procedure||15
6461773|NCT01210716|7378464|FG000|NOT COMPLETED|First TPE Procedure||2
6461774|NCT01210716|7378465|FG001|NOT COMPLETED|First TPE Procedure||2
6461775|NCT01210716|7378464|FG000|STARTED|Second TPE Procedure||18
6461776|NCT01210716|7378465|FG001|STARTED|Second TPE Procedure||15
6461777|NCT01210716|7378464|FG000|COMPLETED|Second TPE Procedure||15
6461778|NCT01210716|7378465|FG001|COMPLETED|Second TPE Procedure||15
6461779|NCT01210716|7378464|FG000|NOT COMPLETED|Second TPE Procedure||3
6461780|NCT01210716|7378465|FG001|NOT COMPLETED|Second TPE Procedure||0
6461781|NCT01210807|7378473|FG000|STARTED|Overall Study||36
6461782|NCT01210807|7378474|FG001|STARTED|Overall Study||34
6461783|NCT01210807|7378473|FG000|COMPLETED|Overall Study||33
6461784|NCT01210807|7378474|FG001|COMPLETED|Overall Study||31
6461785|NCT01210807|7378473|FG000|NOT COMPLETED|Overall Study||3
6461786|NCT01210807|7378474|FG001|NOT COMPLETED|Overall Study||3
6461787|NCT01210820|7378482|FG000|STARTED|Overall Study||17
6461788|NCT01210820|7378483|FG001|STARTED|Overall Study||4
6461789|NCT01210820|7378482|FG000|COMPLETED|Overall Study||17
6461790|NCT01210820|7378483|FG001|COMPLETED|Overall Study||4
6461791|NCT01210820|7378482|FG000|NOT COMPLETED|Overall Study||0
6461792|NCT01210820|7378483|FG001|NOT COMPLETED|Overall Study||0
6461793|NCT01211106|7378491|FG000|STARTED|Overall Study||95
6461794|NCT01211106|7378492|FG001|STARTED|Overall Study||88
6461795|NCT01211106|7378491|FG000|COMPLETED|Overall Study||82
6461796|NCT01211106|7378492|FG001|COMPLETED|Overall Study||77
6461797|NCT01211106|7378491|FG000|NOT COMPLETED|Overall Study||13
6461798|NCT01211106|7378492|FG001|NOT COMPLETED|Overall Study||11
6461799|NCT01211145|7378504|FG000|STARTED|Overall Study||296
6461800|NCT01211145|7378505|FG001|STARTED|Overall Study||115
6461801|NCT01211145|7378506|FG002|STARTED|Overall Study||99
6461802|NCT01211145|7378507|FG003|STARTED|Overall Study||288
6461803|NCT01211145|7378504|FG000|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
6461804|NCT01211145|7378505|FG001|COMPLETED|Overall Study||98
6461805|NCT01211145|7378506|FG002|COMPLETED|Overall Study||86
6461806|NCT01211145|7378507|FG003|COMPLETED|Overall Study||268
6461807|NCT01211145|7378504|FG000|NOT COMPLETED|Overall Study||26
6461808|NCT01211145|7378505|FG001|NOT COMPLETED|Overall Study||17
6461809|NCT01211145|7378506|FG002|NOT COMPLETED|Overall Study||13
6461810|NCT01211145|7378507|FG003|NOT COMPLETED|Overall Study||20
6461811|NCT01211184|7378520|FG000|STARTED|Overall Study||20
6461812|NCT01211184|7378521|FG001|STARTED|Overall Study||20
6461813|NCT01211184|7378522|FG002|STARTED|Overall Study||20
6461814|NCT01211184|7378520|FG000|COMPLETED|Overall Study||20
6461815|NCT01211184|7378521|FG001|COMPLETED|Overall Study||18
6461816|NCT01211184|7378522|FG002|COMPLETED|Overall Study||19
6461817|NCT01211184|7378520|FG000|NOT COMPLETED|Overall Study||0
6461818|NCT01211184|7378521|FG001|NOT COMPLETED|Overall Study||2
6461819|NCT01211184|7378522|FG002|NOT COMPLETED|Overall Study||1
6461820|NCT01211197|7378533|FG000|STARTED|Treatment Period 1 (1 Day)||3
6461821|NCT01211197|7378534|FG001|STARTED|Treatment Period 1 (1 Day)||3
6461822|NCT01211197|7378535|FG002|STARTED|Treatment Period 1 (1 Day)||3
6461823|NCT01211197|7378536|FG003|STARTED|Treatment Period 1 (1 Day)||3
6461824|NCT01211197|7378537|FG004|STARTED|Treatment Period 1 (1 Day)||2
6461825|NCT01211197|7378538|FG005|STARTED|Treatment Period 1 (1 Day)||2
6461826|NCT01211197|7378533|FG000|COMPLETED|Treatment Period 1 (1 Day)||3
6461827|NCT01211197|7378534|FG001|COMPLETED|Treatment Period 1 (1 Day)||3
6461828|NCT01211197|7378535|FG002|COMPLETED|Treatment Period 1 (1 Day)||3
6461829|NCT01211197|7378536|FG003|COMPLETED|Treatment Period 1 (1 Day)||3
6461830|NCT01211197|7378537|FG004|COMPLETED|Treatment Period 1 (1 Day)||2
6461831|NCT01211197|7378538|FG005|COMPLETED|Treatment Period 1 (1 Day)||2
6461832|NCT01211197|7378533|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6461833|NCT01211197|7378534|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6461834|NCT01211197|7378535|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6461835|NCT01211197|7378536|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6461836|NCT01211197|7378537|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6461837|NCT01211197|7378538|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6461838|NCT01211197|7378533|FG000|STARTED|Washout Period 1 (7 Days)||3
6461839|NCT01211197|7378534|FG001|STARTED|Washout Period 1 (7 Days)||3
6461840|NCT01211197|7378535|FG002|STARTED|Washout Period 1 (7 Days)||3
6461841|NCT01211197|7378536|FG003|STARTED|Washout Period 1 (7 Days)||3
6461842|NCT01211197|7378537|FG004|STARTED|Washout Period 1 (7 Days)||2
6461843|NCT01211197|7378538|FG005|STARTED|Washout Period 1 (7 Days)||2
6461844|NCT01211197|7378533|FG000|COMPLETED|Washout Period 1 (7 Days)||3
6461845|NCT01211197|7378534|FG001|COMPLETED|Washout Period 1 (7 Days)||3
6461846|NCT01211197|7378535|FG002|COMPLETED|Washout Period 1 (7 Days)||2
6461847|NCT01211197|7378536|FG003|COMPLETED|Washout Period 1 (7 Days)||3
6461848|NCT01211197|7378537|FG004|COMPLETED|Washout Period 1 (7 Days)||2
6461849|NCT01211197|7378538|FG005|COMPLETED|Washout Period 1 (7 Days)||2
6461850|NCT01211197|7378533|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6461851|NCT01211197|7378534|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6461852|NCT01211197|7378535|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
6461853|NCT01211197|7378536|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6461854|NCT01211197|7378537|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
6461855|NCT01211197|7378538|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
6461856|NCT01211197|7378533|FG000|STARTED|Treatment Period 2 (1 Day)||3
6461857|NCT01211197|7378534|FG001|STARTED|Treatment Period 2 (1 Day)||3
6461858|NCT01211197|7378535|FG002|STARTED|Treatment Period 2 (1 Day)||2
6461859|NCT01211197|7378536|FG003|STARTED|Treatment Period 2 (1 Day)||3
6461860|NCT01211197|7378537|FG004|STARTED|Treatment Period 2 (1 Day)||2
6461861|NCT01211197|7378538|FG005|STARTED|Treatment Period 2 (1 Day)||2
6461862|NCT01211197|7378533|FG000|COMPLETED|Treatment Period 2 (1 Day)||3
6461863|NCT01211197|7378534|FG001|COMPLETED|Treatment Period 2 (1 Day)||3
6461864|NCT01211197|7378535|FG002|COMPLETED|Treatment Period 2 (1 Day)||2
6461865|NCT01211197|7378536|FG003|COMPLETED|Treatment Period 2 (1 Day)||3
6461866|NCT01211197|7378537|FG004|COMPLETED|Treatment Period 2 (1 Day)||2
6461867|NCT01211197|7378538|FG005|COMPLETED|Treatment Period 2 (1 Day)||2
6461868|NCT01211197|7378533|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6461869|NCT01211197|7378534|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6461870|NCT01211197|7378535|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6461871|NCT01211197|7378536|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6461872|NCT01211197|7378537|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6461873|NCT01211197|7378538|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6461874|NCT01211197|7378533|FG000|STARTED|Washout Period 2 (7 Days)||3
6461875|NCT01211197|7378534|FG001|STARTED|Washout Period 2 (7 Days)||3
6461876|NCT01211197|7378535|FG002|STARTED|Washout Period 2 (7 Days)||2
6461877|NCT01211197|7378536|FG003|STARTED|Washout Period 2 (7 Days)||3
6461878|NCT01211197|7378537|FG004|STARTED|Washout Period 2 (7 Days)||2
6461879|NCT01211197|7378538|FG005|STARTED|Washout Period 2 (7 Days)||2
6461880|NCT01211197|7378533|FG000|COMPLETED|Washout Period 2 (7 Days)||2
6461881|NCT01211197|7378534|FG001|COMPLETED|Washout Period 2 (7 Days)||3
6461882|NCT01211197|7378535|FG002|COMPLETED|Washout Period 2 (7 Days)||2
6461883|NCT01211197|7378536|FG003|COMPLETED|Washout Period 2 (7 Days)||3
6461884|NCT01211197|7378537|FG004|COMPLETED|Washout Period 2 (7 Days)||2
6461885|NCT01211197|7378538|FG005|COMPLETED|Washout Period 2 (7 Days)||2
6461886|NCT01211197|7378533|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||1
6461887|NCT01211197|7378534|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6461888|NCT01211197|7378535|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6461889|NCT01211197|7378536|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6461890|NCT01211197|7378537|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6461891|NCT01211197|7378538|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6745825|NCT03364309|7673725|FG000|Received at Least One Dose of Study Drug|Induction Period||88
6745826|NCT03364309|7673726|FG001|Received at Least One Dose of Study Drug|Induction Period||174
6745827|NCT03364309|7673727|FG002|Received at Least One Dose of Study Drug|Induction Period||176
6745828|NCT03364309|7673728|FG003|Received at Least One Dose of Study Drug|Induction Period||0
6745829|NCT03364309|7673729|FG004|Received at Least One Dose of Study Drug|Induction Period||0
6745830|NCT03364309|7673730|FG005|Received at Least One Dose of Study Drug|Induction Period||0
6745831|NCT03364309|7673731|FG006|Received at Least One Dose of Study Drug|Induction Period||0
6745832|NCT03364309|7673732|FG007|Received at Least One Dose of Study Drug|Induction Period||0
6745833|NCT03364309|7673733|FG008|Received at Least One Dose of Study Drug|Induction Period||0
6745834|NCT03364309|7673734|FG009|Received at Least One Dose of Study Drug|Induction Period||0
6745835|NCT03364309|7673735|FG010|Received at Least One Dose of Study Drug|Induction Period||0
6745836|NCT03364309|7673736|FG011|Received at Least One Dose of Study Drug|Induction Period||0
6745837|NCT03364309|7673737|FG012|Received at Least One Dose of Study Drug|Induction Period||0
6745838|NCT03364309|7673738|FG013|Received at Least One Dose of Study Drug|Induction Period||0
6745839|NCT03364309|7673739|FG014|Received at Least One Dose of Study Drug|Induction Period||0
6745840|NCT03364309|7673740|FG015|Received at Least One Dose of Study Drug|Induction Period||0
6745841|NCT03364309|7673741|FG016|Received at Least One Dose of Study Drug|Induction Period||0
6745842|NCT03364309|7673742|FG017|Received at Least One Dose of Study Drug|Induction Period||0
6745843|NCT03364309|7673743|FG018|Received at Least One Dose of Study Drug|Induction Period||0
6745844|NCT03364309|7673725|FG000|COMPLETED|Induction Period||82
6745845|NCT03364309|7673726|FG001|COMPLETED|Induction Period||170
6745846|NCT03364309|7673727|FG002|COMPLETED|Induction Period||175
6745847|NCT03364309|7673728|FG003|COMPLETED|Induction Period||0
6745848|NCT03364309|7673729|FG004|COMPLETED|Induction Period||0
6745849|NCT03364309|7673730|FG005|COMPLETED|Induction Period||0
6745850|NCT03364309|7673731|FG006|COMPLETED|Induction Period||0
6745851|NCT03364309|7673732|FG007|COMPLETED|Induction Period||0
6745852|NCT03364309|7673733|FG008|COMPLETED|Induction Period||0
6745853|NCT03364309|7673734|FG009|COMPLETED|Induction Period||0
6745854|NCT03364309|7673735|FG010|COMPLETED|Induction Period||0
6745855|NCT03364309|7673736|FG011|COMPLETED|Induction Period||0
6461892|NCT01211197|7378533|FG000|STARTED|Treatment Period 3 (1 Day)||2
6461893|NCT01211197|7378534|FG001|STARTED|Treatment Period 3 (1 Day)||3
6461894|NCT01211197|7378535|FG002|STARTED|Treatment Period 3 (1 Day)||2
6461895|NCT01211197|7378536|FG003|STARTED|Treatment Period 3 (1 Day)||3
6461896|NCT01211197|7378537|FG004|STARTED|Treatment Period 3 (1 Day)||2
6461897|NCT01211197|7378538|FG005|STARTED|Treatment Period 3 (1 Day)||2
6461898|NCT01211197|7378533|FG000|COMPLETED|Treatment Period 3 (1 Day)||2
6461899|NCT01211197|7378534|FG001|COMPLETED|Treatment Period 3 (1 Day)||3
6461900|NCT01211197|7378535|FG002|COMPLETED|Treatment Period 3 (1 Day)||2
6461901|NCT01211197|7378536|FG003|COMPLETED|Treatment Period 3 (1 Day)||3
6461902|NCT01211197|7378537|FG004|COMPLETED|Treatment Period 3 (1 Day)||2
6461903|NCT01211197|7378538|FG005|COMPLETED|Treatment Period 3 (1 Day)||2
6461904|NCT01211197|7378533|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6461905|NCT01211197|7378534|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6461906|NCT01211197|7378535|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6461907|NCT01211197|7378536|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6461908|NCT01211197|7378537|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6461909|NCT01211197|7378538|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6461910|NCT01211262|7378548|FG000|STARTED|Overall Study||66
6461911|NCT01211262|7378549|FG001|STARTED|Overall Study||18
6461912|NCT01211262|7378548|FG000|COMPLETED|Overall Study||43
6461913|NCT01211262|7378549|FG001|COMPLETED|Overall Study||8
6461914|NCT01211262|7378548|FG000|NOT COMPLETED|Overall Study||23
6461915|NCT01211262|7378549|FG001|NOT COMPLETED|Overall Study||10
6461916|NCT01211288|7378560|FG000|STARTED|Overall Study||21
6461917|NCT01211288|7378561|FG001|STARTED|Overall Study||20
6461918|NCT01211288|7378560|FG000|COMPLETED|Overall Study||20
6461919|NCT01211288|7378561|FG001|COMPLETED|Overall Study||19
6461920|NCT01211288|7378560|FG000|NOT COMPLETED|Overall Study||1
6461921|NCT01211288|7378561|FG001|NOT COMPLETED|Overall Study||1
6461922|NCT01211340|7378571|FG000|STARTED|Overall Study||223
6461923|NCT01211340|7378572|FG001|STARTED|Overall Study||223
6461924|NCT01211340|7378571|FG000|COMPLETED|Overall Study||223
6461925|NCT01211340|7378572|FG001|COMPLETED|Overall Study||223
6461926|NCT01211340|7378571|FG000|NOT COMPLETED|Overall Study||0
6461927|NCT01211340|7378572|FG001|NOT COMPLETED|Overall Study||0
6461928|NCT01211483|7378582|FG000|STARTED|Phase 1b||7
6461929|NCT01211483|7378583|FG001|STARTED|Phase 1b||0
6461930|NCT01211483|7378584|FG002|STARTED|Phase 1b||0
6461931|NCT01211483|7378585|FG003|STARTED|Phase 1b||0
6461932|NCT01211483|7378582|FG000|COMPLETED|Phase 1b||0
6461933|NCT01211483|7378583|FG001|COMPLETED|Phase 1b||0
6461934|NCT01211483|7378584|FG002|COMPLETED|Phase 1b||0
6461935|NCT01211483|7378585|FG003|COMPLETED|Phase 1b||0
6461936|NCT01211483|7378582|FG000|NOT COMPLETED|Phase 1b||7
6461937|NCT01211483|7378583|FG001|NOT COMPLETED|Phase 1b||0
6461938|NCT01211483|7378584|FG002|NOT COMPLETED|Phase 1b||0
6461939|NCT01211483|7378585|FG003|NOT COMPLETED|Phase 1b||0
6461940|NCT01211483|7378582|FG000|STARTED|Phase 2||0
6461941|NCT01211483|7378583|FG001|STARTED|Phase 2|Participants entered only at Period 2.|72
6461942|NCT01211483|7378584|FG002|STARTED|Phase 2|Participants entered only at Period 2.|72
6461943|NCT01211483|7378585|FG003|STARTED|Phase 2|Participants entered only at Period 2.|71
6461944|NCT01211483|7378582|FG000|COMPLETED|Phase 2||0
6461945|NCT01211483|7378583|FG001|COMPLETED|Phase 2||0
6461946|NCT01211483|7378584|FG002|COMPLETED|Phase 2||0
6461947|NCT01211483|7378585|FG003|COMPLETED|Phase 2||0
6461948|NCT01211483|7378582|FG000|NOT COMPLETED|Phase 2||0
6461949|NCT01211483|7378583|FG001|NOT COMPLETED|Phase 2||72
6461950|NCT01211483|7378584|FG002|NOT COMPLETED|Phase 2||72
6461951|NCT01211483|7378585|FG003|NOT COMPLETED|Phase 2||71
6461952|NCT01211522|7378602|FG000|STARTED|Overall Study||192
6461953|NCT01211522|7378603|FG001|STARTED|Overall Study||190
6461954|NCT01211522|7378604|FG002|STARTED|Overall Study||184
6461955|NCT01211522|7378602|FG000|COMPLETED|Overall Study||189
6461956|NCT01211522|7378603|FG001|COMPLETED|Overall Study||183
6461957|NCT01211522|7378604|FG002|COMPLETED|Overall Study||179
6461958|NCT01211522|7378602|FG000|NOT COMPLETED|Overall Study||3
6461959|NCT01211522|7378603|FG001|NOT COMPLETED|Overall Study||7
6461960|NCT01211522|7378604|FG002|NOT COMPLETED|Overall Study||5
6461961|NCT01211535|7378614|FG000|STARTED|Overall Study||52
6461962|NCT01211535|7378615|FG001|STARTED|Overall Study||52
6461963|NCT01211535|7378614|FG000|COMPLETED|Overall Study||52
6461964|NCT01211535|7378615|FG001|COMPLETED|Overall Study||51
6461965|NCT01211535|7378614|FG000|NOT COMPLETED|Overall Study||0
6461966|NCT01211535|7378615|FG001|NOT COMPLETED|Overall Study||1
6461967|NCT01211600|7378623|FG000|STARTED|Overall Study||370
6461968|NCT01211600|7378624|FG001|STARTED|Overall Study||376
6461969|NCT01211600|7378623|FG000|COMPLETED|Overall Study||370
6461970|NCT01211600|7378624|FG001|COMPLETED|Overall Study||376
6461971|NCT01211600|7378623|FG000|NOT COMPLETED|Overall Study||0
6461972|NCT01211600|7378624|FG001|NOT COMPLETED|Overall Study||0
6461973|NCT01211613|7378635|FG000|STARTED|Overall Study||37
6461974|NCT01211613|7378636|FG001|STARTED|Overall Study||35
6461975|NCT01211613|7378637|FG002|STARTED|Overall Study||35
6461976|NCT01211613|7378635|FG000|COMPLETED|Overall Study||34
6461977|NCT01211613|7378636|FG001|COMPLETED|Overall Study||33
6461978|NCT01211613|7378637|FG002|COMPLETED|Overall Study||33
6461979|NCT01211613|7378635|FG000|NOT COMPLETED|Overall Study||3
6461980|NCT01211613|7378636|FG001|NOT COMPLETED|Overall Study||2
6461981|NCT01211613|7378637|FG002|NOT COMPLETED|Overall Study||2
6461982|NCT01211665|7378647|FG000|STARTED|Overall Study||2
6461983|NCT01211665|7378648|FG001|STARTED|Overall Study||1
6461984|NCT01211665|7378647|FG000|COMPLETED|Overall Study||0
6461985|NCT01211665|7378648|FG001|COMPLETED|Overall Study|completed treatment with study drug|1
6461986|NCT01211665|7378647|FG000|NOT COMPLETED|Overall Study||2
6461987|NCT01211665|7378648|FG001|NOT COMPLETED|Overall Study||0
6461988|NCT01211730|7378656|FG000|STARTED|Overall Study||82
6461989|NCT01211730|7378657|FG001|STARTED|Overall Study||82
6461990|NCT01211730|7378656|FG000|COMPLETED|Overall Study||82
6461991|NCT01211730|7378657|FG001|COMPLETED|Overall Study||82
6461992|NCT01211730|7378656|FG000|NOT COMPLETED|Overall Study||0
6461993|NCT01211730|7378657|FG001|NOT COMPLETED|Overall Study||0
6461994|NCT01211769|7378667|FG000|STARTED|Overall Study||20
6461995|NCT01211769|7378668|FG001|STARTED|Overall Study||20
6461996|NCT01211769|7378669|FG002|STARTED|Overall Study||20
6461997|NCT01211769|7378670|FG003|STARTED|Overall Study||20
6461998|NCT01211769|7378667|FG000|Participants/Group|Overall Study||20
6461999|NCT01211769|7378668|FG001|Participants/Group|Overall Study||20
6462000|NCT01211769|7378669|FG002|Participants/Group|Overall Study||20
6462001|NCT01211769|7378670|FG003|Participants/Group|Overall Study||20
6462002|NCT01211769|7378667|FG000|COMPLETED|Overall Study||11
6462003|NCT01211769|7378668|FG001|COMPLETED|Overall Study||10
6462004|NCT01211769|7378669|FG002|COMPLETED|Overall Study||12
6462005|NCT01211769|7378670|FG003|COMPLETED|Overall Study||9
6462006|NCT01211769|7378667|FG000|NOT COMPLETED|Overall Study||9
6462007|NCT01211769|7378668|FG001|NOT COMPLETED|Overall Study||10
6462008|NCT01211769|7378669|FG002|NOT COMPLETED|Overall Study||8
6462009|NCT01211769|7378670|FG003|NOT COMPLETED|Overall Study||11
6462010|NCT01211873|7378683|FG000|STARTED|Overall Study||245
6462011|NCT01211873|7378684|FG001|STARTED|Overall Study||119
6462012|NCT01211873|7378685|FG002|STARTED|Overall Study||38
6462013|NCT01211873|7378683|FG000|COMPLETED|Overall Study||240
6462014|NCT01211873|7378684|FG001|COMPLETED|Overall Study||117
6462015|NCT01211873|7378685|FG002|COMPLETED|Overall Study||36
6462016|NCT01211873|7378683|FG000|NOT COMPLETED|Overall Study||5
6462017|NCT01211873|7378684|FG001|NOT COMPLETED|Overall Study||2
6462018|NCT01211873|7378685|FG002|NOT COMPLETED|Overall Study||2
6462019|NCT01212094|7378697|FG000|STARTED|Year 1: Baseline Monitoring||43
6462020|NCT01212094|7378698|FG001|STARTED|Year 1: Baseline Monitoring||0
6462021|NCT01212094|7378699|FG002|STARTED|Year 1: Baseline Monitoring||0
6745856|NCT03364309|7673737|FG012|COMPLETED|Induction Period||0
6745857|NCT03364309|7673738|FG013|COMPLETED|Induction Period||0
6745858|NCT03364309|7673739|FG014|COMPLETED|Induction Period||0
6745859|NCT03364309|7673740|FG015|COMPLETED|Induction Period||0
6745860|NCT03364309|7673741|FG016|COMPLETED|Induction Period||0
6745861|NCT03364309|7673742|FG017|COMPLETED|Induction Period||0
6745862|NCT03364309|7673743|FG018|COMPLETED|Induction Period||0
6745863|NCT03364309|7673725|FG000|NOT COMPLETED|Induction Period||6
6745864|NCT03364309|7673726|FG001|NOT COMPLETED|Induction Period||4
6745865|NCT03364309|7673727|FG002|NOT COMPLETED|Induction Period||1
6745866|NCT03364309|7673728|FG003|NOT COMPLETED|Induction Period||0
6745867|NCT03364309|7673729|FG004|NOT COMPLETED|Induction Period||0
6745868|NCT03364309|7673730|FG005|NOT COMPLETED|Induction Period||0
6745869|NCT03364309|7673731|FG006|NOT COMPLETED|Induction Period||0
6462022|NCT01212094|7378697|FG000|COMPLETED|Year 1: Baseline Monitoring||27
6462023|NCT01212094|7378698|FG001|COMPLETED|Year 1: Baseline Monitoring||0
6462024|NCT01212094|7378699|FG002|COMPLETED|Year 1: Baseline Monitoring||0
6462025|NCT01212094|7378697|FG000|NOT COMPLETED|Year 1: Baseline Monitoring||16
6745870|NCT03364309|7673732|FG007|NOT COMPLETED|Induction Period||0
6745871|NCT03364309|7673733|FG008|NOT COMPLETED|Induction Period||0
6745872|NCT03364309|7673734|FG009|NOT COMPLETED|Induction Period||0
6745873|NCT03364309|7673735|FG010|NOT COMPLETED|Induction Period||0
6745874|NCT03364309|7673736|FG011|NOT COMPLETED|Induction Period||0
6745875|NCT03364309|7673737|FG012|NOT COMPLETED|Induction Period||0
6745876|NCT03364309|7673738|FG013|NOT COMPLETED|Induction Period||0
6745877|NCT03364309|7673739|FG014|NOT COMPLETED|Induction Period||0
6745878|NCT03364309|7673740|FG015|NOT COMPLETED|Induction Period||0
6745879|NCT03364309|7673741|FG016|NOT COMPLETED|Induction Period||0
6745880|NCT03364309|7673742|FG017|NOT COMPLETED|Induction Period||0
6745881|NCT03364309|7673743|FG018|NOT COMPLETED|Induction Period||0
6745882|NCT03364309|7673725|FG000|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
6745883|NCT03364309|7673726|FG001|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
6745884|NCT03364309|7673727|FG002|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|0
6745885|NCT03364309|7673728|FG003|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|47
6745886|NCT03364309|7673729|FG004|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|92
6745887|NCT03364309|7673730|FG005|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|50
6779703|NCT03723603|7707921|FG000|COMPLETED|Overall Study||5
6462026|NCT01212094|7378698|FG001|NOT COMPLETED|Year 1: Baseline Monitoring||0
6462027|NCT01212094|7378699|FG002|NOT COMPLETED|Year 1: Baseline Monitoring||0
6462028|NCT01212094|7378697|FG000|STARTED|Years 2 & 3: Treatment Randomization||0
6462029|NCT01212094|7378698|FG001|STARTED|Years 2 & 3: Treatment Randomization||9
6462030|NCT01212094|7378699|FG002|STARTED|Years 2 & 3: Treatment Randomization||18
6462031|NCT01212094|7378697|FG000|COMPLETED|Years 2 & 3: Treatment Randomization||0
6462032|NCT01212094|7378698|FG001|COMPLETED|Years 2 & 3: Treatment Randomization||5
6462033|NCT01212094|7378699|FG002|COMPLETED|Years 2 & 3: Treatment Randomization||7
6462034|NCT01212094|7378697|FG000|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
6462035|NCT01212094|7378698|FG001|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
6462036|NCT01212094|7378699|FG002|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
6462037|NCT01212107|7378718|FG000|STARTED|Overall Study||3
6462038|NCT01212107|7378719|FG001|STARTED|Overall Study||3
6462039|NCT01212107|7378720|FG002|STARTED|Overall Study||6
6462040|NCT01212107|7378721|FG003|STARTED|Overall Study||3
6462041|NCT01212107|7378722|FG004|STARTED|Overall Study||3
6462042|NCT01212107|7378723|FG005|STARTED|Overall Study||3
6462043|NCT01212107|7378724|FG006|STARTED|Overall Study||3
6462044|NCT01212107|7378725|FG007|STARTED|Overall Study||3
6462045|NCT01212107|7378726|FG008|STARTED|Overall Study||3
6462046|NCT01212107|7378727|FG009|STARTED|Overall Study||3
6462047|NCT01212107|7378728|FG010|STARTED|Overall Study||3
6462048|NCT01212107|7378729|FG011|STARTED|Overall Study||58
6462049|NCT01212107|7378718|FG000|COMPLETED|Overall Study||2
6462050|NCT01212107|7378719|FG001|COMPLETED|Overall Study||2
6462051|NCT01212107|7378720|FG002|COMPLETED|Overall Study||3
6462052|NCT01212107|7378721|FG003|COMPLETED|Overall Study||3
6462053|NCT01212107|7378722|FG004|COMPLETED|Overall Study||2
6462054|NCT01212107|7378723|FG005|COMPLETED|Overall Study||2
6462055|NCT01212107|7378724|FG006|COMPLETED|Overall Study||3
6462056|NCT01212107|7378725|FG007|COMPLETED|Overall Study||2
6462057|NCT01212107|7378726|FG008|COMPLETED|Overall Study||1
6462058|NCT01212107|7378727|FG009|COMPLETED|Overall Study||1
6462059|NCT01212107|7378728|FG010|COMPLETED|Overall Study||2
6462060|NCT01212107|7378729|FG011|COMPLETED|Overall Study||26
6462061|NCT01212107|7378718|FG000|NOT COMPLETED|Overall Study||1
6462062|NCT01212107|7378719|FG001|NOT COMPLETED|Overall Study||1
6462063|NCT01212107|7378720|FG002|NOT COMPLETED|Overall Study||3
6462064|NCT01212107|7378721|FG003|NOT COMPLETED|Overall Study||0
6462065|NCT01212107|7378722|FG004|NOT COMPLETED|Overall Study||1
6462066|NCT01212107|7378723|FG005|NOT COMPLETED|Overall Study||1
6462067|NCT01212107|7378724|FG006|NOT COMPLETED|Overall Study||0
6462068|NCT01212107|7378725|FG007|NOT COMPLETED|Overall Study||1
6462069|NCT01212107|7378726|FG008|NOT COMPLETED|Overall Study||2
6462070|NCT01212107|7378727|FG009|NOT COMPLETED|Overall Study||2
6462071|NCT01212107|7378728|FG010|NOT COMPLETED|Overall Study||1
6462072|NCT01212107|7378729|FG011|NOT COMPLETED|Overall Study||32
6462073|NCT01212159|7378773|FG000|STARTED|Overall Study||26
6462074|NCT01212159|7378774|FG001|STARTED|Overall Study||44
6462075|NCT01212159|7378773|FG000|COMPLETED|Overall Study||14
6462076|NCT01212159|7378774|FG001|COMPLETED|Overall Study||32
6462077|NCT01212159|7378773|FG000|NOT COMPLETED|Overall Study||12
6462078|NCT01212159|7378774|FG001|NOT COMPLETED|Overall Study||12
6462079|NCT01212172|7378780|FG000|STARTED|Overall Study||10
6462080|NCT01212172|7378781|FG001|STARTED|Overall Study||10
6462081|NCT01212172|7378780|FG000|COMPLETED|Overall Study||9
6462082|NCT01212172|7378781|FG001|COMPLETED|Overall Study||9
6462083|NCT01212172|7378780|FG000|NOT COMPLETED|Overall Study||1
6462084|NCT01212172|7378781|FG001|NOT COMPLETED|Overall Study||1
6462085|NCT01212185|7378791|FG000|STARTED|Overall Study||6
6462086|NCT01212185|7378792|FG001|STARTED|Overall Study||8
6462087|NCT01212185|7378791|FG000|COMPLETED|Overall Study||4
6462088|NCT01212185|7378792|FG001|COMPLETED|Overall Study||7
6462089|NCT01212185|7378791|FG000|NOT COMPLETED|Overall Study||2
6462090|NCT01212185|7378792|FG001|NOT COMPLETED|Overall Study||1
6462091|NCT01212302|7378798|FG000|STARTED|Overall Study||504
6462092|NCT01212302|7378798|FG000|COMPLETED|Overall Study||504
6462093|NCT01212302|7378798|FG000|NOT COMPLETED|Overall Study||0
6462094|NCT01212445|7378805|FG000|STARTED|Overall Study||52
6462095|NCT01212445|7378806|FG001|STARTED|Overall Study||51
6462096|NCT01212445|7378807|FG002|STARTED|Overall Study||51
6462097|NCT01212445|7378805|FG000|COMPLETED|Overall Study||52
6462098|NCT01212445|7378806|FG001|COMPLETED|Overall Study||51
6462099|NCT01212445|7378807|FG002|COMPLETED|Overall Study||51
6462100|NCT01212445|7378805|FG000|NOT COMPLETED|Overall Study||0
6462101|NCT01212445|7378806|FG001|NOT COMPLETED|Overall Study||0
6462102|NCT01212445|7378807|FG002|NOT COMPLETED|Overall Study||0
6462103|NCT01212471|7378819|FG000|STARTED|Overall Study||141
6462104|NCT01212471|7378820|FG001|STARTED|Overall Study||140
6462105|NCT01212471|7378821|FG002|STARTED|Overall Study||139
6462106|NCT01212471|7378819|FG000|COMPLETED|Overall Study||139
6462107|NCT01212471|7378820|FG001|COMPLETED|Overall Study||137
6462108|NCT01212471|7378821|FG002|COMPLETED|Overall Study||132
6462109|NCT01212471|7378819|FG000|NOT COMPLETED|Overall Study||2
6462110|NCT01212471|7378820|FG001|NOT COMPLETED|Overall Study||3
6462111|NCT01212471|7378821|FG002|NOT COMPLETED|Overall Study||7
6462112|NCT01212484|7378829|FG000|STARTED|Carbidopa Titration Period (4 Weeks)||6
6462113|NCT01212484|7378830|FG001|STARTED|Carbidopa Titration Period (4 Weeks)||6
6462114|NCT01212484|7378829|FG000|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
6462115|NCT01212484|7378830|FG001|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
6462116|NCT01212484|7378829|FG000|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
6462117|NCT01212484|7378830|FG001|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
6462118|NCT01212484|7378829|FG000|STARTED|First Intervention (4 Weeks)||5
6462119|NCT01212484|7378830|FG001|STARTED|First Intervention (4 Weeks)||6
6462120|NCT01212484|7378829|FG000|COMPLETED|First Intervention (4 Weeks)||5
6462121|NCT01212484|7378830|FG001|COMPLETED|First Intervention (4 Weeks)||4
6462122|NCT01212484|7378829|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6462123|NCT01212484|7378830|FG001|NOT COMPLETED|First Intervention (4 Weeks)||2
6462124|NCT01212484|7378829|FG000|STARTED|Second Intervention (4 Weeks)||5
6462125|NCT01212484|7378830|FG001|STARTED|Second Intervention (4 Weeks)||4
6462126|NCT01212484|7378829|FG000|COMPLETED|Second Intervention (4 Weeks)||5
6462127|NCT01212484|7378830|FG001|COMPLETED|Second Intervention (4 Weeks)||3
6462128|NCT01212484|7378829|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6462129|NCT01212484|7378830|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
6462130|NCT01212588|7378838|FG000|STARTED|Overall Study||10
6462131|NCT01212588|7378839|FG001|STARTED|Overall Study||12
6462132|NCT01212588|7378838|FG000|COMPLETED|Overall Study||9
6462133|NCT01212588|7378839|FG001|COMPLETED|Overall Study||10
6462134|NCT01212588|7378838|FG000|NOT COMPLETED|Overall Study||1
6462135|NCT01212588|7378839|FG001|NOT COMPLETED|Overall Study||2
6462136|NCT01212627|7378845|FG000|STARTED|Overall Study||12
6462137|NCT01212627|7378845|FG000|COMPLETED|Overall Study||12
6462138|NCT01212627|7378845|FG000|NOT COMPLETED|Overall Study||0
6462139|NCT01212744|7378849|FG000|STARTED|Overall Study||16
6462140|NCT01212744|7378849|FG000|COMPLETED|Overall Study||15
6462141|NCT01212744|7378849|FG000|NOT COMPLETED|Overall Study||1
6462142|NCT01212757|7378858|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
6462143|NCT01212757|7378859|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
6462144|NCT01212757|7378860|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
6462145|NCT01212757|7378861|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462146|NCT01212757|7378862|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462147|NCT01212757|7378863|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462148|NCT01212757|7378864|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462149|NCT01212757|7378865|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462150|NCT01212757|7378866|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462151|NCT01212757|7378858|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
6462152|NCT01212757|7378859|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
6462153|NCT01212757|7378860|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
6462154|NCT01212757|7378861|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462155|NCT01212757|7378862|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462156|NCT01212757|7378863|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462157|NCT01212757|7378864|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462158|NCT01212757|7378865|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462159|NCT01212757|7378866|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462160|NCT01212757|7378858|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
6462161|NCT01212757|7378859|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
6462162|NCT01212757|7378860|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
6462163|NCT01212757|7378861|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462164|NCT01212757|7378862|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462165|NCT01212757|7378863|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462166|NCT01212757|7378864|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462167|NCT01212757|7378865|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462168|NCT01212757|7378866|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462169|NCT01212757|7378858|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
6462170|NCT01212757|7378859|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
6462171|NCT01212757|7378860|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
6462172|NCT01212757|7378861|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462173|NCT01212757|7378862|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462174|NCT01212757|7378863|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462175|NCT01212757|7378864|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462176|NCT01212757|7378865|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462177|NCT01212757|7378866|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462178|NCT01212757|7378858|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
6462179|NCT01212757|7378859|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
6462180|NCT01212757|7378860|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
6462181|NCT01212757|7378861|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462182|NCT01212757|7378862|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462183|NCT01212757|7378863|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462184|NCT01212757|7378864|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462185|NCT01212757|7378865|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462186|NCT01212757|7378866|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462187|NCT01212757|7378858|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
6462188|NCT01212757|7378859|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
6462189|NCT01212757|7378860|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
6462190|NCT01212757|7378861|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462191|NCT01212757|7378862|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462192|NCT01212757|7378863|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462193|NCT01212757|7378864|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462194|NCT01212757|7378865|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462195|NCT01212757|7378866|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462196|NCT01212757|7378858|FG000|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6462197|NCT01212757|7378859|FG001|STARTED|Active Treatment Phase (Weeks 24 - 52)|6 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|137
6462198|NCT01212757|7378860|FG002|STARTED|Active Treatment Phase (Weeks 24 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|134
6462199|NCT01212757|7378861|FG003|STARTED|Active Treatment Phase (Weeks 24 - 52)||43
6462200|NCT01212757|7378862|FG004|STARTED|Active Treatment Phase (Weeks 24 - 52)||27
6462201|NCT01212757|7378863|FG005|STARTED|Active Treatment Phase (Weeks 24 - 52)|2 participants who EE and completed Week 24 did not enter the Week 24-52 active treatment phase|41
6462202|NCT01212757|7378864|FG006|STARTED|Active Treatment Phase (Weeks 24 - 52)||28
6462203|NCT01212757|7378865|FG007|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6462204|NCT01212757|7378866|FG008|STARTED|Active Treatment Phase (Weeks 24 - 52)||0
6462205|NCT01212757|7378858|FG000|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6462206|NCT01212757|7378859|FG001|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||125
6462207|NCT01212757|7378860|FG002|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||114
6462208|NCT01212757|7378861|FG003|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||35
6462209|NCT01212757|7378862|FG004|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||25
6462210|NCT01212757|7378863|FG005|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||34
6462211|NCT01212757|7378864|FG006|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||28
6462212|NCT01212757|7378865|FG007|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6462213|NCT01212757|7378866|FG008|COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6462214|NCT01212757|7378858|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6462215|NCT01212757|7378859|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||12
6462216|NCT01212757|7378860|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||20
6745888|NCT03364309|7673731|FG006|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|100
6745889|NCT03364309|7673732|FG007|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|3
6745890|NCT03364309|7673733|FG008|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|79
6745891|NCT03364309|7673734|FG009|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|31
6745892|NCT03364309|7673735|FG010|STARTED|Maintenance Period|This period is to report Maintenance Period participants.|23
6745893|NCT03364309|7673736|FG011|STARTED|Maintenance Period||0
6745894|NCT03364309|7673737|FG012|STARTED|Maintenance Period||0
6745895|NCT03364309|7673738|FG013|STARTED|Maintenance Period||0
6745896|NCT03364309|7673739|FG014|STARTED|Maintenance Period||0
6745897|NCT03364309|7673740|FG015|STARTED|Maintenance Period||0
6745898|NCT03364309|7673741|FG016|STARTED|Maintenance Period||0
6745899|NCT03364309|7673742|FG017|STARTED|Maintenance Period||0
6745900|NCT03364309|7673743|FG018|STARTED|Maintenance Period||0
6745901|NCT03364309|7673725|FG000|Received at Least One Dose of Study Drug|Maintenance Period||0
6745902|NCT03364309|7673726|FG001|Received at Least One Dose of Study Drug|Maintenance Period||0
6745903|NCT03364309|7673727|FG002|Received at Least One Dose of Study Drug|Maintenance Period||0
6745904|NCT03364309|7673728|FG003|Received at Least One Dose of Study Drug|Maintenance Period||47
6745905|NCT03364309|7673729|FG004|Received at Least One Dose of Study Drug|Maintenance Period||92
6745906|NCT03364309|7673730|FG005|Received at Least One Dose of Study Drug|Maintenance Period||50
6745907|NCT03364309|7673731|FG006|Received at Least One Dose of Study Drug|Maintenance Period||100
6745908|NCT03364309|7673732|FG007|Received at Least One Dose of Study Drug|Maintenance Period||3
6745909|NCT03364309|7673733|FG008|Received at Least One Dose of Study Drug|Maintenance Period||79
6745910|NCT03364309|7673734|FG009|Received at Least One Dose of Study Drug|Maintenance Period||31
6745911|NCT03364309|7673735|FG010|Received at Least One Dose of Study Drug|Maintenance Period||23
6745912|NCT03364309|7673736|FG011|Received at Least One Dose of Study Drug|Maintenance Period||0
6745913|NCT03364309|7673737|FG012|Received at Least One Dose of Study Drug|Maintenance Period||0
6745914|NCT03364309|7673738|FG013|Received at Least One Dose of Study Drug|Maintenance Period||0
6745915|NCT03364309|7673739|FG014|Received at Least One Dose of Study Drug|Maintenance Period||0
6745916|NCT03364309|7673740|FG015|Received at Least One Dose of Study Drug|Maintenance Period||0
6745917|NCT03364309|7673741|FG016|Received at Least One Dose of Study Drug|Maintenance Period||0
6745918|NCT03364309|7673742|FG017|Received at Least One Dose of Study Drug|Maintenance Period||0
6745919|NCT03364309|7673743|FG018|Received at Least One Dose of Study Drug|Maintenance Period||0
6745920|NCT03364309|7673725|FG000|COMPLETED|Maintenance Period||0
6745921|NCT03364309|7673726|FG001|COMPLETED|Maintenance Period||0
6745922|NCT03364309|7673727|FG002|COMPLETED|Maintenance Period||0
6745923|NCT03364309|7673728|FG003|COMPLETED|Maintenance Period||3
6745924|NCT03364309|7673729|FG004|COMPLETED|Maintenance Period||80
6745925|NCT03364309|7673730|FG005|COMPLETED|Maintenance Period||4
6745926|NCT03364309|7673731|FG006|COMPLETED|Maintenance Period||84
6745927|NCT03364309|7673732|FG007|COMPLETED|Maintenance Period||1
6745928|NCT03364309|7673733|FG008|COMPLETED|Maintenance Period||73
6745929|NCT03364309|7673734|FG009|COMPLETED|Maintenance Period||27
6745930|NCT03364309|7673735|FG010|COMPLETED|Maintenance Period||17
6745931|NCT03364309|7673736|FG011|COMPLETED|Maintenance Period||0
6745932|NCT03364309|7673737|FG012|COMPLETED|Maintenance Period||0
6745933|NCT03364309|7673738|FG013|COMPLETED|Maintenance Period||0
6745934|NCT03364309|7673739|FG014|COMPLETED|Maintenance Period||0
6745935|NCT03364309|7673740|FG015|COMPLETED|Maintenance Period||0
6745936|NCT03364309|7673741|FG016|COMPLETED|Maintenance Period||0
6745937|NCT03364309|7673742|FG017|COMPLETED|Maintenance Period||0
6462217|NCT01212757|7378861|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||8
6462218|NCT01212757|7378862|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||2
6462219|NCT01212757|7378863|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||7
6462220|NCT01212757|7378864|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6462221|NCT01212757|7378865|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6462222|NCT01212757|7378866|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 24 - 52)||0
6462223|NCT01212757|7378858|FG000|STARTED|Long-Term Safety Phase (Year 2)||0
6462224|NCT01212757|7378859|FG001|STARTED|Long-Term Safety Phase (Year 2)|6 participants who completed Week 52 did not enter the long-term safety phase|119
6462225|NCT01212757|7378860|FG002|STARTED|Long-Term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|109
6462226|NCT01212757|7378861|FG003|STARTED|Long-Term Safety Phase (Year 2)||0
6745938|NCT03364309|7673743|FG018|COMPLETED|Maintenance Period||0
6745939|NCT03364309|7673725|FG000|NOT COMPLETED|Maintenance Period||0
6745940|NCT03364309|7673726|FG001|NOT COMPLETED|Maintenance Period||0
6745941|NCT03364309|7673727|FG002|NOT COMPLETED|Maintenance Period||0
6745942|NCT03364309|7673728|FG003|NOT COMPLETED|Maintenance Period||44
6745943|NCT03364309|7673729|FG004|NOT COMPLETED|Maintenance Period||12
6745944|NCT03364309|7673730|FG005|NOT COMPLETED|Maintenance Period||46
6745945|NCT03364309|7673731|FG006|NOT COMPLETED|Maintenance Period||16
6745946|NCT03364309|7673732|FG007|NOT COMPLETED|Maintenance Period||2
6745947|NCT03364309|7673733|FG008|NOT COMPLETED|Maintenance Period||6
6745948|NCT03364309|7673734|FG009|NOT COMPLETED|Maintenance Period||4
6745949|NCT03364309|7673735|FG010|NOT COMPLETED|Maintenance Period||6
6745950|NCT03364309|7673736|FG011|NOT COMPLETED|Maintenance Period||0
6745951|NCT03364309|7673737|FG012|NOT COMPLETED|Maintenance Period||0
6745952|NCT03364309|7673738|FG013|NOT COMPLETED|Maintenance Period||0
6745953|NCT03364309|7673739|FG014|NOT COMPLETED|Maintenance Period||0
6745954|NCT03364309|7673740|FG015|NOT COMPLETED|Maintenance Period||0
6745955|NCT03364309|7673741|FG016|NOT COMPLETED|Maintenance Period||0
6745956|NCT03364309|7673742|FG017|NOT COMPLETED|Maintenance Period||0
6745957|NCT03364309|7673743|FG018|NOT COMPLETED|Maintenance Period||0
6745958|NCT03364309|7673725|FG000|STARTED|Re-treatment (Maintenance) Period||0
6745959|NCT03364309|7673726|FG001|STARTED|Re-treatment (Maintenance) Period||0
6745960|NCT03364309|7673727|FG002|STARTED|Re-treatment (Maintenance) Period||0
6745961|NCT03364309|7673728|FG003|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
6745962|NCT03364309|7673729|FG004|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
6745963|NCT03364309|7673730|FG005|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
6745964|NCT03364309|7673731|FG006|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
6745965|NCT03364309|7673732|FG007|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
6745966|NCT03364309|7673733|FG008|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
6745967|NCT03364309|7673734|FG009|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
6745968|NCT03364309|7673735|FG010|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|0
6745969|NCT03364309|7673736|FG011|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|2
6745970|NCT03364309|7673737|FG012|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|43
6745971|NCT03364309|7673738|FG013|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|7
6745972|NCT03364309|7673739|FG014|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|45
6745973|NCT03364309|7673740|FG015|STARTED|Re-treatment (Maintenance) Period|This period is to report for Re-treatment (Maintenance) Period.|10
6745974|NCT03364309|7673741|FG016|STARTED|Re-treatment (Maintenance) Period||0
6745975|NCT03364309|7673742|FG017|STARTED|Re-treatment (Maintenance) Period||0
6745976|NCT03364309|7673743|FG018|STARTED|Re-treatment (Maintenance) Period||0
6745977|NCT03364309|7673725|FG000|COMPLETED|Re-treatment (Maintenance) Period||0
6745978|NCT03364309|7673726|FG001|COMPLETED|Re-treatment (Maintenance) Period||0
6745979|NCT03364309|7673727|FG002|COMPLETED|Re-treatment (Maintenance) Period||0
6745980|NCT03364309|7673728|FG003|COMPLETED|Re-treatment (Maintenance) Period||0
6745981|NCT03364309|7673729|FG004|COMPLETED|Re-treatment (Maintenance) Period||0
6745982|NCT03364309|7673730|FG005|COMPLETED|Re-treatment (Maintenance) Period||0
6745983|NCT03364309|7673731|FG006|COMPLETED|Re-treatment (Maintenance) Period||0
6745984|NCT03364309|7673732|FG007|COMPLETED|Re-treatment (Maintenance) Period||0
6745985|NCT03364309|7673733|FG008|COMPLETED|Re-treatment (Maintenance) Period||0
6745986|NCT03364309|7673734|FG009|COMPLETED|Re-treatment (Maintenance) Period||0
6745987|NCT03364309|7673735|FG010|COMPLETED|Re-treatment (Maintenance) Period||0
6745988|NCT03364309|7673736|FG011|COMPLETED|Re-treatment (Maintenance) Period||2
6745989|NCT03364309|7673737|FG012|COMPLETED|Re-treatment (Maintenance) Period||42
6745990|NCT03364309|7673738|FG013|COMPLETED|Re-treatment (Maintenance) Period||6
6745991|NCT03364309|7673739|FG014|COMPLETED|Re-treatment (Maintenance) Period||43
6745992|NCT03364309|7673740|FG015|COMPLETED|Re-treatment (Maintenance) Period||8
6745993|NCT03364309|7673741|FG016|COMPLETED|Re-treatment (Maintenance) Period||0
6779704|NCT03723603|7707921|FG000|NOT COMPLETED|Overall Study||3
6462227|NCT01212757|7378862|FG004|STARTED|Long-Term Safety Phase (Year 2)||0
6462228|NCT01212757|7378863|FG005|STARTED|Long-Term Safety Phase (Year 2)||0
6462229|NCT01212757|7378864|FG006|STARTED|Long-Term Safety Phase (Year 2)||0
6462230|NCT01212757|7378865|FG007|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 20EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|58
6462231|NCT01212757|7378866|FG008|STARTED|Long-Term Safety Phase (Year 2)|Combined PBO-APR 30EE+XO;2 participants who completed Week 52 did not enter long-term safety phase|60
6462232|NCT01212757|7378858|FG000|COMPLETED|Long-Term Safety Phase (Year 2)||0
6462233|NCT01212757|7378859|FG001|COMPLETED|Long-Term Safety Phase (Year 2)||107
6462234|NCT01212757|7378860|FG002|COMPLETED|Long-Term Safety Phase (Year 2)||95
6462235|NCT01212757|7378861|FG003|COMPLETED|Long-Term Safety Phase (Year 2)||0
6462236|NCT01212757|7378862|FG004|COMPLETED|Long-Term Safety Phase (Year 2)||0
6462237|NCT01212757|7378863|FG005|COMPLETED|Long-Term Safety Phase (Year 2)||0
6462238|NCT01212757|7378864|FG006|COMPLETED|Long-Term Safety Phase (Year 2)||0
6462239|NCT01212757|7378865|FG007|COMPLETED|Long-Term Safety Phase (Year 2)||48
6462240|NCT01212757|7378866|FG008|COMPLETED|Long-Term Safety Phase (Year 2)||51
6462241|NCT01212757|7378858|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6462242|NCT01212757|7378859|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 2)||12
6462243|NCT01212757|7378860|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 2)||14
6462244|NCT01212757|7378861|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6462245|NCT01212757|7378862|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6462246|NCT01212757|7378863|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6462247|NCT01212757|7378864|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 2)||0
6462248|NCT01212757|7378865|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 2)||10
6462249|NCT01212757|7378866|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 2)||9
6462250|NCT01212757|7378858|FG000|STARTED|Long-Term Safety Phase (Year 3)||0
6462251|NCT01212757|7378859|FG001|STARTED|Long-Term Safety Phase (Year 3)||107
6462252|NCT01212757|7378860|FG002|STARTED|Long-Term Safety Phase (Year 3)||95
6462253|NCT01212757|7378861|FG003|STARTED|Long-Term Safety Phase (Year 3)||0
6462254|NCT01212757|7378862|FG004|STARTED|Long-Term Safety Phase (Year 3)||0
6462255|NCT01212757|7378863|FG005|STARTED|Long-Term Safety Phase (Year 3)||0
6462256|NCT01212757|7378864|FG006|STARTED|Long-Term Safety Phase (Year 3)||0
6462257|NCT01212757|7378865|FG007|STARTED|Long-Term Safety Phase (Year 3)||48
6462258|NCT01212757|7378866|FG008|STARTED|Long-Term Safety Phase (Year 3)||51
6462259|NCT01212757|7378858|FG000|COMPLETED|Long-Term Safety Phase (Year 3)||0
6462260|NCT01212757|7378859|FG001|COMPLETED|Long-Term Safety Phase (Year 3)||89
6462261|NCT01212757|7378860|FG002|COMPLETED|Long-Term Safety Phase (Year 3)||84
6462262|NCT01212757|7378861|FG003|COMPLETED|Long-Term Safety Phase (Year 3)||0
6462263|NCT01212757|7378862|FG004|COMPLETED|Long-Term Safety Phase (Year 3)||0
6462264|NCT01212757|7378863|FG005|COMPLETED|Long-Term Safety Phase (Year 3)||0
6462265|NCT01212757|7378864|FG006|COMPLETED|Long-Term Safety Phase (Year 3)||0
6462266|NCT01212757|7378865|FG007|COMPLETED|Long-Term Safety Phase (Year 3)||42
6462267|NCT01212757|7378866|FG008|COMPLETED|Long-Term Safety Phase (Year 3)||46
6462268|NCT01212757|7378858|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6462269|NCT01212757|7378859|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 3)||18
6462270|NCT01212757|7378860|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 3)||11
6462271|NCT01212757|7378861|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6462272|NCT01212757|7378862|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6462273|NCT01212757|7378863|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6462274|NCT01212757|7378864|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 3)||0
6462275|NCT01212757|7378865|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 3)||6
6462276|NCT01212757|7378866|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 3)||5
6462277|NCT01212757|7378858|FG000|STARTED|Long-Term Safety Phase (Year 4)||0
6462278|NCT01212757|7378859|FG001|STARTED|Long-Term Safety Phase (Year 4)||89
6462279|NCT01212757|7378860|FG002|STARTED|Long-Term Safety Phase (Year 4)||84
6462280|NCT01212757|7378861|FG003|STARTED|Long-Term Safety Phase (Year 4)||0
6462281|NCT01212757|7378862|FG004|STARTED|Long-Term Safety Phase (Year 4)||0
6462282|NCT01212757|7378863|FG005|STARTED|Long-Term Safety Phase (Year 4)||0
6462283|NCT01212757|7378864|FG006|STARTED|Long-Term Safety Phase (Year 4)||0
6462284|NCT01212757|7378865|FG007|STARTED|Long-Term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|41
6462285|NCT01212757|7378866|FG008|STARTED|Long-Term Safety Phase (Year 4)||46
6462286|NCT01212757|7378858|FG000|COMPLETED|Long-Term Safety Phase (Year 4)||0
6462287|NCT01212757|7378859|FG001|COMPLETED|Long-Term Safety Phase (Year 4)||80
6462288|NCT01212757|7378860|FG002|COMPLETED|Long-Term Safety Phase (Year 4)||77
6462289|NCT01212757|7378861|FG003|COMPLETED|Long-Term Safety Phase (Year 4)||0
6462290|NCT01212757|7378862|FG004|COMPLETED|Long-Term Safety Phase (Year 4)||0
6462291|NCT01212757|7378863|FG005|COMPLETED|Long-Term Safety Phase (Year 4)||0
6462292|NCT01212757|7378864|FG006|COMPLETED|Long-Term Safety Phase (Year 4)||0
6462293|NCT01212757|7378865|FG007|COMPLETED|Long-Term Safety Phase (Year 4)||37
6462294|NCT01212757|7378866|FG008|COMPLETED|Long-Term Safety Phase (Year 4)||39
6462295|NCT01212757|7378858|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6462296|NCT01212757|7378859|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 4)||9
6462297|NCT01212757|7378860|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
6462298|NCT01212757|7378861|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6462299|NCT01212757|7378862|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6462300|NCT01212757|7378863|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6462301|NCT01212757|7378864|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 4)||0
6462302|NCT01212757|7378865|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 4)||4
6462303|NCT01212757|7378866|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 4)||7
6462304|NCT01212757|7378858|FG000|STARTED|Long-Term Safety Phase (Year 5)||0
6462305|NCT01212757|7378859|FG001|STARTED|Long-Term Safety Phase (Year 5)||80
6462306|NCT01212757|7378860|FG002|STARTED|Long-Term Safety Phase (Year 5)||77
6462307|NCT01212757|7378861|FG003|STARTED|Long-Term Safety Phase (Year 5)||0
6462308|NCT01212757|7378862|FG004|STARTED|Long-Term Safety Phase (Year 5)||0
6462309|NCT01212757|7378863|FG005|STARTED|Long-Term Safety Phase (Year 5)||0
6462310|NCT01212757|7378864|FG006|STARTED|Long-Term Safety Phase (Year 5)||0
6462311|NCT01212757|7378865|FG007|STARTED|Long-Term Safety Phase (Year 5)|1 participant was only counted in year 5 but not in 4 year due to late APR dispensing|38
6462312|NCT01212757|7378866|FG008|STARTED|Long-Term Safety Phase (Year 5)||39
6462313|NCT01212757|7378858|FG000|COMPLETED|Long-Term Safety Phase (Year 5)||0
6745994|NCT03364309|7673742|FG017|COMPLETED|Re-treatment (Maintenance) Period||0
6745995|NCT03364309|7673743|FG018|COMPLETED|Re-treatment (Maintenance) Period||0
6745996|NCT03364309|7673725|FG000|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6745997|NCT03364309|7673726|FG001|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6745998|NCT03364309|7673727|FG002|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6745999|NCT03364309|7673728|FG003|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746000|NCT03364309|7673729|FG004|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746001|NCT03364309|7673730|FG005|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746002|NCT03364309|7673731|FG006|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746003|NCT03364309|7673732|FG007|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746004|NCT03364309|7673733|FG008|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746005|NCT03364309|7673734|FG009|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746006|NCT03364309|7673735|FG010|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746007|NCT03364309|7673736|FG011|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746008|NCT03364309|7673737|FG012|NOT COMPLETED|Re-treatment (Maintenance) Period||1
6746009|NCT03364309|7673738|FG013|NOT COMPLETED|Re-treatment (Maintenance) Period||1
6746010|NCT03364309|7673739|FG014|NOT COMPLETED|Re-treatment (Maintenance) Period||2
6746011|NCT03364309|7673740|FG015|NOT COMPLETED|Re-treatment (Maintenance) Period||2
6746012|NCT03364309|7673741|FG016|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746013|NCT03364309|7673742|FG017|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746014|NCT03364309|7673743|FG018|NOT COMPLETED|Re-treatment (Maintenance) Period||0
6746015|NCT03364309|7673725|FG000|STARTED|Post-Treatment Followup Period||0
6746016|NCT03364309|7673726|FG001|STARTED|Post-Treatment Followup Period||0
6746017|NCT03364309|7673727|FG002|STARTED|Post-Treatment Followup Period||0
6746018|NCT03364309|7673728|FG003|STARTED|Post-Treatment Followup Period||0
6746019|NCT03364309|7673729|FG004|STARTED|Post-Treatment Followup Period||0
6746020|NCT03364309|7673730|FG005|STARTED|Post-Treatment Followup Period||0
6746021|NCT03364309|7673731|FG006|STARTED|Post-Treatment Followup Period||0
6746022|NCT03364309|7673732|FG007|STARTED|Post-Treatment Followup Period||0
6746023|NCT03364309|7673733|FG008|STARTED|Post-Treatment Followup Period||0
6746024|NCT03364309|7673734|FG009|STARTED|Post-Treatment Followup Period||0
6746025|NCT03364309|7673735|FG010|STARTED|Post-Treatment Followup Period||0
6746026|NCT03364309|7673736|FG011|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
6746027|NCT03364309|7673737|FG012|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
6746028|NCT03364309|7673738|FG013|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
6746029|NCT03364309|7673739|FG014|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
6746030|NCT03364309|7673740|FG015|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|0
6746031|NCT03364309|7673741|FG016|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|11
6746032|NCT03364309|7673742|FG017|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|375
6746033|NCT03364309|7673743|FG018|STARTED|Post-Treatment Followup Period|This period is to report for Follow-up Period participants.|2
6746034|NCT03364309|7673725|FG000|COMPLETED|Post-Treatment Followup Period||0
6746035|NCT03364309|7673726|FG001|COMPLETED|Post-Treatment Followup Period||0
6746036|NCT03364309|7673727|FG002|COMPLETED|Post-Treatment Followup Period||0
6746037|NCT03364309|7673728|FG003|COMPLETED|Post-Treatment Followup Period||0
6746038|NCT03364309|7673729|FG004|COMPLETED|Post-Treatment Followup Period||0
6746039|NCT03364309|7673730|FG005|COMPLETED|Post-Treatment Followup Period||0
6746040|NCT03364309|7673731|FG006|COMPLETED|Post-Treatment Followup Period||0
6746041|NCT03364309|7673732|FG007|COMPLETED|Post-Treatment Followup Period||0
6746042|NCT03364309|7673733|FG008|COMPLETED|Post-Treatment Followup Period||0
6746043|NCT03364309|7673734|FG009|COMPLETED|Post-Treatment Followup Period||0
6746044|NCT03364309|7673735|FG010|COMPLETED|Post-Treatment Followup Period||0
6746045|NCT03364309|7673736|FG011|COMPLETED|Post-Treatment Followup Period||0
6746046|NCT03364309|7673737|FG012|COMPLETED|Post-Treatment Followup Period||0
6462314|NCT01212757|7378859|FG001|COMPLETED|Long-Term Safety Phase (Year 5)||72
6462315|NCT01212757|7378860|FG002|COMPLETED|Long-Term Safety Phase (Year 5)||69
6462316|NCT01212757|7378861|FG003|COMPLETED|Long-Term Safety Phase (Year 5)||0
6462317|NCT01212757|7378862|FG004|COMPLETED|Long-Term Safety Phase (Year 5)||0
6462318|NCT01212757|7378863|FG005|COMPLETED|Long-Term Safety Phase (Year 5)||0
6462319|NCT01212757|7378864|FG006|COMPLETED|Long-Term Safety Phase (Year 5)||0
6462320|NCT01212757|7378865|FG007|COMPLETED|Long-Term Safety Phase (Year 5)||33
6462321|NCT01212757|7378866|FG008|COMPLETED|Long-Term Safety Phase (Year 5)||37
6462322|NCT01212757|7378858|FG000|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6462323|NCT01212757|7378859|FG001|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
6462324|NCT01212757|7378860|FG002|NOT COMPLETED|Long-Term Safety Phase (Year 5)||8
6462325|NCT01212757|7378861|FG003|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6746047|NCT03364309|7673738|FG013|COMPLETED|Post-Treatment Followup Period||0
6746048|NCT03364309|7673739|FG014|COMPLETED|Post-Treatment Followup Period||0
6746049|NCT03364309|7673740|FG015|COMPLETED|Post-Treatment Followup Period||0
6746050|NCT03364309|7673741|FG016|COMPLETED|Post-Treatment Followup Period||6
6746051|NCT03364309|7673742|FG017|COMPLETED|Post-Treatment Followup Period||344
6746052|NCT03364309|7673743|FG018|COMPLETED|Post-Treatment Followup Period||0
6746053|NCT03364309|7673725|FG000|NOT COMPLETED|Post-Treatment Followup Period||0
6746054|NCT03364309|7673726|FG001|NOT COMPLETED|Post-Treatment Followup Period||0
6746055|NCT03364309|7673727|FG002|NOT COMPLETED|Post-Treatment Followup Period||0
6746056|NCT03364309|7673728|FG003|NOT COMPLETED|Post-Treatment Followup Period||0
6746057|NCT03364309|7673729|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
6746058|NCT03364309|7673730|FG005|NOT COMPLETED|Post-Treatment Followup Period||0
6746059|NCT03364309|7673731|FG006|NOT COMPLETED|Post-Treatment Followup Period||0
6746060|NCT03364309|7673732|FG007|NOT COMPLETED|Post-Treatment Followup Period||0
6746061|NCT03364309|7673733|FG008|NOT COMPLETED|Post-Treatment Followup Period||0
6746062|NCT03364309|7673734|FG009|NOT COMPLETED|Post-Treatment Followup Period||0
6746063|NCT03364309|7673735|FG010|NOT COMPLETED|Post-Treatment Followup Period||0
6746064|NCT03364309|7673736|FG011|NOT COMPLETED|Post-Treatment Followup Period||0
6746065|NCT03364309|7673737|FG012|NOT COMPLETED|Post-Treatment Followup Period||0
6746066|NCT03364309|7673738|FG013|NOT COMPLETED|Post-Treatment Followup Period||0
6746067|NCT03364309|7673739|FG014|NOT COMPLETED|Post-Treatment Followup Period||0
6746068|NCT03364309|7673740|FG015|NOT COMPLETED|Post-Treatment Followup Period||0
6746069|NCT03364309|7673741|FG016|NOT COMPLETED|Post-Treatment Followup Period||5
6746070|NCT03364309|7673742|FG017|NOT COMPLETED|Post-Treatment Followup Period||31
6746071|NCT03364309|7673743|FG018|NOT COMPLETED|Post-Treatment Followup Period||2
6746072|NCT03364335|7673772|FG000|STARTED|Overall Study||52
6746073|NCT03364335|7673773|FG001|STARTED|Overall Study||51
6746074|NCT03364335|7673774|FG002|STARTED|Overall Study||53
6746075|NCT03364335|7673775|FG003|STARTED|Overall Study||50
6746076|NCT03364335|7673776|FG004|STARTED|Overall Study||52
6746077|NCT03364335|7673772|FG000|COMPLETED|Overall Study||42
6746078|NCT03364335|7673773|FG001|COMPLETED|Overall Study||40
6746079|NCT03364335|7673774|FG002|COMPLETED|Overall Study||42
6746080|NCT03364335|7673775|FG003|COMPLETED|Overall Study||37
6746081|NCT03364335|7673776|FG004|COMPLETED|Overall Study||41
6746082|NCT03364335|7673772|FG000|NOT COMPLETED|Overall Study||10
6746083|NCT03364335|7673773|FG001|NOT COMPLETED|Overall Study||11
6746084|NCT03364335|7673774|FG002|NOT COMPLETED|Overall Study||11
6746085|NCT03364335|7673775|FG003|NOT COMPLETED|Overall Study||13
6746086|NCT03364335|7673776|FG004|NOT COMPLETED|Overall Study||11
6746087|NCT03364608|7673788|FG000|STARTED|Overall Study||86
6746088|NCT03364608|7673788|FG000|Placebo MDI|Overall Study||82
6746089|NCT03364608|7673788|FG000|AS MDI 90 µg|Overall Study||81
6746090|NCT03364608|7673788|FG000|AS MDI 180 µg|Overall Study||81
6746091|NCT03364608|7673788|FG000|Proventil 90 µg|Overall Study||82
6746092|NCT03364608|7673788|FG000|Proventil 180 µg|Overall Study||79
6746093|NCT03364608|7673788|FG000|COMPLETED|Overall Study||78
6746094|NCT03364608|7673788|FG000|NOT COMPLETED|Overall Study||8
6746095|NCT03364673|7673800|FG000|STARTED|Overall Study||29
6746096|NCT03364673|7673800|FG000|COMPLETED|Overall Study||24
6746097|NCT03364673|7673800|FG000|NOT COMPLETED|Overall Study||5
6746098|NCT03364738|7673804|FG000|STARTED|Overall Study||22
6746099|NCT03364738|7673804|FG000|COMPLETED|Overall Study||14
6746100|NCT03364738|7673804|FG000|NOT COMPLETED|Overall Study||8
6746101|NCT03364751|7673813|FG000|STARTED|Overall Study||70
6746102|NCT03364751|7673814|FG001|STARTED|Overall Study||84
6746103|NCT03364751|7673815|FG002|STARTED|Overall Study||17
6746104|NCT03364751|7673816|FG003|STARTED|Overall Study||1
6746105|NCT03364751|7673813|FG000|COMPLETED|Overall Study||69
6746106|NCT03364751|7673814|FG001|COMPLETED|Overall Study||83
6746107|NCT03364751|7673815|FG002|COMPLETED|Overall Study||17
6746108|NCT03364751|7673816|FG003|COMPLETED|Overall Study||1
6746109|NCT03364751|7673813|FG000|NOT COMPLETED|Overall Study||1
6746110|NCT03364751|7673814|FG001|NOT COMPLETED|Overall Study||1
6746111|NCT03364751|7673815|FG002|NOT COMPLETED|Overall Study||0
6746112|NCT03364751|7673816|FG003|NOT COMPLETED|Overall Study||0
6746113|NCT03365011|7673832|FG000|STARTED|Overall Study||20
6746114|NCT03365011|7673833|FG001|STARTED|Overall Study||20
6746115|NCT03365011|7673832|FG000|COMPLETED|Overall Study||19
6462326|NCT01212757|7378862|FG004|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6462327|NCT01212757|7378863|FG005|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6462328|NCT01212757|7378864|FG006|NOT COMPLETED|Long-Term Safety Phase (Year 5)||0
6462329|NCT01212757|7378865|FG007|NOT COMPLETED|Long-Term Safety Phase (Year 5)||5
6462330|NCT01212757|7378866|FG008|NOT COMPLETED|Long-Term Safety Phase (Year 5)||2
6462331|NCT01212770|7378887|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
6462332|NCT01212770|7378888|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
6462333|NCT01212770|7378889|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
6462334|NCT01212770|7378890|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6746116|NCT03365011|7673833|FG001|COMPLETED|Overall Study||18
6746117|NCT03365011|7673832|FG000|NOT COMPLETED|Overall Study||1
6746118|NCT03365011|7673833|FG001|NOT COMPLETED|Overall Study||2
6746119|NCT03365154|7673839|FG000|STARTED|Overall Study||10
6746120|NCT03365154|7673839|FG000|COMPLETED|Overall Study||10
6462335|NCT01212770|7378891|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462336|NCT01212770|7378892|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462337|NCT01212770|7378893|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462338|NCT01212770|7378894|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462339|NCT01212770|7378895|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6462340|NCT01212770|7378887|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
6462341|NCT01212770|7378888|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
6462342|NCT01212770|7378889|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
6462343|NCT01212770|7378890|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462344|NCT01212770|7378891|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462345|NCT01212770|7378892|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462346|NCT01212770|7378893|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462347|NCT01212770|7378894|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462348|NCT01212770|7378895|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6462349|NCT01212770|7378887|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
6462350|NCT01212770|7378888|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
6462351|NCT01212770|7378889|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
6462352|NCT01212770|7378890|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462353|NCT01212770|7378891|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462354|NCT01212770|7378892|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462355|NCT01212770|7378893|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462356|NCT01212770|7378894|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462357|NCT01212770|7378895|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6746121|NCT03365154|7673839|FG000|NOT COMPLETED|Overall Study||0
6746122|NCT03365778|7673846|FG000|STARTED|Overall Study||16
6746123|NCT03365778|7673847|FG001|STARTED|Overall Study||17
6746124|NCT03365778|7673848|FG002|STARTED|Overall Study||53
6746125|NCT03365778|7673846|FG000|COMPLETED|Overall Study||16
6746126|NCT03365778|7673847|FG001|COMPLETED|Overall Study||17
6746127|NCT03365778|7673848|FG002|COMPLETED|Overall Study||53
6746128|NCT03365778|7673846|FG000|NOT COMPLETED|Overall Study||0
6746129|NCT03365778|7673847|FG001|NOT COMPLETED|Overall Study||0
6746130|NCT03365778|7673848|FG002|NOT COMPLETED|Overall Study||0
6746131|NCT03365934|7673856|FG000|STARTED|Overall Study||35
6746132|NCT03365934|7673856|FG000|COMPLETED|Overall Study||33
6746133|NCT03365934|7673856|FG000|NOT COMPLETED|Overall Study||2
6746134|NCT03366207|7673865|FG000|STARTED|Overall Study||250
6746135|NCT03366207|7673865|FG000|COMPLETED|Overall Study||242
6746136|NCT03366207|7673865|FG000|NOT COMPLETED|Overall Study||8
6746137|NCT03366298|7673869|FG000|STARTED|Overall Study||3
6746138|NCT03366298|7673870|FG001|STARTED|Overall Study||3
6746139|NCT03366298|7673871|FG002|STARTED|Overall Study||3
6746140|NCT03366298|7673872|FG003|STARTED|Overall Study||3
6746141|NCT03366298|7673869|FG000|COMPLETED|Overall Study||3
6746142|NCT03366298|7673870|FG001|COMPLETED|Overall Study||3
6746143|NCT03366298|7673871|FG002|COMPLETED|Overall Study||3
6746144|NCT03366298|7673872|FG003|COMPLETED|Overall Study||3
6746145|NCT03366298|7673869|FG000|NOT COMPLETED|Overall Study||0
6746146|NCT03366298|7673870|FG001|NOT COMPLETED|Overall Study||0
6746147|NCT03366298|7673871|FG002|NOT COMPLETED|Overall Study||0
6746148|NCT03366298|7673872|FG003|NOT COMPLETED|Overall Study||0
6746149|NCT03367793|7673886|FG000|STARTED|Initial Acuity at Dispense Visit (10min)||5
6746150|NCT03367793|7673887|FG001|STARTED|Initial Acuity at Dispense Visit (10min)||5
6746151|NCT03367793|7673888|FG002|STARTED|Initial Acuity at Dispense Visit (10min)||5
6746152|NCT03367793|7673889|FG003|STARTED|Initial Acuity at Dispense Visit (10min)||5
6746153|NCT03367793|7673890|FG004|STARTED|Initial Acuity at Dispense Visit (10min)||5
6746154|NCT03367793|7673891|FG005|STARTED|Initial Acuity at Dispense Visit (10min)||5
6746155|NCT03367793|7673886|FG000|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
6746156|NCT03367793|7673887|FG001|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
6746157|NCT03367793|7673888|FG002|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
6746158|NCT03367793|7673889|FG003|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
6746159|NCT03367793|7673890|FG004|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
6746160|NCT03367793|7673891|FG005|COMPLETED|Initial Acuity at Dispense Visit (10min)||5
6746161|NCT03367793|7673886|FG000|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
6746162|NCT03367793|7673887|FG001|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
6746163|NCT03367793|7673888|FG002|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
6746164|NCT03367793|7673889|FG003|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
6746165|NCT03367793|7673890|FG004|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
6746166|NCT03367793|7673891|FG005|NOT COMPLETED|Initial Acuity at Dispense Visit (10min)||0
6746167|NCT03367793|7673886|FG000|STARTED|Treatment 1 Dispense to 2 Months Wear||5
6746168|NCT03367793|7673887|FG001|STARTED|Treatment 1 Dispense to 2 Months Wear||5
6746169|NCT03367793|7673888|FG002|STARTED|Treatment 1 Dispense to 2 Months Wear||5
6746170|NCT03367793|7673889|FG003|STARTED|Treatment 1 Dispense to 2 Months Wear||5
6746171|NCT03367793|7673890|FG004|STARTED|Treatment 1 Dispense to 2 Months Wear||5
6746172|NCT03367793|7673891|FG005|STARTED|Treatment 1 Dispense to 2 Months Wear||5
6746173|NCT03367793|7673886|FG000|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
6746174|NCT03367793|7673887|FG001|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
6746175|NCT03367793|7673888|FG002|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
6462358|NCT01212770|7378887|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week (Wk) 24|97
6462359|NCT01212770|7378888|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
6462360|NCT01212770|7378889|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|1 participant who escaped early did not complete Week 24|53
6462361|NCT01212770|7378890|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462362|NCT01212770|7378891|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462363|NCT01212770|7378892|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462364|NCT01212770|7378893|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462365|NCT01212770|7378894|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462366|NCT01212770|7378895|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6462367|NCT01212770|7378887|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
6462368|NCT01212770|7378888|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
6462369|NCT01212770|7378889|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
6462370|NCT01212770|7378890|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462371|NCT01212770|7378891|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462372|NCT01212770|7378892|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462373|NCT01212770|7378893|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462374|NCT01212770|7378894|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462375|NCT01212770|7378895|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462376|NCT01212770|7378887|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
6462377|NCT01212770|7378888|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
6462378|NCT01212770|7378889|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
6462379|NCT01212770|7378890|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462380|NCT01212770|7378891|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462381|NCT01212770|7378892|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462382|NCT01212770|7378893|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462383|NCT01212770|7378894|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462384|NCT01212770|7378895|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6462385|NCT01212770|7378887|FG000|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
6746176|NCT03367793|7673889|FG003|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
6746177|NCT03367793|7673890|FG004|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
6746178|NCT03367793|7673891|FG005|COMPLETED|Treatment 1 Dispense to 2 Months Wear||5
6746179|NCT03367793|7673886|FG000|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
6746180|NCT03367793|7673887|FG001|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
6746181|NCT03367793|7673888|FG002|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
6746182|NCT03367793|7673889|FG003|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
6746183|NCT03367793|7673890|FG004|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
6746184|NCT03367793|7673891|FG005|NOT COMPLETED|Treatment 1 Dispense to 2 Months Wear||0
6746185|NCT03367793|7673886|FG000|STARTED|Treatment 2 Dispense to 2 Months Wear||5
6746186|NCT03367793|7673887|FG001|STARTED|Treatment 2 Dispense to 2 Months Wear||5
6746187|NCT03367793|7673888|FG002|STARTED|Treatment 2 Dispense to 2 Months Wear||5
6746188|NCT03367793|7673889|FG003|STARTED|Treatment 2 Dispense to 2 Months Wear||5
6746189|NCT03367793|7673890|FG004|STARTED|Treatment 2 Dispense to 2 Months Wear||5
6746190|NCT03367793|7673891|FG005|STARTED|Treatment 2 Dispense to 2 Months Wear||5
6746191|NCT03367793|7673886|FG000|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
6746192|NCT03367793|7673887|FG001|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
6746193|NCT03367793|7673888|FG002|COMPLETED|Treatment 2 Dispense to 2 Months Wear||4
6746194|NCT03367793|7673889|FG003|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
6746195|NCT03367793|7673890|FG004|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
6746196|NCT03367793|7673891|FG005|COMPLETED|Treatment 2 Dispense to 2 Months Wear||5
6746197|NCT03367793|7673886|FG000|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
6746198|NCT03367793|7673887|FG001|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
6746199|NCT03367793|7673888|FG002|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||1
6746200|NCT03367793|7673889|FG003|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
6746201|NCT03367793|7673890|FG004|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
6746202|NCT03367793|7673891|FG005|NOT COMPLETED|Treatment 2 Dispense to 2 Months Wear||0
6746203|NCT03367793|7673886|FG000|STARTED|Treatment 3 Dispense to 2 Months Wear||5
6746204|NCT03367793|7673887|FG001|STARTED|Treatment 3 Dispense to 2 Months Wear||5
6746205|NCT03367793|7673888|FG002|STARTED|Treatment 3 Dispense to 2 Months Wear||5
6746206|NCT03367793|7673889|FG003|STARTED|Treatment 3 Dispense to 2 Months Wear||5
6746207|NCT03367793|7673890|FG004|STARTED|Treatment 3 Dispense to 2 Months Wear||5
6746208|NCT03367793|7673891|FG005|STARTED|Treatment 3 Dispense to 2 Months Wear||5
6746209|NCT03367793|7673886|FG000|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
6746210|NCT03367793|7673887|FG001|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
6746211|NCT03367793|7673888|FG002|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
6746212|NCT03367793|7673889|FG003|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
6746213|NCT03367793|7673890|FG004|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
6746214|NCT03367793|7673891|FG005|COMPLETED|Treatment 3 Dispense to 2 Months Wear||5
6746215|NCT03367793|7673886|FG000|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
6746216|NCT03367793|7673887|FG001|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
6746217|NCT03367793|7673888|FG002|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
6462386|NCT01212770|7378888|FG001|STARTED|Active Treatment Phase (Weeks 25 - 52)|8 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|139
6462387|NCT01212770|7378889|FG002|STARTED|Active Treatment Phase (Weeks 25 - 52)|7 participants who completed Week 24 did not enter the Week 24-52 active treatment phase|138
6462388|NCT01212770|7378890|FG003|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|43
6462389|NCT01212770|7378891|FG004|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
6462390|NCT01212770|7378892|FG005|STARTED|Active Treatment Phase (Weeks 25 - 52)|3 participants who EE completed Week 24 did not enter the Week 24-52 active treatment phase|47
6462391|NCT01212770|7378893|FG006|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
6462392|NCT01212770|7378894|FG007|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
6462393|NCT01212770|7378895|FG008|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
6462394|NCT01212770|7378887|FG000|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6462395|NCT01212770|7378888|FG001|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
6462396|NCT01212770|7378889|FG002|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
6462397|NCT01212770|7378890|FG003|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
6462398|NCT01212770|7378891|FG004|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
6462399|NCT01212770|7378892|FG005|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
6462400|NCT01212770|7378893|FG006|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
6462401|NCT01212770|7378894|FG007|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6462402|NCT01212770|7378895|FG008|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6462403|NCT01212770|7378887|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6462404|NCT01212770|7378888|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
6462405|NCT01212770|7378889|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
6746218|NCT03367793|7673889|FG003|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
6746219|NCT03367793|7673890|FG004|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
6746220|NCT03367793|7673891|FG005|NOT COMPLETED|Treatment 3 Dispense to 2 Months Wear||0
6746221|NCT03368053|7673902|FG000|STARTED|Overall Study||36
6746222|NCT03368053|7673902|FG000|COMPLETED|Overall Study||36
6746223|NCT03368053|7673902|FG000|NOT COMPLETED|Overall Study||0
6746224|NCT03368235|7673908|FG000|STARTED|Overall Study||11
6746225|NCT03368235|7673909|FG001|STARTED|Overall Study||10
6746226|NCT03368235|7673908|FG000|COMPLETED|Overall Study||11
6746227|NCT03368235|7673909|FG001|COMPLETED|Overall Study||10
6746228|NCT03368235|7673908|FG000|NOT COMPLETED|Overall Study||0
6746229|NCT03368235|7673909|FG001|NOT COMPLETED|Overall Study||0
6746230|NCT03368807|7673915|FG000|STARTED|Period 1 (Blinded CGM)||79
6746231|NCT03368807|7673915|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Blinded CGM)||78
6746232|NCT03368807|7673915|FG000|COMPLETED|Period 1 (Blinded CGM)||73
6746233|NCT03368807|7673915|FG000|NOT COMPLETED|Period 1 (Blinded CGM)||6
6746234|NCT03368807|7673915|FG000|STARTED|Period 2 (Unblinded CGM)||73
6746235|NCT03368807|7673915|FG000|COMPLETED|Period 2 (Unblinded CGM)||73
6746236|NCT03368807|7673915|FG000|NOT COMPLETED|Period 2 (Unblinded CGM)||0
6746237|NCT03368859|7673923|FG000|STARTED|Overall Study||36
6746238|NCT03368859|7673924|FG001|STARTED|Overall Study||34
6746239|NCT03368859|7673923|FG000|COMPLETED|Overall Study||0
6746240|NCT03368859|7673924|FG001|COMPLETED|Overall Study||0
6746241|NCT03368859|7673923|FG000|NOT COMPLETED|Overall Study||36
6746242|NCT03368859|7673924|FG001|NOT COMPLETED|Overall Study||34
6746243|NCT03368898|7673933|FG000|STARTED|Overall Study||37
6746244|NCT03368898|7673934|FG001|STARTED|Overall Study||33
6746245|NCT03368898|7673935|FG002|STARTED|Overall Study||34
6746246|NCT03368898|7673933|FG000|COMPLETED|Overall Study||37
6746247|NCT03368898|7673934|FG001|COMPLETED|Overall Study||33
6746248|NCT03368898|7673935|FG002|COMPLETED|Overall Study||34
6746249|NCT03368898|7673933|FG000|NOT COMPLETED|Overall Study||0
6746250|NCT03368898|7673934|FG001|NOT COMPLETED|Overall Study||0
6746251|NCT03368898|7673935|FG002|NOT COMPLETED|Overall Study||0
6746252|NCT03368937|7673943|FG000|STARTED|Overall Study||5
6746253|NCT03368937|7673943|FG000|COMPLETED|Overall Study||5
6746254|NCT03368937|7673943|FG000|NOT COMPLETED|Overall Study||0
6746255|NCT03369158|7673949|FG000|STARTED|Overall Study||14
6746256|NCT03369158|7673950|FG001|STARTED|Overall Study||15
6746257|NCT03369158|7673949|FG000|COMPLETED|Overall Study||14
6746258|NCT03369158|7673950|FG001|COMPLETED|Overall Study||15
6746259|NCT03369158|7673949|FG000|NOT COMPLETED|Overall Study||0
6746260|NCT03369158|7673950|FG001|NOT COMPLETED|Overall Study||0
6746261|NCT03369236|7673958|FG000|STARTED|Double-blind Treatment Period||6
6746262|NCT03369236|7673959|FG001|STARTED|Double-blind Treatment Period||7
6746263|NCT03369236|7673958|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||6
6746264|NCT03369236|7673959|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||7
6746265|NCT03369236|7673958|FG000|COMPLETED|Double-blind Treatment Period||6
6746266|NCT03369236|7673959|FG001|COMPLETED|Double-blind Treatment Period||6
6746267|NCT03369236|7673958|FG000|NOT COMPLETED|Double-blind Treatment Period||0
6746268|NCT03369236|7673959|FG001|NOT COMPLETED|Double-blind Treatment Period||1
6746269|NCT03369236|7673958|FG000|STARTED|Open-label Extension Period||6
6746270|NCT03369236|7673959|FG001|STARTED|Open-label Extension Period||6
6746271|NCT03369236|7673958|FG000|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
6746272|NCT03369236|7673959|FG001|Received at Least 1 Dose of Study Drug|Open-label Extension Period|All participants received danicopan in the open-label extension period.|6
6746273|NCT03369236|7673958|FG000|COMPLETED|Open-label Extension Period||1
6462406|NCT01212770|7378890|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
6462407|NCT01212770|7378891|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
6462408|NCT01212770|7378892|FG005|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
6462409|NCT01212770|7378893|FG006|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
6462410|NCT01212770|7378894|FG007|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6462411|NCT01212770|7378895|FG008|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
6462412|NCT01212770|7378887|FG000|STARTED|Long-term Safety Phase (Year 2)||0
6462413|NCT01212770|7378888|FG001|STARTED|Long-term Safety Phase (Year 2)|9 participants who completed Week 52 did not enter the long-term safety phase (LTSP)|111
6462414|NCT01212770|7378889|FG002|STARTED|Long-term Safety Phase (Year 2)|5 participants who completed Week 52 did not enter the long-term safety phase|121
6462415|NCT01212770|7378890|FG003|STARTED|Long-term Safety Phase (Year 2)||0
6462416|NCT01212770|7378891|FG004|STARTED|Long-term Safety Phase (Year 2)||0
6462417|NCT01212770|7378892|FG005|STARTED|Long-term Safety Phase (Year 2)||0
6462418|NCT01212770|7378893|FG006|STARTED|Long-term Safety Phase (Year 2)||0
6462419|NCT01212770|7378894|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|51
6462420|NCT01212770|7378895|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;3 patients finished Wk 52;no entry into LTSP|64
6462421|NCT01212770|7378887|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
6462422|NCT01212770|7378888|FG001|COMPLETED|Long-term Safety Phase (Year 2)||88
6462423|NCT01212770|7378889|FG002|COMPLETED|Long-term Safety Phase (Year 2)||106
6462424|NCT01212770|7378890|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
6462425|NCT01212770|7378891|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
6462426|NCT01212770|7378892|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
6462427|NCT01212770|7378893|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
6462428|NCT01212770|7378894|FG007|COMPLETED|Long-term Safety Phase (Year 2)||42
6462429|NCT01212770|7378895|FG008|COMPLETED|Long-term Safety Phase (Year 2)||50
6462430|NCT01212770|7378887|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6746274|NCT03369236|7673959|FG001|COMPLETED|Open-label Extension Period||0
6746275|NCT03369236|7673958|FG000|NOT COMPLETED|Open-label Extension Period||5
6746276|NCT03369236|7673959|FG001|NOT COMPLETED|Open-label Extension Period||6
6746277|NCT03369340|7673971|FG000|STARTED|Day 2||3
6746278|NCT03369340|7673972|FG001|STARTED|Day 2||3
6746279|NCT03369340|7673973|FG002|STARTED|Day 2||3
6746280|NCT03369340|7673974|FG003|STARTED|Day 2||3
6746281|NCT03369340|7673975|FG004|STARTED|Day 2||3
6746282|NCT03369340|7673976|FG005|STARTED|Day 2||3
6746283|NCT03369340|7673971|FG000|COMPLETED|Day 2||3
6746284|NCT03369340|7673972|FG001|COMPLETED|Day 2||3
6746285|NCT03369340|7673973|FG002|COMPLETED|Day 2||3
6746286|NCT03369340|7673974|FG003|COMPLETED|Day 2||3
6746287|NCT03369340|7673975|FG004|COMPLETED|Day 2||3
6746288|NCT03369340|7673976|FG005|COMPLETED|Day 2||3
6746289|NCT03369340|7673971|FG000|NOT COMPLETED|Day 2||0
6746290|NCT03369340|7673972|FG001|NOT COMPLETED|Day 2||0
6746291|NCT03369340|7673973|FG002|NOT COMPLETED|Day 2||0
6746292|NCT03369340|7673974|FG003|NOT COMPLETED|Day 2||0
6746293|NCT03369340|7673975|FG004|NOT COMPLETED|Day 2||0
6746294|NCT03369340|7673976|FG005|NOT COMPLETED|Day 2||0
6746295|NCT03369340|7673971|FG000|STARTED|Day 3||3
6746296|NCT03369340|7673972|FG001|STARTED|Day 3||3
6746297|NCT03369340|7673973|FG002|STARTED|Day 3||3
6746298|NCT03369340|7673974|FG003|STARTED|Day 3||3
6746299|NCT03369340|7673975|FG004|STARTED|Day 3||3
6746300|NCT03369340|7673976|FG005|STARTED|Day 3||3
6746301|NCT03369340|7673971|FG000|COMPLETED|Day 3||3
6746302|NCT03369340|7673972|FG001|COMPLETED|Day 3||3
6746303|NCT03369340|7673973|FG002|COMPLETED|Day 3||3
6746304|NCT03369340|7673974|FG003|COMPLETED|Day 3||3
6746305|NCT03369340|7673975|FG004|COMPLETED|Day 3||3
6746306|NCT03369340|7673976|FG005|COMPLETED|Day 3||3
6746307|NCT03369340|7673971|FG000|NOT COMPLETED|Day 3||0
6746308|NCT03369340|7673972|FG001|NOT COMPLETED|Day 3||0
6746309|NCT03369340|7673973|FG002|NOT COMPLETED|Day 3||0
6746310|NCT03369340|7673974|FG003|NOT COMPLETED|Day 3||0
6746311|NCT03369340|7673975|FG004|NOT COMPLETED|Day 3||0
6746312|NCT03369340|7673976|FG005|NOT COMPLETED|Day 3||0
6746313|NCT03369340|7673971|FG000|STARTED|Day 4||3
6746314|NCT03369340|7673972|FG001|STARTED|Day 4||3
6746315|NCT03369340|7673973|FG002|STARTED|Day 4||3
6746316|NCT03369340|7673974|FG003|STARTED|Day 4||3
6746317|NCT03369340|7673975|FG004|STARTED|Day 4||3
6746318|NCT03369340|7673976|FG005|STARTED|Day 4||3
6746319|NCT03369340|7673971|FG000|COMPLETED|Day 4||3
6746320|NCT03369340|7673972|FG001|COMPLETED|Day 4||3
6746321|NCT03369340|7673973|FG002|COMPLETED|Day 4||3
6746322|NCT03369340|7673974|FG003|COMPLETED|Day 4||3
6746323|NCT03369340|7673975|FG004|COMPLETED|Day 4||3
6746324|NCT03369340|7673976|FG005|COMPLETED|Day 4||3
6746325|NCT03369340|7673971|FG000|NOT COMPLETED|Day 4||0
6746326|NCT03369340|7673972|FG001|NOT COMPLETED|Day 4||0
6746327|NCT03369340|7673973|FG002|NOT COMPLETED|Day 4||0
6746328|NCT03369340|7673974|FG003|NOT COMPLETED|Day 4||0
6746329|NCT03369340|7673975|FG004|NOT COMPLETED|Day 4||0
6746330|NCT03369340|7673976|FG005|NOT COMPLETED|Day 4||0
6746331|NCT03369418|7673988|FG000|STARTED|Overall Study||16
6746332|NCT03369418|7673989|FG001|STARTED|Overall Study||14
6746333|NCT03369418|7673988|FG000|COMPLETED|Overall Study||13
6746334|NCT03369418|7673989|FG001|COMPLETED|Overall Study||11
6746335|NCT03369418|7673988|FG000|NOT COMPLETED|Overall Study||3
6746336|NCT03369418|7673989|FG001|NOT COMPLETED|Overall Study||3
6746337|NCT03369704|7673997|FG000|STARTED|Treatment Epoch||162
6746338|NCT03369704|7673998|FG001|STARTED|Treatment Epoch||175
6746339|NCT03369704|7673997|FG000|COMPLETED|Treatment Epoch||158
6746340|NCT03369704|7673998|FG001|COMPLETED|Treatment Epoch||172
6746341|NCT03369704|7673997|FG000|NOT COMPLETED|Treatment Epoch||4
6746342|NCT03369704|7673998|FG001|NOT COMPLETED|Treatment Epoch||3
6746343|NCT03369704|7673997|FG000|STARTED|Follow-up Epoch||161
6746344|NCT03369704|7673998|FG001|STARTED|Follow-up Epoch||174
6746345|NCT03369704|7673997|FG000|COMPLETED|Follow-up Epoch||160
6746346|NCT03369704|7673998|FG001|COMPLETED|Follow-up Epoch||174
6746347|NCT03369704|7673997|FG000|NOT COMPLETED|Follow-up Epoch||1
6746348|NCT03369704|7673998|FG001|NOT COMPLETED|Follow-up Epoch||0
6746349|NCT03369756|7674004|FG000|STARTED|Overall Study||43
6746350|NCT03369756|7674004|FG000|COMPLETED|Overall Study|36 completed 4 weeks of treatment; 40 were considered statistical completers|36
6746351|NCT03369756|7674004|FG000|NOT COMPLETED|Overall Study||7
6746352|NCT03369951|7674008|FG000|STARTED|Overall Study||58
6746353|NCT03369951|7674008|FG000|Received Study Drug|Overall Study||57
6746354|NCT03369951|7674008|FG000|COMPLETED|Overall Study||52
6746355|NCT03369951|7674008|FG000|NOT COMPLETED|Overall Study||6
6746356|NCT03370042|7674014|FG000|STARTED|Overall Study||10
6746357|NCT03370042|7674015|FG001|STARTED|Overall Study||10
6746358|NCT03370042|7674014|FG000|COMPLETED|Overall Study||10
6746359|NCT03370042|7674015|FG001|COMPLETED|Overall Study||10
6746360|NCT03370042|7674014|FG000|NOT COMPLETED|Overall Study||0
6746361|NCT03370042|7674015|FG001|NOT COMPLETED|Overall Study||0
6746362|NCT03370289|7674025|FG000|STARTED|Overall Study||55
6746363|NCT03370289|7674025|FG000|COMPLETED|Overall Study||50
6746364|NCT03370289|7674025|FG000|NOT COMPLETED|Overall Study||5
6779705|NCT03723447|7707927|FG000|STARTED|Overall Study||50
6779706|NCT03723447|7707928|FG001|STARTED|Overall Study||51
6779707|NCT03723447|7707927|FG000|COMPLETED|Overall Study||50
6779708|NCT03723447|7707928|FG001|COMPLETED|Overall Study||51
6779709|NCT03723447|7707927|FG000|NOT COMPLETED|Overall Study||0
6779710|NCT03723447|7707928|FG001|NOT COMPLETED|Overall Study||0
6779711|NCT03723070|7707934|FG000|STARTED|Overall Study||88
6779712|NCT03723070|7707934|FG000|COMPLETED|Overall Study||79
6779713|NCT03723070|7707934|FG000|NOT COMPLETED|Overall Study||9
6779714|NCT03720210|7707938|FG000|STARTED|Overall Study||1
6779715|NCT03720210|7707938|FG000|COMPLETED|Overall Study||0
6779716|NCT03720210|7707938|FG000|NOT COMPLETED|Overall Study||1
6779717|NCT03718455|7707942|FG000|STARTED|Overall Study||1
6779718|NCT03718455|7707942|FG000|COMPLETED|Overall Study||1
6779719|NCT03718455|7707942|FG000|NOT COMPLETED|Overall Study||0
6779720|NCT03718143|7707946|FG000|STARTED|Overall Study||3
6779721|NCT03718143|7707947|FG001|STARTED|Overall Study||2
6779722|NCT03718143|7707948|FG002|STARTED|Overall Study||1
6779723|NCT03718143|7707946|FG000|COMPLETED|Overall Study||0
6779724|NCT03718143|7707947|FG001|COMPLETED|Overall Study||0
6779725|NCT03718143|7707948|FG002|COMPLETED|Overall Study||0
6779726|NCT03718143|7707946|FG000|NOT COMPLETED|Overall Study||3
6779727|NCT03718143|7707947|FG001|NOT COMPLETED|Overall Study||2
6779728|NCT03718143|7707948|FG002|NOT COMPLETED|Overall Study||1
6779729|NCT03709576|7707956|FG000|STARTED|Overall Study||3
6779730|NCT03709576|7707956|FG000|COMPLETED|Overall Study||2
6779731|NCT03709576|7707956|FG000|NOT COMPLETED|Overall Study||1
6779732|NCT03704636|7707961|FG000|STARTED|Overall Study||23
6779733|NCT03704636|7707961|FG000|COMPLETED|Overall Study||20
6779734|NCT03704636|7707961|FG000|NOT COMPLETED|Overall Study||3
6779735|NCT03703791|7707967|FG000|STARTED|Overall Study||0
6779736|NCT03703791|7707968|FG001|STARTED|Overall Study||1
6779737|NCT03703791|7707967|FG000|COMPLETED|Overall Study||0
6779738|NCT03703791|7707968|FG001|COMPLETED|Overall Study||0
6779739|NCT03703791|7707967|FG000|NOT COMPLETED|Overall Study||0
6779740|NCT03703791|7707968|FG001|NOT COMPLETED|Overall Study||1
6779741|NCT03701295|7707974|FG000|STARTED|Overall Study||1
6779742|NCT03701295|7707974|FG000|COMPLETED|Overall Study||1
6779743|NCT03701295|7707974|FG000|NOT COMPLETED|Overall Study||0
6779744|NCT03697551|7707978|FG000|STARTED|Overall Study||4
6779745|NCT03697551|7707978|FG000|COMPLETED|Overall Study||4
6779746|NCT03697551|7707978|FG000|NOT COMPLETED|Overall Study||0
6779747|NCT03694821|7707985|FG000|STARTED|Overall Study||4
6779748|NCT03694821|7707986|FG001|STARTED|Overall Study||8
6779749|NCT03694821|7707987|FG002|STARTED|Overall Study||6
6779750|NCT03694821|7707985|FG000|COMPLETED|Overall Study||0
6779751|NCT03694821|7707986|FG001|COMPLETED|Overall Study||0
6779752|NCT03694821|7707987|FG002|COMPLETED|Overall Study||2
6779753|NCT03694821|7707985|FG000|NOT COMPLETED|Overall Study||4
6779754|NCT03694821|7707986|FG001|NOT COMPLETED|Overall Study||8
6779755|NCT03694821|7707987|FG002|NOT COMPLETED|Overall Study||4
6779756|NCT03686969|7707997|FG000|STARTED|Overall Study||1
6779757|NCT03686969|7707998|FG001|STARTED|Overall Study||0
6779758|NCT03686969|7707997|FG000|COMPLETED|Overall Study||0
6779759|NCT03686969|7707998|FG001|COMPLETED|Overall Study||0
6779760|NCT03686969|7707997|FG000|NOT COMPLETED|Overall Study||1
6779761|NCT03686969|7707998|FG001|NOT COMPLETED|Overall Study||0
6779762|NCT03682367|7708006|FG000|STARTED|Overall Study||4
6779763|NCT03682367|7708007|FG001|STARTED|Overall Study||4
6779764|NCT03682367|7708006|FG000|COMPLETED|Overall Study|Withdrawn due to non-compliance|2
6779765|NCT03682367|7708007|FG001|COMPLETED|Overall Study|Patients withdrawn due to confounding neuropathic pain or exited early from study.|0
6779766|NCT03682367|7708006|FG000|NOT COMPLETED|Overall Study||2
6779767|NCT03682367|7708007|FG001|NOT COMPLETED|Overall Study||4
6779768|NCT03680911|7708015|FG000|STARTED|Visit 1 (Baseline)||3
6462431|NCT01212770|7378888|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
6462432|NCT01212770|7378889|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||15
6462433|NCT01212770|7378890|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6462434|NCT01212770|7378891|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6462435|NCT01212770|7378892|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6462436|NCT01212770|7378893|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6462437|NCT01212770|7378894|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
6462438|NCT01212770|7378895|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||14
6462439|NCT01212770|7378887|FG000|STARTED|Long-term Safety Phase (Year 3)||0
6462440|NCT01212770|7378888|FG001|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|87
6746365|NCT03370302|7674035|FG000|STARTED|Dose Escalation Phase||3
6746366|NCT03370302|7674036|FG001|STARTED|Dose Escalation Phase||6
6746367|NCT03370302|7674037|FG002|STARTED|Dose Escalation Phase||7
6746368|NCT03370302|7674038|FG003|STARTED|Dose Escalation Phase||0
6746369|NCT03370302|7674039|FG004|STARTED|Dose Escalation Phase||3
6746370|NCT03370302|7674040|FG005|STARTED|Dose Escalation Phase||3
6746371|NCT03370302|7674035|FG000|COMPLETED|Dose Escalation Phase||0
6746372|NCT03370302|7674036|FG001|COMPLETED|Dose Escalation Phase||0
6746373|NCT03370302|7674037|FG002|COMPLETED|Dose Escalation Phase||0
6746374|NCT03370302|7674038|FG003|COMPLETED|Dose Escalation Phase||0
6746375|NCT03370302|7674039|FG004|COMPLETED|Dose Escalation Phase||0
6746376|NCT03370302|7674040|FG005|COMPLETED|Dose Escalation Phase||0
6746377|NCT03370302|7674035|FG000|NOT COMPLETED|Dose Escalation Phase||3
6746378|NCT03370302|7674036|FG001|NOT COMPLETED|Dose Escalation Phase||6
6746379|NCT03370302|7674037|FG002|NOT COMPLETED|Dose Escalation Phase||7
6746380|NCT03370302|7674038|FG003|NOT COMPLETED|Dose Escalation Phase||0
6746381|NCT03370302|7674039|FG004|NOT COMPLETED|Dose Escalation Phase||3
6746382|NCT03370302|7674040|FG005|NOT COMPLETED|Dose Escalation Phase||3
6746383|NCT03370302|7674035|FG000|STARTED|Dose Expansion Phase||0
6746384|NCT03370302|7674036|FG001|STARTED|Dose Expansion Phase||0
6746385|NCT03370302|7674037|FG002|STARTED|Dose Expansion Phase||0
6746386|NCT03370302|7674038|FG003|STARTED|Dose Expansion Phase||6
6746387|NCT03370302|7674039|FG004|STARTED|Dose Expansion Phase||0
6746388|NCT03370302|7674040|FG005|STARTED|Dose Expansion Phase||0
6746389|NCT03370302|7674035|FG000|COMPLETED|Dose Expansion Phase||0
6746390|NCT03370302|7674036|FG001|COMPLETED|Dose Expansion Phase||0
6746391|NCT03370302|7674037|FG002|COMPLETED|Dose Expansion Phase||0
6746392|NCT03370302|7674038|FG003|COMPLETED|Dose Expansion Phase||0
6746393|NCT03370302|7674039|FG004|COMPLETED|Dose Expansion Phase||0
6746394|NCT03370302|7674040|FG005|COMPLETED|Dose Expansion Phase||0
6746395|NCT03370302|7674035|FG000|NOT COMPLETED|Dose Expansion Phase||0
6746396|NCT03370302|7674036|FG001|NOT COMPLETED|Dose Expansion Phase||0
6746397|NCT03370302|7674037|FG002|NOT COMPLETED|Dose Expansion Phase||0
6746398|NCT03370302|7674038|FG003|NOT COMPLETED|Dose Expansion Phase||6
6746399|NCT03370302|7674039|FG004|NOT COMPLETED|Dose Expansion Phase||0
6746400|NCT03370302|7674040|FG005|NOT COMPLETED|Dose Expansion Phase||0
6746401|NCT03370419|7674058|FG000|STARTED|Overall Study||40
6746402|NCT03370419|7674058|FG000|COMPLETED|Overall Study||24
6746403|NCT03370419|7674058|FG000|NOT COMPLETED|Overall Study||16
6746404|NCT03370471|7674064|FG000|STARTED|Overall Study||23
6746405|NCT03370471|7674065|FG001|STARTED|Overall Study||5
6746406|NCT03370471|7674064|FG000|COMPLETED|Overall Study||16
6746407|NCT03370471|7674065|FG001|COMPLETED|Overall Study||3
6746408|NCT03370471|7674064|FG000|NOT COMPLETED|Overall Study||7
6746409|NCT03370471|7674065|FG001|NOT COMPLETED|Overall Study||2
6746410|NCT03370770|7674073|FG000|STARTED|Overall Study||204
6746411|NCT03370770|7674073|FG000|COMPLETED|Overall Study||98
6746412|NCT03370770|7674073|FG000|NOT COMPLETED|Overall Study||106
6746413|NCT03371355|7674081|FG000|STARTED|Overall Study||27
6746414|NCT03371355|7674082|FG001|STARTED|Overall Study||26
6746415|NCT03371355|7674083|FG002|STARTED|Overall Study||26
6746416|NCT03371355|7674084|FG003|STARTED|Overall Study||26
6746417|NCT03371355|7674081|FG000|COMPLETED|Overall Study||26
6746418|NCT03371355|7674082|FG001|COMPLETED|Overall Study||24
6746419|NCT03371355|7674083|FG002|COMPLETED|Overall Study||22
6746420|NCT03371355|7674084|FG003|COMPLETED|Overall Study||19
6746421|NCT03371355|7674081|FG000|NOT COMPLETED|Overall Study||1
6746422|NCT03371355|7674082|FG001|NOT COMPLETED|Overall Study||2
6746423|NCT03371355|7674083|FG002|NOT COMPLETED|Overall Study||4
6746424|NCT03371355|7674084|FG003|NOT COMPLETED|Overall Study||7
6746425|NCT03371381|7674098|FG000|STARTED|Overall Study||12
6746426|NCT03371381|7674098|FG000|COMPLETED|Overall Study||0
6746427|NCT03371381|7674098|FG000|NOT COMPLETED|Overall Study||12
6746428|NCT03371459|7674102|FG000|STARTED|Period 1||23
6746429|NCT03371459|7674103|FG001|STARTED|Period 1||23
6746430|NCT03371459|7674102|FG000|COMPLETED|Period 1||23
6746431|NCT03371459|7674103|FG001|COMPLETED|Period 1||23
6746432|NCT03371459|7674102|FG000|NOT COMPLETED|Period 1||0
6746433|NCT03371459|7674103|FG001|NOT COMPLETED|Period 1||0
6746434|NCT03371459|7674102|FG000|STARTED|Washout||23
6746435|NCT03371459|7674103|FG001|STARTED|Washout||23
6746436|NCT03371459|7674102|FG000|COMPLETED|Washout||23
6746437|NCT03371459|7674103|FG001|COMPLETED|Washout||22
6746438|NCT03371459|7674102|FG000|NOT COMPLETED|Washout||0
6746439|NCT03371459|7674103|FG001|NOT COMPLETED|Washout||1
6746440|NCT03371459|7674102|FG000|STARTED|Period 2||23
6746441|NCT03371459|7674103|FG001|STARTED|Period 2||22
6746442|NCT03371459|7674102|FG000|COMPLETED|Period 2||23
6462441|NCT01212770|7378889|FG002|STARTED|Long-term Safety Phase (Year 3)|1 participant who completed Year 2 did not continue treatment in Year 3|105
6462442|NCT01212770|7378890|FG003|STARTED|Long-term Safety Phase (Year 3)||0
6462443|NCT01212770|7378891|FG004|STARTED|Long-term Safety Phase (Year 3)||0
6462444|NCT01212770|7378892|FG005|STARTED|Long-term Safety Phase (Year 3)||0
6462445|NCT01212770|7378893|FG006|STARTED|Long-term Safety Phase (Year 3)||0
6462446|NCT01212770|7378894|FG007|STARTED|Long-term Safety Phase (Year 3)|The PBO/APR 20 mg EE and XO participants from week 24-52 are combined within the LTSP.|42
6462447|NCT01212770|7378895|FG008|STARTED|Long-term Safety Phase (Year 3)|Patients from the PBO/APR 30 mg EE and XO are combined;1 patient finished Wk 52;no entry into LTSP|49
6462448|NCT01212770|7378887|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
6462449|NCT01212770|7378888|FG001|COMPLETED|Long-term Safety Phase (Year 3)|1 participant missed due to APR dispensed late|76
6746443|NCT03371459|7674103|FG001|COMPLETED|Period 2||22
6746444|NCT03371459|7674102|FG000|NOT COMPLETED|Period 2||0
6746445|NCT03371459|7674103|FG001|NOT COMPLETED|Period 2||0
6746446|NCT03371732|7674111|FG000|STARTED|Overall Study||51
6746447|NCT03371732|7674112|FG001|STARTED|Overall Study||53
6746448|NCT03371732|7674111|FG000|COMPLETED|Overall Study||39
6746449|NCT03371732|7674112|FG001|COMPLETED|Overall Study||46
6746450|NCT03371732|7674111|FG000|NOT COMPLETED|Overall Study||12
6746451|NCT03371732|7674112|FG001|NOT COMPLETED|Overall Study||7
6746452|NCT03371836|7674120|FG000|STARTED|Overall Study||20
6746453|NCT03371836|7674120|FG000|COMPLETED|Overall Study||18
6746454|NCT03371836|7674120|FG000|NOT COMPLETED|Overall Study||2
6746455|NCT03372083|7674124|FG000|STARTED|Overall Study||44
6746456|NCT03372083|7674124|FG000|COMPLETED|Overall Study||39
6746457|NCT03372083|7674124|FG000|NOT COMPLETED|Overall Study||5
6746458|NCT03372096|7674128|FG000|STARTED|Overall Study||18
6746459|NCT03372096|7674128|FG000|Received Intervention|Overall Study||10
6746460|NCT03372096|7674128|FG000|COMPLETED|Overall Study||10
6746461|NCT03372096|7674128|FG000|NOT COMPLETED|Overall Study||8
6746462|NCT03372369|7674137|FG000|STARTED|Qualification Period||495
6746463|NCT03372369|7674138|FG001|STARTED|Qualification Period||495
6746464|NCT03372369|7674137|FG000|COMPLETED|Qualification Period||469
6746465|NCT03372369|7674138|FG001|COMPLETED|Qualification Period||473
6746466|NCT03372369|7674137|FG000|NOT COMPLETED|Qualification Period||26
6746467|NCT03372369|7674138|FG001|NOT COMPLETED|Qualification Period||22
6746468|NCT03372369|7674137|FG000|STARTED|Intervention and Follow-Up Period||469
6746469|NCT03372369|7674138|FG001|STARTED|Intervention and Follow-Up Period||473
6746470|NCT03372369|7674137|FG000|COMPLETED|Intervention and Follow-Up Period||466
6746471|NCT03372369|7674138|FG001|COMPLETED|Intervention and Follow-Up Period||470
6746472|NCT03372369|7674137|FG000|NOT COMPLETED|Intervention and Follow-Up Period||3
6746473|NCT03372369|7674138|FG001|NOT COMPLETED|Intervention and Follow-Up Period||3
6746474|NCT03372382|7674146|FG000|STARTED|Overall Study||85
6746475|NCT03372382|7674147|FG001|STARTED|Overall Study||85
6746476|NCT03372382|7674146|FG000|COMPLETED|Overall Study||76
6746477|NCT03372382|7674147|FG001|COMPLETED|Overall Study||81
6746478|NCT03372382|7674146|FG000|NOT COMPLETED|Overall Study||9
6746479|NCT03372382|7674147|FG001|NOT COMPLETED|Overall Study||4
6746480|NCT03372434|7674158|FG000|STARTED|Overall Study||78
6746481|NCT03372434|7674159|FG001|STARTED|Overall Study||73
6746482|NCT03372434|7674160|FG002|STARTED|Overall Study||74
6746483|NCT03372434|7674158|FG000|1 Month Follow-up|Overall Study||76
6746484|NCT03372434|7674159|FG001|1 Month Follow-up|Overall Study||72
6746485|NCT03372434|7674160|FG002|1 Month Follow-up|Overall Study||73
6746486|NCT03372434|7674158|FG000|COMPLETED|Overall Study||76
6746487|NCT03372434|7674159|FG001|COMPLETED|Overall Study||70
6746488|NCT03372434|7674160|FG002|COMPLETED|Overall Study||72
6746489|NCT03372434|7674158|FG000|NOT COMPLETED|Overall Study||2
6746490|NCT03372434|7674159|FG001|NOT COMPLETED|Overall Study||3
6746491|NCT03372434|7674160|FG002|NOT COMPLETED|Overall Study||2
6746492|NCT03372551|7674168|FG000|STARTED|First Intervention (1 Week)||17
6746493|NCT03372551|7674169|FG001|STARTED|First Intervention (1 Week)||16
6746494|NCT03372551|7674168|FG000|COMPLETED|First Intervention (1 Week)||16
6746495|NCT03372551|7674169|FG001|COMPLETED|First Intervention (1 Week)||16
6746496|NCT03372551|7674168|FG000|NOT COMPLETED|First Intervention (1 Week)||1
6746497|NCT03372551|7674169|FG001|NOT COMPLETED|First Intervention (1 Week)||0
6746498|NCT03372551|7674168|FG000|STARTED|Second Intervention (1 Week)||16
6746499|NCT03372551|7674169|FG001|STARTED|Second Intervention (1 Week)||16
6746500|NCT03372551|7674168|FG000|COMPLETED|Second Intervention (1 Week)||16
6746501|NCT03372551|7674169|FG001|COMPLETED|Second Intervention (1 Week)||16
6746502|NCT03372551|7674168|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6746503|NCT03372551|7674169|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6746504|NCT03372603|7674182|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||9
6746505|NCT03372603|7674183|FG001|STARTED|Treatment Period 1 (Up to 7 Days)||8
6746506|NCT03372603|7674182|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||9
6746507|NCT03372603|7674183|FG001|COMPLETED|Treatment Period 1 (Up to 7 Days)||8
6746508|NCT03372603|7674182|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
6746509|NCT03372603|7674183|FG001|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
6746510|NCT03372603|7674182|FG000|STARTED|Wash-out Period (14-21 Days)||9
6746511|NCT03372603|7674183|FG001|STARTED|Wash-out Period (14-21 Days)||8
6746512|NCT03372603|7674182|FG000|COMPLETED|Wash-out Period (14-21 Days)||8
6746513|NCT03372603|7674183|FG001|COMPLETED|Wash-out Period (14-21 Days)||8
6746514|NCT03372603|7674182|FG000|NOT COMPLETED|Wash-out Period (14-21 Days)||1
6746515|NCT03372603|7674183|FG001|NOT COMPLETED|Wash-out Period (14-21 Days)||0
6462450|NCT01212770|7378889|FG002|COMPLETED|Long-term Safety Phase (Year 3)||94
6462451|NCT01212770|7378890|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
6462452|NCT01212770|7378891|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
6462453|NCT01212770|7378892|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
6462454|NCT01212770|7378893|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
6462455|NCT01212770|7378894|FG007|COMPLETED|Long-term Safety Phase (Year 3)||35
6462456|NCT01212770|7378895|FG008|COMPLETED|Long-term Safety Phase (Year 3)||44
6462457|NCT01212770|7378887|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6462458|NCT01212770|7378888|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
6462459|NCT01212770|7378889|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
6746516|NCT03372603|7674182|FG000|STARTED|Treatment Period 2 (Up to 7 Days)||8
6746517|NCT03372603|7674183|FG001|STARTED|Treatment Period 2 (Up to 7 Days)||8
6746518|NCT03372603|7674182|FG000|COMPLETED|Treatment Period 2 (Up to 7 Days)||7
6746519|NCT03372603|7674183|FG001|COMPLETED|Treatment Period 2 (Up to 7 Days)||8
6746520|NCT03372603|7674182|FG000|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||1
6746521|NCT03372603|7674183|FG001|NOT COMPLETED|Treatment Period 2 (Up to 7 Days)||0
6746522|NCT03372928|7674189|FG000|STARTED|First Intervention (5 d Energy Deficit)||10
6746523|NCT03372928|7674190|FG001|STARTED|First Intervention (5 d Energy Deficit)||10
6746524|NCT03372928|7674189|FG000|COMPLETED|First Intervention (5 d Energy Deficit)||10
6746525|NCT03372928|7674190|FG001|COMPLETED|First Intervention (5 d Energy Deficit)||10
6746526|NCT03372928|7674189|FG000|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
6746527|NCT03372928|7674190|FG001|NOT COMPLETED|First Intervention (5 d Energy Deficit)||0
6746528|NCT03372928|7674189|FG000|STARTED|Washout (14 d)||10
6746529|NCT03372928|7674190|FG001|STARTED|Washout (14 d)||10
6746530|NCT03372928|7674189|FG000|COMPLETED|Washout (14 d)||10
6746531|NCT03372928|7674190|FG001|COMPLETED|Washout (14 d)||9
6746532|NCT03372928|7674189|FG000|NOT COMPLETED|Washout (14 d)||0
6746533|NCT03372928|7674190|FG001|NOT COMPLETED|Washout (14 d)||1
6746534|NCT03372928|7674189|FG000|STARTED|Second Intervention (5 d Energy Deficit)||10
6746535|NCT03372928|7674190|FG001|STARTED|Second Intervention (5 d Energy Deficit)||9
6746536|NCT03372928|7674189|FG000|COMPLETED|Second Intervention (5 d Energy Deficit)||10
6746537|NCT03372928|7674190|FG001|COMPLETED|Second Intervention (5 d Energy Deficit)||9
6746538|NCT03372928|7674189|FG000|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
6746539|NCT03372928|7674190|FG001|NOT COMPLETED|Second Intervention (5 d Energy Deficit)||0
6746540|NCT03373006|7674201|FG000|STARTED|Overall Study||20
6746541|NCT03373006|7674201|FG000|COMPLETED|Overall Study||20
6746542|NCT03373006|7674201|FG000|NOT COMPLETED|Overall Study||0
6746543|NCT03373162|7674205|FG000|STARTED|Overall Study||10
6746544|NCT03373162|7674205|FG000|COMPLETED|Overall Study||10
6746545|NCT03373162|7674205|FG000|NOT COMPLETED|Overall Study||0
6746546|NCT03373240|7674212|FG000|STARTED|Overall Study||22
6746547|NCT03373240|7674213|FG001|STARTED|Overall Study||24
6746548|NCT03373240|7674212|FG000|4-week Post Treatment|Overall Study||14
6746549|NCT03373240|7674213|FG001|4-week Post Treatment|Overall Study||23
6746550|NCT03373240|7674212|FG000|COMPLETED|Overall Study|This is the 1-month post follow-up|11
6746551|NCT03373240|7674213|FG001|COMPLETED|Overall Study|This is the 1-month post follow-up|20
6746552|NCT03373240|7674212|FG000|NOT COMPLETED|Overall Study||11
6746553|NCT03373240|7674213|FG001|NOT COMPLETED|Overall Study||4
6746554|NCT03373383|7674224|FG000|STARTED|Treatment Period: Wk0-16||83
6746555|NCT03373383|7674225|FG001|STARTED|Treatment Period: Wk0-16||81
6746556|NCT03373383|7674226|FG002|STARTED|Treatment Period: Wk0-16||83
6746557|NCT03373383|7674227|FG003|STARTED|Treatment Period: Wk0-16||82
6746558|NCT03373383|7674228|FG004|STARTED|Treatment Period: Wk0-16||82
6746559|NCT03373383|7674224|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||78
6746560|NCT03373383|7674225|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||72
6746561|NCT03373383|7674226|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||71
6746562|NCT03373383|7674227|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||68
6746563|NCT03373383|7674228|FG004|Completed Titration and Stabilization|Treatment Period: Wk0-16||65
6746564|NCT03373383|7674224|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||70
6746565|NCT03373383|7674225|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||66
6746566|NCT03373383|7674226|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||68
6746567|NCT03373383|7674227|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||61
6746568|NCT03373383|7674228|FG004|Completed Maintenance Period|Treatment Period: Wk0-16||58
6746569|NCT03373383|7674224|FG000|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||6
6746570|NCT03373383|7674225|FG001|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||11
6746571|NCT03373383|7674226|FG002|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||8
6746572|NCT03373383|7674227|FG003|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||18
6746573|NCT03373383|7674228|FG004|Had Taper and Safety Follow-up|Treatment Period: Wk0-16||21
6746574|NCT03373383|7674224|FG000|COMPLETED|Treatment Period: Wk0-16||70
6746575|NCT03373383|7674225|FG001|COMPLETED|Treatment Period: Wk0-16||66
6746576|NCT03373383|7674226|FG002|COMPLETED|Treatment Period: Wk0-16||68
6746577|NCT03373383|7674227|FG003|COMPLETED|Treatment Period: Wk0-16||61
6746578|NCT03373383|7674228|FG004|COMPLETED|Treatment Period: Wk0-16||58
6746579|NCT03373383|7674224|FG000|NOT COMPLETED|Treatment Period: Wk0-16||13
6746580|NCT03373383|7674225|FG001|NOT COMPLETED|Treatment Period: Wk0-16||15
6746581|NCT03373383|7674226|FG002|NOT COMPLETED|Treatment Period: Wk0-16||15
6746582|NCT03373383|7674227|FG003|NOT COMPLETED|Treatment Period: Wk0-16||21
6746583|NCT03373383|7674228|FG004|NOT COMPLETED|Treatment Period: Wk0-16||24
6462460|NCT01212770|7378890|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6462461|NCT01212770|7378891|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6462462|NCT01212770|7378892|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6462463|NCT01212770|7378893|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6462464|NCT01212770|7378894|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||7
6462465|NCT01212770|7378895|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||5
6746584|NCT03373383|7674224|FG000|STARTED|Post-Treatment Period: Wk16-23||70
6746585|NCT03373383|7674225|FG001|STARTED|Post-Treatment Period: Wk16-23||66
6746586|NCT03373383|7674226|FG002|STARTED|Post-Treatment Period: Wk16-23||68
6746587|NCT03373383|7674227|FG003|STARTED|Post-Treatment Period: Wk16-23||61
6746588|NCT03373383|7674228|FG004|STARTED|Post-Treatment Period: Wk16-23||58
6746589|NCT03373383|7674224|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||69
6746590|NCT03373383|7674225|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||64
6746591|NCT03373383|7674226|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||66
6746592|NCT03373383|7674227|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||55
6746593|NCT03373383|7674228|FG004|Started Conversion Period|Post-Treatment Period: Wk16-23||57
6746594|NCT03373383|7674224|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||68
6746595|NCT03373383|7674225|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||64
6746596|NCT03373383|7674226|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||66
6746597|NCT03373383|7674227|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||55
6746598|NCT03373383|7674228|FG004|Completed Conversion Period|Post-Treatment Period: Wk16-23||57
6746599|NCT03373383|7674224|FG000|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
6746600|NCT03373383|7674225|FG001|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
6746601|NCT03373383|7674226|FG002|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||3
6746602|NCT03373383|7674227|FG003|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||6
6746603|NCT03373383|7674228|FG004|Had Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||1
6746604|NCT03373383|7674224|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||67
6746605|NCT03373383|7674225|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||63
6746606|NCT03373383|7674226|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||65
6746607|NCT03373383|7674227|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||55
6746608|NCT03373383|7674228|FG004|Enrolled in EP0093|Post-Treatment Period: Wk16-23||57
6746609|NCT03373383|7674224|FG000|COMPLETED|Post-Treatment Period: Wk16-23||69
6746610|NCT03373383|7674225|FG001|COMPLETED|Post-Treatment Period: Wk16-23||66
6746611|NCT03373383|7674226|FG002|COMPLETED|Post-Treatment Period: Wk16-23||68
6746612|NCT03373383|7674227|FG003|COMPLETED|Post-Treatment Period: Wk16-23||61
6746613|NCT03373383|7674228|FG004|COMPLETED|Post-Treatment Period: Wk16-23||58
6746614|NCT03373383|7674224|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
6746615|NCT03373383|7674225|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
6746616|NCT03373383|7674226|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
6746617|NCT03373383|7674227|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
6746618|NCT03373383|7674228|FG004|NOT COMPLETED|Post-Treatment Period: Wk16-23||0
6746619|NCT03373591|7674258|FG000|STARTED|Overall Study||75
6746620|NCT03373591|7674259|FG001|STARTED|Overall Study||71
6746621|NCT03373591|7674260|FG002|STARTED|Overall Study||73
6746622|NCT03373591|7674258|FG000|COMPLETED|Overall Study||75
6746623|NCT03373591|7674259|FG001|COMPLETED|Overall Study||71
6746624|NCT03373591|7674260|FG002|COMPLETED|Overall Study||73
6746625|NCT03373591|7674258|FG000|NOT COMPLETED|Overall Study||0
6746626|NCT03373591|7674259|FG001|NOT COMPLETED|Overall Study||0
6746627|NCT03373591|7674260|FG002|NOT COMPLETED|Overall Study||0
6746628|NCT03373890|7674270|FG000|STARTED|Overall Study||6
6746629|NCT03373890|7674271|FG001|STARTED|Overall Study||6
6746630|NCT03373890|7674270|FG000|COMPLETED|Overall Study||6
6746631|NCT03373890|7674271|FG001|COMPLETED|Overall Study||6
6746632|NCT03373890|7674270|FG000|NOT COMPLETED|Overall Study||0
6746633|NCT03373890|7674271|FG001|NOT COMPLETED|Overall Study||0
6746634|NCT03374176|7674281|FG000|STARTED|Overall Study||21
6746635|NCT03374176|7674282|FG001|STARTED|Overall Study||21
6746636|NCT03374176|7674281|FG000|COMPLETED|Overall Study||21
6746637|NCT03374176|7674282|FG001|COMPLETED|Overall Study||21
6746638|NCT03374176|7674281|FG000|NOT COMPLETED|Overall Study||0
6746639|NCT03374176|7674282|FG001|NOT COMPLETED|Overall Study||0
6746640|NCT03374189|7674290|FG000|STARTED|Overall Study||40
6746641|NCT03374189|7674291|FG001|STARTED|Overall Study||39
6746642|NCT03374189|7674290|FG000|COMPLETED|Overall Study||39
6746643|NCT03374189|7674291|FG001|COMPLETED|Overall Study||39
6746644|NCT03374189|7674290|FG000|NOT COMPLETED|Overall Study||1
6746645|NCT03374189|7674291|FG001|NOT COMPLETED|Overall Study||0
6746646|NCT03374358|7674299|FG000|STARTED|Overall Study||24
6746647|NCT03374358|7674300|FG001|STARTED|Overall Study||21
6746648|NCT03374358|7674299|FG000|COMPLETED|Overall Study||24
6746649|NCT03374358|7674300|FG001|COMPLETED|Overall Study||19
6746650|NCT03374358|7674299|FG000|NOT COMPLETED|Overall Study||0
6746651|NCT03374358|7674300|FG001|NOT COMPLETED|Overall Study||2
6746652|NCT03374488|7674308|FG000|STARTED|Overall Study||42
6746653|NCT03374488|7674309|FG001|STARTED|Overall Study||42
6746654|NCT03374488|7674308|FG000|Intention-to-Treat (ITT)|Overall Study||42
6746655|NCT03374488|7674309|FG001|Intention-to-Treat (ITT)|Overall Study||42
6746656|NCT03374488|7674308|FG000|All Participants as Treated (APaT)|Overall Study||42
6462466|NCT01212770|7378887|FG000|STARTED|Long-term Safety Phase (Year 4)||0
6500778|NCT01425801|7419346|FG002|NOT COMPLETED|Period 6||0
6462467|NCT01212770|7378888|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant was counted in Year 4 but not in year 3 due to late APR dispensing|77
6462468|NCT01212770|7378889|FG002|STARTED|Long-term Safety Phase (Year 4)||94
6462469|NCT01212770|7378890|FG003|STARTED|Long-term Safety Phase (Year 4)||0
6462470|NCT01212770|7378891|FG004|STARTED|Long-term Safety Phase (Year 4)||0
6462471|NCT01212770|7378892|FG005|STARTED|Long-term Safety Phase (Year 4)||0
6462472|NCT01212770|7378893|FG006|STARTED|Long-term Safety Phase (Year 4)||0
6462473|NCT01212770|7378894|FG007|STARTED|Long-term Safety Phase (Year 4)||35
6462474|NCT01212770|7378895|FG008|STARTED|Long-term Safety Phase (Year 4)||44
6462475|NCT01212770|7378887|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
6462476|NCT01212770|7378888|FG001|COMPLETED|Long-term Safety Phase (Year 4)||71
6462477|NCT01212770|7378889|FG002|COMPLETED|Long-term Safety Phase (Year 4)||83
6462478|NCT01212770|7378890|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
6462479|NCT01212770|7378891|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
6462480|NCT01212770|7378892|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
6462481|NCT01212770|7378893|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
6462482|NCT01212770|7378894|FG007|COMPLETED|Long-term Safety Phase (Year 4)||32
6462483|NCT01212770|7378895|FG008|COMPLETED|Long-term Safety Phase (Year 4)||42
6462484|NCT01212770|7378887|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6462485|NCT01212770|7378888|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||6
6462486|NCT01212770|7378889|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||11
6462487|NCT01212770|7378890|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6462488|NCT01212770|7378891|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6462489|NCT01212770|7378892|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6462490|NCT01212770|7378893|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6462491|NCT01212770|7378894|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||3
6462492|NCT01212770|7378895|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
6462493|NCT01212770|7378887|FG000|STARTED|Long-term Safety Phase (Year 5)||0
6462494|NCT01212770|7378888|FG001|STARTED|Long-term Safety Phase (Year 5)|1 participant who completed Year 4 did not continue treatment in Year 5|70
6462495|NCT01212770|7378889|FG002|STARTED|Long-term Safety Phase (Year 5)||83
6462496|NCT01212770|7378890|FG003|STARTED|Long-term Safety Phase (Year 5)||0
6462497|NCT01212770|7378891|FG004|STARTED|Long-term Safety Phase (Year 5)||0
6462498|NCT01212770|7378892|FG005|STARTED|Long-term Safety Phase (Year 5)||0
6462499|NCT01212770|7378893|FG006|STARTED|Long-term Safety Phase (Year 5)||0
6462500|NCT01212770|7378894|FG007|STARTED|Long-term Safety Phase (Year 5)||32
6462501|NCT01212770|7378895|FG008|STARTED|Long-term Safety Phase (Year 5)||42
6462502|NCT01212770|7378887|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
6462503|NCT01212770|7378888|FG001|COMPLETED|Long-term Safety Phase (Year 5)||68
6462504|NCT01212770|7378889|FG002|COMPLETED|Long-term Safety Phase (Year 5)||72
6462505|NCT01212770|7378890|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
6462506|NCT01212770|7378891|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
6462507|NCT01212770|7378892|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
6462508|NCT01212770|7378893|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
6462509|NCT01212770|7378894|FG007|COMPLETED|Long-term Safety Phase (Year 5)||30
6462510|NCT01212770|7378895|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
6462511|NCT01212770|7378887|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6462512|NCT01212770|7378888|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
6462513|NCT01212770|7378889|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||11
6462514|NCT01212770|7378890|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6462515|NCT01212770|7378891|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6462516|NCT01212770|7378892|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6462517|NCT01212770|7378893|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6462518|NCT01212770|7378894|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||2
6462519|NCT01212770|7378895|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
6462520|NCT01212874|7378919|FG000|STARTED|Overall Study||35
6462521|NCT01212874|7378920|FG001|STARTED|Overall Study||35
6462522|NCT01212874|7378919|FG000|Received Allocated Intervention|Overall Study||13
6462523|NCT01212874|7378920|FG001|Received Allocated Intervention|Overall Study||12
6462524|NCT01212874|7378919|FG000|COMPLETED|Overall Study||13
6462525|NCT01212874|7378920|FG001|COMPLETED|Overall Study||12
6462526|NCT01212874|7378919|FG000|NOT COMPLETED|Overall Study||22
6462527|NCT01212874|7378920|FG001|NOT COMPLETED|Overall Study||23
6462528|NCT01212900|7378928|FG000|STARTED|Overall Study||116
6462529|NCT01212900|7378929|FG001|STARTED|Overall Study||114
6462530|NCT01212900|7378928|FG000|COMPLETED|Overall Study||104
6462531|NCT01212900|7378929|FG001|COMPLETED|Overall Study||107
6462532|NCT01212900|7378928|FG000|NOT COMPLETED|Overall Study||12
6462533|NCT01212900|7378929|FG001|NOT COMPLETED|Overall Study||7
6462534|NCT01212952|7378938|FG000|STARTED|Overall Study||3
6462535|NCT01212952|7378939|FG001|STARTED|Overall Study||6
6462536|NCT01212952|7378940|FG002|STARTED|Overall Study||41
6462537|NCT01212952|7378938|FG000|COMPLETED|Overall Study||3
6462538|NCT01212952|7378939|FG001|COMPLETED|Overall Study||6
6462539|NCT01212952|7378940|FG002|COMPLETED|Overall Study||41
6462540|NCT01212952|7378938|FG000|NOT COMPLETED|Overall Study||0
6462541|NCT01212952|7378939|FG001|NOT COMPLETED|Overall Study||0
6462542|NCT01212952|7378940|FG002|NOT COMPLETED|Overall Study||0
6462543|NCT01212991|7378952|FG000|STARTED|Double-blind||872
6462544|NCT01212991|7378953|FG001|STARTED|Double-blind||845
6462545|NCT01212991|7378954|FG002|STARTED|Double-blind||0
6462546|NCT01212991|7378952|FG000|Safety Population|Double-blind||871
6462547|NCT01212991|7378953|FG001|Safety Population|Double-blind||844
6462548|NCT01212991|7378954|FG002|Safety Population|Double-blind||0
6462549|NCT01212991|7378952|FG000|COMPLETED|Double-blind||0
6462550|NCT01212991|7378953|FG001|COMPLETED|Double-blind||234
6462551|NCT01212991|7378954|FG002|COMPLETED|Double-blind||0
6462552|NCT01212991|7378952|FG000|NOT COMPLETED|Double-blind||872
6462553|NCT01212991|7378953|FG001|NOT COMPLETED|Double-blind||611
6462554|NCT01212991|7378954|FG002|NOT COMPLETED|Double-blind||0
6462555|NCT01212991|7378952|FG000|STARTED|Open-label||0
6462556|NCT01212991|7378953|FG001|STARTED|Open-label|participants were given the opportunity to receive open-label access to enzalutamide|0
6462557|NCT01212991|7378954|FG002|STARTED|Open-label|previous placebo treated participants were given the opportunity to receive enzalutamide|234
6462558|NCT01212991|7378952|FG000|COMPLETED|Open-label||0
6462559|NCT01212991|7378953|FG001|COMPLETED|Open-label||0
6462560|NCT01212991|7378954|FG002|COMPLETED|Open-label||0
6462561|NCT01212991|7378952|FG000|NOT COMPLETED|Open-label||0
6462562|NCT01212991|7378953|FG001|NOT COMPLETED|Open-label||0
6462563|NCT01212991|7378954|FG002|NOT COMPLETED|Open-label||234
6462564|NCT01213043|7378964|FG000|STARTED|Treatment Period 1||15
6462565|NCT01213043|7378965|FG001|STARTED|Treatment Period 1||15
6462566|NCT01213043|7378964|FG000|COMPLETED|Treatment Period 1||15
6462567|NCT01213043|7378965|FG001|COMPLETED|Treatment Period 1||15
6462568|NCT01213043|7378964|FG000|NOT COMPLETED|Treatment Period 1||0
6554022|NCT01746732|7476493|FG002|NOT COMPLETED|Lead-In Period||0
6554023|NCT01746732|7476491|FG000|STARTED|Period 1||0
6554024|NCT01746732|7476492|FG001|STARTED|Period 1||11
6554025|NCT01746732|7476493|FG002|STARTED|Period 1||11
6554026|NCT01746732|7476491|FG000|COMPLETED|Period 1||0
6554027|NCT01746732|7476492|FG001|COMPLETED|Period 1||10
6554028|NCT01746732|7476493|FG002|COMPLETED|Period 1||11
6554029|NCT01746732|7476491|FG000|NOT COMPLETED|Period 1||0
6554030|NCT01746732|7476492|FG001|NOT COMPLETED|Period 1||1
6554031|NCT01746732|7476493|FG002|NOT COMPLETED|Period 1||0
6462569|NCT01213043|7378965|FG001|NOT COMPLETED|Treatment Period 1||0
6462570|NCT01213043|7378964|FG000|STARTED|Washout Period||15
6462571|NCT01213043|7378965|FG001|STARTED|Washout Period||15
6462572|NCT01213043|7378964|FG000|COMPLETED|Washout Period||15
6462573|NCT01213043|7378965|FG001|COMPLETED|Washout Period||15
6462574|NCT01213043|7378964|FG000|NOT COMPLETED|Washout Period||0
6462575|NCT01213043|7378965|FG001|NOT COMPLETED|Washout Period||0
6462576|NCT01213043|7378964|FG000|STARTED|Treatment Period 2||15
6462577|NCT01213043|7378965|FG001|STARTED|Treatment Period 2||15
6462578|NCT01213043|7378964|FG000|COMPLETED|Treatment Period 2||15
6462579|NCT01213043|7378965|FG001|COMPLETED|Treatment Period 2||15
6462580|NCT01213043|7378964|FG000|NOT COMPLETED|Treatment Period 2||0
6462581|NCT01213043|7378965|FG001|NOT COMPLETED|Treatment Period 2||0
6462582|NCT01213043|7378964|FG000|STARTED|Follow-up||15
6462583|NCT01213043|7378965|FG001|STARTED|Follow-up||15
6462584|NCT01213043|7378964|FG000|COMPLETED|Follow-up||15
6462585|NCT01213043|7378965|FG001|COMPLETED|Follow-up||15
6462586|NCT01213043|7378964|FG000|NOT COMPLETED|Follow-up||0
6462587|NCT01213043|7378965|FG001|NOT COMPLETED|Follow-up||0
6462588|NCT01213082|7378974|FG000|STARTED|Overall Study||12
6462589|NCT01213082|7378975|FG001|STARTED|Overall Study||11
6462590|NCT01213082|7378976|FG002|STARTED|Overall Study||11
6462591|NCT01213082|7378974|FG000|COMPLETED|Overall Study||6
6462592|NCT01213082|7378975|FG001|COMPLETED|Overall Study||4
6462593|NCT01213082|7378976|FG002|COMPLETED|Overall Study||6
6462594|NCT01213082|7378974|FG000|NOT COMPLETED|Overall Study||6
6462595|NCT01213082|7378975|FG001|NOT COMPLETED|Overall Study||7
6462596|NCT01213082|7378976|FG002|NOT COMPLETED|Overall Study||5
6462597|NCT01213173|7378986|FG000|STARTED|Overall Study|Patients who were randomized and received treatment|125
6462598|NCT01213173|7378987|FG001|STARTED|Overall Study|Patients who were randomized and received treatment|126
6462599|NCT01213173|7378986|FG000|Patients Included in Safety Population|Overall Study||139
6462600|NCT01213173|7378987|FG001|Patients Included in Safety Population|Overall Study||112
6462601|NCT01213173|7378986|FG000|Patients Included in ITT Population|Overall Study||116
6462602|NCT01213173|7378987|FG001|Patients Included in ITT Population|Overall Study||115
6462603|NCT01213173|7378986|FG000|Patients Included in PP Population|Overall Study||102
6462604|NCT01213173|7378987|FG001|Patients Included in PP Population|Overall Study||89
6462605|NCT01213173|7378986|FG000|COMPLETED|Overall Study|Patients who completed the study|113
6462606|NCT01213173|7378987|FG001|COMPLETED|Overall Study|Patients who completed the study|110
6462607|NCT01213173|7378986|FG000|NOT COMPLETED|Overall Study||12
6462608|NCT01213173|7378987|FG001|NOT COMPLETED|Overall Study||16
6462609|NCT01213199|7378993|FG000|STARTED|Overall Study||20
6462610|NCT01213199|7378993|FG000|COMPLETED|Overall Study||16
6462611|NCT01213199|7378993|FG000|NOT COMPLETED|Overall Study||4
6462612|NCT01213251|7379000|FG000|STARTED|Overall Study||40
6462613|NCT01213251|7379001|FG001|STARTED|Overall Study||41
6462614|NCT01213251|7379002|FG002|STARTED|Overall Study||45
6462615|NCT01213251|7379000|FG000|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
6462616|NCT01213251|7379001|FG001|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
6462617|NCT01213251|7379002|FG002|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
6462618|NCT01213251|7379000|FG000|NOT COMPLETED|Overall Study||6
6462619|NCT01213251|7379001|FG001|NOT COMPLETED|Overall Study||4
6462620|NCT01213251|7379002|FG002|NOT COMPLETED|Overall Study||11
6462621|NCT01213264|7379018|FG000|STARTED|Overall Study||155
6554032|NCT01746732|7476491|FG000|STARTED|Period 2||0
6554033|NCT01746732|7476492|FG001|STARTED|Period 2||10
6554034|NCT01746732|7476493|FG002|STARTED|Period 2||11
6462622|NCT01213264|7379019|FG001|STARTED|Overall Study||177
6462623|NCT01213264|7379020|FG002|STARTED|Overall Study||327
6462624|NCT01213264|7379018|FG000|COMPLETED|Overall Study||153
6462625|NCT01213264|7379019|FG001|COMPLETED|Overall Study||175
6462626|NCT01213264|7379020|FG002|COMPLETED|Overall Study||321
6462627|NCT01213264|7379018|FG000|NOT COMPLETED|Overall Study||2
6462628|NCT01213264|7379019|FG001|NOT COMPLETED|Overall Study||2
6462629|NCT01213264|7379020|FG002|NOT COMPLETED|Overall Study||6
6462630|NCT01213316|7379031|FG000|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
6462631|NCT01213316|7379031|FG000|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
6462632|NCT01213316|7379031|FG000|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
6462633|NCT01213316|7379031|FG000|Discontinued Treatment Before 48 Weeks|Overall Study||67
6462634|NCT01213316|7379031|FG000|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
6462635|NCT01213316|7379031|FG000|COMPLETED|Overall Study||451
6462636|NCT01213316|7379031|FG000|NOT COMPLETED|Overall Study||0
6462637|NCT01213472|7379039|FG000|STARTED|Overall Study||33
6462638|NCT01213472|7379039|FG000|COMPLETED|Overall Study||6
6462639|NCT01213472|7379039|FG000|NOT COMPLETED|Overall Study||27
6462640|NCT01213524|7379045|FG000|STARTED|Baseline|Total number who signed informed consent.|75
6462641|NCT01213524|7379045|FG000|COMPLETED|Baseline|Number of participants who continued in the study past baseline|68
6462642|NCT01213524|7379045|FG000|NOT COMPLETED|Baseline||7
6462643|NCT01213524|7379045|FG000|STARTED|Session 2||68
6462644|NCT01213524|7379045|FG000|COMPLETED|Session 2|Number who continued in the study to the next session|63
6462645|NCT01213524|7379045|FG000|NOT COMPLETED|Session 2||5
6462646|NCT01213524|7379045|FG000|STARTED|Session 3||63
6462647|NCT01213524|7379045|FG000|COMPLETED|Session 3|Number who continued in study to next session|59
6462648|NCT01213524|7379045|FG000|NOT COMPLETED|Session 3||4
6462649|NCT01213524|7379045|FG000|STARTED|Session 4||59
6462650|NCT01213524|7379045|FG000|COMPLETED|Session 4|Number who continued in the study to the next session|56
6462651|NCT01213524|7379045|FG000|NOT COMPLETED|Session 4||3
6462652|NCT01213524|7379045|FG000|STARTED|Session 5||56
6462653|NCT01213524|7379045|FG000|COMPLETED|Session 5|Number who continued in the study to the next session|56
6462654|NCT01213524|7379045|FG000|NOT COMPLETED|Session 5||0
6462655|NCT01213524|7379045|FG000|STARTED|Session 6||56
6462656|NCT01213524|7379045|FG000|COMPLETED|Session 6|Number who continued in the study to the next session|56
6462657|NCT01213524|7379045|FG000|NOT COMPLETED|Session 6||0
6462658|NCT01213524|7379045|FG000|STARTED|Session 7||56
6462659|NCT01213524|7379045|FG000|COMPLETED|Session 7||56
6462660|NCT01213524|7379045|FG000|NOT COMPLETED|Session 7||0
6462661|NCT01213576|7379060|FG000|STARTED|Overall Study||18
6462662|NCT01213576|7379061|FG001|STARTED|Overall Study||17
6462663|NCT01213576|7379062|FG002|STARTED|Overall Study||18
6462664|NCT01213576|7379063|FG003|STARTED|Overall Study||17
6462665|NCT01213576|7379060|FG000|COMPLETED|Overall Study||15
6462666|NCT01213576|7379061|FG001|COMPLETED|Overall Study||13
6462667|NCT01213576|7379062|FG002|COMPLETED|Overall Study||13
6462668|NCT01213576|7379063|FG003|COMPLETED|Overall Study||13
6462669|NCT01213576|7379060|FG000|NOT COMPLETED|Overall Study||3
6462670|NCT01213576|7379061|FG001|NOT COMPLETED|Overall Study||4
6462671|NCT01213576|7379062|FG002|NOT COMPLETED|Overall Study||5
6462672|NCT01213576|7379063|FG003|NOT COMPLETED|Overall Study||4
6462673|NCT01213589|7379076|FG000|STARTED|Overall Study||50
6462674|NCT01213589|7379077|FG001|STARTED|Overall Study||24
6462675|NCT01213589|7379078|FG002|STARTED|Overall Study||26
6462676|NCT01213589|7379076|FG000|COMPLETED|Overall Study||37
6462677|NCT01213589|7379077|FG001|COMPLETED|Overall Study||19
6462678|NCT01213589|7379078|FG002|COMPLETED|Overall Study||18
6462679|NCT01213589|7379076|FG000|NOT COMPLETED|Overall Study||13
6462680|NCT01213589|7379077|FG001|NOT COMPLETED|Overall Study||5
6462681|NCT01213589|7379078|FG002|NOT COMPLETED|Overall Study||8
6462682|NCT01213706|7379086|FG000|STARTED|Sham WBPA||45
6462683|NCT01213706|7379086|FG000|COMPLETED|Sham WBPA||45
6462684|NCT01213706|7379086|FG000|NOT COMPLETED|Sham WBPA||0
6462685|NCT01213706|7379086|FG000|STARTED|Washout (1 Hour)||45
6462686|NCT01213706|7379086|FG000|COMPLETED|Washout (1 Hour)||45
6462687|NCT01213706|7379086|FG000|NOT COMPLETED|Washout (1 Hour)||0
6462688|NCT01213706|7379086|FG000|STARTED|WBPA||45
6462689|NCT01213706|7379086|FG000|COMPLETED|WBPA||45
6462690|NCT01213706|7379086|FG000|NOT COMPLETED|WBPA||0
6462691|NCT01213823|7379094|FG000|STARTED|Overall Study||69
6462692|NCT01213823|7379095|FG001|STARTED|Overall Study||467
6746657|NCT03374488|7674309|FG001|All Participants as Treated (APaT)|Overall Study||41
6746658|NCT03374488|7674308|FG000|COMPLETED|Overall Study||23
6746659|NCT03374488|7674309|FG001|COMPLETED|Overall Study||28
6746660|NCT03374488|7674308|FG000|NOT COMPLETED|Overall Study||19
6462693|NCT01213823|7379094|FG000|COMPLETED|Overall Study||69
6462694|NCT01213823|7379095|FG001|COMPLETED|Overall Study||467
6462695|NCT01213823|7379094|FG000|NOT COMPLETED|Overall Study||0
6462696|NCT01213823|7379095|FG001|NOT COMPLETED|Overall Study||0
6462697|NCT01213836|7379103|FG000|STARTED|Period 1, First Intervention||34
6462698|NCT01213836|7379104|FG001|STARTED|Period 1, First Intervention||32
6462699|NCT01213836|7379103|FG000|COMPLETED|Period 1, First Intervention||31
6462700|NCT01213836|7379104|FG001|COMPLETED|Period 1, First Intervention||29
6462701|NCT01213836|7379103|FG000|NOT COMPLETED|Period 1, First Intervention||3
6462702|NCT01213836|7379104|FG001|NOT COMPLETED|Period 1, First Intervention||3
6746661|NCT03374488|7674309|FG001|NOT COMPLETED|Overall Study||14
6554035|NCT01746732|7476491|FG000|COMPLETED|Period 2||0
6554036|NCT01746732|7476492|FG001|COMPLETED|Period 2||10
6554037|NCT01746732|7476493|FG002|COMPLETED|Period 2||7
6462703|NCT01213836|7379103|FG000|STARTED|Period 2, Second Intervention||31
6462704|NCT01213836|7379104|FG001|STARTED|Period 2, Second Intervention||29
6462705|NCT01213836|7379103|FG000|COMPLETED|Period 2, Second Intervention||31
6462706|NCT01213836|7379104|FG001|COMPLETED|Period 2, Second Intervention||29
6462707|NCT01213836|7379103|FG000|NOT COMPLETED|Period 2, Second Intervention||0
6462708|NCT01213836|7379104|FG001|NOT COMPLETED|Period 2, Second Intervention||0
6462709|NCT01213940|7379115|FG000|STARTED|Overall Study||14
6462710|NCT01213940|7379116|FG001|STARTED|Overall Study||6
6462711|NCT01213940|7379115|FG000|COMPLETED|Overall Study||14
6462712|NCT01213940|7379116|FG001|COMPLETED|Overall Study||6
6462713|NCT01213940|7379115|FG000|NOT COMPLETED|Overall Study||0
6462714|NCT01213940|7379116|FG001|NOT COMPLETED|Overall Study||0
6462715|NCT01213966|7379126|FG000|STARTED|Overall Study||20
6462716|NCT01213966|7379127|FG001|STARTED|Overall Study||20
6462717|NCT01213966|7379128|FG002|STARTED|Overall Study||20
6462718|NCT01213966|7379129|FG003|STARTED|Overall Study||21
6462719|NCT01213966|7379126|FG000|COMPLETED|Overall Study||19
6462720|NCT01213966|7379127|FG001|COMPLETED|Overall Study||20
6462721|NCT01213966|7379128|FG002|COMPLETED|Overall Study||17
6462722|NCT01213966|7379129|FG003|COMPLETED|Overall Study||20
6462723|NCT01213966|7379126|FG000|NOT COMPLETED|Overall Study||1
6554038|NCT01746732|7476491|FG000|NOT COMPLETED|Period 2||0
6554039|NCT01746732|7476492|FG001|NOT COMPLETED|Period 2||0
6554040|NCT01746732|7476493|FG002|NOT COMPLETED|Period 2||4
6554041|NCT01746745|7476501|FG000|STARTED|Overall Study||6
6554042|NCT01746745|7476501|FG000|Received Study Drug|Overall Study||6
6554043|NCT01746745|7476501|FG000|COMPLETED|Overall Study||6
6554044|NCT01746745|7476501|FG000|NOT COMPLETED|Overall Study||0
6554045|NCT01746784|7476510|FG000|STARTED|Overall Study||19
6554046|NCT01746784|7476511|FG001|STARTED|Overall Study||10
6554047|NCT01746784|7476512|FG002|STARTED|Overall Study||9
6554048|NCT01746784|7476513|FG003|STARTED|Overall Study||9
6554049|NCT01746784|7476514|FG004|STARTED|Overall Study||19
6554050|NCT01746784|7476510|FG000|Enrolled|Overall Study||19
6554051|NCT01746784|7476511|FG001|Enrolled|Overall Study||10
6554052|NCT01746784|7476512|FG002|Enrolled|Overall Study||9
6554053|NCT01746784|7476513|FG003|Enrolled|Overall Study||9
6554054|NCT01746784|7476514|FG004|Enrolled|Overall Study||19
6554055|NCT01746784|7476510|FG000|COMPLETED|Overall Study||19
6554056|NCT01746784|7476511|FG001|COMPLETED|Overall Study||10
6554057|NCT01746784|7476512|FG002|COMPLETED|Overall Study||9
6554058|NCT01746784|7476513|FG003|COMPLETED|Overall Study||9
6554059|NCT01746784|7476514|FG004|COMPLETED|Overall Study||19
6554060|NCT01746784|7476510|FG000|NOT COMPLETED|Overall Study||0
6554061|NCT01746784|7476511|FG001|NOT COMPLETED|Overall Study||0
6554062|NCT01746784|7476512|FG002|NOT COMPLETED|Overall Study||0
6554063|NCT01746784|7476513|FG003|NOT COMPLETED|Overall Study||0
6554064|NCT01746784|7476514|FG004|NOT COMPLETED|Overall Study||0
6554065|NCT01746862|7476537|FG000|STARTED|Overall Study||60
6554066|NCT01746862|7476538|FG001|STARTED|Overall Study||30
6746662|NCT03374683|7674319|FG000|STARTED|Overall Study||148
6462724|NCT01213966|7379127|FG001|NOT COMPLETED|Overall Study||0
6462725|NCT01213966|7379128|FG002|NOT COMPLETED|Overall Study||3
6462726|NCT01213966|7379129|FG003|NOT COMPLETED|Overall Study||1
6462727|NCT01214044|7379139|FG000|STARTED|Visit 1: Screening and Consent, Washout||31
6462728|NCT01214044|7379139|FG000|COMPLETED|Visit 1: Screening and Consent, Washout||19
6462729|NCT01214044|7379139|FG000|NOT COMPLETED|Visit 1: Screening and Consent, Washout||12
6462730|NCT01214044|7379139|FG000|STARTED|Visit 2: End Washout & Start Placebo||19
6462731|NCT01214044|7379139|FG000|COMPLETED|Visit 2: End Washout & Start Placebo|2 subjects dropped out during the placebo week (between study visits 2 & 3)|17
6746663|NCT03374683|7674320|FG001|STARTED|Overall Study||150
6746664|NCT03374683|7674321|FG002|STARTED|Overall Study||153
6462732|NCT01214044|7379139|FG000|NOT COMPLETED|Visit 2: End Washout & Start Placebo||2
6462733|NCT01214044|7379139|FG000|STARTED|Visits 3-5: Escitalopram 10 mg Daily||17
6462734|NCT01214044|7379139|FG000|COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||14
6462735|NCT01214044|7379139|FG000|NOT COMPLETED|Visits 3-5: Escitalopram 10 mg Daily||3
6462736|NCT01214044|7379139|FG000|STARTED|Visits 6-11: Escitalopram 20 mg Daily||14
6462737|NCT01214044|7379139|FG000|COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||10
6462738|NCT01214044|7379139|FG000|NOT COMPLETED|Visits 6-11: Escitalopram 20 mg Daily||4
6462739|NCT01214057|7379149|FG000|STARTED|Overall Study||12
6462740|NCT01214057|7379150|FG001|STARTED|Overall Study||11
6462741|NCT01214057|7379149|FG000|COMPLETED|Overall Study||12
6462742|NCT01214057|7379150|FG001|COMPLETED|Overall Study||11
6462743|NCT01214057|7379149|FG000|NOT COMPLETED|Overall Study||0
6462744|NCT01214057|7379150|FG001|NOT COMPLETED|Overall Study||0
6462745|NCT01214083|7379159|FG000|STARTED|Overall Study||31
6462746|NCT01214083|7379160|FG001|STARTED|Overall Study||33
6462747|NCT01214083|7379161|FG002|STARTED|Overall Study||31
6462748|NCT01214083|7379159|FG000|COMPLETED|Overall Study||19
6462749|NCT01214083|7379160|FG001|COMPLETED|Overall Study||23
6554067|NCT01746862|7476537|FG000|Treated|Overall Study||59
6554068|NCT01746862|7476538|FG001|Treated|Overall Study||30
6554069|NCT01746862|7476537|FG000|COMPLETED|Overall Study||52
6554070|NCT01746862|7476538|FG001|COMPLETED|Overall Study||27
6554071|NCT01746862|7476537|FG000|NOT COMPLETED|Overall Study||8
6554072|NCT01746862|7476538|FG001|NOT COMPLETED|Overall Study||3
6746665|NCT03374683|7674319|FG000|1-week Post-intervention|Overall Study||135
6462750|NCT01214083|7379161|FG002|COMPLETED|Overall Study||21
6462751|NCT01214083|7379159|FG000|NOT COMPLETED|Overall Study||12
6462752|NCT01214083|7379160|FG001|NOT COMPLETED|Overall Study||10
6462753|NCT01214083|7379161|FG002|NOT COMPLETED|Overall Study||10
6462754|NCT01214109|7379169|FG000|STARTED|Overall Study||24
6462755|NCT01214109|7379170|FG001|STARTED|Overall Study||24
6462756|NCT01214109|7379171|FG002|STARTED|Overall Study||24
6462757|NCT01214109|7379172|FG003|STARTED|Overall Study||24
6462758|NCT01214109|7379169|FG000|COMPLETED|Overall Study||24
6462759|NCT01214109|7379170|FG001|COMPLETED|Overall Study||24
6462760|NCT01214109|7379171|FG002|COMPLETED|Overall Study||24
6462761|NCT01214109|7379172|FG003|COMPLETED|Overall Study||24
6462762|NCT01214109|7379169|FG000|NOT COMPLETED|Overall Study||0
6462763|NCT01214109|7379170|FG001|NOT COMPLETED|Overall Study||0
6462764|NCT01214109|7379171|FG002|NOT COMPLETED|Overall Study||0
6462765|NCT01214109|7379172|FG003|NOT COMPLETED|Overall Study||0
6462766|NCT01214161|7379187|FG000|STARTED|Overall Study||100
6462767|NCT01214161|7379188|FG001|STARTED|Overall Study||100
6462768|NCT01214161|7379187|FG000|COMPLETED|Overall Study||100
6462769|NCT01214161|7379188|FG001|COMPLETED|Overall Study||100
6462770|NCT01214161|7379187|FG000|NOT COMPLETED|Overall Study||0
6462771|NCT01214161|7379188|FG001|NOT COMPLETED|Overall Study||0
6462772|NCT01214174|7379199|FG000|STARTED|Overall Study||13
6462773|NCT01214174|7379200|FG001|STARTED|Overall Study||16
6462774|NCT01214174|7379201|FG002|STARTED|Overall Study||14
6462775|NCT01214174|7379199|FG000|COMPLETED|Overall Study||13
6462776|NCT01214174|7379200|FG001|COMPLETED|Overall Study||16
6462777|NCT01214174|7379201|FG002|COMPLETED|Overall Study||13
6462778|NCT01214174|7379199|FG000|NOT COMPLETED|Overall Study||0
6462779|NCT01214174|7379200|FG001|NOT COMPLETED|Overall Study||0
6462780|NCT01214174|7379201|FG002|NOT COMPLETED|Overall Study||1
6462781|NCT01214187|7379211|FG000|STARTED|Overall Study||29
6462782|NCT01214187|7379212|FG001|STARTED|Overall Study||29
6462783|NCT01214187|7379211|FG000|COMPLETED|Overall Study||22
6462784|NCT01214187|7379212|FG001|COMPLETED|Overall Study||23
6462785|NCT01214187|7379211|FG000|NOT COMPLETED|Overall Study||7
6462786|NCT01214187|7379212|FG001|NOT COMPLETED|Overall Study||6
6462787|NCT01214200|7379218|FG000|STARTED|Overall Study||20
6462788|NCT01214200|7379218|FG000|COMPLETED|Overall Study||9
6462789|NCT01214200|7379218|FG000|NOT COMPLETED|Overall Study||11
6462790|NCT01214239|7379226|FG000|STARTED|Overall Study|patients who were randomised and treated with placebo|99
6462791|NCT01214239|7379227|FG001|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
6462792|NCT01214239|7379226|FG000|COMPLETED|Overall Study||87
6462793|NCT01214239|7379227|FG001|COMPLETED|Overall Study||182
6462794|NCT01214239|7379226|FG000|NOT COMPLETED|Overall Study||12
6462795|NCT01214239|7379227|FG001|NOT COMPLETED|Overall Study||18
6462796|NCT01214252|7379233|FG000|STARTED|Overall Study||425
6462797|NCT01214252|7379233|FG000|COMPLETED|Overall Study||343
6462798|NCT01214252|7379233|FG000|NOT COMPLETED|Overall Study||82
6462799|NCT01214317|7379240|FG000|STARTED|Overall Study||18
6462800|NCT01214317|7379241|FG001|STARTED|Overall Study||22
6462801|NCT01214317|7379240|FG000|COMPLETED|Overall Study||18
6462802|NCT01214317|7379241|FG001|COMPLETED|Overall Study||22
6462803|NCT01214317|7379240|FG000|NOT COMPLETED|Overall Study||0
6462804|NCT01214317|7379241|FG001|NOT COMPLETED|Overall Study||0
6462805|NCT01214330|7379249|FG000|STARTED|Overall Study||150
6462806|NCT01214330|7379249|FG000|COMPLETED|Overall Study||102
6462807|NCT01214330|7379249|FG000|NOT COMPLETED|Overall Study||48
6462808|NCT01214356|7379255|FG000|STARTED|Overall Study||27
6462809|NCT01214356|7379256|FG001|STARTED|Overall Study||27
6462810|NCT01214356|7379255|FG000|COMPLETED|Overall Study||10
6462811|NCT01214356|7379256|FG001|COMPLETED|Overall Study||13
6462812|NCT01214356|7379255|FG000|NOT COMPLETED|Overall Study||17
6462813|NCT01214356|7379256|FG001|NOT COMPLETED|Overall Study||14
6462814|NCT01214395|7379262|FG000|STARTED|Overall Study||5
6462815|NCT01214395|7379262|FG000|COMPLETED|Overall Study||0
6462816|NCT01214395|7379262|FG000|NOT COMPLETED|Overall Study||5
6462817|NCT01214421|7379271|FG000|STARTED|Overall Study||557
6462818|NCT01214421|7379272|FG001|STARTED|Overall Study||314
6462819|NCT01214421|7379273|FG002|STARTED|Overall Study||181
6462820|NCT01214421|7379274|FG003|STARTED|Overall Study||31
6462821|NCT01214421|7379271|FG000|COMPLETED|Overall Study||507
6462822|NCT01214421|7379272|FG001|COMPLETED|Overall Study||256
6462823|NCT01214421|7379273|FG002|COMPLETED|Overall Study||143
6462824|NCT01214421|7379274|FG003|COMPLETED|Overall Study||22
6462825|NCT01214421|7379271|FG000|NOT COMPLETED|Overall Study||50
6462826|NCT01214421|7379272|FG001|NOT COMPLETED|Overall Study||58
6462827|NCT01214421|7379273|FG002|NOT COMPLETED|Overall Study||38
6462828|NCT01214421|7379274|FG003|NOT COMPLETED|Overall Study||9
6462829|NCT01214434|7379286|FG000|STARTED|Overall Study||15
6462830|NCT01214434|7379287|FG001|STARTED|Overall Study||27
6462831|NCT01214434|7379286|FG000|COMPLETED|Overall Study||11
6462832|NCT01214434|7379287|FG001|COMPLETED|Overall Study||25
6462833|NCT01214434|7379286|FG000|NOT COMPLETED|Overall Study||4
6462834|NCT01214434|7379287|FG001|NOT COMPLETED|Overall Study||2
6462835|NCT01214603|7379296|FG000|STARTED|Overall Study||7
6462836|NCT01214603|7379297|FG001|STARTED|Overall Study||6
6462837|NCT01214603|7379298|FG002|STARTED|Overall Study||7
6462838|NCT01214603|7379296|FG000|Received at Least 1 Dose of LY2090314|Overall Study||7
6462839|NCT01214603|7379297|FG001|Received at Least 1 Dose of LY2090314|Overall Study||6
6462840|NCT01214603|7379298|FG002|Received at Least 1 Dose of LY2090314|Overall Study||7
6462841|NCT01214603|7379296|FG000|COMPLETED|Overall Study||2
6462842|NCT01214603|7379297|FG001|COMPLETED|Overall Study||5
6462843|NCT01214603|7379298|FG002|COMPLETED|Overall Study||3
6462844|NCT01214603|7379296|FG000|NOT COMPLETED|Overall Study||5
6462845|NCT01214603|7379297|FG001|NOT COMPLETED|Overall Study||1
6462846|NCT01214603|7379298|FG002|NOT COMPLETED|Overall Study||4
6462847|NCT01214616|7379311|FG000|STARTED|Overall Study||3
6462848|NCT01214616|7379312|FG001|STARTED|Overall Study||5
6462849|NCT01214616|7379313|FG002|STARTED|Overall Study||3
6462850|NCT01214616|7379314|FG003|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
6462851|NCT01214616|7379311|FG000|COMPLETED|Overall Study||0
6462852|NCT01214616|7379312|FG001|COMPLETED|Overall Study||0
6462853|NCT01214616|7379313|FG002|COMPLETED|Overall Study||0
6462854|NCT01214616|7379314|FG003|COMPLETED|Overall Study||0
6462855|NCT01214616|7379311|FG000|NOT COMPLETED|Overall Study||3
6462856|NCT01214616|7379312|FG001|NOT COMPLETED|Overall Study||5
6462857|NCT01214616|7379313|FG002|NOT COMPLETED|Overall Study||3
6462858|NCT01214616|7379314|FG003|NOT COMPLETED|Overall Study||6
6462859|NCT01214629|7379343|FG000|STARTED|Overall Study||1
6462860|NCT01214629|7379344|FG001|STARTED|Overall Study||1
6462861|NCT01214629|7379345|FG002|STARTED|Overall Study||1
6462862|NCT01214629|7379346|FG003|STARTED|Overall Study||3
6462863|NCT01214629|7379347|FG004|STARTED|Overall Study||3
6462864|NCT01214629|7379348|FG005|STARTED|Overall Study||13
6462865|NCT01214629|7379349|FG006|STARTED|Overall Study||5
6462866|NCT01214629|7379350|FG007|STARTED|Overall Study||3
6462867|NCT01214629|7379351|FG008|STARTED|Overall Study||3
6462868|NCT01214629|7379352|FG009|STARTED|Overall Study||18
6462869|NCT01214629|7379353|FG010|STARTED|Overall Study||3
6462870|NCT01214629|7379343|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
6462871|NCT01214629|7379344|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
6462872|NCT01214629|7379345|FG002|Received at Least 1 Dose of Study Drug|Overall Study||1
6462873|NCT01214629|7379346|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6462874|NCT01214629|7379347|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
6462875|NCT01214629|7379348|FG005|Received at Least 1 Dose of Study Drug|Overall Study||13
6462876|NCT01214629|7379349|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
6462877|NCT01214629|7379350|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
6462878|NCT01214629|7379351|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
6462879|NCT01214629|7379352|FG009|Received at Least 1 Dose of Study Drug|Overall Study||18
6462880|NCT01214629|7379353|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
6462881|NCT01214629|7379343|FG000|COMPLETED|Overall Study||0
6462882|NCT01214629|7379344|FG001|COMPLETED|Overall Study||0
6462883|NCT01214629|7379345|FG002|COMPLETED|Overall Study||1
6462884|NCT01214629|7379346|FG003|COMPLETED|Overall Study||1
6462885|NCT01214629|7379347|FG004|COMPLETED|Overall Study||1
6462886|NCT01214629|7379348|FG005|COMPLETED|Overall Study||9
6462887|NCT01214629|7379349|FG006|COMPLETED|Overall Study||4
6462888|NCT01214629|7379350|FG007|COMPLETED|Overall Study||2
6462889|NCT01214629|7379351|FG008|COMPLETED|Overall Study||2
6462890|NCT01214629|7379352|FG009|COMPLETED|Overall Study||11
6462891|NCT01214629|7379353|FG010|COMPLETED|Overall Study||1
6462892|NCT01214629|7379343|FG000|NOT COMPLETED|Overall Study||1
6462893|NCT01214629|7379344|FG001|NOT COMPLETED|Overall Study||1
6462894|NCT01214629|7379345|FG002|NOT COMPLETED|Overall Study||0
6462895|NCT01214629|7379346|FG003|NOT COMPLETED|Overall Study||2
6462896|NCT01214629|7379347|FG004|NOT COMPLETED|Overall Study||2
6462897|NCT01214629|7379348|FG005|NOT COMPLETED|Overall Study||4
6462898|NCT01214629|7379349|FG006|NOT COMPLETED|Overall Study||1
6462899|NCT01214629|7379350|FG007|NOT COMPLETED|Overall Study||1
6462900|NCT01214629|7379351|FG008|NOT COMPLETED|Overall Study||1
6462901|NCT01214629|7379352|FG009|NOT COMPLETED|Overall Study||7
6462902|NCT01214629|7379353|FG010|NOT COMPLETED|Overall Study||2
6462903|NCT01214642|7379403|FG000|STARTED|Overall Study||3
6462904|NCT01214642|7379404|FG001|STARTED|Overall Study||3
6462905|NCT01214642|7379405|FG002|STARTED|Overall Study||6
6462906|NCT01214642|7379406|FG003|STARTED|Overall Study||6
6462907|NCT01214642|7379407|FG004|STARTED|Overall Study||6
6462908|NCT01214642|7379408|FG005|STARTED|Overall Study||3
6462909|NCT01214642|7379409|FG006|STARTED|Overall Study||6
6462910|NCT01214642|7379410|FG007|STARTED|Overall Study||3
6462911|NCT01214642|7379411|FG008|STARTED|Overall Study|All participants who received 12 mg/m2/day on Days 1 and 5 plus PEG in Part A and Part B.|13
6462912|NCT01214642|7379412|FG009|STARTED|Overall Study||4
6462913|NCT01214642|7379413|FG010|STARTED|Overall Study||4
6462914|NCT01214642|7379414|FG011|STARTED|Overall Study||6
6462915|NCT01214642|7379403|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6462916|NCT01214642|7379404|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6462917|NCT01214642|7379405|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6462918|NCT01214642|7379406|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6462919|NCT01214642|7379407|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
6462920|NCT01214642|7379408|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
6462921|NCT01214642|7379409|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
6462922|NCT01214642|7379410|FG007|Received at Least 1 Dose of Study Drug|Overall Study||3
6462923|NCT01214642|7379411|FG008|Received at Least 1 Dose of Study Drug|Overall Study||13
6462924|NCT01214642|7379412|FG009|Received at Least 1 Dose of Study Drug|Overall Study||4
6462925|NCT01214642|7379413|FG010|Received at Least 1 Dose of Study Drug|Overall Study||4
6462926|NCT01214642|7379414|FG011|Received at Least 1 Dose of Study Drug|Overall Study||6
6462927|NCT01214642|7379403|FG000|Complete at Least 2 Cycles of Study Drug|Overall Study||3
6462928|NCT01214642|7379404|FG001|Complete at Least 2 Cycles of Study Drug|Overall Study||1
6462929|NCT01214642|7379405|FG002|Complete at Least 2 Cycles of Study Drug|Overall Study||5
6462930|NCT01214642|7379406|FG003|Complete at Least 2 Cycles of Study Drug|Overall Study||4
6462931|NCT01214642|7379407|FG004|Complete at Least 2 Cycles of Study Drug|Overall Study||6
6462932|NCT01214642|7379408|FG005|Complete at Least 2 Cycles of Study Drug|Overall Study||1
6462933|NCT01214642|7379409|FG006|Complete at Least 2 Cycles of Study Drug|Overall Study||6
6462934|NCT01214642|7379410|FG007|Complete at Least 2 Cycles of Study Drug|Overall Study||3
6462935|NCT01214642|7379411|FG008|Complete at Least 2 Cycles of Study Drug|Overall Study||12
6462936|NCT01214642|7379412|FG009|Complete at Least 2 Cycles of Study Drug|Overall Study||2
6462937|NCT01214642|7379413|FG010|Complete at Least 2 Cycles of Study Drug|Overall Study||2
6462938|NCT01214642|7379414|FG011|Complete at Least 2 Cycles of Study Drug|Overall Study||5
6462939|NCT01214642|7379403|FG000|COMPLETED|Overall Study||0
6462940|NCT01214642|7379404|FG001|COMPLETED|Overall Study||0
6462941|NCT01214642|7379405|FG002|COMPLETED|Overall Study||0
6462942|NCT01214642|7379406|FG003|COMPLETED|Overall Study||0
6462943|NCT01214642|7379407|FG004|COMPLETED|Overall Study||0
6462944|NCT01214642|7379408|FG005|COMPLETED|Overall Study||0
6462945|NCT01214642|7379409|FG006|COMPLETED|Overall Study||0
6462946|NCT01214642|7379410|FG007|COMPLETED|Overall Study||0
6462947|NCT01214642|7379411|FG008|COMPLETED|Overall Study||0
6462948|NCT01214642|7379412|FG009|COMPLETED|Overall Study||0
6462949|NCT01214642|7379413|FG010|COMPLETED|Overall Study||0
6462950|NCT01214642|7379414|FG011|COMPLETED|Overall Study||0
6462951|NCT01214642|7379403|FG000|NOT COMPLETED|Overall Study||3
6462952|NCT01214642|7379404|FG001|NOT COMPLETED|Overall Study||3
6462953|NCT01214642|7379405|FG002|NOT COMPLETED|Overall Study||6
6462954|NCT01214642|7379406|FG003|NOT COMPLETED|Overall Study||6
6462955|NCT01214642|7379407|FG004|NOT COMPLETED|Overall Study||6
6462956|NCT01214642|7379408|FG005|NOT COMPLETED|Overall Study||3
6462957|NCT01214642|7379409|FG006|NOT COMPLETED|Overall Study||6
6462958|NCT01214642|7379410|FG007|NOT COMPLETED|Overall Study||3
6462959|NCT01214642|7379411|FG008|NOT COMPLETED|Overall Study||13
6462960|NCT01214642|7379412|FG009|NOT COMPLETED|Overall Study||4
6462961|NCT01214642|7379413|FG010|NOT COMPLETED|Overall Study||4
6462962|NCT01214642|7379414|FG011|NOT COMPLETED|Overall Study||6
6462963|NCT01214655|7379460|FG000|STARTED|Part A|Total on Schedule A, dose days 1,2,3|10
6462964|NCT01214655|7379461|FG001|STARTED|Part A||0
6462965|NCT01214655|7379462|FG002|STARTED|Part A||0
6462966|NCT01214655|7379460|FG000|Received 2 mg Study Drug|Part A||3
6462967|NCT01214655|7379461|FG001|Received 2 mg Study Drug|Part A||0
6462968|NCT01214655|7379462|FG002|Received 2 mg Study Drug|Part A||0
6462969|NCT01214655|7379460|FG000|Escalated From 2 to 4 mg/m²/Day|Part A||3
6462970|NCT01214655|7379461|FG001|Escalated From 2 to 4 mg/m²/Day|Part A||0
6462971|NCT01214655|7379462|FG002|Escalated From 2 to 4 mg/m²/Day|Part A||0
6462972|NCT01214655|7379460|FG000|Joined 4 mg Group|Part A||1
6462973|NCT01214655|7379461|FG001|Joined 4 mg Group|Part A||0
6462974|NCT01214655|7379462|FG002|Joined 4 mg Group|Part A||0
6462975|NCT01214655|7379460|FG000|Escalated From 4 mg Study Drug|Part A||0
6462976|NCT01214655|7379461|FG001|Escalated From 4 mg Study Drug|Part A||0
6462977|NCT01214655|7379462|FG002|Escalated From 4 mg Study Drug|Part A||0
6462978|NCT01214655|7379460|FG000|Joined 5 mg Study Drug|Part A||2
6462979|NCT01214655|7379461|FG001|Joined 5 mg Study Drug|Part A||0
6462980|NCT01214655|7379462|FG002|Joined 5 mg Study Drug|Part A||0
6462981|NCT01214655|7379460|FG000|Escalated From 5 mg Study Drug|Part A||1
6462982|NCT01214655|7379461|FG001|Escalated From 5 mg Study Drug|Part A||0
6462983|NCT01214655|7379462|FG002|Escalated From 5 mg Study Drug|Part A||0
6462984|NCT01214655|7379460|FG000|Joined 6 mg Group|Part A||4
6462985|NCT01214655|7379461|FG001|Joined 6 mg Group|Part A||0
6462986|NCT01214655|7379462|FG002|Joined 6 mg Group|Part A||0
6462987|NCT01214655|7379460|FG000|Received 6 mg Study Drug|Part A||5
6462988|NCT01214655|7379461|FG001|Received 6 mg Study Drug|Part A||0
6462989|NCT01214655|7379462|FG002|Received 6 mg Study Drug|Part A||0
6462990|NCT01214655|7379460|FG000|COMPLETED|Part A||2
6462991|NCT01214655|7379461|FG001|COMPLETED|Part A||0
6462992|NCT01214655|7379462|FG002|COMPLETED|Part A||0
6462993|NCT01214655|7379460|FG000|NOT COMPLETED|Part A||8
6462994|NCT01214655|7379461|FG001|NOT COMPLETED|Part A||0
6462995|NCT01214655|7379462|FG002|NOT COMPLETED|Part A||0
6462996|NCT01214655|7379460|FG000|STARTED|Part B|Part A participants did not enroll in Part B. Participants in A, B, C are considered Cohorts.|0
6462997|NCT01214655|7379461|FG001|STARTED|Part B|Total on Schedule B, dose days 1,5,9|15
6462998|NCT01214655|7379462|FG002|STARTED|Part B||0
6462999|NCT01214655|7379460|FG000|Received at Least 1 Dose of Study Drug|Part B||0
6463000|NCT01214655|7379461|FG001|Received at Least 1 Dose of Study Drug|Part B||15
6463001|NCT01214655|7379462|FG002|Received at Least 1 Dose of Study Drug|Part B||0
6463002|NCT01214655|7379460|FG000|Recieved 8 mg/m²/Day Study Drug|Part B||0
6463003|NCT01214655|7379461|FG001|Recieved 8 mg/m²/Day Study Drug|Part B||4
6463004|NCT01214655|7379462|FG002|Recieved 8 mg/m²/Day Study Drug|Part B||0
6463005|NCT01214655|7379460|FG000|Escalated From 8 to 10 mg/m²/Day|Part B||0
6463006|NCT01214655|7379461|FG001|Escalated From 8 to 10 mg/m²/Day|Part B||2
6463007|NCT01214655|7379462|FG002|Escalated From 8 to 10 mg/m²/Day|Part B||0
6463008|NCT01214655|7379460|FG000|Joined 10 mg/m²/Day Study D|Part B||0
6463009|NCT01214655|7379461|FG001|Joined 10 mg/m²/Day Study D|Part B||3
6463010|NCT01214655|7379462|FG002|Joined 10 mg/m²/Day Study D|Part B||0
6463011|NCT01214655|7379460|FG000|Escalated to 12 mg/m²/Day|Part B||0
6463012|NCT01214655|7379461|FG001|Escalated to 12 mg/m²/Day|Part B||2
6463013|NCT01214655|7379462|FG002|Escalated to 12 mg/m²/Day|Part B||0
6463014|NCT01214655|7379460|FG000|Joined 12 mg/m²/Day|Part B||0
6463015|NCT01214655|7379461|FG001|Joined 12 mg/m²/Day|Part B||5
6463016|NCT01214655|7379462|FG002|Joined 12 mg/m²/Day|Part B||0
6463017|NCT01214655|7379460|FG000|Escalated From 12 to 14 mg/m²/Day|Part B||0
6463018|NCT01214655|7379461|FG001|Escalated From 12 to 14 mg/m²/Day|Part B||1
6463019|NCT01214655|7379462|FG002|Escalated From 12 to 14 mg/m²/Day|Part B||0
6463020|NCT01214655|7379460|FG000|Joined 14 mg/m²/Day|Part B||0
6463021|NCT01214655|7379461|FG001|Joined 14 mg/m²/Day|Part B||3
6463022|NCT01214655|7379462|FG002|Joined 14 mg/m²/Day|Part B||0
6463023|NCT01214655|7379460|FG000|COMPLETED|Part B||0
6463024|NCT01214655|7379461|FG001|COMPLETED|Part B||2
6463025|NCT01214655|7379462|FG002|COMPLETED|Part B||0
6463026|NCT01214655|7379460|FG000|NOT COMPLETED|Part B||0
6463027|NCT01214655|7379461|FG001|NOT COMPLETED|Part B||13
6463028|NCT01214655|7379462|FG002|NOT COMPLETED|Part B||0
6463029|NCT01214655|7379460|FG000|STARTED|Part C||0
6463030|NCT01214655|7379461|FG001|STARTED|Part C||0
6463031|NCT01214655|7379462|FG002|STARTED|Part C|Total on Schedule C, dose days 1,2,3|8
6463032|NCT01214655|7379460|FG000|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
6463033|NCT01214655|7379461|FG001|Received at Least 1 Dose of 5 mg/m²/Day|Part C||0
6463034|NCT01214655|7379462|FG002|Received at Least 1 Dose of 5 mg/m²/Day|Part C||8
6463035|NCT01214655|7379460|FG000|COMPLETED|Part C||0
6463036|NCT01214655|7379461|FG001|COMPLETED|Part C||0
6463037|NCT01214655|7379462|FG002|COMPLETED|Part C||1
6554073|NCT01746901|7476545|FG000|STARTED|Naloxone Challenge Phase||75
6554074|NCT01746901|7476546|FG001|STARTED|Naloxone Challenge Phase||0
6554075|NCT01746901|7476547|FG002|STARTED|Naloxone Challenge Phase||0
6554076|NCT01746901|7476548|FG003|STARTED|Naloxone Challenge Phase||0
6554077|NCT01746901|7476549|FG004|STARTED|Naloxone Challenge Phase||0
6554078|NCT01746901|7476550|FG005|STARTED|Naloxone Challenge Phase||0
6463038|NCT01214655|7379460|FG000|NOT COMPLETED|Part C||0
6463039|NCT01214655|7379461|FG001|NOT COMPLETED|Part C||0
6463040|NCT01214655|7379462|FG002|NOT COMPLETED|Part C||7
6463041|NCT01214668|7379514|FG000|STARTED|Overall Study||4
6463042|NCT01214668|7379515|FG001|STARTED|Overall Study||3
6463043|NCT01214668|7379516|FG002|STARTED|Overall Study||6
6463044|NCT01214668|7379517|FG003|STARTED|Overall Study||6
6463045|NCT01214668|7379518|FG004|STARTED|Overall Study||6
6554079|NCT01746901|7476551|FG006|STARTED|Naloxone Challenge Phase||0
6554080|NCT01746901|7476552|FG007|STARTED|Naloxone Challenge Phase||0
6554081|NCT01746901|7476553|FG008|STARTED|Naloxone Challenge Phase||0
6554082|NCT01746901|7476545|FG000|COMPLETED|Naloxone Challenge Phase||72
6554083|NCT01746901|7476546|FG001|COMPLETED|Naloxone Challenge Phase||0
6554084|NCT01746901|7476547|FG002|COMPLETED|Naloxone Challenge Phase||0
6463046|NCT01214668|7379519|FG005|STARTED|Overall Study||6
6463047|NCT01214668|7379514|FG000|Received at Least One Dose of Study Drug|Overall Study||4
6463048|NCT01214668|7379515|FG001|Received at Least One Dose of Study Drug|Overall Study||3
6463049|NCT01214668|7379516|FG002|Received at Least One Dose of Study Drug|Overall Study||6
6463050|NCT01214668|7379517|FG003|Received at Least One Dose of Study Drug|Overall Study||6
6463051|NCT01214668|7379518|FG004|Received at Least One Dose of Study Drug|Overall Study||6
6463052|NCT01214668|7379519|FG005|Received at Least One Dose of Study Drug|Overall Study||6
6463053|NCT01214668|7379514|FG000|COMPLETED|Overall Study||0
6463054|NCT01214668|7379515|FG001|COMPLETED|Overall Study||0
6463055|NCT01214668|7379516|FG002|COMPLETED|Overall Study||0
6463056|NCT01214668|7379517|FG003|COMPLETED|Overall Study||0
6463057|NCT01214668|7379518|FG004|COMPLETED|Overall Study||0
6463058|NCT01214668|7379519|FG005|COMPLETED|Overall Study||0
6463059|NCT01214668|7379514|FG000|NOT COMPLETED|Overall Study||4
6463060|NCT01214668|7379515|FG001|NOT COMPLETED|Overall Study||3
6463061|NCT01214668|7379516|FG002|NOT COMPLETED|Overall Study||6
6463062|NCT01214668|7379517|FG003|NOT COMPLETED|Overall Study||6
6463063|NCT01214668|7379518|FG004|NOT COMPLETED|Overall Study||6
6463064|NCT01214668|7379519|FG005|NOT COMPLETED|Overall Study||6
6500779|NCT01425801|7419347|FG003|NOT COMPLETED|Period 6||0
6500780|NCT01425801|7419348|FG004|NOT COMPLETED|Period 6||0
6500781|NCT01425801|7419349|FG005|NOT COMPLETED|Period 6||0
6500782|NCT01425814|7419363|FG000|STARTED|Period 1||12
6500783|NCT01425814|7419364|FG001|STARTED|Period 1||11
6500784|NCT01425814|7419365|FG002|STARTED|Period 1||12
6500785|NCT01425814|7419366|FG003|STARTED|Period 1||10
6500786|NCT01425814|7419367|FG004|STARTED|Period 1||12
6500787|NCT01425814|7419368|FG005|STARTED|Period 1||13
6500788|NCT01425814|7419363|FG000|COMPLETED|Period 1||12
6554085|NCT01746901|7476548|FG003|COMPLETED|Naloxone Challenge Phase||0
6554086|NCT01746901|7476549|FG004|COMPLETED|Naloxone Challenge Phase||0
6554087|NCT01746901|7476550|FG005|COMPLETED|Naloxone Challenge Phase||0
6500789|NCT01425814|7419364|FG001|COMPLETED|Period 1||10
6500790|NCT01425814|7419365|FG002|COMPLETED|Period 1||12
6500791|NCT01425814|7419366|FG003|COMPLETED|Period 1||10
6500792|NCT01425814|7419367|FG004|COMPLETED|Period 1||12
6500793|NCT01425814|7419368|FG005|COMPLETED|Period 1||13
6500794|NCT01425814|7419363|FG000|NOT COMPLETED|Period 1||0
6500795|NCT01425814|7419364|FG001|NOT COMPLETED|Period 1||1
6500796|NCT01425814|7419365|FG002|NOT COMPLETED|Period 1||0
6500797|NCT01425814|7419366|FG003|NOT COMPLETED|Period 1||0
6463065|NCT01214720|7379536|FG000|STARTED|Overall Study||306
6463066|NCT01214720|7379537|FG001|STARTED|Overall Study||301
6463067|NCT01214720|7379536|FG000|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
6463068|NCT01214720|7379537|FG001|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
6463069|NCT01214720|7379536|FG000|NOT COMPLETED|Overall Study||85
6463070|NCT01214720|7379537|FG001|NOT COMPLETED|Overall Study||68
6463071|NCT01214759|7379543|FG000|STARTED|Overall Study||103
6463072|NCT01214759|7379543|FG000|28 Days nPEP Completion|Overall Study||85
6463073|NCT01214759|7379543|FG000|COMPLETED|Overall Study||55
6463074|NCT01214759|7379543|FG000|NOT COMPLETED|Overall Study||48
6463075|NCT01214811|7379547|FG000|STARTED|Overall Study||27
6463076|NCT01214811|7379547|FG000|COMPLETED|Overall Study||24
6463077|NCT01214811|7379547|FG000|NOT COMPLETED|Overall Study||3
6463078|NCT01214824|7379551|FG000|STARTED|Overall Study||32
6463079|NCT01214824|7379551|FG000|COMPLETED|Overall Study||29
6463080|NCT01214824|7379551|FG000|NOT COMPLETED|Overall Study||3
6463081|NCT01214837|7379559|FG000|STARTED|Overall Study||249
6463082|NCT01214837|7379560|FG001|STARTED|Overall Study||256
6463083|NCT01214837|7379561|FG002|STARTED|Overall Study||246
6463084|NCT01214837|7379559|FG000|COMPLETED|Overall Study||195
6463085|NCT01214837|7379560|FG001|COMPLETED|Overall Study||192
6463086|NCT01214837|7379561|FG002|COMPLETED|Overall Study||184
6463087|NCT01214837|7379559|FG000|NOT COMPLETED|Overall Study||54
6463088|NCT01214837|7379560|FG001|NOT COMPLETED|Overall Study||64
6463089|NCT01214837|7379561|FG002|NOT COMPLETED|Overall Study||62
6463090|NCT01214850|7379573|FG000|STARTED|Overall Study||979
6463091|NCT01214850|7379574|FG001|STARTED|Overall Study||988
6463092|NCT01214850|7379575|FG002|STARTED|Overall Study||987
6463093|NCT01214850|7379573|FG000|COMPLETED|Overall Study||796
6463094|NCT01214850|7379574|FG001|COMPLETED|Overall Study||844
6463095|NCT01214850|7379575|FG002|COMPLETED|Overall Study||826
6463096|NCT01214850|7379573|FG000|NOT COMPLETED|Overall Study||183
6463097|NCT01214850|7379574|FG001|NOT COMPLETED|Overall Study||144
6463098|NCT01214850|7379575|FG002|NOT COMPLETED|Overall Study||161
6463099|NCT01214915|7379586|FG000|STARTED|Overall Study||53
6463100|NCT01214915|7379586|FG000|COMPLETED|Overall Study||42
6463101|NCT01214915|7379586|FG000|NOT COMPLETED|Overall Study||11
6463102|NCT01214980|7379592|FG000|STARTED|Overall Study||16
6463103|NCT01214980|7379593|FG001|STARTED|Overall Study||16
6463104|NCT01214980|7379592|FG000|COMPLETED|Overall Study||13
6463105|NCT01214980|7379593|FG001|COMPLETED|Overall Study||14
6463106|NCT01214980|7379592|FG000|NOT COMPLETED|Overall Study||3
6463107|NCT01214980|7379593|FG001|NOT COMPLETED|Overall Study||2
6463108|NCT01215032|7379599|FG000|STARTED|Overall Study||21
6463109|NCT01215032|7379599|FG000|COMPLETED|Overall Study||1
6463110|NCT01215032|7379599|FG000|NOT COMPLETED|Overall Study||20
6463111|NCT01215097|7379607|FG000|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
6463112|NCT01215097|7379608|FG001|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
6463113|NCT01215097|7379607|FG000|COMPLETED|Overall Study||88
6463114|NCT01215097|7379608|FG001|COMPLETED|Overall Study||191
6463115|NCT01215097|7379607|FG000|NOT COMPLETED|Overall Study||12
6463116|NCT01215097|7379608|FG001|NOT COMPLETED|Overall Study||14
6463117|NCT01215110|7379619|FG000|STARTED|Overall Study||15
6463118|NCT01215110|7379620|FG001|STARTED|Overall Study||15
6463119|NCT01215110|7379621|FG002|STARTED|Overall Study||15
6463120|NCT01215110|7379622|FG003|STARTED|Overall Study||15
6463121|NCT01215110|7379623|FG004|STARTED|Overall Study||8
6463122|NCT01215110|7379619|FG000|COMPLETED|Overall Study||15
6463123|NCT01215110|7379620|FG001|COMPLETED|Overall Study||15
6463124|NCT01215110|7379621|FG002|COMPLETED|Overall Study||13
6463125|NCT01215110|7379622|FG003|COMPLETED|Overall Study||14
6463126|NCT01215110|7379623|FG004|COMPLETED|Overall Study||8
6463127|NCT01215110|7379619|FG000|NOT COMPLETED|Overall Study||0
6463128|NCT01215110|7379620|FG001|NOT COMPLETED|Overall Study||0
6463129|NCT01215110|7379621|FG002|NOT COMPLETED|Overall Study||2
6463130|NCT01215110|7379622|FG003|NOT COMPLETED|Overall Study||1
6463131|NCT01215110|7379623|FG004|NOT COMPLETED|Overall Study||0
6463132|NCT01215123|7379639|FG000|STARTED|Overall Study||28
6463133|NCT01215123|7379639|FG000|COMPLETED|Overall Study||28
6463134|NCT01215123|7379639|FG000|NOT COMPLETED|Overall Study||0
6463135|NCT01215175|7379648|FG000|STARTED|Overall Study||30
6463136|NCT01215175|7379649|FG001|STARTED|Overall Study||30
6463137|NCT01215175|7379650|FG002|STARTED|Overall Study||33
6463138|NCT01215175|7379651|FG003|STARTED|Overall Study||29
6463139|NCT01215175|7379652|FG004|STARTED|Overall Study||28
6463140|NCT01215175|7379648|FG000|Treated|Overall Study||30
6463141|NCT01215175|7379649|FG001|Treated|Overall Study||30
6463142|NCT01215175|7379650|FG002|Treated|Overall Study||33
6463143|NCT01215175|7379651|FG003|Treated|Overall Study||29
6463144|NCT01215175|7379652|FG004|Treated|Overall Study||28
6463145|NCT01215175|7379648|FG000|COMPLETED|Overall Study||30
6463146|NCT01215175|7379649|FG001|COMPLETED|Overall Study||29
6463147|NCT01215175|7379650|FG002|COMPLETED|Overall Study||33
6463148|NCT01215175|7379651|FG003|COMPLETED|Overall Study||28
6463149|NCT01215175|7379652|FG004|COMPLETED|Overall Study||28
6463150|NCT01215175|7379648|FG000|NOT COMPLETED|Overall Study||0
6463151|NCT01215175|7379649|FG001|NOT COMPLETED|Overall Study||1
6463152|NCT01215175|7379650|FG002|NOT COMPLETED|Overall Study||0
6463153|NCT01215175|7379651|FG003|NOT COMPLETED|Overall Study||1
6463154|NCT01215175|7379652|FG004|NOT COMPLETED|Overall Study||0
6463155|NCT01215188|7379667|FG000|STARTED|Overall Study||378
6463156|NCT01215188|7379668|FG001|STARTED|Overall Study||386
6463157|NCT01215188|7379669|FG002|STARTED|Overall Study||378
6463158|NCT01215188|7379667|FG000|COMPLETED|Overall Study||320
6463159|NCT01215188|7379668|FG001|COMPLETED|Overall Study||327
6463160|NCT01215188|7379669|FG002|COMPLETED|Overall Study||326
6463161|NCT01215188|7379667|FG000|NOT COMPLETED|Overall Study||58
6463162|NCT01215188|7379668|FG001|NOT COMPLETED|Overall Study||59
6463163|NCT01215188|7379669|FG002|NOT COMPLETED|Overall Study||52
6463164|NCT01215227|7379683|FG000|STARTED|Overall Study||218
6463165|NCT01215227|7379684|FG001|STARTED|Overall Study||215
6463166|NCT01215227|7379685|FG002|STARTED|Overall Study||107
6463167|NCT01215227|7379686|FG003|STARTED|Overall Study||97
6463168|NCT01215227|7379687|FG004|STARTED|Overall Study||93
6463169|NCT01215227|7379688|FG005|STARTED|Overall Study||109
6463170|NCT01215227|7379683|FG000|Treated|Overall Study||218
6463171|NCT01215227|7379684|FG001|Treated|Overall Study||215
6463172|NCT01215227|7379685|FG002|Treated|Overall Study||106
6463173|NCT01215227|7379686|FG003|Treated|Overall Study||96
6463174|NCT01215227|7379687|FG004|Treated|Overall Study||93
6463175|NCT01215227|7379688|FG005|Treated|Overall Study||108
6463176|NCT01215227|7379683|FG000|COMPLETED|Overall Study||97
6463177|NCT01215227|7379684|FG001|COMPLETED|Overall Study||96
6463178|NCT01215227|7379685|FG002|COMPLETED|Overall Study||50
6463179|NCT01215227|7379686|FG003|COMPLETED|Overall Study||48
6463180|NCT01215227|7379687|FG004|COMPLETED|Overall Study||45
6463181|NCT01215227|7379688|FG005|COMPLETED|Overall Study||51
6463182|NCT01215227|7379683|FG000|NOT COMPLETED|Overall Study||121
6463183|NCT01215227|7379684|FG001|NOT COMPLETED|Overall Study||119
6463184|NCT01215227|7379685|FG002|NOT COMPLETED|Overall Study||57
6463185|NCT01215227|7379686|FG003|NOT COMPLETED|Overall Study||49
6463186|NCT01215227|7379687|FG004|NOT COMPLETED|Overall Study||48
6463187|NCT01215227|7379688|FG005|NOT COMPLETED|Overall Study||58
6463188|NCT01215240|7379704|FG000|STARTED|Overall Study||10
6463189|NCT01215240|7379705|FG001|STARTED|Overall Study||12
6463190|NCT01215240|7379704|FG000|COMPLETED|Overall Study||10
6463191|NCT01215240|7379705|FG001|COMPLETED|Overall Study||12
6554088|NCT01746901|7476551|FG006|COMPLETED|Naloxone Challenge Phase||0
6554089|NCT01746901|7476552|FG007|COMPLETED|Naloxone Challenge Phase||0
6463192|NCT01215240|7379704|FG000|NOT COMPLETED|Overall Study||0
6463193|NCT01215240|7379705|FG001|NOT COMPLETED|Overall Study||0
6463194|NCT01215253|7379713|FG000|STARTED|Overall Study||510
6463195|NCT01215253|7379714|FG001|STARTED|Overall Study||502
6463196|NCT01215253|7379713|FG000|COMPLETED|Overall Study||424
6463197|NCT01215253|7379714|FG001|COMPLETED|Overall Study||439
6463198|NCT01215253|7379713|FG000|NOT COMPLETED|Overall Study||86
6463199|NCT01215253|7379714|FG001|NOT COMPLETED|Overall Study||63
6463200|NCT01215279|7379723|FG000|STARTED|Overall Study||31
6463201|NCT01215279|7379724|FG001|STARTED|Overall Study||32
6463202|NCT01215279|7379723|FG000|COMPLETED|Overall Study||31
6463203|NCT01215279|7379724|FG001|COMPLETED|Overall Study||32
6463204|NCT01215279|7379723|FG000|NOT COMPLETED|Overall Study||0
6463205|NCT01215279|7379724|FG001|NOT COMPLETED|Overall Study||0
6463206|NCT01215292|7379735|FG000|STARTED|Overall Study||8
6463207|NCT01215292|7379736|FG001|STARTED|Overall Study||8
6463208|NCT01215292|7379737|FG002|STARTED|Overall Study||8
6463209|NCT01215292|7379738|FG003|STARTED|Overall Study||8
6463210|NCT01215292|7379739|FG004|STARTED|Overall Study||8
6463211|NCT01215292|7379735|FG000|COMPLETED|Overall Study||8
6463212|NCT01215292|7379736|FG001|COMPLETED|Overall Study||8
6463213|NCT01215292|7379737|FG002|COMPLETED|Overall Study||8
6463214|NCT01215292|7379738|FG003|COMPLETED|Overall Study||8
6463215|NCT01215292|7379739|FG004|COMPLETED|Overall Study||8
6463216|NCT01215292|7379735|FG000|NOT COMPLETED|Overall Study||0
6463217|NCT01215292|7379736|FG001|NOT COMPLETED|Overall Study||0
6463218|NCT01215292|7379737|FG002|NOT COMPLETED|Overall Study||0
6463219|NCT01215292|7379738|FG003|NOT COMPLETED|Overall Study||0
6463220|NCT01215292|7379739|FG004|NOT COMPLETED|Overall Study||0
6463221|NCT01215318|7379761|FG000|STARTED|Overall Study||20
6463222|NCT01215318|7379762|FG001|STARTED|Overall Study||24
6463223|NCT01215318|7379761|FG000|COMPLETED|Overall Study||20
6463224|NCT01215318|7379762|FG001|COMPLETED|Overall Study||24
6463225|NCT01215318|7379761|FG000|NOT COMPLETED|Overall Study||0
6463226|NCT01215318|7379762|FG001|NOT COMPLETED|Overall Study||0
6463227|NCT01215344|7379772|FG000|STARTED|Overall Study||33
6463228|NCT01215344|7379773|FG001|STARTED|Overall Study||3
6463229|NCT01215344|7379772|FG000|COMPLETED|Overall Study||23
6463230|NCT01215344|7379773|FG001|COMPLETED|Overall Study||3
6463231|NCT01215344|7379772|FG000|NOT COMPLETED|Overall Study||10
6463232|NCT01215344|7379773|FG001|NOT COMPLETED|Overall Study||0
6463233|NCT01215357|7379781|FG000|STARTED|Overall Study||34
6463234|NCT01215357|7379781|FG000|COMPLETED|Overall Study||22
6463235|NCT01215357|7379781|FG000|NOT COMPLETED|Overall Study||12
6463236|NCT01215422|7379789|FG000|STARTED|Overall Study||14
6463237|NCT01215422|7379790|FG001|STARTED|Overall Study||249
6463238|NCT01215422|7379791|FG002|STARTED|Overall Study||196
6463239|NCT01215422|7379792|FG003|STARTED|Overall Study||201
6463240|NCT01215422|7379789|FG000|COMPLETED|Overall Study||6
6463241|NCT01215422|7379790|FG001|COMPLETED|Overall Study||249
6463242|NCT01215422|7379791|FG002|COMPLETED|Overall Study||193
6554090|NCT01746901|7476553|FG008|COMPLETED|Naloxone Challenge Phase||0
6463243|NCT01215422|7379792|FG003|COMPLETED|Overall Study||193
6463244|NCT01215422|7379789|FG000|NOT COMPLETED|Overall Study||8
6463245|NCT01215422|7379790|FG001|NOT COMPLETED|Overall Study||0
6463246|NCT01215422|7379791|FG002|NOT COMPLETED|Overall Study||3
6463247|NCT01215422|7379792|FG003|NOT COMPLETED|Overall Study||8
6463248|NCT01215435|7379816|FG000|STARTED|Overall Study||122
6463249|NCT01215435|7379817|FG001|STARTED|Overall Study||123
6463250|NCT01215435|7379816|FG000|COMPLETED|Overall Study||103
6463251|NCT01215435|7379817|FG001|COMPLETED|Overall Study||107
6463252|NCT01215435|7379816|FG000|NOT COMPLETED|Overall Study||19
6463253|NCT01215435|7379817|FG001|NOT COMPLETED|Overall Study||16
6463254|NCT01215513|7379823|FG000|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
6463255|NCT01215513|7379823|FG000|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
6463256|NCT01215513|7379823|FG000|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
6463257|NCT01215513|7379823|FG000|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
6463258|NCT01215513|7379823|FG000|COMPLETED|Overall Study||112
6463259|NCT01215513|7379823|FG000|NOT COMPLETED|Overall Study||45
6463260|NCT01215643|7379833|FG000|STARTED|Overall Study||83
6463261|NCT01215643|7379834|FG001|STARTED|Overall Study||84
6463262|NCT01215643|7379835|FG002|STARTED|Overall Study||94
6463263|NCT01215643|7379836|FG003|STARTED|Overall Study||39
6463264|NCT01215643|7379837|FG004|STARTED|Overall Study||40
6463265|NCT01215643|7379833|FG000|COMPLETED|Overall Study||74
6463266|NCT01215643|7379834|FG001|COMPLETED|Overall Study||80
6463267|NCT01215643|7379835|FG002|COMPLETED|Overall Study||82
6463268|NCT01215643|7379836|FG003|COMPLETED|Overall Study||35
6463269|NCT01215643|7379837|FG004|COMPLETED|Overall Study||29
6463270|NCT01215643|7379833|FG000|NOT COMPLETED|Overall Study||9
6463271|NCT01215643|7379834|FG001|NOT COMPLETED|Overall Study||4
6463272|NCT01215643|7379835|FG002|NOT COMPLETED|Overall Study||12
6463273|NCT01215643|7379836|FG003|NOT COMPLETED|Overall Study||4
6463274|NCT01215643|7379837|FG004|NOT COMPLETED|Overall Study||11
6463275|NCT01215695|7379856|FG000|STARTED|Overall Study||70
6463276|NCT01215695|7379857|FG001|STARTED|Overall Study||70
6463277|NCT01215695|7379856|FG000|COMPLETED|Overall Study||70
6463278|NCT01215695|7379857|FG001|COMPLETED|Overall Study||70
6463279|NCT01215695|7379856|FG000|NOT COMPLETED|Overall Study||0
6463280|NCT01215695|7379857|FG001|NOT COMPLETED|Overall Study||0
6463281|NCT01215721|7379863|FG000|STARTED|Overall Study||40
6463282|NCT01215721|7379863|FG000|COMPLETED|Overall Study||38
6463283|NCT01215721|7379863|FG000|NOT COMPLETED|Overall Study||2
6463284|NCT01215734|7379869|FG000|STARTED|Overall Study||29
6463285|NCT01215734|7379870|FG001|STARTED|Overall Study||15
6463286|NCT01215734|7379869|FG000|COMPLETED|Overall Study||29
6463287|NCT01215734|7379870|FG001|COMPLETED|Overall Study||14
6463288|NCT01215734|7379869|FG000|NOT COMPLETED|Overall Study||0
6463289|NCT01215734|7379870|FG001|NOT COMPLETED|Overall Study||1
6463290|NCT01215786|7379879|FG000|STARTED|Overall Study||21
6463291|NCT01215786|7379880|FG001|STARTED|Overall Study||19
6463292|NCT01215786|7379881|FG002|STARTED|Overall Study||10
6463293|NCT01215786|7379879|FG000|COMPLETED|Overall Study||21
6463294|NCT01215786|7379880|FG001|COMPLETED|Overall Study||19
6463295|NCT01215786|7379881|FG002|COMPLETED|Overall Study||10
6463296|NCT01215786|7379879|FG000|NOT COMPLETED|Overall Study||0
6463297|NCT01215786|7379880|FG001|NOT COMPLETED|Overall Study||0
6463298|NCT01215786|7379881|FG002|NOT COMPLETED|Overall Study||0
6463299|NCT01215851|7379895|FG000|STARTED|Treatment Period||15
6463300|NCT01215851|7379896|FG001|STARTED|Treatment Period||15
6463301|NCT01215851|7379897|FG002|STARTED|Treatment Period||15
6463302|NCT01215851|7379898|FG003|STARTED|Treatment Period||15
6463303|NCT01215851|7379899|FG004|STARTED|Treatment Period||10
6463304|NCT01215851|7379900|FG005|STARTED|Treatment Period||15
6463305|NCT01215851|7379895|FG000|COMPLETED|Treatment Period||14
6463306|NCT01215851|7379896|FG001|COMPLETED|Treatment Period||14
6463307|NCT01215851|7379897|FG002|COMPLETED|Treatment Period||14
6463308|NCT01215851|7379898|FG003|COMPLETED|Treatment Period||12
6463309|NCT01215851|7379899|FG004|COMPLETED|Treatment Period||10
6463310|NCT01215851|7379900|FG005|COMPLETED|Treatment Period||14
6463311|NCT01215851|7379895|FG000|NOT COMPLETED|Treatment Period||1
6463312|NCT01215851|7379896|FG001|NOT COMPLETED|Treatment Period||1
6463313|NCT01215851|7379897|FG002|NOT COMPLETED|Treatment Period||1
6463314|NCT01215851|7379898|FG003|NOT COMPLETED|Treatment Period||3
6463315|NCT01215851|7379899|FG004|NOT COMPLETED|Treatment Period||0
6463316|NCT01215851|7379900|FG005|NOT COMPLETED|Treatment Period||1
6463317|NCT01215851|7379895|FG000|STARTED|Follow up Period||14
6463318|NCT01215851|7379896|FG001|STARTED|Follow up Period||14
6463319|NCT01215851|7379897|FG002|STARTED|Follow up Period||14
6463320|NCT01215851|7379898|FG003|STARTED|Follow up Period||12
6463321|NCT01215851|7379899|FG004|STARTED|Follow up Period||10
6463322|NCT01215851|7379900|FG005|STARTED|Follow up Period||14
6463323|NCT01215851|7379895|FG000|COMPLETED|Follow up Period||14
6463324|NCT01215851|7379896|FG001|COMPLETED|Follow up Period||14
6463325|NCT01215851|7379897|FG002|COMPLETED|Follow up Period||14
6463326|NCT01215851|7379898|FG003|COMPLETED|Follow up Period||12
6463327|NCT01215851|7379899|FG004|COMPLETED|Follow up Period||10
6463328|NCT01215851|7379900|FG005|COMPLETED|Follow up Period||13
6463329|NCT01215851|7379895|FG000|NOT COMPLETED|Follow up Period||0
6463330|NCT01215851|7379896|FG001|NOT COMPLETED|Follow up Period||0
6463331|NCT01215851|7379897|FG002|NOT COMPLETED|Follow up Period||0
6463332|NCT01215851|7379898|FG003|NOT COMPLETED|Follow up Period||0
6463333|NCT01215851|7379899|FG004|NOT COMPLETED|Follow up Period||0
6463334|NCT01215851|7379900|FG005|NOT COMPLETED|Follow up Period||1
6463335|NCT01215916|7379924|FG000|STARTED|Overall Study||1
6463336|NCT01215916|7379925|FG001|STARTED|Overall Study||5
6463337|NCT01215916|7379926|FG002|STARTED|Overall Study||3
6463338|NCT01215916|7379927|FG003|STARTED|Overall Study||6
6463339|NCT01215916|7379928|FG004|STARTED|Overall Study||6
6463340|NCT01215916|7379929|FG005|STARTED|Overall Study||4
6463341|NCT01215916|7379930|FG006|STARTED|Overall Study||9
6463342|NCT01215916|7379931|FG007|STARTED|Overall Study||3
6463343|NCT01215916|7379932|FG008|STARTED|Overall Study||2
6463344|NCT01215916|7379924|FG000|Received at Least 1 Dose of Either Drug|Overall Study||1
6463345|NCT01215916|7379925|FG001|Received at Least 1 Dose of Either Drug|Overall Study||5
6463346|NCT01215916|7379926|FG002|Received at Least 1 Dose of Either Drug|Overall Study||3
6463347|NCT01215916|7379927|FG003|Received at Least 1 Dose of Either Drug|Overall Study||6
6463348|NCT01215916|7379928|FG004|Received at Least 1 Dose of Either Drug|Overall Study||6
6463349|NCT01215916|7379929|FG005|Received at Least 1 Dose of Either Drug|Overall Study||4
6463350|NCT01215916|7379930|FG006|Received at Least 1 Dose of Either Drug|Overall Study||9
6463351|NCT01215916|7379931|FG007|Received at Least 1 Dose of Either Drug|Overall Study||3
6463352|NCT01215916|7379932|FG008|Received at Least 1 Dose of Either Drug|Overall Study||2
6463353|NCT01215916|7379924|FG000|COMPLETED|Overall Study||0
6463354|NCT01215916|7379925|FG001|COMPLETED|Overall Study||0
6463355|NCT01215916|7379926|FG002|COMPLETED|Overall Study||0
6463356|NCT01215916|7379927|FG003|COMPLETED|Overall Study||0
6554091|NCT01746901|7476545|FG000|NOT COMPLETED|Naloxone Challenge Phase||3
6554092|NCT01746901|7476546|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
6554093|NCT01746901|7476547|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
6554094|NCT01746901|7476548|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
6554095|NCT01746901|7476549|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
6554096|NCT01746901|7476550|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
6463357|NCT01215916|7379928|FG004|COMPLETED|Overall Study||0
6463358|NCT01215916|7379929|FG005|COMPLETED|Overall Study||0
6463359|NCT01215916|7379930|FG006|COMPLETED|Overall Study||0
6463360|NCT01215916|7379931|FG007|COMPLETED|Overall Study||0
6463361|NCT01215916|7379932|FG008|COMPLETED|Overall Study||0
6463362|NCT01215916|7379924|FG000|NOT COMPLETED|Overall Study||1
6463363|NCT01215916|7379925|FG001|NOT COMPLETED|Overall Study||5
6463364|NCT01215916|7379926|FG002|NOT COMPLETED|Overall Study||3
6463365|NCT01215916|7379927|FG003|NOT COMPLETED|Overall Study||6
6463366|NCT01215916|7379928|FG004|NOT COMPLETED|Overall Study||6
6463367|NCT01215916|7379929|FG005|NOT COMPLETED|Overall Study||4
6463368|NCT01215916|7379930|FG006|NOT COMPLETED|Overall Study||9
6463369|NCT01215916|7379931|FG007|NOT COMPLETED|Overall Study||3
6463370|NCT01215916|7379932|FG008|NOT COMPLETED|Overall Study||2
6463371|NCT01215929|7379958|FG000|STARTED|Overall Study||18
6463372|NCT01215929|7379959|FG001|STARTED|Overall Study||17
6463373|NCT01215929|7379958|FG000|COMPLETED|Overall Study||12
6463374|NCT01215929|7379959|FG001|COMPLETED|Overall Study||12
6463375|NCT01215929|7379958|FG000|NOT COMPLETED|Overall Study||6
6463376|NCT01215929|7379959|FG001|NOT COMPLETED|Overall Study||5
6463377|NCT01215942|7379967|FG000|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|414
6463378|NCT01215942|7379968|FG001|STARTED|Treatment Period|Participants who discontinued treatment were followed in post-treatment follow-up.|672
6463379|NCT01215942|7379967|FG000|COMPLETED|Treatment Period||0
6463380|NCT01215942|7379968|FG001|COMPLETED|Treatment Period||0
6463381|NCT01215942|7379967|FG000|NOT COMPLETED|Treatment Period||414
6463382|NCT01215942|7379968|FG001|NOT COMPLETED|Treatment Period||672
6463383|NCT01215942|7379967|FG000|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|368
6463384|NCT01215942|7379968|FG001|STARTED|Post-Treatment Follow-Up Period|Not all participants who discontinued treatment entered post-treatment follow-up period.|591
6463385|NCT01215942|7379967|FG000|COMPLETED|Post-Treatment Follow-Up Period||283
6463386|NCT01215942|7379968|FG001|COMPLETED|Post-Treatment Follow-Up Period||445
6463387|NCT01215942|7379967|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||85
6463388|NCT01215942|7379968|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||146
6463389|NCT01215955|7379989|FG000|STARTED|Overall Study||268
6463390|NCT01215955|7379990|FG001|STARTED|Overall Study||263
6463391|NCT01215955|7379991|FG002|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
6463392|NCT01215955|7379992|FG003|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
6463393|NCT01215955|7379989|FG000|Received at Least 1 Dose of Study Drug|Overall Study||267
6463394|NCT01215955|7379990|FG001|Received at Least 1 Dose of Study Drug|Overall Study||261
6463395|NCT01215955|7379991|FG002|Received at Least 1 Dose of Study Drug|Overall Study||288
6463396|NCT01215955|7379992|FG003|Received at Least 1 Dose of Study Drug|Overall Study||290
6463397|NCT01215955|7379989|FG000|COMPLETED|Overall Study||223
6463398|NCT01215955|7379990|FG001|COMPLETED|Overall Study||210
6463399|NCT01215955|7379991|FG002|COMPLETED|Overall Study||244
6463400|NCT01215955|7379992|FG003|COMPLETED|Overall Study||241
6463401|NCT01215955|7379989|FG000|NOT COMPLETED|Overall Study||45
6463402|NCT01215955|7379990|FG001|NOT COMPLETED|Overall Study||53
6463403|NCT01215955|7379991|FG002|NOT COMPLETED|Overall Study||48
6463404|NCT01215955|7379992|FG003|NOT COMPLETED|Overall Study||53
6463405|NCT01215968|7380007|FG000|STARTED|Overall Study||13
6463406|NCT01215968|7380008|FG001|STARTED|Overall Study||25
6463407|NCT01215968|7380007|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
6463408|NCT01215968|7380008|FG001|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
6463409|NCT01215968|7380007|FG000|COMPLETED|Overall Study||11
6463410|NCT01215968|7380008|FG001|COMPLETED|Overall Study||18
6463411|NCT01215968|7380007|FG000|NOT COMPLETED|Overall Study||2
6463412|NCT01215968|7380008|FG001|NOT COMPLETED|Overall Study||7
6463413|NCT01215981|7380019|FG000|STARTED|Overall Study||35
6463414|NCT01215981|7380020|FG001|STARTED|Overall Study||33
6463415|NCT01215981|7380019|FG000|COMPLETED|Overall Study||33
6463416|NCT01215981|7380020|FG001|COMPLETED|Overall Study||32
6463417|NCT01215981|7380019|FG000|NOT COMPLETED|Overall Study||2
6463418|NCT01215981|7380020|FG001|NOT COMPLETED|Overall Study||1
6463419|NCT01216072|7380028|FG000|STARTED|Open-Label Core Period ( 6 Months)||790
6463420|NCT01216072|7380029|FG001|STARTED|Open-Label Core Period ( 6 Months)||263
6463421|NCT01216072|7380028|FG000|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
6463422|NCT01216072|7380029|FG001|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
6463423|NCT01216072|7380028|FG000|Safety Set|Open-Label Core Period ( 6 Months)||783
6463424|NCT01216072|7380029|FG001|Safety Set|Open-Label Core Period ( 6 Months)||245
6463425|NCT01216072|7380028|FG000|COMPLETED|Open-Label Core Period ( 6 Months)||714
6463426|NCT01216072|7380029|FG001|COMPLETED|Open-Label Core Period ( 6 Months)||229
6463427|NCT01216072|7380028|FG000|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
6463428|NCT01216072|7380029|FG001|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
6463429|NCT01216072|7380028|FG000|STARTED|Open-Label Extension Period (3 Months)||0
6463430|NCT01216072|7380029|FG001|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
6463431|NCT01216072|7380028|FG000|Safety Set|Open-Label Extension Period (3 Months)||0
6463432|NCT01216072|7380029|FG001|Safety Set|Open-Label Extension Period (3 Months)||193
6463433|NCT01216072|7380028|FG000|COMPLETED|Open-Label Extension Period (3 Months)||0
6463434|NCT01216072|7380029|FG001|COMPLETED|Open-Label Extension Period (3 Months)||181
6463435|NCT01216072|7380028|FG000|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
6463436|NCT01216072|7380029|FG001|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
6463437|NCT01216163|7380041|FG000|STARTED|Overall Study||45
6463438|NCT01216163|7380042|FG001|STARTED|Overall Study||88
6463439|NCT01216163|7380043|FG002|STARTED|Overall Study||85
6463440|NCT01216163|7380041|FG000|COMPLETED|Overall Study||44
6463441|NCT01216163|7380042|FG001|COMPLETED|Overall Study||87
6463442|NCT01216163|7380043|FG002|COMPLETED|Overall Study||85
6463443|NCT01216163|7380041|FG000|NOT COMPLETED|Overall Study||1
6463444|NCT01216163|7380042|FG001|NOT COMPLETED|Overall Study||1
6463445|NCT01216163|7380043|FG002|NOT COMPLETED|Overall Study||0
6463446|NCT01216176|7380054|FG000|STARTED|Overall Study||12
6463447|NCT01216176|7380055|FG001|STARTED|Overall Study||39
6463448|NCT01216176|7380056|FG002|STARTED|Overall Study||20
6463449|NCT01216176|7380054|FG000|COMPLETED|Overall Study||12
6463450|NCT01216176|7380055|FG001|COMPLETED|Overall Study||31
6463451|NCT01216176|7380056|FG002|COMPLETED|Overall Study||19
6463452|NCT01216176|7380054|FG000|NOT COMPLETED|Overall Study||0
6463453|NCT01216176|7380055|FG001|NOT COMPLETED|Overall Study||8
6463454|NCT01216176|7380056|FG002|NOT COMPLETED|Overall Study||1
6463455|NCT01216189|7380067|FG000|STARTED|Overall Study||110
6463456|NCT01216189|7380068|FG001|STARTED|Overall Study||32
6463457|NCT01216189|7380067|FG000|COMPLETED|Overall Study||85
6463458|NCT01216189|7380068|FG001|COMPLETED|Overall Study||27
6463459|NCT01216189|7380067|FG000|NOT COMPLETED|Overall Study||25
6463460|NCT01216189|7380068|FG001|NOT COMPLETED|Overall Study||5
6463461|NCT01216202|7380076|FG000|STARTED|Overall Study||101
6463462|NCT01216202|7380077|FG001|STARTED|Overall Study||77
6463463|NCT01216202|7380076|FG000|Analysed at Baseline|Overall Study||93
6463464|NCT01216202|7380077|FG001|Analysed at Baseline|Overall Study||75
6463465|NCT01216202|7380076|FG000|Analysed After RT|Overall Study||79
6463466|NCT01216202|7380077|FG001|Analysed After RT|Overall Study||0
6463467|NCT01216202|7380076|FG000|COMPLETED|Overall Study||79
6463468|NCT01216202|7380077|FG001|COMPLETED|Overall Study||75
6463469|NCT01216202|7380076|FG000|NOT COMPLETED|Overall Study||22
6463470|NCT01216202|7380077|FG001|NOT COMPLETED|Overall Study||2
6463471|NCT01216241|7380087|FG000|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
6463472|NCT01216241|7380088|FG001|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
6463473|NCT01216241|7380087|FG000|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
6463474|NCT01216241|7380088|FG001|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
6463475|NCT01216241|7380087|FG000|NOT COMPLETED|Overall Study||0
6463476|NCT01216241|7380088|FG001|NOT COMPLETED|Overall Study||0
6463477|NCT01216319|7380094|FG000|STARTED|Overall Study||50
6463478|NCT01216319|7380094|FG000|COMPLETED|Overall Study||46
6463479|NCT01216319|7380094|FG000|NOT COMPLETED|Overall Study||4
6463480|NCT01216332|7380100|FG000|STARTED|Overall Study||34
6463481|NCT01216332|7380101|FG001|STARTED|Overall Study||16
6463482|NCT01216332|7380100|FG000|COMPLETED|Overall Study||30
6463483|NCT01216332|7380101|FG001|COMPLETED|Overall Study||16
6463484|NCT01216332|7380100|FG000|NOT COMPLETED|Overall Study||4
6463485|NCT01216332|7380101|FG001|NOT COMPLETED|Overall Study||0
6463486|NCT01216397|7380107|FG000|STARTED|Period 1||20
6463487|NCT01216397|7380108|FG001|STARTED|Period 1||20
6463488|NCT01216397|7380107|FG000|COMPLETED|Period 1||20
6463489|NCT01216397|7380108|FG001|COMPLETED|Period 1||20
6463490|NCT01216397|7380107|FG000|NOT COMPLETED|Period 1||0
6463491|NCT01216397|7380108|FG001|NOT COMPLETED|Period 1||0
6463492|NCT01216397|7380107|FG000|STARTED|Washout (35 Days)||20
6463493|NCT01216397|7380108|FG001|STARTED|Washout (35 Days)||20
6463494|NCT01216397|7380107|FG000|COMPLETED|Washout (35 Days)||20
6463495|NCT01216397|7380108|FG001|COMPLETED|Washout (35 Days)||20
6463496|NCT01216397|7380107|FG000|NOT COMPLETED|Washout (35 Days)||0
6463497|NCT01216397|7380108|FG001|NOT COMPLETED|Washout (35 Days)||0
6463498|NCT01216397|7380107|FG000|STARTED|Period 2||20
6463499|NCT01216397|7380108|FG001|STARTED|Period 2||20
6463500|NCT01216397|7380107|FG000|COMPLETED|Period 2||20
6463501|NCT01216397|7380108|FG001|COMPLETED|Period 2||20
6463502|NCT01216397|7380107|FG000|NOT COMPLETED|Period 2||0
6463503|NCT01216397|7380108|FG001|NOT COMPLETED|Period 2||0
6463504|NCT01216410|7380117|FG000|STARTED|Overall Study||103
6463505|NCT01216410|7380118|FG001|STARTED|Overall Study||100
6463506|NCT01216410|7380119|FG002|STARTED|Overall Study||103
6463507|NCT01216410|7380117|FG000|COMPLETED|Overall Study||101
6463508|NCT01216410|7380118|FG001|COMPLETED|Overall Study||99
6463509|NCT01216410|7380119|FG002|COMPLETED|Overall Study||100
6463510|NCT01216410|7380117|FG000|NOT COMPLETED|Overall Study||2
6463511|NCT01216410|7380118|FG001|NOT COMPLETED|Overall Study||1
6463512|NCT01216410|7380119|FG002|NOT COMPLETED|Overall Study||3
6463513|NCT01216735|7380129|FG000|STARTED|First Intervention (3 Weeks)||8
6463514|NCT01216735|7380130|FG001|STARTED|First Intervention (3 Weeks)||7
6463515|NCT01216735|7380129|FG000|COMPLETED|First Intervention (3 Weeks)||8
6463516|NCT01216735|7380130|FG001|COMPLETED|First Intervention (3 Weeks)||7
6463517|NCT01216735|7380129|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
6463518|NCT01216735|7380130|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
6463519|NCT01216735|7380129|FG000|STARTED|Washout (3 Weeks)||8
6463520|NCT01216735|7380130|FG001|STARTED|Washout (3 Weeks)||7
6463521|NCT01216735|7380129|FG000|COMPLETED|Washout (3 Weeks)||8
6463522|NCT01216735|7380130|FG001|COMPLETED|Washout (3 Weeks)||7
6463523|NCT01216735|7380129|FG000|NOT COMPLETED|Washout (3 Weeks)||0
6463524|NCT01216735|7380130|FG001|NOT COMPLETED|Washout (3 Weeks)||0
6463525|NCT01216735|7380129|FG000|STARTED|Second Intervention (3 Weeks)||8
6463526|NCT01216735|7380130|FG001|STARTED|Second Intervention (3 Weeks)||7
6463527|NCT01216735|7380129|FG000|COMPLETED|Second Intervention (3 Weeks)||8
6463528|NCT01216735|7380130|FG001|COMPLETED|Second Intervention (3 Weeks)||7
6463529|NCT01216735|7380129|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6463530|NCT01216735|7380130|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6463531|NCT01216748|7380136|FG000|STARTED|Overall Study||10
6463532|NCT01216748|7380136|FG000|Quiet Breathing|Overall Study||10
6463533|NCT01216748|7380136|FG000|Hypocapnic Hyperventilation|Overall Study||10
6463534|NCT01216748|7380136|FG000|Hypercapnic Hyperventilation|Overall Study||10
6463535|NCT01216748|7380136|FG000|Eucapnic Hyperventilation|Overall Study||10
6463536|NCT01216748|7380136|FG000|COMPLETED|Overall Study||10
6463537|NCT01216748|7380136|FG000|NOT COMPLETED|Overall Study||0
6463538|NCT01216761|7380140|FG000|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
6463539|NCT01216761|7380141|FG001|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
6463540|NCT01216761|7380142|FG002|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
6463541|NCT01216761|7380140|FG000|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
6463542|NCT01216761|7380141|FG001|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
6463543|NCT01216761|7380142|FG002|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
6463544|NCT01216761|7380140|FG000|NOT COMPLETED|Overall Study||0
6463545|NCT01216761|7380141|FG001|NOT COMPLETED|Overall Study||0
6463546|NCT01216761|7380142|FG002|NOT COMPLETED|Overall Study||0
6463547|NCT01216943|7380150|FG000|STARTED|Overall Study||126
6463548|NCT01216943|7380150|FG000|COMPLETED|Overall Study||113
6463549|NCT01216943|7380150|FG000|NOT COMPLETED|Overall Study||13
6463550|NCT01217073|7380160|FG000|STARTED|Base Period||113
6463551|NCT01217073|7380161|FG001|STARTED|Base Period||115
6463552|NCT01217073|7380162|FG002|STARTED|Base Period||114
6463553|NCT01217073|7380163|FG003|STARTED|Base Period||115
6463554|NCT01217073|7380164|FG004|STARTED|Base Period||114
6463555|NCT01217073|7380165|FG005|STARTED|Base Period||114
6463556|NCT01217073|7380166|FG006|STARTED|Base Period||0
6463557|NCT01217073|7380167|FG007|STARTED|Base Period||0
6463558|NCT01217073|7380160|FG000|COMPLETED|Base Period||106
6463559|NCT01217073|7380161|FG001|COMPLETED|Base Period||110
6463560|NCT01217073|7380162|FG002|COMPLETED|Base Period||107
6463561|NCT01217073|7380163|FG003|COMPLETED|Base Period||113
6463562|NCT01217073|7380164|FG004|COMPLETED|Base Period||99
6463563|NCT01217073|7380165|FG005|COMPLETED|Base Period||105
6463564|NCT01217073|7380166|FG006|COMPLETED|Base Period||0
6463565|NCT01217073|7380167|FG007|COMPLETED|Base Period||0
6463566|NCT01217073|7380160|FG000|NOT COMPLETED|Base Period||7
6463567|NCT01217073|7380161|FG001|NOT COMPLETED|Base Period||5
6463568|NCT01217073|7380162|FG002|NOT COMPLETED|Base Period||7
6463569|NCT01217073|7380163|FG003|NOT COMPLETED|Base Period||2
6463570|NCT01217073|7380164|FG004|NOT COMPLETED|Base Period||15
6463571|NCT01217073|7380165|FG005|NOT COMPLETED|Base Period||9
6463572|NCT01217073|7380166|FG006|NOT COMPLETED|Base Period||0
6463573|NCT01217073|7380167|FG007|NOT COMPLETED|Base Period||0
6463574|NCT01217073|7380160|FG000|STARTED|Extension Period||0
6463575|NCT01217073|7380161|FG001|STARTED|Extension Period||0
6463576|NCT01217073|7380162|FG002|STARTED|Extension Period||0
6463577|NCT01217073|7380163|FG003|STARTED|Extension Period||0
6463578|NCT01217073|7380164|FG004|STARTED|Extension Period||0
6463579|NCT01217073|7380165|FG005|STARTED|Extension Period||0
6463580|NCT01217073|7380166|FG006|STARTED|Extension Period||405
6463581|NCT01217073|7380167|FG007|STARTED|Extension Period||80
6463582|NCT01217073|7380160|FG000|COMPLETED|Extension Period||0
6463583|NCT01217073|7380161|FG001|COMPLETED|Extension Period||0
6463584|NCT01217073|7380162|FG002|COMPLETED|Extension Period||0
6463585|NCT01217073|7380163|FG003|COMPLETED|Extension Period||0
6463586|NCT01217073|7380164|FG004|COMPLETED|Extension Period||0
6463587|NCT01217073|7380165|FG005|COMPLETED|Extension Period||0
6463588|NCT01217073|7380166|FG006|COMPLETED|Extension Period||314
6463589|NCT01217073|7380167|FG007|COMPLETED|Extension Period||60
6463590|NCT01217073|7380160|FG000|NOT COMPLETED|Extension Period||0
6463591|NCT01217073|7380161|FG001|NOT COMPLETED|Extension Period||0
6463592|NCT01217073|7380162|FG002|NOT COMPLETED|Extension Period||0
6463593|NCT01217073|7380163|FG003|NOT COMPLETED|Extension Period||0
6463594|NCT01217073|7380164|FG004|NOT COMPLETED|Extension Period||0
6463595|NCT01217073|7380165|FG005|NOT COMPLETED|Extension Period||0
6463596|NCT01217073|7380166|FG006|NOT COMPLETED|Extension Period||91
6463597|NCT01217073|7380167|FG007|NOT COMPLETED|Extension Period||20
6463598|NCT01217112|7380196|FG000|STARTED|Overall Study||11
6463599|NCT01217112|7380197|FG001|STARTED|Overall Study||12
6463600|NCT01217112|7380198|FG002|STARTED|Overall Study||13
6463601|NCT01217112|7380199|FG003|STARTED|Overall Study||12
6463602|NCT01217112|7380200|FG004|STARTED|Overall Study||14
6463603|NCT01217112|7380196|FG000|COMPLETED|Overall Study||11
6463604|NCT01217112|7380197|FG001|COMPLETED|Overall Study||10
6463605|NCT01217112|7380198|FG002|COMPLETED|Overall Study||12
6463606|NCT01217112|7380199|FG003|COMPLETED|Overall Study||10
6463607|NCT01217112|7380200|FG004|COMPLETED|Overall Study||13
6463608|NCT01217112|7380196|FG000|NOT COMPLETED|Overall Study||0
6463609|NCT01217112|7380197|FG001|NOT COMPLETED|Overall Study||2
6463610|NCT01217112|7380198|FG002|NOT COMPLETED|Overall Study||1
6463611|NCT01217112|7380199|FG003|NOT COMPLETED|Overall Study||2
6463612|NCT01217112|7380200|FG004|NOT COMPLETED|Overall Study||1
6463613|NCT01217190|7380214|FG000|STARTED|First Dosing||24
6463614|NCT01217190|7380215|FG001|STARTED|First Dosing||24
6463615|NCT01217190|7380214|FG000|COMPLETED|First Dosing||24
6463616|NCT01217190|7380215|FG001|COMPLETED|First Dosing||24
6463617|NCT01217190|7380214|FG000|NOT COMPLETED|First Dosing||0
6463618|NCT01217190|7380215|FG001|NOT COMPLETED|First Dosing||0
6463619|NCT01217190|7380214|FG000|STARTED|Second Dosing||24
6463620|NCT01217190|7380215|FG001|STARTED|Second Dosing||24
6463621|NCT01217190|7380214|FG000|COMPLETED|Second Dosing||24
6463622|NCT01217190|7380215|FG001|COMPLETED|Second Dosing|Two subjects withdrew for personal reasons (other than adverse event).|22
6463623|NCT01217190|7380214|FG000|NOT COMPLETED|Second Dosing||0
6463624|NCT01217190|7380215|FG001|NOT COMPLETED|Second Dosing||2
6463625|NCT01217229|7380224|FG000|STARTED|Overall Study||20
6463626|NCT01217229|7380224|FG000|COMPLETED|Overall Study||0
6463627|NCT01217229|7380224|FG000|NOT COMPLETED|Overall Study||20
6463628|NCT01217307|7380230|FG000|STARTED|Overall Study||191
6463629|NCT01217307|7380231|FG001|STARTED|Overall Study||189
6463630|NCT01217307|7380230|FG000|COMPLETED|Overall Study||191
6463631|NCT01217307|7380231|FG001|COMPLETED|Overall Study||188
6463632|NCT01217307|7380230|FG000|NOT COMPLETED|Overall Study||0
6463633|NCT01217307|7380231|FG001|NOT COMPLETED|Overall Study||1
6463634|NCT01217385|7380237|FG000|STARTED|Overall Study||60
6463635|NCT01217385|7380237|FG000|COMPLETED|Overall Study||34
6463636|NCT01217385|7380237|FG000|NOT COMPLETED|Overall Study||26
6463637|NCT01217411|7380249|FG000|STARTED|Overall Study||3
6463638|NCT01217411|7380250|FG001|STARTED|Overall Study||2
6463639|NCT01217411|7380249|FG000|5mg|Overall Study||3
6463640|NCT01217411|7380250|FG001|5mg|Overall Study||2
6463641|NCT01217411|7380249|FG000|10mg|Overall Study||0
6463642|NCT01217411|7380250|FG001|10mg|Overall Study||0
6463643|NCT01217411|7380249|FG000|20mg|Overall Study||0
6463644|NCT01217411|7380250|FG001|20mg|Overall Study||0
6463645|NCT01217411|7380249|FG000|COMPLETED|Overall Study||0
6463646|NCT01217411|7380250|FG001|COMPLETED|Overall Study||0
6463647|NCT01217411|7380249|FG000|NOT COMPLETED|Overall Study||3
6463648|NCT01217411|7380250|FG001|NOT COMPLETED|Overall Study||2
6463649|NCT01217437|7380260|FG000|STARTED|Overall Study||55
6463650|NCT01217437|7380261|FG001|STARTED|Overall Study||53
6463651|NCT01217437|7380260|FG000|COMPLETED|Overall Study||12
6463652|NCT01217437|7380261|FG001|COMPLETED|Overall Study||12
6463653|NCT01217437|7380260|FG000|NOT COMPLETED|Overall Study||43
6463654|NCT01217437|7380261|FG001|NOT COMPLETED|Overall Study||41
6463655|NCT01217463|7380269|FG000|STARTED|Overall Study||99
6463656|NCT01217463|7380270|FG001|STARTED|Overall Study||102
6463657|NCT01217463|7380269|FG000|COMPLETED|Overall Study||86
6463658|NCT01217463|7380270|FG001|COMPLETED|Overall Study||94
6463659|NCT01217463|7380269|FG000|NOT COMPLETED|Overall Study||13
6463660|NCT01217463|7380270|FG001|NOT COMPLETED|Overall Study||8
6463661|NCT01217476|7380280|FG000|STARTED|Overall Study||105
6463662|NCT01217476|7380281|FG001|STARTED|Overall Study||102
6463663|NCT01217476|7380280|FG000|COMPLETED|Overall Study||93
6463664|NCT01217476|7380281|FG001|COMPLETED|Overall Study||95
6463665|NCT01217476|7380280|FG000|NOT COMPLETED|Overall Study||12
6463666|NCT01217476|7380281|FG001|NOT COMPLETED|Overall Study||7
6463667|NCT01217515|7380290|FG000|STARTED|Overall Study||154
6463668|NCT01217515|7380291|FG001|STARTED|Overall Study||156
6463669|NCT01217515|7380292|FG002|STARTED|Overall Study||155
6463670|NCT01217515|7380290|FG000|COMPLETED|Overall Study||147
6554097|NCT01746901|7476551|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
6554098|NCT01746901|7476552|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
6554099|NCT01746901|7476553|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
6554100|NCT01746901|7476545|FG000|STARTED|Drug Discrimination Phase: Day 1||0
6554101|NCT01746901|7476546|FG001|STARTED|Drug Discrimination Phase: Day 1||36
6463671|NCT01217515|7380291|FG001|COMPLETED|Overall Study||148
6463672|NCT01217515|7380292|FG002|COMPLETED|Overall Study||145
6463673|NCT01217515|7380290|FG000|NOT COMPLETED|Overall Study||7
6463674|NCT01217515|7380291|FG001|NOT COMPLETED|Overall Study||8
6463675|NCT01217515|7380292|FG002|NOT COMPLETED|Overall Study||10
6463676|NCT01217606|7380302|FG000|STARTED|Initial Treatment Phase||90
6463677|NCT01217606|7380303|FG001|STARTED|Initial Treatment Phase||95
6463678|NCT01217606|7380302|FG000|COMPLETED|Initial Treatment Phase||76
6463679|NCT01217606|7380303|FG001|COMPLETED|Initial Treatment Phase||83
6463680|NCT01217606|7380302|FG000|NOT COMPLETED|Initial Treatment Phase||14
6463681|NCT01217606|7380303|FG001|NOT COMPLETED|Initial Treatment Phase||12
6463682|NCT01217606|7380302|FG000|STARTED|9-Month Masked Extension||67
6463683|NCT01217606|7380303|FG001|STARTED|9-Month Masked Extension||73
6463684|NCT01217606|7380302|FG000|Not Enrolled in Masked Extension|9-Month Masked Extension||9
6463685|NCT01217606|7380303|FG001|Not Enrolled in Masked Extension|9-Month Masked Extension||10
6463686|NCT01217606|7380302|FG000|COMPLETED|9-Month Masked Extension||54
6463687|NCT01217606|7380303|FG001|COMPLETED|9-Month Masked Extension||62
6463688|NCT01217606|7380302|FG000|NOT COMPLETED|9-Month Masked Extension||13
6463689|NCT01217606|7380303|FG001|NOT COMPLETED|9-Month Masked Extension||11
6463690|NCT01217749|7380312|FG000|STARTED|Overall Study||27
6463691|NCT01217749|7380313|FG001|STARTED|Overall Study||20
6463692|NCT01217749|7380314|FG002|STARTED|Overall Study||24
6463693|NCT01217749|7380312|FG000|COMPLETED|Overall Study||24
6463694|NCT01217749|7380313|FG001|COMPLETED|Overall Study||17
6463695|NCT01217749|7380314|FG002|COMPLETED|Overall Study||22
6463696|NCT01217749|7380312|FG000|NOT COMPLETED|Overall Study||3
6463697|NCT01217749|7380313|FG001|NOT COMPLETED|Overall Study||3
6463698|NCT01217749|7380314|FG002|NOT COMPLETED|Overall Study||2
6463699|NCT01217801|7380326|FG000|STARTED|Period 1||24
6463700|NCT01217801|7380327|FG001|STARTED|Period 1||24
6463701|NCT01217801|7380326|FG000|COMPLETED|Period 1||23
6463702|NCT01217801|7380327|FG001|COMPLETED|Period 1||22
6463703|NCT01217801|7380326|FG000|NOT COMPLETED|Period 1||1
6463704|NCT01217801|7380327|FG001|NOT COMPLETED|Period 1||2
6463705|NCT01217801|7380326|FG000|STARTED|Period 2||23
6463706|NCT01217801|7380327|FG001|STARTED|Period 2||22
6463707|NCT01217801|7380326|FG000|COMPLETED|Period 2||23
6463708|NCT01217801|7380327|FG001|COMPLETED|Period 2||22
6463709|NCT01217801|7380326|FG000|NOT COMPLETED|Period 2||0
6463710|NCT01217801|7380327|FG001|NOT COMPLETED|Period 2||0
6463711|NCT01217814|7380336|FG000|STARTED|Overall Study||4
6463712|NCT01217814|7380337|FG001|STARTED|Overall Study||5
6463713|NCT01217814|7380338|FG002|STARTED|Overall Study||7
6463714|NCT01217814|7380336|FG000|COMPLETED|Overall Study||3
6463715|NCT01217814|7380337|FG001|COMPLETED|Overall Study||4
6463716|NCT01217814|7380338|FG002|COMPLETED|Overall Study||6
6463717|NCT01217814|7380336|FG000|NOT COMPLETED|Overall Study||1
6463718|NCT01217814|7380337|FG001|NOT COMPLETED|Overall Study||1
6463719|NCT01217814|7380338|FG002|NOT COMPLETED|Overall Study||1
6463720|NCT01217827|7380349|FG000|STARTED|Overall Study||46
6463721|NCT01217827|7380350|FG001|STARTED|Overall Study||43
6463722|NCT01217827|7380349|FG000|COMPLETED|Overall Study||46
6463723|NCT01217827|7380350|FG001|COMPLETED|Overall Study||43
6463724|NCT01217827|7380349|FG000|NOT COMPLETED|Overall Study||0
6463725|NCT01217827|7380350|FG001|NOT COMPLETED|Overall Study||0
6463726|NCT01217840|7380358|FG000|STARTED|Overall Study||20
6463727|NCT01217840|7380359|FG001|STARTED|Overall Study||20
6463728|NCT01217840|7380358|FG000|COMPLETED|Overall Study||14
6463729|NCT01217840|7380359|FG001|COMPLETED|Overall Study||17
6463730|NCT01217840|7380358|FG000|NOT COMPLETED|Overall Study||6
6463731|NCT01217840|7380359|FG001|NOT COMPLETED|Overall Study||3
6463732|NCT01217892|7380370|FG000|STARTED|Overall Study||100
6463733|NCT01217892|7380371|FG001|STARTED|Overall Study||100
6463734|NCT01217892|7380372|FG002|STARTED|Overall Study||99
6463735|NCT01217892|7380373|FG003|STARTED|Overall Study||101
6463736|NCT01217892|7380370|FG000|COMPLETED|Overall Study||93
6463737|NCT01217892|7380371|FG001|COMPLETED|Overall Study||94
6463738|NCT01217892|7380372|FG002|COMPLETED|Overall Study||90
6463739|NCT01217892|7380373|FG003|COMPLETED|Overall Study||93
6463740|NCT01217892|7380370|FG000|NOT COMPLETED|Overall Study||7
6463741|NCT01217892|7380371|FG001|NOT COMPLETED|Overall Study||6
6463742|NCT01217892|7380372|FG002|NOT COMPLETED|Overall Study||9
6463743|NCT01217892|7380373|FG003|NOT COMPLETED|Overall Study||8
6463744|NCT01217944|7380386|FG000|STARTED|Overall Study||106
6463745|NCT01217944|7380387|FG001|STARTED|Overall Study||116
6463746|NCT01217944|7380388|FG002|STARTED|Overall Study||55
6463747|NCT01217944|7380386|FG000|Completed 3 Months|Overall Study||105
6463748|NCT01217944|7380387|FG001|Completed 3 Months|Overall Study||116
6463749|NCT01217944|7380388|FG002|Completed 3 Months|Overall Study||55
6463750|NCT01217944|7380386|FG000|Completed 6 Months|Overall Study||103
6463751|NCT01217944|7380387|FG001|Completed 6 Months|Overall Study||116
6463752|NCT01217944|7380388|FG002|Completed 6 Months|Overall Study||55
6463753|NCT01217944|7380386|FG000|COMPLETED|Overall Study||100
6463754|NCT01217944|7380387|FG001|COMPLETED|Overall Study||112
6463755|NCT01217944|7380388|FG002|COMPLETED|Overall Study||55
6463756|NCT01217944|7380386|FG000|NOT COMPLETED|Overall Study||6
6463757|NCT01217944|7380387|FG001|NOT COMPLETED|Overall Study||4
6463758|NCT01217944|7380388|FG002|NOT COMPLETED|Overall Study||0
6463759|NCT01217957|7380403|FG000|STARTED|Phase 1||3
6463760|NCT01217957|7380404|FG001|STARTED|Phase 1||3
6463761|NCT01217957|7380405|FG002|STARTED|Phase 1||6
6463762|NCT01217957|7380406|FG003|STARTED|Phase 1||3
6463763|NCT01217957|7380407|FG004|STARTED|Phase 1||0
6463764|NCT01217957|7380403|FG000|COMPLETED|Phase 1||2
6463765|NCT01217957|7380404|FG001|COMPLETED|Phase 1||3
6463766|NCT01217957|7380405|FG002|COMPLETED|Phase 1||5
6463767|NCT01217957|7380406|FG003|COMPLETED|Phase 1||2
6463768|NCT01217957|7380407|FG004|COMPLETED|Phase 1||0
6463769|NCT01217957|7380403|FG000|NOT COMPLETED|Phase 1||1
6463770|NCT01217957|7380404|FG001|NOT COMPLETED|Phase 1||0
6463771|NCT01217957|7380405|FG002|NOT COMPLETED|Phase 1||1
6463772|NCT01217957|7380406|FG003|NOT COMPLETED|Phase 1||1
6463773|NCT01217957|7380407|FG004|NOT COMPLETED|Phase 1||0
6463774|NCT01217957|7380403|FG000|STARTED|Phase 2||0
6463775|NCT01217957|7380404|FG001|STARTED|Phase 2||0
6463776|NCT01217957|7380405|FG002|STARTED|Phase 2||0
6463777|NCT01217957|7380406|FG003|STARTED|Phase 2||0
6463778|NCT01217957|7380407|FG004|STARTED|Phase 2||50
6463779|NCT01217957|7380403|FG000|COMPLETED|Phase 2||0
6463780|NCT01217957|7380404|FG001|COMPLETED|Phase 2||0
6463781|NCT01217957|7380405|FG002|COMPLETED|Phase 2||0
6463782|NCT01217957|7380406|FG003|COMPLETED|Phase 2||0
6463783|NCT01217957|7380407|FG004|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
6463784|NCT01217957|7380403|FG000|NOT COMPLETED|Phase 2||0
6463785|NCT01217957|7380404|FG001|NOT COMPLETED|Phase 2||0
6463786|NCT01217957|7380405|FG002|NOT COMPLETED|Phase 2||0
6463787|NCT01217957|7380406|FG003|NOT COMPLETED|Phase 2||0
6463788|NCT01217957|7380407|FG004|NOT COMPLETED|Phase 2||1
6463789|NCT01218009|7380430|FG000|STARTED|Overall Study||166
6463790|NCT01218009|7380431|FG001|STARTED|Overall Study||165
6463791|NCT01218009|7380430|FG000|COMPLETED|Overall Study||0
6463792|NCT01218009|7380431|FG001|COMPLETED|Overall Study||0
6463793|NCT01218009|7380430|FG000|NOT COMPLETED|Overall Study||166
6463794|NCT01218009|7380431|FG001|NOT COMPLETED|Overall Study||165
6463795|NCT01218048|7380437|FG000|STARTED|Overall Study||40
6463796|NCT01218048|7380437|FG000|COMPLETED|Overall Study||40
6463797|NCT01218048|7380437|FG000|NOT COMPLETED|Overall Study||0
6463798|NCT01218087|7380444|FG000|STARTED|Overall Study||42
6463799|NCT01218087|7380445|FG001|STARTED|Overall Study||41
6463800|NCT01218087|7380444|FG000|COMPLETED|Overall Study||27
6463801|NCT01218087|7380445|FG001|COMPLETED|Overall Study||35
6463802|NCT01218087|7380444|FG000|NOT COMPLETED|Overall Study||15
6463803|NCT01218087|7380445|FG001|NOT COMPLETED|Overall Study||6
6463804|NCT01218100|7380455|FG000|STARTED|Overall Study||95
6463805|NCT01218100|7380456|FG001|STARTED|Overall Study||190
6463806|NCT01218100|7380457|FG002|STARTED|Overall Study||189
6463807|NCT01218100|7380458|FG003|STARTED|Overall Study||190
6463808|NCT01218100|7380455|FG000|COMPLETED|Overall Study||71
6463809|NCT01218100|7380456|FG001|COMPLETED|Overall Study||165
6463810|NCT01218100|7380457|FG002|COMPLETED|Overall Study||162
6463811|NCT01218100|7380458|FG003|COMPLETED|Overall Study||156
6463812|NCT01218100|7380455|FG000|NOT COMPLETED|Overall Study||24
6463813|NCT01218100|7380456|FG001|NOT COMPLETED|Overall Study||25
6463814|NCT01218100|7380457|FG002|NOT COMPLETED|Overall Study||27
6463815|NCT01218100|7380458|FG003|NOT COMPLETED|Overall Study||34
6463816|NCT01218113|7380471|FG000|STARTED|Overall Study||62
6463817|NCT01218113|7380472|FG001|STARTED|Overall Study||64
6463818|NCT01218113|7380473|FG002|STARTED|Overall Study||64
6463819|NCT01218113|7380471|FG000|COMPLETED|Overall Study||57
6463820|NCT01218113|7380472|FG001|COMPLETED|Overall Study||63
6463821|NCT01218113|7380473|FG002|COMPLETED|Overall Study||58
6463822|NCT01218113|7380471|FG000|NOT COMPLETED|Overall Study||5
6463823|NCT01218113|7380472|FG001|NOT COMPLETED|Overall Study||1
6463824|NCT01218113|7380473|FG002|NOT COMPLETED|Overall Study||6
6463825|NCT01218126|7380492|FG000|STARTED|Overall Study||153
6463826|NCT01218126|7380493|FG001|STARTED|Overall Study||149
6463827|NCT01218126|7380494|FG002|STARTED|Overall Study||151
6463828|NCT01218126|7380495|FG003|STARTED|Overall Study||149
6463829|NCT01218126|7380492|FG000|COMPLETED|Overall Study||129
6463830|NCT01218126|7380493|FG001|COMPLETED|Overall Study||127
6463831|NCT01218126|7380494|FG002|COMPLETED|Overall Study||127
6463832|NCT01218126|7380495|FG003|COMPLETED|Overall Study||114
6463833|NCT01218126|7380492|FG000|NOT COMPLETED|Overall Study||24
6463834|NCT01218126|7380493|FG001|NOT COMPLETED|Overall Study||22
6463835|NCT01218126|7380494|FG002|NOT COMPLETED|Overall Study||24
6463836|NCT01218126|7380495|FG003|NOT COMPLETED|Overall Study||35
6463837|NCT01218204|7380507|FG000|STARTED|Part A||6
6463838|NCT01218204|7380508|FG001|STARTED|Part A||0
6463839|NCT01218204|7380509|FG002|STARTED|Part A||0
6463840|NCT01218204|7380510|FG003|STARTED|Part A||0
6463841|NCT01218204|7380507|FG000|COMPLETED|Part A||6
6463842|NCT01218204|7380508|FG001|COMPLETED|Part A||0
6463843|NCT01218204|7380509|FG002|COMPLETED|Part A||0
6463844|NCT01218204|7380510|FG003|COMPLETED|Part A||0
6463845|NCT01218204|7380507|FG000|NOT COMPLETED|Part A||0
6463846|NCT01218204|7380508|FG001|NOT COMPLETED|Part A||0
6463847|NCT01218204|7380509|FG002|NOT COMPLETED|Part A||0
6463848|NCT01218204|7380510|FG003|NOT COMPLETED|Part A||0
6463849|NCT01218204|7380507|FG000|STARTED|Part B Washout||0
6463850|NCT01218204|7380508|FG001|STARTED|Part B Washout||281
6463851|NCT01218204|7380509|FG002|STARTED|Part B Washout||0
6463852|NCT01218204|7380510|FG003|STARTED|Part B Washout||0
6463853|NCT01218204|7380507|FG000|COMPLETED|Part B Washout||0
6463854|NCT01218204|7380508|FG001|COMPLETED|Part B Washout||136
6463855|NCT01218204|7380509|FG002|COMPLETED|Part B Washout||0
6463856|NCT01218204|7380510|FG003|COMPLETED|Part B Washout||0
6463857|NCT01218204|7380507|FG000|NOT COMPLETED|Part B Washout||0
6463858|NCT01218204|7380508|FG001|NOT COMPLETED|Part B Washout||145
6463859|NCT01218204|7380509|FG002|NOT COMPLETED|Part B Washout||0
6463860|NCT01218204|7380510|FG003|NOT COMPLETED|Part B Washout||0
6463861|NCT01218204|7380507|FG000|STARTED|Part B Run-in||0
6463862|NCT01218204|7380508|FG001|STARTED|Part B Run-in||0
6463863|NCT01218204|7380509|FG002|STARTED|Part B Run-in||89
6463864|NCT01218204|7380510|FG003|STARTED|Part B Run-in||0
6463865|NCT01218204|7380507|FG000|COMPLETED|Part B Run-in||0
6463866|NCT01218204|7380508|FG001|COMPLETED|Part B Run-in||0
6463867|NCT01218204|7380509|FG002|COMPLETED|Part B Run-in||83
6463868|NCT01218204|7380510|FG003|COMPLETED|Part B Run-in||0
6463869|NCT01218204|7380507|FG000|NOT COMPLETED|Part B Run-in||0
6463870|NCT01218204|7380508|FG001|NOT COMPLETED|Part B Run-in||0
6463871|NCT01218204|7380509|FG002|NOT COMPLETED|Part B Run-in||6
6463872|NCT01218204|7380510|FG003|NOT COMPLETED|Part B Run-in||0
6463873|NCT01218204|7380507|FG000|STARTED|Part B Pooled Treatment Arm||0
6463874|NCT01218204|7380508|FG001|STARTED|Part B Pooled Treatment Arm||0
6463875|NCT01218204|7380509|FG002|STARTED|Part B Pooled Treatment Arm||0
6463876|NCT01218204|7380510|FG003|STARTED|Part B Pooled Treatment Arm||130
6463877|NCT01218204|7380507|FG000|COMPLETED|Part B Pooled Treatment Arm||0
6463878|NCT01218204|7380508|FG001|COMPLETED|Part B Pooled Treatment Arm||0
6463879|NCT01218204|7380509|FG002|COMPLETED|Part B Pooled Treatment Arm||0
6463880|NCT01218204|7380510|FG003|COMPLETED|Part B Pooled Treatment Arm||127
6463881|NCT01218204|7380507|FG000|NOT COMPLETED|Part B Pooled Treatment Arm||0
6463882|NCT01218204|7380508|FG001|NOT COMPLETED|Part B Pooled Treatment Arm||0
6463883|NCT01218204|7380509|FG002|NOT COMPLETED|Part B Pooled Treatment Arm||0
6463884|NCT01218204|7380510|FG003|NOT COMPLETED|Part B Pooled Treatment Arm||3
6463885|NCT01218243|7380559|FG000|STARTED|Overall Study||50
6463886|NCT01218243|7380560|FG001|STARTED|Overall Study||50
6463887|NCT01218243|7380559|FG000|Treatment Completed|Overall Study||45
6463888|NCT01218243|7380560|FG001|Treatment Completed|Overall Study||42
6463889|NCT01218243|7380559|FG000|COMPLETED|Overall Study||41
6463890|NCT01218243|7380560|FG001|COMPLETED|Overall Study||36
6463891|NCT01218243|7380559|FG000|NOT COMPLETED|Overall Study||9
6463892|NCT01218243|7380560|FG001|NOT COMPLETED|Overall Study||14
6463893|NCT01218308|7380568|FG000|STARTED|Overall Study||2584
6463894|NCT01218308|7380569|FG001|STARTED|Overall Study||2584
6463895|NCT01218308|7380568|FG000|COMPLETED|Overall Study||2481
6463896|NCT01218308|7380569|FG001|COMPLETED|Overall Study||2464
6463897|NCT01218308|7380568|FG000|NOT COMPLETED|Overall Study||103
6463898|NCT01218308|7380569|FG001|NOT COMPLETED|Overall Study||120
6463899|NCT01218399|7380577|FG000|STARTED|Overall Study||5
6463900|NCT01218399|7380578|FG001|STARTED|Overall Study||5
6463901|NCT01218399|7380577|FG000|COMPLETED|Overall Study||5
6463902|NCT01218399|7380578|FG001|COMPLETED|Overall Study||5
6463903|NCT01218399|7380577|FG000|NOT COMPLETED|Overall Study||0
6463904|NCT01218399|7380578|FG001|NOT COMPLETED|Overall Study||0
6463905|NCT01218438|7380584|FG000|STARTED|Epoch 1||77
6463906|NCT01218438|7380584|FG000|COMPLETED|Epoch 1||74
6463907|NCT01218438|7380584|FG000|NOT COMPLETED|Epoch 1||3
6463908|NCT01218438|7380584|FG000|STARTED|Epoch 2||45
6463909|NCT01218438|7380584|FG000|COMPLETED|Epoch 2||45
6463910|NCT01218438|7380584|FG000|NOT COMPLETED|Epoch 2||0
6463911|NCT01218438|7380584|FG000|STARTED|Epoch 3||74
6463912|NCT01218438|7380584|FG000|COMPLETED|Epoch 3||70
6463913|NCT01218438|7380584|FG000|NOT COMPLETED|Epoch 3||4
6463914|NCT01218438|7380584|FG000|STARTED|Epoch 4||70
6463915|NCT01218438|7380584|FG000|COMPLETED|Epoch 4||67
6463916|NCT01218438|7380584|FG000|NOT COMPLETED|Epoch 4||3
6463917|NCT01218477|7380662|FG000|STARTED|Overall Study|Participants who received treatment|3
6463918|NCT01218477|7380663|FG001|STARTED|Overall Study|Participants who received treatment|8
6463919|NCT01218477|7380664|FG002|STARTED|Overall Study|Participants who received treatment|14
6463920|NCT01218477|7380665|FG003|STARTED|Overall Study|Participants who received treatment|2
6463921|NCT01218477|7380662|FG000|COMPLETED|Overall Study|Still receiving study drug|0
6463922|NCT01218477|7380663|FG001|COMPLETED|Overall Study|Still receiving study drug|0
6463923|NCT01218477|7380664|FG002|COMPLETED|Overall Study|Still receiving study drug|0
6463924|NCT01218477|7380665|FG003|COMPLETED|Overall Study|Still receiving study drug|0
6463925|NCT01218477|7380662|FG000|NOT COMPLETED|Overall Study||3
6463926|NCT01218477|7380663|FG001|NOT COMPLETED|Overall Study||8
6463927|NCT01218477|7380664|FG002|NOT COMPLETED|Overall Study||14
6463928|NCT01218477|7380665|FG003|NOT COMPLETED|Overall Study||2
6463929|NCT01218516|7380681|FG000|STARTED|Combination Therapy (up to 4.5 Months)||67
6463930|NCT01218516|7380682|FG001|STARTED|Combination Therapy (up to 4.5 Months)||63
6463931|NCT01218516|7380683|FG002|STARTED|Combination Therapy (up to 4.5 Months)||0
6463932|NCT01218516|7380684|FG003|STARTED|Combination Therapy (up to 4.5 Months)||0
6463933|NCT01218516|7380681|FG000|COMPLETED|Combination Therapy (up to 4.5 Months)||38
6463934|NCT01218516|7380682|FG001|COMPLETED|Combination Therapy (up to 4.5 Months)||28
6463935|NCT01218516|7380683|FG002|COMPLETED|Combination Therapy (up to 4.5 Months)||0
6463936|NCT01218516|7380684|FG003|COMPLETED|Combination Therapy (up to 4.5 Months)||0
6463937|NCT01218516|7380681|FG000|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||29
6463938|NCT01218516|7380682|FG001|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||35
6463939|NCT01218516|7380683|FG002|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
6463940|NCT01218516|7380684|FG003|NOT COMPLETED|Combination Therapy (up to 4.5 Months)||0
6463941|NCT01218516|7380681|FG000|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
6463942|NCT01218516|7380682|FG001|STARTED|Monotherapy (up to 23.5 Months)|This phase ended once all participants finished.|0
6463943|NCT01218516|7380683|FG002|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|38
6463944|NCT01218516|7380684|FG003|STARTED|Monotherapy (up to 23.5 Months)|Only eligible participants entered this phase of the study.|28
6463945|NCT01218516|7380681|FG000|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
6463946|NCT01218516|7380682|FG001|Safety Analysis Set|Monotherapy (up to 23.5 Months)||0
6463947|NCT01218516|7380683|FG002|Safety Analysis Set|Monotherapy (up to 23.5 Months)||35
6463948|NCT01218516|7380684|FG003|Safety Analysis Set|Monotherapy (up to 23.5 Months)|Three participants were randomized to placebo but actually received Farletuzumab.|31
6463949|NCT01218516|7380681|FG000|COMPLETED|Monotherapy (up to 23.5 Months)||0
6463950|NCT01218516|7380682|FG001|COMPLETED|Monotherapy (up to 23.5 Months)||0
6463951|NCT01218516|7380683|FG002|COMPLETED|Monotherapy (up to 23.5 Months)||38
6463952|NCT01218516|7380684|FG003|COMPLETED|Monotherapy (up to 23.5 Months)||28
6463953|NCT01218516|7380681|FG000|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
6463954|NCT01218516|7380682|FG001|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
6463955|NCT01218516|7380683|FG002|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
6463956|NCT01218516|7380684|FG003|NOT COMPLETED|Monotherapy (up to 23.5 Months)||0
6463957|NCT01218542|7380694|FG000|STARTED|Overall Study||22
6463958|NCT01218542|7380694|FG000|COMPLETED|Overall Study||13
6746666|NCT03374683|7674320|FG001|1-week Post-intervention|Overall Study||113
6746667|NCT03374683|7674321|FG002|1-week Post-intervention|Overall Study||85
6746668|NCT03374683|7674319|FG000|COMPLETED|Overall Study||123
6746669|NCT03374683|7674320|FG001|COMPLETED|Overall Study||105
6746670|NCT03374683|7674321|FG002|COMPLETED|Overall Study||84
6463959|NCT01218542|7380694|FG000|NOT COMPLETED|Overall Study||9
6463960|NCT01218594|7380699|FG000|STARTED|Overall Study||48
6463961|NCT01218594|7380699|FG000|COMPLETED|Overall Study||36
6463962|NCT01218594|7380699|FG000|NOT COMPLETED|Overall Study||12
6463963|NCT01218646|7380707|FG000|STARTED|Overall Study||225
6463964|NCT01218646|7380708|FG001|STARTED|Overall Study||225
6463965|NCT01218646|7380709|FG002|STARTED|Overall Study||225
6463966|NCT01218646|7380710|FG003|STARTED|Overall Study||64
6463967|NCT01218646|7380707|FG000|COMPLETED|Overall Study||224
6463968|NCT01218646|7380708|FG001|COMPLETED|Overall Study||225
6463969|NCT01218646|7380709|FG002|COMPLETED|Overall Study||223
6463970|NCT01218646|7380710|FG003|COMPLETED|Overall Study||63
6463971|NCT01218646|7380707|FG000|NOT COMPLETED|Overall Study||1
6463972|NCT01218646|7380708|FG001|NOT COMPLETED|Overall Study||0
6463973|NCT01218646|7380709|FG002|NOT COMPLETED|Overall Study||2
6463974|NCT01218646|7380710|FG003|NOT COMPLETED|Overall Study||1
6463975|NCT01218659|7380722|FG000|STARTED|18-Month Randomized Period||36
6463976|NCT01218659|7380723|FG001|STARTED|18-Month Randomized Period||24
6463977|NCT01218659|7380724|FG002|STARTED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
6463978|NCT01218659|7380722|FG000|Safety Population|18-Month Randomized Period||36
6463979|NCT01218659|7380723|FG001|Safety Population|18-Month Randomized Period||21
6463980|NCT01218659|7380724|FG002|Safety Population|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
6463981|NCT01218659|7380722|FG000|COMPLETED|18-Month Randomized Period||34
6463982|NCT01218659|7380723|FG001|COMPLETED|18-Month Randomized Period||18
6463983|NCT01218659|7380724|FG002|COMPLETED|18-Month Randomized Period|Zero participants are noted here because participants started in this group during the 12-month OLE.|0
6463984|NCT01218659|7380722|FG000|NOT COMPLETED|18-Month Randomized Period||2
6463985|NCT01218659|7380723|FG001|NOT COMPLETED|18-Month Randomized Period||6
6463986|NCT01218659|7380724|FG002|NOT COMPLETED|18-Month Randomized Period||0
6463987|NCT01218659|7380722|FG000|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6463988|NCT01218659|7380723|FG001|STARTED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6463989|NCT01218659|7380724|FG002|STARTED|12-Month OLE|Fifty-two participants completed the 18-mo. randomized treatment period.|52
6463990|NCT01218659|7380722|FG000|Safety Population|12-Month OLE||0
6463991|NCT01218659|7380723|FG001|Safety Population|12-Month OLE||0
6463992|NCT01218659|7380724|FG002|Safety Population|12-Month OLE||51
6463993|NCT01218659|7380722|FG000|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6463994|NCT01218659|7380723|FG001|Modified Intent-to-Treat (mITT)|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6463995|NCT01218659|7380724|FG002|Modified Intent-to-Treat (mITT)|12-Month OLE||46
6463996|NCT01218659|7380722|FG000|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6463997|NCT01218659|7380723|FG001|COMPLETED|12-Month OLE|Zero participants are noted here because they were combined in the All Migalastat (0-30 mo.) group.|0
6463998|NCT01218659|7380724|FG002|COMPLETED|12-Month OLE||42
6463999|NCT01218659|7380722|FG000|NOT COMPLETED|12-Month OLE||0
6746671|NCT03374683|7674319|FG000|NOT COMPLETED|Overall Study||25
6464000|NCT01218659|7380723|FG001|NOT COMPLETED|12-Month OLE||0
6464001|NCT01218659|7380724|FG002|NOT COMPLETED|12-Month OLE||10
6464002|NCT01218672|7380733|FG000|STARTED|Overall Study||139
6464003|NCT01218672|7380734|FG001|STARTED|Overall Study||142
6464004|NCT01218672|7380733|FG000|Treated|Overall Study||136
6464005|NCT01218672|7380734|FG001|Treated|Overall Study||133
6464006|NCT01218672|7380733|FG000|COMPLETED|Overall Study||128
6464007|NCT01218672|7380734|FG001|COMPLETED|Overall Study||121
6464008|NCT01218672|7380733|FG000|NOT COMPLETED|Overall Study||11
6464009|NCT01218672|7380734|FG001|NOT COMPLETED|Overall Study||21
6464010|NCT01218802|7380744|FG000|STARTED|Overall Study||72
6464011|NCT01218802|7380745|FG001|STARTED|Overall Study||75
6464012|NCT01218802|7380744|FG000|COMPLETED|Overall Study||62
6464013|NCT01218802|7380745|FG001|COMPLETED|Overall Study||57
6464014|NCT01218802|7380744|FG000|NOT COMPLETED|Overall Study||10
6464015|NCT01218802|7380745|FG001|NOT COMPLETED|Overall Study||18
6464016|NCT01218867|7380762|FG000|STARTED|Overall Study||1
6464017|NCT01218867|7380763|FG001|STARTED|Overall Study||1
6464018|NCT01218867|7380764|FG002|STARTED|Overall Study||3
6464019|NCT01218867|7380765|FG003|STARTED|Overall Study||1
6464020|NCT01218867|7380766|FG004|STARTED|Overall Study||1
6464021|NCT01218867|7380767|FG005|STARTED|Overall Study||1
6464022|NCT01218867|7380768|FG006|STARTED|Overall Study||4
6464023|NCT01218867|7380769|FG007|STARTED|Overall Study||3
6464024|NCT01218867|7380770|FG008|STARTED|Overall Study||3
6464025|NCT01218867|7380771|FG009|STARTED|Overall Study||4
6464026|NCT01218867|7380772|FG010|STARTED|Overall Study||2
6464027|NCT01218867|7380762|FG000|COMPLETED|Overall Study||1
6464028|NCT01218867|7380763|FG001|COMPLETED|Overall Study||1
6464029|NCT01218867|7380764|FG002|COMPLETED|Overall Study||3
6464030|NCT01218867|7380765|FG003|COMPLETED|Overall Study||1
6464031|NCT01218867|7380766|FG004|COMPLETED|Overall Study||1
6464032|NCT01218867|7380767|FG005|COMPLETED|Overall Study||1
6464033|NCT01218867|7380768|FG006|COMPLETED|Overall Study||3
6464034|NCT01218867|7380769|FG007|COMPLETED|Overall Study||3
6464035|NCT01218867|7380770|FG008|COMPLETED|Overall Study||3
6464036|NCT01218867|7380771|FG009|COMPLETED|Overall Study||4
6464037|NCT01218867|7380772|FG010|COMPLETED|Overall Study||2
6464038|NCT01218867|7380762|FG000|NOT COMPLETED|Overall Study||0
6464039|NCT01218867|7380763|FG001|NOT COMPLETED|Overall Study||0
6464040|NCT01218867|7380764|FG002|NOT COMPLETED|Overall Study||0
6464041|NCT01218867|7380765|FG003|NOT COMPLETED|Overall Study||0
6464042|NCT01218867|7380766|FG004|NOT COMPLETED|Overall Study||0
6464043|NCT01218867|7380767|FG005|NOT COMPLETED|Overall Study||0
6464044|NCT01218867|7380768|FG006|NOT COMPLETED|Overall Study||1
6464045|NCT01218867|7380769|FG007|NOT COMPLETED|Overall Study||0
6464046|NCT01218867|7380770|FG008|NOT COMPLETED|Overall Study||0
6464047|NCT01218867|7380771|FG009|NOT COMPLETED|Overall Study||0
6464048|NCT01218867|7380772|FG010|NOT COMPLETED|Overall Study||0
6464049|NCT01218958|7380810|FG000|STARTED|Overall Study||210
6464050|NCT01218958|7380811|FG001|STARTED|Overall Study||205
6464051|NCT01218958|7380812|FG002|STARTED|Overall Study||209
6464052|NCT01218958|7380810|FG000|COMPLETED|Overall Study||126
6464053|NCT01218958|7380811|FG001|COMPLETED|Overall Study||124
6464054|NCT01218958|7380812|FG002|COMPLETED|Overall Study||128
6464055|NCT01218958|7380810|FG000|NOT COMPLETED|Overall Study||84
6464056|NCT01218958|7380811|FG001|NOT COMPLETED|Overall Study||81
6464057|NCT01218958|7380812|FG002|NOT COMPLETED|Overall Study||81
6464058|NCT01218971|7380822|FG000|STARTED|Overall Study||175
6464059|NCT01218971|7380823|FG001|STARTED|Overall Study||157
6464060|NCT01218971|7380822|FG000|COMPLETED|Overall Study||71
6464061|NCT01218971|7380823|FG001|COMPLETED|Overall Study||77
6464062|NCT01218971|7380822|FG000|NOT COMPLETED|Overall Study||104
6464063|NCT01218971|7380823|FG001|NOT COMPLETED|Overall Study||80
6464064|NCT01218984|7380836|FG000|STARTED|Overall Study||9
6464065|NCT01218984|7380837|FG001|STARTED|Overall Study||8
6464066|NCT01218984|7380838|FG002|STARTED|Overall Study||10
6464067|NCT01218984|7380836|FG000|COMPLETED|Overall Study||8
6464068|NCT01218984|7380837|FG001|COMPLETED|Overall Study||6
6464069|NCT01218984|7380838|FG002|COMPLETED|Overall Study||7
6464070|NCT01218984|7380836|FG000|NOT COMPLETED|Overall Study||1
6464071|NCT01218984|7380837|FG001|NOT COMPLETED|Overall Study||2
6464072|NCT01218984|7380838|FG002|NOT COMPLETED|Overall Study||3
6464073|NCT01218997|7380848|FG000|STARTED|Overall Study||371
6464074|NCT01218997|7380849|FG001|STARTED|Overall Study||65
6464075|NCT01218997|7380848|FG000|COMPLETED|Overall Study||126
6464076|NCT01218997|7380849|FG001|COMPLETED|Overall Study||24
6464077|NCT01218997|7380848|FG000|NOT COMPLETED|Overall Study||245
6464078|NCT01218997|7380849|FG001|NOT COMPLETED|Overall Study||41
6464079|NCT01219738|7380855|FG000|STARTED|Overall Study||20
6464080|NCT01219738|7380855|FG000|Budesonide 360|Overall Study||20
6464081|NCT01219738|7380855|FG000|Budesonide 720|Overall Study||20
6464082|NCT01219738|7380855|FG000|Budesonide 1440|Overall Study||20
6464083|NCT01219738|7380855|FG000|Budesonide 720- 4 Times|Overall Study||20
6464084|NCT01219738|7380855|FG000|COMPLETED|Overall Study||20
6464085|NCT01219738|7380855|FG000|NOT COMPLETED|Overall Study||0
6464086|NCT01219777|7380868|FG000|STARTED|Overall Study||9
6464087|NCT01219777|7380868|FG000|COMPLETED|Overall Study||9
6464088|NCT01219777|7380868|FG000|NOT COMPLETED|Overall Study||0
6464089|NCT01219855|7380878|FG000|STARTED|Overall Study||17
6464090|NCT01219855|7380879|FG001|STARTED|Overall Study||17
6464091|NCT01219855|7380880|FG002|STARTED|Overall Study||17
6464092|NCT01219855|7380881|FG003|STARTED|Overall Study||13
6464093|NCT01219855|7380882|FG004|STARTED|Overall Study||14
6464094|NCT01219855|7380878|FG000|COMPLETED|Overall Study||16
6464095|NCT01219855|7380879|FG001|COMPLETED|Overall Study||12
6464096|NCT01219855|7380880|FG002|COMPLETED|Overall Study||16
6464097|NCT01219855|7380881|FG003|COMPLETED|Overall Study||12
6464098|NCT01219855|7380882|FG004|COMPLETED|Overall Study||13
6464099|NCT01219855|7380878|FG000|NOT COMPLETED|Overall Study||1
6464100|NCT01219855|7380879|FG001|NOT COMPLETED|Overall Study||5
6464101|NCT01219855|7380880|FG002|NOT COMPLETED|Overall Study||1
6464102|NCT01219855|7380881|FG003|NOT COMPLETED|Overall Study||1
6464103|NCT01219855|7380882|FG004|NOT COMPLETED|Overall Study||1
6464104|NCT01219881|7380895|FG000|STARTED|Overall Study||38
6464105|NCT01219881|7380896|FG001|STARTED|Overall Study||37
6464106|NCT01219881|7380895|FG000|COMPLETED|Overall Study||34
6464107|NCT01219881|7380896|FG001|COMPLETED|Overall Study||32
6464108|NCT01219881|7380895|FG000|NOT COMPLETED|Overall Study||4
6464109|NCT01219881|7380896|FG001|NOT COMPLETED|Overall Study||5
6464110|NCT01219933|7380902|FG000|STARTED|Overall Study||68
6464111|NCT01219933|7380902|FG000|COMPLETED|Overall Study||30
6464112|NCT01219933|7380902|FG000|NOT COMPLETED|Overall Study||38
6500798|NCT01425814|7419367|FG004|NOT COMPLETED|Period 1||0
6500799|NCT01425814|7419368|FG005|NOT COMPLETED|Period 1||0
6500800|NCT01425814|7419363|FG000|STARTED|Period 2||12
6500801|NCT01425814|7419364|FG001|STARTED|Period 2||10
6500802|NCT01425814|7419365|FG002|STARTED|Period 2||12
6500803|NCT01425814|7419366|FG003|STARTED|Period 2||10
6500804|NCT01425814|7419367|FG004|STARTED|Period 2||12
6500805|NCT01425814|7419368|FG005|STARTED|Period 2||13
6500806|NCT01425814|7419363|FG000|COMPLETED|Period 2||12
6500807|NCT01425814|7419364|FG001|COMPLETED|Period 2||9
6500808|NCT01425814|7419365|FG002|COMPLETED|Period 2||12
6500809|NCT01425814|7419366|FG003|COMPLETED|Period 2||10
6500810|NCT01425814|7419367|FG004|COMPLETED|Period 2||12
6500811|NCT01425814|7419368|FG005|COMPLETED|Period 2||13
6500812|NCT01425814|7419363|FG000|NOT COMPLETED|Period 2||0
6500813|NCT01425814|7419364|FG001|NOT COMPLETED|Period 2||1
6500814|NCT01425814|7419365|FG002|NOT COMPLETED|Period 2||0
6500815|NCT01425814|7419366|FG003|NOT COMPLETED|Period 2||0
6500816|NCT01425814|7419367|FG004|NOT COMPLETED|Period 2||0
6500817|NCT01425814|7419368|FG005|NOT COMPLETED|Period 2||0
6500818|NCT01425814|7419363|FG000|STARTED|Period 3||12
6500819|NCT01425814|7419364|FG001|STARTED|Period 3||9
6500820|NCT01425814|7419365|FG002|STARTED|Period 3||12
6500821|NCT01425814|7419366|FG003|STARTED|Period 3||10
6500822|NCT01425814|7419367|FG004|STARTED|Period 3||12
6500823|NCT01425814|7419368|FG005|STARTED|Period 3||13
6500824|NCT01425814|7419363|FG000|COMPLETED|Period 3||12
6500825|NCT01425814|7419364|FG001|COMPLETED|Period 3||9
6500826|NCT01425814|7419365|FG002|COMPLETED|Period 3||12
6500827|NCT01425814|7419366|FG003|COMPLETED|Period 3||10
6500828|NCT01425814|7419367|FG004|COMPLETED|Period 3||12
6500829|NCT01425814|7419368|FG005|COMPLETED|Period 3||12
6500830|NCT01425814|7419363|FG000|NOT COMPLETED|Period 3||0
6500831|NCT01425814|7419364|FG001|NOT COMPLETED|Period 3||0
6500832|NCT01425814|7419365|FG002|NOT COMPLETED|Period 3||0
6500833|NCT01425814|7419366|FG003|NOT COMPLETED|Period 3||0
6500834|NCT01425814|7419367|FG004|NOT COMPLETED|Period 3||0
6500835|NCT01425814|7419368|FG005|NOT COMPLETED|Period 3||1
6500836|NCT01425814|7419363|FG000|STARTED|Period 4||12
6500837|NCT01425814|7419364|FG001|STARTED|Period 4||9
6500838|NCT01425814|7419365|FG002|STARTED|Period 4||12
6500839|NCT01425814|7419366|FG003|STARTED|Period 4||10
6500840|NCT01425814|7419367|FG004|STARTED|Period 4||12
6500841|NCT01425814|7419368|FG005|STARTED|Period 4||12
6500842|NCT01425814|7419363|FG000|COMPLETED|Period 4||11
6500843|NCT01425814|7419364|FG001|COMPLETED|Period 4||9
6500844|NCT01425814|7419365|FG002|COMPLETED|Period 4||11
6500845|NCT01425814|7419366|FG003|COMPLETED|Period 4||10
6500846|NCT01425814|7419367|FG004|COMPLETED|Period 4||12
6500847|NCT01425814|7419368|FG005|COMPLETED|Period 4||12
6500848|NCT01425814|7419363|FG000|NOT COMPLETED|Period 4||1
6500849|NCT01425814|7419364|FG001|NOT COMPLETED|Period 4||0
6500850|NCT01425814|7419365|FG002|NOT COMPLETED|Period 4||1
6500851|NCT01425814|7419366|FG003|NOT COMPLETED|Period 4||0
6500852|NCT01425814|7419367|FG004|NOT COMPLETED|Period 4||0
6500853|NCT01425814|7419368|FG005|NOT COMPLETED|Period 4||0
6500854|NCT01425814|7419363|FG000|STARTED|Period 5||11
6500855|NCT01425814|7419364|FG001|STARTED|Period 5||9
6500856|NCT01425814|7419365|FG002|STARTED|Period 5||11
6500857|NCT01425814|7419366|FG003|STARTED|Period 5||10
6500858|NCT01425814|7419367|FG004|STARTED|Period 5||12
6500859|NCT01425814|7419368|FG005|STARTED|Period 5||12
6500860|NCT01425814|7419363|FG000|COMPLETED|Period 5||11
6500861|NCT01425814|7419364|FG001|COMPLETED|Period 5||9
6500862|NCT01425814|7419365|FG002|COMPLETED|Period 5||10
6500863|NCT01425814|7419366|FG003|COMPLETED|Period 5||10
6500864|NCT01425814|7419367|FG004|COMPLETED|Period 5||12
6500865|NCT01425814|7419368|FG005|COMPLETED|Period 5||11
6500866|NCT01425814|7419363|FG000|NOT COMPLETED|Period 5||0
6500867|NCT01425814|7419364|FG001|NOT COMPLETED|Period 5||0
6500868|NCT01425814|7419365|FG002|NOT COMPLETED|Period 5||1
6500869|NCT01425814|7419366|FG003|NOT COMPLETED|Period 5||0
6500870|NCT01425814|7419367|FG004|NOT COMPLETED|Period 5||0
6500871|NCT01425814|7419368|FG005|NOT COMPLETED|Period 5||1
6500872|NCT01425853|7419384|FG000|STARTED|Overall Study||304
6500873|NCT01425853|7419385|FG001|STARTED|Overall Study||302
6500874|NCT01425853|7419384|FG000|Safety Population|Overall Study||304
6500875|NCT01425853|7419385|FG001|Safety Population|Overall Study||299
6464113|NCT01219959|7380909|FG000|STARTED|Overall Study||127
6464114|NCT01219959|7380910|FG001|STARTED|Overall Study||124
6464115|NCT01219959|7380909|FG000|COMPLETED|Overall Study||120
6464116|NCT01219959|7380910|FG001|COMPLETED|Overall Study||101
6464117|NCT01219959|7380909|FG000|NOT COMPLETED|Overall Study||7
6464118|NCT01219959|7380910|FG001|NOT COMPLETED|Overall Study||23
6464119|NCT01219985|7380916|FG000|STARTED|Overall Study||50
6464120|NCT01219985|7380916|FG000|COMPLETED|Overall Study||30
6464121|NCT01219985|7380916|FG000|NOT COMPLETED|Overall Study||20
6464122|NCT01220024|7380924|FG000|STARTED|Overall Study||25
6464123|NCT01220024|7380925|FG001|STARTED|Overall Study||25
6464124|NCT01220024|7380924|FG000|COMPLETED|Overall Study||24
6464125|NCT01220024|7380925|FG001|COMPLETED|Overall Study||24
6464126|NCT01220024|7380924|FG000|NOT COMPLETED|Overall Study||1
6464127|NCT01220024|7380925|FG001|NOT COMPLETED|Overall Study||1
6464128|NCT01220128|7380938|FG000|STARTED|Overall Study||15
6464129|NCT01220128|7380939|FG001|STARTED|Overall Study||7
6464130|NCT01220128|7380940|FG002|STARTED|Overall Study||9
6464131|NCT01220128|7380941|FG003|STARTED|Overall Study||6
6464132|NCT01220128|7380942|FG004|STARTED|Overall Study||11
6464133|NCT01220128|7380943|FG005|STARTED|Overall Study||4
6464134|NCT01220128|7380944|FG006|STARTED|Overall Study||8
6464135|NCT01220128|7380938|FG000|COMPLETED|Overall Study||11
6464136|NCT01220128|7380939|FG001|COMPLETED|Overall Study||6
6464137|NCT01220128|7380940|FG002|COMPLETED|Overall Study||6
6464138|NCT01220128|7380941|FG003|COMPLETED|Overall Study||6
6464139|NCT01220128|7380942|FG004|COMPLETED|Overall Study||11
6464140|NCT01220128|7380943|FG005|COMPLETED|Overall Study||4
6464141|NCT01220128|7380944|FG006|COMPLETED|Overall Study||3
6464142|NCT01220128|7380938|FG000|NOT COMPLETED|Overall Study||4
6464143|NCT01220128|7380939|FG001|NOT COMPLETED|Overall Study||1
6464144|NCT01220128|7380940|FG002|NOT COMPLETED|Overall Study||3
6464145|NCT01220128|7380941|FG003|NOT COMPLETED|Overall Study||0
6464146|NCT01220128|7380942|FG004|NOT COMPLETED|Overall Study||0
6464147|NCT01220128|7380943|FG005|NOT COMPLETED|Overall Study||0
6464148|NCT01220128|7380944|FG006|NOT COMPLETED|Overall Study||5
6464149|NCT01220167|7380964|FG000|STARTED|Period 1||6
6464150|NCT01220167|7380965|FG001|STARTED|Period 1||6
6464151|NCT01220167|7380966|FG002|STARTED|Period 1||6
6464152|NCT01220167|7380964|FG000|COMPLETED|Period 1||6
6464153|NCT01220167|7380965|FG001|COMPLETED|Period 1||6
6464154|NCT01220167|7380966|FG002|COMPLETED|Period 1||6
6464155|NCT01220167|7380964|FG000|NOT COMPLETED|Period 1||0
6464156|NCT01220167|7380965|FG001|NOT COMPLETED|Period 1||0
6464157|NCT01220167|7380966|FG002|NOT COMPLETED|Period 1||0
6464158|NCT01220167|7380964|FG000|STARTED|Period 2||6
6464159|NCT01220167|7380965|FG001|STARTED|Period 2||6
6464160|NCT01220167|7380966|FG002|STARTED|Period 2||6
6464161|NCT01220167|7380964|FG000|COMPLETED|Period 2||6
6464162|NCT01220167|7380965|FG001|COMPLETED|Period 2||6
6464163|NCT01220167|7380966|FG002|COMPLETED|Period 2||6
6464164|NCT01220167|7380964|FG000|NOT COMPLETED|Period 2||0
6464165|NCT01220167|7380965|FG001|NOT COMPLETED|Period 2||0
6464166|NCT01220167|7380966|FG002|NOT COMPLETED|Period 2||0
6464167|NCT01220167|7380964|FG000|STARTED|Period 3||6
6464168|NCT01220167|7380965|FG001|STARTED|Period 3||6
6464169|NCT01220167|7380966|FG002|STARTED|Period 3||6
6464170|NCT01220167|7380964|FG000|COMPLETED|Period 3||6
6464171|NCT01220167|7380965|FG001|COMPLETED|Period 3||5
6464172|NCT01220167|7380966|FG002|COMPLETED|Period 3||6
6464173|NCT01220167|7380964|FG000|NOT COMPLETED|Period 3||0
6464174|NCT01220167|7380965|FG001|NOT COMPLETED|Period 3||1
6464175|NCT01220167|7380966|FG002|NOT COMPLETED|Period 3||0
6464176|NCT01220180|7380975|FG000|STARTED|Overall Study||4175
6464177|NCT01220180|7380975|FG000|Treated|Overall Study||4174
6464178|NCT01220180|7380975|FG000|COMPLETED|Overall Study||3968
6464179|NCT01220180|7380975|FG000|NOT COMPLETED|Overall Study||207
6464180|NCT01220297|7380981|FG000|STARTED|Overall Study||3
6464181|NCT01220297|7380981|FG000|COMPLETED|Overall Study||0
6464182|NCT01220297|7380981|FG000|NOT COMPLETED|Overall Study||3
6464183|NCT01220401|7380987|FG000|STARTED|Overall Study||21
6464184|NCT01220401|7380987|FG000|COMPLETED|Overall Study||18
6464185|NCT01220401|7380987|FG000|NOT COMPLETED|Overall Study||3
6464186|NCT01220414|7380993|FG000|STARTED|Overall Study||15
6464187|NCT01220414|7380994|FG001|STARTED|Overall Study||14
6464188|NCT01220414|7380995|FG002|STARTED|Overall Study||14
6464189|NCT01220414|7380996|FG003|STARTED|Overall Study||15
6464190|NCT01220414|7380993|FG000|COMPLETED|Overall Study||14
6464191|NCT01220414|7380994|FG001|COMPLETED|Overall Study||14
6464192|NCT01220414|7380995|FG002|COMPLETED|Overall Study||14
6464193|NCT01220414|7380996|FG003|COMPLETED|Overall Study||14
6464194|NCT01220414|7380993|FG000|NOT COMPLETED|Overall Study||1
6464195|NCT01220414|7380994|FG001|NOT COMPLETED|Overall Study||0
6464196|NCT01220414|7380995|FG002|NOT COMPLETED|Overall Study||0
6464197|NCT01220414|7380996|FG003|NOT COMPLETED|Overall Study||1
6464198|NCT01220466|7381006|FG000|STARTED|Overall Study|19 eyes|11
6464199|NCT01220466|7381007|FG001|STARTED|Overall Study|108 eyes|56
6464200|NCT01220466|7381008|FG002|STARTED|Overall Study|16 eyes|10
6464201|NCT01220466|7381006|FG000|COMPLETED|Overall Study|19 eyes|11
6464202|NCT01220466|7381007|FG001|COMPLETED|Overall Study|108 eyes|56
6464203|NCT01220466|7381008|FG002|COMPLETED|Overall Study|16 eyes|10
6464204|NCT01220466|7381006|FG000|NOT COMPLETED|Overall Study||0
6464205|NCT01220466|7381007|FG001|NOT COMPLETED|Overall Study||0
6464206|NCT01220466|7381008|FG002|NOT COMPLETED|Overall Study||0
6464207|NCT01220557|7381018|FG000|STARTED|Overall Study||81
6464208|NCT01220557|7381019|FG001|STARTED|Overall Study||79
6464209|NCT01220557|7381018|FG000|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
6464210|NCT01220557|7381019|FG001|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
6464211|NCT01220557|7381018|FG000|NOT COMPLETED|Overall Study||6
6464212|NCT01220557|7381019|FG001|NOT COMPLETED|Overall Study||5
6464213|NCT01220609|7381025|FG000|STARTED|Overall Study||26
6464214|NCT01220609|7381025|FG000|COMPLETED|Overall Study|Eligible and treated patients|23
6464215|NCT01220609|7381025|FG000|NOT COMPLETED|Overall Study||3
6464216|NCT01220687|7381037|FG000|STARTED|Overall Study||16
6464217|NCT01220687|7381038|FG001|STARTED|Overall Study||15
6464218|NCT01220687|7381037|FG000|COMPLETED|Overall Study||14
6554102|NCT01746901|7476547|FG002|STARTED|Drug Discrimination Phase: Day 1||36
6554103|NCT01746901|7476548|FG003|STARTED|Drug Discrimination Phase: Day 1||0
6554104|NCT01746901|7476549|FG004|STARTED|Drug Discrimination Phase: Day 1||0
6554105|NCT01746901|7476550|FG005|STARTED|Drug Discrimination Phase: Day 1||0
6554106|NCT01746901|7476551|FG006|STARTED|Drug Discrimination Phase: Day 1||0
6554107|NCT01746901|7476552|FG007|STARTED|Drug Discrimination Phase: Day 1||0
6554108|NCT01746901|7476553|FG008|STARTED|Drug Discrimination Phase: Day 1||0
6554109|NCT01746901|7476545|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
6554110|NCT01746901|7476546|FG001|COMPLETED|Drug Discrimination Phase: Day 1||33
6554111|NCT01746901|7476547|FG002|COMPLETED|Drug Discrimination Phase: Day 1||36
6554112|NCT01746901|7476548|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
6554113|NCT01746901|7476549|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
6464219|NCT01220687|7381038|FG001|COMPLETED|Overall Study||14
6464220|NCT01220687|7381037|FG000|NOT COMPLETED|Overall Study||2
6464221|NCT01220687|7381038|FG001|NOT COMPLETED|Overall Study||1
6464222|NCT01220726|7381046|FG000|STARTED|Overall Study||15
6464223|NCT01220726|7381047|FG001|STARTED|Overall Study||15
6464224|NCT01220726|7381046|FG000|COMPLETED|Overall Study||15
6464225|NCT01220726|7381047|FG001|COMPLETED|Overall Study||13
6464226|NCT01220726|7381046|FG000|NOT COMPLETED|Overall Study||0
6464227|NCT01220726|7381047|FG001|NOT COMPLETED|Overall Study||2
6464228|NCT01220739|7381055|FG000|STARTED|Overall Study||7
6464229|NCT01220739|7381056|FG001|STARTED|Overall Study||5
6464230|NCT01220739|7381055|FG000|COMPLETED|Overall Study||7
6464231|NCT01220739|7381056|FG001|COMPLETED|Overall Study||5
6464232|NCT01220739|7381055|FG000|NOT COMPLETED|Overall Study||0
6464233|NCT01220739|7381056|FG001|NOT COMPLETED|Overall Study||0
6464234|NCT01220856|7381064|FG000|STARTED|Overall Study||6
6464235|NCT01220856|7381065|FG001|STARTED|Overall Study||3
6464236|NCT01220856|7381064|FG000|COMPLETED|Overall Study||2
6464237|NCT01220856|7381065|FG001|COMPLETED|Overall Study||0
6464238|NCT01220856|7381064|FG000|NOT COMPLETED|Overall Study||4
6554114|NCT01746901|7476550|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
6554115|NCT01746901|7476551|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
6464239|NCT01220856|7381065|FG001|NOT COMPLETED|Overall Study||3
6464240|NCT01220869|7381074|FG000|STARTED|Overall Study||110
6464241|NCT01220869|7381074|FG000|COMPLETED|Overall Study||104
6464242|NCT01220869|7381074|FG000|NOT COMPLETED|Overall Study||6
6464243|NCT01220973|7381078|FG000|STARTED|Overall Study||27
6464244|NCT01220973|7381078|FG000|COMPLETED|Overall Study||23
6464245|NCT01220973|7381078|FG000|NOT COMPLETED|Overall Study||4
6464246|NCT01220999|7381087|FG000|STARTED|Overall Study||2
6464247|NCT01220999|7381088|FG001|STARTED|Overall Study||4
6464248|NCT01220999|7381089|FG002|STARTED|Overall Study||5
6464249|NCT01220999|7381090|FG003|STARTED|Overall Study||3
6464250|NCT01220999|7381091|FG004|STARTED|Overall Study||5
6464251|NCT01220999|7381087|FG000|COMPLETED|Overall Study||2
6464252|NCT01220999|7381088|FG001|COMPLETED|Overall Study||4
6464253|NCT01220999|7381089|FG002|COMPLETED|Overall Study||4
6464254|NCT01220999|7381090|FG003|COMPLETED|Overall Study||3
6464255|NCT01220999|7381091|FG004|COMPLETED|Overall Study||5
6464256|NCT01220999|7381087|FG000|NOT COMPLETED|Overall Study||0
6464257|NCT01220999|7381088|FG001|NOT COMPLETED|Overall Study||0
6464258|NCT01220999|7381089|FG002|NOT COMPLETED|Overall Study||1
6464259|NCT01220999|7381090|FG003|NOT COMPLETED|Overall Study||0
6464260|NCT01220999|7381091|FG004|NOT COMPLETED|Overall Study||0
6464261|NCT01221090|7381107|FG000|STARTED|Overall Study||101
6464262|NCT01221090|7381108|FG001|STARTED|Overall Study||81
6464263|NCT01221090|7381109|FG002|STARTED|Overall Study||99
6464264|NCT01221090|7381110|FG003|STARTED|Overall Study||95
6464265|NCT01221090|7381107|FG000|COMPLETED|Overall Study||86
6464266|NCT01221090|7381108|FG001|COMPLETED|Overall Study||47
6464267|NCT01221090|7381109|FG002|COMPLETED|Overall Study||57
6464268|NCT01221090|7381110|FG003|COMPLETED|Overall Study||73
6464269|NCT01221090|7381107|FG000|NOT COMPLETED|Overall Study||15
6464270|NCT01221090|7381108|FG001|NOT COMPLETED|Overall Study||34
6305717|NCT01924533|7209063|FG001|COMPLETED|Overall Study||57
6305718|NCT01924533|7209062|FG000|NOT COMPLETED|Overall Study||189
6305719|NCT01924533|7209063|FG001|NOT COMPLETED|Overall Study||205
6305720|NCT01856140|7209071|FG000|STARTED|Overall Study||6
6305721|NCT01856140|7209072|FG001|STARTED|Overall Study||6
6305722|NCT01856140|7209071|FG000|COMPLETED|Overall Study||6
6464271|NCT01221090|7381109|FG002|NOT COMPLETED|Overall Study||42
6464272|NCT01221090|7381110|FG003|NOT COMPLETED|Overall Study||22
6464273|NCT01221181|7381120|FG000|STARTED|Overall Study||6
6464274|NCT01221181|7381120|FG000|COMPLETED|Overall Study||5
6464275|NCT01221181|7381120|FG000|NOT COMPLETED|Overall Study||1
6464276|NCT01221194|7381126|FG000|STARTED|Overall Study||195
6464277|NCT01221194|7381127|FG001|STARTED|Overall Study||186
6464278|NCT01221194|7381126|FG000|COMPLETED|Overall Study||195
6464279|NCT01221194|7381127|FG001|COMPLETED|Overall Study||186
6464280|NCT01221194|7381126|FG000|NOT COMPLETED|Overall Study||0
6464281|NCT01221194|7381127|FG001|NOT COMPLETED|Overall Study||0
6464282|NCT01221207|7381136|FG000|STARTED|Overall Study||75
6464283|NCT01221207|7381137|FG001|STARTED|Overall Study||75
6464284|NCT01221207|7381138|FG002|STARTED|Overall Study||75
6464285|NCT01221207|7381136|FG000|COMPLETED|Overall Study||43
6464286|NCT01221207|7381137|FG001|COMPLETED|Overall Study||66
6464287|NCT01221207|7381138|FG002|COMPLETED|Overall Study||54
6464288|NCT01221207|7381136|FG000|NOT COMPLETED|Overall Study||32
6554116|NCT01746901|7476552|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
6554117|NCT01746901|7476553|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
6554118|NCT01746901|7476545|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6464289|NCT01221207|7381137|FG001|NOT COMPLETED|Overall Study||9
6464290|NCT01221207|7381138|FG002|NOT COMPLETED|Overall Study||21
6464291|NCT01221233|7381148|FG000|STARTED|Overall Study||18
6464292|NCT01221233|7381149|FG001|STARTED|Overall Study||20
6464293|NCT01221233|7381148|FG000|COMPLETED|Overall Study||15
6464294|NCT01221233|7381149|FG001|COMPLETED|Overall Study||19
6464295|NCT01221233|7381148|FG000|NOT COMPLETED|Overall Study||3
6464296|NCT01221233|7381149|FG001|NOT COMPLETED|Overall Study||1
6464297|NCT01221272|7381155|FG000|STARTED|Period 1||41
6464298|NCT01221272|7381156|FG001|STARTED|Period 1||40
6464299|NCT01221272|7381155|FG000|COMPLETED|Period 1||39
6464300|NCT01221272|7381156|FG001|COMPLETED|Period 1||38
6464301|NCT01221272|7381155|FG000|NOT COMPLETED|Period 1||2
6464302|NCT01221272|7381156|FG001|NOT COMPLETED|Period 1||2
6464303|NCT01221272|7381155|FG000|STARTED|Period 2||39
6464304|NCT01221272|7381156|FG001|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
6464305|NCT01221272|7381155|FG000|COMPLETED|Period 2||39
6464306|NCT01221272|7381156|FG001|COMPLETED|Period 2||37
6464307|NCT01221272|7381155|FG000|NOT COMPLETED|Period 2||0
6464308|NCT01221272|7381156|FG001|NOT COMPLETED|Period 2||2
6464309|NCT01221285|7381165|FG000|STARTED|Overall Study||11
6464310|NCT01221285|7381165|FG000|COMPLETED|Overall Study||10
6464311|NCT01221285|7381165|FG000|NOT COMPLETED|Overall Study||1
6464312|NCT01221298|7381169|FG000|STARTED|Overall Study||11
6464313|NCT01221298|7381169|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|11
6464314|NCT01221298|7381169|FG000|NOT COMPLETED|Overall Study||0
6464315|NCT01221311|7381175|FG000|STARTED|Overall Study||57
6464316|NCT01221311|7381176|FG001|STARTED|Overall Study||55
6464317|NCT01221311|7381175|FG000|COMPLETED|Overall Study||57
6464318|NCT01221311|7381176|FG001|COMPLETED|Overall Study||55
6464319|NCT01221311|7381175|FG000|NOT COMPLETED|Overall Study||0
6464320|NCT01221311|7381176|FG001|NOT COMPLETED|Overall Study||0
6464321|NCT01221350|7381184|FG000|STARTED|Overall Study||28
6464322|NCT01221350|7381185|FG001|STARTED|Overall Study||27
6464323|NCT01221350|7381184|FG000|Received Intervention|Overall Study||28
6464324|NCT01221350|7381185|FG001|Received Intervention|Overall Study||27
6464325|NCT01221350|7381184|FG000|Analysis Population|Overall Study||23
6464326|NCT01221350|7381185|FG001|Analysis Population|Overall Study||24
6464327|NCT01221350|7381184|FG000|COMPLETED|Overall Study||23
6464328|NCT01221350|7381185|FG001|COMPLETED|Overall Study||24
6464329|NCT01221350|7381184|FG000|NOT COMPLETED|Overall Study||5
6464330|NCT01221350|7381185|FG001|NOT COMPLETED|Overall Study||3
6464331|NCT01221363|7381195|FG000|STARTED|Overall Study||93
6464332|NCT01221363|7381196|FG001|STARTED|Overall Study||73
6464333|NCT01221363|7381195|FG000|COMPLETED|Overall Study||81
6464334|NCT01221363|7381196|FG001|COMPLETED|Overall Study||68
6464335|NCT01221363|7381195|FG000|NOT COMPLETED|Overall Study||12
6464336|NCT01221363|7381196|FG001|NOT COMPLETED|Overall Study||5
6464337|NCT01221441|7381204|FG000|STARTED|Overall Study||67
6464338|NCT01221441|7381205|FG001|STARTED|Overall Study||35
6464339|NCT01221441|7381204|FG000|COMPLETED|Overall Study||45
6464340|NCT01221441|7381205|FG001|COMPLETED|Overall Study||23
6464341|NCT01221441|7381204|FG000|NOT COMPLETED|Overall Study||22
6464342|NCT01221441|7381205|FG001|NOT COMPLETED|Overall Study||12
6464343|NCT01221597|7381213|FG000|STARTED|Overall Study||277
6464344|NCT01221597|7381214|FG001|STARTED|Overall Study||140
6464345|NCT01221597|7381213|FG000|COMPLETED|Overall Study||241
6464346|NCT01221597|7381214|FG001|COMPLETED|Overall Study||124
6464347|NCT01221597|7381213|FG000|NOT COMPLETED|Overall Study||36
6464348|NCT01221597|7381214|FG001|NOT COMPLETED|Overall Study||16
6464349|NCT01221623|7381223|FG000|STARTED|Overall Study||274
6464350|NCT01221623|7381224|FG001|STARTED|Overall Study||141
6464351|NCT01221623|7381223|FG000|COMPLETED|Overall Study||236
6464352|NCT01221623|7381224|FG001|COMPLETED|Overall Study||127
6464353|NCT01221623|7381223|FG000|NOT COMPLETED|Overall Study||38
6464354|NCT01221623|7381224|FG001|NOT COMPLETED|Overall Study||14
6464355|NCT01221727|7381232|FG000|STARTED|Overall Study|Number of subjects randomized into the study|21
6464356|NCT01221727|7381233|FG001|STARTED|Overall Study|Number of subjects randomized into the study|9
6464357|NCT01221727|7381232|FG000|Treated|Overall Study|Number of subjects received investigational product|19
6464358|NCT01221727|7381233|FG001|Treated|Overall Study|Number of subjects received investigational product|8
6464359|NCT01221727|7381232|FG000|COMPLETED|Overall Study||18
6464360|NCT01221727|7381233|FG001|COMPLETED|Overall Study||8
6464361|NCT01221727|7381232|FG000|NOT COMPLETED|Overall Study||3
6464362|NCT01221727|7381233|FG001|NOT COMPLETED|Overall Study||1
6464363|NCT01221753|7381245|FG000|STARTED|Overall Study||7
6464364|NCT01221753|7381245|FG000|COMPLETED|Overall Study||6
6464365|NCT01221753|7381245|FG000|NOT COMPLETED|Overall Study||1
6464366|NCT01221857|7381249|FG000|STARTED|Overall Study||12
6464367|NCT01221857|7381249|FG000|COMPLETED|Overall Study||12
6464368|NCT01221857|7381249|FG000|NOT COMPLETED|Overall Study||0
6464369|NCT01221948|7381257|FG000|STARTED|Overall Study||53
6464370|NCT01221948|7381257|FG000|COMPLETED|Overall Study||39
6464371|NCT01221948|7381257|FG000|NOT COMPLETED|Overall Study||14
6464372|NCT01222078|7381261|FG000|STARTED|Overall Study||1
6464373|NCT01222078|7381261|FG000|COMPLETED|Overall Study||0
6464374|NCT01222078|7381261|FG000|NOT COMPLETED|Overall Study||1
6464375|NCT01222091|7381266|FG000|STARTED|Overall Study||5
6464376|NCT01222091|7381267|FG001|STARTED|Overall Study||5
6464377|NCT01222091|7381266|FG000|COMPLETED|Overall Study||5
6464378|NCT01222091|7381267|FG001|COMPLETED|Overall Study||5
6464379|NCT01222091|7381266|FG000|NOT COMPLETED|Overall Study||0
6464380|NCT01222091|7381267|FG001|NOT COMPLETED|Overall Study||0
6464381|NCT01222104|7381273|FG000|STARTED|Overall Study||634
6464382|NCT01222104|7381273|FG000|Angio-Seal Deployment Attempted|Overall Study||534
6464383|NCT01222104|7381273|FG000|Successful Deployment|Overall Study||529
6464384|NCT01222104|7381273|FG000|Successful Deployment and Hemostasis|Overall Study||524
6464385|NCT01222104|7381273|FG000|Completed 30-day Visit-Angio-Seal|Overall Study||497
6464386|NCT01222104|7381273|FG000|Completed 30-day Visit-No Angio-Seal|Overall Study||90
6464387|NCT01222104|7381273|FG000|COMPLETED|Overall Study||587
6464388|NCT01222104|7381273|FG000|NOT COMPLETED|Overall Study||47
6464389|NCT01222117|7381294|FG000|STARTED|Overall Study||20
6464390|NCT01222117|7381295|FG001|STARTED|Overall Study||20
6464391|NCT01222117|7381296|FG002|STARTED|Overall Study||22
6464392|NCT01222117|7381297|FG003|STARTED|Overall Study||20
6464393|NCT01222117|7381298|FG004|STARTED|Overall Study||9
6464394|NCT01222117|7381299|FG005|STARTED|Overall Study||10
6464395|NCT01222117|7381300|FG006|STARTED|Overall Study||13
6464396|NCT01222117|7381301|FG007|STARTED|Overall Study||12
6464397|NCT01222117|7381302|FG008|STARTED|Overall Study||23
6464398|NCT01222117|7381303|FG009|STARTED|Overall Study||19
6464399|NCT01222117|7381304|FG010|STARTED|Overall Study||6
6464400|NCT01222117|7381294|FG000|COMPLETED|Overall Study||17
6464401|NCT01222117|7381295|FG001|COMPLETED|Overall Study||19
6464402|NCT01222117|7381296|FG002|COMPLETED|Overall Study||22
6464403|NCT01222117|7381297|FG003|COMPLETED|Overall Study||19
6464404|NCT01222117|7381298|FG004|COMPLETED|Overall Study||8
6464405|NCT01222117|7381299|FG005|COMPLETED|Overall Study||9
6464406|NCT01222117|7381300|FG006|COMPLETED|Overall Study||13
6464407|NCT01222117|7381301|FG007|COMPLETED|Overall Study||12
6464408|NCT01222117|7381302|FG008|COMPLETED|Overall Study||20
6464409|NCT01222117|7381303|FG009|COMPLETED|Overall Study||17
6464410|NCT01222117|7381304|FG010|COMPLETED|Overall Study||6
6464411|NCT01222117|7381294|FG000|NOT COMPLETED|Overall Study||3
6464412|NCT01222117|7381295|FG001|NOT COMPLETED|Overall Study||1
6464413|NCT01222117|7381296|FG002|NOT COMPLETED|Overall Study||0
6464414|NCT01222117|7381297|FG003|NOT COMPLETED|Overall Study||1
6464415|NCT01222117|7381298|FG004|NOT COMPLETED|Overall Study||1
6464416|NCT01222117|7381299|FG005|NOT COMPLETED|Overall Study||1
6464417|NCT01222117|7381300|FG006|NOT COMPLETED|Overall Study||0
6464418|NCT01222117|7381301|FG007|NOT COMPLETED|Overall Study||0
6464419|NCT01222117|7381302|FG008|NOT COMPLETED|Overall Study||3
6464420|NCT01222117|7381303|FG009|NOT COMPLETED|Overall Study||2
6464421|NCT01222117|7381304|FG010|NOT COMPLETED|Overall Study||0
6464422|NCT01222195|7381328|FG000|STARTED|Overall Study||1
6464423|NCT01222195|7381328|FG000|COMPLETED|Overall Study||1
6464424|NCT01222195|7381328|FG000|NOT COMPLETED|Overall Study||0
6464425|NCT01222234|7381335|FG000|STARTED|Overall Study||15
6464426|NCT01222234|7381336|FG001|STARTED|Overall Study||17
6464427|NCT01222234|7381337|FG002|STARTED|Overall Study||24
6464428|NCT01222234|7381335|FG000|COMPLETED|Overall Study||15
6464429|NCT01222234|7381336|FG001|COMPLETED|Overall Study||15
6464430|NCT01222234|7381337|FG002|COMPLETED|Overall Study||22
6464431|NCT01222234|7381335|FG000|NOT COMPLETED|Overall Study||0
6464432|NCT01222234|7381336|FG001|NOT COMPLETED|Overall Study||2
6464433|NCT01222234|7381337|FG002|NOT COMPLETED|Overall Study||2
6464434|NCT01222260|7381346|FG000|STARTED|Overall Study||31
6464435|NCT01222260|7381346|FG000|COMPLETED|Overall Study||29
6464436|NCT01222260|7381346|FG000|NOT COMPLETED|Overall Study||2
6464437|NCT01222273|7381350|FG000|STARTED|Overall Study||7
6464438|NCT01222273|7381350|FG000|COMPLETED|Overall Study||7
6464439|NCT01222273|7381350|FG000|NOT COMPLETED|Overall Study||0
6464440|NCT01222286|7381356|FG000|STARTED|Overall Study||16
6464441|NCT01222286|7381357|FG001|STARTED|Overall Study||14
6464442|NCT01222286|7381356|FG000|COMPLETED|Overall Study||16
6464443|NCT01222286|7381357|FG001|COMPLETED|Overall Study||14
6464444|NCT01222286|7381356|FG000|NOT COMPLETED|Overall Study||0
6464445|NCT01222286|7381357|FG001|NOT COMPLETED|Overall Study||0
6464446|NCT01222299|7381367|FG000|STARTED|Overall Study||21
6464447|NCT01222299|7381368|FG001|STARTED|Overall Study||23
6464448|NCT01222299|7381369|FG002|STARTED|Overall Study||22
6464449|NCT01222299|7381370|FG003|STARTED|Overall Study||23
6464450|NCT01222299|7381367|FG000|COMPLETED|Overall Study||21
6464451|NCT01222299|7381368|FG001|COMPLETED|Overall Study||21
6464452|NCT01222299|7381369|FG002|COMPLETED|Overall Study||20
6464453|NCT01222299|7381370|FG003|COMPLETED|Overall Study||18
6464454|NCT01222299|7381367|FG000|NOT COMPLETED|Overall Study||0
6464455|NCT01222299|7381368|FG001|NOT COMPLETED|Overall Study||2
6464456|NCT01222299|7381369|FG002|NOT COMPLETED|Overall Study||2
6464457|NCT01222299|7381370|FG003|NOT COMPLETED|Overall Study||5
6464458|NCT01222390|7381380|FG000|STARTED|Overall Study||12
6464459|NCT01222390|7381380|FG000|COMPLETED|Overall Study||12
6464460|NCT01222390|7381380|FG000|NOT COMPLETED|Overall Study||0
6464461|NCT01222403|7381386|FG000|STARTED|Overall Study||386
6464462|NCT01222403|7381387|FG001|STARTED|Overall Study||381
6464463|NCT01222403|7381386|FG000|COMPLETED|Overall Study||386
6464464|NCT01222403|7381387|FG001|COMPLETED|Overall Study||379
6464465|NCT01222403|7381386|FG000|NOT COMPLETED|Overall Study||0
6464466|NCT01222403|7381387|FG001|NOT COMPLETED|Overall Study||2
6464467|NCT01222416|7381395|FG000|STARTED|Overall Study||50
6464468|NCT01222416|7381396|FG001|STARTED|Overall Study||0
6464469|NCT01222416|7381395|FG000|COMPLETED|Overall Study||30
6464470|NCT01222416|7381396|FG001|COMPLETED|Overall Study||0
6464471|NCT01222416|7381395|FG000|NOT COMPLETED|Overall Study||20
6464472|NCT01222416|7381396|FG001|NOT COMPLETED|Overall Study||0
6464473|NCT01222494|7381405|FG000|STARTED|Overall Study||7
6464474|NCT01222494|7381406|FG001|STARTED|Overall Study||19
6464475|NCT01222494|7381407|FG002|STARTED|Overall Study||21
6464476|NCT01222494|7381405|FG000|COMPLETED|Overall Study||6
6464477|NCT01222494|7381406|FG001|COMPLETED|Overall Study||15
6464478|NCT01222494|7381407|FG002|COMPLETED|Overall Study||17
6464479|NCT01222494|7381405|FG000|NOT COMPLETED|Overall Study||1
6464480|NCT01222494|7381406|FG001|NOT COMPLETED|Overall Study||4
6464481|NCT01222494|7381407|FG002|NOT COMPLETED|Overall Study||4
6464482|NCT01222507|7381415|FG000|STARTED|Overall Study||62
6464483|NCT01222507|7381415|FG000|COMPLETED|Overall Study||60
6464484|NCT01222507|7381415|FG000|NOT COMPLETED|Overall Study||2
6464485|NCT01222520|7381421|FG000|STARTED|Open-label run-in Period||0
6464486|NCT01222520|7381422|FG001|STARTED|Open-label run-in Period||197
6464487|NCT01222520|7381421|FG000|COMPLETED|Open-label run-in Period||0
6464488|NCT01222520|7381422|FG001|COMPLETED|Open-label run-in Period||174
6464489|NCT01222520|7381421|FG000|NOT COMPLETED|Open-label run-in Period||0
6464490|NCT01222520|7381422|FG001|NOT COMPLETED|Open-label run-in Period||23
6464491|NCT01222520|7381421|FG000|STARTED|Double-blind Period||87
6464492|NCT01222520|7381422|FG001|STARTED|Double-blind Period||87
6464493|NCT01222520|7381421|FG000|COMPLETED|Double-blind Period||86
6464494|NCT01222520|7381422|FG001|COMPLETED|Double-blind Period||85
6464495|NCT01222520|7381421|FG000|NOT COMPLETED|Double-blind Period||1
6464496|NCT01222520|7381422|FG001|NOT COMPLETED|Double-blind Period||2
6464497|NCT01222533|7381428|FG000|STARTED|Overall Study|Entered and treated.|154
6464498|NCT01222533|7381428|FG000|Received Placebo|Overall Study||147
6464499|NCT01222533|7381428|FG000|Received Tio R1.25|Overall Study||147
6464500|NCT01222533|7381428|FG000|Received Tio R2.5|Overall Study||145
6464501|NCT01222533|7381428|FG000|Received Tio R5|Overall Study||150
6464502|NCT01222533|7381428|FG000|Received Tio HH18|Overall Study||146
6464503|NCT01222533|7381428|FG000|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
6464504|NCT01222533|7381428|FG000|NOT COMPLETED|Overall Study||14
6464505|NCT01222572|7381440|FG000|STARTED|Overall Study||1
6464506|NCT01222572|7381441|FG001|STARTED|Overall Study||0
6464507|NCT01222572|7381442|FG002|STARTED|Overall Study||0
6464508|NCT01222572|7381440|FG000|COMPLETED|Overall Study||1
6464509|NCT01222572|7381441|FG001|COMPLETED|Overall Study||0
6464510|NCT01222572|7381442|FG002|COMPLETED|Overall Study||0
6464511|NCT01222572|7381440|FG000|NOT COMPLETED|Overall Study||0
6464512|NCT01222572|7381441|FG001|NOT COMPLETED|Overall Study||0
6464513|NCT01222572|7381442|FG002|NOT COMPLETED|Overall Study||0
6464514|NCT01222585|7381446|FG000|STARTED|Overall Study||24
6554119|NCT01746901|7476546|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
6554120|NCT01746901|7476547|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6554121|NCT01746901|7476548|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6464515|NCT01222585|7381446|FG000|COMPLETED|Overall Study||24
6464516|NCT01222585|7381446|FG000|NOT COMPLETED|Overall Study||0
6464517|NCT01222689|7381450|FG000|STARTED|Overall Study||46
6464518|NCT01222689|7381450|FG000|COMPLETED|Overall Study||46
6464519|NCT01222689|7381450|FG000|NOT COMPLETED|Overall Study||0
6464520|NCT01222715|7381456|FG000|STARTED|Overall Study||44
6464521|NCT01222715|7381457|FG001|STARTED|Overall Study||43
6464522|NCT01222715|7381456|FG000|COMPLETED|Overall Study||8
6464523|NCT01222715|7381457|FG001|COMPLETED|Overall Study||16
6464524|NCT01222715|7381456|FG000|NOT COMPLETED|Overall Study||36
6464525|NCT01222715|7381457|FG001|NOT COMPLETED|Overall Study||27
6464526|NCT01222767|7381463|FG000|STARTED|Overall Study||17
6464527|NCT01222767|7381463|FG000|Received Treatment|Overall Study||16
6464528|NCT01222767|7381463|FG000|COMPLETED|Overall Study||0
6464529|NCT01222767|7381463|FG000|NOT COMPLETED|Overall Study||17
6464530|NCT01222832|7381469|FG000|STARTED|Overall Study||113
6464531|NCT01222832|7381470|FG001|STARTED|Overall Study||113
6464532|NCT01222832|7381469|FG000|COMPLETED|Overall Study||113
6464533|NCT01222832|7381470|FG001|COMPLETED|Overall Study||112
6464534|NCT01222832|7381469|FG000|NOT COMPLETED|Overall Study||0
6464535|NCT01222832|7381470|FG001|NOT COMPLETED|Overall Study||1
6464536|NCT01222884|7381478|FG000|STARTED|Overall Study||234
6464537|NCT01222884|7381479|FG001|STARTED|Overall Study||117
6464538|NCT01222884|7381478|FG000|COMPLETED|Overall Study||210
6464539|NCT01222884|7381479|FG001|COMPLETED|Overall Study||113
6464540|NCT01222884|7381478|FG000|NOT COMPLETED|Overall Study||24
6464541|NCT01222884|7381479|FG001|NOT COMPLETED|Overall Study||4
6464542|NCT01223027|7381487|FG000|STARTED|Overall Study||284
6464543|NCT01223027|7381488|FG001|STARTED|Overall Study||286
6464544|NCT01223027|7381487|FG000|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
6464545|NCT01223027|7381488|FG001|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
6464546|NCT01223027|7381487|FG000|NOT COMPLETED|Overall Study||274
6464547|NCT01223027|7381488|FG001|NOT COMPLETED|Overall Study||277
6464548|NCT01223183|7381496|FG000|STARTED|Imaging Day 1||10
6464549|NCT01223183|7381497|FG001|STARTED|Imaging Day 1||10
6464550|NCT01223183|7381496|FG000|COMPLETED|Imaging Day 1||10
6464551|NCT01223183|7381497|FG001|COMPLETED|Imaging Day 1||9
6464552|NCT01223183|7381496|FG000|NOT COMPLETED|Imaging Day 1||0
6464553|NCT01223183|7381497|FG001|NOT COMPLETED|Imaging Day 1||1
6464554|NCT01223183|7381496|FG000|STARTED|Washout Period (5-24 Days)||10
6464555|NCT01223183|7381497|FG001|STARTED|Washout Period (5-24 Days)||9
6464556|NCT01223183|7381496|FG000|COMPLETED|Washout Period (5-24 Days)||8
6464557|NCT01223183|7381497|FG001|COMPLETED|Washout Period (5-24 Days)||9
6464558|NCT01223183|7381496|FG000|NOT COMPLETED|Washout Period (5-24 Days)||2
6464559|NCT01223183|7381497|FG001|NOT COMPLETED|Washout Period (5-24 Days)||0
6464560|NCT01223183|7381496|FG000|STARTED|Imaging Day 2||8
6464561|NCT01223183|7381497|FG001|STARTED|Imaging Day 2||9
6464562|NCT01223183|7381496|FG000|COMPLETED|Imaging Day 2||8
6464563|NCT01223183|7381497|FG001|COMPLETED|Imaging Day 2||9
6464564|NCT01223183|7381496|FG000|NOT COMPLETED|Imaging Day 2||0
6464565|NCT01223183|7381497|FG001|NOT COMPLETED|Imaging Day 2||0
6464566|NCT01223196|7381506|FG000|STARTED|Overall Study||13
6464567|NCT01223196|7381507|FG001|STARTED|Overall Study||11
6464568|NCT01223196|7381506|FG000|COMPLETED|Overall Study||9
6464569|NCT01223196|7381507|FG001|COMPLETED|Overall Study||11
6464570|NCT01223196|7381506|FG000|NOT COMPLETED|Overall Study||4
6464571|NCT01223196|7381507|FG001|NOT COMPLETED|Overall Study||0
6464572|NCT01223235|7381515|FG000|STARTED|Overall Study||22
6464573|NCT01223235|7381515|FG000|COMPLETED|Overall Study||21
6464574|NCT01223235|7381515|FG000|NOT COMPLETED|Overall Study||1
6464575|NCT01223352|7381521|FG000|STARTED|Overall Study||31
6464576|NCT01223352|7381522|FG001|STARTED|Overall Study||33
6464577|NCT01223352|7381521|FG000|COMPLETED|Overall Study||31
6464578|NCT01223352|7381522|FG001|COMPLETED|Overall Study||33
6464579|NCT01223352|7381521|FG000|NOT COMPLETED|Overall Study||0
6464580|NCT01223352|7381522|FG001|NOT COMPLETED|Overall Study||0
6464581|NCT01223365|7381534|FG000|STARTED|Open-label Titration Period||330
6464582|NCT01223365|7381534|FG000|Safety Analysis Set|Open-label Titration Period||329
6464583|NCT01223365|7381534|FG000|Achieved Stable Pain Relief|Open-label Titration Period||294
6464584|NCT01223365|7381534|FG000|COMPLETED|Open-label Titration Period||291
6464585|NCT01223365|7381534|FG000|NOT COMPLETED|Open-label Titration Period||39
6464586|NCT01223365|7381534|FG000|STARTED|Open-label Treatment Period||291
6464587|NCT01223365|7381534|FG000|COMPLETED|Open-label Treatment Period||189
6464588|NCT01223365|7381534|FG000|NOT COMPLETED|Open-label Treatment Period||102
6464589|NCT01223378|7381548|FG000|STARTED|Overall Study||82
6464590|NCT01223378|7381549|FG001|STARTED|Overall Study||85
6464591|NCT01223378|7381550|FG002|STARTED|Overall Study||83
6464592|NCT01223378|7381551|FG003|STARTED|Overall Study||81
6464593|NCT01223378|7381552|FG004|STARTED|Overall Study||82
6464594|NCT01223378|7381548|FG000|COMPLETED|Overall Study||76
6464595|NCT01223378|7381549|FG001|COMPLETED|Overall Study||81
6464596|NCT01223378|7381550|FG002|COMPLETED|Overall Study||80
6464597|NCT01223378|7381551|FG003|COMPLETED|Overall Study||80
6464598|NCT01223378|7381552|FG004|COMPLETED|Overall Study||79
6464599|NCT01223378|7381548|FG000|NOT COMPLETED|Overall Study||6
6464600|NCT01223378|7381549|FG001|NOT COMPLETED|Overall Study||4
6464601|NCT01223378|7381550|FG002|NOT COMPLETED|Overall Study||3
6464602|NCT01223378|7381551|FG003|NOT COMPLETED|Overall Study||1
6464603|NCT01223378|7381552|FG004|NOT COMPLETED|Overall Study||3
6464604|NCT01223404|7381564|FG000|STARTED|First Intervention (1 Day)||4
6464605|NCT01223404|7381565|FG001|STARTED|First Intervention (1 Day)||3
6464606|NCT01223404|7381566|FG002|STARTED|First Intervention (1 Day)||4
6464607|NCT01223404|7381567|FG003|STARTED|First Intervention (1 Day)||5
6464608|NCT01223404|7381568|FG004|STARTED|First Intervention (1 Day)||2
6464609|NCT01223404|7381569|FG005|STARTED|First Intervention (1 Day)||3
6464610|NCT01223404|7381564|FG000|COMPLETED|First Intervention (1 Day)||4
6464611|NCT01223404|7381565|FG001|COMPLETED|First Intervention (1 Day)||3
6464612|NCT01223404|7381566|FG002|COMPLETED|First Intervention (1 Day)||4
6464613|NCT01223404|7381567|FG003|COMPLETED|First Intervention (1 Day)||4
6464614|NCT01223404|7381568|FG004|COMPLETED|First Intervention (1 Day)||2
6464615|NCT01223404|7381569|FG005|COMPLETED|First Intervention (1 Day)||3
6464616|NCT01223404|7381564|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6464617|NCT01223404|7381565|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6464618|NCT01223404|7381566|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6464619|NCT01223404|7381567|FG003|NOT COMPLETED|First Intervention (1 Day)||1
6464620|NCT01223404|7381568|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6464621|NCT01223404|7381569|FG005|NOT COMPLETED|First Intervention (1 Day)||0
6464622|NCT01223404|7381564|FG000|STARTED|Second Intervention (1 Day)||4
6464623|NCT01223404|7381565|FG001|STARTED|Second Intervention (1 Day)||3
6464624|NCT01223404|7381566|FG002|STARTED|Second Intervention (1 Day)||4
6464625|NCT01223404|7381567|FG003|STARTED|Second Intervention (1 Day)||4
6464626|NCT01223404|7381568|FG004|STARTED|Second Intervention (1 Day)||2
6464627|NCT01223404|7381569|FG005|STARTED|Second Intervention (1 Day)||3
6464628|NCT01223404|7381564|FG000|COMPLETED|Second Intervention (1 Day)||3
6464629|NCT01223404|7381565|FG001|COMPLETED|Second Intervention (1 Day)||3
6464630|NCT01223404|7381566|FG002|COMPLETED|Second Intervention (1 Day)||4
6464631|NCT01223404|7381567|FG003|COMPLETED|Second Intervention (1 Day)||4
6464632|NCT01223404|7381568|FG004|COMPLETED|Second Intervention (1 Day)||2
6464633|NCT01223404|7381569|FG005|COMPLETED|Second Intervention (1 Day)||3
6554122|NCT01746901|7476549|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6554123|NCT01746901|7476550|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6554124|NCT01746901|7476551|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6554125|NCT01746901|7476552|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6554126|NCT01746901|7476553|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6554127|NCT01746901|7476545|FG000|STARTED|Drug Discrimination Phase: Day 2||0
6554128|NCT01746901|7476546|FG001|STARTED|Drug Discrimination Phase: Day 2||33
6464634|NCT01223404|7381564|FG000|NOT COMPLETED|Second Intervention (1 Day)||1
6464635|NCT01223404|7381565|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6464636|NCT01223404|7381566|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6464637|NCT01223404|7381567|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6464638|NCT01223404|7381568|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6464639|NCT01223404|7381569|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
6464640|NCT01223404|7381564|FG000|STARTED|Third Intervention (1 Day)||3
6464641|NCT01223404|7381565|FG001|STARTED|Third Intervention (1 Day)||3
6464642|NCT01223404|7381566|FG002|STARTED|Third Intervention (1 Day)||4
6464643|NCT01223404|7381567|FG003|STARTED|Third Intervention (1 Day)||4
6464644|NCT01223404|7381568|FG004|STARTED|Third Intervention (1 Day)||2
6464645|NCT01223404|7381569|FG005|STARTED|Third Intervention (1 Day)||3
6464646|NCT01223404|7381564|FG000|COMPLETED|Third Intervention (1 Day)||3
6464647|NCT01223404|7381565|FG001|COMPLETED|Third Intervention (1 Day)||3
6464648|NCT01223404|7381566|FG002|COMPLETED|Third Intervention (1 Day)||4
6464649|NCT01223404|7381567|FG003|COMPLETED|Third Intervention (1 Day)||3
6464650|NCT01223404|7381568|FG004|COMPLETED|Third Intervention (1 Day)||2
6464651|NCT01223404|7381569|FG005|COMPLETED|Third Intervention (1 Day)||3
6464652|NCT01223404|7381564|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6464653|NCT01223404|7381565|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6464654|NCT01223404|7381566|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6464655|NCT01223404|7381567|FG003|NOT COMPLETED|Third Intervention (1 Day)||1
6464656|NCT01223404|7381568|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
6464657|NCT01223404|7381569|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
6464658|NCT01223469|7381587|FG000|STARTED|Overall Study||34
6464659|NCT01223469|7381588|FG001|STARTED|Overall Study||43
6464660|NCT01223469|7381587|FG000|COMPLETED|Overall Study||34
6464661|NCT01223469|7381588|FG001|COMPLETED|Overall Study||43
6464662|NCT01223469|7381587|FG000|NOT COMPLETED|Overall Study||0
6464663|NCT01223469|7381588|FG001|NOT COMPLETED|Overall Study||0
6464664|NCT01223703|7381596|FG000|STARTED|Overall Study||67
6464665|NCT01223703|7381597|FG001|STARTED|Overall Study||66
6464666|NCT01223703|7381596|FG000|COMPLETED|Overall Study||67
6464667|NCT01223703|7381597|FG001|COMPLETED|Overall Study||66
6464668|NCT01223703|7381596|FG000|NOT COMPLETED|Overall Study||0
6464669|NCT01223703|7381597|FG001|NOT COMPLETED|Overall Study||0
6464670|NCT01223937|7381605|FG000|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
6464671|NCT01223937|7381606|FG001|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
6464672|NCT01223937|7381605|FG000|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
6464673|NCT01223937|7381606|FG001|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
6464674|NCT01223937|7381605|FG000|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
6464675|NCT01223937|7381606|FG001|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
6464676|NCT01223937|7381605|FG000|COMPLETED|Overall Study||114
6464677|NCT01223937|7381606|FG001|COMPLETED|Overall Study||119
6464678|NCT01223937|7381605|FG000|NOT COMPLETED|Overall Study||17
6464679|NCT01223937|7381606|FG001|NOT COMPLETED|Overall Study||18
6464680|NCT01223963|7381612|FG000|STARTED|Overall Study|All subjects treated between May 1 2008 and Dec 31 2009 in selected clinics were to be asked.|93
6554129|NCT01746901|7476547|FG002|STARTED|Drug Discrimination Phase: Day 2||36
6554130|NCT01746901|7476548|FG003|STARTED|Drug Discrimination Phase: Day 2||0
6554131|NCT01746901|7476549|FG004|STARTED|Drug Discrimination Phase: Day 2||0
6554132|NCT01746901|7476550|FG005|STARTED|Drug Discrimination Phase: Day 2||0
6554133|NCT01746901|7476551|FG006|STARTED|Drug Discrimination Phase: Day 2||0
6554134|NCT01746901|7476552|FG007|STARTED|Drug Discrimination Phase: Day 2||0
6554135|NCT01746901|7476553|FG008|STARTED|Drug Discrimination Phase: Day 2||0
6554136|NCT01746901|7476545|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
6554137|NCT01746901|7476546|FG001|COMPLETED|Drug Discrimination Phase: Day 2||19
6554138|NCT01746901|7476547|FG002|COMPLETED|Drug Discrimination Phase: Day 2||22
6554139|NCT01746901|7476548|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
6554140|NCT01746901|7476549|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
6554141|NCT01746901|7476550|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
6554142|NCT01746901|7476551|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
6554143|NCT01746901|7476552|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
6554144|NCT01746901|7476553|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
6464681|NCT01223963|7381612|FG000|COMPLETED|Overall Study||93
6464682|NCT01223963|7381612|FG000|NOT COMPLETED|Overall Study||0
6464683|NCT01224015|7381620|FG000|STARTED|Overall Study||361
6464684|NCT01224015|7381621|FG001|STARTED|Overall Study||227
6464685|NCT01224015|7381622|FG002|STARTED|Overall Study||96
6464686|NCT01224015|7381620|FG000|COMPLETED|Overall Study||347
6464687|NCT01224015|7381621|FG001|COMPLETED|Overall Study||211
6464688|NCT01224015|7381622|FG002|COMPLETED|Overall Study||83
6464689|NCT01224015|7381620|FG000|NOT COMPLETED|Overall Study||14
6464690|NCT01224015|7381621|FG001|NOT COMPLETED|Overall Study||16
6464691|NCT01224015|7381622|FG002|NOT COMPLETED|Overall Study||13
6464692|NCT01224145|7381630|FG000|STARTED|Overall Study||10
6464693|NCT01224145|7381630|FG000|COMPLETED|Overall Study||10
6464694|NCT01224145|7381630|FG000|NOT COMPLETED|Overall Study||0
6464695|NCT01224158|7381637|FG000|STARTED|Overall Study||76
6464696|NCT01224158|7381638|FG001|STARTED|Overall Study||77
6464697|NCT01224158|7381637|FG000|COMPLETED|Overall Study||75
6464698|NCT01224158|7381638|FG001|COMPLETED|Overall Study||77
6464699|NCT01224158|7381637|FG000|NOT COMPLETED|Overall Study||1
6464700|NCT01224158|7381638|FG001|NOT COMPLETED|Overall Study||0
6464701|NCT01224171|7381646|FG000|STARTED|Overall Study||207
6464702|NCT01224171|7381647|FG001|STARTED|Overall Study||209
6464703|NCT01224171|7381646|FG000|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
6464704|NCT01224171|7381647|FG001|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
6464705|NCT01224171|7381646|FG000|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
6464706|NCT01224171|7381647|FG001|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
6464707|NCT01224171|7381646|FG000|NOT COMPLETED|Overall Study||15
6464708|NCT01224171|7381647|FG001|NOT COMPLETED|Overall Study||13
6464709|NCT01224210|7381653|FG000|STARTED|Overall Study||30
6464710|NCT01224210|7381653|FG000|COMPLETED|Overall Study||23
6464711|NCT01224210|7381653|FG000|NOT COMPLETED|Overall Study||7
6464712|NCT01224236|7381660|FG000|STARTED|Overall Study||76
6464713|NCT01224236|7381661|FG001|STARTED|Overall Study||74
6464714|NCT01224236|7381660|FG000|COMPLETED|Overall Study||75
6464715|NCT01224236|7381661|FG001|COMPLETED|Overall Study||73
6464716|NCT01224236|7381660|FG000|NOT COMPLETED|Overall Study||1
6464717|NCT01224236|7381661|FG001|NOT COMPLETED|Overall Study||1
6464718|NCT01224431|7381669|FG000|STARTED|Overall Study||30
6464719|NCT01224431|7381670|FG001|STARTED|Overall Study||30
6464720|NCT01224431|7381669|FG000|COMPLETED|Overall Study||30
6464721|NCT01224431|7381670|FG001|COMPLETED|Overall Study||25
6464722|NCT01224431|7381669|FG000|NOT COMPLETED|Overall Study||0
6464723|NCT01224431|7381670|FG001|NOT COMPLETED|Overall Study||5
6464724|NCT01224444|7381678|FG000|STARTED|Overall Study||269
6464725|NCT01224444|7381678|FG000|COMPLETED|Overall Study||269
6464726|NCT01224444|7381678|FG000|NOT COMPLETED|Overall Study||0
6464727|NCT01224626|7381682|FG000|STARTED|Overall Study||42
6464728|NCT01224626|7381682|FG000|COMPLETED|Overall Study||41
6464729|NCT01224626|7381682|FG000|NOT COMPLETED|Overall Study||1
6464730|NCT01224639|7381694|FG000|STARTED|Overall Study||19
6464731|NCT01224639|7381695|FG001|STARTED|Overall Study||5
6464732|NCT01224639|7381696|FG002|STARTED|Overall Study||21
6464733|NCT01224639|7381697|FG003|STARTED|Overall Study||3
6464734|NCT01224639|7381698|FG004|STARTED|Overall Study||21
6464735|NCT01224639|7381699|FG005|STARTED|Overall Study||4
6464736|NCT01224639|7381700|FG006|STARTED|Overall Study||18
6464737|NCT01224639|7381701|FG007|STARTED|Overall Study||5
6464738|NCT01224639|7381694|FG000|COMPLETED|Overall Study||19
6464739|NCT01224639|7381695|FG001|COMPLETED|Overall Study||5
6464740|NCT01224639|7381696|FG002|COMPLETED|Overall Study||21
6464741|NCT01224639|7381697|FG003|COMPLETED|Overall Study||3
6464742|NCT01224639|7381698|FG004|COMPLETED|Overall Study||19
6464743|NCT01224639|7381699|FG005|COMPLETED|Overall Study||4
6464744|NCT01224639|7381700|FG006|COMPLETED|Overall Study||17
6464745|NCT01224639|7381701|FG007|COMPLETED|Overall Study||3
6464746|NCT01224639|7381694|FG000|NOT COMPLETED|Overall Study||0
6464747|NCT01224639|7381695|FG001|NOT COMPLETED|Overall Study||0
6464748|NCT01224639|7381696|FG002|NOT COMPLETED|Overall Study||0
6464749|NCT01224639|7381697|FG003|NOT COMPLETED|Overall Study||0
6464750|NCT01224639|7381698|FG004|NOT COMPLETED|Overall Study||2
6464751|NCT01224639|7381699|FG005|NOT COMPLETED|Overall Study||0
6464752|NCT01224639|7381700|FG006|NOT COMPLETED|Overall Study||1
6464753|NCT01224639|7381701|FG007|NOT COMPLETED|Overall Study||2
6464754|NCT01224678|7381721|FG000|STARTED|Overall Study||150
6464755|NCT01224678|7381722|FG001|STARTED|Overall Study||150
6464756|NCT01224678|7381721|FG000|COMPLETED|Overall Study||150
6464757|NCT01224678|7381722|FG001|COMPLETED|Overall Study||150
6464758|NCT01224678|7381721|FG000|NOT COMPLETED|Overall Study||0
6464759|NCT01224678|7381722|FG001|NOT COMPLETED|Overall Study||0
6464760|NCT01224782|7381728|FG000|STARTED|Overall Study||994
6464761|NCT01224782|7381728|FG000|COMPLETED|Overall Study||730
6464762|NCT01224782|7381728|FG000|NOT COMPLETED|Overall Study||264
6464763|NCT01224821|7381732|FG000|STARTED|Dosimetric and Therapeutic Treatment||47
6464764|NCT01224821|7381732|FG000|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
6464765|NCT01224821|7381732|FG000|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
6464766|NCT01224821|7381732|FG000|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
6464767|NCT01224821|7381732|FG000|COMPLETED|Long-Term Follow-Up||0
6464768|NCT01224821|7381732|FG000|NOT COMPLETED|Long-Term Follow-Up||11
6464769|NCT01224925|7381738|FG000|STARTED|Overall Study||37
6464770|NCT01224925|7381739|FG001|STARTED|Overall Study||33
6464771|NCT01224925|7381738|FG000|COMPLETED|Overall Study||34
6464772|NCT01224925|7381739|FG001|COMPLETED|Overall Study||31
6464773|NCT01224925|7381738|FG000|NOT COMPLETED|Overall Study||3
6464774|NCT01224925|7381739|FG001|NOT COMPLETED|Overall Study||2
6464775|NCT01225029|7381749|FG000|STARTED|Overall Study||32
6464776|NCT01225029|7381750|FG001|STARTED|Overall Study||32
6464777|NCT01225029|7381749|FG000|COMPLETED|Overall Study||32
6464778|NCT01225029|7381750|FG001|COMPLETED|Overall Study||32
6464779|NCT01225029|7381749|FG000|NOT COMPLETED|Overall Study||0
6464780|NCT01225029|7381750|FG001|NOT COMPLETED|Overall Study||0
6464781|NCT01225055|7381759|FG000|STARTED|Overall Study||20
6464782|NCT01225055|7381760|FG001|STARTED|Overall Study||20
6464783|NCT01225055|7381761|FG002|STARTED|Overall Study||21
6464784|NCT01225055|7381759|FG000|COMPLETED|Overall Study||20
6464785|NCT01225055|7381760|FG001|COMPLETED|Overall Study||18
6464786|NCT01225055|7381761|FG002|COMPLETED|Overall Study||18
6464787|NCT01225055|7381759|FG000|NOT COMPLETED|Overall Study||0
6464788|NCT01225055|7381760|FG001|NOT COMPLETED|Overall Study||2
6464789|NCT01225055|7381761|FG002|NOT COMPLETED|Overall Study||3
6464790|NCT01225068|7381771|FG000|STARTED|Overall Study||20
6464791|NCT01225068|7381772|FG001|STARTED|Overall Study||20
6464792|NCT01225068|7381771|FG000|COMPLETED|Overall Study||16
6464793|NCT01225068|7381772|FG001|COMPLETED|Overall Study||19
6464794|NCT01225068|7381771|FG000|NOT COMPLETED|Overall Study||4
6464795|NCT01225068|7381772|FG001|NOT COMPLETED|Overall Study||1
6464796|NCT01225146|7381780|FG000|STARTED|Overall Study||6
6464797|NCT01225146|7381781|FG001|STARTED|Overall Study||2
6464798|NCT01225146|7381780|FG000|COMPLETED|Overall Study||6
6464799|NCT01225146|7381781|FG001|COMPLETED|Overall Study||0
6464800|NCT01225146|7381780|FG000|NOT COMPLETED|Overall Study||0
6464801|NCT01225146|7381781|FG001|NOT COMPLETED|Overall Study||2
6464802|NCT01225159|7381791|FG000|STARTED|Overall Study||100
6464803|NCT01225159|7381792|FG001|STARTED|Overall Study||100
6464804|NCT01225159|7381791|FG000|COMPLETED|Overall Study||99
6464805|NCT01225159|7381792|FG001|COMPLETED|Overall Study||100
6464806|NCT01225159|7381791|FG000|NOT COMPLETED|Overall Study||1
6464807|NCT01225159|7381792|FG001|NOT COMPLETED|Overall Study||0
6464808|NCT01225172|7381800|FG000|STARTED|Overall Study||52
6464809|NCT01225172|7381801|FG001|STARTED|Overall Study||7
6464810|NCT01225172|7381800|FG000|COMPLETED|Overall Study||46
6464811|NCT01225172|7381801|FG001|COMPLETED|Overall Study||6
6464812|NCT01225172|7381800|FG000|NOT COMPLETED|Overall Study||6
6464813|NCT01225172|7381801|FG001|NOT COMPLETED|Overall Study||1
6464814|NCT01225211|7381817|FG000|STARTED|Overall Study||21
6464815|NCT01225211|7381818|FG001|STARTED|Overall Study||20
6464816|NCT01225211|7381819|FG002|STARTED|Overall Study||21
6464817|NCT01225211|7381820|FG003|STARTED|Overall Study||27
6464818|NCT01225211|7381821|FG004|STARTED|Overall Study||23
6464819|NCT01225211|7381822|FG005|STARTED|Overall Study||21
6464820|NCT01225211|7381823|FG006|STARTED|Overall Study||42
6464821|NCT01225211|7381824|FG007|STARTED|Overall Study||11
6464822|NCT01225211|7381825|FG008|STARTED|Overall Study||63
6464823|NCT01225211|7381826|FG009|STARTED|Overall Study||62
6464824|NCT01225211|7381817|FG000|COMPLETED|Overall Study||21
6746672|NCT03374683|7674320|FG001|NOT COMPLETED|Overall Study||45
6464825|NCT01225211|7381818|FG001|COMPLETED|Overall Study||20
6464826|NCT01225211|7381819|FG002|COMPLETED|Overall Study||20
6464827|NCT01225211|7381820|FG003|COMPLETED|Overall Study||27
6464828|NCT01225211|7381821|FG004|COMPLETED|Overall Study||23
6464829|NCT01225211|7381822|FG005|COMPLETED|Overall Study||21
6464830|NCT01225211|7381823|FG006|COMPLETED|Overall Study||41
6464831|NCT01225211|7381824|FG007|COMPLETED|Overall Study||11
6464832|NCT01225211|7381825|FG008|COMPLETED|Overall Study||62
6464833|NCT01225211|7381826|FG009|COMPLETED|Overall Study||57
6464834|NCT01225211|7381817|FG000|NOT COMPLETED|Overall Study||0
6464835|NCT01225211|7381818|FG001|NOT COMPLETED|Overall Study||0
6464836|NCT01225211|7381819|FG002|NOT COMPLETED|Overall Study||1
6464837|NCT01225211|7381820|FG003|NOT COMPLETED|Overall Study||0
6464838|NCT01225211|7381821|FG004|NOT COMPLETED|Overall Study||0
6464839|NCT01225211|7381822|FG005|NOT COMPLETED|Overall Study||0
6464840|NCT01225211|7381823|FG006|NOT COMPLETED|Overall Study||1
6464841|NCT01225211|7381824|FG007|NOT COMPLETED|Overall Study||0
6464842|NCT01225211|7381825|FG008|NOT COMPLETED|Overall Study||1
6654435|NCT02445807|7584264|FG001|COMPLETED|Overall Study||89
6654436|NCT02445807|7584263|FG000|NOT COMPLETED|Overall Study||0
6654437|NCT02445807|7584264|FG001|NOT COMPLETED|Overall Study||0
6654438|NCT02445859|7584272|FG000|STARTED|Overall Study||45
6464843|NCT01225211|7381826|FG009|NOT COMPLETED|Overall Study||5
6464844|NCT01225250|7381885|FG000|STARTED|Overall Study||15
6464845|NCT01225250|7381886|FG001|STARTED|Overall Study||15
6464846|NCT01225250|7381885|FG000|COMPLETED|Overall Study||10
6464847|NCT01225250|7381886|FG001|COMPLETED|Overall Study||10
6464848|NCT01225250|7381885|FG000|NOT COMPLETED|Overall Study||5
6464849|NCT01225250|7381886|FG001|NOT COMPLETED|Overall Study||5
6464850|NCT01225263|7381894|FG000|STARTED|Weeks 1 to 12||28
6464851|NCT01225263|7381895|FG001|STARTED|Weeks 1 to 12||29
6464852|NCT01225263|7381894|FG000|COMPLETED|Weeks 1 to 12||28
6464853|NCT01225263|7381895|FG001|COMPLETED|Weeks 1 to 12||29
6464854|NCT01225263|7381894|FG000|NOT COMPLETED|Weeks 1 to 12||0
6464855|NCT01225263|7381895|FG001|NOT COMPLETED|Weeks 1 to 12||0
6464856|NCT01225263|7381894|FG000|STARTED|Weeks 13 to 24||28
6464857|NCT01225263|7381895|FG001|STARTED|Weeks 13 to 24||29
6464858|NCT01225263|7381894|FG000|COMPLETED|Weeks 13 to 24||24
6464859|NCT01225263|7381895|FG001|COMPLETED|Weeks 13 to 24||28
6464860|NCT01225263|7381894|FG000|NOT COMPLETED|Weeks 13 to 24||4
6464861|NCT01225263|7381895|FG001|NOT COMPLETED|Weeks 13 to 24||1
6464862|NCT01225289|7381904|FG000|STARTED|Overall Study||18
6464863|NCT01225289|7381905|FG001|STARTED|Overall Study||18
6464864|NCT01225289|7381904|FG000|COMPLETED|Overall Study||18
6464865|NCT01225289|7381905|FG001|COMPLETED|Overall Study||17
6464866|NCT01225289|7381904|FG000|NOT COMPLETED|Overall Study||0
6464867|NCT01225289|7381905|FG001|NOT COMPLETED|Overall Study||1
6464868|NCT01225354|7381911|FG000|STARTED|Overall Study||20
6464869|NCT01225354|7381911|FG000|COMPLETED|Overall Study||19
6464870|NCT01225354|7381911|FG000|NOT COMPLETED|Overall Study||1
6464871|NCT01225549|7381916|FG000|STARTED|Period 1 - First Treatment Period||1
6464872|NCT01225549|7381917|FG001|STARTED|Period 1 - First Treatment Period||4
6464873|NCT01225549|7381918|FG002|STARTED|Period 1 - First Treatment Period||3
6464874|NCT01225549|7381919|FG003|STARTED|Period 1 - First Treatment Period||1
6464875|NCT01225549|7381920|FG004|STARTED|Period 1 - First Treatment Period||1
6464876|NCT01225549|7381921|FG005|STARTED|Period 1 - First Treatment Period||1
6464877|NCT01225549|7381922|FG006|STARTED|Period 1 - First Treatment Period||3
6464878|NCT01225549|7381923|FG007|STARTED|Period 1 - First Treatment Period||1
6464879|NCT01225549|7381924|FG008|STARTED|Period 1 - First Treatment Period||4
6464880|NCT01225549|7381925|FG009|STARTED|Period 1 - First Treatment Period||1
6464881|NCT01225549|7381916|FG000|COMPLETED|Period 1 - First Treatment Period||1
6464882|NCT01225549|7381917|FG001|COMPLETED|Period 1 - First Treatment Period||4
6464883|NCT01225549|7381918|FG002|COMPLETED|Period 1 - First Treatment Period||3
6464884|NCT01225549|7381919|FG003|COMPLETED|Period 1 - First Treatment Period||1
6464885|NCT01225549|7381920|FG004|COMPLETED|Period 1 - First Treatment Period||1
6464886|NCT01225549|7381921|FG005|COMPLETED|Period 1 - First Treatment Period||1
6464887|NCT01225549|7381922|FG006|COMPLETED|Period 1 - First Treatment Period||3
6464888|NCT01225549|7381923|FG007|COMPLETED|Period 1 - First Treatment Period||1
6464889|NCT01225549|7381924|FG008|COMPLETED|Period 1 - First Treatment Period||4
6464890|NCT01225549|7381925|FG009|COMPLETED|Period 1 - First Treatment Period||1
6464891|NCT01225549|7381916|FG000|NOT COMPLETED|Period 1 - First Treatment Period||0
6464892|NCT01225549|7381917|FG001|NOT COMPLETED|Period 1 - First Treatment Period||0
6464893|NCT01225549|7381918|FG002|NOT COMPLETED|Period 1 - First Treatment Period||0
6464894|NCT01225549|7381919|FG003|NOT COMPLETED|Period 1 - First Treatment Period||0
6464895|NCT01225549|7381920|FG004|NOT COMPLETED|Period 1 - First Treatment Period||0
6464896|NCT01225549|7381921|FG005|NOT COMPLETED|Period 1 - First Treatment Period||0
6464897|NCT01225549|7381922|FG006|NOT COMPLETED|Period 1 - First Treatment Period||0
6464898|NCT01225549|7381923|FG007|NOT COMPLETED|Period 1 - First Treatment Period||0
6464899|NCT01225549|7381924|FG008|NOT COMPLETED|Period 1 - First Treatment Period||0
6464900|NCT01225549|7381925|FG009|NOT COMPLETED|Period 1 - First Treatment Period||0
6464901|NCT01225549|7381916|FG000|STARTED|Period 2 - Washout||1
6464902|NCT01225549|7381917|FG001|STARTED|Period 2 - Washout||4
6464903|NCT01225549|7381918|FG002|STARTED|Period 2 - Washout||3
6464904|NCT01225549|7381919|FG003|STARTED|Period 2 - Washout||1
6464905|NCT01225549|7381920|FG004|STARTED|Period 2 - Washout||1
6464906|NCT01225549|7381921|FG005|STARTED|Period 2 - Washout||1
6464907|NCT01225549|7381922|FG006|STARTED|Period 2 - Washout||3
6464908|NCT01225549|7381923|FG007|STARTED|Period 2 - Washout||1
6464909|NCT01225549|7381924|FG008|STARTED|Period 2 - Washout||4
6464910|NCT01225549|7381925|FG009|STARTED|Period 2 - Washout||1
6464911|NCT01225549|7381916|FG000|COMPLETED|Period 2 - Washout||1
6464912|NCT01225549|7381917|FG001|COMPLETED|Period 2 - Washout||4
6464913|NCT01225549|7381918|FG002|COMPLETED|Period 2 - Washout||3
6464914|NCT01225549|7381919|FG003|COMPLETED|Period 2 - Washout||1
6464915|NCT01225549|7381920|FG004|COMPLETED|Period 2 - Washout||1
6464916|NCT01225549|7381921|FG005|COMPLETED|Period 2 - Washout||1
6464917|NCT01225549|7381922|FG006|COMPLETED|Period 2 - Washout||3
6464918|NCT01225549|7381923|FG007|COMPLETED|Period 2 - Washout||1
6464919|NCT01225549|7381924|FG008|COMPLETED|Period 2 - Washout||4
6464920|NCT01225549|7381925|FG009|COMPLETED|Period 2 - Washout||1
6464921|NCT01225549|7381916|FG000|NOT COMPLETED|Period 2 - Washout||0
6464922|NCT01225549|7381917|FG001|NOT COMPLETED|Period 2 - Washout||0
6464923|NCT01225549|7381918|FG002|NOT COMPLETED|Period 2 - Washout||0
6464924|NCT01225549|7381919|FG003|NOT COMPLETED|Period 2 - Washout||0
6464925|NCT01225549|7381920|FG004|NOT COMPLETED|Period 2 - Washout||0
6464926|NCT01225549|7381921|FG005|NOT COMPLETED|Period 2 - Washout||0
6464927|NCT01225549|7381922|FG006|NOT COMPLETED|Period 2 - Washout||0
6464928|NCT01225549|7381923|FG007|NOT COMPLETED|Period 2 - Washout||0
6464929|NCT01225549|7381924|FG008|NOT COMPLETED|Period 2 - Washout||0
6464930|NCT01225549|7381925|FG009|NOT COMPLETED|Period 2 - Washout||0
6464931|NCT01225549|7381916|FG000|STARTED|Period 3 - Second Treatment Period||1
6464932|NCT01225549|7381917|FG001|STARTED|Period 3 - Second Treatment Period||4
6464933|NCT01225549|7381918|FG002|STARTED|Period 3 - Second Treatment Period||3
6464934|NCT01225549|7381919|FG003|STARTED|Period 3 - Second Treatment Period||1
6464935|NCT01225549|7381920|FG004|STARTED|Period 3 - Second Treatment Period||1
6464936|NCT01225549|7381921|FG005|STARTED|Period 3 - Second Treatment Period||1
6464937|NCT01225549|7381922|FG006|STARTED|Period 3 - Second Treatment Period||3
6464938|NCT01225549|7381923|FG007|STARTED|Period 3 - Second Treatment Period||1
6464939|NCT01225549|7381924|FG008|STARTED|Period 3 - Second Treatment Period||4
6464940|NCT01225549|7381925|FG009|STARTED|Period 3 - Second Treatment Period||1
6464941|NCT01225549|7381916|FG000|COMPLETED|Period 3 - Second Treatment Period||1
6464942|NCT01225549|7381917|FG001|COMPLETED|Period 3 - Second Treatment Period||4
6464943|NCT01225549|7381918|FG002|COMPLETED|Period 3 - Second Treatment Period||3
6464944|NCT01225549|7381919|FG003|COMPLETED|Period 3 - Second Treatment Period||1
6464945|NCT01225549|7381920|FG004|COMPLETED|Period 3 - Second Treatment Period||1
6464946|NCT01225549|7381921|FG005|COMPLETED|Period 3 - Second Treatment Period||1
6464947|NCT01225549|7381922|FG006|COMPLETED|Period 3 - Second Treatment Period||3
6464948|NCT01225549|7381923|FG007|COMPLETED|Period 3 - Second Treatment Period||1
6464949|NCT01225549|7381924|FG008|COMPLETED|Period 3 - Second Treatment Period||4
6464950|NCT01225549|7381925|FG009|COMPLETED|Period 3 - Second Treatment Period||1
6464951|NCT01225549|7381916|FG000|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464952|NCT01225549|7381917|FG001|NOT COMPLETED|Period 3 - Second Treatment Period||0
6554145|NCT01746901|7476545|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6554146|NCT01746901|7476546|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
6554147|NCT01746901|7476547|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||14
6554148|NCT01746901|7476548|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6554149|NCT01746901|7476549|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6464953|NCT01225549|7381918|FG002|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464954|NCT01225549|7381919|FG003|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464955|NCT01225549|7381920|FG004|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464956|NCT01225549|7381921|FG005|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464957|NCT01225549|7381922|FG006|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464958|NCT01225549|7381923|FG007|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464959|NCT01225549|7381924|FG008|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464960|NCT01225549|7381925|FG009|NOT COMPLETED|Period 3 - Second Treatment Period||0
6464961|NCT01225549|7381916|FG000|STARTED|Period 4 - Washout||1
6464962|NCT01225549|7381917|FG001|STARTED|Period 4 - Washout||4
6464963|NCT01225549|7381918|FG002|STARTED|Period 4 - Washout||3
6464964|NCT01225549|7381919|FG003|STARTED|Period 4 - Washout||1
6464965|NCT01225549|7381920|FG004|STARTED|Period 4 - Washout||1
6464966|NCT01225549|7381921|FG005|STARTED|Period 4 - Washout||1
6464967|NCT01225549|7381922|FG006|STARTED|Period 4 - Washout||3
6464968|NCT01225549|7381923|FG007|STARTED|Period 4 - Washout||1
6464969|NCT01225549|7381924|FG008|STARTED|Period 4 - Washout||4
6464970|NCT01225549|7381925|FG009|STARTED|Period 4 - Washout||1
6464971|NCT01225549|7381916|FG000|COMPLETED|Period 4 - Washout||1
6464972|NCT01225549|7381917|FG001|COMPLETED|Period 4 - Washout||3
6464973|NCT01225549|7381918|FG002|COMPLETED|Period 4 - Washout||3
6464974|NCT01225549|7381919|FG003|COMPLETED|Period 4 - Washout||1
6464975|NCT01225549|7381920|FG004|COMPLETED|Period 4 - Washout||1
6464976|NCT01225549|7381921|FG005|COMPLETED|Period 4 - Washout||1
6464977|NCT01225549|7381922|FG006|COMPLETED|Period 4 - Washout||3
6464978|NCT01225549|7381923|FG007|COMPLETED|Period 4 - Washout||1
6464979|NCT01225549|7381924|FG008|COMPLETED|Period 4 - Washout||4
6464980|NCT01225549|7381925|FG009|COMPLETED|Period 4 - Washout||1
6464981|NCT01225549|7381916|FG000|NOT COMPLETED|Period 4 - Washout||0
6464982|NCT01225549|7381917|FG001|NOT COMPLETED|Period 4 - Washout||1
6464983|NCT01225549|7381918|FG002|NOT COMPLETED|Period 4 - Washout||0
6464984|NCT01225549|7381919|FG003|NOT COMPLETED|Period 4 - Washout||0
6464985|NCT01225549|7381920|FG004|NOT COMPLETED|Period 4 - Washout||0
6464986|NCT01225549|7381921|FG005|NOT COMPLETED|Period 4 - Washout||0
6464987|NCT01225549|7381922|FG006|NOT COMPLETED|Period 4 - Washout||0
6464988|NCT01225549|7381923|FG007|NOT COMPLETED|Period 4 - Washout||0
6464989|NCT01225549|7381924|FG008|NOT COMPLETED|Period 4 - Washout||0
6464990|NCT01225549|7381925|FG009|NOT COMPLETED|Period 4 - Washout||0
6464991|NCT01225549|7381916|FG000|STARTED|Period 5 - Third Treatment Period||1
6464992|NCT01225549|7381917|FG001|STARTED|Period 5 - Third Treatment Period||3
6464993|NCT01225549|7381918|FG002|STARTED|Period 5 - Third Treatment Period||3
6464994|NCT01225549|7381919|FG003|STARTED|Period 5 - Third Treatment Period||1
6464995|NCT01225549|7381920|FG004|STARTED|Period 5 - Third Treatment Period||1
6464996|NCT01225549|7381921|FG005|STARTED|Period 5 - Third Treatment Period||1
6464997|NCT01225549|7381922|FG006|STARTED|Period 5 - Third Treatment Period||3
6464998|NCT01225549|7381923|FG007|STARTED|Period 5 - Third Treatment Period||1
6464999|NCT01225549|7381924|FG008|STARTED|Period 5 - Third Treatment Period||4
6465000|NCT01225549|7381925|FG009|STARTED|Period 5 - Third Treatment Period||1
6465001|NCT01225549|7381916|FG000|COMPLETED|Period 5 - Third Treatment Period||1
6465002|NCT01225549|7381917|FG001|COMPLETED|Period 5 - Third Treatment Period||3
6465003|NCT01225549|7381918|FG002|COMPLETED|Period 5 - Third Treatment Period||3
6465004|NCT01225549|7381919|FG003|COMPLETED|Period 5 - Third Treatment Period||1
6465005|NCT01225549|7381920|FG004|COMPLETED|Period 5 - Third Treatment Period||1
6465006|NCT01225549|7381921|FG005|COMPLETED|Period 5 - Third Treatment Period||1
6465007|NCT01225549|7381922|FG006|COMPLETED|Period 5 - Third Treatment Period||3
6465008|NCT01225549|7381923|FG007|COMPLETED|Period 5 - Third Treatment Period||1
6465009|NCT01225549|7381924|FG008|COMPLETED|Period 5 - Third Treatment Period||4
6465010|NCT01225549|7381925|FG009|COMPLETED|Period 5 - Third Treatment Period||1
6465011|NCT01225549|7381916|FG000|NOT COMPLETED|Period 5 - Third Treatment Period||0
6554150|NCT01746901|7476550|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6465012|NCT01225549|7381917|FG001|NOT COMPLETED|Period 5 - Third Treatment Period||0
6465013|NCT01225549|7381918|FG002|NOT COMPLETED|Period 5 - Third Treatment Period||0
6465014|NCT01225549|7381919|FG003|NOT COMPLETED|Period 5 - Third Treatment Period||0
6465015|NCT01225549|7381920|FG004|NOT COMPLETED|Period 5 - Third Treatment Period||0
6465016|NCT01225549|7381921|FG005|NOT COMPLETED|Period 5 - Third Treatment Period||0
6465017|NCT01225549|7381922|FG006|NOT COMPLETED|Period 5 - Third Treatment Period||0
6554151|NCT01746901|7476551|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6554152|NCT01746901|7476552|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6554153|NCT01746901|7476553|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6554154|NCT01746901|7476545|FG000|STARTED|Treatment Phase: First Intervention||0
6554155|NCT01746901|7476546|FG001|STARTED|Treatment Phase: First Intervention||0
6465018|NCT01225549|7381923|FG007|NOT COMPLETED|Period 5 - Third Treatment Period||0
6465019|NCT01225549|7381924|FG008|NOT COMPLETED|Period 5 - Third Treatment Period||0
6465020|NCT01225549|7381925|FG009|NOT COMPLETED|Period 5 - Third Treatment Period||0
6465021|NCT01225549|7381916|FG000|STARTED|Period 6 - Washout||1
6465022|NCT01225549|7381917|FG001|STARTED|Period 6 - Washout||3
6465023|NCT01225549|7381918|FG002|STARTED|Period 6 - Washout||3
6465024|NCT01225549|7381919|FG003|STARTED|Period 6 - Washout||1
6465025|NCT01225549|7381920|FG004|STARTED|Period 6 - Washout||1
6465026|NCT01225549|7381921|FG005|STARTED|Period 6 - Washout||1
6465027|NCT01225549|7381922|FG006|STARTED|Period 6 - Washout||3
6465028|NCT01225549|7381923|FG007|STARTED|Period 6 - Washout||1
6465029|NCT01225549|7381924|FG008|STARTED|Period 6 - Washout||4
6465030|NCT01225549|7381925|FG009|STARTED|Period 6 - Washout||1
6465031|NCT01225549|7381916|FG000|COMPLETED|Period 6 - Washout||1
6465032|NCT01225549|7381917|FG001|COMPLETED|Period 6 - Washout||3
6465033|NCT01225549|7381918|FG002|COMPLETED|Period 6 - Washout||3
6465034|NCT01225549|7381919|FG003|COMPLETED|Period 6 - Washout||0
6465035|NCT01225549|7381920|FG004|COMPLETED|Period 6 - Washout||1
6465036|NCT01225549|7381921|FG005|COMPLETED|Period 6 - Washout||1
6465037|NCT01225549|7381922|FG006|COMPLETED|Period 6 - Washout||3
6465038|NCT01225549|7381923|FG007|COMPLETED|Period 6 - Washout||1
6465039|NCT01225549|7381924|FG008|COMPLETED|Period 6 - Washout||4
6465040|NCT01225549|7381925|FG009|COMPLETED|Period 6 - Washout||1
6465041|NCT01225549|7381916|FG000|NOT COMPLETED|Period 6 - Washout||0
6465042|NCT01225549|7381917|FG001|NOT COMPLETED|Period 6 - Washout||0
6465043|NCT01225549|7381918|FG002|NOT COMPLETED|Period 6 - Washout||0
6465044|NCT01225549|7381919|FG003|NOT COMPLETED|Period 6 - Washout||1
6465045|NCT01225549|7381920|FG004|NOT COMPLETED|Period 6 - Washout||0
6465046|NCT01225549|7381921|FG005|NOT COMPLETED|Period 6 - Washout||0
6465047|NCT01225549|7381922|FG006|NOT COMPLETED|Period 6 - Washout||0
6465048|NCT01225549|7381923|FG007|NOT COMPLETED|Period 6 - Washout||0
6465049|NCT01225549|7381924|FG008|NOT COMPLETED|Period 6 - Washout||0
6465050|NCT01225549|7381925|FG009|NOT COMPLETED|Period 6 - Washout||0
6465051|NCT01225549|7381916|FG000|STARTED|Period 7 - Fourth Treatment Period||1
6465052|NCT01225549|7381917|FG001|STARTED|Period 7 - Fourth Treatment Period||3
6465053|NCT01225549|7381918|FG002|STARTED|Period 7 - Fourth Treatment Period||3
6465054|NCT01225549|7381919|FG003|STARTED|Period 7 - Fourth Treatment Period||0
6465055|NCT01225549|7381920|FG004|STARTED|Period 7 - Fourth Treatment Period||1
6465056|NCT01225549|7381921|FG005|STARTED|Period 7 - Fourth Treatment Period||1
6465057|NCT01225549|7381922|FG006|STARTED|Period 7 - Fourth Treatment Period||3
6465058|NCT01225549|7381923|FG007|STARTED|Period 7 - Fourth Treatment Period||1
6465059|NCT01225549|7381924|FG008|STARTED|Period 7 - Fourth Treatment Period||4
6465060|NCT01225549|7381925|FG009|STARTED|Period 7 - Fourth Treatment Period||1
6465061|NCT01225549|7381916|FG000|COMPLETED|Period 7 - Fourth Treatment Period||1
6465062|NCT01225549|7381917|FG001|COMPLETED|Period 7 - Fourth Treatment Period||3
6465063|NCT01225549|7381918|FG002|COMPLETED|Period 7 - Fourth Treatment Period||3
6465064|NCT01225549|7381919|FG003|COMPLETED|Period 7 - Fourth Treatment Period||0
6465065|NCT01225549|7381920|FG004|COMPLETED|Period 7 - Fourth Treatment Period||1
6465066|NCT01225549|7381921|FG005|COMPLETED|Period 7 - Fourth Treatment Period||1
6465067|NCT01225549|7381922|FG006|COMPLETED|Period 7 - Fourth Treatment Period||3
6465068|NCT01225549|7381923|FG007|COMPLETED|Period 7 - Fourth Treatment Period||1
6465069|NCT01225549|7381924|FG008|COMPLETED|Period 7 - Fourth Treatment Period||4
6465070|NCT01225549|7381925|FG009|COMPLETED|Period 7 - Fourth Treatment Period||1
6465071|NCT01225549|7381916|FG000|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465072|NCT01225549|7381917|FG001|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465073|NCT01225549|7381918|FG002|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465074|NCT01225549|7381919|FG003|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465075|NCT01225549|7381920|FG004|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465076|NCT01225549|7381921|FG005|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465077|NCT01225549|7381922|FG006|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465078|NCT01225549|7381923|FG007|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465079|NCT01225549|7381924|FG008|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465080|NCT01225549|7381925|FG009|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
6465081|NCT01225562|7381938|FG000|STARTED|Overall Study||7050
6465082|NCT01225562|7381939|FG001|STARTED|Overall Study||7045
6465083|NCT01225562|7381940|FG002|STARTED|Overall Study||7067
6465084|NCT01225562|7381938|FG000|COMPLETED|Overall Study||6995
6465085|NCT01225562|7381939|FG001|COMPLETED|Overall Study||6989
6465086|NCT01225562|7381940|FG002|COMPLETED|Overall Study||7014
6465087|NCT01225562|7381938|FG000|NOT COMPLETED|Overall Study||55
6465088|NCT01225562|7381939|FG001|NOT COMPLETED|Overall Study||56
6465089|NCT01225562|7381940|FG002|NOT COMPLETED|Overall Study||53
6500876|NCT01425853|7419384|FG000|Per Protocol (PP)|Overall Study||264
6500877|NCT01425853|7419385|FG001|Per Protocol (PP)|Overall Study||258
6500878|NCT01425853|7419384|FG000|COMPLETED|Overall Study||240
6500879|NCT01425853|7419385|FG001|COMPLETED|Overall Study||225
6500880|NCT01425853|7419384|FG000|NOT COMPLETED|Overall Study||64
6500881|NCT01425853|7419385|FG001|NOT COMPLETED|Overall Study||77
6500882|NCT01425879|7419392|FG000|STARTED|Overall Study||8
6500883|NCT01425879|7419392|FG000|COMPLETED|Overall Study||8
6500884|NCT01425879|7419392|FG000|NOT COMPLETED|Overall Study||0
6500885|NCT01426009|7419396|FG000|STARTED|Period 1-First Intervention (7 Days)||139
6500886|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
6500887|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||24
6500888|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||22
6500889|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 1-First Intervention (7 Days)||23
6500890|NCT01426009|7419396|FG000|Ipratropium Bromide|Period 1-First Intervention (7 Days)||23
6500891|NCT01426009|7419396|FG000|Placebo|Period 1-First Intervention (7 Days)||24
6500892|NCT01426009|7419396|FG000|COMPLETED|Period 1-First Intervention (7 Days)||137
6500893|NCT01426009|7419396|FG000|NOT COMPLETED|Period 1-First Intervention (7 Days)||2
6500894|NCT01426009|7419396|FG000|STARTED|Washout 1||137
6500895|NCT01426009|7419396|FG000|COMPLETED|Washout 1||135
6500896|NCT01426009|7419396|FG000|NOT COMPLETED|Washout 1||2
6500897|NCT01426009|7419396|FG000|STARTED|Period 2-Second Intervention (7 Days)||135
6500898|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||22
6500899|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
6500900|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||24
6500901|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 2-Second Intervention (7 Days)||23
6500902|NCT01426009|7419396|FG000|Ipratropium Bromide|Period 2-Second Intervention (7 Days)||21
6500903|NCT01426009|7419396|FG000|Placebo|Period 2-Second Intervention (7 Days)||21
6500904|NCT01426009|7419396|FG000|COMPLETED|Period 2-Second Intervention (7 Days)||130
6500905|NCT01426009|7419396|FG000|NOT COMPLETED|Period 2-Second Intervention (7 Days)||5
6500906|NCT01426009|7419396|FG000|STARTED|Washout 2||130
6500907|NCT01426009|7419396|FG000|COMPLETED|Washout 2||129
6500908|NCT01426009|7419396|FG000|NOT COMPLETED|Washout 2||1
6500909|NCT01426009|7419396|FG000|STARTED|Period 3-Third Intervention (7 Days)||129
6500910|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||19
6500911|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||23
6500912|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||22
6500913|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 3-Third Intervention (7 Days)||20
6500914|NCT01426009|7419396|FG000|Ipratropium Bromide|Period 3-Third Intervention (7 Days)||23
6500915|NCT01426009|7419396|FG000|Placebo|Period 3-Third Intervention (7 Days)||22
6500916|NCT01426009|7419396|FG000|COMPLETED|Period 3-Third Intervention (7 Days)||129
6500917|NCT01426009|7419396|FG000|NOT COMPLETED|Period 3-Third Intervention (7 Days)||0
6500918|NCT01426009|7419396|FG000|STARTED|Washout 3||129
6500919|NCT01426009|7419396|FG000|COMPLETED|Washout 3||128
6500920|NCT01426009|7419396|FG000|NOT COMPLETED|Washout 3||1
6500921|NCT01426009|7419396|FG000|STARTED|Period 4-Fourth Intervention (7 Days)||128
6500922|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||10
6500923|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||7
6500924|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||8
6500925|NCT01426009|7419396|FG000|EP-101 Via Nebulizer|Period 4-Fourth Intervention (7 Days)||9
6500926|NCT01426009|7419396|FG000|Ipratropium Bromide|Period 4-Fourth Intervention (7 Days)||8
6500927|NCT01426009|7419396|FG000|Tiotropium Bromide|Period 4-Fourth Intervention (7 Days)||76
6500928|NCT01426009|7419396|FG000|Placebo|Period 4-Fourth Intervention (7 Days)||10
6500929|NCT01426009|7419396|FG000|COMPLETED|Period 4-Fourth Intervention (7 Days)||127
6500930|NCT01426009|7419396|FG000|NOT COMPLETED|Period 4-Fourth Intervention (7 Days)||1
6500931|NCT01426009|7419396|FG000|STARTED|Washout 4||127
6500932|NCT01426009|7419396|FG000|COMPLETED|Washout 4||126
6500933|NCT01426009|7419396|FG000|NOT COMPLETED|Washout 4||1
6500934|NCT01426191|7419412|FG000|STARTED|Overall Study||2032
6500935|NCT01426191|7419412|FG000|COMPLETED|Overall Study||2032
6500936|NCT01426191|7419412|FG000|NOT COMPLETED|Overall Study||0
6500937|NCT01426217|7419418|FG000|STARTED|Overall Study||314
6500938|NCT01426217|7419419|FG001|STARTED|Overall Study||280
6500939|NCT01426217|7419418|FG000|COMPLETED|Overall Study||306
6500940|NCT01426217|7419419|FG001|COMPLETED|Overall Study||266
6500941|NCT01426217|7419418|FG000|NOT COMPLETED|Overall Study||8
6500942|NCT01426217|7419419|FG001|NOT COMPLETED|Overall Study||14
6500943|NCT01426230|7419427|FG000|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
6500944|NCT01426230|7419428|FG001|STARTED|Overall Study||111
6500945|NCT01426230|7419427|FG000|COMPLETED|Overall Study||55
6500946|NCT01426230|7419428|FG001|COMPLETED|Overall Study||84
6500947|NCT01426230|7419427|FG000|NOT COMPLETED|Overall Study||31
6500948|NCT01426230|7419428|FG001|NOT COMPLETED|Overall Study||27
6500949|NCT01426269|7419433|FG000|STARTED|Period 1: 12 Weeks||235
6500950|NCT01426269|7419434|FG001|STARTED|Period 1: 12 Weeks||0
6500951|NCT01426269|7419435|FG002|STARTED|Period 1: 12 Weeks||0
6500952|NCT01426269|7419433|FG000|COMPLETED|Period 1: 12 Weeks||180
6500953|NCT01426269|7419434|FG001|COMPLETED|Period 1: 12 Weeks||0
6465090|NCT01225731|7381953|FG000|STARTED|Part 1||42
6465091|NCT01225731|7381954|FG001|STARTED|Part 1||92
6465092|NCT01225731|7381955|FG002|STARTED|Part 1||89
6465093|NCT01225731|7381956|FG003|STARTED|Part 1||86
6465094|NCT01225731|7381957|FG004|STARTED|Part 1||46
6465095|NCT01225731|7381958|FG005|STARTED|Part 1||0
6465096|NCT01225731|7381959|FG006|STARTED|Part 1||0
6465097|NCT01225731|7381960|FG007|STARTED|Part 1||0
6465098|NCT01225731|7381961|FG008|STARTED|Part 1||0
6465099|NCT01225731|7381962|FG009|STARTED|Part 1||0
6465100|NCT01225731|7381963|FG010|STARTED|Part 1||0
6465101|NCT01225731|7381964|FG011|STARTED|Part 1||0
6465102|NCT01225731|7381965|FG012|STARTED|Part 1||0
6465103|NCT01225731|7381953|FG000|COMPLETED|Part 1||40
6465104|NCT01225731|7381954|FG001|COMPLETED|Part 1||87
6465105|NCT01225731|7381955|FG002|COMPLETED|Part 1||88
6465106|NCT01225731|7381956|FG003|COMPLETED|Part 1||84
6465107|NCT01225731|7381957|FG004|COMPLETED|Part 1||40
6465108|NCT01225731|7381958|FG005|COMPLETED|Part 1||0
6465109|NCT01225731|7381959|FG006|COMPLETED|Part 1||0
6465110|NCT01225731|7381960|FG007|COMPLETED|Part 1||0
6465111|NCT01225731|7381961|FG008|COMPLETED|Part 1||0
6465112|NCT01225731|7381962|FG009|COMPLETED|Part 1||0
6465113|NCT01225731|7381963|FG010|COMPLETED|Part 1||0
6465114|NCT01225731|7381964|FG011|COMPLETED|Part 1||0
6465115|NCT01225731|7381965|FG012|COMPLETED|Part 1||0
6465116|NCT01225731|7381953|FG000|NOT COMPLETED|Part 1||2
6465117|NCT01225731|7381954|FG001|NOT COMPLETED|Part 1||5
6465118|NCT01225731|7381955|FG002|NOT COMPLETED|Part 1||1
6465119|NCT01225731|7381956|FG003|NOT COMPLETED|Part 1||2
6465120|NCT01225731|7381957|FG004|NOT COMPLETED|Part 1||6
6465121|NCT01225731|7381958|FG005|NOT COMPLETED|Part 1||0
6465122|NCT01225731|7381959|FG006|NOT COMPLETED|Part 1||0
6465123|NCT01225731|7381960|FG007|NOT COMPLETED|Part 1||0
6465124|NCT01225731|7381961|FG008|NOT COMPLETED|Part 1||0
6465125|NCT01225731|7381962|FG009|NOT COMPLETED|Part 1||0
6465126|NCT01225731|7381963|FG010|NOT COMPLETED|Part 1||0
6465127|NCT01225731|7381964|FG011|NOT COMPLETED|Part 1||0
6465128|NCT01225731|7381965|FG012|NOT COMPLETED|Part 1||0
6465129|NCT01225731|7381953|FG000|STARTED|Part 2|Participants could progress into Part 2|0
6465130|NCT01225731|7381954|FG001|STARTED|Part 2|Participants could progress into Part 2|0
6465131|NCT01225731|7381955|FG002|STARTED|Part 2|Participants could progress into Part 2|0
6465132|NCT01225731|7381956|FG003|STARTED|Part 2|Participants could progress into Part 2|0
6465133|NCT01225731|7381957|FG004|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
6465134|NCT01225731|7381958|FG005|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
6465135|NCT01225731|7381959|FG006|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
6465136|NCT01225731|7381960|FG007|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
6465137|NCT01225731|7381961|FG008|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
6465138|NCT01225731|7381962|FG009|STARTED|Part 2||0
6465139|NCT01225731|7381963|FG010|STARTED|Part 2||0
6465140|NCT01225731|7381964|FG011|STARTED|Part 2||0
6465141|NCT01225731|7381965|FG012|STARTED|Part 2||0
6465142|NCT01225731|7381953|FG000|COMPLETED|Part 2||0
6465143|NCT01225731|7381954|FG001|COMPLETED|Part 2||0
6465144|NCT01225731|7381955|FG002|COMPLETED|Part 2||0
6465145|NCT01225731|7381956|FG003|COMPLETED|Part 2||0
6465146|NCT01225731|7381957|FG004|COMPLETED|Part 2||0
6465147|NCT01225731|7381958|FG005|COMPLETED|Part 2||10
6465148|NCT01225731|7381959|FG006|COMPLETED|Part 2||86
6465149|NCT01225731|7381960|FG007|COMPLETED|Part 2||128
6465150|NCT01225731|7381961|FG008|COMPLETED|Part 2||68
6465151|NCT01225731|7381962|FG009|COMPLETED|Part 2||0
6465152|NCT01225731|7381963|FG010|COMPLETED|Part 2||0
6465153|NCT01225731|7381964|FG011|COMPLETED|Part 2||0
6465154|NCT01225731|7381965|FG012|COMPLETED|Part 2||0
6465155|NCT01225731|7381953|FG000|NOT COMPLETED|Part 2||0
6465156|NCT01225731|7381954|FG001|NOT COMPLETED|Part 2||0
6465157|NCT01225731|7381955|FG002|NOT COMPLETED|Part 2||0
6465158|NCT01225731|7381956|FG003|NOT COMPLETED|Part 2||0
6465159|NCT01225731|7381957|FG004|NOT COMPLETED|Part 2||0
6465160|NCT01225731|7381958|FG005|NOT COMPLETED|Part 2||3
6465161|NCT01225731|7381959|FG006|NOT COMPLETED|Part 2||8
6465162|NCT01225731|7381960|FG007|NOT COMPLETED|Part 2||25
6465163|NCT01225731|7381961|FG008|NOT COMPLETED|Part 2||11
6465164|NCT01225731|7381962|FG009|NOT COMPLETED|Part 2||0
6465165|NCT01225731|7381963|FG010|NOT COMPLETED|Part 2||0
6465166|NCT01225731|7381964|FG011|NOT COMPLETED|Part 2||0
6465167|NCT01225731|7381965|FG012|NOT COMPLETED|Part 2||0
6465168|NCT01225731|7381953|FG000|STARTED|Part 3||0
6465169|NCT01225731|7381954|FG001|STARTED|Part 3||0
6465170|NCT01225731|7381955|FG002|STARTED|Part 3||0
6465171|NCT01225731|7381956|FG003|STARTED|Part 3||0
6465172|NCT01225731|7381957|FG004|STARTED|Part 3||0
6465173|NCT01225731|7381958|FG005|STARTED|Part 3|Participants could enter the follow-up period|0
6465174|NCT01225731|7381959|FG006|STARTED|Part 3|Participants could enter the follow-up period|0
6465175|NCT01225731|7381960|FG007|STARTED|Part 3|Participants could enter the follow-up period|0
6465176|NCT01225731|7381961|FG008|STARTED|Part 3|Participants could enter the follow-up period|0
6465177|NCT01225731|7381962|FG009|STARTED|Part 3|Not all participants entered follow-up|10
6465178|NCT01225731|7381963|FG010|STARTED|Part 3|Not all participants entered follow-up|86
6465179|NCT01225731|7381964|FG011|STARTED|Part 3|Not all participants entered follow-up|126
6465180|NCT01225731|7381965|FG012|STARTED|Part 3|Not all participants entered follow-up|67
6465181|NCT01225731|7381953|FG000|COMPLETED|Part 3||0
6465182|NCT01225731|7381954|FG001|COMPLETED|Part 3||0
6465183|NCT01225731|7381955|FG002|COMPLETED|Part 3||0
6465184|NCT01225731|7381956|FG003|COMPLETED|Part 3||0
6465185|NCT01225731|7381957|FG004|COMPLETED|Part 3||0
6465186|NCT01225731|7381958|FG005|COMPLETED|Part 3||0
6465187|NCT01225731|7381959|FG006|COMPLETED|Part 3||0
6465188|NCT01225731|7381960|FG007|COMPLETED|Part 3||0
6465189|NCT01225731|7381961|FG008|COMPLETED|Part 3||0
6465190|NCT01225731|7381962|FG009|COMPLETED|Part 3||10
6465191|NCT01225731|7381963|FG010|COMPLETED|Part 3||80
6465192|NCT01225731|7381964|FG011|COMPLETED|Part 3||116
6465193|NCT01225731|7381965|FG012|COMPLETED|Part 3||60
6465194|NCT01225731|7381953|FG000|NOT COMPLETED|Part 3||0
6465195|NCT01225731|7381954|FG001|NOT COMPLETED|Part 3||0
6465196|NCT01225731|7381955|FG002|NOT COMPLETED|Part 3||0
6465197|NCT01225731|7381956|FG003|NOT COMPLETED|Part 3||0
6465198|NCT01225731|7381957|FG004|NOT COMPLETED|Part 3||0
6465199|NCT01225731|7381958|FG005|NOT COMPLETED|Part 3||0
6465200|NCT01225731|7381959|FG006|NOT COMPLETED|Part 3||0
6465201|NCT01225731|7381960|FG007|NOT COMPLETED|Part 3||0
6465202|NCT01225731|7381961|FG008|NOT COMPLETED|Part 3||0
6465203|NCT01225731|7381962|FG009|NOT COMPLETED|Part 3||0
6465204|NCT01225731|7381963|FG010|NOT COMPLETED|Part 3||6
6465205|NCT01225731|7381964|FG011|NOT COMPLETED|Part 3||10
6465206|NCT01225731|7381965|FG012|NOT COMPLETED|Part 3||7
6465207|NCT01225822|7381999|FG000|STARTED|Overall Study||389
6465208|NCT01225822|7382000|FG001|STARTED|Overall Study||390
6465209|NCT01225822|7382001|FG002|STARTED|Overall Study||393
6465210|NCT01225822|7382002|FG003|STARTED|Overall Study||385
6465211|NCT01225822|7382003|FG004|STARTED|Overall Study||392
6465212|NCT01225822|7381999|FG000|COMPLETED|Overall Study||351
6465213|NCT01225822|7382000|FG001|COMPLETED|Overall Study||334
6465214|NCT01225822|7382001|FG002|COMPLETED|Overall Study||355
6465215|NCT01225822|7382002|FG003|COMPLETED|Overall Study||333
6465216|NCT01225822|7382003|FG004|COMPLETED|Overall Study||361
6465217|NCT01225822|7381999|FG000|NOT COMPLETED|Overall Study||38
6465218|NCT01225822|7382000|FG001|NOT COMPLETED|Overall Study||56
6465219|NCT01225822|7382001|FG002|NOT COMPLETED|Overall Study||38
6465220|NCT01225822|7382002|FG003|NOT COMPLETED|Overall Study||52
6465221|NCT01225822|7382003|FG004|NOT COMPLETED|Overall Study||31
6465222|NCT01225835|7382020|FG000|STARTED|Overall Study||62
6465223|NCT01225835|7382021|FG001|STARTED|Overall Study||62
6465224|NCT01225835|7382020|FG000|Per Protocol Population|Overall Study||48
6465225|NCT01225835|7382021|FG001|Per Protocol Population|Overall Study||58
6465226|NCT01225835|7382020|FG000|COMPLETED|Overall Study|hCG criterion met|55
6465227|NCT01225835|7382021|FG001|COMPLETED|Overall Study|hCG criterion met|59
6465228|NCT01225835|7382020|FG000|NOT COMPLETED|Overall Study||7
6465229|NCT01225835|7382021|FG001|NOT COMPLETED|Overall Study||3
6465230|NCT01225887|7382033|FG000|STARTED|Overall Study||37
6465231|NCT01225887|7382033|FG000|COMPLETED|Overall Study||32
6465232|NCT01225887|7382033|FG000|NOT COMPLETED|Overall Study||5
6465233|NCT01225926|7382039|FG000|STARTED|Overall Study||12
6465234|NCT01225926|7382040|FG001|STARTED|Overall Study||12
6465235|NCT01225926|7382039|FG000|COMPLETED|Overall Study||12
6465236|NCT01225926|7382040|FG001|COMPLETED|Overall Study||12
6465237|NCT01225926|7382039|FG000|NOT COMPLETED|Overall Study||0
6465238|NCT01225926|7382040|FG001|NOT COMPLETED|Overall Study||0
6465239|NCT01225952|7382049|FG000|STARTED|Overall Study||31
6465240|NCT01225952|7382050|FG001|STARTED|Overall Study||31
6465241|NCT01225952|7382051|FG002|STARTED|Overall Study||31
6465242|NCT01225952|7382049|FG000|COMPLETED|Overall Study||25
6465243|NCT01225952|7382050|FG001|COMPLETED|Overall Study||27
6465244|NCT01225952|7382051|FG002|COMPLETED|Overall Study||25
6465245|NCT01225952|7382049|FG000|NOT COMPLETED|Overall Study||6
6465246|NCT01225952|7382050|FG001|NOT COMPLETED|Overall Study||4
6465247|NCT01225952|7382051|FG002|NOT COMPLETED|Overall Study||6
6465248|NCT01225991|7382059|FG000|STARTED|Overall Study||18
6465249|NCT01225991|7382059|FG000|COMPLETED|Overall Study||12
6465250|NCT01225991|7382059|FG000|NOT COMPLETED|Overall Study||6
6465251|NCT01226043|7382065|FG000|STARTED|4-week Crossover Phase - Period 1||202
6465252|NCT01226043|7382066|FG001|STARTED|4-week Crossover Phase - Period 1||203
6465253|NCT01226043|7382067|FG002|STARTED|4-week Crossover Phase - Period 1||0
6465254|NCT01226043|7382068|FG003|STARTED|4-week Crossover Phase - Period 1||0
6465255|NCT01226043|7382065|FG000|TREATED|4-week Crossover Phase - Period 1||202
6465256|NCT01226043|7382066|FG001|TREATED|4-week Crossover Phase - Period 1||200
6465257|NCT01226043|7382067|FG002|TREATED|4-week Crossover Phase - Period 1||0
6465258|NCT01226043|7382068|FG003|TREATED|4-week Crossover Phase - Period 1||0
6465259|NCT01226043|7382065|FG000|COMPLETED|4-week Crossover Phase - Period 1||199
6465260|NCT01226043|7382066|FG001|COMPLETED|4-week Crossover Phase - Period 1||194
6465261|NCT01226043|7382067|FG002|COMPLETED|4-week Crossover Phase - Period 1||0
6465262|NCT01226043|7382068|FG003|COMPLETED|4-week Crossover Phase - Period 1||0
6465263|NCT01226043|7382065|FG000|NOT COMPLETED|4-week Crossover Phase - Period 1||3
6465264|NCT01226043|7382066|FG001|NOT COMPLETED|4-week Crossover Phase - Period 1||9
6465265|NCT01226043|7382067|FG002|NOT COMPLETED|4-week Crossover Phase - Period 1||0
6465266|NCT01226043|7382068|FG003|NOT COMPLETED|4-week Crossover Phase - Period 1||0
6465267|NCT01226043|7382065|FG000|STARTED|4-week Crossover Phase - Period 2||199
6465268|NCT01226043|7382066|FG001|STARTED|4-week Crossover Phase - Period 2||194
6465269|NCT01226043|7382067|FG002|STARTED|4-week Crossover Phase - Period 2||0
6465270|NCT01226043|7382068|FG003|STARTED|4-week Crossover Phase - Period 2||0
6465271|NCT01226043|7382065|FG000|TREATED|4-week Crossover Phase - Period 2||199
6465272|NCT01226043|7382066|FG001|TREATED|4-week Crossover Phase - Period 2||194
6746673|NCT03374683|7674321|FG002|NOT COMPLETED|Overall Study||69
6746674|NCT03374995|7674331|FG000|STARTED|Overall Study||13
6746675|NCT03374995|7674332|FG001|STARTED|Overall Study||12
6465273|NCT01226043|7382067|FG002|TREATED|4-week Crossover Phase - Period 2||0
6465274|NCT01226043|7382068|FG003|TREATED|4-week Crossover Phase - Period 2||0
6465275|NCT01226043|7382065|FG000|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
6465276|NCT01226043|7382066|FG001|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
6465277|NCT01226043|7382067|FG002|COMPLETED|4-week Crossover Phase - Period 2||0
6465278|NCT01226043|7382068|FG003|COMPLETED|4-week Crossover Phase - Period 2||0
6465279|NCT01226043|7382065|FG000|NOT COMPLETED|4-week Crossover Phase - Period 2||4
6465280|NCT01226043|7382066|FG001|NOT COMPLETED|4-week Crossover Phase - Period 2||6
6465281|NCT01226043|7382067|FG002|NOT COMPLETED|4-week Crossover Phase - Period 2||0
6465282|NCT01226043|7382068|FG003|NOT COMPLETED|4-week Crossover Phase - Period 2||0
6465283|NCT01226043|7382065|FG000|STARTED|6-week Re-randomization Phase||0
6465284|NCT01226043|7382066|FG001|STARTED|6-week Re-randomization Phase||0
6465285|NCT01226043|7382067|FG002|STARTED|6-week Re-randomization Phase||166
6465286|NCT01226043|7382068|FG003|STARTED|6-week Re-randomization Phase||167
6465287|NCT01226043|7382065|FG000|TREATED|6-week Re-randomization Phase||0
6465288|NCT01226043|7382066|FG001|TREATED|6-week Re-randomization Phase||0
6465289|NCT01226043|7382067|FG002|TREATED|6-week Re-randomization Phase||165
6465290|NCT01226043|7382068|FG003|TREATED|6-week Re-randomization Phase||165
6465291|NCT01226043|7382065|FG000|COMPLETED|6-week Re-randomization Phase||0
6465292|NCT01226043|7382066|FG001|COMPLETED|6-week Re-randomization Phase||0
6465293|NCT01226043|7382067|FG002|COMPLETED|6-week Re-randomization Phase||159
6465294|NCT01226043|7382068|FG003|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
6465295|NCT01226043|7382065|FG000|NOT COMPLETED|6-week Re-randomization Phase||0
6465296|NCT01226043|7382066|FG001|NOT COMPLETED|6-week Re-randomization Phase||0
6465297|NCT01226043|7382067|FG002|NOT COMPLETED|6-week Re-randomization Phase||7
6465298|NCT01226043|7382068|FG003|NOT COMPLETED|6-week Re-randomization Phase||11
6465299|NCT01226043|7382065|FG000|STARTED|30-week Observational Phase||0
6465300|NCT01226043|7382066|FG001|STARTED|30-week Observational Phase||0
6465301|NCT01226043|7382067|FG002|STARTED|30-week Observational Phase||159
6465302|NCT01226043|7382068|FG003|STARTED|30-week Observational Phase||153
6465303|NCT01226043|7382065|FG000|TREATED|30-week Observational Phase||0
6465304|NCT01226043|7382066|FG001|TREATED|30-week Observational Phase||0
6465305|NCT01226043|7382067|FG002|TREATED|30-week Observational Phase||159
6465306|NCT01226043|7382068|FG003|TREATED|30-week Observational Phase||153
6465307|NCT01226043|7382065|FG000|COMPLETED|30-week Observational Phase||0
6465308|NCT01226043|7382066|FG001|COMPLETED|30-week Observational Phase||0
6465309|NCT01226043|7382067|FG002|COMPLETED|30-week Observational Phase||153
6465310|NCT01226043|7382068|FG003|COMPLETED|30-week Observational Phase||140
6465311|NCT01226043|7382065|FG000|NOT COMPLETED|30-week Observational Phase||0
6465312|NCT01226043|7382066|FG001|NOT COMPLETED|30-week Observational Phase||0
6465313|NCT01226043|7382067|FG002|NOT COMPLETED|30-week Observational Phase||6
6465314|NCT01226043|7382068|FG003|NOT COMPLETED|30-week Observational Phase||13
6465315|NCT01226095|7382098|FG000|STARTED|Overall Study||519
6465316|NCT01226095|7382098|FG000|COMPLETED|Overall Study||518
6465317|NCT01226095|7382098|FG000|NOT COMPLETED|Overall Study||1
6465318|NCT01226121|7382112|FG000|STARTED|Overall Study||13
6465319|NCT01226121|7382113|FG001|STARTED|Overall Study||11
6465320|NCT01226121|7382114|FG002|STARTED|Overall Study||13
6465321|NCT01226121|7382112|FG000|30 Day Evaluation|Overall Study||12
6465322|NCT01226121|7382113|FG001|30 Day Evaluation|Overall Study||11
6465323|NCT01226121|7382114|FG002|30 Day Evaluation|Overall Study||13
6465324|NCT01226121|7382112|FG000|COMPLETED|Overall Study||11
6465325|NCT01226121|7382113|FG001|COMPLETED|Overall Study||11
6465326|NCT01226121|7382114|FG002|COMPLETED|Overall Study||12
6465327|NCT01226121|7382112|FG000|NOT COMPLETED|Overall Study||2
6465328|NCT01226121|7382113|FG001|NOT COMPLETED|Overall Study||0
6465329|NCT01226121|7382114|FG002|NOT COMPLETED|Overall Study||1
6465330|NCT01226420|7382122|FG000|STARTED|Overall Study||6
6465331|NCT01226420|7382122|FG000|COMPLETED|Overall Study||6
6465332|NCT01226420|7382122|FG000|NOT COMPLETED|Overall Study||0
6465333|NCT01226459|7382128|FG000|STARTED|Overall Study||201
6465334|NCT01226459|7382129|FG001|STARTED|Overall Study||203
6465335|NCT01226459|7382128|FG000|COMPLETED|Overall Study||180
6465336|NCT01226459|7382129|FG001|COMPLETED|Overall Study||171
6465337|NCT01226459|7382128|FG000|NOT COMPLETED|Overall Study||21
6465338|NCT01226459|7382129|FG001|NOT COMPLETED|Overall Study||32
6465339|NCT01226472|7382135|FG000|STARTED|Overall Study||1
6465340|NCT01226472|7382135|FG000|COMPLETED|Overall Study||0
6465341|NCT01226472|7382135|FG000|NOT COMPLETED|Overall Study||1
6465342|NCT01226485|7382146|FG000|STARTED|Overall Study||3
6465343|NCT01226485|7382147|FG001|STARTED|Overall Study||6
6554156|NCT01746901|7476547|FG002|STARTED|Treatment Phase: First Intervention||0
6554157|NCT01746901|7476548|FG003|STARTED|Treatment Phase: First Intervention||6
6554158|NCT01746901|7476549|FG004|STARTED|Treatment Phase: First Intervention||6
6465344|NCT01226485|7382148|FG002|STARTED|Overall Study||3
6554159|NCT01746901|7476550|FG005|STARTED|Treatment Phase: First Intervention||7
6746676|NCT03374995|7674331|FG000|COMPLETED|Overall Study||13
6746677|NCT03374995|7674332|FG001|COMPLETED|Overall Study||11
6746678|NCT03374995|7674331|FG000|NOT COMPLETED|Overall Study||0
6465345|NCT01226485|7382149|FG003|STARTED|Overall Study||6
6465346|NCT01226485|7382150|FG004|STARTED|Overall Study||7
6465347|NCT01226485|7382151|FG005|STARTED|Overall Study||19
6465348|NCT01226485|7382152|FG006|STARTED|Overall Study||40
6465349|NCT01226485|7382146|FG000|Received at Least One Dose of Drug|Overall Study||3
6465350|NCT01226485|7382147|FG001|Received at Least One Dose of Drug|Overall Study||6
6465351|NCT01226485|7382148|FG002|Received at Least One Dose of Drug|Overall Study||3
6465352|NCT01226485|7382149|FG003|Received at Least One Dose of Drug|Overall Study||6
6465353|NCT01226485|7382150|FG004|Received at Least One Dose of Drug|Overall Study||7
6465354|NCT01226485|7382151|FG005|Received at Least One Dose of Drug|Overall Study||19
6465355|NCT01226485|7382152|FG006|Received at Least One Dose of Drug|Overall Study||40
6465356|NCT01226485|7382146|FG000|COMPLETED|Overall Study||3
6465357|NCT01226485|7382147|FG001|COMPLETED|Overall Study||6
6465358|NCT01226485|7382148|FG002|COMPLETED|Overall Study||3
6465359|NCT01226485|7382149|FG003|COMPLETED|Overall Study||6
6465360|NCT01226485|7382150|FG004|COMPLETED|Overall Study||7
6465361|NCT01226485|7382151|FG005|COMPLETED|Overall Study||19
6465362|NCT01226485|7382152|FG006|COMPLETED|Overall Study||40
6465363|NCT01226485|7382146|FG000|NOT COMPLETED|Overall Study||0
6465364|NCT01226485|7382147|FG001|NOT COMPLETED|Overall Study||0
6465365|NCT01226485|7382148|FG002|NOT COMPLETED|Overall Study||0
6465366|NCT01226485|7382149|FG003|NOT COMPLETED|Overall Study||0
6465367|NCT01226485|7382150|FG004|NOT COMPLETED|Overall Study||0
6465368|NCT01226485|7382151|FG005|NOT COMPLETED|Overall Study||0
6465369|NCT01226485|7382152|FG006|NOT COMPLETED|Overall Study||0
6465370|NCT01226511|7382178|FG000|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
6465371|NCT01226511|7382179|FG001|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
6465372|NCT01226511|7382178|FG000|COMPLETED|Acute Treatment Period||108
6465373|NCT01226511|7382179|FG001|COMPLETED|Acute Treatment Period||110
6465374|NCT01226511|7382178|FG000|NOT COMPLETED|Acute Treatment Period||32
6465375|NCT01226511|7382179|FG001|NOT COMPLETED|Acute Treatment Period||31
6465376|NCT01226511|7382178|FG000|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
6465377|NCT01226511|7382179|FG001|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
6465378|NCT01226511|7382178|FG000|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
6465379|NCT01226511|7382179|FG001|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
6465380|NCT01226511|7382178|FG000|NOT COMPLETED|Extension Treatment Period||27
6465381|NCT01226511|7382179|FG001|NOT COMPLETED|Extension Treatment Period||27
6465382|NCT01226511|7382178|FG000|STARTED|Taper Period||51
6465383|NCT01226511|7382179|FG001|STARTED|Taper Period||57
6465384|NCT01226511|7382178|FG000|COMPLETED|Taper Period||46
6465385|NCT01226511|7382179|FG001|COMPLETED|Taper Period||54
6465386|NCT01226511|7382178|FG000|NOT COMPLETED|Taper Period||5
6465387|NCT01226511|7382179|FG001|NOT COMPLETED|Taper Period||3
6465388|NCT01226706|7382193|FG000|STARTED|Overall Study||10
6465389|NCT01226706|7382194|FG001|STARTED|Overall Study||11
6465390|NCT01226706|7382193|FG000|COMPLETED|Overall Study||10
6465391|NCT01226706|7382194|FG001|COMPLETED|Overall Study||11
6465392|NCT01226706|7382193|FG000|NOT COMPLETED|Overall Study||0
6465393|NCT01226706|7382194|FG001|NOT COMPLETED|Overall Study||0
6465394|NCT01226719|7382202|FG000|STARTED|Overall Study||15
6465395|NCT01226719|7382202|FG000|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
6465396|NCT01226719|7382202|FG000|NOT COMPLETED|Overall Study||13
6465397|NCT01226745|7382212|FG000|STARTED|Overall Study||80
6465398|NCT01226745|7382213|FG001|STARTED|Overall Study||87
6465399|NCT01226745|7382214|FG002|STARTED|Overall Study||89
6465400|NCT01226745|7382215|FG003|STARTED|Overall Study||29
6465401|NCT01226745|7382216|FG004|STARTED|Overall Study||26
6465402|NCT01226745|7382217|FG005|STARTED|Overall Study||29
6465403|NCT01226745|7382212|FG000|COMPLETED|Overall Study||63
6465404|NCT01226745|7382213|FG001|COMPLETED|Overall Study||71
6465405|NCT01226745|7382214|FG002|COMPLETED|Overall Study||69
6465406|NCT01226745|7382215|FG003|COMPLETED|Overall Study||24
6465407|NCT01226745|7382216|FG004|COMPLETED|Overall Study||22
6465408|NCT01226745|7382217|FG005|COMPLETED|Overall Study||24
6465409|NCT01226745|7382212|FG000|NOT COMPLETED|Overall Study||17
6465410|NCT01226745|7382213|FG001|NOT COMPLETED|Overall Study||16
6465411|NCT01226745|7382214|FG002|NOT COMPLETED|Overall Study||20
6465412|NCT01226745|7382215|FG003|NOT COMPLETED|Overall Study||5
6465413|NCT01226745|7382216|FG004|NOT COMPLETED|Overall Study||4
6465414|NCT01226745|7382217|FG005|NOT COMPLETED|Overall Study||5
6465415|NCT01226914|7382234|FG000|STARTED|Overall Study||28
6465416|NCT01226914|7382235|FG001|STARTED|Overall Study||27
6465417|NCT01226914|7382234|FG000|COMPLETED|Overall Study||28
6465418|NCT01226914|7382235|FG001|COMPLETED|Overall Study||27
6465419|NCT01226914|7382234|FG000|NOT COMPLETED|Overall Study||0
6465420|NCT01226914|7382235|FG001|NOT COMPLETED|Overall Study||0
6465421|NCT01226979|7382241|FG000|STARTED|Overall Study||16
6465422|NCT01226979|7382241|FG000|COMPLETED|Overall Study||16
6465423|NCT01226979|7382241|FG000|NOT COMPLETED|Overall Study||0
6465424|NCT01227005|7382248|FG000|STARTED|Overall Study||55
6465425|NCT01227005|7382249|FG001|STARTED|Overall Study||52
6465426|NCT01227005|7382248|FG000|COMPLETED|Overall Study||50
6465427|NCT01227005|7382249|FG001|COMPLETED|Overall Study||51
6465428|NCT01227005|7382248|FG000|NOT COMPLETED|Overall Study||5
6465429|NCT01227005|7382249|FG001|NOT COMPLETED|Overall Study||1
6465430|NCT01227018|7382255|FG000|STARTED|Overall Study||15
6465431|NCT01227018|7382255|FG000|COMPLETED|Overall Study||0
6465432|NCT01227018|7382255|FG000|NOT COMPLETED|Overall Study||15
6465433|NCT01227044|7382261|FG000|STARTED|Overall Study||25
6465434|NCT01227044|7382262|FG001|STARTED|Overall Study||26
6465435|NCT01227044|7382261|FG000|COMPLETED|Overall Study||19
6465436|NCT01227044|7382262|FG001|COMPLETED|Overall Study||17
6465437|NCT01227044|7382261|FG000|NOT COMPLETED|Overall Study||6
6465438|NCT01227044|7382262|FG001|NOT COMPLETED|Overall Study||9
6465439|NCT01227057|7382270|FG000|STARTED|Overall Study||31
6465440|NCT01227057|7382271|FG001|STARTED|Overall Study||27
6465441|NCT01227057|7382270|FG000|COMPLETED|Overall Study||25
6465442|NCT01227057|7382271|FG001|COMPLETED|Overall Study||19
6465443|NCT01227057|7382270|FG000|NOT COMPLETED|Overall Study||6
6465444|NCT01227057|7382271|FG001|NOT COMPLETED|Overall Study||8
6465445|NCT01227252|7382282|FG000|STARTED|Overall Study||12
6465446|NCT01227252|7382283|FG001|STARTED|Overall Study||10
6465447|NCT01227252|7382284|FG002|STARTED|Overall Study||10
6465448|NCT01227252|7382285|FG003|STARTED|Overall Study||10
6465449|NCT01227252|7382282|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
6465450|NCT01227252|7382283|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
6465451|NCT01227252|7382284|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
6465452|NCT01227252|7382285|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
6465453|NCT01227252|7382282|FG000|COMPLETED|Overall Study||12
6465454|NCT01227252|7382283|FG001|COMPLETED|Overall Study||7
6465455|NCT01227252|7382284|FG002|COMPLETED|Overall Study||10
6465456|NCT01227252|7382285|FG003|COMPLETED|Overall Study||10
6465457|NCT01227252|7382282|FG000|NOT COMPLETED|Overall Study||0
6465458|NCT01227252|7382283|FG001|NOT COMPLETED|Overall Study||3
6465459|NCT01227252|7382284|FG002|NOT COMPLETED|Overall Study||0
6465460|NCT01227252|7382285|FG003|NOT COMPLETED|Overall Study||0
6465461|NCT01227265|7382301|FG000|STARTED|Overall Study||158
6465462|NCT01227265|7382302|FG001|STARTED|Overall Study||159
6465463|NCT01227265|7382303|FG002|STARTED|Overall Study||159
6465464|NCT01227265|7382301|FG000|Treated|Overall Study||157
6465465|NCT01227265|7382302|FG001|Treated|Overall Study||157
6465466|NCT01227265|7382303|FG002|Treated|Overall Study||159
6465467|NCT01227265|7382301|FG000|COMPLETED|Overall Study||139
6465468|NCT01227265|7382302|FG001|COMPLETED|Overall Study||139
6465469|NCT01227265|7382303|FG002|COMPLETED|Overall Study||145
6465470|NCT01227265|7382301|FG000|NOT COMPLETED|Overall Study||19
6465471|NCT01227265|7382302|FG001|NOT COMPLETED|Overall Study||20
6465472|NCT01227265|7382303|FG002|NOT COMPLETED|Overall Study||14
6465473|NCT01227278|7382313|FG000|STARTED|Overall Study||50
6465474|NCT01227278|7382314|FG001|STARTED|Overall Study||51
6465475|NCT01227278|7382313|FG000|COMPLETED|Overall Study||45
6465476|NCT01227278|7382314|FG001|COMPLETED|Overall Study||43
6465477|NCT01227278|7382313|FG000|NOT COMPLETED|Overall Study||5
6465478|NCT01227278|7382314|FG001|NOT COMPLETED|Overall Study||8
6465479|NCT01227382|7382320|FG000|STARTED|Overall Study||26
6465480|NCT01227382|7382320|FG000|COMPLETED|Overall Study||26
6465481|NCT01227382|7382320|FG000|NOT COMPLETED|Overall Study||0
6465482|NCT01227395|7382328|FG000|STARTED|Overall Study||391
6465483|NCT01227395|7382329|FG001|STARTED|Overall Study||85
6465484|NCT01227395|7382328|FG000|COMPLETED|Overall Study||391
6465485|NCT01227395|7382329|FG001|COMPLETED|Overall Study||84
6465486|NCT01227395|7382328|FG000|NOT COMPLETED|Overall Study||0
6465487|NCT01227395|7382329|FG001|NOT COMPLETED|Overall Study||1
6465488|NCT01227421|7382357|FG000|STARTED|Overall Study||201
6465489|NCT01227421|7382358|FG001|STARTED|Overall Study||212
6465490|NCT01227421|7382359|FG002|STARTED|Overall Study||211
6465491|NCT01227421|7382357|FG000|COMPLETED|Overall Study||190
6465492|NCT01227421|7382358|FG001|COMPLETED|Overall Study||194
6465493|NCT01227421|7382359|FG002|COMPLETED|Overall Study||201
6465494|NCT01227421|7382357|FG000|NOT COMPLETED|Overall Study||11
6465495|NCT01227421|7382358|FG001|NOT COMPLETED|Overall Study||18
6465496|NCT01227421|7382359|FG002|NOT COMPLETED|Overall Study||10
6554160|NCT01746901|7476551|FG006|STARTED|Treatment Phase: First Intervention||8
6465497|NCT01227434|7382369|FG000|STARTED|Overall Study||6
6465498|NCT01227434|7382370|FG001|STARTED|Overall Study||16
6465499|NCT01227434|7382369|FG000|COMPLETED|Overall Study||6
6465500|NCT01227434|7382370|FG001|COMPLETED|Overall Study||16
6465501|NCT01227434|7382369|FG000|NOT COMPLETED|Overall Study||0
6465502|NCT01227434|7382370|FG001|NOT COMPLETED|Overall Study||0
6465503|NCT01227512|7382379|FG000|STARTED|Overall Study||66
6465504|NCT01227512|7382380|FG001|STARTED|Overall Study||58
6465505|NCT01227512|7382379|FG000|COMPLETED|Overall Study||53
6465506|NCT01227512|7382380|FG001|COMPLETED|Overall Study||48
6465507|NCT01227512|7382379|FG000|NOT COMPLETED|Overall Study||13
6465508|NCT01227512|7382380|FG001|NOT COMPLETED|Overall Study||10
6465509|NCT01227551|7382388|FG000|STARTED|Overall Study||57
6465510|NCT01227551|7382388|FG000|COMPLETED|Overall Study||23
6465511|NCT01227551|7382388|FG000|NOT COMPLETED|Overall Study||34
6465512|NCT01227564|7382395|FG000|STARTED|Overall Study||22
6465513|NCT01227564|7382396|FG001|STARTED|Overall Study||20
6465514|NCT01227564|7382397|FG002|STARTED|Overall Study||21
6465515|NCT01227564|7382395|FG000|Treated|Overall Study||22
6465516|NCT01227564|7382396|FG001|Treated|Overall Study||20
6554161|NCT01746901|7476552|FG007|STARTED|Treatment Phase: First Intervention||7
6465517|NCT01227564|7382397|FG002|Treated|Overall Study||21
6465518|NCT01227564|7382395|FG000|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
6465519|NCT01227564|7382396|FG001|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
6465520|NCT01227564|7382397|FG002|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
6465521|NCT01227564|7382395|FG000|COMPLETED|Overall Study|Completed study|18
6465522|NCT01227564|7382396|FG001|COMPLETED|Overall Study|Completed study|18
6465523|NCT01227564|7382397|FG002|COMPLETED|Overall Study|Completed study|15
6465524|NCT01227564|7382395|FG000|NOT COMPLETED|Overall Study||4
6465525|NCT01227564|7382396|FG001|NOT COMPLETED|Overall Study||2
6465526|NCT01227564|7382397|FG002|NOT COMPLETED|Overall Study||6
6465527|NCT01227577|7382407|FG000|STARTED|Overall Study||128
6465528|NCT01227577|7382407|FG000|COMPLETED|Overall Study||93
6465529|NCT01227577|7382407|FG000|NOT COMPLETED|Overall Study||35
6465530|NCT01227629|7382421|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
6465531|NCT01227629|7382422|FG001|STARTED|Overall Study||20
6465532|NCT01227629|7382423|FG002|STARTED|Overall Study||27
6465533|NCT01227629|7382424|FG003|STARTED|Overall Study||99
6465534|NCT01227629|7382425|FG004|STARTED|Overall Study||34
6465535|NCT01227629|7382426|FG005|STARTED|Overall Study||33
6465536|NCT01227629|7382427|FG006|STARTED|Overall Study||98
6465537|NCT01227629|7382428|FG007|STARTED|Overall Study||33
6465538|NCT01227629|7382429|FG008|STARTED|Overall Study||30
6465539|NCT01227629|7382430|FG009|STARTED|Overall Study||70
6465540|NCT01227629|7382421|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
6465541|NCT01227629|7382422|FG001|COMPLETED|Overall Study||18
6465542|NCT01227629|7382423|FG002|COMPLETED|Overall Study||26
6465543|NCT01227629|7382424|FG003|COMPLETED|Overall Study||91
6465544|NCT01227629|7382425|FG004|COMPLETED|Overall Study||32
6465545|NCT01227629|7382426|FG005|COMPLETED|Overall Study||32
6465546|NCT01227629|7382427|FG006|COMPLETED|Overall Study||90
6465547|NCT01227629|7382428|FG007|COMPLETED|Overall Study||27
6465548|NCT01227629|7382429|FG008|COMPLETED|Overall Study||24
6465549|NCT01227629|7382430|FG009|COMPLETED|Overall Study||68
6465550|NCT01227629|7382421|FG000|NOT COMPLETED|Overall Study||2
6465551|NCT01227629|7382422|FG001|NOT COMPLETED|Overall Study||2
6465552|NCT01227629|7382423|FG002|NOT COMPLETED|Overall Study||1
6465553|NCT01227629|7382424|FG003|NOT COMPLETED|Overall Study||8
6465554|NCT01227629|7382425|FG004|NOT COMPLETED|Overall Study||2
6465555|NCT01227629|7382426|FG005|NOT COMPLETED|Overall Study||1
6465556|NCT01227629|7382427|FG006|NOT COMPLETED|Overall Study||8
6465557|NCT01227629|7382428|FG007|NOT COMPLETED|Overall Study||6
6465558|NCT01227629|7382429|FG008|NOT COMPLETED|Overall Study||6
6465559|NCT01227629|7382430|FG009|NOT COMPLETED|Overall Study||2
6465560|NCT01227655|7382479|FG000|STARTED|Overall Study||129
6465561|NCT01227655|7382480|FG001|STARTED|Overall Study||154
6465562|NCT01227655|7382481|FG002|STARTED|Overall Study||144
6465563|NCT01227655|7382479|FG000|Safety Set|Overall Study||125
6465564|NCT01227655|7382480|FG001|Safety Set|Overall Study||150
6465565|NCT01227655|7382481|FG002|Safety Set|Overall Study||136
6465566|NCT01227655|7382479|FG000|Full Analysis Set|Overall Study||125
6465567|NCT01227655|7382480|FG001|Full Analysis Set|Overall Study||147
6465568|NCT01227655|7382481|FG002|Full Analysis Set|Overall Study||135
6465569|NCT01227655|7382479|FG000|COMPLETED|Overall Study||118
6465570|NCT01227655|7382480|FG001|COMPLETED|Overall Study||128
6465571|NCT01227655|7382481|FG002|COMPLETED|Overall Study||130
6465572|NCT01227655|7382479|FG000|NOT COMPLETED|Overall Study||11
6465573|NCT01227655|7382480|FG001|NOT COMPLETED|Overall Study||26
6465574|NCT01227655|7382481|FG002|NOT COMPLETED|Overall Study||14
6465575|NCT01227668|7382491|FG000|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
6465576|NCT01227668|7382492|FG001|STARTED|Phase 1 (Stabilization Phase)||0
6465577|NCT01227668|7382491|FG000|Received Treatment|Phase 1 (Stabilization Phase)||155
6465578|NCT01227668|7382492|FG001|Received Treatment|Phase 1 (Stabilization Phase)||0
6465579|NCT01227668|7382491|FG000|COMPLETED|Phase 1 (Stabilization Phase)||85
6465580|NCT01227668|7382492|FG001|COMPLETED|Phase 1 (Stabilization Phase)||0
6465581|NCT01227668|7382491|FG000|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
6465582|NCT01227668|7382492|FG001|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
6465583|NCT01227668|7382491|FG000|STARTED|Phase 2 (Randomization Phase)|Randomized|41
6465584|NCT01227668|7382492|FG001|STARTED|Phase 2 (Randomization Phase)|Randomized|44
6465585|NCT01227668|7382491|FG000|Received Treatment|Phase 2 (Randomization Phase)||39
6465586|NCT01227668|7382492|FG001|Received Treatment|Phase 2 (Randomization Phase)||43
6465587|NCT01227668|7382491|FG000|COMPLETED|Phase 2 (Randomization Phase)||22
6465588|NCT01227668|7382492|FG001|COMPLETED|Phase 2 (Randomization Phase)||19
6465589|NCT01227668|7382491|FG000|NOT COMPLETED|Phase 2 (Randomization Phase)||19
6465590|NCT01227668|7382492|FG001|NOT COMPLETED|Phase 2 (Randomization Phase)||25
6465591|NCT01227681|7382505|FG000|STARTED|Overall Study||4
6465592|NCT01227681|7382506|FG001|STARTED|Overall Study||0
6465593|NCT01227681|7382507|FG002|STARTED|Overall Study||0
6465594|NCT01227681|7382505|FG000|COMPLETED|Overall Study||4
6465595|NCT01227681|7382506|FG001|COMPLETED|Overall Study||0
6465596|NCT01227681|7382507|FG002|COMPLETED|Overall Study||0
6465597|NCT01227681|7382505|FG000|NOT COMPLETED|Overall Study||0
6465598|NCT01227681|7382506|FG001|NOT COMPLETED|Overall Study||0
6465599|NCT01227681|7382507|FG002|NOT COMPLETED|Overall Study||0
6465600|NCT01227707|7382511|FG000|STARTED|Overall Study||43
6465601|NCT01227707|7382511|FG000|COMPLETED|Overall Study||19
6465602|NCT01227707|7382511|FG000|NOT COMPLETED|Overall Study||24
6465603|NCT01227785|7382515|FG000|STARTED|Overall Study||120
6465604|NCT01227785|7382515|FG000|COMPLETED|Overall Study||108
6465605|NCT01227785|7382515|FG000|NOT COMPLETED|Overall Study||12
6465606|NCT01227824|7382528|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||411
6465607|NCT01227824|7382529|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||411
6465608|NCT01227824|7382530|FG002|STARTED|Double-blind Phase: 96 Weeks Duration||0
6465609|NCT01227824|7382528|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||304
6465610|NCT01227824|7382529|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||332
6465611|NCT01227824|7382530|FG002|COMPLETED|Double-blind Phase: 96 Weeks Duration||0
6465612|NCT01227824|7382528|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||107
6465613|NCT01227824|7382529|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||79
6465614|NCT01227824|7382530|FG002|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||0
6465615|NCT01227824|7382528|FG000|STARTED|Open-label Phase: Median of 1267 Days||0
6465616|NCT01227824|7382529|FG001|STARTED|Open-label Phase: Median of 1267 Days||0
6465617|NCT01227824|7382530|FG002|STARTED|Open-label Phase: Median of 1267 Days|338 participants continued into the Open-label phase on completing the Double-blind Phase|338
6465618|NCT01227824|7382528|FG000|COMPLETED|Open-label Phase: Median of 1267 Days||0
6465619|NCT01227824|7382529|FG001|COMPLETED|Open-label Phase: Median of 1267 Days||0
6465620|NCT01227824|7382530|FG002|COMPLETED|Open-label Phase: Median of 1267 Days||294
6465621|NCT01227824|7382528|FG000|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
6465622|NCT01227824|7382529|FG001|NOT COMPLETED|Open-label Phase: Median of 1267 Days||0
6465623|NCT01227824|7382530|FG002|NOT COMPLETED|Open-label Phase: Median of 1267 Days||44
6465624|NCT01227889|7382539|FG000|STARTED|Randomized Phase (RP)||187
6465625|NCT01227889|7382540|FG001|STARTED|Randomized Phase (RP)||63
6465626|NCT01227889|7382539|FG000|COMPLETED|Randomized Phase (RP)||0
6465627|NCT01227889|7382540|FG001|COMPLETED|Randomized Phase (RP)||0
6465628|NCT01227889|7382539|FG000|NOT COMPLETED|Randomized Phase (RP)||187
6465629|NCT01227889|7382540|FG001|NOT COMPLETED|Randomized Phase (RP)||63
6465630|NCT01227889|7382539|FG000|STARTED|Crossover Phase||0
6465631|NCT01227889|7382540|FG001|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|37
6465632|NCT01227889|7382539|FG000|COMPLETED|Crossover Phase||0
6465633|NCT01227889|7382540|FG001|COMPLETED|Crossover Phase||0
6465634|NCT01227889|7382539|FG000|NOT COMPLETED|Crossover Phase||0
6465635|NCT01227889|7382540|FG001|NOT COMPLETED|Crossover Phase||37
6465636|NCT01227902|7382558|FG000|STARTED|Overall Study||56
6465637|NCT01227902|7382559|FG001|STARTED|Overall Study||51
6465638|NCT01227902|7382560|FG002|STARTED|Overall Study||44
6465639|NCT01227902|7382561|FG003|STARTED|Overall Study||52
6465640|NCT01227902|7382558|FG000|COMPLETED|Overall Study||38
6465641|NCT01227902|7382559|FG001|COMPLETED|Overall Study||38
6465642|NCT01227902|7382560|FG002|COMPLETED|Overall Study||25
6465643|NCT01227902|7382561|FG003|COMPLETED|Overall Study||42
6465644|NCT01227902|7382558|FG000|NOT COMPLETED|Overall Study||18
6465645|NCT01227902|7382559|FG001|NOT COMPLETED|Overall Study||13
6465646|NCT01227902|7382560|FG002|NOT COMPLETED|Overall Study||19
6465647|NCT01227902|7382561|FG003|NOT COMPLETED|Overall Study||10
6465648|NCT01227928|7382574|FG000|STARTED|Overall Study||72
6465649|NCT01227928|7382575|FG001|STARTED|Overall Study||73
6465650|NCT01227928|7382574|FG000|COMPLETED|Overall Study||50
6465651|NCT01227928|7382575|FG001|COMPLETED|Overall Study||56
6465652|NCT01227928|7382574|FG000|NOT COMPLETED|Overall Study||22
6465653|NCT01227928|7382575|FG001|NOT COMPLETED|Overall Study||17
6465654|NCT01227954|7382581|FG000|STARTED|Overall Study||113
6465655|NCT01227954|7382581|FG000|COMPLETED|Overall Study|Eligible subjects available for analysis|100
6465656|NCT01227954|7382581|FG000|NOT COMPLETED|Overall Study||13
6465657|NCT01227967|7382587|FG000|STARTED|Overall Study||314
6465658|NCT01227967|7382588|FG001|STARTED|Overall Study||316
6465659|NCT01227967|7382587|FG000|COMPLETED|Overall Study||298
6465660|NCT01227967|7382588|FG001|COMPLETED|Overall Study||303
6465661|NCT01227967|7382587|FG000|NOT COMPLETED|Overall Study||16
6465662|NCT01227967|7382588|FG001|NOT COMPLETED|Overall Study||13
6465663|NCT01227980|7382596|FG000|STARTED|Overall Study||40
6465664|NCT01227980|7382597|FG001|STARTED|Overall Study||30
6465665|NCT01227980|7382596|FG000|Scripts Challenge Sessions|Overall Study||26
6465666|NCT01227980|7382597|FG001|Scripts Challenge Sessions|Overall Study||25
6465667|NCT01227980|7382596|FG000|Measure Drug Level Concentration|Overall Study||10
6465668|NCT01227980|7382597|FG001|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
6465669|NCT01227980|7382596|FG000|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
6465670|NCT01227980|7382597|FG001|COMPLETED|Overall Study||25
6465671|NCT01227980|7382596|FG000|NOT COMPLETED|Overall Study||2
6305723|NCT01856140|7209072|FG001|COMPLETED|Overall Study||6
6305724|NCT01856140|7209071|FG000|NOT COMPLETED|Overall Study||0
6305725|NCT01856140|7209072|FG001|NOT COMPLETED|Overall Study||0
6465672|NCT01227980|7382597|FG001|NOT COMPLETED|Overall Study||5
6465673|NCT01227993|7382603|FG000|STARTED|Overall Study||3
6465674|NCT01227993|7382603|FG000|COMPLETED|Overall Study||3
6465675|NCT01227993|7382603|FG000|NOT COMPLETED|Overall Study||0
6465676|NCT01228019|7382607|FG000|STARTED|Overall Study||1166
6465677|NCT01228019|7382607|FG000|COMPLETED|Overall Study||862
6465678|NCT01228019|7382607|FG000|NOT COMPLETED|Overall Study||304
6465679|NCT01228071|7382611|FG000|STARTED|Overall Study||34
6465680|NCT01228071|7382611|FG000|COMPLETED|Overall Study||32
6465681|NCT01228071|7382611|FG000|NOT COMPLETED|Overall Study||2
6465682|NCT01228084|7382615|FG000|STARTED|Overall Study||20
6465683|NCT01228084|7382615|FG000|COMPLETED|Overall Study||16
6465684|NCT01228084|7382615|FG000|NOT COMPLETED|Overall Study||4
6465685|NCT01228149|7382621|FG000|STARTED|Overall Study||32
6465686|NCT01228149|7382622|FG001|STARTED|Overall Study||30
6465687|NCT01228149|7382621|FG000|COMPLETED|Overall Study||27
6465688|NCT01228149|7382622|FG001|COMPLETED|Overall Study||26
6465689|NCT01228149|7382621|FG000|NOT COMPLETED|Overall Study||5
6465690|NCT01228149|7382622|FG001|NOT COMPLETED|Overall Study||4
6465691|NCT01228175|7382633|FG000|STARTED|Overall Study||119
6465692|NCT01228175|7382634|FG001|STARTED|Overall Study||99
6465693|NCT01228175|7382633|FG000|COMPLETED|Overall Study||53
6465694|NCT01228175|7382634|FG001|COMPLETED|Overall Study||46
6465695|NCT01228175|7382633|FG000|NOT COMPLETED|Overall Study||66
6465696|NCT01228175|7382634|FG001|NOT COMPLETED|Overall Study||53
6465697|NCT01228318|7382642|FG000|STARTED|Overall Study||34
6465698|NCT01228318|7382643|FG001|STARTED|Overall Study||29
6465699|NCT01228318|7382642|FG000|COMPLETED|Overall Study||30
6465700|NCT01228318|7382643|FG001|COMPLETED|Overall Study||22
6465701|NCT01228318|7382642|FG000|NOT COMPLETED|Overall Study||4
6465702|NCT01228318|7382643|FG001|NOT COMPLETED|Overall Study||7
6465703|NCT01228435|7382651|FG000|STARTED|Overall Study||1
6465704|NCT01228435|7382652|FG001|STARTED|Overall Study||2
6465705|NCT01228435|7382651|FG000|COMPLETED|Overall Study||1
6465706|NCT01228435|7382652|FG001|COMPLETED|Overall Study||2
6465707|NCT01228435|7382651|FG000|NOT COMPLETED|Overall Study||0
6465708|NCT01228435|7382652|FG001|NOT COMPLETED|Overall Study||0
6465709|NCT01228591|7382658|FG000|STARTED|Baseline||18
6465710|NCT01228591|7382659|FG001|STARTED|Baseline||18
6465711|NCT01228591|7382658|FG000|COMPLETED|Baseline||17
6465712|NCT01228591|7382659|FG001|COMPLETED|Baseline||16
6465713|NCT01228591|7382658|FG000|NOT COMPLETED|Baseline||1
6465714|NCT01228591|7382659|FG001|NOT COMPLETED|Baseline||2
6465715|NCT01228591|7382658|FG000|STARTED|1-Week Follow-Up||17
6465716|NCT01228591|7382659|FG001|STARTED|1-Week Follow-Up||16
6465717|NCT01228591|7382658|FG000|COMPLETED|1-Week Follow-Up||17
6465718|NCT01228591|7382659|FG001|COMPLETED|1-Week Follow-Up||16
6465719|NCT01228591|7382658|FG000|NOT COMPLETED|1-Week Follow-Up||0
6465720|NCT01228591|7382659|FG001|NOT COMPLETED|1-Week Follow-Up||0
6465721|NCT01228591|7382658|FG000|STARTED|Final Visit||17
6465722|NCT01228591|7382659|FG001|STARTED|Final Visit||16
6465723|NCT01228591|7382658|FG000|COMPLETED|Final Visit||17
6465724|NCT01228591|7382659|FG001|COMPLETED|Final Visit||16
6465725|NCT01228591|7382658|FG000|NOT COMPLETED|Final Visit||0
6465726|NCT01228591|7382659|FG001|NOT COMPLETED|Final Visit||0
6465727|NCT01228734|7382671|FG000|STARTED|Overall Study||193
6465728|NCT01228734|7382672|FG001|STARTED|Overall Study||204
6465729|NCT01228734|7382671|FG000|Modified Intent-to-treat Population|Overall Study||193
6465730|NCT01228734|7382672|FG001|Modified Intent-to-treat Population|Overall Study||200
6465731|NCT01228734|7382671|FG000|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
6465732|NCT01228734|7382672|FG001|Modified Safety Population|Overall Study||199
6465733|NCT01228734|7382671|FG000|COMPLETED|Overall Study||193
6465734|NCT01228734|7382672|FG001|COMPLETED|Overall Study||200
6465735|NCT01228734|7382671|FG000|NOT COMPLETED|Overall Study||0
6465736|NCT01228734|7382672|FG001|NOT COMPLETED|Overall Study||4
6465737|NCT01228747|7382680|FG000|STARTED|Overall Study||125
6465738|NCT01228747|7382681|FG001|STARTED|Overall Study||126
6465739|NCT01228747|7382680|FG000|COMPLETED|Overall Study||60
6465740|NCT01228747|7382681|FG001|COMPLETED|Overall Study||81
6465741|NCT01228747|7382680|FG000|NOT COMPLETED|Overall Study||65
6465742|NCT01228747|7382681|FG001|NOT COMPLETED|Overall Study||45
6465743|NCT01228903|7382689|FG000|STARTED|Overall Study||41
6465744|NCT01228903|7382690|FG001|STARTED|Overall Study||39
6465745|NCT01228903|7382689|FG000|COMPLETED|Overall Study||36
6465746|NCT01228903|7382690|FG001|COMPLETED|Overall Study||34
6465747|NCT01228903|7382689|FG000|NOT COMPLETED|Overall Study||5
6465748|NCT01228903|7382690|FG001|NOT COMPLETED|Overall Study||5
6465749|NCT01228929|7382699|FG000|STARTED|Nominal Condition||6
6465750|NCT01228929|7382700|FG001|STARTED|Nominal Condition||6
6465751|NCT01228929|7382701|FG002|STARTED|Nominal Condition||6
6465752|NCT01228929|7382699|FG000|COMPLETED|Nominal Condition||6
6465753|NCT01228929|7382700|FG001|COMPLETED|Nominal Condition||6
6465754|NCT01228929|7382701|FG002|COMPLETED|Nominal Condition||6
6465755|NCT01228929|7382699|FG000|NOT COMPLETED|Nominal Condition||0
6465756|NCT01228929|7382700|FG001|NOT COMPLETED|Nominal Condition||0
6465757|NCT01228929|7382701|FG002|NOT COMPLETED|Nominal Condition||0
6465758|NCT01228929|7382699|FG000|STARTED|Low Humidity Condition||6
6465759|NCT01228929|7382700|FG001|STARTED|Low Humidity Condition||6
6465760|NCT01228929|7382701|FG002|STARTED|Low Humidity Condition||6
6465761|NCT01228929|7382699|FG000|COMPLETED|Low Humidity Condition||6
6465762|NCT01228929|7382700|FG001|COMPLETED|Low Humidity Condition||6
6465763|NCT01228929|7382701|FG002|COMPLETED|Low Humidity Condition||6
6465764|NCT01228929|7382699|FG000|NOT COMPLETED|Low Humidity Condition||0
6465765|NCT01228929|7382700|FG001|NOT COMPLETED|Low Humidity Condition||0
6465766|NCT01228929|7382701|FG002|NOT COMPLETED|Low Humidity Condition||0
6465767|NCT01228929|7382699|FG000|STARTED|High Temperature Condition||6
6465768|NCT01228929|7382700|FG001|STARTED|High Temperature Condition||6
6465769|NCT01228929|7382701|FG002|STARTED|High Temperature Condition||6
6465770|NCT01228929|7382699|FG000|COMPLETED|High Temperature Condition||6
6465771|NCT01228929|7382700|FG001|COMPLETED|High Temperature Condition||6
6465772|NCT01228929|7382701|FG002|COMPLETED|High Temperature Condition||6
6465773|NCT01228929|7382699|FG000|NOT COMPLETED|High Temperature Condition||0
6465774|NCT01228929|7382700|FG001|NOT COMPLETED|High Temperature Condition||0
6465775|NCT01228929|7382701|FG002|NOT COMPLETED|High Temperature Condition||0
6465776|NCT01228968|7382709|FG000|STARTED|Overall Study||9
6465777|NCT01228968|7382709|FG000|COMPLETED|Overall Study||9
6465778|NCT01228968|7382709|FG000|NOT COMPLETED|Overall Study||0
6465779|NCT01229111|7382713|FG000|STARTED|Overall Study||14
6465780|NCT01229111|7382713|FG000|COMPLETED|Overall Study||13
6465781|NCT01229111|7382713|FG000|NOT COMPLETED|Overall Study||1
6465782|NCT01229150|7382721|FG000|STARTED|Overall Study||30
6465783|NCT01229150|7382722|FG001|STARTED|Overall Study||11
6465784|NCT01229150|7382723|FG002|STARTED|Overall Study||19
6465785|NCT01229150|7382724|FG003|STARTED|Overall Study||19
6465786|NCT01229150|7382721|FG000|COMPLETED|Overall Study||28
6465787|NCT01229150|7382722|FG001|COMPLETED|Overall Study||9
6465788|NCT01229150|7382723|FG002|COMPLETED|Overall Study||19
6465789|NCT01229150|7382724|FG003|COMPLETED|Overall Study||19
6465790|NCT01229150|7382721|FG000|NOT COMPLETED|Overall Study||2
6465791|NCT01229150|7382722|FG001|NOT COMPLETED|Overall Study||2
6465792|NCT01229150|7382723|FG002|NOT COMPLETED|Overall Study||0
6465793|NCT01229150|7382724|FG003|NOT COMPLETED|Overall Study||0
6465794|NCT01229176|7382746|FG000|STARTED|Overall Study||40
6465795|NCT01229176|7382747|FG001|STARTED|Overall Study||40
6465796|NCT01229176|7382748|FG002|STARTED|Overall Study||20
6465797|NCT01229176|7382749|FG003|STARTED|Overall Study||20
6465798|NCT01229176|7382750|FG004|STARTED|Overall Study||20
6465799|NCT01229176|7382751|FG005|STARTED|Overall Study||20
6465800|NCT01229176|7382752|FG006|STARTED|Overall Study||20
6465801|NCT01229176|7382753|FG007|STARTED|Overall Study||20
6465802|NCT01229176|7382746|FG000|COMPLETED|Overall Study||40
6465803|NCT01229176|7382747|FG001|COMPLETED|Overall Study||37
6465804|NCT01229176|7382748|FG002|COMPLETED|Overall Study||20
6465805|NCT01229176|7382749|FG003|COMPLETED|Overall Study||19
6465806|NCT01229176|7382750|FG004|COMPLETED|Overall Study||18
6465807|NCT01229176|7382751|FG005|COMPLETED|Overall Study||18
6465808|NCT01229176|7382752|FG006|COMPLETED|Overall Study||20
6465809|NCT01229176|7382753|FG007|COMPLETED|Overall Study||17
6465810|NCT01229176|7382746|FG000|NOT COMPLETED|Overall Study||0
6465811|NCT01229176|7382747|FG001|NOT COMPLETED|Overall Study||3
6465812|NCT01229176|7382748|FG002|NOT COMPLETED|Overall Study||0
6465813|NCT01229176|7382749|FG003|NOT COMPLETED|Overall Study||1
6465814|NCT01229176|7382750|FG004|NOT COMPLETED|Overall Study||2
6465815|NCT01229176|7382751|FG005|NOT COMPLETED|Overall Study||2
6465816|NCT01229176|7382752|FG006|NOT COMPLETED|Overall Study||0
6465817|NCT01229176|7382753|FG007|NOT COMPLETED|Overall Study||3
6465818|NCT01229228|7382776|FG000|STARTED|Overall Study||51
6465819|NCT01229228|7382777|FG001|STARTED|Overall Study||51
6465820|NCT01229228|7382778|FG002|STARTED|Overall Study||50
6465821|NCT01229228|7382779|FG003|STARTED|Overall Study||51
6465822|NCT01229228|7382780|FG004|STARTED|Overall Study||51
6465823|NCT01229228|7382776|FG000|COMPLETED|Overall Study||50
6465824|NCT01229228|7382777|FG001|COMPLETED|Overall Study||51
6465825|NCT01229228|7382778|FG002|COMPLETED|Overall Study||49
6465826|NCT01229228|7382779|FG003|COMPLETED|Overall Study||51
6465827|NCT01229228|7382780|FG004|COMPLETED|Overall Study||50
6465828|NCT01229228|7382776|FG000|NOT COMPLETED|Overall Study||1
6465829|NCT01229228|7382777|FG001|NOT COMPLETED|Overall Study||0
6465830|NCT01229228|7382778|FG002|NOT COMPLETED|Overall Study||1
6465831|NCT01229228|7382779|FG003|NOT COMPLETED|Overall Study||0
6465832|NCT01229228|7382780|FG004|NOT COMPLETED|Overall Study||1
6465833|NCT01229254|7382795|FG000|STARTED|Overall Study||42
6465834|NCT01229254|7382796|FG001|STARTED|Overall Study||74
6465835|NCT01229254|7382797|FG002|STARTED|Overall Study||73
6465836|NCT01229254|7382795|FG000|COMPLETED|Overall Study||27
6465837|NCT01229254|7382796|FG001|COMPLETED|Overall Study||58
6465838|NCT01229254|7382797|FG002|COMPLETED|Overall Study||61
6465839|NCT01229254|7382795|FG000|NOT COMPLETED|Overall Study||15
6465840|NCT01229254|7382796|FG001|NOT COMPLETED|Overall Study||16
6465841|NCT01229254|7382797|FG002|NOT COMPLETED|Overall Study||12
6465842|NCT01229267|7382811|FG000|STARTED|Overall Study||189
6465843|NCT01229267|7382812|FG001|STARTED|Overall Study||184
6465844|NCT01229267|7382813|FG002|STARTED|Overall Study||187
6465845|NCT01229267|7382814|FG003|STARTED|Overall Study||106
6465846|NCT01229267|7382815|FG004|STARTED|Overall Study||564
6465847|NCT01229267|7382811|FG000|Received Vaccination 1|Overall Study||188
6465848|NCT01229267|7382812|FG001|Received Vaccination 1|Overall Study||180
6465849|NCT01229267|7382813|FG002|Received Vaccination 1|Overall Study||186
6465850|NCT01229267|7382814|FG003|Received Vaccination 1|Overall Study||104
6465851|NCT01229267|7382815|FG004|Received Vaccination 1|Overall Study||556
6465852|NCT01229267|7382811|FG000|Received Vaccination 2|Overall Study||171
6465853|NCT01229267|7382812|FG001|Received Vaccination 2|Overall Study||163
6465854|NCT01229267|7382813|FG002|Received Vaccination 2|Overall Study||168
6465855|NCT01229267|7382814|FG003|Received Vaccination 2|Overall Study||94
6465856|NCT01229267|7382815|FG004|Received Vaccination 2|Overall Study||511
6465857|NCT01229267|7382811|FG000|Received Vaccination 3|Overall Study||163
6465858|NCT01229267|7382812|FG001|Received Vaccination 3|Overall Study||155
6465859|NCT01229267|7382813|FG002|Received Vaccination 3|Overall Study||160
6465860|NCT01229267|7382814|FG003|Received Vaccination 3|Overall Study||89
6465861|NCT01229267|7382815|FG004|Received Vaccination 3|Overall Study||491
6465862|NCT01229267|7382811|FG000|Received Vaccination 4|Overall Study||155
6465863|NCT01229267|7382812|FG001|Received Vaccination 4|Overall Study||149
6465864|NCT01229267|7382813|FG002|Received Vaccination 4|Overall Study||149
6465865|NCT01229267|7382814|FG003|Received Vaccination 4|Overall Study||87
6465866|NCT01229267|7382815|FG004|Received Vaccination 4|Overall Study||477
6465867|NCT01229267|7382811|FG000|COMPLETED|Overall Study||108
6465868|NCT01229267|7382812|FG001|COMPLETED|Overall Study||102
6465869|NCT01229267|7382813|FG002|COMPLETED|Overall Study||101
6465870|NCT01229267|7382814|FG003|COMPLETED|Overall Study||71
6465871|NCT01229267|7382815|FG004|COMPLETED|Overall Study||344
6465872|NCT01229267|7382811|FG000|NOT COMPLETED|Overall Study||81
6465873|NCT01229267|7382812|FG001|NOT COMPLETED|Overall Study||82
6465874|NCT01229267|7382813|FG002|NOT COMPLETED|Overall Study||86
6465875|NCT01229267|7382814|FG003|NOT COMPLETED|Overall Study||35
6465876|NCT01229267|7382815|FG004|NOT COMPLETED|Overall Study||220
6465877|NCT01229371|7382826|FG000|STARTED|Overall Study||109
6465878|NCT01229371|7382827|FG001|STARTED|Overall Study||111
6465879|NCT01229371|7382828|FG002|STARTED|Overall Study||110
6465880|NCT01229371|7382829|FG003|STARTED|Overall Study||110
6465881|NCT01229371|7382826|FG000|COMPLETED|Overall Study||109
6465882|NCT01229371|7382827|FG001|COMPLETED|Overall Study||110
6465883|NCT01229371|7382828|FG002|COMPLETED|Overall Study||110
6465884|NCT01229371|7382829|FG003|COMPLETED|Overall Study||110
6465885|NCT01229371|7382826|FG000|NOT COMPLETED|Overall Study||0
6465886|NCT01229371|7382827|FG001|NOT COMPLETED|Overall Study||1
6465887|NCT01229371|7382828|FG002|NOT COMPLETED|Overall Study||0
6465888|NCT01229371|7382829|FG003|NOT COMPLETED|Overall Study||0
6465889|NCT01229397|7382841|FG000|STARTED|Overall Study||103
6465890|NCT01229397|7382842|FG001|STARTED|Overall Study||102
6465891|NCT01229397|7382841|FG000|COMPLETED|Overall Study||92
6465892|NCT01229397|7382842|FG001|COMPLETED|Overall Study||93
6465893|NCT01229397|7382841|FG000|NOT COMPLETED|Overall Study||11
6465894|NCT01229397|7382842|FG001|NOT COMPLETED|Overall Study||9
6465895|NCT01229410|7382854|FG000|STARTED|Overall Study||12
6465896|NCT01229410|7382855|FG001|STARTED|Overall Study||12
6465897|NCT01229410|7382854|FG000|COMPLETED|Overall Study||7
6465898|NCT01229410|7382855|FG001|COMPLETED|Overall Study||9
6465899|NCT01229410|7382854|FG000|NOT COMPLETED|Overall Study||5
6465900|NCT01229410|7382855|FG001|NOT COMPLETED|Overall Study||3
6465901|NCT01229423|7382861|FG000|STARTED|Overall Study||62
6465902|NCT01229423|7382861|FG000|COMPLETED|Overall Study||47
6465903|NCT01229423|7382861|FG000|NOT COMPLETED|Overall Study||15
6465904|NCT01229436|7382865|FG000|STARTED|Overall Study||254
6465905|NCT01229436|7382865|FG000|COMPLETED|Overall Study||249
6465906|NCT01229436|7382865|FG000|NOT COMPLETED|Overall Study||5
6465907|NCT01229449|7382874|FG000|STARTED|Overall Study||173
6465908|NCT01229449|7382875|FG001|STARTED|Overall Study||168
6465909|NCT01229449|7382876|FG002|STARTED|Overall Study||169
6465910|NCT01229449|7382877|FG003|STARTED|Overall Study||113
6465911|NCT01229449|7382878|FG004|STARTED|Overall Study||55
6465912|NCT01229449|7382874|FG000|COMPLETED|Overall Study||172
6465913|NCT01229449|7382875|FG001|COMPLETED|Overall Study||164
6465914|NCT01229449|7382876|FG002|COMPLETED|Overall Study||167
6465915|NCT01229449|7382877|FG003|COMPLETED|Overall Study||112
6465916|NCT01229449|7382878|FG004|COMPLETED|Overall Study||54
6465917|NCT01229449|7382874|FG000|NOT COMPLETED|Overall Study||1
6465918|NCT01229449|7382875|FG001|NOT COMPLETED|Overall Study||4
6465919|NCT01229449|7382876|FG002|NOT COMPLETED|Overall Study||2
6465920|NCT01229449|7382877|FG003|NOT COMPLETED|Overall Study||1
6465921|NCT01229449|7382878|FG004|NOT COMPLETED|Overall Study||1
6465922|NCT01229462|7382892|FG000|STARTED|Overall Study||120
6465923|NCT01229462|7382893|FG001|STARTED|Overall Study||118
6465924|NCT01229462|7382892|FG000|COMPLETED|Overall Study||115
6465925|NCT01229462|7382893|FG001|COMPLETED|Overall Study||109
6465926|NCT01229462|7382892|FG000|NOT COMPLETED|Overall Study||5
6465927|NCT01229462|7382893|FG001|NOT COMPLETED|Overall Study||9
6465928|NCT01229527|7382902|FG000|STARTED|Overall Study||30
6465929|NCT01229527|7382903|FG001|STARTED|Overall Study||30
6465930|NCT01229527|7382904|FG002|STARTED|Overall Study||30
6465931|NCT01229527|7382902|FG000|COMPLETED|Overall Study||30
6465932|NCT01229527|7382903|FG001|COMPLETED|Overall Study||30
6465933|NCT01229527|7382904|FG002|COMPLETED|Overall Study||30
6465934|NCT01229527|7382902|FG000|NOT COMPLETED|Overall Study||0
6465935|NCT01229527|7382903|FG001|NOT COMPLETED|Overall Study||0
6465936|NCT01229527|7382904|FG002|NOT COMPLETED|Overall Study||0
6465937|NCT01229722|7382914|FG000|STARTED|Overall Study||36
6465938|NCT01229722|7382915|FG001|STARTED|Overall Study||34
6465939|NCT01229722|7382914|FG000|COMPLETED|Overall Study||36
6465940|NCT01229722|7382915|FG001|COMPLETED|Overall Study||30
6465941|NCT01229722|7382914|FG000|NOT COMPLETED|Overall Study||0
6465942|NCT01229722|7382915|FG001|NOT COMPLETED|Overall Study||4
6465943|NCT01229735|7382927|FG000|STARTED|Overall Study||177
6465944|NCT01229735|7382928|FG001|STARTED|Overall Study||166
6465945|NCT01229735|7382927|FG000|COMPLETED|Overall Study||111
6465946|NCT01229735|7382928|FG001|COMPLETED|Overall Study||100
6465947|NCT01229735|7382927|FG000|NOT COMPLETED|Overall Study||66
6465948|NCT01229735|7382928|FG001|NOT COMPLETED|Overall Study||66
6465949|NCT01229891|7382939|FG000|STARTED|Overall Study||30
6465950|NCT01229891|7382940|FG001|STARTED|Overall Study||30
6465951|NCT01229891|7382941|FG002|STARTED|Overall Study||30
6465952|NCT01229891|7382939|FG000|COMPLETED|Overall Study||30
6465953|NCT01229891|7382940|FG001|COMPLETED|Overall Study||30
6465954|NCT01229891|7382941|FG002|COMPLETED|Overall Study||30
6465955|NCT01229891|7382939|FG000|NOT COMPLETED|Overall Study||0
6465956|NCT01229891|7382940|FG001|NOT COMPLETED|Overall Study||0
6465957|NCT01229891|7382941|FG002|NOT COMPLETED|Overall Study||0
6465958|NCT01230021|7382949|FG000|STARTED|Overall Study||6
6465959|NCT01230021|7382949|FG000|COMPLETED|Overall Study||6
6465960|NCT01230021|7382949|FG000|NOT COMPLETED|Overall Study||0
6465961|NCT01230060|7382953|FG000|STARTED|Overall Study||122
6465962|NCT01230060|7382953|FG000|COMPLETED|Overall Study||121
6465963|NCT01230060|7382953|FG000|NOT COMPLETED|Overall Study||1
6465964|NCT01230125|7382959|FG000|STARTED|Overall Study||207
6465965|NCT01230125|7382960|FG001|STARTED|Overall Study||104
6465966|NCT01230125|7382959|FG000|COMPLETED|Overall Study||134
6465967|NCT01230125|7382960|FG001|COMPLETED|Overall Study||54
6465968|NCT01230125|7382959|FG000|NOT COMPLETED|Overall Study||73
6465969|NCT01230125|7382960|FG001|NOT COMPLETED|Overall Study||50
6465970|NCT01230177|7382966|FG000|STARTED|Overall Study||3
6465971|NCT01230177|7382966|FG000|COMPLETED|Overall Study||3
6465972|NCT01230177|7382966|FG000|NOT COMPLETED|Overall Study||0
6465973|NCT01230424|7382972|FG000|STARTED|Overall Study||70
6465974|NCT01230424|7382973|FG001|STARTED|Overall Study||70
6465975|NCT01230424|7382972|FG000|COMPLETED|Overall Study||70
6465976|NCT01230424|7382973|FG001|COMPLETED|Overall Study||70
6465977|NCT01230424|7382972|FG000|NOT COMPLETED|Overall Study||0
6465978|NCT01230424|7382973|FG001|NOT COMPLETED|Overall Study||0
6465979|NCT01230502|7382985|FG000|STARTED|Overall Study||9
6465980|NCT01230502|7382986|FG001|STARTED|Overall Study||0
6465981|NCT01230502|7382987|FG002|STARTED|Overall Study||0
6465982|NCT01230502|7382985|FG000|COMPLETED|Overall Study||9
6465983|NCT01230502|7382986|FG001|COMPLETED|Overall Study||0
6465984|NCT01230502|7382987|FG002|COMPLETED|Overall Study||0
6465985|NCT01230502|7382985|FG000|NOT COMPLETED|Overall Study||0
6465986|NCT01230502|7382986|FG001|NOT COMPLETED|Overall Study||0
6465987|NCT01230502|7382987|FG002|NOT COMPLETED|Overall Study||0
6465988|NCT01230554|7382998|FG000|STARTED|Overall Study||212
6465989|NCT01230554|7382998|FG000|COMPLETED|Overall Study||209
6465990|NCT01230554|7382998|FG000|NOT COMPLETED|Overall Study||3
6465991|NCT01230593|7383005|FG000|STARTED|Overall Study||50
6465992|NCT01230593|7383006|FG001|STARTED|Overall Study||50
6465993|NCT01230593|7383007|FG002|STARTED|Overall Study||50
6465994|NCT01230593|7383005|FG000|COMPLETED|Overall Study||35
6465995|NCT01230593|7383006|FG001|COMPLETED|Overall Study||32
6465996|NCT01230593|7383007|FG002|COMPLETED|Overall Study||38
6465997|NCT01230593|7383005|FG000|NOT COMPLETED|Overall Study||15
6465998|NCT01230593|7383006|FG001|NOT COMPLETED|Overall Study||18
6465999|NCT01230593|7383007|FG002|NOT COMPLETED|Overall Study||12
6466000|NCT01230710|7383015|FG000|STARTED|Overall Study||51
6466001|NCT01230710|7383015|FG000|COMPLETED|Overall Study||2
6466002|NCT01230710|7383015|FG000|NOT COMPLETED|Overall Study||49
6466003|NCT01230749|7383023|FG000|STARTED|Overall Study||22
6466004|NCT01230749|7383024|FG001|STARTED|Overall Study||22
6466005|NCT01230749|7383025|FG002|STARTED|Overall Study||23
6466006|NCT01230749|7383026|FG003|STARTED|Overall Study||22
6466007|NCT01230749|7383023|FG000|COMPLETED|Overall Study||22
6466008|NCT01230749|7383024|FG001|COMPLETED|Overall Study||20
6466009|NCT01230749|7383025|FG002|COMPLETED|Overall Study||21
6466010|NCT01230749|7383026|FG003|COMPLETED|Overall Study||20
6466011|NCT01230749|7383023|FG000|NOT COMPLETED|Overall Study||0
6466012|NCT01230749|7383024|FG001|NOT COMPLETED|Overall Study||2
6466013|NCT01230749|7383025|FG002|NOT COMPLETED|Overall Study||2
6466014|NCT01230749|7383026|FG003|NOT COMPLETED|Overall Study||2
6466015|NCT01230801|7383042|FG000|STARTED|Overall Study||3
6466016|NCT01230801|7383043|FG001|STARTED|Overall Study||3
6466017|NCT01230801|7383044|FG002|STARTED|Overall Study||16
6466018|NCT01230801|7383042|FG000|COMPLETED|Overall Study||3
6466019|NCT01230801|7383043|FG001|COMPLETED|Overall Study||3
6466020|NCT01230801|7383044|FG002|COMPLETED|Overall Study||15
6466021|NCT01230801|7383042|FG000|NOT COMPLETED|Overall Study||0
6466022|NCT01230801|7383043|FG001|NOT COMPLETED|Overall Study||0
6466023|NCT01230801|7383044|FG002|NOT COMPLETED|Overall Study||1
6466024|NCT01230814|7383057|FG000|STARTED|Overall Study||118
6466025|NCT01230814|7383058|FG001|STARTED|Overall Study||116
6466026|NCT01230814|7383057|FG000|COMPLETED|Overall Study||105
6466027|NCT01230814|7383058|FG001|COMPLETED|Overall Study||112
6466028|NCT01230814|7383057|FG000|NOT COMPLETED|Overall Study||13
6466029|NCT01230814|7383058|FG001|NOT COMPLETED|Overall Study||4
6466030|NCT01230827|7383068|FG000|STARTED|Overall Study||19
6466031|NCT01230827|7383069|FG001|STARTED|Overall Study||11
6466032|NCT01230827|7383070|FG002|STARTED|Overall Study||65
6466033|NCT01230827|7383071|FG003|STARTED|Overall Study||78
6466034|NCT01230827|7383068|FG000|COMPLETED|Overall Study||0
6466035|NCT01230827|7383069|FG001|COMPLETED|Overall Study||0
6466036|NCT01230827|7383070|FG002|COMPLETED|Overall Study||0
6466037|NCT01230827|7383071|FG003|COMPLETED|Overall Study||0
6466038|NCT01230827|7383068|FG000|NOT COMPLETED|Overall Study||19
6466039|NCT01230827|7383069|FG001|NOT COMPLETED|Overall Study||11
6466040|NCT01230827|7383070|FG002|NOT COMPLETED|Overall Study||65
6466041|NCT01230827|7383071|FG003|NOT COMPLETED|Overall Study||78
6466042|NCT01230892|7383081|FG000|STARTED|Overall Study||15
6466043|NCT01230892|7383082|FG001|STARTED|Overall Study||14
6466044|NCT01230892|7383081|FG000|COMPLETED|Overall Study||12
6466045|NCT01230892|7383082|FG001|COMPLETED|Overall Study||13
6466046|NCT01230892|7383081|FG000|NOT COMPLETED|Overall Study||3
6466047|NCT01230892|7383082|FG001|NOT COMPLETED|Overall Study||1
6466048|NCT01230931|7383090|FG000|STARTED|Overall Study||10
6466049|NCT01230931|7383091|FG001|STARTED|Overall Study||10
6466050|NCT01230931|7383090|FG000|COMPLETED|Overall Study||10
6466051|NCT01230931|7383091|FG001|COMPLETED|Overall Study||10
6466052|NCT01230931|7383090|FG000|NOT COMPLETED|Overall Study||0
6466053|NCT01230931|7383091|FG001|NOT COMPLETED|Overall Study||0
6466054|NCT01231230|7383098|FG000|STARTED|Overall Study||14
6466055|NCT01231230|7383098|FG000|Fluticasone|Overall Study||14
6466056|NCT01231230|7383098|FG000|Salmeterol|Overall Study||14
6466057|NCT01231230|7383098|FG000|Fluticasone/Salmeterol|Overall Study||14
6466058|NCT01231230|7383098|FG000|Placebo|Overall Study||14
6466059|NCT01231230|7383098|FG000|COMPLETED|Overall Study||14
6466060|NCT01231230|7383098|FG000|NOT COMPLETED|Overall Study||0
6466061|NCT01231321|7383108|FG000|STARTED|Overall Study||100
6466062|NCT01231321|7383108|FG000|COMPLETED|Overall Study||95
6466063|NCT01231321|7383108|FG000|NOT COMPLETED|Overall Study||5
6466064|NCT01231334|7383120|FG000|STARTED|Overall Study||145
6554162|NCT01746901|7476553|FG008|STARTED|Treatment Phase: First Intervention||7
6554163|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: First Intervention||0
6554164|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: First Intervention||0
6466065|NCT01231334|7383121|FG001|STARTED|Overall Study||141
6466066|NCT01231334|7383120|FG000|COMPLETED|Overall Study||126
6466067|NCT01231334|7383121|FG001|COMPLETED|Overall Study||120
6466068|NCT01231334|7383120|FG000|NOT COMPLETED|Overall Study||19
6466069|NCT01231334|7383121|FG001|NOT COMPLETED|Overall Study||21
6466070|NCT01231373|7383131|FG000|STARTED|Overall Study||59
6466071|NCT01231373|7383132|FG001|STARTED|Overall Study||58
6466072|NCT01231373|7383133|FG002|STARTED|Overall Study||60
6466073|NCT01231373|7383134|FG003|STARTED|Overall Study||58
6466074|NCT01231373|7383131|FG000|Patients Receiving Blinded Treatment|Overall Study||57
6466075|NCT01231373|7383132|FG001|Patients Receiving Blinded Treatment|Overall Study||57
6466076|NCT01231373|7383133|FG002|Patients Receiving Blinded Treatment|Overall Study||60
6466077|NCT01231373|7383134|FG003|Patients Receiving Blinded Treatment|Overall Study||58
6466078|NCT01231373|7383131|FG000|COMPLETED|Overall Study||56
6466079|NCT01231373|7383132|FG001|COMPLETED|Overall Study||57
6466080|NCT01231373|7383133|FG002|COMPLETED|Overall Study||60
6466081|NCT01231373|7383134|FG003|COMPLETED|Overall Study||57
6466082|NCT01231373|7383131|FG000|NOT COMPLETED|Overall Study||3
6654439|NCT02445859|7584273|FG001|STARTED|Overall Study||45
6654440|NCT02445859|7584272|FG000|COMPLETED|Overall Study||43
6654441|NCT02445859|7584273|FG001|COMPLETED|Overall Study||42
6654442|NCT02445859|7584272|FG000|NOT COMPLETED|Overall Study||2
6466083|NCT01231373|7383132|FG001|NOT COMPLETED|Overall Study||1
6466084|NCT01231373|7383133|FG002|NOT COMPLETED|Overall Study||0
6466085|NCT01231373|7383134|FG003|NOT COMPLETED|Overall Study||1
6466086|NCT01231399|7383146|FG000|STARTED|Overall Study||6
6466087|NCT01231399|7383146|FG000|COMPLETED|Overall Study||6
6466088|NCT01231399|7383146|FG000|NOT COMPLETED|Overall Study||0
6466089|NCT01231412|7383154|FG000|STARTED|Overall Study||77
6466090|NCT01231412|7383155|FG001|STARTED|Overall Study||91
6466091|NCT01231412|7383156|FG002|STARTED|Overall Study||6
6466092|NCT01231412|7383154|FG000|COMPLETED|Overall Study||77
6466093|NCT01231412|7383155|FG001|COMPLETED|Overall Study||90
6466094|NCT01231412|7383156|FG002|COMPLETED|Overall Study||6
6466095|NCT01231412|7383154|FG000|NOT COMPLETED|Overall Study||0
6466096|NCT01231412|7383155|FG001|NOT COMPLETED|Overall Study||1
6466097|NCT01231412|7383156|FG002|NOT COMPLETED|Overall Study||0
6500954|NCT01426269|7419435|FG002|COMPLETED|Period 1: 12 Weeks||0
6500955|NCT01426269|7419433|FG000|NOT COMPLETED|Period 1: 12 Weeks||55
6500956|NCT01426269|7419434|FG001|NOT COMPLETED|Period 1: 12 Weeks||0
6500957|NCT01426269|7419435|FG002|NOT COMPLETED|Period 1: 12 Weeks||0
6500958|NCT01426269|7419433|FG000|STARTED|Eligibility for Period 2, Randomization||180
6500959|NCT01426269|7419434|FG001|STARTED|Eligibility for Period 2, Randomization||0
6500960|NCT01426269|7419435|FG002|STARTED|Eligibility for Period 2, Randomization||0
6500961|NCT01426269|7419433|FG000|COMPLETED|Eligibility for Period 2, Randomization||130
6500962|NCT01426269|7419434|FG001|COMPLETED|Eligibility for Period 2, Randomization||0
6500963|NCT01426269|7419435|FG002|COMPLETED|Eligibility for Period 2, Randomization||0
6500964|NCT01426269|7419433|FG000|NOT COMPLETED|Eligibility for Period 2, Randomization||50
6500965|NCT01426269|7419434|FG001|NOT COMPLETED|Eligibility for Period 2, Randomization||0
6500966|NCT01426269|7419435|FG002|NOT COMPLETED|Eligibility for Period 2, Randomization||0
6500967|NCT01426269|7419433|FG000|STARTED|Period 2: 40 Weeks||0
6500968|NCT01426269|7419434|FG001|STARTED|Period 2: 40 Weeks||65
6500969|NCT01426269|7419435|FG002|STARTED|Period 2: 40 Weeks||65
6500970|NCT01426269|7419433|FG000|COMPLETED|Period 2: 40 Weeks||0
6500971|NCT01426269|7419434|FG001|COMPLETED|Period 2: 40 Weeks||27
6500972|NCT01426269|7419435|FG002|COMPLETED|Period 2: 40 Weeks||18
6500973|NCT01426269|7419433|FG000|NOT COMPLETED|Period 2: 40 Weeks||0
6500974|NCT01426269|7419434|FG001|NOT COMPLETED|Period 2: 40 Weeks||38
6500975|NCT01426269|7419435|FG002|NOT COMPLETED|Period 2: 40 Weeks||47
6500976|NCT01426347|7419448|FG000|STARTED|Overall Study||41
6500977|NCT01426347|7419449|FG001|STARTED|Overall Study||42
6500978|NCT01426347|7419448|FG000|COMPLETED|Overall Study||34
6554165|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: First Intervention||0
6554166|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: First Intervention||6
6554167|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: First Intervention||6
6466098|NCT01231464|7383166|FG000|STARTED|Overall Study||182
6466099|NCT01231464|7383167|FG001|STARTED|Overall Study||183
6466100|NCT01231464|7383166|FG000|COMPLETED|Overall Study||177
6466101|NCT01231464|7383167|FG001|COMPLETED|Overall Study||176
6466102|NCT01231464|7383166|FG000|NOT COMPLETED|Overall Study||5
6466103|NCT01231464|7383167|FG001|NOT COMPLETED|Overall Study||7
6466104|NCT01231503|7383183|FG000|STARTED|Overall Study||60
6466105|NCT01231503|7383184|FG001|STARTED|Overall Study||59
6466106|NCT01231503|7383185|FG002|STARTED|Overall Study||60
6466107|NCT01231503|7383186|FG003|STARTED|Overall Study||60
6466108|NCT01231503|7383187|FG004|STARTED|Overall Study||60
6466109|NCT01231503|7383188|FG005|STARTED|Overall Study||60
6466110|NCT01231503|7383189|FG006|STARTED|Overall Study||60
6466111|NCT01231503|7383190|FG007|STARTED|Overall Study||60
6466112|NCT01231503|7383183|FG000|COMPLETED|Overall Study||46
6466113|NCT01231503|7383184|FG001|COMPLETED|Overall Study||46
6466114|NCT01231503|7383185|FG002|COMPLETED|Overall Study||48
6466115|NCT01231503|7383186|FG003|COMPLETED|Overall Study||52
6466116|NCT01231503|7383187|FG004|COMPLETED|Overall Study||50
6466117|NCT01231503|7383188|FG005|COMPLETED|Overall Study||44
6554168|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: First Intervention||7
6554169|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: First Intervention||7
6554170|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: First Intervention||7
6746679|NCT03374995|7674332|FG001|NOT COMPLETED|Overall Study||1
6746680|NCT03375294|7674338|FG000|STARTED|Overall Study||3
6746681|NCT03375294|7674338|FG000|COMPLETED|Overall Study||3
6466118|NCT01231503|7383189|FG006|COMPLETED|Overall Study||53
6466119|NCT01231503|7383190|FG007|COMPLETED|Overall Study||52
6466120|NCT01231503|7383183|FG000|NOT COMPLETED|Overall Study||14
6466121|NCT01231503|7383184|FG001|NOT COMPLETED|Overall Study||13
6466122|NCT01231503|7383185|FG002|NOT COMPLETED|Overall Study||12
6466123|NCT01231503|7383186|FG003|NOT COMPLETED|Overall Study||8
6746682|NCT03375294|7674338|FG000|NOT COMPLETED|Overall Study||0
6746683|NCT03376061|7674344|FG000|STARTED|Overall Study||49
6746684|NCT03376061|7674345|FG001|STARTED|Overall Study||48
6746685|NCT03376061|7674344|FG000|COMPLETED|Overall Study||49
6746686|NCT03376061|7674345|FG001|COMPLETED|Overall Study||48
6746687|NCT03376061|7674344|FG000|NOT COMPLETED|Overall Study||0
6746688|NCT03376061|7674345|FG001|NOT COMPLETED|Overall Study||0
6746689|NCT03376256|7674354|FG000|STARTED|Overall Study||2
6466124|NCT01231503|7383187|FG004|NOT COMPLETED|Overall Study||10
6466125|NCT01231503|7383188|FG005|NOT COMPLETED|Overall Study||16
6466126|NCT01231503|7383189|FG006|NOT COMPLETED|Overall Study||7
6466127|NCT01231503|7383190|FG007|NOT COMPLETED|Overall Study||8
6466128|NCT01231555|7383221|FG000|STARTED|Overall Study||8
6466129|NCT01231555|7383222|FG001|STARTED|Overall Study||7
6466130|NCT01231555|7383223|FG002|STARTED|Overall Study||8
6466131|NCT01231555|7383221|FG000|COMPLETED|Overall Study||0
6466132|NCT01231555|7383222|FG001|COMPLETED|Overall Study||0
6466133|NCT01231555|7383223|FG002|COMPLETED|Overall Study||0
6466134|NCT01231555|7383221|FG000|NOT COMPLETED|Overall Study||8
6466135|NCT01231555|7383222|FG001|NOT COMPLETED|Overall Study||7
6466136|NCT01231555|7383223|FG002|NOT COMPLETED|Overall Study||8
6466137|NCT01231581|7383233|FG000|STARTED|Overall Study||80
6466138|NCT01231581|7383234|FG001|STARTED|Overall Study||80
6466139|NCT01231581|7383233|FG000|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
6466140|NCT01231581|7383234|FG001|Ongoing|Overall Study||0
6466141|NCT01231581|7383233|FG000|COMPLETED|Overall Study||0
6466142|NCT01231581|7383234|FG001|COMPLETED|Overall Study||0
6466143|NCT01231581|7383233|FG000|NOT COMPLETED|Overall Study||80
6466144|NCT01231581|7383234|FG001|NOT COMPLETED|Overall Study||80
6466145|NCT01231607|7383245|FG000|STARTED|Overall Study||185
6466146|NCT01231607|7383246|FG001|STARTED|Overall Study||188
6466147|NCT01231607|7383247|FG002|STARTED|Overall Study||184
6466148|NCT01231607|7383248|FG003|STARTED|Overall Study||179
6466149|NCT01231607|7383249|FG004|STARTED|Overall Study||181
6466150|NCT01231607|7383245|FG000|COMPLETED|Overall Study||156
6466151|NCT01231607|7383246|FG001|COMPLETED|Overall Study||154
6466152|NCT01231607|7383247|FG002|COMPLETED|Overall Study||153
6466153|NCT01231607|7383248|FG003|COMPLETED|Overall Study||141
6466154|NCT01231607|7383249|FG004|COMPLETED|Overall Study||157
6466155|NCT01231607|7383245|FG000|NOT COMPLETED|Overall Study||29
6466156|NCT01231607|7383246|FG001|NOT COMPLETED|Overall Study||34
6466157|NCT01231607|7383247|FG002|NOT COMPLETED|Overall Study||31
6466158|NCT01231607|7383248|FG003|NOT COMPLETED|Overall Study||38
6466159|NCT01231607|7383249|FG004|NOT COMPLETED|Overall Study||24
6466160|NCT01231620|7383267|FG000|STARTED|Overall Study||201
6466161|NCT01231620|7383268|FG001|STARTED|Overall Study||209
6466162|NCT01231620|7383269|FG002|STARTED|Overall Study||205
6466163|NCT01231620|7383267|FG000|COMPLETED|Overall Study||175
6466164|NCT01231620|7383268|FG001|COMPLETED|Overall Study||178
6466165|NCT01231620|7383269|FG002|COMPLETED|Overall Study||166
6466166|NCT01231620|7383267|FG000|NOT COMPLETED|Overall Study||26
6466167|NCT01231620|7383268|FG001|NOT COMPLETED|Overall Study||31
6466168|NCT01231620|7383269|FG002|NOT COMPLETED|Overall Study||39
6466169|NCT01231633|7383279|FG000|STARTED|Overall Study||14
6466170|NCT01231633|7383280|FG001|STARTED|Overall Study||13
6466171|NCT01231633|7383279|FG000|COMPLETED|Overall Study||14
6466172|NCT01231633|7383280|FG001|COMPLETED|Overall Study||13
6746690|NCT03376256|7674355|FG001|STARTED|Overall Study||0
6746691|NCT03376256|7674354|FG000|COMPLETED|Overall Study||2
6746692|NCT03376256|7674355|FG001|COMPLETED|Overall Study||0
6466173|NCT01231633|7383279|FG000|NOT COMPLETED|Overall Study||0
6466174|NCT01231633|7383280|FG001|NOT COMPLETED|Overall Study||0
6466175|NCT01231646|7383290|FG000|STARTED|Overall Study||28
6466176|NCT01231646|7383291|FG001|STARTED|Overall Study||10
6466177|NCT01231646|7383290|FG000|COMPLETED|Overall Study||28
6466178|NCT01231646|7383291|FG001|COMPLETED|Overall Study||10
6466179|NCT01231646|7383290|FG000|NOT COMPLETED|Overall Study||0
6466180|NCT01231646|7383291|FG001|NOT COMPLETED|Overall Study||0
6466181|NCT01231659|7383297|FG000|STARTED|Overall Study||72
6466182|NCT01231659|7383297|FG000|Per Protocol (PP) Set|Overall Study||72
6466183|NCT01231659|7383297|FG000|Safety Set|Overall Study||72
6466184|NCT01231659|7383297|FG000|COMPLETED|Overall Study||0
6466185|NCT01231659|7383297|FG000|NOT COMPLETED|Overall Study||72
6466186|NCT01231841|7383301|FG000|STARTED|Overall Study||20
6466187|NCT01231841|7383301|FG000|COMPLETED|Overall Study||20
6466188|NCT01231841|7383301|FG000|NOT COMPLETED|Overall Study||0
6466189|NCT01231906|7383307|FG000|STARTED|Overall Study||319
6466190|NCT01231906|7383308|FG001|STARTED|Overall Study||323
6466191|NCT01231906|7383307|FG000|Received Therapy|Overall Study||308
6466192|NCT01231906|7383308|FG001|Received Therapy|Overall Study||318
6466193|NCT01231906|7383307|FG000|COMPLETED|Overall Study||198
6466194|NCT01231906|7383308|FG001|COMPLETED|Overall Study||222
6466195|NCT01231906|7383307|FG000|NOT COMPLETED|Overall Study||121
6466196|NCT01231906|7383308|FG001|NOT COMPLETED|Overall Study||101
6466197|NCT01231984|7383316|FG000|STARTED|Study Period 1||69
6466198|NCT01231984|7383317|FG001|STARTED|Study Period 1||70
6466199|NCT01231984|7383318|FG002|STARTED|Study Period 1||66
6466200|NCT01231984|7383319|FG003|STARTED|Study Period 1||69
6466201|NCT01231984|7383316|FG000|COMPLETED|Study Period 1||57
6466202|NCT01231984|7383317|FG001|COMPLETED|Study Period 1||63
6466203|NCT01231984|7383318|FG002|COMPLETED|Study Period 1||59
6466204|NCT01231984|7383319|FG003|COMPLETED|Study Period 1||60
6466205|NCT01231984|7383316|FG000|NOT COMPLETED|Study Period 1||12
6466206|NCT01231984|7383317|FG001|NOT COMPLETED|Study Period 1||7
6466207|NCT01231984|7383318|FG002|NOT COMPLETED|Study Period 1||7
6466208|NCT01231984|7383319|FG003|NOT COMPLETED|Study Period 1||9
6466209|NCT01231984|7383316|FG000|STARTED|Study Period 2||57
6466210|NCT01231984|7383317|FG001|STARTED|Study Period 2||63
6466211|NCT01231984|7383318|FG002|STARTED|Study Period 2||59
6466212|NCT01231984|7383319|FG003|STARTED|Study Period 2||60
6466213|NCT01231984|7383316|FG000|COMPLETED|Study Period 2||54
6466214|NCT01231984|7383317|FG001|COMPLETED|Study Period 2||61
6466215|NCT01231984|7383318|FG002|COMPLETED|Study Period 2||59
6466216|NCT01231984|7383319|FG003|COMPLETED|Study Period 2||56
6466217|NCT01231984|7383316|FG000|NOT COMPLETED|Study Period 2||3
6466218|NCT01231984|7383317|FG001|NOT COMPLETED|Study Period 2||2
6466219|NCT01231984|7383318|FG002|NOT COMPLETED|Study Period 2||0
6466220|NCT01231984|7383319|FG003|NOT COMPLETED|Study Period 2||4
6466221|NCT01232127|7383337|FG000|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
6466222|NCT01232127|7383338|FG001|STARTED|Period 1: Days 1-10||0
6466223|NCT01232127|7383339|FG002|STARTED|Period 1: Days 1-10||0
6466224|NCT01232127|7383337|FG000|COMPLETED|Period 1: Days 1-10||24
6466225|NCT01232127|7383338|FG001|COMPLETED|Period 1: Days 1-10||0
6466226|NCT01232127|7383339|FG002|COMPLETED|Period 1: Days 1-10||0
6466227|NCT01232127|7383337|FG000|NOT COMPLETED|Period 1: Days 1-10||1
6466228|NCT01232127|7383338|FG001|NOT COMPLETED|Period 1: Days 1-10||0
6466229|NCT01232127|7383339|FG002|NOT COMPLETED|Period 1: Days 1-10||0
6466230|NCT01232127|7383337|FG000|STARTED|Period 2: Days 11-17||0
6466231|NCT01232127|7383338|FG001|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
6466232|NCT01232127|7383339|FG002|STARTED|Period 2: Days 11-17||0
6466233|NCT01232127|7383337|FG000|COMPLETED|Period 2: Days 11-17||0
6466234|NCT01232127|7383338|FG001|COMPLETED|Period 2: Days 11-17||24
6466235|NCT01232127|7383339|FG002|COMPLETED|Period 2: Days 11-17||0
6466236|NCT01232127|7383337|FG000|NOT COMPLETED|Period 2: Days 11-17||0
6466237|NCT01232127|7383338|FG001|NOT COMPLETED|Period 2: Days 11-17||0
6466238|NCT01232127|7383339|FG002|NOT COMPLETED|Period 2: Days 11-17||0
6466239|NCT01232127|7383337|FG000|STARTED|Period 3: Days 18-24||0
6466240|NCT01232127|7383338|FG001|STARTED|Period 3: Days 18-24||0
6466241|NCT01232127|7383339|FG002|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
6466242|NCT01232127|7383337|FG000|COMPLETED|Period 3: Days 18-24||0
6466243|NCT01232127|7383338|FG001|COMPLETED|Period 3: Days 18-24||0
6466244|NCT01232127|7383339|FG002|COMPLETED|Period 3: Days 18-24||24
6466245|NCT01232127|7383337|FG000|NOT COMPLETED|Period 3: Days 18-24||0
6466246|NCT01232127|7383338|FG001|NOT COMPLETED|Period 3: Days 18-24||0
6466247|NCT01232127|7383339|FG002|NOT COMPLETED|Period 3: Days 18-24||0
6466248|NCT01232205|7383353|FG000|STARTED|Overall Study||52
6466249|NCT01232205|7383354|FG001|STARTED|Overall Study||58
6466250|NCT01232205|7383353|FG000|COMPLETED|Overall Study||49
6466251|NCT01232205|7383354|FG001|COMPLETED|Overall Study||55
6466252|NCT01232205|7383353|FG000|NOT COMPLETED|Overall Study||3
6466253|NCT01232205|7383354|FG001|NOT COMPLETED|Overall Study||3
6466254|NCT01232296|7383362|FG000|STARTED|Overall Study||82
6466255|NCT01232296|7383363|FG001|STARTED|Overall Study||83
6466256|NCT01232296|7383362|FG000|Full Analysis Set|Overall Study||82
6466257|NCT01232296|7383363|FG001|Full Analysis Set|Overall Study||83
6466258|NCT01232296|7383362|FG000|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
6466259|NCT01232296|7383363|FG001|Safety Set|Overall Study||83
6466260|NCT01232296|7383362|FG000|COMPLETED|Overall Study||0
6466261|NCT01232296|7383363|FG001|COMPLETED|Overall Study||0
6466262|NCT01232296|7383362|FG000|NOT COMPLETED|Overall Study||82
6466263|NCT01232296|7383363|FG001|NOT COMPLETED|Overall Study||83
6466264|NCT01232452|7383371|FG000|STARTED|Overall Study||87
6466265|NCT01232452|7383372|FG001|STARTED|Overall Study||85
6466266|NCT01232452|7383371|FG000|Received at Least One Dose of Study Drug|Overall Study||85
6466267|NCT01232452|7383372|FG001|Received at Least One Dose of Study Drug|Overall Study||81
6466268|NCT01232452|7383371|FG000|COMPLETED|Overall Study||48
6466269|NCT01232452|7383372|FG001|COMPLETED|Overall Study||46
6466270|NCT01232452|7383371|FG000|NOT COMPLETED|Overall Study||39
6466271|NCT01232452|7383372|FG001|NOT COMPLETED|Overall Study||39
6466272|NCT01232465|7383380|FG000|STARTED|Overall Study||337
6466273|NCT01232465|7383381|FG001|STARTED|Overall Study||402
6466274|NCT01232465|7383380|FG000|COMPLETED|Overall Study||337
6466275|NCT01232465|7383381|FG001|COMPLETED|Overall Study||402
6466276|NCT01232465|7383380|FG000|NOT COMPLETED|Overall Study||0
6466277|NCT01232465|7383381|FG001|NOT COMPLETED|Overall Study||0
6466278|NCT01232491|7383389|FG000|STARTED|Overall Study||306
6466279|NCT01232491|7383390|FG001|STARTED|Overall Study||305
6466280|NCT01232491|7383389|FG000|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
6466281|NCT01232491|7383390|FG001|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
6466282|NCT01232491|7383389|FG000|COMPLETED|Overall Study||246
6466283|NCT01232491|7383390|FG001|COMPLETED|Overall Study||242
6466284|NCT01232491|7383389|FG000|NOT COMPLETED|Overall Study||60
6466285|NCT01232491|7383390|FG001|NOT COMPLETED|Overall Study||63
6466286|NCT01232504|7383399|FG000|STARTED|Overall Study||68
6466287|NCT01232504|7383400|FG001|STARTED|Overall Study||69
6466288|NCT01232504|7383401|FG002|STARTED|Overall Study||69
6466289|NCT01232504|7383399|FG000|COMPLETED|Overall Study||59
6466290|NCT01232504|7383400|FG001|COMPLETED|Overall Study||67
6466291|NCT01232504|7383401|FG002|COMPLETED|Overall Study||61
6466292|NCT01232504|7383399|FG000|NOT COMPLETED|Overall Study||9
6466293|NCT01232504|7383400|FG001|NOT COMPLETED|Overall Study||2
6466294|NCT01232504|7383401|FG002|NOT COMPLETED|Overall Study||8
6466295|NCT01232556|7383419|FG000|STARTED|Overall Study||166
6466296|NCT01232556|7383420|FG001|STARTED|Overall Study||172
6466297|NCT01232556|7383419|FG000|Treated|Overall Study|One subject in this arm received rituximab only and was excluded from the safety population.|165
6466298|NCT01232556|7383420|FG001|Treated|Overall Study||167
6466299|NCT01232556|7383419|FG000|COMPLETED|Overall Study||7
6466300|NCT01232556|7383420|FG001|COMPLETED|Overall Study||1
6466301|NCT01232556|7383419|FG000|NOT COMPLETED|Overall Study||159
6466302|NCT01232556|7383420|FG001|NOT COMPLETED|Overall Study||171
6466303|NCT01232569|7383428|FG000|STARTED|Double-blind Treatment Period||438
6466304|NCT01232569|7383429|FG001|STARTED|Double-blind Treatment Period||218
6466305|NCT01232569|7383430|FG002|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
6466306|NCT01232569|7383431|FG003|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
6466307|NCT01232569|7383428|FG000|COMPLETED|Double-blind Treatment Period||410
6466308|NCT01232569|7383429|FG001|COMPLETED|Double-blind Treatment Period||209
6466309|NCT01232569|7383430|FG002|COMPLETED|Double-blind Treatment Period||0
6466310|NCT01232569|7383431|FG003|COMPLETED|Double-blind Treatment Period||0
6466311|NCT01232569|7383428|FG000|NOT COMPLETED|Double-blind Treatment Period||28
6466312|NCT01232569|7383429|FG001|NOT COMPLETED|Double-blind Treatment Period||9
6466313|NCT01232569|7383430|FG002|NOT COMPLETED|Double-blind Treatment Period||0
6466314|NCT01232569|7383431|FG003|NOT COMPLETED|Double-blind Treatment Period||0
6466315|NCT01232569|7383428|FG000|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
6466316|NCT01232569|7383429|FG001|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
6466317|NCT01232569|7383430|FG002|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
6466318|NCT01232569|7383431|FG003|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
6466319|NCT01232569|7383428|FG000|COMPLETED|Open-label Extension Period||0
6466320|NCT01232569|7383429|FG001|COMPLETED|Open-label Extension Period||0
6466321|NCT01232569|7383430|FG002|COMPLETED|Open-label Extension Period||203
6466322|NCT01232569|7383431|FG003|COMPLETED|Open-label Extension Period||200
6466323|NCT01232569|7383428|FG000|NOT COMPLETED|Open-label Extension Period||0
6466324|NCT01232569|7383429|FG001|NOT COMPLETED|Open-label Extension Period||0
6466325|NCT01232569|7383430|FG002|NOT COMPLETED|Open-label Extension Period||27
6466326|NCT01232569|7383431|FG003|NOT COMPLETED|Open-label Extension Period||27
6466327|NCT01232738|7383440|FG000|STARTED|Overall Study||36
6466328|NCT01232738|7383440|FG000|COMPLETED|Overall Study||23
6466329|NCT01232738|7383440|FG000|NOT COMPLETED|Overall Study||13
6466330|NCT01232790|7383448|FG000|STARTED|Randomization||14
6466331|NCT01232790|7383449|FG001|STARTED|Randomization||14
6466332|NCT01232790|7383448|FG000|COMPLETED|Randomization||12
6466333|NCT01232790|7383449|FG001|COMPLETED|Randomization||12
6466334|NCT01232790|7383448|FG000|NOT COMPLETED|Randomization||2
6466335|NCT01232790|7383449|FG001|NOT COMPLETED|Randomization||2
6466336|NCT01232790|7383448|FG000|STARTED|Initial Assessment||12
6466337|NCT01232790|7383449|FG001|STARTED|Initial Assessment||12
6466338|NCT01232790|7383448|FG000|COMPLETED|Initial Assessment||12
6466339|NCT01232790|7383449|FG001|COMPLETED|Initial Assessment||11
6466340|NCT01232790|7383448|FG000|NOT COMPLETED|Initial Assessment||0
6466341|NCT01232790|7383449|FG001|NOT COMPLETED|Initial Assessment||1
6466342|NCT01232790|7383448|FG000|STARTED|First Crossover||12
6466343|NCT01232790|7383449|FG001|STARTED|First Crossover||11
6466344|NCT01232790|7383448|FG000|COMPLETED|First Crossover||11
6466345|NCT01232790|7383449|FG001|COMPLETED|First Crossover||11
6466346|NCT01232790|7383448|FG000|NOT COMPLETED|First Crossover||1
6466347|NCT01232790|7383449|FG001|NOT COMPLETED|First Crossover||0
6466348|NCT01232790|7383448|FG000|STARTED|Second Crossover||11
6466349|NCT01232790|7383449|FG001|STARTED|Second Crossover||11
6466350|NCT01232790|7383448|FG000|COMPLETED|Second Crossover||10
6466351|NCT01232790|7383449|FG001|COMPLETED|Second Crossover||9
6466352|NCT01232790|7383448|FG000|NOT COMPLETED|Second Crossover||1
6466353|NCT01232790|7383449|FG001|NOT COMPLETED|Second Crossover||2
6466354|NCT01232829|7383465|FG000|STARTED|Overall Study||18
6466355|NCT01232829|7383465|FG000|COMPLETED|Overall Study||18
6466356|NCT01232829|7383465|FG000|NOT COMPLETED|Overall Study||0
6466357|NCT01232868|7383471|FG000|STARTED|Overall Study||22
6466358|NCT01232868|7383472|FG001|STARTED|Overall Study||44
6466359|NCT01232868|7383471|FG000|COMPLETED|Overall Study||20
6466360|NCT01232868|7383472|FG001|COMPLETED|Overall Study||40
6466361|NCT01232868|7383471|FG000|NOT COMPLETED|Overall Study||2
6466362|NCT01232868|7383472|FG001|NOT COMPLETED|Overall Study||4
6466363|NCT01232894|7383480|FG000|STARTED|Overall Study||60
6466364|NCT01232894|7383481|FG001|STARTED|Overall Study||30
6466365|NCT01232894|7383480|FG000|Received Study Drug|Overall Study||59
6466366|NCT01232894|7383481|FG001|Received Study Drug|Overall Study||28
6466367|NCT01232894|7383480|FG000|COMPLETED|Overall Study||48
6466368|NCT01232894|7383481|FG001|COMPLETED|Overall Study||22
6466369|NCT01232894|7383480|FG000|NOT COMPLETED|Overall Study||12
6466370|NCT01232894|7383481|FG001|NOT COMPLETED|Overall Study||8
6466371|NCT01232920|7383489|FG000|STARTED|Overall Study||41
6466372|NCT01232920|7383490|FG001|STARTED|Overall Study||39
6466373|NCT01232920|7383489|FG000|COMPLETED|Overall Study||35
6466374|NCT01232920|7383490|FG001|COMPLETED|Overall Study||32
6466375|NCT01232920|7383489|FG000|NOT COMPLETED|Overall Study||6
6466376|NCT01232920|7383490|FG001|NOT COMPLETED|Overall Study||7
6466377|NCT01232946|7383499|FG000|STARTED|Overall Study||9
6466378|NCT01232946|7383500|FG001|STARTED|Overall Study||10
6466379|NCT01232946|7383501|FG002|STARTED|Overall Study||11
6466380|NCT01232946|7383499|FG000|COMPLETED|Overall Study||9
6466381|NCT01232946|7383500|FG001|COMPLETED|Overall Study|1 participant died unrelated to study|9
6466382|NCT01232946|7383501|FG002|COMPLETED|Overall Study|2 withdrew after baseline measurements|9
6746693|NCT03376256|7674354|FG000|NOT COMPLETED|Overall Study||0
6746694|NCT03376256|7674355|FG001|NOT COMPLETED|Overall Study||0
6746695|NCT03376295|7674363|FG000|STARTED|Overall Study||1977
6466383|NCT01232946|7383499|FG000|NOT COMPLETED|Overall Study||0
6466384|NCT01232946|7383500|FG001|NOT COMPLETED|Overall Study||1
6466385|NCT01232946|7383501|FG002|NOT COMPLETED|Overall Study||2
6466386|NCT01233050|7383511|FG000|STARTED|Overall Study||400
6466387|NCT01233050|7383512|FG001|STARTED|Overall Study||402
6466388|NCT01233050|7383511|FG000|COMPLETED|Overall Study|8 participants were excluded after treatment administered due to inclusion/exclusion criteria|392
6466389|NCT01233050|7383512|FG001|COMPLETED|Overall Study|6 participants were excluded after treatment administered due to inclusion/exclusion criteria|396
6466390|NCT01233050|7383511|FG000|NOT COMPLETED|Overall Study||8
6466391|NCT01233050|7383512|FG001|NOT COMPLETED|Overall Study||6
6466392|NCT01233076|7383518|FG000|STARTED|Period 1, One Week||30
6466393|NCT01233076|7383519|FG001|STARTED|Period 1, One Week||30
6466394|NCT01233076|7383518|FG000|COMPLETED|Period 1, One Week||30
6466395|NCT01233076|7383519|FG001|COMPLETED|Period 1, One Week||30
6466396|NCT01233076|7383518|FG000|NOT COMPLETED|Period 1, One Week||0
6466397|NCT01233076|7383519|FG001|NOT COMPLETED|Period 1, One Week||0
6466398|NCT01233076|7383518|FG000|STARTED|Period 2, One Week||30
6466399|NCT01233076|7383519|FG001|STARTED|Period 2, One Week||30
6466400|NCT01233076|7383518|FG000|COMPLETED|Period 2, One Week||29
6466401|NCT01233076|7383519|FG001|COMPLETED|Period 2, One Week||30
6466402|NCT01233076|7383518|FG000|NOT COMPLETED|Period 2, One Week||1
6466403|NCT01233076|7383519|FG001|NOT COMPLETED|Period 2, One Week||0
6466404|NCT01233232|7383528|FG000|STARTED|Overall Study||29
6466405|NCT01233232|7383529|FG001|STARTED|Overall Study||30
6466406|NCT01233232|7383530|FG002|STARTED|Overall Study||28
6466407|NCT01233232|7383528|FG000|COMPLETED|Overall Study||28
6466408|NCT01233232|7383529|FG001|COMPLETED|Overall Study||30
6466409|NCT01233232|7383530|FG002|COMPLETED|Overall Study||28
6466410|NCT01233232|7383528|FG000|NOT COMPLETED|Overall Study||1
6466411|NCT01233232|7383529|FG001|NOT COMPLETED|Overall Study||0
6466412|NCT01233232|7383530|FG002|NOT COMPLETED|Overall Study||0
6466413|NCT01233258|7383543|FG000|STARTED|First Intervention (6 Months)||11
6466414|NCT01233258|7383544|FG001|STARTED|First Intervention (6 Months)||10
6466415|NCT01233258|7383545|FG002|STARTED|First Intervention (6 Months)||14
6466416|NCT01233258|7383546|FG003|STARTED|First Intervention (6 Months)||16
6466417|NCT01233258|7383547|FG004|STARTED|First Intervention (6 Months)||16
6466418|NCT01233258|7383548|FG005|STARTED|First Intervention (6 Months)||16
6466419|NCT01233258|7383543|FG000|Participants Received Treatment|First Intervention (6 Months)||11
6466420|NCT01233258|7383544|FG001|Participants Received Treatment|First Intervention (6 Months)||10
6466421|NCT01233258|7383545|FG002|Participants Received Treatment|First Intervention (6 Months)||13
6466422|NCT01233258|7383546|FG003|Participants Received Treatment|First Intervention (6 Months)||15
6466423|NCT01233258|7383547|FG004|Participants Received Treatment|First Intervention (6 Months)||16
6746696|NCT03376295|7674364|FG001|STARTED|Overall Study||1977
6466424|NCT01233258|7383548|FG005|Participants Received Treatment|First Intervention (6 Months)||15
6466425|NCT01233258|7383543|FG000|COMPLETED|First Intervention (6 Months)||10
6466426|NCT01233258|7383544|FG001|COMPLETED|First Intervention (6 Months)||10
6466427|NCT01233258|7383545|FG002|COMPLETED|First Intervention (6 Months)||13
6466428|NCT01233258|7383546|FG003|COMPLETED|First Intervention (6 Months)||15
6466429|NCT01233258|7383547|FG004|COMPLETED|First Intervention (6 Months)||16
6466430|NCT01233258|7383548|FG005|COMPLETED|First Intervention (6 Months)||15
6466431|NCT01233258|7383543|FG000|NOT COMPLETED|First Intervention (6 Months)||1
6466432|NCT01233258|7383544|FG001|NOT COMPLETED|First Intervention (6 Months)||0
6466433|NCT01233258|7383545|FG002|NOT COMPLETED|First Intervention (6 Months)||1
6466434|NCT01233258|7383546|FG003|NOT COMPLETED|First Intervention (6 Months)||1
6466435|NCT01233258|7383547|FG004|NOT COMPLETED|First Intervention (6 Months)||0
6466436|NCT01233258|7383548|FG005|NOT COMPLETED|First Intervention (6 Months)||1
6466437|NCT01233258|7383543|FG000|STARTED|Washout (2-3 Days)||10
6466438|NCT01233258|7383544|FG001|STARTED|Washout (2-3 Days)||10
6466439|NCT01233258|7383545|FG002|STARTED|Washout (2-3 Days)||13
6466440|NCT01233258|7383546|FG003|STARTED|Washout (2-3 Days)||15
6466441|NCT01233258|7383547|FG004|STARTED|Washout (2-3 Days)||16
6466442|NCT01233258|7383548|FG005|STARTED|Washout (2-3 Days)||15
6466443|NCT01233258|7383543|FG000|COMPLETED|Washout (2-3 Days)||10
6466444|NCT01233258|7383544|FG001|COMPLETED|Washout (2-3 Days)||10
6466445|NCT01233258|7383545|FG002|COMPLETED|Washout (2-3 Days)||13
6466446|NCT01233258|7383546|FG003|COMPLETED|Washout (2-3 Days)||15
6466447|NCT01233258|7383547|FG004|COMPLETED|Washout (2-3 Days)||16
6466448|NCT01233258|7383548|FG005|COMPLETED|Washout (2-3 Days)||15
6466449|NCT01233258|7383543|FG000|NOT COMPLETED|Washout (2-3 Days)||0
6466450|NCT01233258|7383544|FG001|NOT COMPLETED|Washout (2-3 Days)||0
6466451|NCT01233258|7383545|FG002|NOT COMPLETED|Washout (2-3 Days)||0
6466452|NCT01233258|7383546|FG003|NOT COMPLETED|Washout (2-3 Days)||0
6466453|NCT01233258|7383547|FG004|NOT COMPLETED|Washout (2-3 Days)||0
6466454|NCT01233258|7383548|FG005|NOT COMPLETED|Washout (2-3 Days)||0
6466455|NCT01233258|7383543|FG000|STARTED|Second Intervention (6 Months)||10
6466456|NCT01233258|7383544|FG001|STARTED|Second Intervention (6 Months)||10
6466457|NCT01233258|7383545|FG002|STARTED|Second Intervention (6 Months)||13
6466458|NCT01233258|7383546|FG003|STARTED|Second Intervention (6 Months)||15
6466459|NCT01233258|7383547|FG004|STARTED|Second Intervention (6 Months)||16
6466460|NCT01233258|7383548|FG005|STARTED|Second Intervention (6 Months)||15
6466461|NCT01233258|7383543|FG000|COMPLETED|Second Intervention (6 Months)||10
6466462|NCT01233258|7383544|FG001|COMPLETED|Second Intervention (6 Months)||10
6466463|NCT01233258|7383545|FG002|COMPLETED|Second Intervention (6 Months)||13
6466464|NCT01233258|7383546|FG003|COMPLETED|Second Intervention (6 Months)||15
6466465|NCT01233258|7383547|FG004|COMPLETED|Second Intervention (6 Months)||16
6466466|NCT01233258|7383548|FG005|COMPLETED|Second Intervention (6 Months)||15
6466467|NCT01233258|7383543|FG000|NOT COMPLETED|Second Intervention (6 Months)||0
6466468|NCT01233258|7383544|FG001|NOT COMPLETED|Second Intervention (6 Months)||0
6466469|NCT01233258|7383545|FG002|NOT COMPLETED|Second Intervention (6 Months)||0
6466470|NCT01233258|7383546|FG003|NOT COMPLETED|Second Intervention (6 Months)||0
6466471|NCT01233258|7383547|FG004|NOT COMPLETED|Second Intervention (6 Months)||0
6466472|NCT01233258|7383548|FG005|NOT COMPLETED|Second Intervention (6 Months)||0
6466473|NCT01233284|7383563|FG000|STARTED|Period 1 (4 Weeks)||37
6466474|NCT01233284|7383564|FG001|STARTED|Period 1 (4 Weeks)||38
6466475|NCT01233284|7383565|FG002|STARTED|Period 1 (4 Weeks)||38
6466476|NCT01233284|7383566|FG003|STARTED|Period 1 (4 Weeks)||35
6466477|NCT01233284|7383567|FG004|STARTED|Period 1 (4 Weeks)||1
6466478|NCT01233284|7383563|FG000|COMPLETED|Period 1 (4 Weeks)||36
6466479|NCT01233284|7383564|FG001|COMPLETED|Period 1 (4 Weeks)||37
6466480|NCT01233284|7383565|FG002|COMPLETED|Period 1 (4 Weeks)||37
6466481|NCT01233284|7383566|FG003|COMPLETED|Period 1 (4 Weeks)||35
6466482|NCT01233284|7383567|FG004|COMPLETED|Period 1 (4 Weeks)||1
6466483|NCT01233284|7383563|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
6466484|NCT01233284|7383564|FG001|NOT COMPLETED|Period 1 (4 Weeks)||1
6466485|NCT01233284|7383565|FG002|NOT COMPLETED|Period 1 (4 Weeks)||1
6466486|NCT01233284|7383566|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
6466487|NCT01233284|7383567|FG004|NOT COMPLETED|Period 1 (4 Weeks)||0
6466488|NCT01233284|7383563|FG000|STARTED|Period 2 (4 Weeks)||36
6466489|NCT01233284|7383564|FG001|STARTED|Period 2 (4 Weeks)||37
6466490|NCT01233284|7383565|FG002|STARTED|Period 2 (4 Weeks)||37
6466491|NCT01233284|7383566|FG003|STARTED|Period 2 (4 Weeks)||35
6466492|NCT01233284|7383567|FG004|STARTED|Period 2 (4 Weeks)||1
6466493|NCT01233284|7383563|FG000|COMPLETED|Period 2 (4 Weeks)||36
6466494|NCT01233284|7383564|FG001|COMPLETED|Period 2 (4 Weeks)||37
6466495|NCT01233284|7383565|FG002|COMPLETED|Period 2 (4 Weeks)||36
6466496|NCT01233284|7383566|FG003|COMPLETED|Period 2 (4 Weeks)||35
6466497|NCT01233284|7383567|FG004|COMPLETED|Period 2 (4 Weeks)||1
6466498|NCT01233284|7383563|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
6466499|NCT01233284|7383564|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
6466500|NCT01233284|7383565|FG002|NOT COMPLETED|Period 2 (4 Weeks)||1
6466501|NCT01233284|7383566|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
6466502|NCT01233284|7383567|FG004|NOT COMPLETED|Period 2 (4 Weeks)||0
6466503|NCT01233284|7383563|FG000|STARTED|Period 3 (4 Weeks)||36
6466504|NCT01233284|7383564|FG001|STARTED|Period 3 (4 Weeks)||37
6466505|NCT01233284|7383565|FG002|STARTED|Period 3 (4 Weeks)||36
6466506|NCT01233284|7383566|FG003|STARTED|Period 3 (4 Weeks)||35
6466507|NCT01233284|7383567|FG004|STARTED|Period 3 (4 Weeks)||1
6466508|NCT01233284|7383563|FG000|COMPLETED|Period 3 (4 Weeks)||36
6466509|NCT01233284|7383564|FG001|COMPLETED|Period 3 (4 Weeks)||37
6466510|NCT01233284|7383565|FG002|COMPLETED|Period 3 (4 Weeks)||35
6466511|NCT01233284|7383566|FG003|COMPLETED|Period 3 (4 Weeks)||34
6466512|NCT01233284|7383567|FG004|COMPLETED|Period 3 (4 Weeks)||1
6466513|NCT01233284|7383563|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
6466514|NCT01233284|7383564|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
6466515|NCT01233284|7383565|FG002|NOT COMPLETED|Period 3 (4 Weeks)||1
6466516|NCT01233284|7383566|FG003|NOT COMPLETED|Period 3 (4 Weeks)||1
6466517|NCT01233284|7383567|FG004|NOT COMPLETED|Period 3 (4 Weeks)||0
6466518|NCT01233284|7383563|FG000|STARTED|Period 4 (4 Weeks)||36
6466519|NCT01233284|7383564|FG001|STARTED|Period 4 (4 Weeks)||37
6466520|NCT01233284|7383565|FG002|STARTED|Period 4 (4 Weeks)||35
6466521|NCT01233284|7383566|FG003|STARTED|Period 4 (4 Weeks)||34
6466522|NCT01233284|7383567|FG004|STARTED|Period 4 (4 Weeks)||1
6466523|NCT01233284|7383563|FG000|COMPLETED|Period 4 (4 Weeks)||36
6466524|NCT01233284|7383564|FG001|COMPLETED|Period 4 (4 Weeks)||36
6466525|NCT01233284|7383565|FG002|COMPLETED|Period 4 (4 Weeks)||35
6466526|NCT01233284|7383566|FG003|COMPLETED|Period 4 (4 Weeks)||33
6466527|NCT01233284|7383567|FG004|COMPLETED|Period 4 (4 Weeks)||1
6466528|NCT01233284|7383563|FG000|NOT COMPLETED|Period 4 (4 Weeks)||0
6466529|NCT01233284|7383564|FG001|NOT COMPLETED|Period 4 (4 Weeks)||1
6466530|NCT01233284|7383565|FG002|NOT COMPLETED|Period 4 (4 Weeks)||0
6466531|NCT01233284|7383566|FG003|NOT COMPLETED|Period 4 (4 Weeks)||1
6466532|NCT01233284|7383567|FG004|NOT COMPLETED|Period 4 (4 Weeks)||0
6466533|NCT01233518|7383577|FG000|STARTED|Overall Study||285
6466534|NCT01233518|7383577|FG000|COMPLETED|Overall Study||252
6466535|NCT01233518|7383577|FG000|NOT COMPLETED|Overall Study||33
6466536|NCT01233609|7383584|FG000|STARTED|Overall Study||46
6466537|NCT01233609|7383585|FG001|STARTED|Overall Study||44
6466538|NCT01233609|7383584|FG000|COMPLETED|Overall Study||37
6466539|NCT01233609|7383585|FG001|COMPLETED|Overall Study||42
6466540|NCT01233609|7383584|FG000|NOT COMPLETED|Overall Study||9
6466541|NCT01233609|7383585|FG001|NOT COMPLETED|Overall Study||2
6466542|NCT01233687|7383599|FG000|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
6466543|NCT01233687|7383599|FG000|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
6466544|NCT01233687|7383599|FG000|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
6466545|NCT01233687|7383599|FG000|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
6466546|NCT01233687|7383599|FG000|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
6466547|NCT01233687|7383599|FG000|COMPLETED|Phase II AMG 102 + Erlotinib||45
6466548|NCT01233687|7383599|FG000|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
6466549|NCT01233726|7383606|FG000|STARTED|Overall Study||53
6466550|NCT01233726|7383607|FG001|STARTED|Overall Study||53
6466551|NCT01233726|7383608|FG002|STARTED|Overall Study||53
6466552|NCT01233726|7383606|FG000|COMPLETED|Overall Study||52
6466553|NCT01233726|7383607|FG001|COMPLETED|Overall Study||53
6466554|NCT01233726|7383608|FG002|COMPLETED|Overall Study||52
6466555|NCT01233726|7383606|FG000|NOT COMPLETED|Overall Study||1
6466556|NCT01233726|7383607|FG001|NOT COMPLETED|Overall Study||0
6466557|NCT01233726|7383608|FG002|NOT COMPLETED|Overall Study||1
6466558|NCT01233817|7383619|FG000|STARTED|Overall Study||12
6466559|NCT01233817|7383619|FG000|COMPLETED|Overall Study||9
6466560|NCT01233817|7383619|FG000|NOT COMPLETED|Overall Study||3
6466561|NCT01233869|7383627|FG000|STARTED|Initial Treatment Period (24 Months)||58
6466562|NCT01233869|7383628|FG001|STARTED|Initial Treatment Period (24 Months)||31
6466563|NCT01233869|7383629|FG002|STARTED|Initial Treatment Period (24 Months)||24
6466564|NCT01233869|7383630|FG003|STARTED|Initial Treatment Period (24 Months)||56
6466565|NCT01233869|7383627|FG000|COMPLETED|Initial Treatment Period (24 Months)||34
6466566|NCT01233869|7383628|FG001|COMPLETED|Initial Treatment Period (24 Months)||3
6466567|NCT01233869|7383629|FG002|COMPLETED|Initial Treatment Period (24 Months)||22
6466568|NCT01233869|7383630|FG003|COMPLETED|Initial Treatment Period (24 Months)||34
6466569|NCT01233869|7383627|FG000|NOT COMPLETED|Initial Treatment Period (24 Months)||24
6466570|NCT01233869|7383628|FG001|NOT COMPLETED|Initial Treatment Period (24 Months)||28
6466571|NCT01233869|7383629|FG002|NOT COMPLETED|Initial Treatment Period (24 Months)||2
6466572|NCT01233869|7383630|FG003|NOT COMPLETED|Initial Treatment Period (24 Months)||22
6466573|NCT01233869|7383627|FG000|STARTED|Washout Period 30 Days||34
6466574|NCT01233869|7383628|FG001|STARTED|Washout Period 30 Days||3
6466575|NCT01233869|7383629|FG002|STARTED|Washout Period 30 Days||22
6466576|NCT01233869|7383630|FG003|STARTED|Washout Period 30 Days||34
6466577|NCT01233869|7383627|FG000|COMPLETED|Washout Period 30 Days||34
6466578|NCT01233869|7383628|FG001|COMPLETED|Washout Period 30 Days||3
6466579|NCT01233869|7383629|FG002|COMPLETED|Washout Period 30 Days||22
6466580|NCT01233869|7383630|FG003|COMPLETED|Washout Period 30 Days||34
6466581|NCT01233869|7383627|FG000|NOT COMPLETED|Washout Period 30 Days||0
6466582|NCT01233869|7383628|FG001|NOT COMPLETED|Washout Period 30 Days||0
6466583|NCT01233869|7383629|FG002|NOT COMPLETED|Washout Period 30 Days||0
6466584|NCT01233869|7383630|FG003|NOT COMPLETED|Washout Period 30 Days||0
6466585|NCT01233869|7383627|FG000|STARTED|Extended Treatment Period (46 Months)||34
6466586|NCT01233869|7383628|FG001|STARTED|Extended Treatment Period (46 Months)||3
6466587|NCT01233869|7383629|FG002|STARTED|Extended Treatment Period (46 Months)||22
6466588|NCT01233869|7383630|FG003|STARTED|Extended Treatment Period (46 Months)||34
6466589|NCT01233869|7383627|FG000|COMPLETED|Extended Treatment Period (46 Months)||20
6466590|NCT01233869|7383628|FG001|COMPLETED|Extended Treatment Period (46 Months)||0
6466591|NCT01233869|7383629|FG002|COMPLETED|Extended Treatment Period (46 Months)||17
6466592|NCT01233869|7383630|FG003|COMPLETED|Extended Treatment Period (46 Months)||18
6466593|NCT01233869|7383627|FG000|NOT COMPLETED|Extended Treatment Period (46 Months)||14
6466594|NCT01233869|7383628|FG001|NOT COMPLETED|Extended Treatment Period (46 Months)||3
6466595|NCT01233869|7383629|FG002|NOT COMPLETED|Extended Treatment Period (46 Months)||5
6466596|NCT01233869|7383630|FG003|NOT COMPLETED|Extended Treatment Period (46 Months)||16
6466597|NCT01233921|7383642|FG000|STARTED|Overall Study||3
6466598|NCT01233921|7383643|FG001|STARTED|Overall Study||3
6466599|NCT01233921|7383642|FG000|COMPLETED|Overall Study||3
6466600|NCT01233921|7383643|FG001|COMPLETED|Overall Study||3
6466601|NCT01233921|7383642|FG000|NOT COMPLETED|Overall Study||0
6466602|NCT01233921|7383643|FG001|NOT COMPLETED|Overall Study||0
6466603|NCT01233999|7383649|FG000|STARTED|Overall Study||10
6466604|NCT01233999|7383649|FG000|COMPLETED|Overall Study||8
6466605|NCT01233999|7383649|FG000|NOT COMPLETED|Overall Study||2
6466606|NCT01234207|7383653|FG000|STARTED|First Intervention||47
6466607|NCT01234207|7383654|FG001|STARTED|First Intervention||48
6466608|NCT01234207|7383653|FG000|COMPLETED|First Intervention||47
6554171|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: First Intervention||7
6554172|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
6554173|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
6554174|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
6554175|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
6554176|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
6466609|NCT01234207|7383654|FG001|COMPLETED|First Intervention||48
6466610|NCT01234207|7383653|FG000|NOT COMPLETED|First Intervention||0
6466611|NCT01234207|7383654|FG001|NOT COMPLETED|First Intervention||0
6466612|NCT01234207|7383653|FG000|STARTED|1-Week Washout Period||47
6466613|NCT01234207|7383654|FG001|STARTED|1-Week Washout Period||48
6466614|NCT01234207|7383653|FG000|COMPLETED|1-Week Washout Period||47
6466615|NCT01234207|7383654|FG001|COMPLETED|1-Week Washout Period||48
6466616|NCT01234207|7383653|FG000|NOT COMPLETED|1-Week Washout Period||0
6466617|NCT01234207|7383654|FG001|NOT COMPLETED|1-Week Washout Period||0
6466618|NCT01234207|7383653|FG000|STARTED|Second Intervention||47
6466619|NCT01234207|7383654|FG001|STARTED|Second Intervention||48
6466620|NCT01234207|7383653|FG000|COMPLETED|Second Intervention||47
6466621|NCT01234207|7383654|FG001|COMPLETED|Second Intervention||48
6466622|NCT01234207|7383653|FG000|NOT COMPLETED|Second Intervention||0
6466623|NCT01234207|7383654|FG001|NOT COMPLETED|Second Intervention||0
6466624|NCT01234337|7383664|FG000|STARTED|Overall Study||266
6466625|NCT01234337|7383665|FG001|STARTED|Overall Study||271
6466626|NCT01234337|7383664|FG000|Participants Received Treatment|Overall Study||260
6466627|NCT01234337|7383665|FG001|Participants Received Treatment|Overall Study||267
6466628|NCT01234337|7383664|FG000|COMPLETED|Overall Study||0
6466629|NCT01234337|7383665|FG001|COMPLETED|Overall Study||0
6466630|NCT01234337|7383664|FG000|NOT COMPLETED|Overall Study||266
6466631|NCT01234337|7383665|FG001|NOT COMPLETED|Overall Study||271
6466632|NCT01234350|7383673|FG000|STARTED|Overall Study||1000
6466633|NCT01234350|7383674|FG001|STARTED|Overall Study||493
6466634|NCT01234350|7383673|FG000|COMPLETED|Overall Study||313
6466635|NCT01234350|7383674|FG001|COMPLETED|Overall Study||226
6466636|NCT01234350|7383673|FG000|NOT COMPLETED|Overall Study||687
6466637|NCT01234350|7383674|FG001|NOT COMPLETED|Overall Study||267
6466638|NCT01234402|7383685|FG000|STARTED|Overall Study||52
6466639|NCT01234402|7383686|FG001|STARTED|Overall Study||51
6466640|NCT01234402|7383687|FG002|STARTED|Overall Study||50
6466641|NCT01234402|7383685|FG000|Received at Least One Dose of Study Drug|Overall Study||52
6466642|NCT01234402|7383686|FG001|Received at Least One Dose of Study Drug|Overall Study||49
6466643|NCT01234402|7383687|FG002|Received at Least One Dose of Study Drug|Overall Study||49
6554177|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
6554178|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: First Intervention||1
6554179|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
6466644|NCT01234402|7383685|FG000|Capecitabine Crossover to Ramucirumab|Overall Study||0
6466645|NCT01234402|7383686|FG001|Capecitabine Crossover to Ramucirumab|Overall Study||0
6466646|NCT01234402|7383687|FG002|Capecitabine Crossover to Ramucirumab|Overall Study||29
6466647|NCT01234402|7383685|FG000|Capecitabine Crossover to Icrucumab|Overall Study||0
6466648|NCT01234402|7383686|FG001|Capecitabine Crossover to Icrucumab|Overall Study||0
6466649|NCT01234402|7383687|FG002|Capecitabine Crossover to Icrucumab|Overall Study||1
6466650|NCT01234402|7383685|FG000|COMPLETED|Overall Study||51
6466651|NCT01234402|7383686|FG001|COMPLETED|Overall Study||45
6466652|NCT01234402|7383687|FG002|COMPLETED|Overall Study||42
6466653|NCT01234402|7383685|FG000|NOT COMPLETED|Overall Study||1
6466654|NCT01234402|7383686|FG001|NOT COMPLETED|Overall Study||6
6466655|NCT01234402|7383687|FG002|NOT COMPLETED|Overall Study||8
6466656|NCT01234467|7383697|FG000|STARTED|Overall Study||23
6466657|NCT01234467|7383697|FG000|COMPLETED|Overall Study||11
6466658|NCT01234467|7383697|FG000|NOT COMPLETED|Overall Study||12
6466659|NCT01234480|7383701|FG000|STARTED|Overall Study||5859
6466660|NCT01234480|7383701|FG000|COMPLETED|Overall Study||5416
6466661|NCT01234480|7383701|FG000|NOT COMPLETED|Overall Study||443
6466662|NCT01234649|7383710|FG000|STARTED|Overall Study||78
6466663|NCT01234649|7383711|FG001|STARTED|Overall Study||75
6466664|NCT01234649|7383710|FG000|COMPLETED|Overall Study||35
6466665|NCT01234649|7383711|FG001|COMPLETED|Overall Study||37
6466666|NCT01234649|7383710|FG000|NOT COMPLETED|Overall Study||43
6466667|NCT01234649|7383711|FG001|NOT COMPLETED|Overall Study||38
6466668|NCT01234675|7383717|FG000|STARTED|First Intervention (6 Weeks)||10
6466669|NCT01234675|7383718|FG001|STARTED|First Intervention (6 Weeks)||9
6466670|NCT01234675|7383717|FG000|COMPLETED|First Intervention (6 Weeks)||9
6466671|NCT01234675|7383718|FG001|COMPLETED|First Intervention (6 Weeks)||8
6466672|NCT01234675|7383717|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
6466673|NCT01234675|7383718|FG001|NOT COMPLETED|First Intervention (6 Weeks)||1
6466674|NCT01234675|7383717|FG000|STARTED|Second Intervention (6 Weeks)||9
6466675|NCT01234675|7383718|FG001|STARTED|Second Intervention (6 Weeks)||8
6466676|NCT01234675|7383717|FG000|COMPLETED|Second Intervention (6 Weeks)||7
6466677|NCT01234675|7383718|FG001|COMPLETED|Second Intervention (6 Weeks)||8
6466678|NCT01234675|7383717|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||2
6466679|NCT01234675|7383718|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6466680|NCT01234714|7383724|FG000|STARTED|Overall Study||84
6466681|NCT01234714|7383724|FG000|COMPLETED|Overall Study||84
6466682|NCT01234714|7383724|FG000|NOT COMPLETED|Overall Study||0
6466683|NCT01234766|7383731|FG000|STARTED|Overall Study||39
6466684|NCT01234766|7383731|FG000|COMPLETED|Overall Study||35
6466685|NCT01234766|7383731|FG000|NOT COMPLETED|Overall Study||4
6466686|NCT01234831|7383737|FG000|STARTED|Overall Study||261
6466687|NCT01234831|7383738|FG001|STARTED|Overall Study||202
6466688|NCT01234831|7383737|FG000|COMPLETED|Overall Study||259
6466689|NCT01234831|7383738|FG001|COMPLETED|Overall Study||198
6466690|NCT01234831|7383737|FG000|NOT COMPLETED|Overall Study||2
6466691|NCT01234831|7383738|FG001|NOT COMPLETED|Overall Study||4
6466692|NCT01234870|7383745|FG000|STARTED|Overall Study||40
6466693|NCT01234870|7383745|FG000|COMPLETED|Overall Study||40
6466694|NCT01234870|7383745|FG000|NOT COMPLETED|Overall Study||0
6466695|NCT01234883|7383752|FG000|STARTED|Overall Study||51
6466696|NCT01234883|7383753|FG001|STARTED|Overall Study||49
6466697|NCT01234883|7383752|FG000|COMPLETED|Overall Study||41
6466698|NCT01234883|7383753|FG001|COMPLETED|Overall Study||36
6466699|NCT01234883|7383752|FG000|NOT COMPLETED|Overall Study||10
6466700|NCT01234883|7383753|FG001|NOT COMPLETED|Overall Study||13
6466701|NCT01234922|7383763|FG000|STARTED|Overall Study||1
6466702|NCT01234922|7383764|FG001|STARTED|Overall Study||1
6466703|NCT01234922|7383765|FG002|STARTED|Overall Study||2
6466704|NCT01234922|7383766|FG003|STARTED|Overall Study||2
6466705|NCT01234922|7383763|FG000|COMPLETED|Overall Study||1
6466706|NCT01234922|7383764|FG001|COMPLETED|Overall Study||1
6466707|NCT01234922|7383765|FG002|COMPLETED|Overall Study||2
6466708|NCT01234922|7383766|FG003|COMPLETED|Overall Study||2
6466709|NCT01234922|7383763|FG000|NOT COMPLETED|Overall Study||0
6466710|NCT01234922|7383764|FG001|NOT COMPLETED|Overall Study||0
6466711|NCT01234922|7383765|FG002|NOT COMPLETED|Overall Study||0
6466712|NCT01234922|7383766|FG003|NOT COMPLETED|Overall Study||0
6466713|NCT01235195|7383776|FG000|STARTED|First Intervention||15
6466714|NCT01235195|7383777|FG001|STARTED|First Intervention||15
6466715|NCT01235195|7383776|FG000|COMPLETED|First Intervention||15
6466716|NCT01235195|7383777|FG001|COMPLETED|First Intervention||15
6466717|NCT01235195|7383776|FG000|NOT COMPLETED|First Intervention||0
6466718|NCT01235195|7383777|FG001|NOT COMPLETED|First Intervention||0
6466719|NCT01235195|7383776|FG000|STARTED|Washout Period of At Least 8 Days||15
6466720|NCT01235195|7383777|FG001|STARTED|Washout Period of At Least 8 Days||15
6466721|NCT01235195|7383776|FG000|COMPLETED|Washout Period of At Least 8 Days||15
6466722|NCT01235195|7383777|FG001|COMPLETED|Washout Period of At Least 8 Days||15
6466723|NCT01235195|7383776|FG000|NOT COMPLETED|Washout Period of At Least 8 Days||0
6466724|NCT01235195|7383777|FG001|NOT COMPLETED|Washout Period of At Least 8 Days||0
6466725|NCT01235195|7383776|FG000|STARTED|Second Intervention||15
6466726|NCT01235195|7383777|FG001|STARTED|Second Intervention||15
6466727|NCT01235195|7383776|FG000|COMPLETED|Second Intervention||15
6466728|NCT01235195|7383777|FG001|COMPLETED|Second Intervention||15
6466729|NCT01235195|7383776|FG000|NOT COMPLETED|Second Intervention||0
6466730|NCT01235195|7383777|FG001|NOT COMPLETED|Second Intervention||0
6466731|NCT01235234|7383786|FG000|STARTED|Overall Study||77
6466732|NCT01235234|7383787|FG001|STARTED|Overall Study||78
6466733|NCT01235234|7383788|FG002|STARTED|Overall Study||81
6466734|NCT01235234|7383786|FG000|COMPLETED|Overall Study||75
6466735|NCT01235234|7383787|FG001|COMPLETED|Overall Study||76
6746697|NCT03376295|7674363|FG000|COMPLETED|Overall Study||1977
6746698|NCT03376295|7674364|FG001|COMPLETED|Overall Study||1977
6466736|NCT01235234|7383788|FG002|COMPLETED|Overall Study||80
6466737|NCT01235234|7383786|FG000|NOT COMPLETED|Overall Study||2
6466738|NCT01235234|7383787|FG001|NOT COMPLETED|Overall Study||2
6466739|NCT01235234|7383788|FG002|NOT COMPLETED|Overall Study||1
6466740|NCT01235338|7383798|FG000|STARTED|Overall Study||42
6466741|NCT01235338|7383799|FG001|STARTED|Overall Study||38
6466742|NCT01235338|7383798|FG000|COMPLETED|Overall Study||31
6466743|NCT01235338|7383799|FG001|COMPLETED|Overall Study||33
6466744|NCT01235338|7383798|FG000|NOT COMPLETED|Overall Study||11
6466745|NCT01235338|7383799|FG001|NOT COMPLETED|Overall Study||5
6746699|NCT03376295|7674363|FG000|NOT COMPLETED|Overall Study||0
6466746|NCT01235351|7383809|FG000|STARTED|Initial Treatment With 75 mg and 150 mg||247
6466747|NCT01235351|7383810|FG001|STARTED|Initial Treatment With 75 mg and 150 mg||86
6466748|NCT01235351|7383809|FG000|COMPLETED|Initial Treatment With 75 mg and 150 mg|4 allocated to initial treatment included in primary analysis|237
6466749|NCT01235351|7383810|FG001|COMPLETED|Initial Treatment With 75 mg and 150 mg||82
6466750|NCT01235351|7383809|FG000|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||10
6466751|NCT01235351|7383810|FG001|NOT COMPLETED|Initial Treatment With 75 mg and 150 mg||4
6466752|NCT01235351|7383809|FG000|STARTED|Treatment With Different Dose Sequences||233
6466753|NCT01235351|7383810|FG001|STARTED|Treatment With Different Dose Sequences||82
6554180|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
6554181|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Washout Period 1||0
6554182|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Washout Period 1||0
6554183|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Washout Period 1||0
6554184|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Washout Period 1||6
6554185|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Washout Period 1||6
6554186|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Washout Period 1||7
6554187|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Washout Period 1||7
6554188|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Washout Period 1||7
6466754|NCT01235351|7383809|FG000|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||116
6466755|NCT01235351|7383810|FG001|75 mg First and Then 150 mg|Treatment With Different Dose Sequences||0
6466756|NCT01235351|7383809|FG000|150 mg First Then 75 mg|Treatment With Different Dose Sequences||117
6466757|NCT01235351|7383810|FG001|150 mg First Then 75 mg|Treatment With Different Dose Sequences||0
6466758|NCT01235351|7383809|FG000|225 mg First Then 300 mg|Treatment With Different Dose Sequences||0
6466759|NCT01235351|7383810|FG001|225 mg First Then 300 mg|Treatment With Different Dose Sequences||41
6554189|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Washout Period 1||7
6554190|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
6554191|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
6554192|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
6554193|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Washout Period 1||6
6466760|NCT01235351|7383809|FG000|300 mg First Then 225 mg|Treatment With Different Dose Sequences||0
6466761|NCT01235351|7383810|FG001|300 mg First Then 225 mg|Treatment With Different Dose Sequences||41
6466762|NCT01235351|7383809|FG000|COMPLETED|Treatment With Different Dose Sequences||233
6466763|NCT01235351|7383810|FG001|COMPLETED|Treatment With Different Dose Sequences||82
6466764|NCT01235351|7383809|FG000|NOT COMPLETED|Treatment With Different Dose Sequences||0
6466765|NCT01235351|7383810|FG001|NOT COMPLETED|Treatment With Different Dose Sequences||0
6466766|NCT01235377|7383822|FG000|STARTED|Overall Study||11
6466767|NCT01235377|7383823|FG001|STARTED|Overall Study||9
6466768|NCT01235377|7383822|FG000|COMPLETED|Overall Study||10
6466769|NCT01235377|7383823|FG001|COMPLETED|Overall Study||8
6466770|NCT01235377|7383822|FG000|NOT COMPLETED|Overall Study||1
6466771|NCT01235377|7383823|FG001|NOT COMPLETED|Overall Study||1
6466772|NCT01235403|7383829|FG000|STARTED|Overall Study||100
6466773|NCT01235403|7383829|FG000|COMPLETED|Overall Study||74
6466774|NCT01235403|7383829|FG000|NOT COMPLETED|Overall Study||26
6466775|NCT01235442|7383835|FG000|STARTED|Overall Study||297
6466776|NCT01235442|7383836|FG001|STARTED|Overall Study||295
6466777|NCT01235442|7383835|FG000|COMPLETED|Overall Study||253
6466778|NCT01235442|7383836|FG001|COMPLETED|Overall Study||251
6466779|NCT01235442|7383835|FG000|NOT COMPLETED|Overall Study||44
6466780|NCT01235442|7383836|FG001|NOT COMPLETED|Overall Study||44
6466781|NCT01235507|7383842|FG000|STARTED|Overall Study||71
6466782|NCT01235507|7383842|FG000|COMPLETED|Overall Study||69
6466783|NCT01235507|7383842|FG000|NOT COMPLETED|Overall Study||2
6466784|NCT01235546|7383848|FG000|STARTED|Overall Study||994
6466785|NCT01235546|7383849|FG001|STARTED|Overall Study||1019
6466786|NCT01235546|7383848|FG000|COMPLETED|Overall Study||992
6466787|NCT01235546|7383849|FG001|COMPLETED|Overall Study||1018
6466788|NCT01235546|7383848|FG000|NOT COMPLETED|Overall Study||2
6466789|NCT01235546|7383849|FG001|NOT COMPLETED|Overall Study||1
6466790|NCT01235598|7383866|FG000|STARTED|Overall Study||13
6466791|NCT01235598|7383867|FG001|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
6466792|NCT01235598|7383866|FG000|COMPLETED|Overall Study||12
6466793|NCT01235598|7383867|FG001|COMPLETED|Overall Study||24
6466794|NCT01235598|7383866|FG000|NOT COMPLETED|Overall Study||1
6466795|NCT01235598|7383867|FG001|NOT COMPLETED|Overall Study||4
6466796|NCT01235689|7383876|FG000|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
6466797|NCT01235689|7383877|FG001|STARTED|Overall Study|Total randomized includes participants who randomized at Week 9 and earlier.|122
6466798|NCT01235689|7383876|FG000|Early Randomized (Baseline to Week 9)|Overall Study||63
6466799|NCT01235689|7383877|FG001|Early Randomized (Baseline to Week 9)|Overall Study||69
6466800|NCT01235689|7383876|FG000|Randomized at Week 9|Overall Study||59
6466801|NCT01235689|7383877|FG001|Randomized at Week 9|Overall Study||53
6466802|NCT01235689|7383876|FG000|COMPLETED|Overall Study||93
6466803|NCT01235689|7383877|FG001|COMPLETED|Overall Study||90
6466804|NCT01235689|7383876|FG000|NOT COMPLETED|Overall Study||29
6466805|NCT01235689|7383877|FG001|NOT COMPLETED|Overall Study||32
6466806|NCT01235715|7383885|FG000|STARTED|Overall Study||98
6466807|NCT01235715|7383886|FG001|STARTED|Overall Study||102
6466808|NCT01235715|7383885|FG000|COMPLETED|Overall Study||98
6466809|NCT01235715|7383886|FG001|COMPLETED|Overall Study||100
6466810|NCT01235715|7383885|FG000|NOT COMPLETED|Overall Study||0
6466811|NCT01235715|7383886|FG001|NOT COMPLETED|Overall Study||2
6466812|NCT01235728|7383893|FG000|STARTED|Overall Study||3
6466813|NCT01235728|7383894|FG001|STARTED|Overall Study||3
6466814|NCT01235728|7383895|FG002|STARTED|Overall Study||3
6466815|NCT01235728|7383896|FG003|STARTED|Overall Study||3
6466816|NCT01235728|7383897|FG004|STARTED|Overall Study||3
6466817|NCT01235728|7383898|FG005|STARTED|Overall Study||3
6554194|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Washout Period 1||6
6466818|NCT01235728|7383899|FG006|STARTED|Overall Study||3
6466819|NCT01235728|7383900|FG007|STARTED|Overall Study||3
6466820|NCT01235728|7383893|FG000|COMPLETED|Overall Study||3
6746700|NCT03376295|7674364|FG001|NOT COMPLETED|Overall Study||0
6466821|NCT01235728|7383894|FG001|COMPLETED|Overall Study||3
6466822|NCT01235728|7383895|FG002|COMPLETED|Overall Study||3
6466823|NCT01235728|7383896|FG003|COMPLETED|Overall Study||2
6466824|NCT01235728|7383897|FG004|COMPLETED|Overall Study||3
6466825|NCT01235728|7383898|FG005|COMPLETED|Overall Study||3
6466826|NCT01235728|7383899|FG006|COMPLETED|Overall Study||3
6466827|NCT01235728|7383900|FG007|COMPLETED|Overall Study||3
6466828|NCT01235728|7383893|FG000|NOT COMPLETED|Overall Study||0
6466829|NCT01235728|7383894|FG001|NOT COMPLETED|Overall Study||0
6466830|NCT01235728|7383895|FG002|NOT COMPLETED|Overall Study||0
6466831|NCT01235728|7383896|FG003|NOT COMPLETED|Overall Study||1
6466832|NCT01235728|7383897|FG004|NOT COMPLETED|Overall Study||0
6466833|NCT01235728|7383898|FG005|NOT COMPLETED|Overall Study||0
6466834|NCT01235728|7383899|FG006|NOT COMPLETED|Overall Study||0
6466835|NCT01235728|7383900|FG007|NOT COMPLETED|Overall Study||0
6466836|NCT01235741|7383911|FG000|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
6466837|NCT01235741|7383912|FG001|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
6466838|NCT01235741|7383913|FG002|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
6466839|NCT01235741|7383911|FG000|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
6466840|NCT01235741|7383912|FG001|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
6466841|NCT01235741|7383913|FG002|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
6466842|NCT01235741|7383911|FG000|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
6466843|NCT01235741|7383912|FG001|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
6466844|NCT01235741|7383913|FG002|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
6466845|NCT01235741|7383911|FG000|STARTED|Randomized to Treatment||0
6466846|NCT01235741|7383912|FG001|STARTED|Randomized to Treatment||36
6466847|NCT01235741|7383913|FG002|STARTED|Randomized to Treatment||36
6466848|NCT01235741|7383911|FG000|COMPLETED|Randomized to Treatment||0
6466849|NCT01235741|7383912|FG001|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
6466850|NCT01235741|7383913|FG002|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
6466851|NCT01235741|7383911|FG000|NOT COMPLETED|Randomized to Treatment||0
6466852|NCT01235741|7383912|FG001|NOT COMPLETED|Randomized to Treatment||36
6466853|NCT01235741|7383913|FG002|NOT COMPLETED|Randomized to Treatment||36
6466854|NCT01235741|7383911|FG000|STARTED|Follow-Up Post Treatment up to Month 6||0
6466855|NCT01235741|7383912|FG001|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
6466856|NCT01235741|7383913|FG002|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
6466857|NCT01235741|7383911|FG000|COMPLETED|Follow-Up Post Treatment up to Month 6||0
6466858|NCT01235741|7383912|FG001|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
6466859|NCT01235741|7383913|FG002|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
6466860|NCT01235741|7383911|FG000|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
6466861|NCT01235741|7383912|FG001|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
6466862|NCT01235741|7383913|FG002|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
6466863|NCT01235793|7383925|FG000|STARTED|Overall Study||11
6466864|NCT01235793|7383925|FG000|COMPLETED|Overall Study||5
6466865|NCT01235793|7383925|FG000|NOT COMPLETED|Overall Study||6
6466866|NCT01235897|7383930|FG000|STARTED|Overall Study||16
6466867|NCT01235897|7383930|FG000|COMPLETED|Overall Study||16
6466868|NCT01235897|7383930|FG000|NOT COMPLETED|Overall Study||0
6466869|NCT01235910|7383935|FG000|STARTED|Overall Study||1
6466870|NCT01235910|7383935|FG000|COMPLETED|Overall Study||1
6466871|NCT01235910|7383935|FG000|NOT COMPLETED|Overall Study||0
6466872|NCT01235923|7383941|FG000|STARTED|Overall Study||10
6466873|NCT01235923|7383942|FG001|STARTED|Overall Study||10
6466874|NCT01235923|7383941|FG000|COMPLETED|Overall Study||10
6466875|NCT01235923|7383942|FG001|COMPLETED|Overall Study||10
6466876|NCT01235923|7383941|FG000|NOT COMPLETED|Overall Study||0
6466877|NCT01235923|7383942|FG001|NOT COMPLETED|Overall Study||0
6466878|NCT01235949|7383966|FG000|STARTED|Primary Phase||198
6466879|NCT01235949|7383967|FG001|STARTED|Primary Phase||198
6466880|NCT01235949|7383968|FG002|STARTED|Primary Phase||199
6466881|NCT01235949|7383969|FG003|STARTED|Primary Phase||71
6466882|NCT01235949|7383970|FG004|STARTED|Primary Phase||72
6466883|NCT01235949|7383971|FG005|STARTED|Primary Phase||74
6466884|NCT01235949|7383972|FG006|STARTED|Primary Phase||0
6466885|NCT01235949|7383973|FG007|STARTED|Primary Phase||0
6466886|NCT01235949|7383974|FG008|STARTED|Primary Phase||0
6466887|NCT01235949|7383975|FG009|STARTED|Primary Phase||0
6466888|NCT01235949|7383976|FG010|STARTED|Primary Phase||0
6466889|NCT01235949|7383977|FG011|STARTED|Primary Phase||0
6466890|NCT01235949|7383978|FG012|STARTED|Primary Phase||0
6466891|NCT01235949|7383979|FG013|STARTED|Primary Phase||0
6466892|NCT01235949|7383980|FG014|STARTED|Primary Phase||0
6466893|NCT01235949|7383981|FG015|STARTED|Primary Phase||0
6466894|NCT01235949|7383982|FG016|STARTED|Primary Phase||0
6466895|NCT01235949|7383983|FG017|STARTED|Primary Phase||0
6500979|NCT01426347|7419449|FG001|COMPLETED|Overall Study||39
6466896|NCT01235949|7383966|FG000|COMPLETED|Primary Phase|After Primary Phase completion, 7 subjects were not willing to participate in the Booster Phase|194
6466897|NCT01235949|7383967|FG001|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|195
6466898|NCT01235949|7383968|FG002|COMPLETED|Primary Phase|After Primary Phase completion, 6 subjects were not willing to participate in the Booster Phase|196
6466899|NCT01235949|7383969|FG003|COMPLETED|Primary Phase|After Primary Phase completion, 2 subjects were not willing to participate in the Booster Phase|69
6466900|NCT01235949|7383970|FG004|COMPLETED|Primary Phase|After Primary Phase completion, 3 subjects were not willing to participate in the Booster Phase|71
6466901|NCT01235949|7383971|FG005|COMPLETED|Primary Phase|After Primary Phase completion, all subjects were willing to participate in the Booster Phase|67
6466902|NCT01235949|7383972|FG006|COMPLETED|Primary Phase||0
6466903|NCT01235949|7383973|FG007|COMPLETED|Primary Phase||0
6466904|NCT01235949|7383974|FG008|COMPLETED|Primary Phase||0
6466905|NCT01235949|7383975|FG009|COMPLETED|Primary Phase||0
6466906|NCT01235949|7383976|FG010|COMPLETED|Primary Phase||0
6466907|NCT01235949|7383977|FG011|COMPLETED|Primary Phase||0
6466908|NCT01235949|7383978|FG012|COMPLETED|Primary Phase||0
6466909|NCT01235949|7383979|FG013|COMPLETED|Primary Phase||0
6466910|NCT01235949|7383980|FG014|COMPLETED|Primary Phase||0
6466911|NCT01235949|7383981|FG015|COMPLETED|Primary Phase||0
6466912|NCT01235949|7383982|FG016|COMPLETED|Primary Phase||0
6466913|NCT01235949|7383983|FG017|COMPLETED|Primary Phase||0
6466914|NCT01235949|7383966|FG000|NOT COMPLETED|Primary Phase||4
6466915|NCT01235949|7383967|FG001|NOT COMPLETED|Primary Phase||3
6466916|NCT01235949|7383968|FG002|NOT COMPLETED|Primary Phase||3
6466917|NCT01235949|7383969|FG003|NOT COMPLETED|Primary Phase||2
6466918|NCT01235949|7383970|FG004|NOT COMPLETED|Primary Phase||1
6466919|NCT01235949|7383971|FG005|NOT COMPLETED|Primary Phase||7
6466920|NCT01235949|7383972|FG006|NOT COMPLETED|Primary Phase||0
6466921|NCT01235949|7383973|FG007|NOT COMPLETED|Primary Phase||0
6466922|NCT01235949|7383974|FG008|NOT COMPLETED|Primary Phase||0
6466923|NCT01235949|7383975|FG009|NOT COMPLETED|Primary Phase||0
6466924|NCT01235949|7383976|FG010|NOT COMPLETED|Primary Phase||0
6466925|NCT01235949|7383977|FG011|NOT COMPLETED|Primary Phase||0
6466926|NCT01235949|7383978|FG012|NOT COMPLETED|Primary Phase||0
6466927|NCT01235949|7383979|FG013|NOT COMPLETED|Primary Phase||0
6466928|NCT01235949|7383980|FG014|NOT COMPLETED|Primary Phase||0
6466929|NCT01235949|7383981|FG015|NOT COMPLETED|Primary Phase||0
6466930|NCT01235949|7383982|FG016|NOT COMPLETED|Primary Phase||0
6466931|NCT01235949|7383983|FG017|NOT COMPLETED|Primary Phase||0
6466932|NCT01235949|7383966|FG000|STARTED|Booster Phase|re-randomized to diverse treatments (IIBU-IIBU, IIBU-DIBU and IIBU-NIBU Groups) in booster phase|0
6466933|NCT01235949|7383967|FG001|STARTED|Booster Phase|re-randomized to diverse treatments (DIBU-IIBU, DIBU-DIBU and DIBU-NIBU Groups) in booster phase|0
6466934|NCT01235949|7383968|FG002|STARTED|Booster Phase|re-randomized to diverse treatments (NIBU-IIBU, NIBU-DIBU and NIBU-NIBU Groups) in booster phase|0
6466935|NCT01235949|7383969|FG003|STARTED|Booster Phase|subjects re-randomized to IPARA-NPARA Group in booster phase|0
6466936|NCT01235949|7383970|FG004|STARTED|Booster Phase|subjects re-randomized to DPARA-IPARA Group in booster phase|0
6466937|NCT01235949|7383971|FG005|STARTED|Booster Phase|subjects re-randomized to NPARA-IPARA Group in booster phase|0
6466938|NCT01235949|7383972|FG006|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|64
6466939|NCT01235949|7383973|FG007|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|60
6466940|NCT01235949|7383974|FG008|STARTED|Booster Phase|1/3 of subjects from primary IIBU group re-randomized to receive diverse booster phase treatments|63
6466941|NCT01235949|7383975|FG009|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
6466942|NCT01235949|7383976|FG010|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
6466943|NCT01235949|7383977|FG011|STARTED|Booster Phase|1/3 of subjects from primary DIBU group re-randomized to receive diverse booster phase treatments|63
6466944|NCT01235949|7383978|FG012|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|63
6466945|NCT01235949|7383979|FG013|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|65
6466946|NCT01235949|7383980|FG014|STARTED|Booster Phase|1/3 of subjects from primary NIBU group re-randomized to receive diverse booster phase treatments|62
6466947|NCT01235949|7383981|FG015|STARTED|Booster Phase|subjects from the primary IPARA group continuing in booster phase with different treatment|67
6466948|NCT01235949|7383982|FG016|STARTED|Booster Phase|subjects from the primary DPARA group continuing in booster phase with different treatment|68
6466949|NCT01235949|7383983|FG017|STARTED|Booster Phase|subjects from the primary NPARA group continuing in booster phase with different treatment|67
6466950|NCT01235949|7383966|FG000|COMPLETED|Booster Phase||0
6466951|NCT01235949|7383967|FG001|COMPLETED|Booster Phase||0
6466952|NCT01235949|7383968|FG002|COMPLETED|Booster Phase||0
6466953|NCT01235949|7383969|FG003|COMPLETED|Booster Phase||0
6466954|NCT01235949|7383970|FG004|COMPLETED|Booster Phase||0
6466955|NCT01235949|7383971|FG005|COMPLETED|Booster Phase||0
6466956|NCT01235949|7383972|FG006|COMPLETED|Booster Phase||64
6466957|NCT01235949|7383973|FG007|COMPLETED|Booster Phase||59
6466958|NCT01235949|7383974|FG008|COMPLETED|Booster Phase||61
6466959|NCT01235949|7383975|FG009|COMPLETED|Booster Phase||62
6466960|NCT01235949|7383976|FG010|COMPLETED|Booster Phase||61
6466961|NCT01235949|7383977|FG011|COMPLETED|Booster Phase||60
6466962|NCT01235949|7383978|FG012|COMPLETED|Booster Phase||60
6466963|NCT01235949|7383979|FG013|COMPLETED|Booster Phase||65
6466964|NCT01235949|7383980|FG014|COMPLETED|Booster Phase||60
6466965|NCT01235949|7383981|FG015|COMPLETED|Booster Phase||66
6466966|NCT01235949|7383982|FG016|COMPLETED|Booster Phase||68
6466967|NCT01235949|7383983|FG017|COMPLETED|Booster Phase||65
6466968|NCT01235949|7383966|FG000|NOT COMPLETED|Booster Phase||0
6466969|NCT01235949|7383967|FG001|NOT COMPLETED|Booster Phase||0
6466970|NCT01235949|7383968|FG002|NOT COMPLETED|Booster Phase||0
6466971|NCT01235949|7383969|FG003|NOT COMPLETED|Booster Phase||0
6466972|NCT01235949|7383970|FG004|NOT COMPLETED|Booster Phase||0
6466973|NCT01235949|7383971|FG005|NOT COMPLETED|Booster Phase||0
6466974|NCT01235949|7383972|FG006|NOT COMPLETED|Booster Phase||0
6466975|NCT01235949|7383973|FG007|NOT COMPLETED|Booster Phase||1
6466976|NCT01235949|7383974|FG008|NOT COMPLETED|Booster Phase||2
6466977|NCT01235949|7383975|FG009|NOT COMPLETED|Booster Phase||1
6466978|NCT01235949|7383976|FG010|NOT COMPLETED|Booster Phase||2
6466979|NCT01235949|7383977|FG011|NOT COMPLETED|Booster Phase||3
6466980|NCT01235949|7383978|FG012|NOT COMPLETED|Booster Phase||3
6466981|NCT01235949|7383979|FG013|NOT COMPLETED|Booster Phase||0
6466982|NCT01235949|7383980|FG014|NOT COMPLETED|Booster Phase||2
6466983|NCT01235949|7383981|FG015|NOT COMPLETED|Booster Phase||1
6466984|NCT01235949|7383982|FG016|NOT COMPLETED|Booster Phase||0
6466985|NCT01235949|7383983|FG017|NOT COMPLETED|Booster Phase||2
6466986|NCT01235975|7384023|FG000|STARTED|Overall Study||274
6466987|NCT01235975|7384024|FG001|STARTED|Overall Study||95
6466988|NCT01235975|7384023|FG000|COMPLETED|Overall Study||257
6466989|NCT01235975|7384024|FG001|COMPLETED|Overall Study||88
6466990|NCT01235975|7384023|FG000|NOT COMPLETED|Overall Study||17
6466991|NCT01235975|7384024|FG001|NOT COMPLETED|Overall Study||7
6466992|NCT01236001|7384032|FG000|STARTED|Overall Study||105
6466993|NCT01236001|7384033|FG001|STARTED|Overall Study||87
6466994|NCT01236001|7384032|FG000|COMPLETED|Overall Study||87
6466995|NCT01236001|7384033|FG001|COMPLETED|Overall Study||65
6466996|NCT01236001|7384032|FG000|NOT COMPLETED|Overall Study||18
6466997|NCT01236001|7384033|FG001|NOT COMPLETED|Overall Study||22
6466998|NCT01236053|7384062|FG000|STARTED|Overall Study||179138
6466999|NCT01236053|7384063|FG001|STARTED|Overall Study||1710950
6467000|NCT01236053|7384064|FG002|STARTED|Overall Study||1877
6467001|NCT01236053|7384065|FG003|STARTED|Overall Study||17853
6467002|NCT01236053|7384066|FG004|STARTED|Overall Study||212
6467003|NCT01236053|7384067|FG005|STARTED|Overall Study||2067
6467004|NCT01236053|7384068|FG006|STARTED|Overall Study||10855
6467005|NCT01236053|7384069|FG007|STARTED|Overall Study||102836
6467006|NCT01236053|7384070|FG008|STARTED|Overall Study||300
6467007|NCT01236053|7384071|FG009|STARTED|Overall Study||2935
6467008|NCT01236053|7384072|FG010|STARTED|Overall Study||19564
6467009|NCT01236053|7384073|FG011|STARTED|Overall Study||188924
6467010|NCT01236053|7384074|FG012|STARTED|Overall Study||148
6467011|NCT01236053|7384075|FG013|STARTED|Overall Study||1396
6467012|NCT01236053|7384076|FG014|STARTED|Overall Study||4600
6467013|NCT01236053|7384077|FG015|STARTED|Overall Study||43559
6467014|NCT01236053|7384078|FG016|STARTED|Overall Study||38
6467015|NCT01236053|7384079|FG017|STARTED|Overall Study||380
6467016|NCT01236053|7384080|FG018|STARTED|Overall Study||2155
6467017|NCT01236053|7384081|FG019|STARTED|Overall Study||20382
6467018|NCT01236053|7384082|FG020|STARTED|Overall Study||1272
6467019|NCT01236053|7384083|FG021|STARTED|Overall Study||12167
6467020|NCT01236053|7384062|FG000|COMPLETED|Overall Study||179138
6467021|NCT01236053|7384063|FG001|COMPLETED|Overall Study||1710950
6467022|NCT01236053|7384064|FG002|COMPLETED|Overall Study||1877
6467023|NCT01236053|7384065|FG003|COMPLETED|Overall Study||17853
6467024|NCT01236053|7384066|FG004|COMPLETED|Overall Study||212
6467025|NCT01236053|7384067|FG005|COMPLETED|Overall Study||2067
6467026|NCT01236053|7384068|FG006|COMPLETED|Overall Study||10855
6467027|NCT01236053|7384069|FG007|COMPLETED|Overall Study||102836
6467028|NCT01236053|7384070|FG008|COMPLETED|Overall Study||300
6467029|NCT01236053|7384071|FG009|COMPLETED|Overall Study||2935
6467030|NCT01236053|7384072|FG010|COMPLETED|Overall Study||19564
6467031|NCT01236053|7384073|FG011|COMPLETED|Overall Study||188924
6467032|NCT01236053|7384074|FG012|COMPLETED|Overall Study||148
6467033|NCT01236053|7384075|FG013|COMPLETED|Overall Study||1396
6467034|NCT01236053|7384076|FG014|COMPLETED|Overall Study||4600
6467035|NCT01236053|7384077|FG015|COMPLETED|Overall Study||43559
6467036|NCT01236053|7384078|FG016|COMPLETED|Overall Study||38
6467037|NCT01236053|7384079|FG017|COMPLETED|Overall Study||380
6467038|NCT01236053|7384080|FG018|COMPLETED|Overall Study||2155
6467039|NCT01236053|7384081|FG019|COMPLETED|Overall Study||20382
6467040|NCT01236053|7384082|FG020|COMPLETED|Overall Study||1272
6467041|NCT01236053|7384083|FG021|COMPLETED|Overall Study||12167
6467042|NCT01236053|7384062|FG000|NOT COMPLETED|Overall Study||0
6467043|NCT01236053|7384063|FG001|NOT COMPLETED|Overall Study||0
6467044|NCT01236053|7384064|FG002|NOT COMPLETED|Overall Study||0
6467045|NCT01236053|7384065|FG003|NOT COMPLETED|Overall Study||0
6467046|NCT01236053|7384066|FG004|NOT COMPLETED|Overall Study||0
6467047|NCT01236053|7384067|FG005|NOT COMPLETED|Overall Study||0
6467048|NCT01236053|7384068|FG006|NOT COMPLETED|Overall Study||0
6467049|NCT01236053|7384069|FG007|NOT COMPLETED|Overall Study||0
6467050|NCT01236053|7384070|FG008|NOT COMPLETED|Overall Study||0
6467051|NCT01236053|7384071|FG009|NOT COMPLETED|Overall Study||0
6467052|NCT01236053|7384072|FG010|NOT COMPLETED|Overall Study||0
6467053|NCT01236053|7384073|FG011|NOT COMPLETED|Overall Study||0
6467054|NCT01236053|7384074|FG012|NOT COMPLETED|Overall Study||0
6467055|NCT01236053|7384075|FG013|NOT COMPLETED|Overall Study||0
6467056|NCT01236053|7384076|FG014|NOT COMPLETED|Overall Study||0
6467057|NCT01236053|7384077|FG015|NOT COMPLETED|Overall Study||0
6467058|NCT01236053|7384078|FG016|NOT COMPLETED|Overall Study||0
6467059|NCT01236053|7384079|FG017|NOT COMPLETED|Overall Study||0
6467060|NCT01236053|7384080|FG018|NOT COMPLETED|Overall Study||0
6467061|NCT01236053|7384081|FG019|NOT COMPLETED|Overall Study||0
6467062|NCT01236053|7384082|FG020|NOT COMPLETED|Overall Study||0
6467063|NCT01236053|7384083|FG021|NOT COMPLETED|Overall Study||0
6467064|NCT01236105|7384132|FG000|STARTED|Overall Study||21
6467065|NCT01236105|7384132|FG000|COMPLETED|Overall Study||21
6467066|NCT01236105|7384132|FG000|NOT COMPLETED|Overall Study||0
6467067|NCT01236118|7384143|FG000|STARTED|Overall Study||6
6467068|NCT01236118|7384144|FG001|STARTED|Overall Study||5
6467069|NCT01236118|7384145|FG002|STARTED|Overall Study||17
6467070|NCT01236118|7384143|FG000|COMPLETED|Overall Study||4
6467071|NCT01236118|7384144|FG001|COMPLETED|Overall Study||4
6467072|NCT01236118|7384145|FG002|COMPLETED|Overall Study||14
6467073|NCT01236118|7384143|FG000|NOT COMPLETED|Overall Study||2
6467074|NCT01236118|7384144|FG001|NOT COMPLETED|Overall Study||1
6467075|NCT01236118|7384145|FG002|NOT COMPLETED|Overall Study||3
6467076|NCT01236170|7384153|FG000|STARTED|Overall Study||497
6467077|NCT01236170|7384153|FG000|COMPLETED|Overall Study||482
6467078|NCT01236170|7384153|FG000|NOT COMPLETED|Overall Study||15
6467079|NCT01236196|7384159|FG000|STARTED|Overall Study||18
6467080|NCT01236196|7384160|FG001|STARTED|Overall Study||21
6467081|NCT01236196|7384159|FG000|COMPLETED|Overall Study||17
6467082|NCT01236196|7384160|FG001|COMPLETED|Overall Study||13
6467083|NCT01236196|7384159|FG000|NOT COMPLETED|Overall Study||1
6467084|NCT01236196|7384160|FG001|NOT COMPLETED|Overall Study||8
6467085|NCT01236300|7384166|FG000|STARTED|Overall Study||66
6467086|NCT01236300|7384166|FG000|COMPLETED|Overall Study||66
6467087|NCT01236300|7384166|FG000|NOT COMPLETED|Overall Study||0
6467088|NCT01236326|7384173|FG000|STARTED|Overall Study||50
6467089|NCT01236326|7384174|FG001|STARTED|Overall Study||55
6467090|NCT01236326|7384173|FG000|COMPLETED|Overall Study||49
6467091|NCT01236326|7384174|FG001|COMPLETED|Overall Study||51
6467092|NCT01236326|7384173|FG000|NOT COMPLETED|Overall Study||1
6467093|NCT01236326|7384174|FG001|NOT COMPLETED|Overall Study||4
6467094|NCT01236339|7384182|FG000|STARTED|Overall Study||13
6467095|NCT01236339|7384183|FG001|STARTED|Overall Study||13
6467096|NCT01236339|7384182|FG000|LVP Crossover to TIPS|Overall Study||0
6467097|NCT01236339|7384183|FG001|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
6467098|NCT01236339|7384182|FG000|COMPLETED|Overall Study||2
6467099|NCT01236339|7384183|FG001|COMPLETED|Overall Study||0
6467100|NCT01236339|7384182|FG000|NOT COMPLETED|Overall Study||11
6467101|NCT01236339|7384183|FG001|NOT COMPLETED|Overall Study||13
6467102|NCT01236352|7384201|FG000|STARTED|Overall Study||4
6467103|NCT01236352|7384202|FG001|STARTED|Overall Study||4
6467104|NCT01236352|7384203|FG002|STARTED|Overall Study||4
6467105|NCT01236352|7384204|FG003|STARTED|Overall Study||4
6467106|NCT01236352|7384205|FG004|STARTED|Overall Study||4
6467107|NCT01236352|7384206|FG005|STARTED|Overall Study||4
6467108|NCT01236352|7384207|FG006|STARTED|Overall Study||8
6467109|NCT01236352|7384208|FG007|STARTED|Overall Study||7
6467110|NCT01236352|7384209|FG008|STARTED|Overall Study||3
6467111|NCT01236352|7384210|FG009|STARTED|Overall Study||22
6467112|NCT01236352|7384211|FG010|STARTED|Overall Study||20
6467113|NCT01236352|7384201|FG000|COMPLETED|Overall Study||0
6467114|NCT01236352|7384202|FG001|COMPLETED|Overall Study||0
6467115|NCT01236352|7384203|FG002|COMPLETED|Overall Study||0
6467116|NCT01236352|7384204|FG003|COMPLETED|Overall Study||1
6467117|NCT01236352|7384205|FG004|COMPLETED|Overall Study||0
6467118|NCT01236352|7384206|FG005|COMPLETED|Overall Study||0
6467119|NCT01236352|7384207|FG006|COMPLETED|Overall Study||0
6467120|NCT01236352|7384208|FG007|COMPLETED|Overall Study||0
6467121|NCT01236352|7384209|FG008|COMPLETED|Overall Study||0
6467122|NCT01236352|7384210|FG009|COMPLETED|Overall Study||0
6467123|NCT01236352|7384211|FG010|COMPLETED|Overall Study||0
6467124|NCT01236352|7384201|FG000|NOT COMPLETED|Overall Study||4
6467125|NCT01236352|7384202|FG001|NOT COMPLETED|Overall Study||4
6467126|NCT01236352|7384203|FG002|NOT COMPLETED|Overall Study||4
6467127|NCT01236352|7384204|FG003|NOT COMPLETED|Overall Study||3
6467128|NCT01236352|7384205|FG004|NOT COMPLETED|Overall Study||4
6467129|NCT01236352|7384206|FG005|NOT COMPLETED|Overall Study||4
6467130|NCT01236352|7384207|FG006|NOT COMPLETED|Overall Study||8
6467131|NCT01236352|7384208|FG007|NOT COMPLETED|Overall Study||7
6467132|NCT01236352|7384209|FG008|NOT COMPLETED|Overall Study||3
6467133|NCT01236352|7384210|FG009|NOT COMPLETED|Overall Study||22
6467134|NCT01236352|7384211|FG010|NOT COMPLETED|Overall Study||20
6467135|NCT01236365|7384237|FG000|STARTED|Overall Study||21
6467136|NCT01236365|7384238|FG001|STARTED|Overall Study||21
6467137|NCT01236365|7384237|FG000|COMPLETED|Overall Study||19
6467138|NCT01236365|7384238|FG001|COMPLETED|Overall Study||19
6467139|NCT01236365|7384237|FG000|NOT COMPLETED|Overall Study||2
6467140|NCT01236365|7384238|FG001|NOT COMPLETED|Overall Study||2
6467141|NCT01236378|7384256|FG000|STARTED|Overall Study||24
6467142|NCT01236378|7384256|FG000|COMPLETED|Overall Study||24
6467143|NCT01236378|7384256|FG000|NOT COMPLETED|Overall Study||0
6467144|NCT01236391|7384260|FG000|STARTED|Overall Study|Participants who received study treatment|111
6467145|NCT01236391|7384260|FG000|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
6467146|NCT01236391|7384260|FG000|NOT COMPLETED|Overall Study||16
6467147|NCT01236521|7384269|FG000|STARTED|Overall Study||131
6467148|NCT01236521|7384270|FG001|STARTED|Overall Study||130
6467149|NCT01236521|7384269|FG000|3-month Completed|Overall Study||122
6467150|NCT01236521|7384270|FG001|3-month Completed|Overall Study||119
6467151|NCT01236521|7384269|FG000|6-month Completed|Overall Study||122
6467152|NCT01236521|7384270|FG001|6-month Completed|Overall Study||116
6467153|NCT01236521|7384269|FG000|9-month Completed|Overall Study||115
6467154|NCT01236521|7384270|FG001|9-month Completed|Overall Study||101
6467155|NCT01236521|7384269|FG000|12-moth Completed|Overall Study||110
6467156|NCT01236521|7384270|FG001|12-moth Completed|Overall Study||105
6467157|NCT01236521|7384269|FG000|COMPLETED|Overall Study||110
6467158|NCT01236521|7384270|FG001|COMPLETED|Overall Study||105
6467159|NCT01236521|7384269|FG000|NOT COMPLETED|Overall Study||21
6467160|NCT01236521|7384270|FG001|NOT COMPLETED|Overall Study||25
6467161|NCT01236534|7384278|FG000|STARTED|Overall Study||11
6467162|NCT01236534|7384279|FG001|STARTED|Overall Study||10
6467163|NCT01236534|7384278|FG000|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
6467164|NCT01236534|7384279|FG001|COMPLETED|Overall Study||10
6467165|NCT01236534|7384278|FG000|NOT COMPLETED|Overall Study||3
6467166|NCT01236534|7384279|FG001|NOT COMPLETED|Overall Study||0
6467167|NCT01236573|7384296|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
6467168|NCT01236573|7384297|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
6467169|NCT01236573|7384298|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
6467170|NCT01236573|7384299|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
6467171|NCT01236573|7384300|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467172|NCT01236573|7384301|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467173|NCT01236573|7384302|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467174|NCT01236573|7384303|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467175|NCT01236573|7384304|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467176|NCT01236573|7384305|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467177|NCT01236573|7384306|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467178|NCT01236573|7384296|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
6467179|NCT01236573|7384297|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
6467180|NCT01236573|7384298|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
6467181|NCT01236573|7384299|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
6467182|NCT01236573|7384300|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467183|NCT01236573|7384301|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467184|NCT01236573|7384302|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467185|NCT01236573|7384303|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467186|NCT01236573|7384304|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467187|NCT01236573|7384305|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467188|NCT01236573|7384306|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467189|NCT01236573|7384296|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467190|NCT01236573|7384297|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467191|NCT01236573|7384298|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467192|NCT01236573|7384299|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467193|NCT01236573|7384300|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467194|NCT01236573|7384301|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467195|NCT01236573|7384302|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467196|NCT01236573|7384303|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467197|NCT01236573|7384304|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467198|NCT01236573|7384305|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467199|NCT01236573|7384306|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
6467200|NCT01236573|7384296|FG000|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467201|NCT01236573|7384297|FG001|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467202|NCT01236573|7384298|FG002|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467203|NCT01236573|7384299|FG003|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467204|NCT01236573|7384300|FG004|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
6467205|NCT01236573|7384301|FG005|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
6467206|NCT01236573|7384302|FG006|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
6467207|NCT01236573|7384303|FG007|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
6467208|NCT01236573|7384304|FG008|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
6467209|NCT01236573|7384305|FG009|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
6467210|NCT01236573|7384306|FG010|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467211|NCT01236573|7384296|FG000|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467212|NCT01236573|7384297|FG001|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467213|NCT01236573|7384298|FG002|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467214|NCT01236573|7384299|FG003|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467215|NCT01236573|7384300|FG004|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
6467216|NCT01236573|7384301|FG005|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
6467217|NCT01236573|7384302|FG006|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
6467218|NCT01236573|7384303|FG007|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
6467219|NCT01236573|7384304|FG008|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
6467220|NCT01236573|7384305|FG009|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
6467221|NCT01236573|7384306|FG010|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467222|NCT01236573|7384296|FG000|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467223|NCT01236573|7384297|FG001|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467224|NCT01236573|7384298|FG002|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467225|NCT01236573|7384299|FG003|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467226|NCT01236573|7384300|FG004|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467227|NCT01236573|7384301|FG005|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467228|NCT01236573|7384302|FG006|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
6467229|NCT01236573|7384303|FG007|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467230|NCT01236573|7384304|FG008|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
6467231|NCT01236573|7384305|FG009|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
6467232|NCT01236573|7384306|FG010|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
6467233|NCT01236573|7384296|FG000|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467234|NCT01236573|7384297|FG001|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467235|NCT01236573|7384298|FG002|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467236|NCT01236573|7384299|FG003|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467237|NCT01236573|7384300|FG004|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467238|NCT01236573|7384301|FG005|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467239|NCT01236573|7384302|FG006|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467240|NCT01236573|7384303|FG007|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467241|NCT01236573|7384304|FG008|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6554195|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
6554196|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Washout Period 1||7
6554197|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Washout Period 1||7
6554198|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Washout Period 1||7
6554199|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6554200|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6554201|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6554202|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6554203|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6467242|NCT01236573|7384305|FG009|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467243|NCT01236573|7384306|FG010|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
6467244|NCT01236573|7384296|FG000|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467245|NCT01236573|7384297|FG001|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467246|NCT01236573|7384298|FG002|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467247|NCT01236573|7384299|FG003|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467248|NCT01236573|7384300|FG004|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467249|NCT01236573|7384301|FG005|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467250|NCT01236573|7384302|FG006|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467251|NCT01236573|7384303|FG007|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467252|NCT01236573|7384304|FG008|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467253|NCT01236573|7384305|FG009|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467254|NCT01236573|7384306|FG010|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
6467255|NCT01236573|7384296|FG000|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467256|NCT01236573|7384297|FG001|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467257|NCT01236573|7384298|FG002|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467258|NCT01236573|7384299|FG003|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467259|NCT01236573|7384300|FG004|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467260|NCT01236573|7384301|FG005|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467261|NCT01236573|7384302|FG006|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467262|NCT01236573|7384303|FG007|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467263|NCT01236573|7384304|FG008|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467264|NCT01236573|7384305|FG009|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
6467265|NCT01236573|7384306|FG010|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
6467266|NCT01236742|7384334|FG000|STARTED|Overall Study||18
6467267|NCT01236742|7384335|FG001|STARTED|Overall Study||19
6467268|NCT01236742|7384336|FG002|STARTED|Overall Study||16
6467269|NCT01236742|7384334|FG000|COMPLETED|Overall Study||15
6467270|NCT01236742|7384335|FG001|COMPLETED|Overall Study||16
6467271|NCT01236742|7384336|FG002|COMPLETED|Overall Study||13
6467272|NCT01236742|7384334|FG000|NOT COMPLETED|Overall Study||3
6467273|NCT01236742|7384335|FG001|NOT COMPLETED|Overall Study||3
6467274|NCT01236742|7384336|FG002|NOT COMPLETED|Overall Study||3
6467275|NCT01236755|7384344|FG000|STARTED|Spectacles Wearing Phase||91
6467276|NCT01236755|7384344|FG000|COMPLETED|Spectacles Wearing Phase||74
6467277|NCT01236755|7384344|FG000|NOT COMPLETED|Spectacles Wearing Phase||17
6467278|NCT01236755|7384344|FG000|STARTED|Orthokeratology Wearing Phase||74
6467279|NCT01236755|7384344|FG000|COMPLETED|Orthokeratology Wearing Phase||66
6467280|NCT01236755|7384344|FG000|NOT COMPLETED|Orthokeratology Wearing Phase||8
6467281|NCT01236768|7384351|FG000|STARTED|Overall Study||201
6467282|NCT01236768|7384352|FG001|STARTED|Overall Study||206
6467283|NCT01236768|7384351|FG000|COMPLETED|Overall Study||112
6467284|NCT01236768|7384352|FG001|COMPLETED|Overall Study||145
6467285|NCT01236768|7384351|FG000|NOT COMPLETED|Overall Study||89
6467286|NCT01236768|7384352|FG001|NOT COMPLETED|Overall Study||61
6467287|NCT01237041|7384364|FG000|STARTED|Overall Study||2
6467288|NCT01237041|7384365|FG001|STARTED|Overall Study||3
6554204|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6554205|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6554206|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6467289|NCT01237041|7384366|FG002|STARTED|Overall Study||2
6467290|NCT01237041|7384367|FG003|STARTED|Overall Study||5
6467291|NCT01237041|7384368|FG004|STARTED|Overall Study||5
6467292|NCT01237041|7384364|FG000|COMPLETED|Overall Study||2
6467293|NCT01237041|7384365|FG001|COMPLETED|Overall Study||3
6467294|NCT01237041|7384366|FG002|COMPLETED|Overall Study||2
6467295|NCT01237041|7384367|FG003|COMPLETED|Overall Study||5
6467296|NCT01237041|7384368|FG004|COMPLETED|Overall Study||5
6467297|NCT01237041|7384364|FG000|NOT COMPLETED|Overall Study||0
6467298|NCT01237041|7384365|FG001|NOT COMPLETED|Overall Study||0
6467299|NCT01237041|7384366|FG002|NOT COMPLETED|Overall Study||0
6467300|NCT01237041|7384367|FG003|NOT COMPLETED|Overall Study||0
6467301|NCT01237041|7384368|FG004|NOT COMPLETED|Overall Study||0
6467302|NCT01237054|7384378|FG000|STARTED|Overall Study||31
6467303|NCT01237054|7384378|FG000|COMPLETED|Overall Study||30
6467304|NCT01237054|7384378|FG000|NOT COMPLETED|Overall Study||1
6467305|NCT01237080|7384387|FG000|STARTED|Overall Study||50
6467306|NCT01237080|7384388|FG001|STARTED|Overall Study||50
6467307|NCT01237080|7384387|FG000|COMPLETED|Overall Study||50
6467308|NCT01237080|7384388|FG001|COMPLETED|Overall Study||50
6467309|NCT01237080|7384387|FG000|NOT COMPLETED|Overall Study||0
6467310|NCT01237080|7384388|FG001|NOT COMPLETED|Overall Study||0
6467311|NCT01237197|7384396|FG000|STARTED|Randomization Period||13
6467312|NCT01237197|7384397|FG001|STARTED|Randomization Period||13
6467313|NCT01237197|7384396|FG000|COMPLETED|Randomization Period||12
6467314|NCT01237197|7384397|FG001|COMPLETED|Randomization Period||10
6467315|NCT01237197|7384396|FG000|NOT COMPLETED|Randomization Period||1
6467316|NCT01237197|7384397|FG001|NOT COMPLETED|Randomization Period||3
6467317|NCT01237197|7384396|FG000|STARTED|Open Label Period||12
6467318|NCT01237197|7384397|FG001|STARTED|Open Label Period||10
6467319|NCT01237197|7384396|FG000|COMPLETED|Open Label Period||12
6467320|NCT01237197|7384397|FG001|COMPLETED|Open Label Period||10
6467321|NCT01237197|7384396|FG000|NOT COMPLETED|Open Label Period||0
6467322|NCT01237197|7384397|FG001|NOT COMPLETED|Open Label Period||0
6467323|NCT01237223|7384409|FG000|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
6467324|NCT01237223|7384410|FG001|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6467325|NCT01237223|7384411|FG002|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6467326|NCT01237223|7384412|FG003|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6467327|NCT01237223|7384413|FG004|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6467328|NCT01237223|7384414|FG005|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
6467329|NCT01237223|7384409|FG000|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
6467330|NCT01237223|7384410|FG001|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467331|NCT01237223|7384411|FG002|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467332|NCT01237223|7384412|FG003|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467333|NCT01237223|7384413|FG004|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467334|NCT01237223|7384414|FG005|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467335|NCT01237223|7384409|FG000|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
6467336|NCT01237223|7384410|FG001|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467337|NCT01237223|7384411|FG002|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467338|NCT01237223|7384412|FG003|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467339|NCT01237223|7384413|FG004|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467340|NCT01237223|7384414|FG005|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
6467341|NCT01237223|7384409|FG000|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
6467342|NCT01237223|7384410|FG001|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
6467343|NCT01237223|7384411|FG002|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
6467344|NCT01237223|7384412|FG003|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
6467345|NCT01237223|7384413|FG004|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
6467346|NCT01237223|7384414|FG005|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
6467347|NCT01237223|7384409|FG000|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
6467348|NCT01237223|7384410|FG001|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
6467349|NCT01237223|7384411|FG002|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
6467350|NCT01237223|7384412|FG003|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
6467351|NCT01237223|7384413|FG004|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
6467352|NCT01237223|7384414|FG005|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
6467353|NCT01237223|7384409|FG000|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
6467354|NCT01237223|7384410|FG001|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
6467355|NCT01237223|7384411|FG002|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
6467356|NCT01237223|7384412|FG003|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
6467357|NCT01237223|7384413|FG004|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
6467358|NCT01237223|7384414|FG005|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
6467359|NCT01237301|7384432|FG000|STARTED|Overall Study||65
6467360|NCT01237301|7384433|FG001|STARTED|Overall Study||59
6467361|NCT01237301|7384432|FG000|COMPLETED|Overall Study||60
6467362|NCT01237301|7384433|FG001|COMPLETED|Overall Study||55
6467363|NCT01237301|7384432|FG000|NOT COMPLETED|Overall Study||5
6467364|NCT01237301|7384433|FG001|NOT COMPLETED|Overall Study||4
6500980|NCT01426347|7419448|FG000|NOT COMPLETED|Overall Study||7
6500981|NCT01426347|7419449|FG001|NOT COMPLETED|Overall Study||3
6500982|NCT01426360|7419457|FG000|STARTED|Overall Study||38
6500983|NCT01426360|7419458|FG001|STARTED|Overall Study||41
6500984|NCT01426360|7419457|FG000|COMPLETED|Overall Study||38
6467365|NCT01237327|7384443|FG000|STARTED|Overall Study||43
6467366|NCT01237327|7384444|FG001|STARTED|Overall Study||41
6467367|NCT01237327|7384443|FG000|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
6467368|NCT01237327|7384444|FG001|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
6467369|NCT01237327|7384443|FG000|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
6467370|NCT01237327|7384444|FG001|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
6467371|NCT01237327|7384443|FG000|Continued Treatment in Extension Study|Overall Study||21
6467372|NCT01237327|7384444|FG001|Continued Treatment in Extension Study|Overall Study||17
6467373|NCT01237327|7384443|FG000|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
6467374|NCT01237327|7384444|FG001|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
6467375|NCT01237327|7384443|FG000|NOT COMPLETED|Overall Study||42
6467376|NCT01237327|7384444|FG001|NOT COMPLETED|Overall Study||40
6467377|NCT01237340|7384450|FG000|STARTED|Overall Study||59
6467378|NCT01237340|7384450|FG000|COMPLETED|Overall Study||19
6467379|NCT01237340|7384450|FG000|NOT COMPLETED|Overall Study||40
6467380|NCT01237353|7384457|FG000|STARTED|Overall Study||6
6467381|NCT01237353|7384457|FG000|COMPLETED|Overall Study||6
6467382|NCT01237353|7384457|FG000|NOT COMPLETED|Overall Study||0
6467383|NCT01237587|7384463|FG000|STARTED|Double Blind Treatment (Acute Phase)||91
6467384|NCT01237587|7384464|FG001|STARTED|Double Blind Treatment (Acute Phase)||93
6467385|NCT01237587|7384463|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||91
6467386|NCT01237587|7384464|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment (Acute Phase)||93
6467387|NCT01237587|7384463|FG000|COMPLETED|Double Blind Treatment (Acute Phase)||74
6467388|NCT01237587|7384464|FG001|COMPLETED|Double Blind Treatment (Acute Phase)||75
6467389|NCT01237587|7384463|FG000|NOT COMPLETED|Double Blind Treatment (Acute Phase)||17
6467390|NCT01237587|7384464|FG001|NOT COMPLETED|Double Blind Treatment (Acute Phase)||18
6467391|NCT01237587|7384463|FG000|STARTED|Open Label Treatment (Extension Phase)||74
6467392|NCT01237587|7384464|FG001|STARTED|Open Label Treatment (Extension Phase)||75
6467393|NCT01237587|7384463|FG000|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||74
6467394|NCT01237587|7384464|FG001|Received at Least One Dose of Study Drug|Open Label Treatment (Extension Phase)||75
6467395|NCT01237587|7384463|FG000|COMPLETED|Open Label Treatment (Extension Phase)||56
6467396|NCT01237587|7384464|FG001|COMPLETED|Open Label Treatment (Extension Phase)||50
6467397|NCT01237587|7384463|FG000|NOT COMPLETED|Open Label Treatment (Extension Phase)||18
6467398|NCT01237587|7384464|FG001|NOT COMPLETED|Open Label Treatment (Extension Phase)||25
6467399|NCT01237587|7384463|FG000|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|36
6467400|NCT01237587|7384464|FG001|STARTED|Taper Phase|Participants who discontinued Acute or Extension phase had an option to enter tapering phase.|44
6467401|NCT01237587|7384463|FG000|COMPLETED|Taper Phase||31
6467402|NCT01237587|7384464|FG001|COMPLETED|Taper Phase||34
6467403|NCT01237587|7384463|FG000|NOT COMPLETED|Taper Phase||5
6467404|NCT01237587|7384464|FG001|NOT COMPLETED|Taper Phase||10
6467405|NCT01237678|7384480|FG000|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||33
6467406|NCT01237678|7384481|FG001|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
6467407|NCT01237678|7384482|FG002|STARTED|Phase I - IMGN901+Carboplatin+Etoposide||0
6467408|NCT01237678|7384480|FG000|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||33
6467409|NCT01237678|7384481|FG001|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
6467410|NCT01237678|7384482|FG002|Received Intervention|Phase I - IMGN901+Carboplatin+Etoposide||0
6467411|NCT01237678|7384480|FG000|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6467412|NCT01237678|7384481|FG001|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6467413|NCT01237678|7384482|FG002|COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6467414|NCT01237678|7384480|FG000|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||33
6467415|NCT01237678|7384481|FG001|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6467416|NCT01237678|7384482|FG002|NOT COMPLETED|Phase I - IMGN901+Carboplatin+Etoposide||0
6467417|NCT01237678|7384480|FG000|STARTED|Phase II||0
6467418|NCT01237678|7384481|FG001|STARTED|Phase II|98 subjects were randomized, 94 subjects treated|98
6467419|NCT01237678|7384482|FG002|STARTED|Phase II|50 subjects were randomized, 47 subjects treated|50
6467420|NCT01237678|7384480|FG000|Received Intervention|Phase II||0
6467421|NCT01237678|7384481|FG001|Received Intervention|Phase II||94
6467422|NCT01237678|7384482|FG002|Received Intervention|Phase II||47
6467423|NCT01237678|7384480|FG000|COMPLETED|Phase II||0
6467424|NCT01237678|7384481|FG001|COMPLETED|Phase II||0
6467425|NCT01237678|7384482|FG002|COMPLETED|Phase II||0
6467426|NCT01237678|7384480|FG000|NOT COMPLETED|Phase II||0
6467427|NCT01237678|7384481|FG001|NOT COMPLETED|Phase II||98
6467428|NCT01237678|7384482|FG002|NOT COMPLETED|Phase II||50
6467429|NCT01237821|7384499|FG000|STARTED|Overall Study||32
6467430|NCT01237821|7384500|FG001|STARTED|Overall Study||34
6467431|NCT01237821|7384499|FG000|COMPLETED|Overall Study||26
6467432|NCT01237821|7384500|FG001|COMPLETED|Overall Study||34
6467433|NCT01237821|7384499|FG000|NOT COMPLETED|Overall Study||6
6467434|NCT01237821|7384500|FG001|NOT COMPLETED|Overall Study||0
6467435|NCT01237899|7384517|FG000|STARTED|First Dosing Period||1
6554207|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6554208|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Second Intervention||0
6467436|NCT01237899|7384518|FG001|STARTED|First Dosing Period||3
6467437|NCT01237899|7384519|FG002|STARTED|First Dosing Period||4
6467438|NCT01237899|7384520|FG003|STARTED|First Dosing Period||3
6467439|NCT01237899|7384521|FG004|STARTED|First Dosing Period||2
6467440|NCT01237899|7384522|FG005|STARTED|First Dosing Period||4
6467441|NCT01237899|7384523|FG006|STARTED|First Dosing Period||1
6467442|NCT01237899|7384524|FG007|STARTED|First Dosing Period||3
6467443|NCT01237899|7384525|FG008|STARTED|First Dosing Period||4
6746701|NCT03376321|7674372|FG000|STARTED|Overall Study||168
6746702|NCT03376321|7674373|FG001|STARTED|Overall Study||166
6467444|NCT01237899|7384526|FG009|STARTED|First Dosing Period||3
6467445|NCT01237899|7384527|FG010|STARTED|First Dosing Period||4
6467446|NCT01237899|7384517|FG000|COMPLETED|First Dosing Period||1
6467447|NCT01237899|7384518|FG001|COMPLETED|First Dosing Period||3
6467448|NCT01237899|7384519|FG002|COMPLETED|First Dosing Period||4
6467449|NCT01237899|7384520|FG003|COMPLETED|First Dosing Period||3
6467450|NCT01237899|7384521|FG004|COMPLETED|First Dosing Period||2
6467451|NCT01237899|7384522|FG005|COMPLETED|First Dosing Period||4
6467452|NCT01237899|7384523|FG006|COMPLETED|First Dosing Period||1
6467453|NCT01237899|7384524|FG007|COMPLETED|First Dosing Period||3
6467454|NCT01237899|7384525|FG008|COMPLETED|First Dosing Period||4
6467455|NCT01237899|7384526|FG009|COMPLETED|First Dosing Period||3
6467456|NCT01237899|7384527|FG010|COMPLETED|First Dosing Period||4
6467457|NCT01237899|7384517|FG000|NOT COMPLETED|First Dosing Period||0
6467458|NCT01237899|7384518|FG001|NOT COMPLETED|First Dosing Period||0
6467459|NCT01237899|7384519|FG002|NOT COMPLETED|First Dosing Period||0
6467460|NCT01237899|7384520|FG003|NOT COMPLETED|First Dosing Period||0
6467461|NCT01237899|7384521|FG004|NOT COMPLETED|First Dosing Period||0
6467462|NCT01237899|7384522|FG005|NOT COMPLETED|First Dosing Period||0
6467463|NCT01237899|7384523|FG006|NOT COMPLETED|First Dosing Period||0
6467464|NCT01237899|7384524|FG007|NOT COMPLETED|First Dosing Period||0
6467465|NCT01237899|7384525|FG008|NOT COMPLETED|First Dosing Period||0
6467466|NCT01237899|7384526|FG009|NOT COMPLETED|First Dosing Period||0
6467467|NCT01237899|7384527|FG010|NOT COMPLETED|First Dosing Period||0
6467468|NCT01237899|7384517|FG000|STARTED|Washout Period of at Least 7 Days||1
6467469|NCT01237899|7384518|FG001|STARTED|Washout Period of at Least 7 Days||3
6467470|NCT01237899|7384519|FG002|STARTED|Washout Period of at Least 7 Days||4
6467471|NCT01237899|7384520|FG003|STARTED|Washout Period of at Least 7 Days||3
6467472|NCT01237899|7384521|FG004|STARTED|Washout Period of at Least 7 Days||2
6467473|NCT01237899|7384522|FG005|STARTED|Washout Period of at Least 7 Days||4
6467474|NCT01237899|7384523|FG006|STARTED|Washout Period of at Least 7 Days||1
6467475|NCT01237899|7384524|FG007|STARTED|Washout Period of at Least 7 Days||3
6467476|NCT01237899|7384525|FG008|STARTED|Washout Period of at Least 7 Days||4
6467477|NCT01237899|7384526|FG009|STARTED|Washout Period of at Least 7 Days||3
6467478|NCT01237899|7384527|FG010|STARTED|Washout Period of at Least 7 Days||4
6467479|NCT01237899|7384517|FG000|COMPLETED|Washout Period of at Least 7 Days||1
6467480|NCT01237899|7384518|FG001|COMPLETED|Washout Period of at Least 7 Days||3
6467481|NCT01237899|7384519|FG002|COMPLETED|Washout Period of at Least 7 Days||3
6467482|NCT01237899|7384520|FG003|COMPLETED|Washout Period of at Least 7 Days||3
6467483|NCT01237899|7384521|FG004|COMPLETED|Washout Period of at Least 7 Days||2
6467484|NCT01237899|7384522|FG005|COMPLETED|Washout Period of at Least 7 Days||4
6467485|NCT01237899|7384523|FG006|COMPLETED|Washout Period of at Least 7 Days||1
6467486|NCT01237899|7384524|FG007|COMPLETED|Washout Period of at Least 7 Days||3
6467487|NCT01237899|7384525|FG008|COMPLETED|Washout Period of at Least 7 Days||4
6467488|NCT01237899|7384526|FG009|COMPLETED|Washout Period of at Least 7 Days||3
6467489|NCT01237899|7384527|FG010|COMPLETED|Washout Period of at Least 7 Days||4
6467490|NCT01237899|7384517|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467491|NCT01237899|7384518|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467492|NCT01237899|7384519|FG002|NOT COMPLETED|Washout Period of at Least 7 Days||1
6467493|NCT01237899|7384520|FG003|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467494|NCT01237899|7384521|FG004|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467495|NCT01237899|7384522|FG005|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467496|NCT01237899|7384523|FG006|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467497|NCT01237899|7384524|FG007|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467498|NCT01237899|7384525|FG008|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467499|NCT01237899|7384526|FG009|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467500|NCT01237899|7384527|FG010|NOT COMPLETED|Washout Period of at Least 7 Days||0
6467501|NCT01237899|7384517|FG000|STARTED|Second Dosing Period||1
6467502|NCT01237899|7384518|FG001|STARTED|Second Dosing Period||3
6467503|NCT01237899|7384519|FG002|STARTED|Second Dosing Period||3
6467504|NCT01237899|7384520|FG003|STARTED|Second Dosing Period||3
6467505|NCT01237899|7384521|FG004|STARTED|Second Dosing Period||2
6467506|NCT01237899|7384522|FG005|STARTED|Second Dosing Period||4
6467507|NCT01237899|7384523|FG006|STARTED|Second Dosing Period||1
6467508|NCT01237899|7384524|FG007|STARTED|Second Dosing Period||3
6467509|NCT01237899|7384525|FG008|STARTED|Second Dosing Period||4
6467510|NCT01237899|7384526|FG009|STARTED|Second Dosing Period||3
6467511|NCT01237899|7384527|FG010|STARTED|Second Dosing Period||4
6467512|NCT01237899|7384517|FG000|COMPLETED|Second Dosing Period||1
6467513|NCT01237899|7384518|FG001|COMPLETED|Second Dosing Period||3
6467514|NCT01237899|7384519|FG002|COMPLETED|Second Dosing Period||3
6467515|NCT01237899|7384520|FG003|COMPLETED|Second Dosing Period||3
6467516|NCT01237899|7384521|FG004|COMPLETED|Second Dosing Period||2
6467517|NCT01237899|7384522|FG005|COMPLETED|Second Dosing Period||4
6467518|NCT01237899|7384523|FG006|COMPLETED|Second Dosing Period||1
6467519|NCT01237899|7384524|FG007|COMPLETED|Second Dosing Period||3
6467520|NCT01237899|7384525|FG008|COMPLETED|Second Dosing Period||4
6467521|NCT01237899|7384526|FG009|COMPLETED|Second Dosing Period||3
6467522|NCT01237899|7384527|FG010|COMPLETED|Second Dosing Period||4
6467523|NCT01237899|7384517|FG000|NOT COMPLETED|Second Dosing Period||0
6467524|NCT01237899|7384518|FG001|NOT COMPLETED|Second Dosing Period||0
6467525|NCT01237899|7384519|FG002|NOT COMPLETED|Second Dosing Period||0
6467526|NCT01237899|7384520|FG003|NOT COMPLETED|Second Dosing Period||0
6467527|NCT01237899|7384521|FG004|NOT COMPLETED|Second Dosing Period||0
6467528|NCT01237899|7384522|FG005|NOT COMPLETED|Second Dosing Period||0
6467529|NCT01237899|7384523|FG006|NOT COMPLETED|Second Dosing Period||0
6467530|NCT01237899|7384524|FG007|NOT COMPLETED|Second Dosing Period||0
6467531|NCT01237899|7384525|FG008|NOT COMPLETED|Second Dosing Period||0
6467532|NCT01237899|7384526|FG009|NOT COMPLETED|Second Dosing Period||0
6467533|NCT01237899|7384527|FG010|NOT COMPLETED|Second Dosing Period||0
6467534|NCT01237951|7384545|FG000|STARTED|Overall Study||75
6467535|NCT01237951|7384545|FG000|COMPLETED|Overall Study||74
6467536|NCT01237951|7384545|FG000|NOT COMPLETED|Overall Study||1
6467537|NCT01238120|7384553|FG000|STARTED|Overall Study||25
6467538|NCT01238120|7384554|FG001|STARTED|Overall Study||23
6467539|NCT01238120|7384555|FG002|STARTED|Overall Study||25
6467540|NCT01238120|7384556|FG003|STARTED|Overall Study||24
6467541|NCT01238120|7384553|FG000|Received Intervention and Completed Baseline Assessments|Overall Study||21
6467542|NCT01238120|7384554|FG001|Received Intervention and Completed Baseline Assessments|Overall Study||22
6467543|NCT01238120|7384555|FG002|Received Intervention and Completed Baseline Assessments|Overall Study||22
6467544|NCT01238120|7384556|FG003|Received Intervention and Completed Baseline Assessments|Overall Study||21
6467545|NCT01238120|7384553|FG000|COMPLETED|Overall Study||17
6467546|NCT01238120|7384554|FG001|COMPLETED|Overall Study||22
6467547|NCT01238120|7384555|FG002|COMPLETED|Overall Study||21
6467548|NCT01238120|7384556|FG003|COMPLETED|Overall Study||18
6467549|NCT01238120|7384553|FG000|NOT COMPLETED|Overall Study||8
6467550|NCT01238120|7384554|FG001|NOT COMPLETED|Overall Study||1
6467551|NCT01238120|7384555|FG002|NOT COMPLETED|Overall Study||4
6467552|NCT01238120|7384556|FG003|NOT COMPLETED|Overall Study||6
6467553|NCT01238172|7384568|FG000|STARTED|Overall Study||237
6467554|NCT01238172|7384569|FG001|STARTED|Overall Study||241
6467555|NCT01238172|7384568|FG000|COMPLETED|Overall Study||226
6467556|NCT01238172|7384569|FG001|COMPLETED|Overall Study||217
6554209|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Second Intervention||0
6554210|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Second Intervention||0
6554211|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Second Intervention||6
6554212|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Second Intervention||6
6554213|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Second Intervention||7
6554214|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Second Intervention||7
6554215|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Second Intervention||7
6554216|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Second Intervention||7
6554217|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Second Intervention||0
6554218|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Second Intervention||0
6554219|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Second Intervention||0
6554220|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Second Intervention||6
6554221|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Second Intervention||6
6554222|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Second Intervention||7
6554223|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Second Intervention||7
6554224|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Second Intervention||6
6554225|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Second Intervention||7
6554226|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
6467557|NCT01238172|7384568|FG000|NOT COMPLETED|Overall Study||11
6467558|NCT01238172|7384569|FG001|NOT COMPLETED|Overall Study||24
6467559|NCT01238341|7384575|FG000|STARTED|Overall Study||7
6467560|NCT01238341|7384575|FG000|COMPLETED|Overall Study||7
6554227|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
6554228|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
6554229|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
6554230|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
6554231|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
6467561|NCT01238341|7384575|FG000|NOT COMPLETED|Overall Study||0
6467562|NCT01238471|7384581|FG000|STARTED|Overall Study||10
6467563|NCT01238471|7384582|FG001|STARTED|Overall Study||10
6467564|NCT01238471|7384581|FG000|COMPLETED|Overall Study||10
6467565|NCT01238471|7384582|FG001|COMPLETED|Overall Study||10
6467566|NCT01238471|7384581|FG000|NOT COMPLETED|Overall Study||0
6467567|NCT01238471|7384582|FG001|NOT COMPLETED|Overall Study||0
6467568|NCT01238536|7384590|FG000|STARTED|Overall Study||200
6467569|NCT01238536|7384591|FG001|STARTED|Overall Study||200
6467570|NCT01238536|7384590|FG000|COMPLETED|Overall Study||153
6467571|NCT01238536|7384591|FG001|COMPLETED|Overall Study||150
6467572|NCT01238536|7384590|FG000|NOT COMPLETED|Overall Study||47
6467573|NCT01238536|7384591|FG001|NOT COMPLETED|Overall Study||50
6467574|NCT01238549|7384599|FG000|STARTED|Overall Study||284
6467575|NCT01238549|7384599|FG000|COMPLETED|Overall Study||248
6554232|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
6467576|NCT01238549|7384599|FG000|NOT COMPLETED|Overall Study||36
6467577|NCT01238575|7384605|FG000|STARTED|Overall Study||30
6467578|NCT01238575|7384606|FG001|STARTED|Overall Study||32
6467579|NCT01238575|7384605|FG000|COMPLETED|Overall Study||26
6467580|NCT01238575|7384606|FG001|COMPLETED|Overall Study||28
6467581|NCT01238575|7384605|FG000|NOT COMPLETED|Overall Study||4
6467582|NCT01238575|7384606|FG001|NOT COMPLETED|Overall Study||4
6467583|NCT01238588|7384612|FG000|STARTED|Overall Study||12
6467584|NCT01238588|7384612|FG000|COMPLETED|Overall Study||9
6467585|NCT01238588|7384612|FG000|NOT COMPLETED|Overall Study||3
6467586|NCT01238640|7384616|FG000|STARTED|Overall Study||84
6467587|NCT01238640|7384616|FG000|COMPLETED|Overall Study||84
6467588|NCT01238640|7384616|FG000|NOT COMPLETED|Overall Study||0
6467589|NCT01238822|7384624|FG000|STARTED|Overall Study||96
6467590|NCT01238822|7384624|FG000|Received Placebo|Overall Study||93
6467591|NCT01238822|7384624|FG000|Received Low Dosage|Overall Study||93
6467592|NCT01238822|7384624|FG000|Received Medium Dosage|Overall Study||93
6467593|NCT01238822|7384624|FG000|Received High Dosage|Overall Study||93
6467594|NCT01238822|7384624|FG000|COMPLETED|Overall Study||93
6467595|NCT01238822|7384624|FG000|NOT COMPLETED|Overall Study||3
6467596|NCT01238835|7384634|FG000|STARTED|Overall Study||218
6467597|NCT01238835|7384634|FG000|COMPLETED|Overall Study||82
6467598|NCT01238835|7384634|FG000|NOT COMPLETED|Overall Study||136
6467599|NCT01238848|7384640|FG000|STARTED|Overall Study||50
6467600|NCT01238848|7384641|FG001|STARTED|Overall Study||50
6467601|NCT01238848|7384640|FG000|COMPLETED|Overall Study||37
6467602|NCT01238848|7384641|FG001|COMPLETED|Overall Study||45
6467603|NCT01238848|7384640|FG000|NOT COMPLETED|Overall Study||13
6746703|NCT03376321|7674372|FG000|Treated|Overall Study||163
6746704|NCT03376321|7674373|FG001|Treated|Overall Study||163
6746705|NCT03376321|7674372|FG000|COMPLETED|Overall Study||145
6746706|NCT03376321|7674373|FG001|COMPLETED|Overall Study||141
6746707|NCT03376321|7674372|FG000|NOT COMPLETED|Overall Study||23
6746708|NCT03376321|7674373|FG001|NOT COMPLETED|Overall Study||25
6467604|NCT01238848|7384641|FG001|NOT COMPLETED|Overall Study||5
6467605|NCT01238861|7384653|FG000|STARTED|Overall Study||80
6467606|NCT01238861|7384654|FG001|STARTED|Overall Study||81
6467607|NCT01238861|7384655|FG002|STARTED|Overall Study||81
6554233|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||1
6554234|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
6554235|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Washout Period 2||0
6554236|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Washout Period 2||0
6554237|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Washout Period 2||0
6554238|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Washout Period 2||6
6554239|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Washout Period 2||6
6554240|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Washout Period 2||7
6554241|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Washout Period 2||7
6554242|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Washout Period 2||6
6554243|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Washout Period 2||7
6467608|NCT01238861|7384656|FG003|STARTED|Overall Study||82
6467609|NCT01238861|7384657|FG004|STARTED|Overall Study||142
6467610|NCT01238861|7384658|FG005|STARTED|Overall Study||140
6467611|NCT01238861|7384653|FG000|COMPLETED|Overall Study||69
6467612|NCT01238861|7384654|FG001|COMPLETED|Overall Study||73
6467613|NCT01238861|7384655|FG002|COMPLETED|Overall Study||70
6467614|NCT01238861|7384656|FG003|COMPLETED|Overall Study||69
6467615|NCT01238861|7384657|FG004|COMPLETED|Overall Study||129
6467616|NCT01238861|7384658|FG005|COMPLETED|Overall Study||125
6467617|NCT01238861|7384653|FG000|NOT COMPLETED|Overall Study||11
6467618|NCT01238861|7384654|FG001|NOT COMPLETED|Overall Study||8
6467619|NCT01238861|7384655|FG002|NOT COMPLETED|Overall Study||11
6467620|NCT01238861|7384656|FG003|NOT COMPLETED|Overall Study||13
6467621|NCT01238861|7384657|FG004|NOT COMPLETED|Overall Study||13
6467622|NCT01238861|7384658|FG005|NOT COMPLETED|Overall Study||15
6467623|NCT01238900|7384679|FG000|STARTED|6 Months Post Stent Placement||23
6467624|NCT01238900|7384679|FG000|COMPLETED|6 Months Post Stent Placement||23
6467625|NCT01238900|7384679|FG000|NOT COMPLETED|6 Months Post Stent Placement||0
6467626|NCT01238900|7384679|FG000|STARTED|<12 Months Post Stent Removal||23
6467627|NCT01238900|7384679|FG000|COMPLETED|<12 Months Post Stent Removal||18
6467628|NCT01238900|7384679|FG000|NOT COMPLETED|<12 Months Post Stent Removal||5
6467629|NCT01238991|7384694|FG000|STARTED|Overall Study||7
6467630|NCT01238991|7384695|FG001|STARTED|Overall Study||3
6467631|NCT01238991|7384696|FG002|STARTED|Overall Study||11
6467632|NCT01238991|7384697|FG003|STARTED|Overall Study||6
6467633|NCT01238991|7384698|FG004|STARTED|Overall Study||5
6467634|NCT01238991|7384699|FG005|STARTED|Overall Study||2
6467635|NCT01238991|7384700|FG006|STARTED|Overall Study||8
6467636|NCT01238991|7384701|FG007|STARTED|Overall Study||5
6467637|NCT01238991|7384702|FG008|STARTED|Overall Study||4
6467638|NCT01238991|7384703|FG009|STARTED|Overall Study||2
6467639|NCT01238991|7384694|FG000|Received Treatment|Overall Study||7
6467640|NCT01238991|7384695|FG001|Received Treatment|Overall Study||3
6467641|NCT01238991|7384696|FG002|Received Treatment|Overall Study||11
6467642|NCT01238991|7384697|FG003|Received Treatment|Overall Study||6
6467643|NCT01238991|7384698|FG004|Received Treatment|Overall Study||5
6554244|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
6467644|NCT01238991|7384699|FG005|Received Treatment|Overall Study||2
6467645|NCT01238991|7384700|FG006|Received Treatment|Overall Study||8
6467646|NCT01238991|7384701|FG007|Received Treatment|Overall Study||5
6467647|NCT01238991|7384702|FG008|Received Treatment|Overall Study||4
6467648|NCT01238991|7384703|FG009|Received Treatment|Overall Study||2
6467649|NCT01238991|7384694|FG000|COMPLETED|Overall Study||5
6467650|NCT01238991|7384695|FG001|COMPLETED|Overall Study||3
6467651|NCT01238991|7384696|FG002|COMPLETED|Overall Study||5
6467652|NCT01238991|7384697|FG003|COMPLETED|Overall Study||4
6467653|NCT01238991|7384698|FG004|COMPLETED|Overall Study||3
6467654|NCT01238991|7384699|FG005|COMPLETED|Overall Study||2
6467655|NCT01238991|7384700|FG006|COMPLETED|Overall Study||0
6467656|NCT01238991|7384701|FG007|COMPLETED|Overall Study||0
6467657|NCT01238991|7384702|FG008|COMPLETED|Overall Study||0
6467658|NCT01238991|7384703|FG009|COMPLETED|Overall Study||0
6467659|NCT01238991|7384694|FG000|NOT COMPLETED|Overall Study||2
6467660|NCT01238991|7384695|FG001|NOT COMPLETED|Overall Study||0
6467661|NCT01238991|7384696|FG002|NOT COMPLETED|Overall Study||6
6467662|NCT01238991|7384697|FG003|NOT COMPLETED|Overall Study||2
6467663|NCT01238991|7384698|FG004|NOT COMPLETED|Overall Study||2
6467664|NCT01238991|7384699|FG005|NOT COMPLETED|Overall Study||0
6467665|NCT01238991|7384700|FG006|NOT COMPLETED|Overall Study||8
6467666|NCT01238991|7384701|FG007|NOT COMPLETED|Overall Study||5
6467667|NCT01238991|7384702|FG008|NOT COMPLETED|Overall Study||4
6467668|NCT01238991|7384703|FG009|NOT COMPLETED|Overall Study||2
6467669|NCT01239043|7384730|FG000|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
6467670|NCT01239043|7384731|FG001|STARTED|Overall Study||103
6467671|NCT01239043|7384730|FG000|COMPLETED|Overall Study||34
6467672|NCT01239043|7384731|FG001|COMPLETED|Overall Study||102
6467673|NCT01239043|7384730|FG000|NOT COMPLETED|Overall Study||2
6467674|NCT01239043|7384731|FG001|NOT COMPLETED|Overall Study||1
6467675|NCT01239056|7384737|FG000|STARTED|Overall Study||20
6467676|NCT01239056|7384737|FG000|COMPLETED|Overall Study||20
6467677|NCT01239056|7384737|FG000|NOT COMPLETED|Overall Study||0
6467678|NCT01239121|7384745|FG000|STARTED|Overall Study||188
6467679|NCT01239121|7384746|FG001|STARTED|Overall Study||199
6467680|NCT01239121|7384747|FG002|STARTED|Overall Study||15
6467681|NCT01239121|7384745|FG000|COMPLETED|Overall Study||186
6467682|NCT01239121|7384746|FG001|COMPLETED|Overall Study||195
6467683|NCT01239121|7384747|FG002|COMPLETED|Overall Study||15
6467684|NCT01239121|7384745|FG000|NOT COMPLETED|Overall Study||2
6467685|NCT01239121|7384746|FG001|NOT COMPLETED|Overall Study||4
6467686|NCT01239121|7384747|FG002|NOT COMPLETED|Overall Study||0
6467687|NCT01239160|7384757|FG000|STARTED|Overall Study||114
6467688|NCT01239160|7384758|FG001|STARTED|Overall Study||114
6467689|NCT01239160|7384759|FG002|STARTED|Overall Study||10
6467690|NCT01239160|7384757|FG000|COMPLETED|Overall Study||89
6467691|NCT01239160|7384758|FG001|COMPLETED|Overall Study||95
6467692|NCT01239160|7384759|FG002|COMPLETED|Overall Study||0
6467693|NCT01239160|7384757|FG000|NOT COMPLETED|Overall Study||25
6467694|NCT01239160|7384758|FG001|NOT COMPLETED|Overall Study||19
6467695|NCT01239160|7384759|FG002|NOT COMPLETED|Overall Study||10
6467696|NCT01239212|7384765|FG000|STARTED|Overall Study||7
6467697|NCT01239212|7384765|FG000|COMPLETED|Overall Study||7
6467698|NCT01239212|7384765|FG000|NOT COMPLETED|Overall Study||0
6467699|NCT01239316|7384769|FG000|STARTED|Overall Study||12
6467700|NCT01239316|7384769|FG000|COMPLETED|Overall Study||0
6467701|NCT01239316|7384769|FG000|NOT COMPLETED|Overall Study||12
6467702|NCT01239342|7384775|FG000|STARTED|Overall Study||29
6467703|NCT01239342|7384776|FG001|STARTED|Overall Study||14
6467704|NCT01239342|7384775|FG000|COMPLETED|Overall Study||26
6467705|NCT01239342|7384776|FG001|COMPLETED|Overall Study||8
6467706|NCT01239342|7384775|FG000|NOT COMPLETED|Overall Study||3
6467707|NCT01239342|7384776|FG001|NOT COMPLETED|Overall Study||6
6467708|NCT01239355|7384782|FG000|STARTED|Overall Study||15
6467709|NCT01239355|7384782|FG000|COMPLETED|Overall Study||15
6467710|NCT01239355|7384782|FG000|NOT COMPLETED|Overall Study||0
6467711|NCT01239381|7384786|FG000|STARTED|Overall Study||92
6467712|NCT01239381|7384786|FG000|COMPLETED|Overall Study||90
6467713|NCT01239381|7384786|FG000|NOT COMPLETED|Overall Study||2
6467714|NCT01239394|7384791|FG000|STARTED|Overall Study||42
6467715|NCT01239394|7384791|FG000|COMPLETED|Overall Study||41
6467716|NCT01239394|7384791|FG000|NOT COMPLETED|Overall Study||1
6467717|NCT01239472|7384797|FG000|STARTED|Overall Study||15
6467718|NCT01239472|7384798|FG001|STARTED|Overall Study||15
6467719|NCT01239472|7384797|FG000|COMPLETED|Overall Study||10
6467720|NCT01239472|7384798|FG001|COMPLETED|Overall Study||12
6467721|NCT01239472|7384797|FG000|NOT COMPLETED|Overall Study||5
6467722|NCT01239472|7384798|FG001|NOT COMPLETED|Overall Study||3
6467723|NCT01239511|7384810|FG000|STARTED|Overall Study||47
6467724|NCT01239511|7384811|FG001|STARTED|Overall Study||45
6467725|NCT01239511|7384812|FG002|STARTED|Overall Study||47
6467726|NCT01239511|7384813|FG003|STARTED|Overall Study||47
6467727|NCT01239511|7384810|FG000|COMPLETED|Overall Study||46
6467728|NCT01239511|7384811|FG001|COMPLETED|Overall Study||40
6467729|NCT01239511|7384812|FG002|COMPLETED|Overall Study||43
6467730|NCT01239511|7384813|FG003|COMPLETED|Overall Study||38
6467731|NCT01239511|7384810|FG000|NOT COMPLETED|Overall Study||1
6467732|NCT01239511|7384811|FG001|NOT COMPLETED|Overall Study||5
6467733|NCT01239511|7384812|FG002|NOT COMPLETED|Overall Study||4
6467734|NCT01239511|7384813|FG003|NOT COMPLETED|Overall Study||9
6467735|NCT01239732|7384823|FG000|STARTED|Overall Study||1021
6467736|NCT01239732|7384823|FG000|COMPLETED|Overall Study||0
6467737|NCT01239732|7384823|FG000|NOT COMPLETED|Overall Study||1021
6467738|NCT01239745|7384827|FG000|STARTED|Overall Study||46
6467739|NCT01239745|7384827|FG000|COMPLETED|Overall Study||0
6467740|NCT01239745|7384827|FG000|NOT COMPLETED|Overall Study||46
6467741|NCT01239797|7384833|FG000|STARTED|Randomized Participants||321
6467742|NCT01239797|7384834|FG001|STARTED|Randomized Participants||325
6467743|NCT01239797|7384833|FG000|COMPLETED|Randomized Participants||319
6467744|NCT01239797|7384834|FG001|COMPLETED|Randomized Participants||316
6467745|NCT01239797|7384833|FG000|NOT COMPLETED|Randomized Participants||2
6467746|NCT01239797|7384834|FG001|NOT COMPLETED|Randomized Participants||9
6467747|NCT01239797|7384833|FG000|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
6467748|NCT01239797|7384834|FG001|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
6467749|NCT01239797|7384833|FG000|COMPLETED|Treated Participants|Completed = Still on Treatment|83
6467750|NCT01239797|7384834|FG001|COMPLETED|Treated Participants|Completed = Still on Treatment|43
6467751|NCT01239797|7384833|FG000|NOT COMPLETED|Treated Participants||235
6467752|NCT01239797|7384834|FG001|NOT COMPLETED|Treated Participants||274
6467753|NCT01239992|7384840|FG000|STARTED|Overall Study||12
6467754|NCT01239992|7384840|FG000|COMPLETED|Overall Study||10
6467755|NCT01239992|7384840|FG000|NOT COMPLETED|Overall Study||2
6467756|NCT01240122|7384844|FG000|STARTED|Overall Study||29
6467757|NCT01240122|7384844|FG000|COMPLETED|Overall Study||29
6467758|NCT01240122|7384844|FG000|NOT COMPLETED|Overall Study||0
6467759|NCT01240135|7384855|FG000|STARTED|Period One, 14 Days of Wear||44
6467760|NCT01240135|7384856|FG001|STARTED|Period One, 14 Days of Wear||45
6467761|NCT01240135|7384855|FG000|COMPLETED|Period One, 14 Days of Wear||44
6467762|NCT01240135|7384856|FG001|COMPLETED|Period One, 14 Days of Wear||45
6467763|NCT01240135|7384855|FG000|NOT COMPLETED|Period One, 14 Days of Wear||0
6467764|NCT01240135|7384856|FG001|NOT COMPLETED|Period One, 14 Days of Wear||0
6467765|NCT01240135|7384855|FG000|STARTED|Period Two, 14 Days of Wear||44
6467766|NCT01240135|7384856|FG001|STARTED|Period Two, 14 Days of Wear||45
6467767|NCT01240135|7384855|FG000|COMPLETED|Period Two, 14 Days of Wear||43
6467768|NCT01240135|7384856|FG001|COMPLETED|Period Two, 14 Days of Wear||43
6467769|NCT01240135|7384855|FG000|NOT COMPLETED|Period Two, 14 Days of Wear||1
6467770|NCT01240135|7384856|FG001|NOT COMPLETED|Period Two, 14 Days of Wear||2
6467771|NCT01240200|7384864|FG000|STARTED|12-week Crossover Phase - Period 1||25
6467772|NCT01240200|7384865|FG001|STARTED|12-week Crossover Phase - Period 1||24
6467773|NCT01240200|7384864|FG000|COMPLETED|12-week Crossover Phase - Period 1||23
6467774|NCT01240200|7384865|FG001|COMPLETED|12-week Crossover Phase - Period 1||23
6467775|NCT01240200|7384864|FG000|NOT COMPLETED|12-week Crossover Phase - Period 1||2
6467776|NCT01240200|7384865|FG001|NOT COMPLETED|12-week Crossover Phase - Period 1||1
6467777|NCT01240200|7384864|FG000|STARTED|12-week Crossover Phase - Period 2||23
6467778|NCT01240200|7384865|FG001|STARTED|12-week Crossover Phase - Period 2||23
6467779|NCT01240200|7384864|FG000|COMPLETED|12-week Crossover Phase - Period 2||23
6467780|NCT01240200|7384865|FG001|COMPLETED|12-week Crossover Phase - Period 2||23
6467781|NCT01240200|7384864|FG000|NOT COMPLETED|12-week Crossover Phase - Period 2||0
6467782|NCT01240200|7384865|FG001|NOT COMPLETED|12-week Crossover Phase - Period 2||0
6467783|NCT01240330|7384874|FG000|STARTED|Overall Study||33
6467784|NCT01240330|7384874|FG000|COMPLETED|Overall Study||33
6467785|NCT01240330|7384874|FG000|NOT COMPLETED|Overall Study||0
6467786|NCT01240356|7384880|FG000|STARTED|Overall Study||18
6467787|NCT01240356|7384881|FG001|STARTED|Overall Study||20
6467788|NCT01240356|7384880|FG000|COMPLETED|Overall Study||15
6467789|NCT01240356|7384881|FG001|COMPLETED|Overall Study||20
6467790|NCT01240356|7384880|FG000|NOT COMPLETED|Overall Study||3
6467791|NCT01240356|7384881|FG001|NOT COMPLETED|Overall Study||0
6467792|NCT01240382|7384892|FG000|STARTED|Overall Study||144
6467793|NCT01240382|7384893|FG001|STARTED|Overall Study||143
6467794|NCT01240382|7384892|FG000|COMPLETED|Overall Study||142
6467795|NCT01240382|7384893|FG001|COMPLETED|Overall Study||139
6467796|NCT01240382|7384892|FG000|NOT COMPLETED|Overall Study||2
6467797|NCT01240382|7384893|FG001|NOT COMPLETED|Overall Study||4
6467798|NCT01240551|7384901|FG000|STARTED|Overall Study||30
6467799|NCT01240551|7384902|FG001|STARTED|Overall Study||30
6467800|NCT01240551|7384901|FG000|COMPLETED|Overall Study||26
6467801|NCT01240551|7384902|FG001|COMPLETED|Overall Study||27
6467802|NCT01240551|7384901|FG000|NOT COMPLETED|Overall Study||4
6467803|NCT01240551|7384902|FG001|NOT COMPLETED|Overall Study||3
6467804|NCT01240590|7384913|FG000|STARTED|Phase I||0
6467805|NCT01240590|7384914|FG001|STARTED|Phase I||6
6467806|NCT01240590|7384915|FG002|STARTED|Phase I||3
6467807|NCT01240590|7384916|FG003|STARTED|Phase I||0
6467808|NCT01240590|7384917|FG004|STARTED|Phase I||0
6467809|NCT01240590|7384913|FG000|COMPLETED|Phase I||0
6467810|NCT01240590|7384914|FG001|COMPLETED|Phase I||6
6467811|NCT01240590|7384915|FG002|COMPLETED|Phase I||0
6467812|NCT01240590|7384916|FG003|COMPLETED|Phase I||0
6467813|NCT01240590|7384917|FG004|COMPLETED|Phase I||0
6467814|NCT01240590|7384913|FG000|NOT COMPLETED|Phase I||0
6467815|NCT01240590|7384914|FG001|NOT COMPLETED|Phase I||0
6467816|NCT01240590|7384915|FG002|NOT COMPLETED|Phase I||3
6467817|NCT01240590|7384916|FG003|NOT COMPLETED|Phase I||0
6554245|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
6554246|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
6554247|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Washout Period 2||6
6467818|NCT01240590|7384917|FG004|NOT COMPLETED|Phase I||0
6467819|NCT01240590|7384913|FG000|STARTED|Phase II||0
6467820|NCT01240590|7384914|FG001|STARTED|Phase II||0
6467821|NCT01240590|7384915|FG002|STARTED|Phase II||0
6467822|NCT01240590|7384916|FG003|STARTED|Phase II||17
6467823|NCT01240590|7384917|FG004|STARTED|Phase II||1
6467824|NCT01240590|7384913|FG000|COMPLETED|Phase II||0
6467825|NCT01240590|7384914|FG001|COMPLETED|Phase II||0
6467826|NCT01240590|7384915|FG002|COMPLETED|Phase II||0
6467827|NCT01240590|7384916|FG003|COMPLETED|Phase II||15
6467828|NCT01240590|7384917|FG004|COMPLETED|Phase II||0
6467829|NCT01240590|7384913|FG000|NOT COMPLETED|Phase II||0
6467830|NCT01240590|7384914|FG001|NOT COMPLETED|Phase II||0
6467831|NCT01240590|7384915|FG002|NOT COMPLETED|Phase II||0
6467832|NCT01240590|7384916|FG003|NOT COMPLETED|Phase II||2
6467833|NCT01240590|7384917|FG004|NOT COMPLETED|Phase II||1
6467834|NCT01240746|7384946|FG000|STARTED|Overall Study||736
6467835|NCT01240746|7384947|FG001|STARTED|Overall Study||725
6467836|NCT01240746|7384948|FG002|STARTED|Overall Study||2902
6467837|NCT01240746|7384946|FG000|COMPLETED|Overall Study||677
6467838|NCT01240746|7384947|FG001|COMPLETED|Overall Study||677
6467839|NCT01240746|7384948|FG002|COMPLETED|Overall Study||2659
6467840|NCT01240746|7384946|FG000|NOT COMPLETED|Overall Study||59
6467841|NCT01240746|7384947|FG001|NOT COMPLETED|Overall Study||48
6467842|NCT01240746|7384948|FG002|NOT COMPLETED|Overall Study||243
6467843|NCT01240785|7384958|FG000|STARTED|Overall Study||111
6467844|NCT01240785|7384959|FG001|STARTED|Overall Study||110
6467845|NCT01240785|7384958|FG000|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
6467846|NCT01240785|7384959|FG001|COMPLETED|Overall Study||107
6467847|NCT01240785|7384958|FG000|NOT COMPLETED|Overall Study||1
6467848|NCT01240785|7384959|FG001|NOT COMPLETED|Overall Study||3
6467849|NCT01240811|7384968|FG000|STARTED|Overall Study||8
6467850|NCT01240811|7384969|FG001|STARTED|Overall Study||17
6467851|NCT01240811|7384970|FG002|STARTED|Overall Study||17
6467852|NCT01240811|7384968|FG000|COMPLETED|Overall Study||8
6467853|NCT01240811|7384969|FG001|COMPLETED|Overall Study||16
6467854|NCT01240811|7384970|FG002|COMPLETED|Overall Study||16
6467855|NCT01240811|7384968|FG000|NOT COMPLETED|Overall Study||0
6467856|NCT01240811|7384969|FG001|NOT COMPLETED|Overall Study||1
6467857|NCT01240811|7384970|FG002|NOT COMPLETED|Overall Study||1
6467858|NCT01240863|7384982|FG000|STARTED|Open-label Titration Period||391
6467859|NCT01240863|7384983|FG001|STARTED|Open-label Titration Period||0
6467860|NCT01240863|7384984|FG002|STARTED|Open-label Titration Period||0
6467861|NCT01240863|7384982|FG000|Safety Analysis Set|Open-label Titration Period||389
6467862|NCT01240863|7384983|FG001|Safety Analysis Set|Open-label Titration Period||0
6467863|NCT01240863|7384984|FG002|Safety Analysis Set|Open-label Titration Period||0
6467864|NCT01240863|7384982|FG000|COMPLETED|Open-label Titration Period||294
6467865|NCT01240863|7384983|FG001|COMPLETED|Open-label Titration Period||0
6467866|NCT01240863|7384984|FG002|COMPLETED|Open-label Titration Period||0
6467867|NCT01240863|7384982|FG000|NOT COMPLETED|Open-label Titration Period||97
6467868|NCT01240863|7384983|FG001|NOT COMPLETED|Open-label Titration Period||0
6467869|NCT01240863|7384984|FG002|NOT COMPLETED|Open-label Titration Period||0
6467870|NCT01240863|7384982|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
6467871|NCT01240863|7384983|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||148
6467872|NCT01240863|7384984|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||146
6467873|NCT01240863|7384982|FG000|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
6467874|NCT01240863|7384983|FG001|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
6467875|NCT01240863|7384984|FG002|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
6467876|NCT01240863|7384982|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
6467877|NCT01240863|7384983|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
6467878|NCT01240863|7384984|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
6746709|NCT03376516|7674379|FG000|STARTED|Overall Study||11
6746710|NCT03376516|7674379|FG000|Received Treatment|Overall Study||10
6746711|NCT03376516|7674379|FG000|SAF Population|Overall Study||10
6746712|NCT03376516|7674379|FG000|FAS Population|Overall Study||10
6467879|NCT01240863|7384982|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
6467880|NCT01240863|7384983|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
6467881|NCT01240863|7384984|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
6746713|NCT03376516|7674379|FG000|PK Population|Overall Study||10
6746714|NCT03376516|7674379|FG000|PP Population|Overall Study||9
6467894|NCT01240915|7385021|FG000|STARTED|Overall Study||2
6746715|NCT03376516|7674379|FG000|SURG Population|Overall Study||2
6746716|NCT03376516|7674379|FG000|COMPLETED|Overall Study||9
6467895|NCT01240915|7385022|FG001|STARTED|Overall Study||3
6467896|NCT01240915|7385023|FG002|STARTED|Overall Study||2
6467897|NCT01240915|7385024|FG003|STARTED|Overall Study||4
6467898|NCT01240915|7385025|FG004|STARTED|Overall Study||6
6467899|NCT01240915|7385026|FG005|STARTED|Overall Study||23
6467900|NCT01240915|7385027|FG006|STARTED|Overall Study||25
6467901|NCT01240915|7385028|FG007|STARTED|Overall Study||19
6467902|NCT01240915|7385029|FG008|STARTED|Overall Study||21
6467903|NCT01240915|7385021|FG000|COMPLETED|Overall Study||0
6467904|NCT01240915|7385022|FG001|COMPLETED|Overall Study||2
6467905|NCT01240915|7385023|FG002|COMPLETED|Overall Study||2
6467906|NCT01240915|7385024|FG003|COMPLETED|Overall Study||1
6467907|NCT01240915|7385025|FG004|COMPLETED|Overall Study||2
6467908|NCT01240915|7385026|FG005|COMPLETED|Overall Study||13
6467909|NCT01240915|7385027|FG006|COMPLETED|Overall Study||17
6467910|NCT01240915|7385028|FG007|COMPLETED|Overall Study||15
6467911|NCT01240915|7385029|FG008|COMPLETED|Overall Study||13
6467912|NCT01240915|7385021|FG000|NOT COMPLETED|Overall Study||2
6467913|NCT01240915|7385022|FG001|NOT COMPLETED|Overall Study||1
6467914|NCT01240915|7385023|FG002|NOT COMPLETED|Overall Study||0
6467915|NCT01240915|7385024|FG003|NOT COMPLETED|Overall Study||3
6467916|NCT01240915|7385025|FG004|NOT COMPLETED|Overall Study||4
6467917|NCT01240915|7385026|FG005|NOT COMPLETED|Overall Study||10
6467918|NCT01240915|7385027|FG006|NOT COMPLETED|Overall Study||8
6467919|NCT01240915|7385028|FG007|NOT COMPLETED|Overall Study||4
6467920|NCT01240915|7385029|FG008|NOT COMPLETED|Overall Study||8
6467921|NCT01241240|7385053|FG000|STARTED|Overall Study||94
6467922|NCT01241240|7385054|FG001|STARTED|Overall Study||98
6467923|NCT01241240|7385053|FG000|COMPLETED|Overall Study||86
6467924|NCT01241240|7385054|FG001|COMPLETED|Overall Study||89
6467925|NCT01241240|7385053|FG000|NOT COMPLETED|Overall Study||8
6467926|NCT01241240|7385054|FG001|NOT COMPLETED|Overall Study||9
6467927|NCT01241292|7385062|FG000|STARTED|Overall Study||3
6467928|NCT01241292|7385063|FG001|STARTED|Overall Study||3
6467929|NCT01241292|7385062|FG000|Entered Treatment Period|Overall Study||3
6467930|NCT01241292|7385063|FG001|Entered Treatment Period|Overall Study||3
6467931|NCT01241292|7385062|FG000|COMPLETED|Overall Study|completed=treatment on-going|0
6467932|NCT01241292|7385063|FG001|COMPLETED|Overall Study|completed=treatment on-going|0
6467933|NCT01241292|7385062|FG000|NOT COMPLETED|Overall Study||3
6467934|NCT01241292|7385063|FG001|NOT COMPLETED|Overall Study||3
6467935|NCT01241318|7385075|FG000|STARTED|Overall Study|Women enrolled|19629
6467936|NCT01241318|7385076|FG001|STARTED|Overall Study|Women enrolled|20050
6467937|NCT01241318|7385075|FG000|Liveborn Infant|Overall Study|Infants|18510
6467938|NCT01241318|7385076|FG001|Liveborn Infant|Overall Study|Infants|19346
6467939|NCT01241318|7385075|FG000|COMPLETED|Overall Study|Infants|18450
6467940|NCT01241318|7385076|FG001|COMPLETED|Overall Study|Infants|19308
6467941|NCT01241318|7385075|FG000|NOT COMPLETED|Overall Study||1179
6467942|NCT01241318|7385076|FG001|NOT COMPLETED|Overall Study||742
6467943|NCT01241344|7385089|FG000|STARTED|Overall Study||14
6467944|NCT01241344|7385090|FG001|STARTED|Overall Study||16
6467945|NCT01241344|7385091|FG002|STARTED|Overall Study||18
6467946|NCT01241344|7385092|FG003|STARTED|Overall Study||4
6467947|NCT01241344|7385089|FG000|Randomized to Open-label|Overall Study||3
6467948|NCT01241344|7385090|FG001|Randomized to Open-label|Overall Study||4
6467949|NCT01241344|7385091|FG002|Randomized to Open-label|Overall Study||5
6467950|NCT01241344|7385092|FG003|Randomized to Open-label|Overall Study||0
6467951|NCT01241344|7385089|FG000|COMPLETED|Overall Study||9
6467952|NCT01241344|7385090|FG001|COMPLETED|Overall Study||7
6467953|NCT01241344|7385091|FG002|COMPLETED|Overall Study||9
6467954|NCT01241344|7385092|FG003|COMPLETED|Overall Study||2
6467955|NCT01241344|7385089|FG000|NOT COMPLETED|Overall Study||5
6467956|NCT01241344|7385090|FG001|NOT COMPLETED|Overall Study||9
6467957|NCT01241344|7385091|FG002|NOT COMPLETED|Overall Study||9
6467958|NCT01241344|7385092|FG003|NOT COMPLETED|Overall Study||2
6467959|NCT01241435|7385105|FG000|STARTED|Overall Study||12
6467960|NCT01241435|7385106|FG001|STARTED|Overall Study||8
6467961|NCT01241435|7385107|FG002|STARTED|Overall Study||8
6467962|NCT01241435|7385108|FG003|STARTED|Overall Study||8
6467963|NCT01241435|7385105|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
6467964|NCT01241435|7385106|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
6467965|NCT01241435|7385107|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
6467966|NCT01241435|7385108|FG003|Received at Least 1 Dose of Study Drug|Overall Study||8
6467967|NCT01241435|7385105|FG000|COMPLETED|Overall Study||12
6467968|NCT01241435|7385106|FG001|COMPLETED|Overall Study||8
6467969|NCT01241435|7385107|FG002|COMPLETED|Overall Study||8
6467970|NCT01241435|7385108|FG003|COMPLETED|Overall Study||8
6467971|NCT01241435|7385105|FG000|NOT COMPLETED|Overall Study||0
6467972|NCT01241435|7385106|FG001|NOT COMPLETED|Overall Study||0
6467973|NCT01241435|7385107|FG002|NOT COMPLETED|Overall Study||0
6467974|NCT01241435|7385108|FG003|NOT COMPLETED|Overall Study||0
6467975|NCT01241448|7385122|FG000|STARTED|Overall Study||66
6467976|NCT01241448|7385123|FG001|STARTED|Overall Study||65
6467977|NCT01241448|7385124|FG002|STARTED|Overall Study||66
6467978|NCT01241448|7385125|FG003|STARTED|Overall Study||66
6467979|NCT01241448|7385122|FG000|Intent-to-Treat Population (ITT)|Overall Study||63
6467980|NCT01241448|7385123|FG001|Intent-to-Treat Population (ITT)|Overall Study||63
6467981|NCT01241448|7385124|FG002|Intent-to-Treat Population (ITT)|Overall Study||64
6467982|NCT01241448|7385125|FG003|Intent-to-Treat Population (ITT)|Overall Study||64
6467983|NCT01241448|7385122|FG000|ITT With ≥1 Post-Baseline Measure|Overall Study||61
6467984|NCT01241448|7385123|FG001|ITT With ≥1 Post-Baseline Measure|Overall Study||61
6467985|NCT01241448|7385124|FG002|ITT With ≥1 Post-Baseline Measure|Overall Study||64
6467986|NCT01241448|7385125|FG003|ITT With ≥1 Post-Baseline Measure|Overall Study||62
6467987|NCT01241448|7385122|FG000|COMPLETED|Overall Study||29
6467988|NCT01241448|7385123|FG001|COMPLETED|Overall Study||36
6467989|NCT01241448|7385124|FG002|COMPLETED|Overall Study||43
6467990|NCT01241448|7385125|FG003|COMPLETED|Overall Study||43
6467991|NCT01241448|7385122|FG000|NOT COMPLETED|Overall Study||37
6467992|NCT01241448|7385123|FG001|NOT COMPLETED|Overall Study||29
6467993|NCT01241448|7385124|FG002|NOT COMPLETED|Overall Study||23
6467994|NCT01241448|7385125|FG003|NOT COMPLETED|Overall Study||23
6467995|NCT01241461|7385138|FG000|STARTED|Overall Study||3
6467996|NCT01241461|7385139|FG001|STARTED|Overall Study||6
6467997|NCT01241461|7385138|FG000|COMPLETED|Overall Study||0
6467998|NCT01241461|7385139|FG001|COMPLETED|Overall Study||0
6467999|NCT01241461|7385138|FG000|NOT COMPLETED|Overall Study||3
6468000|NCT01241461|7385139|FG001|NOT COMPLETED|Overall Study||6
6468001|NCT01241513|7385151|FG000|STARTED|Overall Study||10
6468002|NCT01241513|7385152|FG001|STARTED|Overall Study||9
6468003|NCT01241513|7385151|FG000|COMPLETED|Overall Study|Study has been completed|10
6468004|NCT01241513|7385152|FG001|COMPLETED|Overall Study||9
6468005|NCT01241513|7385151|FG000|NOT COMPLETED|Overall Study||0
6468006|NCT01241513|7385152|FG001|NOT COMPLETED|Overall Study||0
6468007|NCT01241539|7385157|FG000|STARTED|Period 1||7
6468008|NCT01241539|7385157|FG000|COMPLETED|Period 1||7
6468009|NCT01241539|7385157|FG000|NOT COMPLETED|Period 1||0
6468010|NCT01241539|7385157|FG000|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
6468011|NCT01241539|7385157|FG000|COMPLETED|Period 2||7
6468012|NCT01241539|7385157|FG000|NOT COMPLETED|Period 2||0
6468013|NCT01241552|7385167|FG000|STARTED|Overall Study||242
6468014|NCT01241552|7385168|FG001|STARTED|Overall Study||403
6468015|NCT01241552|7385169|FG002|STARTED|Overall Study||403
6468016|NCT01241552|7385170|FG003|STARTED|Overall Study||404
6468017|NCT01241552|7385167|FG000|Treated|Overall Study||235
6468018|NCT01241552|7385168|FG001|Treated|Overall Study||392
6468019|NCT01241552|7385169|FG002|Treated|Overall Study||388
6468020|NCT01241552|7385170|FG003|Treated|Overall Study||397
6468021|NCT01241552|7385167|FG000|COMPLETED|Overall Study||201
6468022|NCT01241552|7385168|FG001|COMPLETED|Overall Study||340
6468023|NCT01241552|7385169|FG002|COMPLETED|Overall Study||343
6468024|NCT01241552|7385170|FG003|COMPLETED|Overall Study||340
6746717|NCT03376516|7674379|FG000|NOT COMPLETED|Overall Study||2
6746718|NCT03377127|7674396|FG000|STARTED|Overall Study||42
6746719|NCT03377127|7674397|FG001|STARTED|Overall Study||44
6746720|NCT03377127|7674396|FG000|COMPLETED|Overall Study||42
6746721|NCT03377127|7674397|FG001|COMPLETED|Overall Study||44
6746722|NCT03377127|7674396|FG000|NOT COMPLETED|Overall Study||0
6746723|NCT03377127|7674397|FG001|NOT COMPLETED|Overall Study||0
6746724|NCT03377244|7674406|FG000|STARTED|Baseline||19
6746725|NCT03377244|7674407|FG001|STARTED|Baseline||14
6746726|NCT03377244|7674408|FG002|STARTED|Baseline||69
6746727|NCT03377244|7674406|FG000|COMPLETED|Baseline||19
6746728|NCT03377244|7674407|FG001|COMPLETED|Baseline||14
6746729|NCT03377244|7674408|FG002|COMPLETED|Baseline||69
6468025|NCT01241552|7385167|FG000|NOT COMPLETED|Overall Study||41
6468026|NCT01241552|7385168|FG001|NOT COMPLETED|Overall Study||63
6468027|NCT01241552|7385169|FG002|NOT COMPLETED|Overall Study||60
6468028|NCT01241552|7385170|FG003|NOT COMPLETED|Overall Study||64
6468029|NCT01241565|7385180|FG000|STARTED|Overall Study||50
6468030|NCT01241565|7385180|FG000|COMPLETED|Overall Study||50
6468031|NCT01241565|7385180|FG000|NOT COMPLETED|Overall Study||0
6468032|NCT01241591|7385189|FG000|STARTED|Overall Study||329
6468033|NCT01241591|7385190|FG001|STARTED|Overall Study||330
6468034|NCT01241591|7385191|FG002|STARTED|Overall Study||335
6468035|NCT01241591|7385192|FG003|STARTED|Overall Study||107
6468036|NCT01241591|7385189|FG000|COMPLETED|Overall Study||306
6468037|NCT01241591|7385190|FG001|COMPLETED|Overall Study||306
6468038|NCT01241591|7385191|FG002|COMPLETED|Overall Study||313
6468039|NCT01241591|7385192|FG003|COMPLETED|Overall Study||95
6468040|NCT01241591|7385189|FG000|NOT COMPLETED|Overall Study||23
6468041|NCT01241591|7385190|FG001|NOT COMPLETED|Overall Study||24
6468042|NCT01241591|7385191|FG002|NOT COMPLETED|Overall Study||22
6468043|NCT01241591|7385192|FG003|NOT COMPLETED|Overall Study||12
6468044|NCT01241604|7385202|FG000|STARTED|Screening Period||11
6468045|NCT01241604|7385203|FG001|STARTED|Screening Period||0
6468046|NCT01241604|7385204|FG002|STARTED|Screening Period||0
6468047|NCT01241604|7385202|FG000|COMPLETED|Screening Period||8
6468048|NCT01241604|7385203|FG001|COMPLETED|Screening Period||0
6468049|NCT01241604|7385204|FG002|COMPLETED|Screening Period||0
6468050|NCT01241604|7385202|FG000|NOT COMPLETED|Screening Period||3
6468051|NCT01241604|7385203|FG001|NOT COMPLETED|Screening Period||0
6468052|NCT01241604|7385204|FG002|NOT COMPLETED|Screening Period||0
6746730|NCT03377244|7674406|FG000|NOT COMPLETED|Baseline||0
6746731|NCT03377244|7674407|FG001|NOT COMPLETED|Baseline||0
6746732|NCT03377244|7674408|FG002|NOT COMPLETED|Baseline||0
6468053|NCT01241604|7385202|FG000|STARTED|Study Period||0
6468054|NCT01241604|7385203|FG001|STARTED|Study Period||5
6468055|NCT01241604|7385204|FG002|STARTED|Study Period||3
6468056|NCT01241604|7385202|FG000|COMPLETED|Study Period||0
6468057|NCT01241604|7385203|FG001|COMPLETED|Study Period||5
6468058|NCT01241604|7385204|FG002|COMPLETED|Study Period||3
6468059|NCT01241604|7385202|FG000|NOT COMPLETED|Study Period||0
6468060|NCT01241604|7385203|FG001|NOT COMPLETED|Study Period||0
6468061|NCT01241604|7385204|FG002|NOT COMPLETED|Study Period||0
6468062|NCT01241760|7385213|FG000|STARTED|Overall Study||371
6746733|NCT03377244|7674406|FG000|STARTED|6 Months Post-intervention||19
6746734|NCT03377244|7674407|FG001|STARTED|6 Months Post-intervention||14
6468063|NCT01241760|7385214|FG001|STARTED|Overall Study||369
6468064|NCT01241760|7385213|FG000|COMPLETED|Overall Study||337
6468065|NCT01241760|7385214|FG001|COMPLETED|Overall Study||329
6468066|NCT01241760|7385213|FG000|NOT COMPLETED|Overall Study||34
6468067|NCT01241760|7385214|FG001|NOT COMPLETED|Overall Study||40
6468068|NCT01241903|7385223|FG000|STARTED|Overall Study||27
6468069|NCT01241903|7385224|FG001|STARTED|Overall Study||27
6468070|NCT01241903|7385223|FG000|COMPLETED|Overall Study||26
6468071|NCT01241903|7385224|FG001|COMPLETED|Overall Study||27
6468072|NCT01241903|7385223|FG000|NOT COMPLETED|Overall Study||1
6468073|NCT01241903|7385224|FG001|NOT COMPLETED|Overall Study||0
6468074|NCT01241916|7385232|FG000|STARTED|Overall Study||35
6468075|NCT01241916|7385233|FG001|STARTED|Overall Study||31
6468076|NCT01241916|7385232|FG000|COMPLETED|Overall Study||28
6468077|NCT01241916|7385233|FG001|COMPLETED|Overall Study||21
6468078|NCT01241916|7385232|FG000|NOT COMPLETED|Overall Study||7
6468079|NCT01241916|7385233|FG001|NOT COMPLETED|Overall Study||10
6468080|NCT01242085|7385242|FG000|STARTED|Overall Study||30
6468081|NCT01242085|7385243|FG001|STARTED|Overall Study||33
6468082|NCT01242085|7385244|FG002|STARTED|Overall Study||1
6468083|NCT01242085|7385242|FG000|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
6468084|NCT01242085|7385243|FG001|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
6468085|NCT01242085|7385244|FG002|COMPLETED|Overall Study||1
6746735|NCT03377244|7674408|FG002|STARTED|6 Months Post-intervention||69
6746736|NCT03377244|7674406|FG000|COMPLETED|6 Months Post-intervention||13
6746737|NCT03377244|7674407|FG001|COMPLETED|6 Months Post-intervention||7
6746738|NCT03377244|7674408|FG002|COMPLETED|6 Months Post-intervention||55
6746739|NCT03377244|7674406|FG000|NOT COMPLETED|6 Months Post-intervention||6
6746740|NCT03377244|7674407|FG001|NOT COMPLETED|6 Months Post-intervention||7
6746741|NCT03377244|7674408|FG002|NOT COMPLETED|6 Months Post-intervention||14
6746742|NCT03377556|7674416|FG000|STARTED|Overall Study||47
6746743|NCT03377556|7674416|FG000|Primary Analysis Population (HRRD-positive Per MDVN Criteria)|Overall Study||24
6746744|NCT03377556|7674416|FG000|COMPLETED|Overall Study||0
6746745|NCT03377556|7674416|FG000|NOT COMPLETED|Overall Study||47
6468086|NCT01242085|7385242|FG000|NOT COMPLETED|Overall Study||8
6468087|NCT01242085|7385243|FG001|NOT COMPLETED|Overall Study||7
6468088|NCT01242085|7385244|FG002|NOT COMPLETED|Overall Study||0
6468089|NCT01242111|7385250|FG000|STARTED|Overall Study||20
6468090|NCT01242111|7385250|FG000|COMPLETED|Overall Study||17
6468091|NCT01242111|7385250|FG000|NOT COMPLETED|Overall Study||3
6468092|NCT01242176|7385254|FG000|STARTED|First Intervention||12
6468093|NCT01242176|7385255|FG001|STARTED|First Intervention||12
6468094|NCT01242176|7385254|FG000|COMPLETED|First Intervention||12
6468095|NCT01242176|7385255|FG001|COMPLETED|First Intervention||12
6468096|NCT01242176|7385254|FG000|NOT COMPLETED|First Intervention||0
6468097|NCT01242176|7385255|FG001|NOT COMPLETED|First Intervention||0
6468098|NCT01242176|7385254|FG000|STARTED|Washout Period of 7 Days||12
6468099|NCT01242176|7385255|FG001|STARTED|Washout Period of 7 Days||12
6468100|NCT01242176|7385254|FG000|COMPLETED|Washout Period of 7 Days||11
6468101|NCT01242176|7385255|FG001|COMPLETED|Washout Period of 7 Days||10
6468102|NCT01242176|7385254|FG000|NOT COMPLETED|Washout Period of 7 Days||1
6468103|NCT01242176|7385255|FG001|NOT COMPLETED|Washout Period of 7 Days||2
6468104|NCT01242176|7385254|FG000|STARTED|Second Intervention||11
6468105|NCT01242176|7385255|FG001|STARTED|Second Intervention||10
6468106|NCT01242176|7385254|FG000|COMPLETED|Second Intervention||11
6468107|NCT01242176|7385255|FG001|COMPLETED|Second Intervention||10
6468108|NCT01242176|7385254|FG000|NOT COMPLETED|Second Intervention||0
6468109|NCT01242176|7385255|FG001|NOT COMPLETED|Second Intervention||0
6468110|NCT01242241|7385263|FG000|STARTED|Overall Study||40
6468111|NCT01242241|7385264|FG001|STARTED|Overall Study||40
6468112|NCT01242241|7385263|FG000|COMPLETED|Overall Study||40
6468113|NCT01242241|7385264|FG001|COMPLETED|Overall Study||40
6468114|NCT01242241|7385263|FG000|NOT COMPLETED|Overall Study||0
6468115|NCT01242241|7385264|FG001|NOT COMPLETED|Overall Study||0
6468116|NCT01242371|7385272|FG000|STARTED|Overall Study||33
6468117|NCT01242371|7385273|FG001|STARTED|Overall Study||32
6468118|NCT01242371|7385272|FG000|COMPLETED|Overall Study||31
6468119|NCT01242371|7385273|FG001|COMPLETED|Overall Study||27
6468120|NCT01242371|7385272|FG000|NOT COMPLETED|Overall Study||2
6468121|NCT01242371|7385273|FG001|NOT COMPLETED|Overall Study||5
6468122|NCT01242514|7385282|FG000|STARTED|Overall Study|Patients who received treatment|1343
6468123|NCT01242514|7385283|FG001|STARTED|Overall Study|Patients who received treatment|357
6468124|NCT01242514|7385284|FG002|STARTED|Overall Study|Patients who received treatment|212
6468125|NCT01242514|7385282|FG000|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
6746746|NCT03377634|7674422|FG000|STARTED|Intervention Usability Testing Period||5
6746747|NCT03377634|7674423|FG001|STARTED|Intervention Usability Testing Period||0
6746748|NCT03377634|7674422|FG000|COMPLETED|Intervention Usability Testing Period||5
6746749|NCT03377634|7674423|FG001|COMPLETED|Intervention Usability Testing Period||0
6746750|NCT03377634|7674422|FG000|NOT COMPLETED|Intervention Usability Testing Period||0
6468126|NCT01242514|7385283|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
6468127|NCT01242514|7385284|FG002|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
6468128|NCT01242514|7385282|FG000|COMPLETED|Overall Study|Due to project closure.|0
6468129|NCT01242514|7385283|FG001|COMPLETED|Overall Study|Due to project closure.|0
6468130|NCT01242514|7385284|FG002|COMPLETED|Overall Study|Due to project closure.|0
6468131|NCT01242514|7385282|FG000|NOT COMPLETED|Overall Study||1343
6468132|NCT01242514|7385283|FG001|NOT COMPLETED|Overall Study||357
6468133|NCT01242514|7385284|FG002|NOT COMPLETED|Overall Study||212
6468134|NCT01242527|7385296|FG000|STARTED|Overall Study||99
6468135|NCT01242527|7385297|FG001|STARTED|Overall Study||100
6468136|NCT01242527|7385298|FG002|STARTED|Overall Study||101
6468137|NCT01242527|7385299|FG003|STARTED|Overall Study||99
6468138|NCT01242527|7385296|FG000|COMPLETED|Overall Study||94
6468139|NCT01242527|7385297|FG001|COMPLETED|Overall Study||93
6468140|NCT01242527|7385298|FG002|COMPLETED|Overall Study||87
6468141|NCT01242527|7385299|FG003|COMPLETED|Overall Study||90
6468142|NCT01242527|7385296|FG000|NOT COMPLETED|Overall Study||5
6468143|NCT01242527|7385297|FG001|NOT COMPLETED|Overall Study||7
6468144|NCT01242527|7385298|FG002|NOT COMPLETED|Overall Study||14
6468145|NCT01242527|7385299|FG003|NOT COMPLETED|Overall Study||9
6468146|NCT01242644|7385312|FG000|STARTED|Overall Study||16
6468147|NCT01242644|7385313|FG001|STARTED|Overall Study||17
6468148|NCT01242644|7385314|FG002|STARTED|Overall Study||15
6468149|NCT01242644|7385312|FG000|COMPLETED|Overall Study||16
6468150|NCT01242644|7385313|FG001|COMPLETED|Overall Study||17
6468151|NCT01242644|7385314|FG002|COMPLETED|Overall Study||15
6468152|NCT01242644|7385312|FG000|NOT COMPLETED|Overall Study||0
6468153|NCT01242644|7385313|FG001|NOT COMPLETED|Overall Study||0
6468154|NCT01242644|7385314|FG002|NOT COMPLETED|Overall Study||0
6468155|NCT01242748|7385324|FG000|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
6468156|NCT01242748|7385325|FG001|STARTED|Overall Study||94
6468157|NCT01242748|7385324|FG000|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
6468158|NCT01242748|7385325|FG001|CS35/CS35A Safety Analysis Set|Overall Study||283
6468159|NCT01242748|7385324|FG000|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
6468160|NCT01242748|7385325|FG001|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
6468161|NCT01242748|7385324|FG000|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
6468162|NCT01242748|7385325|FG001|COMPLETED|Overall Study||80
6468163|NCT01242748|7385324|FG000|NOT COMPLETED|Overall Study||38
6468164|NCT01242748|7385325|FG001|NOT COMPLETED|Overall Study||14
6468165|NCT01242813|7385331|FG000|STARTED|Overall Study||20
6468166|NCT01242813|7385331|FG000|COMPLETED|Overall Study||18
6468167|NCT01242813|7385331|FG000|NOT COMPLETED|Overall Study||2
6468168|NCT01243112|7385335|FG000|STARTED|Overall Study||25
6468169|NCT01243112|7385335|FG000|COMPLETED|Overall Study||25
6468170|NCT01243112|7385335|FG000|NOT COMPLETED|Overall Study||0
6468171|NCT01243151|7385344|FG000|STARTED|Overall Study||12
6468172|NCT01243151|7385345|FG001|STARTED|Overall Study||14
6468173|NCT01243151|7385346|FG002|STARTED|Overall Study||14
6468174|NCT01243151|7385347|FG003|STARTED|Overall Study||14
6468175|NCT01243151|7385348|FG004|STARTED|Overall Study||14
6468176|NCT01243151|7385344|FG000|Treated|Overall Study||12
6468177|NCT01243151|7385345|FG001|Treated|Overall Study||14
6468178|NCT01243151|7385346|FG002|Treated|Overall Study||14
6468179|NCT01243151|7385347|FG003|Treated|Overall Study||13
6468180|NCT01243151|7385348|FG004|Treated|Overall Study||14
6468181|NCT01243151|7385344|FG000|COMPLETED|Overall Study||12
6468182|NCT01243151|7385345|FG001|COMPLETED|Overall Study||13
6468183|NCT01243151|7385346|FG002|COMPLETED|Overall Study||13
6468184|NCT01243151|7385347|FG003|COMPLETED|Overall Study||12
6468185|NCT01243151|7385348|FG004|COMPLETED|Overall Study||14
6468186|NCT01243151|7385344|FG000|NOT COMPLETED|Overall Study||0
6468187|NCT01243151|7385345|FG001|NOT COMPLETED|Overall Study||1
6468188|NCT01243151|7385346|FG002|NOT COMPLETED|Overall Study||1
6468189|NCT01243151|7385347|FG003|NOT COMPLETED|Overall Study||2
6468190|NCT01243151|7385348|FG004|NOT COMPLETED|Overall Study||0
6468191|NCT01243177|7385366|FG000|STARTED|Overall Study||444
6468192|NCT01243177|7385367|FG001|STARTED|Overall Study||442
6468193|NCT01243177|7385366|FG000|COMPLETED|Overall Study||266
6468194|NCT01243177|7385367|FG001|COMPLETED|Overall Study||264
6305726|NCT01773395|7209080|FG000|STARTED|Overall Study||64
6305727|NCT01773395|7209081|FG001|STARTED|Overall Study||59
6305728|NCT01773395|7209080|FG000|COMPLETED|Overall Study||30
6305729|NCT01773395|7209081|FG001|COMPLETED|Overall Study||27
6305730|NCT01773395|7209080|FG000|NOT COMPLETED|Overall Study||34
6305731|NCT01773395|7209081|FG001|NOT COMPLETED|Overall Study||32
6468195|NCT01243177|7385366|FG000|NOT COMPLETED|Overall Study||178
6468196|NCT01243177|7385367|FG001|NOT COMPLETED|Overall Study||178
6468197|NCT01243242|7385375|FG000|STARTED|Overall Study||60
6468198|NCT01243242|7385376|FG001|STARTED|Overall Study||60
6468199|NCT01243242|7385375|FG000|COMPLETED|Overall Study||57
6554248|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Washout Period 2||6
6554249|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
6468200|NCT01243242|7385376|FG001|COMPLETED|Overall Study||56
6468201|NCT01243242|7385375|FG000|NOT COMPLETED|Overall Study||3
6468202|NCT01243242|7385376|FG001|NOT COMPLETED|Overall Study||4
6468203|NCT01243268|7385382|FG000|STARTED|Overall Study||674
6468204|NCT01243268|7385382|FG000|COMPLETED|Overall Study||610
6468205|NCT01243268|7385382|FG000|NOT COMPLETED|Overall Study||64
6468206|NCT01243294|7385386|FG000|STARTED|First Intervention (10 Days +/- 2 Days)||28
6468207|NCT01243294|7385387|FG001|STARTED|First Intervention (10 Days +/- 2 Days)||26
6500985|NCT01426360|7419458|FG001|COMPLETED|Overall Study||41
6554250|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Washout Period 2||7
6554251|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Washout Period 2||6
6468208|NCT01243294|7385386|FG000|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
6468209|NCT01243294|7385387|FG001|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
6468210|NCT01243294|7385386|FG000|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
6468211|NCT01243294|7385387|FG001|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
6468212|NCT01243294|7385386|FG000|STARTED|Second Intervention (10 Days +/- 2 Days)||28
6468213|NCT01243294|7385387|FG001|STARTED|Second Intervention (10 Days +/- 2 Days)||26
6468214|NCT01243294|7385386|FG000|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
6468215|NCT01243294|7385387|FG001|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
6468216|NCT01243294|7385386|FG000|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
6468217|NCT01243294|7385387|FG001|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
6468218|NCT01243320|7385393|FG000|STARTED|10ppm Oral Silver (3 Days)||36
6468219|NCT01243320|7385393|FG000|COMPLETED|10ppm Oral Silver (3 Days)||36
6468220|NCT01243320|7385393|FG000|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
6468221|NCT01243320|7385393|FG000|STARTED|10ppm Oral Silver (7 Days)||36
6468222|NCT01243320|7385393|FG000|COMPLETED|10ppm Oral Silver (7 Days)||36
6468223|NCT01243320|7385393|FG000|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
6468224|NCT01243320|7385393|FG000|STARTED|10ppm Oral Silver (14 Days)||36
6468225|NCT01243320|7385393|FG000|COMPLETED|10ppm Oral Silver (14 Days)||36
6468226|NCT01243320|7385393|FG000|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
6468227|NCT01243320|7385393|FG000|STARTED|Washout (3 Days)||36
6468228|NCT01243320|7385393|FG000|COMPLETED|Washout (3 Days)||36
6468229|NCT01243320|7385393|FG000|NOT COMPLETED|Washout (3 Days)||0
6468230|NCT01243320|7385393|FG000|STARTED|32ppm Oral Silver (14 Days)||24
6468231|NCT01243320|7385393|FG000|COMPLETED|32ppm Oral Silver (14 Days)||24
6468232|NCT01243320|7385393|FG000|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
6468233|NCT01243333|7385399|FG000|STARTED|Overall Study||26
6468234|NCT01243333|7385399|FG000|COMPLETED|Overall Study||18
6468235|NCT01243333|7385399|FG000|NOT COMPLETED|Overall Study||8
6468236|NCT01243411|7385403|FG000|STARTED|Overall Study||347
6468237|NCT01243411|7385403|FG000|COMPLETED|Overall Study||306
6468238|NCT01243411|7385403|FG000|NOT COMPLETED|Overall Study||41
6468239|NCT01243424|7385409|FG000|STARTED|Discontinuation From Study (Treated Set)||3028
6468240|NCT01243424|7385410|FG001|STARTED|Discontinuation From Study (Treated Set)||3014
6468241|NCT01243424|7385409|FG000|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||123
6468242|NCT01243424|7385410|FG001|Patient Died (Other Cause Than CV Death)|Discontinuation From Study (Treated Set)||146
6468243|NCT01243424|7385409|FG000|Treated|Discontinuation From Study (Treated Set)||3023
6468244|NCT01243424|7385410|FG001|Treated|Discontinuation From Study (Treated Set)||3010
6468245|NCT01243424|7385409|FG000|COMPLETED|Discontinuation From Study (Treated Set)||2899
6468246|NCT01243424|7385410|FG001|COMPLETED|Discontinuation From Study (Treated Set)||2895
6468247|NCT01243424|7385409|FG000|NOT COMPLETED|Discontinuation From Study (Treated Set)||129
6468248|NCT01243424|7385410|FG001|NOT COMPLETED|Discontinuation From Study (Treated Set)||119
6468249|NCT01243424|7385409|FG000|STARTED|Discontinuation From Treatment||3028
6468250|NCT01243424|7385410|FG001|STARTED|Discontinuation From Treatment||3014
6468251|NCT01243424|7385409|FG000|Treated|Discontinuation From Treatment||3023
6468252|NCT01243424|7385410|FG001|Treated|Discontinuation From Treatment||3010
6468253|NCT01243424|7385409|FG000|COMPLETED|Discontinuation From Treatment||1896
6468254|NCT01243424|7385410|FG001|COMPLETED|Discontinuation From Treatment||1832
6468255|NCT01243424|7385409|FG000|NOT COMPLETED|Discontinuation From Treatment||1132
6468256|NCT01243424|7385410|FG001|NOT COMPLETED|Discontinuation From Treatment||1182
6468257|NCT01243450|7385420|FG000|STARTED|Overall Study||401
6468258|NCT01243450|7385421|FG001|STARTED|Overall Study||135
6468259|NCT01243450|7385422|FG002|STARTED|Overall Study||404
6468260|NCT01243450|7385420|FG000|COMPLETED|Overall Study||318
6468261|NCT01243450|7385421|FG001|COMPLETED|Overall Study||110
6468262|NCT01243450|7385422|FG002|COMPLETED|Overall Study||337
6468263|NCT01243450|7385420|FG000|NOT COMPLETED|Overall Study||83
6468264|NCT01243450|7385421|FG001|NOT COMPLETED|Overall Study||25
6468265|NCT01243450|7385422|FG002|NOT COMPLETED|Overall Study||67
6468266|NCT01243567|7385432|FG000|STARTED|Overall Study||43
6468267|NCT01243567|7385433|FG001|STARTED|Overall Study||38
6468268|NCT01243567|7385432|FG000|COMPLETED|Overall Study||42
6468269|NCT01243567|7385433|FG001|COMPLETED|Overall Study||38
6468270|NCT01243567|7385432|FG000|NOT COMPLETED|Overall Study||1
6468271|NCT01243567|7385433|FG001|NOT COMPLETED|Overall Study||0
6468272|NCT01243580|7385441|FG000|STARTED|Overall Study||18
6468273|NCT01243580|7385442|FG001|STARTED|Overall Study||18
6468274|NCT01243580|7385441|FG000|COMPLETED|Overall Study||18
6468275|NCT01243580|7385442|FG001|COMPLETED|Overall Study||16
6468276|NCT01243580|7385441|FG000|NOT COMPLETED|Overall Study||0
6468277|NCT01243580|7385442|FG001|NOT COMPLETED|Overall Study||2
6468278|NCT01243593|7385452|FG000|STARTED|Overall Study||16
6468279|NCT01243593|7385453|FG001|STARTED|Overall Study||16
6468280|NCT01243593|7385452|FG000|COMPLETED|Overall Study||16
6468281|NCT01243593|7385453|FG001|COMPLETED|Overall Study||16
6468282|NCT01243593|7385452|FG000|NOT COMPLETED|Overall Study||0
6468283|NCT01243593|7385453|FG001|NOT COMPLETED|Overall Study||0
6468284|NCT01243619|7385459|FG000|STARTED|Overall Study||5
6468285|NCT01243619|7385459|FG000|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
6468286|NCT01243619|7385459|FG000|NOT COMPLETED|Overall Study||0
6468287|NCT01243671|7385463|FG000|STARTED|Overall Study||20
6468288|NCT01243671|7385463|FG000|Completed 24 Weeks of Treatment|Overall Study||18
6468289|NCT01243671|7385463|FG000|Completed 52 Weeks of Treatment|Overall Study||17
6468290|NCT01243671|7385463|FG000|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
6468291|NCT01243671|7385463|FG000|NOT COMPLETED|Overall Study||5
6468292|NCT01243762|7385474|FG000|STARTED|Part 1 (Dose Escalation/MTD)||4
6468293|NCT01243762|7385475|FG001|STARTED|Part 1 (Dose Escalation/MTD)||13
6468294|NCT01243762|7385476|FG002|STARTED|Part 1 (Dose Escalation/MTD)||3
6468295|NCT01243762|7385477|FG003|STARTED|Part 1 (Dose Escalation/MTD)||8
6468296|NCT01243762|7385478|FG004|STARTED|Part 1 (Dose Escalation/MTD)||10
6468297|NCT01243762|7385479|FG005|STARTED|Part 1 (Dose Escalation/MTD)||3
6468298|NCT01243762|7385480|FG006|STARTED|Part 1 (Dose Escalation/MTD)||0
6468299|NCT01243762|7385474|FG000|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|1
6468300|NCT01243762|7385475|FG001|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|5
6468301|NCT01243762|7385476|FG002|COMPLETED|Part 1 (Dose Escalation/MTD)||0
6468302|NCT01243762|7385477|FG003|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|2
6468303|NCT01243762|7385478|FG004|COMPLETED|Part 1 (Dose Escalation/MTD)|Entered Part 2 of Study|4
6468304|NCT01243762|7385479|FG005|COMPLETED|Part 1 (Dose Escalation/MTD)||0
6468305|NCT01243762|7385480|FG006|COMPLETED|Part 1 (Dose Escalation/MTD)||0
6468306|NCT01243762|7385474|FG000|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
6468307|NCT01243762|7385475|FG001|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||8
6468308|NCT01243762|7385476|FG002|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
6468309|NCT01243762|7385477|FG003|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
6468310|NCT01243762|7385478|FG004|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||6
6468311|NCT01243762|7385479|FG005|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||3
6468312|NCT01243762|7385480|FG006|NOT COMPLETED|Part 1 (Dose Escalation/MTD)||0
6468313|NCT01243762|7385474|FG000|STARTED|Part 2 (Dose Confirmation/Efficacy)||1
6468314|NCT01243762|7385475|FG001|STARTED|Part 2 (Dose Confirmation/Efficacy)||5
6468315|NCT01243762|7385476|FG002|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
6468316|NCT01243762|7385477|FG003|STARTED|Part 2 (Dose Confirmation/Efficacy)||2
6468317|NCT01243762|7385478|FG004|STARTED|Part 2 (Dose Confirmation/Efficacy)||4
6468318|NCT01243762|7385479|FG005|STARTED|Part 2 (Dose Confirmation/Efficacy)||0
6468319|NCT01243762|7385480|FG006|STARTED|Part 2 (Dose Confirmation/Efficacy)|New participants were enrolled in Part 2 of the study that did not participate in Part 1|6
6468320|NCT01243762|7385474|FG000|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468321|NCT01243762|7385475|FG001|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468322|NCT01243762|7385476|FG002|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468323|NCT01243762|7385477|FG003|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468324|NCT01243762|7385478|FG004|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468325|NCT01243762|7385479|FG005|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468326|NCT01243762|7385480|FG006|COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468327|NCT01243762|7385474|FG000|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||1
6468328|NCT01243762|7385475|FG001|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||5
6468329|NCT01243762|7385476|FG002|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468330|NCT01243762|7385477|FG003|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||2
6468331|NCT01243762|7385478|FG004|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||4
6468332|NCT01243762|7385479|FG005|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||0
6468333|NCT01243762|7385480|FG006|NOT COMPLETED|Part 2 (Dose Confirmation/Efficacy)||6
6468334|NCT01243775|7385499|FG000|STARTED|Overall Study||33
6468335|NCT01243775|7385499|FG000|COMPLETED|Overall Study||31
6468336|NCT01243775|7385499|FG000|NOT COMPLETED|Overall Study||2
6468337|NCT01243944|7385505|FG000|STARTED|Overall Study||110
6468338|NCT01243944|7385506|FG001|STARTED|Overall Study|One participant withdrew consent 5 days after randomization to BAT & wasn't treated while on study.|112
6468339|NCT01243944|7385505|FG000|Treated|Overall Study||110
6468340|NCT01243944|7385506|FG001|Treated|Overall Study||111
6468341|NCT01243944|7385505|FG000|Followed for Survival|Overall Study||22
6468342|NCT01243944|7385506|FG001|Followed for Survival|Overall Study||21
6468343|NCT01243944|7385505|FG000|COMPLETED|Overall Study||65
6468344|NCT01243944|7385506|FG001|COMPLETED|Overall Study|Study evaluation completion is reported for participants that were treated & those never treatment.|61
6468345|NCT01243944|7385505|FG000|NOT COMPLETED|Overall Study||45
6468346|NCT01243944|7385506|FG001|NOT COMPLETED|Overall Study||51
6468347|NCT01243957|7385513|FG000|STARTED|Overall Study||20
6468348|NCT01243957|7385513|FG000|COMPLETED|Overall Study||20
6468349|NCT01243957|7385513|FG000|NOT COMPLETED|Overall Study||0
6468350|NCT01244035|7385519|FG000|STARTED|Part 1: Period 1||5
6468351|NCT01244035|7385520|FG001|STARTED|Part 1: Period 1||5
6468352|NCT01244035|7385521|FG002|STARTED|Part 1: Period 1||6
6468353|NCT01244035|7385522|FG003|STARTED|Part 1: Period 1||5
6468354|NCT01244035|7385523|FG004|STARTED|Part 1: Period 1||5
6468355|NCT01244035|7385524|FG005|STARTED|Part 1: Period 1||5
6468356|NCT01244035|7385519|FG000|COMPLETED|Part 1: Period 1||4
6468357|NCT01244035|7385520|FG001|COMPLETED|Part 1: Period 1||3
6468358|NCT01244035|7385521|FG002|COMPLETED|Part 1: Period 1||4
6468359|NCT01244035|7385522|FG003|COMPLETED|Part 1: Period 1||5
6468360|NCT01244035|7385523|FG004|COMPLETED|Part 1: Period 1||4
6468361|NCT01244035|7385524|FG005|COMPLETED|Part 1: Period 1||3
6468362|NCT01244035|7385519|FG000|NOT COMPLETED|Part 1: Period 1||1
6468363|NCT01244035|7385520|FG001|NOT COMPLETED|Part 1: Period 1||2
6468364|NCT01244035|7385521|FG002|NOT COMPLETED|Part 1: Period 1||2
6468365|NCT01244035|7385522|FG003|NOT COMPLETED|Part 1: Period 1||0
6468366|NCT01244035|7385523|FG004|NOT COMPLETED|Part 1: Period 1||1
6468367|NCT01244035|7385524|FG005|NOT COMPLETED|Part 1: Period 1||2
6468368|NCT01244035|7385519|FG000|STARTED|Part 1: Period 2||4
6468369|NCT01244035|7385520|FG001|STARTED|Part 1: Period 2||3
6468370|NCT01244035|7385521|FG002|STARTED|Part 1: Period 2||4
6468371|NCT01244035|7385522|FG003|STARTED|Part 1: Period 2||5
6468372|NCT01244035|7385523|FG004|STARTED|Part 1: Period 2||4
6468373|NCT01244035|7385524|FG005|STARTED|Part 1: Period 2||3
6468374|NCT01244035|7385519|FG000|COMPLETED|Part 1: Period 2||4
6468375|NCT01244035|7385520|FG001|COMPLETED|Part 1: Period 2||3
6468376|NCT01244035|7385521|FG002|COMPLETED|Part 1: Period 2||3
6468377|NCT01244035|7385522|FG003|COMPLETED|Part 1: Period 2||5
6468378|NCT01244035|7385523|FG004|COMPLETED|Part 1: Period 2||4
6468379|NCT01244035|7385524|FG005|COMPLETED|Part 1: Period 2||3
6468380|NCT01244035|7385519|FG000|NOT COMPLETED|Part 1: Period 2||0
6468381|NCT01244035|7385520|FG001|NOT COMPLETED|Part 1: Period 2||0
6468382|NCT01244035|7385521|FG002|NOT COMPLETED|Part 1: Period 2||1
6468383|NCT01244035|7385522|FG003|NOT COMPLETED|Part 1: Period 2||0
6468384|NCT01244035|7385523|FG004|NOT COMPLETED|Part 1: Period 2||0
6468385|NCT01244035|7385524|FG005|NOT COMPLETED|Part 1: Period 2||0
6468386|NCT01244035|7385519|FG000|STARTED|Part 1: Period 3||4
6468387|NCT01244035|7385520|FG001|STARTED|Part 1: Period 3||3
6468388|NCT01244035|7385521|FG002|STARTED|Part 1: Period 3||3
6468389|NCT01244035|7385522|FG003|STARTED|Part 1: Period 3||5
6468390|NCT01244035|7385523|FG004|STARTED|Part 1: Period 3||4
6468391|NCT01244035|7385524|FG005|STARTED|Part 1: Period 3||3
6468392|NCT01244035|7385519|FG000|COMPLETED|Part 1: Period 3||4
6468393|NCT01244035|7385520|FG001|COMPLETED|Part 1: Period 3||2
6468394|NCT01244035|7385521|FG002|COMPLETED|Part 1: Period 3||3
6468395|NCT01244035|7385522|FG003|COMPLETED|Part 1: Period 3||5
6468396|NCT01244035|7385523|FG004|COMPLETED|Part 1: Period 3||3
6468397|NCT01244035|7385524|FG005|COMPLETED|Part 1: Period 3||2
6468398|NCT01244035|7385519|FG000|NOT COMPLETED|Part 1: Period 3||0
6468399|NCT01244035|7385520|FG001|NOT COMPLETED|Part 1: Period 3||1
6468400|NCT01244035|7385521|FG002|NOT COMPLETED|Part 1: Period 3||0
6468401|NCT01244035|7385522|FG003|NOT COMPLETED|Part 1: Period 3||0
6468402|NCT01244035|7385523|FG004|NOT COMPLETED|Part 1: Period 3||1
6468403|NCT01244035|7385524|FG005|NOT COMPLETED|Part 1: Period 3||1
6500986|NCT01426360|7419457|FG000|NOT COMPLETED|Overall Study||0
6500987|NCT01426360|7419458|FG001|NOT COMPLETED|Overall Study||0
6554252|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Washout Period 2||7
6554253|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6554254|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6554255|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6554256|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6554257|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6500988|NCT01426373|7419464|FG000|STARTED|Overall Study||165
6500989|NCT01426373|7419464|FG000|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
6500990|NCT01426373|7419464|FG000|NOT COMPLETED|Overall Study||34
6500991|NCT01426386|7419476|FG000|STARTED|Overall Study||42
6500992|NCT01426386|7419477|FG001|STARTED|Overall Study||45
6500993|NCT01426386|7419478|FG002|STARTED|Overall Study||44
6500994|NCT01426386|7419479|FG003|STARTED|Overall Study||44
6500995|NCT01426386|7419480|FG004|STARTED|Overall Study||47
6500996|NCT01426386|7419481|FG005|STARTED|Overall Study||43
6500997|NCT01426386|7419476|FG000|COMPLETED|Overall Study||39
6500998|NCT01426386|7419477|FG001|COMPLETED|Overall Study||39
6500999|NCT01426386|7419478|FG002|COMPLETED|Overall Study||42
6501000|NCT01426386|7419479|FG003|COMPLETED|Overall Study||44
6501001|NCT01426386|7419480|FG004|COMPLETED|Overall Study||43
6501002|NCT01426386|7419481|FG005|COMPLETED|Overall Study||42
6501003|NCT01426386|7419476|FG000|NOT COMPLETED|Overall Study||3
6501004|NCT01426386|7419477|FG001|NOT COMPLETED|Overall Study||6
6501005|NCT01426386|7419478|FG002|NOT COMPLETED|Overall Study||2
6501006|NCT01426386|7419479|FG003|NOT COMPLETED|Overall Study||0
6501007|NCT01426386|7419480|FG004|NOT COMPLETED|Overall Study||4
6501008|NCT01426386|7419481|FG005|NOT COMPLETED|Overall Study||1
6501009|NCT01426412|7419504|FG000|STARTED|Overall Study||6
6501010|NCT01426412|7419505|FG001|STARTED|Overall Study||6
6501011|NCT01426412|7419506|FG002|STARTED|Overall Study||6
6501012|NCT01426412|7419507|FG003|STARTED|Overall Study||6
6501013|NCT01426412|7419508|FG004|STARTED|Overall Study||6
6501014|NCT01426412|7419509|FG005|STARTED|Overall Study||6
6468404|NCT01244061|7385546|FG000|STARTED|Overall Study||251
6468405|NCT01244061|7385547|FG001|STARTED|Overall Study||247
6468406|NCT01244061|7385546|FG000|COMPLETED|Overall Study||169
6468407|NCT01244061|7385547|FG001|COMPLETED|Overall Study||144
6468408|NCT01244061|7385546|FG000|NOT COMPLETED|Overall Study||82
6468409|NCT01244061|7385547|FG001|NOT COMPLETED|Overall Study||103
6468410|NCT01244126|7385556|FG000|STARTED|Overall Study||59
6468411|NCT01244126|7385557|FG001|STARTED|Overall Study||55
6468412|NCT01244126|7385558|FG002|STARTED|Overall Study||57
6468413|NCT01244126|7385556|FG000|COMPLETED|Overall Study||56
6468414|NCT01244126|7385557|FG001|COMPLETED|Overall Study||52
6468415|NCT01244126|7385558|FG002|COMPLETED|Overall Study||48
6468416|NCT01244126|7385556|FG000|NOT COMPLETED|Overall Study||3
6468417|NCT01244126|7385557|FG001|NOT COMPLETED|Overall Study||3
6468418|NCT01244126|7385558|FG002|NOT COMPLETED|Overall Study||9
6554258|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6554259|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6554260|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6554261|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6554262|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Third Intervention||0
6554263|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Third Intervention||0
6554264|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Third Intervention||0
6554265|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Third Intervention||6
6554266|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Third Intervention||6
6554267|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Third Intervention||7
6554268|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Third Intervention||7
6554269|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Third Intervention||6
6554270|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Third Intervention||7
6554271|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Third Intervention||0
6554272|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Third Intervention||0
6554273|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Third Intervention||0
6554274|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Third Intervention||6
6554275|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Third Intervention||6
6554276|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Third Intervention||6
6554277|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Third Intervention||6
6554278|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Third Intervention||6
6554279|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Third Intervention||7
6554280|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
6554281|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
6554282|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
6554283|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
6468419|NCT01244191|7385568|FG000|STARTED|Overall Study||526
6468420|NCT01244191|7385569|FG001|STARTED|Overall Study||522
6468421|NCT01244191|7385568|FG000|Did Not Receive Treatment|Overall Study||6
6468422|NCT01244191|7385569|FG001|Did Not Receive Treatment|Overall Study||5
6468423|NCT01244191|7385568|FG000|COMPLETED|Overall Study||46
6468424|NCT01244191|7385569|FG001|COMPLETED|Overall Study||24
6468425|NCT01244191|7385568|FG000|NOT COMPLETED|Overall Study||480
6468426|NCT01244191|7385569|FG001|NOT COMPLETED|Overall Study||498
6468427|NCT01244243|7385575|FG000|STARTED|Overall Study||41
6468428|NCT01244243|7385575|FG000|COMPLETED|Overall Study||41
6468429|NCT01244243|7385575|FG000|NOT COMPLETED|Overall Study||0
6468430|NCT01244412|7385579|FG000|STARTED|Overall Study||1
6468431|NCT01244412|7385579|FG000|COMPLETED|Overall Study||1
6468432|NCT01244412|7385579|FG000|NOT COMPLETED|Overall Study||0
6468433|NCT01244425|7385585|FG000|STARTED|Overall Study||35
6468434|NCT01244425|7385586|FG001|STARTED|Overall Study||35
6468435|NCT01244425|7385585|FG000|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
6468436|NCT01244425|7385586|FG001|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
6468437|NCT01244425|7385585|FG000|NOT COMPLETED|Overall Study||3
6468438|NCT01244425|7385586|FG001|NOT COMPLETED|Overall Study||3
6468439|NCT01244451|7385600|FG000|STARTED|Overall Study||49
6468440|NCT01244451|7385600|FG000|COMPLETED|Overall Study||36
6468441|NCT01244451|7385600|FG000|NOT COMPLETED|Overall Study||13
6468442|NCT01244477|7385607|FG000|STARTED|Overall Study||38
6468443|NCT01244477|7385608|FG001|STARTED|Overall Study||23
6468444|NCT01244477|7385607|FG000|COMPLETED|Overall Study||18
6468445|NCT01244477|7385608|FG001|COMPLETED|Overall Study||20
6468446|NCT01244477|7385607|FG000|NOT COMPLETED|Overall Study||20
6468447|NCT01244477|7385608|FG001|NOT COMPLETED|Overall Study||3
6468448|NCT01244490|7385619|FG000|STARTED|Overall Study||111
6468449|NCT01244490|7385620|FG001|STARTED|Overall Study||115
6468450|NCT01244490|7385621|FG002|STARTED|Overall Study||112
6468451|NCT01244490|7385619|FG000|COMPLETED|Overall Study||92
6468452|NCT01244490|7385620|FG001|COMPLETED|Overall Study||91
6468453|NCT01244490|7385621|FG002|COMPLETED|Overall Study||89
6468454|NCT01244490|7385619|FG000|NOT COMPLETED|Overall Study||19
6468455|NCT01244490|7385620|FG001|NOT COMPLETED|Overall Study||24
6468456|NCT01244490|7385621|FG002|NOT COMPLETED|Overall Study||23
6468457|NCT01244503|7385629|FG000|STARTED|Overall Study||61
6468458|NCT01244503|7385629|FG000|COMPLETED|Overall Study||61
6468459|NCT01244503|7385629|FG000|NOT COMPLETED|Overall Study||0
6468460|NCT01244516|7385636|FG000|STARTED|Period 1 (Baseline to 1-week Visit)||170
6468461|NCT01244516|7385637|FG001|STARTED|Period 1 (Baseline to 1-week Visit)||177
6468462|NCT01244516|7385638|FG002|STARTED|Period 1 (Baseline to 1-week Visit)||173
6468463|NCT01244516|7385636|FG000|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
6468464|NCT01244516|7385637|FG001|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
6468465|NCT01244516|7385638|FG002|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
6468466|NCT01244516|7385636|FG000|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
6468467|NCT01244516|7385637|FG001|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
6468468|NCT01244516|7385638|FG002|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
6468469|NCT01244516|7385636|FG000|STARTED|Period 2 (1-week to 2-week Visit)||166
6468470|NCT01244516|7385637|FG001|STARTED|Period 2 (1-week to 2-week Visit)||171
6468471|NCT01244516|7385638|FG002|STARTED|Period 2 (1-week to 2-week Visit)||170
6468472|NCT01244516|7385636|FG000|COMPLETED|Period 2 (1-week to 2-week Visit)||163
6468473|NCT01244516|7385637|FG001|COMPLETED|Period 2 (1-week to 2-week Visit)||170
6468474|NCT01244516|7385638|FG002|COMPLETED|Period 2 (1-week to 2-week Visit)||168
6468475|NCT01244516|7385636|FG000|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
6468476|NCT01244516|7385637|FG001|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
6468477|NCT01244516|7385638|FG002|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
6468478|NCT01244529|7385647|FG000|STARTED|Overall Study||41
6468479|NCT01244529|7385647|FG000|COMPLETED|Overall Study||41
6468480|NCT01244529|7385647|FG000|NOT COMPLETED|Overall Study||0
6468481|NCT01244633|7385663|FG000|STARTED|Overall Study||18
6468482|NCT01244633|7385663|FG000|COMPLETED|Overall Study||15
6468483|NCT01244633|7385663|FG000|NOT COMPLETED|Overall Study||3
6468484|NCT01244711|7385667|FG000|STARTED|Overall Study||1
6468485|NCT01244711|7385667|FG000|COMPLETED|Overall Study||1
6468486|NCT01244711|7385667|FG000|NOT COMPLETED|Overall Study||0
6468487|NCT01244724|7385671|FG000|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
6746751|NCT03377634|7674423|FG001|NOT COMPLETED|Intervention Usability Testing Period||0
6468488|NCT01244724|7385671|FG000|Week 2 Visit|Overall Study||15
6468489|NCT01244724|7385671|FG000|COMPLETED|Overall Study||9
6468490|NCT01244724|7385671|FG000|NOT COMPLETED|Overall Study||8
6468491|NCT01244893|7385675|FG000|STARTED|Baseline||22
6468492|NCT01244893|7385676|FG001|STARTED|Baseline||22
6468493|NCT01244893|7385675|FG000|COMPLETED|Baseline||22
6468494|NCT01244893|7385676|FG001|COMPLETED|Baseline||21
6468495|NCT01244893|7385675|FG000|NOT COMPLETED|Baseline||0
6468496|NCT01244893|7385676|FG001|NOT COMPLETED|Baseline||1
6468497|NCT01244893|7385675|FG000|STARTED|1-Week Follow Up||22
6468498|NCT01244893|7385676|FG001|STARTED|1-Week Follow Up||21
6468499|NCT01244893|7385675|FG000|COMPLETED|1-Week Follow Up||21
6468500|NCT01244893|7385676|FG001|COMPLETED|1-Week Follow Up||21
6468501|NCT01244893|7385675|FG000|NOT COMPLETED|1-Week Follow Up||1
6468502|NCT01244893|7385676|FG001|NOT COMPLETED|1-Week Follow Up||0
6468503|NCT01244893|7385675|FG000|STARTED|Final Visit||21
6468504|NCT01244893|7385676|FG001|STARTED|Final Visit||21
6468505|NCT01244893|7385675|FG000|COMPLETED|Final Visit||21
6468506|NCT01244893|7385676|FG001|COMPLETED|Final Visit||21
6468507|NCT01244893|7385675|FG000|NOT COMPLETED|Final Visit||0
6468508|NCT01244893|7385676|FG001|NOT COMPLETED|Final Visit||0
6468509|NCT01244906|7385687|FG000|STARTED|Overall Study||26
6468510|NCT01244906|7385687|FG000|COMPLETED|Overall Study||18
6468511|NCT01244906|7385687|FG000|NOT COMPLETED|Overall Study||8
6468512|NCT01244984|7385694|FG000|STARTED|Overall Study||60
6468513|NCT01244984|7385695|FG001|STARTED|Overall Study||93
6468514|NCT01244984|7385696|FG002|STARTED|Overall Study||90
6468515|NCT01244984|7385694|FG000|COMPLETED|Overall Study||55
6468516|NCT01244984|7385695|FG001|COMPLETED|Overall Study||79
6468517|NCT01244984|7385696|FG002|COMPLETED|Overall Study||86
6468518|NCT01244984|7385694|FG000|NOT COMPLETED|Overall Study||5
6468519|NCT01244984|7385695|FG001|NOT COMPLETED|Overall Study||14
6468520|NCT01244984|7385696|FG002|NOT COMPLETED|Overall Study||4
6468521|NCT01245049|7385707|FG000|STARTED|Overall Study||255
6468522|NCT01245049|7385708|FG001|STARTED|Overall Study||130
6468523|NCT01245049|7385707|FG000|COMPLETED|Overall Study||254
6468524|NCT01245049|7385708|FG001|COMPLETED|Overall Study||126
6468525|NCT01245049|7385707|FG000|NOT COMPLETED|Overall Study||1
6468526|NCT01245049|7385708|FG001|NOT COMPLETED|Overall Study||4
6468527|NCT01245062|7385716|FG000|STARTED|Randomization and Crossover Phase||214
6468528|NCT01245062|7385717|FG001|STARTED|Randomization and Crossover Phase||108
6468529|NCT01245062|7385718|FG002|STARTED|Randomization and Crossover Phase||0
6468530|NCT01245062|7385716|FG000|COMPLETED|Randomization and Crossover Phase||173
6468531|NCT01245062|7385717|FG001|COMPLETED|Randomization and Crossover Phase||77
6468532|NCT01245062|7385718|FG002|COMPLETED|Randomization and Crossover Phase||0
6468533|NCT01245062|7385716|FG000|NOT COMPLETED|Randomization and Crossover Phase||41
6468534|NCT01245062|7385717|FG001|NOT COMPLETED|Randomization and Crossover Phase||31
6468535|NCT01245062|7385718|FG002|NOT COMPLETED|Randomization and Crossover Phase||0
6468536|NCT01245062|7385716|FG000|STARTED|Cross-over Phase||0
6746752|NCT03377634|7674422|FG000|STARTED|Study Period||15
6746753|NCT03377634|7674423|FG001|STARTED|Study Period||13
6468537|NCT01245062|7385717|FG001|STARTED|Cross-over Phase||0
6468538|NCT01245062|7385718|FG002|STARTED|Cross-over Phase|As of the data cut on December 16, 2016, 70 of 108 participants crossed over from CT to trametinib.|70
6468539|NCT01245062|7385716|FG000|COMPLETED|Cross-over Phase||0
6468540|NCT01245062|7385717|FG001|COMPLETED|Cross-over Phase||0
6468541|NCT01245062|7385718|FG002|COMPLETED|Cross-over Phase||53
6468542|NCT01245062|7385716|FG000|NOT COMPLETED|Cross-over Phase||0
6468543|NCT01245062|7385717|FG001|NOT COMPLETED|Cross-over Phase||0
6468544|NCT01245062|7385718|FG002|NOT COMPLETED|Cross-over Phase||17
6468545|NCT01245101|7385728|FG000|STARTED|Period 1 (Treatment)||15
6468546|NCT01245101|7385729|FG001|STARTED|Period 1 (Treatment)||0
6468547|NCT01245101|7385728|FG000|COMPLETED|Period 1 (Treatment)||13
6468548|NCT01245101|7385729|FG001|COMPLETED|Period 1 (Treatment)||0
6468549|NCT01245101|7385728|FG000|NOT COMPLETED|Period 1 (Treatment)||2
6468550|NCT01245101|7385729|FG001|NOT COMPLETED|Period 1 (Treatment)||0
6468551|NCT01245101|7385728|FG000|STARTED|Period 2 (Washout)||13
6468552|NCT01245101|7385729|FG001|STARTED|Period 2 (Washout)||0
6468553|NCT01245101|7385728|FG000|COMPLETED|Period 2 (Washout)||12
6468554|NCT01245101|7385729|FG001|COMPLETED|Period 2 (Washout)||0
6468555|NCT01245101|7385728|FG000|NOT COMPLETED|Period 2 (Washout)||1
6468556|NCT01245101|7385729|FG001|NOT COMPLETED|Period 2 (Washout)||0
6468557|NCT01245101|7385728|FG000|STARTED|Period 3 (Treatment)||12
6468558|NCT01245101|7385729|FG001|STARTED|Period 3 (Treatment)||0
6468559|NCT01245101|7385728|FG000|COMPLETED|Period 3 (Treatment)||11
6468560|NCT01245101|7385729|FG001|COMPLETED|Period 3 (Treatment)||0
6468561|NCT01245101|7385728|FG000|NOT COMPLETED|Period 3 (Treatment)||1
6468562|NCT01245101|7385729|FG001|NOT COMPLETED|Period 3 (Treatment)||0
6468563|NCT01245140|7385737|FG000|STARTED|Overall Study||9
6468564|NCT01245140|7385738|FG001|STARTED|Overall Study||24
6468565|NCT01245140|7385737|FG000|COMPLETED|Overall Study||6
6468566|NCT01245140|7385738|FG001|COMPLETED|Overall Study||14
6468567|NCT01245140|7385737|FG000|NOT COMPLETED|Overall Study||3
6468568|NCT01245140|7385738|FG001|NOT COMPLETED|Overall Study||10
6468569|NCT01245270|7385746|FG000|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
6468570|NCT01245270|7385747|FG001|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
6468571|NCT01245270|7385746|FG000|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
6468572|NCT01245270|7385747|FG001|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
6468573|NCT01245270|7385746|FG000|NOT COMPLETED|Overall Study||0
6468574|NCT01245270|7385747|FG001|NOT COMPLETED|Overall Study||0
6468575|NCT01245283|7385758|FG000|STARTED|Overall Study||32
6468576|NCT01245283|7385759|FG001|STARTED|Overall Study||28
6468577|NCT01245283|7385760|FG002|STARTED|Overall Study||30
6468578|NCT01245283|7385758|FG000|COMPLETED|Overall Study||18
6468579|NCT01245283|7385759|FG001|COMPLETED|Overall Study||17
6468580|NCT01245283|7385760|FG002|COMPLETED|Overall Study||19
6468581|NCT01245283|7385758|FG000|NOT COMPLETED|Overall Study||14
6468582|NCT01245283|7385759|FG001|NOT COMPLETED|Overall Study||11
6468583|NCT01245283|7385760|FG002|NOT COMPLETED|Overall Study||11
6468584|NCT01245374|7385771|FG000|STARTED|Overall Study||103
6468585|NCT01245374|7385771|FG000|COMPLETED|Overall Study||99
6468586|NCT01245374|7385771|FG000|NOT COMPLETED|Overall Study||4
6468587|NCT01245387|7385776|FG000|STARTED|Overall Study||1001
6468588|NCT01245387|7385776|FG000|COMPLETED|Overall Study||188
6468589|NCT01245387|7385776|FG000|NOT COMPLETED|Overall Study||813
6468590|NCT01245413|7385780|FG000|STARTED|Sensura First,||16
6468591|NCT01245413|7385781|FG001|STARTED|Sensura First,||16
6468592|NCT01245413|7385780|FG000|COMPLETED|Sensura First,||16
6468593|NCT01245413|7385781|FG001|COMPLETED|Sensura First,||16
6468594|NCT01245413|7385780|FG000|NOT COMPLETED|Sensura First,||0
6468595|NCT01245413|7385781|FG001|NOT COMPLETED|Sensura First,||0
6468596|NCT01245413|7385780|FG000|STARTED|Athena First,||16
6468597|NCT01245413|7385781|FG001|STARTED|Athena First,||16
6468598|NCT01245413|7385780|FG000|COMPLETED|Athena First,||16
6468599|NCT01245413|7385781|FG001|COMPLETED|Athena First,||16
6468600|NCT01245413|7385780|FG000|NOT COMPLETED|Athena First,||0
6468601|NCT01245413|7385781|FG001|NOT COMPLETED|Athena First,||0
6468602|NCT01245439|7385787|FG000|STARTED|Overall Study||65
6468603|NCT01245439|7385787|FG000|COMPLETED|Overall Study||65
6468604|NCT01245439|7385787|FG000|NOT COMPLETED|Overall Study||0
6468605|NCT01245595|7385795|FG000|STARTED|Overall Study||72
6468606|NCT01245595|7385796|FG001|STARTED|Overall Study||72
6468607|NCT01245595|7385795|FG000|Completed Full Course of Study Drug|Overall Study||57
6468608|NCT01245595|7385796|FG001|Completed Full Course of Study Drug|Overall Study||61
6468609|NCT01245595|7385795|FG000|COMPLETED|Overall Study||72
6468610|NCT01245595|7385796|FG001|COMPLETED|Overall Study||72
6468611|NCT01245595|7385795|FG000|NOT COMPLETED|Overall Study||0
6468612|NCT01245595|7385796|FG001|NOT COMPLETED|Overall Study||0
6468613|NCT01245647|7385804|FG000|STARTED|Overall Study||7
6468614|NCT01245647|7385805|FG001|STARTED|Overall Study||12
6468615|NCT01245647|7385804|FG000|COMPLETED|Overall Study||7
6554284|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
6554285|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||1
6654443|NCT02445859|7584273|FG001|NOT COMPLETED|Overall Study||3
6468616|NCT01245647|7385805|FG001|COMPLETED|Overall Study||8
6468617|NCT01245647|7385804|FG000|NOT COMPLETED|Overall Study||0
6468618|NCT01245647|7385805|FG001|NOT COMPLETED|Overall Study||4
6468619|NCT01245673|7385811|FG000|STARTED|Enrollment||28
6468620|NCT01245673|7385811|FG000|COMPLETED|Enrollment|One subject failed to meet screening criteria for the trial.|27
6468621|NCT01245673|7385811|FG000|NOT COMPLETED|Enrollment||1
6468622|NCT01245673|7385811|FG000|STARTED|Pre Transplant Vaccinations||27
6468623|NCT01245673|7385811|FG000|Pre Transplant Vaccinations 1-3|Pre Transplant Vaccinations||27
6468624|NCT01245673|7385811|FG000|COMPLETED|Pre Transplant Vaccinations||27
6468625|NCT01245673|7385811|FG000|NOT COMPLETED|Pre Transplant Vaccinations||0
6468626|NCT01245673|7385811|FG000|STARTED|Activated/Costimulated Autologous T Cell||27
6468627|NCT01245673|7385811|FG000|COMPLETED|Activated/Costimulated Autologous T Cell||27
6468628|NCT01245673|7385811|FG000|NOT COMPLETED|Activated/Costimulated Autologous T Cell||0
6468629|NCT01245673|7385811|FG000|STARTED|MAGE-A3, Hiltonol®, PVC After T Cells||27
6468630|NCT01245673|7385811|FG000|COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||26
6468631|NCT01245673|7385811|FG000|NOT COMPLETED|MAGE-A3, Hiltonol®, PVC After T Cells||1
6468632|NCT01245673|7385811|FG000|STARTED|Start Lenalidomide||26
6468633|NCT01245673|7385811|FG000|COMPLETED|Start Lenalidomide||26
6468634|NCT01245673|7385811|FG000|NOT COMPLETED|Start Lenalidomide||0
6468635|NCT01245673|7385811|FG000|STARTED|Maintenance: MAGE-A3, PVC After T Cells||26
6468636|NCT01245673|7385811|FG000|COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||26
6468637|NCT01245673|7385811|FG000|NOT COMPLETED|Maintenance: MAGE-A3, PVC After T Cells||0
6468638|NCT01245699|7385817|FG000|STARTED|Overall Study||61
6468639|NCT01245699|7385818|FG001|STARTED|Overall Study||54
6468640|NCT01245699|7385817|FG000|COMPLETED|Overall Study||52
6468641|NCT01245699|7385818|FG001|COMPLETED|Overall Study||49
6468642|NCT01245699|7385817|FG000|NOT COMPLETED|Overall Study||9
6468643|NCT01245699|7385818|FG001|NOT COMPLETED|Overall Study||5
6468644|NCT01245738|7385825|FG000|STARTED|Overall Study||514
6468645|NCT01245738|7385825|FG000|COMPLETED|Overall Study||474
6554286|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||1
6554287|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
6554288|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||0
6554289|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Washout Period 3||0
6554290|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Washout Period 3||0
6468646|NCT01245738|7385825|FG000|NOT COMPLETED|Overall Study||40
6468647|NCT01245751|7385833|FG000|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
6468648|NCT01245751|7385834|FG001|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
6468649|NCT01245751|7385835|FG002|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
6468650|NCT01245751|7385836|FG003|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
6468651|NCT01245751|7385833|FG000|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
6468652|NCT01245751|7385834|FG001|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
6468653|NCT01245751|7385835|FG002|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
6468654|NCT01245751|7385836|FG003|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
6468655|NCT01245751|7385833|FG000|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
6468656|NCT01245751|7385834|FG001|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
6468657|NCT01245751|7385835|FG002|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
6468658|NCT01245751|7385836|FG003|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
6468659|NCT01245751|7385833|FG000|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
6468660|NCT01245751|7385834|FG001|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
6468661|NCT01245751|7385835|FG002|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
6468662|NCT01245751|7385836|FG003|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
6468663|NCT01245751|7385833|FG000|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
6468664|NCT01245751|7385834|FG001|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
6468665|NCT01245751|7385835|FG002|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
6468666|NCT01245751|7385836|FG003|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
6468667|NCT01245751|7385833|FG000|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
6468668|NCT01245751|7385834|FG001|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
6468669|NCT01245751|7385835|FG002|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6468670|NCT01245751|7385836|FG003|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6468671|NCT01245751|7385833|FG000|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6468672|NCT01245751|7385834|FG001|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6468673|NCT01245751|7385835|FG002|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6468674|NCT01245751|7385836|FG003|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
6468675|NCT01245764|7385851|FG000|STARTED|Study Phase A||80
6468676|NCT01245764|7385852|FG001|STARTED|Study Phase A||30
6468677|NCT01245764|7385853|FG002|STARTED|Study Phase A||120
6468678|NCT01245764|7385854|FG003|STARTED|Study Phase A||20
6468679|NCT01245764|7385851|FG000|Completed Vaccinations in Study Phase A|Study Phase A||77
6468680|NCT01245764|7385852|FG001|Completed Vaccinations in Study Phase A|Study Phase A||28
6468681|NCT01245764|7385853|FG002|Completed Vaccinations in Study Phase A|Study Phase A||117
6468682|NCT01245764|7385854|FG003|Completed Vaccinations in Study Phase A|Study Phase A||19
6468683|NCT01245764|7385851|FG000|COMPLETED|Study Phase A||71
6468684|NCT01245764|7385852|FG001|COMPLETED|Study Phase A||25
6468685|NCT01245764|7385853|FG002|COMPLETED|Study Phase A||110
6468686|NCT01245764|7385854|FG003|COMPLETED|Study Phase A||17
6468687|NCT01245764|7385851|FG000|NOT COMPLETED|Study Phase A||9
6468688|NCT01245764|7385852|FG001|NOT COMPLETED|Study Phase A||5
6468689|NCT01245764|7385853|FG002|NOT COMPLETED|Study Phase A||10
6468690|NCT01245764|7385854|FG003|NOT COMPLETED|Study Phase A||3
6468691|NCT01245764|7385851|FG000|STARTED|Study Phase B||0
6468692|NCT01245764|7385852|FG001|STARTED|Study Phase B||0
6468693|NCT01245764|7385853|FG002|STARTED|Study Phase B||0
6468694|NCT01245764|7385854|FG003|STARTED|Study Phase B||17
6468695|NCT01245764|7385851|FG000|Completed Vaccinations in Study Phase B|Study Phase B||0
6468696|NCT01245764|7385852|FG001|Completed Vaccinations in Study Phase B|Study Phase B||0
6468697|NCT01245764|7385853|FG002|Completed Vaccinations in Study Phase B|Study Phase B||0
6501015|NCT01426412|7419510|FG006|STARTED|Overall Study||6
6468698|NCT01245764|7385854|FG003|Completed Vaccinations in Study Phase B|Study Phase B||17
6468699|NCT01245764|7385851|FG000|COMPLETED|Study Phase B||0
6468700|NCT01245764|7385852|FG001|COMPLETED|Study Phase B||0
6468701|NCT01245764|7385853|FG002|COMPLETED|Study Phase B||0
6468702|NCT01245764|7385854|FG003|COMPLETED|Study Phase B||17
6468703|NCT01245764|7385851|FG000|NOT COMPLETED|Study Phase B||0
6468704|NCT01245764|7385852|FG001|NOT COMPLETED|Study Phase B||0
6468705|NCT01245764|7385853|FG002|NOT COMPLETED|Study Phase B||0
6468706|NCT01245764|7385854|FG003|NOT COMPLETED|Study Phase B||0
6468707|NCT01245972|7385875|FG000|STARTED|Overall Study||7
6468708|NCT01245972|7385876|FG001|STARTED|Overall Study||8
6468709|NCT01245972|7385877|FG002|STARTED|Overall Study||8
6468710|NCT01245972|7385875|FG000|COMPLETED|Overall Study||7
6468711|NCT01245972|7385876|FG001|COMPLETED|Overall Study||8
6468712|NCT01245972|7385877|FG002|COMPLETED|Overall Study||8
6468713|NCT01245972|7385875|FG000|NOT COMPLETED|Overall Study||0
6468714|NCT01245972|7385876|FG001|NOT COMPLETED|Overall Study||0
6468715|NCT01245972|7385877|FG002|NOT COMPLETED|Overall Study||0
6468716|NCT01246050|7385887|FG000|STARTED|Overall Study||6
6468717|NCT01246050|7385888|FG001|STARTED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
6468718|NCT01246050|7385887|FG000|COMPLETED|Overall Study||6
6468719|NCT01246050|7385888|FG001|COMPLETED|Overall Study|Control providers were other providers in the same Primary Care Clinic, not enrolled in the study|6
6468720|NCT01246050|7385887|FG000|NOT COMPLETED|Overall Study||0
6468721|NCT01246050|7385888|FG001|NOT COMPLETED|Overall Study||0
6468722|NCT01246063|7385900|FG000|STARTED|Overall Study||3
6468723|NCT01246063|7385901|FG001|STARTED|Overall Study||4
6468724|NCT01246063|7385902|FG002|STARTED|Overall Study||4
6468725|NCT01246063|7385903|FG003|STARTED|Overall Study||5
6468726|NCT01246063|7385904|FG004|STARTED|Overall Study||7
6468727|NCT01246063|7385905|FG005|STARTED|Overall Study||17
6468728|NCT01246063|7385900|FG000|COMPLETED|Overall Study||3
6468729|NCT01246063|7385901|FG001|COMPLETED|Overall Study||4
6468730|NCT01246063|7385902|FG002|COMPLETED|Overall Study||4
6468731|NCT01246063|7385903|FG003|COMPLETED|Overall Study||5
6468732|NCT01246063|7385904|FG004|COMPLETED|Overall Study||7
6468733|NCT01246063|7385905|FG005|COMPLETED|Overall Study||17
6468734|NCT01246063|7385900|FG000|NOT COMPLETED|Overall Study||0
6468735|NCT01246063|7385901|FG001|NOT COMPLETED|Overall Study||0
6468736|NCT01246063|7385902|FG002|NOT COMPLETED|Overall Study||0
6468737|NCT01246063|7385903|FG003|NOT COMPLETED|Overall Study||0
6468738|NCT01246063|7385904|FG004|NOT COMPLETED|Overall Study||0
6468739|NCT01246063|7385905|FG005|NOT COMPLETED|Overall Study||0
6468740|NCT01246076|7385923|FG000|STARTED|Overall Study||24
6468741|NCT01246076|7385923|FG000|COMPLETED|Overall Study||24
6468742|NCT01246076|7385923|FG000|NOT COMPLETED|Overall Study||0
6468743|NCT01246206|7385927|FG000|STARTED|Overall Study||21
6468744|NCT01246206|7385927|FG000|COMPLETED|Overall Study||20
6468745|NCT01246206|7385927|FG000|NOT COMPLETED|Overall Study||1
6468746|NCT01246258|7385931|FG000|STARTED|Overall Study||5
6468747|NCT01246258|7385931|FG000|COMPLETED|Overall Study||5
6468748|NCT01246258|7385931|FG000|NOT COMPLETED|Overall Study||0
6468749|NCT01246349|7385938|FG000|STARTED|Overall Study||20
6468750|NCT01246349|7385939|FG001|STARTED|Overall Study||20
6468751|NCT01246349|7385938|FG000|COMPLETED|Overall Study||20
6468752|NCT01246349|7385939|FG001|COMPLETED|Overall Study||20
6468753|NCT01246349|7385938|FG000|NOT COMPLETED|Overall Study||0
6468754|NCT01246349|7385939|FG001|NOT COMPLETED|Overall Study||0
6468755|NCT01246401|7385947|FG000|STARTED|Overall Study||66
6468756|NCT01246401|7385948|FG001|STARTED|Overall Study||27
6468757|NCT01246401|7385947|FG000|COMPLETED|Overall Study||66
6468758|NCT01246401|7385948|FG001|COMPLETED|Overall Study||27
6654444|NCT02445911|7584283|FG000|STARTED|Overall Study||20
6654445|NCT02445911|7584284|FG001|STARTED|Overall Study||20
6654446|NCT02445911|7584285|FG002|STARTED|Overall Study||21
6654447|NCT02445911|7584286|FG003|STARTED|Overall Study||20
6654448|NCT02445911|7584283|FG000|COMPLETED|Overall Study||20
6654449|NCT02445911|7584284|FG001|COMPLETED|Overall Study||20
6468759|NCT01246401|7385947|FG000|NOT COMPLETED|Overall Study||0
6468760|NCT01246401|7385948|FG001|NOT COMPLETED|Overall Study||0
6468761|NCT01246466|7385956|FG000|STARTED|Overall Study||24
6468762|NCT01246466|7385956|FG000|COMPLETED|Overall Study||22
6468763|NCT01246466|7385956|FG000|NOT COMPLETED|Overall Study||2
6468764|NCT01246479|7385961|FG000|STARTED|Overall Study||23
6468765|NCT01246479|7385961|FG000|COMPLETED|Overall Study|primary endpoint at Month 12|18
6468766|NCT01246479|7385961|FG000|NOT COMPLETED|Overall Study||5
6468767|NCT01246583|7385969|FG000|STARTED|Overall Study||23
6468768|NCT01246583|7385970|FG001|STARTED|Overall Study||13
6468769|NCT01246583|7385971|FG002|STARTED|Overall Study||25
6468770|NCT01246583|7385972|FG003|STARTED|Overall Study||10
6468771|NCT01246583|7385969|FG000|COMPLETED|Overall Study||22
6468772|NCT01246583|7385970|FG001|COMPLETED|Overall Study||13
6468773|NCT01246583|7385971|FG002|COMPLETED|Overall Study||24
6468774|NCT01246583|7385972|FG003|COMPLETED|Overall Study||9
6468775|NCT01246583|7385969|FG000|NOT COMPLETED|Overall Study||1
6468776|NCT01246583|7385970|FG001|NOT COMPLETED|Overall Study||0
6468777|NCT01246583|7385971|FG002|NOT COMPLETED|Overall Study||1
6468778|NCT01246583|7385972|FG003|NOT COMPLETED|Overall Study||1
6468779|NCT01246713|7385983|FG000|STARTED|First Acetaminophen Dosing (1 Day)||6
6654450|NCT02445911|7584285|FG002|COMPLETED|Overall Study||21
6654451|NCT02445911|7584286|FG003|COMPLETED|Overall Study||20
6468780|NCT01246713|7385984|FG001|STARTED|First Acetaminophen Dosing (1 Day)||9
6468781|NCT01246713|7385983|FG000|COMPLETED|First Acetaminophen Dosing (1 Day)||6
6468782|NCT01246713|7385984|FG001|COMPLETED|First Acetaminophen Dosing (1 Day)||9
6468783|NCT01246713|7385983|FG000|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
6468784|NCT01246713|7385984|FG001|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
6468785|NCT01246713|7385983|FG000|STARTED|Washout (at Least 14 Days)||6
6468786|NCT01246713|7385984|FG001|STARTED|Washout (at Least 14 Days)||9
6468787|NCT01246713|7385983|FG000|COMPLETED|Washout (at Least 14 Days)||6
6468788|NCT01246713|7385984|FG001|COMPLETED|Washout (at Least 14 Days)||9
6468789|NCT01246713|7385983|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
6468790|NCT01246713|7385984|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
6468791|NCT01246713|7385983|FG000|STARTED|Second Acetaminophen Dosing (1 Day)||6
6468792|NCT01246713|7385984|FG001|STARTED|Second Acetaminophen Dosing (1 Day)||9
6468793|NCT01246713|7385983|FG000|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
6468794|NCT01246713|7385984|FG001|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
6468795|NCT01246713|7385983|FG000|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
6468796|NCT01246713|7385984|FG001|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
6468797|NCT01246791|7385990|FG000|STARTED|Overall Study||12
6468798|NCT01246791|7385990|FG000|COMPLETED|Overall Study||12
6468799|NCT01246791|7385990|FG000|NOT COMPLETED|Overall Study||0
6468800|NCT01246895|7385996|FG000|STARTED|Overall Study||37
6468801|NCT01246895|7385997|FG001|STARTED|Overall Study||30
6468802|NCT01246895|7385996|FG000|COMPLETED|Overall Study||34
6468803|NCT01246895|7385997|FG001|COMPLETED|Overall Study||26
6468804|NCT01246895|7385996|FG000|NOT COMPLETED|Overall Study||3
6468805|NCT01246895|7385997|FG001|NOT COMPLETED|Overall Study||4
6468806|NCT01246960|7386007|FG000|STARTED|Overall Study||84
6468807|NCT01246960|7386008|FG001|STARTED|Overall Study||84
6468808|NCT01246960|7386007|FG000|Received Any Quantity of Study Drug|Overall Study||82
6468809|NCT01246960|7386008|FG001|Received Any Quantity of Study Drug|Overall Study||80
6468810|NCT01246960|7386007|FG000|COMPLETED|Overall Study||78
6468811|NCT01246960|7386008|FG001|COMPLETED|Overall Study||80
6468812|NCT01246960|7386007|FG000|NOT COMPLETED|Overall Study||6
6468813|NCT01246960|7386008|FG001|NOT COMPLETED|Overall Study||4
6468814|NCT01246973|7386016|FG000|STARTED|Overall Study||344
6468815|NCT01246973|7386017|FG001|STARTED|Overall Study||342
6468816|NCT01246973|7386016|FG000|COMPLETED|Overall Study||283
6468817|NCT01246973|7386017|FG001|COMPLETED|Overall Study||295
6468818|NCT01246973|7386016|FG000|NOT COMPLETED|Overall Study||61
6468819|NCT01246973|7386017|FG001|NOT COMPLETED|Overall Study||47
6468820|NCT01246986|7386030|FG000|STARTED|Overall Study||37
6468821|NCT01246986|7386031|FG001|STARTED|Overall Study||72
6468822|NCT01246986|7386032|FG002|STARTED|Overall Study||40
6468823|NCT01246986|7386033|FG003|STARTED|Overall Study||3
6468824|NCT01246986|7386034|FG004|STARTED|Overall Study||44
6468825|NCT01246986|7386035|FG005|STARTED|Overall Study||3
6468826|NCT01246986|7386036|FG006|STARTED|Overall Study||5
6468827|NCT01246986|7386030|FG000|Received at Least 1 Dose of Study Drug|Overall Study||37
6468828|NCT01246986|7386031|FG001|Received at Least 1 Dose of Study Drug|Overall Study||72
6468829|NCT01246986|7386032|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
6468830|NCT01246986|7386033|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6468831|NCT01246986|7386034|FG004|Received at Least 1 Dose of Study Drug|Overall Study||44
6468832|NCT01246986|7386035|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
6468833|NCT01246986|7386036|FG006|Received at Least 1 Dose of Study Drug|Overall Study||5
6468834|NCT01246986|7386030|FG000|COMPLETED|Overall Study||34
6468835|NCT01246986|7386031|FG001|COMPLETED|Overall Study||67
6468836|NCT01246986|7386032|FG002|COMPLETED|Overall Study||34
6468837|NCT01246986|7386033|FG003|COMPLETED|Overall Study||3
6468838|NCT01246986|7386034|FG004|COMPLETED|Overall Study||40
6468839|NCT01246986|7386035|FG005|COMPLETED|Overall Study||2
6654452|NCT02445911|7584283|FG000|NOT COMPLETED|Overall Study||0
6654453|NCT02445911|7584284|FG001|NOT COMPLETED|Overall Study||0
6654454|NCT02445911|7584285|FG002|NOT COMPLETED|Overall Study||0
6654455|NCT02445911|7584286|FG003|NOT COMPLETED|Overall Study||0
6654456|NCT02445963|7584300|FG000|STARTED|Overall Study||9
6654457|NCT02445963|7584301|FG001|STARTED|Overall Study||9
6654458|NCT02445963|7584302|FG002|STARTED|Overall Study||10
6654459|NCT02445963|7584303|FG003|STARTED|Overall Study||10
6654460|NCT02445963|7584300|FG000|COMPLETED|Overall Study||7
6654461|NCT02445963|7584301|FG001|COMPLETED|Overall Study||9
6468840|NCT01246986|7386036|FG006|COMPLETED|Overall Study||5
6468841|NCT01246986|7386030|FG000|NOT COMPLETED|Overall Study||3
6468842|NCT01246986|7386031|FG001|NOT COMPLETED|Overall Study||5
6468843|NCT01246986|7386032|FG002|NOT COMPLETED|Overall Study||6
6468844|NCT01246986|7386033|FG003|NOT COMPLETED|Overall Study||0
6468845|NCT01246986|7386034|FG004|NOT COMPLETED|Overall Study||4
6468846|NCT01246986|7386035|FG005|NOT COMPLETED|Overall Study||1
6468847|NCT01246986|7386036|FG006|NOT COMPLETED|Overall Study||0
6468848|NCT01246999|7386071|FG000|STARTED|Overall Study||11
6468849|NCT01246999|7386072|FG001|STARTED|Overall Study||4
6468850|NCT01246999|7386073|FG002|STARTED|Overall Study||2
6468851|NCT01246999|7386074|FG003|STARTED|Overall Study||17
6468852|NCT01246999|7386071|FG000|COMPLETED|Overall Study||11
6654462|NCT02445963|7584302|FG002|COMPLETED|Overall Study||9
6654463|NCT02445963|7584303|FG003|COMPLETED|Overall Study||10
6654464|NCT02445963|7584300|FG000|NOT COMPLETED|Overall Study||2
6654465|NCT02445963|7584301|FG001|NOT COMPLETED|Overall Study||0
6654466|NCT02445963|7584302|FG002|NOT COMPLETED|Overall Study||1
6468853|NCT01246999|7386072|FG001|COMPLETED|Overall Study||3
6468854|NCT01246999|7386073|FG002|COMPLETED|Overall Study||2
6468855|NCT01246999|7386074|FG003|COMPLETED|Overall Study||15
6468856|NCT01246999|7386071|FG000|NOT COMPLETED|Overall Study||0
6468857|NCT01246999|7386072|FG001|NOT COMPLETED|Overall Study||1
6468858|NCT01246999|7386073|FG002|NOT COMPLETED|Overall Study||0
6468859|NCT01246999|7386074|FG003|NOT COMPLETED|Overall Study||2
6468860|NCT01247064|7386089|FG000|STARTED|Overall Study||31
6468861|NCT01247064|7386090|FG001|STARTED|Overall Study||31
6468862|NCT01247064|7386089|FG000|COMPLETED|Overall Study||31
6468863|NCT01247064|7386090|FG001|COMPLETED|Overall Study||31
6468864|NCT01247064|7386089|FG000|NOT COMPLETED|Overall Study||0
6468865|NCT01247064|7386090|FG001|NOT COMPLETED|Overall Study||0
6468866|NCT01247090|7386099|FG000|STARTED|Overall Study||4
6468867|NCT01247090|7386100|FG001|STARTED|Overall Study||4
6468868|NCT01247090|7386101|FG002|STARTED|Overall Study||4
6468869|NCT01247090|7386099|FG000|COMPLETED|Overall Study||3
6468870|NCT01247090|7386100|FG001|COMPLETED|Overall Study||3
6468871|NCT01247090|7386101|FG002|COMPLETED|Overall Study||4
6468872|NCT01247090|7386099|FG000|NOT COMPLETED|Overall Study||1
6468873|NCT01247090|7386100|FG001|NOT COMPLETED|Overall Study||1
6468874|NCT01247090|7386101|FG002|NOT COMPLETED|Overall Study||0
6468875|NCT01247220|7386111|FG000|STARTED|Overall Study||6
6468876|NCT01247220|7386112|FG001|STARTED|Overall Study||6
6468877|NCT01247220|7386111|FG000|COMPLETED|Overall Study||6
6468878|NCT01247220|7386112|FG001|COMPLETED|Overall Study||6
6468879|NCT01247220|7386111|FG000|NOT COMPLETED|Overall Study||0
6468880|NCT01247220|7386112|FG001|NOT COMPLETED|Overall Study||0
6468881|NCT01247272|7386120|FG000|STARTED|First Intervention||13
6468882|NCT01247272|7386121|FG001|STARTED|First Intervention||13
6468883|NCT01247272|7386120|FG000|COMPLETED|First Intervention||13
6468884|NCT01247272|7386121|FG001|COMPLETED|First Intervention||13
6468885|NCT01247272|7386120|FG000|NOT COMPLETED|First Intervention||0
6468886|NCT01247272|7386121|FG001|NOT COMPLETED|First Intervention||0
6468887|NCT01247272|7386120|FG000|STARTED|Washout of 28 Days||13
6468888|NCT01247272|7386121|FG001|STARTED|Washout of 28 Days||13
6468889|NCT01247272|7386120|FG000|COMPLETED|Washout of 28 Days||13
6468890|NCT01247272|7386121|FG001|COMPLETED|Washout of 28 Days||13
6468891|NCT01247272|7386120|FG000|NOT COMPLETED|Washout of 28 Days||0
6468892|NCT01247272|7386121|FG001|NOT COMPLETED|Washout of 28 Days||0
6468893|NCT01247272|7386120|FG000|STARTED|Second Intervention||13
6468894|NCT01247272|7386121|FG001|STARTED|Second Intervention||13
6468895|NCT01247272|7386120|FG000|COMPLETED|Second Intervention||13
6468896|NCT01247272|7386121|FG001|COMPLETED|Second Intervention||13
6468897|NCT01247272|7386120|FG000|NOT COMPLETED|Second Intervention||0
6468898|NCT01247272|7386121|FG001|NOT COMPLETED|Second Intervention||0
6468899|NCT01247285|7386129|FG000|STARTED|First Intervention||13
6468900|NCT01247285|7386130|FG001|STARTED|First Intervention||13
6468901|NCT01247285|7386129|FG000|COMPLETED|First Intervention||13
6468902|NCT01247285|7386130|FG001|COMPLETED|First Intervention||13
6468903|NCT01247285|7386129|FG000|NOT COMPLETED|First Intervention||0
6468904|NCT01247285|7386130|FG001|NOT COMPLETED|First Intervention||0
6468905|NCT01247285|7386129|FG000|STARTED|Washout of 28 Days||13
6468906|NCT01247285|7386130|FG001|STARTED|Washout of 28 Days||13
6468907|NCT01247285|7386129|FG000|COMPLETED|Washout of 28 Days||13
6468908|NCT01247285|7386130|FG001|COMPLETED|Washout of 28 Days||13
6468909|NCT01247285|7386129|FG000|NOT COMPLETED|Washout of 28 Days||0
6468910|NCT01247285|7386130|FG001|NOT COMPLETED|Washout of 28 Days||0
6468911|NCT01247285|7386129|FG000|STARTED|Second Intervention||13
6468912|NCT01247285|7386130|FG001|STARTED|Second Intervention||13
6468913|NCT01247285|7386129|FG000|COMPLETED|Second Intervention||13
6468914|NCT01247285|7386130|FG001|COMPLETED|Second Intervention||13
6468915|NCT01247285|7386129|FG000|NOT COMPLETED|Second Intervention||0
6468916|NCT01247285|7386130|FG001|NOT COMPLETED|Second Intervention||0
6468917|NCT01247298|7386136|FG000|STARTED|Overall Study||17
6468918|NCT01247298|7386136|FG000|COMPLETED|Overall Study||17
6468919|NCT01247298|7386136|FG000|NOT COMPLETED|Overall Study||0
6468920|NCT01247350|7386146|FG000|STARTED|Overall Study||6
6468921|NCT01247350|7386147|FG001|STARTED|Overall Study||6
6468922|NCT01247350|7386148|FG002|STARTED|Overall Study||6
6468923|NCT01247350|7386149|FG003|STARTED|Overall Study||7
6468924|NCT01247350|7386150|FG004|STARTED|Overall Study||9
6468925|NCT01247350|7386146|FG000|Received Multiple Doses of Study Drug|Overall Study||0
6468926|NCT01247350|7386147|FG001|Received Multiple Doses of Study Drug|Overall Study||0
6468927|NCT01247350|7386148|FG002|Received Multiple Doses of Study Drug|Overall Study||6
6468928|NCT01247350|7386149|FG003|Received Multiple Doses of Study Drug|Overall Study||6
6468929|NCT01247350|7386150|FG004|Received Multiple Doses of Study Drug|Overall Study||5
6468930|NCT01247350|7386146|FG000|COMPLETED|Overall Study||6
6468931|NCT01247350|7386147|FG001|COMPLETED|Overall Study||6
6468932|NCT01247350|7386148|FG002|COMPLETED|Overall Study||5
6468933|NCT01247350|7386149|FG003|COMPLETED|Overall Study||6
6468934|NCT01247350|7386150|FG004|COMPLETED|Overall Study||8
6468935|NCT01247350|7386146|FG000|NOT COMPLETED|Overall Study||0
6468936|NCT01247350|7386147|FG001|NOT COMPLETED|Overall Study||0
6468937|NCT01247350|7386148|FG002|NOT COMPLETED|Overall Study||1
6468938|NCT01247350|7386149|FG003|NOT COMPLETED|Overall Study||1
6468939|NCT01247350|7386150|FG004|NOT COMPLETED|Overall Study||1
6468940|NCT01247363|7386176|FG000|STARTED|Overall Study||20
6468941|NCT01247363|7386176|FG000|COMPLETED|Overall Study||20
6468942|NCT01247363|7386176|FG000|NOT COMPLETED|Overall Study||0
6468943|NCT01247428|7386191|FG000|STARTED|Overall Study||30
6468944|NCT01247428|7386191|FG000|COMPLETED|Overall Study||30
6468945|NCT01247428|7386191|FG000|NOT COMPLETED|Overall Study||0
6468946|NCT01247571|7386195|FG000|STARTED|Overall Study||22
6468947|NCT01247571|7386195|FG000|COMPLETED|Overall Study||19
6468948|NCT01247571|7386195|FG000|NOT COMPLETED|Overall Study||3
6468949|NCT01247675|7386203|FG000|STARTED|Overall Study||10
6468950|NCT01247675|7386204|FG001|STARTED|Overall Study||10
6468951|NCT01247675|7386205|FG002|STARTED|Overall Study||9
6468952|NCT01247675|7386206|FG003|STARTED|Overall Study||8
6468953|NCT01247675|7386203|FG000|COMPLETED|Overall Study||8
6468954|NCT01247675|7386204|FG001|COMPLETED|Overall Study||8
6468955|NCT01247675|7386205|FG002|COMPLETED|Overall Study||9
6468956|NCT01247675|7386206|FG003|COMPLETED|Overall Study||8
6468957|NCT01247675|7386203|FG000|NOT COMPLETED|Overall Study||2
6468958|NCT01247675|7386204|FG001|NOT COMPLETED|Overall Study||2
6468959|NCT01247675|7386205|FG002|NOT COMPLETED|Overall Study||0
6468960|NCT01247675|7386206|FG003|NOT COMPLETED|Overall Study||0
6468961|NCT01247922|7386218|FG000|STARTED|Overall Study||4
6468962|NCT01247922|7386218|FG000|Treated|Overall Study||4
6468963|NCT01247922|7386218|FG000|COMPLETED|Overall Study||0
6468964|NCT01247922|7386218|FG000|NOT COMPLETED|Overall Study||4
6468965|NCT01247974|7386224|FG000|STARTED|Overall Study||217
6468966|NCT01247974|7386225|FG001|STARTED|Overall Study||222
6468967|NCT01247974|7386224|FG000|COMPLETED|Overall Study||191
6468968|NCT01247974|7386225|FG001|COMPLETED|Overall Study||203
6468969|NCT01247974|7386224|FG000|NOT COMPLETED|Overall Study||26
6468970|NCT01247974|7386225|FG001|NOT COMPLETED|Overall Study||19
6468971|NCT01248013|7386231|FG000|STARTED|Overall Study||89
6468972|NCT01248013|7386231|FG000|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
6468973|NCT01248013|7386231|FG000|COMPLETED|Overall Study||75
6468974|NCT01248013|7386231|FG000|NOT COMPLETED|Overall Study||14
6468975|NCT01248065|7386237|FG000|STARTED|Overall Study||207
6468976|NCT01248065|7386238|FG001|STARTED|Overall Study||201
6468977|NCT01248065|7386237|FG000|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
6468978|NCT01248065|7386238|FG001|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
6468979|NCT01248065|7386237|FG000|NOT COMPLETED|Overall Study||26
6468980|NCT01248065|7386238|FG001|NOT COMPLETED|Overall Study||22
6468981|NCT01248104|7386246|FG000|STARTED|Overall Study||50
6468982|NCT01248104|7386247|FG001|STARTED|Overall Study||50
6468983|NCT01248104|7386246|FG000|COMPLETED|Overall Study||40
6468984|NCT01248104|7386247|FG001|COMPLETED|Overall Study||42
6468985|NCT01248104|7386246|FG000|NOT COMPLETED|Overall Study||10
6468986|NCT01248104|7386247|FG001|NOT COMPLETED|Overall Study||8
6468987|NCT01248221|7386255|FG000|STARTED|Overall Study||15
6468988|NCT01248221|7386256|FG001|STARTED|Overall Study||15
6468989|NCT01248221|7386255|FG000|COMPLETED|Overall Study||15
6468990|NCT01248221|7386256|FG001|COMPLETED|Overall Study||15
6468991|NCT01248221|7386255|FG000|NOT COMPLETED|Overall Study||0
6468992|NCT01248221|7386256|FG001|NOT COMPLETED|Overall Study||0
6468993|NCT01248364|7386268|FG000|STARTED|Overall Study||32
6468994|NCT01248364|7386269|FG001|STARTED|Overall Study||34
6468995|NCT01248364|7386270|FG002|STARTED|Overall Study||13
6468996|NCT01248364|7386271|FG003|STARTED|Overall Study||12
6468997|NCT01248364|7386268|FG000|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
6468998|NCT01248364|7386269|FG001|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
6468999|NCT01248364|7386270|FG002|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
6469000|NCT01248364|7386271|FG003|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
6469001|NCT01248364|7386268|FG000|Completed Chronic Phase:28-day Treatment|Overall Study||32
6469002|NCT01248364|7386269|FG001|Completed Chronic Phase:28-day Treatment|Overall Study||33
6469003|NCT01248364|7386270|FG002|Completed Chronic Phase:28-day Treatment|Overall Study||13
6469004|NCT01248364|7386271|FG003|Completed Chronic Phase:28-day Treatment|Overall Study||0
6469005|NCT01248364|7386268|FG000|COMPLETED|Overall Study||32
6469006|NCT01248364|7386269|FG001|COMPLETED|Overall Study||33
6469007|NCT01248364|7386270|FG002|COMPLETED|Overall Study||13
6469008|NCT01248364|7386271|FG003|COMPLETED|Overall Study||12
6469009|NCT01248364|7386268|FG000|NOT COMPLETED|Overall Study||0
6469010|NCT01248364|7386269|FG001|NOT COMPLETED|Overall Study||1
6469011|NCT01248364|7386270|FG002|NOT COMPLETED|Overall Study||0
6469012|NCT01248364|7386271|FG003|NOT COMPLETED|Overall Study||0
6469013|NCT01248416|7386284|FG000|STARTED|Overall Study||25
6469014|NCT01248416|7386285|FG001|STARTED|Overall Study||25
6469015|NCT01248416|7386286|FG002|STARTED|Overall Study||26
6469016|NCT01248416|7386284|FG000|COMPLETED|Overall Study||21
6469017|NCT01248416|7386285|FG001|COMPLETED|Overall Study||25
6469018|NCT01248416|7386286|FG002|COMPLETED|Overall Study||25
6469019|NCT01248416|7386284|FG000|NOT COMPLETED|Overall Study||4
6469020|NCT01248416|7386285|FG001|NOT COMPLETED|Overall Study||0
6469021|NCT01248416|7386286|FG002|NOT COMPLETED|Overall Study||1
6469022|NCT01248455|7386296|FG000|STARTED|Overall Study||9
6469023|NCT01248455|7386296|FG000|COMPLETED|Overall Study||8
6469024|NCT01248455|7386296|FG000|NOT COMPLETED|Overall Study||1
6469025|NCT01248468|7386303|FG000|STARTED|Overall Study||299
6469026|NCT01248468|7386304|FG001|STARTED|Overall Study||304
6469027|NCT01248468|7386305|FG002|STARTED|Overall Study||149
6469028|NCT01248468|7386303|FG000|Safety Population|Overall Study||266
6469029|NCT01248468|7386304|FG001|Safety Population|Overall Study||271
6469030|NCT01248468|7386305|FG002|Safety Population|Overall Study||133
6469031|NCT01248468|7386303|FG000|ITT Population|Overall Study||256
6469032|NCT01248468|7386304|FG001|ITT Population|Overall Study||261
6469033|NCT01248468|7386305|FG002|ITT Population|Overall Study||125
6469034|NCT01248468|7386303|FG000|COMPLETED|Overall Study||284
6469035|NCT01248468|7386304|FG001|COMPLETED|Overall Study||290
6469036|NCT01248468|7386305|FG002|COMPLETED|Overall Study||145
6469037|NCT01248468|7386303|FG000|NOT COMPLETED|Overall Study||15
6469038|NCT01248468|7386304|FG001|NOT COMPLETED|Overall Study||14
6469039|NCT01248468|7386305|FG002|NOT COMPLETED|Overall Study||4
6469040|NCT01248585|7386315|FG000|STARTED|Overall Study||148
6469041|NCT01248585|7386316|FG001|STARTED|Overall Study||150
6469042|NCT01248585|7386315|FG000|COMPLETED|Overall Study||148
6469043|NCT01248585|7386316|FG001|COMPLETED|Overall Study||150
6469044|NCT01248585|7386315|FG000|NOT COMPLETED|Overall Study||0
6469045|NCT01248585|7386316|FG001|NOT COMPLETED|Overall Study||0
6469046|NCT01248715|7386324|FG000|STARTED|Overall Study||556
6469047|NCT01248715|7386325|FG001|STARTED|Overall Study||551
6469048|NCT01248715|7386324|FG000|COMPLETED|Overall Study||55
6469049|NCT01248715|7386325|FG001|COMPLETED|Overall Study||41
6469050|NCT01248715|7386324|FG000|NOT COMPLETED|Overall Study||501
6469051|NCT01248715|7386325|FG001|NOT COMPLETED|Overall Study||510
6469052|NCT01248728|7386333|FG000|STARTED|Overall Study||19
6469053|NCT01248728|7386334|FG001|STARTED|Overall Study||19
6469054|NCT01248728|7386333|FG000|COMPLETED|Overall Study||15
6469055|NCT01248728|7386334|FG001|COMPLETED|Overall Study||17
6469056|NCT01248728|7386333|FG000|NOT COMPLETED|Overall Study||4
6469057|NCT01248728|7386334|FG001|NOT COMPLETED|Overall Study||2
6469058|NCT01248741|7386342|FG000|STARTED|Overall Study||20
6469059|NCT01248741|7386342|FG000|COMPLETED|Overall Study||20
6469060|NCT01248741|7386342|FG000|NOT COMPLETED|Overall Study||0
6469061|NCT01248780|7386348|FG000|STARTED|Overall Study||132
6469062|NCT01248780|7386349|FG001|STARTED|Overall Study||132
6469063|NCT01248780|7386348|FG000|COMPLETED|Overall Study||123
6469064|NCT01248780|7386349|FG001|COMPLETED|Overall Study||117
6469065|NCT01248780|7386348|FG000|NOT COMPLETED|Overall Study||9
6469066|NCT01248780|7386349|FG001|NOT COMPLETED|Overall Study||15
6469067|NCT01248793|7386357|FG000|STARTED|Overall Study||105
6469068|NCT01248793|7386358|FG001|STARTED|Overall Study||108
6469069|NCT01248793|7386357|FG000|COMPLETED|Overall Study||101
6469070|NCT01248793|7386358|FG001|COMPLETED|Overall Study||102
6469071|NCT01248793|7386357|FG000|NOT COMPLETED|Overall Study||4
6469072|NCT01248793|7386358|FG001|NOT COMPLETED|Overall Study||6
6469073|NCT01248884|7386367|FG000|STARTED|Overall Study||240
6469074|NCT01248884|7386368|FG001|STARTED|Overall Study||242
6469075|NCT01248884|7386369|FG002|STARTED|Overall Study||239
6469076|NCT01248884|7386367|FG000|COMPLETED|Overall Study||238
6469077|NCT01248884|7386368|FG001|COMPLETED|Overall Study||239
6469078|NCT01248884|7386369|FG002|COMPLETED|Overall Study||238
6469079|NCT01248884|7386367|FG000|NOT COMPLETED|Overall Study||2
6469080|NCT01248884|7386368|FG001|NOT COMPLETED|Overall Study||3
6469081|NCT01248884|7386369|FG002|NOT COMPLETED|Overall Study||1
6469082|NCT01248936|7386379|FG000|STARTED|Overall Study||374
6469083|NCT01248936|7386379|FG000|COMPLETED|Overall Study||0
6469084|NCT01248936|7386379|FG000|NOT COMPLETED|Overall Study||374
6469085|NCT01248949|7386389|FG000|STARTED|Overall Study||42
6469086|NCT01248949|7386390|FG001|STARTED|Overall Study||16
6469087|NCT01248949|7386391|FG002|STARTED|Overall Study||38
6469088|NCT01248949|7386392|FG003|STARTED|Overall Study||13
6469089|NCT01248949|7386393|FG004|STARTED|Overall Study||7
6469090|NCT01248949|7386389|FG000|COMPLETED|Overall Study||9
6469091|NCT01248949|7386390|FG001|COMPLETED|Overall Study||3
6469092|NCT01248949|7386391|FG002|COMPLETED|Overall Study||1
6469093|NCT01248949|7386392|FG003|COMPLETED|Overall Study||3
6469094|NCT01248949|7386393|FG004|COMPLETED|Overall Study||3
6469095|NCT01248949|7386389|FG000|NOT COMPLETED|Overall Study||33
6469096|NCT01248949|7386390|FG001|NOT COMPLETED|Overall Study||13
6469097|NCT01248949|7386391|FG002|NOT COMPLETED|Overall Study||37
6469098|NCT01248949|7386392|FG003|NOT COMPLETED|Overall Study||10
6469099|NCT01248949|7386393|FG004|NOT COMPLETED|Overall Study||4
6469100|NCT01248962|7386407|FG000|STARTED|Overall Study||74
6469101|NCT01248962|7386408|FG001|STARTED|Overall Study||72
6469102|NCT01248962|7386407|FG000|COMPLETED|Overall Study||58
6469103|NCT01248962|7386408|FG001|COMPLETED|Overall Study||56
6469104|NCT01248962|7386407|FG000|NOT COMPLETED|Overall Study||16
6469105|NCT01248962|7386408|FG001|NOT COMPLETED|Overall Study||16
6469106|NCT01249027|7386415|FG000|STARTED|1 Year Clinical Follow up||2482
6469107|NCT01249027|7386415|FG000|COMPLETED|1 Year Clinical Follow up||2391
6469108|NCT01249027|7386415|FG000|NOT COMPLETED|1 Year Clinical Follow up||91
6469109|NCT01249027|7386415|FG000|STARTED|2 Years Clinical Follow up||2391
6469110|NCT01249027|7386415|FG000|COMPLETED|2 Years Clinical Follow up||2254
6469111|NCT01249027|7386415|FG000|NOT COMPLETED|2 Years Clinical Follow up||137
6469112|NCT01249027|7386415|FG000|STARTED|3 Years Clinical Follow up||2254
6469113|NCT01249027|7386415|FG000|COMPLETED|3 Years Clinical Follow up||2223
6469114|NCT01249027|7386415|FG000|NOT COMPLETED|3 Years Clinical Follow up||31
6469115|NCT01249027|7386415|FG000|STARTED|4 Years Clinical Follow up||2223
6469116|NCT01249027|7386415|FG000|COMPLETED|4 Years Clinical Follow up||2210
6469117|NCT01249027|7386415|FG000|NOT COMPLETED|4 Years Clinical Follow up||13
6469118|NCT01249027|7386415|FG000|STARTED|5 Years Clinical Follow up||2210
6469119|NCT01249027|7386415|FG000|COMPLETED|5 Years Clinical Follow up||2142
6469120|NCT01249027|7386415|FG000|NOT COMPLETED|5 Years Clinical Follow up||68
6469121|NCT01249092|7386419|FG000|STARTED|Overall Study||20
6469122|NCT01249092|7386419|FG000|COMPLETED|Overall Study||18
6469123|NCT01249092|7386419|FG000|NOT COMPLETED|Overall Study||2
6469124|NCT01249118|7386425|FG000|STARTED|First Intervention Period||2
6469125|NCT01249118|7386426|FG001|STARTED|First Intervention Period||6
6469126|NCT01249118|7386427|FG002|STARTED|First Intervention Period||5
6469127|NCT01249118|7386425|FG000|COMPLETED|First Intervention Period||2
6469128|NCT01249118|7386426|FG001|COMPLETED|First Intervention Period||6
6469129|NCT01249118|7386427|FG002|COMPLETED|First Intervention Period||5
6469130|NCT01249118|7386425|FG000|NOT COMPLETED|First Intervention Period||0
6469131|NCT01249118|7386426|FG001|NOT COMPLETED|First Intervention Period||0
6469132|NCT01249118|7386427|FG002|NOT COMPLETED|First Intervention Period||0
6469133|NCT01249118|7386425|FG000|STARTED|First Washout Period||2
6469134|NCT01249118|7386426|FG001|STARTED|First Washout Period||6
6469135|NCT01249118|7386427|FG002|STARTED|First Washout Period||5
6469136|NCT01249118|7386425|FG000|COMPLETED|First Washout Period||2
6469137|NCT01249118|7386426|FG001|COMPLETED|First Washout Period||5
6469138|NCT01249118|7386427|FG002|COMPLETED|First Washout Period||5
6469139|NCT01249118|7386425|FG000|NOT COMPLETED|First Washout Period||0
6469140|NCT01249118|7386426|FG001|NOT COMPLETED|First Washout Period||1
6469141|NCT01249118|7386427|FG002|NOT COMPLETED|First Washout Period||0
6469142|NCT01249118|7386425|FG000|STARTED|Second Intervention Period||2
6469143|NCT01249118|7386426|FG001|STARTED|Second Intervention Period||5
6469144|NCT01249118|7386427|FG002|STARTED|Second Intervention Period||5
6469145|NCT01249118|7386425|FG000|COMPLETED|Second Intervention Period||2
6469146|NCT01249118|7386426|FG001|COMPLETED|Second Intervention Period||5
6469147|NCT01249118|7386427|FG002|COMPLETED|Second Intervention Period||5
6469148|NCT01249118|7386425|FG000|NOT COMPLETED|Second Intervention Period||0
6469149|NCT01249118|7386426|FG001|NOT COMPLETED|Second Intervention Period||0
6469150|NCT01249118|7386427|FG002|NOT COMPLETED|Second Intervention Period||0
6469151|NCT01249118|7386425|FG000|STARTED|Second Washout Period||2
6469152|NCT01249118|7386426|FG001|STARTED|Second Washout Period||5
6469153|NCT01249118|7386427|FG002|STARTED|Second Washout Period||5
6469154|NCT01249118|7386425|FG000|COMPLETED|Second Washout Period||2
6469155|NCT01249118|7386426|FG001|COMPLETED|Second Washout Period||5
6469156|NCT01249118|7386427|FG002|COMPLETED|Second Washout Period||5
6469157|NCT01249118|7386425|FG000|NOT COMPLETED|Second Washout Period||0
6469158|NCT01249118|7386426|FG001|NOT COMPLETED|Second Washout Period||0
6469159|NCT01249118|7386427|FG002|NOT COMPLETED|Second Washout Period||0
6469160|NCT01249131|7386434|FG000|STARTED|First Intervention||3
6469161|NCT01249131|7386435|FG001|STARTED|First Intervention||3
6469162|NCT01249131|7386436|FG002|STARTED|First Intervention||4
6469163|NCT01249131|7386437|FG003|STARTED|First Intervention||3
6469164|NCT01249131|7386438|FG004|STARTED|First Intervention||3
6469165|NCT01249131|7386439|FG005|STARTED|First Intervention||4
6469166|NCT01249131|7386434|FG000|COMPLETED|First Intervention||3
6469167|NCT01249131|7386435|FG001|COMPLETED|First Intervention||3
6469168|NCT01249131|7386436|FG002|COMPLETED|First Intervention||4
6469169|NCT01249131|7386437|FG003|COMPLETED|First Intervention||3
6469170|NCT01249131|7386438|FG004|COMPLETED|First Intervention||3
6469171|NCT01249131|7386439|FG005|COMPLETED|First Intervention||4
6469172|NCT01249131|7386434|FG000|NOT COMPLETED|First Intervention||0
6469173|NCT01249131|7386435|FG001|NOT COMPLETED|First Intervention||0
6469174|NCT01249131|7386436|FG002|NOT COMPLETED|First Intervention||0
6469175|NCT01249131|7386437|FG003|NOT COMPLETED|First Intervention||0
6469176|NCT01249131|7386438|FG004|NOT COMPLETED|First Intervention||0
6469177|NCT01249131|7386439|FG005|NOT COMPLETED|First Intervention||0
6469178|NCT01249131|7386434|FG000|STARTED|Washout Period of 10 Days||3
6469179|NCT01249131|7386435|FG001|STARTED|Washout Period of 10 Days||3
6469180|NCT01249131|7386436|FG002|STARTED|Washout Period of 10 Days||4
6469181|NCT01249131|7386437|FG003|STARTED|Washout Period of 10 Days||3
6469182|NCT01249131|7386438|FG004|STARTED|Washout Period of 10 Days||3
6469183|NCT01249131|7386439|FG005|STARTED|Washout Period of 10 Days||4
6469184|NCT01249131|7386434|FG000|COMPLETED|Washout Period of 10 Days||3
6469185|NCT01249131|7386435|FG001|COMPLETED|Washout Period of 10 Days||3
6469186|NCT01249131|7386436|FG002|COMPLETED|Washout Period of 10 Days||4
6469187|NCT01249131|7386437|FG003|COMPLETED|Washout Period of 10 Days||3
6469188|NCT01249131|7386438|FG004|COMPLETED|Washout Period of 10 Days||2
6469189|NCT01249131|7386439|FG005|COMPLETED|Washout Period of 10 Days||4
6469190|NCT01249131|7386434|FG000|NOT COMPLETED|Washout Period of 10 Days||0
6469191|NCT01249131|7386435|FG001|NOT COMPLETED|Washout Period of 10 Days||0
6469192|NCT01249131|7386436|FG002|NOT COMPLETED|Washout Period of 10 Days||0
6469193|NCT01249131|7386437|FG003|NOT COMPLETED|Washout Period of 10 Days||0
6469194|NCT01249131|7386438|FG004|NOT COMPLETED|Washout Period of 10 Days||1
6469195|NCT01249131|7386439|FG005|NOT COMPLETED|Washout Period of 10 Days||0
6469196|NCT01249131|7386434|FG000|STARTED|Second Intervention||3
6469197|NCT01249131|7386435|FG001|STARTED|Second Intervention||3
6469198|NCT01249131|7386436|FG002|STARTED|Second Intervention||4
6469199|NCT01249131|7386437|FG003|STARTED|Second Intervention||3
6469200|NCT01249131|7386438|FG004|STARTED|Second Intervention||2
6469201|NCT01249131|7386439|FG005|STARTED|Second Intervention||4
6469202|NCT01249131|7386434|FG000|COMPLETED|Second Intervention||3
6469203|NCT01249131|7386435|FG001|COMPLETED|Second Intervention||3
6469204|NCT01249131|7386436|FG002|COMPLETED|Second Intervention||4
6469205|NCT01249131|7386437|FG003|COMPLETED|Second Intervention||3
6469206|NCT01249131|7386438|FG004|COMPLETED|Second Intervention||2
6469207|NCT01249131|7386439|FG005|COMPLETED|Second Intervention||4
6469208|NCT01249131|7386434|FG000|NOT COMPLETED|Second Intervention||0
6469209|NCT01249131|7386435|FG001|NOT COMPLETED|Second Intervention||0
6469210|NCT01249131|7386436|FG002|NOT COMPLETED|Second Intervention||0
6469211|NCT01249131|7386437|FG003|NOT COMPLETED|Second Intervention||0
6469212|NCT01249131|7386438|FG004|NOT COMPLETED|Second Intervention||0
6469213|NCT01249131|7386439|FG005|NOT COMPLETED|Second Intervention||0
6469214|NCT01249131|7386434|FG000|STARTED|Washout Period of 10 Days||3
6469215|NCT01249131|7386435|FG001|STARTED|Washout Period of 10 Days||3
6469216|NCT01249131|7386436|FG002|STARTED|Washout Period of 10 Days||4
6469217|NCT01249131|7386437|FG003|STARTED|Washout Period of 10 Days||3
6469218|NCT01249131|7386438|FG004|STARTED|Washout Period of 10 Days||2
6469219|NCT01249131|7386439|FG005|STARTED|Washout Period of 10 Days||4
6469220|NCT01249131|7386434|FG000|COMPLETED|Washout Period of 10 Days||3
6469221|NCT01249131|7386435|FG001|COMPLETED|Washout Period of 10 Days||3
6469222|NCT01249131|7386436|FG002|COMPLETED|Washout Period of 10 Days||4
6469223|NCT01249131|7386437|FG003|COMPLETED|Washout Period of 10 Days||3
6469224|NCT01249131|7386438|FG004|COMPLETED|Washout Period of 10 Days||2
6469225|NCT01249131|7386439|FG005|COMPLETED|Washout Period of 10 Days||4
6469226|NCT01249131|7386434|FG000|NOT COMPLETED|Washout Period of 10 Days||0
6469227|NCT01249131|7386435|FG001|NOT COMPLETED|Washout Period of 10 Days||0
6469228|NCT01249131|7386436|FG002|NOT COMPLETED|Washout Period of 10 Days||0
6469229|NCT01249131|7386437|FG003|NOT COMPLETED|Washout Period of 10 Days||0
6469230|NCT01249131|7386438|FG004|NOT COMPLETED|Washout Period of 10 Days||0
6469231|NCT01249131|7386439|FG005|NOT COMPLETED|Washout Period of 10 Days||0
6469232|NCT01249131|7386434|FG000|STARTED|Third Intervention||3
6469233|NCT01249131|7386435|FG001|STARTED|Third Intervention||3
6469234|NCT01249131|7386436|FG002|STARTED|Third Intervention||4
6469235|NCT01249131|7386437|FG003|STARTED|Third Intervention||3
6469236|NCT01249131|7386438|FG004|STARTED|Third Intervention||2
6469237|NCT01249131|7386439|FG005|STARTED|Third Intervention||4
6469238|NCT01249131|7386434|FG000|COMPLETED|Third Intervention||3
6469239|NCT01249131|7386435|FG001|COMPLETED|Third Intervention||3
6469240|NCT01249131|7386436|FG002|COMPLETED|Third Intervention||4
6469241|NCT01249131|7386437|FG003|COMPLETED|Third Intervention||3
6469242|NCT01249131|7386438|FG004|COMPLETED|Third Intervention||2
6469243|NCT01249131|7386439|FG005|COMPLETED|Third Intervention||4
6469244|NCT01249131|7386434|FG000|NOT COMPLETED|Third Intervention||0
6469245|NCT01249131|7386435|FG001|NOT COMPLETED|Third Intervention||0
6469246|NCT01249131|7386436|FG002|NOT COMPLETED|Third Intervention||0
6469247|NCT01249131|7386437|FG003|NOT COMPLETED|Third Intervention||0
6469248|NCT01249131|7386438|FG004|NOT COMPLETED|Third Intervention||0
6469249|NCT01249131|7386439|FG005|NOT COMPLETED|Third Intervention||0
6469250|NCT01249261|7386449|FG000|STARTED|Overall Study||30
6469251|NCT01249261|7386450|FG001|STARTED|Overall Study||31
6469252|NCT01249261|7386449|FG000|COMPLETED|Overall Study||29
6469253|NCT01249261|7386450|FG001|COMPLETED|Overall Study||31
6469254|NCT01249261|7386449|FG000|NOT COMPLETED|Overall Study||1
6469255|NCT01249261|7386450|FG001|NOT COMPLETED|Overall Study||0
6469256|NCT01249274|7386458|FG000|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
6469257|NCT01249274|7386459|FG001|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
6469258|NCT01249274|7386458|FG000|Completed Treatment|Overall Study||21
6469259|NCT01249274|7386459|FG001|Completed Treatment|Overall Study||19
6469260|NCT01249274|7386458|FG000|Completed Treatment & Post Trial Visit|Overall Study||20
6469261|NCT01249274|7386459|FG001|Completed Treatment & Post Trial Visit|Overall Study||17
6469262|NCT01249274|7386458|FG000|Completed Post Trial Visit But Not tx|Overall Study||1
6469263|NCT01249274|7386459|FG001|Completed Post Trial Visit But Not tx|Overall Study||2
6469264|NCT01249274|7386458|FG000|COMPLETED|Overall Study||21
6469265|NCT01249274|7386459|FG001|COMPLETED|Overall Study||19
6469266|NCT01249274|7386458|FG000|NOT COMPLETED|Overall Study||4
6469267|NCT01249274|7386459|FG001|NOT COMPLETED|Overall Study||6
6469268|NCT01249365|7386467|FG000|STARTED|Overall Study||199
6469269|NCT01249365|7386467|FG000|COMPLETED|Overall Study||198
6469270|NCT01249365|7386467|FG000|NOT COMPLETED|Overall Study||1
6469271|NCT01249404|7386474|FG000|STARTED|Overall Study||127
6469272|NCT01249404|7386475|FG001|STARTED|Overall Study||129
6469273|NCT01249404|7386476|FG002|STARTED|Overall Study||132
6469274|NCT01249404|7386474|FG000|COMPLETED|Overall Study||120
6469275|NCT01249404|7386475|FG001|COMPLETED|Overall Study||121
6469276|NCT01249404|7386476|FG002|COMPLETED|Overall Study||125
6469277|NCT01249404|7386474|FG000|NOT COMPLETED|Overall Study||7
6469278|NCT01249404|7386475|FG001|NOT COMPLETED|Overall Study||8
6469279|NCT01249404|7386476|FG002|NOT COMPLETED|Overall Study||7
6469280|NCT01249417|7386487|FG000|STARTED|Randomised Population||80
6469281|NCT01249417|7386488|FG001|STARTED|Randomised Population||80
6469282|NCT01249417|7386489|FG002|STARTED|Randomised Population||81
6469283|NCT01249417|7386487|FG000|Treated|Randomised Population||80
6469284|NCT01249417|7386488|FG001|Treated|Randomised Population||80
6469285|NCT01249417|7386489|FG002|Treated|Randomised Population||79
6469286|NCT01249417|7386487|FG000|COMPLETED|Randomised Population||79
6469287|NCT01249417|7386488|FG001|COMPLETED|Randomised Population||79
6469288|NCT01249417|7386489|FG002|COMPLETED|Randomised Population||77
6469289|NCT01249417|7386487|FG000|NOT COMPLETED|Randomised Population||1
6469290|NCT01249417|7386488|FG001|NOT COMPLETED|Randomised Population||1
6469291|NCT01249417|7386489|FG002|NOT COMPLETED|Randomised Population||4
6469292|NCT01249417|7386487|FG000|STARTED|Treatment Phase - ITT Population||79
6469293|NCT01249417|7386488|FG001|STARTED|Treatment Phase - ITT Population||79
6469294|NCT01249417|7386489|FG002|STARTED|Treatment Phase - ITT Population||77
6469295|NCT01249417|7386487|FG000|COMPLETED|Treatment Phase - ITT Population||78
6469296|NCT01249417|7386488|FG001|COMPLETED|Treatment Phase - ITT Population||75
6469297|NCT01249417|7386489|FG002|COMPLETED|Treatment Phase - ITT Population||73
6469298|NCT01249417|7386487|FG000|NOT COMPLETED|Treatment Phase - ITT Population||1
6469299|NCT01249417|7386488|FG001|NOT COMPLETED|Treatment Phase - ITT Population||4
6469300|NCT01249417|7386489|FG002|NOT COMPLETED|Treatment Phase - ITT Population||4
6469301|NCT01249625|7386499|FG000|STARTED|Overall Study||1374
6469302|NCT01249625|7386500|FG001|STARTED|Overall Study||1488
6469303|NCT01249625|7386499|FG000|COMPLETED|Overall Study||1374
6469304|NCT01249625|7386500|FG001|COMPLETED|Overall Study||1488
6469305|NCT01249625|7386499|FG000|NOT COMPLETED|Overall Study||0
6469306|NCT01249625|7386500|FG001|NOT COMPLETED|Overall Study||0
6469307|NCT01249651|7386506|FG000|STARTED|Overall Study|Enrolled|101
6469308|NCT01249651|7386506|FG000|COMPLETED|Overall Study|Completed the 8-week treatment period|94
6469309|NCT01249651|7386506|FG000|NOT COMPLETED|Overall Study||7
6469310|NCT01249664|7386512|FG000|STARTED|Overall Study||91
6469311|NCT01249664|7386513|FG001|STARTED|Overall Study||31
6469312|NCT01249664|7386512|FG000|Participants Received Treatment|Overall Study|Safety population|91
6469313|NCT01249664|7386513|FG001|Participants Received Treatment|Overall Study|Safety population|31
6469314|NCT01249664|7386512|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
6469315|NCT01249664|7386513|FG001|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
6469316|NCT01249664|7386512|FG000|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
6469317|NCT01249664|7386513|FG001|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
6469318|NCT01249664|7386512|FG000|Completed 48 Weeks Treatment|Overall Study||78
6469319|NCT01249664|7386513|FG001|Completed 48 Weeks Treatment|Overall Study||24
6469320|NCT01249664|7386512|FG000|COMPLETED|Overall Study|Completers of study visits up to week 48|85
6469321|NCT01249664|7386513|FG001|COMPLETED|Overall Study|Completers of study visits up to week 48|31
6469322|NCT01249664|7386512|FG000|NOT COMPLETED|Overall Study||6
6469323|NCT01249664|7386513|FG001|NOT COMPLETED|Overall Study||0
6469324|NCT01249833|7386523|FG000|STARTED|Overall Study||59
6469325|NCT01249833|7386524|FG001|STARTED|Overall Study||63
6469326|NCT01249833|7386523|FG000|COMPLETED|Overall Study||59
6469327|NCT01249833|7386524|FG001|COMPLETED|Overall Study||62
6469328|NCT01249833|7386523|FG000|NOT COMPLETED|Overall Study||0
6469329|NCT01249833|7386524|FG001|NOT COMPLETED|Overall Study||1
6469330|NCT01249872|7386536|FG000|STARTED|Overall Study||16
6469331|NCT01249872|7386537|FG001|STARTED|Overall Study||16
6469332|NCT01249872|7386538|FG002|STARTED|Overall Study||16
6469333|NCT01249872|7386539|FG003|STARTED|Overall Study||16
6469334|NCT01249872|7386540|FG004|STARTED|Overall Study||16
6469335|NCT01249872|7386541|FG005|STARTED|Overall Study||16
6469336|NCT01249872|7386536|FG000|COMPLETED|Overall Study||16
6469337|NCT01249872|7386537|FG001|COMPLETED|Overall Study||16
6469338|NCT01249872|7386538|FG002|COMPLETED|Overall Study||16
6469339|NCT01249872|7386539|FG003|COMPLETED|Overall Study||16
6469340|NCT01249872|7386540|FG004|COMPLETED|Overall Study||16
6469341|NCT01249872|7386541|FG005|COMPLETED|Overall Study||16
6469342|NCT01249872|7386536|FG000|NOT COMPLETED|Overall Study||0
6469343|NCT01249872|7386537|FG001|NOT COMPLETED|Overall Study||0
6469344|NCT01249872|7386538|FG002|NOT COMPLETED|Overall Study||0
6469345|NCT01249872|7386539|FG003|NOT COMPLETED|Overall Study||0
6469346|NCT01249872|7386540|FG004|NOT COMPLETED|Overall Study||0
6469347|NCT01249872|7386541|FG005|NOT COMPLETED|Overall Study||0
6469348|NCT01250002|7386565|FG000|STARTED|Overall Study||35
6469349|NCT01250002|7386566|FG001|STARTED|Overall Study||35
6469350|NCT01250002|7386565|FG000|COMPLETED|Overall Study||31
6469351|NCT01250002|7386566|FG001|COMPLETED|Overall Study||32
6469352|NCT01250002|7386565|FG000|NOT COMPLETED|Overall Study||4
6469353|NCT01250002|7386566|FG001|NOT COMPLETED|Overall Study||3
6469354|NCT01250054|7386572|FG000|STARTED|Period 1, One Week of Wear||8
6469355|NCT01250054|7386573|FG001|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
6469356|NCT01250054|7386572|FG000|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
6469357|NCT01250054|7386573|FG001|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
6469358|NCT01250054|7386572|FG000|NOT COMPLETED|Period 1, One Week of Wear||0
6469359|NCT01250054|7386573|FG001|NOT COMPLETED|Period 1, One Week of Wear||0
6469360|NCT01250054|7386572|FG000|STARTED|Period 2, One Week of Wear||7
6469361|NCT01250054|7386573|FG001|STARTED|Period 2, One Week of Wear||8
6469362|NCT01250054|7386572|FG000|COMPLETED|Period 2, One Week of Wear||6
6469363|NCT01250054|7386573|FG001|COMPLETED|Period 2, One Week of Wear||8
6469364|NCT01250054|7386572|FG000|NOT COMPLETED|Period 2, One Week of Wear||1
6469365|NCT01250054|7386573|FG001|NOT COMPLETED|Period 2, One Week of Wear||0
6501016|NCT01426412|7419511|FG007|STARTED|Overall Study||10
6501017|NCT01426412|7419512|FG008|STARTED|Overall Study||17
6501018|NCT01426412|7419504|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6501019|NCT01426412|7419505|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6501020|NCT01426412|7419506|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6469366|NCT01250119|7386579|FG000|STARTED|Diagnostic Phase||688
6469367|NCT01250119|7386580|FG001|STARTED|Diagnostic Phase||0
6469368|NCT01250119|7386579|FG000|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
6469369|NCT01250119|7386580|FG001|COMPLETED|Diagnostic Phase||0
6469370|NCT01250119|7386579|FG000|NOT COMPLETED|Diagnostic Phase||113
6469371|NCT01250119|7386580|FG001|NOT COMPLETED|Diagnostic Phase||0
6469372|NCT01250119|7386579|FG000|STARTED|Treatment Phase||0
6469373|NCT01250119|7386580|FG001|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
6469374|NCT01250119|7386579|FG000|COMPLETED|Treatment Phase||0
6469375|NCT01250119|7386580|FG001|COMPLETED|Treatment Phase||0
6469376|NCT01250119|7386579|FG000|NOT COMPLETED|Treatment Phase||0
6469377|NCT01250119|7386580|FG001|NOT COMPLETED|Treatment Phase||41
6469378|NCT01250145|7386589|FG000|STARTED|Overall Study||41
6469379|NCT01250145|7386590|FG001|STARTED|Overall Study||210
6469380|NCT01250145|7386589|FG000|COMPLETED|Overall Study||39
6469381|NCT01250145|7386590|FG001|COMPLETED|Overall Study||205
6469382|NCT01250145|7386589|FG000|NOT COMPLETED|Overall Study||2
6469383|NCT01250145|7386590|FG001|NOT COMPLETED|Overall Study||5
6469384|NCT01250171|7386613|FG000|STARTED|Overall Study||26
6469385|NCT01250171|7386614|FG001|STARTED|Overall Study||22
6469386|NCT01250171|7386615|FG002|STARTED|Overall Study||24
6469387|NCT01250171|7386613|FG000|COMPLETED|Overall Study||25
6469388|NCT01250171|7386614|FG001|COMPLETED|Overall Study||22
6469389|NCT01250171|7386615|FG002|COMPLETED|Overall Study||24
6469390|NCT01250171|7386613|FG000|NOT COMPLETED|Overall Study||1
6469391|NCT01250171|7386614|FG001|NOT COMPLETED|Overall Study||0
6469392|NCT01250171|7386615|FG002|NOT COMPLETED|Overall Study||0
6469393|NCT01250184|7386626|FG000|STARTED|Overall Study||43
6469394|NCT01250184|7386627|FG001|STARTED|Overall Study||41
6469395|NCT01250184|7386628|FG002|STARTED|Overall Study||43
6469396|NCT01250184|7386626|FG000|COMPLETED|Overall Study||43
6469397|NCT01250184|7386627|FG001|COMPLETED|Overall Study||41
6469398|NCT01250184|7386628|FG002|COMPLETED|Overall Study||43
6469399|NCT01250184|7386626|FG000|NOT COMPLETED|Overall Study||0
6469400|NCT01250184|7386627|FG001|NOT COMPLETED|Overall Study||0
6469401|NCT01250184|7386628|FG002|NOT COMPLETED|Overall Study||0
6469402|NCT01250210|7386639|FG000|STARTED|Overall Study||45
6469403|NCT01250210|7386640|FG001|STARTED|Overall Study||45
6469404|NCT01250210|7386641|FG002|STARTED|Overall Study||33
6469405|NCT01250210|7386639|FG000|COMPLETED|Overall Study||41
6469406|NCT01250210|7386640|FG001|COMPLETED|Overall Study||41
6469407|NCT01250210|7386641|FG002|COMPLETED|Overall Study||25
6469408|NCT01250210|7386639|FG000|NOT COMPLETED|Overall Study||4
6469409|NCT01250210|7386640|FG001|NOT COMPLETED|Overall Study||4
6469410|NCT01250210|7386641|FG002|NOT COMPLETED|Overall Study||8
6469411|NCT01250379|7386651|FG000|STARTED|Overall Study||247
6469412|NCT01250379|7386652|FG001|STARTED|Overall Study||247
6469413|NCT01250379|7386651|FG000|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
6469414|NCT01250379|7386652|FG001|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
6469415|NCT01250379|7386651|FG000|NOT COMPLETED|Overall Study||202
6469416|NCT01250379|7386652|FG001|NOT COMPLETED|Overall Study||193
6469417|NCT01250418|7386660|FG000|STARTED|Overall Study||9
6469418|NCT01250418|7386661|FG001|STARTED|Overall Study||16
6469419|NCT01250418|7386660|FG000|COMPLETED|Overall Study||8
6469420|NCT01250418|7386661|FG001|COMPLETED|Overall Study||15
6469421|NCT01250418|7386660|FG000|NOT COMPLETED|Overall Study||1
6469422|NCT01250418|7386661|FG001|NOT COMPLETED|Overall Study||1
6469423|NCT01250509|7386669|FG000|STARTED|Overall Study||24
6469424|NCT01250509|7386670|FG001|STARTED|Overall Study||23
6469425|NCT01250509|7386669|FG000|COMPLETED|Overall Study||19
6469426|NCT01250509|7386670|FG001|COMPLETED|Overall Study||21
6469427|NCT01250509|7386669|FG000|NOT COMPLETED|Overall Study||5
6469428|NCT01250509|7386670|FG001|NOT COMPLETED|Overall Study||2
6469429|NCT01250717|7386678|FG000|STARTED|Overall Study||28
6469430|NCT01250717|7386678|FG000|COMPLETED|Overall Study||28
6469431|NCT01250717|7386678|FG000|NOT COMPLETED|Overall Study||0
6469432|NCT01250730|7386685|FG000|STARTED|Overall Study||6
6469433|NCT01250730|7386686|FG001|STARTED|Overall Study||6
6469434|NCT01250730|7386687|FG002|STARTED|Overall Study||6
6469435|NCT01250730|7386685|FG000|COMPLETED|Overall Study||6
6469436|NCT01250730|7386686|FG001|COMPLETED|Overall Study||6
6469437|NCT01250730|7386687|FG002|COMPLETED|Overall Study||6
6469438|NCT01250730|7386685|FG000|NOT COMPLETED|Overall Study||0
6469439|NCT01250730|7386686|FG001|NOT COMPLETED|Overall Study||0
6469440|NCT01250730|7386687|FG002|NOT COMPLETED|Overall Study||0
6469441|NCT01250756|7386697|FG000|STARTED|Infant Series||161
6469442|NCT01250756|7386698|FG001|STARTED|Infant Series||160
6469443|NCT01250756|7386697|FG000|Vaccinated Dose 1|Infant Series||159
6469444|NCT01250756|7386698|FG001|Vaccinated Dose 1|Infant Series||158
6469445|NCT01250756|7386697|FG000|Vaccinated Dose 2|Infant Series||147
6469446|NCT01250756|7386698|FG001|Vaccinated Dose 2|Infant Series||157
6469447|NCT01250756|7386697|FG000|Vaccinated Dose 3|Infant Series||133
6469448|NCT01250756|7386698|FG001|Vaccinated Dose 3|Infant Series||155
6469449|NCT01250756|7386697|FG000|COMPLETED|Infant Series||133
6469450|NCT01250756|7386698|FG001|COMPLETED|Infant Series||153
6469451|NCT01250756|7386697|FG000|NOT COMPLETED|Infant Series||28
6469452|NCT01250756|7386698|FG001|NOT COMPLETED|Infant Series||7
6469453|NCT01250756|7386697|FG000|STARTED|After Infant Series||133
6469454|NCT01250756|7386698|FG001|STARTED|After Infant Series||153
6469455|NCT01250756|7386697|FG000|COMPLETED|After Infant Series||122
6469456|NCT01250756|7386698|FG001|COMPLETED|After Infant Series||149
6469457|NCT01250756|7386697|FG000|NOT COMPLETED|After Infant Series||11
6469458|NCT01250756|7386698|FG001|NOT COMPLETED|After Infant Series||4
6469459|NCT01250756|7386697|FG000|STARTED|Toddler Dose||122
6554291|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Washout Period 3||0
6554292|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Washout Period 3||6
6554293|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Washout Period 3||6
6554294|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Washout Period 3||6
6554295|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Washout Period 3||6
6554296|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Washout Period 3||6
6469460|NCT01250756|7386698|FG001|STARTED|Toddler Dose||149
6469461|NCT01250756|7386697|FG000|COMPLETED|Toddler Dose||122
6469462|NCT01250756|7386698|FG001|COMPLETED|Toddler Dose||148
6469463|NCT01250756|7386697|FG000|NOT COMPLETED|Toddler Dose||0
6469464|NCT01250756|7386698|FG001|NOT COMPLETED|Toddler Dose||1
6469465|NCT01250756|7386697|FG000|STARTED|After Toddler Dose||0
6469466|NCT01250756|7386698|FG001|STARTED|After Toddler Dose||148
6469467|NCT01250756|7386697|FG000|COMPLETED|After Toddler Dose||0
6469468|NCT01250756|7386698|FG001|COMPLETED|After Toddler Dose||147
6469469|NCT01250756|7386697|FG000|NOT COMPLETED|After Toddler Dose||0
6469470|NCT01250756|7386698|FG001|NOT COMPLETED|After Toddler Dose||1
6469471|NCT01250769|7386714|FG000|STARTED|Overall Study||11
6469472|NCT01250769|7386715|FG001|STARTED|Overall Study||73
6469473|NCT01250769|7386716|FG002|STARTED|Overall Study||75
6469474|NCT01250769|7386717|FG003|STARTED|Overall Study||11
6469475|NCT01250769|7386714|FG000|Day 14|Overall Study||11
6469476|NCT01250769|7386715|FG001|Day 14|Overall Study||72
6469477|NCT01250769|7386716|FG002|Day 14|Overall Study||74
6469478|NCT01250769|7386717|FG003|Day 14|Overall Study||11
6469479|NCT01250769|7386714|FG000|COMPLETED|Overall Study||11
6469480|NCT01250769|7386715|FG001|COMPLETED|Overall Study||72
6469481|NCT01250769|7386716|FG002|COMPLETED|Overall Study||73
6469482|NCT01250769|7386717|FG003|COMPLETED|Overall Study||11
6469483|NCT01250769|7386714|FG000|NOT COMPLETED|Overall Study||0
6469484|NCT01250769|7386715|FG001|NOT COMPLETED|Overall Study||1
6469485|NCT01250769|7386716|FG002|NOT COMPLETED|Overall Study||2
6469486|NCT01250769|7386717|FG003|NOT COMPLETED|Overall Study||0
6469487|NCT01250834|7386727|FG000|STARTED|Overall Study||27
6469488|NCT01250834|7386727|FG000|COMPLETED|Overall Study||27
6469489|NCT01250834|7386727|FG000|NOT COMPLETED|Overall Study||0
6469490|NCT01250873|7386734|FG000|STARTED|Period 1: LY2216684 (Days 1-3)||20
6469491|NCT01250873|7386734|FG000|COMPLETED|Period 1: LY2216684 (Days 1-3)||18
6469492|NCT01250873|7386734|FG000|NOT COMPLETED|Period 1: LY2216684 (Days 1-3)||2
6469493|NCT01250873|7386734|FG000|STARTED|Period 2: Sertraline (Day 4, 5-10)||18
6469494|NCT01250873|7386734|FG000|COMPLETED|Period 2: Sertraline (Day 4, 5-10)||18
6469495|NCT01250873|7386734|FG000|NOT COMPLETED|Period 2: Sertraline (Day 4, 5-10)||0
6469496|NCT01250873|7386734|FG000|STARTED|Period 3:LY2216684+Sertraline(Days11-13)||18
6469497|NCT01250873|7386734|FG000|COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||17
6469498|NCT01250873|7386734|FG000|NOT COMPLETED|Period 3:LY2216684+Sertraline(Days11-13)||1
6469499|NCT01250899|7386742|FG000|STARTED|Overall Study||40
6469500|NCT01250899|7386743|FG001|STARTED|Overall Study||82
6469501|NCT01250899|7386742|FG000|COMPLETED|Overall Study||40
6469502|NCT01250899|7386743|FG001|COMPLETED|Overall Study||82
6469503|NCT01250899|7386742|FG000|NOT COMPLETED|Overall Study||0
6469504|NCT01250899|7386743|FG001|NOT COMPLETED|Overall Study||0
6469505|NCT01250925|7386750|FG000|STARTED|Overall Study||31
6469506|NCT01250925|7386751|FG001|STARTED|Overall Study||31
6469507|NCT01250925|7386752|FG002|STARTED|Overall Study||32
6469508|NCT01250925|7386750|FG000|COMPLETED|Overall Study||26
6469509|NCT01250925|7386751|FG001|COMPLETED|Overall Study||28
6469510|NCT01250925|7386752|FG002|COMPLETED|Overall Study||30
6469511|NCT01250925|7386750|FG000|NOT COMPLETED|Overall Study||5
6469512|NCT01250925|7386751|FG001|NOT COMPLETED|Overall Study||3
6469513|NCT01250925|7386752|FG002|NOT COMPLETED|Overall Study||2
6469514|NCT01250977|7386762|FG000|STARTED|Overall Study||6
6469515|NCT01250977|7386763|FG001|STARTED|Overall Study||14
6469516|NCT01250977|7386762|FG000|COMPLETED|Overall Study||6
6469517|NCT01250977|7386763|FG001|COMPLETED|Overall Study||12
6469518|NCT01250977|7386762|FG000|NOT COMPLETED|Overall Study||0
6469519|NCT01250977|7386763|FG001|NOT COMPLETED|Overall Study||2
6469520|NCT01250990|7386771|FG000|STARTED|Overall Study||11
6469521|NCT01250990|7386772|FG001|STARTED|Overall Study||11
6469522|NCT01250990|7386771|FG000|COMPLETED|Overall Study||7
6469523|NCT01250990|7386772|FG001|COMPLETED|Overall Study||9
6469524|NCT01250990|7386771|FG000|NOT COMPLETED|Overall Study||4
6469525|NCT01250990|7386772|FG001|NOT COMPLETED|Overall Study||2
6469526|NCT01251042|7386780|FG000|STARTED|Overall Study||26
6469527|NCT01251042|7386781|FG001|STARTED|Overall Study||23
6469528|NCT01251042|7386780|FG000|COMPLETED|Overall Study||26
6469529|NCT01251042|7386781|FG001|COMPLETED|Overall Study||23
6469530|NCT01251042|7386780|FG000|NOT COMPLETED|Overall Study||0
6469531|NCT01251042|7386781|FG001|NOT COMPLETED|Overall Study||0
6469532|NCT01251146|7386789|FG000|STARTED|Overall Study||86
6469533|NCT01251146|7386790|FG001|STARTED|Overall Study||91
6469534|NCT01251146|7386789|FG000|COMPLETED|Overall Study||83
6469535|NCT01251146|7386790|FG001|COMPLETED|Overall Study||81
6469536|NCT01251146|7386789|FG000|NOT COMPLETED|Overall Study||3
6469537|NCT01251146|7386790|FG001|NOT COMPLETED|Overall Study||10
6469538|NCT01251276|7386798|FG000|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
6469539|NCT01251276|7386799|FG001|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
6469540|NCT01251276|7386798|FG000|Vaccinated|Overall Study||96
6469541|NCT01251276|7386799|FG001|Vaccinated|Overall Study||108
6469542|NCT01251276|7386798|FG000|COMPLETED|Overall Study||95
6469543|NCT01251276|7386799|FG001|COMPLETED|Overall Study||107
6469544|NCT01251276|7386798|FG000|NOT COMPLETED|Overall Study||1
6469545|NCT01251276|7386799|FG001|NOT COMPLETED|Overall Study||1
6469546|NCT01251315|7386811|FG000|STARTED|Overall Study||4
6469547|NCT01251315|7386812|FG001|STARTED|Overall Study||4
6469548|NCT01251315|7386813|FG002|STARTED|Overall Study||4
6469549|NCT01251315|7386814|FG003|STARTED|Overall Study||4
6746754|NCT03377634|7674422|FG000|COMPLETED|Study Period||13
6746755|NCT03377634|7674423|FG001|COMPLETED|Study Period||13
6746756|NCT03377634|7674422|FG000|NOT COMPLETED|Study Period||2
6746757|NCT03377634|7674423|FG001|NOT COMPLETED|Study Period||0
6746758|NCT03378076|7674431|FG000|STARTED|Overall Study||12
6746759|NCT03378076|7674432|FG001|STARTED|Overall Study||12
6746760|NCT03378076|7674431|FG000|COMPLETED|Overall Study||12
6746761|NCT03378076|7674432|FG001|COMPLETED|Overall Study||12
6469550|NCT01251315|7386815|FG004|STARTED|Overall Study||4
6469551|NCT01251315|7386816|FG005|STARTED|Overall Study||4
6469552|NCT01251315|7386811|FG000|COMPLETED|Overall Study||4
6469553|NCT01251315|7386812|FG001|COMPLETED|Overall Study||4
6469554|NCT01251315|7386813|FG002|COMPLETED|Overall Study||4
6469555|NCT01251315|7386814|FG003|COMPLETED|Overall Study||4
6469556|NCT01251315|7386815|FG004|COMPLETED|Overall Study||4
6469557|NCT01251315|7386816|FG005|COMPLETED|Overall Study||4
6469558|NCT01251315|7386811|FG000|NOT COMPLETED|Overall Study||0
6469559|NCT01251315|7386812|FG001|NOT COMPLETED|Overall Study||0
6469560|NCT01251315|7386813|FG002|NOT COMPLETED|Overall Study||0
6469561|NCT01251315|7386814|FG003|NOT COMPLETED|Overall Study||0
6469562|NCT01251315|7386815|FG004|NOT COMPLETED|Overall Study||0
6469563|NCT01251315|7386816|FG005|NOT COMPLETED|Overall Study||0
6469564|NCT01251354|7386834|FG000|STARTED|Overall Study||6
6469565|NCT01251354|7386834|FG000|COMPLETED|Overall Study||0
6469566|NCT01251354|7386834|FG000|NOT COMPLETED|Overall Study||6
6469567|NCT01251367|7386838|FG000|STARTED|Overall Study||345
6469568|NCT01251367|7386838|FG000|Cycle 1|Overall Study||345
6469569|NCT01251367|7386838|FG000|Cycle 2|Overall Study||297
6469570|NCT01251367|7386838|FG000|Cycle 3|Overall Study||224
6469571|NCT01251367|7386838|FG000|Cycle 4|Overall Study||139
6469572|NCT01251367|7386838|FG000|COMPLETED|Overall Study||269
6469573|NCT01251367|7386838|FG000|NOT COMPLETED|Overall Study||76
6469574|NCT01251380|7386842|FG000|STARTED|Overall Study|Safety population.|216
6469575|NCT01251380|7386842|FG000|Cycle 1|Overall Study||207
6469576|NCT01251380|7386842|FG000|Cycle 2|Overall Study||175
6469577|NCT01251380|7386842|FG000|Cycle 3|Overall Study||86
6469578|NCT01251380|7386842|FG000|Cycle 4|Overall Study||11
6469579|NCT01251380|7386842|FG000|COMPLETED|Overall Study||194
6469580|NCT01251380|7386842|FG000|NOT COMPLETED|Overall Study||22
6469581|NCT01251393|7386853|FG000|STARTED|Overall Study||56
6469582|NCT01251393|7386854|FG001|STARTED|Overall Study||55
6469583|NCT01251393|7386853|FG000|COMPLETED|Overall Study||24
6469584|NCT01251393|7386854|FG001|COMPLETED|Overall Study||11
6469585|NCT01251393|7386853|FG000|NOT COMPLETED|Overall Study||32
6469586|NCT01251393|7386854|FG001|NOT COMPLETED|Overall Study||44
6469587|NCT01251536|7386863|FG000|STARTED|Overall Study||8
6469588|NCT01251536|7386864|FG001|STARTED|Overall Study||93
6469589|NCT01251536|7386865|FG002|STARTED|Overall Study||7
6469590|NCT01251536|7386863|FG000|COMPLETED|Overall Study||8
6469591|NCT01251536|7386864|FG001|COMPLETED|Overall Study||93
6469592|NCT01251536|7386865|FG002|COMPLETED|Overall Study||7
6469593|NCT01251536|7386863|FG000|NOT COMPLETED|Overall Study||0
6469594|NCT01251536|7386864|FG001|NOT COMPLETED|Overall Study||0
6469595|NCT01251536|7386865|FG002|NOT COMPLETED|Overall Study||0
6469596|NCT01251575|7386875|FG000|STARTED|Overall Study||77
6469597|NCT01251575|7386875|FG000|COMPLETED|Overall Study||76
6469598|NCT01251575|7386875|FG000|NOT COMPLETED|Overall Study||1
6469599|NCT01251588|7386883|FG000|STARTED|Overall Study||65
6469600|NCT01251588|7386884|FG001|STARTED|Overall Study||63
6469601|NCT01251588|7386883|FG000|COMPLETED|Overall Study||65
6469602|NCT01251588|7386884|FG001|COMPLETED|Overall Study||59
6469603|NCT01251588|7386883|FG000|NOT COMPLETED|Overall Study||0
6469604|NCT01251588|7386884|FG001|NOT COMPLETED|Overall Study||4
6469605|NCT01251614|7386895|FG000|STARTED|Overall Study||37
6469606|NCT01251614|7386896|FG001|STARTED|Overall Study||39
6469607|NCT01251614|7386897|FG002|STARTED|Overall Study||38
6469608|NCT01251614|7386895|FG000|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
6469609|NCT01251614|7386896|FG001|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
6469610|NCT01251614|7386897|FG002|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
6469611|NCT01251614|7386895|FG000|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
6469612|NCT01251614|7386896|FG001|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
6501021|NCT01426412|7419507|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6746762|NCT03378076|7674431|FG000|NOT COMPLETED|Overall Study||0
6554297|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Washout Period 3||7
6554298|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
6554299|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
6554300|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
6554301|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
6554302|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Washout Period 3||6
6554303|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Washout Period 3||6
6554304|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Washout Period 3||6
6469613|NCT01251614|7386897|FG002|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
6469614|NCT01251614|7386895|FG000|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
6469615|NCT01251614|7386896|FG001|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
6469616|NCT01251614|7386897|FG002|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
6469617|NCT01251614|7386895|FG000|COMPLETED|Overall Study||34
6469618|NCT01251614|7386896|FG001|COMPLETED|Overall Study||26
6469619|NCT01251614|7386897|FG002|COMPLETED|Overall Study||30
6469620|NCT01251614|7386895|FG000|NOT COMPLETED|Overall Study||3
6469621|NCT01251614|7386896|FG001|NOT COMPLETED|Overall Study||13
6469622|NCT01251614|7386897|FG002|NOT COMPLETED|Overall Study||8
6469623|NCT01251653|7386924|FG000|STARTED|Overall Study||3
6469624|NCT01251653|7386925|FG001|STARTED|Overall Study||8
6469625|NCT01251653|7386926|FG002|STARTED|Overall Study||20
6469626|NCT01251653|7386927|FG003|STARTED|Overall Study||6
6469627|NCT01251653|7386928|FG004|STARTED|Overall Study||2
6469628|NCT01251653|7386929|FG005|STARTED|Overall Study||18
6469629|NCT01251653|7386930|FG006|STARTED|Overall Study||18
6469630|NCT01251653|7386931|FG007|STARTED|Overall Study||12
6469631|NCT01251653|7386932|FG008|STARTED|Overall Study||6
6469632|NCT01251653|7386924|FG000|COMPLETED|Overall Study||0
6469633|NCT01251653|7386925|FG001|COMPLETED|Overall Study||0
6469634|NCT01251653|7386926|FG002|COMPLETED|Overall Study||0
6469635|NCT01251653|7386927|FG003|COMPLETED|Overall Study||0
6469636|NCT01251653|7386928|FG004|COMPLETED|Overall Study||0
6469637|NCT01251653|7386929|FG005|COMPLETED|Overall Study||0
6469638|NCT01251653|7386930|FG006|COMPLETED|Overall Study||0
6469639|NCT01251653|7386931|FG007|COMPLETED|Overall Study||0
6469640|NCT01251653|7386932|FG008|COMPLETED|Overall Study||0
6469641|NCT01251653|7386924|FG000|NOT COMPLETED|Overall Study||3
6469642|NCT01251653|7386925|FG001|NOT COMPLETED|Overall Study||8
6469643|NCT01251653|7386926|FG002|NOT COMPLETED|Overall Study||20
6469644|NCT01251653|7386927|FG003|NOT COMPLETED|Overall Study||6
6469645|NCT01251653|7386928|FG004|NOT COMPLETED|Overall Study||2
6469646|NCT01251653|7386929|FG005|NOT COMPLETED|Overall Study||18
6469647|NCT01251653|7386930|FG006|NOT COMPLETED|Overall Study||18
6469648|NCT01251653|7386931|FG007|NOT COMPLETED|Overall Study||12
6469649|NCT01251653|7386932|FG008|NOT COMPLETED|Overall Study||6
6469650|NCT01251744|7386970|FG000|STARTED|Overall Study||77
6469651|NCT01251744|7386971|FG001|STARTED|Overall Study||78
6469652|NCT01251744|7386970|FG000|COMPLETED|Overall Study||76
6469653|NCT01251744|7386971|FG001|COMPLETED|Overall Study||78
6469654|NCT01251744|7386970|FG000|NOT COMPLETED|Overall Study||1
6469655|NCT01251744|7386971|FG001|NOT COMPLETED|Overall Study||0
6469656|NCT01251757|7386987|FG000|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
6469657|NCT01251757|7386988|FG001|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
6469658|NCT01251757|7386989|FG002|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
6469659|NCT01251757|7386987|FG000|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
6469660|NCT01251757|7386988|FG001|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
6469661|NCT01251757|7386989|FG002|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
6469662|NCT01251757|7386987|FG000|NOT COMPLETED|Overall Study||0
6469663|NCT01251757|7386988|FG001|NOT COMPLETED|Overall Study||0
6469664|NCT01251757|7386989|FG002|NOT COMPLETED|Overall Study||0
6469665|NCT01251770|7387003|FG000|STARTED|Overall Study||42
6469666|NCT01251770|7387004|FG001|STARTED|Overall Study||36
6469667|NCT01251770|7387003|FG000|COMPLETED|Overall Study||29
6469668|NCT01251770|7387004|FG001|COMPLETED|Overall Study||29
6469669|NCT01251770|7387003|FG000|NOT COMPLETED|Overall Study||13
6469670|NCT01251770|7387004|FG001|NOT COMPLETED|Overall Study||7
6469671|NCT01251887|7387013|FG000|STARTED|Overall Study||18
6469672|NCT01251887|7387014|FG001|STARTED|Overall Study||29
6469673|NCT01251887|7387015|FG002|STARTED|Overall Study||18
6469674|NCT01251887|7387013|FG000|COMPLETED|Overall Study||17
6469675|NCT01251887|7387014|FG001|COMPLETED|Overall Study||26
6469676|NCT01251887|7387015|FG002|COMPLETED|Overall Study||16
6469677|NCT01251887|7387013|FG000|NOT COMPLETED|Overall Study||1
6469678|NCT01251887|7387014|FG001|NOT COMPLETED|Overall Study||3
6469679|NCT01251887|7387015|FG002|NOT COMPLETED|Overall Study||2
6469680|NCT01251965|7387026|FG000|STARTED|Overall Study||4
6469681|NCT01251965|7387027|FG001|STARTED|Overall Study||5
6469682|NCT01251965|7387028|FG002|STARTED|Overall Study||18
6469683|NCT01251965|7387026|FG000|COMPLETED|Overall Study||3
6469684|NCT01251965|7387027|FG001|COMPLETED|Overall Study||3
6554305|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Washout Period 3||6
6469685|NCT01251965|7387028|FG002|COMPLETED|Overall Study||7
6469686|NCT01251965|7387026|FG000|NOT COMPLETED|Overall Study||1
6469687|NCT01251965|7387027|FG001|NOT COMPLETED|Overall Study||2
6469688|NCT01251965|7387028|FG002|NOT COMPLETED|Overall Study||11
6469689|NCT01251978|7387039|FG000|STARTED|Overall Study||5
6469690|NCT01251978|7387040|FG001|STARTED|Overall Study||3
6469691|NCT01251978|7387039|FG000|COMPLETED|Overall Study||5
6469692|NCT01251978|7387040|FG001|COMPLETED|Overall Study||3
6469693|NCT01251978|7387039|FG000|NOT COMPLETED|Overall Study||0
6469694|NCT01251978|7387040|FG001|NOT COMPLETED|Overall Study||0
6469695|NCT01252095|7387048|FG000|STARTED|Overall Study||3
6469696|NCT01252095|7387049|FG001|STARTED|Overall Study||1
6469697|NCT01252095|7387048|FG000|COMPLETED|Overall Study||2
6469698|NCT01252095|7387049|FG001|COMPLETED|Overall Study||1
6469699|NCT01252095|7387048|FG000|NOT COMPLETED|Overall Study||1
6469700|NCT01252095|7387049|FG001|NOT COMPLETED|Overall Study||0
6469701|NCT01252134|7387055|FG000|STARTED|Period 1, 8 Hours||3
6469702|NCT01252134|7387056|FG001|STARTED|Period 1, 8 Hours||4
6469703|NCT01252134|7387057|FG002|STARTED|Period 1, 8 Hours||3
6469704|NCT01252134|7387058|FG003|STARTED|Period 1, 8 Hours||5
6469705|NCT01252134|7387059|FG004|STARTED|Period 1, 8 Hours||3
6469706|NCT01252134|7387060|FG005|STARTED|Period 1, 8 Hours||4
6469707|NCT01252134|7387055|FG000|COMPLETED|Period 1, 8 Hours||3
6469708|NCT01252134|7387056|FG001|COMPLETED|Period 1, 8 Hours||3
6469709|NCT01252134|7387057|FG002|COMPLETED|Period 1, 8 Hours||2
6469710|NCT01252134|7387058|FG003|COMPLETED|Period 1, 8 Hours||5
6469711|NCT01252134|7387059|FG004|COMPLETED|Period 1, 8 Hours||3
6469712|NCT01252134|7387060|FG005|COMPLETED|Period 1, 8 Hours||4
6469713|NCT01252134|7387055|FG000|NOT COMPLETED|Period 1, 8 Hours||0
6469714|NCT01252134|7387056|FG001|NOT COMPLETED|Period 1, 8 Hours||1
6469715|NCT01252134|7387057|FG002|NOT COMPLETED|Period 1, 8 Hours||1
6469716|NCT01252134|7387058|FG003|NOT COMPLETED|Period 1, 8 Hours||0
6469717|NCT01252134|7387059|FG004|NOT COMPLETED|Period 1, 8 Hours||0
6469718|NCT01252134|7387060|FG005|NOT COMPLETED|Period 1, 8 Hours||0
6469719|NCT01252134|7387055|FG000|STARTED|Period 2, 8 Hours||3
6469720|NCT01252134|7387056|FG001|STARTED|Period 2, 8 Hours||3
6469721|NCT01252134|7387057|FG002|STARTED|Period 2, 8 Hours||2
6469722|NCT01252134|7387058|FG003|STARTED|Period 2, 8 Hours||5
6469723|NCT01252134|7387059|FG004|STARTED|Period 2, 8 Hours||3
6469724|NCT01252134|7387060|FG005|STARTED|Period 2, 8 Hours||4
6469725|NCT01252134|7387055|FG000|COMPLETED|Period 2, 8 Hours||3
6469726|NCT01252134|7387056|FG001|COMPLETED|Period 2, 8 Hours||3
6469727|NCT01252134|7387057|FG002|COMPLETED|Period 2, 8 Hours||2
6469728|NCT01252134|7387058|FG003|COMPLETED|Period 2, 8 Hours||5
6469729|NCT01252134|7387059|FG004|COMPLETED|Period 2, 8 Hours||3
6469730|NCT01252134|7387060|FG005|COMPLETED|Period 2, 8 Hours||4
6469731|NCT01252134|7387055|FG000|NOT COMPLETED|Period 2, 8 Hours||0
6469732|NCT01252134|7387056|FG001|NOT COMPLETED|Period 2, 8 Hours||0
6469733|NCT01252134|7387057|FG002|NOT COMPLETED|Period 2, 8 Hours||0
6469734|NCT01252134|7387058|FG003|NOT COMPLETED|Period 2, 8 Hours||0
6469735|NCT01252134|7387059|FG004|NOT COMPLETED|Period 2, 8 Hours||0
6469736|NCT01252134|7387060|FG005|NOT COMPLETED|Period 2, 8 Hours||0
6469737|NCT01252134|7387055|FG000|STARTED|Period 3, 8 Hours||3
6469738|NCT01252134|7387056|FG001|STARTED|Period 3, 8 Hours||3
6469739|NCT01252134|7387057|FG002|STARTED|Period 3, 8 Hours||2
6469740|NCT01252134|7387058|FG003|STARTED|Period 3, 8 Hours||5
6469741|NCT01252134|7387059|FG004|STARTED|Period 3, 8 Hours||3
6469742|NCT01252134|7387060|FG005|STARTED|Period 3, 8 Hours||4
6469743|NCT01252134|7387055|FG000|COMPLETED|Period 3, 8 Hours||3
6469744|NCT01252134|7387056|FG001|COMPLETED|Period 3, 8 Hours||3
6469745|NCT01252134|7387057|FG002|COMPLETED|Period 3, 8 Hours||2
6469746|NCT01252134|7387058|FG003|COMPLETED|Period 3, 8 Hours||5
6469747|NCT01252134|7387059|FG004|COMPLETED|Period 3, 8 Hours||3
6469748|NCT01252134|7387060|FG005|COMPLETED|Period 3, 8 Hours||4
6469749|NCT01252134|7387055|FG000|NOT COMPLETED|Period 3, 8 Hours||0
6469750|NCT01252134|7387056|FG001|NOT COMPLETED|Period 3, 8 Hours||0
6469751|NCT01252134|7387057|FG002|NOT COMPLETED|Period 3, 8 Hours||0
6469752|NCT01252134|7387058|FG003|NOT COMPLETED|Period 3, 8 Hours||0
6469753|NCT01252134|7387059|FG004|NOT COMPLETED|Period 3, 8 Hours||0
6469754|NCT01252134|7387060|FG005|NOT COMPLETED|Period 3, 8 Hours||0
6469755|NCT01252147|7387068|FG000|STARTED|Overall Study||68
6469756|NCT01252147|7387068|FG000|COMPLETED|Overall Study||68
6469757|NCT01252147|7387068|FG000|NOT COMPLETED|Overall Study||0
6554306|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Washout Period 3||7
6554307|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6469758|NCT01252186|7387075|FG000|STARTED|Overall Study||87
6469759|NCT01252186|7387076|FG001|STARTED|Overall Study||91
6469760|NCT01252186|7387077|FG002|STARTED|Overall Study||87
6469761|NCT01252186|7387075|FG000|Received Study Drug|Overall Study||83
6469762|NCT01252186|7387076|FG001|Received Study Drug|Overall Study||89
6469763|NCT01252186|7387077|FG002|Received Study Drug|Overall Study||80
6469764|NCT01252186|7387075|FG000|COMPLETED|Overall Study||57
6554308|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6469765|NCT01252186|7387076|FG001|COMPLETED|Overall Study||59
6469766|NCT01252186|7387077|FG002|COMPLETED|Overall Study||53
6469767|NCT01252186|7387075|FG000|NOT COMPLETED|Overall Study||30
6469768|NCT01252186|7387076|FG001|NOT COMPLETED|Overall Study||32
6469769|NCT01252186|7387077|FG002|NOT COMPLETED|Overall Study||34
6469770|NCT01252238|7387088|FG000|STARTED|Overall Study||8
6469771|NCT01252238|7387089|FG001|STARTED|Overall Study||8
6469772|NCT01252238|7387090|FG002|STARTED|Overall Study||8
6469773|NCT01252238|7387088|FG000|COMPLETED|Overall Study|sponsor terminated study|4
6469774|NCT01252238|7387089|FG001|COMPLETED|Overall Study|sponsor terminated study|4
6469775|NCT01252238|7387090|FG002|COMPLETED|Overall Study|sponsor terminated study|4
6469776|NCT01252238|7387088|FG000|NOT COMPLETED|Overall Study||4
6469777|NCT01252238|7387089|FG001|NOT COMPLETED|Overall Study||4
6469778|NCT01252238|7387090|FG002|NOT COMPLETED|Overall Study||4
6554309|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6554310|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6554311|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6554312|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6554313|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6554314|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6554315|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6554316|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Fourth Intervention||0
6554317|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Fourth Intervention||0
6554318|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Fourth Intervention||0
6554319|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Fourth Intervention||6
6554320|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Fourth Intervention||6
6554321|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Fourth Intervention||6
6554322|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Fourth Intervention||6
6554323|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Fourth Intervention||6
6554324|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Fourth Intervention||7
6554325|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
6554326|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
6554327|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
6554328|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Fourth Intervention||5
6554329|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Fourth Intervention||6
6469779|NCT01252251|7387101|FG000|STARTED|Overall Study||14
6469780|NCT01252251|7387101|FG000|COMPLETED|Overall Study||13
6469781|NCT01252251|7387101|FG000|NOT COMPLETED|Overall Study||1
6469782|NCT01252277|7387105|FG000|STARTED|Overall Study||36
6469783|NCT01252277|7387105|FG000|COMPLETED|Overall Study||34
6469784|NCT01252277|7387105|FG000|NOT COMPLETED|Overall Study||2
6469785|NCT01252290|7387110|FG000|STARTED|Overall Study||35
6469786|NCT01252290|7387110|FG000|COMPLETED|Overall Study||34
6469787|NCT01252290|7387110|FG000|NOT COMPLETED|Overall Study||1
6469788|NCT01252355|7387117|FG000|STARTED|Overall Study|Randomized.|177
6469789|NCT01252355|7387118|FG001|STARTED|Overall Study|Randomized.|178
6469790|NCT01252355|7387119|FG002|STARTED|Overall Study|Randomized.|179
6469791|NCT01252355|7387117|FG000|Treated|Overall Study||175
6469792|NCT01252355|7387118|FG001|Treated|Overall Study||178
6469793|NCT01252355|7387119|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
6469794|NCT01252355|7387117|FG000|COMPLETED|Overall Study||0
6469795|NCT01252355|7387118|FG001|COMPLETED|Overall Study||0
6469796|NCT01252355|7387119|FG002|COMPLETED|Overall Study||0
6469797|NCT01252355|7387117|FG000|NOT COMPLETED|Overall Study||177
6469798|NCT01252355|7387118|FG001|NOT COMPLETED|Overall Study||178
6469799|NCT01252355|7387119|FG002|NOT COMPLETED|Overall Study||179
6469800|NCT01252563|7387127|FG000|STARTED|Overall Study||13775
6469801|NCT01252563|7387127|FG000|COMPLETED|Overall Study||13343
6469802|NCT01252563|7387127|FG000|NOT COMPLETED|Overall Study||432
6469803|NCT01252667|7387168|FG000|STARTED|Overall Study||3
6469804|NCT01252667|7387169|FG001|STARTED|Overall Study||3
6469805|NCT01252667|7387170|FG002|STARTED|Overall Study||3
6469806|NCT01252667|7387171|FG003|STARTED|Overall Study||0
6469807|NCT01252667|7387172|FG004|STARTED|Overall Study||0
6469808|NCT01252667|7387173|FG005|STARTED|Overall Study||35
6469809|NCT01252667|7387168|FG000|COMPLETED|Overall Study||3
6469810|NCT01252667|7387169|FG001|COMPLETED|Overall Study||3
6469811|NCT01252667|7387170|FG002|COMPLETED|Overall Study||3
6469812|NCT01252667|7387171|FG003|COMPLETED|Overall Study||0
6469813|NCT01252667|7387172|FG004|COMPLETED|Overall Study||0
6469814|NCT01252667|7387173|FG005|COMPLETED|Overall Study||34
6469815|NCT01252667|7387168|FG000|NOT COMPLETED|Overall Study||0
6469816|NCT01252667|7387169|FG001|NOT COMPLETED|Overall Study||0
6469817|NCT01252667|7387170|FG002|NOT COMPLETED|Overall Study||0
6469818|NCT01252667|7387171|FG003|NOT COMPLETED|Overall Study||0
6469819|NCT01252667|7387172|FG004|NOT COMPLETED|Overall Study||0
6469820|NCT01252667|7387173|FG005|NOT COMPLETED|Overall Study||1
6469821|NCT01252732|7387189|FG000|STARTED|Overall Study|Randomized|509
6469822|NCT01252732|7387190|FG001|STARTED|Overall Study|Randomized|510
6469823|NCT01252732|7387189|FG000|Modified Intent to Treat Population|Overall Study||503
6469824|NCT01252732|7387190|FG001|Modified Intent to Treat Population|Overall Study||502
6469825|NCT01252732|7387189|FG000|COMPLETED|Overall Study||455
6469826|NCT01252732|7387190|FG001|COMPLETED|Overall Study||446
6469827|NCT01252732|7387189|FG000|NOT COMPLETED|Overall Study||54
6469828|NCT01252732|7387190|FG001|NOT COMPLETED|Overall Study||64
6469829|NCT01252745|7387199|FG000|STARTED|Overall Study||8
6469830|NCT01252745|7387200|FG001|STARTED|Overall Study||7
6469831|NCT01252745|7387201|FG002|STARTED|Overall Study||7
6469832|NCT01252745|7387199|FG000|COMPLETED|Overall Study||8
6469833|NCT01252745|7387200|FG001|COMPLETED|Overall Study||7
6469834|NCT01252745|7387201|FG002|COMPLETED|Overall Study||7
6469835|NCT01252745|7387199|FG000|NOT COMPLETED|Overall Study||0
6469836|NCT01252745|7387200|FG001|NOT COMPLETED|Overall Study||0
6554330|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Fourth Intervention||5
6469837|NCT01252745|7387201|FG002|NOT COMPLETED|Overall Study||0
6469838|NCT01252810|7387214|FG000|STARTED|Overall Study||142
6469839|NCT01252810|7387215|FG001|STARTED|Overall Study||142
6469840|NCT01252810|7387214|FG000|COMPLETED|Overall Study||128
6469841|NCT01252810|7387215|FG001|COMPLETED|Overall Study||139
6469842|NCT01252810|7387214|FG000|NOT COMPLETED|Overall Study||14
6469843|NCT01252810|7387215|FG001|NOT COMPLETED|Overall Study||3
6469844|NCT01252940|7387223|FG000|STARTED|Main Study Phase||321
6469845|NCT01252940|7387224|FG001|STARTED|Main Study Phase||161
6469846|NCT01252940|7387223|FG000|Completed 24 Weeks|Main Study Phase||0
6469847|NCT01252940|7387224|FG001|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
6469848|NCT01252940|7387223|FG000|COMPLETED|Main Study Phase||295
6469849|NCT01252940|7387224|FG001|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
6469850|NCT01252940|7387223|FG000|NOT COMPLETED|Main Study Phase||26
6469851|NCT01252940|7387224|FG001|NOT COMPLETED|Main Study Phase||12
6469852|NCT01252940|7387223|FG000|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
6469853|NCT01252940|7387224|FG001|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
6469854|NCT01252940|7387223|FG000|COMPLETED|Extension Phase||100
6469855|NCT01252940|7387224|FG001|COMPLETED|Extension Phase||46
6469856|NCT01252940|7387223|FG000|NOT COMPLETED|Extension Phase||10
6469857|NCT01252940|7387224|FG001|NOT COMPLETED|Extension Phase||3
6469858|NCT01252966|7387233|FG000|STARTED|Overall Study||108
6469859|NCT01252966|7387234|FG001|STARTED|Overall Study||105
6469860|NCT01252966|7387233|FG000|COMPLETED|Overall Study||85
6469861|NCT01252966|7387234|FG001|COMPLETED|Overall Study||92
6469862|NCT01252966|7387233|FG000|NOT COMPLETED|Overall Study||23
6469863|NCT01252966|7387234|FG001|NOT COMPLETED|Overall Study||13
6469864|NCT01253018|7387244|FG000|STARTED|Overall Study||22
6469865|NCT01253018|7387245|FG001|STARTED|Overall Study||23
6469866|NCT01253018|7387244|FG000|COMPLETED|Overall Study||18
6469867|NCT01253018|7387245|FG001|COMPLETED|Overall Study||21
6469868|NCT01253018|7387244|FG000|NOT COMPLETED|Overall Study||4
6469869|NCT01253018|7387245|FG001|NOT COMPLETED|Overall Study||2
6469870|NCT01253044|7387254|FG000|STARTED|Overall Study||80
6469871|NCT01253044|7387255|FG001|STARTED|Overall Study||80
6469872|NCT01253044|7387254|FG000|COMPLETED|Overall Study||42
6469873|NCT01253044|7387255|FG001|COMPLETED|Overall Study||51
6469874|NCT01253044|7387254|FG000|NOT COMPLETED|Overall Study||38
6469875|NCT01253044|7387255|FG001|NOT COMPLETED|Overall Study||29
6469876|NCT01253135|7387261|FG000|STARTED|Original Protocol||15
6469877|NCT01253135|7387261|FG000|COMPLETED|Original Protocol||0
6469878|NCT01253135|7387261|FG000|NOT COMPLETED|Original Protocol||15
6469879|NCT01253135|7387261|FG000|STARTED|Amended Protocol||25
6469880|NCT01253135|7387261|FG000|COMPLETED|Amended Protocol||24
6469881|NCT01253135|7387261|FG000|NOT COMPLETED|Amended Protocol||1
6469882|NCT01253148|7387269|FG000|STARTED|Overall Study||25
6469883|NCT01253148|7387269|FG000|COMPLETED|Overall Study||25
6469884|NCT01253148|7387269|FG000|NOT COMPLETED|Overall Study||0
6469885|NCT01253174|7387273|FG000|STARTED|Period 1||6
6469886|NCT01253174|7387274|FG001|STARTED|Period 1||10
6469887|NCT01253174|7387275|FG002|STARTED|Period 1||9
6469888|NCT01253174|7387276|FG003|STARTED|Period 1||7
6469889|NCT01253174|7387277|FG004|STARTED|Period 1||9
6469890|NCT01253174|7387278|FG005|STARTED|Period 1||7
6469891|NCT01253174|7387273|FG000|COMPLETED|Period 1||6
6469892|NCT01253174|7387274|FG001|COMPLETED|Period 1||9
6469893|NCT01253174|7387275|FG002|COMPLETED|Period 1||8
6469894|NCT01253174|7387276|FG003|COMPLETED|Period 1||7
6469895|NCT01253174|7387277|FG004|COMPLETED|Period 1||8
6469896|NCT01253174|7387278|FG005|COMPLETED|Period 1||7
6469897|NCT01253174|7387273|FG000|NOT COMPLETED|Period 1||0
6469898|NCT01253174|7387274|FG001|NOT COMPLETED|Period 1||1
6469899|NCT01253174|7387275|FG002|NOT COMPLETED|Period 1||1
6469900|NCT01253174|7387276|FG003|NOT COMPLETED|Period 1||0
6469901|NCT01253174|7387277|FG004|NOT COMPLETED|Period 1||1
6469902|NCT01253174|7387278|FG005|NOT COMPLETED|Period 1||0
6469903|NCT01253174|7387273|FG000|STARTED|Period 2||6
6469904|NCT01253174|7387274|FG001|STARTED|Period 2||9
6469905|NCT01253174|7387275|FG002|STARTED|Period 2||8
6469906|NCT01253174|7387276|FG003|STARTED|Period 2||7
6469907|NCT01253174|7387277|FG004|STARTED|Period 2||8
6469908|NCT01253174|7387278|FG005|STARTED|Period 2||7
6469909|NCT01253174|7387273|FG000|COMPLETED|Period 2||6
6469910|NCT01253174|7387274|FG001|COMPLETED|Period 2||9
6469911|NCT01253174|7387275|FG002|COMPLETED|Period 2||7
6469912|NCT01253174|7387276|FG003|COMPLETED|Period 2||7
6554331|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Fourth Intervention||5
6554332|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Fourth Intervention||6
6554333|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Fourth Intervention||5
6469913|NCT01253174|7387277|FG004|COMPLETED|Period 2||8
6469914|NCT01253174|7387278|FG005|COMPLETED|Period 2||7
6469915|NCT01253174|7387273|FG000|NOT COMPLETED|Period 2||0
6469916|NCT01253174|7387274|FG001|NOT COMPLETED|Period 2||0
6469917|NCT01253174|7387275|FG002|NOT COMPLETED|Period 2||1
6469918|NCT01253174|7387276|FG003|NOT COMPLETED|Period 2||0
6469919|NCT01253174|7387277|FG004|NOT COMPLETED|Period 2||0
6469920|NCT01253174|7387278|FG005|NOT COMPLETED|Period 2||0
6469921|NCT01253174|7387273|FG000|STARTED|Period 3||6
6469922|NCT01253174|7387274|FG001|STARTED|Period 3||9
6469923|NCT01253174|7387275|FG002|STARTED|Period 3||7
6469924|NCT01253174|7387276|FG003|STARTED|Period 3||7
6469925|NCT01253174|7387277|FG004|STARTED|Period 3||8
6469926|NCT01253174|7387278|FG005|STARTED|Period 3||7
6469927|NCT01253174|7387273|FG000|COMPLETED|Period 3||6
6469928|NCT01253174|7387274|FG001|COMPLETED|Period 3||8
6469929|NCT01253174|7387275|FG002|COMPLETED|Period 3||6
6469930|NCT01253174|7387276|FG003|COMPLETED|Period 3||7
6469931|NCT01253174|7387277|FG004|COMPLETED|Period 3||7
6469932|NCT01253174|7387278|FG005|COMPLETED|Period 3||7
6469933|NCT01253174|7387273|FG000|NOT COMPLETED|Period 3||0
6469934|NCT01253174|7387274|FG001|NOT COMPLETED|Period 3||1
6469935|NCT01253174|7387275|FG002|NOT COMPLETED|Period 3||1
6469936|NCT01253174|7387276|FG003|NOT COMPLETED|Period 3||0
6469937|NCT01253174|7387277|FG004|NOT COMPLETED|Period 3||1
6469938|NCT01253174|7387278|FG005|NOT COMPLETED|Period 3||0
6469939|NCT01253187|7387287|FG000|STARTED|Period 1||7
6469940|NCT01253187|7387288|FG001|STARTED|Period 1||8
6469941|NCT01253187|7387289|FG002|STARTED|Period 1||7
6469942|NCT01253187|7387290|FG003|STARTED|Period 1||7
6469943|NCT01253187|7387291|FG004|STARTED|Period 1||9
6554334|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6554335|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6554336|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6554337|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
6469944|NCT01253187|7387292|FG005|STARTED|Period 1||6
6469945|NCT01253187|7387287|FG000|COMPLETED|Period 1||7
6469946|NCT01253187|7387288|FG001|COMPLETED|Period 1||8
6469947|NCT01253187|7387289|FG002|COMPLETED|Period 1||7
6469948|NCT01253187|7387290|FG003|COMPLETED|Period 1||7
6469949|NCT01253187|7387291|FG004|COMPLETED|Period 1||9
6469950|NCT01253187|7387292|FG005|COMPLETED|Period 1||6
6469951|NCT01253187|7387287|FG000|NOT COMPLETED|Period 1||0
6469952|NCT01253187|7387288|FG001|NOT COMPLETED|Period 1||0
6469953|NCT01253187|7387289|FG002|NOT COMPLETED|Period 1||0
6469954|NCT01253187|7387290|FG003|NOT COMPLETED|Period 1||0
6469955|NCT01253187|7387291|FG004|NOT COMPLETED|Period 1||0
6469956|NCT01253187|7387292|FG005|NOT COMPLETED|Period 1||0
6469957|NCT01253187|7387287|FG000|STARTED|Period 2||7
6469958|NCT01253187|7387288|FG001|STARTED|Period 2||8
6469959|NCT01253187|7387289|FG002|STARTED|Period 2||7
6469960|NCT01253187|7387290|FG003|STARTED|Period 2||7
6469961|NCT01253187|7387291|FG004|STARTED|Period 2||9
6469962|NCT01253187|7387292|FG005|STARTED|Period 2||6
6469963|NCT01253187|7387287|FG000|COMPLETED|Period 2||7
6469964|NCT01253187|7387288|FG001|COMPLETED|Period 2||8
6469965|NCT01253187|7387289|FG002|COMPLETED|Period 2||7
6469966|NCT01253187|7387290|FG003|COMPLETED|Period 2||7
6469967|NCT01253187|7387291|FG004|COMPLETED|Period 2||8
6469968|NCT01253187|7387292|FG005|COMPLETED|Period 2||6
6469969|NCT01253187|7387287|FG000|NOT COMPLETED|Period 2||0
6469970|NCT01253187|7387288|FG001|NOT COMPLETED|Period 2||0
6469971|NCT01253187|7387289|FG002|NOT COMPLETED|Period 2||0
6469972|NCT01253187|7387290|FG003|NOT COMPLETED|Period 2||0
6469973|NCT01253187|7387291|FG004|NOT COMPLETED|Period 2||1
6469974|NCT01253187|7387292|FG005|NOT COMPLETED|Period 2||0
6469975|NCT01253187|7387287|FG000|STARTED|Period 3||7
6469976|NCT01253187|7387288|FG001|STARTED|Period 3||8
6469977|NCT01253187|7387289|FG002|STARTED|Period 3||7
6469978|NCT01253187|7387290|FG003|STARTED|Period 3||7
6469979|NCT01253187|7387291|FG004|STARTED|Period 3||8
6469980|NCT01253187|7387292|FG005|STARTED|Period 3||6
6469981|NCT01253187|7387287|FG000|COMPLETED|Period 3||6
6469982|NCT01253187|7387288|FG001|COMPLETED|Period 3||7
6469983|NCT01253187|7387289|FG002|COMPLETED|Period 3||7
6469984|NCT01253187|7387290|FG003|COMPLETED|Period 3||7
6469985|NCT01253187|7387291|FG004|COMPLETED|Period 3||7
6469986|NCT01253187|7387292|FG005|COMPLETED|Period 3||6
6469987|NCT01253187|7387287|FG000|NOT COMPLETED|Period 3||1
6469988|NCT01253187|7387288|FG001|NOT COMPLETED|Period 3||1
6469989|NCT01253187|7387289|FG002|NOT COMPLETED|Period 3||0
6469990|NCT01253187|7387290|FG003|NOT COMPLETED|Period 3||0
6469991|NCT01253187|7387291|FG004|NOT COMPLETED|Period 3||1
6469992|NCT01253187|7387292|FG005|NOT COMPLETED|Period 3||0
6469993|NCT01253200|7387308|FG000|STARTED|Overall Study||125
6469994|NCT01253200|7387309|FG001|STARTED|Overall Study||125
6469995|NCT01253200|7387310|FG002|STARTED|Overall Study||30
6469996|NCT01253200|7387311|FG003|STARTED|Overall Study||17
6469997|NCT01253200|7387312|FG004|STARTED|Overall Study||5
6469998|NCT01253200|7387308|FG000|Procedure|Overall Study||109
6469999|NCT01253200|7387309|FG001|Procedure|Overall Study||111
6470000|NCT01253200|7387310|FG002|Procedure|Overall Study||28
6470001|NCT01253200|7387311|FG003|Procedure|Overall Study||12
6470002|NCT01253200|7387312|FG004|Procedure|Overall Study||0
6470003|NCT01253200|7387308|FG000|10 Day Follow-up|Overall Study||106
6470004|NCT01253200|7387309|FG001|10 Day Follow-up|Overall Study||111
6470005|NCT01253200|7387310|FG002|10 Day Follow-up|Overall Study||28
6470006|NCT01253200|7387311|FG003|10 Day Follow-up|Overall Study||12
6470007|NCT01253200|7387312|FG004|10 Day Follow-up|Overall Study||0
6470008|NCT01253200|7387308|FG000|3 Month Follow-up|Overall Study||104
6470009|NCT01253200|7387309|FG001|3 Month Follow-up|Overall Study||106
6470010|NCT01253200|7387310|FG002|3 Month Follow-up|Overall Study||28
6470011|NCT01253200|7387311|FG003|3 Month Follow-up|Overall Study||12
6470012|NCT01253200|7387312|FG004|3 Month Follow-up|Overall Study||0
6470013|NCT01253200|7387308|FG000|COMPLETED|Overall Study||104
6470014|NCT01253200|7387309|FG001|COMPLETED|Overall Study||106
6470015|NCT01253200|7387310|FG002|COMPLETED|Overall Study||28
6470016|NCT01253200|7387311|FG003|COMPLETED|Overall Study||12
6470017|NCT01253200|7387312|FG004|COMPLETED|Overall Study||0
6470018|NCT01253200|7387308|FG000|NOT COMPLETED|Overall Study||21
6470019|NCT01253200|7387309|FG001|NOT COMPLETED|Overall Study||19
6470020|NCT01253200|7387310|FG002|NOT COMPLETED|Overall Study||2
6470021|NCT01253200|7387311|FG003|NOT COMPLETED|Overall Study||5
6470022|NCT01253200|7387312|FG004|NOT COMPLETED|Overall Study||5
6470023|NCT01253226|7387326|FG000|STARTED|Overall Study||6
6470024|NCT01253226|7387327|FG001|STARTED|Overall Study||6
6470025|NCT01253226|7387328|FG002|STARTED|Overall Study||6
6470026|NCT01253226|7387329|FG003|STARTED|Overall Study||6
6470027|NCT01253226|7387330|FG004|STARTED|Overall Study||8
6470028|NCT01253226|7387326|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6470029|NCT01253226|7387327|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6470030|NCT01253226|7387328|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6470031|NCT01253226|7387329|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6470032|NCT01253226|7387330|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
6470033|NCT01253226|7387326|FG000|COMPLETED|Overall Study||6
6470034|NCT01253226|7387327|FG001|COMPLETED|Overall Study||5
6470035|NCT01253226|7387328|FG002|COMPLETED|Overall Study||5
6470036|NCT01253226|7387329|FG003|COMPLETED|Overall Study||5
6470037|NCT01253226|7387330|FG004|COMPLETED|Overall Study||6
6470038|NCT01253226|7387326|FG000|NOT COMPLETED|Overall Study||0
6470039|NCT01253226|7387327|FG001|NOT COMPLETED|Overall Study||1
6470040|NCT01253226|7387328|FG002|NOT COMPLETED|Overall Study||1
6470041|NCT01253226|7387329|FG003|NOT COMPLETED|Overall Study||1
6470042|NCT01253226|7387330|FG004|NOT COMPLETED|Overall Study||2
6470043|NCT01253265|7387347|FG000|STARTED|Overall Study||6
6470044|NCT01253265|7387348|FG001|STARTED|Overall Study||6
6470045|NCT01253265|7387349|FG002|STARTED|Overall Study||6
6470046|NCT01253265|7387350|FG003|STARTED|Overall Study||6
6470047|NCT01253265|7387351|FG004|STARTED|Overall Study||8
6470048|NCT01253265|7387347|FG000|COMPLETED|Overall Study||5
6470049|NCT01253265|7387348|FG001|COMPLETED|Overall Study||6
6470050|NCT01253265|7387349|FG002|COMPLETED|Overall Study||6
6470051|NCT01253265|7387350|FG003|COMPLETED|Overall Study||6
6470052|NCT01253265|7387351|FG004|COMPLETED|Overall Study||7
6470053|NCT01253265|7387347|FG000|NOT COMPLETED|Overall Study||1
6470054|NCT01253265|7387348|FG001|NOT COMPLETED|Overall Study||0
6470055|NCT01253265|7387349|FG002|NOT COMPLETED|Overall Study||0
6470056|NCT01253265|7387350|FG003|NOT COMPLETED|Overall Study||0
6470057|NCT01253265|7387351|FG004|NOT COMPLETED|Overall Study||1
6470058|NCT01253291|7387368|FG000|STARTED|Overall Study||6
6470059|NCT01253291|7387369|FG001|STARTED|Overall Study||6
6470060|NCT01253291|7387370|FG002|STARTED|Overall Study||4
6470061|NCT01253291|7387371|FG003|STARTED|Overall Study||5
6470062|NCT01253291|7387372|FG004|STARTED|Overall Study||5
6470063|NCT01253291|7387368|FG000|Received Study Drug During BCDL|Overall Study||6
6470064|NCT01253291|7387369|FG001|Received Study Drug During BCDL|Overall Study||6
6470065|NCT01253291|7387370|FG002|Received Study Drug During BCDL|Overall Study||4
6470066|NCT01253291|7387371|FG003|Received Study Drug During BCDL|Overall Study||5
6470067|NCT01253291|7387372|FG004|Received Study Drug During BCDL|Overall Study||5
6470068|NCT01253291|7387368|FG000|COMPLETED|Overall Study||2
6470069|NCT01253291|7387369|FG001|COMPLETED|Overall Study||4
6470070|NCT01253291|7387370|FG002|COMPLETED|Overall Study||4
6470071|NCT01253291|7387371|FG003|COMPLETED|Overall Study||5
6470072|NCT01253291|7387372|FG004|COMPLETED|Overall Study||3
6470073|NCT01253291|7387368|FG000|NOT COMPLETED|Overall Study||4
6470074|NCT01253291|7387369|FG001|NOT COMPLETED|Overall Study||2
6470075|NCT01253291|7387370|FG002|NOT COMPLETED|Overall Study||0
6470076|NCT01253291|7387371|FG003|NOT COMPLETED|Overall Study||0
6470077|NCT01253291|7387372|FG004|NOT COMPLETED|Overall Study||2
6470078|NCT01253304|7387389|FG000|STARTED|Overall Study||11
6470079|NCT01253304|7387390|FG001|STARTED|Overall Study||6
6470080|NCT01253304|7387391|FG002|STARTED|Overall Study||6
6470081|NCT01253304|7387392|FG003|STARTED|Overall Study||3
6470082|NCT01253304|7387389|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
6470083|NCT01253304|7387390|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6470084|NCT01253304|7387391|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6562909|NCT01803464|7485828|FG002|STARTED|Overall Study||10
6470085|NCT01253304|7387392|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6470086|NCT01253304|7387389|FG000|COMPLETED|Overall Study||11
6470087|NCT01253304|7387390|FG001|COMPLETED|Overall Study||6
6470088|NCT01253304|7387391|FG002|COMPLETED|Overall Study||6
6470089|NCT01253304|7387392|FG003|COMPLETED|Overall Study||2
6470090|NCT01253304|7387389|FG000|NOT COMPLETED|Overall Study||0
6470091|NCT01253304|7387390|FG001|NOT COMPLETED|Overall Study||0
6470092|NCT01253304|7387391|FG002|NOT COMPLETED|Overall Study||0
6470093|NCT01253304|7387392|FG003|NOT COMPLETED|Overall Study||1
6470094|NCT01253317|7387402|FG000|STARTED|Overall Study||12
6470095|NCT01253317|7387402|FG000|COMPLETED|Overall Study||10
6470096|NCT01253317|7387402|FG000|NOT COMPLETED|Overall Study||2
6470097|NCT01253343|7387412|FG000|STARTED|Overall Study||9
6470098|NCT01253343|7387413|FG001|STARTED|Overall Study||8
6470099|NCT01253343|7387412|FG000|COMPLETED|Overall Study||9
6470100|NCT01253343|7387413|FG001|COMPLETED|Overall Study||8
6470101|NCT01253343|7387412|FG000|NOT COMPLETED|Overall Study||0
6470102|NCT01253343|7387413|FG001|NOT COMPLETED|Overall Study||0
6470103|NCT01253369|7387435|FG000|STARTED|Overall Study||33
6470104|NCT01253369|7387435|FG000|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
6470105|NCT01253369|7387435|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6470106|NCT01253369|7387435|FG000|NOT COMPLETED|Overall Study||33
6470107|NCT01253408|7387442|FG000|STARTED|Overall Study||10
6470108|NCT01253408|7387443|FG001|STARTED|Overall Study||13
6470109|NCT01253408|7387444|FG002|STARTED|Overall Study||13
6470110|NCT01253408|7387442|FG000|COMPLETED|Overall Study||10
6470111|NCT01253408|7387443|FG001|COMPLETED|Overall Study||12
6470112|NCT01253408|7387444|FG002|COMPLETED|Overall Study||13
6470113|NCT01253408|7387442|FG000|NOT COMPLETED|Overall Study||0
6554338|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6554339|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
6554340|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||1
6554341|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6554342|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Fourth Intervention||2
6554343|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Washout Period 4||0
6554344|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Washout Period 4||0
6554345|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Washout Period 4||0
6554346|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Washout Period 4||5
6554347|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Washout Period 4||6
6554348|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Washout Period 4||5
6554349|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Washout Period 4||5
6554350|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Washout Period 4||6
6554351|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Washout Period 4||5
6554352|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Washout Period 4||0
6470114|NCT01253408|7387443|FG001|NOT COMPLETED|Overall Study||1
6470115|NCT01253408|7387444|FG002|NOT COMPLETED|Overall Study||0
6470116|NCT01253421|7387456|FG000|STARTED|Assessment and Scheduling||159
6470117|NCT01253421|7387457|FG001|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
6470118|NCT01253421|7387458|FG002|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
6470119|NCT01253421|7387459|FG003|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
6470120|NCT01253421|7387460|FG004|STARTED|Assessment and Scheduling|Arm has no participants until randomization.|0
6470121|NCT01253421|7387456|FG000|Eligible After Screening Visit|Assessment and Scheduling||85
6470122|NCT01253421|7387457|FG001|Eligible After Screening Visit|Assessment and Scheduling||0
6470123|NCT01253421|7387458|FG002|Eligible After Screening Visit|Assessment and Scheduling||0
6470124|NCT01253421|7387459|FG003|Eligible After Screening Visit|Assessment and Scheduling||0
6470125|NCT01253421|7387460|FG004|Eligible After Screening Visit|Assessment and Scheduling||0
6470126|NCT01253421|7387456|FG000|Returned for Drug+Scanning Visit|Assessment and Scheduling||60
6470127|NCT01253421|7387457|FG001|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
6470128|NCT01253421|7387458|FG002|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
6470129|NCT01253421|7387459|FG003|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
6470130|NCT01253421|7387460|FG004|Returned for Drug+Scanning Visit|Assessment and Scheduling||0
6470131|NCT01253421|7387456|FG000|COMPLETED|Assessment and Scheduling||60
6470132|NCT01253421|7387457|FG001|COMPLETED|Assessment and Scheduling||0
6470133|NCT01253421|7387458|FG002|COMPLETED|Assessment and Scheduling||0
6470134|NCT01253421|7387459|FG003|COMPLETED|Assessment and Scheduling||0
6470135|NCT01253421|7387460|FG004|COMPLETED|Assessment and Scheduling||0
6470136|NCT01253421|7387456|FG000|NOT COMPLETED|Assessment and Scheduling||99
6470137|NCT01253421|7387457|FG001|NOT COMPLETED|Assessment and Scheduling||0
6470138|NCT01253421|7387458|FG002|NOT COMPLETED|Assessment and Scheduling||0
6470139|NCT01253421|7387459|FG003|NOT COMPLETED|Assessment and Scheduling||0
6470140|NCT01253421|7387460|FG004|NOT COMPLETED|Assessment and Scheduling||0
6470141|NCT01253421|7387456|FG000|STARTED|Drug+Scanning Visit|Arm has no participants once randomization has occurred.|0
6470142|NCT01253421|7387457|FG001|STARTED|Drug+Scanning Visit||15
6470143|NCT01253421|7387458|FG002|STARTED|Drug+Scanning Visit||14
6470144|NCT01253421|7387459|FG003|STARTED|Drug+Scanning Visit||16
6470145|NCT01253421|7387460|FG004|STARTED|Drug+Scanning Visit||15
6470146|NCT01253421|7387456|FG000|Received Drug Challenge|Drug+Scanning Visit||0
6470147|NCT01253421|7387457|FG001|Received Drug Challenge|Drug+Scanning Visit||15
6470148|NCT01253421|7387458|FG002|Received Drug Challenge|Drug+Scanning Visit||14
6470149|NCT01253421|7387459|FG003|Received Drug Challenge|Drug+Scanning Visit||16
6470150|NCT01253421|7387460|FG004|Received Drug Challenge|Drug+Scanning Visit||15
6470151|NCT01253421|7387456|FG000|COMPLETED|Drug+Scanning Visit||0
6470152|NCT01253421|7387457|FG001|COMPLETED|Drug+Scanning Visit||15
6470153|NCT01253421|7387458|FG002|COMPLETED|Drug+Scanning Visit||14
6470154|NCT01253421|7387459|FG003|COMPLETED|Drug+Scanning Visit||16
6470155|NCT01253421|7387460|FG004|COMPLETED|Drug+Scanning Visit||14
6470156|NCT01253421|7387456|FG000|NOT COMPLETED|Drug+Scanning Visit||0
6470157|NCT01253421|7387457|FG001|NOT COMPLETED|Drug+Scanning Visit||0
6470158|NCT01253421|7387458|FG002|NOT COMPLETED|Drug+Scanning Visit||0
6470159|NCT01253421|7387459|FG003|NOT COMPLETED|Drug+Scanning Visit||0
6470160|NCT01253421|7387460|FG004|NOT COMPLETED|Drug+Scanning Visit||1
6470161|NCT01253447|7387470|FG000|STARTED|Overall Study||19
6470162|NCT01253447|7387470|FG000|COMPLETED|Overall Study||17
6470163|NCT01253447|7387470|FG000|NOT COMPLETED|Overall Study||2
6470164|NCT01253460|7387475|FG000|STARTED|Overall Study||18
6470165|NCT01253460|7387475|FG000|COMPLETED|Overall Study||18
6470166|NCT01253460|7387475|FG000|NOT COMPLETED|Overall Study||0
6470167|NCT01253525|7387479|FG000|STARTED|Overall Study||6
6470168|NCT01253525|7387479|FG000|Received Any Quantity of Study Drug|Overall Study||6
6470169|NCT01253525|7387479|FG000|COMPLETED|Overall Study||6
6470170|NCT01253525|7387479|FG000|NOT COMPLETED|Overall Study||0
6470171|NCT01253564|7387483|FG000|STARTED|Overall Study||24
6470172|NCT01253564|7387483|FG000|COMPLETED|Overall Study||0
6470173|NCT01253564|7387483|FG000|NOT COMPLETED|Overall Study||24
6470174|NCT01253577|7387487|FG000|STARTED|Overall Study||105
6470175|NCT01253577|7387487|FG000|COMPLETED|Overall Study||102
6470176|NCT01253577|7387487|FG000|NOT COMPLETED|Overall Study||3
6470177|NCT01253642|7387493|FG000|STARTED|Overall Study||11
6470178|NCT01253642|7387493|FG000|COMPLETED|Overall Study||6
6470179|NCT01253642|7387493|FG000|NOT COMPLETED|Overall Study||5
6470180|NCT01253811|7387498|FG000|STARTED|Overall Study||6
6470181|NCT01253811|7387498|FG000|Exposed|Overall Study||6
6470182|NCT01253811|7387498|FG000|COMPLETED|Overall Study||5
6470183|NCT01253811|7387498|FG000|NOT COMPLETED|Overall Study||1
6470184|NCT01253824|7387504|FG000|STARTED|Overall Study||7
6470185|NCT01253824|7387505|FG001|STARTED|Overall Study||7
6470186|NCT01253824|7387504|FG000|COMPLETED|Overall Study||7
6470187|NCT01253824|7387505|FG001|COMPLETED|Overall Study||7
6470188|NCT01253824|7387504|FG000|NOT COMPLETED|Overall Study||0
6470189|NCT01253824|7387505|FG001|NOT COMPLETED|Overall Study||0
6470190|NCT01253902|7387514|FG000|STARTED|Overall Study||56
6470191|NCT01253902|7387515|FG001|STARTED|Overall Study||53
6470192|NCT01253902|7387516|FG002|STARTED|Overall Study||55
6470193|NCT01253902|7387514|FG000|COMPLETED|Overall Study||51
6470194|NCT01253902|7387515|FG001|COMPLETED|Overall Study||51
6470195|NCT01253902|7387516|FG002|COMPLETED|Overall Study||51
6470196|NCT01253902|7387514|FG000|NOT COMPLETED|Overall Study||5
6470197|NCT01253902|7387515|FG001|NOT COMPLETED|Overall Study||2
6470198|NCT01253902|7387516|FG002|NOT COMPLETED|Overall Study||4
6470199|NCT01253980|7387526|FG000|STARTED|Overall Study||35
6470200|NCT01253980|7387527|FG001|STARTED|Overall Study||39
6470201|NCT01253980|7387526|FG000|COMPLETED|Overall Study||35
6470202|NCT01253980|7387527|FG001|COMPLETED|Overall Study||39
6470203|NCT01253980|7387526|FG000|NOT COMPLETED|Overall Study||0
6470204|NCT01253980|7387527|FG001|NOT COMPLETED|Overall Study||0
6470205|NCT01254019|7387535|FG000|STARTED|Overall Study||61
6470206|NCT01254019|7387536|FG001|STARTED|Overall Study||125
6470207|NCT01254019|7387535|FG000|COMPLETED|Overall Study||60
6470208|NCT01254019|7387536|FG001|COMPLETED|Overall Study||121
6470209|NCT01254019|7387535|FG000|NOT COMPLETED|Overall Study||1
6470210|NCT01254019|7387536|FG001|NOT COMPLETED|Overall Study||4
6470211|NCT01254045|7387545|FG000|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
6470212|NCT01254045|7387546|FG001|STARTED|First/Baseline (1 Day at Week 1 )||2
6470213|NCT01254045|7387547|FG002|STARTED|First/Baseline (1 Day at Week 1 )||2
6470214|NCT01254045|7387548|FG003|STARTED|First/Baseline (1 Day at Week 1 )||1
6470215|NCT01254045|7387549|FG004|STARTED|First/Baseline (1 Day at Week 1 )||1
6470216|NCT01254045|7387550|FG005|STARTED|First/Baseline (1 Day at Week 1 )||1
6470217|NCT01254045|7387545|FG000|COMPLETED|First/Baseline (1 Day at Week 1 )||1
6470218|NCT01254045|7387546|FG001|COMPLETED|First/Baseline (1 Day at Week 1 )||2
6470219|NCT01254045|7387547|FG002|COMPLETED|First/Baseline (1 Day at Week 1 )||2
6470220|NCT01254045|7387548|FG003|COMPLETED|First/Baseline (1 Day at Week 1 )||1
6470221|NCT01254045|7387549|FG004|COMPLETED|First/Baseline (1 Day at Week 1 )||1
6470222|NCT01254045|7387550|FG005|COMPLETED|First/Baseline (1 Day at Week 1 )||1
6470223|NCT01254045|7387545|FG000|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
6470224|NCT01254045|7387546|FG001|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6470225|NCT01254045|7387547|FG002|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6470226|NCT01254045|7387548|FG003|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6470227|NCT01254045|7387549|FG004|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6470228|NCT01254045|7387550|FG005|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
6470229|NCT01254045|7387545|FG000|STARTED|Second/Time 2 (1 Day at Week 2)||1
6470230|NCT01254045|7387546|FG001|STARTED|Second/Time 2 (1 Day at Week 2)||2
6470231|NCT01254045|7387547|FG002|STARTED|Second/Time 2 (1 Day at Week 2)||2
6470232|NCT01254045|7387548|FG003|STARTED|Second/Time 2 (1 Day at Week 2)||1
6470233|NCT01254045|7387549|FG004|STARTED|Second/Time 2 (1 Day at Week 2)||1
6470234|NCT01254045|7387550|FG005|STARTED|Second/Time 2 (1 Day at Week 2)||1
6470235|NCT01254045|7387545|FG000|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
6470236|NCT01254045|7387546|FG001|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
6470237|NCT01254045|7387547|FG002|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
6470238|NCT01254045|7387548|FG003|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
6470239|NCT01254045|7387549|FG004|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
6470240|NCT01254045|7387550|FG005|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
6470241|NCT01254045|7387545|FG000|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6470242|NCT01254045|7387546|FG001|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6554353|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Washout Period 4||0
6470243|NCT01254045|7387547|FG002|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6470244|NCT01254045|7387548|FG003|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6470245|NCT01254045|7387549|FG004|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6470246|NCT01254045|7387550|FG005|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
6470247|NCT01254045|7387545|FG000|STARTED|Third/Time 3 (1 Day at Week 3)||1
6554354|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Washout Period 4||0
6554355|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Washout Period 4||5
6554356|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Washout Period 4||6
6554357|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Washout Period 4||5
6470248|NCT01254045|7387546|FG001|STARTED|Third/Time 3 (1 Day at Week 3)||2
6470249|NCT01254045|7387547|FG002|STARTED|Third/Time 3 (1 Day at Week 3)||2
6470250|NCT01254045|7387548|FG003|STARTED|Third/Time 3 (1 Day at Week 3)||1
6470251|NCT01254045|7387549|FG004|STARTED|Third/Time 3 (1 Day at Week 3)||1
6470252|NCT01254045|7387550|FG005|STARTED|Third/Time 3 (1 Day at Week 3)||1
6470253|NCT01254045|7387545|FG000|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
6470254|NCT01254045|7387546|FG001|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
6470255|NCT01254045|7387547|FG002|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
6470256|NCT01254045|7387548|FG003|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
6470257|NCT01254045|7387549|FG004|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
6470258|NCT01254045|7387550|FG005|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
6470259|NCT01254045|7387545|FG000|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6470260|NCT01254045|7387546|FG001|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6470261|NCT01254045|7387547|FG002|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6470262|NCT01254045|7387548|FG003|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6470263|NCT01254045|7387549|FG004|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6470264|NCT01254045|7387550|FG005|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
6470265|NCT01254188|7387560|FG000|STARTED|Overall Study||421
6470266|NCT01254188|7387560|FG000|COMPLETED|Overall Study||328
6470267|NCT01254188|7387560|FG000|NOT COMPLETED|Overall Study||93
6470268|NCT01254214|7387566|FG000|STARTED|Overall Study||27
6470269|NCT01254214|7387567|FG001|STARTED|Overall Study||28
6470270|NCT01254214|7387566|FG000|COMPLETED|Overall Study||24
6470271|NCT01254214|7387567|FG001|COMPLETED|Overall Study||27
6470272|NCT01254214|7387566|FG000|NOT COMPLETED|Overall Study||3
6470273|NCT01254214|7387567|FG001|NOT COMPLETED|Overall Study||1
6470274|NCT01254227|7387573|FG000|STARTED|Overall Study||60
6470275|NCT01254227|7387573|FG000|Completion of 12 Months|Overall Study||39
6470276|NCT01254227|7387573|FG000|Completion of 24 Months|Overall Study||34
6470277|NCT01254227|7387573|FG000|COMPLETED|Overall Study||34
6470278|NCT01254227|7387573|FG000|NOT COMPLETED|Overall Study||26
6554358|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Washout Period 4||5
6554359|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Washout Period 4||6
6554360|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Washout Period 4||5
6470279|NCT01254292|7387579|FG000|STARTED|Comparative Phase||282
6470280|NCT01254292|7387580|FG001|STARTED|Comparative Phase||285
6470281|NCT01254292|7387579|FG000|Participants Received Treatment|Comparative Phase|safety population|279
6470282|NCT01254292|7387580|FG001|Participants Received Treatment|Comparative Phase|safety population|281
6470283|NCT01254292|7387579|FG000|COMPLETED|Comparative Phase||227
6470284|NCT01254292|7387580|FG001|COMPLETED|Comparative Phase||204
6470285|NCT01254292|7387579|FG000|NOT COMPLETED|Comparative Phase||55
6470286|NCT01254292|7387580|FG001|NOT COMPLETED|Comparative Phase||81
6470287|NCT01254292|7387579|FG000|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
6470288|NCT01254292|7387580|FG001|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
6470289|NCT01254292|7387579|FG000|COMPLETED|LCS12 Extension Phase||163
6470290|NCT01254292|7387580|FG001|COMPLETED|LCS12 Extension Phase||0
6470291|NCT01254292|7387579|FG000|NOT COMPLETED|LCS12 Extension Phase||37
6470292|NCT01254292|7387580|FG001|NOT COMPLETED|LCS12 Extension Phase||0
6470293|NCT01254305|7387590|FG000|STARTED|Overall Study||93
6470294|NCT01254305|7387591|FG001|STARTED|Overall Study||90
6470295|NCT01254305|7387592|FG002|STARTED|Overall Study||79
6470296|NCT01254305|7387590|FG000|Safety Population|Overall Study||89
6470297|NCT01254305|7387591|FG001|Safety Population|Overall Study||85
6470298|NCT01254305|7387592|FG002|Safety Population|Overall Study||77
6470299|NCT01254305|7387590|FG000|COMPLETED|Overall Study||71
6470300|NCT01254305|7387591|FG001|COMPLETED|Overall Study||72
6470301|NCT01254305|7387592|FG002|COMPLETED|Overall Study||62
6470302|NCT01254305|7387590|FG000|NOT COMPLETED|Overall Study||22
6470303|NCT01254305|7387591|FG001|NOT COMPLETED|Overall Study||18
6470304|NCT01254305|7387592|FG002|NOT COMPLETED|Overall Study||17
6470305|NCT01254318|7387603|FG000|STARTED|Overall Study|Alive at start of study|130
6470306|NCT01254318|7387603|FG000|COMPLETED|Overall Study|Alive at end of study|78
6470307|NCT01254318|7387603|FG000|NOT COMPLETED|Overall Study||52
6470308|NCT01254331|7387607|FG000|STARTED|Initial Phase||51
6470309|NCT01254331|7387607|FG000|COMPLETED|Initial Phase||46
6470310|NCT01254331|7387607|FG000|NOT COMPLETED|Initial Phase||5
6470311|NCT01254331|7387607|FG000|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
6470312|NCT01254331|7387607|FG000|COMPLETED|Extension Phase||41
6470313|NCT01254331|7387607|FG000|NOT COMPLETED|Extension Phase||4
6470314|NCT01254344|7387613|FG000|STARTED|Overall Study||299
6470315|NCT01254344|7387614|FG001|STARTED|Overall Study||300
6470316|NCT01254344|7387613|FG000|Treated|Overall Study||290
6470317|NCT01254344|7387614|FG001|Treated|Overall Study||297
6470318|NCT01254344|7387613|FG000|COMPLETED|Overall Study||286
6470319|NCT01254344|7387614|FG001|COMPLETED|Overall Study||281
6470320|NCT01254344|7387613|FG000|NOT COMPLETED|Overall Study||13
6470321|NCT01254344|7387614|FG001|NOT COMPLETED|Overall Study||19
6470322|NCT01254396|7387620|FG000|STARTED|First Intervention Period||6
6470323|NCT01254396|7387621|FG001|STARTED|First Intervention Period||6
6470324|NCT01254396|7387620|FG000|COMPLETED|First Intervention Period||6
6470325|NCT01254396|7387621|FG001|COMPLETED|First Intervention Period||6
6470326|NCT01254396|7387620|FG000|NOT COMPLETED|First Intervention Period||0
6470327|NCT01254396|7387621|FG001|NOT COMPLETED|First Intervention Period||0
6470328|NCT01254396|7387620|FG000|STARTED|Washout Period (at Least 1 Day)||6
6470329|NCT01254396|7387621|FG001|STARTED|Washout Period (at Least 1 Day)||6
6470330|NCT01254396|7387620|FG000|COMPLETED|Washout Period (at Least 1 Day)||6
6470331|NCT01254396|7387621|FG001|COMPLETED|Washout Period (at Least 1 Day)||6
6470332|NCT01254396|7387620|FG000|NOT COMPLETED|Washout Period (at Least 1 Day)||0
6470333|NCT01254396|7387621|FG001|NOT COMPLETED|Washout Period (at Least 1 Day)||0
6470334|NCT01254396|7387620|FG000|STARTED|Second Intervention Period||6
6470335|NCT01254396|7387621|FG001|STARTED|Second Intervention Period||6
6470336|NCT01254396|7387620|FG000|COMPLETED|Second Intervention Period||6
6470337|NCT01254396|7387621|FG001|COMPLETED|Second Intervention Period||6
6470338|NCT01254396|7387620|FG000|NOT COMPLETED|Second Intervention Period||0
6470339|NCT01254396|7387621|FG001|NOT COMPLETED|Second Intervention Period||0
6470340|NCT01254552|7387627|FG000|STARTED|Screening Visit||351
6470341|NCT01254552|7387627|FG000|COMPLETED|Screening Visit||348
6470342|NCT01254552|7387627|FG000|NOT COMPLETED|Screening Visit||3
6470343|NCT01254552|7387627|FG000|STARTED|Delayed-enhanced MRI With Dotarem||348
6470344|NCT01254552|7387627|FG000|COMPLETED|Delayed-enhanced MRI With Dotarem||328
6470345|NCT01254552|7387627|FG000|NOT COMPLETED|Delayed-enhanced MRI With Dotarem||20
6470346|NCT01254552|7387627|FG000|STARTED|CCTA With Xenetix 350||328
6470347|NCT01254552|7387627|FG000|COMPLETED|CCTA With Xenetix 350||322
6470348|NCT01254552|7387627|FG000|NOT COMPLETED|CCTA With Xenetix 350||6
6470349|NCT01254565|7387641|FG000|STARTED|Overall Study||5
6470350|NCT01254565|7387642|FG001|STARTED|Overall Study||7
6470351|NCT01254565|7387643|FG002|STARTED|Overall Study||21
6470352|NCT01254565|7387644|FG003|STARTED|Overall Study||21
6470353|NCT01254565|7387645|FG004|STARTED|Overall Study||16
6470354|NCT01254565|7387646|FG005|STARTED|Overall Study||17
6470355|NCT01254565|7387641|FG000|Received Treatment|Overall Study||4
6470356|NCT01254565|7387642|FG001|Received Treatment|Overall Study||6
6470357|NCT01254565|7387643|FG002|Received Treatment|Overall Study||21
6470358|NCT01254565|7387644|FG003|Received Treatment|Overall Study||21
6470359|NCT01254565|7387645|FG004|Received Treatment|Overall Study||13
6470360|NCT01254565|7387646|FG005|Received Treatment|Overall Study||13
6470361|NCT01254565|7387641|FG000|COMPLETED|Overall Study||4
6470362|NCT01254565|7387642|FG001|COMPLETED|Overall Study||6
6470363|NCT01254565|7387643|FG002|COMPLETED|Overall Study||21
6470364|NCT01254565|7387644|FG003|COMPLETED|Overall Study||20
6470365|NCT01254565|7387645|FG004|COMPLETED|Overall Study||12
6470366|NCT01254565|7387646|FG005|COMPLETED|Overall Study||13
6470367|NCT01254565|7387641|FG000|NOT COMPLETED|Overall Study||1
6470368|NCT01254565|7387642|FG001|NOT COMPLETED|Overall Study||1
6470369|NCT01254565|7387643|FG002|NOT COMPLETED|Overall Study||0
6470370|NCT01254565|7387644|FG003|NOT COMPLETED|Overall Study||1
6470371|NCT01254565|7387645|FG004|NOT COMPLETED|Overall Study||4
6470372|NCT01254565|7387646|FG005|NOT COMPLETED|Overall Study||4
6470373|NCT01254604|7387662|FG000|STARTED|Overall Study||95
6470374|NCT01254604|7387663|FG001|STARTED|Overall Study||95
6470375|NCT01254604|7387662|FG000|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
6470376|NCT01254604|7387663|FG001|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
6470377|NCT01254604|7387662|FG000|COMPLETED|Overall Study||87
6470378|NCT01254604|7387663|FG001|COMPLETED|Overall Study||86
6470379|NCT01254604|7387662|FG000|NOT COMPLETED|Overall Study||8
6470380|NCT01254604|7387663|FG001|NOT COMPLETED|Overall Study||9
6470381|NCT01254630|7387673|FG000|STARTED|Overall Study||1348
6470382|NCT01254630|7387674|FG001|STARTED|Overall Study||1288
6470383|NCT01254630|7387675|FG002|STARTED|Overall Study||1364
6470384|NCT01254630|7387676|FG003|STARTED|Overall Study||1285
6470385|NCT01254630|7387673|FG000|Received Vaccination 1|Overall Study||1328
6470386|NCT01254630|7387674|FG001|Received Vaccination 1|Overall Study||1277
6470387|NCT01254630|7387675|FG002|Received Vaccination 1|Overall Study||1350
6470388|NCT01254630|7387676|FG003|Received Vaccination 1|Overall Study||1275
6470389|NCT01254630|7387673|FG000|Received Vaccination 2|Overall Study||1255
6470390|NCT01254630|7387674|FG001|Received Vaccination 2|Overall Study||1217
6470391|NCT01254630|7387675|FG002|Received Vaccination 2|Overall Study||1286
6470392|NCT01254630|7387676|FG003|Received Vaccination 2|Overall Study||1226
6470393|NCT01254630|7387673|FG000|Received Vaccination 3|Overall Study||1198
6470394|NCT01254630|7387674|FG001|Received Vaccination 3|Overall Study||1178
6470395|NCT01254630|7387675|FG002|Received Vaccination 3|Overall Study||1247
6470396|NCT01254630|7387676|FG003|Received Vaccination 3|Overall Study||1194
6470397|NCT01254630|7387673|FG000|Received Vaccination 4|Overall Study||1155
6470398|NCT01254630|7387674|FG001|Received Vaccination 4|Overall Study||1145
6470399|NCT01254630|7387675|FG002|Received Vaccination 4|Overall Study||1212
6470400|NCT01254630|7387676|FG003|Received Vaccination 4|Overall Study||1160
6470401|NCT01254630|7387673|FG000|COMPLETED|Overall Study||546
6470402|NCT01254630|7387674|FG001|COMPLETED|Overall Study||0
6470403|NCT01254630|7387675|FG002|COMPLETED|Overall Study||552
6470404|NCT01254630|7387676|FG003|COMPLETED|Overall Study||0
6470405|NCT01254630|7387673|FG000|NOT COMPLETED|Overall Study||802
6470406|NCT01254630|7387674|FG001|NOT COMPLETED|Overall Study||1288
6470407|NCT01254630|7387675|FG002|NOT COMPLETED|Overall Study||812
6470408|NCT01254630|7387676|FG003|NOT COMPLETED|Overall Study||1285
6470409|NCT01254643|7387684|FG000|STARTED|Overall Study||100
6470410|NCT01254643|7387684|FG000|Vaccination 1|Overall Study||100
6470411|NCT01254643|7387684|FG000|Vaccination 2|Overall Study||99
6470412|NCT01254643|7387684|FG000|Vaccination 3|Overall Study||99
6470413|NCT01254643|7387684|FG000|COMPLETED|Overall Study||99
6470414|NCT01254643|7387684|FG000|NOT COMPLETED|Overall Study||1
6470415|NCT01254656|7387691|FG000|STARTED|Overall Study||47
6470416|NCT01254656|7387692|FG001|STARTED|Overall Study||43
6470417|NCT01254656|7387693|FG002|STARTED|Overall Study||18
6470418|NCT01254656|7387691|FG000|Treated|Overall Study||47
6470419|NCT01254656|7387692|FG001|Treated|Overall Study||43
6470420|NCT01254656|7387693|FG002|Treated|Overall Study||18
6470421|NCT01254656|7387691|FG000|COMPLETED|Overall Study||0
6470422|NCT01254656|7387692|FG001|COMPLETED|Overall Study||0
6470423|NCT01254656|7387693|FG002|COMPLETED|Overall Study||0
6470424|NCT01254656|7387691|FG000|NOT COMPLETED|Overall Study||47
6470425|NCT01254656|7387692|FG001|NOT COMPLETED|Overall Study||43
6470426|NCT01254656|7387693|FG002|NOT COMPLETED|Overall Study||18
6470427|NCT01254669|7387703|FG000|STARTED|Overall Study||100
6470428|NCT01254669|7387704|FG001|STARTED|Overall Study||100
6470429|NCT01254669|7387703|FG000|COMPLETED|Overall Study||97
6470430|NCT01254669|7387704|FG001|COMPLETED|Overall Study||96
6470431|NCT01254669|7387703|FG000|NOT COMPLETED|Overall Study||3
6470432|NCT01254669|7387704|FG001|NOT COMPLETED|Overall Study||4
6470433|NCT01254721|7387714|FG000|STARTED|Overall Study|Seroquel XR: 300mg|67
6470434|NCT01254721|7387715|FG001|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
6470435|NCT01254721|7387714|FG000|COMPLETED|Overall Study||52
6470436|NCT01254721|7387715|FG001|COMPLETED|Overall Study||42
6470437|NCT01254721|7387714|FG000|NOT COMPLETED|Overall Study||15
6470438|NCT01254721|7387715|FG001|NOT COMPLETED|Overall Study||22
6470439|NCT01254747|7387725|FG000|STARTED|Overall Study||40
6470440|NCT01254747|7387726|FG001|STARTED|Overall Study||29
6470441|NCT01254747|7387727|FG002|STARTED|Overall Study||30
6470442|NCT01254747|7387728|FG003|STARTED|Overall Study||30
6470443|NCT01254747|7387725|FG000|COMPLETED|Overall Study||40
6470444|NCT01254747|7387726|FG001|COMPLETED|Overall Study||23
6470445|NCT01254747|7387727|FG002|COMPLETED|Overall Study||26
6470446|NCT01254747|7387728|FG003|COMPLETED|Overall Study||28
6470447|NCT01254747|7387725|FG000|NOT COMPLETED|Overall Study||0
6470448|NCT01254747|7387726|FG001|NOT COMPLETED|Overall Study||6
6470449|NCT01254747|7387727|FG002|NOT COMPLETED|Overall Study||4
6470450|NCT01254747|7387728|FG003|NOT COMPLETED|Overall Study||2
6470451|NCT01254760|7387738|FG000|STARTED|First Period, 5 Days of Wear||34
6470452|NCT01254760|7387739|FG001|STARTED|First Period, 5 Days of Wear||38
6470453|NCT01254760|7387738|FG000|COMPLETED|First Period, 5 Days of Wear||34
6470454|NCT01254760|7387739|FG001|COMPLETED|First Period, 5 Days of Wear||38
6470455|NCT01254760|7387738|FG000|NOT COMPLETED|First Period, 5 Days of Wear||0
6470456|NCT01254760|7387739|FG001|NOT COMPLETED|First Period, 5 Days of Wear||0
6470457|NCT01254760|7387738|FG000|STARTED|Second Period, 5 Days of Wear||34
6470458|NCT01254760|7387739|FG001|STARTED|Second Period, 5 Days of Wear||38
6470459|NCT01254760|7387738|FG000|COMPLETED|Second Period, 5 Days of Wear||34
6470460|NCT01254760|7387739|FG001|COMPLETED|Second Period, 5 Days of Wear||38
6470461|NCT01254760|7387738|FG000|NOT COMPLETED|Second Period, 5 Days of Wear||0
6470462|NCT01254760|7387739|FG001|NOT COMPLETED|Second Period, 5 Days of Wear||0
6501022|NCT01426412|7419508|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
6501023|NCT01426412|7419509|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
6501024|NCT01426412|7419510|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
6501025|NCT01426412|7419511|FG007|Received at Least 1 Dose of Study Drug|Overall Study||10
6501026|NCT01426412|7419512|FG008|Received at Least 1 Dose of Study Drug|Overall Study||17
6501027|NCT01426412|7419504|FG000|COMPLETED|Overall Study||5
6501028|NCT01426412|7419505|FG001|COMPLETED|Overall Study||6
6501029|NCT01426412|7419506|FG002|COMPLETED|Overall Study||6
6501030|NCT01426412|7419507|FG003|COMPLETED|Overall Study||6
6501031|NCT01426412|7419508|FG004|COMPLETED|Overall Study||5
6501032|NCT01426412|7419509|FG005|COMPLETED|Overall Study||6
6501033|NCT01426412|7419510|FG006|COMPLETED|Overall Study||6
6501034|NCT01426412|7419511|FG007|COMPLETED|Overall Study||7
6501035|NCT01426412|7419512|FG008|COMPLETED|Overall Study||16
6501036|NCT01426412|7419504|FG000|NOT COMPLETED|Overall Study||1
6501037|NCT01426412|7419505|FG001|NOT COMPLETED|Overall Study||0
6501038|NCT01426412|7419506|FG002|NOT COMPLETED|Overall Study||0
6501039|NCT01426412|7419507|FG003|NOT COMPLETED|Overall Study||0
6501040|NCT01426412|7419508|FG004|NOT COMPLETED|Overall Study||1
6501041|NCT01426412|7419509|FG005|NOT COMPLETED|Overall Study||0
6501042|NCT01426412|7419510|FG006|NOT COMPLETED|Overall Study||0
6501043|NCT01426412|7419511|FG007|NOT COMPLETED|Overall Study||3
6501044|NCT01426412|7419512|FG008|NOT COMPLETED|Overall Study||1
6501045|NCT01426425|7419543|FG000|STARTED|Overall Study||572
6501046|NCT01426425|7419543|FG000|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
6501047|NCT01426425|7419543|FG000|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
6501048|NCT01426425|7419543|FG000|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
6501049|NCT01426425|7419543|FG000|NOT COMPLETED|Overall Study||175
6501050|NCT01426438|7419550|FG000|STARTED|Overall Study||50
6501051|NCT01426438|7419551|FG001|STARTED|Overall Study||49
6501052|NCT01426438|7419550|FG000|COMPLETED|Overall Study||35
6501053|NCT01426438|7419551|FG001|COMPLETED|Overall Study||39
6470463|NCT01254851|7387748|FG000|STARTED|Overall Study||69
6470464|NCT01254851|7387749|FG001|STARTED|Overall Study||77
6470465|NCT01254851|7387748|FG000|COMPLETED|Overall Study||61
6470466|NCT01254851|7387749|FG001|COMPLETED|Overall Study||68
6470467|NCT01254851|7387748|FG000|NOT COMPLETED|Overall Study||8
6470468|NCT01254851|7387749|FG001|NOT COMPLETED|Overall Study||9
6470469|NCT01254877|7387758|FG000|STARTED|Overall Study||67
6470470|NCT01254877|7387759|FG001|STARTED|Overall Study||69
6470471|NCT01254877|7387760|FG002|STARTED|Overall Study||69
6470472|NCT01254877|7387758|FG000|COMPLETED|Overall Study||57
6470473|NCT01254877|7387759|FG001|COMPLETED|Overall Study||58
6470474|NCT01254877|7387760|FG002|COMPLETED|Overall Study||64
6470475|NCT01254877|7387758|FG000|NOT COMPLETED|Overall Study||10
6470476|NCT01254877|7387759|FG001|NOT COMPLETED|Overall Study||11
6470477|NCT01254877|7387760|FG002|NOT COMPLETED|Overall Study||5
6470478|NCT01254890|7387770|FG000|STARTED|Overall Study||3
6470479|NCT01254890|7387771|FG001|STARTED|Overall Study||57
6470480|NCT01254890|7387770|FG000|COMPLETED|Overall Study||2
6470481|NCT01254890|7387771|FG001|COMPLETED|Overall Study||47
6470482|NCT01254890|7387770|FG000|NOT COMPLETED|Overall Study||1
6470483|NCT01254890|7387771|FG001|NOT COMPLETED|Overall Study||10
6470484|NCT01255137|7387776|FG000|STARTED|Overall Study||13
6470485|NCT01255137|7387776|FG000|COMPLETED|Overall Study||13
6470486|NCT01255137|7387776|FG000|NOT COMPLETED|Overall Study||0
6470487|NCT01255163|7387782|FG000|STARTED|Overall Study||13
6470488|NCT01255163|7387783|FG001|STARTED|Overall Study||14
6470489|NCT01255163|7387782|FG000|COMPLETED|Overall Study||9
6470490|NCT01255163|7387783|FG001|COMPLETED|Overall Study||9
6470491|NCT01255163|7387782|FG000|NOT COMPLETED|Overall Study||4
6470492|NCT01255163|7387783|FG001|NOT COMPLETED|Overall Study||5
6470493|NCT01255306|7387793|FG000|STARTED|Overall Study||26
6470494|NCT01255306|7387794|FG001|STARTED|Overall Study||33
6470495|NCT01255306|7387793|FG000|COMPLETED|Overall Study||25
6470496|NCT01255306|7387794|FG001|COMPLETED|Overall Study||32
6470497|NCT01255306|7387793|FG000|NOT COMPLETED|Overall Study||1
6470498|NCT01255306|7387794|FG001|NOT COMPLETED|Overall Study||1
6470499|NCT01255423|7387805|FG000|STARTED|Overall Study||104
6470500|NCT01255423|7387806|FG001|STARTED|Overall Study||102
6470501|NCT01255423|7387805|FG000|COMPLETED|Overall Study||101
6470502|NCT01255423|7387806|FG001|COMPLETED|Overall Study||99
6470503|NCT01255423|7387805|FG000|NOT COMPLETED|Overall Study||3
6470504|NCT01255423|7387806|FG001|NOT COMPLETED|Overall Study||3
6470505|NCT01255436|7387814|FG000|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
6470506|NCT01255436|7387815|FG001|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
6470507|NCT01255436|7387814|FG000|COMPLETED|Overall Study||151
6470508|NCT01255436|7387815|FG001|COMPLETED|Overall Study||135
6470509|NCT01255436|7387814|FG000|NOT COMPLETED|Overall Study||182
6470510|NCT01255436|7387815|FG001|NOT COMPLETED|Overall Study||194
6470511|NCT01255449|7387821|FG000|STARTED|Overall Study||26
6470512|NCT01255449|7387821|FG000|COMPLETED|Overall Study||26
6470513|NCT01255449|7387821|FG000|NOT COMPLETED|Overall Study||0
6470514|NCT01255592|7387828|FG000|STARTED|Overall Study||26
6470515|NCT01255592|7387829|FG001|STARTED|Overall Study||26
6470516|NCT01255592|7387828|FG000|COMPLETED|Overall Study||20
6470517|NCT01255592|7387829|FG001|COMPLETED|Overall Study||25
6470518|NCT01255592|7387828|FG000|NOT COMPLETED|Overall Study||6
6470519|NCT01255592|7387829|FG001|NOT COMPLETED|Overall Study||1
6470520|NCT01255631|7387838|FG000|STARTED|Overall Study||13
6470521|NCT01255631|7387839|FG001|STARTED|Overall Study||9
6470522|NCT01255631|7387838|FG000|COMPLETED|Overall Study|study terminated due to poor enrollment|4
6470523|NCT01255631|7387839|FG001|COMPLETED|Overall Study|study terminated due to poor enrollment|3
6470524|NCT01255631|7387838|FG000|NOT COMPLETED|Overall Study||9
6470525|NCT01255631|7387839|FG001|NOT COMPLETED|Overall Study||6
6470526|NCT01255670|7387847|FG000|STARTED|Overall Study||100
6470527|NCT01255670|7387848|FG001|STARTED|Overall Study||100
6470528|NCT01255670|7387847|FG000|COMPLETED|Overall Study||74
6470529|NCT01255670|7387848|FG001|COMPLETED|Overall Study||80
6470530|NCT01255670|7387847|FG000|NOT COMPLETED|Overall Study||26
6470531|NCT01255670|7387848|FG001|NOT COMPLETED|Overall Study||20
6470532|NCT01255722|7387857|FG000|STARTED|Overall Study||155
6470533|NCT01255722|7387858|FG001|STARTED|Overall Study||160
6470534|NCT01255722|7387859|FG002|STARTED|Overall Study||153
6470535|NCT01255722|7387857|FG000|COMPLETED|Overall Study||152
6470536|NCT01255722|7387858|FG001|COMPLETED|Overall Study||159
6470537|NCT01255722|7387859|FG002|COMPLETED|Overall Study||152
6470538|NCT01255722|7387857|FG000|NOT COMPLETED|Overall Study||3
6470539|NCT01255722|7387858|FG001|NOT COMPLETED|Overall Study||1
6470540|NCT01255722|7387859|FG002|NOT COMPLETED|Overall Study||1
6470541|NCT01255761|7387870|FG000|STARTED|Overall Study||369
6470542|NCT01255761|7387871|FG001|STARTED|Overall Study||367
6470543|NCT01255761|7387870|FG000|COMPLETED|Overall Study||187
6470544|NCT01255761|7387871|FG001|COMPLETED|Overall Study||192
6470545|NCT01255761|7387870|FG000|NOT COMPLETED|Overall Study||182
6470546|NCT01255761|7387871|FG001|NOT COMPLETED|Overall Study||175
6470547|NCT01255787|7387881|FG000|STARTED|Overall Study||152
6470548|NCT01255787|7387882|FG001|STARTED|Overall Study||144
6470549|NCT01255787|7387883|FG002|STARTED|Overall Study||150
6470550|NCT01255787|7387884|FG003|STARTED|Overall Study||154
6470551|NCT01255787|7387881|FG000|Treated|Overall Study||152
6470552|NCT01255787|7387882|FG001|Treated|Overall Study||144
6470553|NCT01255787|7387883|FG002|Treated|Overall Study||148
6470554|NCT01255787|7387884|FG003|Treated|Overall Study||150
6470555|NCT01255787|7387881|FG000|COMPLETED|Overall Study||136
6470556|NCT01255787|7387882|FG001|COMPLETED|Overall Study||127
6470557|NCT01255787|7387883|FG002|COMPLETED|Overall Study||132
6470558|NCT01255787|7387884|FG003|COMPLETED|Overall Study||132
6470559|NCT01255787|7387881|FG000|NOT COMPLETED|Overall Study||16
6470560|NCT01255787|7387882|FG001|NOT COMPLETED|Overall Study||17
6470561|NCT01255787|7387883|FG002|NOT COMPLETED|Overall Study||18
6470562|NCT01255787|7387884|FG003|NOT COMPLETED|Overall Study||22
6470563|NCT01255865|7387901|FG000|STARTED|Overall Study||1
6470564|NCT01255865|7387902|FG001|STARTED|Overall Study||10
6470565|NCT01255865|7387903|FG002|STARTED|Overall Study||10
6470566|NCT01255865|7387904|FG003|STARTED|Overall Study||30
6470567|NCT01255865|7387905|FG004|STARTED|Overall Study||20
6470568|NCT01255865|7387906|FG005|STARTED|Overall Study||20
6470569|NCT01255865|7387907|FG006|STARTED|Overall Study||20
6470570|NCT01255865|7387901|FG000|COMPLETED|Overall Study||1
6470571|NCT01255865|7387902|FG001|COMPLETED|Overall Study||10
6470572|NCT01255865|7387903|FG002|COMPLETED|Overall Study||10
6470573|NCT01255865|7387904|FG003|COMPLETED|Overall Study||30
6470574|NCT01255865|7387905|FG004|COMPLETED|Overall Study||20
6470575|NCT01255865|7387906|FG005|COMPLETED|Overall Study||20
6470576|NCT01255865|7387907|FG006|COMPLETED|Overall Study||20
6470577|NCT01255865|7387901|FG000|NOT COMPLETED|Overall Study||0
6470578|NCT01255865|7387902|FG001|NOT COMPLETED|Overall Study||0
6470579|NCT01255865|7387903|FG002|NOT COMPLETED|Overall Study||0
6470580|NCT01255865|7387904|FG003|NOT COMPLETED|Overall Study||0
6470581|NCT01255865|7387905|FG004|NOT COMPLETED|Overall Study||0
6470582|NCT01255865|7387906|FG005|NOT COMPLETED|Overall Study||0
6470583|NCT01255865|7387907|FG006|NOT COMPLETED|Overall Study||0
6470584|NCT01255904|7387925|FG000|STARTED|Overall Study||45
6470585|NCT01255904|7387926|FG001|STARTED|Overall Study||45
6470586|NCT01255904|7387925|FG000|COMPLETED|Overall Study||44
6470587|NCT01255904|7387926|FG001|COMPLETED|Overall Study||41
6470588|NCT01255904|7387925|FG000|NOT COMPLETED|Overall Study||1
6470589|NCT01255904|7387926|FG001|NOT COMPLETED|Overall Study||4
6470590|NCT01256008|7387935|FG000|STARTED|Overall Study||98
6470591|NCT01256008|7387936|FG001|STARTED|Overall Study||98
6470592|NCT01256008|7387937|FG002|STARTED|Overall Study||196
6470593|NCT01256008|7387935|FG000|COMPLETED|Overall Study||90
6470594|NCT01256008|7387936|FG001|COMPLETED|Overall Study||91
6470595|NCT01256008|7387937|FG002|COMPLETED|Overall Study||175
6470596|NCT01256008|7387935|FG000|NOT COMPLETED|Overall Study||8
6470597|NCT01256008|7387936|FG001|NOT COMPLETED|Overall Study||7
6470598|NCT01256008|7387937|FG002|NOT COMPLETED|Overall Study||21
6470599|NCT01256034|7387949|FG000|STARTED|Overall Study||25
6470600|NCT01256034|7387950|FG001|STARTED|Overall Study||25
6470601|NCT01256034|7387949|FG000|COMPLETED|Overall Study||0
6470602|NCT01256034|7387950|FG001|COMPLETED|Overall Study||0
6470603|NCT01256034|7387949|FG000|NOT COMPLETED|Overall Study||25
6470604|NCT01256034|7387950|FG001|NOT COMPLETED|Overall Study||25
6470605|NCT01256060|7387956|FG000|STARTED|Overall Study||3
6470606|NCT01256060|7387957|FG001|STARTED|Overall Study||3
6470607|NCT01256060|7387958|FG002|STARTED|Overall Study||3
6470608|NCT01256060|7387959|FG003|STARTED|Overall Study||6
6470609|NCT01256060|7387956|FG000|COMPLETED|Overall Study||3
6470610|NCT01256060|7387957|FG001|COMPLETED|Overall Study||2
6470611|NCT01256060|7387958|FG002|COMPLETED|Overall Study||3
6470612|NCT01256060|7387959|FG003|COMPLETED|Overall Study||6
6470613|NCT01256060|7387956|FG000|NOT COMPLETED|Overall Study||0
6470614|NCT01256060|7387957|FG001|NOT COMPLETED|Overall Study||1
6470615|NCT01256060|7387958|FG002|NOT COMPLETED|Overall Study||0
6470616|NCT01256060|7387959|FG003|NOT COMPLETED|Overall Study||0
6470617|NCT01256164|7387967|FG000|STARTED|Overall Study||47
6470618|NCT01256164|7387968|FG001|STARTED|Overall Study||23
6470619|NCT01256164|7387967|FG000|COMPLETED|Overall Study||47
6470620|NCT01256164|7387968|FG001|COMPLETED|Overall Study||23
6470621|NCT01256164|7387967|FG000|NOT COMPLETED|Overall Study||0
6470622|NCT01256164|7387968|FG001|NOT COMPLETED|Overall Study||0
6470623|NCT01256177|7387976|FG000|STARTED|Overall Study||148
6470624|NCT01256177|7387977|FG001|STARTED|Overall Study||148
6470625|NCT01256177|7387976|FG000|COMPLETED|Overall Study||98
6470626|NCT01256177|7387977|FG001|COMPLETED|Overall Study||111
6470627|NCT01256177|7387976|FG000|NOT COMPLETED|Overall Study||50
6470628|NCT01256177|7387977|FG001|NOT COMPLETED|Overall Study||37
6470629|NCT01256190|7387985|FG000|STARTED|Overall Study||39
6470630|NCT01256190|7387986|FG001|STARTED|Overall Study||17
6470631|NCT01256190|7387985|FG000|COMPLETED|Overall Study||37
6470632|NCT01256190|7387986|FG001|COMPLETED|Overall Study||17
6470633|NCT01256190|7387985|FG000|NOT COMPLETED|Overall Study||2
6470634|NCT01256190|7387986|FG001|NOT COMPLETED|Overall Study||0
6470635|NCT01256294|7387992|FG000|STARTED|Overall Study||36
6470636|NCT01256294|7387993|FG001|STARTED|Overall Study||35
6470637|NCT01256294|7387992|FG000|COMPLETED|Overall Study||32
6470638|NCT01256294|7387993|FG001|COMPLETED|Overall Study||33
6470639|NCT01256294|7387992|FG000|NOT COMPLETED|Overall Study||4
6470640|NCT01256294|7387993|FG001|NOT COMPLETED|Overall Study||2
6470641|NCT01256385|7388001|FG000|STARTED|Overall Study||43
6470642|NCT01256385|7388002|FG001|STARTED|Overall Study||43
6470643|NCT01256385|7388001|FG000|Crossover From Arm B to Arm A|Overall Study||0
6470644|NCT01256385|7388002|FG001|Crossover From Arm B to Arm A|Overall Study||15
6470645|NCT01256385|7388001|FG000|COMPLETED|Overall Study||40
6470646|NCT01256385|7388002|FG001|COMPLETED|Overall Study||40
6470647|NCT01256385|7388001|FG000|NOT COMPLETED|Overall Study||3
6470648|NCT01256385|7388002|FG001|NOT COMPLETED|Overall Study||3
6470649|NCT01256411|7388012|FG000|STARTED|Extension by Maximum Treatment||139
6470650|NCT01256411|7388013|FG001|STARTED|Extension by Maximum Treatment||89
6470651|NCT01256411|7388014|FG002|STARTED|Extension by Maximum Treatment||109
6470652|NCT01256411|7388015|FG003|STARTED|Extension by Maximum Treatment||4
6470653|NCT01256411|7388016|FG004|STARTED|Extension by Maximum Treatment||0
6470654|NCT01256411|7388017|FG005|STARTED|Extension by Maximum Treatment||0
6470655|NCT01256411|7388012|FG000|Down Titrated to 100 mg|Extension by Maximum Treatment||12
6470656|NCT01256411|7388013|FG001|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6470657|NCT01256411|7388014|FG002|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6470658|NCT01256411|7388015|FG003|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6470659|NCT01256411|7388016|FG004|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6470660|NCT01256411|7388017|FG005|Down Titrated to 100 mg|Extension by Maximum Treatment||0
6470661|NCT01256411|7388012|FG000|COMPLETED|Extension by Maximum Treatment||132
6470662|NCT01256411|7388013|FG001|COMPLETED|Extension by Maximum Treatment||79
6470663|NCT01256411|7388014|FG002|COMPLETED|Extension by Maximum Treatment||105
6470664|NCT01256411|7388015|FG003|COMPLETED|Extension by Maximum Treatment||4
6470665|NCT01256411|7388016|FG004|COMPLETED|Extension by Maximum Treatment||0
6470666|NCT01256411|7388017|FG005|COMPLETED|Extension by Maximum Treatment||0
6470667|NCT01256411|7388012|FG000|NOT COMPLETED|Extension by Maximum Treatment||7
6470668|NCT01256411|7388013|FG001|NOT COMPLETED|Extension by Maximum Treatment||10
6470669|NCT01256411|7388014|FG002|NOT COMPLETED|Extension by Maximum Treatment||4
6470670|NCT01256411|7388015|FG003|NOT COMPLETED|Extension by Maximum Treatment||0
6470671|NCT01256411|7388016|FG004|NOT COMPLETED|Extension by Maximum Treatment||0
6554361|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6554362|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6554363|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6554364|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6554365|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6554366|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6470672|NCT01256411|7388017|FG005|NOT COMPLETED|Extension by Maximum Treatment||0
6470673|NCT01256411|7388012|FG000|STARTED|Extension by Mono or Combination Therapy||0
6470674|NCT01256411|7388013|FG001|STARTED|Extension by Mono or Combination Therapy||0
6470675|NCT01256411|7388014|FG002|STARTED|Extension by Mono or Combination Therapy||0
6470676|NCT01256411|7388015|FG003|STARTED|Extension by Mono or Combination Therapy||0
6470677|NCT01256411|7388016|FG004|STARTED|Extension by Mono or Combination Therapy||228
6470678|NCT01256411|7388017|FG005|STARTED|Extension by Mono or Combination Therapy||113
6470679|NCT01256411|7388012|FG000|COMPLETED|Extension by Mono or Combination Therapy||0
6470680|NCT01256411|7388013|FG001|COMPLETED|Extension by Mono or Combination Therapy||0
6470681|NCT01256411|7388014|FG002|COMPLETED|Extension by Mono or Combination Therapy||0
6470682|NCT01256411|7388015|FG003|COMPLETED|Extension by Mono or Combination Therapy||0
6554367|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6554368|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6554369|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Washout Period 4||0
6554370|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Fifth Intervention||0
6554371|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Fifth Intervention||0
6554372|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Fifth Intervention||0
6554373|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Fifth Intervention||5
6554374|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Fifth Intervention||6
6554375|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Fifth Intervention||5
6470683|NCT01256411|7388016|FG004|COMPLETED|Extension by Mono or Combination Therapy||211
6470684|NCT01256411|7388017|FG005|COMPLETED|Extension by Mono or Combination Therapy||109
6470685|NCT01256411|7388012|FG000|NOT COMPLETED|Extension by Mono or Combination Therapy||0
6470686|NCT01256411|7388013|FG001|NOT COMPLETED|Extension by Mono or Combination Therapy||0
6470687|NCT01256411|7388014|FG002|NOT COMPLETED|Extension by Mono or Combination Therapy||0
6470688|NCT01256411|7388015|FG003|NOT COMPLETED|Extension by Mono or Combination Therapy||0
6470689|NCT01256411|7388016|FG004|NOT COMPLETED|Extension by Mono or Combination Therapy||17
6470690|NCT01256411|7388017|FG005|NOT COMPLETED|Extension by Mono or Combination Therapy||4
6470691|NCT01256424|7388035|FG000|STARTED|Overall Study||65
6470692|NCT01256424|7388036|FG001|STARTED|Overall Study||67
6470693|NCT01256424|7388037|FG002|STARTED|Overall Study||62
6470694|NCT01256424|7388038|FG003|STARTED|Overall Study||68
6470695|NCT01256424|7388035|FG000|COMPLETED|Overall Study||56
6470696|NCT01256424|7388036|FG001|COMPLETED|Overall Study||59
6470697|NCT01256424|7388037|FG002|COMPLETED|Overall Study||55
6470698|NCT01256424|7388038|FG003|COMPLETED|Overall Study||61
6470699|NCT01256424|7388035|FG000|NOT COMPLETED|Overall Study||9
6470700|NCT01256424|7388036|FG001|NOT COMPLETED|Overall Study||8
6470701|NCT01256424|7388037|FG002|NOT COMPLETED|Overall Study||7
6554376|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Fifth Intervention||5
6554377|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Fifth Intervention||6
6554378|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Fifth Intervention||5
6554379|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Fifth Intervention||0
6554380|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Fifth Intervention||0
6554381|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Fifth Intervention||0
6470702|NCT01256424|7388038|FG003|NOT COMPLETED|Overall Study||7
6470703|NCT01256450|7388051|FG000|STARTED|Open-label Titration||334
6470704|NCT01256450|7388052|FG001|STARTED|Open-label Titration||0
6470705|NCT01256450|7388053|FG002|STARTED|Open-label Titration||0
6470706|NCT01256450|7388051|FG000|COMPLETED|Open-label Titration||235
6470707|NCT01256450|7388052|FG001|COMPLETED|Open-label Titration||0
6470708|NCT01256450|7388053|FG002|COMPLETED|Open-label Titration||0
6470709|NCT01256450|7388051|FG000|NOT COMPLETED|Open-label Titration||99
6470710|NCT01256450|7388052|FG001|NOT COMPLETED|Open-label Titration||0
6470711|NCT01256450|7388053|FG002|NOT COMPLETED|Open-label Titration||0
6470712|NCT01256450|7388051|FG000|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
6470713|NCT01256450|7388052|FG001|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
6470714|NCT01256450|7388053|FG002|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
6470715|NCT01256450|7388051|FG000|COMPLETED|Double-blind Treatment||0
6470716|NCT01256450|7388052|FG001|COMPLETED|Double-blind Treatment||89
6470717|NCT01256450|7388053|FG002|COMPLETED|Double-blind Treatment||81
6470718|NCT01256450|7388051|FG000|NOT COMPLETED|Double-blind Treatment||0
6470719|NCT01256450|7388052|FG001|NOT COMPLETED|Double-blind Treatment||28
6470720|NCT01256450|7388053|FG002|NOT COMPLETED|Double-blind Treatment||37
6470721|NCT01256476|7388062|FG000|STARTED|Overall Study||164
6470722|NCT01256476|7388063|FG001|STARTED|Overall Study||164
6470723|NCT01256476|7388062|FG000|COMPLETED|Overall Study||158
6470724|NCT01256476|7388063|FG001|COMPLETED|Overall Study||157
6470725|NCT01256476|7388062|FG000|NOT COMPLETED|Overall Study||6
6470726|NCT01256476|7388063|FG001|NOT COMPLETED|Overall Study||7
6470727|NCT01256502|7388069|FG000|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
6470728|NCT01256502|7388069|FG000|COMPLETED|Overall Study||129
6470729|NCT01256502|7388069|FG000|NOT COMPLETED|Overall Study||10
6470730|NCT01256567|7388078|FG000|STARTED|Overall Study||7
6470731|NCT01256567|7388078|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
6470732|NCT01256567|7388078|FG000|COMPLETED|Overall Study||6
6470733|NCT01256567|7388078|FG000|NOT COMPLETED|Overall Study||1
6470734|NCT01256593|7388083|FG000|STARTED|Overall Study||3827
6470735|NCT01256593|7388083|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|3613
6470736|NCT01256593|7388083|FG000|NOT COMPLETED|Overall Study||214
6470737|NCT01256658|7388089|FG000|STARTED|Period 1||6817
6470738|NCT01256658|7388090|FG001|STARTED|Period 1||7258
6470739|NCT01256658|7388089|FG000|COMPLETED|Period 1||5897
6470740|NCT01256658|7388090|FG001|COMPLETED|Period 1||6510
6470741|NCT01256658|7388089|FG000|NOT COMPLETED|Period 1||920
6470742|NCT01256658|7388090|FG001|NOT COMPLETED|Period 1||748
6470743|NCT01256658|7388089|FG000|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
6470744|NCT01256658|7388090|FG001|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
6470745|NCT01256658|7388089|FG000|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
6470746|NCT01256658|7388090|FG001|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
6470747|NCT01256658|7388089|FG000|Death|Period 2 - Follow up Only - No Treatment||6
6470748|NCT01256658|7388090|FG001|Death|Period 2 - Follow up Only - No Treatment||8
6470749|NCT01256658|7388089|FG000|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
6470750|NCT01256658|7388090|FG001|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
6470751|NCT01256658|7388089|FG000|COMPLETED|Period 2 - Follow up Only - No Treatment||0
6470752|NCT01256658|7388090|FG001|COMPLETED|Period 2 - Follow up Only - No Treatment||0
6470753|NCT01256658|7388089|FG000|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
6470754|NCT01256658|7388090|FG001|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
6470755|NCT01256671|7388099|FG000|STARTED|Overall Study||530
6470756|NCT01256671|7388099|FG000|Safety Population|Overall Study||521
6470757|NCT01256671|7388099|FG000|COMPLETED|Overall Study||435
6470758|NCT01256671|7388099|FG000|NOT COMPLETED|Overall Study||95
6470759|NCT01256684|7388106|FG000|STARTED|Overall Study||81
6470760|NCT01256684|7388107|FG001|STARTED|Overall Study||87
6470761|NCT01256684|7388108|FG002|STARTED|Overall Study||87
6470762|NCT01256684|7388106|FG000|Safety Population|Overall Study||80
6470763|NCT01256684|7388107|FG001|Safety Population|Overall Study||86
6470764|NCT01256684|7388108|FG002|Safety Population|Overall Study||87
6470765|NCT01256684|7388106|FG000|ITT Population|Overall Study||77
6470766|NCT01256684|7388107|FG001|ITT Population|Overall Study||79
6470767|NCT01256684|7388108|FG002|ITT Population|Overall Study||81
6470768|NCT01256684|7388106|FG000|COMPLETED|Overall Study||72
6470769|NCT01256684|7388107|FG001|COMPLETED|Overall Study||74
6470770|NCT01256684|7388108|FG002|COMPLETED|Overall Study||76
6470771|NCT01256684|7388106|FG000|NOT COMPLETED|Overall Study||9
6470772|NCT01256684|7388107|FG001|NOT COMPLETED|Overall Study||13
6470773|NCT01256684|7388108|FG002|NOT COMPLETED|Overall Study||11
6470774|NCT01256788|7388119|FG000|STARTED|Overall Study||12
6470775|NCT01256788|7388120|FG001|STARTED|Overall Study||14
6470776|NCT01256788|7388121|FG002|STARTED|Overall Study||8
6470777|NCT01256788|7388119|FG000|COMPLETED|Overall Study||7
6470778|NCT01256788|7388120|FG001|COMPLETED|Overall Study||6
6470779|NCT01256788|7388121|FG002|COMPLETED|Overall Study||5
6470780|NCT01256788|7388119|FG000|NOT COMPLETED|Overall Study||5
6470781|NCT01256788|7388120|FG001|NOT COMPLETED|Overall Study||8
6470782|NCT01256788|7388121|FG002|NOT COMPLETED|Overall Study||3
6470783|NCT01256840|7388132|FG000|STARTED|Overall Study||30
6470784|NCT01256840|7388133|FG001|STARTED|Overall Study||16
6470785|NCT01256840|7388134|FG002|STARTED|Overall Study||25
6470786|NCT01256840|7388132|FG000|COMPLETED|Overall Study||30
6470787|NCT01256840|7388133|FG001|COMPLETED|Overall Study||16
6470788|NCT01256840|7388134|FG002|COMPLETED|Overall Study||25
6470789|NCT01256840|7388132|FG000|NOT COMPLETED|Overall Study||0
6470790|NCT01256840|7388133|FG001|NOT COMPLETED|Overall Study||0
6470791|NCT01256840|7388134|FG002|NOT COMPLETED|Overall Study||0
6470792|NCT01256879|7388142|FG000|STARTED|Overall Study|25 started in this cross-over study but only 24 completed|25
6470793|NCT01256879|7388142|FG000|CimTest-A|Overall Study|25 started this intervention but only 24 completed|25
6470794|NCT01256879|7388142|FG000|CimTest-B|Overall Study|24 started this intervention and 24 completed|24
6470795|NCT01256879|7388142|FG000|Sorbitol-free Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
6470796|NCT01256879|7388142|FG000|Commercial Cimetidine Solution|Overall Study|24 started this intervention and 24 completed|24
6470797|NCT01256879|7388142|FG000|COMPLETED|Overall Study||24
6470798|NCT01256879|7388142|FG000|NOT COMPLETED|Overall Study||1
6470799|NCT01256918|7388152|FG000|STARTED|Overall Study||200
6470800|NCT01256918|7388152|FG000|Full Thickness Nuclear Crack Achieved|Overall Study||200
6470801|NCT01256918|7388152|FG000|COMPLETED|Overall Study||200
6470802|NCT01256918|7388152|FG000|NOT COMPLETED|Overall Study||0
6470803|NCT01256944|7388165|FG000|STARTED|Overall Study||70
6470804|NCT01256944|7388166|FG001|STARTED|Overall Study||220
6470805|NCT01256944|7388165|FG000|COMPLETED|Overall Study||70
6470806|NCT01256944|7388166|FG001|COMPLETED|Overall Study||220
6470807|NCT01256944|7388165|FG000|NOT COMPLETED|Overall Study||0
6470808|NCT01256944|7388166|FG001|NOT COMPLETED|Overall Study||0
6470809|NCT01256983|7388178|FG000|STARTED|Overall Study||15
6470810|NCT01256983|7388179|FG001|STARTED|Overall Study||15
6470811|NCT01256983|7388178|FG000|COMPLETED|Overall Study||14
6470812|NCT01256983|7388179|FG001|COMPLETED|Overall Study||12
6470813|NCT01256983|7388178|FG000|NOT COMPLETED|Overall Study||1
6470814|NCT01256983|7388179|FG001|NOT COMPLETED|Overall Study||3
6470815|NCT01257087|7388187|FG000|STARTED|Overall Study||18
6470816|NCT01257087|7388188|FG001|STARTED|Overall Study||17
6470817|NCT01257087|7388187|FG000|COMPLETED|Overall Study||18
6470818|NCT01257087|7388188|FG001|COMPLETED|Overall Study||17
6470819|NCT01257087|7388187|FG000|NOT COMPLETED|Overall Study||0
6470820|NCT01257087|7388188|FG001|NOT COMPLETED|Overall Study||0
6470821|NCT01257204|7388197|FG000|STARTED|Treatment Period (up to Week 24)||50
6470822|NCT01257204|7388198|FG001|STARTED|Treatment Period (up to Week 24)||50
6470823|NCT01257204|7388199|FG002|STARTED|Treatment Period (up to Week 24)||51
6470824|NCT01257204|7388197|FG000|COMPLETED|Treatment Period (up to Week 24)||45
6470825|NCT01257204|7388198|FG001|COMPLETED|Treatment Period (up to Week 24)||44
6470826|NCT01257204|7388199|FG002|COMPLETED|Treatment Period (up to Week 24)||42
6470827|NCT01257204|7388197|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||5
6470828|NCT01257204|7388198|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
6470829|NCT01257204|7388199|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
6470830|NCT01257204|7388197|FG000|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
6470831|NCT01257204|7388198|FG001|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
6470832|NCT01257204|7388199|FG002|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
6470833|NCT01257204|7388197|FG000|COMPLETED|Follow-up Period (up to Week 48)||48
6470834|NCT01257204|7388198|FG001|COMPLETED|Follow-up Period (up to Week 48)||41
6470835|NCT01257204|7388199|FG002|COMPLETED|Follow-up Period (up to Week 48)||39
6470836|NCT01257204|7388197|FG000|NOT COMPLETED|Follow-up Period (up to Week 48)||1
6470837|NCT01257204|7388198|FG001|NOT COMPLETED|Follow-up Period (up to Week 48)||6
6470838|NCT01257204|7388199|FG002|NOT COMPLETED|Follow-up Period (up to Week 48)||10
6470839|NCT01257217|7388221|FG000|STARTED|Overall Study||15
6470840|NCT01257217|7388222|FG001|STARTED|Overall Study||10
6470841|NCT01257217|7388221|FG000|COMPLETED|Overall Study||13
6470842|NCT01257217|7388222|FG001|COMPLETED|Overall Study||10
6470843|NCT01257217|7388221|FG000|NOT COMPLETED|Overall Study||2
6554382|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Fifth Intervention||5
6554383|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Fifth Intervention||6
6554384|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Fifth Intervention||5
6470844|NCT01257217|7388222|FG001|NOT COMPLETED|Overall Study||0
6470845|NCT01257230|7388235|FG000|STARTED|Overall Study||138
6470846|NCT01257230|7388236|FG001|STARTED|Overall Study||125
6470847|NCT01257230|7388237|FG002|STARTED|Overall Study||135
6470848|NCT01257230|7388235|FG000|COMPLETED|Overall Study||132
6470849|NCT01257230|7388236|FG001|COMPLETED|Overall Study||115
6470850|NCT01257230|7388237|FG002|COMPLETED|Overall Study||129
6470851|NCT01257230|7388235|FG000|NOT COMPLETED|Overall Study||6
6470852|NCT01257230|7388236|FG001|NOT COMPLETED|Overall Study||10
6470853|NCT01257230|7388237|FG002|NOT COMPLETED|Overall Study||6
6470854|NCT01257347|7388250|FG000|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
6470855|NCT01257347|7388251|FG001|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
6470856|NCT01257347|7388252|FG002|STARTED|Overall Study||35
6470857|NCT01257347|7388253|FG003|STARTED|Overall Study||65
6470858|NCT01257347|7388250|FG000|COMPLETED|Overall Study||12
6470859|NCT01257347|7388251|FG001|COMPLETED|Overall Study||12
6470860|NCT01257347|7388252|FG002|COMPLETED|Overall Study||35
6470861|NCT01257347|7388253|FG003|COMPLETED|Overall Study||65
6470862|NCT01257347|7388250|FG000|NOT COMPLETED|Overall Study||0
6470863|NCT01257347|7388251|FG001|NOT COMPLETED|Overall Study||0
6470864|NCT01257347|7388252|FG002|NOT COMPLETED|Overall Study||0
6470865|NCT01257347|7388253|FG003|NOT COMPLETED|Overall Study||0
6470866|NCT01257425|7388268|FG000|STARTED|Overall Study||52
6470867|NCT01257425|7388269|FG001|STARTED|Overall Study||51
6470868|NCT01257425|7388268|FG000|COMPLETED|Overall Study||46
6470869|NCT01257425|7388269|FG001|COMPLETED|Overall Study||45
6470870|NCT01257425|7388268|FG000|NOT COMPLETED|Overall Study||6
6470871|NCT01257425|7388269|FG001|NOT COMPLETED|Overall Study||6
6470872|NCT01257438|7388277|FG000|STARTED|Overall Study||132
6470873|NCT01257438|7388278|FG001|STARTED|Overall Study||143
6470874|NCT01257438|7388277|FG000|COMPLETED|Overall Study||102
6470875|NCT01257438|7388278|FG001|COMPLETED|Overall Study||97
6470876|NCT01257438|7388277|FG000|NOT COMPLETED|Overall Study||30
6470877|NCT01257438|7388278|FG001|NOT COMPLETED|Overall Study||46
6470878|NCT01257503|7388286|FG000|STARTED|Overall Study||133
6470879|NCT01257503|7388287|FG001|STARTED|Overall Study||130
6470880|NCT01257503|7388286|FG000|Returned Symptom Diaries|Overall Study||80
6470881|NCT01257503|7388287|FG001|Returned Symptom Diaries|Overall Study||83
6470882|NCT01257503|7388286|FG000|Returned Dosage Logbooks|Overall Study||75
6470883|NCT01257503|7388287|FG001|Returned Dosage Logbooks|Overall Study||80
6470884|NCT01257503|7388286|FG000|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
6470885|NCT01257503|7388287|FG001|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
6470886|NCT01257503|7388286|FG000|NOT COMPLETED|Overall Study||8
6470887|NCT01257503|7388287|FG001|NOT COMPLETED|Overall Study||11
6470888|NCT01257542|7388295|FG000|STARTED|Overall Study||55
6470889|NCT01257542|7388296|FG001|STARTED|Overall Study||52
6470890|NCT01257542|7388295|FG000|COMPLETED|Overall Study||52
6654467|NCT02445963|7584303|FG003|NOT COMPLETED|Overall Study||0
6654468|NCT02446015|7584317|FG000|STARTED|Overall Study||34
6654469|NCT02446015|7584318|FG001|STARTED|Overall Study||63
6654470|NCT02446015|7584317|FG000|COMPLETED|Overall Study||33
6654471|NCT02446015|7584318|FG001|COMPLETED|Overall Study||62
6654472|NCT02446015|7584317|FG000|NOT COMPLETED|Overall Study||1
6654473|NCT02446015|7584318|FG001|NOT COMPLETED|Overall Study||1
6654474|NCT02446171|7584329|FG000|STARTED|Overall Study||11
6654475|NCT02446171|7584330|FG001|STARTED|Overall Study||11
6654476|NCT02446171|7584331|FG002|STARTED|Overall Study||11
6654477|NCT02446171|7584332|FG003|STARTED|Overall Study||11
6654478|NCT02446171|7584329|FG000|COMPLETED|Overall Study||11
6654479|NCT02446171|7584330|FG001|COMPLETED|Overall Study||11
6654480|NCT02446171|7584331|FG002|COMPLETED|Overall Study||9
6654481|NCT02446171|7584332|FG003|COMPLETED|Overall Study||11
6654482|NCT02446171|7584329|FG000|NOT COMPLETED|Overall Study||0
6654483|NCT02446171|7584330|FG001|NOT COMPLETED|Overall Study||0
6654484|NCT02446171|7584331|FG002|NOT COMPLETED|Overall Study||2
6654485|NCT02446171|7584332|FG003|NOT COMPLETED|Overall Study||0
6654486|NCT02446223|7584344|FG000|STARTED|Overall Study||21
6654487|NCT02446223|7584344|FG000|COMPLETED|Overall Study||20
6654488|NCT02446223|7584344|FG000|NOT COMPLETED|Overall Study||1
6654489|NCT02446314|7584352|FG000|STARTED|Zero to Twelve Weeks.||30
6654490|NCT02446314|7584353|FG001|STARTED|Zero to Twelve Weeks.||30
6654491|NCT02446314|7584354|FG002|STARTED|Zero to Twelve Weeks.||31
6654492|NCT02446314|7584355|FG003|STARTED|Zero to Twelve Weeks.||31
6654493|NCT02446314|7584352|FG000|COMPLETED|Zero to Twelve Weeks.||27
6654494|NCT02446314|7584353|FG001|COMPLETED|Zero to Twelve Weeks.||29
6654495|NCT02446314|7584354|FG002|COMPLETED|Zero to Twelve Weeks.||31
6654496|NCT02446314|7584355|FG003|COMPLETED|Zero to Twelve Weeks.||29
6654497|NCT02446314|7584352|FG000|NOT COMPLETED|Zero to Twelve Weeks.||3
6654498|NCT02446314|7584353|FG001|NOT COMPLETED|Zero to Twelve Weeks.||1
6654499|NCT02446314|7584354|FG002|NOT COMPLETED|Zero to Twelve Weeks.||0
6654500|NCT02446314|7584355|FG003|NOT COMPLETED|Zero to Twelve Weeks.||2
6654501|NCT02446314|7584352|FG000|STARTED|Thirteen to Twenty Four Weeks||27
6654502|NCT02446314|7584353|FG001|STARTED|Thirteen to Twenty Four Weeks||29
6654503|NCT02446314|7584354|FG002|STARTED|Thirteen to Twenty Four Weeks||31
6654504|NCT02446314|7584355|FG003|STARTED|Thirteen to Twenty Four Weeks||29
6654505|NCT02446314|7584352|FG000|COMPLETED|Thirteen to Twenty Four Weeks||27
6654506|NCT02446314|7584353|FG001|COMPLETED|Thirteen to Twenty Four Weeks||28
6654507|NCT02446314|7584354|FG002|COMPLETED|Thirteen to Twenty Four Weeks||29
6654508|NCT02446314|7584355|FG003|COMPLETED|Thirteen to Twenty Four Weeks||28
6654509|NCT02446314|7584352|FG000|NOT COMPLETED|Thirteen to Twenty Four Weeks||0
6470891|NCT01257542|7388296|FG001|COMPLETED|Overall Study||45
6470892|NCT01257542|7388295|FG000|NOT COMPLETED|Overall Study||3
6470893|NCT01257542|7388296|FG001|NOT COMPLETED|Overall Study||7
6470894|NCT01257581|7388305|FG000|STARTED|Overall Study||22
6470895|NCT01257581|7388306|FG001|STARTED|Overall Study||21
6470896|NCT01257581|7388307|FG002|STARTED|Overall Study||17
6470897|NCT01257581|7388305|FG000|COMPLETED|Overall Study||17
6654510|NCT02446314|7584353|FG001|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
6654511|NCT02446314|7584354|FG002|NOT COMPLETED|Thirteen to Twenty Four Weeks||2
6654512|NCT02446314|7584355|FG003|NOT COMPLETED|Thirteen to Twenty Four Weeks||1
6654513|NCT02446418|7584371|FG000|STARTED|Overall Study||210
6654514|NCT02446418|7584372|FG001|STARTED|Overall Study||210
6654515|NCT02446418|7584371|FG000|COMPLETED|Overall Study||192
6654516|NCT02446418|7584372|FG001|COMPLETED|Overall Study||194
6654517|NCT02446418|7584371|FG000|NOT COMPLETED|Overall Study||18
6654518|NCT02446418|7584372|FG001|NOT COMPLETED|Overall Study||16
6654519|NCT02446483|7584378|FG000|STARTED|Period 1: Intervention Period 1||30
6654520|NCT02446483|7584379|FG001|STARTED|Period 1: Intervention Period 1||30
6654521|NCT02446483|7584378|FG000|COMPLETED|Period 1: Intervention Period 1||30
6654522|NCT02446483|7584379|FG001|COMPLETED|Period 1: Intervention Period 1||30
6654523|NCT02446483|7584378|FG000|NOT COMPLETED|Period 1: Intervention Period 1||0
6654524|NCT02446483|7584379|FG001|NOT COMPLETED|Period 1: Intervention Period 1||0
6654525|NCT02446483|7584378|FG000|STARTED|Period 2: Washout Period (7 Days)||30
6654526|NCT02446483|7584379|FG001|STARTED|Period 2: Washout Period (7 Days)||30
6654527|NCT02446483|7584378|FG000|COMPLETED|Period 2: Washout Period (7 Days)||30
6654528|NCT02446483|7584379|FG001|COMPLETED|Period 2: Washout Period (7 Days)||30
6654529|NCT02446483|7584378|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6654530|NCT02446483|7584379|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6654531|NCT02446483|7584378|FG000|STARTED|Period 3: Intervention Period 2||30
6654532|NCT02446483|7584379|FG001|STARTED|Period 3: Intervention Period 2||30
6654533|NCT02446483|7584378|FG000|COMPLETED|Period 3: Intervention Period 2||30
6470898|NCT01257581|7388306|FG001|COMPLETED|Overall Study||18
6470899|NCT01257581|7388307|FG002|COMPLETED|Overall Study||11
6470900|NCT01257581|7388305|FG000|NOT COMPLETED|Overall Study||5
6470901|NCT01257581|7388306|FG001|NOT COMPLETED|Overall Study||3
6470902|NCT01257581|7388307|FG002|NOT COMPLETED|Overall Study||6
6470903|NCT01257698|7388317|FG000|STARTED|Overall Study||12
6470904|NCT01257698|7388318|FG001|STARTED|Overall Study||9
6470905|NCT01257698|7388317|FG000|COMPLETED|Overall Study||8
6470906|NCT01257698|7388318|FG001|COMPLETED|Overall Study||9
6470907|NCT01257698|7388317|FG000|NOT COMPLETED|Overall Study||4
6470908|NCT01257698|7388318|FG001|NOT COMPLETED|Overall Study||0
6470909|NCT01257737|7388326|FG000|STARTED|Overall Study||45
6470910|NCT01257737|7388327|FG001|STARTED|Overall Study||43
6470911|NCT01257737|7388326|FG000|COMPLETED|Overall Study||43
6470912|NCT01257737|7388327|FG001|COMPLETED|Overall Study||39
6470913|NCT01257737|7388326|FG000|NOT COMPLETED|Overall Study||2
6470914|NCT01257737|7388327|FG001|NOT COMPLETED|Overall Study||4
6470915|NCT01257750|7388334|FG000|STARTED|Overall Study||20
6470916|NCT01257750|7388334|FG000|COMPLETED|Overall Study||20
6470917|NCT01257750|7388334|FG000|NOT COMPLETED|Overall Study||0
6470918|NCT01257802|7388341|FG000|STARTED|Overall Study||6
6470919|NCT01257802|7388342|FG001|STARTED|Overall Study||8
6470920|NCT01257802|7388341|FG000|6 Month / 24 Week Visit|Overall Study||5
6470921|NCT01257802|7388342|FG001|6 Month / 24 Week Visit|Overall Study||2
6470922|NCT01257802|7388341|FG000|COMPLETED|Overall Study||5
6470923|NCT01257802|7388342|FG001|COMPLETED|Overall Study||2
6470924|NCT01257802|7388341|FG000|NOT COMPLETED|Overall Study||1
6470925|NCT01257802|7388342|FG001|NOT COMPLETED|Overall Study||6
6470926|NCT01257880|7388351|FG000|STARTED|Overall Study||12
6470927|NCT01257880|7388352|FG001|STARTED|Overall Study||19
6470928|NCT01257880|7388351|FG000|COMPLETED|Overall Study||12
6470929|NCT01257880|7388352|FG001|COMPLETED|Overall Study||19
6470930|NCT01257880|7388351|FG000|NOT COMPLETED|Overall Study||0
6470931|NCT01257880|7388352|FG001|NOT COMPLETED|Overall Study||0
6470932|NCT01258049|7388360|FG000|STARTED|Overall Study||77
6470933|NCT01258049|7388361|FG001|STARTED|Overall Study||74
6470934|NCT01258049|7388360|FG000|COMPLETED|Overall Study||75
6470935|NCT01258049|7388361|FG001|COMPLETED|Overall Study||72
6470936|NCT01258049|7388360|FG000|NOT COMPLETED|Overall Study||2
6470937|NCT01258049|7388361|FG001|NOT COMPLETED|Overall Study||2
6470938|NCT01258075|7388369|FG000|STARTED|Overall Study||141
6470939|NCT01258075|7388370|FG001|STARTED|Overall Study||95
6470940|NCT01258075|7388369|FG000|COMPLETED|Overall Study||99
6470941|NCT01258075|7388370|FG001|COMPLETED|Overall Study||72
6470942|NCT01258075|7388369|FG000|NOT COMPLETED|Overall Study||42
6470943|NCT01258075|7388370|FG001|NOT COMPLETED|Overall Study||23
6470944|NCT01258101|7388380|FG000|STARTED|Overall Study||151
6470945|NCT01258101|7388381|FG001|STARTED|Overall Study||144
6470946|NCT01258101|7388382|FG002|STARTED|Overall Study||33
6470947|NCT01258101|7388383|FG003|STARTED|Overall Study||52
6470948|NCT01258101|7388380|FG000|Safety Analysis Population|Overall Study||144
6470949|NCT01258101|7388381|FG001|Safety Analysis Population|Overall Study||141
6470950|NCT01258101|7388382|FG002|Safety Analysis Population|Overall Study||30
6470951|NCT01258101|7388383|FG003|Safety Analysis Population|Overall Study||48
6470952|NCT01258101|7388380|FG000|Standard Analysis Population|Overall Study||115
6470953|NCT01258101|7388381|FG001|Standard Analysis Population|Overall Study||110
6470954|NCT01258101|7388382|FG002|Standard Analysis Population|Overall Study||21
6470955|NCT01258101|7388383|FG003|Standard Analysis Population|Overall Study||26
6470956|NCT01258101|7388380|FG000|COMPLETED|Overall Study||118
6470957|NCT01258101|7388381|FG001|COMPLETED|Overall Study||110
6470958|NCT01258101|7388382|FG002|COMPLETED|Overall Study||22
6470959|NCT01258101|7388383|FG003|COMPLETED|Overall Study||27
6470960|NCT01258101|7388380|FG000|NOT COMPLETED|Overall Study||33
6470961|NCT01258101|7388381|FG001|NOT COMPLETED|Overall Study||34
6470962|NCT01258101|7388382|FG002|NOT COMPLETED|Overall Study||11
6470963|NCT01258101|7388383|FG003|NOT COMPLETED|Overall Study||25
6470964|NCT01258153|7388396|FG000|STARTED|Overall Study||40
6654534|NCT02446483|7584379|FG001|COMPLETED|Period 3: Intervention Period 2||30
6470965|NCT01258153|7388397|FG001|STARTED|Overall Study||38
6470966|NCT01258153|7388398|FG002|STARTED|Overall Study||37
6470967|NCT01258153|7388396|FG000|COMPLETED|Overall Study||39
6470968|NCT01258153|7388397|FG001|COMPLETED|Overall Study||37
6470969|NCT01258153|7388398|FG002|COMPLETED|Overall Study||36
6470970|NCT01258153|7388396|FG000|NOT COMPLETED|Overall Study||1
6470971|NCT01258153|7388397|FG001|NOT COMPLETED|Overall Study||1
6470972|NCT01258153|7388398|FG002|NOT COMPLETED|Overall Study||1
6470973|NCT01258348|7388408|FG000|STARTED|Overall Study||1
6470974|NCT01258348|7388409|FG001|STARTED|Overall Study||5
6470975|NCT01258348|7388410|FG002|STARTED|Overall Study||3
6470976|NCT01258348|7388411|FG003|STARTED|Overall Study||6
6470977|NCT01258348|7388412|FG004|STARTED|Overall Study||6
6470978|NCT01258348|7388408|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
6470979|NCT01258348|7388409|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
6470980|NCT01258348|7388410|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6470981|NCT01258348|7388411|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6470982|NCT01258348|7388412|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
6470983|NCT01258348|7388408|FG000|COMPLETED|Overall Study||0
6470984|NCT01258348|7388409|FG001|COMPLETED|Overall Study||0
6470985|NCT01258348|7388410|FG002|COMPLETED|Overall Study||0
6470986|NCT01258348|7388411|FG003|COMPLETED|Overall Study||0
6470987|NCT01258348|7388412|FG004|COMPLETED|Overall Study||0
6470988|NCT01258348|7388408|FG000|NOT COMPLETED|Overall Study||1
6470989|NCT01258348|7388409|FG001|NOT COMPLETED|Overall Study||5
6470990|NCT01258348|7388410|FG002|NOT COMPLETED|Overall Study||3
6470991|NCT01258348|7388411|FG003|NOT COMPLETED|Overall Study||6
6470992|NCT01258348|7388412|FG004|NOT COMPLETED|Overall Study||6
6470993|NCT01258374|7388426|FG000|STARTED|Overall Study||15
6470994|NCT01258374|7388426|FG000|COMPLETED|Overall Study||15
6470995|NCT01258374|7388426|FG000|NOT COMPLETED|Overall Study||0
6470996|NCT01258387|7388439|FG000|STARTED|Overall Study||6
6470997|NCT01258387|7388440|FG001|STARTED|Overall Study||6
6470998|NCT01258387|7388441|FG002|STARTED|Overall Study||6
6470999|NCT01258387|7388442|FG003|STARTED|Overall Study||6
6471000|NCT01258387|7388443|FG004|STARTED|Overall Study||6
6471001|NCT01258387|7388444|FG005|STARTED|Overall Study||6
6471002|NCT01258387|7388445|FG006|STARTED|Overall Study||4
6471003|NCT01258387|7388439|FG000|Patients Randomized to GGF2|Overall Study||4
6471004|NCT01258387|7388440|FG001|Patients Randomized to GGF2|Overall Study||4
6471005|NCT01258387|7388441|FG002|Patients Randomized to GGF2|Overall Study||4
6471006|NCT01258387|7388442|FG003|Patients Randomized to GGF2|Overall Study||4
6471007|NCT01258387|7388443|FG004|Patients Randomized to GGF2|Overall Study||4
6471008|NCT01258387|7388444|FG005|Patients Randomized to GGF2|Overall Study||4
6471009|NCT01258387|7388445|FG006|Patients Randomized to GGF2|Overall Study||3
6471010|NCT01258387|7388439|FG000|Patients Randomized to Placebo|Overall Study||2
6471011|NCT01258387|7388440|FG001|Patients Randomized to Placebo|Overall Study||2
6471012|NCT01258387|7388441|FG002|Patients Randomized to Placebo|Overall Study||2
6471013|NCT01258387|7388442|FG003|Patients Randomized to Placebo|Overall Study||2
6471014|NCT01258387|7388443|FG004|Patients Randomized to Placebo|Overall Study||2
6471015|NCT01258387|7388444|FG005|Patients Randomized to Placebo|Overall Study||2
6471016|NCT01258387|7388445|FG006|Patients Randomized to Placebo|Overall Study||1
6471017|NCT01258387|7388439|FG000|COMPLETED|Overall Study||6
6471018|NCT01258387|7388440|FG001|COMPLETED|Overall Study||6
6471019|NCT01258387|7388441|FG002|COMPLETED|Overall Study||6
6471020|NCT01258387|7388442|FG003|COMPLETED|Overall Study||6
6471021|NCT01258387|7388443|FG004|COMPLETED|Overall Study||6
6471022|NCT01258387|7388444|FG005|COMPLETED|Overall Study||6
6471023|NCT01258387|7388445|FG006|COMPLETED|Overall Study||4
6471024|NCT01258387|7388439|FG000|NOT COMPLETED|Overall Study||0
6471025|NCT01258387|7388440|FG001|NOT COMPLETED|Overall Study||0
6471026|NCT01258387|7388441|FG002|NOT COMPLETED|Overall Study||0
6471027|NCT01258387|7388442|FG003|NOT COMPLETED|Overall Study||0
6471028|NCT01258387|7388443|FG004|NOT COMPLETED|Overall Study||0
6471029|NCT01258387|7388444|FG005|NOT COMPLETED|Overall Study||0
6471030|NCT01258387|7388445|FG006|NOT COMPLETED|Overall Study||0
6471031|NCT01258504|7388463|FG000|STARTED|Bosentan Single Dose||13
6471032|NCT01258504|7388463|FG000|COMPLETED|Bosentan Single Dose||13
6471033|NCT01258504|7388463|FG000|NOT COMPLETED|Bosentan Single Dose||0
6471034|NCT01258504|7388463|FG000|STARTED|Bosentan Steady-state||13
6471035|NCT01258504|7388463|FG000|COMPLETED|Bosentan Steady-state||13
6471036|NCT01258504|7388463|FG000|NOT COMPLETED|Bosentan Steady-state||0
6471037|NCT01258504|7388463|FG000|STARTED|Bosentan and SJW||13
6471038|NCT01258504|7388463|FG000|COMPLETED|Bosentan and SJW||13
6471039|NCT01258504|7388463|FG000|NOT COMPLETED|Bosentan and SJW||0
6471040|NCT01258582|7388474|FG000|STARTED|Overall Study||830
6471041|NCT01258582|7388475|FG001|STARTED|Overall Study||821
6471042|NCT01258582|7388474|FG000|COMPLETED|Overall Study||548
6471043|NCT01258582|7388475|FG001|COMPLETED|Overall Study||563
6471044|NCT01258582|7388474|FG000|NOT COMPLETED|Overall Study||282
6471045|NCT01258582|7388475|FG001|NOT COMPLETED|Overall Study||258
6471046|NCT01258595|7388483|FG000|STARTED|Overall Study||148
6471047|NCT01258595|7388484|FG001|STARTED|Overall Study||152
6471048|NCT01258595|7388483|FG000|COMPLETED|Overall Study||147
6471049|NCT01258595|7388484|FG001|COMPLETED|Overall Study||151
6471050|NCT01258595|7388483|FG000|NOT COMPLETED|Overall Study||1
6471051|NCT01258595|7388484|FG001|NOT COMPLETED|Overall Study||1
6471052|NCT01258608|7388492|FG000|STARTED|Overall Study||51
6471053|NCT01258608|7388493|FG001|STARTED|Overall Study||50
6471054|NCT01258608|7388492|FG000|COMPLETED|Overall Study||30
6471055|NCT01258608|7388493|FG001|COMPLETED|Overall Study||31
6471056|NCT01258608|7388492|FG000|NOT COMPLETED|Overall Study||21
6471057|NCT01258608|7388493|FG001|NOT COMPLETED|Overall Study||19
6471058|NCT01258660|7388502|FG000|STARTED|Overall Study|randomized and received at least one dose of treatment|86
6471059|NCT01258660|7388503|FG001|STARTED|Overall Study|randomized and received at least one dose of treatment|86
6471060|NCT01258660|7388502|FG000|Received Treatment|Overall Study||79
6471061|NCT01258660|7388503|FG001|Received Treatment|Overall Study||82
6471062|NCT01258660|7388502|FG000|Completed Treatment|Overall Study||79
6471063|NCT01258660|7388503|FG001|Completed Treatment|Overall Study||81
6471064|NCT01258660|7388502|FG000|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
6471065|NCT01258660|7388503|FG001|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
6471066|NCT01258660|7388502|FG000|NOT COMPLETED|Overall Study||11
6471067|NCT01258660|7388503|FG001|NOT COMPLETED|Overall Study||11
6471068|NCT01258738|7388512|FG000|STARTED|Double-blind Period||111
6471069|NCT01258738|7388513|FG001|STARTED|Double-blind Period||114
6471070|NCT01258738|7388512|FG000|Treated|Double-blind Period||111
6471071|NCT01258738|7388513|FG001|Treated|Double-blind Period||113
6471072|NCT01258738|7388512|FG000|COMPLETED|Double-blind Period||102
6471073|NCT01258738|7388513|FG001|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
6471074|NCT01258738|7388512|FG000|NOT COMPLETED|Double-blind Period||9
6471075|NCT01258738|7388513|FG001|NOT COMPLETED|Double-blind Period||7
6471076|NCT01258738|7388512|FG000|STARTED|Open-label Period||102
6471077|NCT01258738|7388513|FG001|STARTED|Open-label Period||106
6471078|NCT01258738|7388512|FG000|COMPLETED|Open-label Period||85
6471079|NCT01258738|7388513|FG001|COMPLETED|Open-label Period||85
6471080|NCT01258738|7388512|FG000|NOT COMPLETED|Open-label Period||17
6471081|NCT01258738|7388513|FG001|NOT COMPLETED|Open-label Period||21
6471082|NCT01258790|7388521|FG000|STARTED|Overall Study||6
6471083|NCT01258790|7388522|FG001|STARTED|Overall Study||6
6471084|NCT01258790|7388521|FG000|COMPLETED|Overall Study||6
6471085|NCT01258790|7388522|FG001|COMPLETED|Overall Study||6
6471086|NCT01258790|7388521|FG000|NOT COMPLETED|Overall Study||0
6471087|NCT01258790|7388522|FG001|NOT COMPLETED|Overall Study||0
6471088|NCT01258855|7388530|FG000|STARTED|Overall Study||55
6471089|NCT01258855|7388531|FG001|STARTED|Overall Study||29
6471090|NCT01258855|7388530|FG000|COMPLETED|Overall Study||55
6471091|NCT01258855|7388531|FG001|COMPLETED|Overall Study||29
6471092|NCT01258855|7388530|FG000|NOT COMPLETED|Overall Study||0
6471093|NCT01258855|7388531|FG001|NOT COMPLETED|Overall Study||0
6471094|NCT01258985|7388539|FG000|STARTED|Overall Study||106
6471095|NCT01258985|7388540|FG001|STARTED|Overall Study||98
6471096|NCT01258985|7388539|FG000|COMPLETED|Overall Study||106
6471097|NCT01258985|7388540|FG001|COMPLETED|Overall Study||98
6471098|NCT01258985|7388539|FG000|NOT COMPLETED|Overall Study||0
6471099|NCT01258985|7388540|FG001|NOT COMPLETED|Overall Study||0
6471100|NCT01258998|7388546|FG000|STARTED|Overall Study||60
6471101|NCT01258998|7388546|FG000|COMPLETED|Overall Study||59
6471102|NCT01258998|7388546|FG000|NOT COMPLETED|Overall Study||1
6471103|NCT01259011|7388552|FG000|STARTED|Main Study Period|101 dyads (=202 individuals)|101
6471104|NCT01259011|7388553|FG001|STARTED|Main Study Period|109 dyads (=218 individuals)|109
6471105|NCT01259011|7388552|FG000|COMPLETED|Main Study Period||101
6471106|NCT01259011|7388553|FG001|COMPLETED|Main Study Period||109
6471107|NCT01259011|7388552|FG000|NOT COMPLETED|Main Study Period||0
6471108|NCT01259011|7388553|FG001|NOT COMPLETED|Main Study Period||0
6471109|NCT01259011|7388552|FG000|STARTED|After Patient Death|of 101 patient-surrogate dyads/pairs randomized, 17 surrogates of patients who died|17
6471110|NCT01259011|7388553|FG001|STARTED|After Patient Death|of 109 patient-surrogate dyads/pairs randomized, 28 surrogates of patients who died|28
6471111|NCT01259011|7388552|FG000|COMPLETED|After Patient Death||17
6471112|NCT01259011|7388553|FG001|COMPLETED|After Patient Death||28
6471113|NCT01259011|7388552|FG000|NOT COMPLETED|After Patient Death||0
6471114|NCT01259011|7388553|FG001|NOT COMPLETED|After Patient Death||0
6471115|NCT01259063|7388561|FG000|STARTED|Overall Study||33
6471116|NCT01259063|7388561|FG000|COMPLETED|Overall Study||33
6471117|NCT01259063|7388561|FG000|NOT COMPLETED|Overall Study||0
6471118|NCT01259089|7388565|FG000|STARTED|Reached First Response at 4 Weeks||3
6471119|NCT01259089|7388566|FG001|STARTED|Reached First Response at 4 Weeks||3
6471120|NCT01259089|7388567|FG002|STARTED|Reached First Response at 4 Weeks||3
6471121|NCT01259089|7388568|FG003|STARTED|Reached First Response at 4 Weeks||3
6471122|NCT01259089|7388569|FG004|STARTED|Reached First Response at 4 Weeks||6
6471123|NCT01259089|7388570|FG005|STARTED|Reached First Response at 4 Weeks||20
6471124|NCT01259089|7388565|FG000|Started Treatment on Study|Reached First Response at 4 Weeks||3
6471125|NCT01259089|7388566|FG001|Started Treatment on Study|Reached First Response at 4 Weeks||3
6471126|NCT01259089|7388567|FG002|Started Treatment on Study|Reached First Response at 4 Weeks||3
6501054|NCT01426438|7419550|FG000|NOT COMPLETED|Overall Study||15
6471127|NCT01259089|7388568|FG003|Started Treatment on Study|Reached First Response at 4 Weeks||3
6471128|NCT01259089|7388569|FG004|Started Treatment on Study|Reached First Response at 4 Weeks||6
6471129|NCT01259089|7388570|FG005|Started Treatment on Study|Reached First Response at 4 Weeks||19
6471130|NCT01259089|7388565|FG000|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
6471131|NCT01259089|7388566|FG001|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
6471132|NCT01259089|7388567|FG002|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
6471133|NCT01259089|7388568|FG003|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||3
6471134|NCT01259089|7388569|FG004|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||6
6471135|NCT01259089|7388570|FG005|Completed 4 Weeks of Treatment|Reached First Response at 4 Weeks||18
6471136|NCT01259089|7388565|FG000|COMPLETED|Reached First Response at 4 Weeks||3
6471137|NCT01259089|7388566|FG001|COMPLETED|Reached First Response at 4 Weeks||3
6471138|NCT01259089|7388567|FG002|COMPLETED|Reached First Response at 4 Weeks||3
6471139|NCT01259089|7388568|FG003|COMPLETED|Reached First Response at 4 Weeks||3
6471140|NCT01259089|7388569|FG004|COMPLETED|Reached First Response at 4 Weeks||6
6471141|NCT01259089|7388570|FG005|COMPLETED|Reached First Response at 4 Weeks||18
6471142|NCT01259089|7388565|FG000|NOT COMPLETED|Reached First Response at 4 Weeks||0
6471143|NCT01259089|7388566|FG001|NOT COMPLETED|Reached First Response at 4 Weeks||0
6471144|NCT01259089|7388567|FG002|NOT COMPLETED|Reached First Response at 4 Weeks||0
6471145|NCT01259089|7388568|FG003|NOT COMPLETED|Reached First Response at 4 Weeks||0
6471146|NCT01259089|7388569|FG004|NOT COMPLETED|Reached First Response at 4 Weeks||0
6471147|NCT01259089|7388570|FG005|NOT COMPLETED|Reached First Response at 4 Weeks||2
6471148|NCT01259089|7388565|FG000|STARTED|Confirmed Response at 8 Weeks||3
6471149|NCT01259089|7388566|FG001|STARTED|Confirmed Response at 8 Weeks||3
6471150|NCT01259089|7388567|FG002|STARTED|Confirmed Response at 8 Weeks||3
6471151|NCT01259089|7388568|FG003|STARTED|Confirmed Response at 8 Weeks||3
6471152|NCT01259089|7388569|FG004|STARTED|Confirmed Response at 8 Weeks||6
6471153|NCT01259089|7388570|FG005|STARTED|Confirmed Response at 8 Weeks||18
6471154|NCT01259089|7388565|FG000|COMPLETED|Confirmed Response at 8 Weeks||3
6471155|NCT01259089|7388566|FG001|COMPLETED|Confirmed Response at 8 Weeks||3
6471156|NCT01259089|7388567|FG002|COMPLETED|Confirmed Response at 8 Weeks||2
6471157|NCT01259089|7388568|FG003|COMPLETED|Confirmed Response at 8 Weeks||2
6471158|NCT01259089|7388569|FG004|COMPLETED|Confirmed Response at 8 Weeks||2
6471159|NCT01259089|7388570|FG005|COMPLETED|Confirmed Response at 8 Weeks||8
6471160|NCT01259089|7388565|FG000|NOT COMPLETED|Confirmed Response at 8 Weeks||0
6471161|NCT01259089|7388566|FG001|NOT COMPLETED|Confirmed Response at 8 Weeks||0
6471162|NCT01259089|7388567|FG002|NOT COMPLETED|Confirmed Response at 8 Weeks||1
6471163|NCT01259089|7388568|FG003|NOT COMPLETED|Confirmed Response at 8 Weeks||1
6471164|NCT01259089|7388569|FG004|NOT COMPLETED|Confirmed Response at 8 Weeks||4
6471165|NCT01259089|7388570|FG005|NOT COMPLETED|Confirmed Response at 8 Weeks||10
6471166|NCT01259089|7388565|FG000|STARTED|Continued Treatment After 8 Weeks||3
6471167|NCT01259089|7388566|FG001|STARTED|Continued Treatment After 8 Weeks||3
6471168|NCT01259089|7388567|FG002|STARTED|Continued Treatment After 8 Weeks||2
6471169|NCT01259089|7388568|FG003|STARTED|Continued Treatment After 8 Weeks||2
6471170|NCT01259089|7388569|FG004|STARTED|Continued Treatment After 8 Weeks||2
6471171|NCT01259089|7388570|FG005|STARTED|Continued Treatment After 8 Weeks||8
6471172|NCT01259089|7388565|FG000|COMPLETED|Continued Treatment After 8 Weeks||1
6471173|NCT01259089|7388566|FG001|COMPLETED|Continued Treatment After 8 Weeks||2
6471174|NCT01259089|7388567|FG002|COMPLETED|Continued Treatment After 8 Weeks||1
6471175|NCT01259089|7388568|FG003|COMPLETED|Continued Treatment After 8 Weeks||1
6471176|NCT01259089|7388569|FG004|COMPLETED|Continued Treatment After 8 Weeks||0
6471177|NCT01259089|7388570|FG005|COMPLETED|Continued Treatment After 8 Weeks||7
6471178|NCT01259089|7388565|FG000|NOT COMPLETED|Continued Treatment After 8 Weeks||2
6471179|NCT01259089|7388566|FG001|NOT COMPLETED|Continued Treatment After 8 Weeks||1
6471180|NCT01259089|7388567|FG002|NOT COMPLETED|Continued Treatment After 8 Weeks||1
6471181|NCT01259089|7388568|FG003|NOT COMPLETED|Continued Treatment After 8 Weeks||1
6471182|NCT01259089|7388569|FG004|NOT COMPLETED|Continued Treatment After 8 Weeks||2
6471183|NCT01259089|7388570|FG005|NOT COMPLETED|Continued Treatment After 8 Weeks||1
6471184|NCT01259089|7388565|FG000|STARTED|Survival Follow up for Two Years||3
6471185|NCT01259089|7388566|FG001|STARTED|Survival Follow up for Two Years||3
6471186|NCT01259089|7388567|FG002|STARTED|Survival Follow up for Two Years||3
6471187|NCT01259089|7388568|FG003|STARTED|Survival Follow up for Two Years||3
6471188|NCT01259089|7388569|FG004|STARTED|Survival Follow up for Two Years||6
6471189|NCT01259089|7388570|FG005|STARTED|Survival Follow up for Two Years||19
6471190|NCT01259089|7388565|FG000|COMPLETED|Survival Follow up for Two Years||0
6471191|NCT01259089|7388566|FG001|COMPLETED|Survival Follow up for Two Years||1
6471192|NCT01259089|7388567|FG002|COMPLETED|Survival Follow up for Two Years||1
6471193|NCT01259089|7388568|FG003|COMPLETED|Survival Follow up for Two Years||0
6471194|NCT01259089|7388569|FG004|COMPLETED|Survival Follow up for Two Years||0
6471195|NCT01259089|7388570|FG005|COMPLETED|Survival Follow up for Two Years||0
6471196|NCT01259089|7388565|FG000|NOT COMPLETED|Survival Follow up for Two Years||3
6471197|NCT01259089|7388566|FG001|NOT COMPLETED|Survival Follow up for Two Years||2
6471198|NCT01259089|7388567|FG002|NOT COMPLETED|Survival Follow up for Two Years||2
6501055|NCT01426438|7419551|FG001|NOT COMPLETED|Overall Study||10
6554385|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Fifth Intervention||5
6554386|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Fifth Intervention||6
6471199|NCT01259089|7388568|FG003|NOT COMPLETED|Survival Follow up for Two Years||3
6471200|NCT01259089|7388569|FG004|NOT COMPLETED|Survival Follow up for Two Years||6
6471201|NCT01259089|7388570|FG005|NOT COMPLETED|Survival Follow up for Two Years||19
6471202|NCT01259102|7388589|FG000|STARTED|Overall Study||13
6471203|NCT01259102|7388590|FG001|STARTED|Overall Study||14
6471204|NCT01259102|7388591|FG002|STARTED|Overall Study||15
6471205|NCT01259102|7388592|FG003|STARTED|Overall Study||14
6471206|NCT01259102|7388593|FG004|STARTED|Overall Study||14
6471207|NCT01259102|7388589|FG000|COMPLETED|Overall Study||12
6471208|NCT01259102|7388590|FG001|COMPLETED|Overall Study||14
6471209|NCT01259102|7388591|FG002|COMPLETED|Overall Study||13
6471210|NCT01259102|7388592|FG003|COMPLETED|Overall Study||12
6471211|NCT01259102|7388593|FG004|COMPLETED|Overall Study||13
6471212|NCT01259102|7388589|FG000|NOT COMPLETED|Overall Study||1
6471213|NCT01259102|7388590|FG001|NOT COMPLETED|Overall Study||0
6471214|NCT01259102|7388591|FG002|NOT COMPLETED|Overall Study||2
6471215|NCT01259102|7388592|FG003|NOT COMPLETED|Overall Study||2
6471216|NCT01259102|7388593|FG004|NOT COMPLETED|Overall Study||1
6471217|NCT01259115|7388605|FG000|STARTED|Period 1||10
6471218|NCT01259115|7388606|FG001|STARTED|Period 1||10
6471219|NCT01259115|7388605|FG000|COMPLETED|Period 1||7
6471220|NCT01259115|7388606|FG001|COMPLETED|Period 1||9
6471221|NCT01259115|7388605|FG000|NOT COMPLETED|Period 1||3
6471222|NCT01259115|7388606|FG001|NOT COMPLETED|Period 1||1
6471223|NCT01259115|7388605|FG000|STARTED|Period: Washout Period of 4 to 18 Days||7
6471224|NCT01259115|7388606|FG001|STARTED|Period: Washout Period of 4 to 18 Days||9
6471225|NCT01259115|7388605|FG000|COMPLETED|Period: Washout Period of 4 to 18 Days||7
6471226|NCT01259115|7388606|FG001|COMPLETED|Period: Washout Period of 4 to 18 Days||9
6471227|NCT01259115|7388605|FG000|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
6471228|NCT01259115|7388606|FG001|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
6471229|NCT01259115|7388605|FG000|STARTED|Period 2||7
6471230|NCT01259115|7388606|FG001|STARTED|Period 2||9
6471231|NCT01259115|7388605|FG000|COMPLETED|Period 2||6
6471232|NCT01259115|7388606|FG001|COMPLETED|Period 2||9
6471233|NCT01259115|7388605|FG000|NOT COMPLETED|Period 2||1
6471234|NCT01259115|7388606|FG001|NOT COMPLETED|Period 2||0
6471235|NCT01259128|7388619|FG000|STARTED|Overall Study||15
6471236|NCT01259128|7388620|FG001|STARTED|Overall Study||17
6471237|NCT01259128|7388619|FG000|COMPLETED|Overall Study||15
6471238|NCT01259128|7388620|FG001|COMPLETED|Overall Study||15
6471239|NCT01259128|7388619|FG000|NOT COMPLETED|Overall Study||0
6471240|NCT01259128|7388620|FG001|NOT COMPLETED|Overall Study||2
6471241|NCT01259245|7388628|FG000|STARTED|Overall Study||98
6471242|NCT01259245|7388629|FG001|STARTED|Overall Study||94
6471243|NCT01259245|7388628|FG000|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
6471244|NCT01259245|7388629|FG001|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
6471245|NCT01259245|7388628|FG000|NOT COMPLETED|Overall Study||28
6471246|NCT01259245|7388629|FG001|NOT COMPLETED|Overall Study||26
6471247|NCT01259297|7388645|FG000|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
6471248|NCT01259297|7388646|FG001|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6471249|NCT01259297|7388647|FG002|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
6471250|NCT01259297|7388648|FG003|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6471251|NCT01259297|7388649|FG004|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6471252|NCT01259297|7388650|FG005|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6471253|NCT01259297|7388651|FG006|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6471254|NCT01259297|7388652|FG007|STARTED|Run-in Open Label Period (4-5 Weeks)||0
6471255|NCT01259297|7388645|FG000|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
6471256|NCT01259297|7388646|FG001|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471257|NCT01259297|7388647|FG002|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
6471258|NCT01259297|7388648|FG003|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471259|NCT01259297|7388649|FG004|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471260|NCT01259297|7388650|FG005|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471261|NCT01259297|7388651|FG006|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471262|NCT01259297|7388652|FG007|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471263|NCT01259297|7388645|FG000|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
6471264|NCT01259297|7388646|FG001|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471265|NCT01259297|7388647|FG002|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
6471266|NCT01259297|7388648|FG003|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471267|NCT01259297|7388649|FG004|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471268|NCT01259297|7388650|FG005|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471269|NCT01259297|7388651|FG006|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471270|NCT01259297|7388652|FG007|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
6471271|NCT01259297|7388645|FG000|STARTED|Double Blind Randomized Period||244
6471272|NCT01259297|7388646|FG001|STARTED|Double Blind Randomized Period||232
6471273|NCT01259297|7388647|FG002|STARTED|Double Blind Randomized Period||189
6471274|NCT01259297|7388648|FG003|STARTED|Double Blind Randomized Period||195
6471275|NCT01259297|7388649|FG004|STARTED|Double Blind Randomized Period||251
6471276|NCT01259297|7388650|FG005|STARTED|Double Blind Randomized Period||253
6471277|NCT01259297|7388651|FG006|STARTED|Double Blind Randomized Period||196
6471278|NCT01259297|7388652|FG007|STARTED|Double Blind Randomized Period||199
6471279|NCT01259297|7388645|FG000|COMPLETED|Double Blind Randomized Period||242
6471280|NCT01259297|7388646|FG001|COMPLETED|Double Blind Randomized Period||229
6471281|NCT01259297|7388647|FG002|COMPLETED|Double Blind Randomized Period||188
6471282|NCT01259297|7388648|FG003|COMPLETED|Double Blind Randomized Period||191
6471283|NCT01259297|7388649|FG004|COMPLETED|Double Blind Randomized Period||247
6471284|NCT01259297|7388650|FG005|COMPLETED|Double Blind Randomized Period||245
6471285|NCT01259297|7388651|FG006|COMPLETED|Double Blind Randomized Period||190
6471286|NCT01259297|7388652|FG007|COMPLETED|Double Blind Randomized Period||196
6471287|NCT01259297|7388645|FG000|NOT COMPLETED|Double Blind Randomized Period||2
6471288|NCT01259297|7388646|FG001|NOT COMPLETED|Double Blind Randomized Period||3
6471289|NCT01259297|7388647|FG002|NOT COMPLETED|Double Blind Randomized Period||1
6471290|NCT01259297|7388648|FG003|NOT COMPLETED|Double Blind Randomized Period||4
6471291|NCT01259297|7388649|FG004|NOT COMPLETED|Double Blind Randomized Period||4
6471292|NCT01259297|7388650|FG005|NOT COMPLETED|Double Blind Randomized Period||8
6471293|NCT01259297|7388651|FG006|NOT COMPLETED|Double Blind Randomized Period||6
6471294|NCT01259297|7388652|FG007|NOT COMPLETED|Double Blind Randomized Period||3
6471295|NCT01259375|7388669|FG000|STARTED|Overall Study||24
6471296|NCT01259375|7388669|FG000|COMPLETED|Overall Study||23
6471297|NCT01259375|7388669|FG000|NOT COMPLETED|Overall Study||1
6471298|NCT01259388|7388677|FG000|STARTED|Overall Study||11
6471299|NCT01259388|7388678|FG001|STARTED|Overall Study||12
6471300|NCT01259388|7388677|FG000|COMPLETED|Overall Study||6
6471301|NCT01259388|7388678|FG001|COMPLETED|Overall Study||11
6471302|NCT01259388|7388677|FG000|NOT COMPLETED|Overall Study||5
6471303|NCT01259388|7388678|FG001|NOT COMPLETED|Overall Study||1
6471304|NCT01259401|7388686|FG000|STARTED|End of 4-week Intervention||21
6471305|NCT01259401|7388687|FG001|STARTED|End of 4-week Intervention||21
6471306|NCT01259401|7388686|FG000|COMPLETED|End of 4-week Intervention||21
6471307|NCT01259401|7388687|FG001|COMPLETED|End of 4-week Intervention||21
6471308|NCT01259401|7388686|FG000|NOT COMPLETED|End of 4-week Intervention||0
6471309|NCT01259401|7388687|FG001|NOT COMPLETED|End of 4-week Intervention||0
6471310|NCT01259401|7388686|FG000|STARTED|4-month Follow-up||21
6471311|NCT01259401|7388687|FG001|STARTED|4-month Follow-up||21
6471312|NCT01259401|7388686|FG000|COMPLETED|4-month Follow-up||21
6471313|NCT01259401|7388687|FG001|COMPLETED|4-month Follow-up||19
6471314|NCT01259401|7388686|FG000|NOT COMPLETED|4-month Follow-up||0
6471315|NCT01259401|7388687|FG001|NOT COMPLETED|4-month Follow-up||2
6471316|NCT01259427|7388695|FG000|STARTED|Overall Study||124
6471317|NCT01259427|7388696|FG001|STARTED|Overall Study||124
6471318|NCT01259427|7388695|FG000|COMPLETED|Overall Study||106
6471319|NCT01259427|7388696|FG001|COMPLETED|Overall Study||110
6471320|NCT01259427|7388695|FG000|NOT COMPLETED|Overall Study||18
6471321|NCT01259427|7388696|FG001|NOT COMPLETED|Overall Study||14
6471322|NCT01259440|7388705|FG000|STARTED|Overall Study||13
6471323|NCT01259440|7388706|FG001|STARTED|Overall Study||10
6471324|NCT01259440|7388705|FG000|COMPLETED|Overall Study||13
6471325|NCT01259440|7388706|FG001|COMPLETED|Overall Study||10
6471326|NCT01259440|7388705|FG000|NOT COMPLETED|Overall Study||0
6471327|NCT01259440|7388706|FG001|NOT COMPLETED|Overall Study||0
6471328|NCT01259466|7388714|FG000|STARTED|Overall Study||27
6471329|NCT01259466|7388715|FG001|STARTED|Overall Study||27
6471330|NCT01259466|7388714|FG000|COMPLETED|Overall Study||26
6471331|NCT01259466|7388715|FG001|COMPLETED|Overall Study||18
6471332|NCT01259466|7388714|FG000|NOT COMPLETED|Overall Study||1
6471333|NCT01259466|7388715|FG001|NOT COMPLETED|Overall Study||9
6471334|NCT01259492|7388725|FG000|STARTED|Period 1 (9 Weeks)||181
6471335|NCT01259492|7388726|FG001|STARTED|Period 1 (9 Weeks)||182
6471336|NCT01259492|7388727|FG002|STARTED|Period 1 (9 Weeks)||181
6471337|NCT01259492|7388728|FG003|STARTED|Period 1 (9 Weeks)||181
6471338|NCT01259492|7388725|FG000|Full Analysis Set|Period 1 (9 Weeks)||174
6471339|NCT01259492|7388726|FG001|Full Analysis Set|Period 1 (9 Weeks)||175
6471340|NCT01259492|7388727|FG002|Full Analysis Set|Period 1 (9 Weeks)||179
6471341|NCT01259492|7388728|FG003|Full Analysis Set|Period 1 (9 Weeks)||172
6471342|NCT01259492|7388725|FG000|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
6471343|NCT01259492|7388726|FG001|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
6471344|NCT01259492|7388727|FG002|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
6471345|NCT01259492|7388728|FG003|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
6471346|NCT01259492|7388725|FG000|NOT COMPLETED|Period 1 (9 Weeks)||29
6471347|NCT01259492|7388726|FG001|NOT COMPLETED|Period 1 (9 Weeks)||41
6471348|NCT01259492|7388727|FG002|NOT COMPLETED|Period 1 (9 Weeks)||43
6471349|NCT01259492|7388728|FG003|NOT COMPLETED|Period 1 (9 Weeks)||28
6471350|NCT01259492|7388725|FG000|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
6471351|NCT01259492|7388726|FG001|STARTED|Period 2 (Week 10 to Week 14)||141
6471352|NCT01259492|7388727|FG002|STARTED|Period 2 (Week 10 to Week 14)||138
6471353|NCT01259492|7388728|FG003|STARTED|Period 2 (Week 10 to Week 14)||153
6471354|NCT01259492|7388725|FG000|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
6471355|NCT01259492|7388726|FG001|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
6471356|NCT01259492|7388727|FG002|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
6471357|NCT01259492|7388728|FG003|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
6471358|NCT01259492|7388725|FG000|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
6471359|NCT01259492|7388726|FG001|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
6471360|NCT01259492|7388727|FG002|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
6471361|NCT01259492|7388728|FG003|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
6471362|NCT01259492|7388725|FG000|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
6471363|NCT01259492|7388726|FG001|STARTED|Period 3 (Week 15 to End of Week 40)||132
6471364|NCT01259492|7388727|FG002|STARTED|Period 3 (Week 15 to End of Week 40)||120
6471365|NCT01259492|7388728|FG003|STARTED|Period 3 (Week 15 to End of Week 40)||123
6471366|NCT01259492|7388725|FG000|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
6471367|NCT01259492|7388726|FG001|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
6471368|NCT01259492|7388727|FG002|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
6471369|NCT01259492|7388728|FG003|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
6471370|NCT01259492|7388725|FG000|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
6471371|NCT01259492|7388726|FG001|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
6471372|NCT01259492|7388727|FG002|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
6471373|NCT01259492|7388728|FG003|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
6471374|NCT01259492|7388725|FG000|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
6471375|NCT01259492|7388726|FG001|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
6471376|NCT01259492|7388727|FG002|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
6471377|NCT01259492|7388728|FG003|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
6471378|NCT01259596|7388739|FG000|STARTED|Overall Study||70
6471379|NCT01259596|7388740|FG001|STARTED|Overall Study||71
6471380|NCT01259596|7388739|FG000|COMPLETED|Overall Study||66
6471381|NCT01259596|7388740|FG001|COMPLETED|Overall Study||65
6471382|NCT01259596|7388739|FG000|NOT COMPLETED|Overall Study||4
6471383|NCT01259596|7388740|FG001|NOT COMPLETED|Overall Study||6
6471384|NCT01259713|7388750|FG000|STARTED|Overall Study||237
6471385|NCT01259713|7388751|FG001|STARTED|Overall Study||118
6471386|NCT01259713|7388750|FG000|COMPLETED|Overall Study||142
6471387|NCT01259713|7388751|FG001|COMPLETED|Overall Study||77
6471388|NCT01259713|7388750|FG000|NOT COMPLETED|Overall Study||95
6471389|NCT01259713|7388751|FG001|NOT COMPLETED|Overall Study||41
6471390|NCT01259726|7388761|FG000|STARTED|Overall Study||43
6471391|NCT01259726|7388762|FG001|STARTED|Overall Study||41
6471392|NCT01259726|7388763|FG002|STARTED|Overall Study||43
6471393|NCT01259726|7388764|FG003|STARTED|Overall Study||41
6471394|NCT01259726|7388761|FG000|Treated|Overall Study||40
6471395|NCT01259726|7388762|FG001|Treated|Overall Study||37
6471396|NCT01259726|7388763|FG002|Treated|Overall Study||41
6471397|NCT01259726|7388764|FG003|Treated|Overall Study||39
6471398|NCT01259726|7388761|FG000|COMPLETED|Overall Study||38
6471399|NCT01259726|7388762|FG001|COMPLETED|Overall Study||37
6471400|NCT01259726|7388763|FG002|COMPLETED|Overall Study||39
6471401|NCT01259726|7388764|FG003|COMPLETED|Overall Study||36
6471402|NCT01259726|7388761|FG000|NOT COMPLETED|Overall Study||5
6471403|NCT01259726|7388762|FG001|NOT COMPLETED|Overall Study||4
6471404|NCT01259726|7388763|FG002|NOT COMPLETED|Overall Study||4
6471405|NCT01259726|7388764|FG003|NOT COMPLETED|Overall Study||5
6471406|NCT01259856|7388776|FG000|STARTED|Overall Study||82
6471407|NCT01259856|7388777|FG001|STARTED|Overall Study||86
6471408|NCT01259856|7388776|FG000|COMPLETED|Overall Study||13
6471409|NCT01259856|7388777|FG001|COMPLETED|Overall Study||12
6471410|NCT01259856|7388776|FG000|NOT COMPLETED|Overall Study||69
6471411|NCT01259856|7388777|FG001|NOT COMPLETED|Overall Study||74
6471412|NCT01259869|7388783|FG000|STARTED|Overall Study||34
6471413|NCT01259869|7388783|FG000|COMPLETED|Overall Study||33
6471414|NCT01259869|7388783|FG000|NOT COMPLETED|Overall Study||1
6471415|NCT01260142|7388793|FG000|STARTED|Treatment Period 1||6
6471416|NCT01260142|7388794|FG001|STARTED|Treatment Period 1||6
6471417|NCT01260142|7388795|FG002|STARTED|Treatment Period 1||6
6471418|NCT01260142|7388796|FG003|STARTED|Treatment Period 1||6
6471419|NCT01260142|7388797|FG004|STARTED|Treatment Period 1||6
6471420|NCT01260142|7388798|FG005|STARTED|Treatment Period 1||6
6471421|NCT01260142|7388793|FG000|COMPLETED|Treatment Period 1||5
6471422|NCT01260142|7388794|FG001|COMPLETED|Treatment Period 1||5
6471423|NCT01260142|7388795|FG002|COMPLETED|Treatment Period 1||6
6471424|NCT01260142|7388796|FG003|COMPLETED|Treatment Period 1||6
6471425|NCT01260142|7388797|FG004|COMPLETED|Treatment Period 1||4
6471426|NCT01260142|7388798|FG005|COMPLETED|Treatment Period 1||3
6471427|NCT01260142|7388793|FG000|NOT COMPLETED|Treatment Period 1||1
6471428|NCT01260142|7388794|FG001|NOT COMPLETED|Treatment Period 1||1
6471429|NCT01260142|7388795|FG002|NOT COMPLETED|Treatment Period 1||0
6471430|NCT01260142|7388796|FG003|NOT COMPLETED|Treatment Period 1||0
6554387|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Fifth Intervention||5
6554388|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6554389|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6562910|NCT01803464|7485829|FG003|STARTED|Overall Study||10
6471431|NCT01260142|7388797|FG004|NOT COMPLETED|Treatment Period 1||2
6471432|NCT01260142|7388798|FG005|NOT COMPLETED|Treatment Period 1||3
6471433|NCT01260142|7388793|FG000|STARTED|Treatment Period 2||5
6471434|NCT01260142|7388794|FG001|STARTED|Treatment Period 2||5
6471435|NCT01260142|7388795|FG002|STARTED|Treatment Period 2||6
6471436|NCT01260142|7388796|FG003|STARTED|Treatment Period 2||6
6471437|NCT01260142|7388797|FG004|STARTED|Treatment Period 2||4
6471438|NCT01260142|7388798|FG005|STARTED|Treatment Period 2||3
6471439|NCT01260142|7388793|FG000|COMPLETED|Treatment Period 2||5
6471440|NCT01260142|7388794|FG001|COMPLETED|Treatment Period 2||5
6471441|NCT01260142|7388795|FG002|COMPLETED|Treatment Period 2||6
6471442|NCT01260142|7388796|FG003|COMPLETED|Treatment Period 2||6
6746763|NCT03378076|7674432|FG001|NOT COMPLETED|Overall Study||0
6471443|NCT01260142|7388797|FG004|COMPLETED|Treatment Period 2||4
6471444|NCT01260142|7388798|FG005|COMPLETED|Treatment Period 2||3
6471445|NCT01260142|7388793|FG000|NOT COMPLETED|Treatment Period 2||0
6471446|NCT01260142|7388794|FG001|NOT COMPLETED|Treatment Period 2||0
6471447|NCT01260142|7388795|FG002|NOT COMPLETED|Treatment Period 2||0
6471448|NCT01260142|7388796|FG003|NOT COMPLETED|Treatment Period 2||0
6471449|NCT01260142|7388797|FG004|NOT COMPLETED|Treatment Period 2||0
6471450|NCT01260142|7388798|FG005|NOT COMPLETED|Treatment Period 2||0
6471451|NCT01260181|7388818|FG000|STARTED|Overall Study||30
6471452|NCT01260181|7388818|FG000|COMPLETED|Overall Study||29
6471453|NCT01260181|7388818|FG000|NOT COMPLETED|Overall Study||1
6471454|NCT01260194|7388822|FG000|STARTED|Overall Study||4
6471455|NCT01260194|7388822|FG000|COMPLETED|Overall Study||3
6471456|NCT01260194|7388822|FG000|NOT COMPLETED|Overall Study||1
6471457|NCT01260272|7388828|FG000|STARTED|Overall Study||17
6471458|NCT01260272|7388829|FG001|STARTED|Overall Study||32
6471459|NCT01260272|7388828|FG000|COMPLETED|Overall Study||15
6471460|NCT01260272|7388829|FG001|COMPLETED|Overall Study||30
6471461|NCT01260272|7388828|FG000|NOT COMPLETED|Overall Study||2
6471462|NCT01260272|7388829|FG001|NOT COMPLETED|Overall Study||2
6471463|NCT01260311|7388837|FG000|STARTED|Overall Study||508
6746764|NCT03378635|7674441|FG000|STARTED|Overall Study||84
6746765|NCT03378635|7674442|FG001|STARTED|Overall Study||43
6746766|NCT03378635|7674443|FG002|STARTED|Overall Study||43
6554390|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6746767|NCT03378635|7674441|FG000|Randomized and Exposed to Treatment|Overall Study||82
6471464|NCT01260311|7388837|FG000|COMPLETED|Overall Study||381
6471465|NCT01260311|7388837|FG000|NOT COMPLETED|Overall Study||127
6471466|NCT01260324|7388843|FG000|STARTED|Overall Study||1283
6471467|NCT01260324|7388844|FG001|STARTED|Overall Study||20000
6471468|NCT01260324|7388843|FG000|COMPLETED|Overall Study||1283
6471469|NCT01260324|7388844|FG001|COMPLETED|Overall Study||20000
6471470|NCT01260324|7388843|FG000|NOT COMPLETED|Overall Study||0
6471471|NCT01260324|7388844|FG001|NOT COMPLETED|Overall Study||0
6471472|NCT01260350|7388870|FG000|STARTED|Overall Study||10
6471473|NCT01260350|7388871|FG001|STARTED|Overall Study||9
6471474|NCT01260350|7388872|FG002|STARTED|Overall Study||10
6471475|NCT01260350|7388873|FG003|STARTED|Overall Study||11
6471476|NCT01260350|7388874|FG004|STARTED|Overall Study||10
6471477|NCT01260350|7388875|FG005|STARTED|Overall Study||10
6471478|NCT01260350|7388876|FG006|STARTED|Overall Study||10
6471479|NCT01260350|7388877|FG007|STARTED|Overall Study||25
6471480|NCT01260350|7388878|FG008|STARTED|Overall Study||25
6471481|NCT01260350|7388879|FG009|STARTED|Overall Study||25
6471482|NCT01260350|7388880|FG010|STARTED|Overall Study||10
6471483|NCT01260350|7388881|FG011|STARTED|Overall Study||9
6471484|NCT01260350|7388882|FG012|STARTED|Overall Study||25
6471485|NCT01260350|7388883|FG013|STARTED|Overall Study||10
6471486|NCT01260350|7388884|FG014|STARTED|Overall Study||25
6471487|NCT01260350|7388885|FG015|STARTED|Overall Study||10
6471488|NCT01260350|7388886|FG016|STARTED|Overall Study||9
6471489|NCT01260350|7388887|FG017|STARTED|Overall Study||10
6471490|NCT01260350|7388888|FG018|STARTED|Overall Study||0
6471491|NCT01260350|7388889|FG019|STARTED|Overall Study||14
6471492|NCT01260350|7388890|FG020|STARTED|Overall Study||25
6471493|NCT01260350|7388891|FG021|STARTED|Overall Study||0
6471494|NCT01260350|7388870|FG000|COMPLETED|Overall Study||10
6471495|NCT01260350|7388871|FG001|COMPLETED|Overall Study||9
6471496|NCT01260350|7388872|FG002|COMPLETED|Overall Study||10
6471497|NCT01260350|7388873|FG003|COMPLETED|Overall Study||11
6471498|NCT01260350|7388874|FG004|COMPLETED|Overall Study||10
6471499|NCT01260350|7388875|FG005|COMPLETED|Overall Study||10
6471500|NCT01260350|7388876|FG006|COMPLETED|Overall Study||10
6471501|NCT01260350|7388877|FG007|COMPLETED|Overall Study||25
6471502|NCT01260350|7388878|FG008|COMPLETED|Overall Study||24
6471503|NCT01260350|7388879|FG009|COMPLETED|Overall Study||25
6471504|NCT01260350|7388880|FG010|COMPLETED|Overall Study||10
6471505|NCT01260350|7388881|FG011|COMPLETED|Overall Study||9
6471506|NCT01260350|7388882|FG012|COMPLETED|Overall Study||25
6471507|NCT01260350|7388883|FG013|COMPLETED|Overall Study||10
6471508|NCT01260350|7388884|FG014|COMPLETED|Overall Study||25
6471509|NCT01260350|7388885|FG015|COMPLETED|Overall Study||10
6471510|NCT01260350|7388886|FG016|COMPLETED|Overall Study||9
6471511|NCT01260350|7388887|FG017|COMPLETED|Overall Study||9
6471512|NCT01260350|7388888|FG018|COMPLETED|Overall Study||0
6471513|NCT01260350|7388889|FG019|COMPLETED|Overall Study||14
6471514|NCT01260350|7388890|FG020|COMPLETED|Overall Study||22
6746768|NCT03378635|7674442|FG001|Randomized and Exposed to Treatment|Overall Study||43
6471515|NCT01260350|7388891|FG021|COMPLETED|Overall Study||0
6471516|NCT01260350|7388870|FG000|NOT COMPLETED|Overall Study||0
6471517|NCT01260350|7388871|FG001|NOT COMPLETED|Overall Study||0
6471518|NCT01260350|7388872|FG002|NOT COMPLETED|Overall Study||0
6471519|NCT01260350|7388873|FG003|NOT COMPLETED|Overall Study||0
6471520|NCT01260350|7388874|FG004|NOT COMPLETED|Overall Study||0
6471521|NCT01260350|7388875|FG005|NOT COMPLETED|Overall Study||0
6471522|NCT01260350|7388876|FG006|NOT COMPLETED|Overall Study||0
6471523|NCT01260350|7388877|FG007|NOT COMPLETED|Overall Study||0
6471524|NCT01260350|7388878|FG008|NOT COMPLETED|Overall Study||1
6471525|NCT01260350|7388879|FG009|NOT COMPLETED|Overall Study||0
6471526|NCT01260350|7388880|FG010|NOT COMPLETED|Overall Study||0
6471527|NCT01260350|7388881|FG011|NOT COMPLETED|Overall Study||0
6471528|NCT01260350|7388882|FG012|NOT COMPLETED|Overall Study||0
6471529|NCT01260350|7388883|FG013|NOT COMPLETED|Overall Study||0
6471530|NCT01260350|7388884|FG014|NOT COMPLETED|Overall Study||0
6471531|NCT01260350|7388885|FG015|NOT COMPLETED|Overall Study||0
6471532|NCT01260350|7388886|FG016|NOT COMPLETED|Overall Study||0
6471533|NCT01260350|7388887|FG017|NOT COMPLETED|Overall Study||1
6554391|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6554392|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6554393|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6471534|NCT01260350|7388888|FG018|NOT COMPLETED|Overall Study||0
6471535|NCT01260350|7388889|FG019|NOT COMPLETED|Overall Study||0
6471536|NCT01260350|7388890|FG020|NOT COMPLETED|Overall Study||3
6471537|NCT01260350|7388891|FG021|NOT COMPLETED|Overall Study||0
6501056|NCT01426581|7419559|FG000|STARTED|Overall Study||62
6501057|NCT01426581|7419560|FG001|STARTED|Overall Study||58
6501058|NCT01426581|7419559|FG000|COMPLETED|Overall Study||62
6501059|NCT01426581|7419560|FG001|COMPLETED|Overall Study||58
6501060|NCT01426581|7419559|FG000|NOT COMPLETED|Overall Study||0
6501061|NCT01426581|7419560|FG001|NOT COMPLETED|Overall Study||0
6501062|NCT01426763|7419570|FG000|STARTED|Overall Study||6
6501063|NCT01426763|7419571|FG001|STARTED|Overall Study||6
6501064|NCT01426763|7419570|FG000|COMPLETED|Overall Study||6
6501065|NCT01426763|7419571|FG001|COMPLETED|Overall Study||6
6501066|NCT01426763|7419570|FG000|NOT COMPLETED|Overall Study||0
6501067|NCT01426763|7419571|FG001|NOT COMPLETED|Overall Study||0
6501068|NCT01426789|7419581|FG000|STARTED|Part 1||68
6554394|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6554395|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6554396|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Fifth Intervention||0
6554397|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Washout Period 5||0
6554398|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Washout Period 5||0
6554399|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Washout Period 5||0
6554400|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Washout Period 5||5
6554401|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Washout Period 5||6
6554402|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Washout Period 5||5
6746769|NCT03378635|7674443|FG002|Randomized and Exposed to Treatment|Overall Study||43
6746770|NCT03378635|7674441|FG000|COMPLETED|Overall Study||82
6746771|NCT03378635|7674442|FG001|COMPLETED|Overall Study||43
6501069|NCT01426789|7419582|FG001|STARTED|Part 1||32
6501070|NCT01426789|7419583|FG002|STARTED|Part 1||0
6501071|NCT01426789|7419584|FG003|STARTED|Part 1||0
6501072|NCT01426789|7419585|FG004|STARTED|Part 1||0
6501073|NCT01426789|7419586|FG005|STARTED|Part 1||0
6501074|NCT01426789|7419581|FG000|COMPLETED|Part 1||62
6501075|NCT01426789|7419582|FG001|COMPLETED|Part 1||28
6501076|NCT01426789|7419583|FG002|COMPLETED|Part 1||0
6501077|NCT01426789|7419584|FG003|COMPLETED|Part 1||0
6501078|NCT01426789|7419585|FG004|COMPLETED|Part 1||0
6501079|NCT01426789|7419586|FG005|COMPLETED|Part 1||0
6501080|NCT01426789|7419581|FG000|NOT COMPLETED|Part 1||6
6501081|NCT01426789|7419582|FG001|NOT COMPLETED|Part 1||4
6501082|NCT01426789|7419583|FG002|NOT COMPLETED|Part 1||0
6501083|NCT01426789|7419584|FG003|NOT COMPLETED|Part 1||0
6501084|NCT01426789|7419585|FG004|NOT COMPLETED|Part 1||0
6501085|NCT01426789|7419586|FG005|NOT COMPLETED|Part 1||0
6501086|NCT01426789|7419581|FG000|STARTED|Part 2||0
6501087|NCT01426789|7419582|FG001|STARTED|Part 2||0
6501088|NCT01426789|7419583|FG002|STARTED|Part 2||49
6501089|NCT01426789|7419584|FG003|STARTED|Part 2||13
6501090|NCT01426789|7419585|FG004|STARTED|Part 2||27
6501091|NCT01426789|7419586|FG005|STARTED|Part 2||1
6501092|NCT01426789|7419581|FG000|COMPLETED|Part 2||0
6501093|NCT01426789|7419582|FG001|COMPLETED|Part 2||0
6501094|NCT01426789|7419583|FG002|COMPLETED|Part 2||34
6501095|NCT01426789|7419584|FG003|COMPLETED|Part 2||12
6501096|NCT01426789|7419585|FG004|COMPLETED|Part 2||19
6501097|NCT01426789|7419586|FG005|COMPLETED|Part 2||1
6501098|NCT01426789|7419581|FG000|NOT COMPLETED|Part 2||0
6501099|NCT01426789|7419582|FG001|NOT COMPLETED|Part 2||0
6501100|NCT01426789|7419583|FG002|NOT COMPLETED|Part 2||15
6501101|NCT01426789|7419584|FG003|NOT COMPLETED|Part 2||1
6501102|NCT01426789|7419585|FG004|NOT COMPLETED|Part 2||8
6501103|NCT01426789|7419586|FG005|NOT COMPLETED|Part 2||0
6501104|NCT01426828|7419596|FG000|STARTED|Overall Study Evaluations||22
6501105|NCT01426828|7419597|FG001|STARTED|Overall Study Evaluations||18
6501106|NCT01426828|7419596|FG000|COMPLETED|Overall Study Evaluations||17
6501107|NCT01426828|7419597|FG001|COMPLETED|Overall Study Evaluations||15
6501108|NCT01426828|7419596|FG000|NOT COMPLETED|Overall Study Evaluations||5
6501109|NCT01426828|7419597|FG001|NOT COMPLETED|Overall Study Evaluations||3
6501110|NCT01426828|7419596|FG000|STARTED|Immune Response Analysis||17
6501111|NCT01426828|7419597|FG001|STARTED|Immune Response Analysis||15
6501112|NCT01426828|7419596|FG000|COMPLETED|Immune Response Analysis||8
6501113|NCT01426828|7419597|FG001|COMPLETED|Immune Response Analysis||8
6501114|NCT01426828|7419596|FG000|NOT COMPLETED|Immune Response Analysis||9
6501115|NCT01426828|7419597|FG001|NOT COMPLETED|Immune Response Analysis||7
6501116|NCT01426854|7419605|FG000|STARTED|Overall Study||131
6501117|NCT01426854|7419606|FG001|STARTED|Overall Study||129
6501118|NCT01426854|7419605|FG000|COMPLETED|Overall Study||119
6501119|NCT01426854|7419606|FG001|COMPLETED|Overall Study||98
6501120|NCT01426854|7419605|FG000|NOT COMPLETED|Overall Study||12
6501121|NCT01426854|7419606|FG001|NOT COMPLETED|Overall Study||31
6501122|NCT01426867|7419615|FG000|STARTED|Overall Study||33
6501123|NCT01426867|7419616|FG001|STARTED|Overall Study||34
6471538|NCT01260454|7388945|FG000|STARTED|Overall Study||6
6471539|NCT01260454|7388945|FG000|COMPLETED|Overall Study||6
6471540|NCT01260454|7388945|FG000|NOT COMPLETED|Overall Study||0
6471541|NCT01260467|7388949|FG000|STARTED|Overall Study||4
6471542|NCT01260467|7388949|FG000|COMPLETED|Overall Study||2
6471543|NCT01260467|7388949|FG000|NOT COMPLETED|Overall Study||2
6471544|NCT01260493|7388957|FG000|STARTED|Overall Study||92
6471545|NCT01260493|7388958|FG001|STARTED|Overall Study||89
6471546|NCT01260493|7388957|FG000|COMPLETED|Overall Study||76
6471547|NCT01260493|7388958|FG001|COMPLETED|Overall Study||85
6471548|NCT01260493|7388957|FG000|NOT COMPLETED|Overall Study||16
6471549|NCT01260493|7388958|FG001|NOT COMPLETED|Overall Study||4
6471550|NCT01260584|7388968|FG000|STARTED|Period 1||27
6471551|NCT01260584|7388969|FG001|STARTED|Period 1||28
6471552|NCT01260584|7388970|FG002|STARTED|Period 1||27
6471553|NCT01260584|7388971|FG003|STARTED|Period 1||28
6471554|NCT01260584|7388968|FG000|COMPLETED|Period 1||27
6471555|NCT01260584|7388969|FG001|COMPLETED|Period 1||28
6471556|NCT01260584|7388970|FG002|COMPLETED|Period 1||25
6471557|NCT01260584|7388971|FG003|COMPLETED|Period 1||27
6471558|NCT01260584|7388968|FG000|NOT COMPLETED|Period 1||0
6471559|NCT01260584|7388969|FG001|NOT COMPLETED|Period 1||0
6471560|NCT01260584|7388970|FG002|NOT COMPLETED|Period 1||2
6471561|NCT01260584|7388971|FG003|NOT COMPLETED|Period 1||1
6471562|NCT01260584|7388968|FG000|STARTED|Period 2||27
6471563|NCT01260584|7388969|FG001|STARTED|Period 2||28
6471564|NCT01260584|7388970|FG002|STARTED|Period 2||25
6471565|NCT01260584|7388971|FG003|STARTED|Period 2||27
6471566|NCT01260584|7388968|FG000|COMPLETED|Period 2||26
6471567|NCT01260584|7388969|FG001|COMPLETED|Period 2||25
6471568|NCT01260584|7388970|FG002|COMPLETED|Period 2||20
6471569|NCT01260584|7388971|FG003|COMPLETED|Period 2||26
6471570|NCT01260584|7388968|FG000|NOT COMPLETED|Period 2||1
6471571|NCT01260584|7388969|FG001|NOT COMPLETED|Period 2||3
6471572|NCT01260584|7388970|FG002|NOT COMPLETED|Period 2||5
6471573|NCT01260584|7388971|FG003|NOT COMPLETED|Period 2||1
6471574|NCT01260649|7388983|FG000|STARTED|Overall Study||8
6471575|NCT01260649|7388984|FG001|STARTED|Overall Study||9
6471576|NCT01260649|7388983|FG000|COMPLETED|Overall Study||6
6471577|NCT01260649|7388984|FG001|COMPLETED|Overall Study||8
6471578|NCT01260649|7388983|FG000|NOT COMPLETED|Overall Study||2
6471579|NCT01260649|7388984|FG001|NOT COMPLETED|Overall Study||1
6471580|NCT01260662|7388993|FG000|STARTED|Overall Study||90
6471581|NCT01260662|7388994|FG001|STARTED|Overall Study||85
6471582|NCT01260662|7388995|FG002|STARTED|Overall Study||96
6471583|NCT01260662|7388993|FG000|COMPLETED|Overall Study||90
6471584|NCT01260662|7388994|FG001|COMPLETED|Overall Study||85
6471585|NCT01260662|7388995|FG002|COMPLETED|Overall Study||96
6471586|NCT01260662|7388993|FG000|NOT COMPLETED|Overall Study||0
6471587|NCT01260662|7388994|FG001|NOT COMPLETED|Overall Study||0
6471588|NCT01260662|7388995|FG002|NOT COMPLETED|Overall Study||0
6471589|NCT01260688|7389005|FG000|STARTED|Overall Study||11
6471590|NCT01260688|7389006|FG001|STARTED|Overall Study||11
6471591|NCT01260688|7389005|FG000|COMPLETED|Overall Study||11
6471592|NCT01260688|7389006|FG001|COMPLETED|Overall Study||11
6471593|NCT01260688|7389005|FG000|NOT COMPLETED|Overall Study||0
6471594|NCT01260688|7389006|FG001|NOT COMPLETED|Overall Study||0
6471595|NCT01260701|7389015|FG000|STARTED|Overall Study||75
6471596|NCT01260701|7389015|FG000|Eligible|Overall Study||71
6471597|NCT01260701|7389015|FG000|Eligible and Began Protocol Therapy|Overall Study||70
6471598|NCT01260701|7389015|FG000|COMPLETED|Overall Study||0
6471599|NCT01260701|7389015|FG000|NOT COMPLETED|Overall Study||75
6471600|NCT01260883|7389022|FG000|STARTED|Overall Study||22
6471601|NCT01260883|7389023|FG001|STARTED|Overall Study||11
6471602|NCT01260883|7389024|FG002|STARTED|Overall Study||18
6471603|NCT01260883|7389022|FG000|COMPLETED|Overall Study||22
6471604|NCT01260883|7389023|FG001|COMPLETED|Overall Study||11
6471605|NCT01260883|7389024|FG002|COMPLETED|Overall Study||18
6471606|NCT01260883|7389022|FG000|NOT COMPLETED|Overall Study||0
6471607|NCT01260883|7389023|FG001|NOT COMPLETED|Overall Study||0
6471608|NCT01260883|7389024|FG002|NOT COMPLETED|Overall Study||0
6471609|NCT01260896|7389055|FG000|STARTED|First Intervention||12
6471610|NCT01260896|7389056|FG001|STARTED|First Intervention||12
6471611|NCT01260896|7389055|FG000|COMPLETED|First Intervention||10
6471612|NCT01260896|7389056|FG001|COMPLETED|First Intervention||12
6471613|NCT01260896|7389055|FG000|NOT COMPLETED|First Intervention||2
6471614|NCT01260896|7389056|FG001|NOT COMPLETED|First Intervention||0
6471615|NCT01260896|7389055|FG000|STARTED|Washout of 7 Days||10
6471616|NCT01260896|7389056|FG001|STARTED|Washout of 7 Days||12
6471617|NCT01260896|7389055|FG000|COMPLETED|Washout of 7 Days||10
6471618|NCT01260896|7389056|FG001|COMPLETED|Washout of 7 Days||12
6471619|NCT01260896|7389055|FG000|NOT COMPLETED|Washout of 7 Days||0
6471620|NCT01260896|7389056|FG001|NOT COMPLETED|Washout of 7 Days||0
6471621|NCT01260896|7389055|FG000|STARTED|Second Intervention||10
6471622|NCT01260896|7389056|FG001|STARTED|Second Intervention||12
6471623|NCT01260896|7389055|FG000|COMPLETED|Second Intervention||10
6471624|NCT01260896|7389056|FG001|COMPLETED|Second Intervention||12
6471625|NCT01260896|7389055|FG000|NOT COMPLETED|Second Intervention||0
6471626|NCT01260896|7389056|FG001|NOT COMPLETED|Second Intervention||0
6471627|NCT01260922|7389064|FG000|STARTED|First Intervention||13
6471628|NCT01260922|7389065|FG001|STARTED|First Intervention||13
6471629|NCT01260922|7389064|FG000|COMPLETED|First Intervention||13
6471630|NCT01260922|7389065|FG001|COMPLETED|First Intervention||12
6471631|NCT01260922|7389064|FG000|NOT COMPLETED|First Intervention||0
6471632|NCT01260922|7389065|FG001|NOT COMPLETED|First Intervention||1
6471633|NCT01260922|7389064|FG000|STARTED|Washout of 28 Days||13
6471634|NCT01260922|7389065|FG001|STARTED|Washout of 28 Days||12
6471635|NCT01260922|7389064|FG000|COMPLETED|Washout of 28 Days||9
6471636|NCT01260922|7389065|FG001|COMPLETED|Washout of 28 Days||10
6471637|NCT01260922|7389064|FG000|NOT COMPLETED|Washout of 28 Days||4
6471638|NCT01260922|7389065|FG001|NOT COMPLETED|Washout of 28 Days||2
6471639|NCT01260922|7389064|FG000|STARTED|Second Intervention||9
6471640|NCT01260922|7389065|FG001|STARTED|Second Intervention||10
6471641|NCT01260922|7389064|FG000|COMPLETED|Second Intervention||9
6471642|NCT01260922|7389065|FG001|COMPLETED|Second Intervention||8
6471643|NCT01260922|7389064|FG000|NOT COMPLETED|Second Intervention||0
6471644|NCT01260922|7389065|FG001|NOT COMPLETED|Second Intervention||2
6471645|NCT01260948|7389073|FG000|STARTED|First Intervention||13
6471646|NCT01260948|7389074|FG001|STARTED|First Intervention||13
6471647|NCT01260948|7389073|FG000|COMPLETED|First Intervention||13
6471648|NCT01260948|7389074|FG001|COMPLETED|First Intervention||13
6471649|NCT01260948|7389073|FG000|NOT COMPLETED|First Intervention||0
6471650|NCT01260948|7389074|FG001|NOT COMPLETED|First Intervention||0
6471651|NCT01260948|7389073|FG000|STARTED|Washout of 28 Days||13
6471652|NCT01260948|7389074|FG001|STARTED|Washout of 28 Days||13
6471653|NCT01260948|7389073|FG000|COMPLETED|Washout of 28 Days||12
6471654|NCT01260948|7389074|FG001|COMPLETED|Washout of 28 Days||10
6471655|NCT01260948|7389073|FG000|NOT COMPLETED|Washout of 28 Days||1
6471656|NCT01260948|7389074|FG001|NOT COMPLETED|Washout of 28 Days||3
6471657|NCT01260948|7389073|FG000|STARTED|Second Intervention||12
6471658|NCT01260948|7389074|FG001|STARTED|Second Intervention||10
6471659|NCT01260948|7389073|FG000|COMPLETED|Second Intervention||12
6471660|NCT01260948|7389074|FG001|COMPLETED|Second Intervention||9
6471661|NCT01260948|7389073|FG000|NOT COMPLETED|Second Intervention||0
6471662|NCT01260948|7389074|FG001|NOT COMPLETED|Second Intervention||1
6471663|NCT01261000|7389080|FG000|STARTED|Overall Study||8
6471664|NCT01261000|7389080|FG000|COMPLETED|Overall Study||7
6471665|NCT01261000|7389080|FG000|NOT COMPLETED|Overall Study||1
6471666|NCT01261052|7389084|FG000|STARTED|FMPD/APD Intervention (33 Hours)||14
6471667|NCT01261052|7389084|FG000|COMPLETED|FMPD/APD Intervention (33 Hours)||14
6471668|NCT01261052|7389084|FG000|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
6471669|NCT01261052|7389084|FG000|STARTED|APD Only Intervention (33 Hours)||14
6471670|NCT01261052|7389084|FG000|COMPLETED|APD Only Intervention (33 Hours)||14
6471671|NCT01261052|7389084|FG000|NOT COMPLETED|APD Only Intervention (33 Hours)||0
6471672|NCT01261325|7389092|FG000|STARTED|Overall Study||263
6471673|NCT01261325|7389093|FG001|STARTED|Overall Study||254
6471674|NCT01261325|7389094|FG002|STARTED|Overall Study||251
6471675|NCT01261325|7389092|FG000|COMPLETED|Overall Study||246
6471676|NCT01261325|7389093|FG001|COMPLETED|Overall Study||225
6471677|NCT01261325|7389094|FG002|COMPLETED|Overall Study||225
6471678|NCT01261325|7389092|FG000|NOT COMPLETED|Overall Study||17
6471679|NCT01261325|7389093|FG001|NOT COMPLETED|Overall Study||29
6471680|NCT01261325|7389094|FG002|NOT COMPLETED|Overall Study||26
6471681|NCT01261338|7389107|FG000|STARTED|Overall Study|One person in the olestra group started 4 months after the trial began.|14
6471682|NCT01261338|7389108|FG001|STARTED|Overall Study||14
6471683|NCT01261338|7389107|FG000|COMPLETED|Overall Study||11
6471684|NCT01261338|7389108|FG001|COMPLETED|Overall Study||12
6471685|NCT01261338|7389107|FG000|NOT COMPLETED|Overall Study||3
6471686|NCT01261338|7389108|FG001|NOT COMPLETED|Overall Study||2
6471687|NCT01261390|7389118|FG000|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
6471688|NCT01261390|7389119|FG001|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
6471689|NCT01261390|7389120|FG002|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
6471690|NCT01261390|7389121|FG003|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
6554403|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Washout Period 5||5
6554404|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Washout Period 5||6
6554405|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Washout Period 5||5
6471691|NCT01261390|7389118|FG000|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
6471692|NCT01261390|7389119|FG001|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
6471693|NCT01261390|7389120|FG002|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
6471694|NCT01261390|7389121|FG003|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
6471695|NCT01261390|7389118|FG000|12-Month Visit|Overall Study||23
6471696|NCT01261390|7389119|FG001|12-Month Visit|Overall Study||21
6554406|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Washout Period 5||0
6554407|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Washout Period 5||0
6554408|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Washout Period 5||0
6554409|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Washout Period 5||5
6554410|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Washout Period 5||6
6471697|NCT01261390|7389120|FG002|12-Month Visit|Overall Study||19
6471698|NCT01261390|7389121|FG003|12-Month Visit|Overall Study||19
6471699|NCT01261390|7389118|FG000|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
6471700|NCT01261390|7389119|FG001|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
6554411|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Washout Period 5||5
6554412|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Washout Period 5||5
6554413|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Washout Period 5||6
6554414|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Washout Period 5||5
6471701|NCT01261390|7389120|FG002|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
6471702|NCT01261390|7389121|FG003|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
6471703|NCT01261390|7389118|FG000|NOT COMPLETED|Overall Study||7
6471704|NCT01261390|7389119|FG001|NOT COMPLETED|Overall Study||9
6471705|NCT01261390|7389120|FG002|NOT COMPLETED|Overall Study||7
6471706|NCT01261390|7389121|FG003|NOT COMPLETED|Overall Study||8
6471707|NCT01261507|7389136|FG000|STARTED|Overall Study||15
6471708|NCT01261507|7389136|FG000|COMPLETED|Overall Study||15
6471709|NCT01261507|7389136|FG000|NOT COMPLETED|Overall Study||0
6471710|NCT01261559|7389145|FG000|STARTED|Overall Study||36
6471711|NCT01261559|7389146|FG001|STARTED|Overall Study||36
6471712|NCT01261559|7389145|FG000|COMPLETED|Overall Study||36
6471713|NCT01261559|7389146|FG001|COMPLETED|Overall Study||36
6471714|NCT01261559|7389145|FG000|NOT COMPLETED|Overall Study||0
6471715|NCT01261559|7389146|FG001|NOT COMPLETED|Overall Study||0
6471716|NCT01261611|7389156|FG000|STARTED|Treatment Cycle 1||156
6471717|NCT01261611|7389157|FG001|STARTED|Treatment Cycle 1||159
6471718|NCT01261611|7389158|FG002|STARTED|Treatment Cycle 1||54
6471719|NCT01261611|7389156|FG000|COMPLETED|Treatment Cycle 1||152
6471720|NCT01261611|7389157|FG001|COMPLETED|Treatment Cycle 1||156
6471721|NCT01261611|7389158|FG002|COMPLETED|Treatment Cycle 1||52
6471722|NCT01261611|7389156|FG000|NOT COMPLETED|Treatment Cycle 1||4
6471723|NCT01261611|7389157|FG001|NOT COMPLETED|Treatment Cycle 1||3
6471724|NCT01261611|7389158|FG002|NOT COMPLETED|Treatment Cycle 1||2
6471725|NCT01261611|7389156|FG000|STARTED|Treatment Cycle 2|All but 1 who completed DB period entered the open label period. This subject remained at Cycle 1.|359
6471726|NCT01261611|7389157|FG001|STARTED|Treatment Cycle 2||0
6471727|NCT01261611|7389158|FG002|STARTED|Treatment Cycle 2||0
6471728|NCT01261611|7389156|FG000|COMPLETED|Treatment Cycle 2||346
6471729|NCT01261611|7389157|FG001|COMPLETED|Treatment Cycle 2||0
6471730|NCT01261611|7389158|FG002|COMPLETED|Treatment Cycle 2||0
6471731|NCT01261611|7389156|FG000|NOT COMPLETED|Treatment Cycle 2||13
6471732|NCT01261611|7389157|FG001|NOT COMPLETED|Treatment Cycle 2||0
6471733|NCT01261611|7389158|FG002|NOT COMPLETED|Treatment Cycle 2||0
6471734|NCT01261611|7389156|FG000|STARTED|Treatment Cycle 3||346
6471735|NCT01261611|7389157|FG001|STARTED|Treatment Cycle 3||0
6471736|NCT01261611|7389158|FG002|STARTED|Treatment Cycle 3||0
6471737|NCT01261611|7389156|FG000|COMPLETED|Treatment Cycle 3||316
6471738|NCT01261611|7389157|FG001|COMPLETED|Treatment Cycle 3||0
6471739|NCT01261611|7389158|FG002|COMPLETED|Treatment Cycle 3||0
6471740|NCT01261611|7389156|FG000|NOT COMPLETED|Treatment Cycle 3||30
6471741|NCT01261611|7389157|FG001|NOT COMPLETED|Treatment Cycle 3||0
6471742|NCT01261611|7389158|FG002|NOT COMPLETED|Treatment Cycle 3||0
6471743|NCT01261611|7389156|FG000|STARTED|Treatment Cycle 4||316
6471744|NCT01261611|7389157|FG001|STARTED|Treatment Cycle 4||0
6471745|NCT01261611|7389158|FG002|STARTED|Treatment Cycle 4||0
6471746|NCT01261611|7389156|FG000|COMPLETED|Treatment Cycle 4||220
6471747|NCT01261611|7389157|FG001|COMPLETED|Treatment Cycle 4||0
6471748|NCT01261611|7389158|FG002|COMPLETED|Treatment Cycle 4||0
6471749|NCT01261611|7389156|FG000|NOT COMPLETED|Treatment Cycle 4||96
6471750|NCT01261611|7389157|FG001|NOT COMPLETED|Treatment Cycle 4||0
6471751|NCT01261611|7389158|FG002|NOT COMPLETED|Treatment Cycle 4||0
6471752|NCT01261611|7389156|FG000|STARTED|Treatment Cycle 5||220
6471753|NCT01261611|7389157|FG001|STARTED|Treatment Cycle 5||0
6471754|NCT01261611|7389158|FG002|STARTED|Treatment Cycle 5||0
6471755|NCT01261611|7389156|FG000|COMPLETED|Treatment Cycle 5||217
6471756|NCT01261611|7389157|FG001|COMPLETED|Treatment Cycle 5||0
6471757|NCT01261611|7389158|FG002|COMPLETED|Treatment Cycle 5||0
6471758|NCT01261611|7389156|FG000|NOT COMPLETED|Treatment Cycle 5||3
6471759|NCT01261611|7389157|FG001|NOT COMPLETED|Treatment Cycle 5||0
6471760|NCT01261611|7389158|FG002|NOT COMPLETED|Treatment Cycle 5||0
6471761|NCT01261624|7389172|FG000|STARTED|Week 0 to Week 12||10
6471762|NCT01261624|7389173|FG001|STARTED|Week 0 to Week 12||6
6471763|NCT01261624|7389172|FG000|COMPLETED|Week 0 to Week 12||9
6471764|NCT01261624|7389173|FG001|COMPLETED|Week 0 to Week 12||3
6471765|NCT01261624|7389172|FG000|NOT COMPLETED|Week 0 to Week 12||1
6471766|NCT01261624|7389173|FG001|NOT COMPLETED|Week 0 to Week 12||3
6471767|NCT01261624|7389172|FG000|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
6471768|NCT01261624|7389173|FG001|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
6471769|NCT01261624|7389172|FG000|COMPLETED|Week 13 to Week 24||1
6471770|NCT01261624|7389173|FG001|COMPLETED|Week 13 to Week 24||10
6471771|NCT01261624|7389172|FG000|NOT COMPLETED|Week 13 to Week 24||0
6471772|NCT01261624|7389173|FG001|NOT COMPLETED|Week 13 to Week 24||1
6471773|NCT01261780|7389187|FG000|STARTED|Overall Study||7
6471774|NCT01261780|7389188|FG001|STARTED|Overall Study||7
6471775|NCT01261780|7389187|FG000|COMPLETED|Overall Study||5
6471776|NCT01261780|7389188|FG001|COMPLETED|Overall Study||5
6471777|NCT01261780|7389187|FG000|NOT COMPLETED|Overall Study||2
6471778|NCT01261780|7389188|FG001|NOT COMPLETED|Overall Study||2
6471779|NCT01261793|7389197|FG000|STARTED|Overall Study||263
6471780|NCT01261793|7389198|FG001|STARTED|Overall Study||262
6471781|NCT01261793|7389199|FG002|STARTED|Overall Study||266
6471782|NCT01261793|7389197|FG000|COMPLETED|Overall Study||178
6471783|NCT01261793|7389198|FG001|COMPLETED|Overall Study||171
6471784|NCT01261793|7389199|FG002|COMPLETED|Overall Study||184
6471785|NCT01261793|7389197|FG000|NOT COMPLETED|Overall Study||85
6471786|NCT01261793|7389198|FG001|NOT COMPLETED|Overall Study||91
6471787|NCT01261793|7389199|FG002|NOT COMPLETED|Overall Study||82
6471788|NCT01261819|7389209|FG000|STARTED|Overall Study||33
6471789|NCT01261819|7389210|FG001|STARTED|Overall Study||33
6471790|NCT01261819|7389209|FG000|COMPLETED|Overall Study||33
6471791|NCT01261819|7389210|FG001|COMPLETED|Overall Study||33
6471792|NCT01261819|7389209|FG000|NOT COMPLETED|Overall Study||0
6471793|NCT01261819|7389210|FG001|NOT COMPLETED|Overall Study||0
6471794|NCT01261975|7389216|FG000|STARTED|Overall Study|36 Participants 72 eyes started|36
6471795|NCT01261975|7389216|FG000|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
6471796|NCT01261975|7389216|FG000|NOT COMPLETED|Overall Study||1
6471797|NCT01262027|7389223|FG000|STARTED|Overall Study||22
6471798|NCT01262027|7389223|FG000|COMPLETED|Overall Study||17
6471799|NCT01262027|7389223|FG000|NOT COMPLETED|Overall Study||5
6471800|NCT01262092|7389229|FG000|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
6471801|NCT01262092|7389230|FG001|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
6471802|NCT01262092|7389229|FG000|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
6471803|NCT01262092|7389230|FG001|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
6471804|NCT01262092|7389229|FG000|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
6471805|NCT01262092|7389230|FG001|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
6471806|NCT01262092|7389229|FG000|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
6471807|NCT01262092|7389230|FG001|STARTED|Buprenorphine Taper||13
6471808|NCT01262092|7389229|FG000|COMPLETED|Buprenorphine Taper||11
6471809|NCT01262092|7389230|FG001|COMPLETED|Buprenorphine Taper||12
6471810|NCT01262092|7389229|FG000|NOT COMPLETED|Buprenorphine Taper||1
6471811|NCT01262092|7389230|FG001|NOT COMPLETED|Buprenorphine Taper||1
6471812|NCT01262092|7389229|FG000|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
6471813|NCT01262092|7389230|FG001|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
6471814|NCT01262092|7389229|FG000|COMPLETED|Gabapentin Taper||9
6471815|NCT01262092|7389230|FG001|COMPLETED|Gabapentin Taper||11
6471816|NCT01262092|7389229|FG000|NOT COMPLETED|Gabapentin Taper||1
6471817|NCT01262092|7389230|FG001|NOT COMPLETED|Gabapentin Taper||0
6471818|NCT01262105|7389238|FG000|STARTED|Overall Study||13
6471819|NCT01262105|7389239|FG001|STARTED|Overall Study||10
6471820|NCT01262105|7389238|FG000|COMPLETED|Overall Study||13
6471821|NCT01262105|7389239|FG001|COMPLETED|Overall Study||10
6471822|NCT01262105|7389238|FG000|NOT COMPLETED|Overall Study||0
6471823|NCT01262105|7389239|FG001|NOT COMPLETED|Overall Study||0
6471824|NCT01262118|7389247|FG000|STARTED|Baseline Assessment Period (3 Days)||36
6471825|NCT01262118|7389248|FG001|STARTED|Baseline Assessment Period (3 Days)||33
6471826|NCT01262118|7389247|FG000|COMPLETED|Baseline Assessment Period (3 Days)||36
6471827|NCT01262118|7389248|FG001|COMPLETED|Baseline Assessment Period (3 Days)||33
6471828|NCT01262118|7389247|FG000|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
6471829|NCT01262118|7389248|FG001|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
6471830|NCT01262118|7389247|FG000|STARTED|Treatment Period (6 Weeks)||36
6471831|NCT01262118|7389248|FG001|STARTED|Treatment Period (6 Weeks)||0
6471832|NCT01262118|7389247|FG000|COMPLETED|Treatment Period (6 Weeks)||36
6471833|NCT01262118|7389248|FG001|COMPLETED|Treatment Period (6 Weeks)||0
6471834|NCT01262118|7389247|FG000|NOT COMPLETED|Treatment Period (6 Weeks)||0
6471835|NCT01262118|7389248|FG001|NOT COMPLETED|Treatment Period (6 Weeks)||0
6471836|NCT01262131|7389257|FG000|STARTED|Overall Study||5
6471837|NCT01262131|7389258|FG001|STARTED|Overall Study||4
6471838|NCT01262131|7389259|FG002|STARTED|Overall Study||4
6471839|NCT01262131|7389257|FG000|COMPLETED|Overall Study||5
6471840|NCT01262131|7389258|FG001|COMPLETED|Overall Study||4
6471841|NCT01262131|7389259|FG002|COMPLETED|Overall Study||4
6471842|NCT01262131|7389257|FG000|NOT COMPLETED|Overall Study||0
6471843|NCT01262131|7389258|FG001|NOT COMPLETED|Overall Study||0
6471844|NCT01262131|7389259|FG002|NOT COMPLETED|Overall Study||0
6471845|NCT01262287|7389269|FG000|STARTED|Overall Study||20
6471846|NCT01262287|7389270|FG001|STARTED|Overall Study||19
6471847|NCT01262287|7389269|FG000|COMPLETED|Overall Study||18
6471848|NCT01262287|7389270|FG001|COMPLETED|Overall Study||18
6471849|NCT01262287|7389269|FG000|NOT COMPLETED|Overall Study||2
6471850|NCT01262287|7389270|FG001|NOT COMPLETED|Overall Study||1
6471851|NCT01262352|7389282|FG000|STARTED|Period 1||11
6471852|NCT01262352|7389283|FG001|STARTED|Period 1||10
6471853|NCT01262352|7389282|FG000|Dosed|Period 1||10
6471854|NCT01262352|7389283|FG001|Dosed|Period 1||10
6471855|NCT01262352|7389282|FG000|COMPLETED|Period 1||10
6471856|NCT01262352|7389283|FG001|COMPLETED|Period 1||10
6471857|NCT01262352|7389282|FG000|NOT COMPLETED|Period 1||1
6471858|NCT01262352|7389283|FG001|NOT COMPLETED|Period 1||0
6471859|NCT01262352|7389282|FG000|STARTED|Washout||10
6471860|NCT01262352|7389283|FG001|STARTED|Washout||10
6471861|NCT01262352|7389282|FG000|COMPLETED|Washout||9
6471862|NCT01262352|7389283|FG001|COMPLETED|Washout||8
6471863|NCT01262352|7389282|FG000|NOT COMPLETED|Washout||1
6471864|NCT01262352|7389283|FG001|NOT COMPLETED|Washout||2
6471865|NCT01262352|7389282|FG000|STARTED|Period 2||9
6471866|NCT01262352|7389283|FG001|STARTED|Period 2||8
6471867|NCT01262352|7389282|FG000|Dosed|Period 2||9
6471868|NCT01262352|7389283|FG001|Dosed|Period 2||8
6471869|NCT01262352|7389282|FG000|COMPLETED|Period 2||9
6471870|NCT01262352|7389283|FG001|COMPLETED|Period 2||8
6471871|NCT01262352|7389282|FG000|NOT COMPLETED|Period 2||0
6471872|NCT01262352|7389283|FG001|NOT COMPLETED|Period 2||0
6471873|NCT01262365|7389292|FG000|STARTED|Overall Study||266
6471874|NCT01262365|7389293|FG001|STARTED|Overall Study||262
6471875|NCT01262365|7389294|FG002|STARTED|Overall Study||265
6471876|NCT01262365|7389292|FG000|COMPLETED|Overall Study||176
6471877|NCT01262365|7389293|FG001|COMPLETED|Overall Study||181
6471878|NCT01262365|7389294|FG002|COMPLETED|Overall Study||171
6471879|NCT01262365|7389292|FG000|NOT COMPLETED|Overall Study||90
6471880|NCT01262365|7389293|FG001|NOT COMPLETED|Overall Study||81
6471881|NCT01262365|7389294|FG002|NOT COMPLETED|Overall Study||94
6471882|NCT01262456|7389305|FG000|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
6471883|NCT01262456|7389306|FG001|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
6471884|NCT01262456|7389307|FG002|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
6471885|NCT01262456|7389305|FG000|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
6471886|NCT01262456|7389306|FG001|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
6471887|NCT01262456|7389307|FG002|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
6471888|NCT01262456|7389305|FG000|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
6471889|NCT01262456|7389306|FG001|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
6471890|NCT01262456|7389307|FG002|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
6471891|NCT01262456|7389305|FG000|COMPLETED|3-Month Double-Blind Period||124
6471892|NCT01262456|7389306|FG001|COMPLETED|3-Month Double-Blind Period||100
6471893|NCT01262456|7389307|FG002|COMPLETED|3-Month Double-Blind Period||103
6471894|NCT01262456|7389305|FG000|NOT COMPLETED|3-Month Double-Blind Period||19
6471895|NCT01262456|7389306|FG001|NOT COMPLETED|3-Month Double-Blind Period||23
6471896|NCT01262456|7389307|FG002|NOT COMPLETED|3-Month Double-Blind Period||26
6471897|NCT01262456|7389305|FG000|STARTED|1-Month Open-Label Extension Period||124
6471898|NCT01262456|7389306|FG001|STARTED|1-Month Open-Label Extension Period||100
6471899|NCT01262456|7389307|FG002|STARTED|1-Month Open-Label Extension Period||103
6471900|NCT01262456|7389305|FG000|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
6471901|NCT01262456|7389306|FG001|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
6471902|NCT01262456|7389307|FG002|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
6471903|NCT01262456|7389305|FG000|COMPLETED|1-Month Open-Label Extension Period||120
6471904|NCT01262456|7389306|FG001|COMPLETED|1-Month Open-Label Extension Period||97
6471905|NCT01262456|7389307|FG002|COMPLETED|1-Month Open-Label Extension Period||98
6471906|NCT01262456|7389305|FG000|NOT COMPLETED|1-Month Open-Label Extension Period||4
6471907|NCT01262456|7389306|FG001|NOT COMPLETED|1-Month Open-Label Extension Period||3
6471908|NCT01262456|7389307|FG002|NOT COMPLETED|1-Month Open-Label Extension Period||5
6471909|NCT01262547|7389323|FG000|STARTED|Overall Study||3
6471910|NCT01262547|7389323|FG000|COMPLETED|Overall Study||3
6471911|NCT01262547|7389323|FG000|NOT COMPLETED|Overall Study||0
6471912|NCT01262560|7389335|FG000|STARTED|Overall Study||53
6471913|NCT01262560|7389336|FG001|STARTED|Overall Study||54
6471914|NCT01262560|7389337|FG002|STARTED|Overall Study||56
6471915|NCT01262560|7389335|FG000|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
6471916|NCT01262560|7389336|FG001|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
6471917|NCT01262560|7389337|FG002|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
6471918|NCT01262560|7389335|FG000|NOT COMPLETED|Overall Study||0
6471919|NCT01262560|7389336|FG001|NOT COMPLETED|Overall Study||1
6471920|NCT01262560|7389337|FG002|NOT COMPLETED|Overall Study||2
6471921|NCT01262573|7389347|FG000|STARTED|Overall Study||32
6471922|NCT01262573|7389348|FG001|STARTED|Overall Study||32
6471923|NCT01262573|7389347|FG000|COMPLETED|Overall Study||32
6471924|NCT01262573|7389348|FG001|COMPLETED|Overall Study||31
6471925|NCT01262573|7389347|FG000|NOT COMPLETED|Overall Study||0
6471926|NCT01262573|7389348|FG001|NOT COMPLETED|Overall Study||1
6471927|NCT01262599|7389356|FG000|STARTED|Overall Study||16
6471928|NCT01262599|7389357|FG001|STARTED|Overall Study||16
6471929|NCT01262599|7389356|FG000|COMPLETED|Overall Study||16
6471930|NCT01262599|7389357|FG001|COMPLETED|Overall Study||16
6471931|NCT01262599|7389356|FG000|NOT COMPLETED|Overall Study||0
6471932|NCT01262599|7389357|FG001|NOT COMPLETED|Overall Study||0
6554415|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6554416|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6554417|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6554418|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6471933|NCT01262638|7389369|FG000|STARTED|Overall Study||45
6554419|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6471934|NCT01262638|7389370|FG001|STARTED|Overall Study||44
6471935|NCT01262638|7389371|FG002|STARTED|Overall Study||44
6471936|NCT01262638|7389372|FG003|STARTED|Overall Study||44
6471937|NCT01262638|7389369|FG000|COMPLETED|Overall Study||38
6471938|NCT01262638|7389370|FG001|COMPLETED|Overall Study||38
6471939|NCT01262638|7389371|FG002|COMPLETED|Overall Study||38
6471940|NCT01262638|7389372|FG003|COMPLETED|Overall Study||37
6471941|NCT01262638|7389369|FG000|NOT COMPLETED|Overall Study||7
6471942|NCT01262638|7389370|FG001|NOT COMPLETED|Overall Study||6
6471943|NCT01262638|7389371|FG002|NOT COMPLETED|Overall Study||6
6471944|NCT01262638|7389372|FG003|NOT COMPLETED|Overall Study||7
6471945|NCT01262651|7389387|FG000|STARTED|Overall Study||199
6471946|NCT01262651|7389388|FG001|STARTED|Overall Study||198
6471947|NCT01262651|7389387|FG000|Received at Least 1 Dose of Study Drug|Overall Study||199
6471948|NCT01262651|7389388|FG001|Received at Least 1 Dose of Study Drug|Overall Study||198
6471949|NCT01262651|7389387|FG000|Safety Population|Overall Study||199
6471950|NCT01262651|7389388|FG001|Safety Population|Overall Study||198
6471951|NCT01262651|7389387|FG000|ITT Population|Overall Study||199
6471952|NCT01262651|7389388|FG001|ITT Population|Overall Study||198
6471953|NCT01262651|7389387|FG000|COMPLETED|Overall Study||141
6471954|NCT01262651|7389388|FG001|COMPLETED|Overall Study||150
6471955|NCT01262651|7389387|FG000|NOT COMPLETED|Overall Study||58
6471956|NCT01262651|7389388|FG001|NOT COMPLETED|Overall Study||48
6471957|NCT01262677|7389397|FG000|STARTED|Overall Study||100
6471958|NCT01262677|7389398|FG001|STARTED|Overall Study||113
6471959|NCT01262677|7389399|FG002|STARTED|Overall Study||110
6471960|NCT01262677|7389397|FG000|COMPLETED|Overall Study||91
6471961|NCT01262677|7389398|FG001|COMPLETED|Overall Study||98
6471962|NCT01262677|7389399|FG002|COMPLETED|Overall Study||98
6471963|NCT01262677|7389397|FG000|NOT COMPLETED|Overall Study||9
6471964|NCT01262677|7389398|FG001|NOT COMPLETED|Overall Study||15
6471965|NCT01262677|7389399|FG002|NOT COMPLETED|Overall Study||12
6471966|NCT01262755|7389407|FG000|STARTED|Overall Study||450
6471967|NCT01262755|7389407|FG000|COMPLETED|Overall Study||450
6471968|NCT01262755|7389407|FG000|NOT COMPLETED|Overall Study||0
6471969|NCT01262820|7389411|FG000|STARTED|Overall Study||15
6471970|NCT01262820|7389411|FG000|COMPLETED|Overall Study||0
6471971|NCT01262820|7389411|FG000|NOT COMPLETED|Overall Study||15
6471972|NCT01262846|7389417|FG000|STARTED|Overall Study||95
6471973|NCT01262846|7389418|FG001|STARTED|Overall Study||100
6471974|NCT01262846|7389417|FG000|COMPLETED|Overall Study||93
6471975|NCT01262846|7389418|FG001|COMPLETED|Overall Study||97
6471976|NCT01262846|7389417|FG000|NOT COMPLETED|Overall Study||2
6471977|NCT01262846|7389418|FG001|NOT COMPLETED|Overall Study||3
6471978|NCT01262872|7389432|FG000|STARTED|Step 1||60
6471979|NCT01262872|7389433|FG001|STARTED|Step 1||60
6471980|NCT01262872|7389434|FG002|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471981|NCT01262872|7389435|FG003|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471982|NCT01262872|7389436|FG004|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471983|NCT01262872|7389437|FG005|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471984|NCT01262872|7389438|FG006|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471985|NCT01262872|7389439|FG007|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471986|NCT01262872|7389432|FG000|COMPLETED|Step 1||60
6471987|NCT01262872|7389433|FG001|COMPLETED|Step 1||60
6471988|NCT01262872|7389434|FG002|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471989|NCT01262872|7389435|FG003|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
6471990|NCT01262872|7389436|FG004|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471991|NCT01262872|7389437|FG005|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471992|NCT01262872|7389438|FG006|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471993|NCT01262872|7389439|FG007|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6471994|NCT01262872|7389432|FG000|NOT COMPLETED|Step 1||0
6471995|NCT01262872|7389433|FG001|NOT COMPLETED|Step 1||0
6471996|NCT01262872|7389434|FG002|NOT COMPLETED|Step 1||0
6471997|NCT01262872|7389435|FG003|NOT COMPLETED|Step 1||0
6471998|NCT01262872|7389436|FG004|NOT COMPLETED|Step 1||0
6471999|NCT01262872|7389437|FG005|NOT COMPLETED|Step 1||0
6472000|NCT01262872|7389438|FG006|NOT COMPLETED|Step 1||0
6472001|NCT01262872|7389439|FG007|NOT COMPLETED|Step 1||0
6472002|NCT01262872|7389432|FG000|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6472003|NCT01262872|7389433|FG001|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6472004|NCT01262872|7389434|FG002|STARTED|Step 2||200
6472005|NCT01262872|7389435|FG003|STARTED|Step 2||200
6472006|NCT01262872|7389436|FG004|STARTED|Step 2||200
6472007|NCT01262872|7389437|FG005|STARTED|Step 2||200
6472008|NCT01262872|7389438|FG006|STARTED|Step 2||200
6472009|NCT01262872|7389439|FG007|STARTED|Step 2||200
6472010|NCT01262872|7389432|FG000|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6472011|NCT01262872|7389433|FG001|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
6472012|NCT01262872|7389434|FG002|COMPLETED|Step 2||191
6472013|NCT01262872|7389435|FG003|COMPLETED|Step 2||190
6472014|NCT01262872|7389436|FG004|COMPLETED|Step 2||195
6472015|NCT01262872|7389437|FG005|COMPLETED|Step 2||191
6472016|NCT01262872|7389438|FG006|COMPLETED|Step 2||191
6472017|NCT01262872|7389439|FG007|COMPLETED|Step 2||194
6472018|NCT01262872|7389432|FG000|NOT COMPLETED|Step 2||0
6472019|NCT01262872|7389433|FG001|NOT COMPLETED|Step 2||0
6472020|NCT01262872|7389434|FG002|NOT COMPLETED|Step 2||9
6472021|NCT01262872|7389435|FG003|NOT COMPLETED|Step 2||10
6472022|NCT01262872|7389436|FG004|NOT COMPLETED|Step 2||5
6472023|NCT01262872|7389437|FG005|NOT COMPLETED|Step 2||9
6472024|NCT01262872|7389438|FG006|NOT COMPLETED|Step 2||9
6472025|NCT01262872|7389439|FG007|NOT COMPLETED|Step 2||6
6472026|NCT01262898|7389477|FG000|STARTED|Overall Study||21
6472027|NCT01262898|7389478|FG001|STARTED|Overall Study||18
6472028|NCT01262898|7389479|FG002|STARTED|Overall Study||18
6472029|NCT01262898|7389480|FG003|STARTED|Overall Study||22
6472030|NCT01262898|7389477|FG000|COMPLETED|Overall Study||18
6472031|NCT01262898|7389478|FG001|COMPLETED|Overall Study||16
6472032|NCT01262898|7389479|FG002|COMPLETED|Overall Study||18
6472033|NCT01262898|7389480|FG003|COMPLETED|Overall Study||22
6472034|NCT01262898|7389477|FG000|NOT COMPLETED|Overall Study||3
6472035|NCT01262898|7389478|FG001|NOT COMPLETED|Overall Study||2
6472036|NCT01262898|7389479|FG002|NOT COMPLETED|Overall Study||0
6472037|NCT01262898|7389480|FG003|NOT COMPLETED|Overall Study||0
6472038|NCT01262976|7389499|FG000|STARTED|Up to Month 2||40
6472039|NCT01262976|7389500|FG001|STARTED|Up to Month 2||40
6472040|NCT01262976|7389501|FG002|STARTED|Up to Month 2||40
6472041|NCT01262976|7389502|FG003|STARTED|Up to Month 2||40
6472042|NCT01262976|7389503|FG004|STARTED|Up to Month 2||40
6472043|NCT01262976|7389504|FG005|STARTED|Up to Month 2||40
6472044|NCT01262976|7389499|FG000|COMPLETED|Up to Month 2||37
6472045|NCT01262976|7389500|FG001|COMPLETED|Up to Month 2||39
6472046|NCT01262976|7389501|FG002|COMPLETED|Up to Month 2||39
6472047|NCT01262976|7389502|FG003|COMPLETED|Up to Month 2||38
6472048|NCT01262976|7389503|FG004|COMPLETED|Up to Month 2||38
6472049|NCT01262976|7389504|FG005|COMPLETED|Up to Month 2||36
6472050|NCT01262976|7389499|FG000|NOT COMPLETED|Up to Month 2||3
6472051|NCT01262976|7389500|FG001|NOT COMPLETED|Up to Month 2||1
6472052|NCT01262976|7389501|FG002|NOT COMPLETED|Up to Month 2||1
6472053|NCT01262976|7389502|FG003|NOT COMPLETED|Up to Month 2||2
6472054|NCT01262976|7389503|FG004|NOT COMPLETED|Up to Month 2||2
6472055|NCT01262976|7389504|FG005|NOT COMPLETED|Up to Month 2||4
6472056|NCT01262976|7389499|FG000|STARTED|Up to Month 7||40
6472057|NCT01262976|7389500|FG001|STARTED|Up to Month 7||40
6472058|NCT01262976|7389501|FG002|STARTED|Up to Month 7||40
6472059|NCT01262976|7389502|FG003|STARTED|Up to Month 7||40
6472060|NCT01262976|7389503|FG004|STARTED|Up to Month 7||40
6472061|NCT01262976|7389504|FG005|STARTED|Up to Month 7||40
6472062|NCT01262976|7389499|FG000|COMPLETED|Up to Month 7||35
6472063|NCT01262976|7389500|FG001|COMPLETED|Up to Month 7||40
6472064|NCT01262976|7389501|FG002|COMPLETED|Up to Month 7||34
6472065|NCT01262976|7389502|FG003|COMPLETED|Up to Month 7||34
6472066|NCT01262976|7389503|FG004|COMPLETED|Up to Month 7||38
6472067|NCT01262976|7389504|FG005|COMPLETED|Up to Month 7||36
6472068|NCT01262976|7389499|FG000|NOT COMPLETED|Up to Month 7||5
6472069|NCT01262976|7389500|FG001|NOT COMPLETED|Up to Month 7||0
6472070|NCT01262976|7389501|FG002|NOT COMPLETED|Up to Month 7||6
6472071|NCT01262976|7389502|FG003|NOT COMPLETED|Up to Month 7||6
6472072|NCT01262976|7389503|FG004|NOT COMPLETED|Up to Month 7||2
6472073|NCT01262976|7389504|FG005|NOT COMPLETED|Up to Month 7||4
6472074|NCT01262976|7389499|FG000|STARTED|Up to Year 1||40
6472075|NCT01262976|7389500|FG001|STARTED|Up to Year 1||40
6472076|NCT01262976|7389501|FG002|STARTED|Up to Year 1||40
6472077|NCT01262976|7389502|FG003|STARTED|Up to Year 1||40
6472078|NCT01262976|7389503|FG004|STARTED|Up to Year 1||40
6472079|NCT01262976|7389504|FG005|STARTED|Up to Year 1||40
6472080|NCT01262976|7389499|FG000|COMPLETED|Up to Year 1||31
6472081|NCT01262976|7389500|FG001|COMPLETED|Up to Year 1||39
6472082|NCT01262976|7389501|FG002|COMPLETED|Up to Year 1||37
6472083|NCT01262976|7389502|FG003|COMPLETED|Up to Year 1||36
6472084|NCT01262976|7389503|FG004|COMPLETED|Up to Year 1||29
6472085|NCT01262976|7389504|FG005|COMPLETED|Up to Year 1||31
6472086|NCT01262976|7389499|FG000|NOT COMPLETED|Up to Year 1||9
6472087|NCT01262976|7389500|FG001|NOT COMPLETED|Up to Year 1||1
6472088|NCT01262976|7389501|FG002|NOT COMPLETED|Up to Year 1||3
6472089|NCT01262976|7389502|FG003|NOT COMPLETED|Up to Year 1||4
6472090|NCT01262976|7389503|FG004|NOT COMPLETED|Up to Year 1||11
6472091|NCT01262976|7389504|FG005|NOT COMPLETED|Up to Year 1||9
6472092|NCT01262976|7389499|FG000|STARTED|Up to Year 2||40
6472093|NCT01262976|7389500|FG001|STARTED|Up to Year 2||40
6472094|NCT01262976|7389501|FG002|STARTED|Up to Year 2||40
6472095|NCT01262976|7389502|FG003|STARTED|Up to Year 2||40
6472096|NCT01262976|7389503|FG004|STARTED|Up to Year 2||40
6472097|NCT01262976|7389504|FG005|STARTED|Up to Year 2||40
6472098|NCT01262976|7389499|FG000|COMPLETED|Up to Year 2||35
6472099|NCT01262976|7389500|FG001|COMPLETED|Up to Year 2||39
6472100|NCT01262976|7389501|FG002|COMPLETED|Up to Year 2||35
6472101|NCT01262976|7389502|FG003|COMPLETED|Up to Year 2||36
6472102|NCT01262976|7389503|FG004|COMPLETED|Up to Year 2||36
6472103|NCT01262976|7389504|FG005|COMPLETED|Up to Year 2||35
6472104|NCT01262976|7389499|FG000|NOT COMPLETED|Up to Year 2||5
6472105|NCT01262976|7389500|FG001|NOT COMPLETED|Up to Year 2||1
6472106|NCT01262976|7389501|FG002|NOT COMPLETED|Up to Year 2||5
6472107|NCT01262976|7389502|FG003|NOT COMPLETED|Up to Year 2||4
6472108|NCT01262976|7389503|FG004|NOT COMPLETED|Up to Year 2||4
6472109|NCT01262976|7389504|FG005|NOT COMPLETED|Up to Year 2||5
6472110|NCT01262976|7389499|FG000|STARTED|Up to Year 3||40
6472111|NCT01262976|7389500|FG001|STARTED|Up to Year 3||40
6472112|NCT01262976|7389501|FG002|STARTED|Up to Year 3||40
6472113|NCT01262976|7389502|FG003|STARTED|Up to Year 3||40
6472114|NCT01262976|7389503|FG004|STARTED|Up to Year 3||40
6472115|NCT01262976|7389504|FG005|STARTED|Up to Year 3||40
6472116|NCT01262976|7389499|FG000|COMPLETED|Up to Year 3||34
6472117|NCT01262976|7389500|FG001|COMPLETED|Up to Year 3||38
6472118|NCT01262976|7389501|FG002|COMPLETED|Up to Year 3||33
6472119|NCT01262976|7389502|FG003|COMPLETED|Up to Year 3||35
6472120|NCT01262976|7389503|FG004|COMPLETED|Up to Year 3||38
6472121|NCT01262976|7389504|FG005|COMPLETED|Up to Year 3||36
6472122|NCT01262976|7389499|FG000|NOT COMPLETED|Up to Year 3||6
6472123|NCT01262976|7389500|FG001|NOT COMPLETED|Up to Year 3||2
6472124|NCT01262976|7389501|FG002|NOT COMPLETED|Up to Year 3||7
6472125|NCT01262976|7389502|FG003|NOT COMPLETED|Up to Year 3||5
6472126|NCT01262976|7389503|FG004|NOT COMPLETED|Up to Year 3||2
6472127|NCT01262976|7389504|FG005|NOT COMPLETED|Up to Year 3||4
6472128|NCT01262989|7389519|FG000|STARTED|Period 1||20
6472129|NCT01262989|7389520|FG001|STARTED|Period 1||20
6472130|NCT01262989|7389519|FG000|COMPLETED|Period 1||19
6472131|NCT01262989|7389520|FG001|COMPLETED|Period 1||17
6472132|NCT01262989|7389519|FG000|NOT COMPLETED|Period 1||1
6472133|NCT01262989|7389520|FG001|NOT COMPLETED|Period 1||3
6472134|NCT01262989|7389519|FG000|STARTED|7-Day Washout Period||19
6472135|NCT01262989|7389520|FG001|STARTED|7-Day Washout Period||17
6472136|NCT01262989|7389519|FG000|COMPLETED|7-Day Washout Period||19
6472137|NCT01262989|7389520|FG001|COMPLETED|7-Day Washout Period||17
6472138|NCT01262989|7389519|FG000|NOT COMPLETED|7-Day Washout Period||0
6472139|NCT01262989|7389520|FG001|NOT COMPLETED|7-Day Washout Period||0
6472140|NCT01262989|7389519|FG000|STARTED|Period 2||19
6472141|NCT01262989|7389520|FG001|STARTED|Period 2||17
6472142|NCT01262989|7389519|FG000|COMPLETED|Period 2||19
6472143|NCT01262989|7389520|FG001|COMPLETED|Period 2||16
6472144|NCT01262989|7389519|FG000|NOT COMPLETED|Period 2||0
6472145|NCT01262989|7389520|FG001|NOT COMPLETED|Period 2||1
6472146|NCT01263015|7389528|FG000|STARTED|Double-blind Phase: 96 Weeks Duration||414
6472147|NCT01263015|7389529|FG001|STARTED|Double-blind Phase: 96 Weeks Duration||419
6472148|NCT01263015|7389528|FG000|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
6472149|NCT01263015|7389529|FG001|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
6472150|NCT01263015|7389528|FG000|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
6472151|NCT01263015|7389529|FG001|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
6472152|NCT01263015|7389528|FG000|STARTED|Open-label Phase: 48 Weeks Duration||341
6472153|NCT01263015|7389529|FG001|STARTED|Open-label Phase: 48 Weeks Duration||309
6472154|NCT01263015|7389528|FG000|COMPLETED|Open-label Phase: 48 Weeks Duration||317
6472155|NCT01263015|7389529|FG001|COMPLETED|Open-label Phase: 48 Weeks Duration||278
6472156|NCT01263015|7389528|FG000|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
6472157|NCT01263015|7389529|FG001|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
6472158|NCT01263054|7389537|FG000|STARTED|Overall Study||29
6472159|NCT01263054|7389538|FG001|STARTED|Overall Study||34
6472160|NCT01263054|7389537|FG000|COMPLETED|Overall Study||24
6472161|NCT01263054|7389538|FG001|COMPLETED|Overall Study||28
6472162|NCT01263054|7389537|FG000|NOT COMPLETED|Overall Study||5
6472163|NCT01263054|7389538|FG001|NOT COMPLETED|Overall Study||6
6472164|NCT01263093|7389546|FG000|STARTED|Period 1||24
6472165|NCT01263093|7389547|FG001|STARTED|Period 1||23
6472166|NCT01263093|7389546|FG000|COMPLETED|Period 1||24
6472167|NCT01263093|7389547|FG001|COMPLETED|Period 1||23
6472168|NCT01263093|7389546|FG000|NOT COMPLETED|Period 1||0
6472169|NCT01263093|7389547|FG001|NOT COMPLETED|Period 1||0
6472170|NCT01263093|7389546|FG000|STARTED|Washout||24
6472171|NCT01263093|7389547|FG001|STARTED|Washout||23
6472172|NCT01263093|7389546|FG000|COMPLETED|Washout||23
6472173|NCT01263093|7389547|FG001|COMPLETED|Washout||23
6472174|NCT01263093|7389546|FG000|NOT COMPLETED|Washout||1
6472175|NCT01263093|7389547|FG001|NOT COMPLETED|Washout||0
6472176|NCT01263093|7389546|FG000|STARTED|Period 2||23
6472177|NCT01263093|7389547|FG001|STARTED|Period 2||23
6472178|NCT01263093|7389546|FG000|COMPLETED|Period 2||22
6472179|NCT01263093|7389547|FG001|COMPLETED|Period 2||23
6472180|NCT01263093|7389546|FG000|NOT COMPLETED|Period 2||1
6472181|NCT01263093|7389547|FG001|NOT COMPLETED|Period 2||0
6472182|NCT01263106|7389554|FG000|STARTED|Period 1 (7 Days)||11
6472183|NCT01263106|7389555|FG001|STARTED|Period 1 (7 Days)||10
6472184|NCT01263106|7389554|FG000|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took theophylline alone but was not given LY + theophylline.|11
6472185|NCT01263106|7389555|FG001|COMPLETED|Period 1 (7 Days)|Period 1: 1 participant took LY + theophylline but was not given theophylline alone.|10
6472186|NCT01263106|7389554|FG000|NOT COMPLETED|Period 1 (7 Days)||0
6472187|NCT01263106|7389555|FG001|NOT COMPLETED|Period 1 (7 Days)||0
6472188|NCT01263106|7389554|FG000|STARTED|Washout (at Least 7 Days)||11
6472189|NCT01263106|7389555|FG001|STARTED|Washout (at Least 7 Days)||10
6472190|NCT01263106|7389554|FG000|COMPLETED|Washout (at Least 7 Days)||10
6472191|NCT01263106|7389555|FG001|COMPLETED|Washout (at Least 7 Days)||9
6472192|NCT01263106|7389554|FG000|NOT COMPLETED|Washout (at Least 7 Days)||1
6472193|NCT01263106|7389555|FG001|NOT COMPLETED|Washout (at Least 7 Days)||1
6472194|NCT01263106|7389554|FG000|STARTED|Period 2 (7 Days)||10
6472195|NCT01263106|7389555|FG001|STARTED|Period 2 (7 Days)||9
6472196|NCT01263106|7389554|FG000|COMPLETED|Period 2 (7 Days)||10
6472197|NCT01263106|7389555|FG001|COMPLETED|Period 2 (7 Days)||9
6472198|NCT01263106|7389554|FG000|NOT COMPLETED|Period 2 (7 Days)||0
6472199|NCT01263106|7389555|FG001|NOT COMPLETED|Period 2 (7 Days)||0
6472200|NCT01263119|7389564|FG000|STARTED|Period 1||18
6472201|NCT01263119|7389564|FG000|COMPLETED|Period 1||16
6472202|NCT01263119|7389564|FG000|NOT COMPLETED|Period 1||2
6472203|NCT01263119|7389564|FG000|STARTED|Period 2||16
6472204|NCT01263119|7389564|FG000|COMPLETED|Period 2||14
6472205|NCT01263119|7389564|FG000|NOT COMPLETED|Period 2||2
6472206|NCT01263132|7389574|FG000|STARTED|Overall Study||38
6472207|NCT01263132|7389575|FG001|STARTED|Overall Study||37
6472208|NCT01263132|7389574|FG000|COMPLETED|Overall Study||38
6472209|NCT01263132|7389575|FG001|COMPLETED|Overall Study||37
6472210|NCT01263132|7389574|FG000|NOT COMPLETED|Overall Study||0
6472211|NCT01263132|7389575|FG001|NOT COMPLETED|Overall Study||0
6472212|NCT01263197|7389583|FG000|STARTED|First Intervention (Period 1)||8
6472213|NCT01263197|7389584|FG001|STARTED|First Intervention (Period 1)||8
6472214|NCT01263197|7389585|FG002|STARTED|First Intervention (Period 1)||8
6472215|NCT01263197|7389586|FG003|STARTED|First Intervention (Period 1)||8
6472216|NCT01263197|7389587|FG004|STARTED|First Intervention (Period 1)||8
6472217|NCT01263197|7389588|FG005|STARTED|First Intervention (Period 1)||8
6472218|NCT01263197|7389583|FG000|COMPLETED|First Intervention (Period 1)||8
6472219|NCT01263197|7389584|FG001|COMPLETED|First Intervention (Period 1)||8
6472220|NCT01263197|7389585|FG002|COMPLETED|First Intervention (Period 1)||8
6472221|NCT01263197|7389586|FG003|COMPLETED|First Intervention (Period 1)||8
6472222|NCT01263197|7389587|FG004|COMPLETED|First Intervention (Period 1)||8
6472223|NCT01263197|7389588|FG005|COMPLETED|First Intervention (Period 1)||7
6472224|NCT01263197|7389583|FG000|NOT COMPLETED|First Intervention (Period 1)||0
6472225|NCT01263197|7389584|FG001|NOT COMPLETED|First Intervention (Period 1)||0
6472226|NCT01263197|7389585|FG002|NOT COMPLETED|First Intervention (Period 1)||0
6472227|NCT01263197|7389586|FG003|NOT COMPLETED|First Intervention (Period 1)||0
6472228|NCT01263197|7389587|FG004|NOT COMPLETED|First Intervention (Period 1)||0
6472229|NCT01263197|7389588|FG005|NOT COMPLETED|First Intervention (Period 1)||1
6472230|NCT01263197|7389583|FG000|STARTED|Washout Period 1||8
6472231|NCT01263197|7389584|FG001|STARTED|Washout Period 1||8
6472232|NCT01263197|7389585|FG002|STARTED|Washout Period 1||8
6472233|NCT01263197|7389586|FG003|STARTED|Washout Period 1||8
6472234|NCT01263197|7389587|FG004|STARTED|Washout Period 1||8
6472235|NCT01263197|7389588|FG005|STARTED|Washout Period 1||7
6472236|NCT01263197|7389583|FG000|COMPLETED|Washout Period 1||8
6472237|NCT01263197|7389584|FG001|COMPLETED|Washout Period 1||8
6472238|NCT01263197|7389585|FG002|COMPLETED|Washout Period 1||8
6472239|NCT01263197|7389586|FG003|COMPLETED|Washout Period 1||8
6472240|NCT01263197|7389587|FG004|COMPLETED|Washout Period 1||7
6472241|NCT01263197|7389588|FG005|COMPLETED|Washout Period 1||7
6472242|NCT01263197|7389583|FG000|NOT COMPLETED|Washout Period 1||0
6472243|NCT01263197|7389584|FG001|NOT COMPLETED|Washout Period 1||0
6472244|NCT01263197|7389585|FG002|NOT COMPLETED|Washout Period 1||0
6472245|NCT01263197|7389586|FG003|NOT COMPLETED|Washout Period 1||0
6472246|NCT01263197|7389587|FG004|NOT COMPLETED|Washout Period 1||1
6472247|NCT01263197|7389588|FG005|NOT COMPLETED|Washout Period 1||0
6472248|NCT01263197|7389583|FG000|STARTED|Second Intervention (Period 2)||8
6472249|NCT01263197|7389584|FG001|STARTED|Second Intervention (Period 2)||8
6472250|NCT01263197|7389585|FG002|STARTED|Second Intervention (Period 2)||8
6472251|NCT01263197|7389586|FG003|STARTED|Second Intervention (Period 2)||8
6472252|NCT01263197|7389587|FG004|STARTED|Second Intervention (Period 2)||7
6472253|NCT01263197|7389588|FG005|STARTED|Second Intervention (Period 2)||7
6472254|NCT01263197|7389583|FG000|COMPLETED|Second Intervention (Period 2)||8
6472255|NCT01263197|7389584|FG001|COMPLETED|Second Intervention (Period 2)||8
6472256|NCT01263197|7389585|FG002|COMPLETED|Second Intervention (Period 2)||8
6472257|NCT01263197|7389586|FG003|COMPLETED|Second Intervention (Period 2)||8
6472258|NCT01263197|7389587|FG004|COMPLETED|Second Intervention (Period 2)||7
6472259|NCT01263197|7389588|FG005|COMPLETED|Second Intervention (Period 2)||7
6472260|NCT01263197|7389583|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
6472261|NCT01263197|7389584|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
6472262|NCT01263197|7389585|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
6472263|NCT01263197|7389586|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
6472264|NCT01263197|7389587|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
6472265|NCT01263197|7389588|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
6472266|NCT01263197|7389583|FG000|STARTED|Washout Period 2||8
6472267|NCT01263197|7389584|FG001|STARTED|Washout Period 2||8
6472268|NCT01263197|7389585|FG002|STARTED|Washout Period 2||8
6472269|NCT01263197|7389586|FG003|STARTED|Washout Period 2||8
6472270|NCT01263197|7389587|FG004|STARTED|Washout Period 2||7
6472271|NCT01263197|7389588|FG005|STARTED|Washout Period 2||7
6472272|NCT01263197|7389583|FG000|COMPLETED|Washout Period 2||8
6472273|NCT01263197|7389584|FG001|COMPLETED|Washout Period 2||8
6472274|NCT01263197|7389585|FG002|COMPLETED|Washout Period 2||8
6472275|NCT01263197|7389586|FG003|COMPLETED|Washout Period 2||7
6472276|NCT01263197|7389587|FG004|COMPLETED|Washout Period 2||7
6472277|NCT01263197|7389588|FG005|COMPLETED|Washout Period 2||6
6472278|NCT01263197|7389583|FG000|NOT COMPLETED|Washout Period 2||0
6472279|NCT01263197|7389584|FG001|NOT COMPLETED|Washout Period 2||0
6472280|NCT01263197|7389585|FG002|NOT COMPLETED|Washout Period 2||0
6472281|NCT01263197|7389586|FG003|NOT COMPLETED|Washout Period 2||1
6472282|NCT01263197|7389587|FG004|NOT COMPLETED|Washout Period 2||0
6472283|NCT01263197|7389588|FG005|NOT COMPLETED|Washout Period 2||1
6472284|NCT01263197|7389583|FG000|STARTED|Third Intervention (Period 3)||8
6472285|NCT01263197|7389584|FG001|STARTED|Third Intervention (Period 3)||8
6472286|NCT01263197|7389585|FG002|STARTED|Third Intervention (Period 3)||8
6472287|NCT01263197|7389586|FG003|STARTED|Third Intervention (Period 3)||7
6472288|NCT01263197|7389587|FG004|STARTED|Third Intervention (Period 3)||7
6472289|NCT01263197|7389588|FG005|STARTED|Third Intervention (Period 3)||6
6472290|NCT01263197|7389583|FG000|COMPLETED|Third Intervention (Period 3)||8
6472291|NCT01263197|7389584|FG001|COMPLETED|Third Intervention (Period 3)||7
6472292|NCT01263197|7389585|FG002|COMPLETED|Third Intervention (Period 3)||8
6472293|NCT01263197|7389586|FG003|COMPLETED|Third Intervention (Period 3)||7
6472294|NCT01263197|7389587|FG004|COMPLETED|Third Intervention (Period 3)||7
6472295|NCT01263197|7389588|FG005|COMPLETED|Third Intervention (Period 3)||6
6472296|NCT01263197|7389583|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
6472297|NCT01263197|7389584|FG001|NOT COMPLETED|Third Intervention (Period 3)||1
6472298|NCT01263197|7389585|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
6472299|NCT01263197|7389586|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
6472300|NCT01263197|7389587|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
6472301|NCT01263197|7389588|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
6472302|NCT01263223|7389602|FG000|STARTED|Period 1||12
6472303|NCT01263223|7389603|FG001|STARTED|Period 1||12
6472304|NCT01263223|7389602|FG000|COMPLETED|Period 1||12
6472305|NCT01263223|7389603|FG001|COMPLETED|Period 1||12
6472306|NCT01263223|7389602|FG000|NOT COMPLETED|Period 1||0
6472307|NCT01263223|7389603|FG001|NOT COMPLETED|Period 1||0
6472308|NCT01263223|7389602|FG000|STARTED|3-Day Washout||12
6472309|NCT01263223|7389603|FG001|STARTED|3-Day Washout||12
6472310|NCT01263223|7389602|FG000|COMPLETED|3-Day Washout||12
6472311|NCT01263223|7389603|FG001|COMPLETED|3-Day Washout||12
6472312|NCT01263223|7389602|FG000|NOT COMPLETED|3-Day Washout||0
6472313|NCT01263223|7389603|FG001|NOT COMPLETED|3-Day Washout||0
6472314|NCT01263223|7389602|FG000|STARTED|Period 2||12
6472315|NCT01263223|7389603|FG001|STARTED|Period 2||12
6472316|NCT01263223|7389602|FG000|COMPLETED|Period 2||12
6472317|NCT01263223|7389603|FG001|COMPLETED|Period 2||11
6472318|NCT01263223|7389602|FG000|NOT COMPLETED|Period 2||0
6472319|NCT01263223|7389603|FG001|NOT COMPLETED|Period 2||1
6472320|NCT01263223|7389602|FG000|STARTED|Period 3||12
6472321|NCT01263223|7389603|FG001|STARTED|Period 3||11
6472322|NCT01263223|7389602|FG000|COMPLETED|Period 3||12
6472323|NCT01263223|7389603|FG001|COMPLETED|Period 3||11
6472324|NCT01263223|7389602|FG000|NOT COMPLETED|Period 3||0
6472325|NCT01263223|7389603|FG001|NOT COMPLETED|Period 3||0
6472326|NCT01263223|7389602|FG000|STARTED|7-day Follow-up||12
6472327|NCT01263223|7389603|FG001|STARTED|7-day Follow-up||11
6472328|NCT01263223|7389602|FG000|COMPLETED|7-day Follow-up|One participant who did not complete received Placebo in Period 3.|11
6472329|NCT01263223|7389603|FG001|COMPLETED|7-day Follow-up|One participant who did not complete received 36-mg LY2216684 in Period 3.|10
6472330|NCT01263223|7389602|FG000|NOT COMPLETED|7-day Follow-up||1
6472331|NCT01263223|7389603|FG001|NOT COMPLETED|7-day Follow-up||1
6472332|NCT01263301|7389614|FG000|STARTED|Overall Study||5
6472333|NCT01263301|7389615|FG001|STARTED|Overall Study||11
6472334|NCT01263301|7389614|FG000|COMPLETED|Overall Study||5
6472335|NCT01263301|7389615|FG001|COMPLETED|Overall Study||11
6472336|NCT01263301|7389614|FG000|NOT COMPLETED|Overall Study||0
6472337|NCT01263301|7389615|FG001|NOT COMPLETED|Overall Study||0
6472338|NCT01263314|7389629|FG000|STARTED|Period 1||2
6472339|NCT01263314|7389630|FG001|STARTED|Period 1||2
6472340|NCT01263314|7389631|FG002|STARTED|Period 1||2
6472341|NCT01263314|7389632|FG003|STARTED|Period 1||2
6472342|NCT01263314|7389633|FG004|STARTED|Period 1||2
6472343|NCT01263314|7389634|FG005|STARTED|Period 1||2
6472344|NCT01263314|7389635|FG006|STARTED|Period 1||2
6472345|NCT01263314|7389636|FG007|STARTED|Period 1||2
6472346|NCT01263314|7389629|FG000|COMPLETED|Period 1||2
6472347|NCT01263314|7389630|FG001|COMPLETED|Period 1||2
6472348|NCT01263314|7389631|FG002|COMPLETED|Period 1||2
6472349|NCT01263314|7389632|FG003|COMPLETED|Period 1||2
6472350|NCT01263314|7389633|FG004|COMPLETED|Period 1||2
6472351|NCT01263314|7389634|FG005|COMPLETED|Period 1||2
6472352|NCT01263314|7389635|FG006|COMPLETED|Period 1||2
6472353|NCT01263314|7389636|FG007|COMPLETED|Period 1||2
6472354|NCT01263314|7389629|FG000|NOT COMPLETED|Period 1||0
6472355|NCT01263314|7389630|FG001|NOT COMPLETED|Period 1||0
6472356|NCT01263314|7389631|FG002|NOT COMPLETED|Period 1||0
6472357|NCT01263314|7389632|FG003|NOT COMPLETED|Period 1||0
6472358|NCT01263314|7389633|FG004|NOT COMPLETED|Period 1||0
6472359|NCT01263314|7389634|FG005|NOT COMPLETED|Period 1||0
6472360|NCT01263314|7389635|FG006|NOT COMPLETED|Period 1||0
6472361|NCT01263314|7389636|FG007|NOT COMPLETED|Period 1||0
6472362|NCT01263314|7389629|FG000|STARTED|Period 2||2
6472363|NCT01263314|7389630|FG001|STARTED|Period 2||2
6472364|NCT01263314|7389631|FG002|STARTED|Period 2||2
6472365|NCT01263314|7389632|FG003|STARTED|Period 2||2
6472366|NCT01263314|7389633|FG004|STARTED|Period 2||2
6472367|NCT01263314|7389634|FG005|STARTED|Period 2||2
6472368|NCT01263314|7389635|FG006|STARTED|Period 2||2
6472369|NCT01263314|7389636|FG007|STARTED|Period 2||2
6472370|NCT01263314|7389629|FG000|COMPLETED|Period 2||2
6472371|NCT01263314|7389630|FG001|COMPLETED|Period 2||2
6472372|NCT01263314|7389631|FG002|COMPLETED|Period 2||2
6472373|NCT01263314|7389632|FG003|COMPLETED|Period 2||2
6472374|NCT01263314|7389633|FG004|COMPLETED|Period 2||2
6472375|NCT01263314|7389634|FG005|COMPLETED|Period 2||2
6472376|NCT01263314|7389635|FG006|COMPLETED|Period 2||2
6472377|NCT01263314|7389636|FG007|COMPLETED|Period 2||2
6472378|NCT01263314|7389629|FG000|NOT COMPLETED|Period 2||0
6472379|NCT01263314|7389630|FG001|NOT COMPLETED|Period 2||0
6472380|NCT01263314|7389631|FG002|NOT COMPLETED|Period 2||0
6472381|NCT01263314|7389632|FG003|NOT COMPLETED|Period 2||0
6472382|NCT01263314|7389633|FG004|NOT COMPLETED|Period 2||0
6472383|NCT01263314|7389634|FG005|NOT COMPLETED|Period 2||0
6472384|NCT01263314|7389635|FG006|NOT COMPLETED|Period 2||0
6472385|NCT01263314|7389636|FG007|NOT COMPLETED|Period 2||0
6472386|NCT01263314|7389629|FG000|STARTED|Period 3||2
6472387|NCT01263314|7389630|FG001|STARTED|Period 3||2
6472388|NCT01263314|7389631|FG002|STARTED|Period 3||2
6472389|NCT01263314|7389632|FG003|STARTED|Period 3||2
6472390|NCT01263314|7389633|FG004|STARTED|Period 3||2
6472391|NCT01263314|7389634|FG005|STARTED|Period 3||2
6472392|NCT01263314|7389635|FG006|STARTED|Period 3||2
6472393|NCT01263314|7389636|FG007|STARTED|Period 3||2
6472394|NCT01263314|7389629|FG000|COMPLETED|Period 3||2
6472395|NCT01263314|7389630|FG001|COMPLETED|Period 3||2
6472396|NCT01263314|7389631|FG002|COMPLETED|Period 3||2
6472397|NCT01263314|7389632|FG003|COMPLETED|Period 3||2
6472398|NCT01263314|7389633|FG004|COMPLETED|Period 3||2
6472399|NCT01263314|7389634|FG005|COMPLETED|Period 3||2
6472400|NCT01263314|7389635|FG006|COMPLETED|Period 3||2
6472401|NCT01263314|7389636|FG007|COMPLETED|Period 3||2
6472402|NCT01263314|7389629|FG000|NOT COMPLETED|Period 3||0
6746772|NCT03378635|7674443|FG002|COMPLETED|Overall Study||43
6746773|NCT03378635|7674441|FG000|NOT COMPLETED|Overall Study||2
6746774|NCT03378635|7674442|FG001|NOT COMPLETED|Overall Study||0
6746775|NCT03378635|7674443|FG002|NOT COMPLETED|Overall Study||0
6746776|NCT03378921|7674454|FG000|STARTED|Overall Study||13
6746777|NCT03378921|7674455|FG001|STARTED|Overall Study||13
6746778|NCT03378921|7674454|FG000|COMPLETED|Overall Study||13
6746779|NCT03378921|7674455|FG001|COMPLETED|Overall Study||13
6746780|NCT03378921|7674454|FG000|NOT COMPLETED|Overall Study||0
6472403|NCT01263314|7389630|FG001|NOT COMPLETED|Period 3||0
6472404|NCT01263314|7389631|FG002|NOT COMPLETED|Period 3||0
6472405|NCT01263314|7389632|FG003|NOT COMPLETED|Period 3||0
6472406|NCT01263314|7389633|FG004|NOT COMPLETED|Period 3||0
6472407|NCT01263314|7389634|FG005|NOT COMPLETED|Period 3||0
6472408|NCT01263314|7389635|FG006|NOT COMPLETED|Period 3||0
6472409|NCT01263314|7389636|FG007|NOT COMPLETED|Period 3||0
6472410|NCT01263444|7389660|FG000|STARTED|Overall Study||47
6472411|NCT01263444|7389660|FG000|COMPLETED|Overall Study||37
6472412|NCT01263444|7389660|FG000|NOT COMPLETED|Overall Study||10
6472413|NCT01263470|7389670|FG000|STARTED|Overall Study||75
6472414|NCT01263470|7389671|FG001|STARTED|Overall Study||79
6472415|NCT01263470|7389672|FG002|STARTED|Overall Study||84
6472416|NCT01263470|7389673|FG003|STARTED|Overall Study||80
6472417|NCT01263470|7389674|FG004|STARTED|Overall Study||79
6472418|NCT01263470|7389675|FG005|STARTED|Overall Study||83
6472419|NCT01263470|7389670|FG000|COMPLETED|Overall Study||73
6472420|NCT01263470|7389671|FG001|COMPLETED|Overall Study||74
6472421|NCT01263470|7389672|FG002|COMPLETED|Overall Study||80
6472422|NCT01263470|7389673|FG003|COMPLETED|Overall Study||77
6472423|NCT01263470|7389674|FG004|COMPLETED|Overall Study||76
6472424|NCT01263470|7389675|FG005|COMPLETED|Overall Study||78
6472425|NCT01263470|7389670|FG000|NOT COMPLETED|Overall Study||2
6472426|NCT01263470|7389671|FG001|NOT COMPLETED|Overall Study||5
6472427|NCT01263470|7389672|FG002|NOT COMPLETED|Overall Study||4
6472428|NCT01263470|7389673|FG003|NOT COMPLETED|Overall Study||3
6472429|NCT01263470|7389674|FG004|NOT COMPLETED|Overall Study||3
6472430|NCT01263470|7389675|FG005|NOT COMPLETED|Overall Study||5
6472431|NCT01263483|7389692|FG000|STARTED|Overall Study||75
6472432|NCT01263483|7389693|FG001|STARTED|Overall Study||76
6472433|NCT01263483|7389694|FG002|STARTED|Overall Study||79
6472434|NCT01263483|7389692|FG000|COMPLETED|Overall Study||68
6472435|NCT01263483|7389693|FG001|COMPLETED|Overall Study||74
6472436|NCT01263483|7389694|FG002|COMPLETED|Overall Study||74
6472437|NCT01263483|7389692|FG000|NOT COMPLETED|Overall Study||7
6472438|NCT01263483|7389693|FG001|NOT COMPLETED|Overall Study||2
6472439|NCT01263483|7389694|FG002|NOT COMPLETED|Overall Study||5
6472440|NCT01263496|7389707|FG000|STARTED|Enrolled - Long-Term Extension Study||72
6472441|NCT01263496|7389708|FG001|STARTED|Enrolled - Long-Term Extension Study||75
6472442|NCT01263496|7389709|FG002|STARTED|Enrolled - Long-Term Extension Study||72
6472443|NCT01263496|7389710|FG003|STARTED|Enrolled - Long-Term Extension Study||75
6472444|NCT01263496|7389711|FG004|STARTED|Enrolled - Long-Term Extension Study||74
6472445|NCT01263496|7389712|FG005|STARTED|Enrolled - Long-Term Extension Study||17
6472446|NCT01263496|7389713|FG006|STARTED|Enrolled - Long-Term Extension Study||17
6472447|NCT01263496|7389714|FG007|STARTED|Enrolled - Long-Term Extension Study||18
6746781|NCT03378921|7674455|FG001|NOT COMPLETED|Overall Study||0
6746782|NCT03378973|7674463|FG000|STARTED|Overall Study||4
6746783|NCT03378973|7674464|FG001|STARTED|Overall Study||3
6472448|NCT01263496|7389715|FG008|STARTED|Enrolled - Long-Term Extension Study||18
6472449|NCT01263496|7389707|FG000|COMPLETED|Enrolled - Long-Term Extension Study||71
6472450|NCT01263496|7389708|FG001|COMPLETED|Enrolled - Long-Term Extension Study||75
6472451|NCT01263496|7389709|FG002|COMPLETED|Enrolled - Long-Term Extension Study||72
6472452|NCT01263496|7389710|FG003|COMPLETED|Enrolled - Long-Term Extension Study||74
6472453|NCT01263496|7389711|FG004|COMPLETED|Enrolled - Long-Term Extension Study||72
6472454|NCT01263496|7389712|FG005|COMPLETED|Enrolled - Long-Term Extension Study||17
6472455|NCT01263496|7389713|FG006|COMPLETED|Enrolled - Long-Term Extension Study||17
6472456|NCT01263496|7389714|FG007|COMPLETED|Enrolled - Long-Term Extension Study||18
6472457|NCT01263496|7389715|FG008|COMPLETED|Enrolled - Long-Term Extension Study||18
6472458|NCT01263496|7389707|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
6472459|NCT01263496|7389708|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472460|NCT01263496|7389709|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472461|NCT01263496|7389710|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
6472462|NCT01263496|7389711|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
6472463|NCT01263496|7389712|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472464|NCT01263496|7389713|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472465|NCT01263496|7389714|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472466|NCT01263496|7389715|FG008|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472467|NCT01263496|7389707|FG000|STARTED|Entered - Long-Term Extension Study||71
6472468|NCT01263496|7389708|FG001|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
6472469|NCT01263496|7389709|FG002|STARTED|Entered - Long-Term Extension Study||72
6472470|NCT01263496|7389710|FG003|STARTED|Entered - Long-Term Extension Study||74
6472471|NCT01263496|7389711|FG004|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
6472472|NCT01263496|7389712|FG005|STARTED|Entered - Long-Term Extension Study||17
6472473|NCT01263496|7389713|FG006|STARTED|Entered - Long-Term Extension Study||17
6472474|NCT01263496|7389714|FG007|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
6472475|NCT01263496|7389715|FG008|STARTED|Entered - Long-Term Extension Study||18
6472476|NCT01263496|7389707|FG000|COMPLETED|Entered - Long-Term Extension Study||62
6472477|NCT01263496|7389708|FG001|COMPLETED|Entered - Long-Term Extension Study||59
6472478|NCT01263496|7389709|FG002|COMPLETED|Entered - Long-Term Extension Study||62
6472479|NCT01263496|7389710|FG003|COMPLETED|Entered - Long-Term Extension Study||68
6472480|NCT01263496|7389711|FG004|COMPLETED|Entered - Long-Term Extension Study||61
6472481|NCT01263496|7389712|FG005|COMPLETED|Entered - Long-Term Extension Study||16
6472482|NCT01263496|7389713|FG006|COMPLETED|Entered - Long-Term Extension Study||16
6472483|NCT01263496|7389714|FG007|COMPLETED|Entered - Long-Term Extension Study||16
6472484|NCT01263496|7389715|FG008|COMPLETED|Entered - Long-Term Extension Study||15
6472485|NCT01263496|7389707|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
6472486|NCT01263496|7389708|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
6472487|NCT01263496|7389709|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||10
6472488|NCT01263496|7389710|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||6
6472489|NCT01263496|7389711|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||10
6472490|NCT01263496|7389712|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||1
6472491|NCT01263496|7389713|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
6472492|NCT01263496|7389714|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||1
6472493|NCT01263496|7389715|FG008|NOT COMPLETED|Entered - Long-Term Extension Study||3
6472494|NCT01263509|7389729|FG000|STARTED|Enrolled - Long-Term Extension Study||61
6472495|NCT01263509|7389730|FG001|STARTED|Enrolled - Long-Term Extension Study||60
6472496|NCT01263509|7389731|FG002|STARTED|Enrolled - Long-Term Extension Study||32
6472497|NCT01263509|7389732|FG003|STARTED|Enrolled - Long-Term Extension Study||26
6472498|NCT01263509|7389729|FG000|COMPLETED|Enrolled - Long-Term Extension Study||61
6472499|NCT01263509|7389730|FG001|COMPLETED|Enrolled - Long-Term Extension Study||60
6472500|NCT01263509|7389731|FG002|COMPLETED|Enrolled - Long-Term Extension Study||32
6472501|NCT01263509|7389732|FG003|COMPLETED|Enrolled - Long-Term Extension Study||26
6472502|NCT01263509|7389729|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472503|NCT01263509|7389730|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472504|NCT01263509|7389731|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472505|NCT01263509|7389732|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6472506|NCT01263509|7389729|FG000|STARTED|Entered - Long-Term Extension Study||61
6472507|NCT01263509|7389730|FG001|STARTED|Entered - Long-Term Extension Study||60
6472508|NCT01263509|7389731|FG002|STARTED|Entered - Long-Term Extension Study||32
6472509|NCT01263509|7389732|FG003|STARTED|Entered - Long-Term Extension Study||26
6472510|NCT01263509|7389729|FG000|COMPLETED|Entered - Long-Term Extension Study||53
6472511|NCT01263509|7389730|FG001|COMPLETED|Entered - Long-Term Extension Study||48
6472512|NCT01263509|7389731|FG002|COMPLETED|Entered - Long-Term Extension Study||27
6472513|NCT01263509|7389732|FG003|COMPLETED|Entered - Long-Term Extension Study||24
6472514|NCT01263509|7389729|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||8
6472515|NCT01263509|7389730|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||12
6472516|NCT01263509|7389731|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||5
6472517|NCT01263509|7389732|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||2
6472518|NCT01263561|7389740|FG000|STARTED|Overall Study||31
6472519|NCT01263561|7389741|FG001|STARTED|Overall Study||33
6472520|NCT01263561|7389740|FG000|COMPLETED|Overall Study||30
6472521|NCT01263561|7389741|FG001|COMPLETED|Overall Study||31
6472522|NCT01263561|7389740|FG000|NOT COMPLETED|Overall Study||1
6472523|NCT01263561|7389741|FG001|NOT COMPLETED|Overall Study||2
6472524|NCT01263639|7389749|FG000|STARTED|Overall Study||107
6472525|NCT01263639|7389750|FG001|STARTED|Overall Study||121
6472526|NCT01263639|7389749|FG000|COMPLETED|Overall Study||34
6472527|NCT01263639|7389750|FG001|COMPLETED|Overall Study||42
6472528|NCT01263639|7389749|FG000|NOT COMPLETED|Overall Study||73
6472529|NCT01263639|7389750|FG001|NOT COMPLETED|Overall Study||79
6472530|NCT01263665|7389756|FG000|STARTED|Overall Study||71
6472531|NCT01263665|7389756|FG000|COMPLETED|Overall Study||62
6472532|NCT01263665|7389756|FG000|NOT COMPLETED|Overall Study||9
6472533|NCT01263691|7389766|FG000|STARTED|Overall Study||18
6472534|NCT01263691|7389767|FG001|STARTED|Overall Study||18
6472535|NCT01263691|7389768|FG002|STARTED|Overall Study||17
6472536|NCT01263691|7389769|FG003|STARTED|Overall Study||19
6472537|NCT01263691|7389770|FG004|STARTED|Overall Study||18
6472538|NCT01263691|7389771|FG005|STARTED|Overall Study||15
6472539|NCT01263691|7389766|FG000|COMPLETED|Overall Study||15
6746784|NCT03378973|7674463|FG000|COMPLETED|Overall Study||4
6746785|NCT03378973|7674464|FG001|COMPLETED|Overall Study||3
6746786|NCT03378973|7674463|FG000|NOT COMPLETED|Overall Study||0
6746787|NCT03378973|7674464|FG001|NOT COMPLETED|Overall Study||0
6746788|NCT03379259|7674476|FG000|STARTED|Overall Study||3
6746789|NCT03379259|7674477|FG001|STARTED|Overall Study||3
6746790|NCT03379259|7674478|FG002|STARTED|Overall Study||6
6746791|NCT03379259|7674479|FG003|STARTED|Overall Study||3
6472540|NCT01263691|7389767|FG001|COMPLETED|Overall Study||18
6472541|NCT01263691|7389768|FG002|COMPLETED|Overall Study||16
6472542|NCT01263691|7389769|FG003|COMPLETED|Overall Study||18
6472543|NCT01263691|7389770|FG004|COMPLETED|Overall Study||18
6472544|NCT01263691|7389771|FG005|COMPLETED|Overall Study||15
6472545|NCT01263691|7389766|FG000|NOT COMPLETED|Overall Study||3
6472546|NCT01263691|7389767|FG001|NOT COMPLETED|Overall Study||0
6472547|NCT01263691|7389768|FG002|NOT COMPLETED|Overall Study||1
6472548|NCT01263691|7389769|FG003|NOT COMPLETED|Overall Study||1
6472549|NCT01263691|7389770|FG004|NOT COMPLETED|Overall Study||0
6472550|NCT01263691|7389771|FG005|NOT COMPLETED|Overall Study||0
6472551|NCT01263704|7389806|FG000|STARTED|Overall Study||42
6472552|NCT01263704|7389806|FG000|COMPLETED|Overall Study||13
6472553|NCT01263704|7389806|FG000|NOT COMPLETED|Overall Study||29
6472554|NCT01263717|7389812|FG000|STARTED|Overall Study||28
6472555|NCT01263717|7389813|FG001|STARTED|Overall Study||26
6472556|NCT01263717|7389812|FG000|Baseline Visit|Overall Study||28
6472557|NCT01263717|7389813|FG001|Baseline Visit|Overall Study||22
6472558|NCT01263717|7389812|FG000|COMPLETED|Overall Study||23
6472559|NCT01263717|7389813|FG001|COMPLETED|Overall Study||20
6472560|NCT01263717|7389812|FG000|NOT COMPLETED|Overall Study||5
6472561|NCT01263717|7389813|FG001|NOT COMPLETED|Overall Study||6
6472562|NCT01263782|7389823|FG000|STARTED|Overall Study||6
6472563|NCT01263782|7389824|FG001|STARTED|Overall Study||6
6472564|NCT01263782|7389825|FG002|STARTED|Overall Study||6
6472565|NCT01263782|7389826|FG003|STARTED|Overall Study||6
6472566|NCT01263782|7389823|FG000|COMPLETED|Overall Study||6
6472567|NCT01263782|7389824|FG001|COMPLETED|Overall Study||6
6472568|NCT01263782|7389825|FG002|COMPLETED|Overall Study||3
6472569|NCT01263782|7389826|FG003|COMPLETED|Overall Study||5
6472570|NCT01263782|7389823|FG000|NOT COMPLETED|Overall Study||0
6472571|NCT01263782|7389824|FG001|NOT COMPLETED|Overall Study||0
6472572|NCT01263782|7389825|FG002|NOT COMPLETED|Overall Study||3
6472573|NCT01263782|7389826|FG003|NOT COMPLETED|Overall Study||1
6472574|NCT01263873|7389838|FG000|STARTED|Overall Study||30
6472575|NCT01263873|7389839|FG001|STARTED|Overall Study||30
6746792|NCT03379259|7674480|FG004|STARTED|Overall Study||12
6746793|NCT03379259|7674481|FG005|STARTED|Overall Study||12
6472576|NCT01263873|7389838|FG000|COMPLETED|Overall Study||29
6472577|NCT01263873|7389839|FG001|COMPLETED|Overall Study||29
6472578|NCT01263873|7389838|FG000|NOT COMPLETED|Overall Study||1
6472579|NCT01263873|7389839|FG001|NOT COMPLETED|Overall Study||1
6472580|NCT01263925|7389847|FG000|STARTED|Overall Study||276
6472581|NCT01263925|7389848|FG001|STARTED|Overall Study||285
6472582|NCT01263925|7389847|FG000|Full Analysis Set|Overall Study||269
6472583|NCT01263925|7389848|FG001|Full Analysis Set|Overall Study||272
6472584|NCT01263925|7389847|FG000|COMPLETED|Overall Study||225
6472585|NCT01263925|7389848|FG001|COMPLETED|Overall Study||233
6472586|NCT01263925|7389847|FG000|NOT COMPLETED|Overall Study||51
6472587|NCT01263925|7389848|FG001|NOT COMPLETED|Overall Study||52
6472588|NCT01263938|7389854|FG000|STARTED|Overall Study||5
6472589|NCT01263938|7389854|FG000|COMPLETED|Overall Study||5
6472590|NCT01263938|7389854|FG000|NOT COMPLETED|Overall Study||0
6472591|NCT01264016|7389859|FG000|STARTED|Overall Study||96
6472592|NCT01264016|7389859|FG000|COMPLETED|Overall Study||94
6472593|NCT01264016|7389859|FG000|NOT COMPLETED|Overall Study||2
6472594|NCT01264081|7389864|FG000|STARTED|Participants Screened||34
6472595|NCT01264081|7389864|FG000|COMPLETED|Participants Screened||4
6472596|NCT01264081|7389864|FG000|NOT COMPLETED|Participants Screened||30
6472597|NCT01264081|7389864|FG000|STARTED|Started Treatment||4
6472598|NCT01264081|7389864|FG000|COMPLETED|Started Treatment||2
6472599|NCT01264081|7389864|FG000|NOT COMPLETED|Started Treatment||2
6472600|NCT01264081|7389864|FG000|STARTED|Analysis||2
6472601|NCT01264081|7389864|FG000|COMPLETED|Analysis||2
6472602|NCT01264081|7389864|FG000|NOT COMPLETED|Analysis||0
6472603|NCT01264380|7389868|FG000|STARTED|Period A||8
6472604|NCT01264380|7389869|FG001|STARTED|Period A||8
6746794|NCT03379259|7674476|FG000|COMPLETED|Overall Study||2
6746795|NCT03379259|7674477|FG001|COMPLETED|Overall Study||2
6746796|NCT03379259|7674478|FG002|COMPLETED|Overall Study||3
6746797|NCT03379259|7674479|FG003|COMPLETED|Overall Study||0
6472605|NCT01264380|7389870|FG002|STARTED|Period A||0
6472606|NCT01264380|7389868|FG000|COMPLETED|Period A||8
6472607|NCT01264380|7389869|FG001|COMPLETED|Period A||8
6472608|NCT01264380|7389870|FG002|COMPLETED|Period A||0
6472609|NCT01264380|7389868|FG000|NOT COMPLETED|Period A||0
6472610|NCT01264380|7389869|FG001|NOT COMPLETED|Period A||0
6472611|NCT01264380|7389870|FG002|NOT COMPLETED|Period A||0
6472612|NCT01264380|7389868|FG000|STARTED|Period B||8
6472613|NCT01264380|7389869|FG001|STARTED|Period B||8
6472614|NCT01264380|7389870|FG002|STARTED|Period B||0
6472615|NCT01264380|7389868|FG000|COMPLETED|Period B||8
6472616|NCT01264380|7389869|FG001|COMPLETED|Period B||8
6472617|NCT01264380|7389870|FG002|COMPLETED|Period B||0
6472618|NCT01264380|7389868|FG000|NOT COMPLETED|Period B||0
6472619|NCT01264380|7389869|FG001|NOT COMPLETED|Period B||0
6472620|NCT01264380|7389870|FG002|NOT COMPLETED|Period B||0
6472621|NCT01264380|7389868|FG000|STARTED|Period C||0
6472622|NCT01264380|7389869|FG001|STARTED|Period C||0
6472623|NCT01264380|7389870|FG002|STARTED|Period C||16
6472624|NCT01264380|7389868|FG000|COMPLETED|Period C||0
6472625|NCT01264380|7389869|FG001|COMPLETED|Period C||0
6472626|NCT01264380|7389870|FG002|COMPLETED|Period C||2
6472627|NCT01264380|7389868|FG000|NOT COMPLETED|Period C||0
6472628|NCT01264380|7389869|FG001|NOT COMPLETED|Period C||0
6472629|NCT01264380|7389870|FG002|NOT COMPLETED|Period C||14
6472630|NCT01264419|7389878|FG000|STARTED|Overall Study||75
6472631|NCT01264419|7389878|FG000|COMPLETED|Overall Study||72
6472632|NCT01264419|7389878|FG000|NOT COMPLETED|Overall Study||3
6472633|NCT01264601|7389884|FG000|STARTED|Overall Study||17
6472634|NCT01264601|7389885|FG001|STARTED|Overall Study||14
6472635|NCT01264601|7389884|FG000|COMPLETED|Overall Study||17
6472636|NCT01264601|7389885|FG001|COMPLETED|Overall Study||14
6472637|NCT01264601|7389884|FG000|NOT COMPLETED|Overall Study||0
6472638|NCT01264601|7389885|FG001|NOT COMPLETED|Overall Study||0
6472639|NCT01264614|7389893|FG000|STARTED|Overall Study||13
6472640|NCT01264614|7389894|FG001|STARTED|Overall Study||9
6472641|NCT01264614|7389893|FG000|COMPLETED|Overall Study||12
6472642|NCT01264614|7389894|FG001|COMPLETED|Overall Study||7
6472643|NCT01264614|7389893|FG000|NOT COMPLETED|Overall Study||1
6472644|NCT01264614|7389894|FG001|NOT COMPLETED|Overall Study||2
6472645|NCT01264705|7389903|FG000|STARTED|Overall Study||3
6472646|NCT01264705|7389904|FG001|STARTED|Overall Study||3
6472647|NCT01264705|7389905|FG002|STARTED|Overall Study||41
6472648|NCT01264705|7389903|FG000|COMPLETED|Overall Study||3
6472649|NCT01264705|7389904|FG001|COMPLETED|Overall Study||3
6472650|NCT01264705|7389905|FG002|COMPLETED|Overall Study||41
6554420|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6554421|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6472651|NCT01264705|7389903|FG000|NOT COMPLETED|Overall Study||0
6472652|NCT01264705|7389904|FG001|NOT COMPLETED|Overall Study||0
6472653|NCT01264705|7389905|FG002|NOT COMPLETED|Overall Study||0
6472654|NCT01264718|7389918|FG000|STARTED|Overall Study||172
6472655|NCT01264718|7389919|FG001|STARTED|Overall Study||157
6472656|NCT01264718|7389918|FG000|COMPLETED|Overall Study||123
6472657|NCT01264718|7389919|FG001|COMPLETED|Overall Study||114
6472658|NCT01264718|7389918|FG000|NOT COMPLETED|Overall Study||49
6472659|NCT01264718|7389919|FG001|NOT COMPLETED|Overall Study||43
6472660|NCT01264770|7389931|FG000|STARTED|Overall Study|Patients who received treatment|54
6472661|NCT01264770|7389932|FG001|STARTED|Overall Study|Patients who received treatment|48
6472662|NCT01264770|7389933|FG002|STARTED|Overall Study|Patients who received treatment|57
6472663|NCT01264770|7389934|FG003|STARTED|Overall Study|Patients who received treatment|54
6472664|NCT01264770|7389935|FG004|STARTED|Overall Study|Patients who received treatment|27
6472665|NCT01264770|7389936|FG005|STARTED|Overall Study|Patients who received treatment|25
6472666|NCT01264770|7389931|FG000|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
6472667|NCT01264770|7389932|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
6472668|NCT01264770|7389933|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
6472669|NCT01264770|7389934|FG003|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
6472670|NCT01264770|7389935|FG004|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
6472671|NCT01264770|7389936|FG005|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
6472672|NCT01264770|7389931|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
6472673|NCT01264770|7389932|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
6472674|NCT01264770|7389933|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
6472675|NCT01264770|7389934|FG003|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
6472676|NCT01264770|7389935|FG004|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
6472677|NCT01264770|7389936|FG005|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
6472678|NCT01264770|7389931|FG000|NOT COMPLETED|Overall Study||18
6472679|NCT01264770|7389932|FG001|NOT COMPLETED|Overall Study||10
6472680|NCT01264770|7389933|FG002|NOT COMPLETED|Overall Study||16
6554422|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6554423|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Washout Period 5||0
6472681|NCT01264770|7389934|FG003|NOT COMPLETED|Overall Study||6
6472682|NCT01264770|7389935|FG004|NOT COMPLETED|Overall Study||8
6472683|NCT01264770|7389936|FG005|NOT COMPLETED|Overall Study||6
6472684|NCT01264887|7389956|FG000|STARTED|Overall Study||31
6472685|NCT01264887|7389956|FG000|COMPLETED|Overall Study||0
6472686|NCT01264887|7389956|FG000|NOT COMPLETED|Overall Study||31
6472687|NCT01264939|7389964|FG000|STARTED|Overall Study||84
6472688|NCT01264939|7389965|FG001|STARTED|Overall Study||252
6472689|NCT01264939|7389964|FG000|COMPLETED|Overall Study||66
6472690|NCT01264939|7389965|FG001|COMPLETED|Overall Study||224
6472691|NCT01264939|7389964|FG000|NOT COMPLETED|Overall Study||18
6472692|NCT01264939|7389965|FG001|NOT COMPLETED|Overall Study||28
6472693|NCT01264952|7389974|FG000|STARTED|Overall Study||6
6472694|NCT01264952|7389975|FG001|STARTED|Overall Study||2
6472695|NCT01264952|7389976|FG002|STARTED|Overall Study||8
6472696|NCT01264952|7389974|FG000|COMPLETED|Overall Study||6
6472697|NCT01264952|7389975|FG001|COMPLETED|Overall Study||2
6472698|NCT01264952|7389976|FG002|COMPLETED|Overall Study||8
6472699|NCT01264952|7389974|FG000|NOT COMPLETED|Overall Study||0
6472700|NCT01264952|7389975|FG001|NOT COMPLETED|Overall Study||0
6472701|NCT01264952|7389976|FG002|NOT COMPLETED|Overall Study||0
6472702|NCT01265056|7389986|FG000|STARTED|Initial Study Period||26
6472703|NCT01265056|7389987|FG001|STARTED|Initial Study Period||27
6472704|NCT01265056|7389986|FG000|COMPLETED|Initial Study Period||24
6472705|NCT01265056|7389987|FG001|COMPLETED|Initial Study Period||25
6472706|NCT01265056|7389986|FG000|NOT COMPLETED|Initial Study Period||2
6472707|NCT01265056|7389987|FG001|NOT COMPLETED|Initial Study Period||2
6472708|NCT01265056|7389986|FG000|STARTED|Follow up||26
6472709|NCT01265056|7389987|FG001|STARTED|Follow up||27
6472710|NCT01265056|7389986|FG000|COMPLETED|Follow up||19
6472711|NCT01265056|7389987|FG001|COMPLETED|Follow up||24
6472712|NCT01265056|7389986|FG000|NOT COMPLETED|Follow up||7
6472713|NCT01265056|7389987|FG001|NOT COMPLETED|Follow up||3
6472714|NCT01265394|7389993|FG000|STARTED|Overall Study||218
6472715|NCT01265394|7389993|FG000|COMPLETED|Overall Study||181
6472716|NCT01265394|7389993|FG000|NOT COMPLETED|Overall Study||37
6472717|NCT01265420|7389998|FG000|STARTED|Overall Study||7
6472718|NCT01265420|7389998|FG000|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
6472719|NCT01265420|7389998|FG000|NOT COMPLETED|Overall Study||1
6472720|NCT01265446|7390004|FG000|STARTED|Overall Study||125
6472721|NCT01265446|7390005|FG001|STARTED|Overall Study||125
6472722|NCT01265446|7390004|FG000|COMPLETED|Overall Study||124
6472723|NCT01265446|7390005|FG001|COMPLETED|Overall Study||125
6472724|NCT01265446|7390004|FG000|NOT COMPLETED|Overall Study||1
6472725|NCT01265446|7390005|FG001|NOT COMPLETED|Overall Study||0
6472726|NCT01265459|7390014|FG000|STARTED|Overall Study||23
6472727|NCT01265459|7390015|FG001|STARTED|Overall Study||23
6472728|NCT01265459|7390016|FG002|STARTED|Overall Study||22
6472729|NCT01265459|7390014|FG000|COMPLETED|Overall Study||23
6472730|NCT01265459|7390015|FG001|COMPLETED|Overall Study||23
6472731|NCT01265459|7390016|FG002|COMPLETED|Overall Study||20
6472732|NCT01265459|7390014|FG000|NOT COMPLETED|Overall Study||0
6472733|NCT01265459|7390015|FG001|NOT COMPLETED|Overall Study||0
6472734|NCT01265459|7390016|FG002|NOT COMPLETED|Overall Study||2
6472735|NCT01265498|7390038|FG000|STARTED|Overall Study||141
6472736|NCT01265498|7390039|FG001|STARTED|Overall Study||142
6472737|NCT01265498|7390038|FG000|Both Baseline and Week 72 Biopsy|Overall Study||102
6472738|NCT01265498|7390039|FG001|Both Baseline and Week 72 Biopsy|Overall Study||98
6472739|NCT01265498|7390038|FG000|COMPLETED|Overall Study||110
6472740|NCT01265498|7390039|FG001|COMPLETED|Overall Study||109
6472741|NCT01265498|7390038|FG000|NOT COMPLETED|Overall Study||31
6472742|NCT01265498|7390039|FG001|NOT COMPLETED|Overall Study||33
6472743|NCT01265511|7390047|FG000|STARTED|Overall Study||2
6472744|NCT01265511|7390048|FG001|STARTED|Overall Study||8
6472745|NCT01265511|7390047|FG000|COMPLETED|Overall Study||0
6472746|NCT01265511|7390048|FG001|COMPLETED|Overall Study||5
6472747|NCT01265511|7390047|FG000|NOT COMPLETED|Overall Study||2
6472748|NCT01265511|7390048|FG001|NOT COMPLETED|Overall Study||3
6472749|NCT01265524|7390056|FG000|STARTED|Overall Study||59
6472750|NCT01265524|7390057|FG001|STARTED|Overall Study||52
6472751|NCT01265524|7390056|FG000|COMPLETED|Overall Study||41
6472752|NCT01265524|7390057|FG001|COMPLETED|Overall Study||46
6472753|NCT01265524|7390056|FG000|NOT COMPLETED|Overall Study||18
6472754|NCT01265524|7390057|FG001|NOT COMPLETED|Overall Study||6
6472755|NCT01265537|7390065|FG000|STARTED|Overall Study||15
6472756|NCT01265537|7390066|FG001|STARTED|Overall Study||15
6472757|NCT01265537|7390065|FG000|COMPLETED|Overall Study||13
6472758|NCT01265537|7390066|FG001|COMPLETED|Overall Study||13
6472759|NCT01265537|7390065|FG000|NOT COMPLETED|Overall Study||2
6472760|NCT01265537|7390066|FG001|NOT COMPLETED|Overall Study||2
6472761|NCT01265550|7390076|FG000|STARTED|Pre Randomization||0
6472762|NCT01265550|7390077|FG001|STARTED|Pre Randomization||0
6472763|NCT01265550|7390078|FG002|STARTED|Pre Randomization||0
6472764|NCT01265550|7390079|FG003|STARTED|Pre Randomization||366
6472765|NCT01265550|7390076|FG000|COMPLETED|Pre Randomization||0
6472766|NCT01265550|7390077|FG001|COMPLETED|Pre Randomization||0
6472767|NCT01265550|7390078|FG002|COMPLETED|Pre Randomization||0
6472768|NCT01265550|7390079|FG003|COMPLETED|Pre Randomization||78
6472769|NCT01265550|7390076|FG000|NOT COMPLETED|Pre Randomization||0
6472770|NCT01265550|7390077|FG001|NOT COMPLETED|Pre Randomization||0
6472771|NCT01265550|7390078|FG002|NOT COMPLETED|Pre Randomization||0
6472772|NCT01265550|7390079|FG003|NOT COMPLETED|Pre Randomization||288
6654535|NCT02446483|7584378|FG000|NOT COMPLETED|Period 3: Intervention Period 2||0
6554424|NCT01746901|7476545|FG000|STARTED|Treatment Phase: Sixth Intervention||0
6554425|NCT01746901|7476546|FG001|STARTED|Treatment Phase: Sixth Intervention||0
6554426|NCT01746901|7476547|FG002|STARTED|Treatment Phase: Sixth Intervention||0
6654536|NCT02446483|7584379|FG001|NOT COMPLETED|Period 3: Intervention Period 2||0
6654537|NCT02446496|7584385|FG000|STARTED|Overall Study||24
6654538|NCT02446496|7584385|FG000|COMPLETED|Overall Study||24
6654539|NCT02446496|7584385|FG000|NOT COMPLETED|Overall Study||0
6472773|NCT01265550|7390076|FG000|STARTED|Post Randomization||25
6472774|NCT01265550|7390077|FG001|STARTED|Post Randomization||27
6746798|NCT03379259|7674480|FG004|COMPLETED|Overall Study||3
6746799|NCT03379259|7674481|FG005|COMPLETED|Overall Study||5
6746800|NCT03379259|7674476|FG000|NOT COMPLETED|Overall Study||1
6746801|NCT03379259|7674477|FG001|NOT COMPLETED|Overall Study||1
6746802|NCT03379259|7674478|FG002|NOT COMPLETED|Overall Study||3
6472775|NCT01265550|7390078|FG002|STARTED|Post Randomization||26
6472776|NCT01265550|7390079|FG003|STARTED|Post Randomization||0
6472777|NCT01265550|7390076|FG000|COMPLETED|Post Randomization||10
6472778|NCT01265550|7390077|FG001|COMPLETED|Post Randomization||19
6472779|NCT01265550|7390078|FG002|COMPLETED|Post Randomization||6
6472780|NCT01265550|7390079|FG003|COMPLETED|Post Randomization||0
6472781|NCT01265550|7390076|FG000|NOT COMPLETED|Post Randomization||15
6472782|NCT01265550|7390077|FG001|NOT COMPLETED|Post Randomization||8
6472783|NCT01265550|7390078|FG002|NOT COMPLETED|Post Randomization||20
6472784|NCT01265550|7390079|FG003|NOT COMPLETED|Post Randomization||0
6472785|NCT01265563|7390098|FG000|STARTED|Overall Study||16
6472786|NCT01265563|7390099|FG001|STARTED|Overall Study||13
6472787|NCT01265563|7390100|FG002|STARTED|Overall Study||17
6472788|NCT01265563|7390101|FG003|STARTED|Overall Study||16
6472789|NCT01265563|7390102|FG004|STARTED|Overall Study||16
6554427|NCT01746901|7476548|FG003|STARTED|Treatment Phase: Sixth Intervention||5
6554428|NCT01746901|7476549|FG004|STARTED|Treatment Phase: Sixth Intervention||6
6554429|NCT01746901|7476550|FG005|STARTED|Treatment Phase: Sixth Intervention||5
6554430|NCT01746901|7476551|FG006|STARTED|Treatment Phase: Sixth Intervention||5
6554431|NCT01746901|7476552|FG007|STARTED|Treatment Phase: Sixth Intervention||6
6554432|NCT01746901|7476553|FG008|STARTED|Treatment Phase: Sixth Intervention||5
6554433|NCT01746901|7476545|FG000|COMPLETED|Treatment Phase: Sixth Intervention||0
6554434|NCT01746901|7476546|FG001|COMPLETED|Treatment Phase: Sixth Intervention||0
6554435|NCT01746901|7476547|FG002|COMPLETED|Treatment Phase: Sixth Intervention||0
6554436|NCT01746901|7476548|FG003|COMPLETED|Treatment Phase: Sixth Intervention||5
6554437|NCT01746901|7476549|FG004|COMPLETED|Treatment Phase: Sixth Intervention||6
6554438|NCT01746901|7476550|FG005|COMPLETED|Treatment Phase: Sixth Intervention||5
6554439|NCT01746901|7476551|FG006|COMPLETED|Treatment Phase: Sixth Intervention||5
6554440|NCT01746901|7476552|FG007|COMPLETED|Treatment Phase: Sixth Intervention||6
6554441|NCT01746901|7476553|FG008|COMPLETED|Treatment Phase: Sixth Intervention||5
6554442|NCT01746901|7476545|FG000|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554443|NCT01746901|7476546|FG001|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554444|NCT01746901|7476547|FG002|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554445|NCT01746901|7476548|FG003|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554446|NCT01746901|7476549|FG004|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554447|NCT01746901|7476550|FG005|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554448|NCT01746901|7476551|FG006|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554449|NCT01746901|7476552|FG007|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554450|NCT01746901|7476553|FG008|NOT COMPLETED|Treatment Phase: Sixth Intervention||0
6554451|NCT01746940|7476593|FG000|STARTED|Safety and Efficacy First Phase||39
6554452|NCT01746940|7476594|FG001|STARTED|Safety and Efficacy First Phase||41
6554453|NCT01746940|7476595|FG002|STARTED|Safety and Efficacy First Phase||40
6554454|NCT01746940|7476596|FG003|STARTED|Safety and Efficacy First Phase||3
6554455|NCT01746940|7476593|FG000|COMPLETED|Safety and Efficacy First Phase||39
6554456|NCT01746940|7476594|FG001|COMPLETED|Safety and Efficacy First Phase||41
6554457|NCT01746940|7476595|FG002|COMPLETED|Safety and Efficacy First Phase||40
6554458|NCT01746940|7476596|FG003|COMPLETED|Safety and Efficacy First Phase||0
6554459|NCT01746940|7476593|FG000|NOT COMPLETED|Safety and Efficacy First Phase||0
6554460|NCT01746940|7476594|FG001|NOT COMPLETED|Safety and Efficacy First Phase||0
6554461|NCT01746940|7476595|FG002|NOT COMPLETED|Safety and Efficacy First Phase||0
6554462|NCT01746940|7476596|FG003|NOT COMPLETED|Safety and Efficacy First Phase||3
6554463|NCT01746940|7476593|FG000|STARTED|Safety Second Phase||18
6554464|NCT01746940|7476594|FG001|STARTED|Safety Second Phase||18
6654540|NCT02446613|7584393|FG000|STARTED|Overall Study||6
6654541|NCT02446613|7584394|FG001|STARTED|Overall Study||10
6654542|NCT02446613|7584393|FG000|COMPLETED|Overall Study||6
6654543|NCT02446613|7584394|FG001|COMPLETED|Overall Study||10
6654544|NCT02446613|7584393|FG000|NOT COMPLETED|Overall Study||0
6654545|NCT02446613|7584394|FG001|NOT COMPLETED|Overall Study||0
6654546|NCT02446691|7584404|FG000|STARTED|Overall Study||128
6654547|NCT02446691|7584404|FG000|COMPLETED|Overall Study||117
6654548|NCT02446691|7584404|FG000|NOT COMPLETED|Overall Study||11
6654549|NCT02446717|7584413|FG000|STARTED|Overall Study||6
6654550|NCT02446717|7584414|FG001|STARTED|Overall Study||22
6654551|NCT02446717|7584415|FG002|STARTED|Overall Study||22
6654552|NCT02446717|7584416|FG003|STARTED|Overall Study||44
6654553|NCT02446717|7584417|FG004|STARTED|Overall Study||47
6746803|NCT03379259|7674479|FG003|NOT COMPLETED|Overall Study||3
6472790|NCT01265563|7390098|FG000|COMPLETED|Overall Study||16
6472791|NCT01265563|7390099|FG001|COMPLETED|Overall Study||12
6472792|NCT01265563|7390100|FG002|COMPLETED|Overall Study||16
6472793|NCT01265563|7390101|FG003|COMPLETED|Overall Study||16
6472794|NCT01265563|7390102|FG004|COMPLETED|Overall Study||14
6472795|NCT01265563|7390098|FG000|NOT COMPLETED|Overall Study||0
6472796|NCT01265563|7390099|FG001|NOT COMPLETED|Overall Study||1
6472797|NCT01265563|7390100|FG002|NOT COMPLETED|Overall Study||1
6472798|NCT01265563|7390101|FG003|NOT COMPLETED|Overall Study||0
6472799|NCT01265563|7390102|FG004|NOT COMPLETED|Overall Study||2
6472800|NCT01265615|7390123|FG000|STARTED|Overall Study||30
6472801|NCT01265615|7390124|FG001|STARTED|Overall Study||30
6472802|NCT01265615|7390125|FG002|STARTED|Overall Study||30
6472803|NCT01265615|7390126|FG003|STARTED|Overall Study||30
6472804|NCT01265615|7390123|FG000|COMPLETED|Overall Study||28
6472805|NCT01265615|7390124|FG001|COMPLETED|Overall Study||28
6472806|NCT01265615|7390125|FG002|COMPLETED|Overall Study||26
6472807|NCT01265615|7390126|FG003|COMPLETED|Overall Study||27
6472808|NCT01265615|7390123|FG000|NOT COMPLETED|Overall Study||2
6472809|NCT01265615|7390124|FG001|NOT COMPLETED|Overall Study||2
6472810|NCT01265615|7390125|FG002|NOT COMPLETED|Overall Study||4
6472811|NCT01265615|7390126|FG003|NOT COMPLETED|Overall Study||3
6472812|NCT01265667|7390138|FG000|STARTED|Overall Study||145
6472813|NCT01265667|7390139|FG001|STARTED|Overall Study||148
6746804|NCT03379259|7674480|FG004|NOT COMPLETED|Overall Study||9
6746805|NCT03379259|7674481|FG005|NOT COMPLETED|Overall Study||7
6746806|NCT03379376|7674498|FG000|STARTED|Overall Study||10
6746807|NCT03379376|7674498|FG000|COMPLETED|Overall Study||5
6746808|NCT03379376|7674498|FG000|NOT COMPLETED|Overall Study||5
6746809|NCT03379506|7674506|FG000|STARTED|Overall Study||22
6472814|NCT01265667|7390138|FG000|COMPLETED|Overall Study||125
6472815|NCT01265667|7390139|FG001|COMPLETED|Overall Study||135
6472816|NCT01265667|7390138|FG000|NOT COMPLETED|Overall Study||20
6472817|NCT01265667|7390139|FG001|NOT COMPLETED|Overall Study||13
6472818|NCT01265719|7390147|FG000|STARTED|Overall Study||102
6472819|NCT01265719|7390148|FG001|STARTED|Overall Study||73
6472820|NCT01265719|7390147|FG000|COMPLETED|Overall Study||88
6472821|NCT01265719|7390148|FG001|COMPLETED|Overall Study||60
6472822|NCT01265719|7390147|FG000|NOT COMPLETED|Overall Study||14
6472823|NCT01265719|7390148|FG001|NOT COMPLETED|Overall Study||13
6472824|NCT01265797|7390156|FG000|STARTED|Run-in Month||34
6472825|NCT01265797|7390157|FG001|STARTED|Run-in Month||34
6472826|NCT01265797|7390156|FG000|COMPLETED|Run-in Month||34
6472827|NCT01265797|7390157|FG001|COMPLETED|Run-in Month||29
6472828|NCT01265797|7390156|FG000|NOT COMPLETED|Run-in Month||0
6472829|NCT01265797|7390157|FG001|NOT COMPLETED|Run-in Month||5
6472830|NCT01265797|7390156|FG000|STARTED|Blinded Month||34
6472831|NCT01265797|7390157|FG001|STARTED|Blinded Month||29
6472832|NCT01265797|7390156|FG000|COMPLETED|Blinded Month||24
6472833|NCT01265797|7390157|FG001|COMPLETED|Blinded Month||27
6472834|NCT01265797|7390156|FG000|NOT COMPLETED|Blinded Month||10
6472835|NCT01265797|7390157|FG001|NOT COMPLETED|Blinded Month||2
6472836|NCT01265797|7390156|FG000|STARTED|Open Label Month||24
6472837|NCT01265797|7390157|FG001|STARTED|Open Label Month||27
6472838|NCT01265797|7390156|FG000|COMPLETED|Open Label Month||24
6472839|NCT01265797|7390157|FG001|COMPLETED|Open Label Month||26
6472840|NCT01265797|7390156|FG000|NOT COMPLETED|Open Label Month||0
6472841|NCT01265797|7390157|FG001|NOT COMPLETED|Open Label Month||1
6501124|NCT01426867|7419617|FG002|STARTED|Overall Study||34
6501125|NCT01426867|7419615|FG000|COMPLETED|Overall Study||33
6501126|NCT01426867|7419616|FG001|COMPLETED|Overall Study||34
6501127|NCT01426867|7419617|FG002|COMPLETED|Overall Study||34
6501128|NCT01426867|7419615|FG000|NOT COMPLETED|Overall Study||0
6501129|NCT01426867|7419616|FG001|NOT COMPLETED|Overall Study||0
6501130|NCT01426867|7419617|FG002|NOT COMPLETED|Overall Study||0
6501131|NCT01426958|7419625|FG000|STARTED|Overall Study||24
6746810|NCT03379506|7674507|FG001|STARTED|Overall Study||17
6501132|NCT01426958|7419625|FG000|COMPLETED|Overall Study||22
6501133|NCT01426958|7419625|FG000|NOT COMPLETED|Overall Study||2
6501134|NCT01427296|7419635|FG000|STARTED|Overall Study||1041
6501135|NCT01427296|7419636|FG001|STARTED|Overall Study||1051
6501136|NCT01427296|7419635|FG000|COMPLETED|Overall Study||1041
6501137|NCT01427296|7419636|FG001|COMPLETED|Overall Study||1051
6501138|NCT01427296|7419635|FG000|NOT COMPLETED|Overall Study||0
6501139|NCT01427296|7419636|FG001|NOT COMPLETED|Overall Study||0
6501140|NCT01427309|7419646|FG000|STARTED|Overall Study||7253
6501141|NCT01427309|7419647|FG001|STARTED|Overall Study||7244
6501142|NCT01427309|7419648|FG002|STARTED|Overall Study||8737
6501143|NCT01427309|7419649|FG003|STARTED|Overall Study||8749
6501144|NCT01427309|7419646|FG000|COMPLETED|Overall Study||6881
6501145|NCT01427309|7419647|FG001|COMPLETED|Overall Study||6837
6501146|NCT01427309|7419648|FG002|COMPLETED|Overall Study||8376
6501147|NCT01427309|7419649|FG003|COMPLETED|Overall Study||8373
6501148|NCT01427309|7419646|FG000|NOT COMPLETED|Overall Study||372
6501149|NCT01427309|7419647|FG001|NOT COMPLETED|Overall Study||407
6501150|NCT01427309|7419648|FG002|NOT COMPLETED|Overall Study||361
6501151|NCT01427309|7419649|FG003|NOT COMPLETED|Overall Study||376
6501152|NCT01427504|7419665|FG000|STARTED|Overall Study||4
6501153|NCT01427504|7419666|FG001|STARTED|Overall Study||3
6501154|NCT01427504|7419667|FG002|STARTED|Overall Study||4
6501155|NCT01427504|7419668|FG003|STARTED|Overall Study||6
6746811|NCT03379506|7674508|FG002|STARTED|Overall Study||7
6746812|NCT03379506|7674509|FG003|STARTED|Overall Study||11
6746813|NCT03379506|7674506|FG000|COMPLETED|Overall Study||22
6472842|NCT01265823|7390165|FG000|STARTED|Overall Study||150
6472843|NCT01265823|7390165|FG000|COMPLETED|Overall Study||143
6472844|NCT01265823|7390165|FG000|NOT COMPLETED|Overall Study||7
6472845|NCT01265875|7390173|FG000|STARTED|Overall Study||12
6472846|NCT01265875|7390173|FG000|COMPLETED|Overall Study||11
6472847|NCT01265875|7390173|FG000|NOT COMPLETED|Overall Study||1
6472848|NCT01265953|7390180|FG000|STARTED|Overall Study||50
6472849|NCT01265953|7390181|FG001|STARTED|Overall Study||48
6472850|NCT01265953|7390180|FG000|COMPLETED|Overall Study||45
6472851|NCT01265953|7390181|FG001|COMPLETED|Overall Study||45
6472852|NCT01265953|7390180|FG000|NOT COMPLETED|Overall Study||5
6472853|NCT01265953|7390181|FG001|NOT COMPLETED|Overall Study||3
6472854|NCT01265966|7390190|FG000|STARTED|Overall Study||47
6472855|NCT01265966|7390191|FG001|STARTED|Overall Study||41
6472856|NCT01265966|7390192|FG002|STARTED|Overall Study||29
6472857|NCT01265966|7390190|FG000|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
6472858|NCT01265966|7390191|FG001|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
6472859|NCT01265966|7390192|FG002|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
6472860|NCT01265966|7390190|FG000|COMPLETED|Overall Study||44
6472861|NCT01265966|7390191|FG001|COMPLETED|Overall Study||39
6472862|NCT01265966|7390192|FG002|COMPLETED|Overall Study||27
6472863|NCT01265966|7390190|FG000|NOT COMPLETED|Overall Study||3
6472864|NCT01265966|7390191|FG001|NOT COMPLETED|Overall Study||2
6472865|NCT01265966|7390192|FG002|NOT COMPLETED|Overall Study||2
6472866|NCT01265992|7390200|FG000|STARTED|Overall Study||50
6472867|NCT01265992|7390200|FG000|Received Treatment|Overall Study||49
6472868|NCT01265992|7390200|FG000|COMPLETED|Overall Study||41
6472869|NCT01265992|7390200|FG000|NOT COMPLETED|Overall Study||9
6472870|NCT01266018|7390204|FG000|STARTED|Overall Study||9
6472871|NCT01266018|7390205|FG001|STARTED|Overall Study||13
6472872|NCT01266018|7390204|FG000|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
6472873|NCT01266018|7390205|FG001|COMPLETED|Overall Study||12
6472874|NCT01266018|7390204|FG000|NOT COMPLETED|Overall Study||1
6472875|NCT01266018|7390205|FG001|NOT COMPLETED|Overall Study||1
6472876|NCT01266070|7390211|FG000|STARTED|Overall Study||6
6472877|NCT01266070|7390211|FG000|COMPLETED|Overall Study||2
6472878|NCT01266070|7390211|FG000|NOT COMPLETED|Overall Study||4
6472879|NCT01266122|7390217|FG000|STARTED|Overall Study||48
6472880|NCT01266122|7390218|FG001|STARTED|Overall Study||48
6472881|NCT01266122|7390217|FG000|COMPLETED|Overall Study||42
6472882|NCT01266122|7390218|FG001|COMPLETED|Overall Study||42
6472883|NCT01266122|7390217|FG000|NOT COMPLETED|Overall Study||6
6472884|NCT01266122|7390218|FG001|NOT COMPLETED|Overall Study||6
6472885|NCT01266148|7390226|FG000|STARTED|Overall Study||56
6472886|NCT01266148|7390227|FG001|STARTED|Overall Study||59
6472887|NCT01266148|7390226|FG000|COMPLETED|Overall Study||49
6472888|NCT01266148|7390227|FG001|COMPLETED|Overall Study||56
6472889|NCT01266148|7390226|FG000|NOT COMPLETED|Overall Study||7
6472890|NCT01266148|7390227|FG001|NOT COMPLETED|Overall Study||3
6472891|NCT01266161|7390235|FG000|STARTED|Overall Study||52
6472892|NCT01266161|7390236|FG001|STARTED|Overall Study||54
6472893|NCT01266161|7390235|FG000|COMPLETED|Overall Study||48
6472894|NCT01266161|7390236|FG001|COMPLETED|Overall Study||53
6472895|NCT01266161|7390235|FG000|NOT COMPLETED|Overall Study||4
6472896|NCT01266161|7390236|FG001|NOT COMPLETED|Overall Study||1
6472897|NCT01266265|7390244|FG000|STARTED|Overall Study||666
6472898|NCT01266265|7390245|FG001|STARTED|Overall Study||667
6472899|NCT01266265|7390244|FG000|COMPLETED|Overall Study||461
6472900|NCT01266265|7390245|FG001|COMPLETED|Overall Study||477
6472901|NCT01266265|7390244|FG000|NOT COMPLETED|Overall Study||205
6472902|NCT01266265|7390245|FG001|NOT COMPLETED|Overall Study||190
6472903|NCT01266291|7390251|FG000|STARTED|Overall Study||1
6472904|NCT01266291|7390251|FG000|COMPLETED|Overall Study||0
6472905|NCT01266291|7390251|FG000|NOT COMPLETED|Overall Study||1
6472906|NCT01266317|7390255|FG000|STARTED|Overall Study|One additional patient was a protocol violation post consent when autoantibodies returned positive|9
6472907|NCT01266317|7390255|FG000|COMPLETED|Overall Study||7
6472908|NCT01266317|7390255|FG000|NOT COMPLETED|Overall Study||2
6472909|NCT01266447|7390259|FG000|STARTED|Overall Study||27
6472910|NCT01266447|7390259|FG000|COMPLETED|Overall Study|Eligible and treated patients|27
6472911|NCT01266447|7390259|FG000|NOT COMPLETED|Overall Study||0
6472912|NCT01266460|7390263|FG000|STARTED|Overall Study||50
6472913|NCT01266460|7390263|FG000|COMPLETED|Overall Study||16
6472914|NCT01266460|7390263|FG000|NOT COMPLETED|Overall Study||34
6472915|NCT01266590|7390267|FG000|STARTED|Overall Study||30
6472916|NCT01266590|7390267|FG000|COMPLETED|Overall Study||24
6472917|NCT01266590|7390267|FG000|NOT COMPLETED|Overall Study||6
6472918|NCT01266603|7390274|FG000|STARTED|Overall Study||44
6472919|NCT01266603|7390274|FG000|MAGE-A3 Positive Tumor|Overall Study||18
6472920|NCT01266603|7390274|FG000|Patients Evaluable for Safety|Overall Study||17
6472921|NCT01266603|7390274|FG000|Patients Evaluable for Response|Overall Study||16
6472922|NCT01266603|7390274|FG000|Continued to Maintenance- MAGE-A3|Overall Study||4
6472923|NCT01266603|7390274|FG000|Maintenance Completion|Overall Study||2
6472924|NCT01266603|7390274|FG000|COMPLETED|Overall Study||2
6472925|NCT01266603|7390274|FG000|NOT COMPLETED|Overall Study||42
6472926|NCT01266642|7390280|FG000|STARTED|Overall Study||149
6472927|NCT01266642|7390281|FG001|STARTED|Overall Study||138
6472928|NCT01266642|7390280|FG000|COMPLETED|Overall Study||149
6472929|NCT01266642|7390281|FG001|COMPLETED|Overall Study||137
6472930|NCT01266642|7390280|FG000|NOT COMPLETED|Overall Study||0
6472931|NCT01266642|7390281|FG001|NOT COMPLETED|Overall Study||1
6472932|NCT01266850|7390292|FG000|STARTED|Overall Study||242
6472933|NCT01266850|7390293|FG001|STARTED|Overall Study||248
6472934|NCT01266850|7390294|FG002|STARTED|Overall Study||238
6472935|NCT01266850|7390295|FG003|STARTED|Overall Study||329
6472936|NCT01266850|7390296|FG004|STARTED|Overall Study||327
6472937|NCT01266850|7390292|FG000|Received Second Vaccine|Overall Study||231
6472938|NCT01266850|7390293|FG001|Received Second Vaccine|Overall Study||233
6472939|NCT01266850|7390294|FG002|Received Second Vaccine|Overall Study||227
6472940|NCT01266850|7390295|FG003|Received Second Vaccine|Overall Study||311
6472941|NCT01266850|7390296|FG004|Received Second Vaccine|Overall Study||307
6472942|NCT01266850|7390292|FG000|Received Third Vaccine|Overall Study||221
6472943|NCT01266850|7390293|FG001|Received Third Vaccine|Overall Study||221
6472944|NCT01266850|7390294|FG002|Received Third Vaccine|Overall Study||217
6472945|NCT01266850|7390295|FG003|Received Third Vaccine|Overall Study||0
6472946|NCT01266850|7390296|FG004|Received Third Vaccine|Overall Study||299
6472947|NCT01266850|7390292|FG000|COMPLETED|Overall Study||212
6472948|NCT01266850|7390293|FG001|COMPLETED|Overall Study||212
6472949|NCT01266850|7390294|FG002|COMPLETED|Overall Study||214
6472950|NCT01266850|7390295|FG003|COMPLETED|Overall Study||301
6472951|NCT01266850|7390296|FG004|COMPLETED|Overall Study||297
6472952|NCT01266850|7390292|FG000|NOT COMPLETED|Overall Study||30
6472953|NCT01266850|7390293|FG001|NOT COMPLETED|Overall Study||36
6472954|NCT01266850|7390294|FG002|NOT COMPLETED|Overall Study||24
6472955|NCT01266850|7390295|FG003|NOT COMPLETED|Overall Study||28
6472956|NCT01266850|7390296|FG004|NOT COMPLETED|Overall Study||30
6472957|NCT01266876|7390313|FG000|STARTED|Overall Study||15
6472958|NCT01266876|7390314|FG001|STARTED|Overall Study||15
6472959|NCT01266876|7390315|FG002|STARTED|Overall Study||16
6472960|NCT01266876|7390316|FG003|STARTED|Overall Study||15
6472961|NCT01266876|7390317|FG004|STARTED|Overall Study||16
6472962|NCT01266876|7390313|FG000|COMPLETED|Overall Study||15
6472963|NCT01266876|7390314|FG001|COMPLETED|Overall Study||15
6472964|NCT01266876|7390315|FG002|COMPLETED|Overall Study||16
6472965|NCT01266876|7390316|FG003|COMPLETED|Overall Study||14
6472966|NCT01266876|7390317|FG004|COMPLETED|Overall Study||16
6472967|NCT01266876|7390313|FG000|NOT COMPLETED|Overall Study||0
6472968|NCT01266876|7390314|FG001|NOT COMPLETED|Overall Study||0
6472969|NCT01266876|7390315|FG002|NOT COMPLETED|Overall Study||0
6472970|NCT01266876|7390316|FG003|NOT COMPLETED|Overall Study||1
6472971|NCT01266876|7390317|FG004|NOT COMPLETED|Overall Study||0
6472972|NCT01266902|7390331|FG000|STARTED|Period 1 (Main Study)||119
6472973|NCT01266902|7390332|FG001|STARTED|Period 1 (Main Study)||363
6472974|NCT01266902|7390333|FG002|STARTED|Period 1 (Main Study)||0
6472975|NCT01266902|7390331|FG000|COMPLETED|Period 1 (Main Study)||89
6472976|NCT01266902|7390332|FG001|COMPLETED|Period 1 (Main Study)||282
6472977|NCT01266902|7390333|FG002|COMPLETED|Period 1 (Main Study)||0
6472978|NCT01266902|7390331|FG000|NOT COMPLETED|Period 1 (Main Study)||30
6472979|NCT01266902|7390332|FG001|NOT COMPLETED|Period 1 (Main Study)||81
6472980|NCT01266902|7390333|FG002|NOT COMPLETED|Period 1 (Main Study)||0
6472981|NCT01266902|7390331|FG000|STARTED|Period 2 (After Protocol Amendment 3)||0
6472982|NCT01266902|7390332|FG001|STARTED|Period 2 (After Protocol Amendment 3)||0
6472983|NCT01266902|7390333|FG002|STARTED|Period 2 (After Protocol Amendment 3)||45
6472984|NCT01266902|7390331|FG000|COMPLETED|Period 2 (After Protocol Amendment 3)||0
6472985|NCT01266902|7390332|FG001|COMPLETED|Period 2 (After Protocol Amendment 3)||0
6472986|NCT01266902|7390333|FG002|COMPLETED|Period 2 (After Protocol Amendment 3)||37
6472987|NCT01266902|7390331|FG000|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
6472988|NCT01266902|7390332|FG001|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||0
6472989|NCT01266902|7390333|FG002|NOT COMPLETED|Period 2 (After Protocol Amendment 3)||8
6472990|NCT01266967|7390343|FG000|STARTED|Overall Study||89
6472991|NCT01266967|7390344|FG001|STARTED|Overall Study||83
6472992|NCT01266967|7390343|FG000|COMPLETED|Overall Study||0
6472993|NCT01266967|7390344|FG001|COMPLETED|Overall Study||0
6472994|NCT01266967|7390343|FG000|NOT COMPLETED|Overall Study||89
6472995|NCT01266967|7390344|FG001|NOT COMPLETED|Overall Study||83
6472996|NCT01266993|7390355|FG000|STARTED|Persistence Phase (Month 32-44)||199
6472997|NCT01266993|7390356|FG001|STARTED|Persistence Phase (Month 32-44)||72
6472998|NCT01266993|7390355|FG000|COMPLETED|Persistence Phase (Month 32-44)||199
6472999|NCT01266993|7390356|FG001|COMPLETED|Persistence Phase (Month 32-44)||72
6473000|NCT01266993|7390355|FG000|NOT COMPLETED|Persistence Phase (Month 32-44)||0
6473001|NCT01266993|7390356|FG001|NOT COMPLETED|Persistence Phase (Month 32-44)||0
6473002|NCT01266993|7390355|FG000|STARTED|Persistence Phase (Month 44-56)||193
6473003|NCT01266993|7390356|FG001|STARTED|Persistence Phase (Month 44-56)||68
6473004|NCT01266993|7390355|FG000|COMPLETED|Persistence Phase (Month 44-56)||193
6473005|NCT01266993|7390356|FG001|COMPLETED|Persistence Phase (Month 44-56)||68
6473006|NCT01266993|7390355|FG000|NOT COMPLETED|Persistence Phase (Month 44-56)||0
6473007|NCT01266993|7390356|FG001|NOT COMPLETED|Persistence Phase (Month 44-56)||0
6473008|NCT01266993|7390355|FG000|STARTED|Persistence Phase (Month 56-68)||193
6473009|NCT01266993|7390356|FG001|STARTED|Persistence Phase (Month 56-68)||67
6473010|NCT01266993|7390355|FG000|COMPLETED|Persistence Phase (Month 56-68)||193
6473011|NCT01266993|7390356|FG001|COMPLETED|Persistence Phase (Month 56-68)||67
6473012|NCT01266993|7390355|FG000|NOT COMPLETED|Persistence Phase (Month 56-68)||0
6473013|NCT01266993|7390356|FG001|NOT COMPLETED|Persistence Phase (Month 56-68)||0
6473014|NCT01266993|7390355|FG000|STARTED|Booster Phase (Month 68-69)||179
6473015|NCT01266993|7390356|FG001|STARTED|Booster Phase (Month 68-69)||62
6473016|NCT01266993|7390355|FG000|COMPLETED|Booster Phase (Month 68-69)||174
6473017|NCT01266993|7390356|FG001|COMPLETED|Booster Phase (Month 68-69)||60
6473018|NCT01266993|7390355|FG000|NOT COMPLETED|Booster Phase (Month 68-69)||5
6473019|NCT01266993|7390356|FG001|NOT COMPLETED|Booster Phase (Month 68-69)||2
6473020|NCT01267019|7390365|FG000|STARTED|Overall Study||47
6473021|NCT01267019|7390366|FG001|STARTED|Overall Study||53
6473022|NCT01267019|7390367|FG002|STARTED|Overall Study||53
6473023|NCT01267019|7390365|FG000|COMPLETED|Overall Study||41
6473024|NCT01267019|7390366|FG001|COMPLETED|Overall Study||47
6473025|NCT01267019|7390367|FG002|COMPLETED|Overall Study||47
6473026|NCT01267019|7390365|FG000|NOT COMPLETED|Overall Study||6
6473027|NCT01267019|7390366|FG001|NOT COMPLETED|Overall Study||6
6473028|NCT01267019|7390367|FG002|NOT COMPLETED|Overall Study||6
6473029|NCT01267045|7390377|FG000|STARTED|2-month Outcomes||26
6473030|NCT01267045|7390378|FG001|STARTED|2-month Outcomes||29
6473031|NCT01267045|7390377|FG000|COMPLETED|2-month Outcomes||22
6473032|NCT01267045|7390378|FG001|COMPLETED|2-month Outcomes||26
6473033|NCT01267045|7390377|FG000|NOT COMPLETED|2-month Outcomes||4
6473034|NCT01267045|7390378|FG001|NOT COMPLETED|2-month Outcomes||3
6473035|NCT01267045|7390377|FG000|STARTED|6-month Outcome||22
6473036|NCT01267045|7390378|FG001|STARTED|6-month Outcome||26
6473037|NCT01267045|7390377|FG000|COMPLETED|6-month Outcome||22
6473038|NCT01267045|7390378|FG001|COMPLETED|6-month Outcome||23
6473039|NCT01267045|7390377|FG000|NOT COMPLETED|6-month Outcome||0
6473040|NCT01267045|7390378|FG001|NOT COMPLETED|6-month Outcome||3
6473041|NCT01267136|7390387|FG000|STARTED|Overall Study||42
6473042|NCT01267136|7390388|FG001|STARTED|Overall Study||42
6473043|NCT01267136|7390387|FG000|COMPLETED|Overall Study||38
6473044|NCT01267136|7390388|FG001|COMPLETED|Overall Study||36
6473045|NCT01267136|7390387|FG000|NOT COMPLETED|Overall Study||4
6473046|NCT01267136|7390388|FG001|NOT COMPLETED|Overall Study||6
6473047|NCT01267175|7390396|FG000|STARTED|Overall Study||31
6473048|NCT01267175|7390396|FG000|COMPLETED|Overall Study||29
6473049|NCT01267175|7390396|FG000|NOT COMPLETED|Overall Study||2
6746814|NCT03379506|7674507|FG001|COMPLETED|Overall Study||17
6746815|NCT03379506|7674508|FG002|COMPLETED|Overall Study||7
6746816|NCT03379506|7674509|FG003|COMPLETED|Overall Study||11
6746817|NCT03379506|7674506|FG000|NOT COMPLETED|Overall Study||0
6746818|NCT03379506|7674507|FG001|NOT COMPLETED|Overall Study||0
6746819|NCT03379506|7674508|FG002|NOT COMPLETED|Overall Study||0
6746820|NCT03379506|7674509|FG003|NOT COMPLETED|Overall Study||0
6746821|NCT03379545|7674519|FG000|STARTED|Overall Study||29
6746822|NCT03379545|7674519|FG000|COMPLETED|Overall Study||29
6746823|NCT03379545|7674519|FG000|NOT COMPLETED|Overall Study||0
6746824|NCT03379662|7674526|FG000|STARTED|Overall Study||21
6746825|NCT03379662|7674527|FG001|STARTED|Overall Study||19
6746826|NCT03379662|7674526|FG000|COMPLETED|Overall Study||21
6746827|NCT03379662|7674527|FG001|COMPLETED|Overall Study||19
6746828|NCT03379662|7674526|FG000|NOT COMPLETED|Overall Study||0
6746829|NCT03379662|7674527|FG001|NOT COMPLETED|Overall Study||0
6746830|NCT03379740|7674535|FG000|STARTED|Overall Study||8
6746831|NCT03379740|7674536|FG001|STARTED|Overall Study||7
6746832|NCT03379740|7674535|FG000|COMPLETED|Overall Study||8
6746833|NCT03379740|7674536|FG001|COMPLETED|Overall Study||7
6746834|NCT03379740|7674535|FG000|NOT COMPLETED|Overall Study||0
6746835|NCT03379740|7674536|FG001|NOT COMPLETED|Overall Study||0
6746836|NCT03379753|7674551|FG000|STARTED|Overall Study||61
6746837|NCT03379753|7674552|FG001|STARTED|Overall Study||71
6746838|NCT03379753|7674551|FG000|COMPLETED|Overall Study||46
6746839|NCT03379753|7674552|FG001|COMPLETED|Overall Study||46
6746840|NCT03379753|7674551|FG000|NOT COMPLETED|Overall Study||15
6746841|NCT03379753|7674552|FG001|NOT COMPLETED|Overall Study||25
6746842|NCT03380000|7674558|FG000|STARTED|First Intervention (1day)||8
6746843|NCT03380000|7674559|FG001|STARTED|First Intervention (1day)||8
6746844|NCT03380000|7674558|FG000|COMPLETED|First Intervention (1day)||8
6746845|NCT03380000|7674559|FG001|COMPLETED|First Intervention (1day)||8
6746846|NCT03380000|7674558|FG000|NOT COMPLETED|First Intervention (1day)||0
6746847|NCT03380000|7674559|FG001|NOT COMPLETED|First Intervention (1day)||0
6746848|NCT03380000|7674558|FG000|STARTED|Washout (>7days)||8
6746849|NCT03380000|7674559|FG001|STARTED|Washout (>7days)||8
6746850|NCT03380000|7674558|FG000|COMPLETED|Washout (>7days)||8
6746851|NCT03380000|7674559|FG001|COMPLETED|Washout (>7days)||8
6746852|NCT03380000|7674558|FG000|NOT COMPLETED|Washout (>7days)||0
6746853|NCT03380000|7674559|FG001|NOT COMPLETED|Washout (>7days)||0
6746854|NCT03380000|7674558|FG000|STARTED|Second Intervention (1day)||8
6746855|NCT03380000|7674559|FG001|STARTED|Second Intervention (1day)||8
6746856|NCT03380000|7674558|FG000|COMPLETED|Second Intervention (1day)||8
6746857|NCT03380000|7674559|FG001|COMPLETED|Second Intervention (1day)||8
6746858|NCT03380000|7674558|FG000|NOT COMPLETED|Second Intervention (1day)||0
6746859|NCT03380000|7674559|FG001|NOT COMPLETED|Second Intervention (1day)||0
6746860|NCT03380026|7674565|FG000|STARTED|Overall Study||28
6473050|NCT01267201|7390400|FG000|STARTED|First Intervention Period||4
6473051|NCT01267201|7390401|FG001|STARTED|First Intervention Period||4
6473052|NCT01267201|7390402|FG002|STARTED|First Intervention Period||4
6473053|NCT01267201|7390403|FG003|STARTED|First Intervention Period||4
6746861|NCT03380026|7674565|FG000|Half of Body Assigned to Treatment With Valchlor Only|Overall Study||28
6746862|NCT03380026|7674565|FG000|Half of Body Assigned to Treatment With Valchlor and Triamcinolone Acetonide|Overall Study||28
6473054|NCT01267201|7390404|FG004|STARTED|First Intervention Period||4
6473055|NCT01267201|7390405|FG005|STARTED|First Intervention Period||4
6473056|NCT01267201|7390400|FG000|COMPLETED|First Intervention Period||3
6473057|NCT01267201|7390401|FG001|COMPLETED|First Intervention Period||4
6473058|NCT01267201|7390402|FG002|COMPLETED|First Intervention Period||4
6473059|NCT01267201|7390403|FG003|COMPLETED|First Intervention Period||4
6473060|NCT01267201|7390404|FG004|COMPLETED|First Intervention Period||4
6473061|NCT01267201|7390405|FG005|COMPLETED|First Intervention Period||4
6473062|NCT01267201|7390400|FG000|NOT COMPLETED|First Intervention Period||1
6473063|NCT01267201|7390401|FG001|NOT COMPLETED|First Intervention Period||0
6473064|NCT01267201|7390402|FG002|NOT COMPLETED|First Intervention Period||0
6473065|NCT01267201|7390403|FG003|NOT COMPLETED|First Intervention Period||0
6473066|NCT01267201|7390404|FG004|NOT COMPLETED|First Intervention Period||0
6473067|NCT01267201|7390405|FG005|NOT COMPLETED|First Intervention Period||0
6473068|NCT01267201|7390400|FG000|STARTED|Washout Period (At Least 2 Days)||3
6473069|NCT01267201|7390401|FG001|STARTED|Washout Period (At Least 2 Days)||4
6473070|NCT01267201|7390402|FG002|STARTED|Washout Period (At Least 2 Days)||4
6473071|NCT01267201|7390403|FG003|STARTED|Washout Period (At Least 2 Days)||4
6473072|NCT01267201|7390404|FG004|STARTED|Washout Period (At Least 2 Days)||4
6473073|NCT01267201|7390405|FG005|STARTED|Washout Period (At Least 2 Days)||4
6473074|NCT01267201|7390400|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
6473075|NCT01267201|7390401|FG001|COMPLETED|Washout Period (At Least 2 Days)||4
6473076|NCT01267201|7390402|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
6473077|NCT01267201|7390403|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
6554465|NCT01746940|7476595|FG002|STARTED|Safety Second Phase||0
6554466|NCT01746940|7476596|FG003|STARTED|Safety Second Phase||0
6554467|NCT01746940|7476593|FG000|COMPLETED|Safety Second Phase||18
6554468|NCT01746940|7476594|FG001|COMPLETED|Safety Second Phase||18
6554469|NCT01746940|7476595|FG002|COMPLETED|Safety Second Phase||0
6554470|NCT01746940|7476596|FG003|COMPLETED|Safety Second Phase||0
6554471|NCT01746940|7476593|FG000|NOT COMPLETED|Safety Second Phase||0
6554472|NCT01746940|7476594|FG001|NOT COMPLETED|Safety Second Phase||0
6473078|NCT01267201|7390404|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
6473079|NCT01267201|7390405|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
6473080|NCT01267201|7390400|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473081|NCT01267201|7390401|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473082|NCT01267201|7390402|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473083|NCT01267201|7390403|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473084|NCT01267201|7390404|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473085|NCT01267201|7390405|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473086|NCT01267201|7390400|FG000|STARTED|Second Intervention Period||3
6473087|NCT01267201|7390401|FG001|STARTED|Second Intervention Period||4
6473088|NCT01267201|7390402|FG002|STARTED|Second Intervention Period||4
6473089|NCT01267201|7390403|FG003|STARTED|Second Intervention Period||4
6473090|NCT01267201|7390404|FG004|STARTED|Second Intervention Period||4
6473091|NCT01267201|7390405|FG005|STARTED|Second Intervention Period||4
6473092|NCT01267201|7390400|FG000|COMPLETED|Second Intervention Period||3
6473093|NCT01267201|7390401|FG001|COMPLETED|Second Intervention Period||3
6473094|NCT01267201|7390402|FG002|COMPLETED|Second Intervention Period||4
6473095|NCT01267201|7390403|FG003|COMPLETED|Second Intervention Period||4
6473096|NCT01267201|7390404|FG004|COMPLETED|Second Intervention Period||4
6473097|NCT01267201|7390405|FG005|COMPLETED|Second Intervention Period||4
6473098|NCT01267201|7390400|FG000|NOT COMPLETED|Second Intervention Period||0
6473099|NCT01267201|7390401|FG001|NOT COMPLETED|Second Intervention Period||1
6473100|NCT01267201|7390402|FG002|NOT COMPLETED|Second Intervention Period||0
6473101|NCT01267201|7390403|FG003|NOT COMPLETED|Second Intervention Period||0
6473102|NCT01267201|7390404|FG004|NOT COMPLETED|Second Intervention Period||0
6473103|NCT01267201|7390405|FG005|NOT COMPLETED|Second Intervention Period||0
6473104|NCT01267201|7390400|FG000|STARTED|Washout Period (At Least 2 Days)||3
6473105|NCT01267201|7390401|FG001|STARTED|Washout Period (At Least 2 Days)||3
6473106|NCT01267201|7390402|FG002|STARTED|Washout Period (At Least 2 Days)||4
6473107|NCT01267201|7390403|FG003|STARTED|Washout Period (At Least 2 Days)||4
6473108|NCT01267201|7390404|FG004|STARTED|Washout Period (At Least 2 Days)||4
6473109|NCT01267201|7390405|FG005|STARTED|Washout Period (At Least 2 Days)||4
6473110|NCT01267201|7390400|FG000|COMPLETED|Washout Period (At Least 2 Days)||3
6473111|NCT01267201|7390401|FG001|COMPLETED|Washout Period (At Least 2 Days)||3
6473112|NCT01267201|7390402|FG002|COMPLETED|Washout Period (At Least 2 Days)||4
6473113|NCT01267201|7390403|FG003|COMPLETED|Washout Period (At Least 2 Days)||4
6473114|NCT01267201|7390404|FG004|COMPLETED|Washout Period (At Least 2 Days)||4
6473115|NCT01267201|7390405|FG005|COMPLETED|Washout Period (At Least 2 Days)||4
6473116|NCT01267201|7390400|FG000|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473117|NCT01267201|7390401|FG001|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473118|NCT01267201|7390402|FG002|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473119|NCT01267201|7390403|FG003|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473120|NCT01267201|7390404|FG004|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473121|NCT01267201|7390405|FG005|NOT COMPLETED|Washout Period (At Least 2 Days)||0
6473122|NCT01267201|7390400|FG000|STARTED|Third Intervention Period||3
6473123|NCT01267201|7390401|FG001|STARTED|Third Intervention Period||3
6554473|NCT01746940|7476595|FG002|NOT COMPLETED|Safety Second Phase||0
6554474|NCT01746940|7476596|FG003|NOT COMPLETED|Safety Second Phase||0
6473124|NCT01267201|7390402|FG002|STARTED|Third Intervention Period||4
6473125|NCT01267201|7390403|FG003|STARTED|Third Intervention Period||4
6473126|NCT01267201|7390404|FG004|STARTED|Third Intervention Period||4
6473127|NCT01267201|7390405|FG005|STARTED|Third Intervention Period||4
6473128|NCT01267201|7390400|FG000|COMPLETED|Third Intervention Period||3
6473129|NCT01267201|7390401|FG001|COMPLETED|Third Intervention Period||3
6473130|NCT01267201|7390402|FG002|COMPLETED|Third Intervention Period||4
6473131|NCT01267201|7390403|FG003|COMPLETED|Third Intervention Period||4
6473132|NCT01267201|7390404|FG004|COMPLETED|Third Intervention Period||4
6473133|NCT01267201|7390405|FG005|COMPLETED|Third Intervention Period||4
6473134|NCT01267201|7390400|FG000|NOT COMPLETED|Third Intervention Period||0
6473135|NCT01267201|7390401|FG001|NOT COMPLETED|Third Intervention Period||0
6473136|NCT01267201|7390402|FG002|NOT COMPLETED|Third Intervention Period||0
6473137|NCT01267201|7390403|FG003|NOT COMPLETED|Third Intervention Period||0
6473138|NCT01267201|7390404|FG004|NOT COMPLETED|Third Intervention Period||0
6473139|NCT01267201|7390405|FG005|NOT COMPLETED|Third Intervention Period||0
6473140|NCT01267227|7390417|FG000|STARTED|Overall Study||20
6473141|NCT01267227|7390418|FG001|STARTED|Overall Study||20
6473142|NCT01267227|7390419|FG002|STARTED|Overall Study||20
6473143|NCT01267227|7390420|FG003|STARTED|Overall Study||20
6473144|NCT01267227|7390417|FG000|COMPLETED|Overall Study||19
6473145|NCT01267227|7390418|FG001|COMPLETED|Overall Study||19
6473146|NCT01267227|7390419|FG002|COMPLETED|Overall Study||18
6473147|NCT01267227|7390420|FG003|COMPLETED|Overall Study||17
6473148|NCT01267227|7390417|FG000|NOT COMPLETED|Overall Study||1
6473149|NCT01267227|7390418|FG001|NOT COMPLETED|Overall Study||1
6473150|NCT01267227|7390419|FG002|NOT COMPLETED|Overall Study||2
6473151|NCT01267227|7390420|FG003|NOT COMPLETED|Overall Study||3
6473152|NCT01267240|7390434|FG000|STARTED|Overall Study||25
6473153|NCT01267240|7390434|FG000|COMPLETED|Overall Study||25
6473154|NCT01267240|7390434|FG000|NOT COMPLETED|Overall Study||0
6473155|NCT01267253|7390438|FG000|STARTED|Overall Study||31
6473156|NCT01267253|7390438|FG000|COMPLETED|Overall Study|Eligible and treated patients|28
6473157|NCT01267253|7390438|FG000|NOT COMPLETED|Overall Study||3
6473158|NCT01267266|7390442|FG000|STARTED|Enrollment Phase||33
6473159|NCT01267266|7390443|FG001|STARTED|Enrollment Phase||0
6473160|NCT01267266|7390442|FG000|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
6473161|NCT01267266|7390443|FG001|COMPLETED|Enrollment Phase||0
6473162|NCT01267266|7390442|FG000|NOT COMPLETED|Enrollment Phase||2
6473163|NCT01267266|7390443|FG001|NOT COMPLETED|Enrollment Phase||0
6473164|NCT01267266|7390442|FG000|STARTED|Lead-in Phase||31
6473165|NCT01267266|7390443|FG001|STARTED|Lead-in Phase||0
6473166|NCT01267266|7390442|FG000|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
6473167|NCT01267266|7390443|FG001|COMPLETED|Lead-in Phase||0
6473168|NCT01267266|7390442|FG000|NOT COMPLETED|Lead-in Phase||23
6473169|NCT01267266|7390443|FG001|NOT COMPLETED|Lead-in Phase||0
6473170|NCT01267266|7390442|FG000|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
6473171|NCT01267266|7390443|FG001|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
6473172|NCT01267266|7390442|FG000|COMPLETED|Randomized Phase||3
6473173|NCT01267266|7390443|FG001|COMPLETED|Randomized Phase||5
6473174|NCT01267266|7390442|FG000|NOT COMPLETED|Randomized Phase||0
6473175|NCT01267266|7390443|FG001|NOT COMPLETED|Randomized Phase||0
6473176|NCT01267279|7390454|FG000|STARTED|Overall Study||24
6473177|NCT01267279|7390455|FG001|STARTED|Overall Study||27
6473178|NCT01267279|7390454|FG000|COMPLETED|Overall Study||22
6473179|NCT01267279|7390455|FG001|COMPLETED|Overall Study||21
6473180|NCT01267279|7390454|FG000|NOT COMPLETED|Overall Study||2
6473181|NCT01267279|7390455|FG001|NOT COMPLETED|Overall Study||6
6473182|NCT01267292|7390463|FG000|STARTED|Overall Study||24
6473183|NCT01267292|7390464|FG001|STARTED|Overall Study||26
6473184|NCT01267292|7390463|FG000|COMPLETED|Overall Study||20
6473185|NCT01267292|7390464|FG001|COMPLETED|Overall Study||20
6473186|NCT01267292|7390463|FG000|NOT COMPLETED|Overall Study||4
6473187|NCT01267292|7390464|FG001|NOT COMPLETED|Overall Study||6
6473188|NCT01267422|7390470|FG000|STARTED|Intravitreal rAAV2-ND4 Injection||5
6473189|NCT01267422|7390471|FG001|STARTED|Intravitreal rAAV2-ND4 Injection||4
6473190|NCT01267422|7390470|FG000|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
6654554|NCT02446717|7584413|FG000|COMPLETED|Overall Study||6
6654555|NCT02446717|7584414|FG001|COMPLETED|Overall Study||21
6473191|NCT01267422|7390471|FG001|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
6473192|NCT01267422|7390470|FG000|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
6473193|NCT01267422|7390471|FG001|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
6473194|NCT01267422|7390470|FG000|STARTED|Safety and Efficacy Study||5
6554475|NCT01746979|7476606|FG000|STARTED|Overall Study||346
6554476|NCT01746979|7476607|FG001|STARTED|Overall Study||347
6554477|NCT01746979|7476606|FG000|COMPLETED|Overall Study||0
6554478|NCT01746979|7476607|FG001|COMPLETED|Overall Study||0
6473195|NCT01267422|7390471|FG001|STARTED|Safety and Efficacy Study||4
6473196|NCT01267422|7390470|FG000|COMPLETED|Safety and Efficacy Study||5
6473197|NCT01267422|7390471|FG001|COMPLETED|Safety and Efficacy Study||4
6473198|NCT01267422|7390470|FG000|NOT COMPLETED|Safety and Efficacy Study||0
6473199|NCT01267422|7390471|FG001|NOT COMPLETED|Safety and Efficacy Study||0
6473200|NCT01267656|7390489|FG000|STARTED|Overall Study||83
6473201|NCT01267656|7390490|FG001|STARTED|Overall Study||83
6554479|NCT01746979|7476606|FG000|NOT COMPLETED|Overall Study||346
6554480|NCT01746979|7476607|FG001|NOT COMPLETED|Overall Study||347
6473202|NCT01267656|7390489|FG000|COMPLETED|Overall Study||82
6473203|NCT01267656|7390490|FG001|COMPLETED|Overall Study||82
6473204|NCT01267656|7390489|FG000|NOT COMPLETED|Overall Study||1
6473205|NCT01267656|7390490|FG001|NOT COMPLETED|Overall Study||1
6473206|NCT01267864|7390499|FG000|STARTED|Overall Study||110
6473207|NCT01267864|7390500|FG001|STARTED|Overall Study||110
6473208|NCT01267864|7390501|FG002|STARTED|Overall Study||110
6473209|NCT01267864|7390499|FG000|COMPLETED|Overall Study||110
6473210|NCT01267864|7390500|FG001|COMPLETED|Overall Study||110
6473211|NCT01267864|7390501|FG002|COMPLETED|Overall Study||110
6473212|NCT01267864|7390499|FG000|NOT COMPLETED|Overall Study||0
6473213|NCT01267864|7390500|FG001|NOT COMPLETED|Overall Study||0
6473214|NCT01267864|7390501|FG002|NOT COMPLETED|Overall Study||0
6473215|NCT01267929|7390511|FG000|STARTED|Overall Study||15
6473216|NCT01267929|7390512|FG001|STARTED|Overall Study||15
6473217|NCT01267929|7390511|FG000|COMPLETED|Overall Study||15
6473218|NCT01267929|7390512|FG001|COMPLETED|Overall Study||15
6473219|NCT01267929|7390511|FG000|NOT COMPLETED|Overall Study||0
6473220|NCT01267929|7390512|FG001|NOT COMPLETED|Overall Study||0
6473221|NCT01267994|7390518|FG000|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
6473222|NCT01267994|7390518|FG000|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
6473223|NCT01267994|7390518|FG000|NOT COMPLETED|Overall Study||2
6473224|NCT01268046|7390527|FG000|STARTED|Overall Study||13
6473225|NCT01268046|7390528|FG001|STARTED|Overall Study||9
6473226|NCT01268046|7390529|FG002|STARTED|Overall Study||8
6473227|NCT01268046|7390530|FG003|STARTED|Overall Study||8
6473228|NCT01268046|7390527|FG000|COMPLETED|Overall Study||12
6473229|NCT01268046|7390528|FG001|COMPLETED|Overall Study||9
6473230|NCT01268046|7390529|FG002|COMPLETED|Overall Study||7
6473231|NCT01268046|7390530|FG003|COMPLETED|Overall Study||7
6473232|NCT01268046|7390527|FG000|NOT COMPLETED|Overall Study||1
6473233|NCT01268046|7390528|FG001|NOT COMPLETED|Overall Study||0
6473234|NCT01268046|7390529|FG002|NOT COMPLETED|Overall Study||1
6473235|NCT01268046|7390530|FG003|NOT COMPLETED|Overall Study||1
6473236|NCT01268059|7390544|FG000|STARTED|Overall Study||40
6473237|NCT01268059|7390545|FG001|STARTED|Overall Study|Arm applicable for both dose-determination (Phase 1b) and randomization phase (Phase 2) of study.|45
6473238|NCT01268059|7390546|FG002|STARTED|Overall Study||6
6473239|NCT01268059|7390547|FG003|STARTED|Overall Study||8
6473240|NCT01268059|7390544|FG000|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|12
6473241|NCT01268059|7390545|FG001|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|10
6473242|NCT01268059|7390546|FG002|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
6473243|NCT01268059|7390547|FG003|COMPLETED|Overall Study|End of study defined as 14 months from the last participant enrolled, or sponsor stopped the study.|3
6473244|NCT01268059|7390544|FG000|NOT COMPLETED|Overall Study||28
6473245|NCT01268059|7390545|FG001|NOT COMPLETED|Overall Study||35
6473246|NCT01268059|7390546|FG002|NOT COMPLETED|Overall Study||3
6473247|NCT01268059|7390547|FG003|NOT COMPLETED|Overall Study||5
6473248|NCT01268098|7390562|FG000|STARTED|Overall Study||19
6473249|NCT01268098|7390563|FG001|STARTED|Overall Study||23
6473250|NCT01268098|7390562|FG000|COMPLETED|Overall Study||18
6473251|NCT01268098|7390563|FG001|COMPLETED|Overall Study||23
6473252|NCT01268098|7390562|FG000|NOT COMPLETED|Overall Study||1
6473253|NCT01268098|7390563|FG001|NOT COMPLETED|Overall Study||0
6473254|NCT01268111|7390571|FG000|STARTED|Overall Study||6
6473255|NCT01268111|7390572|FG001|STARTED|Overall Study||6
6473256|NCT01268111|7390571|FG000|COMPLETED|Overall Study||6
6473257|NCT01268111|7390572|FG001|COMPLETED|Overall Study||6
6473258|NCT01268111|7390571|FG000|NOT COMPLETED|Overall Study||0
6473259|NCT01268111|7390572|FG001|NOT COMPLETED|Overall Study||0
6473260|NCT01268150|7390578|FG000|STARTED|Treatment Phase||56
6473261|NCT01268150|7390578|FG000|COMPLETED|Treatment Phase||28
6473262|NCT01268150|7390578|FG000|NOT COMPLETED|Treatment Phase||28
6473263|NCT01268150|7390578|FG000|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
6473264|NCT01268150|7390578|FG000|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
6473265|NCT01268150|7390578|FG000|COMPLETED|Extension Phase||1
6473266|NCT01268150|7390578|FG000|NOT COMPLETED|Extension Phase||27
6473267|NCT01268189|7390582|FG000|STARTED|Overall Study||20
6473268|NCT01268189|7390582|FG000|COMPLETED|Overall Study||17
6473269|NCT01268189|7390582|FG000|NOT COMPLETED|Overall Study||3
6473270|NCT01268267|7390588|FG000|STARTED|Overall Study||94
6473271|NCT01268267|7390588|FG000|COMPLETED|Overall Study||93
6473272|NCT01268267|7390588|FG000|NOT COMPLETED|Overall Study||1
6473273|NCT01268293|7390593|FG000|STARTED|Overall Study||9
6473274|NCT01268293|7390593|FG000|Completed Cycle 1|Overall Study||9
6473275|NCT01268293|7390593|FG000|COMPLETED|Overall Study||0
6473276|NCT01268293|7390593|FG000|NOT COMPLETED|Overall Study||9
6473277|NCT01268306|7390597|FG000|STARTED|Overall Study||8
6473278|NCT01268306|7390597|FG000|COMPLETED|Overall Study||7
6473279|NCT01268306|7390597|FG000|NOT COMPLETED|Overall Study||1
6473280|NCT01268488|7390601|FG000|STARTED|Overall Study||98
6473281|NCT01268488|7390601|FG000|COMPLETED|Overall Study||93
6473282|NCT01268488|7390601|FG000|NOT COMPLETED|Overall Study||5
6473283|NCT01268501|7390606|FG000|STARTED|Overall Study||96
6473284|NCT01268501|7390606|FG000|COMPLETED|Overall Study||87
6473285|NCT01268501|7390606|FG000|NOT COMPLETED|Overall Study||9
6746863|NCT03380026|7674565|FG000|COMPLETED|Overall Study||25
6746864|NCT03380026|7674565|FG000|NOT COMPLETED|Overall Study||3
6746865|NCT03380091|7674574|FG000|STARTED|Overall Study||3
6746866|NCT03380091|7674575|FG001|STARTED|Overall Study||2
6746867|NCT03380091|7674574|FG000|Began Arm Treatment|Overall Study|1 participant withdrew after completing baseline measures and another withdrew just after enrolling.|1
6554481|NCT01747330|7476613|FG000|STARTED|Overall Study||40
6554482|NCT01747330|7476613|FG000|COMPLETED|Overall Study||40
6554483|NCT01747330|7476613|FG000|NOT COMPLETED|Overall Study||0
6746868|NCT03380091|7674575|FG001|Began Arm Treatment|Overall Study|1 of the 2 participant assigned to Metformin withdrew from the study just after enrolling.|1
6746869|NCT03380091|7674574|FG000|COMPLETED|Overall Study||1
6473286|NCT01268514|7390610|FG000|STARTED|Overall Study||115
6473287|NCT01268514|7390610|FG000|Participants Who Received the Device|Overall Study||114
6473288|NCT01268514|7390610|FG000|COMPLETED|Overall Study||74
6473289|NCT01268514|7390610|FG000|NOT COMPLETED|Overall Study||41
6473290|NCT01268527|7390618|FG000|STARTED|Overall Study||15
6473291|NCT01268527|7390619|FG001|STARTED|Overall Study||15
6473292|NCT01268527|7390618|FG000|COMPLETED|Overall Study||15
6473293|NCT01268527|7390619|FG001|COMPLETED|Overall Study||15
6473294|NCT01268527|7390618|FG000|NOT COMPLETED|Overall Study||0
6473295|NCT01268527|7390619|FG001|NOT COMPLETED|Overall Study||0
6473296|NCT01268553|7390638|FG000|STARTED|Overall Study||6
6473297|NCT01268553|7390638|FG000|COMPLETED|Overall Study||6
6473298|NCT01268553|7390638|FG000|NOT COMPLETED|Overall Study||0
6473299|NCT01268566|7390642|FG000|STARTED|Overall Study||56
6473300|NCT01268566|7390642|FG000|COMPLETED|Overall Study||13
6473301|NCT01268566|7390642|FG000|NOT COMPLETED|Overall Study||43
6473302|NCT01268644|7390646|FG000|STARTED|Baseline Period (Week 0)||8
6473303|NCT01268644|7390646|FG000|COMPLETED|Baseline Period (Week 0)||8
6473304|NCT01268644|7390646|FG000|NOT COMPLETED|Baseline Period (Week 0)||0
6473305|NCT01268644|7390646|FG000|STARTED|Phase A (Weeks 0-12) Leptin Therapy||8
6473306|NCT01268644|7390646|FG000|COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||8
6473307|NCT01268644|7390646|FG000|NOT COMPLETED|Phase A (Weeks 0-12) Leptin Therapy||0
6473308|NCT01268644|7390646|FG000|STARTED|Phase B (Weeks 12-20) Leptin Therapy|One subject withdrew after 12 weeks .|7
6473309|NCT01268644|7390646|FG000|COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||7
6473310|NCT01268644|7390646|FG000|NOT COMPLETED|Phase B (Weeks 12-20) Leptin Therapy||0
6473311|NCT01268644|7390646|FG000|STARTED|Phase C (Weeks 20-24) Off Leptin Therapy||7
6473312|NCT01268644|7390646|FG000|COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||7
6473313|NCT01268644|7390646|FG000|NOT COMPLETED|Phase C (Weeks 20-24) Off Leptin Therapy||0
6473314|NCT01268683|7390653|FG000|STARTED|Overall Study||10
6473315|NCT01268683|7390653|FG000|COMPLETED|Overall Study||8
6473316|NCT01268683|7390653|FG000|NOT COMPLETED|Overall Study||2
6473317|NCT01268891|7390659|FG000|STARTED|Overall Study||66
6554484|NCT01747343|7476617|FG000|STARTED|Baseline||4
6554485|NCT01747343|7476617|FG000|COMPLETED|Baseline||4
6554486|NCT01747343|7476617|FG000|NOT COMPLETED|Baseline||0
6554487|NCT01747343|7476617|FG000|STARTED|Underwear||4
6554488|NCT01747343|7476617|FG000|COMPLETED|Underwear||4
6554489|NCT01747343|7476617|FG000|NOT COMPLETED|Underwear||0
6473318|NCT01268891|7390660|FG001|STARTED|Overall Study||66
6473319|NCT01268891|7390659|FG000|COMPLETED|Overall Study||58
6473320|NCT01268891|7390660|FG001|COMPLETED|Overall Study||58
6473321|NCT01268891|7390659|FG000|NOT COMPLETED|Overall Study||8
6473322|NCT01268891|7390660|FG001|NOT COMPLETED|Overall Study||8
6473323|NCT01268943|7390670|FG000|STARTED|Overall Study||6
6473324|NCT01268943|7390671|FG001|STARTED|Overall Study||3
6473325|NCT01268943|7390672|FG002|STARTED|Overall Study||3
6473326|NCT01268943|7390673|FG003|STARTED|Overall Study||6
6473327|NCT01268943|7390670|FG000|COMPLETED|Overall Study||6
6473328|NCT01268943|7390671|FG001|COMPLETED|Overall Study||3
6473329|NCT01268943|7390672|FG002|COMPLETED|Overall Study||3
6473330|NCT01268943|7390673|FG003|COMPLETED|Overall Study||6
6473331|NCT01268943|7390670|FG000|NOT COMPLETED|Overall Study||0
6473332|NCT01268943|7390671|FG001|NOT COMPLETED|Overall Study||0
6473333|NCT01268943|7390672|FG002|NOT COMPLETED|Overall Study||0
6473334|NCT01268943|7390673|FG003|NOT COMPLETED|Overall Study||0
6473335|NCT01269047|7390686|FG000|STARTED|Overall Study||13
6473336|NCT01269047|7390687|FG001|STARTED|Overall Study||13
6473337|NCT01269047|7390688|FG002|STARTED|Overall Study||11
6473338|NCT01269047|7390686|FG000|COMPLETED|Overall Study||12
6473339|NCT01269047|7390687|FG001|COMPLETED|Overall Study||11
6473340|NCT01269047|7390688|FG002|COMPLETED|Overall Study||10
6473341|NCT01269047|7390686|FG000|NOT COMPLETED|Overall Study||1
6473342|NCT01269047|7390687|FG001|NOT COMPLETED|Overall Study||2
6473343|NCT01269047|7390688|FG002|NOT COMPLETED|Overall Study||1
6473344|NCT01269125|7390701|FG000|STARTED|Overall Study||60
6473345|NCT01269125|7390702|FG001|STARTED|Overall Study||60
6554490|NCT01747343|7476617|FG000|STARTED|Underwear/Differential Reinforcement||4
6554491|NCT01747343|7476617|FG000|COMPLETED|Underwear/Differential Reinforcement||4
6554492|NCT01747343|7476617|FG000|NOT COMPLETED|Underwear/Differential Reinforcement||0
6554493|NCT01747486|7476623|FG000|STARTED|Stage 1||15
6554494|NCT01747486|7476624|FG001|STARTED|Stage 1||15
6554495|NCT01747486|7476623|FG000|COMPLETED|Stage 1||3
6473346|NCT01269125|7390703|FG002|STARTED|Overall Study||60
6473347|NCT01269125|7390701|FG000|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
6473348|NCT01269125|7390702|FG001|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
6554496|NCT01747486|7476624|FG001|COMPLETED|Stage 1||2
6473349|NCT01269125|7390703|FG002|COMPLETED|Overall Study||60
6473350|NCT01269125|7390701|FG000|NOT COMPLETED|Overall Study||7
6473351|NCT01269125|7390702|FG001|NOT COMPLETED|Overall Study||5
6473352|NCT01269125|7390703|FG002|NOT COMPLETED|Overall Study||0
6473353|NCT01269346|7390711|FG000|STARTED|Treatment Phase||52
6473354|NCT01269346|7390711|FG000|Completed 6 Cycles|Treatment Phase||45
6473355|NCT01269346|7390711|FG000|COMPLETED|Treatment Phase||43
6473356|NCT01269346|7390711|FG000|NOT COMPLETED|Treatment Phase||9
6473357|NCT01269346|7390711|FG000|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
6473358|NCT01269346|7390711|FG000|COMPLETED|Extension Phase||0
6473359|NCT01269346|7390711|FG000|NOT COMPLETED|Extension Phase||43
6473360|NCT01269372|7390716|FG000|STARTED|Overall Study||30
6473361|NCT01269372|7390716|FG000|COMPLETED|Overall Study||30
6473362|NCT01269372|7390716|FG000|NOT COMPLETED|Overall Study||0
6473363|NCT01269385|7390725|FG000|STARTED|Overall Study||4
6473364|NCT01269385|7390726|FG001|STARTED|Overall Study||4
6473365|NCT01269385|7390727|FG002|STARTED|Overall Study||6
6473366|NCT01269385|7390728|FG003|STARTED|Overall Study||8
6473367|NCT01269385|7390725|FG000|COMPLETED|Overall Study||3
6473368|NCT01269385|7390726|FG001|COMPLETED|Overall Study||3
6473369|NCT01269385|7390727|FG002|COMPLETED|Overall Study||6
6473370|NCT01269385|7390728|FG003|COMPLETED|Overall Study||8
6473371|NCT01269385|7390725|FG000|NOT COMPLETED|Overall Study||1
6473372|NCT01269385|7390726|FG001|NOT COMPLETED|Overall Study||1
6473373|NCT01269385|7390727|FG002|NOT COMPLETED|Overall Study||0
6473374|NCT01269385|7390728|FG003|NOT COMPLETED|Overall Study||0
6473375|NCT01269710|7390738|FG000|STARTED|Overall Study||4
6473376|NCT01269710|7390738|FG000|Week 12|Overall Study||3
6473377|NCT01269710|7390738|FG000|Week 36|Overall Study||2
6473378|NCT01269710|7390738|FG000|COMPLETED|Overall Study|This refers to Week 52.|1
6473379|NCT01269710|7390738|FG000|NOT COMPLETED|Overall Study||3
6473380|NCT01269736|7390744|FG000|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
6473381|NCT01269736|7390745|FG001|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
6473382|NCT01269736|7390744|FG000|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
6473383|NCT01269736|7390745|FG001|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
6473384|NCT01269736|7390744|FG000|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
6473385|NCT01269736|7390745|FG001|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
6554497|NCT01747486|7476623|FG000|NOT COMPLETED|Stage 1||12
6554498|NCT01747486|7476624|FG001|NOT COMPLETED|Stage 1||13
6554499|NCT01747486|7476623|FG000|STARTED|Stage 2||12
6554500|NCT01747486|7476624|FG001|STARTED|Stage 2||0
6554501|NCT01747486|7476623|FG000|COMPLETED|Stage 2||3
6554502|NCT01747486|7476624|FG001|COMPLETED|Stage 2||0
6473386|NCT01269736|7390744|FG000|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
6473387|NCT01269736|7390745|FG001|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
6473388|NCT01269736|7390744|FG000|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
6473389|NCT01269736|7390745|FG001|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
6473390|NCT01269736|7390744|FG000|NOT COMPLETED|Nurses' Knowledge Assessments||0
6473391|NCT01269736|7390745|FG001|NOT COMPLETED|Nurses' Knowledge Assessments||0
6473392|NCT01269736|7390744|FG000|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
6473393|NCT01269736|7390745|FG001|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
6473394|NCT01269736|7390744|FG000|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
6473395|NCT01269736|7390745|FG001|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
6473396|NCT01269736|7390744|FG000|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
6473397|NCT01269736|7390745|FG001|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
6473398|NCT01269736|7390744|FG000|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
6473399|NCT01269736|7390745|FG001|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
6473400|NCT01269736|7390744|FG000|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
6473401|NCT01269736|7390745|FG001|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
6473402|NCT01269736|7390744|FG000|NOT COMPLETED|Patient Quality of Care Assessments||0
6473403|NCT01269736|7390745|FG001|NOT COMPLETED|Patient Quality of Care Assessments||0
6473404|NCT01269736|7390744|FG000|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
6473405|NCT01269736|7390745|FG001|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
6501156|NCT01427504|7419669|FG004|STARTED|Overall Study||3
6554503|NCT01747486|7476623|FG000|NOT COMPLETED|Stage 2||9
6554504|NCT01747486|7476624|FG001|NOT COMPLETED|Stage 2||0
6554505|NCT01747499|7476635|FG000|STARTED|Overall Study||3
6554506|NCT01747499|7476636|FG001|STARTED|Overall Study||3
6554507|NCT01747499|7476637|FG002|STARTED|Overall Study||3
6554508|NCT01747499|7476638|FG003|STARTED|Overall Study||6
6554509|NCT01747499|7476639|FG004|STARTED|Overall Study||39
6554510|NCT01747499|7476635|FG000|COMPLETED|Overall Study||2
6554511|NCT01747499|7476636|FG001|COMPLETED|Overall Study||2
6554512|NCT01747499|7476637|FG002|COMPLETED|Overall Study||3
6554513|NCT01747499|7476638|FG003|COMPLETED|Overall Study||4
6554514|NCT01747499|7476639|FG004|COMPLETED|Overall Study||24
6554515|NCT01747499|7476635|FG000|NOT COMPLETED|Overall Study||1
6473406|NCT01269736|7390744|FG000|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
6473407|NCT01269736|7390745|FG001|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
6473408|NCT01269736|7390744|FG000|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
6473409|NCT01269736|7390745|FG001|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
6473410|NCT01269736|7390744|FG000|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
6473411|NCT01269736|7390745|FG001|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
6473412|NCT01269736|7390744|FG000|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
6473413|NCT01269736|7390745|FG001|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
6473414|NCT01269736|7390744|FG000|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
6473415|NCT01269736|7390745|FG001|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
6473416|NCT01269801|7390755|FG000|STARTED|Overall Study||74
6473417|NCT01269801|7390756|FG001|STARTED|Overall Study||80
6473418|NCT01269801|7390755|FG000|COMPLETED|Overall Study||74
6473419|NCT01269801|7390756|FG001|COMPLETED|Overall Study||77
6473420|NCT01269801|7390755|FG000|NOT COMPLETED|Overall Study||0
6473421|NCT01269801|7390756|FG001|NOT COMPLETED|Overall Study||3
6473422|NCT01269918|7390764|FG000|STARTED|Overall Study||71
6473423|NCT01269918|7390765|FG001|STARTED|Overall Study||71
6473424|NCT01269918|7390764|FG000|COMPLETED|Overall Study||71
6473425|NCT01269918|7390765|FG001|COMPLETED|Overall Study||68
6473426|NCT01269918|7390764|FG000|NOT COMPLETED|Overall Study||0
6473427|NCT01269918|7390765|FG001|NOT COMPLETED|Overall Study||3
6473428|NCT01270126|7390773|FG000|STARTED|Overall Study||12
6473429|NCT01270126|7390774|FG001|STARTED|Overall Study||10
6473430|NCT01270126|7390773|FG000|COMPLETED|Overall Study||12
6473431|NCT01270126|7390774|FG001|COMPLETED|Overall Study||10
6473432|NCT01270126|7390773|FG000|NOT COMPLETED|Overall Study||0
6473433|NCT01270126|7390774|FG001|NOT COMPLETED|Overall Study||0
6473434|NCT01270139|7390783|FG000|STARTED|Overall Study|Intention-to-treat population|60
6473435|NCT01270139|7390784|FG001|STARTED|Overall Study|Intention-to-treat population|60
6473436|NCT01270139|7390785|FG002|STARTED|Overall Study|Intention-to-treat population|60
6473437|NCT01270139|7390783|FG000|COMPLETED|Overall Study|Pre-treatment evaluable population|42
6473438|NCT01270139|7390784|FG001|COMPLETED|Overall Study|Pre-treatment evaluable population|34
6473439|NCT01270139|7390785|FG002|COMPLETED|Overall Study|Pre-treatment evaluable population|40
6473440|NCT01270139|7390783|FG000|NOT COMPLETED|Overall Study||18
6473441|NCT01270139|7390784|FG001|NOT COMPLETED|Overall Study||26
6473442|NCT01270139|7390785|FG002|NOT COMPLETED|Overall Study||20
6473443|NCT01270256|7390802|FG000|STARTED|Overall Study||21
6473444|NCT01270256|7390803|FG001|STARTED|Overall Study||20
6473445|NCT01270256|7390802|FG000|COMPLETED|Overall Study||20
6473446|NCT01270256|7390803|FG001|COMPLETED|Overall Study||20
6473447|NCT01270256|7390802|FG000|NOT COMPLETED|Overall Study||1
6473448|NCT01270256|7390803|FG001|NOT COMPLETED|Overall Study||0
6473449|NCT01270321|7390812|FG000|STARTED|Overall Study||19
6473450|NCT01270321|7390813|FG001|STARTED|Overall Study||11
6473451|NCT01270321|7390814|FG002|STARTED|Overall Study||12
6473452|NCT01270321|7390812|FG000|COMPLETED|Overall Study||9
6473453|NCT01270321|7390813|FG001|COMPLETED|Overall Study||1
6473454|NCT01270321|7390814|FG002|COMPLETED|Overall Study||3
6473455|NCT01270321|7390812|FG000|NOT COMPLETED|Overall Study||10
6473456|NCT01270321|7390813|FG001|NOT COMPLETED|Overall Study||10
6473457|NCT01270321|7390814|FG002|NOT COMPLETED|Overall Study||9
6473458|NCT01270464|7390825|FG000|STARTED|Overall Study||105
6473459|NCT01270464|7390826|FG001|STARTED|Overall Study||104
6473460|NCT01270464|7390827|FG002|STARTED|Overall Study||106
6473461|NCT01270464|7390825|FG000|Safety Analysis Set|Overall Study||105
6473462|NCT01270464|7390826|FG001|Safety Analysis Set|Overall Study||103
6473463|NCT01270464|7390827|FG002|Safety Analysis Set|Overall Study||103
6473464|NCT01270464|7390825|FG000|Full Analysis Set|Overall Study||105
6473465|NCT01270464|7390826|FG001|Full Analysis Set|Overall Study||103
6473466|NCT01270464|7390827|FG002|Full Analysis Set|Overall Study||103
6473467|NCT01270464|7390825|FG000|Pharmacokinetic Analysis Set|Overall Study||105
6473468|NCT01270464|7390826|FG001|Pharmacokinetic Analysis Set|Overall Study||103
6473469|NCT01270464|7390827|FG002|Pharmacokinetic Analysis Set|Overall Study||103
6473470|NCT01270464|7390825|FG000|COMPLETED|Overall Study||85
6473471|NCT01270464|7390826|FG001|COMPLETED|Overall Study||92
6473472|NCT01270464|7390827|FG002|COMPLETED|Overall Study||88
6473473|NCT01270464|7390825|FG000|NOT COMPLETED|Overall Study||20
6473474|NCT01270464|7390826|FG001|NOT COMPLETED|Overall Study||12
6473475|NCT01270464|7390827|FG002|NOT COMPLETED|Overall Study||18
6473476|NCT01270503|7390835|FG000|STARTED|Overall Study||538
6554516|NCT01747499|7476636|FG001|NOT COMPLETED|Overall Study||1
6554517|NCT01747499|7476637|FG002|NOT COMPLETED|Overall Study||0
6554518|NCT01747499|7476638|FG003|NOT COMPLETED|Overall Study||2
6473477|NCT01270503|7390835|FG000|COMPLETED|Overall Study||537
6473478|NCT01270503|7390835|FG000|NOT COMPLETED|Overall Study||1
6473479|NCT01270516|7390844|FG000|STARTED|Overall Study||20
6473480|NCT01270516|7390845|FG001|STARTED|Overall Study||17
6473481|NCT01270516|7390846|FG002|STARTED|Overall Study||18
6473482|NCT01270516|7390847|FG003|STARTED|Overall Study||18
6473483|NCT01270516|7390844|FG000|COMPLETED|Overall Study||17
6473484|NCT01270516|7390845|FG001|COMPLETED|Overall Study||13
6473485|NCT01270516|7390846|FG002|COMPLETED|Overall Study||13
6473486|NCT01270516|7390847|FG003|COMPLETED|Overall Study||13
6473487|NCT01270516|7390844|FG000|NOT COMPLETED|Overall Study||3
6473488|NCT01270516|7390845|FG001|NOT COMPLETED|Overall Study||4
6473489|NCT01270516|7390846|FG002|NOT COMPLETED|Overall Study||5
6473490|NCT01270516|7390847|FG003|NOT COMPLETED|Overall Study||5
6473491|NCT01270529|7390860|FG000|STARTED|Overall Study||12
6473492|NCT01270529|7390861|FG001|STARTED|Overall Study||7
6473493|NCT01270529|7390862|FG002|STARTED|Overall Study||25
6473494|NCT01270529|7390860|FG000|COMPLETED|Overall Study||12
6473495|NCT01270529|7390861|FG001|COMPLETED|Overall Study||7
6473496|NCT01270529|7390862|FG002|COMPLETED|Overall Study||25
6473497|NCT01270529|7390860|FG000|NOT COMPLETED|Overall Study||0
6473498|NCT01270529|7390861|FG001|NOT COMPLETED|Overall Study||0
6473499|NCT01270529|7390862|FG002|NOT COMPLETED|Overall Study||0
6473500|NCT01270542|7390872|FG000|STARTED|Overall Study||10
6473501|NCT01270542|7390873|FG001|STARTED|Overall Study||9
6473502|NCT01270542|7390872|FG000|COMPLETED|Overall Study||9
6473503|NCT01270542|7390873|FG001|COMPLETED|Overall Study||8
6473504|NCT01270542|7390872|FG000|NOT COMPLETED|Overall Study||1
6473505|NCT01270542|7390873|FG001|NOT COMPLETED|Overall Study||1
6473506|NCT01270555|7390879|FG000|STARTED|Overall Study||32
6473507|NCT01270555|7390879|FG000|COMPLETED|Overall Study||19
6473508|NCT01270555|7390879|FG000|NOT COMPLETED|Overall Study||13
6473509|NCT01270620|7390885|FG000|STARTED|Overall Study||50
6473510|NCT01270620|7390886|FG001|STARTED|Overall Study||50
6473511|NCT01270620|7390885|FG000|COMPLETED|Overall Study||49
6473512|NCT01270620|7390886|FG001|COMPLETED|Overall Study||47
6473513|NCT01270620|7390885|FG000|NOT COMPLETED|Overall Study||1
6473514|NCT01270620|7390886|FG001|NOT COMPLETED|Overall Study||3
6473515|NCT01270659|7390902|FG000|STARTED|Overall Study||6
6473516|NCT01270659|7390903|FG001|STARTED|Overall Study||25
6473517|NCT01270659|7390904|FG002|STARTED|Overall Study||4
6473518|NCT01270659|7390905|FG003|STARTED|Overall Study||25
6473519|NCT01270659|7390902|FG000|COMPLETED|Overall Study||6
6473520|NCT01270659|7390903|FG001|COMPLETED|Overall Study||25
6473521|NCT01270659|7390904|FG002|COMPLETED|Overall Study||4
6473522|NCT01270659|7390905|FG003|COMPLETED|Overall Study||25
6473523|NCT01270659|7390902|FG000|NOT COMPLETED|Overall Study||0
6473524|NCT01270659|7390903|FG001|NOT COMPLETED|Overall Study||0
6473525|NCT01270659|7390904|FG002|NOT COMPLETED|Overall Study||0
6473526|NCT01270659|7390905|FG003|NOT COMPLETED|Overall Study||0
6473527|NCT01270711|7390923|FG000|STARTED|Part 1: Compliance||7537
6473528|NCT01270711|7390924|FG001|STARTED|Part 1: Compliance||6580
6473529|NCT01270711|7390925|FG002|STARTED|Part 1: Compliance||326
6473530|NCT01270711|7390926|FG003|STARTED|Part 1: Compliance||5486
6473531|NCT01270711|7390927|FG004|STARTED|Part 1: Compliance||2024
6473532|NCT01270711|7390928|FG005|STARTED|Part 1: Compliance||0
6473533|NCT01270711|7390929|FG006|STARTED|Part 1: Compliance||0
6473534|NCT01270711|7390930|FG007|STARTED|Part 1: Compliance||0
6473535|NCT01270711|7390923|FG000|COMPLETED|Part 1: Compliance||7537
6473536|NCT01270711|7390924|FG001|COMPLETED|Part 1: Compliance||6580
6473537|NCT01270711|7390925|FG002|COMPLETED|Part 1: Compliance||326
6473538|NCT01270711|7390926|FG003|COMPLETED|Part 1: Compliance||5486
6473539|NCT01270711|7390927|FG004|COMPLETED|Part 1: Compliance||2024
6473540|NCT01270711|7390928|FG005|COMPLETED|Part 1: Compliance||0
6473541|NCT01270711|7390929|FG006|COMPLETED|Part 1: Compliance||0
6473542|NCT01270711|7390930|FG007|COMPLETED|Part 1: Compliance||0
6473543|NCT01270711|7390923|FG000|NOT COMPLETED|Part 1: Compliance||0
6473544|NCT01270711|7390924|FG001|NOT COMPLETED|Part 1: Compliance||0
6473545|NCT01270711|7390925|FG002|NOT COMPLETED|Part 1: Compliance||0
6473546|NCT01270711|7390926|FG003|NOT COMPLETED|Part 1: Compliance||0
6473547|NCT01270711|7390927|FG004|NOT COMPLETED|Part 1: Compliance||0
6473548|NCT01270711|7390928|FG005|NOT COMPLETED|Part 1: Compliance||0
6473549|NCT01270711|7390929|FG006|NOT COMPLETED|Part 1: Compliance||0
6473550|NCT01270711|7390930|FG007|NOT COMPLETED|Part 1: Compliance||0
6473551|NCT01270711|7390923|FG000|STARTED|Part 2: Effectiveness||0
6473552|NCT01270711|7390924|FG001|STARTED|Part 2: Effectiveness||0
6473553|NCT01270711|7390925|FG002|STARTED|Part 2: Effectiveness||0
6473554|NCT01270711|7390926|FG003|STARTED|Part 2: Effectiveness||0
6473555|NCT01270711|7390927|FG004|STARTED|Part 2: Effectiveness||0
6473556|NCT01270711|7390928|FG005|STARTED|Part 2: Effectiveness||11
6473557|NCT01270711|7390929|FG006|STARTED|Part 2: Effectiveness||2
6473558|NCT01270711|7390930|FG007|STARTED|Part 2: Effectiveness||48
6473559|NCT01270711|7390923|FG000|COMPLETED|Part 2: Effectiveness||0
6473560|NCT01270711|7390924|FG001|COMPLETED|Part 2: Effectiveness||0
6473561|NCT01270711|7390925|FG002|COMPLETED|Part 2: Effectiveness||0
6473562|NCT01270711|7390926|FG003|COMPLETED|Part 2: Effectiveness||0
6473563|NCT01270711|7390927|FG004|COMPLETED|Part 2: Effectiveness||0
6473564|NCT01270711|7390928|FG005|COMPLETED|Part 2: Effectiveness||11
6473565|NCT01270711|7390929|FG006|COMPLETED|Part 2: Effectiveness||2
6473566|NCT01270711|7390930|FG007|COMPLETED|Part 2: Effectiveness||48
6473567|NCT01270711|7390923|FG000|NOT COMPLETED|Part 2: Effectiveness||0
6473568|NCT01270711|7390924|FG001|NOT COMPLETED|Part 2: Effectiveness||0
6473569|NCT01270711|7390925|FG002|NOT COMPLETED|Part 2: Effectiveness||0
6473570|NCT01270711|7390926|FG003|NOT COMPLETED|Part 2: Effectiveness||0
6473571|NCT01270711|7390927|FG004|NOT COMPLETED|Part 2: Effectiveness||0
6473572|NCT01270711|7390928|FG005|NOT COMPLETED|Part 2: Effectiveness||0
6473573|NCT01270711|7390929|FG006|NOT COMPLETED|Part 2: Effectiveness||0
6473574|NCT01270711|7390930|FG007|NOT COMPLETED|Part 2: Effectiveness||0
6473575|NCT01270802|7390951|FG000|STARTED|Overall Study||15
6473576|NCT01270802|7390952|FG001|STARTED|Overall Study||15
6473577|NCT01270802|7390951|FG000|COMPLETED|Overall Study||13
6473578|NCT01270802|7390952|FG001|COMPLETED|Overall Study||14
6473579|NCT01270802|7390951|FG000|NOT COMPLETED|Overall Study||2
6473580|NCT01270802|7390952|FG001|NOT COMPLETED|Overall Study||1
6473581|NCT01270828|7390961|FG000|STARTED|Pregabalin CR SB||0
6473582|NCT01270828|7390962|FG001|STARTED|Pregabalin CR SB||0
6473583|NCT01270828|7390963|FG002|STARTED|Pregabalin CR SB||806
6473584|NCT01270828|7390961|FG000|COMPLETED|Pregabalin CR SB||0
6473585|NCT01270828|7390962|FG001|COMPLETED|Pregabalin CR SB||0
6473586|NCT01270828|7390963|FG002|COMPLETED|Pregabalin CR SB||660
6473587|NCT01270828|7390961|FG000|NOT COMPLETED|Pregabalin CR SB||0
6473588|NCT01270828|7390962|FG001|NOT COMPLETED|Pregabalin CR SB||0
6473589|NCT01270828|7390963|FG002|NOT COMPLETED|Pregabalin CR SB||146
6473590|NCT01270828|7390961|FG000|STARTED|Double Blind Phase||208
6473591|NCT01270828|7390962|FG001|STARTED|Double Blind Phase||205
6473592|NCT01270828|7390963|FG002|STARTED|Double Blind Phase||0
6473593|NCT01270828|7390961|FG000|COMPLETED|Double Blind Phase||182
6473594|NCT01270828|7390962|FG001|COMPLETED|Double Blind Phase||160
6473595|NCT01270828|7390963|FG002|COMPLETED|Double Blind Phase||0
6473596|NCT01270828|7390961|FG000|NOT COMPLETED|Double Blind Phase||26
6473597|NCT01270828|7390962|FG001|NOT COMPLETED|Double Blind Phase||45
6473598|NCT01270828|7390963|FG002|NOT COMPLETED|Double Blind Phase||0
6473599|NCT01270841|7390975|FG000|STARTED|Overall Study||29
6473600|NCT01270841|7390976|FG001|STARTED|Overall Study||33
6473601|NCT01270841|7390977|FG002|STARTED|Overall Study||29
6473602|NCT01270841|7390978|FG003|STARTED|Overall Study||33
6473603|NCT01270841|7390975|FG000|COMPLETED|Overall Study||16
6473604|NCT01270841|7390976|FG001|COMPLETED|Overall Study||19
6473605|NCT01270841|7390977|FG002|COMPLETED|Overall Study||18
6473606|NCT01270841|7390978|FG003|COMPLETED|Overall Study||20
6473607|NCT01270841|7390975|FG000|NOT COMPLETED|Overall Study||13
6473608|NCT01270841|7390976|FG001|NOT COMPLETED|Overall Study||14
6473609|NCT01270841|7390977|FG002|NOT COMPLETED|Overall Study||11
6473610|NCT01270841|7390978|FG003|NOT COMPLETED|Overall Study||13
6473611|NCT01270867|7390990|FG000|STARTED|Overall Study||90
6473612|NCT01270867|7390991|FG001|STARTED|Overall Study||88
6473613|NCT01270867|7390990|FG000|COMPLETED|Overall Study||89
6473614|NCT01270867|7390991|FG001|COMPLETED|Overall Study||88
6473615|NCT01270867|7390990|FG000|NOT COMPLETED|Overall Study||1
6473616|NCT01270867|7390991|FG001|NOT COMPLETED|Overall Study||0
6473617|NCT01270880|7390997|FG000|STARTED|Overall Study||18
6473618|NCT01270880|7390997|FG000|COMPLETED|Overall Study||17
6473619|NCT01270880|7390997|FG000|NOT COMPLETED|Overall Study||1
6473620|NCT01270958|7391001|FG000|STARTED|Overall Study||60
6473621|NCT01270958|7391001|FG000|COMPLETED|Overall Study||56
6473622|NCT01270958|7391001|FG000|NOT COMPLETED|Overall Study||4
6473623|NCT01270971|7391007|FG000|STARTED|Overall Study||400
6473624|NCT01270971|7391008|FG001|STARTED|Overall Study||194
6473625|NCT01270971|7391007|FG000|COMPLETED|Overall Study||348
6473626|NCT01270971|7391008|FG001|COMPLETED|Overall Study||171
6473627|NCT01270971|7391007|FG000|NOT COMPLETED|Overall Study||52
6473628|NCT01270971|7391008|FG001|NOT COMPLETED|Overall Study||23
6473629|NCT01271010|7391014|FG000|STARTED|Overall Study||89
6473630|NCT01271010|7391014|FG000|COMPLETED|Overall Study||28
6473631|NCT01271010|7391014|FG000|NOT COMPLETED|Overall Study||61
6473632|NCT01271036|7391020|FG000|STARTED|Overall Study||62
6473633|NCT01271036|7391021|FG001|STARTED|Overall Study||62
6473634|NCT01271036|7391020|FG000|COMPLETED|Overall Study||62
6473635|NCT01271036|7391021|FG001|COMPLETED|Overall Study||62
6473636|NCT01271036|7391020|FG000|NOT COMPLETED|Overall Study||0
6473637|NCT01271036|7391021|FG001|NOT COMPLETED|Overall Study||0
6473638|NCT01271244|7391029|FG000|STARTED|Overall Study||18
6473639|NCT01271244|7391030|FG001|STARTED|Overall Study||8
6473640|NCT01271244|7391029|FG000|COMPLETED|Overall Study||11
6473641|NCT01271244|7391030|FG001|COMPLETED|Overall Study||5
6473642|NCT01271244|7391029|FG000|NOT COMPLETED|Overall Study||7
6473643|NCT01271244|7391030|FG001|NOT COMPLETED|Overall Study||3
6473644|NCT01271413|7391038|FG000|STARTED|Overall Study||37
6473645|NCT01271413|7391039|FG001|STARTED|Overall Study||36
6473646|NCT01271413|7391038|FG000|COMPLETED|Overall Study||28
6473647|NCT01271413|7391039|FG001|COMPLETED|Overall Study||28
6473648|NCT01271413|7391038|FG000|NOT COMPLETED|Overall Study||9
6473649|NCT01271413|7391039|FG001|NOT COMPLETED|Overall Study||8
6473650|NCT01271452|7391047|FG000|STARTED|Overall Study||112
6473651|NCT01271452|7391048|FG001|STARTED|Overall Study||112
6473652|NCT01271452|7391047|FG000|COMPLETED|Overall Study||105
6473653|NCT01271452|7391048|FG001|COMPLETED|Overall Study||104
6473654|NCT01271452|7391047|FG000|NOT COMPLETED|Overall Study||7
6473655|NCT01271452|7391048|FG001|NOT COMPLETED|Overall Study||8
6473656|NCT01271504|7391058|FG000|STARTED|Overall Study||7
6473657|NCT01271504|7391059|FG001|STARTED|Overall Study||8
6473658|NCT01271504|7391060|FG002|STARTED|Overall Study||44
6473659|NCT01271504|7391061|FG003|STARTED|Overall Study||43
6473660|NCT01271504|7391058|FG000|Treated|Overall Study||7
6473661|NCT01271504|7391059|FG001|Treated|Overall Study||7
6473662|NCT01271504|7391060|FG002|Treated|Overall Study||42
6473663|NCT01271504|7391061|FG003|Treated|Overall Study||42
6473664|NCT01271504|7391058|FG000|COMPLETED|Overall Study||0
6473665|NCT01271504|7391059|FG001|COMPLETED|Overall Study||0
6473666|NCT01271504|7391060|FG002|COMPLETED|Overall Study||0
6473667|NCT01271504|7391061|FG003|COMPLETED|Overall Study||0
6473668|NCT01271504|7391058|FG000|NOT COMPLETED|Overall Study||7
6473669|NCT01271504|7391059|FG001|NOT COMPLETED|Overall Study||8
6473670|NCT01271504|7391060|FG002|NOT COMPLETED|Overall Study||44
6473671|NCT01271504|7391061|FG003|NOT COMPLETED|Overall Study||43
6473672|NCT01271543|7391083|FG000|STARTED|Overall Study||30
6473673|NCT01271543|7391084|FG001|STARTED|Overall Study||30
6473674|NCT01271543|7391083|FG000|COMPLETED|Overall Study||29
6473675|NCT01271543|7391084|FG001|COMPLETED|Overall Study||29
6473676|NCT01271543|7391083|FG000|NOT COMPLETED|Overall Study||1
6473677|NCT01271543|7391084|FG001|NOT COMPLETED|Overall Study||1
6473678|NCT01271686|7391091|FG000|STARTED|Overall Study||16
6473679|NCT01271686|7391091|FG000|COMPLETED|Overall Study||16
6473680|NCT01271686|7391091|FG000|NOT COMPLETED|Overall Study||0
6473681|NCT01271712|7391097|FG000|STARTED|Double Blind Treatment||133
6473682|NCT01271712|7391098|FG001|STARTED|Double Blind Treatment||66
6473683|NCT01271712|7391097|FG000|Participants Received Treatment|Double Blind Treatment||132
6473684|NCT01271712|7391098|FG001|Participants Received Treatment|Double Blind Treatment||66
6473685|NCT01271712|7391097|FG000|COMPLETED|Double Blind Treatment|91 participants started open-label treatment with regorafenib|91
6473686|NCT01271712|7391098|FG001|COMPLETED|Double Blind Treatment|58 participants started open-label treatment with regorafenib|58
6473687|NCT01271712|7391097|FG000|NOT COMPLETED|Double Blind Treatment||42
6473688|NCT01271712|7391098|FG001|NOT COMPLETED|Double Blind Treatment||8
6473689|NCT01271712|7391097|FG000|STARTED|Open Label Treatment||91
6473690|NCT01271712|7391098|FG001|STARTED|Open Label Treatment||58
6473691|NCT01271712|7391097|FG000|COMPLETED|Open Label Treatment||0
6473692|NCT01271712|7391098|FG001|COMPLETED|Open Label Treatment||0
6473693|NCT01271712|7391097|FG000|NOT COMPLETED|Open Label Treatment||91
6473694|NCT01271712|7391098|FG001|NOT COMPLETED|Open Label Treatment||58
6473695|NCT01271712|7391097|FG000|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|118
6473696|NCT01271712|7391098|FG001|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|52
6473697|NCT01271712|7391097|FG000|COMPLETED|Safety Follow-up||97
6473698|NCT01271712|7391098|FG001|COMPLETED|Safety Follow-up||37
6473699|NCT01271712|7391097|FG000|NOT COMPLETED|Safety Follow-up||21
6473700|NCT01271712|7391098|FG001|NOT COMPLETED|Safety Follow-up||15
6473701|NCT01271712|7391097|FG000|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|100
6473702|NCT01271712|7391098|FG001|STARTED|Survival Follow-up|All participants entered Survival Follow-up immediately after safety follow-up|39
6473703|NCT01271712|7391097|FG000|COMPLETED|Survival Follow-up|85 participants died and completed survival follow-up.|85
6473704|NCT01271712|7391098|FG001|COMPLETED|Survival Follow-up|33 participants died and completed survival follow-up.|33
6473705|NCT01271712|7391097|FG000|NOT COMPLETED|Survival Follow-up||15
6473706|NCT01271712|7391098|FG001|NOT COMPLETED|Survival Follow-up||6
6473707|NCT01271725|7391107|FG000|STARTED|Part A|Started are the treated patients|74
6473708|NCT01271725|7391108|FG001|STARTED|Part A||0
6473709|NCT01271725|7391107|FG000|COMPLETED|Part A||39
6473710|NCT01271725|7391108|FG001|COMPLETED|Part A||0
6473711|NCT01271725|7391107|FG000|NOT COMPLETED|Part A||35
6473712|NCT01271725|7391108|FG001|NOT COMPLETED|Part A||0
6473713|NCT01271725|7391107|FG000|STARTED|Part B||0
6473714|NCT01271725|7391108|FG001|STARTED|Part B||39
6473715|NCT01271725|7391107|FG000|COMPLETED|Part B||0
6473716|NCT01271725|7391108|FG001|COMPLETED|Part B|Patient deemed to have completed the trial once they showed progressive disease according to RECIST|27
6473717|NCT01271725|7391107|FG000|NOT COMPLETED|Part B||0
6473718|NCT01271725|7391108|FG001|NOT COMPLETED|Part B||12
6473719|NCT01271803|7391120|FG000|STARTED|Overall Study||66
6473720|NCT01271803|7391121|FG001|STARTED|Overall Study||63
6473721|NCT01271803|7391122|FG002|STARTED|Overall Study||2
6473722|NCT01271803|7391120|FG000|COMPLETED|Overall Study||11
6473723|NCT01271803|7391121|FG001|COMPLETED|Overall Study||24
6473724|NCT01271803|7391122|FG002|COMPLETED|Overall Study||0
6473725|NCT01271803|7391120|FG000|NOT COMPLETED|Overall Study||55
6473726|NCT01271803|7391121|FG001|NOT COMPLETED|Overall Study||39
6473727|NCT01271803|7391122|FG002|NOT COMPLETED|Overall Study||2
6473728|NCT01271855|7391169|FG000|STARTED|Overall Study||48
6473729|NCT01271855|7391170|FG001|STARTED|Overall Study||52
6473730|NCT01271855|7391169|FG000|COMPLETED|Overall Study||48
6473731|NCT01271855|7391170|FG001|COMPLETED|Overall Study||52
6473732|NCT01271855|7391169|FG000|NOT COMPLETED|Overall Study||0
6473733|NCT01271855|7391170|FG001|NOT COMPLETED|Overall Study||0
6473734|NCT01271868|7391176|FG000|STARTED|Pharmacokinetic Study||9
6473735|NCT01271868|7391176|FG000|COMPLETED|Pharmacokinetic Study||9
6473736|NCT01271868|7391176|FG000|NOT COMPLETED|Pharmacokinetic Study||0
6473737|NCT01271868|7391176|FG000|STARTED|Treatment Study||9
6473738|NCT01271868|7391176|FG000|COMPLETED|Treatment Study||9
6473739|NCT01271868|7391176|FG000|NOT COMPLETED|Treatment Study||0
6501157|NCT01427504|7419670|FG005|STARTED|Overall Study||6
6501158|NCT01427504|7419665|FG000|Received Boceprevir|Overall Study||4
6501159|NCT01427504|7419666|FG001|Received Boceprevir|Overall Study||3
6501160|NCT01427504|7419667|FG002|Received Boceprevir|Overall Study||3
6473740|NCT01271907|7391185|FG000|STARTED|Overall Study||3
6473741|NCT01271907|7391186|FG001|STARTED|Overall Study||0
6473742|NCT01271907|7391187|FG002|STARTED|Overall Study||0
6473743|NCT01271907|7391185|FG000|COMPLETED|Overall Study||3
6473744|NCT01271907|7391186|FG001|COMPLETED|Overall Study||0
6473745|NCT01271907|7391187|FG002|COMPLETED|Overall Study||0
6473746|NCT01271907|7391185|FG000|NOT COMPLETED|Overall Study||0
6473747|NCT01271907|7391186|FG001|NOT COMPLETED|Overall Study||0
6473748|NCT01271907|7391187|FG002|NOT COMPLETED|Overall Study||0
6473749|NCT01271933|7391195|FG000|STARTED|Single-Blind Phase||441
6473750|NCT01271933|7391196|FG001|STARTED|Single-Blind Phase||0
6473751|NCT01271933|7391197|FG002|STARTED|Single-Blind Phase||0
6473752|NCT01271933|7391195|FG000|COMPLETED|Single-Blind Phase||320
6473753|NCT01271933|7391196|FG001|COMPLETED|Single-Blind Phase||0
6473754|NCT01271933|7391197|FG002|COMPLETED|Single-Blind Phase||0
6473755|NCT01271933|7391195|FG000|NOT COMPLETED|Single-Blind Phase||121
6473756|NCT01271933|7391196|FG001|NOT COMPLETED|Single-Blind Phase||0
6473757|NCT01271933|7391197|FG002|NOT COMPLETED|Single-Blind Phase||0
6473758|NCT01271933|7391195|FG000|STARTED|Double-Blind Phase||0
6473759|NCT01271933|7391196|FG001|STARTED|Double-Blind Phase||63
6473760|NCT01271933|7391197|FG002|STARTED|Double-Blind Phase||59
6473761|NCT01271933|7391195|FG000|Treated|Double-Blind Phase||0
6473762|NCT01271933|7391196|FG001|Treated|Double-Blind Phase||63
6473763|NCT01271933|7391197|FG002|Treated|Double-Blind Phase||58
6473764|NCT01271933|7391195|FG000|COMPLETED|Double-Blind Phase||0
6473765|NCT01271933|7391196|FG001|COMPLETED|Double-Blind Phase||46
6473766|NCT01271933|7391197|FG002|COMPLETED|Double-Blind Phase||47
6473767|NCT01271933|7391195|FG000|NOT COMPLETED|Double-Blind Phase||0
6473768|NCT01271933|7391196|FG001|NOT COMPLETED|Double-Blind Phase||17
6473769|NCT01271933|7391197|FG002|NOT COMPLETED|Double-Blind Phase||12
6473770|NCT01271946|7391209|FG000|STARTED|Overall Study||346
6473771|NCT01271946|7391210|FG001|STARTED|Overall Study||5
6473772|NCT01271946|7391209|FG000|COMPLETED|Overall Study||346
6473773|NCT01271946|7391210|FG001|COMPLETED|Overall Study||5
6473774|NCT01271946|7391209|FG000|NOT COMPLETED|Overall Study||0
6473775|NCT01271946|7391210|FG001|NOT COMPLETED|Overall Study||0
6473776|NCT01272011|7391233|FG000|STARTED|Overall Study||3
6473777|NCT01272011|7391234|FG001|STARTED|Overall Study||10
6473778|NCT01272011|7391235|FG002|STARTED|Overall Study||3
6473779|NCT01272011|7391233|FG000|COMPLETED|Overall Study||3
6473780|NCT01272011|7391234|FG001|COMPLETED|Overall Study||8
6473781|NCT01272011|7391235|FG002|COMPLETED|Overall Study||3
6473782|NCT01272011|7391233|FG000|NOT COMPLETED|Overall Study||0
6473783|NCT01272011|7391234|FG001|NOT COMPLETED|Overall Study||2
6473784|NCT01272011|7391235|FG002|NOT COMPLETED|Overall Study||0
6473785|NCT01272076|7391243|FG000|STARTED|Overall Study||52
6473786|NCT01272076|7391243|FG000|COMPLETED|Overall Study||52
6473787|NCT01272076|7391243|FG000|NOT COMPLETED|Overall Study||0
6473788|NCT01272180|7391251|FG000|STARTED|Overall Study||120
6473789|NCT01272180|7391252|FG001|STARTED|Overall Study||121
6473790|NCT01272180|7391253|FG002|STARTED|Overall Study||122
6473791|NCT01272180|7391254|FG003|STARTED|Overall Study||121
6473792|NCT01272180|7391251|FG000|COMPLETED|Overall Study||103
6473793|NCT01272180|7391252|FG001|COMPLETED|Overall Study||100
6473794|NCT01272180|7391253|FG002|COMPLETED|Overall Study||109
6473795|NCT01272180|7391254|FG003|COMPLETED|Overall Study||107
6473796|NCT01272180|7391251|FG000|NOT COMPLETED|Overall Study||17
6473797|NCT01272180|7391252|FG001|NOT COMPLETED|Overall Study||21
6473798|NCT01272180|7391253|FG002|NOT COMPLETED|Overall Study||13
6473799|NCT01272180|7391254|FG003|NOT COMPLETED|Overall Study||14
6473800|NCT01272193|7391270|FG000|STARTED|Overall Study||147
6473801|NCT01272193|7391271|FG001|STARTED|Overall Study||149
6473802|NCT01272193|7391270|FG000|COMPLETED|Overall Study||137
6473803|NCT01272193|7391271|FG001|COMPLETED|Overall Study||137
6473804|NCT01272193|7391270|FG000|NOT COMPLETED|Overall Study||10
6473805|NCT01272193|7391271|FG001|NOT COMPLETED|Overall Study||12
6473806|NCT01272219|7391281|FG000|STARTED|Main Period: Week 0 to Week 56||959
6473807|NCT01272219|7391282|FG001|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
6473808|NCT01272219|7391283|FG002|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
6473809|NCT01272219|7391284|FG003|STARTED|Main Period: Week 0 to Week 56||487
6473810|NCT01272219|7391285|FG004|STARTED|Main Period: Week 0 to Week 56||1528
6473811|NCT01272219|7391286|FG005|STARTED|Main Period: Week 0 to Week 56||757
6473812|NCT01272219|7391281|FG000|Exposed|Main Period: Week 0 to Week 56||957
6473813|NCT01272219|7391282|FG001|Exposed|Main Period: Week 0 to Week 56||0
6473814|NCT01272219|7391283|FG002|Exposed|Main Period: Week 0 to Week 56||0
6473815|NCT01272219|7391284|FG003|Exposed|Main Period: Week 0 to Week 56||487
6473816|NCT01272219|7391285|FG004|Exposed|Main Period: Week 0 to Week 56||1524
6473817|NCT01272219|7391286|FG005|Exposed|Main Period: Week 0 to Week 56||755
6473818|NCT01272219|7391281|FG000|COMPLETED|Main Period: Week 0 to Week 56||679
6473819|NCT01272219|7391282|FG001|COMPLETED|Main Period: Week 0 to Week 56||0
6473820|NCT01272219|7391283|FG002|COMPLETED|Main Period: Week 0 to Week 56||0
6473821|NCT01272219|7391284|FG003|COMPLETED|Main Period: Week 0 to Week 56||296
6473822|NCT01272219|7391285|FG004|COMPLETED|Main Period: Week 0 to Week 56||1110
6473823|NCT01272219|7391286|FG005|COMPLETED|Main Period: Week 0 to Week 56||505
6473824|NCT01272219|7391281|FG000|NOT COMPLETED|Main Period: Week 0 to Week 56||280
6473825|NCT01272219|7391282|FG001|NOT COMPLETED|Main Period: Week 0 to Week 56||0
6473826|NCT01272219|7391283|FG002|NOT COMPLETED|Main Period: Week 0 to Week 56||0
6473827|NCT01272219|7391284|FG003|NOT COMPLETED|Main Period: Week 0 to Week 56||191
6473828|NCT01272219|7391285|FG004|NOT COMPLETED|Main Period: Week 0 to Week 56||418
6473829|NCT01272219|7391286|FG005|NOT COMPLETED|Main Period: Week 0 to Week 56||252
6473830|NCT01272219|7391281|FG000|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
6473831|NCT01272219|7391282|FG001|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
6473832|NCT01272219|7391283|FG002|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
6473833|NCT01272219|7391284|FG003|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
6473834|NCT01272219|7391285|FG004|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
6473835|NCT01272219|7391286|FG005|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
6473836|NCT01272219|7391281|FG000|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6473837|NCT01272219|7391282|FG001|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
6473838|NCT01272219|7391283|FG002|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
6473839|NCT01272219|7391284|FG003|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
6473840|NCT01272219|7391285|FG004|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6473841|NCT01272219|7391286|FG005|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6473842|NCT01272219|7391281|FG000|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6473843|NCT01272219|7391282|FG001|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
6473844|NCT01272219|7391283|FG002|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
6473845|NCT01272219|7391284|FG003|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
6473846|NCT01272219|7391285|FG004|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6473847|NCT01272219|7391286|FG005|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
6473848|NCT01272219|7391281|FG000|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
6473849|NCT01272219|7391282|FG001|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
6473850|NCT01272219|7391283|FG002|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
6473851|NCT01272219|7391284|FG003|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
6473852|NCT01272219|7391285|FG004|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
6473853|NCT01272219|7391286|FG005|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
6473854|NCT01272219|7391281|FG000|Exposed|Main + Extension Period: Week 0-172||0
6473855|NCT01272219|7391282|FG001|Exposed|Main + Extension Period: Week 0-172||0
6473856|NCT01272219|7391283|FG002|Exposed|Main + Extension Period: Week 0-172||0
6473857|NCT01272219|7391284|FG003|Exposed|Main + Extension Period: Week 0-172||0
6473858|NCT01272219|7391285|FG004|Exposed|Main + Extension Period: Week 0-172||1501
6473859|NCT01272219|7391286|FG005|Exposed|Main + Extension Period: Week 0-172||747
6473860|NCT01272219|7391281|FG000|COMPLETED|Main + Extension Period: Week 0-172||0
6473861|NCT01272219|7391282|FG001|COMPLETED|Main + Extension Period: Week 0-172||0
6473862|NCT01272219|7391283|FG002|COMPLETED|Main + Extension Period: Week 0-172||0
6473863|NCT01272219|7391284|FG003|COMPLETED|Main + Extension Period: Week 0-172||0
6473864|NCT01272219|7391285|FG004|COMPLETED|Main + Extension Period: Week 0-172||783
6473865|NCT01272219|7391286|FG005|COMPLETED|Main + Extension Period: Week 0-172||327
6473866|NCT01272219|7391281|FG000|NOT COMPLETED|Main + Extension Period: Week 0-172||0
6473867|NCT01272219|7391282|FG001|NOT COMPLETED|Main + Extension Period: Week 0-172||0
6473868|NCT01272219|7391283|FG002|NOT COMPLETED|Main + Extension Period: Week 0-172||0
6473869|NCT01272219|7391284|FG003|NOT COMPLETED|Main + Extension Period: Week 0-172||0
6473870|NCT01272219|7391285|FG004|NOT COMPLETED|Main + Extension Period: Week 0-172||722
6473871|NCT01272219|7391286|FG005|NOT COMPLETED|Main + Extension Period: Week 0-172||422
6473872|NCT01272232|7391302|FG000|STARTED|Weeks 0-56||423
6473873|NCT01272232|7391303|FG001|STARTED|Weeks 0-56||211
6473874|NCT01272232|7391304|FG002|STARTED|Weeks 0-56||212
6473875|NCT01272232|7391302|FG000|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
6473876|NCT01272232|7391303|FG001|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
6473877|NCT01272232|7391304|FG002|Exposed|Weeks 0-56||212
6473878|NCT01272232|7391302|FG000|COMPLETED|Weeks 0-56||324
6473879|NCT01272232|7391303|FG001|COMPLETED|Weeks 0-56||164
6473880|NCT01272232|7391304|FG002|COMPLETED|Weeks 0-56||140
6473881|NCT01272232|7391302|FG000|NOT COMPLETED|Weeks 0-56||99
6473882|NCT01272232|7391303|FG001|NOT COMPLETED|Weeks 0-56||47
6473883|NCT01272232|7391304|FG002|NOT COMPLETED|Weeks 0-56||72
6473884|NCT01272232|7391302|FG000|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
6473885|NCT01272232|7391303|FG001|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
6473886|NCT01272232|7391304|FG002|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
6473887|NCT01272232|7391302|FG000|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
6473888|NCT01272232|7391303|FG001|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
6473889|NCT01272232|7391304|FG002|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
6473890|NCT01272232|7391302|FG000|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
6473891|NCT01272232|7391303|FG001|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
6473892|NCT01272232|7391304|FG002|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
6473893|NCT01272245|7391312|FG000|STARTED|Overall Study||36
6473894|NCT01272245|7391312|FG000|COMPLETED|Overall Study||36
6473895|NCT01272245|7391312|FG000|NOT COMPLETED|Overall Study||0
6473896|NCT01272284|7391316|FG000|STARTED|3-month Follow-up Visit||113
6473897|NCT01272284|7391316|FG000|COMPLETED|3-month Follow-up Visit||112
6473898|NCT01272284|7391316|FG000|NOT COMPLETED|3-month Follow-up Visit||1
6473899|NCT01272284|7391316|FG000|STARTED|6-month Follow-up Visit||112
6473900|NCT01272284|7391316|FG000|COMPLETED|6-month Follow-up Visit||109
6473901|NCT01272284|7391316|FG000|NOT COMPLETED|6-month Follow-up Visit||3
6473902|NCT01272284|7391316|FG000|STARTED|12-month Follow-up Visit||109
6473903|NCT01272284|7391316|FG000|COMPLETED|12-month Follow-up Visit||105
6473904|NCT01272284|7391316|FG000|NOT COMPLETED|12-month Follow-up Visit||4
6473905|NCT01272388|7391323|FG000|STARTED|Overall Study||1
6473906|NCT01272388|7391324|FG001|STARTED|Overall Study||0
6473907|NCT01272388|7391323|FG000|COMPLETED|Overall Study||1
6473908|NCT01272388|7391324|FG001|COMPLETED|Overall Study||0
6473909|NCT01272388|7391323|FG000|NOT COMPLETED|Overall Study||0
6473910|NCT01272388|7391324|FG001|NOT COMPLETED|Overall Study||0
6473911|NCT01272583|7391332|FG000|STARTED|Overall Study||8
6473912|NCT01272583|7391333|FG001|STARTED|Overall Study||8
6473913|NCT01272583|7391332|FG000|COMPLETED|Overall Study||8
6473914|NCT01272583|7391333|FG001|COMPLETED|Overall Study||8
6473915|NCT01272583|7391332|FG000|NOT COMPLETED|Overall Study||0
6473916|NCT01272583|7391333|FG001|NOT COMPLETED|Overall Study||0
6473917|NCT01272635|7391343|FG000|STARTED|Overall Study||153
6473918|NCT01272635|7391344|FG001|STARTED|Overall Study||154
6473919|NCT01272635|7391345|FG002|STARTED|Overall Study||148
6473920|NCT01272635|7391346|FG003|STARTED|Overall Study||152
6473921|NCT01272635|7391343|FG000|COMPLETED|Overall Study||122
6473922|NCT01272635|7391344|FG001|COMPLETED|Overall Study||134
6473923|NCT01272635|7391345|FG002|COMPLETED|Overall Study||117
6473924|NCT01272635|7391346|FG003|COMPLETED|Overall Study||129
6473925|NCT01272635|7391343|FG000|NOT COMPLETED|Overall Study||31
6473926|NCT01272635|7391344|FG001|NOT COMPLETED|Overall Study||20
6473927|NCT01272635|7391345|FG002|NOT COMPLETED|Overall Study||31
6473928|NCT01272635|7391346|FG003|NOT COMPLETED|Overall Study||23
6473929|NCT01272661|7391357|FG000|STARTED|Overall Study||413
6473930|NCT01272661|7391358|FG001|STARTED|Overall Study||497
6473931|NCT01272661|7391359|FG002|STARTED|Overall Study||386
6473932|NCT01272661|7391357|FG000|COMPLETED|Overall Study||287
6473933|NCT01272661|7391358|FG001|COMPLETED|Overall Study||288
6473934|NCT01272661|7391359|FG002|COMPLETED|Overall Study||314
6473935|NCT01272661|7391357|FG000|NOT COMPLETED|Overall Study||126
6473936|NCT01272661|7391358|FG001|NOT COMPLETED|Overall Study||209
6473937|NCT01272661|7391359|FG002|NOT COMPLETED|Overall Study||72
6473938|NCT01272804|7391373|FG000|STARTED|Overall Study||9
6473939|NCT01272804|7391374|FG001|STARTED|Overall Study||9
6473940|NCT01272804|7391375|FG002|STARTED|Overall Study||9
6473941|NCT01272804|7391376|FG003|STARTED|Overall Study||9
6473942|NCT01272804|7391377|FG004|STARTED|Overall Study||9
6473943|NCT01272804|7391378|FG005|STARTED|Overall Study||16
6473944|NCT01272804|7391373|FG000|COMPLETED|Overall Study||8
6473945|NCT01272804|7391374|FG001|COMPLETED|Overall Study||9
6473946|NCT01272804|7391375|FG002|COMPLETED|Overall Study||9
6473947|NCT01272804|7391376|FG003|COMPLETED|Overall Study||9
6473948|NCT01272804|7391377|FG004|COMPLETED|Overall Study||7
6473949|NCT01272804|7391378|FG005|COMPLETED|Overall Study||15
6473950|NCT01272804|7391373|FG000|NOT COMPLETED|Overall Study||1
6473951|NCT01272804|7391374|FG001|NOT COMPLETED|Overall Study||0
6473952|NCT01272804|7391375|FG002|NOT COMPLETED|Overall Study||0
6473953|NCT01272804|7391376|FG003|NOT COMPLETED|Overall Study||0
6473954|NCT01272804|7391377|FG004|NOT COMPLETED|Overall Study||2
6473955|NCT01272804|7391378|FG005|NOT COMPLETED|Overall Study||1
6473956|NCT01272830|7391394|FG000|STARTED|Overall Study||25
6473957|NCT01272830|7391395|FG001|STARTED|Overall Study||26
6473958|NCT01272830|7391394|FG000|COMPLETED|Overall Study||17
6473959|NCT01272830|7391395|FG001|COMPLETED|Overall Study||21
6473960|NCT01272830|7391394|FG000|NOT COMPLETED|Overall Study||8
6473961|NCT01272830|7391395|FG001|NOT COMPLETED|Overall Study||5
6473962|NCT01272869|7391403|FG000|STARTED|Period 1 (14 Days)||10
6473963|NCT01272869|7391404|FG001|STARTED|Period 1 (14 Days)||10
6473964|NCT01272869|7391403|FG000|COMPLETED|Period 1 (14 Days)||10
6473965|NCT01272869|7391404|FG001|COMPLETED|Period 1 (14 Days)||10
6473966|NCT01272869|7391403|FG000|NOT COMPLETED|Period 1 (14 Days)||0
6473967|NCT01272869|7391404|FG001|NOT COMPLETED|Period 1 (14 Days)||0
6473968|NCT01272869|7391403|FG000|STARTED|Period 2 (14 Days)||10
6473969|NCT01272869|7391404|FG001|STARTED|Period 2 (14 Days)||10
6473970|NCT01272869|7391403|FG000|COMPLETED|Period 2 (14 Days)||9
6473971|NCT01272869|7391404|FG001|COMPLETED|Period 2 (14 Days)||10
6473972|NCT01272869|7391403|FG000|NOT COMPLETED|Period 2 (14 Days)||1
6473973|NCT01272869|7391404|FG001|NOT COMPLETED|Period 2 (14 Days)||0
6473974|NCT01272882|7391410|FG000|STARTED|Overall Study||13
6473975|NCT01272882|7391410|FG000|COMPLETED|Overall Study||13
6473976|NCT01272882|7391410|FG000|NOT COMPLETED|Overall Study||0
6473977|NCT01272908|7391414|FG000|STARTED|Initial Treatment Period||120
6473978|NCT01272908|7391414|FG000|COMPLETED|Initial Treatment Period||112
6473979|NCT01272908|7391414|FG000|NOT COMPLETED|Initial Treatment Period||8
6473980|NCT01272908|7391414|FG000|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
6473981|NCT01272908|7391414|FG000|COMPLETED|Re-Treatment Period||71
6473982|NCT01272908|7391414|FG000|NOT COMPLETED|Re-Treatment Period||6
6473983|NCT01272921|7391422|FG000|STARTED|Overall Study||71
6473984|NCT01272921|7391423|FG001|STARTED|Overall Study||71
6473985|NCT01272921|7391422|FG000|COMPLETED|Overall Study||69
6473986|NCT01272921|7391423|FG001|COMPLETED|Overall Study||70
6473987|NCT01272921|7391422|FG000|NOT COMPLETED|Overall Study||2
6473988|NCT01272921|7391423|FG001|NOT COMPLETED|Overall Study||1
6473989|NCT01272934|7391433|FG000|STARTED|Overall Study||102
6473990|NCT01272934|7391434|FG001|STARTED|Overall Study||103
6473991|NCT01272934|7391433|FG000|COMPLETED|Overall Study||102
6473992|NCT01272934|7391434|FG001|COMPLETED|Overall Study||101
6473993|NCT01272934|7391433|FG000|NOT COMPLETED|Overall Study||0
6473994|NCT01272934|7391434|FG001|NOT COMPLETED|Overall Study||2
6473995|NCT01272947|7391443|FG000|STARTED|Overall Study||104
6473996|NCT01272947|7391444|FG001|STARTED|Overall Study||100
6473997|NCT01272947|7391443|FG000|COMPLETED|Overall Study||102
6473998|NCT01272947|7391444|FG001|COMPLETED|Overall Study||98
6473999|NCT01272947|7391443|FG000|NOT COMPLETED|Overall Study||2
6474000|NCT01272947|7391444|FG001|NOT COMPLETED|Overall Study||2
6474001|NCT01272960|7391452|FG000|STARTED|Overall Study||14
6474002|NCT01272960|7391453|FG001|STARTED|Overall Study||15
6474003|NCT01272960|7391452|FG000|COMPLETED|Overall Study||14
6474004|NCT01272960|7391453|FG001|COMPLETED|Overall Study||15
6474005|NCT01272960|7391452|FG000|NOT COMPLETED|Overall Study||0
6474006|NCT01272960|7391453|FG001|NOT COMPLETED|Overall Study||0
6554519|NCT01747499|7476639|FG004|NOT COMPLETED|Overall Study||15
6746870|NCT03380091|7674575|FG001|COMPLETED|Overall Study||1
6746871|NCT03380091|7674574|FG000|NOT COMPLETED|Overall Study||2
6746872|NCT03380091|7674575|FG001|NOT COMPLETED|Overall Study||1
6474007|NCT01272999|7391464|FG000|STARTED|Overall Study||357
6474008|NCT01272999|7391465|FG001|STARTED|Overall Study||34
6474009|NCT01272999|7391464|FG000|COMPLETED|Overall Study||357
6474010|NCT01272999|7391465|FG001|COMPLETED|Overall Study||34
6474011|NCT01272999|7391464|FG000|NOT COMPLETED|Overall Study||0
6474012|NCT01272999|7391465|FG001|NOT COMPLETED|Overall Study||0
6474013|NCT01273038|7391473|FG000|STARTED|First Intervention (14 Days)||10
6474014|NCT01273038|7391474|FG001|STARTED|First Intervention (14 Days)||10
6474015|NCT01273038|7391473|FG000|COMPLETED|First Intervention (14 Days)||10
6474016|NCT01273038|7391474|FG001|COMPLETED|First Intervention (14 Days)||10
6474017|NCT01273038|7391473|FG000|NOT COMPLETED|First Intervention (14 Days)||0
6474018|NCT01273038|7391474|FG001|NOT COMPLETED|First Intervention (14 Days)||0
6474019|NCT01273038|7391473|FG000|STARTED|Second Intervention (14 Days)||10
6474020|NCT01273038|7391474|FG001|STARTED|Second Intervention (14 Days)||10
6474021|NCT01273038|7391473|FG000|COMPLETED|Second Intervention (14 Days)||10
6746873|NCT03380390|7674583|FG000|STARTED|Overall Study||46
6746874|NCT03380390|7674583|FG000|COMPLETED|Overall Study||43
6746875|NCT03380390|7674583|FG000|NOT COMPLETED|Overall Study||3
6746876|NCT03380429|7674592|FG000|STARTED|Overall Study||87
6746877|NCT03380429|7674593|FG001|STARTED|Overall Study||88
6746878|NCT03380429|7674594|FG002|STARTED|Overall Study||88
6746879|NCT03380429|7674595|FG003|STARTED|Overall Study||88
6746880|NCT03380429|7674596|FG004|STARTED|Overall Study||86
6746881|NCT03380429|7674592|FG000|COMPLETED|Overall Study||82
6746882|NCT03380429|7674593|FG001|COMPLETED|Overall Study||81
6746883|NCT03380429|7674594|FG002|COMPLETED|Overall Study||77
6746884|NCT03380429|7674595|FG003|COMPLETED|Overall Study||78
6746885|NCT03380429|7674596|FG004|COMPLETED|Overall Study||81
6746886|NCT03380429|7674592|FG000|NOT COMPLETED|Overall Study||5
6746887|NCT03380429|7674593|FG001|NOT COMPLETED|Overall Study||7
6746888|NCT03380429|7674594|FG002|NOT COMPLETED|Overall Study||11
6746889|NCT03380429|7674595|FG003|NOT COMPLETED|Overall Study||10
6746890|NCT03380429|7674596|FG004|NOT COMPLETED|Overall Study||5
6746891|NCT03380572|7674615|FG000|STARTED|Overall Study||20
6746892|NCT03380572|7674616|FG001|STARTED|Overall Study||20
6746893|NCT03380572|7674615|FG000|COMPLETED|Overall Study||20
6746894|NCT03380572|7674616|FG001|COMPLETED|Overall Study||20
6746895|NCT03380572|7674615|FG000|NOT COMPLETED|Overall Study||0
6746896|NCT03380572|7674616|FG001|NOT COMPLETED|Overall Study||0
6746897|NCT03380624|7674622|FG000|STARTED|Overall Study||10
6746898|NCT03380624|7674623|FG001|STARTED|Overall Study||9
6474022|NCT01273038|7391474|FG001|COMPLETED|Second Intervention (14 Days)||8
6474023|NCT01273038|7391473|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
6474024|NCT01273038|7391474|FG001|NOT COMPLETED|Second Intervention (14 Days)||2
6474025|NCT01273155|7391484|FG000|STARTED|Overall Study||14
6474026|NCT01273155|7391485|FG001|STARTED|Overall Study||12
6474027|NCT01273155|7391486|FG002|STARTED|Overall Study||18
6474028|NCT01273155|7391487|FG003|STARTED|Overall Study||5
6474029|NCT01273155|7391488|FG004|STARTED|Overall Study||5
6474030|NCT01273155|7391489|FG005|STARTED|Overall Study||10
6746899|NCT03380624|7674622|FG000|COMPLETED|Overall Study||10
6474031|NCT01273155|7391490|FG006|STARTED|Overall Study||8
6474032|NCT01273155|7391484|FG000|COMPLETED|Overall Study||12
6474033|NCT01273155|7391485|FG001|COMPLETED|Overall Study||8
6474034|NCT01273155|7391486|FG002|COMPLETED|Overall Study||6
6554520|NCT01747551|7476655|FG000|STARTED|Overall Study||43
6746900|NCT03380624|7674623|FG001|COMPLETED|Overall Study||9
6746901|NCT03380624|7674622|FG000|NOT COMPLETED|Overall Study||0
6746902|NCT03380624|7674623|FG001|NOT COMPLETED|Overall Study||0
6746903|NCT03380780|7674629|FG000|STARTED|Overall Study||16
6474035|NCT01273155|7391487|FG003|COMPLETED|Overall Study||4
6474036|NCT01273155|7391488|FG004|COMPLETED|Overall Study||3
6474037|NCT01273155|7391489|FG005|COMPLETED|Overall Study||5
6474038|NCT01273155|7391490|FG006|COMPLETED|Overall Study||2
6474039|NCT01273155|7391484|FG000|NOT COMPLETED|Overall Study||2
6474040|NCT01273155|7391485|FG001|NOT COMPLETED|Overall Study||4
6474041|NCT01273155|7391486|FG002|NOT COMPLETED|Overall Study||12
6474042|NCT01273155|7391487|FG003|NOT COMPLETED|Overall Study||1
6474043|NCT01273155|7391488|FG004|NOT COMPLETED|Overall Study||2
6474044|NCT01273155|7391489|FG005|NOT COMPLETED|Overall Study||5
6474045|NCT01273155|7391490|FG006|NOT COMPLETED|Overall Study||6
6474046|NCT01273181|7391517|FG000|STARTED|Phase I, Dose 1||3
6474047|NCT01273181|7391518|FG001|STARTED|Phase I, Dose 1||0
6474048|NCT01273181|7391519|FG002|STARTED|Phase I, Dose 1||0
6474049|NCT01273181|7391520|FG003|STARTED|Phase I, Dose 1||0
6474050|NCT01273181|7391517|FG000|COMPLETED|Phase I, Dose 1||2
6474051|NCT01273181|7391518|FG001|COMPLETED|Phase I, Dose 1||0
6474052|NCT01273181|7391519|FG002|COMPLETED|Phase I, Dose 1||0
6474053|NCT01273181|7391520|FG003|COMPLETED|Phase I, Dose 1||0
6474054|NCT01273181|7391517|FG000|NOT COMPLETED|Phase I, Dose 1||1
6474055|NCT01273181|7391518|FG001|NOT COMPLETED|Phase I, Dose 1||0
6474056|NCT01273181|7391519|FG002|NOT COMPLETED|Phase I, Dose 1||0
6474057|NCT01273181|7391520|FG003|NOT COMPLETED|Phase I, Dose 1||0
6474058|NCT01273181|7391517|FG000|STARTED|Phase I, Dose 2||0
6474059|NCT01273181|7391518|FG001|STARTED|Phase I, Dose 2||3
6474060|NCT01273181|7391519|FG002|STARTED|Phase I, Dose 2||0
6474061|NCT01273181|7391520|FG003|STARTED|Phase I, Dose 2||0
6474062|NCT01273181|7391517|FG000|COMPLETED|Phase I, Dose 2||0
6474063|NCT01273181|7391518|FG001|COMPLETED|Phase I, Dose 2||2
6474064|NCT01273181|7391519|FG002|COMPLETED|Phase I, Dose 2||0
6474065|NCT01273181|7391520|FG003|COMPLETED|Phase I, Dose 2||0
6474066|NCT01273181|7391517|FG000|NOT COMPLETED|Phase I, Dose 2||0
6474067|NCT01273181|7391518|FG001|NOT COMPLETED|Phase I, Dose 2||1
6474068|NCT01273181|7391519|FG002|NOT COMPLETED|Phase I, Dose 2||0
6474069|NCT01273181|7391520|FG003|NOT COMPLETED|Phase I, Dose 2||0
6474070|NCT01273181|7391517|FG000|STARTED|Phase 2, Dose 1||0
6474071|NCT01273181|7391518|FG001|STARTED|Phase 2, Dose 1||0
6474072|NCT01273181|7391519|FG002|STARTED|Phase 2, Dose 1||2
6474073|NCT01273181|7391520|FG003|STARTED|Phase 2, Dose 1||0
6474074|NCT01273181|7391517|FG000|COMPLETED|Phase 2, Dose 1||0
6474075|NCT01273181|7391518|FG001|COMPLETED|Phase 2, Dose 1||0
6474076|NCT01273181|7391519|FG002|COMPLETED|Phase 2, Dose 1||1
6474077|NCT01273181|7391520|FG003|COMPLETED|Phase 2, Dose 1||0
6474078|NCT01273181|7391517|FG000|NOT COMPLETED|Phase 2, Dose 1||0
6474079|NCT01273181|7391518|FG001|NOT COMPLETED|Phase 2, Dose 1||0
6474080|NCT01273181|7391519|FG002|NOT COMPLETED|Phase 2, Dose 1||1
6474081|NCT01273181|7391520|FG003|NOT COMPLETED|Phase 2, Dose 1||0
6474082|NCT01273181|7391517|FG000|STARTED|Phase 2, Dose 2||0
6474083|NCT01273181|7391518|FG001|STARTED|Phase 2, Dose 2||0
6474084|NCT01273181|7391519|FG002|STARTED|Phase 2, Dose 2||0
6474085|NCT01273181|7391520|FG003|STARTED|Phase 2, Dose 2||1
6474086|NCT01273181|7391517|FG000|COMPLETED|Phase 2, Dose 2||0
6474087|NCT01273181|7391518|FG001|COMPLETED|Phase 2, Dose 2||0
6474088|NCT01273181|7391519|FG002|COMPLETED|Phase 2, Dose 2||0
6474089|NCT01273181|7391520|FG003|COMPLETED|Phase 2, Dose 2||0
6474090|NCT01273181|7391517|FG000|NOT COMPLETED|Phase 2, Dose 2||0
6474091|NCT01273181|7391518|FG001|NOT COMPLETED|Phase 2, Dose 2||0
6474092|NCT01273181|7391519|FG002|NOT COMPLETED|Phase 2, Dose 2||0
6474093|NCT01273181|7391520|FG003|NOT COMPLETED|Phase 2, Dose 2||1
6474094|NCT01273207|7391534|FG000|STARTED|Overall Study||7
6474095|NCT01273207|7391534|FG000|COMPLETED|Overall Study||2
6474096|NCT01273207|7391534|FG000|NOT COMPLETED|Overall Study||5
6474097|NCT01273519|7391541|FG000|STARTED|Overall Study||78
6474098|NCT01273519|7391542|FG001|STARTED|Overall Study||30
6474099|NCT01273519|7391543|FG002|STARTED|Overall Study||47
6474100|NCT01273519|7391541|FG000|COMPLETED|Overall Study||59
6474101|NCT01273519|7391542|FG001|COMPLETED|Overall Study||25
6474102|NCT01273519|7391543|FG002|COMPLETED|Overall Study||39
6474103|NCT01273519|7391541|FG000|NOT COMPLETED|Overall Study||19
6474104|NCT01273519|7391542|FG001|NOT COMPLETED|Overall Study||5
6474105|NCT01273519|7391543|FG002|NOT COMPLETED|Overall Study||8
6474106|NCT01273597|7391554|FG000|STARTED|Overall Study||60
6474107|NCT01273597|7391554|FG000|COMPLETED|Overall Study||52
6474108|NCT01273597|7391554|FG000|NOT COMPLETED|Overall Study||8
6474109|NCT01273623|7391558|FG000|STARTED|Overall Study|met angiographic criteria|55
6474110|NCT01273623|7391558|FG000|COMPLETED|Overall Study|met IVUS criteria|26
6474111|NCT01273623|7391558|FG000|NOT COMPLETED|Overall Study||29
6474112|NCT01273766|7391567|FG000|STARTED|Overall Study||4
6474113|NCT01273766|7391568|FG001|STARTED|Overall Study||7
6474114|NCT01273766|7391569|FG002|STARTED|Overall Study||5
6474115|NCT01273766|7391567|FG000|COMPLETED|Overall Study||4
6474116|NCT01273766|7391568|FG001|COMPLETED|Overall Study||7
6474117|NCT01273766|7391569|FG002|COMPLETED|Overall Study||5
6474118|NCT01273766|7391567|FG000|NOT COMPLETED|Overall Study||0
6474119|NCT01273766|7391568|FG001|NOT COMPLETED|Overall Study||0
6474120|NCT01273766|7391569|FG002|NOT COMPLETED|Overall Study||0
6474121|NCT01273805|7391578|FG000|STARTED|Overall Study||10
6474122|NCT01273805|7391579|FG001|STARTED|Overall Study||10
6474123|NCT01273805|7391578|FG000|COMPLETED|Overall Study||0
6474124|NCT01273805|7391579|FG001|COMPLETED|Overall Study||0
6474125|NCT01273805|7391578|FG000|NOT COMPLETED|Overall Study||10
6474126|NCT01273805|7391579|FG001|NOT COMPLETED|Overall Study||10
6474127|NCT01273818|7391588|FG000|STARTED|Overall Study||100
6474128|NCT01273818|7391589|FG001|STARTED|Overall Study||100
6474129|NCT01273818|7391590|FG002|STARTED|Overall Study||100
6474130|NCT01273818|7391588|FG000|COMPLETED|Overall Study||87
6474131|NCT01273818|7391589|FG001|COMPLETED|Overall Study||98
6474132|NCT01273818|7391590|FG002|COMPLETED|Overall Study||91
6474133|NCT01273818|7391588|FG000|NOT COMPLETED|Overall Study||13
6474134|NCT01273818|7391589|FG001|NOT COMPLETED|Overall Study||2
6474135|NCT01273818|7391590|FG002|NOT COMPLETED|Overall Study||9
6474136|NCT01273857|7391600|FG000|STARTED|Overall Study||7
6474137|NCT01273857|7391601|FG001|STARTED|Overall Study||7
6474138|NCT01273857|7391600|FG000|COMPLETED|Overall Study||7
6474139|NCT01273857|7391601|FG001|COMPLETED|Overall Study||7
6474140|NCT01273857|7391600|FG000|NOT COMPLETED|Overall Study||0
6474141|NCT01273857|7391601|FG001|NOT COMPLETED|Overall Study||0
6474142|NCT01273883|7391607|FG000|STARTED|First Intervention|Received at least 1 dose of study drug.|19
6474143|NCT01273883|7391608|FG001|STARTED|First Intervention|Received at least 1 dose of study drug.|19
6474144|NCT01273883|7391607|FG000|COMPLETED|First Intervention||17
6474145|NCT01273883|7391608|FG001|COMPLETED|First Intervention||18
6474146|NCT01273883|7391607|FG000|NOT COMPLETED|First Intervention||2
6474147|NCT01273883|7391608|FG001|NOT COMPLETED|First Intervention||1
6474148|NCT01273883|7391607|FG000|STARTED|Washout Period of 2 Weeks||17
6474149|NCT01273883|7391608|FG001|STARTED|Washout Period of 2 Weeks||18
6474150|NCT01273883|7391607|FG000|COMPLETED|Washout Period of 2 Weeks||17
6474151|NCT01273883|7391608|FG001|COMPLETED|Washout Period of 2 Weeks||18
6474152|NCT01273883|7391607|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6474153|NCT01273883|7391608|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6474154|NCT01273883|7391607|FG000|STARTED|Second Intervention||17
6474155|NCT01273883|7391608|FG001|STARTED|Second Intervention||18
6474156|NCT01273883|7391607|FG000|COMPLETED|Second Intervention||15
6474157|NCT01273883|7391608|FG001|COMPLETED|Second Intervention||17
6474158|NCT01273883|7391607|FG000|NOT COMPLETED|Second Intervention||2
6474159|NCT01273883|7391608|FG001|NOT COMPLETED|Second Intervention||1
6474160|NCT01273896|7391614|FG000|STARTED|Overall Study||22
6474161|NCT01273896|7391614|FG000|COMPLETED|Overall Study||22
6474162|NCT01273896|7391614|FG000|NOT COMPLETED|Overall Study||0
6474163|NCT01274182|7391621|FG000|STARTED|Overall Study||133
6474164|NCT01274182|7391622|FG001|STARTED|Overall Study||87
6474165|NCT01274182|7391623|FG002|STARTED|Overall Study||92
6474166|NCT01274182|7391621|FG000|24 Weeks|Overall Study||123
6474167|NCT01274182|7391622|FG001|24 Weeks|Overall Study||83
6474168|NCT01274182|7391623|FG002|24 Weeks|Overall Study||84
6474169|NCT01274182|7391621|FG000|COMPLETED|Overall Study||112
6474170|NCT01274182|7391622|FG001|COMPLETED|Overall Study||69
6654556|NCT02446717|7584415|FG002|COMPLETED|Overall Study||20
6654557|NCT02446717|7584416|FG003|COMPLETED|Overall Study||43
6654558|NCT02446717|7584417|FG004|COMPLETED|Overall Study||46
6654559|NCT02446717|7584413|FG000|NOT COMPLETED|Overall Study||0
6654560|NCT02446717|7584414|FG001|NOT COMPLETED|Overall Study||1
6654561|NCT02446717|7584415|FG002|NOT COMPLETED|Overall Study||2
6654562|NCT02446717|7584416|FG003|NOT COMPLETED|Overall Study||1
6654563|NCT02446717|7584417|FG004|NOT COMPLETED|Overall Study||1
6654564|NCT02446743|7584431|FG000|STARTED|Overall Study||276
6654565|NCT02446743|7584432|FG001|STARTED|Overall Study||255
6654566|NCT02446743|7584431|FG000|COMPLETED|Overall Study||271
6654567|NCT02446743|7584432|FG001|COMPLETED|Overall Study||250
6474171|NCT01274182|7391623|FG002|COMPLETED|Overall Study||80
6474172|NCT01274182|7391621|FG000|NOT COMPLETED|Overall Study||21
6474173|NCT01274182|7391622|FG001|NOT COMPLETED|Overall Study||18
6474174|NCT01274182|7391623|FG002|NOT COMPLETED|Overall Study||12
6474175|NCT01274338|7391641|FG000|STARTED|Overall Study||511
6474176|NCT01274338|7391642|FG001|STARTED|Overall Study||636
6474177|NCT01274338|7391643|FG002|STARTED|Overall Study||523
6474178|NCT01274338|7391644|FG003|STARTED|Overall Study||1
6474179|NCT01274338|7391645|FG004|STARTED|Overall Study||1
6474180|NCT01274338|7391646|FG005|STARTED|Overall Study||1
6474181|NCT01274338|7391641|FG000|Received Treatment|Overall Study||503
6474182|NCT01274338|7391642|FG001|Received Treatment|Overall Study||520
6474183|NCT01274338|7391643|FG002|Received Treatment|Overall Study||516
6474184|NCT01274338|7391644|FG003|Received Treatment|Overall Study||1
6474185|NCT01274338|7391645|FG004|Received Treatment|Overall Study||1
6474186|NCT01274338|7391646|FG005|Received Treatment|Overall Study||1
6474187|NCT01274338|7391641|FG000|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||110
6474188|NCT01274338|7391642|FG001|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||114
6474189|NCT01274338|7391643|FG002|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||97
6474190|NCT01274338|7391644|FG003|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
6474191|NCT01274338|7391645|FG004|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
6474192|NCT01274338|7391646|FG005|Data Available for the FACT-G and FACT-BRM Analyses|Overall Study||0
6474193|NCT01274338|7391641|FG000|Data Available for FACIT-D Analysis|Overall Study||109
6474194|NCT01274338|7391642|FG001|Data Available for FACIT-D Analysis|Overall Study||114
6474195|NCT01274338|7391643|FG002|Data Available for FACIT-D Analysis|Overall Study||97
6474196|NCT01274338|7391644|FG003|Data Available for FACIT-D Analysis|Overall Study||0
6474197|NCT01274338|7391645|FG004|Data Available for FACIT-D Analysis|Overall Study||0
6474198|NCT01274338|7391646|FG005|Data Available for FACIT-D Analysis|Overall Study||0
6474199|NCT01274338|7391641|FG000|COMPLETED|Overall Study||108
6474200|NCT01274338|7391642|FG001|COMPLETED|Overall Study||182
6474201|NCT01274338|7391643|FG002|COMPLETED|Overall Study||198
6474202|NCT01274338|7391644|FG003|COMPLETED|Overall Study||0
6474203|NCT01274338|7391645|FG004|COMPLETED|Overall Study||0
6474204|NCT01274338|7391646|FG005|COMPLETED|Overall Study||1
6474205|NCT01274338|7391641|FG000|NOT COMPLETED|Overall Study||403
6474206|NCT01274338|7391642|FG001|NOT COMPLETED|Overall Study||454
6474207|NCT01274338|7391643|FG002|NOT COMPLETED|Overall Study||325
6474208|NCT01274338|7391644|FG003|NOT COMPLETED|Overall Study||1
6474209|NCT01274338|7391645|FG004|NOT COMPLETED|Overall Study||1
6474210|NCT01274338|7391646|FG005|NOT COMPLETED|Overall Study||0
6474211|NCT01274351|7391659|FG000|STARTED|Overall Study||112
6474212|NCT01274351|7391659|FG000|COMPLETED|Overall Study||92
6474213|NCT01274351|7391659|FG000|NOT COMPLETED|Overall Study||20
6474214|NCT01274520|7391665|FG000|STARTED|Overall Study||25
6474215|NCT01274520|7391666|FG001|STARTED|Overall Study||24
6474216|NCT01274520|7391665|FG000|COMPLETED|Overall Study||25
6474217|NCT01274520|7391666|FG001|COMPLETED|Overall Study||24
6474218|NCT01274520|7391665|FG000|NOT COMPLETED|Overall Study||0
6474219|NCT01274520|7391666|FG001|NOT COMPLETED|Overall Study||0
6474220|NCT01274585|7391677|FG000|STARTED|Overall Study||2
6474221|NCT01274585|7391678|FG001|STARTED|Overall Study||3
6474222|NCT01274585|7391677|FG000|COMPLETED|Overall Study||2
6474223|NCT01274585|7391678|FG001|COMPLETED|Overall Study||3
6474224|NCT01274585|7391677|FG000|NOT COMPLETED|Overall Study||0
6474225|NCT01274585|7391678|FG001|NOT COMPLETED|Overall Study||0
6474226|NCT01274637|7391686|FG000|STARTED|Overall Study||30
6474227|NCT01274637|7391687|FG001|STARTED|Overall Study||32
6474228|NCT01274637|7391686|FG000|COMPLETED|Overall Study||30
6474229|NCT01274637|7391687|FG001|COMPLETED|Overall Study||30
6474230|NCT01274637|7391686|FG000|NOT COMPLETED|Overall Study||0
6474231|NCT01274637|7391687|FG001|NOT COMPLETED|Overall Study||2
6474232|NCT01274715|7391693|FG000|STARTED|Overall Study||12
6474233|NCT01274715|7391693|FG000|Screened Out at Baseline|Overall Study||3
6474234|NCT01274715|7391693|FG000|COMPLETED|Overall Study||8
6474235|NCT01274715|7391693|FG000|NOT COMPLETED|Overall Study||4
6474236|NCT01274897|7391699|FG000|STARTED|Overall Study||297
6474237|NCT01274897|7391700|FG001|STARTED|Overall Study||153
6474238|NCT01274897|7391699|FG000|COMPLETED|Overall Study||297
6474239|NCT01274897|7391700|FG001|COMPLETED|Overall Study||153
6474240|NCT01274897|7391699|FG000|NOT COMPLETED|Overall Study||0
6474241|NCT01274897|7391700|FG001|NOT COMPLETED|Overall Study||0
6474242|NCT01275053|7391706|FG000|STARTED|Overall Study||12
6474243|NCT01275053|7391706|FG000|COMPLETED|Overall Study||12
6474244|NCT01275053|7391706|FG000|NOT COMPLETED|Overall Study||0
6474245|NCT01275066|7391713|FG000|STARTED|Overall Study||60
6474246|NCT01275066|7391714|FG001|STARTED|Overall Study||59
6474247|NCT01275066|7391715|FG002|STARTED|Overall Study||58
6474248|NCT01275066|7391713|FG000|Treated|Overall Study||59
6474249|NCT01275066|7391714|FG001|Treated|Overall Study||59
6474250|NCT01275066|7391715|FG002|Treated|Overall Study||58
6474251|NCT01275066|7391713|FG000|COMPLETED|Overall Study||59
6474252|NCT01275066|7391714|FG001|COMPLETED|Overall Study||59
6474253|NCT01275066|7391715|FG002|COMPLETED|Overall Study||57
6474254|NCT01275066|7391713|FG000|NOT COMPLETED|Overall Study||1
6474255|NCT01275066|7391714|FG001|NOT COMPLETED|Overall Study||0
6474256|NCT01275066|7391715|FG002|NOT COMPLETED|Overall Study||1
6474257|NCT01275092|7391723|FG000|STARTED|Overall Study||164
6474258|NCT01275092|7391723|FG000|COMPLETED|Overall Study||164
6474259|NCT01275092|7391723|FG000|NOT COMPLETED|Overall Study||0
6474260|NCT01275131|7391731|FG000|STARTED|Period 1||11
6474261|NCT01275131|7391732|FG001|STARTED|Period 1||9
6474262|NCT01275131|7391733|FG002|STARTED|Period 1||13
6474263|NCT01275131|7391734|FG003|STARTED|Period 1||12
6474264|NCT01275131|7391731|FG000|Received at Least One Dose of Study Drug|Period 1||11
6474265|NCT01275131|7391732|FG001|Received at Least One Dose of Study Drug|Period 1||9
6474266|NCT01275131|7391733|FG002|Received at Least One Dose of Study Drug|Period 1||13
6474267|NCT01275131|7391734|FG003|Received at Least One Dose of Study Drug|Period 1||12
6474268|NCT01275131|7391731|FG000|COMPLETED|Period 1||9
6474269|NCT01275131|7391732|FG001|COMPLETED|Period 1||9
6474270|NCT01275131|7391733|FG002|COMPLETED|Period 1||10
6474271|NCT01275131|7391734|FG003|COMPLETED|Period 1||10
6474272|NCT01275131|7391731|FG000|NOT COMPLETED|Period 1||2
6474273|NCT01275131|7391732|FG001|NOT COMPLETED|Period 1||0
6474274|NCT01275131|7391733|FG002|NOT COMPLETED|Period 1||3
6474275|NCT01275131|7391734|FG003|NOT COMPLETED|Period 1||2
6474276|NCT01275131|7391731|FG000|STARTED|5- to 14-Day Washout Period||9
6474277|NCT01275131|7391732|FG001|STARTED|5- to 14-Day Washout Period||9
6474278|NCT01275131|7391733|FG002|STARTED|5- to 14-Day Washout Period||10
6474279|NCT01275131|7391734|FG003|STARTED|5- to 14-Day Washout Period||10
6474280|NCT01275131|7391731|FG000|COMPLETED|5- to 14-Day Washout Period||9
6474281|NCT01275131|7391732|FG001|COMPLETED|5- to 14-Day Washout Period||9
6474282|NCT01275131|7391733|FG002|COMPLETED|5- to 14-Day Washout Period||10
6474283|NCT01275131|7391734|FG003|COMPLETED|5- to 14-Day Washout Period||10
6474284|NCT01275131|7391731|FG000|NOT COMPLETED|5- to 14-Day Washout Period||0
6474285|NCT01275131|7391732|FG001|NOT COMPLETED|5- to 14-Day Washout Period||0
6474286|NCT01275131|7391733|FG002|NOT COMPLETED|5- to 14-Day Washout Period||0
6474287|NCT01275131|7391734|FG003|NOT COMPLETED|5- to 14-Day Washout Period||0
6474288|NCT01275131|7391731|FG000|STARTED|Period 2 (Crossover)||9
6474289|NCT01275131|7391732|FG001|STARTED|Period 2 (Crossover)||9
6474290|NCT01275131|7391733|FG002|STARTED|Period 2 (Crossover)||10
6474291|NCT01275131|7391734|FG003|STARTED|Period 2 (Crossover)||10
6474292|NCT01275131|7391731|FG000|COMPLETED|Period 2 (Crossover)||8
6474293|NCT01275131|7391732|FG001|COMPLETED|Period 2 (Crossover)||8
6474294|NCT01275131|7391733|FG002|COMPLETED|Period 2 (Crossover)||9
6474295|NCT01275131|7391734|FG003|COMPLETED|Period 2 (Crossover)||8
6474296|NCT01275131|7391731|FG000|NOT COMPLETED|Period 2 (Crossover)||1
6474297|NCT01275131|7391732|FG001|NOT COMPLETED|Period 2 (Crossover)||1
6474298|NCT01275131|7391733|FG002|NOT COMPLETED|Period 2 (Crossover)||1
6474299|NCT01275131|7391734|FG003|NOT COMPLETED|Period 2 (Crossover)||2
6474300|NCT01275144|7391752|FG000|STARTED|First Intervention (6 Days)||14
6474301|NCT01275144|7391753|FG001|STARTED|First Intervention (6 Days)||14
6474302|NCT01275144|7391752|FG000|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
6474303|NCT01275144|7391753|FG001|Received at Least 1 Dose of Study Drug|First Intervention (6 Days)||14
6474304|NCT01275144|7391752|FG000|COMPLETED|First Intervention (6 Days)||14
6554521|NCT01747551|7476656|FG001|STARTED|Overall Study||21
6554522|NCT01747551|7476655|FG000|COMPLETED|Overall Study||0
6554523|NCT01747551|7476656|FG001|COMPLETED|Overall Study||0
6474305|NCT01275144|7391753|FG001|COMPLETED|First Intervention (6 Days)||14
6474306|NCT01275144|7391752|FG000|NOT COMPLETED|First Intervention (6 Days)||0
6474307|NCT01275144|7391753|FG001|NOT COMPLETED|First Intervention (6 Days)||0
6474308|NCT01275144|7391752|FG000|STARTED|Washout (7 Days)||14
6474309|NCT01275144|7391753|FG001|STARTED|Washout (7 Days)||14
6474310|NCT01275144|7391752|FG000|COMPLETED|Washout (7 Days)||14
6474311|NCT01275144|7391753|FG001|COMPLETED|Washout (7 Days)||14
6474312|NCT01275144|7391752|FG000|NOT COMPLETED|Washout (7 Days)||0
6474313|NCT01275144|7391753|FG001|NOT COMPLETED|Washout (7 Days)||0
6474314|NCT01275144|7391752|FG000|STARTED|Second Intervention (6 Days)||14
6474315|NCT01275144|7391753|FG001|STARTED|Second Intervention (6 Days)||14
6474316|NCT01275144|7391752|FG000|COMPLETED|Second Intervention (6 Days)||13
6474317|NCT01275144|7391753|FG001|COMPLETED|Second Intervention (6 Days)||14
6474318|NCT01275144|7391752|FG000|NOT COMPLETED|Second Intervention (6 Days)||1
6474319|NCT01275144|7391753|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
6474320|NCT01275170|7391769|FG000|STARTED|Part 1: Period 1||7
6474321|NCT01275170|7391770|FG001|STARTED|Part 1: Period 1||6
6474322|NCT01275170|7391771|FG002|STARTED|Part 1: Period 1||6
6474323|NCT01275170|7391772|FG003|STARTED|Part 1: Period 1||6
6474324|NCT01275170|7391773|FG004|STARTED|Part 1: Period 1||6
6474325|NCT01275170|7391774|FG005|STARTED|Part 1: Period 1||6
6474326|NCT01275170|7391775|FG006|STARTED|Part 1: Period 1||6
6474327|NCT01275170|7391776|FG007|STARTED|Part 1: Period 1||6
6474328|NCT01275170|7391769|FG000|Treated|Part 1: Period 1||6
6474329|NCT01275170|7391770|FG001|Treated|Part 1: Period 1||6
6474330|NCT01275170|7391771|FG002|Treated|Part 1: Period 1||6
6474331|NCT01275170|7391772|FG003|Treated|Part 1: Period 1||6
6474332|NCT01275170|7391773|FG004|Treated|Part 1: Period 1||6
6474333|NCT01275170|7391774|FG005|Treated|Part 1: Period 1||6
6474334|NCT01275170|7391775|FG006|Treated|Part 1: Period 1||6
6474335|NCT01275170|7391776|FG007|Treated|Part 1: Period 1||6
6474336|NCT01275170|7391769|FG000|COMPLETED|Part 1: Period 1||6
6474337|NCT01275170|7391770|FG001|COMPLETED|Part 1: Period 1||6
6474338|NCT01275170|7391771|FG002|COMPLETED|Part 1: Period 1||6
6474339|NCT01275170|7391772|FG003|COMPLETED|Part 1: Period 1||6
6474340|NCT01275170|7391773|FG004|COMPLETED|Part 1: Period 1||6
6474341|NCT01275170|7391774|FG005|COMPLETED|Part 1: Period 1||6
6474342|NCT01275170|7391775|FG006|COMPLETED|Part 1: Period 1||6
6474343|NCT01275170|7391776|FG007|COMPLETED|Part 1: Period 1||6
6474344|NCT01275170|7391769|FG000|NOT COMPLETED|Part 1: Period 1||1
6474345|NCT01275170|7391770|FG001|NOT COMPLETED|Part 1: Period 1||0
6474346|NCT01275170|7391771|FG002|NOT COMPLETED|Part 1: Period 1||0
6474347|NCT01275170|7391772|FG003|NOT COMPLETED|Part 1: Period 1||0
6474348|NCT01275170|7391773|FG004|NOT COMPLETED|Part 1: Period 1||0
6474349|NCT01275170|7391774|FG005|NOT COMPLETED|Part 1: Period 1||0
6474350|NCT01275170|7391775|FG006|NOT COMPLETED|Part 1: Period 1||0
6474351|NCT01275170|7391776|FG007|NOT COMPLETED|Part 1: Period 1||0
6474352|NCT01275170|7391769|FG000|STARTED|Part 1: Period 2|Panel A participated in Part 1, Period 1 only.|0
6474353|NCT01275170|7391770|FG001|STARTED|Part 1: Period 2|Panel B participated in Part 1, Period 1 only.|0
6474354|NCT01275170|7391771|FG002|STARTED|Part 1: Period 2|Panel C participated in Part 1, Period 1 only.|0
6474355|NCT01275170|7391772|FG003|STARTED|Part 1: Period 2|Panel D participated in Part 1, Period 1 only.|0
6474356|NCT01275170|7391773|FG004|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
6474357|NCT01275170|7391774|FG005|STARTED|Part 1: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
6474358|NCT01275170|7391775|FG006|STARTED|Part 1: Period 2||6
6474359|NCT01275170|7391776|FG007|STARTED|Part 1: Period 2||6
6474360|NCT01275170|7391769|FG000|COMPLETED|Part 1: Period 2||0
6474361|NCT01275170|7391770|FG001|COMPLETED|Part 1: Period 2||0
6474362|NCT01275170|7391771|FG002|COMPLETED|Part 1: Period 2||0
6474363|NCT01275170|7391772|FG003|COMPLETED|Part 1: Period 2||0
6474364|NCT01275170|7391773|FG004|COMPLETED|Part 1: Period 2||0
6474365|NCT01275170|7391774|FG005|COMPLETED|Part 1: Period 2||0
6474366|NCT01275170|7391775|FG006|COMPLETED|Part 1: Period 2||6
6474367|NCT01275170|7391776|FG007|COMPLETED|Part 1: Period 2||6
6474368|NCT01275170|7391769|FG000|NOT COMPLETED|Part 1: Period 2||0
6474369|NCT01275170|7391770|FG001|NOT COMPLETED|Part 1: Period 2||0
6474370|NCT01275170|7391771|FG002|NOT COMPLETED|Part 1: Period 2||0
6474371|NCT01275170|7391772|FG003|NOT COMPLETED|Part 1: Period 2||0
6474372|NCT01275170|7391773|FG004|NOT COMPLETED|Part 1: Period 2||0
6474373|NCT01275170|7391774|FG005|NOT COMPLETED|Part 1: Period 2||0
6554524|NCT01747551|7476655|FG000|NOT COMPLETED|Overall Study||43
6474374|NCT01275170|7391775|FG006|NOT COMPLETED|Part 1: Period 2||0
6474375|NCT01275170|7391776|FG007|NOT COMPLETED|Part 1: Period 2||0
6474376|NCT01275170|7391769|FG000|STARTED|Part 2: Period 1||0
6474377|NCT01275170|7391770|FG001|STARTED|Part 2: Period 1||0
6474378|NCT01275170|7391771|FG002|STARTED|Part 2: Period 1||0
6474379|NCT01275170|7391772|FG003|STARTED|Part 2: Period 1||0
6474380|NCT01275170|7391773|FG004|STARTED|Part 2: Period 1||6
6474381|NCT01275170|7391774|FG005|STARTED|Part 2: Period 1||6
6474382|NCT01275170|7391775|FG006|STARTED|Part 2: Period 1||6
6474383|NCT01275170|7391776|FG007|STARTED|Part 2: Period 1||6
6474384|NCT01275170|7391769|FG000|COMPLETED|Part 2: Period 1||0
6474385|NCT01275170|7391770|FG001|COMPLETED|Part 2: Period 1||0
6474386|NCT01275170|7391771|FG002|COMPLETED|Part 2: Period 1||0
6474387|NCT01275170|7391772|FG003|COMPLETED|Part 2: Period 1||0
6474388|NCT01275170|7391773|FG004|COMPLETED|Part 2: Period 1||6
6474389|NCT01275170|7391774|FG005|COMPLETED|Part 2: Period 1||6
6474390|NCT01275170|7391775|FG006|COMPLETED|Part 2: Period 1||6
6474391|NCT01275170|7391776|FG007|COMPLETED|Part 2: Period 1||6
6474392|NCT01275170|7391769|FG000|NOT COMPLETED|Part 2: Period 1||0
6474393|NCT01275170|7391770|FG001|NOT COMPLETED|Part 2: Period 1||0
6474394|NCT01275170|7391771|FG002|NOT COMPLETED|Part 2: Period 1||0
6474395|NCT01275170|7391772|FG003|NOT COMPLETED|Part 2: Period 1||0
6474396|NCT01275170|7391773|FG004|NOT COMPLETED|Part 2: Period 1||0
6474397|NCT01275170|7391774|FG005|NOT COMPLETED|Part 2: Period 1||0
6474398|NCT01275170|7391775|FG006|NOT COMPLETED|Part 2: Period 1||0
6474399|NCT01275170|7391776|FG007|NOT COMPLETED|Part 2: Period 1||0
6474400|NCT01275170|7391769|FG000|STARTED|Part 2: Period 2||0
6474401|NCT01275170|7391770|FG001|STARTED|Part 2: Period 2||0
6474402|NCT01275170|7391771|FG002|STARTED|Part 2: Period 2||0
6474403|NCT01275170|7391772|FG003|STARTED|Part 2: Period 2||0
6474404|NCT01275170|7391773|FG004|STARTED|Part 2: Period 2|Panel E participated in Part 1, Period 1 and Part 2, Period 1.|0
6474405|NCT01275170|7391774|FG005|STARTED|Part 2: Period 2|Panel F participated in Part 1, Period 1 and Part 2, Period 1.|0
6474406|NCT01275170|7391775|FG006|STARTED|Part 2: Period 2||6
6474407|NCT01275170|7391776|FG007|STARTED|Part 2: Period 2||6
6474408|NCT01275170|7391769|FG000|COMPLETED|Part 2: Period 2||0
6474409|NCT01275170|7391770|FG001|COMPLETED|Part 2: Period 2||0
6474410|NCT01275170|7391771|FG002|COMPLETED|Part 2: Period 2||0
6474411|NCT01275170|7391772|FG003|COMPLETED|Part 2: Period 2||0
6474412|NCT01275170|7391773|FG004|COMPLETED|Part 2: Period 2||0
6474413|NCT01275170|7391774|FG005|COMPLETED|Part 2: Period 2||0
6474414|NCT01275170|7391775|FG006|COMPLETED|Part 2: Period 2||6
6474415|NCT01275170|7391776|FG007|COMPLETED|Part 2: Period 2||6
6474416|NCT01275170|7391769|FG000|NOT COMPLETED|Part 2: Period 2||0
6474417|NCT01275170|7391770|FG001|NOT COMPLETED|Part 2: Period 2||0
6474418|NCT01275170|7391771|FG002|NOT COMPLETED|Part 2: Period 2||0
6474419|NCT01275170|7391772|FG003|NOT COMPLETED|Part 2: Period 2||0
6474420|NCT01275170|7391773|FG004|NOT COMPLETED|Part 2: Period 2||0
6474421|NCT01275170|7391774|FG005|NOT COMPLETED|Part 2: Period 2||0
6474422|NCT01275170|7391775|FG006|NOT COMPLETED|Part 2: Period 2||0
6474423|NCT01275170|7391776|FG007|NOT COMPLETED|Part 2: Period 2||0
6474424|NCT01275196|7391811|FG000|STARTED|Overall Study||133
6474425|NCT01275196|7391812|FG001|STARTED|Overall Study||134
6474426|NCT01275196|7391811|FG000|Intended to Continue Into Extension|Overall Study||112
6474427|NCT01275196|7391812|FG001|Intended to Continue Into Extension|Overall Study||113
6474428|NCT01275196|7391811|FG000|COMPLETED|Overall Study||113
6474429|NCT01275196|7391812|FG001|COMPLETED|Overall Study||113
6474430|NCT01275196|7391811|FG000|NOT COMPLETED|Overall Study||20
6474431|NCT01275196|7391812|FG001|NOT COMPLETED|Overall Study||21
6474432|NCT01275222|7391826|FG000|STARTED|Phase l by Treatment||13
6474433|NCT01275222|7391827|FG001|STARTED|Phase l by Treatment||13
6474434|NCT01275222|7391828|FG002|STARTED|Phase l by Treatment||5
6474435|NCT01275222|7391829|FG003|STARTED|Phase l by Treatment||11
6474436|NCT01275222|7391830|FG004|STARTED|Phase l by Treatment||0
6474437|NCT01275222|7391831|FG005|STARTED|Phase l by Treatment||0
6474438|NCT01275222|7391826|FG000|COMPLETED|Phase l by Treatment||0
6474439|NCT01275222|7391827|FG001|COMPLETED|Phase l by Treatment||0
6474440|NCT01275222|7391828|FG002|COMPLETED|Phase l by Treatment||0
6474441|NCT01275222|7391829|FG003|COMPLETED|Phase l by Treatment||0
6474442|NCT01275222|7391830|FG004|COMPLETED|Phase l by Treatment||0
6474443|NCT01275222|7391831|FG005|COMPLETED|Phase l by Treatment||0
6474444|NCT01275222|7391826|FG000|NOT COMPLETED|Phase l by Treatment||13
6474445|NCT01275222|7391827|FG001|NOT COMPLETED|Phase l by Treatment||13
6474446|NCT01275222|7391828|FG002|NOT COMPLETED|Phase l by Treatment||5
6474447|NCT01275222|7391829|FG003|NOT COMPLETED|Phase l by Treatment||11
6474448|NCT01275222|7391830|FG004|NOT COMPLETED|Phase l by Treatment||0
6474449|NCT01275222|7391831|FG005|NOT COMPLETED|Phase l by Treatment||0
6474450|NCT01275222|7391826|FG000|STARTED|Phase ll by Stratum||0
6474451|NCT01275222|7391827|FG001|STARTED|Phase ll by Stratum||0
6474452|NCT01275222|7391828|FG002|STARTED|Phase ll by Stratum||0
6474453|NCT01275222|7391829|FG003|STARTED|Phase ll by Stratum||0
6474454|NCT01275222|7391830|FG004|STARTED|Phase ll by Stratum||28
6474455|NCT01275222|7391831|FG005|STARTED|Phase ll by Stratum||47
6474456|NCT01275222|7391826|FG000|COMPLETED|Phase ll by Stratum||0
6474457|NCT01275222|7391827|FG001|COMPLETED|Phase ll by Stratum||0
6474458|NCT01275222|7391828|FG002|COMPLETED|Phase ll by Stratum||0
6474459|NCT01275222|7391829|FG003|COMPLETED|Phase ll by Stratum||0
6474460|NCT01275222|7391830|FG004|COMPLETED|Phase ll by Stratum||0
6474461|NCT01275222|7391831|FG005|COMPLETED|Phase ll by Stratum||1
6474462|NCT01275222|7391826|FG000|NOT COMPLETED|Phase ll by Stratum||0
6474463|NCT01275222|7391827|FG001|NOT COMPLETED|Phase ll by Stratum||0
6474464|NCT01275222|7391828|FG002|NOT COMPLETED|Phase ll by Stratum||0
6474465|NCT01275222|7391829|FG003|NOT COMPLETED|Phase ll by Stratum||0
6474466|NCT01275222|7391830|FG004|NOT COMPLETED|Phase ll by Stratum||28
6474467|NCT01275222|7391831|FG005|NOT COMPLETED|Phase ll by Stratum||46
6474468|NCT01275300|7391849|FG000|STARTED|1st Intervention (5 Days)||5
6474469|NCT01275300|7391850|FG001|STARTED|1st Intervention (5 Days)||4
6474470|NCT01275300|7391849|FG000|COMPLETED|1st Intervention (5 Days)||5
6474471|NCT01275300|7391850|FG001|COMPLETED|1st Intervention (5 Days)||4
6474472|NCT01275300|7391849|FG000|NOT COMPLETED|1st Intervention (5 Days)||0
6474473|NCT01275300|7391850|FG001|NOT COMPLETED|1st Intervention (5 Days)||0
6474474|NCT01275300|7391849|FG000|STARTED|Washout (14 Days)||5
6474475|NCT01275300|7391850|FG001|STARTED|Washout (14 Days)||4
6474476|NCT01275300|7391849|FG000|COMPLETED|Washout (14 Days)||5
6474477|NCT01275300|7391850|FG001|COMPLETED|Washout (14 Days)||4
6474478|NCT01275300|7391849|FG000|NOT COMPLETED|Washout (14 Days)||0
6474479|NCT01275300|7391850|FG001|NOT COMPLETED|Washout (14 Days)||0
6474480|NCT01275300|7391849|FG000|STARTED|2nd Intervention(5 Days)||5
6474481|NCT01275300|7391850|FG001|STARTED|2nd Intervention(5 Days)||4
6474482|NCT01275300|7391849|FG000|COMPLETED|2nd Intervention(5 Days)||5
6474483|NCT01275300|7391850|FG001|COMPLETED|2nd Intervention(5 Days)||4
6474484|NCT01275300|7391849|FG000|NOT COMPLETED|2nd Intervention(5 Days)||0
6474485|NCT01275300|7391850|FG001|NOT COMPLETED|2nd Intervention(5 Days)||0
6474486|NCT01275300|7391849|FG000|STARTED|Washout (14 Days)||5
6474487|NCT01275300|7391850|FG001|STARTED|Washout (14 Days)||4
6474488|NCT01275300|7391849|FG000|COMPLETED|Washout (14 Days)||5
6474489|NCT01275300|7391850|FG001|COMPLETED|Washout (14 Days)||4
6474490|NCT01275300|7391849|FG000|NOT COMPLETED|Washout (14 Days)||0
6474491|NCT01275300|7391850|FG001|NOT COMPLETED|Washout (14 Days)||0
6474492|NCT01275300|7391849|FG000|STARTED|Phase 2: Open-label 6days)||5
6474493|NCT01275300|7391850|FG001|STARTED|Phase 2: Open-label 6days)||4
6474494|NCT01275300|7391849|FG000|COMPLETED|Phase 2: Open-label 6days)||5
6474495|NCT01275300|7391850|FG001|COMPLETED|Phase 2: Open-label 6days)||4
6474496|NCT01275300|7391849|FG000|NOT COMPLETED|Phase 2: Open-label 6days)||0
6474497|NCT01275300|7391850|FG001|NOT COMPLETED|Phase 2: Open-label 6days)||0
6474498|NCT01275313|7391858|FG000|STARTED|Overall Study||127
6474499|NCT01275313|7391859|FG001|STARTED|Overall Study||131
6474500|NCT01275313|7391858|FG000|COMPLETED|Overall Study||102
6474501|NCT01275313|7391859|FG001|COMPLETED|Overall Study||79
6474502|NCT01275313|7391858|FG000|NOT COMPLETED|Overall Study||25
6474503|NCT01275313|7391859|FG001|NOT COMPLETED|Overall Study||52
6474504|NCT01275339|7391869|FG000|STARTED|Overall Study||2
6474505|NCT01275339|7391870|FG001|STARTED|Overall Study||0
6474506|NCT01275339|7391871|FG002|STARTED|Overall Study||4
6474507|NCT01275339|7391872|FG003|STARTED|Overall Study||4
6474508|NCT01275339|7391869|FG000|COMPLETED|Overall Study||1
6474509|NCT01275339|7391870|FG001|COMPLETED|Overall Study||0
6474510|NCT01275339|7391871|FG002|COMPLETED|Overall Study||3
6474511|NCT01275339|7391872|FG003|COMPLETED|Overall Study||4
6474512|NCT01275339|7391869|FG000|NOT COMPLETED|Overall Study||1
6474513|NCT01275339|7391870|FG001|NOT COMPLETED|Overall Study||0
6474514|NCT01275339|7391871|FG002|NOT COMPLETED|Overall Study||1
6474515|NCT01275339|7391872|FG003|NOT COMPLETED|Overall Study||0
6474516|NCT01275365|7391886|FG000|STARTED|Overall Study||24
6474517|NCT01275365|7391887|FG001|STARTED|Overall Study||24
6474518|NCT01275365|7391888|FG002|STARTED|Overall Study||22
6474519|NCT01275365|7391889|FG003|STARTED|Overall Study||22
6474520|NCT01275365|7391886|FG000|COMPLETED|Overall Study||21
6474521|NCT01275365|7391887|FG001|COMPLETED|Overall Study||21
6474522|NCT01275365|7391888|FG002|COMPLETED|Overall Study||17
6474523|NCT01275365|7391889|FG003|COMPLETED|Overall Study||19
6474524|NCT01275365|7391886|FG000|NOT COMPLETED|Overall Study||3
6474525|NCT01275365|7391887|FG001|NOT COMPLETED|Overall Study||3
6474526|NCT01275365|7391888|FG002|NOT COMPLETED|Overall Study||5
6474527|NCT01275365|7391889|FG003|NOT COMPLETED|Overall Study||3
6474528|NCT01275430|7391899|FG000|STARTED|Overall Study||27
6474529|NCT01275430|7391899|FG000|COMPLETED|Overall Study||18
6474530|NCT01275430|7391899|FG000|NOT COMPLETED|Overall Study||9
6474531|NCT01275586|7391904|FG000|STARTED|Overall Study||6
6474532|NCT01275586|7391904|FG000|COMPLETED|Overall Study||3
6474533|NCT01275586|7391904|FG000|NOT COMPLETED|Overall Study||3
6474534|NCT01275625|7391908|FG000|STARTED|Overall Study||77
6474535|NCT01275625|7391908|FG000|Treated|Overall Study||77
6474536|NCT01275625|7391908|FG000|COMPLETED|Overall Study||64
6474537|NCT01275625|7391908|FG000|NOT COMPLETED|Overall Study||13
6474538|NCT01275664|7391912|FG000|STARTED|Overall Study||4
6474539|NCT01275664|7391912|FG000|COMPLETED|Overall Study||4
6474540|NCT01275664|7391912|FG000|NOT COMPLETED|Overall Study||0
6474541|NCT01275755|7391918|FG000|STARTED|Run-in Placebo Period||41
6474542|NCT01275755|7391919|FG001|STARTED|Run-in Placebo Period||40
6474543|NCT01275755|7391918|FG000|COMPLETED|Run-in Placebo Period||41
6474544|NCT01275755|7391919|FG001|COMPLETED|Run-in Placebo Period||40
6474545|NCT01275755|7391918|FG000|NOT COMPLETED|Run-in Placebo Period||0
6474546|NCT01275755|7391919|FG001|NOT COMPLETED|Run-in Placebo Period||0
6474547|NCT01275755|7391918|FG000|STARTED|Double-blind Treatment Period||41
6474548|NCT01275755|7391919|FG001|STARTED|Double-blind Treatment Period||40
6474549|NCT01275755|7391918|FG000|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
6474550|NCT01275755|7391919|FG001|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
6474551|NCT01275755|7391918|FG000|COMPLETED|Double-blind Treatment Period||39
6474552|NCT01275755|7391919|FG001|COMPLETED|Double-blind Treatment Period||37
6474553|NCT01275755|7391918|FG000|NOT COMPLETED|Double-blind Treatment Period||2
6474554|NCT01275755|7391919|FG001|NOT COMPLETED|Double-blind Treatment Period||3
6474555|NCT01275755|7391918|FG000|STARTED|Run-out Placebo Period||39
6474556|NCT01275755|7391919|FG001|STARTED|Run-out Placebo Period||37
6474557|NCT01275755|7391918|FG000|COMPLETED|Run-out Placebo Period||38
6474558|NCT01275755|7391919|FG001|COMPLETED|Run-out Placebo Period||37
6474559|NCT01275755|7391918|FG000|NOT COMPLETED|Run-out Placebo Period||1
6474560|NCT01275755|7391919|FG001|NOT COMPLETED|Run-out Placebo Period||0
6474561|NCT01275833|7391927|FG000|STARTED|Overall Study||1
6474562|NCT01275833|7391928|FG001|STARTED|Overall Study||1
6474563|NCT01275833|7391927|FG000|COMPLETED|Overall Study||0
6474564|NCT01275833|7391928|FG001|COMPLETED|Overall Study||0
6474565|NCT01275833|7391927|FG000|NOT COMPLETED|Overall Study||1
6474566|NCT01275833|7391928|FG001|NOT COMPLETED|Overall Study||1
6474567|NCT01276041|7391934|FG000|STARTED|Overall Study||70
6474568|NCT01276041|7391934|FG000|COMPLETED|Overall Study||67
6474569|NCT01276041|7391934|FG000|NOT COMPLETED|Overall Study||3
6474570|NCT01276106|7391942|FG000|STARTED|Overall Study||65
6474571|NCT01276106|7391943|FG001|STARTED|Overall Study||64
6474572|NCT01276106|7391944|FG002|STARTED|Overall Study||65
6474573|NCT01276106|7391945|FG003|STARTED|Overall Study||65
6474574|NCT01276106|7391942|FG000|COMPLETED|Overall Study||53
6474575|NCT01276106|7391943|FG001|COMPLETED|Overall Study||55
6474576|NCT01276106|7391944|FG002|COMPLETED|Overall Study||49
6474577|NCT01276106|7391945|FG003|COMPLETED|Overall Study||52
6474578|NCT01276106|7391942|FG000|NOT COMPLETED|Overall Study||12
6474579|NCT01276106|7391943|FG001|NOT COMPLETED|Overall Study||9
6474580|NCT01276106|7391944|FG002|NOT COMPLETED|Overall Study||16
6474581|NCT01276106|7391945|FG003|NOT COMPLETED|Overall Study||13
6474582|NCT01276171|7391958|FG000|STARTED|Overall Study||249
6474583|NCT01276171|7391959|FG001|STARTED|Overall Study||244
6474584|NCT01276171|7391960|FG002|STARTED|Overall Study||256
6474585|NCT01276171|7391958|FG000|COMPLETED|Overall Study||249
6474586|NCT01276171|7391959|FG001|COMPLETED|Overall Study||244
6474587|NCT01276171|7391960|FG002|COMPLETED|Overall Study||256
6474588|NCT01276171|7391958|FG000|NOT COMPLETED|Overall Study||0
6474589|NCT01276171|7391959|FG001|NOT COMPLETED|Overall Study||0
6474590|NCT01276171|7391960|FG002|NOT COMPLETED|Overall Study||0
6474591|NCT01276184|7391970|FG000|STARTED|Overall Study||13
6474592|NCT01276184|7391971|FG001|STARTED|Overall Study||9
6474593|NCT01276184|7391970|FG000|COMPLETED|Overall Study||13
6474594|NCT01276184|7391971|FG001|COMPLETED|Overall Study||9
6474595|NCT01276184|7391970|FG000|NOT COMPLETED|Overall Study||0
6474596|NCT01276184|7391971|FG001|NOT COMPLETED|Overall Study||0
6474597|NCT01276197|7391979|FG000|STARTED|Overall Study||308
6474598|NCT01276197|7391980|FG001|STARTED|Overall Study||310
6474599|NCT01276197|7391979|FG000|COMPLETED|Overall Study||200
6474600|NCT01276197|7391980|FG001|COMPLETED|Overall Study||200
6474601|NCT01276197|7391979|FG000|NOT COMPLETED|Overall Study||108
6474602|NCT01276197|7391980|FG001|NOT COMPLETED|Overall Study||110
6474603|NCT01276223|7391989|FG000|STARTED|Overall Study||78
6474604|NCT01276223|7391990|FG001|STARTED|Overall Study||107
6474605|NCT01276223|7391991|FG002|STARTED|Overall Study||104
6474606|NCT01276223|7391989|FG000|COMPLETED|Overall Study||67
6474607|NCT01276223|7391990|FG001|COMPLETED|Overall Study||103
6474608|NCT01276223|7391991|FG002|COMPLETED|Overall Study||101
6474609|NCT01276223|7391989|FG000|NOT COMPLETED|Overall Study||11
6474610|NCT01276223|7391990|FG001|NOT COMPLETED|Overall Study||4
6474611|NCT01276223|7391991|FG002|NOT COMPLETED|Overall Study||3
6474612|NCT01276236|7391998|FG000|STARTED|Overall Study||13
6474613|NCT01276236|7391998|FG000|Week 36 Visit|Overall Study||13
6474614|NCT01276236|7391998|FG000|Week 56 Visit|Overall Study||9
6474615|NCT01276236|7391998|FG000|Week 76 Visit|Overall Study||8
6474616|NCT01276236|7391998|FG000|COMPLETED|Overall Study||7
6474617|NCT01276236|7391998|FG000|NOT COMPLETED|Overall Study||6
6474618|NCT01276288|7392002|FG000|STARTED|Overall Study||7
6474619|NCT01276288|7392003|FG001|STARTED|Overall Study||6
6474620|NCT01276288|7392004|FG002|STARTED|Overall Study||5
6474621|NCT01276288|7392005|FG003|STARTED|Overall Study||5
6474622|NCT01276288|7392002|FG000|Received EMPA|Overall Study||6
6554525|NCT01747551|7476656|FG001|NOT COMPLETED|Overall Study||21
6474623|NCT01276288|7392003|FG001|Received EMPA|Overall Study||5
6474624|NCT01276288|7392004|FG002|Received EMPA|Overall Study||5
6474625|NCT01276288|7392005|FG003|Received EMPA|Overall Study||5
6474626|NCT01276288|7392002|FG000|Received EMPA+HCT|Overall Study||5
6474627|NCT01276288|7392003|FG001|Received EMPA+HCT|Overall Study||5
6474628|NCT01276288|7392004|FG002|Received EMPA+HCT|Overall Study||0
6474629|NCT01276288|7392005|FG003|Received EMPA+HCT|Overall Study||0
6474630|NCT01276288|7392002|FG000|Received EMPA+TOR|Overall Study||0
6474631|NCT01276288|7392003|FG001|Received EMPA+TOR|Overall Study||0
6474632|NCT01276288|7392004|FG002|Received EMPA+TOR|Overall Study||5
6474633|NCT01276288|7392005|FG003|Received EMPA+TOR|Overall Study||5
6474634|NCT01276288|7392002|FG000|COMPLETED|Overall Study||5
6474635|NCT01276288|7392003|FG001|COMPLETED|Overall Study||5
6474636|NCT01276288|7392004|FG002|COMPLETED|Overall Study||5
6474637|NCT01276288|7392005|FG003|COMPLETED|Overall Study||5
6474638|NCT01276288|7392002|FG000|NOT COMPLETED|Overall Study||2
6474639|NCT01276288|7392003|FG001|NOT COMPLETED|Overall Study||1
6474640|NCT01276288|7392004|FG002|NOT COMPLETED|Overall Study||0
6474641|NCT01276288|7392005|FG003|NOT COMPLETED|Overall Study||0
6474642|NCT01276301|7392027|FG000|STARTED|First Intervention||8
6474643|NCT01276301|7392028|FG001|STARTED|First Intervention||8
6474644|NCT01276301|7392027|FG000|COMPLETED|First Intervention||8
6474645|NCT01276301|7392028|FG001|COMPLETED|First Intervention||8
6474646|NCT01276301|7392027|FG000|NOT COMPLETED|First Intervention||0
6474647|NCT01276301|7392028|FG001|NOT COMPLETED|First Intervention||0
6474648|NCT01276301|7392027|FG000|STARTED|Washout Period of 7 Days||8
6474649|NCT01276301|7392028|FG001|STARTED|Washout Period of 7 Days||8
6474650|NCT01276301|7392027|FG000|COMPLETED|Washout Period of 7 Days||8
6474651|NCT01276301|7392028|FG001|COMPLETED|Washout Period of 7 Days||8
6474652|NCT01276301|7392027|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6474653|NCT01276301|7392028|FG001|NOT COMPLETED|Washout Period of 7 Days||0
6474654|NCT01276301|7392027|FG000|STARTED|Second Intervention||8
6474655|NCT01276301|7392028|FG001|STARTED|Second Intervention||8
6474656|NCT01276301|7392027|FG000|COMPLETED|Second Intervention||8
6474657|NCT01276301|7392028|FG001|COMPLETED|Second Intervention||8
6474658|NCT01276301|7392027|FG000|NOT COMPLETED|Second Intervention||0
6474659|NCT01276301|7392028|FG001|NOT COMPLETED|Second Intervention||0
6474660|NCT01276314|7392039|FG000|STARTED|Overall Study||48
6474661|NCT01276314|7392040|FG001|STARTED|Overall Study||43
6474662|NCT01276314|7392041|FG002|STARTED|Overall Study||22
6474663|NCT01276314|7392042|FG003|STARTED|Overall Study||22
6474664|NCT01276314|7392039|FG000|COMPLETED|Overall Study||38
6474665|NCT01276314|7392040|FG001|COMPLETED|Overall Study||33
6474666|NCT01276314|7392041|FG002|COMPLETED|Overall Study||18
6474667|NCT01276314|7392042|FG003|COMPLETED|Overall Study||17
6474668|NCT01276314|7392039|FG000|NOT COMPLETED|Overall Study||10
6474669|NCT01276314|7392040|FG001|NOT COMPLETED|Overall Study||10
6474670|NCT01276314|7392041|FG002|NOT COMPLETED|Overall Study||4
6474671|NCT01276314|7392042|FG003|NOT COMPLETED|Overall Study||5
6474672|NCT01276327|7392054|FG000|STARTED|Overall Study||32
6474673|NCT01276327|7392055|FG001|STARTED|Overall Study||32
6474674|NCT01276327|7392054|FG000|COMPLETED|Overall Study||30
6474675|NCT01276327|7392055|FG001|COMPLETED|Overall Study||29
6474676|NCT01276327|7392054|FG000|NOT COMPLETED|Overall Study||2
6474677|NCT01276327|7392055|FG001|NOT COMPLETED|Overall Study||3
6474678|NCT01276353|7392063|FG000|STARTED|Double-blind||22
6474679|NCT01276353|7392064|FG001|STARTED|Double-blind||23
6654568|NCT02446743|7584431|FG000|NOT COMPLETED|Overall Study||5
6654569|NCT02446743|7584432|FG001|NOT COMPLETED|Overall Study||5
6654570|NCT02446769|7584447|FG000|STARTED|Screening Period||18
6654571|NCT02446769|7584448|FG001|STARTED|Screening Period||0
6474680|NCT01276353|7392063|FG000|COMPLETED|Double-blind||19
6474681|NCT01276353|7392064|FG001|COMPLETED|Double-blind||23
6474682|NCT01276353|7392063|FG000|NOT COMPLETED|Double-blind||3
6474683|NCT01276353|7392064|FG001|NOT COMPLETED|Double-blind||0
6474684|NCT01276353|7392063|FG000|STARTED|Extension||19
6474685|NCT01276353|7392064|FG001|STARTED|Extension||23
6474686|NCT01276353|7392063|FG000|COMPLETED|Extension||12
6474687|NCT01276353|7392064|FG001|COMPLETED|Extension||14
6474688|NCT01276353|7392063|FG000|NOT COMPLETED|Extension||7
6474689|NCT01276353|7392064|FG001|NOT COMPLETED|Extension||9
6474690|NCT01276379|7392076|FG000|STARTED|Overall Study||221
6474691|NCT01276379|7392076|FG000|COMPLETED|Overall Study||181
6474692|NCT01276379|7392076|FG000|NOT COMPLETED|Overall Study||40
6474693|NCT01276457|7392084|FG000|STARTED|Core Study||142
6474694|NCT01276457|7392085|FG001|STARTED|Core Study||143
6474695|NCT01276457|7392084|FG000|COMPLETED|Core Study||129
6474696|NCT01276457|7392085|FG001|COMPLETED|Core Study||123
6474697|NCT01276457|7392084|FG000|NOT COMPLETED|Core Study||13
6474698|NCT01276457|7392085|FG001|NOT COMPLETED|Core Study||20
6474699|NCT01276457|7392084|FG000|STARTED|Extension Study||111
6474700|NCT01276457|7392085|FG001|STARTED|Extension Study||112
6474701|NCT01276457|7392084|FG000|COMPLETED|Extension Study||105
6474702|NCT01276457|7392085|FG001|COMPLETED|Extension Study||110
6474703|NCT01276457|7392084|FG000|NOT COMPLETED|Extension Study||6
6474704|NCT01276457|7392085|FG001|NOT COMPLETED|Extension Study||2
6474705|NCT01276509|7392095|FG000|STARTED|Overall Study||66
6474706|NCT01276509|7392096|FG001|STARTED|Overall Study||65
6474707|NCT01276509|7392097|FG002|STARTED|Overall Study||68
6474708|NCT01276509|7392098|FG003|STARTED|Overall Study||63
6474709|NCT01276509|7392095|FG000|COMPLETED|Overall Study||53
6474710|NCT01276509|7392096|FG001|COMPLETED|Overall Study||53
6474711|NCT01276509|7392097|FG002|COMPLETED|Overall Study||63
6474712|NCT01276509|7392098|FG003|COMPLETED|Overall Study||58
6474713|NCT01276509|7392095|FG000|NOT COMPLETED|Overall Study||13
6474714|NCT01276509|7392096|FG001|NOT COMPLETED|Overall Study||12
6474715|NCT01276509|7392097|FG002|NOT COMPLETED|Overall Study||5
6474716|NCT01276509|7392098|FG003|NOT COMPLETED|Overall Study||5
6474717|NCT01276535|7392108|FG000|STARTED|Overall Study||12
6474718|NCT01276535|7392108|FG000|COMPLETED|Overall Study||12
6474719|NCT01276535|7392108|FG000|NOT COMPLETED|Overall Study||0
6474720|NCT01276639|7392115|FG000|STARTED|Week 0 to 16||363
6474721|NCT01276639|7392116|FG001|STARTED|Week 0 to 16||361
6474722|NCT01276639|7392117|FG002|STARTED|Week 0 to 16||177
6474723|NCT01276639|7392118|FG003|STARTED|Week 0 to 16||0
6474724|NCT01276639|7392119|FG004|STARTED|Week 0 to 16||0
6474725|NCT01276639|7392115|FG000|Treated|Week 0 to 16||363
6474726|NCT01276639|7392116|FG001|Treated|Week 0 to 16||360
6654572|NCT02446769|7584449|FG002|STARTED|Screening Period||0
6654573|NCT02446769|7584447|FG000|COMPLETED|Screening Period||7
6474727|NCT01276639|7392117|FG002|Treated|Week 0 to 16||177
6474728|NCT01276639|7392118|FG003|Treated|Week 0 to 16||0
6474729|NCT01276639|7392119|FG004|Treated|Week 0 to 16||0
6474730|NCT01276639|7392115|FG000|COMPLETED|Week 0 to 16||313
6474731|NCT01276639|7392116|FG001|COMPLETED|Week 0 to 16||320
6474732|NCT01276639|7392117|FG002|COMPLETED|Week 0 to 16||132
6474733|NCT01276639|7392118|FG003|COMPLETED|Week 0 to 16||0
6474734|NCT01276639|7392119|FG004|COMPLETED|Week 0 to 16||0
6474735|NCT01276639|7392115|FG000|NOT COMPLETED|Week 0 to 16||50
6474736|NCT01276639|7392116|FG001|NOT COMPLETED|Week 0 to 16||41
6474737|NCT01276639|7392117|FG002|NOT COMPLETED|Week 0 to 16||45
6474738|NCT01276639|7392118|FG003|NOT COMPLETED|Week 0 to 16||0
6474739|NCT01276639|7392119|FG004|NOT COMPLETED|Week 0 to 16||0
6474740|NCT01276639|7392115|FG000|STARTED|Week 16 to 52||313
6474741|NCT01276639|7392116|FG001|STARTED|Week 16 to 52||320
6474742|NCT01276639|7392117|FG002|STARTED|Week 16 to 52||0
6474743|NCT01276639|7392118|FG003|STARTED|Week 16 to 52||66
6474744|NCT01276639|7392119|FG004|STARTED|Week 16 to 52||66
6474745|NCT01276639|7392115|FG000|COMPLETED|Week 16 to 52||186
6474746|NCT01276639|7392116|FG001|COMPLETED|Week 16 to 52||219
6474747|NCT01276639|7392117|FG002|COMPLETED|Week 16 to 52||0
6474748|NCT01276639|7392118|FG003|COMPLETED|Week 16 to 52||50
6474749|NCT01276639|7392119|FG004|COMPLETED|Week 16 to 52||45
6474750|NCT01276639|7392115|FG000|NOT COMPLETED|Week 16 to 52||127
6474751|NCT01276639|7392116|FG001|NOT COMPLETED|Week 16 to 52||101
6474752|NCT01276639|7392117|FG002|NOT COMPLETED|Week 16 to 52||0
6474753|NCT01276639|7392118|FG003|NOT COMPLETED|Week 16 to 52||16
6474754|NCT01276639|7392119|FG004|NOT COMPLETED|Week 16 to 52||21
6474755|NCT01276652|7392137|FG000|STARTED|Period 1: Randomization||9
6474756|NCT01276652|7392138|FG001|STARTED|Period 1: Randomization||8
6474757|NCT01276652|7392139|FG002|STARTED|Period 1: Randomization|No subjects were enrolled in this arm during Period 1.|0
6474758|NCT01276652|7392137|FG000|COMPLETED|Period 1: Randomization||9
6474759|NCT01276652|7392138|FG001|COMPLETED|Period 1: Randomization||8
6474760|NCT01276652|7392139|FG002|COMPLETED|Period 1: Randomization||0
6474761|NCT01276652|7392137|FG000|NOT COMPLETED|Period 1: Randomization||0
6474762|NCT01276652|7392138|FG001|NOT COMPLETED|Period 1: Randomization||0
6474763|NCT01276652|7392139|FG002|NOT COMPLETED|Period 1: Randomization||0
6474764|NCT01276652|7392137|FG000|STARTED|Period 2: Observational||9
6474765|NCT01276652|7392138|FG001|STARTED|Period 2: Observational||8
6474766|NCT01276652|7392139|FG002|STARTED|Period 2: Observational|Subjects were only enrolled in the Observational arm during Period 2.|5
6474767|NCT01276652|7392137|FG000|COMPLETED|Period 2: Observational||9
6474768|NCT01276652|7392138|FG001|COMPLETED|Period 2: Observational||8
6474769|NCT01276652|7392139|FG002|COMPLETED|Period 2: Observational||5
6474770|NCT01276652|7392137|FG000|NOT COMPLETED|Period 2: Observational||0
6474771|NCT01276652|7392138|FG001|NOT COMPLETED|Period 2: Observational||0
6474772|NCT01276652|7392139|FG002|NOT COMPLETED|Period 2: Observational||0
6474773|NCT01276756|7392154|FG000|STARTED|Overall Study||50
6474774|NCT01276756|7392155|FG001|STARTED|Overall Study||50
6474775|NCT01276756|7392154|FG000|COMPLETED|Overall Study||45
6474776|NCT01276756|7392155|FG001|COMPLETED|Overall Study||48
6474777|NCT01276756|7392154|FG000|NOT COMPLETED|Overall Study||5
6474778|NCT01276756|7392155|FG001|NOT COMPLETED|Overall Study||2
6474779|NCT01276821|7392163|FG000|STARTED|Overall Study||50
6474780|NCT01276821|7392164|FG001|STARTED|Overall Study||50
6554526|NCT01747629|7476664|FG000|STARTED|Overall Study||85
6554527|NCT01747629|7476665|FG001|STARTED|Overall Study||75
6554528|NCT01747629|7476664|FG000|Treated|Overall Study|Safety set and full analysis set|84
6474781|NCT01276821|7392163|FG000|COMPLETED|Overall Study||50
6474782|NCT01276821|7392164|FG001|COMPLETED|Overall Study||49
6474783|NCT01276821|7392163|FG000|NOT COMPLETED|Overall Study||0
6474784|NCT01276821|7392164|FG001|NOT COMPLETED|Overall Study||1
6474785|NCT01276847|7392173|FG000|STARTED|Overall Study||10
6474786|NCT01276847|7392174|FG001|STARTED|Overall Study||10
6554529|NCT01747629|7476665|FG001|Treated|Overall Study|Safety set and full analysis set|75
6554530|NCT01747629|7476664|FG000|COMPLETED|Overall Study||77
6554531|NCT01747629|7476665|FG001|COMPLETED|Overall Study||69
6474787|NCT01276847|7392175|FG002|STARTED|Overall Study||20
6474788|NCT01276847|7392173|FG000|COMPLETED|Overall Study||9
6474789|NCT01276847|7392174|FG001|COMPLETED|Overall Study||10
6474790|NCT01276847|7392175|FG002|COMPLETED|Overall Study||20
6474791|NCT01276847|7392173|FG000|NOT COMPLETED|Overall Study||1
6474792|NCT01276847|7392174|FG001|NOT COMPLETED|Overall Study||0
6474793|NCT01276847|7392175|FG002|NOT COMPLETED|Overall Study||0
6474794|NCT01276860|7392184|FG000|STARTED|Overall Study||5
6474795|NCT01276860|7392185|FG001|STARTED|Overall Study||2
6474796|NCT01276860|7392184|FG000|COMPLETED|Overall Study||5
6474797|NCT01276860|7392185|FG001|COMPLETED|Overall Study||2
6474798|NCT01276860|7392184|FG000|NOT COMPLETED|Overall Study||0
6474799|NCT01276860|7392185|FG001|NOT COMPLETED|Overall Study||0
6554532|NCT01747629|7476664|FG000|NOT COMPLETED|Overall Study||8
6474800|NCT01277042|7392193|FG000|STARTED|Overall Study||606
6474801|NCT01277042|7392194|FG001|STARTED|Overall Study||606
6474802|NCT01277042|7392193|FG000|COMPLETED|Overall Study||598
6474803|NCT01277042|7392194|FG001|COMPLETED|Overall Study||601
6474804|NCT01277042|7392193|FG000|NOT COMPLETED|Overall Study||8
6474805|NCT01277042|7392194|FG001|NOT COMPLETED|Overall Study||5
6474806|NCT01277081|7392203|FG000|STARTED|Overall Study||100
6474807|NCT01277081|7392204|FG001|STARTED|Overall Study||100
6474808|NCT01277081|7392203|FG000|COMPLETED|Overall Study||100
6474809|NCT01277081|7392204|FG001|COMPLETED|Overall Study||100
6474810|NCT01277081|7392203|FG000|NOT COMPLETED|Overall Study||0
6474811|NCT01277081|7392204|FG001|NOT COMPLETED|Overall Study||0
6474812|NCT01277159|7392215|FG000|STARTED|Overall Study||21
6474813|NCT01277159|7392216|FG001|STARTED|Overall Study||22
6474814|NCT01277159|7392217|FG002|STARTED|Overall Study||22
6474815|NCT01277159|7392218|FG003|STARTED|Overall Study||22
6474816|NCT01277159|7392219|FG004|STARTED|Overall Study||21
6474817|NCT01277159|7392215|FG000|COMPLETED|Overall Study||17
6474818|NCT01277159|7392216|FG001|COMPLETED|Overall Study||21
6474819|NCT01277159|7392217|FG002|COMPLETED|Overall Study||19
6474820|NCT01277159|7392218|FG003|COMPLETED|Overall Study||19
6474821|NCT01277159|7392219|FG004|COMPLETED|Overall Study||16
6474822|NCT01277159|7392215|FG000|NOT COMPLETED|Overall Study||4
6474823|NCT01277159|7392216|FG001|NOT COMPLETED|Overall Study||1
6474824|NCT01277159|7392217|FG002|NOT COMPLETED|Overall Study||3
6474825|NCT01277159|7392218|FG003|NOT COMPLETED|Overall Study||3
6474826|NCT01277159|7392219|FG004|NOT COMPLETED|Overall Study||5
6474827|NCT01277302|7392234|FG000|STARTED|7-Month Fixed Treatment Period||85
6474828|NCT01277302|7392235|FG001|STARTED|7-Month Fixed Treatment Period||86
6474829|NCT01277302|7392236|FG002|STARTED|7-Month Fixed Treatment Period||31
6474830|NCT01277302|7392234|FG000|COMPLETED|7-Month Fixed Treatment Period||85
6474831|NCT01277302|7392235|FG001|COMPLETED|7-Month Fixed Treatment Period||86
6474832|NCT01277302|7392236|FG002|COMPLETED|7-Month Fixed Treatment Period||19
6474833|NCT01277302|7392234|FG000|NOT COMPLETED|7-Month Fixed Treatment Period||0
6474834|NCT01277302|7392235|FG001|NOT COMPLETED|7-Month Fixed Treatment Period||0
6474835|NCT01277302|7392236|FG002|NOT COMPLETED|7-Month Fixed Treatment Period||12
6474836|NCT01277302|7392234|FG000|STARTED|8-Month Alternate Dose Regimen Period||85
6474837|NCT01277302|7392235|FG001|STARTED|8-Month Alternate Dose Regimen Period||86
6474838|NCT01277302|7392236|FG002|STARTED|8-Month Alternate Dose Regimen Period||19
6474839|NCT01277302|7392234|FG000|COMPLETED|8-Month Alternate Dose Regimen Period||80
6474840|NCT01277302|7392235|FG001|COMPLETED|8-Month Alternate Dose Regimen Period||82
6474841|NCT01277302|7392236|FG002|COMPLETED|8-Month Alternate Dose Regimen Period||13
6474842|NCT01277302|7392234|FG000|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
6474843|NCT01277302|7392235|FG001|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
6474844|NCT01277302|7392236|FG002|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
6474845|NCT01277341|7392248|FG000|STARTED|Overall Study||150
6474846|NCT01277341|7392249|FG001|STARTED|Overall Study||150
6474847|NCT01277341|7392250|FG002|STARTED|Overall Study||149
6474848|NCT01277341|7392251|FG003|STARTED|Overall Study||152
6474849|NCT01277341|7392248|FG000|COMPLETED|Overall Study||146
6474850|NCT01277341|7392249|FG001|COMPLETED|Overall Study||145
6474851|NCT01277341|7392250|FG002|COMPLETED|Overall Study||145
6474852|NCT01277341|7392251|FG003|COMPLETED|Overall Study||146
6474853|NCT01277341|7392248|FG000|NOT COMPLETED|Overall Study||4
6474854|NCT01277341|7392249|FG001|NOT COMPLETED|Overall Study||5
6474855|NCT01277341|7392250|FG002|NOT COMPLETED|Overall Study||4
6474856|NCT01277341|7392251|FG003|NOT COMPLETED|Overall Study||6
6474857|NCT01277354|7392263|FG000|STARTED|Overall Study||1
6474858|NCT01277354|7392264|FG001|STARTED|Overall Study||1
6474859|NCT01277354|7392263|FG000|COMPLETED|Overall Study||1
6474860|NCT01277354|7392264|FG001|COMPLETED|Overall Study||1
6474861|NCT01277354|7392263|FG000|NOT COMPLETED|Overall Study||0
6474862|NCT01277354|7392264|FG001|NOT COMPLETED|Overall Study||0
6474863|NCT01277510|7392272|FG000|STARTED|Double-blind Phase||21
6474864|NCT01277510|7392273|FG001|STARTED|Double-blind Phase||22
6474865|NCT01277510|7392272|FG000|Received Investigational Product|Double-blind Phase||21
6474866|NCT01277510|7392273|FG001|Received Investigational Product|Double-blind Phase||22
6474867|NCT01277510|7392272|FG000|COMPLETED|Double-blind Phase|Completed investigational product|8
6474868|NCT01277510|7392273|FG001|COMPLETED|Double-blind Phase|Completed investigational product|4
6474869|NCT01277510|7392272|FG000|NOT COMPLETED|Double-blind Phase||13
6474870|NCT01277510|7392273|FG001|NOT COMPLETED|Double-blind Phase||18
6474871|NCT01277510|7392272|FG000|STARTED|Open-label Phase||8
6474872|NCT01277510|7392273|FG001|STARTED|Open-label Phase||4
6474873|NCT01277510|7392272|FG000|Received Investigational Product|Open-label Phase||6
6474874|NCT01277510|7392273|FG001|Received Investigational Product|Open-label Phase||4
6474875|NCT01277510|7392272|FG000|COMPLETED|Open-label Phase|Completed investigational product|1
6474876|NCT01277510|7392273|FG001|COMPLETED|Open-label Phase|Completed investigational product|1
6474877|NCT01277510|7392272|FG000|NOT COMPLETED|Open-label Phase||7
6474878|NCT01277510|7392273|FG001|NOT COMPLETED|Open-label Phase||3
6474879|NCT01277523|7392284|FG000|STARTED|Overall Study||135
6474880|NCT01277523|7392285|FG001|STARTED|Overall Study||127
6474881|NCT01277523|7392286|FG002|STARTED|Overall Study||130
6474882|NCT01277523|7392284|FG000|COMPLETED|Overall Study||132
6474883|NCT01277523|7392285|FG001|COMPLETED|Overall Study||126
6474884|NCT01277523|7392286|FG002|COMPLETED|Overall Study||130
6474885|NCT01277523|7392284|FG000|NOT COMPLETED|Overall Study||3
6474886|NCT01277523|7392285|FG001|NOT COMPLETED|Overall Study||1
6474887|NCT01277523|7392286|FG002|NOT COMPLETED|Overall Study||0
6474888|NCT01277549|7392296|FG000|STARTED|Overall Study||41
6474889|NCT01277549|7392297|FG001|STARTED|Overall Study||29
6474890|NCT01277549|7392296|FG000|COMPLETED|Overall Study||15
6474891|NCT01277549|7392297|FG001|COMPLETED|Overall Study||15
6474892|NCT01277549|7392296|FG000|NOT COMPLETED|Overall Study||26
6474893|NCT01277549|7392297|FG001|NOT COMPLETED|Overall Study||14
6474894|NCT01277601|7392310|FG000|STARTED|Overall Study||188
6474895|NCT01277601|7392311|FG001|STARTED|Overall Study||187
6474896|NCT01277601|7392312|FG002|STARTED|Overall Study||190
6474897|NCT01277601|7392313|FG003|STARTED|Overall Study||186
6474898|NCT01277601|7392310|FG000|COMPLETED|Overall Study||151
6474899|NCT01277601|7392311|FG001|COMPLETED|Overall Study||139
6474900|NCT01277601|7392312|FG002|COMPLETED|Overall Study||163
6474901|NCT01277601|7392313|FG003|COMPLETED|Overall Study||150
6474902|NCT01277601|7392310|FG000|NOT COMPLETED|Overall Study||37
6474903|NCT01277601|7392311|FG001|NOT COMPLETED|Overall Study||48
6474904|NCT01277601|7392312|FG002|NOT COMPLETED|Overall Study||27
6474905|NCT01277601|7392313|FG003|NOT COMPLETED|Overall Study||36
6474906|NCT01277666|7392343|FG000|STARTED|Overall Study||203
6474907|NCT01277666|7392344|FG001|STARTED|Overall Study||203
6474908|NCT01277666|7392345|FG002|STARTED|Overall Study||202
6474909|NCT01277666|7392343|FG000|COMPLETED|Overall Study||158
6474910|NCT01277666|7392344|FG001|COMPLETED|Overall Study||144
6474911|NCT01277666|7392345|FG002|COMPLETED|Overall Study||153
6474912|NCT01277666|7392343|FG000|NOT COMPLETED|Overall Study||45
6474913|NCT01277666|7392344|FG001|NOT COMPLETED|Overall Study||59
6474914|NCT01277666|7392345|FG002|NOT COMPLETED|Overall Study||49
6474915|NCT01277718|7392353|FG000|STARTED|Period 1 - First Intervention||10
6474916|NCT01277718|7392354|FG001|STARTED|Period 1 - First Intervention||10
6474917|NCT01277718|7392353|FG000|COMPLETED|Period 1 - First Intervention||10
6474918|NCT01277718|7392354|FG001|COMPLETED|Period 1 - First Intervention||10
6474919|NCT01277718|7392353|FG000|NOT COMPLETED|Period 1 - First Intervention||0
6474920|NCT01277718|7392354|FG001|NOT COMPLETED|Period 1 - First Intervention||0
6474921|NCT01277718|7392353|FG000|STARTED|Washout Period of 13 Days||10
6474922|NCT01277718|7392354|FG001|STARTED|Washout Period of 13 Days||10
6474923|NCT01277718|7392353|FG000|COMPLETED|Washout Period of 13 Days||10
6474924|NCT01277718|7392354|FG001|COMPLETED|Washout Period of 13 Days||10
6474925|NCT01277718|7392353|FG000|NOT COMPLETED|Washout Period of 13 Days||0
6474926|NCT01277718|7392354|FG001|NOT COMPLETED|Washout Period of 13 Days||0
6474927|NCT01277718|7392353|FG000|STARTED|Period 2 - Second Intervention||10
6474928|NCT01277718|7392354|FG001|STARTED|Period 2 - Second Intervention||10
6474929|NCT01277718|7392353|FG000|COMPLETED|Period 2 - Second Intervention||10
6474930|NCT01277718|7392354|FG001|COMPLETED|Period 2 - Second Intervention||7
6474931|NCT01277718|7392353|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
6474932|NCT01277718|7392354|FG001|NOT COMPLETED|Period 2 - Second Intervention||3
6474933|NCT01277718|7392353|FG000|STARTED|Washout Period of 13 Days||10
6474934|NCT01277718|7392354|FG001|STARTED|Washout Period of 13 Days||7
6474935|NCT01277718|7392353|FG000|COMPLETED|Washout Period of 13 Days||10
6474936|NCT01277718|7392354|FG001|COMPLETED|Washout Period of 13 Days||7
6474937|NCT01277718|7392353|FG000|NOT COMPLETED|Washout Period of 13 Days||0
6474938|NCT01277718|7392354|FG001|NOT COMPLETED|Washout Period of 13 Days||0
6474939|NCT01277718|7392353|FG000|STARTED|Period 3 - Third Intervention||10
6474940|NCT01277718|7392354|FG001|STARTED|Period 3 - Third Intervention||7
6474941|NCT01277718|7392353|FG000|COMPLETED|Period 3 - Third Intervention||10
6474942|NCT01277718|7392354|FG001|COMPLETED|Period 3 - Third Intervention||7
6474943|NCT01277718|7392353|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
6474944|NCT01277718|7392354|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
6474945|NCT01277744|7392362|FG000|STARTED|Overall Study||22
6474946|NCT01277744|7392362|FG000|COMPLETED|Overall Study||20
6474947|NCT01277744|7392362|FG000|NOT COMPLETED|Overall Study||2
6474948|NCT01277757|7392366|FG000|STARTED|Overall Study||30
6474949|NCT01277757|7392366|FG000|COMPLETED|Overall Study||28
6474950|NCT01277757|7392366|FG000|NOT COMPLETED|Overall Study||2
6501161|NCT01427504|7419668|FG003|Received Boceprevir|Overall Study||5
6501162|NCT01427504|7419669|FG004|Received Boceprevir|Overall Study||2
6501163|NCT01427504|7419670|FG005|Received Boceprevir|Overall Study||4
6501164|NCT01427504|7419665|FG000|Received Etravirine|Overall Study||4
6501165|NCT01427504|7419666|FG001|Received Etravirine|Overall Study||2
6501166|NCT01427504|7419667|FG002|Received Etravirine|Overall Study||4
6501167|NCT01427504|7419668|FG003|Received Etravirine|Overall Study||6
6501168|NCT01427504|7419669|FG004|Received Etravirine|Overall Study||2
6501169|NCT01427504|7419670|FG005|Received Etravirine|Overall Study||4
6501170|NCT01427504|7419665|FG000|Received Combination|Overall Study||4
6501171|NCT01427504|7419666|FG001|Received Combination|Overall Study||3
6501172|NCT01427504|7419667|FG002|Received Combination|Overall Study||3
6501173|NCT01427504|7419668|FG003|Received Combination|Overall Study||6
6501174|NCT01427504|7419669|FG004|Received Combination|Overall Study||3
6501175|NCT01427504|7419670|FG005|Received Combination|Overall Study||6
6501176|NCT01427504|7419665|FG000|COMPLETED|Overall Study||4
6501177|NCT01427504|7419666|FG001|COMPLETED|Overall Study||2
6501178|NCT01427504|7419667|FG002|COMPLETED|Overall Study||3
6501179|NCT01427504|7419668|FG003|COMPLETED|Overall Study||5
6501180|NCT01427504|7419669|FG004|COMPLETED|Overall Study||2
6501181|NCT01427504|7419670|FG005|COMPLETED|Overall Study||4
6501182|NCT01427504|7419665|FG000|NOT COMPLETED|Overall Study||0
6746904|NCT03380780|7674629|FG000|COMPLETED|Overall Study||16
6746905|NCT03380780|7674629|FG000|NOT COMPLETED|Overall Study||0
6746906|NCT03380845|7674633|FG000|STARTED|Overall Study|Participants got bilateral face treatments with Fraxel on one side of face; Fractora on the other.|4
6746907|NCT03380845|7674633|FG000|COMPLETED|Overall Study||4
6474951|NCT01277783|7392370|FG000|STARTED|Overall Study||138
6474952|NCT01277783|7392370|FG000|COMPLETED|Overall Study||138
6474953|NCT01277783|7392370|FG000|NOT COMPLETED|Overall Study||0
6474954|NCT01277861|7392377|FG000|STARTED|Overall Study||51
6474955|NCT01277861|7392378|FG001|STARTED|Overall Study||49
6474956|NCT01277861|7392377|FG000|COMPLETED|Overall Study||49
6474957|NCT01277861|7392378|FG001|COMPLETED|Overall Study||47
6474958|NCT01277861|7392377|FG000|NOT COMPLETED|Overall Study||2
6474959|NCT01277861|7392378|FG001|NOT COMPLETED|Overall Study||2
6474960|NCT01277887|7392388|FG000|STARTED|Pre-Quit Treatment Phase||9
6474961|NCT01277887|7392389|FG001|STARTED|Pre-Quit Treatment Phase||10
6474962|NCT01277887|7392388|FG000|Entered Study|Pre-Quit Treatment Phase||7
6474963|NCT01277887|7392389|FG001|Entered Study|Pre-Quit Treatment Phase||10
6474964|NCT01277887|7392388|FG000|COMPLETED|Pre-Quit Treatment Phase||6
6474965|NCT01277887|7392389|FG001|COMPLETED|Pre-Quit Treatment Phase||10
6474966|NCT01277887|7392388|FG000|NOT COMPLETED|Pre-Quit Treatment Phase||3
6474967|NCT01277887|7392389|FG001|NOT COMPLETED|Pre-Quit Treatment Phase||0
6474968|NCT01277887|7392388|FG000|STARTED|Post-Quit Treatment Phase||6
6474969|NCT01277887|7392389|FG001|STARTED|Post-Quit Treatment Phase||10
6474970|NCT01277887|7392388|FG000|COMPLETED|Post-Quit Treatment Phase||3
6474971|NCT01277887|7392389|FG001|COMPLETED|Post-Quit Treatment Phase||5
6474972|NCT01277887|7392388|FG000|NOT COMPLETED|Post-Quit Treatment Phase||3
6474973|NCT01277887|7392389|FG001|NOT COMPLETED|Post-Quit Treatment Phase||5
6474974|NCT01278030|7392397|FG000|STARTED|Overall Study||43
6474975|NCT01278030|7392398|FG001|STARTED|Overall Study||35
6474976|NCT01278030|7392397|FG000|COMPLETED|Overall Study||35
6474977|NCT01278030|7392398|FG001|COMPLETED|Overall Study||31
6474978|NCT01278030|7392397|FG000|NOT COMPLETED|Overall Study||8
6474979|NCT01278030|7392398|FG001|NOT COMPLETED|Overall Study||4
6474980|NCT01278160|7392406|FG000|STARTED|Overall Study||89
6474981|NCT01278160|7392407|FG001|STARTED|Overall Study||90
6474982|NCT01278160|7392406|FG000|COMPLETED|Overall Study||84
6474983|NCT01278160|7392407|FG001|COMPLETED|Overall Study||84
6474984|NCT01278160|7392406|FG000|NOT COMPLETED|Overall Study||5
6474985|NCT01278160|7392407|FG001|NOT COMPLETED|Overall Study||6
6474986|NCT01278173|7392413|FG000|STARTED|Overall Study||65
6474987|NCT01278173|7392413|FG000|COMPLETED|Overall Study||38
6474988|NCT01278173|7392413|FG000|NOT COMPLETED|Overall Study||27
6474989|NCT01278303|7392417|FG000|STARTED|Overall Study||82
6474990|NCT01278303|7392417|FG000|COMPLETED|Overall Study||82
6474991|NCT01278303|7392417|FG000|NOT COMPLETED|Overall Study||0
6474992|NCT01278342|7392424|FG000|STARTED|Overall Study||7
6474993|NCT01278342|7392425|FG001|STARTED|Overall Study||31
6474994|NCT01278342|7392426|FG002|STARTED|Overall Study||32
6474995|NCT01278342|7392424|FG000|COMPLETED|Overall Study||3
6474996|NCT01278342|7392425|FG001|COMPLETED|Overall Study||30
6474997|NCT01278342|7392426|FG002|COMPLETED|Overall Study||32
6474998|NCT01278342|7392424|FG000|NOT COMPLETED|Overall Study||4
6474999|NCT01278342|7392425|FG001|NOT COMPLETED|Overall Study||1
6475000|NCT01278342|7392426|FG002|NOT COMPLETED|Overall Study||0
6475001|NCT01278394|7392434|FG000|STARTED|Overall Study||29
6475002|NCT01278394|7392434|FG000|COMPLETED|Overall Study||28
6475003|NCT01278394|7392434|FG000|NOT COMPLETED|Overall Study||1
6475004|NCT01278407|7392441|FG000|STARTED|Confirmatory Phase||46
6475005|NCT01278407|7392442|FG001|STARTED|Confirmatory Phase||47
6475006|NCT01278407|7392443|FG002|STARTED|Confirmatory Phase||49
6475007|NCT01278407|7392444|FG003|STARTED|Confirmatory Phase||0
6475008|NCT01278407|7392445|FG004|STARTED|Confirmatory Phase||0
6475009|NCT01278407|7392441|FG000|COMPLETED|Confirmatory Phase||37
6475010|NCT01278407|7392442|FG001|COMPLETED|Confirmatory Phase||31
6475011|NCT01278407|7392443|FG002|COMPLETED|Confirmatory Phase||43
6475012|NCT01278407|7392444|FG003|COMPLETED|Confirmatory Phase||0
6475013|NCT01278407|7392445|FG004|COMPLETED|Confirmatory Phase||0
6475014|NCT01278407|7392441|FG000|NOT COMPLETED|Confirmatory Phase||9
6475015|NCT01278407|7392442|FG001|NOT COMPLETED|Confirmatory Phase||16
6475016|NCT01278407|7392443|FG002|NOT COMPLETED|Confirmatory Phase||6
6554533|NCT01747629|7476665|FG001|NOT COMPLETED|Overall Study||6
6554534|NCT01747655|7476671|FG000|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
6554535|NCT01747655|7476672|FG001|STARTED|Temporary Naso-jejunal Tube Period||0
6554536|NCT01747655|7476671|FG000|COMPLETED|Temporary Naso-jejunal Tube Period||64
6554537|NCT01747655|7476672|FG001|COMPLETED|Temporary Naso-jejunal Tube Period||0
6554538|NCT01747655|7476671|FG000|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
6475017|NCT01278407|7392444|FG003|NOT COMPLETED|Confirmatory Phase||0
6475018|NCT01278407|7392445|FG004|NOT COMPLETED|Confirmatory Phase||0
6475019|NCT01278407|7392441|FG000|STARTED|Extension Phase||0
6475020|NCT01278407|7392442|FG001|STARTED|Extension Phase||0
6475021|NCT01278407|7392443|FG002|STARTED|Extension Phase||0
6475022|NCT01278407|7392444|FG003|STARTED|Extension Phase||46
6475023|NCT01278407|7392445|FG004|STARTED|Extension Phase||96
6475024|NCT01278407|7392441|FG000|COMPLETED|Extension Phase||0
6475025|NCT01278407|7392442|FG001|COMPLETED|Extension Phase||0
6475026|NCT01278407|7392443|FG002|COMPLETED|Extension Phase||0
6475027|NCT01278407|7392444|FG003|COMPLETED|Extension Phase||34
6475028|NCT01278407|7392445|FG004|COMPLETED|Extension Phase||66
6475029|NCT01278407|7392441|FG000|NOT COMPLETED|Extension Phase||0
6475030|NCT01278407|7392442|FG001|NOT COMPLETED|Extension Phase||0
6475031|NCT01278407|7392443|FG002|NOT COMPLETED|Extension Phase||0
6475032|NCT01278407|7392444|FG003|NOT COMPLETED|Extension Phase||12
6475033|NCT01278407|7392445|FG004|NOT COMPLETED|Extension Phase||30
6475034|NCT01278485|7392455|FG000|STARTED|Overall Study||719
6475035|NCT01278485|7392455|FG000|COMPLETED|Overall Study||719
6475036|NCT01278485|7392455|FG000|NOT COMPLETED|Overall Study||0
6475037|NCT01278615|7392459|FG000|STARTED|Overall Study||16
6475038|NCT01278615|7392459|FG000|COMPLETED|Overall Study||14
6475039|NCT01278615|7392459|FG000|NOT COMPLETED|Overall Study||2
6475040|NCT01278745|7392465|FG000|STARTED|Overall Study||89
6475041|NCT01278745|7392466|FG001|STARTED|Overall Study||74
6475042|NCT01278745|7392467|FG002|STARTED|Overall Study||121
6475043|NCT01278745|7392468|FG003|STARTED|Overall Study||78
6475044|NCT01278745|7392465|FG000|COMPLETED|Overall Study||84
6475045|NCT01278745|7392466|FG001|COMPLETED|Overall Study||68
6475046|NCT01278745|7392467|FG002|COMPLETED|Overall Study||0
6475047|NCT01278745|7392468|FG003|COMPLETED|Overall Study||0
6475048|NCT01278745|7392465|FG000|NOT COMPLETED|Overall Study||5
6475049|NCT01278745|7392466|FG001|NOT COMPLETED|Overall Study||6
6554539|NCT01747655|7476672|FG001|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
6554540|NCT01747655|7476671|FG000|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
6554541|NCT01747655|7476672|FG001|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
6554542|NCT01747655|7476671|FG000|COMPLETED|PEG-J Period (Duodopa Treatment)||44
6746908|NCT03380845|7674633|FG000|NOT COMPLETED|Overall Study||0
6746909|NCT03381196|7674641|FG000|STARTED|Overall Study||276
6746910|NCT03381196|7674642|FG001|STARTED|Overall Study||277
6746911|NCT03381196|7674641|FG000|Treated|Overall Study||273
6746912|NCT03381196|7674642|FG001|Treated|Overall Study||271
6746913|NCT03381196|7674641|FG000|COMPLETED|Overall Study||260
6746914|NCT03381196|7674642|FG001|COMPLETED|Overall Study||258
6746915|NCT03381196|7674641|FG000|NOT COMPLETED|Overall Study||16
6746916|NCT03381196|7674642|FG001|NOT COMPLETED|Overall Study||19
6746917|NCT03381248|7674650|FG000|STARTED|Overall Study||89
6746918|NCT03381248|7674651|FG001|STARTED|Overall Study||88
6746919|NCT03381248|7674650|FG000|COMPLETED|Overall Study||76
6746920|NCT03381248|7674651|FG001|COMPLETED|Overall Study||82
6746921|NCT03381248|7674650|FG000|NOT COMPLETED|Overall Study||13
6746922|NCT03381248|7674651|FG001|NOT COMPLETED|Overall Study||6
6746923|NCT03381339|7674659|FG000|STARTED|Overall Study||27
6746924|NCT03381339|7674660|FG001|STARTED|Overall Study||28
6746925|NCT03381339|7674659|FG000|COMPLETED|Overall Study||23
6746926|NCT03381339|7674660|FG001|COMPLETED|Overall Study||24
6746927|NCT03381339|7674659|FG000|NOT COMPLETED|Overall Study||4
6746928|NCT03381339|7674660|FG001|NOT COMPLETED|Overall Study||4
6746929|NCT03381742|7674670|FG000|STARTED|Overall Study||525
6746930|NCT03381742|7674671|FG001|STARTED|Overall Study||501
6746931|NCT03381742|7674672|FG002|STARTED|Overall Study||1511
6746932|NCT03381742|7674673|FG003|STARTED|Overall Study||506
6746933|NCT03381742|7674670|FG000|COMPLETED|Overall Study||525
6746934|NCT03381742|7674671|FG001|COMPLETED|Overall Study||501
6746935|NCT03381742|7674672|FG002|COMPLETED|Overall Study||1511
6746936|NCT03381742|7674673|FG003|COMPLETED|Overall Study||506
6746937|NCT03381742|7674670|FG000|NOT COMPLETED|Overall Study||0
6746938|NCT03381742|7674671|FG001|NOT COMPLETED|Overall Study||0
6746939|NCT03381742|7674672|FG002|NOT COMPLETED|Overall Study||0
6746940|NCT03381742|7674673|FG003|NOT COMPLETED|Overall Study||0
6746941|NCT03381989|7674683|FG000|STARTED|Overall Study||30
6746942|NCT03381989|7674683|FG000|COMPLETED|Overall Study||22
6746943|NCT03381989|7674683|FG000|NOT COMPLETED|Overall Study||8
6746944|NCT03382262|7674692|FG000|STARTED|Overall Study||12
6746945|NCT03382262|7674693|FG001|STARTED|Overall Study||13
6746946|NCT03382262|7674694|FG002|STARTED|Overall Study||15
6746947|NCT03382262|7674695|FG003|STARTED|Overall Study||15
6746948|NCT03382262|7674692|FG000|COMPLETED|Overall Study||12
6746949|NCT03382262|7674693|FG001|COMPLETED|Overall Study||13
6746950|NCT03382262|7674694|FG002|COMPLETED|Overall Study||14
6746951|NCT03382262|7674695|FG003|COMPLETED|Overall Study||14
6746952|NCT03382262|7674692|FG000|NOT COMPLETED|Overall Study||0
6475050|NCT01278745|7392467|FG002|NOT COMPLETED|Overall Study||121
6475051|NCT01278745|7392468|FG003|NOT COMPLETED|Overall Study||78
6475052|NCT01278797|7392476|FG000|STARTED|Period 1||14
6475053|NCT01278797|7392477|FG001|STARTED|Period 1||14
6475054|NCT01278797|7392476|FG000|COMPLETED|Period 1||13
6475055|NCT01278797|7392477|FG001|COMPLETED|Period 1||13
6746953|NCT03382262|7674693|FG001|NOT COMPLETED|Overall Study||0
6475056|NCT01278797|7392476|FG000|NOT COMPLETED|Period 1||1
6475057|NCT01278797|7392477|FG001|NOT COMPLETED|Period 1||1
6746954|NCT03382262|7674694|FG002|NOT COMPLETED|Overall Study||1
6746955|NCT03382262|7674695|FG003|NOT COMPLETED|Overall Study||1
6746956|NCT03382418|7674708|FG000|STARTED|Overall Study||25
6746957|NCT03382418|7674709|FG001|STARTED|Overall Study||15
6746958|NCT03382418|7674710|FG002|STARTED|Overall Study||5
6746959|NCT03382418|7674708|FG000|Month .5 Immunogenicity Cohort|Overall Study||25
6746960|NCT03382418|7674709|FG001|Month .5 Immunogenicity Cohort|Overall Study||14
6746961|NCT03382418|7674710|FG002|Month .5 Immunogenicity Cohort|Overall Study||5
6746962|NCT03382418|7674708|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||21
6746963|NCT03382418|7674709|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||13
6475058|NCT01278797|7392476|FG000|STARTED|Washout Period of 21 Days||13
6475059|NCT01278797|7392477|FG001|STARTED|Washout Period of 21 Days||13
6475060|NCT01278797|7392476|FG000|COMPLETED|Washout Period of 21 Days||13
6475061|NCT01278797|7392477|FG001|COMPLETED|Washout Period of 21 Days||13
6475062|NCT01278797|7392476|FG000|NOT COMPLETED|Washout Period of 21 Days||0
6475063|NCT01278797|7392477|FG001|NOT COMPLETED|Washout Period of 21 Days||0
6475064|NCT01278797|7392476|FG000|STARTED|Period 2||13
6475065|NCT01278797|7392477|FG001|STARTED|Period 2||13
6475066|NCT01278797|7392476|FG000|COMPLETED|Period 2||13
6475067|NCT01278797|7392477|FG001|COMPLETED|Period 2||13
6475068|NCT01278797|7392476|FG000|NOT COMPLETED|Period 2||0
6475069|NCT01278797|7392477|FG001|NOT COMPLETED|Period 2||0
6475070|NCT01278862|7392485|FG000|STARTED|Overall Study||45
6475071|NCT01278862|7392486|FG001|STARTED|Overall Study||43
6475072|NCT01278862|7392485|FG000|COMPLETED|Overall Study||44
6475073|NCT01278862|7392486|FG001|COMPLETED|Overall Study||42
6475074|NCT01278862|7392485|FG000|NOT COMPLETED|Overall Study||1
6475075|NCT01278862|7392486|FG001|NOT COMPLETED|Overall Study||1
6475076|NCT01278927|7392496|FG000|STARTED|Overall Study||180
6475077|NCT01278927|7392497|FG001|STARTED|Overall Study||178
6475078|NCT01278927|7392498|FG002|STARTED|Overall Study||178
6475079|NCT01278927|7392499|FG003|STARTED|Overall Study||175
6475080|NCT01278927|7392496|FG000|COMPLETED|Overall Study||180
6475081|NCT01278927|7392497|FG001|COMPLETED|Overall Study||178
6475082|NCT01278927|7392498|FG002|COMPLETED|Overall Study||178
6475083|NCT01278927|7392499|FG003|COMPLETED|Overall Study||175
6475084|NCT01278927|7392496|FG000|NOT COMPLETED|Overall Study||0
6475085|NCT01278927|7392497|FG001|NOT COMPLETED|Overall Study||0
6475086|NCT01278927|7392498|FG002|NOT COMPLETED|Overall Study||0
6475087|NCT01278927|7392499|FG003|NOT COMPLETED|Overall Study||0
6475088|NCT01278953|7392512|FG000|STARTED|Overall Study||155
6475089|NCT01278953|7392513|FG001|STARTED|Overall Study||145
6475090|NCT01278953|7392512|FG000|COMPLETED|Overall Study||146
6475091|NCT01278953|7392513|FG001|COMPLETED|Overall Study||134
6475092|NCT01278953|7392512|FG000|NOT COMPLETED|Overall Study||9
6475093|NCT01278953|7392513|FG001|NOT COMPLETED|Overall Study||11
6475094|NCT01279044|7392522|FG000|STARTED|PHASE 1 - Formative||59
6475095|NCT01279044|7392523|FG001|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
6475096|NCT01279044|7392524|FG002|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
6475097|NCT01279044|7392522|FG000|COMPLETED|PHASE 1 - Formative||59
6475098|NCT01279044|7392523|FG001|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
6475099|NCT01279044|7392524|FG002|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
6475100|NCT01279044|7392522|FG000|NOT COMPLETED|PHASE 1 - Formative||0
6475101|NCT01279044|7392523|FG001|NOT COMPLETED|PHASE 1 - Formative||0
6475102|NCT01279044|7392524|FG002|NOT COMPLETED|PHASE 1 - Formative||0
6475103|NCT01279044|7392522|FG000|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
6475104|NCT01279044|7392523|FG001|STARTED|PHASE 2 - Randmonized Controlled Trial||162
6475105|NCT01279044|7392524|FG002|STARTED|PHASE 2 - Randmonized Controlled Trial||164
6475106|NCT01279044|7392522|FG000|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
6475107|NCT01279044|7392523|FG001|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
6475108|NCT01279044|7392524|FG002|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
6475109|NCT01279044|7392522|FG000|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
6475110|NCT01279044|7392523|FG001|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
6475111|NCT01279044|7392524|FG002|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
6475112|NCT01279057|7392533|FG000|STARTED|Overall Study||288
6475113|NCT01279057|7392534|FG001|STARTED|Overall Study||292
6475114|NCT01279057|7392535|FG002|STARTED|Overall Study||147
6475115|NCT01279057|7392533|FG000|Per-Protocol (PPP) Population|Overall Study||257
6554543|NCT01747655|7476672|FG001|COMPLETED|PEG-J Period (Duodopa Treatment)||6
6554544|NCT01747655|7476671|FG000|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
6554545|NCT01747655|7476672|FG001|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
6554546|NCT01747655|7476671|FG000|STARTED|PEG-J Period (Continued Treatment)||41
6554547|NCT01747655|7476672|FG001|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
6475116|NCT01279057|7392534|FG001|Per-Protocol (PPP) Population|Overall Study||245
6475117|NCT01279057|7392535|FG002|Per-Protocol (PPP) Population|Overall Study||126
6475118|NCT01279057|7392533|FG000|Intent-to-Treat (ITT) Population|Overall Study||284
6475119|NCT01279057|7392534|FG001|Intent-to-Treat (ITT) Population|Overall Study||285
6475120|NCT01279057|7392535|FG002|Intent-to-Treat (ITT) Population|Overall Study||144
6475121|NCT01279057|7392533|FG000|COMPLETED|Overall Study||282
6475122|NCT01279057|7392534|FG001|COMPLETED|Overall Study||287
6475123|NCT01279057|7392535|FG002|COMPLETED|Overall Study||144
6475124|NCT01279057|7392533|FG000|NOT COMPLETED|Overall Study||6
6475125|NCT01279057|7392534|FG001|NOT COMPLETED|Overall Study||5
6475126|NCT01279057|7392535|FG002|NOT COMPLETED|Overall Study||3
6475127|NCT01279070|7392545|FG000|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
6475128|NCT01279070|7392546|FG001|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
6475129|NCT01279070|7392545|FG000|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
6501183|NCT01427504|7419666|FG001|NOT COMPLETED|Overall Study||1
6475130|NCT01279070|7392546|FG001|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
6475131|NCT01279070|7392545|FG000|NOT COMPLETED|Overall Study||5
6475132|NCT01279070|7392546|FG001|NOT COMPLETED|Overall Study||4
6475133|NCT01279109|7392558|FG000|STARTED|Overall Study||68
6475134|NCT01279109|7392559|FG001|STARTED|Overall Study||67
6475135|NCT01279109|7392558|FG000|COMPLETED|Overall Study||55
6475136|NCT01279109|7392559|FG001|COMPLETED|Overall Study||55
6475137|NCT01279109|7392558|FG000|NOT COMPLETED|Overall Study||13
6475138|NCT01279109|7392559|FG001|NOT COMPLETED|Overall Study||12
6475139|NCT01279187|7392567|FG000|STARTED|Overall Study||14
6475140|NCT01279187|7392568|FG001|STARTED|Overall Study||13
6475141|NCT01279187|7392567|FG000|COMPLETED|Overall Study||14
6475142|NCT01279187|7392568|FG001|COMPLETED|Overall Study||13
6475143|NCT01279187|7392567|FG000|NOT COMPLETED|Overall Study||0
6475144|NCT01279187|7392568|FG001|NOT COMPLETED|Overall Study||0
6475145|NCT01279200|7392576|FG000|STARTED|Overall Study||10
6475146|NCT01279200|7392577|FG001|STARTED|Overall Study||11
6475147|NCT01279200|7392576|FG000|COMPLETED|Overall Study||8
6475148|NCT01279200|7392577|FG001|COMPLETED|Overall Study||4
6475149|NCT01279200|7392576|FG000|NOT COMPLETED|Overall Study||2
6475150|NCT01279200|7392577|FG001|NOT COMPLETED|Overall Study||7
6475151|NCT01279265|7392585|FG000|STARTED|Overall Study||13
6475152|NCT01279265|7392586|FG001|STARTED|Overall Study||17
6475153|NCT01279265|7392585|FG000|COMPLETED|Overall Study||9
6475154|NCT01279265|7392586|FG001|COMPLETED|Overall Study||11
6475155|NCT01279265|7392585|FG000|NOT COMPLETED|Overall Study||4
6475156|NCT01279265|7392586|FG001|NOT COMPLETED|Overall Study||6
6475157|NCT01279317|7392594|FG000|STARTED|Period 1||6
6475158|NCT01279317|7392595|FG001|STARTED|Period 1||6
6475159|NCT01279317|7392594|FG000|COMPLETED|Period 1||6
6475160|NCT01279317|7392595|FG001|COMPLETED|Period 1||6
6475161|NCT01279317|7392594|FG000|NOT COMPLETED|Period 1||0
6475162|NCT01279317|7392595|FG001|NOT COMPLETED|Period 1||0
6475163|NCT01279317|7392594|FG000|STARTED|Washout||6
6475164|NCT01279317|7392595|FG001|STARTED|Washout||6
6475165|NCT01279317|7392594|FG000|COMPLETED|Washout||6
6475166|NCT01279317|7392595|FG001|COMPLETED|Washout||6
6475167|NCT01279317|7392594|FG000|NOT COMPLETED|Washout||0
6475168|NCT01279317|7392595|FG001|NOT COMPLETED|Washout||0
6475169|NCT01279317|7392594|FG000|STARTED|Period 2||6
6475170|NCT01279317|7392595|FG001|STARTED|Period 2||6
6475171|NCT01279317|7392594|FG000|COMPLETED|Period 2||6
6475172|NCT01279317|7392595|FG001|COMPLETED|Period 2||6
6475173|NCT01279317|7392594|FG000|NOT COMPLETED|Period 2||0
6475174|NCT01279317|7392595|FG001|NOT COMPLETED|Period 2||0
6475175|NCT01279343|7392602|FG000|STARTED|Overall Study||59
6475176|NCT01279343|7392603|FG001|STARTED|Overall Study||64
6475177|NCT01279343|7392602|FG000|COMPLETED|Overall Study||57
6475178|NCT01279343|7392603|FG001|COMPLETED|Overall Study||58
6475179|NCT01279343|7392602|FG000|NOT COMPLETED|Overall Study||2
6475180|NCT01279343|7392603|FG001|NOT COMPLETED|Overall Study||6
6475181|NCT01279447|7392611|FG000|STARTED|Overall Study||34
6475182|NCT01279447|7392612|FG001|STARTED|Overall Study||34
6475183|NCT01279447|7392611|FG000|COMPLETED|Overall Study||31
6475184|NCT01279447|7392612|FG001|COMPLETED|Overall Study||33
6475185|NCT01279447|7392611|FG000|NOT COMPLETED|Overall Study||3
6475186|NCT01279447|7392612|FG001|NOT COMPLETED|Overall Study||1
6475187|NCT01279486|7392618|FG000|STARTED|Overall Study||120
6475188|NCT01279486|7392618|FG000|COMPLETED|Overall Study|1 result questionnaire was not returned so 119 volunteers results were used for consumer accuracy.|119
6475189|NCT01279486|7392618|FG000|NOT COMPLETED|Overall Study||1
6475190|NCT01279564|7392624|FG000|STARTED|Overall Study||40
6654574|NCT02446769|7584448|FG001|COMPLETED|Screening Period||0
6654575|NCT02446769|7584449|FG002|COMPLETED|Screening Period||0
6654576|NCT02446769|7584447|FG000|NOT COMPLETED|Screening Period||11
6654577|NCT02446769|7584448|FG001|NOT COMPLETED|Screening Period||0
6654578|NCT02446769|7584449|FG002|NOT COMPLETED|Screening Period||0
6654579|NCT02446769|7584447|FG000|STARTED|Study Period||0
6654580|NCT02446769|7584448|FG001|STARTED|Study Period||4
6654581|NCT02446769|7584449|FG002|STARTED|Study Period||3
6654582|NCT02446769|7584447|FG000|COMPLETED|Study Period||0
6654583|NCT02446769|7584448|FG001|COMPLETED|Study Period||2
6654584|NCT02446769|7584449|FG002|COMPLETED|Study Period||3
6654585|NCT02446769|7584447|FG000|NOT COMPLETED|Study Period||0
6654586|NCT02446769|7584448|FG001|NOT COMPLETED|Study Period||2
6475191|NCT01279564|7392625|FG001|STARTED|Overall Study||32
6475192|NCT01279564|7392624|FG000|COMPLETED|Overall Study||40
6475193|NCT01279564|7392625|FG001|COMPLETED|Overall Study||32
6475194|NCT01279564|7392624|FG000|NOT COMPLETED|Overall Study||0
6475195|NCT01279564|7392625|FG001|NOT COMPLETED|Overall Study||0
6475196|NCT01279681|7392633|FG000|STARTED|Overall Study||15
6654587|NCT02446769|7584449|FG002|NOT COMPLETED|Study Period||0
6475197|NCT01279681|7392634|FG001|STARTED|Overall Study||17
6475198|NCT01279681|7392633|FG000|COMPLETED|Overall Study||0
6475199|NCT01279681|7392634|FG001|COMPLETED|Overall Study||0
6475200|NCT01279681|7392633|FG000|NOT COMPLETED|Overall Study||15
6475201|NCT01279681|7392634|FG001|NOT COMPLETED|Overall Study||17
6475202|NCT01279850|7392640|FG000|STARTED|Overall Study||891
6475203|NCT01279850|7392640|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|800
6475204|NCT01279850|7392640|FG000|NOT COMPLETED|Overall Study||91
6475205|NCT01279954|7392646|FG000|STARTED|Overall Study||5
6475206|NCT01279954|7392647|FG001|STARTED|Overall Study||5
6654588|NCT02446847|7584458|FG000|STARTED|Overall Study||8
6746964|NCT03382418|7674710|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||5
6746965|NCT03382418|7674708|FG000|COMPLETED|Overall Study||22
6746966|NCT03382418|7674709|FG001|COMPLETED|Overall Study||12
6746967|NCT03382418|7674710|FG002|COMPLETED|Overall Study||5
6746968|NCT03382418|7674708|FG000|NOT COMPLETED|Overall Study||3
6746969|NCT03382418|7674709|FG001|NOT COMPLETED|Overall Study||3
6746970|NCT03382418|7674710|FG002|NOT COMPLETED|Overall Study||0
6746971|NCT03382509|7674721|FG000|STARTED|Overall Study||8
6746972|NCT03382509|7674722|FG001|STARTED|Overall Study||8
6746973|NCT03382509|7674721|FG000|COMPLETED|Overall Study||8
6746974|NCT03382509|7674722|FG001|COMPLETED|Overall Study||8
6746975|NCT03382509|7674721|FG000|NOT COMPLETED|Overall Study||0
6746976|NCT03382509|7674722|FG001|NOT COMPLETED|Overall Study||0
6746977|NCT03382665|7674729|FG000|STARTED|Overall Study||70
6746978|NCT03382665|7674729|FG000|Actual Enrollment|Overall Study||59
6746979|NCT03382665|7674729|FG000|5 Year Follow up|Overall Study||25
6746980|NCT03382665|7674729|FG000|COMPLETED|Overall Study||25
6746981|NCT03382665|7674729|FG000|NOT COMPLETED|Overall Study||45
6746982|NCT03382821|7674739|FG000|STARTED|Overall Study||60
6746983|NCT03382821|7674740|FG001|STARTED|Overall Study||60
6746984|NCT03382821|7674739|FG000|COMPLETED|Overall Study||60
6746985|NCT03382821|7674740|FG001|COMPLETED|Overall Study||57
6746986|NCT03382821|7674739|FG000|NOT COMPLETED|Overall Study||0
6746987|NCT03382821|7674740|FG001|NOT COMPLETED|Overall Study||3
6746988|NCT03382847|7674747|FG000|STARTED|Overall Study||25
6746989|NCT03382847|7674747|FG000|COMPLETED|Overall Study||25
6746990|NCT03382847|7674747|FG000|NOT COMPLETED|Overall Study||0
6746991|NCT03382899|7674753|FG000|STARTED|Overall Study||51
6746992|NCT03382899|7674754|FG001|STARTED|Overall Study||50
6746993|NCT03382899|7674753|FG000|Received at Least 1 Dose of Study Drug|Overall Study||50
6746994|NCT03382899|7674754|FG001|Received at Least 1 Dose of Study Drug|Overall Study||48
6746995|NCT03382899|7674753|FG000|COMPLETED|Overall Study||20
6746996|NCT03382899|7674754|FG001|COMPLETED|Overall Study||15
6746997|NCT03382899|7674753|FG000|NOT COMPLETED|Overall Study||31
6746998|NCT03382899|7674754|FG001|NOT COMPLETED|Overall Study||35
6746999|NCT03382912|7674762|FG000|STARTED|Overall Study||27
6747000|NCT03382912|7674763|FG001|STARTED|Overall Study||25
6747001|NCT03382912|7674762|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
6747002|NCT03382912|7674763|FG001|Received at Least 1 Dose of Study Drug|Overall Study||24
6747003|NCT03382912|7674762|FG000|COMPLETED|Overall Study||21
6747004|NCT03382912|7674763|FG001|COMPLETED|Overall Study||13
6747005|NCT03382912|7674762|FG000|NOT COMPLETED|Overall Study||6
6747006|NCT03382912|7674763|FG001|NOT COMPLETED|Overall Study||12
6747007|NCT03383146|7674771|FG000|STARTED|Overall Study||148
6747008|NCT03383146|7674772|FG001|STARTED|Overall Study||302
6747009|NCT03383146|7674771|FG000|Safety Population|Overall Study||145
6747010|NCT03383146|7674772|FG001|Safety Population|Overall Study||299
6654589|NCT02446847|7584459|FG001|STARTED|Overall Study||8
6654590|NCT02446847|7584458|FG000|COMPLETED|Overall Study||8
6654591|NCT02446847|7584459|FG001|COMPLETED|Overall Study||6
6654592|NCT02446847|7584458|FG000|NOT COMPLETED|Overall Study||0
6654593|NCT02446847|7584459|FG001|NOT COMPLETED|Overall Study||2
6654594|NCT02446886|7584467|FG000|STARTED|Overall Study||8
6654595|NCT02446886|7584468|FG001|STARTED|Overall Study||7
6654596|NCT02446886|7584467|FG000|COMPLETED|Overall Study||6
6654597|NCT02446886|7584468|FG001|COMPLETED|Overall Study||3
6654598|NCT02446886|7584467|FG000|NOT COMPLETED|Overall Study||2
6654599|NCT02446886|7584468|FG001|NOT COMPLETED|Overall Study||4
6654600|NCT02446899|7584477|FG000|STARTED|Overall Study||181
6654601|NCT02446899|7584478|FG001|STARTED|Overall Study||184
6654602|NCT02446899|7584477|FG000|Received Study Drug|Overall Study||180
6654603|NCT02446899|7584478|FG001|Received Study Drug|Overall Study||182
6654604|NCT02446899|7584477|FG000|COMPLETED|Overall Study||156
6654605|NCT02446899|7584478|FG001|COMPLETED|Overall Study||136
6654606|NCT02446899|7584477|FG000|NOT COMPLETED|Overall Study||25
6654607|NCT02446899|7584478|FG001|NOT COMPLETED|Overall Study||48
6654608|NCT02446912|7584487|FG000|STARTED|Overall Study||93
6654609|NCT02446912|7584488|FG001|STARTED|Overall Study||180
6654610|NCT02446912|7584489|FG002|STARTED|Overall Study||184
6654611|NCT02446912|7584487|FG000|Participants Who Completed Week 52|Overall Study||80
6654612|NCT02446912|7584488|FG001|Participants Who Completed Week 52|Overall Study||153
6654613|NCT02446912|7584489|FG002|Participants Who Completed Week 52|Overall Study||157
6654614|NCT02446912|7584487|FG000|COMPLETED|Overall Study||75
6654615|NCT02446912|7584488|FG001|COMPLETED|Overall Study||145
6654616|NCT02446912|7584489|FG002|COMPLETED|Overall Study||149
6747011|NCT03383146|7674771|FG000|Run-in Period|Overall Study||91
6747012|NCT03383146|7674772|FG001|Run-in Period|Overall Study||207
6747013|NCT03383146|7674771|FG000|COMPLETED|Overall Study||63
6747014|NCT03383146|7674772|FG001|COMPLETED|Overall Study||118
6747015|NCT03383146|7674771|FG000|NOT COMPLETED|Overall Study||85
6747016|NCT03383146|7674772|FG001|NOT COMPLETED|Overall Study||184
6747017|NCT03383198|7674781|FG000|STARTED|Overall Study||4
6747018|NCT03383198|7674782|FG001|STARTED|Overall Study||1
6747019|NCT03383198|7674781|FG000|COMPLETED|Overall Study||4
6654617|NCT02446912|7584487|FG000|NOT COMPLETED|Overall Study||18
6654618|NCT02446912|7584488|FG001|NOT COMPLETED|Overall Study||35
6654619|NCT02446912|7584489|FG002|NOT COMPLETED|Overall Study||35
6654620|NCT02446990|7584499|FG000|STARTED|Overall Study||9550
6654621|NCT02446990|7584500|FG001|STARTED|Overall Study||9552
6654622|NCT02446990|7584499|FG000|COMPLETED|Overall Study||8830
6747020|NCT03383198|7674782|FG001|COMPLETED|Overall Study||1
6654623|NCT02446990|7584500|FG001|COMPLETED|Overall Study||8894
6654624|NCT02446990|7584499|FG000|NOT COMPLETED|Overall Study||720
6654625|NCT02446990|7584500|FG001|NOT COMPLETED|Overall Study||658
6656192|NCT02458690|7586309|FG000|NOT COMPLETED|Overall Study||8
6656193|NCT02458690|7586310|FG001|NOT COMPLETED|Overall Study||9
6656194|NCT02458768|7586318|FG000|STARTED|Overall Study||57
6656195|NCT02458768|7586319|FG001|STARTED|Overall Study||55
6656196|NCT02458768|7586318|FG000|COMPLETED|Overall Study||50
6656197|NCT02458768|7586319|FG001|COMPLETED|Overall Study||50
6656198|NCT02458768|7586318|FG000|NOT COMPLETED|Overall Study||7
6656199|NCT02458768|7586319|FG001|NOT COMPLETED|Overall Study||5
6656200|NCT02459093|7586327|FG000|STARTED|Overall Study||275
6656201|NCT02459093|7586328|FG001|STARTED|Overall Study||275
6656202|NCT02459093|7586327|FG000|COMPLETED|Overall Study||263
6656203|NCT02459093|7586328|FG001|COMPLETED|Overall Study||257
6656204|NCT02459093|7586327|FG000|NOT COMPLETED|Overall Study||12
6656205|NCT02459093|7586328|FG001|NOT COMPLETED|Overall Study||18
6656206|NCT02459119|7586334|FG000|STARTED|Overall Study||17
6656207|NCT02459119|7586334|FG000|COMPLETED|Overall Study||17
6656208|NCT02459119|7586334|FG000|NOT COMPLETED|Overall Study||0
6656209|NCT02459197|7586340|FG000|STARTED|Overall Study||58
6656210|NCT02459197|7586341|FG001|STARTED|Overall Study||56
6656211|NCT02459197|7586340|FG000|COMPLETED|Overall Study||58
6656212|NCT02459197|7586341|FG001|COMPLETED|Overall Study||55
6656213|NCT02459197|7586340|FG000|NOT COMPLETED|Overall Study||0
6656214|NCT02459197|7586341|FG001|NOT COMPLETED|Overall Study||1
6656215|NCT02459262|7586358|FG000|STARTED|Overall Study||8
6656216|NCT02459262|7586359|FG001|STARTED|Overall Study||8
6656217|NCT02459262|7586360|FG002|STARTED|Overall Study||8
6656218|NCT02459262|7586361|FG003|STARTED|Overall Study||8
6656219|NCT02459262|7586362|FG004|STARTED|Overall Study||8
6656220|NCT02459262|7586363|FG005|STARTED|Overall Study||8
6656221|NCT02459262|7586364|FG006|STARTED|Overall Study||12
6656222|NCT02459262|7586365|FG007|STARTED|Overall Study||45
6656223|NCT02459262|7586366|FG008|STARTED|Overall Study||45
6656224|NCT02459262|7586367|FG009|STARTED|Overall Study||45
6656225|NCT02459262|7586368|FG010|STARTED|Overall Study||45
6656226|NCT02459262|7586358|FG000|COMPLETED|Overall Study||8
6747021|NCT03383198|7674781|FG000|NOT COMPLETED|Overall Study||0
6747022|NCT03383198|7674782|FG001|NOT COMPLETED|Overall Study||0
6747023|NCT03383523|7674795|FG000|STARTED|Overall Study||11
6747024|NCT03383523|7674796|FG001|STARTED|Overall Study||11
6747025|NCT03383523|7674797|FG002|STARTED|Overall Study||10
6747026|NCT03383523|7674798|FG003|STARTED|Overall Study||12
6747027|NCT03383523|7674799|FG004|STARTED|Overall Study||11
6747028|NCT03383523|7674800|FG005|STARTED|Overall Study||12
6747029|NCT03383523|7674801|FG006|STARTED|Overall Study||10
6747030|NCT03383523|7674795|FG000|COMPLETED|Overall Study||10
6747031|NCT03383523|7674796|FG001|COMPLETED|Overall Study||11
6747032|NCT03383523|7674797|FG002|COMPLETED|Overall Study||9
6747033|NCT03383523|7674798|FG003|COMPLETED|Overall Study||12
6747034|NCT03383523|7674799|FG004|COMPLETED|Overall Study||11
6747035|NCT03383523|7674800|FG005|COMPLETED|Overall Study||12
6747036|NCT03383523|7674801|FG006|COMPLETED|Overall Study||10
6747037|NCT03383523|7674795|FG000|NOT COMPLETED|Overall Study||1
6747038|NCT03383523|7674796|FG001|NOT COMPLETED|Overall Study||0
6747039|NCT03383523|7674797|FG002|NOT COMPLETED|Overall Study||1
6747040|NCT03383523|7674798|FG003|NOT COMPLETED|Overall Study||0
6747041|NCT03383523|7674799|FG004|NOT COMPLETED|Overall Study||0
6747042|NCT03383523|7674800|FG005|NOT COMPLETED|Overall Study||0
6747043|NCT03383523|7674801|FG006|NOT COMPLETED|Overall Study||0
6747044|NCT03383588|7674820|FG000|STARTED|Overall Study||8
6747045|NCT03383588|7674821|FG001|STARTED|Overall Study||9
6747046|NCT03383588|7674822|FG002|STARTED|Overall Study||9
6747047|NCT03383588|7674820|FG000|COMPLETED|Overall Study||8
6747048|NCT03383588|7674821|FG001|COMPLETED|Overall Study||9
6747049|NCT03383588|7674822|FG002|COMPLETED|Overall Study||9
6747050|NCT03383588|7674820|FG000|NOT COMPLETED|Overall Study||0
6747051|NCT03383588|7674821|FG001|NOT COMPLETED|Overall Study||0
6747052|NCT03383588|7674822|FG002|NOT COMPLETED|Overall Study||0
6747053|NCT03383614|7674834|FG000|STARTED|Overall Study||6
6747054|NCT03383614|7674835|FG001|STARTED|Overall Study||6
6475207|NCT01279954|7392646|FG000|COMPLETED|Overall Study||2
6475208|NCT01279954|7392647|FG001|COMPLETED|Overall Study||1
6656227|NCT02459262|7586359|FG001|COMPLETED|Overall Study||8
6656228|NCT02459262|7586360|FG002|COMPLETED|Overall Study||8
6656229|NCT02459262|7586361|FG003|COMPLETED|Overall Study||8
6656230|NCT02459262|7586362|FG004|COMPLETED|Overall Study||8
6747055|NCT03383614|7674836|FG002|STARTED|Overall Study||6
6747056|NCT03383614|7674837|FG003|STARTED|Overall Study||6
6747057|NCT03383614|7674834|FG000|COMPLETED|Overall Study||6
6656231|NCT02459262|7586363|FG005|COMPLETED|Overall Study||8
6656232|NCT02459262|7586364|FG006|COMPLETED|Overall Study||12
6656233|NCT02459262|7586365|FG007|COMPLETED|Overall Study||45
6656234|NCT02459262|7586366|FG008|COMPLETED|Overall Study||45
6747058|NCT03383614|7674835|FG001|COMPLETED|Overall Study||5
6747059|NCT03383614|7674836|FG002|COMPLETED|Overall Study||6
6747060|NCT03383614|7674837|FG003|COMPLETED|Overall Study||6
6747061|NCT03383614|7674834|FG000|NOT COMPLETED|Overall Study||0
6747062|NCT03383614|7674835|FG001|NOT COMPLETED|Overall Study||1
6656235|NCT02459262|7586367|FG009|COMPLETED|Overall Study||44
6656236|NCT02459262|7586368|FG010|COMPLETED|Overall Study||45
6747063|NCT03383614|7674836|FG002|NOT COMPLETED|Overall Study||0
6747064|NCT03383614|7674837|FG003|NOT COMPLETED|Overall Study||0
6654626|NCT02447003|7584508|FG000|STARTED|Overall Study||170
6654627|NCT02447003|7584509|FG001|STARTED|Overall Study||84
6654628|NCT02447003|7584508|FG000|COMPLETED|Overall Study||0
6654629|NCT02447003|7584509|FG001|COMPLETED|Overall Study||0
6654630|NCT02447003|7584508|FG000|NOT COMPLETED|Overall Study||170
6654631|NCT02447003|7584509|FG001|NOT COMPLETED|Overall Study||84
6654632|NCT02447029|7584519|FG000|STARTED|Overall Study||72
6654633|NCT02447029|7584520|FG001|STARTED|Overall Study||70
6654634|NCT02447029|7584519|FG000|Treated|Overall Study||69
6475209|NCT01279954|7392646|FG000|NOT COMPLETED|Overall Study||3
6475210|NCT01279954|7392647|FG001|NOT COMPLETED|Overall Study||4
6475211|NCT01280058|7392658|FG000|STARTED|Overall Study||36
6475212|NCT01280058|7392659|FG001|STARTED|Overall Study||37
6475213|NCT01280058|7392658|FG000|COMPLETED|Overall Study||36
6475214|NCT01280058|7392659|FG001|COMPLETED|Overall Study||37
6475215|NCT01280058|7392658|FG000|NOT COMPLETED|Overall Study||0
6475216|NCT01280058|7392659|FG001|NOT COMPLETED|Overall Study||0
6475217|NCT01280110|7392669|FG000|STARTED|Overall Study||22
6475218|NCT01280110|7392670|FG001|STARTED|Overall Study||22
6475219|NCT01280110|7392669|FG000|COMPLETED|Overall Study||22
6475220|NCT01280110|7392670|FG001|COMPLETED|Overall Study||22
6475221|NCT01280110|7392669|FG000|NOT COMPLETED|Overall Study||0
6475222|NCT01280110|7392670|FG001|NOT COMPLETED|Overall Study||0
6475223|NCT01280123|7392681|FG000|STARTED|Overall Study||72
6475224|NCT01280123|7392682|FG001|STARTED|Overall Study||67
6475225|NCT01280123|7392683|FG002|STARTED|Overall Study||71
6475226|NCT01280123|7392681|FG000|COMPLETED|Overall Study||71
6475227|NCT01280123|7392682|FG001|COMPLETED|Overall Study||63
6475228|NCT01280123|7392683|FG002|COMPLETED|Overall Study||70
6475229|NCT01280123|7392681|FG000|NOT COMPLETED|Overall Study||1
6475230|NCT01280123|7392682|FG001|NOT COMPLETED|Overall Study||4
6475231|NCT01280123|7392683|FG002|NOT COMPLETED|Overall Study||1
6475232|NCT01280201|7392691|FG000|STARTED|Overall Study||44
6475233|NCT01280201|7392691|FG000|COMPLETED|Overall Study||44
6475234|NCT01280201|7392691|FG000|NOT COMPLETED|Overall Study||0
6475235|NCT01280266|7392697|FG000|STARTED|First Intervention (Week 1-4)||15
6475236|NCT01280266|7392698|FG001|STARTED|First Intervention (Week 1-4)||14
6475237|NCT01280266|7392697|FG000|COMPLETED|First Intervention (Week 1-4)||14
6475238|NCT01280266|7392698|FG001|COMPLETED|First Intervention (Week 1-4)||12
6475239|NCT01280266|7392697|FG000|NOT COMPLETED|First Intervention (Week 1-4)||1
6475240|NCT01280266|7392698|FG001|NOT COMPLETED|First Intervention (Week 1-4)||2
6475241|NCT01280266|7392697|FG000|STARTED|Washout Period (Week 4-5)||14
6475242|NCT01280266|7392698|FG001|STARTED|Washout Period (Week 4-5)||12
6475243|NCT01280266|7392697|FG000|COMPLETED|Washout Period (Week 4-5)||14
6475244|NCT01280266|7392698|FG001|COMPLETED|Washout Period (Week 4-5)||12
6475245|NCT01280266|7392697|FG000|NOT COMPLETED|Washout Period (Week 4-5)||0
6475246|NCT01280266|7392698|FG001|NOT COMPLETED|Washout Period (Week 4-5)||0
6475247|NCT01280266|7392697|FG000|STARTED|Second Intervention (Week 5-9)||14
6475248|NCT01280266|7392698|FG001|STARTED|Second Intervention (Week 5-9)||12
6475249|NCT01280266|7392697|FG000|COMPLETED|Second Intervention (Week 5-9)||14
6475250|NCT01280266|7392698|FG001|COMPLETED|Second Intervention (Week 5-9)||12
6475251|NCT01280266|7392697|FG000|NOT COMPLETED|Second Intervention (Week 5-9)||0
6475252|NCT01280266|7392698|FG001|NOT COMPLETED|Second Intervention (Week 5-9)||0
6475253|NCT01280357|7392708|FG000|STARTED|Overall Study||60
6475254|NCT01280357|7392708|FG000|COMPLETED|Overall Study||34
6475255|NCT01280357|7392708|FG000|NOT COMPLETED|Overall Study||26
6475256|NCT01280409|7392717|FG000|STARTED|Overall Study||59
6475257|NCT01280409|7392718|FG001|STARTED|Overall Study||55
6475258|NCT01280409|7392717|FG000|COMPLETED|Overall Study||43
6475259|NCT01280409|7392718|FG001|COMPLETED|Overall Study||36
6475260|NCT01280409|7392717|FG000|NOT COMPLETED|Overall Study||16
6475261|NCT01280409|7392718|FG001|NOT COMPLETED|Overall Study||19
6475262|NCT01280552|7392726|FG000|STARTED|Overall Study||81
6475263|NCT01280552|7392727|FG001|STARTED|Overall Study||43
6475264|NCT01280552|7392726|FG000|COMPLETED|Overall Study|Survival is still being assessed|75
6475265|NCT01280552|7392727|FG001|COMPLETED|Overall Study||42
6475266|NCT01280552|7392726|FG000|NOT COMPLETED|Overall Study||6
6475267|NCT01280552|7392727|FG001|NOT COMPLETED|Overall Study||1
6475268|NCT01280591|7392740|FG000|STARTED|Overall Study||203
6475269|NCT01280591|7392741|FG001|STARTED|Overall Study||204
6475270|NCT01280591|7392742|FG002|STARTED|Overall Study||203
6475271|NCT01280591|7392743|FG003|STARTED|Overall Study||102
6475272|NCT01280591|7392740|FG000|COMPLETED|Overall Study||203
6475273|NCT01280591|7392741|FG001|COMPLETED|Overall Study||204
6475274|NCT01280591|7392742|FG002|COMPLETED|Overall Study||203
6475275|NCT01280591|7392743|FG003|COMPLETED|Overall Study||99
6475276|NCT01280591|7392740|FG000|NOT COMPLETED|Overall Study||0
6475277|NCT01280591|7392741|FG001|NOT COMPLETED|Overall Study||0
6475278|NCT01280591|7392742|FG002|NOT COMPLETED|Overall Study||0
6475279|NCT01280591|7392743|FG003|NOT COMPLETED|Overall Study||3
6475280|NCT01280604|7392755|FG000|STARTED|Overall Study||33
6475281|NCT01280604|7392756|FG001|STARTED|Overall Study||33
6475282|NCT01280604|7392755|FG000|Subjects Meeting All Inclusion Criteria|Overall Study||25
6475283|NCT01280604|7392756|FG001|Subjects Meeting All Inclusion Criteria|Overall Study||29
6475284|NCT01280604|7392755|FG000|COMPLETED|Overall Study||24
6475285|NCT01280604|7392756|FG001|COMPLETED|Overall Study||28
6475286|NCT01280604|7392755|FG000|NOT COMPLETED|Overall Study||9
6654635|NCT02447029|7584520|FG001|Treated|Overall Study||68
6654636|NCT02447029|7584519|FG000|COMPLETED|Overall Study||69
6654637|NCT02447029|7584520|FG001|COMPLETED|Overall Study||68
6475287|NCT01280604|7392756|FG001|NOT COMPLETED|Overall Study||5
6475288|NCT01280617|7392764|FG000|STARTED|Overall Study||23
6475289|NCT01280617|7392765|FG001|STARTED|Overall Study||21
6475290|NCT01280617|7392764|FG000|COMPLETED|Overall Study||23
6475291|NCT01280617|7392765|FG001|COMPLETED|Overall Study||20
6475292|NCT01280617|7392764|FG000|NOT COMPLETED|Overall Study||0
6475293|NCT01280617|7392765|FG001|NOT COMPLETED|Overall Study||1
6475294|NCT01280656|7392774|FG000|STARTED|Overall Study||62
6475295|NCT01280656|7392775|FG001|STARTED|Overall Study||312
6475296|NCT01280656|7392776|FG002|STARTED|Overall Study||286
6475297|NCT01280656|7392774|FG000|COMPLETED|Overall Study||59
6475298|NCT01280656|7392775|FG001|COMPLETED|Overall Study||265
6475299|NCT01280656|7392776|FG002|COMPLETED|Overall Study||223
6475300|NCT01280656|7392774|FG000|NOT COMPLETED|Overall Study||3
6475301|NCT01280656|7392775|FG001|NOT COMPLETED|Overall Study||47
6475302|NCT01280656|7392776|FG002|NOT COMPLETED|Overall Study||63
6475303|NCT01280695|7392789|FG000|STARTED|Overall Study||26
6475304|NCT01280695|7392790|FG001|STARTED|Overall Study||25
6475305|NCT01280695|7392791|FG002|STARTED|Overall Study||26
6475306|NCT01280695|7392792|FG003|STARTED|Overall Study||26
6475307|NCT01280695|7392793|FG004|STARTED|Overall Study||26
6475308|NCT01280695|7392789|FG000|COMPLETED|Overall Study||26
6475309|NCT01280695|7392790|FG001|COMPLETED|Overall Study||24
6475310|NCT01280695|7392791|FG002|COMPLETED|Overall Study||21
6475311|NCT01280695|7392792|FG003|COMPLETED|Overall Study||22
6475312|NCT01280695|7392793|FG004|COMPLETED|Overall Study||24
6475313|NCT01280695|7392789|FG000|NOT COMPLETED|Overall Study||0
6475314|NCT01280695|7392790|FG001|NOT COMPLETED|Overall Study||1
6475315|NCT01280695|7392791|FG002|NOT COMPLETED|Overall Study||5
6475316|NCT01280695|7392792|FG003|NOT COMPLETED|Overall Study||4
6475317|NCT01280695|7392793|FG004|NOT COMPLETED|Overall Study||2
6475318|NCT01280721|7392805|FG000|STARTED|Overall Study||135
6475319|NCT01280721|7392805|FG000|COMPLETED|Overall Study||113
6475320|NCT01280721|7392805|FG000|NOT COMPLETED|Overall Study||22
6475321|NCT01280812|7392823|FG000|STARTED|Overall Study||70
6475322|NCT01280812|7392824|FG001|STARTED|Overall Study||71
6475323|NCT01280812|7392825|FG002|STARTED|Overall Study||69
6475324|NCT01280812|7392823|FG000|COMPLETED|Overall Study||67
6475325|NCT01280812|7392824|FG001|COMPLETED|Overall Study||69
6475326|NCT01280812|7392825|FG002|COMPLETED|Overall Study||68
6475327|NCT01280812|7392823|FG000|NOT COMPLETED|Overall Study||3
6475328|NCT01280812|7392824|FG001|NOT COMPLETED|Overall Study||2
6475329|NCT01280812|7392825|FG002|NOT COMPLETED|Overall Study||1
6475330|NCT01280903|7392836|FG000|STARTED|Overall Study||91
6475331|NCT01280903|7392837|FG001|STARTED|Overall Study||91
6475332|NCT01280903|7392836|FG000|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|68
6475333|NCT01280903|7392837|FG001|COMPLETED|Overall Study|91 participants analyzed per intention-to-treat|75
6475334|NCT01280903|7392836|FG000|NOT COMPLETED|Overall Study||23
6475335|NCT01280903|7392837|FG001|NOT COMPLETED|Overall Study||16
6475336|NCT01280942|7392845|FG000|STARTED|Overall Study||10120
6475337|NCT01280942|7392846|FG001|STARTED|Overall Study||9911
6475338|NCT01280942|7392845|FG000|COMPLETED|Overall Study||10120
6475339|NCT01280942|7392846|FG001|COMPLETED|Overall Study||9911
6475340|NCT01280942|7392845|FG000|NOT COMPLETED|Overall Study||0
6475341|NCT01280942|7392846|FG001|NOT COMPLETED|Overall Study||0
6475342|NCT01280955|7392852|FG000|STARTED|Overall Study||30
6475343|NCT01280955|7392852|FG000|COMPLETED|Overall Study||27
6475344|NCT01280955|7392852|FG000|NOT COMPLETED|Overall Study||3
6475345|NCT01280968|7392860|FG000|STARTED|Overall Study||45
6475346|NCT01280968|7392861|FG001|STARTED|Overall Study||7
6475347|NCT01280968|7392860|FG000|COMPLETED|Overall Study||27
6475348|NCT01280968|7392861|FG001|COMPLETED|Overall Study||4
6475349|NCT01280968|7392860|FG000|NOT COMPLETED|Overall Study||18
6475350|NCT01280968|7392861|FG001|NOT COMPLETED|Overall Study||3
6475351|NCT01280981|7392868|FG000|STARTED|Overall Study||288
6475352|NCT01280981|7392868|FG000|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
6475353|NCT01280981|7392868|FG000|COMPLETED|Overall Study||196
6475354|NCT01280981|7392868|FG000|NOT COMPLETED|Overall Study||92
6475355|NCT01281007|7392874|FG000|STARTED|Overall Study||75
6475356|NCT01281007|7392875|FG001|STARTED|Overall Study||75
6475357|NCT01281007|7392874|FG000|COMPLETED|Overall Study||71
6475358|NCT01281007|7392875|FG001|COMPLETED|Overall Study||67
6475359|NCT01281007|7392874|FG000|NOT COMPLETED|Overall Study||4
6475360|NCT01281007|7392875|FG001|NOT COMPLETED|Overall Study||8
6475361|NCT01281137|7392883|FG000|STARTED|Baseline Population||25
6475362|NCT01281137|7392884|FG001|STARTED|Baseline Population||79
6475363|NCT01281137|7392883|FG000|COMPLETED|Baseline Population||25
6475364|NCT01281137|7392884|FG001|COMPLETED|Baseline Population||78
6475365|NCT01281137|7392883|FG000|NOT COMPLETED|Baseline Population||0
6475366|NCT01281137|7392884|FG001|NOT COMPLETED|Baseline Population||1
6475367|NCT01281137|7392883|FG000|STARTED|Analysis Population (Baseline)||25
6475368|NCT01281137|7392884|FG001|STARTED|Analysis Population (Baseline)||78
6475369|NCT01281137|7392883|FG000|COMPLETED|Analysis Population (Baseline)||21
6475370|NCT01281137|7392884|FG001|COMPLETED|Analysis Population (Baseline)||69
6475371|NCT01281137|7392883|FG000|NOT COMPLETED|Analysis Population (Baseline)||4
6475372|NCT01281137|7392884|FG001|NOT COMPLETED|Analysis Population (Baseline)||9
6475373|NCT01281137|7392883|FG000|STARTED|Analysis Population (9 Months)||21
6475374|NCT01281137|7392884|FG001|STARTED|Analysis Population (9 Months)||69
6475375|NCT01281137|7392883|FG000|COMPLETED|Analysis Population (9 Months)||21
6475376|NCT01281137|7392884|FG001|COMPLETED|Analysis Population (9 Months)||64
6475377|NCT01281137|7392883|FG000|NOT COMPLETED|Analysis Population (9 Months)||0
6475378|NCT01281137|7392884|FG001|NOT COMPLETED|Analysis Population (9 Months)||5
6475379|NCT01281137|7392883|FG000|STARTED|Analysis Population (10.5 Months)||21
6475380|NCT01281137|7392884|FG001|STARTED|Analysis Population (10.5 Months)||64
6475381|NCT01281137|7392883|FG000|COMPLETED|Analysis Population (10.5 Months)||20
6475382|NCT01281137|7392884|FG001|COMPLETED|Analysis Population (10.5 Months)||64
6475383|NCT01281137|7392883|FG000|NOT COMPLETED|Analysis Population (10.5 Months)||1
6475384|NCT01281137|7392884|FG001|NOT COMPLETED|Analysis Population (10.5 Months)||0
6475385|NCT01281137|7392883|FG000|STARTED|Analysis Population (12 Months)||20
6475386|NCT01281137|7392884|FG001|STARTED|Analysis Population (12 Months)||64
6475387|NCT01281137|7392883|FG000|COMPLETED|Analysis Population (12 Months)||19
6475388|NCT01281137|7392884|FG001|COMPLETED|Analysis Population (12 Months)||62
6475389|NCT01281137|7392883|FG000|NOT COMPLETED|Analysis Population (12 Months)||1
6475390|NCT01281137|7392884|FG001|NOT COMPLETED|Analysis Population (12 Months)||2
6475391|NCT01281189|7392910|FG000|STARTED|Overall Study||468
6475392|NCT01281189|7392911|FG001|STARTED|Overall Study||474
6475393|NCT01281189|7392910|FG000|COMPLETED|Overall Study||321
6475394|NCT01281189|7392911|FG001|COMPLETED|Overall Study||331
6475395|NCT01281189|7392910|FG000|NOT COMPLETED|Overall Study||147
6475396|NCT01281189|7392911|FG001|NOT COMPLETED|Overall Study||143
6475397|NCT01281202|7392919|FG000|STARTED|Overall Study||103
6475398|NCT01281202|7392920|FG001|STARTED|Overall Study||104
6475399|NCT01281202|7392919|FG000|COMPLETED|Overall Study||75
6475400|NCT01281202|7392920|FG001|COMPLETED|Overall Study||68
6475401|NCT01281202|7392919|FG000|NOT COMPLETED|Overall Study||28
6475402|NCT01281202|7392920|FG001|NOT COMPLETED|Overall Study||36
6475403|NCT01281306|7392935|FG000|STARTED|Overall Study||144
6475404|NCT01281306|7392936|FG001|STARTED|Overall Study||145
6475405|NCT01281306|7392937|FG002|STARTED|Overall Study||141
6475406|NCT01281306|7392938|FG003|STARTED|Overall Study||134
6475407|NCT01281306|7392939|FG004|STARTED|Overall Study||143
6475408|NCT01281306|7392940|FG005|STARTED|Overall Study||142
6475409|NCT01281306|7392941|FG006|STARTED|Overall Study||58
6475410|NCT01281306|7392935|FG000|Full Analysis Set|Overall Study||143
6475411|NCT01281306|7392936|FG001|Full Analysis Set|Overall Study||145
6475412|NCT01281306|7392937|FG002|Full Analysis Set|Overall Study||141
6475413|NCT01281306|7392938|FG003|Full Analysis Set|Overall Study||133
6475414|NCT01281306|7392939|FG004|Full Analysis Set|Overall Study||143
6475415|NCT01281306|7392940|FG005|Full Analysis Set|Overall Study||142
6475416|NCT01281306|7392941|FG006|Full Analysis Set|Overall Study||58
6475417|NCT01281306|7392935|FG000|Safety Set|Overall Study||143
6475418|NCT01281306|7392936|FG001|Safety Set|Overall Study||145
6475419|NCT01281306|7392937|FG002|Safety Set|Overall Study||141
6475420|NCT01281306|7392938|FG003|Safety Set|Overall Study||133
6475421|NCT01281306|7392939|FG004|Safety Set|Overall Study||143
6475422|NCT01281306|7392940|FG005|Safety Set|Overall Study||142
6475423|NCT01281306|7392941|FG006|Safety Set|Overall Study||58
6475424|NCT01281306|7392935|FG000|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
6475425|NCT01281306|7392936|FG001|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
6475426|NCT01281306|7392937|FG002|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
6475427|NCT01281306|7392938|FG003|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
6475428|NCT01281306|7392939|FG004|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
6475429|NCT01281306|7392940|FG005|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
6475430|NCT01281306|7392941|FG006|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
6475431|NCT01281306|7392935|FG000|COMPLETED|Overall Study||136
6475432|NCT01281306|7392936|FG001|COMPLETED|Overall Study||141
6475433|NCT01281306|7392937|FG002|COMPLETED|Overall Study||133
6475434|NCT01281306|7392938|FG003|COMPLETED|Overall Study||123
6475435|NCT01281306|7392939|FG004|COMPLETED|Overall Study||134
6475436|NCT01281306|7392940|FG005|COMPLETED|Overall Study||135
6475437|NCT01281306|7392941|FG006|COMPLETED|Overall Study||51
6475438|NCT01281306|7392935|FG000|NOT COMPLETED|Overall Study||8
6475439|NCT01281306|7392936|FG001|NOT COMPLETED|Overall Study||4
6475440|NCT01281306|7392937|FG002|NOT COMPLETED|Overall Study||8
6475441|NCT01281306|7392938|FG003|NOT COMPLETED|Overall Study||11
6475442|NCT01281306|7392939|FG004|NOT COMPLETED|Overall Study||9
6475443|NCT01281306|7392940|FG005|NOT COMPLETED|Overall Study||7
6475444|NCT01281306|7392941|FG006|NOT COMPLETED|Overall Study||7
6475445|NCT01281475|7392959|FG000|STARTED|Overall Study||33
6475446|NCT01281475|7392960|FG001|STARTED|Overall Study||34
6475447|NCT01281475|7392959|FG000|COMPLETED|Overall Study||29
6475448|NCT01281475|7392960|FG001|COMPLETED|Overall Study||26
6475449|NCT01281475|7392959|FG000|NOT COMPLETED|Overall Study||4
6475450|NCT01281475|7392960|FG001|NOT COMPLETED|Overall Study||8
6475451|NCT01281501|7392970|FG000|STARTED|Overall Study||44
6475452|NCT01281501|7392971|FG001|STARTED|Overall Study||43
6475453|NCT01281501|7392970|FG000|COMPLETED|Overall Study||44
6475454|NCT01281501|7392971|FG001|COMPLETED|Overall Study||43
6475455|NCT01281501|7392970|FG000|NOT COMPLETED|Overall Study||0
6475456|NCT01281501|7392971|FG001|NOT COMPLETED|Overall Study||0
6475457|NCT01281839|7392979|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
6475458|NCT01281839|7392980|FG001|STARTED|Overall Study||133
6475459|NCT01281839|7392979|FG000|COMPLETED|Overall Study||250
6475460|NCT01281839|7392980|FG001|COMPLETED|Overall Study||119
6475461|NCT01281839|7392979|FG000|NOT COMPLETED|Overall Study||10
6475462|NCT01281839|7392980|FG001|NOT COMPLETED|Overall Study||14
6475463|NCT01281865|7392988|FG000|STARTED|Overall Study||12
6475464|NCT01281865|7392989|FG001|STARTED|Overall Study||2
6475465|NCT01281865|7392988|FG000|COMPLETED|Overall Study||9
6475466|NCT01281865|7392989|FG001|COMPLETED|Overall Study||1
6475467|NCT01281865|7392988|FG000|NOT COMPLETED|Overall Study||3
6475468|NCT01281865|7392989|FG001|NOT COMPLETED|Overall Study||1
6475469|NCT01281917|7392995|FG000|STARTED|Overall Study||40
6475470|NCT01281917|7392995|FG000|COMPLETED|Overall Study||39
6475471|NCT01281917|7392995|FG000|NOT COMPLETED|Overall Study||1
6475472|NCT01281956|7392999|FG000|STARTED|1st Intervention (3 Months)||5
6475473|NCT01281956|7393000|FG001|STARTED|1st Intervention (3 Months)||5
6475474|NCT01281956|7392999|FG000|COMPLETED|1st Intervention (3 Months)||5
6475475|NCT01281956|7393000|FG001|COMPLETED|1st Intervention (3 Months)||5
6475476|NCT01281956|7392999|FG000|NOT COMPLETED|1st Intervention (3 Months)||0
6475477|NCT01281956|7393000|FG001|NOT COMPLETED|1st Intervention (3 Months)||0
6475478|NCT01281956|7392999|FG000|STARTED|2nd Intervention (3 Months)||5
6475479|NCT01281956|7393000|FG001|STARTED|2nd Intervention (3 Months)||5
6475480|NCT01281956|7392999|FG000|COMPLETED|2nd Intervention (3 Months)||4
6475481|NCT01281956|7393000|FG001|COMPLETED|2nd Intervention (3 Months)||5
6475482|NCT01281956|7392999|FG000|NOT COMPLETED|2nd Intervention (3 Months)||1
6475483|NCT01281956|7393000|FG001|NOT COMPLETED|2nd Intervention (3 Months)||0
6475484|NCT01281969|7393011|FG000|STARTED|Overall Study||18
6475485|NCT01281969|7393012|FG001|STARTED|Overall Study||18
6475486|NCT01281969|7393013|FG002|STARTED|Overall Study||12
6475487|NCT01281969|7393011|FG000|COMPLETED|Overall Study||17
6475488|NCT01281969|7393012|FG001|COMPLETED|Overall Study||18
6475489|NCT01281969|7393013|FG002|COMPLETED|Overall Study||0
6475490|NCT01281969|7393011|FG000|NOT COMPLETED|Overall Study||1
6475491|NCT01281969|7393012|FG001|NOT COMPLETED|Overall Study||0
6475492|NCT01281969|7393013|FG002|NOT COMPLETED|Overall Study||12
6475493|NCT01282086|7393021|FG000|STARTED|Overall Study||1365
6475494|NCT01282086|7393021|FG000|COMPLETED|Overall Study||1365
6475495|NCT01282086|7393021|FG000|NOT COMPLETED|Overall Study||0
6747065|NCT03383627|7674852|FG000|STARTED|Overall Study||80
6747066|NCT03383627|7674852|FG000|COMPLETED|Overall Study||80
6747067|NCT03383627|7674852|FG000|NOT COMPLETED|Overall Study||0
6747068|NCT03383757|7674856|FG000|STARTED|Overall Study||117
6747069|NCT03383757|7674856|FG000|TruSignal AllFit Sensor Subjects|Overall Study||56
6747070|NCT03383757|7674856|FG000|TruSignal Sensitive Sensor Subjects|Overall Study||59
6747071|NCT03383757|7674856|FG000|TruSignal AllFit Sensor Data Pairs|Overall Study||52
6747072|NCT03383757|7674856|FG000|TruSignal Sensitive Sensor Data Pairs|Overall Study||51
6747073|NCT03383757|7674856|FG000|COMPLETED|Overall Study||78
6747074|NCT03383757|7674856|FG000|NOT COMPLETED|Overall Study||39
6747075|NCT03383783|7674860|FG000|STARTED|Overall Study||27
6747076|NCT03383783|7674860|FG000|COMPLETED|Overall Study||25
6747077|NCT03383783|7674860|FG000|NOT COMPLETED|Overall Study||2
6747078|NCT03383887|7674876|FG000|STARTED|Overall Study||5
6747079|NCT03383887|7674877|FG001|STARTED|Overall Study||6
6747080|NCT03383887|7674876|FG000|COMPLETED|Overall Study||5
6747081|NCT03383887|7674877|FG001|COMPLETED|Overall Study||5
6747082|NCT03383887|7674876|FG000|NOT COMPLETED|Overall Study||0
6747083|NCT03383887|7674877|FG001|NOT COMPLETED|Overall Study||1
6747084|NCT03384173|7674885|FG000|STARTED|Overall Study||35
6747085|NCT03384173|7674885|FG000|COMPLETED|Overall Study||35
6747086|NCT03384173|7674885|FG000|NOT COMPLETED|Overall Study||0
6747087|NCT03384316|7674897|FG000|STARTED|Overall Study||6
6747088|NCT03384316|7674898|FG001|STARTED|Overall Study||5
6747089|NCT03384316|7674897|FG000|COMPLETED|Overall Study||6
6747090|NCT03384316|7674898|FG001|COMPLETED|Overall Study||4
6747091|NCT03384316|7674897|FG000|NOT COMPLETED|Overall Study||0
6747092|NCT03384316|7674898|FG001|NOT COMPLETED|Overall Study||1
6747093|NCT03384329|7674908|FG000|STARTED|Overall Study||11
6747094|NCT03384329|7674909|FG001|STARTED|Overall Study||11
6747095|NCT03384329|7674908|FG000|COMPLETED|Overall Study||11
6747096|NCT03384329|7674909|FG001|COMPLETED|Overall Study||11
6747097|NCT03384329|7674908|FG000|NOT COMPLETED|Overall Study||0
6747098|NCT03384329|7674909|FG001|NOT COMPLETED|Overall Study||0
6747099|NCT03384693|7674915|FG000|STARTED|Overall Study||25
6747100|NCT03384693|7674915|FG000|COMPLETED|Overall Study||22
6747101|NCT03384693|7674915|FG000|NOT COMPLETED|Overall Study||3
6747102|NCT03384745|7674925|FG000|STARTED|Placebo Controlled Induction (W0 - W12)||52
6747103|NCT03384745|7674926|FG001|STARTED|Placebo Controlled Induction (W0 - W12)||52
6747104|NCT03384745|7674927|FG002|STARTED|Placebo Controlled Induction (W0 - W12)||53
6747105|NCT03384745|7674928|FG003|STARTED|Placebo Controlled Induction (W0 - W12)||51
6747106|NCT03384745|7674929|FG004|STARTED|Placebo Controlled Induction (W0 - W12)||52
6747107|NCT03384745|7674930|FG005|STARTED|Placebo Controlled Induction (W0 - W12)||53
6747108|NCT03384745|7674925|FG000|COMPLETED|Placebo Controlled Induction (W0 - W12)||52
6747109|NCT03384745|7674926|FG001|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
6747110|NCT03384745|7674927|FG002|COMPLETED|Placebo Controlled Induction (W0 - W12)||50
6475496|NCT01282138|7393028|FG000|STARTED|EEC||6
6475497|NCT01282138|7393029|FG001|STARTED|EEC||7
6475498|NCT01282138|7393028|FG000|COMPLETED|EEC||6
6475499|NCT01282138|7393029|FG001|COMPLETED|EEC||7
6475500|NCT01282138|7393028|FG000|NOT COMPLETED|EEC||0
6475501|NCT01282138|7393029|FG001|NOT COMPLETED|EEC||0
6475502|NCT01282138|7393028|FG000|STARTED|CAPT||6
6475503|NCT01282138|7393029|FG001|STARTED|CAPT||7
6475504|NCT01282138|7393028|FG000|COMPLETED|CAPT||6
6475505|NCT01282138|7393029|FG001|COMPLETED|CAPT||7
6475506|NCT01282138|7393028|FG000|NOT COMPLETED|CAPT||0
6475507|NCT01282138|7393029|FG001|NOT COMPLETED|CAPT||0
6475508|NCT01282164|7393037|FG000|STARTED|Overall Study||29
6475509|NCT01282164|7393038|FG001|STARTED|Overall Study||14
6475510|NCT01282164|7393037|FG000|COMPLETED|Overall Study||28
6475511|NCT01282164|7393038|FG001|COMPLETED|Overall Study||14
6475512|NCT01282164|7393037|FG000|NOT COMPLETED|Overall Study||1
6475513|NCT01282164|7393038|FG001|NOT COMPLETED|Overall Study||0
6475514|NCT01282203|7393052|FG000|STARTED|Overall Study||1122
6475515|NCT01282203|7393052|FG000|COMPLETED|Overall Study||1121
6475516|NCT01282203|7393052|FG000|NOT COMPLETED|Overall Study||1
6475517|NCT01282229|7393059|FG000|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
6475518|NCT01282229|7393059|FG000|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
6475519|NCT01282229|7393059|FG000|NOT COMPLETED|Overall Study||2
6475520|NCT01282242|7393079|FG000|STARTED|Overall Study||80
6475521|NCT01282242|7393080|FG001|STARTED|Overall Study||8
6475522|NCT01282242|7393079|FG000|COMPLETED|Overall Study||80
6475523|NCT01282242|7393080|FG001|COMPLETED|Overall Study||8
6475524|NCT01282242|7393079|FG000|NOT COMPLETED|Overall Study||0
6475525|NCT01282242|7393080|FG001|NOT COMPLETED|Overall Study||0
6475526|NCT01282294|7393086|FG000|STARTED|Overall Study||100
6475527|NCT01282294|7393086|FG000|Intra-operative|Overall Study||99
6475528|NCT01282294|7393086|FG000|Post-operative|Overall Study||99
6475529|NCT01282294|7393086|FG000|6 Weeks|Overall Study||95
6475530|NCT01282294|7393086|FG000|3 Months|Overall Study||95
6475531|NCT01282294|7393086|FG000|6 Months|Overall Study||94
6475532|NCT01282294|7393086|FG000|12 Months|Overall Study||86
6475533|NCT01282294|7393086|FG000|COMPLETED|Overall Study||81
6475534|NCT01282294|7393086|FG000|NOT COMPLETED|Overall Study||19
6475535|NCT01282372|7393090|FG000|STARTED|Overall Study||500
6475536|NCT01282372|7393090|FG000|COMPLETED|Overall Study||421
6475537|NCT01282372|7393090|FG000|NOT COMPLETED|Overall Study||79
6475538|NCT01282424|7393101|FG000|STARTED|Treatment Period (TP) (81 Months)||125
6475539|NCT01282424|7393101|FG000|Completed: Disease Progression|Treatment Period (TP) (81 Months)||70
6475540|NCT01282424|7393101|FG000|Completed: Death|Treatment Period (TP) (81 Months)||9
6475541|NCT01282424|7393101|FG000|COMPLETED|Treatment Period (TP) (81 Months)||79
6475542|NCT01282424|7393101|FG000|NOT COMPLETED|Treatment Period (TP) (81 Months)||46
6475543|NCT01282424|7393101|FG000|STARTED|Long-term Follow-up Period (5 Years)|Participants did not have to complete the TP in order to enter the Long-term Follow-up Period.|84
6475544|NCT01282424|7393101|FG000|COMPLETED|Long-term Follow-up Period (5 Years)||20
6475545|NCT01282424|7393101|FG000|NOT COMPLETED|Long-term Follow-up Period (5 Years)||64
6475546|NCT01282463|7393108|FG000|STARTED|Overall Study||49
6475547|NCT01282463|7393109|FG001|STARTED|Overall Study||49
6554548|NCT01747655|7476671|FG000|COMPLETED|PEG-J Period (Continued Treatment)||41
6554549|NCT01747655|7476672|FG001|COMPLETED|PEG-J Period (Continued Treatment)||15
6554550|NCT01747655|7476671|FG000|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
6554551|NCT01747655|7476672|FG001|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
6475548|NCT01282463|7393110|FG002|STARTED|Overall Study||50
6475549|NCT01282463|7393108|FG000|Received at Least 1 Dose of Study Drug|Overall Study||45
6475550|NCT01282463|7393109|FG001|Received at Least 1 Dose of Study Drug|Overall Study||46
6475551|NCT01282463|7393110|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
6475552|NCT01282463|7393108|FG000|COMPLETED|Overall Study||41
6475553|NCT01282463|7393109|FG001|COMPLETED|Overall Study||45
6475554|NCT01282463|7393110|FG002|COMPLETED|Overall Study||46
6475555|NCT01282463|7393108|FG000|NOT COMPLETED|Overall Study||8
6475556|NCT01282463|7393109|FG001|NOT COMPLETED|Overall Study||4
6475557|NCT01282463|7393110|FG002|NOT COMPLETED|Overall Study||4
6475558|NCT01282476|7393126|FG000|STARTED|Overall Study||18
6475559|NCT01282476|7393126|FG000|COMPLETED|Overall Study||7
6475560|NCT01282476|7393126|FG000|NOT COMPLETED|Overall Study||11
6475561|NCT01282710|7393130|FG000|STARTED|Overall Study||20
6475562|NCT01282710|7393130|FG000|COMPLETED|Overall Study||20
6475563|NCT01282710|7393130|FG000|NOT COMPLETED|Overall Study||0
6475564|NCT01282723|7393134|FG000|STARTED|Overall Study||20
6475565|NCT01282723|7393134|FG000|COMPLETED|Overall Study||20
6475566|NCT01282723|7393134|FG000|NOT COMPLETED|Overall Study||0
6475567|NCT01282801|7393140|FG000|STARTED|First Intervention||9
6475568|NCT01282801|7393141|FG001|STARTED|First Intervention||9
6475569|NCT01282801|7393140|FG000|COMPLETED|First Intervention||9
6475570|NCT01282801|7393141|FG001|COMPLETED|First Intervention||9
6475571|NCT01282801|7393140|FG000|NOT COMPLETED|First Intervention||0
6475572|NCT01282801|7393141|FG001|NOT COMPLETED|First Intervention||0
6475573|NCT01282801|7393140|FG000|STARTED|Washout of 7 Days||9
6475574|NCT01282801|7393141|FG001|STARTED|Washout of 7 Days||9
6475575|NCT01282801|7393140|FG000|COMPLETED|Washout of 7 Days||9
6475576|NCT01282801|7393141|FG001|COMPLETED|Washout of 7 Days||9
6475577|NCT01282801|7393140|FG000|NOT COMPLETED|Washout of 7 Days||0
6475578|NCT01282801|7393141|FG001|NOT COMPLETED|Washout of 7 Days||0
6475579|NCT01282801|7393140|FG000|STARTED|Second Intervention||9
6475580|NCT01282801|7393141|FG001|STARTED|Second Intervention||9
6475581|NCT01282801|7393140|FG000|COMPLETED|Second Intervention||9
6475582|NCT01282801|7393141|FG001|COMPLETED|Second Intervention||8
6475583|NCT01282801|7393140|FG000|NOT COMPLETED|Second Intervention||0
6475584|NCT01282801|7393141|FG001|NOT COMPLETED|Second Intervention||1
6554552|NCT01747772|7476678|FG000|STARTED|Overall Study||180
6475585|NCT01282814|7393149|FG000|STARTED|First Intervention||12
6475586|NCT01282814|7393150|FG001|STARTED|First Intervention||12
6475587|NCT01282814|7393149|FG000|COMPLETED|First Intervention||12
6475588|NCT01282814|7393150|FG001|COMPLETED|First Intervention||9
6475589|NCT01282814|7393149|FG000|NOT COMPLETED|First Intervention||0
6475590|NCT01282814|7393150|FG001|NOT COMPLETED|First Intervention||3
6475591|NCT01282814|7393149|FG000|STARTED|Washout of 7 Days||12
6475592|NCT01282814|7393150|FG001|STARTED|Washout of 7 Days||9
6475593|NCT01282814|7393149|FG000|COMPLETED|Washout of 7 Days||10
6475594|NCT01282814|7393150|FG001|COMPLETED|Washout of 7 Days||9
6475595|NCT01282814|7393149|FG000|NOT COMPLETED|Washout of 7 Days||2
6475596|NCT01282814|7393150|FG001|NOT COMPLETED|Washout of 7 Days||0
6475597|NCT01282814|7393149|FG000|STARTED|Second Intervention||10
6475598|NCT01282814|7393150|FG001|STARTED|Second Intervention||9
6475599|NCT01282814|7393149|FG000|COMPLETED|Second Intervention||10
6475600|NCT01282814|7393150|FG001|COMPLETED|Second Intervention||9
6475601|NCT01282814|7393149|FG000|NOT COMPLETED|Second Intervention||0
6475602|NCT01282814|7393150|FG001|NOT COMPLETED|Second Intervention||0
6475603|NCT01282866|7393156|FG000|STARTED|Overall Study||35
6475604|NCT01282866|7393156|FG000|COMPLETED|Overall Study||34
6475605|NCT01282866|7393156|FG000|NOT COMPLETED|Overall Study||1
6475606|NCT01283009|7393162|FG000|STARTED|Overall Study||287
6475607|NCT01283009|7393163|FG001|STARTED|Overall Study||297
6475608|NCT01283009|7393162|FG000|COMPLETED|Overall Study||169
6475609|NCT01283009|7393163|FG001|COMPLETED|Overall Study||180
6475610|NCT01283009|7393162|FG000|NOT COMPLETED|Overall Study||118
6475611|NCT01283009|7393163|FG001|NOT COMPLETED|Overall Study||117
6475612|NCT01283022|7393169|FG000|STARTED|Overall Study||24
6475613|NCT01283022|7393169|FG000|COMPLETED|Overall Study||24
6475614|NCT01283022|7393169|FG000|NOT COMPLETED|Overall Study||0
6475615|NCT01283035|7393174|FG000|STARTED|Overall Study||6
6475616|NCT01283035|7393174|FG000|COMPLETED|Overall Study||5
6475617|NCT01283035|7393174|FG000|NOT COMPLETED|Overall Study||1
6475618|NCT01283139|7393182|FG000|STARTED|Overall Study||108
6475619|NCT01283139|7393183|FG001|STARTED|Overall Study||108
6475620|NCT01283139|7393184|FG002|STARTED|Overall Study||109
6475621|NCT01283139|7393185|FG003|STARTED|Overall Study||107
6475622|NCT01283139|7393182|FG000|COMPLETED|Overall Study||91
6475623|NCT01283139|7393183|FG001|COMPLETED|Overall Study||90
6475624|NCT01283139|7393184|FG002|COMPLETED|Overall Study||91
6475625|NCT01283139|7393185|FG003|COMPLETED|Overall Study||92
6475626|NCT01283139|7393182|FG000|NOT COMPLETED|Overall Study||17
6475627|NCT01283139|7393183|FG001|NOT COMPLETED|Overall Study||18
6475628|NCT01283139|7393184|FG002|NOT COMPLETED|Overall Study||18
6475629|NCT01283139|7393185|FG003|NOT COMPLETED|Overall Study||15
6475630|NCT01283152|7393197|FG000|STARTED|Overall Study||25
6475631|NCT01283152|7393198|FG001|STARTED|Overall Study||25
6475632|NCT01283152|7393197|FG000|ITT Population|Overall Study||25
6475633|NCT01283152|7393198|FG001|ITT Population|Overall Study||25
6475634|NCT01283152|7393197|FG000|Study Treatment Received|Overall Study||25
6475635|NCT01283152|7393198|FG001|Study Treatment Received|Overall Study||25
6475636|NCT01283152|7393197|FG000|24-hr HESA Attempted|Overall Study||25
6475637|NCT01283152|7393198|FG001|24-hr HESA Attempted|Overall Study||25
6475638|NCT01283152|7393197|FG000|COMPLETED|Overall Study||23
6475639|NCT01283152|7393198|FG001|COMPLETED|Overall Study||25
6475640|NCT01283152|7393197|FG000|NOT COMPLETED|Overall Study||2
6475641|NCT01283152|7393198|FG001|NOT COMPLETED|Overall Study||0
6475642|NCT01283282|7393204|FG000|STARTED|First Intervention (6 Weeks)||25
6475643|NCT01283282|7393205|FG001|STARTED|First Intervention (6 Weeks)||23
6475644|NCT01283282|7393204|FG000|COMPLETED|First Intervention (6 Weeks)||22
6475645|NCT01283282|7393205|FG001|COMPLETED|First Intervention (6 Weeks)||19
6475646|NCT01283282|7393204|FG000|NOT COMPLETED|First Intervention (6 Weeks)||3
6475647|NCT01283282|7393205|FG001|NOT COMPLETED|First Intervention (6 Weeks)||4
6475648|NCT01283282|7393204|FG000|STARTED|Second Intervention (6 Weeks)||22
6475649|NCT01283282|7393205|FG001|STARTED|Second Intervention (6 Weeks)||19
6475650|NCT01283282|7393204|FG000|COMPLETED|Second Intervention (6 Weeks)||22
6475651|NCT01283282|7393205|FG001|COMPLETED|Second Intervention (6 Weeks)||19
6475652|NCT01283282|7393204|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6475653|NCT01283282|7393205|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6475654|NCT01283321|7393214|FG000|STARTED|Overall Study||10
6475655|NCT01283321|7393215|FG001|STARTED|Overall Study||10
6475656|NCT01283321|7393214|FG000|COMPLETED|Overall Study||10
6475657|NCT01283321|7393215|FG001|COMPLETED|Overall Study||10
6562789|NCT01803074|7485702|FG003|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6475658|NCT01283321|7393214|FG000|NOT COMPLETED|Overall Study||0
6475659|NCT01283321|7393215|FG001|NOT COMPLETED|Overall Study||0
6475660|NCT01283334|7393223|FG000|STARTED|Overall Study||20
6475661|NCT01283334|7393223|FG000|COMPLETED|Overall Study||13
6475662|NCT01283334|7393223|FG000|NOT COMPLETED|Overall Study||7
6475663|NCT01283386|7393231|FG000|STARTED|Overall Study||10
6475664|NCT01283386|7393232|FG001|STARTED|Overall Study||16
6475665|NCT01283386|7393231|FG000|COMPLETED|Overall Study||2
6475666|NCT01283386|7393232|FG001|COMPLETED|Overall Study||4
6475667|NCT01283386|7393231|FG000|NOT COMPLETED|Overall Study||8
6475668|NCT01283386|7393232|FG001|NOT COMPLETED|Overall Study||12
6475669|NCT01283464|7393240|FG000|STARTED|Overall Study||12
6475670|NCT01283464|7393241|FG001|STARTED|Overall Study||12
6475671|NCT01283464|7393240|FG000|COMPLETED|Overall Study||10
6475672|NCT01283464|7393241|FG001|COMPLETED|Overall Study||11
6475673|NCT01283464|7393240|FG000|NOT COMPLETED|Overall Study||2
6475674|NCT01283464|7393241|FG001|NOT COMPLETED|Overall Study||1
6475675|NCT01283516|7393256|FG000|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
6554553|NCT01747772|7476678|FG000|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
6554554|NCT01747772|7476678|FG000|COMPLETED|Overall Study||171
6554555|NCT01747772|7476678|FG000|NOT COMPLETED|Overall Study||9
6554556|NCT01747811|7476688|FG000|STARTED|Overall Study||16
6554557|NCT01747811|7476689|FG001|STARTED|Overall Study||16
6554558|NCT01747811|7476688|FG000|COMPLETED|Overall Study||14
6554559|NCT01747811|7476689|FG001|COMPLETED|Overall Study||12
6554560|NCT01747811|7476688|FG000|NOT COMPLETED|Overall Study||2
6554561|NCT01747811|7476689|FG001|NOT COMPLETED|Overall Study||4
6554562|NCT01747837|7476699|FG000|STARTED|Overall Study||25
6554563|NCT01747837|7476700|FG001|STARTED|Overall Study||23
6554564|NCT01747837|7476699|FG000|COMPLETED|Overall Study||16
6554565|NCT01747837|7476700|FG001|COMPLETED|Overall Study||17
6554566|NCT01747837|7476699|FG000|NOT COMPLETED|Overall Study||9
6554567|NCT01747837|7476700|FG001|NOT COMPLETED|Overall Study||6
6554568|NCT01747850|7476709|FG000|STARTED|Overall Study||5
6554569|NCT01747850|7476710|FG001|STARTED|Overall Study||20
6554570|NCT01747850|7476711|FG002|STARTED|Overall Study||20
6554571|NCT01747850|7476709|FG000|COMPLETED|Overall Study||4
6747111|NCT03384745|7674928|FG003|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
6747112|NCT03384745|7674929|FG004|COMPLETED|Placebo Controlled Induction (W0 - W12)||49
6475676|NCT01283516|7393257|FG001|STARTED|Overall Study||2
6475677|NCT01283516|7393258|FG002|STARTED|Overall Study||3
6475678|NCT01283516|7393259|FG003|STARTED|Overall Study||3
6475679|NCT01283516|7393260|FG004|STARTED|Overall Study||14
6475680|NCT01283516|7393261|FG005|STARTED|Overall Study||10
6475681|NCT01283516|7393262|FG006|STARTED|Overall Study||10
6475682|NCT01283516|7393263|FG007|STARTED|Overall Study||5
6475683|NCT01283516|7393264|FG008|STARTED|Overall Study||255
6475684|NCT01283516|7393256|FG000|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
6475685|NCT01283516|7393257|FG001|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
6475686|NCT01283516|7393258|FG002|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
6475687|NCT01283516|7393259|FG003|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
6475688|NCT01283516|7393260|FG004|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
6475689|NCT01283516|7393261|FG005|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
6475690|NCT01283516|7393262|FG006|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
6475691|NCT01283516|7393263|FG007|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
6475692|NCT01283516|7393264|FG008|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
6475693|NCT01283516|7393256|FG000|Dose-Determining Set (DDS)|Overall Study||2
6475694|NCT01283516|7393257|FG001|Dose-Determining Set (DDS)|Overall Study||1
6475695|NCT01283516|7393258|FG002|Dose-Determining Set (DDS)|Overall Study||3
6475696|NCT01283516|7393259|FG003|Dose-Determining Set (DDS)|Overall Study||3
6475697|NCT01283516|7393260|FG004|Dose-Determining Set (DDS)|Overall Study||14
6475698|NCT01283516|7393261|FG005|Dose-Determining Set (DDS)|Overall Study||8
6475699|NCT01283516|7393262|FG006|Dose-Determining Set (DDS)|Overall Study||10
6475700|NCT01283516|7393263|FG007|Dose-Determining Set (DDS)|Overall Study||5
6475701|NCT01283516|7393264|FG008|Dose-Determining Set (DDS)|Overall Study||8
6475702|NCT01283516|7393256|FG000|Non-NSCLC|Overall Study||0
6475703|NCT01283516|7393257|FG001|Non-NSCLC|Overall Study||1
6475704|NCT01283516|7393258|FG002|Non-NSCLC|Overall Study||1
6475705|NCT01283516|7393259|FG003|Non-NSCLC|Overall Study||0
6475706|NCT01283516|7393260|FG004|Non-NSCLC|Overall Study||2
6475707|NCT01283516|7393261|FG005|Non-NSCLC|Overall Study||0
6475708|NCT01283516|7393262|FG006|Non-NSCLC|Overall Study||1
6475709|NCT01283516|7393263|FG007|Non-NSCLC|Overall Study||0
6475710|NCT01283516|7393264|FG008|Non-NSCLC|Overall Study|Small number of patients at 750 mg - non-NSCLC, assessment limited, not included in efficacy tables|9
6475711|NCT01283516|7393256|FG000|COMPLETED|Overall Study|Completed - see explanation in Recruitment Details.|0
6475712|NCT01283516|7393257|FG001|COMPLETED|Overall Study||0
6475713|NCT01283516|7393258|FG002|COMPLETED|Overall Study||0
6475714|NCT01283516|7393259|FG003|COMPLETED|Overall Study||0
6747113|NCT03384745|7674930|FG005|COMPLETED|Placebo Controlled Induction (W0 - W12)||51
6747114|NCT03384745|7674925|FG000|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||0
6747115|NCT03384745|7674926|FG001|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||1
6747116|NCT03384745|7674927|FG002|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
6747117|NCT03384745|7674928|FG003|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
6747118|NCT03384745|7674929|FG004|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||3
6747119|NCT03384745|7674930|FG005|NOT COMPLETED|Placebo Controlled Induction (W0 - W12)||2
6747120|NCT03384745|7674925|FG000|STARTED|Maintenance/Escalation (W12-W24)||52
6747121|NCT03384745|7674926|FG001|STARTED|Maintenance/Escalation (W12-W24)||51
6747122|NCT03384745|7674927|FG002|STARTED|Maintenance/Escalation (W12-W24)||50
6747123|NCT03384745|7674928|FG003|STARTED|Maintenance/Escalation (W12-W24)||49
6747124|NCT03384745|7674929|FG004|STARTED|Maintenance/Escalation (W12-W24)||49
6747125|NCT03384745|7674930|FG005|STARTED|Maintenance/Escalation (W12-W24)||51
6747126|NCT03384745|7674925|FG000|COMPLETED|Maintenance/Escalation (W12-W24)||52
6747127|NCT03384745|7674926|FG001|COMPLETED|Maintenance/Escalation (W12-W24)||51
6747128|NCT03384745|7674927|FG002|COMPLETED|Maintenance/Escalation (W12-W24)||49
6747129|NCT03384745|7674928|FG003|COMPLETED|Maintenance/Escalation (W12-W24)||47
6779769|NCT03680911|7708016|FG001|STARTED|Visit 1 (Baseline)||4
6475715|NCT01283516|7393260|FG004|COMPLETED|Overall Study||0
6554572|NCT01747850|7476710|FG001|COMPLETED|Overall Study||13
6554573|NCT01747850|7476711|FG002|COMPLETED|Overall Study||14
6554574|NCT01747850|7476709|FG000|NOT COMPLETED|Overall Study||1
6554575|NCT01747850|7476710|FG001|NOT COMPLETED|Overall Study||7
6475716|NCT01283516|7393261|FG005|COMPLETED|Overall Study||0
6475717|NCT01283516|7393262|FG006|COMPLETED|Overall Study||0
6475718|NCT01283516|7393263|FG007|COMPLETED|Overall Study||0
6475719|NCT01283516|7393264|FG008|COMPLETED|Overall Study||0
6475720|NCT01283516|7393256|FG000|NOT COMPLETED|Overall Study||2
6475721|NCT01283516|7393257|FG001|NOT COMPLETED|Overall Study||2
6475722|NCT01283516|7393258|FG002|NOT COMPLETED|Overall Study||3
6475723|NCT01283516|7393259|FG003|NOT COMPLETED|Overall Study||3
6475724|NCT01283516|7393260|FG004|NOT COMPLETED|Overall Study||14
6475725|NCT01283516|7393261|FG005|NOT COMPLETED|Overall Study||10
6475726|NCT01283516|7393262|FG006|NOT COMPLETED|Overall Study||10
6475727|NCT01283516|7393263|FG007|NOT COMPLETED|Overall Study||5
6475728|NCT01283516|7393264|FG008|NOT COMPLETED|Overall Study||255
6475729|NCT01283542|7393292|FG000|STARTED|Main Phase||20
6475730|NCT01283542|7393292|FG000|Full Analysis Set (FAS)|Main Phase||20
6475731|NCT01283542|7393292|FG000|Safety Analysis Set|Main Phase||20
6475732|NCT01283542|7393292|FG000|COMPLETED|Main Phase||13
6475733|NCT01283542|7393292|FG000|NOT COMPLETED|Main Phase||7
6475734|NCT01283542|7393292|FG000|STARTED|Extension Phase||13
6475735|NCT01283542|7393292|FG000|Full Analysis Set (FAS)|Extension Phase||13
6475736|NCT01283542|7393292|FG000|Safety Analysis Set|Extension Phase||13
6475737|NCT01283542|7393292|FG000|COMPLETED|Extension Phase||10
6475738|NCT01283542|7393292|FG000|NOT COMPLETED|Extension Phase||3
6475739|NCT01283555|7393314|FG000|STARTED|First Intervention||13
6475740|NCT01283555|7393315|FG001|STARTED|First Intervention||12
6475741|NCT01283555|7393314|FG000|COMPLETED|First Intervention||13
6475742|NCT01283555|7393315|FG001|COMPLETED|First Intervention||12
6475743|NCT01283555|7393314|FG000|NOT COMPLETED|First Intervention||0
6475744|NCT01283555|7393315|FG001|NOT COMPLETED|First Intervention||0
6475745|NCT01283555|7393314|FG000|STARTED|Washout Period of at Least 21 Days||13
6475746|NCT01283555|7393315|FG001|STARTED|Washout Period of at Least 21 Days||12
6475747|NCT01283555|7393314|FG000|COMPLETED|Washout Period of at Least 21 Days||13
6475748|NCT01283555|7393315|FG001|COMPLETED|Washout Period of at Least 21 Days||12
6475749|NCT01283555|7393314|FG000|NOT COMPLETED|Washout Period of at Least 21 Days||0
6475750|NCT01283555|7393315|FG001|NOT COMPLETED|Washout Period of at Least 21 Days||0
6475751|NCT01283555|7393314|FG000|STARTED|Second Intervention||13
6475752|NCT01283555|7393315|FG001|STARTED|Second Intervention||12
6747130|NCT03384745|7674929|FG004|COMPLETED|Maintenance/Escalation (W12-W24)||47
6747131|NCT03384745|7674930|FG005|COMPLETED|Maintenance/Escalation (W12-W24)||51
6747132|NCT03384745|7674925|FG000|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
6747133|NCT03384745|7674926|FG001|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
6747134|NCT03384745|7674927|FG002|NOT COMPLETED|Maintenance/Escalation (W12-W24)||1
6747135|NCT03384745|7674928|FG003|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
6747136|NCT03384745|7674929|FG004|NOT COMPLETED|Maintenance/Escalation (W12-W24)||2
6747137|NCT03384745|7674930|FG005|NOT COMPLETED|Maintenance/Escalation (W12-W24)||0
6747138|NCT03384745|7674925|FG000|STARTED|Response Assess/Dose Hold (W24-W48)||52
6747139|NCT03384745|7674926|FG001|STARTED|Response Assess/Dose Hold (W24-W48)||51
6747140|NCT03384745|7674927|FG002|STARTED|Response Assess/Dose Hold (W24-W48)||49
6747141|NCT03384745|7674928|FG003|STARTED|Response Assess/Dose Hold (W24-W48)||47
6747142|NCT03384745|7674929|FG004|STARTED|Response Assess/Dose Hold (W24-W48)||47
6747143|NCT03384745|7674930|FG005|STARTED|Response Assess/Dose Hold (W24-W48)||51
6747144|NCT03384745|7674925|FG000|COMPLETED|Response Assess/Dose Hold (W24-W48)||51
6747145|NCT03384745|7674926|FG001|COMPLETED|Response Assess/Dose Hold (W24-W48)||48
6747146|NCT03384745|7674927|FG002|COMPLETED|Response Assess/Dose Hold (W24-W48)||45
6747147|NCT03384745|7674928|FG003|COMPLETED|Response Assess/Dose Hold (W24-W48)||43
6747148|NCT03384745|7674929|FG004|COMPLETED|Response Assess/Dose Hold (W24-W48)||46
6747149|NCT03384745|7674930|FG005|COMPLETED|Response Assess/Dose Hold (W24-W48)||49
6747150|NCT03384745|7674925|FG000|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
6747151|NCT03384745|7674926|FG001|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||3
6747152|NCT03384745|7674927|FG002|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
6747153|NCT03384745|7674928|FG003|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||4
6747154|NCT03384745|7674929|FG004|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||1
6747155|NCT03384745|7674930|FG005|NOT COMPLETED|Response Assess/Dose Hold (W24-W48)||2
6747156|NCT03384940|7674953|FG000|STARTED|Overall Study||53
6747157|NCT03384940|7674954|FG001|STARTED|Overall Study||15
6747158|NCT03384940|7674955|FG002|STARTED|Overall Study||18
6747159|NCT03384940|7674953|FG000|COMPLETED|Overall Study||0
6747160|NCT03384940|7674954|FG001|COMPLETED|Overall Study||0
6747161|NCT03384940|7674955|FG002|COMPLETED|Overall Study||0
6747162|NCT03384940|7674953|FG000|NOT COMPLETED|Overall Study||53
6747163|NCT03384940|7674954|FG001|NOT COMPLETED|Overall Study||15
6475753|NCT01283555|7393314|FG000|COMPLETED|Second Intervention||13
6475754|NCT01283555|7393315|FG001|COMPLETED|Second Intervention||12
6475755|NCT01283555|7393314|FG000|NOT COMPLETED|Second Intervention||0
6475756|NCT01283555|7393315|FG001|NOT COMPLETED|Second Intervention||0
6747164|NCT03384940|7674955|FG002|NOT COMPLETED|Overall Study||18
6747165|NCT03384953|7674965|FG000|STARTED|Overall Study||91
6747166|NCT03384953|7674966|FG001|STARTED|Overall Study||12
6747167|NCT03384953|7674965|FG000|Completed Treatment|Overall Study||68
6747168|NCT03384953|7674966|FG001|Completed Treatment|Overall Study||6
6747169|NCT03384953|7674965|FG000|COMPLETED|Overall Study||51
6747170|NCT03384953|7674966|FG001|COMPLETED|Overall Study||4
6475757|NCT01283581|7393328|FG000|STARTED|Overall Study||81
6475758|NCT01283581|7393329|FG001|STARTED|Overall Study||77
6475759|NCT01283581|7393330|FG002|STARTED|Overall Study||98
6475760|NCT01283581|7393328|FG000|COMPLETED|Overall Study||69
6475761|NCT01283581|7393329|FG001|COMPLETED|Overall Study||63
6475762|NCT01283581|7393330|FG002|COMPLETED|Overall Study||78
6475763|NCT01283581|7393328|FG000|NOT COMPLETED|Overall Study||12
6475764|NCT01283581|7393329|FG001|NOT COMPLETED|Overall Study||14
6475765|NCT01283581|7393330|FG002|NOT COMPLETED|Overall Study||20
6475766|NCT01283971|7393343|FG000|STARTED|Overall Study||48
6475767|NCT01283971|7393344|FG001|STARTED|Overall Study||48
6475768|NCT01283971|7393343|FG000|Intent to Treat Population|Overall Study||46
6475769|NCT01283971|7393344|FG001|Intent to Treat Population|Overall Study||48
6475770|NCT01283971|7393343|FG000|COMPLETED|Overall Study||33
6475771|NCT01283971|7393344|FG001|COMPLETED|Overall Study||36
6475772|NCT01283971|7393343|FG000|NOT COMPLETED|Overall Study||15
6475773|NCT01283971|7393344|FG001|NOT COMPLETED|Overall Study||12
6475774|NCT01284062|7393354|FG000|STARTED|Overall Study||21
6475775|NCT01284062|7393355|FG001|STARTED|Overall Study||21
6475776|NCT01284062|7393356|FG002|STARTED|Overall Study||21
6475777|NCT01284062|7393357|FG003|STARTED|Overall Study||21
6475778|NCT01284062|7393354|FG000|COMPLETED|Overall Study||10
6475779|NCT01284062|7393355|FG001|COMPLETED|Overall Study||13
6475780|NCT01284062|7393356|FG002|COMPLETED|Overall Study||15
6475781|NCT01284062|7393357|FG003|COMPLETED|Overall Study||7
6475782|NCT01284062|7393354|FG000|NOT COMPLETED|Overall Study||11
6475783|NCT01284062|7393355|FG001|NOT COMPLETED|Overall Study||8
6475784|NCT01284062|7393356|FG002|NOT COMPLETED|Overall Study||6
6475785|NCT01284062|7393357|FG003|NOT COMPLETED|Overall Study||14
6475786|NCT01284114|7393370|FG000|STARTED|Overall Study||23
6475787|NCT01284114|7393370|FG000|COMPLETED|Overall Study||19
6475788|NCT01284114|7393370|FG000|NOT COMPLETED|Overall Study||4
6475789|NCT01284127|7393375|FG000|STARTED|Overall Study||38
6475790|NCT01284127|7393375|FG000|COMPLETED|Overall Study||31
6475791|NCT01284127|7393375|FG000|NOT COMPLETED|Overall Study||7
6475792|NCT01284140|7393381|FG000|STARTED|Randomization and Intervention||11
6475793|NCT01284140|7393382|FG001|STARTED|Randomization and Intervention||11
6475794|NCT01284140|7393381|FG000|COMPLETED|Randomization and Intervention||11
6475795|NCT01284140|7393382|FG001|COMPLETED|Randomization and Intervention||11
6475796|NCT01284140|7393381|FG000|NOT COMPLETED|Randomization and Intervention||0
6475797|NCT01284140|7393382|FG001|NOT COMPLETED|Randomization and Intervention||0
6475798|NCT01284140|7393381|FG000|STARTED|Subjects With Paired 24hr Collections||11
6475799|NCT01284140|7393382|FG001|STARTED|Subjects With Paired 24hr Collections||11
6475800|NCT01284140|7393381|FG000|COMPLETED|Subjects With Paired 24hr Collections||6
6475801|NCT01284140|7393382|FG001|COMPLETED|Subjects With Paired 24hr Collections||5
6475802|NCT01284140|7393381|FG000|NOT COMPLETED|Subjects With Paired 24hr Collections||5
6475803|NCT01284140|7393382|FG001|NOT COMPLETED|Subjects With Paired 24hr Collections||6
6475804|NCT01284244|7393390|FG000|STARTED|Overall Study||18
6475805|NCT01284244|7393391|FG001|STARTED|Overall Study||18
6475806|NCT01284244|7393390|FG000|COMPLETED|Overall Study||18
6475807|NCT01284244|7393391|FG001|COMPLETED|Overall Study||18
6475808|NCT01284244|7393390|FG000|NOT COMPLETED|Overall Study||0
6475809|NCT01284244|7393391|FG001|NOT COMPLETED|Overall Study||0
6501184|NCT01427504|7419667|FG002|NOT COMPLETED|Overall Study||1
6501185|NCT01427504|7419668|FG003|NOT COMPLETED|Overall Study||1
6501186|NCT01427504|7419669|FG004|NOT COMPLETED|Overall Study||1
6501187|NCT01427504|7419670|FG005|NOT COMPLETED|Overall Study||2
6501188|NCT01427517|7419690|FG000|STARTED|Overall Study||3
6501189|NCT01427517|7419691|FG001|STARTED|Overall Study||3
6501190|NCT01427517|7419692|FG002|STARTED|Overall Study||3
6501191|NCT01427517|7419690|FG000|COMPLETED|Overall Study||3
6501192|NCT01427517|7419691|FG001|COMPLETED|Overall Study||3
6501193|NCT01427517|7419692|FG002|COMPLETED|Overall Study||3
6501194|NCT01427517|7419690|FG000|NOT COMPLETED|Overall Study||0
6501195|NCT01427517|7419691|FG001|NOT COMPLETED|Overall Study||0
6501196|NCT01427517|7419692|FG002|NOT COMPLETED|Overall Study||0
6501197|NCT01427595|7419700|FG000|STARTED|Overall Study||25
6501198|NCT01427595|7419700|FG000|COMPLETED|Overall Study||12
6501199|NCT01427595|7419700|FG000|NOT COMPLETED|Overall Study||13
6501200|NCT01427608|7419706|FG000|STARTED|Overall Study||64
6501201|NCT01427608|7419707|FG001|STARTED|Overall Study||62
6501202|NCT01427608|7419706|FG000|COMPLETED|Overall Study||43
6501203|NCT01427608|7419707|FG001|COMPLETED|Overall Study||24
6501204|NCT01427608|7419706|FG000|NOT COMPLETED|Overall Study||21
6501205|NCT01427608|7419707|FG001|NOT COMPLETED|Overall Study||38
6501206|NCT01427738|7419717|FG000|STARTED|Overall Study||110
6501207|NCT01427738|7419718|FG001|STARTED|Overall Study||111
6501208|NCT01427738|7419717|FG000|COMPLETED|Overall Study||91
6501209|NCT01427738|7419718|FG001|COMPLETED|Overall Study||90
6501210|NCT01427738|7419717|FG000|NOT COMPLETED|Overall Study||19
6501211|NCT01427738|7419718|FG001|NOT COMPLETED|Overall Study||21
6501212|NCT01427751|7419726|FG000|STARTED|Overall Study||154
6501213|NCT01427751|7419727|FG001|STARTED|Overall Study||153
6501214|NCT01427751|7419726|FG000|COMPLETED|Overall Study||112
6501215|NCT01427751|7419727|FG001|COMPLETED|Overall Study||139
6501216|NCT01427751|7419726|FG000|NOT COMPLETED|Overall Study||42
6501217|NCT01427751|7419727|FG001|NOT COMPLETED|Overall Study||14
6501218|NCT01427803|7419735|FG000|STARTED|Overall Study||526
6501219|NCT01427803|7419736|FG001|STARTED|Overall Study||252
6501220|NCT01427803|7419735|FG000|Purchased Product|Overall Study|Only 516 participants used e-diary|525
6501221|NCT01427803|7419736|FG001|Purchased Product|Overall Study||252
6501222|NCT01427803|7419735|FG000|Baseline Assessment|Overall Study||516
6475810|NCT01284296|7393397|FG000|STARTED|Overall Study||20
6475811|NCT01284296|7393397|FG000|COMPLETED|Overall Study||20
6475812|NCT01284296|7393397|FG000|NOT COMPLETED|Overall Study||0
6475813|NCT01284335|7393415|FG000|STARTED|Overall Study||25
6475814|NCT01284335|7393416|FG001|STARTED|Overall Study||33
6475815|NCT01284335|7393417|FG002|STARTED|Overall Study||5
6475816|NCT01284335|7393418|FG003|STARTED|Overall Study||5
6475817|NCT01284335|7393419|FG004|STARTED|Overall Study||24
6747171|NCT03384953|7674965|FG000|NOT COMPLETED|Overall Study||40
6747172|NCT03384953|7674966|FG001|NOT COMPLETED|Overall Study||8
6747173|NCT03384966|7674975|FG000|STARTED|Randomized at End of Screening Period||115
6475818|NCT01284335|7393420|FG005|STARTED|Overall Study||26
6475819|NCT01284335|7393421|FG006|STARTED|Overall Study||19
6475820|NCT01284335|7393422|FG007|STARTED|Overall Study||6
6475821|NCT01284335|7393423|FG008|STARTED|Overall Study||4
6475822|NCT01284335|7393424|FG009|STARTED|Overall Study||14
6475823|NCT01284335|7393425|FG010|STARTED|Overall Study||45
6475824|NCT01284335|7393426|FG011|STARTED|Overall Study||16
6475825|NCT01284335|7393427|FG012|STARTED|Overall Study||12
6475826|NCT01284335|7393415|FG000|Received at Least One Dose of Study Drug|Overall Study||25
6554576|NCT01747850|7476711|FG002|NOT COMPLETED|Overall Study||6
6554577|NCT01747876|7476734|FG000|STARTED|Overall Study||5
6554578|NCT01747876|7476735|FG001|STARTED|Overall Study||15
6554579|NCT01747876|7476736|FG002|STARTED|Overall Study||12
6747174|NCT03384966|7674976|FG001|STARTED|Randomized at End of Screening Period||115
6747175|NCT03384966|7674977|FG002|STARTED|Randomized at End of Screening Period||116
6747176|NCT03384966|7674975|FG000|COMPLETED|Randomized at End of Screening Period||114
6747177|NCT03384966|7674976|FG001|COMPLETED|Randomized at End of Screening Period||115
6747178|NCT03384966|7674977|FG002|COMPLETED|Randomized at End of Screening Period||116
6475827|NCT01284335|7393416|FG001|Received at Least One Dose of Study Drug|Overall Study||33
6475828|NCT01284335|7393417|FG002|Received at Least One Dose of Study Drug|Overall Study||5
6475829|NCT01284335|7393418|FG003|Received at Least One Dose of Study Drug|Overall Study||5
6475830|NCT01284335|7393419|FG004|Received at Least One Dose of Study Drug|Overall Study||24
6475831|NCT01284335|7393420|FG005|Received at Least One Dose of Study Drug|Overall Study||26
6475832|NCT01284335|7393421|FG006|Received at Least One Dose of Study Drug|Overall Study||19
6475833|NCT01284335|7393422|FG007|Received at Least One Dose of Study Drug|Overall Study||6
6475834|NCT01284335|7393423|FG008|Received at Least One Dose of Study Drug|Overall Study||4
6475835|NCT01284335|7393424|FG009|Received at Least One Dose of Study Drug|Overall Study||14
6475836|NCT01284335|7393425|FG010|Received at Least One Dose of Study Drug|Overall Study||45
6475837|NCT01284335|7393426|FG011|Received at Least One Dose of Study Drug|Overall Study||16
6475838|NCT01284335|7393427|FG012|Received at Least One Dose of Study Drug|Overall Study||12
6475839|NCT01284335|7393415|FG000|COMPLETED|Overall Study||25
6475840|NCT01284335|7393416|FG001|COMPLETED|Overall Study||33
6475841|NCT01284335|7393417|FG002|COMPLETED|Overall Study||5
6475842|NCT01284335|7393418|FG003|COMPLETED|Overall Study||5
6475843|NCT01284335|7393419|FG004|COMPLETED|Overall Study||24
6475844|NCT01284335|7393420|FG005|COMPLETED|Overall Study||26
6475845|NCT01284335|7393421|FG006|COMPLETED|Overall Study||19
6475846|NCT01284335|7393422|FG007|COMPLETED|Overall Study||6
6475847|NCT01284335|7393423|FG008|COMPLETED|Overall Study||4
6475848|NCT01284335|7393424|FG009|COMPLETED|Overall Study||14
6475849|NCT01284335|7393425|FG010|COMPLETED|Overall Study||45
6475850|NCT01284335|7393426|FG011|COMPLETED|Overall Study||16
6475851|NCT01284335|7393427|FG012|COMPLETED|Overall Study||12
6475852|NCT01284335|7393415|FG000|NOT COMPLETED|Overall Study||0
6475853|NCT01284335|7393416|FG001|NOT COMPLETED|Overall Study||0
6475854|NCT01284335|7393417|FG002|NOT COMPLETED|Overall Study||0
6475855|NCT01284335|7393418|FG003|NOT COMPLETED|Overall Study||0
6475856|NCT01284335|7393419|FG004|NOT COMPLETED|Overall Study||0
6475857|NCT01284335|7393420|FG005|NOT COMPLETED|Overall Study||0
6475858|NCT01284335|7393421|FG006|NOT COMPLETED|Overall Study||0
6475859|NCT01284335|7393422|FG007|NOT COMPLETED|Overall Study||0
6475860|NCT01284335|7393423|FG008|NOT COMPLETED|Overall Study||0
6475861|NCT01284335|7393424|FG009|NOT COMPLETED|Overall Study||0
6747179|NCT03384966|7674975|FG000|NOT COMPLETED|Randomized at End of Screening Period||1
6747180|NCT03384966|7674976|FG001|NOT COMPLETED|Randomized at End of Screening Period||0
6747181|NCT03384966|7674977|FG002|NOT COMPLETED|Randomized at End of Screening Period||0
6747182|NCT03384966|7674975|FG000|STARTED|Treatment Period||114
6747183|NCT03384966|7674976|FG001|STARTED|Treatment Period||115
6747184|NCT03384966|7674977|FG002|STARTED|Treatment Period||116
6747185|NCT03384966|7674975|FG000|Thigh Administration|Treatment Period||57
6747186|NCT03384966|7674976|FG001|Thigh Administration|Treatment Period||57
6747187|NCT03384966|7674977|FG002|Thigh Administration|Treatment Period||58
6747188|NCT03384966|7674975|FG000|Abdomen Administration|Treatment Period||57
6747189|NCT03384966|7674976|FG001|Abdomen Administration|Treatment Period||58
6747190|NCT03384966|7674977|FG002|Abdomen Administration|Treatment Period||58
6747191|NCT03384966|7674975|FG000|Per-protocol Analysis Set|Treatment Period||96
6747192|NCT03384966|7674976|FG001|Per-protocol Analysis Set|Treatment Period||90
6554580|NCT01747876|7476734|FG000|COMPLETED|Overall Study||0
6554581|NCT01747876|7476735|FG001|COMPLETED|Overall Study||0
6554582|NCT01747876|7476736|FG002|COMPLETED|Overall Study||0
6554583|NCT01747876|7476734|FG000|NOT COMPLETED|Overall Study||5
6747193|NCT03384966|7674977|FG002|Per-protocol Analysis Set|Treatment Period||93
6747194|NCT03384966|7674975|FG000|Safety Analysis Set|Treatment Period||114
6747195|NCT03384966|7674976|FG001|Safety Analysis Set|Treatment Period||115
6475862|NCT01284335|7393425|FG010|NOT COMPLETED|Overall Study||0
6475863|NCT01284335|7393426|FG011|NOT COMPLETED|Overall Study||0
6475864|NCT01284335|7393427|FG012|NOT COMPLETED|Overall Study||0
6475865|NCT01284361|7393467|FG000|STARTED|Overall Study||91
6475866|NCT01284361|7393467|FG000|COMPLETED|Overall Study||82
6475867|NCT01284361|7393467|FG000|NOT COMPLETED|Overall Study||9
6475868|NCT01284426|7393474|FG000|STARTED|Overall Study||94
6475869|NCT01284426|7393474|FG000|COMPLETED|Overall Study||92
6475870|NCT01284426|7393474|FG000|NOT COMPLETED|Overall Study||2
6475871|NCT01284517|7393480|FG000|STARTED|Overall Study||180
6475872|NCT01284517|7393481|FG001|STARTED|Overall Study||176
6475873|NCT01284517|7393480|FG000|COMPLETED|Overall Study||148
6475874|NCT01284517|7393481|FG001|COMPLETED|Overall Study||140
6475875|NCT01284517|7393480|FG000|NOT COMPLETED|Overall Study||32
6475876|NCT01284517|7393481|FG001|NOT COMPLETED|Overall Study||36
6475877|NCT01284621|7393487|FG000|STARTED|First Intervention (8 Days)||3
6475878|NCT01284621|7393488|FG001|STARTED|First Intervention (8 Days)||4
6475879|NCT01284621|7393489|FG002|STARTED|First Intervention (8 Days)||4
6475880|NCT01284621|7393490|FG003|STARTED|First Intervention (8 Days)||4
6475881|NCT01284621|7393491|FG004|STARTED|First Intervention (8 Days)||4
6475882|NCT01284621|7393492|FG005|STARTED|First Intervention (8 Days)||4
6475883|NCT01284621|7393487|FG000|COMPLETED|First Intervention (8 Days)||3
6475884|NCT01284621|7393488|FG001|COMPLETED|First Intervention (8 Days)||4
6475885|NCT01284621|7393489|FG002|COMPLETED|First Intervention (8 Days)||4
6475886|NCT01284621|7393490|FG003|COMPLETED|First Intervention (8 Days)||4
6475887|NCT01284621|7393491|FG004|COMPLETED|First Intervention (8 Days)||4
6475888|NCT01284621|7393492|FG005|COMPLETED|First Intervention (8 Days)||4
6475889|NCT01284621|7393487|FG000|NOT COMPLETED|First Intervention (8 Days)||0
6475890|NCT01284621|7393488|FG001|NOT COMPLETED|First Intervention (8 Days)||0
6475891|NCT01284621|7393489|FG002|NOT COMPLETED|First Intervention (8 Days)||0
6475892|NCT01284621|7393490|FG003|NOT COMPLETED|First Intervention (8 Days)||0
6475893|NCT01284621|7393491|FG004|NOT COMPLETED|First Intervention (8 Days)||0
6475894|NCT01284621|7393492|FG005|NOT COMPLETED|First Intervention (8 Days)||0
6475895|NCT01284621|7393487|FG000|STARTED|Washout Period 1 (7 Days)||3
6475896|NCT01284621|7393488|FG001|STARTED|Washout Period 1 (7 Days)||4
6475897|NCT01284621|7393489|FG002|STARTED|Washout Period 1 (7 Days)||4
6475898|NCT01284621|7393490|FG003|STARTED|Washout Period 1 (7 Days)||4
6475899|NCT01284621|7393491|FG004|STARTED|Washout Period 1 (7 Days)||4
6475900|NCT01284621|7393492|FG005|STARTED|Washout Period 1 (7 Days)||4
6475901|NCT01284621|7393487|FG000|COMPLETED|Washout Period 1 (7 Days)||3
6475902|NCT01284621|7393488|FG001|COMPLETED|Washout Period 1 (7 Days)||4
6475903|NCT01284621|7393489|FG002|COMPLETED|Washout Period 1 (7 Days)||4
6475904|NCT01284621|7393490|FG003|COMPLETED|Washout Period 1 (7 Days)||4
6475905|NCT01284621|7393491|FG004|COMPLETED|Washout Period 1 (7 Days)||3
6475906|NCT01284621|7393492|FG005|COMPLETED|Washout Period 1 (7 Days)||4
6475907|NCT01284621|7393487|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6475908|NCT01284621|7393488|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6475909|NCT01284621|7393489|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6475910|NCT01284621|7393490|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6475911|NCT01284621|7393491|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||1
6475912|NCT01284621|7393492|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
6475913|NCT01284621|7393487|FG000|STARTED|Second Intervention (8 Days)||3
6475914|NCT01284621|7393488|FG001|STARTED|Second Intervention (8 Days)||4
6475915|NCT01284621|7393489|FG002|STARTED|Second Intervention (8 Days)||4
6475916|NCT01284621|7393490|FG003|STARTED|Second Intervention (8 Days)||4
6475917|NCT01284621|7393491|FG004|STARTED|Second Intervention (8 Days)||3
6475918|NCT01284621|7393492|FG005|STARTED|Second Intervention (8 Days)||4
6475919|NCT01284621|7393487|FG000|COMPLETED|Second Intervention (8 Days)||3
6475920|NCT01284621|7393488|FG001|COMPLETED|Second Intervention (8 Days)||4
6475921|NCT01284621|7393489|FG002|COMPLETED|Second Intervention (8 Days)||4
6475922|NCT01284621|7393490|FG003|COMPLETED|Second Intervention (8 Days)||4
6554584|NCT01747876|7476735|FG001|NOT COMPLETED|Overall Study||15
6554585|NCT01747876|7476736|FG002|NOT COMPLETED|Overall Study||12
6554586|NCT01747915|7476750|FG000|STARTED|Overall Study||75
6554587|NCT01747915|7476751|FG001|STARTED|Overall Study||72
6654638|NCT02447029|7584519|FG000|NOT COMPLETED|Overall Study||3
6747196|NCT03384966|7674977|FG002|Safety Analysis Set|Treatment Period||116
6475923|NCT01284621|7393491|FG004|COMPLETED|Second Intervention (8 Days)||3
6475924|NCT01284621|7393492|FG005|COMPLETED|Second Intervention (8 Days)||4
6475925|NCT01284621|7393487|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
6475926|NCT01284621|7393488|FG001|NOT COMPLETED|Second Intervention (8 Days)||0
6475927|NCT01284621|7393489|FG002|NOT COMPLETED|Second Intervention (8 Days)||0
6475928|NCT01284621|7393490|FG003|NOT COMPLETED|Second Intervention (8 Days)||0
6475929|NCT01284621|7393491|FG004|NOT COMPLETED|Second Intervention (8 Days)||0
6475930|NCT01284621|7393492|FG005|NOT COMPLETED|Second Intervention (8 Days)||0
6475931|NCT01284621|7393487|FG000|STARTED|Washout Period 2 (7 Days)||3
6475932|NCT01284621|7393488|FG001|STARTED|Washout Period 2 (7 Days)||4
6475933|NCT01284621|7393489|FG002|STARTED|Washout Period 2 (7 Days)||4
6475934|NCT01284621|7393490|FG003|STARTED|Washout Period 2 (7 Days)||4
6475935|NCT01284621|7393491|FG004|STARTED|Washout Period 2 (7 Days)||3
6475936|NCT01284621|7393492|FG005|STARTED|Washout Period 2 (7 Days)||4
6554588|NCT01747915|7476752|FG002|STARTED|Overall Study||72
6554589|NCT01747915|7476750|FG000|COMPLETED|Overall Study||60
6554590|NCT01747915|7476751|FG001|COMPLETED|Overall Study||61
6475937|NCT01284621|7393487|FG000|COMPLETED|Washout Period 2 (7 Days)||3
6475938|NCT01284621|7393488|FG001|COMPLETED|Washout Period 2 (7 Days)||4
6475939|NCT01284621|7393489|FG002|COMPLETED|Washout Period 2 (7 Days)||4
6475940|NCT01284621|7393490|FG003|COMPLETED|Washout Period 2 (7 Days)||4
6475941|NCT01284621|7393491|FG004|COMPLETED|Washout Period 2 (7 Days)||3
6475942|NCT01284621|7393492|FG005|COMPLETED|Washout Period 2 (7 Days)||4
6475943|NCT01284621|7393487|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6475944|NCT01284621|7393488|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6475945|NCT01284621|7393489|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6475946|NCT01284621|7393490|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6475947|NCT01284621|7393491|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6475948|NCT01284621|7393492|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6475949|NCT01284621|7393487|FG000|STARTED|Third Intervention (8 Days)||3
6475950|NCT01284621|7393488|FG001|STARTED|Third Intervention (8 Days)||4
6475951|NCT01284621|7393489|FG002|STARTED|Third Intervention (8 Days)||4
6475952|NCT01284621|7393490|FG003|STARTED|Third Intervention (8 Days)||4
6475953|NCT01284621|7393491|FG004|STARTED|Third Intervention (8 Days)||3
6475954|NCT01284621|7393492|FG005|STARTED|Third Intervention (8 Days)||4
6475955|NCT01284621|7393487|FG000|COMPLETED|Third Intervention (8 Days)||3
6475956|NCT01284621|7393488|FG001|COMPLETED|Third Intervention (8 Days)||4
6475957|NCT01284621|7393489|FG002|COMPLETED|Third Intervention (8 Days)||4
6475958|NCT01284621|7393490|FG003|COMPLETED|Third Intervention (8 Days)||4
6475959|NCT01284621|7393491|FG004|COMPLETED|Third Intervention (8 Days)||3
6475960|NCT01284621|7393492|FG005|COMPLETED|Third Intervention (8 Days)||4
6475961|NCT01284621|7393487|FG000|NOT COMPLETED|Third Intervention (8 Days)||0
6475962|NCT01284621|7393488|FG001|NOT COMPLETED|Third Intervention (8 Days)||0
6475963|NCT01284621|7393489|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
6475964|NCT01284621|7393490|FG003|NOT COMPLETED|Third Intervention (8 Days)||0
6475965|NCT01284621|7393491|FG004|NOT COMPLETED|Third Intervention (8 Days)||0
6475966|NCT01284621|7393492|FG005|NOT COMPLETED|Third Intervention (8 Days)||0
6475967|NCT01284634|7393506|FG000|STARTED|Overall Study||7
6475968|NCT01284634|7393507|FG001|STARTED|Overall Study||6
6475969|NCT01284634|7393508|FG002|STARTED|Overall Study||7
6475970|NCT01284634|7393509|FG003|STARTED|Overall Study||5
6475971|NCT01284634|7393506|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
6475972|NCT01284634|7393507|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6475973|NCT01284634|7393508|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
6475974|NCT01284634|7393509|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
6475975|NCT01284634|7393506|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||7
6475976|NCT01284634|7393507|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||6
6475977|NCT01284634|7393508|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||7
6475978|NCT01284634|7393509|FG003|Intent to Treat (ITT) Analysis Set|Overall Study||5
6475979|NCT01284634|7393506|FG000|COMPLETED|Overall Study||6
6475980|NCT01284634|7393507|FG001|COMPLETED|Overall Study||6
6475981|NCT01284634|7393508|FG002|COMPLETED|Overall Study||5
6475982|NCT01284634|7393509|FG003|COMPLETED|Overall Study||4
6475983|NCT01284634|7393506|FG000|NOT COMPLETED|Overall Study||1
6475984|NCT01284634|7393507|FG001|NOT COMPLETED|Overall Study||0
6475985|NCT01284634|7393508|FG002|NOT COMPLETED|Overall Study||2
6747197|NCT03384966|7674975|FG000|Pharmacokinetic Analysis Set|Treatment Period||111
6747198|NCT03384966|7674976|FG001|Pharmacokinetic Analysis Set|Treatment Period||115
6747199|NCT03384966|7674977|FG002|Pharmacokinetic Analysis Set|Treatment Period||0
6747200|NCT03384966|7674975|FG000|COMPLETED|Treatment Period||114
6747201|NCT03384966|7674976|FG001|COMPLETED|Treatment Period||115
6747202|NCT03384966|7674977|FG002|COMPLETED|Treatment Period||116
6747203|NCT03384966|7674975|FG000|NOT COMPLETED|Treatment Period||0
6747204|NCT03384966|7674976|FG001|NOT COMPLETED|Treatment Period||0
6747205|NCT03384966|7674977|FG002|NOT COMPLETED|Treatment Period||0
6747206|NCT03384966|7674975|FG000|STARTED|Follow-up Period||114
6747207|NCT03384966|7674976|FG001|STARTED|Follow-up Period||115
6747208|NCT03384966|7674977|FG002|STARTED|Follow-up Period||116
6747209|NCT03384966|7674975|FG000|COMPLETED|Follow-up Period||113
6747210|NCT03384966|7674976|FG001|COMPLETED|Follow-up Period||115
6747211|NCT03384966|7674977|FG002|COMPLETED|Follow-up Period||116
6747212|NCT03384966|7674975|FG000|NOT COMPLETED|Follow-up Period||1
6747213|NCT03384966|7674976|FG001|NOT COMPLETED|Follow-up Period||0
6747214|NCT03384966|7674977|FG002|NOT COMPLETED|Follow-up Period||0
6747215|NCT03386032|7674997|FG000|STARTED|Overall Study||36
6747216|NCT03386032|7674998|FG001|STARTED|Overall Study||18
6747217|NCT03386032|7674999|FG002|STARTED|Overall Study||11
6747218|NCT03386032|7674997|FG000|COMPLETED|Overall Study||18
6747219|NCT03386032|7674998|FG001|COMPLETED|Overall Study||11
6747220|NCT03386032|7674999|FG002|COMPLETED|Overall Study||11
6747221|NCT03386032|7674997|FG000|NOT COMPLETED|Overall Study||18
6747222|NCT03386032|7674998|FG001|NOT COMPLETED|Overall Study||7
6747223|NCT03386032|7674999|FG002|NOT COMPLETED|Overall Study||0
6747224|NCT03386110|7675009|FG000|STARTED|Overall Study||56
6747225|NCT03386110|7675010|FG001|STARTED|Overall Study||44
6747226|NCT03386110|7675009|FG000|COMPLETED|Overall Study||41
6747227|NCT03386110|7675010|FG001|COMPLETED|Overall Study||38
6747228|NCT03386110|7675009|FG000|NOT COMPLETED|Overall Study||15
6747229|NCT03386110|7675010|FG001|NOT COMPLETED|Overall Study||6
6475986|NCT01284634|7393509|FG003|NOT COMPLETED|Overall Study||1
6747230|NCT03386344|7675019|FG000|STARTED|Overall Study||126
6747231|NCT03386344|7675020|FG001|STARTED|Overall Study||125
6475987|NCT01284959|7393522|FG000|STARTED|Overall Study||11
6475988|NCT01284959|7393523|FG001|STARTED|Overall Study||12
6475989|NCT01284959|7393524|FG002|STARTED|Overall Study||11
6475990|NCT01284959|7393522|FG000|COMPLETED|Overall Study||10
6475991|NCT01284959|7393523|FG001|COMPLETED|Overall Study||12
6475992|NCT01284959|7393524|FG002|COMPLETED|Overall Study||10
6475993|NCT01284959|7393522|FG000|NOT COMPLETED|Overall Study||1
6475994|NCT01284959|7393523|FG001|NOT COMPLETED|Overall Study||0
6475995|NCT01284959|7393524|FG002|NOT COMPLETED|Overall Study||1
6475996|NCT01285024|7393534|FG000|STARTED|Overall Study||49
6475997|NCT01285024|7393535|FG001|STARTED|Overall Study||60
6475998|NCT01285024|7393534|FG000|COMPLETED|Overall Study||49
6475999|NCT01285024|7393535|FG001|COMPLETED|Overall Study||60
6476000|NCT01285024|7393534|FG000|NOT COMPLETED|Overall Study||0
6476001|NCT01285024|7393535|FG001|NOT COMPLETED|Overall Study||0
6476002|NCT01285050|7393541|FG000|STARTED|Overall Study||20
6476003|NCT01285050|7393541|FG000|COMPLETED|Overall Study||19
6476004|NCT01285050|7393541|FG000|NOT COMPLETED|Overall Study||1
6476005|NCT01285076|7393546|FG000|STARTED|Overall Study||834
6476006|NCT01285076|7393546|FG000|COMPLETED|Overall Study||834
6476007|NCT01285076|7393546|FG000|NOT COMPLETED|Overall Study||0
6476008|NCT01285310|7393553|FG000|STARTED|Placebo Controlled Phase: Weeks 0-24||79
6476009|NCT01285310|7393554|FG001|STARTED|Placebo Controlled Phase: Weeks 0-24||82
6476010|NCT01285310|7393555|FG002|STARTED|Placebo Controlled Phase: Weeks 0-24||76
6476011|NCT01285310|7393556|FG003|STARTED|Placebo Controlled Phase: Weeks 0-24||0
6476012|NCT01285310|7393557|FG004|STARTED|Placebo Controlled Phase: Weeks 0-24||0
6476013|NCT01285310|7393553|FG000|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
6476014|NCT01285310|7393554|FG001|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
6476015|NCT01285310|7393555|FG002|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
6476016|NCT01285310|7393556|FG003|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
6476017|NCT01285310|7393557|FG004|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
6476018|NCT01285310|7393553|FG000|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
6476019|NCT01285310|7393554|FG001|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
6476020|NCT01285310|7393555|FG002|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
6476021|NCT01285310|7393556|FG003|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
6476022|NCT01285310|7393557|FG004|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
6476023|NCT01285310|7393553|FG000|STARTED|Active Treatment Phase: Weeks 25-52||0
6476024|NCT01285310|7393554|FG001|STARTED|Active Treatment Phase: Weeks 25-52||63
6747232|NCT03386344|7675021|FG002|STARTED|Overall Study||125
6747233|NCT03386344|7675019|FG000|COMPLETED|Overall Study||9
6747234|NCT03386344|7675020|FG001|COMPLETED|Overall Study||9
6747235|NCT03386344|7675021|FG002|COMPLETED|Overall Study||9
6747236|NCT03386344|7675019|FG000|NOT COMPLETED|Overall Study||117
6747237|NCT03386344|7675020|FG001|NOT COMPLETED|Overall Study||116
6747238|NCT03386344|7675021|FG002|NOT COMPLETED|Overall Study||116
6747239|NCT03386435|7675031|FG000|STARTED|Overall Study||80
6747240|NCT03386435|7675032|FG001|STARTED|Overall Study||80
6747241|NCT03386435|7675031|FG000|COMPLETED|Overall Study||75
6747242|NCT03386435|7675032|FG001|COMPLETED|Overall Study||73
6747243|NCT03386435|7675031|FG000|NOT COMPLETED|Overall Study||5
6747244|NCT03386435|7675032|FG001|NOT COMPLETED|Overall Study||7
6747245|NCT03386448|7675040|FG000|STARTED|Overall Study||6
6747246|NCT03386448|7675041|FG001|STARTED|Overall Study||8
6747247|NCT03386448|7675040|FG000|COMPLETED|Overall Study||6
6747248|NCT03386448|7675041|FG001|COMPLETED|Overall Study||6
6747249|NCT03386448|7675040|FG000|NOT COMPLETED|Overall Study||0
6747250|NCT03386448|7675041|FG001|NOT COMPLETED|Overall Study||2
6747251|NCT03386474|7675049|FG000|STARTED|Overall Study||107
6747252|NCT03386474|7675050|FG001|STARTED|Overall Study||43
6747253|NCT03386474|7675049|FG000|COMPLETED|Overall Study||106
6747254|NCT03386474|7675050|FG001|COMPLETED|Overall Study||42
6747255|NCT03386474|7675049|FG000|NOT COMPLETED|Overall Study||1
6747256|NCT03386474|7675050|FG001|NOT COMPLETED|Overall Study||1
6747257|NCT03386994|7675064|FG000|STARTED|Overall Study||204
6747258|NCT03386994|7675064|FG000|COMPLETED|Overall Study||166
6747259|NCT03386994|7675064|FG000|NOT COMPLETED|Overall Study||38
6747260|NCT03387020|7675082|FG000|STARTED|Overall Study||13
6747261|NCT03387020|7675083|FG001|STARTED|Overall Study||3
6747262|NCT03387020|7675084|FG002|STARTED|Overall Study||5
6747263|NCT03387020|7675082|FG000|Received Treatment|Overall Study||12
6747264|NCT03387020|7675083|FG001|Received Treatment|Overall Study||3
6747265|NCT03387020|7675084|FG002|Received Treatment|Overall Study||5
6747266|NCT03387020|7675082|FG000|COMPLETED|Overall Study||11
6747267|NCT03387020|7675083|FG001|COMPLETED|Overall Study||1
6747268|NCT03387020|7675084|FG002|COMPLETED|Overall Study||5
6747269|NCT03387020|7675082|FG000|NOT COMPLETED|Overall Study||2
6747270|NCT03387020|7675083|FG001|NOT COMPLETED|Overall Study||2
6747271|NCT03387020|7675084|FG002|NOT COMPLETED|Overall Study||0
6476025|NCT01285310|7393555|FG002|STARTED|Active Treatment Phase: Weeks 25-52||60
6476026|NCT01285310|7393556|FG003|STARTED|Active Treatment Phase: Weeks 25-52||27
6476027|NCT01285310|7393557|FG004|STARTED|Active Treatment Phase: Weeks 25-52||42
6476028|NCT01285310|7393553|FG000|COMPLETED|Active Treatment Phase: Weeks 25-52||0
6747272|NCT03387033|7675102|FG000|STARTED|Overall Study||20
6747273|NCT03387033|7675102|FG000|COMPLETED|Overall Study||20
6747274|NCT03387033|7675102|FG000|NOT COMPLETED|Overall Study||0
6476029|NCT01285310|7393554|FG001|COMPLETED|Active Treatment Phase: Weeks 25-52||31
6476030|NCT01285310|7393555|FG002|COMPLETED|Active Treatment Phase: Weeks 25-52||34
6476031|NCT01285310|7393556|FG003|COMPLETED|Active Treatment Phase: Weeks 25-52||17
6476032|NCT01285310|7393557|FG004|COMPLETED|Active Treatment Phase: Weeks 25-52||23
6476033|NCT01285310|7393553|FG000|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
6476034|NCT01285310|7393554|FG001|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
6476035|NCT01285310|7393555|FG002|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
6476036|NCT01285310|7393556|FG003|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
6476037|NCT01285310|7393557|FG004|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
6476038|NCT01285323|7393597|FG000|STARTED|Overall Study||232
6476039|NCT01285323|7393598|FG001|STARTED|Overall Study||232
6476040|NCT01285323|7393597|FG000|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
6476041|NCT01285323|7393598|FG001|Full Analysis Set|Overall Study||232
6476042|NCT01285323|7393597|FG000|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
6476043|NCT01285323|7393598|FG001|Safety Analysis Set|Overall Study||232
6476044|NCT01285323|7393597|FG000|COMPLETED|Overall Study||199
6476045|NCT01285323|7393598|FG001|COMPLETED|Overall Study||202
6476046|NCT01285323|7393597|FG000|NOT COMPLETED|Overall Study||33
6476047|NCT01285323|7393598|FG001|NOT COMPLETED|Overall Study||30
6476048|NCT01285349|7393607|FG000|STARTED|Overall Study||190
6476049|NCT01285349|7393608|FG001|STARTED|Overall Study||190
6476050|NCT01285349|7393609|FG002|STARTED|Overall Study||184
6476051|NCT01285349|7393607|FG000|COMPLETED|Overall Study||163
6476052|NCT01285349|7393608|FG001|COMPLETED|Overall Study||170
6476053|NCT01285349|7393609|FG002|COMPLETED|Overall Study||157
6476054|NCT01285349|7393607|FG000|NOT COMPLETED|Overall Study||27
6476055|NCT01285349|7393608|FG001|NOT COMPLETED|Overall Study||20
6476056|NCT01285349|7393609|FG002|NOT COMPLETED|Overall Study||27
6476057|NCT01285401|7393620|FG000|STARTED|Overall Study||115
6476058|NCT01285401|7393621|FG001|STARTED|Overall Study||117
6476059|NCT01285401|7393620|FG000|Treated|Overall Study||113
6476060|NCT01285401|7393621|FG001|Treated|Overall Study||116
6476061|NCT01285401|7393620|FG000|COMPLETED|Overall Study||98
6476062|NCT01285401|7393621|FG001|COMPLETED|Overall Study||88
6476063|NCT01285401|7393620|FG000|NOT COMPLETED|Overall Study||17
6476064|NCT01285401|7393621|FG001|NOT COMPLETED|Overall Study||29
6476065|NCT01285427|7393627|FG000|STARTED|Overall Study||300
6476066|NCT01285427|7393627|FG000|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
6476067|NCT01285427|7393627|FG000|NOT COMPLETED|Overall Study||1
6476068|NCT01285492|7393641|FG000|STARTED|Overall Study|All patients randomized to this group|121
6476069|NCT01285492|7393642|FG001|STARTED|Overall Study|All patients randomized to this group|39
6476070|NCT01285492|7393641|FG000|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
6476071|NCT01285492|7393642|FG001|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
6476072|NCT01285492|7393641|FG000|COMPLETED|Overall Study||104
6476073|NCT01285492|7393642|FG001|COMPLETED|Overall Study||38
6476074|NCT01285492|7393641|FG000|NOT COMPLETED|Overall Study||17
6476075|NCT01285492|7393642|FG001|NOT COMPLETED|Overall Study||1
6476076|NCT01285518|7393656|FG000|STARTED|Overall Study||10
6476077|NCT01285518|7393657|FG001|STARTED|Overall Study||10
6476078|NCT01285518|7393658|FG002|STARTED|Overall Study||10
6476079|NCT01285518|7393659|FG003|STARTED|Overall Study||10
6476080|NCT01285518|7393660|FG004|STARTED|Overall Study||10
6476081|NCT01285518|7393661|FG005|STARTED|Overall Study||10
6476082|NCT01285518|7393662|FG006|STARTED|Overall Study||10
6476083|NCT01285518|7393663|FG007|STARTED|Overall Study||14
6476084|NCT01285518|7393656|FG000|COMPLETED|Overall Study||10
6476085|NCT01285518|7393657|FG001|COMPLETED|Overall Study||10
6476086|NCT01285518|7393658|FG002|COMPLETED|Overall Study||10
6476087|NCT01285518|7393659|FG003|COMPLETED|Overall Study||10
6476088|NCT01285518|7393660|FG004|COMPLETED|Overall Study||10
6476089|NCT01285518|7393661|FG005|COMPLETED|Overall Study||9
6476090|NCT01285518|7393662|FG006|COMPLETED|Overall Study||10
6476091|NCT01285518|7393663|FG007|COMPLETED|Overall Study||14
6476092|NCT01285518|7393656|FG000|NOT COMPLETED|Overall Study||0
6476093|NCT01285518|7393657|FG001|NOT COMPLETED|Overall Study||0
6476094|NCT01285518|7393658|FG002|NOT COMPLETED|Overall Study||0
6476095|NCT01285518|7393659|FG003|NOT COMPLETED|Overall Study||0
6476096|NCT01285518|7393660|FG004|NOT COMPLETED|Overall Study||0
6476097|NCT01285518|7393661|FG005|NOT COMPLETED|Overall Study||1
6476098|NCT01285518|7393662|FG006|NOT COMPLETED|Overall Study||0
6476099|NCT01285518|7393663|FG007|NOT COMPLETED|Overall Study||0
6476100|NCT01285609|7393684|FG000|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
6476101|NCT01285609|7393685|FG001|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
6476102|NCT01285609|7393684|FG000|Treated With Chemotherapy (1st Dose)|Randomized||475
6476103|NCT01285609|7393685|FG001|Treated With Chemotherapy (1st Dose)|Randomized||473
6476104|NCT01285609|7393684|FG000|COMPLETED|Randomized||388
6476105|NCT01285609|7393685|FG001|COMPLETED|Randomized||361
6476106|NCT01285609|7393684|FG000|NOT COMPLETED|Randomized||91
6476107|NCT01285609|7393685|FG001|NOT COMPLETED|Randomized||116
6476108|NCT01285609|7393684|FG000|STARTED|Treated With Blinded Therapy||388
6476109|NCT01285609|7393685|FG001|STARTED|Treated With Blinded Therapy||361
6476110|NCT01285609|7393684|FG000|COMPLETED|Treated With Blinded Therapy||1
6476111|NCT01285609|7393685|FG001|COMPLETED|Treated With Blinded Therapy||2
6476112|NCT01285609|7393684|FG000|NOT COMPLETED|Treated With Blinded Therapy||387
6476113|NCT01285609|7393685|FG001|NOT COMPLETED|Treated With Blinded Therapy||359
6476114|NCT01285635|7393696|FG000|STARTED|First Intervention (2 Weeks)||13
6476115|NCT01285635|7393697|FG001|STARTED|First Intervention (2 Weeks)||11
6476116|NCT01285635|7393698|FG002|STARTED|First Intervention (2 Weeks)||11
6476117|NCT01285635|7393696|FG000|COMPLETED|First Intervention (2 Weeks)||13
6476118|NCT01285635|7393697|FG001|COMPLETED|First Intervention (2 Weeks)||11
6476119|NCT01285635|7393698|FG002|COMPLETED|First Intervention (2 Weeks)||11
6476120|NCT01285635|7393696|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6476121|NCT01285635|7393697|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
6476122|NCT01285635|7393698|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
6476123|NCT01285635|7393696|FG000|STARTED|Second Intervention (10, 3 Week Cycles)||13
6476124|NCT01285635|7393697|FG001|STARTED|Second Intervention (10, 3 Week Cycles)||11
6476125|NCT01285635|7393698|FG002|STARTED|Second Intervention (10, 3 Week Cycles)||11
6476126|NCT01285635|7393696|FG000|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
6476127|NCT01285635|7393697|FG001|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
6476128|NCT01285635|7393698|FG002|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
6476129|NCT01285635|7393696|FG000|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
6476130|NCT01285635|7393697|FG001|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
6476131|NCT01285635|7393698|FG002|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
6476132|NCT01285713|7393711|FG000|STARTED|Overall Study||42
6476133|NCT01285713|7393712|FG001|STARTED|Overall Study||41
6476134|NCT01285713|7393711|FG000|COMPLETED|Overall Study||42
6476135|NCT01285713|7393712|FG001|COMPLETED|Overall Study||41
6476136|NCT01285713|7393711|FG000|NOT COMPLETED|Overall Study||0
6476137|NCT01285713|7393712|FG001|NOT COMPLETED|Overall Study||0
6476138|NCT01285791|7393721|FG000|STARTED|Overall Study||11
6476139|NCT01285791|7393722|FG001|STARTED|Overall Study||15
6476140|NCT01285791|7393723|FG002|STARTED|Overall Study||13
6476141|NCT01285791|7393721|FG000|COMPLETED|Overall Study||11
6476142|NCT01285791|7393722|FG001|COMPLETED|Overall Study||15
6476143|NCT01285791|7393723|FG002|COMPLETED|Overall Study||13
6476144|NCT01285791|7393721|FG000|NOT COMPLETED|Overall Study||0
6476145|NCT01285791|7393722|FG001|NOT COMPLETED|Overall Study||0
6476146|NCT01285791|7393723|FG002|NOT COMPLETED|Overall Study||0
6476147|NCT01285843|7393733|FG000|STARTED|Overall Study||20
6476148|NCT01285843|7393734|FG001|STARTED|Overall Study||20
6476149|NCT01285843|7393733|FG000|COMPLETED|Overall Study||18
6476150|NCT01285843|7393734|FG001|COMPLETED|Overall Study||18
6476151|NCT01285843|7393733|FG000|NOT COMPLETED|Overall Study||2
6476152|NCT01285843|7393734|FG001|NOT COMPLETED|Overall Study||2
6476153|NCT01285908|7393740|FG000|STARTED|Baseline Measurement||6
6476154|NCT01285908|7393741|FG001|STARTED|Baseline Measurement||0
6476155|NCT01285908|7393742|FG002|STARTED|Baseline Measurement||0
6476156|NCT01285908|7393740|FG000|COMPLETED|Baseline Measurement||3
6476157|NCT01285908|7393741|FG001|COMPLETED|Baseline Measurement||0
6476158|NCT01285908|7393742|FG002|COMPLETED|Baseline Measurement||0
6476159|NCT01285908|7393740|FG000|NOT COMPLETED|Baseline Measurement||3
6476160|NCT01285908|7393741|FG001|NOT COMPLETED|Baseline Measurement||0
6476161|NCT01285908|7393742|FG002|NOT COMPLETED|Baseline Measurement||0
6476162|NCT01285908|7393740|FG000|STARTED|Treatment Crossover||0
6476163|NCT01285908|7393741|FG001|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
6476164|NCT01285908|7393742|FG002|STARTED|Treatment Crossover||2
6476165|NCT01285908|7393740|FG000|COMPLETED|Treatment Crossover||0
6476166|NCT01285908|7393741|FG001|COMPLETED|Treatment Crossover||2
6476167|NCT01285908|7393742|FG002|COMPLETED|Treatment Crossover||2
6476168|NCT01285908|7393740|FG000|NOT COMPLETED|Treatment Crossover||0
6476169|NCT01285908|7393741|FG001|NOT COMPLETED|Treatment Crossover||0
6476170|NCT01285908|7393742|FG002|NOT COMPLETED|Treatment Crossover||0
6476171|NCT01285960|7393772|FG000|STARTED|Overall Study|2 subjects receiving fewer than 10 sonications were added to the 106 for safety population of 108|108
6476172|NCT01285960|7393772|FG000|COMPLETED|Overall Study|An additional 2 subjects receiving fewer than 10 sonications were included in the safety population|102
6476173|NCT01285960|7393772|FG000|NOT COMPLETED|Overall Study||6
6476174|NCT01286012|7393778|FG000|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
6476175|NCT01286012|7393779|FG001|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
6476176|NCT01286012|7393778|FG000|COMPLETED|Overall Study||41
6476177|NCT01286012|7393779|FG001|COMPLETED|Overall Study||40
6476178|NCT01286012|7393778|FG000|NOT COMPLETED|Overall Study||13
6476179|NCT01286012|7393779|FG001|NOT COMPLETED|Overall Study||14
6476180|NCT01286077|7393788|FG000|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
6476181|NCT01286077|7393789|FG001|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
6476182|NCT01286077|7393788|FG000|COMPLETED|Overall Study||41
6476183|NCT01286077|7393789|FG001|COMPLETED|Overall Study||46
6476184|NCT01286077|7393788|FG000|NOT COMPLETED|Overall Study||10
6476185|NCT01286077|7393789|FG001|NOT COMPLETED|Overall Study||7
6476186|NCT01286129|7393797|FG000|STARTED|Overall Study||27
6476187|NCT01286129|7393798|FG001|STARTED|Overall Study||18
6476188|NCT01286129|7393797|FG000|COMPLETED|Overall Study||19
6476189|NCT01286129|7393798|FG001|COMPLETED|Overall Study||13
6476190|NCT01286129|7393797|FG000|NOT COMPLETED|Overall Study||8
6476191|NCT01286129|7393798|FG001|NOT COMPLETED|Overall Study||5
6476192|NCT01286168|7393806|FG000|STARTED|Overall Study||104
6476193|NCT01286168|7393806|FG000|COMPLETED|Overall Study||101
6476194|NCT01286168|7393806|FG000|NOT COMPLETED|Overall Study||3
6476195|NCT01286259|7393811|FG000|STARTED|Overall Study||16
6476196|NCT01286259|7393811|FG000|COMPLETED|Overall Study||16
6476197|NCT01286259|7393811|FG000|NOT COMPLETED|Overall Study||0
6476198|NCT01286311|7393817|FG000|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
6476199|NCT01286311|7393818|FG001|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
6476200|NCT01286311|7393817|FG000|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
6476201|NCT01286311|7393818|FG001|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
6476202|NCT01286311|7393817|FG000|NOT COMPLETED|Overall Study||14
6476203|NCT01286311|7393818|FG001|NOT COMPLETED|Overall Study||0
6476204|NCT01286324|7393826|FG000|STARTED|Overall Study||17
6476205|NCT01286324|7393827|FG001|STARTED|Overall Study||17
6476206|NCT01286324|7393826|FG000|COMPLETED|Overall Study||17
6476207|NCT01286324|7393827|FG001|COMPLETED|Overall Study||17
6476208|NCT01286324|7393826|FG000|NOT COMPLETED|Overall Study||0
6476209|NCT01286324|7393827|FG001|NOT COMPLETED|Overall Study||0
6476210|NCT01286402|7393835|FG000|STARTED|Overall Study||5
6476211|NCT01286402|7393836|FG001|STARTED|Overall Study||6
6476212|NCT01286402|7393835|FG000|COMPLETED|Overall Study||5
6476213|NCT01286402|7393836|FG001|COMPLETED|Overall Study||6
6476214|NCT01286402|7393835|FG000|NOT COMPLETED|Overall Study||0
6476215|NCT01286402|7393836|FG001|NOT COMPLETED|Overall Study||0
6476216|NCT01286441|7393846|FG000|STARTED|Overall Study||45
6476217|NCT01286441|7393847|FG001|STARTED|Overall Study||44
6476218|NCT01286441|7393848|FG002|STARTED|Overall Study||46
6476219|NCT01286441|7393849|FG003|STARTED|Overall Study||48
6476220|NCT01286441|7393846|FG000|COMPLETED|Overall Study||38
6476221|NCT01286441|7393847|FG001|COMPLETED|Overall Study||37
6476222|NCT01286441|7393848|FG002|COMPLETED|Overall Study||39
6476223|NCT01286441|7393849|FG003|COMPLETED|Overall Study||37
6476224|NCT01286441|7393846|FG000|NOT COMPLETED|Overall Study||7
6476225|NCT01286441|7393847|FG001|NOT COMPLETED|Overall Study||7
6476226|NCT01286441|7393848|FG002|NOT COMPLETED|Overall Study||7
6476227|NCT01286441|7393849|FG003|NOT COMPLETED|Overall Study||11
6476228|NCT01286454|7393859|FG000|STARTED|Part I- First Intervention Period||2
6476229|NCT01286454|7393860|FG001|STARTED|Part I- First Intervention Period||2
6476230|NCT01286454|7393861|FG002|STARTED|Part I- First Intervention Period||2
6476231|NCT01286454|7393862|FG003|STARTED|Part I- First Intervention Period||2
6476232|NCT01286454|7393863|FG004|STARTED|Part I- First Intervention Period||2
6476233|NCT01286454|7393864|FG005|STARTED|Part I- First Intervention Period||2
6476234|NCT01286454|7393865|FG006|STARTED|Part I- First Intervention Period||2
6476235|NCT01286454|7393866|FG007|STARTED|Part I- First Intervention Period||2
6476236|NCT01286454|7393867|FG008|STARTED|Part I- First Intervention Period||2
6476237|NCT01286454|7393868|FG009|STARTED|Part I- First Intervention Period||2
6476238|NCT01286454|7393869|FG010|STARTED|Part I- First Intervention Period||0
6476239|NCT01286454|7393859|FG000|COMPLETED|Part I- First Intervention Period||2
6476240|NCT01286454|7393860|FG001|COMPLETED|Part I- First Intervention Period||2
6476241|NCT01286454|7393861|FG002|COMPLETED|Part I- First Intervention Period||2
6476242|NCT01286454|7393862|FG003|COMPLETED|Part I- First Intervention Period||2
6476243|NCT01286454|7393863|FG004|COMPLETED|Part I- First Intervention Period||2
6476244|NCT01286454|7393864|FG005|COMPLETED|Part I- First Intervention Period||2
6476245|NCT01286454|7393865|FG006|COMPLETED|Part I- First Intervention Period||2
6476246|NCT01286454|7393866|FG007|COMPLETED|Part I- First Intervention Period||2
6476247|NCT01286454|7393867|FG008|COMPLETED|Part I- First Intervention Period||2
6476248|NCT01286454|7393868|FG009|COMPLETED|Part I- First Intervention Period||2
6476249|NCT01286454|7393869|FG010|COMPLETED|Part I- First Intervention Period||0
6476250|NCT01286454|7393859|FG000|NOT COMPLETED|Part I- First Intervention Period||0
6476251|NCT01286454|7393860|FG001|NOT COMPLETED|Part I- First Intervention Period||0
6476252|NCT01286454|7393861|FG002|NOT COMPLETED|Part I- First Intervention Period||0
6476253|NCT01286454|7393862|FG003|NOT COMPLETED|Part I- First Intervention Period||0
6476254|NCT01286454|7393863|FG004|NOT COMPLETED|Part I- First Intervention Period||0
6476255|NCT01286454|7393864|FG005|NOT COMPLETED|Part I- First Intervention Period||0
6476256|NCT01286454|7393865|FG006|NOT COMPLETED|Part I- First Intervention Period||0
6476257|NCT01286454|7393866|FG007|NOT COMPLETED|Part I- First Intervention Period||0
6476258|NCT01286454|7393867|FG008|NOT COMPLETED|Part I- First Intervention Period||0
6476259|NCT01286454|7393868|FG009|NOT COMPLETED|Part I- First Intervention Period||0
6476260|NCT01286454|7393869|FG010|NOT COMPLETED|Part I- First Intervention Period||0
6476261|NCT01286454|7393859|FG000|STARTED|Washout Period (At Least 3 Days)||2
6476262|NCT01286454|7393860|FG001|STARTED|Washout Period (At Least 3 Days)||2
6476263|NCT01286454|7393861|FG002|STARTED|Washout Period (At Least 3 Days)||2
6476264|NCT01286454|7393862|FG003|STARTED|Washout Period (At Least 3 Days)||2
6476265|NCT01286454|7393863|FG004|STARTED|Washout Period (At Least 3 Days)||2
6476266|NCT01286454|7393864|FG005|STARTED|Washout Period (At Least 3 Days)||2
6476267|NCT01286454|7393865|FG006|STARTED|Washout Period (At Least 3 Days)||2
6476268|NCT01286454|7393866|FG007|STARTED|Washout Period (At Least 3 Days)||2
6476269|NCT01286454|7393867|FG008|STARTED|Washout Period (At Least 3 Days)||2
6476270|NCT01286454|7393868|FG009|STARTED|Washout Period (At Least 3 Days)||2
6476271|NCT01286454|7393869|FG010|STARTED|Washout Period (At Least 3 Days)||0
6476272|NCT01286454|7393859|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
6476273|NCT01286454|7393860|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
6476274|NCT01286454|7393861|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
6476275|NCT01286454|7393862|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
6476276|NCT01286454|7393863|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
6476277|NCT01286454|7393864|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
6476278|NCT01286454|7393865|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
6476279|NCT01286454|7393866|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
6476280|NCT01286454|7393867|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
6476281|NCT01286454|7393868|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
6476282|NCT01286454|7393869|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
6476283|NCT01286454|7393859|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476284|NCT01286454|7393860|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476285|NCT01286454|7393861|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476286|NCT01286454|7393862|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476287|NCT01286454|7393863|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476288|NCT01286454|7393864|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476289|NCT01286454|7393865|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476290|NCT01286454|7393866|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476291|NCT01286454|7393867|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476292|NCT01286454|7393868|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476293|NCT01286454|7393869|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476294|NCT01286454|7393859|FG000|STARTED|Second Intervention Period||2
6476295|NCT01286454|7393860|FG001|STARTED|Second Intervention Period||2
6476296|NCT01286454|7393861|FG002|STARTED|Second Intervention Period||2
6476297|NCT01286454|7393862|FG003|STARTED|Second Intervention Period||2
6476298|NCT01286454|7393863|FG004|STARTED|Second Intervention Period||2
6476299|NCT01286454|7393864|FG005|STARTED|Second Intervention Period||2
6476300|NCT01286454|7393865|FG006|STARTED|Second Intervention Period||2
6476301|NCT01286454|7393866|FG007|STARTED|Second Intervention Period||2
6476302|NCT01286454|7393867|FG008|STARTED|Second Intervention Period||2
6476303|NCT01286454|7393868|FG009|STARTED|Second Intervention Period||2
6476304|NCT01286454|7393869|FG010|STARTED|Second Intervention Period||0
6476305|NCT01286454|7393859|FG000|COMPLETED|Second Intervention Period||2
6476306|NCT01286454|7393860|FG001|COMPLETED|Second Intervention Period||2
6476307|NCT01286454|7393861|FG002|COMPLETED|Second Intervention Period||2
6476308|NCT01286454|7393862|FG003|COMPLETED|Second Intervention Period||2
6476309|NCT01286454|7393863|FG004|COMPLETED|Second Intervention Period||2
6476310|NCT01286454|7393864|FG005|COMPLETED|Second Intervention Period||2
6476311|NCT01286454|7393865|FG006|COMPLETED|Second Intervention Period||2
6476312|NCT01286454|7393866|FG007|COMPLETED|Second Intervention Period||2
6476313|NCT01286454|7393867|FG008|COMPLETED|Second Intervention Period||2
6476314|NCT01286454|7393868|FG009|COMPLETED|Second Intervention Period||2
6476315|NCT01286454|7393869|FG010|COMPLETED|Second Intervention Period||0
6476316|NCT01286454|7393859|FG000|NOT COMPLETED|Second Intervention Period||0
6476317|NCT01286454|7393860|FG001|NOT COMPLETED|Second Intervention Period||0
6476318|NCT01286454|7393861|FG002|NOT COMPLETED|Second Intervention Period||0
6476319|NCT01286454|7393862|FG003|NOT COMPLETED|Second Intervention Period||0
6476320|NCT01286454|7393863|FG004|NOT COMPLETED|Second Intervention Period||0
6476321|NCT01286454|7393864|FG005|NOT COMPLETED|Second Intervention Period||0
6476322|NCT01286454|7393865|FG006|NOT COMPLETED|Second Intervention Period||0
6476323|NCT01286454|7393866|FG007|NOT COMPLETED|Second Intervention Period||0
6476324|NCT01286454|7393867|FG008|NOT COMPLETED|Second Intervention Period||0
6476325|NCT01286454|7393868|FG009|NOT COMPLETED|Second Intervention Period||0
6476326|NCT01286454|7393869|FG010|NOT COMPLETED|Second Intervention Period||0
6476327|NCT01286454|7393859|FG000|STARTED|Washout Period (At Least 3 Days)||2
6476328|NCT01286454|7393860|FG001|STARTED|Washout Period (At Least 3 Days)||2
6476329|NCT01286454|7393861|FG002|STARTED|Washout Period (At Least 3 Days)||2
6476330|NCT01286454|7393862|FG003|STARTED|Washout Period (At Least 3 Days)||2
6476331|NCT01286454|7393863|FG004|STARTED|Washout Period (At Least 3 Days)||2
6476332|NCT01286454|7393864|FG005|STARTED|Washout Period (At Least 3 Days)||2
6476333|NCT01286454|7393865|FG006|STARTED|Washout Period (At Least 3 Days)||2
6476334|NCT01286454|7393866|FG007|STARTED|Washout Period (At Least 3 Days)||2
6476335|NCT01286454|7393867|FG008|STARTED|Washout Period (At Least 3 Days)||2
6476336|NCT01286454|7393868|FG009|STARTED|Washout Period (At Least 3 Days)||2
6476337|NCT01286454|7393869|FG010|STARTED|Washout Period (At Least 3 Days)||0
6476338|NCT01286454|7393859|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
6476339|NCT01286454|7393860|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
6476340|NCT01286454|7393861|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
6476341|NCT01286454|7393862|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
6476342|NCT01286454|7393863|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
6476343|NCT01286454|7393864|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
6476344|NCT01286454|7393865|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
6476345|NCT01286454|7393866|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
6476346|NCT01286454|7393867|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
6476347|NCT01286454|7393868|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
6476348|NCT01286454|7393869|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
6476349|NCT01286454|7393859|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476350|NCT01286454|7393860|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476351|NCT01286454|7393861|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476352|NCT01286454|7393862|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476353|NCT01286454|7393863|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476354|NCT01286454|7393864|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476355|NCT01286454|7393865|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476356|NCT01286454|7393866|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476357|NCT01286454|7393867|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476358|NCT01286454|7393868|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476359|NCT01286454|7393869|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476360|NCT01286454|7393859|FG000|STARTED|Third Intervention Period||2
6476361|NCT01286454|7393860|FG001|STARTED|Third Intervention Period||2
6476362|NCT01286454|7393861|FG002|STARTED|Third Intervention Period||2
6476363|NCT01286454|7393862|FG003|STARTED|Third Intervention Period||2
6476364|NCT01286454|7393863|FG004|STARTED|Third Intervention Period||2
6476365|NCT01286454|7393864|FG005|STARTED|Third Intervention Period||2
6476366|NCT01286454|7393865|FG006|STARTED|Third Intervention Period||2
6476367|NCT01286454|7393866|FG007|STARTED|Third Intervention Period||2
6476368|NCT01286454|7393867|FG008|STARTED|Third Intervention Period||2
6476369|NCT01286454|7393868|FG009|STARTED|Third Intervention Period||2
6476370|NCT01286454|7393869|FG010|STARTED|Third Intervention Period||0
6476371|NCT01286454|7393859|FG000|COMPLETED|Third Intervention Period||2
6476372|NCT01286454|7393860|FG001|COMPLETED|Third Intervention Period||2
6476373|NCT01286454|7393861|FG002|COMPLETED|Third Intervention Period||2
6476374|NCT01286454|7393862|FG003|COMPLETED|Third Intervention Period||2
6476375|NCT01286454|7393863|FG004|COMPLETED|Third Intervention Period||2
6476376|NCT01286454|7393864|FG005|COMPLETED|Third Intervention Period||2
6476377|NCT01286454|7393865|FG006|COMPLETED|Third Intervention Period||2
6476378|NCT01286454|7393866|FG007|COMPLETED|Third Intervention Period||2
6476379|NCT01286454|7393867|FG008|COMPLETED|Third Intervention Period||2
6476380|NCT01286454|7393868|FG009|COMPLETED|Third Intervention Period||2
6476381|NCT01286454|7393869|FG010|COMPLETED|Third Intervention Period||0
6476382|NCT01286454|7393859|FG000|NOT COMPLETED|Third Intervention Period||0
6476383|NCT01286454|7393860|FG001|NOT COMPLETED|Third Intervention Period||0
6476384|NCT01286454|7393861|FG002|NOT COMPLETED|Third Intervention Period||0
6476385|NCT01286454|7393862|FG003|NOT COMPLETED|Third Intervention Period||0
6476386|NCT01286454|7393863|FG004|NOT COMPLETED|Third Intervention Period||0
6476387|NCT01286454|7393864|FG005|NOT COMPLETED|Third Intervention Period||0
6476388|NCT01286454|7393865|FG006|NOT COMPLETED|Third Intervention Period||0
6476389|NCT01286454|7393866|FG007|NOT COMPLETED|Third Intervention Period||0
6476390|NCT01286454|7393867|FG008|NOT COMPLETED|Third Intervention Period||0
6476391|NCT01286454|7393868|FG009|NOT COMPLETED|Third Intervention Period||0
6476392|NCT01286454|7393869|FG010|NOT COMPLETED|Third Intervention Period||0
6476393|NCT01286454|7393859|FG000|STARTED|Washout Period (At Least 3 Days)||2
6476394|NCT01286454|7393860|FG001|STARTED|Washout Period (At Least 3 Days)||2
6476395|NCT01286454|7393861|FG002|STARTED|Washout Period (At Least 3 Days)||2
6476396|NCT01286454|7393862|FG003|STARTED|Washout Period (At Least 3 Days)||2
6476397|NCT01286454|7393863|FG004|STARTED|Washout Period (At Least 3 Days)||2
6476398|NCT01286454|7393864|FG005|STARTED|Washout Period (At Least 3 Days)||2
6476399|NCT01286454|7393865|FG006|STARTED|Washout Period (At Least 3 Days)||2
6476400|NCT01286454|7393866|FG007|STARTED|Washout Period (At Least 3 Days)||2
6476401|NCT01286454|7393867|FG008|STARTED|Washout Period (At Least 3 Days)||2
6476402|NCT01286454|7393868|FG009|STARTED|Washout Period (At Least 3 Days)||2
6476403|NCT01286454|7393869|FG010|STARTED|Washout Period (At Least 3 Days)||0
6476404|NCT01286454|7393859|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
6476405|NCT01286454|7393860|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
6476406|NCT01286454|7393861|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
6476407|NCT01286454|7393862|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
6476408|NCT01286454|7393863|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
6476409|NCT01286454|7393864|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
6476410|NCT01286454|7393865|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
6476411|NCT01286454|7393866|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
6476412|NCT01286454|7393867|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
6476413|NCT01286454|7393868|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
6476414|NCT01286454|7393869|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
6476415|NCT01286454|7393859|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476416|NCT01286454|7393860|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476417|NCT01286454|7393861|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476418|NCT01286454|7393862|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476419|NCT01286454|7393863|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476420|NCT01286454|7393864|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476421|NCT01286454|7393865|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476422|NCT01286454|7393866|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476423|NCT01286454|7393867|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476424|NCT01286454|7393868|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476425|NCT01286454|7393869|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476426|NCT01286454|7393859|FG000|STARTED|Fourth Intervention Period||2
6476427|NCT01286454|7393860|FG001|STARTED|Fourth Intervention Period||2
6476428|NCT01286454|7393861|FG002|STARTED|Fourth Intervention Period||2
6476429|NCT01286454|7393862|FG003|STARTED|Fourth Intervention Period||2
6476430|NCT01286454|7393863|FG004|STARTED|Fourth Intervention Period||2
6476431|NCT01286454|7393864|FG005|STARTED|Fourth Intervention Period||2
6476432|NCT01286454|7393865|FG006|STARTED|Fourth Intervention Period||2
6476433|NCT01286454|7393866|FG007|STARTED|Fourth Intervention Period||2
6476434|NCT01286454|7393867|FG008|STARTED|Fourth Intervention Period||2
6476435|NCT01286454|7393868|FG009|STARTED|Fourth Intervention Period||2
6476436|NCT01286454|7393869|FG010|STARTED|Fourth Intervention Period||0
6476437|NCT01286454|7393859|FG000|COMPLETED|Fourth Intervention Period||2
6476438|NCT01286454|7393860|FG001|COMPLETED|Fourth Intervention Period||2
6476439|NCT01286454|7393861|FG002|COMPLETED|Fourth Intervention Period||2
6476440|NCT01286454|7393862|FG003|COMPLETED|Fourth Intervention Period||2
6476441|NCT01286454|7393863|FG004|COMPLETED|Fourth Intervention Period||2
6476442|NCT01286454|7393864|FG005|COMPLETED|Fourth Intervention Period||2
6476443|NCT01286454|7393865|FG006|COMPLETED|Fourth Intervention Period||2
6476444|NCT01286454|7393866|FG007|COMPLETED|Fourth Intervention Period||2
6476445|NCT01286454|7393867|FG008|COMPLETED|Fourth Intervention Period||2
6476446|NCT01286454|7393868|FG009|COMPLETED|Fourth Intervention Period||2
6476447|NCT01286454|7393869|FG010|COMPLETED|Fourth Intervention Period||0
6476448|NCT01286454|7393859|FG000|NOT COMPLETED|Fourth Intervention Period||0
6476449|NCT01286454|7393860|FG001|NOT COMPLETED|Fourth Intervention Period||0
6476450|NCT01286454|7393861|FG002|NOT COMPLETED|Fourth Intervention Period||0
6476451|NCT01286454|7393862|FG003|NOT COMPLETED|Fourth Intervention Period||0
6476452|NCT01286454|7393863|FG004|NOT COMPLETED|Fourth Intervention Period||0
6476453|NCT01286454|7393864|FG005|NOT COMPLETED|Fourth Intervention Period||0
6476454|NCT01286454|7393865|FG006|NOT COMPLETED|Fourth Intervention Period||0
6476455|NCT01286454|7393866|FG007|NOT COMPLETED|Fourth Intervention Period||0
6476456|NCT01286454|7393867|FG008|NOT COMPLETED|Fourth Intervention Period||0
6476457|NCT01286454|7393868|FG009|NOT COMPLETED|Fourth Intervention Period||0
6476458|NCT01286454|7393869|FG010|NOT COMPLETED|Fourth Intervention Period||0
6476459|NCT01286454|7393859|FG000|STARTED|Washout Period (At Least 3 Days)||2
6476460|NCT01286454|7393860|FG001|STARTED|Washout Period (At Least 3 Days)||2
6476461|NCT01286454|7393861|FG002|STARTED|Washout Period (At Least 3 Days)||2
6476462|NCT01286454|7393862|FG003|STARTED|Washout Period (At Least 3 Days)||2
6476463|NCT01286454|7393863|FG004|STARTED|Washout Period (At Least 3 Days)||2
6476464|NCT01286454|7393864|FG005|STARTED|Washout Period (At Least 3 Days)||2
6476465|NCT01286454|7393865|FG006|STARTED|Washout Period (At Least 3 Days)||2
6476466|NCT01286454|7393866|FG007|STARTED|Washout Period (At Least 3 Days)||2
6476467|NCT01286454|7393867|FG008|STARTED|Washout Period (At Least 3 Days)||2
6476468|NCT01286454|7393868|FG009|STARTED|Washout Period (At Least 3 Days)||2
6476469|NCT01286454|7393869|FG010|STARTED|Washout Period (At Least 3 Days)||0
6476470|NCT01286454|7393859|FG000|COMPLETED|Washout Period (At Least 3 Days)||2
6476471|NCT01286454|7393860|FG001|COMPLETED|Washout Period (At Least 3 Days)||2
6476472|NCT01286454|7393861|FG002|COMPLETED|Washout Period (At Least 3 Days)||2
6476473|NCT01286454|7393862|FG003|COMPLETED|Washout Period (At Least 3 Days)||2
6476474|NCT01286454|7393863|FG004|COMPLETED|Washout Period (At Least 3 Days)||2
6476475|NCT01286454|7393864|FG005|COMPLETED|Washout Period (At Least 3 Days)||2
6476476|NCT01286454|7393865|FG006|COMPLETED|Washout Period (At Least 3 Days)||2
6476477|NCT01286454|7393866|FG007|COMPLETED|Washout Period (At Least 3 Days)||2
6476478|NCT01286454|7393867|FG008|COMPLETED|Washout Period (At Least 3 Days)||2
6476479|NCT01286454|7393868|FG009|COMPLETED|Washout Period (At Least 3 Days)||2
6476480|NCT01286454|7393869|FG010|COMPLETED|Washout Period (At Least 3 Days)||0
6476481|NCT01286454|7393859|FG000|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476482|NCT01286454|7393860|FG001|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476483|NCT01286454|7393861|FG002|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476484|NCT01286454|7393862|FG003|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476485|NCT01286454|7393863|FG004|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476486|NCT01286454|7393864|FG005|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476487|NCT01286454|7393865|FG006|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476488|NCT01286454|7393866|FG007|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476489|NCT01286454|7393867|FG008|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476490|NCT01286454|7393868|FG009|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476491|NCT01286454|7393869|FG010|NOT COMPLETED|Washout Period (At Least 3 Days)||0
6476492|NCT01286454|7393859|FG000|STARTED|Fifth Intervention Period||2
6476493|NCT01286454|7393860|FG001|STARTED|Fifth Intervention Period||2
6476494|NCT01286454|7393861|FG002|STARTED|Fifth Intervention Period||2
6476495|NCT01286454|7393862|FG003|STARTED|Fifth Intervention Period||2
6476496|NCT01286454|7393863|FG004|STARTED|Fifth Intervention Period||2
6476497|NCT01286454|7393864|FG005|STARTED|Fifth Intervention Period||2
6476498|NCT01286454|7393865|FG006|STARTED|Fifth Intervention Period||2
6476499|NCT01286454|7393866|FG007|STARTED|Fifth Intervention Period||2
6476500|NCT01286454|7393867|FG008|STARTED|Fifth Intervention Period||2
6476501|NCT01286454|7393868|FG009|STARTED|Fifth Intervention Period||2
6476502|NCT01286454|7393869|FG010|STARTED|Fifth Intervention Period||0
6476503|NCT01286454|7393859|FG000|COMPLETED|Fifth Intervention Period||2
6476504|NCT01286454|7393860|FG001|COMPLETED|Fifth Intervention Period||2
6747275|NCT03387046|7675108|FG000|STARTED|Overall Study||5
6747276|NCT03387046|7675109|FG001|STARTED|Overall Study||2
6747277|NCT03387046|7675108|FG000|COMPLETED|Overall Study||4
6747278|NCT03387046|7675109|FG001|COMPLETED|Overall Study||1
6476505|NCT01286454|7393861|FG002|COMPLETED|Fifth Intervention Period||2
6476506|NCT01286454|7393862|FG003|COMPLETED|Fifth Intervention Period||2
6476507|NCT01286454|7393863|FG004|COMPLETED|Fifth Intervention Period||2
6476508|NCT01286454|7393864|FG005|COMPLETED|Fifth Intervention Period||2
6476509|NCT01286454|7393865|FG006|COMPLETED|Fifth Intervention Period||2
6476510|NCT01286454|7393866|FG007|COMPLETED|Fifth Intervention Period||2
6476511|NCT01286454|7393867|FG008|COMPLETED|Fifth Intervention Period||2
6476512|NCT01286454|7393868|FG009|COMPLETED|Fifth Intervention Period||2
6476513|NCT01286454|7393869|FG010|COMPLETED|Fifth Intervention Period||0
6476514|NCT01286454|7393859|FG000|NOT COMPLETED|Fifth Intervention Period||0
6476515|NCT01286454|7393860|FG001|NOT COMPLETED|Fifth Intervention Period||0
6476516|NCT01286454|7393861|FG002|NOT COMPLETED|Fifth Intervention Period||0
6476517|NCT01286454|7393862|FG003|NOT COMPLETED|Fifth Intervention Period||0
6476518|NCT01286454|7393863|FG004|NOT COMPLETED|Fifth Intervention Period||0
6476519|NCT01286454|7393864|FG005|NOT COMPLETED|Fifth Intervention Period||0
6476520|NCT01286454|7393865|FG006|NOT COMPLETED|Fifth Intervention Period||0
6476521|NCT01286454|7393866|FG007|NOT COMPLETED|Fifth Intervention Period||0
6747279|NCT03387046|7675108|FG000|NOT COMPLETED|Overall Study||1
6747280|NCT03387046|7675109|FG001|NOT COMPLETED|Overall Study||1
6747281|NCT03387267|7675115|FG000|STARTED|Overall Study||452
6747282|NCT03387267|7675115|FG000|COMPLETED|Overall Study||438
6747283|NCT03387267|7675115|FG000|NOT COMPLETED|Overall Study||14
6779770|NCT03680911|7708015|FG000|COMPLETED|Visit 1 (Baseline)||3
6779771|NCT03680911|7708016|FG001|COMPLETED|Visit 1 (Baseline)||4
6779772|NCT03680911|7708015|FG000|NOT COMPLETED|Visit 1 (Baseline)||0
6779773|NCT03680911|7708016|FG001|NOT COMPLETED|Visit 1 (Baseline)||0
6779774|NCT03680911|7708015|FG000|STARTED|At Home Treatment||3
6779775|NCT03680911|7708016|FG001|STARTED|At Home Treatment||4
6779776|NCT03680911|7708015|FG000|COMPLETED|At Home Treatment||0
6779777|NCT03680911|7708016|FG001|COMPLETED|At Home Treatment||1
6779778|NCT03680911|7708015|FG000|NOT COMPLETED|At Home Treatment||3
6779779|NCT03680911|7708016|FG001|NOT COMPLETED|At Home Treatment||3
6779780|NCT03680911|7708015|FG000|STARTED|Visit 2 (1 Month Follow up)||0
6779781|NCT03680911|7708016|FG001|STARTED|Visit 2 (1 Month Follow up)||1
6779782|NCT03680911|7708015|FG000|COMPLETED|Visit 2 (1 Month Follow up)||0
6779783|NCT03680911|7708016|FG001|COMPLETED|Visit 2 (1 Month Follow up)||1
6779784|NCT03680911|7708015|FG000|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
6779785|NCT03680911|7708016|FG001|NOT COMPLETED|Visit 2 (1 Month Follow up)||0
6779786|NCT03680911|7708015|FG000|STARTED|Visit 3 (4 Month Follow up)||0
6779787|NCT03680911|7708016|FG001|STARTED|Visit 3 (4 Month Follow up)||1
6779788|NCT03680911|7708015|FG000|COMPLETED|Visit 3 (4 Month Follow up)||0
6779789|NCT03680911|7708016|FG001|COMPLETED|Visit 3 (4 Month Follow up)||0
6779790|NCT03680911|7708015|FG000|NOT COMPLETED|Visit 3 (4 Month Follow up)||0
6779791|NCT03680911|7708016|FG001|NOT COMPLETED|Visit 3 (4 Month Follow up)||1
6779792|NCT03656692|7708022|FG000|STARTED|Overall Study||5
6779793|NCT03656692|7708022|FG000|COMPLETED|Overall Study||2
6779794|NCT03656692|7708022|FG000|NOT COMPLETED|Overall Study||3
6779795|NCT03648983|7708026|FG000|STARTED|Overall Study||95
6779796|NCT03648983|7708026|FG000|COMPLETED|Overall Study||0
6779797|NCT03648983|7708026|FG000|NOT COMPLETED|Overall Study||95
6779798|NCT03643159|7708033|FG000|STARTED|Overall Study||2
6779799|NCT03643159|7708033|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||2
6779800|NCT03643159|7708033|FG000|COMPLETED|Overall Study||0
6779801|NCT03643159|7708033|FG000|NOT COMPLETED|Overall Study||2
6779802|NCT03632655|7708040|FG000|STARTED|Overall Study||22
6779803|NCT03632655|7708041|FG001|STARTED|Overall Study||16
6779804|NCT03632655|7708040|FG000|COMPLETED|Overall Study||0
6779805|NCT03632655|7708041|FG001|COMPLETED|Overall Study||0
6779806|NCT03632655|7708040|FG000|NOT COMPLETED|Overall Study||22
6779807|NCT03632655|7708041|FG001|NOT COMPLETED|Overall Study||16
6779808|NCT03630120|7708051|FG000|STARTED|Overall Study||2
6779809|NCT03630120|7708052|FG001|STARTED|Overall Study||2
6779810|NCT03630120|7708053|FG002|STARTED|Overall Study||1
6779811|NCT03630120|7708054|FG003|STARTED|Overall Study||1
6779812|NCT03630120|7708051|FG000|COMPLETED|Overall Study||2
6779813|NCT03630120|7708052|FG001|COMPLETED|Overall Study||1
6779814|NCT03630120|7708053|FG002|COMPLETED|Overall Study||0
6779815|NCT03630120|7708054|FG003|COMPLETED|Overall Study||0
6779816|NCT03630120|7708051|FG000|NOT COMPLETED|Overall Study||0
6779817|NCT03630120|7708052|FG001|NOT COMPLETED|Overall Study||1
6779818|NCT03630120|7708053|FG002|NOT COMPLETED|Overall Study||1
6779819|NCT03630120|7708054|FG003|NOT COMPLETED|Overall Study||1
6779820|NCT03621657|7708067|FG000|STARTED|Overall Study||0
6779821|NCT03621657|7708068|FG001|STARTED|Overall Study||0
6779822|NCT03621657|7708069|FG002|STARTED|Overall Study||1
6779823|NCT03621657|7708067|FG000|COMPLETED|Overall Study||0
6779824|NCT03621657|7708068|FG001|COMPLETED|Overall Study||0
6779825|NCT03621657|7708069|FG002|COMPLETED|Overall Study||1
6779826|NCT03621657|7708067|FG000|NOT COMPLETED|Overall Study||0
6779827|NCT03621657|7708068|FG001|NOT COMPLETED|Overall Study||0
6779828|NCT03621657|7708069|FG002|NOT COMPLETED|Overall Study||0
6779829|NCT03615144|7708081|FG000|STARTED|Overall Study||1
6779830|NCT03615144|7708082|FG001|STARTED|Overall Study||0
6779831|NCT03615144|7708081|FG000|COMPLETED|Overall Study||0
6779832|NCT03615144|7708082|FG001|COMPLETED|Overall Study||0
6779833|NCT03615144|7708081|FG000|NOT COMPLETED|Overall Study||1
6779834|NCT03615144|7708082|FG001|NOT COMPLETED|Overall Study||0
6779835|NCT03605303|7708088|FG000|STARTED|Period 1||2
6476522|NCT01286454|7393867|FG008|NOT COMPLETED|Fifth Intervention Period||0
6476523|NCT01286454|7393868|FG009|NOT COMPLETED|Fifth Intervention Period||0
6476524|NCT01286454|7393869|FG010|NOT COMPLETED|Fifth Intervention Period||0
6476525|NCT01286454|7393859|FG000|STARTED|Washout Period (Approximately 2 Weeks)||2
6476526|NCT01286454|7393860|FG001|STARTED|Washout Period (Approximately 2 Weeks)||2
6476527|NCT01286454|7393861|FG002|STARTED|Washout Period (Approximately 2 Weeks)||2
6476528|NCT01286454|7393862|FG003|STARTED|Washout Period (Approximately 2 Weeks)||2
6476529|NCT01286454|7393863|FG004|STARTED|Washout Period (Approximately 2 Weeks)||2
6476530|NCT01286454|7393864|FG005|STARTED|Washout Period (Approximately 2 Weeks)||2
6476531|NCT01286454|7393865|FG006|STARTED|Washout Period (Approximately 2 Weeks)||2
6476532|NCT01286454|7393866|FG007|STARTED|Washout Period (Approximately 2 Weeks)||2
6476533|NCT01286454|7393867|FG008|STARTED|Washout Period (Approximately 2 Weeks)||2
6476534|NCT01286454|7393868|FG009|STARTED|Washout Period (Approximately 2 Weeks)||2
6476535|NCT01286454|7393869|FG010|STARTED|Washout Period (Approximately 2 Weeks)||0
6747284|NCT03387319|7675122|FG000|STARTED|Overall Study||25
6747285|NCT03387319|7675123|FG001|STARTED|Overall Study||25
6747286|NCT03387319|7675122|FG000|COMPLETED|Overall Study||25
6747287|NCT03387319|7675123|FG001|COMPLETED|Overall Study||25
6747288|NCT03387319|7675122|FG000|NOT COMPLETED|Overall Study||0
6747289|NCT03387319|7675123|FG001|NOT COMPLETED|Overall Study||0
6747290|NCT03387462|7675129|FG000|STARTED|Overall Study||20
6747291|NCT03387462|7675129|FG000|4 Weeks|Overall Study||20
6476536|NCT01286454|7393859|FG000|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476537|NCT01286454|7393860|FG001|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476538|NCT01286454|7393861|FG002|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476539|NCT01286454|7393862|FG003|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476540|NCT01286454|7393863|FG004|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476541|NCT01286454|7393864|FG005|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476542|NCT01286454|7393865|FG006|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476543|NCT01286454|7393866|FG007|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476544|NCT01286454|7393867|FG008|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476545|NCT01286454|7393868|FG009|COMPLETED|Washout Period (Approximately 2 Weeks)||2
6476546|NCT01286454|7393869|FG010|COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476547|NCT01286454|7393859|FG000|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476548|NCT01286454|7393860|FG001|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476549|NCT01286454|7393861|FG002|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476550|NCT01286454|7393862|FG003|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476551|NCT01286454|7393863|FG004|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476552|NCT01286454|7393864|FG005|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476553|NCT01286454|7393865|FG006|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476554|NCT01286454|7393866|FG007|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476555|NCT01286454|7393867|FG008|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476556|NCT01286454|7393868|FG009|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476557|NCT01286454|7393869|FG010|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
6476558|NCT01286454|7393859|FG000|STARTED|Part II- Sixth Intervention Period||0
6476559|NCT01286454|7393860|FG001|STARTED|Part II- Sixth Intervention Period||0
6476560|NCT01286454|7393861|FG002|STARTED|Part II- Sixth Intervention Period||0
6476561|NCT01286454|7393862|FG003|STARTED|Part II- Sixth Intervention Period||0
6476562|NCT01286454|7393863|FG004|STARTED|Part II- Sixth Intervention Period||0
6476563|NCT01286454|7393864|FG005|STARTED|Part II- Sixth Intervention Period||0
6476564|NCT01286454|7393865|FG006|STARTED|Part II- Sixth Intervention Period||0
6476565|NCT01286454|7393866|FG007|STARTED|Part II- Sixth Intervention Period||0
6476566|NCT01286454|7393867|FG008|STARTED|Part II- Sixth Intervention Period||0
6476567|NCT01286454|7393868|FG009|STARTED|Part II- Sixth Intervention Period||0
6476568|NCT01286454|7393869|FG010|STARTED|Part II- Sixth Intervention Period||20
6476569|NCT01286454|7393859|FG000|COMPLETED|Part II- Sixth Intervention Period||0
6476570|NCT01286454|7393860|FG001|COMPLETED|Part II- Sixth Intervention Period||0
6476571|NCT01286454|7393861|FG002|COMPLETED|Part II- Sixth Intervention Period||0
6476572|NCT01286454|7393862|FG003|COMPLETED|Part II- Sixth Intervention Period||0
6476573|NCT01286454|7393863|FG004|COMPLETED|Part II- Sixth Intervention Period||0
6476574|NCT01286454|7393864|FG005|COMPLETED|Part II- Sixth Intervention Period||0
6476575|NCT01286454|7393865|FG006|COMPLETED|Part II- Sixth Intervention Period||0
6476576|NCT01286454|7393866|FG007|COMPLETED|Part II- Sixth Intervention Period||0
6476577|NCT01286454|7393867|FG008|COMPLETED|Part II- Sixth Intervention Period||0
6476578|NCT01286454|7393868|FG009|COMPLETED|Part II- Sixth Intervention Period||0
6476579|NCT01286454|7393869|FG010|COMPLETED|Part II- Sixth Intervention Period||20
6476580|NCT01286454|7393859|FG000|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476581|NCT01286454|7393860|FG001|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476582|NCT01286454|7393861|FG002|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476583|NCT01286454|7393862|FG003|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476584|NCT01286454|7393863|FG004|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476585|NCT01286454|7393864|FG005|NOT COMPLETED|Part II- Sixth Intervention Period||0
6747292|NCT03387462|7675129|FG000|8 Weeks|Overall Study||19
6747293|NCT03387462|7675129|FG000|COMPLETED|Overall Study||19
6747294|NCT03387462|7675129|FG000|NOT COMPLETED|Overall Study||1
6747295|NCT03387683|7675135|FG000|STARTED|Overall Study||27
6476586|NCT01286454|7393865|FG006|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476587|NCT01286454|7393866|FG007|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476588|NCT01286454|7393867|FG008|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476589|NCT01286454|7393868|FG009|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476590|NCT01286454|7393869|FG010|NOT COMPLETED|Part II- Sixth Intervention Period||0
6476591|NCT01286480|7393885|FG000|STARTED|Overall Study||32
6476592|NCT01286480|7393886|FG001|STARTED|Overall Study||34
6476593|NCT01286480|7393885|FG000|COMPLETED|Overall Study||27
6476594|NCT01286480|7393886|FG001|COMPLETED|Overall Study||31
6476595|NCT01286480|7393885|FG000|NOT COMPLETED|Overall Study||5
6476596|NCT01286480|7393886|FG001|NOT COMPLETED|Overall Study||3
6476597|NCT01286493|7393892|FG000|STARTED|Overall Study||33
6476598|NCT01286493|7393892|FG000|COMPLETED|Overall Study||30
6476599|NCT01286493|7393892|FG000|NOT COMPLETED|Overall Study||3
6476600|NCT01286558|7393898|FG000|STARTED|Overall Study||112
6476601|NCT01286558|7393899|FG001|STARTED|Overall Study||113
6476602|NCT01286558|7393898|FG000|COMPLETED|Overall Study||111
6476603|NCT01286558|7393899|FG001|COMPLETED|Overall Study||111
6476604|NCT01286558|7393898|FG000|NOT COMPLETED|Overall Study||1
6476605|NCT01286558|7393899|FG001|NOT COMPLETED|Overall Study||2
6476606|NCT01286740|7393905|FG000|STARTED|Overall Study||50
6476607|NCT01286740|7393905|FG000|Enrolled and Treated|Overall Study||49
6476608|NCT01286740|7393905|FG000|Week 12 (Primary Endpoint)|Overall Study||49
6476609|NCT01286740|7393905|FG000|COMPLETED|Overall Study||48
6476610|NCT01286740|7393905|FG000|NOT COMPLETED|Overall Study||2
6476611|NCT01286753|7393911|FG000|STARTED|Overall Study||26
6476612|NCT01286753|7393912|FG001|STARTED|Overall Study||25
6476613|NCT01286753|7393911|FG000|COMPLETED|Overall Study||0
6476614|NCT01286753|7393912|FG001|COMPLETED|Overall Study||0
6476615|NCT01286753|7393911|FG000|NOT COMPLETED|Overall Study||26
6476616|NCT01286753|7393912|FG001|NOT COMPLETED|Overall Study||25
6476617|NCT01286779|7393919|FG000|STARTED|Overall Study||115
6476618|NCT01286779|7393919|FG000|COMPLETED|Overall Study||96
6476619|NCT01286779|7393919|FG000|NOT COMPLETED|Overall Study||19
6476620|NCT01286805|7393935|FG000|STARTED|Overall Study||41
6476621|NCT01286805|7393936|FG001|STARTED|Overall Study||42
6476622|NCT01286805|7393935|FG000|COMPLETED|Overall Study||41
6476623|NCT01286805|7393936|FG001|COMPLETED|Overall Study||41
6476624|NCT01286805|7393935|FG000|NOT COMPLETED|Overall Study||0
6476625|NCT01286805|7393936|FG001|NOT COMPLETED|Overall Study||1
6476626|NCT01286818|7393942|FG000|STARTED|Overall Study||6
6476627|NCT01286818|7393942|FG000|Completed DLT Assessment Period|Overall Study||5
6476628|NCT01286818|7393942|FG000|COMPLETED|Overall Study||6
6476629|NCT01286818|7393942|FG000|NOT COMPLETED|Overall Study||0
6476630|NCT01286870|7393946|FG000|STARTED|Overall Study||11
6476631|NCT01286870|7393946|FG000|COMPLETED|Overall Study||11
6476632|NCT01286870|7393946|FG000|NOT COMPLETED|Overall Study||0
6476633|NCT01286987|7393965|FG000|STARTED|Part 1: Dose Escalation||3
6476634|NCT01286987|7393966|FG001|STARTED|Part 1: Dose Escalation||3
6476635|NCT01286987|7393967|FG002|STARTED|Part 1: Dose Escalation||3
6476636|NCT01286987|7393968|FG003|STARTED|Part 1: Dose Escalation||3
6476637|NCT01286987|7393969|FG004|STARTED|Part 1: Dose Escalation||3
6476638|NCT01286987|7393970|FG005|STARTED|Part 1: Dose Escalation||6
6476639|NCT01286987|7393971|FG006|STARTED|Part 1: Dose Escalation||6
6476640|NCT01286987|7393972|FG007|STARTED|Part 1: Dose Escalation||6
6476641|NCT01286987|7393973|FG008|STARTED|Part 1: Dose Escalation||6
6476642|NCT01286987|7393974|FG009|STARTED|Part 1: Dose Escalation||0
6476643|NCT01286987|7393975|FG010|STARTED|Part 1: Dose Escalation||0
6476644|NCT01286987|7393976|FG011|STARTED|Part 1: Dose Escalation||0
6476645|NCT01286987|7393977|FG012|STARTED|Part 1: Dose Escalation||0
6476646|NCT01286987|7393978|FG013|STARTED|Part 1: Dose Escalation||0
6476647|NCT01286987|7393979|FG014|STARTED|Part 1: Dose Escalation||0
6476648|NCT01286987|7393965|FG000|Colorectal Cancer|Part 1: Dose Escalation||1
6476649|NCT01286987|7393966|FG001|Colorectal Cancer|Part 1: Dose Escalation||0
6476650|NCT01286987|7393967|FG002|Colorectal Cancer|Part 1: Dose Escalation||1
6476651|NCT01286987|7393968|FG003|Colorectal Cancer|Part 1: Dose Escalation||0
6476652|NCT01286987|7393969|FG004|Colorectal Cancer|Part 1: Dose Escalation||0
6476653|NCT01286987|7393970|FG005|Colorectal Cancer|Part 1: Dose Escalation||0
6476654|NCT01286987|7393971|FG006|Colorectal Cancer|Part 1: Dose Escalation||0
6476655|NCT01286987|7393972|FG007|Colorectal Cancer|Part 1: Dose Escalation||0
6476656|NCT01286987|7393973|FG008|Colorectal Cancer|Part 1: Dose Escalation||0
6476657|NCT01286987|7393974|FG009|Colorectal Cancer|Part 1: Dose Escalation||0
6476658|NCT01286987|7393975|FG010|Colorectal Cancer|Part 1: Dose Escalation||0
6476659|NCT01286987|7393976|FG011|Colorectal Cancer|Part 1: Dose Escalation||0
6476660|NCT01286987|7393977|FG012|Colorectal Cancer|Part 1: Dose Escalation||0
6476661|NCT01286987|7393978|FG013|Colorectal Cancer|Part 1: Dose Escalation||0
6476662|NCT01286987|7393979|FG014|Colorectal Cancer|Part 1: Dose Escalation||0
6476663|NCT01286987|7393965|FG000|Prostate Cancer|Part 1: Dose Escalation||0
6476664|NCT01286987|7393966|FG001|Prostate Cancer|Part 1: Dose Escalation||0
6476665|NCT01286987|7393967|FG002|Prostate Cancer|Part 1: Dose Escalation||0
6476666|NCT01286987|7393968|FG003|Prostate Cancer|Part 1: Dose Escalation||0
6476667|NCT01286987|7393969|FG004|Prostate Cancer|Part 1: Dose Escalation||0
6476668|NCT01286987|7393970|FG005|Prostate Cancer|Part 1: Dose Escalation||1
6476669|NCT01286987|7393971|FG006|Prostate Cancer|Part 1: Dose Escalation||0
6476670|NCT01286987|7393972|FG007|Prostate Cancer|Part 1: Dose Escalation||0
6476671|NCT01286987|7393973|FG008|Prostate Cancer|Part 1: Dose Escalation||0
6476672|NCT01286987|7393974|FG009|Prostate Cancer|Part 1: Dose Escalation||0
6476673|NCT01286987|7393975|FG010|Prostate Cancer|Part 1: Dose Escalation||0
6476674|NCT01286987|7393976|FG011|Prostate Cancer|Part 1: Dose Escalation||0
6476675|NCT01286987|7393977|FG012|Prostate Cancer|Part 1: Dose Escalation||0
6476676|NCT01286987|7393978|FG013|Prostate Cancer|Part 1: Dose Escalation||0
6476677|NCT01286987|7393979|FG014|Prostate Cancer|Part 1: Dose Escalation||0
6476678|NCT01286987|7393965|FG000|Ewing Cancer|Part 1: Dose Escalation||0
6476679|NCT01286987|7393966|FG001|Ewing Cancer|Part 1: Dose Escalation||0
6476680|NCT01286987|7393967|FG002|Ewing Cancer|Part 1: Dose Escalation||0
6554591|NCT01747915|7476752|FG002|COMPLETED|Overall Study||66
6554592|NCT01747915|7476750|FG000|NOT COMPLETED|Overall Study||15
6554593|NCT01747915|7476751|FG001|NOT COMPLETED|Overall Study||11
6554594|NCT01747915|7476752|FG002|NOT COMPLETED|Overall Study||6
6554595|NCT01747928|7476768|FG000|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6554596|NCT01747928|7476769|FG001|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6554597|NCT01747928|7476770|FG002|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6554598|NCT01747928|7476771|FG003|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6476681|NCT01286987|7393968|FG003|Ewing Cancer|Part 1: Dose Escalation||0
6476682|NCT01286987|7393969|FG004|Ewing Cancer|Part 1: Dose Escalation||0
6476683|NCT01286987|7393970|FG005|Ewing Cancer|Part 1: Dose Escalation||0
6476684|NCT01286987|7393971|FG006|Ewing Cancer|Part 1: Dose Escalation||0
6476685|NCT01286987|7393972|FG007|Ewing Cancer|Part 1: Dose Escalation||1
6476686|NCT01286987|7393973|FG008|Ewing Cancer|Part 1: Dose Escalation||1
6476687|NCT01286987|7393974|FG009|Ewing Cancer|Part 1: Dose Escalation||0
6476688|NCT01286987|7393975|FG010|Ewing Cancer|Part 1: Dose Escalation||0
6476689|NCT01286987|7393976|FG011|Ewing Cancer|Part 1: Dose Escalation||0
6476690|NCT01286987|7393977|FG012|Ewing Cancer|Part 1: Dose Escalation||0
6476691|NCT01286987|7393978|FG013|Ewing Cancer|Part 1: Dose Escalation||0
6476692|NCT01286987|7393979|FG014|Ewing Cancer|Part 1: Dose Escalation||0
6476693|NCT01286987|7393965|FG000|Pancreatic Cancer|Part 1: Dose Escalation||1
6476694|NCT01286987|7393966|FG001|Pancreatic Cancer|Part 1: Dose Escalation||2
6476695|NCT01286987|7393967|FG002|Pancreatic Cancer|Part 1: Dose Escalation||0
6476696|NCT01286987|7393968|FG003|Pancreatic Cancer|Part 1: Dose Escalation||0
6476697|NCT01286987|7393969|FG004|Pancreatic Cancer|Part 1: Dose Escalation||0
6476698|NCT01286987|7393970|FG005|Pancreatic Cancer|Part 1: Dose Escalation||0
6476699|NCT01286987|7393971|FG006|Pancreatic Cancer|Part 1: Dose Escalation||0
6476700|NCT01286987|7393972|FG007|Pancreatic Cancer|Part 1: Dose Escalation||0
6476701|NCT01286987|7393973|FG008|Pancreatic Cancer|Part 1: Dose Escalation||0
6476702|NCT01286987|7393974|FG009|Pancreatic Cancer|Part 1: Dose Escalation||0
6476703|NCT01286987|7393975|FG010|Pancreatic Cancer|Part 1: Dose Escalation||0
6476704|NCT01286987|7393976|FG011|Pancreatic Cancer|Part 1: Dose Escalation||0
6476705|NCT01286987|7393977|FG012|Pancreatic Cancer|Part 1: Dose Escalation||0
6476706|NCT01286987|7393978|FG013|Pancreatic Cancer|Part 1: Dose Escalation||0
6476707|NCT01286987|7393979|FG014|Pancreatic Cancer|Part 1: Dose Escalation||0
6476708|NCT01286987|7393965|FG000|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
6476709|NCT01286987|7393966|FG001|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||1
6476710|NCT01286987|7393967|FG002|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
6476711|NCT01286987|7393968|FG003|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
6476712|NCT01286987|7393969|FG004|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
6476713|NCT01286987|7393970|FG005|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
6476714|NCT01286987|7393971|FG006|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||4
6476715|NCT01286987|7393972|FG007|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||3
6476716|NCT01286987|7393973|FG008|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||2
6476717|NCT01286987|7393974|FG009|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6476718|NCT01286987|7393975|FG010|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6476719|NCT01286987|7393976|FG011|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6476720|NCT01286987|7393977|FG012|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6476721|NCT01286987|7393978|FG013|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6476722|NCT01286987|7393979|FG014|Ovarian/ Peritoneal Cancer|Part 1: Dose Escalation||0
6476723|NCT01286987|7393965|FG000|Breast Cancer|Part 1: Dose Escalation||0
6476724|NCT01286987|7393966|FG001|Breast Cancer|Part 1: Dose Escalation||0
6476725|NCT01286987|7393967|FG002|Breast Cancer|Part 1: Dose Escalation||0
6476726|NCT01286987|7393968|FG003|Breast Cancer|Part 1: Dose Escalation||0
6476727|NCT01286987|7393969|FG004|Breast Cancer|Part 1: Dose Escalation||0
6476728|NCT01286987|7393970|FG005|Breast Cancer|Part 1: Dose Escalation||1
6476729|NCT01286987|7393971|FG006|Breast Cancer|Part 1: Dose Escalation||2
6476730|NCT01286987|7393972|FG007|Breast Cancer|Part 1: Dose Escalation||2
6476731|NCT01286987|7393973|FG008|Breast Cancer|Part 1: Dose Escalation||3
6476732|NCT01286987|7393974|FG009|Breast Cancer|Part 1: Dose Escalation||0
6476733|NCT01286987|7393975|FG010|Breast Cancer|Part 1: Dose Escalation||0
6476734|NCT01286987|7393976|FG011|Breast Cancer|Part 1: Dose Escalation||0
6476735|NCT01286987|7393977|FG012|Breast Cancer|Part 1: Dose Escalation||0
6476736|NCT01286987|7393978|FG013|Breast Cancer|Part 1: Dose Escalation||0
6476737|NCT01286987|7393979|FG014|Breast Cancer|Part 1: Dose Escalation||0
6476738|NCT01286987|7393965|FG000|COMPLETED|Part 1: Dose Escalation||0
6476739|NCT01286987|7393966|FG001|COMPLETED|Part 1: Dose Escalation||0
6554599|NCT01747928|7476772|FG004|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6476740|NCT01286987|7393967|FG002|COMPLETED|Part 1: Dose Escalation||0
6476741|NCT01286987|7393968|FG003|COMPLETED|Part 1: Dose Escalation||0
6476742|NCT01286987|7393969|FG004|COMPLETED|Part 1: Dose Escalation||0
6476743|NCT01286987|7393970|FG005|COMPLETED|Part 1: Dose Escalation||0
6476744|NCT01286987|7393971|FG006|COMPLETED|Part 1: Dose Escalation||1
6476745|NCT01286987|7393972|FG007|COMPLETED|Part 1: Dose Escalation||1
6476746|NCT01286987|7393973|FG008|COMPLETED|Part 1: Dose Escalation||0
6476747|NCT01286987|7393974|FG009|COMPLETED|Part 1: Dose Escalation||0
6476748|NCT01286987|7393975|FG010|COMPLETED|Part 1: Dose Escalation||0
6476749|NCT01286987|7393976|FG011|COMPLETED|Part 1: Dose Escalation||0
6476750|NCT01286987|7393977|FG012|COMPLETED|Part 1: Dose Escalation||0
6476751|NCT01286987|7393978|FG013|COMPLETED|Part 1: Dose Escalation||0
6476752|NCT01286987|7393979|FG014|COMPLETED|Part 1: Dose Escalation||0
6476753|NCT01286987|7393965|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
6476754|NCT01286987|7393966|FG001|NOT COMPLETED|Part 1: Dose Escalation||3
6476755|NCT01286987|7393967|FG002|NOT COMPLETED|Part 1: Dose Escalation||3
6476756|NCT01286987|7393968|FG003|NOT COMPLETED|Part 1: Dose Escalation||3
6476757|NCT01286987|7393969|FG004|NOT COMPLETED|Part 1: Dose Escalation||3
6476758|NCT01286987|7393970|FG005|NOT COMPLETED|Part 1: Dose Escalation||6
6476759|NCT01286987|7393971|FG006|NOT COMPLETED|Part 1: Dose Escalation||5
6476760|NCT01286987|7393972|FG007|NOT COMPLETED|Part 1: Dose Escalation||5
6476761|NCT01286987|7393973|FG008|NOT COMPLETED|Part 1: Dose Escalation||6
6476762|NCT01286987|7393974|FG009|NOT COMPLETED|Part 1: Dose Escalation||0
6476763|NCT01286987|7393975|FG010|NOT COMPLETED|Part 1: Dose Escalation||0
6476764|NCT01286987|7393976|FG011|NOT COMPLETED|Part 1: Dose Escalation||0
6476765|NCT01286987|7393977|FG012|NOT COMPLETED|Part 1: Dose Escalation||0
6476766|NCT01286987|7393978|FG013|NOT COMPLETED|Part 1: Dose Escalation||0
6476767|NCT01286987|7393979|FG014|NOT COMPLETED|Part 1: Dose Escalation||0
6476768|NCT01286987|7393965|FG000|STARTED|Part 2: Dose Expansion||0
6476769|NCT01286987|7393966|FG001|STARTED|Part 2: Dose Expansion||0
6476770|NCT01286987|7393967|FG002|STARTED|Part 2: Dose Expansion||0
6476771|NCT01286987|7393968|FG003|STARTED|Part 2: Dose Expansion||0
6476772|NCT01286987|7393969|FG004|STARTED|Part 2: Dose Expansion||0
6476773|NCT01286987|7393970|FG005|STARTED|Part 2: Dose Expansion||0
6476774|NCT01286987|7393971|FG006|STARTED|Part 2: Dose Expansion||0
6747296|NCT03387683|7675136|FG001|STARTED|Overall Study||26
6747297|NCT03387683|7675135|FG000|COMPLETED|Overall Study||25
6747298|NCT03387683|7675136|FG001|COMPLETED|Overall Study||26
6747299|NCT03387683|7675135|FG000|NOT COMPLETED|Overall Study||2
6747300|NCT03387683|7675136|FG001|NOT COMPLETED|Overall Study||0
6747301|NCT03388008|7675144|FG000|STARTED|Overall Study||14
6747302|NCT03388008|7675145|FG001|STARTED|Overall Study||13
6747303|NCT03388008|7675144|FG000|COMPLETED|Overall Study||14
6747304|NCT03388008|7675145|FG001|COMPLETED|Overall Study||13
6747305|NCT03388008|7675144|FG000|NOT COMPLETED|Overall Study||0
6747306|NCT03388008|7675145|FG001|NOT COMPLETED|Overall Study||0
6747307|NCT03388164|7675153|FG000|STARTED|Overall Study||10
6747308|NCT03388164|7675154|FG001|STARTED|Overall Study||10
6747309|NCT03388164|7675153|FG000|COMPLETED|Overall Study||7
6747310|NCT03388164|7675154|FG001|COMPLETED|Overall Study||9
6747311|NCT03388164|7675153|FG000|NOT COMPLETED|Overall Study||3
6747312|NCT03388164|7675154|FG001|NOT COMPLETED|Overall Study||1
6747313|NCT03388268|7675162|FG000|STARTED|Overall Study||8
6747314|NCT03388268|7675163|FG001|STARTED|Overall Study||7
6747315|NCT03388268|7675162|FG000|COMPLETED|Overall Study||7
6747316|NCT03388268|7675163|FG001|COMPLETED|Overall Study||4
6747317|NCT03388268|7675162|FG000|NOT COMPLETED|Overall Study||1
6747318|NCT03388268|7675163|FG001|NOT COMPLETED|Overall Study||3
6747319|NCT03388294|7675171|FG000|STARTED|Overall Study||42
6747320|NCT03388294|7675172|FG001|STARTED|Overall Study||30
6747321|NCT03388294|7675171|FG000|Posttest 1|Overall Study||38
6747322|NCT03388294|7675172|FG001|Posttest 1|Overall Study||30
6747323|NCT03388294|7675171|FG000|Posttest 2|Overall Study||38
6747324|NCT03388294|7675172|FG001|Posttest 2|Overall Study||30
6747325|NCT03388294|7675171|FG000|COMPLETED|Overall Study||38
6747326|NCT03388294|7675172|FG001|COMPLETED|Overall Study||30
6747327|NCT03388294|7675171|FG000|NOT COMPLETED|Overall Study||4
6747328|NCT03388294|7675172|FG001|NOT COMPLETED|Overall Study||0
6747329|NCT03388645|7675180|FG000|STARTED|Low Dose RSV A2||4
6747330|NCT03388645|7675181|FG001|STARTED|Low Dose RSV A2||0
6747331|NCT03388645|7675180|FG000|COMPLETED|Low Dose RSV A2||4
6747332|NCT03388645|7675181|FG001|COMPLETED|Low Dose RSV A2||0
6747333|NCT03388645|7675180|FG000|NOT COMPLETED|Low Dose RSV A2||0
6747334|NCT03388645|7675181|FG001|NOT COMPLETED|Low Dose RSV A2||0
6747335|NCT03388645|7675180|FG000|STARTED|High Dose RSV A2||0
6747336|NCT03388645|7675181|FG001|STARTED|High Dose RSV A2||8
6747337|NCT03388645|7675180|FG000|COMPLETED|High Dose RSV A2||0
6747338|NCT03388645|7675181|FG001|COMPLETED|High Dose RSV A2||7
6747339|NCT03388645|7675180|FG000|NOT COMPLETED|High Dose RSV A2||0
6747340|NCT03388645|7675181|FG001|NOT COMPLETED|High Dose RSV A2||1
6747341|NCT03389308|7675187|FG000|STARTED|Overall Study||51
6747342|NCT03389308|7675187|FG000|COMPLETED|Overall Study||39
6476775|NCT01286987|7393972|FG007|STARTED|Part 2: Dose Expansion||0
6476776|NCT01286987|7393973|FG008|STARTED|Part 2: Dose Expansion||0
6476777|NCT01286987|7393974|FG009|STARTED|Part 2: Dose Expansion||12
6476778|NCT01286987|7393975|FG010|STARTED|Part 2: Dose Expansion||12
6476779|NCT01286987|7393976|FG011|STARTED|Part 2: Dose Expansion||11
6476780|NCT01286987|7393977|FG012|STARTED|Part 2: Dose Expansion||12
6747343|NCT03389308|7675187|FG000|NOT COMPLETED|Overall Study||12
6747344|NCT03389555|7675193|FG000|STARTED|Overall Study||103
6476781|NCT01286987|7393978|FG013|STARTED|Part 2: Dose Expansion||24
6476782|NCT01286987|7393979|FG014|STARTED|Part 2: Dose Expansion||3
6476783|NCT01286987|7393965|FG000|Treated|Part 2: Dose Expansion||0
6476784|NCT01286987|7393966|FG001|Treated|Part 2: Dose Expansion||0
6476785|NCT01286987|7393967|FG002|Treated|Part 2: Dose Expansion||0
6476786|NCT01286987|7393968|FG003|Treated|Part 2: Dose Expansion||0
6476787|NCT01286987|7393969|FG004|Treated|Part 2: Dose Expansion||0
6476788|NCT01286987|7393970|FG005|Treated|Part 2: Dose Expansion||0
6476789|NCT01286987|7393971|FG006|Treated|Part 2: Dose Expansion||0
6476790|NCT01286987|7393972|FG007|Treated|Part 2: Dose Expansion||0
6476791|NCT01286987|7393973|FG008|Treated|Part 2: Dose Expansion||0
6476792|NCT01286987|7393974|FG009|Treated|Part 2: Dose Expansion||12
6476793|NCT01286987|7393975|FG010|Treated|Part 2: Dose Expansion||11
6476794|NCT01286987|7393976|FG011|Treated|Part 2: Dose Expansion||10
6476795|NCT01286987|7393977|FG012|Treated|Part 2: Dose Expansion||12
6476796|NCT01286987|7393978|FG013|Treated|Part 2: Dose Expansion||23
6476797|NCT01286987|7393979|FG014|Treated|Part 2: Dose Expansion||3
6476798|NCT01286987|7393965|FG000|COMPLETED|Part 2: Dose Expansion||0
6476799|NCT01286987|7393966|FG001|COMPLETED|Part 2: Dose Expansion||0
6476800|NCT01286987|7393967|FG002|COMPLETED|Part 2: Dose Expansion||0
6476801|NCT01286987|7393968|FG003|COMPLETED|Part 2: Dose Expansion||0
6476802|NCT01286987|7393969|FG004|COMPLETED|Part 2: Dose Expansion||0
6476803|NCT01286987|7393970|FG005|COMPLETED|Part 2: Dose Expansion||0
6476804|NCT01286987|7393971|FG006|COMPLETED|Part 2: Dose Expansion||0
6476805|NCT01286987|7393972|FG007|COMPLETED|Part 2: Dose Expansion||0
6476806|NCT01286987|7393973|FG008|COMPLETED|Part 2: Dose Expansion||0
6476807|NCT01286987|7393974|FG009|COMPLETED|Part 2: Dose Expansion||1
6476808|NCT01286987|7393975|FG010|COMPLETED|Part 2: Dose Expansion||2
6476809|NCT01286987|7393976|FG011|COMPLETED|Part 2: Dose Expansion||1
6476810|NCT01286987|7393977|FG012|COMPLETED|Part 2: Dose Expansion||0
6476811|NCT01286987|7393978|FG013|COMPLETED|Part 2: Dose Expansion||0
6476812|NCT01286987|7393979|FG014|COMPLETED|Part 2: Dose Expansion||1
6476813|NCT01286987|7393965|FG000|NOT COMPLETED|Part 2: Dose Expansion||0
6476814|NCT01286987|7393966|FG001|NOT COMPLETED|Part 2: Dose Expansion||0
6476815|NCT01286987|7393967|FG002|NOT COMPLETED|Part 2: Dose Expansion||0
6476816|NCT01286987|7393968|FG003|NOT COMPLETED|Part 2: Dose Expansion||0
6476817|NCT01286987|7393969|FG004|NOT COMPLETED|Part 2: Dose Expansion||0
6476818|NCT01286987|7393970|FG005|NOT COMPLETED|Part 2: Dose Expansion||0
6476819|NCT01286987|7393971|FG006|NOT COMPLETED|Part 2: Dose Expansion||0
6476820|NCT01286987|7393972|FG007|NOT COMPLETED|Part 2: Dose Expansion||0
6476821|NCT01286987|7393973|FG008|NOT COMPLETED|Part 2: Dose Expansion||0
6476822|NCT01286987|7393974|FG009|NOT COMPLETED|Part 2: Dose Expansion||11
6476823|NCT01286987|7393975|FG010|NOT COMPLETED|Part 2: Dose Expansion||10
6476824|NCT01286987|7393976|FG011|NOT COMPLETED|Part 2: Dose Expansion||10
6476825|NCT01286987|7393977|FG012|NOT COMPLETED|Part 2: Dose Expansion||12
6476826|NCT01286987|7393978|FG013|NOT COMPLETED|Part 2: Dose Expansion||24
6476827|NCT01286987|7393979|FG014|NOT COMPLETED|Part 2: Dose Expansion||2
6476828|NCT01287013|7394023|FG000|STARTED|Overall Study||32
6476829|NCT01287013|7394024|FG001|STARTED|Overall Study||34
6747345|NCT03389555|7675194|FG001|STARTED|Overall Study||102
6747346|NCT03389555|7675193|FG000|COMPLETED|Overall Study||101
6747347|NCT03389555|7675194|FG001|COMPLETED|Overall Study||99
6747348|NCT03389555|7675193|FG000|NOT COMPLETED|Overall Study||2
6747349|NCT03389555|7675194|FG001|NOT COMPLETED|Overall Study||3
6747350|NCT03389854|7675204|FG000|STARTED|Overall Study||28
6747351|NCT03389854|7675205|FG001|STARTED|Overall Study||27
6747352|NCT03389854|7675206|FG002|STARTED|Overall Study||28
6747353|NCT03389854|7675207|FG003|STARTED|Overall Study||27
6747354|NCT03389854|7675204|FG000|COMPLETED|Overall Study||27
6747355|NCT03389854|7675205|FG001|COMPLETED|Overall Study||21
6747356|NCT03389854|7675206|FG002|COMPLETED|Overall Study||23
6747357|NCT03389854|7675207|FG003|COMPLETED|Overall Study||19
6747358|NCT03389854|7675204|FG000|NOT COMPLETED|Overall Study||1
6747359|NCT03389854|7675205|FG001|NOT COMPLETED|Overall Study||6
6747360|NCT03389854|7675206|FG002|NOT COMPLETED|Overall Study||5
6747361|NCT03389854|7675207|FG003|NOT COMPLETED|Overall Study||8
6747362|NCT03389893|7675223|FG000|STARTED|Randomized Double Blind Period||46
6747363|NCT03389893|7675224|FG001|STARTED|Randomized Double Blind Period||26
6747364|NCT03389893|7675225|FG002|STARTED|Randomized Double Blind Period||0
6747365|NCT03389893|7675226|FG003|STARTED|Randomized Double Blind Period||0
6747366|NCT03389893|7675223|FG000|COMPLETED|Randomized Double Blind Period||45
6476830|NCT01287013|7394025|FG002|STARTED|Overall Study||21
6476831|NCT01287013|7394023|FG000|COMPLETED|Overall Study||29
6476832|NCT01287013|7394024|FG001|COMPLETED|Overall Study||29
6747367|NCT03389893|7675224|FG001|COMPLETED|Randomized Double Blind Period||26
6747368|NCT03389893|7675225|FG002|COMPLETED|Randomized Double Blind Period||0
6747369|NCT03389893|7675226|FG003|COMPLETED|Randomized Double Blind Period||0
6476833|NCT01287013|7394025|FG002|COMPLETED|Overall Study||0
6476834|NCT01287013|7394023|FG000|NOT COMPLETED|Overall Study||3
6476835|NCT01287013|7394024|FG001|NOT COMPLETED|Overall Study||5
6476836|NCT01287013|7394025|FG002|NOT COMPLETED|Overall Study||21
6476837|NCT01287039|7394035|FG000|STARTED|Overall Study||244
6476838|NCT01287039|7394036|FG001|STARTED|Overall Study||245
6476839|NCT01287039|7394035|FG000|COMPLETED|Overall Study||215
6476840|NCT01287039|7394036|FG001|COMPLETED|Overall Study||218
6476841|NCT01287039|7394035|FG000|NOT COMPLETED|Overall Study||29
6476842|NCT01287039|7394036|FG001|NOT COMPLETED|Overall Study||27
6476843|NCT01287065|7394042|FG000|STARTED|Treatment Period 1||4
6476844|NCT01287065|7394043|FG001|STARTED|Treatment Period 1||4
6476845|NCT01287065|7394044|FG002|STARTED|Treatment Period 1||4
6476846|NCT01287065|7394045|FG003|STARTED|Treatment Period 1||4
6476847|NCT01287065|7394046|FG004|STARTED|Treatment Period 1||5
6476848|NCT01287065|7394047|FG005|STARTED|Treatment Period 1||5
6476849|NCT01287065|7394042|FG000|COMPLETED|Treatment Period 1||4
6476850|NCT01287065|7394043|FG001|COMPLETED|Treatment Period 1||4
6476851|NCT01287065|7394044|FG002|COMPLETED|Treatment Period 1||4
6476852|NCT01287065|7394045|FG003|COMPLETED|Treatment Period 1||4
6476853|NCT01287065|7394046|FG004|COMPLETED|Treatment Period 1||4
6476854|NCT01287065|7394047|FG005|COMPLETED|Treatment Period 1||4
6476855|NCT01287065|7394042|FG000|NOT COMPLETED|Treatment Period 1||0
6476856|NCT01287065|7394043|FG001|NOT COMPLETED|Treatment Period 1||0
6476857|NCT01287065|7394044|FG002|NOT COMPLETED|Treatment Period 1||0
6476858|NCT01287065|7394045|FG003|NOT COMPLETED|Treatment Period 1||0
6476859|NCT01287065|7394046|FG004|NOT COMPLETED|Treatment Period 1||1
6476860|NCT01287065|7394047|FG005|NOT COMPLETED|Treatment Period 1||1
6476861|NCT01287065|7394042|FG000|STARTED|Washout Period 1||4
6476862|NCT01287065|7394043|FG001|STARTED|Washout Period 1||4
6476863|NCT01287065|7394044|FG002|STARTED|Washout Period 1||4
6476864|NCT01287065|7394045|FG003|STARTED|Washout Period 1||4
6476865|NCT01287065|7394046|FG004|STARTED|Washout Period 1||4
6476866|NCT01287065|7394047|FG005|STARTED|Washout Period 1||4
6476867|NCT01287065|7394042|FG000|COMPLETED|Washout Period 1||4
6476868|NCT01287065|7394043|FG001|COMPLETED|Washout Period 1||4
6476869|NCT01287065|7394044|FG002|COMPLETED|Washout Period 1||4
6476870|NCT01287065|7394045|FG003|COMPLETED|Washout Period 1||4
6476871|NCT01287065|7394046|FG004|COMPLETED|Washout Period 1||4
6476872|NCT01287065|7394047|FG005|COMPLETED|Washout Period 1||4
6476873|NCT01287065|7394042|FG000|NOT COMPLETED|Washout Period 1||0
6476874|NCT01287065|7394043|FG001|NOT COMPLETED|Washout Period 1||0
6476875|NCT01287065|7394044|FG002|NOT COMPLETED|Washout Period 1||0
6476876|NCT01287065|7394045|FG003|NOT COMPLETED|Washout Period 1||0
6476877|NCT01287065|7394046|FG004|NOT COMPLETED|Washout Period 1||0
6476878|NCT01287065|7394047|FG005|NOT COMPLETED|Washout Period 1||0
6476879|NCT01287065|7394042|FG000|STARTED|Treatment Period 2||4
6476880|NCT01287065|7394043|FG001|STARTED|Treatment Period 2||4
6476881|NCT01287065|7394044|FG002|STARTED|Treatment Period 2||4
6476882|NCT01287065|7394045|FG003|STARTED|Treatment Period 2||4
6476883|NCT01287065|7394046|FG004|STARTED|Treatment Period 2||4
6476884|NCT01287065|7394047|FG005|STARTED|Treatment Period 2||4
6476885|NCT01287065|7394042|FG000|COMPLETED|Treatment Period 2||4
6476886|NCT01287065|7394043|FG001|COMPLETED|Treatment Period 2||4
6476887|NCT01287065|7394044|FG002|COMPLETED|Treatment Period 2||4
6476888|NCT01287065|7394045|FG003|COMPLETED|Treatment Period 2||4
6476889|NCT01287065|7394046|FG004|COMPLETED|Treatment Period 2||4
6476890|NCT01287065|7394047|FG005|COMPLETED|Treatment Period 2||4
6476891|NCT01287065|7394042|FG000|NOT COMPLETED|Treatment Period 2||0
6476892|NCT01287065|7394043|FG001|NOT COMPLETED|Treatment Period 2||0
6747370|NCT03389893|7675223|FG000|NOT COMPLETED|Randomized Double Blind Period||1
6747371|NCT03389893|7675224|FG001|NOT COMPLETED|Randomized Double Blind Period||0
6747372|NCT03389893|7675225|FG002|NOT COMPLETED|Randomized Double Blind Period||0
6747373|NCT03389893|7675226|FG003|NOT COMPLETED|Randomized Double Blind Period||0
6747374|NCT03389893|7675223|FG000|STARTED|Open Label Extension and Follow-Up||0
6747375|NCT03389893|7675224|FG001|STARTED|Open Label Extension and Follow-Up||0
6747376|NCT03389893|7675225|FG002|STARTED|Open Label Extension and Follow-Up||45
6747377|NCT03389893|7675226|FG003|STARTED|Open Label Extension and Follow-Up||26
6747378|NCT03389893|7675223|FG000|COMPLETED|Open Label Extension and Follow-Up||0
6747379|NCT03389893|7675224|FG001|COMPLETED|Open Label Extension and Follow-Up||0
6747380|NCT03389893|7675225|FG002|COMPLETED|Open Label Extension and Follow-Up||41
6747381|NCT03389893|7675226|FG003|COMPLETED|Open Label Extension and Follow-Up||25
6747382|NCT03389893|7675223|FG000|NOT COMPLETED|Open Label Extension and Follow-Up||0
6747383|NCT03389893|7675224|FG001|NOT COMPLETED|Open Label Extension and Follow-Up||0
6747384|NCT03389893|7675225|FG002|NOT COMPLETED|Open Label Extension and Follow-Up||4
6747385|NCT03389893|7675226|FG003|NOT COMPLETED|Open Label Extension and Follow-Up||1
6476893|NCT01287065|7394044|FG002|NOT COMPLETED|Treatment Period 2||0
6476894|NCT01287065|7394045|FG003|NOT COMPLETED|Treatment Period 2||0
6476895|NCT01287065|7394046|FG004|NOT COMPLETED|Treatment Period 2||0
6476896|NCT01287065|7394047|FG005|NOT COMPLETED|Treatment Period 2||0
6747386|NCT03390101|7675235|FG000|STARTED|Weeks 0-12||85
6747387|NCT03390101|7675236|FG001|STARTED|Weeks 0-12||84
6747388|NCT03390101|7675237|FG002|STARTED|Weeks 0-12||44
6747389|NCT03390101|7675235|FG000|COMPLETED|Weeks 0-12||85
6476897|NCT01287065|7394042|FG000|STARTED|Washout Period 2||4
6476898|NCT01287065|7394043|FG001|STARTED|Washout Period 2||4
6476899|NCT01287065|7394044|FG002|STARTED|Washout Period 2||4
6476900|NCT01287065|7394045|FG003|STARTED|Washout Period 2||4
6476901|NCT01287065|7394046|FG004|STARTED|Washout Period 2||4
6476902|NCT01287065|7394047|FG005|STARTED|Washout Period 2||4
6476903|NCT01287065|7394042|FG000|COMPLETED|Washout Period 2||4
6476904|NCT01287065|7394043|FG001|COMPLETED|Washout Period 2||4
6476905|NCT01287065|7394044|FG002|COMPLETED|Washout Period 2||4
6476906|NCT01287065|7394045|FG003|COMPLETED|Washout Period 2||4
6476907|NCT01287065|7394046|FG004|COMPLETED|Washout Period 2||4
6476908|NCT01287065|7394047|FG005|COMPLETED|Washout Period 2||4
6476909|NCT01287065|7394042|FG000|NOT COMPLETED|Washout Period 2||0
6476910|NCT01287065|7394043|FG001|NOT COMPLETED|Washout Period 2||0
6476911|NCT01287065|7394044|FG002|NOT COMPLETED|Washout Period 2||0
6476912|NCT01287065|7394045|FG003|NOT COMPLETED|Washout Period 2||0
6476913|NCT01287065|7394046|FG004|NOT COMPLETED|Washout Period 2||0
6476914|NCT01287065|7394047|FG005|NOT COMPLETED|Washout Period 2||0
6476915|NCT01287065|7394042|FG000|STARTED|Treatment Period 3||4
6476916|NCT01287065|7394043|FG001|STARTED|Treatment Period 3||4
6476917|NCT01287065|7394044|FG002|STARTED|Treatment Period 3||4
6476918|NCT01287065|7394045|FG003|STARTED|Treatment Period 3||4
6476919|NCT01287065|7394046|FG004|STARTED|Treatment Period 3||4
6476920|NCT01287065|7394047|FG005|STARTED|Treatment Period 3||4
6476921|NCT01287065|7394042|FG000|COMPLETED|Treatment Period 3||4
6476922|NCT01287065|7394043|FG001|COMPLETED|Treatment Period 3||4
6476923|NCT01287065|7394044|FG002|COMPLETED|Treatment Period 3||4
6476924|NCT01287065|7394045|FG003|COMPLETED|Treatment Period 3||4
6476925|NCT01287065|7394046|FG004|COMPLETED|Treatment Period 3||4
6476926|NCT01287065|7394047|FG005|COMPLETED|Treatment Period 3||4
6476927|NCT01287065|7394042|FG000|NOT COMPLETED|Treatment Period 3||0
6747390|NCT03390101|7675236|FG001|COMPLETED|Weeks 0-12||82
6747391|NCT03390101|7675237|FG002|COMPLETED|Weeks 0-12||43
6747392|NCT03390101|7675235|FG000|NOT COMPLETED|Weeks 0-12||0
6747393|NCT03390101|7675236|FG001|NOT COMPLETED|Weeks 0-12||2
6747394|NCT03390101|7675237|FG002|NOT COMPLETED|Weeks 0-12||1
6747395|NCT03390101|7675235|FG000|STARTED|Weeks 12-54||85
6747396|NCT03390101|7675236|FG001|STARTED|Weeks 12-54||82
6747397|NCT03390101|7675237|FG002|STARTED|Weeks 12-54||43
6747398|NCT03390101|7675235|FG000|COMPLETED|Weeks 12-54||82
6747399|NCT03390101|7675236|FG001|COMPLETED|Weeks 12-54||78
6747400|NCT03390101|7675237|FG002|COMPLETED|Weeks 12-54||41
6747401|NCT03390101|7675235|FG000|NOT COMPLETED|Weeks 12-54||3
6747402|NCT03390101|7675236|FG001|NOT COMPLETED|Weeks 12-54||4
6747403|NCT03390101|7675237|FG002|NOT COMPLETED|Weeks 12-54||2
6747404|NCT03390114|7675247|FG000|STARTED|Overall Study||10
6747405|NCT03390114|7675248|FG001|STARTED|Overall Study||10
6747406|NCT03390114|7675247|FG000|COMPLETED|Overall Study||6
6747407|NCT03390114|7675248|FG001|COMPLETED|Overall Study||8
6747408|NCT03390114|7675247|FG000|NOT COMPLETED|Overall Study||4
6747409|NCT03390114|7675248|FG001|NOT COMPLETED|Overall Study||2
6747410|NCT03390166|7675256|FG000|STARTED|Overall Study||630
6747411|NCT03390166|7675257|FG001|STARTED|Overall Study||315
6747412|NCT03390166|7675256|FG000|COMPLETED|Overall Study||618
6747413|NCT03390166|7675257|FG001|COMPLETED|Overall Study||305
6476928|NCT01287065|7394043|FG001|NOT COMPLETED|Treatment Period 3||0
6747414|NCT03390166|7675256|FG000|NOT COMPLETED|Overall Study||12
6747415|NCT03390166|7675257|FG001|NOT COMPLETED|Overall Study||10
6747416|NCT03390257|7675263|FG000|STARTED|Overall Study||14
6747417|NCT03390257|7675263|FG000|COMPLETED|Overall Study||14
6747418|NCT03390257|7675263|FG000|NOT COMPLETED|Overall Study||0
6747419|NCT03390426|7675271|FG000|STARTED|Overall Study||15
6747420|NCT03390426|7675272|FG001|STARTED|Overall Study||16
6747421|NCT03390426|7675271|FG000|COMPLETED|Overall Study||15
6747422|NCT03390426|7675272|FG001|COMPLETED|Overall Study||15
6747423|NCT03390426|7675271|FG000|NOT COMPLETED|Overall Study||0
6747424|NCT03390426|7675272|FG001|NOT COMPLETED|Overall Study||1
6747425|NCT03390842|7675280|FG000|STARTED|Overall Study||114
6747426|NCT03390842|7675281|FG001|STARTED|Overall Study||82
6747427|NCT03390842|7675280|FG000|COMPLETED|Overall Study||111
6747428|NCT03390842|7675281|FG001|COMPLETED|Overall Study||74
6747429|NCT03390842|7675280|FG000|NOT COMPLETED|Overall Study||3
6747430|NCT03390842|7675281|FG001|NOT COMPLETED|Overall Study||8
6747431|NCT03390907|7675287|FG000|STARTED|Overall Study||40
6747432|NCT03390907|7675287|FG000|COMPLETED|Overall Study||40
6747433|NCT03390907|7675287|FG000|NOT COMPLETED|Overall Study||0
6747434|NCT03391115|7675294|FG000|STARTED|Overall Study||20
6747435|NCT03391115|7675295|FG001|STARTED|Overall Study||18
6747436|NCT03391115|7675294|FG000|COMPLETED|Overall Study||20
6747437|NCT03391115|7675295|FG001|COMPLETED|Overall Study|Two Nurse participants in the dyadic patient-nurse enrollment were not successfully recruited.|18
6747438|NCT03391115|7675294|FG000|NOT COMPLETED|Overall Study||0
6747439|NCT03391115|7675295|FG001|NOT COMPLETED|Overall Study||0
6747440|NCT03391765|7675305|FG000|STARTED|Overall Study||51
6747441|NCT03391765|7675306|FG001|STARTED|Overall Study||45
6747442|NCT03391765|7675307|FG002|STARTED|Overall Study||23
6747443|NCT03391765|7675308|FG003|STARTED|Overall Study||23
6747444|NCT03391765|7675305|FG000|COMPLETED|Overall Study||0
6747445|NCT03391765|7675306|FG001|COMPLETED|Overall Study||0
6747446|NCT03391765|7675307|FG002|COMPLETED|Overall Study||0
6747447|NCT03391765|7675308|FG003|COMPLETED|Overall Study||0
6747448|NCT03391765|7675305|FG000|NOT COMPLETED|Overall Study||51
6747449|NCT03391765|7675306|FG001|NOT COMPLETED|Overall Study||45
6747450|NCT03391765|7675307|FG002|NOT COMPLETED|Overall Study||23
6747451|NCT03391765|7675308|FG003|NOT COMPLETED|Overall Study||23
6747452|NCT03391986|7675321|FG000|STARTED|Overall Study||53
6747453|NCT03391986|7675322|FG001|STARTED|Overall Study||50
6747454|NCT03391986|7675323|FG002|STARTED|Overall Study||50
6747455|NCT03391986|7675321|FG000|COMPLETED|Overall Study||53
6747456|NCT03391986|7675322|FG001|COMPLETED|Overall Study||50
6747457|NCT03391986|7675323|FG002|COMPLETED|Overall Study||50
6747458|NCT03391986|7675321|FG000|NOT COMPLETED|Overall Study||0
6476929|NCT01287065|7394044|FG002|NOT COMPLETED|Treatment Period 3||0
6476930|NCT01287065|7394045|FG003|NOT COMPLETED|Treatment Period 3||0
6476931|NCT01287065|7394046|FG004|NOT COMPLETED|Treatment Period 3||0
6476932|NCT01287065|7394047|FG005|NOT COMPLETED|Treatment Period 3||0
6476933|NCT01287078|7394057|FG000|STARTED|Overall Study||20
6476934|NCT01287078|7394058|FG001|STARTED|Overall Study||3
6476935|NCT01287078|7394057|FG000|COMPLETED|Overall Study||10
6476936|NCT01287078|7394058|FG001|COMPLETED|Overall Study||1
6476937|NCT01287078|7394057|FG000|NOT COMPLETED|Overall Study||10
6476938|NCT01287078|7394058|FG001|NOT COMPLETED|Overall Study||2
6476939|NCT01287104|7394068|FG000|STARTED|Overall Study||4
6476940|NCT01287104|7394069|FG001|STARTED|Overall Study||7
6476941|NCT01287104|7394070|FG002|STARTED|Overall Study||12
6476942|NCT01287104|7394071|FG003|STARTED|Overall Study||11
6476943|NCT01287104|7394068|FG000|COMPLETED|Overall Study||3
6476944|NCT01287104|7394069|FG001|COMPLETED|Overall Study||2
6476945|NCT01287104|7394070|FG002|COMPLETED|Overall Study||5
6476946|NCT01287104|7394071|FG003|COMPLETED|Overall Study||8
6476947|NCT01287104|7394068|FG000|NOT COMPLETED|Overall Study||1
6476948|NCT01287104|7394069|FG001|NOT COMPLETED|Overall Study||5
6476949|NCT01287104|7394070|FG002|NOT COMPLETED|Overall Study||7
6476950|NCT01287104|7394071|FG003|NOT COMPLETED|Overall Study||3
6476951|NCT01287117|7394092|FG000|STARTED|Overall Study||80
6476952|NCT01287117|7394093|FG001|STARTED|Overall Study||78
6476953|NCT01287117|7394094|FG002|STARTED|Overall Study||80
6476954|NCT01287117|7394095|FG003|STARTED|Overall Study||81
6476955|NCT01287117|7394092|FG000|Received Treatment|Overall Study||80
6476956|NCT01287117|7394093|FG001|Received Treatment|Overall Study||77
6476957|NCT01287117|7394094|FG002|Received Treatment|Overall Study||80
6476958|NCT01287117|7394095|FG003|Received Treatment|Overall Study||81
6476959|NCT01287117|7394092|FG000|COMPLETED|Overall Study||65
6476960|NCT01287117|7394093|FG001|COMPLETED|Overall Study||64
6476961|NCT01287117|7394094|FG002|COMPLETED|Overall Study||64
6476962|NCT01287117|7394095|FG003|COMPLETED|Overall Study||69
6476963|NCT01287117|7394092|FG000|NOT COMPLETED|Overall Study||15
6476964|NCT01287117|7394093|FG001|NOT COMPLETED|Overall Study||14
6476965|NCT01287117|7394094|FG002|NOT COMPLETED|Overall Study||16
6476966|NCT01287117|7394095|FG003|NOT COMPLETED|Overall Study||12
6476967|NCT01287195|7394105|FG000|STARTED|Overall Study||6
6476968|NCT01287195|7394105|FG000|COMPLETED|Overall Study||4
6476969|NCT01287195|7394105|FG000|NOT COMPLETED|Overall Study||2
6476970|NCT01287208|7394111|FG000|STARTED|Phase 1: Randomized Phase||52
6476971|NCT01287208|7394112|FG001|STARTED|Phase 1: Randomized Phase||52
6476972|NCT01287208|7394111|FG000|COMPLETED|Phase 1: Randomized Phase||50
6476973|NCT01287208|7394112|FG001|COMPLETED|Phase 1: Randomized Phase||49
6476974|NCT01287208|7394111|FG000|NOT COMPLETED|Phase 1: Randomized Phase||2
6476975|NCT01287208|7394112|FG001|NOT COMPLETED|Phase 1: Randomized Phase||3
6476976|NCT01287208|7394111|FG000|STARTED|Phase 2: Team Competition||50
6476977|NCT01287208|7394112|FG001|STARTED|Phase 2: Team Competition||49
6476978|NCT01287208|7394111|FG000|COMPLETED|Phase 2: Team Competition||50
6476979|NCT01287208|7394112|FG001|COMPLETED|Phase 2: Team Competition||49
6476980|NCT01287208|7394111|FG000|NOT COMPLETED|Phase 2: Team Competition||0
6476981|NCT01287208|7394112|FG001|NOT COMPLETED|Phase 2: Team Competition||0
6476982|NCT01287221|7394122|FG000|STARTED|Overall Study||50
6476983|NCT01287221|7394123|FG001|STARTED|Overall Study||50
6476984|NCT01287221|7394122|FG000|Completed 3 Months Follow-up|Overall Study||49
6476985|NCT01287221|7394123|FG001|Completed 3 Months Follow-up|Overall Study||50
6476986|NCT01287221|7394122|FG000|Completed 6 Months Follow-up|Overall Study||47
6476987|NCT01287221|7394123|FG001|Completed 6 Months Follow-up|Overall Study||43
6476988|NCT01287221|7394122|FG000|Completed 9 Months Follow-up|Overall Study||42
6476989|NCT01287221|7394123|FG001|Completed 9 Months Follow-up|Overall Study||40
6476990|NCT01287221|7394122|FG000|Completed 12 Months Follow-up|Overall Study||40
6476991|NCT01287221|7394123|FG001|Completed 12 Months Follow-up|Overall Study||39
6747459|NCT03391986|7675322|FG001|NOT COMPLETED|Overall Study||0
6747460|NCT03391986|7675323|FG002|NOT COMPLETED|Overall Study||0
6747461|NCT03392168|7675335|FG000|STARTED|Period 1: Cohort 1||8
6747462|NCT03392168|7675336|FG001|STARTED|Period 1: Cohort 1||0
6747463|NCT03392168|7675337|FG002|STARTED|Period 1: Cohort 1||0
6747464|NCT03392168|7675338|FG003|STARTED|Period 1: Cohort 1||0
6747465|NCT03392168|7675335|FG000|COMPLETED|Period 1: Cohort 1||8
6747466|NCT03392168|7675336|FG001|COMPLETED|Period 1: Cohort 1||0
6747467|NCT03392168|7675337|FG002|COMPLETED|Period 1: Cohort 1||0
6747468|NCT03392168|7675338|FG003|COMPLETED|Period 1: Cohort 1||0
6747469|NCT03392168|7675335|FG000|NOT COMPLETED|Period 1: Cohort 1||0
6747470|NCT03392168|7675336|FG001|NOT COMPLETED|Period 1: Cohort 1||0
6747471|NCT03392168|7675337|FG002|NOT COMPLETED|Period 1: Cohort 1||0
6747472|NCT03392168|7675338|FG003|NOT COMPLETED|Period 1: Cohort 1||0
6747473|NCT03392168|7675335|FG000|STARTED|Period 2: Cohort 2||0
6747474|NCT03392168|7675336|FG001|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|30
6747475|NCT03392168|7675337|FG002|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|28
6747476|NCT03392168|7675338|FG003|STARTED|Period 2: Cohort 2|Includes 2 participants from Cohort 1|31
6747477|NCT03392168|7675335|FG000|COMPLETED|Period 2: Cohort 2||0
6747478|NCT03392168|7675336|FG001|COMPLETED|Period 2: Cohort 2||28
6747479|NCT03392168|7675337|FG002|COMPLETED|Period 2: Cohort 2||27
6747480|NCT03392168|7675338|FG003|COMPLETED|Period 2: Cohort 2||30
6476992|NCT01287221|7394122|FG000|COMPLETED|Overall Study||46
6476993|NCT01287221|7394123|FG001|COMPLETED|Overall Study||45
6747481|NCT03392168|7675335|FG000|NOT COMPLETED|Period 2: Cohort 2||0
6747482|NCT03392168|7675336|FG001|NOT COMPLETED|Period 2: Cohort 2||2
6747483|NCT03392168|7675337|FG002|NOT COMPLETED|Period 2: Cohort 2||1
6476994|NCT01287221|7394122|FG000|NOT COMPLETED|Overall Study||4
6476995|NCT01287221|7394123|FG001|NOT COMPLETED|Overall Study||5
6476996|NCT01287364|7394131|FG000|STARTED|Overall Study||94
6476997|NCT01287364|7394132|FG001|STARTED|Overall Study||91
6476998|NCT01287364|7394131|FG000|COMPLETED|Overall Study||85
6476999|NCT01287364|7394132|FG001|COMPLETED|Overall Study||81
6477000|NCT01287364|7394131|FG000|NOT COMPLETED|Overall Study||9
6477001|NCT01287364|7394132|FG001|NOT COMPLETED|Overall Study||10
6477002|NCT01287377|7394154|FG000|STARTED|Overall Study||80
6477003|NCT01287377|7394155|FG001|STARTED|Overall Study||81
6477004|NCT01287377|7394156|FG002|STARTED|Overall Study||82
6477005|NCT01287377|7394154|FG000|COMPLETED|Overall Study|Study Complete|80
6477006|NCT01287377|7394155|FG001|COMPLETED|Overall Study|Study Complete|81
6477007|NCT01287377|7394156|FG002|COMPLETED|Overall Study|Study Complete|82
6477008|NCT01287377|7394154|FG000|NOT COMPLETED|Overall Study||0
6477009|NCT01287377|7394155|FG001|NOT COMPLETED|Overall Study||0
6477010|NCT01287377|7394156|FG002|NOT COMPLETED|Overall Study||0
6477011|NCT01287403|7394164|FG000|STARTED|Diet Restriction (7 Days)||14
6477012|NCT01287403|7394164|FG000|COMPLETED|Diet Restriction (7 Days)||14
6477013|NCT01287403|7394164|FG000|NOT COMPLETED|Diet Restriction (7 Days)||0
6477014|NCT01287403|7394164|FG000|STARTED|1st Intervention (1 Day)||14
6477015|NCT01287403|7394164|FG000|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
6477016|NCT01287403|7394164|FG000|NOT COMPLETED|1st Intervention (1 Day)||1
6477017|NCT01287403|7394164|FG000|STARTED|Washout 7 Days||13
6477018|NCT01287403|7394164|FG000|COMPLETED|Washout 7 Days||13
6477019|NCT01287403|7394164|FG000|NOT COMPLETED|Washout 7 Days||0
6477020|NCT01287403|7394164|FG000|STARTED|2nd Intervention (1 Day)||13
6477021|NCT01287403|7394164|FG000|COMPLETED|2nd Intervention (1 Day)||13
6477022|NCT01287403|7394164|FG000|NOT COMPLETED|2nd Intervention (1 Day)||0
6477023|NCT01287403|7394164|FG000|STARTED|Washout (7 Days)||13
6477024|NCT01287403|7394164|FG000|COMPLETED|Washout (7 Days)||13
6477025|NCT01287403|7394164|FG000|NOT COMPLETED|Washout (7 Days)||0
6477026|NCT01287403|7394164|FG000|STARTED|3rd Intervention (1 Day)||13
6747484|NCT03392168|7675338|FG003|NOT COMPLETED|Period 2: Cohort 2||1
6747485|NCT03392194|7675349|FG000|STARTED|Overall Study||16
6747486|NCT03392194|7675350|FG001|STARTED|Overall Study||17
6747487|NCT03392194|7675349|FG000|COMPLETED|Overall Study||14
6747488|NCT03392194|7675350|FG001|COMPLETED|Overall Study||15
6747489|NCT03392194|7675349|FG000|NOT COMPLETED|Overall Study||2
6747490|NCT03392194|7675350|FG001|NOT COMPLETED|Overall Study||2
6747491|NCT03392532|7675356|FG000|STARTED|Period 1, FIrst 30 Minutes of Wear||18
6747492|NCT03392532|7675357|FG001|STARTED|Period 1, FIrst 30 Minutes of Wear||18
6747493|NCT03392532|7675356|FG000|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
6747494|NCT03392532|7675357|FG001|COMPLETED|Period 1, FIrst 30 Minutes of Wear||18
6747495|NCT03392532|7675356|FG000|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
6747496|NCT03392532|7675357|FG001|NOT COMPLETED|Period 1, FIrst 30 Minutes of Wear||0
6747497|NCT03392532|7675356|FG000|STARTED|Period 2, Second 30 Minutes of Wear||18
6747498|NCT03392532|7675357|FG001|STARTED|Period 2, Second 30 Minutes of Wear||18
6747499|NCT03392532|7675356|FG000|COMPLETED|Period 2, Second 30 Minutes of Wear||18
6747500|NCT03392532|7675357|FG001|COMPLETED|Period 2, Second 30 Minutes of Wear||18
6747501|NCT03392532|7675356|FG000|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
6747502|NCT03392532|7675357|FG001|NOT COMPLETED|Period 2, Second 30 Minutes of Wear||0
6747503|NCT03392935|7675363|FG000|STARTED|Overall Study||37
6747504|NCT03392935|7675363|FG000|COMPLETED|Overall Study||35
6747505|NCT03392935|7675363|FG000|NOT COMPLETED|Overall Study||2
6747506|NCT03392974|7675367|FG000|STARTED|Overall Study||1
6747507|NCT03392974|7675367|FG000|COMPLETED|Overall Study||1
6747508|NCT03392974|7675367|FG000|NOT COMPLETED|Overall Study||0
6747509|NCT03393000|7675372|FG000|STARTED|Overall Study|23 subjects screened|19
6747510|NCT03393000|7675372|FG000|COMPLETED|Overall Study|19 subjects treated|5
6747511|NCT03393000|7675372|FG000|NOT COMPLETED|Overall Study||14
6747512|NCT03393208|7675380|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||13
6747513|NCT03393208|7675381|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||13
6747514|NCT03393208|7675382|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||9
6747515|NCT03393208|7675383|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||9
6747516|NCT03393208|7675380|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
6747517|NCT03393208|7675381|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||13
6747518|NCT03393208|7675382|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
6747519|NCT03393208|7675383|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||9
6477027|NCT01287403|7394164|FG000|COMPLETED|3rd Intervention (1 Day)||13
6477028|NCT01287403|7394164|FG000|NOT COMPLETED|3rd Intervention (1 Day)||0
6477029|NCT01287403|7394164|FG000|STARTED|Washout (7 Days)||13
6477030|NCT01287403|7394164|FG000|COMPLETED|Washout (7 Days)||13
6747520|NCT03393208|7675380|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6747521|NCT03393208|7675381|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6747522|NCT03393208|7675382|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6747523|NCT03393208|7675383|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6747524|NCT03393208|7675380|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||13
6747525|NCT03393208|7675381|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||13
6747526|NCT03393208|7675382|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||9
6747527|NCT03393208|7675383|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||9
6747528|NCT03393208|7675380|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
6747529|NCT03393208|7675381|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||13
6477031|NCT01287403|7394164|FG000|NOT COMPLETED|Washout (7 Days)||0
6477032|NCT01287403|7394164|FG000|STARTED|4th Intervention (1 Day)||13
6747530|NCT03393208|7675382|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
6747531|NCT03393208|7675383|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||9
6747532|NCT03393208|7675380|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6747533|NCT03393208|7675381|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6747534|NCT03393208|7675382|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6747535|NCT03393208|7675383|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6747536|NCT03393494|7675398|FG000|STARTED|Overall Study||329
6747537|NCT03393494|7675399|FG001|STARTED|Overall Study||331
6747538|NCT03393494|7675400|FG002|STARTED|Overall Study||165
6747539|NCT03393494|7675398|FG000|COMPLETED|Overall Study||261
6747540|NCT03393494|7675399|FG001|COMPLETED|Overall Study||256
6747541|NCT03393494|7675400|FG002|COMPLETED|Overall Study||140
6747542|NCT03393494|7675398|FG000|NOT COMPLETED|Overall Study||68
6747543|NCT03393494|7675399|FG001|NOT COMPLETED|Overall Study||75
6747544|NCT03393494|7675400|FG002|NOT COMPLETED|Overall Study||25
6747545|NCT03393754|7675410|FG000|STARTED|Overall Study||811
6747546|NCT03393754|7675411|FG001|STARTED|Overall Study||796
6747547|NCT03393754|7675410|FG000|COMPLETED|Overall Study||785
6747548|NCT03393754|7675411|FG001|COMPLETED|Overall Study||758
6747549|NCT03393754|7675410|FG000|NOT COMPLETED|Overall Study||26
6747550|NCT03393754|7675411|FG001|NOT COMPLETED|Overall Study||38
6747551|NCT03393806|7675419|FG000|STARTED|Overall Study||9
6747552|NCT03393806|7675420|FG001|STARTED|Overall Study||8
6747553|NCT03393806|7675419|FG000|COMPLETED|Overall Study||8
6747554|NCT03393806|7675420|FG001|COMPLETED|Overall Study||8
6747555|NCT03393806|7675419|FG000|NOT COMPLETED|Overall Study||1
6747556|NCT03393806|7675420|FG001|NOT COMPLETED|Overall Study||0
6747557|NCT03394391|7675429|FG000|STARTED|Overall Study||106
6747558|NCT03394391|7675430|FG001|STARTED|Overall Study||106
6747559|NCT03394391|7675429|FG000|COMPLETED|Overall Study||105
6747560|NCT03394391|7675430|FG001|COMPLETED|Overall Study||104
6747561|NCT03394391|7675429|FG000|NOT COMPLETED|Overall Study||1
6747562|NCT03394391|7675430|FG001|NOT COMPLETED|Overall Study||2
6747563|NCT03394508|7675438|FG000|STARTED|Overall Study||13
6747564|NCT03394508|7675439|FG001|STARTED|Overall Study||17
6747565|NCT03394508|7675438|FG000|COMPLETED|Overall Study||12
6747566|NCT03394508|7675439|FG001|COMPLETED|Overall Study||14
6747567|NCT03394508|7675438|FG000|NOT COMPLETED|Overall Study||1
6747568|NCT03394508|7675439|FG001|NOT COMPLETED|Overall Study||3
6747569|NCT03394768|7675449|FG000|STARTED|Overall Study||26
6747570|NCT03394768|7675449|FG000|COMPLETED|Overall Study||26
6747571|NCT03394768|7675449|FG000|NOT COMPLETED|Overall Study||0
6747572|NCT03394885|7675453|FG000|STARTED|Overall Study||18
6747573|NCT03394885|7675453|FG000|COMPLETED|Overall Study||3
6747574|NCT03394885|7675453|FG000|NOT COMPLETED|Overall Study||15
6747575|NCT03394924|7675460|FG000|STARTED|Overall Study||31
6747576|NCT03394924|7675461|FG001|STARTED|Overall Study||28
6747577|NCT03394924|7675462|FG002|STARTED|Overall Study||9
6747578|NCT03394924|7675460|FG000|COMPLETED|Overall Study||28
6747579|NCT03394924|7675461|FG001|COMPLETED|Overall Study||22
6747580|NCT03394924|7675462|FG002|COMPLETED|Overall Study||9
6747581|NCT03394924|7675460|FG000|NOT COMPLETED|Overall Study||3
6747582|NCT03394924|7675461|FG001|NOT COMPLETED|Overall Study||6
6747583|NCT03394924|7675462|FG002|NOT COMPLETED|Overall Study||0
6747584|NCT03395353|7675472|FG000|STARTED|Overall Study||151
6747585|NCT03395353|7675472|FG000|Received At Least 1 Dose of Study Drug|Overall Study||150
6747586|NCT03395353|7675472|FG000|COMPLETED|Overall Study||64
6747587|NCT03395353|7675472|FG000|NOT COMPLETED|Overall Study||87
6747588|NCT03395808|7675480|FG000|STARTED|Overall Study||251
6747589|NCT03395808|7675480|FG000|COMPLETED|Overall Study||251
6747590|NCT03395808|7675480|FG000|NOT COMPLETED|Overall Study||0
6747591|NCT03395886|7675486|FG000|STARTED|Overall Study||52
6747592|NCT03395886|7675487|FG001|STARTED|Overall Study||38
6747593|NCT03395886|7675486|FG000|COMPLETED|Overall Study||0
6747594|NCT03395886|7675487|FG001|COMPLETED|Overall Study||0
6747595|NCT03395886|7675486|FG000|NOT COMPLETED|Overall Study||52
6747596|NCT03395886|7675487|FG001|NOT COMPLETED|Overall Study||38
6747597|NCT03395990|7675495|FG000|STARTED|Overall Study||8
6747598|NCT03395990|7675496|FG001|STARTED|Overall Study||8
6747599|NCT03395990|7675495|FG000|COMPLETED|Overall Study||8
6747600|NCT03395990|7675496|FG001|COMPLETED|Overall Study||8
6747601|NCT03395990|7675495|FG000|NOT COMPLETED|Overall Study||0
6477033|NCT01287403|7394164|FG000|COMPLETED|4th Intervention (1 Day)||13
6477034|NCT01287403|7394164|FG000|NOT COMPLETED|4th Intervention (1 Day)||0
6477035|NCT01287403|7394164|FG000|STARTED|Washout (7 Days)||13
6477036|NCT01287403|7394164|FG000|COMPLETED|Washout (7 Days)||13
6477037|NCT01287403|7394164|FG000|NOT COMPLETED|Washout (7 Days)||0
6477038|NCT01287403|7394164|FG000|STARTED|5th Intervention (1 Day)||13
6477039|NCT01287403|7394164|FG000|COMPLETED|5th Intervention (1 Day)||13
6747602|NCT03395990|7675496|FG001|NOT COMPLETED|Overall Study||0
6747603|NCT03396432|7675504|FG000|STARTED|Overall Study||283
6747604|NCT03396432|7675505|FG001|STARTED|Overall Study||283
6747605|NCT03396432|7675504|FG000|COMPLETED|Overall Study||274
6747606|NCT03396432|7675505|FG001|COMPLETED|Overall Study||277
6747607|NCT03396432|7675504|FG000|NOT COMPLETED|Overall Study||9
6747608|NCT03396432|7675505|FG001|NOT COMPLETED|Overall Study||6
6747609|NCT03396835|7675513|FG000|STARTED|Overall Study||16
6477040|NCT01287403|7394164|FG000|NOT COMPLETED|5th Intervention (1 Day)||0
6747610|NCT03396835|7675513|FG000|COMPLETED|Overall Study||14
6477041|NCT01287403|7394164|FG000|STARTED|Washout (7 Days)||13
6477042|NCT01287403|7394164|FG000|COMPLETED|Washout (7 Days)||13
6477043|NCT01287403|7394164|FG000|NOT COMPLETED|Washout (7 Days)||0
6477044|NCT01287403|7394164|FG000|STARTED|6th and Last Intervention (1 Day)||13
6477045|NCT01287403|7394164|FG000|COMPLETED|6th and Last Intervention (1 Day)||13
6477046|NCT01287403|7394164|FG000|NOT COMPLETED|6th and Last Intervention (1 Day)||0
6477047|NCT01287416|7394180|FG000|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
6477048|NCT01287416|7394181|FG001|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
6477049|NCT01287416|7394180|FG000|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
6477050|NCT01287416|7394181|FG001|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
6477051|NCT01287416|7394180|FG000|Post Training Questionnaire|Pre-post Training||26
6477052|NCT01287416|7394181|FG001|Post Training Questionnaire|Pre-post Training||23
6477053|NCT01287416|7394180|FG000|COMPLETED|Pre-post Training||26
6477054|NCT01287416|7394181|FG001|COMPLETED|Pre-post Training||23
6477055|NCT01287416|7394180|FG000|NOT COMPLETED|Pre-post Training||22
6477056|NCT01287416|7394181|FG001|NOT COMPLETED|Pre-post Training||25
6477057|NCT01287416|7394180|FG000|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
6477058|NCT01287416|7394181|FG001|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
6477059|NCT01287416|7394180|FG000|COMPLETED|6 Month Follow-up||28
6477060|NCT01287416|7394181|FG001|COMPLETED|6 Month Follow-up||22
6477061|NCT01287416|7394180|FG000|NOT COMPLETED|6 Month Follow-up||3
6477062|NCT01287416|7394181|FG001|NOT COMPLETED|6 Month Follow-up||2
6477063|NCT01287520|7394196|FG000|STARTED|Overall Study||3
6477064|NCT01287520|7394197|FG001|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
6477065|NCT01287520|7394198|FG002|STARTED|Overall Study||5
6477066|NCT01287520|7394199|FG003|STARTED|Overall Study|One participant who received study drug but did not complete Cycle 1 was replaced.|7
6477067|NCT01287520|7394200|FG004|STARTED|Overall Study||3
6477068|NCT01287520|7394201|FG005|STARTED|Overall Study||4
6477069|NCT01287520|7394202|FG006|STARTED|Overall Study||2
6477070|NCT01287520|7394203|FG007|STARTED|Overall Study||5
6477071|NCT01287520|7394204|FG008|STARTED|Overall Study||5
6477072|NCT01287520|7394196|FG000|COMPLETED|Overall Study||0
6477073|NCT01287520|7394197|FG001|COMPLETED|Overall Study||0
6477074|NCT01287520|7394198|FG002|COMPLETED|Overall Study||0
6477075|NCT01287520|7394199|FG003|COMPLETED|Overall Study||0
6477076|NCT01287520|7394200|FG004|COMPLETED|Overall Study||0
6477077|NCT01287520|7394201|FG005|COMPLETED|Overall Study||0
6477078|NCT01287520|7394202|FG006|COMPLETED|Overall Study||0
6477079|NCT01287520|7394203|FG007|COMPLETED|Overall Study||0
6477080|NCT01287520|7394204|FG008|COMPLETED|Overall Study||0
6477081|NCT01287520|7394196|FG000|NOT COMPLETED|Overall Study||3
6477082|NCT01287520|7394197|FG001|NOT COMPLETED|Overall Study||7
6477083|NCT01287520|7394198|FG002|NOT COMPLETED|Overall Study||5
6477084|NCT01287520|7394199|FG003|NOT COMPLETED|Overall Study||7
6477085|NCT01287520|7394200|FG004|NOT COMPLETED|Overall Study||3
6477086|NCT01287520|7394201|FG005|NOT COMPLETED|Overall Study||4
6477087|NCT01287520|7394202|FG006|NOT COMPLETED|Overall Study||2
6477088|NCT01287520|7394203|FG007|NOT COMPLETED|Overall Study||5
6477089|NCT01287520|7394204|FG008|NOT COMPLETED|Overall Study||5
6477090|NCT01287754|7394255|FG000|STARTED|Overall Study||3
6477091|NCT01287754|7394256|FG001|STARTED|Overall Study||21
6477092|NCT01287754|7394255|FG000|COMPLETED|Overall Study||0
6477093|NCT01287754|7394256|FG001|COMPLETED|Overall Study||0
6477094|NCT01287754|7394255|FG000|NOT COMPLETED|Overall Study||3
6477095|NCT01287754|7394256|FG001|NOT COMPLETED|Overall Study||21
6477096|NCT01287832|7394264|FG000|STARTED|Overall Study||6
6477097|NCT01287832|7394265|FG001|STARTED|Overall Study||5
6477098|NCT01287832|7394264|FG000|COMPLETED|Overall Study||5
6477099|NCT01287832|7394265|FG001|COMPLETED|Overall Study||4
6477100|NCT01287832|7394264|FG000|NOT COMPLETED|Overall Study||1
6477101|NCT01287832|7394265|FG001|NOT COMPLETED|Overall Study||1
6477102|NCT01287897|7394275|FG000|STARTED|Overall Study||70
6477103|NCT01287897|7394276|FG001|STARTED|Overall Study||69
6477104|NCT01287897|7394277|FG002|STARTED|Overall Study||71
6477105|NCT01287897|7394278|FG003|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
6477106|NCT01287897|7394275|FG000|Treated|Overall Study||69
6477107|NCT01287897|7394276|FG001|Treated|Overall Study||67
6477108|NCT01287897|7394277|FG002|Treated|Overall Study||71
6477109|NCT01287897|7394278|FG003|Treated|Overall Study||40
6477110|NCT01287897|7394275|FG000|Completed Treatment Period|Overall Study||58
6477111|NCT01287897|7394276|FG001|Completed Treatment Period|Overall Study||52
6477112|NCT01287897|7394277|FG002|Completed Treatment Period|Overall Study||58
6477113|NCT01287897|7394278|FG003|Completed Treatment Period|Overall Study||29
6477114|NCT01287897|7394275|FG000|Completed Follow-up Period|Overall Study||3
6477115|NCT01287897|7394276|FG001|Completed Follow-up Period|Overall Study||8
6477116|NCT01287897|7394277|FG002|Completed Follow-up Period|Overall Study||3
6477117|NCT01287897|7394278|FG003|Completed Follow-up Period|Overall Study||4
6477118|NCT01287897|7394275|FG000|Enrolled in NCT01345318|Overall Study||56
6477119|NCT01287897|7394276|FG001|Enrolled in NCT01345318|Overall Study||50
6477120|NCT01287897|7394277|FG002|Enrolled in NCT01345318|Overall Study||56
6477121|NCT01287897|7394278|FG003|Enrolled in NCT01345318|Overall Study||29
6477122|NCT01287897|7394275|FG000|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
6477123|NCT01287897|7394276|FG001|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
6477124|NCT01287897|7394277|FG002|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
6477125|NCT01287897|7394278|FG003|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
6477126|NCT01287897|7394275|FG000|NOT COMPLETED|Overall Study||11
6477127|NCT01287897|7394276|FG001|NOT COMPLETED|Overall Study||11
6477128|NCT01287897|7394277|FG002|NOT COMPLETED|Overall Study||12
6477129|NCT01287897|7394278|FG003|NOT COMPLETED|Overall Study||7
6477130|NCT01288027|7394292|FG000|STARTED|Overall Study||16
6477131|NCT01288027|7394292|FG000|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
6477132|NCT01288027|7394292|FG000|COMPLETED|Overall Study||16
6477133|NCT01288027|7394292|FG000|NOT COMPLETED|Overall Study||0
6477134|NCT01288053|7394296|FG000|STARTED|Overall Study||9
6477135|NCT01288053|7394296|FG000|COMPLETED|Overall Study||8
6477136|NCT01288053|7394296|FG000|NOT COMPLETED|Overall Study||1
6477137|NCT01288079|7394304|FG000|STARTED|Overall Study||37
6477138|NCT01288079|7394305|FG001|STARTED|Overall Study||36
6477139|NCT01288079|7394306|FG002|STARTED|Overall Study||37
6477140|NCT01288079|7394307|FG003|STARTED|Overall Study||35
6477141|NCT01288079|7394304|FG000|COMPLETED|Overall Study||17
6477142|NCT01288079|7394305|FG001|COMPLETED|Overall Study||9
6477143|NCT01288079|7394306|FG002|COMPLETED|Overall Study||18
6477144|NCT01288079|7394307|FG003|COMPLETED|Overall Study||18
6477145|NCT01288079|7394304|FG000|NOT COMPLETED|Overall Study||20
6477146|NCT01288079|7394305|FG001|NOT COMPLETED|Overall Study||27
6477147|NCT01288079|7394306|FG002|NOT COMPLETED|Overall Study||19
6477148|NCT01288079|7394307|FG003|NOT COMPLETED|Overall Study||17
6477149|NCT01288209|7394319|FG000|STARTED|Overall Study||53
6477150|NCT01288209|7394320|FG001|STARTED|Overall Study||53
6477151|NCT01288209|7394319|FG000|COMPLETED|Overall Study||51
6477152|NCT01288209|7394320|FG001|COMPLETED|Overall Study||50
6477153|NCT01288209|7394319|FG000|NOT COMPLETED|Overall Study||2
6477154|NCT01288209|7394320|FG001|NOT COMPLETED|Overall Study||3
6477155|NCT01288287|7394326|FG000|STARTED|Overall Study||149
6747611|NCT03396835|7675513|FG000|NOT COMPLETED|Overall Study||2
6747612|NCT03396913|7675519|FG000|STARTED|Overall Study||43
6747613|NCT03396913|7675520|FG001|STARTED|Overall Study||45
6747614|NCT03396913|7675519|FG000|COMPLETED|Overall Study||43
6747615|NCT03396913|7675520|FG001|COMPLETED|Overall Study||39
6747616|NCT03396913|7675519|FG000|NOT COMPLETED|Overall Study||0
6747617|NCT03396913|7675520|FG001|NOT COMPLETED|Overall Study||6
6747618|NCT03396952|7675526|FG000|STARTED|Overall Study||27
6747619|NCT03396952|7675526|FG000|COMPLETED|Overall Study||27
6747620|NCT03396952|7675526|FG000|NOT COMPLETED|Overall Study||0
6747621|NCT03397121|7675532|FG000|STARTED|Overall Study||242
6747622|NCT03397121|7675533|FG001|STARTED|Overall Study||240
6747623|NCT03397121|7675532|FG000|COMPLETED|Overall Study||235
6747624|NCT03397121|7675533|FG001|COMPLETED|Overall Study||231
6747625|NCT03397121|7675532|FG000|NOT COMPLETED|Overall Study||7
6747626|NCT03397121|7675533|FG001|NOT COMPLETED|Overall Study||9
6747627|NCT03397394|7675543|FG000|STARTED|Overall Study||47
6747628|NCT03397394|7675544|FG001|STARTED|Overall Study||30
6747629|NCT03397394|7675545|FG002|STARTED|Overall Study||20
6747630|NCT03397394|7675543|FG000|COMPLETED|Overall Study||47
6747631|NCT03397394|7675544|FG001|COMPLETED|Overall Study||30
6747632|NCT03397394|7675545|FG002|COMPLETED|Overall Study||20
6747633|NCT03397394|7675543|FG000|NOT COMPLETED|Overall Study||0
6747634|NCT03397394|7675544|FG001|NOT COMPLETED|Overall Study||0
6747635|NCT03397394|7675545|FG002|NOT COMPLETED|Overall Study||0
6747636|NCT03397771|7675557|FG000|STARTED|Overall Study||53
6747637|NCT03397771|7675558|FG001|STARTED|Overall Study||29
6747638|NCT03397771|7675557|FG000|COMPLETED|Overall Study||45
6747639|NCT03397771|7675558|FG001|COMPLETED|Overall Study||22
6747640|NCT03397771|7675557|FG000|NOT COMPLETED|Overall Study||8
6747641|NCT03397771|7675558|FG001|NOT COMPLETED|Overall Study||7
6747642|NCT03398213|7675567|FG000|STARTED|Overall Study||26
6747643|NCT03398213|7675568|FG001|STARTED|Overall Study||24
6747644|NCT03398213|7675569|FG002|STARTED|Overall Study||22
6747645|NCT03398213|7675567|FG000|COMPLETED|Overall Study||26
6747646|NCT03398213|7675568|FG001|COMPLETED|Overall Study||24
6747647|NCT03398213|7675569|FG002|COMPLETED|Overall Study||22
6747648|NCT03398213|7675567|FG000|NOT COMPLETED|Overall Study||0
6477156|NCT01288287|7394326|FG000|Safety Set|Overall Study||147
6477157|NCT01288287|7394326|FG000|Full Analysis Set|Overall Study||111
6477158|NCT01288287|7394326|FG000|COMPLETED|Overall Study||103
6477159|NCT01288287|7394326|FG000|NOT COMPLETED|Overall Study||46
6477160|NCT01288430|7394341|FG000|STARTED|Part 1||2
6477161|NCT01288430|7394342|FG001|STARTED|Part 1||3
6477162|NCT01288430|7394343|FG002|STARTED|Part 1||5
6477163|NCT01288430|7394344|FG003|STARTED|Part 1||7
6477164|NCT01288430|7394345|FG004|STARTED|Part 1||3
6477165|NCT01288430|7394346|FG005|STARTED|Part 1||6
6477166|NCT01288430|7394347|FG006|STARTED|Part 1||7
6747649|NCT03398213|7675568|FG001|NOT COMPLETED|Overall Study||0
6747650|NCT03398213|7675569|FG002|NOT COMPLETED|Overall Study||0
6747651|NCT03398265|7675579|FG000|STARTED|Overall Study||7
6747652|NCT03398265|7675580|FG001|STARTED|Overall Study||8
6747653|NCT03398265|7675579|FG000|COMPLETED|Overall Study||7
6747654|NCT03398265|7675580|FG001|COMPLETED|Overall Study||8
6477167|NCT01288430|7394348|FG007|STARTED|Part 1||0
6477168|NCT01288430|7394349|FG008|STARTED|Part 1||0
6477169|NCT01288430|7394350|FG009|STARTED|Part 1||0
6477170|NCT01288430|7394341|FG000|COMPLETED|Part 1||0
6477171|NCT01288430|7394342|FG001|COMPLETED|Part 1||0
6477172|NCT01288430|7394343|FG002|COMPLETED|Part 1||0
6477173|NCT01288430|7394344|FG003|COMPLETED|Part 1||0
6477174|NCT01288430|7394345|FG004|COMPLETED|Part 1||0
6477175|NCT01288430|7394346|FG005|COMPLETED|Part 1||0
6477176|NCT01288430|7394347|FG006|COMPLETED|Part 1||0
6477177|NCT01288430|7394348|FG007|COMPLETED|Part 1||0
6477178|NCT01288430|7394349|FG008|COMPLETED|Part 1||0
6477179|NCT01288430|7394350|FG009|COMPLETED|Part 1||0
6477180|NCT01288430|7394341|FG000|NOT COMPLETED|Part 1||2
6477181|NCT01288430|7394342|FG001|NOT COMPLETED|Part 1||3
6477182|NCT01288430|7394343|FG002|NOT COMPLETED|Part 1||5
6477183|NCT01288430|7394344|FG003|NOT COMPLETED|Part 1||7
6477184|NCT01288430|7394345|FG004|NOT COMPLETED|Part 1||3
6477185|NCT01288430|7394346|FG005|NOT COMPLETED|Part 1||6
6477186|NCT01288430|7394347|FG006|NOT COMPLETED|Part 1||7
6477187|NCT01288430|7394348|FG007|NOT COMPLETED|Part 1||0
6477188|NCT01288430|7394349|FG008|NOT COMPLETED|Part 1||0
6477189|NCT01288430|7394350|FG009|NOT COMPLETED|Part 1||0
6477190|NCT01288430|7394341|FG000|STARTED|Part 2||0
6477191|NCT01288430|7394342|FG001|STARTED|Part 2||0
6477192|NCT01288430|7394343|FG002|STARTED|Part 2||0
6477193|NCT01288430|7394344|FG003|STARTED|Part 2||0
6477194|NCT01288430|7394345|FG004|STARTED|Part 2||0
6477195|NCT01288430|7394346|FG005|STARTED|Part 2||0
6477196|NCT01288430|7394347|FG006|STARTED|Part 2||0
6477197|NCT01288430|7394348|FG007|STARTED|Part 2||12
6477198|NCT01288430|7394349|FG008|STARTED|Part 2||12
6477199|NCT01288430|7394350|FG009|STARTED|Part 2||3
6477200|NCT01288430|7394341|FG000|COMPLETED|Part 2||0
6477201|NCT01288430|7394342|FG001|COMPLETED|Part 2||0
6477202|NCT01288430|7394343|FG002|COMPLETED|Part 2||0
6477203|NCT01288430|7394344|FG003|COMPLETED|Part 2||0
6477204|NCT01288430|7394345|FG004|COMPLETED|Part 2||0
6477205|NCT01288430|7394346|FG005|COMPLETED|Part 2||0
6477206|NCT01288430|7394347|FG006|COMPLETED|Part 2||0
6477207|NCT01288430|7394348|FG007|COMPLETED|Part 2||0
6477208|NCT01288430|7394349|FG008|COMPLETED|Part 2||0
6477209|NCT01288430|7394350|FG009|COMPLETED|Part 2||0
6477210|NCT01288430|7394341|FG000|NOT COMPLETED|Part 2||0
6477211|NCT01288430|7394342|FG001|NOT COMPLETED|Part 2||0
6477212|NCT01288430|7394343|FG002|NOT COMPLETED|Part 2||0
6477213|NCT01288430|7394344|FG003|NOT COMPLETED|Part 2||0
6477214|NCT01288430|7394345|FG004|NOT COMPLETED|Part 2||0
6477215|NCT01288430|7394346|FG005|NOT COMPLETED|Part 2||0
6477216|NCT01288430|7394347|FG006|NOT COMPLETED|Part 2||0
6477217|NCT01288430|7394348|FG007|NOT COMPLETED|Part 2||12
6477218|NCT01288430|7394349|FG008|NOT COMPLETED|Part 2||12
6477219|NCT01288430|7394350|FG009|NOT COMPLETED|Part 2||3
6477220|NCT01288443|7394383|FG000|STARTED|Overall Study|Randomized|31
6477221|NCT01288443|7394384|FG001|STARTED|Overall Study|Randomized|30
6477222|NCT01288443|7394385|FG002|STARTED|Overall Study|Randomized|31
6747655|NCT03398265|7675579|FG000|NOT COMPLETED|Overall Study||0
6747656|NCT03398265|7675580|FG001|NOT COMPLETED|Overall Study||0
6747657|NCT03398278|7675589|FG000|STARTED|Period 1||19
6747658|NCT03398278|7675590|FG001|STARTED|Period 1||19
6747659|NCT03398278|7675589|FG000|COMPLETED|Period 1||18
6747660|NCT03398278|7675590|FG001|COMPLETED|Period 1||19
6747661|NCT03398278|7675589|FG000|NOT COMPLETED|Period 1||1
6747662|NCT03398278|7675590|FG001|NOT COMPLETED|Period 1||0
6747663|NCT03398278|7675589|FG000|STARTED|Period 2||18
6747664|NCT03398278|7675590|FG001|STARTED|Period 2||19
6747665|NCT03398278|7675589|FG000|COMPLETED|Period 2||16
6747666|NCT03398278|7675590|FG001|COMPLETED|Period 2||17
6747667|NCT03398278|7675589|FG000|NOT COMPLETED|Period 2||2
6747668|NCT03398278|7675590|FG001|NOT COMPLETED|Period 2||2
6747669|NCT03398330|7675612|FG000|STARTED|Period 1||21
6747670|NCT03398330|7675613|FG001|STARTED|Period 1||21
6747671|NCT03398330|7675612|FG000|COMPLETED|Period 1||20
6747672|NCT03398330|7675613|FG001|COMPLETED|Period 1||17
6747673|NCT03398330|7675612|FG000|NOT COMPLETED|Period 1||1
6747674|NCT03398330|7675613|FG001|NOT COMPLETED|Period 1||4
6747675|NCT03398330|7675612|FG000|STARTED|Period 2||20
6747676|NCT03398330|7675613|FG001|STARTED|Period 2||17
6747677|NCT03398330|7675612|FG000|COMPLETED|Period 2||19
6477223|NCT01288443|7394386|FG003|STARTED|Overall Study|Randomized|31
6477224|NCT01288443|7394387|FG004|STARTED|Overall Study|Randomized|30
6477225|NCT01288443|7394388|FG005|STARTED|Overall Study|Randomized|30
6477226|NCT01288443|7394383|FG000|Treated|Overall Study||31
6477227|NCT01288443|7394384|FG001|Treated|Overall Study||30
6477228|NCT01288443|7394385|FG002|Treated|Overall Study||31
6477229|NCT01288443|7394386|FG003|Treated|Overall Study||31
6477230|NCT01288443|7394387|FG004|Treated|Overall Study||29
6477231|NCT01288443|7394388|FG005|Treated|Overall Study||30
6477232|NCT01288443|7394383|FG000|COMPLETED|Overall Study||31
6477233|NCT01288443|7394384|FG001|COMPLETED|Overall Study||29
6477234|NCT01288443|7394385|FG002|COMPLETED|Overall Study||30
6477235|NCT01288443|7394386|FG003|COMPLETED|Overall Study||27
6477236|NCT01288443|7394387|FG004|COMPLETED|Overall Study||23
6477237|NCT01288443|7394388|FG005|COMPLETED|Overall Study||25
6477238|NCT01288443|7394383|FG000|NOT COMPLETED|Overall Study||0
6477239|NCT01288443|7394384|FG001|NOT COMPLETED|Overall Study||1
6477240|NCT01288443|7394385|FG002|NOT COMPLETED|Overall Study||1
6747678|NCT03398330|7675613|FG001|COMPLETED|Period 2||17
6747679|NCT03398330|7675612|FG000|NOT COMPLETED|Period 2||1
6747680|NCT03398330|7675613|FG001|NOT COMPLETED|Period 2||0
6477241|NCT01288443|7394386|FG003|NOT COMPLETED|Overall Study||4
6477242|NCT01288443|7394387|FG004|NOT COMPLETED|Overall Study||7
6477243|NCT01288443|7394388|FG005|NOT COMPLETED|Overall Study||5
6477244|NCT01288469|7394405|FG000|STARTED|Overall Study|Randomized|31
6477245|NCT01288469|7394406|FG001|STARTED|Overall Study|Randomized|31
6477246|NCT01288469|7394407|FG002|STARTED|Overall Study|Randomized|30
6477247|NCT01288469|7394405|FG000|Treated|Overall Study||31
6477248|NCT01288469|7394406|FG001|Treated|Overall Study||31
6477249|NCT01288469|7394407|FG002|Treated|Overall Study||30
6477250|NCT01288469|7394405|FG000|COMPLETED|Overall Study||24
6477251|NCT01288469|7394406|FG001|COMPLETED|Overall Study||28
6747681|NCT03398356|7675636|FG000|STARTED|Before Treatment||15
6747682|NCT03398356|7675637|FG001|STARTED|Before Treatment||21
6747683|NCT03398356|7675638|FG002|STARTED|Before Treatment||11
6747684|NCT03398356|7675636|FG000|COMPLETED|Before Treatment||12
6747685|NCT03398356|7675637|FG001|COMPLETED|Before Treatment||13
6747686|NCT03398356|7675638|FG002|COMPLETED|Before Treatment|only baseline parameters were taken, this group did not participate in the further part of the study|0
6747687|NCT03398356|7675636|FG000|NOT COMPLETED|Before Treatment||3
6747688|NCT03398356|7675637|FG001|NOT COMPLETED|Before Treatment||8
6747689|NCT03398356|7675638|FG002|NOT COMPLETED|Before Treatment||11
6747690|NCT03398356|7675636|FG000|STARTED|After 6 Weeks of Treatment||12
6747691|NCT03398356|7675637|FG001|STARTED|After 6 Weeks of Treatment||13
6747692|NCT03398356|7675638|FG002|STARTED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6747693|NCT03398356|7675636|FG000|COMPLETED|After 6 Weeks of Treatment||12
6747694|NCT03398356|7675637|FG001|COMPLETED|After 6 Weeks of Treatment||11
6747695|NCT03398356|7675638|FG002|COMPLETED|After 6 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6747696|NCT03398356|7675636|FG000|NOT COMPLETED|After 6 Weeks of Treatment||0
6747697|NCT03398356|7675637|FG001|NOT COMPLETED|After 6 Weeks of Treatment||2
6747698|NCT03398356|7675638|FG002|NOT COMPLETED|After 6 Weeks of Treatment||0
6747699|NCT03398356|7675636|FG000|STARTED|Post 6 Week Period Initial Evaluation|two of the patients were moved from group B, because of intolerance of the higher dose of the drug|14
6747700|NCT03398356|7675637|FG001|STARTED|Post 6 Week Period Initial Evaluation||11
6747701|NCT03398356|7675638|FG002|STARTED|Post 6 Week Period Initial Evaluation||0
6747702|NCT03398356|7675636|FG000|COMPLETED|Post 6 Week Period Initial Evaluation||14
6747703|NCT03398356|7675637|FG001|COMPLETED|Post 6 Week Period Initial Evaluation||11
6747704|NCT03398356|7675638|FG002|COMPLETED|Post 6 Week Period Initial Evaluation||0
6747705|NCT03398356|7675636|FG000|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
6747706|NCT03398356|7675637|FG001|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
6747707|NCT03398356|7675638|FG002|NOT COMPLETED|Post 6 Week Period Initial Evaluation||0
6747708|NCT03398356|7675636|FG000|STARTED|After 12 Weeks of Treatment||14
6747709|NCT03398356|7675637|FG001|STARTED|After 12 Weeks of Treatment||11
6747710|NCT03398356|7675638|FG002|STARTED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6747711|NCT03398356|7675636|FG000|COMPLETED|After 12 Weeks of Treatment||14
6747712|NCT03398356|7675637|FG001|COMPLETED|After 12 Weeks of Treatment||11
6747713|NCT03398356|7675638|FG002|COMPLETED|After 12 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6747714|NCT03398356|7675636|FG000|NOT COMPLETED|After 12 Weeks of Treatment||0
6747715|NCT03398356|7675637|FG001|NOT COMPLETED|After 12 Weeks of Treatment||0
6747716|NCT03398356|7675638|FG002|NOT COMPLETED|After 12 Weeks of Treatment||0
6747717|NCT03398356|7675636|FG000|STARTED|After 15 Weeks of Treatment||14
6747718|NCT03398356|7675637|FG001|STARTED|After 15 Weeks of Treatment||11
6747719|NCT03398356|7675638|FG002|STARTED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6747720|NCT03398356|7675636|FG000|COMPLETED|After 15 Weeks of Treatment||14
6747721|NCT03398356|7675637|FG001|COMPLETED|After 15 Weeks of Treatment||11
6747722|NCT03398356|7675638|FG002|COMPLETED|After 15 Weeks of Treatment|control group- only initial parameters were assessed to compare, no follow-up|0
6747723|NCT03398356|7675636|FG000|NOT COMPLETED|After 15 Weeks of Treatment||0
6747724|NCT03398356|7675637|FG001|NOT COMPLETED|After 15 Weeks of Treatment||0
6747725|NCT03398356|7675638|FG002|NOT COMPLETED|After 15 Weeks of Treatment||0
6747726|NCT03398421|7675646|FG000|STARTED|Treatment Period 1 (Up to 6 Days)||20
6747727|NCT03398421|7675647|FG001|STARTED|Treatment Period 1 (Up to 6 Days)||0
6747728|NCT03398421|7675646|FG000|COMPLETED|Treatment Period 1 (Up to 6 Days)||20
6747729|NCT03398421|7675647|FG001|COMPLETED|Treatment Period 1 (Up to 6 Days)||0
6747730|NCT03398421|7675646|FG000|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
6747731|NCT03398421|7675647|FG001|NOT COMPLETED|Treatment Period 1 (Up to 6 Days)||0
6747732|NCT03398421|7675646|FG000|STARTED|Washout Period (Up to 14 Days)||20
6747733|NCT03398421|7675647|FG001|STARTED|Washout Period (Up to 14 Days)||0
6747734|NCT03398421|7675646|FG000|COMPLETED|Washout Period (Up to 14 Days)||20
6747735|NCT03398421|7675647|FG001|COMPLETED|Washout Period (Up to 14 Days)||0
6747736|NCT03398421|7675646|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
6747737|NCT03398421|7675647|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
6747738|NCT03398421|7675646|FG000|STARTED|Treatment Period 2 (Up to 11 Days)||0
6747739|NCT03398421|7675647|FG001|STARTED|Treatment Period 2 (Up to 11 Days)||20
6477252|NCT01288469|7394407|FG002|COMPLETED|Overall Study||28
6477253|NCT01288469|7394405|FG000|NOT COMPLETED|Overall Study||7
6477254|NCT01288469|7394406|FG001|NOT COMPLETED|Overall Study||3
6477255|NCT01288469|7394407|FG002|NOT COMPLETED|Overall Study||2
6477256|NCT01288521|7394417|FG000|STARTED|Overall Study||3
6477257|NCT01288521|7394418|FG001|STARTED|Overall Study||5
6477258|NCT01288521|7394417|FG000|COMPLETED|Overall Study||3
6747740|NCT03398421|7675646|FG000|COMPLETED|Treatment Period 2 (Up to 11 Days)||0
6747741|NCT03398421|7675647|FG001|COMPLETED|Treatment Period 2 (Up to 11 Days)||20
6747742|NCT03398421|7675646|FG000|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
6747743|NCT03398421|7675647|FG001|NOT COMPLETED|Treatment Period 2 (Up to 11 Days)||0
6747744|NCT03398798|7675659|FG000|STARTED|Overall Study||9
6747745|NCT03398798|7675660|FG001|STARTED|Overall Study||9
6747746|NCT03398798|7675661|FG002|STARTED|Overall Study||9
6747747|NCT03398798|7675662|FG003|STARTED|Overall Study||9
6747748|NCT03398798|7675659|FG000|COMPLETED|Overall Study||9
6747749|NCT03398798|7675660|FG001|COMPLETED|Overall Study||9
6747750|NCT03398798|7675661|FG002|COMPLETED|Overall Study||9
6747751|NCT03398798|7675662|FG003|COMPLETED|Overall Study||9
6747752|NCT03398798|7675659|FG000|NOT COMPLETED|Overall Study||0
6747753|NCT03398798|7675660|FG001|NOT COMPLETED|Overall Study||0
6747754|NCT03398798|7675661|FG002|NOT COMPLETED|Overall Study||0
6747755|NCT03398798|7675662|FG003|NOT COMPLETED|Overall Study||0
6747756|NCT03398928|7675674|FG000|STARTED|Overall Study||50
6747757|NCT03398928|7675675|FG001|STARTED|Overall Study||31
6747758|NCT03398928|7675674|FG000|COMPLETED|Overall Study||50
6747759|NCT03398928|7675675|FG001|COMPLETED|Overall Study||31
6747760|NCT03398928|7675674|FG000|NOT COMPLETED|Overall Study||0
6747761|NCT03398928|7675675|FG001|NOT COMPLETED|Overall Study||0
6747762|NCT03399370|7675683|FG000|STARTED|Overall Study||781
6747763|NCT03399370|7675684|FG001|STARTED|Overall Study||780
6747764|NCT03399370|7675683|FG000|COMPLETED|Overall Study||721
6747765|NCT03399370|7675684|FG001|COMPLETED|Overall Study||694
6747766|NCT03399370|7675683|FG000|NOT COMPLETED|Overall Study||60
6747767|NCT03399370|7675684|FG001|NOT COMPLETED|Overall Study||86
6747768|NCT03399786|7675693|FG000|STARTED|Double-blind Treatment Period (DBTP)||22
6747769|NCT03399786|7675694|FG001|STARTED|Double-blind Treatment Period (DBTP)||43
6747770|NCT03399786|7675695|FG002|STARTED|Double-blind Treatment Period (DBTP)||0
6747771|NCT03399786|7675696|FG003|STARTED|Double-blind Treatment Period (DBTP)||0
6747772|NCT03399786|7675693|FG000|COMPLETED|Double-blind Treatment Period (DBTP)||21
6747773|NCT03399786|7675694|FG001|COMPLETED|Double-blind Treatment Period (DBTP)||43
6747774|NCT03399786|7675695|FG002|COMPLETED|Double-blind Treatment Period (DBTP)||0
6747775|NCT03399786|7675696|FG003|COMPLETED|Double-blind Treatment Period (DBTP)||0
6747776|NCT03399786|7675693|FG000|NOT COMPLETED|Double-blind Treatment Period (DBTP)||1
6747777|NCT03399786|7675694|FG001|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
6747778|NCT03399786|7675695|FG002|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
6747779|NCT03399786|7675696|FG003|NOT COMPLETED|Double-blind Treatment Period (DBTP)||0
6747780|NCT03399786|7675693|FG000|STARTED|Open-label Treatment Period (OLTP)||0
6747781|NCT03399786|7675694|FG001|STARTED|Open-label Treatment Period (OLTP)||0
6747782|NCT03399786|7675695|FG002|STARTED|Open-label Treatment Period (OLTP)|One participant from the placebo group received evinacumab during the DBTP|20
6747783|NCT03399786|7675696|FG003|STARTED|Open-label Treatment Period (OLTP)||44
6747784|NCT03399786|7675693|FG000|COMPLETED|Open-label Treatment Period (OLTP)||0
6747785|NCT03399786|7675694|FG001|COMPLETED|Open-label Treatment Period (OLTP)||0
6747786|NCT03399786|7675695|FG002|COMPLETED|Open-label Treatment Period (OLTP)||19
6747787|NCT03399786|7675696|FG003|COMPLETED|Open-label Treatment Period (OLTP)||43
6747788|NCT03399786|7675693|FG000|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
6747789|NCT03399786|7675694|FG001|NOT COMPLETED|Open-label Treatment Period (OLTP)||0
6747790|NCT03399786|7675695|FG002|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
6747791|NCT03399786|7675696|FG003|NOT COMPLETED|Open-label Treatment Period (OLTP)||1
6747792|NCT03400033|7675706|FG000|STARTED|Overall Study||270
6747793|NCT03400033|7675707|FG001|STARTED|Overall Study||137
6747794|NCT03400033|7675706|FG000|COMPLETED|Overall Study||269
6747795|NCT03400033|7675707|FG001|COMPLETED|Overall Study||135
6747796|NCT03400033|7675706|FG000|NOT COMPLETED|Overall Study||1
6747797|NCT03400033|7675707|FG001|NOT COMPLETED|Overall Study||2
6747798|NCT03400163|7675724|FG000|STARTED|Treatment Period||1
6747799|NCT03400163|7675725|FG001|STARTED|Treatment Period||2
6747800|NCT03400163|7675724|FG000|COMPLETED|Treatment Period||1
6747801|NCT03400163|7675725|FG001|COMPLETED|Treatment Period||2
6747802|NCT03400163|7675724|FG000|NOT COMPLETED|Treatment Period||0
6747803|NCT03400163|7675725|FG001|NOT COMPLETED|Treatment Period||0
6747804|NCT03400163|7675724|FG000|STARTED|Follow-up Period||1
6747805|NCT03400163|7675725|FG001|STARTED|Follow-up Period||2
6747806|NCT03400163|7675724|FG000|COMPLETED|Follow-up Period||1
6747807|NCT03400163|7675725|FG001|COMPLETED|Follow-up Period||2
6747808|NCT03400163|7675724|FG000|NOT COMPLETED|Follow-up Period||0
6747809|NCT03400163|7675725|FG001|NOT COMPLETED|Follow-up Period||0
6747810|NCT03400449|7675733|FG000|STARTED|Overall Study||121
6747811|NCT03400449|7675734|FG001|STARTED|Overall Study||119
6747812|NCT03400449|7675733|FG000|COMPLETED|Overall Study||120
6747813|NCT03400449|7675734|FG001|COMPLETED|Overall Study||119
6747814|NCT03400449|7675733|FG000|NOT COMPLETED|Overall Study||1
6747815|NCT03400449|7675734|FG001|NOT COMPLETED|Overall Study||0
6747816|NCT03400475|7675744|FG000|STARTED|Overall Study||24
6747817|NCT03400475|7675745|FG001|STARTED|Overall Study||22
6747818|NCT03400475|7675744|FG000|COMPLETED|Overall Study||24
6747819|NCT03400475|7675745|FG001|COMPLETED|Overall Study||22
6747820|NCT03400475|7675744|FG000|NOT COMPLETED|Overall Study||0
6747821|NCT03400475|7675745|FG001|NOT COMPLETED|Overall Study||0
6477259|NCT01288521|7394418|FG001|COMPLETED|Overall Study||5
6477260|NCT01288521|7394417|FG000|NOT COMPLETED|Overall Study||0
6477261|NCT01288521|7394418|FG001|NOT COMPLETED|Overall Study||0
6477262|NCT01288534|7394424|FG000|STARTED|Overall Study||68
6477263|NCT01288534|7394424|FG000|COMPLETED|Overall Study||68
6477264|NCT01288534|7394424|FG000|NOT COMPLETED|Overall Study||0
6477265|NCT01288612|7394431|FG000|STARTED|Overall Study||150
6477266|NCT01288612|7394432|FG001|STARTED|Overall Study||151
6477267|NCT01288612|7394433|FG002|STARTED|Overall Study||158
6477268|NCT01288612|7394431|FG000|Contacted|Overall Study||139
6477269|NCT01288612|7394432|FG001|Contacted|Overall Study||135
6477270|NCT01288612|7394433|FG002|Contacted|Overall Study||138
6477271|NCT01288612|7394431|FG000|Agreed to Take Part|Overall Study||61
6477272|NCT01288612|7394432|FG001|Agreed to Take Part|Overall Study||72
6477273|NCT01288612|7394433|FG002|Agreed to Take Part|Overall Study||76
6477274|NCT01288612|7394431|FG000|COMPLETED|Overall Study||61
6477275|NCT01288612|7394432|FG001|COMPLETED|Overall Study||69
6477276|NCT01288612|7394433|FG002|COMPLETED|Overall Study||76
6477277|NCT01288612|7394431|FG000|NOT COMPLETED|Overall Study||89
6477278|NCT01288612|7394432|FG001|NOT COMPLETED|Overall Study||82
6477279|NCT01288612|7394433|FG002|NOT COMPLETED|Overall Study||82
6477280|NCT01288729|7394443|FG000|STARTED|Overall Study||10
6477281|NCT01288729|7394444|FG001|STARTED|Overall Study||10
6477282|NCT01288729|7394443|FG000|COMPLETED|Overall Study||9
6477283|NCT01288729|7394444|FG001|COMPLETED|Overall Study||10
6477284|NCT01288729|7394443|FG000|NOT COMPLETED|Overall Study||1
6477285|NCT01288729|7394444|FG001|NOT COMPLETED|Overall Study||0
6477286|NCT01288781|7394452|FG000|STARTED|Overall Study||11
6477287|NCT01288781|7394453|FG001|STARTED|Overall Study||12
6477288|NCT01288781|7394452|FG000|COMPLETED|Overall Study||11
6477289|NCT01288781|7394453|FG001|COMPLETED|Overall Study||12
6477290|NCT01288781|7394452|FG000|NOT COMPLETED|Overall Study||0
6477291|NCT01288781|7394453|FG001|NOT COMPLETED|Overall Study||0
6477292|NCT01288807|7394459|FG000|STARTED|Overall Study||8
6747822|NCT03400579|7675752|FG000|STARTED|Overall Study||10
6747823|NCT03400579|7675752|FG000|COMPLETED|Overall Study||10
6747824|NCT03400579|7675752|FG000|NOT COMPLETED|Overall Study||0
6747825|NCT03400748|7675756|FG000|STARTED|Overall Study||6
6747826|NCT03400748|7675756|FG000|COMPLETED|Overall Study||6
6747827|NCT03400748|7675756|FG000|NOT COMPLETED|Overall Study||0
6747828|NCT03400787|7675762|FG000|STARTED|Overall Study||66
6747829|NCT03400787|7675763|FG001|STARTED|Overall Study||71
6747830|NCT03400787|7675762|FG000|3-Month Follow-up|Overall Study||64
6747831|NCT03400787|7675763|FG001|3-Month Follow-up|Overall Study||63
6747832|NCT03400787|7675762|FG000|COMPLETED|Overall Study||64
6747833|NCT03400787|7675763|FG001|COMPLETED|Overall Study||63
6747834|NCT03400787|7675762|FG000|NOT COMPLETED|Overall Study||2
6747835|NCT03400787|7675763|FG001|NOT COMPLETED|Overall Study||8
6747836|NCT03400800|7675771|FG000|STARTED|Overall Study||810
6747837|NCT03400800|7675772|FG001|STARTED|Overall Study||807
6747838|NCT03400800|7675771|FG000|COMPLETED|Overall Study||772
6747839|NCT03400800|7675772|FG001|COMPLETED|Overall Study||770
6747840|NCT03400800|7675771|FG000|NOT COMPLETED|Overall Study||38
6747841|NCT03400800|7675772|FG001|NOT COMPLETED|Overall Study||37
6747842|NCT03400852|7675780|FG000|STARTED|Blinded Treatment Period||29
6747843|NCT03400852|7675781|FG001|STARTED|Blinded Treatment Period||15
6747844|NCT03400852|7675782|FG002|STARTED|Blinded Treatment Period||0
6747845|NCT03400852|7675780|FG000|COMPLETED|Blinded Treatment Period||20
6747846|NCT03400852|7675781|FG001|COMPLETED|Blinded Treatment Period||9
6747847|NCT03400852|7675782|FG002|COMPLETED|Blinded Treatment Period||0
6747848|NCT03400852|7675780|FG000|NOT COMPLETED|Blinded Treatment Period||9
6747849|NCT03400852|7675781|FG001|NOT COMPLETED|Blinded Treatment Period||6
6747850|NCT03400852|7675782|FG002|NOT COMPLETED|Blinded Treatment Period||0
6747851|NCT03400852|7675780|FG000|STARTED|Open Label Period||0
6747852|NCT03400852|7675781|FG001|STARTED|Open Label Period||0
6747853|NCT03400852|7675782|FG002|STARTED|Open Label Period||24
6747854|NCT03400852|7675780|FG000|COMPLETED|Open Label Period||0
6747855|NCT03400852|7675781|FG001|COMPLETED|Open Label Period||0
6747856|NCT03400852|7675782|FG002|COMPLETED|Open Label Period||2
6747857|NCT03400852|7675780|FG000|NOT COMPLETED|Open Label Period||0
6747858|NCT03400852|7675781|FG001|NOT COMPLETED|Open Label Period||0
6747859|NCT03400852|7675782|FG002|NOT COMPLETED|Open Label Period||22
6747860|NCT03400956|7675793|FG000|STARTED|Treatment Period 1||35
6747861|NCT03400956|7675794|FG001|STARTED|Treatment Period 1||34
6747862|NCT03400956|7675795|FG002|STARTED|Treatment Period 1||34
6477293|NCT01288807|7394459|FG000|COMPLETED|Overall Study||8
6477294|NCT01288807|7394459|FG000|NOT COMPLETED|Overall Study||0
6477295|NCT01288833|7394465|FG000|STARTED|Overall Study||277
6477296|NCT01288833|7394466|FG001|STARTED|Overall Study||281
6477297|NCT01288833|7394465|FG000|COMPLETED|Overall Study||277
6477298|NCT01288833|7394466|FG001|COMPLETED|Overall Study||281
6477299|NCT01288833|7394465|FG000|NOT COMPLETED|Overall Study||0
6477300|NCT01288833|7394466|FG001|NOT COMPLETED|Overall Study||0
6477301|NCT01288859|7394472|FG000|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
6747863|NCT03400956|7675793|FG000|Treated|Treatment Period 1||31
6747864|NCT03400956|7675794|FG001|Treated|Treatment Period 1||30
6747865|NCT03400956|7675795|FG002|Treated|Treatment Period 1||30
6747866|NCT03400956|7675793|FG000|COMPLETED|Treatment Period 1||31
6747867|NCT03400956|7675794|FG001|COMPLETED|Treatment Period 1||26
6747868|NCT03400956|7675795|FG002|COMPLETED|Treatment Period 1||25
6747869|NCT03400956|7675793|FG000|NOT COMPLETED|Treatment Period 1||4
6747870|NCT03400956|7675794|FG001|NOT COMPLETED|Treatment Period 1||8
6747871|NCT03400956|7675795|FG002|NOT COMPLETED|Treatment Period 1||9
6747872|NCT03400956|7675793|FG000|STARTED|Post-treatment Period 1||31
6747873|NCT03400956|7675794|FG001|STARTED|Post-treatment Period 1||26
6747874|NCT03400956|7675795|FG002|STARTED|Post-treatment Period 1||25
6747875|NCT03400956|7675793|FG000|COMPLETED|Post-treatment Period 1||9
6747876|NCT03400956|7675794|FG001|COMPLETED|Post-treatment Period 1||10
6747877|NCT03400956|7675795|FG002|COMPLETED|Post-treatment Period 1||9
6747878|NCT03400956|7675793|FG000|NOT COMPLETED|Post-treatment Period 1||22
6747879|NCT03400956|7675794|FG001|NOT COMPLETED|Post-treatment Period 1||16
6747880|NCT03400956|7675795|FG002|NOT COMPLETED|Post-treatment Period 1||16
6747881|NCT03400956|7675793|FG000|STARTED|Treatment Period 2||9
6747882|NCT03400956|7675794|FG001|STARTED|Treatment Period 2||10
6747883|NCT03400956|7675795|FG002|STARTED|Treatment Period 2||9
6747884|NCT03400956|7675793|FG000|COMPLETED|Treatment Period 2||5
6747885|NCT03400956|7675794|FG001|COMPLETED|Treatment Period 2||7
6747886|NCT03400956|7675795|FG002|COMPLETED|Treatment Period 2||5
6747887|NCT03400956|7675793|FG000|NOT COMPLETED|Treatment Period 2||4
6747888|NCT03400956|7675794|FG001|NOT COMPLETED|Treatment Period 2||3
6747889|NCT03400956|7675795|FG002|NOT COMPLETED|Treatment Period 2||4
6747890|NCT03400956|7675793|FG000|STARTED|Follow-up Period||6
6747891|NCT03400956|7675794|FG001|STARTED|Follow-up Period||9
6747892|NCT03400956|7675795|FG002|STARTED|Follow-up Period||7
6747893|NCT03400956|7675793|FG000|COMPLETED|Follow-up Period||6
6747894|NCT03400956|7675794|FG001|COMPLETED|Follow-up Period||9
6747895|NCT03400956|7675795|FG002|COMPLETED|Follow-up Period||5
6747896|NCT03400956|7675793|FG000|NOT COMPLETED|Follow-up Period||0
6747897|NCT03400956|7675794|FG001|NOT COMPLETED|Follow-up Period||0
6747898|NCT03400956|7675795|FG002|NOT COMPLETED|Follow-up Period||2
6747899|NCT03401229|7675808|FG000|STARTED|Overall Study||207
6747900|NCT03401229|7675809|FG001|STARTED|Overall Study||203
6747901|NCT03401229|7675808|FG000|COMPLETED|Overall Study||167
6747902|NCT03401229|7675809|FG001|COMPLETED|Overall Study||166
6747903|NCT03401229|7675808|FG000|NOT COMPLETED|Overall Study||40
6747904|NCT03401229|7675809|FG001|NOT COMPLETED|Overall Study||37
6747905|NCT03401450|7675817|FG000|STARTED|Overall Study||33
6747906|NCT03401450|7675818|FG001|STARTED|Overall Study||36
6747907|NCT03401450|7675817|FG000|COMPLETED|Overall Study||21
6747908|NCT03401450|7675818|FG001|COMPLETED|Overall Study||23
6747909|NCT03401450|7675817|FG000|NOT COMPLETED|Overall Study||12
6747910|NCT03401450|7675818|FG001|NOT COMPLETED|Overall Study||13
6747911|NCT03401671|7675826|FG000|STARTED|Overall Study||16
6747912|NCT03401671|7675827|FG001|STARTED|Overall Study||16
6747913|NCT03401671|7675826|FG000|COMPLETED|Overall Study||16
6747914|NCT03401671|7675827|FG001|COMPLETED|Overall Study||16
6747915|NCT03401671|7675826|FG000|NOT COMPLETED|Overall Study||0
6747916|NCT03401671|7675827|FG001|NOT COMPLETED|Overall Study||0
6747917|NCT03402126|7675833|FG000|STARTED|Overall Study||138
6747918|NCT03402126|7675833|FG000|COMPLETED|Overall Study||76
6747919|NCT03402126|7675833|FG000|NOT COMPLETED|Overall Study||62
6747920|NCT03402243|7675840|FG000|STARTED|Overall Study||16
6747921|NCT03402243|7675841|FG001|STARTED|Overall Study||15
6747922|NCT03402243|7675842|FG002|STARTED|Overall Study||16
6747923|NCT03402243|7675840|FG000|COMPLETED|Overall Study||13
6747924|NCT03402243|7675841|FG001|COMPLETED|Overall Study||12
6747925|NCT03402243|7675842|FG002|COMPLETED|Overall Study||14
6747926|NCT03402243|7675840|FG000|NOT COMPLETED|Overall Study||3
6747927|NCT03402243|7675841|FG001|NOT COMPLETED|Overall Study||3
6747928|NCT03402243|7675842|FG002|NOT COMPLETED|Overall Study||2
6747929|NCT03402386|7675850|FG000|STARTED|Overall Study||42
6747930|NCT03402386|7675850|FG000|Correction Group|Overall Study||2
6747931|NCT03402386|7675850|FG000|Conversion Group|Overall Study||40
6747932|NCT03402386|7675850|FG000|COMPLETED|Overall Study||36
6747933|NCT03402386|7675850|FG000|NOT COMPLETED|Overall Study||6
6747934|NCT03402555|7675854|FG000|STARTED|Overall Study||96
6747935|NCT03402555|7675854|FG000|COMPLETED|Overall Study||91
6747936|NCT03402555|7675854|FG000|NOT COMPLETED|Overall Study||5
6747937|NCT03402659|7675860|FG000|STARTED|Overall Study||83
6747938|NCT03402659|7675861|FG001|STARTED|Overall Study||78
6747939|NCT03402659|7675860|FG000|COMPLETED|Overall Study||78
6747940|NCT03402659|7675861|FG001|COMPLETED|Overall Study||73
6747941|NCT03402659|7675860|FG000|NOT COMPLETED|Overall Study||5
6747942|NCT03402659|7675861|FG001|NOT COMPLETED|Overall Study||5
6747943|NCT03402750|7675869|FG000|STARTED|Overall Study||20
6747944|NCT03402750|7675870|FG001|STARTED|Overall Study||20
6747945|NCT03402750|7675869|FG000|COMPLETED|Overall Study||18
6747946|NCT03402750|7675870|FG001|COMPLETED|Overall Study||19
6747947|NCT03402750|7675869|FG000|NOT COMPLETED|Overall Study||2
6747948|NCT03402750|7675870|FG001|NOT COMPLETED|Overall Study||1
6747949|NCT03402893|7675876|FG000|STARTED|Overall Study||21
6747950|NCT03402893|7675876|FG000|COMPLETED|Overall Study||20
6747951|NCT03402893|7675876|FG000|NOT COMPLETED|Overall Study||1
6747952|NCT03402932|7675885|FG000|STARTED|Overall Study||13
6747953|NCT03402932|7675886|FG001|STARTED|Overall Study||8
6747954|NCT03402932|7675887|FG002|STARTED|Overall Study||8
6747955|NCT03402932|7675888|FG003|STARTED|Overall Study||8
6747956|NCT03402932|7675885|FG000|COMPLETED|Overall Study||13
6747957|NCT03402932|7675886|FG001|COMPLETED|Overall Study||8
6747958|NCT03402932|7675887|FG002|COMPLETED|Overall Study||8
6747959|NCT03402932|7675888|FG003|COMPLETED|Overall Study||8
6747960|NCT03402932|7675885|FG000|NOT COMPLETED|Overall Study||0
6747961|NCT03402932|7675886|FG001|NOT COMPLETED|Overall Study||0
6747962|NCT03402932|7675887|FG002|NOT COMPLETED|Overall Study||0
6477302|NCT01288859|7394473|FG001|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
6477303|NCT01288859|7394474|FG002|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
6477304|NCT01288859|7394475|FG003|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
6477305|NCT01288859|7394476|FG004|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
6477306|NCT01288859|7394477|FG005|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
6477307|NCT01288859|7394472|FG000|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
6477308|NCT01288859|7394473|FG001|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477309|NCT01288859|7394474|FG002|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477310|NCT01288859|7394475|FG003|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477311|NCT01288859|7394476|FG004|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477312|NCT01288859|7394477|FG005|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
6477313|NCT01288859|7394472|FG000|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477314|NCT01288859|7394473|FG001|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477315|NCT01288859|7394474|FG002|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477316|NCT01288859|7394475|FG003|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477317|NCT01288859|7394476|FG004|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477318|NCT01288859|7394477|FG005|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
6477319|NCT01288859|7394472|FG000|STARTED|Washout Period of 1 Week||5
6477320|NCT01288859|7394473|FG001|STARTED|Washout Period of 1 Week||0
6477321|NCT01288859|7394474|FG002|STARTED|Washout Period of 1 Week||0
6477322|NCT01288859|7394475|FG003|STARTED|Washout Period of 1 Week||0
6477323|NCT01288859|7394476|FG004|STARTED|Washout Period of 1 Week||0
6477324|NCT01288859|7394477|FG005|STARTED|Washout Period of 1 Week||5
6477325|NCT01288859|7394472|FG000|COMPLETED|Washout Period of 1 Week||5
6477326|NCT01288859|7394473|FG001|COMPLETED|Washout Period of 1 Week||0
6477327|NCT01288859|7394474|FG002|COMPLETED|Washout Period of 1 Week||0
6477328|NCT01288859|7394475|FG003|COMPLETED|Washout Period of 1 Week||0
6477329|NCT01288859|7394476|FG004|COMPLETED|Washout Period of 1 Week||0
6477330|NCT01288859|7394477|FG005|COMPLETED|Washout Period of 1 Week||5
6477331|NCT01288859|7394472|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6477332|NCT01288859|7394473|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6477333|NCT01288859|7394474|FG002|NOT COMPLETED|Washout Period of 1 Week||0
6477334|NCT01288859|7394475|FG003|NOT COMPLETED|Washout Period of 1 Week||0
6477335|NCT01288859|7394476|FG004|NOT COMPLETED|Washout Period of 1 Week||0
6477336|NCT01288859|7394477|FG005|NOT COMPLETED|Washout Period of 1 Week||0
6747963|NCT03402932|7675888|FG003|NOT COMPLETED|Overall Study||0
6747964|NCT03403036|7675902|FG000|STARTED|Overall Study||39
6747965|NCT03403036|7675902|FG000|COMPLETED|Overall Study||34
6747966|NCT03403036|7675902|FG000|NOT COMPLETED|Overall Study||5
6747967|NCT03403192|7675910|FG000|STARTED|Overall Study||41
6747968|NCT03403192|7675911|FG001|STARTED|Overall Study||40
6747969|NCT03403192|7675912|FG002|STARTED|Overall Study||40
6747970|NCT03403192|7675913|FG003|STARTED|Overall Study||42
6747971|NCT03403192|7675910|FG000|COMPLETED|Overall Study||37
6747972|NCT03403192|7675911|FG001|COMPLETED|Overall Study||36
6747973|NCT03403192|7675912|FG002|COMPLETED|Overall Study||37
6747974|NCT03403192|7675913|FG003|COMPLETED|Overall Study||36
6747975|NCT03403192|7675910|FG000|NOT COMPLETED|Overall Study||4
6747976|NCT03403192|7675911|FG001|NOT COMPLETED|Overall Study||4
6747977|NCT03403192|7675912|FG002|NOT COMPLETED|Overall Study||3
6747978|NCT03403192|7675913|FG003|NOT COMPLETED|Overall Study||6
6747979|NCT03403231|7675939|FG000|STARTED|Overall Study||9
6747980|NCT03403231|7675940|FG001|STARTED|Overall Study||9
6747981|NCT03403231|7675941|FG002|STARTED|Overall Study||9
6747982|NCT03403231|7675942|FG003|STARTED|Overall Study||9
6747983|NCT03403231|7675943|FG004|STARTED|Overall Study||9
6747984|NCT03403231|7675944|FG005|STARTED|Overall Study||9
6747985|NCT03403231|7675945|FG006|STARTED|Overall Study||9
6747986|NCT03403231|7675946|FG007|STARTED|Overall Study||9
6747987|NCT03403231|7675947|FG008|STARTED|Overall Study||9
6747988|NCT03403231|7675948|FG009|STARTED|Overall Study||9
6747989|NCT03403231|7675949|FG010|STARTED|Overall Study||9
6747990|NCT03403231|7675950|FG011|STARTED|Overall Study||9
6747991|NCT03403231|7675951|FG012|STARTED|Overall Study||9
6747992|NCT03403231|7675952|FG013|STARTED|Overall Study||9
6747993|NCT03403231|7675953|FG014|STARTED|Overall Study||9
6747994|NCT03403231|7675954|FG015|STARTED|Overall Study||9
6747995|NCT03403231|7675939|FG000|COMPLETED|Overall Study||9
6747996|NCT03403231|7675940|FG001|COMPLETED|Overall Study||9
6747997|NCT03403231|7675941|FG002|COMPLETED|Overall Study||9
6477337|NCT01288859|7394472|FG000|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
6477338|NCT01288859|7394473|FG001|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
6477339|NCT01288859|7394474|FG002|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
6477340|NCT01288859|7394475|FG003|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
6477341|NCT01288859|7394476|FG004|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
6747998|NCT03403231|7675942|FG003|COMPLETED|Overall Study||9
6747999|NCT03403231|7675943|FG004|COMPLETED|Overall Study||9
6748000|NCT03403231|7675944|FG005|COMPLETED|Overall Study||9
6748001|NCT03403231|7675945|FG006|COMPLETED|Overall Study||9
6748002|NCT03403231|7675946|FG007|COMPLETED|Overall Study||9
6748003|NCT03403231|7675947|FG008|COMPLETED|Overall Study||9
6748004|NCT03403231|7675948|FG009|COMPLETED|Overall Study||9
6748005|NCT03403231|7675949|FG010|COMPLETED|Overall Study||9
6748006|NCT03403231|7675950|FG011|COMPLETED|Overall Study||9
6748007|NCT03403231|7675951|FG012|COMPLETED|Overall Study||9
6748008|NCT03403231|7675952|FG013|COMPLETED|Overall Study||9
6477342|NCT01288859|7394477|FG005|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
6477343|NCT01288859|7394472|FG000|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
6477344|NCT01288859|7394473|FG001|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6477345|NCT01288859|7394474|FG002|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6477346|NCT01288859|7394475|FG003|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6477347|NCT01288859|7394476|FG004|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6477348|NCT01288859|7394477|FG005|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
6477349|NCT01288859|7394472|FG000|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6477350|NCT01288859|7394473|FG001|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6748009|NCT03403231|7675953|FG014|COMPLETED|Overall Study||9
6748010|NCT03403231|7675954|FG015|COMPLETED|Overall Study||9
6748011|NCT03403231|7675939|FG000|NOT COMPLETED|Overall Study||0
6748012|NCT03403231|7675940|FG001|NOT COMPLETED|Overall Study||0
6748013|NCT03403231|7675941|FG002|NOT COMPLETED|Overall Study||0
6748014|NCT03403231|7675942|FG003|NOT COMPLETED|Overall Study||0
6748015|NCT03403231|7675943|FG004|NOT COMPLETED|Overall Study||0
6748016|NCT03403231|7675944|FG005|NOT COMPLETED|Overall Study||0
6748017|NCT03403231|7675945|FG006|NOT COMPLETED|Overall Study||0
6748018|NCT03403231|7675946|FG007|NOT COMPLETED|Overall Study||0
6748019|NCT03403231|7675947|FG008|NOT COMPLETED|Overall Study||0
6748020|NCT03403231|7675948|FG009|NOT COMPLETED|Overall Study||0
6748021|NCT03403231|7675949|FG010|NOT COMPLETED|Overall Study||0
6748022|NCT03403231|7675950|FG011|NOT COMPLETED|Overall Study||0
6748023|NCT03403231|7675951|FG012|NOT COMPLETED|Overall Study||0
6748024|NCT03403231|7675952|FG013|NOT COMPLETED|Overall Study||0
6748025|NCT03403231|7675953|FG014|NOT COMPLETED|Overall Study||0
6748026|NCT03403231|7675954|FG015|NOT COMPLETED|Overall Study||0
6748027|NCT03403374|7675988|FG000|STARTED|Overall Study||30
6748028|NCT03403374|7675988|FG000|COMPLETED|Overall Study||29
6748029|NCT03403374|7675988|FG000|NOT COMPLETED|Overall Study||1
6748030|NCT03403400|7675995|FG000|STARTED|Overall Study||5
6748031|NCT03403400|7675996|FG001|STARTED|Overall Study||6
6748032|NCT03403400|7675997|FG002|STARTED|Overall Study||6
6748033|NCT03403400|7675995|FG000|COMPLETED|Overall Study||3
6748034|NCT03403400|7675996|FG001|COMPLETED|Overall Study||6
6748035|NCT03403400|7675997|FG002|COMPLETED|Overall Study||4
6748036|NCT03403400|7675995|FG000|NOT COMPLETED|Overall Study||2
6748037|NCT03403400|7675996|FG001|NOT COMPLETED|Overall Study||0
6748038|NCT03403400|7675997|FG002|NOT COMPLETED|Overall Study||2
6748039|NCT03403413|7676020|FG000|STARTED|Overall Study||5
6748040|NCT03403413|7676020|FG000|COMPLETED|Overall Study||3
6748041|NCT03403413|7676020|FG000|NOT COMPLETED|Overall Study||2
6748042|NCT03403426|7676026|FG000|STARTED|Overall Study||85
6748043|NCT03403426|7676026|FG000|COMPLETED|Overall Study||82
6748044|NCT03403426|7676026|FG000|NOT COMPLETED|Overall Study||3
6748045|NCT03403491|7676030|FG000|STARTED|Overall Study||20
6748046|NCT03403491|7676031|FG001|STARTED|Overall Study||23
6748047|NCT03403491|7676030|FG000|COMPLETED|Overall Study||17
6748048|NCT03403491|7676031|FG001|COMPLETED|Overall Study||18
6748049|NCT03403491|7676030|FG000|NOT COMPLETED|Overall Study||3
6748050|NCT03403491|7676031|FG001|NOT COMPLETED|Overall Study||5
6748051|NCT03403504|7676040|FG000|STARTED|Period 1||12
6748052|NCT03403504|7676041|FG001|STARTED|Period 1||12
6748053|NCT03403504|7676040|FG000|COMPLETED|Period 1||12
6748054|NCT03403504|7676041|FG001|COMPLETED|Period 1||11
6748055|NCT03403504|7676040|FG000|NOT COMPLETED|Period 1||0
6748056|NCT03403504|7676041|FG001|NOT COMPLETED|Period 1||1
6748057|NCT03403504|7676040|FG000|STARTED|Period 2||12
6748058|NCT03403504|7676041|FG001|STARTED|Period 2||11
6748059|NCT03403504|7676040|FG000|COMPLETED|Period 2||12
6748060|NCT03403504|7676041|FG001|COMPLETED|Period 2||11
6748061|NCT03403504|7676040|FG000|NOT COMPLETED|Period 2||0
6748062|NCT03403504|7676041|FG001|NOT COMPLETED|Period 2||0
6748063|NCT03403517|7676063|FG000|STARTED|Overall Study||88
6748064|NCT03403517|7676064|FG001|STARTED|Overall Study||86
6748065|NCT03403517|7676063|FG000|COMPLETED|Overall Study||88
6748066|NCT03403517|7676064|FG001|COMPLETED|Overall Study||86
6748067|NCT03403517|7676063|FG000|NOT COMPLETED|Overall Study||0
6748068|NCT03403517|7676064|FG001|NOT COMPLETED|Overall Study||0
6748069|NCT03403712|7676072|FG000|STARTED|Overall Study||200
6748070|NCT03403712|7676073|FG001|STARTED|Overall Study||202
6477351|NCT01288859|7394474|FG002|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6748071|NCT03403712|7676072|FG000|COMPLETED|Overall Study||95
6748072|NCT03403712|7676073|FG001|COMPLETED|Overall Study||102
6748073|NCT03403712|7676072|FG000|NOT COMPLETED|Overall Study||105
6748074|NCT03403712|7676073|FG001|NOT COMPLETED|Overall Study||100
6748075|NCT03403725|7676090|FG000|STARTED|Overall Study||1
6748076|NCT03403725|7676091|FG001|STARTED|Overall Study||1
6748077|NCT03403725|7676092|FG002|STARTED|Overall Study||1
6748078|NCT03403725|7676093|FG003|STARTED|Overall Study||1
6748079|NCT03403725|7676094|FG004|STARTED|Overall Study||1
6748080|NCT03403725|7676095|FG005|STARTED|Overall Study||6
6748081|NCT03403725|7676096|FG006|STARTED|Overall Study||6
6748082|NCT03403725|7676097|FG007|STARTED|Overall Study||3
6748083|NCT03403725|7676098|FG008|STARTED|Overall Study||3
6748084|NCT03403725|7676099|FG009|STARTED|Overall Study||4
6748085|NCT03403725|7676100|FG010|STARTED|Overall Study||1
6748086|NCT03403725|7676090|FG000|COMPLETED|Overall Study||1
6748087|NCT03403725|7676091|FG001|COMPLETED|Overall Study||1
6748088|NCT03403725|7676092|FG002|COMPLETED|Overall Study||1
6748089|NCT03403725|7676093|FG003|COMPLETED|Overall Study||1
6477352|NCT01288859|7394475|FG003|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6477353|NCT01288859|7394476|FG004|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6477354|NCT01288859|7394477|FG005|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
6477355|NCT01288859|7394472|FG000|STARTED|Washout Period of 1 Week||5
6477356|NCT01288859|7394473|FG001|STARTED|Washout Period of 1 Week||0
6477357|NCT01288859|7394474|FG002|STARTED|Washout Period of 1 Week||0
6748090|NCT03403725|7676094|FG004|COMPLETED|Overall Study||1
6748091|NCT03403725|7676095|FG005|COMPLETED|Overall Study||6
6748092|NCT03403725|7676096|FG006|COMPLETED|Overall Study||6
6748093|NCT03403725|7676097|FG007|COMPLETED|Overall Study||3
6748094|NCT03403725|7676098|FG008|COMPLETED|Overall Study||3
6748095|NCT03403725|7676099|FG009|COMPLETED|Overall Study||4
6748096|NCT03403725|7676100|FG010|COMPLETED|Overall Study||1
6748097|NCT03403725|7676090|FG000|NOT COMPLETED|Overall Study||0
6748098|NCT03403725|7676091|FG001|NOT COMPLETED|Overall Study||0
6748099|NCT03403725|7676092|FG002|NOT COMPLETED|Overall Study||0
6748100|NCT03403725|7676093|FG003|NOT COMPLETED|Overall Study||0
6748101|NCT03403725|7676094|FG004|NOT COMPLETED|Overall Study||0
6748102|NCT03403725|7676095|FG005|NOT COMPLETED|Overall Study||0
6748103|NCT03403725|7676096|FG006|NOT COMPLETED|Overall Study||0
6748104|NCT03403725|7676097|FG007|NOT COMPLETED|Overall Study||0
6748105|NCT03403725|7676098|FG008|NOT COMPLETED|Overall Study||0
6748106|NCT03403725|7676099|FG009|NOT COMPLETED|Overall Study||0
6748107|NCT03403725|7676100|FG010|NOT COMPLETED|Overall Study||0
6748108|NCT03403751|7676128|FG000|STARTED|Overall Study||28
6748109|NCT03403751|7676129|FG001|STARTED|Overall Study||30
6748110|NCT03403751|7676128|FG000|COMPLETED|Overall Study||21
6748111|NCT03403751|7676129|FG001|COMPLETED|Overall Study||22
6748112|NCT03403751|7676128|FG000|NOT COMPLETED|Overall Study||7
6748113|NCT03403751|7676129|FG001|NOT COMPLETED|Overall Study||8
6748114|NCT03404167|7676137|FG000|STARTED|Overall Study||8
6748115|NCT03404167|7676137|FG000|COMPLETED|Overall Study||8
6748116|NCT03404167|7676137|FG000|NOT COMPLETED|Overall Study||0
6748117|NCT03404206|7676146|FG000|STARTED|Overall Study||166
6748118|NCT03404206|7676147|FG001|STARTED|Overall Study||166
6748119|NCT03404206|7676148|FG002|STARTED|Overall Study||55
6748120|NCT03404206|7676146|FG000|COMPLETED|Overall Study||162
6748121|NCT03404206|7676147|FG001|COMPLETED|Overall Study||164
6748122|NCT03404206|7676148|FG002|COMPLETED|Overall Study||55
6748123|NCT03404206|7676146|FG000|NOT COMPLETED|Overall Study||4
6748124|NCT03404206|7676147|FG001|NOT COMPLETED|Overall Study||2
6748125|NCT03404206|7676148|FG002|NOT COMPLETED|Overall Study||0
6748126|NCT03404219|7676156|FG000|STARTED|Overall Study||31
6748127|NCT03404219|7676156|FG000|COMPLETED|Overall Study||31
6748128|NCT03404219|7676156|FG000|NOT COMPLETED|Overall Study||0
6748129|NCT03404375|7676163|FG000|STARTED|Overall Study||70
6748130|NCT03404375|7676164|FG001|STARTED|Overall Study||172
6748131|NCT03404375|7676163|FG000|COMPLETED|Overall Study||70
6748132|NCT03404375|7676164|FG001|COMPLETED|Overall Study||172
6748133|NCT03404375|7676163|FG000|NOT COMPLETED|Overall Study||0
6748134|NCT03404375|7676164|FG001|NOT COMPLETED|Overall Study||0
6748135|NCT03404401|7676172|FG000|STARTED|Overall Study||281
6748136|NCT03404401|7676173|FG001|STARTED|Overall Study||271
6748137|NCT03404401|7676172|FG000|COMPLETED|Overall Study||263
6748138|NCT03404401|7676173|FG001|COMPLETED|Overall Study||252
6748139|NCT03404401|7676172|FG000|NOT COMPLETED|Overall Study||18
6748140|NCT03404401|7676173|FG001|NOT COMPLETED|Overall Study||19
6748141|NCT03404609|7676179|FG000|STARTED|Overall Study||7
6748142|NCT03404609|7676179|FG000|COMPLETED|Overall Study||7
6748143|NCT03404609|7676179|FG000|NOT COMPLETED|Overall Study||0
6748144|NCT03404648|7676183|FG000|STARTED|Overall Study||19
6748145|NCT03404648|7676183|FG000|COMPLETED|Overall Study||19
6748146|NCT03404648|7676183|FG000|NOT COMPLETED|Overall Study||0
6748147|NCT03404674|7676193|FG000|STARTED|Overall Study||5
6748148|NCT03404674|7676194|FG001|STARTED|Overall Study||5
6748149|NCT03404674|7676195|FG002|STARTED|Overall Study||10
6748150|NCT03404674|7676196|FG003|STARTED|Overall Study||10
6748151|NCT03404674|7676197|FG004|STARTED|Overall Study||10
6748152|NCT03404674|7676198|FG005|STARTED|Overall Study||10
6748153|NCT03404674|7676193|FG000|Received Dose 2|Overall Study||5
6748154|NCT03404674|7676194|FG001|Received Dose 2|Overall Study||4
6748155|NCT03404674|7676195|FG002|Received Dose 2|Overall Study||10
6748156|NCT03404674|7676196|FG003|Received Dose 2|Overall Study||9
6748157|NCT03404674|7676197|FG004|Received Dose 2|Overall Study||10
6748158|NCT03404674|7676198|FG005|Received Dose 2|Overall Study||10
6748159|NCT03404674|7676193|FG000|Received Dose 3|Overall Study||5
6748160|NCT03404674|7676194|FG001|Received Dose 3|Overall Study||4
6748161|NCT03404674|7676195|FG002|Received Dose 3|Overall Study||9
6748162|NCT03404674|7676196|FG003|Received Dose 3|Overall Study||9
6748163|NCT03404674|7676197|FG004|Received Dose 3|Overall Study||10
6748164|NCT03404674|7676198|FG005|Received Dose 3|Overall Study||9
6748165|NCT03404674|7676193|FG000|COMPLETED|Overall Study||5
6748166|NCT03404674|7676194|FG001|COMPLETED|Overall Study||4
6748167|NCT03404674|7676195|FG002|COMPLETED|Overall Study||8
6748168|NCT03404674|7676196|FG003|COMPLETED|Overall Study||9
6477358|NCT01288859|7394475|FG003|STARTED|Washout Period of 1 Week||0
6477359|NCT01288859|7394476|FG004|STARTED|Washout Period of 1 Week||0
6748169|NCT03404674|7676197|FG004|COMPLETED|Overall Study||10
6748170|NCT03404674|7676198|FG005|COMPLETED|Overall Study||9
6748171|NCT03404674|7676193|FG000|NOT COMPLETED|Overall Study||0
6748172|NCT03404674|7676194|FG001|NOT COMPLETED|Overall Study||1
6477360|NCT01288859|7394477|FG005|STARTED|Washout Period of 1 Week||5
6477361|NCT01288859|7394472|FG000|COMPLETED|Washout Period of 1 Week||5
6477362|NCT01288859|7394473|FG001|COMPLETED|Washout Period of 1 Week||0
6477363|NCT01288859|7394474|FG002|COMPLETED|Washout Period of 1 Week||0
6477364|NCT01288859|7394475|FG003|COMPLETED|Washout Period of 1 Week||0
6477365|NCT01288859|7394476|FG004|COMPLETED|Washout Period of 1 Week||0
6477366|NCT01288859|7394477|FG005|COMPLETED|Washout Period of 1 Week||5
6477367|NCT01288859|7394472|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6477368|NCT01288859|7394473|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6477369|NCT01288859|7394474|FG002|NOT COMPLETED|Washout Period of 1 Week||0
6477370|NCT01288859|7394475|FG003|NOT COMPLETED|Washout Period of 1 Week||0
6477371|NCT01288859|7394476|FG004|NOT COMPLETED|Washout Period of 1 Week||0
6477372|NCT01288859|7394477|FG005|NOT COMPLETED|Washout Period of 1 Week||0
6477373|NCT01288859|7394472|FG000|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477374|NCT01288859|7394473|FG001|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
6748173|NCT03404674|7676195|FG002|NOT COMPLETED|Overall Study||2
6748174|NCT03404674|7676196|FG003|NOT COMPLETED|Overall Study||1
6748175|NCT03404674|7676197|FG004|NOT COMPLETED|Overall Study||0
6748176|NCT03404674|7676198|FG005|NOT COMPLETED|Overall Study||1
6779836|NCT03605303|7708089|FG001|STARTED|Period 1||1
6779837|NCT03605303|7708088|FG000|COMPLETED|Period 1||0
6779838|NCT03605303|7708089|FG001|COMPLETED|Period 1||0
6779839|NCT03605303|7708088|FG000|NOT COMPLETED|Period 1||2
6779840|NCT03605303|7708089|FG001|NOT COMPLETED|Period 1||1
6779841|NCT03605303|7708088|FG000|STARTED|Period 2||0
6779842|NCT03605303|7708089|FG001|STARTED|Period 2||0
6779843|NCT03605303|7708088|FG000|COMPLETED|Period 2||0
6779844|NCT03605303|7708089|FG001|COMPLETED|Period 2||0
6779845|NCT03605303|7708088|FG000|NOT COMPLETED|Period 2||0
6779846|NCT03605303|7708089|FG001|NOT COMPLETED|Period 2||0
6779847|NCT03600740|7708095|FG000|STARTED|Overall Study||1
6779848|NCT03600740|7708095|FG000|COMPLETED|Overall Study||0
6779849|NCT03600740|7708095|FG000|NOT COMPLETED|Overall Study||1
6779850|NCT03598140|7708101|FG000|STARTED|Overall Study||10
6779851|NCT03598140|7708102|FG001|STARTED|Overall Study||11
6779852|NCT03598140|7708101|FG000|COMPLETED|Overall Study||9
6779853|NCT03598140|7708102|FG001|COMPLETED|Overall Study||11
6779854|NCT03598140|7708101|FG000|NOT COMPLETED|Overall Study||1
6779855|NCT03598140|7708102|FG001|NOT COMPLETED|Overall Study||0
6779856|NCT03598036|7708110|FG000|STARTED|Overall Study||5
6779857|NCT03598036|7708111|FG001|STARTED|Overall Study|Trial ended prematurely before any patients were enrolled into Cohort 2|0
6779858|NCT03598036|7708110|FG000|Week 1: 7.9 mg Twice Daily|Overall Study||5
6779859|NCT03598036|7708111|FG001|Week 1: 7.9 mg Twice Daily|Overall Study||0
6779860|NCT03598036|7708110|FG000|Week 2: 15.9 mg Twice Daily|Overall Study||5
6779861|NCT03598036|7708111|FG001|Week 2: 15.9 mg Twice Daily|Overall Study||0
6779862|NCT03598036|7708110|FG000|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study|1 subject withdrew at Week 12|5
6779863|NCT03598036|7708111|FG001|Weeks 3 - 24: 23.7 mg Twice Daily|Overall Study||0
6779864|NCT03598036|7708110|FG000|COMPLETED|Overall Study||4
6779865|NCT03598036|7708111|FG001|COMPLETED|Overall Study||0
6779866|NCT03598036|7708110|FG000|NOT COMPLETED|Overall Study||1
6779867|NCT03598036|7708111|FG001|NOT COMPLETED|Overall Study||0
6779868|NCT03591458|7708121|FG000|STARTED|Overall Study||1
6779869|NCT03591458|7708122|FG001|STARTED|Overall Study||1
6779870|NCT03591458|7708121|FG000|COMPLETED|Overall Study||1
6779871|NCT03591458|7708122|FG001|COMPLETED|Overall Study||1
6779872|NCT03591458|7708121|FG000|NOT COMPLETED|Overall Study||0
6779873|NCT03591458|7708122|FG001|NOT COMPLETED|Overall Study||0
6779874|NCT03590743|7708130|FG000|STARTED|Overall Study||2
6779875|NCT03590743|7708131|FG001|STARTED|Overall Study||3
6779876|NCT03590743|7708130|FG000|COMPLETED|Overall Study||2
6779877|NCT03590743|7708131|FG001|COMPLETED|Overall Study||2
6779878|NCT03590743|7708130|FG000|NOT COMPLETED|Overall Study||0
6779879|NCT03590743|7708131|FG001|NOT COMPLETED|Overall Study||1
6779880|NCT03580382|7708139|FG000|STARTED|Overall Study||0
6779881|NCT03580382|7708140|FG001|STARTED|Overall Study||3
6779882|NCT03580382|7708139|FG000|COMPLETED|Overall Study||0
6779883|NCT03580382|7708140|FG001|COMPLETED|Overall Study||0
6779884|NCT03580382|7708139|FG000|NOT COMPLETED|Overall Study||0
6779885|NCT03580382|7708140|FG001|NOT COMPLETED|Overall Study||3
6779886|NCT03571646|7708147|FG000|STARTED|Overall Study||3
6779887|NCT03571646|7708148|FG001|STARTED|Overall Study||3
6779888|NCT03571646|7708147|FG000|COMPLETED|Overall Study||1
6779889|NCT03571646|7708148|FG001|COMPLETED|Overall Study||2
6779890|NCT03571646|7708147|FG000|NOT COMPLETED|Overall Study||2
6779891|NCT03571646|7708148|FG001|NOT COMPLETED|Overall Study||1
6779892|NCT03565328|7708154|FG000|STARTED|Overall Study||1
6779893|NCT03565328|7708154|FG000|COMPLETED|Overall Study||1
6779894|NCT03565328|7708154|FG000|NOT COMPLETED|Overall Study||0
6779895|NCT03544242|7708161|FG000|STARTED|Overall Study||1
6779896|NCT03544242|7708162|FG001|STARTED|Overall Study||1
6779897|NCT03544242|7708163|FG002|STARTED|Overall Study||2
6477375|NCT01288859|7394474|FG002|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
6477376|NCT01288859|7394475|FG003|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477377|NCT01288859|7394476|FG004|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6779898|NCT03544242|7708161|FG000|COMPLETED|Overall Study||1
6779899|NCT03544242|7708162|FG001|COMPLETED|Overall Study||1
6779900|NCT03544242|7708163|FG002|COMPLETED|Overall Study||2
6779901|NCT03544242|7708161|FG000|NOT COMPLETED|Overall Study||0
6477378|NCT01288859|7394477|FG005|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6748177|NCT03404843|7676215|FG000|STARTED|Overall Study||17
6748178|NCT03404843|7676216|FG001|STARTED|Overall Study||14
6748179|NCT03404843|7676215|FG000|COMPLETED|Overall Study||13
6748180|NCT03404843|7676216|FG001|COMPLETED|Overall Study||13
6748181|NCT03404843|7676215|FG000|NOT COMPLETED|Overall Study||4
6748182|NCT03404843|7676216|FG001|NOT COMPLETED|Overall Study||1
6748183|NCT03405259|7676228|FG000|STARTED|Overall Study||11
6748184|NCT03405259|7676229|FG001|STARTED|Overall Study||11
6748185|NCT03405259|7676228|FG000|COMPLETED|Overall Study||11
6748186|NCT03405259|7676229|FG001|COMPLETED|Overall Study||11
6748187|NCT03405259|7676228|FG000|NOT COMPLETED|Overall Study||0
6748188|NCT03405259|7676229|FG001|NOT COMPLETED|Overall Study||0
6748189|NCT03405363|7676237|FG000|STARTED|Overall Study||14239
6748190|NCT03405363|7676238|FG001|STARTED|Overall Study||51167
6748191|NCT03405363|7676237|FG000|COMPLETED|Overall Study||14239
6748192|NCT03405363|7676238|FG001|COMPLETED|Overall Study||51167
6748193|NCT03405363|7676237|FG000|NOT COMPLETED|Overall Study||0
6748194|NCT03405363|7676238|FG001|NOT COMPLETED|Overall Study||0
6748195|NCT03405818|7676244|FG000|STARTED|Overall Study||55
6748196|NCT03405818|7676244|FG000|COMPLETED|Overall Study||47
6748197|NCT03405818|7676244|FG000|NOT COMPLETED|Overall Study||8
6748198|NCT03405935|7676248|FG000|STARTED|Overall Study||86
6748199|NCT03405935|7676248|FG000|COMPLETED|Overall Study||78
6748200|NCT03405935|7676248|FG000|NOT COMPLETED|Overall Study||8
6748201|NCT03406260|7676258|FG000|STARTED|Period 1||6
6748202|NCT03406260|7676259|FG001|STARTED|Period 1||6
6748203|NCT03406260|7676260|FG002|STARTED|Period 1||6
6748204|NCT03406260|7676261|FG003|STARTED|Period 1||6
6748205|NCT03406260|7676262|FG004|STARTED|Period 1||6
6748206|NCT03406260|7676263|FG005|STARTED|Period 1||6
6748207|NCT03406260|7676258|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
6748208|NCT03406260|7676259|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
6748209|NCT03406260|7676260|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
6748210|NCT03406260|7676261|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
6748211|NCT03406260|7676262|FG004|Received at Least 1 Dose of Study Drug|Period 1||6
6748212|NCT03406260|7676263|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
6748213|NCT03406260|7676258|FG000|COMPLETED|Period 1||6
6748214|NCT03406260|7676259|FG001|COMPLETED|Period 1||6
6748215|NCT03406260|7676260|FG002|COMPLETED|Period 1||6
6748216|NCT03406260|7676261|FG003|COMPLETED|Period 1||6
6748217|NCT03406260|7676262|FG004|COMPLETED|Period 1||5
6748218|NCT03406260|7676263|FG005|COMPLETED|Period 1||6
6748219|NCT03406260|7676258|FG000|NOT COMPLETED|Period 1||0
6748220|NCT03406260|7676259|FG001|NOT COMPLETED|Period 1||0
6748221|NCT03406260|7676260|FG002|NOT COMPLETED|Period 1||0
6748222|NCT03406260|7676261|FG003|NOT COMPLETED|Period 1||0
6748223|NCT03406260|7676262|FG004|NOT COMPLETED|Period 1||1
6748224|NCT03406260|7676263|FG005|NOT COMPLETED|Period 1||0
6748225|NCT03406260|7676258|FG000|STARTED|Period 2||6
6748226|NCT03406260|7676259|FG001|STARTED|Period 2||6
6748227|NCT03406260|7676260|FG002|STARTED|Period 2||6
6748228|NCT03406260|7676261|FG003|STARTED|Period 2||6
6748229|NCT03406260|7676262|FG004|STARTED|Period 2||5
6748230|NCT03406260|7676263|FG005|STARTED|Period 2||6
6748231|NCT03406260|7676258|FG000|COMPLETED|Period 2||6
6748232|NCT03406260|7676259|FG001|COMPLETED|Period 2||6
6748233|NCT03406260|7676260|FG002|COMPLETED|Period 2||6
6748234|NCT03406260|7676261|FG003|COMPLETED|Period 2||6
6748235|NCT03406260|7676262|FG004|COMPLETED|Period 2||5
6748236|NCT03406260|7676263|FG005|COMPLETED|Period 2||6
6748237|NCT03406260|7676258|FG000|NOT COMPLETED|Period 2||0
6748238|NCT03406260|7676259|FG001|NOT COMPLETED|Period 2||0
6748239|NCT03406260|7676260|FG002|NOT COMPLETED|Period 2||0
6748240|NCT03406260|7676261|FG003|NOT COMPLETED|Period 2||0
6748241|NCT03406260|7676262|FG004|NOT COMPLETED|Period 2||0
6748242|NCT03406260|7676263|FG005|NOT COMPLETED|Period 2||0
6748243|NCT03406260|7676258|FG000|STARTED|Period 3||6
6748244|NCT03406260|7676259|FG001|STARTED|Period 3||6
6748245|NCT03406260|7676260|FG002|STARTED|Period 3||6
6748246|NCT03406260|7676261|FG003|STARTED|Period 3||6
6748247|NCT03406260|7676262|FG004|STARTED|Period 3||5
6748248|NCT03406260|7676263|FG005|STARTED|Period 3||6
6748249|NCT03406260|7676258|FG000|COMPLETED|Period 3||6
6748250|NCT03406260|7676259|FG001|COMPLETED|Period 3||6
6748251|NCT03406260|7676260|FG002|COMPLETED|Period 3||6
6748252|NCT03406260|7676261|FG003|COMPLETED|Period 3||6
6748253|NCT03406260|7676262|FG004|COMPLETED|Period 3||5
6748254|NCT03406260|7676263|FG005|COMPLETED|Period 3||6
6748255|NCT03406260|7676258|FG000|NOT COMPLETED|Period 3||0
6748256|NCT03406260|7676259|FG001|NOT COMPLETED|Period 3||0
6477379|NCT01288859|7394472|FG000|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6748257|NCT03406260|7676260|FG002|NOT COMPLETED|Period 3||0
6748258|NCT03406260|7676261|FG003|NOT COMPLETED|Period 3||0
6748259|NCT03406260|7676262|FG004|NOT COMPLETED|Period 3||0
6748260|NCT03406260|7676263|FG005|NOT COMPLETED|Period 3||0
6748261|NCT03406325|7676281|FG000|STARTED|Overall Study||12
6748262|NCT03406325|7676282|FG001|STARTED|Overall Study||1
6748263|NCT03406325|7676283|FG002|STARTED|Overall Study||1
6748264|NCT03406325|7676284|FG003|STARTED|Overall Study||1
6748265|NCT03406325|7676285|FG004|STARTED|Overall Study||1
6748266|NCT03406325|7676286|FG005|STARTED|Overall Study||1
6748267|NCT03406325|7676287|FG006|STARTED|Overall Study||1
6748268|NCT03406325|7676288|FG007|STARTED|Overall Study||1
6748269|NCT03406325|7676281|FG000|COMPLETED|Overall Study||12
6477380|NCT01288859|7394473|FG001|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
6554600|NCT01747928|7476773|FG005|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6554601|NCT01747928|7476774|FG006|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6477381|NCT01288859|7394474|FG002|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
6477382|NCT01288859|7394475|FG003|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477383|NCT01288859|7394476|FG004|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477384|NCT01288859|7394477|FG005|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477385|NCT01288859|7394472|FG000|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477386|NCT01288859|7394473|FG001|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477387|NCT01288859|7394474|FG002|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477388|NCT01288859|7394475|FG003|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477389|NCT01288859|7394476|FG004|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477390|NCT01288859|7394477|FG005|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
6477391|NCT01288859|7394472|FG000|STARTED|Washout Period of 1 Week||0
6477392|NCT01288859|7394473|FG001|STARTED|Washout Period of 1 Week||5
6477393|NCT01288859|7394474|FG002|STARTED|Washout Period of 1 Week||5
6477394|NCT01288859|7394475|FG003|STARTED|Washout Period of 1 Week||0
6477395|NCT01288859|7394476|FG004|STARTED|Washout Period of 1 Week||0
6477396|NCT01288859|7394477|FG005|STARTED|Washout Period of 1 Week||0
6477397|NCT01288859|7394472|FG000|COMPLETED|Washout Period of 1 Week||0
6477398|NCT01288859|7394473|FG001|COMPLETED|Washout Period of 1 Week||5
6477399|NCT01288859|7394474|FG002|COMPLETED|Washout Period of 1 Week||5
6477400|NCT01288859|7394475|FG003|COMPLETED|Washout Period of 1 Week||0
6477401|NCT01288859|7394476|FG004|COMPLETED|Washout Period of 1 Week||0
6477402|NCT01288859|7394477|FG005|COMPLETED|Washout Period of 1 Week||0
6477403|NCT01288859|7394472|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6477404|NCT01288859|7394473|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6477405|NCT01288859|7394474|FG002|NOT COMPLETED|Washout Period of 1 Week||0
6477406|NCT01288859|7394475|FG003|NOT COMPLETED|Washout Period of 1 Week||0
6477407|NCT01288859|7394476|FG004|NOT COMPLETED|Washout Period of 1 Week||0
6477408|NCT01288859|7394477|FG005|NOT COMPLETED|Washout Period of 1 Week||0
6477409|NCT01288859|7394472|FG000|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477410|NCT01288859|7394473|FG001|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
6477411|NCT01288859|7394474|FG002|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
6477412|NCT01288859|7394475|FG003|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477413|NCT01288859|7394476|FG004|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477414|NCT01288859|7394477|FG005|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477415|NCT01288859|7394472|FG000|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477416|NCT01288859|7394473|FG001|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
6477417|NCT01288859|7394474|FG002|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
6477418|NCT01288859|7394475|FG003|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477419|NCT01288859|7394476|FG004|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477420|NCT01288859|7394477|FG005|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477421|NCT01288859|7394472|FG000|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477422|NCT01288859|7394473|FG001|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477423|NCT01288859|7394474|FG002|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477424|NCT01288859|7394475|FG003|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477425|NCT01288859|7394476|FG004|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477426|NCT01288859|7394477|FG005|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
6477427|NCT01288859|7394472|FG000|STARTED|Washout Period of 1 Week||0
6477428|NCT01288859|7394473|FG001|STARTED|Washout Period of 1 Week||0
6477429|NCT01288859|7394474|FG002|STARTED|Washout Period of 1 Week||0
6477430|NCT01288859|7394475|FG003|STARTED|Washout Period of 1 Week||5
6477431|NCT01288859|7394476|FG004|STARTED|Washout Period of 1 Week||5
6477432|NCT01288859|7394477|FG005|STARTED|Washout Period of 1 Week||0
6477433|NCT01288859|7394472|FG000|COMPLETED|Washout Period of 1 Week||0
6477434|NCT01288859|7394473|FG001|COMPLETED|Washout Period of 1 Week||0
6477435|NCT01288859|7394474|FG002|COMPLETED|Washout Period of 1 Week||0
6477436|NCT01288859|7394475|FG003|COMPLETED|Washout Period of 1 Week||5
6477437|NCT01288859|7394476|FG004|COMPLETED|Washout Period of 1 Week||5
6477438|NCT01288859|7394477|FG005|COMPLETED|Washout Period of 1 Week||0
6477439|NCT01288859|7394472|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6477440|NCT01288859|7394473|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6477441|NCT01288859|7394474|FG002|NOT COMPLETED|Washout Period of 1 Week||0
6477442|NCT01288859|7394475|FG003|NOT COMPLETED|Washout Period of 1 Week||0
6477443|NCT01288859|7394476|FG004|NOT COMPLETED|Washout Period of 1 Week||0
6477444|NCT01288859|7394477|FG005|NOT COMPLETED|Washout Period of 1 Week||0
6477445|NCT01288859|7394472|FG000|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
6477446|NCT01288859|7394473|FG001|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
6477447|NCT01288859|7394474|FG002|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
6477448|NCT01288859|7394475|FG003|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
6477449|NCT01288859|7394476|FG004|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
6477450|NCT01288859|7394477|FG005|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
6477451|NCT01288859|7394472|FG000|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477452|NCT01288859|7394473|FG001|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477453|NCT01288859|7394474|FG002|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477454|NCT01288859|7394475|FG003|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
6477455|NCT01288859|7394476|FG004|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
6477456|NCT01288859|7394477|FG005|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477457|NCT01288859|7394472|FG000|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477458|NCT01288859|7394473|FG001|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477459|NCT01288859|7394474|FG002|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477460|NCT01288859|7394475|FG003|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477461|NCT01288859|7394476|FG004|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477462|NCT01288859|7394477|FG005|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
6477463|NCT01288859|7394472|FG000|STARTED|Washout Period of 1 Week||0
6477464|NCT01288859|7394473|FG001|STARTED|Washout Period of 1 Week||0
6477465|NCT01288859|7394474|FG002|STARTED|Washout Period of 1 Week||0
6477466|NCT01288859|7394475|FG003|STARTED|Washout Period of 1 Week||5
6477467|NCT01288859|7394476|FG004|STARTED|Washout Period of 1 Week||5
6477468|NCT01288859|7394477|FG005|STARTED|Washout Period of 1 Week||0
6477469|NCT01288859|7394472|FG000|COMPLETED|Washout Period of 1 Week||0
6477470|NCT01288859|7394473|FG001|COMPLETED|Washout Period of 1 Week||0
6477471|NCT01288859|7394474|FG002|COMPLETED|Washout Period of 1 Week||0
6477472|NCT01288859|7394475|FG003|COMPLETED|Washout Period of 1 Week||5
6477473|NCT01288859|7394476|FG004|COMPLETED|Washout Period of 1 Week||5
6477474|NCT01288859|7394477|FG005|COMPLETED|Washout Period of 1 Week||0
6748270|NCT03406325|7676282|FG001|COMPLETED|Overall Study||1
6748271|NCT03406325|7676283|FG002|COMPLETED|Overall Study||1
6748272|NCT03406325|7676284|FG003|COMPLETED|Overall Study||1
6748273|NCT03406325|7676285|FG004|COMPLETED|Overall Study||1
6748274|NCT03406325|7676286|FG005|COMPLETED|Overall Study||1
6748275|NCT03406325|7676287|FG006|COMPLETED|Overall Study||1
6748276|NCT03406325|7676288|FG007|COMPLETED|Overall Study||1
6748277|NCT03406325|7676281|FG000|NOT COMPLETED|Overall Study||0
6748278|NCT03406325|7676282|FG001|NOT COMPLETED|Overall Study||0
6748279|NCT03406325|7676283|FG002|NOT COMPLETED|Overall Study||0
6748280|NCT03406325|7676284|FG003|NOT COMPLETED|Overall Study||0
6748281|NCT03406325|7676285|FG004|NOT COMPLETED|Overall Study||0
6748282|NCT03406325|7676286|FG005|NOT COMPLETED|Overall Study||0
6748283|NCT03406325|7676287|FG006|NOT COMPLETED|Overall Study||0
6748284|NCT03406325|7676288|FG007|NOT COMPLETED|Overall Study||0
6748285|NCT03406377|7676322|FG000|STARTED|Overall Study||41
6748286|NCT03406377|7676323|FG001|STARTED|Overall Study||72
6748287|NCT03406377|7676322|FG000|COMPLETED|Overall Study||25
6748288|NCT03406377|7676323|FG001|COMPLETED|Overall Study||51
6748289|NCT03406377|7676322|FG000|NOT COMPLETED|Overall Study||16
6748290|NCT03406377|7676323|FG001|NOT COMPLETED|Overall Study||21
6748291|NCT03406962|7676329|FG000|STARTED|Overall Study||8
6748292|NCT03406962|7676329|FG000|COMPLETED|Overall Study||5
6748293|NCT03406962|7676329|FG000|NOT COMPLETED|Overall Study||3
6748294|NCT03407053|7676336|FG000|STARTED|Overall Study||10
6748295|NCT03407053|7676337|FG001|STARTED|Overall Study||10
6748296|NCT03407053|7676336|FG000|COMPLETED|Overall Study||10
6477475|NCT01288859|7394472|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6477476|NCT01288859|7394473|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6477477|NCT01288859|7394474|FG002|NOT COMPLETED|Washout Period of 1 Week||0
6477478|NCT01288859|7394475|FG003|NOT COMPLETED|Washout Period of 1 Week||0
6477479|NCT01288859|7394476|FG004|NOT COMPLETED|Washout Period of 1 Week||0
6477480|NCT01288859|7394477|FG005|NOT COMPLETED|Washout Period of 1 Week||0
6477481|NCT01288859|7394472|FG000|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
6477482|NCT01288859|7394473|FG001|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
6477483|NCT01288859|7394474|FG002|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
6477484|NCT01288859|7394475|FG003|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
6477485|NCT01288859|7394476|FG004|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
6477486|NCT01288859|7394477|FG005|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
6477487|NCT01288859|7394472|FG000|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477488|NCT01288859|7394473|FG001|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477489|NCT01288859|7394474|FG002|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477490|NCT01288859|7394475|FG003|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
6477491|NCT01288859|7394476|FG004|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
6477492|NCT01288859|7394477|FG005|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477493|NCT01288859|7394472|FG000|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477494|NCT01288859|7394473|FG001|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477495|NCT01288859|7394474|FG002|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477496|NCT01288859|7394475|FG003|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477497|NCT01288859|7394476|FG004|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477498|NCT01288859|7394477|FG005|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
6477499|NCT01288911|7394499|FG000|STARTED|Double-blind Period||184
6477500|NCT01288911|7394500|FG001|STARTED|Double-blind Period||191
6477501|NCT01288911|7394499|FG000|Received Treatment|Double-blind Period||183
6477502|NCT01288911|7394500|FG001|Received Treatment|Double-blind Period||189
6748297|NCT03407053|7676337|FG001|COMPLETED|Overall Study||10
6748298|NCT03407053|7676336|FG000|NOT COMPLETED|Overall Study||0
6748299|NCT03407053|7676337|FG001|NOT COMPLETED|Overall Study||0
6748300|NCT03407118|7676343|FG000|STARTED|Period 1||14
6748301|NCT03407118|7676344|FG001|STARTED|Period 1||17
6748302|NCT03407118|7676343|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
6554602|NCT01747928|7476775|FG007|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
6562790|NCT01803074|7485703|FG004|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6477503|NCT01288911|7394499|FG000|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|42
6477504|NCT01288911|7394500|FG001|COMPLETED|Double-blind Period|Indicates participants were still receiving treatment at the data cut-off date of 19 October 2014.|9
6477505|NCT01288911|7394499|FG000|NOT COMPLETED|Double-blind Period||142
6477506|NCT01288911|7394500|FG001|NOT COMPLETED|Double-blind Period||182
6477507|NCT01288911|7394499|FG000|STARTED|Open-label Period (All Enzalutamide)||42
6477508|NCT01288911|7394500|FG001|STARTED|Open-label Period (All Enzalutamide)||9
6477509|NCT01288911|7394499|FG000|Received Treatment|Open-label Period (All Enzalutamide)||42
6477510|NCT01288911|7394500|FG001|Received Treatment|Open-label Period (All Enzalutamide)||9
6477511|NCT01288911|7394499|FG000|COMPLETED|Open-label Period (All Enzalutamide)||0
6477512|NCT01288911|7394500|FG001|COMPLETED|Open-label Period (All Enzalutamide)||0
6477513|NCT01288911|7394499|FG000|NOT COMPLETED|Open-label Period (All Enzalutamide)||42
6477514|NCT01288911|7394500|FG001|NOT COMPLETED|Open-label Period (All Enzalutamide)||9
6477515|NCT01288937|7394511|FG000|STARTED|Overall Study||4
6477516|NCT01288937|7394512|FG001|STARTED|Overall Study||2
6477517|NCT01288937|7394511|FG000|COMPLETED|Overall Study||3
6477518|NCT01288937|7394512|FG001|COMPLETED|Overall Study||2
6477519|NCT01288937|7394511|FG000|NOT COMPLETED|Overall Study||1
6477520|NCT01288937|7394512|FG001|NOT COMPLETED|Overall Study||0
6477521|NCT01288976|7394521|FG000|STARTED|Overall Study||567
6477522|NCT01288976|7394522|FG001|STARTED|Overall Study||49
6477523|NCT01288976|7394523|FG002|STARTED|Overall Study||105
6477524|NCT01288976|7394521|FG000|COMPLETED|Overall Study||389
6477525|NCT01288976|7394522|FG001|COMPLETED|Overall Study||22
6477526|NCT01288976|7394523|FG002|COMPLETED|Overall Study||85
6477527|NCT01288976|7394521|FG000|NOT COMPLETED|Overall Study||178
6477528|NCT01288976|7394522|FG001|NOT COMPLETED|Overall Study||27
6477529|NCT01288976|7394523|FG002|NOT COMPLETED|Overall Study||20
6501223|NCT01427803|7419736|FG001|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
6501224|NCT01427803|7419735|FG000|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
6501225|NCT01427803|7419736|FG001|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
6501226|NCT01427803|7419735|FG000|COMPLETED|Overall Study||463
6501227|NCT01427803|7419736|FG001|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
6501228|NCT01427803|7419735|FG000|NOT COMPLETED|Overall Study||63
6501229|NCT01427803|7419736|FG001|NOT COMPLETED|Overall Study||26
6501230|NCT01427881|7419740|FG000|STARTED|Overall Study||43
6501231|NCT01427881|7419740|FG000|COMPLETED|Overall Study||43
6501232|NCT01427881|7419740|FG000|NOT COMPLETED|Overall Study||0
6501233|NCT01427907|7419746|FG000|STARTED|Overall Study|Randomized|20
6501234|NCT01427907|7419747|FG001|STARTED|Overall Study|Randomized|18
6501235|NCT01427907|7419746|FG000|COMPLETED|Overall Study|Completed study|17
6501236|NCT01427907|7419747|FG001|COMPLETED|Overall Study|Completed study|14
6501237|NCT01427907|7419746|FG000|NOT COMPLETED|Overall Study||3
6501238|NCT01427907|7419747|FG001|NOT COMPLETED|Overall Study||4
6501239|NCT01427920|7419755|FG000|STARTED|Overall Study||174
6501240|NCT01427920|7419756|FG001|STARTED|Overall Study||174
6501241|NCT01427920|7419755|FG000|Exposed|Overall Study||174
6501242|NCT01427920|7419756|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
6501243|NCT01427920|7419755|FG000|COMPLETED|Overall Study||165
6501244|NCT01427920|7419756|FG001|COMPLETED|Overall Study||157
6501245|NCT01427920|7419755|FG000|NOT COMPLETED|Overall Study||9
6501246|NCT01427920|7419756|FG001|NOT COMPLETED|Overall Study||17
6501247|NCT01427933|7419764|FG000|STARTED|Overall Study||71
6501248|NCT01427933|7419765|FG001|STARTED|Overall Study||70
6501249|NCT01427933|7419764|FG000|Received at Least 1 Dose of Study Drug|Overall Study||69
6501250|NCT01427933|7419765|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
6501251|NCT01427933|7419764|FG000|COMPLETED|Overall Study||63
6501252|NCT01427933|7419765|FG001|COMPLETED|Overall Study||57
6501253|NCT01427933|7419764|FG000|NOT COMPLETED|Overall Study||8
6501254|NCT01427933|7419765|FG001|NOT COMPLETED|Overall Study||13
6501255|NCT01427972|7419784|FG000|STARTED|Treatment Period 1 (21 Days)||3
6501256|NCT01427972|7419785|FG001|STARTED|Treatment Period 1 (21 Days)||4
6501257|NCT01427972|7419786|FG002|STARTED|Treatment Period 1 (21 Days)||4
6501258|NCT01427972|7419787|FG003|STARTED|Treatment Period 1 (21 Days)||3
6501259|NCT01427972|7419788|FG004|STARTED|Treatment Period 1 (21 Days)||4
6501260|NCT01427972|7419789|FG005|STARTED|Treatment Period 1 (21 Days)||3
6501261|NCT01427972|7419790|FG006|STARTED|Treatment Period 1 (21 Days)||3
6501262|NCT01427972|7419791|FG007|STARTED|Treatment Period 1 (21 Days)||5
6501263|NCT01427972|7419792|FG008|STARTED|Treatment Period 1 (21 Days)||3
6501264|NCT01427972|7419793|FG009|STARTED|Treatment Period 1 (21 Days)||3
6501265|NCT01427972|7419794|FG010|STARTED|Treatment Period 1 (21 Days)||3
6501266|NCT01427972|7419795|FG011|STARTED|Treatment Period 1 (21 Days)||4
6501267|NCT01427972|7419784|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6501268|NCT01427972|7419785|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
6501269|NCT01427972|7419786|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
6501270|NCT01427972|7419787|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6477530|NCT01288989|7394534|FG000|STARTED|Overall Study||6
6477531|NCT01288989|7394535|FG001|STARTED|Overall Study||3
6477532|NCT01288989|7394536|FG002|STARTED|Overall Study||3
6477533|NCT01288989|7394537|FG003|STARTED|Overall Study||11
6477534|NCT01288989|7394538|FG004|STARTED|Overall Study||21
6477535|NCT01288989|7394534|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6477536|NCT01288989|7394535|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6477537|NCT01288989|7394536|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6477538|NCT01288989|7394537|FG003|Received at Least 1 Dose of Study Drug|Overall Study||11
6477539|NCT01288989|7394538|FG004|Received at Least 1 Dose of Study Drug|Overall Study||21
6477540|NCT01288989|7394534|FG000|COMPLETED|Overall Study||5
6477541|NCT01288989|7394535|FG001|COMPLETED|Overall Study||3
6477542|NCT01288989|7394536|FG002|COMPLETED|Overall Study||3
6477543|NCT01288989|7394537|FG003|COMPLETED|Overall Study||10
6477544|NCT01288989|7394538|FG004|COMPLETED|Overall Study||15
6554603|NCT01747928|7476768|FG000|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6554604|NCT01747928|7476769|FG001|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6554605|NCT01747928|7476770|FG002|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6477545|NCT01288989|7394534|FG000|NOT COMPLETED|Overall Study||1
6477546|NCT01288989|7394535|FG001|NOT COMPLETED|Overall Study||0
6477547|NCT01288989|7394536|FG002|NOT COMPLETED|Overall Study||0
6477548|NCT01288989|7394537|FG003|NOT COMPLETED|Overall Study||1
6477549|NCT01288989|7394538|FG004|NOT COMPLETED|Overall Study||6
6477550|NCT01289015|7394558|FG000|STARTED|Overall Study||571
6477551|NCT01289015|7394559|FG001|STARTED|Overall Study||284
6477552|NCT01289015|7394558|FG000|COMPLETED|Overall Study||472
6477553|NCT01289015|7394559|FG001|COMPLETED|Overall Study||230
6477554|NCT01289015|7394558|FG000|NOT COMPLETED|Overall Study||99
6477555|NCT01289015|7394559|FG001|NOT COMPLETED|Overall Study||54
6477556|NCT01289028|7394565|FG000|STARTED|Overall Study||125
6477557|NCT01289028|7394565|FG000|COMPLETED|Overall Study||42
6477558|NCT01289028|7394565|FG000|NOT COMPLETED|Overall Study||83
6477559|NCT01289041|7394571|FG000|STARTED|Overall Study||70
6477560|NCT01289041|7394571|FG000|COMPLETED|Overall Study||0
6477561|NCT01289041|7394571|FG000|NOT COMPLETED|Overall Study||70
6477562|NCT01289067|7394577|FG000|STARTED|Overall Study||13
6477563|NCT01289067|7394577|FG000|COMPLETED|Overall Study||13
6477564|NCT01289067|7394577|FG000|NOT COMPLETED|Overall Study||0
6477565|NCT01289080|7394583|FG000|STARTED|Overall Study||9
6477566|NCT01289080|7394584|FG001|STARTED|Overall Study||10
6477567|NCT01289080|7394583|FG000|COMPLETED|Overall Study||9
6477568|NCT01289080|7394584|FG001|COMPLETED|Overall Study||10
6477569|NCT01289080|7394583|FG000|NOT COMPLETED|Overall Study||0
6477570|NCT01289080|7394584|FG001|NOT COMPLETED|Overall Study||0
6477571|NCT01289119|7394597|FG000|STARTED|Overall Study||93
6477572|NCT01289119|7394598|FG001|STARTED|Overall Study||92
6477573|NCT01289119|7394599|FG002|STARTED|Overall Study||98
6477574|NCT01289119|7394600|FG003|STARTED|Overall Study||99
6477575|NCT01289119|7394601|FG004|STARTED|Overall Study||63
6477576|NCT01289119|7394602|FG005|STARTED|Overall Study||61
6477577|NCT01289119|7394597|FG000|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
6477578|NCT01289119|7394598|FG001|Treated|Overall Study||92
6477579|NCT01289119|7394599|FG002|Treated|Overall Study||98
6554606|NCT01747928|7476771|FG003|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6554607|NCT01747928|7476772|FG004|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6554608|NCT01747928|7476773|FG005|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6554609|NCT01747928|7476774|FG006|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6554610|NCT01747928|7476775|FG007|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
6748303|NCT03407118|7676344|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
6748304|NCT03407118|7676343|FG000|COMPLETED|Period 1||14
6748305|NCT03407118|7676344|FG001|COMPLETED|Period 1||17
6748306|NCT03407118|7676343|FG000|NOT COMPLETED|Period 1||0
6748307|NCT03407118|7676344|FG001|NOT COMPLETED|Period 1||0
6748308|NCT03407118|7676343|FG000|STARTED|Period 2||14
6748309|NCT03407118|7676344|FG001|STARTED|Period 2||17
6748310|NCT03407118|7676343|FG000|Received at Least 1 Dose of Study Drug|Period 2||13
6748311|NCT03407118|7676344|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
6748312|NCT03407118|7676343|FG000|COMPLETED|Period 2||13
6748313|NCT03407118|7676344|FG001|COMPLETED|Period 2||17
6748314|NCT03407118|7676343|FG000|NOT COMPLETED|Period 2||1
6477580|NCT01289119|7394600|FG003|Treated|Overall Study||99
6477581|NCT01289119|7394601|FG004|Treated|Overall Study||63
6477582|NCT01289119|7394602|FG005|Treated|Overall Study||61
6477583|NCT01289119|7394597|FG000|COMPLETED|Overall Study||84
6477584|NCT01289119|7394598|FG001|COMPLETED|Overall Study||83
6477585|NCT01289119|7394599|FG002|COMPLETED|Overall Study||89
6477586|NCT01289119|7394600|FG003|COMPLETED|Overall Study||93
6477587|NCT01289119|7394601|FG004|COMPLETED|Overall Study||58
6477588|NCT01289119|7394602|FG005|COMPLETED|Overall Study||57
6477589|NCT01289119|7394597|FG000|NOT COMPLETED|Overall Study||9
6477590|NCT01289119|7394598|FG001|NOT COMPLETED|Overall Study||9
6477591|NCT01289119|7394599|FG002|NOT COMPLETED|Overall Study||9
6748315|NCT03407118|7676344|FG001|NOT COMPLETED|Period 2||0
6748316|NCT03407170|7676350|FG000|STARTED|Overall Study||1
6477592|NCT01289119|7394600|FG003|NOT COMPLETED|Overall Study||6
6477593|NCT01289119|7394601|FG004|NOT COMPLETED|Overall Study||5
6477594|NCT01289119|7394602|FG005|NOT COMPLETED|Overall Study||4
6477595|NCT01289210|7394616|FG000|STARTED|Overall Study||2
6477596|NCT01289210|7394616|FG000|COMPLETED|Overall Study||1
6477597|NCT01289210|7394616|FG000|NOT COMPLETED|Overall Study||1
6477598|NCT01289275|7394624|FG000|STARTED|Overall Study||317
6477599|NCT01289275|7394625|FG001|STARTED|Overall Study||320
6477600|NCT01289275|7394626|FG002|STARTED|Overall Study||317
6477601|NCT01289275|7394627|FG003|STARTED|Overall Study||316
6477602|NCT01289275|7394624|FG000|COMPLETED|Overall Study||317
6477603|NCT01289275|7394625|FG001|COMPLETED|Overall Study||320
6477604|NCT01289275|7394626|FG002|COMPLETED|Overall Study||317
6477605|NCT01289275|7394627|FG003|COMPLETED|Overall Study||316
6477606|NCT01289275|7394624|FG000|NOT COMPLETED|Overall Study||0
6477607|NCT01289275|7394625|FG001|NOT COMPLETED|Overall Study||0
6477608|NCT01289275|7394626|FG002|NOT COMPLETED|Overall Study||0
6477609|NCT01289275|7394627|FG003|NOT COMPLETED|Overall Study||0
6477610|NCT01289353|7394641|FG000|STARTED|Overall Study||92
6477611|NCT01289353|7394641|FG000|COMPLETED|Overall Study||90
6477612|NCT01289353|7394641|FG000|NOT COMPLETED|Overall Study||2
6477613|NCT01289392|7394648|FG000|STARTED|Overall Study||9
6477614|NCT01289392|7394649|FG001|STARTED|Overall Study||9
6477615|NCT01289392|7394650|FG002|STARTED|Overall Study||7
6477616|NCT01289392|7394648|FG000|COMPLETED|Overall Study||9
6477617|NCT01289392|7394649|FG001|COMPLETED|Overall Study||9
6477618|NCT01289392|7394650|FG002|COMPLETED|Overall Study||7
6477619|NCT01289392|7394648|FG000|NOT COMPLETED|Overall Study||0
6477620|NCT01289392|7394649|FG001|NOT COMPLETED|Overall Study||0
6477621|NCT01289392|7394650|FG002|NOT COMPLETED|Overall Study||0
6477622|NCT01289418|7394661|FG000|STARTED|Day 8 Survey||6525
6477623|NCT01289418|7394661|FG000|COMPLETED|Day 8 Survey||4307
6477624|NCT01289418|7394661|FG000|NOT COMPLETED|Day 8 Survey||2218
6477625|NCT01289418|7394661|FG000|STARTED|Day 29 Survey||6525
6477626|NCT01289418|7394661|FG000|COMPLETED|Day 29 Survey||4057
6477627|NCT01289418|7394661|FG000|NOT COMPLETED|Day 29 Survey||2468
6477628|NCT01289431|7394674|FG000|STARTED|Overall Study||34
6477629|NCT01289431|7394675|FG001|STARTED|Overall Study||34
6477630|NCT01289431|7394676|FG002|STARTED|Overall Study||34
6477631|NCT01289431|7394677|FG003|STARTED|Overall Study||33
6477632|NCT01289431|7394678|FG004|STARTED|Overall Study||34
6477633|NCT01289431|7394679|FG005|STARTED|Overall Study||33
6477634|NCT01289431|7394680|FG006|STARTED|Overall Study||34
6477635|NCT01289431|7394674|FG000|COMPLETED|Overall Study||29
6477636|NCT01289431|7394675|FG001|COMPLETED|Overall Study||32
6477637|NCT01289431|7394676|FG002|COMPLETED|Overall Study||30
6477638|NCT01289431|7394677|FG003|COMPLETED|Overall Study||28
6477639|NCT01289431|7394678|FG004|COMPLETED|Overall Study||32
6477640|NCT01289431|7394679|FG005|COMPLETED|Overall Study||31
6477641|NCT01289431|7394680|FG006|COMPLETED|Overall Study||33
6477642|NCT01289431|7394674|FG000|NOT COMPLETED|Overall Study||5
6477643|NCT01289431|7394675|FG001|NOT COMPLETED|Overall Study||2
6477644|NCT01289431|7394676|FG002|NOT COMPLETED|Overall Study||4
6477645|NCT01289431|7394677|FG003|NOT COMPLETED|Overall Study||5
6477646|NCT01289431|7394678|FG004|NOT COMPLETED|Overall Study||2
6477647|NCT01289431|7394679|FG005|NOT COMPLETED|Overall Study||2
6477648|NCT01289431|7394680|FG006|NOT COMPLETED|Overall Study||1
6477649|NCT01289457|7394699|FG000|STARTED|Overall Study||12
6477650|NCT01289457|7394700|FG001|STARTED|Overall Study||157
6477651|NCT01289457|7394701|FG002|STARTED|Overall Study||113
6477652|NCT01289457|7394699|FG000|COMPLETED|Overall Study||12
6477653|NCT01289457|7394700|FG001|COMPLETED|Overall Study||157
6477654|NCT01289457|7394701|FG002|COMPLETED|Overall Study||113
6477655|NCT01289457|7394699|FG000|NOT COMPLETED|Overall Study||0
6477656|NCT01289457|7394700|FG001|NOT COMPLETED|Overall Study||0
6477657|NCT01289457|7394701|FG002|NOT COMPLETED|Overall Study||0
6477658|NCT01289522|7394709|FG000|STARTED|Overall Study||54
6477659|NCT01289522|7394709|FG000|COMPLETED|Overall Study||43
6477660|NCT01289522|7394709|FG000|NOT COMPLETED|Overall Study||11
6477661|NCT01289548|7394716|FG000|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
6477662|NCT01289548|7394717|FG001|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
6477663|NCT01289548|7394718|FG002|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
6477664|NCT01289548|7394716|FG000|Donors|Overall Study||20
6477665|NCT01289548|7394717|FG001|Donors|Overall Study||20
6477666|NCT01289548|7394718|FG002|Donors|Overall Study||20
6477667|NCT01289548|7394716|FG000|Recipients|Overall Study||20
6477668|NCT01289548|7394717|FG001|Recipients|Overall Study||20
6477669|NCT01289548|7394718|FG002|Recipients|Overall Study||20
6477670|NCT01289548|7394716|FG000|COMPLETED|Overall Study||40
6477671|NCT01289548|7394717|FG001|COMPLETED|Overall Study||40
6477672|NCT01289548|7394718|FG002|COMPLETED|Overall Study||40
6477673|NCT01289548|7394716|FG000|NOT COMPLETED|Overall Study||0
6477674|NCT01289548|7394717|FG001|NOT COMPLETED|Overall Study||0
6477675|NCT01289548|7394718|FG002|NOT COMPLETED|Overall Study||0
6477676|NCT01289574|7394729|FG000|STARTED|Overall Study||58
6477677|NCT01289574|7394730|FG001|STARTED|Overall Study||60
6748317|NCT03407170|7676350|FG000|COMPLETED|Overall Study||0
6477678|NCT01289574|7394731|FG002|STARTED|Overall Study||63
6477679|NCT01289574|7394729|FG000|COMPLETED|Overall Study||51
6477680|NCT01289574|7394730|FG001|COMPLETED|Overall Study||57
6477681|NCT01289574|7394731|FG002|COMPLETED|Overall Study||60
6477682|NCT01289574|7394729|FG000|NOT COMPLETED|Overall Study||7
6477683|NCT01289574|7394730|FG001|NOT COMPLETED|Overall Study||3
6477684|NCT01289574|7394731|FG002|NOT COMPLETED|Overall Study||3
6477685|NCT01289639|7394743|FG000|STARTED|Overall Study||5
6477686|NCT01289639|7394744|FG001|STARTED|Overall Study||6
6477687|NCT01289639|7394745|FG002|STARTED|Overall Study||0
6477688|NCT01289639|7394743|FG000|COMPLETED|Overall Study||4
6477689|NCT01289639|7394744|FG001|COMPLETED|Overall Study||6
6477690|NCT01289639|7394745|FG002|COMPLETED|Overall Study||0
6477691|NCT01289639|7394743|FG000|NOT COMPLETED|Overall Study||1
6477692|NCT01289639|7394744|FG001|NOT COMPLETED|Overall Study||0
6477693|NCT01289639|7394745|FG002|NOT COMPLETED|Overall Study||0
6477694|NCT01289665|7394755|FG000|STARTED|Overall Study||60
6477695|NCT01289665|7394756|FG001|STARTED|Overall Study||60
6477696|NCT01289665|7394755|FG000|COMPLETED|Overall Study||59
6477697|NCT01289665|7394756|FG001|COMPLETED|Overall Study||60
6477698|NCT01289665|7394755|FG000|NOT COMPLETED|Overall Study||1
6477699|NCT01289665|7394756|FG001|NOT COMPLETED|Overall Study||0
6501271|NCT01427972|7419788|FG004|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
6501272|NCT01427972|7419789|FG005|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6501273|NCT01427972|7419790|FG006|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6501274|NCT01427972|7419791|FG007|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||5
6501275|NCT01427972|7419792|FG008|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6501276|NCT01427972|7419793|FG009|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6501277|NCT01427972|7419794|FG010|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||3
6501278|NCT01427972|7419795|FG011|Received at Least 1 Dose of Study Drug|Treatment Period 1 (21 Days)||4
6501279|NCT01427972|7419784|FG000|COMPLETED|Treatment Period 1 (21 Days)||3
6501280|NCT01427972|7419785|FG001|COMPLETED|Treatment Period 1 (21 Days)||4
6501281|NCT01427972|7419786|FG002|COMPLETED|Treatment Period 1 (21 Days)||4
6501282|NCT01427972|7419787|FG003|COMPLETED|Treatment Period 1 (21 Days)||3
6501283|NCT01427972|7419788|FG004|COMPLETED|Treatment Period 1 (21 Days)||4
6501284|NCT01427972|7419789|FG005|COMPLETED|Treatment Period 1 (21 Days)||3
6501285|NCT01427972|7419790|FG006|COMPLETED|Treatment Period 1 (21 Days)||3
6501286|NCT01427972|7419791|FG007|COMPLETED|Treatment Period 1 (21 Days)||4
6501287|NCT01427972|7419792|FG008|COMPLETED|Treatment Period 1 (21 Days)||3
6501288|NCT01427972|7419793|FG009|COMPLETED|Treatment Period 1 (21 Days)||3
6501289|NCT01427972|7419794|FG010|COMPLETED|Treatment Period 1 (21 Days)||3
6501290|NCT01427972|7419795|FG011|COMPLETED|Treatment Period 1 (21 Days)||4
6501291|NCT01427972|7419784|FG000|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501292|NCT01427972|7419785|FG001|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501293|NCT01427972|7419786|FG002|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501294|NCT01427972|7419787|FG003|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501295|NCT01427972|7419788|FG004|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501296|NCT01427972|7419789|FG005|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501297|NCT01427972|7419790|FG006|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501298|NCT01427972|7419791|FG007|NOT COMPLETED|Treatment Period 1 (21 Days)||1
6501299|NCT01427972|7419792|FG008|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501300|NCT01427972|7419793|FG009|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501301|NCT01427972|7419794|FG010|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501302|NCT01427972|7419795|FG011|NOT COMPLETED|Treatment Period 1 (21 Days)||0
6501303|NCT01427972|7419784|FG000|STARTED|Washout (at Least 28 Days)||3
6501304|NCT01427972|7419785|FG001|STARTED|Washout (at Least 28 Days)||4
6501305|NCT01427972|7419786|FG002|STARTED|Washout (at Least 28 Days)||4
6501306|NCT01427972|7419787|FG003|STARTED|Washout (at Least 28 Days)||3
6501307|NCT01427972|7419788|FG004|STARTED|Washout (at Least 28 Days)||4
6501308|NCT01427972|7419789|FG005|STARTED|Washout (at Least 28 Days)||3
6501309|NCT01427972|7419790|FG006|STARTED|Washout (at Least 28 Days)||3
6501310|NCT01427972|7419791|FG007|STARTED|Washout (at Least 28 Days)||4
6501311|NCT01427972|7419792|FG008|STARTED|Washout (at Least 28 Days)||3
6501312|NCT01427972|7419793|FG009|STARTED|Washout (at Least 28 Days)||3
6501313|NCT01427972|7419794|FG010|STARTED|Washout (at Least 28 Days)||3
6501314|NCT01427972|7419795|FG011|STARTED|Washout (at Least 28 Days)||4
6501315|NCT01427972|7419784|FG000|COMPLETED|Washout (at Least 28 Days)||3
6501316|NCT01427972|7419785|FG001|COMPLETED|Washout (at Least 28 Days)||4
6501317|NCT01427972|7419786|FG002|COMPLETED|Washout (at Least 28 Days)||4
6501318|NCT01427972|7419787|FG003|COMPLETED|Washout (at Least 28 Days)||3
6501319|NCT01427972|7419788|FG004|COMPLETED|Washout (at Least 28 Days)||4
6501320|NCT01427972|7419789|FG005|COMPLETED|Washout (at Least 28 Days)||1
6501321|NCT01427972|7419790|FG006|COMPLETED|Washout (at Least 28 Days)||3
6501322|NCT01427972|7419791|FG007|COMPLETED|Washout (at Least 28 Days)||4
6501323|NCT01427972|7419792|FG008|COMPLETED|Washout (at Least 28 Days)||3
6501324|NCT01427972|7419793|FG009|COMPLETED|Washout (at Least 28 Days)||3
6501325|NCT01427972|7419794|FG010|COMPLETED|Washout (at Least 28 Days)||3
6501326|NCT01427972|7419795|FG011|COMPLETED|Washout (at Least 28 Days)||4
6501327|NCT01427972|7419784|FG000|NOT COMPLETED|Washout (at Least 28 Days)||0
6501328|NCT01427972|7419785|FG001|NOT COMPLETED|Washout (at Least 28 Days)||0
6501329|NCT01427972|7419786|FG002|NOT COMPLETED|Washout (at Least 28 Days)||0
6501330|NCT01427972|7419787|FG003|NOT COMPLETED|Washout (at Least 28 Days)||0
6477700|NCT01289678|7394762|FG000|STARTED|Overall Study||18
6477701|NCT01289678|7394762|FG000|COMPLETED|Overall Study||12
6477702|NCT01289678|7394762|FG000|NOT COMPLETED|Overall Study||6
6477703|NCT01289782|7394768|FG000|STARTED|Overall Study||264
6477704|NCT01289782|7394769|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
6477705|NCT01289782|7394768|FG000|COMPLETED|Overall Study||239
6477706|NCT01289782|7394769|FG001|COMPLETED|Overall Study||118
6477707|NCT01289782|7394768|FG000|NOT COMPLETED|Overall Study||25
6477708|NCT01289782|7394769|FG001|NOT COMPLETED|Overall Study||12
6477709|NCT01289821|7394775|FG000|STARTED|Treatment Period||54
6477710|NCT01289821|7394775|FG000|Participants Received Regorafenib|Treatment Period||54
6477711|NCT01289821|7394775|FG000|COMPLETED|Treatment Period||0
6477712|NCT01289821|7394775|FG000|NOT COMPLETED|Treatment Period||54
6477713|NCT01289821|7394775|FG000|STARTED|Safety Follow-up Period||54
6477714|NCT01289821|7394775|FG000|COMPLETED|Safety Follow-up Period||49
6477715|NCT01289821|7394775|FG000|NOT COMPLETED|Safety Follow-up Period||5
6477716|NCT01289821|7394775|FG000|STARTED|Survival Follow-up Period||52
6477717|NCT01289821|7394775|FG000|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
6477718|NCT01289821|7394775|FG000|NOT COMPLETED|Survival Follow-up Period||18
6477719|NCT01289847|7394779|FG000|STARTED|Overall Study||25
6477720|NCT01289847|7394779|FG000|COMPLETED|Overall Study||24
6477721|NCT01289847|7394779|FG000|NOT COMPLETED|Overall Study||1
6477722|NCT01289912|7394785|FG000|STARTED|Overall Study||32
6477723|NCT01289912|7394786|FG001|STARTED|Overall Study||15
6477724|NCT01289912|7394785|FG000|COMPLETED|Overall Study||29
6477725|NCT01289912|7394786|FG001|COMPLETED|Overall Study||13
6477726|NCT01289912|7394785|FG000|NOT COMPLETED|Overall Study||3
6477727|NCT01289912|7394786|FG001|NOT COMPLETED|Overall Study||2
6477728|NCT01289990|7394815|FG000|STARTED|Overall Study||224
6477729|NCT01289990|7394816|FG001|STARTED|Overall Study||224
6477730|NCT01289990|7394817|FG002|STARTED|Overall Study||228
6477731|NCT01289990|7394818|FG003|STARTED|Overall Study||223
6477732|NCT01289990|7394819|FG004|STARTED|Overall Study||165
6477733|NCT01289990|7394820|FG005|STARTED|Overall Study||168
6477734|NCT01289990|7394821|FG006|STARTED|Overall Study||166
6477735|NCT01289990|7394822|FG007|STARTED|Overall Study||217
6477736|NCT01289990|7394823|FG008|STARTED|Overall Study||214
6477737|NCT01289990|7394824|FG009|STARTED|Overall Study||207
6477738|NCT01289990|7394825|FG010|STARTED|Overall Study||226
6477739|NCT01289990|7394826|FG011|STARTED|Overall Study||218
6477740|NCT01289990|7394827|FG012|STARTED|Overall Study||225
6477741|NCT01289990|7394815|FG000|COMPLETED|Overall Study||147
6477742|NCT01289990|7394816|FG001|COMPLETED|Overall Study||143
6477743|NCT01289990|7394817|FG002|COMPLETED|Overall Study||119
6477744|NCT01289990|7394818|FG003|COMPLETED|Overall Study||136
6477745|NCT01289990|7394819|FG004|COMPLETED|Overall Study||93
6477746|NCT01289990|7394820|FG005|COMPLETED|Overall Study||94
6477747|NCT01289990|7394821|FG006|COMPLETED|Overall Study||78
6477748|NCT01289990|7394822|FG007|COMPLETED|Overall Study||162
6477749|NCT01289990|7394823|FG008|COMPLETED|Overall Study||139
6477750|NCT01289990|7394824|FG009|COMPLETED|Overall Study||121
6477751|NCT01289990|7394825|FG010|COMPLETED|Overall Study||150
6477752|NCT01289990|7394826|FG011|COMPLETED|Overall Study||150
6477753|NCT01289990|7394827|FG012|COMPLETED|Overall Study||127
6477754|NCT01289990|7394815|FG000|NOT COMPLETED|Overall Study||77
6477755|NCT01289990|7394816|FG001|NOT COMPLETED|Overall Study||81
6477756|NCT01289990|7394817|FG002|NOT COMPLETED|Overall Study||109
6477757|NCT01289990|7394818|FG003|NOT COMPLETED|Overall Study||87
6477758|NCT01289990|7394819|FG004|NOT COMPLETED|Overall Study||72
6477759|NCT01289990|7394820|FG005|NOT COMPLETED|Overall Study||74
6477760|NCT01289990|7394821|FG006|NOT COMPLETED|Overall Study||88
6477761|NCT01289990|7394822|FG007|NOT COMPLETED|Overall Study||55
6477762|NCT01289990|7394823|FG008|NOT COMPLETED|Overall Study||75
6477763|NCT01289990|7394824|FG009|NOT COMPLETED|Overall Study||86
6477764|NCT01289990|7394825|FG010|NOT COMPLETED|Overall Study||76
6477765|NCT01289990|7394826|FG011|NOT COMPLETED|Overall Study||68
6477766|NCT01289990|7394827|FG012|NOT COMPLETED|Overall Study||98
6477767|NCT01290029|7394855|FG000|STARTED|Overall Study||14
6477768|NCT01290029|7394855|FG000|Received Study Treatment|Overall Study||12
6477769|NCT01290029|7394855|FG000|COMPLETED|Overall Study||12
6477770|NCT01290029|7394855|FG000|NOT COMPLETED|Overall Study||2
6554611|NCT01747928|7476768|FG000|NOT COMPLETED|Overall Study||0
6477771|NCT01290068|7394861|FG000|STARTED|Overall Study||108
6477772|NCT01290068|7394862|FG001|STARTED|Overall Study||100
6477773|NCT01290068|7394861|FG000|Implanted|Overall Study||108
6477774|NCT01290068|7394862|FG001|Implanted|Overall Study||98
6477775|NCT01290068|7394861|FG000|COMPLETED|Overall Study||101
6477776|NCT01290068|7394862|FG001|COMPLETED|Overall Study||94
6477777|NCT01290068|7394861|FG000|NOT COMPLETED|Overall Study||7
6477778|NCT01290068|7394862|FG001|NOT COMPLETED|Overall Study||6
6477779|NCT01290094|7394868|FG000|STARTED|Overall Study||41
6477780|NCT01290094|7394868|FG000|COMPLETED|Overall Study||35
6477781|NCT01290094|7394868|FG000|NOT COMPLETED|Overall Study||6
6477782|NCT01290224|7394872|FG000|STARTED|Overall Study||10
6477783|NCT01290224|7394872|FG000|COMPLETED|Overall Study||5
6477784|NCT01290224|7394872|FG000|NOT COMPLETED|Overall Study||5
6477785|NCT01290237|7394880|FG000|STARTED|Overall Study||30
6477786|NCT01290237|7394881|FG001|STARTED|Overall Study||29
6477787|NCT01290237|7394880|FG000|COMPLETED|Overall Study||19
6477788|NCT01290237|7394881|FG001|COMPLETED|Overall Study||27
6477789|NCT01290237|7394880|FG000|NOT COMPLETED|Overall Study||11
6477790|NCT01290237|7394881|FG001|NOT COMPLETED|Overall Study||2
6477791|NCT01290263|7394891|FG000|STARTED|Overall Study||11
6477792|NCT01290263|7394892|FG001|STARTED|Overall Study||3
6477793|NCT01290263|7394893|FG002|STARTED|Overall Study||7
6477794|NCT01290263|7394894|FG003|STARTED|Overall Study||27
6477795|NCT01290263|7394895|FG004|STARTED|Overall Study||37
6477796|NCT01290263|7394891|FG000|COMPLETED|Overall Study||0
6477797|NCT01290263|7394892|FG001|COMPLETED|Overall Study||0
6477798|NCT01290263|7394893|FG002|COMPLETED|Overall Study||0
6477799|NCT01290263|7394894|FG003|COMPLETED|Overall Study||0
6477800|NCT01290263|7394895|FG004|COMPLETED|Overall Study||0
6477801|NCT01290263|7394891|FG000|NOT COMPLETED|Overall Study||11
6477802|NCT01290263|7394892|FG001|NOT COMPLETED|Overall Study||3
6477803|NCT01290263|7394893|FG002|NOT COMPLETED|Overall Study||7
6477804|NCT01290263|7394894|FG003|NOT COMPLETED|Overall Study||27
6477805|NCT01290263|7394895|FG004|NOT COMPLETED|Overall Study||37
6477806|NCT01290315|7394907|FG000|STARTED|Overall Study||14
6477807|NCT01290315|7394908|FG001|STARTED|Overall Study||12
6477808|NCT01290315|7394909|FG002|STARTED|Overall Study||10
6477809|NCT01290315|7394910|FG003|STARTED|Overall Study||13
6477810|NCT01290315|7394907|FG000|COMPLETED|Overall Study||11
6477811|NCT01290315|7394908|FG001|COMPLETED|Overall Study||9
6477812|NCT01290315|7394909|FG002|COMPLETED|Overall Study||10
6477813|NCT01290315|7394910|FG003|COMPLETED|Overall Study||8
6477814|NCT01290315|7394907|FG000|NOT COMPLETED|Overall Study||3
6477815|NCT01290315|7394908|FG001|NOT COMPLETED|Overall Study||3
6477816|NCT01290315|7394909|FG002|NOT COMPLETED|Overall Study||0
6477817|NCT01290315|7394910|FG003|NOT COMPLETED|Overall Study||5
6477818|NCT01290341|7394921|FG000|STARTED|Overall Study||573
6477819|NCT01290341|7394922|FG001|STARTED|Overall Study||287
6477820|NCT01290341|7394921|FG000|COMPLETED|Overall Study||481
6477821|NCT01290341|7394922|FG001|COMPLETED|Overall Study||258
6477822|NCT01290341|7394921|FG000|NOT COMPLETED|Overall Study||92
6477823|NCT01290341|7394922|FG001|NOT COMPLETED|Overall Study||29
6477824|NCT01290445|7394931|FG000|STARTED|Overall Study||335
6477825|NCT01290445|7394932|FG001|STARTED|Overall Study||78412
6477826|NCT01290445|7394933|FG002|STARTED|Overall Study||806438
6477827|NCT01290445|7394931|FG000|COMPLETED|Overall Study||335
6477828|NCT01290445|7394932|FG001|COMPLETED|Overall Study||78412
6477829|NCT01290445|7394933|FG002|COMPLETED|Overall Study||806438
6477830|NCT01290445|7394931|FG000|NOT COMPLETED|Overall Study||0
6477831|NCT01290445|7394932|FG001|NOT COMPLETED|Overall Study||0
6477832|NCT01290445|7394933|FG002|NOT COMPLETED|Overall Study||0
6477833|NCT01290484|7394941|FG000|STARTED|Overall Study||7
6477834|NCT01290484|7394941|FG000|COMPLETED|Overall Study||7
6477835|NCT01290484|7394941|FG000|NOT COMPLETED|Overall Study||0
6477836|NCT01290523|7394945|FG000|STARTED|Overall Study||14
6477837|NCT01290523|7394945|FG000|COMPLETED|Overall Study||11
6477838|NCT01290523|7394945|FG000|NOT COMPLETED|Overall Study||3
6477839|NCT01290536|7394949|FG000|STARTED|Overall Study||42
6477840|NCT01290536|7394949|FG000|COMPLETED|Overall Study||42
6477841|NCT01290536|7394949|FG000|NOT COMPLETED|Overall Study||0
6477842|NCT01290601|7394958|FG000|STARTED|Overall Study||46
6477843|NCT01290601|7394959|FG001|STARTED|Overall Study||24
6477844|NCT01290601|7394960|FG002|STARTED|Overall Study||0
6477845|NCT01290601|7394961|FG003|STARTED|Overall Study||0
6477846|NCT01290601|7394958|FG000|COMPLETED|Overall Study||35
6477847|NCT01290601|7394959|FG001|COMPLETED|Overall Study||19
6477848|NCT01290601|7394960|FG002|COMPLETED|Overall Study||0
6748318|NCT03407170|7676350|FG000|NOT COMPLETED|Overall Study||1
6748319|NCT03407313|7676354|FG000|STARTED|Overall Study||68
6748320|NCT03407313|7676354|FG000|COMPLETED|Overall Study||66
6748321|NCT03407313|7676354|FG000|NOT COMPLETED|Overall Study||2
6748322|NCT03407430|7676360|FG000|STARTED|First Intervention||5
6477849|NCT01290601|7394961|FG003|COMPLETED|Overall Study||0
6477850|NCT01290601|7394958|FG000|NOT COMPLETED|Overall Study||11
6477851|NCT01290601|7394959|FG001|NOT COMPLETED|Overall Study||5
6477852|NCT01290601|7394960|FG002|NOT COMPLETED|Overall Study||0
6477853|NCT01290601|7394961|FG003|NOT COMPLETED|Overall Study||0
6477854|NCT01290614|7394969|FG000|STARTED|Overall Study||1070
6477855|NCT01290614|7394970|FG001|STARTED|Overall Study||1129
6477856|NCT01290614|7394969|FG000|COMPLETED|Overall Study||518
6477857|NCT01290614|7394970|FG001|COMPLETED|Overall Study||1129
6477858|NCT01290614|7394969|FG000|NOT COMPLETED|Overall Study||552
6477859|NCT01290614|7394970|FG001|NOT COMPLETED|Overall Study||0
6477860|NCT01290627|7394979|FG000|STARTED|Overall Study||10
6477861|NCT01290627|7394980|FG001|STARTED|Overall Study||10
6477862|NCT01290627|7394981|FG002|STARTED|Overall Study||10
6477863|NCT01290627|7394979|FG000|COMPLETED|Overall Study||10
6477864|NCT01290627|7394980|FG001|COMPLETED|Overall Study||10
6477865|NCT01290627|7394981|FG002|COMPLETED|Overall Study||10
6477866|NCT01290627|7394979|FG000|NOT COMPLETED|Overall Study||0
6477867|NCT01290627|7394980|FG001|NOT COMPLETED|Overall Study||0
6477868|NCT01290627|7394981|FG002|NOT COMPLETED|Overall Study||0
6477869|NCT01290640|7394991|FG000|STARTED|Overall Study||12
6477870|NCT01290640|7394992|FG001|STARTED|Overall Study||10
6477871|NCT01290640|7394991|FG000|COMPLETED|Overall Study||12
6477872|NCT01290640|7394992|FG001|COMPLETED|Overall Study||10
6477873|NCT01290640|7394991|FG000|NOT COMPLETED|Overall Study||0
6477874|NCT01290640|7394992|FG001|NOT COMPLETED|Overall Study||0
6477875|NCT01290666|7394998|FG000|STARTED|Overall Study||93
6748323|NCT03407430|7676361|FG001|STARTED|First Intervention||3
6748324|NCT03407430|7676360|FG000|COMPLETED|First Intervention||5
6477876|NCT01290666|7394998|FG000|COMPLETED|Overall Study||55
6477877|NCT01290666|7394998|FG000|NOT COMPLETED|Overall Study||38
6477878|NCT01290679|7395004|FG000|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
6477879|NCT01290679|7395005|FG001|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
6477880|NCT01290679|7395004|FG000|COMPLETED|Overall Study||241
6477881|NCT01290679|7395005|FG001|COMPLETED|Overall Study||113
6477882|NCT01290679|7395004|FG000|NOT COMPLETED|Overall Study||16
6477883|NCT01290679|7395005|FG001|NOT COMPLETED|Overall Study||21
6477884|NCT01290731|7395011|FG000|STARTED|Overall Study||49
6477885|NCT01290731|7395011|FG000|COMPLETED|Overall Study||48
6477886|NCT01290731|7395011|FG000|NOT COMPLETED|Overall Study||1
6477887|NCT01290757|7395017|FG000|STARTED|Overall Study||90
6477888|NCT01290757|7395018|FG001|STARTED|Overall Study||90
6477889|NCT01290757|7395017|FG000|COMPLETED|Overall Study||88
6477890|NCT01290757|7395018|FG001|COMPLETED|Overall Study||88
6477891|NCT01290757|7395017|FG000|NOT COMPLETED|Overall Study||2
6477892|NCT01290757|7395018|FG001|NOT COMPLETED|Overall Study||2
6477893|NCT01290796|7395024|FG000|STARTED|Overall Study||153
6477894|NCT01290796|7395024|FG000|COMPLETED|Overall Study||123
6654639|NCT02447029|7584520|FG001|NOT COMPLETED|Overall Study||2
6654640|NCT02447081|7584526|FG000|STARTED|Overall Study||1088
6654641|NCT02447081|7584526|FG000|COMPLETED|Overall Study||864
6654642|NCT02447081|7584526|FG000|NOT COMPLETED|Overall Study||224
6654643|NCT02447172|7584533|FG000|STARTED|Overall Study||262
6654644|NCT02447172|7584534|FG001|STARTED|Overall Study||130
6477895|NCT01290796|7395024|FG000|NOT COMPLETED|Overall Study||30
6477896|NCT01290874|7395030|FG000|STARTED|Overall Study||532
6477897|NCT01290874|7395031|FG001|STARTED|Overall Study||538
6477898|NCT01290874|7395030|FG000|COMPLETED|Overall Study||122
6477899|NCT01290874|7395031|FG001|COMPLETED|Overall Study||134
6477900|NCT01290874|7395030|FG000|NOT COMPLETED|Overall Study||410
6477901|NCT01290874|7395031|FG001|NOT COMPLETED|Overall Study||404
6477902|NCT01290887|7395040|FG000|STARTED|Overall Study||481
6477903|NCT01290887|7395041|FG001|STARTED|Overall Study||571
6477904|NCT01290887|7395040|FG000|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
6477905|NCT01290887|7395041|FG001|Safety Analysis Set|Overall Study||571
6477906|NCT01290887|7395040|FG000|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
6477907|NCT01290887|7395041|FG001|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
6477908|NCT01290887|7395040|FG000|NOT COMPLETED|Overall Study||466
6477909|NCT01290887|7395041|FG001|NOT COMPLETED|Overall Study||536
6477910|NCT01290913|7395047|FG000|STARTED|Overall Study||13
6477911|NCT01290913|7395047|FG000|COMPLETED|Overall Study||12
6477912|NCT01290913|7395047|FG000|NOT COMPLETED|Overall Study||1
6748325|NCT03407430|7676361|FG001|COMPLETED|First Intervention||3
6477913|NCT01290952|7395053|FG000|STARTED|Overall Study||204
6477914|NCT01290952|7395054|FG001|STARTED|Overall Study||207
6477915|NCT01290952|7395053|FG000|COMPLETED|Overall Study||192
6477916|NCT01290952|7395054|FG001|COMPLETED|Overall Study||193
6477917|NCT01290952|7395053|FG000|NOT COMPLETED|Overall Study||12
6477918|NCT01290952|7395054|FG001|NOT COMPLETED|Overall Study||14
6477919|NCT01290978|7395062|FG000|STARTED|Overall Study||22
6477920|NCT01290978|7395062|FG000|COMPLETED|Overall Study||22
6477921|NCT01290978|7395062|FG000|NOT COMPLETED|Overall Study||0
6477922|NCT01291017|7395067|FG000|STARTED|Overall Study||19
6477923|NCT01291017|7395067|FG000|COMPLETED|Overall Study||14
6477924|NCT01291017|7395067|FG000|NOT COMPLETED|Overall Study||5
6477925|NCT01291056|7395073|FG000|STARTED|Intervention One (Menstraution Day 3-7)||10
6477926|NCT01291056|7395074|FG001|STARTED|Intervention One (Menstraution Day 3-7)||10
6477927|NCT01291056|7395073|FG000|COMPLETED|Intervention One (Menstraution Day 3-7)||10
6477928|NCT01291056|7395074|FG001|COMPLETED|Intervention One (Menstraution Day 3-7)||10
6477929|NCT01291056|7395073|FG000|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
6477930|NCT01291056|7395074|FG001|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
6477931|NCT01291056|7395073|FG000|STARTED|Washout||10
6477932|NCT01291056|7395074|FG001|STARTED|Washout||10
6477933|NCT01291056|7395073|FG000|COMPLETED|Washout||10
6477934|NCT01291056|7395074|FG001|COMPLETED|Washout||10
6477935|NCT01291056|7395073|FG000|NOT COMPLETED|Washout||0
6477936|NCT01291056|7395074|FG001|NOT COMPLETED|Washout||0
6477937|NCT01291056|7395073|FG000|STARTED|Intervention Two (Menstration Days 3-7)||10
6477938|NCT01291056|7395074|FG001|STARTED|Intervention Two (Menstration Days 3-7)||10
6477939|NCT01291056|7395073|FG000|COMPLETED|Intervention Two (Menstration Days 3-7)||10
6477940|NCT01291056|7395074|FG001|COMPLETED|Intervention Two (Menstration Days 3-7)||10
6477941|NCT01291056|7395073|FG000|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
6477942|NCT01291056|7395074|FG001|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
6654645|NCT02447172|7584535|FG002|STARTED|Overall Study||132
6654646|NCT02447172|7584533|FG000|COMPLETED|Overall Study||231
6654647|NCT02447172|7584534|FG001|COMPLETED|Overall Study||115
6654648|NCT02447172|7584535|FG002|COMPLETED|Overall Study||114
6654649|NCT02447172|7584533|FG000|NOT COMPLETED|Overall Study||31
6654650|NCT02447172|7584534|FG001|NOT COMPLETED|Overall Study||15
6654651|NCT02447172|7584535|FG002|NOT COMPLETED|Overall Study||18
6654652|NCT02447250|7584543|FG000|STARTED|First Dose (180 mcg Albuterol)||14
6654653|NCT02447250|7584543|FG000|COMPLETED|First Dose (180 mcg Albuterol)||14
6477943|NCT01291108|7395084|FG000|STARTED|Month 1 (Monotherapy)||65
6654654|NCT02447250|7584543|FG000|NOT COMPLETED|First Dose (180 mcg Albuterol)||0
6477944|NCT01291108|7395085|FG001|STARTED|Month 1 (Monotherapy)||0
6477945|NCT01291108|7395086|FG002|STARTED|Month 1 (Monotherapy)||0
6477946|NCT01291108|7395087|FG003|STARTED|Month 1 (Monotherapy)||60
6477947|NCT01291108|7395088|FG004|STARTED|Month 1 (Monotherapy)||0
6477948|NCT01291108|7395089|FG005|STARTED|Month 1 (Monotherapy)||0
6477949|NCT01291108|7395084|FG000|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
6477950|NCT01291108|7395085|FG001|COMPLETED|Month 1 (Monotherapy)||0
6477951|NCT01291108|7395086|FG002|COMPLETED|Month 1 (Monotherapy)||0
6477952|NCT01291108|7395087|FG003|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
6477953|NCT01291108|7395088|FG004|COMPLETED|Month 1 (Monotherapy)||0
6477954|NCT01291108|7395089|FG005|COMPLETED|Month 1 (Monotherapy)||0
6477955|NCT01291108|7395084|FG000|NOT COMPLETED|Month 1 (Monotherapy)||1
6477956|NCT01291108|7395085|FG001|NOT COMPLETED|Month 1 (Monotherapy)||0
6477957|NCT01291108|7395086|FG002|NOT COMPLETED|Month 1 (Monotherapy)||0
6477958|NCT01291108|7395087|FG003|NOT COMPLETED|Month 1 (Monotherapy)||0
6477959|NCT01291108|7395088|FG004|NOT COMPLETED|Month 1 (Monotherapy)||0
6477960|NCT01291108|7395089|FG005|NOT COMPLETED|Month 1 (Monotherapy)||0
6477961|NCT01291108|7395084|FG000|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
6477962|NCT01291108|7395085|FG001|STARTED|Month 2 (Adjunctive Therapy)||40
6477963|NCT01291108|7395086|FG002|STARTED|Month 2 (Adjunctive Therapy)||24
6477964|NCT01291108|7395087|FG003|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
6477965|NCT01291108|7395088|FG004|STARTED|Month 2 (Adjunctive Therapy)||34
6477966|NCT01291108|7395089|FG005|STARTED|Month 2 (Adjunctive Therapy)||26
6477967|NCT01291108|7395084|FG000|COMPLETED|Month 2 (Adjunctive Therapy)||0
6477968|NCT01291108|7395085|FG001|COMPLETED|Month 2 (Adjunctive Therapy)||38
6477969|NCT01291108|7395086|FG002|COMPLETED|Month 2 (Adjunctive Therapy)||24
6477970|NCT01291108|7395087|FG003|COMPLETED|Month 2 (Adjunctive Therapy)||0
6477971|NCT01291108|7395088|FG004|COMPLETED|Month 2 (Adjunctive Therapy)||34
6477972|NCT01291108|7395089|FG005|COMPLETED|Month 2 (Adjunctive Therapy)||25
6477973|NCT01291108|7395084|FG000|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
6477974|NCT01291108|7395085|FG001|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
6477975|NCT01291108|7395086|FG002|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
6477976|NCT01291108|7395087|FG003|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
6477977|NCT01291108|7395088|FG004|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
6477978|NCT01291108|7395089|FG005|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
6477979|NCT01291160|7395102|FG000|STARTED|Overall Study||66
6477980|NCT01291160|7395103|FG001|STARTED|Overall Study||64
6477981|NCT01291160|7395102|FG000|COMPLETED|Overall Study||48
6477982|NCT01291160|7395103|FG001|COMPLETED|Overall Study||48
6477983|NCT01291160|7395102|FG000|NOT COMPLETED|Overall Study||18
6477984|NCT01291160|7395103|FG001|NOT COMPLETED|Overall Study||16
6477985|NCT01291173|7395113|FG000|STARTED|Overall Study||64
6477986|NCT01291173|7395114|FG001|STARTED|Overall Study||66
6477987|NCT01291173|7395115|FG002|STARTED|Overall Study||65
6477988|NCT01291173|7395116|FG003|STARTED|Overall Study||65
6477989|NCT01291173|7395113|FG000|COMPLETED|Overall Study||47
6477990|NCT01291173|7395114|FG001|COMPLETED|Overall Study||51
6477991|NCT01291173|7395115|FG002|COMPLETED|Overall Study||52
6477992|NCT01291173|7395116|FG003|COMPLETED|Overall Study||52
6477993|NCT01291173|7395113|FG000|NOT COMPLETED|Overall Study||17
6477994|NCT01291173|7395114|FG001|NOT COMPLETED|Overall Study||15
6477995|NCT01291173|7395115|FG002|NOT COMPLETED|Overall Study||13
6477996|NCT01291173|7395116|FG003|NOT COMPLETED|Overall Study||13
6477997|NCT01291225|7395128|FG000|STARTED|Overall Study||151
6477998|NCT01291225|7395129|FG001|STARTED|Overall Study||160
6477999|NCT01291225|7395128|FG000|COMPLETED|Overall Study||66
6478000|NCT01291225|7395129|FG001|COMPLETED|Overall Study||121
6478001|NCT01291225|7395128|FG000|NOT COMPLETED|Overall Study||85
6478002|NCT01291225|7395129|FG001|NOT COMPLETED|Overall Study||39
6478003|NCT01291264|7395139|FG000|STARTED|Overall Study||260
6478004|NCT01291264|7395139|FG000|COMPLETED|Overall Study||260
6478005|NCT01291264|7395139|FG000|NOT COMPLETED|Overall Study||0
6478006|NCT01291277|7395145|FG000|STARTED|Overall Study||45
6478007|NCT01291277|7395146|FG001|STARTED|Overall Study||45
6478008|NCT01291277|7395145|FG000|COMPLETED|Overall Study||40
6478009|NCT01291277|7395146|FG001|COMPLETED|Overall Study||42
6478010|NCT01291277|7395145|FG000|NOT COMPLETED|Overall Study||5
6478011|NCT01291277|7395146|FG001|NOT COMPLETED|Overall Study||3
6478012|NCT01291498|7395152|FG000|STARTED|Overall Study||1
6478013|NCT01291498|7395152|FG000|COMPLETED|Overall Study||0
6478014|NCT01291498|7395152|FG000|NOT COMPLETED|Overall Study||1
6478015|NCT01291784|7395158|FG000|STARTED|Overall Study||1
6478016|NCT01291784|7395159|FG001|STARTED|Overall Study||1
6478017|NCT01291784|7395160|FG002|STARTED|Overall Study||1
6478018|NCT01291784|7395158|FG000|COMPLETED|Overall Study||1
6478019|NCT01291784|7395159|FG001|COMPLETED|Overall Study||0
6478020|NCT01291784|7395160|FG002|COMPLETED|Overall Study||1
6478021|NCT01291784|7395158|FG000|NOT COMPLETED|Overall Study||0
6478022|NCT01291784|7395159|FG001|NOT COMPLETED|Overall Study||1
6478023|NCT01291784|7395160|FG002|NOT COMPLETED|Overall Study||0
6478024|NCT01291836|7395168|FG000|STARTED|Overall Study||930
6478025|NCT01291836|7395169|FG001|STARTED|Overall Study||71
6478026|NCT01291836|7395168|FG000|COMPLETED|Overall Study||930
6478027|NCT01291836|7395169|FG001|COMPLETED|Overall Study||71
6478028|NCT01291836|7395168|FG000|NOT COMPLETED|Overall Study||0
6478029|NCT01291836|7395169|FG001|NOT COMPLETED|Overall Study||0
6478030|NCT01292005|7395177|FG000|STARTED|Overall Study||14
6478031|NCT01292005|7395178|FG001|STARTED|Overall Study||14
6478032|NCT01292005|7395177|FG000|COMPLETED|Overall Study||14
6478033|NCT01292005|7395178|FG001|COMPLETED|Overall Study||14
6478034|NCT01292005|7395177|FG000|NOT COMPLETED|Overall Study||0
6478035|NCT01292005|7395178|FG001|NOT COMPLETED|Overall Study||0
6478036|NCT01292057|7395186|FG000|STARTED|Overall Study||49
6478037|NCT01292057|7395187|FG001|STARTED|Overall Study||50
6478038|NCT01292057|7395186|FG000|COMPLETED|Overall Study||47
6478039|NCT01292057|7395187|FG001|COMPLETED|Overall Study||48
6478040|NCT01292057|7395186|FG000|NOT COMPLETED|Overall Study||2
6478041|NCT01292057|7395187|FG001|NOT COMPLETED|Overall Study||2
6478042|NCT01292135|7395195|FG000|STARTED|Overall Study||3
6478043|NCT01292135|7395196|FG001|STARTED|Overall Study||30
6478044|NCT01292135|7395195|FG000|COMPLETED|Overall Study||3
6478045|NCT01292135|7395196|FG001|COMPLETED|Overall Study||21
6478046|NCT01292135|7395195|FG000|NOT COMPLETED|Overall Study||0
6478047|NCT01292135|7395196|FG001|NOT COMPLETED|Overall Study||9
6478048|NCT01292187|7395206|FG000|STARTED|Overall Study||86
6478049|NCT01292187|7395207|FG001|STARTED|Overall Study||43
6478050|NCT01292187|7395206|FG000|COMPLETED|Overall Study||69
6478051|NCT01292187|7395207|FG001|COMPLETED|Overall Study||30
6478052|NCT01292187|7395206|FG000|NOT COMPLETED|Overall Study||17
6478053|NCT01292187|7395207|FG001|NOT COMPLETED|Overall Study||13
6478054|NCT01292226|7395214|FG000|STARTED|Overall Study||45
6478055|NCT01292226|7395214|FG000|COMPLETED|Overall Study||32
6478056|NCT01292226|7395214|FG000|NOT COMPLETED|Overall Study||13
6478057|NCT01292239|7395220|FG000|STARTED|Overall Study||123
6478058|NCT01292239|7395221|FG001|STARTED|Overall Study||60
6478059|NCT01292239|7395220|FG000|COMPLETED|Overall Study||119
6478060|NCT01292239|7395221|FG001|COMPLETED|Overall Study||53
6478061|NCT01292239|7395220|FG000|NOT COMPLETED|Overall Study||4
6478062|NCT01292239|7395221|FG001|NOT COMPLETED|Overall Study||7
6478063|NCT01292252|7395229|FG000|STARTED|Overall Study||21
6478064|NCT01292252|7395230|FG001|STARTED|Overall Study||15
6478065|NCT01292252|7395229|FG000|COMPLETED|Overall Study||21
6478066|NCT01292252|7395230|FG001|COMPLETED|Overall Study||14
6478067|NCT01292252|7395229|FG000|NOT COMPLETED|Overall Study||0
6478068|NCT01292252|7395230|FG001|NOT COMPLETED|Overall Study||1
6478069|NCT01292304|7395236|FG000|STARTED|Overall Study||10
6478070|NCT01292304|7395236|FG000|COMPLETED|Overall Study||10
6478071|NCT01292304|7395236|FG000|NOT COMPLETED|Overall Study||0
6478072|NCT01292447|7395242|FG000|STARTED|Overall Study||75
6478073|NCT01292447|7395243|FG001|STARTED|Overall Study||75
6478074|NCT01292447|7395242|FG000|COMPLETED|Overall Study||73
6478075|NCT01292447|7395243|FG001|COMPLETED|Overall Study||72
6478076|NCT01292447|7395242|FG000|NOT COMPLETED|Overall Study||2
6478077|NCT01292447|7395243|FG001|NOT COMPLETED|Overall Study||3
6478078|NCT01292473|7395253|FG000|STARTED|Overall Study||79
6478079|NCT01292473|7395254|FG001|STARTED|Overall Study||82
6478080|NCT01292473|7395255|FG002|STARTED|Overall Study||83
6478081|NCT01292473|7395256|FG003|STARTED|Overall Study||79
6478082|NCT01292473|7395253|FG000|COMPLETED|Overall Study||74
6478083|NCT01292473|7395254|FG001|COMPLETED|Overall Study||75
6478084|NCT01292473|7395255|FG002|COMPLETED|Overall Study||74
6478085|NCT01292473|7395256|FG003|COMPLETED|Overall Study||67
6478086|NCT01292473|7395253|FG000|NOT COMPLETED|Overall Study||5
6478087|NCT01292473|7395254|FG001|NOT COMPLETED|Overall Study||7
6478088|NCT01292473|7395255|FG002|NOT COMPLETED|Overall Study||9
6478089|NCT01292473|7395256|FG003|NOT COMPLETED|Overall Study||12
6478090|NCT01292486|7395270|FG000|STARTED|Overall Study||32
6478091|NCT01292486|7395270|FG000|COMPLETED|Overall Study||26
6478092|NCT01292486|7395270|FG000|NOT COMPLETED|Overall Study||6
6478093|NCT01292538|7395277|FG000|STARTED|Overall Study||35
6478094|NCT01292538|7395278|FG001|STARTED|Overall Study||32
6478095|NCT01292538|7395277|FG000|COMPLETED|Overall Study||35
6478096|NCT01292538|7395278|FG001|COMPLETED|Overall Study||32
6478097|NCT01292538|7395277|FG000|NOT COMPLETED|Overall Study||0
6478098|NCT01292538|7395278|FG001|NOT COMPLETED|Overall Study||0
6478099|NCT01292603|7395289|FG000|STARTED|Part 1: Pilot Dose Selection Period||16
6478100|NCT01292603|7395290|FG001|STARTED|Part 1: Pilot Dose Selection Period||17
6478101|NCT01292603|7395291|FG002|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
6478102|NCT01292603|7395292|FG003|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
6478103|NCT01292603|7395293|FG004|STARTED|Part 1: Pilot Dose Selection Period||0
6478104|NCT01292603|7395294|FG005|STARTED|Part 1: Pilot Dose Selection Period||0
6478105|NCT01292603|7395289|FG000|COMPLETED|Part 1: Pilot Dose Selection Period||16
6478106|NCT01292603|7395290|FG001|COMPLETED|Part 1: Pilot Dose Selection Period||17
6478107|NCT01292603|7395291|FG002|COMPLETED|Part 1: Pilot Dose Selection Period||23
6478108|NCT01292603|7395292|FG003|COMPLETED|Part 1: Pilot Dose Selection Period||0
6478109|NCT01292603|7395293|FG004|COMPLETED|Part 1: Pilot Dose Selection Period||0
6478110|NCT01292603|7395294|FG005|COMPLETED|Part 1: Pilot Dose Selection Period||0
6478111|NCT01292603|7395289|FG000|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6478112|NCT01292603|7395290|FG001|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6478113|NCT01292603|7395291|FG002|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6478114|NCT01292603|7395292|FG003|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
6478115|NCT01292603|7395293|FG004|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6478116|NCT01292603|7395294|FG005|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
6478117|NCT01292603|7395289|FG000|STARTED|Part 1: Regular Follow-Up Period||16
6478118|NCT01292603|7395290|FG001|STARTED|Part 1: Regular Follow-Up Period||17
6478119|NCT01292603|7395291|FG002|STARTED|Part 1: Regular Follow-Up Period||23
6478120|NCT01292603|7395292|FG003|STARTED|Part 1: Regular Follow-Up Period||8
6478121|NCT01292603|7395293|FG004|STARTED|Part 1: Regular Follow-Up Period||0
6478122|NCT01292603|7395294|FG005|STARTED|Part 1: Regular Follow-Up Period||0
6478123|NCT01292603|7395289|FG000|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
6478124|NCT01292603|7395290|FG001|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|10
6478125|NCT01292603|7395291|FG002|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|17
6478126|NCT01292603|7395292|FG003|COMPLETED|Part 1: Regular Follow-Up Period||7
6478127|NCT01292603|7395293|FG004|COMPLETED|Part 1: Regular Follow-Up Period||0
6478128|NCT01292603|7395294|FG005|COMPLETED|Part 1: Regular Follow-Up Period||0
6478129|NCT01292603|7395289|FG000|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
6478130|NCT01292603|7395290|FG001|NOT COMPLETED|Part 1: Regular Follow-Up Period||7
6478131|NCT01292603|7395291|FG002|NOT COMPLETED|Part 1: Regular Follow-Up Period||6
6478132|NCT01292603|7395292|FG003|NOT COMPLETED|Part 1: Regular Follow-Up Period||1
6478133|NCT01292603|7395293|FG004|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
6478134|NCT01292603|7395294|FG005|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
6478135|NCT01292603|7395289|FG000|STARTED|Part 2: Dose Confirmation Period||0
6478136|NCT01292603|7395290|FG001|STARTED|Part 2: Dose Confirmation Period||0
6478137|NCT01292603|7395291|FG002|STARTED|Part 2: Dose Confirmation Period||0
6478138|NCT01292603|7395292|FG003|STARTED|Part 2: Dose Confirmation Period||0
6478139|NCT01292603|7395293|FG004|STARTED|Part 2: Dose Confirmation Period||88
6478140|NCT01292603|7395294|FG005|STARTED|Part 2: Dose Confirmation Period||88
6478141|NCT01292603|7395289|FG000|COMPLETED|Part 2: Dose Confirmation Period||0
6478142|NCT01292603|7395290|FG001|COMPLETED|Part 2: Dose Confirmation Period||0
6478143|NCT01292603|7395291|FG002|COMPLETED|Part 2: Dose Confirmation Period||0
6478144|NCT01292603|7395292|FG003|COMPLETED|Part 2: Dose Confirmation Period||0
6478145|NCT01292603|7395293|FG004|COMPLETED|Part 2: Dose Confirmation Period||72
6478146|NCT01292603|7395294|FG005|COMPLETED|Part 2: Dose Confirmation Period||73
6478147|NCT01292603|7395289|FG000|NOT COMPLETED|Part 2: Dose Confirmation Period||0
6478148|NCT01292603|7395290|FG001|NOT COMPLETED|Part 2: Dose Confirmation Period||0
6478149|NCT01292603|7395291|FG002|NOT COMPLETED|Part 2: Dose Confirmation Period||0
6478150|NCT01292603|7395292|FG003|NOT COMPLETED|Part 2: Dose Confirmation Period||0
6478151|NCT01292603|7395293|FG004|NOT COMPLETED|Part 2: Dose Confirmation Period||16
6478152|NCT01292603|7395294|FG005|NOT COMPLETED|Part 2: Dose Confirmation Period||15
6478153|NCT01292603|7395289|FG000|STARTED|Part 2: Regular Follow-Up||0
6478154|NCT01292603|7395290|FG001|STARTED|Part 2: Regular Follow-Up||0
6478155|NCT01292603|7395291|FG002|STARTED|Part 2: Regular Follow-Up||0
6478156|NCT01292603|7395292|FG003|STARTED|Part 2: Regular Follow-Up||0
6478157|NCT01292603|7395293|FG004|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
6478158|NCT01292603|7395294|FG005|STARTED|Part 2: Regular Follow-Up|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|87
6478159|NCT01292603|7395289|FG000|COMPLETED|Part 2: Regular Follow-Up||0
6478160|NCT01292603|7395290|FG001|COMPLETED|Part 2: Regular Follow-Up||0
6478161|NCT01292603|7395291|FG002|COMPLETED|Part 2: Regular Follow-Up||0
6478162|NCT01292603|7395292|FG003|COMPLETED|Part 2: Regular Follow-Up||0
6478163|NCT01292603|7395293|FG004|COMPLETED|Part 2: Regular Follow-Up||68
6478164|NCT01292603|7395294|FG005|COMPLETED|Part 2: Regular Follow-Up||75
6478165|NCT01292603|7395289|FG000|NOT COMPLETED|Part 2: Regular Follow-Up||0
6478166|NCT01292603|7395290|FG001|NOT COMPLETED|Part 2: Regular Follow-Up||0
6478167|NCT01292603|7395291|FG002|NOT COMPLETED|Part 2: Regular Follow-Up||0
6478168|NCT01292603|7395292|FG003|NOT COMPLETED|Part 2: Regular Follow-Up||0
6478169|NCT01292603|7395293|FG004|NOT COMPLETED|Part 2: Regular Follow-Up||19
6478170|NCT01292603|7395294|FG005|NOT COMPLETED|Part 2: Regular Follow-Up||12
6478171|NCT01292603|7395289|FG000|STARTED|Overall Survival Status||16
6478172|NCT01292603|7395290|FG001|STARTED|Overall Survival Status||17
6478173|NCT01292603|7395291|FG002|STARTED|Overall Survival Status||23
6478174|NCT01292603|7395292|FG003|STARTED|Overall Survival Status||8
6478175|NCT01292603|7395293|FG004|STARTED|Overall Survival Status||88
6478176|NCT01292603|7395294|FG005|STARTED|Overall Survival Status||88
6478177|NCT01292603|7395289|FG000|COMPLETED|Overall Survival Status||13
6478178|NCT01292603|7395290|FG001|COMPLETED|Overall Survival Status||16
6478179|NCT01292603|7395291|FG002|COMPLETED|Overall Survival Status||20
6478180|NCT01292603|7395292|FG003|COMPLETED|Overall Survival Status||7
6478181|NCT01292603|7395293|FG004|COMPLETED|Overall Survival Status||72
6478182|NCT01292603|7395294|FG005|COMPLETED|Overall Survival Status||78
6478183|NCT01292603|7395289|FG000|NOT COMPLETED|Overall Survival Status||3
6478184|NCT01292603|7395290|FG001|NOT COMPLETED|Overall Survival Status||1
6478185|NCT01292603|7395291|FG002|NOT COMPLETED|Overall Survival Status||3
6478186|NCT01292603|7395292|FG003|NOT COMPLETED|Overall Survival Status||1
6478187|NCT01292603|7395293|FG004|NOT COMPLETED|Overall Survival Status||16
6478188|NCT01292603|7395294|FG005|NOT COMPLETED|Overall Survival Status||10
6478189|NCT01292629|7395315|FG000|STARTED|Overall Study||125
6478190|NCT01292629|7395315|FG000|COMPLETED|Overall Study||125
6478191|NCT01292629|7395315|FG000|NOT COMPLETED|Overall Study||0
6478192|NCT01292642|7395320|FG000|STARTED|Overall Study||12
6478193|NCT01292642|7395320|FG000|COMPLETED|Overall Study||7
6478194|NCT01292642|7395320|FG000|NOT COMPLETED|Overall Study||5
6478195|NCT01292746|7395328|FG000|STARTED|Overall Study||14
6478196|NCT01292746|7395328|FG000|COMPLETED|Overall Study||14
6478197|NCT01292746|7395328|FG000|NOT COMPLETED|Overall Study||0
6478198|NCT01292798|7395332|FG000|STARTED|Overall Study||43
6478199|NCT01292798|7395332|FG000|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
6478200|NCT01292798|7395332|FG000|COMPLETED|Overall Study||43
6478201|NCT01292798|7395332|FG000|NOT COMPLETED|Overall Study||0
6478202|NCT01292837|7395336|FG000|STARTED|Overall Study||13
6478203|NCT01292837|7395336|FG000|COMPLETED|Overall Study||11
6478204|NCT01292837|7395336|FG000|NOT COMPLETED|Overall Study||2
6478205|NCT01292876|7395340|FG000|STARTED|Overall Study||17
6478206|NCT01292876|7395340|FG000|COMPLETED|Overall Study||13
6478207|NCT01292876|7395340|FG000|NOT COMPLETED|Overall Study||4
6478208|NCT01292928|7395346|FG000|STARTED|Overall Study||299
6478209|NCT01292928|7395346|FG000|Completed 12-Month Clinical Follow-up|Overall Study||266
6478210|NCT01292928|7395346|FG000|COMPLETED|Overall Study||275
6478211|NCT01292928|7395346|FG000|NOT COMPLETED|Overall Study||24
6478212|NCT01293006|7395356|FG000|STARTED|Period 1||11
6478213|NCT01293006|7395357|FG001|STARTED|Period 1||2
6478214|NCT01293006|7395358|FG002|STARTED|Period 1||9
6478215|NCT01293006|7395359|FG003|STARTED|Period 1||3
6478216|NCT01293006|7395356|FG000|COMPLETED|Period 1||11
6478217|NCT01293006|7395357|FG001|COMPLETED|Period 1||2
6478218|NCT01293006|7395358|FG002|COMPLETED|Period 1||9
6478219|NCT01293006|7395359|FG003|COMPLETED|Period 1||3
6478220|NCT01293006|7395356|FG000|NOT COMPLETED|Period 1||0
6478221|NCT01293006|7395357|FG001|NOT COMPLETED|Period 1||0
6478222|NCT01293006|7395358|FG002|NOT COMPLETED|Period 1||0
6478223|NCT01293006|7395359|FG003|NOT COMPLETED|Period 1||0
6478224|NCT01293006|7395356|FG000|STARTED|Washout||11
6478225|NCT01293006|7395357|FG001|STARTED|Washout||2
6478226|NCT01293006|7395358|FG002|STARTED|Washout||9
6478227|NCT01293006|7395359|FG003|STARTED|Washout||3
6478228|NCT01293006|7395356|FG000|COMPLETED|Washout||11
6478229|NCT01293006|7395357|FG001|COMPLETED|Washout||2
6478230|NCT01293006|7395358|FG002|COMPLETED|Washout||9
6478231|NCT01293006|7395359|FG003|COMPLETED|Washout||3
6478232|NCT01293006|7395356|FG000|NOT COMPLETED|Washout||0
6478233|NCT01293006|7395357|FG001|NOT COMPLETED|Washout||0
6478234|NCT01293006|7395358|FG002|NOT COMPLETED|Washout||0
6478235|NCT01293006|7395359|FG003|NOT COMPLETED|Washout||0
6478236|NCT01293006|7395356|FG000|STARTED|Period 2||11
6478237|NCT01293006|7395357|FG001|STARTED|Period 2||2
6478238|NCT01293006|7395358|FG002|STARTED|Period 2||9
6478239|NCT01293006|7395359|FG003|STARTED|Period 2||3
6478240|NCT01293006|7395356|FG000|COMPLETED|Period 2||10
6478241|NCT01293006|7395357|FG001|COMPLETED|Period 2||2
6478242|NCT01293006|7395358|FG002|COMPLETED|Period 2||9
6478243|NCT01293006|7395359|FG003|COMPLETED|Period 2||3
6478244|NCT01293006|7395356|FG000|NOT COMPLETED|Period 2||1
6478245|NCT01293006|7395357|FG001|NOT COMPLETED|Period 2||0
6478246|NCT01293006|7395358|FG002|NOT COMPLETED|Period 2||0
6478247|NCT01293006|7395359|FG003|NOT COMPLETED|Period 2||0
6478248|NCT01293032|7395378|FG000|STARTED|Recurrence Score(RS)Assigned/Randomized||12
6478249|NCT01293032|7395379|FG001|STARTED|Recurrence Score(RS)Assigned/Randomized||17
6478250|NCT01293032|7395380|FG002|STARTED|Recurrence Score(RS)Assigned/Randomized||16
6478251|NCT01293032|7395381|FG003|STARTED|Recurrence Score(RS)Assigned/Randomized||14
6478252|NCT01293032|7395378|FG000|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
6478253|NCT01293032|7395379|FG001|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
6478254|NCT01293032|7395380|FG002|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
6478255|NCT01293032|7395381|FG003|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
6478256|NCT01293032|7395378|FG000|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
6478257|NCT01293032|7395379|FG001|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
6478258|NCT01293032|7395380|FG002|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
6478259|NCT01293032|7395381|FG003|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
6478260|NCT01293032|7395378|FG000|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
6478261|NCT01293032|7395379|FG001|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
6478262|NCT01293032|7395380|FG002|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
6478263|NCT01293032|7395381|FG003|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
6478264|NCT01293032|7395378|FG000|STARTED|Treatment||12
6478265|NCT01293032|7395379|FG001|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
6478266|NCT01293032|7395380|FG002|STARTED|Treatment||11
6478267|NCT01293032|7395381|FG003|STARTED|Treatment||14
6478268|NCT01293032|7395378|FG000|COMPLETED|Treatment||10
6478269|NCT01293032|7395379|FG001|COMPLETED|Treatment||14
6478270|NCT01293032|7395380|FG002|COMPLETED|Treatment||10
6478271|NCT01293032|7395381|FG003|COMPLETED|Treatment||13
6478272|NCT01293032|7395378|FG000|NOT COMPLETED|Treatment||2
6478273|NCT01293032|7395379|FG001|NOT COMPLETED|Treatment||5
6478274|NCT01293032|7395380|FG002|NOT COMPLETED|Treatment||1
6478275|NCT01293032|7395381|FG003|NOT COMPLETED|Treatment||1
6478276|NCT01293084|7395388|FG000|STARTED|Overall Study||17
6478277|NCT01293084|7395388|FG000|COMPLETED|Overall Study||12
6478278|NCT01293084|7395388|FG000|NOT COMPLETED|Overall Study||5
6478279|NCT01293240|7395394|FG000|STARTED|Overall Study||117
6478280|NCT01293240|7395394|FG000|COMPLETED|Overall Study||115
6478281|NCT01293240|7395394|FG000|NOT COMPLETED|Overall Study||2
6478282|NCT01293396|7395398|FG000|STARTED|First Intervention||6
6478283|NCT01293396|7395399|FG001|STARTED|First Intervention||7
6478284|NCT01293396|7395400|FG002|STARTED|First Intervention||7
6478285|NCT01293396|7395398|FG000|COMPLETED|First Intervention||6
6478286|NCT01293396|7395399|FG001|COMPLETED|First Intervention||7
6478287|NCT01293396|7395400|FG002|COMPLETED|First Intervention||7
6478288|NCT01293396|7395398|FG000|NOT COMPLETED|First Intervention||0
6478289|NCT01293396|7395399|FG001|NOT COMPLETED|First Intervention||0
6478290|NCT01293396|7395400|FG002|NOT COMPLETED|First Intervention||0
6478291|NCT01293396|7395398|FG000|STARTED|Wash Out Period 1 (3 Days)||6
6478292|NCT01293396|7395399|FG001|STARTED|Wash Out Period 1 (3 Days)||7
6478293|NCT01293396|7395400|FG002|STARTED|Wash Out Period 1 (3 Days)||7
6478294|NCT01293396|7395398|FG000|COMPLETED|Wash Out Period 1 (3 Days)||6
6478295|NCT01293396|7395399|FG001|COMPLETED|Wash Out Period 1 (3 Days)||7
6478296|NCT01293396|7395400|FG002|COMPLETED|Wash Out Period 1 (3 Days)||7
6478297|NCT01293396|7395398|FG000|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
6478298|NCT01293396|7395399|FG001|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
6478299|NCT01293396|7395400|FG002|NOT COMPLETED|Wash Out Period 1 (3 Days)||0
6478300|NCT01293396|7395398|FG000|STARTED|Second Intervention||5
6478301|NCT01293396|7395399|FG001|STARTED|Second Intervention||5
6478302|NCT01293396|7395400|FG002|STARTED|Second Intervention||10
6478303|NCT01293396|7395398|FG000|COMPLETED|Second Intervention||5
6478304|NCT01293396|7395399|FG001|COMPLETED|Second Intervention||5
6478305|NCT01293396|7395400|FG002|COMPLETED|Second Intervention||10
6478306|NCT01293396|7395398|FG000|NOT COMPLETED|Second Intervention||0
6478307|NCT01293396|7395399|FG001|NOT COMPLETED|Second Intervention||0
6478308|NCT01293396|7395400|FG002|NOT COMPLETED|Second Intervention||0
6478309|NCT01293396|7395398|FG000|STARTED|Wash Out Period 2 (3 Days)||5
6478310|NCT01293396|7395399|FG001|STARTED|Wash Out Period 2 (3 Days)||5
6478311|NCT01293396|7395400|FG002|STARTED|Wash Out Period 2 (3 Days)||10
6478312|NCT01293396|7395398|FG000|COMPLETED|Wash Out Period 2 (3 Days)||5
6478313|NCT01293396|7395399|FG001|COMPLETED|Wash Out Period 2 (3 Days)||5
6478314|NCT01293396|7395400|FG002|COMPLETED|Wash Out Period 2 (3 Days)||10
6478315|NCT01293396|7395398|FG000|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
6478316|NCT01293396|7395399|FG001|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
6748326|NCT03407430|7676360|FG000|NOT COMPLETED|First Intervention||0
6748327|NCT03407430|7676361|FG001|NOT COMPLETED|First Intervention||0
6748328|NCT03407430|7676360|FG000|STARTED|Washout||5
6748329|NCT03407430|7676361|FG001|STARTED|Washout||3
6748330|NCT03407430|7676360|FG000|COMPLETED|Washout||4
6748331|NCT03407430|7676361|FG001|COMPLETED|Washout||3
6748332|NCT03407430|7676360|FG000|NOT COMPLETED|Washout||1
6748333|NCT03407430|7676361|FG001|NOT COMPLETED|Washout||0
6748334|NCT03407430|7676360|FG000|STARTED|Second Intervention||4
6748335|NCT03407430|7676361|FG001|STARTED|Second Intervention||3
6748336|NCT03407430|7676360|FG000|COMPLETED|Second Intervention||4
6748337|NCT03407430|7676361|FG001|COMPLETED|Second Intervention||3
6478317|NCT01293396|7395400|FG002|NOT COMPLETED|Wash Out Period 2 (3 Days)||0
6478318|NCT01293396|7395398|FG000|STARTED|Third Intervention||9
6478319|NCT01293396|7395399|FG001|STARTED|Third Intervention||8
6478320|NCT01293396|7395400|FG002|STARTED|Third Intervention||3
6478321|NCT01293396|7395398|FG000|COMPLETED|Third Intervention||9
6478322|NCT01293396|7395399|FG001|COMPLETED|Third Intervention||8
6478323|NCT01293396|7395400|FG002|COMPLETED|Third Intervention||3
6478324|NCT01293396|7395398|FG000|NOT COMPLETED|Third Intervention||0
6478325|NCT01293396|7395399|FG001|NOT COMPLETED|Third Intervention||0
6478326|NCT01293396|7395400|FG002|NOT COMPLETED|Third Intervention||0
6478327|NCT01293539|7395408|FG000|STARTED|Overall Study||10
6478328|NCT01293539|7395408|FG000|COMPLETED|Overall Study||9
6478329|NCT01293539|7395408|FG000|NOT COMPLETED|Overall Study||1
6478330|NCT01293695|7395414|FG000|STARTED|Overall Study||93
6478331|NCT01293695|7395415|FG001|STARTED|Overall Study||94
6478332|NCT01293695|7395414|FG000|COMPLETED|Overall Study||78
6478333|NCT01293695|7395415|FG001|COMPLETED|Overall Study||87
6478334|NCT01293695|7395414|FG000|NOT COMPLETED|Overall Study||15
6478335|NCT01293695|7395415|FG001|NOT COMPLETED|Overall Study||7
6478336|NCT01293825|7395424|FG000|STARTED|Overall Study||30
6478337|NCT01293825|7395424|FG000|COMPLETED|Overall Study||20
6478338|NCT01293825|7395424|FG000|NOT COMPLETED|Overall Study||10
6478339|NCT01293968|7395430|FG000|STARTED|Overall Study||20
6478340|NCT01293968|7395431|FG001|STARTED|Overall Study||17
6478341|NCT01293968|7395430|FG000|COMPLETED|Overall Study||17
6478342|NCT01293968|7395431|FG001|COMPLETED|Overall Study||14
6478343|NCT01293968|7395430|FG000|NOT COMPLETED|Overall Study||3
6478344|NCT01293968|7395431|FG001|NOT COMPLETED|Overall Study||3
6478345|NCT01294098|7395440|FG000|STARTED|Overall Study||0
6478346|NCT01294098|7395441|FG001|STARTED|Overall Study||1
6478347|NCT01294098|7395442|FG002|STARTED|Overall Study||1
6478348|NCT01294098|7395440|FG000|COMPLETED|Overall Study||0
6748338|NCT03407430|7676360|FG000|NOT COMPLETED|Second Intervention||0
6748339|NCT03407430|7676361|FG001|NOT COMPLETED|Second Intervention||0
6748340|NCT03407482|7676374|FG000|STARTED|Overall Study||160
6478349|NCT01294098|7395441|FG001|COMPLETED|Overall Study||0
6478350|NCT01294098|7395442|FG002|COMPLETED|Overall Study||0
6478351|NCT01294098|7395440|FG000|NOT COMPLETED|Overall Study||0
6748341|NCT03407482|7676374|FG000|COMPLETED|Overall Study||29
6478352|NCT01294098|7395441|FG001|NOT COMPLETED|Overall Study||1
6478353|NCT01294098|7395442|FG002|NOT COMPLETED|Overall Study||1
6478354|NCT01294150|7395452|FG000|STARTED|Overall Study||140
6478355|NCT01294150|7395453|FG001|STARTED|Overall Study||66
6478356|NCT01294150|7395452|FG000|COMPLETED|Overall Study||138
6478357|NCT01294150|7395453|FG001|COMPLETED|Overall Study||64
6478358|NCT01294150|7395452|FG000|NOT COMPLETED|Overall Study||2
6478359|NCT01294150|7395453|FG001|NOT COMPLETED|Overall Study||2
6478360|NCT01294163|7395464|FG000|STARTED|Overall Study||178
6478361|NCT01294163|7395465|FG001|STARTED|Overall Study||165
6478362|NCT01294163|7395466|FG002|STARTED|Overall Study||166
6478363|NCT01294163|7395464|FG000|COMPLETED|Overall Study||177
6478364|NCT01294163|7395465|FG001|COMPLETED|Overall Study||165
6478365|NCT01294163|7395466|FG002|COMPLETED|Overall Study||163
6478366|NCT01294163|7395464|FG000|NOT COMPLETED|Overall Study||1
6478367|NCT01294163|7395465|FG001|NOT COMPLETED|Overall Study||0
6478368|NCT01294163|7395466|FG002|NOT COMPLETED|Overall Study||3
6478369|NCT01294228|7395473|FG000|STARTED|Overall Study||1001
6478370|NCT01294228|7395473|FG000|COMPLETED|Overall Study||1001
6478371|NCT01294228|7395473|FG000|NOT COMPLETED|Overall Study||0
6478372|NCT01294241|7395477|FG000|STARTED|Overall Study||10
6478373|NCT01294241|7395477|FG000|COMPLETED|Overall Study||10
6478374|NCT01294241|7395477|FG000|NOT COMPLETED|Overall Study||0
6478375|NCT01294267|7395483|FG000|STARTED|Overall Study||20
6478376|NCT01294267|7395483|FG000|COMPLETED|Overall Study||20
6478377|NCT01294267|7395483|FG000|NOT COMPLETED|Overall Study||0
6478378|NCT01294306|7395489|FG000|STARTED|Overall Study||45
6478379|NCT01294306|7395490|FG001|STARTED|Overall Study||35
6478380|NCT01294306|7395489|FG000|COMPLETED|Overall Study||45
6478381|NCT01294306|7395490|FG001|COMPLETED|Overall Study||35
6478382|NCT01294306|7395489|FG000|NOT COMPLETED|Overall Study||0
6478383|NCT01294306|7395490|FG001|NOT COMPLETED|Overall Study||0
6554612|NCT01747928|7476769|FG001|NOT COMPLETED|Overall Study||0
6554613|NCT01747928|7476770|FG002|NOT COMPLETED|Overall Study||0
6554614|NCT01747928|7476771|FG003|NOT COMPLETED|Overall Study||0
6554615|NCT01747928|7476772|FG004|NOT COMPLETED|Overall Study||0
6554616|NCT01747928|7476773|FG005|NOT COMPLETED|Overall Study||0
6554617|NCT01747928|7476774|FG006|NOT COMPLETED|Overall Study||0
6478384|NCT01294319|7395504|FG000|STARTED|Overall Study||4
6478385|NCT01294319|7395505|FG001|STARTED|Overall Study||6
6478386|NCT01294319|7395506|FG002|STARTED|Overall Study||5
6478387|NCT01294319|7395507|FG003|STARTED|Overall Study||5
6478388|NCT01294319|7395508|FG004|STARTED|Overall Study||5
6478389|NCT01294319|7395509|FG005|STARTED|Overall Study||4
6478390|NCT01294319|7395510|FG006|STARTED|Overall Study||5
6478391|NCT01294319|7395511|FG007|STARTED|Overall Study||5
6554618|NCT01747928|7476775|FG007|NOT COMPLETED|Overall Study||0
6554619|NCT01748045|7476796|FG000|STARTED|Overall Study||2
6554620|NCT01748045|7476797|FG001|STARTED|Overall Study||1
6554621|NCT01748045|7476796|FG000|COMPLETED|Overall Study||2
6554622|NCT01748045|7476797|FG001|COMPLETED|Overall Study||1
6554623|NCT01748045|7476796|FG000|NOT COMPLETED|Overall Study||0
6554624|NCT01748045|7476797|FG001|NOT COMPLETED|Overall Study||0
6554625|NCT01748071|7476812|FG000|STARTED|Overall Study||40
6478392|NCT01294319|7395504|FG000|COMPLETED|Overall Study||4
6478393|NCT01294319|7395505|FG001|COMPLETED|Overall Study||6
6478394|NCT01294319|7395506|FG002|COMPLETED|Overall Study||5
6478395|NCT01294319|7395507|FG003|COMPLETED|Overall Study||5
6478396|NCT01294319|7395508|FG004|COMPLETED|Overall Study||5
6478397|NCT01294319|7395509|FG005|COMPLETED|Overall Study||4
6478398|NCT01294319|7395510|FG006|COMPLETED|Overall Study||5
6478399|NCT01294319|7395511|FG007|COMPLETED|Overall Study||5
6478400|NCT01294319|7395504|FG000|NOT COMPLETED|Overall Study||0
6478401|NCT01294319|7395505|FG001|NOT COMPLETED|Overall Study||0
6478402|NCT01294319|7395506|FG002|NOT COMPLETED|Overall Study||0
6478403|NCT01294319|7395507|FG003|NOT COMPLETED|Overall Study||0
6478404|NCT01294319|7395508|FG004|NOT COMPLETED|Overall Study||0
6478405|NCT01294319|7395509|FG005|NOT COMPLETED|Overall Study||0
6478406|NCT01294319|7395510|FG006|NOT COMPLETED|Overall Study||0
6478407|NCT01294319|7395511|FG007|NOT COMPLETED|Overall Study||0
6478408|NCT01294358|7395518|FG000|STARTED|Cohort 1: 5/11/11-11/9/11||4
6478409|NCT01294358|7395519|FG001|STARTED|Cohort 1: 5/11/11-11/9/11||0
6478410|NCT01294358|7395520|FG002|STARTED|Cohort 1: 5/11/11-11/9/11||0
6478411|NCT01294358|7395521|FG003|STARTED|Cohort 1: 5/11/11-11/9/11||0
6478412|NCT01294358|7395522|FG004|STARTED|Cohort 1: 5/11/11-11/9/11||0
6478413|NCT01294358|7395518|FG000|COMPLETED|Cohort 1: 5/11/11-11/9/11||4
6478414|NCT01294358|7395519|FG001|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6478415|NCT01294358|7395520|FG002|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6554626|NCT01748071|7476813|FG001|STARTED|Overall Study||40
6554627|NCT01748071|7476814|FG002|STARTED|Overall Study||40
6554628|NCT01748071|7476812|FG000|COMPLETED|Overall Study||38
6554629|NCT01748071|7476813|FG001|COMPLETED|Overall Study||38
6554630|NCT01748071|7476814|FG002|COMPLETED|Overall Study||40
6554631|NCT01748071|7476812|FG000|NOT COMPLETED|Overall Study||2
6554632|NCT01748071|7476813|FG001|NOT COMPLETED|Overall Study||2
6478416|NCT01294358|7395521|FG003|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6554633|NCT01748071|7476814|FG002|NOT COMPLETED|Overall Study||0
6554634|NCT01748227|7476822|FG000|STARTED|Overall Study||20
6478417|NCT01294358|7395522|FG004|COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6478418|NCT01294358|7395518|FG000|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6554635|NCT01748227|7476822|FG000|COMPLETED|Overall Study||17
6554636|NCT01748227|7476822|FG000|NOT COMPLETED|Overall Study||3
6478419|NCT01294358|7395519|FG001|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6478420|NCT01294358|7395520|FG002|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6478421|NCT01294358|7395521|FG003|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6478422|NCT01294358|7395522|FG004|NOT COMPLETED|Cohort 1: 5/11/11-11/9/11||0
6478423|NCT01294358|7395518|FG000|STARTED|Cohort 2: 6/9/11-9/17/12||0
6478424|NCT01294358|7395519|FG001|STARTED|Cohort 2: 6/9/11-9/17/12|4 participants from 18mg move to 36mg and 2 additional participants were enrolled at this dose.|6
6478425|NCT01294358|7395520|FG002|STARTED|Cohort 2: 6/9/11-9/17/12||0
6478426|NCT01294358|7395521|FG003|STARTED|Cohort 2: 6/9/11-9/17/12||0
6478427|NCT01294358|7395522|FG004|STARTED|Cohort 2: 6/9/11-9/17/12||0
6478428|NCT01294358|7395518|FG000|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6478429|NCT01294358|7395519|FG001|COMPLETED|Cohort 2: 6/9/11-9/17/12||4
6478430|NCT01294358|7395520|FG002|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6478431|NCT01294358|7395521|FG003|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6478432|NCT01294358|7395522|FG004|COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6478433|NCT01294358|7395518|FG000|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6478434|NCT01294358|7395519|FG001|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||2
6478435|NCT01294358|7395520|FG002|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6478436|NCT01294358|7395521|FG003|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6478437|NCT01294358|7395522|FG004|NOT COMPLETED|Cohort 2: 6/9/11-9/17/12||0
6478438|NCT01294358|7395518|FG000|STARTED|Cohort 3: 12/1/11-10/6/12||0
6478439|NCT01294358|7395519|FG001|STARTED|Cohort 3: 12/1/11-10/6/12||0
6478440|NCT01294358|7395520|FG002|STARTED|Cohort 3: 12/1/11-10/6/12|4 participants from 36mg move to 72mg.|4
6478441|NCT01294358|7395521|FG003|STARTED|Cohort 3: 12/1/11-10/6/12||0
6478442|NCT01294358|7395522|FG004|STARTED|Cohort 3: 12/1/11-10/6/12||0
6478443|NCT01294358|7395518|FG000|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6478444|NCT01294358|7395519|FG001|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6478445|NCT01294358|7395520|FG002|COMPLETED|Cohort 3: 12/1/11-10/6/12||2
6478446|NCT01294358|7395521|FG003|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6478447|NCT01294358|7395522|FG004|COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6478448|NCT01294358|7395518|FG000|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6478449|NCT01294358|7395519|FG001|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6478450|NCT01294358|7395520|FG002|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||2
6478451|NCT01294358|7395521|FG003|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6478452|NCT01294358|7395522|FG004|NOT COMPLETED|Cohort 3: 12/1/11-10/6/12||0
6478453|NCT01294358|7395518|FG000|STARTED|Cohort 4: 12/30/11-2/17/17||0
6478454|NCT01294358|7395519|FG001|STARTED|Cohort 4: 12/30/11-2/17/17||0
6478455|NCT01294358|7395520|FG002|STARTED|Cohort 4: 12/30/11-2/17/17||0
6478456|NCT01294358|7395521|FG003|STARTED|Cohort 4: 12/30/11-2/17/17|2 participants from 72mg move to 96mg.|2
6478457|NCT01294358|7395522|FG004|STARTED|Cohort 4: 12/30/11-2/17/17||0
6478458|NCT01294358|7395518|FG000|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6478459|NCT01294358|7395519|FG001|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6478460|NCT01294358|7395520|FG002|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6478461|NCT01294358|7395521|FG003|COMPLETED|Cohort 4: 12/30/11-2/17/17||1
6478462|NCT01294358|7395522|FG004|COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6478463|NCT01294358|7395518|FG000|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6478464|NCT01294358|7395519|FG001|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6554637|NCT01748240|7476827|FG000|STARTED|Overall Study||21
6554638|NCT01748240|7476827|FG000|COMPLETED|Overall Study||21
6554639|NCT01748240|7476827|FG000|NOT COMPLETED|Overall Study||0
6478465|NCT01294358|7395520|FG002|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6478466|NCT01294358|7395521|FG003|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||1
6478467|NCT01294358|7395522|FG004|NOT COMPLETED|Cohort 4: 12/30/11-2/17/17||0
6478468|NCT01294358|7395518|FG000|STARTED|Cohort 5: 3/8/12-3/9/12||0
6478469|NCT01294358|7395519|FG001|STARTED|Cohort 5: 3/8/12-3/9/12||0
6478470|NCT01294358|7395520|FG002|STARTED|Cohort 5: 3/8/12-3/9/12||0
6478471|NCT01294358|7395521|FG003|STARTED|Cohort 5: 3/8/12-3/9/12||0
6478472|NCT01294358|7395522|FG004|STARTED|Cohort 5: 3/8/12-3/9/12|1 participant from 96mg move to 115mg.|1
6478473|NCT01294358|7395518|FG000|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478474|NCT01294358|7395519|FG001|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478475|NCT01294358|7395520|FG002|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478476|NCT01294358|7395521|FG003|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478477|NCT01294358|7395522|FG004|COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478478|NCT01294358|7395518|FG000|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478479|NCT01294358|7395519|FG001|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478480|NCT01294358|7395520|FG002|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478481|NCT01294358|7395521|FG003|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||0
6478482|NCT01294358|7395522|FG004|NOT COMPLETED|Cohort 5: 3/8/12-3/9/12||1
6478483|NCT01294371|7395539|FG000|STARTED|Overall Study||391
6478484|NCT01294371|7395539|FG000|Treated|Overall Study||390
6478485|NCT01294371|7395539|FG000|COMPLETED|Overall Study||357
6478486|NCT01294371|7395539|FG000|NOT COMPLETED|Overall Study||34
6478487|NCT01294384|7395549|FG000|STARTED|Overall Study||101
6554640|NCT01748292|7476833|FG000|STARTED|Overall Study||20
6554641|NCT01748292|7476834|FG001|STARTED|Overall Study||40
6554642|NCT01748292|7476833|FG000|COMPLETED|Overall Study||18
6554643|NCT01748292|7476834|FG001|COMPLETED|Overall Study||28
6554644|NCT01748292|7476833|FG000|NOT COMPLETED|Overall Study||2
6554645|NCT01748292|7476834|FG001|NOT COMPLETED|Overall Study||12
6554646|NCT01748552|7476852|FG000|STARTED|Intervention Period 1 and Washout||3
6554647|NCT01748552|7476853|FG001|STARTED|Intervention Period 1 and Washout||3
6554648|NCT01748552|7476854|FG002|STARTED|Intervention Period 1 and Washout||3
6554649|NCT01748552|7476855|FG003|STARTED|Intervention Period 1 and Washout||3
6478488|NCT01294384|7395550|FG001|STARTED|Overall Study||100
6478489|NCT01294384|7395551|FG002|STARTED|Overall Study||104
6478490|NCT01294384|7395549|FG000|COMPLETED|Overall Study||97
6478491|NCT01294384|7395550|FG001|COMPLETED|Overall Study||94
6478492|NCT01294384|7395551|FG002|COMPLETED|Overall Study||95
6478493|NCT01294384|7395549|FG000|NOT COMPLETED|Overall Study||4
6478494|NCT01294384|7395550|FG001|NOT COMPLETED|Overall Study||6
6478495|NCT01294384|7395551|FG002|NOT COMPLETED|Overall Study||9
6478496|NCT01294397|7395559|FG000|STARTED|Overall Study||19
6478497|NCT01294397|7395559|FG000|COMPLETED|Overall Study||17
6478498|NCT01294397|7395559|FG000|NOT COMPLETED|Overall Study||2
6478499|NCT01294423|7395568|FG000|STARTED|Overall Study||86
6478500|NCT01294423|7395569|FG001|STARTED|Overall Study||88
6478501|NCT01294423|7395570|FG002|STARTED|Overall Study||87
6478502|NCT01294423|7395568|FG000|COMPLETED|Overall Study||81
6478503|NCT01294423|7395569|FG001|COMPLETED|Overall Study||79
6478504|NCT01294423|7395570|FG002|COMPLETED|Overall Study||79
6478505|NCT01294423|7395568|FG000|NOT COMPLETED|Overall Study||5
6478506|NCT01294423|7395569|FG001|NOT COMPLETED|Overall Study||9
6478507|NCT01294423|7395570|FG002|NOT COMPLETED|Overall Study||8
6478508|NCT01294436|7395580|FG000|STARTED|Overall Study||249
6478509|NCT01294436|7395581|FG001|STARTED|Overall Study||479
6478510|NCT01294436|7395580|FG000|COMPLETED|Overall Study||221
6478511|NCT01294436|7395581|FG001|COMPLETED|Overall Study||409
6478512|NCT01294436|7395580|FG000|NOT COMPLETED|Overall Study||28
6478513|NCT01294436|7395581|FG001|NOT COMPLETED|Overall Study||70
6478514|NCT01294449|7395589|FG000|STARTED|Overall Study||156
6478515|NCT01294449|7395590|FG001|STARTED|Overall Study||252
6478516|NCT01294449|7395589|FG000|Consent to Registry|Overall Study||149
6478517|NCT01294449|7395590|FG001|Consent to Registry|Overall Study||245
6478518|NCT01294449|7395589|FG000|COMPLETED|Overall Study||144
6478519|NCT01294449|7395590|FG001|COMPLETED|Overall Study||237
6478520|NCT01294449|7395589|FG000|NOT COMPLETED|Overall Study||12
6478521|NCT01294449|7395590|FG001|NOT COMPLETED|Overall Study||15
6478522|NCT01294462|7395598|FG000|STARTED|Overall Study||401
6478523|NCT01294462|7395599|FG001|STARTED|Overall Study||400
6478524|NCT01294462|7395598|FG000|Received Randomized Treatment|Overall Study||387
6478525|NCT01294462|7395599|FG001|Received Randomized Treatment|Overall Study||380
6478526|NCT01294462|7395598|FG000|COMPLETED|Overall Study||335
6478527|NCT01294462|7395599|FG001|COMPLETED|Overall Study||337
6478528|NCT01294462|7395598|FG000|NOT COMPLETED|Overall Study||66
6478529|NCT01294462|7395599|FG001|NOT COMPLETED|Overall Study||63
6478530|NCT01294514|7395605|FG000|STARTED|Overall Study||27
6478531|NCT01294514|7395605|FG000|COMPLETED|Overall Study||26
6478532|NCT01294514|7395605|FG000|NOT COMPLETED|Overall Study||1
6478533|NCT01294553|7395613|FG000|STARTED|Overall Study||982
6478534|NCT01294553|7395613|FG000|COMPLETED|Overall Study||713
6478535|NCT01294553|7395613|FG000|NOT COMPLETED|Overall Study||269
6478536|NCT01294579|7395618|FG000|STARTED|Overall Study||49
6478537|NCT01294579|7395618|FG000|COMPLETED|Overall Study||14
6478538|NCT01294579|7395618|FG000|NOT COMPLETED|Overall Study||35
6478539|NCT01294592|7395624|FG000|STARTED|Overall Study||369
6478540|NCT01294592|7395625|FG001|STARTED|Overall Study||373
6478541|NCT01294592|7395624|FG000|COMPLETED|Overall Study||292
6478542|NCT01294592|7395625|FG001|COMPLETED|Overall Study||300
6478543|NCT01294592|7395624|FG000|NOT COMPLETED|Overall Study||77
6478544|NCT01294592|7395625|FG001|NOT COMPLETED|Overall Study||73
6478545|NCT01294644|7395637|FG000|STARTED|Overall Study||121
6478546|NCT01294644|7395638|FG001|STARTED|Overall Study||122
6478547|NCT01294644|7395639|FG002|STARTED|Overall Study||117
6554650|NCT01748552|7476856|FG004|STARTED|Intervention Period 1 and Washout||3
6554651|NCT01748552|7476857|FG005|STARTED|Intervention Period 1 and Washout||3
6554652|NCT01748552|7476858|FG006|STARTED|Intervention Period 1 and Washout||3
6554653|NCT01748552|7476859|FG007|STARTED|Intervention Period 1 and Washout||3
6554654|NCT01748552|7476860|FG008|STARTED|Intervention Period 1 and Washout||3
6554655|NCT01748552|7476861|FG009|STARTED|Intervention Period 1 and Washout||3
6554656|NCT01748552|7476862|FG010|STARTED|Intervention Period 1 and Washout||3
6554657|NCT01748552|7476863|FG011|STARTED|Intervention Period 1 and Washout||3
6554658|NCT01748552|7476852|FG000|COMPLETED|Intervention Period 1 and Washout||3
6554659|NCT01748552|7476853|FG001|COMPLETED|Intervention Period 1 and Washout||3
6554660|NCT01748552|7476854|FG002|COMPLETED|Intervention Period 1 and Washout||3
6654655|NCT02447250|7584543|FG000|STARTED|Second Dose (270 mcg Albuterol)||14
6654656|NCT02447250|7584543|FG000|COMPLETED|Second Dose (270 mcg Albuterol)||13
6654657|NCT02447250|7584543|FG000|NOT COMPLETED|Second Dose (270 mcg Albuterol)||1
6654658|NCT02447250|7584543|FG000|STARTED|Third Dose (360 mcg Albuterol)||13
6654659|NCT02447250|7584543|FG000|COMPLETED|Third Dose (360 mcg Albuterol)||8
6654660|NCT02447250|7584543|FG000|NOT COMPLETED|Third Dose (360 mcg Albuterol)||5
6654661|NCT02447302|7584551|FG000|STARTED|Overall Study||52
6654662|NCT02447302|7584552|FG001|STARTED|Overall Study||50
6654663|NCT02447302|7584553|FG002|STARTED|Overall Study||54
6654664|NCT02447302|7584551|FG000|COMPLETED|Overall Study||47
6654665|NCT02447302|7584552|FG001|COMPLETED|Overall Study||46
6478548|NCT01294644|7395637|FG000|Received Treatment|Overall Study||118
6478549|NCT01294644|7395638|FG001|Received Treatment|Overall Study||122
6478550|NCT01294644|7395639|FG002|Received Treatment|Overall Study||114
6478551|NCT01294644|7395637|FG000|COMPLETED|Overall Study||111
6478552|NCT01294644|7395638|FG001|COMPLETED|Overall Study||112
6478553|NCT01294644|7395639|FG002|COMPLETED|Overall Study||103
6554661|NCT01748552|7476855|FG003|COMPLETED|Intervention Period 1 and Washout||3
6654666|NCT02447302|7584553|FG002|COMPLETED|Overall Study||48
6554662|NCT01748552|7476856|FG004|COMPLETED|Intervention Period 1 and Washout||3
6478554|NCT01294644|7395637|FG000|NOT COMPLETED|Overall Study||10
6478555|NCT01294644|7395638|FG001|NOT COMPLETED|Overall Study||10
6478556|NCT01294644|7395639|FG002|NOT COMPLETED|Overall Study||14
6478557|NCT01294683|7395649|FG000|STARTED|Precrossover (Periods I/II)||489
6478558|NCT01294683|7395650|FG001|STARTED|Precrossover (Periods I/II)||488
6478559|NCT01294683|7395649|FG000|Treated|Precrossover (Periods I/II)||486
6478560|NCT01294683|7395650|FG001|Treated|Precrossover (Periods I/II)||486
6478561|NCT01294683|7395649|FG000|COMPLETED|Precrossover (Periods I/II)||232
6478562|NCT01294683|7395650|FG001|COMPLETED|Precrossover (Periods I/II)||222
6478563|NCT01294683|7395649|FG000|NOT COMPLETED|Precrossover (Periods I/II)||257
6478564|NCT01294683|7395650|FG001|NOT COMPLETED|Precrossover (Periods I/II)||266
6478565|NCT01294683|7395649|FG000|STARTED|Post Crossover (Period III)||232
6478566|NCT01294683|7395650|FG001|STARTED|Post Crossover (Period III)||222
6478567|NCT01294683|7395649|FG000|COMPLETED|Post Crossover (Period III)||199
6478568|NCT01294683|7395650|FG001|COMPLETED|Post Crossover (Period III)||190
6478569|NCT01294683|7395649|FG000|NOT COMPLETED|Post Crossover (Period III)||33
6478570|NCT01294683|7395650|FG001|NOT COMPLETED|Post Crossover (Period III)||32
6478571|NCT01294709|7395662|FG000|STARTED|Period 1||31
6478572|NCT01294709|7395663|FG001|STARTED|Period 1||33
6478573|NCT01294709|7395662|FG000|COMPLETED|Period 1||30
6478574|NCT01294709|7395663|FG001|COMPLETED|Period 1||32
6478575|NCT01294709|7395662|FG000|NOT COMPLETED|Period 1||1
6478576|NCT01294709|7395663|FG001|NOT COMPLETED|Period 1||1
6478577|NCT01294709|7395662|FG000|STARTED|Washout Period||30
6478578|NCT01294709|7395663|FG001|STARTED|Washout Period||32
6478579|NCT01294709|7395662|FG000|COMPLETED|Washout Period||29
6478580|NCT01294709|7395663|FG001|COMPLETED|Washout Period||31
6478581|NCT01294709|7395662|FG000|NOT COMPLETED|Washout Period||1
6478582|NCT01294709|7395663|FG001|NOT COMPLETED|Washout Period||1
6478583|NCT01294709|7395662|FG000|STARTED|Period 2||29
6478584|NCT01294709|7395663|FG001|STARTED|Period 2||31
6478585|NCT01294709|7395662|FG000|COMPLETED|Period 2||28
6478586|NCT01294709|7395663|FG001|COMPLETED|Period 2||31
6478587|NCT01294709|7395662|FG000|NOT COMPLETED|Period 2||1
6478588|NCT01294709|7395663|FG001|NOT COMPLETED|Period 2||0
6478589|NCT01294748|7395676|FG000|STARTED|Overall Study||123
6478590|NCT01294748|7395677|FG001|STARTED|Overall Study||61
6478591|NCT01294748|7395676|FG000|COMPLETED|Overall Study|At 270 days|118
6478592|NCT01294748|7395677|FG001|COMPLETED|Overall Study|At 270 days|59
6478593|NCT01294748|7395676|FG000|NOT COMPLETED|Overall Study||5
6478594|NCT01294748|7395677|FG001|NOT COMPLETED|Overall Study||2
6478595|NCT01294787|7395683|FG000|STARTED|Period 1||12
6478596|NCT01294787|7395684|FG001|STARTED|Period 1||16
6478597|NCT01294787|7395685|FG002|STARTED|Period 1||14
6478598|NCT01294787|7395686|FG003|STARTED|Period 1||12
6478599|NCT01294787|7395687|FG004|STARTED|Period 1||16
6478600|NCT01294787|7395688|FG005|STARTED|Period 1|One randomized participant did not receive study drug|15
6478601|NCT01294787|7395683|FG000|COMPLETED|Period 1||12
6478602|NCT01294787|7395684|FG001|COMPLETED|Period 1||16
6478603|NCT01294787|7395685|FG002|COMPLETED|Period 1||13
6478604|NCT01294787|7395686|FG003|COMPLETED|Period 1||11
6478605|NCT01294787|7395687|FG004|COMPLETED|Period 1||14
6478606|NCT01294787|7395688|FG005|COMPLETED|Period 1||13
6478607|NCT01294787|7395683|FG000|NOT COMPLETED|Period 1||0
6478608|NCT01294787|7395684|FG001|NOT COMPLETED|Period 1||0
6478609|NCT01294787|7395685|FG002|NOT COMPLETED|Period 1||1
6478610|NCT01294787|7395686|FG003|NOT COMPLETED|Period 1||1
6478611|NCT01294787|7395687|FG004|NOT COMPLETED|Period 1||2
6478612|NCT01294787|7395688|FG005|NOT COMPLETED|Period 1||2
6478613|NCT01294787|7395683|FG000|STARTED|Period 2||12
6478614|NCT01294787|7395684|FG001|STARTED|Period 2||16
6478615|NCT01294787|7395685|FG002|STARTED|Period 2||13
6478616|NCT01294787|7395686|FG003|STARTED|Period 2||11
6478617|NCT01294787|7395687|FG004|STARTED|Period 2||14
6478618|NCT01294787|7395688|FG005|STARTED|Period 2||13
6478619|NCT01294787|7395683|FG000|COMPLETED|Period 2||12
6478620|NCT01294787|7395684|FG001|COMPLETED|Period 2||13
6478621|NCT01294787|7395685|FG002|COMPLETED|Period 2||13
6478622|NCT01294787|7395686|FG003|COMPLETED|Period 2||9
6478623|NCT01294787|7395687|FG004|COMPLETED|Period 2||14
6478624|NCT01294787|7395688|FG005|COMPLETED|Period 2||13
6478625|NCT01294787|7395683|FG000|NOT COMPLETED|Period 2||0
6478626|NCT01294787|7395684|FG001|NOT COMPLETED|Period 2||3
6478627|NCT01294787|7395685|FG002|NOT COMPLETED|Period 2||0
6478628|NCT01294787|7395686|FG003|NOT COMPLETED|Period 2||2
6478629|NCT01294787|7395687|FG004|NOT COMPLETED|Period 2||0
6478630|NCT01294787|7395688|FG005|NOT COMPLETED|Period 2||0
6478631|NCT01294787|7395683|FG000|STARTED|Period 3||12
6478632|NCT01294787|7395684|FG001|STARTED|Period 3||13
6478633|NCT01294787|7395685|FG002|STARTED|Period 3||13
6478634|NCT01294787|7395686|FG003|STARTED|Period 3||9
6478635|NCT01294787|7395687|FG004|STARTED|Period 3||14
6478636|NCT01294787|7395688|FG005|STARTED|Period 3||13
6478637|NCT01294787|7395683|FG000|COMPLETED|Period 3||12
6478638|NCT01294787|7395684|FG001|COMPLETED|Period 3||13
6478639|NCT01294787|7395685|FG002|COMPLETED|Period 3||13
6478640|NCT01294787|7395686|FG003|COMPLETED|Period 3||9
6554663|NCT01748552|7476857|FG005|COMPLETED|Intervention Period 1 and Washout||3
6478641|NCT01294787|7395687|FG004|COMPLETED|Period 3||13
6478642|NCT01294787|7395688|FG005|COMPLETED|Period 3||13
6478643|NCT01294787|7395683|FG000|NOT COMPLETED|Period 3||0
6478644|NCT01294787|7395684|FG001|NOT COMPLETED|Period 3||0
6478645|NCT01294787|7395685|FG002|NOT COMPLETED|Period 3||0
6478646|NCT01294787|7395686|FG003|NOT COMPLETED|Period 3||0
6478647|NCT01294787|7395687|FG004|NOT COMPLETED|Period 3||1
6478648|NCT01294787|7395688|FG005|NOT COMPLETED|Period 3||0
6478649|NCT01294800|7395703|FG000|STARTED|Overall Study||111
6478650|NCT01294800|7395704|FG001|STARTED|Overall Study||113
6478651|NCT01294800|7395705|FG002|STARTED|Overall Study||113
6478652|NCT01294800|7395706|FG003|STARTED|Overall Study||113
6478653|NCT01294800|7395703|FG000|COMPLETED|Overall Study||100
6478654|NCT01294800|7395704|FG001|COMPLETED|Overall Study||103
6478655|NCT01294800|7395705|FG002|COMPLETED|Overall Study||96
6478656|NCT01294800|7395706|FG003|COMPLETED|Overall Study||97
6478657|NCT01294800|7395703|FG000|NOT COMPLETED|Overall Study||11
6478658|NCT01294800|7395704|FG001|NOT COMPLETED|Overall Study||10
6478659|NCT01294800|7395705|FG002|NOT COMPLETED|Overall Study||17
6478660|NCT01294800|7395706|FG003|NOT COMPLETED|Overall Study||16
6478661|NCT01294917|7395716|FG000|STARTED|Overall Study||42
6478662|NCT01294917|7395716|FG000|Received Investigational MPS|Overall Study||36
6478663|NCT01294917|7395716|FG000|Received Clear Care|Overall Study||36
6478664|NCT01294917|7395716|FG000|Received OptiFree RepleniSH MPS|Overall Study||36
6478665|NCT01294917|7395716|FG000|COMPLETED|Overall Study||36
6478666|NCT01294917|7395716|FG000|NOT COMPLETED|Overall Study||6
6478667|NCT01295034|7395724|FG000|STARTED|Overall Study||32
6478668|NCT01295034|7395725|FG001|STARTED|Overall Study||30
6478669|NCT01295034|7395724|FG000|COMPLETED|Overall Study||27
6478670|NCT01295034|7395725|FG001|COMPLETED|Overall Study||25
6478671|NCT01295034|7395724|FG000|NOT COMPLETED|Overall Study||5
6478672|NCT01295034|7395725|FG001|NOT COMPLETED|Overall Study||5
6501331|NCT01427972|7419788|FG004|NOT COMPLETED|Washout (at Least 28 Days)||0
6501332|NCT01427972|7419789|FG005|NOT COMPLETED|Washout (at Least 28 Days)||2
6501333|NCT01427972|7419790|FG006|NOT COMPLETED|Washout (at Least 28 Days)||0
6501334|NCT01427972|7419791|FG007|NOT COMPLETED|Washout (at Least 28 Days)||0
6501335|NCT01427972|7419792|FG008|NOT COMPLETED|Washout (at Least 28 Days)||0
6501336|NCT01427972|7419793|FG009|NOT COMPLETED|Washout (at Least 28 Days)||0
6501337|NCT01427972|7419794|FG010|NOT COMPLETED|Washout (at Least 28 Days)||0
6501338|NCT01427972|7419795|FG011|NOT COMPLETED|Washout (at Least 28 Days)||0
6501339|NCT01427972|7419784|FG000|STARTED|Treatment Period 2 (21 Days)||3
6501340|NCT01427972|7419785|FG001|STARTED|Treatment Period 2 (21 Days)||4
6501341|NCT01427972|7419786|FG002|STARTED|Treatment Period 2 (21 Days)||4
6501342|NCT01427972|7419787|FG003|STARTED|Treatment Period 2 (21 Days)||3
6501343|NCT01427972|7419788|FG004|STARTED|Treatment Period 2 (21 Days)||4
6501344|NCT01427972|7419789|FG005|STARTED|Treatment Period 2 (21 Days)||1
6501345|NCT01427972|7419790|FG006|STARTED|Treatment Period 2 (21 Days)||3
6501346|NCT01427972|7419791|FG007|STARTED|Treatment Period 2 (21 Days)||4
6501347|NCT01427972|7419792|FG008|STARTED|Treatment Period 2 (21 Days)||3
6501348|NCT01427972|7419793|FG009|STARTED|Treatment Period 2 (21 Days)||3
6501349|NCT01427972|7419794|FG010|STARTED|Treatment Period 2 (21 Days)||3
6501350|NCT01427972|7419795|FG011|STARTED|Treatment Period 2 (21 Days)||4
6501351|NCT01427972|7419784|FG000|COMPLETED|Treatment Period 2 (21 Days)||3
6501352|NCT01427972|7419785|FG001|COMPLETED|Treatment Period 2 (21 Days)||3
6501353|NCT01427972|7419786|FG002|COMPLETED|Treatment Period 2 (21 Days)||4
6501354|NCT01427972|7419787|FG003|COMPLETED|Treatment Period 2 (21 Days)||3
6501355|NCT01427972|7419788|FG004|COMPLETED|Treatment Period 2 (21 Days)||4
6501356|NCT01427972|7419789|FG005|COMPLETED|Treatment Period 2 (21 Days)||1
6501357|NCT01427972|7419790|FG006|COMPLETED|Treatment Period 2 (21 Days)||3
6501358|NCT01427972|7419791|FG007|COMPLETED|Treatment Period 2 (21 Days)||4
6501359|NCT01427972|7419792|FG008|COMPLETED|Treatment Period 2 (21 Days)||3
6501360|NCT01427972|7419793|FG009|COMPLETED|Treatment Period 2 (21 Days)||3
6501361|NCT01427972|7419794|FG010|COMPLETED|Treatment Period 2 (21 Days)||3
6501362|NCT01427972|7419795|FG011|COMPLETED|Treatment Period 2 (21 Days)||4
6501363|NCT01427972|7419784|FG000|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501364|NCT01427972|7419785|FG001|NOT COMPLETED|Treatment Period 2 (21 Days)||1
6501365|NCT01427972|7419786|FG002|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501366|NCT01427972|7419787|FG003|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501367|NCT01427972|7419788|FG004|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501368|NCT01427972|7419789|FG005|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501369|NCT01427972|7419790|FG006|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501370|NCT01427972|7419791|FG007|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501371|NCT01427972|7419792|FG008|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501372|NCT01427972|7419793|FG009|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501373|NCT01427972|7419794|FG010|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501374|NCT01427972|7419795|FG011|NOT COMPLETED|Treatment Period 2 (21 Days)||0
6501375|NCT01428024|7419807|FG000|STARTED|Overall Study||30
6501376|NCT01428024|7419808|FG001|STARTED|Overall Study||30
6501377|NCT01428024|7419807|FG000|COMPLETED|Overall Study||29
6501378|NCT01428024|7419808|FG001|COMPLETED|Overall Study||29
6501379|NCT01428024|7419807|FG000|NOT COMPLETED|Overall Study||1
6501380|NCT01428024|7419808|FG001|NOT COMPLETED|Overall Study||1
6501381|NCT01428063|7419828|FG000|STARTED|Overall Study||99
6501382|NCT01428063|7419829|FG001|STARTED|Overall Study||122
6501383|NCT01428063|7419830|FG002|STARTED|Overall Study||6
6501384|NCT01428063|7419828|FG000|COMPLETED|Overall Study||89
6501385|NCT01428063|7419829|FG001|COMPLETED|Overall Study||112
6501386|NCT01428063|7419830|FG002|COMPLETED|Overall Study||5
6501387|NCT01428063|7419828|FG000|NOT COMPLETED|Overall Study||10
6501388|NCT01428063|7419829|FG001|NOT COMPLETED|Overall Study||10
6478673|NCT01295112|7395734|FG000|STARTED|Overall Study||35
6478674|NCT01295112|7395735|FG001|STARTED|Overall Study||33
6478675|NCT01295112|7395734|FG000|COMPLETED|Overall Study||35
6478676|NCT01295112|7395735|FG001|COMPLETED|Overall Study||33
6478677|NCT01295112|7395734|FG000|NOT COMPLETED|Overall Study||0
6478678|NCT01295112|7395735|FG001|NOT COMPLETED|Overall Study||0
6478679|NCT01295216|7395743|FG000|STARTED|Overall Study||316
6478680|NCT01295216|7395744|FG001|STARTED|Overall Study||321
6478681|NCT01295216|7395743|FG000|COMPLETED|Overall Study||266
6478682|NCT01295216|7395744|FG001|COMPLETED|Overall Study||287
6478683|NCT01295216|7395743|FG000|NOT COMPLETED|Overall Study||50
6478684|NCT01295216|7395744|FG001|NOT COMPLETED|Overall Study||34
6478685|NCT01295281|7395752|FG000|STARTED|First Intervention (7 Days)||53
6478686|NCT01295281|7395753|FG001|STARTED|First Intervention (7 Days)||52
6478687|NCT01295281|7395752|FG000|COMPLETED|First Intervention (7 Days)||53
6478688|NCT01295281|7395753|FG001|COMPLETED|First Intervention (7 Days)||51
6478689|NCT01295281|7395752|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6478690|NCT01295281|7395753|FG001|NOT COMPLETED|First Intervention (7 Days)||1
6478691|NCT01295281|7395752|FG000|STARTED|Second Intervention (7days)||53
6478692|NCT01295281|7395753|FG001|STARTED|Second Intervention (7days)||51
6478693|NCT01295281|7395752|FG000|COMPLETED|Second Intervention (7days)||53
6478694|NCT01295281|7395753|FG001|COMPLETED|Second Intervention (7days)||51
6478695|NCT01295281|7395752|FG000|NOT COMPLETED|Second Intervention (7days)||0
6478696|NCT01295281|7395753|FG001|NOT COMPLETED|Second Intervention (7days)||0
6478697|NCT01295320|7395759|FG000|STARTED|Overall Study||129
6478698|NCT01295320|7395759|FG000|COMPLETED|Overall Study||119
6478699|NCT01295320|7395759|FG000|NOT COMPLETED|Overall Study||10
6478700|NCT01295515|7395763|FG000|STARTED|Overall Study||7
6478701|NCT01295515|7395763|FG000|COMPLETED|Overall Study||7
6478702|NCT01295515|7395763|FG000|NOT COMPLETED|Overall Study||0
6478703|NCT01295580|7395769|FG000|STARTED|Overall Study||174
6478704|NCT01295580|7395770|FG001|STARTED|Overall Study||175
6478705|NCT01295580|7395769|FG000|COMPLETED|Overall Study||164
6478706|NCT01295580|7395770|FG001|COMPLETED|Overall Study||167
6478707|NCT01295580|7395769|FG000|NOT COMPLETED|Overall Study||10
6478708|NCT01295580|7395770|FG001|NOT COMPLETED|Overall Study||8
6478709|NCT01295671|7395779|FG000|STARTED|Overall Study||67
6478710|NCT01295671|7395780|FG001|STARTED|Overall Study||67
6478711|NCT01295671|7395781|FG002|STARTED|Overall Study||69
6478712|NCT01295671|7395779|FG000|COMPLETED|Overall Study||60
6478713|NCT01295671|7395780|FG001|COMPLETED|Overall Study||60
6478714|NCT01295671|7395781|FG002|COMPLETED|Overall Study||66
6478715|NCT01295671|7395779|FG000|NOT COMPLETED|Overall Study||7
6478716|NCT01295671|7395780|FG001|NOT COMPLETED|Overall Study||7
6478717|NCT01295671|7395781|FG002|NOT COMPLETED|Overall Study||3
6478718|NCT01295710|7395791|FG000|STARTED|Overall Study|Randomized and treated|126
6478719|NCT01295710|7395792|FG001|STARTED|Overall Study|Randomized and treated|128
6478720|NCT01295710|7395791|FG000|COMPLETED|Overall Study||48
6478721|NCT01295710|7395792|FG001|COMPLETED|Overall Study||78
6478722|NCT01295710|7395791|FG000|NOT COMPLETED|Overall Study||78
6478723|NCT01295710|7395792|FG001|NOT COMPLETED|Overall Study||50
6478724|NCT01295814|7395800|FG000|STARTED|Overall Study||22
6478725|NCT01295814|7395801|FG001|STARTED|Overall Study||21
6478726|NCT01295814|7395800|FG000|COMPLETED|Overall Study||20
6478727|NCT01295814|7395801|FG001|COMPLETED|Overall Study||19
6478728|NCT01295814|7395800|FG000|NOT COMPLETED|Overall Study||2
6478729|NCT01295814|7395801|FG001|NOT COMPLETED|Overall Study||2
6478730|NCT01295827|7395819|FG000|STARTED|Overall Study||4
6478731|NCT01295827|7395820|FG001|STARTED|Overall Study||3
6478732|NCT01295827|7395821|FG002|STARTED|Overall Study||12
6478733|NCT01295827|7395822|FG003|STARTED|Overall Study||4
6478734|NCT01295827|7395823|FG004|STARTED|Overall Study||3
6478735|NCT01295827|7395824|FG005|STARTED|Overall Study||6
6478736|NCT01295827|7395825|FG006|STARTED|Overall Study||164
6478737|NCT01295827|7395826|FG007|STARTED|Overall Study||321
6478738|NCT01295827|7395827|FG008|STARTED|Overall Study||183
6478739|NCT01295827|7395828|FG009|STARTED|Overall Study||61
6478740|NCT01295827|7395829|FG010|STARTED|Overall Study||296
6478741|NCT01295827|7395830|FG011|STARTED|Overall Study||203
6478742|NCT01295827|7395831|FG012|STARTED|Overall Study||0
6478743|NCT01295827|7395832|FG013|STARTED|Overall Study||0
6478744|NCT01295827|7395833|FG014|STARTED|Overall Study||0
6478745|NCT01295827|7395819|FG000|Treated (All Treated Population)|Overall Study||4
6478746|NCT01295827|7395820|FG001|Treated (All Treated Population)|Overall Study||3
6478747|NCT01295827|7395821|FG002|Treated (All Treated Population)|Overall Study||10
6478748|NCT01295827|7395822|FG003|Treated (All Treated Population)|Overall Study||4
6478749|NCT01295827|7395823|FG004|Treated (All Treated Population)|Overall Study||3
6478750|NCT01295827|7395824|FG005|Treated (All Treated Population)|Overall Study||6
6478751|NCT01295827|7395825|FG006|Treated (All Treated Population)|Overall Study||162
6478752|NCT01295827|7395826|FG007|Treated (All Treated Population)|Overall Study||313
6478753|NCT01295827|7395827|FG008|Treated (All Treated Population)|Overall Study||180
6478754|NCT01295827|7395828|FG009|Treated (All Treated Population)|Overall Study||61
6478755|NCT01295827|7395829|FG010|Treated (All Treated Population)|Overall Study||287
6478756|NCT01295827|7395830|FG011|Treated (All Treated Population)|Overall Study||202
6478757|NCT01295827|7395831|FG012|Treated (All Treated Population)|Overall Study||0
6478758|NCT01295827|7395832|FG013|Treated (All Treated Population)|Overall Study||0
6478759|NCT01295827|7395833|FG014|Treated (All Treated Population)|Overall Study||0
6478760|NCT01295827|7395819|FG000|COMPLETED|Overall Study||0
6478761|NCT01295827|7395820|FG001|COMPLETED|Overall Study||0
6478762|NCT01295827|7395821|FG002|COMPLETED|Overall Study||0
6478763|NCT01295827|7395822|FG003|COMPLETED|Overall Study||0
6478764|NCT01295827|7395823|FG004|COMPLETED|Overall Study||1
6478765|NCT01295827|7395824|FG005|COMPLETED|Overall Study||0
6478766|NCT01295827|7395825|FG006|COMPLETED|Overall Study||18
6478767|NCT01295827|7395826|FG007|COMPLETED|Overall Study||24
6478768|NCT01295827|7395827|FG008|COMPLETED|Overall Study||14
6478769|NCT01295827|7395828|FG009|COMPLETED|Overall Study||6
6478770|NCT01295827|7395829|FG010|COMPLETED|Overall Study||20
6478771|NCT01295827|7395830|FG011|COMPLETED|Overall Study||17
6478772|NCT01295827|7395831|FG012|COMPLETED|Overall Study||0
6478773|NCT01295827|7395832|FG013|COMPLETED|Overall Study||0
6478774|NCT01295827|7395833|FG014|COMPLETED|Overall Study||0
6478775|NCT01295827|7395819|FG000|NOT COMPLETED|Overall Study||4
6478776|NCT01295827|7395820|FG001|NOT COMPLETED|Overall Study||3
6478777|NCT01295827|7395821|FG002|NOT COMPLETED|Overall Study||12
6478778|NCT01295827|7395822|FG003|NOT COMPLETED|Overall Study||4
6478779|NCT01295827|7395823|FG004|NOT COMPLETED|Overall Study||2
6478780|NCT01295827|7395824|FG005|NOT COMPLETED|Overall Study||6
6478781|NCT01295827|7395825|FG006|NOT COMPLETED|Overall Study||146
6478782|NCT01295827|7395826|FG007|NOT COMPLETED|Overall Study||297
6478783|NCT01295827|7395827|FG008|NOT COMPLETED|Overall Study||169
6478784|NCT01295827|7395828|FG009|NOT COMPLETED|Overall Study||55
6478785|NCT01295827|7395829|FG010|NOT COMPLETED|Overall Study||276
6478786|NCT01295827|7395830|FG011|NOT COMPLETED|Overall Study||186
6478787|NCT01295827|7395831|FG012|NOT COMPLETED|Overall Study||0
6478788|NCT01295827|7395832|FG013|NOT COMPLETED|Overall Study||0
6478789|NCT01295827|7395833|FG014|NOT COMPLETED|Overall Study||0
6478790|NCT01295840|7395886|FG000|STARTED|Overall Study||51
6478791|NCT01295840|7395886|FG000|COMPLETED|Overall Study||50
6478792|NCT01295840|7395886|FG000|NOT COMPLETED|Overall Study||1
6478793|NCT01295879|7395892|FG000|STARTED|Overall Study||29
6478794|NCT01295879|7395892|FG000|COMPLETED|Overall Study||29
6478795|NCT01295879|7395892|FG000|NOT COMPLETED|Overall Study||0
6478796|NCT01295905|7395898|FG000|STARTED|Overall Study||60
6478797|NCT01295905|7395899|FG001|STARTED|Overall Study||30
6478798|NCT01295905|7395898|FG000|COMPLETED|Overall Study||58
6478799|NCT01295905|7395899|FG001|COMPLETED|Overall Study||30
6478800|NCT01295905|7395898|FG000|NOT COMPLETED|Overall Study||2
6478801|NCT01295905|7395899|FG001|NOT COMPLETED|Overall Study||0
6478802|NCT01296035|7395905|FG000|STARTED|Overall Study||8
6478803|NCT01296035|7395905|FG000|COMPLETED|Overall Study||7
6478804|NCT01296035|7395905|FG000|NOT COMPLETED|Overall Study||1
6478805|NCT01296152|7395909|FG000|STARTED|Overall Study||25
6478806|NCT01296152|7395909|FG000|COMPLETED|Overall Study||24
6478807|NCT01296152|7395909|FG000|NOT COMPLETED|Overall Study||1
6478808|NCT01296191|7395915|FG000|STARTED|Overall Study||60
6478809|NCT01296191|7395916|FG001|STARTED|Overall Study||60
6478810|NCT01296191|7395915|FG000|COMPLETED|Overall Study||57
6478811|NCT01296191|7395916|FG001|COMPLETED|Overall Study||59
6478812|NCT01296191|7395915|FG000|NOT COMPLETED|Overall Study||3
6478813|NCT01296191|7395916|FG001|NOT COMPLETED|Overall Study||1
6478814|NCT01296347|7395924|FG000|STARTED|Allocation||38
6478815|NCT01296347|7395925|FG001|STARTED|Allocation||39
6478816|NCT01296347|7395924|FG000|COMPLETED|Allocation||35
6478817|NCT01296347|7395925|FG001|COMPLETED|Allocation||35
6478818|NCT01296347|7395924|FG000|NOT COMPLETED|Allocation||3
6478819|NCT01296347|7395925|FG001|NOT COMPLETED|Allocation||4
6478820|NCT01296347|7395924|FG000|STARTED|6 Week Follow up||35
6478821|NCT01296347|7395925|FG001|STARTED|6 Week Follow up||35
6478822|NCT01296347|7395924|FG000|COMPLETED|6 Week Follow up||35
6478823|NCT01296347|7395925|FG001|COMPLETED|6 Week Follow up||34
6478824|NCT01296347|7395924|FG000|NOT COMPLETED|6 Week Follow up||0
6478825|NCT01296347|7395925|FG001|NOT COMPLETED|6 Week Follow up||1
6478826|NCT01296347|7395924|FG000|STARTED|3 Month Follow up||35
6478827|NCT01296347|7395925|FG001|STARTED|3 Month Follow up||34
6478828|NCT01296347|7395924|FG000|COMPLETED|3 Month Follow up||34
6478829|NCT01296347|7395925|FG001|COMPLETED|3 Month Follow up||33
6478830|NCT01296347|7395924|FG000|NOT COMPLETED|3 Month Follow up||1
6478831|NCT01296347|7395925|FG001|NOT COMPLETED|3 Month Follow up||1
6478832|NCT01296347|7395924|FG000|STARTED|6 Month Follow up||34
6478833|NCT01296347|7395925|FG001|STARTED|6 Month Follow up||33
6478834|NCT01296347|7395924|FG000|COMPLETED|6 Month Follow up||32
6478835|NCT01296347|7395925|FG001|COMPLETED|6 Month Follow up||31
6478836|NCT01296347|7395924|FG000|NOT COMPLETED|6 Month Follow up||2
6478837|NCT01296347|7395925|FG001|NOT COMPLETED|6 Month Follow up||2
6478838|NCT01296347|7395924|FG000|STARTED|12 Month Follow up||32
6478839|NCT01296347|7395925|FG001|STARTED|12 Month Follow up||31
6478840|NCT01296347|7395924|FG000|COMPLETED|12 Month Follow up||28
6478841|NCT01296347|7395925|FG001|COMPLETED|12 Month Follow up||28
6478842|NCT01296347|7395924|FG000|NOT COMPLETED|12 Month Follow up||4
6478843|NCT01296347|7395925|FG001|NOT COMPLETED|12 Month Follow up||3
6478844|NCT01296360|7395936|FG000|STARTED|Overall Study||150
6478845|NCT01296360|7395937|FG001|STARTED|Overall Study||150
6478846|NCT01296360|7395936|FG000|Visit 2 (Month 12)|Overall Study|booster was administered|148
6478847|NCT01296360|7395937|FG001|Visit 2 (Month 12)|Overall Study||149
6478848|NCT01296360|7395936|FG000|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
6478849|NCT01296360|7395937|FG001|Visit 2a (Month 13)|Overall Study||0
6478850|NCT01296360|7395936|FG000|COMPLETED|Overall Study||144
6478851|NCT01296360|7395937|FG001|COMPLETED|Overall Study||142
6478852|NCT01296360|7395936|FG000|NOT COMPLETED|Overall Study||6
6478853|NCT01296360|7395937|FG001|NOT COMPLETED|Overall Study||8
6478854|NCT01296412|7395945|FG000|STARTED|Overall Study||326
6478855|NCT01296412|7395946|FG001|STARTED|Overall Study||327
6478856|NCT01296412|7395945|FG000|COMPLETED|Overall Study||275
6478857|NCT01296412|7395946|FG001|COMPLETED|Overall Study||257
6478858|NCT01296412|7395945|FG000|NOT COMPLETED|Overall Study||51
6478859|NCT01296412|7395946|FG001|NOT COMPLETED|Overall Study||70
6478860|NCT01296542|7395954|FG000|STARTED|Overall Study||30
6478861|NCT01296542|7395955|FG001|STARTED|Overall Study||30
6478862|NCT01296542|7395954|FG000|COMPLETED|Overall Study||30
6478863|NCT01296542|7395955|FG001|COMPLETED|Overall Study||28
6478864|NCT01296542|7395954|FG000|NOT COMPLETED|Overall Study||0
6478865|NCT01296542|7395955|FG001|NOT COMPLETED|Overall Study||2
6478866|NCT01296568|7395961|FG000|STARTED|[^14C]LY2603618 Single Dose and Washout||3
6478867|NCT01296568|7395961|FG000|COMPLETED|[^14C]LY2603618 Single Dose and Washout||3
6478868|NCT01296568|7395961|FG000|NOT COMPLETED|[^14C]LY2603618 Single Dose and Washout||0
6478869|NCT01296568|7395961|FG000|STARTED|Continued Access Phase||3
6478870|NCT01296568|7395961|FG000|COMPLETED|Continued Access Phase|After study discontinuation participants assessed for disease progression (21-day safety follow-up).|0
6478871|NCT01296568|7395961|FG000|NOT COMPLETED|Continued Access Phase||3
6478872|NCT01296646|7395969|FG000|STARTED|Overall Study||40
6478873|NCT01296646|7395970|FG001|STARTED|Overall Study||40
6478874|NCT01296646|7395969|FG000|COMPLETED|Overall Study||29
6478875|NCT01296646|7395970|FG001|COMPLETED|Overall Study||29
6478876|NCT01296646|7395969|FG000|NOT COMPLETED|Overall Study||11
6478877|NCT01296646|7395970|FG001|NOT COMPLETED|Overall Study||11
6478878|NCT01296672|7395978|FG000|STARTED|Overall Study||306
6478879|NCT01296672|7395979|FG001|STARTED|Overall Study||77
6478880|NCT01296672|7395978|FG000|COMPLETED|Overall Study||233
6478881|NCT01296672|7395979|FG001|COMPLETED|Overall Study||59
6478882|NCT01296672|7395978|FG000|NOT COMPLETED|Overall Study||73
6478883|NCT01296672|7395979|FG001|NOT COMPLETED|Overall Study||18
6478884|NCT01296698|7395989|FG000|STARTED|Overall Study||244
6478885|NCT01296698|7395990|FG001|STARTED|Overall Study||13
6478886|NCT01296698|7395989|FG000|COMPLETED|Overall Study||0
6478887|NCT01296698|7395990|FG001|COMPLETED|Overall Study||0
6478888|NCT01296698|7395989|FG000|NOT COMPLETED|Overall Study||244
6478889|NCT01296698|7395990|FG001|NOT COMPLETED|Overall Study||13
6478890|NCT01296763|7395999|FG000|STARTED|Overall Study||7
6478891|NCT01296763|7396000|FG001|STARTED|Overall Study||5
6478892|NCT01296763|7396001|FG002|STARTED|Overall Study||6
6478893|NCT01296763|7395999|FG000|COMPLETED|Overall Study||7
6478894|NCT01296763|7396000|FG001|COMPLETED|Overall Study||5
6478895|NCT01296763|7396001|FG002|COMPLETED|Overall Study||6
6478896|NCT01296763|7395999|FG000|NOT COMPLETED|Overall Study||0
6478897|NCT01296763|7396000|FG001|NOT COMPLETED|Overall Study||0
6478898|NCT01296763|7396001|FG002|NOT COMPLETED|Overall Study||0
6478899|NCT01296815|7396011|FG000|STARTED|Overall Study||7
6478900|NCT01296815|7396012|FG001|STARTED|Overall Study||7
6478901|NCT01296815|7396011|FG000|COMPLETED|Overall Study||7
6478902|NCT01296815|7396012|FG001|COMPLETED|Overall Study||7
6478903|NCT01296815|7396011|FG000|NOT COMPLETED|Overall Study||0
6478904|NCT01296815|7396012|FG001|NOT COMPLETED|Overall Study||0
6478905|NCT01296841|7396020|FG000|STARTED|Overall Study||19
6478906|NCT01296841|7396021|FG001|STARTED|Overall Study||15
6478907|NCT01296841|7396020|FG000|COMPLETED|Overall Study||19
6478908|NCT01296841|7396021|FG001|COMPLETED|Overall Study||15
6478909|NCT01296841|7396020|FG000|NOT COMPLETED|Overall Study||0
6478910|NCT01296841|7396021|FG001|NOT COMPLETED|Overall Study||0
6478911|NCT01296932|7396038|FG000|STARTED|Overall Study||3
6478912|NCT01296932|7396039|FG001|STARTED|Overall Study||3
6478913|NCT01296932|7396040|FG002|STARTED|Overall Study||6
6478914|NCT01296932|7396041|FG003|STARTED|Overall Study||6
6478915|NCT01296932|7396042|FG004|STARTED|Overall Study||3
6478916|NCT01296932|7396043|FG005|STARTED|Overall Study||3
6478917|NCT01296932|7396044|FG006|STARTED|Overall Study||6
6478918|NCT01296932|7396045|FG007|STARTED|Overall Study||3
6478919|NCT01296932|7396046|FG008|STARTED|Overall Study||4
6478920|NCT01296932|7396038|FG000|COMPLETED|Overall Study||0
6478921|NCT01296932|7396039|FG001|COMPLETED|Overall Study||0
6478922|NCT01296932|7396040|FG002|COMPLETED|Overall Study||0
6478923|NCT01296932|7396041|FG003|COMPLETED|Overall Study||0
6478924|NCT01296932|7396042|FG004|COMPLETED|Overall Study||0
6478925|NCT01296932|7396043|FG005|COMPLETED|Overall Study||0
6478926|NCT01296932|7396044|FG006|COMPLETED|Overall Study||0
6478927|NCT01296932|7396045|FG007|COMPLETED|Overall Study||1
6478928|NCT01296932|7396046|FG008|COMPLETED|Overall Study||0
6478929|NCT01296932|7396038|FG000|NOT COMPLETED|Overall Study||3
6478930|NCT01296932|7396039|FG001|NOT COMPLETED|Overall Study||3
6478931|NCT01296932|7396040|FG002|NOT COMPLETED|Overall Study||6
6478932|NCT01296932|7396041|FG003|NOT COMPLETED|Overall Study||6
6478933|NCT01296932|7396042|FG004|NOT COMPLETED|Overall Study||3
6478934|NCT01296932|7396043|FG005|NOT COMPLETED|Overall Study||3
6478935|NCT01296932|7396044|FG006|NOT COMPLETED|Overall Study||6
6478936|NCT01296932|7396045|FG007|NOT COMPLETED|Overall Study||2
6478937|NCT01296932|7396046|FG008|NOT COMPLETED|Overall Study||4
6478938|NCT01297062|7396073|FG000|STARTED|Overall Study||15
6478939|NCT01297062|7396074|FG001|STARTED|Overall Study||14
6478940|NCT01297062|7396075|FG002|STARTED|Overall Study||14
6478941|NCT01297062|7396076|FG003|STARTED|Overall Study||14
6478942|NCT01297062|7396077|FG004|STARTED|Overall Study||15
6478943|NCT01297062|7396078|FG005|STARTED|Overall Study||14
6478944|NCT01297062|7396079|FG006|STARTED|Overall Study||8
6478945|NCT01297062|7396073|FG000|Intent to Treat (ITT)|Overall Study||15
6478946|NCT01297062|7396074|FG001|Intent to Treat (ITT)|Overall Study||14
6478947|NCT01297062|7396075|FG002|Intent to Treat (ITT)|Overall Study||14
6478948|NCT01297062|7396076|FG003|Intent to Treat (ITT)|Overall Study||14
6478949|NCT01297062|7396077|FG004|Intent to Treat (ITT)|Overall Study||15
6478950|NCT01297062|7396078|FG005|Intent to Treat (ITT)|Overall Study||14
6478951|NCT01297062|7396079|FG006|Intent to Treat (ITT)|Overall Study||0
6554664|NCT01748552|7476858|FG006|COMPLETED|Intervention Period 1 and Washout||3
6554665|NCT01748552|7476859|FG007|COMPLETED|Intervention Period 1 and Washout||3
6554666|NCT01748552|7476860|FG008|COMPLETED|Intervention Period 1 and Washout||3
6478952|NCT01297062|7396073|FG000|Evaluable Population|Overall Study||11
6478953|NCT01297062|7396074|FG001|Evaluable Population|Overall Study||12
6478954|NCT01297062|7396075|FG002|Evaluable Population|Overall Study||12
6478955|NCT01297062|7396076|FG003|Evaluable Population|Overall Study||13
6478956|NCT01297062|7396077|FG004|Evaluable Population|Overall Study||13
6478957|NCT01297062|7396078|FG005|Evaluable Population|Overall Study||13
6478958|NCT01297062|7396079|FG006|Evaluable Population|Overall Study||0
6478959|NCT01297062|7396073|FG000|COMPLETED|Overall Study||11
6478960|NCT01297062|7396074|FG001|COMPLETED|Overall Study||13
6478961|NCT01297062|7396075|FG002|COMPLETED|Overall Study||12
6478962|NCT01297062|7396076|FG003|COMPLETED|Overall Study||13
6478963|NCT01297062|7396077|FG004|COMPLETED|Overall Study||13
6478964|NCT01297062|7396078|FG005|COMPLETED|Overall Study||13
6478965|NCT01297062|7396079|FG006|COMPLETED|Overall Study||0
6478966|NCT01297062|7396073|FG000|NOT COMPLETED|Overall Study||4
6478967|NCT01297062|7396074|FG001|NOT COMPLETED|Overall Study||1
6478968|NCT01297062|7396075|FG002|NOT COMPLETED|Overall Study||2
6478969|NCT01297062|7396076|FG003|NOT COMPLETED|Overall Study||1
6478970|NCT01297062|7396077|FG004|NOT COMPLETED|Overall Study||2
6478971|NCT01297062|7396078|FG005|NOT COMPLETED|Overall Study||1
6478972|NCT01297062|7396079|FG006|NOT COMPLETED|Overall Study||8
6478973|NCT01297244|7396089|FG000|STARTED|Overall Study||90
6478974|NCT01297244|7396090|FG001|STARTED|Overall Study||15
6478975|NCT01297244|7396089|FG000|COMPLETED|Overall Study||55
6478976|NCT01297244|7396090|FG001|COMPLETED|Overall Study||9
6478977|NCT01297244|7396089|FG000|NOT COMPLETED|Overall Study||35
6478978|NCT01297244|7396090|FG001|NOT COMPLETED|Overall Study||6
6478979|NCT01297257|7396097|FG000|STARTED|Overall Study||7740
6478980|NCT01297257|7396097|FG000|COMPLETED|Overall Study||7740
6478981|NCT01297257|7396097|FG000|NOT COMPLETED|Overall Study||0
6478982|NCT01297270|7396105|FG000|STARTED|Overall Study||262
6478983|NCT01297270|7396106|FG001|STARTED|Overall Study||264
6478984|NCT01297270|7396107|FG002|STARTED|Overall Study||132
6478985|NCT01297270|7396105|FG000|COMPLETED|Overall Study||217
6478986|NCT01297270|7396106|FG001|COMPLETED|Overall Study||192
6478987|NCT01297270|7396107|FG002|COMPLETED|Overall Study||103
6478988|NCT01297270|7396105|FG000|NOT COMPLETED|Overall Study||45
6478989|NCT01297270|7396106|FG001|NOT COMPLETED|Overall Study||72
6478990|NCT01297270|7396107|FG002|NOT COMPLETED|Overall Study||29
6478991|NCT01297283|7396115|FG000|STARTED|Overall Study||195
6478992|NCT01297283|7396115|FG000|COMPLETED|Overall Study||176
6478993|NCT01297283|7396115|FG000|NOT COMPLETED|Overall Study||19
6478994|NCT01297309|7396119|FG000|STARTED|Overall Study||51
6478995|NCT01297309|7396119|FG000|Treated|Overall Study||49
6478996|NCT01297309|7396119|FG000|Started Extension Period|Overall Study||46
6478997|NCT01297309|7396119|FG000|COMPLETED|Overall Study||37
6478998|NCT01297309|7396119|FG000|NOT COMPLETED|Overall Study||14
6478999|NCT01297322|7396125|FG000|STARTED|Overall Study||142
6479000|NCT01297322|7396126|FG001|STARTED|Overall Study||278
6479001|NCT01297322|7396125|FG000|COMPLETED|Overall Study||141
6479002|NCT01297322|7396126|FG001|COMPLETED|Overall Study||274
6479003|NCT01297322|7396125|FG000|NOT COMPLETED|Overall Study||1
6479004|NCT01297322|7396126|FG001|NOT COMPLETED|Overall Study||4
6479005|NCT01297335|7396133|FG000|STARTED|Overall Study||10
6479006|NCT01297335|7396133|FG000|COMPLETED|Overall Study||10
6479007|NCT01297335|7396133|FG000|NOT COMPLETED|Overall Study||0
6479008|NCT01297348|7396141|FG000|STARTED|Overall Study||12281
6479009|NCT01297348|7396142|FG001|STARTED|Overall Study||586401
6479010|NCT01297348|7396141|FG000|COMPLETED|Overall Study||12281
6479011|NCT01297348|7396142|FG001|COMPLETED|Overall Study||586401
6479012|NCT01297348|7396141|FG000|NOT COMPLETED|Overall Study||0
6479013|NCT01297348|7396142|FG001|NOT COMPLETED|Overall Study||0
6479014|NCT01297465|7396151|FG000|STARTED|Overall Study||99
6479015|NCT01297465|7396152|FG001|STARTED|Overall Study||103
6479016|NCT01297465|7396151|FG000|COMPLETED|Overall Study||91
6479017|NCT01297465|7396152|FG001|COMPLETED|Overall Study||93
6479018|NCT01297465|7396151|FG000|NOT COMPLETED|Overall Study||8
6479019|NCT01297465|7396152|FG001|NOT COMPLETED|Overall Study||10
6479020|NCT01297491|7396160|FG000|STARTED|Overall Study||30
6479021|NCT01297491|7396161|FG001|STARTED|Overall Study||33
6479022|NCT01297491|7396160|FG000|COMPLETED|Overall Study||0
6479023|NCT01297491|7396161|FG001|COMPLETED|Overall Study||0
6479024|NCT01297491|7396160|FG000|NOT COMPLETED|Overall Study||30
6479025|NCT01297491|7396161|FG001|NOT COMPLETED|Overall Study||33
6479026|NCT01297504|7396167|FG000|STARTED|Overall Study||464
6479027|NCT01297504|7396167|FG000|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
6554667|NCT01748552|7476861|FG009|COMPLETED|Intervention Period 1 and Washout||3
6479028|NCT01297504|7396167|FG000|COMPLETED|Overall Study||397
6479029|NCT01297504|7396167|FG000|NOT COMPLETED|Overall Study||67
6479030|NCT01297517|7396178|FG000|STARTED|Overall Study||214
6479031|NCT01297517|7396179|FG001|STARTED|Overall Study||226
6479032|NCT01297517|7396180|FG002|STARTED|Overall Study||220
6479033|NCT01297517|7396178|FG000|COMPLETED|Overall Study||187
6479034|NCT01297517|7396179|FG001|COMPLETED|Overall Study||214
6479035|NCT01297517|7396180|FG002|COMPLETED|Overall Study||193
6479036|NCT01297517|7396178|FG000|NOT COMPLETED|Overall Study||27
6479037|NCT01297517|7396179|FG001|NOT COMPLETED|Overall Study||12
6479038|NCT01297517|7396180|FG002|NOT COMPLETED|Overall Study||27
6479039|NCT01297595|7396188|FG000|STARTED|First Intervention Period||11
6479040|NCT01297595|7396189|FG001|STARTED|First Intervention Period||11
6479041|NCT01297595|7396188|FG000|COMPLETED|First Intervention Period||11
6479042|NCT01297595|7396189|FG001|COMPLETED|First Intervention Period||11
6479043|NCT01297595|7396188|FG000|NOT COMPLETED|First Intervention Period||0
6479044|NCT01297595|7396189|FG001|NOT COMPLETED|First Intervention Period||0
6479045|NCT01297595|7396188|FG000|STARTED|Washout Period (At Least 14 Days)||11
6479046|NCT01297595|7396189|FG001|STARTED|Washout Period (At Least 14 Days)||11
6479047|NCT01297595|7396188|FG000|COMPLETED|Washout Period (At Least 14 Days)||11
6479048|NCT01297595|7396189|FG001|COMPLETED|Washout Period (At Least 14 Days)||11
6479049|NCT01297595|7396188|FG000|NOT COMPLETED|Washout Period (At Least 14 Days)||0
6479050|NCT01297595|7396189|FG001|NOT COMPLETED|Washout Period (At Least 14 Days)||0
6479051|NCT01297595|7396188|FG000|STARTED|Second Intervention Period||11
6479052|NCT01297595|7396189|FG001|STARTED|Second Intervention Period||11
6479053|NCT01297595|7396188|FG000|COMPLETED|Second Intervention Period||11
6479054|NCT01297595|7396189|FG001|COMPLETED|Second Intervention Period||11
6479055|NCT01297595|7396188|FG000|NOT COMPLETED|Second Intervention Period||0
6479056|NCT01297595|7396189|FG001|NOT COMPLETED|Second Intervention Period||0
6479057|NCT01297920|7396198|FG000|STARTED|Overall Study||221
6479058|NCT01297920|7396199|FG001|STARTED|Overall Study||234
6479059|NCT01297920|7396200|FG002|STARTED|Overall Study||235
6479060|NCT01297920|7396198|FG000|COMPLETED|Overall Study||163
6479061|NCT01297920|7396199|FG001|COMPLETED|Overall Study||207
6479062|NCT01297920|7396200|FG002|COMPLETED|Overall Study||178
6479063|NCT01297920|7396198|FG000|NOT COMPLETED|Overall Study||58
6479064|NCT01297920|7396199|FG001|NOT COMPLETED|Overall Study||27
6479065|NCT01297920|7396200|FG002|NOT COMPLETED|Overall Study||57
6479066|NCT01297959|7396210|FG000|STARTED|Overall Study||261
6479067|NCT01297959|7396211|FG001|STARTED|Overall Study||242
6479068|NCT01297959|7396210|FG000|COMPLETED|Overall Study||241
6479069|NCT01297959|7396211|FG001|COMPLETED|Overall Study||226
6479070|NCT01297959|7396210|FG000|NOT COMPLETED|Overall Study||20
6479071|NCT01297959|7396211|FG001|NOT COMPLETED|Overall Study||16
6479072|NCT01297985|7396219|FG000|STARTED|Overall Study||212
6479073|NCT01297985|7396220|FG001|STARTED|Overall Study||216
6479074|NCT01297985|7396219|FG000|COMPLETED|Overall Study||157
6479075|NCT01297985|7396220|FG001|COMPLETED|Overall Study||163
6479076|NCT01297985|7396219|FG000|NOT COMPLETED|Overall Study||55
6479077|NCT01297985|7396220|FG001|NOT COMPLETED|Overall Study||53
6479078|NCT01298063|7396231|FG000|STARTED|Overall Study||8
6479079|NCT01298063|7396232|FG001|STARTED|Overall Study||3
6479080|NCT01298063|7396233|FG002|STARTED|Overall Study||8
6479081|NCT01298063|7396234|FG003|STARTED|Overall Study||8
6479082|NCT01298063|7396235|FG004|STARTED|Overall Study||8
6479083|NCT01298063|7396231|FG000|COMPLETED|Overall Study||8
6479084|NCT01298063|7396232|FG001|COMPLETED|Overall Study||3
6479085|NCT01298063|7396233|FG002|COMPLETED|Overall Study||8
6479086|NCT01298063|7396234|FG003|COMPLETED|Overall Study||8
6479087|NCT01298063|7396235|FG004|COMPLETED|Overall Study||8
6479088|NCT01298063|7396231|FG000|NOT COMPLETED|Overall Study||0
6479089|NCT01298063|7396232|FG001|NOT COMPLETED|Overall Study||0
6479090|NCT01298063|7396233|FG002|NOT COMPLETED|Overall Study||0
6479091|NCT01298063|7396234|FG003|NOT COMPLETED|Overall Study||0
6479092|NCT01298063|7396235|FG004|NOT COMPLETED|Overall Study||0
6479093|NCT01298128|7396250|FG000|STARTED|Overall Study||35
6479094|NCT01298128|7396251|FG001|STARTED|Overall Study||35
6479095|NCT01298128|7396250|FG000|COMPLETED|Overall Study||26
6479096|NCT01298128|7396251|FG001|COMPLETED|Overall Study||27
6479097|NCT01298128|7396250|FG000|NOT COMPLETED|Overall Study||9
6479098|NCT01298128|7396251|FG001|NOT COMPLETED|Overall Study||8
6479099|NCT01298141|7396257|FG000|STARTED|Overall Study||171
6479100|NCT01298141|7396257|FG000|Treated|Overall Study||167
6479101|NCT01298141|7396257|FG000|COMPLETED|Overall Study||140
6479102|NCT01298141|7396257|FG000|NOT COMPLETED|Overall Study||31
6479103|NCT01298167|7396263|FG000|STARTED|Overall Study||6
6479104|NCT01298167|7396264|FG001|STARTED|Overall Study||8
6479105|NCT01298167|7396263|FG000|COMPLETED|Overall Study||5
6479106|NCT01298167|7396264|FG001|COMPLETED|Overall Study||8
6479107|NCT01298167|7396263|FG000|NOT COMPLETED|Overall Study||1
6479108|NCT01298167|7396264|FG001|NOT COMPLETED|Overall Study||0
6479109|NCT01298193|7396270|FG000|STARTED|Observational Phase (First Cycle)||212
6479110|NCT01298193|7396270|FG000|COMPLETED|Observational Phase (First Cycle)|From these 185 completed patients, only 24 experiment emesis on Cycle 1 (NCR) (efficacy phase).|185
6479111|NCT01298193|7396270|FG000|NOT COMPLETED|Observational Phase (First Cycle)||27
6479112|NCT01298193|7396270|FG000|STARTED|Efficacy Phase (Second Cycle)||24
6479113|NCT01298193|7396270|FG000|COMPLETED|Efficacy Phase (Second Cycle)||23
6479114|NCT01298193|7396270|FG000|NOT COMPLETED|Efficacy Phase (Second Cycle)||1
6479115|NCT01298219|7396279|FG000|STARTED|Overall Study||219
6479116|NCT01298219|7396280|FG001|STARTED|Overall Study||220
6479117|NCT01298219|7396279|FG000|Intention to Treat (ITT)|Overall Study||219
6479118|NCT01298219|7396280|FG001|Intention to Treat (ITT)|Overall Study||220
6479119|NCT01298219|7396279|FG000|Safety Analysis Set|Overall Study||219
6479120|NCT01298219|7396280|FG001|Safety Analysis Set|Overall Study||220
6479121|NCT01298219|7396279|FG000|COMPLETED|Overall Study||169
6479122|NCT01298219|7396280|FG001|COMPLETED|Overall Study||184
6479123|NCT01298219|7396279|FG000|NOT COMPLETED|Overall Study||50
6479124|NCT01298219|7396280|FG001|NOT COMPLETED|Overall Study||36
6479125|NCT01298323|7396288|FG000|STARTED|Overall Study||102
6479126|NCT01298323|7396289|FG001|STARTED|Overall Study||103
6479127|NCT01298323|7396288|FG000|Ongoing|Overall Study||55
6554668|NCT01748552|7476862|FG010|COMPLETED|Intervention Period 1 and Washout||3
6554669|NCT01748552|7476863|FG011|COMPLETED|Intervention Period 1 and Washout||3
6554670|NCT01748552|7476852|FG000|NOT COMPLETED|Intervention Period 1 and Washout||0
6554671|NCT01748552|7476853|FG001|NOT COMPLETED|Intervention Period 1 and Washout||0
6479128|NCT01298323|7396289|FG001|Ongoing|Overall Study||55
6479129|NCT01298323|7396288|FG000|COMPLETED|Overall Study||16
6479130|NCT01298323|7396289|FG001|COMPLETED|Overall Study||15
6479131|NCT01298323|7396288|FG000|NOT COMPLETED|Overall Study||86
6479132|NCT01298323|7396289|FG001|NOT COMPLETED|Overall Study||88
6479133|NCT01298362|7396297|FG000|STARTED|Overall Study||124
6479134|NCT01298362|7396298|FG001|STARTED|Overall Study||166
6479135|NCT01298362|7396297|FG000|COMPLETED|Overall Study||86
6479136|NCT01298362|7396298|FG001|COMPLETED|Overall Study||123
6479137|NCT01298362|7396297|FG000|NOT COMPLETED|Overall Study||38
6479138|NCT01298362|7396298|FG001|NOT COMPLETED|Overall Study||43
6479139|NCT01298492|7396306|FG000|STARTED|Overall Study||268
6479140|NCT01298492|7396306|FG000|COMPLETED|Overall Study||149
6479141|NCT01298492|7396306|FG000|NOT COMPLETED|Overall Study||119
6479142|NCT01298518|7396313|FG000|STARTED|Overall Study||16
6479143|NCT01298518|7396314|FG001|STARTED|Overall Study||16
6479144|NCT01298518|7396315|FG002|STARTED|Overall Study||16
6479145|NCT01298518|7396313|FG000|COMPLETED|Overall Study||16
6479146|NCT01298518|7396314|FG001|COMPLETED|Overall Study||16
6479147|NCT01298518|7396315|FG002|COMPLETED|Overall Study||15
6479148|NCT01298518|7396313|FG000|NOT COMPLETED|Overall Study||0
6479149|NCT01298518|7396314|FG001|NOT COMPLETED|Overall Study||0
6479150|NCT01298518|7396315|FG002|NOT COMPLETED|Overall Study||1
6479151|NCT01298531|7396325|FG000|STARTED|Overall Study||42
6479152|NCT01298531|7396326|FG001|STARTED|Overall Study||48
6479153|NCT01298531|7396325|FG000|COMPLETED|Overall Study||33
6479154|NCT01298531|7396326|FG001|COMPLETED|Overall Study||41
6479155|NCT01298531|7396325|FG000|NOT COMPLETED|Overall Study||9
6479156|NCT01298531|7396326|FG001|NOT COMPLETED|Overall Study||7
6479157|NCT01298544|7396333|FG000|STARTED|Overall Study||335
6479158|NCT01298544|7396333|FG000|COMPLETED|Overall Study||335
6479159|NCT01298544|7396333|FG000|NOT COMPLETED|Overall Study||0
6479160|NCT01298570|7396341|FG000|STARTED|Overall Study||120
6479161|NCT01298570|7396342|FG001|STARTED|Overall Study||61
6479162|NCT01298570|7396341|FG000|COMPLETED|Overall Study||0
6479163|NCT01298570|7396342|FG001|COMPLETED|Overall Study||0
6479164|NCT01298570|7396341|FG000|NOT COMPLETED|Overall Study||120
6479165|NCT01298570|7396342|FG001|NOT COMPLETED|Overall Study||61
6479166|NCT01298596|7396350|FG000|STARTED|Overall Study||200
6479167|NCT01298596|7396351|FG001|STARTED|Overall Study||200
6479168|NCT01298596|7396350|FG000|COMPLETED|Overall Study||172
6479169|NCT01298596|7396351|FG001|COMPLETED|Overall Study||167
6479170|NCT01298596|7396350|FG000|NOT COMPLETED|Overall Study||28
6479171|NCT01298596|7396351|FG001|NOT COMPLETED|Overall Study||33
6479172|NCT01298648|7396357|FG000|STARTED|Overall Study||1716
6479173|NCT01298648|7396357|FG000|COMPLETED|Overall Study||1693
6479174|NCT01298648|7396357|FG000|NOT COMPLETED|Overall Study||23
6479175|NCT01298661|7396364|FG000|STARTED|Overall Study||33
6479176|NCT01298661|7396365|FG001|STARTED|Overall Study||24
6479177|NCT01298661|7396366|FG002|STARTED|Overall Study||34
6479178|NCT01298661|7396364|FG000|COMPLETED|Overall Study||31
6479179|NCT01298661|7396365|FG001|COMPLETED|Overall Study||24
6479180|NCT01298661|7396366|FG002|COMPLETED|Overall Study||32
6479181|NCT01298661|7396364|FG000|NOT COMPLETED|Overall Study||2
6479182|NCT01298661|7396365|FG001|NOT COMPLETED|Overall Study||0
6479183|NCT01298661|7396366|FG002|NOT COMPLETED|Overall Study||2
6479184|NCT01298700|7396377|FG000|STARTED|Overall Study||403
6479185|NCT01298700|7396378|FG001|STARTED|Overall Study||403
6479186|NCT01298700|7396377|FG000|Safety Population: Received Study Drug|Overall Study||400
6479187|NCT01298700|7396378|FG001|Safety Population: Received Study Drug|Overall Study||398
6479188|NCT01298700|7396377|FG000|COMPLETED|Overall Study||302
6479189|NCT01298700|7396378|FG001|COMPLETED|Overall Study||303
6479190|NCT01298700|7396377|FG000|NOT COMPLETED|Overall Study||101
6479191|NCT01298700|7396378|FG001|NOT COMPLETED|Overall Study||100
6479192|NCT01298752|7396386|FG000|STARTED|Overall Study||120
6479193|NCT01298752|7396387|FG001|STARTED|Overall Study||57
6479194|NCT01298752|7396386|FG000|COMPLETED|Overall Study||77
6479195|NCT01298752|7396387|FG001|COMPLETED|Overall Study||31
6479196|NCT01298752|7396386|FG000|NOT COMPLETED|Overall Study||43
6479197|NCT01298752|7396387|FG001|NOT COMPLETED|Overall Study||26
6479198|NCT01298765|7396393|FG000|STARTED|Titration Period||302
6479199|NCT01298765|7396393|FG000|COMPLETED|Titration Period||226
6479200|NCT01298765|7396393|FG000|NOT COMPLETED|Titration Period||76
6479201|NCT01298765|7396393|FG000|STARTED|Long-Term Treatment Period||226
6479202|NCT01298765|7396393|FG000|COMPLETED|Long-Term Treatment Period||127
6479203|NCT01298765|7396393|FG000|NOT COMPLETED|Long-Term Treatment Period||99
6479204|NCT01298778|7396399|FG000|STARTED|Overall Study||33
6479205|NCT01298778|7396400|FG001|STARTED|Overall Study||36
6479206|NCT01298778|7396399|FG000|COMPLETED|Overall Study||30
6479207|NCT01298778|7396400|FG001|COMPLETED|Overall Study||30
6479208|NCT01298778|7396399|FG000|NOT COMPLETED|Overall Study||3
6479209|NCT01298778|7396400|FG001|NOT COMPLETED|Overall Study||6
6479210|NCT01298999|7396410|FG000|STARTED|Overall Study||13
6479211|NCT01298999|7396411|FG001|STARTED|Overall Study||11
6479212|NCT01298999|7396410|FG000|COMPLETED|Overall Study||10
6479213|NCT01298999|7396411|FG001|COMPLETED|Overall Study||10
6479214|NCT01298999|7396410|FG000|NOT COMPLETED|Overall Study||3
6479215|NCT01298999|7396411|FG001|NOT COMPLETED|Overall Study||1
6479216|NCT01299025|7396419|FG000|STARTED|Overall Study||42
6479217|NCT01299025|7396420|FG001|STARTED|Overall Study||42
6479218|NCT01299025|7396419|FG000|COMPLETED|Overall Study||39
6479219|NCT01299025|7396420|FG001|COMPLETED|Overall Study||41
6479220|NCT01299025|7396419|FG000|NOT COMPLETED|Overall Study||3
6479221|NCT01299025|7396420|FG001|NOT COMPLETED|Overall Study||1
6479222|NCT01299038|7396428|FG000|STARTED|Overall Study|Consented|10
6479223|NCT01299038|7396429|FG001|STARTED|Overall Study|Consented|10
6479224|NCT01299038|7396428|FG000|COMPLETED|Overall Study|Evaluable|9
6479225|NCT01299038|7396429|FG001|COMPLETED|Overall Study|Evaluable|10
6479226|NCT01299038|7396428|FG000|NOT COMPLETED|Overall Study||1
6479227|NCT01299038|7396429|FG001|NOT COMPLETED|Overall Study||0
6479228|NCT01299077|7396435|FG000|STARTED|Overall Study||478
6479229|NCT01299077|7396435|FG000|COMPLETED|Overall Study||478
6479230|NCT01299077|7396435|FG000|NOT COMPLETED|Overall Study||0
6479231|NCT01299090|7396439|FG000|STARTED|Overall Study||49
6479232|NCT01299090|7396439|FG000|COMPLETED|Overall Study||49
6479233|NCT01299090|7396439|FG000|NOT COMPLETED|Overall Study||0
6479234|NCT01299103|7396446|FG000|STARTED|Overall Study||15
6479235|NCT01299103|7396447|FG001|STARTED|Overall Study||15
6479236|NCT01299103|7396448|FG002|STARTED|Overall Study||10
6479237|NCT01299103|7396446|FG000|COMPLETED|Overall Study||15
6479238|NCT01299103|7396447|FG001|COMPLETED|Overall Study||13
6479239|NCT01299103|7396448|FG002|COMPLETED|Overall Study||8
6479240|NCT01299103|7396446|FG000|NOT COMPLETED|Overall Study||0
6479241|NCT01299103|7396447|FG001|NOT COMPLETED|Overall Study||2
6479242|NCT01299103|7396448|FG002|NOT COMPLETED|Overall Study||2
6479243|NCT01299116|7396459|FG000|STARTED|Overall Study||522
6748342|NCT03407482|7676374|FG000|NOT COMPLETED|Overall Study||131
6748343|NCT03407612|7676380|FG000|STARTED|Overall Study||19
6748344|NCT03407612|7676381|FG001|STARTED|Overall Study||23
6479244|NCT01299116|7396460|FG001|STARTED|Overall Study||177
6479245|NCT01299116|7396461|FG002|STARTED|Overall Study||195
6479246|NCT01299116|7396459|FG000|COMPLETED|Overall Study||457
6479247|NCT01299116|7396460|FG001|COMPLETED|Overall Study||168
6479248|NCT01299116|7396461|FG002|COMPLETED|Overall Study||184
6479249|NCT01299116|7396459|FG000|NOT COMPLETED|Overall Study||65
6479250|NCT01299116|7396460|FG001|NOT COMPLETED|Overall Study||9
6479251|NCT01299116|7396461|FG002|NOT COMPLETED|Overall Study||11
6479252|NCT01299272|7396472|FG000|STARTED|Acute Open-label (OL) Period||1249
6479253|NCT01299272|7396473|FG001|STARTED|Acute Open-label (OL) Period||0
6479254|NCT01299272|7396474|FG002|STARTED|Acute Open-label (OL) Period||0
6479255|NCT01299272|7396475|FG003|STARTED|Acute Open-label (OL) Period||0
6479256|NCT01299272|7396472|FG000|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period|Participants who discontinued the Acute OL Period had the option to enter the DC Period.|271
6479257|NCT01299272|7396473|FG001|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
6479258|NCT01299272|7396474|FG002|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
6479259|NCT01299272|7396475|FG003|Entered Discontinuation (DC) Period|Acute Open-label (OL) Period||0
6479260|NCT01299272|7396472|FG000|COMPLETED|Acute Open-label (OL) Period|Participants who completed the Acute OL Period entered the Stabilization OL Period.|835
6479261|NCT01299272|7396473|FG001|COMPLETED|Acute Open-label (OL) Period||0
6479262|NCT01299272|7396474|FG002|COMPLETED|Acute Open-label (OL) Period||0
6479263|NCT01299272|7396475|FG003|COMPLETED|Acute Open-label (OL) Period||0
6479264|NCT01299272|7396472|FG000|NOT COMPLETED|Acute Open-label (OL) Period||414
6479265|NCT01299272|7396473|FG001|NOT COMPLETED|Acute Open-label (OL) Period||0
6479266|NCT01299272|7396474|FG002|NOT COMPLETED|Acute Open-label (OL) Period||0
6479267|NCT01299272|7396475|FG003|NOT COMPLETED|Acute Open-label (OL) Period||0
6479268|NCT01299272|7396472|FG000|STARTED|Stabilization Open-label (OL) Period||0
6479269|NCT01299272|7396473|FG001|STARTED|Stabilization Open-label (OL) Period||835
6479270|NCT01299272|7396474|FG002|STARTED|Stabilization Open-label (OL) Period||0
6479271|NCT01299272|7396475|FG003|STARTED|Stabilization Open-label (OL) Period||0
6479272|NCT01299272|7396472|FG000|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
6479273|NCT01299272|7396473|FG001|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period|Participants who discontinued the Stabilization OL Period had the option to enter the DC Period.|164
6479274|NCT01299272|7396474|FG002|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
6479275|NCT01299272|7396475|FG003|Entered Discontinuation (DC) Period|Stabilization Open-label (OL) Period||0
6479276|NCT01299272|7396472|FG000|COMPLETED|Stabilization Open-label (OL) Period||0
6501389|NCT01428063|7419830|FG002|NOT COMPLETED|Overall Study||1
6748345|NCT03407612|7676380|FG000|COMPLETED|Overall Study||19
6748346|NCT03407612|7676381|FG001|COMPLETED|Overall Study||23
6748347|NCT03407612|7676380|FG000|NOT COMPLETED|Overall Study||0
6748348|NCT03407612|7676381|FG001|NOT COMPLETED|Overall Study||0
6479277|NCT01299272|7396473|FG001|COMPLETED|Stabilization Open-label (OL) Period|Participants who completed the Stabilization OL Period were randomized to the DB Period.|586
6479278|NCT01299272|7396474|FG002|COMPLETED|Stabilization Open-label (OL) Period||0
6479279|NCT01299272|7396475|FG003|COMPLETED|Stabilization Open-label (OL) Period||0
6479280|NCT01299272|7396472|FG000|NOT COMPLETED|Stabilization Open-label (OL) Period||0
6479281|NCT01299272|7396473|FG001|NOT COMPLETED|Stabilization Open-label (OL) Period||249
6479282|NCT01299272|7396474|FG002|NOT COMPLETED|Stabilization Open-label (OL) Period||0
6479283|NCT01299272|7396475|FG003|NOT COMPLETED|Stabilization Open-label (OL) Period||0
6479284|NCT01299272|7396472|FG000|STARTED|Double-blind (DB) Randomized Period||0
6479285|NCT01299272|7396473|FG001|STARTED|Double-blind (DB) Randomized Period||0
6479286|NCT01299272|7396474|FG002|STARTED|Double-blind (DB) Randomized Period||294
6479287|NCT01299272|7396475|FG003|STARTED|Double-blind (DB) Randomized Period||292
6479288|NCT01299272|7396472|FG000|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
6479289|NCT01299272|7396473|FG001|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
6479290|NCT01299272|7396474|FG002|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the taper DC Period.|129
6479291|NCT01299272|7396475|FG003|Entered Taper Discontinuation Period|Double-blind (DB) Randomized Period||0
6479292|NCT01299272|7396472|FG000|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
6479293|NCT01299272|7396473|FG001|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period||0
6479294|NCT01299272|7396474|FG002|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period were randomized to the abrupt DC Period.|132
6479295|NCT01299272|7396475|FG003|Entered Abrupt Discontinuation Period|Double-blind (DB) Randomized Period|Participants who completed or discontinued the DB Period entered the DC Period.|268
6479296|NCT01299272|7396472|FG000|COMPLETED|Double-blind (DB) Randomized Period||0
6479297|NCT01299272|7396473|FG001|COMPLETED|Double-blind (DB) Randomized Period||0
6479298|NCT01299272|7396474|FG002|COMPLETED|Double-blind (DB) Randomized Period||224
6479299|NCT01299272|7396475|FG003|COMPLETED|Double-blind (DB) Randomized Period||234
6479300|NCT01299272|7396472|FG000|NOT COMPLETED|Double-blind (DB) Randomized Period||0
6479301|NCT01299272|7396473|FG001|NOT COMPLETED|Double-blind (DB) Randomized Period||0
6479302|NCT01299272|7396474|FG002|NOT COMPLETED|Double-blind (DB) Randomized Period||70
6479303|NCT01299272|7396475|FG003|NOT COMPLETED|Double-blind (DB) Randomized Period||58
6479304|NCT01299285|7396489|FG000|STARTED|Overall Study||6
6479305|NCT01299285|7396489|FG000|COMPLETED|Overall Study||6
6479306|NCT01299285|7396489|FG000|NOT COMPLETED|Overall Study||0
6479307|NCT01299376|7396497|FG000|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
6479308|NCT01299376|7396498|FG001|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
6479309|NCT01299376|7396497|FG000|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
6479310|NCT01299376|7396498|FG001|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
6479311|NCT01299376|7396497|FG000|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
6479312|NCT01299376|7396498|FG001|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
6479313|NCT01299376|7396497|FG000|STARTED|Extension (Weeks 9 to 52)||134
6479314|NCT01299376|7396498|FG001|STARTED|Extension (Weeks 9 to 52)||133
6479315|NCT01299376|7396497|FG000|COMPLETED|Extension (Weeks 9 to 52)||124
6479316|NCT01299376|7396498|FG001|COMPLETED|Extension (Weeks 9 to 52)||118
6479317|NCT01299376|7396497|FG000|NOT COMPLETED|Extension (Weeks 9 to 52)||10
6479318|NCT01299376|7396498|FG001|NOT COMPLETED|Extension (Weeks 9 to 52)||15
6479319|NCT01299389|7396510|FG000|STARTED|Double-blind||164
6479320|NCT01299389|7396511|FG001|STARTED|Double-blind||159
6479321|NCT01299389|7396512|FG002|STARTED|Double-blind||0
6479322|NCT01299389|7396513|FG003|STARTED|Double-blind||0
6479323|NCT01299389|7396510|FG000|COMPLETED|Double-blind||55
6479324|NCT01299389|7396511|FG001|COMPLETED|Double-blind||95
6479325|NCT01299389|7396512|FG002|COMPLETED|Double-blind||0
6479326|NCT01299389|7396513|FG003|COMPLETED|Double-blind||0
6479327|NCT01299389|7396510|FG000|NOT COMPLETED|Double-blind||109
6479328|NCT01299389|7396511|FG001|NOT COMPLETED|Double-blind||64
6479329|NCT01299389|7396512|FG002|NOT COMPLETED|Double-blind||0
6479330|NCT01299389|7396513|FG003|NOT COMPLETED|Double-blind||0
6479331|NCT01299389|7396510|FG000|STARTED|Post-observational||0
6479332|NCT01299389|7396511|FG001|STARTED|Post-observational||0
6479333|NCT01299389|7396512|FG002|STARTED|Post-observational||156
6479334|NCT01299389|7396513|FG003|STARTED|Post-observational||155
6479335|NCT01299389|7396510|FG000|COMPLETED|Post-observational||0
6479336|NCT01299389|7396511|FG001|COMPLETED|Post-observational||0
6479337|NCT01299389|7396512|FG002|COMPLETED|Post-observational||144
6479338|NCT01299389|7396513|FG003|COMPLETED|Post-observational||149
6479339|NCT01299389|7396510|FG000|NOT COMPLETED|Post-observational||0
6479340|NCT01299389|7396511|FG001|NOT COMPLETED|Post-observational||0
6479341|NCT01299389|7396512|FG002|NOT COMPLETED|Post-observational||12
6479342|NCT01299389|7396513|FG003|NOT COMPLETED|Post-observational||6
6479343|NCT01299454|7396526|FG000|STARTED|Overall Study||8
6479344|NCT01299454|7396527|FG001|STARTED|Overall Study||8
6479345|NCT01299454|7396528|FG002|STARTED|Overall Study||6
6479346|NCT01299454|7396529|FG003|STARTED|Overall Study||23
6479347|NCT01299454|7396526|FG000|COMPLETED|Overall Study||8
6479348|NCT01299454|7396527|FG001|COMPLETED|Overall Study||8
6479349|NCT01299454|7396528|FG002|COMPLETED|Overall Study||6
6479350|NCT01299454|7396529|FG003|COMPLETED|Overall Study||23
6479351|NCT01299454|7396526|FG000|NOT COMPLETED|Overall Study||0
6479352|NCT01299454|7396527|FG001|NOT COMPLETED|Overall Study||0
6479353|NCT01299454|7396528|FG002|NOT COMPLETED|Overall Study||0
6479354|NCT01299454|7396529|FG003|NOT COMPLETED|Overall Study||0
6479355|NCT01299480|7396570|FG000|STARTED|Overall Study||427
6479356|NCT01299480|7396571|FG001|STARTED|Overall Study||430
6479357|NCT01299480|7396572|FG002|STARTED|Overall Study||427
6479358|NCT01299480|7396573|FG003|STARTED|Overall Study||286
6479359|NCT01299480|7396574|FG004|STARTED|Overall Study||143
6479360|NCT01299480|7396570|FG000|COMPLETED|Overall Study||385
6479361|NCT01299480|7396571|FG001|COMPLETED|Overall Study||395
6479362|NCT01299480|7396572|FG002|COMPLETED|Overall Study||386
6479363|NCT01299480|7396573|FG003|COMPLETED|Overall Study||261
6479364|NCT01299480|7396574|FG004|COMPLETED|Overall Study||123
6479365|NCT01299480|7396570|FG000|NOT COMPLETED|Overall Study||42
6479366|NCT01299480|7396571|FG001|NOT COMPLETED|Overall Study||35
6479367|NCT01299480|7396572|FG002|NOT COMPLETED|Overall Study||41
6479368|NCT01299480|7396573|FG003|NOT COMPLETED|Overall Study||25
6479369|NCT01299480|7396574|FG004|NOT COMPLETED|Overall Study||20
6479370|NCT01299571|7396587|FG000|STARTED|Overall Study||3977
6479371|NCT01299571|7396587|FG000|COMPLETED|Overall Study||3870
6479372|NCT01299571|7396587|FG000|NOT COMPLETED|Overall Study||107
6479373|NCT01299584|7396592|FG000|STARTED|Overall Study||775
6479374|NCT01299584|7396592|FG000|COMPLETED|Overall Study||766
6479375|NCT01299584|7396592|FG000|NOT COMPLETED|Overall Study||9
6479376|NCT01299610|7396599|FG000|STARTED|Overall Study||10
6479377|NCT01299610|7396600|FG001|STARTED|Overall Study||5
6479378|NCT01299610|7396601|FG002|STARTED|Overall Study||10
6479379|NCT01299610|7396599|FG000|COMPLETED|Overall Study||10
6479380|NCT01299610|7396600|FG001|COMPLETED|Overall Study||5
6479381|NCT01299610|7396601|FG002|COMPLETED|Overall Study||10
6479382|NCT01299610|7396599|FG000|NOT COMPLETED|Overall Study||0
6479383|NCT01299610|7396600|FG001|NOT COMPLETED|Overall Study||0
6479384|NCT01299610|7396601|FG002|NOT COMPLETED|Overall Study||0
6479385|NCT01299727|7396616|FG000|STARTED|Overall Study||4
6479386|NCT01299727|7396617|FG001|STARTED|Overall Study||4
6479387|NCT01299727|7396618|FG002|STARTED|Overall Study||4
6479388|NCT01299727|7396616|FG000|COMPLETED|Overall Study||0
6479389|NCT01299727|7396617|FG001|COMPLETED|Overall Study||0
6479390|NCT01299727|7396618|FG002|COMPLETED|Overall Study||0
6479391|NCT01299727|7396616|FG000|NOT COMPLETED|Overall Study||4
6479392|NCT01299727|7396617|FG001|NOT COMPLETED|Overall Study||4
6479393|NCT01299727|7396618|FG002|NOT COMPLETED|Overall Study||4
6479394|NCT01299766|7396628|FG000|STARTED|Overall Study||111
6479395|NCT01299766|7396629|FG001|STARTED|Overall Study||110
6479396|NCT01299766|7396628|FG000|COMPLETED|Overall Study||77
6479397|NCT01299766|7396629|FG001|COMPLETED|Overall Study||87
6479398|NCT01299766|7396628|FG000|NOT COMPLETED|Overall Study||34
6479399|NCT01299766|7396629|FG001|NOT COMPLETED|Overall Study||23
6479400|NCT01299805|7396637|FG000|STARTED|Overall Study||12
6479401|NCT01299805|7396638|FG001|STARTED|Overall Study||5
6479402|NCT01299805|7396637|FG000|COMPLETED|Overall Study||10
6479403|NCT01299805|7396638|FG001|COMPLETED|Overall Study||5
6479404|NCT01299805|7396637|FG000|NOT COMPLETED|Overall Study||2
6479405|NCT01299805|7396638|FG001|NOT COMPLETED|Overall Study||0
6479406|NCT01299896|7396646|FG000|STARTED|Overall Study||319
6479407|NCT01299896|7396647|FG001|STARTED|Overall Study||314
6479408|NCT01299896|7396646|FG000|COMPLETED|Overall Study||318
6479409|NCT01299896|7396647|FG001|COMPLETED|Overall Study||296
6554672|NCT01748552|7476854|FG002|NOT COMPLETED|Intervention Period 1 and Washout||0
6554673|NCT01748552|7476855|FG003|NOT COMPLETED|Intervention Period 1 and Washout||0
6554674|NCT01748552|7476856|FG004|NOT COMPLETED|Intervention Period 1 and Washout||0
6479410|NCT01299896|7396646|FG000|NOT COMPLETED|Overall Study||1
6479411|NCT01299896|7396647|FG001|NOT COMPLETED|Overall Study||18
6479412|NCT01299909|7396656|FG000|STARTED|Overall Study||68
6479413|NCT01299909|7396657|FG001|STARTED|Overall Study||67
6479414|NCT01299909|7396658|FG002|STARTED|Overall Study||40
6479415|NCT01299909|7396656|FG000|COMPLETED|Overall Study||46
6479416|NCT01299909|7396657|FG001|COMPLETED|Overall Study||49
6479417|NCT01299909|7396658|FG002|COMPLETED|Overall Study||23
6479418|NCT01299909|7396656|FG000|NOT COMPLETED|Overall Study||22
6479419|NCT01299909|7396657|FG001|NOT COMPLETED|Overall Study||18
6479420|NCT01299909|7396658|FG002|NOT COMPLETED|Overall Study||17
6479421|NCT01299961|7396665|FG000|STARTED|Overall Study||25
6479422|NCT01299961|7396665|FG000|COMPLETED|Overall Study||19
6479423|NCT01299961|7396665|FG000|NOT COMPLETED|Overall Study||6
6479424|NCT01300052|7396671|FG000|STARTED|Overall Study||46
6479425|NCT01300052|7396672|FG001|STARTED|Overall Study||22
6479426|NCT01300052|7396671|FG000|COMPLETED|Overall Study||40
6479427|NCT01300052|7396672|FG001|COMPLETED|Overall Study||19
6554675|NCT01748552|7476857|FG005|NOT COMPLETED|Intervention Period 1 and Washout||0
6479428|NCT01300052|7396671|FG000|NOT COMPLETED|Overall Study||6
6479429|NCT01300052|7396672|FG001|NOT COMPLETED|Overall Study||3
6479430|NCT01300065|7396680|FG000|STARTED|Overall Study||221
6479431|NCT01300065|7396681|FG001|STARTED|Overall Study||220
6479432|NCT01300065|7396680|FG000|COMPLETED|Overall Study||215
6479433|NCT01300065|7396681|FG001|COMPLETED|Overall Study||217
6479434|NCT01300065|7396680|FG000|NOT COMPLETED|Overall Study||6
6479435|NCT01300065|7396681|FG001|NOT COMPLETED|Overall Study||3
6479436|NCT01300234|7396689|FG000|STARTED|Overall Study||257
6479437|NCT01300234|7396690|FG001|STARTED|Overall Study||255
6479438|NCT01300234|7396689|FG000|COMPLETED|Overall Study||229
6479439|NCT01300234|7396690|FG001|COMPLETED|Overall Study||228
6479440|NCT01300234|7396689|FG000|NOT COMPLETED|Overall Study||28
6479441|NCT01300234|7396690|FG001|NOT COMPLETED|Overall Study||27
6479442|NCT01300247|7396709|FG000|STARTED|Overall Study||21
6479443|NCT01300247|7396710|FG001|STARTED|Overall Study||20
6479444|NCT01300247|7396709|FG000|COMPLETED|Overall Study||17
6479445|NCT01300247|7396710|FG001|COMPLETED|Overall Study||18
6479446|NCT01300247|7396709|FG000|NOT COMPLETED|Overall Study||4
6479447|NCT01300247|7396710|FG001|NOT COMPLETED|Overall Study||2
6479448|NCT01300260|7396718|FG000|STARTED|Period 1 of Study: First Intervention||15
6479449|NCT01300260|7396719|FG001|STARTED|Period 1 of Study: First Intervention||17
6479450|NCT01300260|7396718|FG000|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
6479451|NCT01300260|7396719|FG001|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
6479452|NCT01300260|7396718|FG000|COMPLETED|Period 1 of Study: First Intervention||14
6479453|NCT01300260|7396719|FG001|COMPLETED|Period 1 of Study: First Intervention||16
6479454|NCT01300260|7396718|FG000|NOT COMPLETED|Period 1 of Study: First Intervention||1
6479455|NCT01300260|7396719|FG001|NOT COMPLETED|Period 1 of Study: First Intervention||1
6479456|NCT01300260|7396718|FG000|STARTED|Washout Period of at Least 28 Days||14
6479457|NCT01300260|7396719|FG001|STARTED|Washout Period of at Least 28 Days||16
6479458|NCT01300260|7396718|FG000|COMPLETED|Washout Period of at Least 28 Days||14
6479459|NCT01300260|7396719|FG001|COMPLETED|Washout Period of at Least 28 Days||16
6479460|NCT01300260|7396718|FG000|NOT COMPLETED|Washout Period of at Least 28 Days||0
6479461|NCT01300260|7396719|FG001|NOT COMPLETED|Washout Period of at Least 28 Days||0
6479462|NCT01300260|7396718|FG000|STARTED|Period 2 of Study: Second Intervention||14
6479463|NCT01300260|7396719|FG001|STARTED|Period 2 of Study: Second Intervention||16
6479464|NCT01300260|7396718|FG000|COMPLETED|Period 2 of Study: Second Intervention||14
6479465|NCT01300260|7396719|FG001|COMPLETED|Period 2 of Study: Second Intervention||15
6479466|NCT01300260|7396718|FG000|NOT COMPLETED|Period 2 of Study: Second Intervention||0
6479467|NCT01300260|7396719|FG001|NOT COMPLETED|Period 2 of Study: Second Intervention||1
6479468|NCT01300286|7396736|FG000|STARTED|Overall Study||23
6479469|NCT01300286|7396736|FG000|COMPLETED|Overall Study||22
6479470|NCT01300286|7396736|FG000|NOT COMPLETED|Overall Study||1
6479471|NCT01300338|7396743|FG000|STARTED|Overall Study||25
6479472|NCT01300338|7396744|FG001|STARTED|Overall Study||25
6479473|NCT01300338|7396743|FG000|COMPLETED|Overall Study||20
6479474|NCT01300338|7396744|FG001|COMPLETED|Overall Study||25
6479475|NCT01300338|7396743|FG000|NOT COMPLETED|Overall Study||5
6479476|NCT01300338|7396744|FG001|NOT COMPLETED|Overall Study||0
6479477|NCT01300351|7396752|FG000|STARTED|Overall Study||111
6479478|NCT01300351|7396753|FG001|STARTED|Overall Study||110
6479479|NCT01300351|7396752|FG000|Received Study Treatment|Overall Study||109
6479480|NCT01300351|7396753|FG001|Received Study Treatment|Overall Study||110
6479481|NCT01300351|7396752|FG000|COMPLETED|Overall Study||75
6479482|NCT01300351|7396753|FG001|COMPLETED|Overall Study||72
6479483|NCT01300351|7396752|FG000|NOT COMPLETED|Overall Study||36
6479484|NCT01300351|7396753|FG001|NOT COMPLETED|Overall Study||38
6479485|NCT01300455|7396761|FG000|STARTED|Period 1||13
6479486|NCT01300455|7396762|FG001|STARTED|Period 1||13
6479487|NCT01300455|7396761|FG000|COMPLETED|Period 1||13
6479488|NCT01300455|7396762|FG001|COMPLETED|Period 1||13
6479489|NCT01300455|7396761|FG000|NOT COMPLETED|Period 1||0
6479490|NCT01300455|7396762|FG001|NOT COMPLETED|Period 1||0
6479491|NCT01300455|7396761|FG000|STARTED|Washout||13
6479492|NCT01300455|7396762|FG001|STARTED|Washout||13
6479493|NCT01300455|7396761|FG000|COMPLETED|Washout||12
6479494|NCT01300455|7396762|FG001|COMPLETED|Washout||13
6479495|NCT01300455|7396761|FG000|NOT COMPLETED|Washout||1
6479496|NCT01300455|7396762|FG001|NOT COMPLETED|Washout||0
6479497|NCT01300455|7396761|FG000|STARTED|Period 2||12
6479498|NCT01300455|7396762|FG001|STARTED|Period 2||13
6479499|NCT01300455|7396761|FG000|COMPLETED|Period 2||12
6479500|NCT01300455|7396762|FG001|COMPLETED|Period 2||13
6479501|NCT01300455|7396761|FG000|NOT COMPLETED|Period 2||0
6479502|NCT01300455|7396762|FG001|NOT COMPLETED|Period 2||0
6479503|NCT01300546|7396770|FG000|STARTED|Overall Study||19
6479504|NCT01300546|7396771|FG001|STARTED|Overall Study||20
6479505|NCT01300546|7396770|FG000|COMPLETED|Overall Study||18
6479506|NCT01300546|7396771|FG001|COMPLETED|Overall Study||14
6479507|NCT01300546|7396770|FG000|NOT COMPLETED|Overall Study||1
6479508|NCT01300546|7396771|FG001|NOT COMPLETED|Overall Study||6
6479509|NCT01300559|7396779|FG000|STARTED|Overall Study||30
6479510|NCT01300559|7396780|FG001|STARTED|Overall Study||30
6479511|NCT01300559|7396779|FG000|COMPLETED|Overall Study||30
6479512|NCT01300559|7396780|FG001|COMPLETED|Overall Study||30
6479513|NCT01300559|7396779|FG000|NOT COMPLETED|Overall Study||0
6479514|NCT01300559|7396780|FG001|NOT COMPLETED|Overall Study||0
6479515|NCT01300572|7396786|FG000|STARTED|Overall Study||16
6479516|NCT01300572|7396786|FG000|COMPLETED|Overall Study||15
6479517|NCT01300572|7396786|FG000|NOT COMPLETED|Overall Study||1
6479518|NCT01300624|7396791|FG000|STARTED|Overall Study||11
6479519|NCT01300624|7396791|FG000|COMPLETED|Overall Study||11
6479520|NCT01300624|7396791|FG000|NOT COMPLETED|Overall Study||0
6501390|NCT01428076|7419851|FG000|STARTED|Overall Study||9
6501391|NCT01428076|7419852|FG001|STARTED|Overall Study||12
6501392|NCT01428076|7419851|FG000|COMPLETED|Overall Study||9
6501393|NCT01428076|7419852|FG001|COMPLETED|Overall Study||11
6501394|NCT01428076|7419851|FG000|NOT COMPLETED|Overall Study||0
6501395|NCT01428076|7419852|FG001|NOT COMPLETED|Overall Study||1
6501396|NCT01428115|7419860|FG000|STARTED|Overall Study||83
6501397|NCT01428115|7419860|FG000|COMPLETED|Overall Study||62
6501398|NCT01428115|7419860|FG000|NOT COMPLETED|Overall Study||21
6479521|NCT01300650|7396796|FG000|STARTED|Overall Study||8
6479522|NCT01300650|7396796|FG000|COMPLETED|Overall Study||7
6479523|NCT01300650|7396796|FG000|NOT COMPLETED|Overall Study||1
6479524|NCT01300728|7396803|FG000|STARTED|Overall Study||26
6479525|NCT01300728|7396804|FG001|STARTED|Overall Study||26
6479526|NCT01300728|7396803|FG000|COMPLETED|Overall Study||24
6479527|NCT01300728|7396804|FG001|COMPLETED|Overall Study||25
6479528|NCT01300728|7396803|FG000|NOT COMPLETED|Overall Study||2
6479529|NCT01300728|7396804|FG001|NOT COMPLETED|Overall Study||1
6479530|NCT01300741|7396810|FG000|STARTED|Overall Study||75
6479531|NCT01300741|7396810|FG000|COMPLETED|Overall Study||72
6479532|NCT01300741|7396810|FG000|NOT COMPLETED|Overall Study||3
6479533|NCT01300767|7396816|FG000|STARTED|Overall Study||74
6479534|NCT01300767|7396816|FG000|COMPLETED|Overall Study||70
6554676|NCT01748552|7476858|FG006|NOT COMPLETED|Intervention Period 1 and Washout||0
6479535|NCT01300767|7396816|FG000|NOT COMPLETED|Overall Study||4
6479536|NCT01300819|7396824|FG000|STARTED|Overall Study||125
6479537|NCT01300819|7396825|FG001|STARTED|Overall Study||224
6479538|NCT01300819|7396824|FG000|COMPLETED|Overall Study||103
6479539|NCT01300819|7396825|FG001|COMPLETED|Overall Study||180
6479540|NCT01300819|7396824|FG000|NOT COMPLETED|Overall Study||22
6479541|NCT01300819|7396825|FG001|NOT COMPLETED|Overall Study||44
6479542|NCT01300923|7396831|FG000|STARTED|Overall Study||12
6479543|NCT01300923|7396832|FG001|STARTED|Overall Study||2
6479544|NCT01300923|7396831|FG000|COMPLETED|Overall Study||12
6479545|NCT01300923|7396832|FG001|COMPLETED|Overall Study||0
6479546|NCT01300923|7396831|FG000|NOT COMPLETED|Overall Study||0
6479547|NCT01300923|7396832|FG001|NOT COMPLETED|Overall Study||2
6479548|NCT01300949|7396840|FG000|STARTED|Overall Study||154
6479549|NCT01300949|7396841|FG001|STARTED|Overall Study||125
6479550|NCT01300949|7396842|FG002|STARTED|Overall Study||35
6479551|NCT01300949|7396840|FG000|COMPLETED|Overall Study||154
6479552|NCT01300949|7396841|FG001|COMPLETED|Overall Study||125
6479553|NCT01300949|7396842|FG002|COMPLETED|Overall Study||35
6479554|NCT01300949|7396840|FG000|NOT COMPLETED|Overall Study||0
6479555|NCT01300949|7396841|FG001|NOT COMPLETED|Overall Study||0
6479556|NCT01300949|7396842|FG002|NOT COMPLETED|Overall Study||0
6479557|NCT01301001|7396850|FG000|STARTED|First Intervention||44
6479558|NCT01301001|7396851|FG001|STARTED|First Intervention||45
6479559|NCT01301001|7396850|FG000|COMPLETED|First Intervention||34
6479560|NCT01301001|7396851|FG001|COMPLETED|First Intervention||36
6479561|NCT01301001|7396850|FG000|NOT COMPLETED|First Intervention||10
6479562|NCT01301001|7396851|FG001|NOT COMPLETED|First Intervention||9
6479563|NCT01301001|7396850|FG000|STARTED|Washout (2 Weeks)||34
6479564|NCT01301001|7396851|FG001|STARTED|Washout (2 Weeks)||36
6479565|NCT01301001|7396850|FG000|COMPLETED|Washout (2 Weeks)||34
6479566|NCT01301001|7396851|FG001|COMPLETED|Washout (2 Weeks)||36
6479567|NCT01301001|7396850|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6479568|NCT01301001|7396851|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6479569|NCT01301001|7396850|FG000|STARTED|Second Intervention||34
6479570|NCT01301001|7396851|FG001|STARTED|Second Intervention||36
6479571|NCT01301001|7396850|FG000|COMPLETED|Second Intervention||30
6479572|NCT01301001|7396851|FG001|COMPLETED|Second Intervention||36
6479573|NCT01301001|7396850|FG000|NOT COMPLETED|Second Intervention||4
6479574|NCT01301001|7396851|FG001|NOT COMPLETED|Second Intervention||0
6479575|NCT01301027|7396860|FG000|STARTED|Overall Study||48
6479576|NCT01301027|7396861|FG001|STARTED|Overall Study||47
6479577|NCT01301027|7396860|FG000|COMPLETED|Overall Study||40
6479578|NCT01301027|7396861|FG001|COMPLETED|Overall Study||37
6479579|NCT01301027|7396860|FG000|NOT COMPLETED|Overall Study||8
6479580|NCT01301027|7396861|FG001|NOT COMPLETED|Overall Study||10
6479581|NCT01301066|7396869|FG000|STARTED|Overall Study||126
6479582|NCT01301066|7396870|FG001|STARTED|Overall Study||126
6479583|NCT01301066|7396869|FG000|COMPLETED|Overall Study||99
6479584|NCT01301066|7396870|FG001|COMPLETED|Overall Study||91
6479585|NCT01301066|7396869|FG000|NOT COMPLETED|Overall Study||27
6479586|NCT01301066|7396870|FG001|NOT COMPLETED|Overall Study||35
6479587|NCT01301079|7396878|FG000|STARTED|Overall Study||30
6479588|NCT01301079|7396879|FG001|STARTED|Overall Study||30
6479589|NCT01301079|7396878|FG000|COMPLETED|Overall Study||28
6479590|NCT01301079|7396879|FG001|COMPLETED|Overall Study||28
6479591|NCT01301079|7396878|FG000|NOT COMPLETED|Overall Study||2
6479592|NCT01301079|7396879|FG001|NOT COMPLETED|Overall Study||2
6479593|NCT01301092|7396892|FG000|STARTED|Overall Study||6
6479594|NCT01301092|7396893|FG001|STARTED|Overall Study||16
6479595|NCT01301092|7396894|FG002|STARTED|Overall Study||8
6479596|NCT01301092|7396892|FG000|COMPLETED|Overall Study||6
6479597|NCT01301092|7396893|FG001|COMPLETED|Overall Study||16
6479598|NCT01301092|7396894|FG002|COMPLETED|Overall Study||7
6479599|NCT01301092|7396892|FG000|NOT COMPLETED|Overall Study||0
6479600|NCT01301092|7396893|FG001|NOT COMPLETED|Overall Study||0
6479601|NCT01301092|7396894|FG002|NOT COMPLETED|Overall Study||1
6479602|NCT01301183|7396909|FG000|STARTED|Overall Study||38
6479603|NCT01301183|7396910|FG001|STARTED|Overall Study||37
6479604|NCT01301183|7396909|FG000|COMPLETED|Overall Study||12
6479605|NCT01301183|7396910|FG001|COMPLETED|Overall Study||21
6479606|NCT01301183|7396909|FG000|NOT COMPLETED|Overall Study||26
6479607|NCT01301183|7396910|FG001|NOT COMPLETED|Overall Study||16
6479608|NCT01301274|7396918|FG000|STARTED|Overall Study||34
6479609|NCT01301274|7396919|FG001|STARTED|Overall Study||32
6479610|NCT01301274|7396918|FG000|COMPLETED|Overall Study||32
6479611|NCT01301274|7396919|FG001|COMPLETED|Overall Study||31
6479612|NCT01301274|7396918|FG000|NOT COMPLETED|Overall Study||2
6479613|NCT01301274|7396919|FG001|NOT COMPLETED|Overall Study||1
6479614|NCT01301391|7396930|FG000|STARTED|Overall Study|On treatment until disease progression, patient withdrawal of consent, or unacceptable toxicity.|30
6479615|NCT01301391|7396930|FG000|COMPLETED|Overall Study||4
6479616|NCT01301391|7396930|FG000|NOT COMPLETED|Overall Study||26
6479617|NCT01301456|7396946|FG000|STARTED|Stage 1||15
6479618|NCT01301456|7396947|FG001|STARTED|Stage 1||5
6479619|NCT01301456|7396948|FG002|STARTED|Stage 1||6
6479620|NCT01301456|7396949|FG003|STARTED|Stage 1||6
6479621|NCT01301456|7396950|FG004|STARTED|Stage 1||7
6479622|NCT01301456|7396951|FG005|STARTED|Stage 1||5
6479623|NCT01301456|7396952|FG006|STARTED|Stage 1||8
6479624|NCT01301456|7396953|FG007|STARTED|Stage 1||0
6479625|NCT01301456|7396954|FG008|STARTED|Stage 1||0
6479626|NCT01301456|7396955|FG009|STARTED|Stage 1||0
6479627|NCT01301456|7396956|FG010|STARTED|Stage 1||0
6479628|NCT01301456|7396957|FG011|STARTED|Stage 1||0
6479629|NCT01301456|7396946|FG000|Received Treatment|Stage 1||15
6479630|NCT01301456|7396947|FG001|Received Treatment|Stage 1||5
6479631|NCT01301456|7396948|FG002|Received Treatment|Stage 1||6
6479632|NCT01301456|7396949|FG003|Received Treatment|Stage 1||6
6479633|NCT01301456|7396950|FG004|Received Treatment|Stage 1||7
6479634|NCT01301456|7396951|FG005|Received Treatment|Stage 1||5
6479635|NCT01301456|7396952|FG006|Received Treatment|Stage 1||7
6479636|NCT01301456|7396953|FG007|Received Treatment|Stage 1||0
6479637|NCT01301456|7396954|FG008|Received Treatment|Stage 1||0
6479638|NCT01301456|7396955|FG009|Received Treatment|Stage 1||0
6479639|NCT01301456|7396956|FG010|Received Treatment|Stage 1||0
6479640|NCT01301456|7396957|FG011|Received Treatment|Stage 1||0
6479641|NCT01301456|7396946|FG000|COMPLETED|Stage 1||15
6479642|NCT01301456|7396947|FG001|COMPLETED|Stage 1||5
6479643|NCT01301456|7396948|FG002|COMPLETED|Stage 1||5
6479644|NCT01301456|7396949|FG003|COMPLETED|Stage 1||6
6479645|NCT01301456|7396950|FG004|COMPLETED|Stage 1||6
6479646|NCT01301456|7396951|FG005|COMPLETED|Stage 1||5
6479647|NCT01301456|7396952|FG006|COMPLETED|Stage 1||7
6479648|NCT01301456|7396953|FG007|COMPLETED|Stage 1||0
6479649|NCT01301456|7396954|FG008|COMPLETED|Stage 1||0
6479650|NCT01301456|7396955|FG009|COMPLETED|Stage 1||0
6479651|NCT01301456|7396956|FG010|COMPLETED|Stage 1||0
6479652|NCT01301456|7396957|FG011|COMPLETED|Stage 1||0
6479653|NCT01301456|7396946|FG000|NOT COMPLETED|Stage 1||0
6479654|NCT01301456|7396947|FG001|NOT COMPLETED|Stage 1||0
6479655|NCT01301456|7396948|FG002|NOT COMPLETED|Stage 1||1
6479656|NCT01301456|7396949|FG003|NOT COMPLETED|Stage 1||0
6479657|NCT01301456|7396950|FG004|NOT COMPLETED|Stage 1||1
6479658|NCT01301456|7396951|FG005|NOT COMPLETED|Stage 1||0
6479659|NCT01301456|7396952|FG006|NOT COMPLETED|Stage 1||1
6479660|NCT01301456|7396953|FG007|NOT COMPLETED|Stage 1||0
6479661|NCT01301456|7396954|FG008|NOT COMPLETED|Stage 1||0
6479662|NCT01301456|7396955|FG009|NOT COMPLETED|Stage 1||0
6479663|NCT01301456|7396956|FG010|NOT COMPLETED|Stage 1||0
6479664|NCT01301456|7396957|FG011|NOT COMPLETED|Stage 1||0
6479665|NCT01301456|7396946|FG000|STARTED|Stage 2||0
6479666|NCT01301456|7396947|FG001|STARTED|Stage 2||0
6479667|NCT01301456|7396948|FG002|STARTED|Stage 2||0
6479668|NCT01301456|7396949|FG003|STARTED|Stage 2||0
6479669|NCT01301456|7396950|FG004|STARTED|Stage 2||0
6479670|NCT01301456|7396951|FG005|STARTED|Stage 2||0
6479671|NCT01301456|7396952|FG006|STARTED|Stage 2||0
6479672|NCT01301456|7396953|FG007|STARTED|Stage 2||7
6479673|NCT01301456|7396954|FG008|STARTED|Stage 2||5
6479674|NCT01301456|7396955|FG009|STARTED|Stage 2||7
6479675|NCT01301456|7396956|FG010|STARTED|Stage 2||7
6479676|NCT01301456|7396957|FG011|STARTED|Stage 2||6
6479677|NCT01301456|7396946|FG000|Received Treatment|Stage 2||0
6479678|NCT01301456|7396947|FG001|Received Treatment|Stage 2||0
6479679|NCT01301456|7396948|FG002|Received Treatment|Stage 2||0
6479680|NCT01301456|7396949|FG003|Received Treatment|Stage 2||0
6479681|NCT01301456|7396950|FG004|Received Treatment|Stage 2||0
6479682|NCT01301456|7396951|FG005|Received Treatment|Stage 2||0
6479683|NCT01301456|7396952|FG006|Received Treatment|Stage 2||0
6479684|NCT01301456|7396953|FG007|Received Treatment|Stage 2||7
6479685|NCT01301456|7396954|FG008|Received Treatment|Stage 2||5
6479686|NCT01301456|7396955|FG009|Received Treatment|Stage 2||7
6479687|NCT01301456|7396956|FG010|Received Treatment|Stage 2||7
6479688|NCT01301456|7396957|FG011|Received Treatment|Stage 2||6
6479689|NCT01301456|7396946|FG000|COMPLETED|Stage 2||0
6479690|NCT01301456|7396947|FG001|COMPLETED|Stage 2||0
6479691|NCT01301456|7396948|FG002|COMPLETED|Stage 2||0
6479692|NCT01301456|7396949|FG003|COMPLETED|Stage 2||0
6479693|NCT01301456|7396950|FG004|COMPLETED|Stage 2||0
6479694|NCT01301456|7396951|FG005|COMPLETED|Stage 2||0
6479695|NCT01301456|7396952|FG006|COMPLETED|Stage 2||0
6479696|NCT01301456|7396953|FG007|COMPLETED|Stage 2||7
6479697|NCT01301456|7396954|FG008|COMPLETED|Stage 2||5
6479698|NCT01301456|7396955|FG009|COMPLETED|Stage 2||7
6479699|NCT01301456|7396956|FG010|COMPLETED|Stage 2||6
6479700|NCT01301456|7396957|FG011|COMPLETED|Stage 2||6
6479701|NCT01301456|7396946|FG000|NOT COMPLETED|Stage 2||0
6479702|NCT01301456|7396947|FG001|NOT COMPLETED|Stage 2||0
6479703|NCT01301456|7396948|FG002|NOT COMPLETED|Stage 2||0
6479704|NCT01301456|7396949|FG003|NOT COMPLETED|Stage 2||0
6479705|NCT01301456|7396950|FG004|NOT COMPLETED|Stage 2||0
6479706|NCT01301456|7396951|FG005|NOT COMPLETED|Stage 2||0
6479707|NCT01301456|7396952|FG006|NOT COMPLETED|Stage 2||0
6479708|NCT01301456|7396953|FG007|NOT COMPLETED|Stage 2||0
6479709|NCT01301456|7396954|FG008|NOT COMPLETED|Stage 2||0
6479710|NCT01301456|7396955|FG009|NOT COMPLETED|Stage 2||0
6479711|NCT01301456|7396956|FG010|NOT COMPLETED|Stage 2||1
6479712|NCT01301456|7396957|FG011|NOT COMPLETED|Stage 2||0
6479713|NCT01301508|7397003|FG000|STARTED|Overall Study||21
6479714|NCT01301508|7397004|FG001|STARTED|Overall Study||25
6479715|NCT01301508|7397003|FG000|COMPLETED|Overall Study||20
6479716|NCT01301508|7397004|FG001|COMPLETED|Overall Study||22
6479717|NCT01301508|7397003|FG000|NOT COMPLETED|Overall Study||1
6479718|NCT01301508|7397004|FG001|NOT COMPLETED|Overall Study||3
6479719|NCT01301625|7397010|FG000|STARTED|Overall Study||78
6479720|NCT01301625|7397010|FG000|COMPLETED|Overall Study||43
6479721|NCT01301625|7397010|FG000|NOT COMPLETED|Overall Study||35
6479722|NCT01301729|7397014|FG000|STARTED|Overall Study||32
6479723|NCT01301729|7397014|FG000|COMPLETED|Overall Study||28
6479724|NCT01301729|7397014|FG000|NOT COMPLETED|Overall Study||4
6479725|NCT01301742|7397019|FG000|STARTED|First Intervention||9
6479726|NCT01301742|7397020|FG001|STARTED|First Intervention||9
6479727|NCT01301742|7397019|FG000|COMPLETED|First Intervention||9
6479728|NCT01301742|7397020|FG001|COMPLETED|First Intervention||9
6479729|NCT01301742|7397019|FG000|NOT COMPLETED|First Intervention||0
6479730|NCT01301742|7397020|FG001|NOT COMPLETED|First Intervention||0
6479731|NCT01301742|7397019|FG000|STARTED|Washout Period of at Least 7 Days||9
6479732|NCT01301742|7397020|FG001|STARTED|Washout Period of at Least 7 Days||9
6479733|NCT01301742|7397019|FG000|COMPLETED|Washout Period of at Least 7 Days||9
6479734|NCT01301742|7397020|FG001|COMPLETED|Washout Period of at Least 7 Days||9
6479735|NCT01301742|7397019|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||0
6479736|NCT01301742|7397020|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
6479737|NCT01301742|7397019|FG000|STARTED|Second Intervention||9
6479738|NCT01301742|7397020|FG001|STARTED|Second Intervention||9
6479739|NCT01301742|7397019|FG000|COMPLETED|Second Intervention||9
6479740|NCT01301742|7397020|FG001|COMPLETED|Second Intervention||9
6479741|NCT01301742|7397019|FG000|NOT COMPLETED|Second Intervention||0
6479742|NCT01301742|7397020|FG001|NOT COMPLETED|Second Intervention||0
6479743|NCT01301833|7397031|FG000|STARTED|Overall Study||212
6479744|NCT01301833|7397032|FG001|STARTED|Overall Study||80
6479745|NCT01301833|7397033|FG002|STARTED|Overall Study||95
6479746|NCT01301833|7397034|FG003|STARTED|Overall Study||75
6479747|NCT01301833|7397031|FG000|COMPLETED|Overall Study||197
6479748|NCT01301833|7397032|FG001|COMPLETED|Overall Study||72
6479749|NCT01301833|7397033|FG002|COMPLETED|Overall Study||88
6479750|NCT01301833|7397034|FG003|COMPLETED|Overall Study||68
6479751|NCT01301833|7397031|FG000|NOT COMPLETED|Overall Study||15
6479752|NCT01301833|7397032|FG001|NOT COMPLETED|Overall Study||8
6479753|NCT01301833|7397033|FG002|NOT COMPLETED|Overall Study||7
6479754|NCT01301833|7397034|FG003|NOT COMPLETED|Overall Study||7
6479755|NCT01301950|7397046|FG000|STARTED|Overall Study||15
6479756|NCT01301950|7397047|FG001|STARTED|Overall Study||15
6479757|NCT01301950|7397046|FG000|COMPLETED|Overall Study||15
6479758|NCT01301950|7397047|FG001|COMPLETED|Overall Study||14
6479759|NCT01301950|7397046|FG000|NOT COMPLETED|Overall Study||0
6479760|NCT01301950|7397047|FG001|NOT COMPLETED|Overall Study||1
6479761|NCT01302041|7397053|FG000|STARTED|Overall Study||67
6479762|NCT01302041|7397053|FG000|Treatment Received|Overall Study||67
6479763|NCT01302041|7397053|FG000|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|27
6479764|NCT01302041|7397053|FG000|NOT COMPLETED|Overall Study||40
6479765|NCT01302054|7397058|FG000|STARTED|Tolterodine Open-Label Run-In Phase||990
6479766|NCT01302054|7397059|FG001|STARTED|Tolterodine Open-Label Run-In Phase||0
6479767|NCT01302054|7397060|FG002|STARTED|Tolterodine Open-Label Run-In Phase||0
6479768|NCT01302054|7397058|FG000|COMPLETED|Tolterodine Open-Label Run-In Phase||611
6479769|NCT01302054|7397059|FG001|COMPLETED|Tolterodine Open-Label Run-In Phase||0
6479770|NCT01302054|7397060|FG002|COMPLETED|Tolterodine Open-Label Run-In Phase||0
6479771|NCT01302054|7397058|FG000|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
6479772|NCT01302054|7397059|FG001|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
6479773|NCT01302054|7397060|FG002|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
6479774|NCT01302054|7397058|FG000|STARTED|Between Open-Label and Double Blind||611
6479775|NCT01302054|7397059|FG001|STARTED|Between Open-Label and Double Blind||0
6479776|NCT01302054|7397060|FG002|STARTED|Between Open-Label and Double Blind||0
6479777|NCT01302054|7397058|FG000|COMPLETED|Between Open-Label and Double Blind||609
6479778|NCT01302054|7397059|FG001|COMPLETED|Between Open-Label and Double Blind||0
6479779|NCT01302054|7397060|FG002|COMPLETED|Between Open-Label and Double Blind||0
6479780|NCT01302054|7397058|FG000|NOT COMPLETED|Between Open-Label and Double Blind||2
6479781|NCT01302054|7397059|FG001|NOT COMPLETED|Between Open-Label and Double Blind||0
6479782|NCT01302054|7397060|FG002|NOT COMPLETED|Between Open-Label and Double Blind||0
6479783|NCT01302054|7397058|FG000|STARTED|Double-Blind Treatment Phase||0
6479784|NCT01302054|7397059|FG001|STARTED|Double-Blind Treatment Phase||308
6479785|NCT01302054|7397060|FG002|STARTED|Double-Blind Treatment Phase||301
6479786|NCT01302054|7397058|FG000|COMPLETED|Double-Blind Treatment Phase||0
6479787|NCT01302054|7397059|FG001|COMPLETED|Double-Blind Treatment Phase||281
6479788|NCT01302054|7397060|FG002|COMPLETED|Double-Blind Treatment Phase||255
6479789|NCT01302054|7397058|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
6748349|NCT03407625|7676389|FG000|STARTED|Overall Study||1117
6748350|NCT03407625|7676390|FG001|STARTED|Overall Study||1110
6748351|NCT03407625|7676389|FG000|COMPLETED|Overall Study||1117
6748352|NCT03407625|7676390|FG001|COMPLETED|Overall Study||1110
6748353|NCT03407625|7676389|FG000|NOT COMPLETED|Overall Study||0
6748354|NCT03407625|7676390|FG001|NOT COMPLETED|Overall Study||0
6479790|NCT01302054|7397059|FG001|NOT COMPLETED|Double-Blind Treatment Phase||27
6479791|NCT01302054|7397060|FG002|NOT COMPLETED|Double-Blind Treatment Phase||46
6479792|NCT01302067|7397072|FG000|STARTED|Overall Study||790
6479793|NCT01302067|7397073|FG001|STARTED|Overall Study||386
6479794|NCT01302067|7397074|FG002|STARTED|Overall Study||779
6479795|NCT01302067|7397072|FG000|COMPLETED|Overall Study||712
6479796|NCT01302067|7397073|FG001|COMPLETED|Overall Study||352
6479797|NCT01302067|7397074|FG002|COMPLETED|Overall Study||681
6479798|NCT01302067|7397072|FG000|NOT COMPLETED|Overall Study||78
6479799|NCT01302067|7397073|FG001|NOT COMPLETED|Overall Study||34
6479800|NCT01302067|7397074|FG002|NOT COMPLETED|Overall Study||98
6479801|NCT01302080|7397085|FG000|STARTED|Overall Study|Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.|696
6479802|NCT01302080|7397086|FG001|STARTED|Overall Study|Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.|245
6479803|NCT01302080|7397085|FG000|COMPLETED|Overall Study||330
6479804|NCT01302080|7397086|FG001|COMPLETED|Overall Study||102
6479805|NCT01302080|7397085|FG000|NOT COMPLETED|Overall Study||366
6479806|NCT01302080|7397086|FG001|NOT COMPLETED|Overall Study||143
6479807|NCT01302119|7397118|FG000|STARTED|Overall Study||399
6479808|NCT01302119|7397119|FG001|STARTED|Overall Study||205
6479809|NCT01302119|7397118|FG000|COMPLETED|Overall Study||349
6479810|NCT01302119|7397119|FG001|COMPLETED|Overall Study||177
6479811|NCT01302119|7397118|FG000|NOT COMPLETED|Overall Study||50
6479812|NCT01302119|7397119|FG001|NOT COMPLETED|Overall Study||28
6479813|NCT01302366|7397125|FG000|STARTED|Overall Study||20
6479814|NCT01302366|7397125|FG000|COMPLETED|Overall Study||15
6479815|NCT01302366|7397125|FG000|NOT COMPLETED|Overall Study||5
6554677|NCT01748552|7476859|FG007|NOT COMPLETED|Intervention Period 1 and Washout||0
6554678|NCT01748552|7476860|FG008|NOT COMPLETED|Intervention Period 1 and Washout||0
6554679|NCT01748552|7476861|FG009|NOT COMPLETED|Intervention Period 1 and Washout||0
6554680|NCT01748552|7476862|FG010|NOT COMPLETED|Intervention Period 1 and Washout||0
6554681|NCT01748552|7476863|FG011|NOT COMPLETED|Intervention Period 1 and Washout||0
6554682|NCT01748552|7476852|FG000|STARTED|Intervention Period 2 and Washout||3
6554683|NCT01748552|7476853|FG001|STARTED|Intervention Period 2 and Washout||3
6554684|NCT01748552|7476854|FG002|STARTED|Intervention Period 2 and Washout||3
6554685|NCT01748552|7476855|FG003|STARTED|Intervention Period 2 and Washout||3
6554686|NCT01748552|7476856|FG004|STARTED|Intervention Period 2 and Washout||3
6554687|NCT01748552|7476857|FG005|STARTED|Intervention Period 2 and Washout||3
6554688|NCT01748552|7476858|FG006|STARTED|Intervention Period 2 and Washout||3
6554689|NCT01748552|7476859|FG007|STARTED|Intervention Period 2 and Washout||3
6554690|NCT01748552|7476860|FG008|STARTED|Intervention Period 2 and Washout||3
6554691|NCT01748552|7476861|FG009|STARTED|Intervention Period 2 and Washout||3
6554692|NCT01748552|7476862|FG010|STARTED|Intervention Period 2 and Washout||3
6554693|NCT01748552|7476863|FG011|STARTED|Intervention Period 2 and Washout||3
6554694|NCT01748552|7476852|FG000|COMPLETED|Intervention Period 2 and Washout||3
6554695|NCT01748552|7476853|FG001|COMPLETED|Intervention Period 2 and Washout||3
6554696|NCT01748552|7476854|FG002|COMPLETED|Intervention Period 2 and Washout||2
6554697|NCT01748552|7476855|FG003|COMPLETED|Intervention Period 2 and Washout||3
6554698|NCT01748552|7476856|FG004|COMPLETED|Intervention Period 2 and Washout||3
6479816|NCT01302379|7397133|FG000|STARTED|Overall Study||83
6479817|NCT01302379|7397134|FG001|STARTED|Overall Study||83
6479818|NCT01302379|7397135|FG002|STARTED|Overall Study||84
6479819|NCT01302379|7397136|FG003|STARTED|Overall Study||83
6479820|NCT01302379|7397133|FG000|COMPLETED|Overall Study||76
6479821|NCT01302379|7397134|FG001|COMPLETED|Overall Study||78
6479822|NCT01302379|7397135|FG002|COMPLETED|Overall Study||80
6479823|NCT01302379|7397136|FG003|COMPLETED|Overall Study||79
6479824|NCT01302379|7397133|FG000|NOT COMPLETED|Overall Study||7
6479825|NCT01302379|7397134|FG001|NOT COMPLETED|Overall Study||5
6479826|NCT01302379|7397135|FG002|NOT COMPLETED|Overall Study||4
6479827|NCT01302379|7397136|FG003|NOT COMPLETED|Overall Study||4
6479828|NCT01302392|7397146|FG000|STARTED|Overall Study||158
6554699|NCT01748552|7476857|FG005|COMPLETED|Intervention Period 2 and Washout||3
6554700|NCT01748552|7476858|FG006|COMPLETED|Intervention Period 2 and Washout||0
6554701|NCT01748552|7476859|FG007|COMPLETED|Intervention Period 2 and Washout||0
6479829|NCT01302392|7397147|FG001|STARTED|Overall Study||157
6479830|NCT01302392|7397146|FG000|Treated|Overall Study||153
6479831|NCT01302392|7397147|FG001|Treated|Overall Study||157
6479832|NCT01302392|7397146|FG000|COMPLETED|Overall Study||151
6554702|NCT01748552|7476860|FG008|COMPLETED|Intervention Period 2 and Washout||0
6554703|NCT01748552|7476861|FG009|COMPLETED|Intervention Period 2 and Washout||3
6654667|NCT02447302|7584551|FG000|NOT COMPLETED|Overall Study||5
6654668|NCT02447302|7584552|FG001|NOT COMPLETED|Overall Study||4
6654669|NCT02447302|7584553|FG002|NOT COMPLETED|Overall Study||6
6654670|NCT02447328|7584561|FG000|STARTED|Overall Study|Enrolment 85 Screening Failure 2 starting study drug 83|83
6654671|NCT02447328|7584561|FG000|COMPLETED|Overall Study||82
6654672|NCT02447328|7584561|FG000|NOT COMPLETED|Overall Study||1
6654673|NCT02447432|7584567|FG000|STARTED|Epoch 001||160
6654674|NCT02447432|7584568|FG001|STARTED|Epoch 001||160
6479833|NCT01302392|7397147|FG001|COMPLETED|Overall Study||156
6479834|NCT01302392|7397146|FG000|NOT COMPLETED|Overall Study||7
6479835|NCT01302392|7397147|FG001|NOT COMPLETED|Overall Study||1
6479836|NCT01302418|7397153|FG000|STARTED|Overall Study||272
6479837|NCT01302418|7397153|FG000|COMPLETED|Overall Study||254
6654675|NCT02447432|7584567|FG000|COMPLETED|Epoch 001||155
6654676|NCT02447432|7584568|FG001|COMPLETED|Epoch 001||147
6654677|NCT02447432|7584567|FG000|NOT COMPLETED|Epoch 001||5
6479838|NCT01302418|7397153|FG000|NOT COMPLETED|Overall Study||18
6479839|NCT01302483|7397159|FG000|STARTED|Overall Study||30
6479840|NCT01302483|7397160|FG001|STARTED|Overall Study||15
6479841|NCT01302483|7397159|FG000|COMPLETED|Overall Study||30
6479842|NCT01302483|7397160|FG001|COMPLETED|Overall Study||15
6479843|NCT01302483|7397159|FG000|NOT COMPLETED|Overall Study||0
6479844|NCT01302483|7397160|FG001|NOT COMPLETED|Overall Study||0
6479845|NCT01302548|7397174|FG000|STARTED|Overall Study||14
6479846|NCT01302548|7397175|FG001|STARTED|Overall Study||19
6479847|NCT01302548|7397174|FG000|COMPLETED|Overall Study||12
6479848|NCT01302548|7397175|FG001|COMPLETED|Overall Study||18
6479849|NCT01302548|7397174|FG000|NOT COMPLETED|Overall Study||2
6479850|NCT01302548|7397175|FG001|NOT COMPLETED|Overall Study||1
6479851|NCT01302691|7397183|FG000|STARTED|Overall Study||164
6479852|NCT01302691|7397184|FG001|STARTED|Overall Study||163
6479853|NCT01302691|7397183|FG000|COMPLETED|Overall Study||154
6479854|NCT01302691|7397184|FG001|COMPLETED|Overall Study||157
6479855|NCT01302691|7397183|FG000|NOT COMPLETED|Overall Study||10
6479856|NCT01302691|7397184|FG001|NOT COMPLETED|Overall Study||6
6479857|NCT01302743|7397193|FG000|STARTED|Overall Study||7
6479858|NCT01302743|7397194|FG001|STARTED|Overall Study||8
6479859|NCT01302743|7397195|FG002|STARTED|Overall Study||10
6479860|NCT01302743|7397193|FG000|COMPLETED|Overall Study||6
6479861|NCT01302743|7397194|FG001|COMPLETED|Overall Study||7
6479862|NCT01302743|7397195|FG002|COMPLETED|Overall Study||8
6479863|NCT01302743|7397193|FG000|NOT COMPLETED|Overall Study||1
6479864|NCT01302743|7397194|FG001|NOT COMPLETED|Overall Study||1
6479865|NCT01302743|7397195|FG002|NOT COMPLETED|Overall Study||2
6479866|NCT01302808|7397207|FG000|STARTED|Overall Study||3
6479867|NCT01302808|7397208|FG001|STARTED|Overall Study||7
6479868|NCT01302808|7397209|FG002|STARTED|Overall Study||4
6479869|NCT01302808|7397210|FG003|STARTED|Overall Study||3
6479870|NCT01302808|7397207|FG000|COMPLETED|Overall Study||3
6479871|NCT01302808|7397208|FG001|COMPLETED|Overall Study||7
6479872|NCT01302808|7397209|FG002|COMPLETED|Overall Study||4
6479873|NCT01302808|7397210|FG003|COMPLETED|Overall Study||3
6479874|NCT01302808|7397207|FG000|NOT COMPLETED|Overall Study||0
6479875|NCT01302808|7397208|FG001|NOT COMPLETED|Overall Study||0
6479876|NCT01302808|7397209|FG002|NOT COMPLETED|Overall Study||0
6479877|NCT01302808|7397210|FG003|NOT COMPLETED|Overall Study||0
6479878|NCT01302834|7397224|FG000|STARTED|Overall Study||424
6479879|NCT01302834|7397225|FG001|STARTED|Overall Study||425
6479880|NCT01302834|7397224|FG000|Eligible|Overall Study||406
6479881|NCT01302834|7397225|FG001|Eligible|Overall Study||399
6479882|NCT01302834|7397224|FG000|Started Treatment|Overall Study||398
6479883|NCT01302834|7397225|FG001|Started Treatment|Overall Study||394
6479884|NCT01302834|7397224|FG000|AE Assessed 1 Month Post-treatment (PT)|Overall Study||369
6479885|NCT01302834|7397225|FG001|AE Assessed 1 Month Post-treatment (PT)|Overall Study||363
6479886|NCT01302834|7397224|FG000|AE Assessed 3 Months PT|Overall Study||359
6479887|NCT01302834|7397225|FG001|AE Assessed 3 Months PT|Overall Study||367
6479888|NCT01302834|7397224|FG000|AE Assessed 6 Months PT|Overall Study||361
6479889|NCT01302834|7397225|FG001|AE Assessed 6 Months PT|Overall Study||352
6479890|NCT01302834|7397224|FG000|AE Assessment 1 Year PT|Overall Study||360
6479891|NCT01302834|7397225|FG001|AE Assessment 1 Year PT|Overall Study||351
6479892|NCT01302834|7397224|FG000|AE Assessed 2 Years PT|Overall Study||311
6479893|NCT01302834|7397225|FG001|AE Assessed 2 Years PT|Overall Study||303
6479894|NCT01302834|7397224|FG000|AE Assessed 5 Years PT|Overall Study||92
6479895|NCT01302834|7397225|FG001|AE Assessed 5 Years PT|Overall Study||86
6479896|NCT01302834|7397224|FG000|Dental Health Assessed 1 Year PT|Overall Study||267
6479897|NCT01302834|7397225|FG001|Dental Health Assessed 1 Year PT|Overall Study||267
6479898|NCT01302834|7397224|FG000|Dental Health Assessed 2 Years PT|Overall Study||208
6479899|NCT01302834|7397225|FG001|Dental Health Assessed 2 Years PT|Overall Study||201
6479900|NCT01302834|7397224|FG000|Dental Health Assessed 5 Years PT|Overall Study||44
6479901|NCT01302834|7397225|FG001|Dental Health Assessed 5 Years PT|Overall Study||43
6479902|NCT01302834|7397224|FG000|Feeding Tube Assessed|Overall Study||368
6479903|NCT01302834|7397225|FG001|Feeding Tube Assessed|Overall Study||356
6479904|NCT01302834|7397224|FG000|Progressed|Overall Study||76
6654678|NCT02447432|7584568|FG001|NOT COMPLETED|Epoch 001||13
6654679|NCT02447432|7584567|FG000|STARTED|Epoch 002||152
6654680|NCT02447432|7584568|FG001|STARTED|Epoch 002||145
6654681|NCT02447432|7584567|FG000|COMPLETED|Epoch 002||152
6654682|NCT02447432|7584568|FG001|COMPLETED|Epoch 002||145
6654683|NCT02447432|7584567|FG000|NOT COMPLETED|Epoch 002||0
6654684|NCT02447432|7584568|FG001|NOT COMPLETED|Epoch 002||0
6654685|NCT02447458|7584580|FG000|STARTED|Overall Study||5
6654686|NCT02447458|7584581|FG001|STARTED|Overall Study||6
6654687|NCT02447458|7584582|FG002|STARTED|Overall Study||6
6654688|NCT02447458|7584583|FG003|STARTED|Overall Study||6
6654689|NCT02447458|7584584|FG004|STARTED|Overall Study||6
6479905|NCT01302834|7397225|FG001|Progressed|Overall Study||122
6479906|NCT01302834|7397224|FG000|COMPLETED|Overall Study||406
6479907|NCT01302834|7397225|FG001|COMPLETED|Overall Study||399
6479908|NCT01302834|7397224|FG000|NOT COMPLETED|Overall Study||18
6479909|NCT01302834|7397225|FG001|NOT COMPLETED|Overall Study||26
6479910|NCT01302860|7397231|FG000|STARTED|Overall Study||17
6479911|NCT01302860|7397231|FG000|COMPLETED|Overall Study||17
6479912|NCT01302860|7397231|FG000|NOT COMPLETED|Overall Study||0
6479913|NCT01302899|7397237|FG000|STARTED|Period 1 (Day 1 to End of Week 6)||4
6479914|NCT01302899|7397238|FG001|STARTED|Period 1 (Day 1 to End of Week 6)||4
6479915|NCT01302899|7397237|FG000|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
6479916|NCT01302899|7397238|FG001|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
6479917|NCT01302899|7397237|FG000|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
6479918|NCT01302899|7397238|FG001|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
6479919|NCT01302899|7397237|FG000|STARTED|Period 2 (Weeks 7 to 12)||4
6479920|NCT01302899|7397238|FG001|STARTED|Period 2 (Weeks 7 to 12)||4
6479921|NCT01302899|7397237|FG000|COMPLETED|Period 2 (Weeks 7 to 12)||3
6479922|NCT01302899|7397238|FG001|COMPLETED|Period 2 (Weeks 7 to 12)||3
6479923|NCT01302899|7397237|FG000|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
6479924|NCT01302899|7397238|FG001|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
6479925|NCT01302899|7397237|FG000|STARTED|Period 3 (Weeks 13 to 18)||3
6479926|NCT01302899|7397238|FG001|STARTED|Period 3 (Weeks 13 to 18)||3
6479927|NCT01302899|7397237|FG000|COMPLETED|Period 3 (Weeks 13 to 18)||3
6479928|NCT01302899|7397238|FG001|COMPLETED|Period 3 (Weeks 13 to 18)||3
6479929|NCT01302899|7397237|FG000|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
6479930|NCT01302899|7397238|FG001|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
6479931|NCT01302899|7397237|FG000|STARTED|Period 4 (Weeks 19 to 26)||3
6479932|NCT01302899|7397238|FG001|STARTED|Period 4 (Weeks 19 to 26)||3
6479933|NCT01302899|7397237|FG000|COMPLETED|Period 4 (Weeks 19 to 26)||3
6479934|NCT01302899|7397238|FG001|COMPLETED|Period 4 (Weeks 19 to 26)||3
6479935|NCT01302899|7397237|FG000|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
6479936|NCT01302899|7397238|FG001|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
6479937|NCT01302938|7397250|FG000|STARTED|Overall Study||12
6479938|NCT01302938|7397251|FG001|STARTED|Overall Study||6
6479939|NCT01302938|7397250|FG000|COMPLETED|Overall Study||10
6479940|NCT01302938|7397251|FG001|COMPLETED|Overall Study||6
6479941|NCT01302938|7397250|FG000|NOT COMPLETED|Overall Study||2
6479942|NCT01302938|7397251|FG001|NOT COMPLETED|Overall Study||0
6479943|NCT01302964|7397260|FG000|STARTED|Overall Study||20
6479944|NCT01302964|7397261|FG001|STARTED|Overall Study||10
6479945|NCT01302964|7397260|FG000|COMPLETED|Overall Study||19
6479946|NCT01302964|7397261|FG001|COMPLETED|Overall Study||10
6479947|NCT01302964|7397260|FG000|NOT COMPLETED|Overall Study||1
6479948|NCT01302964|7397261|FG001|NOT COMPLETED|Overall Study||0
6479949|NCT01303068|7397269|FG000|STARTED|Overall Study||6
6479950|NCT01303068|7397270|FG001|STARTED|Overall Study||6
6479951|NCT01303068|7397269|FG000|COMPLETED|Overall Study||6
6479952|NCT01303068|7397270|FG001|COMPLETED|Overall Study||6
6479953|NCT01303068|7397269|FG000|NOT COMPLETED|Overall Study||0
6479954|NCT01303068|7397270|FG001|NOT COMPLETED|Overall Study||0
6479955|NCT01303159|7397276|FG000|STARTED|Overall Study||29
6479956|NCT01303159|7397276|FG000|COMPLETED|Overall Study||6
6479957|NCT01303159|7397276|FG000|NOT COMPLETED|Overall Study||23
6479958|NCT01303172|7397282|FG000|STARTED|Overall Study||75
6479959|NCT01303172|7397283|FG001|STARTED|Overall Study||35
6479960|NCT01303172|7397282|FG000|COMPLETED|Overall Study||12
6479961|NCT01303172|7397283|FG001|COMPLETED|Overall Study||1
6479962|NCT01303172|7397282|FG000|NOT COMPLETED|Overall Study||63
6479963|NCT01303172|7397283|FG001|NOT COMPLETED|Overall Study||34
6479964|NCT01303224|7397294|FG000|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
6479965|NCT01303224|7397295|FG001|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
6479966|NCT01303224|7397296|FG002|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
6479967|NCT01303224|7397297|FG003|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
6479968|NCT01303224|7397294|FG000|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
6479969|NCT01303224|7397295|FG001|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
6479970|NCT01303224|7397296|FG002|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
6479971|NCT01303224|7397297|FG003|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
6479972|NCT01303224|7397294|FG000|COMPLETED|Overall Study||130
6479973|NCT01303224|7397295|FG001|COMPLETED|Overall Study||131
6479974|NCT01303224|7397296|FG002|COMPLETED|Overall Study||133
6479975|NCT01303224|7397297|FG003|COMPLETED|Overall Study||133
6479976|NCT01303224|7397294|FG000|NOT COMPLETED|Overall Study||11
6479977|NCT01303224|7397295|FG001|NOT COMPLETED|Overall Study||11
6479978|NCT01303224|7397296|FG002|NOT COMPLETED|Overall Study||6
6479979|NCT01303224|7397297|FG003|NOT COMPLETED|Overall Study||10
6479980|NCT01303380|7397307|FG000|STARTED|Overall Study||9
6479981|NCT01303380|7397307|FG000|COMPLETED|Overall Study||8
6479982|NCT01303380|7397307|FG000|NOT COMPLETED|Overall Study||1
6479983|NCT01303406|7397313|FG000|STARTED|Overall Study||13
6479984|NCT01303406|7397314|FG001|STARTED|Overall Study||16
6479985|NCT01303406|7397313|FG000|COMPLETED|Overall Study||13
6479986|NCT01303406|7397314|FG001|COMPLETED|Overall Study||15
6479987|NCT01303406|7397313|FG000|NOT COMPLETED|Overall Study||0
6479988|NCT01303406|7397314|FG001|NOT COMPLETED|Overall Study||1
6479989|NCT01303419|7397320|FG000|STARTED|Overall Study|Subjects who met all Inclusion and none of the Exclusion criteria|224
6479990|NCT01303419|7397320|FG000|COMPLETED|Overall Study||128
6479991|NCT01303419|7397320|FG000|NOT COMPLETED|Overall Study||96
6479992|NCT01303445|7397324|FG000|STARTED|First Intervention (7 Days)||30
6479993|NCT01303445|7397325|FG001|STARTED|First Intervention (7 Days)||30
6479994|NCT01303445|7397324|FG000|COMPLETED|First Intervention (7 Days)||29
6479995|NCT01303445|7397325|FG001|COMPLETED|First Intervention (7 Days)||30
6479996|NCT01303445|7397324|FG000|NOT COMPLETED|First Intervention (7 Days)||1
6479997|NCT01303445|7397325|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6479998|NCT01303445|7397324|FG000|STARTED|Second Intervention (7 Days)||29
6479999|NCT01303445|7397325|FG001|STARTED|Second Intervention (7 Days)||30
6480000|NCT01303445|7397324|FG000|COMPLETED|Second Intervention (7 Days)||28
6480001|NCT01303445|7397325|FG001|COMPLETED|Second Intervention (7 Days)||28
6480002|NCT01303445|7397324|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
6480003|NCT01303445|7397325|FG001|NOT COMPLETED|Second Intervention (7 Days)||2
6480004|NCT01303445|7397324|FG000|STARTED|Washout (14 Days)||28
6480005|NCT01303445|7397325|FG001|STARTED|Washout (14 Days)||28
6480006|NCT01303445|7397324|FG000|COMPLETED|Washout (14 Days)||27
6480007|NCT01303445|7397325|FG001|COMPLETED|Washout (14 Days)||26
6480008|NCT01303445|7397324|FG000|NOT COMPLETED|Washout (14 Days)||1
6480009|NCT01303445|7397325|FG001|NOT COMPLETED|Washout (14 Days)||2
6480010|NCT01303445|7397324|FG000|STARTED|Third Intervention (7 Days)||27
6480011|NCT01303445|7397325|FG001|STARTED|Third Intervention (7 Days)||26
6480012|NCT01303445|7397324|FG000|COMPLETED|Third Intervention (7 Days)||27
6480013|NCT01303445|7397325|FG001|COMPLETED|Third Intervention (7 Days)||26
6480014|NCT01303445|7397324|FG000|NOT COMPLETED|Third Intervention (7 Days)||0
6480015|NCT01303445|7397325|FG001|NOT COMPLETED|Third Intervention (7 Days)||0
6480016|NCT01303445|7397324|FG000|STARTED|Fourth Intervention (7 Days)||27
6480017|NCT01303445|7397325|FG001|STARTED|Fourth Intervention (7 Days)||26
6480018|NCT01303445|7397324|FG000|COMPLETED|Fourth Intervention (7 Days)||26
6480019|NCT01303445|7397325|FG001|COMPLETED|Fourth Intervention (7 Days)||26
6480020|NCT01303445|7397324|FG000|NOT COMPLETED|Fourth Intervention (7 Days)||1
6480021|NCT01303445|7397325|FG001|NOT COMPLETED|Fourth Intervention (7 Days)||0
6480022|NCT01303445|7397324|FG000|STARTED|Follow-up Period (14 Days)||26
6480023|NCT01303445|7397325|FG001|STARTED|Follow-up Period (14 Days)||26
6480024|NCT01303445|7397324|FG000|COMPLETED|Follow-up Period (14 Days)||26
6480025|NCT01303445|7397325|FG001|COMPLETED|Follow-up Period (14 Days)||25
6480026|NCT01303445|7397324|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
6480027|NCT01303445|7397325|FG001|NOT COMPLETED|Follow-up Period (14 Days)||1
6480028|NCT01303510|7397337|FG000|STARTED|Overall Study||55
6480029|NCT01303510|7397338|FG001|STARTED|Overall Study||56
6480030|NCT01303510|7397337|FG000|COMPLETED|Overall Study||54
6480031|NCT01303510|7397338|FG001|COMPLETED|Overall Study||56
6480032|NCT01303510|7397337|FG000|NOT COMPLETED|Overall Study||1
6480033|NCT01303510|7397338|FG001|NOT COMPLETED|Overall Study||0
6480034|NCT01303627|7397346|FG000|STARTED|Overall Study||21
6480035|NCT01303627|7397347|FG001|STARTED|Overall Study||21
6480036|NCT01303627|7397346|FG000|COMPLETED|Overall Study||21
6480037|NCT01303627|7397347|FG001|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
6480038|NCT01303627|7397346|FG000|NOT COMPLETED|Overall Study||0
6480039|NCT01303627|7397347|FG001|NOT COMPLETED|Overall Study||1
6480040|NCT01303744|7397357|FG000|STARTED|Overall Study||24
6480041|NCT01303744|7397358|FG001|STARTED|Overall Study||24
6480042|NCT01303744|7397359|FG002|STARTED|Overall Study||24
6480043|NCT01303744|7397360|FG003|STARTED|Overall Study||24
6480044|NCT01303744|7397357|FG000|COMPLETED|Overall Study||24
6480045|NCT01303744|7397358|FG001|COMPLETED|Overall Study||24
6480046|NCT01303744|7397359|FG002|COMPLETED|Overall Study||24
6480047|NCT01303744|7397360|FG003|COMPLETED|Overall Study||24
6480048|NCT01303744|7397357|FG000|NOT COMPLETED|Overall Study||0
6480049|NCT01303744|7397358|FG001|NOT COMPLETED|Overall Study||0
6480050|NCT01303744|7397359|FG002|NOT COMPLETED|Overall Study||0
6480051|NCT01303744|7397360|FG003|NOT COMPLETED|Overall Study||0
6480052|NCT01303835|7397372|FG000|STARTED|Overall Study||54
6480053|NCT01303835|7397373|FG001|STARTED|Overall Study||56
6480054|NCT01303835|7397372|FG000|COMPLETED|Overall Study||35
6480055|NCT01303835|7397373|FG001|COMPLETED|Overall Study||31
6480056|NCT01303835|7397372|FG000|NOT COMPLETED|Overall Study||19
6480057|NCT01303835|7397373|FG001|NOT COMPLETED|Overall Study||25
6480058|NCT01303861|7397384|FG000|STARTED|Overall Study||109
6480059|NCT01303861|7397385|FG001|STARTED|Overall Study||50
6554704|NCT01748552|7476862|FG010|COMPLETED|Intervention Period 2 and Washout||3
6554705|NCT01748552|7476863|FG011|COMPLETED|Intervention Period 2 and Washout||3
6554706|NCT01748552|7476852|FG000|NOT COMPLETED|Intervention Period 2 and Washout||0
6554707|NCT01748552|7476853|FG001|NOT COMPLETED|Intervention Period 2 and Washout||0
6554708|NCT01748552|7476854|FG002|NOT COMPLETED|Intervention Period 2 and Washout||1
6554709|NCT01748552|7476855|FG003|NOT COMPLETED|Intervention Period 2 and Washout||0
6554710|NCT01748552|7476856|FG004|NOT COMPLETED|Intervention Period 2 and Washout||0
6480060|NCT01303861|7397386|FG002|STARTED|Overall Study||55
6480061|NCT01303861|7397387|FG003|STARTED|Overall Study||113
6480062|NCT01303861|7397384|FG000|Finished Treatment Phase|Overall Study||71
6480063|NCT01303861|7397385|FG001|Finished Treatment Phase|Overall Study||34
6480064|NCT01303861|7397386|FG002|Finished Treatment Phase|Overall Study||39
6480065|NCT01303861|7397387|FG003|Finished Treatment Phase|Overall Study||72
6480066|NCT01303861|7397384|FG000|COMPLETED|Overall Study||51
6480067|NCT01303861|7397385|FG001|COMPLETED|Overall Study||25
6480068|NCT01303861|7397386|FG002|COMPLETED|Overall Study||19
6480069|NCT01303861|7397387|FG003|COMPLETED|Overall Study||54
6480070|NCT01303861|7397384|FG000|NOT COMPLETED|Overall Study||58
6480071|NCT01303861|7397385|FG001|NOT COMPLETED|Overall Study||25
6480072|NCT01303861|7397386|FG002|NOT COMPLETED|Overall Study||36
6480073|NCT01303861|7397387|FG003|NOT COMPLETED|Overall Study||59
6480074|NCT01303939|7397400|FG000|STARTED|Overall Study||22
6480075|NCT01303939|7397401|FG001|STARTED|Overall Study||15
6554711|NCT01748552|7476857|FG005|NOT COMPLETED|Intervention Period 2 and Washout||0
6554712|NCT01748552|7476858|FG006|NOT COMPLETED|Intervention Period 2 and Washout||3
6554713|NCT01748552|7476859|FG007|NOT COMPLETED|Intervention Period 2 and Washout||3
6554714|NCT01748552|7476860|FG008|NOT COMPLETED|Intervention Period 2 and Washout||3
6554715|NCT01748552|7476861|FG009|NOT COMPLETED|Intervention Period 2 and Washout||0
6554716|NCT01748552|7476862|FG010|NOT COMPLETED|Intervention Period 2 and Washout||0
6554717|NCT01748552|7476863|FG011|NOT COMPLETED|Intervention Period 2 and Washout||0
6554718|NCT01748552|7476852|FG000|STARTED|Intervention Period 3 and Washout||3
6554719|NCT01748552|7476853|FG001|STARTED|Intervention Period 3 and Washout||3
6554720|NCT01748552|7476854|FG002|STARTED|Intervention Period 3 and Washout||2
6554721|NCT01748552|7476855|FG003|STARTED|Intervention Period 3 and Washout||3
6554722|NCT01748552|7476856|FG004|STARTED|Intervention Period 3 and Washout||3
6554723|NCT01748552|7476857|FG005|STARTED|Intervention Period 3 and Washout||3
6554724|NCT01748552|7476858|FG006|STARTED|Intervention Period 3 and Washout||0
6554725|NCT01748552|7476859|FG007|STARTED|Intervention Period 3 and Washout||0
6554726|NCT01748552|7476860|FG008|STARTED|Intervention Period 3 and Washout||0
6554727|NCT01748552|7476861|FG009|STARTED|Intervention Period 3 and Washout||3
6554728|NCT01748552|7476862|FG010|STARTED|Intervention Period 3 and Washout||3
6480076|NCT01303939|7397400|FG000|COMPLETED|Overall Study|Matched controls not found for comparisons. Only best matched glaucoma patients were included.|15
6480077|NCT01303939|7397401|FG001|COMPLETED|Overall Study||15
6480078|NCT01303939|7397400|FG000|NOT COMPLETED|Overall Study||7
6480079|NCT01303939|7397401|FG001|NOT COMPLETED|Overall Study||0
6480080|NCT01303965|7397411|FG000|STARTED|Overall Study||3
6480081|NCT01303965|7397412|FG001|STARTED|Overall Study||11
6480082|NCT01303965|7397411|FG000|COMPLETED|Overall Study||0
6480083|NCT01303965|7397412|FG001|COMPLETED|Overall Study||1
6480084|NCT01303965|7397411|FG000|NOT COMPLETED|Overall Study||3
6480085|NCT01303965|7397412|FG001|NOT COMPLETED|Overall Study||10
6480086|NCT01304082|7397418|FG000|STARTED|Overall Study||3
6480087|NCT01304082|7397419|FG001|STARTED|Overall Study||2
6480088|NCT01304082|7397420|FG002|STARTED|Overall Study||11
6480089|NCT01304082|7397421|FG003|STARTED|Overall Study||8
6480090|NCT01304082|7397422|FG004|STARTED|Overall Study||5
6480091|NCT01304082|7397418|FG000|First Intervention|Overall Study||3
6480092|NCT01304082|7397419|FG001|First Intervention|Overall Study||2
6480093|NCT01304082|7397420|FG002|First Intervention|Overall Study||11
6480094|NCT01304082|7397421|FG003|First Intervention|Overall Study||8
6480095|NCT01304082|7397422|FG004|First Intervention|Overall Study||5
6480096|NCT01304082|7397418|FG000|Second Intervention|Overall Study||3
6480097|NCT01304082|7397419|FG001|Second Intervention|Overall Study||2
6480098|NCT01304082|7397420|FG002|Second Intervention|Overall Study||11
6480099|NCT01304082|7397421|FG003|Second Intervention|Overall Study||8
6480100|NCT01304082|7397422|FG004|Second Intervention|Overall Study||5
6480101|NCT01304082|7397418|FG000|Third Intervention|Overall Study||3
6480102|NCT01304082|7397419|FG001|Third Intervention|Overall Study||2
6480103|NCT01304082|7397420|FG002|Third Intervention|Overall Study||11
6480104|NCT01304082|7397421|FG003|Third Intervention|Overall Study||8
6480105|NCT01304082|7397422|FG004|Third Intervention|Overall Study||5
6480106|NCT01304082|7397418|FG000|COMPLETED|Overall Study||3
6480107|NCT01304082|7397419|FG001|COMPLETED|Overall Study||2
6480108|NCT01304082|7397420|FG002|COMPLETED|Overall Study||11
6480109|NCT01304082|7397421|FG003|COMPLETED|Overall Study||8
6480110|NCT01304082|7397422|FG004|COMPLETED|Overall Study||5
6480111|NCT01304082|7397418|FG000|NOT COMPLETED|Overall Study||0
6480112|NCT01304082|7397419|FG001|NOT COMPLETED|Overall Study||0
6480113|NCT01304082|7397420|FG002|NOT COMPLETED|Overall Study||0
6480114|NCT01304082|7397421|FG003|NOT COMPLETED|Overall Study||0
6480115|NCT01304082|7397422|FG004|NOT COMPLETED|Overall Study||0
6480116|NCT01304147|7397430|FG000|STARTED|First Intervention (7days)||10
6480117|NCT01304147|7397431|FG001|STARTED|First Intervention (7days)||10
6480118|NCT01304147|7397430|FG000|COMPLETED|First Intervention (7days)||10
6480119|NCT01304147|7397431|FG001|COMPLETED|First Intervention (7days)||10
6480120|NCT01304147|7397430|FG000|NOT COMPLETED|First Intervention (7days)||0
6480121|NCT01304147|7397431|FG001|NOT COMPLETED|First Intervention (7days)||0
6480122|NCT01304147|7397430|FG000|STARTED|Washout (1 Day)||10
6480123|NCT01304147|7397431|FG001|STARTED|Washout (1 Day)||10
6480124|NCT01304147|7397430|FG000|COMPLETED|Washout (1 Day)||10
6480125|NCT01304147|7397431|FG001|COMPLETED|Washout (1 Day)||10
6480126|NCT01304147|7397430|FG000|NOT COMPLETED|Washout (1 Day)||0
6480127|NCT01304147|7397431|FG001|NOT COMPLETED|Washout (1 Day)||0
6480128|NCT01304147|7397430|FG000|STARTED|Second Intervention (7days)||10
6480129|NCT01304147|7397431|FG001|STARTED|Second Intervention (7days)||10
6480130|NCT01304147|7397430|FG000|COMPLETED|Second Intervention (7days)||9
6480131|NCT01304147|7397431|FG001|COMPLETED|Second Intervention (7days)||9
6480132|NCT01304147|7397430|FG000|NOT COMPLETED|Second Intervention (7days)||1
6480133|NCT01304147|7397431|FG001|NOT COMPLETED|Second Intervention (7days)||1
6480134|NCT01304238|7397447|FG000|STARTED|Overall Study||32
6480135|NCT01304238|7397448|FG001|STARTED|Overall Study||4
6480136|NCT01304238|7397449|FG002|STARTED|Overall Study||46
6480137|NCT01304238|7397450|FG003|STARTED|Overall Study||78
6480138|NCT01304238|7397451|FG004|STARTED|Overall Study||11
6480139|NCT01304238|7397452|FG005|STARTED|Overall Study||11
6480140|NCT01304238|7397453|FG006|STARTED|Overall Study||5
6480141|NCT01304238|7397454|FG007|STARTED|Overall Study||4
6480142|NCT01304238|7397455|FG008|STARTED|Overall Study||1
6480143|NCT01304238|7397456|FG009|STARTED|Overall Study||3
6480144|NCT01304238|7397447|FG000|COMPLETED|Overall Study||32
6480145|NCT01304238|7397448|FG001|COMPLETED|Overall Study||4
6480146|NCT01304238|7397449|FG002|COMPLETED|Overall Study||46
6480147|NCT01304238|7397450|FG003|COMPLETED|Overall Study||78
6480148|NCT01304238|7397451|FG004|COMPLETED|Overall Study||11
6480149|NCT01304238|7397452|FG005|COMPLETED|Overall Study||11
6480150|NCT01304238|7397453|FG006|COMPLETED|Overall Study||5
6480151|NCT01304238|7397454|FG007|COMPLETED|Overall Study||4
6480152|NCT01304238|7397455|FG008|COMPLETED|Overall Study||1
6480153|NCT01304238|7397456|FG009|COMPLETED|Overall Study||3
6480154|NCT01304238|7397447|FG000|NOT COMPLETED|Overall Study||0
6480155|NCT01304238|7397448|FG001|NOT COMPLETED|Overall Study||0
6480156|NCT01304238|7397449|FG002|NOT COMPLETED|Overall Study||0
6480157|NCT01304238|7397450|FG003|NOT COMPLETED|Overall Study||0
6480158|NCT01304238|7397451|FG004|NOT COMPLETED|Overall Study||0
6480159|NCT01304238|7397452|FG005|NOT COMPLETED|Overall Study||0
6480160|NCT01304238|7397453|FG006|NOT COMPLETED|Overall Study||0
6480161|NCT01304238|7397454|FG007|NOT COMPLETED|Overall Study||0
6480162|NCT01304238|7397455|FG008|NOT COMPLETED|Overall Study||0
6480163|NCT01304238|7397456|FG009|NOT COMPLETED|Overall Study||0
6480164|NCT01304277|7397478|FG000|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
6480165|NCT01304277|7397478|FG000|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
6480166|NCT01304277|7397478|FG000|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
6480167|NCT01304277|7397478|FG000|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
6480168|NCT01304277|7397478|FG000|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
6480169|NCT01304277|7397478|FG000|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
6480170|NCT01304329|7397485|FG000|STARTED|First Intervention (3 Days)||3
6480171|NCT01304329|7397486|FG001|STARTED|First Intervention (3 Days)||3
6480172|NCT01304329|7397487|FG002|STARTED|First Intervention (3 Days)||3
6480173|NCT01304329|7397488|FG003|STARTED|First Intervention (3 Days)||3
6480174|NCT01304329|7397489|FG004|STARTED|First Intervention (3 Days)||3
6480175|NCT01304329|7397490|FG005|STARTED|First Intervention (3 Days)||3
6480176|NCT01304329|7397485|FG000|COMPLETED|First Intervention (3 Days)||3
6480177|NCT01304329|7397486|FG001|COMPLETED|First Intervention (3 Days)||3
6480178|NCT01304329|7397487|FG002|COMPLETED|First Intervention (3 Days)||3
6480179|NCT01304329|7397488|FG003|COMPLETED|First Intervention (3 Days)||3
6480180|NCT01304329|7397489|FG004|COMPLETED|First Intervention (3 Days)||3
6480181|NCT01304329|7397490|FG005|COMPLETED|First Intervention (3 Days)||3
6480182|NCT01304329|7397485|FG000|NOT COMPLETED|First Intervention (3 Days)||0
6480183|NCT01304329|7397486|FG001|NOT COMPLETED|First Intervention (3 Days)||0
6480184|NCT01304329|7397487|FG002|NOT COMPLETED|First Intervention (3 Days)||0
6480185|NCT01304329|7397488|FG003|NOT COMPLETED|First Intervention (3 Days)||0
6480186|NCT01304329|7397489|FG004|NOT COMPLETED|First Intervention (3 Days)||0
6480187|NCT01304329|7397490|FG005|NOT COMPLETED|First Intervention (3 Days)||0
6480188|NCT01304329|7397485|FG000|STARTED|Second Intervention (3 Days)||3
6480189|NCT01304329|7397486|FG001|STARTED|Second Intervention (3 Days)||3
6480190|NCT01304329|7397487|FG002|STARTED|Second Intervention (3 Days)||3
6480191|NCT01304329|7397488|FG003|STARTED|Second Intervention (3 Days)||3
6480192|NCT01304329|7397489|FG004|STARTED|Second Intervention (3 Days)||3
6480193|NCT01304329|7397490|FG005|STARTED|Second Intervention (3 Days)||3
6480194|NCT01304329|7397485|FG000|COMPLETED|Second Intervention (3 Days)||3
6480195|NCT01304329|7397486|FG001|COMPLETED|Second Intervention (3 Days)||3
6480196|NCT01304329|7397487|FG002|COMPLETED|Second Intervention (3 Days)||3
6480197|NCT01304329|7397488|FG003|COMPLETED|Second Intervention (3 Days)||3
6480198|NCT01304329|7397489|FG004|COMPLETED|Second Intervention (3 Days)||3
6480199|NCT01304329|7397490|FG005|COMPLETED|Second Intervention (3 Days)||3
6480200|NCT01304329|7397485|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
6480201|NCT01304329|7397486|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
6480202|NCT01304329|7397487|FG002|NOT COMPLETED|Second Intervention (3 Days)||0
6480203|NCT01304329|7397488|FG003|NOT COMPLETED|Second Intervention (3 Days)||0
6480204|NCT01304329|7397489|FG004|NOT COMPLETED|Second Intervention (3 Days)||0
6480205|NCT01304329|7397490|FG005|NOT COMPLETED|Second Intervention (3 Days)||0
6480206|NCT01304329|7397485|FG000|STARTED|Third Intervention (3 Days)||3
6480207|NCT01304329|7397486|FG001|STARTED|Third Intervention (3 Days)||3
6480208|NCT01304329|7397487|FG002|STARTED|Third Intervention (3 Days)||3
6480209|NCT01304329|7397488|FG003|STARTED|Third Intervention (3 Days)||3
6480210|NCT01304329|7397489|FG004|STARTED|Third Intervention (3 Days)||3
6480211|NCT01304329|7397490|FG005|STARTED|Third Intervention (3 Days)||3
6480212|NCT01304329|7397485|FG000|COMPLETED|Third Intervention (3 Days)||3
6480213|NCT01304329|7397486|FG001|COMPLETED|Third Intervention (3 Days)||2
6480214|NCT01304329|7397487|FG002|COMPLETED|Third Intervention (3 Days)||3
6480215|NCT01304329|7397488|FG003|COMPLETED|Third Intervention (3 Days)||3
6480216|NCT01304329|7397489|FG004|COMPLETED|Third Intervention (3 Days)||3
6480217|NCT01304329|7397490|FG005|COMPLETED|Third Intervention (3 Days)||3
6480218|NCT01304329|7397485|FG000|NOT COMPLETED|Third Intervention (3 Days)||0
6480219|NCT01304329|7397486|FG001|NOT COMPLETED|Third Intervention (3 Days)||1
6480220|NCT01304329|7397487|FG002|NOT COMPLETED|Third Intervention (3 Days)||0
6480221|NCT01304329|7397488|FG003|NOT COMPLETED|Third Intervention (3 Days)||0
6480222|NCT01304329|7397489|FG004|NOT COMPLETED|Third Intervention (3 Days)||0
6480223|NCT01304329|7397490|FG005|NOT COMPLETED|Third Intervention (3 Days)||0
6480224|NCT01304407|7397498|FG000|STARTED|Overall Study||29
6480225|NCT01304407|7397498|FG000|COMPLETED|Overall Study||29
6480226|NCT01304407|7397498|FG000|NOT COMPLETED|Overall Study||0
6480227|NCT01304498|7397504|FG000|STARTED|Overall Study||300
6480228|NCT01304498|7397505|FG001|STARTED|Overall Study||300
6480229|NCT01304498|7397504|FG000|Received ≥1 Dose|Overall Study||300
6480230|NCT01304498|7397505|FG001|Received ≥1 Dose|Overall Study||300
6480231|NCT01304498|7397504|FG000|COMPLETED|Overall Study||294
6480232|NCT01304498|7397505|FG001|COMPLETED|Overall Study||295
6480233|NCT01304498|7397504|FG000|NOT COMPLETED|Overall Study||6
6480234|NCT01304498|7397505|FG001|NOT COMPLETED|Overall Study||5
6480235|NCT01304589|7397511|FG000|STARTED|Overall Study||31
6480236|NCT01304589|7397511|FG000|COMPLETED|Overall Study||18
6480237|NCT01304589|7397511|FG000|NOT COMPLETED|Overall Study||13
6480238|NCT01304641|7397518|FG000|STARTED|Overall Study||11470
6480239|NCT01304641|7397519|FG001|STARTED|Overall Study||20132
6480240|NCT01304641|7397518|FG000|COMPLETED|Overall Study||11470
6480241|NCT01304641|7397519|FG001|COMPLETED|Overall Study||20132
6480242|NCT01304641|7397518|FG000|NOT COMPLETED|Overall Study||0
6480243|NCT01304641|7397519|FG001|NOT COMPLETED|Overall Study||0
6480244|NCT01304693|7397530|FG000|STARTED|Overall Study||10
6480245|NCT01304693|7397531|FG001|STARTED|Overall Study||35
6480246|NCT01304693|7397532|FG002|STARTED|Overall Study||48
6480247|NCT01304693|7397533|FG003|STARTED|Overall Study||40
6480248|NCT01304693|7397534|FG004|STARTED|Overall Study||61
6480249|NCT01304693|7397530|FG000|COMPLETED|Overall Study||10
6480250|NCT01304693|7397531|FG001|COMPLETED|Overall Study||35
6480251|NCT01304693|7397532|FG002|COMPLETED|Overall Study||47
6480252|NCT01304693|7397533|FG003|COMPLETED|Overall Study||39
6480253|NCT01304693|7397534|FG004|COMPLETED|Overall Study||60
6480254|NCT01304693|7397530|FG000|NOT COMPLETED|Overall Study||0
6480255|NCT01304693|7397531|FG001|NOT COMPLETED|Overall Study||0
6480256|NCT01304693|7397532|FG002|NOT COMPLETED|Overall Study||1
6480257|NCT01304693|7397533|FG003|NOT COMPLETED|Overall Study||1
6480258|NCT01304693|7397534|FG004|NOT COMPLETED|Overall Study||1
6480259|NCT01304706|7397546|FG000|STARTED|Overall Study||121
6480260|NCT01304706|7397546|FG000|COMPLETED|Overall Study||104
6480261|NCT01304706|7397546|FG000|NOT COMPLETED|Overall Study||17
6480262|NCT01304940|7397552|FG000|STARTED|Overall Study||25
6480263|NCT01304940|7397553|FG001|STARTED|Overall Study||25
6480264|NCT01304940|7397552|FG000|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
6480265|NCT01304940|7397553|FG001|Completed Study|Overall Study|recruitment ended when 25 participants completed study procedures|25
6480266|NCT01304940|7397552|FG000|COMPLETED|Overall Study|these participants met severity requirement and were included in study analyses|22
6480267|NCT01304940|7397553|FG001|COMPLETED|Overall Study||25
6480268|NCT01304940|7397552|FG000|NOT COMPLETED|Overall Study||3
6480269|NCT01304940|7397553|FG001|NOT COMPLETED|Overall Study||0
6480270|NCT01304966|7397559|FG000|STARTED|Overall Study||15
6480271|NCT01304966|7397559|FG000|COMPLETED|Overall Study||15
6480272|NCT01304966|7397559|FG000|NOT COMPLETED|Overall Study||0
6480273|NCT01305044|7397567|FG000|STARTED|Overall Study||32
6480274|NCT01305044|7397568|FG001|STARTED|Overall Study||31
6480275|NCT01305044|7397567|FG000|COMPLETED|Overall Study||29
6480276|NCT01305044|7397568|FG001|COMPLETED|Overall Study||25
6480277|NCT01305044|7397567|FG000|NOT COMPLETED|Overall Study||3
6480278|NCT01305044|7397568|FG001|NOT COMPLETED|Overall Study||6
6480279|NCT01305200|7397577|FG000|STARTED|Overall Study||111
6480280|NCT01305200|7397578|FG001|STARTED|Overall Study||112
6480281|NCT01305200|7397579|FG002|STARTED|Overall Study||3
6480282|NCT01305200|7397577|FG000|COMPLETED|Overall Study||82
6480283|NCT01305200|7397578|FG001|COMPLETED|Overall Study||81
6480284|NCT01305200|7397579|FG002|COMPLETED|Overall Study||0
6480285|NCT01305200|7397577|FG000|NOT COMPLETED|Overall Study||29
6480286|NCT01305200|7397578|FG001|NOT COMPLETED|Overall Study||31
6480287|NCT01305200|7397579|FG002|NOT COMPLETED|Overall Study||3
6480288|NCT01305213|7397587|FG000|STARTED|Overall Study||53
6480289|NCT01305213|7397588|FG001|STARTED|Overall Study||54
6480290|NCT01305213|7397587|FG000|COMPLETED|Overall Study||53
6480291|NCT01305213|7397588|FG001|COMPLETED|Overall Study||54
6480292|NCT01305213|7397587|FG000|NOT COMPLETED|Overall Study||0
6554729|NCT01748552|7476863|FG011|STARTED|Intervention Period 3 and Washout||3
6554730|NCT01748552|7476852|FG000|COMPLETED|Intervention Period 3 and Washout||3
6554731|NCT01748552|7476853|FG001|COMPLETED|Intervention Period 3 and Washout||3
6480293|NCT01305213|7397588|FG001|NOT COMPLETED|Overall Study||0
6480294|NCT01305239|7397597|FG000|STARTED|Overall Study||398
6480295|NCT01305239|7397597|FG000|Safety Set|Overall Study||397
6480296|NCT01305239|7397597|FG000|Intent to Treat Population|Overall Study||287
6554732|NCT01748552|7476854|FG002|COMPLETED|Intervention Period 3 and Washout||2
6480297|NCT01305239|7397597|FG000|COMPLETED|Overall Study||375
6480298|NCT01305239|7397597|FG000|NOT COMPLETED|Overall Study||23
6480299|NCT01305252|7397603|FG000|STARTED|Overall Study||10
6480300|NCT01305252|7397604|FG001|STARTED|Overall Study||11
6480301|NCT01305252|7397603|FG000|COMPLETED|Overall Study||9
6480302|NCT01305252|7397604|FG001|COMPLETED|Overall Study||11
6480303|NCT01305252|7397603|FG000|NOT COMPLETED|Overall Study||1
6480304|NCT01305252|7397604|FG001|NOT COMPLETED|Overall Study||0
6480305|NCT01305265|7397616|FG000|STARTED|Overall Study||71
6480306|NCT01305265|7397617|FG001|STARTED|Overall Study||70
6480307|NCT01305265|7397616|FG000|COMPLETED|Overall Study||69
6480308|NCT01305265|7397617|FG001|COMPLETED|Overall Study||64
6480309|NCT01305265|7397616|FG000|NOT COMPLETED|Overall Study||2
6480310|NCT01305265|7397617|FG001|NOT COMPLETED|Overall Study||6
6480311|NCT01305356|7397625|FG000|STARTED|Overall Study||132
6480312|NCT01305356|7397626|FG001|STARTED|Overall Study||167
6480313|NCT01305356|7397625|FG000|COMPLETED|Overall Study||132
6480314|NCT01305356|7397626|FG001|COMPLETED|Overall Study||167
6480315|NCT01305356|7397625|FG000|NOT COMPLETED|Overall Study||0
6480316|NCT01305356|7397626|FG001|NOT COMPLETED|Overall Study||0
6480317|NCT01305408|7397634|FG000|STARTED|Overall Study||199
6480318|NCT01305408|7397635|FG001|STARTED|Overall Study||200
6480319|NCT01305408|7397634|FG000|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
6480320|NCT01305408|7397635|FG001|Safety Population|Overall Study|Treated participants.|200
6480321|NCT01305408|7397634|FG000|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
6480322|NCT01305408|7397635|FG001|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
6480323|NCT01305408|7397634|FG000|COMPLETED|Overall Study||167
6480324|NCT01305408|7397635|FG001|COMPLETED|Overall Study||169
6480325|NCT01305408|7397634|FG000|NOT COMPLETED|Overall Study||32
6480326|NCT01305408|7397635|FG001|NOT COMPLETED|Overall Study||31
6480327|NCT01305473|7397641|FG000|STARTED|Overall Study||90
6480328|NCT01305473|7397641|FG000|COMPLETED|Overall Study||90
6480329|NCT01305473|7397641|FG000|NOT COMPLETED|Overall Study||0
6480330|NCT01305564|7397645|FG000|STARTED|Overall Study||200
6480331|NCT01305564|7397645|FG000|COMPLETED|Overall Study||163
6480332|NCT01305564|7397645|FG000|NOT COMPLETED|Overall Study||37
6480333|NCT01305577|7397663|FG000|STARTED|Overall Study||120
6480334|NCT01305577|7397664|FG001|STARTED|Overall Study||121
6480335|NCT01305577|7397665|FG002|STARTED|Overall Study||122
6480336|NCT01305577|7397663|FG000|Received Treatment|Overall Study||119
6480337|NCT01305577|7397664|FG001|Received Treatment|Overall Study||121
6480338|NCT01305577|7397665|FG002|Received Treatment|Overall Study||122
6480339|NCT01305577|7397663|FG000|COMPLETED|Overall Study||107
6480340|NCT01305577|7397664|FG001|COMPLETED|Overall Study||110
6480341|NCT01305577|7397665|FG002|COMPLETED|Overall Study||112
6480342|NCT01305577|7397663|FG000|NOT COMPLETED|Overall Study||13
6480343|NCT01305577|7397664|FG001|NOT COMPLETED|Overall Study||11
6480344|NCT01305577|7397665|FG002|NOT COMPLETED|Overall Study||10
6480345|NCT01305655|7397673|FG000|STARTED|Overall Study|July 2008|47
6480346|NCT01305655|7397673|FG000|COMPLETED|Overall Study|December 31, 2014|47
6480347|NCT01305655|7397673|FG000|NOT COMPLETED|Overall Study||0
6480348|NCT01305772|7397679|FG000|STARTED|Overall Study||5
6480349|NCT01305772|7397680|FG001|STARTED|Overall Study||1
6480350|NCT01305772|7397679|FG000|Genomic Screening + Biopsy #1|Overall Study||5
6480351|NCT01305772|7397680|FG001|Genomic Screening + Biopsy #1|Overall Study||1
6480352|NCT01305772|7397679|FG000|Research PET/CT #1|Overall Study||5
6480353|NCT01305772|7397680|FG001|Research PET/CT #1|Overall Study||1
6480354|NCT01305772|7397679|FG000|Panitumumab Dose #1|Overall Study||5
6480355|NCT01305772|7397680|FG001|Panitumumab Dose #1|Overall Study||1
6480356|NCT01305772|7397679|FG000|Research PET/CT #2|Overall Study||5
6480357|NCT01305772|7397680|FG001|Research PET/CT #2|Overall Study||1
6480358|NCT01305772|7397679|FG000|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
6554733|NCT01748552|7476855|FG003|COMPLETED|Intervention Period 3 and Washout||3
6554734|NCT01748552|7476856|FG004|COMPLETED|Intervention Period 3 and Washout||3
6554735|NCT01748552|7476857|FG005|COMPLETED|Intervention Period 3 and Washout||3
6554736|NCT01748552|7476858|FG006|COMPLETED|Intervention Period 3 and Washout||0
6554737|NCT01748552|7476859|FG007|COMPLETED|Intervention Period 3 and Washout||0
6554738|NCT01748552|7476860|FG008|COMPLETED|Intervention Period 3 and Washout||0
6554739|NCT01748552|7476861|FG009|COMPLETED|Intervention Period 3 and Washout||3
6480359|NCT01305772|7397680|FG001|Surgery/Biopsy #2|Overall Study||1
6480360|NCT01305772|7397679|FG000|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
6480361|NCT01305772|7397680|FG001|RT + Panitumumab Dose #2 / #3|Overall Study||1
6480362|NCT01305772|7397679|FG000|COMPLETED|Overall Study||5
6480363|NCT01305772|7397680|FG001|COMPLETED|Overall Study||1
6480364|NCT01305772|7397679|FG000|NOT COMPLETED|Overall Study||0
6480365|NCT01305772|7397680|FG001|NOT COMPLETED|Overall Study||0
6480366|NCT01305811|7397687|FG000|STARTED|Overall Study||52
6480367|NCT01305811|7397688|FG001|STARTED|Overall Study||52
6480368|NCT01305811|7397687|FG000|COMPLETED|Overall Study||44
6480369|NCT01305811|7397688|FG001|COMPLETED|Overall Study||41
6480370|NCT01305811|7397687|FG000|NOT COMPLETED|Overall Study||8
6480371|NCT01305811|7397688|FG001|NOT COMPLETED|Overall Study||11
6480372|NCT01305941|7397696|FG000|STARTED|Overall Study||32
6480373|NCT01305941|7397696|FG000|COMPLETED|Overall Study||22
6480374|NCT01305941|7397696|FG000|NOT COMPLETED|Overall Study||10
6480375|NCT01306032|7397706|FG000|STARTED|First Intervention||22
6480376|NCT01306032|7397707|FG001|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
6480377|NCT01306032|7397708|FG002|STARTED|First Intervention||37
6480378|NCT01306032|7397709|FG003|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
6480379|NCT01306032|7397710|FG004|STARTED|First Intervention||2
6480380|NCT01306032|7397711|FG005|STARTED|First Intervention||2
6480381|NCT01306032|7397706|FG000|COMPLETED|First Intervention||21
6554740|NCT01748552|7476862|FG010|COMPLETED|Intervention Period 3 and Washout||3
6480382|NCT01306032|7397707|FG001|COMPLETED|First Intervention||18
6480383|NCT01306032|7397708|FG002|COMPLETED|First Intervention||35
6480384|NCT01306032|7397709|FG003|COMPLETED|First Intervention||37
6480385|NCT01306032|7397710|FG004|COMPLETED|First Intervention||0
6480386|NCT01306032|7397711|FG005|COMPLETED|First Intervention||0
6480387|NCT01306032|7397706|FG000|NOT COMPLETED|First Intervention||1
6480388|NCT01306032|7397707|FG001|NOT COMPLETED|First Intervention||2
6480389|NCT01306032|7397708|FG002|NOT COMPLETED|First Intervention||2
6480390|NCT01306032|7397709|FG003|NOT COMPLETED|First Intervention||1
6480391|NCT01306032|7397710|FG004|NOT COMPLETED|First Intervention||2
6480392|NCT01306032|7397711|FG005|NOT COMPLETED|First Intervention||2
6480393|NCT01306032|7397706|FG000|STARTED|Disease Progression/Crossover||0
6480394|NCT01306032|7397707|FG001|STARTED|Disease Progression/Crossover||16
6480395|NCT01306032|7397708|FG002|STARTED|Disease Progression/Crossover||0
6480396|NCT01306032|7397709|FG003|STARTED|Disease Progression/Crossover||29
6480397|NCT01306032|7397710|FG004|STARTED|Disease Progression/Crossover||0
6480398|NCT01306032|7397711|FG005|STARTED|Disease Progression/Crossover||0
6480399|NCT01306032|7397706|FG000|COMPLETED|Disease Progression/Crossover||0
6480400|NCT01306032|7397707|FG001|COMPLETED|Disease Progression/Crossover||14
6480401|NCT01306032|7397708|FG002|COMPLETED|Disease Progression/Crossover||0
6480402|NCT01306032|7397709|FG003|COMPLETED|Disease Progression/Crossover||26
6480403|NCT01306032|7397710|FG004|COMPLETED|Disease Progression/Crossover||0
6480404|NCT01306032|7397711|FG005|COMPLETED|Disease Progression/Crossover||0
6480405|NCT01306032|7397706|FG000|NOT COMPLETED|Disease Progression/Crossover||0
6480406|NCT01306032|7397707|FG001|NOT COMPLETED|Disease Progression/Crossover||2
6480407|NCT01306032|7397708|FG002|NOT COMPLETED|Disease Progression/Crossover||0
6480408|NCT01306032|7397709|FG003|NOT COMPLETED|Disease Progression/Crossover||3
6480409|NCT01306032|7397710|FG004|NOT COMPLETED|Disease Progression/Crossover||0
6480410|NCT01306032|7397711|FG005|NOT COMPLETED|Disease Progression/Crossover||0
6480411|NCT01306058|7397737|FG000|STARTED|Overall Study||27
6480412|NCT01306058|7397737|FG000|COMPLETED|Overall Study||25
6480413|NCT01306058|7397737|FG000|NOT COMPLETED|Overall Study||2
6480414|NCT01306162|7397745|FG000|STARTED|Period 1||9
6480415|NCT01306162|7397746|FG001|STARTED|Period 1||9
6480416|NCT01306162|7397747|FG002|STARTED|Period 1||9
6480417|NCT01306162|7397748|FG003|STARTED|Period 1||9
6480418|NCT01306162|7397745|FG000|COMPLETED|Period 1||9
6480419|NCT01306162|7397746|FG001|COMPLETED|Period 1||9
6480420|NCT01306162|7397747|FG002|COMPLETED|Period 1||9
6480421|NCT01306162|7397748|FG003|COMPLETED|Period 1||8
6480422|NCT01306162|7397745|FG000|NOT COMPLETED|Period 1||0
6480423|NCT01306162|7397746|FG001|NOT COMPLETED|Period 1||0
6480424|NCT01306162|7397747|FG002|NOT COMPLETED|Period 1||0
6480425|NCT01306162|7397748|FG003|NOT COMPLETED|Period 1||1
6480426|NCT01306162|7397745|FG000|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
6480427|NCT01306162|7397746|FG001|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
6480428|NCT01306162|7397747|FG002|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
6480429|NCT01306162|7397748|FG003|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
6480430|NCT01306162|7397745|FG000|COMPLETED|Washout 1||9
6480431|NCT01306162|7397746|FG001|COMPLETED|Washout 1||8
6480432|NCT01306162|7397747|FG002|COMPLETED|Washout 1||9
6480433|NCT01306162|7397748|FG003|COMPLETED|Washout 1||8
6480434|NCT01306162|7397745|FG000|NOT COMPLETED|Washout 1||0
6480435|NCT01306162|7397746|FG001|NOT COMPLETED|Washout 1||1
6480436|NCT01306162|7397747|FG002|NOT COMPLETED|Washout 1||0
6480437|NCT01306162|7397748|FG003|NOT COMPLETED|Washout 1||0
6480438|NCT01306162|7397745|FG000|STARTED|Period 2|No washout phase after Period 2.|9
6480439|NCT01306162|7397746|FG001|STARTED|Period 2|No washout phase after Period 2.|8
6480440|NCT01306162|7397747|FG002|STARTED|Period 2|No washout phase after Period 2.|9
6480441|NCT01306162|7397748|FG003|STARTED|Period 2|No washout phase after Period 2.|8
6480442|NCT01306162|7397745|FG000|COMPLETED|Period 2||9
6480443|NCT01306162|7397746|FG001|COMPLETED|Period 2||8
6480444|NCT01306162|7397747|FG002|COMPLETED|Period 2||9
6480445|NCT01306162|7397748|FG003|COMPLETED|Period 2||8
6480446|NCT01306162|7397745|FG000|NOT COMPLETED|Period 2||0
6480447|NCT01306162|7397746|FG001|NOT COMPLETED|Period 2||0
6480448|NCT01306162|7397747|FG002|NOT COMPLETED|Period 2||0
6480449|NCT01306162|7397748|FG003|NOT COMPLETED|Period 2||0
6480450|NCT01306162|7397745|FG000|STARTED|Period 3||9
6480451|NCT01306162|7397746|FG001|STARTED|Period 3||8
6480452|NCT01306162|7397747|FG002|STARTED|Period 3||9
6480453|NCT01306162|7397748|FG003|STARTED|Period 3||8
6480454|NCT01306162|7397745|FG000|COMPLETED|Period 3||9
6480455|NCT01306162|7397746|FG001|COMPLETED|Period 3||8
6480456|NCT01306162|7397747|FG002|COMPLETED|Period 3||9
6480457|NCT01306162|7397748|FG003|COMPLETED|Period 3||8
6480458|NCT01306162|7397745|FG000|NOT COMPLETED|Period 3||0
6480459|NCT01306162|7397746|FG001|NOT COMPLETED|Period 3||0
6480460|NCT01306162|7397747|FG002|NOT COMPLETED|Period 3||0
6480461|NCT01306162|7397748|FG003|NOT COMPLETED|Period 3||0
6480462|NCT01306162|7397745|FG000|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
6480463|NCT01306162|7397746|FG001|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
6480464|NCT01306162|7397747|FG002|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
6480465|NCT01306162|7397748|FG003|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
6480466|NCT01306162|7397745|FG000|COMPLETED|Washout 2||9
6480467|NCT01306162|7397746|FG001|COMPLETED|Washout 2||8
6480468|NCT01306162|7397747|FG002|COMPLETED|Washout 2||9
6480469|NCT01306162|7397748|FG003|COMPLETED|Washout 2||8
6480470|NCT01306162|7397745|FG000|NOT COMPLETED|Washout 2||0
6480471|NCT01306162|7397746|FG001|NOT COMPLETED|Washout 2||0
6480472|NCT01306162|7397747|FG002|NOT COMPLETED|Washout 2||0
6480473|NCT01306162|7397748|FG003|NOT COMPLETED|Washout 2||0
6480474|NCT01306162|7397745|FG000|STARTED|Period 4||9
6480475|NCT01306162|7397746|FG001|STARTED|Period 4||8
6480476|NCT01306162|7397747|FG002|STARTED|Period 4||9
6480477|NCT01306162|7397748|FG003|STARTED|Period 4||8
6480478|NCT01306162|7397745|FG000|COMPLETED|Period 4||9
6480479|NCT01306162|7397746|FG001|COMPLETED|Period 4||8
6480480|NCT01306162|7397747|FG002|COMPLETED|Period 4||9
6480481|NCT01306162|7397748|FG003|COMPLETED|Period 4||8
6480482|NCT01306162|7397745|FG000|NOT COMPLETED|Period 4||0
6480483|NCT01306162|7397746|FG001|NOT COMPLETED|Period 4||0
6480484|NCT01306162|7397747|FG002|NOT COMPLETED|Period 4||0
6480485|NCT01306162|7397748|FG003|NOT COMPLETED|Period 4||0
6480486|NCT01306175|7397761|FG000|STARTED|First Intervention||20
6480487|NCT01306175|7397761|FG000|COMPLETED|First Intervention||20
6480488|NCT01306175|7397761|FG000|NOT COMPLETED|First Intervention||0
6480489|NCT01306175|7397761|FG000|STARTED|Washout Period of at Least 14 Days||20
6480490|NCT01306175|7397761|FG000|COMPLETED|Washout Period of at Least 14 Days||20
6480491|NCT01306175|7397761|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
6480492|NCT01306175|7397761|FG000|STARTED|Second Intervention||20
6480493|NCT01306175|7397761|FG000|COMPLETED|Second Intervention||20
6480494|NCT01306175|7397761|FG000|NOT COMPLETED|Second Intervention||0
6480495|NCT01306201|7397767|FG000|STARTED|Overall Study||63
6480496|NCT01306201|7397767|FG000|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
6480497|NCT01306201|7397767|FG000|NOT COMPLETED|Overall Study||10
6480498|NCT01306214|7397778|FG000|STARTED|Overall Study||189
6480499|NCT01306214|7397779|FG001|STARTED|Overall Study||187
6480500|NCT01306214|7397780|FG002|STARTED|Overall Study||190
6480501|NCT01306214|7397778|FG000|COMPLETED|Overall Study||161
6480502|NCT01306214|7397779|FG001|COMPLETED|Overall Study||159
6480503|NCT01306214|7397780|FG002|COMPLETED|Overall Study||168
6480504|NCT01306214|7397778|FG000|NOT COMPLETED|Overall Study||28
6480505|NCT01306214|7397779|FG001|NOT COMPLETED|Overall Study||28
6480506|NCT01306214|7397780|FG002|NOT COMPLETED|Overall Study||22
6480507|NCT01306253|7397790|FG000|STARTED|Overall Study||57
6480508|NCT01306253|7397791|FG001|STARTED|Overall Study||57
6480509|NCT01306253|7397790|FG000|COMPLETED|Overall Study||56
6480510|NCT01306253|7397791|FG001|COMPLETED|Overall Study||56
6480511|NCT01306253|7397790|FG000|NOT COMPLETED|Overall Study||1
6480512|NCT01306253|7397791|FG001|NOT COMPLETED|Overall Study||1
6480513|NCT01306292|7397799|FG000|STARTED|First Injection||10
6480514|NCT01306292|7397800|FG001|STARTED|First Injection||8
6480515|NCT01306292|7397801|FG002|STARTED|First Injection||8
6480516|NCT01306292|7397802|FG003|STARTED|First Injection||10
6480517|NCT01306292|7397799|FG000|COMPLETED|First Injection||10
6480518|NCT01306292|7397800|FG001|COMPLETED|First Injection||8
6748355|NCT03407651|7676396|FG000|STARTED|Period 1: Part 1a||11
6748356|NCT03407651|7676396|FG000|COMPLETED|Period 1: Part 1a||10
6748357|NCT03407651|7676396|FG000|NOT COMPLETED|Period 1: Part 1a||1
6748358|NCT03407651|7676396|FG000|STARTED|Period 2: Part 1b||9
6748359|NCT03407651|7676396|FG000|COMPLETED|Period 2: Part 1b||9
6748360|NCT03407651|7676396|FG000|NOT COMPLETED|Period 2: Part 1b||0
6748361|NCT03407651|7676396|FG000|STARTED|Period 3: Part 2|The subject who discontinued after 44 daily SC doses in Part 2 elected to participate in Period 3.|11
6748362|NCT03407651|7676396|FG000|COMPLETED|Period 3: Part 2||8
6748363|NCT03407651|7676396|FG000|NOT COMPLETED|Period 3: Part 2||3
6748364|NCT03408171|7676418|FG000|STARTED|Overall Study||20
6748365|NCT03408171|7676419|FG001|STARTED|Overall Study||20
6748366|NCT03408171|7676418|FG000|COMPLETED|Overall Study||20
6748367|NCT03408171|7676419|FG001|COMPLETED|Overall Study||20
6748368|NCT03408171|7676418|FG000|NOT COMPLETED|Overall Study||0
6748369|NCT03408171|7676419|FG001|NOT COMPLETED|Overall Study||0
6748370|NCT03408392|7676425|FG000|STARTED|Treatment Period 1 (16 Days)||14
6748371|NCT03408392|7676426|FG001|STARTED|Treatment Period 1 (16 Days)||14
6748372|NCT03408392|7676425|FG000|COMPLETED|Treatment Period 1 (16 Days)||14
6748373|NCT03408392|7676426|FG001|COMPLETED|Treatment Period 1 (16 Days)||14
6748374|NCT03408392|7676425|FG000|NOT COMPLETED|Treatment Period 1 (16 Days)||0
6748375|NCT03408392|7676426|FG001|NOT COMPLETED|Treatment Period 1 (16 Days)||0
6748376|NCT03408392|7676425|FG000|STARTED|Wash-out Period (14 Days)||14
6748377|NCT03408392|7676426|FG001|STARTED|Wash-out Period (14 Days)||14
6748378|NCT03408392|7676425|FG000|COMPLETED|Wash-out Period (14 Days)||14
6748379|NCT03408392|7676426|FG001|COMPLETED|Wash-out Period (14 Days)||14
6748380|NCT03408392|7676425|FG000|NOT COMPLETED|Wash-out Period (14 Days)||0
6748381|NCT03408392|7676426|FG001|NOT COMPLETED|Wash-out Period (14 Days)||0
6748382|NCT03408392|7676425|FG000|STARTED|Treatment Period 2 (16 Days)||14
6748383|NCT03408392|7676426|FG001|STARTED|Treatment Period 2 (16 Days)||14
6748384|NCT03408392|7676425|FG000|COMPLETED|Treatment Period 2 (16 Days)||14
6748385|NCT03408392|7676426|FG001|COMPLETED|Treatment Period 2 (16 Days)||14
6748386|NCT03408392|7676425|FG000|NOT COMPLETED|Treatment Period 2 (16 Days)||0
6480519|NCT01306292|7397801|FG002|COMPLETED|First Injection||8
6480520|NCT01306292|7397802|FG003|COMPLETED|First Injection||10
6480521|NCT01306292|7397799|FG000|NOT COMPLETED|First Injection||0
6480522|NCT01306292|7397800|FG001|NOT COMPLETED|First Injection||0
6480523|NCT01306292|7397801|FG002|NOT COMPLETED|First Injection||0
6480524|NCT01306292|7397802|FG003|NOT COMPLETED|First Injection||0
6480525|NCT01306292|7397799|FG000|STARTED|Washout (at Least 10 Minutes)||10
6480526|NCT01306292|7397800|FG001|STARTED|Washout (at Least 10 Minutes)||8
6480527|NCT01306292|7397801|FG002|STARTED|Washout (at Least 10 Minutes)||8
6480528|NCT01306292|7397802|FG003|STARTED|Washout (at Least 10 Minutes)||10
6480529|NCT01306292|7397799|FG000|COMPLETED|Washout (at Least 10 Minutes)||10
6480530|NCT01306292|7397800|FG001|COMPLETED|Washout (at Least 10 Minutes)||8
6480531|NCT01306292|7397801|FG002|COMPLETED|Washout (at Least 10 Minutes)||8
6480532|NCT01306292|7397802|FG003|COMPLETED|Washout (at Least 10 Minutes)||10
6480533|NCT01306292|7397799|FG000|NOT COMPLETED|Washout (at Least 10 Minutes)||0
6480534|NCT01306292|7397800|FG001|NOT COMPLETED|Washout (at Least 10 Minutes)||0
6480535|NCT01306292|7397801|FG002|NOT COMPLETED|Washout (at Least 10 Minutes)||0
6480536|NCT01306292|7397802|FG003|NOT COMPLETED|Washout (at Least 10 Minutes)||0
6480537|NCT01306292|7397799|FG000|STARTED|Second Injection||10
6480538|NCT01306292|7397800|FG001|STARTED|Second Injection||8
6480539|NCT01306292|7397801|FG002|STARTED|Second Injection||8
6480540|NCT01306292|7397802|FG003|STARTED|Second Injection||10
6480541|NCT01306292|7397799|FG000|COMPLETED|Second Injection||10
6480542|NCT01306292|7397800|FG001|COMPLETED|Second Injection||8
6480543|NCT01306292|7397801|FG002|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
6480544|NCT01306292|7397802|FG003|COMPLETED|Second Injection||10
6480545|NCT01306292|7397799|FG000|NOT COMPLETED|Second Injection||0
6480546|NCT01306292|7397800|FG001|NOT COMPLETED|Second Injection||0
6480547|NCT01306292|7397801|FG002|NOT COMPLETED|Second Injection||1
6480548|NCT01306292|7397802|FG003|NOT COMPLETED|Second Injection||0
6480549|NCT01306305|7397812|FG000|STARTED|Overall Study||55
6480550|NCT01306305|7397813|FG001|STARTED|Overall Study||55
6480551|NCT01306305|7397812|FG000|COMPLETED|Overall Study||53
6480552|NCT01306305|7397813|FG001|COMPLETED|Overall Study||55
6748387|NCT03408392|7676426|FG001|NOT COMPLETED|Treatment Period 2 (16 Days)||0
6748388|NCT03408483|7676434|FG000|STARTED|Overall Study||42
6748389|NCT03408483|7676435|FG001|STARTED|Overall Study||38
6748390|NCT03408483|7676434|FG000|COMPLETED|Overall Study||36
6480553|NCT01306305|7397812|FG000|NOT COMPLETED|Overall Study||2
6480554|NCT01306305|7397813|FG001|NOT COMPLETED|Overall Study||0
6480555|NCT01306331|7397821|FG000|STARTED|Overall Study||1659
6480556|NCT01306331|7397822|FG001|STARTED|Overall Study||1665
6480557|NCT01306331|7397821|FG000|COMPLETED|Overall Study||758
6480558|NCT01306331|7397822|FG001|COMPLETED|Overall Study||788
6480559|NCT01306331|7397821|FG000|NOT COMPLETED|Overall Study||901
6480560|NCT01306331|7397822|FG001|NOT COMPLETED|Overall Study||877
6480561|NCT01306617|7397831|FG000|STARTED|Overall Study||19
6480562|NCT01306617|7397832|FG001|STARTED|Overall Study||14
6480563|NCT01306617|7397833|FG002|STARTED|Overall Study||17
6480564|NCT01306617|7397831|FG000|COMPLETED|Overall Study|The number of participants who completed study drug|18
6480565|NCT01306617|7397832|FG001|COMPLETED|Overall Study|The number of participants who completed study drug|13
6480566|NCT01306617|7397833|FG002|COMPLETED|Overall Study|The number of participants who completed study drug|12
6480567|NCT01306617|7397831|FG000|NOT COMPLETED|Overall Study||1
6480568|NCT01306617|7397832|FG001|NOT COMPLETED|Overall Study||1
6480569|NCT01306617|7397833|FG002|NOT COMPLETED|Overall Study||5
6480570|NCT01306643|7397841|FG000|STARTED|Overall Study||18
6480571|NCT01306643|7397841|FG000|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
6480572|NCT01306643|7397841|FG000|NOT COMPLETED|Overall Study||13
6480573|NCT01306656|7397847|FG000|STARTED|Overall Study||7
6480574|NCT01306656|7397848|FG001|STARTED|Overall Study||2
6480575|NCT01306656|7397847|FG000|COMPLETED|Overall Study||6
6480576|NCT01306656|7397848|FG001|COMPLETED|Overall Study||2
6480577|NCT01306656|7397847|FG000|NOT COMPLETED|Overall Study||1
6480578|NCT01306656|7397848|FG001|NOT COMPLETED|Overall Study||0
6480579|NCT01306877|7397858|FG000|STARTED|Overall Study||78
6480580|NCT01306877|7397859|FG001|STARTED|Overall Study||71
6480581|NCT01306877|7397858|FG000|COMPLETED|Overall Study||75
6480582|NCT01306877|7397859|FG001|COMPLETED|Overall Study||67
6480583|NCT01306877|7397858|FG000|NOT COMPLETED|Overall Study||3
6480584|NCT01306877|7397859|FG001|NOT COMPLETED|Overall Study||4
6480585|NCT01306890|7397865|FG000|STARTED|Overall Study||1976
6748391|NCT03408483|7676435|FG001|COMPLETED|Overall Study||35
6748392|NCT03408483|7676434|FG000|NOT COMPLETED|Overall Study||6
6748393|NCT03408483|7676435|FG001|NOT COMPLETED|Overall Study||3
6748394|NCT03408639|7676443|FG000|STARTED|Overall Study||78
6480586|NCT01306890|7397865|FG000|COMPLETED|Overall Study|Subjects were alive at the end of the study and had completed at least 3 years of follow up.|457
6480587|NCT01306890|7397865|FG000|NOT COMPLETED|Overall Study||1519
6480588|NCT01306942|7397872|FG000|STARTED|Phase I||6
6480589|NCT01306942|7397873|FG001|STARTED|Phase I||4
6480590|NCT01306942|7397874|FG002|STARTED|Phase I||0
6480591|NCT01306942|7397875|FG003|STARTED|Phase I||0
6480592|NCT01306942|7397872|FG000|COMPLETED|Phase I||1
6480593|NCT01306942|7397873|FG001|COMPLETED|Phase I||1
6480594|NCT01306942|7397874|FG002|COMPLETED|Phase I||0
6480595|NCT01306942|7397875|FG003|COMPLETED|Phase I||0
6480596|NCT01306942|7397872|FG000|NOT COMPLETED|Phase I||5
6480597|NCT01306942|7397873|FG001|NOT COMPLETED|Phase I||3
6480598|NCT01306942|7397874|FG002|NOT COMPLETED|Phase I||0
6748395|NCT03408639|7676444|FG001|STARTED|Overall Study||78
6480599|NCT01306942|7397875|FG003|NOT COMPLETED|Phase I||0
6480600|NCT01306942|7397872|FG000|STARTED|Phase II|Two patients from phase I with measurable disease and RP2D were included in the phase II analyses.|2
6480601|NCT01306942|7397873|FG001|STARTED|Phase II|Dasatinib 140mg was not the RP2D, so these patients were not included in the phase II analyses.|0
6480602|NCT01306942|7397874|FG002|STARTED|Phase II||0
6480603|NCT01306942|7397875|FG003|STARTED|Phase II||27
6480604|NCT01306942|7397872|FG000|COMPLETED|Phase II||0
6480605|NCT01306942|7397873|FG001|COMPLETED|Phase II||0
6480606|NCT01306942|7397874|FG002|COMPLETED|Phase II||0
6480607|NCT01306942|7397875|FG003|COMPLETED|Phase II||11
6480608|NCT01306942|7397872|FG000|NOT COMPLETED|Phase II||2
6480609|NCT01306942|7397873|FG001|NOT COMPLETED|Phase II||0
6480610|NCT01306942|7397874|FG002|NOT COMPLETED|Phase II||0
6480611|NCT01306942|7397875|FG003|NOT COMPLETED|Phase II||16
6501399|NCT01428128|7419865|FG000|STARTED|Overall Study||50
6501400|NCT01428128|7419865|FG000|COMPLETED|Overall Study||33
6501401|NCT01428128|7419865|FG000|NOT COMPLETED|Overall Study||17
6501402|NCT01428193|7419870|FG000|STARTED|Overall Study||4
6501403|NCT01428193|7419870|FG000|COMPLETED|Overall Study||2
6501404|NCT01428193|7419870|FG000|NOT COMPLETED|Overall Study||2
6501405|NCT01428219|7419874|FG000|STARTED|Overall Study||25
6501406|NCT01428219|7419874|FG000|COMPLETED|Overall Study||22
6501407|NCT01428219|7419874|FG000|NOT COMPLETED|Overall Study||3
6501408|NCT01428245|7419878|FG000|STARTED|Overall Study||1
6501409|NCT01428245|7419878|FG000|COMPLETED|Overall Study||1
6501410|NCT01428245|7419878|FG000|NOT COMPLETED|Overall Study||0
6501411|NCT01428258|7419884|FG000|STARTED|Intervention 1||17
6501412|NCT01428258|7419885|FG001|STARTED|Intervention 1||15
6501413|NCT01428258|7419884|FG000|COMPLETED|Intervention 1||15
6501414|NCT01428258|7419885|FG001|COMPLETED|Intervention 1||15
6501415|NCT01428258|7419884|FG000|NOT COMPLETED|Intervention 1||2
6501416|NCT01428258|7419885|FG001|NOT COMPLETED|Intervention 1||0
6501417|NCT01428258|7419884|FG000|STARTED|Intervention 2||15
6501418|NCT01428258|7419885|FG001|STARTED|Intervention 2||15
6501419|NCT01428258|7419884|FG000|COMPLETED|Intervention 2||15
6501420|NCT01428258|7419885|FG001|COMPLETED|Intervention 2||15
6501421|NCT01428258|7419884|FG000|NOT COMPLETED|Intervention 2||0
6501422|NCT01428258|7419885|FG001|NOT COMPLETED|Intervention 2||0
6501423|NCT01428336|7419901|FG000|STARTED|Overall Study||10
6501424|NCT01428336|7419902|FG001|STARTED|Overall Study||12
6501425|NCT01428336|7419901|FG000|COMPLETED|Overall Study||10
6501426|NCT01428336|7419902|FG001|COMPLETED|Overall Study||12
6501427|NCT01428336|7419901|FG000|NOT COMPLETED|Overall Study||0
6501428|NCT01428336|7419902|FG001|NOT COMPLETED|Overall Study||0
6501429|NCT01428453|7419913|FG000|STARTED|Overall Study||62
6501430|NCT01428453|7419914|FG001|STARTED|Overall Study||61
6501431|NCT01428453|7419913|FG000|COMPLETED|Overall Study||56
6501432|NCT01428453|7419914|FG001|COMPLETED|Overall Study||52
6501433|NCT01428453|7419913|FG000|NOT COMPLETED|Overall Study||6
6501434|NCT01428453|7419914|FG001|NOT COMPLETED|Overall Study||9
6501435|NCT01428583|7419922|FG000|STARTED|Overall Study||395
6501436|NCT01428583|7419922|FG000|COMPLETED|Overall Study||158
6501437|NCT01428583|7419922|FG000|NOT COMPLETED|Overall Study||237
6501438|NCT01428661|7419929|FG000|STARTED|Double-Masked Phase||254
6501439|NCT01428661|7419930|FG001|STARTED|Double-Masked Phase||253
6501440|NCT01428661|7419931|FG002|STARTED|Double-Masked Phase|Does not apply.|0
6501441|NCT01428661|7419929|FG000|COMPLETED|Double-Masked Phase||197
6501442|NCT01428661|7419930|FG001|COMPLETED|Double-Masked Phase||204
6501443|NCT01428661|7419931|FG002|COMPLETED|Double-Masked Phase|Does not apply.|0
6501444|NCT01428661|7419929|FG000|NOT COMPLETED|Double-Masked Phase||57
6501445|NCT01428661|7419930|FG001|NOT COMPLETED|Double-Masked Phase||49
6501446|NCT01428661|7419931|FG002|NOT COMPLETED|Double-Masked Phase||0
6501447|NCT01428661|7419929|FG000|STARTED|Open Label Extension|Does not apply.|0
6501448|NCT01428661|7419930|FG001|STARTED|Open Label Extension|Does not apply.|0
6501449|NCT01428661|7419931|FG002|STARTED|Open Label Extension||339
6501450|NCT01428661|7419929|FG000|COMPLETED|Open Label Extension|Does not apply.|0
6501451|NCT01428661|7419930|FG001|COMPLETED|Open Label Extension|Does not apply.|0
6501452|NCT01428661|7419931|FG002|COMPLETED|Open Label Extension||19
6501453|NCT01428661|7419929|FG000|NOT COMPLETED|Open Label Extension||0
6501454|NCT01428661|7419930|FG001|NOT COMPLETED|Open Label Extension||0
6501455|NCT01428661|7419931|FG002|NOT COMPLETED|Open Label Extension||320
6501456|NCT01428713|7419939|FG000|STARTED|Overall Study||9
6501457|NCT01428713|7419940|FG001|STARTED|Overall Study||8
6501458|NCT01428713|7419939|FG000|COMPLETED|Overall Study||6
6501459|NCT01428713|7419940|FG001|COMPLETED|Overall Study||3
6501460|NCT01428713|7419939|FG000|NOT COMPLETED|Overall Study||3
6501461|NCT01428713|7419940|FG001|NOT COMPLETED|Overall Study||5
6501462|NCT01428765|7419946|FG000|STARTED|Overall Study||1063
6501463|NCT01428765|7419946|FG000|COMPLETED|Overall Study||1063
6748396|NCT03408639|7676443|FG000|COMPLETED|Overall Study||67
6748397|NCT03408639|7676444|FG001|COMPLETED|Overall Study||56
6748398|NCT03408639|7676443|FG000|NOT COMPLETED|Overall Study||11
6748399|NCT03408639|7676444|FG001|NOT COMPLETED|Overall Study||22
6748400|NCT03408730|7676454|FG000|STARTED|Overall Study||712
6501464|NCT01428765|7419946|FG000|NOT COMPLETED|Overall Study||0
6501465|NCT01428882|7419952|FG000|STARTED|Overall Study||67
6501466|NCT01428882|7419953|FG001|STARTED|Overall Study||68
6501467|NCT01428882|7419952|FG000|COMPLETED|Overall Study||61
6501468|NCT01428882|7419953|FG001|COMPLETED|Overall Study||58
6501469|NCT01428882|7419952|FG000|NOT COMPLETED|Overall Study||6
6501470|NCT01428882|7419953|FG001|NOT COMPLETED|Overall Study||10
6480612|NCT01306968|7397891|FG000|STARTED|Overall Study||7
6480613|NCT01306968|7397892|FG001|STARTED|Overall Study||23
6480614|NCT01306968|7397893|FG002|STARTED|Overall Study||24
6480615|NCT01306968|7397894|FG003|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
6480616|NCT01306968|7397891|FG000|COMPLETED|Overall Study||6
6480617|NCT01306968|7397892|FG001|COMPLETED|Overall Study||20
6480618|NCT01306968|7397893|FG002|COMPLETED|Overall Study||23
6480619|NCT01306968|7397894|FG003|COMPLETED|Overall Study||21
6480620|NCT01306968|7397891|FG000|NOT COMPLETED|Overall Study||1
6480621|NCT01306968|7397892|FG001|NOT COMPLETED|Overall Study||3
6480622|NCT01306968|7397893|FG002|NOT COMPLETED|Overall Study||1
6480623|NCT01306968|7397894|FG003|NOT COMPLETED|Overall Study||4
6480624|NCT01307007|7397908|FG000|STARTED|Overall Study||25
6480625|NCT01307007|7397909|FG001|STARTED|Overall Study||30
6480626|NCT01307007|7397908|FG000|COMPLETED|Overall Study||25
6480627|NCT01307007|7397909|FG001|COMPLETED|Overall Study||30
6480628|NCT01307007|7397908|FG000|NOT COMPLETED|Overall Study||0
6480629|NCT01307007|7397909|FG001|NOT COMPLETED|Overall Study||0
6480630|NCT01307020|7397925|FG000|STARTED|Overall Study||61
6480631|NCT01307020|7397926|FG001|STARTED|Overall Study||63
6480632|NCT01307020|7397927|FG002|STARTED|Overall Study||63
6480633|NCT01307020|7397928|FG003|STARTED|Overall Study||61
6480634|NCT01307020|7397929|FG004|STARTED|Overall Study||60
6480635|NCT01307020|7397930|FG005|STARTED|Overall Study||61
6480636|NCT01307020|7397931|FG006|STARTED|Overall Study||59
6480637|NCT01307020|7397932|FG007|STARTED|Overall Study||60
6480638|NCT01307020|7397933|FG008|STARTED|Overall Study||61
6480639|NCT01307020|7397934|FG009|STARTED|Overall Study||62
6480640|NCT01307020|7397925|FG000|Safety Population|Overall Study||61
6480641|NCT01307020|7397926|FG001|Safety Population|Overall Study||63
6480642|NCT01307020|7397927|FG002|Safety Population|Overall Study||63
6480643|NCT01307020|7397928|FG003|Safety Population|Overall Study||61
6480644|NCT01307020|7397929|FG004|Safety Population|Overall Study||60
6480645|NCT01307020|7397930|FG005|Safety Population|Overall Study||61
6480646|NCT01307020|7397931|FG006|Safety Population|Overall Study||59
6480647|NCT01307020|7397932|FG007|Safety Population|Overall Study||60
6480648|NCT01307020|7397933|FG008|Safety Population|Overall Study||61
6480649|NCT01307020|7397934|FG009|Safety Population|Overall Study||62
6480650|NCT01307020|7397925|FG000|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
6480651|NCT01307020|7397926|FG001|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
6480652|NCT01307020|7397927|FG002|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
6480653|NCT01307020|7397928|FG003|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
6480654|NCT01307020|7397929|FG004|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
6480655|NCT01307020|7397930|FG005|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
6480656|NCT01307020|7397931|FG006|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
6480657|NCT01307020|7397932|FG007|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
6480658|NCT01307020|7397933|FG008|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
6480659|NCT01307020|7397934|FG009|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
6480660|NCT01307020|7397925|FG000|COMPLETED|Overall Study||61
6480661|NCT01307020|7397926|FG001|COMPLETED|Overall Study||62
6480662|NCT01307020|7397927|FG002|COMPLETED|Overall Study||62
6480663|NCT01307020|7397928|FG003|COMPLETED|Overall Study||60
6480664|NCT01307020|7397929|FG004|COMPLETED|Overall Study||60
6480665|NCT01307020|7397930|FG005|COMPLETED|Overall Study||61
6480666|NCT01307020|7397931|FG006|COMPLETED|Overall Study||58
6480667|NCT01307020|7397932|FG007|COMPLETED|Overall Study||60
6480668|NCT01307020|7397933|FG008|COMPLETED|Overall Study||61
6480669|NCT01307020|7397934|FG009|COMPLETED|Overall Study||62
6480670|NCT01307020|7397925|FG000|NOT COMPLETED|Overall Study||0
6480671|NCT01307020|7397926|FG001|NOT COMPLETED|Overall Study||1
6480672|NCT01307020|7397927|FG002|NOT COMPLETED|Overall Study||1
6480673|NCT01307020|7397928|FG003|NOT COMPLETED|Overall Study||1
6480674|NCT01307020|7397929|FG004|NOT COMPLETED|Overall Study||0
6480675|NCT01307020|7397930|FG005|NOT COMPLETED|Overall Study||0
6480676|NCT01307020|7397931|FG006|NOT COMPLETED|Overall Study||1
6480677|NCT01307020|7397932|FG007|NOT COMPLETED|Overall Study||0
6480678|NCT01307020|7397933|FG008|NOT COMPLETED|Overall Study||0
6480679|NCT01307020|7397934|FG009|NOT COMPLETED|Overall Study||0
6480680|NCT01307098|7397959|FG000|STARTED|Overall Study||3
6480681|NCT01307098|7397960|FG001|STARTED|Overall Study||3
6480682|NCT01307098|7397961|FG002|STARTED|Overall Study||3
6480683|NCT01307098|7397959|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6480684|NCT01307098|7397960|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6480685|NCT01307098|7397961|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6480686|NCT01307098|7397959|FG000|COMPLETED|Overall Study||3
6480687|NCT01307098|7397960|FG001|COMPLETED|Overall Study||3
6480688|NCT01307098|7397961|FG002|COMPLETED|Overall Study||3
6480689|NCT01307098|7397959|FG000|NOT COMPLETED|Overall Study||0
6480690|NCT01307098|7397960|FG001|NOT COMPLETED|Overall Study||0
6480691|NCT01307098|7397961|FG002|NOT COMPLETED|Overall Study||0
6480692|NCT01307111|7397972|FG000|STARTED|IUD Insertion||42
6480693|NCT01307111|7397973|FG001|STARTED|IUD Insertion||40
6480694|NCT01307111|7397972|FG000|COMPLETED|IUD Insertion||40
6480695|NCT01307111|7397973|FG001|COMPLETED|IUD Insertion||40
6480696|NCT01307111|7397972|FG000|NOT COMPLETED|IUD Insertion||2
6480697|NCT01307111|7397973|FG001|NOT COMPLETED|IUD Insertion||0
6480698|NCT01307111|7397972|FG000|STARTED|1-2 Week IUD Check up||40
6480699|NCT01307111|7397973|FG001|STARTED|1-2 Week IUD Check up||40
6480700|NCT01307111|7397972|FG000|COMPLETED|1-2 Week IUD Check up||38
6480701|NCT01307111|7397973|FG001|COMPLETED|1-2 Week IUD Check up||38
6480702|NCT01307111|7397972|FG000|NOT COMPLETED|1-2 Week IUD Check up||2
6480703|NCT01307111|7397973|FG001|NOT COMPLETED|1-2 Week IUD Check up||2
6480704|NCT01307267|7398002|FG000|STARTED|Overall Study||4
6480705|NCT01307267|7398003|FG001|STARTED|Overall Study||3
6480706|NCT01307267|7398004|FG002|STARTED|Overall Study||6
6480707|NCT01307267|7398005|FG003|STARTED|Overall Study||4
6480708|NCT01307267|7398006|FG004|STARTED|Overall Study||3
6480709|NCT01307267|7398007|FG005|STARTED|Overall Study||42
6480710|NCT01307267|7398008|FG006|STARTED|Overall Study||3
6480711|NCT01307267|7398009|FG007|STARTED|Overall Study||4
6480712|NCT01307267|7398010|FG008|STARTED|Overall Study||31
6480713|NCT01307267|7398011|FG009|STARTED|Overall Study||5
6480714|NCT01307267|7398012|FG010|STARTED|Overall Study||6
6480715|NCT01307267|7398013|FG011|STARTED|Overall Study||11
6554741|NCT01748552|7476863|FG011|COMPLETED|Intervention Period 3 and Washout||3
6554742|NCT01748552|7476852|FG000|NOT COMPLETED|Intervention Period 3 and Washout||0
6480716|NCT01307267|7398014|FG012|STARTED|Overall Study||3
6480717|NCT01307267|7398015|FG013|STARTED|Overall Study||3
6480718|NCT01307267|7398016|FG014|STARTED|Overall Study||4
6480719|NCT01307267|7398017|FG015|STARTED|Overall Study||3
6480720|NCT01307267|7398018|FG016|STARTED|Overall Study||3
6480721|NCT01307267|7398019|FG017|STARTED|Overall Study||3
6480722|NCT01307267|7398020|FG018|STARTED|Overall Study||4
6480723|NCT01307267|7398021|FG019|STARTED|Overall Study||32
6480724|NCT01307267|7398022|FG020|STARTED|Overall Study||3
6480725|NCT01307267|7398023|FG021|STARTED|Overall Study||5
6480726|NCT01307267|7398024|FG022|STARTED|Overall Study||4
6480727|NCT01307267|7398002|FG000|COMPLETED|Overall Study||0
6480728|NCT01307267|7398003|FG001|COMPLETED|Overall Study||0
6480729|NCT01307267|7398004|FG002|COMPLETED|Overall Study||1
6480730|NCT01307267|7398005|FG003|COMPLETED|Overall Study||1
6480731|NCT01307267|7398006|FG004|COMPLETED|Overall Study||2
6480732|NCT01307267|7398007|FG005|COMPLETED|Overall Study||1
6480733|NCT01307267|7398008|FG006|COMPLETED|Overall Study||1
6480734|NCT01307267|7398009|FG007|COMPLETED|Overall Study||0
6480735|NCT01307267|7398010|FG008|COMPLETED|Overall Study||1
6480736|NCT01307267|7398011|FG009|COMPLETED|Overall Study||0
6480737|NCT01307267|7398012|FG010|COMPLETED|Overall Study||0
6480738|NCT01307267|7398013|FG011|COMPLETED|Overall Study||0
6480739|NCT01307267|7398014|FG012|COMPLETED|Overall Study||2
6480740|NCT01307267|7398015|FG013|COMPLETED|Overall Study||3
6480741|NCT01307267|7398016|FG014|COMPLETED|Overall Study||2
6480742|NCT01307267|7398017|FG015|COMPLETED|Overall Study||2
6480743|NCT01307267|7398018|FG016|COMPLETED|Overall Study||2
6480744|NCT01307267|7398019|FG017|COMPLETED|Overall Study||2
6480745|NCT01307267|7398020|FG018|COMPLETED|Overall Study||2
6480746|NCT01307267|7398021|FG019|COMPLETED|Overall Study||0
6480747|NCT01307267|7398022|FG020|COMPLETED|Overall Study||0
6480748|NCT01307267|7398023|FG021|COMPLETED|Overall Study||0
6480749|NCT01307267|7398024|FG022|COMPLETED|Overall Study||0
6480750|NCT01307267|7398002|FG000|NOT COMPLETED|Overall Study||4
6480751|NCT01307267|7398003|FG001|NOT COMPLETED|Overall Study||3
6480752|NCT01307267|7398004|FG002|NOT COMPLETED|Overall Study||5
6480753|NCT01307267|7398005|FG003|NOT COMPLETED|Overall Study||3
6480754|NCT01307267|7398006|FG004|NOT COMPLETED|Overall Study||1
6480755|NCT01307267|7398007|FG005|NOT COMPLETED|Overall Study||41
6480756|NCT01307267|7398008|FG006|NOT COMPLETED|Overall Study||2
6480757|NCT01307267|7398009|FG007|NOT COMPLETED|Overall Study||4
6480758|NCT01307267|7398010|FG008|NOT COMPLETED|Overall Study||30
6480759|NCT01307267|7398011|FG009|NOT COMPLETED|Overall Study||5
6480760|NCT01307267|7398012|FG010|NOT COMPLETED|Overall Study||6
6480761|NCT01307267|7398013|FG011|NOT COMPLETED|Overall Study||11
6480762|NCT01307267|7398014|FG012|NOT COMPLETED|Overall Study||1
6480763|NCT01307267|7398015|FG013|NOT COMPLETED|Overall Study||0
6480764|NCT01307267|7398016|FG014|NOT COMPLETED|Overall Study||2
6480765|NCT01307267|7398017|FG015|NOT COMPLETED|Overall Study||1
6480766|NCT01307267|7398018|FG016|NOT COMPLETED|Overall Study||1
6480767|NCT01307267|7398019|FG017|NOT COMPLETED|Overall Study||1
6480768|NCT01307267|7398020|FG018|NOT COMPLETED|Overall Study||2
6480769|NCT01307267|7398021|FG019|NOT COMPLETED|Overall Study||32
6480770|NCT01307267|7398022|FG020|NOT COMPLETED|Overall Study||3
6480771|NCT01307267|7398023|FG021|NOT COMPLETED|Overall Study||5
6480772|NCT01307267|7398024|FG022|NOT COMPLETED|Overall Study||4
6480773|NCT01307319|7398086|FG000|STARTED|Overall Study|Randomized|239
6480774|NCT01307319|7398087|FG001|STARTED|Overall Study|Randomized|242
6480775|NCT01307319|7398088|FG002|STARTED|Overall Study|Randomized|234
6480776|NCT01307319|7398086|FG000|Safety Population|Overall Study||239
6480777|NCT01307319|7398087|FG001|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
6480778|NCT01307319|7398088|FG002|Safety Population|Overall Study||234
6480779|NCT01307319|7398086|FG000|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
6480780|NCT01307319|7398087|FG001|ITT Population|Overall Study||241
6480781|NCT01307319|7398088|FG002|ITT Population|Overall Study||234
6480782|NCT01307319|7398086|FG000|COMPLETED|Overall Study||235
6480783|NCT01307319|7398087|FG001|COMPLETED|Overall Study||234
6480784|NCT01307319|7398088|FG002|COMPLETED|Overall Study||227
6480785|NCT01307319|7398086|FG000|NOT COMPLETED|Overall Study||4
6480786|NCT01307319|7398087|FG001|NOT COMPLETED|Overall Study||8
6554743|NCT01748552|7476853|FG001|NOT COMPLETED|Intervention Period 3 and Washout||0
6480787|NCT01307319|7398088|FG002|NOT COMPLETED|Overall Study||7
6480788|NCT01307397|7398096|FG000|STARTED|Overall Study||3219
6480789|NCT01307397|7398096|FG000|COMPLETED|Overall Study|A participant completed study in case of progressive disease, adverse events or consent withdrawn|3219
6480790|NCT01307397|7398096|FG000|NOT COMPLETED|Overall Study||0
6480791|NCT01307423|7398103|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
6480792|NCT01307423|7398104|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
6480793|NCT01307423|7398105|FG002|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
6480794|NCT01307423|7398106|FG003|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6480795|NCT01307423|7398107|FG004|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6480796|NCT01307423|7398108|FG005|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6480797|NCT01307423|7398109|FG006|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6480798|NCT01307423|7398110|FG007|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6480799|NCT01307423|7398111|FG008|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
6480800|NCT01307423|7398103|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
6480801|NCT01307423|7398104|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
6480802|NCT01307423|7398105|FG002|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
6480803|NCT01307423|7398106|FG003|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6480804|NCT01307423|7398107|FG004|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6480805|NCT01307423|7398108|FG005|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6480806|NCT01307423|7398109|FG006|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6480807|NCT01307423|7398110|FG007|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6480808|NCT01307423|7398111|FG008|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
6480809|NCT01307423|7398103|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
6480810|NCT01307423|7398104|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
6480811|NCT01307423|7398105|FG002|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
6480812|NCT01307423|7398106|FG003|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480813|NCT01307423|7398107|FG004|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480814|NCT01307423|7398108|FG005|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480815|NCT01307423|7398109|FG006|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480816|NCT01307423|7398110|FG007|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480817|NCT01307423|7398111|FG008|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480818|NCT01307423|7398103|FG000|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
6480819|NCT01307423|7398104|FG001|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
6480820|NCT01307423|7398105|FG002|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
6480821|NCT01307423|7398106|FG003|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480822|NCT01307423|7398107|FG004|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480823|NCT01307423|7398108|FG005|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480824|NCT01307423|7398109|FG006|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480825|NCT01307423|7398110|FG007|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480826|NCT01307423|7398111|FG008|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
6480827|NCT01307423|7398103|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
6480828|NCT01307423|7398104|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
6480829|NCT01307423|7398105|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
6480830|NCT01307423|7398106|FG003|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480831|NCT01307423|7398107|FG004|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480832|NCT01307423|7398108|FG005|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480833|NCT01307423|7398109|FG006|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480834|NCT01307423|7398110|FG007|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480835|NCT01307423|7398111|FG008|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480836|NCT01307423|7398103|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
6480837|NCT01307423|7398104|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
6480838|NCT01307423|7398105|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
6480839|NCT01307423|7398106|FG003|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480840|NCT01307423|7398107|FG004|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6554744|NCT01748552|7476854|FG002|NOT COMPLETED|Intervention Period 3 and Washout||0
6554745|NCT01748552|7476855|FG003|NOT COMPLETED|Intervention Period 3 and Washout||0
6554746|NCT01748552|7476856|FG004|NOT COMPLETED|Intervention Period 3 and Washout||0
6554747|NCT01748552|7476857|FG005|NOT COMPLETED|Intervention Period 3 and Washout||0
6554748|NCT01748552|7476858|FG006|NOT COMPLETED|Intervention Period 3 and Washout||0
6554749|NCT01748552|7476859|FG007|NOT COMPLETED|Intervention Period 3 and Washout||0
6554750|NCT01748552|7476860|FG008|NOT COMPLETED|Intervention Period 3 and Washout||0
6554751|NCT01748552|7476861|FG009|NOT COMPLETED|Intervention Period 3 and Washout||0
6554752|NCT01748552|7476862|FG010|NOT COMPLETED|Intervention Period 3 and Washout||0
6554753|NCT01748552|7476863|FG011|NOT COMPLETED|Intervention Period 3 and Washout||0
6554754|NCT01748643|7476905|FG000|STARTED|Overall Study||30
6554755|NCT01748643|7476906|FG001|STARTED|Overall Study||30
6554756|NCT01748643|7476905|FG000|COMPLETED|Overall Study||30
6554757|NCT01748643|7476906|FG001|COMPLETED|Overall Study||30
6554758|NCT01748643|7476905|FG000|NOT COMPLETED|Overall Study||0
6554759|NCT01748643|7476906|FG001|NOT COMPLETED|Overall Study||0
6554760|NCT01748695|7476912|FG000|STARTED|First Intervention (4 Weeks)||14
6480841|NCT01307423|7398108|FG005|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480842|NCT01307423|7398109|FG006|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480843|NCT01307423|7398110|FG007|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480844|NCT01307423|7398111|FG008|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
6480845|NCT01307423|7398103|FG000|STARTED|Active Treatment Phase (Week 25-52)||0
6480846|NCT01307423|7398104|FG001|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
6480847|NCT01307423|7398105|FG002|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
6480848|NCT01307423|7398106|FG003|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
6480849|NCT01307423|7398107|FG004|STARTED|Active Treatment Phase (Week 25-52)||26
6480850|NCT01307423|7398108|FG005|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
6480851|NCT01307423|7398109|FG006|STARTED|Active Treatment Phase (Week 25-52)||26
6480852|NCT01307423|7398110|FG007|STARTED|Active Treatment Phase (Week 25-52)||0
6480853|NCT01307423|7398111|FG008|STARTED|Active Treatment Phase (Week 25-52)||0
6480854|NCT01307423|7398103|FG000|COMPLETED|Active Treatment Phase (Week 25-52)||0
6480855|NCT01307423|7398104|FG001|COMPLETED|Active Treatment Phase (Week 25-52)||132
6480856|NCT01307423|7398105|FG002|COMPLETED|Active Treatment Phase (Week 25-52)||141
6480857|NCT01307423|7398106|FG003|COMPLETED|Active Treatment Phase (Week 25-52)||38
6480858|NCT01307423|7398107|FG004|COMPLETED|Active Treatment Phase (Week 25-52)||23
6480859|NCT01307423|7398108|FG005|COMPLETED|Active Treatment Phase (Week 25-52)||43
6480860|NCT01307423|7398109|FG006|COMPLETED|Active Treatment Phase (Week 25-52)||25
6480861|NCT01307423|7398110|FG007|COMPLETED|Active Treatment Phase (Week 25-52)||0
6480862|NCT01307423|7398111|FG008|COMPLETED|Active Treatment Phase (Week 25-52)||0
6480863|NCT01307423|7398103|FG000|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
6480864|NCT01307423|7398104|FG001|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
6480865|NCT01307423|7398105|FG002|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
6480866|NCT01307423|7398106|FG003|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
6480867|NCT01307423|7398107|FG004|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
6480868|NCT01307423|7398108|FG005|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
6480869|NCT01307423|7398109|FG006|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
6480870|NCT01307423|7398110|FG007|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
6480871|NCT01307423|7398111|FG008|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
6480872|NCT01307423|7398103|FG000|STARTED|Long-term Safety Phase (Year 2)||0
6480873|NCT01307423|7398104|FG001|STARTED|Long-term Safety Phase (Year 2)|10 participants who completed Week 52 did not enter the long-term safety phase|122
6480874|NCT01307423|7398105|FG002|STARTED|Long-term Safety Phase (Year 2)|7 participants who completed Week 52 did not enter the long-term safety phase|134
6480875|NCT01307423|7398106|FG003|STARTED|Long-term Safety Phase (Year 2)||0
6480876|NCT01307423|7398107|FG004|STARTED|Long-term Safety Phase (Year 2)||0
6480877|NCT01307423|7398108|FG005|STARTED|Long-term Safety Phase (Year 2)||0
6480878|NCT01307423|7398109|FG006|STARTED|Long-term Safety Phase (Year 2)||0
6480879|NCT01307423|7398110|FG007|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 20 mg EE and XO are combined;15 patients finished Wk 52;no entry into LTSP|57
6480880|NCT01307423|7398111|FG008|STARTED|Long-term Safety Phase (Year 2)|Patients from the PBO/APR 30 mg EE and XO are combined;5 patients finished Wk 52;no entry into LTSP|67
6480881|NCT01307423|7398103|FG000|COMPLETED|Long-term Safety Phase (Year 2)||0
6480882|NCT01307423|7398104|FG001|COMPLETED|Long-term Safety Phase (Year 2)||99
6480883|NCT01307423|7398105|FG002|COMPLETED|Long-term Safety Phase (Year 2)||109
6480884|NCT01307423|7398106|FG003|COMPLETED|Long-term Safety Phase (Year 2)||0
6480885|NCT01307423|7398107|FG004|COMPLETED|Long-term Safety Phase (Year 2)||0
6480886|NCT01307423|7398108|FG005|COMPLETED|Long-term Safety Phase (Year 2)||0
6480887|NCT01307423|7398109|FG006|COMPLETED|Long-term Safety Phase (Year 2)||0
6480888|NCT01307423|7398110|FG007|COMPLETED|Long-term Safety Phase (Year 2)||48
6480889|NCT01307423|7398111|FG008|COMPLETED|Long-term Safety Phase (Year 2)||60
6480890|NCT01307423|7398103|FG000|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6480891|NCT01307423|7398104|FG001|NOT COMPLETED|Long-term Safety Phase (Year 2)||23
6480892|NCT01307423|7398105|FG002|NOT COMPLETED|Long-term Safety Phase (Year 2)||25
6480893|NCT01307423|7398106|FG003|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6480894|NCT01307423|7398107|FG004|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6480895|NCT01307423|7398108|FG005|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6480896|NCT01307423|7398109|FG006|NOT COMPLETED|Long-term Safety Phase (Year 2)||0
6480897|NCT01307423|7398110|FG007|NOT COMPLETED|Long-term Safety Phase (Year 2)||9
6480898|NCT01307423|7398111|FG008|NOT COMPLETED|Long-term Safety Phase (Year 2)||7
6480899|NCT01307423|7398103|FG000|STARTED|Long-term Safety Phase (Year 3)||0
6480900|NCT01307423|7398104|FG001|STARTED|Long-term Safety Phase (Year 3)||99
6480901|NCT01307423|7398105|FG002|STARTED|Long-term Safety Phase (Year 3)||109
6480902|NCT01307423|7398106|FG003|STARTED|Long-term Safety Phase (Year 3)||0
6480903|NCT01307423|7398107|FG004|STARTED|Long-term Safety Phase (Year 3)||0
6480904|NCT01307423|7398108|FG005|STARTED|Long-term Safety Phase (Year 3)||0
6480905|NCT01307423|7398109|FG006|STARTED|Long-term Safety Phase (Year 3)||0
6480906|NCT01307423|7398110|FG007|STARTED|Long-term Safety Phase (Year 3)||48
6480907|NCT01307423|7398111|FG008|STARTED|Long-term Safety Phase (Year 3)||60
6480908|NCT01307423|7398103|FG000|COMPLETED|Long-term Safety Phase (Year 3)||0
6480909|NCT01307423|7398104|FG001|COMPLETED|Long-term Safety Phase (Year 3)||90
6480910|NCT01307423|7398105|FG002|COMPLETED|Long-term Safety Phase (Year 3)||91
6480911|NCT01307423|7398106|FG003|COMPLETED|Long-term Safety Phase (Year 3)||0
6480912|NCT01307423|7398107|FG004|COMPLETED|Long-term Safety Phase (Year 3)||0
6480913|NCT01307423|7398108|FG005|COMPLETED|Long-term Safety Phase (Year 3)||0
6480914|NCT01307423|7398109|FG006|COMPLETED|Long-term Safety Phase (Year 3)||0
6480915|NCT01307423|7398110|FG007|COMPLETED|Long-term Safety Phase (Year 3)||40
6480916|NCT01307423|7398111|FG008|COMPLETED|Long-term Safety Phase (Year 3)||49
6480917|NCT01307423|7398103|FG000|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6480918|NCT01307423|7398104|FG001|NOT COMPLETED|Long-term Safety Phase (Year 3)||9
6480919|NCT01307423|7398105|FG002|NOT COMPLETED|Long-term Safety Phase (Year 3)||18
6480920|NCT01307423|7398106|FG003|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6480921|NCT01307423|7398107|FG004|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6480922|NCT01307423|7398108|FG005|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6480923|NCT01307423|7398109|FG006|NOT COMPLETED|Long-term Safety Phase (Year 3)||0
6480924|NCT01307423|7398110|FG007|NOT COMPLETED|Long-term Safety Phase (Year 3)||8
6480925|NCT01307423|7398111|FG008|NOT COMPLETED|Long-term Safety Phase (Year 3)||11
6480926|NCT01307423|7398103|FG000|STARTED|Long-term Safety Phase (Year 4)||0
6480927|NCT01307423|7398104|FG001|STARTED|Long-term Safety Phase (Year 4)|1 participant who completed Year 3 did not continue treatment in Year 4|89
6480928|NCT01307423|7398105|FG002|STARTED|Long-term Safety Phase (Year 4)||91
6480929|NCT01307423|7398106|FG003|STARTED|Long-term Safety Phase (Year 4)||0
6480930|NCT01307423|7398107|FG004|STARTED|Long-term Safety Phase (Year 4)||0
6480931|NCT01307423|7398108|FG005|STARTED|Long-term Safety Phase (Year 4)||0
6480932|NCT01307423|7398109|FG006|STARTED|Long-term Safety Phase (Year 4)||0
6480933|NCT01307423|7398110|FG007|STARTED|Long-term Safety Phase (Year 4)||40
6480934|NCT01307423|7398111|FG008|STARTED|Long-term Safety Phase (Year 4)||49
6480935|NCT01307423|7398103|FG000|COMPLETED|Long-term Safety Phase (Year 4)||0
6480936|NCT01307423|7398104|FG001|COMPLETED|Long-term Safety Phase (Year 4)||81
6480937|NCT01307423|7398105|FG002|COMPLETED|Long-term Safety Phase (Year 4)||86
6480938|NCT01307423|7398106|FG003|COMPLETED|Long-term Safety Phase (Year 4)||0
6480939|NCT01307423|7398107|FG004|COMPLETED|Long-term Safety Phase (Year 4)||0
6480940|NCT01307423|7398108|FG005|COMPLETED|Long-term Safety Phase (Year 4)||0
6480941|NCT01307423|7398109|FG006|COMPLETED|Long-term Safety Phase (Year 4)||0
6480942|NCT01307423|7398110|FG007|COMPLETED|Long-term Safety Phase (Year 4)||38
6480943|NCT01307423|7398111|FG008|COMPLETED|Long-term Safety Phase (Year 4)||44
6480944|NCT01307423|7398103|FG000|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6480945|NCT01307423|7398104|FG001|NOT COMPLETED|Long-term Safety Phase (Year 4)||8
6480946|NCT01307423|7398105|FG002|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
6480947|NCT01307423|7398106|FG003|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6480948|NCT01307423|7398107|FG004|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6480949|NCT01307423|7398108|FG005|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6480950|NCT01307423|7398109|FG006|NOT COMPLETED|Long-term Safety Phase (Year 4)||0
6480951|NCT01307423|7398110|FG007|NOT COMPLETED|Long-term Safety Phase (Year 4)||2
6480952|NCT01307423|7398111|FG008|NOT COMPLETED|Long-term Safety Phase (Year 4)||5
6480953|NCT01307423|7398103|FG000|STARTED|Long-term Safety Phase (Year 5)||0
6480954|NCT01307423|7398104|FG001|STARTED|Long-term Safety Phase (Year 5)||81
6480955|NCT01307423|7398105|FG002|STARTED|Long-term Safety Phase (Year 5)||86
6480956|NCT01307423|7398106|FG003|STARTED|Long-term Safety Phase (Year 5)||0
6480957|NCT01307423|7398107|FG004|STARTED|Long-term Safety Phase (Year 5)||0
6480958|NCT01307423|7398108|FG005|STARTED|Long-term Safety Phase (Year 5)||0
6480959|NCT01307423|7398109|FG006|STARTED|Long-term Safety Phase (Year 5)||0
6480960|NCT01307423|7398110|FG007|STARTED|Long-term Safety Phase (Year 5)||38
6480961|NCT01307423|7398111|FG008|STARTED|Long-term Safety Phase (Year 5)||44
6480962|NCT01307423|7398103|FG000|COMPLETED|Long-term Safety Phase (Year 5)||0
6480963|NCT01307423|7398104|FG001|COMPLETED|Long-term Safety Phase (Year 5)||71
6480964|NCT01307423|7398105|FG002|COMPLETED|Long-term Safety Phase (Year 5)||80
6480965|NCT01307423|7398106|FG003|COMPLETED|Long-term Safety Phase (Year 5)||0
6480966|NCT01307423|7398107|FG004|COMPLETED|Long-term Safety Phase (Year 5)||0
6480967|NCT01307423|7398108|FG005|COMPLETED|Long-term Safety Phase (Year 5)||0
6480968|NCT01307423|7398109|FG006|COMPLETED|Long-term Safety Phase (Year 5)||0
6480969|NCT01307423|7398110|FG007|COMPLETED|Long-term Safety Phase (Year 5)||37
6480970|NCT01307423|7398111|FG008|COMPLETED|Long-term Safety Phase (Year 5)||41
6480971|NCT01307423|7398103|FG000|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6480972|NCT01307423|7398104|FG001|NOT COMPLETED|Long-term Safety Phase (Year 5)||10
6480973|NCT01307423|7398105|FG002|NOT COMPLETED|Long-term Safety Phase (Year 5)||6
6480974|NCT01307423|7398106|FG003|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6480975|NCT01307423|7398107|FG004|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6480976|NCT01307423|7398108|FG005|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6480977|NCT01307423|7398109|FG006|NOT COMPLETED|Long-term Safety Phase (Year 5)||0
6480978|NCT01307423|7398110|FG007|NOT COMPLETED|Long-term Safety Phase (Year 5)||1
6480979|NCT01307423|7398111|FG008|NOT COMPLETED|Long-term Safety Phase (Year 5)||3
6480980|NCT01307449|7398147|FG000|STARTED|Overall Study||33
6480981|NCT01307449|7398148|FG001|STARTED|Overall Study||33
6480982|NCT01307449|7398149|FG002|STARTED|Overall Study||11
6480983|NCT01307449|7398150|FG003|STARTED|Overall Study||11
6480984|NCT01307449|7398147|FG000|COMPLETED|Overall Study||32
6480985|NCT01307449|7398148|FG001|COMPLETED|Overall Study||33
6480986|NCT01307449|7398149|FG002|COMPLETED|Overall Study||11
6480987|NCT01307449|7398150|FG003|COMPLETED|Overall Study||11
6480988|NCT01307449|7398147|FG000|NOT COMPLETED|Overall Study||1
6480989|NCT01307449|7398148|FG001|NOT COMPLETED|Overall Study||0
6480990|NCT01307449|7398149|FG002|NOT COMPLETED|Overall Study||0
6480991|NCT01307449|7398150|FG003|NOT COMPLETED|Overall Study||0
6480992|NCT01307462|7398160|FG000|STARTED|Overall Study||36
6480993|NCT01307462|7398160|FG000|COMPLETED|Overall Study||35
6480994|NCT01307462|7398160|FG000|NOT COMPLETED|Overall Study||1
6480995|NCT01307501|7398164|FG000|STARTED|Overall Study||40
6480996|NCT01307501|7398164|FG000|Intent-to-Treat (ITT) Population|Overall Study||40
6480997|NCT01307501|7398164|FG000|COMPLETED|Overall Study||17
6480998|NCT01307501|7398164|FG000|NOT COMPLETED|Overall Study||23
6480999|NCT01307579|7398170|FG000|STARTED|Overall Study||257
6481000|NCT01307579|7398171|FG001|STARTED|Overall Study||260
6481001|NCT01307579|7398170|FG000|COMPLETED|Overall Study||117
6481002|NCT01307579|7398171|FG001|COMPLETED|Overall Study||115
6481003|NCT01307579|7398170|FG000|NOT COMPLETED|Overall Study||140
6481004|NCT01307579|7398171|FG001|NOT COMPLETED|Overall Study||145
6481005|NCT01307618|7398179|FG000|STARTED|Overall Study||5
6481006|NCT01307618|7398180|FG001|STARTED|Overall Study||5
6481007|NCT01307618|7398179|FG000|COMPLETED|Overall Study||5
6481008|NCT01307618|7398180|FG001|COMPLETED|Overall Study||5
6481009|NCT01307618|7398179|FG000|NOT COMPLETED|Overall Study||0
6481010|NCT01307618|7398180|FG001|NOT COMPLETED|Overall Study||0
6481011|NCT01307748|7398189|FG000|STARTED|Overall Study||31
6481012|NCT01307748|7398190|FG001|STARTED|Overall Study||31
6481013|NCT01307748|7398191|FG002|STARTED|Overall Study||30
6481014|NCT01307748|7398189|FG000|COMPLETED|Overall Study||31
6481015|NCT01307748|7398190|FG001|COMPLETED|Overall Study||31
6481016|NCT01307748|7398191|FG002|COMPLETED|Overall Study||30
6481017|NCT01307748|7398189|FG000|NOT COMPLETED|Overall Study||0
6481018|NCT01307748|7398190|FG001|NOT COMPLETED|Overall Study||0
6481019|NCT01307748|7398191|FG002|NOT COMPLETED|Overall Study||0
6481020|NCT01307891|7398207|FG000|STARTED|Overall Study||42
6481021|NCT01307891|7398208|FG001|STARTED|Overall Study||22
6481022|NCT01307891|7398207|FG000|COMPLETED|Overall Study||39
6481023|NCT01307891|7398208|FG001|COMPLETED|Overall Study||21
6481024|NCT01307891|7398207|FG000|NOT COMPLETED|Overall Study||3
6481025|NCT01307891|7398208|FG001|NOT COMPLETED|Overall Study||1
6481026|NCT01307930|7398214|FG000|STARTED|Overall Study||20
6481027|NCT01307930|7398214|FG000|COMPLETED|Overall Study||18
6481028|NCT01307930|7398214|FG000|NOT COMPLETED|Overall Study||2
6481029|NCT01307956|7398218|FG000|STARTED|Overall Study||11
6481030|NCT01307956|7398218|FG000|COMPLETED|Overall Study||11
6481031|NCT01307956|7398218|FG000|NOT COMPLETED|Overall Study||0
6481032|NCT01308008|7398224|FG000|STARTED|4 Weeks||71
6481033|NCT01308008|7398225|FG001|STARTED|4 Weeks||73
6481034|NCT01308008|7398224|FG000|COMPLETED|4 Weeks||62
6481035|NCT01308008|7398225|FG001|COMPLETED|4 Weeks||71
6481036|NCT01308008|7398224|FG000|NOT COMPLETED|4 Weeks||9
6481037|NCT01308008|7398225|FG001|NOT COMPLETED|4 Weeks||2
6481038|NCT01308008|7398224|FG000|STARTED|6 Months||62
6481039|NCT01308008|7398225|FG001|STARTED|6 Months||71
6481040|NCT01308008|7398224|FG000|COMPLETED|6 Months||54
6481041|NCT01308008|7398225|FG001|COMPLETED|6 Months||62
6481042|NCT01308008|7398224|FG000|NOT COMPLETED|6 Months||8
6481043|NCT01308008|7398225|FG001|NOT COMPLETED|6 Months||9
6481044|NCT01308008|7398224|FG000|STARTED|12 Months||54
6481045|NCT01308008|7398225|FG001|STARTED|12 Months||62
6481046|NCT01308008|7398224|FG000|COMPLETED|12 Months||46
6481047|NCT01308008|7398225|FG001|COMPLETED|12 Months||58
6481048|NCT01308008|7398224|FG000|NOT COMPLETED|12 Months||8
6481049|NCT01308008|7398225|FG001|NOT COMPLETED|12 Months||4
6481050|NCT01308060|7398233|FG000|STARTED|Part A||252
6481051|NCT01308060|7398234|FG001|STARTED|Part A||83
6481052|NCT01308060|7398233|FG000|COMPLETED|Part A||238
6481053|NCT01308060|7398234|FG001|COMPLETED|Part A||77
6481054|NCT01308060|7398233|FG000|NOT COMPLETED|Part A||14
6481055|NCT01308060|7398234|FG001|NOT COMPLETED|Part A||6
6481056|NCT01308060|7398233|FG000|STARTED|Part B||238
6481057|NCT01308060|7398234|FG001|STARTED|Part B||77
6481058|NCT01308060|7398233|FG000|COMPLETED|Part B||219
6481059|NCT01308060|7398234|FG001|COMPLETED|Part B||69
6481060|NCT01308060|7398233|FG000|NOT COMPLETED|Part B||19
6481061|NCT01308060|7398234|FG001|NOT COMPLETED|Part B||8
6481062|NCT01308294|7398244|FG000|STARTED|Cycle 1||10
6481063|NCT01308294|7398245|FG001|STARTED|Cycle 1||6
6481064|NCT01308294|7398246|FG002|STARTED|Cycle 1||0
6481065|NCT01308294|7398244|FG000|COMPLETED|Cycle 1||10
6481066|NCT01308294|7398245|FG001|COMPLETED|Cycle 1||6
6481067|NCT01308294|7398246|FG002|COMPLETED|Cycle 1||0
6481068|NCT01308294|7398244|FG000|NOT COMPLETED|Cycle 1||0
6481069|NCT01308294|7398245|FG001|NOT COMPLETED|Cycle 1||0
6481070|NCT01308294|7398246|FG002|NOT COMPLETED|Cycle 1||0
6481071|NCT01308294|7398244|FG000|STARTED|Cycle 2||10
6481072|NCT01308294|7398245|FG001|STARTED|Cycle 2||6
6481073|NCT01308294|7398246|FG002|STARTED|Cycle 2||0
6481074|NCT01308294|7398244|FG000|COMPLETED|Cycle 2||10
6481075|NCT01308294|7398245|FG001|COMPLETED|Cycle 2||5
6481076|NCT01308294|7398246|FG002|COMPLETED|Cycle 2||0
6481077|NCT01308294|7398244|FG000|NOT COMPLETED|Cycle 2||0
6481078|NCT01308294|7398245|FG001|NOT COMPLETED|Cycle 2||1
6481079|NCT01308294|7398246|FG002|NOT COMPLETED|Cycle 2||0
6481080|NCT01308294|7398244|FG000|STARTED|Cycle 3||10
6481081|NCT01308294|7398245|FG001|STARTED|Cycle 3||5
6481082|NCT01308294|7398246|FG002|STARTED|Cycle 3||0
6481083|NCT01308294|7398244|FG000|COMPLETED|Cycle 3||10
6481084|NCT01308294|7398245|FG001|COMPLETED|Cycle 3||4
6481085|NCT01308294|7398246|FG002|COMPLETED|Cycle 3||0
6481086|NCT01308294|7398244|FG000|NOT COMPLETED|Cycle 3||0
6481087|NCT01308294|7398245|FG001|NOT COMPLETED|Cycle 3||1
6481088|NCT01308294|7398246|FG002|NOT COMPLETED|Cycle 3||0
6481089|NCT01308424|7398259|FG000|STARTED|Baseline Eligibility||242
6481090|NCT01308424|7398260|FG001|STARTED|Baseline Eligibility||0
6481091|NCT01308424|7398261|FG002|STARTED|Baseline Eligibility||0
6481092|NCT01308424|7398259|FG000|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
6481093|NCT01308424|7398260|FG001|COMPLETED|Baseline Eligibility||0
6481094|NCT01308424|7398261|FG002|COMPLETED|Baseline Eligibility||0
6481095|NCT01308424|7398259|FG000|NOT COMPLETED|Baseline Eligibility||71
6481096|NCT01308424|7398260|FG001|NOT COMPLETED|Baseline Eligibility||0
6481097|NCT01308424|7398261|FG002|NOT COMPLETED|Baseline Eligibility||0
6481098|NCT01308424|7398259|FG000|STARTED|Randomization||0
6481099|NCT01308424|7398260|FG001|STARTED|Randomization||87
6481100|NCT01308424|7398261|FG002|STARTED|Randomization||84
6481101|NCT01308424|7398259|FG000|COMPLETED|Randomization||0
6481102|NCT01308424|7398260|FG001|COMPLETED|Randomization||84
6481103|NCT01308424|7398261|FG002|COMPLETED|Randomization||82
6481104|NCT01308424|7398259|FG000|NOT COMPLETED|Randomization||0
6481105|NCT01308424|7398260|FG001|NOT COMPLETED|Randomization||3
6481106|NCT01308424|7398261|FG002|NOT COMPLETED|Randomization||2
6481107|NCT01308450|7398268|FG000|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
6481108|NCT01308450|7398268|FG000|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
6481109|NCT01308450|7398268|FG000|NOT COMPLETED|Overall Study||2
6481110|NCT01308463|7398272|FG000|STARTED|Overall Study||29
6481111|NCT01308463|7398272|FG000|6 Months|Overall Study||23
6481112|NCT01308463|7398272|FG000|1 Year|Overall Study||21
6481113|NCT01308463|7398272|FG000|2 Years|Overall Study||18
6481114|NCT01308463|7398272|FG000|3 Years|Overall Study||17
6481115|NCT01308463|7398272|FG000|4 Years|Overall Study||20
6481116|NCT01308463|7398272|FG000|5 Years|Overall Study||20
6481117|NCT01308463|7398272|FG000|6 Years|Overall Study||11
6481118|NCT01308463|7398272|FG000|7 Years|Overall Study||12
6481119|NCT01308463|7398272|FG000|8 Years|Overall Study||14
6481120|NCT01308463|7398272|FG000|9 Years|Overall Study||11
6481121|NCT01308463|7398272|FG000|10 Years|Overall Study||8
6481122|NCT01308463|7398272|FG000|11 Years|Overall Study||8
6481123|NCT01308463|7398272|FG000|12 Years|Overall Study||2
6481124|NCT01308463|7398272|FG000|COMPLETED|Overall Study||0
6481125|NCT01308463|7398272|FG000|NOT COMPLETED|Overall Study||29
6481126|NCT01308476|7398278|FG000|STARTED|Overall Study|Entered and treated.|48
6481127|NCT01308476|7398279|FG001|STARTED|Overall Study|Entered and treated.|47
6481128|NCT01308476|7398278|FG000|COMPLETED|Overall Study||45
6481129|NCT01308476|7398279|FG001|COMPLETED|Overall Study||45
6481130|NCT01308476|7398278|FG000|NOT COMPLETED|Overall Study||3
6481131|NCT01308476|7398279|FG001|NOT COMPLETED|Overall Study||2
6481132|NCT01308567|7398288|FG000|STARTED|Overall Study|Randomized|391
6481133|NCT01308567|7398289|FG001|STARTED|Overall Study|Randomized|389
6481134|NCT01308567|7398290|FG002|STARTED|Overall Study|Randomized|388
6481135|NCT01308567|7398288|FG000|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
6481136|NCT01308567|7398289|FG001|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
6481137|NCT01308567|7398290|FG002|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
6481138|NCT01308567|7398288|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
6481139|NCT01308567|7398289|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
6481140|NCT01308567|7398290|FG002|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
6481141|NCT01308567|7398288|FG000|NOT COMPLETED|Overall Study||2
6481142|NCT01308567|7398289|FG001|NOT COMPLETED|Overall Study||4
6481143|NCT01308567|7398290|FG002|NOT COMPLETED|Overall Study||4
6481144|NCT01308580|7398300|FG000|STARTED|Overall Study||598
6481145|NCT01308580|7398301|FG001|STARTED|Overall Study||602
6481146|NCT01308580|7398300|FG000|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
6481147|NCT01308580|7398301|FG001|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
6481148|NCT01308580|7398300|FG000|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
6481149|NCT01308580|7398301|FG001|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
6481150|NCT01308580|7398300|FG000|NOT COMPLETED|Overall Study||12
6481151|NCT01308580|7398301|FG001|NOT COMPLETED|Overall Study||7
6481152|NCT01308619|7398310|FG000|STARTED|Overall Study||84
6481153|NCT01308619|7398311|FG001|STARTED|Overall Study||86
6481154|NCT01308619|7398310|FG000|COMPLETED|Overall Study||77
6481155|NCT01308619|7398311|FG001|COMPLETED|Overall Study||83
6481156|NCT01308619|7398310|FG000|NOT COMPLETED|Overall Study||7
6481157|NCT01308619|7398311|FG001|NOT COMPLETED|Overall Study||3
6481158|NCT01308736|7398321|FG000|STARTED|Overall Study||31
6481159|NCT01308736|7398322|FG001|STARTED|Overall Study||32
6481160|NCT01308736|7398321|FG000|COMPLETED|Overall Study||25
6481161|NCT01308736|7398322|FG001|COMPLETED|Overall Study||27
6481162|NCT01308736|7398321|FG000|NOT COMPLETED|Overall Study||6
6481163|NCT01308736|7398322|FG001|NOT COMPLETED|Overall Study||5
6481164|NCT01308749|7398330|FG000|STARTED|Period 1: Double Blind Treatment||12
6481165|NCT01308749|7398331|FG001|STARTED|Period 1: Double Blind Treatment||13
6481166|NCT01308749|7398330|FG000|COMPLETED|Period 1: Double Blind Treatment||11
6481167|NCT01308749|7398331|FG001|COMPLETED|Period 1: Double Blind Treatment||13
6481168|NCT01308749|7398330|FG000|NOT COMPLETED|Period 1: Double Blind Treatment||1
6481169|NCT01308749|7398331|FG001|NOT COMPLETED|Period 1: Double Blind Treatment||0
6481170|NCT01308749|7398330|FG000|STARTED|Period 2: Open Label Treatment||11
6481171|NCT01308749|7398331|FG001|STARTED|Period 2: Open Label Treatment||13
6481172|NCT01308749|7398330|FG000|COMPLETED|Period 2: Open Label Treatment||11
6481173|NCT01308749|7398331|FG001|COMPLETED|Period 2: Open Label Treatment||11
6481174|NCT01308749|7398330|FG000|NOT COMPLETED|Period 2: Open Label Treatment||0
6481175|NCT01308749|7398331|FG001|NOT COMPLETED|Period 2: Open Label Treatment||2
6481176|NCT01308762|7398354|FG000|STARTED|Overall Study||6
6481177|NCT01308762|7398355|FG001|STARTED|Overall Study||7
6481178|NCT01308762|7398356|FG002|STARTED|Overall Study||6
6481179|NCT01308762|7398354|FG000|COMPLETED|Overall Study||6
6481180|NCT01308762|7398355|FG001|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
6481181|NCT01308762|7398356|FG002|COMPLETED|Overall Study||6
6481182|NCT01308762|7398354|FG000|NOT COMPLETED|Overall Study||0
6481183|NCT01308762|7398355|FG001|NOT COMPLETED|Overall Study||1
6481184|NCT01308762|7398356|FG002|NOT COMPLETED|Overall Study||0
6481185|NCT01308788|7398369|FG000|STARTED|6-month Treatment||14
6481186|NCT01308788|7398370|FG001|STARTED|6-month Treatment||21
6481187|NCT01308788|7398369|FG000|COMPLETED|6-month Treatment||14
6481188|NCT01308788|7398370|FG001|COMPLETED|6-month Treatment||21
6481189|NCT01308788|7398369|FG000|NOT COMPLETED|6-month Treatment||0
6481190|NCT01308788|7398370|FG001|NOT COMPLETED|6-month Treatment||0
6481191|NCT01308788|7398369|FG000|STARTED|2-year Treatment||14
6481192|NCT01308788|7398370|FG001|STARTED|2-year Treatment||21
6481193|NCT01308788|7398369|FG000|COMPLETED|2-year Treatment||10
6481194|NCT01308788|7398370|FG001|COMPLETED|2-year Treatment||10
6481195|NCT01308788|7398369|FG000|NOT COMPLETED|2-year Treatment||4
6481196|NCT01308788|7398370|FG001|NOT COMPLETED|2-year Treatment||11
6481197|NCT01308814|7398378|FG000|STARTED|Overall Study||86
6481198|NCT01308814|7398379|FG001|STARTED|Overall Study||86
6481199|NCT01308814|7398378|FG000|COMPLETED|Overall Study||69
6481200|NCT01308814|7398379|FG001|COMPLETED|Overall Study||63
6481201|NCT01308814|7398378|FG000|NOT COMPLETED|Overall Study||17
6481202|NCT01308814|7398379|FG001|NOT COMPLETED|Overall Study||23
6481203|NCT01308840|7398385|FG000|STARTED|Overall Study||31
6481204|NCT01308840|7398385|FG000|COMPLETED|Overall Study||31
6481205|NCT01308840|7398385|FG000|NOT COMPLETED|Overall Study||0
6481206|NCT01308853|7398389|FG000|STARTED|Overall Study||24
6481207|NCT01308853|7398389|FG000|COMPLETED|Overall Study||20
6481208|NCT01308853|7398389|FG000|NOT COMPLETED|Overall Study||4
6481209|NCT01308918|7398393|FG000|STARTED|Overall Study||50
6481210|NCT01308918|7398393|FG000|COMPLETED|Overall Study||50
6481211|NCT01308918|7398393|FG000|NOT COMPLETED|Overall Study||0
6481212|NCT01309100|7398397|FG000|STARTED|Overall Study||144
6481213|NCT01309100|7398397|FG000|COMPLETED|Overall Study||142
6481214|NCT01309100|7398397|FG000|NOT COMPLETED|Overall Study||2
6481215|NCT01309165|7398406|FG000|STARTED|Overall Study||19
6481216|NCT01309165|7398407|FG001|STARTED|Overall Study||16
6481217|NCT01309165|7398406|FG000|Received Allocated Intervention|Overall Study||16
6481218|NCT01309165|7398407|FG001|Received Allocated Intervention|Overall Study||14
6481219|NCT01309165|7398406|FG000|Included in Primary Analysis|Overall Study||14
6481220|NCT01309165|7398407|FG001|Included in Primary Analysis|Overall Study||12
6481221|NCT01309165|7398406|FG000|COMPLETED|Overall Study||13
6481222|NCT01309165|7398407|FG001|COMPLETED|Overall Study||9
6481223|NCT01309165|7398406|FG000|NOT COMPLETED|Overall Study||6
6481224|NCT01309165|7398407|FG001|NOT COMPLETED|Overall Study||7
6481225|NCT01309204|7398416|FG000|STARTED|Overall Study||452
6481226|NCT01309204|7398417|FG001|STARTED|Overall Study||436
6481227|NCT01309204|7398416|FG000|COMPLETED|Overall Study||385
6481228|NCT01309204|7398417|FG001|COMPLETED|Overall Study||361
6481229|NCT01309204|7398416|FG000|NOT COMPLETED|Overall Study||67
6481230|NCT01309204|7398417|FG001|NOT COMPLETED|Overall Study||75
6481231|NCT01309243|7398425|FG000|STARTED|Randomized Phase Through Week 96||400
6481232|NCT01309243|7398426|FG001|STARTED|Randomized Phase Through Week 96||399
6481233|NCT01309243|7398425|FG000|Randomized and Treated|Randomized Phase Through Week 96||394
6481234|NCT01309243|7398426|FG001|Randomized and Treated|Randomized Phase Through Week 96||392
6481235|NCT01309243|7398425|FG000|COMPLETED|Randomized Phase Through Week 96||316
6481236|NCT01309243|7398426|FG001|COMPLETED|Randomized Phase Through Week 96||290
6481237|NCT01309243|7398425|FG000|NOT COMPLETED|Randomized Phase Through Week 96||84
6481238|NCT01309243|7398426|FG001|NOT COMPLETED|Randomized Phase Through Week 96||109
6481239|NCT01309243|7398425|FG000|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
6481240|NCT01309243|7398426|FG001|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
6481241|NCT01309243|7398425|FG000|COMPLETED|Extension Phase||34
6481242|NCT01309243|7398426|FG001|COMPLETED|Extension Phase||117
6481243|NCT01309243|7398425|FG000|NOT COMPLETED|Extension Phase||6
6481244|NCT01309243|7398426|FG001|NOT COMPLETED|Extension Phase||0
6481245|NCT01309269|7398432|FG000|STARTED|Overall Study||1085
6481246|NCT01309269|7398432|FG000|Treated|Overall Study||978
6481247|NCT01309269|7398432|FG000|COMPLETED|Overall Study||245
6481248|NCT01309269|7398432|FG000|NOT COMPLETED|Overall Study||840
6481249|NCT01309282|7398436|FG000|STARTED|Overall Study||9
6481250|NCT01309282|7398436|FG000|COMPLETED|Overall Study||8
6481251|NCT01309282|7398436|FG000|NOT COMPLETED|Overall Study||1
6481252|NCT01309308|7398442|FG000|STARTED|Overall Study||75
6481253|NCT01309308|7398443|FG001|STARTED|Overall Study||75
6481254|NCT01309308|7398442|FG000|COMPLETED|Overall Study||69
6481255|NCT01309308|7398443|FG001|COMPLETED|Overall Study||71
6481256|NCT01309308|7398442|FG000|NOT COMPLETED|Overall Study||6
6481257|NCT01309308|7398443|FG001|NOT COMPLETED|Overall Study||4
6481258|NCT01309360|7398452|FG000|STARTED|Overall Study||40
6481259|NCT01309360|7398453|FG001|STARTED|Overall Study||40
6481260|NCT01309360|7398454|FG002|STARTED|Overall Study||40
6481261|NCT01309360|7398452|FG000|COMPLETED|Overall Study||40
6481262|NCT01309360|7398453|FG001|COMPLETED|Overall Study||40
6481263|NCT01309360|7398454|FG002|COMPLETED|Overall Study||40
6481264|NCT01309360|7398452|FG000|NOT COMPLETED|Overall Study||0
6481265|NCT01309360|7398453|FG001|NOT COMPLETED|Overall Study||0
6481266|NCT01309360|7398454|FG002|NOT COMPLETED|Overall Study||0
6481267|NCT01309386|7398464|FG000|STARTED|Overall Study||50
6481268|NCT01309386|7398465|FG001|STARTED|Overall Study||50
6481269|NCT01309386|7398464|FG000|COMPLETED|Overall Study||28
6481270|NCT01309386|7398465|FG001|COMPLETED|Overall Study||29
6481271|NCT01309386|7398464|FG000|NOT COMPLETED|Overall Study||22
6481272|NCT01309386|7398465|FG001|NOT COMPLETED|Overall Study||21
6481273|NCT01309451|7398473|FG000|STARTED|Overall Study|unit of measure is number of eyes|19
6481274|NCT01309451|7398474|FG001|STARTED|Overall Study|unit of measure is number of eyes|21
6481275|NCT01309451|7398473|FG000|COMPLETED|Overall Study|unit of measure is number of eyes|17
6481276|NCT01309451|7398474|FG001|COMPLETED|Overall Study|unit of measure is number of eyes|18
6481277|NCT01309451|7398473|FG000|NOT COMPLETED|Overall Study||2
6554761|NCT01748695|7476913|FG001|STARTED|First Intervention (4 Weeks)||11
6554762|NCT01748695|7476912|FG000|COMPLETED|First Intervention (4 Weeks)||14
6554763|NCT01748695|7476913|FG001|COMPLETED|First Intervention (4 Weeks)||11
6481278|NCT01309451|7398474|FG001|NOT COMPLETED|Overall Study||3
6481279|NCT01309646|7398484|FG000|STARTED|Overall Study||224
6481280|NCT01309646|7398485|FG001|STARTED|Overall Study||227
6481281|NCT01309646|7398484|FG000|COMPLETED|Overall Study||224
6481282|NCT01309646|7398485|FG001|COMPLETED|Overall Study||227
6481283|NCT01309646|7398484|FG000|NOT COMPLETED|Overall Study||0
6481284|NCT01309646|7398485|FG001|NOT COMPLETED|Overall Study||0
6481285|NCT01309659|7398493|FG000|STARTED|Overall Study||9
6481286|NCT01309659|7398494|FG001|STARTED|Overall Study||10
6481287|NCT01309659|7398493|FG000|COMPLETED|Overall Study||9
6481288|NCT01309659|7398494|FG001|COMPLETED|Overall Study||9
6481289|NCT01309659|7398493|FG000|NOT COMPLETED|Overall Study||0
6481290|NCT01309659|7398494|FG001|NOT COMPLETED|Overall Study||1
6481291|NCT01309737|7398503|FG000|STARTED|Week 0 to 16||383
6481292|NCT01309737|7398504|FG001|STARTED|Week 0 to 16||381
6481293|NCT01309737|7398505|FG002|STARTED|Week 0 to 16||196
6481294|NCT01309737|7398506|FG003|STARTED|Week 0 to 16||0
6481295|NCT01309737|7398507|FG004|STARTED|Week 0 to 16||0
6481296|NCT01309737|7398503|FG000|Treated|Week 0 to 16||382
6481297|NCT01309737|7398504|FG001|Treated|Week 0 to 16||381
6481298|NCT01309737|7398505|FG002|Treated|Week 0 to 16||196
6481299|NCT01309737|7398506|FG003|Treated|Week 0 to 16||0
6554764|NCT01748695|7476912|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6554765|NCT01748695|7476913|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6554766|NCT01748695|7476912|FG000|STARTED|Second Intervention (4 Weeks)||14
6554767|NCT01748695|7476913|FG001|STARTED|Second Intervention (4 Weeks)||11
6554768|NCT01748695|7476912|FG000|COMPLETED|Second Intervention (4 Weeks)||14
6481300|NCT01309737|7398507|FG004|Treated|Week 0 to 16||0
6481301|NCT01309737|7398503|FG000|COMPLETED|Week 0 to 16||331
6481302|NCT01309737|7398504|FG001|COMPLETED|Week 0 to 16||341
6481303|NCT01309737|7398505|FG002|COMPLETED|Week 0 to 16||152
6481304|NCT01309737|7398506|FG003|COMPLETED|Week 0 to 16||0
6481305|NCT01309737|7398507|FG004|COMPLETED|Week 0 to 16||0
6481306|NCT01309737|7398503|FG000|NOT COMPLETED|Week 0 to 16||52
6481307|NCT01309737|7398504|FG001|NOT COMPLETED|Week 0 to 16||40
6481308|NCT01309737|7398505|FG002|NOT COMPLETED|Week 0 to 16||44
6481309|NCT01309737|7398506|FG003|NOT COMPLETED|Week 0 to 16||0
6481310|NCT01309737|7398507|FG004|NOT COMPLETED|Week 0 to 16||0
6481311|NCT01309737|7398503|FG000|STARTED|Week 16 to 52||331
6481312|NCT01309737|7398504|FG001|STARTED|Week 16 to 52||341
6481313|NCT01309737|7398505|FG002|STARTED|Week 16 to 52||0
6481314|NCT01309737|7398506|FG003|STARTED|Week 16 to 52||75
6481315|NCT01309737|7398507|FG004|STARTED|Week 16 to 52||77
6481316|NCT01309737|7398503|FG000|COMPLETED|Week 16 to 52||198
6481317|NCT01309737|7398504|FG001|COMPLETED|Week 16 to 52||238
6481318|NCT01309737|7398505|FG002|COMPLETED|Week 16 to 52||0
6481319|NCT01309737|7398506|FG003|COMPLETED|Week 16 to 52||41
6481320|NCT01309737|7398507|FG004|COMPLETED|Week 16 to 52||44
6481321|NCT01309737|7398503|FG000|NOT COMPLETED|Week 16 to 52||133
6481322|NCT01309737|7398504|FG001|NOT COMPLETED|Week 16 to 52||103
6481323|NCT01309737|7398505|FG002|NOT COMPLETED|Week 16 to 52||0
6481324|NCT01309737|7398506|FG003|NOT COMPLETED|Week 16 to 52||34
6481325|NCT01309737|7398507|FG004|NOT COMPLETED|Week 16 to 52||33
6481326|NCT01309802|7398532|FG000|STARTED|Overall Study||25
6481327|NCT01309802|7398533|FG001|STARTED|Overall Study||23
6481328|NCT01309802|7398532|FG000|COMPLETED|Overall Study||13
6481329|NCT01309802|7398533|FG001|COMPLETED|Overall Study||14
6481330|NCT01309802|7398532|FG000|NOT COMPLETED|Overall Study||12
6481331|NCT01309802|7398533|FG001|NOT COMPLETED|Overall Study||9
6481332|NCT01309828|7398541|FG000|STARTED|Overall Study||77
6481333|NCT01309828|7398542|FG001|STARTED|Overall Study||76
6481334|NCT01309828|7398541|FG000|COMPLETED|Overall Study||61
6481335|NCT01309828|7398542|FG001|COMPLETED|Overall Study||60
6481336|NCT01309828|7398541|FG000|NOT COMPLETED|Overall Study||16
6481337|NCT01309828|7398542|FG001|NOT COMPLETED|Overall Study||16
6481338|NCT01309841|7398551|FG000|STARTED|Overall Study||217
6481339|NCT01309841|7398552|FG001|STARTED|Overall Study||218
6481340|NCT01309841|7398553|FG002|STARTED|Overall Study||217
6481341|NCT01309841|7398551|FG000|COMPLETED|Overall Study||178
6481342|NCT01309841|7398552|FG001|COMPLETED|Overall Study||177
6481343|NCT01309841|7398553|FG002|COMPLETED|Overall Study||180
6481344|NCT01309841|7398551|FG000|NOT COMPLETED|Overall Study||39
6481345|NCT01309841|7398552|FG001|NOT COMPLETED|Overall Study||41
6481346|NCT01309841|7398553|FG002|NOT COMPLETED|Overall Study||37
6481347|NCT01309867|7398561|FG000|STARTED|Overall Study||151
6481348|NCT01309867|7398562|FG001|STARTED|Overall Study||151
6481349|NCT01309867|7398561|FG000|COMPLETED|Overall Study||148
6481350|NCT01309867|7398562|FG001|COMPLETED|Overall Study||139
6481351|NCT01309867|7398561|FG000|NOT COMPLETED|Overall Study||3
6481352|NCT01309867|7398562|FG001|NOT COMPLETED|Overall Study||12
6481353|NCT01309880|7398568|FG000|STARTED|Overall Study||33
6481354|NCT01309880|7398569|FG001|STARTED|Overall Study||33
6481355|NCT01309880|7398568|FG000|COMPLETED|Overall Study||33
6481356|NCT01309880|7398569|FG001|COMPLETED|Overall Study||33
6481357|NCT01309880|7398568|FG000|NOT COMPLETED|Overall Study||0
6481358|NCT01309880|7398569|FG001|NOT COMPLETED|Overall Study||0
6481359|NCT01309893|7398575|FG000|STARTED|Week 1 - First Intervention||33
6481360|NCT01309893|7398576|FG001|STARTED|Week 1 - First Intervention||33
6481361|NCT01309893|7398575|FG000|COMPLETED|Week 1 - First Intervention||33
6481362|NCT01309893|7398576|FG001|COMPLETED|Week 1 - First Intervention||33
6481363|NCT01309893|7398575|FG000|NOT COMPLETED|Week 1 - First Intervention||0
6481364|NCT01309893|7398576|FG001|NOT COMPLETED|Week 1 - First Intervention||0
6481365|NCT01309893|7398575|FG000|STARTED|Week 2 - Crossover Intervention||33
6481366|NCT01309893|7398576|FG001|STARTED|Week 2 - Crossover Intervention||33
6481367|NCT01309893|7398575|FG000|COMPLETED|Week 2 - Crossover Intervention||32
6481368|NCT01309893|7398576|FG001|COMPLETED|Week 2 - Crossover Intervention||32
6481369|NCT01309893|7398575|FG000|NOT COMPLETED|Week 2 - Crossover Intervention||1
6481370|NCT01309893|7398576|FG001|NOT COMPLETED|Week 2 - Crossover Intervention||1
6481371|NCT01309906|7398582|FG000|STARTED|Overall Study||33
6481372|NCT01309906|7398583|FG001|STARTED|Overall Study||33
6481373|NCT01309906|7398582|FG000|COMPLETED|Overall Study||32
6481374|NCT01309906|7398583|FG001|COMPLETED|Overall Study||32
6481375|NCT01309906|7398582|FG000|NOT COMPLETED|Overall Study||1
6481376|NCT01309906|7398583|FG001|NOT COMPLETED|Overall Study||1
6481377|NCT01309919|7398591|FG000|STARTED|Overall Study||75
6481378|NCT01309919|7398592|FG001|STARTED|Overall Study||75
6481379|NCT01309919|7398591|FG000|COMPLETED|Overall Study||58
6481380|NCT01309919|7398592|FG001|COMPLETED|Overall Study||27
6481381|NCT01309919|7398591|FG000|NOT COMPLETED|Overall Study||17
6481382|NCT01309919|7398592|FG001|NOT COMPLETED|Overall Study||48
6481383|NCT01309997|7398600|FG000|STARTED|Overall Study||35
6481384|NCT01309997|7398601|FG001|STARTED|Overall Study||37
6481385|NCT01309997|7398600|FG000|Remained on First Arm Only|Overall Study||16
6481386|NCT01309997|7398601|FG001|Remained on First Arm Only|Overall Study||14
6481387|NCT01309997|7398600|FG000|Crossed Over to Second Arm|Overall Study||19
6481388|NCT01309997|7398601|FG001|Crossed Over to Second Arm|Overall Study||23
6481389|NCT01309997|7398600|FG000|COMPLETED|Overall Study||30
6481390|NCT01309997|7398601|FG001|COMPLETED|Overall Study||31
6481391|NCT01309997|7398600|FG000|NOT COMPLETED|Overall Study||5
6481392|NCT01309997|7398601|FG001|NOT COMPLETED|Overall Study||6
6481393|NCT01310036|7398618|FG000|STARTED|Overall Study||208
6481394|NCT01310036|7398618|FG000|COMPLETED|Overall Study||6
6481395|NCT01310036|7398618|FG000|NOT COMPLETED|Overall Study||202
6481396|NCT01310075|7398624|FG000|STARTED|Overall Study||45
6481397|NCT01310075|7398625|FG001|STARTED|Overall Study||45
6481398|NCT01310075|7398624|FG000|COMPLETED|Overall Study||31
6481399|NCT01310075|7398625|FG001|COMPLETED|Overall Study||35
6481400|NCT01310075|7398624|FG000|NOT COMPLETED|Overall Study||14
6481401|NCT01310075|7398625|FG001|NOT COMPLETED|Overall Study||10
6481402|NCT01310127|7398633|FG000|STARTED|Overall Study||12
6481403|NCT01310127|7398634|FG001|STARTED|Overall Study||11
6481404|NCT01310127|7398633|FG000|COMPLETED|Overall Study||10
6481405|NCT01310127|7398634|FG001|COMPLETED|Overall Study||10
6481406|NCT01310127|7398633|FG000|NOT COMPLETED|Overall Study||2
6481407|NCT01310127|7398634|FG001|NOT COMPLETED|Overall Study||1
6481408|NCT01310179|7398640|FG000|STARTED|Overall Study||12
6481409|NCT01310179|7398640|FG000|COMPLETED|Overall Study||12
6481410|NCT01310179|7398640|FG000|NOT COMPLETED|Overall Study||0
6481411|NCT01310231|7398646|FG000|STARTED|Overall Study||22
6481412|NCT01310231|7398647|FG001|STARTED|Overall Study||18
6481413|NCT01310231|7398646|FG000|Received Intervention|Overall Study||22
6481414|NCT01310231|7398647|FG001|Received Intervention|Overall Study||17
6481415|NCT01310231|7398646|FG000|Discontinued Intervention|Overall Study||0
6481416|NCT01310231|7398647|FG001|Discontinued Intervention|Overall Study||1
6481417|NCT01310231|7398646|FG000|Analyzed for Survival|Overall Study||22
6481418|NCT01310231|7398647|FG001|Analyzed for Survival|Overall Study||18
6481419|NCT01310231|7398646|FG000|Analyzed for Response, Toxicity, QOL|Overall Study||22
6481420|NCT01310231|7398647|FG001|Analyzed for Response, Toxicity, QOL|Overall Study||17
6481421|NCT01310231|7398646|FG000|COMPLETED|Overall Study||22
6481422|NCT01310231|7398647|FG001|COMPLETED|Overall Study||17
6481423|NCT01310231|7398646|FG000|NOT COMPLETED|Overall Study||0
6481424|NCT01310231|7398647|FG001|NOT COMPLETED|Overall Study||1
6481425|NCT01310400|7398656|FG000|STARTED|Overall Study||452
6481426|NCT01310400|7398657|FG001|STARTED|Overall Study||452
6481427|NCT01310400|7398658|FG002|STARTED|Overall Study||452
6481428|NCT01310400|7398656|FG000|COMPLETED|Overall Study||424
6481429|NCT01310400|7398657|FG001|COMPLETED|Overall Study||420
6481430|NCT01310400|7398658|FG002|COMPLETED|Overall Study||422
6481431|NCT01310400|7398656|FG000|NOT COMPLETED|Overall Study||28
6481432|NCT01310400|7398657|FG001|NOT COMPLETED|Overall Study||32
6481433|NCT01310400|7398658|FG002|NOT COMPLETED|Overall Study||30
6481434|NCT01310413|7398675|FG000|STARTED|Day 0 to Day 385||199
6481435|NCT01310413|7398676|FG001|STARTED|Day 0 to Day 385||198
6481436|NCT01310413|7398677|FG002|STARTED|Day 0 to Day 385||210
6481437|NCT01310413|7398678|FG003|STARTED|Day 0 to Day 385||75
6481438|NCT01310413|7398679|FG004|STARTED|Day 0 to Day 385||76
6481439|NCT01310413|7398680|FG005|STARTED|Day 0 to Day 385||80
6481440|NCT01310413|7398681|FG006|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
6481441|NCT01310413|7398675|FG000|COMPLETED|Day 0 to Day 385||172
6481442|NCT01310413|7398676|FG001|COMPLETED|Day 0 to Day 385||190
6481443|NCT01310413|7398677|FG002|COMPLETED|Day 0 to Day 385||203
6481444|NCT01310413|7398678|FG003|COMPLETED|Day 0 to Day 385||67
6481445|NCT01310413|7398679|FG004|COMPLETED|Day 0 to Day 385||73
6481446|NCT01310413|7398680|FG005|COMPLETED|Day 0 to Day 385||77
6481447|NCT01310413|7398681|FG006|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
6481448|NCT01310413|7398675|FG000|NOT COMPLETED|Day 0 to Day 385||27
6481449|NCT01310413|7398676|FG001|NOT COMPLETED|Day 0 to Day 385||8
6481450|NCT01310413|7398677|FG002|NOT COMPLETED|Day 0 to Day 385||7
6481451|NCT01310413|7398678|FG003|NOT COMPLETED|Day 0 to Day 385||8
6481452|NCT01310413|7398679|FG004|NOT COMPLETED|Day 0 to Day 385||3
6481453|NCT01310413|7398680|FG005|NOT COMPLETED|Day 0 to Day 385||3
6481454|NCT01310413|7398681|FG006|NOT COMPLETED|Day 0 to Day 385||0
6481455|NCT01310413|7398675|FG000|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6481456|NCT01310413|7398676|FG001|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6481457|NCT01310413|7398677|FG002|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6481458|NCT01310413|7398678|FG003|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6481459|NCT01310413|7398679|FG004|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6481460|NCT01310413|7398680|FG005|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6481461|NCT01310413|7398681|FG006|STARTED|From Day U0 to Day U385|Upto Day U42|155
6481462|NCT01310413|7398675|FG000|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6481463|NCT01310413|7398676|FG001|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6481464|NCT01310413|7398677|FG002|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
6481465|NCT01310413|7398678|FG003|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6481466|NCT01310413|7398679|FG004|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6481467|NCT01310413|7398680|FG005|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
6481468|NCT01310413|7398681|FG006|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
6481469|NCT01310413|7398675|FG000|NOT COMPLETED|From Day U0 to Day U385||0
6481470|NCT01310413|7398676|FG001|NOT COMPLETED|From Day U0 to Day U385||0
6481471|NCT01310413|7398677|FG002|NOT COMPLETED|From Day U0 to Day U385||0
6481472|NCT01310413|7398678|FG003|NOT COMPLETED|From Day U0 to Day U385||0
6481473|NCT01310413|7398679|FG004|NOT COMPLETED|From Day U0 to Day U385||0
6481474|NCT01310413|7398680|FG005|NOT COMPLETED|From Day U0 to Day U385||0
6554769|NCT01748695|7476913|FG001|COMPLETED|Second Intervention (4 Weeks)||11
6554770|NCT01748695|7476912|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6554771|NCT01748695|7476913|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
6554772|NCT01748760|7476921|FG000|STARTED|Overall Study||25
6481475|NCT01310413|7398681|FG006|NOT COMPLETED|From Day U0 to Day U385||3
6481476|NCT01310582|7398712|FG000|STARTED|Overall Study||31
6481477|NCT01310582|7398713|FG001|STARTED|Overall Study||26
6481478|NCT01310582|7398712|FG000|COMPLETED|Overall Study||31
6481479|NCT01310582|7398713|FG001|COMPLETED|Overall Study||26
6481480|NCT01310582|7398712|FG000|NOT COMPLETED|Overall Study||0
6481481|NCT01310582|7398713|FG001|NOT COMPLETED|Overall Study||0
6481482|NCT01310699|7398721|FG000|STARTED|Overall Study||132
6481483|NCT01310699|7398722|FG001|STARTED|Overall Study||149
6481484|NCT01310699|7398721|FG000|COMPLETED|Overall Study||128
6481485|NCT01310699|7398722|FG001|COMPLETED|Overall Study||143
6481486|NCT01310699|7398721|FG000|NOT COMPLETED|Overall Study||4
6481487|NCT01310699|7398722|FG001|NOT COMPLETED|Overall Study||6
6481488|NCT01310777|7398733|FG000|STARTED|Overall Study||193
6481489|NCT01310777|7398734|FG001|STARTED|Overall Study||192
6481490|NCT01310777|7398735|FG002|STARTED|Overall Study||175
6554773|NCT01748760|7476922|FG001|STARTED|Overall Study||25
6481491|NCT01310777|7398733|FG000|COMPLETED|Overall Study||160
6481492|NCT01310777|7398734|FG001|COMPLETED|Overall Study||178
6481493|NCT01310777|7398735|FG002|COMPLETED|Overall Study||145
6481494|NCT01310777|7398733|FG000|NOT COMPLETED|Overall Study||33
6481495|NCT01310777|7398734|FG001|NOT COMPLETED|Overall Study||14
6481496|NCT01310777|7398735|FG002|NOT COMPLETED|Overall Study||30
6481497|NCT01310855|7398745|FG000|STARTED|Overall Study||19
6481498|NCT01310855|7398746|FG001|STARTED|Overall Study||19
6481499|NCT01310855|7398745|FG000|COMPLETED|Overall Study||19
6481500|NCT01310855|7398746|FG001|COMPLETED|Overall Study||19
6481501|NCT01310855|7398745|FG000|NOT COMPLETED|Overall Study||0
6481502|NCT01310855|7398746|FG001|NOT COMPLETED|Overall Study||0
6481503|NCT01310868|7398752|FG000|STARTED|Overall Study||72
6481504|NCT01310868|7398752|FG000|COMPLETED|Overall Study||59
6481505|NCT01310868|7398752|FG000|NOT COMPLETED|Overall Study||13
6481506|NCT01311024|7398758|FG000|STARTED|Overall Study||1530
6481507|NCT01311024|7398759|FG001|STARTED|Overall Study||811
6481508|NCT01311024|7398758|FG000|COMPLETED|Overall Study||1495
6481509|NCT01311024|7398759|FG001|COMPLETED|Overall Study||789
6481510|NCT01311024|7398758|FG000|NOT COMPLETED|Overall Study||35
6481511|NCT01311024|7398759|FG001|NOT COMPLETED|Overall Study||22
6481512|NCT01311102|7398767|FG000|STARTED|Overall Study||20
6481513|NCT01311102|7398768|FG001|STARTED|Overall Study||20
6481514|NCT01311102|7398767|FG000|COMPLETED|Overall Study||20
6481515|NCT01311102|7398768|FG001|COMPLETED|Overall Study||20
6481516|NCT01311102|7398767|FG000|NOT COMPLETED|Overall Study||0
6481517|NCT01311102|7398768|FG001|NOT COMPLETED|Overall Study||0
6481518|NCT01311362|7398776|FG000|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
6481519|NCT01311362|7398776|FG000|COMPLETED|Ambrisentan Single Dose||20
6481520|NCT01311362|7398776|FG000|NOT COMPLETED|Ambrisentan Single Dose||0
6481521|NCT01311362|7398776|FG000|STARTED|Ambrisentan Steady-state||20
6481522|NCT01311362|7398776|FG000|COMPLETED|Ambrisentan Steady-state||20
6481523|NCT01311362|7398776|FG000|NOT COMPLETED|Ambrisentan Steady-state||0
6481524|NCT01311362|7398776|FG000|STARTED|Ambrisentan and SJW||20
6481525|NCT01311362|7398776|FG000|COMPLETED|Ambrisentan and SJW||20
6481526|NCT01311362|7398776|FG000|NOT COMPLETED|Ambrisentan and SJW||0
6481527|NCT01311505|7398785|FG000|STARTED|First Intervention Period||10
6481528|NCT01311505|7398786|FG001|STARTED|First Intervention Period||11
6481529|NCT01311505|7398785|FG000|COMPLETED|First Intervention Period||10
6748401|NCT03408730|7676455|FG001|STARTED|Overall Study||711
6748402|NCT03408730|7676456|FG002|STARTED|Overall Study||709
6748403|NCT03408730|7676457|FG003|STARTED|Overall Study||706
6748404|NCT03408730|7676454|FG000|COMPLETED|Overall Study||643
6748405|NCT03408730|7676455|FG001|COMPLETED|Overall Study||636
6748406|NCT03408730|7676456|FG002|COMPLETED|Overall Study||637
6748407|NCT03408730|7676457|FG003|COMPLETED|Overall Study||625
6748408|NCT03408730|7676454|FG000|NOT COMPLETED|Overall Study||69
6748409|NCT03408730|7676455|FG001|NOT COMPLETED|Overall Study||75
6748410|NCT03408730|7676456|FG002|NOT COMPLETED|Overall Study||72
6748411|NCT03408730|7676457|FG003|NOT COMPLETED|Overall Study||81
6748412|NCT03408808|7676473|FG000|STARTED|Overall Study||8
6748413|NCT03408808|7676474|FG001|STARTED|Overall Study||9
6748414|NCT03408808|7676473|FG000|COMPLETED|Overall Study||8
6748415|NCT03408808|7676474|FG001|COMPLETED|Overall Study||8
6748416|NCT03408808|7676473|FG000|NOT COMPLETED|Overall Study||0
6748417|NCT03408808|7676474|FG001|NOT COMPLETED|Overall Study||1
6748418|NCT03409107|7676482|FG000|STARTED|Overall Study||307
6748419|NCT03409107|7676483|FG001|STARTED|Overall Study||307
6748420|NCT03409107|7676482|FG000|COMPLETED|Overall Study||290
6748421|NCT03409107|7676483|FG001|COMPLETED|Overall Study||300
6748422|NCT03409107|7676482|FG000|NOT COMPLETED|Overall Study||17
6748423|NCT03409107|7676483|FG001|NOT COMPLETED|Overall Study||7
6748424|NCT03409796|7676491|FG000|STARTED|Overall Study||9
6748425|NCT03409796|7676492|FG001|STARTED|Overall Study||7
6748426|NCT03409796|7676491|FG000|COMPLETED|Overall Study||7
6748427|NCT03409796|7676492|FG001|COMPLETED|Overall Study||6
6748428|NCT03409796|7676491|FG000|NOT COMPLETED|Overall Study||2
6748429|NCT03409796|7676492|FG001|NOT COMPLETED|Overall Study||1
6748430|NCT03410056|7676502|FG000|STARTED|Overall Study||8
6748431|NCT03410056|7676503|FG001|STARTED|Overall Study||6
6748432|NCT03410056|7676504|FG002|STARTED|Overall Study||11
6748433|NCT03410056|7676505|FG003|STARTED|Overall Study||11
6748434|NCT03410056|7676506|FG004|STARTED|Overall Study||0
6748435|NCT03410056|7676507|FG005|STARTED|Overall Study||0
6748436|NCT03410056|7676508|FG006|STARTED|Overall Study||0
6748437|NCT03410056|7676502|FG000|Received Treatment|Overall Study||8
6748438|NCT03410056|7676503|FG001|Received Treatment|Overall Study||6
6748439|NCT03410056|7676504|FG002|Received Treatment|Overall Study||11
6748440|NCT03410056|7676505|FG003|Received Treatment|Overall Study||11
6748441|NCT03410056|7676506|FG004|Received Treatment|Overall Study||0
6481530|NCT01311505|7398786|FG001|COMPLETED|First Intervention Period||10
6481531|NCT01311505|7398785|FG000|NOT COMPLETED|First Intervention Period||0
6481532|NCT01311505|7398786|FG001|NOT COMPLETED|First Intervention Period||1
6481533|NCT01311505|7398785|FG000|STARTED|Washout Period (at Least 7 Days)||10
6481534|NCT01311505|7398786|FG001|STARTED|Washout Period (at Least 7 Days)||10
6748442|NCT03410056|7676507|FG005|Received Treatment|Overall Study||0
6748443|NCT03410056|7676508|FG006|Received Treatment|Overall Study||0
6748444|NCT03410056|7676502|FG000|COMPLETED|Overall Study||8
6748445|NCT03410056|7676503|FG001|COMPLETED|Overall Study||4
6748446|NCT03410056|7676504|FG002|COMPLETED|Overall Study||3
6481535|NCT01311505|7398785|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
6481536|NCT01311505|7398786|FG001|COMPLETED|Washout Period (at Least 7 Days)||10
6481537|NCT01311505|7398785|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6481538|NCT01311505|7398786|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6481539|NCT01311505|7398785|FG000|STARTED|Second Intervention Period||10
6481540|NCT01311505|7398786|FG001|STARTED|Second Intervention Period||10
6481541|NCT01311505|7398785|FG000|COMPLETED|Second Intervention Period||10
6748447|NCT03410056|7676505|FG003|COMPLETED|Overall Study||6
6748448|NCT03410056|7676506|FG004|COMPLETED|Overall Study||0
6748449|NCT03410056|7676507|FG005|COMPLETED|Overall Study||0
6748450|NCT03410056|7676508|FG006|COMPLETED|Overall Study||0
6748451|NCT03410056|7676502|FG000|NOT COMPLETED|Overall Study||0
6481542|NCT01311505|7398786|FG001|COMPLETED|Second Intervention Period||10
6481543|NCT01311505|7398785|FG000|NOT COMPLETED|Second Intervention Period||0
6481544|NCT01311505|7398786|FG001|NOT COMPLETED|Second Intervention Period||0
6481545|NCT01311557|7398797|FG000|STARTED|Overall Study||651
6481546|NCT01311557|7398798|FG001|STARTED|Overall Study||651
6481547|NCT01311557|7398797|FG000|COMPLETED|Overall Study||646
6481548|NCT01311557|7398798|FG001|COMPLETED|Overall Study||645
6481549|NCT01311557|7398797|FG000|NOT COMPLETED|Overall Study||5
6481550|NCT01311557|7398798|FG001|NOT COMPLETED|Overall Study||6
6481551|NCT01311648|7398807|FG000|STARTED|Main Study||51
6481552|NCT01311648|7398808|FG001|STARTED|Main Study||43
6481553|NCT01311648|7398807|FG000|Started 0-<6 Years|Main Study||25
6481554|NCT01311648|7398808|FG001|Started 0-<6 Years|Main Study||43
6481555|NCT01311648|7398807|FG000|Started 6-12 Years|Main Study||26
6481556|NCT01311648|7398808|FG001|Started 6-12 Years|Main Study||0
6481557|NCT01311648|7398807|FG000|COMPLETED|Main Study||51
6481558|NCT01311648|7398808|FG001|COMPLETED|Main Study||22
6481559|NCT01311648|7398807|FG000|NOT COMPLETED|Main Study||0
6481560|NCT01311648|7398808|FG001|NOT COMPLETED|Main Study||21
6481561|NCT01311648|7398807|FG000|STARTED|Extension Study||46
6481562|NCT01311648|7398808|FG001|STARTED|Extension Study||36
6481563|NCT01311648|7398807|FG000|COMPLETED|Extension Study||45
6481564|NCT01311648|7398808|FG001|COMPLETED|Extension Study||25
6481565|NCT01311648|7398807|FG000|NOT COMPLETED|Extension Study||1
6481566|NCT01311648|7398808|FG001|NOT COMPLETED|Extension Study||11
6481567|NCT01311661|7398821|FG000|STARTED|Overall Study|Entered and treated|206
6481568|NCT01311661|7398821|FG000|Received Placebo|Overall Study||201
6481569|NCT01311661|7398821|FG000|Received Olo 2.5 mcg Bid|Overall Study||101
6481570|NCT01311661|7398821|FG000|Received Olo 5 mcg qd|Overall Study||101
6481571|NCT01311661|7398821|FG000|Received Olo 5 mcg Bid|Overall Study||101
6481572|NCT01311661|7398821|FG000|Received Olo 10 mcg qd|Overall Study||102
6481573|NCT01311661|7398821|FG000|COMPLETED|Overall Study||199
6481574|NCT01311661|7398821|FG000|NOT COMPLETED|Overall Study||7
6481575|NCT01311674|7398835|FG000|STARTED|Overall Study||72
6481576|NCT01311674|7398836|FG001|STARTED|Overall Study||69
6481577|NCT01311674|7398835|FG000|COMPLETED|Overall Study||28
6481578|NCT01311674|7398836|FG001|COMPLETED|Overall Study||29
6481579|NCT01311674|7398835|FG000|NOT COMPLETED|Overall Study||44
6481580|NCT01311674|7398836|FG001|NOT COMPLETED|Overall Study||40
6481581|NCT01311687|7398845|FG000|STARTED|Treatment Phase||302
6481582|NCT01311687|7398846|FG001|STARTED|Treatment Phase||153
6481583|NCT01311687|7398845|FG000|Received Study Drug|Treatment Phase||300
6481584|NCT01311687|7398846|FG001|Received Study Drug|Treatment Phase||150
6748452|NCT03410056|7676503|FG001|NOT COMPLETED|Overall Study||2
6748453|NCT03410056|7676504|FG002|NOT COMPLETED|Overall Study||8
6748454|NCT03410056|7676505|FG003|NOT COMPLETED|Overall Study||5
6748455|NCT03410056|7676506|FG004|NOT COMPLETED|Overall Study||0
6748456|NCT03410056|7676507|FG005|NOT COMPLETED|Overall Study||0
6748457|NCT03410056|7676508|FG006|NOT COMPLETED|Overall Study||0
6748458|NCT03410628|7676524|FG000|STARTED|Overall Study||21
6748459|NCT03410628|7676524|FG000|COMPLETED|Overall Study||15
6748460|NCT03410628|7676524|FG000|NOT COMPLETED|Overall Study||6
6748461|NCT03410797|7676528|FG000|STARTED|Overall Study||11
6748462|NCT03410797|7676528|FG000|COMPLETED|Overall Study||11
6748463|NCT03410797|7676528|FG000|NOT COMPLETED|Overall Study||0
6748464|NCT03410862|7676535|FG000|STARTED|Overall Study||43
6748465|NCT03410862|7676536|FG001|STARTED|Overall Study||44
6748466|NCT03410862|7676535|FG000|COMPLETED|Overall Study||41
6748467|NCT03410862|7676536|FG001|COMPLETED|Overall Study||42
6748468|NCT03410862|7676535|FG000|NOT COMPLETED|Overall Study||2
6748469|NCT03410862|7676536|FG001|NOT COMPLETED|Overall Study||2
6748470|NCT03410914|7676542|FG000|STARTED|Overall Study||52
6748471|NCT03410914|7676542|FG000|COMPLETED|Overall Study||52
6748472|NCT03410914|7676542|FG000|NOT COMPLETED|Overall Study||0
6748473|NCT03410953|7676546|FG000|STARTED|Overall Study|First patient recruited|67
6481585|NCT01311687|7398845|FG000|Crossed-over to Pomalidomide|Treatment Phase|Not applicable to participants initially randomized to receive pomalidomide|0
6481586|NCT01311687|7398846|FG001|Crossed-over to Pomalidomide|Treatment Phase|After Amendment 4 participants still on HD-Dex treatment were permitted to crossover to pomalidomide|11
6481587|NCT01311687|7398845|FG000|COMPLETED|Treatment Phase||302
6481588|NCT01311687|7398846|FG001|COMPLETED|Treatment Phase||153
6481589|NCT01311687|7398845|FG000|NOT COMPLETED|Treatment Phase||0
6748474|NCT03410953|7676546|FG000|COMPLETED|Overall Study|67 participants were enrolled in the Clinical Trial and included the analyses|67
6748475|NCT03410953|7676546|FG000|NOT COMPLETED|Overall Study||0
6748476|NCT03411902|7676552|FG000|STARTED|Overall Study||11
6748477|NCT03411902|7676553|FG001|STARTED|Overall Study||13
6481590|NCT01311687|7398846|FG001|NOT COMPLETED|Treatment Phase||0
6481591|NCT01311687|7398845|FG000|STARTED|PFS Follow-up Phase||11
6481592|NCT01311687|7398846|FG001|STARTED|PFS Follow-up Phase||8
6481593|NCT01311687|7398845|FG000|Crossed-over to Pomalidomide|PFS Follow-up Phase||11
6481594|NCT01311687|7398846|FG001|Crossed-over to Pomalidomide|PFS Follow-up Phase||0
6481595|NCT01311687|7398845|FG000|COMPLETED|PFS Follow-up Phase||11
6481596|NCT01311687|7398846|FG001|COMPLETED|PFS Follow-up Phase||8
6481597|NCT01311687|7398845|FG000|NOT COMPLETED|PFS Follow-up Phase||0
6481598|NCT01311687|7398846|FG001|NOT COMPLETED|PFS Follow-up Phase||0
6481599|NCT01311895|7398857|FG000|STARTED|Overall Study||175
6481600|NCT01311895|7398858|FG001|STARTED|Overall Study||175
6481601|NCT01311895|7398857|FG000|COMPLETED|Overall Study||175
6481602|NCT01311895|7398858|FG001|COMPLETED|Overall Study||175
6481603|NCT01311895|7398857|FG000|NOT COMPLETED|Overall Study||0
6481604|NCT01311895|7398858|FG001|NOT COMPLETED|Overall Study||0
6481605|NCT01312038|7398866|FG000|STARTED|Overall Study||13
6481606|NCT01312038|7398867|FG001|STARTED|Overall Study||12
6481607|NCT01312038|7398866|FG000|COMPLETED|Overall Study||13
6481608|NCT01312038|7398867|FG001|COMPLETED|Overall Study||12
6481609|NCT01312038|7398866|FG000|NOT COMPLETED|Overall Study||0
6481610|NCT01312038|7398867|FG001|NOT COMPLETED|Overall Study||0
6481611|NCT01312129|7398875|FG000|STARTED|First Intervention (24 Hours)||6
6481612|NCT01312129|7398876|FG001|STARTED|First Intervention (24 Hours)||7
6481613|NCT01312129|7398875|FG000|Control Cue|First Intervention (24 Hours)||6
6481614|NCT01312129|7398876|FG001|Control Cue|First Intervention (24 Hours)||7
6481615|NCT01312129|7398875|FG000|Alcohol Cue|First Intervention (24 Hours)||6
6481616|NCT01312129|7398876|FG001|Alcohol Cue|First Intervention (24 Hours)||7
6481617|NCT01312129|7398875|FG000|COMPLETED|First Intervention (24 Hours)||6
6481618|NCT01312129|7398876|FG001|COMPLETED|First Intervention (24 Hours)||7
6481619|NCT01312129|7398875|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
6481620|NCT01312129|7398876|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
6481621|NCT01312129|7398875|FG000|STARTED|Washout (1 Week)||6
6481622|NCT01312129|7398876|FG001|STARTED|Washout (1 Week)||7
6481623|NCT01312129|7398875|FG000|COMPLETED|Washout (1 Week)||6
6481624|NCT01312129|7398876|FG001|COMPLETED|Washout (1 Week)||7
6481625|NCT01312129|7398875|FG000|NOT COMPLETED|Washout (1 Week)||0
6481626|NCT01312129|7398876|FG001|NOT COMPLETED|Washout (1 Week)||0
6481627|NCT01312129|7398875|FG000|STARTED|Second Intervention (24 Hours)||6
6481628|NCT01312129|7398876|FG001|STARTED|Second Intervention (24 Hours)||7
6481629|NCT01312129|7398875|FG000|Control Cue|Second Intervention (24 Hours)||6
6481630|NCT01312129|7398876|FG001|Control Cue|Second Intervention (24 Hours)||6
6481631|NCT01312129|7398875|FG000|Alcohol Cue|Second Intervention (24 Hours)||6
6481632|NCT01312129|7398876|FG001|Alcohol Cue|Second Intervention (24 Hours)||6
6481633|NCT01312129|7398875|FG000|COMPLETED|Second Intervention (24 Hours)||6
6481634|NCT01312129|7398876|FG001|COMPLETED|Second Intervention (24 Hours)||6
6481635|NCT01312129|7398875|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
6481636|NCT01312129|7398876|FG001|NOT COMPLETED|Second Intervention (24 Hours)||1
6481637|NCT01312181|7398885|FG000|STARTED|Overall Study||80
6481638|NCT01312181|7398886|FG001|STARTED|Overall Study||77
6481639|NCT01312181|7398887|FG002|STARTED|Overall Study||83
6481640|NCT01312181|7398885|FG000|COMPLETED|Overall Study||78
6481641|NCT01312181|7398886|FG001|COMPLETED|Overall Study||71
6481642|NCT01312181|7398887|FG002|COMPLETED|Overall Study||75
6481643|NCT01312181|7398885|FG000|NOT COMPLETED|Overall Study||2
6481644|NCT01312181|7398886|FG001|NOT COMPLETED|Overall Study||6
6481645|NCT01312181|7398887|FG002|NOT COMPLETED|Overall Study||8
6481646|NCT01312233|7398898|FG000|STARTED|Overall Study||44
6481647|NCT01312233|7398899|FG001|STARTED|Overall Study||44
6481648|NCT01312233|7398900|FG002|STARTED|Overall Study||43
6481649|NCT01312233|7398898|FG000|COMPLETED|Overall Study||42
6481650|NCT01312233|7398899|FG001|COMPLETED|Overall Study||44
6481651|NCT01312233|7398900|FG002|COMPLETED|Overall Study||36
6481652|NCT01312233|7398898|FG000|NOT COMPLETED|Overall Study||2
6481653|NCT01312233|7398899|FG001|NOT COMPLETED|Overall Study||0
6481654|NCT01312233|7398900|FG002|NOT COMPLETED|Overall Study||7
6481655|NCT01312272|7398910|FG000|STARTED|Overall Study||12
6481656|NCT01312272|7398911|FG001|STARTED|Overall Study||12
6481657|NCT01312272|7398910|FG000|COMPLETED|Overall Study||12
6481658|NCT01312272|7398911|FG001|COMPLETED|Overall Study||11
6481659|NCT01312272|7398910|FG000|NOT COMPLETED|Overall Study||0
6481660|NCT01312272|7398911|FG001|NOT COMPLETED|Overall Study||1
6481661|NCT01312389|7398920|FG000|STARTED|Phase 1||3
6481662|NCT01312389|7398921|FG001|STARTED|Phase 1||0
6481663|NCT01312389|7398922|FG002|STARTED|Phase 1||0
6481664|NCT01312389|7398920|FG000|COMPLETED|Phase 1||3
6481665|NCT01312389|7398921|FG001|COMPLETED|Phase 1||0
6481666|NCT01312389|7398922|FG002|COMPLETED|Phase 1||0
6481667|NCT01312389|7398920|FG000|NOT COMPLETED|Phase 1||0
6481668|NCT01312389|7398921|FG001|NOT COMPLETED|Phase 1||0
6481669|NCT01312389|7398922|FG002|NOT COMPLETED|Phase 1||0
6481670|NCT01312389|7398920|FG000|STARTED|Phase 2||0
6481671|NCT01312389|7398921|FG001|STARTED|Phase 2||0
6481672|NCT01312389|7398922|FG002|STARTED|Phase 2||0
6481673|NCT01312389|7398920|FG000|COMPLETED|Phase 2||0
6481674|NCT01312389|7398921|FG001|COMPLETED|Phase 2||0
6481675|NCT01312389|7398922|FG002|COMPLETED|Phase 2||0
6481676|NCT01312389|7398920|FG000|NOT COMPLETED|Phase 2||0
6481677|NCT01312389|7398921|FG001|NOT COMPLETED|Phase 2||0
6481678|NCT01312389|7398922|FG002|NOT COMPLETED|Phase 2||0
6481679|NCT01312467|7398930|FG000|STARTED|Overall Study||45
6748478|NCT03411902|7676552|FG000|COMPLETED|Overall Study||8
6748479|NCT03411902|7676553|FG001|COMPLETED|Overall Study||13
6748480|NCT03411902|7676552|FG000|NOT COMPLETED|Overall Study||3
6748481|NCT03411902|7676553|FG001|NOT COMPLETED|Overall Study||0
6748482|NCT03412019|7676561|FG000|STARTED|Overall Study||11
6481680|NCT01312467|7398930|FG000|COMPLETED|Overall Study||32
6481681|NCT01312467|7398930|FG000|NOT COMPLETED|Overall Study||13
6481682|NCT01312519|7398937|FG000|STARTED|Overall Study||26
6481683|NCT01312519|7398938|FG001|STARTED|Overall Study||24
6481684|NCT01312519|7398937|FG000|COMPLETED|Overall Study||26
6481685|NCT01312519|7398938|FG001|COMPLETED|Overall Study||24
6481686|NCT01312519|7398937|FG000|NOT COMPLETED|Overall Study||0
6481687|NCT01312519|7398938|FG001|NOT COMPLETED|Overall Study||0
6481688|NCT01312675|7398946|FG000|STARTED|Overall Study||9
6481689|NCT01312675|7398947|FG001|STARTED|Overall Study||7
6481690|NCT01312675|7398946|FG000|COMPLETED|Overall Study||9
6481691|NCT01312675|7398947|FG001|COMPLETED|Overall Study||7
6481692|NCT01312675|7398946|FG000|NOT COMPLETED|Overall Study||0
6481693|NCT01312675|7398947|FG001|NOT COMPLETED|Overall Study||0
6481694|NCT01312766|7398955|FG000|STARTED|Overall Study||135
6481695|NCT01312766|7398956|FG001|STARTED|Overall Study||135
6481696|NCT01312766|7398955|FG000|COMPLETED|Overall Study||129
6481697|NCT01312766|7398956|FG001|COMPLETED|Overall Study||130
6481698|NCT01312766|7398955|FG000|NOT COMPLETED|Overall Study||6
6481699|NCT01312766|7398956|FG001|NOT COMPLETED|Overall Study||5
6481700|NCT01312779|7398962|FG000|STARTED|Overall Study||39
6481701|NCT01312779|7398962|FG000|Implanted With Device|Overall Study||12
6481702|NCT01312779|7398962|FG000|COMPLETED|Overall Study||7
6481703|NCT01312779|7398962|FG000|NOT COMPLETED|Overall Study||32
6481704|NCT01312805|7398977|FG000|STARTED|Overall Study||1016
6481705|NCT01312805|7398978|FG001|STARTED|Overall Study||1082
6481706|NCT01312805|7398977|FG000|COMPLETED|Overall Study||1016
6481707|NCT01312805|7398978|FG001|COMPLETED|Overall Study||1082
6481708|NCT01312805|7398977|FG000|NOT COMPLETED|Overall Study||0
6481709|NCT01312805|7398978|FG001|NOT COMPLETED|Overall Study||0
6481710|NCT01312818|7398984|FG000|STARTED|Overall Study||2
6481711|NCT01312818|7398984|FG000|COMPLETED|Overall Study||2
6481712|NCT01312818|7398984|FG000|NOT COMPLETED|Overall Study||0
6481713|NCT01312844|7398992|FG000|STARTED|Overall Study||4
6481714|NCT01312844|7398993|FG001|STARTED|Overall Study||3
6481715|NCT01312844|7398992|FG000|COMPLETED|Overall Study||4
6481716|NCT01312844|7398993|FG001|COMPLETED|Overall Study||3
6481717|NCT01312844|7398992|FG000|NOT COMPLETED|Overall Study||0
6481718|NCT01312844|7398993|FG001|NOT COMPLETED|Overall Study||0
6481719|NCT01312909|7399002|FG000|STARTED|Overall Study||109
6481720|NCT01312909|7399003|FG001|STARTED|Overall Study||103
6481721|NCT01312909|7399004|FG002|STARTED|Overall Study||100
6481722|NCT01312909|7399002|FG000|Treated|Overall Study||108
6481723|NCT01312909|7399003|FG001|Treated|Overall Study||100
6481724|NCT01312909|7399004|FG002|Treated|Overall Study||99
6481725|NCT01312909|7399002|FG000|COMPLETED|Overall Study||67
6481726|NCT01312909|7399003|FG001|COMPLETED|Overall Study||67
6481727|NCT01312909|7399004|FG002|COMPLETED|Overall Study||53
6481728|NCT01312909|7399002|FG000|NOT COMPLETED|Overall Study||42
6481729|NCT01312909|7399003|FG001|NOT COMPLETED|Overall Study||36
6481730|NCT01312909|7399004|FG002|NOT COMPLETED|Overall Study||47
6481731|NCT01312948|7399012|FG000|STARTED|Overall Study||6
6481732|NCT01312948|7399012|FG000|COMPLETED|Overall Study||6
6481733|NCT01312948|7399012|FG000|NOT COMPLETED|Overall Study||0
6481734|NCT01312961|7399021|FG000|STARTED|Overall Study||52
6481735|NCT01312961|7399022|FG001|STARTED|Overall Study||52
6481736|NCT01312961|7399021|FG000|Treated|Overall Study||52
6481737|NCT01312961|7399022|FG001|Treated|Overall Study||52
6481738|NCT01312961|7399021|FG000|COMPLETED|Overall Study||35
6481739|NCT01312961|7399022|FG001|COMPLETED|Overall Study||45
6481740|NCT01312961|7399021|FG000|NOT COMPLETED|Overall Study||17
6481741|NCT01312961|7399022|FG001|NOT COMPLETED|Overall Study||7
6481742|NCT01313039|7399029|FG000|STARTED|Overall Study||4
6481743|NCT01313039|7399029|FG000|COMPLETED|Overall Study||2
6748483|NCT03412019|7676562|FG001|STARTED|Overall Study||11
6748484|NCT03412019|7676561|FG000|COMPLETED|Overall Study||10
6748485|NCT03412019|7676562|FG001|COMPLETED|Overall Study||10
6748486|NCT03412019|7676561|FG000|NOT COMPLETED|Overall Study||1
6748487|NCT03412019|7676562|FG001|NOT COMPLETED|Overall Study||1
6748488|NCT03412084|7676570|FG000|STARTED|Overall Study||48
6748489|NCT03412084|7676571|FG001|STARTED|Overall Study||36
6748490|NCT03412084|7676570|FG000|COMPLETED|Overall Study||44
6748491|NCT03412084|7676571|FG001|COMPLETED|Overall Study||35
6748492|NCT03412084|7676570|FG000|NOT COMPLETED|Overall Study||4
6481744|NCT01313039|7399029|FG000|NOT COMPLETED|Overall Study||2
6481745|NCT01313078|7399033|FG000|STARTED|Overall Study||4
6481746|NCT01313078|7399033|FG000|COMPLETED|Overall Study||1
6481747|NCT01313078|7399033|FG000|NOT COMPLETED|Overall Study||3
6481748|NCT01313117|7399037|FG000|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
6481749|NCT01313117|7399037|FG000|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
6481750|NCT01313117|7399037|FG000|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
6481751|NCT01313117|7399037|FG000|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
6481752|NCT01313117|7399037|FG000|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
6481753|NCT01313117|7399037|FG000|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
6481754|NCT01313117|7399037|FG000|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
6481755|NCT01313117|7399037|FG000|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
6481756|NCT01313117|7399037|FG000|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
6481757|NCT01313117|7399037|FG000|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
6481758|NCT01313117|7399037|FG000|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
6481759|NCT01313117|7399037|FG000|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
6481760|NCT01313117|7399037|FG000|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
6481761|NCT01313117|7399037|FG000|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
6481762|NCT01313117|7399037|FG000|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
6501471|NCT01429051|7419959|FG000|STARTED|Titration Phase||45
6501472|NCT01429051|7419959|FG000|COMPLETED|Titration Phase||33
6501473|NCT01429051|7419959|FG000|NOT COMPLETED|Titration Phase||12
6501474|NCT01429051|7419959|FG000|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
6501475|NCT01429051|7419959|FG000|COMPLETED|Efficacy Phase||13
6501476|NCT01429051|7419959|FG000|NOT COMPLETED|Efficacy Phase||2
6501477|NCT01429051|7419959|FG000|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
6501478|NCT01429051|7419959|FG000|COMPLETED|Tolerability Phase||16
6501479|NCT01429051|7419959|FG000|NOT COMPLETED|Tolerability Phase||15
6501480|NCT01429064|7419974|FG000|STARTED|Overall Study||19
6501481|NCT01429064|7419975|FG001|STARTED|Overall Study||22
6501482|NCT01429064|7419976|FG002|STARTED|Overall Study||19
6554774|NCT01748760|7476921|FG000|COMPLETED|Overall Study||19
6554775|NCT01748760|7476922|FG001|COMPLETED|Overall Study||23
6554776|NCT01748760|7476921|FG000|NOT COMPLETED|Overall Study||6
6554777|NCT01748760|7476922|FG001|NOT COMPLETED|Overall Study||2
6501483|NCT01429064|7419977|FG003|STARTED|Overall Study||16
6501484|NCT01429064|7419974|FG000|COMPLETED|Overall Study||19
6501485|NCT01429064|7419975|FG001|COMPLETED|Overall Study||22
6501486|NCT01429064|7419976|FG002|COMPLETED|Overall Study||19
6501487|NCT01429064|7419977|FG003|COMPLETED|Overall Study||16
6501488|NCT01429064|7419974|FG000|NOT COMPLETED|Overall Study||0
6501489|NCT01429064|7419975|FG001|NOT COMPLETED|Overall Study||0
6501490|NCT01429064|7419976|FG002|NOT COMPLETED|Overall Study||0
6501491|NCT01429064|7419977|FG003|NOT COMPLETED|Overall Study||0
6501492|NCT01429077|7419989|FG000|STARTED|Overall Study||19
6501493|NCT01429077|7419990|FG001|STARTED|Overall Study||17
6501494|NCT01429077|7419989|FG000|Completed 6-week Intervention|Overall Study||19
6501495|NCT01429077|7419990|FG001|Completed 6-week Intervention|Overall Study||17
6501496|NCT01429077|7419989|FG000|COMPLETED|Overall Study||19
6501497|NCT01429077|7419990|FG001|COMPLETED|Overall Study||14
6501498|NCT01429077|7419989|FG000|NOT COMPLETED|Overall Study||0
6501499|NCT01429077|7419990|FG001|NOT COMPLETED|Overall Study||3
6501500|NCT01429259|7419996|FG000|STARTED|Overall Study||30
6501501|NCT01429259|7419996|FG000|COMPLETED|Overall Study||30
6501502|NCT01429259|7419996|FG000|NOT COMPLETED|Overall Study||0
6501503|NCT01429272|7420004|FG000|STARTED|Overall Study||30
6501504|NCT01429272|7420005|FG001|STARTED|Overall Study||31
6501505|NCT01429272|7420006|FG002|STARTED|Overall Study||19
6501506|NCT01429272|7420007|FG003|STARTED|Overall Study||19
6501507|NCT01429272|7420004|FG000|COMPLETED|Overall Study||24
6501508|NCT01429272|7420005|FG001|COMPLETED|Overall Study||22
6501509|NCT01429272|7420006|FG002|COMPLETED|Overall Study||15
6501510|NCT01429272|7420007|FG003|COMPLETED|Overall Study||14
6501511|NCT01429272|7420004|FG000|NOT COMPLETED|Overall Study||6
6501512|NCT01429272|7420005|FG001|NOT COMPLETED|Overall Study||9
6501513|NCT01429272|7420006|FG002|NOT COMPLETED|Overall Study||4
6501514|NCT01429272|7420007|FG003|NOT COMPLETED|Overall Study||5
6501515|NCT01429285|7420019|FG000|STARTED|Overall Study||175
6501516|NCT01429285|7420020|FG001|STARTED|Overall Study||175
6501517|NCT01429285|7420019|FG000|Given IV Opioids|Overall Study|9 patients never given IV opioids|166
6501518|NCT01429285|7420020|FG001|Given IV Opioids|Overall Study|4 patients never given IV opioids|171
6501519|NCT01429285|7420019|FG000|Completed Primary Outcome Data|Overall Study|5 patients had missing data|161
6501520|NCT01429285|7420020|FG001|Completed Primary Outcome Data|Overall Study|3 patients had missing data|168
6501521|NCT01429285|7420019|FG000|Confirmation of no Duplicate Enrollment|Overall Study|8 patients were enrolled twice at two separate ED visits, which was only noted at study conclusion.|153
6501522|NCT01429285|7420020|FG001|Confirmation of no Duplicate Enrollment|Overall Study|2 patients were enrolled twice, at two separate ED visits, which was only noted at study conclusion|166
6501523|NCT01429285|7420019|FG000|COMPLETED|Overall Study||153
6501524|NCT01429285|7420020|FG001|COMPLETED|Overall Study||166
6501525|NCT01429285|7420019|FG000|NOT COMPLETED|Overall Study||22
6501526|NCT01429285|7420020|FG001|NOT COMPLETED|Overall Study||9
6501527|NCT01429298|7420028|FG000|STARTED|Overall Study||175
6501528|NCT01429298|7420029|FG001|STARTED|Overall Study||175
6501529|NCT01429298|7420028|FG000|Given IV Opioids|Overall Study|4 never given IV opioids|171
6501530|NCT01429298|7420029|FG001|Given IV Opioids|Overall Study|6 never given IV opioids|169
6501531|NCT01429298|7420028|FG000|COMPLETED|Overall Study||171
6501532|NCT01429298|7420029|FG001|COMPLETED|Overall Study||169
6501533|NCT01429298|7420028|FG000|NOT COMPLETED|Overall Study||4
6501534|NCT01429298|7420029|FG001|NOT COMPLETED|Overall Study||6
6501535|NCT01429350|7420037|FG000|STARTED|Overall Study||53
6501536|NCT01429350|7420038|FG001|STARTED|Overall Study||55
6501537|NCT01429350|7420037|FG000|As-Treated|Overall Study||62
6554778|NCT01748799|7476936|FG000|STARTED|Overall Study||6
6501538|NCT01429350|7420038|FG001|As-Treated|Overall Study||43
6501539|NCT01429350|7420037|FG000|Per Protocol|Overall Study||41
6501540|NCT01429350|7420038|FG001|Per Protocol|Overall Study||37
6501541|NCT01429350|7420037|FG000|90 Day|Overall Study||46
6554779|NCT01748799|7476937|FG001|STARTED|Overall Study||1
6481763|NCT01313182|7399044|FG000|STARTED|Overall Study||842
6554780|NCT01748799|7476938|FG002|STARTED|Overall Study||1
6554781|NCT01748799|7476939|FG003|STARTED|Overall Study||2
6554782|NCT01748799|7476940|FG004|STARTED|Overall Study||1
6554783|NCT01748799|7476941|FG005|STARTED|Overall Study||2
6554784|NCT01748799|7476942|FG006|STARTED|Overall Study||2
6554785|NCT01748799|7476943|FG007|STARTED|Overall Study||1
6554786|NCT01748799|7476936|FG000|Completed SAU of Fixed Dose Placebo|Overall Study||2
6554787|NCT01748799|7476937|FG001|Completed SAU of Fixed Dose Placebo|Overall Study||1
6554788|NCT01748799|7476938|FG002|Completed SAU of Fixed Dose Placebo|Overall Study||1
6481764|NCT01313182|7399045|FG001|STARTED|Overall Study||855
6481765|NCT01313182|7399044|FG000|COMPLETED|Overall Study||776
6481766|NCT01313182|7399045|FG001|COMPLETED|Overall Study||763
6481767|NCT01313182|7399044|FG000|NOT COMPLETED|Overall Study||66
6481768|NCT01313182|7399045|FG001|NOT COMPLETED|Overall Study||92
6481769|NCT01313208|7399053|FG000|STARTED|Double-blind Phase (Weeks 1 - 12)||104
6481770|NCT01313208|7399054|FG001|STARTED|Double-blind Phase (Weeks 1 - 12)||106
6481771|NCT01313208|7399053|FG000|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
6481772|NCT01313208|7399054|FG001|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
6481773|NCT01313208|7399053|FG000|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
6481774|NCT01313208|7399054|FG001|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
6481775|NCT01313208|7399053|FG000|STARTED|Open-label Phase (Weeks 13 - 24)||98
6481776|NCT01313208|7399054|FG001|STARTED|Open-label Phase (Weeks 13 - 24)||101
6481777|NCT01313208|7399053|FG000|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
6481778|NCT01313208|7399054|FG001|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
6481779|NCT01313208|7399053|FG000|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
6481780|NCT01313208|7399054|FG001|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
6481781|NCT01313221|7399065|FG000|STARTED|Overall Study||144
6481782|NCT01313221|7399066|FG001|STARTED|Overall Study||143
6481783|NCT01313221|7399067|FG002|STARTED|Overall Study||23
6481784|NCT01313221|7399065|FG000|Randomized|Overall Study||144
6481785|NCT01313221|7399066|FG001|Randomized|Overall Study||143
6481786|NCT01313221|7399067|FG002|Randomized|Overall Study||0
6554789|NCT01748799|7476939|FG003|Completed SAU of Fixed Dose Placebo|Overall Study||2
6554790|NCT01748799|7476940|FG004|Completed SAU of Fixed Dose Placebo|Overall Study||1
6554791|NCT01748799|7476941|FG005|Completed SAU of Fixed Dose Placebo|Overall Study||1
6554792|NCT01748799|7476942|FG006|Completed SAU of Fixed Dose Placebo|Overall Study||1
6554793|NCT01748799|7476943|FG007|Completed SAU of Fixed Dose Placebo|Overall Study||1
6554794|NCT01748799|7476936|FG000|Completed Fixed Dose Placebo|Overall Study||2
6554795|NCT01748799|7476937|FG001|Completed Fixed Dose Placebo|Overall Study||1
6554796|NCT01748799|7476938|FG002|Completed Fixed Dose Placebo|Overall Study||1
6554797|NCT01748799|7476939|FG003|Completed Fixed Dose Placebo|Overall Study||2
6554798|NCT01748799|7476940|FG004|Completed Fixed Dose Placebo|Overall Study||1
6554799|NCT01748799|7476941|FG005|Completed Fixed Dose Placebo|Overall Study||1
6554800|NCT01748799|7476942|FG006|Completed Fixed Dose Placebo|Overall Study||1
6554801|NCT01748799|7476943|FG007|Completed Fixed Dose Placebo|Overall Study||1
6554802|NCT01748799|7476936|FG000|Completed SAU of Fixed Dose Sativex|Overall Study||1
6481787|NCT01313221|7399065|FG000|COMPLETED|Overall Study||132
6481788|NCT01313221|7399066|FG001|COMPLETED|Overall Study||135
6481789|NCT01313221|7399067|FG002|COMPLETED|Overall Study||0
6481790|NCT01313221|7399065|FG000|NOT COMPLETED|Overall Study||12
6481791|NCT01313221|7399066|FG001|NOT COMPLETED|Overall Study||8
6481792|NCT01313221|7399067|FG002|NOT COMPLETED|Overall Study||23
6481793|NCT01313286|7399075|FG000|STARTED|Period 1||8
6481794|NCT01313286|7399076|FG001|STARTED|Period 1||8
6481795|NCT01313286|7399075|FG000|COMPLETED|Period 1||6
6481796|NCT01313286|7399076|FG001|COMPLETED|Period 1||8
6481797|NCT01313286|7399075|FG000|NOT COMPLETED|Period 1||2
6481798|NCT01313286|7399076|FG001|NOT COMPLETED|Period 1||0
6481799|NCT01313286|7399075|FG000|STARTED|Period 2||6
6481800|NCT01313286|7399076|FG001|STARTED|Period 2||8
6481801|NCT01313286|7399075|FG000|COMPLETED|Period 2||6
6481802|NCT01313286|7399076|FG001|COMPLETED|Period 2||8
6481803|NCT01313286|7399075|FG000|NOT COMPLETED|Period 2||0
6481804|NCT01313286|7399076|FG001|NOT COMPLETED|Period 2||0
6481805|NCT01313299|7399085|FG000|STARTED|Overall Study||81
6481806|NCT01313299|7399086|FG001|STARTED|Overall Study||81
6481807|NCT01313299|7399087|FG002|STARTED|Overall Study||81
6481808|NCT01313299|7399085|FG000|COMPLETED|Overall Study||74
6481809|NCT01313299|7399086|FG001|COMPLETED|Overall Study||78
6481810|NCT01313299|7399087|FG002|COMPLETED|Overall Study||77
6481811|NCT01313299|7399085|FG000|NOT COMPLETED|Overall Study||7
6481812|NCT01313299|7399086|FG001|NOT COMPLETED|Overall Study||3
6481813|NCT01313299|7399087|FG002|NOT COMPLETED|Overall Study||4
6481814|NCT01313312|7399095|FG000|STARTED|Overall Study||258
6481815|NCT01313312|7399095|FG000|Cycle 1|Overall Study||254
6481816|NCT01313312|7399095|FG000|Cycle 2|Overall Study||229
6481817|NCT01313312|7399095|FG000|Cycle 3|Overall Study||175
6481818|NCT01313312|7399095|FG000|Cycle 4|Overall Study||81
6481819|NCT01313312|7399095|FG000|Cycle 5|Overall Study||11
6481820|NCT01313312|7399095|FG000|COMPLETED|Overall Study||222
6481821|NCT01313312|7399095|FG000|NOT COMPLETED|Overall Study||36
6481822|NCT01313494|7399101|FG000|STARTED|Overall Study||313
6481823|NCT01313494|7399102|FG001|STARTED|Overall Study||313
6501542|NCT01429350|7420038|FG001|90 Day|Overall Study||50
6554803|NCT01748799|7476937|FG001|Completed SAU of Fixed Dose Sativex|Overall Study||1
6554804|NCT01748799|7476938|FG002|Completed SAU of Fixed Dose Sativex|Overall Study||1
6481824|NCT01313494|7399101|FG000|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
6481825|NCT01313494|7399102|FG001|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
6481826|NCT01313494|7399101|FG000|COMPLETED|Overall Study||246
6481827|NCT01313494|7399102|FG001|COMPLETED|Overall Study||263
6481828|NCT01313494|7399101|FG000|NOT COMPLETED|Overall Study||67
6481829|NCT01313494|7399102|FG001|NOT COMPLETED|Overall Study||50
6481830|NCT01313507|7399108|FG000|STARTED|Overall Study||21
6481831|NCT01313507|7399108|FG000|COMPLETED|Overall Study||21
6481832|NCT01313507|7399108|FG000|NOT COMPLETED|Overall Study||0
6481833|NCT01313520|7399114|FG000|STARTED|Overall Study||30
6481834|NCT01313520|7399115|FG001|STARTED|Overall Study||31
6481835|NCT01313520|7399114|FG000|COMPLETED|Overall Study||30
6481836|NCT01313520|7399115|FG001|COMPLETED|Overall Study||31
6481837|NCT01313520|7399114|FG000|NOT COMPLETED|Overall Study||0
6481838|NCT01313520|7399115|FG001|NOT COMPLETED|Overall Study||0
6481839|NCT01313559|7399125|FG000|STARTED|Overall Study||4
6481840|NCT01313559|7399126|FG001|STARTED|Overall Study||2
6481841|NCT01313559|7399125|FG000|COMPLETED|Overall Study||0
6481842|NCT01313559|7399126|FG001|COMPLETED|Overall Study||0
6481843|NCT01313559|7399125|FG000|NOT COMPLETED|Overall Study||4
6481844|NCT01313559|7399126|FG001|NOT COMPLETED|Overall Study||2
6481845|NCT01313624|7399134|FG000|STARTED|Double-Blind Phase||134
6481846|NCT01313624|7399135|FG001|STARTED|Double-Blind Phase||132
6481847|NCT01313624|7399134|FG000|COMPLETED|Double-Blind Phase||96
6481848|NCT01313624|7399135|FG001|COMPLETED|Double-Blind Phase||122
6554805|NCT01748799|7476939|FG003|Completed SAU of Fixed Dose Sativex|Overall Study||2
6554806|NCT01748799|7476940|FG004|Completed SAU of Fixed Dose Sativex|Overall Study||1
6554807|NCT01748799|7476941|FG005|Completed SAU of Fixed Dose Sativex|Overall Study||1
6554808|NCT01748799|7476942|FG006|Completed SAU of Fixed Dose Sativex|Overall Study||1
6481849|NCT01313624|7399134|FG000|NOT COMPLETED|Double-Blind Phase||38
6481850|NCT01313624|7399135|FG001|NOT COMPLETED|Double-Blind Phase||10
6481851|NCT01313624|7399134|FG000|STARTED|Open-Label Phase||96
6481852|NCT01313624|7399135|FG001|STARTED|Open-Label Phase||122
6481853|NCT01313624|7399134|FG000|COMPLETED|Open-Label Phase||92
6481854|NCT01313624|7399135|FG001|COMPLETED|Open-Label Phase||109
6481855|NCT01313624|7399134|FG000|NOT COMPLETED|Open-Label Phase||4
6481856|NCT01313624|7399135|FG001|NOT COMPLETED|Open-Label Phase||13
6481857|NCT01313637|7399147|FG000|STARTED|Overall Study||275
6481858|NCT01313637|7399148|FG001|STARTED|Overall Study||407
6481859|NCT01313637|7399149|FG002|STARTED|Overall Study||404
6481860|NCT01313637|7399150|FG003|STARTED|Overall Study||403
6481861|NCT01313637|7399147|FG000|COMPLETED|Overall Study||183
6481862|NCT01313637|7399148|FG001|COMPLETED|Overall Study||312
6481863|NCT01313637|7399149|FG002|COMPLETED|Overall Study||298
6481864|NCT01313637|7399150|FG003|COMPLETED|Overall Study||325
6481865|NCT01313637|7399147|FG000|NOT COMPLETED|Overall Study||92
6481866|NCT01313637|7399148|FG001|NOT COMPLETED|Overall Study||95
6481867|NCT01313637|7399149|FG002|NOT COMPLETED|Overall Study||106
6481868|NCT01313637|7399150|FG003|NOT COMPLETED|Overall Study||78
6481869|NCT01313650|7399164|FG000|STARTED|Overall Study||280
6481870|NCT01313650|7399165|FG001|STARTED|Overall Study||418
6481871|NCT01313650|7399166|FG002|STARTED|Overall Study||421
6481872|NCT01313650|7399167|FG003|STARTED|Overall Study||413
6481873|NCT01313650|7399164|FG000|COMPLETED|Overall Study||204
6481874|NCT01313650|7399165|FG001|COMPLETED|Overall Study||324
6481875|NCT01313650|7399166|FG002|COMPLETED|Overall Study||318
6481876|NCT01313650|7399167|FG003|COMPLETED|Overall Study||332
6481877|NCT01313650|7399164|FG000|NOT COMPLETED|Overall Study||76
6481878|NCT01313650|7399165|FG001|NOT COMPLETED|Overall Study||94
6481879|NCT01313650|7399166|FG002|NOT COMPLETED|Overall Study||103
6481880|NCT01313650|7399167|FG003|NOT COMPLETED|Overall Study||81
6481881|NCT01313663|7399179|FG000|STARTED|Overall Study||9
6481882|NCT01313663|7399180|FG001|STARTED|Overall Study||11
6481883|NCT01313663|7399179|FG000|COMPLETED|Overall Study||5
6481884|NCT01313663|7399180|FG001|COMPLETED|Overall Study||3
6481885|NCT01313663|7399179|FG000|NOT COMPLETED|Overall Study||4
6481886|NCT01313663|7399180|FG001|NOT COMPLETED|Overall Study||8
6481887|NCT01313676|7399190|FG000|STARTED|Overall Study||4131
6481888|NCT01313676|7399191|FG001|STARTED|Overall Study||4157
6481889|NCT01313676|7399192|FG002|STARTED|Overall Study||4140
6481890|NCT01313676|7399193|FG003|STARTED|Overall Study||4140
6481891|NCT01313676|7399190|FG000|COMPLETED|Overall Study||2881
6481892|NCT01313676|7399191|FG001|COMPLETED|Overall Study||3044
6481893|NCT01313676|7399192|FG002|COMPLETED|Overall Study||3052
6481894|NCT01313676|7399193|FG003|COMPLETED|Overall Study||3146
6481895|NCT01313676|7399190|FG000|NOT COMPLETED|Overall Study||1250
6481896|NCT01313676|7399191|FG001|NOT COMPLETED|Overall Study||1113
6481897|NCT01313676|7399192|FG002|NOT COMPLETED|Overall Study||1088
6481898|NCT01313676|7399193|FG003|NOT COMPLETED|Overall Study||994
6481899|NCT01313728|7399204|FG000|STARTED|Informed Consent to Baseline||26
6481900|NCT01313728|7399204|FG000|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
6481901|NCT01313728|7399204|FG000|NOT COMPLETED|Informed Consent to Baseline||1
6481902|NCT01313728|7399204|FG000|STARTED|Baseline to Completion||25
6481903|NCT01313728|7399204|FG000|COMPLETED|Baseline to Completion||25
6481904|NCT01313728|7399204|FG000|NOT COMPLETED|Baseline to Completion||0
6481905|NCT01313767|7399211|FG000|STARTED|Overall Study||98
6481906|NCT01313767|7399212|FG001|STARTED|Overall Study||98
6554809|NCT01748799|7476943|FG007|Completed SAU of Fixed Dose Sativex|Overall Study||1
6481907|NCT01313767|7399211|FG000|COMPLETED|Overall Study||91
6481908|NCT01313767|7399212|FG001|COMPLETED|Overall Study||96
6481909|NCT01313767|7399211|FG000|NOT COMPLETED|Overall Study||7
6481910|NCT01313767|7399212|FG001|NOT COMPLETED|Overall Study||2
6481911|NCT01313780|7399220|FG000|STARTED|Overall Study|FAS|58
6481912|NCT01313780|7399221|FG001|STARTED|Overall Study|FAS|59
6481913|NCT01313780|7399220|FG000|COMPLETED|Overall Study|PPS|33
6481914|NCT01313780|7399221|FG001|COMPLETED|Overall Study|PPS|31
6481915|NCT01313780|7399220|FG000|NOT COMPLETED|Overall Study||25
6481916|NCT01313780|7399221|FG001|NOT COMPLETED|Overall Study||28
6481917|NCT01313858|7399230|FG000|STARTED|Overall Study||524
6481918|NCT01313858|7399231|FG001|STARTED|Overall Study||546
6481919|NCT01313858|7399232|FG002|STARTED|Overall Study||543
6481920|NCT01313858|7399230|FG000|COMPLETED|Overall Study||238
6481921|NCT01313858|7399231|FG001|COMPLETED|Overall Study||276
6481922|NCT01313858|7399232|FG002|COMPLETED|Overall Study||305
6481923|NCT01313858|7399230|FG000|NOT COMPLETED|Overall Study||286
6481924|NCT01313858|7399231|FG001|NOT COMPLETED|Overall Study||270
6481925|NCT01313858|7399232|FG002|NOT COMPLETED|Overall Study||238
6481926|NCT01313884|7399238|FG000|STARTED|Overall Study||3
6481927|NCT01313884|7399238|FG000|COMPLETED|Overall Study||2
6481928|NCT01313884|7399238|FG000|NOT COMPLETED|Overall Study||1
6481929|NCT01313897|7399242|FG000|STARTED|Overall Study||10
6481930|NCT01313897|7399242|FG000|COMPLETED|Overall Study||8
6481931|NCT01313897|7399242|FG000|NOT COMPLETED|Overall Study||2
6748493|NCT03412084|7676571|FG001|NOT COMPLETED|Overall Study||1
6748494|NCT03412734|7676579|FG000|STARTED|Overall Study||47
6748495|NCT03412734|7676580|FG001|STARTED|Overall Study||41
6748496|NCT03412734|7676579|FG000|COMPLETED|Overall Study||44
6481932|NCT01313910|7399246|FG000|STARTED|Overall Study||8
6481933|NCT01313910|7399246|FG000|COMPLETED|Overall Study||8
6481934|NCT01313910|7399246|FG000|NOT COMPLETED|Overall Study||0
6481935|NCT01313936|7399252|FG000|STARTED|Overall Study||6
6481936|NCT01313936|7399253|FG001|STARTED|Overall Study||26
6481937|NCT01313936|7399252|FG000|COMPLETED|Overall Study||6
6481938|NCT01313936|7399253|FG001|COMPLETED|Overall Study||26
6481939|NCT01313936|7399252|FG000|NOT COMPLETED|Overall Study||0
6481940|NCT01313936|7399253|FG001|NOT COMPLETED|Overall Study||0
6481941|NCT01314001|7399268|FG000|STARTED|Overall Study||215
6481942|NCT01314001|7399269|FG001|STARTED|Overall Study||193
6481943|NCT01314001|7399270|FG002|STARTED|Overall Study||227
6481944|NCT01314001|7399271|FG003|STARTED|Overall Study||191
6481945|NCT01314001|7399272|FG004|STARTED|Overall Study||220
6481946|NCT01314001|7399273|FG005|STARTED|Overall Study||200
6481947|NCT01314001|7399268|FG000|End-of-Treatment Visit|Overall Study||156
6481948|NCT01314001|7399269|FG001|End-of-Treatment Visit|Overall Study||141
6481949|NCT01314001|7399270|FG002|End-of-Treatment Visit|Overall Study||179
6481950|NCT01314001|7399271|FG003|End-of-Treatment Visit|Overall Study||146
6481951|NCT01314001|7399272|FG004|End-of-Treatment Visit|Overall Study||174
6481952|NCT01314001|7399273|FG005|End-of-Treatment Visit|Overall Study||160
6481953|NCT01314001|7399268|FG000|6-Month Follow Up Survey|Overall Study||146
6481954|NCT01314001|7399269|FG001|6-Month Follow Up Survey|Overall Study||137
6481955|NCT01314001|7399270|FG002|6-Month Follow Up Survey|Overall Study||165
6481956|NCT01314001|7399271|FG003|6-Month Follow Up Survey|Overall Study||135
6481957|NCT01314001|7399272|FG004|6-Month Follow Up Survey|Overall Study||157
6481958|NCT01314001|7399273|FG005|6-Month Follow Up Survey|Overall Study||139
6481959|NCT01314001|7399268|FG000|COMPLETED|Overall Study||140
6481960|NCT01314001|7399269|FG001|COMPLETED|Overall Study||124
6481961|NCT01314001|7399270|FG002|COMPLETED|Overall Study||158
6481962|NCT01314001|7399271|FG003|COMPLETED|Overall Study||122
6481963|NCT01314001|7399272|FG004|COMPLETED|Overall Study||148
6481964|NCT01314001|7399273|FG005|COMPLETED|Overall Study||129
6481965|NCT01314001|7399268|FG000|NOT COMPLETED|Overall Study||75
6481966|NCT01314001|7399269|FG001|NOT COMPLETED|Overall Study||69
6481967|NCT01314001|7399270|FG002|NOT COMPLETED|Overall Study||69
6481968|NCT01314001|7399271|FG003|NOT COMPLETED|Overall Study||69
6481969|NCT01314001|7399272|FG004|NOT COMPLETED|Overall Study||72
6481970|NCT01314001|7399273|FG005|NOT COMPLETED|Overall Study||71
6481971|NCT01314014|7399287|FG000|STARTED|Overall Study||22
6481972|NCT01314014|7399287|FG000|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
6481973|NCT01314014|7399287|FG000|NOT COMPLETED|Overall Study||0
6481974|NCT01314105|7399293|FG000|STARTED|Overall Study||7
6481975|NCT01314105|7399294|FG001|STARTED|Overall Study||12
6481976|NCT01314105|7399293|FG000|COMPLETED|Overall Study||0
6481977|NCT01314105|7399294|FG001|COMPLETED|Overall Study||0
6481978|NCT01314105|7399293|FG000|NOT COMPLETED|Overall Study||7
6481979|NCT01314105|7399294|FG001|NOT COMPLETED|Overall Study||12
6481980|NCT01314261|7399306|FG000|STARTED|Overall Study||9
6481981|NCT01314261|7399307|FG001|STARTED|Overall Study||9
6481982|NCT01314261|7399308|FG002|STARTED|Overall Study||10
6481983|NCT01314261|7399309|FG003|STARTED|Overall Study||9
6481984|NCT01314261|7399306|FG000|Discontinued ABT-267 or Placebo|Overall Study||1
6481985|NCT01314261|7399307|FG001|Discontinued ABT-267 or Placebo|Overall Study||0
6481986|NCT01314261|7399308|FG002|Discontinued ABT-267 or Placebo|Overall Study||1
6481987|NCT01314261|7399309|FG003|Discontinued ABT-267 or Placebo|Overall Study||0
6481988|NCT01314261|7399306|FG000|Discontinued pegIFN/RBV|Overall Study||1
6481989|NCT01314261|7399307|FG001|Discontinued pegIFN/RBV|Overall Study||4
6481990|NCT01314261|7399308|FG002|Discontinued pegIFN/RBV|Overall Study||5
6481991|NCT01314261|7399309|FG003|Discontinued pegIFN/RBV|Overall Study||1
6481992|NCT01314261|7399306|FG000|COMPLETED|Overall Study||7
6481993|NCT01314261|7399307|FG001|COMPLETED|Overall Study||5
6481994|NCT01314261|7399308|FG002|COMPLETED|Overall Study||7
6481995|NCT01314261|7399309|FG003|COMPLETED|Overall Study||6
6481996|NCT01314261|7399306|FG000|NOT COMPLETED|Overall Study||2
6481997|NCT01314261|7399307|FG001|NOT COMPLETED|Overall Study||4
6481998|NCT01314261|7399308|FG002|NOT COMPLETED|Overall Study||3
6481999|NCT01314261|7399309|FG003|NOT COMPLETED|Overall Study||3
6482000|NCT01314313|7399321|FG000|STARTED|Overall Study||1011
6482001|NCT01314313|7399322|FG001|STARTED|Overall Study||1021
6482002|NCT01314313|7399321|FG000|As Treated|Overall Study||994
6482003|NCT01314313|7399322|FG001|As Treated|Overall Study||944
6482004|NCT01314313|7399321|FG000|Valve Implanted|Overall Study||974
6482005|NCT01314313|7399322|FG001|Valve Implanted|Overall Study||936
6554810|NCT01748799|7476936|FG000|Completed Fixed Dose Sativex|Overall Study||1
6554811|NCT01748799|7476937|FG001|Completed Fixed Dose Sativex|Overall Study||1
6482006|NCT01314313|7399321|FG000|COMPLETED|Overall Study||784
6482007|NCT01314313|7399322|FG001|COMPLETED|Overall Study||710
6482008|NCT01314313|7399321|FG000|NOT COMPLETED|Overall Study||227
6482009|NCT01314313|7399322|FG001|NOT COMPLETED|Overall Study||311
6482010|NCT01314417|7399330|FG000|STARTED|Overall Study||2
6482011|NCT01314417|7399330|FG000|COMPLETED|Overall Study||2
6482012|NCT01314417|7399330|FG000|NOT COMPLETED|Overall Study||0
6482013|NCT01314443|7399338|FG000|STARTED|Overall Study||18
6482014|NCT01314443|7399339|FG001|STARTED|Overall Study||19
6482015|NCT01314443|7399340|FG002|STARTED|Overall Study||15
6482016|NCT01314443|7399341|FG003|STARTED|Overall Study||15
6482017|NCT01314443|7399338|FG000|COMPLETED|Overall Study||14
6482018|NCT01314443|7399339|FG001|COMPLETED|Overall Study||16
6482019|NCT01314443|7399340|FG002|COMPLETED|Overall Study||13
6482020|NCT01314443|7399341|FG003|COMPLETED|Overall Study||13
6482021|NCT01314443|7399338|FG000|NOT COMPLETED|Overall Study||4
6482022|NCT01314443|7399339|FG001|NOT COMPLETED|Overall Study||3
6482023|NCT01314443|7399340|FG002|NOT COMPLETED|Overall Study||2
6482024|NCT01314443|7399341|FG003|NOT COMPLETED|Overall Study||2
6482025|NCT01314703|7399351|FG000|STARTED|Overall Study||35
6482026|NCT01314703|7399351|FG000|Signed Informed Consent|Overall Study||35
6482027|NCT01314703|7399351|FG000|Completed Screen Visit|Overall Study||33
6482028|NCT01314703|7399351|FG000|Completed Treatment Visit|Overall Study||27
6482029|NCT01314703|7399351|FG000|Completed Study|Overall Study||27
6482030|NCT01314703|7399351|FG000|Excluded Prior to Screening Baseline|Overall Study||2
6482031|NCT01314703|7399351|FG000|Non Qualified Bacterial Screening Counts|Overall Study||3
6482032|NCT01314703|7399351|FG000|Discontinued When Enrollment Completed|Overall Study||3
6482033|NCT01314703|7399351|FG000|COMPLETED|Overall Study||27
6482034|NCT01314703|7399351|FG000|NOT COMPLETED|Overall Study||8
6482035|NCT01314716|7399358|FG000|STARTED|Double-Blind Phase||136
6482036|NCT01314716|7399359|FG001|STARTED|Double-Blind Phase||138
6482037|NCT01314716|7399358|FG000|Randomized and Treated|Double-Blind Phase||135
6482038|NCT01314716|7399359|FG001|Randomized and Treated|Double-Blind Phase||137
6482039|NCT01314716|7399358|FG000|COMPLETED|Double-Blind Phase||119
6482040|NCT01314716|7399359|FG001|COMPLETED|Double-Blind Phase||123
6482041|NCT01314716|7399358|FG000|NOT COMPLETED|Double-Blind Phase||17
6482042|NCT01314716|7399359|FG001|NOT COMPLETED|Double-Blind Phase||15
6482043|NCT01314716|7399358|FG000|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
6482044|NCT01314716|7399359|FG001|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
6482045|NCT01314716|7399358|FG000|COMPLETED|Open-Label Phase||102
6482046|NCT01314716|7399359|FG001|COMPLETED|Open-Label Phase||98
6482047|NCT01314716|7399358|FG000|NOT COMPLETED|Open-Label Phase||10
6482048|NCT01314716|7399359|FG001|NOT COMPLETED|Open-Label Phase||12
6482049|NCT01314742|7399369|FG000|STARTED|Overall Study||20
6482050|NCT01314742|7399370|FG001|STARTED|Overall Study||21
6482051|NCT01314742|7399369|FG000|COMPLETED|Overall Study||20
6482052|NCT01314742|7399370|FG001|COMPLETED|Overall Study||21
6482053|NCT01314742|7399369|FG000|NOT COMPLETED|Overall Study||0
6482054|NCT01314742|7399370|FG001|NOT COMPLETED|Overall Study||0
6482055|NCT01314872|7399389|FG000|STARTED|Treatment Period 1||141
6482056|NCT01314872|7399390|FG001|STARTED|Treatment Period 1||144
6482057|NCT01314872|7399391|FG002|STARTED|Treatment Period 1||134
6482058|NCT01314872|7399392|FG003|STARTED|Treatment Period 1||150
6482059|NCT01314872|7399393|FG004|STARTED|Treatment Period 1||149
6482060|NCT01314872|7399394|FG005|STARTED|Treatment Period 1||135
6482061|NCT01314872|7399395|FG006|STARTED|Treatment Period 1||134
6482062|NCT01314872|7399396|FG007|STARTED|Treatment Period 1||64
6482063|NCT01314872|7399397|FG008|STARTED|Treatment Period 1||112
6482064|NCT01314872|7399398|FG009|STARTED|Treatment Period 1||122
6482065|NCT01314872|7399399|FG010|STARTED|Treatment Period 1||110
6482066|NCT01314872|7399400|FG011|STARTED|Treatment Period 1||0
6482067|NCT01314872|7399401|FG012|STARTED|Treatment Period 1||0
6482068|NCT01314872|7399402|FG013|STARTED|Treatment Period 1||0
6482069|NCT01314872|7399403|FG014|STARTED|Treatment Period 1||0
6482070|NCT01314872|7399389|FG000|COMPLETED|Treatment Period 1||131
6482071|NCT01314872|7399390|FG001|COMPLETED|Treatment Period 1||138
6482072|NCT01314872|7399391|FG002|COMPLETED|Treatment Period 1||128
6482073|NCT01314872|7399392|FG003|COMPLETED|Treatment Period 1||143
6482074|NCT01314872|7399393|FG004|COMPLETED|Treatment Period 1||142
6482075|NCT01314872|7399394|FG005|COMPLETED|Treatment Period 1||128
6554812|NCT01748799|7476938|FG002|Completed Fixed Dose Sativex|Overall Study||1
6482076|NCT01314872|7399395|FG006|COMPLETED|Treatment Period 1||126
6482077|NCT01314872|7399396|FG007|COMPLETED|Treatment Period 1||57
6482078|NCT01314872|7399397|FG008|COMPLETED|Treatment Period 1||106
6482079|NCT01314872|7399398|FG009|COMPLETED|Treatment Period 1||118
6482080|NCT01314872|7399399|FG010|COMPLETED|Treatment Period 1||107
6482081|NCT01314872|7399400|FG011|COMPLETED|Treatment Period 1||0
6482082|NCT01314872|7399401|FG012|COMPLETED|Treatment Period 1||0
6482083|NCT01314872|7399402|FG013|COMPLETED|Treatment Period 1||0
6482084|NCT01314872|7399403|FG014|COMPLETED|Treatment Period 1||0
6482085|NCT01314872|7399389|FG000|NOT COMPLETED|Treatment Period 1||10
6482086|NCT01314872|7399390|FG001|NOT COMPLETED|Treatment Period 1||6
6482087|NCT01314872|7399391|FG002|NOT COMPLETED|Treatment Period 1||6
6482088|NCT01314872|7399392|FG003|NOT COMPLETED|Treatment Period 1||7
6482089|NCT01314872|7399393|FG004|NOT COMPLETED|Treatment Period 1||7
6482090|NCT01314872|7399394|FG005|NOT COMPLETED|Treatment Period 1||7
6482091|NCT01314872|7399395|FG006|NOT COMPLETED|Treatment Period 1||8
6482092|NCT01314872|7399396|FG007|NOT COMPLETED|Treatment Period 1||7
6482093|NCT01314872|7399397|FG008|NOT COMPLETED|Treatment Period 1||6
6482094|NCT01314872|7399398|FG009|NOT COMPLETED|Treatment Period 1||4
6482095|NCT01314872|7399399|FG010|NOT COMPLETED|Treatment Period 1||3
6482096|NCT01314872|7399400|FG011|NOT COMPLETED|Treatment Period 1||0
6482097|NCT01314872|7399401|FG012|NOT COMPLETED|Treatment Period 1||0
6482098|NCT01314872|7399402|FG013|NOT COMPLETED|Treatment Period 1||0
6482099|NCT01314872|7399403|FG014|NOT COMPLETED|Treatment Period 1||0
6482100|NCT01314872|7399389|FG000|STARTED|Period 2||0
6482101|NCT01314872|7399390|FG001|STARTED|Period 2||0
6482102|NCT01314872|7399391|FG002|STARTED|Period 2||0
6482103|NCT01314872|7399392|FG003|STARTED|Period 2||0
6482104|NCT01314872|7399393|FG004|STARTED|Period 2||0
6482105|NCT01314872|7399394|FG005|STARTED|Period 2||0
6482106|NCT01314872|7399395|FG006|STARTED|Period 2||0
6482107|NCT01314872|7399396|FG007|STARTED|Period 2||0
6482108|NCT01314872|7399397|FG008|STARTED|Period 2||0
6482109|NCT01314872|7399398|FG009|STARTED|Period 2||0
6482110|NCT01314872|7399399|FG010|STARTED|Period 2||0
6482111|NCT01314872|7399400|FG011|STARTED|Period 2||223
6482112|NCT01314872|7399401|FG012|STARTED|Period 2||248
6482113|NCT01314872|7399402|FG013|STARTED|Period 2||240
6482114|NCT01314872|7399403|FG014|STARTED|Period 2||134
6482115|NCT01314872|7399389|FG000|COMPLETED|Period 2||0
6482116|NCT01314872|7399390|FG001|COMPLETED|Period 2||0
6482117|NCT01314872|7399391|FG002|COMPLETED|Period 2||0
6482118|NCT01314872|7399392|FG003|COMPLETED|Period 2||0
6482119|NCT01314872|7399393|FG004|COMPLETED|Period 2||0
6482120|NCT01314872|7399394|FG005|COMPLETED|Period 2||0
6482121|NCT01314872|7399395|FG006|COMPLETED|Period 2||0
6482122|NCT01314872|7399396|FG007|COMPLETED|Period 2||0
6482123|NCT01314872|7399397|FG008|COMPLETED|Period 2||0
6482124|NCT01314872|7399398|FG009|COMPLETED|Period 2||0
6482125|NCT01314872|7399399|FG010|COMPLETED|Period 2||0
6482126|NCT01314872|7399400|FG011|COMPLETED|Period 2||175
6482127|NCT01314872|7399401|FG012|COMPLETED|Period 2||188
6482128|NCT01314872|7399402|FG013|COMPLETED|Period 2||187
6482129|NCT01314872|7399403|FG014|COMPLETED|Period 2||110
6482130|NCT01314872|7399389|FG000|NOT COMPLETED|Period 2||0
6482131|NCT01314872|7399390|FG001|NOT COMPLETED|Period 2||0
6482132|NCT01314872|7399391|FG002|NOT COMPLETED|Period 2||0
6482133|NCT01314872|7399392|FG003|NOT COMPLETED|Period 2||0
6482134|NCT01314872|7399393|FG004|NOT COMPLETED|Period 2||0
6482135|NCT01314872|7399394|FG005|NOT COMPLETED|Period 2||0
6482136|NCT01314872|7399395|FG006|NOT COMPLETED|Period 2||0
6482137|NCT01314872|7399396|FG007|NOT COMPLETED|Period 2||0
6482138|NCT01314872|7399397|FG008|NOT COMPLETED|Period 2||0
6482139|NCT01314872|7399398|FG009|NOT COMPLETED|Period 2||0
6482140|NCT01314872|7399399|FG010|NOT COMPLETED|Period 2||0
6482141|NCT01314872|7399400|FG011|NOT COMPLETED|Period 2||48
6482142|NCT01314872|7399401|FG012|NOT COMPLETED|Period 2||60
6482143|NCT01314872|7399402|FG013|NOT COMPLETED|Period 2||53
6482144|NCT01314872|7399403|FG014|NOT COMPLETED|Period 2||24
6482145|NCT01314911|7399437|FG000|STARTED|Overall Study||278
6554813|NCT01748799|7476939|FG003|Completed Fixed Dose Sativex|Overall Study||2
6554814|NCT01748799|7476940|FG004|Completed Fixed Dose Sativex|Overall Study||1
6482146|NCT01314911|7399438|FG001|STARTED|Overall Study||280
6482147|NCT01314911|7399437|FG000|COMPLETED|Overall Study||273
6482148|NCT01314911|7399438|FG001|COMPLETED|Overall Study||274
6482149|NCT01314911|7399437|FG000|NOT COMPLETED|Overall Study||5
6482150|NCT01314911|7399438|FG001|NOT COMPLETED|Overall Study||6
6482151|NCT01314963|7399444|FG000|STARTED|Overall Study||50
6482152|NCT01314963|7399444|FG000|COMPLETED|Overall Study||50
6482153|NCT01314963|7399444|FG000|NOT COMPLETED|Overall Study||0
6482154|NCT01315002|7399450|FG000|STARTED|Overall Study||61
6482155|NCT01315002|7399451|FG001|STARTED|Overall Study||60
6482156|NCT01315002|7399450|FG000|COMPLETED|Overall Study||56
6482157|NCT01315002|7399451|FG001|COMPLETED|Overall Study||55
6482158|NCT01315002|7399450|FG000|NOT COMPLETED|Overall Study||5
6482159|NCT01315002|7399451|FG001|NOT COMPLETED|Overall Study||5
6482160|NCT01315028|7399459|FG000|STARTED|Overall Study||10
6482161|NCT01315028|7399460|FG001|STARTED|Overall Study||10
6482162|NCT01315028|7399459|FG000|COMPLETED|Overall Study||9
6482163|NCT01315028|7399460|FG001|COMPLETED|Overall Study||9
6482164|NCT01315028|7399459|FG000|NOT COMPLETED|Overall Study||1
6482165|NCT01315028|7399460|FG001|NOT COMPLETED|Overall Study||1
6482166|NCT01315132|7399466|FG000|STARTED|Overall Study||47
6482167|NCT01315132|7399466|FG000|COMPLETED|Overall Study||46
6482168|NCT01315132|7399466|FG000|NOT COMPLETED|Overall Study||1
6482169|NCT01315145|7399472|FG000|STARTED|Overall Study||122
6482170|NCT01315145|7399473|FG001|STARTED|Overall Study||16
6482171|NCT01315145|7399472|FG000|COMPLETED|Overall Study||105
6482172|NCT01315145|7399473|FG001|COMPLETED|Overall Study||11
6554815|NCT01748799|7476941|FG005|Completed Fixed Dose Sativex|Overall Study||1
6554816|NCT01748799|7476942|FG006|Completed Fixed Dose Sativex|Overall Study||1
6554817|NCT01748799|7476943|FG007|Completed Fixed Dose Sativex|Overall Study||1
6482173|NCT01315145|7399472|FG000|NOT COMPLETED|Overall Study||17
6482174|NCT01315145|7399473|FG001|NOT COMPLETED|Overall Study||5
6482175|NCT01315158|7399481|FG000|STARTED|Overall Study||17
6482176|NCT01315158|7399482|FG001|STARTED|Overall Study||19
6482177|NCT01315158|7399481|FG000|COMPLETED|Overall Study||17
6748497|NCT03412734|7676580|FG001|COMPLETED|Overall Study||41
6748498|NCT03412734|7676579|FG000|NOT COMPLETED|Overall Study||3
6748499|NCT03412734|7676580|FG001|NOT COMPLETED|Overall Study||0
6748500|NCT03412929|7676586|FG000|STARTED|Overall Study||8
6748501|NCT03412929|7676586|FG000|COMPLETED|Overall Study||5
6748502|NCT03412929|7676586|FG000|NOT COMPLETED|Overall Study||3
6748503|NCT03413618|7676592|FG000|STARTED|Overall Study||45
6748504|NCT03413618|7676593|FG001|STARTED|Overall Study||45
6482178|NCT01315158|7399482|FG001|COMPLETED|Overall Study||19
6482179|NCT01315158|7399481|FG000|NOT COMPLETED|Overall Study||0
6482180|NCT01315158|7399482|FG001|NOT COMPLETED|Overall Study||0
6482181|NCT01315236|7399490|FG000|STARTED|Double-blind Phase||44
6482182|NCT01315236|7399491|FG001|STARTED|Double-blind Phase||45
6482183|NCT01315236|7399490|FG000|COMPLETED|Double-blind Phase||40
6482184|NCT01315236|7399491|FG001|COMPLETED|Double-blind Phase||45
6482185|NCT01315236|7399490|FG000|NOT COMPLETED|Double-blind Phase||4
6482186|NCT01315236|7399491|FG001|NOT COMPLETED|Double-blind Phase||0
6482187|NCT01315236|7399490|FG000|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|35
6482188|NCT01315236|7399491|FG001|STARTED|Open-label Phase|Some subjects did not consent to the open label after the double blind phase.|43
6482189|NCT01315236|7399490|FG000|COMPLETED|Open-label Phase||34
6482190|NCT01315236|7399491|FG001|COMPLETED|Open-label Phase||41
6482191|NCT01315236|7399490|FG000|NOT COMPLETED|Open-label Phase||1
6482192|NCT01315236|7399491|FG001|NOT COMPLETED|Open-label Phase||2
6482193|NCT01315236|7399490|FG000|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|27
6482194|NCT01315236|7399491|FG001|STARTED|12-Month Follow-up Period|Some subjects did not consent to the 12 month safety.|32
6482195|NCT01315236|7399490|FG000|COMPLETED|12-Month Follow-up Period||26
6482196|NCT01315236|7399491|FG001|COMPLETED|12-Month Follow-up Period||31
6482197|NCT01315236|7399490|FG000|NOT COMPLETED|12-Month Follow-up Period||1
6482198|NCT01315236|7399491|FG001|NOT COMPLETED|12-Month Follow-up Period||1
6482199|NCT01315249|7399501|FG000|STARTED|Overall Study||259
6482200|NCT01315249|7399502|FG001|STARTED|Overall Study||264
6482201|NCT01315249|7399501|FG000|COMPLETED|Overall Study||215
6482202|NCT01315249|7399502|FG001|COMPLETED|Overall Study||217
6482203|NCT01315249|7399501|FG000|NOT COMPLETED|Overall Study||44
6482204|NCT01315249|7399502|FG001|NOT COMPLETED|Overall Study||47
6482205|NCT01315574|7399510|FG000|STARTED|Overall Study||7
6482206|NCT01315574|7399511|FG001|STARTED|Overall Study||7
6482207|NCT01315574|7399510|FG000|COMPLETED|Overall Study||7
6482208|NCT01315574|7399511|FG001|COMPLETED|Overall Study||7
6482209|NCT01315574|7399510|FG000|NOT COMPLETED|Overall Study||0
6482210|NCT01315574|7399511|FG001|NOT COMPLETED|Overall Study||0
6482211|NCT01315665|7399519|FG000|STARTED|Overall Study||10
6482212|NCT01315665|7399520|FG001|STARTED|Overall Study||5
6482213|NCT01315665|7399519|FG000|COMPLETED|Overall Study||10
6482214|NCT01315665|7399520|FG001|COMPLETED|Overall Study||5
6482215|NCT01315665|7399519|FG000|NOT COMPLETED|Overall Study||0
6482216|NCT01315665|7399520|FG001|NOT COMPLETED|Overall Study||0
6482217|NCT01315678|7399530|FG000|STARTED|Overall Study||148
6482218|NCT01315678|7399531|FG001|STARTED|Overall Study||146
6482219|NCT01315678|7399530|FG000|COMPLETED|Overall Study||134
6482220|NCT01315678|7399531|FG001|COMPLETED|Overall Study||140
6482221|NCT01315678|7399530|FG000|NOT COMPLETED|Overall Study||14
6482222|NCT01315678|7399531|FG001|NOT COMPLETED|Overall Study||6
6482223|NCT01315847|7399541|FG000|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
6482224|NCT01315847|7399542|FG001|STARTED|Part I, Period 1||0
6482225|NCT01315847|7399541|FG000|Received Telcagepant|Part I, Period 1||5
6482226|NCT01315847|7399542|FG001|Received Telcagepant|Part I, Period 1||0
6482227|NCT01315847|7399541|FG000|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
6482228|NCT01315847|7399542|FG001|Received [11C]MK-4232|Part I, Period 1||0
6554818|NCT01748799|7476936|FG000|Completed SAU of Self-titrated Placebo|Overall Study||5
6554819|NCT01748799|7476937|FG001|Completed SAU of Self-titrated Placebo|Overall Study||1
6748505|NCT03413618|7676592|FG000|COMPLETED|Overall Study||45
6748506|NCT03413618|7676593|FG001|COMPLETED|Overall Study||45
6748507|NCT03413618|7676592|FG000|NOT COMPLETED|Overall Study||0
6748508|NCT03413618|7676593|FG001|NOT COMPLETED|Overall Study||0
6482229|NCT01315847|7399541|FG000|COMPLETED|Part I, Period 1||2
6482230|NCT01315847|7399542|FG001|COMPLETED|Part I, Period 1||0
6482231|NCT01315847|7399541|FG000|NOT COMPLETED|Part I, Period 1||3
6482232|NCT01315847|7399542|FG001|NOT COMPLETED|Part I, Period 1||0
6482233|NCT01315847|7399541|FG000|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
6482234|NCT01315847|7399542|FG001|STARTED|Part I, Period 2||0
6482235|NCT01315847|7399541|FG000|Received Telcagepant|Part I, Period 2||3
6482236|NCT01315847|7399542|FG001|Received Telcagepant|Part I, Period 2||0
6482237|NCT01315847|7399541|FG000|Received [11C]MK-4232|Part I, Period 2||3
6482238|NCT01315847|7399542|FG001|Received [11C]MK-4232|Part I, Period 2||0
6482239|NCT01315847|7399541|FG000|COMPLETED|Part I, Period 2||3
6482240|NCT01315847|7399542|FG001|COMPLETED|Part I, Period 2||0
6482241|NCT01315847|7399541|FG000|NOT COMPLETED|Part I, Period 2||0
6482242|NCT01315847|7399542|FG001|NOT COMPLETED|Part I, Period 2||0
6482243|NCT01315847|7399541|FG000|STARTED|Part III, Period 1||0
6482244|NCT01315847|7399542|FG001|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
6482245|NCT01315847|7399541|FG000|Received Telcagepant|Part III, Period 1||0
6482246|NCT01315847|7399542|FG001|Received Telcagepant|Part III, Period 1||4
6482247|NCT01315847|7399541|FG000|Received [11C]MK-4232|Part III, Period 1||0
6482248|NCT01315847|7399542|FG001|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
6482249|NCT01315847|7399541|FG000|COMPLETED|Part III, Period 1||0
6482250|NCT01315847|7399542|FG001|COMPLETED|Part III, Period 1||3
6482251|NCT01315847|7399541|FG000|NOT COMPLETED|Part III, Period 1||0
6482252|NCT01315847|7399542|FG001|NOT COMPLETED|Part III, Period 1||1
6482253|NCT01315847|7399541|FG000|STARTED|Part III, Period 2||0
6482254|NCT01315847|7399542|FG001|STARTED|Part III, Period 2||3
6482255|NCT01315847|7399541|FG000|Received Telcagepant|Part III, Period 2||0
6482256|NCT01315847|7399542|FG001|Received Telcagepant|Part III, Period 2||3
6482257|NCT01315847|7399541|FG000|Received [11C]MK-4232|Part III, Period 2||0
6482258|NCT01315847|7399542|FG001|Received [11C]MK-4232|Part III, Period 2||3
6482259|NCT01315847|7399541|FG000|COMPLETED|Part III, Period 2||0
6482260|NCT01315847|7399542|FG001|COMPLETED|Part III, Period 2||3
6482261|NCT01315847|7399541|FG000|NOT COMPLETED|Part III, Period 2||0
6482262|NCT01315847|7399542|FG001|NOT COMPLETED|Part III, Period 2||0
6482263|NCT01316042|7399550|FG000|STARTED|Overall Study||2
6482264|NCT01316042|7399551|FG001|STARTED|Overall Study||2
6482265|NCT01316042|7399550|FG000|COMPLETED|Overall Study||2
6482266|NCT01316042|7399551|FG001|COMPLETED|Overall Study||1
6482267|NCT01316042|7399550|FG000|NOT COMPLETED|Overall Study||0
6482268|NCT01316042|7399551|FG001|NOT COMPLETED|Overall Study||1
6482269|NCT01316055|7399560|FG000|STARTED|Overall Study||13
6482270|NCT01316055|7399561|FG001|STARTED|Overall Study||17
6482271|NCT01316055|7399562|FG002|STARTED|Overall Study||12
6482272|NCT01316055|7399560|FG000|COMPLETED|Overall Study||12
6482273|NCT01316055|7399561|FG001|COMPLETED|Overall Study||17
6482274|NCT01316055|7399562|FG002|COMPLETED|Overall Study||12
6482275|NCT01316055|7399560|FG000|NOT COMPLETED|Overall Study||1
6554820|NCT01748799|7476938|FG002|Completed SAU of Self-titrated Placebo|Overall Study||1
6554821|NCT01748799|7476939|FG003|Completed SAU of Self-titrated Placebo|Overall Study||2
6554822|NCT01748799|7476940|FG004|Completed SAU of Self-titrated Placebo|Overall Study||1
6554823|NCT01748799|7476941|FG005|Completed SAU of Self-titrated Placebo|Overall Study||2
6554824|NCT01748799|7476942|FG006|Completed SAU of Self-titrated Placebo|Overall Study||1
6554825|NCT01748799|7476943|FG007|Completed SAU of Self-titrated Placebo|Overall Study||1
6554826|NCT01748799|7476936|FG000|Completed Self-titrated Placebo|Overall Study||4
6554827|NCT01748799|7476937|FG001|Completed Self-titrated Placebo|Overall Study||1
6554828|NCT01748799|7476938|FG002|Completed Self-titrated Placebo|Overall Study||1
6554829|NCT01748799|7476939|FG003|Completed Self-titrated Placebo|Overall Study||2
6554830|NCT01748799|7476940|FG004|Completed Self-titrated Placebo|Overall Study||1
6554831|NCT01748799|7476941|FG005|Completed Self-titrated Placebo|Overall Study||2
6554832|NCT01748799|7476942|FG006|Completed Self-titrated Placebo|Overall Study||1
6554833|NCT01748799|7476943|FG007|Completed Self-titrated Placebo|Overall Study||1
6554834|NCT01748799|7476936|FG000|Completed SAU of Self-titrated Sativex|Overall Study||2
6554835|NCT01748799|7476937|FG001|Completed SAU of Self-titrated Sativex|Overall Study||1
6554836|NCT01748799|7476938|FG002|Completed SAU of Self-titrated Sativex|Overall Study||1
6554837|NCT01748799|7476939|FG003|Completed SAU of Self-titrated Sativex|Overall Study||2
6554838|NCT01748799|7476940|FG004|Completed SAU of Self-titrated Sativex|Overall Study||1
6554839|NCT01748799|7476941|FG005|Completed SAU of Self-titrated Sativex|Overall Study||2
6554840|NCT01748799|7476942|FG006|Completed SAU of Self-titrated Sativex|Overall Study||1
6554841|NCT01748799|7476943|FG007|Completed SAU of Self-titrated Sativex|Overall Study||1
6554842|NCT01748799|7476936|FG000|Completed Self-titrated Sativex|Overall Study||1
6554843|NCT01748799|7476937|FG001|Completed Self-titrated Sativex|Overall Study||1
6554844|NCT01748799|7476938|FG002|Completed Self-titrated Sativex|Overall Study||1
6554845|NCT01748799|7476939|FG003|Completed Self-titrated Sativex|Overall Study||2
6554846|NCT01748799|7476940|FG004|Completed Self-titrated Sativex|Overall Study||1
6554847|NCT01748799|7476941|FG005|Completed Self-titrated Sativex|Overall Study||1
6554848|NCT01748799|7476942|FG006|Completed Self-titrated Sativex|Overall Study||1
6554849|NCT01748799|7476943|FG007|Completed Self-titrated Sativex|Overall Study||1
6554850|NCT01748799|7476936|FG000|COMPLETED|Overall Study||1
6554851|NCT01748799|7476937|FG001|COMPLETED|Overall Study||1
6554852|NCT01748799|7476938|FG002|COMPLETED|Overall Study||1
6482276|NCT01316055|7399561|FG001|NOT COMPLETED|Overall Study||0
6482277|NCT01316055|7399562|FG002|NOT COMPLETED|Overall Study||0
6482278|NCT01316211|7399575|FG000|STARTED|Overall Study||116
6482279|NCT01316211|7399576|FG001|STARTED|Overall Study||123
6482280|NCT01316211|7399575|FG000|COMPLETED|Overall Study||105
6482281|NCT01316211|7399576|FG001|COMPLETED|Overall Study||111
6554853|NCT01748799|7476939|FG003|COMPLETED|Overall Study||2
6482282|NCT01316211|7399575|FG000|NOT COMPLETED|Overall Study||11
6482283|NCT01316211|7399576|FG001|NOT COMPLETED|Overall Study||12
6482284|NCT01316224|7399582|FG000|STARTED|Overall Study||52
6482285|NCT01316224|7399582|FG000|Completed Visit 1 to Dermatologist|Overall Study||52
6482286|NCT01316224|7399582|FG000|Completed Visit 1 to Rheumatologist|Overall Study||49
6482287|NCT01316224|7399582|FG000|Completed Visit 2 to Dermatologist|Overall Study||51
6482288|NCT01316224|7399582|FG000|Completed Visit 3 to Dermatologist|Overall Study||48
6482289|NCT01316224|7399582|FG000|Completed Visit 3 to Rheumatologist|Overall Study||39
6482290|NCT01316224|7399582|FG000|Completed Visit 4 to Dermatologist|Overall Study||42
6482291|NCT01316224|7399582|FG000|Completed Visit 4 to Rheumatologist|Overall Study||28
6482292|NCT01316224|7399582|FG000|COMPLETED|Overall Study||42
6482293|NCT01316224|7399582|FG000|NOT COMPLETED|Overall Study||10
6482294|NCT01316263|7399588|FG000|STARTED|Overall Study||7
6482295|NCT01316263|7399589|FG001|STARTED|Overall Study||14
6482296|NCT01316263|7399588|FG000|Received Any Study Drug|Overall Study||7
6482297|NCT01316263|7399589|FG001|Received Any Study Drug|Overall Study||14
6482298|NCT01316263|7399588|FG000|COMPLETED|Overall Study||7
6482299|NCT01316263|7399589|FG001|COMPLETED|Overall Study||14
6482300|NCT01316263|7399588|FG000|NOT COMPLETED|Overall Study||0
6482301|NCT01316263|7399589|FG001|NOT COMPLETED|Overall Study||0
6482302|NCT01316276|7399597|FG000|STARTED|Overall Study||206
6482303|NCT01316276|7399597|FG000|COMPLETED|Overall Study||139
6482304|NCT01316276|7399597|FG000|NOT COMPLETED|Overall Study||67
6482305|NCT01316302|7399604|FG000|STARTED|Overall Study||30
6482306|NCT01316302|7399605|FG001|STARTED|Overall Study||33
6305732|NCT01711879|7209089|FG000|STARTED|Overall Study||3
6305733|NCT01711879|7209090|FG001|STARTED|Overall Study||4
6305734|NCT01711879|7209089|FG000|COMPLETED|Overall Study||2
6305735|NCT01711879|7209090|FG001|COMPLETED|Overall Study||4
6305736|NCT01711879|7209089|FG000|NOT COMPLETED|Overall Study||1
6305737|NCT01711879|7209090|FG001|NOT COMPLETED|Overall Study||0
6305738|NCT01697267|7209100|FG000|STARTED|Overall Study||85
6305739|NCT01697267|7209101|FG001|STARTED|Overall Study||85
6305740|NCT01697267|7209100|FG000|Month 24|Overall Study||78
6305741|NCT01697267|7209101|FG001|Month 24|Overall Study||78
6305742|NCT01697267|7209100|FG000|COMPLETED|Overall Study||71
6305743|NCT01697267|7209101|FG001|COMPLETED|Overall Study||70
6305744|NCT01697267|7209100|FG000|NOT COMPLETED|Overall Study||14
6305745|NCT01697267|7209101|FG001|NOT COMPLETED|Overall Study||15
6305746|NCT01527149|7209107|FG000|STARTED|Overall Study||37
6305747|NCT01527149|7209107|FG000|COMPLETED|Overall Study||35
6305748|NCT01527149|7209107|FG000|NOT COMPLETED|Overall Study||2
6374924|NCT00753142|7285511|FG001|COMPLETED|Overall Study||7
6374925|NCT00753142|7285512|FG002|COMPLETED|Overall Study||13
6374926|NCT00753142|7285510|FG000|NOT COMPLETED|Overall Study||0
6374927|NCT00753142|7285511|FG001|NOT COMPLETED|Overall Study||0
6374928|NCT00753142|7285512|FG002|NOT COMPLETED|Overall Study||0
6374929|NCT00753220|7285520|FG000|STARTED|Overall Study||7
6374930|NCT00753220|7285520|FG000|COMPLETED|Overall Study||2
6482307|NCT01316302|7399604|FG000|COMPLETED|Overall Study||20
6482308|NCT01316302|7399605|FG001|COMPLETED|Overall Study||22
6482309|NCT01316302|7399604|FG000|NOT COMPLETED|Overall Study||10
6482310|NCT01316302|7399605|FG001|NOT COMPLETED|Overall Study||11
6482311|NCT01316315|7399615|FG000|STARTED|Sequence 1||7
6482312|NCT01316315|7399616|FG001|STARTED|Sequence 1||7
6482313|NCT01316315|7399615|FG000|COMPLETED|Sequence 1||7
6482314|NCT01316315|7399616|FG001|COMPLETED|Sequence 1||7
6482315|NCT01316315|7399615|FG000|NOT COMPLETED|Sequence 1||0
6482316|NCT01316315|7399616|FG001|NOT COMPLETED|Sequence 1||0
6482317|NCT01316315|7399615|FG000|STARTED|Sequence 2||7
6482318|NCT01316315|7399616|FG001|STARTED|Sequence 2||7
6482319|NCT01316315|7399615|FG000|COMPLETED|Sequence 2||7
6482320|NCT01316315|7399616|FG001|COMPLETED|Sequence 2||7
6482321|NCT01316315|7399615|FG000|NOT COMPLETED|Sequence 2||0
6482322|NCT01316315|7399616|FG001|NOT COMPLETED|Sequence 2||0
6482323|NCT01316341|7399627|FG000|STARTED|Overall Study||6
6482324|NCT01316341|7399628|FG001|STARTED|Overall Study||9
6482325|NCT01316341|7399629|FG002|STARTED|Overall Study||9
6482326|NCT01316341|7399627|FG000|COMPLETED|Overall Study||6
6482327|NCT01316341|7399628|FG001|COMPLETED|Overall Study||9
6482328|NCT01316341|7399629|FG002|COMPLETED|Overall Study||9
6482329|NCT01316341|7399627|FG000|NOT COMPLETED|Overall Study||0
6482330|NCT01316341|7399628|FG001|NOT COMPLETED|Overall Study||0
6482331|NCT01316341|7399629|FG002|NOT COMPLETED|Overall Study||0
6482332|NCT01316380|7399649|FG000|STARTED|Overall Study||156
6374931|NCT00753220|7285520|FG000|NOT COMPLETED|Overall Study||5
6374932|NCT00753272|7285526|FG000|STARTED|Overall Study||21893
6374933|NCT00753272|7285527|FG001|STARTED|Overall Study||21802
6374934|NCT00753272|7285526|FG000|COMPLETED|Overall Study||16911
6374935|NCT00753272|7285527|FG001|COMPLETED|Overall Study||16895
6374936|NCT00753272|7285526|FG000|NOT COMPLETED|Overall Study||4982
6374937|NCT00753272|7285527|FG001|NOT COMPLETED|Overall Study||4907
6374938|NCT00753298|7285538|FG000|STARTED|Overall Study||97
6374939|NCT00753298|7285539|FG001|STARTED|Overall Study||98
6374940|NCT00753298|7285538|FG000|COMPLETED|Overall Study||89
6374941|NCT00753298|7285539|FG001|COMPLETED|Overall Study||94
6374942|NCT00753298|7285538|FG000|NOT COMPLETED|Overall Study||8
6374943|NCT00753298|7285539|FG001|NOT COMPLETED|Overall Study||4
6374944|NCT00753337|7285545|FG000|STARTED|Overall Study||123
6482333|NCT01316380|7399650|FG001|STARTED|Overall Study||154
6482334|NCT01316380|7399651|FG002|STARTED|Overall Study||155
6482335|NCT01316380|7399649|FG000|COMPLETED|Overall Study||154
6482336|NCT01316380|7399650|FG001|COMPLETED|Overall Study||149
6482337|NCT01316380|7399651|FG002|COMPLETED|Overall Study||152
6482338|NCT01316380|7399649|FG000|NOT COMPLETED|Overall Study||2
6482339|NCT01316380|7399650|FG001|NOT COMPLETED|Overall Study||5
6482340|NCT01316380|7399651|FG002|NOT COMPLETED|Overall Study||3
6482341|NCT01316419|7399659|FG000|STARTED|Overall Study||2089
6482342|NCT01316419|7399659|FG000|COMPLETED|Overall Study||1824
6482343|NCT01316419|7399659|FG000|NOT COMPLETED|Overall Study||265
6482344|NCT01316510|7399665|FG000|STARTED|Overall Study||12
6482345|NCT01316510|7399666|FG001|STARTED|Overall Study||12
6482346|NCT01316510|7399665|FG000|COMPLETED|Overall Study||12
6482347|NCT01316510|7399666|FG001|COMPLETED|Overall Study||12
6482348|NCT01316510|7399665|FG000|NOT COMPLETED|Overall Study||0
6482349|NCT01316510|7399666|FG001|NOT COMPLETED|Overall Study||0
6482350|NCT01316575|7399674|FG000|STARTED|Overall Study||20
6482351|NCT01316575|7399675|FG001|STARTED|Overall Study||20
6482352|NCT01316575|7399674|FG000|COMPLETED|Overall Study||18
6482353|NCT01316575|7399675|FG001|COMPLETED|Overall Study||19
6482354|NCT01316575|7399674|FG000|NOT COMPLETED|Overall Study||2
6482355|NCT01316575|7399675|FG001|NOT COMPLETED|Overall Study||1
6482356|NCT01316614|7399681|FG000|STARTED|Overall Study||137
6482357|NCT01316614|7399681|FG000|COMPLETED|Overall Study||100
6482358|NCT01316614|7399681|FG000|NOT COMPLETED|Overall Study||37
6482359|NCT01316692|7399686|FG000|STARTED|Overall Study||12
6482360|NCT01316692|7399686|FG000|COMPLETED|Overall Study||0
6482361|NCT01316692|7399686|FG000|NOT COMPLETED|Overall Study||12
6482362|NCT01316770|7399690|FG000|STARTED|Overall Study|Each study participant received the dexamethasone parotid irrigation on one side of mouth.|9
6482363|NCT01316770|7399691|FG001|STARTED|Overall Study|Each study participant received the placebo parotid irrigation on the other side of mouth.|9
6482364|NCT01316770|7399690|FG000|COMPLETED|Overall Study||9
6482365|NCT01316770|7399691|FG001|COMPLETED|Overall Study||9
6482366|NCT01316770|7399690|FG000|NOT COMPLETED|Overall Study||0
6482367|NCT01316770|7399691|FG001|NOT COMPLETED|Overall Study||0
6482368|NCT01316887|7399704|FG000|STARTED|Overall Study||109
6482369|NCT01316887|7399705|FG001|STARTED|Overall Study||227
6482370|NCT01316887|7399706|FG002|STARTED|Overall Study||226
6482371|NCT01316887|7399704|FG000|COMPLETED|Overall Study||66
6482372|NCT01316887|7399705|FG001|COMPLETED|Overall Study||133
6482373|NCT01316887|7399706|FG002|COMPLETED|Overall Study||143
6482374|NCT01316887|7399704|FG000|NOT COMPLETED|Overall Study||43
6482375|NCT01316887|7399705|FG001|NOT COMPLETED|Overall Study||94
6482376|NCT01316887|7399706|FG002|NOT COMPLETED|Overall Study||83
6482377|NCT01316900|7399719|FG000|STARTED|Overall Study||209
6482378|NCT01316900|7399720|FG001|STARTED|Overall Study||212
6482379|NCT01316900|7399721|FG002|STARTED|Overall Study||214
6482380|NCT01316900|7399722|FG003|STARTED|Overall Study||208
6482381|NCT01316900|7399719|FG000|COMPLETED|Overall Study||165
6482382|NCT01316900|7399720|FG001|COMPLETED|Overall Study||181
6482383|NCT01316900|7399721|FG002|COMPLETED|Overall Study||173
6482384|NCT01316900|7399722|FG003|COMPLETED|Overall Study||177
6482385|NCT01316900|7399719|FG000|NOT COMPLETED|Overall Study||44
6482386|NCT01316900|7399720|FG001|NOT COMPLETED|Overall Study||31
6482387|NCT01316900|7399721|FG002|NOT COMPLETED|Overall Study||41
6482388|NCT01316900|7399722|FG003|NOT COMPLETED|Overall Study||31
6482389|NCT01316913|7399736|FG000|STARTED|Overall Study||222
6482390|NCT01316913|7399737|FG001|STARTED|Overall Study||217
6482391|NCT01316913|7399738|FG002|STARTED|Overall Study||215
6482392|NCT01316913|7399739|FG003|STARTED|Overall Study||215
6482393|NCT01316913|7399736|FG000|COMPLETED|Overall Study||165
6482394|NCT01316913|7399737|FG001|COMPLETED|Overall Study||163
6482395|NCT01316913|7399738|FG002|COMPLETED|Overall Study||166
6482396|NCT01316913|7399739|FG003|COMPLETED|Overall Study||176
6482397|NCT01316913|7399736|FG000|NOT COMPLETED|Overall Study||57
6482398|NCT01316913|7399737|FG001|NOT COMPLETED|Overall Study||54
6482399|NCT01316913|7399738|FG002|NOT COMPLETED|Overall Study||49
6482400|NCT01316913|7399739|FG003|NOT COMPLETED|Overall Study||39
6482401|NCT01316926|7399750|FG000|STARTED|Period 1||30
6482402|NCT01316926|7399751|FG001|STARTED|Period 1||30
6482403|NCT01316926|7399750|FG000|COMPLETED|Period 1||30
6482404|NCT01316926|7399751|FG001|COMPLETED|Period 1||30
6482405|NCT01316926|7399750|FG000|NOT COMPLETED|Period 1||0
6482406|NCT01316926|7399751|FG001|NOT COMPLETED|Period 1||0
6482407|NCT01316926|7399750|FG000|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
6482408|NCT01316926|7399751|FG001|STARTED|Period 2||30
6482409|NCT01316926|7399750|FG000|COMPLETED|Period 2||29
6482410|NCT01316926|7399751|FG001|COMPLETED|Period 2||30
6482411|NCT01316926|7399750|FG000|NOT COMPLETED|Period 2||0
6482412|NCT01316926|7399751|FG001|NOT COMPLETED|Period 2||0
6482413|NCT01316939|7399761|FG000|STARTED|Overall Study||76
6482414|NCT01316939|7399762|FG001|STARTED|Overall Study||77
6482415|NCT01316939|7399763|FG002|STARTED|Overall Study||76
6482416|NCT01316939|7399761|FG000|COMPLETED|Overall Study||13
6482417|NCT01316939|7399762|FG001|COMPLETED|Overall Study||9
6482418|NCT01316939|7399763|FG002|COMPLETED|Overall Study||7
6482419|NCT01316939|7399761|FG000|NOT COMPLETED|Overall Study||63
6482420|NCT01316939|7399762|FG001|NOT COMPLETED|Overall Study||68
6482421|NCT01316939|7399763|FG002|NOT COMPLETED|Overall Study||69
6482422|NCT01317004|7399773|FG000|STARTED|Overall Study||51
6482423|NCT01317004|7399774|FG001|STARTED|Overall Study||14
6482424|NCT01317004|7399773|FG000|Safety Set|Overall Study||50
6482425|NCT01317004|7399774|FG001|Safety Set|Overall Study||11
6482426|NCT01317004|7399773|FG000|COMPLETED|Overall Study||47
6482427|NCT01317004|7399774|FG001|COMPLETED|Overall Study||5
6482428|NCT01317004|7399773|FG000|NOT COMPLETED|Overall Study||4
6482429|NCT01317004|7399774|FG001|NOT COMPLETED|Overall Study||9
6482430|NCT01317030|7399782|FG000|STARTED|Overall Study||12
6482431|NCT01317030|7399783|FG001|STARTED|Overall Study||13
6482432|NCT01317030|7399782|FG000|COMPLETED|Overall Study||12
6482433|NCT01317030|7399783|FG001|COMPLETED|Overall Study||13
6482434|NCT01317030|7399782|FG000|NOT COMPLETED|Overall Study||0
6482435|NCT01317030|7399783|FG001|NOT COMPLETED|Overall Study||0
6482436|NCT01317095|7399791|FG000|STARTED|Overall Study||39
6482437|NCT01317095|7399792|FG001|STARTED|Overall Study||41
6482438|NCT01317095|7399791|FG000|COMPLETED|Overall Study||39
6482439|NCT01317095|7399792|FG001|COMPLETED|Overall Study||41
6482440|NCT01317095|7399791|FG000|NOT COMPLETED|Overall Study||0
6482441|NCT01317095|7399792|FG001|NOT COMPLETED|Overall Study||0
6554854|NCT01748799|7476940|FG004|COMPLETED|Overall Study||1
6554855|NCT01748799|7476941|FG005|COMPLETED|Overall Study||1
6554856|NCT01748799|7476942|FG006|COMPLETED|Overall Study||1
6482442|NCT01317160|7399800|FG000|STARTED|Overall Study||75
6482443|NCT01317160|7399801|FG001|STARTED|Overall Study||75
6482444|NCT01317160|7399800|FG000|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
6482445|NCT01317160|7399801|FG001|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
6482446|NCT01317160|7399800|FG000|COMPLETED|Overall Study||71
6482447|NCT01317160|7399801|FG001|COMPLETED|Overall Study||69
6482448|NCT01317160|7399800|FG000|NOT COMPLETED|Overall Study||4
6482449|NCT01317160|7399801|FG001|NOT COMPLETED|Overall Study||6
6482450|NCT01317199|7399811|FG000|STARTED|Dose-escalation Phase 1||14
6482451|NCT01317199|7399812|FG001|STARTED|Dose-escalation Phase 1||0
6482452|NCT01317199|7399813|FG002|STARTED|Dose-escalation Phase 1||0
6482453|NCT01317199|7399814|FG003|STARTED|Dose-escalation Phase 1||0
6482454|NCT01317199|7399811|FG000|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||2
6482455|NCT01317199|7399812|FG001|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
6482456|NCT01317199|7399813|FG002|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
6482457|NCT01317199|7399814|FG003|Cycle 1: 500mg MPX Once Daily for 28 Day|Dose-escalation Phase 1||0
6482458|NCT01317199|7399811|FG000|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
6482459|NCT01317199|7399812|FG001|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482460|NCT01317199|7399813|FG002|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482461|NCT01317199|7399814|FG003|Cycle 2: 1000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482462|NCT01317199|7399811|FG000|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
6482463|NCT01317199|7399812|FG001|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482464|NCT01317199|7399813|FG002|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482465|NCT01317199|7399814|FG003|Cycle 3: 2000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482466|NCT01317199|7399811|FG000|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||2
6482467|NCT01317199|7399812|FG001|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482468|NCT01317199|7399813|FG002|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482469|NCT01317199|7399814|FG003|Cycle 4: 3000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482470|NCT01317199|7399811|FG000|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||6
6482471|NCT01317199|7399812|FG001|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482472|NCT01317199|7399813|FG002|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482473|NCT01317199|7399814|FG003|Cycle 5: 4000mg MPX Daily for 28 Days|Dose-escalation Phase 1||0
6482474|NCT01317199|7399811|FG000|COMPLETED|Dose-escalation Phase 1||7
6482475|NCT01317199|7399812|FG001|COMPLETED|Dose-escalation Phase 1||0
6482476|NCT01317199|7399813|FG002|COMPLETED|Dose-escalation Phase 1||0
6482477|NCT01317199|7399814|FG003|COMPLETED|Dose-escalation Phase 1||0
6482478|NCT01317199|7399811|FG000|NOT COMPLETED|Dose-escalation Phase 1||7
6482479|NCT01317199|7399812|FG001|NOT COMPLETED|Dose-escalation Phase 1||0
6482480|NCT01317199|7399813|FG002|NOT COMPLETED|Dose-escalation Phase 1||0
6482481|NCT01317199|7399814|FG003|NOT COMPLETED|Dose-escalation Phase 1||0
6482482|NCT01317199|7399811|FG000|STARTED|Randomized Phase 2||0
6482483|NCT01317199|7399812|FG001|STARTED|Randomized Phase 2||24
6482484|NCT01317199|7399813|FG002|STARTED|Randomized Phase 2||56
6482485|NCT01317199|7399814|FG003|STARTED|Randomized Phase 2||49
6482486|NCT01317199|7399811|FG000|COMPLETED|Randomized Phase 2||0
6482487|NCT01317199|7399812|FG001|COMPLETED|Randomized Phase 2||13
6482488|NCT01317199|7399813|FG002|COMPLETED|Randomized Phase 2||35
6482489|NCT01317199|7399814|FG003|COMPLETED|Randomized Phase 2||32
6482490|NCT01317199|7399811|FG000|NOT COMPLETED|Randomized Phase 2||0
6482491|NCT01317199|7399812|FG001|NOT COMPLETED|Randomized Phase 2||11
6482492|NCT01317199|7399813|FG002|NOT COMPLETED|Randomized Phase 2||21
6482493|NCT01317199|7399814|FG003|NOT COMPLETED|Randomized Phase 2||17
6482494|NCT01317277|7399833|FG000|STARTED|Overall Study||50
6482495|NCT01317277|7399834|FG001|STARTED|Overall Study||25
6482496|NCT01317277|7399833|FG000|COMPLETED|Overall Study||43
6482497|NCT01317277|7399834|FG001|COMPLETED|Overall Study||23
6482498|NCT01317277|7399833|FG000|NOT COMPLETED|Overall Study||7
6482499|NCT01317277|7399834|FG001|NOT COMPLETED|Overall Study||2
6482500|NCT01317472|7399842|FG000|STARTED|Overall Study||9
6482501|NCT01317472|7399843|FG001|STARTED|Overall Study||2
6482502|NCT01317472|7399842|FG000|COMPLETED|Overall Study||7
6482503|NCT01317472|7399843|FG001|COMPLETED|Overall Study||2
6482504|NCT01317472|7399842|FG000|NOT COMPLETED|Overall Study||2
6554857|NCT01748799|7476943|FG007|COMPLETED|Overall Study||1
6554858|NCT01748799|7476936|FG000|NOT COMPLETED|Overall Study||5
6554859|NCT01748799|7476937|FG001|NOT COMPLETED|Overall Study||0
6554860|NCT01748799|7476938|FG002|NOT COMPLETED|Overall Study||0
6554861|NCT01748799|7476939|FG003|NOT COMPLETED|Overall Study||0
6554862|NCT01748799|7476940|FG004|NOT COMPLETED|Overall Study||0
6554863|NCT01748799|7476941|FG005|NOT COMPLETED|Overall Study||1
6554864|NCT01748799|7476942|FG006|NOT COMPLETED|Overall Study||1
6554865|NCT01748799|7476943|FG007|NOT COMPLETED|Overall Study||0
6554866|NCT01748825|7476979|FG000|STARTED|Dose Escalation||6
6554867|NCT01748825|7476980|FG001|STARTED|Dose Escalation||4
6554868|NCT01748825|7476981|FG002|STARTED|Dose Escalation||6
6554869|NCT01748825|7476982|FG003|STARTED|Dose Escalation||3
6554870|NCT01748825|7476983|FG004|STARTED|Dose Escalation||3
6554871|NCT01748825|7476984|FG005|STARTED|Dose Escalation||6
6554872|NCT01748825|7476985|FG006|STARTED|Dose Escalation||3
6554873|NCT01748825|7476986|FG007|STARTED|Dose Escalation||3
6554874|NCT01748825|7476987|FG008|STARTED|Dose Escalation||0
6554875|NCT01748825|7476988|FG009|STARTED|Dose Escalation||0
6554876|NCT01748825|7476979|FG000|COMPLETED|Dose Escalation||4
6554877|NCT01748825|7476980|FG001|COMPLETED|Dose Escalation||2
6554878|NCT01748825|7476981|FG002|COMPLETED|Dose Escalation||6
6554879|NCT01748825|7476982|FG003|COMPLETED|Dose Escalation||2
6482505|NCT01317472|7399843|FG001|NOT COMPLETED|Overall Study||0
6482506|NCT01317550|7399853|FG000|STARTED|Overall Study||5
6482507|NCT01317550|7399854|FG001|STARTED|Overall Study||3
6482508|NCT01317550|7399855|FG002|STARTED|Overall Study||3
6482509|NCT01317550|7399856|FG003|STARTED|Overall Study||3
6482510|NCT01317550|7399853|FG000|COMPLETED|Overall Study||3
6482511|NCT01317550|7399854|FG001|COMPLETED|Overall Study||3
6482512|NCT01317550|7399855|FG002|COMPLETED|Overall Study||3
6482513|NCT01317550|7399856|FG003|COMPLETED|Overall Study||3
6482514|NCT01317550|7399853|FG000|NOT COMPLETED|Overall Study||2
6482515|NCT01317550|7399854|FG001|NOT COMPLETED|Overall Study||0
6482516|NCT01317550|7399855|FG002|NOT COMPLETED|Overall Study||0
6482517|NCT01317550|7399856|FG003|NOT COMPLETED|Overall Study||0
6482518|NCT01317615|7399866|FG000|STARTED|Overall Study||49
6482519|NCT01317615|7399866|FG000|COMPLETED|Overall Study||0
6482520|NCT01317615|7399866|FG000|NOT COMPLETED|Overall Study||49
6482521|NCT01317641|7399879|FG000|STARTED|Overall Study||4
6482522|NCT01317641|7399880|FG001|STARTED|Overall Study||7
6482523|NCT01317641|7399881|FG002|STARTED|Overall Study||3
6482524|NCT01317641|7399882|FG003|STARTED|Overall Study||4
6482525|NCT01317641|7399883|FG004|STARTED|Overall Study||3
6482526|NCT01317641|7399884|FG005|STARTED|Overall Study||3
6482527|NCT01317641|7399885|FG006|STARTED|Overall Study||38
6482528|NCT01317641|7399886|FG007|STARTED|Overall Study||38
6482529|NCT01317641|7399887|FG008|STARTED|Overall Study||36
6482530|NCT01317641|7399879|FG000|COMPLETED|Overall Study||3
6482531|NCT01317641|7399880|FG001|COMPLETED|Overall Study||6
6482532|NCT01317641|7399881|FG002|COMPLETED|Overall Study||3
6482533|NCT01317641|7399882|FG003|COMPLETED|Overall Study||3
6482534|NCT01317641|7399883|FG004|COMPLETED|Overall Study||3
6482535|NCT01317641|7399884|FG005|COMPLETED|Overall Study||3
6482536|NCT01317641|7399885|FG006|COMPLETED|Overall Study||35
6482537|NCT01317641|7399886|FG007|COMPLETED|Overall Study||33
6482538|NCT01317641|7399887|FG008|COMPLETED|Overall Study||31
6482539|NCT01317641|7399879|FG000|NOT COMPLETED|Overall Study||1
6482540|NCT01317641|7399880|FG001|NOT COMPLETED|Overall Study||1
6482541|NCT01317641|7399881|FG002|NOT COMPLETED|Overall Study||0
6482542|NCT01317641|7399882|FG003|NOT COMPLETED|Overall Study||1
6482543|NCT01317641|7399883|FG004|NOT COMPLETED|Overall Study||0
6482544|NCT01317641|7399884|FG005|NOT COMPLETED|Overall Study||0
6482545|NCT01317641|7399885|FG006|NOT COMPLETED|Overall Study||3
6482546|NCT01317641|7399886|FG007|NOT COMPLETED|Overall Study||5
6482547|NCT01317641|7399887|FG008|NOT COMPLETED|Overall Study||5
6482548|NCT01317667|7399926|FG000|STARTED|Overall Study||10
6482549|NCT01317667|7399927|FG001|STARTED|Overall Study||10
6482550|NCT01317667|7399928|FG002|STARTED|Overall Study||10
6482551|NCT01317667|7399926|FG000|COMPLETED|Overall Study||10
6482552|NCT01317667|7399927|FG001|COMPLETED|Overall Study||10
6482553|NCT01317667|7399928|FG002|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
6482554|NCT01317667|7399926|FG000|NOT COMPLETED|Overall Study||0
6482555|NCT01317667|7399927|FG001|NOT COMPLETED|Overall Study||0
6482556|NCT01317667|7399928|FG002|NOT COMPLETED|Overall Study||0
6482557|NCT01317797|7399939|FG000|STARTED|Overall Study||8
6482558|NCT01317797|7399940|FG001|STARTED|Overall Study||7
6554880|NCT01748825|7476983|FG004|COMPLETED|Dose Escalation||2
6554881|NCT01748825|7476984|FG005|COMPLETED|Dose Escalation||4
6554882|NCT01748825|7476985|FG006|COMPLETED|Dose Escalation||2
6554883|NCT01748825|7476986|FG007|COMPLETED|Dose Escalation||3
6482559|NCT01317797|7399941|FG002|STARTED|Overall Study||9
6482560|NCT01317797|7399939|FG000|COMPLETED|Overall Study||8
6482561|NCT01317797|7399940|FG001|COMPLETED|Overall Study||6
6482562|NCT01317797|7399941|FG002|COMPLETED|Overall Study||8
6482563|NCT01317797|7399939|FG000|NOT COMPLETED|Overall Study||0
6482564|NCT01317797|7399940|FG001|NOT COMPLETED|Overall Study||1
6482565|NCT01317797|7399941|FG002|NOT COMPLETED|Overall Study||1
6482566|NCT01317901|7399951|FG000|STARTED|Overall Study||6
6482567|NCT01317901|7399952|FG001|STARTED|Overall Study||6
6482568|NCT01317901|7399951|FG000|COMPLETED|Overall Study||6
6482569|NCT01317901|7399952|FG001|COMPLETED|Overall Study||6
6482570|NCT01317901|7399951|FG000|NOT COMPLETED|Overall Study||0
6554884|NCT01748825|7476987|FG008|COMPLETED|Dose Escalation||0
6482571|NCT01317901|7399952|FG001|NOT COMPLETED|Overall Study||0
6482572|NCT01317940|7399964|FG000|STARTED|Overall Study||19
6482573|NCT01317940|7399965|FG001|STARTED|Overall Study||10
6482574|NCT01317940|7399966|FG002|STARTED|Overall Study||20
6482575|NCT01317940|7399967|FG003|STARTED|Overall Study||6
6482576|NCT01317940|7399968|FG004|STARTED|Overall Study||13
6482577|NCT01317940|7399969|FG005|STARTED|Overall Study||4
6482578|NCT01317940|7399964|FG000|COMPLETED|Overall Study||18
6482579|NCT01317940|7399965|FG001|COMPLETED|Overall Study||10
6482580|NCT01317940|7399966|FG002|COMPLETED|Overall Study||15
6482581|NCT01317940|7399967|FG003|COMPLETED|Overall Study||5
6482582|NCT01317940|7399968|FG004|COMPLETED|Overall Study||12
6482583|NCT01317940|7399969|FG005|COMPLETED|Overall Study||4
6482584|NCT01317940|7399964|FG000|NOT COMPLETED|Overall Study||1
6482585|NCT01317940|7399965|FG001|NOT COMPLETED|Overall Study||0
6482586|NCT01317940|7399966|FG002|NOT COMPLETED|Overall Study||5
6482587|NCT01317940|7399967|FG003|NOT COMPLETED|Overall Study||1
6482588|NCT01317940|7399968|FG004|NOT COMPLETED|Overall Study||1
6482589|NCT01317940|7399969|FG005|NOT COMPLETED|Overall Study||0
6482590|NCT01318018|7399986|FG000|STARTED|Overall Study||10
6482591|NCT01318018|7399987|FG001|STARTED|Overall Study||10
6482592|NCT01318018|7399986|FG000|COMPLETED|Overall Study||10
6482593|NCT01318018|7399987|FG001|COMPLETED|Overall Study||10
6482594|NCT01318018|7399986|FG000|NOT COMPLETED|Overall Study||0
6482595|NCT01318018|7399987|FG001|NOT COMPLETED|Overall Study||0
6482596|NCT01318070|7399996|FG000|STARTED|Overall Study||111
6482597|NCT01318070|7399997|FG001|STARTED|Overall Study||113
6482598|NCT01318070|7399998|FG002|STARTED|Overall Study||115
6482599|NCT01318070|7399996|FG000|COMPLETED|Overall Study||109
6482600|NCT01318070|7399997|FG001|COMPLETED|Overall Study||111
6482601|NCT01318070|7399998|FG002|COMPLETED|Overall Study||108
6482602|NCT01318070|7399996|FG000|NOT COMPLETED|Overall Study||2
6482603|NCT01318070|7399997|FG001|NOT COMPLETED|Overall Study||2
6482604|NCT01318070|7399998|FG002|NOT COMPLETED|Overall Study||7
6482605|NCT01318083|7400009|FG000|STARTED|Overall Study||105
6482606|NCT01318083|7400010|FG001|STARTED|Overall Study||104
6482607|NCT01318083|7400011|FG002|STARTED|Overall Study||103
6482608|NCT01318083|7400009|FG000|COMPLETED|Overall Study||99
6482609|NCT01318083|7400010|FG001|COMPLETED|Overall Study||102
6482610|NCT01318083|7400011|FG002|COMPLETED|Overall Study||98
6482611|NCT01318083|7400009|FG000|NOT COMPLETED|Overall Study||6
6482612|NCT01318083|7400010|FG001|NOT COMPLETED|Overall Study||2
6482613|NCT01318083|7400011|FG002|NOT COMPLETED|Overall Study||5
6482614|NCT01318109|7400022|FG000|STARTED|Overall Study||92
6482615|NCT01318109|7400023|FG001|STARTED|Overall Study||96
6482616|NCT01318109|7400024|FG002|STARTED|Overall Study||100
6482617|NCT01318109|7400022|FG000|COMPLETED|Overall Study||91
6482618|NCT01318109|7400023|FG001|COMPLETED|Overall Study||93
6482619|NCT01318109|7400024|FG002|COMPLETED|Overall Study||100
6482620|NCT01318109|7400022|FG000|NOT COMPLETED|Overall Study||1
6482621|NCT01318109|7400023|FG001|NOT COMPLETED|Overall Study||3
6482622|NCT01318109|7400024|FG002|NOT COMPLETED|Overall Study||0
6482623|NCT01318122|7400034|FG000|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
6482624|NCT01318122|7400035|FG001|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
6482625|NCT01318122|7400036|FG002|STARTED|Enrolled - Long-Term Extension Study||57
6482626|NCT01318122|7400037|FG003|STARTED|Enrolled - Long-Term Extension Study||53
6482627|NCT01318122|7400034|FG000|COMPLETED|Enrolled - Long-Term Extension Study||105
6482628|NCT01318122|7400035|FG001|COMPLETED|Enrolled - Long-Term Extension Study||110
6482629|NCT01318122|7400036|FG002|COMPLETED|Enrolled - Long-Term Extension Study||55
6482630|NCT01318122|7400037|FG003|COMPLETED|Enrolled - Long-Term Extension Study||52
6482631|NCT01318122|7400034|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
6482632|NCT01318122|7400035|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6482633|NCT01318122|7400036|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
6482634|NCT01318122|7400037|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
6482635|NCT01318122|7400034|FG000|STARTED|Entered - Long-Term Extension Study||105
6482636|NCT01318122|7400035|FG001|STARTED|Entered - Long-Term Extension Study||110
6482637|NCT01318122|7400036|FG002|STARTED|Entered - Long-Term Extension Study||55
6482638|NCT01318122|7400037|FG003|STARTED|Entered - Long-Term Extension Study||52
6482639|NCT01318122|7400034|FG000|COMPLETED|Entered - Long-Term Extension Study||96
6482640|NCT01318122|7400035|FG001|COMPLETED|Entered - Long-Term Extension Study||99
6482641|NCT01318122|7400036|FG002|COMPLETED|Entered - Long-Term Extension Study||49
6482642|NCT01318122|7400037|FG003|COMPLETED|Entered - Long-Term Extension Study||48
6482643|NCT01318122|7400034|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||9
6482644|NCT01318122|7400035|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||11
6482645|NCT01318122|7400036|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||6
6482646|NCT01318122|7400037|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||4
6482647|NCT01318135|7400047|FG000|STARTED|Enrolled - Long-Term Extension Study||99
6482648|NCT01318135|7400048|FG001|STARTED|Enrolled - Long-Term Extension Study||102
6482649|NCT01318135|7400049|FG002|STARTED|Enrolled - Long-Term Extension Study||46
6482650|NCT01318135|7400050|FG003|STARTED|Enrolled - Long-Term Extension Study||49
6482651|NCT01318135|7400051|FG004|STARTED|Enrolled - Long-Term Extension Study||91
6482652|NCT01318135|7400052|FG005|STARTED|Enrolled - Long-Term Extension Study||90
6482653|NCT01318135|7400053|FG006|STARTED|Enrolled - Long-Term Extension Study||50
6482654|NCT01318135|7400054|FG007|STARTED|Enrolled - Long-Term Extension Study||49
6482655|NCT01318135|7400047|FG000|COMPLETED|Enrolled - Long-Term Extension Study||97
6482656|NCT01318135|7400048|FG001|COMPLETED|Enrolled - Long-Term Extension Study||102
6482657|NCT01318135|7400049|FG002|COMPLETED|Enrolled - Long-Term Extension Study||46
6482658|NCT01318135|7400050|FG003|COMPLETED|Enrolled - Long-Term Extension Study||49
6482659|NCT01318135|7400051|FG004|COMPLETED|Enrolled - Long-Term Extension Study||91
6482660|NCT01318135|7400052|FG005|COMPLETED|Enrolled - Long-Term Extension Study||90
6482661|NCT01318135|7400053|FG006|COMPLETED|Enrolled - Long-Term Extension Study||50
6482662|NCT01318135|7400054|FG007|COMPLETED|Enrolled - Long-Term Extension Study||49
6482663|NCT01318135|7400047|FG000|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
6482664|NCT01318135|7400048|FG001|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6482665|NCT01318135|7400049|FG002|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6482666|NCT01318135|7400050|FG003|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6482667|NCT01318135|7400051|FG004|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6482668|NCT01318135|7400052|FG005|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6482669|NCT01318135|7400053|FG006|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6482670|NCT01318135|7400054|FG007|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
6482671|NCT01318135|7400047|FG000|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
6482672|NCT01318135|7400048|FG001|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
6482673|NCT01318135|7400049|FG002|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
6482674|NCT01318135|7400050|FG003|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
6482675|NCT01318135|7400051|FG004|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
6482676|NCT01318135|7400052|FG005|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
6482677|NCT01318135|7400053|FG006|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
6482678|NCT01318135|7400054|FG007|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
6482679|NCT01318135|7400047|FG000|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
6482680|NCT01318135|7400048|FG001|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
6482681|NCT01318135|7400049|FG002|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
6482682|NCT01318135|7400050|FG003|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
6482683|NCT01318135|7400051|FG004|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
6482684|NCT01318135|7400052|FG005|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
6482685|NCT01318135|7400053|FG006|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
6482686|NCT01318135|7400054|FG007|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
6482687|NCT01318135|7400047|FG000|NOT COMPLETED|Entered - Long-Term Extension Study||17
6482688|NCT01318135|7400048|FG001|NOT COMPLETED|Entered - Long-Term Extension Study||13
6482689|NCT01318135|7400049|FG002|NOT COMPLETED|Entered - Long-Term Extension Study||8
6482690|NCT01318135|7400050|FG003|NOT COMPLETED|Entered - Long-Term Extension Study||7
6482691|NCT01318135|7400051|FG004|NOT COMPLETED|Entered - Long-Term Extension Study||9
6482692|NCT01318135|7400052|FG005|NOT COMPLETED|Entered - Long-Term Extension Study||4
6482693|NCT01318135|7400053|FG006|NOT COMPLETED|Entered - Long-Term Extension Study||1
6482694|NCT01318135|7400054|FG007|NOT COMPLETED|Entered - Long-Term Extension Study||3
6482695|NCT01318278|7400067|FG000|STARTED|Overall Study||10
6482696|NCT01318278|7400068|FG001|STARTED|Overall Study||10
6482697|NCT01318278|7400069|FG002|STARTED|Overall Study||50
6482698|NCT01318278|7400067|FG000|COMPLETED|Overall Study||10
6482699|NCT01318278|7400068|FG001|COMPLETED|Overall Study||10
6482700|NCT01318278|7400069|FG002|COMPLETED|Overall Study||50
6482701|NCT01318278|7400067|FG000|NOT COMPLETED|Overall Study||0
6482702|NCT01318278|7400068|FG001|NOT COMPLETED|Overall Study||0
6482703|NCT01318278|7400069|FG002|NOT COMPLETED|Overall Study||0
6482704|NCT01318356|7400081|FG000|STARTED|Overall Study||51
6482705|NCT01318356|7400082|FG001|STARTED|Overall Study||52
6482706|NCT01318356|7400083|FG002|STARTED|Overall Study||52
6482707|NCT01318356|7400081|FG000|COMPLETED|Overall Study||43
6482708|NCT01318356|7400082|FG001|COMPLETED|Overall Study||49
6482709|NCT01318356|7400083|FG002|COMPLETED|Overall Study||50
6482710|NCT01318356|7400081|FG000|NOT COMPLETED|Overall Study||8
6482711|NCT01318356|7400082|FG001|NOT COMPLETED|Overall Study||3
6482712|NCT01318356|7400083|FG002|NOT COMPLETED|Overall Study||2
6482713|NCT01318382|7400091|FG000|STARTED|Overall Study||302
6482714|NCT01318382|7400091|FG000|COMPLETED|Overall Study||289
6482715|NCT01318382|7400091|FG000|NOT COMPLETED|Overall Study||13
6482716|NCT01318408|7400096|FG000|STARTED|Overall Study||24
6482717|NCT01318408|7400096|FG000|COMPLETED|Overall Study||16
6482718|NCT01318408|7400096|FG000|NOT COMPLETED|Overall Study||8
6482719|NCT01318499|7400103|FG000|STARTED|Overall Study||540
6482720|NCT01318499|7400104|FG001|STARTED|Overall Study||534
6482721|NCT01318499|7400105|FG002|STARTED|Overall Study||268
6482722|NCT01318499|7400103|FG000|COMPLETED|Overall Study||475
6482723|NCT01318499|7400104|FG001|COMPLETED|Overall Study||458
6482724|NCT01318499|7400105|FG002|COMPLETED|Overall Study||121
6482725|NCT01318499|7400103|FG000|NOT COMPLETED|Overall Study||65
6482726|NCT01318499|7400104|FG001|NOT COMPLETED|Overall Study||76
6482727|NCT01318499|7400105|FG002|NOT COMPLETED|Overall Study||147
6482728|NCT01318512|7400115|FG000|STARTED|Titration Period (4 Months)||340
6482729|NCT01318512|7400115|FG000|COMPLETED|Titration Period (4 Months)||340
6482730|NCT01318512|7400115|FG000|NOT COMPLETED|Titration Period (4 Months)||0
6482731|NCT01318512|7400115|FG000|STARTED|Maintenance Period (6 Months)||340
6482732|NCT01318512|7400115|FG000|COMPLETED|Maintenance Period (6 Months)||329
6482733|NCT01318512|7400115|FG000|NOT COMPLETED|Maintenance Period (6 Months)||11
6482734|NCT01318538|7400123|FG000|STARTED|Overall Study||52
6482735|NCT01318538|7400124|FG001|STARTED|Overall Study||106
6482736|NCT01318538|7400125|FG002|STARTED|Overall Study||8
6482737|NCT01318538|7400123|FG000|COMPLETED|Overall Study||52
6482738|NCT01318538|7400124|FG001|COMPLETED|Overall Study||106
6482739|NCT01318538|7400125|FG002|COMPLETED|Overall Study||8
6482740|NCT01318538|7400123|FG000|NOT COMPLETED|Overall Study||0
6482741|NCT01318538|7400124|FG001|NOT COMPLETED|Overall Study||0
6482742|NCT01318538|7400125|FG002|NOT COMPLETED|Overall Study||0
6482743|NCT01318577|7400135|FG000|STARTED|Overall Study||224
6482744|NCT01318577|7400136|FG001|STARTED|Overall Study||220
6482745|NCT01318577|7400135|FG000|COMPLETED|Overall Study||211
6482746|NCT01318577|7400136|FG001|COMPLETED|Overall Study||212
6482747|NCT01318577|7400135|FG000|NOT COMPLETED|Overall Study||13
6482748|NCT01318577|7400136|FG001|NOT COMPLETED|Overall Study||8
6482749|NCT01318694|7400146|FG000|STARTED|Overall Study||275
6482750|NCT01318694|7400147|FG001|STARTED|Overall Study||270
6482751|NCT01318694|7400148|FG002|STARTED|Overall Study||268
6482752|NCT01318694|7400149|FG003|STARTED|Overall Study||268
6554885|NCT01748825|7476988|FG009|COMPLETED|Dose Escalation||0
6554886|NCT01748825|7476979|FG000|NOT COMPLETED|Dose Escalation||2
6554887|NCT01748825|7476980|FG001|NOT COMPLETED|Dose Escalation||2
6482753|NCT01318694|7400146|FG000|Full Analysis Set|Overall Study||274
6482754|NCT01318694|7400147|FG001|Full Analysis Set|Overall Study||270
6482755|NCT01318694|7400148|FG002|Full Analysis Set|Overall Study||265
6482756|NCT01318694|7400149|FG003|Full Analysis Set|Overall Study||268
6482757|NCT01318694|7400146|FG000|Safety Set|Overall Study||273
6482758|NCT01318694|7400147|FG001|Safety Set|Overall Study||268
6482759|NCT01318694|7400148|FG002|Safety Set|Overall Study||265
6482760|NCT01318694|7400149|FG003|Safety Set|Overall Study||265
6482761|NCT01318694|7400146|FG000|COMPLETED|Overall Study||223
6482762|NCT01318694|7400147|FG001|COMPLETED|Overall Study||212
6482763|NCT01318694|7400148|FG002|COMPLETED|Overall Study||225
6482764|NCT01318694|7400149|FG003|COMPLETED|Overall Study||200
6482765|NCT01318694|7400146|FG000|NOT COMPLETED|Overall Study||52
6482766|NCT01318694|7400147|FG001|NOT COMPLETED|Overall Study||58
6482767|NCT01318694|7400148|FG002|NOT COMPLETED|Overall Study||43
6482768|NCT01318694|7400149|FG003|NOT COMPLETED|Overall Study||68
6482769|NCT01318733|7400159|FG000|STARTED|Overall Study||449
6482770|NCT01318733|7400159|FG000|COMPLETED|Overall Study||279
6482771|NCT01318733|7400159|FG000|NOT COMPLETED|Overall Study||170
6482772|NCT01318811|7400165|FG000|STARTED|Overall Study||4
6482773|NCT01318811|7400166|FG001|STARTED|Overall Study||8
6482774|NCT01318811|7400165|FG000|COMPLETED|Overall Study||3
6482775|NCT01318811|7400166|FG001|COMPLETED|Overall Study||4
6482776|NCT01318811|7400165|FG000|NOT COMPLETED|Overall Study||1
6482777|NCT01318811|7400166|FG001|NOT COMPLETED|Overall Study||4
6482778|NCT01318876|7400172|FG000|STARTED|Day 8 Survey||7645
6482779|NCT01318876|7400172|FG000|COMPLETED|Day 8 Survey||5825
6482780|NCT01318876|7400172|FG000|NOT COMPLETED|Day 8 Survey||1820
6482781|NCT01318876|7400172|FG000|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
6482782|NCT01318876|7400172|FG000|COMPLETED|Day 29 Survey||5724
6482783|NCT01318876|7400172|FG000|NOT COMPLETED|Day 29 Survey||1825
6501543|NCT01429350|7420037|FG000|COMPLETED|Overall Study||46
6501544|NCT01429350|7420038|FG001|COMPLETED|Overall Study||50
6501545|NCT01429350|7420037|FG000|NOT COMPLETED|Overall Study||7
6501546|NCT01429350|7420038|FG001|NOT COMPLETED|Overall Study||5
6501547|NCT01429441|7420046|FG000|STARTED|Overall Study||146
6501548|NCT01429441|7420047|FG001|STARTED|Overall Study||74
6501549|NCT01429441|7420046|FG000|COMPLETED|Overall Study||108
6501550|NCT01429441|7420047|FG001|COMPLETED|Overall Study||51
6501551|NCT01429441|7420046|FG000|NOT COMPLETED|Overall Study||38
6501552|NCT01429441|7420047|FG001|NOT COMPLETED|Overall Study||23
6501553|NCT01429454|7420055|FG000|STARTED|Overall Study||62
6501554|NCT01429454|7420056|FG001|STARTED|Overall Study||65
6501555|NCT01429454|7420055|FG000|COMPLETED|Overall Study||35
6501556|NCT01429454|7420056|FG001|COMPLETED|Overall Study||35
6501557|NCT01429454|7420055|FG000|NOT COMPLETED|Overall Study||27
6501558|NCT01429454|7420056|FG001|NOT COMPLETED|Overall Study||30
6501559|NCT01429532|7420066|FG000|STARTED|Overall Study||40
6501560|NCT01429532|7420067|FG001|STARTED|Overall Study||40
6501561|NCT01429532|7420068|FG002|STARTED|Overall Study||40
6501562|NCT01429532|7420066|FG000|COMPLETED|Overall Study||40
6501563|NCT01429532|7420067|FG001|COMPLETED|Overall Study||40
6501564|NCT01429532|7420068|FG002|COMPLETED|Overall Study||40
6482784|NCT01318902|7400180|FG000|STARTED|Overall Study||6
6482785|NCT01318902|7400181|FG001|STARTED|Overall Study||5
6482786|NCT01318902|7400182|FG002|STARTED|Overall Study||5
6482787|NCT01318902|7400183|FG003|STARTED|Overall Study||11
6482788|NCT01318902|7400180|FG000|COMPLETED|Overall Study||5
6482789|NCT01318902|7400181|FG001|COMPLETED|Overall Study||2
6482790|NCT01318902|7400182|FG002|COMPLETED|Overall Study||3
6482791|NCT01318902|7400183|FG003|COMPLETED|Overall Study||5
6482792|NCT01318902|7400180|FG000|NOT COMPLETED|Overall Study||1
6482793|NCT01318902|7400181|FG001|NOT COMPLETED|Overall Study||3
6482794|NCT01318902|7400182|FG002|NOT COMPLETED|Overall Study||2
6482795|NCT01318902|7400183|FG003|NOT COMPLETED|Overall Study||6
6482796|NCT01318915|7400195|FG000|STARTED|Overall Study||10
6482797|NCT01318915|7400195|FG000|COMPLETED|Overall Study||9
6482798|NCT01318915|7400195|FG000|NOT COMPLETED|Overall Study||1
6482799|NCT01318967|7400201|FG000|STARTED|Overall Study||10
6482800|NCT01318967|7400201|FG000|COMPLETED|Overall Study||10
6482801|NCT01318967|7400201|FG000|NOT COMPLETED|Overall Study||0
6482802|NCT01319045|7400206|FG000|STARTED|Overall Study||5
6482803|NCT01319045|7400206|FG000|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
6482804|NCT01319045|7400206|FG000|NOT COMPLETED|Overall Study||2
6482805|NCT01319110|7400212|FG000|STARTED|Overall Study||5
6482806|NCT01319110|7400213|FG001|STARTED|Overall Study||5
6482807|NCT01319110|7400212|FG000|COMPLETED|Overall Study||5
6482808|NCT01319110|7400213|FG001|COMPLETED|Overall Study||5
6482809|NCT01319110|7400212|FG000|NOT COMPLETED|Overall Study||0
6482810|NCT01319110|7400213|FG001|NOT COMPLETED|Overall Study||0
6482811|NCT01319318|7400219|FG000|STARTED|Overall Study||25
6482812|NCT01319318|7400219|FG000|COMPLETED|Overall Study||25
6482813|NCT01319318|7400219|FG000|NOT COMPLETED|Overall Study||0
6482814|NCT01319383|7400223|FG000|STARTED|Overall Study||12
6482815|NCT01319383|7400224|FG001|STARTED|Overall Study||13
6482816|NCT01319383|7400223|FG000|Step 1|Overall Study||8
6482817|NCT01319383|7400224|FG001|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
6482818|NCT01319383|7400223|FG000|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
6482819|NCT01319383|7400224|FG001|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
6482820|NCT01319383|7400223|FG000|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
6482821|NCT01319383|7400224|FG001|Step 2|Overall Study||0
6482822|NCT01319383|7400223|FG000|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
6482823|NCT01319383|7400224|FG001|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
6482824|NCT01319383|7400223|FG000|Step 4|Overall Study|Arm 1 did not have a Step 4|0
6482825|NCT01319383|7400224|FG001|Step 4|Overall Study|Only 3/6 completed the study.|3
6482826|NCT01319383|7400223|FG000|COMPLETED|Overall Study||0
6482827|NCT01319383|7400224|FG001|COMPLETED|Overall Study||3
6482828|NCT01319383|7400223|FG000|NOT COMPLETED|Overall Study||12
6482829|NCT01319383|7400224|FG001|NOT COMPLETED|Overall Study||10
6482830|NCT01319396|7400241|FG000|STARTED|Overall Study||24
6482831|NCT01319396|7400241|FG000|COMPLETED|Overall Study||24
6482832|NCT01319396|7400241|FG000|NOT COMPLETED|Overall Study||0
6482833|NCT01319422|7400247|FG000|STARTED|Overall Study||20
6482834|NCT01319422|7400248|FG001|STARTED|Overall Study||20
6482835|NCT01319422|7400247|FG000|COMPLETED|Overall Study||19
6482836|NCT01319422|7400248|FG001|COMPLETED|Overall Study||20
6482837|NCT01319422|7400247|FG000|NOT COMPLETED|Overall Study||1
6482838|NCT01319422|7400248|FG001|NOT COMPLETED|Overall Study||0
6482839|NCT01319500|7400256|FG000|STARTED|Overall Study||1187
6482840|NCT01319500|7400257|FG001|STARTED|Overall Study||2589
6482841|NCT01319500|7400256|FG000|COMPLETED|Overall Study||1187
6482842|NCT01319500|7400257|FG001|COMPLETED|Overall Study||2589
6482843|NCT01319500|7400256|FG000|NOT COMPLETED|Overall Study||0
6482844|NCT01319500|7400257|FG001|NOT COMPLETED|Overall Study||0
6482845|NCT01319539|7400268|FG000|STARTED|Overall Study||12
6482846|NCT01319539|7400268|FG000|COMPLETED|Overall Study||12
6482847|NCT01319539|7400268|FG000|NOT COMPLETED|Overall Study||0
6482848|NCT01319552|7400274|FG000|STARTED|Overall Study||14
6482849|NCT01319552|7400274|FG000|COMPLETED|Overall Study||14
6482850|NCT01319552|7400274|FG000|NOT COMPLETED|Overall Study||0
6482851|NCT01319617|7400279|FG000|STARTED|Overall Study||41
6482852|NCT01319617|7400279|FG000|COMPLETED|Overall Study||40
6482853|NCT01319617|7400279|FG000|NOT COMPLETED|Overall Study||1
6482854|NCT01319721|7400285|FG000|STARTED|Overall Study|The unit of measure is eyes.|48
6482855|NCT01319721|7400286|FG001|STARTED|Overall Study|The unit of measure is eyes.|48
6482856|NCT01319721|7400285|FG000|COMPLETED|Overall Study|The unit of measure is eyes.|47
6482857|NCT01319721|7400286|FG001|COMPLETED|Overall Study|The unit of measure is eyes.|42
6482858|NCT01319721|7400285|FG000|NOT COMPLETED|Overall Study||1
6482859|NCT01319721|7400286|FG001|NOT COMPLETED|Overall Study||6
6482860|NCT01319773|7400297|FG000|STARTED|Overall Study||10
6482861|NCT01319773|7400298|FG001|STARTED|Overall Study||10
6482862|NCT01319773|7400299|FG002|STARTED|Overall Study||8
6482863|NCT01319773|7400300|FG003|STARTED|Overall Study||8
6482864|NCT01319773|7400301|FG004|STARTED|Overall Study||8
6482865|NCT01319773|7400297|FG000|COMPLETED|Overall Study||10
6482866|NCT01319773|7400298|FG001|COMPLETED|Overall Study||10
6482867|NCT01319773|7400299|FG002|COMPLETED|Overall Study||8
6482868|NCT01319773|7400300|FG003|COMPLETED|Overall Study||8
6482869|NCT01319773|7400301|FG004|COMPLETED|Overall Study||8
6482870|NCT01319773|7400297|FG000|NOT COMPLETED|Overall Study||0
6482871|NCT01319773|7400298|FG001|NOT COMPLETED|Overall Study||0
6482872|NCT01319773|7400299|FG002|NOT COMPLETED|Overall Study||0
6482873|NCT01319773|7400300|FG003|NOT COMPLETED|Overall Study||0
6482874|NCT01319773|7400301|FG004|NOT COMPLETED|Overall Study||0
6482875|NCT01319799|7400311|FG000|STARTED|Overall Study||10
6482876|NCT01319799|7400311|FG000|COMPLETED|Overall Study||10
6482877|NCT01319799|7400311|FG000|NOT COMPLETED|Overall Study||0
6482878|NCT01319812|7400317|FG000|STARTED|Overall Study||161
6482879|NCT01319812|7400318|FG001|STARTED|Overall Study||302
6482880|NCT01319812|7400317|FG000|COMPLETED|Overall Study||145
6482881|NCT01319812|7400318|FG001|COMPLETED|Overall Study||280
6482882|NCT01319812|7400317|FG000|NOT COMPLETED|Overall Study||16
6482883|NCT01319812|7400318|FG001|NOT COMPLETED|Overall Study||22
6482884|NCT01319851|7400331|FG000|STARTED|Overall Study||3
6482885|NCT01319851|7400331|FG000|COMPLETED|Overall Study||3
6482886|NCT01319851|7400331|FG000|NOT COMPLETED|Overall Study||0
6482887|NCT01319877|7400337|FG000|STARTED|Overall Study||453
6482888|NCT01319877|7400338|FG001|STARTED|Overall Study||153
6482889|NCT01319877|7400337|FG000|COMPLETED|Overall Study||345
6482890|NCT01319877|7400338|FG001|COMPLETED|Overall Study||108
6482891|NCT01319877|7400337|FG000|NOT COMPLETED|Overall Study||108
6482892|NCT01319877|7400338|FG001|NOT COMPLETED|Overall Study||45
6482893|NCT01319929|7400345|FG000|STARTED|First Treatment Period (4 Weeks)||20
6482894|NCT01319929|7400346|FG001|STARTED|First Treatment Period (4 Weeks)||19
6482895|NCT01319929|7400345|FG000|COMPLETED|First Treatment Period (4 Weeks)||17
6482896|NCT01319929|7400346|FG001|COMPLETED|First Treatment Period (4 Weeks)||17
6482897|NCT01319929|7400345|FG000|NOT COMPLETED|First Treatment Period (4 Weeks)||3
6482898|NCT01319929|7400346|FG001|NOT COMPLETED|First Treatment Period (4 Weeks)||2
6482899|NCT01319929|7400345|FG000|STARTED|Washout Period (3 Weeks)||17
6482900|NCT01319929|7400346|FG001|STARTED|Washout Period (3 Weeks)||17
6482901|NCT01319929|7400345|FG000|COMPLETED|Washout Period (3 Weeks)||17
6482902|NCT01319929|7400346|FG001|COMPLETED|Washout Period (3 Weeks)||17
6482903|NCT01319929|7400345|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
6482904|NCT01319929|7400346|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
6482905|NCT01319929|7400345|FG000|STARTED|Second Treatment Period (4 Weeks)||17
6482906|NCT01319929|7400346|FG001|STARTED|Second Treatment Period (4 Weeks)||17
6482907|NCT01319929|7400345|FG000|COMPLETED|Second Treatment Period (4 Weeks)||16
6482908|NCT01319929|7400346|FG001|COMPLETED|Second Treatment Period (4 Weeks)||16
6482909|NCT01319929|7400345|FG000|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
6482910|NCT01319929|7400346|FG001|NOT COMPLETED|Second Treatment Period (4 Weeks)||1
6482911|NCT01319994|7400355|FG000|STARTED|Overall Study||26
6482912|NCT01319994|7400356|FG001|STARTED|Overall Study||27
6482913|NCT01319994|7400355|FG000|Abto Keep Appoinment Shedule|Overall Study||23
6482914|NCT01319994|7400356|FG001|Abto Keep Appoinment Shedule|Overall Study||24
6482915|NCT01319994|7400355|FG000|Tolerated at Least 1.7g/Day Dose|Overall Study||19
6482916|NCT01319994|7400356|FG001|Tolerated at Least 1.7g/Day Dose|Overall Study||24
6482917|NCT01319994|7400355|FG000|Glucocorticoid Dose as Inc Cri|Overall Study||19
6482918|NCT01319994|7400356|FG001|Glucocorticoid Dose as Inc Cri|Overall Study||22
6482919|NCT01319994|7400355|FG000|Did Not Develop Overt Diabetes|Overall Study||19
6482920|NCT01319994|7400356|FG001|Did Not Develop Overt Diabetes|Overall Study||21
6482921|NCT01319994|7400355|FG000|COMPLETED|Overall Study||19
6482922|NCT01319994|7400356|FG001|COMPLETED|Overall Study||21
6482923|NCT01319994|7400355|FG000|NOT COMPLETED|Overall Study||7
6482924|NCT01319994|7400356|FG001|NOT COMPLETED|Overall Study||6
6482925|NCT01320033|7400365|FG000|STARTED|Overall Study||216
6482926|NCT01320033|7400366|FG001|STARTED|Overall Study||224
6482927|NCT01320033|7400367|FG002|STARTED|Overall Study||222
6482928|NCT01320033|7400365|FG000|COMPLETED|Overall Study||158
6482929|NCT01320033|7400366|FG001|COMPLETED|Overall Study||160
6482930|NCT01320033|7400367|FG002|COMPLETED|Overall Study||169
6482931|NCT01320033|7400365|FG000|NOT COMPLETED|Overall Study||58
6482932|NCT01320033|7400366|FG001|NOT COMPLETED|Overall Study||64
6482933|NCT01320033|7400367|FG002|NOT COMPLETED|Overall Study||53
6482934|NCT01320085|7400378|FG000|STARTED|Overall Study||41
6482935|NCT01320085|7400379|FG001|STARTED|Overall Study||117
6482936|NCT01320085|7400380|FG002|STARTED|Overall Study||25
6482937|NCT01320085|7400378|FG000|COMPLETED|Overall Study||0
6482938|NCT01320085|7400379|FG001|COMPLETED|Overall Study||0
6482939|NCT01320085|7400380|FG002|COMPLETED|Overall Study||0
6482940|NCT01320085|7400378|FG000|NOT COMPLETED|Overall Study||41
6482941|NCT01320085|7400379|FG001|NOT COMPLETED|Overall Study||117
6482942|NCT01320085|7400380|FG002|NOT COMPLETED|Overall Study||25
6482943|NCT01320137|7400390|FG000|STARTED|Overall Study||40
6482944|NCT01320137|7400391|FG001|STARTED|Overall Study||40
6482945|NCT01320137|7400390|FG000|COMPLETED|Overall Study||40
6482946|NCT01320137|7400391|FG001|COMPLETED|Overall Study||40
6482947|NCT01320137|7400390|FG000|NOT COMPLETED|Overall Study||0
6482948|NCT01320137|7400391|FG001|NOT COMPLETED|Overall Study||0
6482949|NCT01320150|7400399|FG000|STARTED|Overall Study||311
6482950|NCT01320150|7400399|FG000|PPP|Overall Study||34
6482951|NCT01320150|7400399|FG000|Non-PPP|Overall Study||211
6482952|NCT01320150|7400399|FG000|COMPLETED|Overall Study||245
6482953|NCT01320150|7400399|FG000|NOT COMPLETED|Overall Study||66
6482954|NCT01320202|7400405|FG000|STARTED|Overall Study||152
6482955|NCT01320202|7400406|FG001|STARTED|Overall Study||153
6482956|NCT01320202|7400405|FG000|Comp 48 Wks in St 2|Overall Study||27
6482957|NCT01320202|7400406|FG001|Comp 48 Wks in St 2|Overall Study||27
6482958|NCT01320202|7400405|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
6482959|NCT01320202|7400406|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
6482960|NCT01320202|7400405|FG000|Enrolled in St 3|Overall Study||98
6482961|NCT01320202|7400406|FG001|Enrolled in St 3|Overall Study||109
6482962|NCT01320202|7400405|FG000|Completed St 3|Overall Study||79
6482963|NCT01320202|7400406|FG001|Completed St 3|Overall Study||82
6482964|NCT01320202|7400405|FG000|COMPLETED|Overall Study||96
6482965|NCT01320202|7400406|FG001|COMPLETED|Overall Study||109
6482966|NCT01320202|7400405|FG000|NOT COMPLETED|Overall Study||56
6482967|NCT01320202|7400406|FG001|NOT COMPLETED|Overall Study||44
6482968|NCT01320293|7400415|FG000|STARTED|Overall Study||18
6482969|NCT01320293|7400415|FG000|COMPLETED|Overall Study||16
6482970|NCT01320293|7400415|FG000|NOT COMPLETED|Overall Study||2
6482971|NCT01320553|7400423|FG000|STARTED|Overall Study||31
6482972|NCT01320553|7400424|FG001|STARTED|Overall Study||30
6482973|NCT01320553|7400425|FG002|STARTED|Overall Study||31
6482974|NCT01320553|7400426|FG003|STARTED|Overall Study||30
6482975|NCT01320553|7400423|FG000|COMPLETED|Overall Study||30
6482976|NCT01320553|7400424|FG001|COMPLETED|Overall Study||26
6482977|NCT01320553|7400425|FG002|COMPLETED|Overall Study||29
6482978|NCT01320553|7400426|FG003|COMPLETED|Overall Study||29
6482979|NCT01320553|7400423|FG000|NOT COMPLETED|Overall Study||1
6482980|NCT01320553|7400424|FG001|NOT COMPLETED|Overall Study||4
6482981|NCT01320553|7400425|FG002|NOT COMPLETED|Overall Study||2
6482982|NCT01320553|7400426|FG003|NOT COMPLETED|Overall Study||1
6482983|NCT01320722|7400441|FG000|STARTED|Overall Study||46
6482984|NCT01320722|7400442|FG001|STARTED|Overall Study||47
6554888|NCT01748825|7476981|FG002|NOT COMPLETED|Dose Escalation||0
6554889|NCT01748825|7476982|FG003|NOT COMPLETED|Dose Escalation||1
6554890|NCT01748825|7476983|FG004|NOT COMPLETED|Dose Escalation||1
6554891|NCT01748825|7476984|FG005|NOT COMPLETED|Dose Escalation||2
6554892|NCT01748825|7476985|FG006|NOT COMPLETED|Dose Escalation||1
6482985|NCT01320722|7400443|FG002|STARTED|Overall Study||47
6482986|NCT01320722|7400444|FG003|STARTED|Overall Study||49
6482987|NCT01320722|7400445|FG004|STARTED|Overall Study||53
6482988|NCT01320722|7400441|FG000|Received Intervention|Overall Study||43
6482989|NCT01320722|7400442|FG001|Received Intervention|Overall Study||45
6482990|NCT01320722|7400443|FG002|Received Intervention|Overall Study||46
6482991|NCT01320722|7400444|FG003|Received Intervention|Overall Study||48
6482992|NCT01320722|7400445|FG004|Received Intervention|Overall Study||51
6482993|NCT01320722|7400441|FG000|COMPLETED|Overall Study||43
6482994|NCT01320722|7400442|FG001|COMPLETED|Overall Study||41
6482995|NCT01320722|7400443|FG002|COMPLETED|Overall Study||40
6482996|NCT01320722|7400444|FG003|COMPLETED|Overall Study||35
6482997|NCT01320722|7400445|FG004|COMPLETED|Overall Study||45
6482998|NCT01320722|7400441|FG000|NOT COMPLETED|Overall Study||3
6482999|NCT01320722|7400442|FG001|NOT COMPLETED|Overall Study||6
6483000|NCT01320722|7400443|FG002|NOT COMPLETED|Overall Study||7
6483001|NCT01320722|7400444|FG003|NOT COMPLETED|Overall Study||14
6483002|NCT01320722|7400445|FG004|NOT COMPLETED|Overall Study||8
6483003|NCT01320735|7400460|FG000|STARTED|Overall Study||300
6483004|NCT01320735|7400460|FG000|COMPLETED|Overall Study||194
6483005|NCT01320735|7400460|FG000|NOT COMPLETED|Overall Study||106
6483006|NCT01320826|7400464|FG000|STARTED|Overall Study||577
6483007|NCT01320826|7400464|FG000|COMPLETED|Overall Study||577
6483008|NCT01320826|7400464|FG000|NOT COMPLETED|Overall Study||0
6483009|NCT01320943|7400481|FG000|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
6483010|NCT01320943|7400482|FG001|STARTED|Overall Study||22
6483011|NCT01320943|7400481|FG000|COMPLETED|Overall Study||20
6483012|NCT01320943|7400482|FG001|COMPLETED|Overall Study||20
6483013|NCT01320943|7400481|FG000|NOT COMPLETED|Overall Study||1
6483014|NCT01320943|7400482|FG001|NOT COMPLETED|Overall Study||2
6483015|NCT01321073|7400495|FG000|STARTED|Overall Study||64
6483016|NCT01321073|7400495|FG000|COMPLETED|Overall Study||57
6483017|NCT01321073|7400495|FG000|NOT COMPLETED|Overall Study||7
6483018|NCT01321151|7400501|FG000|STARTED|Overall Study|The boxer was treated once-a-day for 30 days.|6
6483019|NCT01321151|7400502|FG001|STARTED|Overall Study|The boxer was treated with once-a-day for 30 days.|6
6483020|NCT01321151|7400501|FG000|COMPLETED|Overall Study||6
6483021|NCT01321151|7400502|FG001|COMPLETED|Overall Study||6
6483022|NCT01321151|7400501|FG000|NOT COMPLETED|Overall Study||0
6483023|NCT01321151|7400502|FG001|NOT COMPLETED|Overall Study||0
6483024|NCT01321177|7400510|FG000|STARTED|Overall Study||223
6483025|NCT01321177|7400511|FG001|STARTED|Overall Study||181
6483026|NCT01321177|7400510|FG000|COMPLETED|Overall Study||147
6483027|NCT01321177|7400511|FG001|COMPLETED|Overall Study||84
6483028|NCT01321177|7400510|FG000|NOT COMPLETED|Overall Study||76
6483029|NCT01321177|7400511|FG001|NOT COMPLETED|Overall Study||97
6483030|NCT01321437|7400517|FG000|STARTED|Overall Study||11
6483031|NCT01321437|7400517|FG000|COMPLETED|Overall Study||11
6483032|NCT01321437|7400517|FG000|NOT COMPLETED|Overall Study||0
6483033|NCT01321541|7400523|FG000|STARTED|Overall Study||155
6483034|NCT01321541|7400524|FG001|STARTED|Overall Study||157
6483035|NCT01321541|7400523|FG000|COMPLETED|Overall Study||72
6483036|NCT01321541|7400524|FG001|COMPLETED|Overall Study||61
6483037|NCT01321541|7400523|FG000|NOT COMPLETED|Overall Study||83
6483038|NCT01321541|7400524|FG001|NOT COMPLETED|Overall Study||96
6483039|NCT01321554|7400532|FG000|STARTED|Randomization Phase||261
6483040|NCT01321554|7400533|FG001|STARTED|Randomization Phase||131
6483041|NCT01321554|7400534|FG002|STARTED|Randomization Phase||0
6483042|NCT01321554|7400535|FG003|STARTED|Randomization Phase||0
6483043|NCT01321554|7400532|FG000|COMPLETED|Randomization Phase||261
6483044|NCT01321554|7400533|FG001|COMPLETED|Randomization Phase||131
6483045|NCT01321554|7400534|FG002|COMPLETED|Randomization Phase||0
6483046|NCT01321554|7400535|FG003|COMPLETED|Randomization Phase||0
6483047|NCT01321554|7400532|FG000|NOT COMPLETED|Randomization Phase||0
6483048|NCT01321554|7400533|FG001|NOT COMPLETED|Randomization Phase||0
6483049|NCT01321554|7400534|FG002|NOT COMPLETED|Randomization Phase||0
6483050|NCT01321554|7400535|FG003|NOT COMPLETED|Randomization Phase||0
6483051|NCT01321554|7400532|FG000|STARTED|OOL Lenvatinib Treatment Period||0
6483052|NCT01321554|7400533|FG001|STARTED|OOL Lenvatinib Treatment Period||0
6483053|NCT01321554|7400534|FG002|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|85
6483054|NCT01321554|7400535|FG003|STARTED|OOL Lenvatinib Treatment Period|Participants from randomization phase were re-randomized to OOL, treatment period.|30
6483055|NCT01321554|7400532|FG000|COMPLETED|OOL Lenvatinib Treatment Period||0
6483056|NCT01321554|7400533|FG001|COMPLETED|OOL Lenvatinib Treatment Period||0
6483057|NCT01321554|7400534|FG002|COMPLETED|OOL Lenvatinib Treatment Period||85
6483058|NCT01321554|7400535|FG003|COMPLETED|OOL Lenvatinib Treatment Period||30
6483059|NCT01321554|7400532|FG000|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
6483060|NCT01321554|7400533|FG001|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
6483061|NCT01321554|7400534|FG002|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
6483062|NCT01321554|7400535|FG003|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
6483063|NCT01321606|7400545|FG000|STARTED|Overall Study||18
6483064|NCT01321606|7400546|FG001|STARTED|Overall Study||32
6483065|NCT01321606|7400547|FG002|STARTED|Overall Study||34
6483066|NCT01321606|7400548|FG003|STARTED|Overall Study||29
6483067|NCT01321606|7400545|FG000|COMPLETED|Overall Study||18
6483068|NCT01321606|7400546|FG001|COMPLETED|Overall Study||32
6483069|NCT01321606|7400547|FG002|COMPLETED|Overall Study||34
6483070|NCT01321606|7400548|FG003|COMPLETED|Overall Study||28
6483071|NCT01321606|7400545|FG000|NOT COMPLETED|Overall Study||0
6483072|NCT01321606|7400546|FG001|NOT COMPLETED|Overall Study||0
6483073|NCT01321606|7400547|FG002|NOT COMPLETED|Overall Study||0
6483074|NCT01321606|7400548|FG003|NOT COMPLETED|Overall Study||1
6483075|NCT01321710|7400561|FG000|STARTED|Overall Study||50
6483076|NCT01321710|7400562|FG001|STARTED|Overall Study||58
6483077|NCT01321710|7400563|FG002|STARTED|Overall Study||44
6483078|NCT01321710|7400561|FG000|COMPLETED|Overall Study||46
6483079|NCT01321710|7400562|FG001|COMPLETED|Overall Study||53
6483080|NCT01321710|7400563|FG002|COMPLETED|Overall Study||44
6483081|NCT01321710|7400561|FG000|NOT COMPLETED|Overall Study||4
6483082|NCT01321710|7400562|FG001|NOT COMPLETED|Overall Study||5
6483083|NCT01321710|7400563|FG002|NOT COMPLETED|Overall Study||0
6483084|NCT01321723|7400576|FG000|STARTED|Overall Study||32
6483085|NCT01321723|7400577|FG001|STARTED|Overall Study||33
6483086|NCT01321723|7400578|FG002|STARTED|Overall Study||32
6483087|NCT01321723|7400576|FG000|COMPLETED|Overall Study||27
6483088|NCT01321723|7400577|FG001|COMPLETED|Overall Study||28
6483089|NCT01321723|7400578|FG002|COMPLETED|Overall Study||28
6483090|NCT01321723|7400576|FG000|NOT COMPLETED|Overall Study||5
6483091|NCT01321723|7400577|FG001|NOT COMPLETED|Overall Study||5
6483092|NCT01321723|7400578|FG002|NOT COMPLETED|Overall Study||4
6483093|NCT01321749|7400588|FG000|STARTED|Overall Study||51
6483094|NCT01321749|7400589|FG001|STARTED|Overall Study||52
6483095|NCT01321749|7400588|FG000|COMPLETED|Overall Study||38
6483096|NCT01321749|7400589|FG001|COMPLETED|Overall Study||30
6483097|NCT01321749|7400588|FG000|NOT COMPLETED|Overall Study||13
6483098|NCT01321749|7400589|FG001|NOT COMPLETED|Overall Study||22
6483099|NCT01321879|7400595|FG000|STARTED|Overall Study||39
6483100|NCT01321879|7400595|FG000|COMPLETED|Overall Study||25
6483101|NCT01321879|7400595|FG000|NOT COMPLETED|Overall Study||14
6483102|NCT01322009|7400601|FG000|STARTED|Overall Study||7
6483103|NCT01322009|7400602|FG001|STARTED|Overall Study||7
6483104|NCT01322009|7400601|FG000|COMPLETED|Overall Study||7
6483105|NCT01322009|7400602|FG001|COMPLETED|Overall Study||4
6483106|NCT01322009|7400601|FG000|NOT COMPLETED|Overall Study||0
6483107|NCT01322009|7400602|FG001|NOT COMPLETED|Overall Study||3
6483108|NCT01322022|7400610|FG000|STARTED|Overall Study||20
6483109|NCT01322022|7400611|FG001|STARTED|Overall Study||20
6483110|NCT01322022|7400610|FG000|Week 4|Overall Study||15
6483111|NCT01322022|7400611|FG001|Week 4|Overall Study||18
6483112|NCT01322022|7400610|FG000|COMPLETED|Overall Study||15
6483113|NCT01322022|7400611|FG001|COMPLETED|Overall Study||18
6483114|NCT01322022|7400610|FG000|NOT COMPLETED|Overall Study||5
6483115|NCT01322022|7400611|FG001|NOT COMPLETED|Overall Study||2
6483116|NCT01322048|7400619|FG000|STARTED|Overall Study||21
6483117|NCT01322048|7400620|FG001|STARTED|Overall Study||26
6483118|NCT01322048|7400619|FG000|COMPLETED|Overall Study||21
6483119|NCT01322048|7400620|FG001|COMPLETED|Overall Study||26
6483120|NCT01322048|7400619|FG000|NOT COMPLETED|Overall Study||0
6483121|NCT01322048|7400620|FG001|NOT COMPLETED|Overall Study||0
6483122|NCT01322347|7400628|FG000|STARTED|Overall Study||147
6483123|NCT01322347|7400629|FG001|STARTED|Overall Study||147
6483124|NCT01322347|7400628|FG000|Completed 48 Wks in St 2|Overall Study||28
6483125|NCT01322347|7400629|FG001|Completed 48 Wks in St 2|Overall Study||22
6483126|NCT01322347|7400628|FG000|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
6483127|NCT01322347|7400629|FG001|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
6483128|NCT01322347|7400628|FG000|Enrolled in St 3|Overall Study||101
6483129|NCT01322347|7400629|FG001|Enrolled in St 3|Overall Study||113
6483130|NCT01322347|7400628|FG000|Completed St 3|Overall Study||82
6483131|NCT01322347|7400629|FG001|Completed St 3|Overall Study||86
6483132|NCT01322347|7400628|FG000|COMPLETED|Overall Study||96
6483133|NCT01322347|7400629|FG001|COMPLETED|Overall Study||112
6483134|NCT01322347|7400628|FG000|NOT COMPLETED|Overall Study||51
6554893|NCT01748825|7476986|FG007|NOT COMPLETED|Dose Escalation||0
6554894|NCT01748825|7476987|FG008|NOT COMPLETED|Dose Escalation||0
6483135|NCT01322347|7400629|FG001|NOT COMPLETED|Overall Study||35
6483136|NCT01322360|7400636|FG000|STARTED|Overall Study||50
6483137|NCT01322360|7400636|FG000|COMPLETED|Overall Study||50
6483138|NCT01322360|7400636|FG000|NOT COMPLETED|Overall Study||0
6483139|NCT01322386|7400643|FG000|STARTED|Overall Study||10
6483140|NCT01322386|7400644|FG001|STARTED|Overall Study||11
6483141|NCT01322386|7400643|FG000|COMPLETED|Overall Study||10
6483142|NCT01322386|7400644|FG001|COMPLETED|Overall Study||9
6483143|NCT01322386|7400643|FG000|NOT COMPLETED|Overall Study||0
6483144|NCT01322386|7400644|FG001|NOT COMPLETED|Overall Study||2
6483145|NCT01322490|7400655|FG000|STARTED|Treatment Period||432
6483146|NCT01322490|7400656|FG001|STARTED|Treatment Period||432
6483147|NCT01322490|7400657|FG002|STARTED|Treatment Period||433
6483148|NCT01322490|7400655|FG000|Treated|Treatment Period||429
6483149|NCT01322490|7400656|FG001|Treated|Treatment Period||429
6483150|NCT01322490|7400657|FG002|Treated|Treatment Period||428
6483151|NCT01322490|7400655|FG000|COMPLETED|Treatment Period||300
6483152|NCT01322490|7400656|FG001|COMPLETED|Treatment Period||279
6483153|NCT01322490|7400657|FG002|COMPLETED|Treatment Period||280
6483154|NCT01322490|7400655|FG000|NOT COMPLETED|Treatment Period||132
6483155|NCT01322490|7400656|FG001|NOT COMPLETED|Treatment Period||153
6483156|NCT01322490|7400657|FG002|NOT COMPLETED|Treatment Period||153
6483157|NCT01322490|7400655|FG000|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|409
6483158|NCT01322490|7400656|FG001|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|408
6483159|NCT01322490|7400657|FG002|STARTED|Long Term Follow-up Period|You did not have to complete treatment to enter follow up.|413
6483160|NCT01322490|7400655|FG000|COMPLETED|Long Term Follow-up Period||0
6483161|NCT01322490|7400656|FG001|COMPLETED|Long Term Follow-up Period||0
6483162|NCT01322490|7400657|FG002|COMPLETED|Long Term Follow-up Period||0
6483163|NCT01322490|7400655|FG000|NOT COMPLETED|Long Term Follow-up Period||409
6483164|NCT01322490|7400656|FG001|NOT COMPLETED|Long Term Follow-up Period||408
6483165|NCT01322490|7400657|FG002|NOT COMPLETED|Long Term Follow-up Period||413
6483166|NCT01322594|7400671|FG000|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
6483167|NCT01322594|7400672|FG001|STARTED|Overall Study||3
6483168|NCT01322594|7400673|FG002|STARTED|Overall Study||3
6483169|NCT01322594|7400674|FG003|STARTED|Overall Study||6
6483170|NCT01322594|7400675|FG004|STARTED|Overall Study||7
6483171|NCT01322594|7400676|FG005|STARTED|Overall Study||6
6483172|NCT01322594|7400671|FG000|COMPLETED|Overall Study||6
6483173|NCT01322594|7400672|FG001|COMPLETED|Overall Study||3
6483174|NCT01322594|7400673|FG002|COMPLETED|Overall Study||3
6483175|NCT01322594|7400674|FG003|COMPLETED|Overall Study||6
6305749|NCT01388920|7209114|FG000|STARTED|Overall Study||1
6305750|NCT01388920|7209115|FG001|STARTED|Overall Study||1
6305751|NCT01388920|7209116|FG002|STARTED|Overall Study||0
6305752|NCT01388920|7209114|FG000|COMPLETED|Overall Study||1
6305753|NCT01388920|7209115|FG001|COMPLETED|Overall Study||1
6305754|NCT01388920|7209116|FG002|COMPLETED|Overall Study||0
6305755|NCT01388920|7209114|FG000|NOT COMPLETED|Overall Study||0
6305756|NCT01388920|7209115|FG001|NOT COMPLETED|Overall Study||0
6305757|NCT01388920|7209116|FG002|NOT COMPLETED|Overall Study||0
6305758|NCT01164202|7209126|FG000|STARTED|Overall Study||39
6305759|NCT01164202|7209127|FG001|STARTED|Overall Study||39
6305760|NCT01164202|7209126|FG000|COMPLETED|Overall Study||38
6305761|NCT01164202|7209127|FG001|COMPLETED|Overall Study||39
6305762|NCT01164202|7209126|FG000|NOT COMPLETED|Overall Study||1
6305763|NCT01164202|7209127|FG001|NOT COMPLETED|Overall Study||0
6305764|NCT00554840|7209137|FG000|STARTED|Overall Study||4
6305765|NCT00554840|7209138|FG001|STARTED|Overall Study||5
6305766|NCT00554840|7209137|FG000|COMPLETED|Overall Study||4
6305767|NCT00554840|7209138|FG001|COMPLETED|Overall Study||4
6305768|NCT00554840|7209137|FG000|NOT COMPLETED|Overall Study||0
6305769|NCT00554840|7209138|FG001|NOT COMPLETED|Overall Study||1
6305770|NCT00003656|7209148|FG000|STARTED|Overall Study||12
6305771|NCT00003656|7209149|FG001|STARTED|Overall Study||14
6305772|NCT00003656|7209148|FG000|COMPLETED|Overall Study||12
6483176|NCT01322594|7400675|FG004|COMPLETED|Overall Study||7
6483177|NCT01322594|7400676|FG005|COMPLETED|Overall Study||6
6554895|NCT01748825|7476988|FG009|NOT COMPLETED|Dose Escalation||0
6305773|NCT00003656|7209149|FG001|COMPLETED|Overall Study||13
6305774|NCT00003656|7209148|FG000|NOT COMPLETED|Overall Study||0
6305775|NCT00003656|7209149|FG001|NOT COMPLETED|Overall Study||1
6305776|NCT00370331|7209158|FG000|STARTED|Overall Study||62
6305777|NCT00370331|7209159|FG001|STARTED|Overall Study||135
6305778|NCT00370331|7209158|FG000|COMPLETED|Overall Study||55
6305779|NCT00370331|7209159|FG001|COMPLETED|Overall Study||112
6305780|NCT00370331|7209158|FG000|NOT COMPLETED|Overall Study||7
6305781|NCT00370331|7209159|FG001|NOT COMPLETED|Overall Study||23
6305782|NCT00370396|7209168|FG000|STARTED|Overall Study||737
6305783|NCT00370396|7209169|FG001|STARTED|Overall Study||92
6305784|NCT00370396|7209170|FG002|STARTED|Overall Study||283
6305785|NCT00370396|7209168|FG000|COMPLETED|Overall Study||726
6554896|NCT01748825|7476979|FG000|STARTED|Dose Expansion||0
6483178|NCT01322594|7400671|FG000|NOT COMPLETED|Overall Study||0
6483179|NCT01322594|7400672|FG001|NOT COMPLETED|Overall Study||0
6483180|NCT01322594|7400673|FG002|NOT COMPLETED|Overall Study||0
6483181|NCT01322594|7400674|FG003|NOT COMPLETED|Overall Study||0
6483182|NCT01322594|7400675|FG004|NOT COMPLETED|Overall Study||0
6483183|NCT01322594|7400676|FG005|NOT COMPLETED|Overall Study||0
6483184|NCT01322607|7400692|FG000|STARTED|Overall Study||11
6483185|NCT01322607|7400693|FG001|STARTED|Overall Study||9
6483186|NCT01322607|7400692|FG000|COMPLETED|Overall Study||10
6483187|NCT01322607|7400693|FG001|COMPLETED|Overall Study||9
6483188|NCT01322607|7400692|FG000|NOT COMPLETED|Overall Study||1
6483189|NCT01322607|7400693|FG001|NOT COMPLETED|Overall Study||0
6483190|NCT01322633|7400701|FG000|STARTED|Overall Study||34178
6483191|NCT01322633|7400702|FG001|STARTED|Overall Study||27686
6483192|NCT01322633|7400701|FG000|COMPLETED|Overall Study||34178
6483193|NCT01322633|7400702|FG001|COMPLETED|Overall Study||27686
6483194|NCT01322633|7400701|FG000|NOT COMPLETED|Overall Study||0
6483195|NCT01322633|7400702|FG001|NOT COMPLETED|Overall Study||0
6483196|NCT01322815|7400710|FG000|STARTED|Overall Study||7
6483197|NCT01322815|7400711|FG001|STARTED|Overall Study||4
6483198|NCT01322815|7400710|FG000|COMPLETED|Overall Study||7
6483199|NCT01322815|7400711|FG001|COMPLETED|Overall Study||4
6483200|NCT01322815|7400710|FG000|NOT COMPLETED|Overall Study||0
6483201|NCT01322815|7400711|FG001|NOT COMPLETED|Overall Study||0
6483202|NCT01322841|7400719|FG000|STARTED|Overall Study||1116
6483203|NCT01322841|7400720|FG001|STARTED|Overall Study||1123
6483204|NCT01322841|7400719|FG000|COMPLETED|Overall Study||1116
6483205|NCT01322841|7400720|FG001|COMPLETED|Overall Study||1123
6483206|NCT01322841|7400719|FG000|NOT COMPLETED|Overall Study||0
6483207|NCT01322841|7400720|FG001|NOT COMPLETED|Overall Study||0
6483208|NCT01322945|7400728|FG000|STARTED|Overall Study||52
6483209|NCT01322945|7400729|FG001|STARTED|Overall Study||42
6483210|NCT01322945|7400728|FG000|COMPLETED|Overall Study||52
6483211|NCT01322945|7400729|FG001|COMPLETED|Overall Study||42
6483212|NCT01322945|7400728|FG000|NOT COMPLETED|Overall Study||0
6483213|NCT01322945|7400729|FG001|NOT COMPLETED|Overall Study||0
6483214|NCT01323010|7400739|FG000|STARTED|Overall Study||60
6483215|NCT01323010|7400740|FG001|STARTED|Overall Study||59
6483216|NCT01323010|7400739|FG000|COMPLETED|Overall Study||60
6483217|NCT01323010|7400740|FG001|COMPLETED|Overall Study||59
6483218|NCT01323010|7400739|FG000|NOT COMPLETED|Overall Study||0
6483219|NCT01323010|7400740|FG001|NOT COMPLETED|Overall Study||0
6483220|NCT01323140|7400758|FG000|STARTED|Overall Study||40
6305786|NCT00370396|7209169|FG001|COMPLETED|Overall Study||91
6305787|NCT00370396|7209170|FG002|COMPLETED|Overall Study||282
6305788|NCT00370396|7209168|FG000|NOT COMPLETED|Overall Study||11
6305789|NCT00370396|7209169|FG001|NOT COMPLETED|Overall Study||1
6305790|NCT00370396|7209170|FG002|NOT COMPLETED|Overall Study||1
6305791|NCT00370552|7209181|FG000|STARTED|Overall Study|Randomized|46
6305792|NCT00370552|7209182|FG001|STARTED|Overall Study|Randomized|45
6305793|NCT00370552|7209183|FG002|STARTED|Overall Study|Randomized|32
6305794|NCT00370552|7209181|FG000|COMPLETED|Overall Study||0
6305795|NCT00370552|7209182|FG001|COMPLETED|Overall Study||0
6305796|NCT00370552|7209183|FG002|COMPLETED|Overall Study||0
6305797|NCT00370552|7209181|FG000|NOT COMPLETED|Overall Study||46
6483221|NCT01323140|7400758|FG000|COMPLETED|Overall Study||38
6483222|NCT01323140|7400758|FG000|NOT COMPLETED|Overall Study||2
6483223|NCT01323153|7400764|FG000|STARTED|Overall Study||150
6483224|NCT01323153|7400765|FG001|STARTED|Overall Study||150
6483225|NCT01323153|7400764|FG000|COMPLETED|Overall Study||133
6483226|NCT01323153|7400765|FG001|COMPLETED|Overall Study||142
6483227|NCT01323153|7400764|FG000|NOT COMPLETED|Overall Study||17
6483228|NCT01323153|7400765|FG001|NOT COMPLETED|Overall Study||8
6483229|NCT01323192|7400773|FG000|STARTED|Overall Study||143
6483230|NCT01323192|7400774|FG001|STARTED|Overall Study||141
6483231|NCT01323192|7400773|FG000|COMPLETED|Overall Study||134
6483232|NCT01323192|7400774|FG001|COMPLETED|Overall Study||135
6483233|NCT01323192|7400773|FG000|NOT COMPLETED|Overall Study||9
6483234|NCT01323192|7400774|FG001|NOT COMPLETED|Overall Study||6
6483235|NCT01323270|7400782|FG000|STARTED|Overall Study||373
6483236|NCT01323270|7400783|FG001|STARTED|Overall Study||376
6483237|NCT01323270|7400782|FG000|COMPLETED|Overall Study||330
6483238|NCT01323270|7400783|FG001|COMPLETED|Overall Study||347
6483239|NCT01323270|7400782|FG000|NOT COMPLETED|Overall Study||43
6483240|NCT01323270|7400783|FG001|NOT COMPLETED|Overall Study||29
6483241|NCT01323387|7400790|FG000|STARTED|Overall Study||178
6483242|NCT01323387|7400790|FG000|COMPLETED|Overall Study||94
6483243|NCT01323387|7400790|FG000|NOT COMPLETED|Overall Study||84
6483244|NCT01323478|7400796|FG000|STARTED|Overall Study||71
6483245|NCT01323478|7400796|FG000|COMPLETED|Overall Study||47
6483246|NCT01323478|7400796|FG000|NOT COMPLETED|Overall Study||24
6483247|NCT01323517|7400800|FG000|STARTED|Overall Study||26
6483248|NCT01323517|7400800|FG000|COMPLETED|Overall Study||26
6483249|NCT01323517|7400800|FG000|NOT COMPLETED|Overall Study||0
6483250|NCT01323530|7400811|FG000|STARTED|Phase 1b (Dose Escalation Phase)||8
6483251|NCT01323530|7400812|FG001|STARTED|Phase 1b (Dose Escalation Phase)||6
6483252|NCT01323530|7400813|FG002|STARTED|Phase 1b (Dose Escalation Phase)||5
6483253|NCT01323530|7400814|FG003|STARTED|Phase 1b (Dose Escalation Phase)||3
6483254|NCT01323530|7400815|FG004|STARTED|Phase 1b (Dose Escalation Phase)||6
6305798|NCT00370552|7209182|FG001|NOT COMPLETED|Overall Study||45
6305799|NCT00370552|7209183|FG002|NOT COMPLETED|Overall Study||32
6483255|NCT01323530|7400816|FG005|STARTED|Phase 1b (Dose Escalation Phase)||6
6483256|NCT01323530|7400817|FG006|STARTED|Phase 1b (Dose Escalation Phase)||0
6483257|NCT01323530|7400811|FG000|COMPLETED|Phase 1b (Dose Escalation Phase)||5
6483258|NCT01323530|7400812|FG001|COMPLETED|Phase 1b (Dose Escalation Phase)||4
6483259|NCT01323530|7400813|FG002|COMPLETED|Phase 1b (Dose Escalation Phase)||4
6483260|NCT01323530|7400814|FG003|COMPLETED|Phase 1b (Dose Escalation Phase)||3
6483261|NCT01323530|7400815|FG004|COMPLETED|Phase 1b (Dose Escalation Phase)||3
6483262|NCT01323530|7400816|FG005|COMPLETED|Phase 1b (Dose Escalation Phase)||3
6483263|NCT01323530|7400817|FG006|COMPLETED|Phase 1b (Dose Escalation Phase)||0
6483264|NCT01323530|7400811|FG000|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
6483265|NCT01323530|7400812|FG001|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||2
6483266|NCT01323530|7400813|FG002|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||1
6483267|NCT01323530|7400814|FG003|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
6483268|NCT01323530|7400815|FG004|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
6483269|NCT01323530|7400816|FG005|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||3
6483270|NCT01323530|7400817|FG006|NOT COMPLETED|Phase 1b (Dose Escalation Phase)||0
6483271|NCT01323530|7400811|FG000|STARTED|Phase 2 (Dose-confirmation Phase)||0
6483272|NCT01323530|7400812|FG001|STARTED|Phase 2 (Dose-confirmation Phase)||0
6483273|NCT01323530|7400813|FG002|STARTED|Phase 2 (Dose-confirmation Phase)||0
6483274|NCT01323530|7400814|FG003|STARTED|Phase 2 (Dose-confirmation Phase)||0
6483275|NCT01323530|7400815|FG004|STARTED|Phase 2 (Dose-confirmation Phase)||0
6483276|NCT01323530|7400816|FG005|STARTED|Phase 2 (Dose-confirmation Phase)||0
6483277|NCT01323530|7400817|FG006|STARTED|Phase 2 (Dose-confirmation Phase)||42
6748509|NCT03414047|7676603|FG000|STARTED|Overall Study||53
6748510|NCT03414047|7676604|FG001|STARTED|Overall Study||46
6748511|NCT03414047|7676605|FG002|STARTED|Overall Study||41
6748512|NCT03414047|7676606|FG003|STARTED|Overall Study||29
6748513|NCT03414047|7676603|FG000|Received at Least One Dose of Study Drug|Overall Study||53
6748514|NCT03414047|7676604|FG001|Received at Least One Dose of Study Drug|Overall Study||46
6748515|NCT03414047|7676605|FG002|Received at Least One Dose of Study Drug|Overall Study||41
6748516|NCT03414047|7676606|FG003|Received at Least One Dose of Study Drug|Overall Study||29
6748517|NCT03414047|7676603|FG000|COMPLETED|Overall Study||51
6748518|NCT03414047|7676604|FG001|COMPLETED|Overall Study||46
6748519|NCT03414047|7676605|FG002|COMPLETED|Overall Study||38
6748520|NCT03414047|7676606|FG003|COMPLETED|Overall Study||27
6748521|NCT03414047|7676603|FG000|NOT COMPLETED|Overall Study||2
6748522|NCT03414047|7676604|FG001|NOT COMPLETED|Overall Study||0
6748523|NCT03414047|7676605|FG002|NOT COMPLETED|Overall Study||3
6748524|NCT03414047|7676606|FG003|NOT COMPLETED|Overall Study||2
6748525|NCT03414359|7676619|FG000|STARTED|Overall Study||35
6748526|NCT03414359|7676620|FG001|STARTED|Overall Study||35
6748527|NCT03414359|7676619|FG000|COMPLETED|Overall Study||34
6748528|NCT03414359|7676620|FG001|COMPLETED|Overall Study||33
6748529|NCT03414359|7676619|FG000|NOT COMPLETED|Overall Study||1
6748530|NCT03414359|7676620|FG001|NOT COMPLETED|Overall Study||2
6748531|NCT03415152|7676626|FG000|STARTED|Overall Study||3000
6748532|NCT03415152|7676626|FG000|COMPLETED|Overall Study||1975
6748533|NCT03415152|7676626|FG000|NOT COMPLETED|Overall Study||1025
6748534|NCT03415178|7676635|FG000|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|34
6748535|NCT03415178|7676636|FG001|STARTED|Parallel-Arm Period (up to Week 4)|Randomized|35
6748536|NCT03415178|7676635|FG000|Treated|Parallel-Arm Period (up to Week 4)||34
6748537|NCT03415178|7676636|FG001|Treated|Parallel-Arm Period (up to Week 4)||33
6748538|NCT03415178|7676635|FG000|COMPLETED|Parallel-Arm Period (up to Week 4)|33 participants entered in single arm period & 1 participant decided not to enter single arm period.|34
6748539|NCT03415178|7676636|FG001|COMPLETED|Parallel-Arm Period (up to Week 4)|32 participants entered in single arm period & 1 participant decided not to enter single arm period.|33
6748540|NCT03415178|7676635|FG000|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||0
6748541|NCT03415178|7676636|FG001|NOT COMPLETED|Parallel-Arm Period (up to Week 4)||2
6748542|NCT03415178|7676635|FG000|STARTED|Single Arm Period (up to Week 16)|Out of 34 participants from AI group, 33 participants entered entered in single arm period.|0
6748543|NCT03415178|7676636|FG001|STARTED|Single Arm Period (up to Week 16)|65 (participants completed period 1) + 1 (randomized to SYDNEY arm but not treated in period 1).|66
6748544|NCT03415178|7676635|FG000|COMPLETED|Single Arm Period (up to Week 16)||0
6748545|NCT03415178|7676636|FG001|COMPLETED|Single Arm Period (up to Week 16)||65
6748546|NCT03415178|7676635|FG000|NOT COMPLETED|Single Arm Period (up to Week 16)||0
6748547|NCT03415178|7676636|FG001|NOT COMPLETED|Single Arm Period (up to Week 16)||1
6748548|NCT03415243|7676648|FG000|STARTED|Overall Study||14
6748549|NCT03415243|7676649|FG001|STARTED|Overall Study||14
6748550|NCT03415243|7676648|FG000|COMPLETED|Overall Study||14
6748551|NCT03415243|7676649|FG001|COMPLETED|Overall Study||14
6748552|NCT03415243|7676648|FG000|NOT COMPLETED|Overall Study||0
6748553|NCT03415243|7676649|FG001|NOT COMPLETED|Overall Study||0
6748554|NCT03415581|7676657|FG000|STARTED|Overall Study||7
6748555|NCT03415581|7676658|FG001|STARTED|Overall Study||6
6748556|NCT03415581|7676657|FG000|COMPLETED|Overall Study||1
6748557|NCT03415581|7676658|FG001|COMPLETED|Overall Study||1
6748558|NCT03415581|7676657|FG000|NOT COMPLETED|Overall Study||6
6748559|NCT03415581|7676658|FG001|NOT COMPLETED|Overall Study||5
6748560|NCT03416127|7676669|FG000|STARTED|Overall Study||12
6748561|NCT03416127|7676670|FG001|STARTED|Overall Study||12
6748562|NCT03416127|7676671|FG002|STARTED|Overall Study||12
6483278|NCT01323530|7400811|FG000|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483279|NCT01323530|7400812|FG001|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483280|NCT01323530|7400813|FG002|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483281|NCT01323530|7400814|FG003|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483282|NCT01323530|7400815|FG004|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483283|NCT01323530|7400816|FG005|COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483284|NCT01323530|7400817|FG006|COMPLETED|Phase 2 (Dose-confirmation Phase)||25
6483285|NCT01323530|7400811|FG000|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483286|NCT01323530|7400812|FG001|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483287|NCT01323530|7400813|FG002|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483288|NCT01323530|7400814|FG003|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483289|NCT01323530|7400815|FG004|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483290|NCT01323530|7400816|FG005|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||0
6483291|NCT01323530|7400817|FG006|NOT COMPLETED|Phase 2 (Dose-confirmation Phase)||17
6483292|NCT01323582|7400836|FG000|STARTED|Weeks 1-4 (First Period)||12
6483293|NCT01323582|7400837|FG001|STARTED|Weeks 1-4 (First Period)||14
6483294|NCT01323582|7400836|FG000|COMPLETED|Weeks 1-4 (First Period)||10
6483295|NCT01323582|7400837|FG001|COMPLETED|Weeks 1-4 (First Period)||12
6483296|NCT01323582|7400836|FG000|NOT COMPLETED|Weeks 1-4 (First Period)||2
6483297|NCT01323582|7400837|FG001|NOT COMPLETED|Weeks 1-4 (First Period)||2
6483298|NCT01323582|7400836|FG000|STARTED|Weeks 5-7 (Washout)||10
6483299|NCT01323582|7400837|FG001|STARTED|Weeks 5-7 (Washout)||12
6483300|NCT01323582|7400836|FG000|COMPLETED|Weeks 5-7 (Washout)||10
6483301|NCT01323582|7400837|FG001|COMPLETED|Weeks 5-7 (Washout)||11
6483302|NCT01323582|7400836|FG000|NOT COMPLETED|Weeks 5-7 (Washout)||0
6483303|NCT01323582|7400837|FG001|NOT COMPLETED|Weeks 5-7 (Washout)||1
6483304|NCT01323582|7400836|FG000|STARTED|Weeks 8-11 (Period 2)||10
6554897|NCT01748825|7476980|FG001|STARTED|Dose Expansion||0
6554898|NCT01748825|7476981|FG002|STARTED|Dose Expansion||0
6554899|NCT01748825|7476982|FG003|STARTED|Dose Expansion||0
6483305|NCT01323582|7400837|FG001|STARTED|Weeks 8-11 (Period 2)||11
6483306|NCT01323582|7400836|FG000|COMPLETED|Weeks 8-11 (Period 2)||10
6483307|NCT01323582|7400837|FG001|COMPLETED|Weeks 8-11 (Period 2)||10
6483308|NCT01323582|7400836|FG000|NOT COMPLETED|Weeks 8-11 (Period 2)||0
6483309|NCT01323582|7400837|FG001|NOT COMPLETED|Weeks 8-11 (Period 2)||1
6483310|NCT01323595|7400847|FG000|STARTED|Overall Study||39
6483311|NCT01323595|7400848|FG001|STARTED|Overall Study||39
6483312|NCT01323595|7400847|FG000|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
6483313|NCT01323595|7400848|FG001|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
6483314|NCT01323595|7400847|FG000|NOT COMPLETED|Overall Study||23
6483315|NCT01323595|7400848|FG001|NOT COMPLETED|Overall Study||21
6483316|NCT01323621|7400858|FG000|STARTED|2-week, Single-blind Run In Period||739
6483317|NCT01323621|7400859|FG001|STARTED|2-week, Single-blind Run In Period||0
6483318|NCT01323621|7400860|FG002|STARTED|2-week, Single-blind Run In Period||0
6483319|NCT01323621|7400858|FG000|COMPLETED|2-week, Single-blind Run In Period||511
6483320|NCT01323621|7400859|FG001|COMPLETED|2-week, Single-blind Run In Period||0
6483321|NCT01323621|7400860|FG002|COMPLETED|2-week, Single-blind Run In Period||0
6483322|NCT01323621|7400858|FG000|NOT COMPLETED|2-week, Single-blind Run In Period||228
6483323|NCT01323621|7400859|FG001|NOT COMPLETED|2-week, Single-blind Run In Period||0
6483324|NCT01323621|7400860|FG002|NOT COMPLETED|2-week, Single-blind Run In Period||0
6483325|NCT01323621|7400858|FG000|STARTED|12-week, Double-blind Treatment Period||0
6483326|NCT01323621|7400859|FG001|STARTED|12-week, Double-blind Treatment Period||252
6483327|NCT01323621|7400860|FG002|STARTED|12-week, Double-blind Treatment Period||259
6483328|NCT01323621|7400858|FG000|COMPLETED|12-week, Double-blind Treatment Period||0
6483329|NCT01323621|7400859|FG001|COMPLETED|12-week, Double-blind Treatment Period||237
6483330|NCT01323621|7400860|FG002|COMPLETED|12-week, Double-blind Treatment Period||239
6483331|NCT01323621|7400858|FG000|NOT COMPLETED|12-week, Double-blind Treatment Period||0
6483332|NCT01323621|7400859|FG001|NOT COMPLETED|12-week, Double-blind Treatment Period||15
6483333|NCT01323621|7400860|FG002|NOT COMPLETED|12-week, Double-blind Treatment Period||20
6483334|NCT01323634|7400868|FG000|STARTED|2-week Run-in Period||733
6483335|NCT01323634|7400869|FG001|STARTED|2-week Run-in Period||0
6483336|NCT01323634|7400870|FG002|STARTED|2-week Run-in Period||0
6483337|NCT01323634|7400868|FG000|COMPLETED|2-week Run-in Period||521
6748563|NCT03416127|7676669|FG000|COMPLETED|Overall Study||12
6748564|NCT03416127|7676670|FG001|COMPLETED|Overall Study||11
6748565|NCT03416127|7676671|FG002|COMPLETED|Overall Study||11
6748566|NCT03416127|7676669|FG000|NOT COMPLETED|Overall Study||0
6748567|NCT03416127|7676670|FG001|NOT COMPLETED|Overall Study||1
6748568|NCT03416127|7676671|FG002|NOT COMPLETED|Overall Study||1
6748569|NCT03416621|7676683|FG000|STARTED|Overall Study||13
6483338|NCT01323634|7400869|FG001|COMPLETED|2-week Run-in Period||0
6483339|NCT01323634|7400870|FG002|COMPLETED|2-week Run-in Period||0
6483340|NCT01323634|7400868|FG000|NOT COMPLETED|2-week Run-in Period||212
6483341|NCT01323634|7400869|FG001|NOT COMPLETED|2-week Run-in Period||0
6483342|NCT01323634|7400870|FG002|NOT COMPLETED|2-week Run-in Period||0
6483343|NCT01323634|7400868|FG000|STARTED|Double-Blind (DB) Treatment Period||0
6483344|NCT01323634|7400869|FG001|STARTED|Double-Blind (DB) Treatment Period||260
6554900|NCT01748825|7476983|FG004|STARTED|Dose Expansion||0
6748570|NCT03416621|7676684|FG001|STARTED|Overall Study||12
6483345|NCT01323634|7400870|FG002|STARTED|Double-Blind (DB) Treatment Period||261
6554901|NCT01748825|7476984|FG005|STARTED|Dose Expansion||0
6748571|NCT03416621|7676685|FG002|STARTED|Overall Study||6
6748572|NCT03416621|7676683|FG000|COMPLETED|Overall Study||13
6748573|NCT03416621|7676684|FG001|COMPLETED|Overall Study||11
6748574|NCT03416621|7676685|FG002|COMPLETED|Overall Study||1
6748575|NCT03416621|7676683|FG000|NOT COMPLETED|Overall Study||0
6748576|NCT03416621|7676684|FG001|NOT COMPLETED|Overall Study||1
6483346|NCT01323634|7400868|FG000|COMPLETED|Double-Blind (DB) Treatment Period||0
6483347|NCT01323634|7400869|FG001|COMPLETED|Double-Blind (DB) Treatment Period||235
6483348|NCT01323634|7400870|FG002|COMPLETED|Double-Blind (DB) Treatment Period||239
6483349|NCT01323634|7400868|FG000|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
6483350|NCT01323634|7400869|FG001|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
6483351|NCT01323634|7400870|FG002|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
6483352|NCT01323647|7400878|FG000|STARTED|Overall Study||470
6483353|NCT01323647|7400879|FG001|STARTED|Overall Study||487
6483354|NCT01323647|7400878|FG000|COMPLETED|Overall Study||461
6483355|NCT01323647|7400879|FG001|COMPLETED|Overall Study||487
6483356|NCT01323647|7400878|FG000|NOT COMPLETED|Overall Study||9
6483357|NCT01323647|7400879|FG001|NOT COMPLETED|Overall Study||0
6483358|NCT01323660|7400885|FG000|STARTED|Treatment Period 1 (12 Weeks)||84
6483359|NCT01323660|7400886|FG001|STARTED|Treatment Period 1 (12 Weeks)||22
6483360|NCT01323660|7400887|FG002|STARTED|Treatment Period 1 (12 Weeks)||24
6483361|NCT01323660|7400888|FG003|STARTED|Treatment Period 1 (12 Weeks)||36
6483362|NCT01323660|7400889|FG004|STARTED|Treatment Period 1 (12 Weeks)||71
6483363|NCT01323660|7400890|FG005|STARTED|Treatment Period 1 (12 Weeks)||70
6483364|NCT01323660|7400885|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||65
6483365|NCT01323660|7400886|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
6483366|NCT01323660|7400887|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||19
6483367|NCT01323660|7400888|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||31
6483368|NCT01323660|7400889|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||61
6483369|NCT01323660|7400890|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||61
6483370|NCT01323660|7400885|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
6483371|NCT01323660|7400886|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
6483372|NCT01323660|7400887|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
6483373|NCT01323660|7400888|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
6483374|NCT01323660|7400889|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
6483375|NCT01323660|7400890|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
6483376|NCT01323660|7400885|FG000|STARTED|Washout Period (14 Days)||65
6483377|NCT01323660|7400886|FG001|STARTED|Washout Period (14 Days)||21
6483378|NCT01323660|7400887|FG002|STARTED|Washout Period (14 Days)||19
6483379|NCT01323660|7400888|FG003|STARTED|Washout Period (14 Days)||31
6483380|NCT01323660|7400889|FG004|STARTED|Washout Period (14 Days)||61
6483381|NCT01323660|7400890|FG005|STARTED|Washout Period (14 Days)||61
6483382|NCT01323660|7400885|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
6483383|NCT01323660|7400886|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
6483384|NCT01323660|7400887|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
6483385|NCT01323660|7400888|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
6483386|NCT01323660|7400889|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
6483387|NCT01323660|7400890|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
6483388|NCT01323660|7400885|FG000|NOT COMPLETED|Washout Period (14 Days)||0
6483389|NCT01323660|7400886|FG001|NOT COMPLETED|Washout Period (14 Days)||0
6483390|NCT01323660|7400887|FG002|NOT COMPLETED|Washout Period (14 Days)||1
6483391|NCT01323660|7400888|FG003|NOT COMPLETED|Washout Period (14 Days)||3
6483392|NCT01323660|7400889|FG004|NOT COMPLETED|Washout Period (14 Days)||3
6483393|NCT01323660|7400890|FG005|NOT COMPLETED|Washout Period (14 Days)||2
6483394|NCT01323660|7400885|FG000|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|67
6483395|NCT01323660|7400886|FG001|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|18
6483396|NCT01323660|7400887|FG002|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|17
6483397|NCT01323660|7400888|FG003|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|28
6483398|NCT01323660|7400889|FG004|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|59
6483399|NCT01323660|7400890|FG005|STARTED|Treatment Period 2 (12 Weeks)|"By crossover design, participants were assigned to a different treatment arm in each period."|58
6483400|NCT01323660|7400885|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||55
6483401|NCT01323660|7400886|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||17
6483402|NCT01323660|7400887|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||14
6483403|NCT01323660|7400888|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||25
6483404|NCT01323660|7400889|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||55
6483405|NCT01323660|7400890|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||51
6483406|NCT01323660|7400885|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
6483407|NCT01323660|7400886|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
6748577|NCT03416621|7676685|FG002|NOT COMPLETED|Overall Study||5
6748578|NCT03416946|7676697|FG000|STARTED|Overall Study||25
6748579|NCT03416946|7676698|FG001|STARTED|Overall Study||29
6748580|NCT03416946|7676697|FG000|COMPLETED|Overall Study||25
6654690|NCT02447458|7584585|FG005|STARTED|Overall Study||10
6654691|NCT02447458|7584580|FG000|COMPLETED|Overall Study||5
6654692|NCT02447458|7584581|FG001|COMPLETED|Overall Study||6
6654693|NCT02447458|7584582|FG002|COMPLETED|Overall Study||5
6654694|NCT02447458|7584583|FG003|COMPLETED|Overall Study||6
6748581|NCT03416946|7676698|FG001|COMPLETED|Overall Study||29
6483408|NCT01323660|7400887|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
6483409|NCT01323660|7400888|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
6483410|NCT01323660|7400889|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
6483411|NCT01323660|7400890|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
6483412|NCT01323673|7400906|FG000|STARTED|Overall Study||62
6483413|NCT01323673|7400907|FG001|STARTED|Overall Study||63
6483414|NCT01323673|7400906|FG000|COMPLETED|Overall Study||59
6483415|NCT01323673|7400907|FG001|COMPLETED|Overall Study||58
6483416|NCT01323673|7400906|FG000|NOT COMPLETED|Overall Study||3
6483417|NCT01323673|7400907|FG001|NOT COMPLETED|Overall Study||5
6483418|NCT01323777|7400913|FG000|STARTED|Overall Study||65
6483419|NCT01323777|7400913|FG000|COMPLETED|Overall Study||65
6483420|NCT01323777|7400913|FG000|NOT COMPLETED|Overall Study||0
6483421|NCT01323790|7400927|FG000|STARTED|Overall Study||233
6748582|NCT03416946|7676697|FG000|NOT COMPLETED|Overall Study||0
6483422|NCT01323790|7400928|FG001|STARTED|Overall Study||234
6483423|NCT01323790|7400929|FG002|STARTED|Overall Study||233
6483424|NCT01323790|7400927|FG000|COMPLETED|Overall Study||178
6483425|NCT01323790|7400928|FG001|COMPLETED|Overall Study||174
6483426|NCT01323790|7400929|FG002|COMPLETED|Overall Study||188
6483427|NCT01323790|7400927|FG000|NOT COMPLETED|Overall Study||55
6483428|NCT01323790|7400928|FG001|NOT COMPLETED|Overall Study||60
6483429|NCT01323790|7400929|FG002|NOT COMPLETED|Overall Study||45
6483430|NCT01323855|7400942|FG000|STARTED|Overall Study||9
6483431|NCT01323855|7400943|FG001|STARTED|Overall Study||9
6483432|NCT01323855|7400944|FG002|STARTED|Overall Study||8
6483433|NCT01323855|7400945|FG003|STARTED|Overall Study||9
6483434|NCT01323855|7400946|FG004|STARTED|Overall Study||11
6483435|NCT01323855|7400942|FG000|COMPLETED|Overall Study||9
6483436|NCT01323855|7400943|FG001|COMPLETED|Overall Study||9
6483437|NCT01323855|7400944|FG002|COMPLETED|Overall Study||8
6483438|NCT01323855|7400945|FG003|COMPLETED|Overall Study||9
6483439|NCT01323855|7400946|FG004|COMPLETED|Overall Study||11
6483440|NCT01323855|7400942|FG000|NOT COMPLETED|Overall Study||0
6483441|NCT01323855|7400943|FG001|NOT COMPLETED|Overall Study||0
6483442|NCT01323855|7400944|FG002|NOT COMPLETED|Overall Study||0
6483443|NCT01323855|7400945|FG003|NOT COMPLETED|Overall Study||0
6483444|NCT01323855|7400946|FG004|NOT COMPLETED|Overall Study||0
6483445|NCT01323920|7400958|FG000|STARTED|Overall Study||35
6483446|NCT01323920|7400958|FG000|COMPLETED|Overall Study||29
6483447|NCT01323920|7400958|FG000|NOT COMPLETED|Overall Study||6
6483448|NCT01323946|7400965|FG000|STARTED|Overall Study||46
6483449|NCT01323946|7400966|FG001|STARTED|Overall Study||34
6483450|NCT01323946|7400967|FG002|STARTED|Overall Study||33
6483451|NCT01323946|7400965|FG000|COMPLETED|Overall Study||43
6483452|NCT01323946|7400966|FG001|COMPLETED|Overall Study||31
6483453|NCT01323946|7400967|FG002|COMPLETED|Overall Study||33
6483454|NCT01323946|7400965|FG000|NOT COMPLETED|Overall Study||3
6483455|NCT01323946|7400966|FG001|NOT COMPLETED|Overall Study||3
6483456|NCT01323946|7400967|FG002|NOT COMPLETED|Overall Study||0
6483457|NCT01323959|7400980|FG000|STARTED|Overall Study||67
6483458|NCT01323959|7400981|FG001|STARTED|Overall Study||72
6483459|NCT01323959|7400982|FG002|STARTED|Overall Study||72
6483460|NCT01323959|7400980|FG000|COMPLETED|Overall Study||67
6483461|NCT01323959|7400981|FG001|COMPLETED|Overall Study||72
6483462|NCT01323959|7400982|FG002|COMPLETED|Overall Study||72
6483463|NCT01323959|7400980|FG000|NOT COMPLETED|Overall Study||0
6483464|NCT01323959|7400981|FG001|NOT COMPLETED|Overall Study||0
6483465|NCT01323959|7400982|FG002|NOT COMPLETED|Overall Study||0
6483466|NCT01323972|7400994|FG000|STARTED|Overall Study||81
6483467|NCT01323972|7400995|FG001|STARTED|Overall Study||79
6483468|NCT01323972|7400996|FG002|STARTED|Overall Study||80
6483469|NCT01323972|7400997|FG003|STARTED|Overall Study||80
6483470|NCT01323972|7400994|FG000|COMPLETED|Overall Study||79
6483471|NCT01323972|7400995|FG001|COMPLETED|Overall Study||76
6483472|NCT01323972|7400996|FG002|COMPLETED|Overall Study||78
6483473|NCT01323972|7400997|FG003|COMPLETED|Overall Study||79
6483474|NCT01323972|7400994|FG000|NOT COMPLETED|Overall Study||2
6654695|NCT02447458|7584584|FG004|COMPLETED|Overall Study||6
6483475|NCT01323972|7400995|FG001|NOT COMPLETED|Overall Study||3
6483476|NCT01323972|7400996|FG002|NOT COMPLETED|Overall Study||2
6483477|NCT01323972|7400997|FG003|NOT COMPLETED|Overall Study||1
6483478|NCT01323998|7401014|FG000|STARTED|Overall Study||200631
6483479|NCT01323998|7401015|FG001|STARTED|Overall Study||18681
6483480|NCT01323998|7401016|FG002|STARTED|Overall Study||10294
6654696|NCT02447458|7584585|FG005|COMPLETED|Overall Study||10
6483481|NCT01323998|7401017|FG003|STARTED|Overall Study||12052
6483482|NCT01323998|7401018|FG004|STARTED|Overall Study||6735
6483483|NCT01323998|7401014|FG000|COMPLETED|Overall Study||200631
6483484|NCT01323998|7401015|FG001|COMPLETED|Overall Study||18681
6483485|NCT01323998|7401016|FG002|COMPLETED|Overall Study||10294
6483486|NCT01323998|7401017|FG003|COMPLETED|Overall Study||12052
6483487|NCT01323998|7401018|FG004|COMPLETED|Overall Study||6735
6483488|NCT01323998|7401014|FG000|NOT COMPLETED|Overall Study||0
6483489|NCT01323998|7401015|FG001|NOT COMPLETED|Overall Study||0
6654697|NCT02447458|7584580|FG000|NOT COMPLETED|Overall Study||0
6654698|NCT02447458|7584581|FG001|NOT COMPLETED|Overall Study||0
6483490|NCT01323998|7401016|FG002|NOT COMPLETED|Overall Study||0
6483491|NCT01323998|7401017|FG003|NOT COMPLETED|Overall Study||0
6483492|NCT01323998|7401018|FG004|NOT COMPLETED|Overall Study||0
6483493|NCT01324024|7401030|FG000|STARTED|First Intervention (4 Weeks)||18
6483494|NCT01324024|7401031|FG001|STARTED|First Intervention (4 Weeks)||17
6483495|NCT01324024|7401030|FG000|COMPLETED|First Intervention (4 Weeks)||18
6483496|NCT01324024|7401031|FG001|COMPLETED|First Intervention (4 Weeks)||17
6483497|NCT01324024|7401030|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6483498|NCT01324024|7401031|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6483499|NCT01324024|7401030|FG000|STARTED|Washout (2 Weeks)||18
6483500|NCT01324024|7401031|FG001|STARTED|Washout (2 Weeks)||17
6483501|NCT01324024|7401030|FG000|COMPLETED|Washout (2 Weeks)||18
6483502|NCT01324024|7401031|FG001|COMPLETED|Washout (2 Weeks)||17
6483503|NCT01324024|7401030|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6483504|NCT01324024|7401031|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6483505|NCT01324024|7401030|FG000|STARTED|Second Intervention (4 Weeks)||18
6483506|NCT01324024|7401031|FG001|STARTED|Second Intervention (4 Weeks)||17
6483507|NCT01324024|7401030|FG000|COMPLETED|Second Intervention (4 Weeks)||16
6483508|NCT01324024|7401031|FG001|COMPLETED|Second Intervention (4 Weeks)||16
6483509|NCT01324024|7401030|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||2
6483510|NCT01324024|7401031|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
6483511|NCT01324102|7401043|FG000|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
6483512|NCT01324102|7401044|FG001|STARTED|Overall Study|Yoga group 4 and 6|12
6483513|NCT01324102|7401043|FG000|COMPLETED|Overall Study||10
6483514|NCT01324102|7401044|FG001|COMPLETED|Overall Study||6
6483515|NCT01324102|7401043|FG000|NOT COMPLETED|Overall Study||1
6483516|NCT01324102|7401044|FG001|NOT COMPLETED|Overall Study||6
6483517|NCT01324128|7401053|FG000|STARTED|Stage 1||710
6483518|NCT01324128|7401054|FG001|STARTED|Stage 1||349
6483519|NCT01324128|7401055|FG002|STARTED|Stage 1||0
6483520|NCT01324128|7401056|FG003|STARTED|Stage 1||0
6483521|NCT01324128|7401053|FG000|COMPLETED|Stage 1||515
6483522|NCT01324128|7401054|FG001|COMPLETED|Stage 1||293
6483523|NCT01324128|7401055|FG002|COMPLETED|Stage 1||0
6483524|NCT01324128|7401056|FG003|COMPLETED|Stage 1||0
6483525|NCT01324128|7401053|FG000|NOT COMPLETED|Stage 1||195
6483526|NCT01324128|7401054|FG001|NOT COMPLETED|Stage 1||56
6483527|NCT01324128|7401055|FG002|NOT COMPLETED|Stage 1||0
6483528|NCT01324128|7401056|FG003|NOT COMPLETED|Stage 1||0
6483529|NCT01324128|7401053|FG000|STARTED|Stage 2||0
6483530|NCT01324128|7401054|FG001|STARTED|Stage 2||0
6483531|NCT01324128|7401055|FG002|STARTED|Stage 2||50
6483532|NCT01324128|7401056|FG003|STARTED|Stage 2||49
6483533|NCT01324128|7401053|FG000|COMPLETED|Stage 2||0
6483534|NCT01324128|7401054|FG001|COMPLETED|Stage 2||0
6483535|NCT01324128|7401055|FG002|COMPLETED|Stage 2||42
6483536|NCT01324128|7401056|FG003|COMPLETED|Stage 2||46
6483537|NCT01324128|7401053|FG000|NOT COMPLETED|Stage 2||0
6483538|NCT01324128|7401054|FG001|NOT COMPLETED|Stage 2||0
6483539|NCT01324128|7401055|FG002|NOT COMPLETED|Stage 2||8
6483540|NCT01324128|7401056|FG003|NOT COMPLETED|Stage 2||3
6483541|NCT01324141|7401066|FG000|STARTED|Overall Study||6
6483542|NCT01324141|7401066|FG000|COMPLETED|Overall Study||4
6483543|NCT01324141|7401066|FG000|NOT COMPLETED|Overall Study||2
6483544|NCT01324232|7401084|FG000|STARTED|Overall Study||49
6483545|NCT01324232|7401085|FG001|STARTED|Overall Study||53
6483546|NCT01324232|7401086|FG002|STARTED|Overall Study||54
6483547|NCT01324232|7401087|FG003|STARTED|Overall Study||53
6483548|NCT01324232|7401084|FG000|COMPLETED|Overall Study||44
6483549|NCT01324232|7401085|FG001|COMPLETED|Overall Study||42
6483550|NCT01324232|7401086|FG002|COMPLETED|Overall Study||41
6483551|NCT01324232|7401087|FG003|COMPLETED|Overall Study||42
6483552|NCT01324232|7401084|FG000|NOT COMPLETED|Overall Study||5
6483553|NCT01324232|7401085|FG001|NOT COMPLETED|Overall Study||11
6483554|NCT01324232|7401086|FG002|NOT COMPLETED|Overall Study||13
6483555|NCT01324232|7401087|FG003|NOT COMPLETED|Overall Study||11
6483556|NCT01324271|7401102|FG000|STARTED|Overall Study||57
6483557|NCT01324271|7401103|FG001|STARTED|Overall Study||28
6483558|NCT01324271|7401102|FG000|COMPLETED|Overall Study||53
6483559|NCT01324271|7401103|FG001|COMPLETED|Overall Study||28
6483560|NCT01324271|7401102|FG000|NOT COMPLETED|Overall Study||4
6483561|NCT01324271|7401103|FG001|NOT COMPLETED|Overall Study||0
6483562|NCT01324310|7401109|FG000|STARTED|Overall Study||15
6483563|NCT01324310|7401109|FG000|COMPLETED|Overall Study||13
6483564|NCT01324310|7401109|FG000|NOT COMPLETED|Overall Study||2
6483565|NCT01324323|7401115|FG000|STARTED|Overall Study||14
6483566|NCT01324323|7401115|FG000|COMPLETED|Overall Study||13
6483567|NCT01324323|7401115|FG000|NOT COMPLETED|Overall Study||1
6483568|NCT01324349|7401129|FG000|STARTED|Overall Study||32
6483569|NCT01324349|7401130|FG001|STARTED|Overall Study||18
6483570|NCT01324349|7401129|FG000|COMPLETED|Overall Study||31
6483571|NCT01324349|7401130|FG001|COMPLETED|Overall Study||16
6483572|NCT01324349|7401129|FG000|NOT COMPLETED|Overall Study||1
6483573|NCT01324349|7401130|FG001|NOT COMPLETED|Overall Study||2
6483574|NCT01324388|7401139|FG000|STARTED|Part 1 of Study||23
6483575|NCT01324388|7401140|FG001|STARTED|Part 1 of Study||8
6483576|NCT01324388|7401141|FG002|STARTED|Part 1 of Study||0
6483577|NCT01324388|7401142|FG003|STARTED|Part 1 of Study||0
6483578|NCT01324388|7401139|FG000|Received at Least 1 Dose|Part 1 of Study||23
6483579|NCT01324388|7401140|FG001|Received at Least 1 Dose|Part 1 of Study||8
6483580|NCT01324388|7401141|FG002|Received at Least 1 Dose|Part 1 of Study||0
6483581|NCT01324388|7401142|FG003|Received at Least 1 Dose|Part 1 of Study||0
6483582|NCT01324388|7401139|FG000|COMPLETED|Part 1 of Study||19
6483583|NCT01324388|7401140|FG001|COMPLETED|Part 1 of Study||6
6483584|NCT01324388|7401141|FG002|COMPLETED|Part 1 of Study||0
6483585|NCT01324388|7401142|FG003|COMPLETED|Part 1 of Study||0
6483586|NCT01324388|7401139|FG000|NOT COMPLETED|Part 1 of Study||4
6483587|NCT01324388|7401140|FG001|NOT COMPLETED|Part 1 of Study||2
6483588|NCT01324388|7401141|FG002|NOT COMPLETED|Part 1 of Study||0
6483589|NCT01324388|7401142|FG003|NOT COMPLETED|Part 1 of Study||0
6483590|NCT01324388|7401139|FG000|STARTED|Part 2 of Study: First Intervention||0
6483591|NCT01324388|7401140|FG001|STARTED|Part 2 of Study: First Intervention||0
6483592|NCT01324388|7401141|FG002|STARTED|Part 2 of Study: First Intervention||10
6483593|NCT01324388|7401142|FG003|STARTED|Part 2 of Study: First Intervention||10
6483594|NCT01324388|7401139|FG000|COMPLETED|Part 2 of Study: First Intervention||0
6483595|NCT01324388|7401140|FG001|COMPLETED|Part 2 of Study: First Intervention||0
6483596|NCT01324388|7401141|FG002|COMPLETED|Part 2 of Study: First Intervention||10
6483597|NCT01324388|7401142|FG003|COMPLETED|Part 2 of Study: First Intervention||9
6483598|NCT01324388|7401139|FG000|NOT COMPLETED|Part 2 of Study: First Intervention||0
6483599|NCT01324388|7401140|FG001|NOT COMPLETED|Part 2 of Study: First Intervention||0
6483600|NCT01324388|7401141|FG002|NOT COMPLETED|Part 2 of Study: First Intervention||0
6483601|NCT01324388|7401142|FG003|NOT COMPLETED|Part 2 of Study: First Intervention||1
6483602|NCT01324388|7401139|FG000|STARTED|Part 2: Washout of at Least 21 Days||0
6483603|NCT01324388|7401140|FG001|STARTED|Part 2: Washout of at Least 21 Days||0
6483604|NCT01324388|7401141|FG002|STARTED|Part 2: Washout of at Least 21 Days||10
6483605|NCT01324388|7401142|FG003|STARTED|Part 2: Washout of at Least 21 Days||9
6483606|NCT01324388|7401139|FG000|COMPLETED|Part 2: Washout of at Least 21 Days||0
6483607|NCT01324388|7401140|FG001|COMPLETED|Part 2: Washout of at Least 21 Days||0
6483608|NCT01324388|7401141|FG002|COMPLETED|Part 2: Washout of at Least 21 Days||10
6483609|NCT01324388|7401142|FG003|COMPLETED|Part 2: Washout of at Least 21 Days||9
6483610|NCT01324388|7401139|FG000|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
6483611|NCT01324388|7401140|FG001|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
6483612|NCT01324388|7401141|FG002|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
6483613|NCT01324388|7401142|FG003|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
6483614|NCT01324388|7401139|FG000|STARTED|Part 2 of Study: Second Intervention||0
6483615|NCT01324388|7401140|FG001|STARTED|Part 2 of Study: Second Intervention||0
6483616|NCT01324388|7401141|FG002|STARTED|Part 2 of Study: Second Intervention||10
6483617|NCT01324388|7401142|FG003|STARTED|Part 2 of Study: Second Intervention||9
6483618|NCT01324388|7401139|FG000|COMPLETED|Part 2 of Study: Second Intervention||0
6483619|NCT01324388|7401140|FG001|COMPLETED|Part 2 of Study: Second Intervention||0
6483620|NCT01324388|7401141|FG002|COMPLETED|Part 2 of Study: Second Intervention||9
6483621|NCT01324388|7401142|FG003|COMPLETED|Part 2 of Study: Second Intervention||9
6483622|NCT01324388|7401139|FG000|NOT COMPLETED|Part 2 of Study: Second Intervention||0
6483623|NCT01324388|7401140|FG001|NOT COMPLETED|Part 2 of Study: Second Intervention||0
6483624|NCT01324388|7401141|FG002|NOT COMPLETED|Part 2 of Study: Second Intervention||1
6483625|NCT01324388|7401142|FG003|NOT COMPLETED|Part 2 of Study: Second Intervention||0
6483626|NCT01324401|7401156|FG000|STARTED|Overall Study||4
6483627|NCT01324401|7401157|FG001|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
6483628|NCT01324401|7401156|FG000|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
6483629|NCT01324401|7401157|FG001|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
6483630|NCT01324401|7401156|FG000|NOT COMPLETED|Overall Study||1
6483631|NCT01324401|7401157|FG001|NOT COMPLETED|Overall Study||6
6483632|NCT01324440|7401165|FG000|STARTED|Overall Study||32
6483633|NCT01324440|7401166|FG001|STARTED|Overall Study||32
6483634|NCT01324440|7401165|FG000|COMPLETED|Overall Study||32
6483635|NCT01324440|7401166|FG001|COMPLETED|Overall Study||31
6483636|NCT01324440|7401165|FG000|NOT COMPLETED|Overall Study||0
6483637|NCT01324440|7401166|FG001|NOT COMPLETED|Overall Study||1
6483638|NCT01324453|7401174|FG000|STARTED|Overall Study||54
6483639|NCT01324453|7401175|FG001|STARTED|Overall Study||49
6483640|NCT01324453|7401174|FG000|COMPLETED|Overall Study||54
6483641|NCT01324453|7401175|FG001|COMPLETED|Overall Study||49
6483642|NCT01324453|7401174|FG000|NOT COMPLETED|Overall Study||0
6483643|NCT01324453|7401175|FG001|NOT COMPLETED|Overall Study||0
6483644|NCT01324518|7401184|FG000|STARTED|Overall Study||33
6483645|NCT01324518|7401185|FG001|STARTED|Overall Study||33
6483646|NCT01324518|7401186|FG002|STARTED|Overall Study||34
6483647|NCT01324518|7401184|FG000|COMPLETED|Overall Study||28
6483648|NCT01324518|7401185|FG001|COMPLETED|Overall Study||30
6483649|NCT01324518|7401186|FG002|COMPLETED|Overall Study||33
6483650|NCT01324518|7401184|FG000|NOT COMPLETED|Overall Study||5
6483651|NCT01324518|7401185|FG001|NOT COMPLETED|Overall Study||3
6483652|NCT01324518|7401186|FG002|NOT COMPLETED|Overall Study||1
6483653|NCT01324570|7401196|FG000|STARTED|Overall Study||6
6483654|NCT01324570|7401197|FG001|STARTED|Overall Study||35
6483655|NCT01324570|7401196|FG000|COMPLETED|Overall Study||2
6483656|NCT01324570|7401197|FG001|COMPLETED|Overall Study||21
6483657|NCT01324570|7401196|FG000|NOT COMPLETED|Overall Study||4
6483658|NCT01324570|7401197|FG001|NOT COMPLETED|Overall Study||14
6483659|NCT01324622|7401207|FG000|STARTED|Overall Study||13
6483660|NCT01324622|7401208|FG001|STARTED|Overall Study||11
6483661|NCT01324622|7401207|FG000|COMPLETED|Overall Study||4
6483662|NCT01324622|7401208|FG001|COMPLETED|Overall Study||4
6483663|NCT01324622|7401207|FG000|NOT COMPLETED|Overall Study||9
6483664|NCT01324622|7401208|FG001|NOT COMPLETED|Overall Study||7
6483665|NCT01324687|7401217|FG000|STARTED|Overall Study||1058
6483666|NCT01324687|7401218|FG001|STARTED|Overall Study||494
6483667|NCT01324687|7401217|FG000|COMPLETED|Overall Study||1058
6483668|NCT01324687|7401218|FG001|COMPLETED|Overall Study||479
6483669|NCT01324687|7401217|FG000|NOT COMPLETED|Overall Study||0
6483670|NCT01324687|7401218|FG001|NOT COMPLETED|Overall Study||15
6483671|NCT01324700|7401228|FG000|STARTED|Overall Study||22
6483672|NCT01324700|7401229|FG001|STARTED|Overall Study||20
6483673|NCT01324700|7401230|FG002|STARTED|Overall Study||49
6483674|NCT01324700|7401231|FG003|STARTED|Overall Study||48
6483675|NCT01324700|7401228|FG000|COMPLETED|Overall Study||13
6483676|NCT01324700|7401229|FG001|COMPLETED|Overall Study||16
6483677|NCT01324700|7401230|FG002|COMPLETED|Overall Study||33
6483678|NCT01324700|7401231|FG003|COMPLETED|Overall Study||37
6483679|NCT01324700|7401228|FG000|NOT COMPLETED|Overall Study||9
6483680|NCT01324700|7401229|FG001|NOT COMPLETED|Overall Study||4
6483681|NCT01324700|7401230|FG002|NOT COMPLETED|Overall Study||16
6483682|NCT01324700|7401231|FG003|NOT COMPLETED|Overall Study||11
6483683|NCT01324830|7401260|FG000|STARTED|Overall Study||3
6483684|NCT01324830|7401261|FG001|STARTED|Overall Study||3
6483685|NCT01324830|7401262|FG002|STARTED|Overall Study||3
6483686|NCT01324830|7401263|FG003|STARTED|Overall Study||3
6483687|NCT01324830|7401264|FG004|STARTED|Overall Study||7
6483688|NCT01324830|7401265|FG005|STARTED|Overall Study||7
6483689|NCT01324830|7401266|FG006|STARTED|Overall Study||3
6483690|NCT01324830|7401267|FG007|STARTED|Overall Study||3
6483691|NCT01324830|7401268|FG008|STARTED|Overall Study||5
6483692|NCT01324830|7401269|FG009|STARTED|Overall Study||6
6483693|NCT01324830|7401270|FG010|STARTED|Overall Study||4
6483694|NCT01324830|7401271|FG011|STARTED|Overall Study||1
6483695|NCT01324830|7401272|FG012|STARTED|Overall Study||1
6483696|NCT01324830|7401273|FG013|STARTED|Overall Study||1
6483697|NCT01324830|7401274|FG014|STARTED|Overall Study||1
6483698|NCT01324830|7401275|FG015|STARTED|Overall Study||3
6483699|NCT01324830|7401276|FG016|STARTED|Overall Study||3
6483700|NCT01324830|7401277|FG017|STARTED|Overall Study||6
6483701|NCT01324830|7401278|FG018|STARTED|Overall Study||6
6483702|NCT01324830|7401260|FG000|COMPLETED|Overall Study||0
6483703|NCT01324830|7401261|FG001|COMPLETED|Overall Study||0
6483704|NCT01324830|7401262|FG002|COMPLETED|Overall Study||0
6483705|NCT01324830|7401263|FG003|COMPLETED|Overall Study||0
6483706|NCT01324830|7401264|FG004|COMPLETED|Overall Study||0
6483707|NCT01324830|7401265|FG005|COMPLETED|Overall Study||0
6483708|NCT01324830|7401266|FG006|COMPLETED|Overall Study||0
6483709|NCT01324830|7401267|FG007|COMPLETED|Overall Study||0
6483710|NCT01324830|7401268|FG008|COMPLETED|Overall Study||0
6483711|NCT01324830|7401269|FG009|COMPLETED|Overall Study||0
6483712|NCT01324830|7401270|FG010|COMPLETED|Overall Study||0
6483713|NCT01324830|7401271|FG011|COMPLETED|Overall Study||0
6483714|NCT01324830|7401272|FG012|COMPLETED|Overall Study||0
6483715|NCT01324830|7401273|FG013|COMPLETED|Overall Study||0
6483716|NCT01324830|7401274|FG014|COMPLETED|Overall Study||0
6483717|NCT01324830|7401275|FG015|COMPLETED|Overall Study||0
6483718|NCT01324830|7401276|FG016|COMPLETED|Overall Study||0
6483719|NCT01324830|7401277|FG017|COMPLETED|Overall Study||0
6483720|NCT01324830|7401278|FG018|COMPLETED|Overall Study||0
6483721|NCT01324830|7401260|FG000|NOT COMPLETED|Overall Study||3
6483722|NCT01324830|7401261|FG001|NOT COMPLETED|Overall Study||3
6483723|NCT01324830|7401262|FG002|NOT COMPLETED|Overall Study||3
6483724|NCT01324830|7401263|FG003|NOT COMPLETED|Overall Study||3
6483725|NCT01324830|7401264|FG004|NOT COMPLETED|Overall Study||7
6483726|NCT01324830|7401265|FG005|NOT COMPLETED|Overall Study||7
6483727|NCT01324830|7401266|FG006|NOT COMPLETED|Overall Study||3
6483728|NCT01324830|7401267|FG007|NOT COMPLETED|Overall Study||3
6483729|NCT01324830|7401268|FG008|NOT COMPLETED|Overall Study||5
6483730|NCT01324830|7401269|FG009|NOT COMPLETED|Overall Study||6
6483731|NCT01324830|7401270|FG010|NOT COMPLETED|Overall Study||4
6483732|NCT01324830|7401271|FG011|NOT COMPLETED|Overall Study||1
6483733|NCT01324830|7401272|FG012|NOT COMPLETED|Overall Study||1
6483734|NCT01324830|7401273|FG013|NOT COMPLETED|Overall Study||1
6483735|NCT01324830|7401274|FG014|NOT COMPLETED|Overall Study||1
6483736|NCT01324830|7401275|FG015|NOT COMPLETED|Overall Study||3
6483737|NCT01324830|7401276|FG016|NOT COMPLETED|Overall Study||3
6483738|NCT01324830|7401277|FG017|NOT COMPLETED|Overall Study||6
6483739|NCT01324830|7401278|FG018|NOT COMPLETED|Overall Study||6
6483740|NCT01324882|7401326|FG000|STARTED|Overall Study|27 patients were randomized to this arm.|27
6554902|NCT01748825|7476985|FG006|STARTED|Dose Expansion||0
6554903|NCT01748825|7476986|FG007|STARTED|Dose Expansion||0
6554904|NCT01748825|7476987|FG008|STARTED|Dose Expansion||13
6554905|NCT01748825|7476988|FG009|STARTED|Dose Expansion||20
6554906|NCT01748825|7476979|FG000|COMPLETED|Dose Expansion||0
6554907|NCT01748825|7476980|FG001|COMPLETED|Dose Expansion||0
6554908|NCT01748825|7476981|FG002|COMPLETED|Dose Expansion||0
6483741|NCT01324882|7401327|FG001|STARTED|Overall Study|30 patients were randomized to this arm|30
6483742|NCT01324882|7401326|FG000|COMPLETED|Overall Study|27 patients had the colonoscopy|27
6483743|NCT01324882|7401327|FG001|COMPLETED|Overall Study|30 patients had the colonoscopy|30
6483744|NCT01324882|7401326|FG000|NOT COMPLETED|Overall Study||0
6483745|NCT01324882|7401327|FG001|NOT COMPLETED|Overall Study||0
6501565|NCT01429532|7420066|FG000|NOT COMPLETED|Overall Study||0
6501566|NCT01429532|7420067|FG001|NOT COMPLETED|Overall Study||0
6554909|NCT01748825|7476982|FG003|COMPLETED|Dose Expansion||0
6554910|NCT01748825|7476983|FG004|COMPLETED|Dose Expansion||0
6554911|NCT01748825|7476984|FG005|COMPLETED|Dose Expansion||0
6554912|NCT01748825|7476985|FG006|COMPLETED|Dose Expansion||0
6554913|NCT01748825|7476986|FG007|COMPLETED|Dose Expansion||0
6483746|NCT01324947|7401335|FG000|STARTED|Overall Study||74
6483747|NCT01324947|7401335|FG000|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
6483748|NCT01324947|7401335|FG000|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
6483749|NCT01324947|7401335|FG000|COMPLETED|Overall Study||0
6483750|NCT01324947|7401335|FG000|NOT COMPLETED|Overall Study||74
6483751|NCT01324999|7401341|FG000|STARTED|Overall Study||12
6483752|NCT01324999|7401341|FG000|COMPLETED|Overall Study||7
6483753|NCT01324999|7401341|FG000|NOT COMPLETED|Overall Study||5
6483754|NCT01325181|7401347|FG000|STARTED|Overall Study||18
6483755|NCT01325181|7401348|FG001|STARTED|Overall Study||16
6483756|NCT01325181|7401347|FG000|COMPLETED|Overall Study||18
6483757|NCT01325181|7401348|FG001|COMPLETED|Overall Study||14
6483758|NCT01325181|7401347|FG000|NOT COMPLETED|Overall Study||0
6483759|NCT01325181|7401348|FG001|NOT COMPLETED|Overall Study||2
6483760|NCT01325207|7401360|FG000|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
6483761|NCT01325207|7401361|FG001|STARTED|Completed 4 Weeks/1 Cycle of Treatment||3
6483762|NCT01325207|7401362|FG002|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
6483763|NCT01325207|7401363|FG003|STARTED|Completed 4 Weeks/1 Cycle of Treatment||1
6483764|NCT01325207|7401364|FG004|STARTED|Completed 4 Weeks/1 Cycle of Treatment||7
6483765|NCT01325207|7401365|FG005|STARTED|Completed 4 Weeks/1 Cycle of Treatment||19
6483766|NCT01325207|7401360|FG000|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
6483767|NCT01325207|7401361|FG001|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||3
6483768|NCT01325207|7401362|FG002|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
6483769|NCT01325207|7401363|FG003|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||1
6483770|NCT01325207|7401364|FG004|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||5
6483771|NCT01325207|7401365|FG005|COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||19
6483772|NCT01325207|7401360|FG000|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6483773|NCT01325207|7401361|FG001|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6483774|NCT01325207|7401362|FG002|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6483775|NCT01325207|7401363|FG003|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6483776|NCT01325207|7401364|FG004|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||2
6483777|NCT01325207|7401365|FG005|NOT COMPLETED|Completed 4 Weeks/1 Cycle of Treatment||0
6483778|NCT01325207|7401360|FG000|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
6483779|NCT01325207|7401361|FG001|STARTED|Completed 8 Weeks/2 Cycles of Treatment||3
6483780|NCT01325207|7401362|FG002|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
6483781|NCT01325207|7401363|FG003|STARTED|Completed 8 Weeks/2 Cycles of Treatment||1
6483782|NCT01325207|7401364|FG004|STARTED|Completed 8 Weeks/2 Cycles of Treatment||5
6483783|NCT01325207|7401365|FG005|STARTED|Completed 8 Weeks/2 Cycles of Treatment||19
6483784|NCT01325207|7401360|FG000|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
6483785|NCT01325207|7401361|FG001|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
6483786|NCT01325207|7401362|FG002|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
6483787|NCT01325207|7401363|FG003|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
6483788|NCT01325207|7401364|FG004|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||3
6483789|NCT01325207|7401365|FG005|COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||14
6483790|NCT01325207|7401360|FG000|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
6483791|NCT01325207|7401361|FG001|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||1
6483792|NCT01325207|7401362|FG002|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
6483793|NCT01325207|7401363|FG003|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||0
6483794|NCT01325207|7401364|FG004|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||2
6483795|NCT01325207|7401365|FG005|NOT COMPLETED|Completed 8 Weeks/2 Cycles of Treatment||5
6483796|NCT01325207|7401360|FG000|STARTED|Started 9th Week/Cycle 3 of Treatment||2
6483797|NCT01325207|7401361|FG001|STARTED|Started 9th Week/Cycle 3 of Treatment||2
6483798|NCT01325207|7401362|FG002|STARTED|Started 9th Week/Cycle 3 of Treatment||1
6483799|NCT01325207|7401363|FG003|STARTED|Started 9th Week/Cycle 3 of Treatment||1
6483800|NCT01325207|7401364|FG004|STARTED|Started 9th Week/Cycle 3 of Treatment||3
6483801|NCT01325207|7401365|FG005|STARTED|Started 9th Week/Cycle 3 of Treatment||14
6483802|NCT01325207|7401360|FG000|COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
6483803|NCT01325207|7401361|FG001|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
6483804|NCT01325207|7401362|FG002|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
6483805|NCT01325207|7401363|FG003|COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
6483806|NCT01325207|7401364|FG004|COMPLETED|Started 9th Week/Cycle 3 of Treatment||3
6483807|NCT01325207|7401365|FG005|COMPLETED|Started 9th Week/Cycle 3 of Treatment||9
6483808|NCT01325207|7401360|FG000|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
6483809|NCT01325207|7401361|FG001|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||2
6483810|NCT01325207|7401362|FG002|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
6483811|NCT01325207|7401363|FG003|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||1
6483812|NCT01325207|7401364|FG004|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||0
6483813|NCT01325207|7401365|FG005|NOT COMPLETED|Started 9th Week/Cycle 3 of Treatment||5
6483814|NCT01325207|7401360|FG000|STARTED|Follow-up Every 3 Months Until Death||3
6483815|NCT01325207|7401361|FG001|STARTED|Follow-up Every 3 Months Until Death||3
6554914|NCT01748825|7476987|FG008|COMPLETED|Dose Expansion||11
6483816|NCT01325207|7401362|FG002|STARTED|Follow-up Every 3 Months Until Death||1
6483817|NCT01325207|7401363|FG003|STARTED|Follow-up Every 3 Months Until Death||1
6483818|NCT01325207|7401364|FG004|STARTED|Follow-up Every 3 Months Until Death||7
6483819|NCT01325207|7401365|FG005|STARTED|Follow-up Every 3 Months Until Death||19
6483820|NCT01325207|7401360|FG000|COMPLETED|Follow-up Every 3 Months Until Death||3
6483821|NCT01325207|7401361|FG001|COMPLETED|Follow-up Every 3 Months Until Death||3
6483822|NCT01325207|7401362|FG002|COMPLETED|Follow-up Every 3 Months Until Death||1
6483823|NCT01325207|7401363|FG003|COMPLETED|Follow-up Every 3 Months Until Death||1
6483824|NCT01325207|7401364|FG004|COMPLETED|Follow-up Every 3 Months Until Death||6
6483825|NCT01325207|7401365|FG005|COMPLETED|Follow-up Every 3 Months Until Death||18
6483826|NCT01325207|7401360|FG000|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
6483827|NCT01325207|7401361|FG001|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
6483828|NCT01325207|7401362|FG002|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
6483829|NCT01325207|7401363|FG003|NOT COMPLETED|Follow-up Every 3 Months Until Death||0
6483830|NCT01325207|7401364|FG004|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
6483831|NCT01325207|7401365|FG005|NOT COMPLETED|Follow-up Every 3 Months Until Death||1
6483832|NCT01325311|7401382|FG000|STARTED|Overall Study||8
6483833|NCT01325311|7401383|FG001|STARTED|Overall Study||7
6483834|NCT01325311|7401382|FG000|COMPLETED|Overall Study||8
6483835|NCT01325311|7401383|FG001|COMPLETED|Overall Study||7
6483836|NCT01325311|7401382|FG000|NOT COMPLETED|Overall Study||0
6483837|NCT01325311|7401383|FG001|NOT COMPLETED|Overall Study||0
6483838|NCT01325337|7401394|FG000|STARTED|Overall Study||61
6483839|NCT01325337|7401395|FG001|STARTED|Overall Study||61
6483840|NCT01325337|7401396|FG002|STARTED|Overall Study||62
6483841|NCT01325337|7401397|FG003|STARTED|Overall Study||62
6483842|NCT01325337|7401398|FG004|STARTED|Overall Study||61
6483843|NCT01325337|7401394|FG000|COMPLETED|Overall Study||56
6483844|NCT01325337|7401395|FG001|COMPLETED|Overall Study||52
6483845|NCT01325337|7401396|FG002|COMPLETED|Overall Study||53
6483846|NCT01325337|7401397|FG003|COMPLETED|Overall Study||52
6483847|NCT01325337|7401398|FG004|COMPLETED|Overall Study||53
6483848|NCT01325337|7401394|FG000|NOT COMPLETED|Overall Study||5
6483849|NCT01325337|7401395|FG001|NOT COMPLETED|Overall Study||9
6483850|NCT01325337|7401396|FG002|NOT COMPLETED|Overall Study||9
6483851|NCT01325337|7401397|FG003|NOT COMPLETED|Overall Study||10
6483852|NCT01325337|7401398|FG004|NOT COMPLETED|Overall Study||8
6483853|NCT01325350|7401415|FG000|STARTED|Overall Study||61
6483854|NCT01325350|7401416|FG001|STARTED|Overall Study||61
6483855|NCT01325350|7401417|FG002|STARTED|Overall Study||61
6483856|NCT01325350|7401418|FG003|STARTED|Overall Study||61
6483857|NCT01325350|7401419|FG004|STARTED|Overall Study||62
6483858|NCT01325350|7401415|FG000|COMPLETED|Overall Study||55
6483859|NCT01325350|7401416|FG001|COMPLETED|Overall Study||56
6483860|NCT01325350|7401417|FG002|COMPLETED|Overall Study||44
6483861|NCT01325350|7401418|FG003|COMPLETED|Overall Study||52
6483862|NCT01325350|7401419|FG004|COMPLETED|Overall Study||50
6483863|NCT01325350|7401415|FG000|NOT COMPLETED|Overall Study||6
6483864|NCT01325350|7401416|FG001|NOT COMPLETED|Overall Study||5
6483865|NCT01325350|7401417|FG002|NOT COMPLETED|Overall Study||17
6483866|NCT01325350|7401418|FG003|NOT COMPLETED|Overall Study||9
6483867|NCT01325350|7401419|FG004|NOT COMPLETED|Overall Study||12
6483868|NCT01325428|7401431|FG000|STARTED|Part A||26
6483869|NCT01325428|7401431|FG000|COMPLETED|Part A||10
6483870|NCT01325428|7401431|FG000|NOT COMPLETED|Part A||16
6483871|NCT01325428|7401431|FG000|STARTED|Part B||10
6483872|NCT01325428|7401431|FG000|COMPLETED|Part B||7
6483873|NCT01325428|7401431|FG000|NOT COMPLETED|Part B||3
6483874|NCT01325493|7401442|FG000|STARTED|Overall Study||30
6483875|NCT01325493|7401443|FG001|STARTED|Overall Study||24
6483876|NCT01325493|7401442|FG000|COMPLETED|Overall Study||29
6483877|NCT01325493|7401443|FG001|COMPLETED|Overall Study||21
6483878|NCT01325493|7401442|FG000|NOT COMPLETED|Overall Study||1
6483879|NCT01325493|7401443|FG001|NOT COMPLETED|Overall Study||3
6483880|NCT01325532|7401451|FG000|STARTED|Overall Study||17
6483881|NCT01325532|7401452|FG001|STARTED|Overall Study||13
6483882|NCT01325532|7401451|FG000|COMPLETED|Overall Study||15
6483883|NCT01325532|7401452|FG001|COMPLETED|Overall Study||13
6483884|NCT01325532|7401451|FG000|NOT COMPLETED|Overall Study||2
6483885|NCT01325532|7401452|FG001|NOT COMPLETED|Overall Study||0
6483886|NCT01325584|7401458|FG000|STARTED|Overall Study||12
6483887|NCT01325584|7401458|FG000|COMPLETED|Overall Study||11
6483888|NCT01325584|7401458|FG000|NOT COMPLETED|Overall Study||1
6483889|NCT01325623|7401462|FG000|STARTED|Overall Study||31
6483890|NCT01325623|7401462|FG000|COMPLETED|Overall Study||28
6748583|NCT03416946|7676698|FG001|NOT COMPLETED|Overall Study||0
6748584|NCT03416985|7676707|FG000|STARTED|Overall Study||30
6748585|NCT03416985|7676708|FG001|STARTED|Overall Study||30
6748586|NCT03416985|7676709|FG002|STARTED|Overall Study||30
6748587|NCT03416985|7676707|FG000|COMPLETED|Overall Study||28
6483891|NCT01325623|7401462|FG000|NOT COMPLETED|Overall Study||3
6483892|NCT01325701|7401501|FG000|STARTED|Overall Study||70
6483893|NCT01325701|7401502|FG001|STARTED|Overall Study||8
6748588|NCT03416985|7676708|FG001|COMPLETED|Overall Study||30
6483894|NCT01325701|7401501|FG000|COMPLETED|Overall Study||49
6483895|NCT01325701|7401502|FG001|COMPLETED|Overall Study||5
6483896|NCT01325701|7401501|FG000|NOT COMPLETED|Overall Study||21
6483897|NCT01325701|7401502|FG001|NOT COMPLETED|Overall Study||3
6483898|NCT01325714|7401511|FG000|STARTED|Overall Study||101
6748589|NCT03416985|7676709|FG002|COMPLETED|Overall Study||24
6483899|NCT01325714|7401512|FG001|STARTED|Overall Study||102
6483900|NCT01325714|7401511|FG000|3 Month Assessment|Overall Study||82
6483901|NCT01325714|7401512|FG001|3 Month Assessment|Overall Study||86
6483902|NCT01325714|7401511|FG000|6 Month Asessment|Overall Study||75
6483903|NCT01325714|7401512|FG001|6 Month Asessment|Overall Study||82
6483904|NCT01325714|7401511|FG000|12 Month Assessment|Overall Study||67
6483905|NCT01325714|7401512|FG001|12 Month Assessment|Overall Study||71
6483906|NCT01325714|7401511|FG000|COMPLETED|Overall Study||67
6483907|NCT01325714|7401512|FG001|COMPLETED|Overall Study||71
6483908|NCT01325714|7401511|FG000|NOT COMPLETED|Overall Study||34
6483909|NCT01325714|7401512|FG001|NOT COMPLETED|Overall Study||31
6483910|NCT01325792|7401520|FG000|STARTED|Overall Study||104
6483911|NCT01325792|7401520|FG000|COMPLETED|Overall Study||87
6483912|NCT01325792|7401520|FG000|NOT COMPLETED|Overall Study||17
6483913|NCT01325870|7401527|FG000|STARTED|Overall Study||18
6483914|NCT01325870|7401528|FG001|STARTED|Overall Study||16
6483915|NCT01325870|7401529|FG002|STARTED|Overall Study||14
6483916|NCT01325870|7401527|FG000|COMPLETED|Overall Study||7
6483917|NCT01325870|7401528|FG001|COMPLETED|Overall Study||3
6483918|NCT01325870|7401529|FG002|COMPLETED|Overall Study||6
6483919|NCT01325870|7401527|FG000|NOT COMPLETED|Overall Study||11
6483920|NCT01325870|7401528|FG001|NOT COMPLETED|Overall Study||13
6483921|NCT01325870|7401529|FG002|NOT COMPLETED|Overall Study||8
6483922|NCT01326026|7401539|FG000|STARTED|Overall Study||111
6483923|NCT01326026|7401540|FG001|STARTED|Overall Study||111
6483924|NCT01326026|7401539|FG000|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
6483925|NCT01326026|7401540|FG001|Exposed|Overall Study||111
6483926|NCT01326026|7401539|FG000|COMPLETED|Overall Study||99
6483927|NCT01326026|7401540|FG001|COMPLETED|Overall Study||98
6483928|NCT01326026|7401539|FG000|NOT COMPLETED|Overall Study||12
6483929|NCT01326026|7401540|FG001|NOT COMPLETED|Overall Study||13
6483930|NCT01326481|7401546|FG000|STARTED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||4
6483931|NCT01326481|7401546|FG000|COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||3
6483932|NCT01326481|7401546|FG000|NOT COMPLETED|7.5 mg/kg TRC105, 1000 mg/m2 Cape||1
6654699|NCT02447458|7584582|FG002|NOT COMPLETED|Overall Study||1
6654700|NCT02447458|7584583|FG003|NOT COMPLETED|Overall Study||0
6654701|NCT02447458|7584584|FG004|NOT COMPLETED|Overall Study||0
6654702|NCT02447458|7584585|FG005|NOT COMPLETED|Overall Study||0
6654703|NCT02447497|7584608|FG000|STARTED|Overall Study||25
6654704|NCT02447497|7584609|FG001|STARTED|Overall Study||25
6483933|NCT01326481|7401546|FG000|STARTED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
6483934|NCT01326481|7401546|FG000|COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||15
6483935|NCT01326481|7401546|FG000|NOT COMPLETED|10 mg/kg TRC105, 1000 mg/m2 Cape||0
6483936|NCT01326533|7401554|FG000|STARTED|Overall Study||17
6483937|NCT01326533|7401555|FG001|STARTED|Overall Study||15
6483938|NCT01326533|7401554|FG000|COMPLETED|Overall Study||13
6483939|NCT01326533|7401555|FG001|COMPLETED|Overall Study||15
6483940|NCT01326533|7401554|FG000|NOT COMPLETED|Overall Study||4
6483941|NCT01326533|7401555|FG001|NOT COMPLETED|Overall Study||0
6483942|NCT01326546|7401563|FG000|STARTED|Overall Study||189
6483943|NCT01326546|7401564|FG001|STARTED|Overall Study||189
6483944|NCT01326546|7401563|FG000|COMPLETED|Overall Study||172
6483945|NCT01326546|7401564|FG001|COMPLETED|Overall Study||176
6483946|NCT01326546|7401563|FG000|NOT COMPLETED|Overall Study||17
6483947|NCT01326546|7401564|FG001|NOT COMPLETED|Overall Study||13
6483948|NCT01326702|7401577|FG000|STARTED|Overall Study||3
6483949|NCT01326702|7401578|FG001|STARTED|Overall Study||3
6483950|NCT01326702|7401579|FG002|STARTED|Overall Study||6
6483951|NCT01326702|7401580|FG003|STARTED|Overall Study||4
6483952|NCT01326702|7401581|FG004|STARTED|Overall Study||5
6483953|NCT01326702|7401582|FG005|STARTED|Overall Study||15
6483954|NCT01326702|7401583|FG006|STARTED|Overall Study||7
6483955|NCT01326702|7401577|FG000|COMPLETED|Overall Study||1
6483956|NCT01326702|7401578|FG001|COMPLETED|Overall Study||1
6483957|NCT01326702|7401579|FG002|COMPLETED|Overall Study||1
6483958|NCT01326702|7401580|FG003|COMPLETED|Overall Study||1
6483959|NCT01326702|7401581|FG004|COMPLETED|Overall Study||1
6483960|NCT01326702|7401582|FG005|COMPLETED|Overall Study||7
6483961|NCT01326702|7401583|FG006|COMPLETED|Overall Study||0
6483962|NCT01326702|7401577|FG000|NOT COMPLETED|Overall Study||2
6483963|NCT01326702|7401578|FG001|NOT COMPLETED|Overall Study||2
6483964|NCT01326702|7401579|FG002|NOT COMPLETED|Overall Study||5
6483965|NCT01326702|7401580|FG003|NOT COMPLETED|Overall Study||3
6483966|NCT01326702|7401581|FG004|NOT COMPLETED|Overall Study||4
6483967|NCT01326702|7401582|FG005|NOT COMPLETED|Overall Study||8
6483968|NCT01326702|7401583|FG006|NOT COMPLETED|Overall Study||7
6483969|NCT01326728|7401604|FG000|STARTED|Overall Study||47
6483970|NCT01326728|7401605|FG001|STARTED|Overall Study||9
6483971|NCT01326728|7401604|FG000|COMPLETED|Overall Study||0
6483972|NCT01326728|7401605|FG001|COMPLETED|Overall Study||0
6483973|NCT01326728|7401604|FG000|NOT COMPLETED|Overall Study||47
6483974|NCT01326728|7401605|FG001|NOT COMPLETED|Overall Study||9
6483975|NCT01326780|7401614|FG000|STARTED|Overall Study||106
6483976|NCT01326780|7401615|FG001|STARTED|Overall Study||109
6483977|NCT01326780|7401616|FG002|STARTED|Overall Study||109
6483978|NCT01326780|7401617|FG003|STARTED|Overall Study||107
6483979|NCT01326780|7401614|FG000|COMPLETED|Overall Study||93
6483980|NCT01326780|7401615|FG001|COMPLETED|Overall Study||100
6483981|NCT01326780|7401616|FG002|COMPLETED|Overall Study||103
6483982|NCT01326780|7401617|FG003|COMPLETED|Overall Study||94
6483983|NCT01326780|7401614|FG000|NOT COMPLETED|Overall Study||13
6483984|NCT01326780|7401615|FG001|NOT COMPLETED|Overall Study||9
6483985|NCT01326780|7401616|FG002|NOT COMPLETED|Overall Study||6
6483986|NCT01326780|7401617|FG003|NOT COMPLETED|Overall Study||13
6483987|NCT01326910|7401629|FG000|STARTED|Overall Study||45
6483988|NCT01326910|7401630|FG001|STARTED|Overall Study||45
6483989|NCT01326910|7401629|FG000|COMPLETED|Overall Study||41
6483990|NCT01326910|7401630|FG001|COMPLETED|Overall Study||42
6483991|NCT01326910|7401629|FG000|NOT COMPLETED|Overall Study||4
6483992|NCT01326910|7401630|FG001|NOT COMPLETED|Overall Study||3
6483993|NCT01326962|7401636|FG000|STARTED|Overall Study||28
6483994|NCT01326962|7401636|FG000|COMPLETED|Overall Study||21
6483995|NCT01326962|7401636|FG000|NOT COMPLETED|Overall Study||7
6483996|NCT01327053|7401642|FG000|STARTED|Overall Study||79
6483997|NCT01327053|7401643|FG001|STARTED|Overall Study||151
6483998|NCT01327053|7401642|FG000|Untreated|Overall Study||0
6483999|NCT01327053|7401643|FG001|Untreated|Overall Study|one patient randomized to LDE225 (sonidegib) 800 mg did not receive study treatment|1
6484000|NCT01327053|7401642|FG000|Patients Cont. to Next Phase of Trial|Overall Study||52
6484001|NCT01327053|7401643|FG001|Patients Cont. to Next Phase of Trial|Overall Study||89
6484002|NCT01327053|7401642|FG000|Survival Follow-up|Overall Study||33
6484003|NCT01327053|7401643|FG001|Survival Follow-up|Overall Study||49
6484004|NCT01327053|7401642|FG000|Post-treatment Follow-up|Overall Study||19
6484005|NCT01327053|7401643|FG001|Post-treatment Follow-up|Overall Study||40
6484006|NCT01327053|7401642|FG000|COMPLETED|Overall Study||0
6484007|NCT01327053|7401643|FG001|COMPLETED|Overall Study||0
6484008|NCT01327053|7401642|FG000|NOT COMPLETED|Overall Study||79
6484009|NCT01327053|7401643|FG001|NOT COMPLETED|Overall Study||151
6484010|NCT01327157|7401655|FG000|STARTED|01-90||7
6484011|NCT01327157|7401656|FG001|STARTED|01-90||7
6484012|NCT01327157|7401655|FG000|COMPLETED|01-90||7
6484013|NCT01327157|7401656|FG001|COMPLETED|01-90||7
6484014|NCT01327157|7401655|FG000|NOT COMPLETED|01-90||0
6484015|NCT01327157|7401656|FG001|NOT COMPLETED|01-90||0
6554915|NCT01748825|7476988|FG009|COMPLETED|Dose Expansion||15
6554916|NCT01748825|7476979|FG000|NOT COMPLETED|Dose Expansion||0
6484016|NCT01327157|7401655|FG000|STARTED|91-180||7
6484017|NCT01327157|7401656|FG001|STARTED|91-180||0
6484018|NCT01327157|7401655|FG000|COMPLETED|91-180||7
6484019|NCT01327157|7401656|FG001|COMPLETED|91-180||0
6484020|NCT01327157|7401655|FG000|NOT COMPLETED|91-180||0
6484021|NCT01327157|7401656|FG001|NOT COMPLETED|91-180||0
6484022|NCT01327274|7401667|FG000|STARTED|Overall Study||15
6484023|NCT01327274|7401667|FG000|COMPLETED|Overall Study||15
6484024|NCT01327274|7401667|FG000|NOT COMPLETED|Overall Study||0
6484025|NCT01327300|7401672|FG000|STARTED|First Intervention (12 Weeks)||5
6484026|NCT01327300|7401673|FG001|STARTED|First Intervention (12 Weeks)||2
6484027|NCT01327300|7401672|FG000|COMPLETED|First Intervention (12 Weeks)||5
6484028|NCT01327300|7401673|FG001|COMPLETED|First Intervention (12 Weeks)||2
6484029|NCT01327300|7401672|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
6484030|NCT01327300|7401673|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
6484031|NCT01327300|7401672|FG000|STARTED|Washout (3 Weeks)||5
6484032|NCT01327300|7401673|FG001|STARTED|Washout (3 Weeks)||2
6484033|NCT01327300|7401672|FG000|COMPLETED|Washout (3 Weeks)||4
6484034|NCT01327300|7401673|FG001|COMPLETED|Washout (3 Weeks)||2
6484035|NCT01327300|7401672|FG000|NOT COMPLETED|Washout (3 Weeks)||1
6484036|NCT01327300|7401673|FG001|NOT COMPLETED|Washout (3 Weeks)||0
6484037|NCT01327300|7401672|FG000|STARTED|Second Intervention (12 Weeks)||4
6484038|NCT01327300|7401673|FG001|STARTED|Second Intervention (12 Weeks)||2
6484039|NCT01327300|7401672|FG000|COMPLETED|Second Intervention (12 Weeks)||4
6484040|NCT01327300|7401673|FG001|COMPLETED|Second Intervention (12 Weeks)||2
6484041|NCT01327300|7401672|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
6484042|NCT01327300|7401673|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
6484043|NCT01327313|7401693|FG000|STARTED|Overall Study||8
6484044|NCT01327313|7401694|FG001|STARTED|Overall Study||6
6484045|NCT01327313|7401695|FG002|STARTED|Overall Study||6
6484046|NCT01327313|7401696|FG003|STARTED|Overall Study||7
6484047|NCT01327313|7401693|FG000|COMPLETED|Overall Study||8
6484048|NCT01327313|7401694|FG001|COMPLETED|Overall Study||6
6484049|NCT01327313|7401695|FG002|COMPLETED|Overall Study||6
6484050|NCT01327313|7401696|FG003|COMPLETED|Overall Study||7
6484051|NCT01327313|7401693|FG000|NOT COMPLETED|Overall Study||0
6484052|NCT01327313|7401694|FG001|NOT COMPLETED|Overall Study||0
6484053|NCT01327313|7401695|FG002|NOT COMPLETED|Overall Study||0
6484054|NCT01327313|7401696|FG003|NOT COMPLETED|Overall Study||0
6484055|NCT01327339|7401706|FG000|STARTED|Overall Study||755
6484056|NCT01327339|7401706|FG000|COMPLETED|Overall Study||747
6484057|NCT01327339|7401706|FG000|NOT COMPLETED|Overall Study||8
6484058|NCT01327482|7401710|FG000|STARTED|Overall Study||10
6484059|NCT01327482|7401710|FG000|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
6484060|NCT01327482|7401710|FG000|NOT COMPLETED|Overall Study||1
6484061|NCT01327495|7401720|FG000|STARTED|Overall Study||10
6484062|NCT01327495|7401721|FG001|STARTED|Overall Study||11
6484063|NCT01327495|7401722|FG002|STARTED|Overall Study||10
6484064|NCT01327495|7401723|FG003|STARTED|Overall Study||9
6554917|NCT01748825|7476980|FG001|NOT COMPLETED|Dose Expansion||0
6484065|NCT01327495|7401724|FG004|STARTED|Overall Study||11
6484066|NCT01327495|7401725|FG005|STARTED|Overall Study||11
6484067|NCT01327495|7401720|FG000|COMPLETED|Overall Study|1 dropped due to decreased libido & energy, 1 dropped due to too much pain with acyline injections|8
6501567|NCT01429532|7420068|FG002|NOT COMPLETED|Overall Study||0
6484068|NCT01327495|7401721|FG001|COMPLETED|Overall Study|1 subject declined prostate biopsy & no-showed to final visit, 1 subject dropped d/t elevated LFTs.|9
6484069|NCT01327495|7401722|FG002|COMPLETED|Overall Study|1 withdrawn due to injection AE. 1 drop-out (declined prostate biopsy and final visit).|8
6484070|NCT01327495|7401723|FG003|COMPLETED|Overall Study||9
6484071|NCT01327495|7401724|FG004|COMPLETED|Overall Study|1 dropped out pre drug finish, 2 non-compliant subjects dropped|8
6484072|NCT01327495|7401725|FG005|COMPLETED|Overall Study|1 subject withdrawn d/t elevated LFTs, 1 dropped out d/t ski accident|9
6484073|NCT01327495|7401720|FG000|NOT COMPLETED|Overall Study||2
6484074|NCT01327495|7401721|FG001|NOT COMPLETED|Overall Study||2
6484075|NCT01327495|7401722|FG002|NOT COMPLETED|Overall Study||2
6484076|NCT01327495|7401723|FG003|NOT COMPLETED|Overall Study||0
6484077|NCT01327495|7401724|FG004|NOT COMPLETED|Overall Study||3
6484078|NCT01327495|7401725|FG005|NOT COMPLETED|Overall Study||2
6484079|NCT01327508|7401747|FG000|STARTED|Overall Study||30
6484080|NCT01327508|7401748|FG001|STARTED|Overall Study||30
6484081|NCT01327508|7401747|FG000|COMPLETED|Overall Study||30
6484082|NCT01327508|7401748|FG001|COMPLETED|Overall Study||30
6484083|NCT01327508|7401747|FG000|NOT COMPLETED|Overall Study||0
6484084|NCT01327508|7401748|FG001|NOT COMPLETED|Overall Study||0
6484085|NCT01327547|7401756|FG000|STARTED|Overall Study||70
6484086|NCT01327547|7401757|FG001|STARTED|Overall Study||67
6484087|NCT01327547|7401756|FG000|Randomized and Not Treated|Overall Study||0
6484088|NCT01327547|7401757|FG001|Randomized and Not Treated|Overall Study|Randomized but was withdrawn prior to receiving treatment due to poor venous access.|1
6484089|NCT01327547|7401756|FG000|COMPLETED|Overall Study||50
6484090|NCT01327547|7401757|FG001|COMPLETED|Overall Study||45
6484091|NCT01327547|7401756|FG000|NOT COMPLETED|Overall Study||20
6484092|NCT01327547|7401757|FG001|NOT COMPLETED|Overall Study||22
6484093|NCT01327573|7401774|FG000|STARTED|Overall Study||11
6484094|NCT01327573|7401775|FG001|STARTED|Overall Study||5
6484095|NCT01327573|7401774|FG000|Received Treatment/Control as Allocated|Overall Study||10
6484096|NCT01327573|7401775|FG001|Received Treatment/Control as Allocated|Overall Study||5
6484097|NCT01327573|7401774|FG000|COMPLETED|Overall Study||8
6484098|NCT01327573|7401775|FG001|COMPLETED|Overall Study||4
6484099|NCT01327573|7401774|FG000|NOT COMPLETED|Overall Study||3
6484100|NCT01327573|7401775|FG001|NOT COMPLETED|Overall Study||1
6484101|NCT01327599|7401782|FG000|STARTED|Overall Study||60
6484102|NCT01327599|7401782|FG000|COMPLETED|Overall Study||57
6484103|NCT01327599|7401782|FG000|NOT COMPLETED|Overall Study||3
6484104|NCT01327612|7401793|FG000|STARTED|Overall Study||2
6484105|NCT01327612|7401794|FG001|STARTED|Overall Study||1
6484106|NCT01327612|7401795|FG002|STARTED|Overall Study||1
6484107|NCT01327612|7401796|FG003|STARTED|Overall Study||1
6484108|NCT01327612|7401797|FG004|STARTED|Overall Study||2
6484109|NCT01327612|7401798|FG005|STARTED|Overall Study||3
6484110|NCT01327612|7401799|FG006|STARTED|Overall Study||2
6484111|NCT01327612|7401793|FG000|COMPLETED|Overall Study||1
6484112|NCT01327612|7401794|FG001|COMPLETED|Overall Study||0
6484113|NCT01327612|7401795|FG002|COMPLETED|Overall Study||0
6484114|NCT01327612|7401796|FG003|COMPLETED|Overall Study||0
6484115|NCT01327612|7401797|FG004|COMPLETED|Overall Study||0
6484116|NCT01327612|7401798|FG005|COMPLETED|Overall Study||0
6484117|NCT01327612|7401799|FG006|COMPLETED|Overall Study||0
6484118|NCT01327612|7401793|FG000|NOT COMPLETED|Overall Study||1
6484119|NCT01327612|7401794|FG001|NOT COMPLETED|Overall Study||1
6484120|NCT01327612|7401795|FG002|NOT COMPLETED|Overall Study||1
6484121|NCT01327612|7401796|FG003|NOT COMPLETED|Overall Study||1
6484122|NCT01327612|7401797|FG004|NOT COMPLETED|Overall Study||2
6484123|NCT01327612|7401798|FG005|NOT COMPLETED|Overall Study||3
6484124|NCT01327612|7401799|FG006|NOT COMPLETED|Overall Study||2
6484125|NCT01327651|7401825|FG000|STARTED|Self-administered Dosing Period||60
6484126|NCT01327651|7401826|FG001|STARTED|Self-administered Dosing Period||59
6484127|NCT01327651|7401827|FG002|STARTED|Self-administered Dosing Period||60
6484128|NCT01327651|7401828|FG003|STARTED|Self-administered Dosing Period||60
6484129|NCT01327651|7401829|FG004|STARTED|Self-administered Dosing Period||59
6484130|NCT01327651|7401830|FG005|STARTED|Self-administered Dosing Period||59
6484131|NCT01327651|7401831|FG006|STARTED|Self-administered Dosing Period||59
6484132|NCT01327651|7401832|FG007|STARTED|Self-administered Dosing Period||60
6484133|NCT01327651|7401833|FG008|STARTED|Self-administered Dosing Period||60
6484134|NCT01327651|7401825|FG000|Week 10|Self-administered Dosing Period||59
6484135|NCT01327651|7401826|FG001|Week 10|Self-administered Dosing Period||58
6484136|NCT01327651|7401827|FG002|Week 10|Self-administered Dosing Period||60
6484137|NCT01327651|7401828|FG003|Week 10|Self-administered Dosing Period||60
6484138|NCT01327651|7401829|FG004|Week 10|Self-administered Dosing Period||59
6484139|NCT01327651|7401830|FG005|Week 10|Self-administered Dosing Period||59
6484140|NCT01327651|7401831|FG006|Week 10|Self-administered Dosing Period||57
6484141|NCT01327651|7401832|FG007|Week 10|Self-administered Dosing Period||57
6484142|NCT01327651|7401833|FG008|Week 10|Self-administered Dosing Period||56
6484143|NCT01327651|7401825|FG000|Week 14|Self-administered Dosing Period||59
6484144|NCT01327651|7401826|FG001|Week 14|Self-administered Dosing Period||55
6484145|NCT01327651|7401827|FG002|Week 14|Self-administered Dosing Period||57
6484146|NCT01327651|7401828|FG003|Week 14|Self-administered Dosing Period||60
6484147|NCT01327651|7401829|FG004|Week 14|Self-administered Dosing Period||58
6484148|NCT01327651|7401830|FG005|Week 14|Self-administered Dosing Period||59
6484149|NCT01327651|7401831|FG006|Week 14|Self-administered Dosing Period||54
6484150|NCT01327651|7401832|FG007|Week 14|Self-administered Dosing Period||51
6484151|NCT01327651|7401833|FG008|Week 14|Self-administered Dosing Period||54
6484152|NCT01327651|7401825|FG000|Week 18|Self-administered Dosing Period||57
6484153|NCT01327651|7401826|FG001|Week 18|Self-administered Dosing Period||56
6484154|NCT01327651|7401827|FG002|Week 18|Self-administered Dosing Period||56
6484155|NCT01327651|7401828|FG003|Week 18|Self-administered Dosing Period||60
6484156|NCT01327651|7401829|FG004|Week 18|Self-administered Dosing Period||57
6484157|NCT01327651|7401830|FG005|Week 18|Self-administered Dosing Period||59
6484158|NCT01327651|7401831|FG006|Week 18|Self-administered Dosing Period||53
6484159|NCT01327651|7401832|FG007|Week 18|Self-administered Dosing Period||49
6484160|NCT01327651|7401833|FG008|Week 18|Self-administered Dosing Period||53
6484161|NCT01327651|7401825|FG000|Week 22|Self-administered Dosing Period||59
6484162|NCT01327651|7401826|FG001|Week 22|Self-administered Dosing Period||56
6484163|NCT01327651|7401827|FG002|Week 22|Self-administered Dosing Period||55
6484164|NCT01327651|7401828|FG003|Week 22|Self-administered Dosing Period||58
6484165|NCT01327651|7401829|FG004|Week 22|Self-administered Dosing Period||56
6484166|NCT01327651|7401830|FG005|Week 22|Self-administered Dosing Period||59
6484167|NCT01327651|7401831|FG006|Week 22|Self-administered Dosing Period||50
6484168|NCT01327651|7401832|FG007|Week 22|Self-administered Dosing Period||50
6484169|NCT01327651|7401833|FG008|Week 22|Self-administered Dosing Period||51
6484170|NCT01327651|7401825|FG000|Week 26|Self-administered Dosing Period||58
6484171|NCT01327651|7401826|FG001|Week 26|Self-administered Dosing Period||56
6484172|NCT01327651|7401827|FG002|Week 26|Self-administered Dosing Period||53
6484173|NCT01327651|7401828|FG003|Week 26|Self-administered Dosing Period||57
6484174|NCT01327651|7401829|FG004|Week 26|Self-administered Dosing Period||56
6484175|NCT01327651|7401830|FG005|Week 26|Self-administered Dosing Period||58
6554918|NCT01748825|7476981|FG002|NOT COMPLETED|Dose Expansion||0
6554919|NCT01748825|7476982|FG003|NOT COMPLETED|Dose Expansion||0
6554920|NCT01748825|7476983|FG004|NOT COMPLETED|Dose Expansion||0
6554921|NCT01748825|7476984|FG005|NOT COMPLETED|Dose Expansion||0
6554922|NCT01748825|7476985|FG006|NOT COMPLETED|Dose Expansion||0
6484176|NCT01327651|7401831|FG006|Week 26|Self-administered Dosing Period||50
6484177|NCT01327651|7401832|FG007|Week 26|Self-administered Dosing Period||51
6484178|NCT01327651|7401833|FG008|Week 26|Self-administered Dosing Period||49
6484179|NCT01327651|7401825|FG000|COMPLETED|Self-administered Dosing Period||56
6484180|NCT01327651|7401826|FG001|COMPLETED|Self-administered Dosing Period||56
6484181|NCT01327651|7401827|FG002|COMPLETED|Self-administered Dosing Period||56
6484182|NCT01327651|7401828|FG003|COMPLETED|Self-administered Dosing Period||57
6484183|NCT01327651|7401829|FG004|COMPLETED|Self-administered Dosing Period||56
6484184|NCT01327651|7401830|FG005|COMPLETED|Self-administered Dosing Period||59
6484185|NCT01327651|7401831|FG006|COMPLETED|Self-administered Dosing Period||49
6484186|NCT01327651|7401832|FG007|COMPLETED|Self-administered Dosing Period||50
6484187|NCT01327651|7401833|FG008|COMPLETED|Self-administered Dosing Period||49
6484188|NCT01327651|7401825|FG000|NOT COMPLETED|Self-administered Dosing Period||4
6484189|NCT01327651|7401826|FG001|NOT COMPLETED|Self-administered Dosing Period||3
6484190|NCT01327651|7401827|FG002|NOT COMPLETED|Self-administered Dosing Period||4
6484191|NCT01327651|7401828|FG003|NOT COMPLETED|Self-administered Dosing Period||3
6484192|NCT01327651|7401829|FG004|NOT COMPLETED|Self-administered Dosing Period||3
6484193|NCT01327651|7401830|FG005|NOT COMPLETED|Self-administered Dosing Period||0
6484194|NCT01327651|7401831|FG006|NOT COMPLETED|Self-administered Dosing Period||10
6484195|NCT01327651|7401832|FG007|NOT COMPLETED|Self-administered Dosing Period||10
6484196|NCT01327651|7401833|FG008|NOT COMPLETED|Self-administered Dosing Period||11
6484197|NCT01327651|7401825|FG000|STARTED|Post Study Follow-up||56
6484198|NCT01327651|7401826|FG001|STARTED|Post Study Follow-up||56
6484199|NCT01327651|7401827|FG002|STARTED|Post Study Follow-up||56
6484200|NCT01327651|7401828|FG003|STARTED|Post Study Follow-up||57
6484201|NCT01327651|7401829|FG004|STARTED|Post Study Follow-up||56
6484202|NCT01327651|7401830|FG005|STARTED|Post Study Follow-up||59
6484203|NCT01327651|7401831|FG006|STARTED|Post Study Follow-up||49
6484204|NCT01327651|7401832|FG007|STARTED|Post Study Follow-up||50
6484205|NCT01327651|7401833|FG008|STARTED|Post Study Follow-up||49
6484206|NCT01327651|7401825|FG000|COMPLETED|Post Study Follow-up||56
6484207|NCT01327651|7401826|FG001|COMPLETED|Post Study Follow-up||55
6484208|NCT01327651|7401827|FG002|COMPLETED|Post Study Follow-up||55
6484209|NCT01327651|7401828|FG003|COMPLETED|Post Study Follow-up||57
6484210|NCT01327651|7401829|FG004|COMPLETED|Post Study Follow-up||56
6484211|NCT01327651|7401830|FG005|COMPLETED|Post Study Follow-up||59
6484212|NCT01327651|7401831|FG006|COMPLETED|Post Study Follow-up||45
6484213|NCT01327651|7401832|FG007|COMPLETED|Post Study Follow-up||49
6484214|NCT01327651|7401833|FG008|COMPLETED|Post Study Follow-up||47
6484215|NCT01327651|7401825|FG000|NOT COMPLETED|Post Study Follow-up||0
6484216|NCT01327651|7401826|FG001|NOT COMPLETED|Post Study Follow-up||1
6484217|NCT01327651|7401827|FG002|NOT COMPLETED|Post Study Follow-up||1
6484218|NCT01327651|7401828|FG003|NOT COMPLETED|Post Study Follow-up||0
6484219|NCT01327651|7401829|FG004|NOT COMPLETED|Post Study Follow-up||0
6484220|NCT01327651|7401830|FG005|NOT COMPLETED|Post Study Follow-up||0
6554923|NCT01748825|7476986|FG007|NOT COMPLETED|Dose Expansion||0
6484221|NCT01327651|7401831|FG006|NOT COMPLETED|Post Study Follow-up||4
6484222|NCT01327651|7401832|FG007|NOT COMPLETED|Post Study Follow-up||1
6484223|NCT01327651|7401833|FG008|NOT COMPLETED|Post Study Follow-up||2
6484224|NCT01327677|7401874|FG000|STARTED|Overall Study||68
6484225|NCT01327677|7401875|FG001|STARTED|Overall Study||69
6484226|NCT01327677|7401874|FG000|COMPLETED|Overall Study||48
6554924|NCT01748825|7476987|FG008|NOT COMPLETED|Dose Expansion||2
6484227|NCT01327677|7401875|FG001|COMPLETED|Overall Study||56
6484228|NCT01327677|7401874|FG000|NOT COMPLETED|Overall Study||20
6484229|NCT01327677|7401875|FG001|NOT COMPLETED|Overall Study||13
6484230|NCT01327703|7401883|FG000|STARTED|First Treatment Period||42
6484231|NCT01327703|7401884|FG001|STARTED|First Treatment Period||45
6484232|NCT01327703|7401883|FG000|COMPLETED|First Treatment Period||42
6484233|NCT01327703|7401884|FG001|COMPLETED|First Treatment Period||45
6484234|NCT01327703|7401883|FG000|NOT COMPLETED|First Treatment Period||0
6484235|NCT01327703|7401884|FG001|NOT COMPLETED|First Treatment Period||0
6484236|NCT01327703|7401883|FG000|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
6484237|NCT01327703|7401884|FG001|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
6484238|NCT01327703|7401883|FG000|COMPLETED|Second Treatment Period||39
6484239|NCT01327703|7401884|FG001|COMPLETED|Second Treatment Period||42
6484240|NCT01327703|7401883|FG000|NOT COMPLETED|Second Treatment Period||1
6484241|NCT01327703|7401884|FG001|NOT COMPLETED|Second Treatment Period||2
6484242|NCT01327846|7401897|FG000|STARTED|Core Phase||2263
6484243|NCT01327846|7401898|FG001|STARTED|Core Phase||2284
6484244|NCT01327846|7401899|FG002|STARTED|Core Phase||2170
6484245|NCT01327846|7401900|FG003|STARTED|Core Phase||3344
6484246|NCT01327846|7401897|FG000|COMPLETED|Core Phase||2235
6484247|NCT01327846|7401898|FG001|COMPLETED|Core Phase||2252
6484248|NCT01327846|7401899|FG002|COMPLETED|Core Phase||2144
6484249|NCT01327846|7401900|FG003|COMPLETED|Core Phase||3311
6484250|NCT01327846|7401897|FG000|NOT COMPLETED|Core Phase||28
6484251|NCT01327846|7401898|FG001|NOT COMPLETED|Core Phase||32
6484252|NCT01327846|7401899|FG002|NOT COMPLETED|Core Phase||26
6484253|NCT01327846|7401900|FG003|NOT COMPLETED|Core Phase||33
6484254|NCT01327846|7401897|FG000|STARTED|Extension Phase||1267
6484255|NCT01327846|7401898|FG001|STARTED|Extension Phase||1287
6484256|NCT01327846|7401899|FG002|STARTED|Extension Phase||1279
6484257|NCT01327846|7401900|FG003|STARTED|Extension Phase||1944
6484258|NCT01327846|7401897|FG000|Stopped/Discontinued Study at Washout|Extension Phase||127
6484259|NCT01327846|7401898|FG001|Stopped/Discontinued Study at Washout|Extension Phase||97
6484260|NCT01327846|7401899|FG002|Stopped/Discontinued Study at Washout|Extension Phase||137
6484261|NCT01327846|7401900|FG003|Stopped/Discontinued Study at Washout|Extension Phase||178
6484262|NCT01327846|7401897|FG000|Completed Treatment Period|Extension Phase||41
6484263|NCT01327846|7401898|FG001|Completed Treatment Period|Extension Phase||45
6484264|NCT01327846|7401899|FG002|Completed Treatment Period|Extension Phase||49
6484265|NCT01327846|7401900|FG003|Completed Treatment Period|Extension Phase||60
6484266|NCT01327846|7401897|FG000|Details Missing|Extension Phase||0
6484267|NCT01327846|7401898|FG001|Details Missing|Extension Phase||1
6484268|NCT01327846|7401899|FG002|Details Missing|Extension Phase||1
6484269|NCT01327846|7401900|FG003|Details Missing|Extension Phase||0
6484270|NCT01327846|7401897|FG000|COMPLETED|Extension Phase||168
6484271|NCT01327846|7401898|FG001|COMPLETED|Extension Phase||143
6484272|NCT01327846|7401899|FG002|COMPLETED|Extension Phase||187
6484273|NCT01327846|7401900|FG003|COMPLETED|Extension Phase||238
6484274|NCT01327846|7401897|FG000|NOT COMPLETED|Extension Phase||1099
6484275|NCT01327846|7401898|FG001|NOT COMPLETED|Extension Phase||1144
6484276|NCT01327846|7401899|FG002|NOT COMPLETED|Extension Phase||1092
6484277|NCT01327846|7401900|FG003|NOT COMPLETED|Extension Phase||1706
6484278|NCT01327885|7401913|FG000|STARTED|Overall Study||228
6484279|NCT01327885|7401914|FG001|STARTED|Overall Study||224
6484280|NCT01327885|7401913|FG000|COMPLETED|Overall Study||0
6484281|NCT01327885|7401914|FG001|COMPLETED|Overall Study||0
6484282|NCT01327885|7401913|FG000|NOT COMPLETED|Overall Study||228
6484283|NCT01327885|7401914|FG001|NOT COMPLETED|Overall Study||224
6484284|NCT01327963|7401921|FG000|STARTED|Overall Study||110
6484285|NCT01327963|7401921|FG000|COMPLETED|Overall Study|110 participants signed informed consent to be included in the study.|110
6484286|NCT01327963|7401921|FG000|NOT COMPLETED|Overall Study||0
6484287|NCT01327976|7401929|FG000|STARTED|Overall Study||162
6484288|NCT01327976|7401930|FG001|STARTED|Overall Study||77
6484289|NCT01327976|7401929|FG000|COMPLETED|Overall Study||154
6484290|NCT01327976|7401930|FG001|COMPLETED|Overall Study||70
6484291|NCT01327976|7401929|FG000|NOT COMPLETED|Overall Study||8
6484292|NCT01327976|7401930|FG001|NOT COMPLETED|Overall Study||7
6484293|NCT01327989|7401938|FG000|STARTED|Overall Study||202
6484294|NCT01327989|7401938|FG000|COMPLETED|Overall Study||188
6484295|NCT01327989|7401938|FG000|NOT COMPLETED|Overall Study||14
6484296|NCT01328002|7401942|FG000|STARTED|Open-Label Period||116
6484297|NCT01328002|7401943|FG001|STARTED|Open-Label Period||0
6484298|NCT01328002|7401942|FG000|COMPLETED|Open-Label Period||20
6484299|NCT01328002|7401943|FG001|COMPLETED|Open-Label Period||0
6484300|NCT01328002|7401942|FG000|NOT COMPLETED|Open-Label Period||96
6484301|NCT01328002|7401943|FG001|NOT COMPLETED|Open-Label Period||0
6484302|NCT01328002|7401942|FG000|STARTED|Double-Blind Period||14
6484303|NCT01328002|7401943|FG001|STARTED|Double-Blind Period||6
6484304|NCT01328002|7401942|FG000|COMPLETED|Double-Blind Period||12
6484305|NCT01328002|7401943|FG001|COMPLETED|Double-Blind Period||6
6484306|NCT01328002|7401942|FG000|NOT COMPLETED|Double-Blind Period||2
6484307|NCT01328002|7401943|FG001|NOT COMPLETED|Double-Blind Period||0
6484308|NCT01328041|7401950|FG000|STARTED|Overall Study||183
6484309|NCT01328041|7401950|FG000|COMPLETED|Overall Study||126
6484310|NCT01328041|7401950|FG000|NOT COMPLETED|Overall Study||57
6484311|NCT01328054|7401954|FG000|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
6501568|NCT01429584|7420078|FG000|STARTED|Overall Study||15
6484312|NCT01328054|7401955|FG001|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
6484313|NCT01328054|7401954|FG000|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
6484314|NCT01328054|7401955|FG001|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
6484315|NCT01328054|7401954|FG000|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
6484316|NCT01328054|7401955|FG001|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
6484317|NCT01328054|7401954|FG000|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
6484318|NCT01328054|7401955|FG001|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
6484319|NCT01328054|7401954|FG000|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
6484320|NCT01328054|7401955|FG001|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
6484321|NCT01328054|7401954|FG000|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
6484322|NCT01328054|7401955|FG001|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
6484323|NCT01328080|7401967|FG000|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
6484324|NCT01328080|7401967|FG000|COMPLETED|Overall Study||6
6484325|NCT01328080|7401967|FG000|NOT COMPLETED|Overall Study||5
6484326|NCT01328158|7401971|FG000|STARTED|Overall Study||220
6484327|NCT01328158|7401971|FG000|COMPLETED|Overall Study||220
6484328|NCT01328158|7401971|FG000|NOT COMPLETED|Overall Study||0
6484329|NCT01328184|7401978|FG000|STARTED|Overall Study||18
6484330|NCT01328184|7401978|FG000|COMPLETED|Overall Study||18
6484331|NCT01328184|7401978|FG000|NOT COMPLETED|Overall Study||0
6484332|NCT01328249|7401986|FG000|STARTED|Overall Study||55
6484333|NCT01328249|7401987|FG001|STARTED|Overall Study||26
6484334|NCT01328249|7401986|FG000|COMPLETED|Overall Study||48
6484335|NCT01328249|7401987|FG001|COMPLETED|Overall Study||23
6484336|NCT01328249|7401986|FG000|NOT COMPLETED|Overall Study||7
6484337|NCT01328249|7401987|FG001|NOT COMPLETED|Overall Study||3
6484338|NCT01328366|7401995|FG000|STARTED|Overall Study||153
6484339|NCT01328366|7401995|FG000|COMPLETED|Overall Study||143
6484340|NCT01328366|7401995|FG000|NOT COMPLETED|Overall Study||10
6484341|NCT01328379|7402002|FG000|STARTED|Overall Study||143
6484342|NCT01328379|7402003|FG001|STARTED|Overall Study||144
6484343|NCT01328379|7402004|FG002|STARTED|Overall Study||143
6484344|NCT01328379|7402002|FG000|COMPLETED|Overall Study||142
6484345|NCT01328379|7402003|FG001|COMPLETED|Overall Study||144
6484346|NCT01328379|7402004|FG002|COMPLETED|Overall Study||143
6484347|NCT01328379|7402002|FG000|NOT COMPLETED|Overall Study||1
6484348|NCT01328379|7402003|FG001|NOT COMPLETED|Overall Study||0
6484349|NCT01328379|7402004|FG002|NOT COMPLETED|Overall Study||0
6484350|NCT01328405|7402014|FG000|STARTED|Overall Study||52
6484351|NCT01328405|7402015|FG001|STARTED|Overall Study||48
6484352|NCT01328405|7402014|FG000|COMPLETED|Overall Study||52
6484353|NCT01328405|7402015|FG001|COMPLETED|Overall Study||48
6484354|NCT01328405|7402014|FG000|NOT COMPLETED|Overall Study||0
6484355|NCT01328405|7402015|FG001|NOT COMPLETED|Overall Study||0
6484356|NCT01328431|7402023|FG000|STARTED|Baseline||390
6484357|NCT01328431|7402024|FG001|STARTED|Baseline||390
6484358|NCT01328431|7402023|FG000|COMPLETED|Baseline||390
6484359|NCT01328431|7402024|FG001|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
6484360|NCT01328431|7402023|FG000|NOT COMPLETED|Baseline||0
6484361|NCT01328431|7402024|FG001|NOT COMPLETED|Baseline||2
6484362|NCT01328431|7402023|FG000|STARTED|1 Month (1M)||390
6484363|NCT01328431|7402024|FG001|STARTED|1 Month (1M)||388
6484364|NCT01328431|7402023|FG000|COMPLETED|1 Month (1M)||335
6484365|NCT01328431|7402024|FG001|COMPLETED|1 Month (1M)||330
6484366|NCT01328431|7402023|FG000|NOT COMPLETED|1 Month (1M)||55
6484367|NCT01328431|7402024|FG001|NOT COMPLETED|1 Month (1M)||58
6484368|NCT01328431|7402023|FG000|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
6554925|NCT01748825|7476988|FG009|NOT COMPLETED|Dose Expansion||5
6554926|NCT01748916|7477017|FG000|STARTED|Overall Study||2
6554927|NCT01748916|7477018|FG001|STARTED|Overall Study||3
6484369|NCT01328431|7402024|FG001|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
6484370|NCT01328431|7402023|FG000|COMPLETED|3 Month (3M)||313
6484371|NCT01328431|7402024|FG001|COMPLETED|3 Month (3M)||316
6484372|NCT01328431|7402023|FG000|NOT COMPLETED|3 Month (3M)||77
6484373|NCT01328431|7402024|FG001|NOT COMPLETED|3 Month (3M)||72
6484374|NCT01328431|7402023|FG000|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
6484375|NCT01328431|7402024|FG001|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
6484376|NCT01328431|7402023|FG000|COMPLETED|12 Month (12M)||304
6484377|NCT01328431|7402024|FG001|COMPLETED|12 Month (12M)||289
6484378|NCT01328431|7402023|FG000|NOT COMPLETED|12 Month (12M)||84
6484379|NCT01328431|7402024|FG001|NOT COMPLETED|12 Month (12M)||97
6484380|NCT01328444|7402030|FG000|STARTED|Treatment Period 1 (12 Weeks)||94
6554928|NCT01748916|7477019|FG002|STARTED|Overall Study||2
6484381|NCT01328444|7402031|FG001|STARTED|Treatment Period 1 (12 Weeks)||26
6484382|NCT01328444|7402032|FG002|STARTED|Treatment Period 1 (12 Weeks)||28
6484383|NCT01328444|7402033|FG003|STARTED|Treatment Period 1 (12 Weeks)||41
6484384|NCT01328444|7402034|FG004|STARTED|Treatment Period 1 (12 Weeks)||81
6484385|NCT01328444|7402035|FG005|STARTED|Treatment Period 1 (12 Weeks)||78
6484386|NCT01328444|7402030|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||83
6484387|NCT01328444|7402031|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||21
6484388|NCT01328444|7402032|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||25
6484389|NCT01328444|7402033|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||33
6554929|NCT01748916|7477020|FG003|STARTED|Overall Study||3
6484390|NCT01328444|7402034|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||67
6484391|NCT01328444|7402035|FG005|COMPLETED|Treatment Period 1 (12 Weeks)||72
6484392|NCT01328444|7402030|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
6484393|NCT01328444|7402031|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
6484394|NCT01328444|7402032|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
6484395|NCT01328444|7402033|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
6484396|NCT01328444|7402034|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
6484397|NCT01328444|7402035|FG005|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
6484398|NCT01328444|7402030|FG000|STARTED|Washout Period (14 Days)||83
6484399|NCT01328444|7402031|FG001|STARTED|Washout Period (14 Days)||21
6484400|NCT01328444|7402032|FG002|STARTED|Washout Period (14 Days)||25
6484401|NCT01328444|7402033|FG003|STARTED|Washout Period (14 Days)||33
6484402|NCT01328444|7402034|FG004|STARTED|Washout Period (14 Days)||67
6484403|NCT01328444|7402035|FG005|STARTED|Washout Period (14 Days)||72
6484404|NCT01328444|7402030|FG000|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
6484405|NCT01328444|7402031|FG001|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
6484406|NCT01328444|7402032|FG002|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
6484407|NCT01328444|7402033|FG003|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
6484408|NCT01328444|7402034|FG004|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
6484409|NCT01328444|7402035|FG005|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
6484410|NCT01328444|7402030|FG000|NOT COMPLETED|Washout Period (14 Days)||1
6484411|NCT01328444|7402031|FG001|NOT COMPLETED|Washout Period (14 Days)||1
6484412|NCT01328444|7402032|FG002|NOT COMPLETED|Washout Period (14 Days)||0
6484413|NCT01328444|7402033|FG003|NOT COMPLETED|Washout Period (14 Days)||1
6484414|NCT01328444|7402034|FG004|NOT COMPLETED|Washout Period (14 Days)||1
6484415|NCT01328444|7402035|FG005|NOT COMPLETED|Washout Period (14 Days)||4
6484416|NCT01328444|7402030|FG000|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
6484417|NCT01328444|7402031|FG001|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
6484418|NCT01328444|7402032|FG002|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
6484419|NCT01328444|7402033|FG003|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
6484420|NCT01328444|7402034|FG004|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
6484421|NCT01328444|7402035|FG005|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
6484422|NCT01328444|7402030|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||65
6484423|NCT01328444|7402031|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||22
6484424|NCT01328444|7402032|FG002|COMPLETED|Treatment Period 2 (12 Weeks)||19
6484425|NCT01328444|7402033|FG003|COMPLETED|Treatment Period 2 (12 Weeks)||30
6484426|NCT01328444|7402034|FG004|COMPLETED|Treatment Period 2 (12 Weeks)||63
6484427|NCT01328444|7402035|FG005|COMPLETED|Treatment Period 2 (12 Weeks)||59
6484428|NCT01328444|7402030|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
6484429|NCT01328444|7402031|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
6484430|NCT01328444|7402032|FG002|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
6484431|NCT01328444|7402033|FG003|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
6484432|NCT01328444|7402034|FG004|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
6484433|NCT01328444|7402035|FG005|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
6484434|NCT01328496|7402051|FG000|STARTED|Overall Study||10
6484435|NCT01328496|7402052|FG001|STARTED|Overall Study||4
6484436|NCT01328496|7402051|FG000|COMPLETED|Overall Study||9
6484437|NCT01328496|7402052|FG001|COMPLETED|Overall Study||4
6484438|NCT01328496|7402051|FG000|NOT COMPLETED|Overall Study||1
6484439|NCT01328496|7402052|FG001|NOT COMPLETED|Overall Study||0
6484440|NCT01328535|7402061|FG000|STARTED|Overall Study||25
6484441|NCT01328535|7402061|FG000|COMPLETED|Overall Study||24
6484442|NCT01328535|7402061|FG000|NOT COMPLETED|Overall Study||1
6484443|NCT01328548|7402069|FG000|STARTED|Overall Study||191
6484444|NCT01328548|7402070|FG001|STARTED|Overall Study||50
6484445|NCT01328548|7402069|FG000|COMPLETED|Overall Study||187
6484446|NCT01328548|7402070|FG001|COMPLETED|Overall Study||50
6484447|NCT01328548|7402069|FG000|NOT COMPLETED|Overall Study||4
6484448|NCT01328548|7402070|FG001|NOT COMPLETED|Overall Study||0
6484449|NCT01328574|7402076|FG000|STARTED|Overall Study||13
6484450|NCT01328574|7402076|FG000|COMPLETED|Overall Study||12
6484451|NCT01328574|7402076|FG000|NOT COMPLETED|Overall Study||1
6484452|NCT01328717|7402085|FG000|STARTED|Overall Study||78
6484453|NCT01328717|7402085|FG000|COMPLETED|Overall Study||77
6484454|NCT01328717|7402085|FG000|NOT COMPLETED|Overall Study||1
6484455|NCT01328743|7402091|FG000|STARTED|Overall Study||91
6484456|NCT01328743|7402092|FG001|STARTED|Overall Study||89
6484457|NCT01328743|7402091|FG000|COMPLETED|Overall Study||82
6484458|NCT01328743|7402092|FG001|COMPLETED|Overall Study||79
6484459|NCT01328743|7402091|FG000|NOT COMPLETED|Overall Study||9
6484460|NCT01328743|7402092|FG001|NOT COMPLETED|Overall Study||10
6484461|NCT01328756|7402098|FG000|STARTED|Overall Study||314
6484462|NCT01328756|7402098|FG000|COMPLETED|Overall Study||191
6484463|NCT01328756|7402098|FG000|NOT COMPLETED|Overall Study||123
6484464|NCT01328769|7402104|FG000|STARTED|Overall Study||25
6484465|NCT01328769|7402105|FG001|STARTED|Overall Study||24
6484466|NCT01328769|7402104|FG000|COMPLETED|Overall Study||25
6484467|NCT01328769|7402105|FG001|COMPLETED|Overall Study||23
6484468|NCT01328769|7402104|FG000|NOT COMPLETED|Overall Study||0
6484469|NCT01328769|7402105|FG001|NOT COMPLETED|Overall Study||1
6484470|NCT01328782|7402114|FG000|STARTED|Overall Study||43
6484471|NCT01328782|7402115|FG001|STARTED|Overall Study||42
6484472|NCT01328782|7402116|FG002|STARTED|Overall Study||39
6484473|NCT01328782|7402114|FG000|COMPLETED|Overall Study||43
6484474|NCT01328782|7402115|FG001|COMPLETED|Overall Study||42
6484475|NCT01328782|7402116|FG002|COMPLETED|Overall Study||39
6484476|NCT01328782|7402114|FG000|NOT COMPLETED|Overall Study||0
6484477|NCT01328782|7402115|FG001|NOT COMPLETED|Overall Study||0
6484478|NCT01328782|7402116|FG002|NOT COMPLETED|Overall Study||0
6484479|NCT01328873|7402124|FG000|STARTED|Overall Study||49
6484480|NCT01328873|7402124|FG000|COMPLETED|Overall Study||49
6484481|NCT01328873|7402124|FG000|NOT COMPLETED|Overall Study||0
6484482|NCT01328951|7402132|FG000|STARTED|Overall Study||321
6484483|NCT01328951|7402133|FG001|STARTED|Overall Study||322
6484484|NCT01328951|7402132|FG000|COMPLETED|Overall Study||0
6484485|NCT01328951|7402133|FG001|COMPLETED|Overall Study||0
6484486|NCT01328951|7402132|FG000|NOT COMPLETED|Overall Study||321
6484487|NCT01328951|7402133|FG001|NOT COMPLETED|Overall Study||322
6484488|NCT01328964|7402146|FG000|STARTED|Overall Study||2212
6484489|NCT01328964|7402147|FG001|STARTED|Overall Study||3270
6484490|NCT01328964|7402148|FG002|STARTED|Overall Study||4424
6484491|NCT01328964|7402146|FG000|COMPLETED|Overall Study||2212
6484492|NCT01328964|7402147|FG001|COMPLETED|Overall Study||3270
6484493|NCT01328964|7402148|FG002|COMPLETED|Overall Study||4424
6484494|NCT01328964|7402146|FG000|NOT COMPLETED|Overall Study||0
6484495|NCT01328964|7402147|FG001|NOT COMPLETED|Overall Study||0
6484496|NCT01328964|7402148|FG002|NOT COMPLETED|Overall Study||0
6484497|NCT01329029|7402158|FG000|STARTED|Overall Study||973
6484498|NCT01329029|7402159|FG001|STARTED|Overall Study||972
6484499|NCT01329029|7402158|FG000|Full Analysis Set (FAS)|Overall Study||969
6484500|NCT01329029|7402159|FG001|Full Analysis Set (FAS)|Overall Study||966
6484501|NCT01329029|7402158|FG000|Safety Population|Overall Study||968
6484502|NCT01329029|7402159|FG001|Safety Population|Overall Study||967
6484503|NCT01329029|7402158|FG000|COMPLETED|Overall Study||704
6484504|NCT01329029|7402159|FG001|COMPLETED|Overall Study||780
6484505|NCT01329029|7402158|FG000|NOT COMPLETED|Overall Study||269
6484506|NCT01329029|7402159|FG001|NOT COMPLETED|Overall Study||192
6484507|NCT01329185|7402167|FG000|STARTED|Overall Study||10
6484508|NCT01329185|7402168|FG001|STARTED|Overall Study||7
6484509|NCT01329185|7402167|FG000|CMV Disease|Overall Study||1
6484510|NCT01329185|7402168|FG001|CMV Disease|Overall Study||0
6484511|NCT01329185|7402167|FG000|PTLD|Overall Study||1
6484512|NCT01329185|7402168|FG001|PTLD|Overall Study||0
6484513|NCT01329185|7402167|FG000|COMPLETED|Overall Study||10
6484514|NCT01329185|7402168|FG001|COMPLETED|Overall Study||7
6484515|NCT01329185|7402167|FG000|NOT COMPLETED|Overall Study||0
6484516|NCT01329185|7402168|FG001|NOT COMPLETED|Overall Study||0
6484517|NCT01329198|7402176|FG000|STARTED|Overall Study||3
6484518|NCT01329198|7402177|FG001|STARTED|Overall Study||2
6484519|NCT01329198|7402176|FG000|COMPLETED|Overall Study||3
6484520|NCT01329198|7402177|FG001|COMPLETED|Overall Study||2
6484521|NCT01329198|7402176|FG000|NOT COMPLETED|Overall Study||0
6484522|NCT01329198|7402177|FG001|NOT COMPLETED|Overall Study||0
6484523|NCT01329263|7402190|FG000|STARTED|Overall Study||15
6484524|NCT01329263|7402191|FG001|STARTED|Overall Study||45
6484525|NCT01329263|7402190|FG000|Completed Period 1 Own Menthol|Overall Study||15
6484526|NCT01329263|7402191|FG001|Completed Period 1 Own Menthol|Overall Study||45
6484527|NCT01329263|7402190|FG000|Completed Period 2 Own or CCrush Menthol|Overall Study||10
6484528|NCT01329263|7402191|FG001|Completed Period 2 Own or CCrush Menthol|Overall Study||30
6484529|NCT01329263|7402190|FG000|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
6484530|NCT01329263|7402191|FG001|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
6484531|NCT01329263|7402190|FG000|COMPLETED|Overall Study||10
6484532|NCT01329263|7402191|FG001|COMPLETED|Overall Study||22
6484533|NCT01329263|7402190|FG000|NOT COMPLETED|Overall Study||5
6484534|NCT01329263|7402191|FG001|NOT COMPLETED|Overall Study||23
6484535|NCT01329328|7402202|FG000|STARTED|Overall Study||15
6484536|NCT01329328|7402203|FG001|STARTED|Overall Study||17
6484537|NCT01329328|7402204|FG002|STARTED|Overall Study||18
6484538|NCT01329328|7402202|FG000|COMPLETED|Overall Study||13
6484539|NCT01329328|7402203|FG001|COMPLETED|Overall Study||13
6484540|NCT01329328|7402204|FG002|COMPLETED|Overall Study||15
6484541|NCT01329328|7402202|FG000|NOT COMPLETED|Overall Study||2
6484542|NCT01329328|7402203|FG001|NOT COMPLETED|Overall Study||4
6484543|NCT01329328|7402204|FG002|NOT COMPLETED|Overall Study||3
6484544|NCT01329380|7402212|FG000|STARTED|Overall Study||403
6484545|NCT01329380|7402212|FG000|Safety Population|Overall Study||396
6484546|NCT01329380|7402212|FG000|COMPLETED|Overall Study||374
6484547|NCT01329380|7402212|FG000|NOT COMPLETED|Overall Study||29
6484548|NCT01329419|7402216|FG000|STARTED|Overall Study||4393
6484549|NCT01329419|7402216|FG000|COMPLETED|Overall Study||4158
6484550|NCT01329419|7402216|FG000|NOT COMPLETED|Overall Study||235
6484551|NCT01329562|7402223|FG000|STARTED|Overall Study||20
6484552|NCT01329562|7402224|FG001|STARTED|Overall Study||21
6484553|NCT01329562|7402223|FG000|COMPLETED|Overall Study||11
6484554|NCT01329562|7402224|FG001|COMPLETED|Overall Study||14
6484555|NCT01329562|7402223|FG000|NOT COMPLETED|Overall Study||9
6484556|NCT01329562|7402224|FG001|NOT COMPLETED|Overall Study||7
6484557|NCT01329679|7402232|FG000|STARTED|Overall Study||13
6484558|NCT01329679|7402233|FG001|STARTED|Overall Study||13
6484559|NCT01329679|7402232|FG000|COMPLETED|Overall Study||13
6484560|NCT01329679|7402233|FG001|COMPLETED|Overall Study||13
6484561|NCT01329679|7402232|FG000|NOT COMPLETED|Overall Study||0
6484562|NCT01329679|7402233|FG001|NOT COMPLETED|Overall Study||0
6484563|NCT01329848|7402241|FG000|STARTED|Overall Study||83
6484564|NCT01329848|7402241|FG000|COMPLETED|Overall Study||54
6484565|NCT01329848|7402241|FG000|NOT COMPLETED|Overall Study||29
6484566|NCT01329900|7402245|FG000|STARTED|Overall Study||50
6484567|NCT01329900|7402245|FG000|COMPLETED|Overall Study||49
6484568|NCT01329900|7402245|FG000|NOT COMPLETED|Overall Study||1
6484569|NCT01329939|7402253|FG000|STARTED|Overall Study||7
6484570|NCT01329939|7402254|FG001|STARTED|Overall Study||5
6484571|NCT01329939|7402255|FG002|STARTED|Overall Study||5
6484572|NCT01329939|7402256|FG003|STARTED|Overall Study||9
6484573|NCT01329939|7402253|FG000|COMPLETED|Overall Study||4
6484574|NCT01329939|7402254|FG001|COMPLETED|Overall Study||4
6484575|NCT01329939|7402255|FG002|COMPLETED|Overall Study||4
6484576|NCT01329939|7402256|FG003|COMPLETED|Overall Study||4
6484577|NCT01329939|7402253|FG000|NOT COMPLETED|Overall Study||3
6484578|NCT01329939|7402254|FG001|NOT COMPLETED|Overall Study||1
6484579|NCT01329939|7402255|FG002|NOT COMPLETED|Overall Study||1
6484580|NCT01329939|7402256|FG003|NOT COMPLETED|Overall Study||5
6484581|NCT01329978|7402269|FG000|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
6484582|NCT01329978|7402270|FG001|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
6484583|NCT01329978|7402271|FG002|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
6484584|NCT01329978|7402272|FG003|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
6484585|NCT01329978|7402273|FG004|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
6484586|NCT01329978|7402269|FG000|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
6484587|NCT01329978|7402270|FG001|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
6484588|NCT01329978|7402271|FG002|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
6484589|NCT01329978|7402272|FG003|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
6484590|NCT01329978|7402273|FG004|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
6484591|NCT01329978|7402269|FG000|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
6484592|NCT01329978|7402270|FG001|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
6484593|NCT01329978|7402271|FG002|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
6484594|NCT01329978|7402272|FG003|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
6484595|NCT01329978|7402273|FG004|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
6484596|NCT01329978|7402269|FG000|STARTED|Rerandomization Treatment Period||0
6484597|NCT01329978|7402270|FG001|STARTED|Rerandomization Treatment Period||0
6484598|NCT01329978|7402271|FG002|STARTED|Rerandomization Treatment Period||0
6484599|NCT01329978|7402272|FG003|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
6484600|NCT01329978|7402273|FG004|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
6484601|NCT01329978|7402269|FG000|COMPLETED|Rerandomization Treatment Period||0
6484602|NCT01329978|7402270|FG001|COMPLETED|Rerandomization Treatment Period||0
6554930|NCT01748916|7477021|FG004|STARTED|Overall Study||3
6554931|NCT01748916|7477022|FG005|STARTED|Overall Study||3
6554932|NCT01748916|7477017|FG000|COMPLETED|Overall Study||2
6554933|NCT01748916|7477018|FG001|COMPLETED|Overall Study||3
6554934|NCT01748916|7477019|FG002|COMPLETED|Overall Study||2
6484603|NCT01329978|7402271|FG002|COMPLETED|Rerandomization Treatment Period||0
6484604|NCT01329978|7402272|FG003|COMPLETED|Rerandomization Treatment Period||70
6484605|NCT01329978|7402273|FG004|COMPLETED|Rerandomization Treatment Period||71
6484606|NCT01329978|7402269|FG000|NOT COMPLETED|Rerandomization Treatment Period||0
6484607|NCT01329978|7402270|FG001|NOT COMPLETED|Rerandomization Treatment Period||0
6484608|NCT01329978|7402271|FG002|NOT COMPLETED|Rerandomization Treatment Period||0
6484609|NCT01329978|7402272|FG003|NOT COMPLETED|Rerandomization Treatment Period||5
6484610|NCT01329978|7402273|FG004|NOT COMPLETED|Rerandomization Treatment Period||4
6484611|NCT01330017|7402290|FG000|STARTED|Overall Study||109
6484612|NCT01330017|7402291|FG001|STARTED|Overall Study||108
6484613|NCT01330017|7402292|FG002|STARTED|Overall Study||107
6484614|NCT01330017|7402293|FG003|STARTED|Overall Study||112
6484615|NCT01330017|7402294|FG004|STARTED|Overall Study||103
6484616|NCT01330017|7402290|FG000|COMPLETED|Overall Study||104
6484617|NCT01330017|7402291|FG001|COMPLETED|Overall Study||104
6484618|NCT01330017|7402292|FG002|COMPLETED|Overall Study||99
6484619|NCT01330017|7402293|FG003|COMPLETED|Overall Study||100
6484620|NCT01330017|7402294|FG004|COMPLETED|Overall Study||100
6484621|NCT01330017|7402290|FG000|NOT COMPLETED|Overall Study||5
6484622|NCT01330017|7402291|FG001|NOT COMPLETED|Overall Study||4
6484623|NCT01330017|7402292|FG002|NOT COMPLETED|Overall Study||8
6484624|NCT01330017|7402293|FG003|NOT COMPLETED|Overall Study||12
6484625|NCT01330017|7402294|FG004|NOT COMPLETED|Overall Study||3
6484626|NCT01330030|7402308|FG000|STARTED|Overall Study||121
6484627|NCT01330030|7402309|FG001|STARTED|Overall Study||122
6554935|NCT01748916|7477020|FG003|COMPLETED|Overall Study||3
6554936|NCT01748916|7477021|FG004|COMPLETED|Overall Study||3
6554937|NCT01748916|7477022|FG005|COMPLETED|Overall Study||3
6484628|NCT01330030|7402308|FG000|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
6484629|NCT01330030|7402309|FG001|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
6484630|NCT01330030|7402308|FG000|NOT COMPLETED|Overall Study||16
6484631|NCT01330030|7402309|FG001|NOT COMPLETED|Overall Study||17
6484632|NCT01330043|7402317|FG000|STARTED|Overall Study||111
6484633|NCT01330043|7402318|FG001|STARTED|Overall Study||112
6484634|NCT01330043|7402317|FG000|COMPLETED|Overall Study||111
6484635|NCT01330043|7402318|FG001|COMPLETED|Overall Study||108
6484636|NCT01330043|7402317|FG000|NOT COMPLETED|Overall Study||0
6484637|NCT01330043|7402318|FG001|NOT COMPLETED|Overall Study||4
6484638|NCT01330108|7402324|FG000|STARTED|Overall Study||32
6484639|NCT01330108|7402324|FG000|COMPLETED|Overall Study||28
6484640|NCT01330108|7402324|FG000|NOT COMPLETED|Overall Study||4
6484641|NCT01330134|7402330|FG000|STARTED|Overall Study||244
6484642|NCT01330134|7402331|FG001|STARTED|Overall Study||237
6484643|NCT01330134|7402330|FG000|COMPLETED|Overall Study||244
6484644|NCT01330134|7402331|FG001|COMPLETED|Overall Study||237
6484645|NCT01330134|7402330|FG000|NOT COMPLETED|Overall Study||0
6484646|NCT01330134|7402331|FG001|NOT COMPLETED|Overall Study||0
6484647|NCT01330290|7402337|FG000|STARTED|Overall Study||148
6484648|NCT01330290|7402337|FG000|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
6484649|NCT01330290|7402337|FG000|NOT COMPLETED|Overall Study||0
6484650|NCT01330303|7402341|FG000|STARTED|Period 1||20
6484651|NCT01330303|7402342|FG001|STARTED|Period 1||20
6484652|NCT01330303|7402341|FG000|COMPLETED|Period 1||19
6484653|NCT01330303|7402342|FG001|COMPLETED|Period 1||18
6484654|NCT01330303|7402341|FG000|NOT COMPLETED|Period 1||1
6484655|NCT01330303|7402342|FG001|NOT COMPLETED|Period 1||2
6484656|NCT01330303|7402341|FG000|STARTED|7-Day Washout Period||19
6484657|NCT01330303|7402342|FG001|STARTED|7-Day Washout Period||18
6484658|NCT01330303|7402341|FG000|COMPLETED|7-Day Washout Period||19
6484659|NCT01330303|7402342|FG001|COMPLETED|7-Day Washout Period||18
6484660|NCT01330303|7402341|FG000|NOT COMPLETED|7-Day Washout Period||0
6484661|NCT01330303|7402342|FG001|NOT COMPLETED|7-Day Washout Period||0
6484662|NCT01330303|7402341|FG000|STARTED|Period 2||19
6484663|NCT01330303|7402342|FG001|STARTED|Period 2||18
6484664|NCT01330303|7402341|FG000|COMPLETED|Period 2||19
6484665|NCT01330303|7402342|FG001|COMPLETED|Period 2||18
6484666|NCT01330303|7402341|FG000|NOT COMPLETED|Period 2||0
6484667|NCT01330303|7402342|FG001|NOT COMPLETED|Period 2||0
6484668|NCT01330316|7402351|FG000|STARTED|Overall Study||43
6484669|NCT01330316|7402352|FG001|STARTED|Overall Study||75
6484670|NCT01330316|7402351|FG000|COMPLETED|Overall Study||41
6484671|NCT01330316|7402352|FG001|COMPLETED|Overall Study||60
6484672|NCT01330316|7402351|FG000|NOT COMPLETED|Overall Study||2
6484673|NCT01330316|7402352|FG001|NOT COMPLETED|Overall Study||15
6484674|NCT01330355|7402360|FG000|STARTED|Overall Study||16
6484675|NCT01330355|7402361|FG001|STARTED|Overall Study||17
6484676|NCT01330355|7402360|FG000|COMPLETED|Overall Study||16
6484677|NCT01330355|7402361|FG001|COMPLETED|Overall Study||17
6484678|NCT01330355|7402360|FG000|NOT COMPLETED|Overall Study||0
6484679|NCT01330355|7402361|FG001|NOT COMPLETED|Overall Study||0
6484680|NCT01330381|7402369|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||107
6484681|NCT01330381|7402370|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||108
6484682|NCT01330381|7402371|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||0
6484683|NCT01330381|7402369|FG000|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
6484684|NCT01330381|7402370|FG001|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
6484685|NCT01330381|7402371|FG002|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
6484686|NCT01330381|7402369|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
6484687|NCT01330381|7402370|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
6484688|NCT01330381|7402371|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
6484689|NCT01330381|7402369|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
6484690|NCT01330381|7402370|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
6484691|NCT01330381|7402371|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
6484692|NCT01330381|7402369|FG000|STARTED|Open-label Treatment Period (16 Weeks)||98
6484693|NCT01330381|7402370|FG001|STARTED|Open-label Treatment Period (16 Weeks)||0
6484694|NCT01330381|7402371|FG002|STARTED|Open-label Treatment Period (16 Weeks)||99
6484695|NCT01330381|7402369|FG000|COMPLETED|Open-label Treatment Period (16 Weeks)||88
6484696|NCT01330381|7402370|FG001|COMPLETED|Open-label Treatment Period (16 Weeks)||0
6484697|NCT01330381|7402371|FG002|COMPLETED|Open-label Treatment Period (16 Weeks)||81
6484698|NCT01330381|7402369|FG000|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
6484699|NCT01330381|7402370|FG001|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
6484700|NCT01330381|7402371|FG002|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
6484701|NCT01330394|7402382|FG000|STARTED|Overall Study||17
6484702|NCT01330394|7402383|FG001|STARTED|Overall Study||16
6484703|NCT01330394|7402382|FG000|COMPLETED|Overall Study||17
6484704|NCT01330394|7402383|FG001|COMPLETED|Overall Study||16
6484705|NCT01330394|7402382|FG000|NOT COMPLETED|Overall Study||0
6484706|NCT01330394|7402383|FG001|NOT COMPLETED|Overall Study||0
6484707|NCT01330420|7402389|FG000|STARTED|Overall Study||28
6484708|NCT01330420|7402389|FG000|COMPLETED|Overall Study||24
6484709|NCT01330420|7402389|FG000|NOT COMPLETED|Overall Study||4
6484710|NCT01330433|7402395|FG000|STARTED|Overall Study||16
6484711|NCT01330433|7402396|FG001|STARTED|Overall Study||19
6484712|NCT01330433|7402395|FG000|COMPLETED|Overall Study||14
6484713|NCT01330433|7402396|FG001|COMPLETED|Overall Study||16
6484714|NCT01330433|7402395|FG000|NOT COMPLETED|Overall Study||2
6554938|NCT01748916|7477017|FG000|NOT COMPLETED|Overall Study||0
6554939|NCT01748916|7477018|FG001|NOT COMPLETED|Overall Study||0
6554940|NCT01748916|7477019|FG002|NOT COMPLETED|Overall Study||0
6554941|NCT01748916|7477020|FG003|NOT COMPLETED|Overall Study||0
6554942|NCT01748916|7477021|FG004|NOT COMPLETED|Overall Study||0
6554943|NCT01748916|7477022|FG005|NOT COMPLETED|Overall Study||0
6554944|NCT01748942|7477032|FG000|STARTED|Overall Study||39
6554945|NCT01748942|7477033|FG001|STARTED|Overall Study||37
6554946|NCT01748942|7477032|FG000|COMPLETED|Overall Study||35
6554947|NCT01748942|7477033|FG001|COMPLETED|Overall Study||33
6484715|NCT01330433|7402396|FG001|NOT COMPLETED|Overall Study||3
6484716|NCT01330459|7402404|FG000|STARTED|Overall Study||61
6484717|NCT01330459|7402405|FG001|STARTED|Overall Study||60
6484718|NCT01330459|7402404|FG000|COMPLETED|Overall Study||61
6484719|NCT01330459|7402405|FG001|COMPLETED|Overall Study||58
6484720|NCT01330459|7402404|FG000|NOT COMPLETED|Overall Study||0
6484721|NCT01330459|7402405|FG001|NOT COMPLETED|Overall Study||2
6484722|NCT01330628|7402415|FG000|STARTED|Overall Study||170
6484723|NCT01330628|7402416|FG001|STARTED|Overall Study||82
6484724|NCT01330628|7402415|FG000|30 Day Follow-up|Overall Study||165
6484725|NCT01330628|7402416|FG001|30 Day Follow-up|Overall Study||73
6484726|NCT01330628|7402415|FG000|6 Month Follow-up|Overall Study||135
6484727|NCT01330628|7402416|FG001|6 Month Follow-up|Overall Study||60
6484728|NCT01330628|7402415|FG000|COMPLETED|Overall Study||100
6484729|NCT01330628|7402416|FG001|COMPLETED|Overall Study||42
6484730|NCT01330628|7402415|FG000|NOT COMPLETED|Overall Study||70
6484731|NCT01330628|7402416|FG001|NOT COMPLETED|Overall Study||40
6484732|NCT01330914|7402422|FG000|STARTED|Overall Study||55
6484733|NCT01330914|7402422|FG000|COMPLETED|Overall Study||48
6484734|NCT01330914|7402422|FG000|NOT COMPLETED|Overall Study||7
6484735|NCT01330953|7402431|FG000|STARTED|Overall Study||8
6484736|NCT01330953|7402432|FG001|STARTED|Overall Study||6
6484737|NCT01330953|7402433|FG002|STARTED|Overall Study||6
6484738|NCT01330953|7402434|FG003|STARTED|Overall Study||6
6484739|NCT01330953|7402435|FG004|STARTED|Overall Study||6
6484740|NCT01330953|7402431|FG000|COMPLETED|Overall Study||8
6484741|NCT01330953|7402432|FG001|COMPLETED|Overall Study||6
6484742|NCT01330953|7402433|FG002|COMPLETED|Overall Study||6
6484743|NCT01330953|7402434|FG003|COMPLETED|Overall Study||6
6484744|NCT01330953|7402435|FG004|COMPLETED|Overall Study||6
6484745|NCT01330953|7402431|FG000|NOT COMPLETED|Overall Study||0
6484746|NCT01330953|7402432|FG001|NOT COMPLETED|Overall Study||0
6484747|NCT01330953|7402433|FG002|NOT COMPLETED|Overall Study||0
6484748|NCT01330953|7402434|FG003|NOT COMPLETED|Overall Study||0
6484749|NCT01330953|7402435|FG004|NOT COMPLETED|Overall Study||0
6501569|NCT01429584|7420079|FG001|STARTED|Overall Study||15
6501570|NCT01429584|7420078|FG000|COMPLETED|Overall Study||14
6501571|NCT01429584|7420079|FG001|COMPLETED|Overall Study||14
6501572|NCT01429584|7420078|FG000|NOT COMPLETED|Overall Study||1
6501573|NCT01429584|7420079|FG001|NOT COMPLETED|Overall Study||1
6501574|NCT01429623|7420087|FG000|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
6501575|NCT01429623|7420088|FG001|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
6501576|NCT01429623|7420087|FG000|Converted to Alzheimer's|Overall Study|14 of 99|14
6501577|NCT01429623|7420088|FG001|Converted to Alzheimer's|Overall Study|21 of 103|21
6501578|NCT01429623|7420087|FG000|COMPLETED|Overall Study||51
6501579|NCT01429623|7420088|FG001|COMPLETED|Overall Study||48
6501580|NCT01429623|7420087|FG000|NOT COMPLETED|Overall Study||51
6501581|NCT01429623|7420088|FG001|NOT COMPLETED|Overall Study||59
6501582|NCT01429792|7420094|FG000|STARTED|Overall Study||1013
6501583|NCT01429792|7420094|FG000|Genotype 1|Overall Study||687
6501584|NCT01429792|7420094|FG000|Genotype 2 & 3|Overall Study||305
6501585|NCT01429792|7420094|FG000|Genotype 4|Overall Study||5
6501586|NCT01429792|7420094|FG000|COMPLETED|Overall Study||607
6501587|NCT01429792|7420094|FG000|NOT COMPLETED|Overall Study||406
6501588|NCT01429987|7420102|FG000|STARTED|Overall Study||238
6501589|NCT01429987|7420103|FG001|STARTED|Overall Study||238
6501590|NCT01429987|7420104|FG002|STARTED|Overall Study||238
6501591|NCT01429987|7420105|FG003|STARTED|Overall Study||237
6501592|NCT01429987|7420102|FG000|COMPLETED|Overall Study||189
6501593|NCT01429987|7420103|FG001|COMPLETED|Overall Study||176
6501594|NCT01429987|7420104|FG002|COMPLETED|Overall Study||202
6501595|NCT01429987|7420105|FG003|COMPLETED|Overall Study||171
6501596|NCT01429987|7420102|FG000|NOT COMPLETED|Overall Study||49
6501597|NCT01429987|7420103|FG001|NOT COMPLETED|Overall Study||62
6501598|NCT01429987|7420104|FG002|NOT COMPLETED|Overall Study||36
6501599|NCT01429987|7420105|FG003|NOT COMPLETED|Overall Study||66
6501600|NCT01430091|7420115|FG000|STARTED|Overall Study||18
6501601|NCT01430091|7420115|FG000|COMPLETED|Overall Study||18
6501602|NCT01430091|7420115|FG000|NOT COMPLETED|Overall Study||0
6501603|NCT01430104|7420129|FG000|STARTED|14-Day Lead-In Period||30
6501604|NCT01430104|7420129|FG000|COMPLETED|14-Day Lead-In Period||30
6554948|NCT01748942|7477032|FG000|NOT COMPLETED|Overall Study||4
6554949|NCT01748942|7477033|FG001|NOT COMPLETED|Overall Study||4
6501605|NCT01430104|7420129|FG000|NOT COMPLETED|14-Day Lead-In Period||0
6501606|NCT01430104|7420129|FG000|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
6501607|NCT01430104|7420129|FG000|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
6501608|NCT01430104|7420129|FG000|COMPLETED|28-Day Teriparatide Treatment Period||28
6554950|NCT01748955|7477041|FG000|STARTED|Overall Study||6
6484750|NCT01330966|7402452|FG000|STARTED|Overall Study||47
6484751|NCT01330966|7402452|FG000|COMPLETED|Overall Study|Tumor responses evaluable in 42 of 47 pts; 5 pts discontinued prior to first tumor assessment.|42
6484752|NCT01330966|7402452|FG000|NOT COMPLETED|Overall Study||5
6748590|NCT03416985|7676707|FG000|NOT COMPLETED|Overall Study||2
6748591|NCT03416985|7676708|FG001|NOT COMPLETED|Overall Study||0
6748592|NCT03416985|7676709|FG002|NOT COMPLETED|Overall Study||6
6748593|NCT03417024|7676720|FG000|STARTED|Overall Study||13
6748594|NCT03417024|7676720|FG000|COMPLETED|Overall Study||0
6748595|NCT03417024|7676720|FG000|NOT COMPLETED|Overall Study||13
6748596|NCT03417141|7676724|FG000|STARTED|Overall Study||12
6748597|NCT03417141|7676724|FG000|COMPLETED|Overall Study||8
6748598|NCT03417141|7676724|FG000|NOT COMPLETED|Overall Study||4
6748599|NCT03417219|7676730|FG000|STARTED|Overall Study||8
6748600|NCT03417219|7676731|FG001|STARTED|Overall Study||8
6748601|NCT03417219|7676730|FG000|COMPLETED|Overall Study||8
6748602|NCT03417219|7676731|FG001|COMPLETED|Overall Study||5
6748603|NCT03417219|7676730|FG000|NOT COMPLETED|Overall Study||0
6748604|NCT03417219|7676731|FG001|NOT COMPLETED|Overall Study||3
6748605|NCT03417466|7676737|FG000|STARTED|Overall Study||66
6748606|NCT03417466|7676737|FG000|COMPLETED|Overall Study||66
6748607|NCT03417466|7676737|FG000|NOT COMPLETED|Overall Study||0
6748608|NCT03417505|7676741|FG000|STARTED|First Lens Type (30 Days)||9
6748609|NCT03417505|7676742|FG001|STARTED|First Lens Type (30 Days)||12
6748610|NCT03417505|7676741|FG000|COMPLETED|First Lens Type (30 Days)||8
6748611|NCT03417505|7676742|FG001|COMPLETED|First Lens Type (30 Days)||11
6748612|NCT03417505|7676741|FG000|NOT COMPLETED|First Lens Type (30 Days)||1
6748613|NCT03417505|7676742|FG001|NOT COMPLETED|First Lens Type (30 Days)||1
6748614|NCT03417505|7676741|FG000|STARTED|Washout Period (7 Days)||8
6748615|NCT03417505|7676742|FG001|STARTED|Washout Period (7 Days)||11
6748616|NCT03417505|7676741|FG000|COMPLETED|Washout Period (7 Days)||8
6748617|NCT03417505|7676742|FG001|COMPLETED|Washout Period (7 Days)||11
6748618|NCT03417505|7676741|FG000|NOT COMPLETED|Washout Period (7 Days)||0
6484753|NCT01331005|7402458|FG000|STARTED|Overall Study||64
6484754|NCT01331005|7402459|FG001|STARTED|Overall Study||61
6484755|NCT01331005|7402458|FG000|COMPLETED|Overall Study||60
6484756|NCT01331005|7402459|FG001|COMPLETED|Overall Study||57
6484757|NCT01331005|7402458|FG000|NOT COMPLETED|Overall Study||4
6484758|NCT01331005|7402459|FG001|NOT COMPLETED|Overall Study||4
6484759|NCT01331083|7402467|FG000|STARTED|Overall Study||43
6484760|NCT01331083|7402468|FG001|STARTED|Overall Study||25
6484761|NCT01331083|7402467|FG000|COMPLETED|Overall Study||43
6484762|NCT01331083|7402468|FG001|COMPLETED|Overall Study||25
6484763|NCT01331083|7402467|FG000|NOT COMPLETED|Overall Study||0
6484764|NCT01331083|7402468|FG001|NOT COMPLETED|Overall Study||0
6484765|NCT01331109|7402474|FG000|STARTED|Overall Study||57
6484766|NCT01331109|7402474|FG000|COMPLETED|Overall Study||0
6484767|NCT01331109|7402474|FG000|NOT COMPLETED|Overall Study||57
6484768|NCT01331161|7402480|FG000|STARTED|Overall Study||44
6484769|NCT01331161|7402481|FG001|STARTED|Overall Study||33
6484770|NCT01331161|7402480|FG000|COMPLETED|Overall Study||43
6484771|NCT01331161|7402481|FG001|COMPLETED|Overall Study||31
6484772|NCT01331161|7402480|FG000|NOT COMPLETED|Overall Study||1
6484773|NCT01331161|7402481|FG001|NOT COMPLETED|Overall Study||2
6484774|NCT01331213|7402491|FG000|STARTED|Overall Study||8
6484775|NCT01331213|7402492|FG001|STARTED|Overall Study||10
6484776|NCT01331213|7402491|FG000|COMPLETED|Overall Study||8
6484777|NCT01331213|7402492|FG001|COMPLETED|Overall Study||10
6484778|NCT01331213|7402491|FG000|NOT COMPLETED|Overall Study||0
6484779|NCT01331213|7402492|FG001|NOT COMPLETED|Overall Study||0
6484780|NCT01331239|7402500|FG000|STARTED|Part I: Core Study||12
6484781|NCT01331239|7402501|FG001|STARTED|Part I: Core Study||0
6484782|NCT01331239|7402502|FG002|STARTED|Part I: Core Study||0
6484783|NCT01331239|7402500|FG000|COMPLETED|Part I: Core Study||12
6484784|NCT01331239|7402501|FG001|COMPLETED|Part I: Core Study||0
6484785|NCT01331239|7402502|FG002|COMPLETED|Part I: Core Study||0
6484786|NCT01331239|7402500|FG000|NOT COMPLETED|Part I: Core Study||0
6484787|NCT01331239|7402501|FG001|NOT COMPLETED|Part I: Core Study||0
6484788|NCT01331239|7402502|FG002|NOT COMPLETED|Part I: Core Study||0
6484789|NCT01331239|7402500|FG000|STARTED|Part II: Core Study||0
6484790|NCT01331239|7402501|FG001|STARTED|Part II: Core Study||15
6484791|NCT01331239|7402502|FG002|STARTED|Part II: Core Study||4
6484792|NCT01331239|7402500|FG000|COMPLETED|Part II: Core Study||0
6484793|NCT01331239|7402501|FG001|COMPLETED|Part II: Core Study||7
6484794|NCT01331239|7402502|FG002|COMPLETED|Part II: Core Study||3
6484795|NCT01331239|7402500|FG000|NOT COMPLETED|Part II: Core Study||0
6484796|NCT01331239|7402501|FG001|NOT COMPLETED|Part II: Core Study||8
6484797|NCT01331239|7402502|FG002|NOT COMPLETED|Part II: Core Study||1
6484798|NCT01331291|7402520|FG000|STARTED|Overall Study||2
6484799|NCT01331291|7402521|FG001|STARTED|Overall Study||9
6484800|NCT01331291|7402520|FG000|COMPLETED|Overall Study||0
6484801|NCT01331291|7402521|FG001|COMPLETED|Overall Study||0
6484802|NCT01331291|7402520|FG000|NOT COMPLETED|Overall Study||2
6748619|NCT03417505|7676742|FG001|NOT COMPLETED|Washout Period (7 Days)||0
6748620|NCT03417505|7676741|FG000|STARTED|Second Lens Type (30 Days)||8
6748621|NCT03417505|7676742|FG001|STARTED|Second Lens Type (30 Days)||11
6748622|NCT03417505|7676741|FG000|COMPLETED|Second Lens Type (30 Days)||8
6748623|NCT03417505|7676742|FG001|COMPLETED|Second Lens Type (30 Days)||11
6748624|NCT03417505|7676741|FG000|NOT COMPLETED|Second Lens Type (30 Days)||0
6484803|NCT01331291|7402521|FG001|NOT COMPLETED|Overall Study||9
6484804|NCT01331304|7402528|FG000|STARTED|Overall Study||240
6484805|NCT01331304|7402529|FG001|STARTED|Overall Study||242
6484806|NCT01331304|7402528|FG000|COMPLETED|Overall Study||182
6484807|NCT01331304|7402529|FG001|COMPLETED|Overall Study||182
6484808|NCT01331304|7402528|FG000|NOT COMPLETED|Overall Study||58
6484809|NCT01331304|7402529|FG001|NOT COMPLETED|Overall Study||60
6484810|NCT01331408|7402536|FG000|STARTED|Overall Study||61
6484811|NCT01331408|7402536|FG000|COMPLETED|Overall Study||50
6484812|NCT01331408|7402536|FG000|NOT COMPLETED|Overall Study||11
6484813|NCT01331681|7402543|FG000|STARTED|Overall Study|randomized|136
6484814|NCT01331681|7402544|FG001|STARTED|Overall Study|randomized|135
6484815|NCT01331681|7402545|FG002|STARTED|Overall Study|randomized|135
6484816|NCT01331681|7402543|FG000|Participants Received Treatment|Overall Study|safety population|136
6484817|NCT01331681|7402544|FG001|Participants Received Treatment|Overall Study|safety population|135
6484818|NCT01331681|7402545|FG002|Participants Received Treatment|Overall Study|safety population|133
6484819|NCT01331681|7402543|FG000|Completed Week 52|Overall Study||125
6484820|NCT01331681|7402544|FG001|Completed Week 52|Overall Study||121
6484821|NCT01331681|7402545|FG002|Completed Week 52|Overall Study||115
6484822|NCT01331681|7402543|FG000|Completed Week 100|Overall Study||115
6484823|NCT01331681|7402544|FG001|Completed Week 100|Overall Study||110
6484824|NCT01331681|7402545|FG002|Completed Week 100|Overall Study||105
6484825|NCT01331681|7402543|FG000|Completed Week 148|Overall Study||101
6484826|NCT01331681|7402544|FG001|Completed Week 148|Overall Study||101
6554951|NCT01748955|7477042|FG001|STARTED|Overall Study||9
6554952|NCT01748955|7477041|FG000|COMPLETED|Overall Study||3
6484827|NCT01331681|7402545|FG002|Completed Week 148|Overall Study||100
6484828|NCT01331681|7402543|FG000|COMPLETED|Overall Study|Completed Week 148|101
6484829|NCT01331681|7402544|FG001|COMPLETED|Overall Study|Completed Week 148|101
6484830|NCT01331681|7402545|FG002|COMPLETED|Overall Study|Completed Week 148|100
6484831|NCT01331681|7402543|FG000|NOT COMPLETED|Overall Study||35
6484832|NCT01331681|7402544|FG001|NOT COMPLETED|Overall Study||34
6484833|NCT01331681|7402545|FG002|NOT COMPLETED|Overall Study||35
6484834|NCT01331694|7402559|FG000|STARTED|Overall Study||16684
6484835|NCT01331694|7402560|FG001|STARTED|Overall Study||14449
6484836|NCT01331694|7402561|FG002|STARTED|Overall Study||12659
6484837|NCT01331694|7402562|FG003|STARTED|Overall Study||12595
6484838|NCT01331694|7402563|FG004|STARTED|Overall Study||10617
6484839|NCT01331694|7402564|FG005|STARTED|Overall Study||9126
6484840|NCT01331694|7402559|FG000|COMPLETED|Overall Study||16684
6484841|NCT01331694|7402560|FG001|COMPLETED|Overall Study||14449
6484842|NCT01331694|7402561|FG002|COMPLETED|Overall Study||12659
6484843|NCT01331694|7402562|FG003|COMPLETED|Overall Study||12595
6484844|NCT01331694|7402563|FG004|COMPLETED|Overall Study||10617
6484845|NCT01331694|7402564|FG005|COMPLETED|Overall Study||9126
6484846|NCT01331694|7402559|FG000|NOT COMPLETED|Overall Study||0
6484847|NCT01331694|7402560|FG001|NOT COMPLETED|Overall Study||0
6484848|NCT01331694|7402561|FG002|NOT COMPLETED|Overall Study||0
6484849|NCT01331694|7402562|FG003|NOT COMPLETED|Overall Study||0
6484850|NCT01331694|7402563|FG004|NOT COMPLETED|Overall Study||0
6484851|NCT01331694|7402564|FG005|NOT COMPLETED|Overall Study||0
6484852|NCT01331824|7402578|FG000|STARTED|Overall Study||22
6484853|NCT01331824|7402578|FG000|COMPLETED|Overall Study||9
6484854|NCT01331824|7402578|FG000|NOT COMPLETED|Overall Study||13
6484855|NCT01331837|7402584|FG000|STARTED|Overall Study||1538
6484856|NCT01331837|7402585|FG001|STARTED|Overall Study||1542
6484857|NCT01331837|7402584|FG000|COMPLETED|Overall Study||1482
6484858|NCT01331837|7402585|FG001|COMPLETED|Overall Study||1475
6484859|NCT01331837|7402584|FG000|NOT COMPLETED|Overall Study||56
6484860|NCT01331837|7402585|FG001|NOT COMPLETED|Overall Study||67
6484861|NCT01332019|7402593|FG000|STARTED|Overall Study||530
6484862|NCT01332019|7402594|FG001|STARTED|Overall Study||547
6484863|NCT01332019|7402593|FG000|COMPLETED|Overall Study||417
6484864|NCT01332019|7402594|FG001|COMPLETED|Overall Study||425
6484865|NCT01332019|7402593|FG000|NOT COMPLETED|Overall Study||113
6484866|NCT01332019|7402594|FG001|NOT COMPLETED|Overall Study||122
6484867|NCT01332071|7402600|FG000|STARTED|Period 1||13
6484868|NCT01332071|7402601|FG001|STARTED|Period 1||13
6484869|NCT01332071|7402600|FG000|COMPLETED|Period 1||13
6484870|NCT01332071|7402601|FG001|COMPLETED|Period 1||13
6484871|NCT01332071|7402600|FG000|NOT COMPLETED|Period 1||0
6484872|NCT01332071|7402601|FG001|NOT COMPLETED|Period 1||0
6484873|NCT01332071|7402600|FG000|STARTED|7-Day Washout Period||13
6484874|NCT01332071|7402601|FG001|STARTED|7-Day Washout Period||13
6484875|NCT01332071|7402600|FG000|COMPLETED|7-Day Washout Period||13
6484876|NCT01332071|7402601|FG001|COMPLETED|7-Day Washout Period||13
6484877|NCT01332071|7402600|FG000|NOT COMPLETED|7-Day Washout Period||0
6484878|NCT01332071|7402601|FG001|NOT COMPLETED|7-Day Washout Period||0
6484879|NCT01332071|7402600|FG000|STARTED|Period 2||13
6484880|NCT01332071|7402601|FG001|STARTED|Period 2||13
6484881|NCT01332071|7402600|FG000|COMPLETED|Period 2||13
6484882|NCT01332071|7402601|FG001|COMPLETED|Period 2||13
6484883|NCT01332071|7402600|FG000|NOT COMPLETED|Period 2||0
6484884|NCT01332071|7402601|FG001|NOT COMPLETED|Period 2||0
6484885|NCT01332123|7402609|FG000|STARTED|Overall Study||10
6484886|NCT01332123|7402609|FG000|COMPLETED|Overall Study||10
6484887|NCT01332123|7402609|FG000|NOT COMPLETED|Overall Study||0
6484888|NCT01332149|7402616|FG000|STARTED|Overall Study|Assigned to study treatment.|314
6484889|NCT01332149|7402617|FG001|STARTED|Overall Study|Assigned to study treatment.|309
6484890|NCT01332149|7402616|FG000|Treated|Overall Study||313
6484891|NCT01332149|7402617|FG001|Treated|Overall Study||307
6748625|NCT03417505|7676742|FG001|NOT COMPLETED|Second Lens Type (30 Days)||0
6748626|NCT03417557|7676748|FG000|STARTED|1st Intervention (3 Hours)||8
6748627|NCT03417557|7676749|FG001|STARTED|1st Intervention (3 Hours)||9
6748628|NCT03417557|7676748|FG000|COMPLETED|1st Intervention (3 Hours)||8
6748629|NCT03417557|7676749|FG001|COMPLETED|1st Intervention (3 Hours)||9
6748630|NCT03417557|7676748|FG000|NOT COMPLETED|1st Intervention (3 Hours)||0
6748631|NCT03417557|7676749|FG001|NOT COMPLETED|1st Intervention (3 Hours)||0
6748632|NCT03417557|7676748|FG000|STARTED|2nd Intervention (3 Hours)||9
6748633|NCT03417557|7676749|FG001|STARTED|2nd Intervention (3 Hours)||8
6748634|NCT03417557|7676748|FG000|COMPLETED|2nd Intervention (3 Hours)||9
6748635|NCT03417557|7676749|FG001|COMPLETED|2nd Intervention (3 Hours)||8
6748636|NCT03417557|7676748|FG000|NOT COMPLETED|2nd Intervention (3 Hours)||0
6748637|NCT03417557|7676749|FG001|NOT COMPLETED|2nd Intervention (3 Hours)||0
6484892|NCT01332149|7402616|FG000|COMPLETED|Overall Study||284
6484893|NCT01332149|7402617|FG001|COMPLETED|Overall Study||271
6484894|NCT01332149|7402616|FG000|NOT COMPLETED|Overall Study||30
6484895|NCT01332149|7402617|FG001|NOT COMPLETED|Overall Study||38
6484896|NCT01332188|7402627|FG000|STARTED|Overall Study||25
6484897|NCT01332188|7402628|FG001|STARTED|Overall Study||26
6484898|NCT01332188|7402629|FG002|STARTED|Overall Study||25
6484899|NCT01332188|7402630|FG003|STARTED|Overall Study||25
6484900|NCT01332188|7402627|FG000|COMPLETED|Overall Study||23
6484901|NCT01332188|7402628|FG001|COMPLETED|Overall Study||25
6484902|NCT01332188|7402629|FG002|COMPLETED|Overall Study||21
6484903|NCT01332188|7402630|FG003|COMPLETED|Overall Study||25
6484904|NCT01332188|7402627|FG000|NOT COMPLETED|Overall Study||2
6484905|NCT01332188|7402628|FG001|NOT COMPLETED|Overall Study||1
6484906|NCT01332188|7402629|FG002|NOT COMPLETED|Overall Study||4
6484907|NCT01332188|7402630|FG003|NOT COMPLETED|Overall Study||0
6484908|NCT01332227|7402642|FG000|STARTED|Overall Study|Participants who received treatment|72
6484909|NCT01332227|7402643|FG001|STARTED|Overall Study|Participants who received treatment|37
6484910|NCT01332227|7402642|FG000|COMPLETED|Overall Study||56
6484911|NCT01332227|7402643|FG001|COMPLETED|Overall Study||32
6484912|NCT01332227|7402642|FG000|NOT COMPLETED|Overall Study||16
6484913|NCT01332227|7402643|FG001|NOT COMPLETED|Overall Study||5
6484914|NCT01332253|7402651|FG000|STARTED|Overall Study||82
6484915|NCT01332253|7402652|FG001|STARTED|Overall Study||79
6484916|NCT01332253|7402651|FG000|COMPLETED|Overall Study||82
6484917|NCT01332253|7402652|FG001|COMPLETED|Overall Study||79
6484918|NCT01332253|7402651|FG000|NOT COMPLETED|Overall Study||0
6484919|NCT01332253|7402652|FG001|NOT COMPLETED|Overall Study||0
6484920|NCT01332292|7402658|FG000|STARTED|Treatment Period 1 (14 Days)||14
6484921|NCT01332292|7402659|FG001|STARTED|Treatment Period 1 (14 Days)||13
6484922|NCT01332292|7402658|FG000|COMPLETED|Treatment Period 1 (14 Days)||12
6484923|NCT01332292|7402659|FG001|COMPLETED|Treatment Period 1 (14 Days)||12
6484924|NCT01332292|7402658|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6484925|NCT01332292|7402659|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6484926|NCT01332292|7402658|FG000|STARTED|Washout Period (>=7 Days)||12
6484927|NCT01332292|7402659|FG001|STARTED|Washout Period (>=7 Days)||12
6484928|NCT01332292|7402658|FG000|COMPLETED|Washout Period (>=7 Days)||12
6484929|NCT01332292|7402659|FG001|COMPLETED|Washout Period (>=7 Days)||12
6484930|NCT01332292|7402658|FG000|NOT COMPLETED|Washout Period (>=7 Days)||0
6484931|NCT01332292|7402659|FG001|NOT COMPLETED|Washout Period (>=7 Days)||0
6484932|NCT01332292|7402658|FG000|STARTED|Treatment Period 2 (14 Days)||12
6484933|NCT01332292|7402659|FG001|STARTED|Treatment Period 2 (14 Days)||12
6484934|NCT01332292|7402658|FG000|COMPLETED|Treatment Period 2 (14 Days)||11
6484935|NCT01332292|7402659|FG001|COMPLETED|Treatment Period 2 (14 Days)||11
6484936|NCT01332292|7402658|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6484937|NCT01332292|7402659|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6484938|NCT01332305|7402672|FG000|STARTED|Overall Study||41
6484939|NCT01332305|7402673|FG001|STARTED|Overall Study||48
6484940|NCT01332305|7402674|FG002|STARTED|Overall Study||45
6484941|NCT01332305|7402675|FG003|STARTED|Overall Study||38
6484942|NCT01332305|7402676|FG004|STARTED|Overall Study||45
6484943|NCT01332305|7402672|FG000|COMPLETED|Overall Study||31
6484944|NCT01332305|7402673|FG001|COMPLETED|Overall Study||34
6484945|NCT01332305|7402674|FG002|COMPLETED|Overall Study||31
6484946|NCT01332305|7402675|FG003|COMPLETED|Overall Study||30
6484947|NCT01332305|7402676|FG004|COMPLETED|Overall Study||33
6484948|NCT01332305|7402672|FG000|NOT COMPLETED|Overall Study||10
6484949|NCT01332305|7402673|FG001|NOT COMPLETED|Overall Study||14
6484950|NCT01332305|7402674|FG002|NOT COMPLETED|Overall Study||14
6484951|NCT01332305|7402675|FG003|NOT COMPLETED|Overall Study||8
6484952|NCT01332305|7402676|FG004|NOT COMPLETED|Overall Study||12
6484953|NCT01332318|7402692|FG000|STARTED|Overall Study||34
6484954|NCT01332318|7402693|FG001|STARTED|Overall Study||32
6484955|NCT01332318|7402694|FG002|STARTED|Overall Study||34
6484956|NCT01332318|7402695|FG003|STARTED|Overall Study||30
6484957|NCT01332318|7402692|FG000|COMPLETED|Overall Study||32
6484958|NCT01332318|7402693|FG001|COMPLETED|Overall Study||28
6484959|NCT01332318|7402694|FG002|COMPLETED|Overall Study||33
6484960|NCT01332318|7402695|FG003|COMPLETED|Overall Study||28
6484961|NCT01332318|7402692|FG000|NOT COMPLETED|Overall Study||2
6484962|NCT01332318|7402693|FG001|NOT COMPLETED|Overall Study||4
6484963|NCT01332318|7402694|FG002|NOT COMPLETED|Overall Study||1
6484964|NCT01332318|7402695|FG003|NOT COMPLETED|Overall Study||2
6748638|NCT03417713|7676755|FG000|STARTED|Overall Study||33
6748639|NCT03417713|7676755|FG000|COMPLETED|Overall Study||30
6484965|NCT01332331|7402708|FG000|STARTED|Overall Study||21
6484966|NCT01332331|7402709|FG001|STARTED|Overall Study||20
6484967|NCT01332331|7402708|FG000|COMPLETED|Overall Study||19
6484968|NCT01332331|7402709|FG001|COMPLETED|Overall Study||18
6484969|NCT01332331|7402708|FG000|NOT COMPLETED|Overall Study||2
6484970|NCT01332331|7402709|FG001|NOT COMPLETED|Overall Study||2
6484971|NCT01332357|7402716|FG000|STARTED|Overall Study||6139
6484972|NCT01332357|7402716|FG000|COMPLETED|Overall Study||6139
6484973|NCT01332357|7402716|FG000|NOT COMPLETED|Overall Study||0
6484974|NCT01332435|7402724|FG000|STARTED|Overall Study||1572
6484975|NCT01332435|7402725|FG001|STARTED|Overall Study||1064
6484976|NCT01332435|7402726|FG002|STARTED|Overall Study||2604
6484977|NCT01332435|7402727|FG003|STARTED|Overall Study||1656
6484978|NCT01332435|7402724|FG000|COMPLETED|Overall Study||1572
6484979|NCT01332435|7402725|FG001|COMPLETED|Overall Study||1064
6484980|NCT01332435|7402726|FG002|COMPLETED|Overall Study||2604
6484981|NCT01332435|7402727|FG003|COMPLETED|Overall Study||1656
6484982|NCT01332435|7402724|FG000|NOT COMPLETED|Overall Study||0
6484983|NCT01332435|7402725|FG001|NOT COMPLETED|Overall Study||0
6484984|NCT01332435|7402726|FG002|NOT COMPLETED|Overall Study||0
6484985|NCT01332435|7402727|FG003|NOT COMPLETED|Overall Study||0
6484986|NCT01332461|7402740|FG000|STARTED|Overall Study||1291
6484987|NCT01332461|7402741|FG001|STARTED|Overall Study||4386
6484988|NCT01332461|7402740|FG000|COMPLETED|Overall Study||1291
6484989|NCT01332461|7402741|FG001|COMPLETED|Overall Study||4386
6484990|NCT01332461|7402740|FG000|NOT COMPLETED|Overall Study||0
6484991|NCT01332461|7402741|FG001|NOT COMPLETED|Overall Study||0
6484992|NCT01332487|7402749|FG000|STARTED|Overall Study||5554
6484993|NCT01332487|7402750|FG001|STARTED|Overall Study||3063
6484994|NCT01332487|7402749|FG000|COMPLETED|Overall Study||5554
6484995|NCT01332487|7402750|FG001|COMPLETED|Overall Study||3063
6484996|NCT01332487|7402749|FG000|NOT COMPLETED|Overall Study||0
6484997|NCT01332487|7402750|FG001|NOT COMPLETED|Overall Study||0
6484998|NCT01332500|7402760|FG000|STARTED|Overall Study||13257
6484999|NCT01332500|7402761|FG001|STARTED|Overall Study||39771
6485000|NCT01332500|7402762|FG002|STARTED|Overall Study||2903
6485001|NCT01332500|7402763|FG003|STARTED|Overall Study||5806
6485002|NCT01332500|7402760|FG000|COMPLETED|Overall Study||13257
6485003|NCT01332500|7402761|FG001|COMPLETED|Overall Study||39771
6485004|NCT01332500|7402762|FG002|COMPLETED|Overall Study||2903
6485005|NCT01332500|7402763|FG003|COMPLETED|Overall Study||5806
6485006|NCT01332500|7402760|FG000|NOT COMPLETED|Overall Study||0
6485007|NCT01332500|7402761|FG001|NOT COMPLETED|Overall Study||0
6485008|NCT01332500|7402762|FG002|NOT COMPLETED|Overall Study||0
6485009|NCT01332500|7402763|FG003|NOT COMPLETED|Overall Study||0
6485010|NCT01332578|7402773|FG000|STARTED|Period I||12
6485011|NCT01332578|7402774|FG001|STARTED|Period I||13
6485012|NCT01332578|7402773|FG000|COMPLETED|Period I||12
6485013|NCT01332578|7402774|FG001|COMPLETED|Period I||13
6485014|NCT01332578|7402773|FG000|NOT COMPLETED|Period I||0
6485015|NCT01332578|7402774|FG001|NOT COMPLETED|Period I||0
6485016|NCT01332578|7402773|FG000|STARTED|Washout Period||12
6485017|NCT01332578|7402774|FG001|STARTED|Washout Period||13
6485018|NCT01332578|7402773|FG000|COMPLETED|Washout Period||12
6485019|NCT01332578|7402774|FG001|COMPLETED|Washout Period||13
6485020|NCT01332578|7402773|FG000|NOT COMPLETED|Washout Period||0
6485021|NCT01332578|7402774|FG001|NOT COMPLETED|Washout Period||0
6485022|NCT01332578|7402773|FG000|STARTED|Period II||12
6485023|NCT01332578|7402774|FG001|STARTED|Period II||13
6485024|NCT01332578|7402773|FG000|COMPLETED|Period II||12
6485025|NCT01332578|7402774|FG001|COMPLETED|Period II||13
6485026|NCT01332578|7402773|FG000|NOT COMPLETED|Period II||0
6485027|NCT01332578|7402774|FG001|NOT COMPLETED|Period II||0
6485028|NCT01332630|7402781|FG000|STARTED|Overall Study||24
6485029|NCT01332630|7402781|FG000|COMPLETED|Overall Study||21
6485030|NCT01332630|7402781|FG000|NOT COMPLETED|Overall Study||3
6485031|NCT01332721|7402785|FG000|STARTED|Overall Study||38
6485032|NCT01332721|7402785|FG000|COMPLETED|Overall Study||38
6485033|NCT01332721|7402785|FG000|NOT COMPLETED|Overall Study||0
6485034|NCT01332851|7402791|FG000|STARTED|Overall Study||124
6485035|NCT01332851|7402792|FG001|STARTED|Overall Study||123
6485036|NCT01332851|7402791|FG000|Completed Intervention|Overall Study|9 no intervention, 8 <full dose, 107 full dose; 3 new caregivers enrolled-initial parent dropped out|107
6485037|NCT01332851|7402792|FG001|Completed Intervention|Overall Study|4 no intervention, 9 <full dose, 110 full dose; 4 new caregivers enrolled-initial parent dropped out|110
6485038|NCT01332851|7402791|FG000|Completed Follow up 1|Overall Study||116
6485039|NCT01332851|7402792|FG001|Completed Follow up 1|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|112
6485040|NCT01332851|7402791|FG000|Completed Follow up 2|Overall Study|Includes 1 new caregiver enrolled due to initial parent no longer parenting|111
6485041|NCT01332851|7402792|FG001|Completed Follow up 2|Overall Study|Includes 4 new caregivers enrolled due to initial parent no longer parenting|111
6485042|NCT01332851|7402791|FG000|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|113
6485043|NCT01332851|7402792|FG001|Completed Follow up 3|Overall Study|Includes 3 new caregivers enrolled due to initial parent no longer parenting|110
6485044|NCT01332851|7402791|FG000|COMPLETED|Overall Study||113
6485045|NCT01332851|7402792|FG001|COMPLETED|Overall Study||110
6485046|NCT01332851|7402791|FG000|NOT COMPLETED|Overall Study||11
6485047|NCT01332851|7402792|FG001|NOT COMPLETED|Overall Study||13
6485048|NCT01332981|7402802|FG000|STARTED|Overall Study||220
6485049|NCT01332981|7402802|FG000|COMPLETED|Overall Study||220
6485050|NCT01332981|7402802|FG000|NOT COMPLETED|Overall Study||0
6485051|NCT01332994|7402809|FG000|STARTED|Overall Study||519
6485052|NCT01332994|7402809|FG000|Completed Week 16|Overall Study||463
6485053|NCT01332994|7402809|FG000|Completed Week 32 (TCZ/TCZ)|Overall Study||200
6485054|NCT01332994|7402809|FG000|Completed Week 32 (TCZ/RTX)|Overall Study||26
6485055|NCT01332994|7402809|FG000|Completed Week 66 (TCZ/RTX)|Overall Study||25
6485056|NCT01332994|7402809|FG000|COMPLETED|Overall Study||448
6485057|NCT01332994|7402809|FG000|NOT COMPLETED|Overall Study||71
6485058|NCT01333033|7402815|FG000|STARTED|Overall Study||72
6485059|NCT01333033|7402816|FG001|STARTED|Overall Study||39
6485060|NCT01333033|7402817|FG002|STARTED|Overall Study||64
6485061|NCT01333033|7402818|FG003|STARTED|Overall Study||50
6485062|NCT01333033|7402819|FG004|STARTED|Overall Study||14
6485063|NCT01333033|7402820|FG005|STARTED|Overall Study||18
6485064|NCT01333033|7402815|FG000|COMPLETED|Overall Study||72
6485065|NCT01333033|7402816|FG001|COMPLETED|Overall Study||39
6485066|NCT01333033|7402817|FG002|COMPLETED|Overall Study||64
6485067|NCT01333033|7402818|FG003|COMPLETED|Overall Study||50
6485068|NCT01333033|7402819|FG004|COMPLETED|Overall Study||0
6485069|NCT01333033|7402820|FG005|COMPLETED|Overall Study||0
6485070|NCT01333033|7402815|FG000|NOT COMPLETED|Overall Study||0
6485071|NCT01333033|7402816|FG001|NOT COMPLETED|Overall Study||0
6485072|NCT01333033|7402817|FG002|NOT COMPLETED|Overall Study||0
6485073|NCT01333033|7402818|FG003|NOT COMPLETED|Overall Study||0
6485074|NCT01333033|7402819|FG004|NOT COMPLETED|Overall Study||14
6485075|NCT01333033|7402820|FG005|NOT COMPLETED|Overall Study||18
6485076|NCT01333059|7402840|FG000|STARTED|Overall Study||14
6485077|NCT01333059|7402841|FG001|STARTED|Overall Study||11
6485078|NCT01333059|7402840|FG000|COMPLETED|Overall Study||8
6485079|NCT01333059|7402841|FG001|COMPLETED|Overall Study||8
6485080|NCT01333059|7402840|FG000|NOT COMPLETED|Overall Study||6
6485081|NCT01333059|7402841|FG001|NOT COMPLETED|Overall Study||3
6485082|NCT01333072|7402851|FG000|STARTED|Overall Study||30
6485083|NCT01333072|7402852|FG001|STARTED|Overall Study||31
6485084|NCT01333072|7402851|FG000|COMPLETED|Overall Study||24
6485085|NCT01333072|7402852|FG001|COMPLETED|Overall Study||27
6485086|NCT01333072|7402851|FG000|NOT COMPLETED|Overall Study||6
6748640|NCT03417713|7676755|FG000|NOT COMPLETED|Overall Study||3
6748641|NCT03417739|7676759|FG000|STARTED|Overall Study||13
6748642|NCT03417739|7676759|FG000|COMPLETED|Overall Study||13
6748643|NCT03417739|7676759|FG000|NOT COMPLETED|Overall Study||0
6748644|NCT03417752|7676766|FG000|STARTED|Overall Study||149
6748645|NCT03417752|7676767|FG001|STARTED|Overall Study||175
6748646|NCT03417752|7676768|FG002|STARTED|Overall Study||150
6485087|NCT01333072|7402852|FG001|NOT COMPLETED|Overall Study||4
6485088|NCT01333098|7402858|FG000|STARTED|Overall Study||15
6485089|NCT01333098|7402858|FG000|COMPLETED|Overall Study||12
6485090|NCT01333098|7402858|FG000|NOT COMPLETED|Overall Study||3
6485091|NCT01333111|7402867|FG000|STARTED|Overall Study||30
6485092|NCT01333111|7402868|FG001|STARTED|Overall Study||29
6485093|NCT01333111|7402869|FG002|STARTED|Overall Study||15
6485094|NCT01333111|7402867|FG000|COMPLETED|Overall Study||28
6485095|NCT01333111|7402868|FG001|COMPLETED|Overall Study||26
6485096|NCT01333111|7402869|FG002|COMPLETED|Overall Study||13
6485097|NCT01333111|7402867|FG000|NOT COMPLETED|Overall Study||2
6485098|NCT01333111|7402868|FG001|NOT COMPLETED|Overall Study||3
6485099|NCT01333111|7402869|FG002|NOT COMPLETED|Overall Study||2
6485100|NCT01333189|7402879|FG000|STARTED|Overall Study||13
6485101|NCT01333189|7402880|FG001|STARTED|Overall Study||13
6485102|NCT01333189|7402879|FG000|COMPLETED|Overall Study||11
6485103|NCT01333189|7402880|FG001|COMPLETED|Overall Study||11
6485104|NCT01333189|7402879|FG000|NOT COMPLETED|Overall Study||2
6485105|NCT01333189|7402880|FG001|NOT COMPLETED|Overall Study||2
6485106|NCT01333397|7402891|FG000|STARTED|Overall Study||35
6485107|NCT01333397|7402892|FG001|STARTED|Overall Study||36
6485108|NCT01333397|7402893|FG002|STARTED|Overall Study||35
6485109|NCT01333397|7402894|FG003|STARTED|Overall Study||35
6485110|NCT01333397|7402895|FG004|STARTED|Overall Study||35
6485111|NCT01333397|7402891|FG000|COMPLETED|Overall Study||34
6485112|NCT01333397|7402892|FG001|COMPLETED|Overall Study||36
6485113|NCT01333397|7402893|FG002|COMPLETED|Overall Study||35
6485114|NCT01333397|7402894|FG003|COMPLETED|Overall Study||34
6554953|NCT01748955|7477042|FG001|COMPLETED|Overall Study||4
6554954|NCT01748955|7477041|FG000|NOT COMPLETED|Overall Study||3
6554955|NCT01748955|7477042|FG001|NOT COMPLETED|Overall Study||5
6485115|NCT01333397|7402895|FG004|COMPLETED|Overall Study||35
6485116|NCT01333397|7402891|FG000|NOT COMPLETED|Overall Study||1
6485117|NCT01333397|7402892|FG001|NOT COMPLETED|Overall Study||0
6485118|NCT01333397|7402893|FG002|NOT COMPLETED|Overall Study||0
6485119|NCT01333397|7402894|FG003|NOT COMPLETED|Overall Study||1
6485120|NCT01333397|7402895|FG004|NOT COMPLETED|Overall Study||0
6485121|NCT01333475|7402918|FG000|STARTED|Overall Study||12
6485122|NCT01333475|7402919|FG001|STARTED|Overall Study||9
6485123|NCT01333475|7402918|FG000|COMPLETED|Overall Study||10
6748647|NCT03417752|7676766|FG000|COMPLETED|Overall Study||115
6485124|NCT01333475|7402919|FG001|COMPLETED|Overall Study||6
6485125|NCT01333475|7402918|FG000|NOT COMPLETED|Overall Study||2
6485126|NCT01333475|7402919|FG001|NOT COMPLETED|Overall Study||3
6485127|NCT01333488|7402929|FG000|STARTED|Overall Study||2
6485128|NCT01333488|7402930|FG001|STARTED|Overall Study||1
6485129|NCT01333488|7402931|FG002|STARTED|Overall Study||3
6485130|NCT01333488|7402929|FG000|COMPLETED|Overall Study||2
6485131|NCT01333488|7402930|FG001|COMPLETED|Overall Study||1
6485132|NCT01333488|7402931|FG002|COMPLETED|Overall Study||3
6485133|NCT01333488|7402929|FG000|NOT COMPLETED|Overall Study||0
6485134|NCT01333488|7402930|FG001|NOT COMPLETED|Overall Study||0
6485135|NCT01333488|7402931|FG002|NOT COMPLETED|Overall Study||0
6485136|NCT01333501|7402942|FG000|STARTED|Overall Study||106
6485137|NCT01333501|7402943|FG001|STARTED|Overall Study||51
6485138|NCT01333501|7402942|FG000|Full Analysis Set (FAS)|Overall Study||80
6485139|NCT01333501|7402943|FG001|Full Analysis Set (FAS)|Overall Study||28
6485140|NCT01333501|7402942|FG000|Safety Population|Overall Study||104
6485141|NCT01333501|7402943|FG001|Safety Population|Overall Study||47
6485142|NCT01333501|7402942|FG000|COMPLETED|Overall Study||97
6485143|NCT01333501|7402943|FG001|COMPLETED|Overall Study||30
6485144|NCT01333501|7402942|FG000|NOT COMPLETED|Overall Study||9
6485145|NCT01333501|7402943|FG001|NOT COMPLETED|Overall Study||21
6485146|NCT01333527|7402951|FG000|STARTED|Overall Study||105
6485147|NCT01333527|7402952|FG001|STARTED|Overall Study||106
6485148|NCT01333527|7402951|FG000|COMPLETED|Overall Study||87
6485149|NCT01333527|7402952|FG001|COMPLETED|Overall Study||89
6485150|NCT01333527|7402951|FG000|NOT COMPLETED|Overall Study||18
6485151|NCT01333527|7402952|FG001|NOT COMPLETED|Overall Study||17
6485152|NCT01333592|7402960|FG000|STARTED|Overall Study||67
6485153|NCT01333592|7402961|FG001|STARTED|Overall Study||69
6485154|NCT01333592|7402960|FG000|COMPLETED|Overall Study||58
6485155|NCT01333592|7402961|FG001|COMPLETED|Overall Study||52
6485156|NCT01333592|7402960|FG000|NOT COMPLETED|Overall Study||9
6485157|NCT01333592|7402961|FG001|NOT COMPLETED|Overall Study||17
6485158|NCT01333722|7402969|FG000|STARTED|Overall Study||51
6485159|NCT01333722|7402970|FG001|STARTED|Overall Study||49
6485160|NCT01333722|7402969|FG000|COMPLETED|Overall Study||51
6485161|NCT01333722|7402970|FG001|COMPLETED|Overall Study||46
6485162|NCT01333722|7402969|FG000|NOT COMPLETED|Overall Study||0
6485163|NCT01333722|7402970|FG001|NOT COMPLETED|Overall Study||3
6485164|NCT01333813|7402978|FG000|STARTED|Overall Study||297
6485165|NCT01333813|7402978|FG000|COMPLETED|Overall Study||297
6485166|NCT01333813|7402978|FG000|NOT COMPLETED|Overall Study||0
6485167|NCT01333865|7402982|FG000|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
6485168|NCT01333865|7402982|FG000|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
6485169|NCT01333865|7402982|FG000|NOT COMPLETED|Overall Study||2
6485170|NCT01333943|7402988|FG000|STARTED|Overall Study||47
6485171|NCT01333943|7402989|FG001|STARTED|Overall Study||47
6485172|NCT01333943|7402988|FG000|COMPLETED|Overall Study||46
6485173|NCT01333943|7402989|FG001|COMPLETED|Overall Study||47
6485174|NCT01333943|7402988|FG000|NOT COMPLETED|Overall Study||1
6485175|NCT01333943|7402989|FG001|NOT COMPLETED|Overall Study||0
6485176|NCT01333956|7402999|FG000|STARTED|Overall Study||30
6485177|NCT01333956|7403000|FG001|STARTED|Overall Study||30
6485178|NCT01333956|7403001|FG002|STARTED|Overall Study||30
6485179|NCT01333956|7403002|FG003|STARTED|Overall Study||30
6485180|NCT01333956|7402999|FG000|COMPLETED|Overall Study||28
6485181|NCT01333956|7403000|FG001|COMPLETED|Overall Study||26
6485182|NCT01333956|7403001|FG002|COMPLETED|Overall Study||29
6485183|NCT01333956|7403002|FG003|COMPLETED|Overall Study||28
6485184|NCT01333956|7402999|FG000|NOT COMPLETED|Overall Study||2
6485185|NCT01333956|7403000|FG001|NOT COMPLETED|Overall Study||4
6485186|NCT01333956|7403001|FG002|NOT COMPLETED|Overall Study||1
6485187|NCT01333956|7403002|FG003|NOT COMPLETED|Overall Study||2
6485188|NCT01334086|7403013|FG000|STARTED|Overall Study||41
6485189|NCT01334086|7403013|FG000|COMPLETED|Overall Study||41
6485190|NCT01334086|7403013|FG000|NOT COMPLETED|Overall Study||0
6485191|NCT01334125|7403019|FG000|STARTED|Overall Study||15
6485192|NCT01334125|7403020|FG001|STARTED|Overall Study||13
6485193|NCT01334125|7403019|FG000|COMPLETED|Overall Study|3 subjects move to another city|12
6485194|NCT01334125|7403020|FG001|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
6485195|NCT01334125|7403019|FG000|NOT COMPLETED|Overall Study||3
6485196|NCT01334125|7403020|FG001|NOT COMPLETED|Overall Study||3
6485197|NCT01334216|7403029|FG000|STARTED|Overall Study||168
6485198|NCT01334216|7403030|FG001|STARTED|Overall Study||194
6485199|NCT01334216|7403029|FG000|COMPLETED|Overall Study||168
6485200|NCT01334216|7403030|FG001|COMPLETED|Overall Study||194
6485201|NCT01334216|7403029|FG000|NOT COMPLETED|Overall Study||0
6485202|NCT01334216|7403030|FG001|NOT COMPLETED|Overall Study||0
6485203|NCT01334229|7403038|FG000|STARTED|Overall Study||11
6485204|NCT01334229|7403039|FG001|STARTED|Overall Study||11
6485205|NCT01334229|7403038|FG000|COMPLETED|Overall Study||11
6485206|NCT01334229|7403039|FG001|COMPLETED|Overall Study||11
6485207|NCT01334229|7403038|FG000|NOT COMPLETED|Overall Study||0
6485208|NCT01334229|7403039|FG001|NOT COMPLETED|Overall Study||0
6485209|NCT01334515|7403047|FG000|STARTED|Overall Study||16
6485210|NCT01334515|7403048|FG001|STARTED|Overall Study||36
6485211|NCT01334515|7403047|FG000|COMPLETED|Overall Study||4
6485212|NCT01334515|7403048|FG001|COMPLETED|Overall Study||7
6485213|NCT01334515|7403047|FG000|NOT COMPLETED|Overall Study||12
6485214|NCT01334515|7403048|FG001|NOT COMPLETED|Overall Study||29
6485215|NCT01334554|7403056|FG000|STARTED|Overall Study||23
6485216|NCT01334554|7403057|FG001|STARTED|Overall Study||23
6485217|NCT01334554|7403056|FG000|COMPLETED|Overall Study||19
6485218|NCT01334554|7403057|FG001|COMPLETED|Overall Study||21
6485219|NCT01334554|7403056|FG000|NOT COMPLETED|Overall Study||4
6485220|NCT01334554|7403057|FG001|NOT COMPLETED|Overall Study||2
6485221|NCT01334710|7403065|FG000|STARTED|Overall Study||3
6485222|NCT01334710|7403065|FG000|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in hepatocellular cancer the trial was stopped.|0
6485223|NCT01334710|7403065|FG000|NOT COMPLETED|Overall Study||3
6485224|NCT01334723|7403072|FG000|STARTED|Overall Study||17293
6485225|NCT01334723|7403073|FG001|STARTED|Overall Study||17739
6485226|NCT01334723|7403072|FG000|COMPLETED|Overall Study||17293
6485227|NCT01334723|7403073|FG001|COMPLETED|Overall Study||17739
6485228|NCT01334723|7403072|FG000|NOT COMPLETED|Overall Study||0
6485229|NCT01334723|7403073|FG001|NOT COMPLETED|Overall Study||0
6485230|NCT01334827|7403093|FG000|STARTED|Overall Study||48
6485231|NCT01334827|7403093|FG000|COMPLETED|Overall Study||48
6485232|NCT01334827|7403093|FG000|NOT COMPLETED|Overall Study||0
6485233|NCT01334866|7403099|FG000|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
6485234|NCT01334866|7403099|FG000|COMPLETED|Overall Study||72
6485235|NCT01334866|7403099|FG000|NOT COMPLETED|Overall Study||19
6485236|NCT01334918|7403107|FG000|STARTED|Overall Study||63
6485237|NCT01334918|7403108|FG001|STARTED|Overall Study||61
6485238|NCT01334918|7403107|FG000|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
6485239|NCT01334918|7403108|FG001|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
6485240|NCT01334918|7403107|FG000|COMPLETED|Overall Study||55
6485241|NCT01334918|7403108|FG001|COMPLETED|Overall Study||60
6485242|NCT01334918|7403107|FG000|NOT COMPLETED|Overall Study||8
6485243|NCT01334918|7403108|FG001|NOT COMPLETED|Overall Study||1
6485244|NCT01334944|7403125|FG000|STARTED|Overall Study||11
6485245|NCT01334944|7403126|FG001|STARTED|Overall Study||139
6485246|NCT01334944|7403125|FG000|Received Singel Dose|Overall Study||1
6485247|NCT01334944|7403126|FG001|Received Singel Dose|Overall Study||96
6485248|NCT01334944|7403125|FG000|Received Multiple Doses|Overall Study||10
6485249|NCT01334944|7403126|FG001|Received Multiple Doses|Overall Study||43
6485250|NCT01334944|7403125|FG000|COMPLETED|Overall Study||11
6485251|NCT01334944|7403126|FG001|COMPLETED|Overall Study||139
6485252|NCT01334944|7403125|FG000|NOT COMPLETED|Overall Study||0
6748648|NCT03417752|7676767|FG001|COMPLETED|Overall Study||133
6748649|NCT03417752|7676768|FG002|COMPLETED|Overall Study||110
6748650|NCT03417752|7676766|FG000|NOT COMPLETED|Overall Study||34
6748651|NCT03417752|7676767|FG001|NOT COMPLETED|Overall Study||42
6748652|NCT03417752|7676768|FG002|NOT COMPLETED|Overall Study||40
6485253|NCT01334944|7403126|FG001|NOT COMPLETED|Overall Study||0
6485254|NCT01334957|7403135|FG000|STARTED|Overall Study||300
6485255|NCT01334957|7403135|FG000|Received Single Dose|Overall Study||252
6485256|NCT01334957|7403135|FG000|Received Multiple Doses|Overall Study||48
6485257|NCT01334957|7403135|FG000|COMPLETED|Overall Study||300
6485258|NCT01334957|7403135|FG000|NOT COMPLETED|Overall Study||0
6485259|NCT01335009|7403141|FG000|STARTED|Overall Study||40
6485260|NCT01335009|7403142|FG001|STARTED|Overall Study||36
6485261|NCT01335009|7403141|FG000|COMPLETED|Overall Study||9
6485262|NCT01335009|7403142|FG001|COMPLETED|Overall Study||3
6485263|NCT01335009|7403141|FG000|NOT COMPLETED|Overall Study||31
6485264|NCT01335009|7403142|FG001|NOT COMPLETED|Overall Study||33
6485265|NCT01335061|7403148|FG000|STARTED|Overall Study||25
6485266|NCT01335061|7403148|FG000|COMPLETED|Overall Study||25
6485267|NCT01335061|7403148|FG000|NOT COMPLETED|Overall Study||0
6485268|NCT01335191|7403161|FG000|STARTED|Overall Study||16
6485269|NCT01335191|7403162|FG001|STARTED|Overall Study||11
6485270|NCT01335191|7403161|FG000|COMPLETED|Overall Study||16
6485271|NCT01335191|7403162|FG001|COMPLETED|Overall Study||11
6485272|NCT01335191|7403161|FG000|NOT COMPLETED|Overall Study||0
6485273|NCT01335191|7403162|FG001|NOT COMPLETED|Overall Study||0
6485274|NCT01335204|7403168|FG000|STARTED|Overall Study||4
6485275|NCT01335204|7403168|FG000|COMPLETED|Overall Study||4
6485276|NCT01335204|7403168|FG000|NOT COMPLETED|Overall Study||0
6485277|NCT01335230|7403176|FG000|STARTED|Overall Study|subjects|10
6485278|NCT01335230|7403177|FG001|STARTED|Overall Study|subjects|10
6485279|NCT01335230|7403178|FG002|STARTED|Overall Study|subjects|10
6485280|NCT01335230|7403179|FG003|STARTED|Overall Study|subjects|10
6748653|NCT03417778|7676778|FG000|STARTED|Overall Study||10
6485281|NCT01335230|7403176|FG000|COMPLETED|Overall Study|subjects|10
6485282|NCT01335230|7403177|FG001|COMPLETED|Overall Study|subjects|10
6485283|NCT01335230|7403178|FG002|COMPLETED|Overall Study|subjects|10
6485284|NCT01335230|7403179|FG003|COMPLETED|Overall Study|subjects|10
6485285|NCT01335230|7403176|FG000|NOT COMPLETED|Overall Study||0
6485286|NCT01335230|7403177|FG001|NOT COMPLETED|Overall Study||0
6485287|NCT01335230|7403178|FG002|NOT COMPLETED|Overall Study||0
6485288|NCT01335230|7403179|FG003|NOT COMPLETED|Overall Study||0
6485289|NCT01335308|7403192|FG000|STARTED|Overall Study||198
6485290|NCT01335308|7403193|FG001|STARTED|Overall Study||212
6485291|NCT01335308|7403194|FG002|STARTED|Overall Study||235
6748654|NCT03417778|7676779|FG001|STARTED|Overall Study||10
6485292|NCT01335308|7403192|FG000|COMPLETED|Overall Study||158
6485293|NCT01335308|7403193|FG001|COMPLETED|Overall Study||145
6485294|NCT01335308|7403194|FG002|COMPLETED|Overall Study||154
6485295|NCT01335308|7403192|FG000|NOT COMPLETED|Overall Study||40
6485296|NCT01335308|7403193|FG001|NOT COMPLETED|Overall Study||67
6485297|NCT01335308|7403194|FG002|NOT COMPLETED|Overall Study||81
6485298|NCT01335464|7403204|FG000|STARTED|Overall Study||206
6485299|NCT01335464|7403205|FG001|STARTED|Overall Study||309
6485300|NCT01335464|7403204|FG000|COMPLETED|Overall Study||174
6485301|NCT01335464|7403205|FG001|COMPLETED|Overall Study||260
6485302|NCT01335464|7403204|FG000|NOT COMPLETED|Overall Study||32
6485303|NCT01335464|7403205|FG001|NOT COMPLETED|Overall Study||49
6485304|NCT01335477|7403213|FG000|STARTED|Overall Study||220
6485305|NCT01335477|7403214|FG001|STARTED|Overall Study||331
6485306|NCT01335477|7403213|FG000|COMPLETED|Overall Study||179
6485307|NCT01335477|7403214|FG001|COMPLETED|Overall Study||272
6485308|NCT01335477|7403213|FG000|NOT COMPLETED|Overall Study||41
6485309|NCT01335477|7403214|FG001|NOT COMPLETED|Overall Study||59
6485310|NCT01335542|7403222|FG000|STARTED|Overall Study||45
6485311|NCT01335542|7403223|FG001|STARTED|Overall Study||45
6485312|NCT01335542|7403222|FG000|COMPLETED|Overall Study||45
6485313|NCT01335542|7403223|FG001|COMPLETED|Overall Study||45
6485314|NCT01335542|7403222|FG000|NOT COMPLETED|Overall Study||0
6485315|NCT01335542|7403223|FG001|NOT COMPLETED|Overall Study||0
6485316|NCT01335620|7403229|FG000|STARTED|Overall Study||19
6485317|NCT01335620|7403229|FG000|COMPLETED|Overall Study||19
6485318|NCT01335620|7403229|FG000|NOT COMPLETED|Overall Study||0
6485319|NCT01335698|7403238|FG000|STARTED|Treatment Stage 1||23
6485320|NCT01335698|7403239|FG001|STARTED|Treatment Stage 1||12
6485321|NCT01335698|7403240|FG002|STARTED|Treatment Stage 1||21
6485322|NCT01335698|7403241|FG003|STARTED|Treatment Stage 1||35
6485323|NCT01335698|7403242|FG004|STARTED|Treatment Stage 1||8
6485324|NCT01335698|7403238|FG000|COMPLETED|Treatment Stage 1||15
6485325|NCT01335698|7403239|FG001|COMPLETED|Treatment Stage 1||4
6485326|NCT01335698|7403240|FG002|COMPLETED|Treatment Stage 1||16
6485327|NCT01335698|7403241|FG003|COMPLETED|Treatment Stage 1||26
6485328|NCT01335698|7403242|FG004|COMPLETED|Treatment Stage 1||6
6485329|NCT01335698|7403238|FG000|NOT COMPLETED|Treatment Stage 1||8
6485330|NCT01335698|7403239|FG001|NOT COMPLETED|Treatment Stage 1||8
6485331|NCT01335698|7403240|FG002|NOT COMPLETED|Treatment Stage 1||5
6485332|NCT01335698|7403241|FG003|NOT COMPLETED|Treatment Stage 1||9
6485333|NCT01335698|7403242|FG004|NOT COMPLETED|Treatment Stage 1||2
6485334|NCT01335698|7403238|FG000|STARTED|Treatment Stage 2||15
6485335|NCT01335698|7403239|FG001|STARTED|Treatment Stage 2||4
6485336|NCT01335698|7403240|FG002|STARTED|Treatment Stage 2||16
6485337|NCT01335698|7403241|FG003|STARTED|Treatment Stage 2||26
6485338|NCT01335698|7403242|FG004|STARTED|Treatment Stage 2||6
6485339|NCT01335698|7403238|FG000|COMPLETED|Treatment Stage 2||4
6485340|NCT01335698|7403239|FG001|COMPLETED|Treatment Stage 2||1
6485341|NCT01335698|7403240|FG002|COMPLETED|Treatment Stage 2||11
6485342|NCT01335698|7403241|FG003|COMPLETED|Treatment Stage 2||18
6485343|NCT01335698|7403242|FG004|COMPLETED|Treatment Stage 2||5
6485344|NCT01335698|7403238|FG000|NOT COMPLETED|Treatment Stage 2||11
6485345|NCT01335698|7403239|FG001|NOT COMPLETED|Treatment Stage 2||3
6485346|NCT01335698|7403240|FG002|NOT COMPLETED|Treatment Stage 2||5
6485347|NCT01335698|7403241|FG003|NOT COMPLETED|Treatment Stage 2||8
6485348|NCT01335698|7403242|FG004|NOT COMPLETED|Treatment Stage 2||1
6485349|NCT01335724|7403258|FG000|STARTED|Overall Study||36
6485350|NCT01335724|7403259|FG001|STARTED|Overall Study||36
6485351|NCT01335724|7403258|FG000|COMPLETED|Overall Study||36
6485352|NCT01335724|7403259|FG001|COMPLETED|Overall Study||36
6485353|NCT01335724|7403258|FG000|NOT COMPLETED|Overall Study||0
6485354|NCT01335724|7403259|FG001|NOT COMPLETED|Overall Study||0
6485355|NCT01335750|7403265|FG000|STARTED|Overall Study||32
6485356|NCT01335750|7403265|FG000|COMPLETED|Overall Study||32
6485357|NCT01335750|7403265|FG000|NOT COMPLETED|Overall Study||0
6485358|NCT01335789|7403279|FG000|STARTED|Overall Study||8
6485359|NCT01335789|7403280|FG001|STARTED|Overall Study||8
6485360|NCT01335789|7403279|FG000|COMPLETED|Overall Study||8
6485361|NCT01335789|7403280|FG001|COMPLETED|Overall Study||8
6485362|NCT01335789|7403279|FG000|NOT COMPLETED|Overall Study||0
6485363|NCT01335789|7403280|FG001|NOT COMPLETED|Overall Study||0
6485364|NCT01335867|7403288|FG000|STARTED|Overall Study||16
6485365|NCT01335867|7403289|FG001|STARTED|Overall Study||16
6485366|NCT01335867|7403288|FG000|COMPLETED|Overall Study||9
6485367|NCT01335867|7403289|FG001|COMPLETED|Overall Study||12
6485368|NCT01335867|7403288|FG000|NOT COMPLETED|Overall Study||7
6485369|NCT01335867|7403289|FG001|NOT COMPLETED|Overall Study||4
6485370|NCT01335932|7403304|FG000|STARTED|Overall Study||84
6485371|NCT01335932|7403305|FG001|STARTED|Overall Study||76
6485372|NCT01335932|7403304|FG000|COMPLETED|Overall Study||84
6485373|NCT01335932|7403305|FG001|COMPLETED|Overall Study||72
6485374|NCT01335932|7403304|FG000|NOT COMPLETED|Overall Study||0
6485375|NCT01335932|7403305|FG001|NOT COMPLETED|Overall Study||4
6485376|NCT01335971|7403314|FG000|STARTED|Overall Study||31
6485377|NCT01335971|7403315|FG001|STARTED|Overall Study||29
6485378|NCT01335971|7403316|FG002|STARTED|Overall Study||29
6485379|NCT01335971|7403314|FG000|COMPLETED|Overall Study||29
6485380|NCT01335971|7403315|FG001|COMPLETED|Overall Study||28
6485381|NCT01335971|7403316|FG002|COMPLETED|Overall Study||28
6485382|NCT01335971|7403314|FG000|NOT COMPLETED|Overall Study||2
6485383|NCT01335971|7403315|FG001|NOT COMPLETED|Overall Study||1
6485384|NCT01335971|7403316|FG002|NOT COMPLETED|Overall Study||1
6485385|NCT01336023|7403327|FG000|STARTED|Week 0 to Week 26||414
6485386|NCT01336023|7403328|FG001|STARTED|Week 0 to Week 26||834
6485387|NCT01336023|7403329|FG002|STARTED|Week 0 to Week 26||415
6485388|NCT01336023|7403327|FG000|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
6485389|NCT01336023|7403328|FG001|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
6485390|NCT01336023|7403329|FG002|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
6485391|NCT01336023|7403327|FG000|COMPLETED|Week 0 to Week 26||366
6485392|NCT01336023|7403328|FG001|COMPLETED|Week 0 to Week 26||736
6485393|NCT01336023|7403329|FG002|COMPLETED|Week 0 to Week 26||342
6485394|NCT01336023|7403327|FG000|NOT COMPLETED|Week 0 to Week 26||48
6485395|NCT01336023|7403328|FG001|NOT COMPLETED|Week 0 to Week 26||98
6485396|NCT01336023|7403329|FG002|NOT COMPLETED|Week 0 to Week 26||73
6485397|NCT01336023|7403327|FG000|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
6485398|NCT01336023|7403328|FG001|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
6485399|NCT01336023|7403329|FG002|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
6485400|NCT01336023|7403327|FG000|COMPLETED|Week 27 to 52||305
6485401|NCT01336023|7403328|FG001|COMPLETED|Week 27 to 52||621
6485402|NCT01336023|7403329|FG002|COMPLETED|Week 27 to 52||285
6485403|NCT01336023|7403327|FG000|NOT COMPLETED|Week 27 to 52||28
6485404|NCT01336023|7403328|FG001|NOT COMPLETED|Week 27 to 52||44
6485405|NCT01336023|7403329|FG002|NOT COMPLETED|Week 27 to 52||28
6485406|NCT01336140|7403339|FG000|STARTED|Overall Study||150
6485407|NCT01336140|7403340|FG001|STARTED|Overall Study||150
6485408|NCT01336140|7403339|FG000|COMPLETED|Overall Study||150
6485409|NCT01336140|7403340|FG001|COMPLETED|Overall Study||150
6485410|NCT01336140|7403339|FG000|NOT COMPLETED|Overall Study||0
6485411|NCT01336140|7403340|FG001|NOT COMPLETED|Overall Study||0
6485412|NCT01336205|7403348|FG000|STARTED|Overall Study||563
6485413|NCT01336205|7403349|FG001|STARTED|Overall Study||281
6485414|NCT01336205|7403348|FG000|COMPLETED|Overall Study||330
6485415|NCT01336205|7403349|FG001|COMPLETED|Overall Study||192
6485416|NCT01336205|7403348|FG000|NOT COMPLETED|Overall Study||233
6485417|NCT01336205|7403349|FG001|NOT COMPLETED|Overall Study||89
6485418|NCT01336296|7403357|FG000|STARTED|Overall Study||40
6485419|NCT01336296|7403358|FG001|STARTED|Overall Study||21
6485420|NCT01336296|7403357|FG000|COMPLETED|Overall Study||35
6485421|NCT01336296|7403358|FG001|COMPLETED|Overall Study||17
6485422|NCT01336296|7403357|FG000|NOT COMPLETED|Overall Study||5
6485423|NCT01336296|7403358|FG001|NOT COMPLETED|Overall Study||4
6485424|NCT01336413|7403366|FG000|STARTED|Overall Study||27
6485425|NCT01336413|7403367|FG001|STARTED|Overall Study||26
6485426|NCT01336413|7403366|FG000|COMPLETED|Overall Study||26
6485427|NCT01336413|7403367|FG001|COMPLETED|Overall Study||18
6485428|NCT01336413|7403366|FG000|NOT COMPLETED|Overall Study||1
6485429|NCT01336413|7403367|FG001|NOT COMPLETED|Overall Study||8
6485430|NCT01336569|7403375|FG000|STARTED|Overall Study||49
6485431|NCT01336569|7403375|FG000|COMPLETED|Overall Study||45
6485432|NCT01336569|7403375|FG000|NOT COMPLETED|Overall Study||4
6485433|NCT01336608|7403382|FG000|STARTED|2-week, Single-blind Run-In Period||559
6485434|NCT01336608|7403383|FG001|STARTED|2-week, Single-blind Run-In Period||0
6485435|NCT01336608|7403384|FG002|STARTED|2-week, Single-blind Run-In Period||0
6485436|NCT01336608|7403385|FG003|STARTED|2-week, Single-blind Run-In Period||0
6485437|NCT01336608|7403382|FG000|COMPLETED|2-week, Single-blind Run-In Period||444
6485438|NCT01336608|7403383|FG001|COMPLETED|2-week, Single-blind Run-In Period||0
6485439|NCT01336608|7403384|FG002|COMPLETED|2-week, Single-blind Run-In Period||0
6485440|NCT01336608|7403385|FG003|COMPLETED|2-week, Single-blind Run-In Period||0
6485441|NCT01336608|7403382|FG000|NOT COMPLETED|2-week, Single-blind Run-In Period||115
6485442|NCT01336608|7403383|FG001|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6485443|NCT01336608|7403384|FG002|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6485444|NCT01336608|7403385|FG003|NOT COMPLETED|2-week, Single-blind Run-In Period||0
6485445|NCT01336608|7403382|FG000|STARTED|24-week, Double-blind Treatment Period||0
6485446|NCT01336608|7403383|FG001|STARTED|24-week, Double-blind Treatment Period||141
6485447|NCT01336608|7403384|FG002|STARTED|24-week, Double-blind Treatment Period||154
6485448|NCT01336608|7403385|FG003|STARTED|24-week, Double-blind Treatment Period||135
6485449|NCT01336608|7403382|FG000|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
6485450|NCT01336608|7403383|FG001|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
6485451|NCT01336608|7403384|FG002|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
6485452|NCT01336608|7403385|FG003|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
6485453|NCT01336608|7403382|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
6485454|NCT01336608|7403383|FG001|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
6485455|NCT01336608|7403384|FG002|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
6485456|NCT01336608|7403385|FG003|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
6485457|NCT01336608|7403382|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
6748655|NCT03417778|7676778|FG000|COMPLETED|Overall Study||10
6748656|NCT03417778|7676779|FG001|COMPLETED|Overall Study||10
6748657|NCT03417778|7676778|FG000|NOT COMPLETED|Overall Study||0
6748658|NCT03417778|7676779|FG001|NOT COMPLETED|Overall Study||0
6554956|NCT01748994|7477050|FG000|STARTED|Overall Study||31
6554957|NCT01748994|7477051|FG001|STARTED|Overall Study||32
6554958|NCT01748994|7477050|FG000|COMPLETED|Overall Study||23
6554959|NCT01748994|7477051|FG001|COMPLETED|Overall Study||26
6748659|NCT03417804|7676785|FG000|STARTED|Overall Study|at least 360 patients|366
6485458|NCT01336608|7403383|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||44
6554960|NCT01748994|7477050|FG000|NOT COMPLETED|Overall Study||8
6748660|NCT03417804|7676785|FG000|COMPLETED|Overall Study||366
6485459|NCT01336608|7403384|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||30
6485460|NCT01336608|7403385|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||24
6485461|NCT01336647|7403396|FG000|STARTED|Overall Study||46
6485462|NCT01336647|7403397|FG001|STARTED|Overall Study||49
6485463|NCT01336647|7403398|FG002|STARTED|Overall Study||47
6485464|NCT01336647|7403396|FG000|COMPLETED|Overall Study||42
6485465|NCT01336647|7403397|FG001|COMPLETED|Overall Study||48
6485466|NCT01336647|7403398|FG002|COMPLETED|Overall Study||44
6485467|NCT01336647|7403396|FG000|NOT COMPLETED|Overall Study||4
6485468|NCT01336647|7403397|FG001|NOT COMPLETED|Overall Study||1
6485469|NCT01336647|7403398|FG002|NOT COMPLETED|Overall Study||3
6485470|NCT01336712|7403408|FG000|STARTED|Overall Study||30
6485471|NCT01336712|7403408|FG000|COMPLETED|Overall Study||27
6485472|NCT01336712|7403408|FG000|NOT COMPLETED|Overall Study||3
6485473|NCT01336738|7403417|FG000|STARTED|Overall Study||52
6485474|NCT01336738|7403418|FG001|STARTED|Overall Study||54
6485475|NCT01336738|7403419|FG002|STARTED|Overall Study||53
6485476|NCT01336738|7403420|FG003|STARTED|Overall Study||54
6485477|NCT01336738|7403421|FG004|STARTED|Overall Study||53
6485478|NCT01336738|7403417|FG000|COMPLETED|Overall Study||45
6485479|NCT01336738|7403418|FG001|COMPLETED|Overall Study||45
6485480|NCT01336738|7403419|FG002|COMPLETED|Overall Study||45
6485481|NCT01336738|7403420|FG003|COMPLETED|Overall Study||47
6485482|NCT01336738|7403421|FG004|COMPLETED|Overall Study||43
6485483|NCT01336738|7403417|FG000|NOT COMPLETED|Overall Study||7
6485484|NCT01336738|7403418|FG001|NOT COMPLETED|Overall Study||9
6485485|NCT01336738|7403419|FG002|NOT COMPLETED|Overall Study||8
6485486|NCT01336738|7403420|FG003|NOT COMPLETED|Overall Study||7
6485487|NCT01336738|7403421|FG004|NOT COMPLETED|Overall Study||10
6485488|NCT01336764|7403435|FG000|STARTED|Overall Study||12
6485489|NCT01336764|7403436|FG001|STARTED|Overall Study||10
6485490|NCT01336764|7403435|FG000|COMPLETED|Overall Study||7
6485491|NCT01336764|7403436|FG001|COMPLETED|Overall Study||5
6485492|NCT01336764|7403435|FG000|NOT COMPLETED|Overall Study||5
6485493|NCT01336764|7403436|FG001|NOT COMPLETED|Overall Study||5
6485494|NCT01336803|7403442|FG000|STARTED|Overall Study||21
6485495|NCT01336803|7403442|FG000|Bone Sarcoma|Overall Study||10
6485496|NCT01336803|7403442|FG000|Osteomyelitis|Overall Study||4
6485497|NCT01336803|7403442|FG000|Lymphoma|Overall Study||7
6485498|NCT01336803|7403442|FG000|COMPLETED|Overall Study||21
6485499|NCT01336803|7403442|FG000|NOT COMPLETED|Overall Study||0
6485500|NCT01336894|7403456|FG000|STARTED|Protocol Interventions||4
6485501|NCT01336894|7403457|FG001|STARTED|Protocol Interventions||7
6485502|NCT01336894|7403456|FG000|COMPLETED|Protocol Interventions||4
6485503|NCT01336894|7403457|FG001|COMPLETED|Protocol Interventions||7
6485504|NCT01336894|7403456|FG000|NOT COMPLETED|Protocol Interventions||0
6485505|NCT01336894|7403457|FG001|NOT COMPLETED|Protocol Interventions||0
6485506|NCT01336894|7403456|FG000|STARTED|Follow-up||4
6485507|NCT01336894|7403457|FG001|STARTED|Follow-up||7
6485508|NCT01336894|7403456|FG000|COMPLETED|Follow-up||2
6485509|NCT01336894|7403457|FG001|COMPLETED|Follow-up||0
6485510|NCT01336894|7403456|FG000|NOT COMPLETED|Follow-up||2
6485511|NCT01336894|7403457|FG001|NOT COMPLETED|Follow-up||7
6485512|NCT01336933|7403463|FG000|STARTED|Overall Study||34
6485513|NCT01336933|7403463|FG000|COMPLETED|Overall Study||33
6485514|NCT01336933|7403463|FG000|NOT COMPLETED|Overall Study||1
6485515|NCT01336959|7403471|FG000|STARTED|Overall Study||8
6485516|NCT01336959|7403472|FG001|STARTED|Overall Study||42
6485517|NCT01336959|7403473|FG002|STARTED|Overall Study||41
6485518|NCT01336959|7403471|FG000|COMPLETED|Overall Study||8
6485519|NCT01336959|7403472|FG001|COMPLETED|Overall Study||37
6485520|NCT01336959|7403473|FG002|COMPLETED|Overall Study||40
6485521|NCT01336959|7403471|FG000|NOT COMPLETED|Overall Study||0
6485522|NCT01336959|7403472|FG001|NOT COMPLETED|Overall Study||5
6485523|NCT01336959|7403473|FG002|NOT COMPLETED|Overall Study||1
6485524|NCT01336972|7403487|FG000|STARTED|Overall Study||10
6485525|NCT01336972|7403488|FG001|STARTED|Overall Study||10
6485526|NCT01336972|7403489|FG002|STARTED|Overall Study||9
6485527|NCT01336972|7403487|FG000|COMPLETED|Overall Study||9
6485528|NCT01336972|7403488|FG001|COMPLETED|Overall Study||9
6485529|NCT01336972|7403489|FG002|COMPLETED|Overall Study||9
6485530|NCT01336972|7403487|FG000|NOT COMPLETED|Overall Study||1
6485531|NCT01336972|7403488|FG001|NOT COMPLETED|Overall Study||1
6485532|NCT01336972|7403489|FG002|NOT COMPLETED|Overall Study||0
6485533|NCT01337050|7403501|FG000|STARTED|Overall Study||4
6485534|NCT01337050|7403502|FG001|STARTED|Overall Study||13
6485535|NCT01337050|7403503|FG002|STARTED|Overall Study||19
6485536|NCT01337050|7403501|FG000|COMPLETED|Overall Study||0
6485537|NCT01337050|7403502|FG001|COMPLETED|Overall Study||0
6485538|NCT01337050|7403503|FG002|COMPLETED|Overall Study||0
6485539|NCT01337050|7403501|FG000|NOT COMPLETED|Overall Study||4
6485540|NCT01337050|7403502|FG001|NOT COMPLETED|Overall Study||13
6485541|NCT01337050|7403503|FG002|NOT COMPLETED|Overall Study||19
6501609|NCT01430104|7420129|FG000|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
6501610|NCT01430130|7420136|FG000|STARTED|Overall Study||12
6501611|NCT01430130|7420136|FG000|COMPLETED|Overall Study||10
6501612|NCT01430130|7420136|FG000|NOT COMPLETED|Overall Study||2
6501613|NCT01430169|7420142|FG000|STARTED|Overall Study||20
6501614|NCT01430169|7420142|FG000|COMPLETED|Overall Study||20
6501615|NCT01430169|7420142|FG000|NOT COMPLETED|Overall Study||0
6501616|NCT01430182|7420148|FG000|STARTED|Overall Study||9
6501617|NCT01430182|7420149|FG001|STARTED|Overall Study||8
6501618|NCT01430182|7420148|FG000|COMPLETED|Overall Study||9
6485542|NCT01337076|7403512|FG000|STARTED|Overall Study|subjects implanted|21
6485543|NCT01337076|7403512|FG000|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
6485544|NCT01337076|7403512|FG000|NOT COMPLETED|Overall Study||2
6485545|NCT01337089|7403516|FG000|STARTED|Overall Study||660
6485546|NCT01337089|7403516|FG000|Received at Least 1 Dose of Study Drug|Overall Study||660
6485547|NCT01337089|7403516|FG000|Safety Population|Overall Study||660
6485548|NCT01337089|7403516|FG000|Efficacy Dataset|Overall Study|One participant withdrew after administering nabiximols, but no efficacy data were collected.|659
6485549|NCT01337089|7403516|FG000|COMPLETED|Overall Study||256
6485550|NCT01337089|7403516|FG000|NOT COMPLETED|Overall Study||404
6485551|NCT01337115|7403522|FG000|STARTED|Overall Study||25
6485552|NCT01337115|7403523|FG001|STARTED|Overall Study||25
6485553|NCT01337115|7403522|FG000|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
6485554|NCT01337115|7403523|FG001|COMPLETED|Overall Study||25
6485555|NCT01337115|7403522|FG000|NOT COMPLETED|Overall Study||2
6485556|NCT01337115|7403523|FG001|NOT COMPLETED|Overall Study||0
6485557|NCT01337167|7403533|FG000|STARTED|Infant Series||986
6485558|NCT01337167|7403534|FG001|STARTED|Infant Series||487
6485559|NCT01337167|7403533|FG000|COMPLETED|Infant Series||924
6485560|NCT01337167|7403534|FG001|COMPLETED|Infant Series||460
6485561|NCT01337167|7403533|FG000|NOT COMPLETED|Infant Series||62
6485562|NCT01337167|7403534|FG001|NOT COMPLETED|Infant Series||27
6485563|NCT01337167|7403533|FG000|STARTED|Interim Period||924
6485564|NCT01337167|7403534|FG001|STARTED|Interim Period||460
6485565|NCT01337167|7403533|FG000|COMPLETED|Interim Period||843
6485566|NCT01337167|7403534|FG001|COMPLETED|Interim Period||420
6485567|NCT01337167|7403533|FG000|NOT COMPLETED|Interim Period||81
6485568|NCT01337167|7403534|FG001|NOT COMPLETED|Interim Period||40
6485569|NCT01337167|7403533|FG000|STARTED|Toddler Vaccinations||843
6485570|NCT01337167|7403534|FG001|STARTED|Toddler Vaccinations||420
6485571|NCT01337167|7403533|FG000|COMPLETED|Toddler Vaccinations||829
6485572|NCT01337167|7403534|FG001|COMPLETED|Toddler Vaccinations||407
6485573|NCT01337167|7403533|FG000|NOT COMPLETED|Toddler Vaccinations||14
6485574|NCT01337167|7403534|FG001|NOT COMPLETED|Toddler Vaccinations||13
6485575|NCT01337297|7403542|FG000|STARTED|Overall Study||11
6485576|NCT01337297|7403543|FG001|STARTED|Overall Study||9
6485577|NCT01337297|7403542|FG000|COMPLETED|Overall Study||6
6485578|NCT01337297|7403543|FG001|COMPLETED|Overall Study||3
6485579|NCT01337297|7403542|FG000|NOT COMPLETED|Overall Study||5
6485580|NCT01337297|7403543|FG001|NOT COMPLETED|Overall Study||6
6485581|NCT01337336|7403551|FG000|STARTED|Overall Study||1078
6485582|NCT01337336|7403552|FG001|STARTED|Overall Study||2923
6485583|NCT01337336|7403551|FG000|COMPLETED|Overall Study||1078
6485584|NCT01337336|7403552|FG001|COMPLETED|Overall Study||2923
6485585|NCT01337336|7403551|FG000|NOT COMPLETED|Overall Study||0
6485586|NCT01337336|7403552|FG001|NOT COMPLETED|Overall Study||0
6485587|NCT01337596|7403567|FG000|STARTED|Overall Study||7
6485588|NCT01337596|7403568|FG001|STARTED|Overall Study||7
6485589|NCT01337596|7403569|FG002|STARTED|Overall Study||7
6485590|NCT01337596|7403570|FG003|STARTED|Overall Study||7
6485591|NCT01337596|7403571|FG004|STARTED|Overall Study||7
6485592|NCT01337596|7403572|FG005|STARTED|Overall Study||7
6485593|NCT01337596|7403573|FG006|STARTED|Overall Study||12
6485594|NCT01337596|7403574|FG007|STARTED|Overall Study||2
6485595|NCT01337596|7403575|FG008|STARTED|Overall Study||7
6485596|NCT01337596|7403567|FG000|Safety Population|Overall Study||7
6485597|NCT01337596|7403568|FG001|Safety Population|Overall Study||7
6485598|NCT01337596|7403569|FG002|Safety Population|Overall Study||7
6485599|NCT01337596|7403570|FG003|Safety Population|Overall Study||7
6485600|NCT01337596|7403571|FG004|Safety Population|Overall Study||7
6485601|NCT01337596|7403572|FG005|Safety Population|Overall Study||7
6485602|NCT01337596|7403573|FG006|Safety Population|Overall Study||12
6485603|NCT01337596|7403574|FG007|Safety Population|Overall Study||2
6485604|NCT01337596|7403575|FG008|Safety Population|Overall Study||7
6485605|NCT01337596|7403567|FG000|COMPLETED|Overall Study||7
6485606|NCT01337596|7403568|FG001|COMPLETED|Overall Study||7
6485607|NCT01337596|7403569|FG002|COMPLETED|Overall Study||7
6485608|NCT01337596|7403570|FG003|COMPLETED|Overall Study||7
6485609|NCT01337596|7403571|FG004|COMPLETED|Overall Study||5
6485610|NCT01337596|7403572|FG005|COMPLETED|Overall Study||7
6485611|NCT01337596|7403573|FG006|COMPLETED|Overall Study||12
6485612|NCT01337596|7403574|FG007|COMPLETED|Overall Study||2
6485613|NCT01337596|7403575|FG008|COMPLETED|Overall Study||7
6748661|NCT03417804|7676785|FG000|NOT COMPLETED|Overall Study||0
6748662|NCT03417830|7676792|FG000|STARTED|Part A (up to 26 Days)||2
6748663|NCT03417830|7676793|FG001|STARTED|Part A (up to 26 Days)||0
6748664|NCT03417830|7676792|FG000|COMPLETED|Part A (up to 26 Days)||1
6748665|NCT03417830|7676793|FG001|COMPLETED|Part A (up to 26 Days)||0
6748666|NCT03417830|7676792|FG000|NOT COMPLETED|Part A (up to 26 Days)||1
6485614|NCT01337596|7403567|FG000|NOT COMPLETED|Overall Study||0
6485615|NCT01337596|7403568|FG001|NOT COMPLETED|Overall Study||0
6485616|NCT01337596|7403569|FG002|NOT COMPLETED|Overall Study||0
6485617|NCT01337596|7403570|FG003|NOT COMPLETED|Overall Study||0
6485618|NCT01337596|7403571|FG004|NOT COMPLETED|Overall Study||2
6485619|NCT01337596|7403572|FG005|NOT COMPLETED|Overall Study||0
6485620|NCT01337596|7403573|FG006|NOT COMPLETED|Overall Study||0
6485621|NCT01337596|7403574|FG007|NOT COMPLETED|Overall Study||0
6485622|NCT01337596|7403575|FG008|NOT COMPLETED|Overall Study||0
6485623|NCT01337635|7403600|FG000|STARTED|Overall Study||3
6485624|NCT01337635|7403601|FG001|STARTED|Overall Study||4
6485625|NCT01337635|7403600|FG000|COMPLETED|Overall Study||3
6485626|NCT01337635|7403601|FG001|COMPLETED|Overall Study||3
6485627|NCT01337635|7403600|FG000|NOT COMPLETED|Overall Study||0
6485628|NCT01337635|7403601|FG001|NOT COMPLETED|Overall Study||1
6485629|NCT01337674|7403609|FG000|STARTED|Treatment Period 1||6
6485630|NCT01337674|7403610|FG001|STARTED|Treatment Period 1|The discontinued participant was replaced|7
6485631|NCT01337674|7403611|FG002|STARTED|Treatment Period 1||6
6485632|NCT01337674|7403612|FG003|STARTED|Treatment Period 1|The discontinued participant was replaced|7
6485633|NCT01337674|7403609|FG000|COMPLETED|Treatment Period 1||6
6485634|NCT01337674|7403610|FG001|COMPLETED|Treatment Period 1||6
6485635|NCT01337674|7403611|FG002|COMPLETED|Treatment Period 1||6
6485636|NCT01337674|7403612|FG003|COMPLETED|Treatment Period 1||6
6485637|NCT01337674|7403609|FG000|NOT COMPLETED|Treatment Period 1||0
6485638|NCT01337674|7403610|FG001|NOT COMPLETED|Treatment Period 1||1
6485639|NCT01337674|7403611|FG002|NOT COMPLETED|Treatment Period 1||0
6485640|NCT01337674|7403612|FG003|NOT COMPLETED|Treatment Period 1||1
6485641|NCT01337674|7403609|FG000|STARTED|Two-week Washout Period||6
6485642|NCT01337674|7403610|FG001|STARTED|Two-week Washout Period||6
6485643|NCT01337674|7403611|FG002|STARTED|Two-week Washout Period||6
6485644|NCT01337674|7403612|FG003|STARTED|Two-week Washout Period||6
6485645|NCT01337674|7403609|FG000|COMPLETED|Two-week Washout Period||6
6485646|NCT01337674|7403610|FG001|COMPLETED|Two-week Washout Period||6
6485647|NCT01337674|7403611|FG002|COMPLETED|Two-week Washout Period||6
6485648|NCT01337674|7403612|FG003|COMPLETED|Two-week Washout Period||6
6485649|NCT01337674|7403609|FG000|NOT COMPLETED|Two-week Washout Period||0
6485650|NCT01337674|7403610|FG001|NOT COMPLETED|Two-week Washout Period||0
6485651|NCT01337674|7403611|FG002|NOT COMPLETED|Two-week Washout Period||0
6485652|NCT01337674|7403612|FG003|NOT COMPLETED|Two-week Washout Period||0
6485653|NCT01337674|7403609|FG000|STARTED|Treatment Period 2||6
6485654|NCT01337674|7403610|FG001|STARTED|Treatment Period 2||6
6485655|NCT01337674|7403611|FG002|STARTED|Treatment Period 2||6
6485656|NCT01337674|7403612|FG003|STARTED|Treatment Period 2||6
6485657|NCT01337674|7403609|FG000|COMPLETED|Treatment Period 2||6
6485658|NCT01337674|7403610|FG001|COMPLETED|Treatment Period 2||6
6485659|NCT01337674|7403611|FG002|COMPLETED|Treatment Period 2||5
6485660|NCT01337674|7403612|FG003|COMPLETED|Treatment Period 2||6
6485661|NCT01337674|7403609|FG000|NOT COMPLETED|Treatment Period 2||0
6485662|NCT01337674|7403610|FG001|NOT COMPLETED|Treatment Period 2||0
6485663|NCT01337674|7403611|FG002|NOT COMPLETED|Treatment Period 2||1
6485664|NCT01337674|7403612|FG003|NOT COMPLETED|Treatment Period 2||0
6485665|NCT01337687|7403627|FG000|STARTED|Overall Study||10
6485666|NCT01337687|7403628|FG001|STARTED|Overall Study||9
6485667|NCT01337687|7403627|FG000|COMPLETED|Overall Study||10
6485668|NCT01337687|7403628|FG001|COMPLETED|Overall Study||9
6485669|NCT01337687|7403627|FG000|NOT COMPLETED|Overall Study||0
6485670|NCT01337687|7403628|FG001|NOT COMPLETED|Overall Study||0
6485671|NCT01337700|7403636|FG000|STARTED|Overall Study||5
6485672|NCT01337700|7403637|FG001|STARTED|Overall Study||5
6485673|NCT01337700|7403636|FG000|COMPLETED|Overall Study||5
6485674|NCT01337700|7403637|FG001|COMPLETED|Overall Study||5
6485675|NCT01337700|7403636|FG000|NOT COMPLETED|Overall Study||0
6485676|NCT01337700|7403637|FG001|NOT COMPLETED|Overall Study||0
6485677|NCT01337739|7403645|FG000|STARTED|Overall Study||6
6485678|NCT01337739|7403646|FG001|STARTED|Overall Study||4
6485679|NCT01337739|7403645|FG000|COMPLETED|Overall Study||6
6485680|NCT01337739|7403646|FG001|COMPLETED|Overall Study||4
6485681|NCT01337739|7403645|FG000|NOT COMPLETED|Overall Study||0
6485682|NCT01337739|7403646|FG001|NOT COMPLETED|Overall Study||0
6485683|NCT01337960|7403655|FG000|STARTED|Overall Study||14
6485684|NCT01337960|7403656|FG001|STARTED|Overall Study||14
6485685|NCT01337960|7403657|FG002|STARTED|Overall Study||6
6485686|NCT01337960|7403655|FG000|COMPLETED|Overall Study||12
6485687|NCT01337960|7403656|FG001|COMPLETED|Overall Study||14
6485688|NCT01337960|7403657|FG002|COMPLETED|Overall Study||6
6485689|NCT01337960|7403655|FG000|NOT COMPLETED|Overall Study||2
6485690|NCT01337960|7403656|FG001|NOT COMPLETED|Overall Study||0
6485691|NCT01337960|7403657|FG002|NOT COMPLETED|Overall Study||0
6485692|NCT01337973|7403668|FG000|STARTED|Overall Study||60
6485693|NCT01337973|7403669|FG001|STARTED|Overall Study||60
6485694|NCT01337973|7403670|FG002|STARTED|Overall Study||60
6485695|NCT01337973|7403668|FG000|COMPLETED|Overall Study||44
6485696|NCT01337973|7403669|FG001|COMPLETED|Overall Study||45
6485697|NCT01337973|7403670|FG002|COMPLETED|Overall Study||49
6485698|NCT01337973|7403668|FG000|NOT COMPLETED|Overall Study||16
6485699|NCT01337973|7403669|FG001|NOT COMPLETED|Overall Study||15
6485700|NCT01337973|7403670|FG002|NOT COMPLETED|Overall Study||11
6485701|NCT01337986|7403680|FG000|STARTED|Overall Study||23
6485702|NCT01337986|7403681|FG001|STARTED|Overall Study||23
6485703|NCT01337986|7403680|FG000|COMPLETED|Overall Study||20
6485704|NCT01337986|7403681|FG001|COMPLETED|Overall Study||18
6485705|NCT01337986|7403680|FG000|NOT COMPLETED|Overall Study||3
6485706|NCT01337986|7403681|FG001|NOT COMPLETED|Overall Study||5
6485707|NCT01338012|7403703|FG000|STARTED|Overall Study||8
6485708|NCT01338012|7403703|FG000|COMPLETED|Overall Study||0
6485709|NCT01338012|7403703|FG000|NOT COMPLETED|Overall Study||8
6485710|NCT01338025|7403709|FG000|STARTED|Overall Study||16
6485711|NCT01338025|7403710|FG001|STARTED|Overall Study||17
6485712|NCT01338025|7403709|FG000|COMPLETED|Overall Study||5
6485713|NCT01338025|7403710|FG001|COMPLETED|Overall Study||6
6485714|NCT01338025|7403709|FG000|NOT COMPLETED|Overall Study||11
6485715|NCT01338025|7403710|FG001|NOT COMPLETED|Overall Study||11
6485716|NCT01338298|7403718|FG000|STARTED|Overall Study||24
6485717|NCT01338298|7403719|FG001|STARTED|Overall Study||18
6485718|NCT01338298|7403718|FG000|COMPLETED|Overall Study||20
6485719|NCT01338298|7403719|FG001|COMPLETED|Overall Study||15
6485720|NCT01338298|7403718|FG000|NOT COMPLETED|Overall Study||4
6485721|NCT01338298|7403719|FG001|NOT COMPLETED|Overall Study||3
6485722|NCT01338415|7403727|FG000|STARTED|Core + Extension||33
6485723|NCT01338415|7403728|FG001|STARTED|Core + Extension||31
6485724|NCT01338415|7403729|FG002|STARTED|Core + Extension||0
6485725|NCT01338415|7403727|FG000|Enrolled in FUTURE 3 Extension|Core + Extension||31
6485726|NCT01338415|7403728|FG001|Enrolled in FUTURE 3 Extension|Core + Extension||27
6485727|NCT01338415|7403729|FG002|Enrolled in FUTURE 3 Extension|Core + Extension||0
6485728|NCT01338415|7403727|FG000|COMPLETED|Core + Extension||23
6485729|NCT01338415|7403728|FG001|COMPLETED|Core + Extension||22
6485730|NCT01338415|7403729|FG002|COMPLETED|Core + Extension||0
6485731|NCT01338415|7403727|FG000|NOT COMPLETED|Core + Extension||10
6485732|NCT01338415|7403728|FG001|NOT COMPLETED|Core + Extension||9
6485733|NCT01338415|7403729|FG002|NOT COMPLETED|Core + Extension||0
6485734|NCT01338415|7403727|FG000|STARTED|Exceptional Use Treatment Period||0
6485735|NCT01338415|7403728|FG001|STARTED|Exceptional Use Treatment Period||0
6485736|NCT01338415|7403729|FG002|STARTED|Exceptional Use Treatment Period||10
6485737|NCT01338415|7403727|FG000|COMPLETED|Exceptional Use Treatment Period||0
6485738|NCT01338415|7403728|FG001|COMPLETED|Exceptional Use Treatment Period||0
6485739|NCT01338415|7403729|FG002|COMPLETED|Exceptional Use Treatment Period||4
6485740|NCT01338415|7403727|FG000|NOT COMPLETED|Exceptional Use Treatment Period||0
6485741|NCT01338415|7403728|FG001|NOT COMPLETED|Exceptional Use Treatment Period||0
6485742|NCT01338415|7403729|FG002|NOT COMPLETED|Exceptional Use Treatment Period||6
6485743|NCT01338493|7403737|FG000|STARTED|Enrolled||139
6485744|NCT01338493|7403737|FG000|COMPLETED|Enrolled||134
6485745|NCT01338493|7403737|FG000|NOT COMPLETED|Enrolled||5
6485746|NCT01338493|7403737|FG000|STARTED|Implant||134
6485747|NCT01338493|7403737|FG000|COMPLETED|Implant||134
6485748|NCT01338493|7403737|FG000|NOT COMPLETED|Implant||0
6485749|NCT01338493|7403737|FG000|STARTED|Discharge||134
6485750|NCT01338493|7403737|FG000|COMPLETED|Discharge||132
6485751|NCT01338493|7403737|FG000|NOT COMPLETED|Discharge||2
6485752|NCT01338493|7403737|FG000|STARTED|6 Months Follow up||132
6485753|NCT01338493|7403737|FG000|COMPLETED|6 Months Follow up||113
6485754|NCT01338493|7403737|FG000|NOT COMPLETED|6 Months Follow up||19
6485755|NCT01338493|7403737|FG000|STARTED|12 Months Follow up||113
6485756|NCT01338493|7403737|FG000|COMPLETED|12 Months Follow up||104
6485757|NCT01338493|7403737|FG000|NOT COMPLETED|12 Months Follow up||9
6485758|NCT01338493|7403737|FG000|STARTED|24 Months Follow up||104
6485759|NCT01338493|7403737|FG000|COMPLETED|24 Months Follow up||104
6485760|NCT01338493|7403737|FG000|NOT COMPLETED|24 Months Follow up||0
6485761|NCT01338506|7403743|FG000|STARTED|Overall Study||54
6485762|NCT01338506|7403744|FG001|STARTED|Overall Study||27
6485763|NCT01338506|7403743|FG000|COMPLETED|Overall Study||29
6485764|NCT01338506|7403744|FG001|COMPLETED|Overall Study||13
6485765|NCT01338506|7403743|FG000|NOT COMPLETED|Overall Study||25
6485766|NCT01338506|7403744|FG001|NOT COMPLETED|Overall Study||14
6485767|NCT01338610|7403757|FG000|STARTED|Overall Study||39
6485768|NCT01338610|7403758|FG001|STARTED|Overall Study||56
6485769|NCT01338610|7403759|FG002|STARTED|Overall Study||29
6485770|NCT01338610|7403757|FG000|COMPLETED|Overall Study||34
6485771|NCT01338610|7403758|FG001|COMPLETED|Overall Study||55
6485772|NCT01338610|7403759|FG002|COMPLETED|Overall Study||28
6485773|NCT01338610|7403757|FG000|NOT COMPLETED|Overall Study||5
6485774|NCT01338610|7403758|FG001|NOT COMPLETED|Overall Study||1
6485775|NCT01338610|7403759|FG002|NOT COMPLETED|Overall Study||1
6485776|NCT01338649|7403768|FG000|STARTED|Overall Study||13
6485777|NCT01338649|7403769|FG001|STARTED|Overall Study||14
6485778|NCT01338649|7403768|FG000|COMPLETED|Overall Study||13
6485779|NCT01338649|7403769|FG001|COMPLETED|Overall Study||14
6485780|NCT01338649|7403768|FG000|NOT COMPLETED|Overall Study||0
6485781|NCT01338649|7403769|FG001|NOT COMPLETED|Overall Study||0
6485782|NCT01338792|7403775|FG000|STARTED|Overall Study||47
6485783|NCT01338792|7403775|FG000|COMPLETED|Overall Study||43
6485784|NCT01338792|7403775|FG000|NOT COMPLETED|Overall Study||4
6485785|NCT01338818|7403779|FG000|STARTED|Overall Study||298
6485786|NCT01338818|7403779|FG000|COMPLETED|Overall Study||262
6485787|NCT01338818|7403779|FG000|NOT COMPLETED|Overall Study||36
6485788|NCT01338857|7403783|FG000|STARTED|Overall Study||12
6485789|NCT01338857|7403783|FG000|COMPLETED|Overall Study||1
6485790|NCT01338857|7403783|FG000|NOT COMPLETED|Overall Study||11
6485791|NCT01338870|7403793|FG000|STARTED|Overall Study||50
6485792|NCT01338870|7403794|FG001|STARTED|Overall Study||49
6485793|NCT01338870|7403795|FG002|STARTED|Overall Study||50
6485794|NCT01338870|7403796|FG003|STARTED|Overall Study||50
6485795|NCT01338870|7403797|FG004|STARTED|Overall Study||52
6485796|NCT01338870|7403798|FG005|STARTED|Overall Study||50
6485797|NCT01338870|7403793|FG000|COMPLETED|Overall Study||41
6485798|NCT01338870|7403794|FG001|COMPLETED|Overall Study||37
6485799|NCT01338870|7403795|FG002|COMPLETED|Overall Study||39
6485800|NCT01338870|7403796|FG003|COMPLETED|Overall Study||41
6485801|NCT01338870|7403797|FG004|COMPLETED|Overall Study||46
6485802|NCT01338870|7403798|FG005|COMPLETED|Overall Study||44
6485803|NCT01338870|7403793|FG000|NOT COMPLETED|Overall Study||9
6485804|NCT01338870|7403794|FG001|NOT COMPLETED|Overall Study||12
6485805|NCT01338870|7403795|FG002|NOT COMPLETED|Overall Study||11
6485806|NCT01338870|7403796|FG003|NOT COMPLETED|Overall Study||9
6485807|NCT01338870|7403797|FG004|NOT COMPLETED|Overall Study||6
6485808|NCT01338870|7403798|FG005|NOT COMPLETED|Overall Study||6
6485809|NCT01338987|7403817|FG000|STARTED|Overall Study||12
6485810|NCT01338987|7403818|FG001|STARTED|Overall Study||9
6485811|NCT01338987|7403819|FG002|STARTED|Overall Study||22
6485812|NCT01338987|7403820|FG003|STARTED|Overall Study||31
6485813|NCT01338987|7403821|FG004|STARTED|Overall Study||2
6485814|NCT01338987|7403817|FG000|COMPLETED|Overall Study||10
6485815|NCT01338987|7403818|FG001|COMPLETED|Overall Study||8
6485816|NCT01338987|7403819|FG002|COMPLETED|Overall Study||20
6485817|NCT01338987|7403820|FG003|COMPLETED|Overall Study||31
6485818|NCT01338987|7403821|FG004|COMPLETED|Overall Study||2
6485819|NCT01338987|7403817|FG000|NOT COMPLETED|Overall Study||2
6485820|NCT01338987|7403818|FG001|NOT COMPLETED|Overall Study||1
6485821|NCT01338987|7403819|FG002|NOT COMPLETED|Overall Study||2
6485822|NCT01338987|7403820|FG003|NOT COMPLETED|Overall Study||0
6485823|NCT01338987|7403821|FG004|NOT COMPLETED|Overall Study||0
6485824|NCT01339000|7403837|FG000|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
6485825|NCT01339000|7403838|FG001|STARTED|Overall Study||0
6485826|NCT01339000|7403837|FG000|COMPLETED|Overall Study||0
6485827|NCT01339000|7403838|FG001|COMPLETED|Overall Study||0
6485828|NCT01339000|7403837|FG000|NOT COMPLETED|Overall Study||1
6485829|NCT01339000|7403838|FG001|NOT COMPLETED|Overall Study||0
6485830|NCT01339013|7403847|FG000|STARTED|Overall Study||6
6485831|NCT01339013|7403847|FG000|COMPLETED|Overall Study||6
6485832|NCT01339013|7403847|FG000|NOT COMPLETED|Overall Study||0
6485833|NCT01339052|7403853|FG000|STARTED|Overall Study||15
6485834|NCT01339052|7403854|FG001|STARTED|Overall Study||50
6485835|NCT01339052|7403853|FG000|Measurable Disease|Overall Study||11
6485836|NCT01339052|7403854|FG001|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
6485837|NCT01339052|7403853|FG000|Evaluable Tumor Sample at Surgery|Overall Study||14
6485838|NCT01339052|7403854|FG001|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
6485839|NCT01339052|7403853|FG000|Evaluable Plasma Sample at Surgery|Overall Study||13
6485840|NCT01339052|7403854|FG001|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
6485841|NCT01339052|7403853|FG000|COMPLETED|Overall Study||0
6485842|NCT01339052|7403854|FG001|COMPLETED|Overall Study||0
6485843|NCT01339052|7403853|FG000|NOT COMPLETED|Overall Study||15
6485844|NCT01339052|7403854|FG001|NOT COMPLETED|Overall Study||50
6485845|NCT01339091|7403865|FG000|STARTED|Overall Study||288
6485846|NCT01339091|7403866|FG001|STARTED|Overall Study||285
6485847|NCT01339091|7403865|FG000|Safety Population|Overall Study||284
6485848|NCT01339091|7403866|FG001|Safety Population|Overall Study||284
6485849|NCT01339091|7403865|FG000|COMPLETED|Overall Study||261
6485850|NCT01339091|7403866|FG001|COMPLETED|Overall Study||257
6485851|NCT01339091|7403865|FG000|NOT COMPLETED|Overall Study||27
6485852|NCT01339091|7403866|FG001|NOT COMPLETED|Overall Study||28
6485853|NCT01339247|7403872|FG000|STARTED|Period 1||30
6485854|NCT01339247|7403873|FG001|STARTED|Period 1||30
6485855|NCT01339247|7403872|FG000|COMPLETED|Period 1||30
6485856|NCT01339247|7403873|FG001|COMPLETED|Period 1||30
6485857|NCT01339247|7403872|FG000|NOT COMPLETED|Period 1||0
6485858|NCT01339247|7403873|FG001|NOT COMPLETED|Period 1||0
6485859|NCT01339247|7403872|FG000|STARTED|Period 2||30
6485860|NCT01339247|7403873|FG001|STARTED|Period 2||30
6485861|NCT01339247|7403872|FG000|COMPLETED|Period 2||30
6485862|NCT01339247|7403873|FG001|COMPLETED|Period 2||30
6485863|NCT01339247|7403872|FG000|NOT COMPLETED|Period 2||0
6485864|NCT01339247|7403873|FG001|NOT COMPLETED|Period 2||0
6485865|NCT01339260|7403881|FG000|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
6485866|NCT01339260|7403882|FG001|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
6485867|NCT01339260|7403881|FG000|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
6485868|NCT01339260|7403882|FG001|Safety Population|Cycle 1|Patients receiving palonosetron|725
6485869|NCT01339260|7403881|FG000|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
6485870|NCT01339260|7403882|FG001|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
6485871|NCT01339260|7403881|FG000|COMPLETED|Cycle 1||719
6485872|NCT01339260|7403882|FG001|COMPLETED|Cycle 1||719
6485873|NCT01339260|7403881|FG000|NOT COMPLETED|Cycle 1||7
6485874|NCT01339260|7403882|FG001|NOT COMPLETED|Cycle 1||10
6485875|NCT01339260|7403881|FG000|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
6485876|NCT01339260|7403882|FG001|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
6485877|NCT01339260|7403881|FG000|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
6485878|NCT01339260|7403882|FG001|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
6485879|NCT01339260|7403881|FG000|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
6485880|NCT01339260|7403882|FG001|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
6485881|NCT01339260|7403881|FG000|NOT COMPLETED|Multi-cycle Extension||186
6485882|NCT01339260|7403882|FG001|NOT COMPLETED|Multi-cycle Extension||193
6485883|NCT01339273|7403892|FG000|STARTED|Overall Study||36
6485884|NCT01339273|7403893|FG001|STARTED|Overall Study||36
6485885|NCT01339273|7403892|FG000|COMPLETED|Overall Study||28
6485886|NCT01339273|7403893|FG001|COMPLETED|Overall Study||28
6485887|NCT01339273|7403892|FG000|NOT COMPLETED|Overall Study||8
6485888|NCT01339273|7403893|FG001|NOT COMPLETED|Overall Study||8
6485889|NCT01339299|7403901|FG000|STARTED|Overall Study||50
6485890|NCT01339299|7403902|FG001|STARTED|Overall Study||50
6485891|NCT01339299|7403901|FG000|COMPLETED|Overall Study||50
6485892|NCT01339299|7403902|FG001|COMPLETED|Overall Study||50
6485893|NCT01339299|7403901|FG000|NOT COMPLETED|Overall Study||0
6485894|NCT01339299|7403902|FG001|NOT COMPLETED|Overall Study||0
6485895|NCT01339390|7403910|FG000|STARTED|Overall Study||1571
6485896|NCT01339390|7403911|FG001|STARTED|Overall Study||1598
6485897|NCT01339390|7403910|FG000|COMPLETED|Overall Study||1414
6485898|NCT01339390|7403911|FG001|COMPLETED|Overall Study||1442
6485899|NCT01339390|7403910|FG000|NOT COMPLETED|Overall Study||157
6485900|NCT01339390|7403911|FG001|NOT COMPLETED|Overall Study||156
6485901|NCT01339403|7403919|FG000|STARTED|Overall Study||24768
6485902|NCT01339403|7403920|FG001|STARTED|Overall Study||257600
6485903|NCT01339403|7403919|FG000|COMPLETED|Overall Study||24768
6485904|NCT01339403|7403920|FG001|COMPLETED|Overall Study||257600
6485905|NCT01339403|7403919|FG000|NOT COMPLETED|Overall Study||0
6485906|NCT01339403|7403920|FG001|NOT COMPLETED|Overall Study||0
6485907|NCT01339416|7403926|FG000|STARTED|Overall Study||8202
6485908|NCT01339416|7403926|FG000|COMPLETED|Overall Study||8202
6485909|NCT01339416|7403926|FG000|NOT COMPLETED|Overall Study||0
6485910|NCT01339429|7403930|FG000|STARTED|Overall Study||41
6485911|NCT01339429|7403930|FG000|COMPLETED|Overall Study||37
6485912|NCT01339429|7403930|FG000|NOT COMPLETED|Overall Study||4
6485913|NCT01339559|7403934|FG000|STARTED|Overall Study||766
6485914|NCT01339559|7403934|FG000|COMPLETED|Overall Study||368
6485915|NCT01339559|7403934|FG000|NOT COMPLETED|Overall Study||398
6485916|NCT01339832|7403939|FG000|STARTED|Overall Study||51
6485917|NCT01339832|7403939|FG000|COMPLETED|Overall Study||37
6485918|NCT01339832|7403939|FG000|NOT COMPLETED|Overall Study||14
6485919|NCT01339858|7403945|FG000|STARTED|Overall Study||30
6485920|NCT01339858|7403946|FG001|STARTED|Overall Study||30
6485921|NCT01339858|7403945|FG000|COMPLETED|Overall Study||14
6485922|NCT01339858|7403946|FG001|COMPLETED|Overall Study||18
6485923|NCT01339858|7403945|FG000|NOT COMPLETED|Overall Study||16
6485924|NCT01339858|7403946|FG001|NOT COMPLETED|Overall Study||12
6485925|NCT01339897|7403958|FG000|STARTED|Overall Study||7
6485926|NCT01339897|7403959|FG001|STARTED|Overall Study||6
6485927|NCT01339897|7403960|FG002|STARTED|Overall Study||6
6485928|NCT01339897|7403961|FG003|STARTED|Overall Study||6
6485929|NCT01339897|7403958|FG000|COMPLETED|Overall Study||6
6485930|NCT01339897|7403959|FG001|COMPLETED|Overall Study||6
6485931|NCT01339897|7403960|FG002|COMPLETED|Overall Study||6
6485932|NCT01339897|7403961|FG003|COMPLETED|Overall Study||5
6485933|NCT01339897|7403958|FG000|NOT COMPLETED|Overall Study||1
6485934|NCT01339897|7403959|FG001|NOT COMPLETED|Overall Study||0
6485935|NCT01339897|7403960|FG002|NOT COMPLETED|Overall Study||0
6485936|NCT01339897|7403961|FG003|NOT COMPLETED|Overall Study||1
6485937|NCT01339910|7403975|FG000|STARTED|Overall Study||135
6485938|NCT01339910|7403976|FG001|STARTED|Overall Study||137
6485939|NCT01339910|7403975|FG000|COMPLETED|Overall Study||132
6485940|NCT01339910|7403976|FG001|COMPLETED|Overall Study||133
6485941|NCT01339910|7403975|FG000|NOT COMPLETED|Overall Study||3
6485942|NCT01339910|7403976|FG001|NOT COMPLETED|Overall Study||4
6485943|NCT01339923|7403989|FG000|STARTED|Overall Study||253
6485944|NCT01339923|7403990|FG001|STARTED|Overall Study||250
6485945|NCT01339923|7403991|FG002|STARTED|Overall Study||251
6485946|NCT01339923|7403992|FG003|STARTED|Overall Study||104
6485947|NCT01339923|7403993|FG004|STARTED|Overall Study||300
6485948|NCT01339923|7403994|FG005|STARTED|Overall Study||126
6485949|NCT01339923|7403995|FG006|STARTED|Overall Study||125
6485950|NCT01339923|7403989|FG000|COMPLETED|Overall Study||239
6485951|NCT01339923|7403990|FG001|COMPLETED|Overall Study||234
6485952|NCT01339923|7403991|FG002|COMPLETED|Overall Study||243
6485953|NCT01339923|7403992|FG003|COMPLETED|Overall Study||100
6485954|NCT01339923|7403993|FG004|COMPLETED|Overall Study||295
6485955|NCT01339923|7403994|FG005|COMPLETED|Overall Study||117
6485956|NCT01339923|7403995|FG006|COMPLETED|Overall Study||111
6485957|NCT01339923|7403989|FG000|NOT COMPLETED|Overall Study||14
6485958|NCT01339923|7403990|FG001|NOT COMPLETED|Overall Study||16
6485959|NCT01339923|7403991|FG002|NOT COMPLETED|Overall Study||8
6485960|NCT01339923|7403992|FG003|NOT COMPLETED|Overall Study||4
6485961|NCT01339923|7403993|FG004|NOT COMPLETED|Overall Study||5
6485962|NCT01339923|7403994|FG005|NOT COMPLETED|Overall Study||9
6485963|NCT01339923|7403995|FG006|NOT COMPLETED|Overall Study||14
6485964|NCT01339936|7404024|FG000|STARTED|Overall Study|plus 2 screen failures|38
6485965|NCT01339936|7404024|FG000|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
6485966|NCT01339936|7404024|FG000|NOT COMPLETED|Overall Study||2
6485967|NCT01340014|7404030|FG000|STARTED|Period 1, First 7 Days||55
6485968|NCT01340014|7404031|FG001|STARTED|Period 1, First 7 Days||57
6485969|NCT01340014|7404030|FG000|COMPLETED|Period 1, First 7 Days||53
6485970|NCT01340014|7404031|FG001|COMPLETED|Period 1, First 7 Days||57
6485971|NCT01340014|7404030|FG000|NOT COMPLETED|Period 1, First 7 Days||2
6485972|NCT01340014|7404031|FG001|NOT COMPLETED|Period 1, First 7 Days||0
6485973|NCT01340014|7404030|FG000|STARTED|Period 2, Second 7 Days||53
6485974|NCT01340014|7404031|FG001|STARTED|Period 2, Second 7 Days||57
6485975|NCT01340014|7404030|FG000|COMPLETED|Period 2, Second 7 Days||53
6485976|NCT01340014|7404031|FG001|COMPLETED|Period 2, Second 7 Days||56
6485977|NCT01340014|7404030|FG000|NOT COMPLETED|Period 2, Second 7 Days||0
6485978|NCT01340014|7404031|FG001|NOT COMPLETED|Period 2, Second 7 Days||1
6485979|NCT01340027|7404049|FG000|STARTED|Overall Study||81
6485980|NCT01340027|7404050|FG001|STARTED|Overall Study||78
6485981|NCT01340027|7404051|FG002|STARTED|Overall Study||79
6485982|NCT01340027|7404052|FG003|STARTED|Overall Study||79
6485983|NCT01340027|7404053|FG004|STARTED|Overall Study||156
6485984|NCT01340027|7404054|FG005|STARTED|Overall Study||78
6485985|NCT01340027|7404055|FG006|STARTED|Overall Study||149
6485986|NCT01340027|7404056|FG007|STARTED|Overall Study||149
6485987|NCT01340027|7404057|FG008|STARTED|Overall Study||144
6485988|NCT01340027|7404058|FG009|STARTED|Overall Study||152
6485989|NCT01340027|7404059|FG010|STARTED|Overall Study||81
6485990|NCT01340027|7404060|FG011|STARTED|Overall Study||81
6485991|NCT01340027|7404049|FG000|Received Treatment|Overall Study||81
6485992|NCT01340027|7404050|FG001|Received Treatment|Overall Study||78
6485993|NCT01340027|7404051|FG002|Received Treatment|Overall Study||78
6485994|NCT01340027|7404052|FG003|Received Treatment|Overall Study||79
6485995|NCT01340027|7404053|FG004|Received Treatment|Overall Study||156
6485996|NCT01340027|7404054|FG005|Received Treatment|Overall Study||78
6485997|NCT01340027|7404055|FG006|Received Treatment|Overall Study||149
6485998|NCT01340027|7404056|FG007|Received Treatment|Overall Study||149
6485999|NCT01340027|7404057|FG008|Received Treatment|Overall Study||144
6486000|NCT01340027|7404058|FG009|Received Treatment|Overall Study||152
6486001|NCT01340027|7404059|FG010|Received Treatment|Overall Study||81
6486002|NCT01340027|7404060|FG011|Received Treatment|Overall Study||81
6486003|NCT01340027|7404049|FG000|COMPLETED|Overall Study||76
6486004|NCT01340027|7404050|FG001|COMPLETED|Overall Study||71
6486005|NCT01340027|7404051|FG002|COMPLETED|Overall Study||75
6486006|NCT01340027|7404052|FG003|COMPLETED|Overall Study||75
6486007|NCT01340027|7404053|FG004|COMPLETED|Overall Study||146
6486008|NCT01340027|7404054|FG005|COMPLETED|Overall Study||74
6486009|NCT01340027|7404055|FG006|COMPLETED|Overall Study||142
6486010|NCT01340027|7404056|FG007|COMPLETED|Overall Study||142
6486011|NCT01340027|7404057|FG008|COMPLETED|Overall Study||136
6486012|NCT01340027|7404058|FG009|COMPLETED|Overall Study||146
6486013|NCT01340027|7404059|FG010|COMPLETED|Overall Study||79
6486014|NCT01340027|7404060|FG011|COMPLETED|Overall Study||77
6486015|NCT01340027|7404049|FG000|NOT COMPLETED|Overall Study||5
6486016|NCT01340027|7404050|FG001|NOT COMPLETED|Overall Study||7
6486017|NCT01340027|7404051|FG002|NOT COMPLETED|Overall Study||4
6486018|NCT01340027|7404052|FG003|NOT COMPLETED|Overall Study||4
6486019|NCT01340027|7404053|FG004|NOT COMPLETED|Overall Study||10
6486020|NCT01340027|7404054|FG005|NOT COMPLETED|Overall Study||4
6486021|NCT01340027|7404055|FG006|NOT COMPLETED|Overall Study||7
6486022|NCT01340027|7404056|FG007|NOT COMPLETED|Overall Study||7
6486023|NCT01340027|7404057|FG008|NOT COMPLETED|Overall Study||8
6486024|NCT01340027|7404058|FG009|NOT COMPLETED|Overall Study||6
6486025|NCT01340027|7404059|FG010|NOT COMPLETED|Overall Study||2
6486026|NCT01340027|7404060|FG011|NOT COMPLETED|Overall Study||4
6486027|NCT01340053|7404090|FG000|STARTED|Overall Study||47
6486028|NCT01340053|7404091|FG001|STARTED|Overall Study||46
6486029|NCT01340053|7404092|FG002|STARTED|Overall Study||47
6486030|NCT01340053|7404093|FG003|STARTED|Overall Study||46
6486031|NCT01340053|7404090|FG000|COMPLETED|Overall Study||43
6486032|NCT01340053|7404091|FG001|COMPLETED|Overall Study||44
6486033|NCT01340053|7404092|FG002|COMPLETED|Overall Study||43
6486034|NCT01340053|7404093|FG003|COMPLETED|Overall Study||43
6486035|NCT01340053|7404090|FG000|NOT COMPLETED|Overall Study||4
6486036|NCT01340053|7404091|FG001|NOT COMPLETED|Overall Study||2
6486037|NCT01340053|7404092|FG002|NOT COMPLETED|Overall Study||4
6486038|NCT01340053|7404093|FG003|NOT COMPLETED|Overall Study||3
6486039|NCT01340066|7404105|FG000|STARTED|Placebo Run in Period||94
6486040|NCT01340066|7404106|FG001|STARTED|Placebo Run in Period||0
6486041|NCT01340066|7404107|FG002|STARTED|Placebo Run in Period||0
6486042|NCT01340066|7404105|FG000|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
6486043|NCT01340066|7404106|FG001|COMPLETED|Placebo Run in Period||0
6486044|NCT01340066|7404107|FG002|COMPLETED|Placebo Run in Period||0
6486045|NCT01340066|7404105|FG000|NOT COMPLETED|Placebo Run in Period||27
6486046|NCT01340066|7404106|FG001|NOT COMPLETED|Placebo Run in Period||0
6486047|NCT01340066|7404107|FG002|NOT COMPLETED|Placebo Run in Period||0
6486048|NCT01340066|7404105|FG000|STARTED|5 Week Double Blind Randomization Period||0
6486049|NCT01340066|7404106|FG001|STARTED|5 Week Double Blind Randomization Period||33
6486050|NCT01340066|7404107|FG002|STARTED|5 Week Double Blind Randomization Period||34
6554961|NCT01748994|7477051|FG001|NOT COMPLETED|Overall Study||6
6486051|NCT01340066|7404105|FG000|COMPLETED|5 Week Double Blind Randomization Period||0
6486052|NCT01340066|7404106|FG001|COMPLETED|5 Week Double Blind Randomization Period||28
6486053|NCT01340066|7404107|FG002|COMPLETED|5 Week Double Blind Randomization Period||31
6486054|NCT01340066|7404105|FG000|NOT COMPLETED|5 Week Double Blind Randomization Period||0
6486055|NCT01340066|7404106|FG001|NOT COMPLETED|5 Week Double Blind Randomization Period||5
6486056|NCT01340066|7404107|FG002|NOT COMPLETED|5 Week Double Blind Randomization Period||3
6486057|NCT01340144|7404116|FG000|STARTED|Overall Study||625
6486058|NCT01340144|7404117|FG001|STARTED|Overall Study||625
6486059|NCT01340144|7404116|FG000|COMPLETED|Overall Study||553
6486060|NCT01340144|7404117|FG001|COMPLETED|Overall Study||567
6486061|NCT01340144|7404116|FG000|NOT COMPLETED|Overall Study||72
6486062|NCT01340144|7404117|FG001|NOT COMPLETED|Overall Study||58
6486063|NCT01340196|7404123|FG000|STARTED|Treat. Period 1 (Tenofovir)||16
6486064|NCT01340196|7404123|FG000|COMPLETED|Treat. Period 1 (Tenofovir)||16
6486065|NCT01340196|7404123|FG000|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
6486066|NCT01340196|7404123|FG000|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
6486067|NCT01340196|7404123|FG000|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
6486068|NCT01340196|7404123|FG000|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
6486069|NCT01340196|7404123|FG000|STARTED|Treat. Period 3 (Faldaprevir)||16
6486070|NCT01340196|7404123|FG000|COMPLETED|Treat. Period 3 (Faldaprevir)||14
6486071|NCT01340196|7404123|FG000|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
6486072|NCT01340209|7404135|FG000|STARTED|Overall Study||57
6486073|NCT01340209|7404136|FG001|STARTED|Overall Study||114
6486074|NCT01340209|7404137|FG002|STARTED|Overall Study||114
6486075|NCT01340209|7404135|FG000|COMPLETED|Overall Study||52
6486076|NCT01340209|7404136|FG001|COMPLETED|Overall Study||106
6486077|NCT01340209|7404137|FG002|COMPLETED|Overall Study||106
6486078|NCT01340209|7404135|FG000|NOT COMPLETED|Overall Study||5
6486079|NCT01340209|7404136|FG001|NOT COMPLETED|Overall Study||8
6486080|NCT01340209|7404137|FG002|NOT COMPLETED|Overall Study||8
6486081|NCT01340300|7404149|FG000|STARTED|Overall Study||35
6486082|NCT01340300|7404150|FG001|STARTED|Overall Study||35
6486083|NCT01340300|7404151|FG002|STARTED|Overall Study||35
6486084|NCT01340300|7404152|FG003|STARTED|Overall Study||34
6486085|NCT01340300|7404149|FG000|Baseline Blood Sample|Overall Study||33
6486086|NCT01340300|7404150|FG001|Baseline Blood Sample|Overall Study||34
6486087|NCT01340300|7404151|FG002|Baseline Blood Sample|Overall Study||32
6486088|NCT01340300|7404152|FG003|Baseline Blood Sample|Overall Study||29
6486089|NCT01340300|7404149|FG000|Follow-up Blood Sample|Overall Study||25
6486090|NCT01340300|7404150|FG001|Follow-up Blood Sample|Overall Study||26
6486091|NCT01340300|7404151|FG002|Follow-up Blood Sample|Overall Study||19
6486092|NCT01340300|7404152|FG003|Follow-up Blood Sample|Overall Study||18
6486093|NCT01340300|7404149|FG000|COMPLETED|Overall Study||26
6486094|NCT01340300|7404150|FG001|COMPLETED|Overall Study||26
6486095|NCT01340300|7404151|FG002|COMPLETED|Overall Study||20
6486096|NCT01340300|7404152|FG003|COMPLETED|Overall Study||20
6486097|NCT01340300|7404149|FG000|NOT COMPLETED|Overall Study||9
6486098|NCT01340300|7404150|FG001|NOT COMPLETED|Overall Study||9
6486099|NCT01340300|7404151|FG002|NOT COMPLETED|Overall Study||15
6486100|NCT01340300|7404152|FG003|NOT COMPLETED|Overall Study||14
6486101|NCT01340482|7404165|FG000|STARTED|Overall Study||27
6486102|NCT01340482|7404166|FG001|STARTED|Overall Study||1
6486103|NCT01340482|7404167|FG002|STARTED|Overall Study||1
6486104|NCT01340482|7404165|FG000|COMPLETED|Overall Study||25
6486105|NCT01340482|7404166|FG001|COMPLETED|Overall Study||1
6486106|NCT01340482|7404167|FG002|COMPLETED|Overall Study||1
6486107|NCT01340482|7404165|FG000|NOT COMPLETED|Overall Study||2
6486108|NCT01340482|7404166|FG001|NOT COMPLETED|Overall Study||0
6486109|NCT01340482|7404167|FG002|NOT COMPLETED|Overall Study||0
6486110|NCT01340495|7404177|FG000|STARTED|Overall Study||70
6486111|NCT01340495|7404177|FG000|COMPLETED|Overall Study||69
6486112|NCT01340495|7404177|FG000|NOT COMPLETED|Overall Study||1
6486113|NCT01340586|7404183|FG000|STARTED|Overall Study||8
6486114|NCT01340586|7404184|FG001|STARTED|Overall Study||8
6486115|NCT01340586|7404183|FG000|COMPLETED|Overall Study||8
6486116|NCT01340586|7404184|FG001|COMPLETED|Overall Study||8
6486117|NCT01340586|7404183|FG000|NOT COMPLETED|Overall Study||0
6486118|NCT01340586|7404184|FG001|NOT COMPLETED|Overall Study||0
6486119|NCT01340625|7404197|FG000|STARTED|First Intervention||18
6554962|NCT01749033|7477060|FG000|STARTED|Overall Study||150
6554963|NCT01749033|7477061|FG001|STARTED|Overall Study||150
6486120|NCT01340625|7404198|FG001|STARTED|First Intervention||18
6486121|NCT01340625|7404197|FG000|COMPLETED|First Intervention||17
6486122|NCT01340625|7404198|FG001|COMPLETED|First Intervention||18
6486123|NCT01340625|7404197|FG000|NOT COMPLETED|First Intervention||1
6486124|NCT01340625|7404198|FG001|NOT COMPLETED|First Intervention||0
6486125|NCT01340625|7404197|FG000|STARTED|Washout Period of 28 Days||17
6486126|NCT01340625|7404198|FG001|STARTED|Washout Period of 28 Days||18
6486127|NCT01340625|7404197|FG000|COMPLETED|Washout Period of 28 Days||16
6486128|NCT01340625|7404198|FG001|COMPLETED|Washout Period of 28 Days||18
6486129|NCT01340625|7404197|FG000|NOT COMPLETED|Washout Period of 28 Days||1
6486130|NCT01340625|7404198|FG001|NOT COMPLETED|Washout Period of 28 Days||0
6486131|NCT01340625|7404197|FG000|STARTED|Second Intervention||16
6486132|NCT01340625|7404198|FG001|STARTED|Second Intervention||18
6486133|NCT01340625|7404197|FG000|COMPLETED|Second Intervention||16
6486134|NCT01340625|7404198|FG001|COMPLETED|Second Intervention||18
6486135|NCT01340625|7404197|FG000|NOT COMPLETED|Second Intervention||0
6486136|NCT01340625|7404198|FG001|NOT COMPLETED|Second Intervention||0
6486137|NCT01340651|7404204|FG000|STARTED|Overall Study||41
6486138|NCT01340651|7404204|FG000|COMPLETED|Overall Study||24
6486139|NCT01340651|7404204|FG000|NOT COMPLETED|Overall Study||17
6486140|NCT01340664|7404213|FG000|STARTED|Overall Study||93
6486141|NCT01340664|7404214|FG001|STARTED|Overall Study||93
6486142|NCT01340664|7404215|FG002|STARTED|Overall Study||93
6486143|NCT01340664|7404213|FG000|COMPLETED|Overall Study||86
6486144|NCT01340664|7404214|FG001|COMPLETED|Overall Study||85
6554964|NCT01749033|7477062|FG002|STARTED|Overall Study||150
6486145|NCT01340664|7404215|FG002|COMPLETED|Overall Study||80
6486146|NCT01340664|7404213|FG000|NOT COMPLETED|Overall Study||7
6486147|NCT01340664|7404214|FG001|NOT COMPLETED|Overall Study||8
6486148|NCT01340664|7404215|FG002|NOT COMPLETED|Overall Study||13
6486149|NCT01340768|7404225|FG000|STARTED|Overall Study||436
6486150|NCT01340768|7404226|FG001|STARTED|Overall Study||434
6486151|NCT01340768|7404225|FG000|COMPLETED|Overall Study||419
6554965|NCT01749033|7477060|FG000|COMPLETED|Overall Study||147
6486152|NCT01340768|7404226|FG001|COMPLETED|Overall Study||429
6486153|NCT01340768|7404225|FG000|NOT COMPLETED|Overall Study||17
6486154|NCT01340768|7404226|FG001|NOT COMPLETED|Overall Study||5
6486155|NCT01340794|7404234|FG000|STARTED|Overall Study||2
6486156|NCT01340794|7404235|FG001|STARTED|Overall Study||5
6486157|NCT01340794|7404234|FG000|COMPLETED|Overall Study||2
6486158|NCT01340794|7404235|FG001|COMPLETED|Overall Study||4
6486159|NCT01340794|7404234|FG000|NOT COMPLETED|Overall Study||0
6486160|NCT01340794|7404235|FG001|NOT COMPLETED|Overall Study||1
6486161|NCT01340872|7404245|FG000|STARTED|Double-blind Phase||64
6486162|NCT01340872|7404246|FG001|STARTED|Double-blind Phase||64
6486163|NCT01340872|7404247|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
6486164|NCT01340872|7404248|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
6486165|NCT01340872|7404245|FG000|COMPLETED|Double-blind Phase||55
6486166|NCT01340872|7404246|FG001|COMPLETED|Double-blind Phase||53
6486167|NCT01340872|7404247|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
6486168|NCT01340872|7404248|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
6486169|NCT01340872|7404245|FG000|NOT COMPLETED|Double-blind Phase||9
6486170|NCT01340872|7404246|FG001|NOT COMPLETED|Double-blind Phase||11
6486171|NCT01340872|7404247|FG002|NOT COMPLETED|Double-blind Phase||0
6486172|NCT01340872|7404248|FG003|NOT COMPLETED|Double-blind Phase||0
6486173|NCT01340872|7404245|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
6486174|NCT01340872|7404246|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
6486175|NCT01340872|7404247|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
6486176|NCT01340872|7404248|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
6486177|NCT01340872|7404245|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
6486178|NCT01340872|7404246|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
6486179|NCT01340872|7404247|FG002|COMPLETED|Open-label Phase||37
6486180|NCT01340872|7404248|FG003|COMPLETED|Open-label Phase||36
6486181|NCT01340872|7404245|FG000|NOT COMPLETED|Open-label Phase||0
6486182|NCT01340872|7404246|FG001|NOT COMPLETED|Open-label Phase||0
6486183|NCT01340872|7404247|FG002|NOT COMPLETED|Open-label Phase||13
6486184|NCT01340872|7404248|FG003|NOT COMPLETED|Open-label Phase||11
6486185|NCT01340898|7404263|FG000|STARTED|Primary Phase||376
6486186|NCT01340898|7404264|FG001|STARTED|Primary Phase||187
6486187|NCT01340898|7404265|FG002|STARTED|Primary Phase||187
6486188|NCT01340898|7404263|FG000|COMPLETED|Primary Phase||360
6486189|NCT01340898|7404264|FG001|COMPLETED|Primary Phase||178
6486190|NCT01340898|7404265|FG002|COMPLETED|Primary Phase||181
6486191|NCT01340898|7404263|FG000|NOT COMPLETED|Primary Phase||16
6486192|NCT01340898|7404264|FG001|NOT COMPLETED|Primary Phase||9
6486193|NCT01340898|7404265|FG002|NOT COMPLETED|Primary Phase||6
6486194|NCT01340898|7404263|FG000|STARTED|Booster Phase||342
6486195|NCT01340898|7404264|FG001|STARTED|Booster Phase||166
6486196|NCT01340898|7404265|FG002|STARTED|Booster Phase||170
6486197|NCT01340898|7404263|FG000|COMPLETED|Booster Phase||332
6486198|NCT01340898|7404264|FG001|COMPLETED|Booster Phase||164
6486199|NCT01340898|7404265|FG002|COMPLETED|Booster Phase||163
6486200|NCT01340898|7404263|FG000|NOT COMPLETED|Booster Phase||10
6486201|NCT01340898|7404264|FG001|NOT COMPLETED|Booster Phase||2
6486202|NCT01340898|7404265|FG002|NOT COMPLETED|Booster Phase||7
6486203|NCT01340937|7404279|FG000|STARTED|Period 1: Infant Series||800
6486204|NCT01340937|7404280|FG001|STARTED|Period 1: Infant Series||797
6486205|NCT01340937|7404281|FG002|STARTED|Period 1: Infant Series||809
6486206|NCT01340937|7404282|FG003|STARTED|Period 1: Infant Series||402
6486207|NCT01340937|7404279|FG000|COMPLETED|Period 1: Infant Series||742
6486208|NCT01340937|7404280|FG001|COMPLETED|Period 1: Infant Series||737
6486209|NCT01340937|7404281|FG002|COMPLETED|Period 1: Infant Series||753
6486210|NCT01340937|7404282|FG003|COMPLETED|Period 1: Infant Series||370
6486211|NCT01340937|7404279|FG000|NOT COMPLETED|Period 1: Infant Series||58
6486212|NCT01340937|7404280|FG001|NOT COMPLETED|Period 1: Infant Series||60
6486213|NCT01340937|7404281|FG002|NOT COMPLETED|Period 1: Infant Series||56
6486214|NCT01340937|7404282|FG003|NOT COMPLETED|Period 1: Infant Series||32
6486215|NCT01340937|7404279|FG000|STARTED|Period 2: Interim Period||742
6486216|NCT01340937|7404280|FG001|STARTED|Period 2: Interim Period||737
6486217|NCT01340937|7404281|FG002|STARTED|Period 2: Interim Period||753
6486218|NCT01340937|7404282|FG003|STARTED|Period 2: Interim Period||370
6486219|NCT01340937|7404279|FG000|COMPLETED|Period 2: Interim Period||675
6486220|NCT01340937|7404280|FG001|COMPLETED|Period 2: Interim Period||658
6486221|NCT01340937|7404281|FG002|COMPLETED|Period 2: Interim Period||669
6486222|NCT01340937|7404282|FG003|COMPLETED|Period 2: Interim Period||329
6486223|NCT01340937|7404279|FG000|NOT COMPLETED|Period 2: Interim Period||67
6486224|NCT01340937|7404280|FG001|NOT COMPLETED|Period 2: Interim Period||79
6486225|NCT01340937|7404281|FG002|NOT COMPLETED|Period 2: Interim Period||84
6486226|NCT01340937|7404282|FG003|NOT COMPLETED|Period 2: Interim Period||41
6486227|NCT01340937|7404279|FG000|STARTED|Period 3: Toddler Vaccinations||675
6486228|NCT01340937|7404280|FG001|STARTED|Period 3: Toddler Vaccinations||658
6486229|NCT01340937|7404281|FG002|STARTED|Period 3: Toddler Vaccinations||669
6486230|NCT01340937|7404282|FG003|STARTED|Period 3: Toddler Vaccinations||329
6486231|NCT01340937|7404279|FG000|COMPLETED|Period 3: Toddler Vaccinations||666
6486232|NCT01340937|7404280|FG001|COMPLETED|Period 3: Toddler Vaccinations||641
6486233|NCT01340937|7404281|FG002|COMPLETED|Period 3: Toddler Vaccinations||660
6486234|NCT01340937|7404282|FG003|COMPLETED|Period 3: Toddler Vaccinations||319
6486235|NCT01340937|7404279|FG000|NOT COMPLETED|Period 3: Toddler Vaccinations||9
6486236|NCT01340937|7404280|FG001|NOT COMPLETED|Period 3: Toddler Vaccinations||17
6486237|NCT01340937|7404281|FG002|NOT COMPLETED|Period 3: Toddler Vaccinations||9
6486238|NCT01340937|7404282|FG003|NOT COMPLETED|Period 3: Toddler Vaccinations||10
6486239|NCT01340976|7404304|FG000|STARTED|Overall Study||4
6486240|NCT01340976|7404305|FG001|STARTED|Overall Study||3
6486241|NCT01340976|7404306|FG002|STARTED|Overall Study||7
6486242|NCT01340976|7404307|FG003|STARTED|Overall Study||5
6486243|NCT01340976|7404308|FG004|STARTED|Overall Study||7
6486244|NCT01340976|7404309|FG005|STARTED|Overall Study||7
6486245|NCT01340976|7404304|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
6486246|NCT01340976|7404305|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6486247|NCT01340976|7404306|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
6486248|NCT01340976|7404307|FG003|Received at Least 1 Dose of Study Drug|Overall Study||5
6486249|NCT01340976|7404308|FG004|Received at Least 1 Dose of Study Drug|Overall Study||7
6486250|NCT01340976|7404309|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
6486251|NCT01340976|7404304|FG000|COMPLETED|Overall Study||0
6486252|NCT01340976|7404305|FG001|COMPLETED|Overall Study||1
6486253|NCT01340976|7404306|FG002|COMPLETED|Overall Study||4
6486254|NCT01340976|7404307|FG003|COMPLETED|Overall Study||2
6486255|NCT01340976|7404308|FG004|COMPLETED|Overall Study||5
6486256|NCT01340976|7404309|FG005|COMPLETED|Overall Study||6
6486257|NCT01340976|7404304|FG000|NOT COMPLETED|Overall Study||4
6486258|NCT01340976|7404305|FG001|NOT COMPLETED|Overall Study||2
6486259|NCT01340976|7404306|FG002|NOT COMPLETED|Overall Study||3
6486260|NCT01340976|7404307|FG003|NOT COMPLETED|Overall Study||3
6486261|NCT01340976|7404308|FG004|NOT COMPLETED|Overall Study||2
6486262|NCT01340976|7404309|FG005|NOT COMPLETED|Overall Study||1
6486263|NCT01341067|7404329|FG000|STARTED|Overall Study||30
6486264|NCT01341067|7404329|FG000|COMPLETED|Overall Study||26
6554966|NCT01749033|7477061|FG001|COMPLETED|Overall Study||145
6554967|NCT01749033|7477062|FG002|COMPLETED|Overall Study||149
6554968|NCT01749033|7477060|FG000|NOT COMPLETED|Overall Study||3
6554969|NCT01749033|7477061|FG001|NOT COMPLETED|Overall Study||5
6486265|NCT01341067|7404329|FG000|NOT COMPLETED|Overall Study||4
6486266|NCT01341301|7404333|FG000|STARTED|Overall Study||25
6486267|NCT01341301|7404333|FG000|COMPLETED|Overall Study||25
6486268|NCT01341301|7404333|FG000|NOT COMPLETED|Overall Study||0
6486269|NCT01341444|7404341|FG000|STARTED|Overall Study||31
6486270|NCT01341444|7404342|FG001|STARTED|Overall Study||32
6486271|NCT01341444|7404341|FG000|COMPLETED|Overall Study||26
6486272|NCT01341444|7404342|FG001|COMPLETED|Overall Study||29
6486273|NCT01341444|7404341|FG000|NOT COMPLETED|Overall Study||5
6486274|NCT01341444|7404342|FG001|NOT COMPLETED|Overall Study||3
6486275|NCT01341457|7404350|FG000|STARTED|Overall Study||7
6486276|NCT01341457|7404351|FG001|STARTED|Overall Study||10
6486277|NCT01341457|7404350|FG000|Received at Least One Dose of Study Drug|Overall Study||7
6486278|NCT01341457|7404351|FG001|Received at Least One Dose of Study Drug|Overall Study||10
6486279|NCT01341457|7404350|FG000|COMPLETED|Overall Study||5
6486280|NCT01341457|7404351|FG001|COMPLETED|Overall Study||10
6486281|NCT01341457|7404350|FG000|NOT COMPLETED|Overall Study||2
6486282|NCT01341457|7404351|FG001|NOT COMPLETED|Overall Study||0
6486283|NCT01341470|7404364|FG000|STARTED|Overall Study||6
6486284|NCT01341470|7404365|FG001|STARTED|Overall Study||9
6486285|NCT01341470|7404366|FG002|STARTED|Overall Study||10
6486286|NCT01341470|7404367|FG003|STARTED|Overall Study||10
6486287|NCT01341470|7404368|FG004|STARTED|Overall Study||2
6486288|NCT01341470|7404369|FG005|STARTED|Overall Study||10
6486289|NCT01341470|7404364|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6486290|NCT01341470|7404365|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
6486291|NCT01341470|7404366|FG002|Received at Least 1 Dose of Study Drug|Overall Study||10
6486292|NCT01341470|7404367|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
6486293|NCT01341470|7404368|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
6486294|NCT01341470|7404369|FG005|Received at Least 1 Dose of Study Drug|Overall Study||10
6486295|NCT01341470|7404364|FG000|COMPLETED|Overall Study||6
6486296|NCT01341470|7404365|FG001|COMPLETED|Overall Study||9
6486297|NCT01341470|7404366|FG002|COMPLETED|Overall Study||9
6486298|NCT01341470|7404367|FG003|COMPLETED|Overall Study||9
6486299|NCT01341470|7404368|FG004|COMPLETED|Overall Study||2
6486300|NCT01341470|7404369|FG005|COMPLETED|Overall Study||9
6486301|NCT01341470|7404364|FG000|NOT COMPLETED|Overall Study||0
6486302|NCT01341470|7404365|FG001|NOT COMPLETED|Overall Study||0
6486303|NCT01341470|7404366|FG002|NOT COMPLETED|Overall Study||1
6486304|NCT01341470|7404367|FG003|NOT COMPLETED|Overall Study||1
6486305|NCT01341470|7404368|FG004|NOT COMPLETED|Overall Study||0
6486306|NCT01341470|7404369|FG005|NOT COMPLETED|Overall Study||1
6486307|NCT01341639|7404387|FG000|STARTED|Infant Series||628
6486308|NCT01341639|7404388|FG001|STARTED|Infant Series||622
6486309|NCT01341639|7404387|FG000|Site 0048 Excluded|Infant Series||611
6554970|NCT01749033|7477062|FG002|NOT COMPLETED|Overall Study||1
6486310|NCT01341639|7404388|FG001|Site 0048 Excluded|Infant Series||606
6486311|NCT01341639|7404387|FG000|Treated|Infant Series||610
6486312|NCT01341639|7404388|FG001|Treated|Infant Series||605
6486313|NCT01341639|7404387|FG000|COMPLETED|Infant Series||599
6486314|NCT01341639|7404388|FG001|COMPLETED|Infant Series||590
6486315|NCT01341639|7404387|FG000|NOT COMPLETED|Infant Series||29
6486316|NCT01341639|7404388|FG001|NOT COMPLETED|Infant Series||32
6486317|NCT01341639|7404387|FG000|STARTED|Interim Period||599
6486318|NCT01341639|7404388|FG001|STARTED|Interim Period||590
6486319|NCT01341639|7404387|FG000|COMPLETED|Interim Period||591
6486320|NCT01341639|7404388|FG001|COMPLETED|Interim Period||581
6486321|NCT01341639|7404387|FG000|NOT COMPLETED|Interim Period||8
6486322|NCT01341639|7404388|FG001|NOT COMPLETED|Interim Period||9
6486323|NCT01341639|7404387|FG000|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|590
6486324|NCT01341639|7404388|FG001|STARTED|Toddler Dose|One participant randomized to the PR5I group mistakenly received INFANRIX™ hexa instead|582
6486325|NCT01341639|7404387|FG000|COMPLETED|Toddler Dose||539
6486326|NCT01341639|7404388|FG001|COMPLETED|Toddler Dose||548
6486327|NCT01341639|7404387|FG000|NOT COMPLETED|Toddler Dose||51
6486328|NCT01341639|7404388|FG001|NOT COMPLETED|Toddler Dose||34
6486329|NCT01341639|7404387|FG000|STARTED|Post-Treatment||539
6486330|NCT01341639|7404388|FG001|STARTED|Post-Treatment||548
6486331|NCT01341639|7404387|FG000|COMPLETED|Post-Treatment||539
6486332|NCT01341639|7404388|FG001|COMPLETED|Post-Treatment||545
6486333|NCT01341639|7404387|FG000|NOT COMPLETED|Post-Treatment||0
6486334|NCT01341639|7404388|FG001|NOT COMPLETED|Post-Treatment||3
6486335|NCT01341652|7404396|FG000|STARTED|Overall Study||49
6486336|NCT01341652|7404397|FG001|STARTED|Overall Study||50
6486337|NCT01341652|7404396|FG000|COMPLETED|Overall Study||49
6486338|NCT01341652|7404397|FG001|COMPLETED|Overall Study||48
6486339|NCT01341652|7404396|FG000|NOT COMPLETED|Overall Study||0
6486340|NCT01341652|7404397|FG001|NOT COMPLETED|Overall Study||2
6486341|NCT01341730|7404405|FG000|STARTED|Overall Study||20
6486342|NCT01341730|7404406|FG001|STARTED|Overall Study||21
6486343|NCT01341730|7404405|FG000|COMPLETED|Overall Study||16
6486344|NCT01341730|7404406|FG001|COMPLETED|Overall Study||17
6486345|NCT01341730|7404405|FG000|NOT COMPLETED|Overall Study||4
6486346|NCT01341730|7404406|FG001|NOT COMPLETED|Overall Study||4
6486347|NCT01341782|7404416|FG000|STARTED|Overall Study||127
6486348|NCT01341782|7404417|FG001|STARTED|Overall Study||128
6554971|NCT01749215|7477073|FG000|STARTED|Overall Study||72
6486349|NCT01341782|7404416|FG000|COMPLETED|Overall Study||112
6486350|NCT01341782|7404417|FG001|COMPLETED|Overall Study||114
6486351|NCT01341782|7404416|FG000|NOT COMPLETED|Overall Study||15
6486352|NCT01341782|7404417|FG001|NOT COMPLETED|Overall Study||14
6486353|NCT01341912|7404423|FG000|STARTED|Overall Study||3
6486354|NCT01341912|7404423|FG000|COMPLETED|Overall Study||3
6486355|NCT01341912|7404423|FG000|NOT COMPLETED|Overall Study||0
6486356|NCT01341977|7404429|FG000|STARTED|Overall Study||288
6486357|NCT01341977|7404430|FG001|STARTED|Overall Study||285
6486358|NCT01341977|7404429|FG000|COMPLETED|Overall Study||274
6486359|NCT01341977|7404430|FG001|COMPLETED|Overall Study||270
6486360|NCT01341977|7404429|FG000|NOT COMPLETED|Overall Study||14
6486361|NCT01341977|7404430|FG001|NOT COMPLETED|Overall Study||15
6486362|NCT01341990|7404438|FG000|STARTED|Overall Study||35
6486363|NCT01341990|7404439|FG001|STARTED|Overall Study||33
6486364|NCT01341990|7404438|FG000|COMPLETED|Overall Study||32
6486365|NCT01341990|7404439|FG001|COMPLETED|Overall Study||32
6486366|NCT01341990|7404438|FG000|NOT COMPLETED|Overall Study||3
6486367|NCT01341990|7404439|FG001|NOT COMPLETED|Overall Study||1
6486368|NCT01342029|7404445|FG000|STARTED|Period 1||70
6486369|NCT01342029|7404446|FG001|STARTED|Period 1||72
6486370|NCT01342029|7404445|FG000|Dropout|Period 1||3
6486371|NCT01342029|7404446|FG001|Dropout|Period 1||1
6486372|NCT01342029|7404445|FG000|COMPLETED|Period 1||67
6486373|NCT01342029|7404446|FG001|COMPLETED|Period 1||71
6486374|NCT01342029|7404445|FG000|NOT COMPLETED|Period 1||3
6486375|NCT01342029|7404446|FG001|NOT COMPLETED|Period 1||1
6486376|NCT01342029|7404445|FG000|STARTED|Washout||67
6486377|NCT01342029|7404446|FG001|STARTED|Washout||71
6486378|NCT01342029|7404445|FG000|COMPLETED|Washout||67
6486379|NCT01342029|7404446|FG001|COMPLETED|Washout||67
6486380|NCT01342029|7404445|FG000|NOT COMPLETED|Washout||0
6486381|NCT01342029|7404446|FG001|NOT COMPLETED|Washout||4
6486382|NCT01342029|7404445|FG000|STARTED|Period 2||67
6486383|NCT01342029|7404446|FG001|STARTED|Period 2||67
6486384|NCT01342029|7404445|FG000|Dropout|Period 2||2
6486385|NCT01342029|7404446|FG001|Dropout|Period 2||0
6486386|NCT01342029|7404445|FG000|COMPLETED|Period 2||65
6486387|NCT01342029|7404446|FG001|COMPLETED|Period 2||67
6486388|NCT01342029|7404445|FG000|NOT COMPLETED|Period 2||2
6486389|NCT01342029|7404446|FG001|NOT COMPLETED|Period 2||0
6486390|NCT01342081|7404457|FG000|STARTED|Overall Study||161
6486391|NCT01342081|7404458|FG001|STARTED|Overall Study||164
6486392|NCT01342081|7404459|FG002|STARTED|Overall Study||164
6486393|NCT01342081|7404457|FG000|COMPLETED|Overall Study||159
6486394|NCT01342081|7404458|FG001|COMPLETED|Overall Study||162
6486395|NCT01342081|7404459|FG002|COMPLETED|Overall Study||163
6486396|NCT01342081|7404457|FG000|NOT COMPLETED|Overall Study||2
6486397|NCT01342081|7404458|FG001|NOT COMPLETED|Overall Study||2
6486398|NCT01342081|7404459|FG002|NOT COMPLETED|Overall Study||1
6486399|NCT01342094|7404469|FG000|STARTED|Overall Study||82
6486400|NCT01342094|7404470|FG001|STARTED|Overall Study||84
6486401|NCT01342094|7404469|FG000|COMPLETED|Overall Study||77
6486402|NCT01342094|7404470|FG001|COMPLETED|Overall Study||81
6486403|NCT01342094|7404469|FG000|NOT COMPLETED|Overall Study||5
6486404|NCT01342094|7404470|FG001|NOT COMPLETED|Overall Study||3
6486405|NCT01342107|7404478|FG000|STARTED|Overall Study||34
6486406|NCT01342107|7404479|FG001|STARTED|Overall Study||32
6486407|NCT01342107|7404478|FG000|COMPLETED|Overall Study||34
6486408|NCT01342107|7404479|FG001|COMPLETED|Overall Study||32
6486409|NCT01342107|7404478|FG000|NOT COMPLETED|Overall Study||0
6486410|NCT01342107|7404479|FG001|NOT COMPLETED|Overall Study||0
6486411|NCT01342172|7404485|FG000|STARTED|Overall Study||9
6486412|NCT01342172|7404485|FG000|COMPLETED|Overall Study||9
6486413|NCT01342172|7404485|FG000|NOT COMPLETED|Overall Study||0
6486414|NCT01342211|7404495|FG000|STARTED|Overall Study||19
6486415|NCT01342211|7404496|FG001|STARTED|Overall Study||19
6486416|NCT01342211|7404497|FG002|STARTED|Overall Study||18
6486417|NCT01342211|7404498|FG003|STARTED|Overall Study||19
6486418|NCT01342211|7404499|FG004|STARTED|Overall Study||18
6486419|NCT01342211|7404495|FG000|Treated|Overall Study||19
6486420|NCT01342211|7404496|FG001|Treated|Overall Study||17
6486421|NCT01342211|7404497|FG002|Treated|Overall Study||18
6486422|NCT01342211|7404498|FG003|Treated|Overall Study||19
6486423|NCT01342211|7404499|FG004|Treated|Overall Study||17
6486424|NCT01342211|7404495|FG000|COMPLETED|Overall Study||19
6486425|NCT01342211|7404496|FG001|COMPLETED|Overall Study||17
6486426|NCT01342211|7404497|FG002|COMPLETED|Overall Study||18
6486427|NCT01342211|7404498|FG003|COMPLETED|Overall Study||17
6486428|NCT01342211|7404499|FG004|COMPLETED|Overall Study||16
6486429|NCT01342211|7404495|FG000|NOT COMPLETED|Overall Study||0
6486430|NCT01342211|7404496|FG001|NOT COMPLETED|Overall Study||2
6486431|NCT01342211|7404497|FG002|NOT COMPLETED|Overall Study||0
6486432|NCT01342211|7404498|FG003|NOT COMPLETED|Overall Study||2
6486433|NCT01342211|7404499|FG004|NOT COMPLETED|Overall Study||2
6486434|NCT01342341|7404517|FG000|STARTED|Overall Study||24
6486435|NCT01342341|7404518|FG001|STARTED|Overall Study||24
6486436|NCT01342341|7404517|FG000|COMPLETED|Overall Study||20
6486437|NCT01342341|7404518|FG001|COMPLETED|Overall Study||20
6486438|NCT01342341|7404517|FG000|NOT COMPLETED|Overall Study||4
6486439|NCT01342341|7404518|FG001|NOT COMPLETED|Overall Study||4
6486440|NCT01342367|7404526|FG000|STARTED|Overall Study||32
6486441|NCT01342367|7404527|FG001|STARTED|Overall Study||42
6486442|NCT01342367|7404526|FG000|COMPLETED|Overall Study||30
6486443|NCT01342367|7404527|FG001|COMPLETED|Overall Study||40
6486444|NCT01342367|7404526|FG000|NOT COMPLETED|Overall Study||2
6486445|NCT01342367|7404527|FG001|NOT COMPLETED|Overall Study||2
6486446|NCT01342445|7404535|FG000|STARTED|Overall Study||26
6486447|NCT01342445|7404536|FG001|STARTED|Overall Study||24
6486448|NCT01342445|7404535|FG000|COMPLETED|Overall Study||26
6486449|NCT01342445|7404536|FG001|COMPLETED|Overall Study||22
6486450|NCT01342445|7404535|FG000|NOT COMPLETED|Overall Study||0
6486451|NCT01342445|7404536|FG001|NOT COMPLETED|Overall Study||2
6486452|NCT01342458|7404548|FG000|STARTED|Overall Study||28
6486453|NCT01342458|7404549|FG001|STARTED|Overall Study||28
6486454|NCT01342458|7404548|FG000|COMPLETED|Overall Study||26
6486455|NCT01342458|7404549|FG001|COMPLETED|Overall Study||24
6486456|NCT01342458|7404548|FG000|NOT COMPLETED|Overall Study||2
6486457|NCT01342458|7404549|FG001|NOT COMPLETED|Overall Study||4
6486458|NCT01342471|7404571|FG000|STARTED|Overall Study||29
6486459|NCT01342471|7404572|FG001|STARTED|Overall Study||29
6486460|NCT01342471|7404571|FG000|COMPLETED|Overall Study||24
6486461|NCT01342471|7404572|FG001|COMPLETED|Overall Study||23
6486462|NCT01342471|7404571|FG000|NOT COMPLETED|Overall Study||5
6486463|NCT01342471|7404572|FG001|NOT COMPLETED|Overall Study||6
6486464|NCT01342484|7404581|FG000|STARTED|Overall Study||15
6486465|NCT01342484|7404582|FG001|STARTED|Overall Study||10
6486466|NCT01342484|7404583|FG002|STARTED|Overall Study||14
6486467|NCT01342484|7404581|FG000|COMPLETED|Overall Study||13
6486468|NCT01342484|7404582|FG001|COMPLETED|Overall Study||10
6486469|NCT01342484|7404583|FG002|COMPLETED|Overall Study||13
6486470|NCT01342484|7404581|FG000|NOT COMPLETED|Overall Study||2
6486471|NCT01342484|7404582|FG001|NOT COMPLETED|Overall Study||0
6486472|NCT01342484|7404583|FG002|NOT COMPLETED|Overall Study||1
6486473|NCT01342510|7404595|FG000|STARTED|Overall Study||50
6486474|NCT01342510|7404596|FG001|STARTED|Overall Study||50
6486475|NCT01342510|7404597|FG002|STARTED|Overall Study||50
6486476|NCT01342510|7404598|FG003|STARTED|Overall Study||50
6486477|NCT01342510|7404595|FG000|COMPLETED|Overall Study||38
6486478|NCT01342510|7404596|FG001|COMPLETED|Overall Study||44
6486479|NCT01342510|7404597|FG002|COMPLETED|Overall Study||37
6486480|NCT01342510|7404598|FG003|COMPLETED|Overall Study||39
6486481|NCT01342510|7404595|FG000|NOT COMPLETED|Overall Study||12
6486482|NCT01342510|7404596|FG001|NOT COMPLETED|Overall Study||6
6486483|NCT01342510|7404597|FG002|NOT COMPLETED|Overall Study||13
6486484|NCT01342510|7404598|FG003|NOT COMPLETED|Overall Study||11
6486485|NCT01342523|7404644|FG000|STARTED|Overall Study||35
6486486|NCT01342523|7404645|FG001|STARTED|Overall Study||32
6486487|NCT01342523|7404646|FG002|STARTED|Overall Study||36
6486488|NCT01342523|7404647|FG003|STARTED|Overall Study||33
6486489|NCT01342523|7404648|FG004|STARTED|Overall Study||36
6486490|NCT01342523|7404649|FG005|STARTED|Overall Study||36
6486491|NCT01342523|7404650|FG006|STARTED|Overall Study||22
6486492|NCT01342523|7404651|FG007|STARTED|Overall Study||27
6486493|NCT01342523|7404652|FG008|STARTED|Overall Study||28
6486494|NCT01342523|7404653|FG009|STARTED|Overall Study||28
6486495|NCT01342523|7404654|FG010|STARTED|Overall Study||38
6486496|NCT01342523|7404655|FG011|STARTED|Overall Study||38
6486497|NCT01342523|7404656|FG012|STARTED|Overall Study||39
6486498|NCT01342523|7404657|FG013|STARTED|Overall Study||38
6486499|NCT01342523|7404658|FG014|STARTED|Overall Study||38
6486500|NCT01342523|7404659|FG015|STARTED|Overall Study||32
6486501|NCT01342523|7404660|FG016|STARTED|Overall Study||29
6486502|NCT01342523|7404661|FG017|STARTED|Overall Study||27
6486503|NCT01342523|7404662|FG018|STARTED|Overall Study||21
6486504|NCT01342523|7404663|FG019|STARTED|Overall Study||27
6486505|NCT01342523|7404664|FG020|STARTED|Overall Study||29
6486506|NCT01342523|7404665|FG021|STARTED|Overall Study||30
6486507|NCT01342523|7404666|FG022|STARTED|Overall Study||36
6486508|NCT01342523|7404667|FG023|STARTED|Overall Study||36
6486509|NCT01342523|7404668|FG024|STARTED|Overall Study||37
6486510|NCT01342523|7404669|FG025|STARTED|Overall Study||38
6486511|NCT01342523|7404670|FG026|STARTED|Overall Study||34
6486512|NCT01342523|7404671|FG027|STARTED|Overall Study||31
6486513|NCT01342523|7404672|FG028|STARTED|Overall Study||35
6486514|NCT01342523|7404673|FG029|STARTED|Overall Study||29
6486515|NCT01342523|7404674|FG030|STARTED|Overall Study||31
6486516|NCT01342523|7404675|FG031|STARTED|Overall Study||28
6486517|NCT01342523|7404644|FG000|COMPLETED|Overall Study||34
6486518|NCT01342523|7404645|FG001|COMPLETED|Overall Study||32
6486519|NCT01342523|7404646|FG002|COMPLETED|Overall Study||36
6486520|NCT01342523|7404647|FG003|COMPLETED|Overall Study||32
6486521|NCT01342523|7404648|FG004|COMPLETED|Overall Study||36
6486522|NCT01342523|7404649|FG005|COMPLETED|Overall Study||36
6486523|NCT01342523|7404650|FG006|COMPLETED|Overall Study||22
6486524|NCT01342523|7404651|FG007|COMPLETED|Overall Study||27
6486525|NCT01342523|7404652|FG008|COMPLETED|Overall Study||28
6486526|NCT01342523|7404653|FG009|COMPLETED|Overall Study||28
6486527|NCT01342523|7404654|FG010|COMPLETED|Overall Study||38
6486528|NCT01342523|7404655|FG011|COMPLETED|Overall Study||36
6486529|NCT01342523|7404656|FG012|COMPLETED|Overall Study||39
6486530|NCT01342523|7404657|FG013|COMPLETED|Overall Study||36
6486531|NCT01342523|7404658|FG014|COMPLETED|Overall Study||37
6486532|NCT01342523|7404659|FG015|COMPLETED|Overall Study||32
6486533|NCT01342523|7404660|FG016|COMPLETED|Overall Study||28
6486534|NCT01342523|7404661|FG017|COMPLETED|Overall Study||27
6486535|NCT01342523|7404662|FG018|COMPLETED|Overall Study||21
6486536|NCT01342523|7404663|FG019|COMPLETED|Overall Study||27
6486537|NCT01342523|7404664|FG020|COMPLETED|Overall Study||29
6486538|NCT01342523|7404665|FG021|COMPLETED|Overall Study||30
6486539|NCT01342523|7404666|FG022|COMPLETED|Overall Study||36
6486540|NCT01342523|7404667|FG023|COMPLETED|Overall Study||35
6486541|NCT01342523|7404668|FG024|COMPLETED|Overall Study||36
6486542|NCT01342523|7404669|FG025|COMPLETED|Overall Study||36
6486543|NCT01342523|7404670|FG026|COMPLETED|Overall Study||33
6486544|NCT01342523|7404671|FG027|COMPLETED|Overall Study||30
6486545|NCT01342523|7404672|FG028|COMPLETED|Overall Study||34
6486546|NCT01342523|7404673|FG029|COMPLETED|Overall Study||28
6486547|NCT01342523|7404674|FG030|COMPLETED|Overall Study||30
6486548|NCT01342523|7404675|FG031|COMPLETED|Overall Study||27
6486549|NCT01342523|7404644|FG000|NOT COMPLETED|Overall Study||1
6486550|NCT01342523|7404645|FG001|NOT COMPLETED|Overall Study||0
6486551|NCT01342523|7404646|FG002|NOT COMPLETED|Overall Study||0
6486552|NCT01342523|7404647|FG003|NOT COMPLETED|Overall Study||1
6486553|NCT01342523|7404648|FG004|NOT COMPLETED|Overall Study||0
6486554|NCT01342523|7404649|FG005|NOT COMPLETED|Overall Study||0
6486555|NCT01342523|7404650|FG006|NOT COMPLETED|Overall Study||0
6486556|NCT01342523|7404651|FG007|NOT COMPLETED|Overall Study||0
6486557|NCT01342523|7404652|FG008|NOT COMPLETED|Overall Study||0
6486558|NCT01342523|7404653|FG009|NOT COMPLETED|Overall Study||0
6486559|NCT01342523|7404654|FG010|NOT COMPLETED|Overall Study||0
6486560|NCT01342523|7404655|FG011|NOT COMPLETED|Overall Study||2
6486561|NCT01342523|7404656|FG012|NOT COMPLETED|Overall Study||0
6486562|NCT01342523|7404657|FG013|NOT COMPLETED|Overall Study||2
6748667|NCT03417830|7676793|FG001|NOT COMPLETED|Part A (up to 26 Days)||0
6748668|NCT03417830|7676792|FG000|STARTED|Part B (up to 26 Days)||0
6748669|NCT03417830|7676793|FG001|STARTED|Part B (up to 26 Days)||0
6748670|NCT03417830|7676792|FG000|COMPLETED|Part B (up to 26 Days)||0
6486563|NCT01342523|7404658|FG014|NOT COMPLETED|Overall Study||1
6486564|NCT01342523|7404659|FG015|NOT COMPLETED|Overall Study||0
6486565|NCT01342523|7404660|FG016|NOT COMPLETED|Overall Study||1
6486566|NCT01342523|7404661|FG017|NOT COMPLETED|Overall Study||0
6486567|NCT01342523|7404662|FG018|NOT COMPLETED|Overall Study||0
6486568|NCT01342523|7404663|FG019|NOT COMPLETED|Overall Study||0
6486569|NCT01342523|7404664|FG020|NOT COMPLETED|Overall Study||0
6486570|NCT01342523|7404665|FG021|NOT COMPLETED|Overall Study||0
6486571|NCT01342523|7404666|FG022|NOT COMPLETED|Overall Study||0
6486572|NCT01342523|7404667|FG023|NOT COMPLETED|Overall Study||1
6486573|NCT01342523|7404668|FG024|NOT COMPLETED|Overall Study||1
6486574|NCT01342523|7404669|FG025|NOT COMPLETED|Overall Study||2
6486575|NCT01342523|7404670|FG026|NOT COMPLETED|Overall Study||1
6486576|NCT01342523|7404671|FG027|NOT COMPLETED|Overall Study||1
6486577|NCT01342523|7404672|FG028|NOT COMPLETED|Overall Study||1
6486578|NCT01342523|7404673|FG029|NOT COMPLETED|Overall Study||1
6486579|NCT01342523|7404674|FG030|NOT COMPLETED|Overall Study||1
6486580|NCT01342523|7404675|FG031|NOT COMPLETED|Overall Study||1
6486581|NCT01342549|7404690|FG000|STARTED|Overall Study||31
6486582|NCT01342549|7404691|FG001|STARTED|Overall Study||31
6486583|NCT01342549|7404690|FG000|COMPLETED|Overall Study||31
6486584|NCT01342549|7404691|FG001|COMPLETED|Overall Study||31
6486585|NCT01342549|7404690|FG000|NOT COMPLETED|Overall Study||0
6486586|NCT01342549|7404691|FG001|NOT COMPLETED|Overall Study||0
6486587|NCT01342640|7404697|FG000|STARTED|Overall Study||70
6486588|NCT01342640|7404697|FG000|COMPLETED|Overall Study||29
6486589|NCT01342640|7404697|FG000|NOT COMPLETED|Overall Study||41
6486590|NCT01342666|7404703|FG000|STARTED|Overall Study||26
6486591|NCT01342666|7404704|FG001|STARTED|Overall Study||24
6486592|NCT01342666|7404703|FG000|COMPLETED|Overall Study||26
6486593|NCT01342666|7404704|FG001|COMPLETED|Overall Study||24
6486594|NCT01342666|7404703|FG000|NOT COMPLETED|Overall Study||0
6486595|NCT01342666|7404704|FG001|NOT COMPLETED|Overall Study||0
6486596|NCT01342757|7404710|FG000|STARTED|Overall Study||12
6486597|NCT01342757|7404710|FG000|COMPLETED|Overall Study||12
6486598|NCT01342757|7404710|FG000|NOT COMPLETED|Overall Study||0
6486599|NCT01342770|7404714|FG000|STARTED|Overall Study||6
6486600|NCT01342770|7404714|FG000|COMPLETED|Overall Study||6
6486601|NCT01342770|7404714|FG000|NOT COMPLETED|Overall Study||0
6486602|NCT01342796|7404720|FG000|STARTED|Overall Study||43
6486603|NCT01342796|7404721|FG001|STARTED|Overall Study||41
6486604|NCT01342796|7404720|FG000|COMPLETED|Overall Study||40
6486605|NCT01342796|7404721|FG001|COMPLETED|Overall Study||38
6486606|NCT01342796|7404720|FG000|NOT COMPLETED|Overall Study||3
6486607|NCT01342796|7404721|FG001|NOT COMPLETED|Overall Study||3
6486608|NCT01342887|7404727|FG000|STARTED|Overall Study||6
6486609|NCT01342887|7404727|FG000|COMPLETED|Overall Study||4
6486610|NCT01342887|7404727|FG000|NOT COMPLETED|Overall Study||2
6501619|NCT01430182|7420149|FG001|COMPLETED|Overall Study||8
6501620|NCT01430182|7420148|FG000|NOT COMPLETED|Overall Study||0
6501621|NCT01430182|7420149|FG001|NOT COMPLETED|Overall Study||0
6501622|NCT01430299|7420157|FG000|STARTED|Overall Study||20
6501623|NCT01430299|7420158|FG001|STARTED|Overall Study||23
6501624|NCT01430299|7420157|FG000|COMPLETED|Overall Study||16
6501625|NCT01430299|7420158|FG001|COMPLETED|Overall Study||21
6501626|NCT01430299|7420157|FG000|NOT COMPLETED|Overall Study||4
6501627|NCT01430299|7420158|FG001|NOT COMPLETED|Overall Study||2
6501628|NCT01430325|7420168|FG000|STARTED|Overall Study||10
6501629|NCT01430325|7420169|FG001|STARTED|Overall Study||12
6501630|NCT01430325|7420170|FG002|STARTED|Overall Study||8
6501631|NCT01430325|7420171|FG003|STARTED|Overall Study||12
6501632|NCT01430325|7420168|FG000|COMPLETED|Overall Study||10
6501633|NCT01430325|7420169|FG001|COMPLETED|Overall Study||12
6501634|NCT01430325|7420170|FG002|COMPLETED|Overall Study||8
6501635|NCT01430325|7420171|FG003|COMPLETED|Overall Study||12
6501636|NCT01430325|7420168|FG000|NOT COMPLETED|Overall Study||0
6501637|NCT01430325|7420169|FG001|NOT COMPLETED|Overall Study||0
6501638|NCT01430325|7420170|FG002|NOT COMPLETED|Overall Study||0
6501639|NCT01430325|7420171|FG003|NOT COMPLETED|Overall Study||0
6501640|NCT01430403|7420184|FG000|STARTED|Overall Study|Intent-to-treat|259
6501641|NCT01430403|7420185|FG001|STARTED|Overall Study|Intent-to-treat|130
6501642|NCT01430403|7420186|FG002|STARTED|Overall Study|Intent-to-treat|89
6501643|NCT01430403|7420184|FG000|COMPLETED|Overall Study||242
6501644|NCT01430403|7420185|FG001|COMPLETED|Overall Study||121
6501645|NCT01430403|7420186|FG002|COMPLETED|Overall Study||81
6501646|NCT01430403|7420184|FG000|NOT COMPLETED|Overall Study||17
6501647|NCT01430403|7420185|FG001|NOT COMPLETED|Overall Study||9
6501648|NCT01430403|7420186|FG002|NOT COMPLETED|Overall Study||8
6501649|NCT01430442|7420207|FG000|STARTED|Overall Study||85
6501650|NCT01430442|7420208|FG001|STARTED|Overall Study||68
6501651|NCT01430442|7420209|FG002|STARTED|Overall Study||91
6501652|NCT01430442|7420210|FG003|STARTED|Overall Study||90
6501653|NCT01430442|7420211|FG004|STARTED|Overall Study||121
6501654|NCT01430442|7420212|FG005|STARTED|Overall Study||92
6501655|NCT01430442|7420213|FG006|STARTED|Overall Study||229
6501656|NCT01430442|7420214|FG007|STARTED|Overall Study||109
6501657|NCT01430442|7420207|FG000|COMPLETED|Overall Study||72
6501658|NCT01430442|7420208|FG001|COMPLETED|Overall Study||62
6501659|NCT01430442|7420209|FG002|COMPLETED|Overall Study||86
6501660|NCT01430442|7420210|FG003|COMPLETED|Overall Study||86
6501661|NCT01430442|7420211|FG004|COMPLETED|Overall Study||112
6501662|NCT01430442|7420212|FG005|COMPLETED|Overall Study||84
6501663|NCT01430442|7420213|FG006|COMPLETED|Overall Study||210
6501664|NCT01430442|7420214|FG007|COMPLETED|Overall Study||100
6501665|NCT01430442|7420207|FG000|NOT COMPLETED|Overall Study||13
6501666|NCT01430442|7420208|FG001|NOT COMPLETED|Overall Study||6
6501667|NCT01430442|7420209|FG002|NOT COMPLETED|Overall Study||5
6501668|NCT01430442|7420210|FG003|NOT COMPLETED|Overall Study||4
6501669|NCT01430442|7420211|FG004|NOT COMPLETED|Overall Study||9
6501670|NCT01430442|7420212|FG005|NOT COMPLETED|Overall Study||8
6501671|NCT01430442|7420213|FG006|NOT COMPLETED|Overall Study||19
6501672|NCT01430442|7420214|FG007|NOT COMPLETED|Overall Study||9
6501673|NCT01430455|7420232|FG000|STARTED|Overall Study||7
6501674|NCT01430455|7420232|FG000|COMPLETED|Overall Study||5
6501675|NCT01430455|7420232|FG000|NOT COMPLETED|Overall Study||2
6501676|NCT01430468|7420238|FG000|STARTED|Overall Study||22
6501677|NCT01430468|7420239|FG001|STARTED|Overall Study||22
6501678|NCT01430468|7420238|FG000|COMPLETED|Overall Study||15
6501679|NCT01430468|7420239|FG001|COMPLETED|Overall Study||16
6501680|NCT01430468|7420238|FG000|NOT COMPLETED|Overall Study||7
6501681|NCT01430468|7420239|FG001|NOT COMPLETED|Overall Study||6
6501682|NCT01430559|7420247|FG000|STARTED|Overall Study||146
6501683|NCT01430559|7420248|FG001|STARTED|Overall Study||147
6501684|NCT01430559|7420247|FG000|Treated|Overall Study||143
6501685|NCT01430559|7420248|FG001|Treated|Overall Study||144
6501686|NCT01430559|7420247|FG000|COMPLETED|Overall Study||126
6501687|NCT01430559|7420248|FG001|COMPLETED|Overall Study||135
6501688|NCT01430559|7420247|FG000|NOT COMPLETED|Overall Study||20
6501689|NCT01430559|7420248|FG001|NOT COMPLETED|Overall Study||12
6501690|NCT01430585|7420259|FG000|STARTED|Overall Study||14
6501691|NCT01430585|7420259|FG000|COMPLETED|Overall Study||0
6501692|NCT01430585|7420259|FG000|NOT COMPLETED|Overall Study||14
6486611|NCT01342913|7404733|FG000|STARTED|2-week Run-in Period||702
6486612|NCT01342913|7404734|FG001|STARTED|2-week Run-in Period||0
6486613|NCT01342913|7404735|FG002|STARTED|2-week Run-in Period||0
6486614|NCT01342913|7404733|FG000|COMPLETED|2-week Run-in Period||528
6486615|NCT01342913|7404734|FG001|COMPLETED|2-week Run-in Period||0
6486616|NCT01342913|7404735|FG002|COMPLETED|2-week Run-in Period||0
6486617|NCT01342913|7404733|FG000|NOT COMPLETED|2-week Run-in Period||174
6486618|NCT01342913|7404734|FG001|NOT COMPLETED|2-week Run-in Period||0
6486619|NCT01342913|7404735|FG002|NOT COMPLETED|2-week Run-in Period||0
6486620|NCT01342913|7404733|FG000|STARTED|Double-Blind Treatment Period||0
6486621|NCT01342913|7404734|FG001|STARTED|Double-Blind Treatment Period||262
6486622|NCT01342913|7404735|FG002|STARTED|Double-Blind Treatment Period||266
6486623|NCT01342913|7404733|FG000|COMPLETED|Double-Blind Treatment Period||0
6486624|NCT01342913|7404734|FG001|COMPLETED|Double-Blind Treatment Period||246
6486625|NCT01342913|7404735|FG002|COMPLETED|Double-Blind Treatment Period||243
6486626|NCT01342913|7404733|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6486627|NCT01342913|7404734|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
6486628|NCT01342913|7404735|FG002|NOT COMPLETED|Double-Blind Treatment Period||23
6486629|NCT01342926|7404745|FG000|STARTED|Overall Study||46
6486630|NCT01342926|7404746|FG001|STARTED|Overall Study||46
6486631|NCT01342926|7404747|FG002|STARTED|Overall Study||48
6486632|NCT01342926|7404748|FG003|STARTED|Overall Study||51
6486633|NCT01342926|7404745|FG000|COMPLETED|Overall Study||37
6486634|NCT01342926|7404746|FG001|COMPLETED|Overall Study||31
6486635|NCT01342926|7404747|FG002|COMPLETED|Overall Study||34
6486636|NCT01342926|7404748|FG003|COMPLETED|Overall Study||39
6486637|NCT01342926|7404745|FG000|NOT COMPLETED|Overall Study||9
6486638|NCT01342926|7404746|FG001|NOT COMPLETED|Overall Study||15
6486639|NCT01342926|7404747|FG002|NOT COMPLETED|Overall Study||14
6486640|NCT01342926|7404748|FG003|NOT COMPLETED|Overall Study||12
6486641|NCT01342965|7404760|FG000|STARTED|Overall Study||110
6486642|NCT01342965|7404761|FG001|STARTED|Overall Study||107
6486643|NCT01342965|7404760|FG000|Received Treatment|Overall Study||110
6486644|NCT01342965|7404761|FG001|Received Treatment|Overall Study||104
6486645|NCT01342965|7404760|FG000|COMPLETED|Overall Study||1
6486646|NCT01342965|7404761|FG001|COMPLETED|Overall Study||0
6486647|NCT01342965|7404760|FG000|NOT COMPLETED|Overall Study||109
6486648|NCT01342965|7404761|FG001|NOT COMPLETED|Overall Study||107
6486649|NCT01343004|7404770|FG000|STARTED|Overall Study||821
6486650|NCT01343004|7404771|FG001|STARTED|Overall Study||824
6486651|NCT01343004|7404772|FG002|STARTED|Overall Study||818
6486652|NCT01343004|7404770|FG000|COMPLETED|Overall Study||637
6486653|NCT01343004|7404771|FG001|COMPLETED|Overall Study||606
6486654|NCT01343004|7404772|FG002|COMPLETED|Overall Study||658
6486655|NCT01343004|7404770|FG000|NOT COMPLETED|Overall Study||184
6486656|NCT01343004|7404771|FG001|NOT COMPLETED|Overall Study||218
6486657|NCT01343004|7404772|FG002|NOT COMPLETED|Overall Study||160
6486658|NCT01343043|7404784|FG000|STARTED|Overall Study||15
6486659|NCT01343043|7404785|FG001|STARTED|Overall Study||14
6486660|NCT01343043|7404786|FG002|STARTED|Overall Study||5
6486661|NCT01343043|7404787|FG003|STARTED|Overall Study||16
6486662|NCT01343043|7404784|FG000|Received T-cell Infusion|Overall Study||12
6486663|NCT01343043|7404785|FG001|Received T-cell Infusion|Overall Study||13
6486664|NCT01343043|7404786|FG002|Received T-cell Infusion|Overall Study||5
6486665|NCT01343043|7404787|FG003|Received T-cell Infusion|Overall Study||15
6486666|NCT01343043|7404784|FG000|COMPLETED|Overall Study||12
6486667|NCT01343043|7404785|FG001|COMPLETED|Overall Study||13
6486668|NCT01343043|7404786|FG002|COMPLETED|Overall Study||5
6486669|NCT01343043|7404787|FG003|COMPLETED|Overall Study||15
6486670|NCT01343043|7404784|FG000|NOT COMPLETED|Overall Study||3
6486671|NCT01343043|7404785|FG001|NOT COMPLETED|Overall Study||1
6486672|NCT01343043|7404786|FG002|NOT COMPLETED|Overall Study||0
6486673|NCT01343043|7404787|FG003|NOT COMPLETED|Overall Study||1
6486674|NCT01343056|7404804|FG000|STARTED|Overall Study||35
6486675|NCT01343056|7404805|FG001|STARTED|Overall Study||36
6486676|NCT01343056|7404806|FG002|STARTED|Overall Study||32
6486677|NCT01343056|7404807|FG003|STARTED|Overall Study||38
6486678|NCT01343056|7404804|FG000|COMPLETED|Overall Study||28
6486679|NCT01343056|7404805|FG001|COMPLETED|Overall Study||31
6486680|NCT01343056|7404806|FG002|COMPLETED|Overall Study||29
6486681|NCT01343056|7404807|FG003|COMPLETED|Overall Study||29
6486682|NCT01343056|7404804|FG000|NOT COMPLETED|Overall Study||7
6486683|NCT01343056|7404805|FG001|NOT COMPLETED|Overall Study||5
6486684|NCT01343056|7404806|FG002|NOT COMPLETED|Overall Study||3
6486685|NCT01343056|7404807|FG003|NOT COMPLETED|Overall Study||9
6486686|NCT01343082|7404821|FG000|STARTED|The run-in Period||51
6486687|NCT01343082|7404822|FG001|STARTED|The run-in Period||49
6486688|NCT01343082|7404823|FG002|STARTED|The run-in Period||48
6486689|NCT01343082|7404821|FG000|COMPLETED|The run-in Period||48
6486690|NCT01343082|7404822|FG001|COMPLETED|The run-in Period||45
6486691|NCT01343082|7404823|FG002|COMPLETED|The run-in Period||43
6486692|NCT01343082|7404821|FG000|NOT COMPLETED|The run-in Period||3
6486693|NCT01343082|7404822|FG001|NOT COMPLETED|The run-in Period||4
6486694|NCT01343082|7404823|FG002|NOT COMPLETED|The run-in Period||5
6486695|NCT01343082|7404821|FG000|STARTED|Treatment Period , Switched to DE-111||48
6486696|NCT01343082|7404822|FG001|STARTED|Treatment Period , Switched to DE-111||45
6486697|NCT01343082|7404823|FG002|STARTED|Treatment Period , Switched to DE-111||43
6486698|NCT01343082|7404821|FG000|COMPLETED|Treatment Period , Switched to DE-111||43
6486699|NCT01343082|7404822|FG001|COMPLETED|Treatment Period , Switched to DE-111||36
6486700|NCT01343082|7404823|FG002|COMPLETED|Treatment Period , Switched to DE-111||31
6486701|NCT01343082|7404821|FG000|NOT COMPLETED|Treatment Period , Switched to DE-111||5
6486702|NCT01343082|7404822|FG001|NOT COMPLETED|Treatment Period , Switched to DE-111||9
6486703|NCT01343082|7404823|FG002|NOT COMPLETED|Treatment Period , Switched to DE-111||12
6486704|NCT01343095|7404830|FG000|STARTED|Overall Study||2
6486705|NCT01343095|7404831|FG001|STARTED|Overall Study||3
6486706|NCT01343095|7404832|FG002|STARTED|Overall Study||3
6486707|NCT01343095|7404830|FG000|COMPLETED|Overall Study||2
6486708|NCT01343095|7404831|FG001|COMPLETED|Overall Study||3
6486709|NCT01343095|7404832|FG002|COMPLETED|Overall Study||3
6486710|NCT01343095|7404830|FG000|NOT COMPLETED|Overall Study||0
6486711|NCT01343095|7404831|FG001|NOT COMPLETED|Overall Study||0
6486712|NCT01343095|7404832|FG002|NOT COMPLETED|Overall Study||0
6486713|NCT01343160|7404842|FG000|STARTED|Overall Study||36
6486714|NCT01343160|7404842|FG000|COMPLETED|Overall Study||31
6486715|NCT01343160|7404842|FG000|NOT COMPLETED|Overall Study||5
6486716|NCT01343251|7404849|FG000|STARTED|Overall Study||16
6486717|NCT01343251|7404850|FG001|STARTED|Overall Study||17
6486718|NCT01343251|7404849|FG000|COMPLETED|Overall Study||16
6486719|NCT01343251|7404850|FG001|COMPLETED|Overall Study||17
6486720|NCT01343251|7404849|FG000|NOT COMPLETED|Overall Study||0
6486721|NCT01343251|7404850|FG001|NOT COMPLETED|Overall Study||0
6486722|NCT01343277|7404861|FG000|STARTED|Overall Study||384
6486723|NCT01343277|7404862|FG001|STARTED|Overall Study||193
6486724|NCT01343277|7404861|FG000|Treated|Overall Study||378
6486725|NCT01343277|7404862|FG001|Treated|Overall Study||172
6486726|NCT01343277|7404861|FG000|COMPLETED|Overall Study||0
6486727|NCT01343277|7404862|FG001|COMPLETED|Overall Study||0
6486728|NCT01343277|7404861|FG000|NOT COMPLETED|Overall Study||384
6486729|NCT01343277|7404862|FG001|NOT COMPLETED|Overall Study||193
6486730|NCT01343368|7404870|FG000|STARTED|Overall Study||9
6486731|NCT01343368|7404871|FG001|STARTED|Overall Study||10
6486732|NCT01343368|7404870|FG000|COMPLETED|Overall Study||7
6486733|NCT01343368|7404871|FG001|COMPLETED|Overall Study||10
6486734|NCT01343368|7404870|FG000|NOT COMPLETED|Overall Study||2
6486735|NCT01343368|7404871|FG001|NOT COMPLETED|Overall Study||0
6486736|NCT01343407|7404877|FG000|STARTED|First Treatment Period (Part 2)||2
6486737|NCT01343407|7404878|FG001|STARTED|First Treatment Period (Part 2)||2
6486738|NCT01343407|7404879|FG002|STARTED|First Treatment Period (Part 2)||3
6486739|NCT01343407|7404880|FG003|STARTED|First Treatment Period (Part 2)||3
6486740|NCT01343407|7404881|FG004|STARTED|First Treatment Period (Part 2)||3
6486741|NCT01343407|7404882|FG005|STARTED|First Treatment Period (Part 2)||3
6486742|NCT01343407|7404877|FG000|COMPLETED|First Treatment Period (Part 2)||2
6486743|NCT01343407|7404878|FG001|COMPLETED|First Treatment Period (Part 2)||2
6486744|NCT01343407|7404879|FG002|COMPLETED|First Treatment Period (Part 2)||3
6486745|NCT01343407|7404880|FG003|COMPLETED|First Treatment Period (Part 2)||3
6486746|NCT01343407|7404881|FG004|COMPLETED|First Treatment Period (Part 2)||3
6486747|NCT01343407|7404882|FG005|COMPLETED|First Treatment Period (Part 2)||3
6486748|NCT01343407|7404877|FG000|NOT COMPLETED|First Treatment Period (Part 2)||0
6486749|NCT01343407|7404878|FG001|NOT COMPLETED|First Treatment Period (Part 2)||0
6486750|NCT01343407|7404879|FG002|NOT COMPLETED|First Treatment Period (Part 2)||0
6486751|NCT01343407|7404880|FG003|NOT COMPLETED|First Treatment Period (Part 2)||0
6486752|NCT01343407|7404881|FG004|NOT COMPLETED|First Treatment Period (Part 2)||0
6486753|NCT01343407|7404882|FG005|NOT COMPLETED|First Treatment Period (Part 2)||0
6486754|NCT01343407|7404877|FG000|STARTED|First Washout (Part 2)||2
6486755|NCT01343407|7404878|FG001|STARTED|First Washout (Part 2)||2
6486756|NCT01343407|7404879|FG002|STARTED|First Washout (Part 2)||3
6486757|NCT01343407|7404880|FG003|STARTED|First Washout (Part 2)||3
6486758|NCT01343407|7404881|FG004|STARTED|First Washout (Part 2)||3
6486759|NCT01343407|7404882|FG005|STARTED|First Washout (Part 2)||3
6486760|NCT01343407|7404877|FG000|COMPLETED|First Washout (Part 2)||2
6486761|NCT01343407|7404878|FG001|COMPLETED|First Washout (Part 2)||2
6486762|NCT01343407|7404879|FG002|COMPLETED|First Washout (Part 2)||3
6486763|NCT01343407|7404880|FG003|COMPLETED|First Washout (Part 2)||3
6486764|NCT01343407|7404881|FG004|COMPLETED|First Washout (Part 2)||3
6486765|NCT01343407|7404882|FG005|COMPLETED|First Washout (Part 2)||3
6486766|NCT01343407|7404877|FG000|NOT COMPLETED|First Washout (Part 2)||0
6486767|NCT01343407|7404878|FG001|NOT COMPLETED|First Washout (Part 2)||0
6486768|NCT01343407|7404879|FG002|NOT COMPLETED|First Washout (Part 2)||0
6486769|NCT01343407|7404880|FG003|NOT COMPLETED|First Washout (Part 2)||0
6486770|NCT01343407|7404881|FG004|NOT COMPLETED|First Washout (Part 2)||0
6486771|NCT01343407|7404882|FG005|NOT COMPLETED|First Washout (Part 2)||0
6486772|NCT01343407|7404877|FG000|STARTED|Second Treatment Period (Part 2)||2
6486773|NCT01343407|7404878|FG001|STARTED|Second Treatment Period (Part 2)||2
6486774|NCT01343407|7404879|FG002|STARTED|Second Treatment Period (Part 2)||3
6486775|NCT01343407|7404880|FG003|STARTED|Second Treatment Period (Part 2)||3
6486776|NCT01343407|7404881|FG004|STARTED|Second Treatment Period (Part 2)||3
6486777|NCT01343407|7404882|FG005|STARTED|Second Treatment Period (Part 2)||3
6486778|NCT01343407|7404877|FG000|COMPLETED|Second Treatment Period (Part 2)||2
6486779|NCT01343407|7404878|FG001|COMPLETED|Second Treatment Period (Part 2)||2
6486780|NCT01343407|7404879|FG002|COMPLETED|Second Treatment Period (Part 2)||2
6486781|NCT01343407|7404880|FG003|COMPLETED|Second Treatment Period (Part 2)||3
6486782|NCT01343407|7404881|FG004|COMPLETED|Second Treatment Period (Part 2)||3
6486783|NCT01343407|7404882|FG005|COMPLETED|Second Treatment Period (Part 2)||3
6501693|NCT01430611|7420271|FG000|STARTED|Overall Study||332
6486784|NCT01343407|7404877|FG000|NOT COMPLETED|Second Treatment Period (Part 2)||0
6486785|NCT01343407|7404878|FG001|NOT COMPLETED|Second Treatment Period (Part 2)||0
6486786|NCT01343407|7404879|FG002|NOT COMPLETED|Second Treatment Period (Part 2)||1
6486787|NCT01343407|7404880|FG003|NOT COMPLETED|Second Treatment Period (Part 2)||0
6486788|NCT01343407|7404881|FG004|NOT COMPLETED|Second Treatment Period (Part 2)||0
6486789|NCT01343407|7404882|FG005|NOT COMPLETED|Second Treatment Period (Part 2)||0
6486790|NCT01343407|7404877|FG000|STARTED|Second Washout (Part 2)||2
6486791|NCT01343407|7404878|FG001|STARTED|Second Washout (Part 2)||2
6486792|NCT01343407|7404879|FG002|STARTED|Second Washout (Part 2)||2
6486793|NCT01343407|7404880|FG003|STARTED|Second Washout (Part 2)||3
6486794|NCT01343407|7404881|FG004|STARTED|Second Washout (Part 2)||3
6486795|NCT01343407|7404882|FG005|STARTED|Second Washout (Part 2)||3
6486796|NCT01343407|7404877|FG000|COMPLETED|Second Washout (Part 2)||2
6486797|NCT01343407|7404878|FG001|COMPLETED|Second Washout (Part 2)||2
6486798|NCT01343407|7404879|FG002|COMPLETED|Second Washout (Part 2)||1
6486799|NCT01343407|7404880|FG003|COMPLETED|Second Washout (Part 2)||3
6486800|NCT01343407|7404881|FG004|COMPLETED|Second Washout (Part 2)||3
6554972|NCT01749215|7477074|FG001|STARTED|Overall Study||79
6554973|NCT01749215|7477073|FG000|COMPLETED|Overall Study||47
6554974|NCT01749215|7477074|FG001|COMPLETED|Overall Study||53
6554975|NCT01749215|7477073|FG000|NOT COMPLETED|Overall Study||25
6554976|NCT01749215|7477074|FG001|NOT COMPLETED|Overall Study||26
6554977|NCT01749293|7477080|FG000|STARTED|Overall Study||3
6554978|NCT01749293|7477080|FG000|COMPLETED|Overall Study||3
6554979|NCT01749293|7477080|FG000|NOT COMPLETED|Overall Study||0
6486801|NCT01343407|7404882|FG005|COMPLETED|Second Washout (Part 2)||3
6486802|NCT01343407|7404877|FG000|NOT COMPLETED|Second Washout (Part 2)||0
6486803|NCT01343407|7404878|FG001|NOT COMPLETED|Second Washout (Part 2)||0
6486804|NCT01343407|7404879|FG002|NOT COMPLETED|Second Washout (Part 2)||1
6486805|NCT01343407|7404880|FG003|NOT COMPLETED|Second Washout (Part 2)||0
6486806|NCT01343407|7404881|FG004|NOT COMPLETED|Second Washout (Part 2)||0
6486807|NCT01343407|7404882|FG005|NOT COMPLETED|Second Washout (Part 2)||0
6486808|NCT01343407|7404877|FG000|STARTED|Third Treatment Period (Part 2)||2
6486809|NCT01343407|7404878|FG001|STARTED|Third Treatment Period (Part 2)||2
6486810|NCT01343407|7404879|FG002|STARTED|Third Treatment Period (Part 2)||1
6486811|NCT01343407|7404880|FG003|STARTED|Third Treatment Period (Part 2)||3
6486812|NCT01343407|7404881|FG004|STARTED|Third Treatment Period (Part 2)||3
6486813|NCT01343407|7404882|FG005|STARTED|Third Treatment Period (Part 2)||3
6486814|NCT01343407|7404877|FG000|COMPLETED|Third Treatment Period (Part 2)||2
6486815|NCT01343407|7404878|FG001|COMPLETED|Third Treatment Period (Part 2)||2
6486816|NCT01343407|7404879|FG002|COMPLETED|Third Treatment Period (Part 2)||1
6486817|NCT01343407|7404880|FG003|COMPLETED|Third Treatment Period (Part 2)||3
6486818|NCT01343407|7404881|FG004|COMPLETED|Third Treatment Period (Part 2)||3
6486819|NCT01343407|7404882|FG005|COMPLETED|Third Treatment Period (Part 2)||3
6486820|NCT01343407|7404877|FG000|NOT COMPLETED|Third Treatment Period (Part 2)||0
6486821|NCT01343407|7404878|FG001|NOT COMPLETED|Third Treatment Period (Part 2)||0
6486822|NCT01343407|7404879|FG002|NOT COMPLETED|Third Treatment Period (Part 2)||0
6486823|NCT01343407|7404880|FG003|NOT COMPLETED|Third Treatment Period (Part 2)||0
6486824|NCT01343407|7404881|FG004|NOT COMPLETED|Third Treatment Period (Part 2)||0
6486825|NCT01343407|7404882|FG005|NOT COMPLETED|Third Treatment Period (Part 2)||0
6486826|NCT01343485|7404892|FG000|STARTED|Overall Study||185
6486827|NCT01343485|7404893|FG001|STARTED|Overall Study||180
6486828|NCT01343485|7404892|FG000|COMPLETED|Overall Study||36
6486829|NCT01343485|7404893|FG001|COMPLETED|Overall Study||46
6486830|NCT01343485|7404892|FG000|NOT COMPLETED|Overall Study||149
6486831|NCT01343485|7404893|FG001|NOT COMPLETED|Overall Study||134
6486832|NCT01343667|7404901|FG000|STARTED|Overall Study||425
6486833|NCT01343667|7404902|FG001|STARTED|Overall Study||972
6486834|NCT01343667|7404901|FG000|COMPLETED|Overall Study||413
6486835|NCT01343667|7404902|FG001|COMPLETED|Overall Study||916
6486836|NCT01343667|7404901|FG000|NOT COMPLETED|Overall Study||12
6486837|NCT01343667|7404902|FG001|NOT COMPLETED|Overall Study||56
6486838|NCT01343693|7404908|FG000|STARTED|Overall Study||119
6486839|NCT01343693|7404908|FG000|COMPLETED|Overall Study||110
6486840|NCT01343693|7404908|FG000|NOT COMPLETED|Overall Study||9
6486841|NCT01343823|7404916|FG000|STARTED|Overall Study||20
6486842|NCT01343823|7404917|FG001|STARTED|Overall Study||20
6486843|NCT01343823|7404918|FG002|STARTED|Overall Study||19
6486844|NCT01343823|7404919|FG003|STARTED|Overall Study||20
6554980|NCT01749410|7477085|FG000|STARTED|Overall Study||33
6486845|NCT01343823|7404916|FG000|COMPLETED|Overall Study||18
6486846|NCT01343823|7404917|FG001|COMPLETED|Overall Study||20
6486847|NCT01343823|7404918|FG002|COMPLETED|Overall Study||19
6486848|NCT01343823|7404919|FG003|COMPLETED|Overall Study||19
6486849|NCT01343823|7404916|FG000|NOT COMPLETED|Overall Study||2
6486850|NCT01343823|7404917|FG001|NOT COMPLETED|Overall Study||0
6486851|NCT01343823|7404918|FG002|NOT COMPLETED|Overall Study||0
6486852|NCT01343823|7404919|FG003|NOT COMPLETED|Overall Study||1
6486853|NCT01343888|7404932|FG000|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
6486854|NCT01343888|7404933|FG001|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
6554981|NCT01749410|7477085|FG000|COMPLETED|Overall Study||33
6554982|NCT01749410|7477085|FG000|NOT COMPLETED|Overall Study||0
6486855|NCT01343888|7404934|FG002|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
6486856|NCT01343888|7404932|FG000|COMPLETED|Overall Study||234
6486857|NCT01343888|7404933|FG001|COMPLETED|Overall Study||222
6486858|NCT01343888|7404934|FG002|COMPLETED|Overall Study||110
6486859|NCT01343888|7404932|FG000|NOT COMPLETED|Overall Study||25
6486860|NCT01343888|7404933|FG001|NOT COMPLETED|Overall Study||39
6486861|NCT01343888|7404934|FG002|NOT COMPLETED|Overall Study||22
6486862|NCT01343901|7404942|FG000|STARTED|Overall Study||210
6486863|NCT01343901|7404942|FG000|Efficacy Population|Overall Study||205
6486864|NCT01343901|7404942|FG000|COMPLETED|Overall Study||97
6486865|NCT01343901|7404942|FG000|NOT COMPLETED|Overall Study||113
6486866|NCT01344057|7404946|FG000|STARTED|Overall Study||63
6486867|NCT01344057|7404946|FG000|COMPLETED|Overall Study||62
6486868|NCT01344057|7404946|FG000|NOT COMPLETED|Overall Study||1
6486869|NCT01344161|7404952|FG000|STARTED|Overall Study||43
6486870|NCT01344161|7404953|FG001|STARTED|Overall Study||42
6486871|NCT01344161|7404952|FG000|COMPLETED|Overall Study||38
6486872|NCT01344161|7404953|FG001|COMPLETED|Overall Study||39
6486873|NCT01344161|7404952|FG000|NOT COMPLETED|Overall Study||5
6486874|NCT01344161|7404953|FG001|NOT COMPLETED|Overall Study||3
6486875|NCT01344226|7404959|FG000|STARTED|Overall Study||49
6486876|NCT01344226|7404959|FG000|COMPLETED|Overall Study||41
6486877|NCT01344226|7404959|FG000|NOT COMPLETED|Overall Study||8
6486878|NCT01344356|7404965|FG000|STARTED|Overall Study||1
6486879|NCT01344356|7404966|FG001|STARTED|Overall Study||18
6486880|NCT01344356|7404965|FG000|COMPLETED|Overall Study||1
6486881|NCT01344356|7404966|FG001|COMPLETED|Overall Study||9
6486882|NCT01344356|7404965|FG000|NOT COMPLETED|Overall Study||0
6486883|NCT01344356|7404966|FG001|NOT COMPLETED|Overall Study||9
6486884|NCT01344369|7404976|FG000|STARTED|First Intervention||18
6486885|NCT01344369|7404977|FG001|STARTED|First Intervention||18
6486886|NCT01344369|7404976|FG000|COMPLETED|First Intervention||18
6486887|NCT01344369|7404977|FG001|COMPLETED|First Intervention||18
6486888|NCT01344369|7404976|FG000|NOT COMPLETED|First Intervention||0
6486889|NCT01344369|7404977|FG001|NOT COMPLETED|First Intervention||0
6486890|NCT01344369|7404976|FG000|STARTED|Washout of 28 Days||18
6486891|NCT01344369|7404977|FG001|STARTED|Washout of 28 Days||18
6486892|NCT01344369|7404976|FG000|COMPLETED|Washout of 28 Days||17
6486893|NCT01344369|7404977|FG001|COMPLETED|Washout of 28 Days||17
6486894|NCT01344369|7404976|FG000|NOT COMPLETED|Washout of 28 Days||1
6486895|NCT01344369|7404977|FG001|NOT COMPLETED|Washout of 28 Days||1
6486896|NCT01344369|7404976|FG000|STARTED|Second Intervention||17
6486897|NCT01344369|7404977|FG001|STARTED|Second Intervention||17
6486898|NCT01344369|7404976|FG000|COMPLETED|Second Intervention||17
6486899|NCT01344369|7404977|FG001|COMPLETED|Second Intervention||16
6486900|NCT01344369|7404976|FG000|NOT COMPLETED|Second Intervention||0
6486901|NCT01344369|7404977|FG001|NOT COMPLETED|Second Intervention||1
6486902|NCT01344447|7404983|FG000|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
6486903|NCT01344447|7404983|FG000|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
6486904|NCT01344447|7404983|FG000|COMPLETED|Overall Study||471
6486905|NCT01344447|7404983|FG000|NOT COMPLETED|Overall Study||8
6486906|NCT01344460|7404991|FG000|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
6486907|NCT01344460|7404991|FG000|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
6486908|NCT01344460|7404991|FG000|COMPLETED|Overall Study||312
6486909|NCT01344460|7404991|FG000|NOT COMPLETED|Overall Study||3
6486910|NCT01344538|7405001|FG000|STARTED|Overall Study||16
6486911|NCT01344538|7405002|FG001|STARTED|Overall Study||17
6486912|NCT01344538|7405001|FG000|COMPLETED|Overall Study||14
6486913|NCT01344538|7405002|FG001|COMPLETED|Overall Study||16
6486914|NCT01344538|7405001|FG000|NOT COMPLETED|Overall Study||2
6486915|NCT01344538|7405002|FG001|NOT COMPLETED|Overall Study||1
6486916|NCT01344616|7405010|FG000|STARTED|Overall Study||244
6486917|NCT01344616|7405011|FG001|STARTED|Overall Study||238
6486918|NCT01344616|7405010|FG000|COMPLETED|Overall Study||209
6486919|NCT01344616|7405011|FG001|COMPLETED|Overall Study||194
6486920|NCT01344616|7405010|FG000|NOT COMPLETED|Overall Study||35
6486921|NCT01344616|7405011|FG001|NOT COMPLETED|Overall Study||44
6486922|NCT01344629|7405019|FG000|STARTED|Crossover Period 1||32
6486923|NCT01344629|7405020|FG001|STARTED|Crossover Period 1||32
6486924|NCT01344629|7405019|FG000|COMPLETED|Crossover Period 1||32
6486925|NCT01344629|7405020|FG001|COMPLETED|Crossover Period 1||32
6486926|NCT01344629|7405019|FG000|NOT COMPLETED|Crossover Period 1||0
6486927|NCT01344629|7405020|FG001|NOT COMPLETED|Crossover Period 1||0
6486928|NCT01344629|7405019|FG000|STARTED|Crossover Period 2||32
6486929|NCT01344629|7405020|FG001|STARTED|Crossover Period 2||32
6486930|NCT01344629|7405019|FG000|COMPLETED|Crossover Period 2||32
6486931|NCT01344629|7405020|FG001|COMPLETED|Crossover Period 2||31
6486932|NCT01344629|7405019|FG000|NOT COMPLETED|Crossover Period 2||0
6486933|NCT01344629|7405020|FG001|NOT COMPLETED|Crossover Period 2||1
6486934|NCT01344629|7405019|FG000|STARTED|Crossover Period 3||32
6486935|NCT01344629|7405020|FG001|STARTED|Crossover Period 3||31
6486936|NCT01344629|7405019|FG000|COMPLETED|Crossover Period 3||32
6486937|NCT01344629|7405020|FG001|COMPLETED|Crossover Period 3||31
6486938|NCT01344629|7405019|FG000|NOT COMPLETED|Crossover Period 3||0
6486939|NCT01344629|7405020|FG001|NOT COMPLETED|Crossover Period 3||0
6486940|NCT01344629|7405019|FG000|STARTED|Crossover Period 4||32
6486941|NCT01344629|7405020|FG001|STARTED|Crossover Period 4||31
6486942|NCT01344629|7405019|FG000|COMPLETED|Crossover Period 4||32
6486943|NCT01344629|7405020|FG001|COMPLETED|Crossover Period 4||31
6486944|NCT01344629|7405019|FG000|NOT COMPLETED|Crossover Period 4||0
6486945|NCT01344629|7405020|FG001|NOT COMPLETED|Crossover Period 4||0
6486946|NCT01344759|7405028|FG000|STARTED|Overall Study||30
6486947|NCT01344759|7405029|FG001|STARTED|Overall Study||30
6486948|NCT01344759|7405028|FG000|COMPLETED|Overall Study||30
6486949|NCT01344759|7405029|FG001|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
6554983|NCT01749501|7477091|FG000|STARTED|Overall Study||22
6554984|NCT01749501|7477092|FG001|STARTED|Overall Study||23
6748671|NCT03417830|7676793|FG001|COMPLETED|Part B (up to 26 Days)||0
6748672|NCT03417830|7676792|FG000|NOT COMPLETED|Part B (up to 26 Days)||0
6748673|NCT03417830|7676793|FG001|NOT COMPLETED|Part B (up to 26 Days)||0
6486950|NCT01344759|7405028|FG000|NOT COMPLETED|Overall Study||0
6554985|NCT01749501|7477091|FG000|COMPLETED|Overall Study||22
6554986|NCT01749501|7477092|FG001|COMPLETED|Overall Study||23
6554987|NCT01749501|7477091|FG000|NOT COMPLETED|Overall Study||0
6554988|NCT01749501|7477092|FG001|NOT COMPLETED|Overall Study||0
6554989|NCT01749605|7477100|FG000|STARTED|Overall Study||18
6554990|NCT01749605|7477101|FG001|STARTED|Overall Study||17
6486951|NCT01344759|7405029|FG001|NOT COMPLETED|Overall Study||2
6486952|NCT01344824|7405041|FG000|STARTED|Overall Study||38
6486953|NCT01344824|7405041|FG000|COMPLETED|Overall Study||1
6486954|NCT01344824|7405041|FG000|NOT COMPLETED|Overall Study||37
6486955|NCT01344876|7405046|FG000|STARTED|Overall Study||4
6486956|NCT01344876|7405047|FG001|STARTED|Overall Study||3
6486957|NCT01344876|7405048|FG002|STARTED|Overall Study||4
6486958|NCT01344876|7405049|FG003|STARTED|Overall Study||6
6486959|NCT01344876|7405050|FG004|STARTED|Overall Study||3
6486960|NCT01344876|7405046|FG000|COMPLETED|Overall Study||3
6486961|NCT01344876|7405047|FG001|COMPLETED|Overall Study||3
6486962|NCT01344876|7405048|FG002|COMPLETED|Overall Study||3
6486963|NCT01344876|7405049|FG003|COMPLETED|Overall Study||3
6486964|NCT01344876|7405050|FG004|COMPLETED|Overall Study||2
6486965|NCT01344876|7405046|FG000|NOT COMPLETED|Overall Study||1
6486966|NCT01344876|7405047|FG001|NOT COMPLETED|Overall Study||0
6486967|NCT01344876|7405048|FG002|NOT COMPLETED|Overall Study||1
6486968|NCT01344876|7405049|FG003|NOT COMPLETED|Overall Study||3
6486969|NCT01344876|7405050|FG004|NOT COMPLETED|Overall Study||1
6486970|NCT01345019|7405065|FG000|STARTED|Blinded Treatment Phase||859
6486971|NCT01345019|7405066|FG001|STARTED|Blinded Treatment Phase||859
6486972|NCT01345019|7405065|FG000|Received Treatment|Blinded Treatment Phase||852
6486973|NCT01345019|7405066|FG001|Received Treatment|Blinded Treatment Phase||850
6486974|NCT01345019|7405065|FG000|COMPLETED|Blinded Treatment Phase||541
6486975|NCT01345019|7405066|FG001|COMPLETED|Blinded Treatment Phase||555
6486976|NCT01345019|7405065|FG000|NOT COMPLETED|Blinded Treatment Phase||318
6486977|NCT01345019|7405066|FG001|NOT COMPLETED|Blinded Treatment Phase||304
6486978|NCT01345019|7405065|FG000|STARTED|Open Label Treatment Phase||418
6486979|NCT01345019|7405066|FG001|STARTED|Open Label Treatment Phase||426
6486980|NCT01345019|7405065|FG000|COMPLETED|Open Label Treatment Phase||227
6486981|NCT01345019|7405066|FG001|COMPLETED|Open Label Treatment Phase||233
6486982|NCT01345019|7405065|FG000|NOT COMPLETED|Open Label Treatment Phase||191
6486983|NCT01345019|7405066|FG001|NOT COMPLETED|Open Label Treatment Phase||193
6486984|NCT01345058|7405076|FG000|STARTED|Overall Study||20
6486985|NCT01345058|7405077|FG001|STARTED|Overall Study||36
6486986|NCT01345058|7405076|FG000|Received Lacosamide|Overall Study||19
6486987|NCT01345058|7405077|FG001|Received Lacosamide|Overall Study||0
6486988|NCT01345058|7405076|FG000|COMPLETED|Overall Study||15
6486989|NCT01345058|7405077|FG001|COMPLETED|Overall Study||36
6486990|NCT01345058|7405076|FG000|NOT COMPLETED|Overall Study||5
6486991|NCT01345058|7405077|FG001|NOT COMPLETED|Overall Study||0
6486992|NCT01345123|7405086|FG000|STARTED|Overall Study||3323
6486993|NCT01345123|7405087|FG001|STARTED|Overall Study||3311
6486994|NCT01345123|7405088|FG002|STARTED|Overall Study||3291
6486995|NCT01345123|7405086|FG000|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
6554991|NCT01749605|7477100|FG000|COMPLETED|Overall Study||14
6554992|NCT01749605|7477101|FG001|COMPLETED|Overall Study||14
6554993|NCT01749605|7477100|FG000|NOT COMPLETED|Overall Study||4
6748674|NCT03418051|7676803|FG000|STARTED|Overall Study||20
6486996|NCT01345123|7405087|FG001|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
6486997|NCT01345123|7405088|FG002|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
6486998|NCT01345123|7405086|FG000|NOT COMPLETED|Overall Study||79
6486999|NCT01345123|7405087|FG001|NOT COMPLETED|Overall Study||85
6487000|NCT01345123|7405088|FG002|NOT COMPLETED|Overall Study||88
6487001|NCT01345162|7405099|FG000|STARTED|Overall Study||100
6487002|NCT01345162|7405100|FG001|STARTED|Overall Study||100
6487003|NCT01345162|7405099|FG000|COMPLETED|Overall Study||98
6487004|NCT01345162|7405100|FG001|COMPLETED|Overall Study||96
6487005|NCT01345162|7405099|FG000|NOT COMPLETED|Overall Study||2
6487006|NCT01345162|7405100|FG001|NOT COMPLETED|Overall Study||4
6487007|NCT01345188|7405106|FG000|STARTED|Randomization Ranolazine/Placebo 6 Weeks||28
6554994|NCT01749605|7477101|FG001|NOT COMPLETED|Overall Study||3
6487008|NCT01345188|7405106|FG000|COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||26
6487009|NCT01345188|7405106|FG000|NOT COMPLETED|Randomization Ranolazine/Placebo 6 Weeks||2
6554995|NCT01749631|7477107|FG000|STARTED|Overall Study||97
6554996|NCT01749631|7477107|FG000|COMPLETED|Overall Study||97
6554997|NCT01749631|7477107|FG000|NOT COMPLETED|Overall Study||0
6487010|NCT01345188|7405106|FG000|STARTED|Crossover Ranolazine/Placebo 6 Weeks||26
6487011|NCT01345188|7405106|FG000|COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||25
6487012|NCT01345188|7405106|FG000|NOT COMPLETED|Crossover Ranolazine/Placebo 6 Weeks||1
6487013|NCT01345253|7405115|FG000|STARTED|Double-blind (DB) Phase (52 Weeks)||226
6487014|NCT01345253|7405116|FG001|STARTED|Double-blind (DB) Phase (52 Weeks)||451
6487015|NCT01345253|7405115|FG000|COMPLETED|Double-blind (DB) Phase (52 Weeks)||170
6487016|NCT01345253|7405116|FG001|COMPLETED|Double-blind (DB) Phase (52 Weeks)||372
6487017|NCT01345253|7405115|FG000|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||56
6487018|NCT01345253|7405116|FG001|NOT COMPLETED|Double-blind (DB) Phase (52 Weeks)||79
6487019|NCT01345253|7405115|FG000|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 9 China par. from Safety Pop|134
6487020|NCT01345253|7405116|FG001|STARTED|Open-label Phase (Up to Year 5 Week 44)|Only eligible China par. enrolled in OL phase from MITT + additional 16 China par. from Safety Pop|290
6487021|NCT01345253|7405115|FG000|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||69
6487022|NCT01345253|7405116|FG001|COMPLETED|Open-label Phase (Up to Year 5 Week 44)||146
6487023|NCT01345253|7405115|FG000|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||65
6487024|NCT01345253|7405116|FG001|NOT COMPLETED|Open-label Phase (Up to Year 5 Week 44)||144
6487025|NCT01345292|7405127|FG000|STARTED|Overall Study||75
6487026|NCT01345292|7405128|FG001|STARTED|Overall Study||76
6487027|NCT01345292|7405129|FG002|STARTED|Overall Study||75
6487028|NCT01345292|7405127|FG000|COMPLETED|Overall Study||73
6487029|NCT01345292|7405128|FG001|COMPLETED|Overall Study||76
6487030|NCT01345292|7405129|FG002|COMPLETED|Overall Study||74
6487031|NCT01345292|7405127|FG000|NOT COMPLETED|Overall Study||2
6487032|NCT01345292|7405128|FG001|NOT COMPLETED|Overall Study||0
6487033|NCT01345292|7405129|FG002|NOT COMPLETED|Overall Study||1
6487034|NCT01345318|7405137|FG000|STARTED|Overall Study||191
6487035|NCT01345318|7405137|FG000|COMPLETED|Overall Study||111
6487036|NCT01345318|7405137|FG000|NOT COMPLETED|Overall Study||80
6487037|NCT01345513|7405142|FG000|STARTED|Overall Study||50
6487038|NCT01345513|7405142|FG000|COMPLETED|Overall Study||50
6487039|NCT01345513|7405142|FG000|NOT COMPLETED|Overall Study||0
6487040|NCT01345591|7405146|FG000|STARTED|Overall Study||20
6487041|NCT01345591|7405146|FG000|COMPLETED|Overall Study||19
6487042|NCT01345591|7405146|FG000|NOT COMPLETED|Overall Study||1
6487043|NCT01345630|7405157|FG000|STARTED|Overall Study||396
6487044|NCT01345630|7405158|FG001|STARTED|Overall Study||401
6487045|NCT01345630|7405157|FG000|COMPLETED|Overall Study||35
6487046|NCT01345630|7405158|FG001|COMPLETED|Overall Study||42
6487047|NCT01345630|7405157|FG000|NOT COMPLETED|Overall Study||361
6487048|NCT01345630|7405158|FG001|NOT COMPLETED|Overall Study||359
6487049|NCT01345669|7405170|FG000|STARTED|Overall Study||411
6487050|NCT01345669|7405171|FG001|STARTED|Overall Study||206
6487051|NCT01345669|7405170|FG000|COMPLETED|Overall Study||124
6487052|NCT01345669|7405171|FG001|COMPLETED|Overall Study||87
6487053|NCT01345669|7405170|FG000|NOT COMPLETED|Overall Study||287
6487054|NCT01345669|7405171|FG001|NOT COMPLETED|Overall Study||119
6487055|NCT01345682|7405179|FG000|STARTED|Overall Study|Randomised|322
6487056|NCT01345682|7405180|FG001|STARTED|Overall Study|Randomised|161
6487057|NCT01345682|7405179|FG000|COMPLETED|Overall Study||0
6487058|NCT01345682|7405180|FG001|COMPLETED|Overall Study||0
6487059|NCT01345682|7405179|FG000|NOT COMPLETED|Overall Study||322
6487060|NCT01345682|7405180|FG001|NOT COMPLETED|Overall Study||161
6487061|NCT01345721|7405189|FG000|STARTED|Overall Study||74
6487062|NCT01345721|7405190|FG001|STARTED|Overall Study||66
6487063|NCT01345721|7405191|FG002|STARTED|Overall Study||65
6487064|NCT01345721|7405189|FG000|COMPLETED|Overall Study||74
6487065|NCT01345721|7405190|FG001|COMPLETED|Overall Study||66
6554998|NCT01749735|7477113|FG000|STARTED|Overall Study||2
6554999|NCT01749735|7477114|FG001|STARTED|Overall Study||0
6555000|NCT01749735|7477113|FG000|COMPLETED|Overall Study||1
6487066|NCT01345721|7405191|FG002|COMPLETED|Overall Study||65
6487067|NCT01345721|7405189|FG000|NOT COMPLETED|Overall Study||0
6487068|NCT01345721|7405190|FG001|NOT COMPLETED|Overall Study||0
6487069|NCT01345721|7405191|FG002|NOT COMPLETED|Overall Study||0
6487070|NCT01345929|7405205|FG000|STARTED|Overall Study||533
6487071|NCT01345929|7405206|FG001|STARTED|Overall Study||535
6487072|NCT01345929|7405205|FG000|COMPLETED|Overall Study||512
6487073|NCT01345929|7405206|FG001|COMPLETED|Overall Study||516
6487074|NCT01345929|7405205|FG000|NOT COMPLETED|Overall Study||21
6487075|NCT01345929|7405206|FG001|NOT COMPLETED|Overall Study||19
6487076|NCT01346059|7405214|FG000|STARTED|Overall Study||1
6487077|NCT01346059|7405215|FG001|STARTED|Overall Study||1
6487078|NCT01346059|7405214|FG000|COMPLETED|Overall Study||0
6487079|NCT01346059|7405215|FG001|COMPLETED|Overall Study||1
6487080|NCT01346059|7405214|FG000|NOT COMPLETED|Overall Study||1
6487081|NCT01346059|7405215|FG001|NOT COMPLETED|Overall Study||0
6487082|NCT01346072|7405223|FG000|STARTED|Overall Study||11
6487083|NCT01346072|7405224|FG001|STARTED|Overall Study||10
6654705|NCT02447497|7584610|FG002|STARTED|Overall Study||23
6487084|NCT01346072|7405223|FG000|COMPLETED|Overall Study||11
6555001|NCT01749735|7477114|FG001|COMPLETED|Overall Study||0
6555002|NCT01749735|7477113|FG000|NOT COMPLETED|Overall Study||1
6654706|NCT02447497|7584611|FG003|STARTED|Overall Study||23
6487085|NCT01346072|7405224|FG001|COMPLETED|Overall Study||10
6487086|NCT01346072|7405223|FG000|NOT COMPLETED|Overall Study||0
6487087|NCT01346072|7405224|FG001|NOT COMPLETED|Overall Study||0
6487088|NCT01346085|7405230|FG000|STARTED|Overall Study||10
6487089|NCT01346085|7405230|FG000|COMPLETED|Overall Study||10
6654707|NCT02447497|7584608|FG000|COMPLETED|Overall Study||19
6654708|NCT02447497|7584609|FG001|COMPLETED|Overall Study||19
6654709|NCT02447497|7584610|FG002|COMPLETED|Overall Study||21
6654710|NCT02447497|7584611|FG003|COMPLETED|Overall Study||21
6654711|NCT02447497|7584608|FG000|NOT COMPLETED|Overall Study||6
6654712|NCT02447497|7584609|FG001|NOT COMPLETED|Overall Study||6
6654713|NCT02447497|7584610|FG002|NOT COMPLETED|Overall Study||2
6654714|NCT02447497|7584611|FG003|NOT COMPLETED|Overall Study||2
6656237|NCT02459262|7586358|FG000|NOT COMPLETED|Overall Study||0
6487090|NCT01346085|7405230|FG000|NOT COMPLETED|Overall Study||0
6487091|NCT01346176|7405237|FG000|STARTED|Recruited||49
6487092|NCT01346176|7405238|FG001|STARTED|Recruited||40
6487093|NCT01346176|7405239|FG002|STARTED|Recruited||43
6487094|NCT01346176|7405237|FG000|COMPLETED|Recruited||48
6487095|NCT01346176|7405238|FG001|COMPLETED|Recruited||40
6487096|NCT01346176|7405239|FG002|COMPLETED|Recruited||43
6487097|NCT01346176|7405237|FG000|NOT COMPLETED|Recruited||1
6487098|NCT01346176|7405238|FG001|NOT COMPLETED|Recruited||0
6487099|NCT01346176|7405239|FG002|NOT COMPLETED|Recruited||0
6487100|NCT01346176|7405237|FG000|STARTED|Completed Advance Directive||48
6487101|NCT01346176|7405238|FG001|STARTED|Completed Advance Directive||40
6487102|NCT01346176|7405239|FG002|STARTED|Completed Advance Directive||43
6487103|NCT01346176|7405237|FG000|COMPLETED|Completed Advance Directive||35
6487104|NCT01346176|7405238|FG001|COMPLETED|Completed Advance Directive||26
6487105|NCT01346176|7405239|FG002|COMPLETED|Completed Advance Directive||33
6487106|NCT01346176|7405237|FG000|NOT COMPLETED|Completed Advance Directive||13
6487107|NCT01346176|7405238|FG001|NOT COMPLETED|Completed Advance Directive||14
6487108|NCT01346176|7405239|FG002|NOT COMPLETED|Completed Advance Directive||10
6487109|NCT01346176|7405237|FG000|STARTED|Completed Satisfaction Survey||35
6487110|NCT01346176|7405238|FG001|STARTED|Completed Satisfaction Survey||26
6487111|NCT01346176|7405239|FG002|STARTED|Completed Satisfaction Survey||33
6487112|NCT01346176|7405237|FG000|COMPLETED|Completed Satisfaction Survey||29
6487113|NCT01346176|7405238|FG001|COMPLETED|Completed Satisfaction Survey||22
6487114|NCT01346176|7405239|FG002|COMPLETED|Completed Satisfaction Survey||27
6487115|NCT01346176|7405237|FG000|NOT COMPLETED|Completed Satisfaction Survey||6
6487116|NCT01346176|7405238|FG001|NOT COMPLETED|Completed Satisfaction Survey||4
6487117|NCT01346176|7405239|FG002|NOT COMPLETED|Completed Satisfaction Survey||6
6487118|NCT01346189|7405251|FG000|STARTED|Overall Study||433
6487119|NCT01346189|7405252|FG001|STARTED|Overall Study||358
6487120|NCT01346189|7405253|FG002|STARTED|Overall Study||346
6487121|NCT01346189|7405254|FG003|STARTED|Overall Study||366
6487122|NCT01346189|7405251|FG000|COMPLETED|Overall Study|433 patients (64 primary care physicians) included in analysis|417
6487123|NCT01346189|7405252|FG001|COMPLETED|Overall Study|358 Patients (58 primary care physicians) included in analysis|341
6487124|NCT01346189|7405253|FG002|COMPLETED|Overall Study|346 patients (58 primary care physicians) included in analysis|332
6487125|NCT01346189|7405254|FG003|COMPLETED|Overall Study|366 patients (58 primary care physicians) included in analysis|355
6487126|NCT01346189|7405251|FG000|NOT COMPLETED|Overall Study||16
6487127|NCT01346189|7405252|FG001|NOT COMPLETED|Overall Study||17
6487128|NCT01346189|7405253|FG002|NOT COMPLETED|Overall Study||14
6487129|NCT01346189|7405254|FG003|NOT COMPLETED|Overall Study||11
6487130|NCT01346267|7405266|FG000|STARTED|Overall Study||93
6487131|NCT01346267|7405267|FG001|STARTED|Overall Study||94
6487132|NCT01346267|7405266|FG000|COMPLETED|Overall Study||70
6487133|NCT01346267|7405267|FG001|COMPLETED|Overall Study||67
6487134|NCT01346267|7405266|FG000|NOT COMPLETED|Overall Study||23
6487135|NCT01346267|7405267|FG001|NOT COMPLETED|Overall Study||27
6487136|NCT01346293|7405275|FG000|STARTED|Overall Study||2743
6487137|NCT01346293|7405276|FG001|STARTED|Overall Study||629
6487138|NCT01346293|7405275|FG000|COMPLETED|Overall Study||2676
6487139|NCT01346293|7405276|FG001|COMPLETED|Overall Study||608
6487140|NCT01346293|7405275|FG000|NOT COMPLETED|Overall Study||67
6487141|NCT01346293|7405276|FG001|NOT COMPLETED|Overall Study||21
6487142|NCT01346371|7405286|FG000|STARTED|Overall Study||20
6487143|NCT01346371|7405287|FG001|STARTED|Overall Study||20
6487144|NCT01346371|7405286|FG000|COMPLETED|Overall Study||18
6487145|NCT01346371|7405287|FG001|COMPLETED|Overall Study||20
6487146|NCT01346371|7405286|FG000|NOT COMPLETED|Overall Study||2
6487147|NCT01346371|7405287|FG001|NOT COMPLETED|Overall Study||0
6487148|NCT01346397|7405295|FG000|STARTED|Overall Study||85
6487149|NCT01346397|7405296|FG001|STARTED|Overall Study||85
6487150|NCT01346397|7405295|FG000|COMPLETED|Overall Study||85
6487151|NCT01346397|7405296|FG001|COMPLETED|Overall Study||85
6487152|NCT01346397|7405295|FG000|NOT COMPLETED|Overall Study||0
6487153|NCT01346397|7405296|FG001|NOT COMPLETED|Overall Study||0
6487154|NCT01346410|7405302|FG000|STARTED|Overall Study||1
6487155|NCT01346410|7405302|FG000|COMPLETED|Overall Study||0
6487156|NCT01346410|7405302|FG000|NOT COMPLETED|Overall Study||1
6487157|NCT01346475|7405308|FG000|STARTED|First Intervention||22
6487158|NCT01346475|7405309|FG001|STARTED|First Intervention||28
6487159|NCT01346475|7405308|FG000|COMPLETED|First Intervention||18
6487160|NCT01346475|7405309|FG001|COMPLETED|First Intervention||25
6487161|NCT01346475|7405308|FG000|NOT COMPLETED|First Intervention||4
6487162|NCT01346475|7405309|FG001|NOT COMPLETED|First Intervention||3
6487163|NCT01346475|7405308|FG000|STARTED|Second Intervention||18
6487164|NCT01346475|7405309|FG001|STARTED|Second Intervention||25
6487165|NCT01346475|7405308|FG000|COMPLETED|Second Intervention||18
6487166|NCT01346475|7405309|FG001|COMPLETED|Second Intervention||25
6487167|NCT01346475|7405308|FG000|NOT COMPLETED|Second Intervention||0
6487168|NCT01346475|7405309|FG001|NOT COMPLETED|Second Intervention||0
6487169|NCT01346488|7405315|FG000|STARTED|Overall Study||1968
6487170|NCT01346488|7405315|FG000|COMPLETED|Overall Study||1262
6487171|NCT01346488|7405315|FG000|NOT COMPLETED|Overall Study||706
6487172|NCT01346501|7405321|FG000|STARTED|Overall Study||79
6487173|NCT01346501|7405322|FG001|STARTED|Overall Study||93
6487174|NCT01346501|7405321|FG000|COMPLETED|Overall Study||68
6487175|NCT01346501|7405322|FG001|COMPLETED|Overall Study||80
6487176|NCT01346501|7405321|FG000|NOT COMPLETED|Overall Study||11
6487177|NCT01346501|7405322|FG001|NOT COMPLETED|Overall Study||13
6487178|NCT01346514|7405332|FG000|STARTED|Overall Study||91
6487179|NCT01346514|7405333|FG001|STARTED|Overall Study||90
6487180|NCT01346514|7405332|FG000|3 Month Assessment|Overall Study||83
6487181|NCT01346514|7405333|FG001|3 Month Assessment|Overall Study||68
6487182|NCT01346514|7405332|FG000|6 Month Assessment|Overall Study||74
6487183|NCT01346514|7405333|FG001|6 Month Assessment|Overall Study||61
6487184|NCT01346514|7405332|FG000|9 Month Assessment|Overall Study||67
6487185|NCT01346514|7405333|FG001|9 Month Assessment|Overall Study||59
6487186|NCT01346514|7405332|FG000|12 Month Assessment|Overall Study||62
6487187|NCT01346514|7405333|FG001|12 Month Assessment|Overall Study||53
6487188|NCT01346514|7405332|FG000|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
6487189|NCT01346514|7405333|FG001|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
6487190|NCT01346514|7405332|FG000|NOT COMPLETED|Overall Study||29
6487191|NCT01346514|7405333|FG001|NOT COMPLETED|Overall Study||37
6487192|NCT01346540|7405343|FG000|STARTED|Overall Study||4
6487193|NCT01346540|7405344|FG001|STARTED|Overall Study||12
6487194|NCT01346540|7405343|FG000|COMPLETED|Overall Study||1
6487195|NCT01346540|7405344|FG001|COMPLETED|Overall Study||0
6487196|NCT01346540|7405343|FG000|NOT COMPLETED|Overall Study||3
6487197|NCT01346540|7405344|FG001|NOT COMPLETED|Overall Study||12
6487198|NCT01346592|7405354|FG000|STARTED|Overall Study||3136
6487199|NCT01346592|7405355|FG001|STARTED|Overall Study||1478
6487200|NCT01346592|7405356|FG002|STARTED|Overall Study||1486
6487201|NCT01346592|7405354|FG000|COMPLETED|Overall Study||2983
6487202|NCT01346592|7405355|FG001|COMPLETED|Overall Study||1389
6487203|NCT01346592|7405356|FG002|COMPLETED|Overall Study||1408
6487204|NCT01346592|7405354|FG000|NOT COMPLETED|Overall Study||153
6487205|NCT01346592|7405355|FG001|NOT COMPLETED|Overall Study||89
6487206|NCT01346592|7405356|FG002|NOT COMPLETED|Overall Study||78
6487207|NCT01346683|7405381|FG000|STARTED|Overall Study||45
6487208|NCT01346683|7405381|FG000|COMPLETED|Overall Study||45
6487209|NCT01346683|7405381|FG000|NOT COMPLETED|Overall Study||0
6487210|NCT01346696|7405385|FG000|STARTED|Overall Study||45
6487211|NCT01346696|7405385|FG000|COMPLETED|Overall Study||44
6487212|NCT01346696|7405385|FG000|NOT COMPLETED|Overall Study||1
6487213|NCT01346774|7405391|FG000|STARTED|Overall Study||80
6487214|NCT01346774|7405392|FG001|STARTED|Overall Study||80
6487215|NCT01346774|7405391|FG000|COMPLETED|Overall Study||67
6487216|NCT01346774|7405392|FG001|COMPLETED|Overall Study||63
6487217|NCT01346774|7405391|FG000|NOT COMPLETED|Overall Study||13
6487218|NCT01346774|7405392|FG001|NOT COMPLETED|Overall Study||17
6487219|NCT01346839|7405400|FG000|STARTED|Overall Study||683
6487220|NCT01346839|7405401|FG001|STARTED|Overall Study||573
6487221|NCT01346839|7405400|FG000|COMPLETED|Overall Study||369
6487222|NCT01346839|7405401|FG001|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
6487223|NCT01346839|7405400|FG000|NOT COMPLETED|Overall Study||314
6487224|NCT01346839|7405401|FG001|NOT COMPLETED|Overall Study||209
6487225|NCT01346852|7405409|FG000|STARTED|Overall Study||41753
6487226|NCT01346852|7405410|FG001|STARTED|Overall Study||59684
6487227|NCT01346852|7405409|FG000|COMPLETED|Overall Study||41753
6487228|NCT01346852|7405410|FG001|COMPLETED|Overall Study||59684
6487229|NCT01346852|7405409|FG000|NOT COMPLETED|Overall Study||0
6487230|NCT01346852|7405410|FG001|NOT COMPLETED|Overall Study||0
6487231|NCT01346969|7405420|FG000|STARTED|Overall Study||28
6487232|NCT01346969|7405421|FG001|STARTED|Overall Study||14
6487233|NCT01346969|7405422|FG002|STARTED|Overall Study||13
6487234|NCT01346969|7405423|FG003|STARTED|Overall Study||13
6487235|NCT01346969|7405420|FG000|Safety Population|Overall Study||27
6487236|NCT01346969|7405421|FG001|Safety Population|Overall Study||14
6487237|NCT01346969|7405422|FG002|Safety Population|Overall Study||13
6487238|NCT01346969|7405423|FG003|Safety Population|Overall Study||13
6487239|NCT01346969|7405420|FG000|COMPLETED|Overall Study||26
6487240|NCT01346969|7405421|FG001|COMPLETED|Overall Study||14
6487241|NCT01346969|7405422|FG002|COMPLETED|Overall Study||10
6487242|NCT01346969|7405423|FG003|COMPLETED|Overall Study||12
6487243|NCT01346969|7405420|FG000|NOT COMPLETED|Overall Study||2
6487244|NCT01346969|7405421|FG001|NOT COMPLETED|Overall Study||0
6487245|NCT01346969|7405422|FG002|NOT COMPLETED|Overall Study||3
6487246|NCT01346969|7405423|FG003|NOT COMPLETED|Overall Study||1
6487247|NCT01347008|7405435|FG000|STARTED|Overall Study||21
6487248|NCT01347008|7405436|FG001|STARTED|Overall Study||20
6487249|NCT01347008|7405435|FG000|COMPLETED|Overall Study||21
6487250|NCT01347008|7405436|FG001|COMPLETED|Overall Study||20
6487251|NCT01347008|7405435|FG000|NOT COMPLETED|Overall Study||0
6487252|NCT01347008|7405436|FG001|NOT COMPLETED|Overall Study||0
6487253|NCT01347034|7405444|FG000|STARTED|Overall Study||6
6487254|NCT01347034|7405445|FG001|STARTED|Overall Study||14
6487255|NCT01347034|7405444|FG000|COMPLETED|Overall Study||6
6487256|NCT01347034|7405445|FG001|COMPLETED|Overall Study||14
6487257|NCT01347034|7405444|FG000|NOT COMPLETED|Overall Study||0
6487258|NCT01347034|7405445|FG001|NOT COMPLETED|Overall Study||0
6487259|NCT01347060|7405453|FG000|STARTED|Overall Study||9868
6487260|NCT01347060|7405454|FG001|STARTED|Overall Study||7580
6487261|NCT01347060|7405453|FG000|COMPLETED|Overall Study||9868
6487262|NCT01347060|7405454|FG001|COMPLETED|Overall Study||7580
6487263|NCT01347060|7405453|FG000|NOT COMPLETED|Overall Study||0
6487264|NCT01347060|7405454|FG001|NOT COMPLETED|Overall Study||0
6487265|NCT01347073|7405460|FG000|STARTED|Overall Study||23
6487266|NCT01347073|7405460|FG000|COMPLETED|Overall Study||21
6487267|NCT01347073|7405460|FG000|NOT COMPLETED|Overall Study||2
6487268|NCT01347086|7405480|FG000|STARTED|Overall Study||2
6487269|NCT01347086|7405481|FG001|STARTED|Overall Study||6
6487270|NCT01347086|7405482|FG002|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
6487271|NCT01347086|7405483|FG003|STARTED|Overall Study||6
6487272|NCT01347086|7405484|FG004|STARTED|Overall Study||6
6487273|NCT01347086|7405485|FG005|STARTED|Overall Study||6
6487274|NCT01347086|7405486|FG006|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.~1 subject was not treated."|7
6487275|NCT01347086|7405487|FG007|STARTED|Overall Study|One subject was not treated.|7
6487276|NCT01347086|7405488|FG008|STARTED|Overall Study||6
6487277|NCT01347086|7405489|FG009|STARTED|Overall Study|One subject was not treated.|7
6487278|NCT01347086|7405480|FG000|COMPLETED|Overall Study||2
6487279|NCT01347086|7405481|FG001|COMPLETED|Overall Study||6
6487280|NCT01347086|7405482|FG002|COMPLETED|Overall Study||6
6487281|NCT01347086|7405483|FG003|COMPLETED|Overall Study||6
6487282|NCT01347086|7405484|FG004|COMPLETED|Overall Study||6
6487283|NCT01347086|7405485|FG005|COMPLETED|Overall Study||6
6487284|NCT01347086|7405486|FG006|COMPLETED|Overall Study||6
6487285|NCT01347086|7405487|FG007|COMPLETED|Overall Study||6
6487286|NCT01347086|7405488|FG008|COMPLETED|Overall Study||6
6487287|NCT01347086|7405489|FG009|COMPLETED|Overall Study||6
6487288|NCT01347086|7405480|FG000|NOT COMPLETED|Overall Study||0
6487289|NCT01347086|7405481|FG001|NOT COMPLETED|Overall Study||0
6487290|NCT01347086|7405482|FG002|NOT COMPLETED|Overall Study||1
6487291|NCT01347086|7405483|FG003|NOT COMPLETED|Overall Study||0
6487292|NCT01347086|7405484|FG004|NOT COMPLETED|Overall Study||0
6487293|NCT01347086|7405485|FG005|NOT COMPLETED|Overall Study||0
6487294|NCT01347086|7405486|FG006|NOT COMPLETED|Overall Study||1
6487295|NCT01347086|7405487|FG007|NOT COMPLETED|Overall Study||1
6487296|NCT01347086|7405488|FG008|NOT COMPLETED|Overall Study||0
6487297|NCT01347086|7405489|FG009|NOT COMPLETED|Overall Study||1
6487298|NCT01347112|7405523|FG000|STARTED|Overall Study||16
6487299|NCT01347112|7405524|FG001|STARTED|Overall Study||17
6487300|NCT01347112|7405523|FG000|COMPLETED|Overall Study||12
6487301|NCT01347112|7405524|FG001|COMPLETED|Overall Study||5
6487302|NCT01347112|7405523|FG000|NOT COMPLETED|Overall Study||4
6487303|NCT01347112|7405524|FG001|NOT COMPLETED|Overall Study||12
6487304|NCT01347255|7405531|FG000|STARTED|Overall Study||24
6487305|NCT01347255|7405531|FG000|COMPLETED|Overall Study||24
6487306|NCT01347255|7405531|FG000|NOT COMPLETED|Overall Study||0
6487307|NCT01347307|7405540|FG000|STARTED|Overall Study||3
6487308|NCT01347307|7405541|FG001|STARTED|Overall Study||33
6487309|NCT01347307|7405540|FG000|COMPLETED|Overall Study||3
6487310|NCT01347307|7405541|FG001|COMPLETED|Overall Study||28
6487311|NCT01347307|7405540|FG000|NOT COMPLETED|Overall Study||0
6487312|NCT01347307|7405541|FG001|NOT COMPLETED|Overall Study||5
6487313|NCT01347333|7405549|FG000|STARTED|Overall Study||23
6748675|NCT03418051|7676804|FG001|STARTED|Overall Study||20
6748676|NCT03418051|7676805|FG002|STARTED|Overall Study||20
6748677|NCT03418051|7676803|FG000|COMPLETED|Overall Study||14
6748678|NCT03418051|7676804|FG001|COMPLETED|Overall Study||18
6748679|NCT03418051|7676805|FG002|COMPLETED|Overall Study||17
6748680|NCT03418051|7676803|FG000|NOT COMPLETED|Overall Study||6
6748681|NCT03418051|7676804|FG001|NOT COMPLETED|Overall Study||2
6748682|NCT03418051|7676805|FG002|NOT COMPLETED|Overall Study||3
6748683|NCT03418064|7676813|FG000|STARTED|First Intervention (1 Month)||21
6748684|NCT03418064|7676814|FG001|STARTED|First Intervention (1 Month)||21
6748685|NCT03418064|7676813|FG000|COMPLETED|First Intervention (1 Month)||21
6748686|NCT03418064|7676814|FG001|COMPLETED|First Intervention (1 Month)||21
6748687|NCT03418064|7676813|FG000|NOT COMPLETED|First Intervention (1 Month)||0
6748688|NCT03418064|7676814|FG001|NOT COMPLETED|First Intervention (1 Month)||0
6487314|NCT01347333|7405550|FG001|STARTED|Overall Study|No participants were enrolled in the Primary Liver Tumor arm.|0
6487315|NCT01347333|7405549|FG000|COMPLETED|Overall Study||23
6487316|NCT01347333|7405550|FG001|COMPLETED|Overall Study||0
6487317|NCT01347333|7405549|FG000|NOT COMPLETED|Overall Study||0
6487318|NCT01347333|7405550|FG001|NOT COMPLETED|Overall Study||0
6487319|NCT01347541|7405558|FG000|STARTED|Overall Study||3
6487320|NCT01347541|7405559|FG001|STARTED|Overall Study||1
6487321|NCT01347541|7405558|FG000|COMPLETED|Overall Study||3
6487322|NCT01347541|7405559|FG001|COMPLETED|Overall Study||1
6487323|NCT01347541|7405558|FG000|NOT COMPLETED|Overall Study||0
6487324|NCT01347541|7405559|FG001|NOT COMPLETED|Overall Study||0
6487325|NCT01347554|7405567|FG000|STARTED|Overall Study||237
6487326|NCT01347554|7405568|FG001|STARTED|Overall Study||242
6487327|NCT01347554|7405567|FG000|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
6487328|NCT01347554|7405568|FG001|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
6487329|NCT01347554|7405567|FG000|NOT COMPLETED|Overall Study||7
6487330|NCT01347554|7405568|FG001|NOT COMPLETED|Overall Study||11
6487331|NCT01347580|7405576|FG000|STARTED|Overall Study|based on randomized treatment|909
6487332|NCT01347580|7405577|FG001|STARTED|Overall Study|based on randomized treatment|953
6487333|NCT01347580|7405576|FG000|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
6487334|NCT01347580|7405577|FG001|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
6487335|NCT01347580|7405576|FG000|Safety Population|Overall Study|based on actual treatment|908
6487336|NCT01347580|7405577|FG001|Safety Population|Overall Study|based on actual treatment|950
6487337|NCT01347580|7405576|FG000|COMPLETED|Overall Study|based on randomized treatment|844
6487338|NCT01347580|7405577|FG001|COMPLETED|Overall Study|based on randomized treatment|897
6487339|NCT01347580|7405576|FG000|NOT COMPLETED|Overall Study||65
6487340|NCT01347580|7405577|FG001|NOT COMPLETED|Overall Study||56
6487341|NCT01347710|7405583|FG000|STARTED|Overall Study||795
6487342|NCT01347710|7405583|FG000|COMPLETED|Overall Study||764
6487343|NCT01347710|7405583|FG000|NOT COMPLETED|Overall Study||31
6487344|NCT01347762|7405595|FG000|STARTED|Overall Study||10
6487345|NCT01347762|7405596|FG001|STARTED|Overall Study||8
6487346|NCT01347762|7405597|FG002|STARTED|Overall Study||16
6487347|NCT01347762|7405598|FG003|STARTED|Overall Study||18
6487348|NCT01347762|7405595|FG000|COMPLETED|Overall Study||6
6487349|NCT01347762|7405596|FG001|COMPLETED|Overall Study||6
6487350|NCT01347762|7405597|FG002|COMPLETED|Overall Study||7
6487351|NCT01347762|7405598|FG003|COMPLETED|Overall Study||10
6487352|NCT01347762|7405595|FG000|NOT COMPLETED|Overall Study||4
6487353|NCT01347762|7405596|FG001|NOT COMPLETED|Overall Study||2
6487354|NCT01347762|7405597|FG002|NOT COMPLETED|Overall Study||9
6487355|NCT01347762|7405598|FG003|NOT COMPLETED|Overall Study||8
6487356|NCT01347788|7405608|FG000|STARTED|Overall Study||11
6487357|NCT01347788|7405609|FG001|STARTED|Overall Study||10
6487358|NCT01347788|7405610|FG002|STARTED|Overall Study||13
6487359|NCT01347788|7405608|FG000|COMPLETED|Overall Study||11
6487360|NCT01347788|7405609|FG001|COMPLETED|Overall Study||10
6487361|NCT01347788|7405610|FG002|COMPLETED|Overall Study||13
6487362|NCT01347788|7405608|FG000|NOT COMPLETED|Overall Study||0
6487363|NCT01347788|7405609|FG001|NOT COMPLETED|Overall Study||0
6487364|NCT01347788|7405610|FG002|NOT COMPLETED|Overall Study||0
6487365|NCT01347866|7405635|FG000|STARTED|Overall Study||5
6487366|NCT01347866|7405636|FG001|STARTED|Overall Study||1
6487367|NCT01347866|7405637|FG002|STARTED|Overall Study||1
6487368|NCT01347866|7405638|FG003|STARTED|Overall Study||7
6487369|NCT01347866|7405639|FG004|STARTED|Overall Study||7
6487370|NCT01347866|7405640|FG005|STARTED|Overall Study||3
6487371|NCT01347866|7405641|FG006|STARTED|Overall Study||6
6487372|NCT01347866|7405642|FG007|STARTED|Overall Study||4
6487373|NCT01347866|7405643|FG008|STARTED|Overall Study||31
6487374|NCT01347866|7405644|FG009|STARTED|Overall Study||7
6487375|NCT01347866|7405645|FG010|STARTED|Overall Study||3
6487376|NCT01347866|7405646|FG011|STARTED|Overall Study||4
6487377|NCT01347866|7405647|FG012|STARTED|Overall Study||7
6487378|NCT01347866|7405648|FG013|STARTED|Overall Study||7
6487379|NCT01347866|7405649|FG014|STARTED|Overall Study||3
6487380|NCT01347866|7405650|FG015|STARTED|Overall Study||4
6487381|NCT01347866|7405651|FG016|STARTED|Overall Study||2
6487382|NCT01347866|7405635|FG000|COMPLETED|Overall Study||0
6487383|NCT01347866|7405636|FG001|COMPLETED|Overall Study||0
6487384|NCT01347866|7405637|FG002|COMPLETED|Overall Study||0
6487385|NCT01347866|7405638|FG003|COMPLETED|Overall Study||0
6487386|NCT01347866|7405639|FG004|COMPLETED|Overall Study||0
6487387|NCT01347866|7405640|FG005|COMPLETED|Overall Study||0
6487388|NCT01347866|7405641|FG006|COMPLETED|Overall Study||0
6487389|NCT01347866|7405642|FG007|COMPLETED|Overall Study||0
6487390|NCT01347866|7405643|FG008|COMPLETED|Overall Study||0
6487391|NCT01347866|7405644|FG009|COMPLETED|Overall Study||0
6487392|NCT01347866|7405645|FG010|COMPLETED|Overall Study||0
6487393|NCT01347866|7405646|FG011|COMPLETED|Overall Study||0
6487394|NCT01347866|7405647|FG012|COMPLETED|Overall Study||0
6487395|NCT01347866|7405648|FG013|COMPLETED|Overall Study||0
6487396|NCT01347866|7405649|FG014|COMPLETED|Overall Study||0
6487397|NCT01347866|7405650|FG015|COMPLETED|Overall Study||0
6487398|NCT01347866|7405651|FG016|COMPLETED|Overall Study||0
6487399|NCT01347866|7405635|FG000|NOT COMPLETED|Overall Study||5
6487400|NCT01347866|7405636|FG001|NOT COMPLETED|Overall Study||1
6487401|NCT01347866|7405637|FG002|NOT COMPLETED|Overall Study||1
6487402|NCT01347866|7405638|FG003|NOT COMPLETED|Overall Study||7
6487403|NCT01347866|7405639|FG004|NOT COMPLETED|Overall Study||7
6487404|NCT01347866|7405640|FG005|NOT COMPLETED|Overall Study||3
6487405|NCT01347866|7405641|FG006|NOT COMPLETED|Overall Study||6
6487406|NCT01347866|7405642|FG007|NOT COMPLETED|Overall Study||4
6487407|NCT01347866|7405643|FG008|NOT COMPLETED|Overall Study||31
6487408|NCT01347866|7405644|FG009|NOT COMPLETED|Overall Study||7
6487409|NCT01347866|7405645|FG010|NOT COMPLETED|Overall Study||3
6487410|NCT01347866|7405646|FG011|NOT COMPLETED|Overall Study||4
6487411|NCT01347866|7405647|FG012|NOT COMPLETED|Overall Study||7
6487412|NCT01347866|7405648|FG013|NOT COMPLETED|Overall Study||7
6487413|NCT01347866|7405649|FG014|NOT COMPLETED|Overall Study||3
6487414|NCT01347866|7405650|FG015|NOT COMPLETED|Overall Study||4
6487415|NCT01347866|7405651|FG016|NOT COMPLETED|Overall Study||2
6487416|NCT01347879|7405724|FG000|STARTED|Overall Study||53
6487417|NCT01347879|7405725|FG001|STARTED|Overall Study||100
6487418|NCT01347879|7405724|FG000|COMPLETED|Overall Study||46
6487419|NCT01347879|7405725|FG001|COMPLETED|Overall Study||83
6487420|NCT01347879|7405724|FG000|NOT COMPLETED|Overall Study||7
6487421|NCT01347879|7405725|FG001|NOT COMPLETED|Overall Study||17
6487422|NCT01347931|7405731|FG000|STARTED|Standard Oxygen Therapy||30
6487423|NCT01347931|7405731|FG000|COMPLETED|Standard Oxygen Therapy||29
6487424|NCT01347931|7405731|FG000|NOT COMPLETED|Standard Oxygen Therapy||1
6487425|NCT01347931|7405731|FG000|STARTED|NIOV System||29
6487426|NCT01347931|7405731|FG000|COMPLETED|NIOV System||29
6487427|NCT01347931|7405731|FG000|NOT COMPLETED|NIOV System||0
6487428|NCT01348087|7405737|FG000|STARTED|Overall Study||148
6555003|NCT01749735|7477114|FG001|NOT COMPLETED|Overall Study||0
6487429|NCT01348087|7405737|FG000|COMPLETED|Overall Study||0
6487430|NCT01348087|7405737|FG000|NOT COMPLETED|Overall Study||148
6487431|NCT01348100|7405758|FG000|STARTED|Overall Study||2
6487432|NCT01348100|7405759|FG001|STARTED|Overall Study||2
6487433|NCT01348100|7405760|FG002|STARTED|Overall Study||15
6487434|NCT01348100|7405761|FG003|STARTED|Overall Study||15
6487435|NCT01348100|7405762|FG004|STARTED|Overall Study||15
6487436|NCT01348100|7405763|FG005|STARTED|Overall Study||16
6487437|NCT01348100|7405764|FG006|STARTED|Overall Study||16
6487438|NCT01348100|7405758|FG000|COMPLETED|Overall Study||2
6487439|NCT01348100|7405759|FG001|COMPLETED|Overall Study||2
6487440|NCT01348100|7405760|FG002|COMPLETED|Overall Study||13
6487441|NCT01348100|7405761|FG003|COMPLETED|Overall Study||14
6487442|NCT01348100|7405762|FG004|COMPLETED|Overall Study||14
6487443|NCT01348100|7405763|FG005|COMPLETED|Overall Study||14
6487444|NCT01348100|7405764|FG006|COMPLETED|Overall Study||13
6487445|NCT01348100|7405758|FG000|NOT COMPLETED|Overall Study||0
6487446|NCT01348100|7405759|FG001|NOT COMPLETED|Overall Study||0
6487447|NCT01348100|7405760|FG002|NOT COMPLETED|Overall Study||2
6487448|NCT01348100|7405761|FG003|NOT COMPLETED|Overall Study||1
6487449|NCT01348100|7405762|FG004|NOT COMPLETED|Overall Study||1
6487450|NCT01348100|7405763|FG005|NOT COMPLETED|Overall Study||2
6487451|NCT01348100|7405764|FG006|NOT COMPLETED|Overall Study||3
6487452|NCT01348139|7405785|FG000|STARTED|Period 1||5
6487453|NCT01348139|7405786|FG001|STARTED|Period 1||4
6487454|NCT01348139|7405787|FG002|STARTED|Period 1||4
6487455|NCT01348139|7405788|FG003|STARTED|Period 1||4
6487456|NCT01348139|7405789|FG004|STARTED|Period 1||5
6487457|NCT01348139|7405790|FG005|STARTED|Period 1||4
6487458|NCT01348139|7405785|FG000|COMPLETED|Period 1||4
6487459|NCT01348139|7405786|FG001|COMPLETED|Period 1||4
6487460|NCT01348139|7405787|FG002|COMPLETED|Period 1||4
6487461|NCT01348139|7405788|FG003|COMPLETED|Period 1||4
6487462|NCT01348139|7405789|FG004|COMPLETED|Period 1||5
6487463|NCT01348139|7405790|FG005|COMPLETED|Period 1||4
6487464|NCT01348139|7405785|FG000|NOT COMPLETED|Period 1||1
6487465|NCT01348139|7405786|FG001|NOT COMPLETED|Period 1||0
6487466|NCT01348139|7405787|FG002|NOT COMPLETED|Period 1||0
6487467|NCT01348139|7405788|FG003|NOT COMPLETED|Period 1||0
6487468|NCT01348139|7405789|FG004|NOT COMPLETED|Period 1||0
6487469|NCT01348139|7405790|FG005|NOT COMPLETED|Period 1||0
6487470|NCT01348139|7405785|FG000|STARTED|Period 2||4
6487471|NCT01348139|7405786|FG001|STARTED|Period 2||4
6487472|NCT01348139|7405787|FG002|STARTED|Period 2||4
6487473|NCT01348139|7405788|FG003|STARTED|Period 2||4
6487474|NCT01348139|7405789|FG004|STARTED|Period 2||5
6487475|NCT01348139|7405790|FG005|STARTED|Period 2||4
6487476|NCT01348139|7405785|FG000|COMPLETED|Period 2||4
6487477|NCT01348139|7405786|FG001|COMPLETED|Period 2||4
6487478|NCT01348139|7405787|FG002|COMPLETED|Period 2||4
6487479|NCT01348139|7405788|FG003|COMPLETED|Period 2||4
6487480|NCT01348139|7405789|FG004|COMPLETED|Period 2||5
6487481|NCT01348139|7405790|FG005|COMPLETED|Period 2||4
6487482|NCT01348139|7405785|FG000|NOT COMPLETED|Period 2||0
6487483|NCT01348139|7405786|FG001|NOT COMPLETED|Period 2||0
6487484|NCT01348139|7405787|FG002|NOT COMPLETED|Period 2||0
6487485|NCT01348139|7405788|FG003|NOT COMPLETED|Period 2||0
6487486|NCT01348139|7405789|FG004|NOT COMPLETED|Period 2||0
6487487|NCT01348139|7405790|FG005|NOT COMPLETED|Period 2||0
6487488|NCT01348139|7405785|FG000|STARTED|Period 3||4
6487489|NCT01348139|7405786|FG001|STARTED|Period 3||4
6487490|NCT01348139|7405787|FG002|STARTED|Period 3||4
6487491|NCT01348139|7405788|FG003|STARTED|Period 3||4
6487492|NCT01348139|7405789|FG004|STARTED|Period 3||5
6487493|NCT01348139|7405790|FG005|STARTED|Period 3||4
6487494|NCT01348139|7405785|FG000|COMPLETED|Period 3||4
6487495|NCT01348139|7405786|FG001|COMPLETED|Period 3||4
6487496|NCT01348139|7405787|FG002|COMPLETED|Period 3||4
6487497|NCT01348139|7405788|FG003|COMPLETED|Period 3||4
6487498|NCT01348139|7405789|FG004|COMPLETED|Period 3||5
6487499|NCT01348139|7405790|FG005|COMPLETED|Period 3||4
6487500|NCT01348139|7405785|FG000|NOT COMPLETED|Period 3||0
6487501|NCT01348139|7405786|FG001|NOT COMPLETED|Period 3||0
6487502|NCT01348139|7405787|FG002|NOT COMPLETED|Period 3||0
6487503|NCT01348139|7405788|FG003|NOT COMPLETED|Period 3||0
6487504|NCT01348139|7405789|FG004|NOT COMPLETED|Period 3||0
6487505|NCT01348139|7405790|FG005|NOT COMPLETED|Period 3||0
6487506|NCT01348139|7405785|FG000|STARTED|Period 4||4
6487507|NCT01348139|7405786|FG001|STARTED|Period 4||4
6487508|NCT01348139|7405787|FG002|STARTED|Period 4||4
6487509|NCT01348139|7405788|FG003|STARTED|Period 4||4
6487510|NCT01348139|7405789|FG004|STARTED|Period 4||5
6487511|NCT01348139|7405790|FG005|STARTED|Period 4||4
6487512|NCT01348139|7405785|FG000|COMPLETED|Period 4||4
6487513|NCT01348139|7405786|FG001|COMPLETED|Period 4||4
6487514|NCT01348139|7405787|FG002|COMPLETED|Period 4||4
6487515|NCT01348139|7405788|FG003|COMPLETED|Period 4||4
6487516|NCT01348139|7405789|FG004|COMPLETED|Period 4||5
6487517|NCT01348139|7405790|FG005|COMPLETED|Period 4||4
6487518|NCT01348139|7405785|FG000|NOT COMPLETED|Period 4||0
6487519|NCT01348139|7405786|FG001|NOT COMPLETED|Period 4||0
6487520|NCT01348139|7405787|FG002|NOT COMPLETED|Period 4||0
6487521|NCT01348139|7405788|FG003|NOT COMPLETED|Period 4||0
6487522|NCT01348139|7405789|FG004|NOT COMPLETED|Period 4||0
6487523|NCT01348139|7405790|FG005|NOT COMPLETED|Period 4||0
6487524|NCT01348139|7405785|FG000|STARTED|Period 5||4
6487525|NCT01348139|7405786|FG001|STARTED|Period 5||4
6487526|NCT01348139|7405787|FG002|STARTED|Period 5||4
6487527|NCT01348139|7405788|FG003|STARTED|Period 5||4
6487528|NCT01348139|7405789|FG004|STARTED|Period 5||5
6487529|NCT01348139|7405790|FG005|STARTED|Period 5||4
6487530|NCT01348139|7405785|FG000|COMPLETED|Period 5||4
6487531|NCT01348139|7405786|FG001|COMPLETED|Period 5||4
6487532|NCT01348139|7405787|FG002|COMPLETED|Period 5||4
6487533|NCT01348139|7405788|FG003|COMPLETED|Period 5||4
6487534|NCT01348139|7405789|FG004|COMPLETED|Period 5||5
6487535|NCT01348139|7405790|FG005|COMPLETED|Period 5||4
6487536|NCT01348139|7405785|FG000|NOT COMPLETED|Period 5||0
6487537|NCT01348139|7405786|FG001|NOT COMPLETED|Period 5||0
6487538|NCT01348139|7405787|FG002|NOT COMPLETED|Period 5||0
6487539|NCT01348139|7405788|FG003|NOT COMPLETED|Period 5||0
6487540|NCT01348139|7405789|FG004|NOT COMPLETED|Period 5||0
6487541|NCT01348139|7405790|FG005|NOT COMPLETED|Period 5||0
6487542|NCT01348139|7405785|FG000|STARTED|Period 6||4
6487543|NCT01348139|7405786|FG001|STARTED|Period 6||4
6487544|NCT01348139|7405787|FG002|STARTED|Period 6||4
6487545|NCT01348139|7405788|FG003|STARTED|Period 6||4
6487546|NCT01348139|7405789|FG004|STARTED|Period 6||5
6487547|NCT01348139|7405790|FG005|STARTED|Period 6||4
6487548|NCT01348139|7405785|FG000|COMPLETED|Period 6||4
6487549|NCT01348139|7405786|FG001|COMPLETED|Period 6||4
6487550|NCT01348139|7405787|FG002|COMPLETED|Period 6||4
6487551|NCT01348139|7405788|FG003|COMPLETED|Period 6||4
6487552|NCT01348139|7405789|FG004|COMPLETED|Period 6||5
6487553|NCT01348139|7405790|FG005|COMPLETED|Period 6||4
6487554|NCT01348139|7405785|FG000|NOT COMPLETED|Period 6||0
6487555|NCT01348139|7405786|FG001|NOT COMPLETED|Period 6||0
6487556|NCT01348139|7405787|FG002|NOT COMPLETED|Period 6||0
6487557|NCT01348139|7405788|FG003|NOT COMPLETED|Period 6||0
6487558|NCT01348139|7405789|FG004|NOT COMPLETED|Period 6||0
6555004|NCT01749800|7477123|FG000|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
6555005|NCT01749800|7477124|FG001|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
6555006|NCT01749800|7477125|FG002|STARTED|Overall Study||0
6555007|NCT01749800|7477123|FG000|COMPLETED|Overall Study||3
6555008|NCT01749800|7477124|FG001|COMPLETED|Overall Study||0
6555009|NCT01749800|7477125|FG002|COMPLETED|Overall Study||0
6555010|NCT01749800|7477123|FG000|NOT COMPLETED|Overall Study||3
6555011|NCT01749800|7477124|FG001|NOT COMPLETED|Overall Study||1
6555012|NCT01749800|7477125|FG002|NOT COMPLETED|Overall Study||0
6487559|NCT01348139|7405790|FG005|NOT COMPLETED|Period 6||0
6487560|NCT01348165|7405811|FG000|STARTED|Overall Study||10
6487561|NCT01348165|7405812|FG001|STARTED|Overall Study||5
6487562|NCT01348165|7405813|FG002|STARTED|Overall Study||6
6487563|NCT01348165|7405814|FG003|STARTED|Overall Study||6
6487564|NCT01348165|7405815|FG004|STARTED|Overall Study||6
6555013|NCT01749904|7477135|FG000|STARTED|Overall Study|randomized population|286
6555014|NCT01749904|7477136|FG001|STARTED|Overall Study|randomized population|134
6555015|NCT01749904|7477135|FG000|COMPLETED|Overall Study|randomized population|264
6555016|NCT01749904|7477136|FG001|COMPLETED|Overall Study|randomized population|123
6555017|NCT01749904|7477135|FG000|NOT COMPLETED|Overall Study||22
6555018|NCT01749904|7477136|FG001|NOT COMPLETED|Overall Study||11
6555019|NCT01749930|7477148|FG000|STARTED|Overall Study|randomized population|283
6487565|NCT01348165|7405816|FG005|STARTED|Overall Study||1
6487566|NCT01348165|7405817|FG006|STARTED|Overall Study||6
6487567|NCT01348165|7405811|FG000|COMPLETED|Overall Study||10
6487568|NCT01348165|7405812|FG001|COMPLETED|Overall Study||5
6487569|NCT01348165|7405813|FG002|COMPLETED|Overall Study||6
6487570|NCT01348165|7405814|FG003|COMPLETED|Overall Study||6
6487571|NCT01348165|7405815|FG004|COMPLETED|Overall Study||6
6487572|NCT01348165|7405816|FG005|COMPLETED|Overall Study||1
6487573|NCT01348165|7405817|FG006|COMPLETED|Overall Study||5
6487574|NCT01348165|7405811|FG000|NOT COMPLETED|Overall Study||0
6487575|NCT01348165|7405812|FG001|NOT COMPLETED|Overall Study||0
6487576|NCT01348165|7405813|FG002|NOT COMPLETED|Overall Study||0
6487577|NCT01348165|7405814|FG003|NOT COMPLETED|Overall Study||0
6487578|NCT01348165|7405815|FG004|NOT COMPLETED|Overall Study||0
6487579|NCT01348165|7405816|FG005|NOT COMPLETED|Overall Study||0
6487580|NCT01348165|7405817|FG006|NOT COMPLETED|Overall Study||1
6487581|NCT01348347|7405840|FG000|STARTED|Overall Study||3
6487582|NCT01348347|7405841|FG001|STARTED|Overall Study||6
6487583|NCT01348347|7405842|FG002|STARTED|Overall Study||6
6487584|NCT01348347|7405840|FG000|COMPLETED|Overall Study||0
6487585|NCT01348347|7405841|FG001|COMPLETED|Overall Study||0
6487586|NCT01348347|7405842|FG002|COMPLETED|Overall Study||0
6487587|NCT01348347|7405840|FG000|NOT COMPLETED|Overall Study||3
6487588|NCT01348347|7405841|FG001|NOT COMPLETED|Overall Study||6
6487589|NCT01348347|7405842|FG002|NOT COMPLETED|Overall Study||6
6487590|NCT01348425|7405853|FG000|STARTED|Overall Study||31
6487591|NCT01348425|7405854|FG001|STARTED|Overall Study||14
6487592|NCT01348425|7405853|FG000|COMPLETED|Overall Study||30
6487593|NCT01348425|7405854|FG001|COMPLETED|Overall Study||13
6487594|NCT01348425|7405853|FG000|NOT COMPLETED|Overall Study||1
6487595|NCT01348425|7405854|FG001|NOT COMPLETED|Overall Study||1
6487596|NCT01348490|7405859|FG000|STARTED|Overall Study||66
6487597|NCT01348490|7405859|FG000|COMPLETED|Overall Study||42
6487598|NCT01348490|7405859|FG000|NOT COMPLETED|Overall Study||24
6487599|NCT01348542|7405882|FG000|STARTED|Overall Study||13
6487600|NCT01348542|7405883|FG001|STARTED|Overall Study||11
6487601|NCT01348542|7405882|FG000|COMPLETED|Overall Study||10
6487602|NCT01348542|7405883|FG001|COMPLETED|Overall Study||11
6487603|NCT01348542|7405882|FG000|NOT COMPLETED|Overall Study||3
6487604|NCT01348542|7405883|FG001|NOT COMPLETED|Overall Study||0
6487605|NCT01348607|7405892|FG000|STARTED|Overall Study||1
6487606|NCT01348607|7405893|FG001|STARTED|Overall Study||0
6487607|NCT01348607|7405894|FG002|STARTED|Overall Study||0
6487608|NCT01348607|7405892|FG000|COMPLETED|Overall Study||1
6487609|NCT01348607|7405893|FG001|COMPLETED|Overall Study||0
6487610|NCT01348607|7405894|FG002|COMPLETED|Overall Study||0
6487611|NCT01348607|7405892|FG000|NOT COMPLETED|Overall Study||0
6487612|NCT01348607|7405893|FG001|NOT COMPLETED|Overall Study||0
6487613|NCT01348607|7405894|FG002|NOT COMPLETED|Overall Study||0
6487614|NCT01348698|7405902|FG000|STARTED|Overall Study||74
6487615|NCT01348698|7405902|FG000|COMPLETED|Overall Study||2
6487616|NCT01348698|7405902|FG000|NOT COMPLETED|Overall Study||72
6555020|NCT01749930|7477149|FG001|STARTED|Overall Study|randomized population|137
6555021|NCT01749930|7477148|FG000|COMPLETED|Overall Study|randomized population|253
6748689|NCT03418064|7676813|FG000|STARTED|Second Intervention (1 Month)||21
6487617|NCT01348763|7405906|FG000|STARTED|With Tenofovir/Emtricitabine (10 Days)||13
6555022|NCT01749930|7477149|FG001|COMPLETED|Overall Study|randomized population|125
6555023|NCT01749930|7477148|FG000|NOT COMPLETED|Overall Study||30
6555024|NCT01749930|7477149|FG001|NOT COMPLETED|Overall Study||12
6555025|NCT01749956|7477159|FG000|STARTED|Overall Study||39
6555026|NCT01749956|7477159|FG000|COMPLETED|Overall Study||24
6555027|NCT01749956|7477159|FG000|NOT COMPLETED|Overall Study||15
6555028|NCT01749982|7477168|FG000|STARTED|Overall Study||15
6555029|NCT01749982|7477169|FG001|STARTED|Overall Study||15
6555030|NCT01749982|7477170|FG002|STARTED|Overall Study||15
6555031|NCT01749982|7477171|FG003|STARTED|Overall Study||15
6555032|NCT01749982|7477168|FG000|COMPLETED|Overall Study||15
6555033|NCT01749982|7477169|FG001|COMPLETED|Overall Study||15
6555034|NCT01749982|7477170|FG002|COMPLETED|Overall Study||15
6555035|NCT01749982|7477171|FG003|COMPLETED|Overall Study||12
6487618|NCT01348763|7405906|FG000|COMPLETED|With Tenofovir/Emtricitabine (10 Days)||11
6487619|NCT01348763|7405906|FG000|NOT COMPLETED|With Tenofovir/Emtricitabine (10 Days)||2
6487620|NCT01348763|7405906|FG000|STARTED|Without Tenofovir/Emtricitabine (11 Day)||11
6487621|NCT01348763|7405906|FG000|COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||11
6487622|NCT01348763|7405906|FG000|NOT COMPLETED|Without Tenofovir/Emtricitabine (11 Day)||0
6487623|NCT01348776|7405910|FG000|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
6487624|NCT01348776|7405910|FG000|COMPLETED|Overall Study||84
6487625|NCT01348776|7405910|FG000|NOT COMPLETED|Overall Study||3
6487626|NCT01348789|7405923|FG000|STARTED|Overall Study||37
6487627|NCT01348789|7405923|FG000|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
6487628|NCT01348789|7405923|FG000|NOT COMPLETED|Overall Study||4
6501694|NCT01430611|7420272|FG001|STARTED|Overall Study||333
6501695|NCT01430611|7420271|FG000|COMPLETED|Overall Study||315
6501696|NCT01430611|7420272|FG001|COMPLETED|Overall Study||318
6501697|NCT01430611|7420271|FG000|NOT COMPLETED|Overall Study||17
6501698|NCT01430611|7420272|FG001|NOT COMPLETED|Overall Study||15
6501699|NCT01430624|7420281|FG000|STARTED|Overall Study|Initial potential eligible screened enrolled|82
6501700|NCT01430624|7420282|FG001|STARTED|Overall Study||82
6501701|NCT01430624|7420283|FG002|STARTED|Overall Study||81
6501702|NCT01430624|7420281|FG000|Eligible Baseline Completes|Overall Study||77
6501703|NCT01430624|7420282|FG001|Eligible Baseline Completes|Overall Study||77
6501704|NCT01430624|7420283|FG002|Eligible Baseline Completes|Overall Study||79
6501705|NCT01430624|7420281|FG000|COMPLETED|Overall Study|Completed one or more follow-ups|54
6501706|NCT01430624|7420282|FG001|COMPLETED|Overall Study|Completed one or more follow-ups|48
6501707|NCT01430624|7420283|FG002|COMPLETED|Overall Study|Completed one or more follow-ups|52
6501708|NCT01430624|7420281|FG000|NOT COMPLETED|Overall Study||28
6501709|NCT01430624|7420282|FG001|NOT COMPLETED|Overall Study||34
6501710|NCT01430624|7420283|FG002|NOT COMPLETED|Overall Study||29
6501711|NCT01430741|7420299|FG000|STARTED|Overall Study||22
6501712|NCT01430741|7420300|FG001|STARTED|Overall Study||87
6501713|NCT01430741|7420301|FG002|STARTED|Overall Study||47
6501714|NCT01430741|7420302|FG003|STARTED|Overall Study||81
6501715|NCT01430741|7420299|FG000|COMPLETED|Overall Study||22
6501716|NCT01430741|7420300|FG001|COMPLETED|Overall Study||87
6501717|NCT01430741|7420301|FG002|COMPLETED|Overall Study||37
6501718|NCT01430741|7420302|FG003|COMPLETED|Overall Study||81
6501719|NCT01430741|7420299|FG000|NOT COMPLETED|Overall Study||0
6501720|NCT01430741|7420300|FG001|NOT COMPLETED|Overall Study||0
6501721|NCT01430741|7420301|FG002|NOT COMPLETED|Overall Study||10
6555036|NCT01749982|7477168|FG000|NOT COMPLETED|Overall Study||0
6555037|NCT01749982|7477169|FG001|NOT COMPLETED|Overall Study||0
6555038|NCT01749982|7477170|FG002|NOT COMPLETED|Overall Study||0
6748690|NCT03418064|7676814|FG001|STARTED|Second Intervention (1 Month)||21
6501722|NCT01430741|7420302|FG003|NOT COMPLETED|Overall Study||0
6501723|NCT01430754|7420315|FG000|STARTED|Run-In Phase||57
6487629|NCT01348828|7405934|FG000|STARTED|Overall Study||49
6555039|NCT01749982|7477171|FG003|NOT COMPLETED|Overall Study||3
6555040|NCT01749995|7477181|FG000|STARTED|Overall Study||200
6555041|NCT01749995|7477181|FG000|COMPLETED|Overall Study||196
6555042|NCT01749995|7477181|FG000|NOT COMPLETED|Overall Study||4
6555043|NCT01750086|7477187|FG000|STARTED|Overall Study||13
6555044|NCT01750086|7477188|FG001|STARTED|Overall Study||14
6555045|NCT01750086|7477187|FG000|COMPLETED|Overall Study||12
6555046|NCT01750086|7477188|FG001|COMPLETED|Overall Study||13
6487630|NCT01348828|7405934|FG000|COMPLETED|Overall Study||16
6487631|NCT01348828|7405934|FG000|NOT COMPLETED|Overall Study||33
6487632|NCT01348854|7405940|FG000|STARTED|Overall Study|53 eyes of 34 participants|34
6487633|NCT01348854|7405941|FG001|STARTED|Overall Study|10 eyes of 6 participants|6
6487634|NCT01348854|7405940|FG000|COMPLETED|Overall Study|47 eyes of 31 participants|31
6487635|NCT01348854|7405941|FG001|COMPLETED|Overall Study|9 eyes of 5 participants|5
6487636|NCT01348854|7405940|FG000|NOT COMPLETED|Overall Study||3
6487637|NCT01348854|7405941|FG001|NOT COMPLETED|Overall Study||1
6487638|NCT01349036|7405949|FG000|STARTED|Overall Study||14
6487639|NCT01349036|7405950|FG001|STARTED|Overall Study||24
6487640|NCT01349036|7405949|FG000|COMPLETED|Overall Study||0
6487641|NCT01349036|7405950|FG001|COMPLETED|Overall Study||0
6487642|NCT01349036|7405949|FG000|NOT COMPLETED|Overall Study||14
6487643|NCT01349036|7405950|FG001|NOT COMPLETED|Overall Study||24
6487644|NCT01349049|7405969|FG000|STARTED|Overall Study||3
6487645|NCT01349049|7405970|FG001|STARTED|Overall Study||7
6487646|NCT01349049|7405971|FG002|STARTED|Overall Study||3
6487647|NCT01349049|7405972|FG003|STARTED|Overall Study||3
6487648|NCT01349049|7405973|FG004|STARTED|Overall Study||3
6487649|NCT01349049|7405974|FG005|STARTED|Overall Study||6
6487650|NCT01349049|7405975|FG006|STARTED|Overall Study||5
6487651|NCT01349049|7405976|FG007|STARTED|Overall Study||4
6487652|NCT01349049|7405977|FG008|STARTED|Overall Study||56
6487653|NCT01349049|7405969|FG000|COMPLETED|Overall Study||0
6487654|NCT01349049|7405970|FG001|COMPLETED|Overall Study||0
6487655|NCT01349049|7405971|FG002|COMPLETED|Overall Study||0
6487656|NCT01349049|7405972|FG003|COMPLETED|Overall Study||0
6487657|NCT01349049|7405973|FG004|COMPLETED|Overall Study||0
6487658|NCT01349049|7405974|FG005|COMPLETED|Overall Study||0
6487659|NCT01349049|7405975|FG006|COMPLETED|Overall Study||0
6487660|NCT01349049|7405976|FG007|COMPLETED|Overall Study||0
6487661|NCT01349049|7405977|FG008|COMPLETED|Overall Study||1
6487662|NCT01349049|7405969|FG000|NOT COMPLETED|Overall Study||3
6487663|NCT01349049|7405970|FG001|NOT COMPLETED|Overall Study||7
6487664|NCT01349049|7405971|FG002|NOT COMPLETED|Overall Study||3
6487665|NCT01349049|7405972|FG003|NOT COMPLETED|Overall Study||3
6487666|NCT01349049|7405973|FG004|NOT COMPLETED|Overall Study||3
6487667|NCT01349049|7405974|FG005|NOT COMPLETED|Overall Study||6
6487668|NCT01349049|7405975|FG006|NOT COMPLETED|Overall Study||5
6487669|NCT01349049|7405976|FG007|NOT COMPLETED|Overall Study||4
6487670|NCT01349049|7405977|FG008|NOT COMPLETED|Overall Study||55
6487671|NCT01349114|7406011|FG000|STARTED|Overall Study||10
6487672|NCT01349114|7406012|FG001|STARTED|Overall Study||11
6487673|NCT01349114|7406011|FG000|COMPLETED|Overall Study||10
6487674|NCT01349114|7406012|FG001|COMPLETED|Overall Study||11
6487675|NCT01349114|7406011|FG000|NOT COMPLETED|Overall Study||0
6487676|NCT01349114|7406012|FG001|NOT COMPLETED|Overall Study||0
6487677|NCT01349140|7406020|FG000|STARTED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
6487678|NCT01349140|7406020|FG000|COMPLETED|Overall Study|"We enrolled 14 subjects, and therefore Protocol Enrollment is 14. However, each leg of each subject was treated separately with a different dose of liposomal bupivacaine (Exparel); and, therefore the number of units for each subject was 2 and the total number of units analyzed was 28."|14
6487679|NCT01349140|7406020|FG000|NOT COMPLETED|Overall Study||0
6487680|NCT01349192|7406026|FG000|STARTED|Overall Study||24
6487681|NCT01349192|7406027|FG001|STARTED|Overall Study||23
6487682|NCT01349192|7406026|FG000|Evaluable for Primary Endpoint|Overall Study||22
6487683|NCT01349192|7406027|FG001|Evaluable for Primary Endpoint|Overall Study||19
6487684|NCT01349192|7406026|FG000|Withdrawals|Overall Study||3
6487685|NCT01349192|7406027|FG001|Withdrawals|Overall Study||6
6487686|NCT01349192|7406026|FG000|COMPLETED|Overall Study||21
6487687|NCT01349192|7406027|FG001|COMPLETED|Overall Study||17
6487688|NCT01349192|7406026|FG000|NOT COMPLETED|Overall Study||3
6487689|NCT01349192|7406027|FG001|NOT COMPLETED|Overall Study||6
6487690|NCT01349231|7406035|FG000|STARTED|Overall Study||10
6487691|NCT01349231|7406035|FG000|COMPLETED|Overall Study||10
6487692|NCT01349231|7406035|FG000|NOT COMPLETED|Overall Study||0
6555047|NCT01750086|7477187|FG000|NOT COMPLETED|Overall Study||1
6555048|NCT01750086|7477188|FG001|NOT COMPLETED|Overall Study||1
6555049|NCT01750190|7477196|FG000|STARTED|Overall Study||616
6487693|NCT01349465|7406041|FG000|STARTED|Overall Study||200
6487694|NCT01349465|7406042|FG001|STARTED|Overall Study||49
6487695|NCT01349465|7406041|FG000|COMPLETED|Overall Study||182
6487696|NCT01349465|7406042|FG001|COMPLETED|Overall Study||27
6487697|NCT01349465|7406041|FG000|NOT COMPLETED|Overall Study||18
6487698|NCT01349465|7406042|FG001|NOT COMPLETED|Overall Study||22
6487699|NCT01349491|7406052|FG000|STARTED|Overall Study||5
6487700|NCT01349491|7406053|FG001|STARTED|Overall Study||5
6487701|NCT01349491|7406052|FG000|COMPLETED|Overall Study||5
6487702|NCT01349491|7406053|FG001|COMPLETED|Overall Study||5
6487703|NCT01349491|7406052|FG000|NOT COMPLETED|Overall Study||0
6487704|NCT01349491|7406053|FG001|NOT COMPLETED|Overall Study||0
6487705|NCT01349569|7406059|FG000|STARTED|Overall Study||16
6487706|NCT01349569|7406059|FG000|COMPLETED|Overall Study||12
6487707|NCT01349569|7406059|FG000|NOT COMPLETED|Overall Study||4
6487708|NCT01349660|7406069|FG000|STARTED|Overall Study||6
6487709|NCT01349660|7406070|FG001|STARTED|Overall Study||6
6487710|NCT01349660|7406071|FG002|STARTED|Overall Study||76
6487711|NCT01349660|7406069|FG000|COMPLETED|Overall Study||0
6487712|NCT01349660|7406070|FG001|COMPLETED|Overall Study||0
6487713|NCT01349660|7406071|FG002|COMPLETED|Overall Study||0
6487714|NCT01349660|7406069|FG000|NOT COMPLETED|Overall Study||6
6487715|NCT01349660|7406070|FG001|NOT COMPLETED|Overall Study||6
6487716|NCT01349660|7406071|FG002|NOT COMPLETED|Overall Study||76
6487717|NCT01349673|7406086|FG000|STARTED|Overall Study||114
6487718|NCT01349673|7406086|FG000|Participants Entered Cycle 1|Overall Study||114
6487719|NCT01349673|7406086|FG000|Participants Entered Cycle 2|Overall Study||65
6487720|NCT01349673|7406086|FG000|Participants Entered Cycle 3|Overall Study||41
6487721|NCT01349673|7406086|FG000|Participants Entered Cycle 4|Overall Study||22
6487722|NCT01349673|7406086|FG000|Participants Entered Cycle 5|Overall Study||12
6487723|NCT01349673|7406086|FG000|Participants Entered Cycle 6|Overall Study||5
6487724|NCT01349673|7406086|FG000|Participants Entered Cycle 7|Overall Study||3
6487725|NCT01349673|7406086|FG000|Participants Entered Cycle 8|Overall Study||1
6487726|NCT01349673|7406086|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||114
6487727|NCT01349673|7406086|FG000|COMPLETED|Overall Study||0
6487728|NCT01349673|7406086|FG000|NOT COMPLETED|Overall Study||114
6487729|NCT01349790|7406090|FG000|STARTED|Overall Study||40
6487730|NCT01349790|7406090|FG000|COMPLETED|Overall Study||31
6487731|NCT01349790|7406090|FG000|NOT COMPLETED|Overall Study||9
6487732|NCT01349803|7406098|FG000|STARTED|Overall Study||60
6487733|NCT01349803|7406099|FG001|STARTED|Overall Study||58
6487734|NCT01349803|7406100|FG002|STARTED|Overall Study||60
6487735|NCT01349803|7406101|FG003|STARTED|Overall Study||59
6487736|NCT01349803|7406098|FG000|COMPLETED|Overall Study||59
6487737|NCT01349803|7406099|FG001|COMPLETED|Overall Study||57
6487738|NCT01349803|7406100|FG002|COMPLETED|Overall Study||57
6487739|NCT01349803|7406101|FG003|COMPLETED|Overall Study||57
6487740|NCT01349803|7406098|FG000|NOT COMPLETED|Overall Study||1
6487741|NCT01349803|7406099|FG001|NOT COMPLETED|Overall Study||1
6487742|NCT01349803|7406100|FG002|NOT COMPLETED|Overall Study||3
6487743|NCT01349803|7406101|FG003|NOT COMPLETED|Overall Study||2
6487744|NCT01349816|7406119|FG000|STARTED|Overall Study||185
6487745|NCT01349816|7406119|FG000|GP MDI 36 µg|Overall Study||61
6487746|NCT01349816|7406119|FG000|GFF MDI 36/7.2 µg|Overall Study||58
6487747|NCT01349816|7406119|FG000|GFF MDI 36/9.6 µg|Overall Study||56
6487748|NCT01349816|7406119|FG000|GFF MDI 18/9.6 µg|Overall Study||57
6487749|NCT01349816|7406119|FG000|GFF MDI 9/9.6 µg|Overall Study||57
6487750|NCT01349816|7406119|FG000|FF MDI 9.6 µg|Overall Study||61
6487751|NCT01349816|7406119|FG000|COMPLETED|Overall Study||155
6487752|NCT01349816|7406119|FG000|NOT COMPLETED|Overall Study||30
6487753|NCT01349829|7406135|FG000|STARTED|Overall Study||126
6487754|NCT01349829|7406136|FG001|STARTED|Overall Study||125
6487755|NCT01349829|7406135|FG000|COMPLETED|Overall Study||117
6487756|NCT01349829|7406136|FG001|COMPLETED|Overall Study||102
6487757|NCT01349829|7406135|FG000|NOT COMPLETED|Overall Study||9
6487758|NCT01349829|7406136|FG001|NOT COMPLETED|Overall Study||23
6487759|NCT01349920|7406144|FG000|STARTED|Overall Study||15
6487760|NCT01349920|7406144|FG000|COMPLETED|Overall Study||15
6487761|NCT01349920|7406144|FG000|NOT COMPLETED|Overall Study||0
6487762|NCT01349933|7406150|FG000|STARTED|Overall Study||21
6487763|NCT01349933|7406150|FG000|COMPLETED|Overall Study||21
6487764|NCT01349933|7406150|FG000|NOT COMPLETED|Overall Study||0
6487765|NCT01349972|7406156|FG000|STARTED|Overall Study||114
6487766|NCT01349972|7406157|FG001|STARTED|Overall Study||58
6487767|NCT01349972|7406156|FG000|COMPLETED|Overall Study||109
6487768|NCT01349972|7406157|FG001|COMPLETED|Overall Study||56
6487769|NCT01349972|7406156|FG000|NOT COMPLETED|Overall Study||5
6487770|NCT01349972|7406157|FG001|NOT COMPLETED|Overall Study||2
6487771|NCT01350102|7406167|FG000|STARTED|Overall Study||0
6487772|NCT01350102|7406168|FG001|STARTED|Overall Study||1
6487773|NCT01350102|7406169|FG002|STARTED|Overall Study||1
6487774|NCT01350102|7406170|FG003|STARTED|Overall Study||0
6487775|NCT01350102|7406167|FG000|COMPLETED|Overall Study||0
6487776|NCT01350102|7406168|FG001|COMPLETED|Overall Study||1
6487777|NCT01350102|7406169|FG002|COMPLETED|Overall Study||0
6487778|NCT01350102|7406170|FG003|COMPLETED|Overall Study||0
6487779|NCT01350102|7406167|FG000|NOT COMPLETED|Overall Study||0
6487780|NCT01350102|7406168|FG001|NOT COMPLETED|Overall Study||0
6487781|NCT01350102|7406169|FG002|NOT COMPLETED|Overall Study||1
6487782|NCT01350102|7406170|FG003|NOT COMPLETED|Overall Study||0
6487783|NCT01350115|7406182|FG000|STARTED|Core Study (All Patients)||8
6487784|NCT01350115|7406183|FG001|STARTED|Core Study (All Patients)||2
6487785|NCT01350115|7406182|FG000|Safety Anlysis Set|Core Study (All Patients)||8
6487786|NCT01350115|7406183|FG001|Safety Anlysis Set|Core Study (All Patients)||2
6487787|NCT01350115|7406182|FG000|Pharmacodynamic Set|Core Study (All Patients)||7
6487788|NCT01350115|7406183|FG001|Pharmacodynamic Set|Core Study (All Patients)||2
6487789|NCT01350115|7406182|FG000|COMPLETED|Core Study (All Patients)||8
6487790|NCT01350115|7406183|FG001|COMPLETED|Core Study (All Patients)||2
6487791|NCT01350115|7406182|FG000|NOT COMPLETED|Core Study (All Patients)||0
6487792|NCT01350115|7406183|FG001|NOT COMPLETED|Core Study (All Patients)||0
6487793|NCT01350115|7406182|FG000|STARTED|Long Term Follow-Up (All Patients)||8
6487794|NCT01350115|7406183|FG001|STARTED|Long Term Follow-Up (All Patients)||2
6487795|NCT01350115|7406182|FG000|COMPLETED|Long Term Follow-Up (All Patients)||7
6487796|NCT01350115|7406183|FG001|COMPLETED|Long Term Follow-Up (All Patients)||0
6487797|NCT01350115|7406182|FG000|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
6487798|NCT01350115|7406183|FG001|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
6487799|NCT01350128|7406191|FG000|STARTED|Overall Study||103
6487800|NCT01350128|7406191|FG000|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
6487801|NCT01350128|7406191|FG000|GP MDI 18 µg BID|Overall Study||49
6487802|NCT01350128|7406191|FG000|GP MDI 9 µg BID|Overall Study||49
6487803|NCT01350128|7406191|FG000|GP MDI 4.6 µg BID|Overall Study||45
6487804|NCT01350128|7406191|FG000|Placebo MDI BID|Overall Study||48
6487805|NCT01350128|7406191|FG000|Atrovent HFA 34 µg BID|Overall Study||48
6487806|NCT01350128|7406191|FG000|COMPLETED|Overall Study||89
6487807|NCT01350128|7406191|FG000|NOT COMPLETED|Overall Study||14
6487808|NCT01350141|7406208|FG000|STARTED|Overall Study||15
6487809|NCT01350141|7406209|FG001|STARTED|Overall Study||15
6487810|NCT01350141|7406210|FG002|STARTED|Overall Study||16
6487811|NCT01350141|7406208|FG000|Treated|Overall Study||14
6487812|NCT01350141|7406209|FG001|Treated|Overall Study||15
6487813|NCT01350141|7406210|FG002|Treated|Overall Study||16
6487814|NCT01350141|7406208|FG000|COMPLETED|Overall Study||12
6487815|NCT01350141|7406209|FG001|COMPLETED|Overall Study||15
6487816|NCT01350141|7406210|FG002|COMPLETED|Overall Study||15
6487817|NCT01350141|7406208|FG000|NOT COMPLETED|Overall Study||3
6487818|NCT01350141|7406209|FG001|NOT COMPLETED|Overall Study||0
6487819|NCT01350141|7406210|FG002|NOT COMPLETED|Overall Study||1
6487820|NCT01350245|7406220|FG000|STARTED|Overall Study||28
6487821|NCT01350245|7406220|FG000|COMPLETED|Overall Study||28
6487822|NCT01350245|7406220|FG000|NOT COMPLETED|Overall Study||0
6487823|NCT01350271|7406227|FG000|STARTED|Overall Study||70
6487824|NCT01350271|7406228|FG001|STARTED|Overall Study||70
6487825|NCT01350271|7406229|FG002|STARTED|Overall Study||74
6487826|NCT01350271|7406227|FG000|COMPLETED|Overall Study||49
6487827|NCT01350271|7406228|FG001|COMPLETED|Overall Study||53
6487828|NCT01350271|7406229|FG002|COMPLETED|Overall Study||48
6487829|NCT01350271|7406227|FG000|NOT COMPLETED|Overall Study||21
6487830|NCT01350271|7406228|FG001|NOT COMPLETED|Overall Study||17
6487831|NCT01350271|7406229|FG002|NOT COMPLETED|Overall Study||26
6487832|NCT01350336|7406240|FG000|STARTED|Overall Study||284
6487833|NCT01350336|7406240|FG000|COMPLETED|Overall Study||227
6487834|NCT01350336|7406240|FG000|NOT COMPLETED|Overall Study||57
6487835|NCT01350388|7406291|FG000|STARTED|Overall Study||40
6487836|NCT01350388|7406292|FG001|STARTED|Overall Study||40
6487837|NCT01350388|7406291|FG000|COMPLETED|Overall Study||37
6487838|NCT01350388|7406292|FG001|COMPLETED|Overall Study||39
6487839|NCT01350388|7406291|FG000|NOT COMPLETED|Overall Study||3
6487840|NCT01350388|7406292|FG001|NOT COMPLETED|Overall Study||1
6487841|NCT01350401|7406298|FG000|STARTED|Overall Study||4
6487842|NCT01350401|7406298|FG000|COMPLETED|Overall Study||4
6487843|NCT01350401|7406298|FG000|NOT COMPLETED|Overall Study||0
6487844|NCT01350414|7406306|FG000|STARTED|Overall Study||181
6487845|NCT01350414|7406306|FG000|Year 2|Overall Study||165
6487846|NCT01350414|7406306|FG000|Year 3|Overall Study||162
6487847|NCT01350414|7406306|FG000|Year 4|Overall Study||159
6487848|NCT01350414|7406306|FG000|Year 5|Overall Study||162
6487849|NCT01350414|7406306|FG000|COMPLETED|Overall Study||162
6487850|NCT01350414|7406306|FG000|NOT COMPLETED|Overall Study||19
6487851|NCT01350453|7406318|FG000|STARTED|Overall Study||11
6487852|NCT01350453|7406319|FG001|STARTED|Overall Study||8
6487853|NCT01350453|7406318|FG000|COMPLETED|Overall Study||9
6487854|NCT01350453|7406319|FG001|COMPLETED|Overall Study||7
6487855|NCT01350453|7406318|FG000|NOT COMPLETED|Overall Study||2
6487856|NCT01350453|7406319|FG001|NOT COMPLETED|Overall Study||1
6487857|NCT01350479|7406329|FG000|STARTED|Overall Study||94
6487858|NCT01350479|7406330|FG001|STARTED|Overall Study||106
6487859|NCT01350479|7406329|FG000|COMPLETED|Overall Study||94
6487860|NCT01350479|7406330|FG001|COMPLETED|Overall Study||106
6487861|NCT01350479|7406329|FG000|NOT COMPLETED|Overall Study||0
6487862|NCT01350479|7406330|FG001|NOT COMPLETED|Overall Study||0
6487863|NCT01350492|7406338|FG000|STARTED|Intervention||28
6487864|NCT01350492|7406339|FG001|STARTED|Intervention||26
6487865|NCT01350492|7406338|FG000|6-week MRI Scan|Intervention||24
6487866|NCT01350492|7406339|FG001|6-week MRI Scan|Intervention||22
6487867|NCT01350492|7406338|FG000|11-week MRI Scan|Intervention||23
6487868|NCT01350492|7406339|FG001|11-week MRI Scan|Intervention||21
6487869|NCT01350492|7406338|FG000|COMPLETED|Intervention||23
6487870|NCT01350492|7406339|FG001|COMPLETED|Intervention||20
6487871|NCT01350492|7406338|FG000|NOT COMPLETED|Intervention||5
6487872|NCT01350492|7406339|FG001|NOT COMPLETED|Intervention||6
6487873|NCT01350492|7406338|FG000|STARTED|Post Intervention Follow-Up||23
6487874|NCT01350492|7406339|FG001|STARTED|Post Intervention Follow-Up||20
6487875|NCT01350492|7406338|FG000|6-month MRI Scan|Post Intervention Follow-Up||20
6487876|NCT01350492|7406339|FG001|6-month MRI Scan|Post Intervention Follow-Up||20
6487877|NCT01350492|7406338|FG000|COMPLETED|Post Intervention Follow-Up||17
6487878|NCT01350492|7406339|FG001|COMPLETED|Post Intervention Follow-Up||18
6487879|NCT01350492|7406338|FG000|NOT COMPLETED|Post Intervention Follow-Up||6
6487880|NCT01350492|7406339|FG001|NOT COMPLETED|Post Intervention Follow-Up||2
6487881|NCT01350505|7406345|FG000|STARTED|Overall Study||21
6487882|NCT01350505|7406345|FG000|COMPLETED|Overall Study||17
6487883|NCT01350505|7406345|FG000|NOT COMPLETED|Overall Study||4
6487884|NCT01350544|7406351|FG000|STARTED|Overall Study||108
6487885|NCT01350544|7406352|FG001|STARTED|Overall Study||108
6487886|NCT01350544|7406351|FG000|COMPLETED|Overall Study||85
6487887|NCT01350544|7406352|FG001|COMPLETED|Overall Study||86
6487888|NCT01350544|7406351|FG000|NOT COMPLETED|Overall Study||23
6487889|NCT01350544|7406352|FG001|NOT COMPLETED|Overall Study||22
6487890|NCT01350804|7406362|FG000|STARTED|Core Study||138
6487891|NCT01350804|7406363|FG001|STARTED|Core Study||137
6487892|NCT01350804|7406364|FG002|STARTED|Core Study||138
6487893|NCT01350804|7406365|FG003|STARTED|Core Study||138
6487894|NCT01350804|7406362|FG000|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
6487895|NCT01350804|7406363|FG001|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
6487896|NCT01350804|7406364|FG002|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
6487897|NCT01350804|7406365|FG003|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
6487898|NCT01350804|7406362|FG000|Tratment Switch to AIN457 at Week 16|Core Study||0
6487899|NCT01350804|7406363|FG001|Tratment Switch to AIN457 at Week 16|Core Study||0
6487900|NCT01350804|7406364|FG002|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
6487901|NCT01350804|7406365|FG003|Tratment Switch to AIN457 at Week 16|Core Study||0
6487902|NCT01350804|7406362|FG000|Treatment Switch to AIN457 at Week 24|Core Study||0
6487903|NCT01350804|7406363|FG001|Treatment Switch to AIN457 at Week 24|Core Study||0
6487904|NCT01350804|7406364|FG002|Treatment Switch to AIN457 at Week 24|Core Study||45
6487905|NCT01350804|7406365|FG003|Treatment Switch to AIN457 at Week 24|Core Study||37
6487906|NCT01350804|7406362|FG000|Full Analysis Set|Core Study||138
6487907|NCT01350804|7406363|FG001|Full Analysis Set|Core Study||137
6487908|NCT01350804|7406364|FG002|Full Analysis Set|Core Study||138
6487909|NCT01350804|7406365|FG003|Full Analysis Set|Core Study||138
6487910|NCT01350804|7406362|FG000|COMPLETED|Core Study||97
6487911|NCT01350804|7406363|FG001|COMPLETED|Core Study||90
6487912|NCT01350804|7406364|FG002|COMPLETED|Core Study||91
6487913|NCT01350804|7406365|FG003|COMPLETED|Core Study||112
6487914|NCT01350804|7406362|FG000|NOT COMPLETED|Core Study||41
6487915|NCT01350804|7406363|FG001|NOT COMPLETED|Core Study||47
6487916|NCT01350804|7406364|FG002|NOT COMPLETED|Core Study||47
6487917|NCT01350804|7406365|FG003|NOT COMPLETED|Core Study||26
6487918|NCT01350804|7406362|FG000|STARTED|Extension Study, Weeks 52 - 260||80
6487919|NCT01350804|7406363|FG001|STARTED|Extension Study, Weeks 52 - 260||79
6487920|NCT01350804|7406364|FG002|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
6487921|NCT01350804|7406365|FG003|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
6487922|NCT01350804|7406362|FG000|COMPLETED|Extension Study, Weeks 52 - 260||0
6487923|NCT01350804|7406363|FG001|COMPLETED|Extension Study, Weeks 52 - 260||0
6487924|NCT01350804|7406364|FG002|COMPLETED|Extension Study, Weeks 52 - 260||0
6487925|NCT01350804|7406365|FG003|COMPLETED|Extension Study, Weeks 52 - 260||0
6487926|NCT01350804|7406362|FG000|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
6487927|NCT01350804|7406363|FG001|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
6487928|NCT01350804|7406364|FG002|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
6487929|NCT01350804|7406365|FG003|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
6487930|NCT01350947|7406385|FG000|STARTED|Overall Study||11
6487931|NCT01350947|7406385|FG000|COMPLETED|Overall Study||11
6487932|NCT01350947|7406385|FG000|NOT COMPLETED|Overall Study||0
6487933|NCT01350973|7406392|FG000|STARTED|Overall Study||206
6487934|NCT01350973|7406393|FG001|STARTED|Overall Study||210
6487935|NCT01350973|7406394|FG002|STARTED|Overall Study||195
6487936|NCT01350973|7406392|FG000|Received Treatment|Overall Study||205
6487937|NCT01350973|7406393|FG001|Received Treatment|Overall Study||210
6487938|NCT01350973|7406394|FG002|Received Treatment|Overall Study||195
6487939|NCT01350973|7406392|FG000|COMPLETED|Overall Study||200
6487940|NCT01350973|7406393|FG001|COMPLETED|Overall Study||202
6487941|NCT01350973|7406394|FG002|COMPLETED|Overall Study||187
6487942|NCT01350973|7406392|FG000|NOT COMPLETED|Overall Study||6
6487943|NCT01350973|7406393|FG001|NOT COMPLETED|Overall Study||8
6487944|NCT01350973|7406394|FG002|NOT COMPLETED|Overall Study||8
6487945|NCT01350999|7406405|FG000|STARTED|Overall Study||165
6487946|NCT01350999|7406406|FG001|STARTED|Overall Study||171
6487947|NCT01350999|7406407|FG002|STARTED|Overall Study||167
6487948|NCT01350999|7406405|FG000|Treated|Overall Study||165
6487949|NCT01350999|7406406|FG001|Treated|Overall Study||171
6487950|NCT01350999|7406407|FG002|Treated|Overall Study||167
6487951|NCT01350999|7406405|FG000|COMPLETED|Overall Study||157
6487952|NCT01350999|7406406|FG001|COMPLETED|Overall Study||157
6487953|NCT01350999|7406407|FG002|COMPLETED|Overall Study||146
6487954|NCT01350999|7406405|FG000|NOT COMPLETED|Overall Study||8
6487955|NCT01350999|7406406|FG001|NOT COMPLETED|Overall Study||14
6487956|NCT01350999|7406407|FG002|NOT COMPLETED|Overall Study||21
6487957|NCT01351025|7406417|FG000|STARTED|Week 0 - 20||46
6487958|NCT01351025|7406418|FG001|STARTED|Week 0 - 20||48
6487959|NCT01351025|7406417|FG000|COMPLETED|Week 0 - 20||43
6487960|NCT01351025|7406418|FG001|COMPLETED|Week 0 - 20||47
6487961|NCT01351025|7406417|FG000|NOT COMPLETED|Week 0 - 20||3
6487962|NCT01351025|7406418|FG001|NOT COMPLETED|Week 0 - 20||1
6487963|NCT01351025|7406417|FG000|STARTED|Week 20 - 24||43
6487964|NCT01351025|7406418|FG001|STARTED|Week 20 - 24||47
6487965|NCT01351025|7406417|FG000|COMPLETED|Week 20 - 24||43
6487966|NCT01351025|7406418|FG001|COMPLETED|Week 20 - 24||47
6487967|NCT01351025|7406417|FG000|NOT COMPLETED|Week 20 - 24||0
6487968|NCT01351025|7406418|FG001|NOT COMPLETED|Week 20 - 24||0
6487969|NCT01351025|7406417|FG000|STARTED|Week 24 - 44||43
6487970|NCT01351025|7406418|FG001|STARTED|Week 24 - 44||47
6487971|NCT01351025|7406417|FG000|COMPLETED|Week 24 - 44||42
6487972|NCT01351025|7406418|FG001|COMPLETED|Week 24 - 44||43
6487973|NCT01351025|7406417|FG000|NOT COMPLETED|Week 24 - 44||1
6487974|NCT01351025|7406418|FG001|NOT COMPLETED|Week 24 - 44||4
6487975|NCT01351025|7406417|FG000|STARTED|Week 44 - 48||42
6487976|NCT01351025|7406418|FG001|STARTED|Week 44 - 48||43
6487977|NCT01351025|7406417|FG000|COMPLETED|Week 44 - 48||42
6487978|NCT01351025|7406418|FG001|COMPLETED|Week 44 - 48||43
6487979|NCT01351025|7406417|FG000|NOT COMPLETED|Week 44 - 48||0
6487980|NCT01351025|7406418|FG001|NOT COMPLETED|Week 44 - 48||0
6487981|NCT01351064|7406432|FG000|STARTED|Overall Study||42
6487982|NCT01351064|7406433|FG001|STARTED|Overall Study||42
6487983|NCT01351064|7406432|FG000|COMPLETED|Overall Study||42
6487984|NCT01351064|7406433|FG001|COMPLETED|Overall Study||42
6487985|NCT01351064|7406432|FG000|NOT COMPLETED|Overall Study||0
6487986|NCT01351064|7406433|FG001|NOT COMPLETED|Overall Study||0
6487987|NCT01351077|7406441|FG000|STARTED|Overall Study||180
6487988|NCT01351077|7406442|FG001|STARTED|Overall Study||180
6487989|NCT01351077|7406441|FG000|COMPLETED|Overall Study||180
6487990|NCT01351077|7406442|FG001|COMPLETED|Overall Study||180
6487991|NCT01351077|7406441|FG000|NOT COMPLETED|Overall Study||0
6487992|NCT01351077|7406442|FG001|NOT COMPLETED|Overall Study||0
6487993|NCT01351090|7406451|FG000|STARTED|Overall Study||43
6487994|NCT01351090|7406452|FG001|STARTED|Overall Study||42
6487995|NCT01351090|7406453|FG002|STARTED|Overall Study||42
6487996|NCT01351090|7406451|FG000|COMPLETED|Overall Study||32
6487997|NCT01351090|7406452|FG001|COMPLETED|Overall Study||31
6487998|NCT01351090|7406453|FG002|COMPLETED|Overall Study||36
6487999|NCT01351090|7406451|FG000|NOT COMPLETED|Overall Study||11
6488000|NCT01351090|7406452|FG001|NOT COMPLETED|Overall Study||11
6488001|NCT01351090|7406453|FG002|NOT COMPLETED|Overall Study||6
6488002|NCT01351337|7406461|FG000|STARTED|Overall Study||58
6488003|NCT01351337|7406461|FG000|COMPLETED|Overall Study||58
6488004|NCT01351337|7406461|FG000|NOT COMPLETED|Overall Study||0
6488005|NCT01351350|7406471|FG000|STARTED|Overall Study||8
6488006|NCT01351350|7406472|FG001|STARTED|Overall Study||29
6488007|NCT01351350|7406473|FG002|STARTED|Overall Study||11
6488008|NCT01351350|7406474|FG003|STARTED|Overall Study||13
6488009|NCT01351350|7406475|FG004|STARTED|Overall Study||7
6488010|NCT01351350|7406471|FG000|Treated|Overall Study||8
6488011|NCT01351350|7406472|FG001|Treated|Overall Study||29
6488012|NCT01351350|7406473|FG002|Treated|Overall Study||10
6488013|NCT01351350|7406474|FG003|Treated|Overall Study||13
6488014|NCT01351350|7406475|FG004|Treated|Overall Study||7
6488015|NCT01351350|7406471|FG000|Dose-escalation Evaluable|Overall Study||7
6488016|NCT01351350|7406472|FG001|Dose-escalation Evaluable|Overall Study||23
6488017|NCT01351350|7406473|FG002|Dose-escalation Evaluable|Overall Study||10
6488018|NCT01351350|7406474|FG003|Dose-escalation Evaluable|Overall Study||0
6488019|NCT01351350|7406475|FG004|Dose-escalation Evaluable|Overall Study||0
6488020|NCT01351350|7406471|FG000|COMPLETED|Overall Study||0
6488021|NCT01351350|7406472|FG001|COMPLETED|Overall Study||0
6488022|NCT01351350|7406473|FG002|COMPLETED|Overall Study||0
6488023|NCT01351350|7406474|FG003|COMPLETED|Overall Study||0
6488024|NCT01351350|7406475|FG004|COMPLETED|Overall Study||0
6488025|NCT01351350|7406471|FG000|NOT COMPLETED|Overall Study||8
6488026|NCT01351350|7406472|FG001|NOT COMPLETED|Overall Study||29
6488027|NCT01351350|7406473|FG002|NOT COMPLETED|Overall Study||11
6488028|NCT01351350|7406474|FG003|NOT COMPLETED|Overall Study||13
6488029|NCT01351350|7406475|FG004|NOT COMPLETED|Overall Study||7
6488030|NCT01351376|7406502|FG000|STARTED|Overall Study||10
6488031|NCT01351376|7406503|FG001|STARTED|Overall Study||11
6488032|NCT01351376|7406502|FG000|COMPLETED|Overall Study||10
6488033|NCT01351376|7406503|FG001|COMPLETED|Overall Study||11
6488034|NCT01351376|7406502|FG000|NOT COMPLETED|Overall Study||0
6488035|NCT01351376|7406503|FG001|NOT COMPLETED|Overall Study||0
6488036|NCT01351415|7406511|FG000|STARTED|Overall Study||245
6488037|NCT01351415|7406512|FG001|STARTED|Overall Study||240
6488038|NCT01351415|7406511|FG000|Treated Participants|Overall Study||243
6488039|NCT01351415|7406512|FG001|Treated Participants|Overall Study||232
6488040|NCT01351415|7406511|FG000|COMPLETED|Overall Study||0
6488041|NCT01351415|7406512|FG001|COMPLETED|Overall Study||0
6488042|NCT01351415|7406511|FG000|NOT COMPLETED|Overall Study||245
6488043|NCT01351415|7406512|FG001|NOT COMPLETED|Overall Study||240
6488044|NCT01351480|7406518|FG000|STARTED|Overall Study||34
6488045|NCT01351480|7406518|FG000|COMPLETED|Overall Study||26
6488046|NCT01351480|7406518|FG000|NOT COMPLETED|Overall Study||8
6488047|NCT01351506|7406524|FG000|STARTED|Overall Study||602
6488048|NCT01351506|7406524|FG000|COMPLETED|Overall Study||465
6488049|NCT01351506|7406524|FG000|NOT COMPLETED|Overall Study||137
6488050|NCT01351623|7406530|FG000|STARTED|Overall Study||44
6488051|NCT01351623|7406530|FG000|COMPLETED|Overall Study||35
6488052|NCT01351623|7406530|FG000|NOT COMPLETED|Overall Study||9
6488053|NCT01351740|7406536|FG000|STARTED|Overall Study||25
6488054|NCT01351740|7406537|FG001|STARTED|Overall Study||25
6488055|NCT01351740|7406536|FG000|COMPLETED|Overall Study||23
6488056|NCT01351740|7406537|FG001|COMPLETED|Overall Study||19
6488057|NCT01351740|7406536|FG000|NOT COMPLETED|Overall Study||2
6488058|NCT01351740|7406537|FG001|NOT COMPLETED|Overall Study||6
6488059|NCT01351753|7406550|FG000|STARTED|Overall Study||22
6488060|NCT01351753|7406551|FG001|STARTED|Overall Study||20
6488061|NCT01351753|7406552|FG002|STARTED|Overall Study||21
6488062|NCT01351753|7406553|FG003|STARTED|Overall Study||21
6488063|NCT01351753|7406554|FG004|STARTED|Overall Study||21
6488064|NCT01351753|7406555|FG005|STARTED|Overall Study||23
6488065|NCT01351753|7406550|FG000|COMPLETED|Overall Study||15
6488066|NCT01351753|7406551|FG001|COMPLETED|Overall Study||13
6488067|NCT01351753|7406552|FG002|COMPLETED|Overall Study||14
6488068|NCT01351753|7406553|FG003|COMPLETED|Overall Study||21
6488069|NCT01351753|7406554|FG004|COMPLETED|Overall Study||14
6488070|NCT01351753|7406555|FG005|COMPLETED|Overall Study||22
6488071|NCT01351753|7406550|FG000|NOT COMPLETED|Overall Study||7
6488072|NCT01351753|7406551|FG001|NOT COMPLETED|Overall Study||7
6488073|NCT01351753|7406552|FG002|NOT COMPLETED|Overall Study||7
6488074|NCT01351753|7406553|FG003|NOT COMPLETED|Overall Study||0
6555050|NCT01750190|7477197|FG001|STARTED|Overall Study||306
6555051|NCT01750190|7477196|FG000|Safety Population|Overall Study||611
6555052|NCT01750190|7477197|FG001|Safety Population|Overall Study||305
6555053|NCT01750190|7477196|FG000|Full Analysis Set (FAS)|Overall Study||608
6555054|NCT01750190|7477197|FG001|Full Analysis Set (FAS)|Overall Study||305
6488075|NCT01351753|7406554|FG004|NOT COMPLETED|Overall Study||7
6488076|NCT01351753|7406555|FG005|NOT COMPLETED|Overall Study||1
6488077|NCT01351766|7406571|FG000|STARTED|Overall Study||39
6488078|NCT01351766|7406571|FG000|COMPLETED|Overall Study||36
6488079|NCT01351766|7406571|FG000|NOT COMPLETED|Overall Study||3
6488080|NCT01351805|7406579|FG000|STARTED|Overall Study||6463
6488081|NCT01351805|7406580|FG001|STARTED|Overall Study||6464
6488082|NCT01351805|7406581|FG002|STARTED|Overall Study||6470
6488083|NCT01351805|7406582|FG003|STARTED|Overall Study||6474
6488084|NCT01351805|7406579|FG000|Knee Pain Cohort Within VITAL Trial|Overall Study||342
6488085|NCT01351805|7406580|FG001|Knee Pain Cohort Within VITAL Trial|Overall Study||332
6488086|NCT01351805|7406581|FG002|Knee Pain Cohort Within VITAL Trial|Overall Study||353
6488087|NCT01351805|7406582|FG003|Knee Pain Cohort Within VITAL Trial|Overall Study||371
6488088|NCT01351805|7406579|FG000|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
6488089|NCT01351805|7406580|FG001|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
6488090|NCT01351805|7406581|FG002|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||392
6488091|NCT01351805|7406582|FG003|Biomarkers of Systemic Inflammation Cohort Within VITAL Trial|Overall Study||385
6488092|NCT01351805|7406579|FG000|COMPLETED|Overall Study||6463
6488093|NCT01351805|7406580|FG001|COMPLETED|Overall Study||6464
6488094|NCT01351805|7406581|FG002|COMPLETED|Overall Study||6470
6488095|NCT01351805|7406582|FG003|COMPLETED|Overall Study||6474
6488096|NCT01351805|7406579|FG000|NOT COMPLETED|Overall Study||0
6488097|NCT01351805|7406580|FG001|NOT COMPLETED|Overall Study||0
6488098|NCT01351805|7406581|FG002|NOT COMPLETED|Overall Study||0
6488099|NCT01351805|7406582|FG003|NOT COMPLETED|Overall Study||0
6488100|NCT01352117|7406598|FG000|STARTED|Overall Study||96
6488101|NCT01352117|7406599|FG001|STARTED|Overall Study||96
6488102|NCT01352117|7406598|FG000|Entered Step 2 to Initiate Delayed ET|Overall Study||32
6488103|NCT01352117|7406599|FG001|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
6488104|NCT01352117|7406598|FG000|Study Week 48 Data Potential|Overall Study||80
6488105|NCT01352117|7406599|FG001|Study Week 48 Data Potential|Overall Study||83
6488106|NCT01352117|7406598|FG000|Study Week 96 Data Potential|Overall Study||58
6488107|NCT01352117|7406599|FG001|Study Week 96 Data Potential|Overall Study||61
6488108|NCT01352117|7406598|FG000|COMPLETED|Overall Study||75
6488109|NCT01352117|7406599|FG001|COMPLETED|Overall Study||72
6488110|NCT01352117|7406598|FG000|NOT COMPLETED|Overall Study||21
6488111|NCT01352117|7406599|FG001|NOT COMPLETED|Overall Study||24
6488112|NCT01352182|7406610|FG000|STARTED|Overall Study||8
6488113|NCT01352182|7406611|FG001|STARTED|Overall Study||4
6488114|NCT01352182|7406610|FG000|COMPLETED|Overall Study||8
6488115|NCT01352182|7406611|FG001|COMPLETED|Overall Study||4
6488116|NCT01352182|7406610|FG000|NOT COMPLETED|Overall Study||0
6488117|NCT01352182|7406611|FG001|NOT COMPLETED|Overall Study||0
6488118|NCT01352221|7406621|FG000|STARTED|Double-blind Phase||64
6488119|NCT01352221|7406622|FG001|STARTED|Double-blind Phase||64
6488120|NCT01352221|7406623|FG002|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
6488121|NCT01352221|7406624|FG003|STARTED|Double-blind Phase|Not Applicable to double-blind phase|0
6488122|NCT01352221|7406621|FG000|COMPLETED|Double-blind Phase||55
6488123|NCT01352221|7406622|FG001|COMPLETED|Double-blind Phase||53
6488124|NCT01352221|7406623|FG002|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
6488125|NCT01352221|7406624|FG003|COMPLETED|Double-blind Phase|Not Applicable to double-blind phase|0
6488126|NCT01352221|7406621|FG000|NOT COMPLETED|Double-blind Phase||9
6488127|NCT01352221|7406622|FG001|NOT COMPLETED|Double-blind Phase||11
6555055|NCT01750190|7477196|FG000|COMPLETED|Overall Study||349
6488128|NCT01352221|7406623|FG002|NOT COMPLETED|Double-blind Phase||0
6488129|NCT01352221|7406624|FG003|NOT COMPLETED|Double-blind Phase||0
6488130|NCT01352221|7406621|FG000|STARTED|Open-label Phase|Not Applicable to open-label phase|0
6488131|NCT01352221|7406622|FG001|STARTED|Open-label Phase|Not Applicable to open-label phase|0
6488132|NCT01352221|7406623|FG002|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|50
6488133|NCT01352221|7406624|FG003|STARTED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|47
6488134|NCT01352221|7406621|FG000|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
6488135|NCT01352221|7406622|FG001|COMPLETED|Open-label Phase|Not Applicable to open-label phase|0
6488136|NCT01352221|7406623|FG002|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|37
6488137|NCT01352221|7406624|FG003|COMPLETED|Open-label Phase|Only subjects in DE, UK and HU could enter the open-label extension (OLE); OLE rejected by EC in AT|36
6488138|NCT01352221|7406621|FG000|NOT COMPLETED|Open-label Phase||0
6488139|NCT01352221|7406622|FG001|NOT COMPLETED|Open-label Phase||0
6488140|NCT01352221|7406623|FG002|NOT COMPLETED|Open-label Phase||13
6488141|NCT01352221|7406624|FG003|NOT COMPLETED|Open-label Phase||11
6488142|NCT01352286|7406636|FG000|STARTED|Overall Study||25
6488143|NCT01352286|7406636|FG000|Received T-cells|Overall Study||25
6488144|NCT01352286|7406636|FG000|COMPLETED|Overall Study||25
6488145|NCT01352286|7406636|FG000|NOT COMPLETED|Overall Study||0
6488146|NCT01352442|7406641|FG000|STARTED|Overall Study||151
6488147|NCT01352442|7406641|FG000|COMPLETED|Overall Study||139
6488148|NCT01352442|7406641|FG000|NOT COMPLETED|Overall Study||12
6488149|NCT01352468|7406647|FG000|STARTED|Overall Study||22
6488150|NCT01352468|7406648|FG001|STARTED|Overall Study||22
6488151|NCT01352468|7406647|FG000|COMPLETED|Overall Study||17
6488152|NCT01352468|7406648|FG001|COMPLETED|Overall Study||18
6488153|NCT01352468|7406647|FG000|NOT COMPLETED|Overall Study||5
6488154|NCT01352468|7406648|FG001|NOT COMPLETED|Overall Study||4
6488155|NCT01352507|7406656|FG000|STARTED|Treatment Period 1||190
6488156|NCT01352507|7406657|FG001|STARTED|Treatment Period 1||193
6488157|NCT01352507|7406656|FG000|Received Treatment|Treatment Period 1||182
6488158|NCT01352507|7406657|FG001|Received Treatment|Treatment Period 1||188
6488159|NCT01352507|7406656|FG000|COMPLETED|Treatment Period 1||176
6488160|NCT01352507|7406657|FG001|COMPLETED|Treatment Period 1||184
6488161|NCT01352507|7406656|FG000|NOT COMPLETED|Treatment Period 1||14
6488162|NCT01352507|7406657|FG001|NOT COMPLETED|Treatment Period 1||9
6488163|NCT01352507|7406656|FG000|STARTED|Washout Period||176
6488164|NCT01352507|7406657|FG001|STARTED|Washout Period||184
6488165|NCT01352507|7406656|FG000|COMPLETED|Washout Period||176
6488166|NCT01352507|7406657|FG001|COMPLETED|Washout Period||183
6488167|NCT01352507|7406656|FG000|NOT COMPLETED|Washout Period||0
6488168|NCT01352507|7406657|FG001|NOT COMPLETED|Washout Period||1
6488169|NCT01352507|7406656|FG000|STARTED|Treatment Period 2||176
6488170|NCT01352507|7406657|FG001|STARTED|Treatment Period 2||183
6488171|NCT01352507|7406656|FG000|Received Treatment|Treatment Period 2||173
6488172|NCT01352507|7406657|FG001|Received Treatment|Treatment Period 2||181
6488173|NCT01352507|7406656|FG000|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
6488174|NCT01352507|7406657|FG001|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
6488175|NCT01352507|7406656|FG000|NOT COMPLETED|Treatment Period 2||6
6488176|NCT01352507|7406657|FG001|NOT COMPLETED|Treatment Period 2||3
6488177|NCT01352507|7406656|FG000|STARTED|Extension Phase||164
6488178|NCT01352507|7406657|FG001|STARTED|Extension Phase||173
6488179|NCT01352507|7406656|FG000|COMPLETED|Extension Phase||164
6488180|NCT01352507|7406657|FG001|COMPLETED|Extension Phase||173
6488181|NCT01352507|7406656|FG000|NOT COMPLETED|Extension Phase||0
6488182|NCT01352507|7406657|FG001|NOT COMPLETED|Extension Phase||0
6488183|NCT01352546|7406669|FG000|STARTED|Overall Study||31
6488184|NCT01352546|7406669|FG000|COMPLETED|Overall Study||31
6488185|NCT01352546|7406669|FG000|NOT COMPLETED|Overall Study||0
6488186|NCT01352585|7406675|FG000|STARTED|Overall Study||23
6488187|NCT01352585|7406676|FG001|STARTED|Overall Study||24
6488188|NCT01352585|7406675|FG000|COMPLETED|Overall Study||15
6488189|NCT01352585|7406676|FG001|COMPLETED|Overall Study||21
6488190|NCT01352585|7406675|FG000|NOT COMPLETED|Overall Study||8
6488191|NCT01352585|7406676|FG001|NOT COMPLETED|Overall Study||3
6488192|NCT01352598|7406683|FG000|STARTED|Overall Study||84
6488193|NCT01352598|7406683|FG000|COMPLETED|Overall Study||72
6488194|NCT01352598|7406683|FG000|NOT COMPLETED|Overall Study||12
6488195|NCT01352637|7406691|FG000|STARTED|Exposure Therapy||97
6488196|NCT01352637|7406692|FG001|STARTED|Exposure Therapy||95
6488197|NCT01352637|7406693|FG002|STARTED|Exposure Therapy||0
6488198|NCT01352637|7406694|FG003|STARTED|Exposure Therapy||0
6488199|NCT01352637|7406691|FG000|COMPLETED|Exposure Therapy||70
6488200|NCT01352637|7406692|FG001|COMPLETED|Exposure Therapy||62
6488201|NCT01352637|7406693|FG002|COMPLETED|Exposure Therapy||0
6488202|NCT01352637|7406694|FG003|COMPLETED|Exposure Therapy||0
6488203|NCT01352637|7406691|FG000|NOT COMPLETED|Exposure Therapy||27
6488204|NCT01352637|7406692|FG001|NOT COMPLETED|Exposure Therapy||33
6488205|NCT01352637|7406693|FG002|NOT COMPLETED|Exposure Therapy||0
6488206|NCT01352637|7406694|FG003|NOT COMPLETED|Exposure Therapy||0
6488207|NCT01352637|7406691|FG000|STARTED|Drug||0
6488208|NCT01352637|7406692|FG001|STARTED|Drug||0
6488209|NCT01352637|7406693|FG002|STARTED|Drug||95
6488210|NCT01352637|7406694|FG003|STARTED|Drug||97
6488211|NCT01352637|7406691|FG000|COMPLETED|Drug||0
6488212|NCT01352637|7406692|FG001|COMPLETED|Drug||0
6488213|NCT01352637|7406693|FG002|COMPLETED|Drug||70
6488214|NCT01352637|7406694|FG003|COMPLETED|Drug||62
6488215|NCT01352637|7406691|FG000|NOT COMPLETED|Drug||0
6488216|NCT01352637|7406692|FG001|NOT COMPLETED|Drug||0
6488217|NCT01352637|7406693|FG002|NOT COMPLETED|Drug||25
6488218|NCT01352637|7406694|FG003|NOT COMPLETED|Drug||35
6488219|NCT01352715|7406706|FG000|STARTED|Overall Study||260
6488220|NCT01352715|7406707|FG001|STARTED|Overall Study||255
6488221|NCT01352715|7406706|FG000|COMPLETED|Overall Study||215
6488222|NCT01352715|7406707|FG001|COMPLETED|Overall Study||209
6488223|NCT01352715|7406706|FG000|NOT COMPLETED|Overall Study||45
6488224|NCT01352715|7406707|FG001|NOT COMPLETED|Overall Study||46
6488225|NCT01352741|7406713|FG000|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
6488226|NCT01352741|7406714|FG001|STARTED|Open-label Tapentadol Titration Period||0
6488227|NCT01352741|7406713|FG000|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
6488228|NCT01352741|7406714|FG001|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
6488229|NCT01352741|7406713|FG000|Full Analysis Set|Open-label Tapentadol Titration Period||436
6488230|NCT01352741|7406714|FG001|Full Analysis Set|Open-label Tapentadol Titration Period||0
6488231|NCT01352741|7406713|FG000|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
6488232|NCT01352741|7406714|FG001|COMPLETED|Open-label Tapentadol Titration Period||0
6488233|NCT01352741|7406713|FG000|NOT COMPLETED|Open-label Tapentadol Titration Period||73
6488234|NCT01352741|7406714|FG001|NOT COMPLETED|Open-label Tapentadol Titration Period||0
6488235|NCT01352741|7406713|FG000|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
6488236|NCT01352741|7406714|FG001|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
6488237|NCT01352741|7406713|FG000|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
6488238|NCT01352741|7406714|FG001|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
6488239|NCT01352741|7406713|FG000|No Pain Assessments Available|Double-blind Comparative Period||2
6488240|NCT01352741|7406714|FG001|No Pain Assessments Available|Double-blind Comparative Period||2
6488241|NCT01352741|7406713|FG000|Full Analysis Set|Double-blind Comparative Period||152
6488242|NCT01352741|7406714|FG001|Full Analysis Set|Double-blind Comparative Period||157
6488243|NCT01352741|7406713|FG000|Major Protocol Deviations|Double-blind Comparative Period||13
6488244|NCT01352741|7406714|FG001|Major Protocol Deviations|Double-blind Comparative Period||8
6488245|NCT01352741|7406713|FG000|Per Protocol Set|Double-blind Comparative Period||139
6488246|NCT01352741|7406714|FG001|Per Protocol Set|Double-blind Comparative Period||149
6488247|NCT01352741|7406713|FG000|painDetect Per Protocol Set|Double-blind Comparative Period||109
6488248|NCT01352741|7406714|FG001|painDetect Per Protocol Set|Double-blind Comparative Period||127
6488249|NCT01352741|7406713|FG000|SF-12 Per Protocol Set|Double-blind Comparative Period||131
6488250|NCT01352741|7406714|FG001|SF-12 Per Protocol Set|Double-blind Comparative Period||143
6488251|NCT01352741|7406713|FG000|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
6488252|NCT01352741|7406714|FG001|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
6488253|NCT01352741|7406713|FG000|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
6488254|NCT01352741|7406714|FG001|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
6488255|NCT01352741|7406713|FG000|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
6488256|NCT01352741|7406714|FG001|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
6488257|NCT01352741|7406713|FG000|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
6488258|NCT01352741|7406714|FG001|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
6488259|NCT01352741|7406713|FG000|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
6488260|NCT01352741|7406714|FG001|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
6488261|NCT01352741|7406713|FG000|COMPLETED|Double-blind Comparative Period||126
6488262|NCT01352741|7406714|FG001|COMPLETED|Double-blind Comparative Period||133
6488263|NCT01352741|7406713|FG000|NOT COMPLETED|Double-blind Comparative Period||28
6488264|NCT01352741|7406714|FG001|NOT COMPLETED|Double-blind Comparative Period||26
6488265|NCT01352741|7406713|FG000|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
6488266|NCT01352741|7406714|FG001|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
6488267|NCT01352741|7406713|FG000|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
6488268|NCT01352741|7406714|FG001|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
6488269|NCT01352741|7406713|FG000|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
6488270|NCT01352741|7406714|FG001|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
6488271|NCT01352741|7406713|FG000|COMPLETED|Open-Label Tapentadol Continuation Arm||51
6488272|NCT01352741|7406714|FG001|COMPLETED|Open-Label Tapentadol Continuation Arm||0
6488273|NCT01352741|7406713|FG000|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
6488274|NCT01352741|7406714|FG001|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
6488275|NCT01352741|7406713|FG000|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
6488276|NCT01352741|7406714|FG001|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
6488277|NCT01352741|7406713|FG000|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
6488278|NCT01352741|7406714|FG001|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
6555056|NCT01750190|7477197|FG001|COMPLETED|Overall Study||98
6555057|NCT01750190|7477196|FG000|NOT COMPLETED|Overall Study||267
6555058|NCT01750190|7477197|FG001|NOT COMPLETED|Overall Study||208
6555059|NCT01750229|7477203|FG000|STARTED|Randomized Crossover Phase||30
6555060|NCT01750229|7477203|FG000|Subject Received Sham|Randomized Crossover Phase||24
6488279|NCT01352741|7406713|FG000|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
6488280|NCT01352741|7406714|FG001|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
6488281|NCT01352793|7406736|FG000|STARTED|Overall Study||3804
6488282|NCT01352793|7406737|FG001|STARTED|Overall Study||1908
6488283|NCT01352793|7406736|FG000|Vaccination 1|Overall Study||3796
6488284|NCT01352793|7406737|FG001|Vaccination 1|Overall Study||1908
6488285|NCT01352793|7406736|FG000|Vaccination 2|Overall Study||3530
6488286|NCT01352793|7406737|FG001|Vaccination 2|Overall Study||1806
6488287|NCT01352793|7406736|FG000|Vaccination 3|Overall Study||3314
6488288|NCT01352793|7406737|FG001|Vaccination 3|Overall Study||1710
6488289|NCT01352793|7406736|FG000|COMPLETED|Overall Study||3219
6488290|NCT01352793|7406737|FG001|COMPLETED|Overall Study||1663
6488291|NCT01352793|7406736|FG000|NOT COMPLETED|Overall Study||585
6488292|NCT01352793|7406737|FG001|NOT COMPLETED|Overall Study||245
6488293|NCT01352845|7406745|FG000|STARTED|Overall Study||2471
6488294|NCT01352845|7406746|FG001|STARTED|Overall Study||822
6488295|NCT01352845|7406745|FG000|COMPLETED|Overall Study||1800
6488296|NCT01352845|7406746|FG001|COMPLETED|Overall Study||619
6488297|NCT01352845|7406745|FG000|NOT COMPLETED|Overall Study||671
6488298|NCT01352845|7406746|FG001|NOT COMPLETED|Overall Study||203
6488299|NCT01353079|7406754|FG000|STARTED|Overall Study||218
6488300|NCT01353079|7406755|FG001|STARTED|Overall Study||211
6488301|NCT01353079|7406754|FG000|COMPLETED|Overall Study||191
6488302|NCT01353079|7406755|FG001|COMPLETED|Overall Study||190
6488303|NCT01353079|7406754|FG000|NOT COMPLETED|Overall Study||27
6488304|NCT01353079|7406755|FG001|NOT COMPLETED|Overall Study||21
6488305|NCT01353144|7406765|FG000|STARTED|Overall Study||89
6488306|NCT01353144|7406766|FG001|STARTED|Overall Study||89
6488307|NCT01353144|7406765|FG000|COMPLETED|Overall Study||80
6488308|NCT01353144|7406766|FG001|COMPLETED|Overall Study||81
6488309|NCT01353144|7406765|FG000|NOT COMPLETED|Overall Study||9
6488310|NCT01353144|7406766|FG001|NOT COMPLETED|Overall Study||8
6488311|NCT01353196|7406776|FG000|STARTED|Overall Study||100
6488312|NCT01353196|7406777|FG001|STARTED|Overall Study||70
6488313|NCT01353196|7406776|FG000|COMPLETED|Overall Study||71
6488314|NCT01353196|7406777|FG001|COMPLETED|Overall Study||59
6488315|NCT01353196|7406776|FG000|NOT COMPLETED|Overall Study||29
6488316|NCT01353196|7406777|FG001|NOT COMPLETED|Overall Study||11
6488317|NCT01353222|7406785|FG000|STARTED|Overall Study||70
6488318|NCT01353222|7406786|FG001|STARTED|Overall Study||72
6488319|NCT01353222|7406785|FG000|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
6488320|NCT01353222|7406786|FG001|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
6488321|NCT01353222|7406785|FG000|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
6488322|NCT01353222|7406786|FG001|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
6488323|NCT01353222|7406785|FG000|COMPLETED|Overall Study||0
6488324|NCT01353222|7406786|FG001|COMPLETED|Overall Study||0
6488325|NCT01353222|7406785|FG000|NOT COMPLETED|Overall Study||70
6488326|NCT01353222|7406786|FG001|NOT COMPLETED|Overall Study||72
6488327|NCT01353274|7406792|FG000|STARTED|Overall Study||1157
6488328|NCT01353274|7406792|FG000|COMPLETED|Overall Study||1129
6488329|NCT01353274|7406792|FG000|NOT COMPLETED|Overall Study||28
6488330|NCT01353495|7406798|FG000|STARTED|Overall Study||19
6488331|NCT01353495|7406799|FG001|STARTED|Overall Study||20
6488332|NCT01353495|7406798|FG000|COMPLETED|Overall Study||19
6488333|NCT01353495|7406799|FG001|COMPLETED|Overall Study||20
6488334|NCT01353495|7406798|FG000|NOT COMPLETED|Overall Study||0
6488335|NCT01353495|7406799|FG001|NOT COMPLETED|Overall Study||0
6488336|NCT01353508|7406809|FG000|STARTED|Period 1 - First Intervention (7 Days)||8
6488337|NCT01353508|7406810|FG001|STARTED|Period 1 - First Intervention (7 Days)||8
6488338|NCT01353508|7406811|FG002|STARTED|Period 1 - First Intervention (7 Days)||8
6488339|NCT01353508|7406812|FG003|STARTED|Period 1 - First Intervention (7 Days)||8
6488340|NCT01353508|7406809|FG000|COMPLETED|Period 1 - First Intervention (7 Days)||8
6488341|NCT01353508|7406810|FG001|COMPLETED|Period 1 - First Intervention (7 Days)||8
6488342|NCT01353508|7406811|FG002|COMPLETED|Period 1 - First Intervention (7 Days)||8
6488343|NCT01353508|7406812|FG003|COMPLETED|Period 1 - First Intervention (7 Days)||7
6488344|NCT01353508|7406809|FG000|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
6488345|NCT01353508|7406810|FG001|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
6488346|NCT01353508|7406811|FG002|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
6488347|NCT01353508|7406812|FG003|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
6488348|NCT01353508|7406809|FG000|STARTED|Period 2 - Second Intervention (7 Days)||8
6488349|NCT01353508|7406810|FG001|STARTED|Period 2 - Second Intervention (7 Days)||8
6488350|NCT01353508|7406811|FG002|STARTED|Period 2 - Second Intervention (7 Days)||8
6488351|NCT01353508|7406812|FG003|STARTED|Period 2 - Second Intervention (7 Days)||7
6488352|NCT01353508|7406809|FG000|COMPLETED|Period 2 - Second Intervention (7 Days)||7
6488353|NCT01353508|7406810|FG001|COMPLETED|Period 2 - Second Intervention (7 Days)||8
6488354|NCT01353508|7406811|FG002|COMPLETED|Period 2 - Second Intervention (7 Days)||8
6488355|NCT01353508|7406812|FG003|COMPLETED|Period 2 - Second Intervention (7 Days)||7
6488356|NCT01353508|7406809|FG000|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
6488357|NCT01353508|7406810|FG001|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
6488358|NCT01353508|7406811|FG002|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
6488359|NCT01353508|7406812|FG003|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
6488360|NCT01353586|7406824|FG000|STARTED|Overall Study||167
6488361|NCT01353586|7406825|FG001|STARTED|Overall Study||19
6488362|NCT01353586|7406824|FG000|Participated in Workflow Phase|Overall Study||20
6488363|NCT01353586|7406825|FG001|Participated in Workflow Phase|Overall Study||0
6488364|NCT01353586|7406824|FG000|Participated in Roll-in Phase|Overall Study||22
6488365|NCT01353586|7406825|FG001|Participated in Roll-in Phase|Overall Study||0
6488366|NCT01353586|7406824|FG000|Participated in SNA Substudy|Overall Study||19
6488367|NCT01353586|7406825|FG001|Participated in SNA Substudy|Overall Study||19
6488368|NCT01353586|7406824|FG000|COMPLETED|Overall Study||160
6488369|NCT01353586|7406825|FG001|COMPLETED|Overall Study||17
6488370|NCT01353586|7406824|FG000|NOT COMPLETED|Overall Study||7
6488371|NCT01353586|7406825|FG001|NOT COMPLETED|Overall Study||2
6488372|NCT01353664|7406834|FG000|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
6488373|NCT01353664|7406834|FG000|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
6488374|NCT01353664|7406834|FG000|NOT COMPLETED|Overall Study||19
6488375|NCT01353703|7406840|FG000|STARTED|Overall Study||112
6488376|NCT01353703|7406841|FG001|STARTED|Overall Study||112
6488377|NCT01353703|7406840|FG000|COMPLETED|Overall Study||111
6488378|NCT01353703|7406841|FG001|COMPLETED|Overall Study||112
6488379|NCT01353703|7406840|FG000|NOT COMPLETED|Overall Study||1
6488380|NCT01353703|7406841|FG001|NOT COMPLETED|Overall Study||0
6488381|NCT01353859|7406849|FG000|STARTED|Overall Study||39
6488382|NCT01353859|7406849|FG000|COMPLETED|Overall Study||35
6488383|NCT01353859|7406849|FG000|NOT COMPLETED|Overall Study||4
6488384|NCT01353898|7406859|FG000|STARTED|Overall Study||2
6488385|NCT01353898|7406860|FG001|STARTED|Overall Study||2
6488386|NCT01353898|7406861|FG002|STARTED|Overall Study||2
6488387|NCT01353898|7406862|FG003|STARTED|Overall Study||2
6488388|NCT01353898|7406863|FG004|STARTED|Overall Study||2
6488389|NCT01353898|7406864|FG005|STARTED|Overall Study||2
6488390|NCT01353898|7406859|FG000|COMPLETED|Overall Study||2
6488391|NCT01353898|7406860|FG001|COMPLETED|Overall Study||2
6488392|NCT01353898|7406861|FG002|COMPLETED|Overall Study||2
6488393|NCT01353898|7406862|FG003|COMPLETED|Overall Study||2
6488394|NCT01353898|7406863|FG004|COMPLETED|Overall Study||2
6488395|NCT01353898|7406864|FG005|COMPLETED|Overall Study||1
6488396|NCT01353898|7406859|FG000|NOT COMPLETED|Overall Study||0
6488397|NCT01353898|7406860|FG001|NOT COMPLETED|Overall Study||0
6488398|NCT01353898|7406861|FG002|NOT COMPLETED|Overall Study||0
6488399|NCT01353898|7406862|FG003|NOT COMPLETED|Overall Study||0
6488400|NCT01353898|7406863|FG004|NOT COMPLETED|Overall Study||0
6488401|NCT01353898|7406864|FG005|NOT COMPLETED|Overall Study||1
6488402|NCT01353911|7406886|FG000|STARTED|Overall Study||36
6488403|NCT01353911|7406887|FG001|STARTED|Overall Study||66
6488404|NCT01353911|7406888|FG002|STARTED|Overall Study||68
6488405|NCT01353911|7406889|FG003|STARTED|Overall Study||24
6488406|NCT01353911|7406890|FG004|STARTED|Overall Study||29
6488407|NCT01353911|7406891|FG005|STARTED|Overall Study||43
6488408|NCT01353911|7406892|FG006|STARTED|Overall Study||36
6488409|NCT01353911|7406893|FG007|STARTED|Overall Study||66
6488410|NCT01353911|7406886|FG000|COMPLETED|Overall Study||28
6488411|NCT01353911|7406887|FG001|COMPLETED|Overall Study||57
6488412|NCT01353911|7406888|FG002|COMPLETED|Overall Study||59
6488413|NCT01353911|7406889|FG003|COMPLETED|Overall Study||22
6488414|NCT01353911|7406890|FG004|COMPLETED|Overall Study||23
6488415|NCT01353911|7406891|FG005|COMPLETED|Overall Study||36
6488416|NCT01353911|7406892|FG006|COMPLETED|Overall Study||30
6488417|NCT01353911|7406893|FG007|COMPLETED|Overall Study||51
6488418|NCT01353911|7406886|FG000|NOT COMPLETED|Overall Study||8
6488419|NCT01353911|7406887|FG001|NOT COMPLETED|Overall Study||9
6488420|NCT01353911|7406888|FG002|NOT COMPLETED|Overall Study||9
6488421|NCT01353911|7406889|FG003|NOT COMPLETED|Overall Study||2
6488422|NCT01353911|7406890|FG004|NOT COMPLETED|Overall Study||6
6488423|NCT01353911|7406891|FG005|NOT COMPLETED|Overall Study||7
6488424|NCT01353911|7406892|FG006|NOT COMPLETED|Overall Study||6
6488425|NCT01353911|7406893|FG007|NOT COMPLETED|Overall Study||15
6488426|NCT01353963|7406911|FG000|STARTED|Overall Study||13
6488427|NCT01353963|7406911|FG000|COMPLETED|Overall Study||11
6488428|NCT01353963|7406911|FG000|NOT COMPLETED|Overall Study||2
6488429|NCT01353976|7406917|FG000|STARTED|Overall Study||130
6488430|NCT01353976|7406918|FG001|STARTED|Overall Study||134
6488431|NCT01353976|7406917|FG000|COMPLETED|Overall Study||82
6488432|NCT01353976|7406918|FG001|COMPLETED|Overall Study||83
6488433|NCT01353976|7406917|FG000|NOT COMPLETED|Overall Study||48
6488434|NCT01353976|7406918|FG001|NOT COMPLETED|Overall Study||51
6488435|NCT01354015|7406926|FG000|STARTED|Overall Study||50
6488436|NCT01354015|7406927|FG001|STARTED|Overall Study||48
6488437|NCT01354015|7406926|FG000|COMPLETED|Overall Study||44
6488438|NCT01354015|7406927|FG001|COMPLETED|Overall Study||43
6488439|NCT01354015|7406926|FG000|NOT COMPLETED|Overall Study||6
6488440|NCT01354015|7406927|FG001|NOT COMPLETED|Overall Study||5
6488441|NCT01354028|7406933|FG000|STARTED|Overall Study||15
6488442|NCT01354028|7406934|FG001|STARTED|Overall Study||15
6488443|NCT01354028|7406933|FG000|COMPLETED|Overall Study||13
6488444|NCT01354028|7406934|FG001|COMPLETED|Overall Study||10
6488445|NCT01354028|7406933|FG000|NOT COMPLETED|Overall Study||2
6488446|NCT01354028|7406934|FG001|NOT COMPLETED|Overall Study||5
6488447|NCT01354106|7406946|FG000|STARTED|Overall Study||26
6488448|NCT01354106|7406946|FG000|COMPLETED|Overall Study||24
6488449|NCT01354106|7406946|FG000|NOT COMPLETED|Overall Study||2
6488450|NCT01354132|7406954|FG000|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
6488451|NCT01354132|7406955|FG001|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
6488452|NCT01354132|7406954|FG000|COMPLETED|Randomization||31
6488453|NCT01354132|7406955|FG001|COMPLETED|Randomization||30
6488454|NCT01354132|7406954|FG000|NOT COMPLETED|Randomization||1
6488455|NCT01354132|7406955|FG001|NOT COMPLETED|Randomization||1
6488456|NCT01354132|7406954|FG000|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
6488457|NCT01354132|7406955|FG001|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
6488458|NCT01354132|7406954|FG000|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
6488459|NCT01354132|7406955|FG001|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
6488460|NCT01354132|7406954|FG000|Stopped After First Visit|Double Blind (Visits 1-7)||3
6488461|NCT01354132|7406955|FG001|Stopped After First Visit|Double Blind (Visits 1-7)||2
6488462|NCT01354132|7406954|FG000|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
6488463|NCT01354132|7406955|FG001|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
6488464|NCT01354132|7406954|FG000|COMPLETED|Double Blind (Visits 1-7)||22
6488465|NCT01354132|7406955|FG001|COMPLETED|Double Blind (Visits 1-7)||19
6488466|NCT01354132|7406954|FG000|NOT COMPLETED|Double Blind (Visits 1-7)||9
6488467|NCT01354132|7406955|FG001|NOT COMPLETED|Double Blind (Visits 1-7)||11
6488468|NCT01354132|7406954|FG000|STARTED|1 Month Post Study Medication||22
6488469|NCT01354132|7406955|FG001|STARTED|1 Month Post Study Medication||19
6488470|NCT01354132|7406954|FG000|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
6488471|NCT01354132|7406955|FG001|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
6488472|NCT01354132|7406954|FG000|COMPLETED|1 Month Post Study Medication||21
6748691|NCT03418064|7676813|FG000|COMPLETED|Second Intervention (1 Month)||21
6748692|NCT03418064|7676814|FG001|COMPLETED|Second Intervention (1 Month)||21
6748693|NCT03418064|7676813|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
6488473|NCT01354132|7406955|FG001|COMPLETED|1 Month Post Study Medication||16
6488474|NCT01354132|7406954|FG000|NOT COMPLETED|1 Month Post Study Medication||1
6488475|NCT01354132|7406955|FG001|NOT COMPLETED|1 Month Post Study Medication||3
6488476|NCT01354145|7406966|FG000|STARTED|Overall Study||97
6488477|NCT01354145|7406967|FG001|STARTED|Overall Study||97
6488478|NCT01354145|7406966|FG000|COMPLETED|Overall Study||58
6488479|NCT01354145|7406967|FG001|COMPLETED|Overall Study||63
6488480|NCT01354145|7406966|FG000|NOT COMPLETED|Overall Study||39
6488481|NCT01354145|7406967|FG001|NOT COMPLETED|Overall Study||34
6488482|NCT01354197|7406975|FG000|STARTED|Overall Study||4652
6488483|NCT01354197|7406975|FG000|COMPLETED|Overall Study||4652
6488484|NCT01354197|7406975|FG000|NOT COMPLETED|Overall Study||0
6488485|NCT01354223|7406982|FG000|STARTED|Overall Study||60
6555061|NCT01750229|7477203|FG000|Subjects Received 1200 Hz|Randomized Crossover Phase||24
6555062|NCT01750229|7477203|FG000|Subjects Received 3030 Hz|Randomized Crossover Phase||24
6555063|NCT01750229|7477203|FG000|Subjects Received 5882 Hz|Randomized Crossover Phase||24
6555064|NCT01750229|7477203|FG000|Protocol Violation|Randomized Crossover Phase||4
6555065|NCT01750229|7477203|FG000|COMPLETED|Randomized Crossover Phase||28
6555066|NCT01750229|7477203|FG000|NOT COMPLETED|Randomized Crossover Phase||2
6555067|NCT01750229|7477203|FG000|STARTED|Long-term Follow-up Phase|Four subjects who had protocol violations continued to be followed in long-term follow-up phase.|28
6555068|NCT01750229|7477203|FG000|COMPLETED|Long-term Follow-up Phase||25
6555069|NCT01750229|7477203|FG000|NOT COMPLETED|Long-term Follow-up Phase||3
6555070|NCT01750242|7477213|FG000|STARTED|Overall Study||23
6555071|NCT01750242|7477213|FG000|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
6555072|NCT01750242|7477213|FG000|COMPLETED|Overall Study||20
6488486|NCT01354223|7406983|FG001|STARTED|Overall Study||30
6488487|NCT01354223|7406982|FG000|COMPLETED|Overall Study||57
6488488|NCT01354223|7406983|FG001|COMPLETED|Overall Study||29
6488489|NCT01354223|7406982|FG000|NOT COMPLETED|Overall Study||3
6488490|NCT01354223|7406983|FG001|NOT COMPLETED|Overall Study||1
6488491|NCT01354314|7406993|FG000|STARTED|Overall Study||12
6488492|NCT01354314|7406994|FG001|STARTED|Overall Study||11
6488493|NCT01354314|7406995|FG002|STARTED|Overall Study||11
6488494|NCT01354314|7406996|FG003|STARTED|Overall Study||11
6488495|NCT01354314|7406993|FG000|Completed (ITT)|Overall Study||11
6488496|NCT01354314|7406994|FG001|Completed (ITT)|Overall Study||11
6488497|NCT01354314|7406995|FG002|Completed (ITT)|Overall Study||9
6488498|NCT01354314|7406996|FG003|Completed (ITT)|Overall Study||10
6488499|NCT01354314|7406993|FG000|COMPLETED|Overall Study||6
6488500|NCT01354314|7406994|FG001|COMPLETED|Overall Study||8
6488501|NCT01354314|7406995|FG002|COMPLETED|Overall Study||3
6488502|NCT01354314|7406996|FG003|COMPLETED|Overall Study||5
6488503|NCT01354314|7406993|FG000|NOT COMPLETED|Overall Study||6
6488504|NCT01354314|7406994|FG001|NOT COMPLETED|Overall Study||3
6488505|NCT01354314|7406995|FG002|NOT COMPLETED|Overall Study||8
6488506|NCT01354314|7406996|FG003|NOT COMPLETED|Overall Study||6
6488507|NCT01354353|7407014|FG000|STARTED|Overall Study||16
6488508|NCT01354353|7407015|FG001|STARTED|Overall Study|Included in this arm are six participants who erroneously received oral 80 mg LY2140023 BID.|12
6488509|NCT01354353|7407016|FG002|STARTED|Overall Study||11
6555073|NCT01750242|7477213|FG000|NOT COMPLETED|Overall Study||3
6748694|NCT03418064|7676814|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
6488510|NCT01354353|7407017|FG003|STARTED|Overall Study||12
6488511|NCT01354353|7407018|FG004|STARTED|Overall Study||12
6488512|NCT01354353|7407019|FG005|STARTED|Overall Study||12
6488513|NCT01354353|7407014|FG000|Received at Least One Dose of Study Drug|Overall Study||16
6488514|NCT01354353|7407015|FG001|Received at Least One Dose of Study Drug|Overall Study||11
6488515|NCT01354353|7407016|FG002|Received at Least One Dose of Study Drug|Overall Study||10
6488516|NCT01354353|7407017|FG003|Received at Least One Dose of Study Drug|Overall Study||11
6488517|NCT01354353|7407018|FG004|Received at Least One Dose of Study Drug|Overall Study||11
6488518|NCT01354353|7407019|FG005|Received at Least One Dose of Study Drug|Overall Study||11
6488519|NCT01354353|7407014|FG000|COMPLETED|Overall Study||13
6488520|NCT01354353|7407015|FG001|COMPLETED|Overall Study||11
6488521|NCT01354353|7407016|FG002|COMPLETED|Overall Study||9
6488522|NCT01354353|7407017|FG003|COMPLETED|Overall Study||7
6488523|NCT01354353|7407018|FG004|COMPLETED|Overall Study||11
6488524|NCT01354353|7407019|FG005|COMPLETED|Overall Study||6
6488525|NCT01354353|7407014|FG000|NOT COMPLETED|Overall Study||3
6488526|NCT01354353|7407015|FG001|NOT COMPLETED|Overall Study||1
6488527|NCT01354353|7407016|FG002|NOT COMPLETED|Overall Study||2
6488528|NCT01354353|7407017|FG003|NOT COMPLETED|Overall Study||5
6488529|NCT01354353|7407018|FG004|NOT COMPLETED|Overall Study||1
6488530|NCT01354353|7407019|FG005|NOT COMPLETED|Overall Study||6
6488531|NCT01354444|7407042|FG000|STARTED|Overall Study||14
6488532|NCT01354444|7407043|FG001|STARTED|Overall Study||15
6488533|NCT01354444|7407042|FG000|COMPLETED|Overall Study||6
6488534|NCT01354444|7407043|FG001|COMPLETED|Overall Study||11
6488535|NCT01354444|7407042|FG000|NOT COMPLETED|Overall Study||8
6488536|NCT01354444|7407043|FG001|NOT COMPLETED|Overall Study||4
6488537|NCT01354496|7407053|FG000|STARTED|Period 1||6
6488538|NCT01354496|7407054|FG001|STARTED|Period 1||6
6488539|NCT01354496|7407055|FG002|STARTED|Period 1||6
6488540|NCT01354496|7407056|FG003|STARTED|Period 1||6
6488541|NCT01354496|7407057|FG004|STARTED|Period 1||5
6488542|NCT01354496|7407058|FG005|STARTED|Period 1||6
6488543|NCT01354496|7407053|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
6488544|NCT01354496|7407054|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
6488545|NCT01354496|7407055|FG002|Received at Least 1 Dose of Study Drug|Period 1||6
6488546|NCT01354496|7407056|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
6488547|NCT01354496|7407057|FG004|Received at Least 1 Dose of Study Drug|Period 1||5
6488548|NCT01354496|7407058|FG005|Received at Least 1 Dose of Study Drug|Period 1||6
6488549|NCT01354496|7407053|FG000|COMPLETED|Period 1||6
6488550|NCT01354496|7407054|FG001|COMPLETED|Period 1||6
6488551|NCT01354496|7407055|FG002|COMPLETED|Period 1||4
6488552|NCT01354496|7407056|FG003|COMPLETED|Period 1||6
6488553|NCT01354496|7407057|FG004|COMPLETED|Period 1||5
6488554|NCT01354496|7407058|FG005|COMPLETED|Period 1||6
6488555|NCT01354496|7407053|FG000|NOT COMPLETED|Period 1||0
6488556|NCT01354496|7407054|FG001|NOT COMPLETED|Period 1||0
6488557|NCT01354496|7407055|FG002|NOT COMPLETED|Period 1||2
6488558|NCT01354496|7407056|FG003|NOT COMPLETED|Period 1||0
6488559|NCT01354496|7407057|FG004|NOT COMPLETED|Period 1||0
6488560|NCT01354496|7407058|FG005|NOT COMPLETED|Period 1||0
6488561|NCT01354496|7407053|FG000|STARTED|Washout (at Least 14 Days)||6
6488562|NCT01354496|7407054|FG001|STARTED|Washout (at Least 14 Days)||6
6488563|NCT01354496|7407055|FG002|STARTED|Washout (at Least 14 Days)||4
6488564|NCT01354496|7407056|FG003|STARTED|Washout (at Least 14 Days)||6
6488565|NCT01354496|7407057|FG004|STARTED|Washout (at Least 14 Days)||5
6488566|NCT01354496|7407058|FG005|STARTED|Washout (at Least 14 Days)||6
6488567|NCT01354496|7407053|FG000|COMPLETED|Washout (at Least 14 Days)||6
6488568|NCT01354496|7407054|FG001|COMPLETED|Washout (at Least 14 Days)||6
6488569|NCT01354496|7407055|FG002|COMPLETED|Washout (at Least 14 Days)||4
6488570|NCT01354496|7407056|FG003|COMPLETED|Washout (at Least 14 Days)||6
6488571|NCT01354496|7407057|FG004|COMPLETED|Washout (at Least 14 Days)||5
6488572|NCT01354496|7407058|FG005|COMPLETED|Washout (at Least 14 Days)||6
6488573|NCT01354496|7407053|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
6488574|NCT01354496|7407054|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
6488575|NCT01354496|7407055|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
6488576|NCT01354496|7407056|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
6488577|NCT01354496|7407057|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
6488578|NCT01354496|7407058|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
6488579|NCT01354496|7407053|FG000|STARTED|Period 2||6
6488580|NCT01354496|7407054|FG001|STARTED|Period 2||6
6488581|NCT01354496|7407055|FG002|STARTED|Period 2||4
6488582|NCT01354496|7407056|FG003|STARTED|Period 2||6
6488583|NCT01354496|7407057|FG004|STARTED|Period 2||5
6488584|NCT01354496|7407058|FG005|STARTED|Period 2||6
6488585|NCT01354496|7407053|FG000|COMPLETED|Period 2||6
6488586|NCT01354496|7407054|FG001|COMPLETED|Period 2||6
6488587|NCT01354496|7407055|FG002|COMPLETED|Period 2||4
6488588|NCT01354496|7407056|FG003|COMPLETED|Period 2||5
6488589|NCT01354496|7407057|FG004|COMPLETED|Period 2||5
6488590|NCT01354496|7407058|FG005|COMPLETED|Period 2||6
6488591|NCT01354496|7407053|FG000|NOT COMPLETED|Period 2||0
6488592|NCT01354496|7407054|FG001|NOT COMPLETED|Period 2||0
6488593|NCT01354496|7407055|FG002|NOT COMPLETED|Period 2||0
6488594|NCT01354496|7407056|FG003|NOT COMPLETED|Period 2||1
6488595|NCT01354496|7407057|FG004|NOT COMPLETED|Period 2||0
6488596|NCT01354496|7407058|FG005|NOT COMPLETED|Period 2||0
6488597|NCT01354496|7407053|FG000|STARTED|Washout (at Least 14 Days)||6
6488598|NCT01354496|7407054|FG001|STARTED|Washout (at Least 14 Days)||6
6488599|NCT01354496|7407055|FG002|STARTED|Washout (at Least 14 Days)||4
6488600|NCT01354496|7407056|FG003|STARTED|Washout (at Least 14 Days)||5
6488601|NCT01354496|7407057|FG004|STARTED|Washout (at Least 14 Days)||5
6488602|NCT01354496|7407058|FG005|STARTED|Washout (at Least 14 Days)||6
6488603|NCT01354496|7407053|FG000|COMPLETED|Washout (at Least 14 Days)||6
6488604|NCT01354496|7407054|FG001|COMPLETED|Washout (at Least 14 Days)||5
6488605|NCT01354496|7407055|FG002|COMPLETED|Washout (at Least 14 Days)||4
6488606|NCT01354496|7407056|FG003|COMPLETED|Washout (at Least 14 Days)||4
6488607|NCT01354496|7407057|FG004|COMPLETED|Washout (at Least 14 Days)||5
6488608|NCT01354496|7407058|FG005|COMPLETED|Washout (at Least 14 Days)||6
6488609|NCT01354496|7407053|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
6488610|NCT01354496|7407054|FG001|NOT COMPLETED|Washout (at Least 14 Days)||1
6488611|NCT01354496|7407055|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
6488612|NCT01354496|7407056|FG003|NOT COMPLETED|Washout (at Least 14 Days)||1
6488613|NCT01354496|7407057|FG004|NOT COMPLETED|Washout (at Least 14 Days)||0
6488614|NCT01354496|7407058|FG005|NOT COMPLETED|Washout (at Least 14 Days)||0
6488615|NCT01354496|7407053|FG000|STARTED|Period 3||6
6488616|NCT01354496|7407054|FG001|STARTED|Period 3||5
6488617|NCT01354496|7407055|FG002|STARTED|Period 3||4
6488618|NCT01354496|7407056|FG003|STARTED|Period 3||4
6488619|NCT01354496|7407057|FG004|STARTED|Period 3||5
6488620|NCT01354496|7407058|FG005|STARTED|Period 3||6
6488621|NCT01354496|7407053|FG000|COMPLETED|Period 3||6
6488622|NCT01354496|7407054|FG001|COMPLETED|Period 3||5
6488623|NCT01354496|7407055|FG002|COMPLETED|Period 3||4
6488624|NCT01354496|7407056|FG003|COMPLETED|Period 3||4
6488625|NCT01354496|7407057|FG004|COMPLETED|Period 3||5
6488626|NCT01354496|7407058|FG005|COMPLETED|Period 3||6
6488627|NCT01354496|7407053|FG000|NOT COMPLETED|Period 3||0
6488628|NCT01354496|7407054|FG001|NOT COMPLETED|Period 3||0
6488629|NCT01354496|7407055|FG002|NOT COMPLETED|Period 3||0
6488630|NCT01354496|7407056|FG003|NOT COMPLETED|Period 3||0
6488631|NCT01354496|7407057|FG004|NOT COMPLETED|Period 3||0
6488632|NCT01354496|7407058|FG005|NOT COMPLETED|Period 3||0
6488633|NCT01354652|7407082|FG000|STARTED|Overall Study||3
6488634|NCT01354652|7407083|FG001|STARTED|Overall Study||2
6488635|NCT01354652|7407084|FG002|STARTED|Overall Study||0
6488636|NCT01354652|7407082|FG000|COMPLETED|Overall Study||0
6488637|NCT01354652|7407083|FG001|COMPLETED|Overall Study||0
6488638|NCT01354652|7407084|FG002|COMPLETED|Overall Study||0
6488639|NCT01354652|7407082|FG000|NOT COMPLETED|Overall Study||3
6488640|NCT01354652|7407083|FG001|NOT COMPLETED|Overall Study||2
6488641|NCT01354652|7407084|FG002|NOT COMPLETED|Overall Study||0
6488642|NCT01354691|7407095|FG000|STARTED|Overall Study||101
6488643|NCT01354691|7407096|FG001|STARTED|Overall Study||99
6488644|NCT01354691|7407095|FG000|ITT|Overall Study||99
6488645|NCT01354691|7407096|FG001|ITT|Overall Study||96
6488646|NCT01354691|7407095|FG000|PP|Overall Study||79
6488647|NCT01354691|7407096|FG001|PP|Overall Study||75
6488648|NCT01354691|7407095|FG000|COMPLETED|Overall Study||80
6488649|NCT01354691|7407096|FG001|COMPLETED|Overall Study||77
6488650|NCT01354691|7407095|FG000|NOT COMPLETED|Overall Study||21
6488651|NCT01354691|7407096|FG001|NOT COMPLETED|Overall Study||22
6488652|NCT01354899|7407102|FG000|STARTED|Overall Study||24
6488653|NCT01354899|7407102|FG000|COMPLETED|Overall Study||21
6488654|NCT01354899|7407102|FG000|NOT COMPLETED|Overall Study||3
6488655|NCT01354938|7407106|FG000|STARTED|Overall Study||220
6488656|NCT01354938|7407106|FG000|COMPLETED|Overall Study||219
6488657|NCT01354938|7407106|FG000|NOT COMPLETED|Overall Study||1
6488658|NCT01354964|7407112|FG000|STARTED|Overall Study||11
6488659|NCT01354964|7407113|FG001|STARTED|Overall Study||8
6488660|NCT01354964|7407112|FG000|COMPLETED|Overall Study||7
6488661|NCT01354964|7407113|FG001|COMPLETED|Overall Study||7
6488662|NCT01354964|7407112|FG000|NOT COMPLETED|Overall Study||4
6488663|NCT01354964|7407113|FG001|NOT COMPLETED|Overall Study||1
6501724|NCT01430754|7420316|FG001|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
6501725|NCT01430754|7420315|FG000|Entrained - After Run-In Phase|Run-In Phase||24
6501726|NCT01430754|7420316|FG001|Entrained - After Run-In Phase|Run-In Phase||0
6501727|NCT01430754|7420315|FG000|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
6501728|NCT01430754|7420316|FG001|COMPLETED|Run-In Phase||0
6501729|NCT01430754|7420315|FG000|NOT COMPLETED|Run-In Phase||37
6501730|NCT01430754|7420316|FG001|NOT COMPLETED|Run-In Phase||0
6501731|NCT01430754|7420315|FG000|STARTED|Randomized Phase||10
6501732|NCT01430754|7420316|FG001|STARTED|Randomized Phase||10
6501733|NCT01430754|7420315|FG000|COMPLETED|Randomized Phase||10
6501734|NCT01430754|7420316|FG001|COMPLETED|Randomized Phase||10
6501735|NCT01430754|7420315|FG000|NOT COMPLETED|Randomized Phase||0
6501736|NCT01430754|7420316|FG001|NOT COMPLETED|Randomized Phase||0
6501737|NCT01430819|7420326|FG000|STARTED|Overall Study||150
6501738|NCT01430819|7420327|FG001|STARTED|Overall Study||150
6501739|NCT01430819|7420326|FG000|COMPLETED|Overall Study||150
6501740|NCT01430819|7420327|FG001|COMPLETED|Overall Study||150
6501741|NCT01430819|7420326|FG000|NOT COMPLETED|Overall Study||0
6501742|NCT01430819|7420327|FG001|NOT COMPLETED|Overall Study||0
6501743|NCT01431014|7420335|FG000|STARTED|Overall Study||34
6501744|NCT01431014|7420336|FG001|STARTED|Overall Study||34
6501745|NCT01431014|7420335|FG000|COMPLETED|Overall Study||31
6501746|NCT01431014|7420336|FG001|COMPLETED|Overall Study||25
6501747|NCT01431014|7420335|FG000|NOT COMPLETED|Overall Study||3
6501748|NCT01431014|7420336|FG001|NOT COMPLETED|Overall Study||9
6501749|NCT01431079|7420344|FG000|STARTED|Overall Study||45
6501750|NCT01431079|7420345|FG001|STARTED|Overall Study||45
6501751|NCT01431079|7420344|FG000|Post-test|Overall Study||45
6501752|NCT01431079|7420345|FG001|Post-test|Overall Study||45
6501753|NCT01431079|7420344|FG000|COMPLETED|Overall Study||10
6501754|NCT01431079|7420345|FG001|COMPLETED|Overall Study||6
6488664|NCT01354990|7407121|FG000|STARTED|Overall Study||2974
6488665|NCT01354990|7407121|FG000|COMPLETED|Overall Study||2974
6488666|NCT01354990|7407121|FG000|NOT COMPLETED|Overall Study||0
6488667|NCT01355068|7407125|FG000|STARTED|First Intervention Period||13
6555074|NCT01750255|7477220|FG000|STARTED|Overall Study||49
6555075|NCT01750255|7477221|FG001|STARTED|Overall Study||43
6555076|NCT01750255|7477220|FG000|COMPLETED|Overall Study||43
6555077|NCT01750255|7477221|FG001|COMPLETED|Overall Study||38
6555078|NCT01750255|7477220|FG000|NOT COMPLETED|Overall Study||6
6555079|NCT01750255|7477221|FG001|NOT COMPLETED|Overall Study||5
6555080|NCT01750268|7477230|FG000|STARTED|Overall Study||15
6555081|NCT01750268|7477231|FG001|STARTED|Overall Study||17
6555082|NCT01750268|7477230|FG000|COMPLETED|Overall Study||13
6555083|NCT01750268|7477231|FG001|COMPLETED|Overall Study||12
6555084|NCT01750268|7477230|FG000|NOT COMPLETED|Overall Study||2
6555085|NCT01750268|7477231|FG001|NOT COMPLETED|Overall Study||5
6555086|NCT01750294|7477237|FG000|STARTED|Overall Study||14
6555087|NCT01750294|7477237|FG000|COMPLETED|Overall Study||12
6555088|NCT01750294|7477237|FG000|NOT COMPLETED|Overall Study||2
6488668|NCT01355068|7407126|FG001|STARTED|First Intervention Period||13
6488669|NCT01355068|7407125|FG000|COMPLETED|First Intervention Period||13
6488670|NCT01355068|7407126|FG001|COMPLETED|First Intervention Period||11
6488671|NCT01355068|7407125|FG000|NOT COMPLETED|First Intervention Period||0
6488672|NCT01355068|7407126|FG001|NOT COMPLETED|First Intervention Period||2
6488673|NCT01355068|7407125|FG000|STARTED|Washout Period (at Least 7 Days)||13
6488674|NCT01355068|7407126|FG001|STARTED|Washout Period (at Least 7 Days)||11
6488675|NCT01355068|7407125|FG000|COMPLETED|Washout Period (at Least 7 Days)||13
6488676|NCT01355068|7407126|FG001|COMPLETED|Washout Period (at Least 7 Days)||11
6488677|NCT01355068|7407125|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6488678|NCT01355068|7407126|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6488679|NCT01355068|7407125|FG000|STARTED|Second Intervention Period||13
6488680|NCT01355068|7407126|FG001|STARTED|Second Intervention Period||11
6488681|NCT01355068|7407125|FG000|COMPLETED|Second Intervention Period||13
6488682|NCT01355068|7407126|FG001|COMPLETED|Second Intervention Period||11
6488683|NCT01355068|7407125|FG000|NOT COMPLETED|Second Intervention Period||0
6488684|NCT01355068|7407126|FG001|NOT COMPLETED|Second Intervention Period||0
6488685|NCT01355081|7407135|FG000|STARTED|Overall Study||119
6488686|NCT01355081|7407136|FG001|STARTED|Overall Study||123
6488687|NCT01355081|7407137|FG002|STARTED|Overall Study||124
6488688|NCT01355081|7407135|FG000|COMPLETED|Overall Study||112
6488689|NCT01355081|7407136|FG001|COMPLETED|Overall Study||113
6488690|NCT01355081|7407137|FG002|COMPLETED|Overall Study||113
6488691|NCT01355081|7407135|FG000|NOT COMPLETED|Overall Study||7
6488692|NCT01355081|7407136|FG001|NOT COMPLETED|Overall Study||10
6488693|NCT01355081|7407137|FG002|NOT COMPLETED|Overall Study||11
6488694|NCT01355159|7407147|FG000|STARTED|Overall Study||1228
6488695|NCT01355159|7407148|FG001|STARTED|Overall Study||1236
6488696|NCT01355159|7407147|FG000|COMPLETED|Overall Study||1144
6488697|NCT01355159|7407148|FG001|COMPLETED|Overall Study||1157
6488698|NCT01355159|7407147|FG000|NOT COMPLETED|Overall Study||84
6488699|NCT01355159|7407148|FG001|NOT COMPLETED|Overall Study||79
6488700|NCT01355224|7407158|FG000|STARTED|Overall Study||198
6488701|NCT01355224|7407159|FG001|STARTED|Overall Study||203
6488702|NCT01355224|7407160|FG002|STARTED|Overall Study||196
6488703|NCT01355224|7407161|FG003|STARTED|Overall Study||201
6488704|NCT01355224|7407158|FG000|Competed Baseline|Overall Study||191
6488705|NCT01355224|7407159|FG001|Competed Baseline|Overall Study||200
6488706|NCT01355224|7407160|FG002|Competed Baseline|Overall Study||193
6488707|NCT01355224|7407161|FG003|Competed Baseline|Overall Study||193
6488708|NCT01355224|7407158|FG000|COMPLETED|Overall Study||167
6488709|NCT01355224|7407159|FG001|COMPLETED|Overall Study||180
6488710|NCT01355224|7407160|FG002|COMPLETED|Overall Study||177
6488711|NCT01355224|7407161|FG003|COMPLETED|Overall Study||172
6488712|NCT01355224|7407158|FG000|NOT COMPLETED|Overall Study||31
6488713|NCT01355224|7407159|FG001|NOT COMPLETED|Overall Study||23
6488714|NCT01355224|7407160|FG002|NOT COMPLETED|Overall Study||19
6488715|NCT01355224|7407161|FG003|NOT COMPLETED|Overall Study||29
6488716|NCT01355289|7407183|FG000|STARTED|Core Study||17
6488717|NCT01355289|7407184|FG001|STARTED|Core Study||16
6488718|NCT01355289|7407185|FG002|STARTED|Core Study||18
6488719|NCT01355289|7407186|FG003|STARTED|Core Study||14
6488720|NCT01355289|7407187|FG004|STARTED|Core Study||0
6488721|NCT01355289|7407183|FG000|COMPLETED|Core Study||16
6488722|NCT01355289|7407184|FG001|COMPLETED|Core Study||16
6488723|NCT01355289|7407185|FG002|COMPLETED|Core Study||18
6488724|NCT01355289|7407186|FG003|COMPLETED|Core Study||12
6488725|NCT01355289|7407187|FG004|COMPLETED|Core Study||0
6488726|NCT01355289|7407183|FG000|NOT COMPLETED|Core Study||1
6488727|NCT01355289|7407184|FG001|NOT COMPLETED|Core Study||0
6488728|NCT01355289|7407185|FG002|NOT COMPLETED|Core Study||0
6488729|NCT01355289|7407186|FG003|NOT COMPLETED|Core Study||2
6488730|NCT01355289|7407187|FG004|NOT COMPLETED|Core Study||0
6555089|NCT01750346|7477244|FG000|STARTED|Overall Study||3
6555090|NCT01750346|7477245|FG001|STARTED|Overall Study||2
6555091|NCT01750346|7477246|FG002|STARTED|Overall Study||3
6488731|NCT01355289|7407183|FG000|STARTED|Open Label Extension||0
6488732|NCT01355289|7407184|FG001|STARTED|Open Label Extension||0
6555092|NCT01750346|7477244|FG000|COMPLETED|Overall Study||2
6555093|NCT01750346|7477245|FG001|COMPLETED|Overall Study||2
6555094|NCT01750346|7477246|FG002|COMPLETED|Overall Study||3
6555095|NCT01750346|7477244|FG000|NOT COMPLETED|Overall Study||1
6488733|NCT01355289|7407185|FG002|STARTED|Open Label Extension||0
6488734|NCT01355289|7407186|FG003|STARTED|Open Label Extension||0
6488735|NCT01355289|7407187|FG004|STARTED|Open Label Extension||62
6488736|NCT01355289|7407183|FG000|COMPLETED|Open Label Extension||0
6488737|NCT01355289|7407184|FG001|COMPLETED|Open Label Extension||0
6488738|NCT01355289|7407185|FG002|COMPLETED|Open Label Extension||0
6488739|NCT01355289|7407186|FG003|COMPLETED|Open Label Extension||0
6488740|NCT01355289|7407187|FG004|COMPLETED|Open Label Extension||28
6488741|NCT01355289|7407183|FG000|NOT COMPLETED|Open Label Extension||0
6488742|NCT01355289|7407184|FG001|NOT COMPLETED|Open Label Extension||0
6488743|NCT01355289|7407185|FG002|NOT COMPLETED|Open Label Extension||0
6488744|NCT01355289|7407186|FG003|NOT COMPLETED|Open Label Extension||0
6488745|NCT01355289|7407187|FG004|NOT COMPLETED|Open Label Extension||34
6488746|NCT01355302|7407200|FG000|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
6488747|NCT01355302|7407201|FG001|STARTED|Phase 1b||0
6488748|NCT01355302|7407202|FG002|STARTED|Phase 1b||0
6488749|NCT01355302|7407200|FG000|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
6488750|NCT01355302|7407201|FG001|COMPLETED|Phase 1b||0
6488751|NCT01355302|7407202|FG002|COMPLETED|Phase 1b||0
6488752|NCT01355302|7407200|FG000|NOT COMPLETED|Phase 1b||6
6488753|NCT01355302|7407201|FG001|NOT COMPLETED|Phase 1b||0
6488754|NCT01355302|7407202|FG002|NOT COMPLETED|Phase 1b||0
6488755|NCT01355302|7407200|FG000|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
6488756|NCT01355302|7407201|FG001|STARTED|Phase 2|The study was terminated prior to enrollment|0
6488757|NCT01355302|7407202|FG002|STARTED|Phase 2|The study was terminated prior to enrollment|0
6488758|NCT01355302|7407200|FG000|COMPLETED|Phase 2||0
6488759|NCT01355302|7407201|FG001|COMPLETED|Phase 2||0
6488760|NCT01355302|7407202|FG002|COMPLETED|Phase 2||0
6488761|NCT01355302|7407200|FG000|NOT COMPLETED|Phase 2||0
6488762|NCT01355302|7407201|FG001|NOT COMPLETED|Phase 2||0
6488763|NCT01355302|7407202|FG002|NOT COMPLETED|Phase 2||0
6488764|NCT01355419|7407210|FG000|STARTED|Overall Study||150
6488765|NCT01355419|7407210|FG000|COMPLETED|Overall Study||142
6488766|NCT01355419|7407210|FG000|NOT COMPLETED|Overall Study||8
6488767|NCT01355458|7407216|FG000|STARTED|Overall Study||129
6488768|NCT01355458|7407217|FG001|STARTED|Overall Study||131
6488769|NCT01355458|7407216|FG000|COMPLETED|Overall Study||127
6488770|NCT01355458|7407217|FG001|COMPLETED|Overall Study||127
6488771|NCT01355458|7407216|FG000|NOT COMPLETED|Overall Study||2
6488772|NCT01355458|7407217|FG001|NOT COMPLETED|Overall Study||4
6488773|NCT01355471|7407225|FG000|STARTED|Overall Study||148
6488774|NCT01355471|7407226|FG001|STARTED|Overall Study||145
6488775|NCT01355471|7407225|FG000|COMPLETED|Overall Study||141
6488776|NCT01355471|7407226|FG001|COMPLETED|Overall Study||142
6488777|NCT01355471|7407225|FG000|NOT COMPLETED|Overall Study||7
6488778|NCT01355471|7407226|FG001|NOT COMPLETED|Overall Study||3
6488779|NCT01355484|7407234|FG000|STARTED|Overall Study||160
6488780|NCT01355484|7407235|FG001|STARTED|Overall Study||161
6488781|NCT01355484|7407234|FG000|COMPLETED|Overall Study||109
6488782|NCT01355484|7407235|FG001|COMPLETED|Overall Study||107
6488783|NCT01355484|7407234|FG000|NOT COMPLETED|Overall Study||51
6488784|NCT01355484|7407235|FG001|NOT COMPLETED|Overall Study||54
6488785|NCT01355497|7407243|FG000|STARTED|Overall Study||165
6488786|NCT01355497|7407244|FG001|STARTED|Overall Study||165
6488787|NCT01355497|7407243|FG000|COMPLETED|Overall Study||99
6488788|NCT01355497|7407244|FG001|COMPLETED|Overall Study||102
6488789|NCT01355497|7407243|FG000|NOT COMPLETED|Overall Study||66
6488790|NCT01355497|7407244|FG001|NOT COMPLETED|Overall Study||63
6488791|NCT01355523|7407252|FG000|STARTED|Overall Study||28
6488792|NCT01355523|7407253|FG001|STARTED|Overall Study||26
6488793|NCT01355523|7407252|FG000|COMPLETED|Overall Study||27
6488794|NCT01355523|7407253|FG001|COMPLETED|Overall Study||16
6488795|NCT01355523|7407252|FG000|NOT COMPLETED|Overall Study||1
6488796|NCT01355523|7407253|FG001|NOT COMPLETED|Overall Study||10
6488797|NCT01355575|7407259|FG000|STARTED|Overall Study||15
6488798|NCT01355575|7407259|FG000|COMPLETED|Overall Study||13
6488799|NCT01355575|7407259|FG000|NOT COMPLETED|Overall Study||2
6488800|NCT01355588|7407271|FG000|STARTED|First Intervention (Day 1)||4
6488801|NCT01355588|7407272|FG001|STARTED|First Intervention (Day 1)||4
6488802|NCT01355588|7407273|FG002|STARTED|First Intervention (Day 1)||4
6488803|NCT01355588|7407274|FG003|STARTED|First Intervention (Day 1)||4
6488804|NCT01355588|7407271|FG000|COMPLETED|First Intervention (Day 1)||4
6488805|NCT01355588|7407272|FG001|COMPLETED|First Intervention (Day 1)||4
6488806|NCT01355588|7407273|FG002|COMPLETED|First Intervention (Day 1)||4
6488807|NCT01355588|7407274|FG003|COMPLETED|First Intervention (Day 1)||4
6488808|NCT01355588|7407271|FG000|NOT COMPLETED|First Intervention (Day 1)||0
6488809|NCT01355588|7407272|FG001|NOT COMPLETED|First Intervention (Day 1)||0
6488810|NCT01355588|7407273|FG002|NOT COMPLETED|First Intervention (Day 1)||0
6488811|NCT01355588|7407274|FG003|NOT COMPLETED|First Intervention (Day 1)||0
6488812|NCT01355588|7407271|FG000|STARTED|Washout (3-7 Days)||4
6488813|NCT01355588|7407272|FG001|STARTED|Washout (3-7 Days)||4
6488814|NCT01355588|7407273|FG002|STARTED|Washout (3-7 Days)||4
6488815|NCT01355588|7407274|FG003|STARTED|Washout (3-7 Days)||4
6488816|NCT01355588|7407271|FG000|COMPLETED|Washout (3-7 Days)||4
6488817|NCT01355588|7407272|FG001|COMPLETED|Washout (3-7 Days)||4
6488818|NCT01355588|7407273|FG002|COMPLETED|Washout (3-7 Days)||4
6488819|NCT01355588|7407274|FG003|COMPLETED|Washout (3-7 Days)||4
6488820|NCT01355588|7407271|FG000|NOT COMPLETED|Washout (3-7 Days)||0
6488821|NCT01355588|7407272|FG001|NOT COMPLETED|Washout (3-7 Days)||0
6488822|NCT01355588|7407273|FG002|NOT COMPLETED|Washout (3-7 Days)||0
6488823|NCT01355588|7407274|FG003|NOT COMPLETED|Washout (3-7 Days)||0
6488824|NCT01355588|7407271|FG000|STARTED|Second Intervention (After Washout)||4
6488825|NCT01355588|7407272|FG001|STARTED|Second Intervention (After Washout)||4
6488826|NCT01355588|7407273|FG002|STARTED|Second Intervention (After Washout)||4
6488827|NCT01355588|7407274|FG003|STARTED|Second Intervention (After Washout)||4
6488828|NCT01355588|7407271|FG000|COMPLETED|Second Intervention (After Washout)||4
6488829|NCT01355588|7407272|FG001|COMPLETED|Second Intervention (After Washout)||4
6748695|NCT03418324|7676830|FG000|STARTED|Overall Study||3
6748696|NCT03418324|7676831|FG001|STARTED|Overall Study||8
6488830|NCT01355588|7407273|FG002|COMPLETED|Second Intervention (After Washout)||4
6488831|NCT01355588|7407274|FG003|COMPLETED|Second Intervention (After Washout)||4
6488832|NCT01355588|7407271|FG000|NOT COMPLETED|Second Intervention (After Washout)||0
6488833|NCT01355588|7407272|FG001|NOT COMPLETED|Second Intervention (After Washout)||0
6488834|NCT01355588|7407273|FG002|NOT COMPLETED|Second Intervention (After Washout)||0
6488835|NCT01355588|7407274|FG003|NOT COMPLETED|Second Intervention (After Washout)||0
6488836|NCT01355588|7407271|FG000|STARTED|Washout (3-7 Days)||4
6488837|NCT01355588|7407272|FG001|STARTED|Washout (3-7 Days)||4
6488838|NCT01355588|7407273|FG002|STARTED|Washout (3-7 Days)||4
6488839|NCT01355588|7407274|FG003|STARTED|Washout (3-7 Days)||4
6488840|NCT01355588|7407271|FG000|COMPLETED|Washout (3-7 Days)||4
6488841|NCT01355588|7407272|FG001|COMPLETED|Washout (3-7 Days)||4
6488842|NCT01355588|7407273|FG002|COMPLETED|Washout (3-7 Days)||4
6488843|NCT01355588|7407274|FG003|COMPLETED|Washout (3-7 Days)||4
6488844|NCT01355588|7407271|FG000|NOT COMPLETED|Washout (3-7 Days)||0
6488845|NCT01355588|7407272|FG001|NOT COMPLETED|Washout (3-7 Days)||0
6488846|NCT01355588|7407273|FG002|NOT COMPLETED|Washout (3-7 Days)||0
6488847|NCT01355588|7407274|FG003|NOT COMPLETED|Washout (3-7 Days)||0
6488848|NCT01355588|7407271|FG000|STARTED|Third Intervention (After Washout)||4
6488849|NCT01355588|7407272|FG001|STARTED|Third Intervention (After Washout)||4
6488850|NCT01355588|7407273|FG002|STARTED|Third Intervention (After Washout)||4
6488851|NCT01355588|7407274|FG003|STARTED|Third Intervention (After Washout)||4
6488852|NCT01355588|7407271|FG000|COMPLETED|Third Intervention (After Washout)||4
6488853|NCT01355588|7407272|FG001|COMPLETED|Third Intervention (After Washout)||4
6488854|NCT01355588|7407273|FG002|COMPLETED|Third Intervention (After Washout)||4
6488855|NCT01355588|7407274|FG003|COMPLETED|Third Intervention (After Washout)||4
6488856|NCT01355588|7407271|FG000|NOT COMPLETED|Third Intervention (After Washout)||0
6488857|NCT01355588|7407272|FG001|NOT COMPLETED|Third Intervention (After Washout)||0
6488858|NCT01355588|7407273|FG002|NOT COMPLETED|Third Intervention (After Washout)||0
6488859|NCT01355588|7407274|FG003|NOT COMPLETED|Third Intervention (After Washout)||0
6488860|NCT01355588|7407271|FG000|STARTED|Washout (3-7 Days)||4
6488861|NCT01355588|7407272|FG001|STARTED|Washout (3-7 Days)||4
6488862|NCT01355588|7407273|FG002|STARTED|Washout (3-7 Days)||4
6488863|NCT01355588|7407274|FG003|STARTED|Washout (3-7 Days)||4
6488864|NCT01355588|7407271|FG000|COMPLETED|Washout (3-7 Days)||4
6488865|NCT01355588|7407272|FG001|COMPLETED|Washout (3-7 Days)||4
6488866|NCT01355588|7407273|FG002|COMPLETED|Washout (3-7 Days)||4
6488867|NCT01355588|7407274|FG003|COMPLETED|Washout (3-7 Days)||4
6488868|NCT01355588|7407271|FG000|NOT COMPLETED|Washout (3-7 Days)||0
6488869|NCT01355588|7407272|FG001|NOT COMPLETED|Washout (3-7 Days)||0
6488870|NCT01355588|7407273|FG002|NOT COMPLETED|Washout (3-7 Days)||0
6488871|NCT01355588|7407274|FG003|NOT COMPLETED|Washout (3-7 Days)||0
6488872|NCT01355588|7407271|FG000|STARTED|Fourth Intervention (After Washout)||4
6488873|NCT01355588|7407272|FG001|STARTED|Fourth Intervention (After Washout)||4
6488874|NCT01355588|7407273|FG002|STARTED|Fourth Intervention (After Washout)||4
6488875|NCT01355588|7407274|FG003|STARTED|Fourth Intervention (After Washout)||4
6488876|NCT01355588|7407271|FG000|COMPLETED|Fourth Intervention (After Washout)||4
6488877|NCT01355588|7407272|FG001|COMPLETED|Fourth Intervention (After Washout)||4
6488878|NCT01355588|7407273|FG002|COMPLETED|Fourth Intervention (After Washout)||4
6488879|NCT01355588|7407274|FG003|COMPLETED|Fourth Intervention (After Washout)||4
6488880|NCT01355588|7407271|FG000|NOT COMPLETED|Fourth Intervention (After Washout)||0
6488881|NCT01355588|7407272|FG001|NOT COMPLETED|Fourth Intervention (After Washout)||0
6488882|NCT01355588|7407273|FG002|NOT COMPLETED|Fourth Intervention (After Washout)||0
6488883|NCT01355588|7407274|FG003|NOT COMPLETED|Fourth Intervention (After Washout)||0
6488884|NCT01355627|7407286|FG000|STARTED|Overall Study||362
6488885|NCT01355627|7407287|FG001|STARTED|Overall Study||364
6488886|NCT01355627|7407286|FG000|Safety Analysis Set|Overall Study||362
6488887|NCT01355627|7407287|FG001|Safety Analysis Set|Overall Study||364
6488888|NCT01355627|7407286|FG000|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
6488889|NCT01355627|7407287|FG001|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
6488890|NCT01355627|7407286|FG000|COMPLETED|Overall Study||329
6488891|NCT01355627|7407287|FG001|COMPLETED|Overall Study||326
6488892|NCT01355627|7407286|FG000|NOT COMPLETED|Overall Study||33
6488893|NCT01355627|7407287|FG001|NOT COMPLETED|Overall Study||38
6488894|NCT01355705|7407293|FG000|STARTED|Overall Study||14
6488895|NCT01355705|7407293|FG000|COMPLETED|Overall Study||14
6488896|NCT01355705|7407293|FG000|NOT COMPLETED|Overall Study||0
6488897|NCT01355796|7407298|FG000|STARTED|Overall Study||15
6488898|NCT01355796|7407299|FG001|STARTED|Overall Study||15
6488899|NCT01355796|7407298|FG000|First Intervention for 14 Days|Overall Study||15
6488900|NCT01355796|7407299|FG001|First Intervention for 14 Days|Overall Study||15
6488901|NCT01355796|7407298|FG000|Washout Period for 7 Days|Overall Study||15
6488902|NCT01355796|7407299|FG001|Washout Period for 7 Days|Overall Study||15
6488903|NCT01355796|7407298|FG000|Second Intervention for 14 Days|Overall Study||15
6488904|NCT01355796|7407299|FG001|Second Intervention for 14 Days|Overall Study||15
6488905|NCT01355796|7407298|FG000|COMPLETED|Overall Study||15
6488906|NCT01355796|7407299|FG001|COMPLETED|Overall Study||15
6488907|NCT01355796|7407298|FG000|NOT COMPLETED|Overall Study||0
6488908|NCT01355796|7407299|FG001|NOT COMPLETED|Overall Study||0
6488909|NCT01355978|7407305|FG000|STARTED|Overall Study||22
6488910|NCT01355978|7407305|FG000|COMPLETED|Overall Study||18
6488911|NCT01355978|7407305|FG000|NOT COMPLETED|Overall Study||4
6488912|NCT01356147|7407311|FG000|STARTED|Overall Study||5
6488913|NCT01356147|7407312|FG001|STARTED|Overall Study||6
6488914|NCT01356147|7407311|FG000|COMPLETED|Overall Study||5
6488915|NCT01356147|7407312|FG001|COMPLETED|Overall Study||6
6488916|NCT01356147|7407311|FG000|NOT COMPLETED|Overall Study||0
6488917|NCT01356147|7407312|FG001|NOT COMPLETED|Overall Study||0
6488918|NCT01356277|7407320|FG000|STARTED|Run-in||81
6488919|NCT01356277|7407321|FG001|STARTED|Run-in||88
6488920|NCT01356277|7407320|FG000|COMPLETED|Run-in||76
6488921|NCT01356277|7407321|FG001|COMPLETED|Run-in||88
6488922|NCT01356277|7407320|FG000|NOT COMPLETED|Run-in||5
6488923|NCT01356277|7407321|FG001|NOT COMPLETED|Run-in||0
6488924|NCT01356277|7407320|FG000|STARTED|Intervention Interval||76
6488925|NCT01356277|7407321|FG001|STARTED|Intervention Interval||88
6488926|NCT01356277|7407320|FG000|COMPLETED|Intervention Interval||66
6488927|NCT01356277|7407321|FG001|COMPLETED|Intervention Interval||81
6488928|NCT01356277|7407320|FG000|NOT COMPLETED|Intervention Interval||10
6488929|NCT01356277|7407321|FG001|NOT COMPLETED|Intervention Interval||7
6488930|NCT01356407|7407331|FG000|STARTED|Overall Study||150
6488931|NCT01356407|7407332|FG001|STARTED|Overall Study||150
6488932|NCT01356407|7407331|FG000|COMPLETED|Overall Study||144
6488933|NCT01356407|7407332|FG001|COMPLETED|Overall Study||146
6488934|NCT01356407|7407331|FG000|NOT COMPLETED|Overall Study||6
6488935|NCT01356407|7407332|FG001|NOT COMPLETED|Overall Study||4
6488936|NCT01356498|7407344|FG000|STARTED|Overall Study||35
6488937|NCT01356498|7407345|FG001|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
6488938|NCT01356498|7407346|FG002|STARTED|Overall Study||23
6488939|NCT01356498|7407347|FG003|STARTED|Overall Study||22
6488940|NCT01356498|7407348|FG004|STARTED|Overall Study||28
6488941|NCT01356498|7407349|FG005|STARTED|Overall Study||16
6488942|NCT01356498|7407344|FG000|COMPLETED|Overall Study||24
6488943|NCT01356498|7407345|FG001|COMPLETED|Overall Study||17
6488944|NCT01356498|7407346|FG002|COMPLETED|Overall Study||11
6488945|NCT01356498|7407347|FG003|COMPLETED|Overall Study||8
6488946|NCT01356498|7407348|FG004|COMPLETED|Overall Study||8
6488947|NCT01356498|7407349|FG005|COMPLETED|Overall Study||2
6488948|NCT01356498|7407344|FG000|NOT COMPLETED|Overall Study||11
6488949|NCT01356498|7407345|FG001|NOT COMPLETED|Overall Study||8
6488950|NCT01356498|7407346|FG002|NOT COMPLETED|Overall Study||12
6488951|NCT01356498|7407347|FG003|NOT COMPLETED|Overall Study||14
6488952|NCT01356498|7407348|FG004|NOT COMPLETED|Overall Study||20
6488953|NCT01356498|7407349|FG005|NOT COMPLETED|Overall Study||14
6488954|NCT01356589|7407369|FG000|STARTED|Overall Study||1288
6488955|NCT01356589|7407369|FG000|Treated|Overall Study||1285
6488956|NCT01356589|7407369|FG000|COMPLETED|Overall Study||1283
6488957|NCT01356589|7407369|FG000|NOT COMPLETED|Overall Study||5
6488958|NCT01356602|7407376|FG000|STARTED|Overall Study||133
6488959|NCT01356602|7407377|FG001|STARTED|Overall Study||132
6488960|NCT01356602|7407378|FG002|STARTED|Overall Study||132
6488961|NCT01356602|7407376|FG000|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
6488962|NCT01356602|7407377|FG001|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
6488963|NCT01356602|7407378|FG002|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
6488964|NCT01356602|7407376|FG000|Full Analysis Set|Overall Study||131
6488965|NCT01356602|7407377|FG001|Full Analysis Set|Overall Study||129
6488966|NCT01356602|7407378|FG002|Full Analysis Set|Overall Study||129
6488967|NCT01356602|7407376|FG000|COMPLETED|Overall Study||124
6488968|NCT01356602|7407377|FG001|COMPLETED|Overall Study||117
6488969|NCT01356602|7407378|FG002|COMPLETED|Overall Study||108
6488970|NCT01356602|7407376|FG000|NOT COMPLETED|Overall Study||9
6488971|NCT01356602|7407377|FG001|NOT COMPLETED|Overall Study||15
6488972|NCT01356602|7407378|FG002|NOT COMPLETED|Overall Study||24
6488973|NCT01356628|7407386|FG000|STARTED|Overall Study||23
6488974|NCT01356628|7407386|FG000|COMPLETED|Overall Study||23
6488975|NCT01356628|7407386|FG000|NOT COMPLETED|Overall Study||0
6488976|NCT01356940|7407392|FG000|STARTED|First Intervention (28 Days)||22
6488977|NCT01356940|7407393|FG001|STARTED|First Intervention (28 Days)||21
6488978|NCT01356940|7407392|FG000|COMPLETED|First Intervention (28 Days)||21
6488979|NCT01356940|7407393|FG001|COMPLETED|First Intervention (28 Days)||21
6488980|NCT01356940|7407392|FG000|NOT COMPLETED|First Intervention (28 Days)||1
6488981|NCT01356940|7407393|FG001|NOT COMPLETED|First Intervention (28 Days)||0
6488982|NCT01356940|7407392|FG000|STARTED|Washout (14 Days)||21
6488983|NCT01356940|7407393|FG001|STARTED|Washout (14 Days)||21
6488984|NCT01356940|7407392|FG000|COMPLETED|Washout (14 Days)||21
6488985|NCT01356940|7407393|FG001|COMPLETED|Washout (14 Days)||21
6488986|NCT01356940|7407392|FG000|NOT COMPLETED|Washout (14 Days)||0
6488987|NCT01356940|7407393|FG001|NOT COMPLETED|Washout (14 Days)||0
6488988|NCT01356940|7407392|FG000|STARTED|Second Intervention (28 Days)||21
6488989|NCT01356940|7407393|FG001|STARTED|Second Intervention (28 Days)||21
6488990|NCT01356940|7407392|FG000|COMPLETED|Second Intervention (28 Days)||20
6488991|NCT01356940|7407393|FG001|COMPLETED|Second Intervention (28 Days)||21
6488992|NCT01356940|7407392|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
6488993|NCT01356940|7407393|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
6488994|NCT01356966|7407403|FG000|STARTED|Overall Study||18
6488995|NCT01356966|7407404|FG001|STARTED|Overall Study||14
6488996|NCT01356966|7407403|FG000|COMPLETED|Overall Study||16
6488997|NCT01356966|7407404|FG001|COMPLETED|Overall Study||12
6488998|NCT01356966|7407403|FG000|NOT COMPLETED|Overall Study||2
6488999|NCT01356966|7407404|FG001|NOT COMPLETED|Overall Study||2
6489000|NCT01357135|7407413|FG000|STARTED|Overall Study||1874
6489001|NCT01357135|7407414|FG001|STARTED|Overall Study||733
6489002|NCT01357135|7407415|FG002|STARTED|Overall Study||846
6489003|NCT01357135|7407413|FG000|COMPLETED|Overall Study||1276
6489004|NCT01357135|7407414|FG001|COMPLETED|Overall Study||510
6489005|NCT01357135|7407415|FG002|COMPLETED|Overall Study||583
6489006|NCT01357135|7407413|FG000|NOT COMPLETED|Overall Study||598
6489007|NCT01357135|7407414|FG001|NOT COMPLETED|Overall Study||223
6489008|NCT01357135|7407415|FG002|NOT COMPLETED|Overall Study||263
6489009|NCT01357148|7407422|FG000|STARTED|Overall Study||143
6489010|NCT01357148|7407422|FG000|COMPLETED|Overall Study||143
6489011|NCT01357148|7407422|FG000|NOT COMPLETED|Overall Study||0
6489012|NCT01357161|7407430|FG000|STARTED|Part 1 (Open Label Run-in)||15
6489013|NCT01357161|7407431|FG001|STARTED|Part 1 (Open Label Run-in)||0
6489014|NCT01357161|7407432|FG002|STARTED|Part 1 (Open Label Run-in)||0
6489015|NCT01357161|7407430|FG000|COMPLETED|Part 1 (Open Label Run-in)||0
6489016|NCT01357161|7407431|FG001|COMPLETED|Part 1 (Open Label Run-in)||0
6489017|NCT01357161|7407432|FG002|COMPLETED|Part 1 (Open Label Run-in)||0
6489018|NCT01357161|7407430|FG000|NOT COMPLETED|Part 1 (Open Label Run-in)||15
6489019|NCT01357161|7407431|FG001|NOT COMPLETED|Part 1 (Open Label Run-in)||0
6489020|NCT01357161|7407432|FG002|NOT COMPLETED|Part 1 (Open Label Run-in)||0
6489021|NCT01357161|7407430|FG000|STARTED|Part 2 (Double-Blind Comparison)||0
6489022|NCT01357161|7407431|FG001|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|59
6489023|NCT01357161|7407432|FG002|STARTED|Part 2 (Double-Blind Comparison)|New participants enrolled in Part 2.|62
6489024|NCT01357161|7407430|FG000|Treated|Part 2 (Double-Blind Comparison)||0
6489025|NCT01357161|7407431|FG001|Treated|Part 2 (Double-Blind Comparison)||59
6489026|NCT01357161|7407432|FG002|Treated|Part 2 (Double-Blind Comparison)||60
6489027|NCT01357161|7407430|FG000|COMPLETED|Part 2 (Double-Blind Comparison)||0
6489028|NCT01357161|7407431|FG001|COMPLETED|Part 2 (Double-Blind Comparison)||0
6489029|NCT01357161|7407432|FG002|COMPLETED|Part 2 (Double-Blind Comparison)||0
6489030|NCT01357161|7407430|FG000|NOT COMPLETED|Part 2 (Double-Blind Comparison)||0
6489031|NCT01357161|7407431|FG001|NOT COMPLETED|Part 2 (Double-Blind Comparison)||59
6489032|NCT01357161|7407432|FG002|NOT COMPLETED|Part 2 (Double-Blind Comparison)||62
6489033|NCT01357239|7407444|FG000|STARTED|Stratum: All Patients||31
6489034|NCT01357239|7407445|FG001|STARTED|Stratum: All Patients||27
6489035|NCT01357239|7407446|FG002|STARTED|Stratum: All Patients||39
6489036|NCT01357239|7407447|FG003|STARTED|Stratum: All Patients||42
6489037|NCT01357239|7407444|FG000|COMPLETED|Stratum: All Patients||31
6489038|NCT01357239|7407445|FG001|COMPLETED|Stratum: All Patients||27
6489039|NCT01357239|7407446|FG002|COMPLETED|Stratum: All Patients||37
6489040|NCT01357239|7407447|FG003|COMPLETED|Stratum: All Patients||40
6489041|NCT01357239|7407444|FG000|NOT COMPLETED|Stratum: All Patients||0
6489042|NCT01357239|7407445|FG001|NOT COMPLETED|Stratum: All Patients||0
6489043|NCT01357239|7407446|FG002|NOT COMPLETED|Stratum: All Patients||2
6489044|NCT01357239|7407447|FG003|NOT COMPLETED|Stratum: All Patients||2
6489045|NCT01357239|7407444|FG000|STARTED|Stratum I: Fully-Methylated||8
6489046|NCT01357239|7407445|FG001|STARTED|Stratum I: Fully-Methylated||6
6489047|NCT01357239|7407446|FG002|STARTED|Stratum I: Fully-Methylated||17
6489048|NCT01357239|7407447|FG003|STARTED|Stratum I: Fully-Methylated||22
6489049|NCT01357239|7407444|FG000|COMPLETED|Stratum I: Fully-Methylated||8
6489050|NCT01357239|7407445|FG001|COMPLETED|Stratum I: Fully-Methylated||6
6489051|NCT01357239|7407446|FG002|COMPLETED|Stratum I: Fully-Methylated||16
6489052|NCT01357239|7407447|FG003|COMPLETED|Stratum I: Fully-Methylated||22
6489053|NCT01357239|7407444|FG000|NOT COMPLETED|Stratum I: Fully-Methylated||0
6489054|NCT01357239|7407445|FG001|NOT COMPLETED|Stratum I: Fully-Methylated||0
6489055|NCT01357239|7407446|FG002|NOT COMPLETED|Stratum I: Fully-Methylated||1
6489056|NCT01357239|7407447|FG003|NOT COMPLETED|Stratum I: Fully-Methylated||0
6489057|NCT01357239|7407444|FG000|STARTED|Stratum II: Partially-Methylated||23
6489058|NCT01357239|7407445|FG001|STARTED|Stratum II: Partially-Methylated||21
6489059|NCT01357239|7407446|FG002|STARTED|Stratum II: Partially-Methylated||22
6489060|NCT01357239|7407447|FG003|STARTED|Stratum II: Partially-Methylated||20
6489061|NCT01357239|7407444|FG000|COMPLETED|Stratum II: Partially-Methylated||23
6489062|NCT01357239|7407445|FG001|COMPLETED|Stratum II: Partially-Methylated||21
6489063|NCT01357239|7407446|FG002|COMPLETED|Stratum II: Partially-Methylated||21
6489064|NCT01357239|7407447|FG003|COMPLETED|Stratum II: Partially-Methylated||18
6489065|NCT01357239|7407444|FG000|NOT COMPLETED|Stratum II: Partially-Methylated||0
6489066|NCT01357239|7407445|FG001|NOT COMPLETED|Stratum II: Partially-Methylated||0
6489067|NCT01357239|7407446|FG002|NOT COMPLETED|Stratum II: Partially-Methylated||1
6489068|NCT01357239|7407447|FG003|NOT COMPLETED|Stratum II: Partially-Methylated||2
6489069|NCT01357356|7407464|FG000|STARTED|Overall Study||188
6489070|NCT01357356|7407465|FG001|STARTED|Overall Study||188
6489071|NCT01357356|7407466|FG002|STARTED|Overall Study||186
6489072|NCT01357356|7407467|FG003|STARTED|Overall Study||188
6489073|NCT01357356|7407464|FG000|COMPLETED|Overall Study||166
6489074|NCT01357356|7407465|FG001|COMPLETED|Overall Study||163
6489075|NCT01357356|7407466|FG002|COMPLETED|Overall Study||158
6489076|NCT01357356|7407467|FG003|COMPLETED|Overall Study||171
6489077|NCT01357356|7407464|FG000|NOT COMPLETED|Overall Study||22
6489078|NCT01357356|7407465|FG001|NOT COMPLETED|Overall Study||25
6489079|NCT01357356|7407466|FG002|NOT COMPLETED|Overall Study||28
6489080|NCT01357356|7407467|FG003|NOT COMPLETED|Overall Study||17
6489081|NCT01357512|7407481|FG000|STARTED|Overall Study||65
6489082|NCT01357512|7407482|FG001|STARTED|Overall Study||65
6489083|NCT01357512|7407481|FG000|COMPLETED|Overall Study||53
6489084|NCT01357512|7407482|FG001|COMPLETED|Overall Study||60
6489085|NCT01357512|7407481|FG000|NOT COMPLETED|Overall Study||12
6489086|NCT01357512|7407482|FG001|NOT COMPLETED|Overall Study||5
6489087|NCT01357525|7407488|FG000|STARTED|Overall Study||50
6489088|NCT01357525|7407488|FG000|COMPLETED|Overall Study||49
6489089|NCT01357525|7407488|FG000|NOT COMPLETED|Overall Study||1
6489090|NCT01357551|7407494|FG000|STARTED|Overall Study||110
6489091|NCT01357551|7407495|FG001|STARTED|Overall Study||112
6489092|NCT01357551|7407494|FG000|COMPLETED|Overall Study||88
6489093|NCT01357551|7407495|FG001|COMPLETED|Overall Study||101
6489094|NCT01357551|7407494|FG000|NOT COMPLETED|Overall Study||22
6489095|NCT01357551|7407495|FG001|NOT COMPLETED|Overall Study||11
6489096|NCT01357564|7407506|FG000|STARTED|Short-term (4-month) Follow up||154
6489097|NCT01357564|7407507|FG001|STARTED|Short-term (4-month) Follow up||168
6489098|NCT01357564|7407506|FG000|COMPLETED|Short-term (4-month) Follow up||106
6489099|NCT01357564|7407507|FG001|COMPLETED|Short-term (4-month) Follow up||118
6489100|NCT01357564|7407506|FG000|NOT COMPLETED|Short-term (4-month) Follow up||48
6489101|NCT01357564|7407507|FG001|NOT COMPLETED|Short-term (4-month) Follow up||50
6489102|NCT01357564|7407506|FG000|STARTED|Long-term (8-month) Follow-up||106
6489103|NCT01357564|7407507|FG001|STARTED|Long-term (8-month) Follow-up||118
6489104|NCT01357564|7407506|FG000|COMPLETED|Long-term (8-month) Follow-up||104
6489105|NCT01357564|7407507|FG001|COMPLETED|Long-term (8-month) Follow-up||102
6489106|NCT01357564|7407506|FG000|NOT COMPLETED|Long-term (8-month) Follow-up||2
6489107|NCT01357564|7407507|FG001|NOT COMPLETED|Long-term (8-month) Follow-up||16
6489108|NCT01357577|7407517|FG000|STARTED|Overall Study||64
6489109|NCT01357577|7407518|FG001|STARTED|Overall Study||65
6489110|NCT01357577|7407517|FG000|Post-Treatment Assessment Completed|Overall Study||24
6489111|NCT01357577|7407518|FG001|Post-Treatment Assessment Completed|Overall Study||39
6489112|NCT01357577|7407517|FG000|COMPLETED|Overall Study||27
6489113|NCT01357577|7407518|FG001|COMPLETED|Overall Study||39
6489114|NCT01357577|7407517|FG000|NOT COMPLETED|Overall Study||37
6489115|NCT01357577|7407518|FG001|NOT COMPLETED|Overall Study||26
6489116|NCT01357616|7407527|FG000|STARTED|Overall Study||166
6489117|NCT01357616|7407528|FG001|STARTED|Overall Study||162
6489118|NCT01357616|7407527|FG000|COMPLETED|Overall Study||156
6489119|NCT01357616|7407528|FG001|COMPLETED|Overall Study||153
6489120|NCT01357616|7407527|FG000|NOT COMPLETED|Overall Study||10
6489121|NCT01357616|7407528|FG001|NOT COMPLETED|Overall Study||9
6489122|NCT01357655|7407536|FG000|STARTED|Overall Study||66
6489123|NCT01357655|7407537|FG001|STARTED|Overall Study||0
6489124|NCT01357655|7407536|FG000|COMPLETED|Overall Study||0
6489125|NCT01357655|7407537|FG001|COMPLETED|Overall Study||0
6489126|NCT01357655|7407536|FG000|NOT COMPLETED|Overall Study||66
6489127|NCT01357655|7407537|FG001|NOT COMPLETED|Overall Study||0
6489128|NCT01357720|7407544|FG000|STARTED|Overall Study||200
6489129|NCT01357720|7407545|FG001|STARTED|Overall Study||200
6489130|NCT01357720|7407544|FG000|COMPLETED|Overall Study||198
6489131|NCT01357720|7407545|FG001|COMPLETED|Overall Study||195
6489132|NCT01357720|7407544|FG000|NOT COMPLETED|Overall Study||2
6489133|NCT01357720|7407545|FG001|NOT COMPLETED|Overall Study||5
6489134|NCT01357850|7407555|FG000|STARTED|Overall Study||30
6489135|NCT01357850|7407556|FG001|STARTED|Overall Study||12
6489136|NCT01357850|7407557|FG002|STARTED|Overall Study||13
6489137|NCT01357850|7407558|FG003|STARTED|Overall Study||27
6489138|NCT01357850|7407555|FG000|COMPLETED|Overall Study||29
6489139|NCT01357850|7407556|FG001|COMPLETED|Overall Study||12
6489140|NCT01357850|7407557|FG002|COMPLETED|Overall Study||13
6489141|NCT01357850|7407558|FG003|COMPLETED|Overall Study||27
6489142|NCT01357850|7407555|FG000|NOT COMPLETED|Overall Study||1
6489143|NCT01357850|7407556|FG001|NOT COMPLETED|Overall Study||0
6489144|NCT01357850|7407557|FG002|NOT COMPLETED|Overall Study||0
6489145|NCT01357850|7407558|FG003|NOT COMPLETED|Overall Study||0
6489146|NCT01357889|7407571|FG000|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
6489147|NCT01357889|7407572|FG001|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
6489148|NCT01357889|7407571|FG000|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
6489149|NCT01357889|7407572|FG001|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
6489150|NCT01357889|7407571|FG000|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
6489151|NCT01357889|7407572|FG001|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
6489152|NCT01357889|7407571|FG000|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
6489153|NCT01357889|7407572|FG001|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
6489154|NCT01357889|7407571|FG000|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
6489155|NCT01357889|7407572|FG001|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
6489156|NCT01357889|7407571|FG000|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
6489157|NCT01357889|7407572|FG001|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
6489158|NCT01357889|7407571|FG000|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
6489159|NCT01357889|7407572|FG001|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
6489160|NCT01357889|7407571|FG000|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
6489161|NCT01357889|7407572|FG001|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
6489162|NCT01357889|7407571|FG000|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
6489163|NCT01357889|7407572|FG001|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
6489164|NCT01357915|7407582|FG000|STARTED|Overall Study||30
6489165|NCT01357915|7407583|FG001|STARTED|Overall Study||17
6748697|NCT03418324|7676830|FG000|COMPLETED|Overall Study||2
6748698|NCT03418324|7676831|FG001|COMPLETED|Overall Study||6
6748699|NCT03418324|7676830|FG000|NOT COMPLETED|Overall Study||1
6489166|NCT01357915|7407582|FG000|COMPLETED|Overall Study||27
6555096|NCT01750346|7477245|FG001|NOT COMPLETED|Overall Study||0
6555097|NCT01750346|7477246|FG002|NOT COMPLETED|Overall Study||0
6555098|NCT01750398|7477254|FG000|STARTED|ADT Lead In Phase||33
6489167|NCT01357915|7407583|FG001|COMPLETED|Overall Study||17
6489168|NCT01357915|7407582|FG000|NOT COMPLETED|Overall Study||3
6489169|NCT01357915|7407583|FG001|NOT COMPLETED|Overall Study||0
6489170|NCT01357980|7407593|FG000|STARTED|Overall Study||16
6489171|NCT01357980|7407594|FG001|STARTED|Overall Study||7
6489172|NCT01357980|7407595|FG002|STARTED|Overall Study||17
6489173|NCT01357980|7407596|FG003|STARTED|Overall Study||7
6489174|NCT01357980|7407593|FG000|COMPLETED|Overall Study||16
6489175|NCT01357980|7407594|FG001|COMPLETED|Overall Study||6
6489176|NCT01357980|7407595|FG002|COMPLETED|Overall Study||16
6489177|NCT01357980|7407596|FG003|COMPLETED|Overall Study||7
6489178|NCT01357980|7407593|FG000|NOT COMPLETED|Overall Study||0
6489179|NCT01357980|7407594|FG001|NOT COMPLETED|Overall Study||1
6489180|NCT01357980|7407595|FG002|NOT COMPLETED|Overall Study||1
6489181|NCT01357980|7407596|FG003|NOT COMPLETED|Overall Study||0
6489182|NCT01358175|7407609|FG000|STARTED|Overall Study||124
6489183|NCT01358175|7407610|FG001|STARTED|Overall Study||125
6489184|NCT01358175|7407611|FG002|STARTED|Overall Study||122
6489185|NCT01358175|7407609|FG000|COMPLETED|Overall Study||103
6489186|NCT01358175|7407610|FG001|COMPLETED|Overall Study||97
6489187|NCT01358175|7407611|FG002|COMPLETED|Overall Study||90
6489188|NCT01358175|7407609|FG000|NOT COMPLETED|Overall Study||21
6489189|NCT01358175|7407610|FG001|NOT COMPLETED|Overall Study||28
6489190|NCT01358175|7407611|FG002|NOT COMPLETED|Overall Study||32
6489191|NCT01358266|7407626|FG000|STARTED|Double-Masked Period||208
6489192|NCT01358266|7407627|FG001|STARTED|Double-Masked Period||208
6489193|NCT01358266|7407628|FG002|STARTED|Double-Masked Period||176
6489194|NCT01358266|7407626|FG000|COMPLETED|Double-Masked Period||175
6489195|NCT01358266|7407627|FG001|COMPLETED|Double-Masked Period||162
6489196|NCT01358266|7407628|FG002|COMPLETED|Double-Masked Period||137
6489197|NCT01358266|7407626|FG000|NOT COMPLETED|Double-Masked Period||33
6489198|NCT01358266|7407627|FG001|NOT COMPLETED|Double-Masked Period||46
6489199|NCT01358266|7407628|FG002|NOT COMPLETED|Double-Masked Period||39
6489200|NCT01358266|7407626|FG000|STARTED|Open-Label Period||119
6489201|NCT01358266|7407627|FG001|STARTED|Open-Label Period||102
6489202|NCT01358266|7407628|FG002|STARTED|Open-Label Period||114
6489203|NCT01358266|7407626|FG000|COMPLETED|Open-Label Period||63
6489204|NCT01358266|7407627|FG001|COMPLETED|Open-Label Period||58
6489205|NCT01358266|7407628|FG002|COMPLETED|Open-Label Period||44
6489206|NCT01358266|7407626|FG000|NOT COMPLETED|Open-Label Period||56
6489207|NCT01358266|7407627|FG001|NOT COMPLETED|Open-Label Period||44
6489208|NCT01358266|7407628|FG002|NOT COMPLETED|Open-Label Period||70
6489209|NCT01358331|7407643|FG000|STARTED|Overall Study||2
6489210|NCT01358331|7407644|FG001|STARTED|Overall Study||3
6489211|NCT01358331|7407645|FG002|STARTED|Overall Study||4
6489212|NCT01358331|7407646|FG003|STARTED|Overall Study||3
6489213|NCT01358331|7407647|FG004|STARTED|Overall Study||7
6489214|NCT01358331|7407648|FG005|STARTED|Overall Study||6
6489215|NCT01358331|7407643|FG000|COMPLETED|Overall Study||0
6489216|NCT01358331|7407644|FG001|COMPLETED|Overall Study||0
6489217|NCT01358331|7407645|FG002|COMPLETED|Overall Study||0
6489218|NCT01358331|7407646|FG003|COMPLETED|Overall Study||0
6489219|NCT01358331|7407647|FG004|COMPLETED|Overall Study||0
6489220|NCT01358331|7407648|FG005|COMPLETED|Overall Study||0
6489221|NCT01358331|7407643|FG000|NOT COMPLETED|Overall Study||2
6489222|NCT01358331|7407644|FG001|NOT COMPLETED|Overall Study||3
6489223|NCT01358331|7407645|FG002|NOT COMPLETED|Overall Study||4
6489224|NCT01358331|7407646|FG003|NOT COMPLETED|Overall Study||3
6489225|NCT01358331|7407647|FG004|NOT COMPLETED|Overall Study||7
6489226|NCT01358331|7407648|FG005|NOT COMPLETED|Overall Study||6
6555099|NCT01750398|7477254|FG000|COMPLETED|ADT Lead In Phase||29
6555100|NCT01750398|7477254|FG000|NOT COMPLETED|ADT Lead In Phase||4
6555101|NCT01750398|7477254|FG000|STARTED|Bipolar Androgen Thearpy Phase||29
6555102|NCT01750398|7477254|FG000|COMPLETED|Bipolar Androgen Thearpy Phase||26
6489227|NCT01358357|7407664|FG000|STARTED|Open Label Phase||0
6489228|NCT01358357|7407665|FG001|STARTED|Open Label Phase||0
6489229|NCT01358357|7407666|FG002|STARTED|Open Label Phase||965
6489230|NCT01358357|7407664|FG000|COMPLETED|Open Label Phase||0
6748700|NCT03418324|7676831|FG001|NOT COMPLETED|Overall Study||2
6489231|NCT01358357|7407665|FG001|COMPLETED|Open Label Phase||0
6489232|NCT01358357|7407666|FG002|COMPLETED|Open Label Phase||503
6489233|NCT01358357|7407664|FG000|NOT COMPLETED|Open Label Phase||0
6489234|NCT01358357|7407665|FG001|NOT COMPLETED|Open Label Phase||0
6489235|NCT01358357|7407666|FG002|NOT COMPLETED|Open Label Phase||462
6489236|NCT01358357|7407664|FG000|STARTED|Double-Blind Phase||246
6489237|NCT01358357|7407665|FG001|STARTED|Double-Blind Phase||250
6489238|NCT01358357|7407666|FG002|STARTED|Double-Blind Phase||0
6489239|NCT01358357|7407664|FG000|COMPLETED|Double-Blind Phase||166
6489240|NCT01358357|7407665|FG001|COMPLETED|Double-Blind Phase||150
6489241|NCT01358357|7407666|FG002|COMPLETED|Double-Blind Phase||0
6489242|NCT01358357|7407664|FG000|NOT COMPLETED|Double-Blind Phase||80
6489243|NCT01358357|7407665|FG001|NOT COMPLETED|Double-Blind Phase||100
6489244|NCT01358357|7407666|FG002|NOT COMPLETED|Double-Blind Phase||0
6489245|NCT01358526|7407675|FG000|STARTED|Open-label Titration Period||1095
6489246|NCT01358526|7407676|FG001|STARTED|Open-label Titration Period||0
6489247|NCT01358526|7407677|FG002|STARTED|Open-label Titration Period||0
6489248|NCT01358526|7407675|FG000|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
6489249|NCT01358526|7407676|FG001|COMPLETED|Open-label Titration Period||0
6489250|NCT01358526|7407677|FG002|COMPLETED|Open-label Titration Period||0
6748701|NCT03418376|7676841|FG000|STARTED|Overall Study||12
6748702|NCT03418376|7676842|FG001|STARTED|Overall Study||11
6748703|NCT03418376|7676843|FG002|STARTED|Overall Study||11
6748704|NCT03418376|7676844|FG003|STARTED|Overall Study||11
6748705|NCT03418376|7676841|FG000|COMPLETED|Overall Study||11
6748706|NCT03418376|7676842|FG001|COMPLETED|Overall Study||6
6748707|NCT03418376|7676843|FG002|COMPLETED|Overall Study||8
6748708|NCT03418376|7676844|FG003|COMPLETED|Overall Study||10
6748709|NCT03418376|7676841|FG000|NOT COMPLETED|Overall Study||1
6748710|NCT03418376|7676842|FG001|NOT COMPLETED|Overall Study||5
6748711|NCT03418376|7676843|FG002|NOT COMPLETED|Overall Study||3
6748712|NCT03418376|7676844|FG003|NOT COMPLETED|Overall Study||1
6748713|NCT03418545|7676856|FG000|STARTED|Overall Study||35
6748714|NCT03418545|7676857|FG001|STARTED|Overall Study||105
6748715|NCT03418545|7676856|FG000|Safety Population|Overall Study||34
6748716|NCT03418545|7676857|FG001|Safety Population|Overall Study||105
6748717|NCT03418545|7676856|FG000|Received Optional or Repeat Treatment|Overall Study||29
6748718|NCT03418545|7676857|FG001|Received Optional or Repeat Treatment|Overall Study||37
6748719|NCT03418545|7676856|FG000|COMPLETED|Overall Study||30
6748720|NCT03418545|7676857|FG001|COMPLETED|Overall Study||94
6748721|NCT03418545|7676856|FG000|NOT COMPLETED|Overall Study||5
6748722|NCT03418545|7676857|FG001|NOT COMPLETED|Overall Study||11
6748723|NCT03418571|7676868|FG000|STARTED|Overall Study||12
6748724|NCT03418571|7676869|FG001|STARTED|Overall Study||3
6748725|NCT03418571|7676868|FG000|COMPLETED|Overall Study||11
6748726|NCT03418571|7676869|FG001|COMPLETED|Overall Study||3
6748727|NCT03418571|7676868|FG000|NOT COMPLETED|Overall Study||1
6748728|NCT03418571|7676869|FG001|NOT COMPLETED|Overall Study||0
6748729|NCT03418662|7676877|FG000|STARTED|Overall Study||287
6748730|NCT03418662|7676878|FG001|STARTED|Overall Study||282
6748731|NCT03418662|7676877|FG000|COMPLETED|Overall Study||284
6748732|NCT03418662|7676878|FG001|COMPLETED|Overall Study||278
6748733|NCT03418662|7676877|FG000|NOT COMPLETED|Overall Study||3
6748734|NCT03418662|7676878|FG001|NOT COMPLETED|Overall Study||4
6748735|NCT03418714|7676884|FG000|STARTED|Overall Study||13
6748736|NCT03418714|7676884|FG000|COMPLETED|Overall Study|One participant moved too much during the practice session and was therefore excluded from the scan.|12
6748737|NCT03418714|7676884|FG000|NOT COMPLETED|Overall Study||1
6748738|NCT03419078|7676891|FG000|STARTED|Overall Study||245
6748739|NCT03419078|7676892|FG001|STARTED|Overall Study||148
6748740|NCT03419078|7676893|FG002|STARTED|Overall Study||91
6748741|NCT03419078|7676891|FG000|COMPLETED|Overall Study||245
6748742|NCT03419078|7676892|FG001|COMPLETED|Overall Study||148
6748743|NCT03419078|7676893|FG002|COMPLETED|Overall Study||91
6748744|NCT03419078|7676891|FG000|NOT COMPLETED|Overall Study||0
6748745|NCT03419078|7676892|FG001|NOT COMPLETED|Overall Study||0
6748746|NCT03419078|7676893|FG002|NOT COMPLETED|Overall Study||0
6748747|NCT03419403|7676904|FG000|STARTED|Overall Study||14
6748748|NCT03419403|7676905|FG001|STARTED|Overall Study||12
6748749|NCT03419403|7676906|FG002|STARTED|Overall Study||12
6748750|NCT03419403|7676907|FG003|STARTED|Overall Study||2
6748751|NCT03419403|7676904|FG000|COMPLETED|Overall Study||2
6748752|NCT03419403|7676905|FG001|COMPLETED|Overall Study||3
6748753|NCT03419403|7676906|FG002|COMPLETED|Overall Study||0
6748754|NCT03419403|7676907|FG003|COMPLETED|Overall Study||0
6748755|NCT03419403|7676904|FG000|NOT COMPLETED|Overall Study||12
6748756|NCT03419403|7676905|FG001|NOT COMPLETED|Overall Study||9
6748757|NCT03419403|7676906|FG002|NOT COMPLETED|Overall Study||12
6748758|NCT03419403|7676907|FG003|NOT COMPLETED|Overall Study||2
6748759|NCT03419533|7676917|FG000|STARTED|Overall Study||4107
6748760|NCT03419533|7676918|FG001|STARTED|Overall Study||2695
6748761|NCT03419533|7676917|FG000|COMPLETED|Overall Study||4107
6748762|NCT03419533|7676918|FG001|COMPLETED|Overall Study||2695
6748763|NCT03419533|7676917|FG000|NOT COMPLETED|Overall Study||0
6748764|NCT03419533|7676918|FG001|NOT COMPLETED|Overall Study||0
6748765|NCT03419598|7676932|FG000|STARTED|Overall Study||30
6748766|NCT03419598|7676932|FG000|Subject Specific Tibia Models Created and Virtual Osteotomy Performed|Overall Study||28
6748767|NCT03419598|7676932|FG000|Virtual Cohort Duplicated Into A. Personalised and B. Generic Copies|Overall Study||28
6489251|NCT01358526|7407675|FG000|NOT COMPLETED|Open-label Titration Period||494
6489252|NCT01358526|7407676|FG001|NOT COMPLETED|Open-label Titration Period||0
6489253|NCT01358526|7407677|FG002|NOT COMPLETED|Open-label Titration Period||0
6489254|NCT01358526|7407675|FG000|STARTED|Double-blind Phase||0
6555103|NCT01750398|7477254|FG000|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
6555104|NCT01750502|7477260|FG000|STARTED|Overall Study||70
6555105|NCT01750502|7477261|FG001|STARTED|Overall Study||186
6555106|NCT01750502|7477260|FG000|COMPLETED|Overall Study||70
6555107|NCT01750502|7477261|FG001|COMPLETED|Overall Study||186
6555108|NCT01750502|7477260|FG000|NOT COMPLETED|Overall Study||0
6489255|NCT01358526|7407676|FG001|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
6489256|NCT01358526|7407677|FG002|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
6489257|NCT01358526|7407675|FG000|COMPLETED|Double-blind Phase||0
6489258|NCT01358526|7407676|FG001|COMPLETED|Double-blind Phase||218
6489259|NCT01358526|7407677|FG002|COMPLETED|Double-blind Phase||181
6489260|NCT01358526|7407675|FG000|NOT COMPLETED|Double-blind Phase||0
6555109|NCT01750502|7477261|FG001|NOT COMPLETED|Overall Study||0
6555110|NCT01750684|7477274|FG000|STARTED|Overall Study||6
6555111|NCT01750684|7477275|FG001|STARTED|Overall Study||7
6555112|NCT01750684|7477274|FG000|COMPLETED|Overall Study||4
6555113|NCT01750684|7477275|FG001|COMPLETED|Overall Study||5
6555114|NCT01750684|7477274|FG000|NOT COMPLETED|Overall Study||2
6489261|NCT01358526|7407676|FG001|NOT COMPLETED|Double-blind Phase||80
6489262|NCT01358526|7407677|FG002|NOT COMPLETED|Double-blind Phase||121
6489263|NCT01358578|7407688|FG000|STARTED|Induction Period||327
6489264|NCT01358578|7407689|FG001|STARTED|Induction Period||327
6489265|NCT01358578|7407690|FG002|STARTED|Induction Period||326
6489266|NCT01358578|7407691|FG003|STARTED|Induction Period||326
6489267|NCT01358578|7407692|FG004|STARTED|Induction Period|These groups are populated after the induction period|0
6489268|NCT01358578|7407693|FG005|STARTED|Induction Period|These groups are populated after the induction period|0
6489269|NCT01358578|7407688|FG000|COMPLETED|Induction Period||315
6489270|NCT01358578|7407689|FG001|COMPLETED|Induction Period||312
6489271|NCT01358578|7407690|FG002|COMPLETED|Induction Period||301
6489272|NCT01358578|7407691|FG003|COMPLETED|Induction Period||305
6489273|NCT01358578|7407692|FG004|COMPLETED|Induction Period|These groups are populated after the induction period|0
6489274|NCT01358578|7407693|FG005|COMPLETED|Induction Period|These groups are populated after the induction period|0
6489275|NCT01358578|7407688|FG000|NOT COMPLETED|Induction Period||12
6489276|NCT01358578|7407689|FG001|NOT COMPLETED|Induction Period||15
6489277|NCT01358578|7407690|FG002|NOT COMPLETED|Induction Period||25
6489278|NCT01358578|7407691|FG003|NOT COMPLETED|Induction Period||21
6489279|NCT01358578|7407692|FG004|NOT COMPLETED|Induction Period||0
6489280|NCT01358578|7407693|FG005|NOT COMPLETED|Induction Period||0
6489281|NCT01358578|7407688|FG000|STARTED|Maintenance Period||315
6489282|NCT01358578|7407689|FG001|STARTED|Maintenance Period||312
6489283|NCT01358578|7407690|FG002|STARTED|Maintenance Period||17
6489284|NCT01358578|7407691|FG003|STARTED|Maintenance Period||305
6489285|NCT01358578|7407692|FG004|STARTED|Maintenance Period||142
6489286|NCT01358578|7407693|FG005|STARTED|Maintenance Period||142
6489287|NCT01358578|7407688|FG000|COMPLETED|Maintenance Period||276
6489288|NCT01358578|7407689|FG001|COMPLETED|Maintenance Period||290
6489289|NCT01358578|7407690|FG002|COMPLETED|Maintenance Period||15
6489290|NCT01358578|7407691|FG003|COMPLETED|Maintenance Period||263
6489291|NCT01358578|7407692|FG004|COMPLETED|Maintenance Period||125
6489292|NCT01358578|7407693|FG005|COMPLETED|Maintenance Period||131
6489293|NCT01358578|7407688|FG000|NOT COMPLETED|Maintenance Period||39
6489294|NCT01358578|7407689|FG001|NOT COMPLETED|Maintenance Period||22
6489295|NCT01358578|7407690|FG002|NOT COMPLETED|Maintenance Period||2
6489296|NCT01358578|7407691|FG003|NOT COMPLETED|Maintenance Period||42
6555115|NCT01750684|7477275|FG001|NOT COMPLETED|Overall Study||2
6555116|NCT01750697|7477282|FG000|STARTED|Overall Study||25
6555117|NCT01750697|7477282|FG000|Completed|Overall Study||25
6555118|NCT01750697|7477282|FG000|Follow-up Phase|Overall Study|Completed required follow-up|24
6489297|NCT01358578|7407692|FG004|NOT COMPLETED|Maintenance Period||17
6489298|NCT01358578|7407693|FG005|NOT COMPLETED|Maintenance Period||11
6489299|NCT01358578|7407688|FG000|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
6489300|NCT01358578|7407689|FG001|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
6489301|NCT01358578|7407690|FG002|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
6489302|NCT01358578|7407691|FG003|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
6489303|NCT01358578|7407692|FG004|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
6489304|NCT01358578|7407693|FG005|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
6489305|NCT01358578|7407688|FG000|COMPLETED|Follow-up Period||138
6489306|NCT01358578|7407689|FG001|COMPLETED|Follow-up Period||119
6489307|NCT01358578|7407690|FG002|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
6501755|NCT01431079|7420344|FG000|NOT COMPLETED|Overall Study||35
6555119|NCT01750697|7477282|FG000|COMPLETED|Overall Study|Completed to CCO. 6 participants entered Extended Safety Follow-up, 10 participants completed Study.|16
6555120|NCT01750697|7477282|FG000|NOT COMPLETED|Overall Study||9
6555121|NCT01750840|7477289|FG000|STARTED|Overall Study||8
6489308|NCT01358578|7407691|FG003|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
6489309|NCT01358578|7407692|FG004|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
6489310|NCT01358578|7407693|FG005|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
6489311|NCT01358578|7407688|FG000|NOT COMPLETED|Follow-up Period||10
6489312|NCT01358578|7407689|FG001|NOT COMPLETED|Follow-up Period||6
6489313|NCT01358578|7407690|FG002|NOT COMPLETED|Follow-up Period||5
6489314|NCT01358578|7407691|FG003|NOT COMPLETED|Follow-up Period||19
6489315|NCT01358578|7407692|FG004|NOT COMPLETED|Follow-up Period||0
6489316|NCT01358578|7407693|FG005|NOT COMPLETED|Follow-up Period||0
6489317|NCT01358708|7407723|FG000|STARTED|Double-Blind Treatment Phase||13
6489318|NCT01358708|7407724|FG001|STARTED|Double-Blind Treatment Phase||13
6489319|NCT01358708|7407723|FG000|Randomized|Double-Blind Treatment Phase||13
6489320|NCT01358708|7407724|FG001|Randomized|Double-Blind Treatment Phase||13
6489321|NCT01358708|7407723|FG000|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
6489322|NCT01358708|7407724|FG001|Received Study Medication|Double-Blind Treatment Phase||13
6489323|NCT01358708|7407723|FG000|COMPLETED|Double-Blind Treatment Phase||10
6489324|NCT01358708|7407724|FG001|COMPLETED|Double-Blind Treatment Phase||13
6489325|NCT01358708|7407723|FG000|NOT COMPLETED|Double-Blind Treatment Phase||3
6489326|NCT01358708|7407724|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
6489327|NCT01358708|7407723|FG000|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
6489328|NCT01358708|7407724|FG001|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
6489329|NCT01358708|7407723|FG000|COMPLETED|Open-Label Treatment Phase||5
6489330|NCT01358708|7407724|FG001|COMPLETED|Open-Label Treatment Phase||12
6489331|NCT01358708|7407723|FG000|NOT COMPLETED|Open-Label Treatment Phase||0
6489332|NCT01358708|7407724|FG001|NOT COMPLETED|Open-Label Treatment Phase||0
6489333|NCT01358721|7407738|FG000|STARTED|Overall Study||22
6489334|NCT01358721|7407739|FG001|STARTED|Overall Study||22
6489335|NCT01358721|7407740|FG002|STARTED|Overall Study||23
6489336|NCT01358721|7407741|FG003|STARTED|Overall Study||24
6489337|NCT01358721|7407738|FG000|COMPLETED|Overall Study||1
6489338|NCT01358721|7407739|FG001|COMPLETED|Overall Study||0
6489339|NCT01358721|7407740|FG002|COMPLETED|Overall Study||1
6489340|NCT01358721|7407741|FG003|COMPLETED|Overall Study||0
6489341|NCT01358721|7407738|FG000|NOT COMPLETED|Overall Study||21
6489342|NCT01358721|7407739|FG001|NOT COMPLETED|Overall Study||22
6489343|NCT01358721|7407740|FG002|NOT COMPLETED|Overall Study||22
6489344|NCT01358721|7407741|FG003|NOT COMPLETED|Overall Study||24
6489345|NCT01358734|7407754|FG000|STARTED|Overall Study||15
6489346|NCT01358734|7407755|FG001|STARTED|Overall Study||39
6489347|NCT01358734|7407756|FG002|STARTED|Overall Study||34
6489348|NCT01358734|7407754|FG000|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
6489349|NCT01358734|7407755|FG001|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
6489350|NCT01358734|7407756|FG002|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
6489351|NCT01358734|7407754|FG000|COMPLETED|Overall Study||0
6489352|NCT01358734|7407755|FG001|COMPLETED|Overall Study||0
6489353|NCT01358734|7407756|FG002|COMPLETED|Overall Study||0
6489354|NCT01358734|7407754|FG000|NOT COMPLETED|Overall Study||15
6489355|NCT01358734|7407755|FG001|NOT COMPLETED|Overall Study||39
6489356|NCT01358734|7407756|FG002|NOT COMPLETED|Overall Study||34
6489357|NCT01358760|7407767|FG000|STARTED|Overall Study||152
6489358|NCT01358760|7407768|FG001|STARTED|Overall Study||148
6489359|NCT01358760|7407769|FG002|STARTED|Overall Study||150
6489360|NCT01358760|7407767|FG000|Safety Population|Overall Study||150
6489361|NCT01358760|7407768|FG001|Safety Population|Overall Study||143
6489362|NCT01358760|7407769|FG002|Safety Population|Overall Study||148
6489363|NCT01358760|7407767|FG000|ITT Population|Overall Study||139
6489364|NCT01358760|7407768|FG001|ITT Population|Overall Study||134
6489365|NCT01358760|7407769|FG002|ITT Population|Overall Study||134
6489366|NCT01358760|7407767|FG000|COMPLETED|Overall Study||130
6489367|NCT01358760|7407768|FG001|COMPLETED|Overall Study||128
6489368|NCT01358760|7407769|FG002|COMPLETED|Overall Study||125
6489369|NCT01358760|7407767|FG000|NOT COMPLETED|Overall Study||22
6489370|NCT01358760|7407768|FG001|NOT COMPLETED|Overall Study||20
6489371|NCT01358760|7407769|FG002|NOT COMPLETED|Overall Study||25
6748768|NCT03419598|7676932|FG000|Finite Element (FE) Model Created for Cohort Copy Stabilised by Personalised HTO Plate|Overall Study||28
6489372|NCT01358825|7407779|FG000|STARTED|Overall Study||12
6489373|NCT01358825|7407780|FG001|STARTED|Overall Study||46
6489374|NCT01358825|7407779|FG000|COMPLETED|Overall Study||12
6489375|NCT01358825|7407780|FG001|COMPLETED|Overall Study||45
6489376|NCT01358825|7407779|FG000|NOT COMPLETED|Overall Study||0
6489377|NCT01358825|7407780|FG001|NOT COMPLETED|Overall Study||1
6489378|NCT01358864|7407794|FG000|STARTED|Overall Study||49
6489379|NCT01358864|7407795|FG001|STARTED|Overall Study||99
6489380|NCT01358864|7407796|FG002|STARTED|Overall Study||103
6489381|NCT01358864|7407797|FG003|STARTED|Overall Study||29
6489382|NCT01358864|7407798|FG004|STARTED|Overall Study||57
6489383|NCT01358864|7407799|FG005|STARTED|Overall Study||55
6489384|NCT01358864|7407800|FG006|STARTED|Overall Study||146
6489385|NCT01358864|7407801|FG007|STARTED|Overall Study||140
6489386|NCT01358864|7407794|FG000|COMPLETED|Overall Study||18
6489387|NCT01358864|7407795|FG001|COMPLETED|Overall Study||86
6489388|NCT01358864|7407796|FG002|COMPLETED|Overall Study||87
6489389|NCT01358864|7407797|FG003|COMPLETED|Overall Study||10
6489390|NCT01358864|7407798|FG004|COMPLETED|Overall Study||46
6489391|NCT01358864|7407799|FG005|COMPLETED|Overall Study||42
6654715|NCT02447575|7584629|FG000|STARTED|Overall Study|23 subjects were enrolled in the study: http://dx.doi.org/10.1016/j.chest.2016.08.017|23
6654716|NCT02447575|7584629|FG000|COMPLETED|Overall Study||23
6654717|NCT02447575|7584629|FG000|NOT COMPLETED|Overall Study||0
6654718|NCT02447718|7584635|FG000|STARTED|Overall Study||78
6654719|NCT02447718|7584636|FG001|STARTED|Overall Study||78
6654720|NCT02447718|7584635|FG000|Received Prevnar®13|Overall Study||74
6654721|NCT02447718|7584636|FG001|Received Prevnar®13|Overall Study|Do not receive vaccination|0
6489392|NCT01358864|7407800|FG006|COMPLETED|Overall Study||81
6489393|NCT01358864|7407801|FG007|COMPLETED|Overall Study||85
6489394|NCT01358864|7407794|FG000|NOT COMPLETED|Overall Study||31
6489395|NCT01358864|7407795|FG001|NOT COMPLETED|Overall Study||13
6489396|NCT01358864|7407796|FG002|NOT COMPLETED|Overall Study||16
6489397|NCT01358864|7407797|FG003|NOT COMPLETED|Overall Study||19
6489398|NCT01358864|7407798|FG004|NOT COMPLETED|Overall Study||11
6489399|NCT01358864|7407799|FG005|NOT COMPLETED|Overall Study||13
6489400|NCT01358864|7407800|FG006|NOT COMPLETED|Overall Study||65
6489401|NCT01358864|7407801|FG007|NOT COMPLETED|Overall Study||55
6489402|NCT01358968|7407821|FG000|STARTED|Period 1||20
6489403|NCT01358968|7407822|FG001|STARTED|Period 1||0
6489404|NCT01358968|7407823|FG002|STARTED|Period 1||0
6489405|NCT01358968|7407824|FG003|STARTED|Period 1||0
6489406|NCT01358968|7407821|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
6489407|NCT01358968|7407822|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
6489408|NCT01358968|7407823|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
6489409|NCT01358968|7407824|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
6489410|NCT01358968|7407821|FG000|COMPLETED|Period 1||20
6489411|NCT01358968|7407822|FG001|COMPLETED|Period 1||0
6489412|NCT01358968|7407823|FG002|COMPLETED|Period 1||0
6489413|NCT01358968|7407824|FG003|COMPLETED|Period 1||0
6489414|NCT01358968|7407821|FG000|NOT COMPLETED|Period 1||0
6489415|NCT01358968|7407822|FG001|NOT COMPLETED|Period 1||0
6489416|NCT01358968|7407823|FG002|NOT COMPLETED|Period 1||0
6489417|NCT01358968|7407824|FG003|NOT COMPLETED|Period 1||0
6489418|NCT01358968|7407821|FG000|STARTED|Period 2||0
6489419|NCT01358968|7407822|FG001|STARTED|Period 2||20
6489420|NCT01358968|7407823|FG002|STARTED|Period 2||0
6489421|NCT01358968|7407824|FG003|STARTED|Period 2||0
6489422|NCT01358968|7407821|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
6489423|NCT01358968|7407822|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
6489424|NCT01358968|7407823|FG002|Received at Least 1 Dose of Study Drug|Period 2||0
6489425|NCT01358968|7407824|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
6489426|NCT01358968|7407821|FG000|COMPLETED|Period 2||0
6489427|NCT01358968|7407822|FG001|COMPLETED|Period 2||19
6489428|NCT01358968|7407823|FG002|COMPLETED|Period 2||0
6489429|NCT01358968|7407824|FG003|COMPLETED|Period 2||0
6489430|NCT01358968|7407821|FG000|NOT COMPLETED|Period 2||0
6489431|NCT01358968|7407822|FG001|NOT COMPLETED|Period 2||1
6489432|NCT01358968|7407823|FG002|NOT COMPLETED|Period 2||0
6489433|NCT01358968|7407824|FG003|NOT COMPLETED|Period 2||0
6489434|NCT01358968|7407821|FG000|STARTED|Continued Access Phase||0
6489435|NCT01358968|7407822|FG001|STARTED|Continued Access Phase||0
6489436|NCT01358968|7407823|FG002|STARTED|Continued Access Phase||12
6489437|NCT01358968|7407824|FG003|STARTED|Continued Access Phase||7
6489438|NCT01358968|7407821|FG000|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
6489439|NCT01358968|7407822|FG001|Received at Least 1 Dose of Study Drug|Continued Access Phase||0
6489440|NCT01358968|7407823|FG002|Received at Least 1 Dose of Study Drug|Continued Access Phase||12
6489441|NCT01358968|7407824|FG003|Received at Least 1 Dose of Study Drug|Continued Access Phase||7
6489442|NCT01358968|7407821|FG000|COMPLETED|Continued Access Phase||0
6489443|NCT01358968|7407822|FG001|COMPLETED|Continued Access Phase||0
6489444|NCT01358968|7407823|FG002|COMPLETED|Continued Access Phase||0
6489445|NCT01358968|7407824|FG003|COMPLETED|Continued Access Phase||0
6489446|NCT01358968|7407821|FG000|NOT COMPLETED|Continued Access Phase||0
6489447|NCT01358968|7407822|FG001|NOT COMPLETED|Continued Access Phase||0
6489448|NCT01358968|7407823|FG002|NOT COMPLETED|Continued Access Phase||12
6489449|NCT01358968|7407824|FG003|NOT COMPLETED|Continued Access Phase||7
6489450|NCT01358981|7407841|FG000|STARTED|Period 1||2
6489451|NCT01358981|7407842|FG001|STARTED|Period 1||2
6489452|NCT01358981|7407843|FG002|STARTED|Period 1||2
6489453|NCT01358981|7407844|FG003|STARTED|Period 1||2
6489454|NCT01358981|7407845|FG004|STARTED|Period 1||3
6489455|NCT01358981|7407846|FG005|STARTED|Period 1||3
6489456|NCT01358981|7407847|FG006|STARTED|Period 1||3
6489457|NCT01358981|7407841|FG000|Received at Least 1dose of Study Drug|Period 1||2
6489458|NCT01358981|7407842|FG001|Received at Least 1dose of Study Drug|Period 1||2
6489459|NCT01358981|7407843|FG002|Received at Least 1dose of Study Drug|Period 1||2
6489460|NCT01358981|7407844|FG003|Received at Least 1dose of Study Drug|Period 1||2
6489461|NCT01358981|7407845|FG004|Received at Least 1dose of Study Drug|Period 1||3
6489462|NCT01358981|7407846|FG005|Received at Least 1dose of Study Drug|Period 1||3
6489463|NCT01358981|7407847|FG006|Received at Least 1dose of Study Drug|Period 1||3
6489464|NCT01358981|7407841|FG000|COMPLETED|Period 1||2
6489465|NCT01358981|7407842|FG001|COMPLETED|Period 1||2
6489466|NCT01358981|7407843|FG002|COMPLETED|Period 1||2
6489467|NCT01358981|7407844|FG003|COMPLETED|Period 1||1
6489468|NCT01358981|7407845|FG004|COMPLETED|Period 1||3
6489469|NCT01358981|7407846|FG005|COMPLETED|Period 1||3
6489470|NCT01358981|7407847|FG006|COMPLETED|Period 1||3
6489471|NCT01358981|7407841|FG000|NOT COMPLETED|Period 1||0
6489472|NCT01358981|7407842|FG001|NOT COMPLETED|Period 1||0
6489473|NCT01358981|7407843|FG002|NOT COMPLETED|Period 1||0
6489474|NCT01358981|7407844|FG003|NOT COMPLETED|Period 1||1
6489475|NCT01358981|7407845|FG004|NOT COMPLETED|Period 1||0
6489476|NCT01358981|7407846|FG005|NOT COMPLETED|Period 1||0
6489477|NCT01358981|7407847|FG006|NOT COMPLETED|Period 1||0
6489478|NCT01358981|7407841|FG000|STARTED|Period 2||2
6489479|NCT01358981|7407842|FG001|STARTED|Period 2||2
6489480|NCT01358981|7407843|FG002|STARTED|Period 2||2
6489481|NCT01358981|7407844|FG003|STARTED|Period 2|One participant who withdrew in period 1 was replaced by another participant in period 2.|2
6489482|NCT01358981|7407845|FG004|STARTED|Period 2||3
6489483|NCT01358981|7407846|FG005|STARTED|Period 2||3
6489484|NCT01358981|7407847|FG006|STARTED|Period 2||3
6489485|NCT01358981|7407841|FG000|COMPLETED|Period 2||2
6489486|NCT01358981|7407842|FG001|COMPLETED|Period 2||2
6489487|NCT01358981|7407843|FG002|COMPLETED|Period 2||2
6489488|NCT01358981|7407844|FG003|COMPLETED|Period 2||2
6489489|NCT01358981|7407845|FG004|COMPLETED|Period 2||3
6489490|NCT01358981|7407846|FG005|COMPLETED|Period 2||3
6489491|NCT01358981|7407847|FG006|COMPLETED|Period 2||3
6489492|NCT01358981|7407841|FG000|NOT COMPLETED|Period 2||0
6489493|NCT01358981|7407842|FG001|NOT COMPLETED|Period 2||0
6489494|NCT01358981|7407843|FG002|NOT COMPLETED|Period 2||0
6489495|NCT01358981|7407844|FG003|NOT COMPLETED|Period 2||0
6489496|NCT01358981|7407845|FG004|NOT COMPLETED|Period 2||0
6489497|NCT01358981|7407846|FG005|NOT COMPLETED|Period 2||0
6489498|NCT01358981|7407847|FG006|NOT COMPLETED|Period 2||0
6489499|NCT01358981|7407841|FG000|STARTED|Period 3||2
6489500|NCT01358981|7407842|FG001|STARTED|Period 3||2
6489501|NCT01358981|7407843|FG002|STARTED|Period 3||2
6489502|NCT01358981|7407844|FG003|STARTED|Period 3||2
6489503|NCT01358981|7407845|FG004|STARTED|Period 3||3
6489504|NCT01358981|7407846|FG005|STARTED|Period 3||3
6489505|NCT01358981|7407847|FG006|STARTED|Period 3||3
6489506|NCT01358981|7407841|FG000|COMPLETED|Period 3||2
6489507|NCT01358981|7407842|FG001|COMPLETED|Period 3||2
6489508|NCT01358981|7407843|FG002|COMPLETED|Period 3||2
6489509|NCT01358981|7407844|FG003|COMPLETED|Period 3||2
6489510|NCT01358981|7407845|FG004|COMPLETED|Period 3||3
6489511|NCT01358981|7407846|FG005|COMPLETED|Period 3||3
6489512|NCT01358981|7407847|FG006|COMPLETED|Period 3||3
6489513|NCT01358981|7407841|FG000|NOT COMPLETED|Period 3||0
6489514|NCT01358981|7407842|FG001|NOT COMPLETED|Period 3||0
6489515|NCT01358981|7407843|FG002|NOT COMPLETED|Period 3||0
6489516|NCT01358981|7407844|FG003|NOT COMPLETED|Period 3||0
6489517|NCT01358981|7407845|FG004|NOT COMPLETED|Period 3||0
6489518|NCT01358981|7407846|FG005|NOT COMPLETED|Period 3||0
6489519|NCT01358981|7407847|FG006|NOT COMPLETED|Period 3||0
6489520|NCT01358981|7407841|FG000|STARTED|Period 4||2
6489521|NCT01358981|7407842|FG001|STARTED|Period 4||2
6489522|NCT01358981|7407843|FG002|STARTED|Period 4||2
6489523|NCT01358981|7407844|FG003|STARTED|Period 4||2
6489524|NCT01358981|7407845|FG004|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
6489525|NCT01358981|7407846|FG005|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
6489526|NCT01358981|7407847|FG006|STARTED|Period 4|Part B was planned for only 3 dosing periods.|0
6489527|NCT01358981|7407841|FG000|COMPLETED|Period 4||2
6489528|NCT01358981|7407842|FG001|COMPLETED|Period 4||2
6489529|NCT01358981|7407843|FG002|COMPLETED|Period 4||2
6489530|NCT01358981|7407844|FG003|COMPLETED|Period 4||2
6489531|NCT01358981|7407845|FG004|COMPLETED|Period 4||0
6489532|NCT01358981|7407846|FG005|COMPLETED|Period 4||0
6489533|NCT01358981|7407847|FG006|COMPLETED|Period 4||0
6489534|NCT01358981|7407841|FG000|NOT COMPLETED|Period 4||0
6489535|NCT01358981|7407842|FG001|NOT COMPLETED|Period 4||0
6489536|NCT01358981|7407843|FG002|NOT COMPLETED|Period 4||0
6489537|NCT01358981|7407844|FG003|NOT COMPLETED|Period 4||0
6489538|NCT01358981|7407845|FG004|NOT COMPLETED|Period 4||0
6489539|NCT01358981|7407846|FG005|NOT COMPLETED|Period 4||0
6489540|NCT01358981|7407847|FG006|NOT COMPLETED|Period 4||0
6489541|NCT01359007|7407872|FG000|STARTED|Overall Study||5
6489542|NCT01359007|7407872|FG000|COMPLETED|Overall Study||3
6489543|NCT01359007|7407872|FG000|NOT COMPLETED|Overall Study||2
6489544|NCT01359046|7407879|FG000|STARTED|Overall Study||144
6489545|NCT01359046|7407880|FG001|STARTED|Overall Study||144
6489546|NCT01359046|7407879|FG000|COMPLETED|Overall Study||137
6489547|NCT01359046|7407880|FG001|COMPLETED|Overall Study||127
6489548|NCT01359046|7407879|FG000|NOT COMPLETED|Overall Study||7
6489549|NCT01359046|7407880|FG001|NOT COMPLETED|Overall Study||17
6489550|NCT01359111|7407886|FG000|STARTED|Overall Study||20
6489551|NCT01359111|7407886|FG000|COMPLETED|Overall Study||20
6489552|NCT01359111|7407886|FG000|NOT COMPLETED|Overall Study||0
6489553|NCT01359150|7407894|FG000|STARTED|Overall Study||112
6489554|NCT01359150|7407895|FG001|STARTED|Overall Study||111
6489555|NCT01359150|7407894|FG000|COMPLETED|Overall Study||105
6489556|NCT01359150|7407895|FG001|COMPLETED|Overall Study||106
6489557|NCT01359150|7407894|FG000|NOT COMPLETED|Overall Study||7
6489558|NCT01359150|7407895|FG001|NOT COMPLETED|Overall Study||5
6489559|NCT01359371|7407901|FG000|STARTED|Overall Study||131
6489560|NCT01359371|7407901|FG000|COMPLETED|Overall Study||131
6489561|NCT01359371|7407901|FG000|NOT COMPLETED|Overall Study||0
6489562|NCT01359410|7407912|FG000|STARTED|Overall Study||54
6489563|NCT01359410|7407913|FG001|STARTED|Overall Study||46
6489564|NCT01359410|7407912|FG000|COMPLETED|Overall Study||54
6489565|NCT01359410|7407913|FG001|COMPLETED|Overall Study||46
6489566|NCT01359410|7407912|FG000|NOT COMPLETED|Overall Study||0
6489567|NCT01359410|7407913|FG001|NOT COMPLETED|Overall Study||0
6489568|NCT01359449|7407921|FG000|STARTED|Overall Study||61
6489569|NCT01359449|7407922|FG001|STARTED|Overall Study||62
6489570|NCT01359449|7407921|FG000|COMPLETED|Overall Study||57
6489571|NCT01359449|7407922|FG001|COMPLETED|Overall Study||58
6489572|NCT01359449|7407921|FG000|NOT COMPLETED|Overall Study||4
6489573|NCT01359449|7407922|FG001|NOT COMPLETED|Overall Study||4
6489574|NCT01359592|7407928|FG000|STARTED|Initial Registration||158
6489575|NCT01359592|7407929|FG001|STARTED|Initial Registration||1
6489576|NCT01359592|7407930|FG002|STARTED|Initial Registration||0
6489577|NCT01359592|7407931|FG003|STARTED|Initial Registration||0
6489578|NCT01359592|7407928|FG000|Eligible and Evaluable|Initial Registration||132
6489579|NCT01359592|7407929|FG001|Eligible and Evaluable|Initial Registration||1
6489580|NCT01359592|7407930|FG002|Eligible and Evaluable|Initial Registration||0
6489581|NCT01359592|7407931|FG003|Eligible and Evaluable|Initial Registration||0
6489582|NCT01359592|7407928|FG000|COMPLETED|Initial Registration||129
6489583|NCT01359592|7407929|FG001|COMPLETED|Initial Registration||1
6489584|NCT01359592|7407930|FG002|COMPLETED|Initial Registration||0
6489585|NCT01359592|7407931|FG003|COMPLETED|Initial Registration||0
6489586|NCT01359592|7407928|FG000|NOT COMPLETED|Initial Registration||29
6489587|NCT01359592|7407929|FG001|NOT COMPLETED|Initial Registration||0
6489588|NCT01359592|7407930|FG002|NOT COMPLETED|Initial Registration||0
6489589|NCT01359592|7407931|FG003|NOT COMPLETED|Initial Registration||0
6489590|NCT01359592|7407928|FG000|STARTED|PET-Directed Therapy||0
6489591|NCT01359592|7407929|FG001|STARTED|PET-Directed Therapy||0
6489592|NCT01359592|7407930|FG002|STARTED|PET-Directed Therapy||137
6489593|NCT01359592|7407931|FG003|STARTED|PET-Directed Therapy||12
6489594|NCT01359592|7407928|FG000|Eligible and Evaluable|PET-Directed Therapy||0
6489595|NCT01359592|7407929|FG001|Eligible and Evaluable|PET-Directed Therapy||0
6489596|NCT01359592|7407930|FG002|Eligible and Evaluable|PET-Directed Therapy||113
6489597|NCT01359592|7407931|FG003|Eligible and Evaluable|PET-Directed Therapy||12
6489598|NCT01359592|7407928|FG000|COMPLETED|PET-Directed Therapy||0
6489599|NCT01359592|7407929|FG001|COMPLETED|PET-Directed Therapy||0
6489600|NCT01359592|7407930|FG002|COMPLETED|PET-Directed Therapy||111
6489601|NCT01359592|7407931|FG003|COMPLETED|PET-Directed Therapy||12
6489602|NCT01359592|7407928|FG000|NOT COMPLETED|PET-Directed Therapy||0
6489603|NCT01359592|7407929|FG001|NOT COMPLETED|PET-Directed Therapy||0
6489604|NCT01359592|7407930|FG002|NOT COMPLETED|PET-Directed Therapy||26
6489605|NCT01359592|7407931|FG003|NOT COMPLETED|PET-Directed Therapy||0
6489606|NCT01359644|7407956|FG000|STARTED|Treatment Period||15
6489607|NCT01359644|7407957|FG001|STARTED|Treatment Period||16
6489608|NCT01359644|7407958|FG002|STARTED|Treatment Period||14
6489609|NCT01359644|7407959|FG003|STARTED|Treatment Period||14
6489610|NCT01359644|7407960|FG004|STARTED|Treatment Period||15
6489611|NCT01359644|7407961|FG005|STARTED|Treatment Period||14
6489612|NCT01359644|7407962|FG006|STARTED|Treatment Period||41
6489613|NCT01359644|7407963|FG007|STARTED|Treatment Period||41
6489614|NCT01359644|7407964|FG008|STARTED|Treatment Period||21
6489615|NCT01359644|7407965|FG009|STARTED|Treatment Period||20
6489616|NCT01359644|7407956|FG000|COMPLETED|Treatment Period||15
6489617|NCT01359644|7407957|FG001|COMPLETED|Treatment Period||15
6489618|NCT01359644|7407958|FG002|COMPLETED|Treatment Period||13
6489619|NCT01359644|7407959|FG003|COMPLETED|Treatment Period||14
6489620|NCT01359644|7407960|FG004|COMPLETED|Treatment Period||15
6489621|NCT01359644|7407961|FG005|COMPLETED|Treatment Period||12
6489622|NCT01359644|7407962|FG006|COMPLETED|Treatment Period||41
6489623|NCT01359644|7407963|FG007|COMPLETED|Treatment Period||41
6489624|NCT01359644|7407964|FG008|COMPLETED|Treatment Period||21
6489625|NCT01359644|7407965|FG009|COMPLETED|Treatment Period||20
6489626|NCT01359644|7407956|FG000|NOT COMPLETED|Treatment Period||0
6489627|NCT01359644|7407957|FG001|NOT COMPLETED|Treatment Period||1
6489628|NCT01359644|7407958|FG002|NOT COMPLETED|Treatment Period||1
6489629|NCT01359644|7407959|FG003|NOT COMPLETED|Treatment Period||0
6489630|NCT01359644|7407960|FG004|NOT COMPLETED|Treatment Period||0
6489631|NCT01359644|7407961|FG005|NOT COMPLETED|Treatment Period||2
6489632|NCT01359644|7407962|FG006|NOT COMPLETED|Treatment Period||0
6489633|NCT01359644|7407963|FG007|NOT COMPLETED|Treatment Period||0
6489634|NCT01359644|7407964|FG008|NOT COMPLETED|Treatment Period||0
6489635|NCT01359644|7407965|FG009|NOT COMPLETED|Treatment Period||0
6489636|NCT01359644|7407956|FG000|STARTED|Follow-up Period||15
6489637|NCT01359644|7407957|FG001|STARTED|Follow-up Period||16
6489638|NCT01359644|7407958|FG002|STARTED|Follow-up Period||14
6489639|NCT01359644|7407959|FG003|STARTED|Follow-up Period||14
6489640|NCT01359644|7407960|FG004|STARTED|Follow-up Period||15
6489641|NCT01359644|7407961|FG005|STARTED|Follow-up Period||13
6489642|NCT01359644|7407962|FG006|STARTED|Follow-up Period||41
6489643|NCT01359644|7407963|FG007|STARTED|Follow-up Period||41
6489644|NCT01359644|7407964|FG008|STARTED|Follow-up Period||21
6489645|NCT01359644|7407965|FG009|STARTED|Follow-up Period||20
6489646|NCT01359644|7407956|FG000|COMPLETED|Follow-up Period||15
6489647|NCT01359644|7407957|FG001|COMPLETED|Follow-up Period||16
6489648|NCT01359644|7407958|FG002|COMPLETED|Follow-up Period||14
6489649|NCT01359644|7407959|FG003|COMPLETED|Follow-up Period||14
6489650|NCT01359644|7407960|FG004|COMPLETED|Follow-up Period||15
6489651|NCT01359644|7407961|FG005|COMPLETED|Follow-up Period||12
6489652|NCT01359644|7407962|FG006|COMPLETED|Follow-up Period||40
6489653|NCT01359644|7407963|FG007|COMPLETED|Follow-up Period||39
6489654|NCT01359644|7407964|FG008|COMPLETED|Follow-up Period||21
6489655|NCT01359644|7407965|FG009|COMPLETED|Follow-up Period||20
6489656|NCT01359644|7407956|FG000|NOT COMPLETED|Follow-up Period||0
6489657|NCT01359644|7407957|FG001|NOT COMPLETED|Follow-up Period||0
6489658|NCT01359644|7407958|FG002|NOT COMPLETED|Follow-up Period||0
6489659|NCT01359644|7407959|FG003|NOT COMPLETED|Follow-up Period||0
6489660|NCT01359644|7407960|FG004|NOT COMPLETED|Follow-up Period||0
6489661|NCT01359644|7407961|FG005|NOT COMPLETED|Follow-up Period||1
6489662|NCT01359644|7407962|FG006|NOT COMPLETED|Follow-up Period||1
6489663|NCT01359644|7407963|FG007|NOT COMPLETED|Follow-up Period||2
6489664|NCT01359644|7407964|FG008|NOT COMPLETED|Follow-up Period||0
6489665|NCT01359644|7407965|FG009|NOT COMPLETED|Follow-up Period||0
6489666|NCT01359735|7408000|FG000|STARTED|Overall Study||4
6489667|NCT01359735|7408001|FG001|STARTED|Overall Study||4
6489668|NCT01359735|7408000|FG000|COMPLETED|Overall Study||4
6489669|NCT01359735|7408001|FG001|COMPLETED|Overall Study||4
6489670|NCT01359735|7408000|FG000|NOT COMPLETED|Overall Study||0
6489671|NCT01359735|7408001|FG001|NOT COMPLETED|Overall Study||0
6489672|NCT01359748|7408011|FG000|STARTED|Overall Study||48
6489673|NCT01359748|7408012|FG001|STARTED|Overall Study||20
6489674|NCT01359748|7408013|FG002|STARTED|Overall Study||10
6489675|NCT01359748|7408014|FG003|STARTED|Overall Study||11
6489676|NCT01359748|7408011|FG000|COMPLETED|Overall Study||48
6489677|NCT01359748|7408012|FG001|COMPLETED|Overall Study||20
6489678|NCT01359748|7408013|FG002|COMPLETED|Overall Study||10
6489679|NCT01359748|7408014|FG003|COMPLETED|Overall Study||11
6489680|NCT01359748|7408011|FG000|NOT COMPLETED|Overall Study||0
6489681|NCT01359748|7408012|FG001|NOT COMPLETED|Overall Study||0
6489682|NCT01359748|7408013|FG002|NOT COMPLETED|Overall Study||0
6489683|NCT01359748|7408014|FG003|NOT COMPLETED|Overall Study||0
6489684|NCT01359904|7408024|FG000|STARTED|Overall Study||15
6489685|NCT01359904|7408025|FG001|STARTED|Overall Study||19
6489686|NCT01359904|7408024|FG000|COMPLETED|Overall Study||14
6489687|NCT01359904|7408025|FG001|COMPLETED|Overall Study||19
6489688|NCT01359904|7408024|FG000|NOT COMPLETED|Overall Study||1
6489689|NCT01359904|7408025|FG001|NOT COMPLETED|Overall Study||0
6489690|NCT01359943|7408034|FG000|STARTED|Double-blind (Weeks 0 - 16)||88
6489691|NCT01359943|7408035|FG001|STARTED|Double-blind (Weeks 0 - 16)||89
6489692|NCT01359943|7408036|FG002|STARTED|Double-blind (Weeks 0 - 16)||44
6489693|NCT01359943|7408034|FG000|COMPLETED|Double-blind (Weeks 0 - 16)||86
6489694|NCT01359943|7408035|FG001|COMPLETED|Double-blind (Weeks 0 - 16)||85
6489695|NCT01359943|7408036|FG002|COMPLETED|Double-blind (Weeks 0 - 16)||44
6748769|NCT03419598|7676932|FG000|FE Models Created for Cohort Copy Stabilised by Generic HTO Plate|Overall Study||28
6748770|NCT03419598|7676932|FG000|FE Models Solved for Personalised HTO Plate Stabilised Cohort Copy|Overall Study||28
6748771|NCT03419598|7676932|FG000|FE Models Solved for Generic HTO Plate Stabilised Cohort Copy|Overall Study||28
6748772|NCT03419598|7676932|FG000|COMPLETED|Overall Study||28
6748773|NCT03419598|7676932|FG000|NOT COMPLETED|Overall Study||2
6748774|NCT03419780|7676940|FG000|STARTED|Overall Study||33
6489696|NCT01359943|7408034|FG000|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
6489697|NCT01359943|7408035|FG001|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
6489698|NCT01359943|7408036|FG002|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
6489699|NCT01359943|7408034|FG000|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
6489700|NCT01359943|7408035|FG001|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
6489701|NCT01359943|7408036|FG002|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
6489702|NCT01359943|7408034|FG000|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
6489703|NCT01359943|7408035|FG001|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
6489704|NCT01359943|7408036|FG002|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
6489705|NCT01359943|7408034|FG000|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
6489706|NCT01359943|7408035|FG001|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
6489707|NCT01359943|7408036|FG002|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
6489708|NCT01359943|7408034|FG000|STARTED|Follow-up (Weeks 52 - 60)||86
6489709|NCT01359943|7408035|FG001|STARTED|Follow-up (Weeks 52 - 60)||84
6489710|NCT01359943|7408036|FG002|STARTED|Follow-up (Weeks 52 - 60)||44
6489711|NCT01359943|7408034|FG000|COMPLETED|Follow-up (Weeks 52 - 60)||78
6489712|NCT01359943|7408035|FG001|COMPLETED|Follow-up (Weeks 52 - 60)||69
6489713|NCT01359943|7408036|FG002|COMPLETED|Follow-up (Weeks 52 - 60)||36
6489714|NCT01359943|7408034|FG000|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
6555122|NCT01750840|7477289|FG000|COMPLETED|Overall Study||4
6555123|NCT01750840|7477289|FG000|NOT COMPLETED|Overall Study||4
6555124|NCT01750879|7477296|FG000|STARTED|Overall Study||30
6555125|NCT01750879|7477297|FG001|STARTED|Overall Study||11
6748775|NCT03419780|7676941|FG001|STARTED|Overall Study||33
6489715|NCT01359943|7408035|FG001|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
6489716|NCT01359943|7408036|FG002|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
6489717|NCT01359956|7408050|FG000|STARTED|Overall Study||67
6489718|NCT01359956|7408051|FG001|STARTED|Overall Study||69
6489719|NCT01359956|7408052|FG002|STARTED|Overall Study||71
6489720|NCT01359956|7408053|FG003|STARTED|Overall Study||62
6489721|NCT01359956|7408050|FG000|COMPLETED|Overall Study||6
6555126|NCT01750879|7477296|FG000|DBPCFC2|Overall Study||20
6555127|NCT01750879|7477297|FG001|DBPCFC2|Overall Study||8
6489722|NCT01359956|7408051|FG001|COMPLETED|Overall Study||5
6489723|NCT01359956|7408052|FG002|COMPLETED|Overall Study||4
6489724|NCT01359956|7408053|FG003|COMPLETED|Overall Study||4
6489725|NCT01359956|7408050|FG000|NOT COMPLETED|Overall Study||61
6489726|NCT01359956|7408051|FG001|NOT COMPLETED|Overall Study||64
6489727|NCT01359956|7408052|FG002|NOT COMPLETED|Overall Study||67
6489728|NCT01359956|7408053|FG003|NOT COMPLETED|Overall Study||58
6489729|NCT01360021|7408066|FG000|STARTED|Overall Study|Patients randomized|71
6489730|NCT01360021|7408067|FG001|STARTED|Overall Study|Patients randomized|71
6489731|NCT01360021|7408068|FG002|STARTED|Overall Study|Patients randomized|72
6489732|NCT01360021|7408066|FG000|COMPLETED|Overall Study|Patients who completed study|63
6489733|NCT01360021|7408067|FG001|COMPLETED|Overall Study|Patients who completed study|67
6489734|NCT01360021|7408068|FG002|COMPLETED|Overall Study|Patients who completed study|65
6489735|NCT01360021|7408066|FG000|NOT COMPLETED|Overall Study||8
6489736|NCT01360021|7408067|FG001|NOT COMPLETED|Overall Study||4
6489737|NCT01360021|7408068|FG002|NOT COMPLETED|Overall Study||7
6489738|NCT01360229|7408078|FG000|STARTED|Overall Study||47
6489739|NCT01360229|7408079|FG001|STARTED|Overall Study||47
6489740|NCT01360229|7408078|FG000|COMPLETED|Overall Study||44
6489741|NCT01360229|7408079|FG001|COMPLETED|Overall Study||45
6489742|NCT01360229|7408078|FG000|NOT COMPLETED|Overall Study||3
6489743|NCT01360229|7408079|FG001|NOT COMPLETED|Overall Study||2
6489744|NCT01360398|7408085|FG000|STARTED|Overall Study||127
6489745|NCT01360398|7408085|FG000|COMPLETED|Overall Study||105
6489746|NCT01360398|7408085|FG000|NOT COMPLETED|Overall Study||22
6489747|NCT01360450|7408091|FG000|STARTED|Overall Study||6
6489748|NCT01360450|7408092|FG001|STARTED|Overall Study||6
6489749|NCT01360450|7408091|FG000|Completed Treatment|Overall Study||6
6489750|NCT01360450|7408092|FG001|Completed Treatment|Overall Study||6
6489751|NCT01360450|7408091|FG000|COMPLETED|Overall Study||6
6489752|NCT01360450|7408092|FG001|COMPLETED|Overall Study||6
6489753|NCT01360450|7408091|FG000|NOT COMPLETED|Overall Study||0
6489754|NCT01360450|7408092|FG001|NOT COMPLETED|Overall Study||0
6489755|NCT01360554|7408101|FG000|STARTED|Overall Study|Three participants were randomized but not treated.|439
6489756|NCT01360554|7408102|FG001|STARTED|Overall Study|Three participants were randomized but not treated.|439
6489757|NCT01360554|7408101|FG000|Treated|Overall Study||436
6489758|NCT01360554|7408102|FG001|Treated|Overall Study||436
6489759|NCT01360554|7408101|FG000|COMPLETED|Overall Study||0
6489760|NCT01360554|7408102|FG001|COMPLETED|Overall Study||0
6489761|NCT01360554|7408101|FG000|NOT COMPLETED|Overall Study||439
6489762|NCT01360554|7408102|FG001|NOT COMPLETED|Overall Study||439
6489763|NCT01360632|7408111|FG000|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
6489764|NCT01360632|7408112|FG001|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
6489765|NCT01360632|7408113|FG002|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
6489766|NCT01360632|7408114|FG003|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
6489767|NCT01360632|7408115|FG004|STARTED|Phase A (8 Weeks)||0
6489768|NCT01360632|7408111|FG000|COMPLETED|Phase A (8 Weeks)||1277
6489769|NCT01360632|7408112|FG001|COMPLETED|Phase A (8 Weeks)||0
6489770|NCT01360632|7408113|FG002|COMPLETED|Phase A (8 Weeks)||0
6489771|NCT01360632|7408114|FG003|COMPLETED|Phase A (8 Weeks)||0
6489772|NCT01360632|7408115|FG004|COMPLETED|Phase A (8 Weeks)||0
6489773|NCT01360632|7408111|FG000|NOT COMPLETED|Phase A (8 Weeks)||255
6489774|NCT01360632|7408112|FG001|NOT COMPLETED|Phase A (8 Weeks)||0
6489775|NCT01360632|7408113|FG002|NOT COMPLETED|Phase A (8 Weeks)||0
6489776|NCT01360632|7408114|FG003|NOT COMPLETED|Phase A (8 Weeks)||0
6489777|NCT01360632|7408115|FG004|NOT COMPLETED|Phase A (8 Weeks)||0
6489778|NCT01360632|7408111|FG000|STARTED|Phase B (6 Weeks)||0
6489779|NCT01360632|7408112|FG001|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
6489780|NCT01360632|7408113|FG002|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
6489781|NCT01360632|7408114|FG003|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
6489782|NCT01360632|7408115|FG004|STARTED|Phase B (6 Weeks)||0
6555128|NCT01750879|7477296|FG000|DBPCFC3|Overall Study||20
6555129|NCT01750879|7477297|FG001|DBPCFC3|Overall Study||0
6555130|NCT01750879|7477296|FG000|COMPLETED|Overall Study||20
6555131|NCT01750879|7477297|FG001|COMPLETED|Overall Study||8
6748776|NCT03419780|7676940|FG000|COMPLETED|Overall Study||33
6748777|NCT03419780|7676941|FG001|COMPLETED|Overall Study||33
6748778|NCT03419780|7676940|FG000|NOT COMPLETED|Overall Study||0
6748779|NCT03419780|7676941|FG001|NOT COMPLETED|Overall Study||0
6748780|NCT03419962|7676947|FG000|STARTED|Overall Study||1359
6748781|NCT03419962|7676947|FG000|COMPLETED|Overall Study||1322
6305800|NCT00370682|7209194|FG000|STARTED|Overall Study||40
6305801|NCT00370682|7209195|FG001|STARTED|Overall Study||40
6305802|NCT00370682|7209196|FG002|STARTED|Overall Study||40
6305803|NCT00370682|7209194|FG000|COMPLETED|Overall Study||40
6305804|NCT00370682|7209195|FG001|COMPLETED|Overall Study||37
6305805|NCT00370682|7209196|FG002|COMPLETED|Overall Study||39
6748782|NCT03419962|7676947|FG000|NOT COMPLETED|Overall Study||37
6748783|NCT03420300|7676951|FG000|STARTED|Overall Study||40
6748784|NCT03420300|7676951|FG000|COMPLETED|Overall Study||38
6748785|NCT03420300|7676951|FG000|NOT COMPLETED|Overall Study||2
6748786|NCT03420625|7676955|FG000|STARTED|Overall Study||10
6305806|NCT00370682|7209194|FG000|NOT COMPLETED|Overall Study||0
6489783|NCT01360632|7408111|FG000|COMPLETED|Phase B (6 Weeks)||0
6555132|NCT01750879|7477296|FG000|NOT COMPLETED|Overall Study||10
6489784|NCT01360632|7408112|FG001|COMPLETED|Phase B (6 Weeks)||216
6489785|NCT01360632|7408113|FG002|COMPLETED|Phase B (6 Weeks)||210
6489786|NCT01360632|7408114|FG003|COMPLETED|Phase B (6 Weeks)||208
6489787|NCT01360632|7408115|FG004|COMPLETED|Phase B (6 Weeks)||0
6489788|NCT01360632|7408111|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
6489789|NCT01360632|7408112|FG001|NOT COMPLETED|Phase B (6 Weeks)||10
6489790|NCT01360632|7408113|FG002|NOT COMPLETED|Phase B (6 Weeks)||20
6489791|NCT01360632|7408114|FG003|NOT COMPLETED|Phase B (6 Weeks)||13
6489792|NCT01360632|7408115|FG004|NOT COMPLETED|Phase B (6 Weeks)||0
6489793|NCT01360632|7408111|FG000|STARTED|Phase A+||0
6489794|NCT01360632|7408112|FG001|STARTED|Phase A+||0
6489795|NCT01360632|7408113|FG002|STARTED|Phase A+||0
6489796|NCT01360632|7408114|FG003|STARTED|Phase A+||0
6489797|NCT01360632|7408115|FG004|STARTED|Phase A+||600
6489798|NCT01360632|7408111|FG000|COMPLETED|Phase A+||0
6489799|NCT01360632|7408112|FG001|COMPLETED|Phase A+||0
6489800|NCT01360632|7408113|FG002|COMPLETED|Phase A+||0
6489801|NCT01360632|7408114|FG003|COMPLETED|Phase A+||0
6489802|NCT01360632|7408115|FG004|COMPLETED|Phase A+||575
6489803|NCT01360632|7408111|FG000|NOT COMPLETED|Phase A+||0
6489804|NCT01360632|7408112|FG001|NOT COMPLETED|Phase A+||0
6489805|NCT01360632|7408113|FG002|NOT COMPLETED|Phase A+||0
6489806|NCT01360632|7408114|FG003|NOT COMPLETED|Phase A+||0
6489807|NCT01360632|7408115|FG004|NOT COMPLETED|Phase A+||25
6489808|NCT01360645|7408125|FG000|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
6489809|NCT01360645|7408126|FG001|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489810|NCT01360645|7408127|FG002|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489811|NCT01360645|7408128|FG003|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489812|NCT01360645|7408125|FG000|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
6489813|NCT01360645|7408126|FG001|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489814|NCT01360645|7408127|FG002|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489815|NCT01360645|7408128|FG003|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489816|NCT01360645|7408125|FG000|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
6489817|NCT01360645|7408126|FG001|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489818|NCT01360645|7408127|FG002|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489819|NCT01360645|7408128|FG003|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
6489820|NCT01360645|7408125|FG000|STARTED|Phase B (6 Weeks)||0
6489821|NCT01360645|7408126|FG001|STARTED|Phase B (6 Weeks)||188
6489822|NCT01360645|7408127|FG002|STARTED|Phase B (6 Weeks)||191
6489823|NCT01360645|7408128|FG003|STARTED|Phase B (6 Weeks)||0
6489824|NCT01360645|7408125|FG000|COMPLETED|Phase B (6 Weeks)||0
6489825|NCT01360645|7408126|FG001|COMPLETED|Phase B (6 Weeks)||174
6489826|NCT01360645|7408127|FG002|COMPLETED|Phase B (6 Weeks)||178
6489827|NCT01360645|7408128|FG003|COMPLETED|Phase B (6 Weeks)||0
6489828|NCT01360645|7408125|FG000|NOT COMPLETED|Phase B (6 Weeks)||0
6489829|NCT01360645|7408126|FG001|NOT COMPLETED|Phase B (6 Weeks)||14
6489830|NCT01360645|7408127|FG002|NOT COMPLETED|Phase B (6 Weeks)||13
6489831|NCT01360645|7408128|FG003|NOT COMPLETED|Phase B (6 Weeks)||0
6489832|NCT01360645|7408125|FG000|STARTED|Phase A+||0
6489833|NCT01360645|7408126|FG001|STARTED|Phase A+||0
6489834|NCT01360645|7408127|FG002|STARTED|Phase A+||0
6489835|NCT01360645|7408128|FG003|STARTED|Phase A+||331
6489836|NCT01360645|7408125|FG000|COMPLETED|Phase A+||0
6489837|NCT01360645|7408126|FG001|COMPLETED|Phase A+||0
6489838|NCT01360645|7408127|FG002|COMPLETED|Phase A+||0
6489839|NCT01360645|7408128|FG003|COMPLETED|Phase A+||307
6489840|NCT01360645|7408125|FG000|NOT COMPLETED|Phase A+||0
6489841|NCT01360645|7408126|FG001|NOT COMPLETED|Phase A+||0
6489842|NCT01360645|7408127|FG002|NOT COMPLETED|Phase A+||0
6489843|NCT01360645|7408128|FG003|NOT COMPLETED|Phase A+||24
6489844|NCT01360762|7408134|FG000|STARTED|Main Study Period (12-month Treatment)||74
6489845|NCT01360762|7408134|FG000|COMPLETED|Main Study Period (12-month Treatment)||45
6489846|NCT01360762|7408134|FG000|NOT COMPLETED|Main Study Period (12-month Treatment)||29
6489847|NCT01360762|7408134|FG000|STARTED|Whole Study Period||74
6489848|NCT01360762|7408134|FG000|COMPLETED|Whole Study Period||38
6489849|NCT01360762|7408134|FG000|NOT COMPLETED|Whole Study Period||36
6489850|NCT01360840|7408141|FG000|STARTED|Overall Study||60
6489851|NCT01360840|7408142|FG001|STARTED|Overall Study||60
6489852|NCT01360840|7408143|FG002|STARTED|Overall Study||60
6489853|NCT01360840|7408141|FG000|COMPLETED|Overall Study||50
6489854|NCT01360840|7408142|FG001|COMPLETED|Overall Study||50
6489855|NCT01360840|7408143|FG002|COMPLETED|Overall Study||51
6489856|NCT01360840|7408141|FG000|NOT COMPLETED|Overall Study||10
6489857|NCT01360840|7408142|FG001|NOT COMPLETED|Overall Study||10
6489858|NCT01360840|7408143|FG002|NOT COMPLETED|Overall Study||9
6489859|NCT01360866|7408157|FG000|STARTED|Overall Study||516
6489860|NCT01360866|7408158|FG001|STARTED|Overall Study||707
6489861|NCT01360866|7408159|FG002|STARTED|Overall Study||1645
6489862|NCT01360866|7408160|FG003|STARTED|Overall Study||76
6489863|NCT01360866|7408157|FG000|COMPLETED|Overall Study||295
6489864|NCT01360866|7408158|FG001|COMPLETED|Overall Study||420
6489865|NCT01360866|7408159|FG002|COMPLETED|Overall Study||1126
6489866|NCT01360866|7408160|FG003|COMPLETED|Overall Study||54
6489867|NCT01360866|7408157|FG000|NOT COMPLETED|Overall Study||221
6489868|NCT01360866|7408158|FG001|NOT COMPLETED|Overall Study||287
6489869|NCT01360866|7408159|FG002|NOT COMPLETED|Overall Study||519
6489870|NCT01360866|7408160|FG003|NOT COMPLETED|Overall Study||22
6489871|NCT01360996|7408173|FG000|STARTED|Overall Study||20
6489872|NCT01360996|7408174|FG001|STARTED|Overall Study||21
6489873|NCT01360996|7408175|FG002|STARTED|Overall Study||23
6489874|NCT01360996|7408173|FG000|COMPLETED|Overall Study||14
6489875|NCT01360996|7408174|FG001|COMPLETED|Overall Study||18
6489876|NCT01360996|7408175|FG002|COMPLETED|Overall Study||21
6489877|NCT01360996|7408173|FG000|NOT COMPLETED|Overall Study||6
6489878|NCT01360996|7408174|FG001|NOT COMPLETED|Overall Study||3
6489879|NCT01360996|7408175|FG002|NOT COMPLETED|Overall Study||2
6489880|NCT01361009|7408182|FG000|STARTED|Overall Study||2017
6489881|NCT01361009|7408182|FG000|COMPLETED|Overall Study||1901
6489882|NCT01361009|7408182|FG000|NOT COMPLETED|Overall Study||116
6489883|NCT01361048|7408189|FG000|STARTED|Overall Study||20
6489884|NCT01361048|7408190|FG001|STARTED|Overall Study||10
6489885|NCT01361048|7408191|FG002|STARTED|Overall Study||10
6489886|NCT01361048|7408189|FG000|COMPLETED|Overall Study||20
6489887|NCT01361048|7408190|FG001|COMPLETED|Overall Study||10
6489888|NCT01361048|7408191|FG002|COMPLETED|Overall Study||9
6489889|NCT01361048|7408189|FG000|NOT COMPLETED|Overall Study||0
6489890|NCT01361048|7408190|FG001|NOT COMPLETED|Overall Study||0
6489891|NCT01361048|7408191|FG002|NOT COMPLETED|Overall Study||1
6489892|NCT01361113|7408202|FG000|STARTED|Overall Study||21
6489893|NCT01361113|7408202|FG000|COMPLETED|Overall Study||21
6489894|NCT01361113|7408202|FG000|NOT COMPLETED|Overall Study||0
6489895|NCT01361126|7408210|FG000|STARTED|Overall Study||13
6489896|NCT01361126|7408211|FG001|STARTED|Overall Study||4
6489897|NCT01361126|7408210|FG000|COMPLETED|Overall Study||13
6489898|NCT01361126|7408211|FG001|COMPLETED|Overall Study||2
6489899|NCT01361126|7408210|FG000|NOT COMPLETED|Overall Study||0
6489900|NCT01361126|7408211|FG001|NOT COMPLETED|Overall Study||2
6489901|NCT01361178|7408220|FG000|STARTED|Overall Study||122
6489902|NCT01361178|7408221|FG001|STARTED|Overall Study||11
6489903|NCT01361178|7408220|FG000|COMPLETED|Overall Study||109
6489904|NCT01361178|7408221|FG001|COMPLETED|Overall Study||11
6489905|NCT01361178|7408220|FG000|NOT COMPLETED|Overall Study||13
6489906|NCT01361178|7408221|FG001|NOT COMPLETED|Overall Study||0
6489907|NCT01361217|7408227|FG000|STARTED|Overall Study||10
6489908|NCT01361217|7408227|FG000|COMPLETED|Overall Study||10
6489909|NCT01361217|7408227|FG000|NOT COMPLETED|Overall Study||0
6489910|NCT01361308|7408235|FG000|STARTED|Overall Study||306
6489911|NCT01361308|7408236|FG001|STARTED|Overall Study||308
6489912|NCT01361308|7408235|FG000|COMPLETED|Overall Study||271
6489913|NCT01361308|7408236|FG001|COMPLETED|Overall Study||278
6489914|NCT01361308|7408235|FG000|NOT COMPLETED|Overall Study||35
6489915|NCT01361308|7408236|FG001|NOT COMPLETED|Overall Study||30
6489916|NCT01361464|7408242|FG000|STARTED|Overall Study||21
6489917|NCT01361464|7408242|FG000|COMPLETED|Overall Study||18
6489918|NCT01361464|7408242|FG000|NOT COMPLETED|Overall Study||3
6489919|NCT01361568|7408252|FG000|STARTED|Overall Study||71
6489920|NCT01361568|7408253|FG001|STARTED|Overall Study||71
6489921|NCT01361568|7408254|FG002|STARTED|Overall Study||20
6489922|NCT01361568|7408255|FG003|STARTED|Overall Study||21
6489923|NCT01361568|7408256|FG004|STARTED|Overall Study||7
6489924|NCT01361568|7408257|FG005|STARTED|Overall Study||13
6489925|NCT01361568|7408252|FG000|COMPLETED|Overall Study||69
6489926|NCT01361568|7408253|FG001|COMPLETED|Overall Study||70
6489927|NCT01361568|7408254|FG002|COMPLETED|Overall Study||20
6489928|NCT01361568|7408255|FG003|COMPLETED|Overall Study||21
6489929|NCT01361568|7408256|FG004|COMPLETED|Overall Study||6
6489930|NCT01361568|7408257|FG005|COMPLETED|Overall Study||11
6489931|NCT01361568|7408252|FG000|NOT COMPLETED|Overall Study||2
6489932|NCT01361568|7408253|FG001|NOT COMPLETED|Overall Study||1
6489933|NCT01361568|7408254|FG002|NOT COMPLETED|Overall Study||0
6489934|NCT01361568|7408255|FG003|NOT COMPLETED|Overall Study||0
6489935|NCT01361568|7408256|FG004|NOT COMPLETED|Overall Study||1
6489936|NCT01361568|7408257|FG005|NOT COMPLETED|Overall Study||2
6489937|NCT01361594|7408274|FG000|STARTED|Overall Study||152
6489938|NCT01361594|7408275|FG001|STARTED|Overall Study||153
6489939|NCT01361594|7408274|FG000|COMPLETED|Overall Study||151
6489940|NCT01361594|7408275|FG001|COMPLETED|Overall Study||151
6489941|NCT01361594|7408274|FG000|NOT COMPLETED|Overall Study||1
6489942|NCT01361594|7408275|FG001|NOT COMPLETED|Overall Study||2
6489943|NCT01361607|7408283|FG000|STARTED|Overall Study|Two participants randomized to nabiximols did not receive any study drug|200
6489944|NCT01361607|7408284|FG001|STARTED|Overall Study||199
6489945|NCT01361607|7408283|FG000|Received at Least 1 Dose of Study Drug|Overall Study||198
6489946|NCT01361607|7408284|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
6489947|NCT01361607|7408283|FG000|Safety Population|Overall Study|One participant randomized to nabiximols received placebo Day 22 but analyzed as nabiximols-treated|199
6489948|NCT01361607|7408284|FG001|Safety Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as nabiximols-treated|198
6489949|NCT01361607|7408283|FG000|ITT Population|Overall Study||198
6489950|NCT01361607|7408284|FG001|ITT Population|Overall Study|One participant randomized to placebo received nabiximols Day 1 but analyzed as placebo-treated|199
6489951|NCT01361607|7408283|FG000|COMPLETED|Overall Study||136
6489952|NCT01361607|7408284|FG001|COMPLETED|Overall Study||158
6489953|NCT01361607|7408283|FG000|NOT COMPLETED|Overall Study||64
6489954|NCT01361607|7408284|FG001|NOT COMPLETED|Overall Study||41
6489955|NCT01361620|7408291|FG000|STARTED|Overall Study||132
6489956|NCT01361620|7408291|FG000|COMPLETED|Overall Study||132
6489957|NCT01361620|7408291|FG000|NOT COMPLETED|Overall Study||0
6489958|NCT01361633|7408297|FG000|STARTED|Overall Study||25
6489959|NCT01361633|7408298|FG001|STARTED|Overall Study||26
6489960|NCT01361633|7408297|FG000|COMPLETED|Overall Study||19
6489961|NCT01361633|7408298|FG001|COMPLETED|Overall Study||23
6489962|NCT01361633|7408297|FG000|NOT COMPLETED|Overall Study||6
6489963|NCT01361633|7408298|FG001|NOT COMPLETED|Overall Study||3
6489964|NCT01361711|7408306|FG000|STARTED|Trial Entry (Registration)||53
6489965|NCT01361711|7408306|FG000|Received Dose of Study Drug|Trial Entry (Registration)||52
6489966|NCT01361711|7408306|FG000|COMPLETED|Trial Entry (Registration)||52
6489967|NCT01361711|7408306|FG000|NOT COMPLETED|Trial Entry (Registration)||1
6489968|NCT01361711|7408306|FG000|STARTED|Week 9 Bone Marrow Response Assessment||52
6489969|NCT01361711|7408306|FG000|COMPLETED|Week 9 Bone Marrow Response Assessment||51
6489970|NCT01361711|7408306|FG000|NOT COMPLETED|Week 9 Bone Marrow Response Assessment||1
6489971|NCT01361711|7408306|FG000|STARTED|Continued Treatment After 9 Weeks||51
6489972|NCT01361711|7408306|FG000|COMPLETED|Continued Treatment After 9 Weeks||44
6489973|NCT01361711|7408306|FG000|NOT COMPLETED|Continued Treatment After 9 Weeks||7
6489974|NCT01361711|7408306|FG000|STARTED|Continued Treatment After 12 Weeks||44
6489975|NCT01361711|7408306|FG000|COMPLETED|Continued Treatment After 12 Weeks||41
6489976|NCT01361711|7408306|FG000|NOT COMPLETED|Continued Treatment After 12 Weeks||3
6489977|NCT01361711|7408306|FG000|STARTED|Completed Week 18 of Treatment||41
6489978|NCT01361711|7408306|FG000|COMPLETED|Completed Week 18 of Treatment||30
6489979|NCT01361711|7408306|FG000|NOT COMPLETED|Completed Week 18 of Treatment||11
6489980|NCT01361711|7408306|FG000|STARTED|10 Year Follow-up|All patients who receive at least one dose of study drug go into follow-up.|52
6489981|NCT01361711|7408306|FG000|COMPLETED|10 Year Follow-up||2
6489982|NCT01361711|7408306|FG000|NOT COMPLETED|10 Year Follow-up||50
6489983|NCT01361854|7408310|FG000|STARTED|Day 1||51
6489984|NCT01361854|7408311|FG001|STARTED|Day 1||51
6489985|NCT01361854|7408310|FG000|COMPLETED|Day 1||47
6489986|NCT01361854|7408311|FG001|COMPLETED|Day 1||48
6489987|NCT01361854|7408310|FG000|NOT COMPLETED|Day 1||4
6489988|NCT01361854|7408311|FG001|NOT COMPLETED|Day 1||3
6489989|NCT01361854|7408310|FG000|STARTED|Wash-out, Maximum 2 Weeks||47
6489990|NCT01361854|7408311|FG001|STARTED|Wash-out, Maximum 2 Weeks||48
6489991|NCT01361854|7408310|FG000|COMPLETED|Wash-out, Maximum 2 Weeks||47
6489992|NCT01361854|7408311|FG001|COMPLETED|Wash-out, Maximum 2 Weeks||48
6748787|NCT03420625|7676955|FG000|Baseline|Overall Study||10
6748788|NCT03420625|7676955|FG000|Foot IPC|Overall Study||10
6748789|NCT03420625|7676955|FG000|Rapid Calf IPC|Overall Study||10
6748790|NCT03420625|7676955|FG000|Slow Calf IPC|Overall Study||10
6748791|NCT03420625|7676955|FG000|Calf NMES|Overall Study||10
6748792|NCT03420625|7676955|FG000|COMPLETED|Overall Study||10
6748793|NCT03420625|7676955|FG000|NOT COMPLETED|Overall Study||0
6748794|NCT03421210|7676971|FG000|STARTED|Overall Study||88
6748795|NCT03421210|7676971|FG000|Received Functional Magnetic Resonance Imaging (fMRI)|Overall Study||42
6748796|NCT03421210|7676971|FG000|COMPLETED|Overall Study||35
6748797|NCT03421210|7676971|FG000|NOT COMPLETED|Overall Study||53
6748798|NCT03421379|7676977|FG000|STARTED|Period 1||34
6748799|NCT03421379|7676978|FG001|STARTED|Period 1||41
6748800|NCT03421379|7676977|FG000|Received at Least One Dose of Study Drug|Period 1||33
6489993|NCT01361854|7408310|FG000|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
6489994|NCT01361854|7408311|FG001|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
6489995|NCT01361854|7408310|FG000|STARTED|Second Intervention||47
6489996|NCT01361854|7408311|FG001|STARTED|Second Intervention||48
6489997|NCT01361854|7408310|FG000|COMPLETED|Second Intervention||47
6489998|NCT01361854|7408311|FG001|COMPLETED|Second Intervention||48
6489999|NCT01361854|7408310|FG000|NOT COMPLETED|Second Intervention||0
6490000|NCT01361854|7408311|FG001|NOT COMPLETED|Second Intervention||0
6490001|NCT01361867|7408317|FG000|STARTED|Overall Study||15
6490002|NCT01361867|7408317|FG000|COMPLETED|Overall Study||15
6490003|NCT01361867|7408317|FG000|NOT COMPLETED|Overall Study||0
6501756|NCT01431079|7420345|FG001|NOT COMPLETED|Overall Study||39
6501757|NCT01431105|7420375|FG000|STARTED|Overall Study||34
6501758|NCT01431105|7420375|FG000|COMPLETED|Overall Study||34
6501759|NCT01431105|7420375|FG000|NOT COMPLETED|Overall Study||0
6501760|NCT01431131|7420381|FG000|STARTED|Overall Study||12
6501761|NCT01431131|7420382|FG001|STARTED|Overall Study||12
6501762|NCT01431131|7420381|FG000|COMPLETED|Overall Study||12
6501763|NCT01431131|7420382|FG001|COMPLETED|Overall Study||12
6501764|NCT01431131|7420381|FG000|NOT COMPLETED|Overall Study||0
6501765|NCT01431131|7420382|FG001|NOT COMPLETED|Overall Study||0
6501766|NCT01431144|7420390|FG000|STARTED|Overall Study||13
6501767|NCT01431144|7420391|FG001|STARTED|Overall Study||14
6501768|NCT01431144|7420390|FG000|COMPLETED|Overall Study||11
6501769|NCT01431144|7420391|FG001|COMPLETED|Overall Study||14
6501770|NCT01431144|7420390|FG000|NOT COMPLETED|Overall Study||2
6501771|NCT01431144|7420391|FG001|NOT COMPLETED|Overall Study||0
6501772|NCT01431170|7420399|FG000|STARTED|Overall Study||12
6501773|NCT01431170|7420400|FG001|STARTED|Overall Study||12
6501774|NCT01431170|7420399|FG000|COMPLETED|Overall Study||9
6501775|NCT01431170|7420400|FG001|COMPLETED|Overall Study||11
6501776|NCT01431170|7420399|FG000|NOT COMPLETED|Overall Study||3
6748801|NCT03421379|7676978|FG001|Received at Least One Dose of Study Drug|Period 1||39
6748802|NCT03421379|7676977|FG000|COMPLETED|Period 1||32
6501777|NCT01431170|7420400|FG001|NOT COMPLETED|Overall Study||1
6501778|NCT01431209|7420418|FG000|STARTED|Overall Study||47
6501779|NCT01431209|7420419|FG001|STARTED|Overall Study||13
6501780|NCT01431209|7420418|FG000|COMPLETED|Overall Study||43
6501781|NCT01431209|7420419|FG001|COMPLETED|Overall Study||12
6501782|NCT01431209|7420418|FG000|NOT COMPLETED|Overall Study||4
6501783|NCT01431209|7420419|FG001|NOT COMPLETED|Overall Study||1
6490004|NCT01361919|7408324|FG000|STARTED|Overall Study||100
6490005|NCT01361919|7408325|FG001|STARTED|Overall Study||100
6490006|NCT01361919|7408326|FG002|STARTED|Overall Study||98
6490007|NCT01361919|7408324|FG000|COMPLETED|Overall Study||90
6490008|NCT01361919|7408325|FG001|COMPLETED|Overall Study||88
6490009|NCT01361919|7408326|FG002|COMPLETED|Overall Study||88
6490010|NCT01361919|7408324|FG000|NOT COMPLETED|Overall Study||10
6490011|NCT01361919|7408325|FG001|NOT COMPLETED|Overall Study||12
6490012|NCT01361919|7408326|FG002|NOT COMPLETED|Overall Study||10
6490013|NCT01362049|7408338|FG000|STARTED|Follow-Up at 7 Weeks||26
6490014|NCT01362049|7408339|FG001|STARTED|Follow-Up at 7 Weeks||19
6490015|NCT01362049|7408340|FG002|STARTED|Follow-Up at 7 Weeks||32
6490016|NCT01362049|7408341|FG003|STARTED|Follow-Up at 7 Weeks||25
6490017|NCT01362049|7408338|FG000|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
6490018|NCT01362049|7408339|FG001|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
6490019|NCT01362049|7408340|FG002|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
6490020|NCT01362049|7408341|FG003|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
6490021|NCT01362049|7408338|FG000|COMPLETED|Follow-Up at 7 Weeks||23
6490022|NCT01362049|7408339|FG001|COMPLETED|Follow-Up at 7 Weeks||16
6490023|NCT01362049|7408340|FG002|COMPLETED|Follow-Up at 7 Weeks||30
6490024|NCT01362049|7408341|FG003|COMPLETED|Follow-Up at 7 Weeks||24
6490025|NCT01362049|7408338|FG000|NOT COMPLETED|Follow-Up at 7 Weeks||3
6490026|NCT01362049|7408339|FG001|NOT COMPLETED|Follow-Up at 7 Weeks||3
6490027|NCT01362049|7408340|FG002|NOT COMPLETED|Follow-Up at 7 Weeks||2
6490028|NCT01362049|7408341|FG003|NOT COMPLETED|Follow-Up at 7 Weeks||1
6490029|NCT01362049|7408338|FG000|STARTED|Follow-Up at 52 Weeks (12 Months)||23
6490030|NCT01362049|7408339|FG001|STARTED|Follow-Up at 52 Weeks (12 Months)||16
6490031|NCT01362049|7408340|FG002|STARTED|Follow-Up at 52 Weeks (12 Months)||30
6490032|NCT01362049|7408341|FG003|STARTED|Follow-Up at 52 Weeks (12 Months)||24
6490033|NCT01362049|7408338|FG000|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
6490034|NCT01362049|7408339|FG001|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
6490035|NCT01362049|7408340|FG002|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
6490036|NCT01362049|7408341|FG003|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
6490037|NCT01362049|7408338|FG000|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
6490038|NCT01362049|7408339|FG001|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
6490039|NCT01362049|7408340|FG002|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
6490040|NCT01362049|7408341|FG003|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
6490041|NCT01362062|7408357|FG000|STARTED|Overall Study||48
6490042|NCT01362062|7408358|FG001|STARTED|Overall Study||62
6490043|NCT01362062|7408357|FG000|COMPLETED|Overall Study||22
6490044|NCT01362062|7408358|FG001|COMPLETED|Overall Study||62
6490045|NCT01362062|7408357|FG000|NOT COMPLETED|Overall Study||26
6490046|NCT01362062|7408358|FG001|NOT COMPLETED|Overall Study||0
6490047|NCT01362127|7408365|FG000|STARTED|Overall Study||90
6490048|NCT01362127|7408366|FG001|STARTED|Overall Study||91
6490049|NCT01362127|7408365|FG000|COMPLETED|Overall Study||90
6490050|NCT01362127|7408366|FG001|COMPLETED|Overall Study||91
6490051|NCT01362127|7408365|FG000|NOT COMPLETED|Overall Study||0
6490052|NCT01362127|7408366|FG001|NOT COMPLETED|Overall Study||0
6490053|NCT01362140|7408374|FG000|STARTED|Overall Study||49
6490054|NCT01362140|7408375|FG001|STARTED|Overall Study||98
6490055|NCT01362140|7408374|FG000|Received Treatment|Overall Study||49
6490056|NCT01362140|7408375|FG001|Received Treatment|Overall Study||97
6490057|NCT01362140|7408374|FG000|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
6490058|NCT01362140|7408375|FG001|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
6490059|NCT01362140|7408374|FG000|NOT COMPLETED|Overall Study||10
6490060|NCT01362140|7408375|FG001|NOT COMPLETED|Overall Study||11
6490061|NCT01362192|7408381|FG000|STARTED|Overall Study||20
6490062|NCT01362192|7408381|FG000|COMPLETED|Overall Study||16
6490063|NCT01362192|7408381|FG000|NOT COMPLETED|Overall Study||4
6490064|NCT01362205|7408387|FG000|STARTED|Overall Study||22
6490065|NCT01362205|7408388|FG001|STARTED|Overall Study||27
6490066|NCT01362205|7408387|FG000|COMPLETED|Overall Study||22
6490067|NCT01362205|7408388|FG001|COMPLETED|Overall Study||27
6490068|NCT01362205|7408387|FG000|NOT COMPLETED|Overall Study||0
6490069|NCT01362205|7408388|FG001|NOT COMPLETED|Overall Study||0
6490070|NCT01362244|7408396|FG000|STARTED|Overall Study||54
6490071|NCT01362244|7408397|FG001|STARTED|Overall Study||51
6490072|NCT01362244|7408396|FG000|COMPLETED|Overall Study||22
6490073|NCT01362244|7408397|FG001|COMPLETED|Overall Study||19
6490074|NCT01362244|7408396|FG000|NOT COMPLETED|Overall Study||32
6490075|NCT01362244|7408397|FG001|NOT COMPLETED|Overall Study||32
6490076|NCT01362270|7408405|FG000|STARTED|Overall Study||7
6490077|NCT01362270|7408406|FG001|STARTED|Overall Study||8
6490078|NCT01362270|7408405|FG000|COMPLETED|Overall Study||5
6490079|NCT01362270|7408406|FG001|COMPLETED|Overall Study||6
6490080|NCT01362270|7408405|FG000|NOT COMPLETED|Overall Study||2
6490081|NCT01362270|7408406|FG001|NOT COMPLETED|Overall Study||2
6490082|NCT01362296|7408414|FG000|STARTED|Randomized Phase (RP)||87
6490083|NCT01362296|7408415|FG001|STARTED|Randomized Phase (RP)||43
6490084|NCT01362296|7408416|FG002|STARTED|Randomized Phase (RP)||0
6490085|NCT01362296|7408417|FG003|STARTED|Randomized Phase (RP)||0
6490086|NCT01362296|7408414|FG000|COMPLETED|Randomized Phase (RP)||0
6490087|NCT01362296|7408415|FG001|COMPLETED|Randomized Phase (RP)||0
6490088|NCT01362296|7408416|FG002|COMPLETED|Randomized Phase (RP)||0
6490089|NCT01362296|7408417|FG003|COMPLETED|Randomized Phase (RP)||0
6490090|NCT01362296|7408414|FG000|NOT COMPLETED|Randomized Phase (RP)||87
6490091|NCT01362296|7408415|FG001|NOT COMPLETED|Randomized Phase (RP)||43
6490092|NCT01362296|7408416|FG002|NOT COMPLETED|Randomized Phase (RP)||0
6490093|NCT01362296|7408417|FG003|NOT COMPLETED|Randomized Phase (RP)||0
6490094|NCT01362296|7408414|FG000|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
6490095|NCT01362296|7408415|FG001|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
6490096|NCT01362296|7408416|FG002|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
6490097|NCT01362296|7408417|FG003|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
6490098|NCT01362296|7408414|FG000|COMPLETED|Crossover Phase||0
6490099|NCT01362296|7408415|FG001|COMPLETED|Crossover Phase||0
6490100|NCT01362296|7408416|FG002|COMPLETED|Crossover Phase||0
6490101|NCT01362296|7408417|FG003|COMPLETED|Crossover Phase||0
6490102|NCT01362296|7408414|FG000|NOT COMPLETED|Crossover Phase||0
6490103|NCT01362296|7408415|FG001|NOT COMPLETED|Crossover Phase||0
6490104|NCT01362296|7408416|FG002|NOT COMPLETED|Crossover Phase||23
6490105|NCT01362296|7408417|FG003|NOT COMPLETED|Crossover Phase||2
6490106|NCT01362322|7408429|FG000|STARTED|Overall Study||335
6490107|NCT01362322|7408430|FG001|STARTED|Overall Study||336
6490108|NCT01362322|7408429|FG000|COMPLETED|Overall Study||330
6490109|NCT01362322|7408430|FG001|COMPLETED|Overall Study||329
6490110|NCT01362322|7408429|FG000|NOT COMPLETED|Overall Study||5
6490111|NCT01362322|7408430|FG001|NOT COMPLETED|Overall Study||7
6490112|NCT01362348|7408436|FG000|STARTED|Overall Study||19
6490113|NCT01362348|7408436|FG000|COMPLETED|Overall Study||5
6490114|NCT01362348|7408436|FG000|NOT COMPLETED|Overall Study||14
6490115|NCT01362439|7408440|FG000|STARTED|Overall Study||133
6490116|NCT01362439|7408440|FG000|COMPLETED|Overall Study||118
6490117|NCT01362439|7408440|FG000|NOT COMPLETED|Overall Study||15
6490118|NCT01362491|7408448|FG000|STARTED|Overall Study||91
6490119|NCT01362491|7408449|FG001|STARTED|Overall Study||89
6490120|NCT01362491|7408450|FG002|STARTED|Overall Study||46
6490121|NCT01362491|7408448|FG000|COMPLETED|Overall Study||90
6490122|NCT01362491|7408449|FG001|COMPLETED|Overall Study||89
6490123|NCT01362491|7408450|FG002|COMPLETED|Overall Study||46
6490124|NCT01362491|7408448|FG000|NOT COMPLETED|Overall Study||1
6490125|NCT01362491|7408449|FG001|NOT COMPLETED|Overall Study||0
6490126|NCT01362491|7408450|FG002|NOT COMPLETED|Overall Study||0
6490127|NCT01362517|7408459|FG000|STARTED|Overall Study||131
6490128|NCT01362517|7408459|FG000|COMPLETED|Overall Study||129
6490129|NCT01362517|7408459|FG000|NOT COMPLETED|Overall Study||2
6490130|NCT01362530|7408468|FG000|STARTED|Base Study (Cycle 1)||155
6490131|NCT01362530|7408469|FG001|STARTED|Base Study (Cycle 1)||152
6490132|NCT01362530|7408468|FG000|Received Study Treatment|Base Study (Cycle 1)||152
6490133|NCT01362530|7408469|FG001|Received Study Treatment|Base Study (Cycle 1)||150
6490134|NCT01362530|7408468|FG000|COMPLETED|Base Study (Cycle 1)||150
6490135|NCT01362530|7408469|FG001|COMPLETED|Base Study (Cycle 1)||149
6490136|NCT01362530|7408468|FG000|NOT COMPLETED|Base Study (Cycle 1)||5
6490137|NCT01362530|7408469|FG001|NOT COMPLETED|Base Study (Cycle 1)||3
6490138|NCT01362530|7408468|FG000|STARTED|Optional Extension (Cycles 2-6)||171
6490139|NCT01362530|7408469|FG001|STARTED|Optional Extension (Cycles 2-6)||0
6490140|NCT01362530|7408468|FG000|COMPLETED|Optional Extension (Cycles 2-6)||46
6490141|NCT01362530|7408469|FG001|COMPLETED|Optional Extension (Cycles 2-6)||0
6490142|NCT01362530|7408468|FG000|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
6490143|NCT01362530|7408469|FG001|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
6490144|NCT01362608|7408478|FG000|STARTED|Overall Study||67
6490145|NCT01362608|7408479|FG001|STARTED|Overall Study||69
6490146|NCT01362608|7408478|FG000|COMPLETED|Overall Study||63
6490147|NCT01362608|7408479|FG001|COMPLETED|Overall Study||61
6490148|NCT01362608|7408478|FG000|NOT COMPLETED|Overall Study||4
6490149|NCT01362608|7408479|FG001|NOT COMPLETED|Overall Study||8
6490150|NCT01362686|7408488|FG000|STARTED|Overall Study||67
6490151|NCT01362686|7408489|FG001|STARTED|Overall Study||66
6490152|NCT01362686|7408490|FG002|STARTED|Overall Study||63
6490153|NCT01362686|7408488|FG000|COMPLETED|Overall Study||59
6490154|NCT01362686|7408489|FG001|COMPLETED|Overall Study||54
6490155|NCT01362686|7408490|FG002|COMPLETED|Overall Study||53
6490156|NCT01362686|7408488|FG000|NOT COMPLETED|Overall Study||8
6490157|NCT01362686|7408489|FG001|NOT COMPLETED|Overall Study||12
6490158|NCT01362686|7408490|FG002|NOT COMPLETED|Overall Study||10
6490159|NCT01362790|7408504|FG000|STARTED|Pilot Phase & Phase 2||11
6490160|NCT01362790|7408505|FG001|STARTED|Pilot Phase & Phase 2||8
6490161|NCT01362790|7408506|FG002|STARTED|Pilot Phase & Phase 2||7
6490162|NCT01362790|7408507|FG003|STARTED|Pilot Phase & Phase 2||15
6490163|NCT01362790|7408508|FG004|STARTED|Pilot Phase & Phase 2||0
6490164|NCT01362790|7408509|FG005|STARTED|Pilot Phase & Phase 2||4
6490165|NCT01362790|7408510|FG006|STARTED|Pilot Phase & Phase 2||0
6490166|NCT01362790|7408504|FG000|COMPLETED|Pilot Phase & Phase 2||1
6490167|NCT01362790|7408505|FG001|COMPLETED|Pilot Phase & Phase 2||0
6490168|NCT01362790|7408506|FG002|COMPLETED|Pilot Phase & Phase 2||2
6490169|NCT01362790|7408507|FG003|COMPLETED|Pilot Phase & Phase 2||1
6490170|NCT01362790|7408508|FG004|COMPLETED|Pilot Phase & Phase 2||0
6490171|NCT01362790|7408509|FG005|COMPLETED|Pilot Phase & Phase 2||0
6490172|NCT01362790|7408510|FG006|COMPLETED|Pilot Phase & Phase 2||0
6490173|NCT01362790|7408504|FG000|NOT COMPLETED|Pilot Phase & Phase 2||10
6490174|NCT01362790|7408505|FG001|NOT COMPLETED|Pilot Phase & Phase 2||8
6748803|NCT03421379|7676978|FG001|COMPLETED|Period 1||37
6748804|NCT03421379|7676977|FG000|NOT COMPLETED|Period 1||2
6748805|NCT03421379|7676978|FG001|NOT COMPLETED|Period 1||4
6748806|NCT03421379|7676977|FG000|STARTED|Washout Period (3 to 14 Days)||32
6748807|NCT03421379|7676978|FG001|STARTED|Washout Period (3 to 14 Days)||37
6748808|NCT03421379|7676977|FG000|COMPLETED|Washout Period (3 to 14 Days)||32
6748809|NCT03421379|7676978|FG001|COMPLETED|Washout Period (3 to 14 Days)||37
6748810|NCT03421379|7676977|FG000|NOT COMPLETED|Washout Period (3 to 14 Days)||0
6748811|NCT03421379|7676978|FG001|NOT COMPLETED|Washout Period (3 to 14 Days)||0
6748812|NCT03421379|7676977|FG000|STARTED|Period 2||32
6748813|NCT03421379|7676978|FG001|STARTED|Period 2||37
6748814|NCT03421379|7676977|FG000|COMPLETED|Period 2||32
6748815|NCT03421379|7676978|FG001|COMPLETED|Period 2||37
6748816|NCT03421379|7676977|FG000|NOT COMPLETED|Period 2||0
6748817|NCT03421379|7676978|FG001|NOT COMPLETED|Period 2||0
6748818|NCT03421431|7676987|FG000|STARTED|Overall Study||24
6748819|NCT03421431|7676988|FG001|STARTED|Overall Study||55
6748820|NCT03421431|7676989|FG002|STARTED|Overall Study||53
6748821|NCT03421431|7676987|FG000|COMPLETED|Overall Study||18
6748822|NCT03421431|7676988|FG001|COMPLETED|Overall Study||49
6748823|NCT03421431|7676989|FG002|COMPLETED|Overall Study||39
6748824|NCT03421431|7676987|FG000|NOT COMPLETED|Overall Study||6
6748825|NCT03421431|7676988|FG001|NOT COMPLETED|Overall Study||6
6748826|NCT03421431|7676989|FG002|NOT COMPLETED|Overall Study||14
6748827|NCT03421730|7676999|FG000|STARTED|First Intervention (Day 1, Visit 2)||1
6748828|NCT03421730|7677000|FG001|STARTED|First Intervention (Day 1, Visit 2)||3
6748829|NCT03421730|7677001|FG002|STARTED|First Intervention (Day 1, Visit 2)||1
6748830|NCT03421730|7677002|FG003|STARTED|First Intervention (Day 1, Visit 2)||1
6748831|NCT03421730|7677003|FG004|STARTED|First Intervention (Day 1, Visit 2)||3
6748832|NCT03421730|7677004|FG005|STARTED|First Intervention (Day 1, Visit 2)||1
6748833|NCT03421730|7677005|FG006|STARTED|First Intervention (Day 1, Visit 2)||1
6748834|NCT03421730|7677006|FG007|STARTED|First Intervention (Day 1, Visit 2)||1
6748835|NCT03421730|7677007|FG008|STARTED|First Intervention (Day 1, Visit 2)||1
6748836|NCT03421730|7677008|FG009|STARTED|First Intervention (Day 1, Visit 2)||2
6748837|NCT03421730|7677009|FG010|STARTED|First Intervention (Day 1, Visit 2)||1
6748838|NCT03421730|7677010|FG011|STARTED|First Intervention (Day 1, Visit 2)||1
6748839|NCT03421730|7676999|FG000|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748840|NCT03421730|7677000|FG001|COMPLETED|First Intervention (Day 1, Visit 2)|Two subjects withdrew without receiving treatment with either A or C.|1
6748841|NCT03421730|7677001|FG002|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748842|NCT03421730|7677002|FG003|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748843|NCT03421730|7677003|FG004|COMPLETED|First Intervention (Day 1, Visit 2)||3
6748844|NCT03421730|7677004|FG005|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748845|NCT03421730|7677005|FG006|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748846|NCT03421730|7677006|FG007|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748847|NCT03421730|7677007|FG008|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748848|NCT03421730|7677008|FG009|COMPLETED|First Intervention (Day 1, Visit 2)||2
6748849|NCT03421730|7677009|FG010|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748850|NCT03421730|7677010|FG011|COMPLETED|First Intervention (Day 1, Visit 2)||1
6748851|NCT03421730|7676999|FG000|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748852|NCT03421730|7677000|FG001|NOT COMPLETED|First Intervention (Day 1, Visit 2)||2
6748853|NCT03421730|7677001|FG002|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748854|NCT03421730|7677002|FG003|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748855|NCT03421730|7677003|FG004|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748856|NCT03421730|7677004|FG005|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748857|NCT03421730|7677005|FG006|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748858|NCT03421730|7677006|FG007|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748859|NCT03421730|7677007|FG008|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748860|NCT03421730|7677008|FG009|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748861|NCT03421730|7677009|FG010|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748862|NCT03421730|7677010|FG011|NOT COMPLETED|First Intervention (Day 1, Visit 2)||0
6748863|NCT03421730|7676999|FG000|STARTED|Washout (Days 4 to 10)||1
6748864|NCT03421730|7677000|FG001|STARTED|Washout (Days 4 to 10)||1
6748865|NCT03421730|7677001|FG002|STARTED|Washout (Days 4 to 10)||1
6748866|NCT03421730|7677002|FG003|STARTED|Washout (Days 4 to 10)||1
6748867|NCT03421730|7677003|FG004|STARTED|Washout (Days 4 to 10)||3
6748868|NCT03421730|7677004|FG005|STARTED|Washout (Days 4 to 10)||1
6748869|NCT03421730|7677005|FG006|STARTED|Washout (Days 4 to 10)||1
6748870|NCT03421730|7677006|FG007|STARTED|Washout (Days 4 to 10)||1
6748871|NCT03421730|7677007|FG008|STARTED|Washout (Days 4 to 10)||1
6748872|NCT03421730|7677008|FG009|STARTED|Washout (Days 4 to 10)||2
6748873|NCT03421730|7677009|FG010|STARTED|Washout (Days 4 to 10)||1
6748874|NCT03421730|7677010|FG011|STARTED|Washout (Days 4 to 10)||1
6748875|NCT03421730|7676999|FG000|COMPLETED|Washout (Days 4 to 10)||1
6748876|NCT03421730|7677000|FG001|COMPLETED|Washout (Days 4 to 10)||1
6748877|NCT03421730|7677001|FG002|COMPLETED|Washout (Days 4 to 10)||1
6748878|NCT03421730|7677002|FG003|COMPLETED|Washout (Days 4 to 10)||1
6748879|NCT03421730|7677003|FG004|COMPLETED|Washout (Days 4 to 10)|Two subjects withdrew after receiving treatment with B but before receiving treatment with C.|1
6748880|NCT03421730|7677004|FG005|COMPLETED|Washout (Days 4 to 10)||1
6748881|NCT03421730|7677005|FG006|COMPLETED|Washout (Days 4 to 10)||1
6748882|NCT03421730|7677006|FG007|COMPLETED|Washout (Days 4 to 10)||1
6748883|NCT03421730|7677007|FG008|COMPLETED|Washout (Days 4 to 10)||1
6748884|NCT03421730|7677008|FG009|COMPLETED|Washout (Days 4 to 10)||2
6748885|NCT03421730|7677009|FG010|COMPLETED|Washout (Days 4 to 10)||1
6748886|NCT03421730|7677010|FG011|COMPLETED|Washout (Days 4 to 10)||1
6748887|NCT03421730|7676999|FG000|NOT COMPLETED|Washout (Days 4 to 10)||0
6748888|NCT03421730|7677000|FG001|NOT COMPLETED|Washout (Days 4 to 10)||0
6748889|NCT03421730|7677001|FG002|NOT COMPLETED|Washout (Days 4 to 10)||0
6748890|NCT03421730|7677002|FG003|NOT COMPLETED|Washout (Days 4 to 10)||0
6748891|NCT03421730|7677003|FG004|NOT COMPLETED|Washout (Days 4 to 10)||2
6748892|NCT03421730|7677004|FG005|NOT COMPLETED|Washout (Days 4 to 10)||0
6748893|NCT03421730|7677005|FG006|NOT COMPLETED|Washout (Days 4 to 10)||0
6748894|NCT03421730|7677006|FG007|NOT COMPLETED|Washout (Days 4 to 10)||0
6748895|NCT03421730|7677007|FG008|NOT COMPLETED|Washout (Days 4 to 10)||0
6748896|NCT03421730|7677008|FG009|NOT COMPLETED|Washout (Days 4 to 10)||0
6748897|NCT03421730|7677009|FG010|NOT COMPLETED|Washout (Days 4 to 10)||0
6748898|NCT03421730|7677010|FG011|NOT COMPLETED|Washout (Days 4 to 10)||0
6490175|NCT01362790|7408506|FG002|NOT COMPLETED|Pilot Phase & Phase 2||5
6490176|NCT01362790|7408507|FG003|NOT COMPLETED|Pilot Phase & Phase 2||14
6490177|NCT01362790|7408508|FG004|NOT COMPLETED|Pilot Phase & Phase 2||0
6490178|NCT01362790|7408509|FG005|NOT COMPLETED|Pilot Phase & Phase 2||4
6490179|NCT01362790|7408510|FG006|NOT COMPLETED|Pilot Phase & Phase 2||0
6490180|NCT01362790|7408504|FG000|STARTED|Dose De-escalation of Regimen A||0
6490181|NCT01362790|7408505|FG001|STARTED|Dose De-escalation of Regimen A||0
6490182|NCT01362790|7408506|FG002|STARTED|Dose De-escalation of Regimen A||0
6490183|NCT01362790|7408507|FG003|STARTED|Dose De-escalation of Regimen A||0
6490184|NCT01362790|7408508|FG004|STARTED|Dose De-escalation of Regimen A||8
6490185|NCT01362790|7408509|FG005|STARTED|Dose De-escalation of Regimen A||0
6490186|NCT01362790|7408510|FG006|STARTED|Dose De-escalation of Regimen A||0
6490187|NCT01362790|7408504|FG000|COMPLETED|Dose De-escalation of Regimen A||0
6490188|NCT01362790|7408505|FG001|COMPLETED|Dose De-escalation of Regimen A||0
6490189|NCT01362790|7408506|FG002|COMPLETED|Dose De-escalation of Regimen A||0
6490190|NCT01362790|7408507|FG003|COMPLETED|Dose De-escalation of Regimen A||0
6490191|NCT01362790|7408508|FG004|COMPLETED|Dose De-escalation of Regimen A||2
6490192|NCT01362790|7408509|FG005|COMPLETED|Dose De-escalation of Regimen A||0
6490193|NCT01362790|7408510|FG006|COMPLETED|Dose De-escalation of Regimen A||0
6490194|NCT01362790|7408504|FG000|NOT COMPLETED|Dose De-escalation of Regimen A||0
6490195|NCT01362790|7408505|FG001|NOT COMPLETED|Dose De-escalation of Regimen A||0
6490196|NCT01362790|7408506|FG002|NOT COMPLETED|Dose De-escalation of Regimen A||0
6490197|NCT01362790|7408507|FG003|NOT COMPLETED|Dose De-escalation of Regimen A||0
6490198|NCT01362790|7408508|FG004|NOT COMPLETED|Dose De-escalation of Regimen A||6
6490199|NCT01362790|7408509|FG005|NOT COMPLETED|Dose De-escalation of Regimen A||0
6490200|NCT01362790|7408510|FG006|NOT COMPLETED|Dose De-escalation of Regimen A||0
6490201|NCT01362894|7408530|FG000|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
6490202|NCT01362894|7408531|FG001|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
6490203|NCT01362894|7408530|FG000|COMPLETED|Period One, 1 Week||119
6490204|NCT01362894|7408531|FG001|COMPLETED|Period One, 1 Week||117
6490205|NCT01362894|7408530|FG000|NOT COMPLETED|Period One, 1 Week||0
6490206|NCT01362894|7408531|FG001|NOT COMPLETED|Period One, 1 Week||0
6490207|NCT01362894|7408530|FG000|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
6490208|NCT01362894|7408531|FG001|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
6490209|NCT01362894|7408530|FG000|COMPLETED|Period Two, 1 Week||118
6490210|NCT01362894|7408531|FG001|COMPLETED|Period Two, 1 Week||115
6490211|NCT01362894|7408530|FG000|NOT COMPLETED|Period Two, 1 Week||0
6490212|NCT01362894|7408531|FG001|NOT COMPLETED|Period Two, 1 Week||0
6490213|NCT01362907|7408537|FG000|STARTED|Period 1, One Week||20
6490214|NCT01362907|7408538|FG001|STARTED|Period 1, One Week||20
6490215|NCT01362907|7408537|FG000|COMPLETED|Period 1, One Week||20
6490216|NCT01362907|7408538|FG001|COMPLETED|Period 1, One Week||20
6490217|NCT01362907|7408537|FG000|NOT COMPLETED|Period 1, One Week||0
6490218|NCT01362907|7408538|FG001|NOT COMPLETED|Period 1, One Week||0
6490219|NCT01362907|7408537|FG000|STARTED|Period 2, One Week||20
6490220|NCT01362907|7408538|FG001|STARTED|Period 2, One Week||20
6490221|NCT01362907|7408537|FG000|COMPLETED|Period 2, One Week||20
6490222|NCT01362907|7408538|FG001|COMPLETED|Period 2, One Week||20
6490223|NCT01362907|7408537|FG000|NOT COMPLETED|Period 2, One Week||0
6490224|NCT01362907|7408538|FG001|NOT COMPLETED|Period 2, One Week||0
6490225|NCT01362946|7408544|FG000|STARTED|First Behavior Modification Block||24
6490226|NCT01362946|7408545|FG001|STARTED|First Behavior Modification Block||24
6490227|NCT01362946|7408544|FG000|COMPLETED|First Behavior Modification Block||24
6490228|NCT01362946|7408545|FG001|COMPLETED|First Behavior Modification Block||24
6490229|NCT01362946|7408544|FG000|NOT COMPLETED|First Behavior Modification Block||0
6490230|NCT01362946|7408545|FG001|NOT COMPLETED|First Behavior Modification Block||0
6490231|NCT01362946|7408544|FG000|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
6490232|NCT01362946|7408545|FG001|STARTED|Second Behavior Modification Block||24
6748899|NCT03421730|7676999|FG000|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748900|NCT03421730|7677000|FG001|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748901|NCT03421730|7677001|FG002|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748902|NCT03421730|7677002|FG003|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6490233|NCT01362946|7408544|FG000|COMPLETED|Second Behavior Modification Block||23
6490234|NCT01362946|7408545|FG001|COMPLETED|Second Behavior Modification Block||24
6490235|NCT01362946|7408544|FG000|NOT COMPLETED|Second Behavior Modification Block||0
6490236|NCT01362946|7408545|FG001|NOT COMPLETED|Second Behavior Modification Block||0
6490237|NCT01362959|7408553|FG000|STARTED|Overall Study||21
6490238|NCT01362959|7408554|FG001|STARTED|Overall Study||26
6490239|NCT01362959|7408553|FG000|COMPLETED|Overall Study||21
6490240|NCT01362959|7408554|FG001|COMPLETED|Overall Study||26
6490241|NCT01362959|7408553|FG000|NOT COMPLETED|Overall Study||0
6490242|NCT01362959|7408554|FG001|NOT COMPLETED|Overall Study||0
6490243|NCT01363011|7408562|FG000|STARTED|Main Study||33
6490244|NCT01363011|7408563|FG001|STARTED|Main Study||73
6490245|NCT01363011|7408562|FG000|COMPLETED|Main Study||29
6490246|NCT01363011|7408563|FG001|COMPLETED|Main Study||64
6490247|NCT01363011|7408562|FG000|NOT COMPLETED|Main Study||4
6490248|NCT01363011|7408563|FG001|NOT COMPLETED|Main Study||9
6490249|NCT01363011|7408562|FG000|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
6490250|NCT01363011|7408563|FG001|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
6490251|NCT01363011|7408562|FG000|COMPLETED|Extension Phase||13
6490252|NCT01363011|7408563|FG001|COMPLETED|Extension Phase||41
6490253|NCT01363011|7408562|FG000|NOT COMPLETED|Extension Phase||5
6490254|NCT01363011|7408563|FG001|NOT COMPLETED|Extension Phase||8
6555133|NCT01750879|7477297|FG001|NOT COMPLETED|Overall Study||3
6555134|NCT01750918|7477324|FG000|STARTED|Overall Study||3
6555135|NCT01750918|7477325|FG001|STARTED|Overall Study||4
6555136|NCT01750918|7477326|FG002|STARTED|Overall Study||36
6555137|NCT01750918|7477327|FG003|STARTED|Overall Study||50
6555138|NCT01750918|7477328|FG004|STARTED|Overall Study||13
6555139|NCT01750918|7477329|FG005|STARTED|Overall Study||20
6555140|NCT01750918|7477330|FG006|STARTED|Overall Study||20
6555141|NCT01750918|7477331|FG007|STARTED|Overall Study||20
6555142|NCT01750918|7477324|FG000|Pharmacokinetic Population|Overall Study||3
6555143|NCT01750918|7477325|FG001|Pharmacokinetic Population|Overall Study||4
6555144|NCT01750918|7477326|FG002|Pharmacokinetic Population|Overall Study||35
6555145|NCT01750918|7477327|FG003|Pharmacokinetic Population|Overall Study||48
6555146|NCT01750918|7477328|FG004|Pharmacokinetic Population|Overall Study||12
6490255|NCT01363050|7408569|FG000|STARTED|Overall Study||15
6490256|NCT01363050|7408569|FG000|COMPLETED|Overall Study||15
6490257|NCT01363050|7408569|FG000|NOT COMPLETED|Overall Study||0
6490258|NCT01363076|7408577|FG000|STARTED|Overall Study||7
6490259|NCT01363076|7408578|FG001|STARTED|Overall Study||13
6490260|NCT01363076|7408577|FG000|COMPLETED|Overall Study||7
6490261|NCT01363076|7408578|FG001|COMPLETED|Overall Study||12
6490262|NCT01363076|7408577|FG000|NOT COMPLETED|Overall Study||0
6490263|NCT01363076|7408578|FG001|NOT COMPLETED|Overall Study||1
6490264|NCT01363128|7408584|FG000|STARTED|Overall Study||69
6490265|NCT01363128|7408584|FG000|COMPLETED|Overall Study||69
6490266|NCT01363128|7408584|FG000|NOT COMPLETED|Overall Study||0
6490267|NCT01363258|7408590|FG000|STARTED|Overall Study||54
6490268|NCT01363258|7408591|FG001|STARTED|Overall Study||46
6490269|NCT01363258|7408590|FG000|COMPLETED|Overall Study||54
6490270|NCT01363258|7408591|FG001|COMPLETED|Overall Study||46
6490271|NCT01363258|7408590|FG000|NOT COMPLETED|Overall Study||0
6490272|NCT01363258|7408591|FG001|NOT COMPLETED|Overall Study||0
6490273|NCT01363297|7408602|FG000|STARTED|Overall Study||3
6490274|NCT01363297|7408603|FG001|STARTED|Overall Study||12
6490275|NCT01363297|7408604|FG002|STARTED|Overall Study||9
6490276|NCT01363297|7408605|FG003|STARTED|Overall Study||13
6490277|NCT01363297|7408606|FG004|STARTED|Overall Study||35
6490278|NCT01363297|7408602|FG000|COMPLETED|Overall Study||0
6490279|NCT01363297|7408603|FG001|COMPLETED|Overall Study||6
6490280|NCT01363297|7408604|FG002|COMPLETED|Overall Study||3
6490281|NCT01363297|7408605|FG003|COMPLETED|Overall Study||3
6490282|NCT01363297|7408606|FG004|COMPLETED|Overall Study||4
6490283|NCT01363297|7408602|FG000|NOT COMPLETED|Overall Study||3
6490284|NCT01363297|7408603|FG001|NOT COMPLETED|Overall Study||6
6490285|NCT01363297|7408604|FG002|NOT COMPLETED|Overall Study||6
6490286|NCT01363297|7408605|FG003|NOT COMPLETED|Overall Study||10
6490287|NCT01363297|7408606|FG004|NOT COMPLETED|Overall Study||31
6490288|NCT01363349|7408625|FG000|STARTED|Overall Study||133
6490289|NCT01363349|7408626|FG001|STARTED|Overall Study||136
6490290|NCT01363349|7408625|FG000|Randomized|Overall Study||133
6490291|NCT01363349|7408626|FG001|Randomized|Overall Study||136
6490292|NCT01363349|7408625|FG000|COMPLETED|Overall Study||66
6490293|NCT01363349|7408626|FG001|COMPLETED|Overall Study||66
6490294|NCT01363349|7408625|FG000|NOT COMPLETED|Overall Study||67
6555147|NCT01750918|7477329|FG005|Pharmacokinetic Population|Overall Study||19
6490295|NCT01363349|7408626|FG001|NOT COMPLETED|Overall Study||70
6490296|NCT01363388|7408635|FG000|STARTED|Overall Study||23
6490297|NCT01363388|7408636|FG001|STARTED|Overall Study||22
6490298|NCT01363388|7408637|FG002|STARTED|Overall Study||22
6555148|NCT01750918|7477330|FG006|Pharmacokinetic Population|Overall Study||18
6555149|NCT01750918|7477331|FG007|Pharmacokinetic Population|Overall Study||20
6490299|NCT01363388|7408635|FG000|COMPLETED|Overall Study||18
6490300|NCT01363388|7408636|FG001|COMPLETED|Overall Study||19
6490301|NCT01363388|7408637|FG002|COMPLETED|Overall Study||18
6490302|NCT01363388|7408635|FG000|NOT COMPLETED|Overall Study||5
6555150|NCT01750918|7477324|FG000|Biomarker Population|Overall Study||3
6555151|NCT01750918|7477325|FG001|Biomarker Population|Overall Study||4
6490303|NCT01363388|7408636|FG001|NOT COMPLETED|Overall Study||3
6490304|NCT01363388|7408637|FG002|NOT COMPLETED|Overall Study||4
6490305|NCT01363440|7408648|FG000|STARTED|Overall Study|randomized|156
6490306|NCT01363440|7408649|FG001|STARTED|Overall Study|randomized|156
6490307|NCT01363440|7408650|FG002|STARTED|Overall Study|randomized|154
6490308|NCT01363440|7408648|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
6490309|NCT01363440|7408649|FG001|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
6490310|NCT01363440|7408650|FG002|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
6490311|NCT01363440|7408648|FG000|Completed Week 52|Overall Study||145
6490312|NCT01363440|7408649|FG001|Completed Week 52|Overall Study||146
6490313|NCT01363440|7408650|FG002|Completed Week 52|Overall Study||144
6490314|NCT01363440|7408648|FG000|Completed Week 100|Overall Study||133
6490315|NCT01363440|7408649|FG001|Completed Week 100|Overall Study||125
6490316|NCT01363440|7408650|FG002|Completed Week 100|Overall Study||127
6490317|NCT01363440|7408648|FG000|COMPLETED|Overall Study|Completed Week 100|133
6490318|NCT01363440|7408649|FG001|COMPLETED|Overall Study|Completed Week 100|125
6490319|NCT01363440|7408650|FG002|COMPLETED|Overall Study|Completed Week 100|127
6490320|NCT01363440|7408648|FG000|NOT COMPLETED|Overall Study||23
6490321|NCT01363440|7408649|FG001|NOT COMPLETED|Overall Study||31
6490322|NCT01363440|7408650|FG002|NOT COMPLETED|Overall Study||27
6490323|NCT01363479|7408663|FG000|STARTED|Overall Study|number of randomised patients|371
6490324|NCT01363479|7408664|FG001|STARTED|Overall Study|number of randomised patients|372
6490325|NCT01363479|7408663|FG000|COMPLETED|Overall Study||359
6490326|NCT01363479|7408664|FG001|COMPLETED|Overall Study||351
6490327|NCT01363479|7408663|FG000|NOT COMPLETED|Overall Study||12
6490328|NCT01363479|7408664|FG001|NOT COMPLETED|Overall Study||21
6490329|NCT01363492|7408670|FG000|STARTED|Overall Study||14
6490330|NCT01363492|7408670|FG000|COMPLETED|Overall Study||14
6490331|NCT01363492|7408670|FG000|NOT COMPLETED|Overall Study||0
6490332|NCT01363661|7408678|FG000|STARTED|Overall Study||32
6490333|NCT01363661|7408679|FG001|STARTED|Overall Study||32
6490334|NCT01363661|7408678|FG000|COMPLETED|Overall Study||18
6490335|NCT01363661|7408679|FG001|COMPLETED|Overall Study||28
6490336|NCT01363661|7408678|FG000|NOT COMPLETED|Overall Study||14
6490337|NCT01363661|7408679|FG001|NOT COMPLETED|Overall Study||4
6490338|NCT01363700|7408688|FG000|STARTED|Epinastine vs Placebo Period1||43
6490339|NCT01363700|7408689|FG001|STARTED|Epinastine vs Placebo Period1||22
6490340|NCT01363700|7408690|FG002|STARTED|Epinastine vs Placebo Period1||22
6490341|NCT01363700|7408691|FG003|STARTED|Epinastine vs Placebo Period1|No Allocation|0
6490342|NCT01363700|7408692|FG004|STARTED|Epinastine vs Placebo Period1|No Allocation|0
6490343|NCT01363700|7408688|FG000|COMPLETED|Epinastine vs Placebo Period1||43
6490344|NCT01363700|7408689|FG001|COMPLETED|Epinastine vs Placebo Period1||21
6490345|NCT01363700|7408690|FG002|COMPLETED|Epinastine vs Placebo Period1||22
6490346|NCT01363700|7408691|FG003|COMPLETED|Epinastine vs Placebo Period1||0
6490347|NCT01363700|7408692|FG004|COMPLETED|Epinastine vs Placebo Period1||0
6490348|NCT01363700|7408688|FG000|NOT COMPLETED|Epinastine vs Placebo Period1||0
6490349|NCT01363700|7408689|FG001|NOT COMPLETED|Epinastine vs Placebo Period1||1
6490350|NCT01363700|7408690|FG002|NOT COMPLETED|Epinastine vs Placebo Period1||0
6490351|NCT01363700|7408691|FG003|NOT COMPLETED|Epinastine vs Placebo Period1||0
6490352|NCT01363700|7408692|FG004|NOT COMPLETED|Epinastine vs Placebo Period1||0
6490353|NCT01363700|7408688|FG000|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
6490354|NCT01363700|7408689|FG001|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
6490355|NCT01363700|7408690|FG002|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
6490356|NCT01363700|7408691|FG003|STARTED|Epinastine vs Olopatadine Period2||43
6490357|NCT01363700|7408692|FG004|STARTED|Epinastine vs Olopatadine Period2||43
6490358|NCT01363700|7408688|FG000|COMPLETED|Epinastine vs Olopatadine Period2||0
6490359|NCT01363700|7408689|FG001|COMPLETED|Epinastine vs Olopatadine Period2||0
6490360|NCT01363700|7408690|FG002|COMPLETED|Epinastine vs Olopatadine Period2||0
6490361|NCT01363700|7408691|FG003|COMPLETED|Epinastine vs Olopatadine Period2||43
6490362|NCT01363700|7408692|FG004|COMPLETED|Epinastine vs Olopatadine Period2||43
6490363|NCT01363700|7408688|FG000|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6490364|NCT01363700|7408689|FG001|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6490365|NCT01363700|7408690|FG002|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6490366|NCT01363700|7408691|FG003|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6490367|NCT01363700|7408692|FG004|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
6490368|NCT01363713|7408703|FG000|STARTED|Overall Study|Assessed for eligibility|130
6490369|NCT01363713|7408703|FG000|ALLOCATED|Overall Study||130
6490370|NCT01363713|7408703|FG000|COMPLETED|Overall Study|Analysed (n=130)|124
6490371|NCT01363713|7408703|FG000|NOT COMPLETED|Overall Study||6
6490372|NCT01363765|7408709|FG000|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
6490373|NCT01363765|7408710|FG001|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
6490374|NCT01363765|7408709|FG000|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
6490375|NCT01363765|7408710|FG001|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
6490376|NCT01363765|7408709|FG000|NOT COMPLETED|Overall Study||5800
6490377|NCT01363765|7408710|FG001|NOT COMPLETED|Overall Study||4731
6490378|NCT01363843|7408718|FG000|STARTED|Overall Study||39
6501784|NCT01431274|7420430|FG000|STARTED|Overall Study||528
6748903|NCT03421730|7677003|FG004|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748904|NCT03421730|7677004|FG005|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748905|NCT03421730|7677005|FG006|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6490379|NCT01363843|7408718|FG000|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
6490380|NCT01363843|7408718|FG000|NOT COMPLETED|Overall Study||1
6490381|NCT01363908|7408725|FG000|STARTED|Screening/Enrollment||14
6490382|NCT01363908|7408726|FG001|STARTED|Screening/Enrollment||16
6490383|NCT01363908|7408725|FG000|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
6490384|NCT01363908|7408726|FG001|COMPLETED|Screening/Enrollment||16
6490385|NCT01363908|7408725|FG000|NOT COMPLETED|Screening/Enrollment||1
6490386|NCT01363908|7408726|FG001|NOT COMPLETED|Screening/Enrollment||0
6490387|NCT01363908|7408725|FG000|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
6490388|NCT01363908|7408726|FG001|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
6490389|NCT01363908|7408725|FG000|COMPLETED|Pharmacokinetic (PK) Phase||8
6490390|NCT01363908|7408726|FG001|COMPLETED|Pharmacokinetic (PK) Phase||8
6490391|NCT01363908|7408725|FG000|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
6490392|NCT01363908|7408726|FG001|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
6490393|NCT01363908|7408725|FG000|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
6490394|NCT01363908|7408726|FG001|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
6490395|NCT01363908|7408725|FG000|COMPLETED|Chronic Dosing (CD) Phase||3
6490396|NCT01363908|7408726|FG001|COMPLETED|Chronic Dosing (CD) Phase||10
6490397|NCT01363908|7408725|FG000|NOT COMPLETED|Chronic Dosing (CD) Phase||10
6490398|NCT01363908|7408726|FG001|NOT COMPLETED|Chronic Dosing (CD) Phase||6
6490399|NCT01363986|7408732|FG000|STARTED|Overall Study||3
6490400|NCT01363986|7408732|FG000|COMPLETED|Overall Study||2
6490401|NCT01363986|7408732|FG000|NOT COMPLETED|Overall Study||1
6490402|NCT01363999|7408736|FG000|STARTED|A: RO5317116/F01 Bilayer Tablet||24
6490403|NCT01363999|7408736|FG000|COMPLETED|A: RO5317116/F01 Bilayer Tablet||24
6490404|NCT01363999|7408736|FG000|NOT COMPLETED|A: RO5317116/F01 Bilayer Tablet||0
6490405|NCT01363999|7408736|FG000|STARTED|B: RO5317116/F03 Bilayer Tablet||24
6490406|NCT01363999|7408736|FG000|COMPLETED|B: RO5317116/F03 Bilayer Tablet||24
6490407|NCT01363999|7408736|FG000|NOT COMPLETED|B: RO5317116/F03 Bilayer Tablet||0
6490408|NCT01363999|7408736|FG000|STARTED|C: RO5317116/ F04 Active-coated Tablet||24
6490409|NCT01363999|7408736|FG000|COMPLETED|C: RO5317116/ F04 Active-coated Tablet||24
6490410|NCT01363999|7408736|FG000|NOT COMPLETED|C: RO5317116/ F04 Active-coated Tablet||0
6490411|NCT01363999|7408736|FG000|STARTED|D: RO4607381/ F49 Tablet||24
6490412|NCT01363999|7408736|FG000|COMPLETED|D: RO4607381/ F49 Tablet||24
6490413|NCT01363999|7408736|FG000|NOT COMPLETED|D: RO4607381/ F49 Tablet||0
6490414|NCT01364090|7408746|FG000|STARTED|Overall Study||61
6490415|NCT01364090|7408747|FG001|STARTED|Overall Study||26
6490416|NCT01364090|7408748|FG002|STARTED|Overall Study||6
6490417|NCT01364090|7408746|FG000|COMPLETED|Overall Study||58
6490418|NCT01364090|7408747|FG001|COMPLETED|Overall Study||12
6490419|NCT01364090|7408748|FG002|COMPLETED|Overall Study||0
6490420|NCT01364090|7408746|FG000|NOT COMPLETED|Overall Study||3
6490421|NCT01364090|7408747|FG001|NOT COMPLETED|Overall Study||14
6490422|NCT01364090|7408748|FG002|NOT COMPLETED|Overall Study||6
6490423|NCT01364207|7408756|FG000|STARTED|First Visit (~1.5-2 Hours)||54
6490424|NCT01364207|7408757|FG001|STARTED|First Visit (~1.5-2 Hours)||58
6490425|NCT01364207|7408756|FG000|COMPLETED|First Visit (~1.5-2 Hours)||54
6490426|NCT01364207|7408757|FG001|COMPLETED|First Visit (~1.5-2 Hours)||58
6490427|NCT01364207|7408756|FG000|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
6490428|NCT01364207|7408757|FG001|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
6490429|NCT01364207|7408756|FG000|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
6490430|NCT01364207|7408757|FG001|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
6490431|NCT01364207|7408756|FG000|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
6490432|NCT01364207|7408757|FG001|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
6748906|NCT03421730|7677006|FG007|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748907|NCT03421730|7677007|FG008|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748908|NCT03421730|7677008|FG009|STARTED|Second Intervention (Day 8±3, Visit 3)||2
6748909|NCT03421730|7677009|FG010|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748910|NCT03421730|7677010|FG011|STARTED|Second Intervention (Day 8±3, Visit 3)||1
6748911|NCT03421730|7676999|FG000|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748912|NCT03421730|7677000|FG001|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748913|NCT03421730|7677001|FG002|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748914|NCT03421730|7677002|FG003|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6490433|NCT01364207|7408756|FG000|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
6490434|NCT01364207|7408757|FG001|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
6490435|NCT01364207|7408756|FG000|STARTED|Second Visit (~1.5-2 Hours)||52
6490436|NCT01364207|7408757|FG001|STARTED|Second Visit (~1.5-2 Hours)||54
6490437|NCT01364207|7408756|FG000|COMPLETED|Second Visit (~1.5-2 Hours)||52
6490438|NCT01364207|7408757|FG001|COMPLETED|Second Visit (~1.5-2 Hours)||54
6490439|NCT01364207|7408756|FG000|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
6490440|NCT01364207|7408757|FG001|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
6490441|NCT01364233|7408763|FG000|STARTED|Overall Study||10
6490442|NCT01364233|7408763|FG000|COMPLETED|Overall Study||9
6490443|NCT01364233|7408763|FG000|NOT COMPLETED|Overall Study||1
6490444|NCT01364259|7408769|FG000|STARTED|Overall Study||9
6490445|NCT01364259|7408770|FG001|STARTED|Overall Study||8
6490446|NCT01364259|7408769|FG000|COMPLETED|Overall Study||9
6490447|NCT01364259|7408770|FG001|COMPLETED|Overall Study||8
6490448|NCT01364259|7408769|FG000|NOT COMPLETED|Overall Study||0
6490449|NCT01364259|7408770|FG001|NOT COMPLETED|Overall Study||0
6490450|NCT01364298|7408778|FG000|STARTED|Overall Study||176
6490451|NCT01364298|7408779|FG001|STARTED|Overall Study||177
6490452|NCT01364298|7408778|FG000|Treated|Overall Study||174
6490453|NCT01364298|7408779|FG001|Treated|Overall Study||174
6490454|NCT01364298|7408778|FG000|COMPLETED|Overall Study||162
6490455|NCT01364298|7408779|FG001|COMPLETED|Overall Study||154
6490456|NCT01364298|7408778|FG000|NOT COMPLETED|Overall Study||14
6490457|NCT01364298|7408779|FG001|NOT COMPLETED|Overall Study||23
6490458|NCT01364389|7408788|FG000|STARTED|Overall Study||5
6490459|NCT01364389|7408789|FG001|STARTED|Overall Study||6
6490460|NCT01364389|7408790|FG002|STARTED|Overall Study||5
6490461|NCT01364389|7408788|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||5
6490462|NCT01364389|7408789|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||6
6490463|NCT01364389|7408790|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
6490464|NCT01364389|7408788|FG000|COMPLETED|Overall Study||3
6490465|NCT01364389|7408789|FG001|COMPLETED|Overall Study||5
6490466|NCT01364389|7408790|FG002|COMPLETED|Overall Study||4
6490467|NCT01364389|7408788|FG000|NOT COMPLETED|Overall Study||2
6490468|NCT01364389|7408789|FG001|NOT COMPLETED|Overall Study||1
6490469|NCT01364389|7408790|FG002|NOT COMPLETED|Overall Study||1
6490470|NCT01364428|7408800|FG000|STARTED|Overall Study||186
6490471|NCT01364428|7408801|FG001|STARTED|Overall Study||187
6490472|NCT01364428|7408800|FG000|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
6490473|NCT01364428|7408801|FG001|Exposed|Overall Study||187
6490474|NCT01364428|7408800|FG000|COMPLETED|Overall Study||166
6490475|NCT01364428|7408801|FG001|COMPLETED|Overall Study||172
6490476|NCT01364428|7408800|FG000|NOT COMPLETED|Overall Study||20
6490477|NCT01364428|7408801|FG001|NOT COMPLETED|Overall Study||15
6490478|NCT01364467|7408809|FG000|STARTED|Overall Study||10
6490479|NCT01364467|7408810|FG001|STARTED|Overall Study||20
6490480|NCT01364467|7408809|FG000|COMPLETED|Overall Study||9
6490481|NCT01364467|7408810|FG001|COMPLETED|Overall Study||18
6490482|NCT01364467|7408809|FG000|NOT COMPLETED|Overall Study||1
6490483|NCT01364467|7408810|FG001|NOT COMPLETED|Overall Study||2
6490484|NCT01364558|7408816|FG000|STARTED|Dose One||8
6490485|NCT01364558|7408817|FG001|STARTED|Dose One||8
6490486|NCT01364558|7408818|FG002|STARTED|Dose One||8
6490487|NCT01364558|7408816|FG000|COMPLETED|Dose One||8
6490488|NCT01364558|7408817|FG001|COMPLETED|Dose One||8
6490489|NCT01364558|7408818|FG002|COMPLETED|Dose One||8
6490490|NCT01364558|7408816|FG000|NOT COMPLETED|Dose One||0
6490491|NCT01364558|7408817|FG001|NOT COMPLETED|Dose One||0
6490492|NCT01364558|7408818|FG002|NOT COMPLETED|Dose One||0
6490493|NCT01364558|7408816|FG000|STARTED|Dose Two||8
6490494|NCT01364558|7408817|FG001|STARTED|Dose Two||8
6490495|NCT01364558|7408818|FG002|STARTED|Dose Two||8
6490496|NCT01364558|7408816|FG000|COMPLETED|Dose Two||8
6490497|NCT01364558|7408817|FG001|COMPLETED|Dose Two||8
6490498|NCT01364558|7408818|FG002|COMPLETED|Dose Two||8
6490499|NCT01364558|7408816|FG000|NOT COMPLETED|Dose Two||0
6490500|NCT01364558|7408817|FG001|NOT COMPLETED|Dose Two||0
6490501|NCT01364558|7408818|FG002|NOT COMPLETED|Dose Two||0
6490502|NCT01364558|7408816|FG000|STARTED|Dose Three||8
6490503|NCT01364558|7408817|FG001|STARTED|Dose Three||8
6490504|NCT01364558|7408818|FG002|STARTED|Dose Three||8
6490505|NCT01364558|7408816|FG000|COMPLETED|Dose Three||8
6490506|NCT01364558|7408817|FG001|COMPLETED|Dose Three||8
6490507|NCT01364558|7408818|FG002|COMPLETED|Dose Three||8
6490508|NCT01364558|7408816|FG000|NOT COMPLETED|Dose Three||0
6490509|NCT01364558|7408817|FG001|NOT COMPLETED|Dose Three||0
6490510|NCT01364558|7408818|FG002|NOT COMPLETED|Dose Three||0
6490511|NCT01364584|7408828|FG000|STARTED|Overall Study||11
6490512|NCT01364584|7408829|FG001|STARTED|Overall Study||12
6490513|NCT01364584|7408828|FG000|COMPLETED|Overall Study||11
6490514|NCT01364584|7408829|FG001|COMPLETED|Overall Study||12
6490515|NCT01364584|7408828|FG000|NOT COMPLETED|Overall Study||0
6490516|NCT01364584|7408829|FG001|NOT COMPLETED|Overall Study||0
6490517|NCT01364623|7408840|FG000|STARTED|Single Dose||8
6490518|NCT01364623|7408841|FG001|STARTED|Single Dose||8
6490519|NCT01364623|7408842|FG002|STARTED|Single Dose||8
6490520|NCT01364623|7408843|FG003|STARTED|Single Dose||0
6490521|NCT01364623|7408840|FG000|COMPLETED|Single Dose||8
6490522|NCT01364623|7408841|FG001|COMPLETED|Single Dose||8
6490523|NCT01364623|7408842|FG002|COMPLETED|Single Dose||8
6490524|NCT01364623|7408843|FG003|COMPLETED|Single Dose||0
6490525|NCT01364623|7408840|FG000|NOT COMPLETED|Single Dose||0
6490526|NCT01364623|7408841|FG001|NOT COMPLETED|Single Dose||0
6490527|NCT01364623|7408842|FG002|NOT COMPLETED|Single Dose||0
6490528|NCT01364623|7408843|FG003|NOT COMPLETED|Single Dose||0
6490529|NCT01364623|7408840|FG000|STARTED|Multiple Dose||0
6490530|NCT01364623|7408841|FG001|STARTED|Multiple Dose||0
6490531|NCT01364623|7408842|FG002|STARTED|Multiple Dose||0
6490532|NCT01364623|7408843|FG003|STARTED|Multiple Dose||8
6490533|NCT01364623|7408840|FG000|COMPLETED|Multiple Dose||0
6490534|NCT01364623|7408841|FG001|COMPLETED|Multiple Dose||0
6490535|NCT01364623|7408842|FG002|COMPLETED|Multiple Dose||0
6490536|NCT01364623|7408843|FG003|COMPLETED|Multiple Dose||8
6490537|NCT01364623|7408840|FG000|NOT COMPLETED|Multiple Dose||0
6490538|NCT01364623|7408841|FG001|NOT COMPLETED|Multiple Dose||0
6490539|NCT01364623|7408842|FG002|NOT COMPLETED|Multiple Dose||0
6490540|NCT01364623|7408843|FG003|NOT COMPLETED|Multiple Dose||0
6490541|NCT01364649|7408860|FG000|STARTED|Overall Study||225
6490542|NCT01364649|7408861|FG001|STARTED|Overall Study||222
6490543|NCT01364649|7408860|FG000|COMPLETED|Overall Study||169
6490544|NCT01364649|7408861|FG001|COMPLETED|Overall Study||179
6490545|NCT01364649|7408860|FG000|NOT COMPLETED|Overall Study||56
6490546|NCT01364649|7408861|FG001|NOT COMPLETED|Overall Study||43
6490547|NCT01364727|7408867|FG000|STARTED|Overall Study||35
6490548|NCT01364727|7408867|FG000|COMPLETED|Overall Study||33
6490549|NCT01364727|7408867|FG000|NOT COMPLETED|Overall Study||2
6490550|NCT01364740|7408873|FG000|STARTED|Overall Study||10
6490551|NCT01364740|7408873|FG000|COMPLETED|Overall Study||10
6490552|NCT01364740|7408873|FG000|NOT COMPLETED|Overall Study||0
6490553|NCT01364870|7408881|FG000|STARTED|Overall Study||122
6490554|NCT01364870|7408882|FG001|STARTED|Overall Study||123
6748915|NCT03421730|7677003|FG004|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748916|NCT03421730|7677004|FG005|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748917|NCT03421730|7677005|FG006|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748918|NCT03421730|7677006|FG007|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748919|NCT03421730|7677007|FG008|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748920|NCT03421730|7677008|FG009|COMPLETED|Second Intervention (Day 8±3, Visit 3)||2
6490555|NCT01364870|7408883|FG002|STARTED|Overall Study||72
6490556|NCT01364870|7408881|FG000|COMPLETED|Overall Study||100
6490557|NCT01364870|7408882|FG001|COMPLETED|Overall Study||93
6490558|NCT01364870|7408883|FG002|COMPLETED|Overall Study||58
6490559|NCT01364870|7408881|FG000|NOT COMPLETED|Overall Study||22
6490560|NCT01364870|7408882|FG001|NOT COMPLETED|Overall Study||30
6490561|NCT01364870|7408883|FG002|NOT COMPLETED|Overall Study||14
6490562|NCT01364896|7408891|FG000|STARTED|Overall Study||46
6490563|NCT01364896|7408891|FG000|COMPLETED|Overall Study||46
6490564|NCT01364896|7408891|FG000|NOT COMPLETED|Overall Study||0
6490565|NCT01364922|7408898|FG000|STARTED|Open-label (OL) Period||168
6490566|NCT01364922|7408899|FG001|STARTED|Open-label (OL) Period||0
6490567|NCT01364922|7408900|FG002|STARTED|Open-label (OL) Period||0
6490568|NCT01364922|7408898|FG000|COMPLETED|Open-label (OL) Period||146
6490569|NCT01364922|7408899|FG001|COMPLETED|Open-label (OL) Period||0
6490570|NCT01364922|7408900|FG002|COMPLETED|Open-label (OL) Period||0
6490571|NCT01364922|7408898|FG000|NOT COMPLETED|Open-label (OL) Period||22
6490572|NCT01364922|7408899|FG001|NOT COMPLETED|Open-label (OL) Period||0
6490573|NCT01364922|7408900|FG002|NOT COMPLETED|Open-label (OL) Period||0
6490574|NCT01364922|7408898|FG000|STARTED|Double-Blind (DB) Period||0
6490575|NCT01364922|7408899|FG001|STARTED|Double-Blind (DB) Period||99
6555152|NCT01750918|7477326|FG002|Biomarker Population|Overall Study||36
6555153|NCT01750918|7477327|FG003|Biomarker Population|Overall Study||50
6555154|NCT01750918|7477328|FG004|Biomarker Population|Overall Study||13
6555155|NCT01750918|7477329|FG005|Biomarker Population|Overall Study||17
6555156|NCT01750918|7477330|FG006|Biomarker Population|Overall Study||19
6555157|NCT01750918|7477331|FG007|Biomarker Population|Overall Study||20
6555158|NCT01750918|7477324|FG000|Crossover Population|Overall Study||0
6555159|NCT01750918|7477325|FG001|Crossover Population|Overall Study||0
6555160|NCT01750918|7477326|FG002|Crossover Population|Overall Study||0
6555161|NCT01750918|7477327|FG003|Crossover Population|Overall Study||0
6555162|NCT01750918|7477328|FG004|Crossover Population|Overall Study||4
6555163|NCT01750918|7477329|FG005|Crossover Population|Overall Study||2
6555164|NCT01750918|7477330|FG006|Crossover Population|Overall Study||5
6748921|NCT03421730|7677009|FG010|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748922|NCT03421730|7677010|FG011|COMPLETED|Second Intervention (Day 8±3, Visit 3)||1
6748923|NCT03421730|7676999|FG000|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6490576|NCT01364922|7408900|FG002|STARTED|Double-Blind (DB) Period||47
6490577|NCT01364922|7408898|FG000|COMPLETED|Double-Blind (DB) Period||0
6490578|NCT01364922|7408899|FG001|COMPLETED|Double-Blind (DB) Period||94
6490579|NCT01364922|7408900|FG002|COMPLETED|Double-Blind (DB) Period||42
6490580|NCT01364922|7408898|FG000|NOT COMPLETED|Double-Blind (DB) Period||0
6490581|NCT01364922|7408899|FG001|NOT COMPLETED|Double-Blind (DB) Period||5
6490582|NCT01364922|7408900|FG002|NOT COMPLETED|Double-Blind (DB) Period||5
6490583|NCT01365039|7408909|FG000|STARTED|Overall Study||86
6490584|NCT01365039|7408910|FG001|STARTED|Overall Study||87
6490585|NCT01365039|7408909|FG000|COMPLETED|Overall Study||85
6490586|NCT01365039|7408910|FG001|COMPLETED|Overall Study||87
6490587|NCT01365039|7408909|FG000|NOT COMPLETED|Overall Study||1
6490588|NCT01365039|7408910|FG001|NOT COMPLETED|Overall Study||0
6490589|NCT01365052|7408919|FG000|STARTED|Overall Study||217
6490590|NCT01365052|7408920|FG001|STARTED|Overall Study||109
6490591|NCT01365052|7408919|FG000|COMPLETED|Overall Study||213
6490592|NCT01365052|7408920|FG001|COMPLETED|Overall Study||105
6490593|NCT01365052|7408919|FG000|NOT COMPLETED|Overall Study||4
6748924|NCT03421730|7677000|FG001|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6490594|NCT01365052|7408920|FG001|NOT COMPLETED|Overall Study||4
6490595|NCT01365091|7408930|FG000|STARTED|Period 1||28
6490596|NCT01365091|7408931|FG001|STARTED|Period 1||28
6490597|NCT01365091|7408932|FG002|STARTED|Period 1||28
6555165|NCT01750918|7477331|FG007|Crossover Population|Overall Study||5
6490598|NCT01365091|7408933|FG003|STARTED|Period 1||28
6490599|NCT01365091|7408930|FG000|COMPLETED|Period 1||26
6490600|NCT01365091|7408931|FG001|COMPLETED|Period 1||26
6490601|NCT01365091|7408932|FG002|COMPLETED|Period 1||25
6490602|NCT01365091|7408933|FG003|COMPLETED|Period 1||25
6490603|NCT01365091|7408930|FG000|NOT COMPLETED|Period 1||2
6490604|NCT01365091|7408931|FG001|NOT COMPLETED|Period 1||2
6490605|NCT01365091|7408932|FG002|NOT COMPLETED|Period 1||3
6490606|NCT01365091|7408933|FG003|NOT COMPLETED|Period 1||3
6490607|NCT01365091|7408930|FG000|STARTED|Period 2||26
6490608|NCT01365091|7408931|FG001|STARTED|Period 2||26
6490609|NCT01365091|7408932|FG002|STARTED|Period 2||25
6490610|NCT01365091|7408933|FG003|STARTED|Period 2||25
6490611|NCT01365091|7408930|FG000|COMPLETED|Period 2||25
6490612|NCT01365091|7408931|FG001|COMPLETED|Period 2||26
6490613|NCT01365091|7408932|FG002|COMPLETED|Period 2||24
6490614|NCT01365091|7408933|FG003|COMPLETED|Period 2||25
6490615|NCT01365091|7408930|FG000|NOT COMPLETED|Period 2||1
6490616|NCT01365091|7408931|FG001|NOT COMPLETED|Period 2||0
6490617|NCT01365091|7408932|FG002|NOT COMPLETED|Period 2||1
6490618|NCT01365091|7408933|FG003|NOT COMPLETED|Period 2||0
6490619|NCT01365130|7408957|FG000|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
6490620|NCT01365130|7408957|FG000|COMPLETED|Overall Study||13
6490621|NCT01365130|7408957|FG000|NOT COMPLETED|Overall Study||2
6490622|NCT01365273|7408963|FG000|STARTED|Overall Study||22
6490623|NCT01365273|7408964|FG001|STARTED|Overall Study||21
6490624|NCT01365273|7408963|FG000|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
6490625|NCT01365273|7408964|FG001|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
6490626|NCT01365273|7408963|FG000|COMPLETED|Overall Study||20
6490627|NCT01365273|7408964|FG001|COMPLETED|Overall Study||20
6490628|NCT01365273|7408963|FG000|NOT COMPLETED|Overall Study||2
6490629|NCT01365273|7408964|FG001|NOT COMPLETED|Overall Study||1
6490630|NCT01365455|7408973|FG000|STARTED|Induction Period||245
6490631|NCT01365455|7408974|FG001|STARTED|Induction Period||245
6490632|NCT01365455|7408975|FG002|STARTED|Induction Period||248
6490633|NCT01365455|7408976|FG003|STARTED|Induction Period||0
6490634|NCT01365455|7408977|FG004|STARTED|Induction Period||0
6490635|NCT01365455|7408973|FG000|COMPLETED|Induction Period||230
6490636|NCT01365455|7408974|FG001|COMPLETED|Induction Period||238
6490637|NCT01365455|7408975|FG002|COMPLETED|Induction Period||232
6490638|NCT01365455|7408976|FG003|COMPLETED|Induction Period||0
6490639|NCT01365455|7408977|FG004|COMPLETED|Induction Period||0
6490640|NCT01365455|7408973|FG000|NOT COMPLETED|Induction Period||15
6490641|NCT01365455|7408974|FG001|NOT COMPLETED|Induction Period||7
6490642|NCT01365455|7408975|FG002|NOT COMPLETED|Induction Period||16
6490643|NCT01365455|7408976|FG003|NOT COMPLETED|Induction Period||0
6490644|NCT01365455|7408977|FG004|NOT COMPLETED|Induction Period||0
6490645|NCT01365455|7408973|FG000|STARTED|Maintenance Period||230
6490646|NCT01365455|7408974|FG001|STARTED|Maintenance Period||238
6490647|NCT01365455|7408975|FG002|STARTED|Maintenance Period||18
6490648|NCT01365455|7408976|FG003|STARTED|Maintenance Period||109
6490649|NCT01365455|7408977|FG004|STARTED|Maintenance Period||105
6490650|NCT01365455|7408973|FG000|COMPLETED|Maintenance Period||201
6490651|NCT01365455|7408974|FG001|COMPLETED|Maintenance Period||215
6490652|NCT01365455|7408975|FG002|COMPLETED|Maintenance Period||15
6490653|NCT01365455|7408976|FG003|COMPLETED|Maintenance Period||100
6490654|NCT01365455|7408977|FG004|COMPLETED|Maintenance Period||92
6490655|NCT01365455|7408973|FG000|NOT COMPLETED|Maintenance Period||29
6490656|NCT01365455|7408974|FG001|NOT COMPLETED|Maintenance Period||23
6490657|NCT01365455|7408975|FG002|NOT COMPLETED|Maintenance Period||3
6490658|NCT01365455|7408976|FG003|NOT COMPLETED|Maintenance Period||9
6490659|NCT01365455|7408977|FG004|NOT COMPLETED|Maintenance Period||13
6490660|NCT01365455|7408973|FG000|STARTED|Follow-up Period||58
6490661|NCT01365455|7408974|FG001|STARTED|Follow-up Period||47
6490662|NCT01365455|7408975|FG002|STARTED|Follow-up Period||18
6490663|NCT01365455|7408976|FG003|STARTED|Follow-up Period||0
6490664|NCT01365455|7408977|FG004|STARTED|Follow-up Period||0
6490665|NCT01365455|7408973|FG000|COMPLETED|Follow-up Period||58
6490666|NCT01365455|7408974|FG001|COMPLETED|Follow-up Period||47
6490667|NCT01365455|7408975|FG002|COMPLETED|Follow-up Period||18
6490668|NCT01365455|7408976|FG003|COMPLETED|Follow-up Period||0
6490669|NCT01365455|7408977|FG004|COMPLETED|Follow-up Period||0
6490670|NCT01365455|7408973|FG000|NOT COMPLETED|Follow-up Period||0
6490671|NCT01365455|7408974|FG001|NOT COMPLETED|Follow-up Period||0
6490672|NCT01365455|7408975|FG002|NOT COMPLETED|Follow-up Period||0
6490673|NCT01365455|7408976|FG003|NOT COMPLETED|Follow-up Period||0
6490674|NCT01365455|7408977|FG004|NOT COMPLETED|Follow-up Period||0
6490675|NCT01365468|7408997|FG000|STARTED|Overall Study||4
6490676|NCT01365468|7408998|FG001|STARTED|Overall Study||5
6490677|NCT01365468|7408997|FG000|COMPLETED|Overall Study||0
6490678|NCT01365468|7408998|FG001|COMPLETED|Overall Study||5
6490679|NCT01365468|7408997|FG000|NOT COMPLETED|Overall Study||4
6490680|NCT01365468|7408998|FG001|NOT COMPLETED|Overall Study||0
6490681|NCT01365481|7409009|FG000|STARTED|Overall Study||23
6490682|NCT01365481|7409010|FG001|STARTED|Overall Study||52
6490683|NCT01365481|7409011|FG002|STARTED|Overall Study||18
6490684|NCT01365481|7409012|FG003|STARTED|Overall Study||57
6490685|NCT01365481|7409009|FG000|COMPLETED|Overall Study||16
6490686|NCT01365481|7409010|FG001|COMPLETED|Overall Study||37
6490687|NCT01365481|7409011|FG002|COMPLETED|Overall Study||14
6490688|NCT01365481|7409012|FG003|COMPLETED|Overall Study||50
6490689|NCT01365481|7409009|FG000|NOT COMPLETED|Overall Study||7
6490690|NCT01365481|7409010|FG001|NOT COMPLETED|Overall Study||15
6490691|NCT01365481|7409011|FG002|NOT COMPLETED|Overall Study||4
6490692|NCT01365481|7409012|FG003|NOT COMPLETED|Overall Study||7
6490693|NCT01365494|7409024|FG000|STARTED|Overall Study||126
6490694|NCT01365494|7409025|FG001|STARTED|Overall Study||124
6490695|NCT01365494|7409024|FG000|COMPLETED|Overall Study||124
6490696|NCT01365494|7409025|FG001|COMPLETED|Overall Study||121
6490697|NCT01365494|7409024|FG000|NOT COMPLETED|Overall Study||2
6490698|NCT01365494|7409025|FG001|NOT COMPLETED|Overall Study||3
6490699|NCT01365507|7409034|FG000|STARTED|Overall Study||136
6490700|NCT01365507|7409035|FG001|STARTED|Overall Study||140
6490701|NCT01365507|7409034|FG000|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
6490702|NCT01365507|7409035|FG001|Exposed|Overall Study||140
6490703|NCT01365507|7409034|FG000|COMPLETED|Overall Study||127
6490704|NCT01365507|7409035|FG001|COMPLETED|Overall Study||131
6490705|NCT01365507|7409034|FG000|NOT COMPLETED|Overall Study||9
6490706|NCT01365507|7409035|FG001|NOT COMPLETED|Overall Study||9
6490707|NCT01365546|7409041|FG000|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
6555166|NCT01750918|7477324|FG000|COMPLETED|Overall Study||3
6555167|NCT01750918|7477325|FG001|COMPLETED|Overall Study||4
6555168|NCT01750918|7477326|FG002|COMPLETED|Overall Study||28
6555169|NCT01750918|7477327|FG003|COMPLETED|Overall Study||44
6555170|NCT01750918|7477328|FG004|COMPLETED|Overall Study||12
6555171|NCT01750918|7477329|FG005|COMPLETED|Overall Study||17
6555172|NCT01750918|7477330|FG006|COMPLETED|Overall Study||17
6490708|NCT01365546|7409041|FG000|COMPLETED|Overall Study||30
6490709|NCT01365546|7409041|FG000|NOT COMPLETED|Overall Study||11
6490710|NCT01365585|7409049|FG000|STARTED|Overall Study||227
6490711|NCT01365585|7409049|FG000|COMPLETED|Overall Study||227
6490712|NCT01365585|7409049|FG000|NOT COMPLETED|Overall Study||0
6490713|NCT01365611|7409053|FG000|STARTED|Overall Study||36
6490714|NCT01365611|7409053|FG000|COMPLETED|Overall Study||36
6490715|NCT01365611|7409053|FG000|NOT COMPLETED|Overall Study||0
6490716|NCT01365624|7409061|FG000|STARTED|Overall Study||15
6490717|NCT01365624|7409062|FG001|STARTED|Overall Study||15
6490718|NCT01365624|7409061|FG000|COMPLETED|Overall Study||15
6490719|NCT01365624|7409062|FG001|COMPLETED|Overall Study||15
6490720|NCT01365624|7409061|FG000|NOT COMPLETED|Overall Study||0
6490721|NCT01365624|7409062|FG001|NOT COMPLETED|Overall Study||0
6490722|NCT01365650|7409068|FG000|STARTED|Treatment A||24
6490723|NCT01365650|7409068|FG000|COMPLETED|Treatment A||24
6490724|NCT01365650|7409068|FG000|NOT COMPLETED|Treatment A||0
6490725|NCT01365650|7409068|FG000|STARTED|Treatment B||24
6490726|NCT01365650|7409068|FG000|COMPLETED|Treatment B||24
6490727|NCT01365650|7409068|FG000|NOT COMPLETED|Treatment B||0
6490728|NCT01365650|7409068|FG000|STARTED|Treatment C||24
6490729|NCT01365650|7409068|FG000|COMPLETED|Treatment C||24
6490730|NCT01365650|7409068|FG000|NOT COMPLETED|Treatment C||0
6490731|NCT01365793|7409080|FG000|STARTED|Overall Study||344
6490732|NCT01365793|7409081|FG001|STARTED|Overall Study||351
6490733|NCT01365793|7409082|FG002|STARTED|Overall Study||345
6490734|NCT01365793|7409083|FG003|STARTED|Overall Study||349
6490735|NCT01365793|7409080|FG000|COMPLETED|Overall Study||342
6490736|NCT01365793|7409081|FG001|COMPLETED|Overall Study||344
6490737|NCT01365793|7409082|FG002|COMPLETED|Overall Study||338
6490738|NCT01365793|7409083|FG003|COMPLETED|Overall Study||347
6490739|NCT01365793|7409080|FG000|NOT COMPLETED|Overall Study||2
6490740|NCT01365793|7409081|FG001|NOT COMPLETED|Overall Study||7
6490741|NCT01365793|7409082|FG002|NOT COMPLETED|Overall Study||7
6490742|NCT01365793|7409083|FG003|NOT COMPLETED|Overall Study||2
6490743|NCT01365819|7409095|FG000|STARTED|Overall Study||25
6490744|NCT01365819|7409096|FG001|STARTED|Overall Study||27
6490745|NCT01365819|7409095|FG000|COMPLETED|Overall Study||12
6490746|NCT01365819|7409096|FG001|COMPLETED|Overall Study||14
6490747|NCT01365819|7409095|FG000|NOT COMPLETED|Overall Study||13
6490748|NCT01365819|7409096|FG001|NOT COMPLETED|Overall Study||13
6490749|NCT01365845|7409102|FG000|STARTED|Induction Phase||18
6490750|NCT01365845|7409103|FG001|STARTED|Induction Phase||0
6490751|NCT01365845|7409104|FG002|STARTED|Induction Phase||0
6490752|NCT01365845|7409102|FG000|COMPLETED|Induction Phase||18
6490753|NCT01365845|7409103|FG001|COMPLETED|Induction Phase||0
6490754|NCT01365845|7409104|FG002|COMPLETED|Induction Phase||0
6490755|NCT01365845|7409102|FG000|NOT COMPLETED|Induction Phase||0
6490756|NCT01365845|7409103|FG001|NOT COMPLETED|Induction Phase||0
6490757|NCT01365845|7409104|FG002|NOT COMPLETED|Induction Phase||0
6490758|NCT01365845|7409102|FG000|STARTED|Treatment Phase||0
6490759|NCT01365845|7409103|FG001|STARTED|Treatment Phase||0
6490760|NCT01365845|7409104|FG002|STARTED|Treatment Phase||18
6490761|NCT01365845|7409102|FG000|COMPLETED|Treatment Phase||0
6490762|NCT01365845|7409103|FG001|COMPLETED|Treatment Phase||0
6490763|NCT01365845|7409104|FG002|COMPLETED|Treatment Phase||18
6490764|NCT01365845|7409102|FG000|NOT COMPLETED|Treatment Phase||0
6490765|NCT01365845|7409103|FG001|NOT COMPLETED|Treatment Phase||0
6490766|NCT01365845|7409104|FG002|NOT COMPLETED|Treatment Phase||0
6490767|NCT01365910|7409109|FG000|STARTED|Overall Study||30
6490768|NCT01365910|7409109|FG000|COMPLETED|Overall Study||0
6490769|NCT01365910|7409109|FG000|NOT COMPLETED|Overall Study||30
6490770|NCT01366196|7409115|FG000|STARTED|Overall Study||43
6490771|NCT01366196|7409116|FG001|STARTED|Overall Study||43
6490772|NCT01366196|7409115|FG000|COMPLETED|Overall Study||43
6555173|NCT01750918|7477331|FG007|COMPLETED|Overall Study||16
6555174|NCT01750918|7477324|FG000|NOT COMPLETED|Overall Study||0
6555175|NCT01750918|7477325|FG001|NOT COMPLETED|Overall Study||0
6490773|NCT01366196|7409116|FG001|COMPLETED|Overall Study||43
6490774|NCT01366196|7409115|FG000|NOT COMPLETED|Overall Study||0
6490775|NCT01366196|7409116|FG001|NOT COMPLETED|Overall Study||0
6490776|NCT01366209|7409124|FG000|STARTED|Overall Study||278
6490777|NCT01366209|7409125|FG001|STARTED|Overall Study||277
6555176|NCT01750918|7477326|FG002|NOT COMPLETED|Overall Study||8
6555177|NCT01750918|7477327|FG003|NOT COMPLETED|Overall Study||6
6555178|NCT01750918|7477328|FG004|NOT COMPLETED|Overall Study||1
6555179|NCT01750918|7477329|FG005|NOT COMPLETED|Overall Study||3
6555180|NCT01750918|7477330|FG006|NOT COMPLETED|Overall Study||3
6555181|NCT01750918|7477331|FG007|NOT COMPLETED|Overall Study||4
6555182|NCT01750931|7477361|FG000|STARTED|Period 1||14
6555183|NCT01750931|7477362|FG001|STARTED|Period 1||14
6555184|NCT01750931|7477361|FG000|COMPLETED|Period 1||14
6555185|NCT01750931|7477362|FG001|COMPLETED|Period 1||14
6555186|NCT01750931|7477361|FG000|NOT COMPLETED|Period 1||0
6555187|NCT01750931|7477362|FG001|NOT COMPLETED|Period 1||0
6555188|NCT01750931|7477361|FG000|STARTED|Wash Out||14
6555189|NCT01750931|7477362|FG001|STARTED|Wash Out||14
6555190|NCT01750931|7477361|FG000|COMPLETED|Wash Out||14
6555191|NCT01750931|7477362|FG001|COMPLETED|Wash Out||14
6555192|NCT01750931|7477361|FG000|NOT COMPLETED|Wash Out||0
6490778|NCT01366209|7409124|FG000|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
6490779|NCT01366209|7409125|FG001|COMPLETED|Overall Study||241
6490780|NCT01366209|7409124|FG000|NOT COMPLETED|Overall Study||35
6490781|NCT01366209|7409125|FG001|NOT COMPLETED|Overall Study||36
6490782|NCT01366417|7409131|FG000|STARTED|Overall Study||43
6490783|NCT01366417|7409131|FG000|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
6490784|NCT01366417|7409131|FG000|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
6490785|NCT01366417|7409131|FG000|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
6490786|NCT01366417|7409131|FG000|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
6490787|NCT01366417|7409131|FG000|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
6490788|NCT01366417|7409131|FG000|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
6490789|NCT01366417|7409131|FG000|COMPLETED|Overall Study|25 subjects included in the analysis|25
6490790|NCT01366417|7409131|FG000|NOT COMPLETED|Overall Study||18
6490791|NCT01366443|7409136|FG000|STARTED|Overall Study||288
6490792|NCT01366443|7409136|FG000|COMPLETED|Overall Study||285
6490793|NCT01366443|7409136|FG000|NOT COMPLETED|Overall Study||3
6490794|NCT01366495|7409145|FG000|STARTED|Testing Study||0
6490795|NCT01366495|7409146|FG001|STARTED|Testing Study||0
6490796|NCT01366495|7409147|FG002|STARTED|Testing Study||349
6490797|NCT01366495|7409148|FG003|STARTED|Testing Study||348
6490798|NCT01366495|7409145|FG000|COMPLETED|Testing Study||0
6490799|NCT01366495|7409146|FG001|COMPLETED|Testing Study||0
6490800|NCT01366495|7409147|FG002|COMPLETED|Testing Study||349
6490801|NCT01366495|7409148|FG003|COMPLETED|Testing Study||348
6490802|NCT01366495|7409145|FG000|NOT COMPLETED|Testing Study||0
6490803|NCT01366495|7409146|FG001|NOT COMPLETED|Testing Study||0
6490804|NCT01366495|7409147|FG002|NOT COMPLETED|Testing Study||0
6490805|NCT01366495|7409148|FG003|NOT COMPLETED|Testing Study||0
6490806|NCT01366495|7409145|FG000|STARTED|HIV Study||50
6490807|NCT01366495|7409146|FG001|STARTED|HIV Study||50
6490808|NCT01366495|7409147|FG002|STARTED|HIV Study||0
6490809|NCT01366495|7409148|FG003|STARTED|HIV Study||0
6490810|NCT01366495|7409145|FG000|COMPLETED|HIV Study||49
6490811|NCT01366495|7409146|FG001|COMPLETED|HIV Study||50
6490812|NCT01366495|7409147|FG002|COMPLETED|HIV Study||0
6490813|NCT01366495|7409148|FG003|COMPLETED|HIV Study||0
6490814|NCT01366495|7409145|FG000|NOT COMPLETED|HIV Study||1
6490815|NCT01366495|7409146|FG001|NOT COMPLETED|HIV Study||0
6490816|NCT01366495|7409147|FG002|NOT COMPLETED|HIV Study||0
6490817|NCT01366495|7409148|FG003|NOT COMPLETED|HIV Study||0
6490818|NCT01366521|7409162|FG000|STARTED|Overall Study||21
6490819|NCT01366521|7409163|FG001|STARTED|Overall Study||15
6490820|NCT01366521|7409164|FG002|STARTED|Overall Study||23
6490821|NCT01366521|7409165|FG003|STARTED|Overall Study||11
6490822|NCT01366521|7409162|FG000|COMPLETED|Overall Study||20
6490823|NCT01366521|7409163|FG001|COMPLETED|Overall Study||14
6490824|NCT01366521|7409164|FG002|COMPLETED|Overall Study||21
6490825|NCT01366521|7409165|FG003|COMPLETED|Overall Study||11
6490826|NCT01366521|7409162|FG000|NOT COMPLETED|Overall Study||1
6490827|NCT01366521|7409163|FG001|NOT COMPLETED|Overall Study||1
6490828|NCT01366521|7409164|FG002|NOT COMPLETED|Overall Study||2
6490829|NCT01366521|7409165|FG003|NOT COMPLETED|Overall Study||0
6490830|NCT01366534|7409180|FG000|STARTED|Overall Study||28
6490831|NCT01366534|7409181|FG001|STARTED|Overall Study||27
6490832|NCT01366534|7409182|FG002|STARTED|Overall Study||12
6490833|NCT01366534|7409180|FG000|COMPLETED|Overall Study||26
6490834|NCT01366534|7409181|FG001|COMPLETED|Overall Study||25
6490835|NCT01366534|7409182|FG002|COMPLETED|Overall Study||12
6555193|NCT01750931|7477362|FG001|NOT COMPLETED|Wash Out||0
6555194|NCT01750931|7477361|FG000|STARTED|Period 2||14
6555195|NCT01750931|7477362|FG001|STARTED|Period 2||14
6555196|NCT01750931|7477361|FG000|COMPLETED|Period 2||14
6555197|NCT01750931|7477362|FG001|COMPLETED|Period 2||14
6555198|NCT01750931|7477361|FG000|NOT COMPLETED|Period 2||0
6555199|NCT01750931|7477362|FG001|NOT COMPLETED|Period 2||0
6555200|NCT01751022|7477371|FG000|STARTED|Overall Study||499
6490836|NCT01366534|7409180|FG000|NOT COMPLETED|Overall Study||2
6490837|NCT01366534|7409181|FG001|NOT COMPLETED|Overall Study||2
6490838|NCT01366534|7409182|FG002|NOT COMPLETED|Overall Study||0
6490839|NCT01366638|7409193|FG000|STARTED|Overall Study||24
6490840|NCT01366638|7409194|FG001|STARTED|Overall Study||29
6490841|NCT01366638|7409195|FG002|STARTED|Overall Study||26
6490842|NCT01366638|7409193|FG000|COMPLETED|Overall Study||23
6490843|NCT01366638|7409194|FG001|COMPLETED|Overall Study||29
6490844|NCT01366638|7409195|FG002|COMPLETED|Overall Study||20
6490845|NCT01366638|7409193|FG000|NOT COMPLETED|Overall Study||1
6490846|NCT01366638|7409194|FG001|NOT COMPLETED|Overall Study||0
6490847|NCT01366638|7409195|FG002|NOT COMPLETED|Overall Study||6
6555201|NCT01751022|7477372|FG001|STARTED|Overall Study||326
6555202|NCT01751022|7477373|FG002|STARTED|Overall Study||300
6555203|NCT01751022|7477371|FG000|COMPLETED|Overall Study|6 month visit|443
6555204|NCT01751022|7477372|FG001|COMPLETED|Overall Study|6 month visit|282
6490848|NCT01366846|7409207|FG000|STARTED|Overall Study||235
6490849|NCT01366846|7409208|FG001|STARTED|Overall Study||228
6490850|NCT01366846|7409209|FG002|STARTED|Overall Study||47
6490851|NCT01366846|7409210|FG003|STARTED|Overall Study||46
6490852|NCT01366846|7409207|FG000|COMPLETED|Overall Study||232
6490853|NCT01366846|7409208|FG001|COMPLETED|Overall Study||224
6490854|NCT01366846|7409209|FG002|COMPLETED|Overall Study||46
6490855|NCT01366846|7409210|FG003|COMPLETED|Overall Study||45
6490856|NCT01366846|7409207|FG000|NOT COMPLETED|Overall Study||3
6490857|NCT01366846|7409208|FG001|NOT COMPLETED|Overall Study||4
6490858|NCT01366846|7409209|FG002|NOT COMPLETED|Overall Study||1
6490859|NCT01366846|7409210|FG003|NOT COMPLETED|Overall Study||1
6490860|NCT01366872|7409223|FG000|STARTED|Overall Study||50
6490861|NCT01366872|7409223|FG000|COMPLETED|Overall Study||50
6490862|NCT01366872|7409223|FG000|NOT COMPLETED|Overall Study||0
6490863|NCT01366885|7409227|FG000|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
6490864|NCT01366885|7409227|FG000|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
6490865|NCT01366885|7409227|FG000|NOT COMPLETED|Overall Study||1
6490866|NCT01366976|7409233|FG000|STARTED|Overall Study||30
6490867|NCT01366976|7409234|FG001|STARTED|Overall Study||30
6490868|NCT01366976|7409233|FG000|COMPLETED|Overall Study||30
6490869|NCT01366976|7409234|FG001|COMPLETED|Overall Study||30
6490870|NCT01366976|7409233|FG000|NOT COMPLETED|Overall Study||0
6490871|NCT01366976|7409234|FG001|NOT COMPLETED|Overall Study||0
6490872|NCT01367080|7409242|FG000|STARTED|1st Administration||6
6490873|NCT01367080|7409243|FG001|STARTED|1st Administration||6
6490874|NCT01367080|7409242|FG000|COMPLETED|1st Administration||6
6490875|NCT01367080|7409243|FG001|COMPLETED|1st Administration||6
6490876|NCT01367080|7409242|FG000|NOT COMPLETED|1st Administration||0
6490877|NCT01367080|7409243|FG001|NOT COMPLETED|1st Administration||0
6490878|NCT01367080|7409242|FG000|STARTED|2nd Administration||6
6490879|NCT01367080|7409243|FG001|STARTED|2nd Administration||6
6490880|NCT01367080|7409242|FG000|COMPLETED|2nd Administration||6
6490881|NCT01367080|7409243|FG001|COMPLETED|2nd Administration||6
6490882|NCT01367080|7409242|FG000|NOT COMPLETED|2nd Administration||0
6490883|NCT01367080|7409243|FG001|NOT COMPLETED|2nd Administration||0
6490884|NCT01367119|7409253|FG000|STARTED|Overall Study||21
6490885|NCT01367119|7409254|FG001|STARTED|Overall Study||17
6490886|NCT01367119|7409253|FG000|COMPLETED|Overall Study||19
6490887|NCT01367119|7409254|FG001|COMPLETED|Overall Study||16
6490888|NCT01367119|7409253|FG000|NOT COMPLETED|Overall Study||2
6490889|NCT01367119|7409254|FG001|NOT COMPLETED|Overall Study||1
6490890|NCT01367158|7409271|FG000|STARTED|Overall Study||25
6490891|NCT01367158|7409272|FG001|STARTED|Overall Study||49
6490892|NCT01367158|7409273|FG002|STARTED|Overall Study||24
6490893|NCT01367158|7409274|FG003|STARTED|Overall Study||49
6490894|NCT01367158|7409275|FG004|STARTED|Overall Study||25
6490895|NCT01367158|7409276|FG005|STARTED|Overall Study||48
6490896|NCT01367158|7409277|FG006|STARTED|Overall Study||25
6490897|NCT01367158|7409278|FG007|STARTED|Overall Study||49
6490898|NCT01367158|7409279|FG008|STARTED|Overall Study||23
6490899|NCT01367158|7409280|FG009|STARTED|Overall Study||50
6490900|NCT01367158|7409281|FG010|STARTED|Overall Study||73
6490901|NCT01367158|7409271|FG000|COMPLETED|Overall Study||25
6490902|NCT01367158|7409272|FG001|COMPLETED|Overall Study||46
6490903|NCT01367158|7409273|FG002|COMPLETED|Overall Study||23
6490904|NCT01367158|7409274|FG003|COMPLETED|Overall Study||48
6490905|NCT01367158|7409275|FG004|COMPLETED|Overall Study||23
6490906|NCT01367158|7409276|FG005|COMPLETED|Overall Study||46
6490907|NCT01367158|7409277|FG006|COMPLETED|Overall Study||25
6490908|NCT01367158|7409278|FG007|COMPLETED|Overall Study||47
6490909|NCT01367158|7409279|FG008|COMPLETED|Overall Study||23
6490910|NCT01367158|7409280|FG009|COMPLETED|Overall Study||50
6490911|NCT01367158|7409281|FG010|COMPLETED|Overall Study||72
6490912|NCT01367158|7409271|FG000|NOT COMPLETED|Overall Study||0
6490913|NCT01367158|7409272|FG001|NOT COMPLETED|Overall Study||3
6490914|NCT01367158|7409273|FG002|NOT COMPLETED|Overall Study||1
6490915|NCT01367158|7409274|FG003|NOT COMPLETED|Overall Study||1
6490916|NCT01367158|7409275|FG004|NOT COMPLETED|Overall Study||2
6490917|NCT01367158|7409276|FG005|NOT COMPLETED|Overall Study||2
6490918|NCT01367158|7409277|FG006|NOT COMPLETED|Overall Study||0
6490919|NCT01367158|7409278|FG007|NOT COMPLETED|Overall Study||2
6555205|NCT01751022|7477373|FG002|COMPLETED|Overall Study|6 month visit|273
6490920|NCT01367158|7409279|FG008|NOT COMPLETED|Overall Study||0
6490921|NCT01367158|7409280|FG009|NOT COMPLETED|Overall Study||0
6490922|NCT01367158|7409281|FG010|NOT COMPLETED|Overall Study||1
6490923|NCT01367236|7409318|FG000|STARTED|Overall Study||30
6555206|NCT01751022|7477371|FG000|NOT COMPLETED|Overall Study||56
6555207|NCT01751022|7477372|FG001|NOT COMPLETED|Overall Study||44
6555208|NCT01751022|7477373|FG002|NOT COMPLETED|Overall Study||27
6555209|NCT01751061|7477402|FG000|STARTED|Overall Study||210
6555210|NCT01751061|7477403|FG001|STARTED|Overall Study||206
6555211|NCT01751061|7477402|FG000|COMPLETED|Overall Study||154
6490924|NCT01367236|7409319|FG001|STARTED|Overall Study||30
6490925|NCT01367236|7409318|FG000|COMPLETED|Overall Study||27
6490926|NCT01367236|7409319|FG001|COMPLETED|Overall Study||29
6490927|NCT01367236|7409318|FG000|NOT COMPLETED|Overall Study||3
6490928|NCT01367236|7409319|FG001|NOT COMPLETED|Overall Study||1
6490929|NCT01367249|7409327|FG000|STARTED|Overall Study||222
6490930|NCT01367249|7409328|FG001|STARTED|Overall Study||218
6490931|NCT01367249|7409327|FG000|COMPLETED|Overall Study||213
6490932|NCT01367249|7409328|FG001|COMPLETED|Overall Study||202
6490933|NCT01367249|7409327|FG000|NOT COMPLETED|Overall Study||9
6490934|NCT01367249|7409328|FG001|NOT COMPLETED|Overall Study||16
6490935|NCT01367262|7409334|FG000|STARTED|Overall Study||6
6490936|NCT01367262|7409334|FG000|COMPLETED|Overall Study||6
6490937|NCT01367262|7409334|FG000|NOT COMPLETED|Overall Study||0
6490938|NCT01367275|7409338|FG000|STARTED|Overall Study||8
6490939|NCT01367275|7409338|FG000|COMPLETED|Overall Study||5
6490940|NCT01367275|7409338|FG000|NOT COMPLETED|Overall Study||3
6490941|NCT01367444|7409349|FG000|STARTED|Overall Study||4
6490942|NCT01367444|7409350|FG001|STARTED|Overall Study||4
6490943|NCT01367444|7409351|FG002|STARTED|Overall Study||4
6490944|NCT01367444|7409352|FG003|STARTED|Overall Study||4
6490945|NCT01367444|7409353|FG004|STARTED|Overall Study||6
6490946|NCT01367444|7409354|FG005|STARTED|Overall Study||4
6490947|NCT01367444|7409355|FG006|STARTED|Overall Study||1
6490948|NCT01367444|7409349|FG000|COMPLETED|Overall Study||4
6490949|NCT01367444|7409350|FG001|COMPLETED|Overall Study||4
6490950|NCT01367444|7409351|FG002|COMPLETED|Overall Study||4
6490951|NCT01367444|7409352|FG003|COMPLETED|Overall Study||4
6490952|NCT01367444|7409353|FG004|COMPLETED|Overall Study||6
6490953|NCT01367444|7409354|FG005|COMPLETED|Overall Study||4
6490954|NCT01367444|7409355|FG006|COMPLETED|Overall Study||1
6490955|NCT01367444|7409349|FG000|NOT COMPLETED|Overall Study||0
6490956|NCT01367444|7409350|FG001|NOT COMPLETED|Overall Study||0
6490957|NCT01367444|7409351|FG002|NOT COMPLETED|Overall Study||0
6490958|NCT01367444|7409352|FG003|NOT COMPLETED|Overall Study||0
6490959|NCT01367444|7409353|FG004|NOT COMPLETED|Overall Study||0
6490960|NCT01367444|7409354|FG005|NOT COMPLETED|Overall Study||0
6490961|NCT01367444|7409355|FG006|NOT COMPLETED|Overall Study||0
6490962|NCT01367457|7409374|FG000|STARTED|Overall Study||193
6490963|NCT01367457|7409375|FG001|STARTED|Overall Study||23
6490964|NCT01367457|7409376|FG002|STARTED|Overall Study||26
6490965|NCT01367457|7409374|FG000|COMPLETED|Overall Study||5
6490966|NCT01367457|7409375|FG001|COMPLETED|Overall Study||23
6490967|NCT01367457|7409376|FG002|COMPLETED|Overall Study||26
6490968|NCT01367457|7409374|FG000|NOT COMPLETED|Overall Study||188
6490969|NCT01367457|7409375|FG001|NOT COMPLETED|Overall Study||0
6490970|NCT01367457|7409376|FG002|NOT COMPLETED|Overall Study||0
6490971|NCT01367665|7409386|FG000|STARTED|Overall Study||1119
6490972|NCT01367665|7409387|FG001|STARTED|Overall Study||96
6490973|NCT01367665|7409386|FG000|COMPLETED|Overall Study||677
6490974|NCT01367665|7409387|FG001|COMPLETED|Overall Study||41
6490975|NCT01367665|7409386|FG000|NOT COMPLETED|Overall Study||442
6490976|NCT01367665|7409387|FG001|NOT COMPLETED|Overall Study||55
6501785|NCT01431274|7420431|FG001|STARTED|Overall Study||525
6501786|NCT01431274|7420432|FG002|STARTED|Overall Study||527
6501787|NCT01431274|7420433|FG003|STARTED|Overall Study||522
6501788|NCT01431274|7420434|FG004|STARTED|Overall Study||522
6501789|NCT01431274|7420430|FG000|COMPLETED|Overall Study||431
6501790|NCT01431274|7420431|FG001|COMPLETED|Overall Study||448
6501791|NCT01431274|7420432|FG002|COMPLETED|Overall Study||455
6501792|NCT01431274|7420433|FG003|COMPLETED|Overall Study||462
6501793|NCT01431274|7420434|FG004|COMPLETED|Overall Study||466
6555212|NCT01751061|7477403|FG001|COMPLETED|Overall Study||172
6555213|NCT01751061|7477402|FG000|NOT COMPLETED|Overall Study||56
6501794|NCT01431274|7420430|FG000|NOT COMPLETED|Overall Study||97
6501795|NCT01431274|7420431|FG001|NOT COMPLETED|Overall Study||77
6501796|NCT01431274|7420432|FG002|NOT COMPLETED|Overall Study||72
6501797|NCT01431274|7420433|FG003|NOT COMPLETED|Overall Study||60
6501798|NCT01431274|7420434|FG004|NOT COMPLETED|Overall Study||56
6501799|NCT01431287|7420451|FG000|STARTED|Overall Study|started are actually the randomized|510
6501800|NCT01431287|7420452|FG001|STARTED|Overall Study||507
6501801|NCT01431287|7420453|FG002|STARTED|Overall Study||507
6501802|NCT01431287|7420454|FG003|STARTED|Overall Study||508
6501803|NCT01431287|7420455|FG004|STARTED|Overall Study||507
6501804|NCT01431287|7420451|FG000|COMPLETED|Overall Study||412
6501805|NCT01431287|7420452|FG001|COMPLETED|Overall Study||409
6555214|NCT01751061|7477403|FG001|NOT COMPLETED|Overall Study||34
6501806|NCT01431287|7420453|FG002|COMPLETED|Overall Study||410
6501807|NCT01431287|7420454|FG003|COMPLETED|Overall Study||445
6555215|NCT01751087|7477412|FG000|STARTED|Overall Study||100
6501808|NCT01431287|7420455|FG004|COMPLETED|Overall Study||430
6501809|NCT01431287|7420451|FG000|NOT COMPLETED|Overall Study||98
6501810|NCT01431287|7420452|FG001|NOT COMPLETED|Overall Study||98
6490977|NCT01367704|7409396|FG000|STARTED|Overall Study||998
6490978|NCT01367704|7409397|FG001|STARTED|Overall Study||1008
6490979|NCT01367704|7409396|FG000|COMPLETED|Overall Study||951
6490980|NCT01367704|7409397|FG001|COMPLETED|Overall Study||847
6490981|NCT01367704|7409396|FG000|NOT COMPLETED|Overall Study||47
6490982|NCT01367704|7409397|FG001|NOT COMPLETED|Overall Study||161
6490983|NCT01367834|7409405|FG000|STARTED|Overall Study||11
6490984|NCT01367834|7409406|FG001|STARTED|Overall Study||6
6490985|NCT01367834|7409405|FG000|COMPLETED|Overall Study||9
6490986|NCT01367834|7409406|FG001|COMPLETED|Overall Study||3
6490987|NCT01367834|7409405|FG000|NOT COMPLETED|Overall Study||2
6490988|NCT01367834|7409406|FG001|NOT COMPLETED|Overall Study||3
6490989|NCT01367847|7409414|FG000|STARTED|Overall Study||10
6555216|NCT01751087|7477413|FG001|STARTED|Overall Study||100
6555217|NCT01751087|7477414|FG002|STARTED|Overall Study||100
6555218|NCT01751087|7477412|FG000|COMPLETED|Overall Study||99
6555219|NCT01751087|7477413|FG001|COMPLETED|Overall Study||100
6555220|NCT01751087|7477414|FG002|COMPLETED|Overall Study||99
6748925|NCT03421730|7677001|FG002|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6490990|NCT01367847|7409415|FG001|STARTED|Overall Study||9
6490991|NCT01367847|7409414|FG000|COMPLETED|Overall Study||8
6490992|NCT01367847|7409415|FG001|COMPLETED|Overall Study||7
6490993|NCT01367847|7409414|FG000|NOT COMPLETED|Overall Study||2
6490994|NCT01367847|7409415|FG001|NOT COMPLETED|Overall Study||2
6490995|NCT01367860|7409424|FG000|STARTED|Overall Study||20
6490996|NCT01367860|7409425|FG001|STARTED|Overall Study||20
6490997|NCT01367860|7409424|FG000|COMPLETED|Overall Study||20
6490998|NCT01367860|7409425|FG001|COMPLETED|Overall Study||20
6490999|NCT01367860|7409424|FG000|NOT COMPLETED|Overall Study||0
6491000|NCT01367860|7409425|FG001|NOT COMPLETED|Overall Study||0
6491001|NCT01367886|7409431|FG000|STARTED|Overall Study||21
6491002|NCT01367886|7409431|FG000|COMPLETED|Overall Study||14
6491003|NCT01367886|7409431|FG000|NOT COMPLETED|Overall Study||7
6491004|NCT01368042|7409436|FG000|STARTED|Overall Study||265
6491005|NCT01368042|7409436|FG000|COMPLETED|Overall Study||235
6491006|NCT01368042|7409436|FG000|NOT COMPLETED|Overall Study||30
6491007|NCT01368081|7409453|FG000|STARTED|Overall Study||136
6491008|NCT01368081|7409454|FG001|STARTED|Overall Study||137
6491009|NCT01368081|7409455|FG002|STARTED|Overall Study||63
6491010|NCT01368081|7409456|FG003|STARTED|Overall Study||68
6491011|NCT01368081|7409457|FG004|STARTED|Overall Study||65
6491012|NCT01368081|7409458|FG005|STARTED|Overall Study||137
6491013|NCT01368081|7409459|FG006|STARTED|Overall Study||136
6491014|NCT01368081|7409460|FG007|STARTED|Overall Study||69
6491015|NCT01368081|7409461|FG008|STARTED|Overall Study||70
6491016|NCT01368081|7409462|FG009|STARTED|Overall Study||68
6491017|NCT01368081|7409463|FG010|STARTED|Overall Study||71
6491018|NCT01368081|7409464|FG011|STARTED|Overall Study||70
6491019|NCT01368081|7409465|FG012|STARTED|Overall Study||70
6491020|NCT01368081|7409453|FG000|COMPLETED|Overall Study||126
6491021|NCT01368081|7409454|FG001|COMPLETED|Overall Study||128
6491022|NCT01368081|7409455|FG002|COMPLETED|Overall Study||59
6491023|NCT01368081|7409456|FG003|COMPLETED|Overall Study||63
6491024|NCT01368081|7409457|FG004|COMPLETED|Overall Study||63
6491025|NCT01368081|7409458|FG005|COMPLETED|Overall Study||127
6491026|NCT01368081|7409459|FG006|COMPLETED|Overall Study||124
6491027|NCT01368081|7409460|FG007|COMPLETED|Overall Study||62
6491028|NCT01368081|7409461|FG008|COMPLETED|Overall Study||62
6491029|NCT01368081|7409462|FG009|COMPLETED|Overall Study||58
6491030|NCT01368081|7409463|FG010|COMPLETED|Overall Study||62
6491031|NCT01368081|7409464|FG011|COMPLETED|Overall Study||67
6491032|NCT01368081|7409465|FG012|COMPLETED|Overall Study||63
6491033|NCT01368081|7409453|FG000|NOT COMPLETED|Overall Study||10
6491034|NCT01368081|7409454|FG001|NOT COMPLETED|Overall Study||9
6491035|NCT01368081|7409455|FG002|NOT COMPLETED|Overall Study||4
6491036|NCT01368081|7409456|FG003|NOT COMPLETED|Overall Study||5
6491037|NCT01368081|7409457|FG004|NOT COMPLETED|Overall Study||2
6491038|NCT01368081|7409458|FG005|NOT COMPLETED|Overall Study||10
6491039|NCT01368081|7409459|FG006|NOT COMPLETED|Overall Study||12
6491040|NCT01368081|7409460|FG007|NOT COMPLETED|Overall Study||7
6491041|NCT01368081|7409461|FG008|NOT COMPLETED|Overall Study||8
6748926|NCT03421730|7677002|FG003|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748927|NCT03421730|7677003|FG004|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748928|NCT03421730|7677004|FG005|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748929|NCT03421730|7677005|FG006|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748930|NCT03421730|7677006|FG007|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748931|NCT03421730|7677007|FG008|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748932|NCT03421730|7677008|FG009|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748933|NCT03421730|7677009|FG010|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748934|NCT03421730|7677010|FG011|NOT COMPLETED|Second Intervention (Day 8±3, Visit 3)||0
6748935|NCT03421886|7677026|FG000|STARTED|Overall Study||30
6491042|NCT01368081|7409462|FG009|NOT COMPLETED|Overall Study||10
6491043|NCT01368081|7409463|FG010|NOT COMPLETED|Overall Study||9
6491044|NCT01368081|7409464|FG011|NOT COMPLETED|Overall Study||3
6491045|NCT01368081|7409465|FG012|NOT COMPLETED|Overall Study||7
6555221|NCT01751087|7477412|FG000|NOT COMPLETED|Overall Study||1
6491046|NCT01368211|7409495|FG000|STARTED|First Platelets Transfusion||8
6555222|NCT01751087|7477413|FG001|NOT COMPLETED|Overall Study||0
6491047|NCT01368211|7409496|FG001|STARTED|First Platelets Transfusion||7
6491048|NCT01368211|7409495|FG000|COMPLETED|First Platelets Transfusion||8
6491049|NCT01368211|7409496|FG001|COMPLETED|First Platelets Transfusion||7
6491050|NCT01368211|7409495|FG000|NOT COMPLETED|First Platelets Transfusion||0
6491051|NCT01368211|7409496|FG001|NOT COMPLETED|First Platelets Transfusion||0
6491052|NCT01368211|7409495|FG000|STARTED|Second Platelets Transfusion||8
6491053|NCT01368211|7409496|FG001|STARTED|Second Platelets Transfusion||7
6491054|NCT01368211|7409495|FG000|COMPLETED|Second Platelets Transfusion||7
6491055|NCT01368211|7409496|FG001|COMPLETED|Second Platelets Transfusion||5
6491056|NCT01368211|7409495|FG000|NOT COMPLETED|Second Platelets Transfusion||1
6491057|NCT01368211|7409496|FG001|NOT COMPLETED|Second Platelets Transfusion||2
6491058|NCT01368263|7409505|FG000|STARTED|Overall Study||6
6555223|NCT01751087|7477414|FG002|NOT COMPLETED|Overall Study||1
6555224|NCT01751113|7477422|FG000|STARTED|Treatment Period 1 (4 Weeks)||8
6555225|NCT01751113|7477423|FG001|STARTED|Treatment Period 1 (4 Weeks)||8
6555226|NCT01751113|7477424|FG002|STARTED|Treatment Period 1 (4 Weeks)||9
6491059|NCT01368263|7409506|FG001|STARTED|Overall Study||1
6491060|NCT01368263|7409507|FG002|STARTED|Overall Study||1
6491061|NCT01368263|7409505|FG000|COMPLETED|Overall Study||6
6491062|NCT01368263|7409506|FG001|COMPLETED|Overall Study||1
6491063|NCT01368263|7409507|FG002|COMPLETED|Overall Study||1
6491064|NCT01368263|7409505|FG000|NOT COMPLETED|Overall Study||0
6491065|NCT01368263|7409506|FG001|NOT COMPLETED|Overall Study||0
6491066|NCT01368263|7409507|FG002|NOT COMPLETED|Overall Study||0
6491067|NCT01368276|7409517|FG000|STARTED|Overall Study||3
6491068|NCT01368276|7409518|FG001|STARTED|Overall Study||28
6491069|NCT01368276|7409517|FG000|COMPLETED|Overall Study||2
6491070|NCT01368276|7409518|FG001|COMPLETED|Overall Study||18
6491071|NCT01368276|7409517|FG000|NOT COMPLETED|Overall Study||1
6491072|NCT01368276|7409518|FG001|NOT COMPLETED|Overall Study||10
6491073|NCT01368406|7409526|FG000|STARTED|Overall Study||81
6491074|NCT01368406|7409527|FG001|STARTED|Overall Study||79
6491075|NCT01368406|7409526|FG000|COMPLETED|Overall Study||60
6491076|NCT01368406|7409527|FG001|COMPLETED|Overall Study||66
6491077|NCT01368406|7409526|FG000|NOT COMPLETED|Overall Study||21
6491078|NCT01368406|7409527|FG001|NOT COMPLETED|Overall Study||13
6491079|NCT01368432|7409535|FG000|STARTED|Overall Study||6
6491080|NCT01368432|7409536|FG001|STARTED|Overall Study||8
6491081|NCT01368432|7409535|FG000|COMPLETED|Overall Study||6
6491082|NCT01368432|7409536|FG001|COMPLETED|Overall Study||7
6491083|NCT01368432|7409535|FG000|NOT COMPLETED|Overall Study||0
6491084|NCT01368432|7409536|FG001|NOT COMPLETED|Overall Study||1
6491085|NCT01368497|7409556|FG000|STARTED|Overall Study||60
6491086|NCT01368497|7409556|FG000|End of Treatment|Overall Study|Five discontinued study drugs early and completed the follow-up period per protocol.|60
6491087|NCT01368497|7409556|FG000|COMPLETED|Overall Study||58
6491088|NCT01368497|7409556|FG000|NOT COMPLETED|Overall Study||2
6491089|NCT01368536|7409563|FG000|STARTED|Overall Study||138
6491090|NCT01368536|7409564|FG001|STARTED|Overall Study||137
6491091|NCT01368536|7409565|FG002|STARTED|Overall Study||142
6491092|NCT01368536|7409563|FG000|Full Analysis Set|Overall Study||138
6491093|NCT01368536|7409564|FG001|Full Analysis Set|Overall Study||137
6491094|NCT01368536|7409565|FG002|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
6491095|NCT01368536|7409563|FG000|COMPLETED|Overall Study||87
6491096|NCT01368536|7409564|FG001|COMPLETED|Overall Study||78
6491097|NCT01368536|7409565|FG002|COMPLETED|Overall Study||83
6491098|NCT01368536|7409563|FG000|NOT COMPLETED|Overall Study||51
6491099|NCT01368536|7409564|FG001|NOT COMPLETED|Overall Study||59
6491100|NCT01368536|7409565|FG002|NOT COMPLETED|Overall Study||59
6491101|NCT01368562|7409574|FG000|STARTED|Overall Study||26
6491102|NCT01368562|7409574|FG000|Received at Least 1 Dose of Study Drug|Overall Study||25
6491103|NCT01368562|7409574|FG000|COMPLETED|Overall Study||7
6491104|NCT01368562|7409574|FG000|NOT COMPLETED|Overall Study||19
6491105|NCT01368614|7409578|FG000|STARTED|Screening Period||90
6491106|NCT01368614|7409579|FG001|STARTED|Screening Period||0
6491107|NCT01368614|7409580|FG002|STARTED|Screening Period||0
6491108|NCT01368614|7409581|FG003|STARTED|Screening Period||0
6491109|NCT01368614|7409578|FG000|COMPLETED|Screening Period||32
6491110|NCT01368614|7409579|FG001|COMPLETED|Screening Period||0
6491111|NCT01368614|7409580|FG002|COMPLETED|Screening Period||0
6491112|NCT01368614|7409581|FG003|COMPLETED|Screening Period||0
6491113|NCT01368614|7409578|FG000|NOT COMPLETED|Screening Period||58
6491114|NCT01368614|7409579|FG001|NOT COMPLETED|Screening Period||0
6491115|NCT01368614|7409580|FG002|NOT COMPLETED|Screening Period||0
6491116|NCT01368614|7409581|FG003|NOT COMPLETED|Screening Period||0
6491117|NCT01368614|7409578|FG000|STARTED|Study Period||0
6491118|NCT01368614|7409579|FG001|STARTED|Study Period||11
6491119|NCT01368614|7409580|FG002|STARTED|Study Period||10
6491120|NCT01368614|7409581|FG003|STARTED|Study Period||11
6491121|NCT01368614|7409578|FG000|COMPLETED|Study Period||0
6491122|NCT01368614|7409579|FG001|COMPLETED|Study Period||10
6491123|NCT01368614|7409580|FG002|COMPLETED|Study Period||8
6491124|NCT01368614|7409581|FG003|COMPLETED|Study Period||8
6491125|NCT01368614|7409578|FG000|NOT COMPLETED|Study Period||0
6491126|NCT01368614|7409579|FG001|NOT COMPLETED|Study Period||1
6491127|NCT01368614|7409580|FG002|NOT COMPLETED|Study Period||2
6491128|NCT01368614|7409581|FG003|NOT COMPLETED|Study Period||3
6491129|NCT01368653|7409591|FG000|STARTED|Overall Study||47
6491130|NCT01368653|7409592|FG001|STARTED|Overall Study||46
6491131|NCT01368653|7409591|FG000|Completed 4-week Follow-up|Overall Study||44
6491132|NCT01368653|7409592|FG001|Completed 4-week Follow-up|Overall Study||37
6491133|NCT01368653|7409591|FG000|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
6491134|NCT01368653|7409592|FG001|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
6491135|NCT01368653|7409591|FG000|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
6491136|NCT01368653|7409592|FG001|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
6491137|NCT01368653|7409591|FG000|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
6491138|NCT01368653|7409592|FG001|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
6491139|NCT01368653|7409591|FG000|Randomized to Advice Only in Phase 2|Overall Study||10
6491140|NCT01368653|7409592|FG001|Randomized to Advice Only in Phase 2|Overall Study||10
6491141|NCT01368653|7409591|FG000|COMPLETED|Overall Study||41
6491142|NCT01368653|7409592|FG001|COMPLETED|Overall Study||37
6491143|NCT01368653|7409591|FG000|NOT COMPLETED|Overall Study||6
6491144|NCT01368653|7409592|FG001|NOT COMPLETED|Overall Study||9
6491145|NCT01368809|7409607|FG000|STARTED|Overall Study||50
6491146|NCT01368809|7409608|FG001|STARTED|Overall Study||50
6491147|NCT01368809|7409607|FG000|COMPLETED|Overall Study||50
6491148|NCT01368809|7409608|FG001|COMPLETED|Overall Study||50
6491149|NCT01368809|7409607|FG000|NOT COMPLETED|Overall Study||0
6491150|NCT01368809|7409608|FG001|NOT COMPLETED|Overall Study||0
6491151|NCT01368835|7409616|FG000|STARTED|Overall Study|103 Subjects Enrolled|103
6491152|NCT01368835|7409616|FG000|COMPLETED|Overall Study||70
6491153|NCT01368835|7409616|FG000|NOT COMPLETED|Overall Study||33
6491154|NCT01368874|7409624|FG000|STARTED|Overall Study||34
6491155|NCT01368874|7409625|FG001|STARTED|Overall Study||5
6491156|NCT01368874|7409626|FG002|STARTED|Overall Study||25
6491157|NCT01368874|7409624|FG000|COMPLETED|Overall Study||31
6491158|NCT01368874|7409625|FG001|COMPLETED|Overall Study||5
6491159|NCT01368874|7409626|FG002|COMPLETED|Overall Study||24
6491160|NCT01368874|7409624|FG000|NOT COMPLETED|Overall Study||3
6491161|NCT01368874|7409625|FG001|NOT COMPLETED|Overall Study||0
6491162|NCT01368874|7409626|FG002|NOT COMPLETED|Overall Study||1
6491163|NCT01368900|7409668|FG000|STARTED|Overall Study||68
6491164|NCT01368900|7409668|FG000|COMPLETED|Overall Study||61
6491165|NCT01368900|7409668|FG000|NOT COMPLETED|Overall Study||7
6491166|NCT01368965|7409674|FG000|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
6491167|NCT01368965|7409674|FG000|Subject Withdrawal Prior to Treatment|Overall Study||2
6491168|NCT01368965|7409674|FG000|COMPLETED|Overall Study||40
6491169|NCT01368965|7409674|FG000|NOT COMPLETED|Overall Study||12
6491170|NCT01369030|7409680|FG000|STARTED|Overall Study||594
6491171|NCT01369030|7409680|FG000|COMPLETED|Overall Study||554
6491172|NCT01369030|7409680|FG000|NOT COMPLETED|Overall Study||40
6491173|NCT01369069|7409686|FG000|STARTED|Overall Study||581
6491174|NCT01369069|7409687|FG001|STARTED|Overall Study||570
6491175|NCT01369069|7409686|FG000|COMPLETED|Overall Study||564
6491176|NCT01369069|7409687|FG001|COMPLETED|Overall Study||554
6491177|NCT01369069|7409686|FG000|NOT COMPLETED|Overall Study||17
6491178|NCT01369069|7409687|FG001|NOT COMPLETED|Overall Study||16
6491179|NCT01369108|7409693|FG000|STARTED|Overall Study|120 teeth|60
6491180|NCT01369108|7409693|FG000|COMPLETED|Overall Study||49
6491181|NCT01369108|7409693|FG000|NOT COMPLETED|Overall Study||11
6491182|NCT01369199|7409698|FG000|STARTED|Overall Study||28
6491183|NCT01369199|7409698|FG000|End of Treatment (EOT)|Overall Study|1 withdrew consent before treatment,1 missed end of treatment (EOT) visit but completed follow-up.|26
6491184|NCT01369199|7409698|FG000|COMPLETED|Overall Study||25
6491185|NCT01369199|7409698|FG000|NOT COMPLETED|Overall Study||3
6491186|NCT01369225|7409708|FG000|STARTED|Overall Study||6
6491187|NCT01369225|7409709|FG001|STARTED|Overall Study||3
6491188|NCT01369225|7409710|FG002|STARTED|Overall Study||12
6491189|NCT01369225|7409711|FG003|STARTED|Overall Study||10
6555227|NCT01751113|7477425|FG003|STARTED|Treatment Period 1 (4 Weeks)||9
6555228|NCT01751113|7477426|FG004|STARTED|Treatment Period 1 (4 Weeks)||9
6555229|NCT01751113|7477427|FG005|STARTED|Treatment Period 1 (4 Weeks)||10
6555230|NCT01751113|7477422|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||8
6555231|NCT01751113|7477423|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||8
6555232|NCT01751113|7477424|FG002|COMPLETED|Treatment Period 1 (4 Weeks)||9
6555233|NCT01751113|7477425|FG003|COMPLETED|Treatment Period 1 (4 Weeks)||8
6555234|NCT01751113|7477426|FG004|COMPLETED|Treatment Period 1 (4 Weeks)||8
6555235|NCT01751113|7477427|FG005|COMPLETED|Treatment Period 1 (4 Weeks)||10
6555236|NCT01751113|7477422|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6555237|NCT01751113|7477423|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6491190|NCT01369225|7409712|FG004|STARTED|Overall Study||12
6491191|NCT01369225|7409713|FG005|STARTED|Overall Study||9
6491192|NCT01369225|7409708|FG000|COMPLETED|Overall Study||4
6491193|NCT01369225|7409709|FG001|COMPLETED|Overall Study||3
6491194|NCT01369225|7409710|FG002|COMPLETED|Overall Study||9
6491195|NCT01369225|7409711|FG003|COMPLETED|Overall Study||8
6562911|NCT01803464|7485826|FG000|COMPLETED|Overall Study||4
6491196|NCT01369225|7409712|FG004|COMPLETED|Overall Study||10
6491197|NCT01369225|7409713|FG005|COMPLETED|Overall Study||9
6491198|NCT01369225|7409708|FG000|NOT COMPLETED|Overall Study||2
6491199|NCT01369225|7409709|FG001|NOT COMPLETED|Overall Study||0
6491200|NCT01369225|7409710|FG002|NOT COMPLETED|Overall Study||3
6491201|NCT01369225|7409711|FG003|NOT COMPLETED|Overall Study||2
6491202|NCT01369225|7409712|FG004|NOT COMPLETED|Overall Study||2
6491203|NCT01369225|7409713|FG005|NOT COMPLETED|Overall Study||0
6491204|NCT01369329|7409730|FG000|STARTED|Overall Study||256
6491205|NCT01369329|7409731|FG001|STARTED|Overall Study||254
6491206|NCT01369329|7409732|FG002|STARTED|Overall Study||259
6491207|NCT01369329|7409730|FG000|COMPLETED|Overall Study||244
6491208|NCT01369329|7409731|FG001|COMPLETED|Overall Study||243
6491209|NCT01369329|7409732|FG002|COMPLETED|Overall Study||245
6491210|NCT01369329|7409730|FG000|NOT COMPLETED|Overall Study||12
6491211|NCT01369329|7409731|FG001|NOT COMPLETED|Overall Study||11
6491212|NCT01369329|7409732|FG002|NOT COMPLETED|Overall Study||14
6491213|NCT01369342|7409743|FG000|STARTED|Overall Study||214
6491214|NCT01369342|7409744|FG001|STARTED|Overall Study||213
6491215|NCT01369342|7409745|FG002|STARTED|Overall Study||213
6491216|NCT01369342|7409743|FG000|COMPLETED|Overall Study||201
6491217|NCT01369342|7409744|FG001|COMPLETED|Overall Study||204
6491218|NCT01369342|7409745|FG002|COMPLETED|Overall Study||210
6491219|NCT01369342|7409743|FG000|NOT COMPLETED|Overall Study||13
6491220|NCT01369342|7409744|FG001|NOT COMPLETED|Overall Study||9
6491221|NCT01369342|7409745|FG002|NOT COMPLETED|Overall Study||3
6491222|NCT01369355|7409759|FG000|STARTED|Week 0 - Week 44 (Maintenance)||133
6491223|NCT01369355|7409760|FG001|STARTED|Week 0 - Week 44 (Maintenance)||132
6491224|NCT01369355|7409761|FG002|STARTED|Week 0 - Week 44 (Maintenance)||132
6491225|NCT01369355|7409762|FG003|STARTED|Week 0 - Week 44 (Maintenance)||123
6491226|NCT01369355|7409763|FG004|STARTED|Week 0 - Week 44 (Maintenance)||285
6491227|NCT01369355|7409764|FG005|STARTED|Week 0 - Week 44 (Maintenance)||476
6491228|NCT01369355|7409765|FG006|STARTED|Week 0 - Week 44 (Maintenance)||0
6491229|NCT01369355|7409766|FG007|STARTED|Week 0 - Week 44 (Maintenance)||0
6491230|NCT01369355|7409767|FG008|STARTED|Week 0 - Week 44 (Maintenance)||0
6491231|NCT01369355|7409759|FG000|COMPLETED|Week 0 - Week 44 (Maintenance)||102
6491232|NCT01369355|7409760|FG001|COMPLETED|Week 0 - Week 44 (Maintenance)||103
6491233|NCT01369355|7409761|FG002|COMPLETED|Week 0 - Week 44 (Maintenance)||101
6491234|NCT01369355|7409762|FG003|COMPLETED|Week 0 - Week 44 (Maintenance)||93
6491235|NCT01369355|7409763|FG004|COMPLETED|Week 0 - Week 44 (Maintenance)||131
6491236|NCT01369355|7409764|FG005|COMPLETED|Week 0 - Week 44 (Maintenance)||204
6491237|NCT01369355|7409765|FG006|COMPLETED|Week 0 - Week 44 (Maintenance)||0
6491238|NCT01369355|7409766|FG007|COMPLETED|Week 0 - Week 44 (Maintenance)||0
6491239|NCT01369355|7409767|FG008|COMPLETED|Week 0 - Week 44 (Maintenance)||0
6491240|NCT01369355|7409759|FG000|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
6491241|NCT01369355|7409760|FG001|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||29
6491242|NCT01369355|7409761|FG002|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||31
6491243|NCT01369355|7409762|FG003|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||30
6491244|NCT01369355|7409763|FG004|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||154
6491245|NCT01369355|7409764|FG005|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||272
6491246|NCT01369355|7409765|FG006|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
6491247|NCT01369355|7409766|FG007|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
6491248|NCT01369355|7409767|FG008|NOT COMPLETED|Week 0 - Week 44 (Maintenance)||0
6491249|NCT01369355|7409759|FG000|STARTED|Long-term Extension (Week 44-272)||0
6491250|NCT01369355|7409760|FG001|STARTED|Long-term Extension (Week 44-272)||0
6491251|NCT01369355|7409761|FG002|STARTED|Long-term Extension (Week 44-272)||0
6491252|NCT01369355|7409762|FG003|STARTED|Long-term Extension (Week 44-272)||0
6491253|NCT01369355|7409763|FG004|STARTED|Long-term Extension (Week 44-272)||0
6491254|NCT01369355|7409764|FG005|STARTED|Long-term Extension (Week 44-272)||0
6491255|NCT01369355|7409765|FG006|STARTED|Long-term Extension (Week 44-272)||151
6491256|NCT01369355|7409766|FG007|STARTED|Long-term Extension (Week 44-272)||213
6491257|NCT01369355|7409767|FG008|STARTED|Long-term Extension (Week 44-272)||354
6491258|NCT01369355|7409759|FG000|COMPLETED|Long-term Extension (Week 44-272)||0
6491259|NCT01369355|7409760|FG001|COMPLETED|Long-term Extension (Week 44-272)||0
6491260|NCT01369355|7409761|FG002|COMPLETED|Long-term Extension (Week 44-272)||0
6491261|NCT01369355|7409762|FG003|COMPLETED|Long-term Extension (Week 44-272)||0
6491262|NCT01369355|7409763|FG004|COMPLETED|Long-term Extension (Week 44-272)||0
6491263|NCT01369355|7409764|FG005|COMPLETED|Long-term Extension (Week 44-272)||0
6491264|NCT01369355|7409765|FG006|COMPLETED|Long-term Extension (Week 44-272)||0
6491265|NCT01369355|7409766|FG007|COMPLETED|Long-term Extension (Week 44-272)||107
6491266|NCT01369355|7409767|FG008|COMPLETED|Long-term Extension (Week 44-272)||183
6491267|NCT01369355|7409759|FG000|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6491268|NCT01369355|7409760|FG001|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6491269|NCT01369355|7409761|FG002|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6491270|NCT01369355|7409762|FG003|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6491271|NCT01369355|7409763|FG004|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6491272|NCT01369355|7409764|FG005|NOT COMPLETED|Long-term Extension (Week 44-272)||0
6748936|NCT03421886|7677027|FG001|STARTED|Overall Study||15
6748937|NCT03421886|7677026|FG000|COMPLETED|Overall Study||23
6748938|NCT03421886|7677027|FG001|COMPLETED|Overall Study||13
6491273|NCT01369355|7409765|FG006|NOT COMPLETED|Long-term Extension (Week 44-272)||151
6491274|NCT01369355|7409766|FG007|NOT COMPLETED|Long-term Extension (Week 44-272)||106
6491275|NCT01369355|7409767|FG008|NOT COMPLETED|Long-term Extension (Week 44-272)||171
6491276|NCT01369433|7409786|FG000|STARTED|Overall Study||209
6491277|NCT01369433|7409787|FG001|STARTED|Overall Study||16
6491278|NCT01369433|7409786|FG000|COMPLETED|Overall Study||0
6491279|NCT01369433|7409787|FG001|COMPLETED|Overall Study||0
6491280|NCT01369433|7409786|FG000|NOT COMPLETED|Overall Study||209
6491281|NCT01369433|7409787|FG001|NOT COMPLETED|Overall Study||16
6491282|NCT01369485|7409795|FG000|STARTED|Randomized Phase (Day 0 to Week 12)||80
6491283|NCT01369485|7409796|FG001|STARTED|Randomized Phase (Day 0 to Week 12)||83
6491284|NCT01369485|7409795|FG000|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
6491285|NCT01369485|7409796|FG001|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
6491286|NCT01369485|7409795|FG000|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
6491287|NCT01369485|7409796|FG001|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
6491288|NCT01369485|7409795|FG000|STARTED|Open Label Phase (Week 12 to Month 12)||57
6491289|NCT01369485|7409796|FG001|STARTED|Open Label Phase (Week 12 to Month 12)||66
6491290|NCT01369485|7409795|FG000|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
6491291|NCT01369485|7409796|FG001|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
6491292|NCT01369485|7409795|FG000|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
6491293|NCT01369485|7409796|FG001|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
6491294|NCT01369498|7409814|FG000|STARTED|Overall Study||12
6491295|NCT01369498|7409815|FG001|STARTED|Overall Study||12
6491296|NCT01369498|7409816|FG002|STARTED|Overall Study||15
6491297|NCT01369498|7409817|FG003|STARTED|Overall Study||15
6555238|NCT01751113|7477424|FG002|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6555239|NCT01751113|7477425|FG003|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
6748939|NCT03421886|7677026|FG000|NOT COMPLETED|Overall Study||7
6491298|NCT01369498|7409814|FG000|COMPLETED|Overall Study||0
6491299|NCT01369498|7409815|FG001|COMPLETED|Overall Study||0
6491300|NCT01369498|7409816|FG002|COMPLETED|Overall Study||0
6491301|NCT01369498|7409817|FG003|COMPLETED|Overall Study||0
6491302|NCT01369498|7409814|FG000|NOT COMPLETED|Overall Study||12
6491303|NCT01369498|7409815|FG001|NOT COMPLETED|Overall Study||12
6491304|NCT01369498|7409816|FG002|NOT COMPLETED|Overall Study||15
6491305|NCT01369498|7409817|FG003|NOT COMPLETED|Overall Study||15
6491306|NCT01369511|7409832|FG000|STARTED|Overall Study||98
6491307|NCT01369511|7409833|FG001|STARTED|Overall Study||104
6491308|NCT01369511|7409834|FG002|STARTED|Overall Study||98
6491309|NCT01369511|7409835|FG003|STARTED|Overall Study||100
6491310|NCT01369511|7409832|FG000|Received at Least 1 Dose of Study Drug|Overall Study||98
6491311|NCT01369511|7409833|FG001|Received at Least 1 Dose of Study Drug|Overall Study|One participant was a screen failure and inadvertently randomized but did not receive study drug.|103
6491312|NCT01369511|7409834|FG002|Received at Least 1 Dose of Study Drug|Overall Study||98
6491313|NCT01369511|7409835|FG003|Received at Least 1 Dose of Study Drug|Overall Study||100
6491314|NCT01369511|7409832|FG000|COMPLETED|Overall Study||85
6491315|NCT01369511|7409833|FG001|COMPLETED|Overall Study||91
6491316|NCT01369511|7409834|FG002|COMPLETED|Overall Study||87
6748940|NCT03421886|7677027|FG001|NOT COMPLETED|Overall Study||2
6748941|NCT03422159|7677035|FG000|STARTED|Overall Study||70
6748942|NCT03422159|7677036|FG001|STARTED|Overall Study||70
6748943|NCT03422159|7677035|FG000|COMPLETED|Overall Study||68
6748944|NCT03422159|7677036|FG001|COMPLETED|Overall Study||69
6748945|NCT03422159|7677035|FG000|NOT COMPLETED|Overall Study||2
6748946|NCT03422159|7677036|FG001|NOT COMPLETED|Overall Study||1
6748947|NCT03422172|7677044|FG000|STARTED|Oral lead-in Phase (4 Weeks)||48
6748948|NCT03422172|7677044|FG000|COMPLETED|Oral lead-in Phase (4 Weeks)||47
6748949|NCT03422172|7677044|FG000|NOT COMPLETED|Oral lead-in Phase (4 Weeks)||1
6748950|NCT03422172|7677044|FG000|STARTED|Washout (7 Days)||47
6748951|NCT03422172|7677044|FG000|COMPLETED|Washout (7 Days)||47
6748952|NCT03422172|7677044|FG000|NOT COMPLETED|Washout (7 Days)||0
6748953|NCT03422172|7677044|FG000|STARTED|Injection Phase (Week 5 to Week 41)||47
6748954|NCT03422172|7677044|FG000|COMPLETED|Injection Phase (Week 5 to Week 41)||43
6748955|NCT03422172|7677044|FG000|NOT COMPLETED|Injection Phase (Week 5 to Week 41)||4
6748956|NCT03422172|7677044|FG000|STARTED|Long Term Follow-up Phase(Upto Week 89)||43
6748957|NCT03422172|7677044|FG000|COMPLETED|Long Term Follow-up Phase(Upto Week 89)||43
6748958|NCT03422172|7677044|FG000|NOT COMPLETED|Long Term Follow-up Phase(Upto Week 89)||0
6748959|NCT03422250|7677057|FG000|STARTED|Intervention||11
6748960|NCT03422250|7677058|FG001|STARTED|Intervention||11
6748961|NCT03422250|7677059|FG002|STARTED|Intervention||12
6748962|NCT03422250|7677060|FG003|STARTED|Intervention||11
6748963|NCT03422250|7677057|FG000|COMPLETED|Intervention||10
6748964|NCT03422250|7677058|FG001|COMPLETED|Intervention||10
6748965|NCT03422250|7677059|FG002|COMPLETED|Intervention||10
6748966|NCT03422250|7677060|FG003|COMPLETED|Intervention||10
6748967|NCT03422250|7677057|FG000|NOT COMPLETED|Intervention||1
6748968|NCT03422250|7677058|FG001|NOT COMPLETED|Intervention||1
6748969|NCT03422250|7677059|FG002|NOT COMPLETED|Intervention||2
6748970|NCT03422250|7677060|FG003|NOT COMPLETED|Intervention||1
6748971|NCT03422250|7677057|FG000|STARTED|Follow-up||10
6748972|NCT03422250|7677058|FG001|STARTED|Follow-up||10
6748973|NCT03422250|7677059|FG002|STARTED|Follow-up||10
6748974|NCT03422250|7677060|FG003|STARTED|Follow-up||10
6748975|NCT03422250|7677057|FG000|COMPLETED|Follow-up||10
6748976|NCT03422250|7677058|FG001|COMPLETED|Follow-up||10
6491317|NCT01369511|7409835|FG003|COMPLETED|Overall Study||89
6491318|NCT01369511|7409832|FG000|NOT COMPLETED|Overall Study||13
6748977|NCT03422250|7677059|FG002|COMPLETED|Follow-up||10
6748978|NCT03422250|7677060|FG003|COMPLETED|Follow-up||8
6748979|NCT03422250|7677057|FG000|NOT COMPLETED|Follow-up||0
6748980|NCT03422250|7677058|FG001|NOT COMPLETED|Follow-up||0
6748981|NCT03422250|7677059|FG002|NOT COMPLETED|Follow-up||0
6748982|NCT03422250|7677060|FG003|NOT COMPLETED|Follow-up||2
6748983|NCT03423082|7677072|FG000|STARTED|Overall Study||1
6491319|NCT01369511|7409833|FG001|NOT COMPLETED|Overall Study||13
6491320|NCT01369511|7409834|FG002|NOT COMPLETED|Overall Study||11
6491321|NCT01369511|7409835|FG003|NOT COMPLETED|Overall Study||11
6491322|NCT01369615|7409847|FG000|STARTED|Overall Study||9
6491323|NCT01369615|7409848|FG001|STARTED|Overall Study||14
6491324|NCT01369615|7409847|FG000|COMPLETED|Overall Study||9
6491325|NCT01369615|7409848|FG001|COMPLETED|Overall Study||12
6491326|NCT01369615|7409847|FG000|NOT COMPLETED|Overall Study||0
6491327|NCT01369615|7409848|FG001|NOT COMPLETED|Overall Study||2
6491328|NCT01369680|7409858|FG000|STARTED|Overall Study||3
6491329|NCT01369680|7409859|FG001|STARTED|Overall Study||3
6491330|NCT01369680|7409860|FG002|STARTED|Overall Study||3
6491331|NCT01369680|7409861|FG003|STARTED|Overall Study||3
6491332|NCT01369680|7409858|FG000|COMPLETED|Overall Study||3
6491333|NCT01369680|7409859|FG001|COMPLETED|Overall Study||3
6491334|NCT01369680|7409860|FG002|COMPLETED|Overall Study||2
6491335|NCT01369680|7409861|FG003|COMPLETED|Overall Study||1
6491336|NCT01369680|7409858|FG000|NOT COMPLETED|Overall Study||0
6491337|NCT01369680|7409859|FG001|NOT COMPLETED|Overall Study||0
6491338|NCT01369680|7409860|FG002|NOT COMPLETED|Overall Study||1
6491339|NCT01369680|7409861|FG003|NOT COMPLETED|Overall Study||2
6491340|NCT01369706|7409882|FG000|STARTED|Overall Study||388
6491341|NCT01369706|7409882|FG000|COMPLETED|Overall Study||388
6491342|NCT01369706|7409882|FG000|NOT COMPLETED|Overall Study||0
6491343|NCT01369732|7409888|FG000|STARTED|Overall Study||33
6491344|NCT01369732|7409889|FG001|STARTED|Overall Study||33
6491345|NCT01369732|7409888|FG000|COMPLETED|Overall Study||29
6491346|NCT01369732|7409889|FG001|COMPLETED|Overall Study||31
6491347|NCT01369732|7409888|FG000|NOT COMPLETED|Overall Study||4
6491348|NCT01369732|7409889|FG001|NOT COMPLETED|Overall Study||2
6491349|NCT01369745|7409900|FG000|STARTED|Overall Study||32
6491350|NCT01369745|7409901|FG001|STARTED|Overall Study||41
6491351|NCT01369745|7409902|FG002|STARTED|Overall Study||18
6491352|NCT01369745|7409903|FG003|STARTED|Overall Study||84
6491353|NCT01369745|7409904|FG004|STARTED|Overall Study||83
6491354|NCT01369745|7409900|FG000|COMPLETED|Overall Study||25
6491355|NCT01369745|7409901|FG001|COMPLETED|Overall Study||28
6491356|NCT01369745|7409902|FG002|COMPLETED|Overall Study||16
6491357|NCT01369745|7409903|FG003|COMPLETED|Overall Study||64
6491358|NCT01369745|7409904|FG004|COMPLETED|Overall Study||65
6491359|NCT01369745|7409900|FG000|NOT COMPLETED|Overall Study||7
6491360|NCT01369745|7409901|FG001|NOT COMPLETED|Overall Study||13
6491361|NCT01369745|7409902|FG002|NOT COMPLETED|Overall Study||2
6491362|NCT01369745|7409903|FG003|NOT COMPLETED|Overall Study||20
6491363|NCT01369745|7409904|FG004|NOT COMPLETED|Overall Study||18
6491364|NCT01369758|7409916|FG000|STARTED|Overall Study||290
6555240|NCT01751113|7477426|FG004|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
6555241|NCT01751113|7477427|FG005|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6555242|NCT01751113|7477422|FG000|STARTED|Washout Period 1 (2 Weeks)||8
6555243|NCT01751113|7477423|FG001|STARTED|Washout Period 1 (2 Weeks)||8
6555244|NCT01751113|7477424|FG002|STARTED|Washout Period 1 (2 Weeks)||9
6491365|NCT01369758|7409916|FG000|COMPLETED|Overall Study||290
6491366|NCT01369758|7409916|FG000|NOT COMPLETED|Overall Study||0
6491367|NCT01369784|7409920|FG000|STARTED|Overall Study||158
6491368|NCT01369784|7409920|FG000|COMPLETED|Overall Study||146
6491369|NCT01369784|7409920|FG000|NOT COMPLETED|Overall Study||12
6491370|NCT01369849|7409927|FG000|STARTED|Overall Study||6
6491371|NCT01369849|7409928|FG001|STARTED|Overall Study||4
6491372|NCT01369849|7409929|FG002|STARTED|Overall Study||5
6491373|NCT01369849|7409927|FG000|COMPLETED|Overall Study||6
6491374|NCT01369849|7409928|FG001|COMPLETED|Overall Study||3
6491375|NCT01369849|7409929|FG002|COMPLETED|Overall Study||4
6491376|NCT01369849|7409927|FG000|NOT COMPLETED|Overall Study||0
6491377|NCT01369849|7409928|FG001|NOT COMPLETED|Overall Study||1
6491378|NCT01369849|7409929|FG002|NOT COMPLETED|Overall Study||1
6491379|NCT01369875|7409941|FG000|STARTED|Overall Study||1
6491380|NCT01369875|7409942|FG001|STARTED|Overall Study||1
6491381|NCT01369875|7409941|FG000|COMPLETED|Overall Study||1
6491382|NCT01369875|7409942|FG001|COMPLETED|Overall Study||1
6491383|NCT01369875|7409941|FG000|NOT COMPLETED|Overall Study||0
6491384|NCT01369875|7409942|FG001|NOT COMPLETED|Overall Study||0
6491385|NCT01369888|7409952|FG000|STARTED|Overall Study||1
6491386|NCT01369888|7409953|FG001|STARTED|Overall Study||2
6491387|NCT01369888|7409954|FG002|STARTED|Overall Study||0
6491388|NCT01369888|7409955|FG003|STARTED|Overall Study||0
6491389|NCT01369888|7409952|FG000|COMPLETED|Overall Study||1
6491390|NCT01369888|7409953|FG001|COMPLETED|Overall Study||2
6491391|NCT01369888|7409954|FG002|COMPLETED|Overall Study||0
6491392|NCT01369888|7409955|FG003|COMPLETED|Overall Study||0
6491393|NCT01369888|7409952|FG000|NOT COMPLETED|Overall Study||0
6491394|NCT01369888|7409953|FG001|NOT COMPLETED|Overall Study||0
6491395|NCT01369888|7409954|FG002|NOT COMPLETED|Overall Study||0
6491396|NCT01369888|7409955|FG003|NOT COMPLETED|Overall Study||0
6491397|NCT01370005|7409964|FG000|STARTED|Overall Study||272
6491398|NCT01370005|7409965|FG001|STARTED|Overall Study||276
6491399|NCT01370005|7409966|FG002|STARTED|Overall Study||277
6491400|NCT01370005|7409964|FG000|COMPLETED|Overall Study||256
6491401|NCT01370005|7409965|FG001|COMPLETED|Overall Study||265
6491402|NCT01370005|7409966|FG002|COMPLETED|Overall Study||266
6491403|NCT01370005|7409964|FG000|NOT COMPLETED|Overall Study||16
6491404|NCT01370005|7409965|FG001|NOT COMPLETED|Overall Study||11
6491405|NCT01370005|7409966|FG002|NOT COMPLETED|Overall Study||11
6491406|NCT01370018|7409974|FG000|STARTED|Overall Study||4
6491407|NCT01370018|7409974|FG000|COMPLETED|Overall Study||3
6491408|NCT01370018|7409974|FG000|NOT COMPLETED|Overall Study||1
6491409|NCT01370083|7409980|FG000|STARTED|Overall Study||7
6491410|NCT01370083|7409981|FG001|STARTED|Overall Study||7
6491411|NCT01370083|7409980|FG000|COMPLETED|Overall Study||5
6491412|NCT01370083|7409981|FG001|COMPLETED|Overall Study||6
6491413|NCT01370083|7409980|FG000|NOT COMPLETED|Overall Study||2
6491414|NCT01370083|7409981|FG001|NOT COMPLETED|Overall Study||1
6491415|NCT01370174|7409991|FG000|STARTED|Overall Study||25
6491416|NCT01370174|7409992|FG001|STARTED|Overall Study||26
6491417|NCT01370174|7409993|FG002|STARTED|Overall Study||25
6491418|NCT01370174|7409994|FG003|STARTED|Overall Study||26
6491419|NCT01370174|7409991|FG000|COMPLETED|Overall Study||18
6491420|NCT01370174|7409992|FG001|COMPLETED|Overall Study||15
6491421|NCT01370174|7409993|FG002|COMPLETED|Overall Study||13
6491422|NCT01370174|7409994|FG003|COMPLETED|Overall Study||17
6491423|NCT01370174|7409991|FG000|NOT COMPLETED|Overall Study||7
6491424|NCT01370174|7409992|FG001|NOT COMPLETED|Overall Study||11
6491425|NCT01370174|7409993|FG002|NOT COMPLETED|Overall Study||12
6491426|NCT01370174|7409994|FG003|NOT COMPLETED|Overall Study||9
6491427|NCT01370213|7410007|FG000|STARTED|Overall Study||7
6491428|NCT01370213|7410008|FG001|STARTED|Overall Study||17
6491429|NCT01370213|7410009|FG002|STARTED|Overall Study||1
6491430|NCT01370213|7410007|FG000|COMPLETED|Overall Study||6
6491431|NCT01370213|7410008|FG001|COMPLETED|Overall Study||15
6491432|NCT01370213|7410009|FG002|COMPLETED|Overall Study||1
6491433|NCT01370213|7410007|FG000|NOT COMPLETED|Overall Study||1
6491434|NCT01370213|7410008|FG001|NOT COMPLETED|Overall Study||2
6491435|NCT01370213|7410009|FG002|NOT COMPLETED|Overall Study||0
6491436|NCT01370265|7410016|FG000|STARTED|Resting Myocardial Blood Flow (MBF)||6
6491437|NCT01370265|7410017|FG001|STARTED|Resting Myocardial Blood Flow (MBF)||6
6491438|NCT01370265|7410016|FG000|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
6491439|NCT01370265|7410017|FG001|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
6491440|NCT01370265|7410016|FG000|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
6491441|NCT01370265|7410017|FG001|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
6491442|NCT01370265|7410016|FG000|STARTED|Washout Period (50-minute Period Decay)||6
6491443|NCT01370265|7410017|FG001|STARTED|Washout Period (50-minute Period Decay)||6
6491444|NCT01370265|7410016|FG000|COMPLETED|Washout Period (50-minute Period Decay)||6
6491445|NCT01370265|7410017|FG001|COMPLETED|Washout Period (50-minute Period Decay)||6
6491446|NCT01370265|7410016|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
6491447|NCT01370265|7410017|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
6491448|NCT01370265|7410016|FG000|STARTED|First Intervention||6
6491449|NCT01370265|7410017|FG001|STARTED|First Intervention||6
6491450|NCT01370265|7410016|FG000|COMPLETED|First Intervention||5
6491451|NCT01370265|7410017|FG001|COMPLETED|First Intervention||5
6491452|NCT01370265|7410016|FG000|NOT COMPLETED|First Intervention||1
6491453|NCT01370265|7410017|FG001|NOT COMPLETED|First Intervention||1
6491454|NCT01370265|7410016|FG000|STARTED|Washout Period (50-minute Period Decay)||5
6491455|NCT01370265|7410017|FG001|STARTED|Washout Period (50-minute Period Decay)||5
6491456|NCT01370265|7410016|FG000|COMPLETED|Washout Period (50-minute Period Decay)||5
6491457|NCT01370265|7410017|FG001|COMPLETED|Washout Period (50-minute Period Decay)||5
6491458|NCT01370265|7410016|FG000|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
6491459|NCT01370265|7410017|FG001|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
6491460|NCT01370265|7410016|FG000|STARTED|Second Intervention||5
6491461|NCT01370265|7410017|FG001|STARTED|Second Intervention||5
6491462|NCT01370265|7410016|FG000|COMPLETED|Second Intervention||5
6491463|NCT01370265|7410017|FG001|COMPLETED|Second Intervention||5
6491464|NCT01370265|7410016|FG000|NOT COMPLETED|Second Intervention||0
6491465|NCT01370265|7410017|FG001|NOT COMPLETED|Second Intervention||0
6491466|NCT01370317|7410026|FG000|STARTED|Overall Study||18
6491467|NCT01370317|7410027|FG001|STARTED|Overall Study||9
6491468|NCT01370317|7410026|FG000|COMPLETED|Overall Study||17
6491469|NCT01370317|7410027|FG001|COMPLETED|Overall Study||8
6491470|NCT01370317|7410026|FG000|NOT COMPLETED|Overall Study||1
6491471|NCT01370317|7410027|FG001|NOT COMPLETED|Overall Study||1
6491472|NCT01370356|7410035|FG000|STARTED|Overall Study||751
6491473|NCT01370356|7410036|FG001|STARTED|Overall Study||742
6491474|NCT01370356|7410035|FG000|COMPLETED|Overall Study||559
6491475|NCT01370356|7410036|FG001|COMPLETED|Overall Study||515
6491476|NCT01370356|7410035|FG000|NOT COMPLETED|Overall Study||192
6491477|NCT01370356|7410036|FG001|NOT COMPLETED|Overall Study||227
6491478|NCT01370369|7410042|FG000|STARTED|Overall Study||20
6491479|NCT01370369|7410042|FG000|COMPLETED|Overall Study||20
6491480|NCT01370369|7410042|FG000|NOT COMPLETED|Overall Study||0
6491481|NCT01370408|7410055|FG000|STARTED|Overall Study||85
6491482|NCT01370408|7410055|FG000|COMPLETED|Overall Study||76
6491483|NCT01370408|7410055|FG000|NOT COMPLETED|Overall Study||9
6491484|NCT01370460|7410061|FG000|STARTED|Overall Study||50
6491485|NCT01370460|7410062|FG001|STARTED|Overall Study||51
6491486|NCT01370460|7410061|FG000|COMPLETED|Overall Study||50
6491487|NCT01370460|7410062|FG001|COMPLETED|Overall Study||51
6491488|NCT01370460|7410061|FG000|NOT COMPLETED|Overall Study||0
6491489|NCT01370460|7410062|FG001|NOT COMPLETED|Overall Study||0
6491490|NCT01370499|7410071|FG000|STARTED|Overall Study||195
6491491|NCT01370499|7410072|FG001|STARTED|Overall Study||93
6491492|NCT01370499|7410071|FG000|Entered Abrupt Discontinuation Phase|Overall Study||188
6501811|NCT01431287|7420453|FG002|NOT COMPLETED|Overall Study||97
6491493|NCT01370499|7410072|FG001|Entered Abrupt Discontinuation Phase|Overall Study|One participant who entered the abrupt discontinuation phase did not receive study drug.|85
6491494|NCT01370499|7410071|FG000|Received at Least 1 Dose of Study Drug|Overall Study||195
6491495|NCT01370499|7410072|FG001|Received at Least 1 Dose of Study Drug|Overall Study||92
6491496|NCT01370499|7410071|FG000|COMPLETED|Overall Study||84
6491497|NCT01370499|7410072|FG001|COMPLETED|Overall Study||49
6491498|NCT01370499|7410071|FG000|NOT COMPLETED|Overall Study||111
6491499|NCT01370499|7410072|FG001|NOT COMPLETED|Overall Study||44
6491500|NCT01370525|7410082|FG000|STARTED|Overall Study||171
6491501|NCT01370525|7410083|FG001|STARTED|Overall Study||169
6491502|NCT01370525|7410082|FG000|Patients Who Received Treatment|Overall Study||168
6491503|NCT01370525|7410083|FG001|Patients Who Received Treatment|Overall Study||163
6491504|NCT01370525|7410082|FG000|Patients Who Completed Treatment|Overall Study||163
6491505|NCT01370525|7410083|FG001|Patients Who Completed Treatment|Overall Study||158
6491506|NCT01370525|7410082|FG000|COMPLETED|Overall Study||163
6491507|NCT01370525|7410083|FG001|COMPLETED|Overall Study||158
6491508|NCT01370525|7410082|FG000|NOT COMPLETED|Overall Study||8
6491509|NCT01370525|7410083|FG001|NOT COMPLETED|Overall Study||11
6491510|NCT01370538|7410091|FG000|STARTED|Overall Study||170
6491511|NCT01370538|7410092|FG001|STARTED|Overall Study||171
6491512|NCT01370538|7410091|FG000|Patients Who Received Treatment|Overall Study||165
6491513|NCT01370538|7410092|FG001|Patients Who Received Treatment|Overall Study||161
6491514|NCT01370538|7410091|FG000|Patients Who Completed Treatment|Overall Study||151
6491515|NCT01370538|7410092|FG001|Patients Who Completed Treatment|Overall Study||152
6491516|NCT01370538|7410091|FG000|COMPLETED|Overall Study||151
6491517|NCT01370538|7410092|FG001|COMPLETED|Overall Study||152
6491518|NCT01370538|7410091|FG000|NOT COMPLETED|Overall Study||19
6491519|NCT01370538|7410092|FG001|NOT COMPLETED|Overall Study||19
6491520|NCT01370564|7410098|FG000|STARTED|Overall Study||21
6491521|NCT01370564|7410098|FG000|COMPLETED|Overall Study||21
6491522|NCT01370564|7410098|FG000|NOT COMPLETED|Overall Study||0
6491523|NCT01370616|7410104|FG000|STARTED|Overall Study|Participants randomized|282
6491524|NCT01370616|7410105|FG001|STARTED|Overall Study|Participants randomized|283
6491525|NCT01370616|7410104|FG000|Treated|Overall Study||275
6491526|NCT01370616|7410105|FG001|Treated|Overall Study||275
6491527|NCT01370616|7410104|FG000|COMPLETED|Overall Study||220
6491528|NCT01370616|7410105|FG001|COMPLETED|Overall Study||216
6491529|NCT01370616|7410104|FG000|NOT COMPLETED|Overall Study||62
6491530|NCT01370616|7410105|FG001|NOT COMPLETED|Overall Study||67
6491531|NCT01370629|7410111|FG000|STARTED|Overall Study||2015
6555245|NCT01751113|7477425|FG003|STARTED|Washout Period 1 (2 Weeks)||8
6555246|NCT01751113|7477426|FG004|STARTED|Washout Period 1 (2 Weeks)||8
6555247|NCT01751113|7477427|FG005|STARTED|Washout Period 1 (2 Weeks)||10
6555248|NCT01751113|7477422|FG000|COMPLETED|Washout Period 1 (2 Weeks)||8
6555249|NCT01751113|7477423|FG001|COMPLETED|Washout Period 1 (2 Weeks)||8
6748984|NCT03423082|7677072|FG000|COMPLETED|Overall Study||1
6491532|NCT01370629|7410111|FG000|COMPLETED|Overall Study||2009
6491533|NCT01370629|7410111|FG000|NOT COMPLETED|Overall Study||6
6491534|NCT01370642|7410118|FG000|STARTED|Overall Study||98
6491535|NCT01370642|7410119|FG001|STARTED|Overall Study||98
6491536|NCT01370642|7410120|FG002|STARTED|Overall Study||98
6491537|NCT01370642|7410118|FG000|FAS Population|Overall Study||98
6748985|NCT03423082|7677072|FG000|NOT COMPLETED|Overall Study||0
6748986|NCT03423173|7677080|FG000|STARTED|Overall Study||132
6748987|NCT03423173|7677081|FG001|STARTED|Overall Study||263
6748988|NCT03423173|7677082|FG002|STARTED|Overall Study||264
6748989|NCT03423173|7677083|FG003|STARTED|Overall Study||264
6748990|NCT03423173|7677080|FG000|Received at Least 1 Dose of the IP|Overall Study||131
6491538|NCT01370642|7410119|FG001|FAS Population|Overall Study||97
6491539|NCT01370642|7410120|FG002|FAS Population|Overall Study||98
6491540|NCT01370642|7410118|FG000|COMPLETED|Overall Study||90
6491541|NCT01370642|7410119|FG001|COMPLETED|Overall Study||92
6491542|NCT01370642|7410120|FG002|COMPLETED|Overall Study||69
6491543|NCT01370642|7410118|FG000|NOT COMPLETED|Overall Study||8
6491544|NCT01370642|7410119|FG001|NOT COMPLETED|Overall Study||6
6491545|NCT01370642|7410120|FG002|NOT COMPLETED|Overall Study||29
6491546|NCT01370655|7410140|FG000|STARTED|Period 1||7
6748991|NCT03423173|7677081|FG001|Received at Least 1 Dose of the IP|Overall Study||263
6748992|NCT03423173|7677082|FG002|Received at Least 1 Dose of the IP|Overall Study|1 participant of TDV Lot 2 received vaccine of Lot 1 and was included in TDV Lot 1 in Safety Set.|262
6748993|NCT03423173|7677083|FG003|Received at Least 1 Dose of the IP|Overall Study||263
6748994|NCT03423173|7677080|FG000|COMPLETED|Overall Study||113
6748995|NCT03423173|7677081|FG001|COMPLETED|Overall Study||228
6748996|NCT03423173|7677082|FG002|COMPLETED|Overall Study||237
6748997|NCT03423173|7677083|FG003|COMPLETED|Overall Study||234
6748998|NCT03423173|7677080|FG000|NOT COMPLETED|Overall Study||19
6748999|NCT03423173|7677081|FG001|NOT COMPLETED|Overall Study||35
6749000|NCT03423173|7677082|FG002|NOT COMPLETED|Overall Study||27
6749001|NCT03423173|7677083|FG003|NOT COMPLETED|Overall Study||30
6749002|NCT03423186|7677095|FG000|STARTED|Overall Study||3
6749003|NCT03423186|7677096|FG001|STARTED|Overall Study||3
6749004|NCT03423186|7677095|FG000|COMPLETED|Overall Study||3
6749005|NCT03423186|7677096|FG001|COMPLETED|Overall Study||3
6491547|NCT01370655|7410141|FG001|STARTED|Period 1||7
6491548|NCT01370655|7410142|FG002|STARTED|Period 1||3
6491549|NCT01370655|7410143|FG003|STARTED|Period 1||3
6491550|NCT01370655|7410144|FG004|STARTED|Period 1||3
6749006|NCT03423186|7677095|FG000|NOT COMPLETED|Overall Study||0
6491551|NCT01370655|7410145|FG005|STARTED|Period 1||4
6491552|NCT01370655|7410146|FG006|STARTED|Period 1||4
6491553|NCT01370655|7410147|FG007|STARTED|Period 1||4
6491554|NCT01370655|7410148|FG008|STARTED|Period 1||3
6491555|NCT01370655|7410149|FG009|STARTED|Period 1||2
6491556|NCT01370655|7410150|FG010|STARTED|Period 1||3
6491557|NCT01370655|7410151|FG011|STARTED|Period 1||3
6491558|NCT01370655|7410140|FG000|COMPLETED|Period 1||5
6491559|NCT01370655|7410141|FG001|COMPLETED|Period 1||7
6491560|NCT01370655|7410142|FG002|COMPLETED|Period 1||3
6491561|NCT01370655|7410143|FG003|COMPLETED|Period 1||3
6491562|NCT01370655|7410144|FG004|COMPLETED|Period 1||3
6491563|NCT01370655|7410145|FG005|COMPLETED|Period 1||4
6491564|NCT01370655|7410146|FG006|COMPLETED|Period 1||3
6491565|NCT01370655|7410147|FG007|COMPLETED|Period 1||4
6491566|NCT01370655|7410148|FG008|COMPLETED|Period 1||3
6491567|NCT01370655|7410149|FG009|COMPLETED|Period 1||2
6491568|NCT01370655|7410150|FG010|COMPLETED|Period 1||3
6491569|NCT01370655|7410151|FG011|COMPLETED|Period 1||3
6491570|NCT01370655|7410140|FG000|NOT COMPLETED|Period 1||2
6491571|NCT01370655|7410141|FG001|NOT COMPLETED|Period 1||0
6491572|NCT01370655|7410142|FG002|NOT COMPLETED|Period 1||0
6491573|NCT01370655|7410143|FG003|NOT COMPLETED|Period 1||0
6491574|NCT01370655|7410144|FG004|NOT COMPLETED|Period 1||0
6491575|NCT01370655|7410145|FG005|NOT COMPLETED|Period 1||0
6491576|NCT01370655|7410146|FG006|NOT COMPLETED|Period 1||1
6491577|NCT01370655|7410147|FG007|NOT COMPLETED|Period 1||0
6491578|NCT01370655|7410148|FG008|NOT COMPLETED|Period 1||0
6491579|NCT01370655|7410149|FG009|NOT COMPLETED|Period 1||0
6491580|NCT01370655|7410150|FG010|NOT COMPLETED|Period 1||0
6491581|NCT01370655|7410151|FG011|NOT COMPLETED|Period 1||0
6491582|NCT01370655|7410140|FG000|STARTED|Period 2||5
6491583|NCT01370655|7410141|FG001|STARTED|Period 2||7
6491584|NCT01370655|7410142|FG002|STARTED|Period 2||3
6491585|NCT01370655|7410143|FG003|STARTED|Period 2||3
6491586|NCT01370655|7410144|FG004|STARTED|Period 2||3
6491587|NCT01370655|7410145|FG005|STARTED|Period 2||4
6491588|NCT01370655|7410146|FG006|STARTED|Period 2||3
6491589|NCT01370655|7410147|FG007|STARTED|Period 2||4
6491590|NCT01370655|7410148|FG008|STARTED|Period 2||3
6491591|NCT01370655|7410149|FG009|STARTED|Period 2||2
6491592|NCT01370655|7410150|FG010|STARTED|Period 2||3
6491593|NCT01370655|7410151|FG011|STARTED|Period 2||3
6491594|NCT01370655|7410140|FG000|COMPLETED|Period 2||5
6491595|NCT01370655|7410141|FG001|COMPLETED|Period 2||7
6491596|NCT01370655|7410142|FG002|COMPLETED|Period 2||1
6491597|NCT01370655|7410143|FG003|COMPLETED|Period 2||3
6491598|NCT01370655|7410144|FG004|COMPLETED|Period 2||2
6491599|NCT01370655|7410145|FG005|COMPLETED|Period 2||4
6491600|NCT01370655|7410146|FG006|COMPLETED|Period 2||2
6491601|NCT01370655|7410147|FG007|COMPLETED|Period 2||3
6491602|NCT01370655|7410148|FG008|COMPLETED|Period 2||1
6491603|NCT01370655|7410149|FG009|COMPLETED|Period 2||2
6491604|NCT01370655|7410150|FG010|COMPLETED|Period 2||2
6491605|NCT01370655|7410151|FG011|COMPLETED|Period 2||3
6491606|NCT01370655|7410140|FG000|NOT COMPLETED|Period 2||0
6491607|NCT01370655|7410141|FG001|NOT COMPLETED|Period 2||0
6491608|NCT01370655|7410142|FG002|NOT COMPLETED|Period 2||2
6491609|NCT01370655|7410143|FG003|NOT COMPLETED|Period 2||0
6491610|NCT01370655|7410144|FG004|NOT COMPLETED|Period 2||1
6749007|NCT03423186|7677096|FG001|NOT COMPLETED|Overall Study||0
6749008|NCT03423238|7677104|FG000|STARTED|Overall Study||19
6749009|NCT03423238|7677105|FG001|STARTED|Overall Study||19
6749010|NCT03423238|7677104|FG000|COMPLETED|Overall Study||17
6749011|NCT03423238|7677105|FG001|COMPLETED|Overall Study||19
6749012|NCT03423238|7677104|FG000|NOT COMPLETED|Overall Study||2
6749013|NCT03423238|7677105|FG001|NOT COMPLETED|Overall Study||0
6749014|NCT03423641|7677114|FG000|STARTED|Overall Study||15524
6749015|NCT03423641|7677115|FG001|STARTED|Overall Study||18284
6749016|NCT03423641|7677114|FG000|COMPLETED|Overall Study||15193
6491611|NCT01370655|7410145|FG005|NOT COMPLETED|Period 2||0
6491612|NCT01370655|7410146|FG006|NOT COMPLETED|Period 2||1
6491613|NCT01370655|7410147|FG007|NOT COMPLETED|Period 2||1
6491614|NCT01370655|7410148|FG008|NOT COMPLETED|Period 2||2
6491615|NCT01370655|7410149|FG009|NOT COMPLETED|Period 2||0
6491616|NCT01370655|7410150|FG010|NOT COMPLETED|Period 2||1
6491617|NCT01370655|7410151|FG011|NOT COMPLETED|Period 2||0
6491618|NCT01370694|7410161|FG000|STARTED|Overall Study||7
6491619|NCT01370694|7410161|FG000|COMPLETED|Overall Study||1
6491620|NCT01370694|7410161|FG000|NOT COMPLETED|Overall Study||6
6491621|NCT01370733|7410167|FG000|STARTED|Overall Study||103
6491622|NCT01370733|7410168|FG001|STARTED|Overall Study||99
6491623|NCT01370733|7410167|FG000|COMPLETED|Overall Study||86
6491624|NCT01370733|7410168|FG001|COMPLETED|Overall Study||77
6491625|NCT01370733|7410167|FG000|NOT COMPLETED|Overall Study||17
6491626|NCT01370733|7410168|FG001|NOT COMPLETED|Overall Study||22
6491627|NCT01370837|7410177|FG000|STARTED|Overall Study||12
6491628|NCT01370837|7410178|FG001|STARTED|Overall Study||12
6491629|NCT01370837|7410179|FG002|STARTED|Overall Study||17
6749017|NCT03423641|7677115|FG001|COMPLETED|Overall Study||10210
6491630|NCT01370837|7410177|FG000|COMPLETED|Overall Study||12
6491631|NCT01370837|7410178|FG001|COMPLETED|Overall Study||12
6491632|NCT01370837|7410179|FG002|COMPLETED|Overall Study||17
6491633|NCT01370837|7410177|FG000|NOT COMPLETED|Overall Study||0
6491634|NCT01370837|7410178|FG001|NOT COMPLETED|Overall Study||0
6491635|NCT01370837|7410179|FG002|NOT COMPLETED|Overall Study||0
6491636|NCT01370863|7410189|FG000|STARTED|Overall Study||34
6749018|NCT03423641|7677114|FG000|NOT COMPLETED|Overall Study||331
6491637|NCT01370863|7410190|FG001|STARTED|Overall Study||33
6491638|NCT01370863|7410189|FG000|COMPLETED|Overall Study||32
6491639|NCT01370863|7410190|FG001|COMPLETED|Overall Study||30
6491640|NCT01370863|7410189|FG000|NOT COMPLETED|Overall Study||2
6491641|NCT01370863|7410190|FG001|NOT COMPLETED|Overall Study||3
6491642|NCT01371006|7410198|FG000|STARTED|Overall Study||14
6491643|NCT01371006|7410199|FG001|STARTED|Overall Study||15
6491644|NCT01371006|7410198|FG000|COMPLETED|Overall Study||13
6491645|NCT01371006|7410199|FG001|COMPLETED|Overall Study||15
6491646|NCT01371006|7410198|FG000|NOT COMPLETED|Overall Study||1
6491647|NCT01371006|7410199|FG001|NOT COMPLETED|Overall Study||0
6491648|NCT01371032|7410227|FG000|STARTED|Overall Study||14
6491649|NCT01371032|7410228|FG001|STARTED|Overall Study||14
6491650|NCT01371032|7410227|FG000|COMPLETED|Overall Study||14
6491651|NCT01371032|7410228|FG001|COMPLETED|Overall Study||14
6491652|NCT01371032|7410227|FG000|NOT COMPLETED|Overall Study||0
6491653|NCT01371032|7410228|FG001|NOT COMPLETED|Overall Study||0
6491654|NCT01371110|7410238|FG000|STARTED|Overall Study||1
6491655|NCT01371110|7410239|FG001|STARTED|Overall Study||2
6491656|NCT01371110|7410238|FG000|COMPLETED|Overall Study||1
6491657|NCT01371110|7410239|FG001|COMPLETED|Overall Study||2
6491658|NCT01371110|7410238|FG000|NOT COMPLETED|Overall Study||0
6491659|NCT01371110|7410239|FG001|NOT COMPLETED|Overall Study||0
6491660|NCT01371539|7410245|FG000|STARTED|Period One: One Week||53
6491661|NCT01371539|7410246|FG001|STARTED|Period One: One Week||51
6491662|NCT01371539|7410245|FG000|COMPLETED|Period One: One Week||53
6491663|NCT01371539|7410246|FG001|COMPLETED|Period One: One Week||50
6491664|NCT01371539|7410245|FG000|NOT COMPLETED|Period One: One Week||0
6491665|NCT01371539|7410246|FG001|NOT COMPLETED|Period One: One Week||1
6491666|NCT01371539|7410245|FG000|STARTED|Period Two: One Week||53
6491667|NCT01371539|7410246|FG001|STARTED|Period Two: One Week||50
6491668|NCT01371539|7410245|FG000|COMPLETED|Period Two: One Week||53
6491669|NCT01371539|7410246|FG001|COMPLETED|Period Two: One Week||47
6491670|NCT01371539|7410245|FG000|NOT COMPLETED|Period Two: One Week||0
6491671|NCT01371539|7410246|FG001|NOT COMPLETED|Period Two: One Week||3
6491672|NCT01371552|7410252|FG000|STARTED|Part 1, First 3 Days||19
6491673|NCT01371552|7410253|FG001|STARTED|Part 1, First 3 Days||17
6491674|NCT01371552|7410254|FG002|STARTED|Part 1, First 3 Days||20
6491675|NCT01371552|7410255|FG003|STARTED|Part 1, First 3 Days||20
6491676|NCT01371552|7410256|FG004|STARTED|Part 1, First 3 Days||15
6491677|NCT01371552|7410257|FG005|STARTED|Part 1, First 3 Days||18
6491678|NCT01371552|7410252|FG000|COMPLETED|Part 1, First 3 Days||19
6491679|NCT01371552|7410253|FG001|COMPLETED|Part 1, First 3 Days||17
6491680|NCT01371552|7410254|FG002|COMPLETED|Part 1, First 3 Days||19
6491681|NCT01371552|7410255|FG003|COMPLETED|Part 1, First 3 Days||20
6491682|NCT01371552|7410256|FG004|COMPLETED|Part 1, First 3 Days||15
6491683|NCT01371552|7410257|FG005|COMPLETED|Part 1, First 3 Days||18
6491684|NCT01371552|7410252|FG000|NOT COMPLETED|Part 1, First 3 Days||0
6491685|NCT01371552|7410253|FG001|NOT COMPLETED|Part 1, First 3 Days||0
6491686|NCT01371552|7410254|FG002|NOT COMPLETED|Part 1, First 3 Days||1
6491687|NCT01371552|7410255|FG003|NOT COMPLETED|Part 1, First 3 Days||0
6491688|NCT01371552|7410256|FG004|NOT COMPLETED|Part 1, First 3 Days||0
6555250|NCT01751113|7477424|FG002|COMPLETED|Washout Period 1 (2 Weeks)||9
6555251|NCT01751113|7477425|FG003|COMPLETED|Washout Period 1 (2 Weeks)||8
6555252|NCT01751113|7477426|FG004|COMPLETED|Washout Period 1 (2 Weeks)||8
6749019|NCT03423641|7677115|FG001|NOT COMPLETED|Overall Study||8074
6749020|NCT03424044|7677121|FG000|STARTED|Dexcom Training Visit (1 Week)||4
6749021|NCT03424044|7677122|FG001|STARTED|Dexcom Training Visit (1 Week)||3
6749022|NCT03424044|7677123|FG002|STARTED|Dexcom Training Visit (1 Week)||3
6749023|NCT03424044|7677124|FG003|STARTED|Dexcom Training Visit (1 Week)||3
6749024|NCT03424044|7677125|FG004|STARTED|Dexcom Training Visit (1 Week)||3
6749025|NCT03424044|7677126|FG005|STARTED|Dexcom Training Visit (1 Week)||4
6749026|NCT03424044|7677127|FG006|STARTED|Dexcom Training Visit (1 Week)||1
6749027|NCT03424044|7677128|FG007|STARTED|Dexcom Training Visit (1 Week)||1
6749028|NCT03424044|7677129|FG008|STARTED|Dexcom Training Visit (1 Week)||1
6749029|NCT03424044|7677121|FG000|COMPLETED|Dexcom Training Visit (1 Week)||4
6749030|NCT03424044|7677122|FG001|COMPLETED|Dexcom Training Visit (1 Week)||3
6749031|NCT03424044|7677123|FG002|COMPLETED|Dexcom Training Visit (1 Week)||3
6749032|NCT03424044|7677124|FG003|COMPLETED|Dexcom Training Visit (1 Week)||3
6749033|NCT03424044|7677125|FG004|COMPLETED|Dexcom Training Visit (1 Week)||3
6749034|NCT03424044|7677126|FG005|COMPLETED|Dexcom Training Visit (1 Week)||4
6749035|NCT03424044|7677127|FG006|COMPLETED|Dexcom Training Visit (1 Week)||1
6491689|NCT01371552|7410257|FG005|NOT COMPLETED|Part 1, First 3 Days||0
6491690|NCT01371552|7410252|FG000|STARTED|Part 1, Second 3 Days||19
6491691|NCT01371552|7410253|FG001|STARTED|Part 1, Second 3 Days||17
6491692|NCT01371552|7410254|FG002|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
6491693|NCT01371552|7410255|FG003|STARTED|Part 1, Second 3 Days||20
6491694|NCT01371552|7410256|FG004|STARTED|Part 1, Second 3 Days||15
6491695|NCT01371552|7410257|FG005|STARTED|Part 1, Second 3 Days||18
6491696|NCT01371552|7410252|FG000|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
6491697|NCT01371552|7410253|FG001|COMPLETED|Part 1, Second 3 Days||17
6491698|NCT01371552|7410254|FG002|COMPLETED|Part 1, Second 3 Days||18
6491699|NCT01371552|7410255|FG003|COMPLETED|Part 1, Second 3 Days||20
6555253|NCT01751113|7477427|FG005|COMPLETED|Washout Period 1 (2 Weeks)||10
6491700|NCT01371552|7410256|FG004|COMPLETED|Part 1, Second 3 Days||15
6491701|NCT01371552|7410257|FG005|COMPLETED|Part 1, Second 3 Days||18
6491702|NCT01371552|7410252|FG000|NOT COMPLETED|Part 1, Second 3 Days||1
6491703|NCT01371552|7410253|FG001|NOT COMPLETED|Part 1, Second 3 Days||0
6491704|NCT01371552|7410254|FG002|NOT COMPLETED|Part 1, Second 3 Days||0
6491705|NCT01371552|7410255|FG003|NOT COMPLETED|Part 1, Second 3 Days||0
6491706|NCT01371552|7410256|FG004|NOT COMPLETED|Part 1, Second 3 Days||0
6491707|NCT01371552|7410257|FG005|NOT COMPLETED|Part 1, Second 3 Days||0
6491708|NCT01371552|7410252|FG000|STARTED|Part 1, Third 3 Days||19
6491709|NCT01371552|7410253|FG001|STARTED|Part 1, Third 3 Days||17
6491710|NCT01371552|7410254|FG002|STARTED|Part 1, Third 3 Days||18
6491711|NCT01371552|7410255|FG003|STARTED|Part 1, Third 3 Days||20
6491712|NCT01371552|7410256|FG004|STARTED|Part 1, Third 3 Days||15
6491713|NCT01371552|7410257|FG005|STARTED|Part 1, Third 3 Days||18
6491714|NCT01371552|7410252|FG000|COMPLETED|Part 1, Third 3 Days||19
6491715|NCT01371552|7410253|FG001|COMPLETED|Part 1, Third 3 Days||17
6491716|NCT01371552|7410254|FG002|COMPLETED|Part 1, Third 3 Days||18
6491717|NCT01371552|7410255|FG003|COMPLETED|Part 1, Third 3 Days||20
6491718|NCT01371552|7410256|FG004|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
6491719|NCT01371552|7410257|FG005|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
6491720|NCT01371552|7410252|FG000|NOT COMPLETED|Part 1, Third 3 Days||0
6491721|NCT01371552|7410253|FG001|NOT COMPLETED|Part 1, Third 3 Days||0
6491722|NCT01371552|7410254|FG002|NOT COMPLETED|Part 1, Third 3 Days||0
6491723|NCT01371552|7410255|FG003|NOT COMPLETED|Part 1, Third 3 Days||0
6491724|NCT01371552|7410256|FG004|NOT COMPLETED|Part 1, Third 3 Days||1
6491725|NCT01371552|7410257|FG005|NOT COMPLETED|Part 1, Third 3 Days||1
6491726|NCT01371552|7410252|FG000|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
6491727|NCT01371552|7410253|FG001|STARTED|Part 2, One Week||17
6491728|NCT01371552|7410254|FG002|STARTED|Part 2, One Week||18
6491729|NCT01371552|7410255|FG003|STARTED|Part 2, One Week||20
6491730|NCT01371552|7410256|FG004|STARTED|Part 2, One Week||15
6491731|NCT01371552|7410257|FG005|STARTED|Part 2, One Week||18
6491732|NCT01371552|7410252|FG000|COMPLETED|Part 2, One Week||18
6491733|NCT01371552|7410253|FG001|COMPLETED|Part 2, One Week||17
6491734|NCT01371552|7410254|FG002|COMPLETED|Part 2, One Week||18
6491735|NCT01371552|7410255|FG003|COMPLETED|Part 2, One Week||20
6491736|NCT01371552|7410256|FG004|COMPLETED|Part 2, One Week||15
6491737|NCT01371552|7410257|FG005|COMPLETED|Part 2, One Week||18
6491738|NCT01371552|7410252|FG000|NOT COMPLETED|Part 2, One Week||0
6491739|NCT01371552|7410253|FG001|NOT COMPLETED|Part 2, One Week||0
6491740|NCT01371552|7410254|FG002|NOT COMPLETED|Part 2, One Week||0
6491741|NCT01371552|7410255|FG003|NOT COMPLETED|Part 2, One Week||0
6491742|NCT01371552|7410256|FG004|NOT COMPLETED|Part 2, One Week||0
6491743|NCT01371552|7410257|FG005|NOT COMPLETED|Part 2, One Week||0
6491744|NCT01371565|7410266|FG000|STARTED|Overall Study||4
6491745|NCT01371565|7410266|FG000|COMPLETED|Overall Study||1
6491746|NCT01371565|7410266|FG000|NOT COMPLETED|Overall Study||3
6491747|NCT01371643|7410272|FG000|STARTED|Overall Study||15
6491748|NCT01371643|7410273|FG001|STARTED|Overall Study||26
6491749|NCT01371643|7410272|FG000|COMPLETED|Overall Study||12
6491750|NCT01371643|7410273|FG001|COMPLETED|Overall Study||26
6491751|NCT01371643|7410272|FG000|NOT COMPLETED|Overall Study||3
6491752|NCT01371643|7410273|FG001|NOT COMPLETED|Overall Study||0
6491753|NCT01371656|7410281|FG000|STARTED|Overall Study||314
6491754|NCT01371656|7410282|FG001|STARTED|Overall Study||310
6491755|NCT01371656|7410281|FG000|COMPLETED|Overall Study||250
6491756|NCT01371656|7410282|FG001|COMPLETED|Overall Study||296
6491757|NCT01371656|7410281|FG000|NOT COMPLETED|Overall Study||64
6491758|NCT01371656|7410282|FG001|NOT COMPLETED|Overall Study||14
6491759|NCT01371708|7410291|FG000|STARTED|Overall Study||92
6491760|NCT01371708|7410292|FG001|STARTED|Overall Study||93
6491761|NCT01371708|7410293|FG002|STARTED|Overall Study||98
6491762|NCT01371708|7410291|FG000|Received Treatment|Overall Study||91
6491763|NCT01371708|7410292|FG001|Received Treatment|Overall Study||93
6491764|NCT01371708|7410293|FG002|Received Treatment|Overall Study||97
6491765|NCT01371708|7410291|FG000|COMPLETED|Overall Study||66
6491766|NCT01371708|7410292|FG001|COMPLETED|Overall Study||63
6491767|NCT01371708|7410293|FG002|COMPLETED|Overall Study||59
6491768|NCT01371708|7410291|FG000|NOT COMPLETED|Overall Study||26
6491769|NCT01371708|7410292|FG001|NOT COMPLETED|Overall Study||30
6491770|NCT01371708|7410293|FG002|NOT COMPLETED|Overall Study||39
6491771|NCT01371721|7410306|FG000|STARTED|Overall Study||88
6491772|NCT01371721|7410307|FG001|STARTED|Overall Study||89
6491773|NCT01371721|7410308|FG002|STARTED|Overall Study||92
6491774|NCT01371721|7410306|FG000|Treated|Overall Study||87
6491775|NCT01371721|7410307|FG001|Treated|Overall Study||89
6491776|NCT01371721|7410308|FG002|Treated|Overall Study||92
6491777|NCT01371721|7410306|FG000|COMPLETED|Overall Study||59
6491778|NCT01371721|7410307|FG001|COMPLETED|Overall Study||65
6491779|NCT01371721|7410308|FG002|COMPLETED|Overall Study||62
6491780|NCT01371721|7410306|FG000|NOT COMPLETED|Overall Study||29
6491781|NCT01371721|7410307|FG001|NOT COMPLETED|Overall Study||24
6491782|NCT01371721|7410308|FG002|NOT COMPLETED|Overall Study||30
6491783|NCT01371734|7410321|FG000|STARTED|Overall Study||120
6491784|NCT01371734|7410322|FG001|STARTED|Overall Study||122
6491785|NCT01371734|7410323|FG002|STARTED|Overall Study||121
6491786|NCT01371734|7410321|FG000|COMPLETED|Overall Study||97
6491787|NCT01371734|7410322|FG001|COMPLETED|Overall Study||103
6491788|NCT01371734|7410323|FG002|COMPLETED|Overall Study||104
6491789|NCT01371734|7410321|FG000|NOT COMPLETED|Overall Study||23
6491790|NCT01371734|7410322|FG001|NOT COMPLETED|Overall Study||19
6491791|NCT01371734|7410323|FG002|NOT COMPLETED|Overall Study||17
6491792|NCT01371747|7410337|FG000|STARTED|Overall Study||74
6491793|NCT01371747|7410338|FG001|STARTED|Overall Study||74
6491794|NCT01371747|7410339|FG002|STARTED|Overall Study||74
6491795|NCT01371747|7410340|FG003|STARTED|Overall Study||26
6491796|NCT01371747|7410341|FG004|STARTED|Overall Study||28
6491797|NCT01371747|7410342|FG005|STARTED|Overall Study||30
6491798|NCT01371747|7410337|FG000|COMPLETED|Overall Study||56
6491799|NCT01371747|7410338|FG001|COMPLETED|Overall Study||51
6491800|NCT01371747|7410339|FG002|COMPLETED|Overall Study||50
6491801|NCT01371747|7410340|FG003|COMPLETED|Overall Study||17
6491802|NCT01371747|7410341|FG004|COMPLETED|Overall Study||21
6491803|NCT01371747|7410342|FG005|COMPLETED|Overall Study||16
6491804|NCT01371747|7410337|FG000|NOT COMPLETED|Overall Study||18
6491805|NCT01371747|7410338|FG001|NOT COMPLETED|Overall Study||23
6491806|NCT01371747|7410339|FG002|NOT COMPLETED|Overall Study||24
6491807|NCT01371747|7410340|FG003|NOT COMPLETED|Overall Study||9
6491808|NCT01371747|7410341|FG004|NOT COMPLETED|Overall Study||7
6491809|NCT01371747|7410342|FG005|NOT COMPLETED|Overall Study||14
6491810|NCT01371786|7410359|FG000|STARTED|Overall Study||7
6491811|NCT01371786|7410360|FG001|STARTED|Overall Study||7
6491812|NCT01371786|7410359|FG000|COMPLETED|Overall Study||7
6491813|NCT01371786|7410360|FG001|COMPLETED|Overall Study||7
6491814|NCT01371786|7410359|FG000|NOT COMPLETED|Overall Study||0
6491815|NCT01371786|7410360|FG001|NOT COMPLETED|Overall Study||0
6491816|NCT01371825|7410366|FG000|STARTED|Overall Study||9
6491817|NCT01371825|7410366|FG000|Received at Least 1 Dose of Study Drug|Overall Study||9
6491818|NCT01371825|7410366|FG000|COMPLETED|Overall Study||5
6491819|NCT01371825|7410366|FG000|NOT COMPLETED|Overall Study||4
6491820|NCT01371838|7410372|FG000|STARTED|Overall Study||381
6491821|NCT01371838|7410373|FG001|STARTED|Overall Study||383
6491822|NCT01371838|7410372|FG000|COMPLETED|Overall Study||332
6491823|NCT01371838|7410373|FG001|COMPLETED|Overall Study||317
6491824|NCT01371838|7410372|FG000|NOT COMPLETED|Overall Study||49
6491825|NCT01371838|7410373|FG001|NOT COMPLETED|Overall Study||66
6491826|NCT01371851|7410381|FG000|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
6491827|NCT01371851|7410382|FG001|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
6491828|NCT01371851|7410381|FG000|COMPLETED|Overall Study||3
6491829|NCT01371851|7410382|FG001|COMPLETED|Overall Study||2
6491830|NCT01371851|7410381|FG000|NOT COMPLETED|Overall Study||8
6491831|NCT01371851|7410382|FG001|NOT COMPLETED|Overall Study||9
6491832|NCT01371877|7410390|FG000|STARTED|Overall Study||21
6491833|NCT01371877|7410391|FG001|STARTED|Overall Study||21
6491834|NCT01371877|7410390|FG000|COMPLETED|Overall Study||21
6491835|NCT01371877|7410391|FG001|COMPLETED|Overall Study||17
6491836|NCT01371877|7410390|FG000|NOT COMPLETED|Overall Study||0
6491837|NCT01371877|7410391|FG001|NOT COMPLETED|Overall Study||4
6491838|NCT01371994|7410399|FG000|STARTED|Overall Study||320
6491839|NCT01371994|7410400|FG001|STARTED|Overall Study||320
6491840|NCT01371994|7410399|FG000|Received Treatment|Overall Study||310
6491841|NCT01371994|7410400|FG001|Received Treatment|Overall Study||313
6491842|NCT01371994|7410399|FG000|COMPLETED|Overall Study||263
6555254|NCT01751113|7477422|FG000|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6555255|NCT01751113|7477423|FG001|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6555256|NCT01751113|7477424|FG002|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6555257|NCT01751113|7477425|FG003|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6491843|NCT01371994|7410400|FG001|COMPLETED|Overall Study||278
6491844|NCT01371994|7410399|FG000|NOT COMPLETED|Overall Study||57
6491845|NCT01371994|7410400|FG001|NOT COMPLETED|Overall Study||42
6491846|NCT01372085|7410416|FG000|STARTED|First Intervention (Period 1)||8
6491847|NCT01372085|7410417|FG001|STARTED|First Intervention (Period 1)||2
6491848|NCT01372085|7410418|FG002|STARTED|First Intervention (Period 1)||2
6491849|NCT01372085|7410419|FG003|STARTED|First Intervention (Period 1)||1
6491850|NCT01372085|7410420|FG004|STARTED|First Intervention (Period 1)|Replacement participant repeated Periods 1, 2 to fulfill treatment arm comparison requirements.|3
6491851|NCT01372085|7410421|FG005|STARTED|First Intervention (Period 1)||5
6491852|NCT01372085|7410422|FG006|STARTED|First Intervention (Period 1)||3
6491853|NCT01372085|7410423|FG007|STARTED|First Intervention (Period 1)||1
6491854|NCT01372085|7410424|FG008|STARTED|First Intervention (Period 1)||1
6491855|NCT01372085|7410425|FG009|STARTED|First Intervention (Period 1)||0
6491856|NCT01372085|7410416|FG000|COMPLETED|First Intervention (Period 1)||8
6491857|NCT01372085|7410417|FG001|COMPLETED|First Intervention (Period 1)||2
6491858|NCT01372085|7410418|FG002|COMPLETED|First Intervention (Period 1)||2
6491859|NCT01372085|7410419|FG003|COMPLETED|First Intervention (Period 1)||1
6491860|NCT01372085|7410420|FG004|COMPLETED|First Intervention (Period 1)||3
6491861|NCT01372085|7410421|FG005|COMPLETED|First Intervention (Period 1)||5
6491862|NCT01372085|7410422|FG006|COMPLETED|First Intervention (Period 1)||3
6491863|NCT01372085|7410423|FG007|COMPLETED|First Intervention (Period 1)||1
6491864|NCT01372085|7410424|FG008|COMPLETED|First Intervention (Period 1)||1
6491865|NCT01372085|7410425|FG009|COMPLETED|First Intervention (Period 1)||0
6491866|NCT01372085|7410416|FG000|NOT COMPLETED|First Intervention (Period 1)||0
6491867|NCT01372085|7410417|FG001|NOT COMPLETED|First Intervention (Period 1)||0
6491868|NCT01372085|7410418|FG002|NOT COMPLETED|First Intervention (Period 1)||0
6491869|NCT01372085|7410419|FG003|NOT COMPLETED|First Intervention (Period 1)||0
6491870|NCT01372085|7410420|FG004|NOT COMPLETED|First Intervention (Period 1)||0
6491871|NCT01372085|7410421|FG005|NOT COMPLETED|First Intervention (Period 1)||0
6491872|NCT01372085|7410422|FG006|NOT COMPLETED|First Intervention (Period 1)||0
6491873|NCT01372085|7410423|FG007|NOT COMPLETED|First Intervention (Period 1)||0
6491874|NCT01372085|7410424|FG008|NOT COMPLETED|First Intervention (Period 1)||0
6491875|NCT01372085|7410425|FG009|NOT COMPLETED|First Intervention (Period 1)||0
6491876|NCT01372085|7410416|FG000|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
6491877|NCT01372085|7410417|FG001|STARTED|Washout Period 1|Pts completed one period and did not enter washout for Part A.|0
6491878|NCT01372085|7410418|FG002|STARTED|Washout Period 1||2
6491879|NCT01372085|7410419|FG003|STARTED|Washout Period 1||1
6491880|NCT01372085|7410420|FG004|STARTED|Washout Period 1||3
6491881|NCT01372085|7410421|FG005|STARTED|Washout Period 1||5
6491882|NCT01372085|7410422|FG006|STARTED|Washout Period 1||3
6491883|NCT01372085|7410423|FG007|STARTED|Washout Period 1||1
6491884|NCT01372085|7410424|FG008|STARTED|Washout Period 1||1
6491885|NCT01372085|7410425|FG009|STARTED|Washout Period 1||0
6491886|NCT01372085|7410416|FG000|COMPLETED|Washout Period 1||0
6491887|NCT01372085|7410417|FG001|COMPLETED|Washout Period 1||0
6491888|NCT01372085|7410418|FG002|COMPLETED|Washout Period 1||2
6491889|NCT01372085|7410419|FG003|COMPLETED|Washout Period 1||1
6491890|NCT01372085|7410420|FG004|COMPLETED|Washout Period 1||3
6491891|NCT01372085|7410421|FG005|COMPLETED|Washout Period 1||5
6491892|NCT01372085|7410422|FG006|COMPLETED|Washout Period 1||3
6491893|NCT01372085|7410423|FG007|COMPLETED|Washout Period 1||1
6491894|NCT01372085|7410424|FG008|COMPLETED|Washout Period 1||1
6491895|NCT01372085|7410425|FG009|COMPLETED|Washout Period 1||0
6491896|NCT01372085|7410416|FG000|NOT COMPLETED|Washout Period 1||0
6491897|NCT01372085|7410417|FG001|NOT COMPLETED|Washout Period 1||0
6491898|NCT01372085|7410418|FG002|NOT COMPLETED|Washout Period 1||0
6491899|NCT01372085|7410419|FG003|NOT COMPLETED|Washout Period 1||0
6491900|NCT01372085|7410420|FG004|NOT COMPLETED|Washout Period 1||0
6491901|NCT01372085|7410421|FG005|NOT COMPLETED|Washout Period 1||0
6749036|NCT03424044|7677128|FG007|COMPLETED|Dexcom Training Visit (1 Week)||1
6749037|NCT03424044|7677129|FG008|COMPLETED|Dexcom Training Visit (1 Week)||1
6749038|NCT03424044|7677121|FG000|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749039|NCT03424044|7677122|FG001|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749040|NCT03424044|7677123|FG002|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749041|NCT03424044|7677124|FG003|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749042|NCT03424044|7677125|FG004|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749043|NCT03424044|7677126|FG005|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749044|NCT03424044|7677127|FG006|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749045|NCT03424044|7677128|FG007|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749046|NCT03424044|7677129|FG008|NOT COMPLETED|Dexcom Training Visit (1 Week)||0
6749047|NCT03424044|7677121|FG000|STARTED|First Rest Period (1-12 Weeks)||4
6749048|NCT03424044|7677122|FG001|STARTED|First Rest Period (1-12 Weeks)||3
6749049|NCT03424044|7677123|FG002|STARTED|First Rest Period (1-12 Weeks)||3
6749050|NCT03424044|7677124|FG003|STARTED|First Rest Period (1-12 Weeks)||3
6749051|NCT03424044|7677125|FG004|STARTED|First Rest Period (1-12 Weeks)||3
6749052|NCT03424044|7677126|FG005|STARTED|First Rest Period (1-12 Weeks)||4
6749053|NCT03424044|7677127|FG006|STARTED|First Rest Period (1-12 Weeks)||1
6749054|NCT03424044|7677128|FG007|STARTED|First Rest Period (1-12 Weeks)||1
6749055|NCT03424044|7677129|FG008|STARTED|First Rest Period (1-12 Weeks)||1
6749056|NCT03424044|7677121|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
6749057|NCT03424044|7677122|FG001|COMPLETED|First Rest Period (1-12 Weeks)||3
6749058|NCT03424044|7677123|FG002|COMPLETED|First Rest Period (1-12 Weeks)||2
6749059|NCT03424044|7677124|FG003|COMPLETED|First Rest Period (1-12 Weeks)||3
6749060|NCT03424044|7677125|FG004|COMPLETED|First Rest Period (1-12 Weeks)||3
6749061|NCT03424044|7677126|FG005|COMPLETED|First Rest Period (1-12 Weeks)||4
6749062|NCT03424044|7677127|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
6749063|NCT03424044|7677128|FG007|COMPLETED|First Rest Period (1-12 Weeks)||1
6749064|NCT03424044|7677129|FG008|COMPLETED|First Rest Period (1-12 Weeks)||1
6749065|NCT03424044|7677121|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6749066|NCT03424044|7677122|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6749067|NCT03424044|7677123|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||1
6749068|NCT03424044|7677124|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6749069|NCT03424044|7677125|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6749070|NCT03424044|7677126|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6749071|NCT03424044|7677127|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6749072|NCT03424044|7677128|FG007|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6749073|NCT03424044|7677129|FG008|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6491902|NCT01372085|7410422|FG006|NOT COMPLETED|Washout Period 1||0
6491903|NCT01372085|7410423|FG007|NOT COMPLETED|Washout Period 1||0
6491904|NCT01372085|7410424|FG008|NOT COMPLETED|Washout Period 1||0
6491905|NCT01372085|7410425|FG009|NOT COMPLETED|Washout Period 1||0
6491906|NCT01372085|7410416|FG000|STARTED|Second Intervention (Period 2)||0
6491907|NCT01372085|7410417|FG001|STARTED|Second Intervention (Period 2)||0
6491908|NCT01372085|7410418|FG002|STARTED|Second Intervention (Period 2)||2
6749074|NCT03424044|7677121|FG000|STARTED|First Intervention (76 Hours)||4
6749075|NCT03424044|7677122|FG001|STARTED|First Intervention (76 Hours)||3
6491909|NCT01372085|7410419|FG003|STARTED|Second Intervention (Period 2)||1
6491910|NCT01372085|7410420|FG004|STARTED|Second Intervention (Period 2)||3
6491911|NCT01372085|7410421|FG005|STARTED|Second Intervention (Period 2)||5
6491912|NCT01372085|7410422|FG006|STARTED|Second Intervention (Period 2)||3
6491913|NCT01372085|7410423|FG007|STARTED|Second Intervention (Period 2)||1
6491914|NCT01372085|7410424|FG008|STARTED|Second Intervention (Period 2)||1
6491915|NCT01372085|7410425|FG009|STARTED|Second Intervention (Period 2)||0
6491916|NCT01372085|7410416|FG000|COMPLETED|Second Intervention (Period 2)||0
6491917|NCT01372085|7410417|FG001|COMPLETED|Second Intervention (Period 2)||0
6491918|NCT01372085|7410418|FG002|COMPLETED|Second Intervention (Period 2)||2
6491919|NCT01372085|7410419|FG003|COMPLETED|Second Intervention (Period 2)||1
6491920|NCT01372085|7410420|FG004|COMPLETED|Second Intervention (Period 2)||3
6491921|NCT01372085|7410421|FG005|COMPLETED|Second Intervention (Period 2)||5
6491922|NCT01372085|7410422|FG006|COMPLETED|Second Intervention (Period 2)||3
6491923|NCT01372085|7410423|FG007|COMPLETED|Second Intervention (Period 2)||1
6491924|NCT01372085|7410424|FG008|COMPLETED|Second Intervention (Period 2)||1
6491925|NCT01372085|7410425|FG009|COMPLETED|Second Intervention (Period 2)||0
6491926|NCT01372085|7410416|FG000|NOT COMPLETED|Second Intervention (Period 2)||0
6491927|NCT01372085|7410417|FG001|NOT COMPLETED|Second Intervention (Period 2)||0
6491928|NCT01372085|7410418|FG002|NOT COMPLETED|Second Intervention (Period 2)||0
6491929|NCT01372085|7410419|FG003|NOT COMPLETED|Second Intervention (Period 2)||0
6491930|NCT01372085|7410420|FG004|NOT COMPLETED|Second Intervention (Period 2)||0
6491931|NCT01372085|7410421|FG005|NOT COMPLETED|Second Intervention (Period 2)||0
6491932|NCT01372085|7410422|FG006|NOT COMPLETED|Second Intervention (Period 2)||0
6491933|NCT01372085|7410423|FG007|NOT COMPLETED|Second Intervention (Period 2)||0
6491934|NCT01372085|7410424|FG008|NOT COMPLETED|Second Intervention (Period 2)||0
6491935|NCT01372085|7410425|FG009|NOT COMPLETED|Second Intervention (Period 2)||0
6491936|NCT01372085|7410416|FG000|STARTED|Washout Period 2||0
6749076|NCT03424044|7677123|FG002|STARTED|First Intervention (76 Hours)||2
6749077|NCT03424044|7677124|FG003|STARTED|First Intervention (76 Hours)||3
6749078|NCT03424044|7677125|FG004|STARTED|First Intervention (76 Hours)||3
6749079|NCT03424044|7677126|FG005|STARTED|First Intervention (76 Hours)||4
6749080|NCT03424044|7677127|FG006|STARTED|First Intervention (76 Hours)||1
6749081|NCT03424044|7677128|FG007|STARTED|First Intervention (76 Hours)||1
6749082|NCT03424044|7677129|FG008|STARTED|First Intervention (76 Hours)||1
6749083|NCT03424044|7677121|FG000|COMPLETED|First Intervention (76 Hours)||4
6749084|NCT03424044|7677122|FG001|COMPLETED|First Intervention (76 Hours)||3
6749085|NCT03424044|7677123|FG002|COMPLETED|First Intervention (76 Hours)||2
6749086|NCT03424044|7677124|FG003|COMPLETED|First Intervention (76 Hours)||3
6749087|NCT03424044|7677125|FG004|COMPLETED|First Intervention (76 Hours)||2
6749088|NCT03424044|7677126|FG005|COMPLETED|First Intervention (76 Hours)||4
6749089|NCT03424044|7677127|FG006|COMPLETED|First Intervention (76 Hours)||0
6749090|NCT03424044|7677128|FG007|COMPLETED|First Intervention (76 Hours)||0
6749091|NCT03424044|7677129|FG008|COMPLETED|First Intervention (76 Hours)||0
6749092|NCT03424044|7677121|FG000|NOT COMPLETED|First Intervention (76 Hours)||0
6749093|NCT03424044|7677122|FG001|NOT COMPLETED|First Intervention (76 Hours)||0
6749094|NCT03424044|7677123|FG002|NOT COMPLETED|First Intervention (76 Hours)||0
6749095|NCT03424044|7677124|FG003|NOT COMPLETED|First Intervention (76 Hours)||0
6749096|NCT03424044|7677125|FG004|NOT COMPLETED|First Intervention (76 Hours)||1
6749097|NCT03424044|7677126|FG005|NOT COMPLETED|First Intervention (76 Hours)||0
6749098|NCT03424044|7677127|FG006|NOT COMPLETED|First Intervention (76 Hours)||1
6749099|NCT03424044|7677128|FG007|NOT COMPLETED|First Intervention (76 Hours)||1
6749100|NCT03424044|7677129|FG008|NOT COMPLETED|First Intervention (76 Hours)||1
6749101|NCT03424044|7677121|FG000|STARTED|Second Rest Period (7-45 Days)||4
6749102|NCT03424044|7677122|FG001|STARTED|Second Rest Period (7-45 Days)||3
6749103|NCT03424044|7677123|FG002|STARTED|Second Rest Period (7-45 Days)||2
6749104|NCT03424044|7677124|FG003|STARTED|Second Rest Period (7-45 Days)||3
6749105|NCT03424044|7677125|FG004|STARTED|Second Rest Period (7-45 Days)||2
6749106|NCT03424044|7677126|FG005|STARTED|Second Rest Period (7-45 Days)||4
6749107|NCT03424044|7677127|FG006|STARTED|Second Rest Period (7-45 Days)||1
6749108|NCT03424044|7677128|FG007|STARTED|Second Rest Period (7-45 Days)||1
6749109|NCT03424044|7677129|FG008|STARTED|Second Rest Period (7-45 Days)||1
6749110|NCT03424044|7677121|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
6749111|NCT03424044|7677122|FG001|COMPLETED|Second Rest Period (7-45 Days)||3
6749112|NCT03424044|7677123|FG002|COMPLETED|Second Rest Period (7-45 Days)||2
6749113|NCT03424044|7677124|FG003|COMPLETED|Second Rest Period (7-45 Days)||3
6749114|NCT03424044|7677125|FG004|COMPLETED|Second Rest Period (7-45 Days)||2
6749115|NCT03424044|7677126|FG005|COMPLETED|Second Rest Period (7-45 Days)||4
6749116|NCT03424044|7677127|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
6749117|NCT03424044|7677128|FG007|COMPLETED|Second Rest Period (7-45 Days)||1
6749118|NCT03424044|7677129|FG008|COMPLETED|Second Rest Period (7-45 Days)||1
6749119|NCT03424044|7677121|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6749120|NCT03424044|7677122|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6749121|NCT03424044|7677123|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6749122|NCT03424044|7677124|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6749123|NCT03424044|7677125|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6749124|NCT03424044|7677126|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6491937|NCT01372085|7410417|FG001|STARTED|Washout Period 2||0
6491938|NCT01372085|7410418|FG002|STARTED|Washout Period 2||2
6491939|NCT01372085|7410419|FG003|STARTED|Washout Period 2||1
6491940|NCT01372085|7410420|FG004|STARTED|Washout Period 2||3
6491941|NCT01372085|7410421|FG005|STARTED|Washout Period 2||5
6491942|NCT01372085|7410422|FG006|STARTED|Washout Period 2||3
6491943|NCT01372085|7410423|FG007|STARTED|Washout Period 2||1
6491944|NCT01372085|7410424|FG008|STARTED|Washout Period 2||1
6491945|NCT01372085|7410425|FG009|STARTED|Washout Period 2||0
6491946|NCT01372085|7410416|FG000|COMPLETED|Washout Period 2||0
6491947|NCT01372085|7410417|FG001|COMPLETED|Washout Period 2||0
6491948|NCT01372085|7410418|FG002|COMPLETED|Washout Period 2||2
6491949|NCT01372085|7410419|FG003|COMPLETED|Washout Period 2||1
6491950|NCT01372085|7410420|FG004|COMPLETED|Washout Period 2|One participant discontinued Washout Period 2 and was replaced in Period 1.|2
6491951|NCT01372085|7410421|FG005|COMPLETED|Washout Period 2||5
6491952|NCT01372085|7410422|FG006|COMPLETED|Washout Period 2||3
6491953|NCT01372085|7410423|FG007|COMPLETED|Washout Period 2||1
6491954|NCT01372085|7410424|FG008|COMPLETED|Washout Period 2||1
6491955|NCT01372085|7410425|FG009|COMPLETED|Washout Period 2||0
6491956|NCT01372085|7410416|FG000|NOT COMPLETED|Washout Period 2||0
6491957|NCT01372085|7410417|FG001|NOT COMPLETED|Washout Period 2||0
6555258|NCT01751113|7477426|FG004|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6555259|NCT01751113|7477427|FG005|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
6555260|NCT01751113|7477422|FG000|STARTED|Treatment Period 2 (4 Weeks)||8
6555261|NCT01751113|7477423|FG001|STARTED|Treatment Period 2 (4 Weeks)||8
6555262|NCT01751113|7477424|FG002|STARTED|Treatment Period 2 (4 Weeks)||9
6555263|NCT01751113|7477425|FG003|STARTED|Treatment Period 2 (4 Weeks)||8
6555264|NCT01751113|7477426|FG004|STARTED|Treatment Period 2 (4 Weeks)||8
6555265|NCT01751113|7477427|FG005|STARTED|Treatment Period 2 (4 Weeks)||10
6555266|NCT01751113|7477422|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||8
6749125|NCT03424044|7677127|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6491958|NCT01372085|7410418|FG002|NOT COMPLETED|Washout Period 2||0
6749126|NCT03424044|7677128|FG007|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6749127|NCT03424044|7677129|FG008|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6491959|NCT01372085|7410419|FG003|NOT COMPLETED|Washout Period 2||0
6491960|NCT01372085|7410420|FG004|NOT COMPLETED|Washout Period 2||1
6491961|NCT01372085|7410421|FG005|NOT COMPLETED|Washout Period 2||0
6491962|NCT01372085|7410422|FG006|NOT COMPLETED|Washout Period 2||0
6491963|NCT01372085|7410423|FG007|NOT COMPLETED|Washout Period 2||0
6491964|NCT01372085|7410424|FG008|NOT COMPLETED|Washout Period 2||0
6491965|NCT01372085|7410425|FG009|NOT COMPLETED|Washout Period 2||0
6491966|NCT01372085|7410416|FG000|STARTED|Third Intervention (Period 3)||0
6491967|NCT01372085|7410417|FG001|STARTED|Third Intervention (Period 3)||0
6491968|NCT01372085|7410418|FG002|STARTED|Third Intervention (Period 3)||2
6491969|NCT01372085|7410419|FG003|STARTED|Third Intervention (Period 3)||1
6491970|NCT01372085|7410420|FG004|STARTED|Third Intervention (Period 3)||2
6491971|NCT01372085|7410421|FG005|STARTED|Third Intervention (Period 3)|Replacement pts repeated Period (P) 3 to fulfill requirement for P3 versus P4a comparison.|7
6491972|NCT01372085|7410422|FG006|STARTED|Third Intervention (Period 3)||3
6491973|NCT01372085|7410423|FG007|STARTED|Third Intervention (Period 3)||1
6491974|NCT01372085|7410424|FG008|STARTED|Third Intervention (Period 3)||1
6491975|NCT01372085|7410425|FG009|STARTED|Third Intervention (Period 3)||0
6491976|NCT01372085|7410416|FG000|COMPLETED|Third Intervention (Period 3)||0
6491977|NCT01372085|7410417|FG001|COMPLETED|Third Intervention (Period 3)||0
6491978|NCT01372085|7410418|FG002|COMPLETED|Third Intervention (Period 3)||2
6491979|NCT01372085|7410419|FG003|COMPLETED|Third Intervention (Period 3)||1
6491980|NCT01372085|7410420|FG004|COMPLETED|Third Intervention (Period 3)||2
6491981|NCT01372085|7410421|FG005|COMPLETED|Third Intervention (Period 3)||7
6491982|NCT01372085|7410422|FG006|COMPLETED|Third Intervention (Period 3)||3
6491983|NCT01372085|7410423|FG007|COMPLETED|Third Intervention (Period 3)||1
6491984|NCT01372085|7410424|FG008|COMPLETED|Third Intervention (Period 3)||1
6491985|NCT01372085|7410425|FG009|COMPLETED|Third Intervention (Period 3)||0
6491986|NCT01372085|7410416|FG000|NOT COMPLETED|Third Intervention (Period 3)||0
6491987|NCT01372085|7410417|FG001|NOT COMPLETED|Third Intervention (Period 3)||0
6491988|NCT01372085|7410418|FG002|NOT COMPLETED|Third Intervention (Period 3)||0
6491989|NCT01372085|7410419|FG003|NOT COMPLETED|Third Intervention (Period 3)||0
6491990|NCT01372085|7410420|FG004|NOT COMPLETED|Third Intervention (Period 3)||0
6491991|NCT01372085|7410421|FG005|NOT COMPLETED|Third Intervention (Period 3)||0
6491992|NCT01372085|7410422|FG006|NOT COMPLETED|Third Intervention (Period 3)||0
6491993|NCT01372085|7410423|FG007|NOT COMPLETED|Third Intervention (Period 3)||0
6491994|NCT01372085|7410424|FG008|NOT COMPLETED|Third Intervention (Period 3)||0
6491995|NCT01372085|7410425|FG009|NOT COMPLETED|Third Intervention (Period 3)||0
6491996|NCT01372085|7410416|FG000|STARTED|Washout Period 3||0
6491997|NCT01372085|7410417|FG001|STARTED|Washout Period 3||0
6491998|NCT01372085|7410418|FG002|STARTED|Washout Period 3||2
6491999|NCT01372085|7410419|FG003|STARTED|Washout Period 3||1
6492000|NCT01372085|7410420|FG004|STARTED|Washout Period 3||2
6492001|NCT01372085|7410421|FG005|STARTED|Washout Period 3||7
6492002|NCT01372085|7410422|FG006|STARTED|Washout Period 3||3
6492003|NCT01372085|7410423|FG007|STARTED|Washout Period 3||1
6492004|NCT01372085|7410424|FG008|STARTED|Washout Period 3||1
6492005|NCT01372085|7410425|FG009|STARTED|Washout Period 3||0
6492006|NCT01372085|7410416|FG000|COMPLETED|Washout Period 3||0
6492007|NCT01372085|7410417|FG001|COMPLETED|Washout Period 3||0
6555267|NCT01751113|7477423|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||8
6555268|NCT01751113|7477424|FG002|COMPLETED|Treatment Period 2 (4 Weeks)||9
6492008|NCT01372085|7410418|FG002|COMPLETED|Washout Period 3||2
6492009|NCT01372085|7410419|FG003|COMPLETED|Washout Period 3||1
6492010|NCT01372085|7410420|FG004|COMPLETED|Washout Period 3||2
6492011|NCT01372085|7410421|FG005|COMPLETED|Washout Period 3|Two participants (pts) discontinued Washout P3 and were replaced in P3.|5
6492012|NCT01372085|7410422|FG006|COMPLETED|Washout Period 3||3
6492013|NCT01372085|7410423|FG007|COMPLETED|Washout Period 3||1
6492014|NCT01372085|7410424|FG008|COMPLETED|Washout Period 3||1
6492015|NCT01372085|7410425|FG009|COMPLETED|Washout Period 3||0
6492016|NCT01372085|7410416|FG000|NOT COMPLETED|Washout Period 3||0
6492017|NCT01372085|7410417|FG001|NOT COMPLETED|Washout Period 3||0
6492018|NCT01372085|7410418|FG002|NOT COMPLETED|Washout Period 3||0
6492019|NCT01372085|7410419|FG003|NOT COMPLETED|Washout Period 3||0
6492020|NCT01372085|7410420|FG004|NOT COMPLETED|Washout Period 3||0
6492021|NCT01372085|7410421|FG005|NOT COMPLETED|Washout Period 3||2
6492022|NCT01372085|7410422|FG006|NOT COMPLETED|Washout Period 3||0
6555269|NCT01751113|7477425|FG003|COMPLETED|Treatment Period 2 (4 Weeks)||8
6555270|NCT01751113|7477426|FG004|COMPLETED|Treatment Period 2 (4 Weeks)||8
6555271|NCT01751113|7477427|FG005|COMPLETED|Treatment Period 2 (4 Weeks)||10
6749128|NCT03424044|7677121|FG000|STARTED|Second Intervention (76 Hours)||4
6749129|NCT03424044|7677122|FG001|STARTED|Second Intervention (76 Hours)||3
6749130|NCT03424044|7677123|FG002|STARTED|Second Intervention (76 Hours)||2
6492023|NCT01372085|7410423|FG007|NOT COMPLETED|Washout Period 3||0
6492024|NCT01372085|7410424|FG008|NOT COMPLETED|Washout Period 3||0
6492025|NCT01372085|7410425|FG009|NOT COMPLETED|Washout Period 3||0
6492026|NCT01372085|7410416|FG000|STARTED|Forth Intervention (Period 4a/4b)||0
6492027|NCT01372085|7410417|FG001|STARTED|Forth Intervention (Period 4a/4b)||0
6492028|NCT01372085|7410418|FG002|STARTED|Forth Intervention (Period 4a/4b)||2
6492029|NCT01372085|7410419|FG003|STARTED|Forth Intervention (Period 4a/4b)||1
6492030|NCT01372085|7410420|FG004|STARTED|Forth Intervention (Period 4a/4b)||2
6492031|NCT01372085|7410421|FG005|STARTED|Forth Intervention (Period 4a/4b)||5
6492032|NCT01372085|7410422|FG006|STARTED|Forth Intervention (Period 4a/4b)||3
6492033|NCT01372085|7410423|FG007|STARTED|Forth Intervention (Period 4a/4b)||1
6492034|NCT01372085|7410424|FG008|STARTED|Forth Intervention (Period 4a/4b)||1
6492035|NCT01372085|7410425|FG009|STARTED|Forth Intervention (Period 4a/4b)|One pt was enrolled directly into P4b to fulfill requirement for safety and tolerability assessment.|1
6492036|NCT01372085|7410416|FG000|COMPLETED|Forth Intervention (Period 4a/4b)||0
6492037|NCT01372085|7410417|FG001|COMPLETED|Forth Intervention (Period 4a/4b)||0
6492038|NCT01372085|7410418|FG002|COMPLETED|Forth Intervention (Period 4a/4b)||2
6492039|NCT01372085|7410419|FG003|COMPLETED|Forth Intervention (Period 4a/4b)||1
6492040|NCT01372085|7410420|FG004|COMPLETED|Forth Intervention (Period 4a/4b)||2
6492041|NCT01372085|7410421|FG005|COMPLETED|Forth Intervention (Period 4a/4b)||5
6492042|NCT01372085|7410422|FG006|COMPLETED|Forth Intervention (Period 4a/4b)||3
6492043|NCT01372085|7410423|FG007|COMPLETED|Forth Intervention (Period 4a/4b)||1
6492044|NCT01372085|7410424|FG008|COMPLETED|Forth Intervention (Period 4a/4b)||1
6492045|NCT01372085|7410425|FG009|COMPLETED|Forth Intervention (Period 4a/4b)||1
6492046|NCT01372085|7410416|FG000|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492047|NCT01372085|7410417|FG001|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492048|NCT01372085|7410418|FG002|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492049|NCT01372085|7410419|FG003|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492050|NCT01372085|7410420|FG004|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492051|NCT01372085|7410421|FG005|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492052|NCT01372085|7410422|FG006|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492053|NCT01372085|7410423|FG007|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6555272|NCT01751113|7477422|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6749131|NCT03424044|7677124|FG003|STARTED|Second Intervention (76 Hours)||3
6749132|NCT03424044|7677125|FG004|STARTED|Second Intervention (76 Hours)||2
6749133|NCT03424044|7677126|FG005|STARTED|Second Intervention (76 Hours)||4
6749134|NCT03424044|7677127|FG006|STARTED|Second Intervention (76 Hours)||1
6749135|NCT03424044|7677128|FG007|STARTED|Second Intervention (76 Hours)||1
6749136|NCT03424044|7677129|FG008|STARTED|Second Intervention (76 Hours)||1
6749137|NCT03424044|7677121|FG000|COMPLETED|Second Intervention (76 Hours)||4
6749138|NCT03424044|7677122|FG001|COMPLETED|Second Intervention (76 Hours)||3
6749139|NCT03424044|7677123|FG002|COMPLETED|Second Intervention (76 Hours)||2
6749140|NCT03424044|7677124|FG003|COMPLETED|Second Intervention (76 Hours)||3
6749141|NCT03424044|7677125|FG004|COMPLETED|Second Intervention (76 Hours)||2
6749142|NCT03424044|7677126|FG005|COMPLETED|Second Intervention (76 Hours)||4
6749143|NCT03424044|7677127|FG006|COMPLETED|Second Intervention (76 Hours)||1
6749144|NCT03424044|7677128|FG007|COMPLETED|Second Intervention (76 Hours)||1
6749145|NCT03424044|7677129|FG008|COMPLETED|Second Intervention (76 Hours)||1
6749146|NCT03424044|7677121|FG000|NOT COMPLETED|Second Intervention (76 Hours)||0
6749147|NCT03424044|7677122|FG001|NOT COMPLETED|Second Intervention (76 Hours)||0
6749148|NCT03424044|7677123|FG002|NOT COMPLETED|Second Intervention (76 Hours)||0
6749149|NCT03424044|7677124|FG003|NOT COMPLETED|Second Intervention (76 Hours)||0
6749150|NCT03424044|7677125|FG004|NOT COMPLETED|Second Intervention (76 Hours)||0
6749151|NCT03424044|7677126|FG005|NOT COMPLETED|Second Intervention (76 Hours)||0
6749152|NCT03424044|7677127|FG006|NOT COMPLETED|Second Intervention (76 Hours)||0
6749153|NCT03424044|7677128|FG007|NOT COMPLETED|Second Intervention (76 Hours)||0
6749154|NCT03424044|7677129|FG008|NOT COMPLETED|Second Intervention (76 Hours)||0
6555273|NCT01751113|7477423|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6492054|NCT01372085|7410424|FG008|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492055|NCT01372085|7410425|FG009|NOT COMPLETED|Forth Intervention (Period 4a/4b)||0
6492056|NCT01372150|7410452|FG000|STARTED|Overall Study||112
6492057|NCT01372150|7410453|FG001|STARTED|Overall Study||113
6492058|NCT01372150|7410454|FG002|STARTED|Overall Study||115
6492059|NCT01372150|7410452|FG000|Treated|Overall Study||112
6492060|NCT01372150|7410453|FG001|Treated|Overall Study||112
6492061|NCT01372150|7410454|FG002|Treated|Overall Study||115
6492062|NCT01372150|7410452|FG000|COMPLETED|Overall Study||99
6492063|NCT01372150|7410453|FG001|COMPLETED|Overall Study||99
6492064|NCT01372150|7410454|FG002|COMPLETED|Overall Study||99
6492065|NCT01372150|7410452|FG000|NOT COMPLETED|Overall Study||13
6492066|NCT01372150|7410453|FG001|NOT COMPLETED|Overall Study||14
6492067|NCT01372150|7410454|FG002|NOT COMPLETED|Overall Study||16
6492068|NCT01372202|7410465|FG000|STARTED|Overall Study||13
6492069|NCT01372202|7410466|FG001|STARTED|Overall Study||9
6492070|NCT01372202|7410467|FG002|STARTED|Overall Study||9
6492071|NCT01372202|7410465|FG000|COMPLETED|Overall Study||13
6492072|NCT01372202|7410466|FG001|COMPLETED|Overall Study||9
6492073|NCT01372202|7410467|FG002|COMPLETED|Overall Study||9
6492074|NCT01372202|7410465|FG000|NOT COMPLETED|Overall Study||0
6492075|NCT01372202|7410466|FG001|NOT COMPLETED|Overall Study||0
6492076|NCT01372202|7410467|FG002|NOT COMPLETED|Overall Study||0
6492077|NCT01372254|7410482|FG000|STARTED|Overall Study||47
6492078|NCT01372254|7410483|FG001|STARTED|Overall Study||49
6492079|NCT01372254|7410482|FG000|COMPLETED|Overall Study||43
6492080|NCT01372254|7410483|FG001|COMPLETED|Overall Study||46
6492081|NCT01372254|7410482|FG000|NOT COMPLETED|Overall Study||4
6492082|NCT01372254|7410483|FG001|NOT COMPLETED|Overall Study||3
6492083|NCT01372384|7410489|FG000|STARTED|Overall Study||6
6492084|NCT01372384|7410489|FG000|COMPLETED|Overall Study||3
6492085|NCT01372384|7410489|FG000|NOT COMPLETED|Overall Study||3
6492086|NCT01372410|7410493|FG000|STARTED|Treatment Period 1 (7 Days)||20
6492087|NCT01372410|7410494|FG001|STARTED|Treatment Period 1 (7 Days)||21
6492088|NCT01372410|7410495|FG002|STARTED|Treatment Period 1 (7 Days)||19
6492089|NCT01372410|7410496|FG003|STARTED|Treatment Period 1 (7 Days)||20
6492090|NCT01372410|7410497|FG004|STARTED|Treatment Period 1 (7 Days)||21
6492091|NCT01372410|7410498|FG005|STARTED|Treatment Period 1 (7 Days)||21
6492092|NCT01372410|7410499|FG006|STARTED|Treatment Period 1 (7 Days)||22
6492093|NCT01372410|7410500|FG007|STARTED|Treatment Period 1 (7 Days)||19
6492094|NCT01372410|7410493|FG000|COMPLETED|Treatment Period 1 (7 Days)||19
6492095|NCT01372410|7410494|FG001|COMPLETED|Treatment Period 1 (7 Days)||19
6492096|NCT01372410|7410495|FG002|COMPLETED|Treatment Period 1 (7 Days)||19
6492097|NCT01372410|7410496|FG003|COMPLETED|Treatment Period 1 (7 Days)||20
6492098|NCT01372410|7410497|FG004|COMPLETED|Treatment Period 1 (7 Days)||19
6492099|NCT01372410|7410498|FG005|COMPLETED|Treatment Period 1 (7 Days)||21
6492100|NCT01372410|7410499|FG006|COMPLETED|Treatment Period 1 (7 Days)||20
6492101|NCT01372410|7410500|FG007|COMPLETED|Treatment Period 1 (7 Days)||19
6492102|NCT01372410|7410493|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||1
6492103|NCT01372410|7410494|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||2
6492104|NCT01372410|7410495|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6492105|NCT01372410|7410496|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6492106|NCT01372410|7410497|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||2
6492107|NCT01372410|7410498|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6492108|NCT01372410|7410499|FG006|NOT COMPLETED|Treatment Period 1 (7 Days)||2
6492109|NCT01372410|7410500|FG007|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6492110|NCT01372410|7410493|FG000|STARTED|Washout Period 1 (10-14 Days)||19
6555274|NCT01751113|7477424|FG002|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6555275|NCT01751113|7477425|FG003|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6555276|NCT01751113|7477426|FG004|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6555277|NCT01751113|7477427|FG005|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6749155|NCT03424044|7677121|FG000|STARTED|Third Rest Period (7-45 Days)||4
6749156|NCT03424044|7677122|FG001|STARTED|Third Rest Period (7-45 Days)||3
6749157|NCT03424044|7677123|FG002|STARTED|Third Rest Period (7-45 Days)||2
6749158|NCT03424044|7677124|FG003|STARTED|Third Rest Period (7-45 Days)||3
6749159|NCT03424044|7677125|FG004|STARTED|Third Rest Period (7-45 Days)||2
6749160|NCT03424044|7677126|FG005|STARTED|Third Rest Period (7-45 Days)||4
6749161|NCT03424044|7677127|FG006|STARTED|Third Rest Period (7-45 Days)||1
6749162|NCT03424044|7677128|FG007|STARTED|Third Rest Period (7-45 Days)||1
6749163|NCT03424044|7677129|FG008|STARTED|Third Rest Period (7-45 Days)||1
6749164|NCT03424044|7677121|FG000|COMPLETED|Third Rest Period (7-45 Days)||4
6749165|NCT03424044|7677122|FG001|COMPLETED|Third Rest Period (7-45 Days)||3
6749166|NCT03424044|7677123|FG002|COMPLETED|Third Rest Period (7-45 Days)||2
6749167|NCT03424044|7677124|FG003|COMPLETED|Third Rest Period (7-45 Days)||3
6749168|NCT03424044|7677125|FG004|COMPLETED|Third Rest Period (7-45 Days)||2
6749169|NCT03424044|7677126|FG005|COMPLETED|Third Rest Period (7-45 Days)||4
6749170|NCT03424044|7677127|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
6749171|NCT03424044|7677128|FG007|COMPLETED|Third Rest Period (7-45 Days)||1
6492111|NCT01372410|7410494|FG001|STARTED|Washout Period 1 (10-14 Days)||19
6492112|NCT01372410|7410495|FG002|STARTED|Washout Period 1 (10-14 Days)||19
6492113|NCT01372410|7410496|FG003|STARTED|Washout Period 1 (10-14 Days)||20
6492114|NCT01372410|7410497|FG004|STARTED|Washout Period 1 (10-14 Days)||19
6492115|NCT01372410|7410498|FG005|STARTED|Washout Period 1 (10-14 Days)||21
6749172|NCT03424044|7677129|FG008|COMPLETED|Third Rest Period (7-45 Days)||1
6749173|NCT03424044|7677121|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6749174|NCT03424044|7677122|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6749175|NCT03424044|7677123|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6749176|NCT03424044|7677124|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6749177|NCT03424044|7677125|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6749178|NCT03424044|7677126|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6749179|NCT03424044|7677127|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6492116|NCT01372410|7410499|FG006|STARTED|Washout Period 1 (10-14 Days)||20
6492117|NCT01372410|7410500|FG007|STARTED|Washout Period 1 (10-14 Days)||19
6492118|NCT01372410|7410493|FG000|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
6492119|NCT01372410|7410494|FG001|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
6492120|NCT01372410|7410495|FG002|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
6492121|NCT01372410|7410496|FG003|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
6492122|NCT01372410|7410497|FG004|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
6492123|NCT01372410|7410498|FG005|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
6492124|NCT01372410|7410499|FG006|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
6492125|NCT01372410|7410500|FG007|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
6492126|NCT01372410|7410493|FG000|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
6492127|NCT01372410|7410494|FG001|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6492128|NCT01372410|7410495|FG002|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6492129|NCT01372410|7410496|FG003|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6492130|NCT01372410|7410497|FG004|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6492131|NCT01372410|7410498|FG005|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6492132|NCT01372410|7410499|FG006|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
6492133|NCT01372410|7410500|FG007|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
6492134|NCT01372410|7410493|FG000|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
6492135|NCT01372410|7410494|FG001|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
6492136|NCT01372410|7410495|FG002|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
6492137|NCT01372410|7410496|FG003|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
6492138|NCT01372410|7410497|FG004|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
6492139|NCT01372410|7410498|FG005|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
6492140|NCT01372410|7410499|FG006|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
6492141|NCT01372410|7410500|FG007|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
6492142|NCT01372410|7410493|FG000|COMPLETED|Treatment Period 2 (7 Days)||19
6492143|NCT01372410|7410494|FG001|COMPLETED|Treatment Period 2 (7 Days)||21
6492144|NCT01372410|7410495|FG002|COMPLETED|Treatment Period 2 (7 Days)||22
6492145|NCT01372410|7410496|FG003|COMPLETED|Treatment Period 2 (7 Days)||17
6492146|NCT01372410|7410497|FG004|COMPLETED|Treatment Period 2 (7 Days)||19
6492147|NCT01372410|7410498|FG005|COMPLETED|Treatment Period 2 (7 Days)||16
6492148|NCT01372410|7410499|FG006|COMPLETED|Treatment Period 2 (7 Days)||21
6492149|NCT01372410|7410500|FG007|COMPLETED|Treatment Period 2 (7 Days)||19
6492150|NCT01372410|7410493|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6492151|NCT01372410|7410494|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6492152|NCT01372410|7410495|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6492153|NCT01372410|7410496|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6492154|NCT01372410|7410497|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6492155|NCT01372410|7410498|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6492156|NCT01372410|7410499|FG006|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6492157|NCT01372410|7410500|FG007|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6492158|NCT01372410|7410493|FG000|STARTED|Washout Period 2 (10-14 Days)||19
6492159|NCT01372410|7410494|FG001|STARTED|Washout Period 2 (10-14 Days)||21
6492160|NCT01372410|7410495|FG002|STARTED|Washout Period 2 (10-14 Days)||22
6492161|NCT01372410|7410496|FG003|STARTED|Washout Period 2 (10-14 Days)||17
6492162|NCT01372410|7410497|FG004|STARTED|Washout Period 2 (10-14 Days)||19
6492163|NCT01372410|7410498|FG005|STARTED|Washout Period 2 (10-14 Days)||16
6492164|NCT01372410|7410499|FG006|STARTED|Washout Period 2 (10-14 Days)||21
6492165|NCT01372410|7410500|FG007|STARTED|Washout Period 2 (10-14 Days)||19
6492166|NCT01372410|7410493|FG000|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
6492167|NCT01372410|7410494|FG001|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
6492168|NCT01372410|7410495|FG002|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
6492169|NCT01372410|7410496|FG003|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
6492170|NCT01372410|7410497|FG004|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
6492171|NCT01372410|7410498|FG005|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
6492172|NCT01372410|7410499|FG006|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
6492173|NCT01372410|7410500|FG007|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
6492174|NCT01372410|7410493|FG000|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6492175|NCT01372410|7410494|FG001|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6492176|NCT01372410|7410495|FG002|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6492177|NCT01372410|7410496|FG003|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6492178|NCT01372410|7410497|FG004|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
6492179|NCT01372410|7410498|FG005|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
6492180|NCT01372410|7410499|FG006|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
6492181|NCT01372410|7410500|FG007|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
6492182|NCT01372410|7410493|FG000|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
6492183|NCT01372410|7410494|FG001|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
6492184|NCT01372410|7410495|FG002|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
6492185|NCT01372410|7410496|FG003|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
6492186|NCT01372410|7410497|FG004|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
6492187|NCT01372410|7410498|FG005|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
6492188|NCT01372410|7410499|FG006|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
6492189|NCT01372410|7410500|FG007|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
6492190|NCT01372410|7410493|FG000|COMPLETED|Treatment Period 3 (7 Days)||21
6492191|NCT01372410|7410494|FG001|COMPLETED|Treatment Period 3 (7 Days)||18
6492192|NCT01372410|7410495|FG002|COMPLETED|Treatment Period 3 (7 Days)||15
6492193|NCT01372410|7410496|FG003|COMPLETED|Treatment Period 3 (7 Days)||22
6492194|NCT01372410|7410497|FG004|COMPLETED|Treatment Period 3 (7 Days)||20
6749180|NCT03424044|7677128|FG007|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6749181|NCT03424044|7677129|FG008|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6749182|NCT03424044|7677121|FG000|STARTED|Third Intervention (76 Hours)||4
6749183|NCT03424044|7677122|FG001|STARTED|Third Intervention (76 Hours)||3
6749184|NCT03424044|7677123|FG002|STARTED|Third Intervention (76 Hours)||2
6749185|NCT03424044|7677124|FG003|STARTED|Third Intervention (76 Hours)||3
6749186|NCT03424044|7677125|FG004|STARTED|Third Intervention (76 Hours)||2
6749187|NCT03424044|7677126|FG005|STARTED|Third Intervention (76 Hours)||4
6749188|NCT03424044|7677127|FG006|STARTED|Third Intervention (76 Hours)||1
6749189|NCT03424044|7677128|FG007|STARTED|Third Intervention (76 Hours)||1
6749190|NCT03424044|7677129|FG008|STARTED|Third Intervention (76 Hours)||1
6749191|NCT03424044|7677121|FG000|COMPLETED|Third Intervention (76 Hours)||3
6749192|NCT03424044|7677122|FG001|COMPLETED|Third Intervention (76 Hours)||3
6749193|NCT03424044|7677123|FG002|COMPLETED|Third Intervention (76 Hours)||2
6749194|NCT03424044|7677124|FG003|COMPLETED|Third Intervention (76 Hours)||2
6749195|NCT03424044|7677125|FG004|COMPLETED|Third Intervention (76 Hours)||2
6749196|NCT03424044|7677126|FG005|COMPLETED|Third Intervention (76 Hours)||4
6749197|NCT03424044|7677127|FG006|COMPLETED|Third Intervention (76 Hours)||0
6749198|NCT03424044|7677128|FG007|COMPLETED|Third Intervention (76 Hours)||1
6749199|NCT03424044|7677129|FG008|COMPLETED|Third Intervention (76 Hours)||1
6749200|NCT03424044|7677121|FG000|NOT COMPLETED|Third Intervention (76 Hours)||1
6749201|NCT03424044|7677122|FG001|NOT COMPLETED|Third Intervention (76 Hours)||0
6749202|NCT03424044|7677123|FG002|NOT COMPLETED|Third Intervention (76 Hours)||0
6749203|NCT03424044|7677124|FG003|NOT COMPLETED|Third Intervention (76 Hours)||1
6749204|NCT03424044|7677125|FG004|NOT COMPLETED|Third Intervention (76 Hours)||0
6749205|NCT03424044|7677126|FG005|NOT COMPLETED|Third Intervention (76 Hours)||0
6749206|NCT03424044|7677127|FG006|NOT COMPLETED|Third Intervention (76 Hours)||1
6749207|NCT03424044|7677128|FG007|NOT COMPLETED|Third Intervention (76 Hours)||0
6749208|NCT03424044|7677129|FG008|NOT COMPLETED|Third Intervention (76 Hours)||0
6749209|NCT03424044|7677121|FG000|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6749210|NCT03424044|7677122|FG001|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6749211|NCT03424044|7677123|FG002|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6749212|NCT03424044|7677124|FG003|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6749213|NCT03424044|7677125|FG004|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6749214|NCT03424044|7677126|FG005|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6749215|NCT03424044|7677127|FG006|STARTED|Optional Fourth Rest Period (7-45 Days)||0
6749216|NCT03424044|7677128|FG007|STARTED|Optional Fourth Rest Period (7-45 Days)||1
6749217|NCT03424044|7677129|FG008|STARTED|Optional Fourth Rest Period (7-45 Days)||1
6749218|NCT03424044|7677121|FG000|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749219|NCT03424044|7677122|FG001|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749220|NCT03424044|7677123|FG002|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749221|NCT03424044|7677124|FG003|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6492195|NCT01372410|7410498|FG005|COMPLETED|Treatment Period 3 (7 Days)||18
6492196|NCT01372410|7410499|FG006|COMPLETED|Treatment Period 3 (7 Days)||15
6492197|NCT01372410|7410500|FG007|COMPLETED|Treatment Period 3 (7 Days)||18
6492198|NCT01372410|7410493|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6492199|NCT01372410|7410494|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6492200|NCT01372410|7410495|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||1
6492201|NCT01372410|7410496|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6492202|NCT01372410|7410497|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6492203|NCT01372410|7410498|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||1
6492204|NCT01372410|7410499|FG006|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6492205|NCT01372410|7410500|FG007|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6492206|NCT01372462|7410519|FG000|STARTED|NIOV - Room Air||15
6492207|NCT01372462|7410519|FG000|COMPLETED|NIOV - Room Air||15
6492208|NCT01372462|7410519|FG000|NOT COMPLETED|NIOV - Room Air||0
6492209|NCT01372462|7410519|FG000|STARTED|NIOV - Oxygen||15
6492210|NCT01372462|7410519|FG000|COMPLETED|NIOV - Oxygen||15
6492211|NCT01372462|7410519|FG000|NOT COMPLETED|NIOV - Oxygen||0
6492212|NCT01372462|7410519|FG000|STARTED|Oxygen Nasal Cannula||15
6492213|NCT01372462|7410519|FG000|COMPLETED|Oxygen Nasal Cannula||15
6492214|NCT01372462|7410519|FG000|NOT COMPLETED|Oxygen Nasal Cannula||0
6492215|NCT01372462|7410519|FG000|STARTED|No Treatment Control||15
6492216|NCT01372462|7410519|FG000|COMPLETED|No Treatment Control||15
6492217|NCT01372462|7410519|FG000|NOT COMPLETED|No Treatment Control||0
6492218|NCT01372501|7410529|FG000|STARTED|Overall Study||19
6492219|NCT01372501|7410529|FG000|COMPLETED|Overall Study||14
6492220|NCT01372501|7410529|FG000|NOT COMPLETED|Overall Study||5
6492221|NCT01372605|7410536|FG000|STARTED|Overall Study||149
6492222|NCT01372605|7410537|FG001|STARTED|Overall Study||155
6492223|NCT01372605|7410536|FG000|COMPLETED|Overall Study||137
6492224|NCT01372605|7410537|FG001|COMPLETED|Overall Study||145
6492225|NCT01372605|7410536|FG000|NOT COMPLETED|Overall Study||12
6492226|NCT01372605|7410537|FG001|NOT COMPLETED|Overall Study||10
6492227|NCT01372748|7410545|FG000|STARTED|Overall Study||11045
6492228|NCT01372748|7410546|FG001|STARTED|Overall Study||12642
6492229|NCT01372748|7410545|FG000|COMPLETED|Overall Study|defined as having vital status|11022
6492230|NCT01372748|7410546|FG001|COMPLETED|Overall Study|defined as having vital status|12603
6492231|NCT01372748|7410545|FG000|NOT COMPLETED|Overall Study||23
6492232|NCT01372748|7410546|FG001|NOT COMPLETED|Overall Study||39
6492233|NCT01372774|7410554|FG000|STARTED|Overall Study||96
6492234|NCT01372774|7410555|FG001|STARTED|Overall Study||98
6492235|NCT01372774|7410554|FG000|COMPLETED|Overall Study||92
6492236|NCT01372774|7410555|FG001|COMPLETED|Overall Study||93
6492237|NCT01372774|7410554|FG000|NOT COMPLETED|Overall Study||4
6492238|NCT01372774|7410555|FG001|NOT COMPLETED|Overall Study||5
6492239|NCT01372813|7410563|FG000|STARTED|Overall Study||3
6492240|NCT01372813|7410563|FG000|COMPLETED|Overall Study||3
6492241|NCT01372813|7410563|FG000|NOT COMPLETED|Overall Study||0
6492242|NCT01372878|7410567|FG000|STARTED|Overall Study||884
6492243|NCT01372878|7410567|FG000|COMPLETED|Overall Study||700
6492244|NCT01372878|7410567|FG000|NOT COMPLETED|Overall Study||184
6492245|NCT01372995|7410574|FG000|STARTED|Overall Study||10
6749222|NCT03424044|7677125|FG004|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749223|NCT03424044|7677126|FG005|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749224|NCT03424044|7677127|FG006|COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749225|NCT03424044|7677128|FG007|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
6749226|NCT03424044|7677129|FG008|COMPLETED|Optional Fourth Rest Period (7-45 Days)||1
6749227|NCT03424044|7677121|FG000|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749228|NCT03424044|7677122|FG001|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749229|NCT03424044|7677123|FG002|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749230|NCT03424044|7677124|FG003|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749231|NCT03424044|7677125|FG004|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749232|NCT03424044|7677126|FG005|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749233|NCT03424044|7677127|FG006|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749234|NCT03424044|7677128|FG007|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749235|NCT03424044|7677129|FG008|NOT COMPLETED|Optional Fourth Rest Period (7-45 Days)||0
6749236|NCT03424044|7677121|FG000|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6749237|NCT03424044|7677122|FG001|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6749238|NCT03424044|7677123|FG002|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6749239|NCT03424044|7677124|FG003|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6749240|NCT03424044|7677125|FG004|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6749241|NCT03424044|7677126|FG005|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6749242|NCT03424044|7677127|FG006|STARTED|Fourth Intervention Repeat Visit (76 hr)||0
6749243|NCT03424044|7677128|FG007|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
6749244|NCT03424044|7677129|FG008|STARTED|Fourth Intervention Repeat Visit (76 hr)||1
6749245|NCT03424044|7677121|FG000|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749246|NCT03424044|7677122|FG001|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6492246|NCT01372995|7410575|FG001|STARTED|Overall Study||10
6492247|NCT01372995|7410576|FG002|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
6492248|NCT01372995|7410574|FG000|COMPLETED|Overall Study||10
6492249|NCT01372995|7410575|FG001|COMPLETED|Overall Study||9
6749247|NCT03424044|7677123|FG002|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6779902|NCT03544242|7708162|FG001|NOT COMPLETED|Overall Study||0
6492250|NCT01372995|7410576|FG002|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
6492251|NCT01372995|7410574|FG000|NOT COMPLETED|Overall Study||0
6492252|NCT01372995|7410575|FG001|NOT COMPLETED|Overall Study||1
6492253|NCT01372995|7410576|FG002|NOT COMPLETED|Overall Study||1
6492254|NCT01373164|7410589|FG000|STARTED|Overall Study||5
6492255|NCT01373164|7410590|FG001|STARTED|Overall Study||4
6492256|NCT01373164|7410591|FG002|STARTED|Overall Study||5
6492257|NCT01373164|7410592|FG003|STARTED|Overall Study||104
6492258|NCT01373164|7410593|FG004|STARTED|Overall Study||52
6492259|NCT01373164|7410589|FG000|Received at Least One Dose|Overall Study||5
6492260|NCT01373164|7410590|FG001|Received at Least One Dose|Overall Study||4
6492261|NCT01373164|7410591|FG002|Received at Least One Dose|Overall Study||5
6492262|NCT01373164|7410592|FG003|Received at Least One Dose|Overall Study||103
6492263|NCT01373164|7410593|FG004|Received at Least One Dose|Overall Study||52
6492264|NCT01373164|7410589|FG000|COMPLETED|Overall Study||5
6492265|NCT01373164|7410590|FG001|COMPLETED|Overall Study||3
6492266|NCT01373164|7410591|FG002|COMPLETED|Overall Study||4
6492267|NCT01373164|7410592|FG003|COMPLETED|Overall Study||92
6492268|NCT01373164|7410593|FG004|COMPLETED|Overall Study||50
6492269|NCT01373164|7410589|FG000|NOT COMPLETED|Overall Study||0
6492270|NCT01373164|7410590|FG001|NOT COMPLETED|Overall Study||1
6492271|NCT01373164|7410591|FG002|NOT COMPLETED|Overall Study||1
6492272|NCT01373164|7410592|FG003|NOT COMPLETED|Overall Study||12
6492273|NCT01373164|7410593|FG004|NOT COMPLETED|Overall Study||2
6501812|NCT01431287|7420454|FG003|NOT COMPLETED|Overall Study||63
6501813|NCT01431287|7420455|FG004|NOT COMPLETED|Overall Study||77
6501814|NCT01431300|7420470|FG000|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
6501815|NCT01431300|7420471|FG001|STARTED|Overall Study||10
6501816|NCT01431300|7420472|FG002|STARTED|Overall Study||10
6501817|NCT01431300|7420470|FG000|COMPLETED|Overall Study||10
6501818|NCT01431300|7420471|FG001|COMPLETED|Overall Study||10
6501819|NCT01431300|7420472|FG002|COMPLETED|Overall Study||10
6501820|NCT01431300|7420470|FG000|NOT COMPLETED|Overall Study||1
6501821|NCT01431300|7420471|FG001|NOT COMPLETED|Overall Study||0
6501822|NCT01431300|7420472|FG002|NOT COMPLETED|Overall Study||0
6501823|NCT01431313|7420483|FG000|STARTED|Overall Study||20
6501824|NCT01431313|7420484|FG001|STARTED|Overall Study||20
6501825|NCT01431313|7420485|FG002|STARTED|Overall Study||8
6501826|NCT01431313|7420483|FG000|COMPLETED|Overall Study||20
6501827|NCT01431313|7420484|FG001|COMPLETED|Overall Study||20
6501828|NCT01431313|7420485|FG002|COMPLETED|Overall Study||8
6501829|NCT01431313|7420483|FG000|NOT COMPLETED|Overall Study||0
6501830|NCT01431313|7420484|FG001|NOT COMPLETED|Overall Study||0
6501831|NCT01431313|7420485|FG002|NOT COMPLETED|Overall Study||0
6749248|NCT03424044|7677124|FG003|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749249|NCT03424044|7677125|FG004|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749250|NCT03424044|7677126|FG005|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749251|NCT03424044|7677127|FG006|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749252|NCT03424044|7677128|FG007|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
6749253|NCT03424044|7677129|FG008|COMPLETED|Fourth Intervention Repeat Visit (76 hr)||1
6749254|NCT03424044|7677121|FG000|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749255|NCT03424044|7677122|FG001|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749256|NCT03424044|7677123|FG002|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749257|NCT03424044|7677124|FG003|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749258|NCT03424044|7677125|FG004|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749259|NCT03424044|7677126|FG005|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749260|NCT03424044|7677127|FG006|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749261|NCT03424044|7677128|FG007|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749262|NCT03424044|7677129|FG008|NOT COMPLETED|Fourth Intervention Repeat Visit (76 hr)||0
6749263|NCT03424187|7677145|FG000|STARTED|Overall Study||2
6749264|NCT03424187|7677146|FG001|STARTED|Overall Study||3
6749265|NCT03424187|7677147|FG002|STARTED|Overall Study||2
6749266|NCT03424187|7677148|FG003|STARTED|Overall Study||3
6749267|NCT03424187|7677149|FG004|STARTED|Overall Study||2
6749268|NCT03424187|7677150|FG005|STARTED|Overall Study||3
6749269|NCT03424187|7677145|FG000|COMPLETED|Overall Study||2
6749270|NCT03424187|7677146|FG001|COMPLETED|Overall Study||3
6749271|NCT03424187|7677147|FG002|COMPLETED|Overall Study||2
6749272|NCT03424187|7677148|FG003|COMPLETED|Overall Study||3
6749273|NCT03424187|7677149|FG004|COMPLETED|Overall Study||2
6749274|NCT03424187|7677150|FG005|COMPLETED|Overall Study||3
6749275|NCT03424187|7677145|FG000|NOT COMPLETED|Overall Study||0
6749276|NCT03424187|7677146|FG001|NOT COMPLETED|Overall Study||0
6749277|NCT03424187|7677147|FG002|NOT COMPLETED|Overall Study||0
6749278|NCT03424187|7677148|FG003|NOT COMPLETED|Overall Study||0
6749279|NCT03424187|7677149|FG004|NOT COMPLETED|Overall Study||0
6749280|NCT03424187|7677150|FG005|NOT COMPLETED|Overall Study||0
6749281|NCT03424239|7677163|FG000|STARTED|Overall Study||6
6749282|NCT03424239|7677163|FG000|Baseline/Zoledronic Acid Administration|Overall Study||4
6749283|NCT03424239|7677163|FG000|2 Week Post-op|Overall Study||4
6502081|NCT01432444|7420720|FG001|COMPLETED|Tolerability/Cross-titration Phase||0
6502082|NCT01432444|7420721|FG002|COMPLETED|Tolerability/Cross-titration Phase||0
6502083|NCT01432444|7420719|FG000|NOT COMPLETED|Tolerability/Cross-titration Phase||60
6555278|NCT01751113|7477422|FG000|STARTED|Washout Period 2 (2 Weeks)||8
6492274|NCT01373229|7410608|FG000|STARTED|Overall Study||15
6492275|NCT01373229|7410608|FG000|COMPLETED|Overall Study||9
6492276|NCT01373229|7410608|FG000|NOT COMPLETED|Overall Study||6
6492277|NCT01373242|7410612|FG000|STARTED|Overall Study||54
6492278|NCT01373242|7410612|FG000|COMPLETED|Overall Study||38
6492279|NCT01373242|7410612|FG000|NOT COMPLETED|Overall Study||16
6492280|NCT01373294|7410620|FG000|STARTED|Overall Study||15
6492281|NCT01373294|7410621|FG001|STARTED|Overall Study||2
6492282|NCT01373294|7410620|FG000|COMPLETED|Overall Study||14
6492283|NCT01373294|7410621|FG001|COMPLETED|Overall Study||2
6492284|NCT01373294|7410620|FG000|NOT COMPLETED|Overall Study||1
6492285|NCT01373294|7410621|FG001|NOT COMPLETED|Overall Study||0
6492286|NCT01373346|7410627|FG000|STARTED|Overall Study||15
6492287|NCT01373346|7410627|FG000|COMPLETED|Overall Study||14
6555279|NCT01751113|7477423|FG001|STARTED|Washout Period 2 (2 Weeks)||8
6555280|NCT01751113|7477424|FG002|STARTED|Washout Period 2 (2 Weeks)||9
6555281|NCT01751113|7477425|FG003|STARTED|Washout Period 2 (2 Weeks)||8
6555282|NCT01751113|7477426|FG004|STARTED|Washout Period 2 (2 Weeks)||8
6654722|NCT02447718|7584635|FG000|Received Pediacel®|Overall Study||73
6749284|NCT03424239|7677163|FG000|12 Week Post-op|Overall Study||4
6749285|NCT03424239|7677163|FG000|24 Week Post-op|Overall Study||4
6749286|NCT03424239|7677163|FG000|COMPLETED|Overall Study||4
6749287|NCT03424239|7677163|FG000|NOT COMPLETED|Overall Study||2
6749288|NCT03424265|7677169|FG000|STARTED|Overall Study||29
6749289|NCT03424265|7677170|FG001|STARTED|Overall Study||34
6749290|NCT03424265|7677169|FG000|COMPLETED|Overall Study||28
6749291|NCT03424265|7677170|FG001|COMPLETED|Overall Study||32
6749292|NCT03424265|7677169|FG000|NOT COMPLETED|Overall Study||1
6749293|NCT03424265|7677170|FG001|NOT COMPLETED|Overall Study||2
6749294|NCT03424681|7677178|FG000|STARTED|Overall Study||6
6749295|NCT03424681|7677179|FG001|STARTED|Overall Study||6
6749296|NCT03424681|7677178|FG000|COMPLETED|Overall Study||6
6749297|NCT03424681|7677179|FG001|COMPLETED|Overall Study||5
6749298|NCT03424681|7677178|FG000|NOT COMPLETED|Overall Study||0
6749299|NCT03424681|7677179|FG001|NOT COMPLETED|Overall Study||1
6749300|NCT03425019|7677185|FG000|STARTED|Overall Study||20
6749301|NCT03425019|7677185|FG000|COMPLETED|Overall Study||20
6749302|NCT03425019|7677185|FG000|NOT COMPLETED|Overall Study||0
6749303|NCT03425097|7677190|FG000|STARTED|Treatment Period 1 (2 Weeks)||6
6749304|NCT03425097|7677191|FG001|STARTED|Treatment Period 1 (2 Weeks)||5
6749305|NCT03425097|7677190|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||6
6749306|NCT03425097|7677191|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||5
6749307|NCT03425097|7677190|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6749308|NCT03425097|7677191|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6749309|NCT03425097|7677190|FG000|STARTED|Washout Period (1 Week)||6
6749310|NCT03425097|7677191|FG001|STARTED|Washout Period (1 Week)||5
6749311|NCT03425097|7677190|FG000|COMPLETED|Washout Period (1 Week)||6
6749312|NCT03425097|7677191|FG001|COMPLETED|Washout Period (1 Week)||5
6749313|NCT03425097|7677190|FG000|NOT COMPLETED|Washout Period (1 Week)||0
6749314|NCT03425097|7677191|FG001|NOT COMPLETED|Washout Period (1 Week)||0
6749315|NCT03425097|7677190|FG000|STARTED|Second Treatment Period (2 Weeks)||6
6749316|NCT03425097|7677191|FG001|STARTED|Second Treatment Period (2 Weeks)||5
6749317|NCT03425097|7677190|FG000|COMPLETED|Second Treatment Period (2 Weeks)||6
6749318|NCT03425097|7677191|FG001|COMPLETED|Second Treatment Period (2 Weeks)||5
6492288|NCT01373346|7410627|FG000|NOT COMPLETED|Overall Study||1
6492289|NCT01373450|7410636|FG000|STARTED|Crossover Period 1||2
6492290|NCT01373450|7410637|FG001|STARTED|Crossover Period 1||2
6492291|NCT01373450|7410638|FG002|STARTED|Crossover Period 1||2
6492292|NCT01373450|7410639|FG003|STARTED|Crossover Period 1||2
6492293|NCT01373450|7410640|FG004|STARTED|Crossover Period 1||2
6492294|NCT01373450|7410641|FG005|STARTED|Crossover Period 1||2
6492295|NCT01373450|7410636|FG000|COMPLETED|Crossover Period 1||2
6492296|NCT01373450|7410637|FG001|COMPLETED|Crossover Period 1||2
6492297|NCT01373450|7410638|FG002|COMPLETED|Crossover Period 1||2
6492298|NCT01373450|7410639|FG003|COMPLETED|Crossover Period 1||2
6492299|NCT01373450|7410640|FG004|COMPLETED|Crossover Period 1||2
6555283|NCT01751113|7477427|FG005|STARTED|Washout Period 2 (2 Weeks)||10
6555284|NCT01751113|7477422|FG000|COMPLETED|Washout Period 2 (2 Weeks)||8
6654723|NCT02447718|7584636|FG001|Received Pediacel®|Overall Study|Do not receive vaccination|0
6654724|NCT02447718|7584635|FG000|Received Pneumovax® 23|Overall Study||73
6654725|NCT02447718|7584636|FG001|Received Pneumovax® 23|Overall Study|Do not receive vaccination|0
6654726|NCT02447718|7584635|FG000|COMPLETED|Overall Study||66
6654727|NCT02447718|7584636|FG001|COMPLETED|Overall Study||78
6654728|NCT02447718|7584635|FG000|NOT COMPLETED|Overall Study||12
6654729|NCT02447718|7584636|FG001|NOT COMPLETED|Overall Study||0
6654730|NCT02447744|7584645|FG000|STARTED|Overall Study|6 subjects are enrolled in the mindfulness program after serving on the waiting list control group|21
6749319|NCT03425097|7677190|FG000|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
6749320|NCT03425097|7677191|FG001|NOT COMPLETED|Second Treatment Period (2 Weeks)||0
6749321|NCT03425188|7677200|FG000|STARTED|Overall Study||53
6749322|NCT03425188|7677200|FG000|COMPLETED|Overall Study||52
6555285|NCT01751113|7477423|FG001|COMPLETED|Washout Period 2 (2 Weeks)||8
6555286|NCT01751113|7477424|FG002|COMPLETED|Washout Period 2 (2 Weeks)||9
6555287|NCT01751113|7477425|FG003|COMPLETED|Washout Period 2 (2 Weeks)||8
6555288|NCT01751113|7477426|FG004|COMPLETED|Washout Period 2 (2 Weeks)||8
6555289|NCT01751113|7477427|FG005|COMPLETED|Washout Period 2 (2 Weeks)||10
6492300|NCT01373450|7410641|FG005|COMPLETED|Crossover Period 1||2
6492301|NCT01373450|7410636|FG000|NOT COMPLETED|Crossover Period 1||0
6492302|NCT01373450|7410637|FG001|NOT COMPLETED|Crossover Period 1||0
6492303|NCT01373450|7410638|FG002|NOT COMPLETED|Crossover Period 1||0
6492304|NCT01373450|7410639|FG003|NOT COMPLETED|Crossover Period 1||0
6492305|NCT01373450|7410640|FG004|NOT COMPLETED|Crossover Period 1||0
6492306|NCT01373450|7410641|FG005|NOT COMPLETED|Crossover Period 1||0
6492307|NCT01373450|7410636|FG000|STARTED|7 Day Wash-out||2
6492308|NCT01373450|7410637|FG001|STARTED|7 Day Wash-out||2
6492309|NCT01373450|7410638|FG002|STARTED|7 Day Wash-out||2
6492310|NCT01373450|7410639|FG003|STARTED|7 Day Wash-out||2
6492311|NCT01373450|7410640|FG004|STARTED|7 Day Wash-out||2
6492312|NCT01373450|7410641|FG005|STARTED|7 Day Wash-out||2
6492313|NCT01373450|7410636|FG000|COMPLETED|7 Day Wash-out||2
6492314|NCT01373450|7410637|FG001|COMPLETED|7 Day Wash-out||2
6492315|NCT01373450|7410638|FG002|COMPLETED|7 Day Wash-out||2
6492316|NCT01373450|7410639|FG003|COMPLETED|7 Day Wash-out||2
6492317|NCT01373450|7410640|FG004|COMPLETED|7 Day Wash-out||2
6492318|NCT01373450|7410641|FG005|COMPLETED|7 Day Wash-out||2
6492319|NCT01373450|7410636|FG000|NOT COMPLETED|7 Day Wash-out||0
6492320|NCT01373450|7410637|FG001|NOT COMPLETED|7 Day Wash-out||0
6492321|NCT01373450|7410638|FG002|NOT COMPLETED|7 Day Wash-out||0
6492322|NCT01373450|7410639|FG003|NOT COMPLETED|7 Day Wash-out||0
6492323|NCT01373450|7410640|FG004|NOT COMPLETED|7 Day Wash-out||0
6492324|NCT01373450|7410641|FG005|NOT COMPLETED|7 Day Wash-out||0
6492325|NCT01373450|7410636|FG000|STARTED|Crossover Period 2||2
6492326|NCT01373450|7410637|FG001|STARTED|Crossover Period 2||2
6492327|NCT01373450|7410638|FG002|STARTED|Crossover Period 2||2
6492328|NCT01373450|7410639|FG003|STARTED|Crossover Period 2||2
6492329|NCT01373450|7410640|FG004|STARTED|Crossover Period 2||2
6492330|NCT01373450|7410641|FG005|STARTED|Crossover Period 2||2
6492331|NCT01373450|7410636|FG000|COMPLETED|Crossover Period 2||2
6492332|NCT01373450|7410637|FG001|COMPLETED|Crossover Period 2||2
6492333|NCT01373450|7410638|FG002|COMPLETED|Crossover Period 2||2
6492334|NCT01373450|7410639|FG003|COMPLETED|Crossover Period 2||2
6492335|NCT01373450|7410640|FG004|COMPLETED|Crossover Period 2||2
6492336|NCT01373450|7410641|FG005|COMPLETED|Crossover Period 2||2
6492337|NCT01373450|7410636|FG000|NOT COMPLETED|Crossover Period 2||0
6492338|NCT01373450|7410637|FG001|NOT COMPLETED|Crossover Period 2||0
6492339|NCT01373450|7410638|FG002|NOT COMPLETED|Crossover Period 2||0
6492340|NCT01373450|7410639|FG003|NOT COMPLETED|Crossover Period 2||0
6492341|NCT01373450|7410640|FG004|NOT COMPLETED|Crossover Period 2||0
6492342|NCT01373450|7410641|FG005|NOT COMPLETED|Crossover Period 2||0
6492343|NCT01373450|7410636|FG000|STARTED|7 Day Wash-out||2
6492344|NCT01373450|7410637|FG001|STARTED|7 Day Wash-out||2
6492345|NCT01373450|7410638|FG002|STARTED|7 Day Wash-out||2
6492346|NCT01373450|7410639|FG003|STARTED|7 Day Wash-out||2
6492347|NCT01373450|7410640|FG004|STARTED|7 Day Wash-out||2
6492348|NCT01373450|7410641|FG005|STARTED|7 Day Wash-out||2
6492349|NCT01373450|7410636|FG000|COMPLETED|7 Day Wash-out||2
6492350|NCT01373450|7410637|FG001|COMPLETED|7 Day Wash-out||2
6492351|NCT01373450|7410638|FG002|COMPLETED|7 Day Wash-out||2
6492352|NCT01373450|7410639|FG003|COMPLETED|7 Day Wash-out||2
6492353|NCT01373450|7410640|FG004|COMPLETED|7 Day Wash-out||2
6492354|NCT01373450|7410641|FG005|COMPLETED|7 Day Wash-out||2
6492355|NCT01373450|7410636|FG000|NOT COMPLETED|7 Day Wash-out||0
6492356|NCT01373450|7410637|FG001|NOT COMPLETED|7 Day Wash-out||0
6492357|NCT01373450|7410638|FG002|NOT COMPLETED|7 Day Wash-out||0
6492358|NCT01373450|7410639|FG003|NOT COMPLETED|7 Day Wash-out||0
6492359|NCT01373450|7410640|FG004|NOT COMPLETED|7 Day Wash-out||0
6492360|NCT01373450|7410641|FG005|NOT COMPLETED|7 Day Wash-out||0
6492361|NCT01373450|7410636|FG000|STARTED|Crossover Period 3||2
6492362|NCT01373450|7410637|FG001|STARTED|Crossover Period 3||2
6492363|NCT01373450|7410638|FG002|STARTED|Crossover Period 3||2
6492364|NCT01373450|7410639|FG003|STARTED|Crossover Period 3||2
6492365|NCT01373450|7410640|FG004|STARTED|Crossover Period 3||2
6492366|NCT01373450|7410641|FG005|STARTED|Crossover Period 3||2
6492367|NCT01373450|7410636|FG000|COMPLETED|Crossover Period 3||2
6492368|NCT01373450|7410637|FG001|COMPLETED|Crossover Period 3||2
6492369|NCT01373450|7410638|FG002|COMPLETED|Crossover Period 3||2
6492370|NCT01373450|7410639|FG003|COMPLETED|Crossover Period 3||2
6492371|NCT01373450|7410640|FG004|COMPLETED|Crossover Period 3||2
6492372|NCT01373450|7410641|FG005|COMPLETED|Crossover Period 3||2
6492373|NCT01373450|7410636|FG000|NOT COMPLETED|Crossover Period 3||0
6492374|NCT01373450|7410637|FG001|NOT COMPLETED|Crossover Period 3||0
6492375|NCT01373450|7410638|FG002|NOT COMPLETED|Crossover Period 3||0
6492376|NCT01373450|7410639|FG003|NOT COMPLETED|Crossover Period 3||0
6492377|NCT01373450|7410640|FG004|NOT COMPLETED|Crossover Period 3||0
6492378|NCT01373450|7410641|FG005|NOT COMPLETED|Crossover Period 3||0
6492379|NCT01373450|7410636|FG000|STARTED|7 Day Wash-out||2
6492380|NCT01373450|7410637|FG001|STARTED|7 Day Wash-out||2
6492381|NCT01373450|7410638|FG002|STARTED|7 Day Wash-out||2
6492382|NCT01373450|7410639|FG003|STARTED|7 Day Wash-out||2
6492383|NCT01373450|7410640|FG004|STARTED|7 Day Wash-out||2
6492384|NCT01373450|7410641|FG005|STARTED|7 Day Wash-out||2
6492385|NCT01373450|7410636|FG000|COMPLETED|7 Day Wash-out||2
6492386|NCT01373450|7410637|FG001|COMPLETED|7 Day Wash-out||2
6492387|NCT01373450|7410638|FG002|COMPLETED|7 Day Wash-out||2
6492388|NCT01373450|7410639|FG003|COMPLETED|7 Day Wash-out||2
6492389|NCT01373450|7410640|FG004|COMPLETED|7 Day Wash-out||2
6492390|NCT01373450|7410641|FG005|COMPLETED|7 Day Wash-out||2
6492391|NCT01373450|7410636|FG000|NOT COMPLETED|7 Day Wash-out||0
6492392|NCT01373450|7410637|FG001|NOT COMPLETED|7 Day Wash-out||0
6492393|NCT01373450|7410638|FG002|NOT COMPLETED|7 Day Wash-out||0
6492394|NCT01373450|7410639|FG003|NOT COMPLETED|7 Day Wash-out||0
6492395|NCT01373450|7410640|FG004|NOT COMPLETED|7 Day Wash-out||0
6492396|NCT01373450|7410641|FG005|NOT COMPLETED|7 Day Wash-out||0
6492397|NCT01373450|7410636|FG000|STARTED|Crossover Period 4||2
6492398|NCT01373450|7410637|FG001|STARTED|Crossover Period 4||2
6492399|NCT01373450|7410638|FG002|STARTED|Crossover Period 4||2
6492400|NCT01373450|7410639|FG003|STARTED|Crossover Period 4||2
6492401|NCT01373450|7410640|FG004|STARTED|Crossover Period 4||2
6492402|NCT01373450|7410641|FG005|STARTED|Crossover Period 4||2
6492403|NCT01373450|7410636|FG000|COMPLETED|Crossover Period 4||2
6492404|NCT01373450|7410637|FG001|COMPLETED|Crossover Period 4||2
6492405|NCT01373450|7410638|FG002|COMPLETED|Crossover Period 4||2
6492406|NCT01373450|7410639|FG003|COMPLETED|Crossover Period 4||2
6492407|NCT01373450|7410640|FG004|COMPLETED|Crossover Period 4||2
6492408|NCT01373450|7410641|FG005|COMPLETED|Crossover Period 4||2
6492409|NCT01373450|7410636|FG000|NOT COMPLETED|Crossover Period 4||0
6492410|NCT01373450|7410637|FG001|NOT COMPLETED|Crossover Period 4||0
6492411|NCT01373450|7410638|FG002|NOT COMPLETED|Crossover Period 4||0
6492412|NCT01373450|7410639|FG003|NOT COMPLETED|Crossover Period 4||0
6492413|NCT01373450|7410640|FG004|NOT COMPLETED|Crossover Period 4||0
6492414|NCT01373450|7410641|FG005|NOT COMPLETED|Crossover Period 4||0
6492415|NCT01373489|7410657|FG000|STARTED|Overall Study||59
6492416|NCT01373489|7410658|FG001|STARTED|Overall Study||54
6492417|NCT01373489|7410657|FG000|COMPLETED|Overall Study||44
6492418|NCT01373489|7410658|FG001|COMPLETED|Overall Study||41
6492419|NCT01373489|7410657|FG000|NOT COMPLETED|Overall Study||15
6492420|NCT01373489|7410658|FG001|NOT COMPLETED|Overall Study||13
6492421|NCT01373580|7410664|FG000|STARTED|Overall Study||373
6492422|NCT01373580|7410664|FG000|COMPLETED|Overall Study||317
6492423|NCT01373580|7410664|FG000|NOT COMPLETED|Overall Study||56
6492424|NCT01373671|7410668|FG000|STARTED|Overall Study||764
6492425|NCT01373671|7410668|FG000|COMPLETED|Overall Study||672
6492426|NCT01373671|7410668|FG000|NOT COMPLETED|Overall Study||92
6492427|NCT01373918|7410675|FG000|STARTED|Overall Study||20
6492428|NCT01373918|7410676|FG001|STARTED|Overall Study||16
6492429|NCT01373918|7410675|FG000|COMPLETED|Overall Study||20
6492430|NCT01373918|7410676|FG001|COMPLETED|Overall Study||15
6492431|NCT01373918|7410675|FG000|NOT COMPLETED|Overall Study||0
6492432|NCT01373918|7410676|FG001|NOT COMPLETED|Overall Study||1
6492433|NCT01373931|7410684|FG000|STARTED|Lead-in Period||10
6492434|NCT01373931|7410685|FG001|STARTED|Lead-in Period||10
6492435|NCT01373931|7410684|FG000|Received at Least 1 Dose of Study Drug|Lead-in Period||8
6492436|NCT01373931|7410685|FG001|Received at Least 1 Dose of Study Drug|Lead-in Period||10
6492437|NCT01373931|7410684|FG000|COMPLETED|Lead-in Period||8
6492438|NCT01373931|7410685|FG001|COMPLETED|Lead-in Period||10
6492439|NCT01373931|7410684|FG000|NOT COMPLETED|Lead-in Period||2
6492440|NCT01373931|7410685|FG001|NOT COMPLETED|Lead-in Period||0
6492441|NCT01373931|7410684|FG000|STARTED|Period 1||8
6492442|NCT01373931|7410685|FG001|STARTED|Period 1||10
6492443|NCT01373931|7410684|FG000|COMPLETED|Period 1||6
6492444|NCT01373931|7410685|FG001|COMPLETED|Period 1||8
6492445|NCT01373931|7410684|FG000|NOT COMPLETED|Period 1||2
6492446|NCT01373931|7410685|FG001|NOT COMPLETED|Period 1||2
6492447|NCT01373931|7410684|FG000|STARTED|Period 2||6
6492448|NCT01373931|7410685|FG001|STARTED|Period 2||8
6492449|NCT01373931|7410684|FG000|COMPLETED|Period 2||6
6492450|NCT01373931|7410685|FG001|COMPLETED|Period 2||8
6492451|NCT01373931|7410684|FG000|NOT COMPLETED|Period 2||0
6492452|NCT01373931|7410685|FG001|NOT COMPLETED|Period 2||0
6492453|NCT01374087|7410694|FG000|STARTED|Overall Study||16
6492454|NCT01374087|7410695|FG001|STARTED|Overall Study||15
6492455|NCT01374087|7410694|FG000|COMPLETED|Overall Study||0
6492456|NCT01374087|7410695|FG001|COMPLETED|Overall Study||0
6492457|NCT01374087|7410694|FG000|NOT COMPLETED|Overall Study||16
6492458|NCT01374087|7410695|FG001|NOT COMPLETED|Overall Study||15
6492459|NCT01374178|7410701|FG000|STARTED|Period 1 (up to 24 Hours After Dosing)||11
6492460|NCT01374178|7410702|FG001|STARTED|Period 1 (up to 24 Hours After Dosing)||5
6492461|NCT01374178|7410701|FG000|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
6492462|NCT01374178|7410702|FG001|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
6492463|NCT01374178|7410701|FG000|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
6492464|NCT01374178|7410702|FG001|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
6749323|NCT03425188|7677200|FG000|NOT COMPLETED|Overall Study||1
6749324|NCT03425253|7677205|FG000|STARTED|Overall Study||58
6749325|NCT03425253|7677205|FG000|Safety Analysis Set|Overall Study||53
6749326|NCT03425253|7677205|FG000|FAS|Overall Study||53
6749327|NCT03425253|7677205|FG000|Evaluable Set (ES)|Overall Study||42
6749328|NCT03425253|7677205|FG000|COMPLETED|Overall Study||42
6749329|NCT03425253|7677205|FG000|NOT COMPLETED|Overall Study||16
6492465|NCT01374178|7410701|FG000|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
6492466|NCT01374178|7410702|FG001|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
6492467|NCT01374178|7410701|FG000|STARTED|Washout Period of at Least 7 Days||11
6492468|NCT01374178|7410702|FG001|STARTED|Washout Period of at Least 7 Days||5
6492469|NCT01374178|7410701|FG000|COMPLETED|Washout Period of at Least 7 Days||10
6492470|NCT01374178|7410702|FG001|COMPLETED|Washout Period of at Least 7 Days||5
6492471|NCT01374178|7410701|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
6492472|NCT01374178|7410702|FG001|NOT COMPLETED|Washout Period of at Least 7 Days||0
6492473|NCT01374178|7410701|FG000|STARTED|Period 2 (up to 24 Hours After Dosing)||10
6492474|NCT01374178|7410702|FG001|STARTED|Period 2 (up to 24 Hours After Dosing)||5
6492475|NCT01374178|7410701|FG000|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
6492476|NCT01374178|7410702|FG001|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
6492477|NCT01374178|7410701|FG000|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
6492478|NCT01374178|7410702|FG001|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
6492479|NCT01374217|7410708|FG000|STARTED|Overall Study||13
6492480|NCT01374217|7410708|FG000|COMPLETED|Overall Study||0
6492481|NCT01374217|7410708|FG000|NOT COMPLETED|Overall Study||13
6492482|NCT01374269|7410714|FG000|STARTED|Overall Study||46
6492483|NCT01374269|7410715|FG001|STARTED|Overall Study||44
6492484|NCT01374269|7410714|FG000|COMPLETED|Overall Study||40
6492485|NCT01374269|7410715|FG001|COMPLETED|Overall Study||39
6492486|NCT01374269|7410714|FG000|NOT COMPLETED|Overall Study||6
6492487|NCT01374269|7410715|FG001|NOT COMPLETED|Overall Study||5
6492488|NCT01374425|7410723|FG000|STARTED|Overall Study||188
6492489|NCT01374425|7410724|FG001|STARTED|Overall Study||188
6492490|NCT01374425|7410723|FG000|COMPLETED|Overall Study||0
6492491|NCT01374425|7410724|FG001|COMPLETED|Overall Study||0
6492492|NCT01374425|7410723|FG000|NOT COMPLETED|Overall Study||188
6492493|NCT01374425|7410724|FG001|NOT COMPLETED|Overall Study||188
6492494|NCT01374438|7410753|FG000|STARTED|Overall Study||16
6492495|NCT01374438|7410754|FG001|STARTED|Overall Study||13
6492496|NCT01374438|7410753|FG000|COMPLETED|Overall Study||16
6492497|NCT01374438|7410754|FG001|COMPLETED|Overall Study||13
6492498|NCT01374438|7410753|FG000|NOT COMPLETED|Overall Study||0
6492499|NCT01374438|7410754|FG001|NOT COMPLETED|Overall Study||0
6492500|NCT01374451|7410762|FG000|STARTED|Overall Study||79
6492501|NCT01374451|7410763|FG001|STARTED|Overall Study||81
6492502|NCT01374451|7410762|FG000|COMPLETED|Overall Study||78
6492503|NCT01374451|7410763|FG001|COMPLETED|Overall Study||81
6492504|NCT01374451|7410762|FG000|NOT COMPLETED|Overall Study||1
6492505|NCT01374451|7410763|FG001|NOT COMPLETED|Overall Study||0
6492506|NCT01374490|7410769|FG000|STARTED|Overall Study||250
6492507|NCT01374490|7410769|FG000|COMPLETED|Overall Study||190
6492508|NCT01374490|7410769|FG000|NOT COMPLETED|Overall Study||60
6492509|NCT01374568|7410775|FG000|STARTED|Overall Study||2
6492510|NCT01374568|7410776|FG001|STARTED|Overall Study||3
6492511|NCT01374568|7410775|FG000|COMPLETED|Overall Study||2
6492512|NCT01374568|7410776|FG001|COMPLETED|Overall Study||1
6492513|NCT01374568|7410775|FG000|NOT COMPLETED|Overall Study||0
6492514|NCT01374568|7410776|FG001|NOT COMPLETED|Overall Study||2
6492515|NCT01374802|7410782|FG000|STARTED|Overall Study||14
6492516|NCT01374802|7410782|FG000|COMPLETED|Overall Study||14
6492517|NCT01374802|7410782|FG000|NOT COMPLETED|Overall Study||0
6492518|NCT01374906|7410790|FG000|STARTED|Overall Study||74
6492519|NCT01374906|7410791|FG001|STARTED|Overall Study||76
6492520|NCT01374906|7410790|FG000|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||24
6492521|NCT01374906|7410791|FG001|DC Dur Core Phs at/Prior to Data Cutoff|Overall Study||22
6492522|NCT01374906|7410790|FG000|Completed Core Phase|Overall Study||50
6492523|NCT01374906|7410791|FG001|Completed Core Phase|Overall Study||54
6492524|NCT01374906|7410790|FG000|Completed Core/Did Not Enter Ext. Phase|Overall Study||10
6492525|NCT01374906|7410791|FG001|Completed Core/Did Not Enter Ext. Phase|Overall Study||13
6492526|NCT01374906|7410790|FG000|Completed Core Phase/Entered Ext. Phase|Overall Study||40
6492527|NCT01374906|7410791|FG001|Completed Core Phase/Entered Ext. Phase|Overall Study||41
6492528|NCT01374906|7410790|FG000|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||16
6492529|NCT01374906|7410791|FG001|DC Dur Ext Phs at/Prior to Data Cutoff|Overall Study||26
6492530|NCT01374906|7410790|FG000|Completed Extension Phase|Overall Study||24
6492531|NCT01374906|7410791|FG001|Completed Extension Phase|Overall Study||15
6492532|NCT01374906|7410790|FG000|COMPLETED|Overall Study||34
6492533|NCT01374906|7410791|FG001|COMPLETED|Overall Study||28
6492534|NCT01374906|7410790|FG000|NOT COMPLETED|Overall Study||40
6492535|NCT01374906|7410791|FG001|NOT COMPLETED|Overall Study||48
6492536|NCT01374919|7410801|FG000|STARTED|Overall Study||60
6492537|NCT01374919|7410801|FG000|COMPLETED|Overall Study||58
6492538|NCT01374919|7410801|FG000|NOT COMPLETED|Overall Study||2
6492539|NCT01374971|7410805|FG000|STARTED|Overall Study||12
6492540|NCT01374971|7410805|FG000|COMPLETED|Overall Study||11
6492541|NCT01374971|7410805|FG000|NOT COMPLETED|Overall Study||1
6492542|NCT01375010|7410811|FG000|STARTED|Overall Study||43
6749330|NCT03425396|7677215|FG000|STARTED|Overall Study||55
6749331|NCT03425396|7677216|FG001|STARTED|Overall Study||54
6749332|NCT03425396|7677217|FG002|STARTED|Overall Study||54
6749333|NCT03425396|7677218|FG003|STARTED|Overall Study||8
6749334|NCT03425396|7677219|FG004|STARTED|Overall Study||54
6749335|NCT03425396|7677215|FG000|Completed End of Treatment Visit|Overall Study||53
6749336|NCT03425396|7677216|FG001|Completed End of Treatment Visit|Overall Study||52
6492543|NCT01375010|7410812|FG001|STARTED|Overall Study||42
6492544|NCT01375010|7410811|FG000|COMPLETED|Overall Study||31
6492545|NCT01375010|7410812|FG001|COMPLETED|Overall Study||38
6492546|NCT01375010|7410811|FG000|NOT COMPLETED|Overall Study||12
6492547|NCT01375010|7410812|FG001|NOT COMPLETED|Overall Study||4
6492548|NCT01375049|7410818|FG000|STARTED|Overall Study||105
6492549|NCT01375049|7410818|FG000|COMPLETED|Overall Study||55
6492550|NCT01375049|7410818|FG000|NOT COMPLETED|Overall Study||50
6492551|NCT01375075|7410832|FG000|STARTED|Overall Study||27
6749337|NCT03425396|7677217|FG002|Completed End of Treatment Visit|Overall Study||51
6749338|NCT03425396|7677218|FG003|Completed End of Treatment Visit|Overall Study||7
6749339|NCT03425396|7677219|FG004|Completed End of Treatment Visit|Overall Study||53
6749340|NCT03425396|7677215|FG000|Completed Post-therapy Evaluation Visit|Overall Study||53
6749341|NCT03425396|7677216|FG001|Completed Post-therapy Evaluation Visit|Overall Study||49
6492552|NCT01375075|7410833|FG001|STARTED|Overall Study||28
6492553|NCT01375075|7410834|FG002|STARTED|Overall Study||27
6492554|NCT01375075|7410835|FG003|STARTED|Overall Study||28
6492555|NCT01375075|7410836|FG004|STARTED|Overall Study||27
6492556|NCT01375075|7410837|FG005|STARTED|Overall Study||28
6492557|NCT01375075|7410832|FG000|Received at Least One Dose of Study Drug|Overall Study||27
6492558|NCT01375075|7410833|FG001|Received at Least One Dose of Study Drug|Overall Study||28
6492559|NCT01375075|7410834|FG002|Received at Least One Dose of Study Drug|Overall Study||27
6492560|NCT01375075|7410835|FG003|Received at Least One Dose of Study Drug|Overall Study||28
6492561|NCT01375075|7410836|FG004|Received at Least One Dose of Study Drug|Overall Study||27
6492562|NCT01375075|7410837|FG005|Received at Least One Dose of Study Drug|Overall Study||28
6492563|NCT01375075|7410832|FG000|COMPLETED|Overall Study||26
6492564|NCT01375075|7410833|FG001|COMPLETED|Overall Study||27
6492565|NCT01375075|7410834|FG002|COMPLETED|Overall Study||24
6492566|NCT01375075|7410835|FG003|COMPLETED|Overall Study||27
6492567|NCT01375075|7410836|FG004|COMPLETED|Overall Study||27
6492568|NCT01375075|7410837|FG005|COMPLETED|Overall Study||25
6492569|NCT01375075|7410832|FG000|NOT COMPLETED|Overall Study||1
6492570|NCT01375075|7410833|FG001|NOT COMPLETED|Overall Study||1
6492571|NCT01375075|7410834|FG002|NOT COMPLETED|Overall Study||3
6492572|NCT01375075|7410835|FG003|NOT COMPLETED|Overall Study||1
6492573|NCT01375075|7410836|FG004|NOT COMPLETED|Overall Study||0
6492574|NCT01375075|7410837|FG005|NOT COMPLETED|Overall Study||3
6492575|NCT01375127|7410861|FG000|STARTED|Overall Study||1
6492576|NCT01375127|7410862|FG001|STARTED|Overall Study||1
6492577|NCT01375127|7410863|FG002|STARTED|Overall Study||40
6492578|NCT01375127|7410864|FG003|STARTED|Overall Study||33
6492579|NCT01375127|7410865|FG004|STARTED|Overall Study||5
6492580|NCT01375127|7410866|FG005|STARTED|Overall Study||3
6555290|NCT01751113|7477422|FG000|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6555291|NCT01751113|7477423|FG001|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6555292|NCT01751113|7477424|FG002|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6555293|NCT01751113|7477425|FG003|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6555294|NCT01751113|7477426|FG004|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6555295|NCT01751113|7477427|FG005|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
6492581|NCT01375127|7410861|FG000|COMPLETED|Overall Study||1
6492582|NCT01375127|7410862|FG001|COMPLETED|Overall Study||1
6492583|NCT01375127|7410863|FG002|COMPLETED|Overall Study||40
6492584|NCT01375127|7410864|FG003|COMPLETED|Overall Study||33
6492585|NCT01375127|7410865|FG004|COMPLETED|Overall Study||5
6492586|NCT01375127|7410866|FG005|COMPLETED|Overall Study||3
6492587|NCT01375127|7410861|FG000|NOT COMPLETED|Overall Study||0
6492588|NCT01375127|7410862|FG001|NOT COMPLETED|Overall Study||0
6492589|NCT01375127|7410863|FG002|NOT COMPLETED|Overall Study||0
6492590|NCT01375127|7410864|FG003|NOT COMPLETED|Overall Study||0
6492591|NCT01375127|7410865|FG004|NOT COMPLETED|Overall Study||0
6492592|NCT01375127|7410866|FG005|NOT COMPLETED|Overall Study||0
6492593|NCT01375140|7410880|FG000|STARTED|Overall Study||31
6492594|NCT01375140|7410880|FG000|COMPLETED|Overall Study||31
6492595|NCT01375140|7410880|FG000|NOT COMPLETED|Overall Study||0
6492596|NCT01375205|7410886|FG000|STARTED|Overall Study||54
6492597|NCT01375205|7410887|FG001|STARTED|Overall Study||46
6492598|NCT01375205|7410886|FG000|COMPLETED|Overall Study||33
6492599|NCT01375205|7410887|FG001|COMPLETED|Overall Study||33
6492600|NCT01375205|7410886|FG000|NOT COMPLETED|Overall Study||21
6492601|NCT01375205|7410887|FG001|NOT COMPLETED|Overall Study||13
6492602|NCT01375374|7410893|FG000|STARTED|Overall Study||11
6492603|NCT01375374|7410893|FG000|COMPLETED|Overall Study||10
6555296|NCT01751113|7477422|FG000|STARTED|Treatment Period 3 (4 Weeks)||8
6555297|NCT01751113|7477423|FG001|STARTED|Treatment Period 3 (4 Weeks)||8
6555298|NCT01751113|7477424|FG002|STARTED|Treatment Period 3 (4 Weeks)||9
6555299|NCT01751113|7477425|FG003|STARTED|Treatment Period 3 (4 Weeks)||8
6555300|NCT01751113|7477426|FG004|STARTED|Treatment Period 3 (4 Weeks)||8
6555301|NCT01751113|7477427|FG005|STARTED|Treatment Period 3 (4 Weeks)||10
6555302|NCT01751113|7477422|FG000|COMPLETED|Treatment Period 3 (4 Weeks)||8
6555303|NCT01751113|7477423|FG001|COMPLETED|Treatment Period 3 (4 Weeks)||8
6555304|NCT01751113|7477424|FG002|COMPLETED|Treatment Period 3 (4 Weeks)||9
6555305|NCT01751113|7477425|FG003|COMPLETED|Treatment Period 3 (4 Weeks)||8
6555306|NCT01751113|7477426|FG004|COMPLETED|Treatment Period 3 (4 Weeks)||8
6555307|NCT01751113|7477427|FG005|COMPLETED|Treatment Period 3 (4 Weeks)||9
6555308|NCT01751113|7477422|FG000|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6492604|NCT01375374|7410893|FG000|NOT COMPLETED|Overall Study||1
6492605|NCT01375491|7410900|FG000|STARTED|Overall Study||11
6492606|NCT01375491|7410901|FG001|STARTED|Overall Study||13
6492607|NCT01375491|7410902|FG002|STARTED|Overall Study||15
6492608|NCT01375491|7410900|FG000|COMPLETED|Overall Study||9
6492609|NCT01375491|7410901|FG001|COMPLETED|Overall Study||12
6492610|NCT01375491|7410902|FG002|COMPLETED|Overall Study||15
6492611|NCT01375491|7410900|FG000|NOT COMPLETED|Overall Study||2
6492612|NCT01375491|7410901|FG001|NOT COMPLETED|Overall Study||1
6492613|NCT01375491|7410902|FG002|NOT COMPLETED|Overall Study||0
6492614|NCT01375569|7410909|FG000|STARTED|Overall Study||11
6562912|NCT01803464|7485827|FG001|COMPLETED|Overall Study||4
6492615|NCT01375569|7410909|FG000|COMPLETED|Overall Study||11
6492616|NCT01375569|7410909|FG000|NOT COMPLETED|Overall Study||0
6492617|NCT01375608|7410913|FG000|STARTED|Overall Study||10
6492618|NCT01375608|7410913|FG000|COMPLETED|Overall Study||8
6492619|NCT01375608|7410913|FG000|NOT COMPLETED|Overall Study||2
6555309|NCT01751113|7477423|FG001|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6555310|NCT01751113|7477424|FG002|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6749342|NCT03425396|7677217|FG002|Completed Post-therapy Evaluation Visit|Overall Study||51
6749343|NCT03425396|7677218|FG003|Completed Post-therapy Evaluation Visit|Overall Study||7
6492620|NCT01375660|7410919|FG000|STARTED|Overall Study||102
6492621|NCT01375660|7410920|FG001|STARTED|Overall Study||103
6492622|NCT01375660|7410919|FG000|COMPLETED|Overall Study||86
6492623|NCT01375660|7410920|FG001|COMPLETED|Overall Study||87
6492624|NCT01375660|7410919|FG000|NOT COMPLETED|Overall Study||16
6492625|NCT01375660|7410920|FG001|NOT COMPLETED|Overall Study||16
6492626|NCT01375673|7410929|FG000|STARTED|Overall Study||7
6492627|NCT01375673|7410930|FG001|STARTED|Overall Study||7
6492628|NCT01375673|7410929|FG000|COMPLETED|Overall Study||7
6492629|NCT01375673|7410930|FG001|COMPLETED|Overall Study||6
6492630|NCT01375673|7410929|FG000|NOT COMPLETED|Overall Study||0
6492631|NCT01375673|7410930|FG001|NOT COMPLETED|Overall Study||1
6492632|NCT01375751|7410939|FG000|STARTED|Overall Study||56
6492633|NCT01375751|7410940|FG001|STARTED|Overall Study||56
6492634|NCT01375751|7410941|FG002|STARTED|Overall Study||56
6492635|NCT01375751|7410939|FG000|Received Treatment|Overall Study||56
6492636|NCT01375751|7410940|FG001|Received Treatment|Overall Study||55
6492637|NCT01375751|7410941|FG002|Received Treatment|Overall Study||56
6492638|NCT01375751|7410939|FG000|COMPLETED|Overall Study||56
6492639|NCT01375751|7410940|FG001|COMPLETED|Overall Study||55
6492640|NCT01375751|7410941|FG002|COMPLETED|Overall Study||56
6492641|NCT01375751|7410939|FG000|NOT COMPLETED|Overall Study||0
6492642|NCT01375751|7410940|FG001|NOT COMPLETED|Overall Study||1
6492643|NCT01375751|7410941|FG002|NOT COMPLETED|Overall Study||0
6492644|NCT01375764|7410954|FG000|STARTED|Overall Study||33
6492645|NCT01375764|7410955|FG001|STARTED|Overall Study||31
6492646|NCT01375764|7410956|FG002|STARTED|Overall Study||32
6492647|NCT01375764|7410957|FG003|STARTED|Overall Study||32
6492648|NCT01375764|7410958|FG004|STARTED|Overall Study||32
6492649|NCT01375764|7410954|FG000|Received Treatment|Overall Study||32
6492650|NCT01375764|7410955|FG001|Received Treatment|Overall Study||30
6492651|NCT01375764|7410956|FG002|Received Treatment|Overall Study||32
6492652|NCT01375764|7410957|FG003|Received Treatment|Overall Study||31
6749344|NCT03425396|7677219|FG004|Completed Post-therapy Evaluation Visit|Overall Study||54
6749345|NCT03425396|7677215|FG000|Completed Final Follow-up Visit|Overall Study||53
6749346|NCT03425396|7677216|FG001|Completed Final Follow-up Visit|Overall Study||47
6749347|NCT03425396|7677217|FG002|Completed Final Follow-up Visit|Overall Study||51
6749348|NCT03425396|7677218|FG003|Completed Final Follow-up Visit|Overall Study||7
6749349|NCT03425396|7677219|FG004|Completed Final Follow-up Visit|Overall Study||53
6749350|NCT03425396|7677215|FG000|COMPLETED|Overall Study||53
6749351|NCT03425396|7677216|FG001|COMPLETED|Overall Study||47
6749352|NCT03425396|7677217|FG002|COMPLETED|Overall Study||51
6749353|NCT03425396|7677218|FG003|COMPLETED|Overall Study||7
6749354|NCT03425396|7677219|FG004|COMPLETED|Overall Study||53
6749355|NCT03425396|7677215|FG000|NOT COMPLETED|Overall Study||2
6749356|NCT03425396|7677216|FG001|NOT COMPLETED|Overall Study||7
6749357|NCT03425396|7677217|FG002|NOT COMPLETED|Overall Study||3
6749358|NCT03425396|7677218|FG003|NOT COMPLETED|Overall Study||1
6749359|NCT03425396|7677219|FG004|NOT COMPLETED|Overall Study||1
6749360|NCT03426228|7677233|FG000|STARTED|Overall Study||158
6749361|NCT03426228|7677234|FG001|STARTED|Overall Study||191
6749362|NCT03426228|7677233|FG000|COMPLETED|Overall Study||117
6749363|NCT03426228|7677234|FG001|COMPLETED|Overall Study||158
6749364|NCT03426228|7677233|FG000|NOT COMPLETED|Overall Study||41
6749365|NCT03426228|7677234|FG001|NOT COMPLETED|Overall Study||33
6779903|NCT03544242|7708163|FG002|NOT COMPLETED|Overall Study||0
6779904|NCT03543358|7708171|FG000|STARTED|Overall Study||3
6779905|NCT03543358|7708172|FG001|STARTED|Overall Study||0
6779906|NCT03543358|7708171|FG000|Received Treatment or Retreatment|Overall Study||0
6779907|NCT03543358|7708172|FG001|Received Treatment or Retreatment|Overall Study||0
6779908|NCT03543358|7708171|FG000|COMPLETED|Overall Study||0
6779909|NCT03543358|7708172|FG001|COMPLETED|Overall Study||0
6779910|NCT03543358|7708171|FG000|NOT COMPLETED|Overall Study||3
6779911|NCT03543358|7708172|FG001|NOT COMPLETED|Overall Study||0
6779912|NCT03538015|7708179|FG000|STARTED|Overall Study||0
6779913|NCT03538015|7708180|FG001|STARTED|Overall Study||0
6779914|NCT03538015|7708181|FG002|STARTED|Overall Study||1
6779915|NCT03538015|7708179|FG000|COMPLETED|Overall Study||0
6779916|NCT03538015|7708180|FG001|COMPLETED|Overall Study||0
6492653|NCT01375764|7410958|FG004|Received Treatment|Overall Study||32
6492654|NCT01375764|7410954|FG000|COMPLETED|Overall Study||31
6492655|NCT01375764|7410955|FG001|COMPLETED|Overall Study||30
6492656|NCT01375764|7410956|FG002|COMPLETED|Overall Study||32
6492657|NCT01375764|7410957|FG003|COMPLETED|Overall Study||31
6492658|NCT01375764|7410958|FG004|COMPLETED|Overall Study||31
6492659|NCT01375764|7410954|FG000|NOT COMPLETED|Overall Study||2
6779917|NCT03538015|7708181|FG002|COMPLETED|Overall Study||0
6779918|NCT03538015|7708179|FG000|NOT COMPLETED|Overall Study||0
6779919|NCT03538015|7708180|FG001|NOT COMPLETED|Overall Study||0
6779920|NCT03538015|7708181|FG002|NOT COMPLETED|Overall Study||1
6779921|NCT03534362|7708191|FG000|STARTED|Overall Study||0
6492660|NCT01375764|7410955|FG001|NOT COMPLETED|Overall Study||1
6492661|NCT01375764|7410956|FG002|NOT COMPLETED|Overall Study||0
6492662|NCT01375764|7410957|FG003|NOT COMPLETED|Overall Study||1
6492663|NCT01375764|7410958|FG004|NOT COMPLETED|Overall Study||1
6492664|NCT01375777|7410979|FG000|STARTED|Overall Study||46
6492665|NCT01375777|7410980|FG001|STARTED|Overall Study||45
6492666|NCT01375777|7410981|FG002|STARTED|Overall Study||46
6492667|NCT01375777|7410982|FG003|STARTED|Overall Study||45
6654731|NCT02447744|7584646|FG001|STARTED|Overall Study||22
6654732|NCT02447744|7584645|FG000|COMPLETED|Overall Study||15
6654733|NCT02447744|7584646|FG001|COMPLETED|Overall Study||21
6654734|NCT02447744|7584645|FG000|NOT COMPLETED|Overall Study||6
6654735|NCT02447744|7584646|FG001|NOT COMPLETED|Overall Study||1
6654736|NCT02447848|7584652|FG000|STARTED|Overall Study||76
6492668|NCT01375777|7410983|FG004|STARTED|Overall Study||46
6492669|NCT01375777|7410984|FG005|STARTED|Overall Study||45
6492670|NCT01375777|7410985|FG006|STARTED|Overall Study||46
6492671|NCT01375777|7410986|FG007|STARTED|Overall Study||46
6492672|NCT01375777|7410987|FG008|STARTED|Overall Study||46
6492673|NCT01375777|7410979|FG000|Received Treatment|Overall Study||45
6492674|NCT01375777|7410980|FG001|Received Treatment|Overall Study||45
6492675|NCT01375777|7410981|FG002|Received Treatment|Overall Study||45
6492676|NCT01375777|7410982|FG003|Received Treatment|Overall Study||45
6492677|NCT01375777|7410983|FG004|Received Treatment|Overall Study||46
6492678|NCT01375777|7410984|FG005|Received Treatment|Overall Study||45
6492679|NCT01375777|7410985|FG006|Received Treatment|Overall Study||45
6492680|NCT01375777|7410986|FG007|Received Treatment|Overall Study||45
6492681|NCT01375777|7410987|FG008|Received Treatment|Overall Study||45
6492682|NCT01375777|7410979|FG000|COMPLETED|Overall Study||44
6492683|NCT01375777|7410980|FG001|COMPLETED|Overall Study||42
6492684|NCT01375777|7410981|FG002|COMPLETED|Overall Study||45
6492685|NCT01375777|7410982|FG003|COMPLETED|Overall Study||45
6492686|NCT01375777|7410983|FG004|COMPLETED|Overall Study||45
6492687|NCT01375777|7410984|FG005|COMPLETED|Overall Study||44
6492688|NCT01375777|7410985|FG006|COMPLETED|Overall Study||44
6492689|NCT01375777|7410986|FG007|COMPLETED|Overall Study||44
6492690|NCT01375777|7410987|FG008|COMPLETED|Overall Study||44
6492691|NCT01375777|7410979|FG000|NOT COMPLETED|Overall Study||2
6492692|NCT01375777|7410980|FG001|NOT COMPLETED|Overall Study||3
6749366|NCT03426267|7677244|FG000|STARTED|Overall Study||163
6749367|NCT03426267|7677245|FG001|STARTED|Overall Study||162
6749368|NCT03426267|7677244|FG000|Modified Intent-to-Treat Population|Overall Study||154
6749369|NCT03426267|7677245|FG001|Modified Intent-to-Treat Population|Overall Study||144
6749370|NCT03426267|7677244|FG000|COMPLETED|Overall Study||142
6749371|NCT03426267|7677245|FG001|COMPLETED|Overall Study||90
6749372|NCT03426267|7677244|FG000|NOT COMPLETED|Overall Study||21
6749373|NCT03426267|7677245|FG001|NOT COMPLETED|Overall Study||72
6749374|NCT03426345|7677253|FG000|STARTED|Overall Study||155
6749375|NCT03426345|7677254|FG001|STARTED|Overall Study||156
6749376|NCT03426345|7677253|FG000|Safety Population|Overall Study||152
6749377|NCT03426345|7677254|FG001|Safety Population|Overall Study||155
6749378|NCT03426345|7677253|FG000|COMPLETED|Overall Study||137
6749379|NCT03426345|7677254|FG001|COMPLETED|Overall Study||139
6749380|NCT03426345|7677253|FG000|NOT COMPLETED|Overall Study||18
6749381|NCT03426345|7677254|FG001|NOT COMPLETED|Overall Study||17
6749382|NCT03426436|7677261|FG000|STARTED|Overall Study||314
6749383|NCT03426436|7677261|FG000|COMPLETED|Overall Study||295
6749384|NCT03426436|7677261|FG000|NOT COMPLETED|Overall Study||19
6749385|NCT03426566|7677265|FG000|STARTED|Overall Study||974
6749386|NCT03426566|7677265|FG000|COMPLETED|Overall Study||974
6749387|NCT03426566|7677265|FG000|NOT COMPLETED|Overall Study||0
6749388|NCT03426631|7677271|FG000|STARTED|Overall Study||7
6749389|NCT03426631|7677272|FG001|STARTED|Overall Study||6
6749390|NCT03426631|7677271|FG000|COMPLETED|Overall Study||7
6749391|NCT03426631|7677272|FG001|COMPLETED|Overall Study||5
6749392|NCT03426631|7677271|FG000|NOT COMPLETED|Overall Study||0
6749393|NCT03426631|7677272|FG001|NOT COMPLETED|Overall Study||1
6749394|NCT03426787|7677278|FG000|STARTED|Overall Study||70
6749395|NCT03426787|7677278|FG000|COMPLETED|Overall Study||56
6749396|NCT03426787|7677278|FG000|NOT COMPLETED|Overall Study||14
6492693|NCT01375777|7410981|FG002|NOT COMPLETED|Overall Study||1
6492694|NCT01375777|7410982|FG003|NOT COMPLETED|Overall Study||0
6492695|NCT01375777|7410983|FG004|NOT COMPLETED|Overall Study||1
6492696|NCT01375777|7410984|FG005|NOT COMPLETED|Overall Study||1
6492697|NCT01375777|7410985|FG006|NOT COMPLETED|Overall Study||2
6492698|NCT01375777|7410986|FG007|NOT COMPLETED|Overall Study||2
6492699|NCT01375777|7410987|FG008|NOT COMPLETED|Overall Study||2
6492700|NCT01375946|7411007|FG000|STARTED|Overall Study||4
6492701|NCT01375946|7411008|FG001|STARTED|Overall Study||4
6654737|NCT02447848|7584652|FG000|COMPLETED|Overall Study||65
6654738|NCT02447848|7584652|FG000|NOT COMPLETED|Overall Study||11
6654739|NCT02447926|7584656|FG000|STARTED|Overall Study||1
6654740|NCT02447926|7584656|FG000|COMPLETED|Overall Study||1
6654741|NCT02447926|7584656|FG000|NOT COMPLETED|Overall Study||0
6654742|NCT02447952|7584660|FG000|STARTED|Overall Study||25
6654743|NCT02447952|7584660|FG000|COMPLETED|Overall Study||18
6749397|NCT03426995|7677307|FG000|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6492702|NCT01375946|7411009|FG002|STARTED|Overall Study||4
6492703|NCT01375946|7411010|FG003|STARTED|Overall Study||4
6749398|NCT03426995|7677308|FG001|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
6749399|NCT03426995|7677309|FG002|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
6492704|NCT01375946|7411011|FG004|STARTED|Overall Study||4
6492705|NCT01375946|7411012|FG005|STARTED|Overall Study||4
6492706|NCT01375946|7411007|FG000|COMPLETED|Overall Study||4
6492707|NCT01375946|7411008|FG001|COMPLETED|Overall Study||4
6492708|NCT01375946|7411009|FG002|COMPLETED|Overall Study||4
6492709|NCT01375946|7411010|FG003|COMPLETED|Overall Study||4
6492710|NCT01375946|7411011|FG004|COMPLETED|Overall Study||4
6492711|NCT01375946|7411012|FG005|COMPLETED|Overall Study||4
6492712|NCT01375946|7411007|FG000|NOT COMPLETED|Overall Study||0
6492713|NCT01375946|7411008|FG001|NOT COMPLETED|Overall Study||0
6492714|NCT01375946|7411009|FG002|NOT COMPLETED|Overall Study||0
6492715|NCT01375946|7411010|FG003|NOT COMPLETED|Overall Study||0
6492716|NCT01375946|7411011|FG004|NOT COMPLETED|Overall Study||0
6492717|NCT01375946|7411012|FG005|NOT COMPLETED|Overall Study||0
6492718|NCT01376037|7411018|FG000|STARTED|Overall Study||31
6492719|NCT01376037|7411019|FG001|STARTED|Overall Study||31
6492720|NCT01376037|7411018|FG000|COMPLETED|Overall Study||31
6492721|NCT01376037|7411019|FG001|COMPLETED|Overall Study||29
6492722|NCT01376037|7411018|FG000|NOT COMPLETED|Overall Study||0
6492723|NCT01376037|7411019|FG001|NOT COMPLETED|Overall Study||2
6492724|NCT01376050|7411027|FG000|STARTED|Overall Study||13
6492725|NCT01376050|7411028|FG001|STARTED|Overall Study||11
6492726|NCT01376050|7411027|FG000|COMPLETED|Overall Study||13
6492727|NCT01376050|7411028|FG001|COMPLETED|Overall Study||11
6492728|NCT01376050|7411027|FG000|NOT COMPLETED|Overall Study||0
6492729|NCT01376050|7411028|FG001|NOT COMPLETED|Overall Study||0
6492730|NCT01376089|7411036|FG000|STARTED|Overall Study||151
6492731|NCT01376089|7411037|FG001|STARTED|Overall Study||148
6492732|NCT01376089|7411036|FG000|COMPLETED|Overall Study||148
6492733|NCT01376089|7411037|FG001|COMPLETED|Overall Study||144
6492734|NCT01376089|7411036|FG000|NOT COMPLETED|Overall Study||3
6492735|NCT01376089|7411037|FG001|NOT COMPLETED|Overall Study||4
6492736|NCT01376167|7411050|FG000|STARTED|Overall Study||133
6492737|NCT01376167|7411051|FG001|STARTED|Overall Study||260
6492738|NCT01376167|7411052|FG002|STARTED|Overall Study||129
6492739|NCT01376167|7411050|FG000|COMPLETED|Overall Study||129
6492740|NCT01376167|7411051|FG001|COMPLETED|Overall Study||250
6492741|NCT01376167|7411052|FG002|COMPLETED|Overall Study||123
6492742|NCT01376167|7411050|FG000|NOT COMPLETED|Overall Study||4
6492743|NCT01376167|7411051|FG001|NOT COMPLETED|Overall Study||10
6492744|NCT01376167|7411052|FG002|NOT COMPLETED|Overall Study||6
6492745|NCT01376245|7411067|FG000|STARTED|2-wk Single-blind Placebo Run-in Period||744
6492746|NCT01376245|7411068|FG001|STARTED|2-wk Single-blind Placebo Run-in Period||0
6492747|NCT01376245|7411069|FG002|STARTED|2-wk Single-blind Placebo Run-in Period||0
6492748|NCT01376245|7411070|FG003|STARTED|2-wk Single-blind Placebo Run-in Period||0
6492749|NCT01376245|7411071|FG004|STARTED|2-wk Single-blind Placebo Run-in Period||0
6492750|NCT01376245|7411067|FG000|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
6492751|NCT01376245|7411068|FG001|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6492752|NCT01376245|7411069|FG002|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6492753|NCT01376245|7411070|FG003|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6492754|NCT01376245|7411071|FG004|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6492755|NCT01376245|7411067|FG000|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
6492756|NCT01376245|7411068|FG001|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6492757|NCT01376245|7411069|FG002|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6492758|NCT01376245|7411070|FG003|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6492759|NCT01376245|7411071|FG004|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
6492760|NCT01376245|7411067|FG000|STARTED|24-week, Double-blind Treatment Period||0
6492761|NCT01376245|7411068|FG001|STARTED|24-week, Double-blind Treatment Period||162
6492762|NCT01376245|7411069|FG002|STARTED|24-week, Double-blind Treatment Period||160
6492763|NCT01376245|7411070|FG003|STARTED|24-week, Double-blind Treatment Period||161
6492764|NCT01376245|7411071|FG004|STARTED|24-week, Double-blind Treatment Period||160
6492765|NCT01376245|7411067|FG000|COMPLETED|24-week, Double-blind Treatment Period||0
6492766|NCT01376245|7411068|FG001|COMPLETED|24-week, Double-blind Treatment Period||130
6492767|NCT01376245|7411069|FG002|COMPLETED|24-week, Double-blind Treatment Period||135
6492768|NCT01376245|7411070|FG003|COMPLETED|24-week, Double-blind Treatment Period||138
6492769|NCT01376245|7411071|FG004|COMPLETED|24-week, Double-blind Treatment Period||134
6492770|NCT01376245|7411067|FG000|NOT COMPLETED|24-week, Double-blind Treatment Period||0
6492771|NCT01376245|7411068|FG001|NOT COMPLETED|24-week, Double-blind Treatment Period||32
6492772|NCT01376245|7411069|FG002|NOT COMPLETED|24-week, Double-blind Treatment Period||25
6492773|NCT01376245|7411070|FG003|NOT COMPLETED|24-week, Double-blind Treatment Period||23
6492774|NCT01376245|7411071|FG004|NOT COMPLETED|24-week, Double-blind Treatment Period||26
6492775|NCT01376297|7411083|FG000|STARTED|Overall Study|number of randomised patients|309
6492776|NCT01376297|7411084|FG001|STARTED|Overall Study|number of randomised patients|104
6492777|NCT01376297|7411083|FG000|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
6492778|NCT01376297|7411084|FG001|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
6492779|NCT01376297|7411083|FG000|NOT COMPLETED|Overall Study||128
6492780|NCT01376297|7411084|FG001|NOT COMPLETED|Overall Study||49
6492781|NCT01376310|7411092|FG000|STARTED|Overall Study||126
6492782|NCT01376310|7411093|FG001|STARTED|Overall Study||33
6492783|NCT01376310|7411092|FG000|COMPLETED|Overall Study||90
6492784|NCT01376310|7411093|FG001|COMPLETED|Overall Study||22
6492785|NCT01376310|7411092|FG000|NOT COMPLETED|Overall Study||36
6492786|NCT01376310|7411093|FG001|NOT COMPLETED|Overall Study||11
6492787|NCT01376349|7411102|FG000|STARTED|Raondomized Treatment||147
6492788|NCT01376349|7411103|FG001|STARTED|Raondomized Treatment||149
6492789|NCT01376349|7411104|FG002|STARTED|Raondomized Treatment||147
6492790|NCT01376349|7411102|FG000|COMPLETED|Raondomized Treatment||123
6492791|NCT01376349|7411103|FG001|COMPLETED|Raondomized Treatment||114
6492792|NCT01376349|7411104|FG002|COMPLETED|Raondomized Treatment||118
6492793|NCT01376349|7411102|FG000|NOT COMPLETED|Raondomized Treatment||24
6492794|NCT01376349|7411103|FG001|NOT COMPLETED|Raondomized Treatment||35
6492795|NCT01376349|7411104|FG002|NOT COMPLETED|Raondomized Treatment||29
6492796|NCT01376349|7411102|FG000|STARTED|Optional Continuation Phase||0
6492797|NCT01376349|7411103|FG001|STARTED|Optional Continuation Phase||0
6492798|NCT01376349|7411104|FG002|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
6492799|NCT01376349|7411102|FG000|COMPLETED|Optional Continuation Phase||0
6492800|NCT01376349|7411103|FG001|COMPLETED|Optional Continuation Phase||0
6492801|NCT01376349|7411104|FG002|COMPLETED|Optional Continuation Phase||94
6492802|NCT01376349|7411102|FG000|NOT COMPLETED|Optional Continuation Phase||0
6492803|NCT01376349|7411103|FG001|NOT COMPLETED|Optional Continuation Phase||0
6492804|NCT01376349|7411104|FG002|NOT COMPLETED|Optional Continuation Phase||0
6492805|NCT01376362|7411113|FG000|STARTED|Overall Study||5
6492806|NCT01376362|7411113|FG000|COMPLETED|Overall Study||5
6492807|NCT01376362|7411113|FG000|NOT COMPLETED|Overall Study||0
6492808|NCT01376388|7411117|FG000|STARTED|Overall Study||130
6492809|NCT01376388|7411117|FG000|COMPLETED|Overall Study||112
6492810|NCT01376388|7411117|FG000|NOT COMPLETED|Overall Study||18
6492811|NCT01376557|7411126|FG000|STARTED|Overall Study||59
6492812|NCT01376557|7411127|FG001|STARTED|Overall Study||60
6492813|NCT01376557|7411128|FG002|STARTED|Overall Study||60
6492814|NCT01376557|7411129|FG003|STARTED|Overall Study||60
6492815|NCT01376557|7411130|FG004|STARTED|Overall Study||60
6492816|NCT01376557|7411126|FG000|COMPLETED|Overall Study||51
6492817|NCT01376557|7411127|FG001|COMPLETED|Overall Study||54
6492818|NCT01376557|7411128|FG002|COMPLETED|Overall Study||55
6749400|NCT03426995|7677310|FG003|STARTED|Part A: Cohort 1-Period 1 (Day1)||2
6749401|NCT03426995|7677311|FG004|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
6749402|NCT03426995|7677312|FG005|STARTED|Part A: Cohort 1-Period 1 (Day1)||1
6749403|NCT03426995|7677313|FG006|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749404|NCT03426995|7677314|FG007|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749405|NCT03426995|7677315|FG008|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749406|NCT03426995|7677316|FG009|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749407|NCT03426995|7677317|FG010|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749408|NCT03426995|7677318|FG011|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749409|NCT03426995|7677319|FG012|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749410|NCT03426995|7677320|FG013|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749411|NCT03426995|7677321|FG014|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749412|NCT03426995|7677322|FG015|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749413|NCT03426995|7677323|FG016|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749414|NCT03426995|7677324|FG017|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749415|NCT03426995|7677325|FG018|STARTED|Part A: Cohort 1-Period 1 (Day1)||0
6749416|NCT03426995|7677307|FG000|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749417|NCT03426995|7677308|FG001|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
6749418|NCT03426995|7677309|FG002|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749419|NCT03426995|7677310|FG003|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||2
6749420|NCT03426995|7677311|FG004|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
6749421|NCT03426995|7677312|FG005|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
6749422|NCT03426995|7677313|FG006|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749423|NCT03426995|7677314|FG007|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749424|NCT03426995|7677315|FG008|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749425|NCT03426995|7677316|FG009|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749426|NCT03426995|7677317|FG010|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749427|NCT03426995|7677318|FG011|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749428|NCT03426995|7677319|FG012|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749429|NCT03426995|7677320|FG013|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749430|NCT03426995|7677321|FG014|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749431|NCT03426995|7677322|FG015|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749432|NCT03426995|7677323|FG016|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749433|NCT03426995|7677324|FG017|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749434|NCT03426995|7677325|FG018|COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6492819|NCT01376557|7411129|FG003|COMPLETED|Overall Study||54
6492820|NCT01376557|7411130|FG004|COMPLETED|Overall Study||53
6492821|NCT01376557|7411126|FG000|NOT COMPLETED|Overall Study||8
6492822|NCT01376557|7411127|FG001|NOT COMPLETED|Overall Study||6
6492823|NCT01376557|7411128|FG002|NOT COMPLETED|Overall Study||5
6492824|NCT01376557|7411129|FG003|NOT COMPLETED|Overall Study||6
6492825|NCT01376557|7411130|FG004|NOT COMPLETED|Overall Study||7
6492826|NCT01376700|7411142|FG000|STARTED|Overall Study||19
6492827|NCT01376700|7411142|FG000|COMPLETED|Overall Study||3
6492828|NCT01376700|7411142|FG000|NOT COMPLETED|Overall Study||16
6492829|NCT01376804|7411149|FG000|STARTED|Treatment Period||57
6492830|NCT01376804|7411149|FG000|Received Study Drug|Treatment Period||56
6492831|NCT01376804|7411149|FG000|COMPLETED|Treatment Period||49
6492832|NCT01376804|7411149|FG000|NOT COMPLETED|Treatment Period||8
6749435|NCT03426995|7677307|FG000|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6492833|NCT01376804|7411149|FG000|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
6492834|NCT01376804|7411149|FG000|COMPLETED|Follow-up Period||55
6492835|NCT01376804|7411149|FG000|NOT COMPLETED|Follow-up Period||0
6492836|NCT01376908|7411155|FG000|STARTED|Overall Study||27
6492837|NCT01376908|7411156|FG001|STARTED|Overall Study||29
6492838|NCT01376908|7411155|FG000|COMPLETED|Overall Study||25
6492839|NCT01376908|7411156|FG001|COMPLETED|Overall Study||26
6492840|NCT01376908|7411155|FG000|NOT COMPLETED|Overall Study||2
6492841|NCT01376908|7411156|FG001|NOT COMPLETED|Overall Study||3
6492842|NCT01377012|7411172|FG000|STARTED|Core Study||210
6492843|NCT01377012|7411173|FG001|STARTED|Core Study||213
6492844|NCT01377012|7411174|FG002|STARTED|Core Study||214
6492845|NCT01377012|7411172|FG000|wk16 Re-randomized to AIN 75mg NR|Core Study||0
6492846|NCT01377012|7411173|FG001|wk16 Re-randomized to AIN 75mg NR|Core Study||0
6492847|NCT01377012|7411174|FG002|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
6492848|NCT01377012|7411172|FG000|wk16 Re-randomized to AIN 150mg NR|Core Study||0
6492849|NCT01377012|7411173|FG001|wk16 Re-randomized to AIN 150mg NR|Core Study||0
6492850|NCT01377012|7411174|FG002|wk16 Re-randomized to AIN 150mg NR|Core Study||53
6492851|NCT01377012|7411172|FG000|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
6492852|NCT01377012|7411173|FG001|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
6492853|NCT01377012|7411174|FG002|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
6492854|NCT01377012|7411172|FG000|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
6492855|NCT01377012|7411173|FG001|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
6492856|NCT01377012|7411174|FG002|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
6492857|NCT01377012|7411172|FG000|COMPLETED|Core Study||76
6492858|NCT01377012|7411173|FG001|COMPLETED|Core Study||81
6492859|NCT01377012|7411174|FG002|COMPLETED|Core Study||80
6492860|NCT01377012|7411172|FG000|NOT COMPLETED|Core Study||134
6492861|NCT01377012|7411173|FG001|NOT COMPLETED|Core Study||132
6492862|NCT01377012|7411174|FG002|NOT COMPLETED|Core Study||134
6492863|NCT01377012|7411172|FG000|STARTED|Extension Study, Weeks 104-260||57
6492864|NCT01377012|7411173|FG001|STARTED|Extension Study, Weeks 104-260||71
6492865|NCT01377012|7411174|FG002|STARTED|Extension Study, Weeks 104-260||68
6492866|NCT01377012|7411172|FG000|COMPLETED|Extension Study, Weeks 104-260||0
6492867|NCT01377012|7411173|FG001|COMPLETED|Extension Study, Weeks 104-260||0
6492868|NCT01377012|7411174|FG002|COMPLETED|Extension Study, Weeks 104-260||0
6492869|NCT01377012|7411172|FG000|NOT COMPLETED|Extension Study, Weeks 104-260||57
6492870|NCT01377012|7411173|FG001|NOT COMPLETED|Extension Study, Weeks 104-260||71
6492871|NCT01377012|7411174|FG002|NOT COMPLETED|Extension Study, Weeks 104-260||68
6492872|NCT01377194|7411185|FG000|STARTED|Overall Study||186
6492873|NCT01377194|7411186|FG001|STARTED|Overall Study||188
6492874|NCT01377194|7411187|FG002|STARTED|Overall Study||188
6492875|NCT01377194|7411185|FG000|COMPLETED|Overall Study||154
6492876|NCT01377194|7411186|FG001|COMPLETED|Overall Study||145
6492877|NCT01377194|7411187|FG002|COMPLETED|Overall Study||142
6492878|NCT01377194|7411185|FG000|NOT COMPLETED|Overall Study||32
6492879|NCT01377194|7411186|FG001|NOT COMPLETED|Overall Study||43
6492880|NCT01377194|7411187|FG002|NOT COMPLETED|Overall Study||46
6492881|NCT01377233|7411203|FG000|STARTED|Open-label||46
6492882|NCT01377233|7411204|FG001|STARTED|Open-label||0
6492883|NCT01377233|7411205|FG002|STARTED|Open-label||0
6492884|NCT01377233|7411206|FG003|STARTED|Open-label||0
6492885|NCT01377233|7411207|FG004|STARTED|Open-label||0
6492886|NCT01377233|7411203|FG000|COMPLETED|Open-label||42
6492887|NCT01377233|7411204|FG001|COMPLETED|Open-label||0
6492888|NCT01377233|7411205|FG002|COMPLETED|Open-label||0
6492889|NCT01377233|7411206|FG003|COMPLETED|Open-label||0
6492890|NCT01377233|7411207|FG004|COMPLETED|Open-label||0
6749436|NCT03426995|7677308|FG001|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749437|NCT03426995|7677309|FG002|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||1
6749438|NCT03426995|7677310|FG003|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749439|NCT03426995|7677311|FG004|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749440|NCT03426995|7677312|FG005|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749441|NCT03426995|7677313|FG006|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749442|NCT03426995|7677314|FG007|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749443|NCT03426995|7677315|FG008|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749444|NCT03426995|7677316|FG009|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6492891|NCT01377233|7411203|FG000|NOT COMPLETED|Open-label||4
6492892|NCT01377233|7411204|FG001|NOT COMPLETED|Open-label||0
6492893|NCT01377233|7411205|FG002|NOT COMPLETED|Open-label||0
6492894|NCT01377233|7411206|FG003|NOT COMPLETED|Open-label||0
6492895|NCT01377233|7411207|FG004|NOT COMPLETED|Open-label||0
6492896|NCT01377233|7411203|FG000|STARTED|Double-blind||0
6492897|NCT01377233|7411204|FG001|STARTED|Double-blind||11
6492898|NCT01377233|7411205|FG002|STARTED|Double-blind||10
6492899|NCT01377233|7411206|FG003|STARTED|Double-blind||11
6492900|NCT01377233|7411207|FG004|STARTED|Double-blind||10
6492901|NCT01377233|7411203|FG000|COMPLETED|Double-blind||0
6492902|NCT01377233|7411204|FG001|COMPLETED|Double-blind||10
6492903|NCT01377233|7411205|FG002|COMPLETED|Double-blind||8
6492904|NCT01377233|7411206|FG003|COMPLETED|Double-blind||7
6492905|NCT01377233|7411207|FG004|COMPLETED|Double-blind||8
6492906|NCT01377233|7411203|FG000|NOT COMPLETED|Double-blind||0
6492907|NCT01377233|7411204|FG001|NOT COMPLETED|Double-blind||1
6492908|NCT01377233|7411205|FG002|NOT COMPLETED|Double-blind||2
6492909|NCT01377233|7411206|FG003|NOT COMPLETED|Double-blind||4
6492910|NCT01377233|7411207|FG004|NOT COMPLETED|Double-blind||2
6492911|NCT01377389|7411223|FG000|STARTED|Overall Study||30
6492912|NCT01377389|7411223|FG000|COMPLETED|Overall Study||27
6492913|NCT01377389|7411223|FG000|NOT COMPLETED|Overall Study||3
6492914|NCT01377402|7411227|FG000|STARTED|Overall Study||982
6492915|NCT01377402|7411227|FG000|COMPLETED|Overall Study||982
6492916|NCT01377402|7411227|FG000|NOT COMPLETED|Overall Study||0
6492917|NCT01377467|7411235|FG000|STARTED|Overall Study||46
6492918|NCT01377467|7411236|FG001|STARTED|Overall Study||44
6492919|NCT01377467|7411235|FG000|COMPLETED|Overall Study||46
6492920|NCT01377467|7411236|FG001|COMPLETED|Overall Study||44
6492921|NCT01377467|7411235|FG000|NOT COMPLETED|Overall Study||0
6492922|NCT01377467|7411236|FG001|NOT COMPLETED|Overall Study||0
6492923|NCT01377480|7411246|FG000|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
6492924|NCT01377480|7411247|FG001|STARTED|Overall Study||30
6492925|NCT01377480|7411248|FG002|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
6492926|NCT01377480|7411249|FG003|STARTED|Overall Study||30
6492927|NCT01377480|7411246|FG000|COMPLETED|Overall Study||32
6492928|NCT01377480|7411247|FG001|COMPLETED|Overall Study||29
6492929|NCT01377480|7411248|FG002|COMPLETED|Overall Study||18
6492930|NCT01377480|7411249|FG003|COMPLETED|Overall Study||19
6492931|NCT01377480|7411246|FG000|NOT COMPLETED|Overall Study||0
6492932|NCT01377480|7411247|FG001|NOT COMPLETED|Overall Study||1
6492933|NCT01377480|7411248|FG002|NOT COMPLETED|Overall Study||10
6492934|NCT01377480|7411249|FG003|NOT COMPLETED|Overall Study||11
6492935|NCT01377584|7411265|FG000|STARTED|Overall Study||8
6492936|NCT01377584|7411266|FG001|STARTED|Overall Study||8
6492937|NCT01377584|7411267|FG002|STARTED|Overall Study||10
6492938|NCT01377584|7411268|FG003|STARTED|Overall Study||10
6492939|NCT01377584|7411269|FG004|STARTED|Overall Study||12
6492940|NCT01377584|7411270|FG005|STARTED|Overall Study||12
6492941|NCT01377584|7411265|FG000|COMPLETED|Overall Study||5
6492942|NCT01377584|7411266|FG001|COMPLETED|Overall Study||5
6492943|NCT01377584|7411267|FG002|COMPLETED|Overall Study||6
6492944|NCT01377584|7411268|FG003|COMPLETED|Overall Study||6
6492945|NCT01377584|7411269|FG004|COMPLETED|Overall Study||9
6492946|NCT01377584|7411270|FG005|COMPLETED|Overall Study||9
6492947|NCT01377584|7411265|FG000|NOT COMPLETED|Overall Study||3
6492948|NCT01377584|7411266|FG001|NOT COMPLETED|Overall Study||3
6492949|NCT01377584|7411267|FG002|NOT COMPLETED|Overall Study||4
6492950|NCT01377584|7411268|FG003|NOT COMPLETED|Overall Study||4
6492951|NCT01377584|7411269|FG004|NOT COMPLETED|Overall Study||3
6492952|NCT01377584|7411270|FG005|NOT COMPLETED|Overall Study||3
6492953|NCT01377623|7411289|FG000|STARTED|Overall Study||33
6492954|NCT01377623|7411290|FG001|STARTED|Overall Study||33
6492955|NCT01377623|7411289|FG000|COMPLETED|Overall Study||26
6492956|NCT01377623|7411290|FG001|COMPLETED|Overall Study||28
6492957|NCT01377623|7411289|FG000|NOT COMPLETED|Overall Study||7
6492958|NCT01377623|7411290|FG001|NOT COMPLETED|Overall Study||5
6492959|NCT01377636|7411296|FG000|STARTED|Overall Study||20
6492960|NCT01377636|7411296|FG000|COMPLETED|Overall Study||20
6492961|NCT01377636|7411296|FG000|NOT COMPLETED|Overall Study||0
6492962|NCT01377844|7411304|FG000|STARTED|Overall Study||145
6492963|NCT01377844|7411305|FG001|STARTED|Overall Study||143
6492964|NCT01377844|7411304|FG000|Safety Population|Overall Study||145
6492965|NCT01377844|7411305|FG001|Safety Population|Overall Study||141
6492966|NCT01377844|7411304|FG000|COMPLETED|Overall Study||109
6492967|NCT01377844|7411305|FG001|COMPLETED|Overall Study||108
6492968|NCT01377844|7411304|FG000|NOT COMPLETED|Overall Study||36
6492969|NCT01377844|7411305|FG001|NOT COMPLETED|Overall Study||35
6492970|NCT01377922|7411314|FG000|STARTED|Overall Study||22
6492971|NCT01377922|7411315|FG001|STARTED|Overall Study||16
6492972|NCT01377922|7411314|FG000|COMPLETED|Overall Study||21
6492973|NCT01377922|7411315|FG001|COMPLETED|Overall Study||16
6492974|NCT01377922|7411314|FG000|NOT COMPLETED|Overall Study||1
6492975|NCT01377922|7411315|FG001|NOT COMPLETED|Overall Study||0
6492976|NCT01377987|7411321|FG000|STARTED|First Intervention (7 Days)||14
6492977|NCT01377987|7411322|FG001|STARTED|First Intervention (7 Days)||15
6492978|NCT01377987|7411321|FG000|COMPLETED|First Intervention (7 Days)||14
6492979|NCT01377987|7411322|FG001|COMPLETED|First Intervention (7 Days)||15
6492980|NCT01377987|7411321|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6492981|NCT01377987|7411322|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6492982|NCT01377987|7411321|FG000|STARTED|Washout (7 Days)||14
6492983|NCT01377987|7411322|FG001|STARTED|Washout (7 Days)||15
6492984|NCT01377987|7411321|FG000|COMPLETED|Washout (7 Days)||13
6492985|NCT01377987|7411322|FG001|COMPLETED|Washout (7 Days)||14
6492986|NCT01377987|7411321|FG000|NOT COMPLETED|Washout (7 Days)||1
6492987|NCT01377987|7411322|FG001|NOT COMPLETED|Washout (7 Days)||1
6492988|NCT01377987|7411321|FG000|STARTED|Second Intervention (7 Days)||13
6492989|NCT01377987|7411322|FG001|STARTED|Second Intervention (7 Days)||14
6492990|NCT01377987|7411321|FG000|COMPLETED|Second Intervention (7 Days)||13
6492991|NCT01377987|7411322|FG001|COMPLETED|Second Intervention (7 Days)||14
6492992|NCT01377987|7411321|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6492993|NCT01377987|7411322|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6492994|NCT01378065|7411328|FG000|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
6492995|NCT01378065|7411328|FG000|6 Week|Overall Study||30
6492996|NCT01378065|7411328|FG000|3 Months|Overall Study||30
6492997|NCT01378065|7411328|FG000|6 Months|Overall Study||30
6492998|NCT01378065|7411328|FG000|12 Months|Overall Study||30
6492999|NCT01378065|7411328|FG000|COMPLETED|Overall Study||30
6493000|NCT01378065|7411328|FG000|NOT COMPLETED|Overall Study||0
6493001|NCT01378104|7411334|FG000|STARTED|Overall Study||92
6493002|NCT01378104|7411335|FG001|STARTED|Overall Study||86
6493003|NCT01378104|7411334|FG000|COMPLETED|Overall Study||65
6493004|NCT01378104|7411335|FG001|COMPLETED|Overall Study||60
6493005|NCT01378104|7411334|FG000|NOT COMPLETED|Overall Study||27
6493006|NCT01378104|7411335|FG001|NOT COMPLETED|Overall Study||26
6493007|NCT01378117|7411346|FG000|STARTED|Overall Study||31
6493008|NCT01378117|7411347|FG001|STARTED|Overall Study||30
6493009|NCT01378117|7411348|FG002|STARTED|Overall Study||29
6493010|NCT01378117|7411346|FG000|COMPLETED|Overall Study||27
6493011|NCT01378117|7411347|FG001|COMPLETED|Overall Study||29
6493012|NCT01378117|7411348|FG002|COMPLETED|Overall Study||26
6493013|NCT01378117|7411346|FG000|NOT COMPLETED|Overall Study||4
6493014|NCT01378117|7411347|FG001|NOT COMPLETED|Overall Study||1
6493015|NCT01378117|7411348|FG002|NOT COMPLETED|Overall Study||3
6749445|NCT03426995|7677317|FG010|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749446|NCT03426995|7677318|FG011|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749447|NCT03426995|7677319|FG012|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749448|NCT03426995|7677320|FG013|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749449|NCT03426995|7677321|FG014|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749450|NCT03426995|7677322|FG015|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749451|NCT03426995|7677323|FG016|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749452|NCT03426995|7677324|FG017|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749453|NCT03426995|7677325|FG018|NOT COMPLETED|Part A: Cohort 1-Period 1 (Day1)||0
6749454|NCT03426995|7677307|FG000|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749455|NCT03426995|7677308|FG001|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
6749456|NCT03426995|7677309|FG002|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749457|NCT03426995|7677310|FG003|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
6749458|NCT03426995|7677311|FG004|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
6749459|NCT03426995|7677312|FG005|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
6749460|NCT03426995|7677313|FG006|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749461|NCT03426995|7677314|FG007|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749462|NCT03426995|7677315|FG008|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749463|NCT03426995|7677316|FG009|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749464|NCT03426995|7677317|FG010|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749465|NCT03426995|7677318|FG011|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749466|NCT03426995|7677319|FG012|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749467|NCT03426995|7677320|FG013|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749468|NCT03426995|7677321|FG014|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749469|NCT03426995|7677322|FG015|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749470|NCT03426995|7677323|FG016|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749471|NCT03426995|7677324|FG017|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749472|NCT03426995|7677325|FG018|STARTED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749473|NCT03426995|7677307|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749474|NCT03426995|7677308|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
6749475|NCT03426995|7677309|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749476|NCT03426995|7677310|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||2
6749477|NCT03426995|7677311|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
6749478|NCT03426995|7677312|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||1
6749479|NCT03426995|7677313|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749480|NCT03426995|7677314|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749481|NCT03426995|7677315|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749482|NCT03426995|7677316|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749483|NCT03426995|7677317|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749484|NCT03426995|7677318|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749485|NCT03426995|7677319|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749486|NCT03426995|7677320|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749487|NCT03426995|7677321|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749488|NCT03426995|7677322|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749489|NCT03426995|7677323|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749490|NCT03426995|7677324|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749491|NCT03426995|7677325|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749492|NCT03426995|7677307|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749493|NCT03426995|7677308|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749494|NCT03426995|7677309|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749495|NCT03426995|7677310|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749496|NCT03426995|7677311|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749497|NCT03426995|7677312|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749498|NCT03426995|7677313|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749499|NCT03426995|7677314|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749500|NCT03426995|7677315|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6779922|NCT03534362|7708192|FG001|STARTED|Overall Study||1
6493016|NCT01378195|7411363|FG000|STARTED|Overall Study||75
6493017|NCT01378195|7411364|FG001|STARTED|Overall Study||75
6493018|NCT01378195|7411363|FG000|COMPLETED|Overall Study||46
6493019|NCT01378195|7411364|FG001|COMPLETED|Overall Study||57
6493020|NCT01378195|7411363|FG000|NOT COMPLETED|Overall Study||29
6493021|NCT01378195|7411364|FG001|NOT COMPLETED|Overall Study||18
6493022|NCT01378221|7411372|FG000|STARTED|Overall Study||36
6493023|NCT01378221|7411373|FG001|STARTED|Overall Study||39
6493024|NCT01378221|7411372|FG000|COMPLETED|Overall Study||29
6493025|NCT01378221|7411373|FG001|COMPLETED|Overall Study||30
6493026|NCT01378221|7411372|FG000|NOT COMPLETED|Overall Study||7
6493027|NCT01378221|7411373|FG001|NOT COMPLETED|Overall Study||9
6493028|NCT01378273|7411381|FG000|STARTED|Overall Study||464
6493029|NCT01378273|7411382|FG001|STARTED|Overall Study||477
6493030|NCT01378273|7411381|FG000|COMPLETED|Overall Study||460
6493031|NCT01378273|7411382|FG001|COMPLETED|Overall Study||476
6493032|NCT01378273|7411381|FG000|NOT COMPLETED|Overall Study||4
6493033|NCT01378273|7411382|FG001|NOT COMPLETED|Overall Study||1
6493034|NCT01378299|7411392|FG000|STARTED|Overall Study||105
6493035|NCT01378299|7411392|FG000|BMI group1|Overall Study||38
6493036|NCT01378299|7411392|FG000|BMI Group 2|Overall Study||40
6493037|NCT01378299|7411392|FG000|BMI Group 3|Overall Study||27
6493038|NCT01378299|7411392|FG000|COMPLETED|Overall Study||74
6493039|NCT01378299|7411392|FG000|NOT COMPLETED|Overall Study||31
6493040|NCT01378325|7411424|FG000|STARTED|Overall Study||40
6493041|NCT01378325|7411425|FG001|STARTED|Overall Study||40
6493042|NCT01378325|7411424|FG000|COMPLETED|Overall Study||40
6493043|NCT01378325|7411425|FG001|COMPLETED|Overall Study||39
6493044|NCT01378325|7411424|FG000|NOT COMPLETED|Overall Study||0
6493045|NCT01378325|7411425|FG001|NOT COMPLETED|Overall Study||1
6493046|NCT01378377|7411434|FG000|STARTED|Overall Study||4
6493047|NCT01378377|7411435|FG001|STARTED|Overall Study||23
6493048|NCT01378377|7411436|FG002|STARTED|Overall Study||6
6493049|NCT01378377|7411434|FG000|COMPLETED|Overall Study||4
6493050|NCT01378377|7411435|FG001|COMPLETED|Overall Study||23
6493051|NCT01378377|7411436|FG002|COMPLETED|Overall Study||6
6493052|NCT01378377|7411434|FG000|NOT COMPLETED|Overall Study||0
6493053|NCT01378377|7411435|FG001|NOT COMPLETED|Overall Study||0
6493054|NCT01378377|7411436|FG002|NOT COMPLETED|Overall Study||0
6493055|NCT01378416|7411449|FG000|STARTED|Overall Study||16
6493056|NCT01378416|7411449|FG000|COMPLETED|Overall Study||16
6493057|NCT01378416|7411449|FG000|NOT COMPLETED|Overall Study||0
6493058|NCT01378429|7411455|FG000|STARTED|Overall Study||42
6493059|NCT01378429|7411456|FG001|STARTED|Overall Study||47
6493060|NCT01378429|7411455|FG000|COMPLETED|Overall Study||41
6493061|NCT01378429|7411456|FG001|COMPLETED|Overall Study||47
6493062|NCT01378429|7411455|FG000|NOT COMPLETED|Overall Study||1
6493063|NCT01378429|7411456|FG001|NOT COMPLETED|Overall Study||0
6493064|NCT01378520|7411465|FG000|STARTED|First Intervention (Day 2-3)||10
6493065|NCT01378520|7411466|FG001|STARTED|First Intervention (Day 2-3)||10
6493066|NCT01378520|7411465|FG000|COMPLETED|First Intervention (Day 2-3)||10
6493067|NCT01378520|7411466|FG001|COMPLETED|First Intervention (Day 2-3)||10
6493068|NCT01378520|7411465|FG000|NOT COMPLETED|First Intervention (Day 2-3)||0
6493069|NCT01378520|7411466|FG001|NOT COMPLETED|First Intervention (Day 2-3)||0
6493070|NCT01378520|7411465|FG000|STARTED|Second Intervention (Day 4-6)||10
6493071|NCT01378520|7411466|FG001|STARTED|Second Intervention (Day 4-6)||10
6493072|NCT01378520|7411465|FG000|COMPLETED|Second Intervention (Day 4-6)||10
6493073|NCT01378520|7411466|FG001|COMPLETED|Second Intervention (Day 4-6)||10
6493074|NCT01378520|7411465|FG000|NOT COMPLETED|Second Intervention (Day 4-6)||0
6493075|NCT01378520|7411466|FG001|NOT COMPLETED|Second Intervention (Day 4-6)||0
6493076|NCT01378858|7411474|FG000|STARTED|Overall Study||50
6493077|NCT01378858|7411475|FG001|STARTED|Overall Study||50
6493078|NCT01378858|7411474|FG000|COMPLETED|Overall Study||46
6493079|NCT01378858|7411475|FG001|COMPLETED|Overall Study||46
6493080|NCT01378858|7411474|FG000|NOT COMPLETED|Overall Study||4
6493081|NCT01378858|7411475|FG001|NOT COMPLETED|Overall Study||4
6493082|NCT01378962|7411481|FG000|STARTED|Overall Study||50
6493083|NCT01378962|7411481|FG000|COMPLETED|Overall Study||33
6493084|NCT01378962|7411481|FG000|NOT COMPLETED|Overall Study||17
6493085|NCT01378975|7411487|FG000|STARTED|Overall Study||90
6493086|NCT01378975|7411488|FG001|STARTED|Overall Study||56
6493087|NCT01378975|7411487|FG000|COMPLETED|Overall Study||4
6493088|NCT01378975|7411488|FG001|COMPLETED|Overall Study||6
6493089|NCT01378975|7411487|FG000|NOT COMPLETED|Overall Study||86
6493090|NCT01378975|7411488|FG001|NOT COMPLETED|Overall Study||50
6493091|NCT01378988|7411497|FG000|STARTED|Overall Study||2
6493092|NCT01378988|7411498|FG001|STARTED|Overall Study||3
6493093|NCT01378988|7411497|FG000|COMPLETED|Overall Study||2
6493094|NCT01378988|7411498|FG001|COMPLETED|Overall Study||3
6493095|NCT01378988|7411497|FG000|NOT COMPLETED|Overall Study||0
6493096|NCT01378988|7411498|FG001|NOT COMPLETED|Overall Study||0
6493097|NCT01379183|7411506|FG000|STARTED|Overall Study||19
6493098|NCT01379183|7411507|FG001|STARTED|Overall Study||21
6493099|NCT01379183|7411506|FG000|COMPLETED|Overall Study||19
6493100|NCT01379183|7411507|FG001|COMPLETED|Overall Study||21
6493101|NCT01379183|7411506|FG000|NOT COMPLETED|Overall Study||0
6493102|NCT01379183|7411507|FG001|NOT COMPLETED|Overall Study||0
6493103|NCT01379222|7411515|FG000|STARTED|Overall Study||178
6493104|NCT01379222|7411515|FG000|COMPLETED|Overall Study||105
6493105|NCT01379222|7411515|FG000|NOT COMPLETED|Overall Study||73
6493106|NCT01379508|7411523|FG000|STARTED|Treatment to Week 104||99
6493107|NCT01379508|7411524|FG001|STARTED|Treatment to Week 104||22
6493108|NCT01379508|7411525|FG002|STARTED|Treatment to Week 104||109
6493109|NCT01379508|7411526|FG003|STARTED|Treatment to Week 104||11
6493110|NCT01379508|7411523|FG000|Completed Wk 24|Treatment to Week 104||93
6493111|NCT01379508|7411524|FG001|Completed Wk 24|Treatment to Week 104||22
6493112|NCT01379508|7411525|FG002|Completed Wk 24|Treatment to Week 104||107
6493113|NCT01379508|7411526|FG003|Completed Wk 24|Treatment to Week 104||11
6493114|NCT01379508|7411523|FG000|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||91
6493115|NCT01379508|7411524|FG001|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||21
6493116|NCT01379508|7411525|FG002|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||105
6493117|NCT01379508|7411526|FG003|Treatment Exposure ≥ 52 Weeks|Treatment to Week 104||11
6493118|NCT01379508|7411523|FG000|COMPLETED|Treatment to Week 104||80
6493119|NCT01379508|7411524|FG001|COMPLETED|Treatment to Week 104||19
6493120|NCT01379508|7411525|FG002|COMPLETED|Treatment to Week 104||96
6493121|NCT01379508|7411526|FG003|COMPLETED|Treatment to Week 104||11
6493122|NCT01379508|7411523|FG000|NOT COMPLETED|Treatment to Week 104||19
6493123|NCT01379508|7411524|FG001|NOT COMPLETED|Treatment to Week 104||3
6493124|NCT01379508|7411525|FG002|NOT COMPLETED|Treatment to Week 104||13
6493125|NCT01379508|7411526|FG003|NOT COMPLETED|Treatment to Week 104||0
6493126|NCT01379508|7411523|FG000|STARTED|Extension Period Weeks 109-156||64
6493127|NCT01379508|7411524|FG001|STARTED|Extension Period Weeks 109-156||17
6493128|NCT01379508|7411525|FG002|STARTED|Extension Period Weeks 109-156||79
6493129|NCT01379508|7411526|FG003|STARTED|Extension Period Weeks 109-156||10
6493130|NCT01379508|7411523|FG000|COMPLETED|Extension Period Weeks 109-156||45
6749501|NCT03426995|7677316|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749502|NCT03426995|7677317|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749503|NCT03426995|7677318|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6493131|NCT01379508|7411524|FG001|COMPLETED|Extension Period Weeks 109-156||14
6493132|NCT01379508|7411525|FG002|COMPLETED|Extension Period Weeks 109-156||65
6493133|NCT01379508|7411526|FG003|COMPLETED|Extension Period Weeks 109-156||10
6493134|NCT01379508|7411523|FG000|NOT COMPLETED|Extension Period Weeks 109-156||19
6493135|NCT01379508|7411524|FG001|NOT COMPLETED|Extension Period Weeks 109-156||3
6493136|NCT01379508|7411525|FG002|NOT COMPLETED|Extension Period Weeks 109-156||14
6493137|NCT01379508|7411526|FG003|NOT COMPLETED|Extension Period Weeks 109-156||0
6493138|NCT01379521|7411542|FG000|STARTED|Overall Study -Treatment Period||33
6493139|NCT01379521|7411543|FG001|STARTED|Overall Study -Treatment Period||26
6493140|NCT01379521|7411542|FG000|COMPLETED|Overall Study -Treatment Period||0
6493141|NCT01379521|7411543|FG001|COMPLETED|Overall Study -Treatment Period||0
6493142|NCT01379521|7411542|FG000|NOT COMPLETED|Overall Study -Treatment Period||33
6493143|NCT01379521|7411543|FG001|NOT COMPLETED|Overall Study -Treatment Period||26
6493144|NCT01379521|7411542|FG000|STARTED|Post-Treatment Evaluations||25
6493145|NCT01379521|7411543|FG001|STARTED|Post-Treatment Evaluations||21
6493146|NCT01379521|7411542|FG000|COMPLETED|Post-Treatment Evaluations||0
6493147|NCT01379521|7411543|FG001|COMPLETED|Post-Treatment Evaluations||0
6749504|NCT03426995|7677319|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749505|NCT03426995|7677320|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749506|NCT03426995|7677321|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749507|NCT03426995|7677322|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749508|NCT03426995|7677323|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749509|NCT03426995|7677324|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749510|NCT03426995|7677325|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod1(Upto Day14)||0
6749511|NCT03426995|7677307|FG000|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
6749512|NCT03426995|7677308|FG001|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
6749513|NCT03426995|7677309|FG002|STARTED|Part A: Cohort 1-Period 2 (Day1)|New participant enrolled and dosed.|1
6749514|NCT03426995|7677310|FG003|STARTED|Part A: Cohort 1-Period 2 (Day1)||2
6749515|NCT03426995|7677311|FG004|STARTED|Part A: Cohort 1-Period 2 (Day1)||1
6749516|NCT03426995|7677312|FG005|STARTED|Part A: Cohort 1-Period 2 (Day1)|Two additional participants were enrolled and dosed.|3
6749517|NCT03426995|7677313|FG006|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749518|NCT03426995|7677314|FG007|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749519|NCT03426995|7677315|FG008|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749520|NCT03426995|7677316|FG009|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749521|NCT03426995|7677317|FG010|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749522|NCT03426995|7677318|FG011|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749523|NCT03426995|7677319|FG012|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749524|NCT03426995|7677320|FG013|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749525|NCT03426995|7677321|FG014|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749526|NCT03426995|7677322|FG015|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749527|NCT03426995|7677323|FG016|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749528|NCT03426995|7677324|FG017|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749529|NCT03426995|7677325|FG018|STARTED|Part A: Cohort 1-Period 2 (Day1)||0
6749530|NCT03426995|7677307|FG000|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
6749531|NCT03426995|7677308|FG001|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
6749532|NCT03426995|7677309|FG002|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
6749533|NCT03426995|7677310|FG003|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
6749534|NCT03426995|7677311|FG004|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6779923|NCT03534362|7708191|FG000|COMPLETED|Overall Study||0
6493148|NCT01379521|7411542|FG000|NOT COMPLETED|Post-Treatment Evaluations||25
6493149|NCT01379521|7411543|FG001|NOT COMPLETED|Post-Treatment Evaluations||21
6493150|NCT01379534|7411551|FG000|STARTED|Treatment Phase||22
6493151|NCT01379534|7411552|FG001|STARTED|Treatment Phase||31
6493152|NCT01379534|7411551|FG000|COMPLETED|Treatment Phase||0
6493153|NCT01379534|7411552|FG001|COMPLETED|Treatment Phase||0
6493154|NCT01379534|7411551|FG000|NOT COMPLETED|Treatment Phase||22
6493155|NCT01379534|7411552|FG001|NOT COMPLETED|Treatment Phase||31
6493156|NCT01379534|7411551|FG000|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
6493157|NCT01379534|7411552|FG001|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
6493158|NCT01379534|7411551|FG000|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
6493159|NCT01379534|7411552|FG001|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
6493160|NCT01379534|7411551|FG000|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
6493161|NCT01379534|7411552|FG001|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
6493162|NCT01379573|7411558|FG000|STARTED|Overall Study||74
6493163|NCT01379573|7411558|FG000|COMPLETED|Overall Study||63
6493164|NCT01379573|7411558|FG000|NOT COMPLETED|Overall Study||11
6493165|NCT01379625|7411564|FG000|STARTED|Overall Study||16
6493166|NCT01379625|7411565|FG001|STARTED|Overall Study||16
6493167|NCT01379625|7411564|FG000|COMPLETED|Overall Study||16
6493168|NCT01379625|7411565|FG001|COMPLETED|Overall Study||16
6493169|NCT01379625|7411564|FG000|NOT COMPLETED|Overall Study||0
6493170|NCT01379625|7411565|FG001|NOT COMPLETED|Overall Study||0
6493171|NCT01379651|7411573|FG000|STARTED|Overall Study||10
6493172|NCT01379651|7411574|FG001|STARTED|Overall Study||10
6493173|NCT01379651|7411573|FG000|COMPLETED|Overall Study||10
6493174|NCT01379651|7411574|FG001|COMPLETED|Overall Study||10
6493175|NCT01379651|7411573|FG000|NOT COMPLETED|Overall Study||0
6493176|NCT01379651|7411574|FG001|NOT COMPLETED|Overall Study||0
6493177|NCT01379664|7411582|FG000|STARTED|Overall Study||714
6493178|NCT01379664|7411583|FG001|STARTED|Overall Study||870
6493179|NCT01379664|7411582|FG000|COMPLETED|Overall Study||714
6493180|NCT01379664|7411583|FG001|COMPLETED|Overall Study||870
6493181|NCT01379664|7411582|FG000|NOT COMPLETED|Overall Study||0
6493182|NCT01379664|7411583|FG001|NOT COMPLETED|Overall Study||0
6493183|NCT01379703|7411589|FG000|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
6493184|NCT01379703|7411590|FG001|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
6555311|NCT01751113|7477425|FG003|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6555312|NCT01751113|7477426|FG004|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
6555313|NCT01751113|7477427|FG005|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
6749535|NCT03426995|7677312|FG005|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
6749536|NCT03426995|7677313|FG006|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749537|NCT03426995|7677314|FG007|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749538|NCT03426995|7677315|FG008|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749539|NCT03426995|7677316|FG009|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749540|NCT03426995|7677317|FG010|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749541|NCT03426995|7677318|FG011|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749542|NCT03426995|7677319|FG012|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749543|NCT03426995|7677320|FG013|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749544|NCT03426995|7677321|FG014|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749545|NCT03426995|7677322|FG015|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749546|NCT03426995|7677323|FG016|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749547|NCT03426995|7677324|FG017|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749548|NCT03426995|7677325|FG018|COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749549|NCT03426995|7677307|FG000|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749550|NCT03426995|7677308|FG001|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749551|NCT03426995|7677309|FG002|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749552|NCT03426995|7677310|FG003|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749553|NCT03426995|7677311|FG004|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||1
6749554|NCT03426995|7677312|FG005|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||2
6749555|NCT03426995|7677313|FG006|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749556|NCT03426995|7677314|FG007|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749557|NCT03426995|7677315|FG008|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749558|NCT03426995|7677316|FG009|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749559|NCT03426995|7677317|FG010|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749560|NCT03426995|7677318|FG011|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749561|NCT03426995|7677319|FG012|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749562|NCT03426995|7677320|FG013|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749563|NCT03426995|7677321|FG014|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749564|NCT03426995|7677322|FG015|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749565|NCT03426995|7677323|FG016|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6493185|NCT01379703|7411591|FG002|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
6493186|NCT01379703|7411589|FG000|COMPLETED|Study Start Through 9 Months||62
6493187|NCT01379703|7411590|FG001|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
6493188|NCT01379703|7411591|FG002|COMPLETED|Study Start Through 9 Months||873
6493189|NCT01379703|7411589|FG000|NOT COMPLETED|Study Start Through 9 Months||4
6493190|NCT01379703|7411590|FG001|NOT COMPLETED|Study Start Through 9 Months||122
6493191|NCT01379703|7411591|FG002|NOT COMPLETED|Study Start Through 9 Months||143
6555314|NCT01751139|7477436|FG000|STARTED|Overall Study||3300
6555315|NCT01751139|7477436|FG000|COMPLETED|Overall Study||1033
6555316|NCT01751139|7477436|FG000|NOT COMPLETED|Overall Study||2267
6555317|NCT01751165|7477443|FG000|STARTED|Overall Study||119
6555318|NCT01751165|7477444|FG001|STARTED|Overall Study||119
6555319|NCT01751165|7477445|FG002|STARTED|Overall Study||116
6555320|NCT01751165|7477443|FG000|COMPLETED|Overall Study||117
6555321|NCT01751165|7477444|FG001|COMPLETED|Overall Study||116
6555322|NCT01751165|7477445|FG002|COMPLETED|Overall Study||113
6555323|NCT01751165|7477443|FG000|NOT COMPLETED|Overall Study||2
6555324|NCT01751165|7477444|FG001|NOT COMPLETED|Overall Study||3
6555325|NCT01751165|7477445|FG002|NOT COMPLETED|Overall Study||3
6749566|NCT03426995|7677324|FG017|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6493192|NCT01379703|7411589|FG000|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
6493193|NCT01379703|7411590|FG001|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
6493194|NCT01379703|7411591|FG002|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
6493195|NCT01379703|7411589|FG000|COMPLETED|9 Months Through 18 Months||0
6493196|NCT01379703|7411590|FG001|COMPLETED|9 Months Through 18 Months||854
6493197|NCT01379703|7411591|FG002|COMPLETED|9 Months Through 18 Months||0
6493198|NCT01379703|7411589|FG000|NOT COMPLETED|9 Months Through 18 Months||0
6493199|NCT01379703|7411590|FG001|NOT COMPLETED|9 Months Through 18 Months||230
6493200|NCT01379703|7411591|FG002|NOT COMPLETED|9 Months Through 18 Months||0
6493201|NCT01379768|7411603|FG000|STARTED|Overall Study||23
6493202|NCT01379768|7411604|FG001|STARTED|Overall Study||22
6493203|NCT01379768|7411605|FG002|STARTED|Overall Study||20
6493204|NCT01379768|7411603|FG000|COMPLETED|Overall Study||20
6493205|NCT01379768|7411604|FG001|COMPLETED|Overall Study||21
6493206|NCT01379768|7411605|FG002|COMPLETED|Overall Study||20
6493207|NCT01379768|7411603|FG000|NOT COMPLETED|Overall Study||3
6493208|NCT01379768|7411604|FG001|NOT COMPLETED|Overall Study||1
6493209|NCT01379768|7411605|FG002|NOT COMPLETED|Overall Study||0
6493210|NCT01379924|7411615|FG000|STARTED|Baseline||72
6493211|NCT01379924|7411616|FG001|STARTED|Baseline||68
6493212|NCT01379924|7411615|FG000|COMPLETED|Baseline||72
6493213|NCT01379924|7411616|FG001|COMPLETED|Baseline||68
6493214|NCT01379924|7411615|FG000|NOT COMPLETED|Baseline||0
6493215|NCT01379924|7411616|FG001|NOT COMPLETED|Baseline||0
6493216|NCT01379924|7411615|FG000|STARTED|12-month Assessment||72
6493217|NCT01379924|7411616|FG001|STARTED|12-month Assessment||68
6749567|NCT03426995|7677325|FG018|NOT COMPLETED|Part A: Cohort 1-Period 2 (Day1)||0
6749568|NCT03426995|7677307|FG000|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
6749569|NCT03426995|7677308|FG001|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
6749570|NCT03426995|7677309|FG002|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
6749571|NCT03426995|7677310|FG003|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
6749572|NCT03426995|7677311|FG004|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749573|NCT03426995|7677312|FG005|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
6749574|NCT03426995|7677313|FG006|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749575|NCT03426995|7677314|FG007|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749576|NCT03426995|7677315|FG008|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749577|NCT03426995|7677316|FG009|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749578|NCT03426995|7677317|FG010|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749579|NCT03426995|7677318|FG011|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749580|NCT03426995|7677319|FG012|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749581|NCT03426995|7677320|FG013|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749582|NCT03426995|7677321|FG014|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749583|NCT03426995|7677322|FG015|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749584|NCT03426995|7677323|FG016|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749585|NCT03426995|7677324|FG017|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749586|NCT03426995|7677325|FG018|STARTED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749587|NCT03426995|7677307|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
6749588|NCT03426995|7677308|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
6749589|NCT03426995|7677309|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
6749590|NCT03426995|7677310|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||2
6749591|NCT03426995|7677311|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749592|NCT03426995|7677312|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||1
6749593|NCT03426995|7677313|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749594|NCT03426995|7677314|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749595|NCT03426995|7677315|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749596|NCT03426995|7677316|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749597|NCT03426995|7677317|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749598|NCT03426995|7677318|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749599|NCT03426995|7677319|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749600|NCT03426995|7677320|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749601|NCT03426995|7677321|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749602|NCT03426995|7677322|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6493218|NCT01379924|7411615|FG000|COMPLETED|12-month Assessment||62
6493219|NCT01379924|7411616|FG001|COMPLETED|12-month Assessment||55
6493220|NCT01379924|7411615|FG000|NOT COMPLETED|12-month Assessment||10
6493221|NCT01379924|7411616|FG001|NOT COMPLETED|12-month Assessment||13
6493222|NCT01379924|7411615|FG000|STARTED|24-month Assessment||62
6493223|NCT01379924|7411616|FG001|STARTED|24-month Assessment||55
6493224|NCT01379924|7411615|FG000|COMPLETED|24-month Assessment||55
6493225|NCT01379924|7411616|FG001|COMPLETED|24-month Assessment||52
6493226|NCT01379924|7411615|FG000|NOT COMPLETED|24-month Assessment||7
6493227|NCT01379924|7411616|FG001|NOT COMPLETED|24-month Assessment||3
6493228|NCT01379924|7411615|FG000|STARTED|36-month Assessment||55
6493229|NCT01379924|7411616|FG001|STARTED|36-month Assessment||52
6493230|NCT01379924|7411615|FG000|COMPLETED|36-month Assessment||52
6493231|NCT01379924|7411616|FG001|COMPLETED|36-month Assessment||48
6493232|NCT01379924|7411615|FG000|NOT COMPLETED|36-month Assessment||3
6493233|NCT01379924|7411616|FG001|NOT COMPLETED|36-month Assessment||4
6493234|NCT01379937|7411629|FG000|STARTED|Overall Study||156
6493235|NCT01379937|7411630|FG001|STARTED|Overall Study||156
6493236|NCT01379937|7411631|FG002|STARTED|Overall Study||104
6493237|NCT01379937|7411632|FG003|STARTED|Overall Study||104
6493238|NCT01379937|7411629|FG000|COMPLETED|Overall Study||155
6749603|NCT03426995|7677323|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749604|NCT03426995|7677324|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749605|NCT03426995|7677325|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749606|NCT03426995|7677307|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749607|NCT03426995|7677308|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749608|NCT03426995|7677309|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749609|NCT03426995|7677310|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749610|NCT03426995|7677311|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749611|NCT03426995|7677312|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749612|NCT03426995|7677313|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749613|NCT03426995|7677314|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749614|NCT03426995|7677315|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749615|NCT03426995|7677316|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749616|NCT03426995|7677317|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749617|NCT03426995|7677318|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749618|NCT03426995|7677319|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749619|NCT03426995|7677320|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749620|NCT03426995|7677321|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749621|NCT03426995|7677322|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749622|NCT03426995|7677323|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749623|NCT03426995|7677324|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749624|NCT03426995|7677325|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod2(Upto Day14)||0
6749625|NCT03426995|7677307|FG000|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
6749626|NCT03426995|7677308|FG001|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
6749627|NCT03426995|7677309|FG002|STARTED|Part A: Cohort 1-Period 3 (Day1)||1
6749628|NCT03426995|7677310|FG003|STARTED|Part A: Cohort 1-Period 3 (Day1)||2
6749629|NCT03426995|7677311|FG004|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|1
6749630|NCT03426995|7677312|FG005|STARTED|Part A: Cohort 1-Period 3 (Day1)|New participant enrolled and dosed.|2
6749631|NCT03426995|7677313|FG006|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749632|NCT03426995|7677314|FG007|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749633|NCT03426995|7677315|FG008|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749634|NCT03426995|7677316|FG009|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749635|NCT03426995|7677317|FG010|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749636|NCT03426995|7677318|FG011|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749637|NCT03426995|7677319|FG012|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749638|NCT03426995|7677320|FG013|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749639|NCT03426995|7677321|FG014|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749640|NCT03426995|7677322|FG015|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749641|NCT03426995|7677323|FG016|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749642|NCT03426995|7677324|FG017|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749643|NCT03426995|7677325|FG018|STARTED|Part A: Cohort 1-Period 3 (Day1)||0
6749644|NCT03426995|7677307|FG000|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
6749645|NCT03426995|7677308|FG001|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
6749646|NCT03426995|7677309|FG002|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
6749647|NCT03426995|7677310|FG003|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
6749648|NCT03426995|7677311|FG004|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||1
6749649|NCT03426995|7677312|FG005|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||2
6749650|NCT03426995|7677313|FG006|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749651|NCT03426995|7677314|FG007|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749652|NCT03426995|7677315|FG008|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749653|NCT03426995|7677316|FG009|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749654|NCT03426995|7677317|FG010|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749655|NCT03426995|7677318|FG011|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749656|NCT03426995|7677319|FG012|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749657|NCT03426995|7677320|FG013|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6493239|NCT01379937|7411630|FG001|COMPLETED|Overall Study||153
6493240|NCT01379937|7411631|FG002|COMPLETED|Overall Study||102
6493241|NCT01379937|7411632|FG003|COMPLETED|Overall Study||103
6493242|NCT01379937|7411629|FG000|NOT COMPLETED|Overall Study||1
6493243|NCT01379937|7411630|FG001|NOT COMPLETED|Overall Study||3
6493244|NCT01379937|7411631|FG002|NOT COMPLETED|Overall Study||2
6493245|NCT01379937|7411632|FG003|NOT COMPLETED|Overall Study||1
6493246|NCT01379963|7411647|FG000|STARTED|Overall Study||780
6493247|NCT01379963|7411647|FG000|COMPLETED|Overall Study||780
6493248|NCT01379963|7411647|FG000|NOT COMPLETED|Overall Study||0
6493249|NCT01380080|7411653|FG000|STARTED|Overall Study||424
6493250|NCT01380080|7411654|FG001|STARTED|Overall Study||426
6493251|NCT01380080|7411653|FG000|COMPLETED|Overall Study||339
6493252|NCT01380080|7411654|FG001|COMPLETED|Overall Study||343
6493253|NCT01380080|7411653|FG000|NOT COMPLETED|Overall Study||85
6493254|NCT01380080|7411654|FG001|NOT COMPLETED|Overall Study||83
6493255|NCT01380093|7411660|FG000|STARTED|Naloxone Challenge Phase||80
6493256|NCT01380093|7411661|FG001|STARTED|Naloxone Challenge Phase||0
6493257|NCT01380093|7411662|FG002|STARTED|Naloxone Challenge Phase||0
6493258|NCT01380093|7411663|FG003|STARTED|Naloxone Challenge Phase||0
6493259|NCT01380093|7411664|FG004|STARTED|Naloxone Challenge Phase||0
6493260|NCT01380093|7411665|FG005|STARTED|Naloxone Challenge Phase||0
6493261|NCT01380093|7411666|FG006|STARTED|Naloxone Challenge Phase||0
6493262|NCT01380093|7411667|FG007|STARTED|Naloxone Challenge Phase||0
6493263|NCT01380093|7411668|FG008|STARTED|Naloxone Challenge Phase||0
6493264|NCT01380093|7411660|FG000|TREATED|Naloxone Challenge Phase||59
6493265|NCT01380093|7411661|FG001|TREATED|Naloxone Challenge Phase||0
6493266|NCT01380093|7411662|FG002|TREATED|Naloxone Challenge Phase||0
6493267|NCT01380093|7411663|FG003|TREATED|Naloxone Challenge Phase||0
6493268|NCT01380093|7411664|FG004|TREATED|Naloxone Challenge Phase||0
6493269|NCT01380093|7411665|FG005|TREATED|Naloxone Challenge Phase||0
6493270|NCT01380093|7411666|FG006|TREATED|Naloxone Challenge Phase||0
6493271|NCT01380093|7411667|FG007|TREATED|Naloxone Challenge Phase||0
6493272|NCT01380093|7411668|FG008|TREATED|Naloxone Challenge Phase||0
6493273|NCT01380093|7411660|FG000|COMPLETED|Naloxone Challenge Phase||59
6493274|NCT01380093|7411661|FG001|COMPLETED|Naloxone Challenge Phase||0
6493275|NCT01380093|7411662|FG002|COMPLETED|Naloxone Challenge Phase||0
6493276|NCT01380093|7411663|FG003|COMPLETED|Naloxone Challenge Phase||0
6493277|NCT01380093|7411664|FG004|COMPLETED|Naloxone Challenge Phase||0
6493278|NCT01380093|7411665|FG005|COMPLETED|Naloxone Challenge Phase||0
6493279|NCT01380093|7411666|FG006|COMPLETED|Naloxone Challenge Phase||0
6493280|NCT01380093|7411667|FG007|COMPLETED|Naloxone Challenge Phase||0
6493281|NCT01380093|7411668|FG008|COMPLETED|Naloxone Challenge Phase||0
6493282|NCT01380093|7411660|FG000|NOT COMPLETED|Naloxone Challenge Phase||21
6749658|NCT03426995|7677321|FG014|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749659|NCT03426995|7677322|FG015|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749660|NCT03426995|7677323|FG016|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749661|NCT03426995|7677324|FG017|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749662|NCT03426995|7677325|FG018|COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749663|NCT03426995|7677307|FG000|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749664|NCT03426995|7677308|FG001|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749665|NCT03426995|7677309|FG002|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749666|NCT03426995|7677310|FG003|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749667|NCT03426995|7677311|FG004|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749668|NCT03426995|7677312|FG005|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749669|NCT03426995|7677313|FG006|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749670|NCT03426995|7677314|FG007|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749671|NCT03426995|7677315|FG008|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749672|NCT03426995|7677316|FG009|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749673|NCT03426995|7677317|FG010|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749674|NCT03426995|7677318|FG011|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749675|NCT03426995|7677319|FG012|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749676|NCT03426995|7677320|FG013|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749677|NCT03426995|7677321|FG014|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749678|NCT03426995|7677322|FG015|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749679|NCT03426995|7677323|FG016|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749680|NCT03426995|7677324|FG017|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749681|NCT03426995|7677325|FG018|NOT COMPLETED|Part A: Cohort 1-Period 3 (Day1)||0
6749682|NCT03426995|7677307|FG000|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
6749683|NCT03426995|7677308|FG001|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
6749684|NCT03426995|7677309|FG002|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
6749685|NCT03426995|7677310|FG003|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
6749686|NCT03426995|7677311|FG004|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
6749687|NCT03426995|7677312|FG005|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
6749688|NCT03426995|7677313|FG006|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749689|NCT03426995|7677314|FG007|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749690|NCT03426995|7677315|FG008|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749691|NCT03426995|7677316|FG009|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749692|NCT03426995|7677317|FG010|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6493283|NCT01380093|7411661|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
6493284|NCT01380093|7411662|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
6493285|NCT01380093|7411663|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
6493286|NCT01380093|7411664|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
6493287|NCT01380093|7411665|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
6493288|NCT01380093|7411666|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
6493289|NCT01380093|7411667|FG007|NOT COMPLETED|Naloxone Challenge Phase||0
6493290|NCT01380093|7411668|FG008|NOT COMPLETED|Naloxone Challenge Phase||0
6493291|NCT01380093|7411660|FG000|STARTED|Drug Discrimination Phase: Day 1||0
6493292|NCT01380093|7411661|FG001|STARTED|Drug Discrimination Phase: Day 1||30
6493293|NCT01380093|7411662|FG002|STARTED|Drug Discrimination Phase: Day 1||29
6493294|NCT01380093|7411663|FG003|STARTED|Drug Discrimination Phase: Day 1||0
6493295|NCT01380093|7411664|FG004|STARTED|Drug Discrimination Phase: Day 1||0
6493296|NCT01380093|7411665|FG005|STARTED|Drug Discrimination Phase: Day 1||0
6493297|NCT01380093|7411666|FG006|STARTED|Drug Discrimination Phase: Day 1||0
6493298|NCT01380093|7411667|FG007|STARTED|Drug Discrimination Phase: Day 1||0
6493299|NCT01380093|7411668|FG008|STARTED|Drug Discrimination Phase: Day 1||0
6493300|NCT01380093|7411660|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
6493301|NCT01380093|7411661|FG001|COMPLETED|Drug Discrimination Phase: Day 1||29
6493302|NCT01380093|7411662|FG002|COMPLETED|Drug Discrimination Phase: Day 1||29
6493303|NCT01380093|7411663|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
6493304|NCT01380093|7411664|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
6493305|NCT01380093|7411665|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
6493306|NCT01380093|7411666|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
6493307|NCT01380093|7411667|FG007|COMPLETED|Drug Discrimination Phase: Day 1||0
6493308|NCT01380093|7411668|FG008|COMPLETED|Drug Discrimination Phase: Day 1||0
6493309|NCT01380093|7411660|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6493310|NCT01380093|7411661|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
6493311|NCT01380093|7411662|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6749693|NCT03426995|7677318|FG011|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749694|NCT03426995|7677319|FG012|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749695|NCT03426995|7677320|FG013|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749696|NCT03426995|7677321|FG014|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749697|NCT03426995|7677322|FG015|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749698|NCT03426995|7677323|FG016|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749699|NCT03426995|7677324|FG017|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749700|NCT03426995|7677325|FG018|STARTED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749701|NCT03426995|7677307|FG000|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
6749702|NCT03426995|7677308|FG001|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
6749703|NCT03426995|7677309|FG002|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
6749704|NCT03426995|7677310|FG003|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
6749705|NCT03426995|7677311|FG004|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||1
6749706|NCT03426995|7677312|FG005|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||2
6749707|NCT03426995|7677313|FG006|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749708|NCT03426995|7677314|FG007|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749709|NCT03426995|7677315|FG008|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749710|NCT03426995|7677316|FG009|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749711|NCT03426995|7677317|FG010|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749712|NCT03426995|7677318|FG011|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749713|NCT03426995|7677319|FG012|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749714|NCT03426995|7677320|FG013|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749715|NCT03426995|7677321|FG014|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749716|NCT03426995|7677322|FG015|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749717|NCT03426995|7677323|FG016|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749718|NCT03426995|7677324|FG017|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749719|NCT03426995|7677325|FG018|COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749720|NCT03426995|7677307|FG000|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749721|NCT03426995|7677308|FG001|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749722|NCT03426995|7677309|FG002|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749723|NCT03426995|7677310|FG003|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749724|NCT03426995|7677311|FG004|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749725|NCT03426995|7677312|FG005|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749726|NCT03426995|7677313|FG006|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749727|NCT03426995|7677314|FG007|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749728|NCT03426995|7677315|FG008|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749729|NCT03426995|7677316|FG009|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749730|NCT03426995|7677317|FG010|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749731|NCT03426995|7677318|FG011|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749732|NCT03426995|7677319|FG012|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749733|NCT03426995|7677320|FG013|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749734|NCT03426995|7677321|FG014|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749735|NCT03426995|7677322|FG015|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749736|NCT03426995|7677323|FG016|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749737|NCT03426995|7677324|FG017|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749738|NCT03426995|7677325|FG018|NOT COMPLETED|PartA:Cohort1-WashoutPeriod3(Upto Day14)||0
6749739|NCT03426995|7677307|FG000|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
6749740|NCT03426995|7677308|FG001|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
6749741|NCT03426995|7677309|FG002|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
6749742|NCT03426995|7677310|FG003|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
6493312|NCT01380093|7411663|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6493313|NCT01380093|7411664|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6493314|NCT01380093|7411665|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6493315|NCT01380093|7411666|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6555326|NCT01751178|7477458|FG000|STARTED|Overall Study||108
6555327|NCT01751178|7477459|FG001|STARTED|Overall Study||109
6749743|NCT03426995|7677311|FG004|STARTED|Part A: Cohort 1-Period 4 (Day1)||1
6493316|NCT01380093|7411667|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6493317|NCT01380093|7411668|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6493318|NCT01380093|7411660|FG000|STARTED|Drug Discrimination Phase: Day 2||0
6493319|NCT01380093|7411661|FG001|STARTED|Drug Discrimination Phase: Day 2||29
6493320|NCT01380093|7411662|FG002|STARTED|Drug Discrimination Phase: Day 2||29
6493321|NCT01380093|7411663|FG003|STARTED|Drug Discrimination Phase: Day 2||0
6493322|NCT01380093|7411664|FG004|STARTED|Drug Discrimination Phase: Day 2||0
6493323|NCT01380093|7411665|FG005|STARTED|Drug Discrimination Phase: Day 2||0
6493324|NCT01380093|7411666|FG006|STARTED|Drug Discrimination Phase: Day 2||0
6493325|NCT01380093|7411667|FG007|STARTED|Drug Discrimination Phase: Day 2||0
6493326|NCT01380093|7411668|FG008|STARTED|Drug Discrimination Phase: Day 2||0
6493327|NCT01380093|7411660|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
6493328|NCT01380093|7411661|FG001|COMPLETED|Drug Discrimination Phase: Day 2||20
6493329|NCT01380093|7411662|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
6493330|NCT01380093|7411663|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
6493331|NCT01380093|7411664|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
6493332|NCT01380093|7411665|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
6493333|NCT01380093|7411666|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
6493334|NCT01380093|7411667|FG007|COMPLETED|Drug Discrimination Phase: Day 2||0
6493335|NCT01380093|7411668|FG008|COMPLETED|Drug Discrimination Phase: Day 2||0
6493336|NCT01380093|7411660|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6493337|NCT01380093|7411661|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
6493338|NCT01380093|7411662|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
6555328|NCT01751178|7477460|FG002|STARTED|Overall Study||107
6555329|NCT01751178|7477458|FG000|COMPLETED|Overall Study||105
6749744|NCT03426995|7677312|FG005|STARTED|Part A: Cohort 1-Period 4 (Day1)||2
6749745|NCT03426995|7677313|FG006|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749746|NCT03426995|7677314|FG007|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749747|NCT03426995|7677315|FG008|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749748|NCT03426995|7677316|FG009|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749749|NCT03426995|7677317|FG010|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749750|NCT03426995|7677318|FG011|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749751|NCT03426995|7677319|FG012|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749752|NCT03426995|7677320|FG013|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749753|NCT03426995|7677321|FG014|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749754|NCT03426995|7677322|FG015|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749755|NCT03426995|7677323|FG016|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749756|NCT03426995|7677324|FG017|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749757|NCT03426995|7677325|FG018|STARTED|Part A: Cohort 1-Period 4 (Day1)||0
6749758|NCT03426995|7677307|FG000|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
6749759|NCT03426995|7677308|FG001|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
6749760|NCT03426995|7677309|FG002|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
6749761|NCT03426995|7677310|FG003|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
6749762|NCT03426995|7677311|FG004|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||1
6749763|NCT03426995|7677312|FG005|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||2
6749764|NCT03426995|7677313|FG006|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749765|NCT03426995|7677314|FG007|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749766|NCT03426995|7677315|FG008|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749767|NCT03426995|7677316|FG009|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749768|NCT03426995|7677317|FG010|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749769|NCT03426995|7677318|FG011|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749770|NCT03426995|7677319|FG012|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749771|NCT03426995|7677320|FG013|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749772|NCT03426995|7677321|FG014|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749773|NCT03426995|7677322|FG015|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749774|NCT03426995|7677323|FG016|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749775|NCT03426995|7677324|FG017|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749776|NCT03426995|7677325|FG018|COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749777|NCT03426995|7677307|FG000|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749778|NCT03426995|7677308|FG001|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749779|NCT03426995|7677309|FG002|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749780|NCT03426995|7677310|FG003|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749781|NCT03426995|7677311|FG004|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749782|NCT03426995|7677312|FG005|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749783|NCT03426995|7677313|FG006|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749784|NCT03426995|7677314|FG007|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749785|NCT03426995|7677315|FG008|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749786|NCT03426995|7677316|FG009|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749787|NCT03426995|7677317|FG010|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749788|NCT03426995|7677318|FG011|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6493339|NCT01380093|7411663|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6493340|NCT01380093|7411664|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6493341|NCT01380093|7411665|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6493342|NCT01380093|7411666|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6493343|NCT01380093|7411667|FG007|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6493344|NCT01380093|7411668|FG008|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6493345|NCT01380093|7411660|FG000|STARTED|Treatment Phase: First Intervention||0
6493346|NCT01380093|7411661|FG001|STARTED|Treatment Phase: First Intervention||0
6493347|NCT01380093|7411662|FG002|STARTED|Treatment Phase: First Intervention||0
6493348|NCT01380093|7411663|FG003|STARTED|Treatment Phase: First Intervention||6
6493349|NCT01380093|7411664|FG004|STARTED|Treatment Phase: First Intervention||6
6493350|NCT01380093|7411665|FG005|STARTED|Treatment Phase: First Intervention||6
6493351|NCT01380093|7411666|FG006|STARTED|Treatment Phase: First Intervention||6
6493352|NCT01380093|7411667|FG007|STARTED|Treatment Phase: First Intervention||6
6493353|NCT01380093|7411668|FG008|STARTED|Treatment Phase: First Intervention||6
6493354|NCT01380093|7411660|FG000|COMPLETED|Treatment Phase: First Intervention||0
6654744|NCT02447952|7584660|FG000|NOT COMPLETED|Overall Study||7
6654745|NCT02447991|7584666|FG000|STARTED|Overall Study||45
6654746|NCT02447991|7584667|FG001|STARTED|Overall Study||89
6493355|NCT01380093|7411661|FG001|COMPLETED|Treatment Phase: First Intervention||0
6493356|NCT01380093|7411662|FG002|COMPLETED|Treatment Phase: First Intervention||0
6493357|NCT01380093|7411663|FG003|COMPLETED|Treatment Phase: First Intervention||6
6493358|NCT01380093|7411664|FG004|COMPLETED|Treatment Phase: First Intervention||6
6493359|NCT01380093|7411665|FG005|COMPLETED|Treatment Phase: First Intervention||6
6493360|NCT01380093|7411666|FG006|COMPLETED|Treatment Phase: First Intervention||6
6493361|NCT01380093|7411667|FG007|COMPLETED|Treatment Phase: First Intervention||6
6493362|NCT01380093|7411668|FG008|COMPLETED|Treatment Phase: First Intervention||6
6493363|NCT01380093|7411660|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
6493364|NCT01380093|7411661|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
6493365|NCT01380093|7411662|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
6493366|NCT01380093|7411663|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
6493367|NCT01380093|7411664|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
6493368|NCT01380093|7411665|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
6749789|NCT03426995|7677319|FG012|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749790|NCT03426995|7677320|FG013|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749791|NCT03426995|7677321|FG014|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749792|NCT03426995|7677322|FG015|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749793|NCT03426995|7677323|FG016|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749794|NCT03426995|7677324|FG017|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749795|NCT03426995|7677325|FG018|NOT COMPLETED|Part A: Cohort 1-Period 4 (Day1)||0
6749796|NCT03426995|7677307|FG000|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749797|NCT03426995|7677308|FG001|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749798|NCT03426995|7677309|FG002|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749799|NCT03426995|7677310|FG003|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749800|NCT03426995|7677311|FG004|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749801|NCT03426995|7677312|FG005|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749802|NCT03426995|7677313|FG006|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
6749803|NCT03426995|7677314|FG007|STARTED|Part A: Cohort 2-Period 1 (Day1)||2
6749804|NCT03426995|7677315|FG008|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
6749805|NCT03426995|7677316|FG009|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749806|NCT03426995|7677317|FG010|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
6749807|NCT03426995|7677318|FG011|STARTED|Part A: Cohort 2-Period 1 (Day1)||1
6749808|NCT03426995|7677319|FG012|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749809|NCT03426995|7677320|FG013|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749810|NCT03426995|7677321|FG014|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749811|NCT03426995|7677322|FG015|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749812|NCT03426995|7677323|FG016|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749813|NCT03426995|7677324|FG017|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749814|NCT03426995|7677325|FG018|STARTED|Part A: Cohort 2-Period 1 (Day1)||0
6749815|NCT03426995|7677307|FG000|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749816|NCT03426995|7677308|FG001|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749817|NCT03426995|7677309|FG002|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749818|NCT03426995|7677310|FG003|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6493369|NCT01380093|7411666|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
6493370|NCT01380093|7411667|FG007|NOT COMPLETED|Treatment Phase: First Intervention||0
6654747|NCT02447991|7584666|FG000|COMPLETED|Overall Study||35
6654748|NCT02447991|7584667|FG001|COMPLETED|Overall Study||59
6654749|NCT02447991|7584666|FG000|NOT COMPLETED|Overall Study||10
6654750|NCT02447991|7584667|FG001|NOT COMPLETED|Overall Study||30
6654751|NCT02448043|7584679|FG000|STARTED|Overall Study||23
6654752|NCT02448043|7584680|FG001|STARTED|Overall Study||22
6654753|NCT02448043|7584679|FG000|COMPLETED|Overall Study||20
6654754|NCT02448043|7584680|FG001|COMPLETED|Overall Study||18
6654755|NCT02448043|7584679|FG000|NOT COMPLETED|Overall Study||3
6654756|NCT02448043|7584680|FG001|NOT COMPLETED|Overall Study||4
6654757|NCT02448303|7584691|FG000|STARTED|Overall Study||38
6493371|NCT01380093|7411668|FG008|NOT COMPLETED|Treatment Phase: First Intervention||0
6493372|NCT01380093|7411660|FG000|STARTED|Treatment Phase: Washout Period||0
6493373|NCT01380093|7411661|FG001|STARTED|Treatment Phase: Washout Period||0
6493374|NCT01380093|7411662|FG002|STARTED|Treatment Phase: Washout Period||0
6493375|NCT01380093|7411663|FG003|STARTED|Treatment Phase: Washout Period||6
6493376|NCT01380093|7411664|FG004|STARTED|Treatment Phase: Washout Period||6
6493377|NCT01380093|7411665|FG005|STARTED|Treatment Phase: Washout Period||6
6493378|NCT01380093|7411666|FG006|STARTED|Treatment Phase: Washout Period||6
6493379|NCT01380093|7411667|FG007|STARTED|Treatment Phase: Washout Period||6
6749819|NCT03426995|7677311|FG004|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749820|NCT03426995|7677312|FG005|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749821|NCT03426995|7677313|FG006|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
6749822|NCT03426995|7677314|FG007|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||2
6749823|NCT03426995|7677315|FG008|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
6749824|NCT03426995|7677316|FG009|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749825|NCT03426995|7677317|FG010|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
6749826|NCT03426995|7677318|FG011|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||1
6749827|NCT03426995|7677319|FG012|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749828|NCT03426995|7677320|FG013|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749829|NCT03426995|7677321|FG014|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749830|NCT03426995|7677322|FG015|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749831|NCT03426995|7677323|FG016|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749832|NCT03426995|7677324|FG017|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749833|NCT03426995|7677325|FG018|COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749834|NCT03426995|7677307|FG000|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749835|NCT03426995|7677308|FG001|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749836|NCT03426995|7677309|FG002|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749837|NCT03426995|7677310|FG003|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749838|NCT03426995|7677311|FG004|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749839|NCT03426995|7677312|FG005|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749840|NCT03426995|7677313|FG006|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749841|NCT03426995|7677314|FG007|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749842|NCT03426995|7677315|FG008|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749843|NCT03426995|7677316|FG009|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749844|NCT03426995|7677317|FG010|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749845|NCT03426995|7677318|FG011|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749846|NCT03426995|7677319|FG012|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749847|NCT03426995|7677320|FG013|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749848|NCT03426995|7677321|FG014|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749849|NCT03426995|7677322|FG015|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749850|NCT03426995|7677323|FG016|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749851|NCT03426995|7677324|FG017|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749852|NCT03426995|7677325|FG018|NOT COMPLETED|Part A: Cohort 2-Period 1 (Day1)||0
6749853|NCT03426995|7677307|FG000|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749854|NCT03426995|7677308|FG001|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749855|NCT03426995|7677309|FG002|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749856|NCT03426995|7677310|FG003|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749857|NCT03426995|7677311|FG004|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749858|NCT03426995|7677312|FG005|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749859|NCT03426995|7677313|FG006|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
6749860|NCT03426995|7677314|FG007|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
6749861|NCT03426995|7677315|FG008|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
6749862|NCT03426995|7677316|FG009|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749863|NCT03426995|7677317|FG010|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
6749864|NCT03426995|7677318|FG011|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
6749865|NCT03426995|7677319|FG012|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749866|NCT03426995|7677320|FG013|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749867|NCT03426995|7677321|FG014|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749868|NCT03426995|7677322|FG015|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749869|NCT03426995|7677323|FG016|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749870|NCT03426995|7677324|FG017|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749871|NCT03426995|7677325|FG018|STARTED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749872|NCT03426995|7677307|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749873|NCT03426995|7677308|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749874|NCT03426995|7677309|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749875|NCT03426995|7677310|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749876|NCT03426995|7677311|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749877|NCT03426995|7677312|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749878|NCT03426995|7677313|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
6749879|NCT03426995|7677314|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||2
6749880|NCT03426995|7677315|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
6749881|NCT03426995|7677316|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749882|NCT03426995|7677317|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
6749883|NCT03426995|7677318|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||1
6493380|NCT01380093|7411668|FG008|STARTED|Treatment Phase: Washout Period||6
6493381|NCT01380093|7411660|FG000|COMPLETED|Treatment Phase: Washout Period||0
6493382|NCT01380093|7411661|FG001|COMPLETED|Treatment Phase: Washout Period||0
6493383|NCT01380093|7411662|FG002|COMPLETED|Treatment Phase: Washout Period||0
6493384|NCT01380093|7411663|FG003|COMPLETED|Treatment Phase: Washout Period||6
6493385|NCT01380093|7411664|FG004|COMPLETED|Treatment Phase: Washout Period||6
6493386|NCT01380093|7411665|FG005|COMPLETED|Treatment Phase: Washout Period||6
6493387|NCT01380093|7411666|FG006|COMPLETED|Treatment Phase: Washout Period||6
6493388|NCT01380093|7411667|FG007|COMPLETED|Treatment Phase: Washout Period||6
6749884|NCT03426995|7677319|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749885|NCT03426995|7677320|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749886|NCT03426995|7677321|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749887|NCT03426995|7677322|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749888|NCT03426995|7677323|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749889|NCT03426995|7677324|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749890|NCT03426995|7677325|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749891|NCT03426995|7677307|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749892|NCT03426995|7677308|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749893|NCT03426995|7677309|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749894|NCT03426995|7677310|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749895|NCT03426995|7677311|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749896|NCT03426995|7677312|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749897|NCT03426995|7677313|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749898|NCT03426995|7677314|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749899|NCT03426995|7677315|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749900|NCT03426995|7677316|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749901|NCT03426995|7677317|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749902|NCT03426995|7677318|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749903|NCT03426995|7677319|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749904|NCT03426995|7677320|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749905|NCT03426995|7677321|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749906|NCT03426995|7677322|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749907|NCT03426995|7677323|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749908|NCT03426995|7677324|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749909|NCT03426995|7677325|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod1(Upto Day14)||0
6749910|NCT03426995|7677307|FG000|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749911|NCT03426995|7677308|FG001|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749912|NCT03426995|7677309|FG002|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749913|NCT03426995|7677310|FG003|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749914|NCT03426995|7677311|FG004|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749915|NCT03426995|7677312|FG005|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749916|NCT03426995|7677313|FG006|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
6749917|NCT03426995|7677314|FG007|STARTED|Part A: Cohort 2-Period 2 (Day1)||2
6749918|NCT03426995|7677315|FG008|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
6749919|NCT03426995|7677316|FG009|STARTED|Part A: Cohort 2-Period 2 (Day1)|Two additional participants were enrolled and dosed.|2
6749920|NCT03426995|7677317|FG010|STARTED|Part A: Cohort 2-Period 2 (Day1)||1
6749921|NCT03426995|7677318|FG011|STARTED|Part A: Cohort 2-Period 2 (Day1)|New participant enrolled and dosed.|2
6749922|NCT03426995|7677319|FG012|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749923|NCT03426995|7677320|FG013|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749924|NCT03426995|7677321|FG014|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749925|NCT03426995|7677322|FG015|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749926|NCT03426995|7677323|FG016|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749927|NCT03426995|7677324|FG017|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749928|NCT03426995|7677325|FG018|STARTED|Part A: Cohort 2-Period 2 (Day1)||0
6749929|NCT03426995|7677307|FG000|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749930|NCT03426995|7677308|FG001|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749931|NCT03426995|7677309|FG002|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749932|NCT03426995|7677310|FG003|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749933|NCT03426995|7677311|FG004|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749934|NCT03426995|7677312|FG005|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749935|NCT03426995|7677313|FG006|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
6749936|NCT03426995|7677314|FG007|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
6749937|NCT03426995|7677315|FG008|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
6749938|NCT03426995|7677316|FG009|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
6749939|NCT03426995|7677317|FG010|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||1
6749940|NCT03426995|7677318|FG011|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||2
6749941|NCT03426995|7677319|FG012|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749942|NCT03426995|7677320|FG013|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749943|NCT03426995|7677321|FG014|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749944|NCT03426995|7677322|FG015|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749945|NCT03426995|7677323|FG016|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749946|NCT03426995|7677324|FG017|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749947|NCT03426995|7677325|FG018|COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749948|NCT03426995|7677307|FG000|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749949|NCT03426995|7677308|FG001|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6779924|NCT03534362|7708192|FG001|COMPLETED|Overall Study||1
6493389|NCT01380093|7411668|FG008|COMPLETED|Treatment Phase: Washout Period||6
6493390|NCT01380093|7411660|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
6493391|NCT01380093|7411661|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
6493392|NCT01380093|7411662|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
6493393|NCT01380093|7411663|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
6493394|NCT01380093|7411664|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
6493395|NCT01380093|7411665|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
6493396|NCT01380093|7411666|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
6493397|NCT01380093|7411667|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
6749950|NCT03426995|7677309|FG002|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749951|NCT03426995|7677310|FG003|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749952|NCT03426995|7677311|FG004|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749953|NCT03426995|7677312|FG005|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749954|NCT03426995|7677313|FG006|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749955|NCT03426995|7677314|FG007|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749956|NCT03426995|7677315|FG008|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749957|NCT03426995|7677316|FG009|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749958|NCT03426995|7677317|FG010|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749959|NCT03426995|7677318|FG011|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749960|NCT03426995|7677319|FG012|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749961|NCT03426995|7677320|FG013|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749962|NCT03426995|7677321|FG014|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749963|NCT03426995|7677322|FG015|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749964|NCT03426995|7677323|FG016|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749965|NCT03426995|7677324|FG017|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749966|NCT03426995|7677325|FG018|NOT COMPLETED|Part A: Cohort 2-Period 2 (Day1)||0
6749967|NCT03426995|7677307|FG000|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749968|NCT03426995|7677308|FG001|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749969|NCT03426995|7677309|FG002|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749970|NCT03426995|7677310|FG003|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749971|NCT03426995|7677311|FG004|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749972|NCT03426995|7677312|FG005|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749973|NCT03426995|7677313|FG006|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
6749974|NCT03426995|7677314|FG007|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
6749975|NCT03426995|7677315|FG008|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
6749976|NCT03426995|7677316|FG009|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
6749977|NCT03426995|7677317|FG010|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
6749978|NCT03426995|7677318|FG011|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
6749979|NCT03426995|7677319|FG012|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749980|NCT03426995|7677320|FG013|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749981|NCT03426995|7677321|FG014|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749982|NCT03426995|7677322|FG015|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749983|NCT03426995|7677323|FG016|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749984|NCT03426995|7677324|FG017|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749985|NCT03426995|7677325|FG018|STARTED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749986|NCT03426995|7677307|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749987|NCT03426995|7677308|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749988|NCT03426995|7677309|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749989|NCT03426995|7677310|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749990|NCT03426995|7677311|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749991|NCT03426995|7677312|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749992|NCT03426995|7677313|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
6749993|NCT03426995|7677314|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
6749994|NCT03426995|7677315|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
6749995|NCT03426995|7677316|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
6749996|NCT03426995|7677317|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||1
6749997|NCT03426995|7677318|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||2
6749998|NCT03426995|7677319|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6749999|NCT03426995|7677320|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750000|NCT03426995|7677321|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750001|NCT03426995|7677322|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750002|NCT03426995|7677323|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750003|NCT03426995|7677324|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750004|NCT03426995|7677325|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750005|NCT03426995|7677307|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750006|NCT03426995|7677308|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750007|NCT03426995|7677309|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750008|NCT03426995|7677310|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750009|NCT03426995|7677311|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750010|NCT03426995|7677312|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750011|NCT03426995|7677313|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750012|NCT03426995|7677314|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750013|NCT03426995|7677315|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6493398|NCT01380093|7411668|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
6493399|NCT01380093|7411660|FG000|STARTED|Treatment Phase: Second Intervention||0
6493400|NCT01380093|7411661|FG001|STARTED|Treatment Phase: Second Intervention||0
6493401|NCT01380093|7411662|FG002|STARTED|Treatment Phase: Second Intervention||0
6493402|NCT01380093|7411663|FG003|STARTED|Treatment Phase: Second Intervention||6
6493403|NCT01380093|7411664|FG004|STARTED|Treatment Phase: Second Intervention||6
6493404|NCT01380093|7411665|FG005|STARTED|Treatment Phase: Second Intervention||6
6493405|NCT01380093|7411666|FG006|STARTED|Treatment Phase: Second Intervention||6
6493406|NCT01380093|7411667|FG007|STARTED|Treatment Phase: Second Intervention||6
6493407|NCT01380093|7411668|FG008|STARTED|Treatment Phase: Second Intervention||6
6493408|NCT01380093|7411660|FG000|COMPLETED|Treatment Phase: Second Intervention||0
6493409|NCT01380093|7411661|FG001|COMPLETED|Treatment Phase: Second Intervention||0
6493410|NCT01380093|7411662|FG002|COMPLETED|Treatment Phase: Second Intervention||0
6493411|NCT01380093|7411663|FG003|COMPLETED|Treatment Phase: Second Intervention||5
6493412|NCT01380093|7411664|FG004|COMPLETED|Treatment Phase: Second Intervention||6
6493413|NCT01380093|7411665|FG005|COMPLETED|Treatment Phase: Second Intervention||6
6493414|NCT01380093|7411666|FG006|COMPLETED|Treatment Phase: Second Intervention||6
6493415|NCT01380093|7411667|FG007|COMPLETED|Treatment Phase: Second Intervention||6
6493416|NCT01380093|7411668|FG008|COMPLETED|Treatment Phase: Second Intervention||6
6493417|NCT01380093|7411660|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
6750014|NCT03426995|7677316|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750015|NCT03426995|7677317|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750016|NCT03426995|7677318|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750017|NCT03426995|7677319|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750018|NCT03426995|7677320|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750019|NCT03426995|7677321|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750020|NCT03426995|7677322|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750021|NCT03426995|7677323|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750022|NCT03426995|7677324|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750023|NCT03426995|7677325|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod2(Upto Day14)||0
6750024|NCT03426995|7677307|FG000|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750025|NCT03426995|7677308|FG001|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750026|NCT03426995|7677309|FG002|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750027|NCT03426995|7677310|FG003|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750028|NCT03426995|7677311|FG004|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750029|NCT03426995|7677312|FG005|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750030|NCT03426995|7677313|FG006|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
6750031|NCT03426995|7677314|FG007|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
6750032|NCT03426995|7677315|FG008|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
6750033|NCT03426995|7677316|FG009|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
6750034|NCT03426995|7677317|FG010|STARTED|Part A: Cohort 2-Period 3 (Day1)||1
6750035|NCT03426995|7677318|FG011|STARTED|Part A: Cohort 2-Period 3 (Day1)||2
6750036|NCT03426995|7677319|FG012|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750037|NCT03426995|7677320|FG013|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750038|NCT03426995|7677321|FG014|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750039|NCT03426995|7677322|FG015|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750040|NCT03426995|7677323|FG016|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750041|NCT03426995|7677324|FG017|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750042|NCT03426995|7677325|FG018|STARTED|Part A: Cohort 2-Period 3 (Day1)||0
6750043|NCT03426995|7677307|FG000|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750044|NCT03426995|7677308|FG001|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750045|NCT03426995|7677309|FG002|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750046|NCT03426995|7677310|FG003|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750047|NCT03426995|7677311|FG004|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750048|NCT03426995|7677312|FG005|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750049|NCT03426995|7677313|FG006|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
6750050|NCT03426995|7677314|FG007|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
6750051|NCT03426995|7677315|FG008|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
6750052|NCT03426995|7677316|FG009|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
6750053|NCT03426995|7677317|FG010|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||1
6750054|NCT03426995|7677318|FG011|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||2
6750055|NCT03426995|7677319|FG012|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750056|NCT03426995|7677320|FG013|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750057|NCT03426995|7677321|FG014|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750058|NCT03426995|7677322|FG015|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750059|NCT03426995|7677323|FG016|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750060|NCT03426995|7677324|FG017|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750061|NCT03426995|7677325|FG018|COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750062|NCT03426995|7677307|FG000|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750063|NCT03426995|7677308|FG001|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750064|NCT03426995|7677309|FG002|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750065|NCT03426995|7677310|FG003|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750066|NCT03426995|7677311|FG004|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750067|NCT03426995|7677312|FG005|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750068|NCT03426995|7677313|FG006|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6493418|NCT01380093|7411661|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
6493419|NCT01380093|7411662|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
6493420|NCT01380093|7411663|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||1
6493421|NCT01380093|7411664|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
6493422|NCT01380093|7411665|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
6493423|NCT01380093|7411666|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
6493424|NCT01380093|7411667|FG007|NOT COMPLETED|Treatment Phase: Second Intervention||0
6493425|NCT01380093|7411668|FG008|NOT COMPLETED|Treatment Phase: Second Intervention||0
6493426|NCT01380093|7411660|FG000|STARTED|Treatment Phase: Washout Period||0
6493427|NCT01380093|7411661|FG001|STARTED|Treatment Phase: Washout Period||0
6493428|NCT01380093|7411662|FG002|STARTED|Treatment Phase: Washout Period||0
6493429|NCT01380093|7411663|FG003|STARTED|Treatment Phase: Washout Period||5
6493430|NCT01380093|7411664|FG004|STARTED|Treatment Phase: Washout Period||6
6493431|NCT01380093|7411665|FG005|STARTED|Treatment Phase: Washout Period||6
6493432|NCT01380093|7411666|FG006|STARTED|Treatment Phase: Washout Period||6
6493433|NCT01380093|7411667|FG007|STARTED|Treatment Phase: Washout Period||6
6493434|NCT01380093|7411668|FG008|STARTED|Treatment Phase: Washout Period||6
6493435|NCT01380093|7411660|FG000|COMPLETED|Treatment Phase: Washout Period||0
6493436|NCT01380093|7411661|FG001|COMPLETED|Treatment Phase: Washout Period||0
6493437|NCT01380093|7411662|FG002|COMPLETED|Treatment Phase: Washout Period||0
6493438|NCT01380093|7411663|FG003|COMPLETED|Treatment Phase: Washout Period||5
6493439|NCT01380093|7411664|FG004|COMPLETED|Treatment Phase: Washout Period||6
6493440|NCT01380093|7411665|FG005|COMPLETED|Treatment Phase: Washout Period||6
6493441|NCT01380093|7411666|FG006|COMPLETED|Treatment Phase: Washout Period||6
6493442|NCT01380093|7411667|FG007|COMPLETED|Treatment Phase: Washout Period||6
6493443|NCT01380093|7411668|FG008|COMPLETED|Treatment Phase: Washout Period||6
6493444|NCT01380093|7411660|FG000|NOT COMPLETED|Treatment Phase: Washout Period||0
6493445|NCT01380093|7411661|FG001|NOT COMPLETED|Treatment Phase: Washout Period||0
6493446|NCT01380093|7411662|FG002|NOT COMPLETED|Treatment Phase: Washout Period||0
6493447|NCT01380093|7411663|FG003|NOT COMPLETED|Treatment Phase: Washout Period||0
6493448|NCT01380093|7411664|FG004|NOT COMPLETED|Treatment Phase: Washout Period||0
6493449|NCT01380093|7411665|FG005|NOT COMPLETED|Treatment Phase: Washout Period||0
6493450|NCT01380093|7411666|FG006|NOT COMPLETED|Treatment Phase: Washout Period||0
6493451|NCT01380093|7411667|FG007|NOT COMPLETED|Treatment Phase: Washout Period||0
6493452|NCT01380093|7411668|FG008|NOT COMPLETED|Treatment Phase: Washout Period||0
6493453|NCT01380093|7411660|FG000|STARTED|Treatment Phase: Third Intervention||0
6493454|NCT01380093|7411661|FG001|STARTED|Treatment Phase: Third Intervention||0
6493455|NCT01380093|7411662|FG002|STARTED|Treatment Phase: Third Intervention||0
6493456|NCT01380093|7411663|FG003|STARTED|Treatment Phase: Third Intervention||5
6493457|NCT01380093|7411664|FG004|STARTED|Treatment Phase: Third Intervention||6
6493458|NCT01380093|7411665|FG005|STARTED|Treatment Phase: Third Intervention||6
6493459|NCT01380093|7411666|FG006|STARTED|Treatment Phase: Third Intervention||6
6493460|NCT01380093|7411667|FG007|STARTED|Treatment Phase: Third Intervention||6
6493461|NCT01380093|7411668|FG008|STARTED|Treatment Phase: Third Intervention||6
6493462|NCT01380093|7411660|FG000|COMPLETED|Treatment Phase: Third Intervention||0
6493463|NCT01380093|7411661|FG001|COMPLETED|Treatment Phase: Third Intervention||0
6493464|NCT01380093|7411662|FG002|COMPLETED|Treatment Phase: Third Intervention||0
6493465|NCT01380093|7411663|FG003|COMPLETED|Treatment Phase: Third Intervention||5
6493466|NCT01380093|7411664|FG004|COMPLETED|Treatment Phase: Third Intervention||6
6493467|NCT01380093|7411665|FG005|COMPLETED|Treatment Phase: Third Intervention||6
6493468|NCT01380093|7411666|FG006|COMPLETED|Treatment Phase: Third Intervention||6
6493469|NCT01380093|7411667|FG007|COMPLETED|Treatment Phase: Third Intervention||6
6493470|NCT01380093|7411668|FG008|COMPLETED|Treatment Phase: Third Intervention||4
6493471|NCT01380093|7411660|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
6493472|NCT01380093|7411661|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
6493473|NCT01380093|7411662|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
6493474|NCT01380093|7411663|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
6493475|NCT01380093|7411664|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
6493476|NCT01380093|7411665|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
6493477|NCT01380093|7411666|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
6493478|NCT01380093|7411667|FG007|NOT COMPLETED|Treatment Phase: Third Intervention||0
6493479|NCT01380093|7411668|FG008|NOT COMPLETED|Treatment Phase: Third Intervention||2
6493480|NCT01380106|7411684|FG000|STARTED|Overall Study||16
6493481|NCT01380106|7411685|FG001|STARTED|Overall Study||17
6493482|NCT01380106|7411684|FG000|COMPLETED|Overall Study||16
6493483|NCT01380106|7411685|FG001|COMPLETED|Overall Study||17
6493484|NCT01380106|7411684|FG000|NOT COMPLETED|Overall Study||0
6493485|NCT01380106|7411685|FG001|NOT COMPLETED|Overall Study||0
6493486|NCT01380145|7411691|FG000|STARTED|Overall Study||13
6493487|NCT01380145|7411691|FG000|COMPLETED|Overall Study||9
6493488|NCT01380145|7411691|FG000|NOT COMPLETED|Overall Study||4
6501832|NCT01431339|7420496|FG000|STARTED|Overall Study||371
6501833|NCT01431339|7420497|FG001|STARTED|Overall Study||368
6501834|NCT01431339|7420496|FG000|Safety Population|Overall Study||368
6501835|NCT01431339|7420497|FG001|Safety Population|Overall Study||367
6501836|NCT01431339|7420496|FG000|COMPLETED|Overall Study||332
6501837|NCT01431339|7420497|FG001|COMPLETED|Overall Study||333
6501838|NCT01431339|7420496|FG000|NOT COMPLETED|Overall Study||39
6501839|NCT01431339|7420497|FG001|NOT COMPLETED|Overall Study||35
6501840|NCT01431391|7420505|FG000|STARTED|Overall Study||34
6493489|NCT01380184|7411697|FG000|STARTED|Part 1 (19 Days)||15
6493490|NCT01380184|7411697|FG000|COMPLETED|Part 1 (19 Days)||14
6493491|NCT01380184|7411697|FG000|NOT COMPLETED|Part 1 (19 Days)||1
6493492|NCT01380184|7411697|FG000|STARTED|Washout Period (≥2 Days)||14
6493493|NCT01380184|7411697|FG000|COMPLETED|Washout Period (≥2 Days)||14
6493494|NCT01380184|7411697|FG000|NOT COMPLETED|Washout Period (≥2 Days)||0
6493495|NCT01380184|7411697|FG000|STARTED|Part 2||14
6493496|NCT01380184|7411697|FG000|COMPLETED|Part 2||0
6493497|NCT01380184|7411697|FG000|NOT COMPLETED|Part 2||14
6493498|NCT01380197|7411703|FG000|STARTED|Overall Study||20
6493499|NCT01380197|7411704|FG001|STARTED|Overall Study||20
6493500|NCT01380197|7411703|FG000|COMPLETED|Overall Study||20
6493501|NCT01380197|7411704|FG001|COMPLETED|Overall Study||20
6493502|NCT01380197|7411703|FG000|NOT COMPLETED|Overall Study||0
6493503|NCT01380197|7411704|FG001|NOT COMPLETED|Overall Study||0
6493504|NCT01380327|7411713|FG000|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
6493505|NCT01380327|7411714|FG001|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
6493506|NCT01380327|7411715|FG002|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
6493507|NCT01380327|7411713|FG000|COMPLETED|Overall Study||27
6493508|NCT01380327|7411714|FG001|COMPLETED|Overall Study||28
6493509|NCT01380327|7411715|FG002|COMPLETED|Overall Study||21
6493510|NCT01380327|7411713|FG000|NOT COMPLETED|Overall Study||3
6493511|NCT01380327|7411714|FG001|NOT COMPLETED|Overall Study||3
6493512|NCT01380327|7411715|FG002|NOT COMPLETED|Overall Study||7
6493513|NCT01380366|7411723|FG000|STARTED|Overall Study||15
6555330|NCT01751178|7477459|FG001|COMPLETED|Overall Study||109
6555331|NCT01751178|7477460|FG002|COMPLETED|Overall Study||105
6555332|NCT01751178|7477458|FG000|NOT COMPLETED|Overall Study||3
6493514|NCT01380366|7411723|FG000|COMPLETED|Overall Study||15
6493515|NCT01380366|7411723|FG000|NOT COMPLETED|Overall Study||0
6493516|NCT01380379|7411728|FG000|STARTED|Overall Study||9
6493517|NCT01380379|7411728|FG000|COMPLETED|Overall Study||8
6493518|NCT01380379|7411728|FG000|NOT COMPLETED|Overall Study||1
6493519|NCT01380535|7411734|FG000|STARTED|Overall Study||29
6493520|NCT01380535|7411735|FG001|STARTED|Overall Study||31
6493521|NCT01380535|7411734|FG000|Baseline Population|Overall Study||29
6493522|NCT01380535|7411735|FG001|Baseline Population|Overall Study||31
6493523|NCT01380535|7411734|FG000|Safety Population|Overall Study||28
6493524|NCT01380535|7411735|FG001|Safety Population|Overall Study||28
6493525|NCT01380535|7411734|FG000|Intent-to-treat Population|Overall Study||29
6493526|NCT01380535|7411735|FG001|Intent-to-treat Population|Overall Study||24
6493527|NCT01380535|7411734|FG000|COMPLETED|Overall Study||22
6493528|NCT01380535|7411735|FG001|COMPLETED|Overall Study||16
6493529|NCT01380535|7411734|FG000|NOT COMPLETED|Overall Study||7
6493530|NCT01380535|7411735|FG001|NOT COMPLETED|Overall Study||15
6493531|NCT01380639|7411743|FG000|STARTED|Overall Study||42
6493532|NCT01380639|7411744|FG001|STARTED|Overall Study||40
6493533|NCT01380639|7411743|FG000|COMPLETED|Overall Study||36
6493534|NCT01380639|7411744|FG001|COMPLETED|Overall Study||36
6493535|NCT01380639|7411743|FG000|NOT COMPLETED|Overall Study||6
6493536|NCT01380639|7411744|FG001|NOT COMPLETED|Overall Study||4
6493537|NCT01380691|7411750|FG000|STARTED|Period 1||7
6493538|NCT01380691|7411751|FG001|STARTED|Period 1||7
6493539|NCT01380691|7411752|FG002|STARTED|Period 1||7
6493540|NCT01380691|7411753|FG003|STARTED|Period 1||7
6493541|NCT01380691|7411750|FG000|COMPLETED|Period 1||7
6493542|NCT01380691|7411751|FG001|COMPLETED|Period 1||7
6493543|NCT01380691|7411752|FG002|COMPLETED|Period 1||7
6493544|NCT01380691|7411753|FG003|COMPLETED|Period 1||7
6493545|NCT01380691|7411750|FG000|NOT COMPLETED|Period 1||0
6555333|NCT01751178|7477459|FG001|NOT COMPLETED|Overall Study||0
6493546|NCT01380691|7411751|FG001|NOT COMPLETED|Period 1||0
6493547|NCT01380691|7411752|FG002|NOT COMPLETED|Period 1||0
6493548|NCT01380691|7411753|FG003|NOT COMPLETED|Period 1||0
6493549|NCT01380691|7411750|FG000|STARTED|Washout (7 Days)||7
6493550|NCT01380691|7411751|FG001|STARTED|Washout (7 Days)||7
6493551|NCT01380691|7411752|FG002|STARTED|Washout (7 Days)||7
6493552|NCT01380691|7411753|FG003|STARTED|Washout (7 Days)||7
6493553|NCT01380691|7411750|FG000|COMPLETED|Washout (7 Days)||7
6493554|NCT01380691|7411751|FG001|COMPLETED|Washout (7 Days)||7
6493555|NCT01380691|7411752|FG002|COMPLETED|Washout (7 Days)||6
6493556|NCT01380691|7411753|FG003|COMPLETED|Washout (7 Days)||6
6493557|NCT01380691|7411750|FG000|NOT COMPLETED|Washout (7 Days)||0
6493558|NCT01380691|7411751|FG001|NOT COMPLETED|Washout (7 Days)||0
6493559|NCT01380691|7411752|FG002|NOT COMPLETED|Washout (7 Days)||1
6493560|NCT01380691|7411753|FG003|NOT COMPLETED|Washout (7 Days)||1
6493561|NCT01380691|7411750|FG000|STARTED|Period 2||7
6493562|NCT01380691|7411751|FG001|STARTED|Period 2||7
6493563|NCT01380691|7411752|FG002|STARTED|Period 2||6
6493564|NCT01380691|7411753|FG003|STARTED|Period 2||6
6493565|NCT01380691|7411750|FG000|COMPLETED|Period 2||7
6493566|NCT01380691|7411751|FG001|COMPLETED|Period 2||7
6493567|NCT01380691|7411752|FG002|COMPLETED|Period 2||6
6493568|NCT01380691|7411753|FG003|COMPLETED|Period 2||6
6493569|NCT01380691|7411750|FG000|NOT COMPLETED|Period 2||0
6493570|NCT01380691|7411751|FG001|NOT COMPLETED|Period 2||0
6493571|NCT01380691|7411752|FG002|NOT COMPLETED|Period 2||0
6493572|NCT01380691|7411753|FG003|NOT COMPLETED|Period 2||0
6493573|NCT01380730|7411772|FG000|STARTED|Overall Study||78
6555334|NCT01751178|7477460|FG002|NOT COMPLETED|Overall Study||2
6493574|NCT01380730|7411773|FG001|STARTED|Overall Study||79
6493575|NCT01380730|7411774|FG002|STARTED|Overall Study||79
6493576|NCT01380730|7411775|FG003|STARTED|Overall Study||79
6493577|NCT01380730|7411776|FG004|STARTED|Overall Study||78
6493578|NCT01380730|7411777|FG005|STARTED|Overall Study||79
6493579|NCT01380730|7411778|FG006|STARTED|Overall Study||79
6493580|NCT01380730|7411779|FG007|STARTED|Overall Study||80
6493581|NCT01380730|7411772|FG000|Received Treatment|Overall Study||78
6493582|NCT01380730|7411773|FG001|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
6493583|NCT01380730|7411774|FG002|Received Treatment|Overall Study||79
6493584|NCT01380730|7411775|FG003|Received Treatment|Overall Study||79
6493585|NCT01380730|7411776|FG004|Received Treatment|Overall Study||78
6493586|NCT01380730|7411777|FG005|Received Treatment|Overall Study||79
6493587|NCT01380730|7411778|FG006|Received Treatment|Overall Study||79
6493588|NCT01380730|7411779|FG007|Received Treatment|Overall Study||80
6493589|NCT01380730|7411772|FG000|COMPLETED|Overall Study||78
6493590|NCT01380730|7411773|FG001|COMPLETED|Overall Study||79
6493591|NCT01380730|7411774|FG002|COMPLETED|Overall Study||79
6493592|NCT01380730|7411775|FG003|COMPLETED|Overall Study||79
6493593|NCT01380730|7411776|FG004|COMPLETED|Overall Study||77
6493594|NCT01380730|7411777|FG005|COMPLETED|Overall Study||79
6493595|NCT01380730|7411778|FG006|COMPLETED|Overall Study||79
6493596|NCT01380730|7411779|FG007|COMPLETED|Overall Study||80
6493597|NCT01380730|7411772|FG000|NOT COMPLETED|Overall Study||0
6493598|NCT01380730|7411773|FG001|NOT COMPLETED|Overall Study||0
6493599|NCT01380730|7411774|FG002|NOT COMPLETED|Overall Study||0
6493600|NCT01380730|7411775|FG003|NOT COMPLETED|Overall Study||0
6493601|NCT01380730|7411776|FG004|NOT COMPLETED|Overall Study||1
6493602|NCT01380730|7411777|FG005|NOT COMPLETED|Overall Study||0
6493603|NCT01380730|7411778|FG006|NOT COMPLETED|Overall Study||0
6493604|NCT01380730|7411779|FG007|NOT COMPLETED|Overall Study||0
6493605|NCT01380743|7411801|FG000|STARTED|Overall Study||6
6493606|NCT01380743|7411802|FG001|STARTED|Overall Study||6
6493607|NCT01380743|7411803|FG002|STARTED|Overall Study||6
6493608|NCT01380743|7411804|FG003|STARTED|Overall Study||7
6493609|NCT01380743|7411801|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6493610|NCT01380743|7411802|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6493611|NCT01380743|7411803|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6493612|NCT01380743|7411804|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
6493613|NCT01380743|7411801|FG000|COMPLETED|Overall Study||6
6493614|NCT01380743|7411802|FG001|COMPLETED|Overall Study||6
6493615|NCT01380743|7411803|FG002|COMPLETED|Overall Study||6
6493616|NCT01380743|7411804|FG003|COMPLETED|Overall Study||7
6493617|NCT01380743|7411801|FG000|NOT COMPLETED|Overall Study||0
6493618|NCT01380743|7411802|FG001|NOT COMPLETED|Overall Study||0
6493619|NCT01380743|7411803|FG002|NOT COMPLETED|Overall Study||0
6493620|NCT01380743|7411804|FG003|NOT COMPLETED|Overall Study||0
6493621|NCT01380769|7411816|FG000|STARTED|Overall Study||100
6493622|NCT01380769|7411817|FG001|STARTED|Overall Study||57
6493623|NCT01380769|7411816|FG000|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
6493624|NCT01380769|7411817|FG001|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
6493625|NCT01380769|7411816|FG000|NOT COMPLETED|Overall Study||9
6493626|NCT01380769|7411817|FG001|NOT COMPLETED|Overall Study||14
6493627|NCT01380782|7411825|FG000|STARTED|Overall Study||12
6493628|NCT01380782|7411826|FG001|STARTED|Overall Study||10
6493629|NCT01380782|7411827|FG002|STARTED|Overall Study||11
6493630|NCT01380782|7411828|FG003|STARTED|Overall Study||4
6493631|NCT01380782|7411825|FG000|COMPLETED|Overall Study||0
6493632|NCT01380782|7411826|FG001|COMPLETED|Overall Study||0
6493633|NCT01380782|7411827|FG002|COMPLETED|Overall Study||0
6493634|NCT01380782|7411828|FG003|COMPLETED|Overall Study||0
6493635|NCT01380782|7411825|FG000|NOT COMPLETED|Overall Study||12
6493636|NCT01380782|7411826|FG001|NOT COMPLETED|Overall Study||10
6493637|NCT01380782|7411827|FG002|NOT COMPLETED|Overall Study||11
6493638|NCT01380782|7411828|FG003|NOT COMPLETED|Overall Study||4
6493639|NCT01380834|7411842|FG000|STARTED|Overall Study||42
6493640|NCT01380834|7411843|FG001|STARTED|Overall Study||42
6493641|NCT01380834|7411842|FG000|COMPLETED|Overall Study||41
6493642|NCT01380834|7411843|FG001|COMPLETED|Overall Study||42
6493643|NCT01380834|7411842|FG000|NOT COMPLETED|Overall Study||1
6493644|NCT01380834|7411843|FG001|NOT COMPLETED|Overall Study||0
6493645|NCT01380899|7411852|FG000|STARTED|Overall Study||34
6493646|NCT01380899|7411853|FG001|STARTED|Overall Study||33
6493647|NCT01380899|7411854|FG002|STARTED|Overall Study||20
6493648|NCT01380899|7411852|FG000|COMPLETED|Overall Study||34
6493649|NCT01380899|7411853|FG001|COMPLETED|Overall Study||33
6493650|NCT01380899|7411854|FG002|COMPLETED|Overall Study||20
6493651|NCT01380899|7411852|FG000|NOT COMPLETED|Overall Study||0
6493652|NCT01380899|7411853|FG001|NOT COMPLETED|Overall Study||0
6493653|NCT01380899|7411854|FG002|NOT COMPLETED|Overall Study||0
6493654|NCT01380990|7411864|FG000|STARTED|Overall Study||20
6493655|NCT01380990|7411865|FG001|STARTED|Overall Study||16
6493656|NCT01380990|7411864|FG000|COMPLETED|Overall Study||19
6493657|NCT01380990|7411865|FG001|COMPLETED|Overall Study||15
6493658|NCT01380990|7411864|FG000|NOT COMPLETED|Overall Study||1
6493659|NCT01380990|7411865|FG001|NOT COMPLETED|Overall Study||1
6493660|NCT01381016|7411877|FG000|STARTED|Overall Study||13
6493661|NCT01381016|7411878|FG001|STARTED|Overall Study||17
6493662|NCT01381016|7411877|FG000|COMPLETED|Overall Study||10
6493663|NCT01381016|7411878|FG001|COMPLETED|Overall Study||11
6493664|NCT01381016|7411877|FG000|NOT COMPLETED|Overall Study||3
6493665|NCT01381016|7411878|FG001|NOT COMPLETED|Overall Study||6
6493666|NCT01381068|7411888|FG000|STARTED|Overall Study||25
6493667|NCT01381068|7411889|FG001|STARTED|Overall Study||24
6493668|NCT01381068|7411888|FG000|COMPLETED|Overall Study||24
6493669|NCT01381068|7411889|FG001|COMPLETED|Overall Study||24
6493670|NCT01381068|7411888|FG000|NOT COMPLETED|Overall Study||1
6493671|NCT01381068|7411889|FG001|NOT COMPLETED|Overall Study||0
6493672|NCT01381120|7411897|FG000|STARTED|Overall Study||50
6493673|NCT01381120|7411898|FG001|STARTED|Overall Study||27
6493674|NCT01381120|7411897|FG000|COMPLETED|Overall Study||39
6493675|NCT01381120|7411898|FG001|COMPLETED|Overall Study||18
6493676|NCT01381120|7411897|FG000|NOT COMPLETED|Overall Study||11
6493677|NCT01381120|7411898|FG001|NOT COMPLETED|Overall Study||9
6493678|NCT01381172|7411906|FG000|STARTED|Overall Study||74
6493679|NCT01381172|7411907|FG001|STARTED|Overall Study||86
6493680|NCT01381172|7411906|FG000|COMPLETED|Overall Study||64
6493681|NCT01381172|7411907|FG001|COMPLETED|Overall Study||73
6493682|NCT01381172|7411906|FG000|NOT COMPLETED|Overall Study||10
6493683|NCT01381172|7411907|FG001|NOT COMPLETED|Overall Study||13
6493684|NCT01381406|7411915|FG000|STARTED|Overall Study||2481
6493685|NCT01381406|7411916|FG001|STARTED|Overall Study||852
6493686|NCT01381406|7411915|FG000|COMPLETED|Overall Study||2481
6493687|NCT01381406|7411916|FG001|COMPLETED|Overall Study||852
6493688|NCT01381406|7411915|FG000|NOT COMPLETED|Overall Study||0
6493689|NCT01381406|7411916|FG001|NOT COMPLETED|Overall Study||0
6493690|NCT01381471|7411922|FG000|STARTED|Overall Study||11060
6493691|NCT01381471|7411922|FG000|COMPLETED|Overall Study||11060
6493692|NCT01381471|7411922|FG000|NOT COMPLETED|Overall Study||0
6493693|NCT01381549|7411929|FG000|STARTED|Overall Study||6
6493694|NCT01381549|7411930|FG001|STARTED|Overall Study||8
6493695|NCT01381549|7411931|FG002|STARTED|Overall Study||6
6493696|NCT01381549|7411929|FG000|COMPLETED|Overall Study||6
6493697|NCT01381549|7411930|FG001|COMPLETED|Overall Study||8
6493698|NCT01381549|7411931|FG002|COMPLETED|Overall Study||5
6493699|NCT01381549|7411929|FG000|NOT COMPLETED|Overall Study||0
6493700|NCT01381549|7411930|FG001|NOT COMPLETED|Overall Study||0
6493701|NCT01381549|7411931|FG002|NOT COMPLETED|Overall Study||1
6493702|NCT01381562|7411943|FG000|STARTED|Overall Study||5
6493703|NCT01381562|7411944|FG001|STARTED|Overall Study||4
6493704|NCT01381562|7411945|FG002|STARTED|Overall Study||5
6493705|NCT01381562|7411943|FG000|COMPLETED|Overall Study||5
6493706|NCT01381562|7411944|FG001|COMPLETED|Overall Study||3
6493707|NCT01381562|7411945|FG002|COMPLETED|Overall Study||5
6493708|NCT01381562|7411943|FG000|NOT COMPLETED|Overall Study||0
6493709|NCT01381562|7411944|FG001|NOT COMPLETED|Overall Study||1
6493710|NCT01381562|7411945|FG002|NOT COMPLETED|Overall Study||0
6493711|NCT01381575|7411956|FG000|STARTED|Overall Study||550
6493712|NCT01381575|7411957|FG001|STARTED|Overall Study||482
6493713|NCT01381575|7411958|FG002|STARTED|Overall Study||415
6493714|NCT01381575|7411956|FG000|COMPLETED|Overall Study||524
6493715|NCT01381575|7411957|FG001|COMPLETED|Overall Study||443
6493716|NCT01381575|7411958|FG002|COMPLETED|Overall Study||395
6493717|NCT01381575|7411956|FG000|NOT COMPLETED|Overall Study||26
6493718|NCT01381575|7411957|FG001|NOT COMPLETED|Overall Study||39
6493719|NCT01381575|7411958|FG002|NOT COMPLETED|Overall Study||20
6493720|NCT01381692|7411969|FG000|STARTED|Overall Study||7
6493721|NCT01381692|7411970|FG001|STARTED|Overall Study||2
6493722|NCT01381692|7411971|FG002|STARTED|Overall Study||0
6493723|NCT01381692|7411972|FG003|STARTED|Overall Study||0
6493724|NCT01381692|7411973|FG004|STARTED|Overall Study||0
6493725|NCT01381692|7411974|FG005|STARTED|Overall Study||0
6493726|NCT01381692|7411969|FG000|COMPLETED|Overall Study||6
6493727|NCT01381692|7411970|FG001|COMPLETED|Overall Study||2
6493728|NCT01381692|7411971|FG002|COMPLETED|Overall Study||0
6493729|NCT01381692|7411972|FG003|COMPLETED|Overall Study||0
6493730|NCT01381692|7411973|FG004|COMPLETED|Overall Study||0
6493731|NCT01381692|7411974|FG005|COMPLETED|Overall Study||0
6493732|NCT01381692|7411969|FG000|NOT COMPLETED|Overall Study||1
6493733|NCT01381692|7411970|FG001|NOT COMPLETED|Overall Study||0
6493734|NCT01381692|7411971|FG002|NOT COMPLETED|Overall Study||0
6493735|NCT01381692|7411972|FG003|NOT COMPLETED|Overall Study||0
6493736|NCT01381692|7411973|FG004|NOT COMPLETED|Overall Study||0
6493737|NCT01381692|7411974|FG005|NOT COMPLETED|Overall Study||0
6493738|NCT01381718|7411984|FG000|STARTED|Overall Study||56
6493739|NCT01381718|7411985|FG001|STARTED|Overall Study||56
6493740|NCT01381718|7411984|FG000|COMPLETED|Overall Study||51
6493741|NCT01381718|7411985|FG001|COMPLETED|Overall Study||43
6493742|NCT01381718|7411984|FG000|NOT COMPLETED|Overall Study||5
6493743|NCT01381718|7411985|FG001|NOT COMPLETED|Overall Study||13
6493744|NCT01381861|7411991|FG000|STARTED|Overall Study||23
6493745|NCT01381861|7411991|FG000|COMPLETED|Overall Study||23
6493746|NCT01381861|7411991|FG000|NOT COMPLETED|Overall Study||0
6493747|NCT01381874|7411998|FG000|STARTED|Overall Study||102
6493748|NCT01381874|7411999|FG001|STARTED|Overall Study||89
6493749|NCT01381874|7412000|FG002|STARTED|Overall Study||106
6493750|NCT01381874|7411998|FG000|Treated|Overall Study||102
6493751|NCT01381874|7411999|FG001|Treated|Overall Study||87
6493752|NCT01381874|7412000|FG002|Treated|Overall Study||104
6493753|NCT01381874|7411998|FG000|COMPLETED|Overall Study||25
6493754|NCT01381874|7411999|FG001|COMPLETED|Overall Study||26
6493755|NCT01381874|7412000|FG002|COMPLETED|Overall Study||30
6493756|NCT01381874|7411998|FG000|NOT COMPLETED|Overall Study||77
6493757|NCT01381874|7411999|FG001|NOT COMPLETED|Overall Study||63
6493758|NCT01381874|7412000|FG002|NOT COMPLETED|Overall Study||76
6493759|NCT01381900|7412011|FG000|STARTED|Overall Study||226
6493760|NCT01381900|7412012|FG001|STARTED|Overall Study||223
6493761|NCT01381900|7412013|FG002|STARTED|Overall Study||227
6493762|NCT01381900|7412011|FG000|COMPLETED|Overall Study||217
6493763|NCT01381900|7412012|FG001|COMPLETED|Overall Study||214
6493764|NCT01381900|7412013|FG002|COMPLETED|Overall Study||215
6493765|NCT01381900|7412011|FG000|NOT COMPLETED|Overall Study||9
6493766|NCT01381900|7412012|FG001|NOT COMPLETED|Overall Study||9
6493767|NCT01381900|7412013|FG002|NOT COMPLETED|Overall Study||12
6493768|NCT01381926|7412023|FG000|STARTED|Low/High Dose of 1st Treatment (2months)||5
6493769|NCT01381926|7412024|FG001|STARTED|Low/High Dose of 1st Treatment (2months)||5
6493770|NCT01381926|7412023|FG000|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
6493771|NCT01381926|7412024|FG001|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
6493772|NCT01381926|7412023|FG000|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
6493773|NCT01381926|7412024|FG001|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
6493774|NCT01381926|7412023|FG000|STARTED|Low/High Dose of 2nd Treatment (2months)||3
6493775|NCT01381926|7412024|FG001|STARTED|Low/High Dose of 2nd Treatment (2months)||4
6493776|NCT01381926|7412023|FG000|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
6493777|NCT01381926|7412024|FG001|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
6493778|NCT01381926|7412023|FG000|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
6493779|NCT01381926|7412024|FG001|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
6493780|NCT01381952|7412032|FG000|STARTED|Overall Study||20
6493781|NCT01381952|7412032|FG000|Collected Dose and Image Information|Overall Study||20
6493782|NCT01381952|7412032|FG000|COMPLETED|Overall Study||20
6493783|NCT01381952|7412032|FG000|NOT COMPLETED|Overall Study||0
6493784|NCT01382108|7412040|FG000|STARTED|Overall Study||20
6493785|NCT01382108|7412041|FG001|STARTED|Overall Study||19
6493786|NCT01382108|7412040|FG000|COMPLETED|Overall Study||20
6493787|NCT01382108|7412041|FG001|COMPLETED|Overall Study||19
6493788|NCT01382108|7412040|FG000|NOT COMPLETED|Overall Study||0
6493789|NCT01382108|7412041|FG001|NOT COMPLETED|Overall Study||0
6493790|NCT01382186|7412050|FG000|STARTED|Overall Study||33
6493791|NCT01382186|7412051|FG001|STARTED|Overall Study||819
6493792|NCT01382186|7412050|FG000|COMPLETED|Overall Study||32
6493793|NCT01382186|7412051|FG001|COMPLETED|Overall Study||819
6493794|NCT01382186|7412050|FG000|NOT COMPLETED|Overall Study||1
6493795|NCT01382186|7412051|FG001|NOT COMPLETED|Overall Study||0
6493796|NCT01382212|7412060|FG000|STARTED|Overall Study||13
6493797|NCT01382212|7412060|FG000|COMPLETED|Overall Study||11
6493798|NCT01382212|7412060|FG000|NOT COMPLETED|Overall Study||2
6493799|NCT01382225|7412066|FG000|STARTED|Overall Study||725
6493800|NCT01382225|7412067|FG001|STARTED|Overall Study||729
6493801|NCT01382225|7412066|FG000|COMPLETED|Overall Study||711
6493802|NCT01382225|7412067|FG001|COMPLETED|Overall Study||722
6493803|NCT01382225|7412066|FG000|NOT COMPLETED|Overall Study||14
6493804|NCT01382225|7412067|FG001|NOT COMPLETED|Overall Study||7
6493805|NCT01382251|7412075|FG000|STARTED|Overall Study||123
6493806|NCT01382251|7412076|FG001|STARTED|Overall Study||123
6493807|NCT01382251|7412075|FG000|COMPLETED|Overall Study||102
6493808|NCT01382251|7412076|FG001|COMPLETED|Overall Study||102
6493809|NCT01382251|7412075|FG000|NOT COMPLETED|Overall Study||21
6750069|NCT03426995|7677314|FG007|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750070|NCT03426995|7677315|FG008|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750071|NCT03426995|7677316|FG009|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750072|NCT03426995|7677317|FG010|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750073|NCT03426995|7677318|FG011|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750074|NCT03426995|7677319|FG012|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750075|NCT03426995|7677320|FG013|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750076|NCT03426995|7677321|FG014|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750077|NCT03426995|7677322|FG015|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750078|NCT03426995|7677323|FG016|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750079|NCT03426995|7677324|FG017|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750080|NCT03426995|7677325|FG018|NOT COMPLETED|Part A: Cohort 2-Period 3 (Day1)||0
6750081|NCT03426995|7677307|FG000|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750082|NCT03426995|7677308|FG001|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750083|NCT03426995|7677309|FG002|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750084|NCT03426995|7677310|FG003|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750085|NCT03426995|7677311|FG004|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750086|NCT03426995|7677312|FG005|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750087|NCT03426995|7677313|FG006|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
6750088|NCT03426995|7677314|FG007|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
6750089|NCT03426995|7677315|FG008|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
6750090|NCT03426995|7677316|FG009|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
6750091|NCT03426995|7677317|FG010|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
6750092|NCT03426995|7677318|FG011|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
6750093|NCT03426995|7677319|FG012|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750094|NCT03426995|7677320|FG013|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6493810|NCT01382251|7412076|FG001|NOT COMPLETED|Overall Study||21
6493811|NCT01382303|7412083|FG000|STARTED|Overall Study||87
6493812|NCT01382303|7412084|FG001|STARTED|Overall Study||87
6493813|NCT01382303|7412083|FG000|COMPLETED|Overall Study||52
6493814|NCT01382303|7412084|FG001|COMPLETED|Overall Study||70
6493815|NCT01382303|7412083|FG000|NOT COMPLETED|Overall Study||35
6493816|NCT01382303|7412084|FG001|NOT COMPLETED|Overall Study||17
6493817|NCT01382446|7412092|FG000|STARTED|Overall Study||33
6493818|NCT01382446|7412093|FG001|STARTED|Overall Study||33
6493819|NCT01382446|7412092|FG000|COMPLETED|Overall Study||30
6493820|NCT01382446|7412093|FG001|COMPLETED|Overall Study||29
6493821|NCT01382446|7412092|FG000|NOT COMPLETED|Overall Study||3
6493822|NCT01382446|7412093|FG001|NOT COMPLETED|Overall Study||4
6493823|NCT01382602|7412101|FG000|STARTED|Overall Study||93
6493824|NCT01382602|7412102|FG001|STARTED|Overall Study||50
6493825|NCT01382602|7412101|FG000|COMPLETED|Overall Study||93
6493826|NCT01382602|7412102|FG001|COMPLETED|Overall Study||46
6493827|NCT01382602|7412101|FG000|NOT COMPLETED|Overall Study||0
6493828|NCT01382602|7412102|FG001|NOT COMPLETED|Overall Study||4
6493829|NCT01382719|7412112|FG000|STARTED|Overall Study||98
6493830|NCT01382719|7412113|FG001|STARTED|Overall Study||100
6493831|NCT01382719|7412114|FG002|STARTED|Overall Study||100
6493832|NCT01382719|7412115|FG003|STARTED|Overall Study||99
6493833|NCT01382719|7412112|FG000|Subjects Not Dosed|Overall Study||1
6493834|NCT01382719|7412113|FG001|Subjects Not Dosed|Overall Study||0
6493835|NCT01382719|7412114|FG002|Subjects Not Dosed|Overall Study||1
6493836|NCT01382719|7412115|FG003|Subjects Not Dosed|Overall Study||1
6493837|NCT01382719|7412112|FG000|COMPLETED|Overall Study||80
6493838|NCT01382719|7412113|FG001|COMPLETED|Overall Study||81
6493839|NCT01382719|7412114|FG002|COMPLETED|Overall Study||66
6493840|NCT01382719|7412115|FG003|COMPLETED|Overall Study||66
6493841|NCT01382719|7412112|FG000|NOT COMPLETED|Overall Study||18
6493842|NCT01382719|7412113|FG001|NOT COMPLETED|Overall Study||19
6493843|NCT01382719|7412114|FG002|NOT COMPLETED|Overall Study||34
6493844|NCT01382719|7412115|FG003|NOT COMPLETED|Overall Study||33
6493845|NCT01382901|7412127|FG000|STARTED|Overall Study||24
6493846|NCT01382901|7412128|FG001|STARTED|Overall Study||21
6493847|NCT01382901|7412127|FG000|COMPLETED|Overall Study||7
6493848|NCT01382901|7412128|FG001|COMPLETED|Overall Study||7
6493849|NCT01382901|7412127|FG000|NOT COMPLETED|Overall Study||17
6493850|NCT01382901|7412128|FG001|NOT COMPLETED|Overall Study||14
6493851|NCT01382940|7412134|FG000|STARTED|Overall Study||351
6493852|NCT01382940|7412134|FG000|Received Day 1 Infusion|Overall Study||351
6493853|NCT01382940|7412134|FG000|Received Day 15 Infusions|Overall Study||341
6493854|NCT01382940|7412134|FG000|Received Day 168 Infusion|Overall Study||290
6493855|NCT01382940|7412134|FG000|Received Day 182 Infusion|Overall Study||278
6493856|NCT01382940|7412134|FG000|COMPLETED|Overall Study||278
6493857|NCT01382940|7412134|FG000|NOT COMPLETED|Overall Study||73
6493858|NCT01383005|7412140|FG000|STARTED|Overall Study||34
6493859|NCT01383005|7412141|FG001|STARTED|Overall Study||60
6493860|NCT01383005|7412140|FG000|COMPLETED|Overall Study||34
6493861|NCT01383005|7412141|FG001|COMPLETED|Overall Study||60
6493862|NCT01383005|7412140|FG000|NOT COMPLETED|Overall Study||0
6493863|NCT01383005|7412141|FG001|NOT COMPLETED|Overall Study||0
6493864|NCT01383018|7412147|FG000|STARTED|Overall Study||1457
6493865|NCT01383018|7412147|FG000|COMPLETED|Overall Study||1082
6493866|NCT01383018|7412147|FG000|NOT COMPLETED|Overall Study||375
6493867|NCT01383096|7412164|FG000|STARTED|First Intervention (8 Days)||19
6493868|NCT01383096|7412165|FG001|STARTED|First Intervention (8 Days)||17
6493869|NCT01383096|7412166|FG002|STARTED|First Intervention (8 Days)||16
6493870|NCT01383096|7412164|FG000|COMPLETED|First Intervention (8 Days)||19
6493871|NCT01383096|7412165|FG001|COMPLETED|First Intervention (8 Days)||17
6493872|NCT01383096|7412166|FG002|COMPLETED|First Intervention (8 Days)||16
6493873|NCT01383096|7412164|FG000|NOT COMPLETED|First Intervention (8 Days)||0
6493874|NCT01383096|7412165|FG001|NOT COMPLETED|First Intervention (8 Days)||0
6493875|NCT01383096|7412166|FG002|NOT COMPLETED|First Intervention (8 Days)||0
6493876|NCT01383096|7412164|FG000|STARTED|Second Intervention (8 Days)||19
6493877|NCT01383096|7412165|FG001|STARTED|Second Intervention (8 Days)||17
6493878|NCT01383096|7412166|FG002|STARTED|Second Intervention (8 Days)||16
6493879|NCT01383096|7412164|FG000|COMPLETED|Second Intervention (8 Days)||19
6493880|NCT01383096|7412165|FG001|COMPLETED|Second Intervention (8 Days)||16
6493881|NCT01383096|7412166|FG002|COMPLETED|Second Intervention (8 Days)||14
6493882|NCT01383096|7412164|FG000|NOT COMPLETED|Second Intervention (8 Days)||0
6493883|NCT01383096|7412165|FG001|NOT COMPLETED|Second Intervention (8 Days)||1
6493884|NCT01383096|7412166|FG002|NOT COMPLETED|Second Intervention (8 Days)||2
6493885|NCT01383096|7412164|FG000|STARTED|Third Intervention (8 Days)||19
6493886|NCT01383096|7412165|FG001|STARTED|Third Intervention (8 Days)||16
6493887|NCT01383096|7412166|FG002|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6493888|NCT01383096|7412164|FG000|COMPLETED|Third Intervention (8 Days)||15
6493889|NCT01383096|7412165|FG001|COMPLETED|Third Intervention (8 Days)||12
6493890|NCT01383096|7412166|FG002|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6493891|NCT01383096|7412164|FG000|NOT COMPLETED|Third Intervention (8 Days)||4
6493892|NCT01383096|7412165|FG001|NOT COMPLETED|Third Intervention (8 Days)||4
6493893|NCT01383096|7412166|FG002|NOT COMPLETED|Third Intervention (8 Days)||0
6493894|NCT01383096|7412164|FG000|STARTED|Fourth Intervention (8 Days)||15
6493895|NCT01383096|7412165|FG001|STARTED|Fourth Intervention (8 Days)||12
6493896|NCT01383096|7412166|FG002|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6493897|NCT01383096|7412164|FG000|COMPLETED|Fourth Intervention (8 Days)||13
6555335|NCT01751230|7477474|FG000|STARTED|Overall Study||20
6555336|NCT01751230|7477475|FG001|STARTED|Overall Study||20
6555337|NCT01751230|7477474|FG000|COMPLETED|Overall Study||19
6555338|NCT01751230|7477475|FG001|COMPLETED|Overall Study||16
6555339|NCT01751230|7477474|FG000|NOT COMPLETED|Overall Study||1
6555340|NCT01751230|7477475|FG001|NOT COMPLETED|Overall Study||4
6555341|NCT01751308|7477490|FG000|STARTED|Phase 1||6
6555342|NCT01751308|7477491|FG001|STARTED|Phase 1||3
6555343|NCT01751308|7477492|FG002|STARTED|Phase 1||7
6493898|NCT01383096|7412165|FG001|COMPLETED|Fourth Intervention (8 Days)||12
6493899|NCT01383096|7412166|FG002|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6493900|NCT01383096|7412164|FG000|NOT COMPLETED|Fourth Intervention (8 Days)||2
6493901|NCT01383096|7412165|FG001|NOT COMPLETED|Fourth Intervention (8 Days)||0
6493902|NCT01383096|7412166|FG002|NOT COMPLETED|Fourth Intervention (8 Days)||0
6493903|NCT01383096|7412164|FG000|STARTED|Fifth Intervention (8 Days)||13
6493904|NCT01383096|7412165|FG001|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
6493905|NCT01383096|7412166|FG002|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6493906|NCT01383096|7412164|FG000|COMPLETED|Fifth Intervention (8 Days)||11
6750095|NCT03426995|7677321|FG014|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750096|NCT03426995|7677322|FG015|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750097|NCT03426995|7677323|FG016|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750098|NCT03426995|7677324|FG017|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750099|NCT03426995|7677325|FG018|STARTED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750100|NCT03426995|7677307|FG000|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750101|NCT03426995|7677308|FG001|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6493907|NCT01383096|7412165|FG001|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
6493908|NCT01383096|7412166|FG002|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
6493909|NCT01383096|7412164|FG000|NOT COMPLETED|Fifth Intervention (8 Days)||2
6493910|NCT01383096|7412165|FG001|NOT COMPLETED|Fifth Intervention (8 Days)||0
6493911|NCT01383096|7412166|FG002|NOT COMPLETED|Fifth Intervention (8 Days)||0
6493912|NCT01383161|7412205|FG000|STARTED|Overall Study||25
6493913|NCT01383161|7412206|FG001|STARTED|Overall Study||21
6493914|NCT01383161|7412205|FG000|COMPLETED|Overall Study||20
6493915|NCT01383161|7412206|FG001|COMPLETED|Overall Study||17
6493916|NCT01383161|7412205|FG000|NOT COMPLETED|Overall Study||5
6493917|NCT01383161|7412206|FG001|NOT COMPLETED|Overall Study||4
6493918|NCT01383174|7412214|FG000|STARTED|Baseline Assessment||76
6493919|NCT01383174|7412215|FG001|STARTED|Baseline Assessment||75
6493920|NCT01383174|7412214|FG000|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
6493921|NCT01383174|7412215|FG001|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
6493922|NCT01383174|7412214|FG000|NOT COMPLETED|Baseline Assessment||0
6493923|NCT01383174|7412215|FG001|NOT COMPLETED|Baseline Assessment||0
6493924|NCT01383174|7412214|FG000|STARTED|3 Month Assessment||76
6493925|NCT01383174|7412215|FG001|STARTED|3 Month Assessment||75
6493926|NCT01383174|7412214|FG000|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
6493927|NCT01383174|7412215|FG001|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
6493928|NCT01383174|7412214|FG000|NOT COMPLETED|3 Month Assessment||6
6493929|NCT01383174|7412215|FG001|NOT COMPLETED|3 Month Assessment||1
6493930|NCT01383174|7412214|FG000|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
6493931|NCT01383174|7412215|FG001|STARTED|6 Month Assessment||74
6493932|NCT01383174|7412214|FG000|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
6493933|NCT01383174|7412215|FG001|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
6493934|NCT01383174|7412214|FG000|NOT COMPLETED|6 Month Assessment||5
6493935|NCT01383174|7412215|FG001|NOT COMPLETED|6 Month Assessment||1
6493936|NCT01383200|7412223|FG000|STARTED|Overall Study||5
6493937|NCT01383200|7412224|FG001|STARTED|Overall Study||6
6493938|NCT01383200|7412223|FG000|COMPLETED|Overall Study||5
6493939|NCT01383200|7412224|FG001|COMPLETED|Overall Study||6
6493940|NCT01383200|7412223|FG000|NOT COMPLETED|Overall Study||0
6493941|NCT01383200|7412224|FG001|NOT COMPLETED|Overall Study||0
6493942|NCT01383213|7412232|FG000|STARTED|Overall Study||40
6493943|NCT01383213|7412233|FG001|STARTED|Overall Study||41
6493944|NCT01383213|7412232|FG000|COMPLETED|Overall Study||40
6493945|NCT01383213|7412233|FG001|COMPLETED|Overall Study||41
6493946|NCT01383213|7412232|FG000|NOT COMPLETED|Overall Study||0
6493947|NCT01383213|7412233|FG001|NOT COMPLETED|Overall Study||0
6555344|NCT01751308|7477493|FG003|STARTED|Phase 1||7
6555345|NCT01751308|7477494|FG004|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
6555346|NCT01751308|7477490|FG000|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
6493948|NCT01383317|7412241|FG000|STARTED|Overall Study||29
6493949|NCT01383317|7412242|FG001|STARTED|Overall Study||35
6493950|NCT01383317|7412241|FG000|COMPLETED|Overall Study||26
6493951|NCT01383317|7412242|FG001|COMPLETED|Overall Study||33
6493952|NCT01383317|7412241|FG000|NOT COMPLETED|Overall Study||3
6493953|NCT01383317|7412242|FG001|NOT COMPLETED|Overall Study||2
6493954|NCT01383356|7412248|FG000|STARTED|Period 1|Entered and treated.|29
6493955|NCT01383356|7412249|FG001|STARTED|Period 1|Entered and treated.|29
6493956|NCT01383356|7412248|FG000|COMPLETED|Period 1|Completed period 1.|21
6562913|NCT01803464|7485828|FG002|COMPLETED|Overall Study||6
6493957|NCT01383356|7412249|FG001|COMPLETED|Period 1|Completed period 1.|23
6493958|NCT01383356|7412248|FG000|NOT COMPLETED|Period 1||8
6493959|NCT01383356|7412249|FG001|NOT COMPLETED|Period 1||6
6493960|NCT01383356|7412248|FG000|STARTED|Washout Period (at Least 35 Days)||21
6493961|NCT01383356|7412249|FG001|STARTED|Washout Period (at Least 35 Days)||23
6493962|NCT01383356|7412248|FG000|COMPLETED|Washout Period (at Least 35 Days)||21
6493963|NCT01383356|7412249|FG001|COMPLETED|Washout Period (at Least 35 Days)||23
6493964|NCT01383356|7412248|FG000|NOT COMPLETED|Washout Period (at Least 35 Days)||0
6493965|NCT01383356|7412249|FG001|NOT COMPLETED|Washout Period (at Least 35 Days)||0
6493966|NCT01383356|7412248|FG000|STARTED|Period 2|Entered and treated.|21
6493967|NCT01383356|7412249|FG001|STARTED|Period 2|Entered and treated.|23
6493968|NCT01383356|7412248|FG000|COMPLETED|Period 2|Completed period 2.|21
6493969|NCT01383356|7412249|FG001|COMPLETED|Period 2|Completed period 2.|23
6493970|NCT01383356|7412248|FG000|NOT COMPLETED|Period 2||0
6493971|NCT01383356|7412249|FG001|NOT COMPLETED|Period 2||0
6493972|NCT01383421|7412255|FG000|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
6493973|NCT01383421|7412255|FG000|COMPLETED|Overall Study||679
6493974|NCT01383421|7412255|FG000|NOT COMPLETED|Overall Study||346
6493975|NCT01383486|7412263|FG000|STARTED|Overall Study|Number of participants who were provided with investigational products|253
6493976|NCT01383486|7412263|FG000|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
6493977|NCT01383486|7412263|FG000|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
6493978|NCT01383486|7412263|FG000|NOT COMPLETED|Overall Study||18
6493979|NCT01383499|7412268|FG000|STARTED|Period 1 (4 Weeks)||27
6493980|NCT01383499|7412269|FG001|STARTED|Period 1 (4 Weeks)||24
6493981|NCT01383499|7412270|FG002|STARTED|Period 1 (4 Weeks)||25
6493982|NCT01383499|7412271|FG003|STARTED|Period 1 (4 Weeks)||25
6493983|NCT01383499|7412268|FG000|COMPLETED|Period 1 (4 Weeks)||26
6493984|NCT01383499|7412269|FG001|COMPLETED|Period 1 (4 Weeks)||24
6493985|NCT01383499|7412270|FG002|COMPLETED|Period 1 (4 Weeks)||25
6493986|NCT01383499|7412271|FG003|COMPLETED|Period 1 (4 Weeks)||25
6493987|NCT01383499|7412268|FG000|NOT COMPLETED|Period 1 (4 Weeks)||1
6493988|NCT01383499|7412269|FG001|NOT COMPLETED|Period 1 (4 Weeks)||0
6493989|NCT01383499|7412270|FG002|NOT COMPLETED|Period 1 (4 Weeks)||0
6493990|NCT01383499|7412271|FG003|NOT COMPLETED|Period 1 (4 Weeks)||0
6493991|NCT01383499|7412268|FG000|STARTED|Period 2 (4 Weeks)||26
6493992|NCT01383499|7412269|FG001|STARTED|Period 2 (4 Weeks)||24
6493993|NCT01383499|7412270|FG002|STARTED|Period 2 (4 Weeks)||25
6493994|NCT01383499|7412271|FG003|STARTED|Period 2 (4 Weeks)||25
6493995|NCT01383499|7412268|FG000|COMPLETED|Period 2 (4 Weeks)||26
6493996|NCT01383499|7412269|FG001|COMPLETED|Period 2 (4 Weeks)||24
6493997|NCT01383499|7412270|FG002|COMPLETED|Period 2 (4 Weeks)||25
6493998|NCT01383499|7412271|FG003|COMPLETED|Period 2 (4 Weeks)||25
6493999|NCT01383499|7412268|FG000|NOT COMPLETED|Period 2 (4 Weeks)||0
6494000|NCT01383499|7412269|FG001|NOT COMPLETED|Period 2 (4 Weeks)||0
6494001|NCT01383499|7412270|FG002|NOT COMPLETED|Period 2 (4 Weeks)||0
6494002|NCT01383499|7412271|FG003|NOT COMPLETED|Period 2 (4 Weeks)||0
6494003|NCT01383499|7412268|FG000|STARTED|Period 3 (4 Weeks)||26
6494004|NCT01383499|7412269|FG001|STARTED|Period 3 (4 Weeks)||24
6494005|NCT01383499|7412270|FG002|STARTED|Period 3 (4 Weeks)||25
6494006|NCT01383499|7412271|FG003|STARTED|Period 3 (4 Weeks)||25
6494007|NCT01383499|7412268|FG000|COMPLETED|Period 3 (4 Weeks)||26
6494008|NCT01383499|7412269|FG001|COMPLETED|Period 3 (4 Weeks)||24
6494009|NCT01383499|7412270|FG002|COMPLETED|Period 3 (4 Weeks)||25
6494010|NCT01383499|7412271|FG003|COMPLETED|Period 3 (4 Weeks)||25
6494011|NCT01383499|7412268|FG000|NOT COMPLETED|Period 3 (4 Weeks)||0
6494012|NCT01383499|7412269|FG001|NOT COMPLETED|Period 3 (4 Weeks)||0
6494013|NCT01383499|7412270|FG002|NOT COMPLETED|Period 3 (4 Weeks)||0
6494014|NCT01383499|7412271|FG003|NOT COMPLETED|Period 3 (4 Weeks)||0
6494015|NCT01383616|7412286|FG000|STARTED|Overall Study||40
6494016|NCT01383616|7412287|FG001|STARTED|Overall Study||44
6494017|NCT01383616|7412286|FG000|COMPLETED|Overall Study||23
6494018|NCT01383616|7412287|FG001|COMPLETED|Overall Study||21
6494019|NCT01383616|7412286|FG000|NOT COMPLETED|Overall Study||17
6494020|NCT01383616|7412287|FG001|NOT COMPLETED|Overall Study||23
6494021|NCT01383707|7412297|FG000|STARTED|Overall Study||77
6494022|NCT01383707|7412297|FG000|COMPLETED|Overall Study||5
6494023|NCT01383707|7412297|FG000|NOT COMPLETED|Overall Study||72
6494024|NCT01383720|7412301|FG000|STARTED|Overall Study||11
6494025|NCT01383720|7412301|FG000|Primary Endpoint (Discharge/7 Days)|Overall Study||11
6494026|NCT01383720|7412301|FG000|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
6494027|NCT01383720|7412301|FG000|NOT COMPLETED|Overall Study||0
6494028|NCT01383759|7412307|FG000|STARTED|Overall Study||19
6494029|NCT01383759|7412308|FG001|STARTED|Overall Study||1
6494030|NCT01383759|7412307|FG000|COMPLETED|Overall Study||19
6494031|NCT01383759|7412308|FG001|COMPLETED|Overall Study||1
6494032|NCT01383759|7412307|FG000|NOT COMPLETED|Overall Study||0
6494033|NCT01383759|7412308|FG001|NOT COMPLETED|Overall Study||0
6494034|NCT01383928|7412317|FG000|STARTED|Overall Study||7
6494035|NCT01383928|7412318|FG001|STARTED|Overall Study||7
6494036|NCT01383928|7412319|FG002|STARTED|Overall Study||50
6494037|NCT01383928|7412317|FG000|COMPLETED|Overall Study||2
6494038|NCT01383928|7412318|FG001|COMPLETED|Overall Study||0
6494039|NCT01383928|7412319|FG002|COMPLETED|Overall Study||10
6494040|NCT01383928|7412317|FG000|NOT COMPLETED|Overall Study||5
6494041|NCT01383928|7412318|FG001|NOT COMPLETED|Overall Study||7
6494042|NCT01383928|7412319|FG002|NOT COMPLETED|Overall Study||40
6494043|NCT01383954|7412329|FG000|STARTED|Overall Study||52
6494044|NCT01383954|7412329|FG000|Safety Population: Received Treatment|Overall Study||48
6494045|NCT01383954|7412329|FG000|COMPLETED|Overall Study||38
6494046|NCT01383954|7412329|FG000|NOT COMPLETED|Overall Study||14
6494047|NCT01383993|7412336|FG000|STARTED|Overall Study||15
6494048|NCT01383993|7412337|FG001|STARTED|Overall Study||4
6494049|NCT01383993|7412338|FG002|STARTED|Overall Study||2
6494050|NCT01383993|7412336|FG000|COMPLETED|Overall Study||12
6494051|NCT01383993|7412337|FG001|COMPLETED|Overall Study||3
6494052|NCT01383993|7412338|FG002|COMPLETED|Overall Study||1
6494053|NCT01383993|7412336|FG000|NOT COMPLETED|Overall Study||3
6494054|NCT01383993|7412337|FG001|NOT COMPLETED|Overall Study||1
6494055|NCT01383993|7412338|FG002|NOT COMPLETED|Overall Study||1
6494056|NCT01384019|7412349|FG000|STARTED|Overall Study||65
6494057|NCT01384019|7412350|FG001|STARTED|Overall Study||61
6494058|NCT01384019|7412349|FG000|COMPLETED|Overall Study||55
6494059|NCT01384019|7412350|FG001|COMPLETED|Overall Study||55
6494060|NCT01384019|7412349|FG000|NOT COMPLETED|Overall Study||10
6494061|NCT01384019|7412350|FG001|NOT COMPLETED|Overall Study||6
6494062|NCT01384292|7412359|FG000|STARTED|Part A||5
6494063|NCT01384292|7412360|FG001|STARTED|Part A||5
6494064|NCT01384292|7412361|FG002|STARTED|Part A||4
6494065|NCT01384292|7412359|FG000|COMPLETED|Part A||5
6494066|NCT01384292|7412360|FG001|COMPLETED|Part A||5
6494067|NCT01384292|7412361|FG002|COMPLETED|Part A||4
6494068|NCT01384292|7412359|FG000|NOT COMPLETED|Part A||0
6494069|NCT01384292|7412360|FG001|NOT COMPLETED|Part A||0
6494070|NCT01384292|7412361|FG002|NOT COMPLETED|Part A||0
6494071|NCT01384292|7412359|FG000|STARTED|Part B||3
6494072|NCT01384292|7412360|FG001|STARTED|Part B||6
6494073|NCT01384292|7412361|FG002|STARTED|Part B||0
6494074|NCT01384292|7412359|FG000|COMPLETED|Part B||2
6494075|NCT01384292|7412360|FG001|COMPLETED|Part B||6
6494076|NCT01384292|7412361|FG002|COMPLETED|Part B||0
6494077|NCT01384292|7412359|FG000|NOT COMPLETED|Part B||1
6494078|NCT01384292|7412360|FG001|NOT COMPLETED|Part B||0
6494079|NCT01384292|7412361|FG002|NOT COMPLETED|Part B||0
6494080|NCT01384539|7412373|FG000|STARTED|Overall Study||64
6494081|NCT01384539|7412374|FG001|STARTED|Overall Study||64
6494082|NCT01384539|7412373|FG000|COMPLETED|Overall Study||58
6494083|NCT01384539|7412374|FG001|COMPLETED|Overall Study||57
6494084|NCT01384539|7412373|FG000|NOT COMPLETED|Overall Study||6
6494085|NCT01384539|7412374|FG001|NOT COMPLETED|Overall Study||7
6494086|NCT01384591|7412383|FG000|STARTED|Overall Study||2
6494087|NCT01384591|7412384|FG001|STARTED|Overall Study||2
6494088|NCT01384591|7412385|FG002|STARTED|Overall Study||2
6494089|NCT01384591|7412383|FG000|COMPLETED|Overall Study||2
6494090|NCT01384591|7412384|FG001|COMPLETED|Overall Study||2
6494091|NCT01384591|7412385|FG002|COMPLETED|Overall Study||2
6494092|NCT01384591|7412383|FG000|NOT COMPLETED|Overall Study||0
6494093|NCT01384591|7412384|FG001|NOT COMPLETED|Overall Study||0
6494094|NCT01384591|7412385|FG002|NOT COMPLETED|Overall Study||0
6494095|NCT01384734|7412398|FG000|STARTED|Overall Study||50
6494096|NCT01384734|7412399|FG001|STARTED|Overall Study||49
6494097|NCT01384734|7412400|FG002|STARTED|Overall Study||51
6494098|NCT01384734|7412401|FG003|STARTED|Overall Study||50
6494099|NCT01384734|7412402|FG004|STARTED|Overall Study||51
6494100|NCT01384734|7412398|FG000|COMPLETED|Overall Study||33
6494101|NCT01384734|7412399|FG001|COMPLETED|Overall Study||25
6494102|NCT01384734|7412400|FG002|COMPLETED|Overall Study||28
6494103|NCT01384734|7412401|FG003|COMPLETED|Overall Study||22
6494104|NCT01384734|7412402|FG004|COMPLETED|Overall Study||22
6494105|NCT01384734|7412398|FG000|NOT COMPLETED|Overall Study||17
6494106|NCT01384734|7412399|FG001|NOT COMPLETED|Overall Study||24
6494107|NCT01384734|7412400|FG002|NOT COMPLETED|Overall Study||23
6494108|NCT01384734|7412401|FG003|NOT COMPLETED|Overall Study||28
6494109|NCT01384734|7412402|FG004|NOT COMPLETED|Overall Study||29
6494110|NCT01384760|7412413|FG000|STARTED|Overall Study||61
6494111|NCT01384760|7412414|FG001|STARTED|Overall Study||43
6494112|NCT01384760|7412413|FG000|Randomized|Overall Study||61
6494113|NCT01384760|7412414|FG001|Randomized|Overall Study||43
6494114|NCT01384760|7412413|FG000|COMPLETED|Overall Study||45
6494115|NCT01384760|7412414|FG001|COMPLETED|Overall Study||37
6494116|NCT01384760|7412413|FG000|NOT COMPLETED|Overall Study||16
6494117|NCT01384760|7412414|FG001|NOT COMPLETED|Overall Study||6
6494118|NCT01384877|7412422|FG000|STARTED|Treatment 1||17
6494119|NCT01384877|7412423|FG001|STARTED|Treatment 1||15
6494120|NCT01384877|7412422|FG000|COMPLETED|Treatment 1||17
6494121|NCT01384877|7412423|FG001|COMPLETED|Treatment 1||15
6494122|NCT01384877|7412422|FG000|NOT COMPLETED|Treatment 1||0
6494123|NCT01384877|7412423|FG001|NOT COMPLETED|Treatment 1||0
6494124|NCT01384877|7412422|FG000|STARTED|Treatment 2|1 Patient died between treatment periods|16
6494125|NCT01384877|7412423|FG001|STARTED|Treatment 2|2 Patients died between treatment periods|13
6494126|NCT01384877|7412422|FG000|COMPLETED|Treatment 2||14
6494127|NCT01384877|7412423|FG001|COMPLETED|Treatment 2||11
6494128|NCT01384877|7412422|FG000|NOT COMPLETED|Treatment 2||2
6494129|NCT01384877|7412423|FG001|NOT COMPLETED|Treatment 2||2
6494130|NCT01385098|7412429|FG000|STARTED|Overall Study||37
6494131|NCT01385098|7412429|FG000|COMPLETED|Overall Study|14 subjects did not complete. 4 subjects loss to follow-up & 10 subjects could not tolerate suppl.|23
6494132|NCT01385098|7412429|FG000|NOT COMPLETED|Overall Study||14
6494133|NCT01385137|7412437|FG000|STARTED|Evaluable at Baseline||131
6494134|NCT01385137|7412438|FG001|STARTED|Evaluable at Baseline||131
6494135|NCT01385137|7412437|FG000|COMPLETED|Evaluable at Baseline||122
6494136|NCT01385137|7412438|FG001|COMPLETED|Evaluable at Baseline||127
6494137|NCT01385137|7412437|FG000|NOT COMPLETED|Evaluable at Baseline||9
6494138|NCT01385137|7412438|FG001|NOT COMPLETED|Evaluable at Baseline||4
6494139|NCT01385137|7412437|FG000|STARTED|Evaluable for Primary Endpoint||131
6494140|NCT01385137|7412438|FG001|STARTED|Evaluable for Primary Endpoint||131
6494141|NCT01385137|7412437|FG000|COMPLETED|Evaluable for Primary Endpoint||102
6494142|NCT01385137|7412438|FG001|COMPLETED|Evaluable for Primary Endpoint||107
6494143|NCT01385137|7412437|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||29
6494144|NCT01385137|7412438|FG001|NOT COMPLETED|Evaluable for Primary Endpoint||24
6494145|NCT01385189|7412449|FG000|STARTED|Overall Study||12
6494146|NCT01385189|7412450|FG001|STARTED|Overall Study||12
6494147|NCT01385189|7412451|FG002|STARTED|Overall Study||4
6494148|NCT01385189|7412452|FG003|STARTED|Overall Study||4
6494149|NCT01385189|7412453|FG004|STARTED|Overall Study||8
6494150|NCT01385189|7412449|FG000|COMPLETED|Overall Study||11
6494151|NCT01385189|7412450|FG001|COMPLETED|Overall Study||11
6494152|NCT01385189|7412451|FG002|COMPLETED|Overall Study||4
6494153|NCT01385189|7412452|FG003|COMPLETED|Overall Study||3
6494154|NCT01385189|7412453|FG004|COMPLETED|Overall Study||6
6494155|NCT01385189|7412449|FG000|NOT COMPLETED|Overall Study||1
6494156|NCT01385189|7412450|FG001|NOT COMPLETED|Overall Study||1
6494157|NCT01385189|7412451|FG002|NOT COMPLETED|Overall Study||0
6494158|NCT01385189|7412452|FG003|NOT COMPLETED|Overall Study||1
6494159|NCT01385189|7412453|FG004|NOT COMPLETED|Overall Study||2
6494160|NCT01385202|7412472|FG000|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
6494161|NCT01385202|7412472|FG000|Study Catheter Inserted|Overall Study||161
6494162|NCT01385202|7412472|FG000|Undergoing Ablation|Overall Study||160
6494163|NCT01385202|7412472|FG000|COMPLETED|Overall Study||154
6494164|NCT01385202|7412472|FG000|NOT COMPLETED|Overall Study||18
6494165|NCT01385293|7412478|FG000|STARTED|Overall Study||30
6494166|NCT01385293|7412478|FG000|COMPLETED|Overall Study||30
6494167|NCT01385293|7412478|FG000|NOT COMPLETED|Overall Study||0
6494168|NCT01385306|7412482|FG000|STARTED|Overall Study||6
6494169|NCT01385306|7412482|FG000|COMPLETED|Overall Study||6
6494170|NCT01385306|7412482|FG000|NOT COMPLETED|Overall Study||0
6494171|NCT01385371|7412488|FG000|STARTED|Overall Study||752
6494172|NCT01385371|7412489|FG001|STARTED|Overall Study||749
6494173|NCT01385371|7412488|FG000|COMPLETED|Overall Study||603
6494174|NCT01385371|7412489|FG001|COMPLETED|Overall Study||652
6494175|NCT01385371|7412488|FG000|NOT COMPLETED|Overall Study||149
6494176|NCT01385371|7412489|FG001|NOT COMPLETED|Overall Study||97
6494177|NCT01385566|7412501|FG000|STARTED|Overall Study||52
6494178|NCT01385566|7412502|FG001|STARTED|Overall Study||34
6494179|NCT01385566|7412503|FG002|STARTED|Overall Study||34
6494180|NCT01385566|7412504|FG003|STARTED|Overall Study||35
6494181|NCT01385566|7412505|FG004|STARTED|Overall Study||34
6494182|NCT01385566|7412506|FG005|STARTED|Overall Study||34
6494183|NCT01385566|7412501|FG000|COMPLETED|Overall Study||51
6494184|NCT01385566|7412502|FG001|COMPLETED|Overall Study||34
6494185|NCT01385566|7412503|FG002|COMPLETED|Overall Study||34
6494186|NCT01385566|7412504|FG003|COMPLETED|Overall Study||34
6494187|NCT01385566|7412505|FG004|COMPLETED|Overall Study||34
6305807|NCT00370682|7209195|FG001|NOT COMPLETED|Overall Study||3
6305808|NCT00370682|7209196|FG002|NOT COMPLETED|Overall Study||1
6305809|NCT00370838|7209210|FG000|STARTED|Period 1 (Days 8-50)||7
6305810|NCT00370838|7209211|FG001|STARTED|Period 1 (Days 8-50)||3
6305811|NCT00370838|7209210|FG000|COMPLETED|Period 1 (Days 8-50)||7
6305812|NCT00370838|7209211|FG001|COMPLETED|Period 1 (Days 8-50)||3
6305813|NCT00370838|7209210|FG000|NOT COMPLETED|Period 1 (Days 8-50)||0
6305814|NCT00370838|7209211|FG001|NOT COMPLETED|Period 1 (Days 8-50)||0
6305815|NCT00370838|7209210|FG000|STARTED|Washout (Days 51-64)||7
6494188|NCT01385566|7412506|FG005|COMPLETED|Overall Study||34
6494189|NCT01385566|7412501|FG000|NOT COMPLETED|Overall Study||1
6494190|NCT01385566|7412502|FG001|NOT COMPLETED|Overall Study||0
6494191|NCT01385566|7412503|FG002|NOT COMPLETED|Overall Study||0
6494192|NCT01385566|7412504|FG003|NOT COMPLETED|Overall Study||1
6494193|NCT01385566|7412505|FG004|NOT COMPLETED|Overall Study||0
6494194|NCT01385566|7412506|FG005|NOT COMPLETED|Overall Study||0
6494195|NCT01385579|7412524|FG000|STARTED|Overall Study||98
6494196|NCT01385579|7412525|FG001|STARTED|Overall Study||104
6494197|NCT01385579|7412524|FG000|COMPLETED|Overall Study||98
6494198|NCT01385579|7412525|FG001|COMPLETED|Overall Study||104
6750102|NCT03426995|7677309|FG002|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750103|NCT03426995|7677310|FG003|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750104|NCT03426995|7677311|FG004|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750105|NCT03426995|7677312|FG005|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6494199|NCT01385579|7412524|FG000|NOT COMPLETED|Overall Study||0
6494200|NCT01385579|7412525|FG001|NOT COMPLETED|Overall Study||0
6494201|NCT01385644|7412533|FG000|STARTED|Overall Study||4
6494202|NCT01385644|7412534|FG001|STARTED|Overall Study||4
6494203|NCT01385644|7412533|FG000|COMPLETED|Overall Study||4
6494204|NCT01385644|7412534|FG001|COMPLETED|Overall Study||4
6494205|NCT01385644|7412533|FG000|NOT COMPLETED|Overall Study||0
6494206|NCT01385644|7412534|FG001|NOT COMPLETED|Overall Study||0
6494207|NCT01385696|7412540|FG000|STARTED|Overall Study||66
6494208|NCT01385696|7412541|FG001|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
6494209|NCT01385696|7412540|FG000|COMPLETED|Overall Study||66
6494210|NCT01385696|7412541|FG001|COMPLETED|Overall Study||64
6494211|NCT01385696|7412540|FG000|NOT COMPLETED|Overall Study||0
6494212|NCT01385696|7412541|FG001|NOT COMPLETED|Overall Study||0
6494213|NCT01385748|7412551|FG000|STARTED|Overall Study||56
6494214|NCT01385748|7412552|FG001|STARTED|Overall Study||65
6494215|NCT01385748|7412553|FG002|STARTED|Overall Study||62
6494216|NCT01385748|7412551|FG000|COMPLETED|Overall Study||41
6494217|NCT01385748|7412552|FG001|COMPLETED|Overall Study||51
6494218|NCT01385748|7412553|FG002|COMPLETED|Overall Study||49
6494219|NCT01385748|7412551|FG000|NOT COMPLETED|Overall Study||15
6494220|NCT01385748|7412552|FG001|NOT COMPLETED|Overall Study||14
6494221|NCT01385748|7412553|FG002|NOT COMPLETED|Overall Study||13
6494222|NCT01385995|7412567|FG000|STARTED|Period 1, 2 Months||25
6494223|NCT01385995|7412568|FG001|STARTED|Period 1, 2 Months||25
6494224|NCT01385995|7412567|FG000|COMPLETED|Period 1, 2 Months||24
6494225|NCT01385995|7412568|FG001|COMPLETED|Period 1, 2 Months||25
6494226|NCT01385995|7412567|FG000|NOT COMPLETED|Period 1, 2 Months||1
6494227|NCT01385995|7412568|FG001|NOT COMPLETED|Period 1, 2 Months||0
6494228|NCT01385995|7412567|FG000|STARTED|Washout Period, 1 Month||24
6494229|NCT01385995|7412568|FG001|STARTED|Washout Period, 1 Month||25
6494230|NCT01385995|7412567|FG000|COMPLETED|Washout Period, 1 Month||24
6494231|NCT01385995|7412568|FG001|COMPLETED|Washout Period, 1 Month||25
6494232|NCT01385995|7412567|FG000|NOT COMPLETED|Washout Period, 1 Month||0
6494233|NCT01385995|7412568|FG001|NOT COMPLETED|Washout Period, 1 Month||0
6494234|NCT01385995|7412567|FG000|STARTED|Period 2, 2 Months||24
6494235|NCT01385995|7412568|FG001|STARTED|Period 2, 2 Months||25
6494236|NCT01385995|7412567|FG000|COMPLETED|Period 2, 2 Months||24
6494237|NCT01385995|7412568|FG001|COMPLETED|Period 2, 2 Months||25
6494238|NCT01385995|7412567|FG000|NOT COMPLETED|Period 2, 2 Months||0
6494239|NCT01385995|7412568|FG001|NOT COMPLETED|Period 2, 2 Months||0
6555347|NCT01751308|7477491|FG001|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
6555348|NCT01751308|7477492|FG002|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
6494240|NCT01386008|7412576|FG000|STARTED|Overall Study||20
6494241|NCT01386008|7412576|FG000|COMPLETED|Overall Study||0
6494242|NCT01386008|7412576|FG000|NOT COMPLETED|Overall Study||20
6494243|NCT01386528|7412580|FG000|STARTED|Overall Study||13
6494244|NCT01386528|7412580|FG000|COMPLETED|Overall Study||13
6494245|NCT01386528|7412580|FG000|NOT COMPLETED|Overall Study||0
6494246|NCT01386554|7412587|FG000|STARTED|Overall Study||4
6494247|NCT01386554|7412588|FG001|STARTED|Overall Study||35
6494248|NCT01386554|7412589|FG002|STARTED|Overall Study||21
6494249|NCT01386554|7412587|FG000|COMPLETED|Overall Study||1
6494250|NCT01386554|7412588|FG001|COMPLETED|Overall Study||26
6494251|NCT01386554|7412589|FG002|COMPLETED|Overall Study||15
6494252|NCT01386554|7412587|FG000|NOT COMPLETED|Overall Study||3
6494253|NCT01386554|7412588|FG001|NOT COMPLETED|Overall Study||9
6494254|NCT01386554|7412589|FG002|NOT COMPLETED|Overall Study||6
6494255|NCT01386606|7412603|FG000|STARTED|Overall Study||16
6494256|NCT01386606|7412604|FG001|STARTED|Overall Study||14
6494257|NCT01386606|7412605|FG002|STARTED|Overall Study||16
6494258|NCT01386606|7412606|FG003|STARTED|Overall Study||14
6494259|NCT01386606|7412603|FG000|COMPLETED|Overall Study||12
6494260|NCT01386606|7412604|FG001|COMPLETED|Overall Study||10
6494261|NCT01386606|7412605|FG002|COMPLETED|Overall Study||13
6494262|NCT01386606|7412606|FG003|COMPLETED|Overall Study||13
6494263|NCT01386606|7412603|FG000|NOT COMPLETED|Overall Study||4
6494264|NCT01386606|7412604|FG001|NOT COMPLETED|Overall Study||4
6494265|NCT01386606|7412605|FG002|NOT COMPLETED|Overall Study||3
6494266|NCT01386606|7412606|FG003|NOT COMPLETED|Overall Study||1
6494267|NCT01386632|7412622|FG000|STARTED|Overall Study||25
6494268|NCT01386632|7412623|FG001|STARTED|Overall Study||25
6494269|NCT01386632|7412622|FG000|COMPLETED|Overall Study||20
6494270|NCT01386632|7412623|FG001|COMPLETED|Overall Study||21
6494271|NCT01386632|7412622|FG000|NOT COMPLETED|Overall Study||5
6494272|NCT01386632|7412623|FG001|NOT COMPLETED|Overall Study||4
6494273|NCT01386645|7412632|FG000|STARTED|Overall Study||18
6494274|NCT01386645|7412633|FG001|STARTED|Overall Study||19
6494275|NCT01386645|7412634|FG002|STARTED|Overall Study||19
6494276|NCT01386645|7412632|FG000|COMPLETED|Overall Study||18
6494277|NCT01386645|7412633|FG001|COMPLETED|Overall Study||18
6494278|NCT01386645|7412634|FG002|COMPLETED|Overall Study||17
6494279|NCT01386645|7412632|FG000|NOT COMPLETED|Overall Study||0
6494280|NCT01386645|7412633|FG001|NOT COMPLETED|Overall Study||1
6494281|NCT01386645|7412634|FG002|NOT COMPLETED|Overall Study||2
6494282|NCT01386788|7412642|FG000|STARTED|Overall Study||102
6494283|NCT01386788|7412642|FG000|COMPLETED|Overall Study||100
6494284|NCT01386788|7412642|FG000|NOT COMPLETED|Overall Study||2
6494285|NCT01386944|7412646|FG000|STARTED|Overall Study||102
6494286|NCT01386944|7412646|FG000|COMPLETED|Overall Study||46
6494287|NCT01386944|7412646|FG000|NOT COMPLETED|Overall Study||56
6494288|NCT01386970|7412652|FG000|STARTED|Overall Study||20
6494289|NCT01386970|7412653|FG001|STARTED|Overall Study||23
6494290|NCT01386970|7412652|FG000|COMPLETED|Overall Study||16
6494291|NCT01386970|7412653|FG001|COMPLETED|Overall Study||21
6494292|NCT01386970|7412652|FG000|NOT COMPLETED|Overall Study||4
6494293|NCT01386970|7412653|FG001|NOT COMPLETED|Overall Study||2
6494294|NCT01386983|7412663|FG000|STARTED|Overall Study||264
6494295|NCT01386983|7412664|FG001|STARTED|Overall Study||68
6494296|NCT01386983|7412663|FG000|COMPLETED|Overall Study||264
6494297|NCT01386983|7412664|FG001|COMPLETED|Overall Study||68
6494298|NCT01386983|7412663|FG000|NOT COMPLETED|Overall Study||0
6494299|NCT01386983|7412664|FG001|NOT COMPLETED|Overall Study||0
6494300|NCT01387022|7412672|FG000|STARTED|Overall Study||29
6494301|NCT01387022|7412673|FG001|STARTED|Overall Study||30
6494302|NCT01387022|7412672|FG000|COMPLETED|Overall Study||28
6494303|NCT01387022|7412673|FG001|COMPLETED|Overall Study||26
6494304|NCT01387022|7412672|FG000|NOT COMPLETED|Overall Study||1
6494305|NCT01387022|7412673|FG001|NOT COMPLETED|Overall Study||4
6494306|NCT01387074|7412679|FG000|STARTED|Overall Study||108
6494307|NCT01387074|7412679|FG000|COMPLETED|Overall Study||100
6494308|NCT01387074|7412679|FG000|NOT COMPLETED|Overall Study||8
6494309|NCT01387139|7412685|FG000|STARTED|Overall Study||99
6494310|NCT01387139|7412686|FG001|STARTED|Overall Study||84
6494311|NCT01387139|7412685|FG000|COMPLETED|Overall Study||99
6494312|NCT01387139|7412686|FG001|COMPLETED|Overall Study||84
6494313|NCT01387139|7412685|FG000|NOT COMPLETED|Overall Study||0
6494314|NCT01387139|7412686|FG001|NOT COMPLETED|Overall Study||0
6494315|NCT01387178|7412694|FG000|STARTED|Overall Study||11582
6494316|NCT01387178|7412695|FG001|STARTED|Overall Study||10641
6494317|NCT01387178|7412694|FG000|COMPLETED|Overall Study||11582
6494318|NCT01387178|7412695|FG001|COMPLETED|Overall Study||10641
6494319|NCT01387178|7412694|FG000|NOT COMPLETED|Overall Study||0
6494320|NCT01387178|7412695|FG001|NOT COMPLETED|Overall Study||0
6494321|NCT01387230|7412705|FG000|STARTED|Overall Study||68
6494322|NCT01387230|7412706|FG001|STARTED|Overall Study||69
6494323|NCT01387230|7412707|FG002|STARTED|Overall Study||69
6494324|NCT01387230|7412705|FG000|COMPLETED|Overall Study||50
6494325|NCT01387230|7412706|FG001|COMPLETED|Overall Study||62
6494326|NCT01387230|7412707|FG002|COMPLETED|Overall Study||56
6494327|NCT01387230|7412705|FG000|NOT COMPLETED|Overall Study||18
6494328|NCT01387230|7412706|FG001|NOT COMPLETED|Overall Study||7
6750106|NCT03426995|7677313|FG006|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
6750107|NCT03426995|7677314|FG007|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
6750108|NCT03426995|7677315|FG008|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
6750109|NCT03426995|7677316|FG009|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
6750110|NCT03426995|7677317|FG010|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||1
6750111|NCT03426995|7677318|FG011|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||2
6750112|NCT03426995|7677319|FG012|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750113|NCT03426995|7677320|FG013|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6494329|NCT01387230|7412707|FG002|NOT COMPLETED|Overall Study||13
6494330|NCT01387269|7412717|FG000|STARTED|Overall Study||323
6494331|NCT01387269|7412718|FG001|STARTED|Overall Study||161
6494332|NCT01387269|7412717|FG000|ITT Population|Overall Study||323
6494333|NCT01387269|7412718|FG001|ITT Population|Overall Study||161
6494334|NCT01387269|7412717|FG000|MITT Population|Overall Study||284
6494335|NCT01387269|7412718|FG001|MITT Population|Overall Study||141
6494336|NCT01387269|7412717|FG000|Safety Population|Overall Study||320
6494337|NCT01387269|7412718|FG001|Safety Population|Overall Study||161
6494338|NCT01387269|7412717|FG000|COMPLETED|Overall Study||231
6494339|NCT01387269|7412718|FG001|COMPLETED|Overall Study||121
6494340|NCT01387269|7412717|FG000|NOT COMPLETED|Overall Study||92
6494341|NCT01387269|7412718|FG001|NOT COMPLETED|Overall Study||40
6494342|NCT01387282|7412726|FG000|STARTED|Overall Study||330
6494343|NCT01387282|7412727|FG001|STARTED|Overall Study||165
6494344|NCT01387282|7412726|FG000|ITT Population|Overall Study||330
6494345|NCT01387282|7412727|FG001|ITT Population|Overall Study||165
6494346|NCT01387282|7412726|FG000|MITT Population|Overall Study||268
6494347|NCT01387282|7412727|FG001|MITT Population|Overall Study||136
6494348|NCT01387282|7412726|FG000|Safety Population|Overall Study||330
6494349|NCT01387282|7412727|FG001|Safety Population|Overall Study||161
6494350|NCT01387282|7412726|FG000|COMPLETED|Overall Study||233
6494351|NCT01387282|7412727|FG001|COMPLETED|Overall Study||118
6494352|NCT01387282|7412726|FG000|NOT COMPLETED|Overall Study||97
6494353|NCT01387282|7412727|FG001|NOT COMPLETED|Overall Study||47
6494354|NCT01387347|7412735|FG000|STARTED|Overall Study||36
6494355|NCT01387347|7412736|FG001|STARTED|Overall Study||36
6494356|NCT01387347|7412735|FG000|COMPLETED|Overall Study||34
6494357|NCT01387347|7412736|FG001|COMPLETED|Overall Study||35
6494358|NCT01387347|7412735|FG000|NOT COMPLETED|Overall Study||2
6494359|NCT01387347|7412736|FG001|NOT COMPLETED|Overall Study||1
6494360|NCT01387464|7412748|FG000|STARTED|Overall Study||30
6494361|NCT01387464|7412749|FG001|STARTED|Overall Study||30
6494362|NCT01387464|7412748|FG000|Safety Population|Overall Study||30
6494363|NCT01387464|7412749|FG001|Safety Population|Overall Study||29
6494364|NCT01387464|7412748|FG000|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
6494365|NCT01387464|7412749|FG001|Per-Protocol Population|Overall Study||29
6494366|NCT01387464|7412748|FG000|COMPLETED|Overall Study||29
6494367|NCT01387464|7412749|FG001|COMPLETED|Overall Study||29
6494368|NCT01387464|7412748|FG000|NOT COMPLETED|Overall Study||1
6494369|NCT01387464|7412749|FG001|NOT COMPLETED|Overall Study||1
6501841|NCT01431391|7420506|FG001|STARTED|Overall Study||34
6501842|NCT01431391|7420505|FG000|Received ≥1 Leaukapheresis|Overall Study||34
6501843|NCT01431391|7420506|FG001|Received ≥1 Leaukapheresis|Overall Study||34
6501844|NCT01431391|7420505|FG000|COMPLETED|Overall Study||26
6501845|NCT01431391|7420506|FG001|COMPLETED|Overall Study||30
6501846|NCT01431391|7420505|FG000|NOT COMPLETED|Overall Study||8
6501847|NCT01431391|7420506|FG001|NOT COMPLETED|Overall Study||4
6501848|NCT01431521|7420517|FG000|STARTED|Overall Study||10
6501849|NCT01431521|7420518|FG001|STARTED|Overall Study||5
6494370|NCT01387516|7412759|FG000|STARTED|Overall Study||80
6494371|NCT01387516|7412760|FG001|STARTED|Overall Study||68
6750114|NCT03426995|7677321|FG014|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750115|NCT03426995|7677322|FG015|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750116|NCT03426995|7677323|FG016|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750117|NCT03426995|7677324|FG017|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6779925|NCT03534362|7708191|FG000|NOT COMPLETED|Overall Study||0
6494372|NCT01387516|7412761|FG002|STARTED|Overall Study||79
6494373|NCT01387516|7412762|FG003|STARTED|Overall Study||69
6494374|NCT01387516|7412759|FG000|COMPLETED|Overall Study||75
6494375|NCT01387516|7412760|FG001|COMPLETED|Overall Study||63
6494376|NCT01387516|7412761|FG002|COMPLETED|Overall Study||75
6494377|NCT01387516|7412762|FG003|COMPLETED|Overall Study||65
6494378|NCT01387516|7412759|FG000|NOT COMPLETED|Overall Study||5
6494379|NCT01387516|7412760|FG001|NOT COMPLETED|Overall Study||5
6494380|NCT01387516|7412761|FG002|NOT COMPLETED|Overall Study||4
6494381|NCT01387516|7412762|FG003|NOT COMPLETED|Overall Study||4
6494382|NCT01387542|7412772|FG000|STARTED|Overall Study||40
6494383|NCT01387542|7412772|FG000|Treated|Overall Study||38
6494384|NCT01387542|7412772|FG000|COMPLETED|Overall Study||32
6494385|NCT01387542|7412772|FG000|NOT COMPLETED|Overall Study||8
6494386|NCT01387581|7412779|FG000|STARTED|Overall Study||108
6494387|NCT01387581|7412780|FG001|STARTED|Overall Study||107
6494388|NCT01387581|7412781|FG002|STARTED|Overall Study||12
6494389|NCT01387581|7412779|FG000|COMPLETED|Overall Study||101
6494390|NCT01387581|7412780|FG001|COMPLETED|Overall Study||101
6494391|NCT01387581|7412781|FG002|COMPLETED|Overall Study||9
6494392|NCT01387581|7412779|FG000|NOT COMPLETED|Overall Study||7
6494393|NCT01387581|7412780|FG001|NOT COMPLETED|Overall Study||6
6494394|NCT01387581|7412781|FG002|NOT COMPLETED|Overall Study||3
6494395|NCT01387594|7412791|FG000|STARTED|Overall Study||10
6494396|NCT01387594|7412792|FG001|STARTED|Overall Study||39
6494397|NCT01387594|7412791|FG000|COMPLETED|Overall Study||10
6494398|NCT01387594|7412792|FG001|COMPLETED|Overall Study||36
6494399|NCT01387594|7412791|FG000|NOT COMPLETED|Overall Study||0
6494400|NCT01387594|7412792|FG001|NOT COMPLETED|Overall Study||3
6494401|NCT01387607|7412803|FG000|STARTED|Overall Study||173
6494402|NCT01387607|7412804|FG001|STARTED|Overall Study||170
6494403|NCT01387607|7412803|FG000|Received Treatment|Overall Study||170
6494404|NCT01387607|7412804|FG001|Received Treatment|Overall Study||164
6494405|NCT01387607|7412803|FG000|COMPLETED|Overall Study||122
6494406|NCT01387607|7412804|FG001|COMPLETED|Overall Study||125
6494407|NCT01387607|7412803|FG000|NOT COMPLETED|Overall Study||51
6494408|NCT01387607|7412804|FG001|NOT COMPLETED|Overall Study||45
6494409|NCT01387672|7412816|FG000|STARTED|Overall Study||39
6494410|NCT01387672|7412817|FG001|STARTED|Overall Study||38
6494411|NCT01387672|7412818|FG002|STARTED|Overall Study||38
6494412|NCT01387672|7412819|FG003|STARTED|Overall Study||39
6494413|NCT01387672|7412820|FG004|STARTED|Overall Study||38
6494414|NCT01387672|7412821|FG005|STARTED|Overall Study||37
6494415|NCT01387672|7412816|FG000|COMPLETED|Overall Study||32
6494416|NCT01387672|7412817|FG001|COMPLETED|Overall Study||31
6494417|NCT01387672|7412818|FG002|COMPLETED|Overall Study||33
6494418|NCT01387672|7412819|FG003|COMPLETED|Overall Study||35
6494419|NCT01387672|7412820|FG004|COMPLETED|Overall Study||34
6494420|NCT01387672|7412821|FG005|COMPLETED|Overall Study||37
6494421|NCT01387672|7412816|FG000|NOT COMPLETED|Overall Study||7
6494422|NCT01387672|7412817|FG001|NOT COMPLETED|Overall Study||7
6494423|NCT01387672|7412818|FG002|NOT COMPLETED|Overall Study||5
6494424|NCT01387672|7412819|FG003|NOT COMPLETED|Overall Study||4
6494425|NCT01387672|7412820|FG004|NOT COMPLETED|Overall Study||4
6494426|NCT01387672|7412821|FG005|NOT COMPLETED|Overall Study||0
6494427|NCT01387737|7412838|FG000|STARTED|Overall Study||584
6494428|NCT01387737|7412839|FG001|STARTED|Overall Study||715
6494429|NCT01387737|7412838|FG000|COMPLETED|Overall Study||532
6494430|NCT01387737|7412839|FG001|COMPLETED|Overall Study||641
6494431|NCT01387737|7412838|FG000|NOT COMPLETED|Overall Study||52
6494432|NCT01387737|7412839|FG001|NOT COMPLETED|Overall Study||74
6494433|NCT01387789|7412845|FG000|STARTED|Overall Study||71
6494434|NCT01387789|7412845|FG000|COMPLETED|Overall Study||63
6494435|NCT01387789|7412845|FG000|NOT COMPLETED|Overall Study||8
6494436|NCT01387815|7412851|FG000|STARTED|Overall Study||302
6494437|NCT01387815|7412852|FG001|STARTED|Overall Study||293
6494438|NCT01387815|7412851|FG000|COMPLETED|Overall Study||162
6494439|NCT01387815|7412852|FG001|COMPLETED|Overall Study||189
6494440|NCT01387815|7412851|FG000|NOT COMPLETED|Overall Study||140
6494441|NCT01387815|7412852|FG001|NOT COMPLETED|Overall Study||104
6494442|NCT01387932|7412860|FG000|STARTED|Randomized and Treated||118
6494443|NCT01387932|7412861|FG001|STARTED|Randomized and Treated||117
6494444|NCT01387932|7412860|FG000|COMPLETED|Randomized and Treated||111
6494445|NCT01387932|7412861|FG001|COMPLETED|Randomized and Treated||113
6494446|NCT01387932|7412860|FG000|NOT COMPLETED|Randomized and Treated||7
6494447|NCT01387932|7412861|FG001|NOT COMPLETED|Randomized and Treated||4
6494448|NCT01387932|7412860|FG000|STARTED|Completion of TACE Cycle||111
6494449|NCT01387932|7412861|FG001|STARTED|Completion of TACE Cycle||113
6494450|NCT01387932|7412860|FG000|COMPLETED|Completion of TACE Cycle||111
6494451|NCT01387932|7412861|FG001|COMPLETED|Completion of TACE Cycle||113
6494452|NCT01387932|7412860|FG000|NOT COMPLETED|Completion of TACE Cycle||0
6494453|NCT01387932|7412861|FG001|NOT COMPLETED|Completion of TACE Cycle||0
6494454|NCT01387932|7412860|FG000|STARTED|Survival Follow-up||111
6494455|NCT01387932|7412861|FG001|STARTED|Survival Follow-up||113
6494456|NCT01387932|7412860|FG000|COMPLETED|Survival Follow-up||27
6494457|NCT01387932|7412861|FG001|COMPLETED|Survival Follow-up||23
6494458|NCT01387932|7412860|FG000|NOT COMPLETED|Survival Follow-up||84
6494459|NCT01387932|7412861|FG001|NOT COMPLETED|Survival Follow-up||90
6494460|NCT01388166|7412869|FG000|STARTED|Overall Study||1253
6494461|NCT01388166|7412869|FG000|COMPLETED|Overall Study||1194
6494462|NCT01388166|7412869|FG000|NOT COMPLETED|Overall Study||59
6494463|NCT01388335|7412873|FG000|STARTED|Period 1||13
6494464|NCT01388335|7412873|FG000|Received at Least 1 Dose of Study Drug|Period 1||13
6494465|NCT01388335|7412873|FG000|COMPLETED|Period 1||12
6494466|NCT01388335|7412873|FG000|NOT COMPLETED|Period 1||1
6494467|NCT01388335|7412873|FG000|STARTED|Period 2||12
6494468|NCT01388335|7412873|FG000|Received at Least 1 Dose of Study Drug|Period 2||12
6494469|NCT01388335|7412873|FG000|COMPLETED|Period 2|Only 6 participants who completed Period 2 entered Safety Extension.|9
6494470|NCT01388335|7412873|FG000|NOT COMPLETED|Period 2||3
6494471|NCT01388335|7412873|FG000|STARTED|Safety Extension|Six completed Period 2 and 1 participant who discontinued Period 2 entered Safety Extension.|7
6494472|NCT01388335|7412873|FG000|COMPLETED|Safety Extension||0
6494473|NCT01388335|7412873|FG000|NOT COMPLETED|Safety Extension||7
6494474|NCT01388361|7412888|FG000|STARTED|Overall Study||236
6494475|NCT01388361|7412889|FG001|STARTED|Overall Study||88
6494476|NCT01388361|7412890|FG002|STARTED|Overall Study||89
6494477|NCT01388361|7412888|FG000|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
6494478|NCT01388361|7412889|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
6494479|NCT01388361|7412890|FG002|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
6494480|NCT01388361|7412888|FG000|COMPLETED|Overall Study||224
6494481|NCT01388361|7412889|FG001|COMPLETED|Overall Study||76
6494482|NCT01388361|7412890|FG002|COMPLETED|Overall Study||75
6494483|NCT01388361|7412888|FG000|NOT COMPLETED|Overall Study||12
6494484|NCT01388361|7412889|FG001|NOT COMPLETED|Overall Study||12
6494485|NCT01388361|7412890|FG002|NOT COMPLETED|Overall Study||14
6494486|NCT01388478|7412898|FG000|STARTED|Overall Study||20
6494487|NCT01388478|7412898|FG000|COMPLETED|Overall Study||15
6494488|NCT01388478|7412898|FG000|NOT COMPLETED|Overall Study||5
6494489|NCT01388530|7412902|FG000|STARTED|Overall Study||25
6494490|NCT01388530|7412902|FG000|COMPLETED|Overall Study||20
6494491|NCT01388530|7412902|FG000|NOT COMPLETED|Overall Study||5
6494492|NCT01388543|7412908|FG000|STARTED|Day 7, Primary End Point||15
6494493|NCT01388543|7412909|FG001|STARTED|Day 7, Primary End Point||16
6494494|NCT01388543|7412908|FG000|COMPLETED|Day 7, Primary End Point||15
6494495|NCT01388543|7412909|FG001|COMPLETED|Day 7, Primary End Point||16
6494496|NCT01388543|7412908|FG000|NOT COMPLETED|Day 7, Primary End Point||0
6494497|NCT01388543|7412909|FG001|NOT COMPLETED|Day 7, Primary End Point||0
6494498|NCT01388543|7412908|FG000|STARTED|Day 14||15
6494499|NCT01388543|7412909|FG001|STARTED|Day 14||16
6494500|NCT01388543|7412908|FG000|COMPLETED|Day 14||14
6494501|NCT01388543|7412909|FG001|COMPLETED|Day 14||12
6494502|NCT01388543|7412908|FG000|NOT COMPLETED|Day 14||1
6494503|NCT01388543|7412909|FG001|NOT COMPLETED|Day 14||4
6494504|NCT01388647|7412917|FG000|STARTED|Overall Study||6
6494505|NCT01388647|7412918|FG001|STARTED|Overall Study||6
6494506|NCT01388647|7412917|FG000|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
6494507|NCT01388647|7412918|FG001|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
6494508|NCT01388647|7412917|FG000|NOT COMPLETED|Overall Study||1
6494509|NCT01388647|7412918|FG001|NOT COMPLETED|Overall Study||2
6494510|NCT01388777|7412925|FG000|STARTED|Overall Study||1
6494511|NCT01388777|7412925|FG000|Cryoablation|Overall Study||1
6494512|NCT01388777|7412925|FG000|COMPLETED|Overall Study||1
6494513|NCT01388777|7412925|FG000|NOT COMPLETED|Overall Study||0
6494514|NCT01388790|7412929|FG000|STARTED|Overall Study||40
6494515|NCT01388790|7412929|FG000|COMPLETED|Overall Study||32
6494516|NCT01388790|7412929|FG000|NOT COMPLETED|Overall Study||8
6494517|NCT01388816|7412937|FG000|STARTED|Overall Study||45
6494518|NCT01388816|7412938|FG001|STARTED|Overall Study||43
6494519|NCT01388816|7412939|FG002|STARTED|Overall Study||44
6494520|NCT01388816|7412940|FG003|STARTED|Overall Study||44
6494521|NCT01388816|7412937|FG000|COMPLETED|Overall Study||43
6494522|NCT01388816|7412938|FG001|COMPLETED|Overall Study||39
6494523|NCT01388816|7412939|FG002|COMPLETED|Overall Study||41
6494524|NCT01388816|7412940|FG003|COMPLETED|Overall Study||44
6494525|NCT01388816|7412937|FG000|NOT COMPLETED|Overall Study||2
6494526|NCT01388816|7412938|FG001|NOT COMPLETED|Overall Study||4
6494527|NCT01388816|7412939|FG002|NOT COMPLETED|Overall Study||3
6494528|NCT01388816|7412940|FG003|NOT COMPLETED|Overall Study||0
6494529|NCT01388907|7412955|FG000|STARTED|Overall Study||33
6494530|NCT01388907|7412956|FG001|STARTED|Overall Study||28
6494531|NCT01388907|7412955|FG000|COMPLETED|Overall Study||31
6494532|NCT01388907|7412956|FG001|COMPLETED|Overall Study||28
6494533|NCT01388907|7412955|FG000|NOT COMPLETED|Overall Study||2
6494534|NCT01388907|7412956|FG001|NOT COMPLETED|Overall Study||0
6494535|NCT01388946|7412966|FG000|STARTED|Overall Study||55
6494536|NCT01388946|7412967|FG001|STARTED|Overall Study||55
6494537|NCT01388946|7412966|FG000|COMPLETED|Overall Study||49
6494538|NCT01388946|7412967|FG001|COMPLETED|Overall Study||52
6494539|NCT01388946|7412966|FG000|NOT COMPLETED|Overall Study||6
6494540|NCT01388946|7412967|FG001|NOT COMPLETED|Overall Study||3
6494541|NCT01388985|7412975|FG000|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
6555349|NCT01751308|7477493|FG003|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
6555350|NCT01751308|7477494|FG004|COMPLETED|Phase 1||0
6555351|NCT01751308|7477490|FG000|NOT COMPLETED|Phase 1||0
6555352|NCT01751308|7477491|FG001|NOT COMPLETED|Phase 1||0
6555353|NCT01751308|7477492|FG002|NOT COMPLETED|Phase 1||0
6494542|NCT01388985|7412976|FG001|STARTED|Overall Study|1 participant (from the 250 enrolled) did not receive any vaccination because of consent withdrawal.|249
6494543|NCT01388985|7412975|FG000|Primary Vaccination Period|Overall Study||231
6494544|NCT01388985|7412976|FG001|Primary Vaccination Period|Overall Study||238
6494545|NCT01388985|7412975|FG000|COMPLETED|Overall Study|From those 200, 15 were excluded from the per protocol analysis.|200
6494546|NCT01388985|7412976|FG001|COMPLETED|Overall Study|From those 200, 28 were excluded from the per protocol analysis.|211
6494547|NCT01388985|7412975|FG000|NOT COMPLETED|Overall Study||49
6494548|NCT01388985|7412976|FG001|NOT COMPLETED|Overall Study||38
6494549|NCT01389076|7412982|FG000|STARTED|Overall Study||22
6494550|NCT01389076|7412982|FG000|COMPLETED|Overall Study||22
6494551|NCT01389076|7412982|FG000|NOT COMPLETED|Overall Study||0
6494552|NCT01389102|7412992|FG000|STARTED|Overall Study||75
6494553|NCT01389102|7412993|FG001|STARTED|Overall Study||76
6494554|NCT01389102|7412994|FG002|STARTED|Overall Study||77
6494555|NCT01389102|7412995|FG003|STARTED|Overall Study||76
6494556|NCT01389102|7412996|FG004|STARTED|Overall Study||74
6494557|NCT01389102|7412997|FG005|STARTED|Overall Study||76
6494558|NCT01389102|7412992|FG000|COMPLETED|Overall Study||57
6494559|NCT01389102|7412993|FG001|COMPLETED|Overall Study||64
6494560|NCT01389102|7412994|FG002|COMPLETED|Overall Study||58
6494561|NCT01389102|7412995|FG003|COMPLETED|Overall Study||69
6494562|NCT01389102|7412996|FG004|COMPLETED|Overall Study||61
6494563|NCT01389102|7412997|FG005|COMPLETED|Overall Study||68
6494564|NCT01389102|7412992|FG000|NOT COMPLETED|Overall Study||18
6494565|NCT01389102|7412993|FG001|NOT COMPLETED|Overall Study||12
6494566|NCT01389102|7412994|FG002|NOT COMPLETED|Overall Study||19
6494567|NCT01389102|7412995|FG003|NOT COMPLETED|Overall Study||7
6494568|NCT01389102|7412996|FG004|NOT COMPLETED|Overall Study||13
6494569|NCT01389102|7412997|FG005|NOT COMPLETED|Overall Study||8
6494570|NCT01389128|7413019|FG000|STARTED|Overall Study||40
6494571|NCT01389128|7413020|FG001|STARTED|Overall Study||40
6494572|NCT01389128|7413019|FG000|COMPLETED|Overall Study||35
6494573|NCT01389128|7413020|FG001|COMPLETED|Overall Study||34
6494574|NCT01389128|7413019|FG000|NOT COMPLETED|Overall Study||5
6494575|NCT01389128|7413020|FG001|NOT COMPLETED|Overall Study||6
6494576|NCT01389232|7413030|FG000|STARTED|Overall Study||100
6494577|NCT01389232|7413030|FG000|COMPLETED|Overall Study||81
6494578|NCT01389232|7413030|FG000|NOT COMPLETED|Overall Study||19
6494579|NCT01389245|7413044|FG000|STARTED|Overall Study||42
6494580|NCT01389245|7413044|FG000|COMPLETED|Overall Study||27
6494581|NCT01389245|7413044|FG000|NOT COMPLETED|Overall Study||15
6494582|NCT01389258|7413048|FG000|STARTED|Overall Study||45
6494583|NCT01389258|7413048|FG000|COMPLETED|Overall Study||40
6494584|NCT01389258|7413048|FG000|NOT COMPLETED|Overall Study||5
6494585|NCT01389284|7413055|FG000|STARTED|Overall Study||120
6494586|NCT01389284|7413056|FG001|STARTED|Overall Study||120
6494587|NCT01389284|7413057|FG002|STARTED|Overall Study||60
6494588|NCT01389284|7413055|FG000|COMPLETED|Overall Study||120
6494589|NCT01389284|7413056|FG001|COMPLETED|Overall Study||120
6494590|NCT01389284|7413057|FG002|COMPLETED|Overall Study||60
6494591|NCT01389284|7413055|FG000|NOT COMPLETED|Overall Study||0
6494592|NCT01389284|7413056|FG001|NOT COMPLETED|Overall Study||0
6494593|NCT01389284|7413057|FG002|NOT COMPLETED|Overall Study||0
6494594|NCT01389323|7413065|FG000|STARTED|Treatment Period (up to 48 Weeks)||246
6494595|NCT01389323|7413065|FG000|COMPLETED|Treatment Period (up to 48 Weeks)||151
6494596|NCT01389323|7413065|FG000|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
6494597|NCT01389323|7413065|FG000|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
6494598|NCT01389323|7413065|FG000|COMPLETED|Follow-up Period (up to 48 Weeks)||184
6494599|NCT01389323|7413065|FG000|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
6494600|NCT01389596|7413079|FG000|STARTED|Overall Study||104
6494601|NCT01389596|7413080|FG001|STARTED|Overall Study||97
6494602|NCT01389596|7413081|FG002|STARTED|Overall Study||94
6494603|NCT01389596|7413079|FG000|COMPLETED|Overall Study||94
6494604|NCT01389596|7413080|FG001|COMPLETED|Overall Study||81
6494605|NCT01389596|7413081|FG002|COMPLETED|Overall Study||84
6494606|NCT01389596|7413079|FG000|NOT COMPLETED|Overall Study||10
6494607|NCT01389596|7413080|FG001|NOT COMPLETED|Overall Study||16
6494608|NCT01389596|7413081|FG002|NOT COMPLETED|Overall Study||10
6494609|NCT01389752|7413089|FG000|STARTED|Study Period 1||11
6494610|NCT01389752|7413090|FG001|STARTED|Study Period 1||11
6494611|NCT01389752|7413089|FG000|COMPLETED|Study Period 1||11
6494612|NCT01389752|7413090|FG001|COMPLETED|Study Period 1||9
6494613|NCT01389752|7413089|FG000|NOT COMPLETED|Study Period 1||0
6494614|NCT01389752|7413090|FG001|NOT COMPLETED|Study Period 1||2
6494615|NCT01389752|7413089|FG000|STARTED|Study Period 2||11
6494616|NCT01389752|7413090|FG001|STARTED|Study Period 2||9
6494617|NCT01389752|7413089|FG000|COMPLETED|Study Period 2||10
6494618|NCT01389752|7413090|FG001|COMPLETED|Study Period 2||9
6494619|NCT01389752|7413089|FG000|NOT COMPLETED|Study Period 2||1
6494620|NCT01389752|7413090|FG001|NOT COMPLETED|Study Period 2||0
6494621|NCT01389765|7413097|FG000|STARTED|First Intervention (Day 1)||12
6494622|NCT01389765|7413098|FG001|STARTED|First Intervention (Day 1)||12
6494623|NCT01389765|7413097|FG000|COMPLETED|First Intervention (Day 1)||12
6494624|NCT01389765|7413098|FG001|COMPLETED|First Intervention (Day 1)||12
6494625|NCT01389765|7413097|FG000|NOT COMPLETED|First Intervention (Day 1)||0
6494626|NCT01389765|7413098|FG001|NOT COMPLETED|First Intervention (Day 1)||0
6494627|NCT01389765|7413097|FG000|STARTED|Washout Period (7 Days)||12
6494628|NCT01389765|7413098|FG001|STARTED|Washout Period (7 Days)||12
6494629|NCT01389765|7413097|FG000|COMPLETED|Washout Period (7 Days)||12
6494630|NCT01389765|7413098|FG001|COMPLETED|Washout Period (7 Days)||12
6494631|NCT01389765|7413097|FG000|NOT COMPLETED|Washout Period (7 Days)||0
6494632|NCT01389765|7413098|FG001|NOT COMPLETED|Washout Period (7 Days)||0
6494633|NCT01389765|7413097|FG000|STARTED|Second Intervention (Day 1)||12
6494634|NCT01389765|7413098|FG001|STARTED|Second Intervention (Day 1)||12
6494635|NCT01389765|7413097|FG000|COMPLETED|Second Intervention (Day 1)||12
6494636|NCT01389765|7413098|FG001|COMPLETED|Second Intervention (Day 1)||12
6494637|NCT01389765|7413097|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
6494638|NCT01389765|7413098|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
6494639|NCT01389856|7413106|FG000|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
6494640|NCT01389856|7413107|FG001|STARTED|Overall Study|Randomized and treated.|8
6494641|NCT01389856|7413106|FG000|COMPLETED|Overall Study||13
6494642|NCT01389856|7413107|FG001|COMPLETED|Overall Study||8
6494643|NCT01389856|7413106|FG000|NOT COMPLETED|Overall Study||0
6494644|NCT01389856|7413107|FG001|NOT COMPLETED|Overall Study||0
6494645|NCT01389882|7413115|FG000|STARTED|Overall Study||13
6494646|NCT01389882|7413116|FG001|STARTED|Overall Study||11
6494647|NCT01389882|7413115|FG000|COMPLETED|Overall Study||12
6494648|NCT01389882|7413116|FG001|COMPLETED|Overall Study||7
6494649|NCT01389882|7413115|FG000|NOT COMPLETED|Overall Study||1
6494650|NCT01389882|7413116|FG001|NOT COMPLETED|Overall Study||4
6494651|NCT01389973|7413122|FG000|STARTED|Overall Study||20
6494652|NCT01389973|7413122|FG000|COMPLETED|Overall Study||0
6494653|NCT01389973|7413122|FG000|NOT COMPLETED|Overall Study||20
6494654|NCT01390038|7413126|FG000|STARTED|Overall Study||157
6494655|NCT01390038|7413126|FG000|COMPLETED|Overall Study||149
6494656|NCT01390038|7413126|FG000|NOT COMPLETED|Overall Study||8
6494657|NCT01390064|7413132|FG000|STARTED|Overall Study||3
6494658|NCT01390064|7413133|FG001|STARTED|Overall Study||3
6494659|NCT01390064|7413132|FG000|COMPLETED|Overall Study||3
6494660|NCT01390064|7413133|FG001|COMPLETED|Overall Study||3
6494661|NCT01390064|7413132|FG000|NOT COMPLETED|Overall Study||0
6494662|NCT01390064|7413133|FG001|NOT COMPLETED|Overall Study||0
6494663|NCT01390077|7413139|FG000|STARTED|Overall Study||8
6494664|NCT01390077|7413139|FG000|Treatment|Overall Study||7
6494665|NCT01390077|7413139|FG000|COMPLETED|Overall Study||7
6494666|NCT01390077|7413139|FG000|NOT COMPLETED|Overall Study||1
6494667|NCT01390220|7413148|FG000|STARTED|Test Dose Phase||292
6494668|NCT01390220|7413149|FG001|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
6494669|NCT01390220|7413150|FG002|STARTED|Test Dose Phase|This arm not applicable in TDP.|0
6494670|NCT01390220|7413148|FG000|COMPLETED|Test Dose Phase||201
6494671|NCT01390220|7413149|FG001|COMPLETED|Test Dose Phase||0
6494672|NCT01390220|7413150|FG002|COMPLETED|Test Dose Phase||0
6494673|NCT01390220|7413148|FG000|NOT COMPLETED|Test Dose Phase||91
6494674|NCT01390220|7413149|FG001|NOT COMPLETED|Test Dose Phase||0
6494675|NCT01390220|7413150|FG002|NOT COMPLETED|Test Dose Phase||0
6494676|NCT01390220|7413148|FG000|STARTED|Comparative Phase|This arm not applicable in CP|0
6555354|NCT01751308|7477493|FG003|NOT COMPLETED|Phase 1||0
6555355|NCT01751308|7477494|FG004|NOT COMPLETED|Phase 1||0
6555356|NCT01751308|7477490|FG000|STARTED|Phase 2||0
6555357|NCT01751308|7477491|FG001|STARTED|Phase 2||0
6555358|NCT01751308|7477492|FG002|STARTED|Phase 2||0
6555359|NCT01751308|7477493|FG003|STARTED|Phase 2||0
6494677|NCT01390220|7413149|FG001|STARTED|Comparative Phase||134
6494678|NCT01390220|7413150|FG002|STARTED|Comparative Phase||67
6494679|NCT01390220|7413148|FG000|COMPLETED|Comparative Phase|This arm not applicable in CP|0
6494680|NCT01390220|7413149|FG001|COMPLETED|Comparative Phase||133
6494681|NCT01390220|7413150|FG002|COMPLETED|Comparative Phase||67
6494682|NCT01390220|7413148|FG000|NOT COMPLETED|Comparative Phase||0
6494683|NCT01390220|7413149|FG001|NOT COMPLETED|Comparative Phase||1
6494684|NCT01390220|7413150|FG002|NOT COMPLETED|Comparative Phase||0
6494685|NCT01390233|7413162|FG000|STARTED|Overall Study||35
6494686|NCT01390233|7413163|FG001|STARTED|Overall Study||31
6494687|NCT01390233|7413164|FG002|STARTED|Overall Study||36
6494688|NCT01390233|7413162|FG000|COMPLETED|Overall Study||30
6494689|NCT01390233|7413163|FG001|COMPLETED|Overall Study||29
6494690|NCT01390233|7413164|FG002|COMPLETED|Overall Study||30
6494691|NCT01390233|7413162|FG000|NOT COMPLETED|Overall Study||5
6494692|NCT01390233|7413163|FG001|NOT COMPLETED|Overall Study||2
6494693|NCT01390233|7413164|FG002|NOT COMPLETED|Overall Study||6
6494694|NCT01390246|7413174|FG000|STARTED|Overall Study||30
6494695|NCT01390246|7413175|FG001|STARTED|Overall Study||35
6494696|NCT01390246|7413174|FG000|Visit 2: Quit Day|Overall Study||24
6555360|NCT01751308|7477494|FG004|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
6494697|NCT01390246|7413175|FG001|Visit 2: Quit Day|Overall Study||24
6494698|NCT01390246|7413174|FG000|Visit 6: End of Treatment|Overall Study||15
6494699|NCT01390246|7413175|FG001|Visit 6: End of Treatment|Overall Study||15
6494700|NCT01390246|7413174|FG000|Visit 7: 36-38 Weeks Gestation|Overall Study||10
6494701|NCT01390246|7413175|FG001|Visit 7: 36-38 Weeks Gestation|Overall Study||10
6494702|NCT01390246|7413174|FG000|COMPLETED|Overall Study||10
6494703|NCT01390246|7413175|FG001|COMPLETED|Overall Study||10
6555361|NCT01751308|7477490|FG000|COMPLETED|Phase 2||0
6494704|NCT01390246|7413174|FG000|NOT COMPLETED|Overall Study||20
6494705|NCT01390246|7413175|FG001|NOT COMPLETED|Overall Study||25
6494706|NCT01390259|7413181|FG000|STARTED|Overall Study||5
6494707|NCT01390259|7413182|FG001|STARTED|Overall Study||6
6494708|NCT01390259|7413181|FG000|COMPLETED|Overall Study||5
6494709|NCT01390259|7413182|FG001|COMPLETED|Overall Study||6
6494710|NCT01390259|7413181|FG000|NOT COMPLETED|Overall Study||0
6494711|NCT01390259|7413182|FG001|NOT COMPLETED|Overall Study||0
6494712|NCT01390272|7413189|FG000|STARTED|Overall Study||192
6555362|NCT01751308|7477491|FG001|COMPLETED|Phase 2||0
6555363|NCT01751308|7477492|FG002|COMPLETED|Phase 2||0
6750118|NCT03426995|7677325|FG018|COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6494713|NCT01390272|7413190|FG001|STARTED|Overall Study||193
6494714|NCT01390272|7413189|FG000|6 Month Follow up|Overall Study|30 of 192 participants in the Titration Intervention group had missing blood pressure measurement|162
6494715|NCT01390272|7413190|FG001|6 Month Follow up|Overall Study|22 of 193 in the LPN control group had missing blood pressure measurement|171
6494716|NCT01390272|7413189|FG000|12 Month Follow up|Overall Study|53 of 192 participants in the Titration Intervention group had missing measurement|139
6494717|NCT01390272|7413190|FG001|12 Month Follow up|Overall Study|34 of 193 in the LPN control group had missing blood pressure measurement|159
6494718|NCT01390272|7413189|FG000|18 Month Follow up|Overall Study|37 of 192 participants in the Titration Intervention group had missing blood pressure measurement|155
6494719|NCT01390272|7413190|FG001|18 Month Follow up|Overall Study|33 of 193 in the LPN control group had missing blood pressure measurement|160
6494720|NCT01390272|7413189|FG000|COMPLETED|Overall Study||175
6494721|NCT01390272|7413190|FG001|COMPLETED|Overall Study||178
6494722|NCT01390272|7413189|FG000|NOT COMPLETED|Overall Study||17
6494723|NCT01390272|7413190|FG001|NOT COMPLETED|Overall Study||15
6494724|NCT01390298|7413196|FG000|STARTED|Overall Study||55
6494725|NCT01390298|7413196|FG000|COMPLETED|Overall Study||31
6494726|NCT01390298|7413196|FG000|NOT COMPLETED|Overall Study||24
6494727|NCT01390389|7413202|FG000|STARTED|Overall Study||10
6494728|NCT01390389|7413203|FG001|STARTED|Overall Study||9
6494729|NCT01390389|7413202|FG000|COMPLETED|Overall Study||6
6494730|NCT01390389|7413203|FG001|COMPLETED|Overall Study||8
6494731|NCT01390389|7413202|FG000|NOT COMPLETED|Overall Study||4
6494732|NCT01390389|7413203|FG001|NOT COMPLETED|Overall Study||1
6494733|NCT01390402|7413213|FG000|STARTED|Overall Study||6
6494734|NCT01390402|7413213|FG000|COMPLETED|Overall Study||1
6494735|NCT01390402|7413213|FG000|NOT COMPLETED|Overall Study||5
6494736|NCT01390428|7413223|FG000|STARTED|Overall Study||8
6494737|NCT01390428|7413224|FG001|STARTED|Overall Study||8
6494738|NCT01390428|7413225|FG002|STARTED|Overall Study||9
6494739|NCT01390428|7413226|FG003|STARTED|Overall Study||9
6494740|NCT01390428|7413227|FG004|STARTED|Overall Study||8
6494741|NCT01390428|7413228|FG005|STARTED|Overall Study||8
6494742|NCT01390428|7413223|FG000|COMPLETED|Overall Study||8
6494743|NCT01390428|7413224|FG001|COMPLETED|Overall Study||8
6494744|NCT01390428|7413225|FG002|COMPLETED|Overall Study||8
6494745|NCT01390428|7413226|FG003|COMPLETED|Overall Study||9
6494746|NCT01390428|7413227|FG004|COMPLETED|Overall Study||7
6494747|NCT01390428|7413228|FG005|COMPLETED|Overall Study||8
6494748|NCT01390428|7413223|FG000|NOT COMPLETED|Overall Study||0
6494749|NCT01390428|7413224|FG001|NOT COMPLETED|Overall Study||0
6494750|NCT01390428|7413225|FG002|NOT COMPLETED|Overall Study||1
6494751|NCT01390428|7413226|FG003|NOT COMPLETED|Overall Study||0
6494752|NCT01390428|7413227|FG004|NOT COMPLETED|Overall Study||1
6494753|NCT01390428|7413228|FG005|NOT COMPLETED|Overall Study||0
6494754|NCT01390441|7413247|FG000|STARTED|Treatment Period||23
6494755|NCT01390441|7413248|FG001|STARTED|Treatment Period||22
6494756|NCT01390441|7413249|FG002|STARTED|Treatment Period||18
6494757|NCT01390441|7413250|FG003|STARTED|Treatment Period||19
6494758|NCT01390441|7413251|FG004|STARTED|Treatment Period||18
6494759|NCT01390441|7413247|FG000|COMPLETED|Treatment Period||22
6750119|NCT03426995|7677307|FG000|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750120|NCT03426995|7677308|FG001|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750121|NCT03426995|7677309|FG002|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750122|NCT03426995|7677310|FG003|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6494760|NCT01390441|7413248|FG001|COMPLETED|Treatment Period||21
6494761|NCT01390441|7413249|FG002|COMPLETED|Treatment Period||8
6494762|NCT01390441|7413250|FG003|COMPLETED|Treatment Period||6
6494763|NCT01390441|7413251|FG004|COMPLETED|Treatment Period||7
6494764|NCT01390441|7413247|FG000|NOT COMPLETED|Treatment Period||1
6494765|NCT01390441|7413248|FG001|NOT COMPLETED|Treatment Period||1
6494766|NCT01390441|7413249|FG002|NOT COMPLETED|Treatment Period||10
6494767|NCT01390441|7413250|FG003|NOT COMPLETED|Treatment Period||13
6494768|NCT01390441|7413251|FG004|NOT COMPLETED|Treatment Period||11
6494769|NCT01390441|7413247|FG000|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
6494770|NCT01390441|7413248|FG001|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
6494771|NCT01390441|7413249|FG002|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
6494772|NCT01390441|7413250|FG003|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
6494773|NCT01390441|7413251|FG004|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
6494774|NCT01390441|7413247|FG000|COMPLETED|Extension Period||12
6750123|NCT03426995|7677311|FG004|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6494775|NCT01390441|7413248|FG001|COMPLETED|Extension Period||12
6494776|NCT01390441|7413249|FG002|COMPLETED|Extension Period||1
6494777|NCT01390441|7413250|FG003|COMPLETED|Extension Period||0
6494778|NCT01390441|7413251|FG004|COMPLETED|Extension Period||3
6494779|NCT01390441|7413247|FG000|NOT COMPLETED|Extension Period||3
6494780|NCT01390441|7413248|FG001|NOT COMPLETED|Extension Period||1
6494781|NCT01390441|7413249|FG002|NOT COMPLETED|Extension Period||0
6494782|NCT01390441|7413250|FG003|NOT COMPLETED|Extension Period||1
6494783|NCT01390441|7413251|FG004|NOT COMPLETED|Extension Period||0
6494784|NCT01390584|7413291|FG000|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||4
6494785|NCT01390584|7413292|FG001|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
6494786|NCT01390584|7413293|FG002|STARTED|Step 1: Induction Tx (ABVD Then PET/CT)||1
6494787|NCT01390584|7413291|FG000|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||4
6494788|NCT01390584|7413292|FG001|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
6494789|NCT01390584|7413293|FG002|COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
6494790|NCT01390584|7413291|FG000|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
6494791|NCT01390584|7413292|FG001|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||0
6494792|NCT01390584|7413293|FG002|NOT COMPLETED|Step 1: Induction Tx (ABVD Then PET/CT)||1
6494793|NCT01390584|7413291|FG000|STARTED|Step 2: ABVD or BEACOPP Then INRT||4
6494794|NCT01390584|7413292|FG001|STARTED|Step 2: ABVD or BEACOPP Then INRT||1
6494795|NCT01390584|7413293|FG002|STARTED|Step 2: ABVD or BEACOPP Then INRT||0
6494796|NCT01390584|7413291|FG000|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||4
6494797|NCT01390584|7413292|FG001|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||1
6494798|NCT01390584|7413293|FG002|COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
6494799|NCT01390584|7413291|FG000|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
6494800|NCT01390584|7413292|FG001|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
6494801|NCT01390584|7413293|FG002|NOT COMPLETED|Step 2: ABVD or BEACOPP Then INRT||0
6494802|NCT01390649|7413302|FG000|STARTED|Overall Study|Subjects treated with Privigen|57
6494803|NCT01390649|7413302|FG000|COMPLETED|Overall Study||56
6494804|NCT01390649|7413302|FG000|NOT COMPLETED|Overall Study||1
6494805|NCT01390779|7413306|FG000|STARTED|Overall Study||33
6494806|NCT01390779|7413306|FG000|COMPLETED|Overall Study||32
6494807|NCT01390779|7413306|FG000|NOT COMPLETED|Overall Study||1
6494808|NCT01390818|7413325|FG000|STARTED|Overall Study||3
6494809|NCT01390818|7413326|FG001|STARTED|Overall Study||3
6494810|NCT01390818|7413327|FG002|STARTED|Overall Study||3
6494811|NCT01390818|7413328|FG003|STARTED|Overall Study||4
6494812|NCT01390818|7413329|FG004|STARTED|Overall Study||4
6494813|NCT01390818|7413330|FG005|STARTED|Overall Study||3
6494814|NCT01390818|7413331|FG006|STARTED|Overall Study||19
6555364|NCT01751308|7477493|FG003|COMPLETED|Phase 2||0
6555365|NCT01751308|7477494|FG004|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
6555366|NCT01751308|7477490|FG000|NOT COMPLETED|Phase 2||0
6555367|NCT01751308|7477491|FG001|NOT COMPLETED|Phase 2||0
6555368|NCT01751308|7477492|FG002|NOT COMPLETED|Phase 2||0
6750124|NCT03426995|7677312|FG005|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6494815|NCT01390818|7413332|FG007|STARTED|Overall Study||14
6494816|NCT01390818|7413333|FG008|STARTED|Overall Study||3
6750125|NCT03426995|7677313|FG006|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750126|NCT03426995|7677314|FG007|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750127|NCT03426995|7677315|FG008|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750128|NCT03426995|7677316|FG009|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750129|NCT03426995|7677317|FG010|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6494817|NCT01390818|7413334|FG009|STARTED|Overall Study||3
6494818|NCT01390818|7413335|FG010|STARTED|Overall Study||4
6494819|NCT01390818|7413336|FG011|STARTED|Overall Study||26
6494820|NCT01390818|7413337|FG012|STARTED|Overall Study||24
6494821|NCT01390818|7413338|FG013|STARTED|Overall Study||18
6494822|NCT01390818|7413339|FG014|STARTED|Overall Study||15
6494823|NCT01390818|7413325|FG000|COMPLETED|Overall Study||3
6494824|NCT01390818|7413326|FG001|COMPLETED|Overall Study||3
6494825|NCT01390818|7413327|FG002|COMPLETED|Overall Study||3
6494826|NCT01390818|7413328|FG003|COMPLETED|Overall Study||4
6494827|NCT01390818|7413329|FG004|COMPLETED|Overall Study||4
6494828|NCT01390818|7413330|FG005|COMPLETED|Overall Study||3
6494829|NCT01390818|7413331|FG006|COMPLETED|Overall Study||19
6494830|NCT01390818|7413332|FG007|COMPLETED|Overall Study||14
6494831|NCT01390818|7413333|FG008|COMPLETED|Overall Study||3
6494832|NCT01390818|7413334|FG009|COMPLETED|Overall Study||3
6494833|NCT01390818|7413335|FG010|COMPLETED|Overall Study||4
6494834|NCT01390818|7413336|FG011|COMPLETED|Overall Study||26
6494835|NCT01390818|7413337|FG012|COMPLETED|Overall Study||24
6494836|NCT01390818|7413338|FG013|COMPLETED|Overall Study||18
6494837|NCT01390818|7413339|FG014|COMPLETED|Overall Study||15
6494838|NCT01390818|7413325|FG000|NOT COMPLETED|Overall Study||0
6494839|NCT01390818|7413326|FG001|NOT COMPLETED|Overall Study||0
6494840|NCT01390818|7413327|FG002|NOT COMPLETED|Overall Study||0
6494841|NCT01390818|7413328|FG003|NOT COMPLETED|Overall Study||0
6494842|NCT01390818|7413329|FG004|NOT COMPLETED|Overall Study||0
6494843|NCT01390818|7413330|FG005|NOT COMPLETED|Overall Study||0
6494844|NCT01390818|7413331|FG006|NOT COMPLETED|Overall Study||0
6494845|NCT01390818|7413332|FG007|NOT COMPLETED|Overall Study||0
6494846|NCT01390818|7413333|FG008|NOT COMPLETED|Overall Study||0
6494847|NCT01390818|7413334|FG009|NOT COMPLETED|Overall Study||0
6555369|NCT01751308|7477493|FG003|NOT COMPLETED|Phase 2||0
6555370|NCT01751308|7477494|FG004|NOT COMPLETED|Phase 2||0
6494848|NCT01390818|7413335|FG010|NOT COMPLETED|Overall Study||0
6494849|NCT01390818|7413336|FG011|NOT COMPLETED|Overall Study||0
6494850|NCT01390818|7413337|FG012|NOT COMPLETED|Overall Study||0
6494851|NCT01390818|7413338|FG013|NOT COMPLETED|Overall Study||0
6494852|NCT01390818|7413339|FG014|NOT COMPLETED|Overall Study||0
6494853|NCT01390844|7413443|FG000|STARTED|Treatment Phase||133
6494854|NCT01390844|7413444|FG001|STARTED|Treatment Phase||65
6494855|NCT01390844|7413445|FG002|STARTED|Treatment Phase||57
6494856|NCT01390844|7413446|FG003|STARTED|Treatment Phase||27
6494857|NCT01390844|7413443|FG000|Followed Good Clinical Practice (GCP)|Treatment Phase||133
6494858|NCT01390844|7413444|FG001|Followed Good Clinical Practice (GCP)|Treatment Phase||65
6494859|NCT01390844|7413445|FG002|Followed Good Clinical Practice (GCP)|Treatment Phase||47
6494860|NCT01390844|7413446|FG003|Followed Good Clinical Practice (GCP)|Treatment Phase||24
6494861|NCT01390844|7413443|FG000|COMPLETED|Treatment Phase||93
6494862|NCT01390844|7413444|FG001|COMPLETED|Treatment Phase||37
6494863|NCT01390844|7413445|FG002|COMPLETED|Treatment Phase||26
6494864|NCT01390844|7413446|FG003|COMPLETED|Treatment Phase||8
6494865|NCT01390844|7413443|FG000|NOT COMPLETED|Treatment Phase||40
6494866|NCT01390844|7413444|FG001|NOT COMPLETED|Treatment Phase||28
6494867|NCT01390844|7413445|FG002|NOT COMPLETED|Treatment Phase||31
6494868|NCT01390844|7413446|FG003|NOT COMPLETED|Treatment Phase||19
6494869|NCT01390844|7413443|FG000|STARTED|Follow-Up Phase||93
6494870|NCT01390844|7413444|FG001|STARTED|Follow-Up Phase||37
6494871|NCT01390844|7413445|FG002|STARTED|Follow-Up Phase||26
6494872|NCT01390844|7413446|FG003|STARTED|Follow-Up Phase||8
6494873|NCT01390844|7413443|FG000|COMPLETED|Follow-Up Phase||92
6494874|NCT01390844|7413444|FG001|COMPLETED|Follow-Up Phase||36
6494875|NCT01390844|7413445|FG002|COMPLETED|Follow-Up Phase||25
6494876|NCT01390844|7413446|FG003|COMPLETED|Follow-Up Phase||8
6494877|NCT01390844|7413443|FG000|NOT COMPLETED|Follow-Up Phase||1
6494878|NCT01390844|7413444|FG001|NOT COMPLETED|Follow-Up Phase||1
6494879|NCT01390844|7413445|FG002|NOT COMPLETED|Follow-Up Phase||1
6494880|NCT01390844|7413446|FG003|NOT COMPLETED|Follow-Up Phase||0
6494881|NCT01390857|7413456|FG000|STARTED|Overall Study||379
6494882|NCT01390857|7413456|FG000|COMPLETED|Overall Study||369
6494883|NCT01390857|7413456|FG000|NOT COMPLETED|Overall Study||10
6494884|NCT01390870|7413460|FG000|STARTED|Overall Study||400
6494885|NCT01390870|7413460|FG000|COMPLETED|Overall Study||400
6494886|NCT01390870|7413460|FG000|NOT COMPLETED|Overall Study||0
6494887|NCT01390909|7413470|FG000|STARTED|Overall Study||3454
6494888|NCT01390909|7413471|FG001|STARTED|Overall Study||3552
6494889|NCT01390909|7413472|FG002|STARTED|Overall Study||3552
6494890|NCT01390909|7413473|FG003|STARTED|Overall Study||602
6494891|NCT01390909|7413474|FG004|STARTED|Overall Study||613
6494892|NCT01390909|7413475|FG005|STARTED|Overall Study||613
6494893|NCT01390909|7413470|FG000|Participants in Subgroup|Overall Study||0
6494894|NCT01390909|7413471|FG001|Participants in Subgroup|Overall Study||3454
6494895|NCT01390909|7413472|FG002|Participants in Subgroup|Overall Study||0
6494896|NCT01390909|7413473|FG003|Participants in Subgroup|Overall Study||0
6494897|NCT01390909|7413474|FG004|Participants in Subgroup|Overall Study||602
6494898|NCT01390909|7413475|FG005|Participants in Subgroup|Overall Study||0
6494899|NCT01390909|7413470|FG000|COMPLETED|Overall Study||3454
6494900|NCT01390909|7413471|FG001|COMPLETED|Overall Study||3552
6494901|NCT01390909|7413472|FG002|COMPLETED|Overall Study||3552
6494902|NCT01390909|7413473|FG003|COMPLETED|Overall Study||602
6494903|NCT01390909|7413474|FG004|COMPLETED|Overall Study||613
6494904|NCT01390909|7413475|FG005|COMPLETED|Overall Study||613
6494905|NCT01390909|7413470|FG000|NOT COMPLETED|Overall Study||0
6494906|NCT01390909|7413471|FG001|NOT COMPLETED|Overall Study||0
6494907|NCT01390909|7413472|FG002|NOT COMPLETED|Overall Study||0
6494908|NCT01390909|7413473|FG003|NOT COMPLETED|Overall Study||0
6494909|NCT01390909|7413474|FG004|NOT COMPLETED|Overall Study||0
6494910|NCT01390909|7413475|FG005|NOT COMPLETED|Overall Study||0
6494911|NCT01390948|7413496|FG000|STARTED|Overall Study||59
6494912|NCT01390948|7413497|FG001|STARTED|Overall Study||62
6494913|NCT01390948|7413498|FG002|STARTED|Overall Study||3
6494914|NCT01390948|7413496|FG000|Treated|Overall Study||56
6494915|NCT01390948|7413497|FG001|Treated|Overall Study||60
6494916|NCT01390948|7413498|FG002|Treated|Overall Study||3
6494917|NCT01390948|7413496|FG000|COMPLETED|Overall Study||44
6494918|NCT01390948|7413497|FG001|COMPLETED|Overall Study||44
6494919|NCT01390948|7413498|FG002|COMPLETED|Overall Study||2
6494920|NCT01390948|7413496|FG000|NOT COMPLETED|Overall Study||15
6494921|NCT01390948|7413497|FG001|NOT COMPLETED|Overall Study||18
6494922|NCT01390948|7413498|FG002|NOT COMPLETED|Overall Study||1
6494923|NCT01391000|7413507|FG000|STARTED|Overall Study||35
6750130|NCT03426995|7677318|FG011|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750131|NCT03426995|7677319|FG012|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6494924|NCT01391000|7413508|FG001|STARTED|Overall Study||35
6494925|NCT01391000|7413507|FG000|COMPLETED|Overall Study||33
6494926|NCT01391000|7413508|FG001|COMPLETED|Overall Study||35
6494927|NCT01391000|7413507|FG000|NOT COMPLETED|Overall Study||2
6494928|NCT01391000|7413508|FG001|NOT COMPLETED|Overall Study||0
6494929|NCT01391013|7413516|FG000|STARTED|Overall Study||15
6494930|NCT01391013|7413517|FG001|STARTED|Overall Study||15
6494931|NCT01391013|7413516|FG000|COMPLETED|Overall Study||15
6494932|NCT01391013|7413517|FG001|COMPLETED|Overall Study||15
6494933|NCT01391013|7413516|FG000|NOT COMPLETED|Overall Study||0
6494934|NCT01391013|7413517|FG001|NOT COMPLETED|Overall Study||0
6494935|NCT01391130|7413525|FG000|STARTED|Overall Study||73
6494936|NCT01391130|7413526|FG001|STARTED|Overall Study||37
6494937|NCT01391130|7413525|FG000|Received At Least One Dose of Study Drug|Overall Study||72
6494938|NCT01391130|7413526|FG001|Received At Least One Dose of Study Drug|Overall Study||36
6494939|NCT01391130|7413525|FG000|COMPLETED|Overall Study||67
6494940|NCT01391130|7413526|FG001|COMPLETED|Overall Study||31
6494941|NCT01391130|7413525|FG000|NOT COMPLETED|Overall Study||6
6494942|NCT01391130|7413526|FG001|NOT COMPLETED|Overall Study||6
6494943|NCT01391273|7413534|FG000|STARTED|Overall Study||88
6494944|NCT01391273|7413535|FG001|STARTED|Overall Study||85
6494945|NCT01391273|7413534|FG000|COMPLETED|Overall Study||84
6494946|NCT01391273|7413535|FG001|COMPLETED|Overall Study||83
6494947|NCT01391273|7413534|FG000|NOT COMPLETED|Overall Study||4
6494948|NCT01391273|7413535|FG001|NOT COMPLETED|Overall Study||2
6494949|NCT01391286|7413543|FG000|STARTED|Overall Study||18
6494950|NCT01391286|7413544|FG001|STARTED|Overall Study||18
6494951|NCT01391286|7413543|FG000|COMPLETED|Overall Study||18
6494952|NCT01391286|7413544|FG001|COMPLETED|Overall Study||18
6494953|NCT01391286|7413543|FG000|NOT COMPLETED|Overall Study||0
6494954|NCT01391286|7413544|FG001|NOT COMPLETED|Overall Study||0
6494955|NCT01391299|7413553|FG000|STARTED|Overall Study||57
6494956|NCT01391299|7413554|FG001|STARTED|Overall Study||60
6494957|NCT01391299|7413555|FG002|STARTED|Overall Study||58
6494958|NCT01391299|7413553|FG000|COMPLETED|Overall Study||57
6494959|NCT01391299|7413554|FG001|COMPLETED|Overall Study||59
6494960|NCT01391299|7413555|FG002|COMPLETED|Overall Study||56
6494961|NCT01391299|7413553|FG000|NOT COMPLETED|Overall Study||0
6494962|NCT01391299|7413554|FG001|NOT COMPLETED|Overall Study||1
6494963|NCT01391299|7413555|FG002|NOT COMPLETED|Overall Study||2
6494964|NCT01391312|7413565|FG000|STARTED|Overall Study||20
6494965|NCT01391312|7413566|FG001|STARTED|Overall Study||20
6494966|NCT01391312|7413565|FG000|COMPLETED|Overall Study||18
6494967|NCT01391312|7413566|FG001|COMPLETED|Overall Study||19
6494968|NCT01391312|7413565|FG000|NOT COMPLETED|Overall Study||2
6494969|NCT01391312|7413566|FG001|NOT COMPLETED|Overall Study||1
6494970|NCT01391325|7413572|FG000|STARTED|Overall Study||1732
6494971|NCT01391325|7413572|FG000|COMPLETED|Overall Study||1238
6494972|NCT01391325|7413572|FG000|NOT COMPLETED|Overall Study||494
6494973|NCT01391364|7413578|FG000|STARTED|Overall Study||222
6494974|NCT01391364|7413579|FG001|STARTED|Overall Study||216
6494975|NCT01391364|7413578|FG000|COMPLETED|Overall Study||217
6494976|NCT01391364|7413579|FG001|COMPLETED|Overall Study||214
6494977|NCT01391364|7413578|FG000|NOT COMPLETED|Overall Study||5
6494978|NCT01391364|7413579|FG001|NOT COMPLETED|Overall Study||2
6494979|NCT01391468|7413587|FG000|STARTED|Overall Study||24
6494980|NCT01391468|7413588|FG001|STARTED|Overall Study||23
6494981|NCT01391468|7413587|FG000|COMPLETED|Overall Study||18
6494982|NCT01391468|7413588|FG001|COMPLETED|Overall Study||21
6494983|NCT01391468|7413587|FG000|NOT COMPLETED|Overall Study||6
6494984|NCT01391468|7413588|FG001|NOT COMPLETED|Overall Study||2
6494985|NCT01391507|7413603|FG000|STARTED|Overall Study||10
6494986|NCT01391507|7413604|FG001|STARTED|Overall Study||8
6555371|NCT01751386|7477512|FG000|STARTED|Overall Study||20
6555372|NCT01751386|7477513|FG001|STARTED|Overall Study||19
6494987|NCT01391507|7413605|FG002|STARTED|Overall Study||6
6494988|NCT01391507|7413606|FG003|STARTED|Overall Study||12
6494989|NCT01391507|7413603|FG000|COMPLETED|Overall Study||6
6494990|NCT01391507|7413604|FG001|COMPLETED|Overall Study||4
6494991|NCT01391507|7413605|FG002|COMPLETED|Overall Study||2
6494992|NCT01391507|7413606|FG003|COMPLETED|Overall Study||5
6494993|NCT01391507|7413603|FG000|NOT COMPLETED|Overall Study||4
6494994|NCT01391507|7413604|FG001|NOT COMPLETED|Overall Study||4
6494995|NCT01391507|7413605|FG002|NOT COMPLETED|Overall Study||4
6494996|NCT01391507|7413606|FG003|NOT COMPLETED|Overall Study||7
6494997|NCT01391546|7413618|FG000|STARTED|Overall Study||177
6494998|NCT01391546|7413619|FG001|STARTED|Overall Study||177
6494999|NCT01391546|7413618|FG000|Vaccinated|Overall Study||176
6495000|NCT01391546|7413619|FG001|Vaccinated|Overall Study||177
6495001|NCT01391546|7413618|FG000|COMPLETED|Overall Study||176
6495002|NCT01391546|7413619|FG001|COMPLETED|Overall Study||177
6495003|NCT01391546|7413618|FG000|NOT COMPLETED|Overall Study||1
6495004|NCT01391546|7413619|FG001|NOT COMPLETED|Overall Study||0
6495005|NCT01391559|7413626|FG000|STARTED|First Intervention||10
6495006|NCT01391559|7413627|FG001|STARTED|First Intervention||10
6495007|NCT01391559|7413626|FG000|COMPLETED|First Intervention||10
6495008|NCT01391559|7413627|FG001|COMPLETED|First Intervention||10
6495009|NCT01391559|7413626|FG000|NOT COMPLETED|First Intervention||0
6495010|NCT01391559|7413627|FG001|NOT COMPLETED|First Intervention||0
6495011|NCT01391559|7413626|FG000|STARTED|Second Intervention||10
6495012|NCT01391559|7413627|FG001|STARTED|Second Intervention||10
6495013|NCT01391559|7413626|FG000|COMPLETED|Second Intervention||10
6495014|NCT01391559|7413627|FG001|COMPLETED|Second Intervention||10
6495015|NCT01391559|7413626|FG000|NOT COMPLETED|Second Intervention||0
6495016|NCT01391559|7413627|FG001|NOT COMPLETED|Second Intervention||0
6555373|NCT01751386|7477512|FG000|COMPLETED|Overall Study||18
6495017|NCT01391611|7413633|FG000|STARTED|Overall Study||25
6495018|NCT01391611|7413633|FG000|COMPLETED|Overall Study||3
6495019|NCT01391611|7413633|FG000|NOT COMPLETED|Overall Study||22
6495020|NCT01391663|7413641|FG000|STARTED|Overall Study||12
6495021|NCT01391663|7413642|FG001|STARTED|Overall Study||12
6495022|NCT01391663|7413643|FG002|STARTED|Overall Study||12
6495023|NCT01391663|7413644|FG003|STARTED|Overall Study||12
6495024|NCT01391663|7413641|FG000|COMPLETED|Overall Study||12
6495025|NCT01391663|7413642|FG001|COMPLETED|Overall Study||12
6495026|NCT01391663|7413643|FG002|COMPLETED|Overall Study||11
6495027|NCT01391663|7413644|FG003|COMPLETED|Overall Study||12
6495028|NCT01391663|7413641|FG000|NOT COMPLETED|Overall Study||0
6495029|NCT01391663|7413642|FG001|NOT COMPLETED|Overall Study||0
6495030|NCT01391663|7413643|FG002|NOT COMPLETED|Overall Study||1
6495031|NCT01391663|7413644|FG003|NOT COMPLETED|Overall Study||0
6495032|NCT01391793|7413656|FG000|STARTED|Overall Study||271
6495033|NCT01391793|7413657|FG001|STARTED|Overall Study||275
6495034|NCT01391793|7413656|FG000|Had a Positive Urine Culture|Overall Study||197
6495035|NCT01391793|7413657|FG001|Had a Positive Urine Culture|Overall Study||188
6495036|NCT01391793|7413656|FG000|COMPLETED|Overall Study||124
6495037|NCT01391793|7413657|FG001|COMPLETED|Overall Study||131
6495038|NCT01391793|7413656|FG000|NOT COMPLETED|Overall Study||147
6495039|NCT01391793|7413657|FG001|NOT COMPLETED|Overall Study||144
6495040|NCT01391819|7413663|FG000|STARTED|Overall Study||2116
6495041|NCT01391819|7413663|FG000|COMPLETED|Overall Study||1714
6495042|NCT01391819|7413663|FG000|NOT COMPLETED|Overall Study||402
6495043|NCT01391832|7413672|FG000|STARTED|Overall Study||49
6495044|NCT01391832|7413673|FG001|STARTED|Overall Study||54
6495045|NCT01391832|7413672|FG000|1 Month Follow-Up|Overall Study||30
6495046|NCT01391832|7413673|FG001|1 Month Follow-Up|Overall Study||31
6495047|NCT01391832|7413672|FG000|3 Month Follow-Up|Overall Study||28
6495048|NCT01391832|7413673|FG001|3 Month Follow-Up|Overall Study||29
6495049|NCT01391832|7413672|FG000|COMPLETED|Overall Study||28
6654758|NCT02448303|7584692|FG001|STARTED|Overall Study||36
6654759|NCT02448303|7584691|FG000|Enrolled|Overall Study||38
6654760|NCT02448303|7584692|FG001|Enrolled|Overall Study||36
6654761|NCT02448303|7584691|FG000|Received Study Medication|Overall Study||33
6654762|NCT02448303|7584692|FG001|Received Study Medication|Overall Study||35
6654763|NCT02448303|7584691|FG000|Discontinued Study|Overall Study||38
6654764|NCT02448303|7584692|FG001|Discontinued Study|Overall Study||36
6654765|NCT02448303|7584691|FG000|COMPLETED|Overall Study||0
6654766|NCT02448303|7584692|FG001|COMPLETED|Overall Study||0
6654767|NCT02448303|7584691|FG000|NOT COMPLETED|Overall Study||38
6654768|NCT02448303|7584692|FG001|NOT COMPLETED|Overall Study||36
6654769|NCT02448368|7584700|FG000|STARTED|Overall Study||2
6495050|NCT01391832|7413673|FG001|COMPLETED|Overall Study||31
6495051|NCT01391832|7413672|FG000|NOT COMPLETED|Overall Study||21
6495052|NCT01391832|7413673|FG001|NOT COMPLETED|Overall Study||23
6495053|NCT01391858|7413681|FG000|STARTED|Overall Study||25
6495054|NCT01391858|7413682|FG001|STARTED|Overall Study||24
6495055|NCT01391858|7413681|FG000|COMPLETED|Overall Study||23
6495056|NCT01391858|7413682|FG001|COMPLETED|Overall Study||24
6495057|NCT01391858|7413681|FG000|NOT COMPLETED|Overall Study||2
6495058|NCT01391858|7413682|FG001|NOT COMPLETED|Overall Study||0
6495059|NCT01392053|7413690|FG000|STARTED|Overall Study||23
6495060|NCT01392053|7413691|FG001|STARTED|Overall Study||23
6495061|NCT01392053|7413690|FG000|COMPLETED|Overall Study||23
6495062|NCT01392053|7413691|FG001|COMPLETED|Overall Study||23
6495063|NCT01392053|7413690|FG000|NOT COMPLETED|Overall Study||0
6495064|NCT01392053|7413691|FG001|NOT COMPLETED|Overall Study||0
6495065|NCT01392183|7413699|FG000|STARTED|First Drug Administration||35
6495066|NCT01392183|7413700|FG001|STARTED|First Drug Administration||34
6495067|NCT01392183|7413699|FG000|Eligible to Cross Over to 2nd Drug|First Drug Administration||29
6495068|NCT01392183|7413700|FG001|Eligible to Cross Over to 2nd Drug|First Drug Administration||31
6495069|NCT01392183|7413699|FG000|COMPLETED|First Drug Administration||21
6495070|NCT01392183|7413700|FG001|COMPLETED|First Drug Administration||15
6495071|NCT01392183|7413699|FG000|NOT COMPLETED|First Drug Administration||14
6495072|NCT01392183|7413700|FG001|NOT COMPLETED|First Drug Administration||19
6495073|NCT01392183|7413699|FG000|STARTED|Second Drug Administration||21
6495074|NCT01392183|7413700|FG001|STARTED|Second Drug Administration||15
6495075|NCT01392183|7413699|FG000|Treatment Ended: Progression|Second Drug Administration||18
6495076|NCT01392183|7413700|FG001|Treatment Ended: Progression|Second Drug Administration||11
6495077|NCT01392183|7413699|FG000|Treatment Ended: Adverse Events|Second Drug Administration||1
6495078|NCT01392183|7413700|FG001|Treatment Ended: Adverse Events|Second Drug Administration||2
6495079|NCT01392183|7413699|FG000|Treatment Ended: Participant Withdrew|Second Drug Administration||2
6495080|NCT01392183|7413700|FG001|Treatment Ended: Participant Withdrew|Second Drug Administration||1
6495081|NCT01392183|7413699|FG000|Treatment Ended: Death|Second Drug Administration||0
6495082|NCT01392183|7413700|FG001|Treatment Ended: Death|Second Drug Administration||1
6495083|NCT01392183|7413699|FG000|COMPLETED|Second Drug Administration||21
6495084|NCT01392183|7413700|FG001|COMPLETED|Second Drug Administration||15
6495085|NCT01392183|7413699|FG000|NOT COMPLETED|Second Drug Administration||0
6495086|NCT01392183|7413700|FG001|NOT COMPLETED|Second Drug Administration||0
6495087|NCT01392300|7413710|FG000|STARTED|Main Period (MP)||210
6495088|NCT01392300|7413711|FG001|STARTED|Main Period (MP)||107
6495089|NCT01392300|7413712|FG002|STARTED|Main Period (MP)||0
6495090|NCT01392300|7413710|FG000|COMPLETED|Main Period (MP)||199
6495091|NCT01392300|7413711|FG001|COMPLETED|Main Period (MP)||100
6495092|NCT01392300|7413712|FG002|COMPLETED|Main Period (MP)||0
6495093|NCT01392300|7413710|FG000|NOT COMPLETED|Main Period (MP)||11
6495094|NCT01392300|7413711|FG001|NOT COMPLETED|Main Period (MP)||7
6495095|NCT01392300|7413712|FG002|NOT COMPLETED|Main Period (MP)||0
6495096|NCT01392300|7413710|FG000|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
6495097|NCT01392300|7413711|FG001|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
6501850|NCT01431521|7420519|FG002|STARTED|Overall Study||11
6495098|NCT01392300|7413712|FG002|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
6495099|NCT01392300|7413710|FG000|COMPLETED|Open Label Extension (OLEX) Period||0
6495100|NCT01392300|7413711|FG001|COMPLETED|Open Label Extension (OLEX) Period||0
6495101|NCT01392300|7413712|FG002|COMPLETED|Open Label Extension (OLEX) Period||248
6495102|NCT01392300|7413710|FG000|NOT COMPLETED|Open Label Extension (OLEX) Period||0
6495103|NCT01392300|7413711|FG001|NOT COMPLETED|Open Label Extension (OLEX) Period||0
6495104|NCT01392300|7413712|FG002|NOT COMPLETED|Open Label Extension (OLEX) Period||51
6495105|NCT01392326|7413722|FG000|STARTED|Overall Study||202
6495106|NCT01392326|7413723|FG001|STARTED|Overall Study||202
6495107|NCT01392326|7413724|FG002|STARTED|Overall Study||202
6495108|NCT01392326|7413722|FG000|COMPLETED|Overall Study||155
6495109|NCT01392326|7413723|FG001|COMPLETED|Overall Study||167
6495110|NCT01392326|7413724|FG002|COMPLETED|Overall Study||154
6495111|NCT01392326|7413722|FG000|NOT COMPLETED|Overall Study||47
6495112|NCT01392326|7413723|FG001|NOT COMPLETED|Overall Study||35
6495113|NCT01392326|7413724|FG002|NOT COMPLETED|Overall Study||48
6495114|NCT01392378|7413737|FG000|STARTED|Infant Series||173
6495115|NCT01392378|7413738|FG001|STARTED|Infant Series||176
6495116|NCT01392378|7413739|FG002|STARTED|Infant Series||172
6495117|NCT01392378|7413740|FG003|STARTED|Infant Series||177
6495118|NCT01392378|7413741|FG004|STARTED|Infant Series||210
6495119|NCT01392378|7413737|FG000|Vaccinated Dose 1|Infant Series||173
6495120|NCT01392378|7413738|FG001|Vaccinated Dose 1|Infant Series||176
6495121|NCT01392378|7413739|FG002|Vaccinated Dose 1|Infant Series||172
6495122|NCT01392378|7413740|FG003|Vaccinated Dose 1|Infant Series||177
6495123|NCT01392378|7413741|FG004|Vaccinated Dose 1|Infant Series||210
6495124|NCT01392378|7413737|FG000|Vaccinated Dose 2|Infant Series||171
6495125|NCT01392378|7413738|FG001|Vaccinated Dose 2|Infant Series||174
6495126|NCT01392378|7413739|FG002|Vaccinated Dose 2|Infant Series||172
6495127|NCT01392378|7413740|FG003|Vaccinated Dose 2|Infant Series||177
6495128|NCT01392378|7413741|FG004|Vaccinated Dose 2|Infant Series||210
6495129|NCT01392378|7413737|FG000|Vaccinated Dose 3|Infant Series||170
6654770|NCT02448368|7584701|FG001|STARTED|Overall Study||2
6654771|NCT02448368|7584702|FG002|STARTED|Overall Study||2
6654772|NCT02448368|7584703|FG003|STARTED|Overall Study||2
6654773|NCT02448368|7584704|FG004|STARTED|Overall Study||2
6654774|NCT02448368|7584705|FG005|STARTED|Overall Study||2
6654775|NCT02448368|7584706|FG006|STARTED|Overall Study||2
6654776|NCT02448368|7584707|FG007|STARTED|Overall Study||2
6654777|NCT02448368|7584708|FG008|STARTED|Overall Study||2
6654778|NCT02448368|7584709|FG009|STARTED|Overall Study||2
6654779|NCT02448368|7584710|FG010|STARTED|Overall Study||5
6654780|NCT02448368|7584711|FG011|STARTED|Overall Study||5
6654781|NCT02448368|7584712|FG012|STARTED|Overall Study||5
6654782|NCT02448368|7584700|FG000|COMPLETED|Overall Study||2
6654783|NCT02448368|7584701|FG001|COMPLETED|Overall Study||2
6495130|NCT01392378|7413738|FG001|Vaccinated Dose 3|Infant Series||174
6495131|NCT01392378|7413739|FG002|Vaccinated Dose 3|Infant Series||172
6495132|NCT01392378|7413740|FG003|Vaccinated Dose 3|Infant Series||176
6495133|NCT01392378|7413741|FG004|Vaccinated Dose 3|Infant Series||210
6495134|NCT01392378|7413737|FG000|COMPLETED|Infant Series||169
6495135|NCT01392378|7413738|FG001|COMPLETED|Infant Series||174
6495136|NCT01392378|7413739|FG002|COMPLETED|Infant Series||172
6495137|NCT01392378|7413740|FG003|COMPLETED|Infant Series||175
6495138|NCT01392378|7413741|FG004|COMPLETED|Infant Series||210
6495139|NCT01392378|7413737|FG000|NOT COMPLETED|Infant Series||4
6495140|NCT01392378|7413738|FG001|NOT COMPLETED|Infant Series||2
6495141|NCT01392378|7413739|FG002|NOT COMPLETED|Infant Series||0
6495142|NCT01392378|7413740|FG003|NOT COMPLETED|Infant Series||2
6495143|NCT01392378|7413741|FG004|NOT COMPLETED|Infant Series||0
6495144|NCT01392378|7413737|FG000|STARTED|After Infant Series||169
6495145|NCT01392378|7413738|FG001|STARTED|After Infant Series||174
6495146|NCT01392378|7413739|FG002|STARTED|After Infant Series||172
6495147|NCT01392378|7413740|FG003|STARTED|After Infant Series||175
6495148|NCT01392378|7413741|FG004|STARTED|After Infant Series||210
6495149|NCT01392378|7413737|FG000|COMPLETED|After Infant Series||169
6495150|NCT01392378|7413738|FG001|COMPLETED|After Infant Series||173
6495151|NCT01392378|7413739|FG002|COMPLETED|After Infant Series||170
6495152|NCT01392378|7413740|FG003|COMPLETED|After Infant Series||175
6495153|NCT01392378|7413741|FG004|COMPLETED|After Infant Series||209
6495154|NCT01392378|7413737|FG000|NOT COMPLETED|After Infant Series||0
6495155|NCT01392378|7413738|FG001|NOT COMPLETED|After Infant Series||1
6495156|NCT01392378|7413739|FG002|NOT COMPLETED|After Infant Series||2
6495157|NCT01392378|7413740|FG003|NOT COMPLETED|After Infant Series||0
6495158|NCT01392378|7413741|FG004|NOT COMPLETED|After Infant Series||1
6495159|NCT01392378|7413737|FG000|STARTED|Toddler Dose||169
6495160|NCT01392378|7413738|FG001|STARTED|Toddler Dose||173
6495161|NCT01392378|7413739|FG002|STARTED|Toddler Dose||170
6495162|NCT01392378|7413740|FG003|STARTED|Toddler Dose||175
6495163|NCT01392378|7413741|FG004|STARTED|Toddler Dose||209
6495164|NCT01392378|7413737|FG000|COMPLETED|Toddler Dose||169
6495165|NCT01392378|7413738|FG001|COMPLETED|Toddler Dose||172
6495166|NCT01392378|7413739|FG002|COMPLETED|Toddler Dose||170
6495167|NCT01392378|7413740|FG003|COMPLETED|Toddler Dose||173
6654784|NCT02448368|7584702|FG002|COMPLETED|Overall Study||2
6654785|NCT02448368|7584703|FG003|COMPLETED|Overall Study||2
6654786|NCT02448368|7584704|FG004|COMPLETED|Overall Study||2
6654787|NCT02448368|7584705|FG005|COMPLETED|Overall Study||2
6654788|NCT02448368|7584706|FG006|COMPLETED|Overall Study||2
6654789|NCT02448368|7584707|FG007|COMPLETED|Overall Study||2
6495168|NCT01392378|7413741|FG004|COMPLETED|Toddler Dose||208
6495169|NCT01392378|7413737|FG000|NOT COMPLETED|Toddler Dose||0
6495170|NCT01392378|7413738|FG001|NOT COMPLETED|Toddler Dose||1
6495171|NCT01392378|7413739|FG002|NOT COMPLETED|Toddler Dose||0
6495172|NCT01392378|7413740|FG003|NOT COMPLETED|Toddler Dose||2
6495173|NCT01392378|7413741|FG004|NOT COMPLETED|Toddler Dose||1
6495174|NCT01392443|7413763|FG000|STARTED|Overall Study||120
6495175|NCT01392443|7413763|FG000|COMPLETED|Overall Study||52
6495176|NCT01392443|7413763|FG000|NOT COMPLETED|Overall Study||68
6495177|NCT01392469|7413767|FG000|STARTED|Overall Study||21
6495178|NCT01392469|7413767|FG000|COMPLETED|Overall Study||17
6495179|NCT01392469|7413767|FG000|NOT COMPLETED|Overall Study||4
6495180|NCT01392495|7413782|FG000|STARTED|Overall Study||17
6495181|NCT01392495|7413782|FG000|Received 200 mg|Overall Study||4
6495182|NCT01392495|7413782|FG000|Received 400 mg|Overall Study||13
6495183|NCT01392495|7413782|FG000|COMPLETED|Overall Study||1
6495184|NCT01392495|7413782|FG000|NOT COMPLETED|Overall Study||16
6495185|NCT01392547|7413788|FG000|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
6495186|NCT01392547|7413788|FG000|COMPLETED|Overall Study||64
6495187|NCT01392547|7413788|FG000|NOT COMPLETED|Overall Study||8
6495188|NCT01392560|7413794|FG000|STARTED|Overall Study||52
6495189|NCT01392560|7413794|FG000|COMPLETED|Overall Study||40
6495190|NCT01392560|7413794|FG000|NOT COMPLETED|Overall Study||12
6495191|NCT01392573|7413802|FG000|STARTED|Overall Study||207
6495192|NCT01392573|7413803|FG001|STARTED|Overall Study||206
6495193|NCT01392573|7413802|FG000|Exposed|Overall Study||207
6495194|NCT01392573|7413803|FG001|Exposed|Overall Study||206
6495195|NCT01392573|7413802|FG000|COMPLETED|Overall Study||175
6495196|NCT01392573|7413803|FG001|COMPLETED|Overall Study||171
6495197|NCT01392573|7413802|FG000|NOT COMPLETED|Overall Study||32
6495198|NCT01392573|7413803|FG001|NOT COMPLETED|Overall Study||35
6495199|NCT01392625|7413811|FG000|STARTED|Overall Study||18
6495200|NCT01392625|7413812|FG001|STARTED|Overall Study||19
6495201|NCT01392625|7413811|FG000|COMPLETED|Overall Study||16
6495202|NCT01392625|7413812|FG001|COMPLETED|Overall Study||18
6495203|NCT01392625|7413811|FG000|NOT COMPLETED|Overall Study||2
6495204|NCT01392625|7413812|FG001|NOT COMPLETED|Overall Study||1
6495205|NCT01392677|7413820|FG000|STARTED|Overall Study||109
6495206|NCT01392677|7413821|FG001|STARTED|Overall Study||109
6495207|NCT01392677|7413820|FG000|COMPLETED|Overall Study||101
6495208|NCT01392677|7413821|FG001|COMPLETED|Overall Study||101
6495209|NCT01392677|7413820|FG000|NOT COMPLETED|Overall Study||8
6495210|NCT01392677|7413821|FG001|NOT COMPLETED|Overall Study||8
6495211|NCT01392703|7413827|FG000|STARTED|Day 1||26
6495212|NCT01392703|7413828|FG001|STARTED|Day 1||26
6495213|NCT01392703|7413829|FG002|STARTED|Day 1||26
6495214|NCT01392703|7413827|FG000|COMPLETED|Day 1||26
6495215|NCT01392703|7413828|FG001|COMPLETED|Day 1||26
6495216|NCT01392703|7413829|FG002|COMPLETED|Day 1||26
6495217|NCT01392703|7413827|FG000|NOT COMPLETED|Day 1||0
6495218|NCT01392703|7413828|FG001|NOT COMPLETED|Day 1||0
6495219|NCT01392703|7413829|FG002|NOT COMPLETED|Day 1||0
6495220|NCT01392703|7413827|FG000|STARTED|Day 5||26
6495221|NCT01392703|7413828|FG001|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
6495222|NCT01392703|7413829|FG002|STARTED|Day 5||26
6495223|NCT01392703|7413827|FG000|COMPLETED|Day 5||26
6495224|NCT01392703|7413828|FG001|COMPLETED|Day 5||25
6495225|NCT01392703|7413829|FG002|COMPLETED|Day 5||26
6495226|NCT01392703|7413827|FG000|NOT COMPLETED|Day 5||0
6495227|NCT01392703|7413828|FG001|NOT COMPLETED|Day 5||0
6495228|NCT01392703|7413829|FG002|NOT COMPLETED|Day 5||0
6495229|NCT01392703|7413827|FG000|STARTED|Day 9||26
6495230|NCT01392703|7413828|FG001|STARTED|Day 9||26
6495231|NCT01392703|7413829|FG002|STARTED|Day 9||25
6495232|NCT01392703|7413827|FG000|COMPLETED|Day 9||26
6495233|NCT01392703|7413828|FG001|COMPLETED|Day 9||26
6495234|NCT01392703|7413829|FG002|COMPLETED|Day 9||25
6495235|NCT01392703|7413827|FG000|NOT COMPLETED|Day 9||0
6495236|NCT01392703|7413828|FG001|NOT COMPLETED|Day 9||0
6495237|NCT01392703|7413829|FG002|NOT COMPLETED|Day 9||0
6495238|NCT01392742|7413839|FG000|STARTED|Overall Study||443
6495239|NCT01392742|7413839|FG000|COMPLETED|Overall Study||242
6495240|NCT01392742|7413839|FG000|NOT COMPLETED|Overall Study||201
6495241|NCT01392859|7413843|FG000|STARTED|Overall Study||15
6495242|NCT01392859|7413844|FG001|STARTED|Overall Study||13
6495243|NCT01392859|7413845|FG002|STARTED|Overall Study||183
6495244|NCT01392859|7413843|FG000|Wash Out 3-7 Days|Overall Study||15
6495245|NCT01392859|7413844|FG001|Wash Out 3-7 Days|Overall Study||13
6495246|NCT01392859|7413845|FG002|Wash Out 3-7 Days|Overall Study||0
6495247|NCT01392859|7413843|FG000|COMPLETED|Overall Study||13
6495248|NCT01392859|7413844|FG001|COMPLETED|Overall Study||13
6495249|NCT01392859|7413845|FG002|COMPLETED|Overall Study||183
6495250|NCT01392859|7413843|FG000|NOT COMPLETED|Overall Study||2
6495251|NCT01392859|7413844|FG001|NOT COMPLETED|Overall Study||0
6495252|NCT01392859|7413845|FG002|NOT COMPLETED|Overall Study||0
6495253|NCT01392963|7413853|FG000|STARTED|Week 0 (First Intervention)||11
6495254|NCT01392963|7413854|FG001|STARTED|Week 0 (First Intervention)||19
6495255|NCT01392963|7413853|FG000|COMPLETED|Week 0 (First Intervention)||11
6495256|NCT01392963|7413854|FG001|COMPLETED|Week 0 (First Intervention)||17
6495257|NCT01392963|7413853|FG000|NOT COMPLETED|Week 0 (First Intervention)||0
6495258|NCT01392963|7413854|FG001|NOT COMPLETED|Week 0 (First Intervention)||2
6495259|NCT01392963|7413853|FG000|STARTED|Week 12 (Second Intervention)||11
6495260|NCT01392963|7413854|FG001|STARTED|Week 12 (Second Intervention)||17
6495261|NCT01392963|7413853|FG000|COMPLETED|Week 12 (Second Intervention)||11
6495262|NCT01392963|7413854|FG001|COMPLETED|Week 12 (Second Intervention)||17
6495263|NCT01392963|7413853|FG000|NOT COMPLETED|Week 12 (Second Intervention)||0
6495264|NCT01392963|7413854|FG001|NOT COMPLETED|Week 12 (Second Intervention)||0
6495265|NCT01392963|7413853|FG000|STARTED|Week 24 Follow-up||11
6495266|NCT01392963|7413854|FG001|STARTED|Week 24 Follow-up||17
6495267|NCT01392963|7413853|FG000|COMPLETED|Week 24 Follow-up||9
6495268|NCT01392963|7413854|FG001|COMPLETED|Week 24 Follow-up||17
6495269|NCT01392963|7413853|FG000|NOT COMPLETED|Week 24 Follow-up||2
6495270|NCT01392963|7413854|FG001|NOT COMPLETED|Week 24 Follow-up||0
6495271|NCT01392989|7413862|FG000|STARTED|Total Lymphoid Irradiation (TLI)||44
6495272|NCT01392989|7413862|FG000|COMPLETED|Total Lymphoid Irradiation (TLI)||44
6495273|NCT01392989|7413862|FG000|NOT COMPLETED|Total Lymphoid Irradiation (TLI)||0
6495274|NCT01392989|7413862|FG000|STARTED|CIK Cell Infusion||31
6495275|NCT01392989|7413862|FG000|COMPLETED|CIK Cell Infusion||31
6495276|NCT01392989|7413862|FG000|NOT COMPLETED|CIK Cell Infusion||0
6495277|NCT01393106|7413867|FG000|STARTED|Overall Study||25
6495278|NCT01393106|7413867|FG000|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
6495279|NCT01393106|7413867|FG000|NOT COMPLETED|Overall Study||5
6495280|NCT01393132|7413873|FG000|STARTED|Overall Study||6
6495281|NCT01393132|7413874|FG001|STARTED|Overall Study||3
6495282|NCT01393132|7413873|FG000|COMPLETED|Overall Study||6
6495283|NCT01393132|7413874|FG001|COMPLETED|Overall Study||3
6495284|NCT01393132|7413873|FG000|NOT COMPLETED|Overall Study||0
6495285|NCT01393132|7413874|FG001|NOT COMPLETED|Overall Study||0
6495286|NCT01393158|7413884|FG000|STARTED|Overall Study||6
6495287|NCT01393158|7413885|FG001|STARTED|Overall Study||10
6495288|NCT01393158|7413884|FG000|COMPLETED|Overall Study||5
6495289|NCT01393158|7413885|FG001|COMPLETED|Overall Study||10
6495290|NCT01393158|7413884|FG000|NOT COMPLETED|Overall Study||1
6495291|NCT01393158|7413885|FG001|NOT COMPLETED|Overall Study||0
6495292|NCT01393301|7413899|FG000|STARTED|Overall Study||26
6495293|NCT01393301|7413900|FG001|STARTED|Overall Study||27
6495294|NCT01393301|7413899|FG000|COMPLETED|Overall Study||17
6495295|NCT01393301|7413900|FG001|COMPLETED|Overall Study||24
6495296|NCT01393301|7413899|FG000|NOT COMPLETED|Overall Study||9
6495297|NCT01393301|7413900|FG001|NOT COMPLETED|Overall Study||3
6501851|NCT01431521|7420520|FG003|STARTED|Overall Study||5
6501852|NCT01431521|7420517|FG000|Treated|Overall Study||10
6501853|NCT01431521|7420518|FG001|Treated|Overall Study||5
6501854|NCT01431521|7420519|FG002|Treated|Overall Study||10
6501855|NCT01431521|7420520|FG003|Treated|Overall Study||5
6501856|NCT01431521|7420517|FG000|COMPLETED|Overall Study||10
6501857|NCT01431521|7420518|FG001|COMPLETED|Overall Study||5
6501858|NCT01431521|7420519|FG002|COMPLETED|Overall Study||10
6501859|NCT01431521|7420520|FG003|COMPLETED|Overall Study||5
6501860|NCT01431521|7420517|FG000|NOT COMPLETED|Overall Study||0
6501861|NCT01431521|7420518|FG001|NOT COMPLETED|Overall Study||0
6501862|NCT01431521|7420519|FG002|NOT COMPLETED|Overall Study||1
6501863|NCT01431521|7420520|FG003|NOT COMPLETED|Overall Study||0
6501864|NCT01431534|7420532|FG000|STARTED|Treatment Phase||4
6501865|NCT01431534|7420533|FG001|STARTED|Treatment Phase||3
6501866|NCT01431534|7420534|FG002|STARTED|Treatment Phase||13
6501867|NCT01431534|7420532|FG000|COMPLETED|Treatment Phase||0
6501868|NCT01431534|7420533|FG001|COMPLETED|Treatment Phase||0
6501869|NCT01431534|7420534|FG002|COMPLETED|Treatment Phase|Participants completing Treatment Phase could continue in Extension Phase.|2
6501870|NCT01431534|7420532|FG000|NOT COMPLETED|Treatment Phase||4
6501871|NCT01431534|7420533|FG001|NOT COMPLETED|Treatment Phase||3
6501872|NCT01431534|7420534|FG002|NOT COMPLETED|Treatment Phase||11
6501873|NCT01431534|7420532|FG000|STARTED|Extension Phase|No participants continued in Extension Phase.|0
6501874|NCT01431534|7420533|FG001|STARTED|Extension Phase|No participants continued in Extension Phase.|0
6501875|NCT01431534|7420534|FG002|STARTED|Extension Phase|Participants from Treatment Phase who continued in Extension Phase.|2
6501876|NCT01431534|7420532|FG000|COMPLETED|Extension Phase||0
6501877|NCT01431534|7420533|FG001|COMPLETED|Extension Phase||0
6501878|NCT01431534|7420534|FG002|COMPLETED|Extension Phase||2
6501879|NCT01431534|7420532|FG000|NOT COMPLETED|Extension Phase||0
6501880|NCT01431534|7420533|FG001|NOT COMPLETED|Extension Phase||0
6501881|NCT01431534|7420534|FG002|NOT COMPLETED|Extension Phase||0
6501882|NCT01431573|7420542|FG000|STARTED|Overall Study||8
6501883|NCT01431573|7420542|FG000|COMPLETED|Overall Study||8
6501884|NCT01431573|7420542|FG000|NOT COMPLETED|Overall Study||0
6501885|NCT01431638|7420549|FG000|STARTED|Overall Study||133
6501886|NCT01431638|7420550|FG001|STARTED|Overall Study||132
6501887|NCT01431638|7420551|FG002|STARTED|Overall Study||132
6501888|NCT01431638|7420549|FG000|Completed Core Study|Overall Study||124
6501889|NCT01431638|7420550|FG001|Completed Core Study|Overall Study||117
6501890|NCT01431638|7420551|FG002|Completed Core Study|Overall Study||108
6501891|NCT01431638|7420549|FG000|Entered Extension 1 Study|Overall Study||85
6501892|NCT01431638|7420550|FG001|Entered Extension 1 Study|Overall Study||71
6501893|NCT01431638|7420551|FG002|Entered Extension 1 Study|Overall Study||76
6501894|NCT01431638|7420549|FG000|COMPLETED|Overall Study||67
6501895|NCT01431638|7420550|FG001|COMPLETED|Overall Study||61
6501896|NCT01431638|7420551|FG002|COMPLETED|Overall Study||70
6501897|NCT01431638|7420549|FG000|NOT COMPLETED|Overall Study||66
6501898|NCT01431638|7420550|FG001|NOT COMPLETED|Overall Study||71
6501899|NCT01431638|7420551|FG002|NOT COMPLETED|Overall Study||62
6501900|NCT01431703|7420559|FG000|STARTED|Overall Study||326
6495298|NCT01393392|7413908|FG000|STARTED|Overall Study||44
6495299|NCT01393392|7413909|FG001|STARTED|Overall Study||43
6495300|NCT01393392|7413908|FG000|COMPLETED|Overall Study||33
6495301|NCT01393392|7413909|FG001|COMPLETED|Overall Study||24
6495302|NCT01393392|7413908|FG000|NOT COMPLETED|Overall Study||11
6495303|NCT01393392|7413909|FG001|NOT COMPLETED|Overall Study||19
6495304|NCT01393405|7413915|FG000|STARTED|Induction Period (week1-16)||179
6495305|NCT01393405|7413916|FG001|STARTED|Induction Period (week1-16)||0
6495306|NCT01393405|7413917|FG002|STARTED|Induction Period (week1-16)||0
6495307|NCT01393405|7413915|FG000|COMPLETED|Induction Period (week1-16)||84
6495308|NCT01393405|7413916|FG001|COMPLETED|Induction Period (week1-16)||0
6495309|NCT01393405|7413917|FG002|COMPLETED|Induction Period (week1-16)||0
6495310|NCT01393405|7413915|FG000|NOT COMPLETED|Induction Period (week1-16)||95
6495311|NCT01393405|7413916|FG001|NOT COMPLETED|Induction Period (week1-16)||0
6495312|NCT01393405|7413917|FG002|NOT COMPLETED|Induction Period (week1-16)||0
6495313|NCT01393405|7413915|FG000|STARTED|Maintenance Period Week||0
6495314|NCT01393405|7413916|FG001|STARTED|Maintenance Period Week||44
6495315|NCT01393405|7413917|FG002|STARTED|Maintenance Period Week||40
6750132|NCT03426995|7677320|FG013|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750133|NCT03426995|7677321|FG014|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6495316|NCT01393405|7413915|FG000|COMPLETED|Maintenance Period Week||0
6495317|NCT01393405|7413916|FG001|COMPLETED|Maintenance Period Week||15
6495318|NCT01393405|7413917|FG002|COMPLETED|Maintenance Period Week||16
6495319|NCT01393405|7413915|FG000|NOT COMPLETED|Maintenance Period Week||0
6495320|NCT01393405|7413916|FG001|NOT COMPLETED|Maintenance Period Week||29
6495321|NCT01393405|7413917|FG002|NOT COMPLETED|Maintenance Period Week||24
6495322|NCT01393444|7413927|FG000|STARTED|Overall Study||6
6495323|NCT01393444|7413927|FG000|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
6495324|NCT01393444|7413927|FG000|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
6495325|NCT01393444|7413927|FG000|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
6495326|NCT01393444|7413927|FG000|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
6495327|NCT01393444|7413927|FG000|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
6495328|NCT01393444|7413927|FG000|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
6495329|NCT01393444|7413927|FG000|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
6495330|NCT01393444|7413927|FG000|NOT COMPLETED|Overall Study||3
6495331|NCT01393457|7413935|FG000|STARTED|Overall Study||26
6495332|NCT01393457|7413936|FG001|STARTED|Overall Study||26
6495333|NCT01393457|7413937|FG002|STARTED|Overall Study||31
6495334|NCT01393457|7413938|FG003|STARTED|Overall Study||27
6495335|NCT01393457|7413935|FG000|COMPLETED|Overall Study||14
6495336|NCT01393457|7413936|FG001|COMPLETED|Overall Study||14
6495337|NCT01393457|7413937|FG002|COMPLETED|Overall Study||16
6495338|NCT01393457|7413938|FG003|COMPLETED|Overall Study||15
6495339|NCT01393457|7413935|FG000|NOT COMPLETED|Overall Study||12
6495340|NCT01393457|7413936|FG001|NOT COMPLETED|Overall Study||12
6495341|NCT01393457|7413937|FG002|NOT COMPLETED|Overall Study||15
6495342|NCT01393457|7413938|FG003|NOT COMPLETED|Overall Study||12
6495343|NCT01393600|7413948|FG000|STARTED|Treatment Period 1 (Day 1 to 14)||9
6495344|NCT01393600|7413949|FG001|STARTED|Treatment Period 1 (Day 1 to 14)||8
6495345|NCT01393600|7413950|FG002|STARTED|Treatment Period 1 (Day 1 to 14)||10
6495346|NCT01393600|7413951|FG003|STARTED|Treatment Period 1 (Day 1 to 14)||10
6495347|NCT01393600|7413948|FG000|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
6495348|NCT01393600|7413949|FG001|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
6495349|NCT01393600|7413950|FG002|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
6495350|NCT01393600|7413951|FG003|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
6495351|NCT01393600|7413948|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
6495352|NCT01393600|7413949|FG001|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
6495353|NCT01393600|7413950|FG002|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
6495354|NCT01393600|7413951|FG003|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
6495355|NCT01393600|7413948|FG000|STARTED|Treatment Period 2 (Day 15 to 28)||9
6495356|NCT01393600|7413949|FG001|STARTED|Treatment Period 2 (Day 15 to 28)||7
6495357|NCT01393600|7413950|FG002|STARTED|Treatment Period 2 (Day 15 to 28)||9
6495358|NCT01393600|7413951|FG003|STARTED|Treatment Period 2 (Day 15 to 28)||9
6495359|NCT01393600|7413948|FG000|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
6495360|NCT01393600|7413949|FG001|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
6495361|NCT01393600|7413950|FG002|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
6495362|NCT01393600|7413951|FG003|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
6495363|NCT01393600|7413948|FG000|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
6495364|NCT01393600|7413949|FG001|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
6495365|NCT01393600|7413950|FG002|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
6495366|NCT01393600|7413951|FG003|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
6495367|NCT01393600|7413948|FG000|STARTED|Follow-up Period (Day 29 to 35)||9
6495368|NCT01393600|7413949|FG001|STARTED|Follow-up Period (Day 29 to 35)||7
6495369|NCT01393600|7413950|FG002|STARTED|Follow-up Period (Day 29 to 35)||7
6495370|NCT01393600|7413951|FG003|STARTED|Follow-up Period (Day 29 to 35)||8
6750134|NCT03426995|7677322|FG015|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6495371|NCT01393600|7413948|FG000|COMPLETED|Follow-up Period (Day 29 to 35)||9
6495372|NCT01393600|7413949|FG001|COMPLETED|Follow-up Period (Day 29 to 35)||7
6495373|NCT01393600|7413950|FG002|COMPLETED|Follow-up Period (Day 29 to 35)||6
6495374|NCT01393600|7413951|FG003|COMPLETED|Follow-up Period (Day 29 to 35)||8
6495375|NCT01393600|7413948|FG000|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
6495376|NCT01393600|7413949|FG001|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
6495377|NCT01393600|7413950|FG002|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
6495378|NCT01393600|7413951|FG003|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
6495379|NCT01393613|7413967|FG000|STARTED|Overall Study||120
6495380|NCT01393613|7413968|FG001|STARTED|Overall Study||186
6495381|NCT01393613|7413969|FG002|STARTED|Overall Study||184
6495382|NCT01393613|7413970|FG003|STARTED|Overall Study||184
6495383|NCT01393613|7413967|FG000|COMPLETED|Overall Study||81
6495384|NCT01393613|7413968|FG001|COMPLETED|Overall Study||129
6495385|NCT01393613|7413969|FG002|COMPLETED|Overall Study||130
6495386|NCT01393613|7413970|FG003|COMPLETED|Overall Study||118
6495387|NCT01393613|7413967|FG000|NOT COMPLETED|Overall Study||39
6495388|NCT01393613|7413968|FG001|NOT COMPLETED|Overall Study||57
6495389|NCT01393613|7413969|FG002|NOT COMPLETED|Overall Study||54
6495390|NCT01393613|7413970|FG003|NOT COMPLETED|Overall Study||66
6495391|NCT01393626|7413986|FG000|STARTED|Overall Study||91
6495392|NCT01393626|7413987|FG001|STARTED|Overall Study||86
6495393|NCT01393626|7413988|FG002|STARTED|Overall Study||86
6495394|NCT01393626|7413989|FG003|STARTED|Overall Study||16
6495395|NCT01393626|7413986|FG000|COMPLETED|Overall Study||73
6495396|NCT01393626|7413987|FG001|COMPLETED|Overall Study||74
6495397|NCT01393626|7413988|FG002|COMPLETED|Overall Study||74
6495398|NCT01393626|7413989|FG003|COMPLETED|Overall Study||15
6495399|NCT01393626|7413986|FG000|NOT COMPLETED|Overall Study||18
6495400|NCT01393626|7413987|FG001|NOT COMPLETED|Overall Study||12
6495401|NCT01393626|7413988|FG002|NOT COMPLETED|Overall Study||12
6495402|NCT01393626|7413989|FG003|NOT COMPLETED|Overall Study||1
6495403|NCT01393704|7414008|FG000|STARTED|Overall Study||76
6495404|NCT01393704|7414009|FG001|STARTED|Overall Study||76
6495405|NCT01393704|7414008|FG000|COMPLETED|Overall Study||76
6495406|NCT01393704|7414009|FG001|COMPLETED|Overall Study||76
6495407|NCT01393704|7414008|FG000|NOT COMPLETED|Overall Study||0
6495408|NCT01393704|7414009|FG001|NOT COMPLETED|Overall Study||0
6495409|NCT01393717|7414015|FG000|STARTED|Overall Study||37
6495410|NCT01393717|7414016|FG001|STARTED|Overall Study||20
6495411|NCT01393717|7414015|FG000|COMPLETED|Overall Study||37
6495412|NCT01393717|7414016|FG001|COMPLETED|Overall Study||20
6495413|NCT01393717|7414015|FG000|NOT COMPLETED|Overall Study||0
6495414|NCT01393717|7414016|FG001|NOT COMPLETED|Overall Study||0
6495415|NCT01393730|7414026|FG000|STARTED|Overall Study||40
6495416|NCT01393730|7414026|FG000|Treated|Overall Study||38
6495417|NCT01393730|7414026|FG000|Evaluable AR Amplification|Overall Study||21
6495418|NCT01393730|7414026|FG000|Evaluable AR Mutation|Overall Study||14
6495419|NCT01393730|7414026|FG000|COMPLETED|Overall Study||34
6495420|NCT01393730|7414026|FG000|NOT COMPLETED|Overall Study||6
6495421|NCT01393743|7414032|FG000|STARTED|Core Study|Treated|82
6495422|NCT01393743|7414033|FG001|STARTED|Core Study|Treated|81
6495423|NCT01393743|7414034|FG002|STARTED|Core Study||0
6495424|NCT01393743|7414032|FG000|COMPLETED|Core Study||72
6495425|NCT01393743|7414033|FG001|COMPLETED|Core Study||68
6495426|NCT01393743|7414034|FG002|COMPLETED|Core Study||0
6495427|NCT01393743|7414032|FG000|NOT COMPLETED|Core Study||10
6495428|NCT01393743|7414033|FG001|NOT COMPLETED|Core Study||13
6495429|NCT01393743|7414034|FG002|NOT COMPLETED|Core Study||0
6495430|NCT01393743|7414032|FG000|STARTED|Extension Phase||0
6495431|NCT01393743|7414033|FG001|STARTED|Extension Phase||0
6495432|NCT01393743|7414034|FG002|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
6495433|NCT01393743|7414032|FG000|COMPLETED|Extension Phase||0
6495434|NCT01393743|7414033|FG001|COMPLETED|Extension Phase||0
6495435|NCT01393743|7414034|FG002|COMPLETED|Extension Phase||78
6495436|NCT01393743|7414032|FG000|NOT COMPLETED|Extension Phase||0
6495437|NCT01393743|7414033|FG001|NOT COMPLETED|Extension Phase||0
6495438|NCT01393743|7414034|FG002|NOT COMPLETED|Extension Phase||60
6495439|NCT01393821|7414047|FG000|STARTED|Overall Study||14
6495440|NCT01393821|7414048|FG001|STARTED|Overall Study||13
6495441|NCT01393821|7414047|FG000|COMPLETED|Overall Study||9
6495442|NCT01393821|7414048|FG001|COMPLETED|Overall Study||10
6495443|NCT01393821|7414047|FG000|NOT COMPLETED|Overall Study||5
6495444|NCT01393821|7414048|FG001|NOT COMPLETED|Overall Study||3
6495445|NCT01393899|7414057|FG000|STARTED|Overall Study||59
6495446|NCT01393899|7414058|FG001|STARTED|Overall Study||60
6495447|NCT01393899|7414059|FG002|STARTED|Overall Study||61
6495448|NCT01393899|7414057|FG000|COMPLETED|Overall Study||27
6495449|NCT01393899|7414058|FG001|COMPLETED|Overall Study||32
6495450|NCT01393899|7414059|FG002|COMPLETED|Overall Study||38
6495451|NCT01393899|7414057|FG000|NOT COMPLETED|Overall Study||32
6495452|NCT01393899|7414058|FG001|NOT COMPLETED|Overall Study||28
6495453|NCT01393899|7414059|FG002|NOT COMPLETED|Overall Study||23
6495454|NCT01393964|7414072|FG000|STARTED|Overall Study||8
6495455|NCT01393964|7414073|FG001|STARTED|Overall Study||9
6495456|NCT01393964|7414074|FG002|STARTED|Overall Study||9
6495457|NCT01393964|7414072|FG000|COMPLETED|Overall Study|Completed=treatment on-going|0
6495458|NCT01393964|7414073|FG001|COMPLETED|Overall Study|Completed=treatment on-going|0
6495459|NCT01393964|7414074|FG002|COMPLETED|Overall Study|Completed=treatment on-going|0
6495460|NCT01393964|7414072|FG000|NOT COMPLETED|Overall Study||8
6495461|NCT01393964|7414073|FG001|NOT COMPLETED|Overall Study||9
6495462|NCT01393964|7414074|FG002|NOT COMPLETED|Overall Study||9
6495463|NCT01393990|7414106|FG000|STARTED|Overall Study||4
6495464|NCT01393990|7414107|FG001|STARTED|Overall Study||3
6495465|NCT01393990|7414108|FG002|STARTED|Overall Study||3
6495466|NCT01393990|7414109|FG003|STARTED|Overall Study||3
6495467|NCT01393990|7414110|FG004|STARTED|Overall Study||5
6495468|NCT01393990|7414111|FG005|STARTED|Overall Study||3
6495469|NCT01393990|7414112|FG006|STARTED|Overall Study||3
6495470|NCT01393990|7414113|FG007|STARTED|Overall Study||7
6495471|NCT01393990|7414114|FG008|STARTED|Overall Study||6
6495472|NCT01393990|7414115|FG009|STARTED|Overall Study||3
6495473|NCT01393990|7414116|FG010|STARTED|Overall Study||3
6495474|NCT01393990|7414117|FG011|STARTED|Overall Study||3
6495475|NCT01393990|7414118|FG012|STARTED|Overall Study||3
6495476|NCT01393990|7414119|FG013|STARTED|Overall Study||5
6495477|NCT01393990|7414120|FG014|STARTED|Overall Study||18
6495478|NCT01393990|7414121|FG015|STARTED|Overall Study||8
6495479|NCT01393990|7414122|FG016|STARTED|Overall Study||3
6495480|NCT01393990|7414123|FG017|STARTED|Overall Study||6
6495481|NCT01393990|7414106|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
6495482|NCT01393990|7414107|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6495483|NCT01393990|7414108|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6495484|NCT01393990|7414109|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6555374|NCT01751386|7477513|FG001|COMPLETED|Overall Study||16
6555375|NCT01751386|7477512|FG000|NOT COMPLETED|Overall Study||2
6555376|NCT01751386|7477513|FG001|NOT COMPLETED|Overall Study||3
6555377|NCT01751399|7477523|FG000|STARTED|Overall Study||12
6555378|NCT01751399|7477524|FG001|STARTED|Overall Study||8
6555379|NCT01751399|7477525|FG002|STARTED|Overall Study||8
6495485|NCT01393990|7414110|FG004|Received at Least 1 Dose of Study Drug|Overall Study||5
6495486|NCT01393990|7414111|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
6495487|NCT01393990|7414112|FG006|Received at Least 1 Dose of Study Drug|Overall Study||3
6495488|NCT01393990|7414113|FG007|Received at Least 1 Dose of Study Drug|Overall Study||7
6495489|NCT01393990|7414114|FG008|Received at Least 1 Dose of Study Drug|Overall Study||6
6495490|NCT01393990|7414115|FG009|Received at Least 1 Dose of Study Drug|Overall Study||3
6495491|NCT01393990|7414116|FG010|Received at Least 1 Dose of Study Drug|Overall Study||3
6495492|NCT01393990|7414117|FG011|Received at Least 1 Dose of Study Drug|Overall Study||3
6495493|NCT01393990|7414118|FG012|Received at Least 1 Dose of Study Drug|Overall Study||3
6495494|NCT01393990|7414119|FG013|Received at Least 1 Dose of Study Drug|Overall Study||5
6495495|NCT01393990|7414120|FG014|Received at Least 1 Dose of Study Drug|Overall Study||18
6495496|NCT01393990|7414121|FG015|Received at Least 1 Dose of Study Drug|Overall Study||8
6495497|NCT01393990|7414122|FG016|Received at Least 1 Dose of Study Drug|Overall Study||3
6495498|NCT01393990|7414123|FG017|Received at Least 1 Dose of Study Drug|Overall Study||6
6495499|NCT01393990|7414106|FG000|COMPLETED|Overall Study||3
6495500|NCT01393990|7414107|FG001|COMPLETED|Overall Study||3
6495501|NCT01393990|7414108|FG002|COMPLETED|Overall Study||3
6495502|NCT01393990|7414109|FG003|COMPLETED|Overall Study||2
6495503|NCT01393990|7414110|FG004|COMPLETED|Overall Study||3
6495504|NCT01393990|7414111|FG005|COMPLETED|Overall Study||2
6495505|NCT01393990|7414112|FG006|COMPLETED|Overall Study||2
6495506|NCT01393990|7414113|FG007|COMPLETED|Overall Study||6
6495507|NCT01393990|7414114|FG008|COMPLETED|Overall Study||3
6495508|NCT01393990|7414115|FG009|COMPLETED|Overall Study||2
6495509|NCT01393990|7414116|FG010|COMPLETED|Overall Study||3
6495510|NCT01393990|7414117|FG011|COMPLETED|Overall Study||3
6495511|NCT01393990|7414118|FG012|COMPLETED|Overall Study||3
6495512|NCT01393990|7414119|FG013|COMPLETED|Overall Study||3
6495513|NCT01393990|7414120|FG014|COMPLETED|Overall Study||9
6495514|NCT01393990|7414121|FG015|COMPLETED|Overall Study||5
6495515|NCT01393990|7414122|FG016|COMPLETED|Overall Study||3
6495516|NCT01393990|7414123|FG017|COMPLETED|Overall Study||6
6495517|NCT01393990|7414106|FG000|NOT COMPLETED|Overall Study||1
6495518|NCT01393990|7414107|FG001|NOT COMPLETED|Overall Study||0
6495519|NCT01393990|7414108|FG002|NOT COMPLETED|Overall Study||0
6495520|NCT01393990|7414109|FG003|NOT COMPLETED|Overall Study||1
6495521|NCT01393990|7414110|FG004|NOT COMPLETED|Overall Study||2
6495522|NCT01393990|7414111|FG005|NOT COMPLETED|Overall Study||1
6495523|NCT01393990|7414112|FG006|NOT COMPLETED|Overall Study||1
6495524|NCT01393990|7414113|FG007|NOT COMPLETED|Overall Study||1
6495525|NCT01393990|7414114|FG008|NOT COMPLETED|Overall Study||3
6495526|NCT01393990|7414115|FG009|NOT COMPLETED|Overall Study||1
6555380|NCT01751399|7477526|FG003|STARTED|Overall Study||7
6555381|NCT01751399|7477523|FG000|Received 1 Dose of Study Drug|Overall Study||12
6555382|NCT01751399|7477524|FG001|Received 1 Dose of Study Drug|Overall Study||8
6555383|NCT01751399|7477525|FG002|Received 1 Dose of Study Drug|Overall Study||8
6555384|NCT01751399|7477526|FG003|Received 1 Dose of Study Drug|Overall Study||7
6555385|NCT01751399|7477523|FG000|COMPLETED|Overall Study||12
6555386|NCT01751399|7477524|FG001|COMPLETED|Overall Study||8
6495527|NCT01393990|7414116|FG010|NOT COMPLETED|Overall Study||0
6495528|NCT01393990|7414117|FG011|NOT COMPLETED|Overall Study||0
6495529|NCT01393990|7414118|FG012|NOT COMPLETED|Overall Study||0
6495530|NCT01393990|7414119|FG013|NOT COMPLETED|Overall Study||2
6495531|NCT01393990|7414120|FG014|NOT COMPLETED|Overall Study||9
6495532|NCT01393990|7414121|FG015|NOT COMPLETED|Overall Study||3
6495533|NCT01393990|7414122|FG016|NOT COMPLETED|Overall Study||0
6495534|NCT01393990|7414123|FG017|NOT COMPLETED|Overall Study||0
6495535|NCT01394003|7414180|FG000|STARTED|Overall Study||3
6495536|NCT01394003|7414181|FG001|STARTED|Overall Study||8
6495537|NCT01394003|7414182|FG002|STARTED|Overall Study||3
6495538|NCT01394003|7414183|FG003|STARTED|Overall Study||6
6495539|NCT01394003|7414184|FG004|STARTED|Overall Study||3
6495540|NCT01394003|7414185|FG005|STARTED|Overall Study||3
6495541|NCT01394003|7414186|FG006|STARTED|Overall Study||6
6495542|NCT01394003|7414187|FG007|STARTED|Overall Study||2
6495543|NCT01394003|7414180|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6495544|NCT01394003|7414181|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
6495545|NCT01394003|7414182|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6495546|NCT01394003|7414183|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6495547|NCT01394003|7414184|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
6495548|NCT01394003|7414185|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
6495549|NCT01394003|7414186|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
6495550|NCT01394003|7414187|FG007|Received at Least 1 Dose of Study Drug|Overall Study||2
6495551|NCT01394003|7414180|FG000|COMPLETED|Overall Study||3
6495552|NCT01394003|7414181|FG001|COMPLETED|Overall Study||8
6495553|NCT01394003|7414182|FG002|COMPLETED|Overall Study||3
6495554|NCT01394003|7414183|FG003|COMPLETED|Overall Study||6
6495555|NCT01394003|7414184|FG004|COMPLETED|Overall Study||3
6495556|NCT01394003|7414185|FG005|COMPLETED|Overall Study||3
6495557|NCT01394003|7414186|FG006|COMPLETED|Overall Study||6
6495558|NCT01394003|7414187|FG007|COMPLETED|Overall Study||2
6495559|NCT01394003|7414180|FG000|NOT COMPLETED|Overall Study||0
6495560|NCT01394003|7414181|FG001|NOT COMPLETED|Overall Study||0
6495561|NCT01394003|7414182|FG002|NOT COMPLETED|Overall Study||0
6495562|NCT01394003|7414183|FG003|NOT COMPLETED|Overall Study||0
6495563|NCT01394003|7414184|FG004|NOT COMPLETED|Overall Study||0
6495564|NCT01394003|7414185|FG005|NOT COMPLETED|Overall Study||0
6495565|NCT01394003|7414186|FG006|NOT COMPLETED|Overall Study||0
6495566|NCT01394003|7414187|FG007|NOT COMPLETED|Overall Study||0
6495567|NCT01394081|7414213|FG000|STARTED|Overall Study||101
6495568|NCT01394081|7414214|FG001|STARTED|Overall Study||102
6495569|NCT01394081|7414213|FG000|COMPLETED|Overall Study||101
6495570|NCT01394081|7414214|FG001|COMPLETED|Overall Study||102
6495571|NCT01394081|7414213|FG000|NOT COMPLETED|Overall Study||0
6495572|NCT01394081|7414214|FG001|NOT COMPLETED|Overall Study||0
6495573|NCT01394159|7414224|FG000|STARTED|Overall Study||28
6495574|NCT01394159|7414225|FG001|STARTED|Overall Study||28
6495575|NCT01394159|7414224|FG000|COMPLETED|Overall Study||28
6495576|NCT01394159|7414225|FG001|COMPLETED|Overall Study||28
6495577|NCT01394159|7414224|FG000|NOT COMPLETED|Overall Study||0
6495578|NCT01394159|7414225|FG001|NOT COMPLETED|Overall Study||0
6495579|NCT01394185|7414231|FG000|STARTED|Overall Study||8
6495580|NCT01394185|7414232|FG001|STARTED|Overall Study||2
6495581|NCT01394185|7414233|FG002|STARTED|Overall Study||2
6495582|NCT01394185|7414234|FG003|STARTED|Overall Study||4
6495583|NCT01394185|7414235|FG004|STARTED|Overall Study||6
6495584|NCT01394185|7414236|FG005|STARTED|Overall Study||3
6495585|NCT01394185|7414231|FG000|COMPLETED|Overall Study||2
6495586|NCT01394185|7414232|FG001|COMPLETED|Overall Study||2
6495587|NCT01394185|7414233|FG002|COMPLETED|Overall Study||2
6495588|NCT01394185|7414234|FG003|COMPLETED|Overall Study||3
6495589|NCT01394185|7414235|FG004|COMPLETED|Overall Study||2
6495590|NCT01394185|7414236|FG005|COMPLETED|Overall Study||2
6495591|NCT01394185|7414231|FG000|NOT COMPLETED|Overall Study||6
6495592|NCT01394185|7414232|FG001|NOT COMPLETED|Overall Study||0
6495593|NCT01394185|7414233|FG002|NOT COMPLETED|Overall Study||0
6495594|NCT01394185|7414234|FG003|NOT COMPLETED|Overall Study||1
6495595|NCT01394185|7414235|FG004|NOT COMPLETED|Overall Study||4
6495596|NCT01394185|7414236|FG005|NOT COMPLETED|Overall Study||1
6495597|NCT01394250|7414246|FG000|STARTED|Randomization and IV Placement Attempt||134
6495598|NCT01394250|7414247|FG001|STARTED|Randomization and IV Placement Attempt||134
6495599|NCT01394250|7414246|FG000|COMPLETED|Randomization and IV Placement Attempt||120
6495600|NCT01394250|7414247|FG001|COMPLETED|Randomization and IV Placement Attempt||121
6495601|NCT01394250|7414246|FG000|NOT COMPLETED|Randomization and IV Placement Attempt||14
6495602|NCT01394250|7414247|FG001|NOT COMPLETED|Randomization and IV Placement Attempt||13
6495603|NCT01394250|7414246|FG000|STARTED|Successful IV Placement & Follow-Up||120
6495604|NCT01394250|7414247|FG001|STARTED|Successful IV Placement & Follow-Up||121
6495605|NCT01394250|7414246|FG000|COMPLETED|Successful IV Placement & Follow-Up||114
6495606|NCT01394250|7414247|FG001|COMPLETED|Successful IV Placement & Follow-Up||110
6495607|NCT01394250|7414246|FG000|NOT COMPLETED|Successful IV Placement & Follow-Up||6
6495608|NCT01394250|7414247|FG001|NOT COMPLETED|Successful IV Placement & Follow-Up||11
6495609|NCT01394276|7414253|FG000|STARTED|Overall Study||322
6495610|NCT01394276|7414253|FG000|COMPLETED|Overall Study||260
6555387|NCT01751399|7477525|FG002|COMPLETED|Overall Study||8
6555388|NCT01751399|7477526|FG003|COMPLETED|Overall Study||7
6555389|NCT01751399|7477523|FG000|NOT COMPLETED|Overall Study||0
6555390|NCT01751399|7477524|FG001|NOT COMPLETED|Overall Study||0
6495611|NCT01394276|7414253|FG000|NOT COMPLETED|Overall Study||62
6555391|NCT01751399|7477525|FG002|NOT COMPLETED|Overall Study||0
6495612|NCT01394510|7414262|FG000|STARTED|Overall Study||13
6495613|NCT01394510|7414262|FG000|COMPLETED|Overall Study||13
6495614|NCT01394510|7414262|FG000|NOT COMPLETED|Overall Study||0
6495615|NCT01394523|7414269|FG000|STARTED|Overall Study||13
6495616|NCT01394523|7414270|FG001|STARTED|Overall Study||13
6495617|NCT01394523|7414271|FG002|STARTED|Overall Study||13
6495618|NCT01394523|7414269|FG000|COMPLETED|Overall Study||12
6495619|NCT01394523|7414270|FG001|COMPLETED|Overall Study||13
6495620|NCT01394523|7414271|FG002|COMPLETED|Overall Study||13
6495621|NCT01394523|7414269|FG000|NOT COMPLETED|Overall Study||1
6495622|NCT01394523|7414270|FG001|NOT COMPLETED|Overall Study||0
6495623|NCT01394523|7414271|FG002|NOT COMPLETED|Overall Study||0
6495624|NCT01394614|7414281|FG000|STARTED|Overall Study||8
6495625|NCT01394614|7414282|FG001|STARTED|Overall Study||16
6495626|NCT01394614|7414281|FG000|COMPLETED|Overall Study||8
6495627|NCT01394614|7414282|FG001|COMPLETED|Overall Study||16
6495628|NCT01394614|7414281|FG000|NOT COMPLETED|Overall Study||0
6495629|NCT01394614|7414282|FG001|NOT COMPLETED|Overall Study||0
6495630|NCT01394627|7414288|FG000|STARTED|First Intervention (1 Day)||8
6495631|NCT01394627|7414289|FG001|STARTED|First Intervention (1 Day)||13
6495632|NCT01394627|7414288|FG000|COMPLETED|First Intervention (1 Day)||8
6495633|NCT01394627|7414289|FG001|COMPLETED|First Intervention (1 Day)||12
6495634|NCT01394627|7414288|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6495635|NCT01394627|7414289|FG001|NOT COMPLETED|First Intervention (1 Day)||1
6495636|NCT01394627|7414288|FG000|STARTED|Washout (1-3 Months)||8
6495637|NCT01394627|7414289|FG001|STARTED|Washout (1-3 Months)||12
6495638|NCT01394627|7414288|FG000|COMPLETED|Washout (1-3 Months)||7
6555392|NCT01751399|7477526|FG003|NOT COMPLETED|Overall Study||0
6555393|NCT01751412|7477536|FG000|STARTED|Overall Study||12
6555394|NCT01751412|7477536|FG000|COMPLETED|Overall Study||11
6495639|NCT01394627|7414289|FG001|COMPLETED|Washout (1-3 Months)||12
6495640|NCT01394627|7414288|FG000|NOT COMPLETED|Washout (1-3 Months)||1
6495641|NCT01394627|7414289|FG001|NOT COMPLETED|Washout (1-3 Months)||0
6495642|NCT01394627|7414288|FG000|STARTED|Second Intervention (1 Day)||7
6495643|NCT01394627|7414289|FG001|STARTED|Second Intervention (1 Day)||12
6495644|NCT01394627|7414288|FG000|COMPLETED|Second Intervention (1 Day)||7
6495645|NCT01394627|7414289|FG001|COMPLETED|Second Intervention (1 Day)||12
6495646|NCT01394627|7414288|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6495647|NCT01394627|7414289|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6495648|NCT01394692|7414297|FG000|STARTED|Overall Study||29
6495649|NCT01394692|7414298|FG001|STARTED|Overall Study||29
6495650|NCT01394692|7414297|FG000|COMPLETED|Overall Study||29
6495651|NCT01394692|7414298|FG001|COMPLETED|Overall Study||29
6495652|NCT01394692|7414297|FG000|NOT COMPLETED|Overall Study||0
6495653|NCT01394692|7414298|FG001|NOT COMPLETED|Overall Study||0
6495654|NCT01394705|7414306|FG000|STARTED|Overall Study||21
6495655|NCT01394705|7414307|FG001|STARTED|Overall Study||21
6495656|NCT01394705|7414306|FG000|COMPLETED|Overall Study||19
6495657|NCT01394705|7414307|FG001|COMPLETED|Overall Study||19
6495658|NCT01394705|7414306|FG000|NOT COMPLETED|Overall Study||2
6495659|NCT01394705|7414307|FG001|NOT COMPLETED|Overall Study||2
6495660|NCT01394718|7414316|FG000|STARTED|Overall Study||30
6495661|NCT01394718|7414317|FG001|STARTED|Overall Study||30
6495662|NCT01394718|7414316|FG000|COMPLETED|Overall Study||28
6495663|NCT01394718|7414317|FG001|COMPLETED|Overall Study||29
6495664|NCT01394718|7414316|FG000|NOT COMPLETED|Overall Study||2
6495665|NCT01394718|7414317|FG001|NOT COMPLETED|Overall Study||1
6495666|NCT01394939|7414327|FG000|STARTED|Overall Study||4
6495667|NCT01394939|7414328|FG001|STARTED|Overall Study||25
6495668|NCT01394939|7414329|FG002|STARTED|Overall Study||4
6495669|NCT01394939|7414330|FG003|STARTED|Overall Study||17
6495670|NCT01394939|7414327|FG000|COMPLETED|Overall Study||3
6495671|NCT01394939|7414328|FG001|COMPLETED|Overall Study||15
6495672|NCT01394939|7414329|FG002|COMPLETED|Overall Study||4
6495673|NCT01394939|7414330|FG003|COMPLETED|Overall Study||10
6495674|NCT01394939|7414327|FG000|NOT COMPLETED|Overall Study||1
6495675|NCT01394939|7414328|FG001|NOT COMPLETED|Overall Study||10
6495676|NCT01394939|7414329|FG002|NOT COMPLETED|Overall Study||0
6495677|NCT01394939|7414330|FG003|NOT COMPLETED|Overall Study||7
6495678|NCT01394952|7414342|FG000|STARTED|Overall Study||4952
6495679|NCT01394952|7414343|FG001|STARTED|Overall Study||4949
6495680|NCT01394952|7414342|FG000|Received at Least One Dose of Study Drug|Overall Study||4949
6495681|NCT01394952|7414343|FG001|Received at Least One Dose of Study Drug|Overall Study||4943
6495682|NCT01394952|7414342|FG000|COMPLETED|Overall Study||4935
6495683|NCT01394952|7414343|FG001|COMPLETED|Overall Study||4932
6495684|NCT01394952|7414342|FG000|NOT COMPLETED|Overall Study||17
6495685|NCT01394952|7414343|FG001|NOT COMPLETED|Overall Study||17
6555395|NCT01751412|7477536|FG000|NOT COMPLETED|Overall Study||1
6495686|NCT01394978|7414352|FG000|STARTED|Overall Study||168
6495687|NCT01394978|7414353|FG001|STARTED|Overall Study||276
6495688|NCT01394978|7414352|FG000|COMPLETED|Overall Study||147
6495689|NCT01394978|7414353|FG001|COMPLETED|Overall Study||245
6495690|NCT01394978|7414352|FG000|NOT COMPLETED|Overall Study||21
6495691|NCT01394978|7414353|FG001|NOT COMPLETED|Overall Study||31
6495692|NCT01394991|7414362|FG000|STARTED|Overall Study||242
6495693|NCT01394991|7414363|FG001|STARTED|Overall Study||262
6495694|NCT01394991|7414362|FG000|COMPLETED|Overall Study||183
6495695|NCT01394991|7414363|FG001|COMPLETED|Overall Study||190
6495696|NCT01394991|7414362|FG000|NOT COMPLETED|Overall Study||59
6495697|NCT01394991|7414363|FG001|NOT COMPLETED|Overall Study||72
6495698|NCT01395017|7414371|FG000|STARTED|Overall Study||100
6495699|NCT01395017|7414372|FG001|STARTED|Overall Study||102
6495700|NCT01395017|7414371|FG000|Treated|Overall Study||98
6495701|NCT01395017|7414372|FG001|Treated|Overall Study||101
6495702|NCT01395017|7414371|FG000|COMPLETED|Overall Study||0
6495703|NCT01395017|7414372|FG001|COMPLETED|Overall Study||0
6495704|NCT01395017|7414371|FG000|NOT COMPLETED|Overall Study||100
6495705|NCT01395017|7414372|FG001|NOT COMPLETED|Overall Study||102
6495706|NCT01395030|7414379|FG000|STARTED|Overall Study||64
6495707|NCT01395030|7414379|FG000|Complete FCH PET/CT|Overall Study||57
6495708|NCT01395030|7414379|FG000|Adequate Tissue for Analysis|Overall Study||50
6495709|NCT01395030|7414379|FG000|COMPLETED|Overall Study||57
6495710|NCT01395030|7414379|FG000|NOT COMPLETED|Overall Study||7
6495711|NCT01395043|7414385|FG000|STARTED|Overall Study||15
6495712|NCT01395043|7414385|FG000|COMPLETED|Overall Study||15
6495713|NCT01395043|7414385|FG000|NOT COMPLETED|Overall Study||0
6495714|NCT01395277|7414392|FG000|STARTED|Overall Study||15
6495715|NCT01395277|7414393|FG001|STARTED|Overall Study||15
6495716|NCT01395277|7414392|FG000|COMPLETED|Overall Study||15
6495717|NCT01395277|7414393|FG001|COMPLETED|Overall Study||15
6495718|NCT01395277|7414392|FG000|NOT COMPLETED|Overall Study||0
6495719|NCT01395277|7414393|FG001|NOT COMPLETED|Overall Study||0
6495720|NCT01395316|7414401|FG000|STARTED|Overall Study||8
6495721|NCT01395316|7414401|FG000|COMPLETED|Overall Study||5
6495722|NCT01395316|7414401|FG000|NOT COMPLETED|Overall Study||3
6495723|NCT01395329|7414408|FG000|STARTED|Overall Study||14
6495724|NCT01395329|7414409|FG001|STARTED|Overall Study||14
6495725|NCT01395329|7414410|FG002|STARTED|Overall Study||14
6495726|NCT01395329|7414408|FG000|COMPLETED|Overall Study||14
6495727|NCT01395329|7414409|FG001|COMPLETED|Overall Study||14
6495728|NCT01395329|7414410|FG002|COMPLETED|Overall Study||14
6495729|NCT01395329|7414408|FG000|NOT COMPLETED|Overall Study||0
6495730|NCT01395329|7414409|FG001|NOT COMPLETED|Overall Study||0
6495731|NCT01395329|7414410|FG002|NOT COMPLETED|Overall Study||0
6495732|NCT01395368|7414421|FG000|STARTED|Overall Study||108
6495733|NCT01395368|7414421|FG000|COMPLETED|Overall Study||92
6495734|NCT01395368|7414421|FG000|NOT COMPLETED|Overall Study||16
6495735|NCT01395394|7414428|FG000|STARTED|Baseline Study Visit||4
6495736|NCT01395394|7414429|FG001|STARTED|Baseline Study Visit||3
6495737|NCT01395394|7414430|FG002|STARTED|Baseline Study Visit||5
6495738|NCT01395394|7414428|FG000|COMPLETED|Baseline Study Visit||3
6495739|NCT01395394|7414429|FG001|COMPLETED|Baseline Study Visit||3
6495740|NCT01395394|7414430|FG002|COMPLETED|Baseline Study Visit||5
6495741|NCT01395394|7414428|FG000|NOT COMPLETED|Baseline Study Visit||1
6495742|NCT01395394|7414429|FG001|NOT COMPLETED|Baseline Study Visit||0
6495743|NCT01395394|7414430|FG002|NOT COMPLETED|Baseline Study Visit||0
6495744|NCT01395394|7414428|FG000|STARTED|Study Visit 2 (Non-responders Only)||3
6495745|NCT01395394|7414429|FG001|STARTED|Study Visit 2 (Non-responders Only)||0
6495746|NCT01395394|7414430|FG002|STARTED|Study Visit 2 (Non-responders Only)||0
6495747|NCT01395394|7414428|FG000|COMPLETED|Study Visit 2 (Non-responders Only)||3
6495748|NCT01395394|7414429|FG001|COMPLETED|Study Visit 2 (Non-responders Only)||0
6495749|NCT01395394|7414430|FG002|COMPLETED|Study Visit 2 (Non-responders Only)||0
6495750|NCT01395394|7414428|FG000|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
6495751|NCT01395394|7414429|FG001|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
6495752|NCT01395394|7414430|FG002|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
6495753|NCT01395524|7414441|FG000|STARTED|Overall Study||97
6495754|NCT01395524|7414442|FG001|STARTED|Overall Study||99
6495755|NCT01395524|7414443|FG002|STARTED|Overall Study||106
6495756|NCT01395524|7414441|FG000|COMPLETED|Overall Study||79
6495757|NCT01395524|7414442|FG001|COMPLETED|Overall Study||83
6495758|NCT01395524|7414443|FG002|COMPLETED|Overall Study||89
6495759|NCT01395524|7414441|FG000|NOT COMPLETED|Overall Study||18
6495760|NCT01395524|7414442|FG001|NOT COMPLETED|Overall Study||16
6495761|NCT01395524|7414443|FG002|NOT COMPLETED|Overall Study||17
6495762|NCT01395537|7414451|FG000|STARTED|Phase I||13
6495763|NCT01395537|7414451|FG000|COMPLETED|Phase I||13
6495764|NCT01395537|7414451|FG000|NOT COMPLETED|Phase I||0
6495765|NCT01395537|7414451|FG000|STARTED|Phase II||1
6495766|NCT01395537|7414451|FG000|COMPLETED|Phase II||1
6495767|NCT01395537|7414451|FG000|NOT COMPLETED|Phase II||0
6495768|NCT01395758|7414457|FG000|STARTED|Open-label Treatment Period||51
6495769|NCT01395758|7414458|FG001|STARTED|Open-label Treatment Period||45
6495770|NCT01395758|7414459|FG002|STARTED|Open-label Treatment Period||0
6495771|NCT01395758|7414457|FG000|COMPLETED|Open-label Treatment Period||47
6555396|NCT01751451|7477543|FG000|STARTED|Overall Study||42
6555397|NCT01751451|7477544|FG001|STARTED|Overall Study||40
6555398|NCT01751451|7477545|FG002|STARTED|Overall Study||42
6555399|NCT01751451|7477543|FG000|COMPLETED|Overall Study||42
6555400|NCT01751451|7477544|FG001|COMPLETED|Overall Study||40
6495772|NCT01395758|7414458|FG001|COMPLETED|Open-label Treatment Period||45
6495773|NCT01395758|7414459|FG002|COMPLETED|Open-label Treatment Period||0
6495774|NCT01395758|7414457|FG000|NOT COMPLETED|Open-label Treatment Period||4
6495775|NCT01395758|7414458|FG001|NOT COMPLETED|Open-label Treatment Period||0
6495776|NCT01395758|7414459|FG002|NOT COMPLETED|Open-label Treatment Period||0
6495777|NCT01395758|7414457|FG000|STARTED|Crossover Period||0
6495778|NCT01395758|7414458|FG001|STARTED|Crossover Period||0
6495779|NCT01395758|7414459|FG002|STARTED|Crossover Period||26
6495780|NCT01395758|7414457|FG000|COMPLETED|Crossover Period||0
6495781|NCT01395758|7414458|FG001|COMPLETED|Crossover Period||0
6495782|NCT01395758|7414459|FG002|COMPLETED|Crossover Period||26
6495783|NCT01395758|7414457|FG000|NOT COMPLETED|Crossover Period||0
6495784|NCT01395758|7414458|FG001|NOT COMPLETED|Crossover Period||0
6495785|NCT01395758|7414459|FG002|NOT COMPLETED|Crossover Period||0
6495786|NCT01395784|7414466|FG000|STARTED|Overall Study||32
6495787|NCT01395784|7414466|FG000|COMPLETED|Overall Study||17
6495788|NCT01395784|7414466|FG000|NOT COMPLETED|Overall Study||15
6495789|NCT01395797|7414476|FG000|STARTED|Overall Study||19
6495790|NCT01395797|7414477|FG001|STARTED|Overall Study||4
6495791|NCT01395797|7414478|FG002|STARTED|Overall Study||18
6495792|NCT01395797|7414479|FG003|STARTED|Overall Study||15
6495793|NCT01395797|7414480|FG004|STARTED|Overall Study||9
6495794|NCT01395797|7414481|FG005|STARTED|Overall Study||17
6495795|NCT01395797|7414476|FG000|COMPLETED|Overall Study||16
6495796|NCT01395797|7414477|FG001|COMPLETED|Overall Study||3
6495797|NCT01395797|7414478|FG002|COMPLETED|Overall Study||14
6495798|NCT01395797|7414479|FG003|COMPLETED|Overall Study||13
6495799|NCT01395797|7414480|FG004|COMPLETED|Overall Study||7
6495800|NCT01395797|7414481|FG005|COMPLETED|Overall Study||14
6495801|NCT01395797|7414476|FG000|NOT COMPLETED|Overall Study||3
6495802|NCT01395797|7414477|FG001|NOT COMPLETED|Overall Study||1
6495803|NCT01395797|7414478|FG002|NOT COMPLETED|Overall Study||4
6495804|NCT01395797|7414479|FG003|NOT COMPLETED|Overall Study||2
6495805|NCT01395797|7414480|FG004|NOT COMPLETED|Overall Study||2
6495806|NCT01395797|7414481|FG005|NOT COMPLETED|Overall Study||3
6495807|NCT01395810|7414505|FG000|STARTED|Overall Study||18
6495808|NCT01395810|7414506|FG001|STARTED|Overall Study||48
6495809|NCT01395810|7414507|FG002|STARTED|Overall Study||0
6495810|NCT01395810|7414508|FG003|STARTED|Overall Study||5
6495811|NCT01395810|7414505|FG000|After Switching the Arms|Overall Study|18 subjects started in this arm and additional 3 subjects from 40 IU/kg switched to this arm|21
6495812|NCT01395810|7414506|FG001|After Switching the Arms|Overall Study|48 subjects started in this arm, 3 subjects in 10 IU/kg+1 subject in on-demand switched to this arm|52
6495813|NCT01395810|7414507|FG002|After Switching the Arms|Overall Study|No subjects started in this arm initially, 2 patients in 40 IU/kg arm switched to this arm.|2
6495814|NCT01395810|7414508|FG003|After Switching the Arms|Overall Study||5
6495815|NCT01395810|7414505|FG000|COMPLETED|Overall Study||16
6495816|NCT01395810|7414506|FG001|COMPLETED|Overall Study||44
6495817|NCT01395810|7414507|FG002|COMPLETED|Overall Study||0
6495818|NCT01395810|7414508|FG003|COMPLETED|Overall Study||5
6495819|NCT01395810|7414505|FG000|NOT COMPLETED|Overall Study||2
6495820|NCT01395810|7414506|FG001|NOT COMPLETED|Overall Study||4
6495821|NCT01395810|7414507|FG002|NOT COMPLETED|Overall Study||0
6495822|NCT01395810|7414508|FG003|NOT COMPLETED|Overall Study||0
6495823|NCT01395823|7414521|FG000|STARTED|Overall Study||137
6495824|NCT01395823|7414522|FG001|STARTED|Overall Study||139
6495825|NCT01395823|7414521|FG000|COMPLETED|Overall Study||122
6495826|NCT01395823|7414522|FG001|COMPLETED|Overall Study||130
6495827|NCT01395823|7414521|FG000|NOT COMPLETED|Overall Study||15
6495828|NCT01395823|7414522|FG001|NOT COMPLETED|Overall Study||9
6495829|NCT01395888|7414530|FG000|STARTED|2-week Run-in Period||279
6495830|NCT01395888|7414531|FG001|STARTED|2-week Run-in Period||0
6495831|NCT01395888|7414532|FG002|STARTED|2-week Run-in Period||0
6495832|NCT01395888|7414530|FG000|COMPLETED|2-week Run-in Period||257
6495833|NCT01395888|7414531|FG001|COMPLETED|2-week Run-in Period||0
6495834|NCT01395888|7414532|FG002|COMPLETED|2-week Run-in Period||0
6495835|NCT01395888|7414530|FG000|NOT COMPLETED|2-week Run-in Period||22
6495836|NCT01395888|7414531|FG001|NOT COMPLETED|2-week Run-in Period||0
6495837|NCT01395888|7414532|FG002|NOT COMPLETED|2-week Run-in Period||0
6495838|NCT01395888|7414530|FG000|STARTED|Treatment Period (TP)||0
6495839|NCT01395888|7414531|FG001|STARTED|Treatment Period (TP)||127
6495840|NCT01395888|7414532|FG002|STARTED|Treatment Period (TP)||130
6750135|NCT03426995|7677323|FG016|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750136|NCT03426995|7677324|FG017|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750137|NCT03426995|7677325|FG018|NOT COMPLETED|PartA:Cohort2-WashoutPeriod3(Upto Day14)||0
6750138|NCT03426995|7677307|FG000|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750139|NCT03426995|7677308|FG001|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750140|NCT03426995|7677309|FG002|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750141|NCT03426995|7677310|FG003|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750142|NCT03426995|7677311|FG004|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750143|NCT03426995|7677312|FG005|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750144|NCT03426995|7677313|FG006|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
6750145|NCT03426995|7677314|FG007|STARTED|Part A: Cohort 2-Period 4 (Day1)|New participant enrolled and dosed.|3
6750146|NCT03426995|7677315|FG008|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
6750147|NCT03426995|7677316|FG009|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
6750148|NCT03426995|7677317|FG010|STARTED|Part A: Cohort 2-Period 4 (Day1)||1
6750149|NCT03426995|7677318|FG011|STARTED|Part A: Cohort 2-Period 4 (Day1)||2
6750150|NCT03426995|7677319|FG012|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750151|NCT03426995|7677320|FG013|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750152|NCT03426995|7677321|FG014|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750153|NCT03426995|7677322|FG015|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750154|NCT03426995|7677323|FG016|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750155|NCT03426995|7677324|FG017|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6495841|NCT01395888|7414530|FG000|Completed the Treatment Period|Treatment Period (TP)||0
6495842|NCT01395888|7414531|FG001|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
6495843|NCT01395888|7414532|FG002|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
6495844|NCT01395888|7414530|FG000|COMPLETED|Treatment Period (TP)||0
6495845|NCT01395888|7414531|FG001|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
6495846|NCT01395888|7414532|FG002|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
6495847|NCT01395888|7414530|FG000|NOT COMPLETED|Treatment Period (TP)||0
6495848|NCT01395888|7414531|FG001|NOT COMPLETED|Treatment Period (TP)||15
6495849|NCT01395888|7414532|FG002|NOT COMPLETED|Treatment Period (TP)||17
6495850|NCT01395901|7414540|FG000|STARTED|Overall Study|Randomized Population|336
6495851|NCT01395901|7414541|FG001|STARTED|Overall Study|Randomized Population|334
6495852|NCT01395901|7414540|FG000|COMPLETED|Overall Study|Treated patients completing the study|326
6495853|NCT01395901|7414541|FG001|COMPLETED|Overall Study|Treated patients completing the study|329
6495854|NCT01395901|7414540|FG000|NOT COMPLETED|Overall Study||10
6495855|NCT01395901|7414541|FG001|NOT COMPLETED|Overall Study||5
6495856|NCT01395914|7414549|FG000|STARTED|Overall Study||345
6495857|NCT01395914|7414550|FG001|STARTED|Overall Study||168
6495858|NCT01395914|7414549|FG000|ITT Population|Overall Study||345
6495859|NCT01395914|7414550|FG001|ITT Population|Overall Study||168
6495860|NCT01395914|7414549|FG000|Safety Population|Overall Study||343
6495861|NCT01395914|7414550|FG001|Safety Population|Overall Study||167
6495862|NCT01395914|7414549|FG000|COMPLETED|Overall Study||273
6495863|NCT01395914|7414550|FG001|COMPLETED|Overall Study||131
6495864|NCT01395914|7414549|FG000|NOT COMPLETED|Overall Study||72
6495865|NCT01395914|7414550|FG001|NOT COMPLETED|Overall Study||37
6495866|NCT01395966|7414559|FG000|STARTED|Overall Study||109
6495867|NCT01395966|7414560|FG001|STARTED|Overall Study||110
6495868|NCT01395966|7414561|FG002|STARTED|Overall Study||112
6495869|NCT01395966|7414559|FG000|COMPLETED|Overall Study||99
6495870|NCT01395966|7414560|FG001|COMPLETED|Overall Study||91
6495871|NCT01395966|7414561|FG002|COMPLETED|Overall Study||104
6495872|NCT01395966|7414559|FG000|NOT COMPLETED|Overall Study||10
6495873|NCT01395966|7414560|FG001|NOT COMPLETED|Overall Study||19
6495874|NCT01395966|7414561|FG002|NOT COMPLETED|Overall Study||8
6495875|NCT01396005|7414571|FG000|STARTED|Overall Study||10
6495876|NCT01396005|7414572|FG001|STARTED|Overall Study||11
6495877|NCT01396005|7414571|FG000|COMPLETED|Overall Study||10
6495878|NCT01396005|7414572|FG001|COMPLETED|Overall Study||9
6495879|NCT01396005|7414571|FG000|NOT COMPLETED|Overall Study||0
6495880|NCT01396005|7414572|FG001|NOT COMPLETED|Overall Study||2
6495881|NCT01396044|7414582|FG000|STARTED|Overall Study||125
6495882|NCT01396044|7414583|FG001|STARTED|Overall Study||171
6495883|NCT01396044|7414582|FG000|COMPLETED|Overall Study||125
6495884|NCT01396044|7414583|FG001|COMPLETED|Overall Study||171
6495885|NCT01396044|7414582|FG000|NOT COMPLETED|Overall Study||0
6495886|NCT01396044|7414583|FG001|NOT COMPLETED|Overall Study||0
6495887|NCT01396057|7414591|FG000|STARTED|Overall Study||126
6495888|NCT01396057|7414592|FG001|STARTED|Overall Study||118
6495889|NCT01396057|7414591|FG000|COMPLETED|Overall Study||115
6495890|NCT01396057|7414592|FG001|COMPLETED|Overall Study||100
6750156|NCT03426995|7677325|FG018|STARTED|Part A: Cohort 2-Period 4 (Day1)||0
6750157|NCT03426995|7677307|FG000|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750158|NCT03426995|7677308|FG001|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750159|NCT03426995|7677309|FG002|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750160|NCT03426995|7677310|FG003|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750161|NCT03426995|7677311|FG004|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750162|NCT03426995|7677312|FG005|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750163|NCT03426995|7677313|FG006|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
6750164|NCT03426995|7677314|FG007|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
6750165|NCT03426995|7677315|FG008|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
6750166|NCT03426995|7677316|FG009|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
6750167|NCT03426995|7677317|FG010|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750168|NCT03426995|7677318|FG011|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||2
6750169|NCT03426995|7677319|FG012|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750170|NCT03426995|7677320|FG013|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750171|NCT03426995|7677321|FG014|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750172|NCT03426995|7677322|FG015|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750173|NCT03426995|7677323|FG016|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750174|NCT03426995|7677324|FG017|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750175|NCT03426995|7677325|FG018|COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750176|NCT03426995|7677307|FG000|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750177|NCT03426995|7677308|FG001|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750178|NCT03426995|7677309|FG002|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750179|NCT03426995|7677310|FG003|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750180|NCT03426995|7677311|FG004|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750181|NCT03426995|7677312|FG005|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750182|NCT03426995|7677313|FG006|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750183|NCT03426995|7677314|FG007|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
6495891|NCT01396057|7414591|FG000|NOT COMPLETED|Overall Study||11
6495892|NCT01396057|7414592|FG001|NOT COMPLETED|Overall Study||18
6495893|NCT01396070|7414598|FG000|STARTED|Overall Study||36
6495894|NCT01396070|7414598|FG000|COMPLETED|Overall Study||17
6495895|NCT01396070|7414598|FG000|NOT COMPLETED|Overall Study||19
6495896|NCT01396083|7414605|FG000|STARTED|Overall Study||124
6495897|NCT01396083|7414606|FG001|STARTED|Overall Study||119
6495898|NCT01396083|7414605|FG000|COMPLETED|Overall Study||113
6495899|NCT01396083|7414606|FG001|COMPLETED|Overall Study||72
6495900|NCT01396083|7414605|FG000|NOT COMPLETED|Overall Study||11
6495901|NCT01396083|7414606|FG001|NOT COMPLETED|Overall Study||47
6495902|NCT01396148|7414612|FG000|STARTED|Overall Study||6
6495903|NCT01396148|7414612|FG000|COMPLETED|Overall Study||5
6495904|NCT01396148|7414612|FG000|NOT COMPLETED|Overall Study||1
6495905|NCT01396161|7414625|FG000|STARTED|Overall Study||12
6495906|NCT01396161|7414626|FG001|STARTED|Overall Study||5
6495907|NCT01396161|7414627|FG002|STARTED|Overall Study||9
6495908|NCT01396161|7414628|FG003|STARTED|Overall Study||9
6495909|NCT01396161|7414629|FG004|STARTED|Overall Study||9
6495910|NCT01396161|7414630|FG005|STARTED|Overall Study||9
6495911|NCT01396161|7414631|FG006|STARTED|Overall Study||11
6495912|NCT01396161|7414625|FG000|COMPLETED|Overall Study||12
6495913|NCT01396161|7414626|FG001|COMPLETED|Overall Study||5
6495914|NCT01396161|7414627|FG002|COMPLETED|Overall Study||9
6495915|NCT01396161|7414628|FG003|COMPLETED|Overall Study||9
6495916|NCT01396161|7414629|FG004|COMPLETED|Overall Study||8
6495917|NCT01396161|7414630|FG005|COMPLETED|Overall Study||9
6495918|NCT01396161|7414631|FG006|COMPLETED|Overall Study||10
6495919|NCT01396161|7414625|FG000|NOT COMPLETED|Overall Study||0
6495920|NCT01396161|7414626|FG001|NOT COMPLETED|Overall Study||0
6495921|NCT01396161|7414627|FG002|NOT COMPLETED|Overall Study||0
6495922|NCT01396161|7414628|FG003|NOT COMPLETED|Overall Study||0
6495923|NCT01396161|7414629|FG004|NOT COMPLETED|Overall Study||1
6495924|NCT01396161|7414630|FG005|NOT COMPLETED|Overall Study||0
6495925|NCT01396161|7414631|FG006|NOT COMPLETED|Overall Study||1
6495926|NCT01396187|7414657|FG000|STARTED|Overall Study||8
6495927|NCT01396187|7414658|FG001|STARTED|Overall Study||12
6495928|NCT01396187|7414659|FG002|STARTED|Overall Study||10
6495929|NCT01396187|7414660|FG003|STARTED|Overall Study||10
6495930|NCT01396187|7414661|FG004|STARTED|Overall Study||10
6495931|NCT01396187|7414657|FG000|COMPLETED|Overall Study||7
6495932|NCT01396187|7414658|FG001|COMPLETED|Overall Study||9
6495933|NCT01396187|7414659|FG002|COMPLETED|Overall Study||9
6495934|NCT01396187|7414660|FG003|COMPLETED|Overall Study||10
6495935|NCT01396187|7414661|FG004|COMPLETED|Overall Study||9
6495936|NCT01396187|7414657|FG000|NOT COMPLETED|Overall Study||1
6495937|NCT01396187|7414658|FG001|NOT COMPLETED|Overall Study||3
6495938|NCT01396187|7414659|FG002|NOT COMPLETED|Overall Study||1
6495939|NCT01396187|7414660|FG003|NOT COMPLETED|Overall Study||0
6495940|NCT01396187|7414661|FG004|NOT COMPLETED|Overall Study||1
6495941|NCT01396226|7414679|FG000|STARTED|Overall Study||12
6495942|NCT01396226|7414680|FG001|STARTED|Overall Study||6
6495943|NCT01396226|7414679|FG000|Patients Who Received Treatment|Overall Study||12
6495944|NCT01396226|7414680|FG001|Patients Who Received Treatment|Overall Study||6
6495945|NCT01396226|7414679|FG000|Patients Who Completed Treatment|Overall Study||12
6495946|NCT01396226|7414680|FG001|Patients Who Completed Treatment|Overall Study||6
6495947|NCT01396226|7414679|FG000|COMPLETED|Overall Study||12
6495948|NCT01396226|7414680|FG001|COMPLETED|Overall Study||6
6495949|NCT01396226|7414679|FG000|NOT COMPLETED|Overall Study||0
6495950|NCT01396226|7414680|FG001|NOT COMPLETED|Overall Study||0
6495951|NCT01396239|7414689|FG000|STARTED|Overall Study||4
6495952|NCT01396239|7414690|FG001|STARTED|Overall Study||2
6495953|NCT01396239|7414691|FG002|STARTED|Overall Study||4
6495954|NCT01396239|7414692|FG003|STARTED|Overall Study||2
6495955|NCT01396239|7414689|FG000|COMPLETED|Overall Study||4
6495956|NCT01396239|7414690|FG001|COMPLETED|Overall Study||2
6495957|NCT01396239|7414691|FG002|COMPLETED|Overall Study||4
6495958|NCT01396239|7414692|FG003|COMPLETED|Overall Study||2
6495959|NCT01396239|7414689|FG000|NOT COMPLETED|Overall Study||0
6495960|NCT01396239|7414690|FG001|NOT COMPLETED|Overall Study||0
6495961|NCT01396239|7414691|FG002|NOT COMPLETED|Overall Study||0
6495962|NCT01396239|7414692|FG003|NOT COMPLETED|Overall Study||0
6495963|NCT01396265|7414709|FG000|STARTED|Afatinib||22
6495964|NCT01396265|7414709|FG000|COMPLETED|Afatinib||22
6495965|NCT01396265|7414709|FG000|NOT COMPLETED|Afatinib||0
6495966|NCT01396265|7414709|FG000|STARTED|Washout||22
6495967|NCT01396265|7414709|FG000|COMPLETED|Washout||22
6495968|NCT01396265|7414709|FG000|NOT COMPLETED|Washout||0
6495969|NCT01396265|7414709|FG000|STARTED|Rifa+Afatinib||22
6495970|NCT01396265|7414709|FG000|COMPLETED|Rifa+Afatinib||21
6495971|NCT01396265|7414709|FG000|NOT COMPLETED|Rifa+Afatinib||1
6495972|NCT01396317|7414717|FG000|STARTED|Overall Study||10
6495973|NCT01396317|7414718|FG001|STARTED|Overall Study||10
6495974|NCT01396317|7414717|FG000|COMPLETED|Overall Study||9
6495975|NCT01396317|7414718|FG001|COMPLETED|Overall Study||10
6495976|NCT01396317|7414717|FG000|NOT COMPLETED|Overall Study||1
6495977|NCT01396317|7414718|FG001|NOT COMPLETED|Overall Study||0
6495978|NCT01396382|7414726|FG000|STARTED|Overall Study||97
6495979|NCT01396382|7414726|FG000|COMPLETED|Overall Study||97
6495980|NCT01396382|7414726|FG000|NOT COMPLETED|Overall Study||0
6495981|NCT01396395|7414733|FG000|STARTED|Overall Study||200
6495982|NCT01396395|7414734|FG001|STARTED|Overall Study||202
6495983|NCT01396395|7414733|FG000|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
6495984|NCT01396395|7414734|FG001|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
6495985|NCT01396395|7414733|FG000|COMPLETED|Overall Study||160
6495986|NCT01396395|7414734|FG001|COMPLETED|Overall Study||175
6495987|NCT01396395|7414733|FG000|NOT COMPLETED|Overall Study||40
6495988|NCT01396395|7414734|FG001|NOT COMPLETED|Overall Study||27
6495989|NCT01396421|7414746|FG000|STARTED|Overall Study||180
6495990|NCT01396421|7414747|FG001|STARTED|Overall Study||182
6495991|NCT01396421|7414748|FG002|STARTED|Overall Study||90
6495992|NCT01396421|7414749|FG003|STARTED|Overall Study||184
6495993|NCT01396421|7414746|FG000|COMPLETED|Overall Study||121
6495994|NCT01396421|7414747|FG001|COMPLETED|Overall Study||124
6495995|NCT01396421|7414748|FG002|COMPLETED|Overall Study||56
6495996|NCT01396421|7414749|FG003|COMPLETED|Overall Study||109
6495997|NCT01396421|7414746|FG000|NOT COMPLETED|Overall Study||59
6495998|NCT01396421|7414747|FG001|NOT COMPLETED|Overall Study||58
6495999|NCT01396421|7414748|FG002|NOT COMPLETED|Overall Study||34
6496000|NCT01396421|7414749|FG003|NOT COMPLETED|Overall Study||75
6496001|NCT01396434|7414776|FG000|STARTED|Overall Study||2817
6496002|NCT01396434|7414777|FG001|STARTED|Overall Study||175
6496003|NCT01396434|7414778|FG002|STARTED|Overall Study||14
6496004|NCT01396434|7414776|FG000|COMPLETED|Overall Study||2806
6496005|NCT01396434|7414777|FG001|COMPLETED|Overall Study||175
6496006|NCT01396434|7414778|FG002|COMPLETED|Overall Study||14
6496007|NCT01396434|7414776|FG000|NOT COMPLETED|Overall Study||11
6496008|NCT01396434|7414777|FG001|NOT COMPLETED|Overall Study||0
6496009|NCT01396434|7414778|FG002|NOT COMPLETED|Overall Study||0
6496010|NCT01396447|7414790|FG000|STARTED|Overall Study||148
6496011|NCT01396447|7414791|FG001|STARTED|Overall Study||143
6496012|NCT01396447|7414792|FG002|STARTED|Overall Study||147
6496013|NCT01396447|7414793|FG003|STARTED|Overall Study||146
6496014|NCT01396447|7414790|FG000|Received Treatment|Overall Study||145
6496015|NCT01396447|7414791|FG001|Received Treatment|Overall Study||141
6496016|NCT01396447|7414792|FG002|Received Treatment|Overall Study||146
6496017|NCT01396447|7414793|FG003|Received Treatment|Overall Study||146
6496018|NCT01396447|7414790|FG000|COMPLETED|Overall Study||105
6496019|NCT01396447|7414791|FG001|COMPLETED|Overall Study||103
6496020|NCT01396447|7414792|FG002|COMPLETED|Overall Study||117
6496021|NCT01396447|7414793|FG003|COMPLETED|Overall Study||94
6496022|NCT01396447|7414790|FG000|NOT COMPLETED|Overall Study||43
6496023|NCT01396447|7414791|FG001|NOT COMPLETED|Overall Study||40
6496024|NCT01396447|7414792|FG002|NOT COMPLETED|Overall Study||30
6496025|NCT01396447|7414793|FG003|NOT COMPLETED|Overall Study||52
6496026|NCT01396486|7414806|FG000|STARTED|Overall Study||20
6496027|NCT01396486|7414807|FG001|STARTED|Overall Study||19
6496028|NCT01396486|7414808|FG002|STARTED|Overall Study||22
6496029|NCT01396486|7414806|FG000|Exposed|Overall Study||19
6496030|NCT01396486|7414807|FG001|Exposed|Overall Study||16
6496031|NCT01396486|7414808|FG002|Exposed|Overall Study||17
6496032|NCT01396486|7414806|FG000|COMPLETED|Overall Study||10
6496033|NCT01396486|7414807|FG001|COMPLETED|Overall Study||7
6496034|NCT01396486|7414808|FG002|COMPLETED|Overall Study||10
6496035|NCT01396486|7414806|FG000|NOT COMPLETED|Overall Study||10
6496036|NCT01396486|7414807|FG001|NOT COMPLETED|Overall Study||12
6496037|NCT01396486|7414808|FG002|NOT COMPLETED|Overall Study||12
6496038|NCT01396512|7414818|FG000|STARTED|Overall Study||137
6496039|NCT01396512|7414819|FG001|STARTED|Overall Study||137
6496040|NCT01396512|7414818|FG000|COMPLETED|Overall Study||137
6496041|NCT01396512|7414819|FG001|COMPLETED|Overall Study||136
6555401|NCT01751451|7477545|FG002|COMPLETED|Overall Study||42
6555402|NCT01751451|7477543|FG000|NOT COMPLETED|Overall Study||0
6555403|NCT01751451|7477544|FG001|NOT COMPLETED|Overall Study||0
6555404|NCT01751451|7477545|FG002|NOT COMPLETED|Overall Study||0
6555405|NCT01751568|7477556|FG000|STARTED|Overall Study||13
6555406|NCT01751568|7477557|FG001|STARTED|Overall Study||14
6555407|NCT01751568|7477558|FG002|STARTED|Overall Study||13
6496042|NCT01396512|7414818|FG000|NOT COMPLETED|Overall Study||0
6496043|NCT01396512|7414819|FG001|NOT COMPLETED|Overall Study||1
6496044|NCT01396525|7414825|FG000|STARTED|Overall Study||153
6496045|NCT01396525|7414825|FG000|COMPLETED|Overall Study||127
6496046|NCT01396525|7414825|FG000|NOT COMPLETED|Overall Study||26
6496047|NCT01396551|7414833|FG000|STARTED|Overall Study||69
6496048|NCT01396551|7414833|FG000|COMPLETED|Overall Study||69
6496049|NCT01396551|7414833|FG000|NOT COMPLETED|Overall Study||0
6496050|NCT01396837|7414837|FG000|STARTED|Overall Study||20
6496051|NCT01396837|7414837|FG000|COMPLETED|Overall Study||16
6496052|NCT01396837|7414837|FG000|NOT COMPLETED|Overall Study||4
6496053|NCT01397071|7414841|FG000|STARTED|Consumption of Beef Patty Alone||11
6496054|NCT01397071|7414841|FG000|COMPLETED|Consumption of Beef Patty Alone||11
6496055|NCT01397071|7414841|FG000|NOT COMPLETED|Consumption of Beef Patty Alone||0
6496056|NCT01397071|7414841|FG000|STARTED|Consumption of Beef Patty With Avocado||11
6496057|NCT01397071|7414841|FG000|COMPLETED|Consumption of Beef Patty With Avocado||11
6496058|NCT01397071|7414841|FG000|NOT COMPLETED|Consumption of Beef Patty With Avocado||0
6555408|NCT01751568|7477556|FG000|COMPLETED|Overall Study||12
6496059|NCT01397084|7414849|FG000|STARTED|Overall Study||108
6496060|NCT01397084|7414849|FG000|COMPLETED|Overall Study||100
6496061|NCT01397084|7414849|FG000|NOT COMPLETED|Overall Study||8
6496062|NCT01397253|7414855|FG000|STARTED|Overall Study||443
6496063|NCT01397253|7414856|FG001|STARTED|Overall Study||392
6496064|NCT01397253|7414855|FG000|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
6496065|NCT01397253|7414856|FG001|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
6496066|NCT01397253|7414855|FG000|NOT COMPLETED|Overall Study||126
6496067|NCT01397253|7414856|FG001|NOT COMPLETED|Overall Study||149
6496068|NCT01397409|7414872|FG000|STARTED|Stage 1||9
6496069|NCT01397409|7414873|FG001|STARTED|Stage 1||6
6496070|NCT01397409|7414874|FG002|STARTED|Stage 1||6
6496071|NCT01397409|7414875|FG003|STARTED|Stage 1||3
6496072|NCT01397409|7414876|FG004|STARTED|Stage 1||0
6496073|NCT01397409|7414877|FG005|STARTED|Stage 1||0
6496074|NCT01397409|7414878|FG006|STARTED|Stage 1||0
6496075|NCT01397409|7414879|FG007|STARTED|Stage 1||0
6496076|NCT01397409|7414880|FG008|STARTED|Stage 1||0
6496077|NCT01397409|7414881|FG009|STARTED|Stage 1||0
6496078|NCT01397409|7414872|FG000|COMPLETED|Stage 1||9
6496079|NCT01397409|7414873|FG001|COMPLETED|Stage 1||6
6496080|NCT01397409|7414874|FG002|COMPLETED|Stage 1||6
6496081|NCT01397409|7414875|FG003|COMPLETED|Stage 1||3
6496082|NCT01397409|7414876|FG004|COMPLETED|Stage 1||0
6496083|NCT01397409|7414877|FG005|COMPLETED|Stage 1||0
6496084|NCT01397409|7414878|FG006|COMPLETED|Stage 1||0
6496085|NCT01397409|7414879|FG007|COMPLETED|Stage 1||0
6496086|NCT01397409|7414880|FG008|COMPLETED|Stage 1||0
6496087|NCT01397409|7414881|FG009|COMPLETED|Stage 1||0
6496088|NCT01397409|7414872|FG000|NOT COMPLETED|Stage 1||0
6496089|NCT01397409|7414873|FG001|NOT COMPLETED|Stage 1||0
6496090|NCT01397409|7414874|FG002|NOT COMPLETED|Stage 1||0
6496091|NCT01397409|7414875|FG003|NOT COMPLETED|Stage 1||0
6496092|NCT01397409|7414876|FG004|NOT COMPLETED|Stage 1||0
6496093|NCT01397409|7414877|FG005|NOT COMPLETED|Stage 1||0
6496094|NCT01397409|7414878|FG006|NOT COMPLETED|Stage 1||0
6496095|NCT01397409|7414879|FG007|NOT COMPLETED|Stage 1||0
6496096|NCT01397409|7414880|FG008|NOT COMPLETED|Stage 1||0
6496097|NCT01397409|7414881|FG009|NOT COMPLETED|Stage 1||0
6496098|NCT01397409|7414872|FG000|STARTED|Stage 2||0
6496099|NCT01397409|7414873|FG001|STARTED|Stage 2||0
6496100|NCT01397409|7414874|FG002|STARTED|Stage 2||0
6496101|NCT01397409|7414875|FG003|STARTED|Stage 2||0
6496102|NCT01397409|7414876|FG004|STARTED|Stage 2||67
6496103|NCT01397409|7414877|FG005|STARTED|Stage 2||58
6496104|NCT01397409|7414878|FG006|STARTED|Stage 2||58
6496105|NCT01397409|7414879|FG007|STARTED|Stage 2||0
6496106|NCT01397409|7414880|FG008|STARTED|Stage 2||0
6496107|NCT01397409|7414881|FG009|STARTED|Stage 2||0
6496108|NCT01397409|7414872|FG000|COMPLETED|Stage 2||0
6496109|NCT01397409|7414873|FG001|COMPLETED|Stage 2||0
6496110|NCT01397409|7414874|FG002|COMPLETED|Stage 2||0
6496111|NCT01397409|7414875|FG003|COMPLETED|Stage 2||0
6496112|NCT01397409|7414876|FG004|COMPLETED|Stage 2||59
6496113|NCT01397409|7414877|FG005|COMPLETED|Stage 2||54
6496114|NCT01397409|7414878|FG006|COMPLETED|Stage 2||58
6496115|NCT01397409|7414879|FG007|COMPLETED|Stage 2||0
6496116|NCT01397409|7414880|FG008|COMPLETED|Stage 2||0
6496117|NCT01397409|7414881|FG009|COMPLETED|Stage 2||0
6496118|NCT01397409|7414872|FG000|NOT COMPLETED|Stage 2||0
6496119|NCT01397409|7414873|FG001|NOT COMPLETED|Stage 2||0
6496120|NCT01397409|7414874|FG002|NOT COMPLETED|Stage 2||0
6496121|NCT01397409|7414875|FG003|NOT COMPLETED|Stage 2||0
6496122|NCT01397409|7414876|FG004|NOT COMPLETED|Stage 2||8
6496123|NCT01397409|7414877|FG005|NOT COMPLETED|Stage 2||4
6555409|NCT01751568|7477557|FG001|COMPLETED|Overall Study||14
6555410|NCT01751568|7477558|FG002|COMPLETED|Overall Study||13
6750184|NCT03426995|7677315|FG008|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6496124|NCT01397409|7414878|FG006|NOT COMPLETED|Stage 2||0
6496125|NCT01397409|7414879|FG007|NOT COMPLETED|Stage 2||0
6496126|NCT01397409|7414880|FG008|NOT COMPLETED|Stage 2||0
6496127|NCT01397409|7414881|FG009|NOT COMPLETED|Stage 2||0
6496128|NCT01397409|7414872|FG000|STARTED|Stage 3||0
6496129|NCT01397409|7414873|FG001|STARTED|Stage 3||0
6496130|NCT01397409|7414874|FG002|STARTED|Stage 3||0
6496131|NCT01397409|7414875|FG003|STARTED|Stage 3||0
6496132|NCT01397409|7414876|FG004|STARTED|Stage 3||0
6496133|NCT01397409|7414877|FG005|STARTED|Stage 3||0
6496134|NCT01397409|7414878|FG006|STARTED|Stage 3||0
6496135|NCT01397409|7414879|FG007|STARTED|Stage 3||23
6496136|NCT01397409|7414880|FG008|STARTED|Stage 3||25
6496137|NCT01397409|7414881|FG009|STARTED|Stage 3||16
6496138|NCT01397409|7414872|FG000|COMPLETED|Stage 3||0
6555411|NCT01751568|7477556|FG000|NOT COMPLETED|Overall Study||1
6750185|NCT03426995|7677316|FG009|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750186|NCT03426995|7677317|FG010|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||1
6750187|NCT03426995|7677318|FG011|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750188|NCT03426995|7677319|FG012|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750189|NCT03426995|7677320|FG013|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750190|NCT03426995|7677321|FG014|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750191|NCT03426995|7677322|FG015|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750192|NCT03426995|7677323|FG016|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750193|NCT03426995|7677324|FG017|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6496139|NCT01397409|7414873|FG001|COMPLETED|Stage 3||0
6496140|NCT01397409|7414874|FG002|COMPLETED|Stage 3||0
6496141|NCT01397409|7414875|FG003|COMPLETED|Stage 3||0
6496142|NCT01397409|7414876|FG004|COMPLETED|Stage 3||0
6496143|NCT01397409|7414877|FG005|COMPLETED|Stage 3||0
6496144|NCT01397409|7414878|FG006|COMPLETED|Stage 3||0
6496145|NCT01397409|7414879|FG007|COMPLETED|Stage 3||21
6496146|NCT01397409|7414880|FG008|COMPLETED|Stage 3||25
6496147|NCT01397409|7414881|FG009|COMPLETED|Stage 3||16
6496148|NCT01397409|7414872|FG000|NOT COMPLETED|Stage 3||0
6496149|NCT01397409|7414873|FG001|NOT COMPLETED|Stage 3||0
6496150|NCT01397409|7414874|FG002|NOT COMPLETED|Stage 3||0
6496151|NCT01397409|7414875|FG003|NOT COMPLETED|Stage 3||0
6496152|NCT01397409|7414876|FG004|NOT COMPLETED|Stage 3||0
6496153|NCT01397409|7414877|FG005|NOT COMPLETED|Stage 3||0
6496154|NCT01397409|7414878|FG006|NOT COMPLETED|Stage 3||0
6496155|NCT01397409|7414879|FG007|NOT COMPLETED|Stage 3||2
6496156|NCT01397409|7414880|FG008|NOT COMPLETED|Stage 3||0
6496157|NCT01397409|7414881|FG009|NOT COMPLETED|Stage 3||0
6496158|NCT01397422|7414908|FG000|STARTED|Overall Study||22
6496159|NCT01397422|7414909|FG001|STARTED|Overall Study||20
6496160|NCT01397422|7414910|FG002|STARTED|Overall Study|Of the 3 participants who discontinued, 1 withdrew due to both an AE and an eGFR < 50 mL/min/1.73m^2|21
6496161|NCT01397422|7414911|FG003|STARTED|Overall Study||20
6496162|NCT01397422|7414908|FG000|COMPLETED|Overall Study||20
6496163|NCT01397422|7414909|FG001|COMPLETED|Overall Study||17
6496164|NCT01397422|7414910|FG002|COMPLETED|Overall Study|AE = adverse event; eGFR = estimated glomerular filtration rate|18
6496165|NCT01397422|7414911|FG003|COMPLETED|Overall Study||12
6496166|NCT01397422|7414908|FG000|NOT COMPLETED|Overall Study||2
6496167|NCT01397422|7414909|FG001|NOT COMPLETED|Overall Study||3
6496168|NCT01397422|7414910|FG002|NOT COMPLETED|Overall Study||3
6496169|NCT01397422|7414911|FG003|NOT COMPLETED|Overall Study||8
6496170|NCT01397448|7414926|FG000|STARTED|Overall Study||156
6496171|NCT01397448|7414927|FG001|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
6496172|NCT01397448|7414928|FG002|STARTED|Overall Study||158
6496173|NCT01397448|7414926|FG000|COMPLETED|Overall Study||138
6496174|NCT01397448|7414927|FG001|COMPLETED|Overall Study||142
6496175|NCT01397448|7414928|FG002|COMPLETED|Overall Study||140
6496176|NCT01397448|7414926|FG000|NOT COMPLETED|Overall Study||18
6496177|NCT01397448|7414927|FG001|NOT COMPLETED|Overall Study||15
6496178|NCT01397448|7414928|FG002|NOT COMPLETED|Overall Study||18
6496179|NCT01397461|7414939|FG000|STARTED|Overall Study||155
6496180|NCT01397461|7414940|FG001|STARTED|Overall Study||156
6555412|NCT01751568|7477557|FG001|NOT COMPLETED|Overall Study||0
6555413|NCT01751568|7477558|FG002|NOT COMPLETED|Overall Study||0
6555414|NCT01751646|7477568|FG000|STARTED|Overall Study||109
6496181|NCT01397461|7414941|FG002|STARTED|Overall Study||154
6496182|NCT01397461|7414939|FG000|COMPLETED|Overall Study||153
6496183|NCT01397461|7414940|FG001|COMPLETED|Overall Study||150
6496184|NCT01397461|7414941|FG002|COMPLETED|Overall Study||152
6496185|NCT01397461|7414939|FG000|NOT COMPLETED|Overall Study||2
6496186|NCT01397461|7414940|FG001|NOT COMPLETED|Overall Study||6
6496187|NCT01397461|7414941|FG002|NOT COMPLETED|Overall Study||2
6496188|NCT01397591|7414949|FG000|STARTED|Overall Study||2
6496189|NCT01397591|7414949|FG000|COMPLETED|Overall Study||2
6496190|NCT01397591|7414949|FG000|NOT COMPLETED|Overall Study||0
6496191|NCT01397617|7414957|FG000|STARTED|Overall Study||64
6496192|NCT01397617|7414958|FG001|STARTED|Overall Study||53
6496193|NCT01397617|7414959|FG002|STARTED|Overall Study||60
6496194|NCT01397617|7414957|FG000|COMPLETED|Overall Study||33
6496195|NCT01397617|7414958|FG001|COMPLETED|Overall Study||30
6496196|NCT01397617|7414959|FG002|COMPLETED|Overall Study||31
6496197|NCT01397617|7414957|FG000|NOT COMPLETED|Overall Study||31
6496198|NCT01397617|7414958|FG001|NOT COMPLETED|Overall Study||23
6496199|NCT01397617|7414959|FG002|NOT COMPLETED|Overall Study||29
6496200|NCT01397656|7414972|FG000|STARTED|Overall Study||33
6496201|NCT01397656|7414973|FG001|STARTED|Overall Study||30
6496202|NCT01397656|7414972|FG000|COMPLETED|Overall Study||33
6496203|NCT01397656|7414973|FG001|COMPLETED|Overall Study||30
6496204|NCT01397656|7414972|FG000|NOT COMPLETED|Overall Study||0
6496205|NCT01397656|7414973|FG001|NOT COMPLETED|Overall Study||0
6496206|NCT01397747|7414981|FG000|STARTED|Overall Study||11016
6496207|NCT01397747|7414981|FG000|COMPLETED|Overall Study||9989
6496208|NCT01397747|7414981|FG000|NOT COMPLETED|Overall Study||1027
6496209|NCT01397786|7414989|FG000|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
6496210|NCT01397786|7414990|FG001|STARTED|Phase A||0
6496211|NCT01397786|7414991|FG002|STARTED|Phase A||227
6496212|NCT01397786|7414989|FG000|COMPLETED|Phase A||12
6496213|NCT01397786|7414990|FG001|COMPLETED|Phase A||0
6496214|NCT01397786|7414991|FG002|COMPLETED|Phase A||199
6496215|NCT01397786|7414989|FG000|NOT COMPLETED|Phase A||0
6496216|NCT01397786|7414990|FG001|NOT COMPLETED|Phase A||0
6555415|NCT01751646|7477569|FG001|STARTED|Overall Study||105
6496217|NCT01397786|7414991|FG002|NOT COMPLETED|Phase A||28
6496218|NCT01397786|7414989|FG000|STARTED|Phase B||611
6496219|NCT01397786|7414990|FG001|STARTED|Phase B||204
6496220|NCT01397786|7414991|FG002|STARTED|Phase B||229
6496221|NCT01397786|7414989|FG000|COMPLETED|Phase B||308
6496222|NCT01397786|7414990|FG001|COMPLETED|Phase B||109
6496223|NCT01397786|7414991|FG002|COMPLETED|Phase B||91
6496224|NCT01397786|7414989|FG000|NOT COMPLETED|Phase B||303
6496225|NCT01397786|7414990|FG001|NOT COMPLETED|Phase B||95
6496226|NCT01397786|7414991|FG002|NOT COMPLETED|Phase B||138
6496227|NCT01397825|7415007|FG000|STARTED|Overall Study||13
6496228|NCT01397825|7415008|FG001|STARTED|Overall Study||4
6496229|NCT01397825|7415009|FG002|STARTED|Overall Study||25
6496230|NCT01397825|7415010|FG003|STARTED|Overall Study||3
6496231|NCT01397825|7415011|FG004|STARTED|Overall Study||0
6496232|NCT01397825|7415007|FG000|COMPLETED|Overall Study||0
6496233|NCT01397825|7415008|FG001|COMPLETED|Overall Study||0
6496234|NCT01397825|7415009|FG002|COMPLETED|Overall Study||0
6555416|NCT01751646|7477568|FG000|COMPLETED|Overall Study||98
6555417|NCT01751646|7477569|FG001|COMPLETED|Overall Study||87
6496235|NCT01397825|7415010|FG003|COMPLETED|Overall Study||0
6496236|NCT01397825|7415011|FG004|COMPLETED|Overall Study||0
6496237|NCT01397825|7415007|FG000|NOT COMPLETED|Overall Study||13
6496238|NCT01397825|7415008|FG001|NOT COMPLETED|Overall Study||4
6496239|NCT01397825|7415009|FG002|NOT COMPLETED|Overall Study||25
6496240|NCT01397825|7415010|FG003|NOT COMPLETED|Overall Study||3
6496241|NCT01397825|7415011|FG004|NOT COMPLETED|Overall Study||0
6496242|NCT01397851|7415027|FG000|STARTED|Overall Study||41634
6496243|NCT01397851|7415028|FG001|STARTED|Overall Study||39963
6496244|NCT01397851|7415027|FG000|COMPLETED|Overall Study||41555
6496245|NCT01397851|7415028|FG001|COMPLETED|Overall Study||39917
6496246|NCT01397851|7415027|FG000|NOT COMPLETED|Overall Study||79
6496247|NCT01397851|7415028|FG001|NOT COMPLETED|Overall Study||46
6496248|NCT01397890|7415036|FG000|STARTED|Overall Study||287
6496249|NCT01397890|7415037|FG001|STARTED|Overall Study||291
6496250|NCT01397890|7415036|FG000|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
6496251|NCT01397890|7415037|FG001|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
6496252|NCT01397890|7415036|FG000|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
6496253|NCT01397890|7415037|FG001|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
6496254|NCT01397890|7415036|FG000|COMPLETED|Overall Study||264
6496255|NCT01397890|7415037|FG001|COMPLETED|Overall Study||260
6496256|NCT01397890|7415036|FG000|NOT COMPLETED|Overall Study||23
6496257|NCT01397890|7415037|FG001|NOT COMPLETED|Overall Study||31
6496258|NCT01398059|7415043|FG000|STARTED|Overall Study||4
6496259|NCT01398059|7415044|FG001|STARTED|Overall Study||3
6496260|NCT01398059|7415045|FG002|STARTED|Overall Study||4
6496261|NCT01398059|7415046|FG003|STARTED|Overall Study||2
6496262|NCT01398059|7415047|FG004|STARTED|Overall Study||4
6496263|NCT01398059|7415048|FG005|STARTED|Overall Study||2
6496264|NCT01398059|7415043|FG000|COMPLETED|Overall Study||4
6496265|NCT01398059|7415044|FG001|COMPLETED|Overall Study||3
6496266|NCT01398059|7415045|FG002|COMPLETED|Overall Study||4
6496267|NCT01398059|7415046|FG003|COMPLETED|Overall Study||2
6750194|NCT03426995|7677325|FG018|NOT COMPLETED|Part A: Cohort 2-Period 4 (Day1)||0
6750195|NCT03426995|7677307|FG000|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750196|NCT03426995|7677308|FG001|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750197|NCT03426995|7677309|FG002|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750198|NCT03426995|7677310|FG003|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750199|NCT03426995|7677311|FG004|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750200|NCT03426995|7677312|FG005|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750201|NCT03426995|7677313|FG006|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750202|NCT03426995|7677314|FG007|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750203|NCT03426995|7677315|FG008|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750204|NCT03426995|7677316|FG009|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750205|NCT03426995|7677317|FG010|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750206|NCT03426995|7677318|FG011|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750207|NCT03426995|7677319|FG012|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750208|NCT03426995|7677320|FG013|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750209|NCT03426995|7677321|FG014|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750210|NCT03426995|7677322|FG015|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750211|NCT03426995|7677323|FG016|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750212|NCT03426995|7677324|FG017|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750213|NCT03426995|7677325|FG018|STARTED|Part B: Cohort 3- Period 1 (Day 1)||0
6750214|NCT03426995|7677307|FG000|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750215|NCT03426995|7677308|FG001|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750216|NCT03426995|7677309|FG002|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750217|NCT03426995|7677310|FG003|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750218|NCT03426995|7677311|FG004|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750219|NCT03426995|7677312|FG005|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750220|NCT03426995|7677313|FG006|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750221|NCT03426995|7677314|FG007|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750222|NCT03426995|7677315|FG008|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750223|NCT03426995|7677316|FG009|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750224|NCT03426995|7677317|FG010|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750225|NCT03426995|7677318|FG011|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750226|NCT03426995|7677319|FG012|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750227|NCT03426995|7677320|FG013|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750228|NCT03426995|7677321|FG014|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750229|NCT03426995|7677322|FG015|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750230|NCT03426995|7677323|FG016|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750231|NCT03426995|7677324|FG017|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750232|NCT03426995|7677325|FG018|COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750233|NCT03426995|7677307|FG000|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750234|NCT03426995|7677308|FG001|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750235|NCT03426995|7677309|FG002|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750236|NCT03426995|7677310|FG003|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750237|NCT03426995|7677311|FG004|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750238|NCT03426995|7677312|FG005|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750239|NCT03426995|7677313|FG006|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750240|NCT03426995|7677314|FG007|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6496268|NCT01398059|7415047|FG004|COMPLETED|Overall Study||4
6496269|NCT01398059|7415048|FG005|COMPLETED|Overall Study||2
6496270|NCT01398059|7415043|FG000|NOT COMPLETED|Overall Study||0
6496271|NCT01398059|7415044|FG001|NOT COMPLETED|Overall Study||0
6496272|NCT01398059|7415045|FG002|NOT COMPLETED|Overall Study||0
6496273|NCT01398059|7415046|FG003|NOT COMPLETED|Overall Study||0
6496274|NCT01398059|7415047|FG004|NOT COMPLETED|Overall Study||0
6496275|NCT01398059|7415048|FG005|NOT COMPLETED|Overall Study||0
6496276|NCT01398176|7415058|FG000|STARTED|Overall Study||26
6496277|NCT01398176|7415059|FG001|STARTED|Overall Study||25
6496278|NCT01398176|7415058|FG000|COMPLETED|Overall Study||23
6496279|NCT01398176|7415059|FG001|COMPLETED|Overall Study||19
6496280|NCT01398176|7415058|FG000|NOT COMPLETED|Overall Study||3
6496281|NCT01398176|7415059|FG001|NOT COMPLETED|Overall Study||6
6496282|NCT01398280|7415067|FG000|STARTED|Overall Study||11
6496283|NCT01398280|7415068|FG001|STARTED|Overall Study||4
6496284|NCT01398280|7415067|FG000|COMPLETED|Overall Study||7
6496285|NCT01398280|7415068|FG001|COMPLETED|Overall Study||4
6496286|NCT01398280|7415067|FG000|NOT COMPLETED|Overall Study||4
6496287|NCT01398280|7415068|FG001|NOT COMPLETED|Overall Study||0
6496288|NCT01398358|7415077|FG000|STARTED|Overall Study||218
6496289|NCT01398358|7415078|FG001|STARTED|Overall Study||224
6496290|NCT01398358|7415079|FG002|STARTED|Overall Study||255
6496291|NCT01398358|7415077|FG000|COMPLETED|Overall Study||203
6496292|NCT01398358|7415078|FG001|COMPLETED|Overall Study||201
6496293|NCT01398358|7415079|FG002|COMPLETED|Overall Study||234
6496294|NCT01398358|7415077|FG000|NOT COMPLETED|Overall Study||15
6496295|NCT01398358|7415078|FG001|NOT COMPLETED|Overall Study||23
6496296|NCT01398358|7415079|FG002|NOT COMPLETED|Overall Study||21
6496297|NCT01398410|7415089|FG000|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
6496298|NCT01398410|7415090|FG001|STARTED|Overall Study||204
6496299|NCT01398410|7415089|FG000|COMPLETED|Overall Study||143
6496300|NCT01398410|7415090|FG001|COMPLETED|Overall Study||148
6496301|NCT01398410|7415089|FG000|NOT COMPLETED|Overall Study||58
6496302|NCT01398410|7415090|FG001|NOT COMPLETED|Overall Study||56
6496303|NCT01398475|7415096|FG000|STARTED|Overall Study||4
6496304|NCT01398475|7415097|FG001|STARTED|Overall Study||3
6496305|NCT01398475|7415098|FG002|STARTED|Overall Study||4
6496306|NCT01398475|7415099|FG003|STARTED|Overall Study||4
6496307|NCT01398475|7415096|FG000|Received First Intervention|Overall Study||4
6496308|NCT01398475|7415097|FG001|Received First Intervention|Overall Study||3
6496309|NCT01398475|7415098|FG002|Received First Intervention|Overall Study||4
6496310|NCT01398475|7415099|FG003|Received First Intervention|Overall Study||4
6496311|NCT01398475|7415096|FG000|Received Second Intervention|Overall Study||4
6496312|NCT01398475|7415097|FG001|Received Second Intervention|Overall Study||3
6496313|NCT01398475|7415098|FG002|Received Second Intervention|Overall Study||4
6496314|NCT01398475|7415099|FG003|Received Second Intervention|Overall Study||4
6496315|NCT01398475|7415096|FG000|Received Third Intervention|Overall Study||4
6496316|NCT01398475|7415097|FG001|Received Third Intervention|Overall Study||3
6496317|NCT01398475|7415098|FG002|Received Third Intervention|Overall Study||4
6496318|NCT01398475|7415099|FG003|Received Third Intervention|Overall Study||4
6496319|NCT01398475|7415096|FG000|Received Fourth Intervention|Overall Study||4
6496320|NCT01398475|7415097|FG001|Received Fourth Intervention|Overall Study||3
6496321|NCT01398475|7415098|FG002|Received Fourth Intervention|Overall Study||4
6496322|NCT01398475|7415099|FG003|Received Fourth Intervention|Overall Study||4
6496323|NCT01398475|7415096|FG000|COMPLETED|Overall Study||4
6496324|NCT01398475|7415097|FG001|COMPLETED|Overall Study||3
6496325|NCT01398475|7415098|FG002|COMPLETED|Overall Study||4
6496326|NCT01398475|7415099|FG003|COMPLETED|Overall Study||4
6496327|NCT01398475|7415096|FG000|NOT COMPLETED|Overall Study||0
6496328|NCT01398475|7415097|FG001|NOT COMPLETED|Overall Study||0
6496329|NCT01398475|7415098|FG002|NOT COMPLETED|Overall Study||0
6496330|NCT01398475|7415099|FG003|NOT COMPLETED|Overall Study||0
6496331|NCT01398514|7415111|FG000|STARTED|Overall Study||26
6496332|NCT01398514|7415112|FG001|STARTED|Overall Study||26
6496333|NCT01398514|7415111|FG000|COMPLETED|Overall Study||18
6496334|NCT01398514|7415112|FG001|COMPLETED|Overall Study||20
6496335|NCT01398514|7415111|FG000|NOT COMPLETED|Overall Study||8
6496336|NCT01398514|7415112|FG001|NOT COMPLETED|Overall Study||6
6496337|NCT01398566|7415120|FG000|STARTED|Overall Study|20 enrolled|20
6496338|NCT01398566|7415120|FG000|COMPLETED|Overall Study||20
6496339|NCT01398566|7415120|FG000|NOT COMPLETED|Overall Study||0
6496340|NCT01398787|7415124|FG000|STARTED|Overall Study||198
6496341|NCT01398787|7415124|FG000|COMPLETED|Overall Study||197
6496342|NCT01398787|7415124|FG000|NOT COMPLETED|Overall Study||1
6496343|NCT01398943|7415132|FG000|STARTED|First Intervention (1 Day)||15
6496344|NCT01398943|7415133|FG001|STARTED|First Intervention (1 Day)||15
6496345|NCT01398943|7415134|FG002|STARTED|First Intervention (1 Day)||15
6496346|NCT01398943|7415135|FG003|STARTED|First Intervention (1 Day)||15
6496347|NCT01398943|7415132|FG000|COMPLETED|First Intervention (1 Day)||15
6496348|NCT01398943|7415133|FG001|COMPLETED|First Intervention (1 Day)||15
6496349|NCT01398943|7415134|FG002|COMPLETED|First Intervention (1 Day)||15
6496350|NCT01398943|7415135|FG003|COMPLETED|First Intervention (1 Day)||15
6496351|NCT01398943|7415132|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6496352|NCT01398943|7415133|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6496353|NCT01398943|7415134|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6496354|NCT01398943|7415135|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6496355|NCT01398943|7415132|FG000|STARTED|Washout (2-7 Days)||15
6496356|NCT01398943|7415133|FG001|STARTED|Washout (2-7 Days)||15
6496357|NCT01398943|7415134|FG002|STARTED|Washout (2-7 Days)||15
6496358|NCT01398943|7415135|FG003|STARTED|Washout (2-7 Days)||15
6496359|NCT01398943|7415132|FG000|COMPLETED|Washout (2-7 Days)||15
6496360|NCT01398943|7415133|FG001|COMPLETED|Washout (2-7 Days)||15
6496361|NCT01398943|7415134|FG002|COMPLETED|Washout (2-7 Days)||15
6496362|NCT01398943|7415135|FG003|COMPLETED|Washout (2-7 Days)||15
6496363|NCT01398943|7415132|FG000|NOT COMPLETED|Washout (2-7 Days)||0
6496364|NCT01398943|7415133|FG001|NOT COMPLETED|Washout (2-7 Days)||0
6496365|NCT01398943|7415134|FG002|NOT COMPLETED|Washout (2-7 Days)||0
6496366|NCT01398943|7415135|FG003|NOT COMPLETED|Washout (2-7 Days)||0
6496367|NCT01398943|7415132|FG000|STARTED|Second Intervention (1 Day)||15
6496368|NCT01398943|7415133|FG001|STARTED|Second Intervention (1 Day)||15
6496369|NCT01398943|7415134|FG002|STARTED|Second Intervention (1 Day)||15
6496370|NCT01398943|7415135|FG003|STARTED|Second Intervention (1 Day)||15
6496371|NCT01398943|7415132|FG000|COMPLETED|Second Intervention (1 Day)||15
6496372|NCT01398943|7415133|FG001|COMPLETED|Second Intervention (1 Day)||15
6496373|NCT01398943|7415134|FG002|COMPLETED|Second Intervention (1 Day)||15
6555418|NCT01751646|7477568|FG000|NOT COMPLETED|Overall Study||11
6555419|NCT01751646|7477569|FG001|NOT COMPLETED|Overall Study||18
6555420|NCT01751724|7477581|FG000|STARTED|Overall Study||42
6496374|NCT01398943|7415135|FG003|COMPLETED|Second Intervention (1 Day)||15
6496375|NCT01398943|7415132|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6496376|NCT01398943|7415133|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6496377|NCT01398943|7415134|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6496378|NCT01398943|7415135|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6496379|NCT01398956|7415143|FG000|STARTED|Overall Study||44
6496380|NCT01398956|7415143|FG000|COMPLETED|Overall Study||34
6496381|NCT01398956|7415143|FG000|NOT COMPLETED|Overall Study||10
6496382|NCT01398982|7415150|FG000|STARTED|Overall Study||44
6496383|NCT01398982|7415151|FG001|STARTED|Overall Study||49
6496384|NCT01398982|7415150|FG000|COMPLETED|Overall Study||38
6496385|NCT01398982|7415151|FG001|COMPLETED|Overall Study||47
6496386|NCT01398982|7415150|FG000|NOT COMPLETED|Overall Study||6
6496387|NCT01398982|7415151|FG001|NOT COMPLETED|Overall Study||2
6501901|NCT01431703|7420559|FG000|COMPLETED|Overall Study||326
6501902|NCT01431703|7420559|FG000|NOT COMPLETED|Overall Study||0
6501903|NCT01431716|7420563|FG000|STARTED|Overall Study||42
6501904|NCT01431716|7420563|FG000|COMPLETED|Overall Study||41
6501905|NCT01431716|7420563|FG000|NOT COMPLETED|Overall Study||1
6501906|NCT01431755|7420567|FG000|STARTED|Overall Study||54
6501907|NCT01431755|7420567|FG000|COMPLETED|Overall Study||49
6501908|NCT01431755|7420567|FG000|NOT COMPLETED|Overall Study||5
6501909|NCT01431794|7420578|FG000|STARTED|Overall Study||13
6501910|NCT01431794|7420579|FG001|STARTED|Overall Study|not started due to early study's termination|0
6501911|NCT01431794|7420580|FG002|STARTED|Overall Study|not started due to early study's termination|0
6501912|NCT01431794|7420581|FG003|STARTED|Overall Study|not started due to early study's termination|0
6501913|NCT01431794|7420582|FG004|STARTED|Overall Study|not started due to early study's termination|0
6501914|NCT01431794|7420578|FG000|COMPLETED|Overall Study||13
6501915|NCT01431794|7420579|FG001|COMPLETED|Overall Study|not started due to early study's termination|0
6501916|NCT01431794|7420580|FG002|COMPLETED|Overall Study|not started due to early study's termination|0
6501917|NCT01431794|7420581|FG003|COMPLETED|Overall Study|not started due to early study's termination|0
6501918|NCT01431794|7420582|FG004|COMPLETED|Overall Study|not started due to early study's termination|0
6501919|NCT01431794|7420578|FG000|NOT COMPLETED|Overall Study||0
6501920|NCT01431794|7420579|FG001|NOT COMPLETED|Overall Study||0
6501921|NCT01431794|7420580|FG002|NOT COMPLETED|Overall Study||0
6501922|NCT01431794|7420581|FG003|NOT COMPLETED|Overall Study||0
6501923|NCT01431794|7420582|FG004|NOT COMPLETED|Overall Study||0
6501924|NCT01431846|7420597|FG000|STARTED|Overall Study||8
6501925|NCT01431846|7420598|FG001|STARTED|Overall Study||3
6501926|NCT01431846|7420599|FG002|STARTED|Overall Study||8
6501927|NCT01431846|7420597|FG000|COMPLETED|Overall Study||8
6501928|NCT01431846|7420598|FG001|COMPLETED|Overall Study||3
6501929|NCT01431846|7420599|FG002|COMPLETED|Overall Study||8
6501930|NCT01431846|7420597|FG000|NOT COMPLETED|Overall Study||0
6501931|NCT01431846|7420598|FG001|NOT COMPLETED|Overall Study||0
6501932|NCT01431846|7420599|FG002|NOT COMPLETED|Overall Study||0
6501933|NCT01431950|7420609|FG000|STARTED|Overall Study||119
6501934|NCT01431950|7420610|FG001|STARTED|Overall Study||119
6501935|NCT01431950|7420609|FG000|COMPLETED|Overall Study||100
6501936|NCT01431950|7420610|FG001|COMPLETED|Overall Study||104
6501937|NCT01431950|7420609|FG000|NOT COMPLETED|Overall Study||19
6501938|NCT01431950|7420610|FG001|NOT COMPLETED|Overall Study||15
6501939|NCT01431963|7420616|FG000|STARTED|Overall Study||67
6501940|NCT01431963|7420616|FG000|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
6501941|NCT01431963|7420616|FG000|Received Treatment|Overall Study||65
6501942|NCT01431963|7420616|FG000|Complete EP (6 Weeks)|Overall Study||52
6555421|NCT01751724|7477582|FG001|STARTED|Overall Study||44
6555422|NCT01751724|7477581|FG000|COMPLETED|Overall Study||41
6555423|NCT01751724|7477582|FG001|COMPLETED|Overall Study||42
6555424|NCT01751724|7477581|FG000|NOT COMPLETED|Overall Study||1
6501943|NCT01431963|7420616|FG000|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
6501944|NCT01431963|7420616|FG000|Complete MP (24 Weeks)|Overall Study||42
6555425|NCT01751724|7477582|FG001|NOT COMPLETED|Overall Study||2
6496388|NCT01399008|7415160|FG000|STARTED|Overall Study||35
6496389|NCT01399008|7415161|FG001|STARTED|Overall Study||32
6496390|NCT01399008|7415162|FG002|STARTED|Overall Study||33
6496391|NCT01399008|7415160|FG000|COMPLETED|Overall Study||32
6496392|NCT01399008|7415161|FG001|COMPLETED|Overall Study||27
6496393|NCT01399008|7415162|FG002|COMPLETED|Overall Study||31
6496394|NCT01399008|7415160|FG000|NOT COMPLETED|Overall Study||3
6496395|NCT01399008|7415161|FG001|NOT COMPLETED|Overall Study||5
6496396|NCT01399008|7415162|FG002|NOT COMPLETED|Overall Study||2
6496397|NCT01399047|7415172|FG000|STARTED|Overall Study||10
6496398|NCT01399047|7415173|FG001|STARTED|Overall Study||9
6496399|NCT01399047|7415172|FG000|COMPLETED|Overall Study||10
6496400|NCT01399047|7415173|FG001|COMPLETED|Overall Study||8
6496401|NCT01399047|7415172|FG000|NOT COMPLETED|Overall Study||0
6496402|NCT01399047|7415173|FG001|NOT COMPLETED|Overall Study||1
6496403|NCT01399099|7415181|FG000|STARTED|Overall Study||67
6496404|NCT01399099|7415181|FG000|6 Months|Overall Study||47
6496405|NCT01399099|7415181|FG000|COMPLETED|Overall Study||36
6496406|NCT01399099|7415181|FG000|NOT COMPLETED|Overall Study||31
6496407|NCT01399125|7415188|FG000|STARTED|Overall Study||248
6496408|NCT01399125|7415189|FG001|STARTED|Overall Study||253
6496409|NCT01399125|7415188|FG000|Per Protocol (PP) Population|Overall Study||192
6496410|NCT01399125|7415189|FG001|Per Protocol (PP) Population|Overall Study||188
6496411|NCT01399125|7415188|FG000|COMPLETED|Overall Study||197
6496412|NCT01399125|7415189|FG001|COMPLETED|Overall Study||193
6496413|NCT01399125|7415188|FG000|NOT COMPLETED|Overall Study||51
6496414|NCT01399125|7415189|FG001|NOT COMPLETED|Overall Study||60
6496415|NCT01399190|7415195|FG000|STARTED|Overall Study||68
6496416|NCT01399190|7415195|FG000|Included in Final Analysis|Overall Study||63
6496417|NCT01399190|7415195|FG000|Evaluable for Primary Endpoint Analysis|Overall Study||60
6496418|NCT01399190|7415195|FG000|COMPLETED|Overall Study||48
6496419|NCT01399190|7415195|FG000|NOT COMPLETED|Overall Study||20
6496420|NCT01399229|7415199|FG000|STARTED|Overall Study||20
6496421|NCT01399229|7415200|FG001|STARTED|Overall Study||5
6496422|NCT01399229|7415201|FG002|STARTED|Overall Study||5
6496423|NCT01399229|7415199|FG000|COMPLETED|Overall Study||20
6496424|NCT01399229|7415200|FG001|COMPLETED|Overall Study||5
6496425|NCT01399229|7415201|FG002|COMPLETED|Overall Study||5
6496426|NCT01399229|7415199|FG000|NOT COMPLETED|Overall Study||0
6496427|NCT01399229|7415200|FG001|NOT COMPLETED|Overall Study||0
6496428|NCT01399229|7415201|FG002|NOT COMPLETED|Overall Study||0
6496429|NCT01399268|7415207|FG000|STARTED|Overall Study||15
6496430|NCT01399268|7415208|FG001|STARTED|Overall Study||15
6496431|NCT01399268|7415207|FG000|COMPLETED|Overall Study||15
6496432|NCT01399268|7415208|FG001|COMPLETED|Overall Study||15
6496433|NCT01399268|7415207|FG000|NOT COMPLETED|Overall Study||0
6496434|NCT01399268|7415208|FG001|NOT COMPLETED|Overall Study||0
6496435|NCT01399372|7415216|FG000|STARTED|Overall Study||47
6496436|NCT01399372|7415217|FG001|STARTED|Overall Study||44
6496437|NCT01399372|7415216|FG000|Eligible|Overall Study||44
6555426|NCT01751802|7477590|FG000|STARTED|Overall Study||5
6555427|NCT01751802|7477591|FG001|STARTED|Overall Study||4
6555428|NCT01751802|7477590|FG000|Completed Period 1|Overall Study||2
6555429|NCT01751802|7477591|FG001|Completed Period 1|Overall Study||4
6496438|NCT01399372|7415217|FG001|Eligible|Overall Study||43
6496439|NCT01399372|7415216|FG000|Eligible and Started Protocol Treatment|Overall Study||43
6496440|NCT01399372|7415217|FG001|Eligible and Started Protocol Treatment|Overall Study||43
6496441|NCT01399372|7415216|FG000|COMPLETED|Overall Study||44
6496442|NCT01399372|7415217|FG001|COMPLETED|Overall Study||43
6496443|NCT01399372|7415216|FG000|NOT COMPLETED|Overall Study||3
6496444|NCT01399372|7415217|FG001|NOT COMPLETED|Overall Study||1
6496445|NCT01399593|7415225|FG000|STARTED|Overall Study||51
6496446|NCT01399593|7415226|FG001|STARTED|Overall Study||51
6496447|NCT01399593|7415225|FG000|COMPLETED|Overall Study||48
6496448|NCT01399593|7415226|FG001|COMPLETED|Overall Study||49
6496449|NCT01399593|7415225|FG000|NOT COMPLETED|Overall Study||3
6496450|NCT01399593|7415226|FG001|NOT COMPLETED|Overall Study||2
6496451|NCT01399619|7415234|FG000|STARTED|Overall Study||123
6496452|NCT01399619|7415235|FG001|STARTED|Overall Study||84
6496453|NCT01399619|7415236|FG002|STARTED|Overall Study||86
6496454|NCT01399619|7415237|FG003|STARTED|Overall Study||17
6496455|NCT01399619|7415234|FG000|COMPLETED|Overall Study||98
6496456|NCT01399619|7415235|FG001|COMPLETED|Overall Study||84
6496457|NCT01399619|7415236|FG002|COMPLETED|Overall Study||74
6496458|NCT01399619|7415237|FG003|COMPLETED|Overall Study||0
6496459|NCT01399619|7415234|FG000|NOT COMPLETED|Overall Study||25
6496460|NCT01399619|7415235|FG001|NOT COMPLETED|Overall Study||0
6496461|NCT01399619|7415236|FG002|NOT COMPLETED|Overall Study||12
6496462|NCT01399619|7415237|FG003|NOT COMPLETED|Overall Study||17
6496463|NCT01399697|7415255|FG000|STARTED|Overall Study||96
6496464|NCT01399697|7415256|FG001|STARTED|Overall Study||83
6496465|NCT01399697|7415257|FG002|STARTED|Overall Study||82
6555430|NCT01751802|7477590|FG000|Completed Period 2|Overall Study||2
6496466|NCT01399697|7415255|FG000|COMPLETED|Overall Study||55
6496467|NCT01399697|7415256|FG001|COMPLETED|Overall Study||80
6496468|NCT01399697|7415257|FG002|COMPLETED|Overall Study||78
6496469|NCT01399697|7415255|FG000|NOT COMPLETED|Overall Study||41
6496470|NCT01399697|7415256|FG001|NOT COMPLETED|Overall Study||3
6496471|NCT01399697|7415257|FG002|NOT COMPLETED|Overall Study||4
6496472|NCT01399723|7415270|FG000|STARTED|Overall Study||263
6496473|NCT01399723|7415271|FG001|STARTED|Overall Study||264
6496474|NCT01399723|7415270|FG000|COMPLETED|Overall Study||263
6496475|NCT01399723|7415271|FG001|COMPLETED|Overall Study||263
6496476|NCT01399723|7415270|FG000|NOT COMPLETED|Overall Study||0
6496477|NCT01399723|7415271|FG001|NOT COMPLETED|Overall Study||1
6496478|NCT01399736|7415280|FG000|STARTED|Overall Study||295
6496479|NCT01399736|7415281|FG001|STARTED|Overall Study||590
6496480|NCT01399736|7415280|FG000|COMPLETED|Overall Study||291
6496481|NCT01399736|7415281|FG001|COMPLETED|Overall Study||586
6496482|NCT01399736|7415280|FG000|NOT COMPLETED|Overall Study||4
6496483|NCT01399736|7415281|FG001|NOT COMPLETED|Overall Study||4
6496484|NCT01399788|7415295|FG000|STARTED|First Intervention Period||18
6496485|NCT01399788|7415296|FG001|STARTED|First Intervention Period||18
6496486|NCT01399788|7415295|FG000|COMPLETED|First Intervention Period||17
6496487|NCT01399788|7415296|FG001|COMPLETED|First Intervention Period||18
6496488|NCT01399788|7415295|FG000|NOT COMPLETED|First Intervention Period||1
6496489|NCT01399788|7415296|FG001|NOT COMPLETED|First Intervention Period||0
6555431|NCT01751802|7477591|FG001|Completed Period 2|Overall Study||1
6555432|NCT01751802|7477590|FG000|Completed Period 3|Overall Study||2
6305816|NCT00370838|7209211|FG001|STARTED|Washout (Days 51-64)||3
6305817|NCT00370838|7209210|FG000|COMPLETED|Washout (Days 51-64)||7
6305818|NCT00370838|7209211|FG001|COMPLETED|Washout (Days 51-64)||3
6305819|NCT00370838|7209210|FG000|NOT COMPLETED|Washout (Days 51-64)||0
6305820|NCT00370838|7209211|FG001|NOT COMPLETED|Washout (Days 51-64)||0
6305821|NCT00370838|7209210|FG000|STARTED|Period 2 (Days 65-107)||7
6305822|NCT00370838|7209211|FG001|STARTED|Period 2 (Days 65-107)||3
6305823|NCT00370838|7209210|FG000|COMPLETED|Period 2 (Days 65-107)||7
6305824|NCT00370838|7209211|FG001|COMPLETED|Period 2 (Days 65-107)||3
6305825|NCT00370838|7209210|FG000|NOT COMPLETED|Period 2 (Days 65-107)||0
6305826|NCT00370838|7209211|FG001|NOT COMPLETED|Period 2 (Days 65-107)||0
6305827|NCT00370838|7209210|FG000|STARTED|Taper||7
6305828|NCT00370838|7209211|FG001|STARTED|Taper||3
6305829|NCT00370838|7209210|FG000|COMPLETED|Taper||7
6496490|NCT01399788|7415295|FG000|STARTED|Washout Period (at Least 1 Week)||17
6496491|NCT01399788|7415296|FG001|STARTED|Washout Period (at Least 1 Week)||18
6496492|NCT01399788|7415295|FG000|COMPLETED|Washout Period (at Least 1 Week)||17
6496493|NCT01399788|7415296|FG001|COMPLETED|Washout Period (at Least 1 Week)||18
6496494|NCT01399788|7415295|FG000|NOT COMPLETED|Washout Period (at Least 1 Week)||0
6496495|NCT01399788|7415296|FG001|NOT COMPLETED|Washout Period (at Least 1 Week)||0
6496496|NCT01399788|7415295|FG000|STARTED|Second Intervention Period||17
6496497|NCT01399788|7415296|FG001|STARTED|Second Intervention Period||18
6496498|NCT01399788|7415295|FG000|COMPLETED|Second Intervention Period||17
6496499|NCT01399788|7415296|FG001|COMPLETED|Second Intervention Period||18
6496500|NCT01399788|7415295|FG000|NOT COMPLETED|Second Intervention Period||0
6496501|NCT01399788|7415296|FG001|NOT COMPLETED|Second Intervention Period||0
6496502|NCT01399827|7415304|FG000|STARTED|Overall Study||1
6496503|NCT01399827|7415305|FG001|STARTED|Overall Study||1
6496504|NCT01399827|7415304|FG000|COMPLETED|Overall Study||1
6496505|NCT01399827|7415305|FG001|COMPLETED|Overall Study||1
6496506|NCT01399827|7415304|FG000|NOT COMPLETED|Overall Study||0
6496507|NCT01399827|7415305|FG001|NOT COMPLETED|Overall Study||0
6496508|NCT01399866|7415313|FG000|STARTED|Overall Study||32
6496509|NCT01399866|7415314|FG001|STARTED|Overall Study||30
6496510|NCT01399866|7415313|FG000|COMPLETED|Overall Study||28
6496511|NCT01399866|7415314|FG001|COMPLETED|Overall Study||28
6496512|NCT01399866|7415313|FG000|NOT COMPLETED|Overall Study||4
6496513|NCT01399866|7415314|FG001|NOT COMPLETED|Overall Study||2
6305830|NCT00370838|7209211|FG001|COMPLETED|Taper||3
6305831|NCT00370838|7209210|FG000|NOT COMPLETED|Taper||0
6305832|NCT00370838|7209211|FG001|NOT COMPLETED|Taper||0
6496514|NCT01399905|7415322|FG000|STARTED|Overall Study||7
6496515|NCT01399905|7415323|FG001|STARTED|Overall Study||7
6496516|NCT01399905|7415322|FG000|COMPLETED|Overall Study|Subject withdrew from the study before receiving treatment.|6
6496517|NCT01399905|7415323|FG001|COMPLETED|Overall Study|Subject was treated at least one dose of carbidopa before withdrawing from the study.|6
6496518|NCT01399905|7415322|FG000|NOT COMPLETED|Overall Study||1
6496519|NCT01399905|7415323|FG001|NOT COMPLETED|Overall Study||1
6496520|NCT01400113|7415336|FG000|STARTED|Overall Study||60
6496521|NCT01400113|7415337|FG001|STARTED|Overall Study||60
6496522|NCT01400113|7415336|FG000|COMPLETED|Overall Study||59
6496523|NCT01400113|7415337|FG001|COMPLETED|Overall Study||59
6496524|NCT01400113|7415336|FG000|NOT COMPLETED|Overall Study||1
6496525|NCT01400113|7415337|FG001|NOT COMPLETED|Overall Study||1
6496526|NCT01400139|7415343|FG000|STARTED|HYD Core Study||922
6496527|NCT01400139|7415343|FG000|COMPLETED|HYD Core Study||410
6496528|NCT01400139|7415343|FG000|NOT COMPLETED|HYD Core Study||512
6496529|NCT01400139|7415343|FG000|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
6496530|NCT01400139|7415343|FG000|COMPLETED|HYD Extension Period||83
6496531|NCT01400139|7415343|FG000|NOT COMPLETED|HYD Extension Period||23
6496532|NCT01400243|7415351|FG000|STARTED|Overall Study||64
6496533|NCT01400243|7415352|FG001|STARTED|Overall Study||63
6496534|NCT01400243|7415351|FG000|COMPLETED|Overall Study||56
6496535|NCT01400243|7415352|FG001|COMPLETED|Overall Study||52
6496536|NCT01400243|7415351|FG000|NOT COMPLETED|Overall Study||8
6496537|NCT01400243|7415352|FG001|NOT COMPLETED|Overall Study||11
6496538|NCT01400412|7415362|FG000|STARTED|Overall Study||130
6496539|NCT01400412|7415363|FG001|STARTED|Overall Study||132
6496540|NCT01400412|7415362|FG000|COMPLETED|Overall Study||120
6496541|NCT01400412|7415363|FG001|COMPLETED|Overall Study||115
6496542|NCT01400412|7415362|FG000|NOT COMPLETED|Overall Study||10
6496543|NCT01400412|7415363|FG001|NOT COMPLETED|Overall Study||17
6496544|NCT01400425|7415371|FG000|STARTED|Overall Study||239
6496545|NCT01400425|7415371|FG000|COMPLETED|Overall Study||229
6496546|NCT01400425|7415371|FG000|NOT COMPLETED|Overall Study||10
6496547|NCT01400451|7415380|FG000|STARTED|28 Day Lead In With Vemurafenib Alone||6
6496548|NCT01400451|7415381|FG001|STARTED|28 Day Lead In With Vemurafenib Alone||4
6496549|NCT01400451|7415382|FG002|STARTED|28 Day Lead In With Vemurafenib Alone||2
6496550|NCT01400451|7415380|FG000|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
6496551|NCT01400451|7415381|FG001|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
6496552|NCT01400451|7415382|FG002|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
6496553|NCT01400451|7415380|FG000|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
6496554|NCT01400451|7415381|FG001|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
6496555|NCT01400451|7415382|FG002|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
6496556|NCT01400451|7415380|FG000|STARTED|Combination Treatment (or Intended)||6
6496557|NCT01400451|7415381|FG001|STARTED|Combination Treatment (or Intended)||4
6496558|NCT01400451|7415382|FG002|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
6496559|NCT01400451|7415380|FG000|COMPLETED|Combination Treatment (or Intended)||0
6496560|NCT01400451|7415381|FG001|COMPLETED|Combination Treatment (or Intended)||0
6496561|NCT01400451|7415382|FG002|COMPLETED|Combination Treatment (or Intended)||0
6496562|NCT01400451|7415380|FG000|NOT COMPLETED|Combination Treatment (or Intended)||6
6496563|NCT01400451|7415381|FG001|NOT COMPLETED|Combination Treatment (or Intended)||4
6496564|NCT01400451|7415382|FG002|NOT COMPLETED|Combination Treatment (or Intended)||2
6496565|NCT01400477|7415397|FG000|STARTED|Overall Study||40
6496566|NCT01400477|7415398|FG001|STARTED|Overall Study||40
6496567|NCT01400477|7415397|FG000|COMPLETED|Overall Study||38
6496568|NCT01400477|7415398|FG001|COMPLETED|Overall Study||40
6496569|NCT01400477|7415397|FG000|NOT COMPLETED|Overall Study||2
6496570|NCT01400477|7415398|FG001|NOT COMPLETED|Overall Study||0
6496571|NCT01400503|7415404|FG000|STARTED|Overall Study||60
6496572|NCT01400503|7415404|FG000|COMPLETED|Overall Study||0
6496573|NCT01400503|7415404|FG000|NOT COMPLETED|Overall Study||60
6496574|NCT01400516|7415410|FG000|STARTED|Primary Trial||12
6496575|NCT01400516|7415411|FG001|STARTED|Primary Trial||14
6496576|NCT01400516|7415410|FG000|COMPLETED|Primary Trial||12
6496577|NCT01400516|7415411|FG001|COMPLETED|Primary Trial||12
6496578|NCT01400516|7415410|FG000|NOT COMPLETED|Primary Trial||0
6496579|NCT01400516|7415411|FG001|NOT COMPLETED|Primary Trial||2
6496580|NCT01400516|7415410|FG000|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
6496581|NCT01400516|7415411|FG001|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
6496582|NCT01400516|7415410|FG000|COMPLETED|Extension Trial||6
6496583|NCT01400516|7415411|FG001|COMPLETED|Extension Trial||7
6496584|NCT01400516|7415410|FG000|NOT COMPLETED|Extension Trial||0
6496585|NCT01400516|7415411|FG001|NOT COMPLETED|Extension Trial||0
6496586|NCT01400698|7415421|FG000|STARTED|Overall Study||23
6496587|NCT01400698|7415422|FG001|STARTED|Overall Study||23
6496588|NCT01400698|7415423|FG002|STARTED|Overall Study||2
6496589|NCT01400698|7415424|FG003|STARTED|Overall Study||14
6496590|NCT01400698|7415425|FG004|STARTED|Overall Study||14
6496591|NCT01400698|7415426|FG005|STARTED|Overall Study||15
6496592|NCT01400698|7415421|FG000|COMPLETED|Overall Study||8
6496593|NCT01400698|7415422|FG001|COMPLETED|Overall Study||12
6496594|NCT01400698|7415423|FG002|COMPLETED|Overall Study||0
6496595|NCT01400698|7415424|FG003|COMPLETED|Overall Study||6
6496596|NCT01400698|7415425|FG004|COMPLETED|Overall Study||7
6496597|NCT01400698|7415426|FG005|COMPLETED|Overall Study||9
6496598|NCT01400698|7415421|FG000|NOT COMPLETED|Overall Study||15
6496599|NCT01400698|7415422|FG001|NOT COMPLETED|Overall Study||11
6496600|NCT01400698|7415423|FG002|NOT COMPLETED|Overall Study||2
6496601|NCT01400698|7415424|FG003|NOT COMPLETED|Overall Study||8
6496602|NCT01400698|7415425|FG004|NOT COMPLETED|Overall Study||7
6496603|NCT01400698|7415426|FG005|NOT COMPLETED|Overall Study||6
6496604|NCT01400815|7415438|FG000|STARTED|Overall Study||118
6496605|NCT01400815|7415439|FG001|STARTED|Overall Study||116
6496606|NCT01400815|7415438|FG000|COMPLETED|Overall Study||80
6496607|NCT01400815|7415439|FG001|COMPLETED|Overall Study||95
6496608|NCT01400815|7415438|FG000|NOT COMPLETED|Overall Study||38
6496609|NCT01400815|7415439|FG001|NOT COMPLETED|Overall Study||21
6496610|NCT01400841|7415445|FG000|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
6496611|NCT01400841|7415445|FG000|COMPLETED|Initial Study Phase (6 Months)||15
6496612|NCT01400841|7415445|FG000|NOT COMPLETED|Initial Study Phase (6 Months)||1
6496613|NCT01400841|7415445|FG000|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation~1 subject death prior to agreeing to extended follow-up"|13
6496614|NCT01400841|7415445|FG000|COMPLETED|Extended Study Phase (2 Years)||11
6496615|NCT01400841|7415445|FG000|NOT COMPLETED|Extended Study Phase (2 Years)||2
6496616|NCT01400880|7415449|FG000|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
6496617|NCT01400880|7415449|FG000|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
6496618|NCT01400880|7415449|FG000|NOT COMPLETED|Overall Study||2
6496619|NCT01400893|7415455|FG000|STARTED|Overall Study||69
6496620|NCT01400893|7415456|FG001|STARTED|Overall Study||65
6496621|NCT01400893|7415455|FG000|COMPLETED|Overall Study||42
6496622|NCT01400893|7415456|FG001|COMPLETED|Overall Study||38
6496623|NCT01400893|7415455|FG000|NOT COMPLETED|Overall Study||27
6496624|NCT01400893|7415456|FG001|NOT COMPLETED|Overall Study||27
6496625|NCT01400906|7415464|FG000|STARTED|Treatment Period 1||6
6496626|NCT01400906|7415465|FG001|STARTED|Treatment Period 1||6
6496627|NCT01400906|7415466|FG002|STARTED|Treatment Period 1||6
6496628|NCT01400906|7415467|FG003|STARTED|Treatment Period 1||6
6496629|NCT01400906|7415468|FG004|STARTED|Treatment Period 1||6
6496630|NCT01400906|7415469|FG005|STARTED|Treatment Period 1||5
6496631|NCT01400906|7415464|FG000|COMPLETED|Treatment Period 1||6
6496632|NCT01400906|7415465|FG001|COMPLETED|Treatment Period 1||6
6496633|NCT01400906|7415466|FG002|COMPLETED|Treatment Period 1||6
6496634|NCT01400906|7415467|FG003|COMPLETED|Treatment Period 1||6
6496635|NCT01400906|7415468|FG004|COMPLETED|Treatment Period 1||6
6496636|NCT01400906|7415469|FG005|COMPLETED|Treatment Period 1||5
6496637|NCT01400906|7415464|FG000|NOT COMPLETED|Treatment Period 1||0
6496638|NCT01400906|7415465|FG001|NOT COMPLETED|Treatment Period 1||0
6496639|NCT01400906|7415466|FG002|NOT COMPLETED|Treatment Period 1||0
6496640|NCT01400906|7415467|FG003|NOT COMPLETED|Treatment Period 1||0
6496641|NCT01400906|7415468|FG004|NOT COMPLETED|Treatment Period 1||0
6496642|NCT01400906|7415469|FG005|NOT COMPLETED|Treatment Period 1||0
6496643|NCT01400906|7415464|FG000|STARTED|Washout Period 1||6
6496644|NCT01400906|7415465|FG001|STARTED|Washout Period 1||6
6496645|NCT01400906|7415466|FG002|STARTED|Washout Period 1||6
6496646|NCT01400906|7415467|FG003|STARTED|Washout Period 1||6
6750241|NCT03426995|7677315|FG008|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750242|NCT03426995|7677316|FG009|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750243|NCT03426995|7677317|FG010|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750244|NCT03426995|7677318|FG011|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750245|NCT03426995|7677319|FG012|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750246|NCT03426995|7677320|FG013|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750247|NCT03426995|7677321|FG014|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750248|NCT03426995|7677322|FG015|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750249|NCT03426995|7677323|FG016|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750250|NCT03426995|7677324|FG017|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750251|NCT03426995|7677325|FG018|NOT COMPLETED|Part B: Cohort 3- Period 1 (Day 1)||0
6750252|NCT03426995|7677307|FG000|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6496647|NCT01400906|7415468|FG004|STARTED|Washout Period 1||6
6496648|NCT01400906|7415469|FG005|STARTED|Washout Period 1||5
6496649|NCT01400906|7415464|FG000|COMPLETED|Washout Period 1||6
6496650|NCT01400906|7415465|FG001|COMPLETED|Washout Period 1||6
6496651|NCT01400906|7415466|FG002|COMPLETED|Washout Period 1||6
6496652|NCT01400906|7415467|FG003|COMPLETED|Washout Period 1||6
6496653|NCT01400906|7415468|FG004|COMPLETED|Washout Period 1||6
6496654|NCT01400906|7415469|FG005|COMPLETED|Washout Period 1||5
6496655|NCT01400906|7415464|FG000|NOT COMPLETED|Washout Period 1||0
6496656|NCT01400906|7415465|FG001|NOT COMPLETED|Washout Period 1||0
6496657|NCT01400906|7415466|FG002|NOT COMPLETED|Washout Period 1||0
6496658|NCT01400906|7415467|FG003|NOT COMPLETED|Washout Period 1||0
6496659|NCT01400906|7415468|FG004|NOT COMPLETED|Washout Period 1||0
6496660|NCT01400906|7415469|FG005|NOT COMPLETED|Washout Period 1||0
6496661|NCT01400906|7415464|FG000|STARTED|Treatment Period 2||6
6496662|NCT01400906|7415465|FG001|STARTED|Treatment Period 2||6
6496663|NCT01400906|7415466|FG002|STARTED|Treatment Period 2||6
6496664|NCT01400906|7415467|FG003|STARTED|Treatment Period 2||6
6496665|NCT01400906|7415468|FG004|STARTED|Treatment Period 2||6
6496666|NCT01400906|7415469|FG005|STARTED|Treatment Period 2||5
6496667|NCT01400906|7415464|FG000|COMPLETED|Treatment Period 2||6
6496668|NCT01400906|7415465|FG001|COMPLETED|Treatment Period 2||6
6496669|NCT01400906|7415466|FG002|COMPLETED|Treatment Period 2||6
6496670|NCT01400906|7415467|FG003|COMPLETED|Treatment Period 2||6
6496671|NCT01400906|7415468|FG004|COMPLETED|Treatment Period 2||6
6496672|NCT01400906|7415469|FG005|COMPLETED|Treatment Period 2||5
6496673|NCT01400906|7415464|FG000|NOT COMPLETED|Treatment Period 2||0
6496674|NCT01400906|7415465|FG001|NOT COMPLETED|Treatment Period 2||0
6496675|NCT01400906|7415466|FG002|NOT COMPLETED|Treatment Period 2||0
6305833|NCT00370994|7209219|FG000|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
6305834|NCT00370994|7209220|FG001|STARTED|Overall Study||60
6305835|NCT00370994|7209219|FG000|COMPLETED|Overall Study||60
6305836|NCT00370994|7209220|FG001|COMPLETED|Overall Study||60
6555433|NCT01751802|7477591|FG001|Completed Period 3|Overall Study||1
6750253|NCT03426995|7677308|FG001|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750254|NCT03426995|7677309|FG002|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750255|NCT03426995|7677310|FG003|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750256|NCT03426995|7677311|FG004|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750257|NCT03426995|7677312|FG005|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750258|NCT03426995|7677313|FG006|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750259|NCT03426995|7677314|FG007|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750260|NCT03426995|7677315|FG008|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6496676|NCT01400906|7415467|FG003|NOT COMPLETED|Treatment Period 2||0
6496677|NCT01400906|7415468|FG004|NOT COMPLETED|Treatment Period 2||0
6496678|NCT01400906|7415469|FG005|NOT COMPLETED|Treatment Period 2||0
6496679|NCT01400906|7415464|FG000|STARTED|Washout Period 2||6
6496680|NCT01400906|7415465|FG001|STARTED|Washout Period 2||6
6496681|NCT01400906|7415466|FG002|STARTED|Washout Period 2||6
6496682|NCT01400906|7415467|FG003|STARTED|Washout Period 2||6
6496683|NCT01400906|7415468|FG004|STARTED|Washout Period 2||6
6496684|NCT01400906|7415469|FG005|STARTED|Washout Period 2||5
6496685|NCT01400906|7415464|FG000|COMPLETED|Washout Period 2||6
6496686|NCT01400906|7415465|FG001|COMPLETED|Washout Period 2||6
6496687|NCT01400906|7415466|FG002|COMPLETED|Washout Period 2||6
6496688|NCT01400906|7415467|FG003|COMPLETED|Washout Period 2||6
6496689|NCT01400906|7415468|FG004|COMPLETED|Washout Period 2||6
6496690|NCT01400906|7415469|FG005|COMPLETED|Washout Period 2||5
6496691|NCT01400906|7415464|FG000|NOT COMPLETED|Washout Period 2||0
6496692|NCT01400906|7415465|FG001|NOT COMPLETED|Washout Period 2||0
6496693|NCT01400906|7415466|FG002|NOT COMPLETED|Washout Period 2||0
6496694|NCT01400906|7415467|FG003|NOT COMPLETED|Washout Period 2||0
6496695|NCT01400906|7415468|FG004|NOT COMPLETED|Washout Period 2||0
6496696|NCT01400906|7415469|FG005|NOT COMPLETED|Washout Period 2||0
6496697|NCT01400906|7415464|FG000|STARTED|Treatment Period 3||6
6496698|NCT01400906|7415465|FG001|STARTED|Treatment Period 3||6
6496699|NCT01400906|7415466|FG002|STARTED|Treatment Period 3||6
6496700|NCT01400906|7415467|FG003|STARTED|Treatment Period 3||6
6496701|NCT01400906|7415468|FG004|STARTED|Treatment Period 3||6
6496702|NCT01400906|7415469|FG005|STARTED|Treatment Period 3||5
6496703|NCT01400906|7415464|FG000|COMPLETED|Treatment Period 3||6
6496704|NCT01400906|7415465|FG001|COMPLETED|Treatment Period 3||6
6496705|NCT01400906|7415466|FG002|COMPLETED|Treatment Period 3||6
6496706|NCT01400906|7415467|FG003|COMPLETED|Treatment Period 3||6
6496707|NCT01400906|7415468|FG004|COMPLETED|Treatment Period 3||6
6496708|NCT01400906|7415469|FG005|COMPLETED|Treatment Period 3||5
6496709|NCT01400906|7415464|FG000|NOT COMPLETED|Treatment Period 3||0
6496710|NCT01400906|7415465|FG001|NOT COMPLETED|Treatment Period 3||0
6496711|NCT01400906|7415466|FG002|NOT COMPLETED|Treatment Period 3||0
6496712|NCT01400906|7415467|FG003|NOT COMPLETED|Treatment Period 3||0
6496713|NCT01400906|7415468|FG004|NOT COMPLETED|Treatment Period 3||0
6496714|NCT01400906|7415469|FG005|NOT COMPLETED|Treatment Period 3||0
6496715|NCT01400919|7415477|FG000|STARTED|Overall Study||75
6496716|NCT01400919|7415477|FG000|COMPLETED|Overall Study||67
6496717|NCT01400919|7415477|FG000|NOT COMPLETED|Overall Study||8
6496718|NCT01400932|7415483|FG000|STARTED|Overall Study||178
6496719|NCT01400932|7415484|FG001|STARTED|Overall Study||182
6496720|NCT01400932|7415483|FG000|COMPLETED|Overall Study||164
6496721|NCT01400932|7415484|FG001|COMPLETED|Overall Study||167
6496722|NCT01400932|7415483|FG000|NOT COMPLETED|Overall Study||14
6496723|NCT01400932|7415484|FG001|NOT COMPLETED|Overall Study||15
6496724|NCT01400958|7415492|FG000|STARTED|Overall Study||3
6305837|NCT00370994|7209219|FG000|NOT COMPLETED|Overall Study||0
6305838|NCT00370994|7209220|FG001|NOT COMPLETED|Overall Study||0
6496725|NCT01400958|7415493|FG001|STARTED|Overall Study||3
6496726|NCT01400958|7415492|FG000|COMPLETED|Overall Study||2
6496727|NCT01400958|7415493|FG001|COMPLETED|Overall Study||1
6496728|NCT01400958|7415492|FG000|NOT COMPLETED|Overall Study||1
6496729|NCT01400958|7415493|FG001|NOT COMPLETED|Overall Study||2
6496730|NCT01400971|7415499|FG000|STARTED|Overall Study||4299
6496731|NCT01400971|7415499|FG000|Complete Treatment Data|Overall Study||2528
6496732|NCT01400971|7415499|FG000|COMPLETED|Overall Study||3382
6496733|NCT01400971|7415499|FG000|NOT COMPLETED|Overall Study||917
6496734|NCT01401010|7415505|FG000|STARTED|Overall Study||6
6496735|NCT01401010|7415506|FG001|STARTED|Overall Study||6
6496736|NCT01401010|7415505|FG000|COMPLETED|Overall Study||5
6496737|NCT01401010|7415506|FG001|COMPLETED|Overall Study||6
6496738|NCT01401010|7415505|FG000|NOT COMPLETED|Overall Study||1
6496739|NCT01401010|7415506|FG001|NOT COMPLETED|Overall Study||0
6496740|NCT01401023|7415517|FG000|STARTED|Overall Study||10
6496741|NCT01401023|7415517|FG000|COMPLETED|Overall Study||10
6496742|NCT01401023|7415517|FG000|NOT COMPLETED|Overall Study||0
6496743|NCT01401062|7415525|FG000|STARTED|Overall Study||11
6496744|NCT01401062|7415526|FG001|STARTED|Overall Study||12
6496745|NCT01401062|7415525|FG000|COMPLETED|Overall Study||0
6496746|NCT01401062|7415526|FG001|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
6496747|NCT01401062|7415525|FG000|NOT COMPLETED|Overall Study||11
6496748|NCT01401062|7415526|FG001|NOT COMPLETED|Overall Study||8
6496749|NCT01401101|7415534|FG000|STARTED|Overall Study||206
6496750|NCT01401101|7415535|FG001|STARTED|Overall Study||198
6496751|NCT01401101|7415534|FG000|COMPLETED|Overall Study||184
6496752|NCT01401101|7415535|FG001|COMPLETED|Overall Study||171
6496753|NCT01401101|7415534|FG000|NOT COMPLETED|Overall Study||22
6496754|NCT01401101|7415535|FG001|NOT COMPLETED|Overall Study||27
6496755|NCT01401153|7415543|FG000|STARTED|First Test Day||66
6496756|NCT01401153|7415544|FG001|STARTED|First Test Day||55
6496757|NCT01401153|7415543|FG000|COMPLETED|First Test Day||65
6496758|NCT01401153|7415544|FG001|COMPLETED|First Test Day||45
6496759|NCT01401153|7415543|FG000|NOT COMPLETED|First Test Day||1
6305839|NCT00371137|7209229|FG000|STARTED|Overall Study||183
6496760|NCT01401153|7415544|FG001|NOT COMPLETED|First Test Day||10
6496761|NCT01401153|7415543|FG000|STARTED|Second Test Day||45
6496762|NCT01401153|7415544|FG001|STARTED|Second Test Day||65
6305840|NCT00371137|7209230|FG001|STARTED|Overall Study||182
6305841|NCT00371137|7209231|FG002|STARTED|Overall Study||183
6496763|NCT01401153|7415543|FG000|COMPLETED|Second Test Day||45
6496764|NCT01401153|7415544|FG001|COMPLETED|Second Test Day||60
6496765|NCT01401153|7415543|FG000|NOT COMPLETED|Second Test Day||0
6496766|NCT01401153|7415544|FG001|NOT COMPLETED|Second Test Day||5
6496767|NCT01401166|7415553|FG000|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
6496768|NCT01401166|7415554|FG001|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
6496769|NCT01401166|7415555|FG002|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
6496770|NCT01401166|7415556|FG003|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
6496771|NCT01401166|7415553|FG000|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
6496772|NCT01401166|7415554|FG001|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
6496773|NCT01401166|7415555|FG002|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
6496774|NCT01401166|7415556|FG003|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
6496775|NCT01401166|7415553|FG000|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
6496776|NCT01401166|7415554|FG001|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
6496777|NCT01401166|7415555|FG002|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
6496778|NCT01401166|7415556|FG003|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
6496779|NCT01401166|7415553|FG000|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
6496780|NCT01401166|7415554|FG001|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
6496781|NCT01401166|7415555|FG002|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
6496782|NCT01401166|7415556|FG003|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
6496783|NCT01401166|7415553|FG000|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
6496784|NCT01401166|7415554|FG001|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
6496785|NCT01401166|7415555|FG002|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
6496786|NCT01401166|7415556|FG003|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
6496787|NCT01401166|7415553|FG000|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
6496788|NCT01401166|7415554|FG001|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
6496789|NCT01401166|7415555|FG002|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
6496790|NCT01401166|7415556|FG003|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
6496791|NCT01401166|7415553|FG000|STARTED|Continuation Treatment (Cycles 9 to 18)||113
6496792|NCT01401166|7415554|FG001|STARTED|Continuation Treatment (Cycles 9 to 18)||116
6496793|NCT01401166|7415555|FG002|STARTED|Continuation Treatment (Cycles 9 to 18)||107
6496794|NCT01401166|7415556|FG003|STARTED|Continuation Treatment (Cycles 9 to 18)||105
6496795|NCT01401166|7415553|FG000|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
6496796|NCT01401166|7415554|FG001|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
6496797|NCT01401166|7415555|FG002|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
6496798|NCT01401166|7415556|FG003|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
6496799|NCT01401166|7415553|FG000|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
6496800|NCT01401166|7415554|FG001|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
6496801|NCT01401166|7415555|FG002|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
6496802|NCT01401166|7415556|FG003|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
6496803|NCT01401166|7415553|FG000|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
6496804|NCT01401166|7415554|FG001|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
6496805|NCT01401166|7415555|FG002|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
6496806|NCT01401166|7415556|FG003|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
6496807|NCT01401166|7415553|FG000|COMPLETED|Safety Follow-Up Period||99
6496808|NCT01401166|7415554|FG001|COMPLETED|Safety Follow-Up Period||106
6496809|NCT01401166|7415555|FG002|COMPLETED|Safety Follow-Up Period||104
6496810|NCT01401166|7415556|FG003|COMPLETED|Safety Follow-Up Period||100
6496811|NCT01401166|7415553|FG000|NOT COMPLETED|Safety Follow-Up Period||25
6496812|NCT01401166|7415554|FG001|NOT COMPLETED|Safety Follow-Up Period||18
6496813|NCT01401166|7415555|FG002|NOT COMPLETED|Safety Follow-Up Period||17
6496814|NCT01401166|7415556|FG003|NOT COMPLETED|Safety Follow-Up Period||19
6496815|NCT01401257|7415577|FG000|STARTED|Overall Study||21
6496816|NCT01401257|7415578|FG001|STARTED|Overall Study||21
6496817|NCT01401257|7415579|FG002|STARTED|Overall Study||19
6496818|NCT01401257|7415580|FG003|STARTED|Overall Study||19
6496819|NCT01401257|7415577|FG000|COMPLETED|Overall Study||21
6496820|NCT01401257|7415578|FG001|COMPLETED|Overall Study||19
6496821|NCT01401257|7415579|FG002|COMPLETED|Overall Study||16
6496822|NCT01401257|7415580|FG003|COMPLETED|Overall Study||17
6496823|NCT01401257|7415577|FG000|NOT COMPLETED|Overall Study||0
6496824|NCT01401257|7415578|FG001|NOT COMPLETED|Overall Study||2
6496825|NCT01401257|7415579|FG002|NOT COMPLETED|Overall Study||3
6496826|NCT01401257|7415580|FG003|NOT COMPLETED|Overall Study||2
6496827|NCT01401283|7415592|FG000|STARTED|Overall Study||89
6496828|NCT01401283|7415593|FG001|STARTED|Overall Study||91
6496829|NCT01401283|7415592|FG000|COMPLETED|Overall Study||79
6496830|NCT01401283|7415593|FG001|COMPLETED|Overall Study||81
6496831|NCT01401283|7415592|FG000|NOT COMPLETED|Overall Study||10
6496832|NCT01401283|7415593|FG001|NOT COMPLETED|Overall Study||10
6496833|NCT01401322|7415599|FG000|STARTED|Overall Study||5
6496834|NCT01401322|7415599|FG000|COMPLETED|Overall Study||3
6496835|NCT01401322|7415599|FG000|NOT COMPLETED|Overall Study||2
6496836|NCT01401361|7415603|FG000|STARTED|Overall Study||150
6496837|NCT01401361|7415603|FG000|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
6496838|NCT01401361|7415603|FG000|NOT COMPLETED|Overall Study||28
6496839|NCT01401452|7415607|FG000|STARTED|Overall Study||246
6496840|NCT01401452|7415607|FG000|Visit 1 (Baseline)|Overall Study||246
6496841|NCT01401452|7415607|FG000|Visit 2 (1 Month)|Overall Study||225
6496842|NCT01401452|7415607|FG000|Visit 3 (3 Months)|Overall Study||217
6496843|NCT01401452|7415607|FG000|Visit 4 (6 Months)|Overall Study||172
6496844|NCT01401452|7415607|FG000|Visit 5 (9 Months)|Overall Study||175
6496845|NCT01401452|7415607|FG000|COMPLETED|Overall Study||174
6496846|NCT01401452|7415607|FG000|NOT COMPLETED|Overall Study||72
6496847|NCT01401465|7415613|FG000|STARTED|Treatment Period 1||165
6496848|NCT01401465|7415614|FG001|STARTED|Treatment Period 1||162
6496849|NCT01401465|7415613|FG000|COMPLETED|Treatment Period 1||150
6496850|NCT01401465|7415614|FG001|COMPLETED|Treatment Period 1||146
6496851|NCT01401465|7415613|FG000|NOT COMPLETED|Treatment Period 1||15
6496852|NCT01401465|7415614|FG001|NOT COMPLETED|Treatment Period 1||16
6496853|NCT01401465|7415613|FG000|STARTED|Washout||150
6496854|NCT01401465|7415614|FG001|STARTED|Washout||146
6496855|NCT01401465|7415613|FG000|COMPLETED|Washout||150
6496856|NCT01401465|7415614|FG001|COMPLETED|Washout||146
6496857|NCT01401465|7415613|FG000|NOT COMPLETED|Washout||0
6496858|NCT01401465|7415614|FG001|NOT COMPLETED|Washout||0
6496859|NCT01401465|7415613|FG000|STARTED|Treatment Period 2||150
6496860|NCT01401465|7415614|FG001|STARTED|Treatment Period 2||146
6496861|NCT01401465|7415613|FG000|COMPLETED|Treatment Period 2||150
6496862|NCT01401465|7415614|FG001|COMPLETED|Treatment Period 2||144
6496863|NCT01401465|7415613|FG000|NOT COMPLETED|Treatment Period 2||0
6496864|NCT01401465|7415614|FG001|NOT COMPLETED|Treatment Period 2||2
6496865|NCT01401478|7415623|FG000|STARTED|Overall Study||86
6496866|NCT01401478|7415623|FG000|COMPLETED|Overall Study||55
6496867|NCT01401478|7415623|FG000|NOT COMPLETED|Overall Study||31
6496868|NCT01401517|7415630|FG000|STARTED|Overall Study||18
6496869|NCT01401517|7415631|FG001|STARTED|Overall Study||19
6496870|NCT01401517|7415632|FG002|STARTED|Overall Study||18
6496871|NCT01401517|7415630|FG000|COMPLETED|Overall Study||15
6496872|NCT01401517|7415631|FG001|COMPLETED|Overall Study||17
6496873|NCT01401517|7415632|FG002|COMPLETED|Overall Study||15
6496874|NCT01401517|7415630|FG000|NOT COMPLETED|Overall Study||3
6496875|NCT01401517|7415631|FG001|NOT COMPLETED|Overall Study||2
6496876|NCT01401517|7415632|FG002|NOT COMPLETED|Overall Study||3
6496877|NCT01401530|7415643|FG000|STARTED|Overall Study||3
6496878|NCT01401530|7415644|FG001|STARTED|Overall Study||7
6496879|NCT01401530|7415645|FG002|STARTED|Overall Study||3
6496880|NCT01401530|7415643|FG000|COMPLETED|Overall Study||0
6496881|NCT01401530|7415644|FG001|COMPLETED|Overall Study||1
6496882|NCT01401530|7415645|FG002|COMPLETED|Overall Study||0
6496883|NCT01401530|7415643|FG000|NOT COMPLETED|Overall Study||3
6496884|NCT01401530|7415644|FG001|NOT COMPLETED|Overall Study||6
6496885|NCT01401530|7415645|FG002|NOT COMPLETED|Overall Study||3
6496886|NCT01401543|7415655|FG000|STARTED|First Intervention||6
6496887|NCT01401543|7415656|FG001|STARTED|First Intervention||6
6496888|NCT01401543|7415657|FG002|STARTED|First Intervention||6
6496889|NCT01401543|7415658|FG003|STARTED|First Intervention||6
6496890|NCT01401543|7415655|FG000|COMPLETED|First Intervention||6
6496891|NCT01401543|7415656|FG001|COMPLETED|First Intervention||6
6496892|NCT01401543|7415657|FG002|COMPLETED|First Intervention||6
6496893|NCT01401543|7415658|FG003|COMPLETED|First Intervention||6
6496894|NCT01401543|7415655|FG000|NOT COMPLETED|First Intervention||0
6496895|NCT01401543|7415656|FG001|NOT COMPLETED|First Intervention||0
6496896|NCT01401543|7415657|FG002|NOT COMPLETED|First Intervention||0
6496897|NCT01401543|7415658|FG003|NOT COMPLETED|First Intervention||0
6496898|NCT01401543|7415655|FG000|STARTED|First Washout Period of 1 Week||6
6496899|NCT01401543|7415656|FG001|STARTED|First Washout Period of 1 Week||6
6496900|NCT01401543|7415657|FG002|STARTED|First Washout Period of 1 Week||6
6496901|NCT01401543|7415658|FG003|STARTED|First Washout Period of 1 Week||6
6496902|NCT01401543|7415655|FG000|COMPLETED|First Washout Period of 1 Week||6
6496903|NCT01401543|7415656|FG001|COMPLETED|First Washout Period of 1 Week||6
6496904|NCT01401543|7415657|FG002|COMPLETED|First Washout Period of 1 Week||6
6496905|NCT01401543|7415658|FG003|COMPLETED|First Washout Period of 1 Week||6
6496906|NCT01401543|7415655|FG000|NOT COMPLETED|First Washout Period of 1 Week||0
6496907|NCT01401543|7415656|FG001|NOT COMPLETED|First Washout Period of 1 Week||0
6496908|NCT01401543|7415657|FG002|NOT COMPLETED|First Washout Period of 1 Week||0
6496909|NCT01401543|7415658|FG003|NOT COMPLETED|First Washout Period of 1 Week||0
6496910|NCT01401543|7415655|FG000|STARTED|Second Intervention||6
6496911|NCT01401543|7415656|FG001|STARTED|Second Intervention||6
6496912|NCT01401543|7415657|FG002|STARTED|Second Intervention||6
6496913|NCT01401543|7415658|FG003|STARTED|Second Intervention||6
6496914|NCT01401543|7415655|FG000|COMPLETED|Second Intervention||6
6496915|NCT01401543|7415656|FG001|COMPLETED|Second Intervention||6
6496916|NCT01401543|7415657|FG002|COMPLETED|Second Intervention||6
6496917|NCT01401543|7415658|FG003|COMPLETED|Second Intervention||6
6496918|NCT01401543|7415655|FG000|NOT COMPLETED|Second Intervention||0
6496919|NCT01401543|7415656|FG001|NOT COMPLETED|Second Intervention||0
6496920|NCT01401543|7415657|FG002|NOT COMPLETED|Second Intervention||0
6496921|NCT01401543|7415658|FG003|NOT COMPLETED|Second Intervention||0
6496922|NCT01401543|7415655|FG000|STARTED|Second Washout Period of 1 Week||6
6496923|NCT01401543|7415656|FG001|STARTED|Second Washout Period of 1 Week||6
6496924|NCT01401543|7415657|FG002|STARTED|Second Washout Period of 1 Week||6
6496925|NCT01401543|7415658|FG003|STARTED|Second Washout Period of 1 Week||6
6496926|NCT01401543|7415655|FG000|COMPLETED|Second Washout Period of 1 Week||6
6496927|NCT01401543|7415656|FG001|COMPLETED|Second Washout Period of 1 Week||6
6496928|NCT01401543|7415657|FG002|COMPLETED|Second Washout Period of 1 Week||6
6496929|NCT01401543|7415658|FG003|COMPLETED|Second Washout Period of 1 Week||6
6496930|NCT01401543|7415655|FG000|NOT COMPLETED|Second Washout Period of 1 Week||0
6496931|NCT01401543|7415656|FG001|NOT COMPLETED|Second Washout Period of 1 Week||0
6496932|NCT01401543|7415657|FG002|NOT COMPLETED|Second Washout Period of 1 Week||0
6496933|NCT01401543|7415658|FG003|NOT COMPLETED|Second Washout Period of 1 Week||0
6496934|NCT01401543|7415655|FG000|STARTED|Third Intervention||6
6496935|NCT01401543|7415656|FG001|STARTED|Third Intervention||6
6496936|NCT01401543|7415657|FG002|STARTED|Third Intervention||6
6496937|NCT01401543|7415658|FG003|STARTED|Third Intervention||6
6496938|NCT01401543|7415655|FG000|COMPLETED|Third Intervention||6
6496939|NCT01401543|7415656|FG001|COMPLETED|Third Intervention||6
6496940|NCT01401543|7415657|FG002|COMPLETED|Third Intervention||6
6496941|NCT01401543|7415658|FG003|COMPLETED|Third Intervention||6
6496942|NCT01401543|7415655|FG000|NOT COMPLETED|Third Intervention||0
6496943|NCT01401543|7415656|FG001|NOT COMPLETED|Third Intervention||0
6496944|NCT01401543|7415657|FG002|NOT COMPLETED|Third Intervention||0
6496945|NCT01401543|7415658|FG003|NOT COMPLETED|Third Intervention||0
6496946|NCT01401543|7415655|FG000|STARTED|Third Washout Period of 1 Week||6
6496947|NCT01401543|7415656|FG001|STARTED|Third Washout Period of 1 Week||6
6496948|NCT01401543|7415657|FG002|STARTED|Third Washout Period of 1 Week||6
6496949|NCT01401543|7415658|FG003|STARTED|Third Washout Period of 1 Week||6
6496950|NCT01401543|7415655|FG000|COMPLETED|Third Washout Period of 1 Week||6
6496951|NCT01401543|7415656|FG001|COMPLETED|Third Washout Period of 1 Week||6
6496952|NCT01401543|7415657|FG002|COMPLETED|Third Washout Period of 1 Week||6
6496953|NCT01401543|7415658|FG003|COMPLETED|Third Washout Period of 1 Week||6
6496954|NCT01401543|7415655|FG000|NOT COMPLETED|Third Washout Period of 1 Week||0
6496955|NCT01401543|7415656|FG001|NOT COMPLETED|Third Washout Period of 1 Week||0
6496956|NCT01401543|7415657|FG002|NOT COMPLETED|Third Washout Period of 1 Week||0
6496957|NCT01401543|7415658|FG003|NOT COMPLETED|Third Washout Period of 1 Week||0
6496958|NCT01401543|7415655|FG000|STARTED|Fourth Intervention||6
6496959|NCT01401543|7415656|FG001|STARTED|Fourth Intervention||6
6496960|NCT01401543|7415657|FG002|STARTED|Fourth Intervention||6
6496961|NCT01401543|7415658|FG003|STARTED|Fourth Intervention||6
6496962|NCT01401543|7415655|FG000|COMPLETED|Fourth Intervention||6
6496963|NCT01401543|7415656|FG001|COMPLETED|Fourth Intervention||6
6496964|NCT01401543|7415657|FG002|COMPLETED|Fourth Intervention||6
6496965|NCT01401543|7415658|FG003|COMPLETED|Fourth Intervention||6
6496966|NCT01401543|7415655|FG000|NOT COMPLETED|Fourth Intervention||0
6496967|NCT01401543|7415656|FG001|NOT COMPLETED|Fourth Intervention||0
6496968|NCT01401543|7415657|FG002|NOT COMPLETED|Fourth Intervention||0
6496969|NCT01401543|7415658|FG003|NOT COMPLETED|Fourth Intervention||0
6496970|NCT01401582|7415674|FG000|STARTED|Overall Study||226
6496971|NCT01401582|7415675|FG001|STARTED|Overall Study||408
6496972|NCT01401582|7415674|FG000|Baseline Completed|Overall Study||168
6496973|NCT01401582|7415675|FG001|Baseline Completed|Overall Study||348
6496974|NCT01401582|7415674|FG000|COMPLETED|Overall Study||116
6496975|NCT01401582|7415675|FG001|COMPLETED|Overall Study||291
6496976|NCT01401582|7415674|FG000|NOT COMPLETED|Overall Study||110
6496977|NCT01401582|7415675|FG001|NOT COMPLETED|Overall Study||117
6496978|NCT01401595|7415686|FG000|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
6496979|NCT01401595|7415687|FG001|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
6496980|NCT01401595|7415686|FG000|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
6496981|NCT01401595|7415687|FG001|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
6496982|NCT01401595|7415686|FG000|NOT COMPLETED|Recruitment and Screening||43
6496983|NCT01401595|7415687|FG001|NOT COMPLETED|Recruitment and Screening||2
6496984|NCT01401595|7415686|FG000|STARTED|Imaging and Treatment (for NE Arm)||32
6496985|NCT01401595|7415687|FG001|STARTED|Imaging and Treatment (for NE Arm)||10
6496986|NCT01401595|7415686|FG000|COMPLETED|Imaging and Treatment (for NE Arm)||18
6496987|NCT01401595|7415687|FG001|COMPLETED|Imaging and Treatment (for NE Arm)||10
6496988|NCT01401595|7415686|FG000|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
6496989|NCT01401595|7415687|FG001|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
6496990|NCT01401647|7415697|FG000|STARTED|Overall Study||972
6496991|NCT01401647|7415698|FG001|STARTED|Overall Study||993
6496992|NCT01401647|7415699|FG002|STARTED|Overall Study||1059
6496993|NCT01401647|7415697|FG000|COMPLETED|Overall Study||968
6496994|NCT01401647|7415698|FG001|COMPLETED|Overall Study||985
6496995|NCT01401647|7415699|FG002|COMPLETED|Overall Study||1056
6496996|NCT01401647|7415697|FG000|NOT COMPLETED|Overall Study||4
6496997|NCT01401647|7415698|FG001|NOT COMPLETED|Overall Study||8
6496998|NCT01401647|7415699|FG002|NOT COMPLETED|Overall Study||3
6496999|NCT01401699|7415707|FG000|STARTED|Overall Study||109
6497000|NCT01401699|7415707|FG000|COMPLETED|Overall Study||109
6497001|NCT01401699|7415707|FG000|NOT COMPLETED|Overall Study||0
6497002|NCT01401842|7415713|FG000|STARTED|Overall Study||298
6497003|NCT01401842|7415714|FG001|STARTED|Overall Study||284
6497004|NCT01401842|7415713|FG000|COMPLETED|Overall Study||230
6497005|NCT01401842|7415714|FG001|COMPLETED|Overall Study||217
6497006|NCT01401842|7415713|FG000|NOT COMPLETED|Overall Study||68
6497007|NCT01401842|7415714|FG001|NOT COMPLETED|Overall Study||67
6497008|NCT01401907|7415722|FG000|STARTED|Overall Study||175
6497009|NCT01401907|7415723|FG001|STARTED|Overall Study||175
6497010|NCT01401907|7415722|FG000|12 Week Outcomes|Overall Study||148
6497011|NCT01401907|7415723|FG001|12 Week Outcomes|Overall Study||153
6497012|NCT01401907|7415722|FG000|COMPLETED|Overall Study||118
6497013|NCT01401907|7415723|FG001|COMPLETED|Overall Study||124
6497014|NCT01401907|7415722|FG000|NOT COMPLETED|Overall Study||57
6497015|NCT01401907|7415723|FG001|NOT COMPLETED|Overall Study||51
6497016|NCT01401959|7415734|FG000|STARTED|Enrolled||54
6497017|NCT01401959|7415735|FG001|STARTED|Enrolled||42
6497018|NCT01401959|7415736|FG002|STARTED|Enrolled||31
6497019|NCT01401959|7415734|FG000|COMPLETED|Enrolled||53
6497020|NCT01401959|7415735|FG001|COMPLETED|Enrolled||42
6497021|NCT01401959|7415736|FG002|COMPLETED|Enrolled||31
6497022|NCT01401959|7415734|FG000|NOT COMPLETED|Enrolled||1
6497023|NCT01401959|7415735|FG001|NOT COMPLETED|Enrolled||0
6497024|NCT01401959|7415736|FG002|NOT COMPLETED|Enrolled||0
6497025|NCT01401959|7415734|FG000|STARTED|Treated||53
6497026|NCT01401959|7415735|FG001|STARTED|Treated||42
6497027|NCT01401959|7415736|FG002|STARTED|Treated||31
6497028|NCT01401959|7415734|FG000|COMPLETED|Treated||46
6497029|NCT01401959|7415735|FG001|COMPLETED|Treated||34
6497030|NCT01401959|7415736|FG002|COMPLETED|Treated||26
6497031|NCT01401959|7415734|FG000|NOT COMPLETED|Treated||7
6497032|NCT01401959|7415735|FG001|NOT COMPLETED|Treated||8
6497033|NCT01401959|7415736|FG002|NOT COMPLETED|Treated||5
6497034|NCT01402011|7415749|FG000|STARTED|Delayed Treatment Period||29
6497035|NCT01402011|7415750|FG001|STARTED|Delayed Treatment Period||23
6497036|NCT01402011|7415751|FG002|STARTED|Delayed Treatment Period||26
6497037|NCT01402011|7415749|FG000|COMPLETED|Delayed Treatment Period|One patient with needle phobia declined to be treated before the 1st set of injections|28
6497038|NCT01402011|7415750|FG001|COMPLETED|Delayed Treatment Period||23
6497039|NCT01402011|7415751|FG002|COMPLETED|Delayed Treatment Period||26
6497040|NCT01402011|7415749|FG000|NOT COMPLETED|Delayed Treatment Period||1
6497041|NCT01402011|7415750|FG001|NOT COMPLETED|Delayed Treatment Period||0
6497042|NCT01402011|7415751|FG002|NOT COMPLETED|Delayed Treatment Period||0
6497043|NCT01402011|7415749|FG000|STARTED|Active Treatment Period||28
6497044|NCT01402011|7415750|FG001|STARTED|Active Treatment Period||23
6497045|NCT01402011|7415751|FG002|STARTED|Active Treatment Period||26
6497046|NCT01402011|7415749|FG000|COMPLETED|Active Treatment Period||27
6497047|NCT01402011|7415750|FG001|COMPLETED|Active Treatment Period||20
6497048|NCT01402011|7415751|FG002|COMPLETED|Active Treatment Period||26
6497049|NCT01402011|7415749|FG000|NOT COMPLETED|Active Treatment Period||1
6497050|NCT01402011|7415750|FG001|NOT COMPLETED|Active Treatment Period||3
6497051|NCT01402011|7415751|FG002|NOT COMPLETED|Active Treatment Period||0
6497052|NCT01402011|7415749|FG000|STARTED|Nine Month Follow-up||27
6497053|NCT01402011|7415750|FG001|STARTED|Nine Month Follow-up||20
6497054|NCT01402011|7415751|FG002|STARTED|Nine Month Follow-up||26
6497055|NCT01402011|7415749|FG000|COMPLETED|Nine Month Follow-up||27
6497056|NCT01402011|7415750|FG001|COMPLETED|Nine Month Follow-up||19
6497057|NCT01402011|7415751|FG002|COMPLETED|Nine Month Follow-up||26
6497058|NCT01402011|7415749|FG000|NOT COMPLETED|Nine Month Follow-up||0
6497059|NCT01402011|7415750|FG001|NOT COMPLETED|Nine Month Follow-up||1
6497060|NCT01402011|7415751|FG002|NOT COMPLETED|Nine Month Follow-up||0
6497061|NCT01402050|7415764|FG000|STARTED|Overall Study||185
6497062|NCT01402050|7415765|FG001|STARTED|Overall Study||191
6497063|NCT01402050|7415764|FG000|COMPLETED|Overall Study||185
6497064|NCT01402050|7415765|FG001|COMPLETED|Overall Study||191
6497065|NCT01402050|7415764|FG000|NOT COMPLETED|Overall Study||0
6497066|NCT01402050|7415765|FG001|NOT COMPLETED|Overall Study||0
6497067|NCT01402063|7415773|FG000|STARTED|Overall Study||42
6497068|NCT01402063|7415774|FG001|STARTED|Overall Study||21
6497069|NCT01402063|7415773|FG000|COMPLETED|Overall Study||39
6497070|NCT01402063|7415774|FG001|COMPLETED|Overall Study||18
6497071|NCT01402063|7415773|FG000|NOT COMPLETED|Overall Study||3
6750261|NCT03426995|7677316|FG009|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750262|NCT03426995|7677317|FG010|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750263|NCT03426995|7677318|FG011|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750264|NCT03426995|7677319|FG012|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750265|NCT03426995|7677320|FG013|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750266|NCT03426995|7677321|FG014|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750267|NCT03426995|7677322|FG015|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750268|NCT03426995|7677323|FG016|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750269|NCT03426995|7677324|FG017|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750270|NCT03426995|7677325|FG018|STARTED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750271|NCT03426995|7677307|FG000|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750272|NCT03426995|7677308|FG001|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750273|NCT03426995|7677309|FG002|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6497072|NCT01402063|7415774|FG001|NOT COMPLETED|Overall Study||3
6497073|NCT01402102|7415782|FG000|STARTED|Overall Study||30
6497074|NCT01402102|7415783|FG001|STARTED|Overall Study||30
6497075|NCT01402102|7415782|FG000|COMPLETED|Overall Study||28
6497076|NCT01402102|7415783|FG001|COMPLETED|Overall Study||27
6497077|NCT01402102|7415782|FG000|NOT COMPLETED|Overall Study||2
6497078|NCT01402102|7415783|FG001|NOT COMPLETED|Overall Study||3
6497079|NCT01402115|7415793|FG000|STARTED|Overall Study||30
6497080|NCT01402115|7415794|FG001|STARTED|Overall Study||30
6497081|NCT01402115|7415793|FG000|COMPLETED|Overall Study||29
6497082|NCT01402115|7415794|FG001|COMPLETED|Overall Study||29
6497083|NCT01402115|7415793|FG000|NOT COMPLETED|Overall Study||1
6497084|NCT01402115|7415794|FG001|NOT COMPLETED|Overall Study||1
6497085|NCT01402128|7415802|FG000|STARTED|Overall Study||40
6750274|NCT03426995|7677310|FG003|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6497086|NCT01402128|7415803|FG001|STARTED|Overall Study||40
6497087|NCT01402128|7415802|FG000|COMPLETED|Overall Study||39
6497088|NCT01402128|7415803|FG001|COMPLETED|Overall Study||40
6497089|NCT01402128|7415802|FG000|NOT COMPLETED|Overall Study||1
6497090|NCT01402128|7415803|FG001|NOT COMPLETED|Overall Study||0
6497091|NCT01402141|7415811|FG000|STARTED|Overall Study||30
6497092|NCT01402141|7415812|FG001|STARTED|Overall Study||30
6497093|NCT01402141|7415811|FG000|COMPLETED|Overall Study||29
6497094|NCT01402141|7415812|FG001|COMPLETED|Overall Study||28
6497095|NCT01402141|7415811|FG000|NOT COMPLETED|Overall Study||1
6497096|NCT01402141|7415812|FG001|NOT COMPLETED|Overall Study||2
6497097|NCT01402284|7415819|FG000|STARTED|Overall Study||45
6497098|NCT01402284|7415819|FG000|COMPLETED|Overall Study||31
6497099|NCT01402284|7415819|FG000|NOT COMPLETED|Overall Study||14
6497100|NCT01402375|7415829|FG000|STARTED|Overall Study||120
6497101|NCT01402375|7415830|FG001|STARTED|Overall Study||120
6497102|NCT01402375|7415831|FG002|STARTED|Overall Study||120
6497103|NCT01402375|7415832|FG003|STARTED|Overall Study||120
6497104|NCT01402375|7415833|FG004|STARTED|Overall Study||120
6497105|NCT01402375|7415834|FG005|STARTED|Overall Study||120
6497106|NCT01402375|7415829|FG000|COMPLETED|Overall Study||120
6497107|NCT01402375|7415830|FG001|COMPLETED|Overall Study||120
6497108|NCT01402375|7415831|FG002|COMPLETED|Overall Study||120
6497109|NCT01402375|7415832|FG003|COMPLETED|Overall Study||120
6497110|NCT01402375|7415833|FG004|COMPLETED|Overall Study||120
6497111|NCT01402375|7415834|FG005|COMPLETED|Overall Study||120
6497112|NCT01402375|7415829|FG000|NOT COMPLETED|Overall Study||0
6497113|NCT01402375|7415830|FG001|NOT COMPLETED|Overall Study||0
6497114|NCT01402375|7415831|FG002|NOT COMPLETED|Overall Study||0
6497115|NCT01402375|7415832|FG003|NOT COMPLETED|Overall Study||0
6497116|NCT01402375|7415833|FG004|NOT COMPLETED|Overall Study||0
6497117|NCT01402375|7415834|FG005|NOT COMPLETED|Overall Study||0
6497118|NCT01402427|7415850|FG000|STARTED|Overall Study||297
6497119|NCT01402427|7415851|FG001|STARTED|Overall Study||294
6497120|NCT01402427|7415850|FG000|COMPLETED|Overall Study||297
6497121|NCT01402427|7415851|FG001|COMPLETED|Overall Study||294
6497122|NCT01402427|7415850|FG000|NOT COMPLETED|Overall Study||0
6497123|NCT01402427|7415851|FG001|NOT COMPLETED|Overall Study||0
6497124|NCT01402492|7415860|FG000|STARTED|Overall Study||100
6497125|NCT01402492|7415861|FG001|STARTED|Overall Study||100
6497126|NCT01402492|7415862|FG002|STARTED|Overall Study||102
6497127|NCT01402492|7415860|FG000|COMPLETED|Overall Study||79
6497128|NCT01402492|7415861|FG001|COMPLETED|Overall Study||83
6497129|NCT01402492|7415862|FG002|COMPLETED|Overall Study||86
6497130|NCT01402492|7415860|FG000|NOT COMPLETED|Overall Study||21
6497131|NCT01402492|7415861|FG001|NOT COMPLETED|Overall Study||17
6497132|NCT01402492|7415862|FG002|NOT COMPLETED|Overall Study||16
6497133|NCT01402544|7415870|FG000|STARTED|Overall Study||12
6497134|NCT01402544|7415870|FG000|COMPLETED|Overall Study||6
6497135|NCT01402544|7415870|FG000|NOT COMPLETED|Overall Study||6
6497136|NCT01402570|7415874|FG000|STARTED|Overall Study||20
6497137|NCT01402570|7415874|FG000|COMPLETED|Overall Study||19
6497138|NCT01402570|7415874|FG000|NOT COMPLETED|Overall Study||1
6497139|NCT01402700|7415879|FG000|STARTED|Overall Study||75
6497140|NCT01402700|7415879|FG000|COMPLETED|Overall Study||68
6497141|NCT01402700|7415879|FG000|NOT COMPLETED|Overall Study||7
6750275|NCT03426995|7677311|FG004|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750276|NCT03426995|7677312|FG005|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750277|NCT03426995|7677313|FG006|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750278|NCT03426995|7677314|FG007|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750279|NCT03426995|7677315|FG008|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750280|NCT03426995|7677316|FG009|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750281|NCT03426995|7677317|FG010|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750282|NCT03426995|7677318|FG011|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750283|NCT03426995|7677319|FG012|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750284|NCT03426995|7677320|FG013|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750285|NCT03426995|7677321|FG014|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750286|NCT03426995|7677322|FG015|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750287|NCT03426995|7677323|FG016|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750288|NCT03426995|7677324|FG017|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750289|NCT03426995|7677325|FG018|COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6497142|NCT01402817|7415883|FG000|STARTED|Overall Study||19
6497143|NCT01402817|7415883|FG000|COMPLETED|Overall Study||8
6497144|NCT01402817|7415883|FG000|NOT COMPLETED|Overall Study||11
6497145|NCT01402869|7415891|FG000|STARTED|Overall Study||30
6497146|NCT01402869|7415892|FG001|STARTED|Overall Study||30
6497147|NCT01402869|7415893|FG002|STARTED|Overall Study||31
6497148|NCT01402869|7415891|FG000|COMPLETED|Overall Study||30
6497149|NCT01402869|7415892|FG001|COMPLETED|Overall Study||30
6497150|NCT01402869|7415893|FG002|COMPLETED|Overall Study||30
6497151|NCT01402869|7415891|FG000|NOT COMPLETED|Overall Study||0
6497152|NCT01402869|7415892|FG001|NOT COMPLETED|Overall Study||0
6497153|NCT01402869|7415893|FG002|NOT COMPLETED|Overall Study||1
6497154|NCT01402908|7415903|FG000|STARTED|Overall Study||258
6497155|NCT01402908|7415904|FG001|STARTED|Overall Study||261
6497156|NCT01402908|7415903|FG000|COMPLETED|Overall Study||224
6497157|NCT01402908|7415904|FG001|COMPLETED|Overall Study||243
6497158|NCT01402908|7415903|FG000|NOT COMPLETED|Overall Study||34
6497159|NCT01402908|7415904|FG001|NOT COMPLETED|Overall Study||18
6497160|NCT01402947|7415912|FG000|STARTED|First Intervention||15
6497161|NCT01402947|7415913|FG001|STARTED|First Intervention||15
6497162|NCT01402947|7415912|FG000|COMPLETED|First Intervention||15
6497163|NCT01402947|7415913|FG001|COMPLETED|First Intervention||14
6497164|NCT01402947|7415912|FG000|NOT COMPLETED|First Intervention||0
6497165|NCT01402947|7415913|FG001|NOT COMPLETED|First Intervention||1
6497166|NCT01402947|7415912|FG000|STARTED|Second Intervention||15
6497167|NCT01402947|7415913|FG001|STARTED|Second Intervention||14
6497168|NCT01402947|7415912|FG000|COMPLETED|Second Intervention||15
6497169|NCT01402947|7415913|FG001|COMPLETED|Second Intervention||14
6497170|NCT01402947|7415912|FG000|NOT COMPLETED|Second Intervention||0
6497171|NCT01402947|7415913|FG001|NOT COMPLETED|Second Intervention||0
6497172|NCT01402986|7415923|FG000|STARTED|Overall Study||76
6497173|NCT01402986|7415924|FG001|STARTED|Overall Study||150
6497174|NCT01402986|7415925|FG002|STARTED|Overall Study||75
6497175|NCT01402986|7415926|FG003|STARTED|Overall Study||151
6497176|NCT01402986|7415923|FG000|COMPLETED|Overall Study||67
6497177|NCT01402986|7415924|FG001|COMPLETED|Overall Study||135
6497178|NCT01402986|7415925|FG002|COMPLETED|Overall Study||67
6497179|NCT01402986|7415926|FG003|COMPLETED|Overall Study||129
6497180|NCT01402986|7415923|FG000|NOT COMPLETED|Overall Study||9
6497181|NCT01402986|7415924|FG001|NOT COMPLETED|Overall Study||15
6497182|NCT01402986|7415925|FG002|NOT COMPLETED|Overall Study||8
6497183|NCT01402986|7415926|FG003|NOT COMPLETED|Overall Study||22
6497184|NCT01403051|7415938|FG000|STARTED|Overall Study||81
6497185|NCT01403051|7415939|FG001|STARTED|Overall Study||86
6497186|NCT01403051|7415938|FG000|Initiated Study Treatment|Overall Study||81
6497187|NCT01403051|7415939|FG001|Initiated Study Treatment|Overall Study||86
6497188|NCT01403051|7415938|FG000|COMPLETED|Overall Study||71
6497189|NCT01403051|7415939|FG001|COMPLETED|Overall Study||80
6497190|NCT01403051|7415938|FG000|NOT COMPLETED|Overall Study||10
6497191|NCT01403051|7415939|FG001|NOT COMPLETED|Overall Study||6
6497192|NCT01403064|7415950|FG000|STARTED|Overall Study||24
6497193|NCT01403064|7415951|FG001|STARTED|Overall Study||7
6497194|NCT01403064|7415952|FG002|STARTED|Overall Study||23
6497195|NCT01403064|7415953|FG003|STARTED|Overall Study||22
6497196|NCT01403064|7415950|FG000|COMPLETED|Overall Study||23
6497197|NCT01403064|7415951|FG001|COMPLETED|Overall Study||7
6497198|NCT01403064|7415952|FG002|COMPLETED|Overall Study||19
6497199|NCT01403064|7415953|FG003|COMPLETED|Overall Study||19
6497200|NCT01403064|7415950|FG000|NOT COMPLETED|Overall Study||1
6497201|NCT01403064|7415951|FG001|NOT COMPLETED|Overall Study||0
6497202|NCT01403064|7415952|FG002|NOT COMPLETED|Overall Study||4
6497203|NCT01403064|7415953|FG003|NOT COMPLETED|Overall Study||3
6497204|NCT01403090|7415968|FG000|STARTED|Overall Study||8
6497205|NCT01403090|7415968|FG000|COMPLETED|Overall Study||8
6497206|NCT01403090|7415968|FG000|NOT COMPLETED|Overall Study||0
6497207|NCT01403116|7415974|FG000|STARTED|Overall Study||161
6497208|NCT01403116|7415975|FG001|STARTED|Overall Study||160
6497209|NCT01403116|7415974|FG000|Randomized|Overall Study||162
6497210|NCT01403116|7415975|FG001|Randomized|Overall Study||163
6497211|NCT01403116|7415974|FG000|Randomized in Error/ No Treatment Recvd|Overall Study||1
6497212|NCT01403116|7415975|FG001|Randomized in Error/ No Treatment Recvd|Overall Study||3
6497213|NCT01403116|7415974|FG000|COMPLETED|Overall Study||129
6497214|NCT01403116|7415975|FG001|COMPLETED|Overall Study||133
6497215|NCT01403116|7415974|FG000|NOT COMPLETED|Overall Study||32
6497216|NCT01403116|7415975|FG001|NOT COMPLETED|Overall Study||27
6497217|NCT01403246|7415981|FG000|STARTED|Overall Study||9
6497218|NCT01403246|7415981|FG000|COMPLETED|Overall Study||9
6497219|NCT01403246|7415981|FG000|NOT COMPLETED|Overall Study||0
6497220|NCT01403376|7415988|FG000|STARTED|Overall Study||41
6497221|NCT01403376|7415989|FG001|STARTED|Overall Study||41
6497222|NCT01403376|7415990|FG002|STARTED|Overall Study||46
6497223|NCT01403376|7415988|FG000|COMPLETED|Overall Study||41
6497224|NCT01403376|7415989|FG001|COMPLETED|Overall Study||41
6497225|NCT01403376|7415990|FG002|COMPLETED|Overall Study||46
6497226|NCT01403376|7415988|FG000|NOT COMPLETED|Overall Study||0
6497227|NCT01403376|7415989|FG001|NOT COMPLETED|Overall Study||0
6497228|NCT01403376|7415990|FG002|NOT COMPLETED|Overall Study||0
6497229|NCT01403441|7415998|FG000|STARTED|Overall Study||3
6497230|NCT01403441|7415998|FG000|COMPLETED|Overall Study||3
6497231|NCT01403441|7415998|FG000|NOT COMPLETED|Overall Study||0
6497232|NCT01403584|7416004|FG000|STARTED|First Intervention (1 Night)||11
6497233|NCT01403584|7416005|FG001|STARTED|First Intervention (1 Night)||10
6497234|NCT01403584|7416004|FG000|COMPLETED|First Intervention (1 Night)||11
6497235|NCT01403584|7416005|FG001|COMPLETED|First Intervention (1 Night)||10
6497236|NCT01403584|7416004|FG000|NOT COMPLETED|First Intervention (1 Night)||0
6497237|NCT01403584|7416005|FG001|NOT COMPLETED|First Intervention (1 Night)||0
6497238|NCT01403584|7416004|FG000|STARTED|Second Intervention(1 Night)||10
6497239|NCT01403584|7416005|FG001|STARTED|Second Intervention(1 Night)||11
6497240|NCT01403584|7416004|FG000|COMPLETED|Second Intervention(1 Night)||10
6497241|NCT01403584|7416005|FG001|COMPLETED|Second Intervention(1 Night)||11
6497242|NCT01403584|7416004|FG000|NOT COMPLETED|Second Intervention(1 Night)||0
6497243|NCT01403584|7416005|FG001|NOT COMPLETED|Second Intervention(1 Night)||0
6497244|NCT01403610|7416015|FG000|STARTED|Overall Study||5
6497245|NCT01403610|7416016|FG001|STARTED|Overall Study||6
6497246|NCT01403610|7416017|FG002|STARTED|Overall Study||4
6497247|NCT01403610|7416018|FG003|STARTED|Overall Study||13
6497248|NCT01403610|7416015|FG000|COMPLETED|Overall Study||3
6497249|NCT01403610|7416016|FG001|COMPLETED|Overall Study||3
6497250|NCT01403610|7416017|FG002|COMPLETED|Overall Study||4
6497251|NCT01403610|7416018|FG003|COMPLETED|Overall Study||13
6497252|NCT01403610|7416015|FG000|NOT COMPLETED|Overall Study||2
6497253|NCT01403610|7416016|FG001|NOT COMPLETED|Overall Study||3
6497254|NCT01403610|7416017|FG002|NOT COMPLETED|Overall Study||0
6497255|NCT01403610|7416018|FG003|NOT COMPLETED|Overall Study||0
6497256|NCT01403805|7416030|FG000|STARTED|Overall Study||94
6497257|NCT01403805|7416031|FG001|STARTED|Overall Study||105
6497258|NCT01403805|7416030|FG000|Pneumonia Diagnosis|Overall Study||21
6497259|NCT01403805|7416031|FG001|Pneumonia Diagnosis|Overall Study||2
6497260|NCT01403805|7416030|FG000|COMPLETED|Overall Study||94
6497261|NCT01403805|7416031|FG001|COMPLETED|Overall Study||98
6497262|NCT01403805|7416030|FG000|NOT COMPLETED|Overall Study||0
6497263|NCT01403805|7416031|FG001|NOT COMPLETED|Overall Study||7
6497264|NCT01403987|7416044|FG000|STARTED|Overall Study||34
6497265|NCT01403987|7416045|FG001|STARTED|Overall Study||34
6497266|NCT01403987|7416046|FG002|STARTED|Overall Study||68
6497267|NCT01403987|7416044|FG000|COMPLETED|Overall Study||16
6497268|NCT01403987|7416045|FG001|COMPLETED|Overall Study||17
6497269|NCT01403987|7416046|FG002|COMPLETED|Overall Study||50
6497270|NCT01403987|7416044|FG000|NOT COMPLETED|Overall Study||18
6497271|NCT01403987|7416045|FG001|NOT COMPLETED|Overall Study||17
6497272|NCT01403987|7416046|FG002|NOT COMPLETED|Overall Study||18
6497273|NCT01404039|7416063|FG000|STARTED|Overall Study||5
6497274|NCT01404039|7416064|FG001|STARTED|Overall Study||5
6497275|NCT01404039|7416065|FG002|STARTED|Overall Study||5
6497276|NCT01404039|7416066|FG003|STARTED|Overall Study||10
6497277|NCT01404039|7416067|FG004|STARTED|Overall Study||10
6497278|NCT01404039|7416068|FG005|STARTED|Overall Study||10
6497279|NCT01404039|7416069|FG006|STARTED|Overall Study||10
6497280|NCT01404039|7416070|FG007|STARTED|Overall Study||15
6497281|NCT01404039|7416071|FG008|STARTED|Overall Study||15
6497282|NCT01404039|7416072|FG009|STARTED|Overall Study||15
6497283|NCT01404039|7416073|FG010|STARTED|Overall Study||15
6497284|NCT01404039|7416074|FG011|STARTED|Overall Study||0
6497285|NCT01404039|7416075|FG012|STARTED|Overall Study||0
6497286|NCT01404039|7416063|FG000|COMPLETED|Overall Study||4
6497287|NCT01404039|7416064|FG001|COMPLETED|Overall Study||5
6497288|NCT01404039|7416065|FG002|COMPLETED|Overall Study||5
6497289|NCT01404039|7416066|FG003|COMPLETED|Overall Study||10
6497290|NCT01404039|7416067|FG004|COMPLETED|Overall Study||10
6497291|NCT01404039|7416068|FG005|COMPLETED|Overall Study||10
6497292|NCT01404039|7416069|FG006|COMPLETED|Overall Study||10
6497293|NCT01404039|7416070|FG007|COMPLETED|Overall Study||15
6497294|NCT01404039|7416071|FG008|COMPLETED|Overall Study||15
6497295|NCT01404039|7416072|FG009|COMPLETED|Overall Study||14
6497296|NCT01404039|7416073|FG010|COMPLETED|Overall Study||14
6497297|NCT01404039|7416074|FG011|COMPLETED|Overall Study||0
6497298|NCT01404039|7416075|FG012|COMPLETED|Overall Study||0
6497299|NCT01404039|7416063|FG000|NOT COMPLETED|Overall Study||1
6497300|NCT01404039|7416064|FG001|NOT COMPLETED|Overall Study||0
6497301|NCT01404039|7416065|FG002|NOT COMPLETED|Overall Study||0
6497302|NCT01404039|7416066|FG003|NOT COMPLETED|Overall Study||0
6497303|NCT01404039|7416067|FG004|NOT COMPLETED|Overall Study||0
6497304|NCT01404039|7416068|FG005|NOT COMPLETED|Overall Study||0
6497305|NCT01404039|7416069|FG006|NOT COMPLETED|Overall Study||0
6497306|NCT01404039|7416070|FG007|NOT COMPLETED|Overall Study||0
6497307|NCT01404039|7416071|FG008|NOT COMPLETED|Overall Study||0
6497308|NCT01404039|7416072|FG009|NOT COMPLETED|Overall Study||1
6497309|NCT01404039|7416073|FG010|NOT COMPLETED|Overall Study||1
6497310|NCT01404039|7416074|FG011|NOT COMPLETED|Overall Study||0
6497311|NCT01404039|7416075|FG012|NOT COMPLETED|Overall Study||0
6497312|NCT01404078|7416101|FG000|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
6497313|NCT01404078|7416102|FG001|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
6497314|NCT01404078|7416101|FG000|COMPLETED|Overall Study||243
6497315|NCT01404078|7416102|FG001|COMPLETED|Overall Study||237
6497316|NCT01404078|7416101|FG000|NOT COMPLETED|Overall Study||18
6497317|NCT01404078|7416102|FG001|NOT COMPLETED|Overall Study||20
6497318|NCT01404208|7416110|FG000|STARTED|Overall Study||70
6497319|NCT01404208|7416111|FG001|STARTED|Overall Study||72
6497320|NCT01404208|7416110|FG000|COMPLETED|Overall Study||67
6497321|NCT01404208|7416111|FG001|COMPLETED|Overall Study||72
6497322|NCT01404208|7416110|FG000|NOT COMPLETED|Overall Study||3
6497323|NCT01404208|7416111|FG001|NOT COMPLETED|Overall Study||0
6497324|NCT01404234|7416117|FG000|STARTED|Overall Study||61
6497325|NCT01404234|7416117|FG000|COMPLETED|Overall Study||59
6497326|NCT01404234|7416117|FG000|NOT COMPLETED|Overall Study||2
6497327|NCT01404260|7416123|FG000|STARTED|Overall Study||109
6497328|NCT01404260|7416124|FG001|STARTED|Overall Study||110
6497329|NCT01404260|7416123|FG000|COMPLETED|Overall Study||106
6497330|NCT01404260|7416124|FG001|COMPLETED|Overall Study||101
6497331|NCT01404260|7416123|FG000|NOT COMPLETED|Overall Study||3
6497332|NCT01404260|7416124|FG001|NOT COMPLETED|Overall Study||9
6497333|NCT01404325|7416132|FG000|STARTED|Overall Study||67
6497334|NCT01404325|7416133|FG001|STARTED|Overall Study||63
6497335|NCT01404325|7416132|FG000|COMPLETED|Overall Study||63
6497336|NCT01404325|7416133|FG001|COMPLETED|Overall Study||61
6497337|NCT01404325|7416132|FG000|NOT COMPLETED|Overall Study||4
6497338|NCT01404325|7416133|FG001|NOT COMPLETED|Overall Study||2
6497339|NCT01404429|7416141|FG000|STARTED|Overall Study||47
6497340|NCT01404429|7416142|FG001|STARTED|Overall Study||53
6497341|NCT01404429|7416141|FG000|COMPLETED|Overall Study||38
6497342|NCT01404429|7416142|FG001|COMPLETED|Overall Study||46
6497343|NCT01404429|7416141|FG000|NOT COMPLETED|Overall Study||9
6497344|NCT01404429|7416142|FG001|NOT COMPLETED|Overall Study||7
6497345|NCT01404559|7416152|FG000|STARTED|Overall Study||5
6497346|NCT01404559|7416153|FG001|STARTED|Overall Study||5
6497347|NCT01404559|7416154|FG002|STARTED|Overall Study||4
6497348|NCT01404559|7416155|FG003|STARTED|Overall Study||14
6497349|NCT01404559|7416152|FG000|COMPLETED|Overall Study||5
6497350|NCT01404559|7416153|FG001|COMPLETED|Overall Study||5
6497351|NCT01404559|7416154|FG002|COMPLETED|Overall Study||4
6497352|NCT01404559|7416155|FG003|COMPLETED|Overall Study||14
6497353|NCT01404559|7416152|FG000|NOT COMPLETED|Overall Study||0
6497354|NCT01404559|7416153|FG001|NOT COMPLETED|Overall Study||0
6497355|NCT01404559|7416154|FG002|NOT COMPLETED|Overall Study||0
6497356|NCT01404559|7416155|FG003|NOT COMPLETED|Overall Study||0
6497357|NCT01404572|7416162|FG000|STARTED|Overall Study||4
6497358|NCT01404572|7416163|FG001|STARTED|Overall Study||4
6497359|NCT01404572|7416164|FG002|STARTED|Overall Study||4
6497360|NCT01404572|7416162|FG000|COMPLETED|Overall Study||4
6497361|NCT01404572|7416163|FG001|COMPLETED|Overall Study||4
6497362|NCT01404572|7416164|FG002|COMPLETED|Overall Study||4
6497363|NCT01404572|7416162|FG000|NOT COMPLETED|Overall Study||0
6497364|NCT01404572|7416163|FG001|NOT COMPLETED|Overall Study||0
6497365|NCT01404572|7416164|FG002|NOT COMPLETED|Overall Study||0
6497366|NCT01404611|7416178|FG000|STARTED|Overall Study||112
6497367|NCT01404611|7416179|FG001|STARTED|Overall Study||108
6497368|NCT01404611|7416180|FG002|STARTED|Overall Study||111
6497369|NCT01404611|7416178|FG000|COMPLETED|Overall Study||104
6497370|NCT01404611|7416179|FG001|COMPLETED|Overall Study||89
6497371|NCT01404611|7416180|FG002|COMPLETED|Overall Study||106
6497372|NCT01404611|7416178|FG000|NOT COMPLETED|Overall Study||8
6497373|NCT01404611|7416179|FG001|NOT COMPLETED|Overall Study||19
6497374|NCT01404611|7416180|FG002|NOT COMPLETED|Overall Study||5
6497375|NCT01404650|7416188|FG000|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
6497376|NCT01404650|7416188|FG000|COMPLETED|Overall Study||25
6497377|NCT01404650|7416188|FG000|NOT COMPLETED|Overall Study||0
6501945|NCT01431963|7420616|FG000|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
6501946|NCT01431963|7420616|FG000|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
6501947|NCT01431963|7420616|FG000|COMPLETED|Overall Study||32
6501948|NCT01431963|7420616|FG000|NOT COMPLETED|Overall Study||35
6501949|NCT01431976|7420620|FG000|STARTED|Overall Study||20
6501950|NCT01431976|7420620|FG000|COMPLETED|Overall Study||6
6501951|NCT01431976|7420620|FG000|NOT COMPLETED|Overall Study||14
6501952|NCT01431989|7420624|FG000|STARTED|Period 1||14
6501953|NCT01431989|7420625|FG001|STARTED|Period 1||14
6501954|NCT01431989|7420624|FG000|COMPLETED|Period 1||14
6501955|NCT01431989|7420625|FG001|COMPLETED|Period 1||14
6501956|NCT01431989|7420624|FG000|NOT COMPLETED|Period 1||0
6501957|NCT01431989|7420625|FG001|NOT COMPLETED|Period 1||0
6501958|NCT01431989|7420624|FG000|STARTED|14-Day Washout Period||14
6501959|NCT01431989|7420625|FG001|STARTED|14-Day Washout Period||14
6501960|NCT01431989|7420624|FG000|COMPLETED|14-Day Washout Period||14
6501961|NCT01431989|7420625|FG001|COMPLETED|14-Day Washout Period||14
6501962|NCT01431989|7420624|FG000|NOT COMPLETED|14-Day Washout Period||0
6501963|NCT01431989|7420625|FG001|NOT COMPLETED|14-Day Washout Period||0
6501964|NCT01431989|7420624|FG000|STARTED|Period 2||14
6501965|NCT01431989|7420625|FG001|STARTED|Period 2||14
6501966|NCT01431989|7420624|FG000|COMPLETED|Period 2||14
6501967|NCT01431989|7420625|FG001|COMPLETED|Period 2||14
6501968|NCT01431989|7420624|FG000|NOT COMPLETED|Period 2||0
6501969|NCT01431989|7420625|FG001|NOT COMPLETED|Period 2||0
6501970|NCT01432015|7420633|FG000|STARTED|Overall Study||10
6501971|NCT01432015|7420634|FG001|STARTED|Overall Study||10
6501972|NCT01432015|7420633|FG000|COMPLETED|Overall Study||10
6501973|NCT01432015|7420634|FG001|COMPLETED|Overall Study||10
6501974|NCT01432015|7420633|FG000|NOT COMPLETED|Overall Study||0
6501975|NCT01432015|7420634|FG001|NOT COMPLETED|Overall Study||0
6501976|NCT01432145|7420640|FG000|STARTED|Overall Study|Corrected from 75. 75 was entered in error|74
6501977|NCT01432145|7420640|FG000|COMPLETED|Overall Study||67
6501978|NCT01432145|7420640|FG000|NOT COMPLETED|Overall Study||7
6750290|NCT03426995|7677307|FG000|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750291|NCT03426995|7677308|FG001|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750292|NCT03426995|7677309|FG002|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750293|NCT03426995|7677310|FG003|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750294|NCT03426995|7677311|FG004|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750295|NCT03426995|7677312|FG005|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750296|NCT03426995|7677313|FG006|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750297|NCT03426995|7677314|FG007|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750298|NCT03426995|7677315|FG008|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6501979|NCT01432171|7420646|FG000|STARTED|Overall Study||18
6501980|NCT01432171|7420647|FG001|STARTED|Overall Study||19
6501981|NCT01432171|7420646|FG000|COMPLETED|Overall Study||4
6501982|NCT01432171|7420647|FG001|COMPLETED|Overall Study||8
6501983|NCT01432171|7420646|FG000|NOT COMPLETED|Overall Study||14
6497378|NCT01404832|7416192|FG000|STARTED|Overall Study||21
6497379|NCT01404832|7416192|FG000|COMPLETED|Overall Study||21
6497380|NCT01404832|7416192|FG000|NOT COMPLETED|Overall Study||0
6497381|NCT01404923|7416198|FG000|STARTED|Overall Study||222
6497382|NCT01404923|7416199|FG001|STARTED|Overall Study||214
6497383|NCT01404923|7416198|FG000|COMPLETED|Overall Study||199
6497384|NCT01404923|7416199|FG001|COMPLETED|Overall Study||197
6497385|NCT01404923|7416198|FG000|NOT COMPLETED|Overall Study||23
6497386|NCT01404923|7416199|FG001|NOT COMPLETED|Overall Study||17
6497387|NCT01404936|7416205|FG000|STARTED|Overall Study||30
6497388|NCT01404936|7416205|FG000|COMPLETED|Overall Study||30
6497389|NCT01404936|7416205|FG000|NOT COMPLETED|Overall Study||0
6497390|NCT01404949|7416209|FG000|STARTED|Overall Study||17
6497391|NCT01404949|7416209|FG000|COMPLETED|Overall Study||16
6497392|NCT01404949|7416209|FG000|NOT COMPLETED|Overall Study||1
6497393|NCT01404988|7416216|FG000|STARTED|Overall Study||33
6497394|NCT01404988|7416217|FG001|STARTED|Overall Study||33
6497395|NCT01404988|7416218|FG002|STARTED|Overall Study||33
6497396|NCT01404988|7416216|FG000|COMPLETED|Overall Study||27
6497397|NCT01404988|7416217|FG001|COMPLETED|Overall Study||29
6497398|NCT01404988|7416218|FG002|COMPLETED|Overall Study||30
6497399|NCT01404988|7416216|FG000|NOT COMPLETED|Overall Study||6
6497400|NCT01404988|7416217|FG001|NOT COMPLETED|Overall Study||4
6497401|NCT01404988|7416218|FG002|NOT COMPLETED|Overall Study||3
6497402|NCT01405027|7416231|FG000|STARTED|Overall Study||84
6497403|NCT01405027|7416232|FG001|STARTED|Overall Study||113
6497404|NCT01405027|7416231|FG000|COMPLETED|Overall Study||52
6497405|NCT01405027|7416232|FG001|COMPLETED|Overall Study||62
6497406|NCT01405027|7416231|FG000|NOT COMPLETED|Overall Study||32
6497407|NCT01405027|7416232|FG001|NOT COMPLETED|Overall Study||51
6497408|NCT01405053|7416242|FG000|STARTED|Overall Study||25
6497409|NCT01405053|7416243|FG001|STARTED|Overall Study||12
6497410|NCT01405053|7416242|FG000|COMPLETED|Overall Study||15
6497411|NCT01405053|7416243|FG001|COMPLETED|Overall Study||4
6497412|NCT01405053|7416242|FG000|NOT COMPLETED|Overall Study||10
6497413|NCT01405053|7416243|FG001|NOT COMPLETED|Overall Study||8
6497414|NCT01405196|7416253|FG000|STARTED|Overall Study||45
6497415|NCT01405196|7416254|FG001|STARTED|Overall Study||47
6497416|NCT01405196|7416255|FG002|STARTED|Overall Study||46
6497417|NCT01405196|7416256|FG003|STARTED|Overall Study||45
6497418|NCT01405196|7416253|FG000|COMPLETED|Overall Study||34
6497419|NCT01405196|7416254|FG001|COMPLETED|Overall Study||35
6497420|NCT01405196|7416255|FG002|COMPLETED|Overall Study||23
6497421|NCT01405196|7416256|FG003|COMPLETED|Overall Study||36
6750299|NCT03426995|7677316|FG009|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750300|NCT03426995|7677317|FG010|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750301|NCT03426995|7677318|FG011|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750302|NCT03426995|7677319|FG012|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750303|NCT03426995|7677320|FG013|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750304|NCT03426995|7677321|FG014|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750305|NCT03426995|7677322|FG015|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750306|NCT03426995|7677323|FG016|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750307|NCT03426995|7677324|FG017|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750308|NCT03426995|7677325|FG018|NOT COMPLETED|PartB:Cohort3-WashoutPeriod (Upto Day14)||0
6750309|NCT03426995|7677307|FG000|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750310|NCT03426995|7677308|FG001|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750311|NCT03426995|7677309|FG002|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750312|NCT03426995|7677310|FG003|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750313|NCT03426995|7677311|FG004|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750314|NCT03426995|7677312|FG005|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750315|NCT03426995|7677313|FG006|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750316|NCT03426995|7677314|FG007|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750317|NCT03426995|7677315|FG008|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750318|NCT03426995|7677316|FG009|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750319|NCT03426995|7677317|FG010|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750320|NCT03426995|7677318|FG011|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750321|NCT03426995|7677319|FG012|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750322|NCT03426995|7677320|FG013|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750323|NCT03426995|7677321|FG014|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750324|NCT03426995|7677322|FG015|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750325|NCT03426995|7677323|FG016|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750326|NCT03426995|7677324|FG017|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750327|NCT03426995|7677325|FG018|STARTED|Part B: Cohort 3- Period 2 (Day 1)||0
6750328|NCT03426995|7677307|FG000|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750329|NCT03426995|7677308|FG001|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750330|NCT03426995|7677309|FG002|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750331|NCT03426995|7677310|FG003|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750332|NCT03426995|7677311|FG004|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6497422|NCT01405196|7416253|FG000|NOT COMPLETED|Overall Study||11
6497423|NCT01405196|7416254|FG001|NOT COMPLETED|Overall Study||12
6497424|NCT01405196|7416255|FG002|NOT COMPLETED|Overall Study||23
6497425|NCT01405196|7416256|FG003|NOT COMPLETED|Overall Study||9
6497426|NCT01405313|7416267|FG000|STARTED|Overall Study||21
6497427|NCT01405313|7416267|FG000|COMPLETED|Overall Study||21
6497428|NCT01405313|7416267|FG000|NOT COMPLETED|Overall Study||0
6497429|NCT01405456|7416277|FG000|STARTED|Overall Study||25
6497430|NCT01405456|7416278|FG001|STARTED|Overall Study||21
6497431|NCT01405456|7416277|FG000|COMPLETED|Overall Study||22
6497432|NCT01405456|7416278|FG001|COMPLETED|Overall Study||20
6497433|NCT01405456|7416277|FG000|NOT COMPLETED|Overall Study||3
6497434|NCT01405456|7416278|FG001|NOT COMPLETED|Overall Study||1
6497435|NCT01405469|7416284|FG000|STARTED|Overall Study||16
6497436|NCT01405469|7416284|FG000|COMPLETED|Overall Study||16
6497437|NCT01405469|7416284|FG000|NOT COMPLETED|Overall Study||0
6750333|NCT03426995|7677312|FG005|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750334|NCT03426995|7677313|FG006|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750335|NCT03426995|7677314|FG007|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750336|NCT03426995|7677315|FG008|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750337|NCT03426995|7677316|FG009|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750338|NCT03426995|7677317|FG010|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6555434|NCT01751802|7477590|FG000|COMPLETED|Overall Study||1
6555435|NCT01751802|7477591|FG001|COMPLETED|Overall Study||2
6555436|NCT01751802|7477590|FG000|NOT COMPLETED|Overall Study||4
6555437|NCT01751802|7477591|FG001|NOT COMPLETED|Overall Study||2
6750339|NCT03426995|7677318|FG011|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750340|NCT03426995|7677319|FG012|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6497438|NCT01405508|7416293|FG000|STARTED|Overall Study||26
6497439|NCT01405508|7416294|FG001|STARTED|Overall Study||26
6497440|NCT01405508|7416295|FG002|STARTED|Overall Study||27
6497441|NCT01405508|7416296|FG003|STARTED|Overall Study||26
6497442|NCT01405508|7416293|FG000|COMPLETED|Overall Study||25
6497443|NCT01405508|7416294|FG001|COMPLETED|Overall Study||25
6497444|NCT01405508|7416295|FG002|COMPLETED|Overall Study||27
6497445|NCT01405508|7416296|FG003|COMPLETED|Overall Study||26
6497446|NCT01405508|7416293|FG000|NOT COMPLETED|Overall Study||1
6497447|NCT01405508|7416294|FG001|NOT COMPLETED|Overall Study||1
6497448|NCT01405508|7416295|FG002|NOT COMPLETED|Overall Study||0
6497449|NCT01405508|7416296|FG003|NOT COMPLETED|Overall Study||0
6497450|NCT01405560|7416306|FG000|STARTED|Overall Study||42
6497451|NCT01405560|7416306|FG000|COMPLETED|Overall Study||41
6497452|NCT01405560|7416306|FG000|NOT COMPLETED|Overall Study||1
6497453|NCT01405742|7416310|FG000|STARTED|Overall Study||2
6497454|NCT01405742|7416311|FG001|STARTED|Overall Study||2
6497455|NCT01405742|7416310|FG000|COMPLETED|Overall Study||1
6497456|NCT01405742|7416311|FG001|COMPLETED|Overall Study||2
6497457|NCT01405742|7416310|FG000|NOT COMPLETED|Overall Study||1
6497458|NCT01405742|7416311|FG001|NOT COMPLETED|Overall Study||0
6497459|NCT01405768|7416319|FG000|STARTED|Overall Study||28
6497460|NCT01405768|7416320|FG001|STARTED|Overall Study||28
6497461|NCT01405768|7416319|FG000|COMPLETED|Overall Study||24
6497462|NCT01405768|7416320|FG001|COMPLETED|Overall Study||28
6497463|NCT01405768|7416319|FG000|NOT COMPLETED|Overall Study||4
6497464|NCT01405768|7416320|FG001|NOT COMPLETED|Overall Study||0
6497465|NCT01405794|7416326|FG000|STARTED|First Dose Placebo (14 Days)||12
6497466|NCT01405794|7416326|FG000|COMPLETED|First Dose Placebo (14 Days)||12
6497467|NCT01405794|7416326|FG000|NOT COMPLETED|First Dose Placebo (14 Days)||0
6497468|NCT01405794|7416326|FG000|STARTED|72 hr Washout||12
6497469|NCT01405794|7416326|FG000|COMPLETED|72 hr Washout||12
6497470|NCT01405794|7416326|FG000|NOT COMPLETED|72 hr Washout||0
6497471|NCT01405794|7416326|FG000|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
6750341|NCT03426995|7677320|FG013|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750342|NCT03426995|7677321|FG014|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750343|NCT03426995|7677322|FG015|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750344|NCT03426995|7677323|FG016|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750345|NCT03426995|7677324|FG017|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750346|NCT03426995|7677325|FG018|COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750347|NCT03426995|7677307|FG000|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750348|NCT03426995|7677308|FG001|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750349|NCT03426995|7677309|FG002|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750350|NCT03426995|7677310|FG003|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750351|NCT03426995|7677311|FG004|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750352|NCT03426995|7677312|FG005|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750353|NCT03426995|7677313|FG006|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750354|NCT03426995|7677314|FG007|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750355|NCT03426995|7677315|FG008|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750356|NCT03426995|7677316|FG009|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750357|NCT03426995|7677317|FG010|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750358|NCT03426995|7677318|FG011|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750359|NCT03426995|7677319|FG012|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750360|NCT03426995|7677320|FG013|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750361|NCT03426995|7677321|FG014|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750362|NCT03426995|7677322|FG015|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750363|NCT03426995|7677323|FG016|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750364|NCT03426995|7677324|FG017|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6497472|NCT01405794|7416326|FG000|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
6497473|NCT01405794|7416326|FG000|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
6497474|NCT01405820|7416338|FG000|STARTED|Randomized Treatment Period||54
6555438|NCT01751867|7477605|FG000|STARTED|Overall Study||36
6497475|NCT01405820|7416339|FG001|STARTED|Randomized Treatment Period||45
6497476|NCT01405820|7416340|FG002|STARTED|Randomized Treatment Period||52
6497477|NCT01405820|7416341|FG003|STARTED|Randomized Treatment Period||54
6497478|NCT01405820|7416342|FG004|STARTED|Randomized Treatment Period||47
6497479|NCT01405820|7416343|FG005|STARTED|Randomized Treatment Period||38
6497480|NCT01405820|7416338|FG000|Safety Population|Randomized Treatment Period||54
6497481|NCT01405820|7416339|FG001|Safety Population|Randomized Treatment Period||45
6497482|NCT01405820|7416340|FG002|Safety Population|Randomized Treatment Period||52
6497483|NCT01405820|7416341|FG003|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
6497484|NCT01405820|7416342|FG004|Safety Population|Randomized Treatment Period||47
6497485|NCT01405820|7416343|FG005|Safety Population|Randomized Treatment Period||38
6497486|NCT01405820|7416338|FG000|COMPLETED|Randomized Treatment Period||43
6497487|NCT01405820|7416339|FG001|COMPLETED|Randomized Treatment Period||35
6497488|NCT01405820|7416340|FG002|COMPLETED|Randomized Treatment Period||9
6497489|NCT01405820|7416341|FG003|COMPLETED|Randomized Treatment Period||3
6497490|NCT01405820|7416342|FG004|COMPLETED|Randomized Treatment Period||2
6497491|NCT01405820|7416343|FG005|COMPLETED|Randomized Treatment Period||1
6497492|NCT01405820|7416338|FG000|NOT COMPLETED|Randomized Treatment Period||11
6497493|NCT01405820|7416339|FG001|NOT COMPLETED|Randomized Treatment Period||10
6497494|NCT01405820|7416340|FG002|NOT COMPLETED|Randomized Treatment Period||43
6497495|NCT01405820|7416341|FG003|NOT COMPLETED|Randomized Treatment Period||51
6497496|NCT01405820|7416342|FG004|NOT COMPLETED|Randomized Treatment Period||45
6497497|NCT01405820|7416343|FG005|NOT COMPLETED|Randomized Treatment Period||37
6497498|NCT01405820|7416338|FG000|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
6497499|NCT01405820|7416339|FG001|STARTED|Open-Label Treatment Period||35
6497500|NCT01405820|7416340|FG002|STARTED|Open-Label Treatment Period||42
6497501|NCT01405820|7416341|FG003|STARTED|Open-Label Treatment Period||42
6497502|NCT01405820|7416342|FG004|STARTED|Open-Label Treatment Period||42
6497503|NCT01405820|7416343|FG005|STARTED|Open-Label Treatment Period||32
6497504|NCT01405820|7416338|FG000|COMPLETED|Open-Label Treatment Period||40
6497505|NCT01405820|7416339|FG001|COMPLETED|Open-Label Treatment Period||33
6497506|NCT01405820|7416340|FG002|COMPLETED|Open-Label Treatment Period||39
6497507|NCT01405820|7416341|FG003|COMPLETED|Open-Label Treatment Period||37
6497508|NCT01405820|7416342|FG004|COMPLETED|Open-Label Treatment Period||40
6497509|NCT01405820|7416343|FG005|COMPLETED|Open-Label Treatment Period||30
6497510|NCT01405820|7416338|FG000|NOT COMPLETED|Open-Label Treatment Period||4
6497511|NCT01405820|7416339|FG001|NOT COMPLETED|Open-Label Treatment Period||2
6497512|NCT01405820|7416340|FG002|NOT COMPLETED|Open-Label Treatment Period||3
6497513|NCT01405820|7416341|FG003|NOT COMPLETED|Open-Label Treatment Period||5
6497514|NCT01405820|7416342|FG004|NOT COMPLETED|Open-Label Treatment Period||2
6497515|NCT01405820|7416343|FG005|NOT COMPLETED|Open-Label Treatment Period||2
6497516|NCT01405898|7416365|FG000|STARTED|Overall Study||34
6497517|NCT01405898|7416366|FG001|STARTED|Overall Study||34
6497518|NCT01405898|7416365|FG000|COMPLETED|Overall Study||32
6497519|NCT01405898|7416366|FG001|COMPLETED|Overall Study||32
6750365|NCT03426995|7677325|FG018|NOT COMPLETED|Part B: Cohort 3- Period 2 (Day 1)||0
6750366|NCT03426995|7677307|FG000|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750367|NCT03426995|7677308|FG001|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750368|NCT03426995|7677309|FG002|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750369|NCT03426995|7677310|FG003|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750370|NCT03426995|7677311|FG004|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750371|NCT03426995|7677312|FG005|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750372|NCT03426995|7677313|FG006|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750373|NCT03426995|7677314|FG007|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750374|NCT03426995|7677315|FG008|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750375|NCT03426995|7677316|FG009|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750376|NCT03426995|7677317|FG010|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750377|NCT03426995|7677318|FG011|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750378|NCT03426995|7677319|FG012|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750379|NCT03426995|7677320|FG013|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750380|NCT03426995|7677321|FG014|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||11
6750381|NCT03426995|7677322|FG015|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||14
6750382|NCT03426995|7677323|FG016|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750383|NCT03426995|7677324|FG017|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750384|NCT03426995|7677325|FG018|STARTED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750385|NCT03426995|7677307|FG000|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750386|NCT03426995|7677308|FG001|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750387|NCT03426995|7677309|FG002|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750388|NCT03426995|7677310|FG003|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750389|NCT03426995|7677311|FG004|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750390|NCT03426995|7677312|FG005|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750391|NCT03426995|7677313|FG006|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750392|NCT03426995|7677314|FG007|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750393|NCT03426995|7677315|FG008|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750394|NCT03426995|7677316|FG009|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6497520|NCT01405898|7416365|FG000|NOT COMPLETED|Overall Study||2
6750395|NCT03426995|7677317|FG010|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6497521|NCT01405898|7416366|FG001|NOT COMPLETED|Overall Study||2
6497522|NCT01405911|7416375|FG000|STARTED|Overall Study||83
6497523|NCT01405911|7416376|FG001|STARTED|Overall Study||82
6497524|NCT01405911|7416377|FG002|STARTED|Overall Study||77
6497525|NCT01405911|7416375|FG000|Treated|Overall Study||82
6497526|NCT01405911|7416376|FG001|Treated|Overall Study|1 participant received study drug but was discontinued due to pre-treatment lab AE.|82
6497527|NCT01405911|7416377|FG002|Treated|Overall Study||77
6497528|NCT01405911|7416375|FG000|COMPLETED|Overall Study||79
6497529|NCT01405911|7416376|FG001|COMPLETED|Overall Study||79
6497530|NCT01405911|7416377|FG002|COMPLETED|Overall Study||76
6497531|NCT01405911|7416375|FG000|NOT COMPLETED|Overall Study||4
6497532|NCT01405911|7416376|FG001|NOT COMPLETED|Overall Study||3
6497533|NCT01405911|7416377|FG002|NOT COMPLETED|Overall Study||1
6497534|NCT01405924|7416385|FG000|STARTED|Overall Study||111
6497535|NCT01405924|7416385|FG000|COMPLETED|Overall Study||101
6497536|NCT01405924|7416385|FG000|NOT COMPLETED|Overall Study||10
6497537|NCT01405937|7416393|FG000|STARTED|Overall Study||25
6497538|NCT01405937|7416394|FG001|STARTED|Overall Study||26
6497539|NCT01405937|7416393|FG000|COMPLETED|Overall Study||25
6497540|NCT01405937|7416394|FG001|COMPLETED|Overall Study||26
6497541|NCT01405937|7416393|FG000|NOT COMPLETED|Overall Study||0
6497542|NCT01405937|7416394|FG001|NOT COMPLETED|Overall Study||0
6497543|NCT01405950|7416402|FG000|STARTED|Overall Study||8
6497544|NCT01405950|7416403|FG001|STARTED|Overall Study||2
6497545|NCT01405950|7416404|FG002|STARTED|Overall Study||0
6497546|NCT01405950|7416405|FG003|STARTED|Overall Study||0
6497547|NCT01405950|7416402|FG000|COMPLETED|Overall Study||7
6497548|NCT01405950|7416403|FG001|COMPLETED|Overall Study||2
6497549|NCT01405950|7416404|FG002|COMPLETED|Overall Study||0
6497550|NCT01405950|7416405|FG003|COMPLETED|Overall Study||0
6497551|NCT01405950|7416402|FG000|NOT COMPLETED|Overall Study||1
6497552|NCT01405950|7416403|FG001|NOT COMPLETED|Overall Study||0
6497553|NCT01405950|7416404|FG002|NOT COMPLETED|Overall Study||0
6497554|NCT01405950|7416405|FG003|NOT COMPLETED|Overall Study||0
6497555|NCT01406015|7416415|FG000|STARTED|Overall Study||19
6497556|NCT01406015|7416416|FG001|STARTED|Overall Study||19
6497557|NCT01406015|7416415|FG000|COMPLETED|Overall Study||16
6497558|NCT01406015|7416416|FG001|COMPLETED|Overall Study||16
6497559|NCT01406015|7416415|FG000|NOT COMPLETED|Overall Study||3
6497560|NCT01406015|7416416|FG001|NOT COMPLETED|Overall Study||3
6497561|NCT01406223|7416426|FG000|STARTED|Overall Study||18
6497562|NCT01406223|7416427|FG001|STARTED|Overall Study||19
6497563|NCT01406223|7416428|FG002|STARTED|Overall Study||20
6497564|NCT01406223|7416429|FG003|STARTED|Overall Study||19
6497565|NCT01406223|7416426|FG000|COMPLETED|Overall Study||6
6497566|NCT01406223|7416427|FG001|COMPLETED|Overall Study||7
6497567|NCT01406223|7416428|FG002|COMPLETED|Overall Study||2
6497568|NCT01406223|7416429|FG003|COMPLETED|Overall Study||3
6497569|NCT01406223|7416426|FG000|NOT COMPLETED|Overall Study||12
6497570|NCT01406223|7416427|FG001|NOT COMPLETED|Overall Study||12
6497571|NCT01406223|7416428|FG002|NOT COMPLETED|Overall Study||18
6497572|NCT01406223|7416429|FG003|NOT COMPLETED|Overall Study||16
6497573|NCT01406444|7416442|FG000|STARTED|Overall Study||33
6497574|NCT01406444|7416443|FG001|STARTED|Overall Study||33
6497575|NCT01406444|7416444|FG002|STARTED|Overall Study||16
6497576|NCT01406444|7416442|FG000|COMPLETED|Overall Study||23
6497577|NCT01406444|7416443|FG001|COMPLETED|Overall Study||24
6497578|NCT01406444|7416444|FG002|COMPLETED|Overall Study||14
6497579|NCT01406444|7416442|FG000|NOT COMPLETED|Overall Study||10
6497580|NCT01406444|7416443|FG001|NOT COMPLETED|Overall Study||9
6497581|NCT01406444|7416444|FG002|NOT COMPLETED|Overall Study||2
6497582|NCT01406574|7416452|FG000|STARTED|Overall Study||7
6497583|NCT01406574|7416453|FG001|STARTED|Overall Study||4
6497584|NCT01406574|7416454|FG002|STARTED|Overall Study||7
6497585|NCT01406574|7416455|FG003|STARTED|Overall Study||5
6497586|NCT01406574|7416452|FG000|COMPLETED|Overall Study||6
6497587|NCT01406574|7416453|FG001|COMPLETED|Overall Study||3
6555439|NCT01751867|7477606|FG001|STARTED|Overall Study||99
6555440|NCT01751867|7477605|FG000|Treated|Overall Study||34
6555441|NCT01751867|7477606|FG001|Treated|Overall Study||98
6750396|NCT03426995|7677318|FG011|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750397|NCT03426995|7677319|FG012|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750398|NCT03426995|7677320|FG013|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750399|NCT03426995|7677321|FG014|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
6750400|NCT03426995|7677322|FG015|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||2
6750401|NCT03426995|7677323|FG016|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750402|NCT03426995|7677324|FG017|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750403|NCT03426995|7677325|FG018|COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750404|NCT03426995|7677307|FG000|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750405|NCT03426995|7677308|FG001|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750406|NCT03426995|7677309|FG002|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6497588|NCT01406574|7416454|FG002|COMPLETED|Overall Study||6
6497589|NCT01406574|7416455|FG003|COMPLETED|Overall Study||1
6497590|NCT01406574|7416452|FG000|NOT COMPLETED|Overall Study||1
6497591|NCT01406574|7416453|FG001|NOT COMPLETED|Overall Study||1
6497592|NCT01406574|7416454|FG002|NOT COMPLETED|Overall Study||1
6497593|NCT01406574|7416455|FG003|NOT COMPLETED|Overall Study||4
6497594|NCT01406652|7416468|FG000|STARTED|Overall Study||109
6497595|NCT01406652|7416469|FG001|STARTED|Overall Study||115
6497596|NCT01406652|7416468|FG000|COMPLETED|Overall Study||89
6497597|NCT01406652|7416469|FG001|COMPLETED|Overall Study||95
6497598|NCT01406652|7416468|FG000|NOT COMPLETED|Overall Study||20
6497599|NCT01406652|7416469|FG001|NOT COMPLETED|Overall Study||20
6497600|NCT01406717|7416479|FG000|STARTED|Overall Study||180
6497601|NCT01406717|7416480|FG001|STARTED|Overall Study||180
6497602|NCT01406717|7416479|FG000|COMPLETED|Overall Study||137
6497603|NCT01406717|7416480|FG001|COMPLETED|Overall Study||149
6497604|NCT01406717|7416479|FG000|NOT COMPLETED|Overall Study||43
6497605|NCT01406717|7416480|FG001|NOT COMPLETED|Overall Study||31
6497606|NCT01406795|7416496|FG000|STARTED|Overall Study||1
6497607|NCT01406795|7416496|FG000|COMPLETED|Overall Study||0
6497608|NCT01406795|7416496|FG000|NOT COMPLETED|Overall Study||1
6497609|NCT01406873|7416502|FG000|STARTED|Overall Study||21
6497610|NCT01406873|7416503|FG001|STARTED|Overall Study||21
6497611|NCT01406873|7416502|FG000|COMPLETED|Overall Study||20
6497612|NCT01406873|7416503|FG001|COMPLETED|Overall Study||20
6497613|NCT01406873|7416502|FG000|NOT COMPLETED|Overall Study||1
6497614|NCT01406873|7416503|FG001|NOT COMPLETED|Overall Study||1
6497615|NCT01406938|7416521|FG000|STARTED|Induction Period||482
6497616|NCT01406938|7416522|FG001|STARTED|Induction Period||484
6497617|NCT01406938|7416523|FG002|STARTED|Induction Period||0
6497618|NCT01406938|7416524|FG003|STARTED|Induction Period||0
6497619|NCT01406938|7416525|FG004|STARTED|Induction Period||0
6497620|NCT01406938|7416526|FG005|STARTED|Induction Period||0
6497621|NCT01406938|7416521|FG000|FAS:Patients Assigned Study Treatment|Induction Period||482
6497622|NCT01406938|7416522|FG001|FAS:Patients Assigned Study Treatment|Induction Period||483
6497623|NCT01406938|7416523|FG002|FAS:Patients Assigned Study Treatment|Induction Period||0
6497624|NCT01406938|7416524|FG003|FAS:Patients Assigned Study Treatment|Induction Period||0
6497625|NCT01406938|7416525|FG004|FAS:Patients Assigned Study Treatment|Induction Period||0
6497626|NCT01406938|7416526|FG005|FAS:Patients Assigned Study Treatment|Induction Period||0
6497627|NCT01406938|7416521|FG000|COMPLETED|Induction Period||464
6497628|NCT01406938|7416522|FG001|COMPLETED|Induction Period||464
6497629|NCT01406938|7416523|FG002|COMPLETED|Induction Period||0
6497630|NCT01406938|7416524|FG003|COMPLETED|Induction Period||0
6497631|NCT01406938|7416525|FG004|COMPLETED|Induction Period||0
6497632|NCT01406938|7416526|FG005|COMPLETED|Induction Period||0
6497633|NCT01406938|7416521|FG000|NOT COMPLETED|Induction Period||18
6497634|NCT01406938|7416522|FG001|NOT COMPLETED|Induction Period||20
6497635|NCT01406938|7416523|FG002|NOT COMPLETED|Induction Period||0
6497636|NCT01406938|7416524|FG003|NOT COMPLETED|Induction Period||0
6497637|NCT01406938|7416525|FG004|NOT COMPLETED|Induction Period||0
6497638|NCT01406938|7416526|FG005|NOT COMPLETED|Induction Period||0
6497639|NCT01406938|7416521|FG000|STARTED|Maintenance Period||0
6497640|NCT01406938|7416522|FG001|STARTED|Maintenance Period||0
6497641|NCT01406938|7416523|FG002|STARTED|Maintenance Period||203
6497642|NCT01406938|7416524|FG003|STARTED|Maintenance Period||217
6497643|NCT01406938|7416525|FG004|STARTED|Maintenance Period||206
6497644|NCT01406938|7416526|FG005|STARTED|Maintenance Period||217
6497645|NCT01406938|7416521|FG000|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
6497646|NCT01406938|7416522|FG001|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
6497647|NCT01406938|7416523|FG002|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
6497648|NCT01406938|7416524|FG003|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
6497649|NCT01406938|7416525|FG004|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
6497650|NCT01406938|7416526|FG005|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
6497651|NCT01406938|7416521|FG000|COMPLETED|Maintenance Period||0
6497652|NCT01406938|7416522|FG001|COMPLETED|Maintenance Period||0
6497653|NCT01406938|7416523|FG002|COMPLETED|Maintenance Period||186
6497654|NCT01406938|7416524|FG003|COMPLETED|Maintenance Period||199
6497655|NCT01406938|7416525|FG004|COMPLETED|Maintenance Period||181
6497656|NCT01406938|7416526|FG005|COMPLETED|Maintenance Period||201
6497657|NCT01406938|7416521|FG000|NOT COMPLETED|Maintenance Period||0
6497658|NCT01406938|7416522|FG001|NOT COMPLETED|Maintenance Period||0
6497659|NCT01406938|7416523|FG002|NOT COMPLETED|Maintenance Period||17
6497660|NCT01406938|7416524|FG003|NOT COMPLETED|Maintenance Period||18
6497661|NCT01406938|7416525|FG004|NOT COMPLETED|Maintenance Period||25
6497662|NCT01406938|7416526|FG005|NOT COMPLETED|Maintenance Period||16
6497663|NCT01406938|7416521|FG000|STARTED|Follow up||26
6497664|NCT01406938|7416522|FG001|STARTED|Follow up||23
6497665|NCT01406938|7416523|FG002|STARTED|Follow up||40
6497666|NCT01406938|7416524|FG003|STARTED|Follow up||39
6497667|NCT01406938|7416525|FG004|STARTED|Follow up||40
6497668|NCT01406938|7416526|FG005|STARTED|Follow up||35
6497669|NCT01406938|7416521|FG000|COMPLETED|Follow up||18
6497670|NCT01406938|7416522|FG001|COMPLETED|Follow up||18
6497671|NCT01406938|7416523|FG002|COMPLETED|Follow up||32
6497672|NCT01406938|7416524|FG003|COMPLETED|Follow up||36
6497673|NCT01406938|7416525|FG004|COMPLETED|Follow up||31
6497674|NCT01406938|7416526|FG005|COMPLETED|Follow up||32
6497675|NCT01406938|7416521|FG000|NOT COMPLETED|Follow up||8
6497676|NCT01406938|7416522|FG001|NOT COMPLETED|Follow up||5
6497677|NCT01406938|7416523|FG002|NOT COMPLETED|Follow up||8
6497678|NCT01406938|7416524|FG003|NOT COMPLETED|Follow up||3
6497679|NCT01406938|7416525|FG004|NOT COMPLETED|Follow up||9
6497680|NCT01406938|7416526|FG005|NOT COMPLETED|Follow up||3
6497681|NCT01406990|7416546|FG000|STARTED|Overall Study||15
6497682|NCT01406990|7416546|FG000|COMPLETED|Overall Study||15
6497683|NCT01406990|7416546|FG000|NOT COMPLETED|Overall Study||0
6497684|NCT01407068|7416550|FG000|STARTED|Overall Study||60
6497685|NCT01407068|7416550|FG000|COMPLETED|Overall Study||60
6497686|NCT01407068|7416550|FG000|NOT COMPLETED|Overall Study||0
6497687|NCT01407094|7416559|FG000|STARTED|Stage 1|Stage 1 Sertraline (SERT): 34 exited|146
6497688|NCT01407094|7416560|FG001|STARTED|Stage 1|Stage 1 Placebo (PBO): 27 exited.|150
6497689|NCT01407094|7416561|FG002|STARTED|Stage 1|Bupropion (BUP) was used only in Stage 2 for non-responders to SERT.|0
6497690|NCT01407094|7416559|FG000|COMPLETED|Stage 1|One participant completed Stage 1 but did not continue to Stage 2.|112
6497691|NCT01407094|7416560|FG001|COMPLETED|Stage 1|Four participants completed Stage 1 but did not continue to Stage 2.|123
6497692|NCT01407094|7416561|FG002|COMPLETED|Stage 1||0
6497693|NCT01407094|7416559|FG000|NOT COMPLETED|Stage 1||34
6497694|NCT01407094|7416560|FG001|NOT COMPLETED|Stage 1||27
6497695|NCT01407094|7416561|FG002|NOT COMPLETED|Stage 1||0
6497696|NCT01407094|7416559|FG000|STARTED|Stage 2|Stage 2 SERT includes Stage 1 SERT responders (n=61) and Stage 1 PBO non-responders (n=73).|134
6497697|NCT01407094|7416560|FG001|STARTED|Stage 2|Stage 2 PBO includes Stage 1 PBO responders (n=47); 1 early exit (n=46).|46
6497698|NCT01407094|7416561|FG002|STARTED|Stage 2|Stage 2 BUP includes Stage 1 SERT non-responders (n=54); 1 early exit (n=53).|53
6497699|NCT01407094|7416559|FG000|COMPLETED|Stage 2||113
6555442|NCT01751867|7477605|FG000|COMPLETED|Overall Study||0
6555443|NCT01751867|7477606|FG001|COMPLETED|Overall Study||0
6555444|NCT01751867|7477605|FG000|NOT COMPLETED|Overall Study||36
6555445|NCT01751867|7477606|FG001|NOT COMPLETED|Overall Study||99
6555446|NCT01751971|7477614|FG000|STARTED|Overall Study||22
6555447|NCT01751971|7477615|FG001|STARTED|Overall Study||25
6750407|NCT03426995|7677310|FG003|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750408|NCT03426995|7677311|FG004|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750409|NCT03426995|7677312|FG005|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750410|NCT03426995|7677313|FG006|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750411|NCT03426995|7677314|FG007|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750412|NCT03426995|7677315|FG008|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750413|NCT03426995|7677316|FG009|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750414|NCT03426995|7677317|FG010|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750415|NCT03426995|7677318|FG011|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750416|NCT03426995|7677319|FG012|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750417|NCT03426995|7677320|FG013|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750418|NCT03426995|7677321|FG014|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||9
6750419|NCT03426995|7677322|FG015|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||12
6750420|NCT03426995|7677323|FG016|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750421|NCT03426995|7677324|FG017|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750422|NCT03426995|7677325|FG018|NOT COMPLETED|Part C: Cohorts 4 to 8 (Days 1 to 14)||0
6750423|NCT03427073|7677380|FG000|STARTED|Overall Study||1
6750424|NCT03427073|7677381|FG001|STARTED|Overall Study||1
6750425|NCT03427073|7677382|FG002|STARTED|Overall Study||1
6750426|NCT03427073|7677383|FG003|STARTED|Overall Study||3
6750427|NCT03427073|7677384|FG004|STARTED|Overall Study||3
6750428|NCT03427073|7677385|FG005|STARTED|Overall Study||4
6750429|NCT03427073|7677386|FG006|STARTED|Overall Study||3
6750430|NCT03427073|7677387|FG007|STARTED|Overall Study||4
6750431|NCT03427073|7677380|FG000|COMPLETED|Overall Study||0
6750432|NCT03427073|7677381|FG001|COMPLETED|Overall Study||0
6750433|NCT03427073|7677382|FG002|COMPLETED|Overall Study||0
6750434|NCT03427073|7677383|FG003|COMPLETED|Overall Study||0
6750435|NCT03427073|7677384|FG004|COMPLETED|Overall Study||0
6750436|NCT03427073|7677385|FG005|COMPLETED|Overall Study||0
6750437|NCT03427073|7677386|FG006|COMPLETED|Overall Study||0
6750438|NCT03427073|7677387|FG007|COMPLETED|Overall Study||0
6750439|NCT03427073|7677380|FG000|NOT COMPLETED|Overall Study||1
6750440|NCT03427073|7677381|FG001|NOT COMPLETED|Overall Study||1
6750441|NCT03427073|7677382|FG002|NOT COMPLETED|Overall Study||1
6750442|NCT03427073|7677383|FG003|NOT COMPLETED|Overall Study||3
6750443|NCT03427073|7677384|FG004|NOT COMPLETED|Overall Study||3
6750444|NCT03427073|7677385|FG005|NOT COMPLETED|Overall Study||4
6750445|NCT03427073|7677386|FG006|NOT COMPLETED|Overall Study||3
6750446|NCT03427073|7677387|FG007|NOT COMPLETED|Overall Study||4
6750447|NCT03427177|7677407|FG000|STARTED|Overall Study||125
6750448|NCT03427177|7677408|FG001|STARTED|Overall Study||132
6750449|NCT03427177|7677407|FG000|COMPLETED|Overall Study||92
6750450|NCT03427177|7677408|FG001|COMPLETED|Overall Study||105
6750451|NCT03427177|7677407|FG000|NOT COMPLETED|Overall Study||33
6750452|NCT03427177|7677408|FG001|NOT COMPLETED|Overall Study||27
6750453|NCT03427268|7677414|FG000|STARTED|Overall Study||32
6750454|NCT03427268|7677414|FG000|COMPLETED|Overall Study||0
6750455|NCT03427268|7677414|FG000|NOT COMPLETED|Overall Study||32
6750456|NCT03427619|7677418|FG000|STARTED|Overall Study||275
6750457|NCT03427619|7677418|FG000|Safety Population|Overall Study||275
6750458|NCT03427619|7677418|FG000|Modified Intention to Treat Population|Overall Study||143
6750459|NCT03427619|7677418|FG000|COMPLETED|Overall Study||209
6750460|NCT03427619|7677418|FG000|NOT COMPLETED|Overall Study||66
6750461|NCT03427892|7677422|FG000|STARTED|Overall Study||21
6750462|NCT03427892|7677422|FG000|COMPLETED|Overall Study|Of the 21 recruited, 19 completed at least one post baseline visit, included in the analysis.|19
6750463|NCT03427892|7677422|FG000|NOT COMPLETED|Overall Study||2
6750464|NCT03427931|7677426|FG000|STARTED|Overall Study||7
6750465|NCT03427931|7677426|FG000|COMPLETED|Overall Study||5
6750466|NCT03427931|7677426|FG000|NOT COMPLETED|Overall Study||2
6750467|NCT03428100|7677434|FG000|STARTED|Overall Study||93
6497700|NCT01407094|7416560|FG001|COMPLETED|Stage 2||35
6497701|NCT01407094|7416561|FG002|COMPLETED|Stage 2||38
6497702|NCT01407094|7416559|FG000|NOT COMPLETED|Stage 2||21
6497703|NCT01407094|7416560|FG001|NOT COMPLETED|Stage 2||11
6497704|NCT01407094|7416561|FG002|NOT COMPLETED|Stage 2||15
6497705|NCT01407107|7416572|FG000|STARTED|Overall Study||7
6497706|NCT01407107|7416573|FG001|STARTED|Overall Study||3
6497707|NCT01407107|7416574|FG002|STARTED|Overall Study||3
6497708|NCT01407107|7416572|FG000|COMPLETED|Overall Study||7
6497709|NCT01407107|7416573|FG001|COMPLETED|Overall Study||3
6497710|NCT01407107|7416574|FG002|COMPLETED|Overall Study||3
6497711|NCT01407107|7416572|FG000|NOT COMPLETED|Overall Study||0
6497712|NCT01407107|7416573|FG001|NOT COMPLETED|Overall Study||0
6497713|NCT01407107|7416574|FG002|NOT COMPLETED|Overall Study||0
6497714|NCT01407276|7416590|FG000|STARTED|Overall Study||6
6497715|NCT01407276|7416591|FG001|STARTED|Overall Study||6
6497716|NCT01407276|7416592|FG002|STARTED|Overall Study||6
6497717|NCT01407276|7416593|FG003|STARTED|Overall Study||6
6497718|NCT01407276|7416594|FG004|STARTED|Overall Study||6
6497719|NCT01407276|7416595|FG005|STARTED|Overall Study||6
6497720|NCT01407276|7416596|FG006|STARTED|Overall Study||6
6497721|NCT01407276|7416597|FG007|STARTED|Overall Study||7
6497722|NCT01407276|7416590|FG000|COMPLETED|Overall Study||6
6497723|NCT01407276|7416591|FG001|COMPLETED|Overall Study||6
6750468|NCT03428100|7677435|FG001|STARTED|Overall Study||93
6750469|NCT03428100|7677436|FG002|STARTED|Overall Study||185
6750470|NCT03428100|7677437|FG003|STARTED|Overall Study||92
6750471|NCT03428100|7677434|FG000|Received at Least One Dose of Study Drug|Overall Study||93
6750472|NCT03428100|7677435|FG001|Received at Least One Dose of Study Drug|Overall Study||93
6750473|NCT03428100|7677436|FG002|Received at Least One Dose of Study Drug|Overall Study||184
6750474|NCT03428100|7677437|FG003|Received at Least One Dose of Study Drug|Overall Study||92
6750475|NCT03428100|7677434|FG000|COMPLETED|Overall Study||72
6750476|NCT03428100|7677435|FG001|COMPLETED|Overall Study||80
6750477|NCT03428100|7677436|FG002|COMPLETED|Overall Study||173
6750478|NCT03428100|7677437|FG003|COMPLETED|Overall Study||85
6750479|NCT03428100|7677434|FG000|NOT COMPLETED|Overall Study||21
6750480|NCT03428100|7677435|FG001|NOT COMPLETED|Overall Study||13
6750481|NCT03428100|7677436|FG002|NOT COMPLETED|Overall Study||12
6750482|NCT03428100|7677437|FG003|NOT COMPLETED|Overall Study||7
6750483|NCT03428152|7677459|FG000|STARTED|Overall Study||37
6750484|NCT03428152|7677460|FG001|STARTED|Overall Study||41
6750485|NCT03428152|7677459|FG000|COMPLETED|Overall Study||30
6750486|NCT03428152|7677460|FG001|COMPLETED|Overall Study|exclusions: epidural / TAP / wound infiltration malignity retroperitone was opened age >65|30
6750487|NCT03428152|7677459|FG000|NOT COMPLETED|Overall Study||7
6750488|NCT03428152|7677460|FG001|NOT COMPLETED|Overall Study||11
6750489|NCT03428230|7677470|FG000|STARTED|Overall Study||15
6750490|NCT03428230|7677471|FG001|STARTED|Overall Study||15
6750491|NCT03428230|7677472|FG002|STARTED|Overall Study||15
6750492|NCT03428230|7677473|FG003|STARTED|Overall Study||15
6750493|NCT03428230|7677470|FG000|COMPLETED|Overall Study||15
6750494|NCT03428230|7677471|FG001|COMPLETED|Overall Study||15
6750495|NCT03428230|7677472|FG002|COMPLETED|Overall Study||15
6750496|NCT03428230|7677473|FG003|COMPLETED|Overall Study||15
6750497|NCT03428230|7677470|FG000|NOT COMPLETED|Overall Study||0
6750498|NCT03428230|7677471|FG001|NOT COMPLETED|Overall Study||0
6750499|NCT03428230|7677472|FG002|NOT COMPLETED|Overall Study||0
6750500|NCT03428230|7677473|FG003|NOT COMPLETED|Overall Study||0
6750501|NCT03428360|7677483|FG000|STARTED|Overall Study||130
6750502|NCT03428360|7677483|FG000|COMPLETED|Overall Study||90
6750503|NCT03428360|7677483|FG000|NOT COMPLETED|Overall Study||40
6750504|NCT03428750|7677493|FG000|STARTED|Overall Study||210
6750505|NCT03428750|7677494|FG001|STARTED|Overall Study||213
6750506|NCT03428750|7677493|FG000|COMPLETED|Overall Study||186
6750507|NCT03428750|7677494|FG001|COMPLETED|Overall Study||192
6750508|NCT03428750|7677493|FG000|NOT COMPLETED|Overall Study||24
6750509|NCT03428750|7677494|FG001|NOT COMPLETED|Overall Study||21
6750510|NCT03428815|7677525|FG000|STARTED|Overall Study||17
6750511|NCT03428815|7677526|FG001|STARTED|Overall Study||19
6750512|NCT03428815|7677525|FG000|COMPLETED|Overall Study||7
6750513|NCT03428815|7677526|FG001|COMPLETED|Overall Study||14
6750514|NCT03428815|7677525|FG000|NOT COMPLETED|Overall Study||10
6750515|NCT03428815|7677526|FG001|NOT COMPLETED|Overall Study||5
6750516|NCT03428997|7677532|FG000|STARTED|Overall Study||24
6750517|NCT03428997|7677532|FG000|COMPLETED|Overall Study||16
6497724|NCT01407276|7416592|FG002|COMPLETED|Overall Study||6
6497725|NCT01407276|7416593|FG003|COMPLETED|Overall Study||6
6497726|NCT01407276|7416594|FG004|COMPLETED|Overall Study||6
6750518|NCT03428997|7677532|FG000|NOT COMPLETED|Overall Study||8
6750519|NCT03429270|7677538|FG000|STARTED|Overall Study||28
6750520|NCT03429270|7677538|FG000|COMPLETED|Overall Study||28
6750521|NCT03429270|7677538|FG000|NOT COMPLETED|Overall Study||0
6750522|NCT03429348|7677544|FG000|STARTED|Overall Study|4 participants had no additional rehab & had no corresponding sauna rehab participant to compare to.|12
6750523|NCT03429348|7677545|FG001|STARTED|Overall Study||12
6497727|NCT01407276|7416595|FG005|COMPLETED|Overall Study||6
6497728|NCT01407276|7416596|FG006|COMPLETED|Overall Study||6
6497729|NCT01407276|7416597|FG007|COMPLETED|Overall Study||6
6497730|NCT01407276|7416590|FG000|NOT COMPLETED|Overall Study||0
6497731|NCT01407276|7416591|FG001|NOT COMPLETED|Overall Study||0
6750524|NCT03429348|7677544|FG000|COMPLETED|Overall Study||12
6497732|NCT01407276|7416592|FG002|NOT COMPLETED|Overall Study||0
6497733|NCT01407276|7416593|FG003|NOT COMPLETED|Overall Study||0
6497734|NCT01407276|7416594|FG004|NOT COMPLETED|Overall Study||0
6497735|NCT01407276|7416595|FG005|NOT COMPLETED|Overall Study||0
6497736|NCT01407276|7416596|FG006|NOT COMPLETED|Overall Study||0
6497737|NCT01407276|7416597|FG007|NOT COMPLETED|Overall Study||1
6497738|NCT01407354|7416622|FG000|STARTED|First Intervention||20
6497739|NCT01407354|7416623|FG001|STARTED|First Intervention||17
6497740|NCT01407354|7416622|FG000|COMPLETED|First Intervention||18
6497741|NCT01407354|7416623|FG001|COMPLETED|First Intervention||15
6497742|NCT01407354|7416622|FG000|NOT COMPLETED|First Intervention||2
6497743|NCT01407354|7416623|FG001|NOT COMPLETED|First Intervention||2
6497744|NCT01407354|7416622|FG000|STARTED|Second Intervention||18
6497745|NCT01407354|7416623|FG001|STARTED|Second Intervention||15
6497746|NCT01407354|7416622|FG000|COMPLETED|Second Intervention||18
6497747|NCT01407354|7416623|FG001|COMPLETED|Second Intervention||13
6497748|NCT01407354|7416622|FG000|NOT COMPLETED|Second Intervention||0
6497749|NCT01407354|7416623|FG001|NOT COMPLETED|Second Intervention||2
6497750|NCT01407367|7416632|FG000|STARTED|Overall Study||108
6497751|NCT01407367|7416633|FG001|STARTED|Overall Study||242
6497752|NCT01407367|7416632|FG000|COMPLETED|Overall Study||68
6497753|NCT01407367|7416633|FG001|COMPLETED|Overall Study||164
6497754|NCT01407367|7416632|FG000|NOT COMPLETED|Overall Study||40
6497755|NCT01407367|7416633|FG001|NOT COMPLETED|Overall Study||78
6497756|NCT01407523|7416642|FG000|STARTED|Overall Study||16
6497757|NCT01407523|7416642|FG000|COMPLETED|Overall Study||16
6497758|NCT01407523|7416642|FG000|NOT COMPLETED|Overall Study||0
6497759|NCT01407575|7416648|FG000|STARTED|Overall Study||7
6497760|NCT01407575|7416649|FG001|STARTED|Overall Study||6
6750525|NCT03429348|7677545|FG001|COMPLETED|Overall Study||12
6750526|NCT03429348|7677544|FG000|NOT COMPLETED|Overall Study||0
6750527|NCT03429348|7677545|FG001|NOT COMPLETED|Overall Study||0
6750528|NCT03429556|7677557|FG000|STARTED|Overall Study||12
6750529|NCT03429556|7677558|FG001|STARTED|Overall Study||4
6750530|NCT03429556|7677559|FG002|STARTED|Overall Study||4
6750531|NCT03429556|7677560|FG003|STARTED|Overall Study||3
6750532|NCT03429556|7677557|FG000|COMPLETED|Overall Study||12
6750533|NCT03429556|7677558|FG001|COMPLETED|Overall Study||3
6750534|NCT03429556|7677559|FG002|COMPLETED|Overall Study||4
6750535|NCT03429556|7677560|FG003|COMPLETED|Overall Study||3
6750536|NCT03429556|7677557|FG000|NOT COMPLETED|Overall Study||0
6750537|NCT03429556|7677558|FG001|NOT COMPLETED|Overall Study||1
6750538|NCT03429556|7677559|FG002|NOT COMPLETED|Overall Study||0
6750539|NCT03429556|7677560|FG003|NOT COMPLETED|Overall Study||0
6750540|NCT03430050|7677572|FG000|STARTED|Overall Study||3
6750541|NCT03430050|7677573|FG001|STARTED|Overall Study||5
6750542|NCT03430050|7677572|FG000|COMPLETED|Overall Study||3
6750543|NCT03430050|7677573|FG001|COMPLETED|Overall Study||5
6750544|NCT03430050|7677572|FG000|NOT COMPLETED|Overall Study||0
6750545|NCT03430050|7677573|FG001|NOT COMPLETED|Overall Study||0
6750546|NCT03430206|7677581|FG000|STARTED|Overall Study||40
6750547|NCT03430206|7677582|FG001|STARTED|Overall Study||38
6750548|NCT03430206|7677581|FG000|COMPLETED|Overall Study||18
6750549|NCT03430206|7677582|FG001|COMPLETED|Overall Study||21
6750550|NCT03430206|7677581|FG000|NOT COMPLETED|Overall Study||22
6750551|NCT03430206|7677582|FG001|NOT COMPLETED|Overall Study||17
6750552|NCT03430245|7677588|FG000|STARTED|Overall Study||16
6750553|NCT03430245|7677588|FG000|COMPLETED|Overall Study|6 subjects withdrew from study due to lengthy treatment. Treatment protocol amended.|9
6750554|NCT03430245|7677588|FG000|NOT COMPLETED|Overall Study||7
6750555|NCT03430349|7677594|FG000|STARTED|Overall Study||15
6750556|NCT03430349|7677595|FG001|STARTED|Overall Study||15
6750557|NCT03430349|7677594|FG000|Received nOPV Vaccination|Overall Study||15
6750558|NCT03430349|7677595|FG001|Received nOPV Vaccination|Overall Study||15
6750559|NCT03430349|7677594|FG000|COMPLETED|Overall Study||15
6750560|NCT03430349|7677595|FG001|COMPLETED|Overall Study||15
6750561|NCT03430349|7677594|FG000|NOT COMPLETED|Overall Study||0
6750562|NCT03430349|7677595|FG001|NOT COMPLETED|Overall Study||0
6750563|NCT03430856|7677605|FG000|STARTED|Overall Study||31
6750564|NCT03430856|7677606|FG001|STARTED|Overall Study||30
6750565|NCT03430856|7677607|FG002|STARTED|Overall Study||30
6750566|NCT03430856|7677605|FG000|Exposed|Overall Study||31
6750567|NCT03430856|7677606|FG001|Exposed|Overall Study||30
6750568|NCT03430856|7677607|FG002|Exposed|Overall Study||30
6750569|NCT03430856|7677605|FG000|COMPLETED|Overall Study||29
6750570|NCT03430856|7677606|FG001|COMPLETED|Overall Study||27
6750571|NCT03430856|7677607|FG002|COMPLETED|Overall Study||29
6750572|NCT03430856|7677605|FG000|NOT COMPLETED|Overall Study||2
6497761|NCT01407575|7416648|FG000|COMPLETED|Overall Study||5
6497762|NCT01407575|7416649|FG001|COMPLETED|Overall Study||5
6497763|NCT01407575|7416648|FG000|NOT COMPLETED|Overall Study||2
6497764|NCT01407575|7416649|FG001|NOT COMPLETED|Overall Study||1
6497765|NCT01407926|7416657|FG000|STARTED|Overall Study||142
6497766|NCT01407926|7416657|FG000|COMPLETED|Overall Study||87
6497767|NCT01407926|7416657|FG000|NOT COMPLETED|Overall Study||55
6750573|NCT03430856|7677606|FG001|NOT COMPLETED|Overall Study||3
6497768|NCT01407952|7416664|FG000|STARTED|Overall Study||297
6497769|NCT01407952|7416665|FG001|STARTED|Overall Study||303
6497770|NCT01407952|7416664|FG000|COMPLETED|Overall Study||251
6497771|NCT01407952|7416665|FG001|COMPLETED|Overall Study||266
6750574|NCT03430856|7677607|FG002|NOT COMPLETED|Overall Study||1
6750575|NCT03430986|7677620|FG000|STARTED|24-week Control Period||42
6497772|NCT01407952|7416664|FG000|NOT COMPLETED|Overall Study||46
6497773|NCT01407952|7416665|FG001|NOT COMPLETED|Overall Study||37
6497774|NCT01408030|7416675|FG000|STARTED|Treatment Phase (on Drug)||29
6497775|NCT01408030|7416676|FG001|STARTED|Treatment Phase (on Drug)||31
6497776|NCT01408030|7416677|FG002|STARTED|Treatment Phase (on Drug)||33
6497777|NCT01408030|7416678|FG003|STARTED|Treatment Phase (on Drug)||28
6497778|NCT01408030|7416675|FG000|COMPLETED|Treatment Phase (on Drug)||26
6497779|NCT01408030|7416676|FG001|COMPLETED|Treatment Phase (on Drug)||24
6497780|NCT01408030|7416677|FG002|COMPLETED|Treatment Phase (on Drug)||32
6497781|NCT01408030|7416678|FG003|COMPLETED|Treatment Phase (on Drug)||25
6497782|NCT01408030|7416675|FG000|NOT COMPLETED|Treatment Phase (on Drug)||3
6497783|NCT01408030|7416676|FG001|NOT COMPLETED|Treatment Phase (on Drug)||7
6497784|NCT01408030|7416677|FG002|NOT COMPLETED|Treatment Phase (on Drug)||1
6497785|NCT01408030|7416678|FG003|NOT COMPLETED|Treatment Phase (on Drug)||3
6497786|NCT01408030|7416675|FG000|STARTED|Observation Phase (Off Drug)||26
6497787|NCT01408030|7416676|FG001|STARTED|Observation Phase (Off Drug)||24
6497788|NCT01408030|7416677|FG002|STARTED|Observation Phase (Off Drug)||32
6750576|NCT03430986|7677621|FG001|STARTED|24-week Control Period||122
6750577|NCT03430986|7677620|FG000|Treated as Randomized|24-week Control Period||42
6750578|NCT03430986|7677621|FG001|Treated as Randomized|24-week Control Period||120
6750579|NCT03430986|7677620|FG000|COMPLETED|24-week Control Period||34
6750580|NCT03430986|7677621|FG001|COMPLETED|24-week Control Period||118
6750581|NCT03430986|7677620|FG000|NOT COMPLETED|24-week Control Period||8
6750582|NCT03430986|7677621|FG001|NOT COMPLETED|24-week Control Period||4
6750583|NCT03430986|7677620|FG000|STARTED|24-week Post-Control Period|Not all participants received the Optional Treatment.|31
6750584|NCT03430986|7677621|FG001|STARTED|24-week Post-Control Period||118
6750585|NCT03430986|7677620|FG000|COMPLETED|24-week Post-Control Period||30
6750586|NCT03430986|7677621|FG001|COMPLETED|24-week Post-Control Period||116
6750587|NCT03430986|7677620|FG000|NOT COMPLETED|24-week Post-Control Period||1
6750588|NCT03430986|7677621|FG001|NOT COMPLETED|24-week Post-Control Period||2
6750589|NCT03431012|7677634|FG000|STARTED|Overall Study||47
6750590|NCT03431012|7677635|FG001|STARTED|Overall Study||60
6750591|NCT03431012|7677636|FG002|STARTED|Overall Study||56
6750592|NCT03431012|7677637|FG003|STARTED|Overall Study||53
6750593|NCT03431012|7677634|FG000|COMPLETED|Overall Study||47
6750594|NCT03431012|7677635|FG001|COMPLETED|Overall Study||60
6750595|NCT03431012|7677636|FG002|COMPLETED|Overall Study||56
6750596|NCT03431012|7677637|FG003|COMPLETED|Overall Study||53
6750597|NCT03431012|7677634|FG000|NOT COMPLETED|Overall Study||0
6750598|NCT03431012|7677635|FG001|NOT COMPLETED|Overall Study||0
6750599|NCT03431012|7677636|FG002|NOT COMPLETED|Overall Study||0
6750600|NCT03431012|7677637|FG003|NOT COMPLETED|Overall Study||0
6750601|NCT03431337|7677653|FG000|STARTED|Overall Study||78
6750602|NCT03431337|7677654|FG001|STARTED|Overall Study||79
6750603|NCT03431337|7677653|FG000|COMPLETED|Overall Study||49
6750604|NCT03431337|7677654|FG001|COMPLETED|Overall Study||57
6750605|NCT03431337|7677653|FG000|NOT COMPLETED|Overall Study||29
6750606|NCT03431337|7677654|FG001|NOT COMPLETED|Overall Study||22
6750607|NCT03431441|7677664|FG000|STARTED|Overall Study||24
6750608|NCT03431441|7677664|FG000|COMPLETED|Overall Study||19
6750609|NCT03431441|7677664|FG000|NOT COMPLETED|Overall Study||5
6750610|NCT03431857|7677668|FG000|STARTED|Overall Study||106
6750611|NCT03431857|7677668|FG000|COMPLETED|Overall Study|52 subjects have completed the study, and 50 had complete data (all pages of CRF visit are complete)|52
6750612|NCT03431857|7677668|FG000|NOT COMPLETED|Overall Study||54
6750613|NCT03432390|7677674|FG000|STARTED|Apnea Period||36
6750614|NCT03432390|7677675|FG001|STARTED|Apnea Period||36
6750615|NCT03432390|7677674|FG000|COMPLETED|Apnea Period||34
6750616|NCT03432390|7677675|FG001|COMPLETED|Apnea Period||34
6750617|NCT03432390|7677674|FG000|NOT COMPLETED|Apnea Period||2
6750618|NCT03432390|7677675|FG001|NOT COMPLETED|Apnea Period||2
6750619|NCT03432390|7677674|FG000|STARTED|Recovery Period||34
6750620|NCT03432390|7677675|FG001|STARTED|Recovery Period||34
6750621|NCT03432390|7677674|FG000|COMPLETED|Recovery Period||34
6750622|NCT03432390|7677675|FG001|COMPLETED|Recovery Period||34
6750623|NCT03432390|7677674|FG000|NOT COMPLETED|Recovery Period||0
6750624|NCT03432390|7677675|FG001|NOT COMPLETED|Recovery Period||0
6750625|NCT03432533|7677683|FG000|STARTED|Overall Study||141
6750626|NCT03432533|7677684|FG001|STARTED|Overall Study||142
6750627|NCT03432533|7677683|FG000|Completed 6-Month Treatment Period|Overall Study||136
6750628|NCT03432533|7677684|FG001|Completed 6-Month Treatment Period|Overall Study||137
6750629|NCT03432533|7677683|FG000|COMPLETED|Overall Study||126
6750630|NCT03432533|7677684|FG001|COMPLETED|Overall Study||131
6750631|NCT03432533|7677683|FG000|NOT COMPLETED|Overall Study||15
6750632|NCT03432533|7677684|FG001|NOT COMPLETED|Overall Study||11
6750633|NCT03432858|7677693|FG000|STARTED|Overall Study||12
6750634|NCT03432858|7677694|FG001|STARTED|Overall Study||83
6497789|NCT01408030|7416678|FG003|STARTED|Observation Phase (Off Drug)||25
6497790|NCT01408030|7416675|FG000|COMPLETED|Observation Phase (Off Drug)||22
6497791|NCT01408030|7416676|FG001|COMPLETED|Observation Phase (Off Drug)||18
6497792|NCT01408030|7416677|FG002|COMPLETED|Observation Phase (Off Drug)||26
6750635|NCT03432858|7677695|FG002|STARTED|Overall Study||89
6497793|NCT01408030|7416678|FG003|COMPLETED|Observation Phase (Off Drug)||21
6750636|NCT03432858|7677693|FG000|COMPLETED|Overall Study||10
6750637|NCT03432858|7677694|FG001|COMPLETED|Overall Study||72
6750638|NCT03432858|7677695|FG002|COMPLETED|Overall Study||72
6750639|NCT03432858|7677693|FG000|NOT COMPLETED|Overall Study||2
6497794|NCT01408030|7416675|FG000|NOT COMPLETED|Observation Phase (Off Drug)||4
6497795|NCT01408030|7416676|FG001|NOT COMPLETED|Observation Phase (Off Drug)||6
6497796|NCT01408030|7416677|FG002|NOT COMPLETED|Observation Phase (Off Drug)||6
6497797|NCT01408030|7416678|FG003|NOT COMPLETED|Observation Phase (Off Drug)||4
6497798|NCT01408043|7416688|FG000|STARTED|Overall Study||25
6497799|NCT01408043|7416688|FG000|COMPLETED|Overall Study||24
6497800|NCT01408043|7416688|FG000|NOT COMPLETED|Overall Study||1
6497801|NCT01408147|7416694|FG000|STARTED|Overall Study|174 participants|174
6555448|NCT01751971|7477614|FG000|COMPLETED|Overall Study||20
6555449|NCT01751971|7477615|FG001|COMPLETED|Overall Study||24
6555450|NCT01751971|7477614|FG000|NOT COMPLETED|Overall Study||2
6555451|NCT01751971|7477615|FG001|NOT COMPLETED|Overall Study||1
6555452|NCT01752036|7477627|FG000|STARTED|Overall Study||33
6555453|NCT01752036|7477627|FG000|COMPLETED|Overall Study||31
6555454|NCT01752036|7477627|FG000|NOT COMPLETED|Overall Study||2
6555455|NCT01752400|7477632|FG000|STARTED|Overall Study||6
6555456|NCT01752400|7477632|FG000|COMPLETED|Overall Study||6
6555457|NCT01752400|7477632|FG000|NOT COMPLETED|Overall Study||0
6555458|NCT01752413|7477638|FG000|STARTED|Overall Study||170
6750640|NCT03432858|7677694|FG001|NOT COMPLETED|Overall Study||11
6750641|NCT03432858|7677695|FG002|NOT COMPLETED|Overall Study||17
6750642|NCT03433482|7677707|FG000|STARTED|Overall Study||420
6750643|NCT03433482|7677708|FG001|STARTED|Overall Study||424
6750644|NCT03433482|7677709|FG002|STARTED|Overall Study||427
6750645|NCT03433482|7677710|FG003|STARTED|Overall Study||419
6750646|NCT03433482|7677707|FG000|COMPLETED|Overall Study||419
6750647|NCT03433482|7677708|FG001|COMPLETED|Overall Study||424
6750648|NCT03433482|7677709|FG002|COMPLETED|Overall Study||423
6750649|NCT03433482|7677710|FG003|COMPLETED|Overall Study||418
6750650|NCT03433482|7677707|FG000|NOT COMPLETED|Overall Study||1
6750651|NCT03433482|7677708|FG001|NOT COMPLETED|Overall Study||0
6750652|NCT03433482|7677709|FG002|NOT COMPLETED|Overall Study||4
6750653|NCT03433482|7677710|FG003|NOT COMPLETED|Overall Study||1
6750654|NCT03433677|7677722|FG000|STARTED|Period 1||24
6750655|NCT03433677|7677723|FG001|STARTED|Period 1||25
6750656|NCT03433677|7677722|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
6750657|NCT03433677|7677723|FG001|Received at Least 1 Dose of Study Drug|Period 1||25
6750658|NCT03433677|7677722|FG000|COMPLETED|Period 1||23
6750659|NCT03433677|7677723|FG001|COMPLETED|Period 1||25
6750660|NCT03433677|7677722|FG000|NOT COMPLETED|Period 1||1
6750661|NCT03433677|7677723|FG001|NOT COMPLETED|Period 1||0
6750662|NCT03433677|7677722|FG000|STARTED|Period 2||23
6750663|NCT03433677|7677723|FG001|STARTED|Period 2||25
6750664|NCT03433677|7677722|FG000|Received at Least 1 Dose of Study Drug|Period 2||23
6750665|NCT03433677|7677723|FG001|Received at Least 1 Dose of Study Drug|Period 2||25
6750666|NCT03433677|7677722|FG000|COMPLETED|Period 2||22
6750667|NCT03433677|7677723|FG001|COMPLETED|Period 2||24
6750668|NCT03433677|7677722|FG000|NOT COMPLETED|Period 2||1
6750669|NCT03433677|7677723|FG001|NOT COMPLETED|Period 2||1
6750670|NCT03433703|7677730|FG000|STARTED|Overall Study||2
6750671|NCT03433703|7677730|FG000|COMPLETED|Overall Study||0
6750672|NCT03433703|7677730|FG000|NOT COMPLETED|Overall Study||2
6750673|NCT03433755|7677738|FG000|STARTED|Overall Study||42
6750674|NCT03433755|7677739|FG001|STARTED|Overall Study||41
6750675|NCT03433755|7677740|FG002|STARTED|Overall Study||79
6750676|NCT03433755|7677741|FG003|STARTED|Overall Study||80
6750677|NCT03433755|7677738|FG000|Randomized and Treated|Overall Study||41
6750678|NCT03433755|7677739|FG001|Randomized and Treated|Overall Study||41
6750679|NCT03433755|7677740|FG002|Randomized and Treated|Overall Study||79
6750680|NCT03433755|7677741|FG003|Randomized and Treated|Overall Study||80
6750681|NCT03433755|7677738|FG000|COMPLETED|Overall Study||40
6750682|NCT03433755|7677739|FG001|COMPLETED|Overall Study||41
6750683|NCT03433755|7677740|FG002|COMPLETED|Overall Study||79
6750684|NCT03433755|7677741|FG003|COMPLETED|Overall Study||80
6750685|NCT03433755|7677738|FG000|NOT COMPLETED|Overall Study||2
6750686|NCT03433755|7677739|FG001|NOT COMPLETED|Overall Study||0
6750687|NCT03433755|7677740|FG002|NOT COMPLETED|Overall Study||0
6750688|NCT03433755|7677741|FG003|NOT COMPLETED|Overall Study||0
6750689|NCT03433794|7677756|FG000|STARTED|Baseline||183
6750690|NCT03433794|7677757|FG001|STARTED|Baseline||173
6750691|NCT03433794|7677758|FG002|STARTED|Baseline||181
6750692|NCT03433794|7677756|FG000|COMPLETED|Baseline||183
6750693|NCT03433794|7677757|FG001|COMPLETED|Baseline||173
6750694|NCT03433794|7677758|FG002|COMPLETED|Baseline||181
6305842|NCT00371137|7209229|FG000|Treated|Overall Study||183
6305843|NCT00371137|7209230|FG001|Treated|Overall Study||182
6305844|NCT00371137|7209231|FG002|Treated|Overall Study||182
6305845|NCT00371137|7209229|FG000|COMPLETED|Overall Study||111
6305846|NCT00371137|7209230|FG001|COMPLETED|Overall Study||119
6305847|NCT00371137|7209231|FG002|COMPLETED|Overall Study||104
6305848|NCT00371137|7209229|FG000|NOT COMPLETED|Overall Study||72
6305849|NCT00371137|7209230|FG001|NOT COMPLETED|Overall Study||63
6305850|NCT00371137|7209231|FG002|NOT COMPLETED|Overall Study||79
6305851|NCT00371150|7209241|FG000|STARTED|Overall Study||40
6305852|NCT00371150|7209242|FG001|STARTED|Overall Study||6
6305853|NCT00371150|7209241|FG000|Discontinued Prior to Week 48 Visit|Overall Study||1
6305854|NCT00371150|7209242|FG001|Discontinued Prior to Week 48 Visit|Overall Study||1
6555459|NCT01752413|7477639|FG001|STARTED|Overall Study||27
6750695|NCT03433794|7677756|FG000|NOT COMPLETED|Baseline||0
6750696|NCT03433794|7677757|FG001|NOT COMPLETED|Baseline||0
6750697|NCT03433794|7677758|FG002|NOT COMPLETED|Baseline||0
6497802|NCT01408147|7416695|FG001|STARTED|Overall Study|197 participants|197
6497803|NCT01408147|7416694|FG000|COMPLETED|Overall Study|1 clinic withdrew due to low census|174
6497804|NCT01408147|7416695|FG001|COMPLETED|Overall Study||196
6497805|NCT01408147|7416694|FG000|NOT COMPLETED|Overall Study||0
6497806|NCT01408147|7416695|FG001|NOT COMPLETED|Overall Study||1
6497807|NCT01408277|7416703|FG000|STARTED|Overall Study||28
6497808|NCT01408277|7416704|FG001|STARTED|Overall Study||27
6497809|NCT01408277|7416703|FG000|COMPLETED|Overall Study||20
6497810|NCT01408277|7416704|FG001|COMPLETED|Overall Study||23
6497811|NCT01408277|7416703|FG000|NOT COMPLETED|Overall Study||8
6497812|NCT01408277|7416704|FG001|NOT COMPLETED|Overall Study||4
6497813|NCT01408303|7416713|FG000|STARTED|Overall Study||215
6497814|NCT01408303|7416714|FG001|STARTED|Overall Study||216
6497815|NCT01408303|7416715|FG002|STARTED|Overall Study||216
6497816|NCT01408303|7416713|FG000|COMPLETED|Overall Study||209
6497817|NCT01408303|7416714|FG001|COMPLETED|Overall Study||204
6497818|NCT01408303|7416715|FG002|COMPLETED|Overall Study||210
6497819|NCT01408303|7416713|FG000|NOT COMPLETED|Overall Study||6
6497820|NCT01408303|7416714|FG001|NOT COMPLETED|Overall Study||12
6497821|NCT01408303|7416715|FG002|NOT COMPLETED|Overall Study||6
6497822|NCT01408329|7416725|FG000|STARTED|Overall Study||13
6497823|NCT01408329|7416726|FG001|STARTED|Overall Study||15
6497824|NCT01408329|7416725|FG000|COMPLETED|Overall Study||10
6497825|NCT01408329|7416726|FG001|COMPLETED|Overall Study||11
6497826|NCT01408329|7416725|FG000|NOT COMPLETED|Overall Study||3
6497827|NCT01408329|7416726|FG001|NOT COMPLETED|Overall Study||4
6497828|NCT01408459|7416734|FG000|STARTED|Overall Study||22
6497829|NCT01408459|7416735|FG001|STARTED|Overall Study||15
6497830|NCT01408459|7416734|FG000|COMPLETED|Overall Study||21
6497831|NCT01408459|7416735|FG001|COMPLETED|Overall Study||14
6497832|NCT01408459|7416734|FG000|NOT COMPLETED|Overall Study||1
6497833|NCT01408459|7416735|FG001|NOT COMPLETED|Overall Study||1
6497834|NCT01408485|7416742|FG000|STARTED|Overall Study||200
6497835|NCT01408485|7416742|FG000|COMPLETED|Overall Study||179
6497836|NCT01408485|7416742|FG000|NOT COMPLETED|Overall Study||21
6497837|NCT01408537|7416746|FG000|STARTED|Overall Study||152
6497838|NCT01408537|7416746|FG000|COMPLETED|Overall Study||144
6497839|NCT01408537|7416746|FG000|NOT COMPLETED|Overall Study||8
6497840|NCT01408563|7416761|FG000|STARTED|Overall Study||33
6497841|NCT01408563|7416761|FG000|Received Transplant|Overall Study||31
6497842|NCT01408563|7416761|FG000|COMPLETED|Overall Study||31
6497843|NCT01408563|7416761|FG000|NOT COMPLETED|Overall Study||2
6497844|NCT01408576|7416768|FG000|STARTED|Overall Study||244
6497845|NCT01408576|7416769|FG001|STARTED|Overall Study||498
6497846|NCT01408576|7416770|FG002|STARTED|Overall Study||508
6497847|NCT01408576|7416768|FG000|COMPLETED|Overall Study||56
6497848|NCT01408576|7416769|FG001|COMPLETED|Overall Study||0
6497849|NCT01408576|7416770|FG002|COMPLETED|Overall Study||0
6497850|NCT01408576|7416768|FG000|NOT COMPLETED|Overall Study||188
6497851|NCT01408576|7416769|FG001|NOT COMPLETED|Overall Study||498
6497852|NCT01408576|7416770|FG002|NOT COMPLETED|Overall Study||508
6497853|NCT01408628|7416790|FG000|STARTED|Consented||51
6497854|NCT01408628|7416790|FG000|COMPLETED|Consented||39
6497855|NCT01408628|7416790|FG000|NOT COMPLETED|Consented||12
6497856|NCT01408628|7416790|FG000|STARTED|Started Classes/Intervention||39
6497857|NCT01408628|7416790|FG000|COMPLETED|Started Classes/Intervention||39
6497858|NCT01408628|7416790|FG000|NOT COMPLETED|Started Classes/Intervention||0
6497859|NCT01408628|7416790|FG000|STARTED|Completed 6 Month Follow-Up||39
6497860|NCT01408628|7416790|FG000|COMPLETED|Completed 6 Month Follow-Up||25
6497861|NCT01408628|7416790|FG000|NOT COMPLETED|Completed 6 Month Follow-Up||14
6497862|NCT01408706|7416797|FG000|STARTED|Overall Study||30
6497863|NCT01408706|7416798|FG001|STARTED|Overall Study||30
6497864|NCT01408706|7416797|FG000|COMPLETED|Overall Study||29
6497865|NCT01408706|7416798|FG001|COMPLETED|Overall Study||30
6497866|NCT01408706|7416797|FG000|NOT COMPLETED|Overall Study||1
6497867|NCT01408706|7416798|FG001|NOT COMPLETED|Overall Study||0
6750698|NCT03433794|7677756|FG000|STARTED|2-Week Assessment||183
6750699|NCT03433794|7677757|FG001|STARTED|2-Week Assessment||173
6750700|NCT03433794|7677758|FG002|STARTED|2-Week Assessment||181
6750701|NCT03433794|7677756|FG000|COMPLETED|2-Week Assessment||117
6750702|NCT03433794|7677757|FG001|COMPLETED|2-Week Assessment||112
6750703|NCT03433794|7677758|FG002|COMPLETED|2-Week Assessment||109
6750704|NCT03433794|7677756|FG000|NOT COMPLETED|2-Week Assessment||66
6750705|NCT03433794|7677757|FG001|NOT COMPLETED|2-Week Assessment||61
6750706|NCT03433794|7677758|FG002|NOT COMPLETED|2-Week Assessment||72
6750707|NCT03433794|7677756|FG000|STARTED|4-Week Assessment||183
6750708|NCT03433794|7677757|FG001|STARTED|4-Week Assessment||173
6750709|NCT03433794|7677758|FG002|STARTED|4-Week Assessment||181
6750710|NCT03433794|7677756|FG000|COMPLETED|4-Week Assessment||98
6497868|NCT01408719|7416826|FG000|STARTED|First Intervention (35 Days)||2
6750711|NCT03433794|7677757|FG001|COMPLETED|4-Week Assessment||95
6750712|NCT03433794|7677758|FG002|COMPLETED|4-Week Assessment||91
6750713|NCT03433794|7677756|FG000|NOT COMPLETED|4-Week Assessment||85
6750714|NCT03433794|7677757|FG001|NOT COMPLETED|4-Week Assessment||78
6750715|NCT03433794|7677758|FG002|NOT COMPLETED|4-Week Assessment||90
6750716|NCT03433794|7677756|FG000|STARTED|6-Week Assessment||183
6497869|NCT01408719|7416827|FG001|STARTED|First Intervention (35 Days)||3
6497870|NCT01408719|7416828|FG002|STARTED|First Intervention (35 Days)||2
6497871|NCT01408719|7416829|FG003|STARTED|First Intervention (35 Days)||2
6497872|NCT01408719|7416830|FG004|STARTED|First Intervention (35 Days)||4
6750717|NCT03433794|7677757|FG001|STARTED|6-Week Assessment||173
6497873|NCT01408719|7416831|FG005|STARTED|First Intervention (35 Days)||3
6497874|NCT01408719|7416832|FG006|STARTED|First Intervention (35 Days)||2
6497875|NCT01408719|7416833|FG007|STARTED|First Intervention (35 Days)||3
6497876|NCT01408719|7416834|FG008|STARTED|First Intervention (35 Days)||2
6497877|NCT01408719|7416835|FG009|STARTED|First Intervention (35 Days)||1
6497878|NCT01408719|7416836|FG010|STARTED|First Intervention (35 Days)||2
6497879|NCT01408719|7416837|FG011|STARTED|First Intervention (35 Days)||2
6497880|NCT01408719|7416838|FG012|STARTED|First Intervention (35 Days)||2
6497881|NCT01408719|7416839|FG013|STARTED|First Intervention (35 Days)||5
6497882|NCT01408719|7416840|FG014|STARTED|First Intervention (35 Days)||1
6497883|NCT01408719|7416841|FG015|STARTED|First Intervention (35 Days)||2
6497884|NCT01408719|7416842|FG016|STARTED|First Intervention (35 Days)||3
6497885|NCT01408719|7416843|FG017|STARTED|First Intervention (35 Days)||2
6497886|NCT01408719|7416844|FG018|STARTED|First Intervention (35 Days)||1
6497887|NCT01408719|7416845|FG019|STARTED|First Intervention (35 Days)||1
6497888|NCT01408719|7416826|FG000|COMPLETED|First Intervention (35 Days)||2
6497889|NCT01408719|7416827|FG001|COMPLETED|First Intervention (35 Days)||3
6497890|NCT01408719|7416828|FG002|COMPLETED|First Intervention (35 Days)||1
6497891|NCT01408719|7416829|FG003|COMPLETED|First Intervention (35 Days)||2
6497892|NCT01408719|7416830|FG004|COMPLETED|First Intervention (35 Days)||3
6497893|NCT01408719|7416831|FG005|COMPLETED|First Intervention (35 Days)||3
6497894|NCT01408719|7416832|FG006|COMPLETED|First Intervention (35 Days)||2
6497895|NCT01408719|7416833|FG007|COMPLETED|First Intervention (35 Days)||3
6497896|NCT01408719|7416834|FG008|COMPLETED|First Intervention (35 Days)||1
6497897|NCT01408719|7416835|FG009|COMPLETED|First Intervention (35 Days)||1
6497898|NCT01408719|7416836|FG010|COMPLETED|First Intervention (35 Days)||2
6497899|NCT01408719|7416837|FG011|COMPLETED|First Intervention (35 Days)||2
6497900|NCT01408719|7416838|FG012|COMPLETED|First Intervention (35 Days)||2
6497901|NCT01408719|7416839|FG013|COMPLETED|First Intervention (35 Days)||4
6497902|NCT01408719|7416840|FG014|COMPLETED|First Intervention (35 Days)||1
6497903|NCT01408719|7416841|FG015|COMPLETED|First Intervention (35 Days)||2
6497904|NCT01408719|7416842|FG016|COMPLETED|First Intervention (35 Days)||2
6497905|NCT01408719|7416843|FG017|COMPLETED|First Intervention (35 Days)||2
6497906|NCT01408719|7416844|FG018|COMPLETED|First Intervention (35 Days)||0
6497907|NCT01408719|7416845|FG019|COMPLETED|First Intervention (35 Days)||1
6497908|NCT01408719|7416826|FG000|NOT COMPLETED|First Intervention (35 Days)||0
6497909|NCT01408719|7416827|FG001|NOT COMPLETED|First Intervention (35 Days)||0
6497910|NCT01408719|7416828|FG002|NOT COMPLETED|First Intervention (35 Days)||1
6497911|NCT01408719|7416829|FG003|NOT COMPLETED|First Intervention (35 Days)||0
6497912|NCT01408719|7416830|FG004|NOT COMPLETED|First Intervention (35 Days)||1
6497913|NCT01408719|7416831|FG005|NOT COMPLETED|First Intervention (35 Days)||0
6497914|NCT01408719|7416832|FG006|NOT COMPLETED|First Intervention (35 Days)||0
6497915|NCT01408719|7416833|FG007|NOT COMPLETED|First Intervention (35 Days)||0
6497916|NCT01408719|7416834|FG008|NOT COMPLETED|First Intervention (35 Days)||1
6497917|NCT01408719|7416835|FG009|NOT COMPLETED|First Intervention (35 Days)||0
6497918|NCT01408719|7416836|FG010|NOT COMPLETED|First Intervention (35 Days)||0
6497919|NCT01408719|7416837|FG011|NOT COMPLETED|First Intervention (35 Days)||0
6497920|NCT01408719|7416838|FG012|NOT COMPLETED|First Intervention (35 Days)||0
6555460|NCT01752413|7477638|FG000|COMPLETED|Overall Study||58
6555461|NCT01752413|7477639|FG001|COMPLETED|Overall Study||6
6555462|NCT01752413|7477638|FG000|NOT COMPLETED|Overall Study||112
6555463|NCT01752413|7477639|FG001|NOT COMPLETED|Overall Study||21
6555464|NCT01752426|7477645|FG000|STARTED|Overall Study||30
6555465|NCT01752426|7477645|FG000|COMPLETED|Overall Study||30
6555466|NCT01752426|7477645|FG000|NOT COMPLETED|Overall Study||0
6555467|NCT01752634|7477655|FG000|STARTED|Up to Week 24 (Primary Analysis)||99
6750718|NCT03433794|7677758|FG002|STARTED|6-Week Assessment||181
6750719|NCT03433794|7677756|FG000|COMPLETED|6-Week Assessment||94
6750720|NCT03433794|7677757|FG001|COMPLETED|6-Week Assessment||85
6750721|NCT03433794|7677758|FG002|COMPLETED|6-Week Assessment||80
6750722|NCT03433794|7677756|FG000|NOT COMPLETED|6-Week Assessment||89
6750723|NCT03433794|7677757|FG001|NOT COMPLETED|6-Week Assessment||88
6750724|NCT03433794|7677758|FG002|NOT COMPLETED|6-Week Assessment||101
6750725|NCT03433794|7677756|FG000|STARTED|3-Month Assessment||183
6750726|NCT03433794|7677757|FG001|STARTED|3-Month Assessment||173
6750727|NCT03433794|7677758|FG002|STARTED|3-Month Assessment||181
6750728|NCT03433794|7677756|FG000|COMPLETED|3-Month Assessment||69
6750729|NCT03433794|7677757|FG001|COMPLETED|3-Month Assessment||73
6750730|NCT03433794|7677758|FG002|COMPLETED|3-Month Assessment||71
6750731|NCT03433794|7677756|FG000|NOT COMPLETED|3-Month Assessment||114
6750732|NCT03433794|7677757|FG001|NOT COMPLETED|3-Month Assessment||100
6750733|NCT03433794|7677758|FG002|NOT COMPLETED|3-Month Assessment||110
6750734|NCT03433794|7677756|FG000|STARTED|6-Month Assessment||183
6750735|NCT03433794|7677757|FG001|STARTED|6-Month Assessment||173
6750736|NCT03433794|7677758|FG002|STARTED|6-Month Assessment||181
6750737|NCT03433794|7677756|FG000|COMPLETED|6-Month Assessment||65
6750738|NCT03433794|7677757|FG001|COMPLETED|6-Month Assessment||58
6750739|NCT03433794|7677758|FG002|COMPLETED|6-Month Assessment||50
6750740|NCT03433794|7677756|FG000|NOT COMPLETED|6-Month Assessment||118
6750741|NCT03433794|7677757|FG001|NOT COMPLETED|6-Month Assessment||115
6750742|NCT03433794|7677758|FG002|NOT COMPLETED|6-Month Assessment||131
6750743|NCT03433794|7677756|FG000|STARTED|9-Month Assessment||183
6497921|NCT01408719|7416839|FG013|NOT COMPLETED|First Intervention (35 Days)||1
6497922|NCT01408719|7416840|FG014|NOT COMPLETED|First Intervention (35 Days)||0
6497923|NCT01408719|7416841|FG015|NOT COMPLETED|First Intervention (35 Days)||0
6497924|NCT01408719|7416842|FG016|NOT COMPLETED|First Intervention (35 Days)||1
6497925|NCT01408719|7416843|FG017|NOT COMPLETED|First Intervention (35 Days)||0
6497926|NCT01408719|7416844|FG018|NOT COMPLETED|First Intervention (35 Days)||1
6497927|NCT01408719|7416845|FG019|NOT COMPLETED|First Intervention (35 Days)||0
6497928|NCT01408719|7416826|FG000|STARTED|Washout Period (28 Days)||2
6497929|NCT01408719|7416827|FG001|STARTED|Washout Period (28 Days)||3
6497930|NCT01408719|7416828|FG002|STARTED|Washout Period (28 Days)||1
6497931|NCT01408719|7416829|FG003|STARTED|Washout Period (28 Days)||2
6497932|NCT01408719|7416830|FG004|STARTED|Washout Period (28 Days)||3
6497933|NCT01408719|7416831|FG005|STARTED|Washout Period (28 Days)||3
6497934|NCT01408719|7416832|FG006|STARTED|Washout Period (28 Days)||2
6497935|NCT01408719|7416833|FG007|STARTED|Washout Period (28 Days)||3
6497936|NCT01408719|7416834|FG008|STARTED|Washout Period (28 Days)||1
6497937|NCT01408719|7416835|FG009|STARTED|Washout Period (28 Days)||1
6497938|NCT01408719|7416836|FG010|STARTED|Washout Period (28 Days)||2
6497939|NCT01408719|7416837|FG011|STARTED|Washout Period (28 Days)||2
6497940|NCT01408719|7416838|FG012|STARTED|Washout Period (28 Days)||2
6497941|NCT01408719|7416839|FG013|STARTED|Washout Period (28 Days)||4
6497942|NCT01408719|7416840|FG014|STARTED|Washout Period (28 Days)||1
6497943|NCT01408719|7416841|FG015|STARTED|Washout Period (28 Days)||2
6497944|NCT01408719|7416842|FG016|STARTED|Washout Period (28 Days)||2
6497945|NCT01408719|7416843|FG017|STARTED|Washout Period (28 Days)||2
6497946|NCT01408719|7416844|FG018|STARTED|Washout Period (28 Days)||0
6497947|NCT01408719|7416845|FG019|STARTED|Washout Period (28 Days)||1
6497948|NCT01408719|7416826|FG000|COMPLETED|Washout Period (28 Days)||2
6497949|NCT01408719|7416827|FG001|COMPLETED|Washout Period (28 Days)||3
6497950|NCT01408719|7416828|FG002|COMPLETED|Washout Period (28 Days)||1
6497951|NCT01408719|7416829|FG003|COMPLETED|Washout Period (28 Days)||2
6750744|NCT03433794|7677757|FG001|STARTED|9-Month Assessment||173
6750745|NCT03433794|7677758|FG002|STARTED|9-Month Assessment||181
6750746|NCT03433794|7677756|FG000|COMPLETED|9-Month Assessment||49
6750747|NCT03433794|7677757|FG001|COMPLETED|9-Month Assessment||52
6750748|NCT03433794|7677758|FG002|COMPLETED|9-Month Assessment||39
6750749|NCT03433794|7677756|FG000|NOT COMPLETED|9-Month Assessment||134
6750750|NCT03433794|7677757|FG001|NOT COMPLETED|9-Month Assessment||121
6750751|NCT03433794|7677758|FG002|NOT COMPLETED|9-Month Assessment||142
6750752|NCT03434249|7677768|FG000|STARTED|Overall Study||40
6750753|NCT03434249|7677769|FG001|STARTED|Overall Study||40
6750754|NCT03434249|7677768|FG000|COMPLETED|Overall Study||35
6750755|NCT03434249|7677769|FG001|COMPLETED|Overall Study||37
6750756|NCT03434249|7677768|FG000|NOT COMPLETED|Overall Study||5
6750757|NCT03434249|7677769|FG001|NOT COMPLETED|Overall Study||3
6750758|NCT03434457|7677775|FG000|STARTED|Overall Study||630
6750759|NCT03434457|7677775|FG000|COMPLETED|Overall Study||630
6750760|NCT03434457|7677775|FG000|NOT COMPLETED|Overall Study||0
6750761|NCT03434834|7677779|FG000|STARTED|Overall Study||53
6750762|NCT03434834|7677779|FG000|COMPLETED|Overall Study||37
6750763|NCT03434834|7677779|FG000|NOT COMPLETED|Overall Study||16
6750764|NCT03434977|7677785|FG000|STARTED|Intervention Period 1 (6 Days)||6
6750765|NCT03434977|7677786|FG001|STARTED|Intervention Period 1 (6 Days)||6
6750766|NCT03434977|7677785|FG000|COMPLETED|Intervention Period 1 (6 Days)||6
6750767|NCT03434977|7677786|FG001|COMPLETED|Intervention Period 1 (6 Days)||6
6750768|NCT03434977|7677785|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6750769|NCT03434977|7677786|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6750770|NCT03434977|7677785|FG000|STARTED|Washout Period (at Least 6 Days)||6
6750771|NCT03434977|7677786|FG001|STARTED|Washout Period (at Least 6 Days)||6
6750772|NCT03434977|7677785|FG000|COMPLETED|Washout Period (at Least 6 Days)||6
6750773|NCT03434977|7677786|FG001|COMPLETED|Washout Period (at Least 6 Days)||5
6750774|NCT03434977|7677785|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
6750775|NCT03434977|7677786|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
6750776|NCT03434977|7677785|FG000|STARTED|Intervention Period 2 (6 Days)||6
6750777|NCT03434977|7677786|FG001|STARTED|Intervention Period 2 (6 Days)||5
6750778|NCT03434977|7677785|FG000|COMPLETED|Intervention Period 2 (6 Days)||6
6750779|NCT03434977|7677786|FG001|COMPLETED|Intervention Period 2 (6 Days)||5
6750780|NCT03434977|7677785|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6750781|NCT03434977|7677786|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6750782|NCT03435055|7677792|FG000|STARTED|Screening||21
6750783|NCT03435055|7677792|FG000|COMPLETED|Screening||19
6750784|NCT03435055|7677792|FG000|NOT COMPLETED|Screening||2
6750785|NCT03435055|7677792|FG000|STARTED|Received Intervention||19
6750786|NCT03435055|7677792|FG000|COMPLETED|Received Intervention||16
6750787|NCT03435055|7677792|FG000|NOT COMPLETED|Received Intervention||3
6750788|NCT03435081|7677806|FG000|STARTED|Overall Study||147
6750789|NCT03435081|7677807|FG001|STARTED|Overall Study||147
6750790|NCT03435081|7677808|FG002|STARTED|Overall Study||146
6779926|NCT03534362|7708192|FG001|NOT COMPLETED|Overall Study||0
6497952|NCT01408719|7416830|FG004|COMPLETED|Washout Period (28 Days)||3
6497953|NCT01408719|7416831|FG005|COMPLETED|Washout Period (28 Days)||3
6497954|NCT01408719|7416832|FG006|COMPLETED|Washout Period (28 Days)||2
6497955|NCT01408719|7416833|FG007|COMPLETED|Washout Period (28 Days)||3
6497956|NCT01408719|7416834|FG008|COMPLETED|Washout Period (28 Days)||1
6497957|NCT01408719|7416835|FG009|COMPLETED|Washout Period (28 Days)||1
6497958|NCT01408719|7416836|FG010|COMPLETED|Washout Period (28 Days)||2
6497959|NCT01408719|7416837|FG011|COMPLETED|Washout Period (28 Days)||2
6497960|NCT01408719|7416838|FG012|COMPLETED|Washout Period (28 Days)||2
6497961|NCT01408719|7416839|FG013|COMPLETED|Washout Period (28 Days)||4
6497962|NCT01408719|7416840|FG014|COMPLETED|Washout Period (28 Days)||1
6497963|NCT01408719|7416841|FG015|COMPLETED|Washout Period (28 Days)||2
6497964|NCT01408719|7416842|FG016|COMPLETED|Washout Period (28 Days)||2
6497965|NCT01408719|7416843|FG017|COMPLETED|Washout Period (28 Days)||2
6497966|NCT01408719|7416844|FG018|COMPLETED|Washout Period (28 Days)||0
6497967|NCT01408719|7416845|FG019|COMPLETED|Washout Period (28 Days)||1
6497968|NCT01408719|7416826|FG000|NOT COMPLETED|Washout Period (28 Days)||0
6497969|NCT01408719|7416827|FG001|NOT COMPLETED|Washout Period (28 Days)||0
6497970|NCT01408719|7416828|FG002|NOT COMPLETED|Washout Period (28 Days)||0
6497971|NCT01408719|7416829|FG003|NOT COMPLETED|Washout Period (28 Days)||0
6497972|NCT01408719|7416830|FG004|NOT COMPLETED|Washout Period (28 Days)||0
6497973|NCT01408719|7416831|FG005|NOT COMPLETED|Washout Period (28 Days)||0
6497974|NCT01408719|7416832|FG006|NOT COMPLETED|Washout Period (28 Days)||0
6497975|NCT01408719|7416833|FG007|NOT COMPLETED|Washout Period (28 Days)||0
6497976|NCT01408719|7416834|FG008|NOT COMPLETED|Washout Period (28 Days)||0
6497977|NCT01408719|7416835|FG009|NOT COMPLETED|Washout Period (28 Days)||0
6497978|NCT01408719|7416836|FG010|NOT COMPLETED|Washout Period (28 Days)||0
6497979|NCT01408719|7416837|FG011|NOT COMPLETED|Washout Period (28 Days)||0
6497980|NCT01408719|7416838|FG012|NOT COMPLETED|Washout Period (28 Days)||0
6497981|NCT01408719|7416839|FG013|NOT COMPLETED|Washout Period (28 Days)||0
6497982|NCT01408719|7416840|FG014|NOT COMPLETED|Washout Period (28 Days)||0
6497983|NCT01408719|7416841|FG015|NOT COMPLETED|Washout Period (28 Days)||0
6750791|NCT03435081|7677806|FG000|Received at Least One Dose of Study Drug|Overall Study||147
6750792|NCT03435081|7677807|FG001|Received at Least One Dose of Study Drug|Overall Study||147
6750793|NCT03435081|7677808|FG002|Received at Least One Dose of Study Drug|Overall Study||146
6750794|NCT03435081|7677806|FG000|COMPLETED|Overall Study||126
6750795|NCT03435081|7677807|FG001|COMPLETED|Overall Study||131
6750796|NCT03435081|7677808|FG002|COMPLETED|Overall Study||127
6750797|NCT03435081|7677806|FG000|NOT COMPLETED|Overall Study||21
6750798|NCT03435081|7677807|FG001|NOT COMPLETED|Overall Study||16
6750799|NCT03435081|7677808|FG002|NOT COMPLETED|Overall Study||19
6750800|NCT03435211|7677817|FG000|STARTED|Overall Study||26
6750801|NCT03435211|7677817|FG000|COMPLETED|Overall Study||25
6750802|NCT03435211|7677817|FG000|NOT COMPLETED|Overall Study||1
6750803|NCT03435224|7677821|FG000|STARTED|Overall Study||29
6750804|NCT03435224|7677821|FG000|COMPLETED|Overall Study||25
6750805|NCT03435224|7677821|FG000|NOT COMPLETED|Overall Study||4
6750806|NCT03435497|7677827|FG000|STARTED|Overall Study||51
6750807|NCT03435497|7677828|FG001|STARTED|Overall Study||47
6750808|NCT03435497|7677827|FG000|COMPLETED|Overall Study||49
6750809|NCT03435497|7677828|FG001|COMPLETED|Overall Study||41
6750810|NCT03435497|7677827|FG000|NOT COMPLETED|Overall Study||2
6750811|NCT03435497|7677828|FG001|NOT COMPLETED|Overall Study||6
6750812|NCT03435562|7677834|FG000|STARTED|Overall Study||22
6750813|NCT03435562|7677834|FG000|COMPLETED|Overall Study||18
6750814|NCT03435562|7677834|FG000|NOT COMPLETED|Overall Study||4
6750815|NCT03435614|7677847|FG000|STARTED|Overall Study||6
6750816|NCT03435614|7677848|FG001|STARTED|Overall Study||23
6750817|NCT03435614|7677847|FG000|COMPLETED|Overall Study||6
6750818|NCT03435614|7677848|FG001|COMPLETED|Overall Study||23
6750819|NCT03435614|7677847|FG000|NOT COMPLETED|Overall Study||0
6750820|NCT03435614|7677848|FG001|NOT COMPLETED|Overall Study||0
6750821|NCT03435692|7677858|FG000|STARTED|Overall Study||17
6750822|NCT03435692|7677859|FG001|STARTED|Overall Study||18
6750823|NCT03435692|7677860|FG002|STARTED|Overall Study||7
6750824|NCT03435692|7677858|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 0, Lumbar Epidural Catheter (LEC) removed and morphine infusion started - patient 1 year old. 2) Lumbar Epidural Catheter (LEC) not working Post-Operative Day (POD) 1, Lumbar Epidural Catheter (LEC) removed and Patient Controlled Analgesia (PCA) started.|15
6750825|NCT03435692|7677859|FG001|COMPLETED|Overall Study|Discontinued intervention (n=2). 1) Successful lumbar plexus injection, but unable to thread catheter, morphine infusion started (patient 1 year old). 2) Lumbar Plexus Catheter (LPC) catheter (10 cm) not long enough to reach lumbar plexus in patient weighing 136kg, Lumbar Epidural Catheter (LEC) placed instead.|16
6750826|NCT03435692|7677860|FG002|COMPLETED|Overall Study||7
6750827|NCT03435692|7677858|FG000|NOT COMPLETED|Overall Study||2
6750828|NCT03435692|7677859|FG001|NOT COMPLETED|Overall Study||2
6750829|NCT03435692|7677860|FG002|NOT COMPLETED|Overall Study||0
6750830|NCT03435783|7677874|FG000|STARTED|Overall Study||20
6750831|NCT03435783|7677875|FG001|STARTED|Overall Study||20
6750832|NCT03435783|7677874|FG000|COMPLETED|Overall Study||20
6750833|NCT03435783|7677875|FG001|COMPLETED|Overall Study||19
6750834|NCT03435783|7677874|FG000|NOT COMPLETED|Overall Study||0
6750835|NCT03435783|7677875|FG001|NOT COMPLETED|Overall Study||1
6750836|NCT03436082|7677883|FG000|STARTED|Overall Study||30
6750837|NCT03436082|7677884|FG001|STARTED|Overall Study||30
6750838|NCT03436082|7677883|FG000|COMPLETED|Overall Study|Had procedure|29
6497984|NCT01408719|7416842|FG016|NOT COMPLETED|Washout Period (28 Days)||0
6497985|NCT01408719|7416843|FG017|NOT COMPLETED|Washout Period (28 Days)||0
6497986|NCT01408719|7416844|FG018|NOT COMPLETED|Washout Period (28 Days)||0
6497987|NCT01408719|7416845|FG019|NOT COMPLETED|Washout Period (28 Days)||0
6497988|NCT01408719|7416826|FG000|STARTED|Second Intervention (35 Days)||2
6497989|NCT01408719|7416827|FG001|STARTED|Second Intervention (35 Days)||3
6497990|NCT01408719|7416828|FG002|STARTED|Second Intervention (35 Days)||1
6497991|NCT01408719|7416829|FG003|STARTED|Second Intervention (35 Days)||2
6497992|NCT01408719|7416830|FG004|STARTED|Second Intervention (35 Days)||3
6497993|NCT01408719|7416831|FG005|STARTED|Second Intervention (35 Days)||3
6497994|NCT01408719|7416832|FG006|STARTED|Second Intervention (35 Days)||2
6497995|NCT01408719|7416833|FG007|STARTED|Second Intervention (35 Days)||3
6497996|NCT01408719|7416834|FG008|STARTED|Second Intervention (35 Days)||1
6497997|NCT01408719|7416835|FG009|STARTED|Second Intervention (35 Days)||1
6497998|NCT01408719|7416836|FG010|STARTED|Second Intervention (35 Days)||2
6497999|NCT01408719|7416837|FG011|STARTED|Second Intervention (35 Days)||2
6498000|NCT01408719|7416838|FG012|STARTED|Second Intervention (35 Days)||2
6498001|NCT01408719|7416839|FG013|STARTED|Second Intervention (35 Days)||4
6498002|NCT01408719|7416840|FG014|STARTED|Second Intervention (35 Days)||1
6498003|NCT01408719|7416841|FG015|STARTED|Second Intervention (35 Days)||2
6498004|NCT01408719|7416842|FG016|STARTED|Second Intervention (35 Days)||2
6498005|NCT01408719|7416843|FG017|STARTED|Second Intervention (35 Days)||2
6498006|NCT01408719|7416844|FG018|STARTED|Second Intervention (35 Days)||0
6555468|NCT01752634|7477656|FG001|STARTED|Up to Week 24 (Primary Analysis)||100
6555469|NCT01752634|7477657|FG002|STARTED|Up to Week 24 (Primary Analysis)||100
6555470|NCT01752634|7477658|FG003|STARTED|Up to Week 24 (Primary Analysis)||43
6555471|NCT01752634|7477659|FG004|STARTED|Up to Week 24 (Primary Analysis)||45
6555472|NCT01752634|7477660|FG005|STARTED|Up to Week 24 (Primary Analysis)||10
6555473|NCT01752634|7477655|FG000|COMPLETED|Up to Week 24 (Primary Analysis)||93
6750839|NCT03436082|7677884|FG001|COMPLETED|Overall Study|Had procedure|30
6750840|NCT03436082|7677883|FG000|NOT COMPLETED|Overall Study||1
6750841|NCT03436082|7677884|FG001|NOT COMPLETED|Overall Study||0
6750842|NCT03436147|7677892|FG000|STARTED|Overall Study||19
6750843|NCT03436147|7677893|FG001|STARTED|Overall Study||30
6750844|NCT03436147|7677892|FG000|COMPLETED|Overall Study||15
6750845|NCT03436147|7677893|FG001|COMPLETED|Overall Study||19
6750846|NCT03436147|7677892|FG000|NOT COMPLETED|Overall Study||4
6750847|NCT03436147|7677893|FG001|NOT COMPLETED|Overall Study||11
6750848|NCT03436420|7677901|FG000|STARTED|Overall Study||6
6750849|NCT03436420|7677901|FG000|COMPLETED|Overall Study||3
6750850|NCT03436420|7677901|FG000|NOT COMPLETED|Overall Study||3
6750851|NCT03436732|7677907|FG000|STARTED|Overall Study||4
6750852|NCT03436732|7677908|FG001|STARTED|Overall Study||1
6750853|NCT03436732|7677907|FG000|COMPLETED|Overall Study||0
6750854|NCT03436732|7677908|FG001|COMPLETED|Overall Study||0
6750855|NCT03436732|7677907|FG000|NOT COMPLETED|Overall Study||4
6750856|NCT03436732|7677908|FG001|NOT COMPLETED|Overall Study||1
6750857|NCT03436810|7677917|FG000|STARTED|Overall Study||20
6750858|NCT03436810|7677918|FG001|STARTED|Overall Study||20
6750859|NCT03436810|7677917|FG000|COMPLETED|Overall Study||20
6750860|NCT03436810|7677918|FG001|COMPLETED|Overall Study||20
6750861|NCT03436810|7677917|FG000|NOT COMPLETED|Overall Study||0
6750862|NCT03436810|7677918|FG001|NOT COMPLETED|Overall Study||0
6750863|NCT03437031|7677926|FG000|STARTED|Overall Study||19
6750864|NCT03437031|7677927|FG001|STARTED|Overall Study||21
6750865|NCT03437031|7677926|FG000|COMPLETED|Overall Study||19
6750866|NCT03437031|7677927|FG001|COMPLETED|Overall Study||21
6750867|NCT03437031|7677926|FG000|NOT COMPLETED|Overall Study||0
6750868|NCT03437031|7677927|FG001|NOT COMPLETED|Overall Study||0
6750869|NCT03437044|7677937|FG000|STARTED|Overall Study||20
6750870|NCT03437044|7677938|FG001|STARTED|Overall Study||20
6750871|NCT03437044|7677937|FG000|COMPLETED|Overall Study||17
6750872|NCT03437044|7677938|FG001|COMPLETED|Overall Study||18
6750873|NCT03437044|7677937|FG000|NOT COMPLETED|Overall Study||3
6750874|NCT03437044|7677938|FG001|NOT COMPLETED|Overall Study||2
6750875|NCT03437265|7677944|FG000|STARTED|Overall Study||19
6750876|NCT03437265|7677944|FG000|COMPLETED|Overall Study||13
6750877|NCT03437265|7677944|FG000|NOT COMPLETED|Overall Study||6
6498007|NCT01408719|7416845|FG019|STARTED|Second Intervention (35 Days)||1
6498008|NCT01408719|7416826|FG000|COMPLETED|Second Intervention (35 Days)||2
6750887|NCT03437447|7677966|FG000|STARTED|Treatment Period 1||20
6750888|NCT03437447|7677967|FG001|STARTED|Treatment Period 1||20
6750889|NCT03437447|7677968|FG002|STARTED|Treatment Period 1||20
6750890|NCT03437447|7677966|FG000|COMPLETED|Treatment Period 1||20
6750891|NCT03437447|7677967|FG001|COMPLETED|Treatment Period 1||20
6750892|NCT03437447|7677968|FG002|COMPLETED|Treatment Period 1||19
6750893|NCT03437447|7677966|FG000|NOT COMPLETED|Treatment Period 1||0
6750894|NCT03437447|7677967|FG001|NOT COMPLETED|Treatment Period 1||0
6750895|NCT03437447|7677968|FG002|NOT COMPLETED|Treatment Period 1||1
6750896|NCT03437447|7677966|FG000|STARTED|Treatment Period 2||20
6750897|NCT03437447|7677967|FG001|STARTED|Treatment Period 2||20
6750898|NCT03437447|7677968|FG002|STARTED|Treatment Period 2||19
6750899|NCT03437447|7677966|FG000|COMPLETED|Treatment Period 2||20
6750900|NCT03437447|7677967|FG001|COMPLETED|Treatment Period 2||20
6498009|NCT01408719|7416827|FG001|COMPLETED|Second Intervention (35 Days)||3
6498010|NCT01408719|7416828|FG002|COMPLETED|Second Intervention (35 Days)||1
6498011|NCT01408719|7416829|FG003|COMPLETED|Second Intervention (35 Days)||2
6498012|NCT01408719|7416830|FG004|COMPLETED|Second Intervention (35 Days)||3
6498013|NCT01408719|7416831|FG005|COMPLETED|Second Intervention (35 Days)||3
6498014|NCT01408719|7416832|FG006|COMPLETED|Second Intervention (35 Days)||2
6498015|NCT01408719|7416833|FG007|COMPLETED|Second Intervention (35 Days)||3
6498016|NCT01408719|7416834|FG008|COMPLETED|Second Intervention (35 Days)||1
6498017|NCT01408719|7416835|FG009|COMPLETED|Second Intervention (35 Days)||1
6498018|NCT01408719|7416836|FG010|COMPLETED|Second Intervention (35 Days)||2
6498019|NCT01408719|7416837|FG011|COMPLETED|Second Intervention (35 Days)||2
6498020|NCT01408719|7416838|FG012|COMPLETED|Second Intervention (35 Days)||2
6498021|NCT01408719|7416839|FG013|COMPLETED|Second Intervention (35 Days)||3
6498022|NCT01408719|7416840|FG014|COMPLETED|Second Intervention (35 Days)||1
6498023|NCT01408719|7416841|FG015|COMPLETED|Second Intervention (35 Days)||2
6498024|NCT01408719|7416842|FG016|COMPLETED|Second Intervention (35 Days)||2
6498025|NCT01408719|7416843|FG017|COMPLETED|Second Intervention (35 Days)||2
6498026|NCT01408719|7416844|FG018|COMPLETED|Second Intervention (35 Days)||0
6555474|NCT01752634|7477656|FG001|COMPLETED|Up to Week 24 (Primary Analysis)||95
6555475|NCT01752634|7477657|FG002|COMPLETED|Up to Week 24 (Primary Analysis)||97
6555476|NCT01752634|7477658|FG003|COMPLETED|Up to Week 24 (Primary Analysis)||43
6750901|NCT03437447|7677968|FG002|COMPLETED|Treatment Period 2||19
6750902|NCT03437447|7677966|FG000|NOT COMPLETED|Treatment Period 2||0
6750903|NCT03437447|7677967|FG001|NOT COMPLETED|Treatment Period 2||0
6750904|NCT03437447|7677968|FG002|NOT COMPLETED|Treatment Period 2||0
6750905|NCT03437447|7677966|FG000|STARTED|Treatment Period 3||20
6750906|NCT03437447|7677967|FG001|STARTED|Treatment Period 3||20
6750907|NCT03437447|7677968|FG002|STARTED|Treatment Period 3||19
6750908|NCT03437447|7677966|FG000|COMPLETED|Treatment Period 3||20
6750909|NCT03437447|7677967|FG001|COMPLETED|Treatment Period 3||20
6750910|NCT03437447|7677968|FG002|COMPLETED|Treatment Period 3||19
6750911|NCT03437447|7677966|FG000|NOT COMPLETED|Treatment Period 3||0
6750912|NCT03437447|7677967|FG001|NOT COMPLETED|Treatment Period 3||0
6750913|NCT03437447|7677968|FG002|NOT COMPLETED|Treatment Period 3||0
6750914|NCT03437512|7677978|FG000|STARTED|Randomized||12
6750915|NCT03437512|7677979|FG001|STARTED|Randomized||13
6750916|NCT03437512|7677978|FG000|COMPLETED|Randomized||12
6750917|NCT03437512|7677979|FG001|COMPLETED|Randomized||11
6750918|NCT03437512|7677978|FG000|NOT COMPLETED|Randomized||0
6750919|NCT03437512|7677979|FG001|NOT COMPLETED|Randomized||2
6750920|NCT03437512|7677978|FG000|STARTED|Received First tDCS Session||12
6750921|NCT03437512|7677979|FG001|STARTED|Received First tDCS Session||11
6750922|NCT03437512|7677978|FG000|COMPLETED|Received First tDCS Session||12
6750923|NCT03437512|7677979|FG001|COMPLETED|Received First tDCS Session||11
6750924|NCT03437512|7677978|FG000|NOT COMPLETED|Received First tDCS Session||0
6750925|NCT03437512|7677979|FG001|NOT COMPLETED|Received First tDCS Session||0
6750926|NCT03437512|7677978|FG000|STARTED|Received Final tDCS Session||12
6750927|NCT03437512|7677979|FG001|STARTED|Received Final tDCS Session||11
6750928|NCT03437512|7677978|FG000|COMPLETED|Received Final tDCS Session||12
6750929|NCT03437512|7677979|FG001|COMPLETED|Received Final tDCS Session||11
6750930|NCT03437512|7677978|FG000|NOT COMPLETED|Received Final tDCS Session||0
6750931|NCT03437512|7677979|FG001|NOT COMPLETED|Received Final tDCS Session||0
6750932|NCT03437512|7677978|FG000|STARTED|Completed Study Follow up||12
6750933|NCT03437512|7677979|FG001|STARTED|Completed Study Follow up||11
6750934|NCT03437512|7677978|FG000|COMPLETED|Completed Study Follow up||10
6750935|NCT03437512|7677979|FG001|COMPLETED|Completed Study Follow up||10
6750936|NCT03437512|7677978|FG000|NOT COMPLETED|Completed Study Follow up||2
6750937|NCT03437512|7677979|FG001|NOT COMPLETED|Completed Study Follow up||1
6750938|NCT03437564|7677987|FG000|STARTED|Overall Study||14
6750939|NCT03437564|7677988|FG001|STARTED|Overall Study||14
6750940|NCT03437564|7677987|FG000|COMPLETED|Overall Study||14
6750941|NCT03437564|7677988|FG001|COMPLETED|Overall Study||14
6750942|NCT03437564|7677987|FG000|NOT COMPLETED|Overall Study||0
6750943|NCT03437564|7677988|FG001|NOT COMPLETED|Overall Study||0
6750944|NCT03437577|7677997|FG000|STARTED|Pre-Randomization||0
6750945|NCT03437577|7677998|FG001|STARTED|Pre-Randomization||0
6750946|NCT03437577|7677999|FG002|STARTED|Pre-Randomization||10
6750947|NCT03437577|7677997|FG000|COMPLETED|Pre-Randomization||0
6750948|NCT03437577|7677998|FG001|COMPLETED|Pre-Randomization||0
6750949|NCT03437577|7677999|FG002|COMPLETED|Pre-Randomization||0
6750950|NCT03437577|7677997|FG000|NOT COMPLETED|Pre-Randomization||0
6750951|NCT03437577|7677998|FG001|NOT COMPLETED|Pre-Randomization||0
6498027|NCT01408719|7416845|FG019|COMPLETED|Second Intervention (35 Days)||1
6498028|NCT01408719|7416826|FG000|NOT COMPLETED|Second Intervention (35 Days)||0
6750952|NCT03437577|7677999|FG002|NOT COMPLETED|Pre-Randomization||10
6750953|NCT03437577|7677997|FG000|STARTED|Post-Randomization||3
6750954|NCT03437577|7677998|FG001|STARTED|Post-Randomization||5
6750955|NCT03437577|7677999|FG002|STARTED|Post-Randomization||0
6750956|NCT03437577|7677997|FG000|COMPLETED|Post-Randomization||3
6750957|NCT03437577|7677998|FG001|COMPLETED|Post-Randomization||3
6750958|NCT03437577|7677999|FG002|COMPLETED|Post-Randomization||0
6750959|NCT03437577|7677997|FG000|NOT COMPLETED|Post-Randomization||0
6750960|NCT03437577|7677998|FG001|NOT COMPLETED|Post-Randomization||2
6750961|NCT03437577|7677999|FG002|NOT COMPLETED|Post-Randomization||0
6750962|NCT03437733|7678007|FG000|STARTED|Overall Study||8
6498029|NCT01408719|7416827|FG001|NOT COMPLETED|Second Intervention (35 Days)||0
6498030|NCT01408719|7416828|FG002|NOT COMPLETED|Second Intervention (35 Days)||0
6498031|NCT01408719|7416829|FG003|NOT COMPLETED|Second Intervention (35 Days)||0
6498032|NCT01408719|7416830|FG004|NOT COMPLETED|Second Intervention (35 Days)||0
6498033|NCT01408719|7416831|FG005|NOT COMPLETED|Second Intervention (35 Days)||0
6498034|NCT01408719|7416832|FG006|NOT COMPLETED|Second Intervention (35 Days)||0
6498035|NCT01408719|7416833|FG007|NOT COMPLETED|Second Intervention (35 Days)||0
6498036|NCT01408719|7416834|FG008|NOT COMPLETED|Second Intervention (35 Days)||0
6498037|NCT01408719|7416835|FG009|NOT COMPLETED|Second Intervention (35 Days)||0
6498038|NCT01408719|7416836|FG010|NOT COMPLETED|Second Intervention (35 Days)||0
6498039|NCT01408719|7416837|FG011|NOT COMPLETED|Second Intervention (35 Days)||0
6498040|NCT01408719|7416838|FG012|NOT COMPLETED|Second Intervention (35 Days)||0
6498041|NCT01408719|7416839|FG013|NOT COMPLETED|Second Intervention (35 Days)||1
6498042|NCT01408719|7416840|FG014|NOT COMPLETED|Second Intervention (35 Days)||0
6498043|NCT01408719|7416841|FG015|NOT COMPLETED|Second Intervention (35 Days)||0
6498044|NCT01408719|7416842|FG016|NOT COMPLETED|Second Intervention (35 Days)||0
6498045|NCT01408719|7416843|FG017|NOT COMPLETED|Second Intervention (35 Days)||0
6498046|NCT01408719|7416844|FG018|NOT COMPLETED|Second Intervention (35 Days)||0
6498047|NCT01408719|7416845|FG019|NOT COMPLETED|Second Intervention (35 Days)||0
6498048|NCT01408719|7416826|FG000|STARTED|Washout Period (28 Days)||2
6498049|NCT01408719|7416827|FG001|STARTED|Washout Period (28 Days)||3
6498050|NCT01408719|7416828|FG002|STARTED|Washout Period (28 Days)||1
6498051|NCT01408719|7416829|FG003|STARTED|Washout Period (28 Days)||2
6498052|NCT01408719|7416830|FG004|STARTED|Washout Period (28 Days)||3
6555477|NCT01752634|7477659|FG004|COMPLETED|Up to Week 24 (Primary Analysis)||45
6555478|NCT01752634|7477660|FG005|COMPLETED|Up to Week 24 (Primary Analysis)||0
6555479|NCT01752634|7477655|FG000|NOT COMPLETED|Up to Week 24 (Primary Analysis)||6
6555480|NCT01752634|7477656|FG001|NOT COMPLETED|Up to Week 24 (Primary Analysis)||5
6555481|NCT01752634|7477657|FG002|NOT COMPLETED|Up to Week 24 (Primary Analysis)||3
6555482|NCT01752634|7477658|FG003|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
6555483|NCT01752634|7477659|FG004|NOT COMPLETED|Up to Week 24 (Primary Analysis)||0
6555484|NCT01752634|7477660|FG005|NOT COMPLETED|Up to Week 24 (Primary Analysis)||10
6555485|NCT01752634|7477655|FG000|STARTED|Week 24 to Week 260||93
6750963|NCT03437733|7678008|FG001|STARTED|Overall Study||90
6750964|NCT03437733|7678007|FG000|Safety|Overall Study||8
6750965|NCT03437733|7678008|FG001|Safety|Overall Study||87
6750966|NCT03437733|7678007|FG000|COMPLETED|Overall Study||8
6750967|NCT03437733|7678008|FG001|COMPLETED|Overall Study||87
6750968|NCT03437733|7678007|FG000|NOT COMPLETED|Overall Study||0
6750969|NCT03437733|7678008|FG001|NOT COMPLETED|Overall Study||3
6750970|NCT03437863|7678013|FG000|STARTED|Overall Study||12
6750971|NCT03437863|7678013|FG000|COMPLETED|Overall Study||12
6750972|NCT03437863|7678013|FG000|NOT COMPLETED|Overall Study||0
6750973|NCT03438006|7678017|FG000|STARTED|Overall Study||3013
6750974|NCT03438006|7678017|FG000|COMPLETED|Overall Study||2895
6750975|NCT03438006|7678017|FG000|NOT COMPLETED|Overall Study||118
6750976|NCT03438045|7678021|FG000|STARTED|Overall Study||75
6750977|NCT03438045|7678021|FG000|COMPLETED|Overall Study||75
6750978|NCT03438045|7678021|FG000|NOT COMPLETED|Overall Study||0
6750979|NCT03438266|7678025|FG000|STARTED|Overall Study||60
6750980|NCT03438266|7678025|FG000|COMPLETED|Overall Study||60
6750981|NCT03438266|7678025|FG000|NOT COMPLETED|Overall Study||0
6750982|NCT03438383|7678033|FG000|STARTED|Overall Study||23
6750983|NCT03438383|7678034|FG001|STARTED|Overall Study||24
6750984|NCT03438383|7678033|FG000|COMPLETED|Overall Study||14
6750985|NCT03438383|7678034|FG001|COMPLETED|Overall Study||21
6750986|NCT03438383|7678033|FG000|NOT COMPLETED|Overall Study||9
6750987|NCT03438383|7678034|FG001|NOT COMPLETED|Overall Study||3
6750988|NCT03438396|7678040|FG000|STARTED|Overall Study||102
6750989|NCT03438396|7678040|FG000|Treated|Overall Study||101
6750990|NCT03438396|7678040|FG000|COMPLETED|Overall Study||0
6750991|NCT03438396|7678040|FG000|NOT COMPLETED|Overall Study||102
6750992|NCT03438539|7678050|FG000|STARTED|Overall Study||76
6750993|NCT03438539|7678051|FG001|STARTED|Overall Study||72
6750994|NCT03438539|7678052|FG002|STARTED|Overall Study||76
6750995|NCT03438539|7678053|FG003|STARTED|Overall Study||73
6750996|NCT03438539|7678054|FG004|STARTED|Overall Study||73
6750997|NCT03438539|7678055|FG005|STARTED|Overall Study||74
6750998|NCT03438539|7678050|FG000|COMPLETED|Overall Study||68
6750999|NCT03438539|7678051|FG001|COMPLETED|Overall Study||68
6751000|NCT03438539|7678052|FG002|COMPLETED|Overall Study||66
6751001|NCT03438539|7678053|FG003|COMPLETED|Overall Study||64
6751002|NCT03438539|7678054|FG004|COMPLETED|Overall Study||70
6751003|NCT03438539|7678055|FG005|COMPLETED|Overall Study||66
6498053|NCT01408719|7416831|FG005|STARTED|Washout Period (28 Days)||3
6498054|NCT01408719|7416832|FG006|STARTED|Washout Period (28 Days)||2
6498055|NCT01408719|7416833|FG007|STARTED|Washout Period (28 Days)||3
6555486|NCT01752634|7477656|FG001|STARTED|Week 24 to Week 260||95
6555487|NCT01752634|7477657|FG002|STARTED|Week 24 to Week 260||97
6555488|NCT01752634|7477658|FG003|STARTED|Week 24 to Week 260||43
6751004|NCT03438539|7678050|FG000|NOT COMPLETED|Overall Study||8
6751005|NCT03438539|7678051|FG001|NOT COMPLETED|Overall Study||4
6751006|NCT03438539|7678052|FG002|NOT COMPLETED|Overall Study||10
6751007|NCT03438539|7678053|FG003|NOT COMPLETED|Overall Study||9
6751008|NCT03438539|7678054|FG004|NOT COMPLETED|Overall Study||3
6555489|NCT01752634|7477659|FG004|STARTED|Week 24 to Week 260||45
6555490|NCT01752634|7477660|FG005|STARTED|Week 24 to Week 260||0
6555491|NCT01752634|7477655|FG000|COMPLETED|Week 24 to Week 260||59
6555492|NCT01752634|7477656|FG001|COMPLETED|Week 24 to Week 260||65
6555493|NCT01752634|7477657|FG002|COMPLETED|Week 24 to Week 260||64
6555494|NCT01752634|7477658|FG003|COMPLETED|Week 24 to Week 260||29
6555495|NCT01752634|7477659|FG004|COMPLETED|Week 24 to Week 260||31
6751009|NCT03438539|7678055|FG005|NOT COMPLETED|Overall Study||8
6751010|NCT03438578|7678071|FG000|STARTED|Overall Study||100
6751011|NCT03438578|7678072|FG001|STARTED|Overall Study||100
6751012|NCT03438578|7678071|FG000|COMPLETED|Overall Study||99
6751013|NCT03438578|7678072|FG001|COMPLETED|Overall Study||96
6751014|NCT03438578|7678071|FG000|NOT COMPLETED|Overall Study||1
6751015|NCT03438578|7678072|FG001|NOT COMPLETED|Overall Study||4
6751016|NCT03439072|7678078|FG000|STARTED|Overall Study||41
6751017|NCT03439072|7678079|FG001|STARTED|Overall Study||40
6751018|NCT03439072|7678078|FG000|COMPLETED|Overall Study|1 subject dropped before G-Pen; another after G-Pen (n=40 G-Pen; N=39 Lilly Glucagon)|39
6751019|NCT03439072|7678079|FG001|COMPLETED|Overall Study|1 subject dropped before Lilly Glucagon; 3 others after Lilly Glucagon (N=39 Lilly; N=36 G-Pen)|36
6751020|NCT03439072|7678078|FG000|NOT COMPLETED|Overall Study||2
6751021|NCT03439072|7678079|FG001|NOT COMPLETED|Overall Study||4
6751022|NCT03439137|7678087|FG000|STARTED|Overall Study||162
6751023|NCT03439137|7678088|FG001|STARTED|Overall Study||161
6751024|NCT03439137|7678087|FG000|COMPLETED|Overall Study||120
6751025|NCT03439137|7678088|FG001|COMPLETED|Overall Study||135
6751026|NCT03439137|7678087|FG000|NOT COMPLETED|Overall Study||42
6751027|NCT03439137|7678088|FG001|NOT COMPLETED|Overall Study||26
6751028|NCT03439189|7678094|FG000|STARTED|Overall Study|Subjects performed at least one Methacetin Breath Test (MBT)|343
6751029|NCT03439189|7678094|FG000|COMPLETED|Overall Study||261
6751030|NCT03439189|7678094|FG000|NOT COMPLETED|Overall Study||82
6751031|NCT03440229|7678101|FG000|STARTED|Overall Study||9
6751032|NCT03440229|7678102|FG001|STARTED|Overall Study||7
6751033|NCT03440229|7678101|FG000|COMPLETED|Overall Study||9
6751034|NCT03440229|7678102|FG001|COMPLETED|Overall Study||7
6751035|NCT03440229|7678101|FG000|NOT COMPLETED|Overall Study||0
6751036|NCT03440229|7678102|FG001|NOT COMPLETED|Overall Study||0
6751037|NCT03440320|7678112|FG000|STARTED|Overall Study||18
6751038|NCT03440320|7678113|FG001|STARTED|Overall Study||14
6751039|NCT03440320|7678112|FG000|COMPLETED|Overall Study||18
6751040|NCT03440320|7678113|FG001|COMPLETED|Overall Study||13
6751041|NCT03440320|7678112|FG000|NOT COMPLETED|Overall Study||0
6751042|NCT03440320|7678113|FG001|NOT COMPLETED|Overall Study||1
6751043|NCT03440411|7678125|FG000|STARTED|Overall Study||3
6751044|NCT03440411|7678126|FG001|STARTED|Overall Study||1
6751045|NCT03440411|7678127|FG002|STARTED|Overall Study||2
6751046|NCT03440411|7678128|FG003|STARTED|Overall Study||2
6751047|NCT03440411|7678125|FG000|COMPLETED|Overall Study||0
6751048|NCT03440411|7678126|FG001|COMPLETED|Overall Study||0
6751049|NCT03440411|7678127|FG002|COMPLETED|Overall Study||0
6751050|NCT03440411|7678128|FG003|COMPLETED|Overall Study||0
6751051|NCT03440411|7678125|FG000|NOT COMPLETED|Overall Study||3
6751052|NCT03440411|7678126|FG001|NOT COMPLETED|Overall Study||1
6751053|NCT03440411|7678127|FG002|NOT COMPLETED|Overall Study||2
6751054|NCT03440411|7678128|FG003|NOT COMPLETED|Overall Study||2
6751055|NCT03440424|7678146|FG000|STARTED|Overall Study||8
6751056|NCT03440424|7678147|FG001|STARTED|Overall Study||8
6751057|NCT03440424|7678148|FG002|STARTED|Overall Study||8
6751058|NCT03440424|7678146|FG000|COMPLETED|Overall Study||8
6751059|NCT03440424|7678147|FG001|COMPLETED|Overall Study||8
6751060|NCT03440424|7678148|FG002|COMPLETED|Overall Study||8
6751061|NCT03440424|7678146|FG000|NOT COMPLETED|Overall Study||0
6751062|NCT03440424|7678147|FG001|NOT COMPLETED|Overall Study||0
6751063|NCT03440424|7678148|FG002|NOT COMPLETED|Overall Study||0
6751064|NCT03440619|7678156|FG000|STARTED|Overall Study||28
6751065|NCT03440619|7678156|FG000|COMPLETED|Overall Study||28
6751066|NCT03440619|7678156|FG000|NOT COMPLETED|Overall Study||0
6751067|NCT03440723|7678162|FG000|STARTED|Overall Study||21
6751068|NCT03440723|7678163|FG001|STARTED|Overall Study||21
6751069|NCT03440723|7678162|FG000|COMPLETED|Overall Study||21
6751070|NCT03440723|7678163|FG001|COMPLETED|Overall Study||21
6751071|NCT03440723|7678162|FG000|NOT COMPLETED|Overall Study||0
6751072|NCT03440723|7678163|FG001|NOT COMPLETED|Overall Study||0
6751073|NCT03440918|7678172|FG000|STARTED|Overall Study||133
6751074|NCT03440918|7678173|FG001|STARTED|Overall Study||138
6751075|NCT03440918|7678172|FG000|COMPLETED|Overall Study||133
6555496|NCT01752634|7477660|FG005|COMPLETED|Week 24 to Week 260||0
6555497|NCT01752634|7477655|FG000|NOT COMPLETED|Week 24 to Week 260||34
6555498|NCT01752634|7477656|FG001|NOT COMPLETED|Week 24 to Week 260||30
6751076|NCT03440918|7678173|FG001|COMPLETED|Overall Study||122
6751077|NCT03440918|7678172|FG000|NOT COMPLETED|Overall Study||0
6751078|NCT03440918|7678173|FG001|NOT COMPLETED|Overall Study||16
6751079|NCT03440944|7678181|FG000|STARTED|Overall Study||9
6751080|NCT03440944|7678182|FG001|STARTED|Overall Study||9
6751081|NCT03440944|7678181|FG000|COMPLETED|Overall Study||8
6751082|NCT03440944|7678182|FG001|COMPLETED|Overall Study||8
6751083|NCT03440944|7678181|FG000|NOT COMPLETED|Overall Study||1
6751084|NCT03440944|7678182|FG001|NOT COMPLETED|Overall Study||1
6751085|NCT03441178|7678189|FG000|STARTED|Overall Study||36
6555499|NCT01752634|7477657|FG002|NOT COMPLETED|Week 24 to Week 260||33
6555500|NCT01752634|7477658|FG003|NOT COMPLETED|Week 24 to Week 260||14
6555501|NCT01752634|7477659|FG004|NOT COMPLETED|Week 24 to Week 260||14
6555502|NCT01752634|7477660|FG005|NOT COMPLETED|Week 24 to Week 260||0
6555503|NCT01752712|7477672|FG000|STARTED|Overall Study||31
6555504|NCT01752712|7477673|FG001|STARTED|Overall Study||31
6555505|NCT01752712|7477672|FG000|COMPLETED|Overall Study||22
6555506|NCT01752712|7477673|FG001|COMPLETED|Overall Study||21
6555507|NCT01752712|7477672|FG000|NOT COMPLETED|Overall Study||9
6555508|NCT01752712|7477673|FG001|NOT COMPLETED|Overall Study||10
6555509|NCT01752842|7477681|FG000|STARTED|Overall Study||34
6555510|NCT01752842|7477682|FG001|STARTED|Overall Study||36
6555511|NCT01752842|7477681|FG000|COMPLETED|Overall Study||31
6555512|NCT01752842|7477682|FG001|COMPLETED|Overall Study||34
6555513|NCT01752842|7477681|FG000|NOT COMPLETED|Overall Study||3
6555514|NCT01752842|7477682|FG001|NOT COMPLETED|Overall Study||2
6555515|NCT01752855|7477690|FG000|STARTED|Overall Study||44
6555516|NCT01752855|7477691|FG001|STARTED|Overall Study||44
6555517|NCT01752855|7477690|FG000|COMPLETED|Overall Study||43
6555518|NCT01752855|7477691|FG001|COMPLETED|Overall Study||40
6555519|NCT01752855|7477690|FG000|NOT COMPLETED|Overall Study||1
6555520|NCT01752855|7477691|FG001|NOT COMPLETED|Overall Study||4
6555521|NCT01752907|7477699|FG000|STARTED|Overall Study||151
6555522|NCT01752907|7477700|FG001|STARTED|Overall Study||153
6555523|NCT01752907|7477699|FG000|Received Pegfilgrastim|Overall Study||149
6751086|NCT03441178|7678190|FG001|STARTED|Overall Study||44
6751087|NCT03441178|7678191|FG002|STARTED|Overall Study||21
6751088|NCT03441178|7678189|FG000|COMPLETED|Overall Study||36
6498056|NCT01408719|7416834|FG008|STARTED|Washout Period (28 Days)||1
6498057|NCT01408719|7416835|FG009|STARTED|Washout Period (28 Days)||1
6498058|NCT01408719|7416836|FG010|STARTED|Washout Period (28 Days)||2
6498059|NCT01408719|7416837|FG011|STARTED|Washout Period (28 Days)||2
6498060|NCT01408719|7416838|FG012|STARTED|Washout Period (28 Days)||2
6498061|NCT01408719|7416839|FG013|STARTED|Washout Period (28 Days)||3
6498062|NCT01408719|7416840|FG014|STARTED|Washout Period (28 Days)||1
6498063|NCT01408719|7416841|FG015|STARTED|Washout Period (28 Days)||1
6498064|NCT01408719|7416842|FG016|STARTED|Washout Period (28 Days)||2
6498065|NCT01408719|7416843|FG017|STARTED|Washout Period (28 Days)||2
6498066|NCT01408719|7416844|FG018|STARTED|Washout Period (28 Days)||0
6498067|NCT01408719|7416845|FG019|STARTED|Washout Period (28 Days)||1
6498068|NCT01408719|7416826|FG000|COMPLETED|Washout Period (28 Days)||2
6498069|NCT01408719|7416827|FG001|COMPLETED|Washout Period (28 Days)||3
6498070|NCT01408719|7416828|FG002|COMPLETED|Washout Period (28 Days)||1
6498071|NCT01408719|7416829|FG003|COMPLETED|Washout Period (28 Days)||2
6498072|NCT01408719|7416830|FG004|COMPLETED|Washout Period (28 Days)||3
6498073|NCT01408719|7416831|FG005|COMPLETED|Washout Period (28 Days)||3
6498074|NCT01408719|7416832|FG006|COMPLETED|Washout Period (28 Days)||2
6498075|NCT01408719|7416833|FG007|COMPLETED|Washout Period (28 Days)||3
6751089|NCT03441178|7678190|FG001|COMPLETED|Overall Study||43
6751090|NCT03441178|7678191|FG002|COMPLETED|Overall Study||20
6751091|NCT03441178|7678189|FG000|NOT COMPLETED|Overall Study||0
6751092|NCT03441178|7678190|FG001|NOT COMPLETED|Overall Study||1
6751093|NCT03441178|7678191|FG002|NOT COMPLETED|Overall Study||1
6751094|NCT03441269|7678204|FG000|STARTED|Overall Study||75
6751095|NCT03441269|7678205|FG001|STARTED|Overall Study||75
6751096|NCT03441269|7678206|FG002|STARTED|Overall Study||75
6751097|NCT03441269|7678204|FG000|COMPLETED|Overall Study||75
6751098|NCT03441269|7678205|FG001|COMPLETED|Overall Study||74
6751099|NCT03441269|7678206|FG002|COMPLETED|Overall Study||74
6751100|NCT03441269|7678204|FG000|NOT COMPLETED|Overall Study||0
6751101|NCT03441269|7678205|FG001|NOT COMPLETED|Overall Study||1
6751102|NCT03441269|7678206|FG002|NOT COMPLETED|Overall Study||1
6751103|NCT03441581|7678216|FG000|STARTED|Overall Study||12
6751104|NCT03441581|7678217|FG001|STARTED|Overall Study||12
6751105|NCT03441581|7678216|FG000|COMPLETED|Overall Study||12
6751106|NCT03441581|7678217|FG001|COMPLETED|Overall Study||12
6751107|NCT03441581|7678216|FG000|NOT COMPLETED|Overall Study||0
6751108|NCT03441581|7678217|FG001|NOT COMPLETED|Overall Study||0
6498076|NCT01408719|7416834|FG008|COMPLETED|Washout Period (28 Days)||1
6498077|NCT01408719|7416835|FG009|COMPLETED|Washout Period (28 Days)||1
6498078|NCT01408719|7416836|FG010|COMPLETED|Washout Period (28 Days)||2
6498079|NCT01408719|7416837|FG011|COMPLETED|Washout Period (28 Days)||2
6498080|NCT01408719|7416838|FG012|COMPLETED|Washout Period (28 Days)||2
6498081|NCT01408719|7416839|FG013|COMPLETED|Washout Period (28 Days)||3
6498082|NCT01408719|7416840|FG014|COMPLETED|Washout Period (28 Days)||1
6498083|NCT01408719|7416841|FG015|COMPLETED|Washout Period (28 Days)||1
6498084|NCT01408719|7416842|FG016|COMPLETED|Washout Period (28 Days)||2
6498085|NCT01408719|7416843|FG017|COMPLETED|Washout Period (28 Days)||2
6498086|NCT01408719|7416844|FG018|COMPLETED|Washout Period (28 Days)||0
6555524|NCT01752907|7477700|FG001|Received Pegfilgrastim|Overall Study||151
6555525|NCT01752907|7477699|FG000|COMPLETED|Overall Study||139
6751109|NCT03441594|7678223|FG000|STARTED|Overall Study||56
6751110|NCT03441594|7678223|FG000|COMPLETED|Overall Study||56
6751111|NCT03441594|7678223|FG000|NOT COMPLETED|Overall Study||0
6498087|NCT01408719|7416845|FG019|COMPLETED|Washout Period (28 Days)||1
6555526|NCT01752907|7477700|FG001|COMPLETED|Overall Study||133
6555527|NCT01752907|7477699|FG000|NOT COMPLETED|Overall Study||12
6751112|NCT03441633|7678237|FG000|STARTED|Overall Study||4712
6751113|NCT03441633|7678238|FG001|STARTED|Overall Study||1423
6751114|NCT03441633|7678239|FG002|STARTED|Overall Study||32212
6751115|NCT03441633|7678240|FG003|STARTED|Overall Study||192
6498088|NCT01408719|7416826|FG000|NOT COMPLETED|Washout Period (28 Days)||0
6498089|NCT01408719|7416827|FG001|NOT COMPLETED|Washout Period (28 Days)||0
6498090|NCT01408719|7416828|FG002|NOT COMPLETED|Washout Period (28 Days)||0
6498091|NCT01408719|7416829|FG003|NOT COMPLETED|Washout Period (28 Days)||0
6498092|NCT01408719|7416830|FG004|NOT COMPLETED|Washout Period (28 Days)||0
6555528|NCT01752907|7477700|FG001|NOT COMPLETED|Overall Study||20
6555529|NCT01752933|7477708|FG000|STARTED|Treatment|Includes all patients who received any treatment|4
6751116|NCT03441633|7678241|FG004|STARTED|Overall Study||2286
6751117|NCT03441633|7678242|FG005|STARTED|Overall Study||363
6751118|NCT03441633|7678243|FG006|STARTED|Overall Study||2855
6751119|NCT03441633|7678244|FG007|STARTED|Overall Study||953
6751120|NCT03441633|7678245|FG008|STARTED|Overall Study||5132
6751121|NCT03441633|7678246|FG009|STARTED|Overall Study||1562
6751122|NCT03441633|7678237|FG000|COMPLETED|Overall Study||4712
6751123|NCT03441633|7678238|FG001|COMPLETED|Overall Study||1423
6751124|NCT03441633|7678239|FG002|COMPLETED|Overall Study||32212
6751125|NCT03441633|7678240|FG003|COMPLETED|Overall Study||192
6751126|NCT03441633|7678241|FG004|COMPLETED|Overall Study||2286
6751127|NCT03441633|7678242|FG005|COMPLETED|Overall Study||363
6751128|NCT03441633|7678243|FG006|COMPLETED|Overall Study||2855
6751129|NCT03441633|7678244|FG007|COMPLETED|Overall Study||953
6751130|NCT03441633|7678245|FG008|COMPLETED|Overall Study||5132
6751131|NCT03441633|7678246|FG009|COMPLETED|Overall Study||1562
6751132|NCT03441633|7678237|FG000|NOT COMPLETED|Overall Study||0
6751133|NCT03441633|7678238|FG001|NOT COMPLETED|Overall Study||0
6751134|NCT03441633|7678239|FG002|NOT COMPLETED|Overall Study||0
6751135|NCT03441633|7678240|FG003|NOT COMPLETED|Overall Study||0
6751136|NCT03441633|7678241|FG004|NOT COMPLETED|Overall Study||0
6751137|NCT03441633|7678242|FG005|NOT COMPLETED|Overall Study||0
6751138|NCT03441633|7678243|FG006|NOT COMPLETED|Overall Study||0
6751139|NCT03441633|7678244|FG007|NOT COMPLETED|Overall Study||0
6751140|NCT03441633|7678245|FG008|NOT COMPLETED|Overall Study||0
6751141|NCT03441633|7678246|FG009|NOT COMPLETED|Overall Study||0
6751142|NCT03441789|7678274|FG000|STARTED|Overall Study||14
6751143|NCT03441789|7678275|FG001|STARTED|Overall Study||14
6751144|NCT03441789|7678274|FG000|COMPLETED|Overall Study||13
6751145|NCT03441789|7678275|FG001|COMPLETED|Overall Study||10
6751146|NCT03441789|7678274|FG000|NOT COMPLETED|Overall Study||1
6751147|NCT03441789|7678275|FG001|NOT COMPLETED|Overall Study||4
6751148|NCT03441984|7678283|FG000|STARTED|Part 1: Period 1 (Up to Day 4)||3
6751149|NCT03441984|7678284|FG001|STARTED|Part 1: Period 1 (Up to Day 4)||3
6751150|NCT03441984|7678285|FG002|STARTED|Part 1: Period 1 (Up to Day 4)||3
6751151|NCT03441984|7678286|FG003|STARTED|Part 1: Period 1 (Up to Day 4)||3
6751152|NCT03441984|7678287|FG004|STARTED|Part 1: Period 1 (Up to Day 4)||3
6751153|NCT03441984|7678288|FG005|STARTED|Part 1: Period 1 (Up to Day 4)||3
6751154|NCT03441984|7678289|FG006|STARTED|Part 1: Period 1 (Up to Day 4)||0
6751155|NCT03441984|7678290|FG007|STARTED|Part 1: Period 1 (Up to Day 4)||0
6751156|NCT03441984|7678291|FG008|STARTED|Part 1: Period 1 (Up to Day 4)||0
6751157|NCT03441984|7678292|FG009|STARTED|Part 1: Period 1 (Up to Day 4)||0
6751158|NCT03441984|7678293|FG010|STARTED|Part 1: Period 1 (Up to Day 4)||0
6751159|NCT03441984|7678294|FG011|STARTED|Part 1: Period 1 (Up to Day 4)||0
6751160|NCT03441984|7678283|FG000|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6751161|NCT03441984|7678284|FG001|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6751162|NCT03441984|7678285|FG002|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6751163|NCT03441984|7678286|FG003|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6751164|NCT03441984|7678287|FG004|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6751165|NCT03441984|7678288|FG005|COMPLETED|Part 1: Period 1 (Up to Day 4)||3
6751166|NCT03441984|7678289|FG006|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751167|NCT03441984|7678290|FG007|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751168|NCT03441984|7678291|FG008|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751169|NCT03441984|7678292|FG009|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751170|NCT03441984|7678293|FG010|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751171|NCT03441984|7678294|FG011|COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751172|NCT03441984|7678283|FG000|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751173|NCT03441984|7678284|FG001|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751174|NCT03441984|7678285|FG002|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751175|NCT03441984|7678286|FG003|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751176|NCT03441984|7678287|FG004|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751177|NCT03441984|7678288|FG005|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751178|NCT03441984|7678289|FG006|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751179|NCT03441984|7678290|FG007|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751180|NCT03441984|7678291|FG008|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751181|NCT03441984|7678292|FG009|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751182|NCT03441984|7678293|FG010|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751183|NCT03441984|7678294|FG011|NOT COMPLETED|Part 1: Period 1 (Up to Day 4)||0
6751184|NCT03441984|7678283|FG000|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751185|NCT03441984|7678284|FG001|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751186|NCT03441984|7678285|FG002|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6498093|NCT01408719|7416831|FG005|NOT COMPLETED|Washout Period (28 Days)||0
6498094|NCT01408719|7416832|FG006|NOT COMPLETED|Washout Period (28 Days)||0
6498095|NCT01408719|7416833|FG007|NOT COMPLETED|Washout Period (28 Days)||0
6498096|NCT01408719|7416834|FG008|NOT COMPLETED|Washout Period (28 Days)||0
6498097|NCT01408719|7416835|FG009|NOT COMPLETED|Washout Period (28 Days)||0
6498098|NCT01408719|7416836|FG010|NOT COMPLETED|Washout Period (28 Days)||0
6498099|NCT01408719|7416837|FG011|NOT COMPLETED|Washout Period (28 Days)||0
6751187|NCT03441984|7678286|FG003|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751188|NCT03441984|7678287|FG004|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751189|NCT03441984|7678288|FG005|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751190|NCT03441984|7678289|FG006|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751191|NCT03441984|7678290|FG007|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751192|NCT03441984|7678291|FG008|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751193|NCT03441984|7678292|FG009|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751194|NCT03441984|7678293|FG010|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751195|NCT03441984|7678294|FG011|STARTED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751196|NCT03441984|7678283|FG000|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751197|NCT03441984|7678284|FG001|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751198|NCT03441984|7678285|FG002|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751199|NCT03441984|7678286|FG003|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751200|NCT03441984|7678287|FG004|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751201|NCT03441984|7678288|FG005|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||3
6751202|NCT03441984|7678289|FG006|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751203|NCT03441984|7678290|FG007|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751204|NCT03441984|7678291|FG008|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751205|NCT03441984|7678292|FG009|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751206|NCT03441984|7678293|FG010|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751207|NCT03441984|7678294|FG011|COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751208|NCT03441984|7678283|FG000|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751209|NCT03441984|7678284|FG001|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751210|NCT03441984|7678285|FG002|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751211|NCT03441984|7678286|FG003|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751212|NCT03441984|7678287|FG004|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751213|NCT03441984|7678288|FG005|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751214|NCT03441984|7678289|FG006|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751215|NCT03441984|7678290|FG007|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751216|NCT03441984|7678291|FG008|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751217|NCT03441984|7678292|FG009|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751218|NCT03441984|7678293|FG010|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751219|NCT03441984|7678294|FG011|NOT COMPLETED|Part 1,Period 1: Wash-out Period: 7 Days||0
6751220|NCT03441984|7678283|FG000|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6751221|NCT03441984|7678284|FG001|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6751222|NCT03441984|7678285|FG002|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6751223|NCT03441984|7678286|FG003|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6751224|NCT03441984|7678287|FG004|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6751225|NCT03441984|7678288|FG005|STARTED|Part 1: Period 2 (Up to Day 4 )||3
6751226|NCT03441984|7678289|FG006|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6751227|NCT03441984|7678290|FG007|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6751228|NCT03441984|7678291|FG008|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6751229|NCT03441984|7678292|FG009|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6751230|NCT03441984|7678293|FG010|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6751231|NCT03441984|7678294|FG011|STARTED|Part 1: Period 2 (Up to Day 4 )||0
6751232|NCT03441984|7678283|FG000|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6751233|NCT03441984|7678284|FG001|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6751234|NCT03441984|7678285|FG002|COMPLETED|Part 1: Period 2 (Up to Day 4 )||2
6751235|NCT03441984|7678286|FG003|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6751236|NCT03441984|7678287|FG004|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6751237|NCT03441984|7678288|FG005|COMPLETED|Part 1: Period 2 (Up to Day 4 )||3
6751238|NCT03441984|7678289|FG006|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751239|NCT03441984|7678290|FG007|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751240|NCT03441984|7678291|FG008|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751241|NCT03441984|7678292|FG009|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751242|NCT03441984|7678293|FG010|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751243|NCT03441984|7678294|FG011|COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751244|NCT03441984|7678283|FG000|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751245|NCT03441984|7678284|FG001|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751246|NCT03441984|7678285|FG002|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||1
6751247|NCT03441984|7678286|FG003|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751248|NCT03441984|7678287|FG004|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751249|NCT03441984|7678288|FG005|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751250|NCT03441984|7678289|FG006|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751251|NCT03441984|7678290|FG007|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751252|NCT03441984|7678291|FG008|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751253|NCT03441984|7678292|FG009|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751254|NCT03441984|7678293|FG010|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751255|NCT03441984|7678294|FG011|NOT COMPLETED|Part 1: Period 2 (Up to Day 4 )||0
6751256|NCT03441984|7678283|FG000|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751257|NCT03441984|7678284|FG001|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751258|NCT03441984|7678285|FG002|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||2
6751259|NCT03441984|7678286|FG003|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751260|NCT03441984|7678287|FG004|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6498100|NCT01408719|7416838|FG012|NOT COMPLETED|Washout Period (28 Days)||0
6498101|NCT01408719|7416839|FG013|NOT COMPLETED|Washout Period (28 Days)||0
6498102|NCT01408719|7416840|FG014|NOT COMPLETED|Washout Period (28 Days)||0
6498103|NCT01408719|7416841|FG015|NOT COMPLETED|Washout Period (28 Days)||0
6751261|NCT03441984|7678288|FG005|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751262|NCT03441984|7678289|FG006|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751263|NCT03441984|7678290|FG007|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751264|NCT03441984|7678291|FG008|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751265|NCT03441984|7678292|FG009|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751266|NCT03441984|7678293|FG010|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751267|NCT03441984|7678294|FG011|STARTED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751268|NCT03441984|7678283|FG000|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751269|NCT03441984|7678284|FG001|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751270|NCT03441984|7678285|FG002|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||2
6751271|NCT03441984|7678286|FG003|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751272|NCT03441984|7678287|FG004|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751273|NCT03441984|7678288|FG005|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||3
6751274|NCT03441984|7678289|FG006|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751275|NCT03441984|7678290|FG007|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751276|NCT03441984|7678291|FG008|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751277|NCT03441984|7678292|FG009|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751278|NCT03441984|7678293|FG010|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751279|NCT03441984|7678294|FG011|COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751280|NCT03441984|7678283|FG000|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751281|NCT03441984|7678284|FG001|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751282|NCT03441984|7678285|FG002|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751283|NCT03441984|7678286|FG003|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751284|NCT03441984|7678287|FG004|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751285|NCT03441984|7678288|FG005|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751286|NCT03441984|7678289|FG006|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751287|NCT03441984|7678290|FG007|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751288|NCT03441984|7678291|FG008|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751289|NCT03441984|7678292|FG009|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751290|NCT03441984|7678293|FG010|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751291|NCT03441984|7678294|FG011|NOT COMPLETED|Part 1: Period 2,Wash-out Period: 7 Days||0
6751292|NCT03441984|7678283|FG000|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6751293|NCT03441984|7678284|FG001|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6751294|NCT03441984|7678285|FG002|STARTED|Part 1: Period 3 (Up to Day 4 )||2
6751295|NCT03441984|7678286|FG003|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6751296|NCT03441984|7678287|FG004|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6751297|NCT03441984|7678288|FG005|STARTED|Part 1: Period 3 (Up to Day 4 )||3
6751298|NCT03441984|7678289|FG006|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6751299|NCT03441984|7678290|FG007|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6751300|NCT03441984|7678291|FG008|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6751301|NCT03441984|7678292|FG009|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6751302|NCT03441984|7678293|FG010|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6751303|NCT03441984|7678294|FG011|STARTED|Part 1: Period 3 (Up to Day 4 )||0
6751304|NCT03441984|7678283|FG000|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6751305|NCT03441984|7678284|FG001|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6751306|NCT03441984|7678285|FG002|COMPLETED|Part 1: Period 3 (Up to Day 4 )||2
6751307|NCT03441984|7678286|FG003|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6751308|NCT03441984|7678287|FG004|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6751309|NCT03441984|7678288|FG005|COMPLETED|Part 1: Period 3 (Up to Day 4 )||3
6751310|NCT03441984|7678289|FG006|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751311|NCT03441984|7678290|FG007|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751312|NCT03441984|7678291|FG008|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751313|NCT03441984|7678292|FG009|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751314|NCT03441984|7678293|FG010|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751315|NCT03441984|7678294|FG011|COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751316|NCT03441984|7678283|FG000|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751317|NCT03441984|7678284|FG001|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751318|NCT03441984|7678285|FG002|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751319|NCT03441984|7678286|FG003|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751320|NCT03441984|7678287|FG004|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751321|NCT03441984|7678288|FG005|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751322|NCT03441984|7678289|FG006|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751323|NCT03441984|7678290|FG007|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751324|NCT03441984|7678291|FG008|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751325|NCT03441984|7678292|FG009|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751326|NCT03441984|7678293|FG010|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751327|NCT03441984|7678294|FG011|NOT COMPLETED|Part 1: Period 3 (Up to Day 4 )||0
6751328|NCT03441984|7678283|FG000|STARTED|Part 2: Period 1(Up to Day 4)||0
6751329|NCT03441984|7678284|FG001|STARTED|Part 2: Period 1(Up to Day 4)||0
6498104|NCT01408719|7416842|FG016|NOT COMPLETED|Washout Period (28 Days)||0
6498105|NCT01408719|7416843|FG017|NOT COMPLETED|Washout Period (28 Days)||0
6498106|NCT01408719|7416844|FG018|NOT COMPLETED|Washout Period (28 Days)||0
6498107|NCT01408719|7416845|FG019|NOT COMPLETED|Washout Period (28 Days)||0
6751330|NCT03441984|7678285|FG002|STARTED|Part 2: Period 1(Up to Day 4)||0
6751331|NCT03441984|7678286|FG003|STARTED|Part 2: Period 1(Up to Day 4)||0
6751332|NCT03441984|7678287|FG004|STARTED|Part 2: Period 1(Up to Day 4)||0
6751333|NCT03441984|7678288|FG005|STARTED|Part 2: Period 1(Up to Day 4)||0
6751334|NCT03441984|7678289|FG006|STARTED|Part 2: Period 1(Up to Day 4)||3
6751335|NCT03441984|7678290|FG007|STARTED|Part 2: Period 1(Up to Day 4)||3
6751336|NCT03441984|7678291|FG008|STARTED|Part 2: Period 1(Up to Day 4)||3
6751337|NCT03441984|7678292|FG009|STARTED|Part 2: Period 1(Up to Day 4)||3
6751338|NCT03441984|7678293|FG010|STARTED|Part 2: Period 1(Up to Day 4)||3
6751339|NCT03441984|7678294|FG011|STARTED|Part 2: Period 1(Up to Day 4)||3
6751340|NCT03441984|7678283|FG000|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751341|NCT03441984|7678284|FG001|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751342|NCT03441984|7678285|FG002|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751343|NCT03441984|7678286|FG003|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751344|NCT03441984|7678287|FG004|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751345|NCT03441984|7678288|FG005|COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751346|NCT03441984|7678289|FG006|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6751347|NCT03441984|7678290|FG007|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6751348|NCT03441984|7678291|FG008|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6751349|NCT03441984|7678292|FG009|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6751350|NCT03441984|7678293|FG010|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6751351|NCT03441984|7678294|FG011|COMPLETED|Part 2: Period 1(Up to Day 4)||3
6751352|NCT03441984|7678283|FG000|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751353|NCT03441984|7678284|FG001|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751354|NCT03441984|7678285|FG002|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751355|NCT03441984|7678286|FG003|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751356|NCT03441984|7678287|FG004|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751357|NCT03441984|7678288|FG005|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751358|NCT03441984|7678289|FG006|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751359|NCT03441984|7678290|FG007|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751360|NCT03441984|7678291|FG008|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751361|NCT03441984|7678292|FG009|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751362|NCT03441984|7678293|FG010|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751363|NCT03441984|7678294|FG011|NOT COMPLETED|Part 2: Period 1(Up to Day 4)||0
6751364|NCT03441984|7678283|FG000|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751365|NCT03441984|7678284|FG001|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751366|NCT03441984|7678285|FG002|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751367|NCT03441984|7678286|FG003|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751368|NCT03441984|7678287|FG004|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751369|NCT03441984|7678288|FG005|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751370|NCT03441984|7678289|FG006|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751371|NCT03441984|7678290|FG007|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751372|NCT03441984|7678291|FG008|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751373|NCT03441984|7678292|FG009|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751374|NCT03441984|7678293|FG010|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751375|NCT03441984|7678294|FG011|STARTED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751376|NCT03441984|7678283|FG000|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751377|NCT03441984|7678284|FG001|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751378|NCT03441984|7678285|FG002|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751379|NCT03441984|7678286|FG003|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751380|NCT03441984|7678287|FG004|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751381|NCT03441984|7678288|FG005|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751382|NCT03441984|7678289|FG006|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751383|NCT03441984|7678290|FG007|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751384|NCT03441984|7678291|FG008|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751385|NCT03441984|7678292|FG009|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751386|NCT03441984|7678293|FG010|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751387|NCT03441984|7678294|FG011|COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||3
6751388|NCT03441984|7678283|FG000|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751389|NCT03441984|7678284|FG001|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751390|NCT03441984|7678285|FG002|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751391|NCT03441984|7678286|FG003|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751392|NCT03441984|7678287|FG004|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751393|NCT03441984|7678288|FG005|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751394|NCT03441984|7678289|FG006|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751395|NCT03441984|7678290|FG007|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751396|NCT03441984|7678291|FG008|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751397|NCT03441984|7678292|FG009|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751398|NCT03441984|7678293|FG010|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6498108|NCT01408719|7416826|FG000|STARTED|Third Intervention (35 Days)||2
6751399|NCT03441984|7678294|FG011|NOT COMPLETED|Part 2: Period 1, Wash-out: Up to 7 Days||0
6751400|NCT03441984|7678283|FG000|STARTED|Part 2: Period 2 (Up to Day 4)||0
6751401|NCT03441984|7678284|FG001|STARTED|Part 2: Period 2 (Up to Day 4)||0
6751402|NCT03441984|7678285|FG002|STARTED|Part 2: Period 2 (Up to Day 4)||0
6751403|NCT03441984|7678286|FG003|STARTED|Part 2: Period 2 (Up to Day 4)||0
6751404|NCT03441984|7678287|FG004|STARTED|Part 2: Period 2 (Up to Day 4)||0
6751405|NCT03441984|7678288|FG005|STARTED|Part 2: Period 2 (Up to Day 4)||0
6751406|NCT03441984|7678289|FG006|STARTED|Part 2: Period 2 (Up to Day 4)||3
6751407|NCT03441984|7678290|FG007|STARTED|Part 2: Period 2 (Up to Day 4)||3
6751408|NCT03441984|7678291|FG008|STARTED|Part 2: Period 2 (Up to Day 4)||3
6751409|NCT03441984|7678292|FG009|STARTED|Part 2: Period 2 (Up to Day 4)||3
6751410|NCT03441984|7678293|FG010|STARTED|Part 2: Period 2 (Up to Day 4)||3
6751411|NCT03441984|7678294|FG011|STARTED|Part 2: Period 2 (Up to Day 4)||3
6751412|NCT03441984|7678283|FG000|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751413|NCT03441984|7678284|FG001|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751414|NCT03441984|7678285|FG002|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751415|NCT03441984|7678286|FG003|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751416|NCT03441984|7678287|FG004|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751417|NCT03441984|7678288|FG005|COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751418|NCT03441984|7678289|FG006|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6751419|NCT03441984|7678290|FG007|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6751420|NCT03441984|7678291|FG008|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6751421|NCT03441984|7678292|FG009|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6751422|NCT03441984|7678293|FG010|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6751423|NCT03441984|7678294|FG011|COMPLETED|Part 2: Period 2 (Up to Day 4)||3
6751424|NCT03441984|7678283|FG000|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751425|NCT03441984|7678284|FG001|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751426|NCT03441984|7678285|FG002|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751427|NCT03441984|7678286|FG003|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751428|NCT03441984|7678287|FG004|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751429|NCT03441984|7678288|FG005|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751430|NCT03441984|7678289|FG006|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751431|NCT03441984|7678290|FG007|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751432|NCT03441984|7678291|FG008|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751433|NCT03441984|7678292|FG009|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751434|NCT03441984|7678293|FG010|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751435|NCT03441984|7678294|FG011|NOT COMPLETED|Part 2: Period 2 (Up to Day 4)||0
6751436|NCT03441984|7678283|FG000|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751437|NCT03441984|7678284|FG001|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751438|NCT03441984|7678285|FG002|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751439|NCT03441984|7678286|FG003|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751440|NCT03441984|7678287|FG004|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751441|NCT03441984|7678288|FG005|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751442|NCT03441984|7678289|FG006|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751443|NCT03441984|7678290|FG007|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751444|NCT03441984|7678291|FG008|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751445|NCT03441984|7678292|FG009|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751446|NCT03441984|7678293|FG010|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751447|NCT03441984|7678294|FG011|STARTED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751448|NCT03441984|7678283|FG000|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6555530|NCT01752933|7477709|FG001|STARTED|Treatment|Includes all patients who received any treatment|46
6555531|NCT01752933|7477708|FG000|COMPLETED|Treatment|Completion not applicable for this survival study|0
6555532|NCT01752933|7477709|FG001|COMPLETED|Treatment|Completion not applicable for this survival study|0
6751449|NCT03441984|7678284|FG001|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751450|NCT03441984|7678285|FG002|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751451|NCT03441984|7678286|FG003|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751452|NCT03441984|7678287|FG004|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751453|NCT03441984|7678288|FG005|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751454|NCT03441984|7678289|FG006|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751455|NCT03441984|7678290|FG007|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751456|NCT03441984|7678291|FG008|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751457|NCT03441984|7678292|FG009|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751458|NCT03441984|7678293|FG010|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751459|NCT03441984|7678294|FG011|COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||3
6751460|NCT03441984|7678283|FG000|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751461|NCT03441984|7678284|FG001|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751462|NCT03441984|7678285|FG002|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751463|NCT03441984|7678286|FG003|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751464|NCT03441984|7678287|FG004|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751465|NCT03441984|7678288|FG005|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751466|NCT03441984|7678289|FG006|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751467|NCT03441984|7678290|FG007|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751468|NCT03441984|7678291|FG008|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751469|NCT03441984|7678292|FG009|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751470|NCT03441984|7678293|FG010|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751471|NCT03441984|7678294|FG011|NOT COMPLETED|Part 2: Period 2, Wash-out: Up to 7 Days||0
6751472|NCT03441984|7678283|FG000|STARTED|Part 2: Period 3 (Up to Day 4)||0
6751473|NCT03441984|7678284|FG001|STARTED|Part 2: Period 3 (Up to Day 4)||0
6751474|NCT03441984|7678285|FG002|STARTED|Part 2: Period 3 (Up to Day 4)||0
6751475|NCT03441984|7678286|FG003|STARTED|Part 2: Period 3 (Up to Day 4)||0
6751476|NCT03441984|7678287|FG004|STARTED|Part 2: Period 3 (Up to Day 4)||0
6751477|NCT03441984|7678288|FG005|STARTED|Part 2: Period 3 (Up to Day 4)||0
6751478|NCT03441984|7678289|FG006|STARTED|Part 2: Period 3 (Up to Day 4)||3
6751479|NCT03441984|7678290|FG007|STARTED|Part 2: Period 3 (Up to Day 4)||3
6751480|NCT03441984|7678291|FG008|STARTED|Part 2: Period 3 (Up to Day 4)||3
6751481|NCT03441984|7678292|FG009|STARTED|Part 2: Period 3 (Up to Day 4)||3
6751482|NCT03441984|7678293|FG010|STARTED|Part 2: Period 3 (Up to Day 4)||3
6751483|NCT03441984|7678294|FG011|STARTED|Part 2: Period 3 (Up to Day 4)||3
6751484|NCT03441984|7678283|FG000|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751485|NCT03441984|7678284|FG001|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751486|NCT03441984|7678285|FG002|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751487|NCT03441984|7678286|FG003|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751488|NCT03441984|7678287|FG004|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751489|NCT03441984|7678288|FG005|COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751490|NCT03441984|7678289|FG006|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6751491|NCT03441984|7678290|FG007|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6751492|NCT03441984|7678291|FG008|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6751493|NCT03441984|7678292|FG009|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6751494|NCT03441984|7678293|FG010|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6751495|NCT03441984|7678294|FG011|COMPLETED|Part 2: Period 3 (Up to Day 4)||3
6751496|NCT03441984|7678283|FG000|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751497|NCT03441984|7678284|FG001|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751498|NCT03441984|7678285|FG002|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751499|NCT03441984|7678286|FG003|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751500|NCT03441984|7678287|FG004|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751501|NCT03441984|7678288|FG005|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751502|NCT03441984|7678289|FG006|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751503|NCT03441984|7678290|FG007|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751504|NCT03441984|7678291|FG008|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751505|NCT03441984|7678292|FG009|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751506|NCT03441984|7678293|FG010|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751507|NCT03441984|7678294|FG011|NOT COMPLETED|Part 2: Period 3 (Up to Day 4)||0
6751508|NCT03442036|7678311|FG000|STARTED|Overall Study||35
6751509|NCT03442036|7678312|FG001|STARTED|Overall Study||35
6751510|NCT03442036|7678311|FG000|COMPLETED|Overall Study||35
6751511|NCT03442036|7678312|FG001|COMPLETED|Overall Study||35
6751512|NCT03442036|7678311|FG000|NOT COMPLETED|Overall Study||0
6751513|NCT03442036|7678312|FG001|NOT COMPLETED|Overall Study||0
6751514|NCT03442296|7678322|FG000|STARTED|3 Month Follow-up||78
6751515|NCT03442296|7678323|FG001|STARTED|3 Month Follow-up||73
6751516|NCT03442296|7678322|FG000|COMPLETED|3 Month Follow-up||73
6751517|NCT03442296|7678323|FG001|COMPLETED|3 Month Follow-up||70
6751518|NCT03442296|7678322|FG000|NOT COMPLETED|3 Month Follow-up||5
6751519|NCT03442296|7678323|FG001|NOT COMPLETED|3 Month Follow-up||3
6751520|NCT03442296|7678322|FG000|STARTED|12 Month Follow-up|15 participants in the immediate group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (6), or withdrew consent (6)|58
6751521|NCT03442296|7678323|FG001|STARTED|12 Month Follow-up|18 participants in the delayed group did not start the 12month visit due to: death unrelated to study (3), loss to follow up (5), or withdrew consent (10)|52
6751522|NCT03442296|7678322|FG000|COMPLETED|12 Month Follow-up||57
6751523|NCT03442296|7678323|FG001|COMPLETED|12 Month Follow-up||51
6751524|NCT03442296|7678322|FG000|NOT COMPLETED|12 Month Follow-up||1
6751525|NCT03442296|7678323|FG001|NOT COMPLETED|12 Month Follow-up||1
6751526|NCT03442569|7678329|FG000|STARTED|Overall Study||56
6751527|NCT03442569|7678329|FG000|Started Treatment|Overall Study||55
6751528|NCT03442569|7678329|FG000|COMPLETED|Overall Study||55
6751529|NCT03442569|7678329|FG000|NOT COMPLETED|Overall Study||1
6751530|NCT03442595|7678335|FG000|STARTED|Overall Study||460
6751531|NCT03442595|7678336|FG001|STARTED|Overall Study||366
6751532|NCT03442595|7678335|FG000|COMPLETED|Overall Study||366
6751533|NCT03442595|7678336|FG001|COMPLETED|Overall Study||366
6751534|NCT03442595|7678335|FG000|NOT COMPLETED|Overall Study||94
6751535|NCT03442595|7678336|FG001|NOT COMPLETED|Overall Study||0
6751536|NCT03442699|7678341|FG000|STARTED|Overall Study||6
6751537|NCT03442699|7678341|FG000|COMPLETED|Overall Study||6
6751538|NCT03442699|7678341|FG000|NOT COMPLETED|Overall Study||0
6751539|NCT03442725|7678349|FG000|STARTED|Overall Study||8
6751540|NCT03442725|7678350|FG001|STARTED|Overall Study||8
6751541|NCT03442725|7678349|FG000|COMPLETED|Overall Study||8
6751542|NCT03442725|7678350|FG001|COMPLETED|Overall Study||8
6751543|NCT03442725|7678349|FG000|NOT COMPLETED|Overall Study||0
6751544|NCT03442725|7678350|FG001|NOT COMPLETED|Overall Study||0
6779927|NCT03509207|7708200|FG000|STARTED|Overall Study||3
6779928|NCT03509207|7708200|FG000|COMPLETED|Overall Study||1
6779929|NCT03509207|7708200|FG000|NOT COMPLETED|Overall Study||2
6779930|NCT03505372|7708204|FG000|STARTED|Overall Study||5
6779931|NCT03505372|7708204|FG000|COMPLETED|Overall Study||5
6779932|NCT03505372|7708204|FG000|NOT COMPLETED|Overall Study||0
6779933|NCT03500406|7708210|FG000|STARTED|Overall Study||4
6779934|NCT03500406|7708211|FG001|STARTED|Overall Study||20
6779935|NCT03500406|7708210|FG000|COMPLETED|Overall Study||4
6779936|NCT03500406|7708211|FG001|COMPLETED|Overall Study||20
6779937|NCT03500406|7708210|FG000|NOT COMPLETED|Overall Study||0
6751545|NCT03442777|7678359|FG000|STARTED|Overall Study|All participants received at least 1 dressing|542
6751546|NCT03442777|7678360|FG001|STARTED|Overall Study|One participant received one Allevyn® Life dressing (wrong brand by mistake), besides 13 Mepilex® Border on sacrum, (0.2%) All participants received at least 1 dressing|545
6751547|NCT03442777|7678361|FG002|STARTED|Overall Study|No participants received dressings|546
6751548|NCT03442777|7678359|FG000|COMPLETED|Overall Study||534
6751549|NCT03442777|7678360|FG001|COMPLETED|Overall Study||532
6751550|NCT03442777|7678361|FG002|COMPLETED|Overall Study||539
6751551|NCT03442777|7678359|FG000|NOT COMPLETED|Overall Study||8
6751552|NCT03442777|7678360|FG001|NOT COMPLETED|Overall Study||13
6751553|NCT03442777|7678361|FG002|NOT COMPLETED|Overall Study||7
6751554|NCT03442829|7678369|FG000|STARTED|Overall Study||27
6751555|NCT03442829|7678370|FG001|STARTED|Overall Study||27
6751556|NCT03442829|7678369|FG000|COMPLETED|Overall Study||23
6751557|NCT03442829|7678370|FG001|COMPLETED|Overall Study||25
6751558|NCT03442829|7678369|FG000|NOT COMPLETED|Overall Study||4
6751559|NCT03442829|7678370|FG001|NOT COMPLETED|Overall Study||2
6751560|NCT03442868|7678376|FG000|STARTED|Overall Study||15
6751561|NCT03442868|7678376|FG000|COMPLETED|Overall Study||15
6751562|NCT03442868|7678376|FG000|NOT COMPLETED|Overall Study||0
6751563|NCT03442933|7678380|FG000|STARTED|Overall Study||20
6751564|NCT03442933|7678381|FG001|STARTED|Overall Study||20
6751565|NCT03442933|7678380|FG000|COMPLETED|Overall Study||20
6751566|NCT03442933|7678381|FG001|COMPLETED|Overall Study||20
6751567|NCT03442933|7678380|FG000|NOT COMPLETED|Overall Study||0
6751568|NCT03442933|7678381|FG001|NOT COMPLETED|Overall Study||0
6751569|NCT03443024|7678394|FG000|STARTED|Overall Study||73
6751570|NCT03443024|7678395|FG001|STARTED|Overall Study||80
6751571|NCT03443024|7678396|FG002|STARTED|Overall Study||75
6751572|NCT03443024|7678397|FG003|STARTED|Overall Study||52
6751573|NCT03443024|7678394|FG000|Received at Least One Dose of Study Drug|Overall Study||73
6751574|NCT03443024|7678395|FG001|Received at Least One Dose of Study Drug|Overall Study||80
6751575|NCT03443024|7678396|FG002|Received at Least One Dose of Study Drug|Overall Study||75
6751576|NCT03443024|7678397|FG003|Received at Least One Dose of Study Drug|Overall Study||52
6751577|NCT03443024|7678394|FG000|COMPLETED|Overall Study||52
6751578|NCT03443024|7678395|FG001|COMPLETED|Overall Study||49
6751579|NCT03443024|7678396|FG002|COMPLETED|Overall Study||56
6751580|NCT03443024|7678397|FG003|COMPLETED|Overall Study||20
6751581|NCT03443024|7678394|FG000|NOT COMPLETED|Overall Study||21
6751582|NCT03443024|7678395|FG001|NOT COMPLETED|Overall Study||31
6751583|NCT03443024|7678396|FG002|NOT COMPLETED|Overall Study||19
6751584|NCT03443024|7678397|FG003|NOT COMPLETED|Overall Study||32
6751585|NCT03443063|7678409|FG000|STARTED|Overall Study||8
6751586|NCT03443063|7678410|FG001|STARTED|Overall Study||8
6751587|NCT03443063|7678409|FG000|COMPLETED|Overall Study||8
6751588|NCT03443063|7678410|FG001|COMPLETED|Overall Study||8
6751589|NCT03443063|7678409|FG000|NOT COMPLETED|Overall Study||0
6751590|NCT03443063|7678410|FG001|NOT COMPLETED|Overall Study||0
6751591|NCT03443414|7678423|FG000|STARTED|Overall Study||82
6751592|NCT03443414|7678424|FG001|STARTED|Overall Study||81
6751593|NCT03443414|7678425|FG002|STARTED|Overall Study||82
6751594|NCT03443414|7678426|FG003|STARTED|Overall Study||80
6751595|NCT03443414|7678427|FG004|STARTED|Overall Study||80
6751596|NCT03443414|7678423|FG000|Received Treatment|Overall Study||81
6751597|NCT03443414|7678424|FG001|Received Treatment|Overall Study||81
6751598|NCT03443414|7678425|FG002|Received Treatment|Overall Study||82
6751599|NCT03443414|7678426|FG003|Received Treatment|Overall Study||80
6751600|NCT03443414|7678427|FG004|Received Treatment|Overall Study||79
6751601|NCT03443414|7678423|FG000|COMPLETED|Overall Study||71
6751602|NCT03443414|7678424|FG001|COMPLETED|Overall Study||78
6751603|NCT03443414|7678425|FG002|COMPLETED|Overall Study||76
6751604|NCT03443414|7678426|FG003|COMPLETED|Overall Study||75
6751605|NCT03443414|7678427|FG004|COMPLETED|Overall Study||75
6751606|NCT03443414|7678423|FG000|NOT COMPLETED|Overall Study||11
6751607|NCT03443414|7678424|FG001|NOT COMPLETED|Overall Study||3
6751608|NCT03443414|7678425|FG002|NOT COMPLETED|Overall Study||6
6751609|NCT03443414|7678426|FG003|NOT COMPLETED|Overall Study||5
6751610|NCT03443414|7678427|FG004|NOT COMPLETED|Overall Study||5
6751611|NCT03443427|7678441|FG000|STARTED|Overall Study||100
6751612|NCT03443427|7678442|FG001|STARTED|Overall Study||100
6751613|NCT03443427|7678441|FG000|COMPLETED|Overall Study||88
6751614|NCT03443427|7678442|FG001|COMPLETED|Overall Study||89
6751615|NCT03443427|7678441|FG000|NOT COMPLETED|Overall Study||12
6751616|NCT03443427|7678442|FG001|NOT COMPLETED|Overall Study||11
6751617|NCT03443713|7678451|FG000|STARTED|Start up Visit (2 Hours)||8
6751618|NCT03443713|7678452|FG001|STARTED|Start up Visit (2 Hours)||8
6751619|NCT03443713|7678453|FG002|STARTED|Start up Visit (2 Hours)||9
6751620|NCT03443713|7678451|FG000|COMPLETED|Start up Visit (2 Hours)||8
6751621|NCT03443713|7678452|FG001|COMPLETED|Start up Visit (2 Hours)||8
6751622|NCT03443713|7678453|FG002|COMPLETED|Start up Visit (2 Hours)||9
6751623|NCT03443713|7678451|FG000|NOT COMPLETED|Start up Visit (2 Hours)||0
6751624|NCT03443713|7678452|FG001|NOT COMPLETED|Start up Visit (2 Hours)||0
6751625|NCT03443713|7678453|FG002|NOT COMPLETED|Start up Visit (2 Hours)||0
6751626|NCT03443713|7678451|FG000|STARTED|First at Home Period (9-14 Days)||8
6751627|NCT03443713|7678452|FG001|STARTED|First at Home Period (9-14 Days)||8
6751628|NCT03443713|7678453|FG002|STARTED|First at Home Period (9-14 Days)||9
6751629|NCT03443713|7678451|FG000|COMPLETED|First at Home Period (9-14 Days)||8
6751630|NCT03443713|7678452|FG001|COMPLETED|First at Home Period (9-14 Days)||8
6498109|NCT01408719|7416827|FG001|STARTED|Third Intervention (35 Days)||3
6498110|NCT01408719|7416828|FG002|STARTED|Third Intervention (35 Days)||1
6498111|NCT01408719|7416829|FG003|STARTED|Third Intervention (35 Days)||2
6498112|NCT01408719|7416830|FG004|STARTED|Third Intervention (35 Days)||3
6498113|NCT01408719|7416831|FG005|STARTED|Third Intervention (35 Days)||3
6498114|NCT01408719|7416832|FG006|STARTED|Third Intervention (35 Days)||2
6498115|NCT01408719|7416833|FG007|STARTED|Third Intervention (35 Days)||3
6751631|NCT03443713|7678453|FG002|COMPLETED|First at Home Period (9-14 Days)||8
6751632|NCT03443713|7678451|FG000|NOT COMPLETED|First at Home Period (9-14 Days)||0
6751633|NCT03443713|7678452|FG001|NOT COMPLETED|First at Home Period (9-14 Days)||0
6751634|NCT03443713|7678453|FG002|NOT COMPLETED|First at Home Period (9-14 Days)||1
6751635|NCT03443713|7678451|FG000|STARTED|First Exercise Visit (1 Hour)||8
6751636|NCT03443713|7678452|FG001|STARTED|First Exercise Visit (1 Hour)||8
6751637|NCT03443713|7678453|FG002|STARTED|First Exercise Visit (1 Hour)||8
6751638|NCT03443713|7678451|FG000|COMPLETED|First Exercise Visit (1 Hour)||8
6751639|NCT03443713|7678452|FG001|COMPLETED|First Exercise Visit (1 Hour)||8
6751640|NCT03443713|7678453|FG002|COMPLETED|First Exercise Visit (1 Hour)||8
6751641|NCT03443713|7678451|FG000|NOT COMPLETED|First Exercise Visit (1 Hour)||0
6751642|NCT03443713|7678452|FG001|NOT COMPLETED|First Exercise Visit (1 Hour)||0
6751643|NCT03443713|7678453|FG002|NOT COMPLETED|First Exercise Visit (1 Hour)||0
6751644|NCT03443713|7678451|FG000|STARTED|Dexcom Insertion Visit (30 Minutes)||8
6751645|NCT03443713|7678452|FG001|STARTED|Dexcom Insertion Visit (30 Minutes)||8
6751646|NCT03443713|7678453|FG002|STARTED|Dexcom Insertion Visit (30 Minutes)||8
6751647|NCT03443713|7678451|FG000|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
6751648|NCT03443713|7678452|FG001|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
6751649|NCT03443713|7678453|FG002|COMPLETED|Dexcom Insertion Visit (30 Minutes)||8
6751650|NCT03443713|7678451|FG000|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
6751651|NCT03443713|7678452|FG001|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
6751652|NCT03443713|7678453|FG002|NOT COMPLETED|Dexcom Insertion Visit (30 Minutes)||0
6751653|NCT03443713|7678451|FG000|STARTED|Second at Home Period (2-11 Days)||8
6751654|NCT03443713|7678452|FG001|STARTED|Second at Home Period (2-11 Days)||8
6751655|NCT03443713|7678453|FG002|STARTED|Second at Home Period (2-11 Days)||8
6751656|NCT03443713|7678451|FG000|COMPLETED|Second at Home Period (2-11 Days)||8
6751657|NCT03443713|7678452|FG001|COMPLETED|Second at Home Period (2-11 Days)||8
6751658|NCT03443713|7678453|FG002|COMPLETED|Second at Home Period (2-11 Days)||8
6751659|NCT03443713|7678451|FG000|NOT COMPLETED|Second at Home Period (2-11 Days)||0
6751660|NCT03443713|7678452|FG001|NOT COMPLETED|Second at Home Period (2-11 Days)||0
6751661|NCT03443713|7678453|FG002|NOT COMPLETED|Second at Home Period (2-11 Days)||0
6751662|NCT03443713|7678451|FG000|STARTED|Second Exercise Visit (1 Hour)||8
6751663|NCT03443713|7678452|FG001|STARTED|Second Exercise Visit (1 Hour)||8
6751664|NCT03443713|7678453|FG002|STARTED|Second Exercise Visit (1 Hour)||8
6751665|NCT03443713|7678451|FG000|COMPLETED|Second Exercise Visit (1 Hour)||8
6751666|NCT03443713|7678452|FG001|COMPLETED|Second Exercise Visit (1 Hour)||8
6751667|NCT03443713|7678453|FG002|COMPLETED|Second Exercise Visit (1 Hour)||8
6751668|NCT03443713|7678451|FG000|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
6751669|NCT03443713|7678452|FG001|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
6751670|NCT03443713|7678453|FG002|NOT COMPLETED|Second Exercise Visit (1 Hour)||0
6751671|NCT03443713|7678451|FG000|STARTED|Third at Home Period (8-12 Days)||8
6751672|NCT03443713|7678452|FG001|STARTED|Third at Home Period (8-12 Days)||8
6751673|NCT03443713|7678453|FG002|STARTED|Third at Home Period (8-12 Days)||8
6751674|NCT03443713|7678451|FG000|COMPLETED|Third at Home Period (8-12 Days)||8
6751675|NCT03443713|7678452|FG001|COMPLETED|Third at Home Period (8-12 Days)||8
6751676|NCT03443713|7678453|FG002|COMPLETED|Third at Home Period (8-12 Days)||8
6751677|NCT03443713|7678451|FG000|NOT COMPLETED|Third at Home Period (8-12 Days)||0
6751678|NCT03443713|7678452|FG001|NOT COMPLETED|Third at Home Period (8-12 Days)||0
6751679|NCT03443713|7678453|FG002|NOT COMPLETED|Third at Home Period (8-12 Days)||0
6751680|NCT03443713|7678451|FG000|STARTED|Close-out Visit (30 Minutes)||8
6751681|NCT03443713|7678452|FG001|STARTED|Close-out Visit (30 Minutes)||8
6751682|NCT03443713|7678453|FG002|STARTED|Close-out Visit (30 Minutes)||8
6751683|NCT03443713|7678451|FG000|COMPLETED|Close-out Visit (30 Minutes)||8
6751684|NCT03443713|7678452|FG001|COMPLETED|Close-out Visit (30 Minutes)||8
6751685|NCT03443713|7678453|FG002|COMPLETED|Close-out Visit (30 Minutes)||8
6751686|NCT03443713|7678451|FG000|NOT COMPLETED|Close-out Visit (30 Minutes)||0
6751687|NCT03443713|7678452|FG001|NOT COMPLETED|Close-out Visit (30 Minutes)||0
6751688|NCT03443713|7678453|FG002|NOT COMPLETED|Close-out Visit (30 Minutes)||0
6751689|NCT03444090|7678467|FG000|STARTED|Overall Study||214
6751690|NCT03444090|7678468|FG001|STARTED|Overall Study||214
6751691|NCT03444090|7678467|FG000|COMPLETED|Overall Study||211
6751692|NCT03444090|7678468|FG001|COMPLETED|Overall Study||210
6751693|NCT03444090|7678467|FG000|NOT COMPLETED|Overall Study||3
6751694|NCT03444090|7678468|FG001|NOT COMPLETED|Overall Study||4
6751695|NCT03444155|7678476|FG000|STARTED|First Intervention (6 Weeks)||15
6751696|NCT03444155|7678477|FG001|STARTED|First Intervention (6 Weeks)||15
6751697|NCT03444155|7678476|FG000|COMPLETED|First Intervention (6 Weeks)||14
6751698|NCT03444155|7678477|FG001|COMPLETED|First Intervention (6 Weeks)||15
6751699|NCT03444155|7678476|FG000|NOT COMPLETED|First Intervention (6 Weeks)||1
6751700|NCT03444155|7678477|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
6751701|NCT03444155|7678476|FG000|STARTED|Washout (2 Weeks)||14
6751702|NCT03444155|7678477|FG001|STARTED|Washout (2 Weeks)||15
6751703|NCT03444155|7678476|FG000|COMPLETED|Washout (2 Weeks)||14
6751704|NCT03444155|7678477|FG001|COMPLETED|Washout (2 Weeks)||15
6751705|NCT03444155|7678476|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6751706|NCT03444155|7678477|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6751707|NCT03444155|7678476|FG000|STARTED|Second Intervention (6 Weeks)||14
6751708|NCT03444155|7678477|FG001|STARTED|Second Intervention (6 Weeks)||15
6751709|NCT03444155|7678476|FG000|COMPLETED|Second Intervention (6 Weeks)||14
6751710|NCT03444155|7678477|FG001|COMPLETED|Second Intervention (6 Weeks)||15
6751711|NCT03444155|7678476|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6751712|NCT03444155|7678477|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6751713|NCT03444584|7678485|FG000|STARTED|Overall Study||24
6751714|NCT03444584|7678486|FG001|STARTED|Overall Study||25
6751715|NCT03444584|7678485|FG000|COMPLETED|Overall Study||24
6751716|NCT03444584|7678486|FG001|COMPLETED|Overall Study||23
6751717|NCT03444584|7678485|FG000|NOT COMPLETED|Overall Study||0
6751718|NCT03444584|7678486|FG001|NOT COMPLETED|Overall Study||2
6751719|NCT03444766|7678493|FG000|STARTED|Overall Study||100
6751720|NCT03444766|7678493|FG000|COMPLETED|Overall Study||34
6751721|NCT03444766|7678493|FG000|NOT COMPLETED|Overall Study||66
6751722|NCT03444961|7678497|FG000|STARTED|Overall Study||4
6751723|NCT03444961|7678497|FG000|COMPLETED|Overall Study||4
6751724|NCT03444961|7678497|FG000|NOT COMPLETED|Overall Study||0
6751725|NCT03445065|7678509|FG000|STARTED|Overall Study||97
6751726|NCT03445065|7678510|FG001|STARTED|Overall Study||52
6751727|NCT03445065|7678511|FG002|STARTED|Overall Study||62
6751728|NCT03445065|7678512|FG003|STARTED|Overall Study||28
6751729|NCT03445065|7678509|FG000|COMPLETED|Overall Study||90
6751730|NCT03445065|7678510|FG001|COMPLETED|Overall Study||43
6751731|NCT03445065|7678511|FG002|COMPLETED|Overall Study||57
6555533|NCT01752933|7477708|FG000|NOT COMPLETED|Treatment||4
6555534|NCT01752933|7477709|FG001|NOT COMPLETED|Treatment||46
6555535|NCT01752933|7477708|FG000|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|4
6751732|NCT03445065|7678512|FG003|COMPLETED|Overall Study||25
6751733|NCT03445065|7678509|FG000|NOT COMPLETED|Overall Study||7
6751734|NCT03445065|7678510|FG001|NOT COMPLETED|Overall Study||9
6751735|NCT03445065|7678511|FG002|NOT COMPLETED|Overall Study||5
6751736|NCT03445065|7678512|FG003|NOT COMPLETED|Overall Study||3
6751737|NCT03445156|7678537|FG000|STARTED|Pilot Study||20
6555536|NCT01752933|7477709|FG001|STARTED|Overall Study and Follow-up|Includes all patients who received any treatment|46
6555537|NCT01752933|7477708|FG000|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
6555538|NCT01752933|7477709|FG001|COMPLETED|Overall Study and Follow-up|Completion not applicable for this survival study|0
6555539|NCT01752933|7477708|FG000|NOT COMPLETED|Overall Study and Follow-up||4
6555540|NCT01752933|7477709|FG001|NOT COMPLETED|Overall Study and Follow-up||46
6555541|NCT01752985|7477719|FG000|STARTED|Treatment Period||29
6555542|NCT01752985|7477720|FG001|STARTED|Treatment Period||30
6555543|NCT01752985|7477721|FG002|STARTED|Treatment Period||29
6555544|NCT01752985|7477719|FG000|COMPLETED|Treatment Period||25
6555545|NCT01752985|7477720|FG001|COMPLETED|Treatment Period||27
6555546|NCT01752985|7477721|FG002|COMPLETED|Treatment Period||24
6555547|NCT01752985|7477719|FG000|NOT COMPLETED|Treatment Period||4
6751738|NCT03445156|7678538|FG001|STARTED|Pilot Study||20
6751739|NCT03445156|7678539|FG002|STARTED|Pilot Study||0
6751740|NCT03445156|7678537|FG000|COMPLETED|Pilot Study||20
6751741|NCT03445156|7678538|FG001|COMPLETED|Pilot Study||20
6751742|NCT03445156|7678539|FG002|COMPLETED|Pilot Study||0
6751743|NCT03445156|7678537|FG000|NOT COMPLETED|Pilot Study||0
6751744|NCT03445156|7678538|FG001|NOT COMPLETED|Pilot Study||0
6751745|NCT03445156|7678539|FG002|NOT COMPLETED|Pilot Study||0
6751746|NCT03445156|7678537|FG000|STARTED|Experiment Proper||113
6751747|NCT03445156|7678538|FG001|STARTED|Experiment Proper||115
6751748|NCT03445156|7678539|FG002|STARTED|Experiment Proper||59
6751749|NCT03445156|7678537|FG000|COMPLETED|Experiment Proper||113
6751750|NCT03445156|7678538|FG001|COMPLETED|Experiment Proper||115
6751751|NCT03445156|7678539|FG002|COMPLETED|Experiment Proper||59
6751752|NCT03445156|7678537|FG000|NOT COMPLETED|Experiment Proper||0
6751753|NCT03445156|7678538|FG001|NOT COMPLETED|Experiment Proper||0
6751754|NCT03445156|7678539|FG002|NOT COMPLETED|Experiment Proper||0
6751755|NCT03445195|7678553|FG000|STARTED|Overall Study||53
6751756|NCT03445195|7678554|FG001|STARTED|Overall Study||27
6751757|NCT03445195|7678553|FG000|COMPLETED|Overall Study||51
6751758|NCT03445195|7678554|FG001|COMPLETED|Overall Study||27
6751759|NCT03445195|7678553|FG000|NOT COMPLETED|Overall Study||2
6751760|NCT03445195|7678554|FG001|NOT COMPLETED|Overall Study||0
6751761|NCT03445390|7678560|FG000|STARTED|First Intervention||14
6751762|NCT03445390|7678561|FG001|STARTED|First Intervention||13
6751763|NCT03445390|7678560|FG000|COMPLETED|First Intervention||12
6751764|NCT03445390|7678561|FG001|COMPLETED|First Intervention||11
6751765|NCT03445390|7678560|FG000|NOT COMPLETED|First Intervention||2
6751766|NCT03445390|7678561|FG001|NOT COMPLETED|First Intervention||2
6555548|NCT01752985|7477720|FG001|NOT COMPLETED|Treatment Period||3
6555549|NCT01752985|7477721|FG002|NOT COMPLETED|Treatment Period||5
6562914|NCT01803464|7485829|FG003|COMPLETED|Overall Study||10
6751767|NCT03445390|7678560|FG000|STARTED|Second Intervention||12
6751768|NCT03445390|7678561|FG001|STARTED|Second Intervention||11
6751769|NCT03445390|7678560|FG000|COMPLETED|Second Intervention||10
6751770|NCT03445390|7678561|FG001|COMPLETED|Second Intervention||10
6751771|NCT03445390|7678560|FG000|NOT COMPLETED|Second Intervention||2
6751772|NCT03445390|7678561|FG001|NOT COMPLETED|Second Intervention||1
6751773|NCT03445793|7678567|FG000|STARTED|Overall Study||5
6751774|NCT03445793|7678567|FG000|COMPLETED|Overall Study||5
6751775|NCT03445793|7678567|FG000|NOT COMPLETED|Overall Study||0
6751776|NCT03446053|7678576|FG000|STARTED|Overall Study||2
6751777|NCT03446053|7678577|FG001|STARTED|Overall Study||6
6751778|NCT03446053|7678578|FG002|STARTED|Overall Study||6
6751779|NCT03446053|7678579|FG003|STARTED|Overall Study||7
6751780|NCT03446053|7678580|FG004|STARTED|Overall Study||6
6751781|NCT03446053|7678581|FG005|STARTED|Overall Study||6
6751782|NCT03446053|7678576|FG000|Randomized Set|Overall Study||2
6751783|NCT03446053|7678577|FG001|Randomized Set|Overall Study||6
6751784|NCT03446053|7678578|FG002|Randomized Set|Overall Study||6
6751785|NCT03446053|7678579|FG003|Randomized Set|Overall Study||7
6751786|NCT03446053|7678580|FG004|Randomized Set|Overall Study||6
6751787|NCT03446053|7678581|FG005|Randomized Set|Overall Study||6
6751788|NCT03446053|7678576|FG000|Safety Analysis Set|Overall Study||2
6751789|NCT03446053|7678577|FG001|Safety Analysis Set|Overall Study||6
6751790|NCT03446053|7678578|FG002|Safety Analysis Set|Overall Study||6
6751791|NCT03446053|7678579|FG003|Safety Analysis Set|Overall Study||6
6751792|NCT03446053|7678580|FG004|Safety Analysis Set|Overall Study||6
6751793|NCT03446053|7678581|FG005|Safety Analysis Set|Overall Study||6
6751794|NCT03446053|7678576|FG000|PK/PD Analysis Set|Overall Study||2
6751795|NCT03446053|7678577|FG001|PK/PD Analysis Set|Overall Study||6
6751796|NCT03446053|7678578|FG002|PK/PD Analysis Set|Overall Study||6
6751797|NCT03446053|7678579|FG003|PK/PD Analysis Set|Overall Study||6
6751798|NCT03446053|7678580|FG004|PK/PD Analysis Set|Overall Study||6
6751799|NCT03446053|7678581|FG005|PK/PD Analysis Set|Overall Study||5
6751800|NCT03446053|7678576|FG000|COMPLETED|Overall Study||2
6751801|NCT03446053|7678577|FG001|COMPLETED|Overall Study||5
6751802|NCT03446053|7678578|FG002|COMPLETED|Overall Study||6
6751803|NCT03446053|7678579|FG003|COMPLETED|Overall Study||6
6751804|NCT03446053|7678580|FG004|COMPLETED|Overall Study||6
6751805|NCT03446053|7678581|FG005|COMPLETED|Overall Study||5
6751806|NCT03446053|7678576|FG000|NOT COMPLETED|Overall Study||0
6751807|NCT03446053|7678577|FG001|NOT COMPLETED|Overall Study||1
6751808|NCT03446053|7678578|FG002|NOT COMPLETED|Overall Study||0
6751809|NCT03446053|7678579|FG003|NOT COMPLETED|Overall Study||1
6751810|NCT03446053|7678580|FG004|NOT COMPLETED|Overall Study||0
6751811|NCT03446053|7678581|FG005|NOT COMPLETED|Overall Study||1
6751812|NCT03446690|7678610|FG000|STARTED|Overall Study||33
6751813|NCT03446690|7678611|FG001|STARTED|Overall Study||29
6751814|NCT03446690|7678610|FG000|COMPLETED|Overall Study||26
6751815|NCT03446690|7678611|FG001|COMPLETED|Overall Study||29
6751816|NCT03446690|7678610|FG000|NOT COMPLETED|Overall Study||7
6751817|NCT03446690|7678611|FG001|NOT COMPLETED|Overall Study||0
6751818|NCT03446781|7678619|FG000|STARTED|Overall Study||214
6751819|NCT03446781|7678620|FG001|STARTED|Overall Study||208
6751820|NCT03446781|7678619|FG000|COMPLETED|Overall Study||186
6751821|NCT03446781|7678620|FG001|COMPLETED|Overall Study||191
6751822|NCT03446781|7678619|FG000|NOT COMPLETED|Overall Study||28
6751823|NCT03446781|7678620|FG001|NOT COMPLETED|Overall Study||17
6751824|NCT03446846|7678651|FG000|STARTED|Overall Study||90
6751825|NCT03446846|7678652|FG001|STARTED|Overall Study||92
6751826|NCT03446846|7678653|FG002|STARTED|Overall Study||178
6751827|NCT03446846|7678651|FG000|COMPLETED|Overall Study||83
6751828|NCT03446846|7678652|FG001|COMPLETED|Overall Study||87
6751829|NCT03446846|7678653|FG002|COMPLETED|Overall Study||162
6751830|NCT03446846|7678651|FG000|NOT COMPLETED|Overall Study||7
6751831|NCT03446846|7678652|FG001|NOT COMPLETED|Overall Study||5
6751832|NCT03446846|7678653|FG002|NOT COMPLETED|Overall Study||16
6751833|NCT03446885|7678661|FG000|STARTED|Overall Study||12
6751834|NCT03446885|7678662|FG001|STARTED|Overall Study||10
6751835|NCT03446885|7678661|FG000|COMPLETED|Overall Study||10
6751836|NCT03446885|7678662|FG001|COMPLETED|Overall Study||10
6751837|NCT03446885|7678661|FG000|NOT COMPLETED|Overall Study||2
6751838|NCT03446885|7678662|FG001|NOT COMPLETED|Overall Study||0
6751839|NCT03447015|7678672|FG000|STARTED|Overall Study||140
6751840|NCT03447015|7678673|FG001|STARTED|Overall Study||150
6751841|NCT03447015|7678672|FG000|COMPLETED|Overall Study||95
6751842|NCT03447015|7678673|FG001|COMPLETED|Overall Study||106
6751843|NCT03447015|7678672|FG000|NOT COMPLETED|Overall Study||45
6751844|NCT03447015|7678673|FG001|NOT COMPLETED|Overall Study||44
6751845|NCT03447249|7678681|FG000|STARTED|Overall Study||190
6751846|NCT03447249|7678682|FG001|STARTED|Overall Study||192
6751847|NCT03447249|7678681|FG000|Safety Set|Overall Study||189
6751848|NCT03447249|7678682|FG001|Safety Set|Overall Study||193
6751849|NCT03447249|7678681|FG000|COMPLETED|Overall Study||185
6751850|NCT03447249|7678682|FG001|COMPLETED|Overall Study||192
6751851|NCT03447249|7678681|FG000|NOT COMPLETED|Overall Study||5
6751852|NCT03447249|7678682|FG001|NOT COMPLETED|Overall Study||0
6751853|NCT03447353|7678690|FG000|STARTED|Overall Study||18
6751854|NCT03447353|7678690|FG000|COMPLETED|Overall Study||8
6751855|NCT03447353|7678690|FG000|NOT COMPLETED|Overall Study||10
6751856|NCT03447730|7678703|FG000|STARTED|Overall Study||6
6751857|NCT03447730|7678704|FG001|STARTED|Overall Study||9
6751858|NCT03447730|7678705|FG002|STARTED|Overall Study||8
6751859|NCT03447730|7678703|FG000|COMPLETED|Overall Study||6
6751860|NCT03447730|7678704|FG001|COMPLETED|Overall Study||7
6751861|NCT03447730|7678705|FG002|COMPLETED|Overall Study||8
6751862|NCT03447730|7678703|FG000|NOT COMPLETED|Overall Study||0
6751863|NCT03447730|7678704|FG001|NOT COMPLETED|Overall Study||2
6751864|NCT03447730|7678705|FG002|NOT COMPLETED|Overall Study||0
6751865|NCT03447821|7678716|FG000|STARTED|Overall Study||14
6751866|NCT03447821|7678717|FG001|STARTED|Overall Study||13
6751867|NCT03447821|7678718|FG002|STARTED|Overall Study||13
6751868|NCT03447821|7678716|FG000|COMPLETED|Overall Study||13
6751869|NCT03447821|7678717|FG001|COMPLETED|Overall Study||12
6751870|NCT03447821|7678718|FG002|COMPLETED|Overall Study||12
6751871|NCT03447821|7678716|FG000|NOT COMPLETED|Overall Study||1
6751872|NCT03447821|7678717|FG001|NOT COMPLETED|Overall Study||1
6751873|NCT03447821|7678718|FG002|NOT COMPLETED|Overall Study||1
6751874|NCT03448068|7678728|FG000|STARTED|Overall Study||17
6751875|NCT03448068|7678729|FG001|STARTED|Overall Study||17
6751876|NCT03448068|7678728|FG000|COMPLETED|Overall Study||17
6751877|NCT03448068|7678729|FG001|COMPLETED|Overall Study||17
6751878|NCT03448068|7678728|FG000|NOT COMPLETED|Overall Study||0
6751879|NCT03448068|7678729|FG001|NOT COMPLETED|Overall Study||0
6751880|NCT03448224|7678737|FG000|STARTED|Overall Study||28
6751881|NCT03448224|7678738|FG001|STARTED|Overall Study||26
6751882|NCT03448224|7678737|FG000|COMPLETED|Overall Study||27
6751883|NCT03448224|7678738|FG001|COMPLETED|Overall Study||26
6751884|NCT03448224|7678737|FG000|NOT COMPLETED|Overall Study||1
6751885|NCT03448224|7678738|FG001|NOT COMPLETED|Overall Study||0
6751886|NCT03448406|7678746|FG000|STARTED|Overall Study||158
6751887|NCT03448406|7678747|FG001|STARTED|Overall Study||157
6751888|NCT03448406|7678746|FG000|COMPLETED|Overall Study||147
6751889|NCT03448406|7678747|FG001|COMPLETED|Overall Study||144
6751890|NCT03448406|7678746|FG000|NOT COMPLETED|Overall Study||11
6751891|NCT03448406|7678747|FG001|NOT COMPLETED|Overall Study||13
6751892|NCT03448419|7678755|FG000|STARTED|Overall Study||156
6751893|NCT03448419|7678756|FG001|STARTED|Overall Study||156
6751894|NCT03448419|7678755|FG000|Treated|Overall Study||156
6751895|NCT03448419|7678756|FG001|Treated|Overall Study||155
6751896|NCT03448419|7678755|FG000|COMPLETED|Overall Study||143
6751897|NCT03448419|7678756|FG001|COMPLETED|Overall Study||140
6751898|NCT03448419|7678755|FG000|NOT COMPLETED|Overall Study||13
6751899|NCT03448419|7678756|FG001|NOT COMPLETED|Overall Study||16
6751900|NCT03448536|7678766|FG000|STARTED|Overall Study||100
6751901|NCT03448536|7678767|FG001|STARTED|Overall Study||101
6751902|NCT03448536|7678766|FG000|Completed First Intervention|Overall Study||83
6751903|NCT03448536|7678767|FG001|Completed First Intervention|Overall Study||78
6751904|NCT03448536|7678766|FG000|Completed First Intervention|Overall Study||95
6751905|NCT03448536|7678767|FG001|Completed First Intervention|Overall Study||97
6751906|NCT03448536|7678766|FG000|Completed Second Intervention|Overall Study||82
6751907|NCT03448536|7678767|FG001|Completed Second Intervention|Overall Study||87
6751908|NCT03448536|7678766|FG000|COMPLETED|Overall Study||88
6751909|NCT03448536|7678767|FG001|COMPLETED|Overall Study||97
6751910|NCT03448536|7678766|FG000|NOT COMPLETED|Overall Study||12
6751911|NCT03448536|7678767|FG001|NOT COMPLETED|Overall Study||4
6751912|NCT03449030|7678783|FG000|STARTED|Overall Study||1
6751913|NCT03449030|7678784|FG001|STARTED|Overall Study||1
6751914|NCT03449030|7678785|FG002|STARTED|Overall Study||1
6751915|NCT03449030|7678786|FG003|STARTED|Overall Study||5
6751916|NCT03449030|7678787|FG004|STARTED|Overall Study||7
6751917|NCT03449030|7678788|FG005|STARTED|Overall Study||7
6751918|NCT03449030|7678789|FG006|STARTED|Overall Study||2
6751919|NCT03449030|7678790|FG007|STARTED|Overall Study||3
6751920|NCT03449030|7678791|FG008|STARTED|Overall Study||3
6751921|NCT03449030|7678792|FG009|STARTED|Overall Study||1
6751922|NCT03449030|7678783|FG000|COMPLETED|Overall Study||0
6751923|NCT03449030|7678784|FG001|COMPLETED|Overall Study||0
6751924|NCT03449030|7678785|FG002|COMPLETED|Overall Study||0
6751925|NCT03449030|7678786|FG003|COMPLETED|Overall Study||0
6751926|NCT03449030|7678787|FG004|COMPLETED|Overall Study||0
6751927|NCT03449030|7678788|FG005|COMPLETED|Overall Study||0
6751928|NCT03449030|7678789|FG006|COMPLETED|Overall Study||0
6751929|NCT03449030|7678790|FG007|COMPLETED|Overall Study||0
6751930|NCT03449030|7678791|FG008|COMPLETED|Overall Study||0
6751931|NCT03449030|7678792|FG009|COMPLETED|Overall Study||0
6751932|NCT03449030|7678783|FG000|NOT COMPLETED|Overall Study||1
6751933|NCT03449030|7678784|FG001|NOT COMPLETED|Overall Study||1
6751934|NCT03449030|7678785|FG002|NOT COMPLETED|Overall Study||1
6751935|NCT03449030|7678786|FG003|NOT COMPLETED|Overall Study||5
6751936|NCT03449030|7678787|FG004|NOT COMPLETED|Overall Study||7
6751937|NCT03449030|7678788|FG005|NOT COMPLETED|Overall Study||7
6751938|NCT03449030|7678789|FG006|NOT COMPLETED|Overall Study||2
6751939|NCT03449030|7678790|FG007|NOT COMPLETED|Overall Study||3
6751940|NCT03449030|7678791|FG008|NOT COMPLETED|Overall Study||3
6751941|NCT03449030|7678792|FG009|NOT COMPLETED|Overall Study||1
6555550|NCT01752985|7477719|FG000|STARTED|Follow-up Period|Includes 25 participants in this period and 3 participants re-joined for follow-up|28
6555551|NCT01752985|7477720|FG001|STARTED|Follow-up Period||27
6555552|NCT01752985|7477721|FG002|STARTED|Follow-up Period|Includes 24 participants in this period and 2 participants re-joined for follow-up|26
6555553|NCT01752985|7477719|FG000|COMPLETED|Follow-up Period||28
6751942|NCT03449134|7678818|FG000|STARTED|52-Week Treatment Period||244
6751943|NCT03449134|7678819|FG001|STARTED|52-Week Treatment Period||244
6751944|NCT03449134|7678820|FG002|STARTED|52-Week Treatment Period||244
6751945|NCT03449134|7678818|FG000|Treated|52-Week Treatment Period||243
6751946|NCT03449134|7678819|FG001|Treated|52-Week Treatment Period||244
6751947|NCT03449134|7678820|FG002|Treated|52-Week Treatment Period||243
6751948|NCT03449134|7678818|FG000|COMPLETED|52-Week Treatment Period||199
6751949|NCT03449134|7678819|FG001|COMPLETED|52-Week Treatment Period||200
6751950|NCT03449134|7678820|FG002|COMPLETED|52-Week Treatment Period||184
6751951|NCT03449134|7678818|FG000|NOT COMPLETED|52-Week Treatment Period||45
6751952|NCT03449134|7678819|FG001|NOT COMPLETED|52-Week Treatment Period||44
6751953|NCT03449134|7678820|FG002|NOT COMPLETED|52-Week Treatment Period||60
6751954|NCT03449134|7678818|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|10
6751955|NCT03449134|7678819|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|18
6751956|NCT03449134|7678820|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|13
6751957|NCT03449134|7678818|FG000|COMPLETED|12-Week Off-Treatment Durability Period||10
6751958|NCT03449134|7678819|FG001|COMPLETED|12-Week Off-Treatment Durability Period||18
6751959|NCT03449134|7678820|FG002|COMPLETED|12-Week Off-Treatment Durability Period||13
6751960|NCT03449134|7678818|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
6751961|NCT03449134|7678819|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
6751962|NCT03449134|7678820|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
6751963|NCT03449147|7678834|FG000|STARTED|52-week Treatment Period||436
6751964|NCT03449147|7678835|FG001|STARTED|52-week Treatment Period||442
6751965|NCT03449147|7678836|FG002|STARTED|52-week Treatment Period||439
6751966|NCT03449147|7678834|FG000|COMPLETED|52-week Treatment Period||382
6751967|NCT03449147|7678835|FG001|COMPLETED|52-week Treatment Period||368
6751968|NCT03449147|7678836|FG002|COMPLETED|52-week Treatment Period||355
6751969|NCT03449147|7678834|FG000|NOT COMPLETED|52-week Treatment Period||54
6751970|NCT03449147|7678835|FG001|NOT COMPLETED|52-week Treatment Period||74
6751971|NCT03449147|7678836|FG002|NOT COMPLETED|52-week Treatment Period||84
6751972|NCT03449147|7678834|FG000|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|48
6751973|NCT03449147|7678835|FG001|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
6751974|NCT03449147|7678836|FG002|STARTED|12-Week Off-Treatment Durability Period|Not all participants continued in the optional Off-Treatment Period.|37
6751975|NCT03449147|7678834|FG000|COMPLETED|12-Week Off-Treatment Durability Period||47
6751976|NCT03449147|7678835|FG001|COMPLETED|12-Week Off-Treatment Durability Period||36
6751977|NCT03449147|7678836|FG002|COMPLETED|12-Week Off-Treatment Durability Period||37
6751978|NCT03449147|7678834|FG000|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
6751979|NCT03449147|7678835|FG001|NOT COMPLETED|12-Week Off-Treatment Durability Period||1
6751980|NCT03449147|7678836|FG002|NOT COMPLETED|12-Week Off-Treatment Durability Period||0
6751981|NCT03449342|7678850|FG000|STARTED|Overall Study||10
6751982|NCT03449342|7678851|FG001|STARTED|Overall Study||50
6751983|NCT03449342|7678850|FG000|COMPLETED|Overall Study||10
6751984|NCT03449342|7678851|FG001|COMPLETED|Overall Study||50
6751985|NCT03449342|7678850|FG000|NOT COMPLETED|Overall Study||0
6751986|NCT03449342|7678851|FG001|NOT COMPLETED|Overall Study||0
6751987|NCT03449433|7678859|FG000|STARTED|Period 1||17
6751988|NCT03449433|7678860|FG001|STARTED|Period 1||16
6751989|NCT03449433|7678861|FG002|STARTED|Period 1||18
6751990|NCT03449433|7678862|FG003|STARTED|Period 1||17
6751991|NCT03449433|7678863|FG004|STARTED|Period 1||12
6751992|NCT03449433|7678859|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
6751993|NCT03449433|7678860|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
6751994|NCT03449433|7678861|FG002|Received at Least 1 Dose of Study Drug|Period 1||18
6751995|NCT03449433|7678862|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
6751996|NCT03449433|7678863|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
6751997|NCT03449433|7678859|FG000|COMPLETED|Period 1||17
6751998|NCT03449433|7678860|FG001|COMPLETED|Period 1||16
6751999|NCT03449433|7678861|FG002|COMPLETED|Period 1||18
6752000|NCT03449433|7678862|FG003|COMPLETED|Period 1||17
6752001|NCT03449433|7678863|FG004|COMPLETED|Period 1||12
6752002|NCT03449433|7678859|FG000|NOT COMPLETED|Period 1||0
6752003|NCT03449433|7678860|FG001|NOT COMPLETED|Period 1||0
6752004|NCT03449433|7678861|FG002|NOT COMPLETED|Period 1||0
6752005|NCT03449433|7678862|FG003|NOT COMPLETED|Period 1||0
6752006|NCT03449433|7678863|FG004|NOT COMPLETED|Period 1||0
6752007|NCT03449433|7678859|FG000|STARTED|Period 2||17
6752008|NCT03449433|7678860|FG001|STARTED|Period 2||16
6752009|NCT03449433|7678861|FG002|STARTED|Period 2||18
6752010|NCT03449433|7678862|FG003|STARTED|Period 2||17
6752011|NCT03449433|7678863|FG004|STARTED|Period 2||12
6752012|NCT03449433|7678859|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
6752013|NCT03449433|7678860|FG001|Received at Least 1 Dose of Study Drug|Period 2||16
6752014|NCT03449433|7678861|FG002|Received at Least 1 Dose of Study Drug|Period 2||18
6752015|NCT03449433|7678862|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
6752016|NCT03449433|7678863|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
6752017|NCT03449433|7678859|FG000|COMPLETED|Period 2||17
6752018|NCT03449433|7678860|FG001|COMPLETED|Period 2||16
6752019|NCT03449433|7678861|FG002|COMPLETED|Period 2||18
6752020|NCT03449433|7678862|FG003|COMPLETED|Period 2||17
6752021|NCT03449433|7678863|FG004|COMPLETED|Period 2||12
6752022|NCT03449433|7678859|FG000|NOT COMPLETED|Period 2||0
6752023|NCT03449433|7678860|FG001|NOT COMPLETED|Period 2||0
6752024|NCT03449433|7678861|FG002|NOT COMPLETED|Period 2||0
6752025|NCT03449433|7678862|FG003|NOT COMPLETED|Period 2||0
6752026|NCT03449433|7678863|FG004|NOT COMPLETED|Period 2||0
6752027|NCT03449433|7678859|FG000|STARTED|Period 3||17
6752028|NCT03449433|7678860|FG001|STARTED|Period 3||16
6752029|NCT03449433|7678861|FG002|STARTED|Period 3||18
6752030|NCT03449433|7678862|FG003|STARTED|Period 3||17
6752031|NCT03449433|7678863|FG004|STARTED|Period 3||12
6752032|NCT03449433|7678859|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
6752033|NCT03449433|7678860|FG001|Received at Least 1 Dose of Study Drug|Period 3||15
6752034|NCT03449433|7678861|FG002|Received at Least 1 Dose of Study Drug|Period 3||18
6752035|NCT03449433|7678862|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
6752036|NCT03449433|7678863|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
6752037|NCT03449433|7678859|FG000|COMPLETED|Period 3||17
6752038|NCT03449433|7678860|FG001|COMPLETED|Period 3||15
6752039|NCT03449433|7678861|FG002|COMPLETED|Period 3||18
6752040|NCT03449433|7678862|FG003|COMPLETED|Period 3||17
6752041|NCT03449433|7678863|FG004|COMPLETED|Period 3||12
6752042|NCT03449433|7678859|FG000|NOT COMPLETED|Period 3||0
6752043|NCT03449433|7678860|FG001|NOT COMPLETED|Period 3||1
6752044|NCT03449433|7678861|FG002|NOT COMPLETED|Period 3||0
6752045|NCT03449433|7678862|FG003|NOT COMPLETED|Period 3||0
6752046|NCT03449433|7678863|FG004|NOT COMPLETED|Period 3||0
6752047|NCT03449433|7678859|FG000|STARTED|Period 4||17
6752048|NCT03449433|7678860|FG001|STARTED|Period 4||15
6752049|NCT03449433|7678861|FG002|STARTED|Period 4||18
6752050|NCT03449433|7678862|FG003|STARTED|Period 4||17
6752051|NCT03449433|7678863|FG004|STARTED|Period 4||12
6752052|NCT03449433|7678859|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
6752053|NCT03449433|7678860|FG001|Received at Least 1 Dose of Study Drug|Period 4||15
6752054|NCT03449433|7678861|FG002|Received at Least 1 Dose of Study Drug|Period 4||18
6752055|NCT03449433|7678862|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
6752056|NCT03449433|7678863|FG004|Received at Least 1 Dose of Study Drug|Period 4||0
6752057|NCT03449433|7678859|FG000|COMPLETED|Period 4||17
6752058|NCT03449433|7678860|FG001|COMPLETED|Period 4||15
6752059|NCT03449433|7678861|FG002|COMPLETED|Period 4||18
6752060|NCT03449433|7678862|FG003|COMPLETED|Period 4||17
6752061|NCT03449433|7678863|FG004|COMPLETED|Period 4||12
6752062|NCT03449433|7678859|FG000|NOT COMPLETED|Period 4||0
6752063|NCT03449433|7678860|FG001|NOT COMPLETED|Period 4||0
6752064|NCT03449433|7678861|FG002|NOT COMPLETED|Period 4||0
6752065|NCT03449433|7678862|FG003|NOT COMPLETED|Period 4||0
6752066|NCT03449433|7678863|FG004|NOT COMPLETED|Period 4||0
6752067|NCT03449446|7678884|FG000|STARTED|Overall Study||39
6752068|NCT03449446|7678885|FG001|STARTED|Overall Study||40
6752069|NCT03449446|7678886|FG002|STARTED|Overall Study||41
6752070|NCT03449446|7678887|FG003|STARTED|Overall Study||80
6752071|NCT03449446|7678888|FG004|STARTED|Overall Study||78
6752072|NCT03449446|7678889|FG005|STARTED|Overall Study||78
6752073|NCT03449446|7678890|FG006|STARTED|Overall Study||39
6752074|NCT03449446|7678884|FG000|COMPLETED|Overall Study||3
6752075|NCT03449446|7678885|FG001|COMPLETED|Overall Study||33
6752076|NCT03449446|7678886|FG002|COMPLETED|Overall Study||34
6752077|NCT03449446|7678887|FG003|COMPLETED|Overall Study||71
6752078|NCT03449446|7678888|FG004|COMPLETED|Overall Study||66
6752079|NCT03449446|7678889|FG005|COMPLETED|Overall Study||69
6752080|NCT03449446|7678890|FG006|COMPLETED|Overall Study||38
6752081|NCT03449446|7678884|FG000|NOT COMPLETED|Overall Study||36
6752082|NCT03449446|7678885|FG001|NOT COMPLETED|Overall Study||7
6752083|NCT03449446|7678886|FG002|NOT COMPLETED|Overall Study||7
6752084|NCT03449446|7678887|FG003|NOT COMPLETED|Overall Study||9
6752085|NCT03449446|7678888|FG004|NOT COMPLETED|Overall Study||12
6752086|NCT03449446|7678889|FG005|NOT COMPLETED|Overall Study||9
6752087|NCT03449446|7678890|FG006|NOT COMPLETED|Overall Study||1
6752091|NCT03449979|7678915|FG000|STARTED|Overall Study||21
6752092|NCT03449979|7678916|FG001|STARTED|Overall Study||20
6752093|NCT03449979|7678917|FG002|STARTED|Overall Study||21
6752094|NCT03449979|7678918|FG003|STARTED|Overall Study||22
6752095|NCT03449979|7678915|FG000|COMPLETED|Overall Study||21
6752096|NCT03449979|7678916|FG001|COMPLETED|Overall Study||20
6752097|NCT03449979|7678917|FG002|COMPLETED|Overall Study||21
6752098|NCT03449979|7678918|FG003|COMPLETED|Overall Study||21
6752099|NCT03449979|7678915|FG000|NOT COMPLETED|Overall Study||0
6752100|NCT03449979|7678916|FG001|NOT COMPLETED|Overall Study||0
6752101|NCT03449979|7678917|FG002|NOT COMPLETED|Overall Study||0
6752102|NCT03449979|7678918|FG003|NOT COMPLETED|Overall Study||1
6752103|NCT03450070|7678928|FG000|STARTED|Overall Study||118
6752104|NCT03450070|7678928|FG000|COMPLETED|Overall Study||110
6752105|NCT03450070|7678928|FG000|NOT COMPLETED|Overall Study||8
6752106|NCT03450083|7678934|FG000|STARTED|Overall Study||12
6752107|NCT03450083|7678935|FG001|STARTED|Overall Study||12
6752108|NCT03450083|7678934|FG000|COMPLETED|Overall Study||12
6752109|NCT03450083|7678935|FG001|COMPLETED|Overall Study||12
6752110|NCT03450083|7678934|FG000|NOT COMPLETED|Overall Study||0
6752111|NCT03450083|7678935|FG001|NOT COMPLETED|Overall Study||0
6752112|NCT03450369|7678943|FG000|STARTED|Overall Study||5
6752113|NCT03450369|7678944|FG001|STARTED|Overall Study||5
6752114|NCT03450369|7678943|FG000|COMPLETED|Overall Study||5
6752115|NCT03450369|7678944|FG001|COMPLETED|Overall Study||5
6752116|NCT03450369|7678943|FG000|NOT COMPLETED|Overall Study||0
6752117|NCT03450369|7678944|FG001|NOT COMPLETED|Overall Study||0
6752118|NCT03450915|7678952|FG000|STARTED|Overall Study||6230
6752119|NCT03450915|7678953|FG001|STARTED|Overall Study||6230
6752120|NCT03450915|7678952|FG000|COMPLETED|Overall Study||5827
6752121|NCT03450915|7678953|FG001|COMPLETED|Overall Study||5855
6752122|NCT03450915|7678952|FG000|NOT COMPLETED|Overall Study||403
6752123|NCT03450915|7678953|FG001|NOT COMPLETED|Overall Study||375
6752124|NCT03451071|7678959|FG000|STARTED|First Vaccine||56
6752125|NCT03451071|7678959|FG000|COMPLETED|First Vaccine||55
6752126|NCT03451071|7678959|FG000|NOT COMPLETED|First Vaccine||1
6752127|NCT03451071|7678959|FG000|STARTED|Second Vaccine||55
6752128|NCT03451071|7678959|FG000|COMPLETED|Second Vaccine||36
6752129|NCT03451071|7678959|FG000|NOT COMPLETED|Second Vaccine||19
6752130|NCT03451071|7678959|FG000|STARTED|Third Vaccine||36
6752131|NCT03451071|7678959|FG000|COMPLETED|Third Vaccine||14
6752132|NCT03451071|7678959|FG000|NOT COMPLETED|Third Vaccine||22
6752133|NCT03451071|7678959|FG000|STARTED|Final Questionnaire and Blood Draw||14
6752134|NCT03451071|7678959|FG000|COMPLETED|Final Questionnaire and Blood Draw||10
6752135|NCT03451071|7678959|FG000|NOT COMPLETED|Final Questionnaire and Blood Draw||4
6752136|NCT03451084|7678967|FG000|STARTED|Overall Study||6
6752137|NCT03451084|7678968|FG001|STARTED|Overall Study||6
6752138|NCT03451084|7678969|FG002|STARTED|Overall Study||6
6752139|NCT03451084|7678970|FG003|STARTED|Overall Study||6
6752140|NCT03451084|7678967|FG000|COMPLETED|Overall Study||0
6752141|NCT03451084|7678968|FG001|COMPLETED|Overall Study||0
6752142|NCT03451084|7678969|FG002|COMPLETED|Overall Study||0
6752143|NCT03451084|7678970|FG003|COMPLETED|Overall Study||0
6752144|NCT03451084|7678967|FG000|NOT COMPLETED|Overall Study||6
6752145|NCT03451084|7678968|FG001|NOT COMPLETED|Overall Study||6
6752146|NCT03451084|7678969|FG002|NOT COMPLETED|Overall Study||6
6752147|NCT03451084|7678970|FG003|NOT COMPLETED|Overall Study||6
6752148|NCT03451721|7678980|FG000|STARTED|Overall Study||20
6752149|NCT03451721|7678980|FG000|COMPLETED|Overall Study||19
6752150|NCT03451721|7678980|FG000|NOT COMPLETED|Overall Study||1
6752151|NCT03451773|7678986|FG000|STARTED|Overall Study||1
6752152|NCT03451773|7678987|FG001|STARTED|Overall Study||6
6752153|NCT03451773|7678986|FG000|COMPLETED|Overall Study||0
6752154|NCT03451773|7678987|FG001|COMPLETED|Overall Study||0
6752155|NCT03451773|7678986|FG000|NOT COMPLETED|Overall Study||1
6752156|NCT03451773|7678987|FG001|NOT COMPLETED|Overall Study||6
6752157|NCT03452033|7678998|FG000|STARTED|Overall Study||21
6752158|NCT03452033|7678999|FG001|STARTED|Overall Study||22
6752159|NCT03452033|7679000|FG002|STARTED|Overall Study||22
6752160|NCT03452033|7679001|FG003|STARTED|Overall Study||22
6752161|NCT03452033|7678998|FG000|COMPLETED|Overall Study||21
6752162|NCT03452033|7678999|FG001|COMPLETED|Overall Study||22
6752163|NCT03452033|7679000|FG002|COMPLETED|Overall Study||22
6752164|NCT03452033|7679001|FG003|COMPLETED|Overall Study||22
6752165|NCT03452033|7678998|FG000|NOT COMPLETED|Overall Study||0
6752166|NCT03452033|7678999|FG001|NOT COMPLETED|Overall Study||0
6752167|NCT03452033|7679000|FG002|NOT COMPLETED|Overall Study||0
6752168|NCT03452033|7679001|FG003|NOT COMPLETED|Overall Study||0
6752169|NCT03452176|7679016|FG000|STARTED|Overall Study||11
6752170|NCT03452176|7679017|FG001|STARTED|Overall Study||11
6752171|NCT03452176|7679016|FG000|COMPLETED|Overall Study||11
6752172|NCT03452176|7679017|FG001|COMPLETED|Overall Study||11
6752173|NCT03452176|7679016|FG000|NOT COMPLETED|Overall Study||0
6752174|NCT03452176|7679017|FG001|NOT COMPLETED|Overall Study||0
6752175|NCT03452189|7679031|FG000|STARTED|First Intervention (3 Months)||10
6752176|NCT03452189|7679032|FG001|STARTED|First Intervention (3 Months)||5
6752177|NCT03452189|7679031|FG000|COMPLETED|First Intervention (3 Months)||5
6752178|NCT03452189|7679032|FG001|COMPLETED|First Intervention (3 Months)||5
6752179|NCT03452189|7679031|FG000|NOT COMPLETED|First Intervention (3 Months)||5
6752180|NCT03452189|7679032|FG001|NOT COMPLETED|First Intervention (3 Months)||0
6752181|NCT03452189|7679031|FG000|STARTED|Intervention 2 (3 Months)||5
6752182|NCT03452189|7679032|FG001|STARTED|Intervention 2 (3 Months)||5
6752183|NCT03452189|7679031|FG000|COMPLETED|Intervention 2 (3 Months)||5
6752184|NCT03452189|7679032|FG001|COMPLETED|Intervention 2 (3 Months)||5
6752185|NCT03452189|7679031|FG000|NOT COMPLETED|Intervention 2 (3 Months)||0
6752186|NCT03452189|7679032|FG001|NOT COMPLETED|Intervention 2 (3 Months)||0
6752187|NCT03452371|7679040|FG000|STARTED|Overall Study||21
6752188|NCT03452371|7679041|FG001|STARTED|Overall Study||23
6752189|NCT03452371|7679040|FG000|COMPLETED|Overall Study||21
6752190|NCT03452371|7679041|FG001|COMPLETED|Overall Study||23
6752191|NCT03452371|7679040|FG000|NOT COMPLETED|Overall Study||0
6752192|NCT03452371|7679041|FG001|NOT COMPLETED|Overall Study||0
6752193|NCT03452527|7679049|FG000|STARTED|Overall Study||7
6752194|NCT03452527|7679050|FG001|STARTED|Overall Study||8
6752195|NCT03452527|7679049|FG000|COMPLETED|Overall Study||4
6752196|NCT03452527|7679050|FG001|COMPLETED|Overall Study||4
6752197|NCT03452527|7679049|FG000|NOT COMPLETED|Overall Study||3
6752198|NCT03452527|7679050|FG001|NOT COMPLETED|Overall Study||4
6752199|NCT03452943|7679058|FG000|STARTED|Titration Period (7 Weeks)||59
6752200|NCT03452943|7679059|FG001|STARTED|Titration Period (7 Weeks)||60
6752201|NCT03452943|7679058|FG000|Safety Analysis Set|Titration Period (7 Weeks)||58
6752202|NCT03452943|7679059|FG001|Safety Analysis Set|Titration Period (7 Weeks)||59
6752203|NCT03452943|7679058|FG000|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||58
6752204|NCT03452943|7679059|FG001|Modified ITT (mITT) Analysis Set|Titration Period (7 Weeks)||59
6752205|NCT03452943|7679058|FG000|COMPLETED|Titration Period (7 Weeks)||54
6752206|NCT03452943|7679059|FG001|COMPLETED|Titration Period (7 Weeks)||56
6752207|NCT03452943|7679058|FG000|NOT COMPLETED|Titration Period (7 Weeks)||5
6752208|NCT03452943|7679059|FG001|NOT COMPLETED|Titration Period (7 Weeks)||4
6752209|NCT03452943|7679058|FG000|STARTED|Maintenance Period (5 Weeks)||54
6752210|NCT03452943|7679059|FG001|STARTED|Maintenance Period (5 Weeks)||56
6752211|NCT03452943|7679058|FG000|COMPLETED|Maintenance Period (5 Weeks)||51
6752212|NCT03452943|7679059|FG001|COMPLETED|Maintenance Period (5 Weeks)||56
6752213|NCT03452943|7679058|FG000|NOT COMPLETED|Maintenance Period (5 Weeks)||3
6752214|NCT03452943|7679059|FG001|NOT COMPLETED|Maintenance Period (5 Weeks)||0
6752215|NCT03453060|7679070|FG000|STARTED|Overall Study||4
6752216|NCT03453060|7679071|FG001|STARTED|Overall Study||4
6752217|NCT03453060|7679072|FG002|STARTED|Overall Study||4
6752218|NCT03453060|7679073|FG003|STARTED|Overall Study||4
6752219|NCT03453060|7679074|FG004|STARTED|Overall Study||5
6752220|NCT03453060|7679070|FG000|COMPLETED|Overall Study||4
6752221|NCT03453060|7679071|FG001|COMPLETED|Overall Study||4
6752222|NCT03453060|7679072|FG002|COMPLETED|Overall Study||4
6752223|NCT03453060|7679073|FG003|COMPLETED|Overall Study||4
6752224|NCT03453060|7679074|FG004|COMPLETED|Overall Study||5
6752225|NCT03453060|7679070|FG000|NOT COMPLETED|Overall Study||0
6752226|NCT03453060|7679071|FG001|NOT COMPLETED|Overall Study||0
6752227|NCT03453060|7679072|FG002|NOT COMPLETED|Overall Study||0
6752228|NCT03453060|7679073|FG003|NOT COMPLETED|Overall Study||0
6752229|NCT03453060|7679074|FG004|NOT COMPLETED|Overall Study||0
6752230|NCT03453151|7679086|FG000|STARTED|Overall Study||19
6752231|NCT03453151|7679086|FG000|COMPLETED|Overall Study||15
6752232|NCT03453151|7679086|FG000|NOT COMPLETED|Overall Study||4
6752233|NCT03453515|7679092|FG000|STARTED|Overall Study||113
6752234|NCT03453515|7679093|FG001|STARTED|Overall Study||113
6752235|NCT03453515|7679092|FG000|COMPLETED|Overall Study||107
6752236|NCT03453515|7679093|FG001|COMPLETED|Overall Study||100
6752237|NCT03453515|7679092|FG000|NOT COMPLETED|Overall Study||6
6752238|NCT03453515|7679093|FG001|NOT COMPLETED|Overall Study||13
6752239|NCT03454048|7679103|FG000|STARTED|Overall Study||6
6752240|NCT03454048|7679104|FG001|STARTED|Overall Study||6
6752241|NCT03454048|7679105|FG002|STARTED|Overall Study||6
6752242|NCT03454048|7679106|FG003|STARTED|Overall Study||6
6752243|NCT03454048|7679103|FG000|COMPLETED|Overall Study||6
6752244|NCT03454048|7679104|FG001|COMPLETED|Overall Study||6
6752245|NCT03454048|7679105|FG002|COMPLETED|Overall Study||6
6752246|NCT03454048|7679106|FG003|COMPLETED|Overall Study||6
6752247|NCT03454048|7679103|FG000|NOT COMPLETED|Overall Study||0
6752248|NCT03454048|7679104|FG001|NOT COMPLETED|Overall Study||0
6752249|NCT03454048|7679105|FG002|NOT COMPLETED|Overall Study||0
6752250|NCT03454048|7679106|FG003|NOT COMPLETED|Overall Study||0
6752251|NCT03454412|7679118|FG000|STARTED|Baseline Assesment||44
6752252|NCT03454412|7679118|FG000|COMPLETED|Baseline Assesment||32
6752253|NCT03454412|7679118|FG000|NOT COMPLETED|Baseline Assesment||12
6752254|NCT03454412|7679118|FG000|STARTED|Treatment Course||32
6752255|NCT03454412|7679118|FG000|COMPLETED|Treatment Course||32
6752256|NCT03454412|7679118|FG000|NOT COMPLETED|Treatment Course||0
6752257|NCT03454412|7679118|FG000|STARTED|Final Assesment||32
6752258|NCT03454412|7679118|FG000|COMPLETED|Final Assesment||32
6752259|NCT03454412|7679118|FG000|NOT COMPLETED|Final Assesment||0
6752260|NCT03454581|7679125|FG000|STARTED|Overall Study||18
6752261|NCT03454581|7679126|FG001|STARTED|Overall Study||16
6752262|NCT03454581|7679127|FG002|STARTED|Overall Study||17
6752263|NCT03454581|7679125|FG000|COMPLETED|Overall Study||14
6752264|NCT03454581|7679126|FG001|COMPLETED|Overall Study||13
6752265|NCT03454581|7679127|FG002|COMPLETED|Overall Study||14
6752266|NCT03454581|7679125|FG000|NOT COMPLETED|Overall Study||4
6752267|NCT03454581|7679126|FG001|NOT COMPLETED|Overall Study||3
6752268|NCT03454581|7679127|FG002|NOT COMPLETED|Overall Study||3
6752269|NCT03455218|7679138|FG000|STARTED|Overall Study||18
6752270|NCT03455218|7679139|FG001|STARTED|Overall Study||22
6752271|NCT03455218|7679138|FG000|COMPLETED|Overall Study||18
6752272|NCT03455218|7679139|FG001|COMPLETED|Overall Study||22
6752273|NCT03455218|7679138|FG000|NOT COMPLETED|Overall Study||0
6752274|NCT03455218|7679139|FG001|NOT COMPLETED|Overall Study||0
6752275|NCT03455491|7679148|FG000|STARTED|Overall Study||40
6752276|NCT03455491|7679149|FG001|STARTED|Overall Study||40
6752277|NCT03455491|7679150|FG002|STARTED|Overall Study||40
6752278|NCT03455491|7679148|FG000|COMPLETED|Overall Study||40
6752279|NCT03455491|7679149|FG001|COMPLETED|Overall Study||40
6752280|NCT03455491|7679150|FG002|COMPLETED|Overall Study||40
6752281|NCT03455491|7679148|FG000|NOT COMPLETED|Overall Study||0
6752282|NCT03455491|7679149|FG001|NOT COMPLETED|Overall Study||0
6752283|NCT03455491|7679150|FG002|NOT COMPLETED|Overall Study||0
6752284|NCT03455543|7679160|FG000|STARTED|Part A: Randomized Treatment (17 Weeks)||92
6752285|NCT03455543|7679161|FG001|STARTED|Part A: Randomized Treatment (17 Weeks)||90
6752286|NCT03455543|7679162|FG002|STARTED|Part A: Randomized Treatment (17 Weeks)||0
6752287|NCT03455543|7679160|FG000|COMPLETED|Part A: Randomized Treatment (17 Weeks)||81
6752288|NCT03455543|7679161|FG001|COMPLETED|Part A: Randomized Treatment (17 Weeks)||83
6752289|NCT03455543|7679162|FG002|COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
6752290|NCT03455543|7679160|FG000|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||11
6752291|NCT03455543|7679161|FG001|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||7
6752292|NCT03455543|7679162|FG002|NOT COMPLETED|Part A: Randomized Treatment (17 Weeks)||0
6752293|NCT03455543|7679160|FG000|STARTED|Part B: Open-label Extension (24 Weeks)||0
6752294|NCT03455543|7679161|FG001|STARTED|Part B: Open-label Extension (24 Weeks)||0
6752295|NCT03455543|7679162|FG002|STARTED|Part B: Open-label Extension (24 Weeks)||152
6752296|NCT03455543|7679160|FG000|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
6752297|NCT03455543|7679161|FG001|COMPLETED|Part B: Open-label Extension (24 Weeks)||0
6752298|NCT03455543|7679162|FG002|COMPLETED|Part B: Open-label Extension (24 Weeks)||115
6752299|NCT03455543|7679160|FG000|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
6752300|NCT03455543|7679161|FG001|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||0
6752301|NCT03455543|7679162|FG002|NOT COMPLETED|Part B: Open-label Extension (24 Weeks)||37
6752302|NCT03456245|7679170|FG000|STARTED|Overall Study||205
6752303|NCT03456245|7679170|FG000|COMPLETED|Overall Study||190
6752304|NCT03456245|7679170|FG000|NOT COMPLETED|Overall Study||15
6752305|NCT03456427|7679174|FG000|STARTED|Overall Study||36
6752306|NCT03456427|7679174|FG000|COMPLETED|Overall Study||33
6752307|NCT03456427|7679174|FG000|NOT COMPLETED|Overall Study||3
6752308|NCT03456856|7679179|FG000|STARTED|Overall Study||30
6752309|NCT03456856|7679179|FG000|COMPLETED|Overall Study||27
6752310|NCT03456856|7679179|FG000|NOT COMPLETED|Overall Study||3
6752311|NCT03456960|7679189|FG000|STARTED|Period 1 (1 Day)||12
6752312|NCT03456960|7679190|FG001|STARTED|Period 1 (1 Day)||12
6752313|NCT03456960|7679191|FG002|STARTED|Period 1 (1 Day)||120
6752314|NCT03456960|7679192|FG003|STARTED|Period 1 (1 Day)||120
6752315|NCT03456960|7679193|FG004|STARTED|Period 1 (1 Day)||6
6752316|NCT03456960|7679194|FG005|STARTED|Period 1 (1 Day)||6
6752317|NCT03456960|7679189|FG000|COMPLETED|Period 1 (1 Day)||12
6752318|NCT03456960|7679190|FG001|COMPLETED|Period 1 (1 Day)||12
6752319|NCT03456960|7679191|FG002|COMPLETED|Period 1 (1 Day)||120
6752320|NCT03456960|7679192|FG003|COMPLETED|Period 1 (1 Day)||120
6752321|NCT03456960|7679193|FG004|COMPLETED|Period 1 (1 Day)||6
6752322|NCT03456960|7679194|FG005|COMPLETED|Period 1 (1 Day)||6
6752323|NCT03456960|7679189|FG000|NOT COMPLETED|Period 1 (1 Day)||0
6752324|NCT03456960|7679190|FG001|NOT COMPLETED|Period 1 (1 Day)||0
6752325|NCT03456960|7679191|FG002|NOT COMPLETED|Period 1 (1 Day)||0
6752326|NCT03456960|7679192|FG003|NOT COMPLETED|Period 1 (1 Day)||0
6752327|NCT03456960|7679193|FG004|NOT COMPLETED|Period 1 (1 Day)||0
6752328|NCT03456960|7679194|FG005|NOT COMPLETED|Period 1 (1 Day)||0
6752329|NCT03456960|7679189|FG000|STARTED|Washout Period (at Least 14 Days)||12
6752330|NCT03456960|7679190|FG001|STARTED|Washout Period (at Least 14 Days)||12
6752331|NCT03456960|7679191|FG002|STARTED|Washout Period (at Least 14 Days)||120
6752332|NCT03456960|7679192|FG003|STARTED|Washout Period (at Least 14 Days)||120
6752333|NCT03456960|7679193|FG004|STARTED|Washout Period (at Least 14 Days)||6
6752334|NCT03456960|7679194|FG005|STARTED|Washout Period (at Least 14 Days)||6
6752335|NCT03456960|7679189|FG000|COMPLETED|Washout Period (at Least 14 Days)||12
6752336|NCT03456960|7679190|FG001|COMPLETED|Washout Period (at Least 14 Days)||12
6752337|NCT03456960|7679191|FG002|COMPLETED|Washout Period (at Least 14 Days)||119
6752338|NCT03456960|7679192|FG003|COMPLETED|Washout Period (at Least 14 Days)||118
6752339|NCT03456960|7679193|FG004|COMPLETED|Washout Period (at Least 14 Days)||6
6752340|NCT03456960|7679194|FG005|COMPLETED|Washout Period (at Least 14 Days)||6
6752341|NCT03456960|7679189|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6752342|NCT03456960|7679190|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6752343|NCT03456960|7679191|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||1
6752344|NCT03456960|7679192|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||2
6752345|NCT03456960|7679193|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6752346|NCT03456960|7679194|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6752347|NCT03456960|7679189|FG000|STARTED|Period 2 (1 Day)||12
6752348|NCT03456960|7679190|FG001|STARTED|Period 2 (1 Day)||12
6752349|NCT03456960|7679191|FG002|STARTED|Period 2 (1 Day)||119
6752350|NCT03456960|7679192|FG003|STARTED|Period 2 (1 Day)||118
6752351|NCT03456960|7679193|FG004|STARTED|Period 2 (1 Day)||6
6752352|NCT03456960|7679194|FG005|STARTED|Period 2 (1 Day)||6
6752353|NCT03456960|7679189|FG000|COMPLETED|Period 2 (1 Day)||11
6752354|NCT03456960|7679190|FG001|COMPLETED|Period 2 (1 Day)||12
6752355|NCT03456960|7679191|FG002|COMPLETED|Period 2 (1 Day)||119
6752356|NCT03456960|7679192|FG003|COMPLETED|Period 2 (1 Day)||117
6752357|NCT03456960|7679193|FG004|COMPLETED|Period 2 (1 Day)||6
6752358|NCT03456960|7679194|FG005|COMPLETED|Period 2 (1 Day)||6
6752359|NCT03456960|7679189|FG000|NOT COMPLETED|Period 2 (1 Day)||1
6752360|NCT03456960|7679190|FG001|NOT COMPLETED|Period 2 (1 Day)||0
6752361|NCT03456960|7679191|FG002|NOT COMPLETED|Period 2 (1 Day)||0
6752362|NCT03456960|7679192|FG003|NOT COMPLETED|Period 2 (1 Day)||1
6752363|NCT03456960|7679193|FG004|NOT COMPLETED|Period 2 (1 Day)||0
6752364|NCT03456960|7679194|FG005|NOT COMPLETED|Period 2 (1 Day)||0
6752365|NCT03457103|7679212|FG000|STARTED|Overall Study||22
6752366|NCT03457103|7679213|FG001|STARTED|Overall Study||9
6752367|NCT03457103|7679212|FG000|COMPLETED|Overall Study||14
6752368|NCT03457103|7679213|FG001|COMPLETED|Overall Study||3
6752369|NCT03457103|7679212|FG000|NOT COMPLETED|Overall Study||8
6752370|NCT03457103|7679213|FG001|NOT COMPLETED|Overall Study||6
6752371|NCT03457116|7679221|FG000|STARTED|Overall Study||41
6752372|NCT03457116|7679222|FG001|STARTED|Overall Study||29
6752373|NCT03457116|7679221|FG000|COMPLETED|Overall Study||41
6752374|NCT03457116|7679222|FG001|COMPLETED|Overall Study||29
6752375|NCT03457116|7679221|FG000|NOT COMPLETED|Overall Study||0
6752376|NCT03457116|7679222|FG001|NOT COMPLETED|Overall Study||0
6752377|NCT03457636|7679228|FG000|STARTED|Overall Study||22
6752378|NCT03457636|7679228|FG000|COMPLETED|Overall Study||20
6752379|NCT03457636|7679228|FG000|NOT COMPLETED|Overall Study||2
6752380|NCT03457727|7679236|FG000|STARTED|Part 1, Period 1 (1 Day)||8
6752381|NCT03457727|7679237|FG001|STARTED|Part 1, Period 1 (1 Day)||8
6752382|NCT03457727|7679238|FG002|STARTED|Part 1, Period 1 (1 Day)||0
6752383|NCT03457727|7679239|FG003|STARTED|Part 1, Period 1 (1 Day)||0
6752384|NCT03457727|7679236|FG000|COMPLETED|Part 1, Period 1 (1 Day)||8
6752385|NCT03457727|7679237|FG001|COMPLETED|Part 1, Period 1 (1 Day)||8
6752386|NCT03457727|7679238|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
6752387|NCT03457727|7679239|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
6752388|NCT03457727|7679236|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6752389|NCT03457727|7679237|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6752390|NCT03457727|7679238|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6752391|NCT03457727|7679239|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6752392|NCT03457727|7679236|FG000|STARTED|Part 1, Washout Period 1 (5 Days)||8
6752393|NCT03457727|7679237|FG001|STARTED|Part 1, Washout Period 1 (5 Days)||8
6752394|NCT03457727|7679238|FG002|STARTED|Part 1, Washout Period 1 (5 Days)||0
6752395|NCT03457727|7679239|FG003|STARTED|Part 1, Washout Period 1 (5 Days)||0
6752396|NCT03457727|7679236|FG000|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
6752397|NCT03457727|7679237|FG001|COMPLETED|Part 1, Washout Period 1 (5 Days)||8
6752398|NCT03457727|7679238|FG002|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6752399|NCT03457727|7679239|FG003|COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6752400|NCT03457727|7679236|FG000|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6752401|NCT03457727|7679237|FG001|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6752402|NCT03457727|7679238|FG002|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6752403|NCT03457727|7679239|FG003|NOT COMPLETED|Part 1, Washout Period 1 (5 Days)||0
6752404|NCT03457727|7679236|FG000|STARTED|Part 1, Period 2 (1 Day)||8
6752405|NCT03457727|7679237|FG001|STARTED|Part 1, Period 2 (1 Day)||8
6752406|NCT03457727|7679238|FG002|STARTED|Part 1, Period 2 (1 Day)||0
6752407|NCT03457727|7679239|FG003|STARTED|Part 1, Period 2 (1 Day)||0
6752408|NCT03457727|7679236|FG000|COMPLETED|Part 1, Period 2 (1 Day)||8
6752409|NCT03457727|7679237|FG001|COMPLETED|Part 1, Period 2 (1 Day)||8
6752410|NCT03457727|7679238|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
6752411|NCT03457727|7679239|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
6752412|NCT03457727|7679236|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6752413|NCT03457727|7679237|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6752414|NCT03457727|7679238|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6752415|NCT03457727|7679239|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6752416|NCT03457727|7679236|FG000|STARTED|Part 1, Washout Period 2 (5 Days)||8
6752417|NCT03457727|7679237|FG001|STARTED|Part 1, Washout Period 2 (5 Days)||8
6752418|NCT03457727|7679238|FG002|STARTED|Part 1, Washout Period 2 (5 Days)||0
6752419|NCT03457727|7679239|FG003|STARTED|Part 1, Washout Period 2 (5 Days)||0
6752420|NCT03457727|7679236|FG000|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
6752421|NCT03457727|7679237|FG001|COMPLETED|Part 1, Washout Period 2 (5 Days)||8
6752422|NCT03457727|7679238|FG002|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6752423|NCT03457727|7679239|FG003|COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6752424|NCT03457727|7679236|FG000|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6752425|NCT03457727|7679237|FG001|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6752426|NCT03457727|7679238|FG002|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6752427|NCT03457727|7679239|FG003|NOT COMPLETED|Part 1, Washout Period 2 (5 Days)||0
6752428|NCT03457727|7679236|FG000|STARTED|Part 1, Period 3 (1 Day)||8
6752429|NCT03457727|7679237|FG001|STARTED|Part 1, Period 3 (1 Day)||8
6752430|NCT03457727|7679238|FG002|STARTED|Part 1, Period 3 (1 Day)||0
6752431|NCT03457727|7679239|FG003|STARTED|Part 1, Period 3 (1 Day)||0
6752432|NCT03457727|7679236|FG000|COMPLETED|Part 1, Period 3 (1 Day)||8
6752433|NCT03457727|7679237|FG001|COMPLETED|Part 1, Period 3 (1 Day)||8
6752434|NCT03457727|7679238|FG002|COMPLETED|Part 1, Period 3 (1 Day)||0
6752435|NCT03457727|7679239|FG003|COMPLETED|Part 1, Period 3 (1 Day)||0
6752436|NCT03457727|7679236|FG000|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
6752437|NCT03457727|7679237|FG001|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
6752438|NCT03457727|7679238|FG002|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
6752439|NCT03457727|7679239|FG003|NOT COMPLETED|Part 1, Period 3 (1 Day)||0
6752440|NCT03457727|7679236|FG000|STARTED|Part 1, Washout Period 3 (5 Days)||8
6752441|NCT03457727|7679237|FG001|STARTED|Part 1, Washout Period 3 (5 Days)||8
6752442|NCT03457727|7679238|FG002|STARTED|Part 1, Washout Period 3 (5 Days)||0
6752443|NCT03457727|7679239|FG003|STARTED|Part 1, Washout Period 3 (5 Days)||0
6752444|NCT03457727|7679236|FG000|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
6752445|NCT03457727|7679237|FG001|COMPLETED|Part 1, Washout Period 3 (5 Days)||8
6752446|NCT03457727|7679238|FG002|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6752447|NCT03457727|7679239|FG003|COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6752448|NCT03457727|7679236|FG000|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6752449|NCT03457727|7679237|FG001|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6752450|NCT03457727|7679238|FG002|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6752451|NCT03457727|7679239|FG003|NOT COMPLETED|Part 1, Washout Period 3 (5 Days)||0
6752452|NCT03457727|7679236|FG000|STARTED|Part 1, Period 4 (1 Day)||8
6752453|NCT03457727|7679237|FG001|STARTED|Part 1, Period 4 (1 Day)||8
6752454|NCT03457727|7679238|FG002|STARTED|Part 1, Period 4 (1 Day)||0
6752455|NCT03457727|7679239|FG003|STARTED|Part 1, Period 4 (1 Day)||0
6752456|NCT03457727|7679236|FG000|COMPLETED|Part 1, Period 4 (1 Day)||8
6752457|NCT03457727|7679237|FG001|COMPLETED|Part 1, Period 4 (1 Day)||8
6752458|NCT03457727|7679238|FG002|COMPLETED|Part 1, Period 4 (1 Day)||0
6752459|NCT03457727|7679239|FG003|COMPLETED|Part 1, Period 4 (1 Day)||0
6752460|NCT03457727|7679236|FG000|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
6752461|NCT03457727|7679237|FG001|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
6752462|NCT03457727|7679238|FG002|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
6752463|NCT03457727|7679239|FG003|NOT COMPLETED|Part 1, Period 4 (1 Day)||0
6752464|NCT03457727|7679236|FG000|STARTED|Part 2, Period 1 (1 Day)||0
6752465|NCT03457727|7679237|FG001|STARTED|Part 2, Period 1 (1 Day)||0
6752466|NCT03457727|7679238|FG002|STARTED|Part 2, Period 1 (1 Day)||12
6752467|NCT03457727|7679239|FG003|STARTED|Part 2, Period 1 (1 Day)||12
6752468|NCT03457727|7679236|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
6752469|NCT03457727|7679237|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
6752470|NCT03457727|7679238|FG002|COMPLETED|Part 2, Period 1 (1 Day)||12
6752471|NCT03457727|7679239|FG003|COMPLETED|Part 2, Period 1 (1 Day)||12
6752472|NCT03457727|7679236|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6752473|NCT03457727|7679237|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6752474|NCT03457727|7679238|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6752475|NCT03457727|7679239|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6752476|NCT03457727|7679236|FG000|STARTED|Part 2, Washout Period 1 (5 Days)||0
6752477|NCT03457727|7679237|FG001|STARTED|Part 2, Washout Period 1 (5 Days)||0
6752478|NCT03457727|7679238|FG002|STARTED|Part 2, Washout Period 1 (5 Days)||12
6752479|NCT03457727|7679239|FG003|STARTED|Part 2, Washout Period 1 (5 Days)||12
6752480|NCT03457727|7679236|FG000|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6752481|NCT03457727|7679237|FG001|COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6752482|NCT03457727|7679238|FG002|COMPLETED|Part 2, Washout Period 1 (5 Days)||12
6752483|NCT03457727|7679239|FG003|COMPLETED|Part 2, Washout Period 1 (5 Days)||11
6752484|NCT03457727|7679236|FG000|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6752485|NCT03457727|7679237|FG001|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6752486|NCT03457727|7679238|FG002|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||0
6752487|NCT03457727|7679239|FG003|NOT COMPLETED|Part 2, Washout Period 1 (5 Days)||1
6752488|NCT03457727|7679236|FG000|STARTED|Part 2, Period 2 (1 Day)||0
6752489|NCT03457727|7679237|FG001|STARTED|Part 2, Period 2 (1 Day)||0
6752490|NCT03457727|7679238|FG002|STARTED|Part 2, Period 2 (1 Day)||12
6752491|NCT03457727|7679239|FG003|STARTED|Part 2, Period 2 (1 Day)||11
6752492|NCT03457727|7679236|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
6752493|NCT03457727|7679237|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
6752494|NCT03457727|7679238|FG002|COMPLETED|Part 2, Period 2 (1 Day)||12
6752495|NCT03457727|7679239|FG003|COMPLETED|Part 2, Period 2 (1 Day)||11
6752496|NCT03457727|7679236|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6752497|NCT03457727|7679237|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6752498|NCT03457727|7679238|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6752499|NCT03457727|7679239|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6752500|NCT03457727|7679236|FG000|STARTED|Part 2, Washout Period 2 (5 Days)||0
6752501|NCT03457727|7679237|FG001|STARTED|Part 2, Washout Period 2 (5 Days)||0
6752502|NCT03457727|7679238|FG002|STARTED|Part 2, Washout Period 2 (5 Days)||12
6752503|NCT03457727|7679239|FG003|STARTED|Part 2, Washout Period 2 (5 Days)||11
6752504|NCT03457727|7679236|FG000|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6752505|NCT03457727|7679237|FG001|COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6752506|NCT03457727|7679238|FG002|COMPLETED|Part 2, Washout Period 2 (5 Days)||12
6752507|NCT03457727|7679239|FG003|COMPLETED|Part 2, Washout Period 2 (5 Days)||11
6752508|NCT03457727|7679236|FG000|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6752509|NCT03457727|7679237|FG001|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6752510|NCT03457727|7679238|FG002|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6752511|NCT03457727|7679239|FG003|NOT COMPLETED|Part 2, Washout Period 2 (5 Days)||0
6752512|NCT03457727|7679236|FG000|STARTED|Part 2, Period 3 (1 Day)||0
6752513|NCT03457727|7679237|FG001|STARTED|Part 2, Period 3 (1 Day)||0
6752514|NCT03457727|7679238|FG002|STARTED|Part 2, Period 3 (1 Day)||12
6752515|NCT03457727|7679239|FG003|STARTED|Part 2, Period 3 (1 Day)||11
6752516|NCT03457727|7679236|FG000|COMPLETED|Part 2, Period 3 (1 Day)||0
6752517|NCT03457727|7679237|FG001|COMPLETED|Part 2, Period 3 (1 Day)||0
6752518|NCT03457727|7679238|FG002|COMPLETED|Part 2, Period 3 (1 Day)||12
6752519|NCT03457727|7679239|FG003|COMPLETED|Part 2, Period 3 (1 Day)||11
6752520|NCT03457727|7679236|FG000|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
6752521|NCT03457727|7679237|FG001|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
6752522|NCT03457727|7679238|FG002|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
6752523|NCT03457727|7679239|FG003|NOT COMPLETED|Part 2, Period 3 (1 Day)||0
6752524|NCT03457727|7679236|FG000|STARTED|Part 2, Washout Period 3 (5 Days)||0
6752525|NCT03457727|7679237|FG001|STARTED|Part 2, Washout Period 3 (5 Days)||0
6752526|NCT03457727|7679238|FG002|STARTED|Part 2, Washout Period 3 (5 Days)||12
6752527|NCT03457727|7679239|FG003|STARTED|Part 2, Washout Period 3 (5 Days)||11
6752528|NCT03457727|7679236|FG000|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6752529|NCT03457727|7679237|FG001|COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6752530|NCT03457727|7679238|FG002|COMPLETED|Part 2, Washout Period 3 (5 Days)||12
6752531|NCT03457727|7679239|FG003|COMPLETED|Part 2, Washout Period 3 (5 Days)||11
6752532|NCT03457727|7679236|FG000|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6752533|NCT03457727|7679237|FG001|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6752534|NCT03457727|7679238|FG002|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6752535|NCT03457727|7679239|FG003|NOT COMPLETED|Part 2, Washout Period 3 (5 Days)||0
6752536|NCT03457727|7679236|FG000|STARTED|Part 2, Period 4 (1 Day)||0
6752537|NCT03457727|7679237|FG001|STARTED|Part 2, Period 4 (1 Day)||0
6752538|NCT03457727|7679238|FG002|STARTED|Part 2, Period 4 (1 Day)||12
6752539|NCT03457727|7679239|FG003|STARTED|Part 2, Period 4 (1 Day)||0
6752540|NCT03457727|7679236|FG000|COMPLETED|Part 2, Period 4 (1 Day)||0
6752541|NCT03457727|7679237|FG001|COMPLETED|Part 2, Period 4 (1 Day)||0
6752542|NCT03457727|7679238|FG002|COMPLETED|Part 2, Period 4 (1 Day)||12
6752543|NCT03457727|7679239|FG003|COMPLETED|Part 2, Period 4 (1 Day)||0
6752544|NCT03457727|7679236|FG000|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
6752545|NCT03457727|7679237|FG001|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
6752546|NCT03457727|7679238|FG002|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
6752547|NCT03457727|7679239|FG003|NOT COMPLETED|Part 2, Period 4 (1 Day)||0
6752548|NCT03457909|7679271|FG000|STARTED|Overall Study||25
6752549|NCT03457909|7679271|FG000|COMPLETED|Overall Study||25
6752550|NCT03457909|7679271|FG000|NOT COMPLETED|Overall Study||0
6752551|NCT03458702|7679275|FG000|STARTED|Study Condition A (Yoga or Rest)||28
6752552|NCT03458702|7679276|FG001|STARTED|Study Condition A (Yoga or Rest)||28
6752553|NCT03458702|7679275|FG000|COMPLETED|Study Condition A (Yoga or Rest)||24
6752554|NCT03458702|7679276|FG001|COMPLETED|Study Condition A (Yoga or Rest)||22
6752555|NCT03458702|7679275|FG000|NOT COMPLETED|Study Condition A (Yoga or Rest)||4
6752556|NCT03458702|7679276|FG001|NOT COMPLETED|Study Condition A (Yoga or Rest)||6
6752557|NCT03458702|7679275|FG000|STARTED|Study Condition B (Yoga or Rest)||24
6752558|NCT03458702|7679276|FG001|STARTED|Study Condition B (Yoga or Rest)||22
6752559|NCT03458702|7679275|FG000|COMPLETED|Study Condition B (Yoga or Rest)||20
6752560|NCT03458702|7679276|FG001|COMPLETED|Study Condition B (Yoga or Rest)||20
6752561|NCT03458702|7679275|FG000|NOT COMPLETED|Study Condition B (Yoga or Rest)||4
6752562|NCT03458702|7679276|FG001|NOT COMPLETED|Study Condition B (Yoga or Rest)||2
6752563|NCT03458702|7679275|FG000|STARTED|Picture Rating/Body Composition||20
6752564|NCT03458702|7679276|FG001|STARTED|Picture Rating/Body Composition||20
6752565|NCT03458702|7679275|FG000|COMPLETED|Picture Rating/Body Composition||20
6752566|NCT03458702|7679276|FG001|COMPLETED|Picture Rating/Body Composition||20
6752567|NCT03458702|7679275|FG000|NOT COMPLETED|Picture Rating/Body Composition||0
6752568|NCT03458702|7679276|FG001|NOT COMPLETED|Picture Rating/Body Composition||0
6752569|NCT03458871|7679282|FG000|STARTED|Overall Study||16
6752570|NCT03458871|7679282|FG000|COMPLETED|Overall Study||16
6752571|NCT03458871|7679282|FG000|NOT COMPLETED|Overall Study||0
6752572|NCT03459040|7679286|FG000|STARTED|Overall Study||30
6752573|NCT03459040|7679286|FG000|COMPLETED|Overall Study||21
6752574|NCT03459040|7679286|FG000|NOT COMPLETED|Overall Study||9
6752575|NCT03459131|7679291|FG000|STARTED|Period 1, First 7 Days of Wear||7
6752576|NCT03459131|7679292|FG001|STARTED|Period 1, First 7 Days of Wear||8
6752577|NCT03459131|7679291|FG000|COMPLETED|Period 1, First 7 Days of Wear||7
6752578|NCT03459131|7679292|FG001|COMPLETED|Period 1, First 7 Days of Wear||8
6752579|NCT03459131|7679291|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
6752580|NCT03459131|7679292|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
6752581|NCT03459131|7679291|FG000|STARTED|Period 2, Second 7 Days of Wear||7
6752582|NCT03459131|7679292|FG001|STARTED|Period 2, Second 7 Days of Wear||8
6752583|NCT03459131|7679291|FG000|COMPLETED|Period 2, Second 7 Days of Wear||7
6752584|NCT03459131|7679292|FG001|COMPLETED|Period 2, Second 7 Days of Wear||8
6752585|NCT03459131|7679291|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
6752586|NCT03459131|7679292|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
6752587|NCT03459196|7679298|FG000|STARTED|Overall Study||54
6752588|NCT03459196|7679298|FG000|COMPLETED|Overall Study||52
6752589|NCT03459196|7679298|FG000|NOT COMPLETED|Overall Study||2
6752590|NCT03459612|7679306|FG000|STARTED|Period 1||17
6752591|NCT03459612|7679307|FG001|STARTED|Period 1||17
6752592|NCT03459612|7679308|FG002|STARTED|Period 1||17
6752593|NCT03459612|7679309|FG003|STARTED|Period 1||17
6752594|NCT03459612|7679306|FG000|Received at Least 1 Dose of Study Drug|Period 1||17
6752595|NCT03459612|7679307|FG001|Received at Least 1 Dose of Study Drug|Period 1||17
6752596|NCT03459612|7679308|FG002|Received at Least 1 Dose of Study Drug|Period 1||17
6752597|NCT03459612|7679309|FG003|Received at Least 1 Dose of Study Drug|Period 1||17
6752598|NCT03459612|7679306|FG000|COMPLETED|Period 1||17
6752599|NCT03459612|7679307|FG001|COMPLETED|Period 1||17
6752600|NCT03459612|7679308|FG002|COMPLETED|Period 1||17
6752601|NCT03459612|7679309|FG003|COMPLETED|Period 1||17
6752602|NCT03459612|7679306|FG000|NOT COMPLETED|Period 1||0
6752603|NCT03459612|7679307|FG001|NOT COMPLETED|Period 1||0
6752604|NCT03459612|7679308|FG002|NOT COMPLETED|Period 1||0
6752605|NCT03459612|7679309|FG003|NOT COMPLETED|Period 1||0
6752606|NCT03459612|7679306|FG000|STARTED|Period 2||17
6752607|NCT03459612|7679307|FG001|STARTED|Period 2||17
6752608|NCT03459612|7679308|FG002|STARTED|Period 2||17
6752609|NCT03459612|7679309|FG003|STARTED|Period 2||17
6752610|NCT03459612|7679306|FG000|Received at Least 1 Dose of Study Drug|Period 2||17
6752611|NCT03459612|7679307|FG001|Received at Least 1 Dose of Study Drug|Period 2||17
6752612|NCT03459612|7679308|FG002|Received at Least 1 Dose of Study Drug|Period 2||17
6752613|NCT03459612|7679309|FG003|Received at Least 1 Dose of Study Drug|Period 2||17
6752614|NCT03459612|7679306|FG000|COMPLETED|Period 2||17
6752615|NCT03459612|7679307|FG001|COMPLETED|Period 2||17
6752616|NCT03459612|7679308|FG002|COMPLETED|Period 2||17
6752617|NCT03459612|7679309|FG003|COMPLETED|Period 2||17
6752618|NCT03459612|7679306|FG000|NOT COMPLETED|Period 2||0
6752619|NCT03459612|7679307|FG001|NOT COMPLETED|Period 2||0
6752620|NCT03459612|7679308|FG002|NOT COMPLETED|Period 2||0
6752621|NCT03459612|7679309|FG003|NOT COMPLETED|Period 2||0
6752622|NCT03459612|7679306|FG000|STARTED|Period 3||17
6752623|NCT03459612|7679307|FG001|STARTED|Period 3||17
6752624|NCT03459612|7679308|FG002|STARTED|Period 3||17
6752625|NCT03459612|7679309|FG003|STARTED|Period 3||17
6752626|NCT03459612|7679306|FG000|Received at Least 1 Dose of Study Drug|Period 3||17
6752627|NCT03459612|7679307|FG001|Received at Least 1 Dose of Study Drug|Period 3||17
6752628|NCT03459612|7679308|FG002|Received at Least 1 Dose of Study Drug|Period 3||17
6752629|NCT03459612|7679309|FG003|Received at Least 1 Dose of Study Drug|Period 3||17
6305855|NCT00371150|7209241|FG000|Discontinued at or After Week 48 Visit|Overall Study||2
6752630|NCT03459612|7679306|FG000|COMPLETED|Period 3||17
6752631|NCT03459612|7679307|FG001|COMPLETED|Period 3||17
6752632|NCT03459612|7679308|FG002|COMPLETED|Period 3||17
6752633|NCT03459612|7679309|FG003|COMPLETED|Period 3||17
6752634|NCT03459612|7679306|FG000|NOT COMPLETED|Period 3||0
6752635|NCT03459612|7679307|FG001|NOT COMPLETED|Period 3||0
6752636|NCT03459612|7679308|FG002|NOT COMPLETED|Period 3||0
6752637|NCT03459612|7679309|FG003|NOT COMPLETED|Period 3||0
6752638|NCT03459612|7679306|FG000|STARTED|Period 4||17
6752639|NCT03459612|7679307|FG001|STARTED|Period 4||17
6752640|NCT03459612|7679308|FG002|STARTED|Period 4|One participant completed period 3 and withdrew for personal reasons prior to Period 4.|16
6752641|NCT03459612|7679309|FG003|STARTED|Period 4||17
6752642|NCT03459612|7679306|FG000|Received at Least 1 Dose of Study Drug|Period 4||17
6752643|NCT03459612|7679307|FG001|Received at Least 1 Dose of Study Drug|Period 4||17
6752644|NCT03459612|7679308|FG002|Received at Least 1 Dose of Study Drug|Period 4||16
6752645|NCT03459612|7679309|FG003|Received at Least 1 Dose of Study Drug|Period 4||17
6752646|NCT03459612|7679306|FG000|COMPLETED|Period 4||17
6752647|NCT03459612|7679307|FG001|COMPLETED|Period 4||17
6752648|NCT03459612|7679308|FG002|COMPLETED|Period 4||16
6752649|NCT03459612|7679309|FG003|COMPLETED|Period 4||17
6752650|NCT03459612|7679306|FG000|NOT COMPLETED|Period 4||0
6752651|NCT03459612|7679307|FG001|NOT COMPLETED|Period 4||0
6752652|NCT03459612|7679308|FG002|NOT COMPLETED|Period 4||0
6752653|NCT03459612|7679309|FG003|NOT COMPLETED|Period 4||0
6752654|NCT03459794|7679324|FG000|STARTED|Overall Study||8
6752655|NCT03459794|7679325|FG001|STARTED|Overall Study||4
6752656|NCT03459794|7679324|FG000|COMPLETED|Overall Study||8
6752657|NCT03459794|7679325|FG001|COMPLETED|Overall Study||4
6752658|NCT03459794|7679324|FG000|NOT COMPLETED|Overall Study||0
6752659|NCT03459794|7679325|FG001|NOT COMPLETED|Overall Study||0
6752660|NCT03460587|7679337|FG000|STARTED|Overall Study||13
6752661|NCT03460587|7679337|FG000|COMPLETED|Overall Study||13
6752662|NCT03460587|7679337|FG000|NOT COMPLETED|Overall Study||0
6752663|NCT03460652|7679341|FG000|STARTED|Overall Study||282
6752664|NCT03460652|7679341|FG000|Entered Treatment Phase|Overall Study||238
6752665|NCT03460652|7679341|FG000|COMPLETED|Overall Study||155
6752666|NCT03460652|7679341|FG000|NOT COMPLETED|Overall Study||127
6752667|NCT03460899|7679346|FG000|STARTED|Euglycaemic Clamp|First Euglycaemic Clamp completed: 05. March 2018|14
6752668|NCT03460899|7679346|FG000|COMPLETED|Euglycaemic Clamp|Last Euglycaemic clamp completed: 23. May 2018|14
6752669|NCT03460899|7679346|FG000|NOT COMPLETED|Euglycaemic Clamp||0
6752670|NCT03460899|7679346|FG000|STARTED|Hyperinsulinaemic/Hypoglycaemic Clamp|First Hyperinsulinaemic/Hypoglycaemic Clamp completed: 15. March 2018|14
6752671|NCT03460899|7679346|FG000|COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp|Last Hyperinsulinaemic/Hypoglycaemic Clamp completed: 05. June 2018|14
6752672|NCT03460899|7679346|FG000|NOT COMPLETED|Hyperinsulinaemic/Hypoglycaemic Clamp||0
6752673|NCT03460990|7679352|FG000|STARTED|Overall Study||57
6752674|NCT03460990|7679353|FG001|STARTED|Overall Study||54
6752675|NCT03460990|7679352|FG000|COMPLETED|Overall Study||57
6752676|NCT03460990|7679353|FG001|COMPLETED|Overall Study||54
6752677|NCT03460990|7679352|FG000|NOT COMPLETED|Overall Study||0
6752678|NCT03460990|7679353|FG001|NOT COMPLETED|Overall Study||0
6752679|NCT03461146|7679359|FG000|STARTED|Overall Study||24
6752680|NCT03461146|7679359|FG000|COMPLETED|Overall Study||21
6752681|NCT03461146|7679359|FG000|NOT COMPLETED|Overall Study||3
6752682|NCT03461289|7679363|FG000|STARTED|Overall Study||33
6752683|NCT03461289|7679363|FG000|COMPLETED|Overall Study||32
6752684|NCT03461289|7679363|FG000|NOT COMPLETED|Overall Study||1
6752685|NCT03461757|7679369|FG000|STARTED|Overall Study||732
6752686|NCT03461757|7679370|FG001|STARTED|Overall Study||734
6752687|NCT03461757|7679369|FG000|Treated|Overall Study||682
6752688|NCT03461757|7679370|FG001|Treated|Overall Study||693
6752689|NCT03461757|7679369|FG000|COMPLETED|Overall Study||679
6752690|NCT03461757|7679370|FG001|COMPLETED|Overall Study||689
6752691|NCT03461757|7679369|FG000|NOT COMPLETED|Overall Study||53
6752692|NCT03461757|7679370|FG001|NOT COMPLETED|Overall Study||45
6752693|NCT03461965|7679378|FG000|STARTED|Overall Study||42
6752694|NCT03461965|7679379|FG001|STARTED|Overall Study||40
6752695|NCT03461965|7679378|FG000|COMPLETED|Overall Study||42
6752696|NCT03461965|7679379|FG001|COMPLETED|Overall Study||40
6752697|NCT03461965|7679378|FG000|NOT COMPLETED|Overall Study||0
6752698|NCT03461965|7679379|FG001|NOT COMPLETED|Overall Study||0
6752699|NCT03462082|7679385|FG000|STARTED|Study Phase (Randomized, Blinded Period)||3
6752700|NCT03462082|7679386|FG001|STARTED|Study Phase (Randomized, Blinded Period)||4
6752701|NCT03462082|7679387|FG002|STARTED|Study Phase (Randomized, Blinded Period)||4
6752702|NCT03462082|7679388|FG003|STARTED|Study Phase (Randomized, Blinded Period)||3
6555554|NCT01752985|7477720|FG001|COMPLETED|Follow-up Period||27
6555555|NCT01752985|7477721|FG002|COMPLETED|Follow-up Period||26
6752703|NCT03462082|7679389|FG004|STARTED|Study Phase (Randomized, Blinded Period)||3
6752704|NCT03462082|7679390|FG005|STARTED|Study Phase (Randomized, Blinded Period)||5
6752705|NCT03462082|7679391|FG006|STARTED|Study Phase (Randomized, Blinded Period)||0
6752706|NCT03462082|7679392|FG007|STARTED|Study Phase (Randomized, Blinded Period)||0
6752707|NCT03462082|7679385|FG000|COMPLETED|Study Phase (Randomized, Blinded Period)||3
6752708|NCT03462082|7679386|FG001|COMPLETED|Study Phase (Randomized, Blinded Period)||4
6752709|NCT03462082|7679387|FG002|COMPLETED|Study Phase (Randomized, Blinded Period)||4
6752710|NCT03462082|7679388|FG003|COMPLETED|Study Phase (Randomized, Blinded Period)||3
6752711|NCT03462082|7679389|FG004|COMPLETED|Study Phase (Randomized, Blinded Period)||3
6752712|NCT03462082|7679390|FG005|COMPLETED|Study Phase (Randomized, Blinded Period)||5
6752713|NCT03462082|7679391|FG006|COMPLETED|Study Phase (Randomized, Blinded Period)||0
6555556|NCT01752985|7477719|FG000|NOT COMPLETED|Follow-up Period||0
6752714|NCT03462082|7679392|FG007|COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752715|NCT03462082|7679385|FG000|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752716|NCT03462082|7679386|FG001|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752717|NCT03462082|7679387|FG002|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752718|NCT03462082|7679388|FG003|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752719|NCT03462082|7679389|FG004|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752720|NCT03462082|7679390|FG005|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752721|NCT03462082|7679391|FG006|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752722|NCT03462082|7679392|FG007|NOT COMPLETED|Study Phase (Randomized, Blinded Period)||0
6752723|NCT03462082|7679385|FG000|STARTED|Open Label Phase||0
6752724|NCT03462082|7679386|FG001|STARTED|Open Label Phase||0
6752725|NCT03462082|7679387|FG002|STARTED|Open Label Phase||0
6752726|NCT03462082|7679388|FG003|STARTED|Open Label Phase||0
6752727|NCT03462082|7679389|FG004|STARTED|Open Label Phase||0
6752728|NCT03462082|7679390|FG005|STARTED|Open Label Phase||0
6752729|NCT03462082|7679391|FG006|STARTED|Open Label Phase||7
6752730|NCT03462082|7679392|FG007|STARTED|Open Label Phase||10
6752731|NCT03462082|7679385|FG000|COMPLETED|Open Label Phase||0
6752732|NCT03462082|7679386|FG001|COMPLETED|Open Label Phase||0
6752733|NCT03462082|7679387|FG002|COMPLETED|Open Label Phase||0
6752734|NCT03462082|7679388|FG003|COMPLETED|Open Label Phase||0
6752735|NCT03462082|7679389|FG004|COMPLETED|Open Label Phase||0
6752736|NCT03462082|7679390|FG005|COMPLETED|Open Label Phase||0
6752737|NCT03462082|7679391|FG006|COMPLETED|Open Label Phase||6
6752738|NCT03462082|7679392|FG007|COMPLETED|Open Label Phase||8
6654790|NCT02448368|7584708|FG008|COMPLETED|Overall Study||2
6654791|NCT02448368|7584709|FG009|COMPLETED|Overall Study||2
6654792|NCT02448368|7584710|FG010|COMPLETED|Overall Study||5
6654793|NCT02448368|7584711|FG011|COMPLETED|Overall Study||5
6654794|NCT02448368|7584712|FG012|COMPLETED|Overall Study||5
6654795|NCT02448368|7584700|FG000|NOT COMPLETED|Overall Study||0
6654796|NCT02448368|7584701|FG001|NOT COMPLETED|Overall Study||0
6654797|NCT02448368|7584702|FG002|NOT COMPLETED|Overall Study||0
6654798|NCT02448368|7584703|FG003|NOT COMPLETED|Overall Study||0
6654799|NCT02448368|7584704|FG004|NOT COMPLETED|Overall Study||0
6654800|NCT02448368|7584705|FG005|NOT COMPLETED|Overall Study||0
6654801|NCT02448368|7584706|FG006|NOT COMPLETED|Overall Study||0
6654802|NCT02448368|7584707|FG007|NOT COMPLETED|Overall Study||0
6654803|NCT02448368|7584708|FG008|NOT COMPLETED|Overall Study||0
6654804|NCT02448368|7584709|FG009|NOT COMPLETED|Overall Study||0
6654805|NCT02448368|7584710|FG010|NOT COMPLETED|Overall Study||0
6654806|NCT02448368|7584711|FG011|NOT COMPLETED|Overall Study||0
6654807|NCT02448368|7584712|FG012|NOT COMPLETED|Overall Study||0
6654808|NCT02448446|7584739|FG000|STARTED|Overall Study||13
6654809|NCT02448446|7584740|FG001|STARTED|Overall Study||12
6654810|NCT02448446|7584739|FG000|COMPLETED|Overall Study||12
6654811|NCT02448446|7584740|FG001|COMPLETED|Overall Study||12
6654812|NCT02448446|7584739|FG000|NOT COMPLETED|Overall Study||1
6654813|NCT02448446|7584740|FG001|NOT COMPLETED|Overall Study||0
6654814|NCT02448537|7584749|FG000|STARTED|Overall Study||20
6654815|NCT02448537|7584750|FG001|STARTED|Overall Study||10
6654816|NCT02448537|7584751|FG002|STARTED|Overall Study||12
6654817|NCT02448537|7584749|FG000|COMPLETED|Overall Study||19
6654818|NCT02448537|7584750|FG001|COMPLETED|Overall Study||9
6654819|NCT02448537|7584751|FG002|COMPLETED|Overall Study||11
6654820|NCT02448537|7584749|FG000|NOT COMPLETED|Overall Study||1
6654821|NCT02448537|7584750|FG001|NOT COMPLETED|Overall Study||1
6654822|NCT02448537|7584751|FG002|NOT COMPLETED|Overall Study||1
6654823|NCT02448563|7584763|FG000|STARTED|Overall Study|Randomized after completing Visit 2|32
6654824|NCT02448563|7584764|FG001|STARTED|Overall Study|Randomized after completing Visit 2|30
6654825|NCT02448563|7584763|FG000|COMPLETED|Overall Study||16
6654826|NCT02448563|7584764|FG001|COMPLETED|Overall Study||19
6654827|NCT02448563|7584763|FG000|NOT COMPLETED|Overall Study||16
6654828|NCT02448563|7584764|FG001|NOT COMPLETED|Overall Study||11
6654829|NCT02448641|7584777|FG000|STARTED|Overall Study||55
6654830|NCT02448641|7584778|FG001|STARTED|Overall Study||56
6654831|NCT02448641|7584779|FG002|STARTED|Overall Study||52
6654832|NCT02448641|7584777|FG000|COMPLETED|Overall Study||54
6654833|NCT02448641|7584778|FG001|COMPLETED|Overall Study||51
6654834|NCT02448641|7584779|FG002|COMPLETED|Overall Study||48
6654835|NCT02448641|7584777|FG000|NOT COMPLETED|Overall Study||1
6654836|NCT02448641|7584778|FG001|NOT COMPLETED|Overall Study||5
6654837|NCT02448641|7584779|FG002|NOT COMPLETED|Overall Study||4
6654838|NCT02448654|7584796|FG000|STARTED|Overall Study||19
6654839|NCT02448654|7584797|FG001|STARTED|Overall Study||17
6654840|NCT02448654|7584796|FG000|Started Pills (Tolcapone or Placebo)|Overall Study||17
6654841|NCT02448654|7584797|FG001|Started Pills (Tolcapone or Placebo)|Overall Study||15
6654842|NCT02448654|7584796|FG000|COMPLETED|Overall Study||16
6654843|NCT02448654|7584797|FG001|COMPLETED|Overall Study||13
6654844|NCT02448654|7584796|FG000|NOT COMPLETED|Overall Study||3
6654845|NCT02448654|7584797|FG001|NOT COMPLETED|Overall Study||4
6654846|NCT02448706|7584803|FG000|STARTED|Overall Study||25
6654847|NCT02448706|7584804|FG001|STARTED|Overall Study||24
6654848|NCT02448706|7584803|FG000|Withdrew for Personal Reasons|Overall Study||1
6654849|NCT02448706|7584804|FG001|Withdrew for Personal Reasons|Overall Study||1
6752739|NCT03462082|7679385|FG000|NOT COMPLETED|Open Label Phase||0
6752740|NCT03462082|7679386|FG001|NOT COMPLETED|Open Label Phase||0
6752741|NCT03462082|7679387|FG002|NOT COMPLETED|Open Label Phase||0
6752742|NCT03462082|7679388|FG003|NOT COMPLETED|Open Label Phase||0
6752743|NCT03462082|7679389|FG004|NOT COMPLETED|Open Label Phase||0
6752744|NCT03462082|7679390|FG005|NOT COMPLETED|Open Label Phase||0
6752745|NCT03462082|7679391|FG006|NOT COMPLETED|Open Label Phase||1
6752746|NCT03462082|7679392|FG007|NOT COMPLETED|Open Label Phase||2
6752747|NCT03462576|7679405|FG000|STARTED|Overall Study||46
6752748|NCT03462576|7679406|FG001|STARTED|Overall Study||48
6752749|NCT03462576|7679407|FG002|STARTED|Overall Study||45
6752750|NCT03462576|7679405|FG000|COMPLETED|Overall Study||41
6752751|NCT03462576|7679406|FG001|COMPLETED|Overall Study||37
6752752|NCT03462576|7679407|FG002|COMPLETED|Overall Study||37
6752753|NCT03462576|7679405|FG000|NOT COMPLETED|Overall Study||5
6752754|NCT03462576|7679406|FG001|NOT COMPLETED|Overall Study||11
6752755|NCT03462576|7679407|FG002|NOT COMPLETED|Overall Study||8
6752756|NCT03462680|7679417|FG000|STARTED|Overall Study||21
6752757|NCT03462680|7679418|FG001|STARTED|Overall Study||26
6752758|NCT03462680|7679417|FG000|COMPLETED|Overall Study||18
6752759|NCT03462680|7679418|FG001|COMPLETED|Overall Study||21
6752760|NCT03462680|7679417|FG000|NOT COMPLETED|Overall Study||3
6752761|NCT03462680|7679418|FG001|NOT COMPLETED|Overall Study||5
6752762|NCT03462745|7679426|FG000|STARTED|Overall Study||92
6752763|NCT03462745|7679427|FG001|STARTED|Overall Study||92
6555557|NCT01752985|7477720|FG001|NOT COMPLETED|Follow-up Period||0
6555558|NCT01752985|7477721|FG002|NOT COMPLETED|Follow-up Period||0
6555559|NCT01753076|7477731|FG000|STARTED|Overall Study||151
6555560|NCT01753076|7477732|FG001|STARTED|Overall Study||152
6555561|NCT01753076|7477731|FG000|COMPLETED|Overall Study||110
6555562|NCT01753076|7477732|FG001|COMPLETED|Overall Study||106
6555563|NCT01753076|7477731|FG000|NOT COMPLETED|Overall Study||41
6555564|NCT01753076|7477732|FG001|NOT COMPLETED|Overall Study||46
6555565|NCT01753115|7477743|FG000|STARTED|Overall Study||44
6752764|NCT03462745|7679426|FG000|COMPLETED|Overall Study||92
6752765|NCT03462745|7679427|FG001|COMPLETED|Overall Study||92
6752766|NCT03462745|7679426|FG000|NOT COMPLETED|Overall Study||0
6555566|NCT01753115|7477744|FG001|STARTED|Overall Study||40
6752767|NCT03462745|7679427|FG001|NOT COMPLETED|Overall Study||0
6752768|NCT03462927|7679435|FG000|STARTED|Overall Study||32
6752769|NCT03462927|7679436|FG001|STARTED|Overall Study||31
6752770|NCT03462927|7679435|FG000|COMPLETED|Overall Study||26
6752771|NCT03462927|7679436|FG001|COMPLETED|Overall Study||29
6752772|NCT03462927|7679435|FG000|NOT COMPLETED|Overall Study||6
6752773|NCT03462927|7679436|FG001|NOT COMPLETED|Overall Study||2
6752774|NCT03463031|7679446|FG000|STARTED|Overall Study||225
6752775|NCT03463031|7679447|FG001|STARTED|Overall Study||221
6752776|NCT03463031|7679446|FG000|COMPLETED|Overall Study||215
6752777|NCT03463031|7679447|FG001|COMPLETED|Overall Study||216
6752778|NCT03463031|7679446|FG000|NOT COMPLETED|Overall Study||10
6752779|NCT03463031|7679447|FG001|NOT COMPLETED|Overall Study||5
6752780|NCT03463161|7679453|FG000|STARTED|Overall Study||2
6752781|NCT03463161|7679453|FG000|COMPLETED|Overall Study||2
6752782|NCT03463161|7679453|FG000|NOT COMPLETED|Overall Study||0
6752783|NCT03463512|7679459|FG000|STARTED|Overall Study||62
6752784|NCT03463512|7679460|FG001|STARTED|Overall Study||62
6752785|NCT03463512|7679459|FG000|COMPLETED|Overall Study||62
6752786|NCT03463512|7679460|FG001|COMPLETED|Overall Study||62
6752787|NCT03463512|7679459|FG000|NOT COMPLETED|Overall Study||0
6752788|NCT03463512|7679460|FG001|NOT COMPLETED|Overall Study||0
6752789|NCT03463889|7679466|FG000|STARTED|Overall Study||12
6752790|NCT03463889|7679466|FG000|COMPLETED|Overall Study||12
6752791|NCT03463889|7679466|FG000|NOT COMPLETED|Overall Study||0
6752792|NCT03463915|7679472|FG000|STARTED|Overall Study||45
6752793|NCT03463915|7679473|FG001|STARTED|Overall Study||45
6752794|NCT03463915|7679472|FG000|COMPLETED|Overall Study||35
6752795|NCT03463915|7679473|FG001|COMPLETED|Overall Study||36
6752796|NCT03463915|7679472|FG000|NOT COMPLETED|Overall Study||10
6752797|NCT03463915|7679473|FG001|NOT COMPLETED|Overall Study||9
6752798|NCT03463941|7679481|FG000|STARTED|Overall Study||80
6752799|NCT03463941|7679481|FG000|COMPLETED|Overall Study||62
6752800|NCT03463941|7679481|FG000|NOT COMPLETED|Overall Study||18
6779938|NCT03500406|7708211|FG001|NOT COMPLETED|Overall Study||0
6779939|NCT03500341|7708217|FG000|STARTED|Overall Study||16
6779940|NCT03500341|7708217|FG000|COMPLETED|Overall Study||14
6779941|NCT03500341|7708217|FG000|NOT COMPLETED|Overall Study||2
6779942|NCT03500159|7708223|FG000|STARTED|Overall Study||2
6779943|NCT03500159|7708224|FG001|STARTED|Overall Study||1
6779944|NCT03500159|7708223|FG000|COMPLETED|Overall Study||0
6779945|NCT03500159|7708224|FG001|COMPLETED|Overall Study||0
6779946|NCT03500159|7708223|FG000|NOT COMPLETED|Overall Study||2
6779947|NCT03500159|7708224|FG001|NOT COMPLETED|Overall Study||1
6779948|NCT03490916|7708232|FG000|STARTED|Overall Study||0
6779949|NCT03490916|7708233|FG001|STARTED|Overall Study||0
6779950|NCT03490916|7708232|FG000|COMPLETED|Overall Study||0
6779951|NCT03490916|7708233|FG001|COMPLETED|Overall Study||0
6779952|NCT03490916|7708232|FG000|NOT COMPLETED|Overall Study||0
6779953|NCT03490916|7708233|FG001|NOT COMPLETED|Overall Study||0
6780998|NCT02717949|7709587|FG000|STARTED|Overall Study||0
6780999|NCT02717949|7709588|FG001|STARTED|Overall Study||0
6781000|NCT02717949|7709587|FG000|COMPLETED|Overall Study||0
6781001|NCT02717949|7709588|FG001|COMPLETED|Overall Study||0
6781002|NCT02717949|7709587|FG000|NOT COMPLETED|Overall Study||0
6781003|NCT02717949|7709588|FG001|NOT COMPLETED|Overall Study||0
6781004|NCT02717130|7709596|FG000|STARTED|Overall Study|Of the nine enrolled subjects, eight received study drug.|8
6781005|NCT02717130|7709596|FG000|COMPLETED|Overall Study||1
6781006|NCT02717130|7709596|FG000|NOT COMPLETED|Overall Study||7
6781007|NCT02685202|7709600|FG000|STARTED|Overall Study||9
6781008|NCT02685202|7709600|FG000|COMPLETED|Overall Study||0
6781009|NCT02685202|7709600|FG000|NOT COMPLETED|Overall Study||9
6781010|NCT02709083|7709604|FG000|STARTED|Overall Study||7
6781011|NCT02709083|7709604|FG000|COMPLETED|Overall Study||0
6781012|NCT02709083|7709604|FG000|NOT COMPLETED|Overall Study||7
6781013|NCT02693171|7709608|FG000|STARTED|Overall Study|At study termination, 13 subjects had enrolled, 12 subjects received at least 1 dose of study drug.|12
6781014|NCT02693171|7709608|FG000|COMPLETED|Overall Study||3
6781015|NCT02693171|7709608|FG000|NOT COMPLETED|Overall Study||9
6781016|NCT02696226|7709616|FG000|STARTED|Overall Study||1
6781017|NCT02696226|7709617|FG001|STARTED|Overall Study||0
6781018|NCT02696226|7709618|FG002|STARTED|Overall Study||2
6781019|NCT02696226|7709619|FG003|STARTED|Overall Study||0
6781020|NCT02696226|7709616|FG000|COMPLETED|Overall Study||0
6781021|NCT02696226|7709617|FG001|COMPLETED|Overall Study||0
6781022|NCT02696226|7709618|FG002|COMPLETED|Overall Study||0
6781023|NCT02696226|7709619|FG003|COMPLETED|Overall Study||0
6781024|NCT02696226|7709616|FG000|NOT COMPLETED|Overall Study||1
6781025|NCT02696226|7709617|FG001|NOT COMPLETED|Overall Study||0
6781026|NCT02696226|7709618|FG002|NOT COMPLETED|Overall Study||2
6781027|NCT02696226|7709619|FG003|NOT COMPLETED|Overall Study||0
6781028|NCT02693743|7709631|FG000|STARTED|Overall Study||1
6781029|NCT02693743|7709632|FG001|STARTED|Overall Study||0
6781030|NCT02693743|7709631|FG000|COMPLETED|Overall Study||0
6781031|NCT02693743|7709632|FG001|COMPLETED|Overall Study||0
6781032|NCT02693743|7709631|FG000|NOT COMPLETED|Overall Study||1
6781033|NCT02693743|7709632|FG001|NOT COMPLETED|Overall Study||0
6781034|NCT02706691|7709638|FG000|STARTED|Overall Study||1
6781035|NCT02706691|7709638|FG000|COMPLETED|Overall Study||0
6781036|NCT02706691|7709638|FG000|NOT COMPLETED|Overall Study||1
6781037|NCT02708849|7709645|FG000|STARTED|Overall Study||2
6781038|NCT02708849|7709646|FG001|STARTED|Overall Study||1
6781039|NCT02708849|7709645|FG000|COMPLETED|Overall Study||1
6752801|NCT03464383|7679489|FG000|STARTED|Overall Study||3
6752802|NCT03464383|7679490|FG001|STARTED|Overall Study||3
6752803|NCT03464383|7679491|FG002|STARTED|Overall Study||63
6752804|NCT03464383|7679489|FG000|COMPLETED|Overall Study||2
6752805|NCT03464383|7679490|FG001|COMPLETED|Overall Study||2
6752806|NCT03464383|7679491|FG002|COMPLETED|Overall Study||63
6752807|NCT03464383|7679489|FG000|NOT COMPLETED|Overall Study||1
6752808|NCT03464383|7679490|FG001|NOT COMPLETED|Overall Study||1
6752809|NCT03464383|7679491|FG002|NOT COMPLETED|Overall Study||0
6752810|NCT03464422|7679500|FG000|STARTED|Overall Study||21
6752811|NCT03464422|7679500|FG000|COMPLETED|Overall Study||17
6752812|NCT03464422|7679500|FG000|NOT COMPLETED|Overall Study||4
6752813|NCT03465436|7679510|FG000|STARTED|Period 1||14
6752814|NCT03465436|7679511|FG001|STARTED|Period 1||14
6752815|NCT03465436|7679512|FG002|STARTED|Period 1||14
6752816|NCT03465436|7679513|FG003|STARTED|Period 1||14
6752817|NCT03465436|7679510|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
6752818|NCT03465436|7679511|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
6752819|NCT03465436|7679512|FG002|Received at Least 1 Dose of Study Drug|Period 1||14
6752820|NCT03465436|7679513|FG003|Received at Least 1 Dose of Study Drug|Period 1||14
6752821|NCT03465436|7679510|FG000|COMPLETED|Period 1||14
6752822|NCT03465436|7679511|FG001|COMPLETED|Period 1||14
6752823|NCT03465436|7679512|FG002|COMPLETED|Period 1||13
6752824|NCT03465436|7679513|FG003|COMPLETED|Period 1||14
6752825|NCT03465436|7679510|FG000|NOT COMPLETED|Period 1||0
6752826|NCT03465436|7679511|FG001|NOT COMPLETED|Period 1||0
6752827|NCT03465436|7679512|FG002|NOT COMPLETED|Period 1||1
6752828|NCT03465436|7679513|FG003|NOT COMPLETED|Period 1||0
6752829|NCT03465436|7679510|FG000|STARTED|Period 2||14
6752830|NCT03465436|7679511|FG001|STARTED|Period 2||14
6752831|NCT03465436|7679512|FG002|STARTED|Period 2||13
6752832|NCT03465436|7679513|FG003|STARTED|Period 2||14
6752833|NCT03465436|7679510|FG000|Received at Least 1 Dose of Study Drug|Period 2||14
6752834|NCT03465436|7679511|FG001|Received at Least 1 Dose of Study Drug|Period 2||13
6752835|NCT03465436|7679512|FG002|Received at Least 1 Dose of Study Drug|Period 2||13
6752836|NCT03465436|7679513|FG003|Received at Least 1 Dose of Study Drug|Period 2||14
6752837|NCT03465436|7679510|FG000|COMPLETED|Period 2||14
6752838|NCT03465436|7679511|FG001|COMPLETED|Period 2||13
6752839|NCT03465436|7679512|FG002|COMPLETED|Period 2||13
6752840|NCT03465436|7679513|FG003|COMPLETED|Period 2||14
6752841|NCT03465436|7679510|FG000|NOT COMPLETED|Period 2||0
6752842|NCT03465436|7679511|FG001|NOT COMPLETED|Period 2||1
6752843|NCT03465436|7679512|FG002|NOT COMPLETED|Period 2||0
6752844|NCT03465436|7679513|FG003|NOT COMPLETED|Period 2||0
6752845|NCT03465436|7679510|FG000|STARTED|Period 3||14
6752846|NCT03465436|7679511|FG001|STARTED|Period 3||13
6555567|NCT01753115|7477745|FG002|STARTED|Overall Study||70
6555568|NCT01753115|7477743|FG000|Treated|Overall Study||38
6555569|NCT01753115|7477744|FG001|Treated|Overall Study||39
6555570|NCT01753115|7477745|FG002|Treated|Overall Study||67
6555571|NCT01753115|7477743|FG000|COMPLETED|Overall Study||32
6555572|NCT01753115|7477744|FG001|COMPLETED|Overall Study||25
6555573|NCT01753115|7477745|FG002|COMPLETED|Overall Study||56
6555574|NCT01753115|7477743|FG000|NOT COMPLETED|Overall Study||12
6555575|NCT01753115|7477744|FG001|NOT COMPLETED|Overall Study||15
6555576|NCT01753115|7477745|FG002|NOT COMPLETED|Overall Study||14
6555577|NCT01753193|7477753|FG000|STARTED|Overall Study||218
6555578|NCT01753193|7477753|FG000|COMPLETED|Overall Study||172
6555579|NCT01753193|7477753|FG000|NOT COMPLETED|Overall Study||46
6555580|NCT01753297|7477759|FG000|STARTED|Overall Study||117
6555581|NCT01753297|7477760|FG001|STARTED|Overall Study||109
6752847|NCT03465436|7679512|FG002|STARTED|Period 3||13
6752848|NCT03465436|7679513|FG003|STARTED|Period 3||14
6752849|NCT03465436|7679510|FG000|Received at Least One Dose of Study Drug|Period 3||13
6752850|NCT03465436|7679511|FG001|Received at Least One Dose of Study Drug|Period 3||12
6752851|NCT03465436|7679512|FG002|Received at Least One Dose of Study Drug|Period 3||13
6752852|NCT03465436|7679513|FG003|Received at Least One Dose of Study Drug|Period 3||14
6752853|NCT03465436|7679510|FG000|COMPLETED|Period 3||13
6752854|NCT03465436|7679511|FG001|COMPLETED|Period 3||12
6752855|NCT03465436|7679512|FG002|COMPLETED|Period 3||13
6752856|NCT03465436|7679513|FG003|COMPLETED|Period 3||14
6752857|NCT03465436|7679510|FG000|NOT COMPLETED|Period 3||1
6752858|NCT03465436|7679511|FG001|NOT COMPLETED|Period 3||1
6752859|NCT03465436|7679512|FG002|NOT COMPLETED|Period 3||0
6752860|NCT03465436|7679513|FG003|NOT COMPLETED|Period 3||0
6752861|NCT03465436|7679510|FG000|STARTED|Period 4||13
6555582|NCT01753297|7477759|FG000|Received Triptorelin Treatment|Overall Study||0
6752862|NCT03465436|7679511|FG001|STARTED|Period 4||12
6752863|NCT03465436|7679512|FG002|STARTED|Period 4||13
6752864|NCT03465436|7679513|FG003|STARTED|Period 4||14
6555583|NCT01753297|7477760|FG001|Received Triptorelin Treatment|Overall Study||105
6555584|NCT01753297|7477759|FG000|COMPLETED|Overall Study||76
6555585|NCT01753297|7477760|FG001|COMPLETED|Overall Study||73
6752865|NCT03465436|7679510|FG000|Received at Least 1 Dose of Study Drug|Period 4||13
6752866|NCT03465436|7679511|FG001|Received at Least 1 Dose of Study Drug|Period 4||12
6752867|NCT03465436|7679512|FG002|Received at Least 1 Dose of Study Drug|Period 4||13
6752868|NCT03465436|7679513|FG003|Received at Least 1 Dose of Study Drug|Period 4||14
6752869|NCT03465436|7679510|FG000|COMPLETED|Period 4||13
6752870|NCT03465436|7679511|FG001|COMPLETED|Period 4||12
6752871|NCT03465436|7679512|FG002|COMPLETED|Period 4||12
6752872|NCT03465436|7679513|FG003|COMPLETED|Period 4||14
6752873|NCT03465436|7679510|FG000|NOT COMPLETED|Period 4||0
6752874|NCT03465436|7679511|FG001|NOT COMPLETED|Period 4||0
6752875|NCT03465436|7679512|FG002|NOT COMPLETED|Period 4||1
6752876|NCT03465436|7679513|FG003|NOT COMPLETED|Period 4||0
6752877|NCT03465709|7679525|FG000|STARTED|Overall Study||17
6752878|NCT03465709|7679525|FG000|COMPLETED|Overall Study||0
6752879|NCT03465709|7679525|FG000|NOT COMPLETED|Overall Study||17
6752880|NCT03465722|7679533|FG000|STARTED|End of Treatment||240
6752881|NCT03465722|7679534|FG001|STARTED|End of Treatment||236
6752882|NCT03465722|7679533|FG000|COMPLETED|End of Treatment||0
6752883|NCT03465722|7679534|FG001|COMPLETED|End of Treatment||0
6752884|NCT03465722|7679533|FG000|NOT COMPLETED|End of Treatment||240
6752885|NCT03465722|7679534|FG001|NOT COMPLETED|End of Treatment||236
6752886|NCT03465722|7679533|FG000|STARTED|End of Study||240
6752887|NCT03465722|7679534|FG001|STARTED|End of Study||236
6752888|NCT03465722|7679533|FG000|COMPLETED|End of Study||0
6752889|NCT03465722|7679534|FG001|COMPLETED|End of Study||0
6752890|NCT03465722|7679533|FG000|NOT COMPLETED|End of Study||240
6752891|NCT03465722|7679534|FG001|NOT COMPLETED|End of Study||236
6752892|NCT03465878|7679542|FG000|STARTED|Period 1-Part A First Intervention Day 1||21
6752893|NCT03465878|7679543|FG001|STARTED|Period 1-Part A First Intervention Day 1||21
6752894|NCT03465878|7679544|FG002|STARTED|Period 1-Part A First Intervention Day 1||0
6752895|NCT03465878|7679545|FG003|STARTED|Period 1-Part A First Intervention Day 1||0
6752896|NCT03465878|7679542|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
6752897|NCT03465878|7679543|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||21
6752898|NCT03465878|7679544|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
6752899|NCT03465878|7679545|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part A First Intervention Day 1||0
6752900|NCT03465878|7679542|FG000|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||7
6752901|NCT03465878|7679543|FG001|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||6
6752902|NCT03465878|7679544|FG002|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
6752903|NCT03465878|7679545|FG003|Children (2-11 Years)|Period 1-Part A First Intervention Day 1||0
6752904|NCT03465878|7679542|FG000|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
6752905|NCT03465878|7679543|FG001|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||7
6752906|NCT03465878|7679544|FG002|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
6752907|NCT03465878|7679545|FG003|Adolescents (12-17 Years)|Period 1-Part A First Intervention Day 1||0
6752908|NCT03465878|7679542|FG000|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||7
6752909|NCT03465878|7679543|FG001|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||8
6752910|NCT03465878|7679544|FG002|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
6752911|NCT03465878|7679545|FG003|Adults (18-64 Years)|Period 1-Part A First Intervention Day 1||0
6752912|NCT03465878|7679542|FG000|COMPLETED|Period 1-Part A First Intervention Day 1||21
6752913|NCT03465878|7679543|FG001|COMPLETED|Period 1-Part A First Intervention Day 1||20
6752914|NCT03465878|7679544|FG002|COMPLETED|Period 1-Part A First Intervention Day 1||0
6752915|NCT03465878|7679545|FG003|COMPLETED|Period 1-Part A First Intervention Day 1||0
6752916|NCT03465878|7679542|FG000|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
6752917|NCT03465878|7679543|FG001|NOT COMPLETED|Period 1-Part A First Intervention Day 1||1
6752918|NCT03465878|7679544|FG002|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
6752919|NCT03465878|7679545|FG003|NOT COMPLETED|Period 1-Part A First Intervention Day 1||0
6752920|NCT03465878|7679542|FG000|STARTED|Period2-Part A Second Intervention Day 1||21
6752921|NCT03465878|7679543|FG001|STARTED|Period2-Part A Second Intervention Day 1||20
6752922|NCT03465878|7679544|FG002|STARTED|Period2-Part A Second Intervention Day 1||0
6752923|NCT03465878|7679545|FG003|STARTED|Period2-Part A Second Intervention Day 1||0
6752924|NCT03465878|7679542|FG000|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||7
6752925|NCT03465878|7679543|FG001|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||6
6752926|NCT03465878|7679544|FG002|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
6752927|NCT03465878|7679545|FG003|Children (2-11 Years)|Period2-Part A Second Intervention Day 1||0
6752928|NCT03465878|7679542|FG000|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
6752929|NCT03465878|7679543|FG001|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||7
6752930|NCT03465878|7679544|FG002|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
6752931|NCT03465878|7679545|FG003|Adolescents (12-17 Years)|Period2-Part A Second Intervention Day 1||0
6752932|NCT03465878|7679542|FG000|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
6752933|NCT03465878|7679543|FG001|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||7
6752934|NCT03465878|7679544|FG002|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
6752935|NCT03465878|7679545|FG003|Adults (18-64 Years)|Period2-Part A Second Intervention Day 1||0
6752936|NCT03465878|7679542|FG000|COMPLETED|Period2-Part A Second Intervention Day 1||21
6555586|NCT01753297|7477759|FG000|NOT COMPLETED|Overall Study||41
6555587|NCT01753297|7477760|FG001|NOT COMPLETED|Overall Study||36
6555588|NCT01753310|7477770|FG000|STARTED|Overall Study||89
6555589|NCT01753310|7477771|FG001|STARTED|Overall Study||45
6555590|NCT01753310|7477770|FG000|COMPLETED|Overall Study||57
6555591|NCT01753310|7477771|FG001|COMPLETED|Overall Study||21
6555592|NCT01753310|7477770|FG000|NOT COMPLETED|Overall Study||32
6555593|NCT01753310|7477771|FG001|NOT COMPLETED|Overall Study||24
6555594|NCT01753323|7477780|FG000|STARTED|Overall Study||11
6555595|NCT01753323|7477781|FG001|STARTED|Overall Study||10
6555596|NCT01753323|7477782|FG002|STARTED|Overall Study||22
6752937|NCT03465878|7679543|FG001|COMPLETED|Period2-Part A Second Intervention Day 1||20
6752938|NCT03465878|7679544|FG002|COMPLETED|Period2-Part A Second Intervention Day 1||0
6752939|NCT03465878|7679545|FG003|COMPLETED|Period2-Part A Second Intervention Day 1||0
6752940|NCT03465878|7679542|FG000|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
6752941|NCT03465878|7679543|FG001|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
6752942|NCT03465878|7679544|FG002|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
6752943|NCT03465878|7679545|FG003|NOT COMPLETED|Period2-Part A Second Intervention Day 1||0
6752944|NCT03465878|7679542|FG000|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
6752945|NCT03465878|7679543|FG001|STARTED|Period 1-Part B First Intervention Day 1|This period is for Part B group.|0
6752946|NCT03465878|7679544|FG002|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|20
6752947|NCT03465878|7679545|FG003|STARTED|Period 1-Part B First Intervention Day 1|25 pts from Part A were re-randomized to Part B, 14 new pts were randomized in Part B.|19
6752948|NCT03465878|7679542|FG000|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
6752949|NCT03465878|7679543|FG001|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||0
6752950|NCT03465878|7679544|FG002|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||20
6752951|NCT03465878|7679545|FG003|Received at Least 1 Dose of Study Drug|Period 1-Part B First Intervention Day 1||17
6752952|NCT03465878|7679542|FG000|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
6752953|NCT03465878|7679543|FG001|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||0
6752954|NCT03465878|7679544|FG002|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
6752955|NCT03465878|7679545|FG003|Children (2-11 Years)|Period 1-Part B First Intervention Day 1||6
6752956|NCT03465878|7679542|FG000|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
6752957|NCT03465878|7679543|FG001|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||0
6752958|NCT03465878|7679544|FG002|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||7
6752959|NCT03465878|7679545|FG003|Adolescents (12-17 Years)|Period 1-Part B First Intervention Day 1||6
6752960|NCT03465878|7679542|FG000|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
6752961|NCT03465878|7679543|FG001|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||0
6752962|NCT03465878|7679544|FG002|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||7
6752963|NCT03465878|7679545|FG003|Adults (18-64 Years)|Period 1-Part B First Intervention Day 1||5
6752964|NCT03465878|7679542|FG000|COMPLETED|Period 1-Part B First Intervention Day 1||0
6752965|NCT03465878|7679543|FG001|COMPLETED|Period 1-Part B First Intervention Day 1||0
6752966|NCT03465878|7679544|FG002|COMPLETED|Period 1-Part B First Intervention Day 1||20
6752967|NCT03465878|7679545|FG003|COMPLETED|Period 1-Part B First Intervention Day 1||17
6752968|NCT03465878|7679542|FG000|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
6752969|NCT03465878|7679543|FG001|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
6752970|NCT03465878|7679544|FG002|NOT COMPLETED|Period 1-Part B First Intervention Day 1||0
6752971|NCT03465878|7679545|FG003|NOT COMPLETED|Period 1-Part B First Intervention Day 1||2
6752972|NCT03465878|7679542|FG000|STARTED|Period2-Part B Second Intervention Day 1||0
6752973|NCT03465878|7679543|FG001|STARTED|Period2-Part B Second Intervention Day 1||0
6752974|NCT03465878|7679544|FG002|STARTED|Period2-Part B Second Intervention Day 1||20
6752975|NCT03465878|7679545|FG003|STARTED|Period2-Part B Second Intervention Day 1||17
6752976|NCT03465878|7679542|FG000|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
6752977|NCT03465878|7679543|FG001|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||0
6752978|NCT03465878|7679544|FG002|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
6752979|NCT03465878|7679545|FG003|Children (2-11 Years)|Period2-Part B Second Intervention Day 1||6
6752980|NCT03465878|7679542|FG000|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
6752981|NCT03465878|7679543|FG001|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||0
6752982|NCT03465878|7679544|FG002|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||7
6752983|NCT03465878|7679545|FG003|Adolescents (12-17 Years)|Period2-Part B Second Intervention Day 1||6
6752984|NCT03465878|7679542|FG000|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
6752985|NCT03465878|7679543|FG001|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||0
6752986|NCT03465878|7679544|FG002|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||7
6752987|NCT03465878|7679545|FG003|Adults (18-64 Years)|Period2-Part B Second Intervention Day 1||5
6752988|NCT03465878|7679542|FG000|COMPLETED|Period2-Part B Second Intervention Day 1||0
6752989|NCT03465878|7679543|FG001|COMPLETED|Period2-Part B Second Intervention Day 1||0
6752990|NCT03465878|7679544|FG002|COMPLETED|Period2-Part B Second Intervention Day 1||20
6752991|NCT03465878|7679545|FG003|COMPLETED|Period2-Part B Second Intervention Day 1||17
6752992|NCT03465878|7679542|FG000|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
6752993|NCT03465878|7679543|FG001|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
6752994|NCT03465878|7679544|FG002|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
6752995|NCT03465878|7679545|FG003|NOT COMPLETED|Period2-Part B Second Intervention Day 1||0
6752996|NCT03465904|7679573|FG000|STARTED|Overall Study||298
6752997|NCT03465904|7679574|FG001|STARTED|Overall Study||303
6752998|NCT03465904|7679573|FG000|COMPLETED|Overall Study||209
6752999|NCT03465904|7679574|FG001|COMPLETED|Overall Study||237
6753000|NCT03465904|7679573|FG000|NOT COMPLETED|Overall Study||89
6753001|NCT03465904|7679574|FG001|NOT COMPLETED|Overall Study||66
6779954|NCT03483051|7708241|FG000|STARTED|First Treatment, Pre Crossover||2
6753002|NCT03466047|7679580|FG000|STARTED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
6753003|NCT03466047|7679580|FG000|COMPLETED|Protein Stomach (1day)|The same 8 patients were studied in all interventions|8
6753004|NCT03466047|7679580|FG000|NOT COMPLETED|Protein Stomach (1day)||0
6753005|NCT03466047|7679580|FG000|STARTED|Protein Small Intestine (1 Day)||8
6753006|NCT03466047|7679580|FG000|COMPLETED|Protein Small Intestine (1 Day)||8
6753007|NCT03466047|7679580|FG000|NOT COMPLETED|Protein Small Intestine (1 Day)||0
6753008|NCT03466047|7679580|FG000|STARTED|CHO Stomach (1 Day)||8
6753009|NCT03466047|7679580|FG000|COMPLETED|CHO Stomach (1 Day)||8
6753010|NCT03466047|7679580|FG000|NOT COMPLETED|CHO Stomach (1 Day)||0
6753011|NCT03466047|7679580|FG000|STARTED|CHO Small Intestine (1 Day)||8
6753012|NCT03466047|7679580|FG000|COMPLETED|CHO Small Intestine (1 Day)||8
6753013|NCT03466047|7679580|FG000|NOT COMPLETED|CHO Small Intestine (1 Day)||0
6555597|NCT01753323|7477780|FG000|Pharmacodynamic (PD) Set|Overall Study||10
6555598|NCT01753323|7477781|FG001|Pharmacodynamic (PD) Set|Overall Study||10
6555599|NCT01753323|7477782|FG002|Pharmacodynamic (PD) Set|Overall Study||21
6555600|NCT01753323|7477780|FG000|Pharmacokinetic(PK) Set|Overall Study||10
6555601|NCT01753323|7477781|FG001|Pharmacokinetic(PK) Set|Overall Study||10
6555602|NCT01753323|7477782|FG002|Pharmacokinetic(PK) Set|Overall Study||21
6753014|NCT03466047|7679580|FG000|STARTED|Fat Stomach (1 Day)||8
6753015|NCT03466047|7679580|FG000|COMPLETED|Fat Stomach (1 Day)||8
6753016|NCT03466047|7679580|FG000|NOT COMPLETED|Fat Stomach (1 Day)||0
6753017|NCT03466047|7679580|FG000|STARTED|Fat Small Intestine (1 Day)||8
6753018|NCT03466047|7679580|FG000|COMPLETED|Fat Small Intestine (1 Day)||8
6753019|NCT03466047|7679580|FG000|NOT COMPLETED|Fat Small Intestine (1 Day)||0
6753020|NCT03466060|7679609|FG000|STARTED|Period 1||19
6753021|NCT03466060|7679610|FG001|STARTED|Period 1||18
6753022|NCT03466060|7679611|FG002|STARTED|Period 1||20
6753023|NCT03466060|7679612|FG003|STARTED|Period 1||18
6753024|NCT03466060|7679613|FG004|STARTED|Period 1||20
6753025|NCT03466060|7679614|FG005|STARTED|Period 1||18
6753026|NCT03466060|7679609|FG000|COMPLETED|Period 1||19
6753027|NCT03466060|7679610|FG001|COMPLETED|Period 1||16
6753028|NCT03466060|7679611|FG002|COMPLETED|Period 1||17
6753029|NCT03466060|7679612|FG003|COMPLETED|Period 1||17
6753030|NCT03466060|7679613|FG004|COMPLETED|Period 1||20
6753031|NCT03466060|7679614|FG005|COMPLETED|Period 1||18
6753032|NCT03466060|7679609|FG000|NOT COMPLETED|Period 1||0
6753033|NCT03466060|7679610|FG001|NOT COMPLETED|Period 1||2
6753034|NCT03466060|7679611|FG002|NOT COMPLETED|Period 1||3
6753035|NCT03466060|7679612|FG003|NOT COMPLETED|Period 1||1
6753036|NCT03466060|7679613|FG004|NOT COMPLETED|Period 1||0
6753037|NCT03466060|7679614|FG005|NOT COMPLETED|Period 1||0
6753038|NCT03466060|7679609|FG000|STARTED|Period 2||19
6753039|NCT03466060|7679610|FG001|STARTED|Period 2||16
6753040|NCT03466060|7679611|FG002|STARTED|Period 2||17
6753041|NCT03466060|7679612|FG003|STARTED|Period 2||17
6753042|NCT03466060|7679613|FG004|STARTED|Period 2||20
6753043|NCT03466060|7679614|FG005|STARTED|Period 2||18
6753044|NCT03466060|7679609|FG000|COMPLETED|Period 2||19
6753045|NCT03466060|7679610|FG001|COMPLETED|Period 2||16
6753046|NCT03466060|7679611|FG002|COMPLETED|Period 2||16
6555603|NCT01753323|7477780|FG000|Safety Set|Overall Study||11
6753047|NCT03466060|7679612|FG003|COMPLETED|Period 2||17
6753048|NCT03466060|7679613|FG004|COMPLETED|Period 2||20
6753049|NCT03466060|7679614|FG005|COMPLETED|Period 2||18
6753050|NCT03466060|7679609|FG000|NOT COMPLETED|Period 2||0
6753051|NCT03466060|7679610|FG001|NOT COMPLETED|Period 2||0
6753052|NCT03466060|7679611|FG002|NOT COMPLETED|Period 2||1
6753053|NCT03466060|7679612|FG003|NOT COMPLETED|Period 2||0
6753054|NCT03466060|7679613|FG004|NOT COMPLETED|Period 2||0
6753055|NCT03466060|7679614|FG005|NOT COMPLETED|Period 2||0
6753056|NCT03466073|7679634|FG000|STARTED|Overall Study||6
6753057|NCT03466073|7679635|FG001|STARTED|Overall Study||2
6753058|NCT03466073|7679636|FG002|STARTED|Overall Study||6
6753059|NCT03466073|7679637|FG003|STARTED|Overall Study||6
6753060|NCT03466073|7679638|FG004|STARTED|Overall Study||6
6753061|NCT03466073|7679639|FG005|STARTED|Overall Study||7
6753062|NCT03466073|7679634|FG000|COMPLETED|Overall Study||5
6753063|NCT03466073|7679635|FG001|COMPLETED|Overall Study||2
6753064|NCT03466073|7679636|FG002|COMPLETED|Overall Study||6
6753065|NCT03466073|7679637|FG003|COMPLETED|Overall Study||6
6753066|NCT03466073|7679638|FG004|COMPLETED|Overall Study||6
6753067|NCT03466073|7679639|FG005|COMPLETED|Overall Study||6
6753068|NCT03466073|7679634|FG000|NOT COMPLETED|Overall Study||1
6753069|NCT03466073|7679635|FG001|NOT COMPLETED|Overall Study||0
6753070|NCT03466073|7679636|FG002|NOT COMPLETED|Overall Study||0
6753071|NCT03466073|7679637|FG003|NOT COMPLETED|Overall Study||0
6753072|NCT03466073|7679638|FG004|NOT COMPLETED|Overall Study||0
6753073|NCT03466073|7679639|FG005|NOT COMPLETED|Overall Study||1
6555604|NCT01753323|7477781|FG001|Safety Set|Overall Study||10
6555605|NCT01753323|7477782|FG002|Safety Set|Overall Study||22
6753074|NCT03466086|7679660|FG000|STARTED|Period 1||28
6753075|NCT03466086|7679661|FG001|STARTED|Period 1||27
6753076|NCT03466086|7679660|FG000|COMPLETED|Period 1||26
6753077|NCT03466086|7679661|FG001|COMPLETED|Period 1||27
6753078|NCT03466086|7679660|FG000|NOT COMPLETED|Period 1||2
6753079|NCT03466086|7679661|FG001|NOT COMPLETED|Period 1||0
6753080|NCT03466086|7679660|FG000|STARTED|Period 2||26
6753081|NCT03466086|7679661|FG001|STARTED|Period 2||27
6753082|NCT03466086|7679660|FG000|COMPLETED|Period 2||26
6753083|NCT03466086|7679661|FG001|COMPLETED|Period 2||27
6753084|NCT03466086|7679660|FG000|NOT COMPLETED|Period 2||0
6753085|NCT03466086|7679661|FG001|NOT COMPLETED|Period 2||0
6753086|NCT03466099|7679670|FG000|STARTED|Overall Study||41
6753087|NCT03466099|7679671|FG001|STARTED|Overall Study||44
6753088|NCT03466099|7679672|FG002|STARTED|Overall Study|One study subject consented and was randomized, but withdrew prior to receiving any study treatments|45
6753089|NCT03466099|7679670|FG000|Treated|Overall Study||41
6753090|NCT03466099|7679671|FG001|Treated|Overall Study||44
6753091|NCT03466099|7679672|FG002|Treated|Overall Study||44
6753092|NCT03466099|7679670|FG000|COMPLETED|Overall Study||24
6753093|NCT03466099|7679671|FG001|COMPLETED|Overall Study||30
6753094|NCT03466099|7679672|FG002|COMPLETED|Overall Study||28
6753095|NCT03466099|7679670|FG000|NOT COMPLETED|Overall Study||17
6753096|NCT03466099|7679671|FG001|NOT COMPLETED|Overall Study||14
6753097|NCT03466099|7679672|FG002|NOT COMPLETED|Overall Study||17
6753098|NCT03466918|7679680|FG000|STARTED|Overall Study||58
6753099|NCT03466918|7679680|FG000|Analysis Population|Overall Study||50
6753100|NCT03466918|7679680|FG000|COMPLETED|Overall Study|All 58 patients completed the 30-day primary endpoint.|58
6753101|NCT03466918|7679680|FG000|NOT COMPLETED|Overall Study||0
6753102|NCT03467048|7679687|FG000|STARTED|Overall Study||66
6753103|NCT03467048|7679688|FG001|STARTED|Overall Study||64
6753104|NCT03467048|7679687|FG000|COMPLETED|Overall Study||66
6753105|NCT03467048|7679688|FG001|COMPLETED|Overall Study||63
6753106|NCT03467048|7679687|FG000|NOT COMPLETED|Overall Study||0
6753107|NCT03467048|7679688|FG001|NOT COMPLETED|Overall Study||1
6753108|NCT03467217|7679696|FG000|STARTED|Overall Study||43
6753109|NCT03467217|7679697|FG001|STARTED|Overall Study||40
6753110|NCT03467217|7679696|FG000|COMPLETED|Overall Study||33
6753111|NCT03467217|7679697|FG001|COMPLETED|Overall Study||34
6753112|NCT03467217|7679696|FG000|NOT COMPLETED|Overall Study||10
6753113|NCT03467217|7679697|FG001|NOT COMPLETED|Overall Study||6
6753114|NCT03467412|7679703|FG000|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
6753115|NCT03467412|7679704|FG001|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
6753116|NCT03467412|7679705|FG002|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
6753117|NCT03467412|7679706|FG003|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|25
6753118|NCT03467412|7679707|FG004|STARTED|Overall Study|Each unique subject will appear in 2 arms. Total sum of subjects is therefore120/2=60.|20
6753119|NCT03467412|7679703|FG000|COMPLETED|Overall Study||22
6753120|NCT03467412|7679704|FG001|COMPLETED|Overall Study||24
6753121|NCT03467412|7679705|FG002|COMPLETED|Overall Study||20
6753122|NCT03467412|7679706|FG003|COMPLETED|Overall Study||23
6753123|NCT03467412|7679707|FG004|COMPLETED|Overall Study||17
6753124|NCT03467412|7679703|FG000|NOT COMPLETED|Overall Study||3
6753125|NCT03467412|7679704|FG001|NOT COMPLETED|Overall Study||1
6753126|NCT03467412|7679705|FG002|NOT COMPLETED|Overall Study||5
6753127|NCT03467412|7679706|FG003|NOT COMPLETED|Overall Study||2
6753128|NCT03467412|7679707|FG004|NOT COMPLETED|Overall Study||3
6753129|NCT03467425|7679728|FG000|STARTED|Overall Study||1545
6753130|NCT03467425|7679729|FG001|STARTED|Overall Study||1547
6753131|NCT03467425|7679728|FG000|Randomized But Did Not Start IP|Overall Study||1
6753132|NCT03467425|7679729|FG001|Randomized But Did Not Start IP|Overall Study||0
6753133|NCT03467425|7679728|FG000|Completed IP|Overall Study||1256
6753134|NCT03467425|7679729|FG001|Completed IP|Overall Study||1359
6753135|NCT03467425|7679728|FG000|Not Completed IP|Overall Study||288
6753136|NCT03467425|7679729|FG001|Not Completed IP|Overall Study||188
6753137|NCT03467425|7679728|FG000|Withdrew IP (WIP): Lost to Follow-up|Overall Study||15
6753138|NCT03467425|7679729|FG001|Withdrew IP (WIP): Lost to Follow-up|Overall Study||24
6753139|NCT03467425|7679728|FG000|WIP: Protocol Deviation|Overall Study||0
6753140|NCT03467425|7679729|FG001|WIP: Protocol Deviation|Overall Study||2
6753141|NCT03467425|7679728|FG000|WIP: Adverse Event|Overall Study||112
6753142|NCT03467425|7679729|FG001|WIP: Adverse Event|Overall Study||29
6753143|NCT03467425|7679728|FG000|WIP: Lack of Efficacy|Overall Study||56
6753144|NCT03467425|7679729|FG001|WIP: Lack of Efficacy|Overall Study||28
6753145|NCT03467425|7679728|FG000|WIP: Physician Decision|Overall Study||14
6753146|NCT03467425|7679729|FG001|WIP: Physician Decision|Overall Study||27
6753147|NCT03467425|7679728|FG000|WIP: Withdrawal by Participant|Overall Study||91
6753148|NCT03467425|7679729|FG001|WIP: Withdrawal by Participant|Overall Study||78
6753149|NCT03467425|7679728|FG000|COMPLETED|Overall Study||1498
6753150|NCT03467425|7679729|FG001|COMPLETED|Overall Study||1493
6753151|NCT03467425|7679728|FG000|NOT COMPLETED|Overall Study||47
6753152|NCT03467425|7679729|FG001|NOT COMPLETED|Overall Study||54
6753153|NCT03467477|7679735|FG000|STARTED|Overall Study||161
6753154|NCT03467477|7679735|FG000|COMPLETED|Overall Study||161
6753155|NCT03467477|7679735|FG000|NOT COMPLETED|Overall Study||0
6753156|NCT03467685|7679744|FG000|STARTED|Overall Study||52
6753157|NCT03467685|7679745|FG001|STARTED|Overall Study||49
6753158|NCT03467685|7679744|FG000|COMPLETED|Overall Study||52
6753159|NCT03467685|7679745|FG001|COMPLETED|Overall Study||49
6753160|NCT03467685|7679744|FG000|NOT COMPLETED|Overall Study||0
6753161|NCT03467685|7679745|FG001|NOT COMPLETED|Overall Study||0
6753162|NCT03467763|7679751|FG000|STARTED|Overall Study||13
6753163|NCT03467763|7679751|FG000|Weeks 1-2|Overall Study||13
6753164|NCT03467763|7679751|FG000|Weeks 3-4|Overall Study||10
6753165|NCT03467763|7679751|FG000|Weeks 5-6|Overall Study||8
6753166|NCT03467763|7679751|FG000|Weeks 7-8|Overall Study||7
6753167|NCT03467763|7679751|FG000|Weeks 9 - 10|Overall Study||6
6753168|NCT03467763|7679751|FG000|Week 11-12|Overall Study||6
6753169|NCT03467763|7679751|FG000|Weeks 13-14|Overall Study||2
6753170|NCT03467763|7679751|FG000|Weeks 15-16|Overall Study||2
6753171|NCT03467763|7679751|FG000|COMPLETED|Overall Study||10
6753172|NCT03467763|7679751|FG000|NOT COMPLETED|Overall Study||3
6753173|NCT03467945|7679761|FG000|STARTED|Treatment Period 1||10
6753174|NCT03467945|7679762|FG001|STARTED|Treatment Period 1||10
6753175|NCT03467945|7679763|FG002|STARTED|Treatment Period 1||10
6753176|NCT03467945|7679764|FG003|STARTED|Treatment Period 1||10
6753177|NCT03467945|7679761|FG000|COMPLETED|Treatment Period 1||10
6753178|NCT03467945|7679762|FG001|COMPLETED|Treatment Period 1||10
6753179|NCT03467945|7679763|FG002|COMPLETED|Treatment Period 1||10
6753180|NCT03467945|7679764|FG003|COMPLETED|Treatment Period 1||10
6753181|NCT03467945|7679761|FG000|NOT COMPLETED|Treatment Period 1||0
6753182|NCT03467945|7679762|FG001|NOT COMPLETED|Treatment Period 1||0
6753183|NCT03467945|7679763|FG002|NOT COMPLETED|Treatment Period 1||0
6753184|NCT03467945|7679764|FG003|NOT COMPLETED|Treatment Period 1||0
6753185|NCT03467945|7679761|FG000|STARTED|Treatment Period 2||10
6753186|NCT03467945|7679762|FG001|STARTED|Treatment Period 2||10
6753187|NCT03467945|7679763|FG002|STARTED|Treatment Period 2||10
6753188|NCT03467945|7679764|FG003|STARTED|Treatment Period 2||10
6753189|NCT03467945|7679761|FG000|COMPLETED|Treatment Period 2||10
6753190|NCT03467945|7679762|FG001|COMPLETED|Treatment Period 2||9
6753191|NCT03467945|7679763|FG002|COMPLETED|Treatment Period 2||10
6753192|NCT03467945|7679764|FG003|COMPLETED|Treatment Period 2||10
6753193|NCT03467945|7679761|FG000|NOT COMPLETED|Treatment Period 2||0
6753194|NCT03467945|7679762|FG001|NOT COMPLETED|Treatment Period 2||1
6753195|NCT03467945|7679763|FG002|NOT COMPLETED|Treatment Period 2||0
6753196|NCT03467945|7679764|FG003|NOT COMPLETED|Treatment Period 2||0
6753197|NCT03467945|7679761|FG000|STARTED|Treatment Period 3||10
6753198|NCT03467945|7679762|FG001|STARTED|Treatment Period 3||9
6753199|NCT03467945|7679763|FG002|STARTED|Treatment Period 3||10
6753200|NCT03467945|7679764|FG003|STARTED|Treatment Period 3||10
6753201|NCT03467945|7679761|FG000|COMPLETED|Treatment Period 3||9
6753202|NCT03467945|7679762|FG001|COMPLETED|Treatment Period 3||9
6753203|NCT03467945|7679763|FG002|COMPLETED|Treatment Period 3||8
6753204|NCT03467945|7679764|FG003|COMPLETED|Treatment Period 3||9
6753205|NCT03467945|7679761|FG000|NOT COMPLETED|Treatment Period 3||1
6753206|NCT03467945|7679762|FG001|NOT COMPLETED|Treatment Period 3||0
6753207|NCT03467945|7679763|FG002|NOT COMPLETED|Treatment Period 3||2
6753208|NCT03467945|7679764|FG003|NOT COMPLETED|Treatment Period 3||1
6753209|NCT03467945|7679761|FG000|STARTED|Treatment Period 4||9
6753210|NCT03467945|7679762|FG001|STARTED|Treatment Period 4||9
6753211|NCT03467945|7679763|FG002|STARTED|Treatment Period 4||8
6753212|NCT03467945|7679764|FG003|STARTED|Treatment Period 4||9
6753213|NCT03467945|7679761|FG000|COMPLETED|Treatment Period 4||9
6753214|NCT03467945|7679762|FG001|COMPLETED|Treatment Period 4||9
6753215|NCT03467945|7679763|FG002|COMPLETED|Treatment Period 4||8
6753216|NCT03467945|7679764|FG003|COMPLETED|Treatment Period 4||9
6753217|NCT03467945|7679761|FG000|NOT COMPLETED|Treatment Period 4||0
6753218|NCT03467945|7679762|FG001|NOT COMPLETED|Treatment Period 4||0
6753219|NCT03467945|7679763|FG002|NOT COMPLETED|Treatment Period 4||0
6753220|NCT03467945|7679764|FG003|NOT COMPLETED|Treatment Period 4||0
6753221|NCT03467971|7679777|FG000|STARTED|Treatment Period 1||10
6753222|NCT03467971|7679778|FG001|STARTED|Treatment Period 1||11
6753223|NCT03467971|7679777|FG000|COMPLETED|Treatment Period 1||10
6753224|NCT03467971|7679778|FG001|COMPLETED|Treatment Period 1||11
6753225|NCT03467971|7679777|FG000|NOT COMPLETED|Treatment Period 1||0
6753226|NCT03467971|7679778|FG001|NOT COMPLETED|Treatment Period 1||0
6753227|NCT03467971|7679777|FG000|STARTED|Treatment Period 2||10
6753228|NCT03467971|7679778|FG001|STARTED|Treatment Period 2||11
6753229|NCT03467971|7679777|FG000|COMPLETED|Treatment Period 2||10
6753230|NCT03467971|7679778|FG001|COMPLETED|Treatment Period 2||10
6753231|NCT03467971|7679777|FG000|NOT COMPLETED|Treatment Period 2||0
6753232|NCT03467971|7679778|FG001|NOT COMPLETED|Treatment Period 2||1
6753233|NCT03468075|7679785|FG000|STARTED|Overall Study||10
6753234|NCT03468075|7679785|FG000|COMPLETED|Overall Study||10
6753235|NCT03468075|7679785|FG000|NOT COMPLETED|Overall Study||0
6555606|NCT01753323|7477780|FG000|Intent-to-treat Analysis Set|Overall Study||11
6555607|NCT01753323|7477781|FG001|Intent-to-treat Analysis Set|Overall Study||10
6555608|NCT01753323|7477782|FG002|Intent-to-treat Analysis Set|Overall Study||22
6555609|NCT01753323|7477780|FG000|COMPLETED|Overall Study||10
6555610|NCT01753323|7477781|FG001|COMPLETED|Overall Study||10
6753236|NCT03468179|7679789|FG000|STARTED|Overall Study||10
6753237|NCT03468179|7679789|FG000|COMPLETED|Overall Study||10
6753238|NCT03468179|7679789|FG000|NOT COMPLETED|Overall Study||0
6753239|NCT03468543|7679796|FG000|STARTED|Overall Study||3
6753240|NCT03468543|7679796|FG000|COMPLETED|Overall Study||0
6753241|NCT03468543|7679796|FG000|NOT COMPLETED|Overall Study||3
6753242|NCT03468816|7679802|FG000|STARTED|Overall Study||2
6555611|NCT01753323|7477782|FG002|COMPLETED|Overall Study||13
6555612|NCT01753323|7477780|FG000|NOT COMPLETED|Overall Study||1
6753243|NCT03468816|7679803|FG001|STARTED|Overall Study||3
6753244|NCT03468816|7679802|FG000|COMPLETED|Overall Study||2
6753245|NCT03468816|7679803|FG001|COMPLETED|Overall Study||3
6753246|NCT03468816|7679802|FG000|NOT COMPLETED|Overall Study||0
6753247|NCT03468816|7679803|FG001|NOT COMPLETED|Overall Study||0
6753248|NCT03468855|7679811|FG000|STARTED|Overall Study||34
6753249|NCT03468855|7679811|FG000|COMPLETED|Overall Study||23
6753250|NCT03468855|7679811|FG000|NOT COMPLETED|Overall Study||11
6753251|NCT03468920|7679817|FG000|STARTED|Overall Study||60
6753252|NCT03468920|7679818|FG001|STARTED|Overall Study||60
6753253|NCT03468920|7679817|FG000|COMPLETED|Overall Study||60
6753254|NCT03468920|7679818|FG001|COMPLETED|Overall Study||60
6753255|NCT03468920|7679817|FG000|NOT COMPLETED|Overall Study||0
6753256|NCT03468920|7679818|FG001|NOT COMPLETED|Overall Study||0
6753257|NCT03468933|7679826|FG000|STARTED|Overall Study||16
6753258|NCT03468933|7679827|FG001|STARTED|Overall Study||16
6753259|NCT03468933|7679826|FG000|COMPLETED|Overall Study||16
6753260|NCT03468933|7679827|FG001|COMPLETED|Overall Study||16
6753261|NCT03468933|7679826|FG000|NOT COMPLETED|Overall Study||0
6753262|NCT03468933|7679827|FG001|NOT COMPLETED|Overall Study||0
6753263|NCT03469336|7679833|FG000|STARTED|Overall Study||18
6753264|NCT03469336|7679833|FG000|COMPLETED|Overall Study||17
6753265|NCT03469336|7679833|FG000|NOT COMPLETED|Overall Study||1
6753266|NCT03469349|7679845|FG000|STARTED|Overall Study||182
6753267|NCT03469349|7679846|FG001|STARTED|Overall Study||184
6753268|NCT03469349|7679845|FG000|COMPLETED|Overall Study||177
6753269|NCT03469349|7679846|FG001|COMPLETED|Overall Study||174
6753270|NCT03469349|7679845|FG000|NOT COMPLETED|Overall Study||5
6753271|NCT03469349|7679846|FG001|NOT COMPLETED|Overall Study||10
6753272|NCT03470012|7679852|FG000|STARTED|Overall Study||24
6753273|NCT03470012|7679852|FG000|COMPLETED|Overall Study||24
6753274|NCT03470012|7679852|FG000|NOT COMPLETED|Overall Study||0
6753275|NCT03470194|7679858|FG000|STARTED|Overall Study||49
6753276|NCT03470194|7679859|FG001|STARTED|Overall Study||57
6753277|NCT03470194|7679858|FG000|COMPLETED|Overall Study||38
6753278|NCT03470194|7679859|FG001|COMPLETED|Overall Study||40
6753279|NCT03470194|7679858|FG000|NOT COMPLETED|Overall Study||11
6753280|NCT03470194|7679859|FG001|NOT COMPLETED|Overall Study||17
6753281|NCT03470493|7679865|FG000|STARTED|Overall Study||130
6753282|NCT03470493|7679865|FG000|Met Primary Endpoint|Overall Study||80
6753283|NCT03470493|7679865|FG000|COMPLETED|Overall Study||130
6753284|NCT03470493|7679865|FG000|NOT COMPLETED|Overall Study||0
6753285|NCT03470545|7679871|FG000|STARTED|Overall Study||123
6753286|NCT03470545|7679872|FG001|STARTED|Overall Study||128
6753287|NCT03470545|7679871|FG000|COMPLETED|Overall Study||119
6753288|NCT03470545|7679872|FG001|COMPLETED|Overall Study||125
6753289|NCT03470545|7679871|FG000|NOT COMPLETED|Overall Study||4
6753290|NCT03470545|7679872|FG001|NOT COMPLETED|Overall Study||3
6753291|NCT03470740|7679881|FG000|STARTED|Overall Study||112
6753292|NCT03470740|7679882|FG001|STARTED|Overall Study||112
6753293|NCT03470740|7679881|FG000|COMPLETED|Overall Study||108
6753294|NCT03470740|7679882|FG001|COMPLETED|Overall Study||106
6753295|NCT03470740|7679881|FG000|NOT COMPLETED|Overall Study||4
6753296|NCT03470740|7679882|FG001|NOT COMPLETED|Overall Study||6
6753297|NCT03471065|7679889|FG000|STARTED|Overall Study||100
6753298|NCT03471065|7679889|FG000|COMPLETED|Overall Study||100
6753299|NCT03471065|7679889|FG000|NOT COMPLETED|Overall Study||0
6753300|NCT03471078|7679895|FG000|STARTED|Overall Study||82
6753301|NCT03471078|7679896|FG001|STARTED|Overall Study||40
6753302|NCT03471078|7679895|FG000|COMPLETED|Overall Study||61
6753303|NCT03471078|7679896|FG001|COMPLETED|Overall Study||34
6753304|NCT03471078|7679895|FG000|NOT COMPLETED|Overall Study||21
6753305|NCT03471078|7679896|FG001|NOT COMPLETED|Overall Study||6
6753306|NCT03471832|7679902|FG000|STARTED|Overall Study||40
6753307|NCT03471832|7679903|FG001|STARTED|Overall Study||40
6753308|NCT03471832|7679902|FG000|COMPLETED|Overall Study||40
6753309|NCT03471832|7679903|FG001|COMPLETED|Overall Study||40
6753310|NCT03471832|7679902|FG000|NOT COMPLETED|Overall Study||0
6753311|NCT03471832|7679903|FG001|NOT COMPLETED|Overall Study||0
6753312|NCT03471871|7679913|FG000|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6753313|NCT03471871|7679914|FG001|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
6753314|NCT03471871|7679915|FG002|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6753315|NCT03471871|7679916|FG003|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
6753316|NCT03471871|7679917|FG004|STARTED|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
6753317|NCT03471871|7679913|FG000|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6753318|NCT03471871|7679914|FG001|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
6753319|NCT03471871|7679915|FG002|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6753320|NCT03471871|7679916|FG003|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
6753321|NCT03471871|7679917|FG004|Treated|Treatment Period 1(HV:1 Day, OSA:8 Days)||20
6753322|NCT03471871|7679913|FG000|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||6
6753323|NCT03471871|7679914|FG001|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
6753324|NCT03471871|7679915|FG002|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||5
6753325|NCT03471871|7679916|FG003|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||18
6753326|NCT03471871|7679917|FG004|COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||19
6753327|NCT03471871|7679913|FG000|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
6753328|NCT03471871|7679914|FG001|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||0
6753329|NCT03471871|7679915|FG002|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
6753330|NCT03471871|7679916|FG003|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
6753331|NCT03471871|7679917|FG004|NOT COMPLETED|Treatment Period 1(HV:1 Day, OSA:8 Days)||1
6753332|NCT03471871|7679913|FG000|STARTED|Washout Period 1 (14 Days)||6
6753333|NCT03471871|7679914|FG001|STARTED|Washout Period 1 (14 Days)||5
6753334|NCT03471871|7679915|FG002|STARTED|Washout Period 1 (14 Days)||5
6753335|NCT03471871|7679916|FG003|STARTED|Washout Period 1 (14 Days)||18
6753336|NCT03471871|7679917|FG004|STARTED|Washout Period 1 (14 Days)||19
6753337|NCT03471871|7679913|FG000|COMPLETED|Washout Period 1 (14 Days)||6
6753338|NCT03471871|7679914|FG001|COMPLETED|Washout Period 1 (14 Days)||5
6753339|NCT03471871|7679915|FG002|COMPLETED|Washout Period 1 (14 Days)||5
6753340|NCT03471871|7679916|FG003|COMPLETED|Washout Period 1 (14 Days)||18
6753341|NCT03471871|7679917|FG004|COMPLETED|Washout Period 1 (14 Days)||19
6753342|NCT03471871|7679913|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
6753343|NCT03471871|7679914|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
6753344|NCT03471871|7679915|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||0
6753345|NCT03471871|7679916|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
6753346|NCT03471871|7679917|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
6753347|NCT03471871|7679913|FG000|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
6753348|NCT03471871|7679914|FG001|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
6753349|NCT03471871|7679915|FG002|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
6753350|NCT03471871|7679916|FG003|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
6753351|NCT03471871|7679917|FG004|STARTED|Treatment Period 2(HV:1 Day, OSA:8 Days)||19
6753352|NCT03471871|7679913|FG000|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||6
6753353|NCT03471871|7679914|FG001|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
6753354|NCT03471871|7679915|FG002|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||5
6753355|NCT03471871|7679916|FG003|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
6753356|NCT03471871|7679917|FG004|COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||18
6753357|NCT03471871|7679913|FG000|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
6753358|NCT03471871|7679914|FG001|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
6753359|NCT03471871|7679915|FG002|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
6753360|NCT03471871|7679916|FG003|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||0
6753361|NCT03471871|7679917|FG004|NOT COMPLETED|Treatment Period 2(HV:1 Day, OSA:8 Days)||1
6753362|NCT03471871|7679913|FG000|STARTED|Washout Period 2 (14 Days)||6
6753363|NCT03471871|7679914|FG001|STARTED|Washout Period 2 (14 Days)||5
6753364|NCT03471871|7679915|FG002|STARTED|Washout Period 2 (14 Days)||5
6753365|NCT03471871|7679916|FG003|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
6753366|NCT03471871|7679917|FG004|STARTED|Washout Period 2 (14 Days)|0=not applicable, as OSA cohort was treated till Treatment Period 2, then directly followed up.|0
6753367|NCT03471871|7679913|FG000|COMPLETED|Washout Period 2 (14 Days)||6
6753368|NCT03471871|7679914|FG001|COMPLETED|Washout Period 2 (14 Days)||5
6753369|NCT03471871|7679915|FG002|COMPLETED|Washout Period 2 (14 Days)||5
6753370|NCT03471871|7679916|FG003|COMPLETED|Washout Period 2 (14 Days)||0
6753371|NCT03471871|7679917|FG004|COMPLETED|Washout Period 2 (14 Days)||0
6753372|NCT03471871|7679913|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
6753373|NCT03471871|7679914|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
6753374|NCT03471871|7679915|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||0
6753375|NCT03471871|7679916|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
6753376|NCT03471871|7679917|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
6753377|NCT03471871|7679913|FG000|STARTED|Treatment Period 3: ( HV:1 Day)||6
6753378|NCT03471871|7679914|FG001|STARTED|Treatment Period 3: ( HV:1 Day)||5
6753379|NCT03471871|7679915|FG002|STARTED|Treatment Period 3: ( HV:1 Day)||5
6753380|NCT03471871|7679916|FG003|STARTED|Treatment Period 3: ( HV:1 Day)||0
6753381|NCT03471871|7679917|FG004|STARTED|Treatment Period 3: ( HV:1 Day)||0
6753382|NCT03471871|7679913|FG000|COMPLETED|Treatment Period 3: ( HV:1 Day)||6
6753383|NCT03471871|7679914|FG001|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
6753384|NCT03471871|7679915|FG002|COMPLETED|Treatment Period 3: ( HV:1 Day)||5
6753385|NCT03471871|7679916|FG003|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6753386|NCT03471871|7679917|FG004|COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6753387|NCT03471871|7679913|FG000|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6753388|NCT03471871|7679914|FG001|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6753389|NCT03471871|7679915|FG002|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6753390|NCT03471871|7679916|FG003|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6753391|NCT03471871|7679917|FG004|NOT COMPLETED|Treatment Period 3: ( HV:1 Day)||0
6753392|NCT03471871|7679913|FG000|STARTED|Follow Up (14 Days for Both HV and OSA)||6
6753393|NCT03471871|7679914|FG001|STARTED|Follow Up (14 Days for Both HV and OSA)||5
6753394|NCT03471871|7679915|FG002|STARTED|Follow Up (14 Days for Both HV and OSA)||5
6753395|NCT03471871|7679916|FG003|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
6753396|NCT03471871|7679917|FG004|STARTED|Follow Up (14 Days for Both HV and OSA)|OSA cohort was treated till Treatment Period 2 only and then entered in follow up period.|18
6753397|NCT03471871|7679913|FG000|COMPLETED|Follow Up (14 Days for Both HV and OSA)||6
6753398|NCT03471871|7679914|FG001|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
6753399|NCT03471871|7679915|FG002|COMPLETED|Follow Up (14 Days for Both HV and OSA)||5
6753400|NCT03471871|7679916|FG003|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
6753401|NCT03471871|7679917|FG004|COMPLETED|Follow Up (14 Days for Both HV and OSA)||17
6753402|NCT03471871|7679913|FG000|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
6753403|NCT03471871|7679914|FG001|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
6753404|NCT03471871|7679915|FG002|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||0
6753405|NCT03471871|7679916|FG003|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
6753406|NCT03471871|7679917|FG004|NOT COMPLETED|Follow Up (14 Days for Both HV and OSA)||1
6753407|NCT03471975|7679931|FG000|STARTED|Overall Study||17
6753408|NCT03471975|7679932|FG001|STARTED|Overall Study||20
6753409|NCT03471975|7679931|FG000|COMPLETED|Overall Study||17
6753410|NCT03471975|7679932|FG001|COMPLETED|Overall Study||20
6753411|NCT03471975|7679931|FG000|NOT COMPLETED|Overall Study||0
6753412|NCT03471975|7679932|FG001|NOT COMPLETED|Overall Study||0
6753413|NCT03472014|7679938|FG000|STARTED|Overall Study||22
6753414|NCT03472014|7679938|FG000|COMPLETED|Overall Study||18
6753415|NCT03472014|7679938|FG000|NOT COMPLETED|Overall Study||4
6753416|NCT03472287|7679944|FG000|STARTED|Overall Study||8
6753417|NCT03472287|7679945|FG001|STARTED|Overall Study||3
6753418|NCT03472287|7679944|FG000|COMPLETED|Overall Study||8
6753419|NCT03472287|7679945|FG001|COMPLETED|Overall Study||3
6753420|NCT03472287|7679944|FG000|NOT COMPLETED|Overall Study||0
6753421|NCT03472287|7679945|FG001|NOT COMPLETED|Overall Study||0
6753422|NCT03472326|7679953|FG000|STARTED|Part 1: GS-9131 Functional Monotherapy||11
6753423|NCT03472326|7679954|FG001|STARTED|Part 1: GS-9131 Functional Monotherapy||10
6753424|NCT03472326|7679955|FG002|STARTED|Part 1: GS-9131 Functional Monotherapy||0
6753425|NCT03472326|7679956|FG003|STARTED|Part 1: GS-9131 Functional Monotherapy||0
6753426|NCT03472326|7679953|FG000|COMPLETED|Part 1: GS-9131 Functional Monotherapy||11
6753427|NCT03472326|7679954|FG001|COMPLETED|Part 1: GS-9131 Functional Monotherapy||10
6753428|NCT03472326|7679955|FG002|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
6753429|NCT03472326|7679956|FG003|COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
6753430|NCT03472326|7679953|FG000|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
6753431|NCT03472326|7679954|FG001|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
6753432|NCT03472326|7679955|FG002|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
6753433|NCT03472326|7679956|FG003|NOT COMPLETED|Part 1: GS-9131 Functional Monotherapy||0
6753434|NCT03472326|7679953|FG000|STARTED|Part 2: Combination Therapy||0
6753435|NCT03472326|7679954|FG001|STARTED|Part 2: Combination Therapy||0
6753436|NCT03472326|7679955|FG002|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 1 participant entered in Part 2.|1
6753437|NCT03472326|7679956|FG003|STARTED|Part 2: Combination Therapy|Of the participants who completed Part 1, only 3 participants entered in Part 2.|3
6753438|NCT03472326|7679953|FG000|COMPLETED|Part 2: Combination Therapy||0
6753439|NCT03472326|7679954|FG001|COMPLETED|Part 2: Combination Therapy||0
6753440|NCT03472326|7679955|FG002|COMPLETED|Part 2: Combination Therapy||0
6753441|NCT03472326|7679956|FG003|COMPLETED|Part 2: Combination Therapy||0
6753442|NCT03472326|7679953|FG000|NOT COMPLETED|Part 2: Combination Therapy||0
6753443|NCT03472326|7679954|FG001|NOT COMPLETED|Part 2: Combination Therapy||0
6753444|NCT03472326|7679955|FG002|NOT COMPLETED|Part 2: Combination Therapy||1
6753445|NCT03472326|7679956|FG003|NOT COMPLETED|Part 2: Combination Therapy||3
6753446|NCT03472469|7679967|FG000|STARTED|Overall Study||787
6753447|NCT03472469|7679968|FG001|STARTED|Overall Study||774
6753448|NCT03472469|7679967|FG000|COMPLETED|Overall Study||787
6753449|NCT03472469|7679968|FG001|COMPLETED|Overall Study||774
6753450|NCT03472469|7679967|FG000|NOT COMPLETED|Overall Study||0
6753451|NCT03472469|7679968|FG001|NOT COMPLETED|Overall Study||0
6753452|NCT03472521|7679976|FG000|STARTED|Overall Study||41
6753453|NCT03472521|7679977|FG001|STARTED|Overall Study||37
6753454|NCT03472521|7679976|FG000|Received Allocated Intervention|Overall Study||41
6753455|NCT03472521|7679977|FG001|Received Allocated Intervention|Overall Study||37
6753456|NCT03472521|7679976|FG000|COMPLETED|Overall Study||35
6753457|NCT03472521|7679977|FG001|COMPLETED|Overall Study||34
6753458|NCT03472521|7679976|FG000|NOT COMPLETED|Overall Study||6
6753459|NCT03472521|7679977|FG001|NOT COMPLETED|Overall Study||3
6753460|NCT03472534|7679983|FG000|STARTED|Overall Study|Each participant receives all 4 unit interventions.|46
6753461|NCT03472534|7679983|FG000|Diacerein 1% Ointment|Overall Study||46
6753462|NCT03472534|7679983|FG000|Vehicle Ointment|Overall Study||46
6753463|NCT03472534|7679983|FG000|0.2% Sodium Lauryl Sulfate (SLS)|Overall Study||46
6753464|NCT03472534|7679983|FG000|0.9% Saline|Overall Study||46
6753465|NCT03472534|7679983|FG000|COMPLETED|Overall Study||35
6753466|NCT03472534|7679983|FG000|NOT COMPLETED|Overall Study||11
6753467|NCT03472547|7679987|FG000|STARTED|Overall Study||234
6753468|NCT03472547|7679987|FG000|COMPLETED|Overall Study||204
6753469|NCT03472547|7679987|FG000|NOT COMPLETED|Overall Study||30
6753470|NCT03473171|7679991|FG000|STARTED|Overall Study||5
6753471|NCT03473171|7679991|FG000|COMPLETED|Overall Study||5
6753472|NCT03473171|7679991|FG000|NOT COMPLETED|Overall Study||0
6753473|NCT03473184|7679995|FG000|STARTED|Overall Study||34
6753474|NCT03473184|7679995|FG000|Diacerein 1% Ointment Irradiated|Overall Study||34
6753475|NCT03473184|7679995|FG000|Vehicle Ointment Irradiated|Overall Study||34
6753476|NCT03473184|7679995|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||34
6753477|NCT03473184|7679995|FG000|Vehicle Ointment Non-irradiated|Overall Study||34
6753478|NCT03473184|7679995|FG000|Untreated Irradiated|Overall Study||34
6753479|NCT03473184|7679995|FG000|COMPLETED|Overall Study||34
6753480|NCT03473184|7679995|FG000|NOT COMPLETED|Overall Study||0
6753481|NCT03473197|7679999|FG000|STARTED|Overall Study||61
6753482|NCT03473197|7679999|FG000|Diacerein 1% Ointment Irradiated|Overall Study||51
6753483|NCT03473197|7679999|FG000|Vehicle Ointment Irradiated|Overall Study||51
6753484|NCT03473197|7679999|FG000|Diacerein 1% Ointment Non-irradiated|Overall Study||51
6753485|NCT03473197|7679999|FG000|Vehicle Ointment Non-irradiated|Overall Study||51
6753486|NCT03473197|7679999|FG000|Untreated Irradiated|Overall Study||51
6753487|NCT03473197|7679999|FG000|COMPLETED|Overall Study||51
6753488|NCT03473197|7679999|FG000|NOT COMPLETED|Overall Study||10
6753489|NCT03473236|7680013|FG000|STARTED|Overall Study||10
6753490|NCT03473236|7680014|FG001|STARTED|Overall Study||6
6753491|NCT03473236|7680015|FG002|STARTED|Overall Study||6
6753492|NCT03473236|7680016|FG003|STARTED|Overall Study||6
6753493|NCT03473236|7680017|FG004|STARTED|Overall Study||6
6753494|NCT03473236|7680018|FG005|STARTED|Overall Study||7
6753495|NCT03473236|7680019|FG006|STARTED|Overall Study||6
6753496|NCT03473236|7680020|FG007|STARTED|Overall Study||6
6753497|NCT03473236|7680021|FG008|STARTED|Overall Study||7
6753498|NCT03473236|7680022|FG009|STARTED|Overall Study||6
6753499|NCT03473236|7680013|FG000|COMPLETED|Overall Study||10
6753500|NCT03473236|7680014|FG001|COMPLETED|Overall Study||6
6753501|NCT03473236|7680015|FG002|COMPLETED|Overall Study||6
6753502|NCT03473236|7680016|FG003|COMPLETED|Overall Study||6
6753503|NCT03473236|7680017|FG004|COMPLETED|Overall Study||6
6753504|NCT03473236|7680018|FG005|COMPLETED|Overall Study||6
6753505|NCT03473236|7680019|FG006|COMPLETED|Overall Study||6
6753506|NCT03473236|7680020|FG007|COMPLETED|Overall Study||6
6753507|NCT03473236|7680021|FG008|COMPLETED|Overall Study||6
6753508|NCT03473236|7680022|FG009|COMPLETED|Overall Study||6
6753509|NCT03473236|7680013|FG000|NOT COMPLETED|Overall Study||0
6753510|NCT03473236|7680014|FG001|NOT COMPLETED|Overall Study||0
6753511|NCT03473236|7680015|FG002|NOT COMPLETED|Overall Study||0
6753512|NCT03473236|7680016|FG003|NOT COMPLETED|Overall Study||0
6753513|NCT03473236|7680017|FG004|NOT COMPLETED|Overall Study||0
6753514|NCT03473236|7680018|FG005|NOT COMPLETED|Overall Study||1
6753515|NCT03473236|7680019|FG006|NOT COMPLETED|Overall Study||0
6753516|NCT03473236|7680020|FG007|NOT COMPLETED|Overall Study||0
6753517|NCT03473236|7680021|FG008|NOT COMPLETED|Overall Study||1
6753518|NCT03473236|7680022|FG009|NOT COMPLETED|Overall Study||0
6753519|NCT03473301|7680055|FG000|STARTED|Overall Study||31
6753520|NCT03473301|7680056|FG001|STARTED|Overall Study||29
6753521|NCT03473301|7680057|FG002|STARTED|Overall Study||31
6753522|NCT03473301|7680055|FG000|COMPLETED|Overall Study||20
6753523|NCT03473301|7680056|FG001|COMPLETED|Overall Study||23
6753524|NCT03473301|7680057|FG002|COMPLETED|Overall Study||25
6753525|NCT03473301|7680055|FG000|NOT COMPLETED|Overall Study||11
6753526|NCT03473301|7680056|FG001|NOT COMPLETED|Overall Study||6
6753527|NCT03473301|7680057|FG002|NOT COMPLETED|Overall Study||6
6753528|NCT03473665|7680067|FG000|STARTED|Overall Study||9
6753529|NCT03473665|7680067|FG000|COMPLETED|Overall Study||9
6753530|NCT03473665|7680067|FG000|NOT COMPLETED|Overall Study||0
6753531|NCT03473808|7680076|FG000|STARTED|Overall Study||5
6753532|NCT03473808|7680076|FG000|COMPLETED|Overall Study||4
6753533|NCT03473808|7680076|FG000|NOT COMPLETED|Overall Study||1
6753534|NCT03473886|7680080|FG000|STARTED|Overall Study||8
6753535|NCT03473886|7680080|FG000|COMPLETED|Overall Study||7
6753536|NCT03473886|7680080|FG000|NOT COMPLETED|Overall Study||1
6753537|NCT03474081|7680086|FG000|STARTED|Overall Study||400
6555613|NCT01753323|7477781|FG001|NOT COMPLETED|Overall Study||0
6555614|NCT01753323|7477782|FG002|NOT COMPLETED|Overall Study||9
6555615|NCT01753336|7477791|FG000|STARTED|Overall Study||112
6555616|NCT01753336|7477791|FG000|Cycle 1|Overall Study||112
6555617|NCT01753336|7477791|FG000|Cycle 2|Overall Study||98
6555618|NCT01753336|7477791|FG000|Cycle 3|Overall Study||93
6555619|NCT01753336|7477791|FG000|COMPLETED|Overall Study||92
6555620|NCT01753336|7477791|FG000|NOT COMPLETED|Overall Study||20
6555621|NCT01753362|7477797|FG000|STARTED|Overall Study||36
6555622|NCT01753362|7477798|FG001|STARTED|Overall Study||48
6555623|NCT01753362|7477797|FG000|COMPLETED|Overall Study||26
6555624|NCT01753362|7477798|FG001|COMPLETED|Overall Study||40
6555625|NCT01753362|7477797|FG000|NOT COMPLETED|Overall Study||10
6555626|NCT01753362|7477798|FG001|NOT COMPLETED|Overall Study||8
6555627|NCT01753401|7477806|FG000|STARTED|Double-blind Period (8 Weeks)||12
6555628|NCT01753401|7477807|FG001|STARTED|Double-blind Period (8 Weeks)||26
6555629|NCT01753401|7477808|FG002|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
6753538|NCT03474081|7680087|FG001|STARTED|Overall Study||400
6753539|NCT03474081|7680086|FG000|Received Study Treatment|Overall Study||400
6753540|NCT03474081|7680087|FG001|Received Study Treatment|Overall Study|One randomized participant withdrew consent and never received study treatment.|399
6753541|NCT03474081|7680086|FG000|COMPLETED|Overall Study||383
6753542|NCT03474081|7680087|FG001|COMPLETED|Overall Study||387
6753543|NCT03474081|7680086|FG000|NOT COMPLETED|Overall Study||17
6753544|NCT03474081|7680087|FG001|NOT COMPLETED|Overall Study||13
6753545|NCT03474172|7680095|FG000|STARTED|Overall Study||30
6753546|NCT03474172|7680096|FG001|STARTED|Overall Study||30
6753547|NCT03474172|7680095|FG000|COMPLETED|Overall Study||30
6753548|NCT03474172|7680096|FG001|COMPLETED|Overall Study||30
6555630|NCT01753401|7477809|FG003|STARTED|Double-blind Period (8 Weeks)|This arm was not included in the double-blind period|0
6555631|NCT01753401|7477806|FG000|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||11
6555632|NCT01753401|7477807|FG001|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||25
6555633|NCT01753401|7477808|FG002|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
6555634|NCT01753401|7477809|FG003|Modified Intent to Treat (mITT)|Double-blind Period (8 Weeks)||0
6555635|NCT01753401|7477806|FG000|COMPLETED|Double-blind Period (8 Weeks)||11
6555636|NCT01753401|7477807|FG001|COMPLETED|Double-blind Period (8 Weeks)||22
6753549|NCT03474172|7680095|FG000|NOT COMPLETED|Overall Study||0
6753550|NCT03474172|7680096|FG001|NOT COMPLETED|Overall Study||0
6753551|NCT03474406|7680105|FG000|STARTED|Overall Study||150
6753552|NCT03474406|7680105|FG000|COMPLETED|Overall Study||72
6753553|NCT03474406|7680105|FG000|NOT COMPLETED|Overall Study||78
6753554|NCT03474874|7680109|FG000|STARTED|Overall Study||68
6753555|NCT03474874|7680109|FG000|COMPLETED|Overall Study||54
6753556|NCT03474874|7680109|FG000|NOT COMPLETED|Overall Study||14
6753557|NCT03475056|7680117|FG000|STARTED|Overall Study||20
6753558|NCT03475056|7680118|FG001|STARTED|Overall Study||20
6753559|NCT03475056|7680117|FG000|Received Product Administration|Overall Study||20
6753560|NCT03475056|7680118|FG001|Received Product Administration|Overall Study||20
6753561|NCT03475056|7680117|FG000|COMPLETED|Overall Study||20
6753562|NCT03475056|7680118|FG001|COMPLETED|Overall Study||17
6753563|NCT03475056|7680117|FG000|NOT COMPLETED|Overall Study||0
6753564|NCT03475056|7680118|FG001|NOT COMPLETED|Overall Study||3
6753565|NCT03475316|7680127|FG000|STARTED|6 Month Intervention||13
6753566|NCT03475316|7680128|FG001|STARTED|6 Month Intervention||12
6753567|NCT03475316|7680127|FG000|COMPLETED|6 Month Intervention||8
6753568|NCT03475316|7680128|FG001|COMPLETED|6 Month Intervention||8
6753569|NCT03475316|7680127|FG000|NOT COMPLETED|6 Month Intervention||5
6753570|NCT03475316|7680128|FG001|NOT COMPLETED|6 Month Intervention||4
6753571|NCT03475316|7680127|FG000|STARTED|9 Months||8
6753572|NCT03475316|7680128|FG001|STARTED|9 Months||8
6753573|NCT03475316|7680127|FG000|COMPLETED|9 Months||5
6753574|NCT03475316|7680128|FG001|COMPLETED|9 Months||4
6753575|NCT03475316|7680127|FG000|NOT COMPLETED|9 Months||3
6753576|NCT03475316|7680128|FG001|NOT COMPLETED|9 Months||4
6753577|NCT03475875|7680134|FG000|STARTED|Period 1||46
6753578|NCT03475875|7680135|FG001|STARTED|Period 1||45
6753579|NCT03475875|7680134|FG000|COMPLETED|Period 1||43
6753580|NCT03475875|7680135|FG001|COMPLETED|Period 1||44
6753581|NCT03475875|7680134|FG000|NOT COMPLETED|Period 1||3
6753582|NCT03475875|7680135|FG001|NOT COMPLETED|Period 1||1
6753583|NCT03475875|7680134|FG000|STARTED|Period 2||43
6753584|NCT03475875|7680135|FG001|STARTED|Period 2||44
6753585|NCT03475875|7680134|FG000|COMPLETED|Period 2||40
6753586|NCT03475875|7680135|FG001|COMPLETED|Period 2||43
6753587|NCT03475875|7680134|FG000|NOT COMPLETED|Period 2||3
6753588|NCT03475875|7680135|FG001|NOT COMPLETED|Period 2||1
6753589|NCT03475875|7680134|FG000|STARTED|Period 3||40
6753590|NCT03475875|7680135|FG001|STARTED|Period 3||43
6753591|NCT03475875|7680134|FG000|COMPLETED|Period 3||40
6753592|NCT03475875|7680135|FG001|COMPLETED|Period 3||43
6753593|NCT03475875|7680134|FG000|NOT COMPLETED|Period 3||0
6753594|NCT03475875|7680135|FG001|NOT COMPLETED|Period 3||0
6753595|NCT03475992|7680144|FG000|STARTED|Overall Study||11
6753596|NCT03475992|7680145|FG001|STARTED|Overall Study||9
6753597|NCT03475992|7680146|FG002|STARTED|Overall Study||5
6753598|NCT03475992|7680144|FG000|COMPLETED|Overall Study||11
6753599|NCT03475992|7680145|FG001|COMPLETED|Overall Study||9
6753600|NCT03475992|7680146|FG002|COMPLETED|Overall Study||5
6753601|NCT03475992|7680144|FG000|NOT COMPLETED|Overall Study||0
6753602|NCT03475992|7680145|FG001|NOT COMPLETED|Overall Study||0
6753603|NCT03475992|7680146|FG002|NOT COMPLETED|Overall Study||0
6753604|NCT03476278|7680154|FG000|STARTED|Overall Study||300
6753605|NCT03476278|7680154|FG000|COMPLETED|Overall Study||300
6753606|NCT03476278|7680154|FG000|NOT COMPLETED|Overall Study||0
6753607|NCT03476798|7680168|FG000|STARTED|Overall Study||33
6753608|NCT03476798|7680168|FG000|COMPLETED|Overall Study||28
6753609|NCT03476798|7680168|FG000|NOT COMPLETED|Overall Study||5
6753610|NCT03476850|7680174|FG000|STARTED|Overall Study||24
6753611|NCT03476850|7680175|FG001|STARTED|Overall Study||24
6753612|NCT03476850|7680174|FG000|COMPLETED|Overall Study||24
6753613|NCT03476850|7680175|FG001|COMPLETED|Overall Study||24
6753614|NCT03476850|7680174|FG000|NOT COMPLETED|Overall Study||0
6753615|NCT03476850|7680175|FG001|NOT COMPLETED|Overall Study||0
6753616|NCT03477006|7680183|FG000|STARTED|Overall Study||40
6753617|NCT03477006|7680184|FG001|STARTED|Overall Study||46
6753618|NCT03477006|7680183|FG000|COMPLETED|Overall Study||40
6753619|NCT03477006|7680184|FG001|COMPLETED|Overall Study||46
6753620|NCT03477006|7680183|FG000|NOT COMPLETED|Overall Study||0
6753621|NCT03477006|7680184|FG001|NOT COMPLETED|Overall Study||0
6753622|NCT03477279|7680195|FG000|STARTED|Overall Study||250
6753623|NCT03477279|7680196|FG001|STARTED|Overall Study||250
6753624|NCT03477279|7680197|FG002|STARTED|Overall Study||98
6753625|NCT03477279|7680198|FG003|STARTED|Overall Study||168
6753626|NCT03477279|7680199|FG004|STARTED|Overall Study||350
6753627|NCT03477279|7680195|FG000|COMPLETED|Overall Study||203
6753628|NCT03477279|7680196|FG001|COMPLETED|Overall Study||202
6753629|NCT03477279|7680197|FG002|COMPLETED|Overall Study||98
6753630|NCT03477279|7680198|FG003|COMPLETED|Overall Study||136
6753631|NCT03477279|7680199|FG004|COMPLETED|Overall Study||349
6753632|NCT03477279|7680195|FG000|NOT COMPLETED|Overall Study||47
6753633|NCT03477279|7680196|FG001|NOT COMPLETED|Overall Study||48
6753634|NCT03477279|7680197|FG002|NOT COMPLETED|Overall Study||0
6753635|NCT03477279|7680198|FG003|NOT COMPLETED|Overall Study||32
6753636|NCT03477279|7680199|FG004|NOT COMPLETED|Overall Study||1
6753637|NCT03477838|7680212|FG000|STARTED|Overall Study||28
6753638|NCT03477838|7680212|FG000|COMPLETED|Overall Study||14
6753639|NCT03477838|7680212|FG000|NOT COMPLETED|Overall Study||14
6753640|NCT03478163|7680218|FG000|STARTED|Overall Study||5
6753641|NCT03478163|7680219|FG001|STARTED|Overall Study||6
6753642|NCT03478163|7680218|FG000|COMPLETED|Overall Study||5
6753643|NCT03478163|7680219|FG001|COMPLETED|Overall Study||6
6753644|NCT03478163|7680218|FG000|NOT COMPLETED|Overall Study||0
6753645|NCT03478163|7680219|FG001|NOT COMPLETED|Overall Study||0
6753646|NCT03478254|7680225|FG000|STARTED|Overall Study||300
6753647|NCT03478254|7680225|FG000|COMPLETED|Overall Study||300
6753648|NCT03478254|7680225|FG000|NOT COMPLETED|Overall Study||0
6753649|NCT03478371|7680230|FG000|STARTED|Overall Study||94
6753650|NCT03478371|7680230|FG000|Received Tampon D|Overall Study||91
6753651|NCT03478371|7680230|FG000|Received Tampon M|Overall Study||92
6753652|NCT03478371|7680230|FG000|Recived Tampon T|Overall Study||90
6753653|NCT03478371|7680230|FG000|Received Tampon V|Overall Study||91
6753654|NCT03478371|7680230|FG000|COMPLETED|Overall Study||89
6753655|NCT03478371|7680230|FG000|NOT COMPLETED|Overall Study||5
6753656|NCT03478644|7680242|FG000|STARTED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
6753657|NCT03478644|7680243|FG001|STARTED|Phase 1||0
6753658|NCT03478644|7680242|FG000|COMPLETED|Phase 1|In Phase 1, only the wipe treatment was administered to eligible participants.|31
6753659|NCT03478644|7680243|FG001|COMPLETED|Phase 1||0
6753660|NCT03478644|7680242|FG000|NOT COMPLETED|Phase 1||0
6753661|NCT03478644|7680243|FG001|NOT COMPLETED|Phase 1||0
6753662|NCT03478644|7680242|FG000|STARTED|Phase 2||76
6753663|NCT03478644|7680243|FG001|STARTED|Phase 2||76
6753664|NCT03478644|7680242|FG000|COMPLETED|Phase 2||73
6753665|NCT03478644|7680243|FG001|COMPLETED|Phase 2||75
6753666|NCT03478644|7680242|FG000|NOT COMPLETED|Phase 2||3
6753667|NCT03478644|7680243|FG001|NOT COMPLETED|Phase 2||1
6753668|NCT03478657|7680251|FG000|STARTED|Overall Study||88
6753669|NCT03478657|7680252|FG001|STARTED|Overall Study||134
6753670|NCT03478657|7680251|FG000|COMPLETED|Overall Study||88
6753671|NCT03478657|7680252|FG001|COMPLETED|Overall Study||133
6753672|NCT03478657|7680251|FG000|NOT COMPLETED|Overall Study||0
6753673|NCT03478657|7680252|FG001|NOT COMPLETED|Overall Study||1
6753674|NCT03478683|7680260|FG000|STARTED|Overall Study||363
6753675|NCT03478683|7680261|FG001|STARTED|Overall Study||365
6753676|NCT03478683|7680260|FG000|COMPLETED|Overall Study||350
6753677|NCT03478683|7680261|FG001|COMPLETED|Overall Study||347
6753678|NCT03478683|7680260|FG000|NOT COMPLETED|Overall Study||13
6753679|NCT03478683|7680261|FG001|NOT COMPLETED|Overall Study||18
6753680|NCT03478696|7680269|FG000|STARTED|Overall Study||366
6753681|NCT03478696|7680270|FG001|STARTED|Overall Study||366
6753682|NCT03478696|7680269|FG000|COMPLETED|Overall Study||349
6753683|NCT03478696|7680270|FG001|COMPLETED|Overall Study||354
6753684|NCT03478696|7680269|FG000|NOT COMPLETED|Overall Study||17
6753685|NCT03478696|7680270|FG001|NOT COMPLETED|Overall Study||12
6753686|NCT03478787|7680278|FG000|STARTED|Overall Study||163
6753687|NCT03478787|7680279|FG001|STARTED|Overall Study||164
6753688|NCT03478787|7680278|FG000|COMPLETED|Overall Study||134
6753689|NCT03478787|7680279|FG001|COMPLETED|Overall Study||151
6753690|NCT03478787|7680278|FG000|NOT COMPLETED|Overall Study||29
6753691|NCT03478787|7680279|FG001|NOT COMPLETED|Overall Study||13
6753692|NCT03478891|7680288|FG000|STARTED|Overall Study||3
6753693|NCT03478891|7680289|FG001|STARTED|Overall Study||5
6753694|NCT03478891|7680290|FG002|STARTED|Overall Study||11
6753695|NCT03478891|7680288|FG000|Received MAb114|Overall Study||3
6753696|NCT03478891|7680289|FG001|Received MAb114|Overall Study||5
6753697|NCT03478891|7680290|FG002|Received MAb114|Overall Study|One Group 3 subject discontinued prior to MAb114 infusion due to inadequate venous access|10
6753698|NCT03478891|7680288|FG000|COMPLETED|Overall Study||2
6753699|NCT03478891|7680289|FG001|COMPLETED|Overall Study||5
6753700|NCT03478891|7680290|FG002|COMPLETED|Overall Study||8
6753701|NCT03478891|7680288|FG000|NOT COMPLETED|Overall Study||1
6753702|NCT03478891|7680289|FG001|NOT COMPLETED|Overall Study||0
6753703|NCT03478891|7680290|FG002|NOT COMPLETED|Overall Study||3
6753704|NCT03478904|7680302|FG000|STARTED|Overall Study||1
6753705|NCT03478904|7680302|FG000|COMPLETED|Overall Study||1
6753706|NCT03478904|7680302|FG000|NOT COMPLETED|Overall Study||0
6753707|NCT03478969|7680316|FG000|STARTED|Overall Study||62
6753708|NCT03478969|7680317|FG001|STARTED|Overall Study||61
6753709|NCT03478969|7680318|FG002|STARTED|Overall Study||58
6753710|NCT03478969|7680316|FG000|Participants at End of Parallel Phase|Overall Study||55
6753711|NCT03478969|7680317|FG001|Participants at End of Parallel Phase|Overall Study||58
6753712|NCT03478969|7680318|FG002|Participants at End of Parallel Phase|Overall Study||52
6753713|NCT03478969|7680316|FG000|COMPLETED|Overall Study||53
6753714|NCT03478969|7680317|FG001|COMPLETED|Overall Study||49
6753715|NCT03478969|7680318|FG002|COMPLETED|Overall Study||40
6753716|NCT03478969|7680316|FG000|NOT COMPLETED|Overall Study||9
6753717|NCT03478969|7680317|FG001|NOT COMPLETED|Overall Study||12
6753718|NCT03478969|7680318|FG002|NOT COMPLETED|Overall Study||18
6753719|NCT03478982|7680332|FG000|STARTED|Overall Study||11
6753720|NCT03478982|7680333|FG001|STARTED|Overall Study||50
6753721|NCT03478982|7680334|FG002|STARTED|Overall Study||47
6753722|NCT03478982|7680335|FG003|STARTED|Overall Study||48
6753723|NCT03478982|7680332|FG000|Enrolled Participants But Not Treated|Overall Study||3
6753724|NCT03478982|7680333|FG001|Enrolled Participants But Not Treated|Overall Study||10
6753725|NCT03478982|7680334|FG002|Enrolled Participants But Not Treated|Overall Study||9
6753726|NCT03478982|7680335|FG003|Enrolled Participants But Not Treated|Overall Study||10
6753727|NCT03478982|7680332|FG000|Intent-to-treat (ITT) Population|Overall Study||8
6753728|NCT03478982|7680333|FG001|Intent-to-treat (ITT) Population|Overall Study||40
6753729|NCT03478982|7680334|FG002|Intent-to-treat (ITT) Population|Overall Study||38
6753730|NCT03478982|7680335|FG003|Intent-to-treat (ITT) Population|Overall Study||38
6753731|NCT03478982|7680332|FG000|COMPLETED|Overall Study||11
6753732|NCT03478982|7680333|FG001|COMPLETED|Overall Study||50
6753733|NCT03478982|7680334|FG002|COMPLETED|Overall Study||47
6753734|NCT03478982|7680335|FG003|COMPLETED|Overall Study||48
6753735|NCT03478982|7680332|FG000|NOT COMPLETED|Overall Study||0
6753736|NCT03478982|7680333|FG001|NOT COMPLETED|Overall Study||0
6753737|NCT03478982|7680334|FG002|NOT COMPLETED|Overall Study||0
6753738|NCT03478982|7680335|FG003|NOT COMPLETED|Overall Study||0
6753739|NCT03479216|7680347|FG000|STARTED|Overall Study||31
6753740|NCT03479216|7680348|FG001|STARTED|Overall Study||31
6753741|NCT03479216|7680347|FG000|COMPLETED|Overall Study||26
6753742|NCT03479216|7680348|FG001|COMPLETED|Overall Study||26
6753743|NCT03479216|7680347|FG000|NOT COMPLETED|Overall Study||5
6753744|NCT03479216|7680348|FG001|NOT COMPLETED|Overall Study||5
6753745|NCT03479944|7680354|FG000|STARTED|Overall Study||55
6753746|NCT03479944|7680354|FG000|FLACS|Overall Study||55
6753747|NCT03479944|7680354|FG000|Conventional|Overall Study||55
6753748|NCT03479944|7680354|FG000|Full Analysis Set|Overall Study||53
6753749|NCT03479944|7680354|FG000|COMPLETED|Overall Study||55
6753750|NCT03479944|7680354|FG000|NOT COMPLETED|Overall Study||0
6753751|NCT03480009|7680366|FG000|STARTED|Overall Study||62
6753752|NCT03480009|7680367|FG001|STARTED|Overall Study||62
6753753|NCT03480009|7680368|FG002|STARTED|Overall Study||16
6753754|NCT03480009|7680369|FG003|STARTED|Overall Study||16
6753755|NCT03480009|7680366|FG000|COMPLETED|Overall Study||58
6753756|NCT03480009|7680367|FG001|COMPLETED|Overall Study||57
6753757|NCT03480009|7680368|FG002|COMPLETED|Overall Study||12
6753758|NCT03480009|7680369|FG003|COMPLETED|Overall Study||16
6753759|NCT03480009|7680366|FG000|NOT COMPLETED|Overall Study||4
6753760|NCT03480009|7680367|FG001|NOT COMPLETED|Overall Study||5
6753761|NCT03480009|7680368|FG002|NOT COMPLETED|Overall Study||4
6753762|NCT03480009|7680369|FG003|NOT COMPLETED|Overall Study||0
6753763|NCT03480022|7680384|FG000|STARTED|Overall Study||55
6753764|NCT03480022|7680385|FG001|STARTED|Overall Study||27
6753765|NCT03480022|7680384|FG000|COMPLETED|Overall Study||44
6753766|NCT03480022|7680385|FG001|COMPLETED|Overall Study||23
6753767|NCT03480022|7680384|FG000|NOT COMPLETED|Overall Study||11
6753768|NCT03480022|7680385|FG001|NOT COMPLETED|Overall Study||4
6753769|NCT03480048|7680393|FG000|STARTED|Overall Study||28
6753770|NCT03480048|7680394|FG001|STARTED|Overall Study||25
6753771|NCT03480048|7680393|FG000|COMPLETED|Overall Study||18
6753772|NCT03480048|7680394|FG001|COMPLETED|Overall Study||17
6753773|NCT03480048|7680393|FG000|NOT COMPLETED|Overall Study||10
6753774|NCT03480048|7680394|FG001|NOT COMPLETED|Overall Study||8
6753775|NCT03480152|7680402|FG000|STARTED|Phase I||3
6753776|NCT03480152|7680403|FG001|STARTED|Phase I||2
6753777|NCT03480152|7680404|FG002|STARTED|Phase I||0
6753778|NCT03480152|7680402|FG000|Received Intervention|Phase I||2
6753779|NCT03480152|7680403|FG001|Received Intervention|Phase I||2
6753780|NCT03480152|7680404|FG002|Received Intervention|Phase I||0
6753781|NCT03480152|7680402|FG000|COMPLETED|Phase I||2
6753782|NCT03480152|7680403|FG001|COMPLETED|Phase I||2
6753783|NCT03480152|7680404|FG002|COMPLETED|Phase I||0
6753784|NCT03480152|7680402|FG000|NOT COMPLETED|Phase I||1
6753785|NCT03480152|7680403|FG001|NOT COMPLETED|Phase I||0
6753786|NCT03480152|7680404|FG002|NOT COMPLETED|Phase I||0
6753787|NCT03480152|7680402|FG000|STARTED|Phase II||0
6753788|NCT03480152|7680403|FG001|STARTED|Phase II||0
6753789|NCT03480152|7680404|FG002|STARTED|Phase II||0
6753790|NCT03480152|7680402|FG000|COMPLETED|Phase II||0
6753791|NCT03480152|7680403|FG001|COMPLETED|Phase II||0
6753792|NCT03480152|7680404|FG002|COMPLETED|Phase II||0
6753793|NCT03480152|7680402|FG000|NOT COMPLETED|Phase II||0
6753794|NCT03480152|7680403|FG001|NOT COMPLETED|Phase II||0
6753795|NCT03480152|7680404|FG002|NOT COMPLETED|Phase II||0
6753796|NCT03480243|7680412|FG000|STARTED|Padsevonil (Period 1)||28
6753797|NCT03480243|7680412|FG000|COMPLETED|Padsevonil (Period 1)||28
6753798|NCT03480243|7680412|FG000|NOT COMPLETED|Padsevonil (Period 1)||0
6753799|NCT03480243|7680412|FG000|STARTED|Padsevonil (Period 2)||28
6753800|NCT03480243|7680412|FG000|COMPLETED|Padsevonil (Period 2)||27
6753801|NCT03480243|7680412|FG000|NOT COMPLETED|Padsevonil (Period 2)||1
6753802|NCT03480243|7680412|FG000|STARTED|Erythromycin (Period 3a)||27
6753803|NCT03480243|7680412|FG000|COMPLETED|Erythromycin (Period 3a)||27
6498116|NCT01408719|7416834|FG008|STARTED|Third Intervention (35 Days)||1
6498117|NCT01408719|7416835|FG009|STARTED|Third Intervention (35 Days)||1
6498118|NCT01408719|7416836|FG010|STARTED|Third Intervention (35 Days)||2
6753804|NCT03480243|7680412|FG000|NOT COMPLETED|Erythromycin (Period 3a)||0
6753805|NCT03480243|7680412|FG000|STARTED|Padsevonil and Erythromycin (Period 3b)||27
6753806|NCT03480243|7680412|FG000|COMPLETED|Padsevonil and Erythromycin (Period 3b)||26
6753807|NCT03480243|7680412|FG000|NOT COMPLETED|Padsevonil and Erythromycin (Period 3b)||1
6753808|NCT03480243|7680412|FG000|STARTED|Erythromycin (Period 3c)||26
6753809|NCT03480243|7680412|FG000|COMPLETED|Erythromycin (Period 3c)||26
6753810|NCT03480243|7680412|FG000|NOT COMPLETED|Erythromycin (Period 3c)||0
6753811|NCT03480425|7680425|FG000|STARTED|Overall Study||11
6753812|NCT03480425|7680425|FG000|COMPLETED|Overall Study||10
6753813|NCT03480425|7680425|FG000|NOT COMPLETED|Overall Study||1
6753814|NCT03480685|7680429|FG000|STARTED|Overall Study||12
6753815|NCT03480685|7680429|FG000|COMPLETED|Overall Study||12
6753816|NCT03480685|7680429|FG000|NOT COMPLETED|Overall Study||0
6753817|NCT03480750|7680441|FG000|STARTED|Overall Study||3
6753818|NCT03480750|7680442|FG001|STARTED|Overall Study||4
6753819|NCT03480750|7680443|FG002|STARTED|Overall Study||3
6753820|NCT03480750|7680444|FG003|STARTED|Overall Study||3
6753821|NCT03480750|7680445|FG004|STARTED|Overall Study||3
6753822|NCT03480750|7680446|FG005|STARTED|Overall Study||2
6753823|NCT03480750|7680441|FG000|COMPLETED|Overall Study||3
6753824|NCT03480750|7680442|FG001|COMPLETED|Overall Study||3
6753825|NCT03480750|7680443|FG002|COMPLETED|Overall Study||3
6753826|NCT03480750|7680444|FG003|COMPLETED|Overall Study||3
6753827|NCT03480750|7680445|FG004|COMPLETED|Overall Study||3
6753828|NCT03480750|7680446|FG005|COMPLETED|Overall Study||1
6753829|NCT03480750|7680441|FG000|NOT COMPLETED|Overall Study||0
6753830|NCT03480750|7680442|FG001|NOT COMPLETED|Overall Study||1
6753831|NCT03480750|7680443|FG002|NOT COMPLETED|Overall Study||0
6753832|NCT03480750|7680444|FG003|NOT COMPLETED|Overall Study||0
6753833|NCT03480750|7680445|FG004|NOT COMPLETED|Overall Study||0
6753834|NCT03480750|7680446|FG005|NOT COMPLETED|Overall Study||1
6753835|NCT03480763|7680471|FG000|STARTED|Overall Study||327
6753836|NCT03480763|7680472|FG001|STARTED|Overall Study||325
6753837|NCT03480763|7680471|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||326
6753838|NCT03480763|7680472|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||325
6753839|NCT03480763|7680471|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||298
6555637|NCT01753401|7477808|FG002|COMPLETED|Double-blind Period (8 Weeks)||0
6555638|NCT01753401|7477809|FG003|COMPLETED|Double-blind Period (8 Weeks)||0
6555639|NCT01753401|7477806|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||1
6555640|NCT01753401|7477807|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||4
6555641|NCT01753401|7477808|FG002|NOT COMPLETED|Double-blind Period (8 Weeks)||0
6555642|NCT01753401|7477809|FG003|NOT COMPLETED|Double-blind Period (8 Weeks)||0
6753840|NCT03480763|7680472|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 12)|Overall Study||302
6753841|NCT03480763|7680471|FG000|COMPLETED|Overall Study||303
6753842|NCT03480763|7680472|FG001|COMPLETED|Overall Study||306
6753843|NCT03480763|7680471|FG000|NOT COMPLETED|Overall Study||24
6753844|NCT03480763|7680472|FG001|NOT COMPLETED|Overall Study||19
6555643|NCT01753401|7477806|FG000|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
6555644|NCT01753401|7477807|FG001|STARTED|Open Label Period (44 Weeks)|This arm was not included in the open label period|0
6555645|NCT01753401|7477808|FG002|STARTED|Open Label Period (44 Weeks)||11
6753845|NCT03480802|7680486|FG000|STARTED|Overall Study||152
6753846|NCT03480802|7680487|FG001|STARTED|Overall Study||150
6753847|NCT03480802|7680486|FG000|Week 8|Overall Study||150
6753848|NCT03480802|7680487|FG001|Week 8|Overall Study||148
6753849|NCT03480802|7680486|FG000|COMPLETED|Overall Study||145
6753850|NCT03480802|7680487|FG001|COMPLETED|Overall Study||147
6753851|NCT03480802|7680486|FG000|NOT COMPLETED|Overall Study||7
6753852|NCT03480802|7680487|FG001|NOT COMPLETED|Overall Study||3
6753853|NCT03480841|7680495|FG000|STARTED|Overall Study||10
6753854|NCT03480841|7680495|FG000|Time 1 Data Collection (T1)|Overall Study||10
6753855|NCT03480841|7680495|FG000|LENA Baseline|Overall Study||10
6753856|NCT03480841|7680495|FG000|LENA Time 1|Overall Study||10
6753857|NCT03480841|7680495|FG000|LENA Time 2|Overall Study||10
6753858|NCT03480841|7680495|FG000|LENA Time 3|Overall Study||10
6753859|NCT03480841|7680495|FG000|LENA Time 4|Overall Study||9
6753860|NCT03480841|7680495|FG000|LENA Time 5|Overall Study||8
6753861|NCT03480841|7680495|FG000|Time 2 Data Collection (T2)|Overall Study||8
6753862|NCT03480841|7680495|FG000|COMPLETED|Overall Study||8
6753863|NCT03480841|7680495|FG000|NOT COMPLETED|Overall Study||2
6753864|NCT03480919|7680502|FG000|STARTED|Overall Study||1
6753865|NCT03480919|7680503|FG001|STARTED|Overall Study||2
6753866|NCT03480919|7680504|FG002|STARTED|Overall Study||1
6753867|NCT03480919|7680502|FG000|COMPLETED|Overall Study||1
6753868|NCT03480919|7680503|FG001|COMPLETED|Overall Study||2
6753869|NCT03480919|7680504|FG002|COMPLETED|Overall Study||1
6753870|NCT03480919|7680502|FG000|NOT COMPLETED|Overall Study||0
6753871|NCT03480919|7680503|FG001|NOT COMPLETED|Overall Study||0
6753872|NCT03480919|7680504|FG002|NOT COMPLETED|Overall Study||0
6753873|NCT03480932|7680515|FG000|STARTED|Overall Study||50
6753874|NCT03480932|7680516|FG001|STARTED|Overall Study||50
6753875|NCT03480932|7680517|FG002|STARTED|Overall Study||50
6753876|NCT03480932|7680515|FG000|COMPLETED|Overall Study||47
6753877|NCT03480932|7680516|FG001|COMPLETED|Overall Study||45
6753878|NCT03480932|7680517|FG002|COMPLETED|Overall Study||45
6753879|NCT03480932|7680515|FG000|NOT COMPLETED|Overall Study||3
6753880|NCT03480932|7680516|FG001|NOT COMPLETED|Overall Study||5
6753881|NCT03480932|7680517|FG002|NOT COMPLETED|Overall Study||5
6753882|NCT03481270|7680527|FG000|STARTED|Overall Study||324
6753883|NCT03481270|7680528|FG001|STARTED|Overall Study||313
6753884|NCT03481270|7680527|FG000|COMPLETED|Overall Study||324
6753885|NCT03481270|7680528|FG001|COMPLETED|Overall Study||313
6753886|NCT03481270|7680527|FG000|NOT COMPLETED|Overall Study||0
6753887|NCT03481270|7680528|FG001|NOT COMPLETED|Overall Study||0
6753888|NCT03481309|7680540|FG000|STARTED|First Intervention (1 Day)||4
6753889|NCT03481309|7680541|FG001|STARTED|First Intervention (1 Day)||3
6753890|NCT03481309|7680542|FG002|STARTED|First Intervention (1 Day)||3
6753891|NCT03481309|7680543|FG003|STARTED|First Intervention (1 Day)||3
6753892|NCT03481309|7680544|FG004|STARTED|First Intervention (1 Day)||3
6753893|NCT03481309|7680545|FG005|STARTED|First Intervention (1 Day)||3
6753894|NCT03481309|7680540|FG000|COMPLETED|First Intervention (1 Day)||4
6753895|NCT03481309|7680541|FG001|COMPLETED|First Intervention (1 Day)||3
6753896|NCT03481309|7680542|FG002|COMPLETED|First Intervention (1 Day)||3
6753897|NCT03481309|7680543|FG003|COMPLETED|First Intervention (1 Day)||3
6753898|NCT03481309|7680544|FG004|COMPLETED|First Intervention (1 Day)||3
6753899|NCT03481309|7680545|FG005|COMPLETED|First Intervention (1 Day)||3
6753900|NCT03481309|7680540|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6753901|NCT03481309|7680541|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6753902|NCT03481309|7680542|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6753903|NCT03481309|7680543|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6753904|NCT03481309|7680544|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6753905|NCT03481309|7680545|FG005|NOT COMPLETED|First Intervention (1 Day)||0
6753906|NCT03481309|7680540|FG000|STARTED|Washout (at Least 3 Days)||4
6753907|NCT03481309|7680541|FG001|STARTED|Washout (at Least 3 Days)||3
6753908|NCT03481309|7680542|FG002|STARTED|Washout (at Least 3 Days)||3
6753909|NCT03481309|7680543|FG003|STARTED|Washout (at Least 3 Days)||3
6753910|NCT03481309|7680544|FG004|STARTED|Washout (at Least 3 Days)||3
6753911|NCT03481309|7680545|FG005|STARTED|Washout (at Least 3 Days)||3
6753912|NCT03481309|7680540|FG000|COMPLETED|Washout (at Least 3 Days)||3
6753913|NCT03481309|7680541|FG001|COMPLETED|Washout (at Least 3 Days)||3
6753914|NCT03481309|7680542|FG002|COMPLETED|Washout (at Least 3 Days)||3
6753915|NCT03481309|7680543|FG003|COMPLETED|Washout (at Least 3 Days)||3
6753916|NCT03481309|7680544|FG004|COMPLETED|Washout (at Least 3 Days)||3
6753917|NCT03481309|7680545|FG005|COMPLETED|Washout (at Least 3 Days)||3
6753918|NCT03481309|7680540|FG000|NOT COMPLETED|Washout (at Least 3 Days)||1
6753919|NCT03481309|7680541|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
6753920|NCT03481309|7680542|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
6753921|NCT03481309|7680543|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
6753922|NCT03481309|7680544|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
6753923|NCT03481309|7680545|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
6753924|NCT03481309|7680540|FG000|STARTED|Second Intervention (1 Day)||3
6753925|NCT03481309|7680541|FG001|STARTED|Second Intervention (1 Day)||3
6753926|NCT03481309|7680542|FG002|STARTED|Second Intervention (1 Day)||3
6753927|NCT03481309|7680543|FG003|STARTED|Second Intervention (1 Day)||3
6753928|NCT03481309|7680544|FG004|STARTED|Second Intervention (1 Day)||3
6753929|NCT03481309|7680545|FG005|STARTED|Second Intervention (1 Day)||3
6753930|NCT03481309|7680540|FG000|COMPLETED|Second Intervention (1 Day)||3
6753931|NCT03481309|7680541|FG001|COMPLETED|Second Intervention (1 Day)||3
6753932|NCT03481309|7680542|FG002|COMPLETED|Second Intervention (1 Day)||3
6753933|NCT03481309|7680543|FG003|COMPLETED|Second Intervention (1 Day)||3
6753934|NCT03481309|7680544|FG004|COMPLETED|Second Intervention (1 Day)||3
6753935|NCT03481309|7680545|FG005|COMPLETED|Second Intervention (1 Day)||3
6753936|NCT03481309|7680540|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6753937|NCT03481309|7680541|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6753938|NCT03481309|7680542|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6753939|NCT03481309|7680543|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6753940|NCT03481309|7680544|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6753941|NCT03481309|7680545|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
6753942|NCT03481309|7680540|FG000|STARTED|Washout (at Least 3 Days)||3
6753943|NCT03481309|7680541|FG001|STARTED|Washout (at Least 3 Days)||3
6753944|NCT03481309|7680542|FG002|STARTED|Washout (at Least 3 Days)||3
6753945|NCT03481309|7680543|FG003|STARTED|Washout (at Least 3 Days)||3
6753946|NCT03481309|7680544|FG004|STARTED|Washout (at Least 3 Days)||3
6753947|NCT03481309|7680545|FG005|STARTED|Washout (at Least 3 Days)||3
6753948|NCT03481309|7680540|FG000|COMPLETED|Washout (at Least 3 Days)||3
6753949|NCT03481309|7680541|FG001|COMPLETED|Washout (at Least 3 Days)||3
6753950|NCT03481309|7680542|FG002|COMPLETED|Washout (at Least 3 Days)||3
6753951|NCT03481309|7680543|FG003|COMPLETED|Washout (at Least 3 Days)||3
6753952|NCT03481309|7680544|FG004|COMPLETED|Washout (at Least 3 Days)||3
6753953|NCT03481309|7680545|FG005|COMPLETED|Washout (at Least 3 Days)||3
6753954|NCT03481309|7680540|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
6753955|NCT03481309|7680541|FG001|NOT COMPLETED|Washout (at Least 3 Days)||0
6753956|NCT03481309|7680542|FG002|NOT COMPLETED|Washout (at Least 3 Days)||0
6753957|NCT03481309|7680543|FG003|NOT COMPLETED|Washout (at Least 3 Days)||0
6753958|NCT03481309|7680544|FG004|NOT COMPLETED|Washout (at Least 3 Days)||0
6753959|NCT03481309|7680545|FG005|NOT COMPLETED|Washout (at Least 3 Days)||0
6753960|NCT03481309|7680540|FG000|STARTED|Third Intervention (1 Day)||3
6753961|NCT03481309|7680541|FG001|STARTED|Third Intervention (1 Day)||3
6753962|NCT03481309|7680542|FG002|STARTED|Third Intervention (1 Day)||3
6753963|NCT03481309|7680543|FG003|STARTED|Third Intervention (1 Day)||3
6753964|NCT03481309|7680544|FG004|STARTED|Third Intervention (1 Day)||3
6753965|NCT03481309|7680545|FG005|STARTED|Third Intervention (1 Day)||3
6753966|NCT03481309|7680540|FG000|COMPLETED|Third Intervention (1 Day)||3
6753967|NCT03481309|7680541|FG001|COMPLETED|Third Intervention (1 Day)||3
6753968|NCT03481309|7680542|FG002|COMPLETED|Third Intervention (1 Day)||3
6753969|NCT03481309|7680543|FG003|COMPLETED|Third Intervention (1 Day)||3
6753970|NCT03481309|7680544|FG004|COMPLETED|Third Intervention (1 Day)||3
6753971|NCT03481309|7680545|FG005|COMPLETED|Third Intervention (1 Day)||3
6753972|NCT03481309|7680540|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6753973|NCT03481309|7680541|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6753974|NCT03481309|7680542|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6753975|NCT03481309|7680543|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6753976|NCT03481309|7680544|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
6753977|NCT03481309|7680545|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
6753978|NCT03481595|7680555|FG000|STARTED|Overall Study||146
6753979|NCT03481595|7680556|FG001|STARTED|Overall Study||148
6753980|NCT03481595|7680555|FG000|COMPLETED|Overall Study||143
6753981|NCT03481595|7680556|FG001|COMPLETED|Overall Study||127
6753982|NCT03481595|7680555|FG000|NOT COMPLETED|Overall Study||3
6753983|NCT03481595|7680556|FG001|NOT COMPLETED|Overall Study||21
6555646|NCT01753401|7477809|FG003|STARTED|Open Label Period (44 Weeks)||22
6555647|NCT01753401|7477806|FG000|mITT|Open Label Period (44 Weeks)||0
6779955|NCT03483051|7708242|FG001|STARTED|First Treatment, Pre Crossover||1
6779956|NCT03483051|7708241|FG000|COMPLETED|First Treatment, Pre Crossover||2
6779957|NCT03483051|7708242|FG001|COMPLETED|First Treatment, Pre Crossover||1
6779958|NCT03483051|7708241|FG000|NOT COMPLETED|First Treatment, Pre Crossover||0
6779959|NCT03483051|7708242|FG001|NOT COMPLETED|First Treatment, Pre Crossover||0
6779960|NCT03483051|7708241|FG000|STARTED|Second Treatment, After Crossover||2
6779961|NCT03483051|7708242|FG001|STARTED|Second Treatment, After Crossover||1
6779962|NCT03483051|7708241|FG000|COMPLETED|Second Treatment, After Crossover||2
6779963|NCT03483051|7708242|FG001|COMPLETED|Second Treatment, After Crossover||1
6779964|NCT03483051|7708241|FG000|NOT COMPLETED|Second Treatment, After Crossover||0
6779965|NCT03483051|7708242|FG001|NOT COMPLETED|Second Treatment, After Crossover||0
6779966|NCT03477903|7708250|FG000|STARTED|Overall Study||1
6779967|NCT03477903|7708250|FG000|COMPLETED|Overall Study||0
6779968|NCT03477903|7708250|FG000|NOT COMPLETED|Overall Study||1
6779969|NCT03469258|7708254|FG000|STARTED|Overall Study||4
6779970|NCT03469258|7708254|FG000|COMPLETED|Overall Study||0
6779971|NCT03469258|7708254|FG000|NOT COMPLETED|Overall Study||4
6779972|NCT03466658|7708258|FG000|STARTED|Overall Study||17
6779973|NCT03466658|7708258|FG000|COMPLETED|Overall Study||14
6779974|NCT03466658|7708258|FG000|NOT COMPLETED|Overall Study||3
6779975|NCT03465891|7708266|FG000|STARTED|Overall Study||1
6779976|NCT03465891|7708267|FG001|STARTED|Overall Study||1
6779977|NCT03465891|7708266|FG000|COMPLETED|Overall Study||0
6779978|NCT03465891|7708267|FG001|COMPLETED|Overall Study||0
6779979|NCT03465891|7708266|FG000|NOT COMPLETED|Overall Study||1
6779980|NCT03465891|7708267|FG001|NOT COMPLETED|Overall Study||1
6753984|NCT03481725|7680564|FG000|STARTED|Overall Study||31
6753985|NCT03481725|7680565|FG001|STARTED|Overall Study||34
6753986|NCT03481725|7680564|FG000|COMPLETED|Overall Study||30
6753987|NCT03481725|7680565|FG001|COMPLETED|Overall Study||34
6753988|NCT03481725|7680564|FG000|NOT COMPLETED|Overall Study||1
6753989|NCT03481725|7680565|FG001|NOT COMPLETED|Overall Study||0
6753990|NCT03481816|7680575|FG000|STARTED|Starting Dose||6
6753991|NCT03481816|7680576|FG001|STARTED|Starting Dose||0
6753992|NCT03481816|7680575|FG000|COMPLETED|Starting Dose||5
6753993|NCT03481816|7680576|FG001|COMPLETED|Starting Dose||0
6753994|NCT03481816|7680575|FG000|NOT COMPLETED|Starting Dose||1
6753995|NCT03481816|7680576|FG001|NOT COMPLETED|Starting Dose||0
6753996|NCT03481816|7680575|FG000|STARTED|Dose Expansion||0
6753997|NCT03481816|7680576|FG001|STARTED|Dose Expansion||12
6753998|NCT03481816|7680575|FG000|COMPLETED|Dose Expansion||0
6753999|NCT03481816|7680576|FG001|COMPLETED|Dose Expansion||0
6754000|NCT03481816|7680575|FG000|NOT COMPLETED|Dose Expansion||0
6754001|NCT03481816|7680576|FG001|NOT COMPLETED|Dose Expansion||12
6754002|NCT03482011|7680586|FG000|STARTED|Induction Period (16 Weeks)||107
6754003|NCT03482011|7680587|FG001|STARTED|Induction Period (16 Weeks)||423
6754004|NCT03482011|7680588|FG002|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6754005|NCT03482011|7680589|FG003|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6754006|NCT03482011|7680590|FG004|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6754007|NCT03482011|7680591|FG005|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6754008|NCT03482011|7680592|FG006|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6754009|NCT03482011|7680593|FG007|STARTED|Induction Period (16 Weeks)|Participants were assigned to this arm during maintenance period.|0
6754010|NCT03482011|7680586|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||107
6754011|NCT03482011|7680587|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||422
6754012|NCT03482011|7680588|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6754013|NCT03482011|7680589|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6754014|NCT03482011|7680590|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6754015|NCT03482011|7680591|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6754016|NCT03482011|7680592|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6754017|NCT03482011|7680593|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6754018|NCT03482011|7680586|FG000|COMPLETED|Induction Period (16 Weeks)||101
6754019|NCT03482011|7680587|FG001|COMPLETED|Induction Period (16 Weeks)||412
6754020|NCT03482011|7680588|FG002|COMPLETED|Induction Period (16 Weeks)||0
6754021|NCT03482011|7680589|FG003|COMPLETED|Induction Period (16 Weeks)||0
6754022|NCT03482011|7680590|FG004|COMPLETED|Induction Period (16 Weeks)||0
6754023|NCT03482011|7680591|FG005|COMPLETED|Induction Period (16 Weeks)||0
6754024|NCT03482011|7680592|FG006|COMPLETED|Induction Period (16 Weeks)||0
6754025|NCT03482011|7680593|FG007|COMPLETED|Induction Period (16 Weeks)||0
6754026|NCT03482011|7680586|FG000|NOT COMPLETED|Induction Period (16 Weeks)||6
6754027|NCT03482011|7680587|FG001|NOT COMPLETED|Induction Period (16 Weeks)||11
6754028|NCT03482011|7680588|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
6754029|NCT03482011|7680589|FG003|NOT COMPLETED|Induction Period (16 Weeks)||0
6754030|NCT03482011|7680590|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
6754031|NCT03482011|7680591|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
6754032|NCT03482011|7680592|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
6754033|NCT03482011|7680593|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
6754034|NCT03482011|7680586|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
6754035|NCT03482011|7680587|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
6754036|NCT03482011|7680588|FG002|STARTED|Maintenance Period (36 Weeks)||7
6754037|NCT03482011|7680589|FG003|STARTED|Maintenance Period (36 Weeks)||94
6754038|NCT03482011|7680590|FG004|STARTED|Maintenance Period (36 Weeks)||91
6754039|NCT03482011|7680591|FG005|STARTED|Maintenance Period (36 Weeks)||90
6754040|NCT03482011|7680592|FG006|STARTED|Maintenance Period (36 Weeks)||91
6754041|NCT03482011|7680593|FG007|STARTED|Maintenance Period (36 Weeks)||140
6754042|NCT03482011|7680586|FG000|Relapse|Maintenance Period (36 Weeks)||0
6754043|NCT03482011|7680587|FG001|Relapse|Maintenance Period (36 Weeks)||0
6754044|NCT03482011|7680588|FG002|Relapse|Maintenance Period (36 Weeks)||1
6754045|NCT03482011|7680589|FG003|Relapse|Maintenance Period (36 Weeks)||0
6754046|NCT03482011|7680590|FG004|Relapse|Maintenance Period (36 Weeks)||41
6754047|NCT03482011|7680591|FG005|Relapse|Maintenance Period (36 Weeks)||3
6754048|NCT03482011|7680592|FG006|Relapse|Maintenance Period (36 Weeks)||2
6754049|NCT03482011|7680593|FG007|Relapse|Maintenance Period (36 Weeks)||0
6754050|NCT03482011|7680586|FG000|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
6754051|NCT03482011|7680587|FG001|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||0
6754052|NCT03482011|7680588|FG002|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||6
6754053|NCT03482011|7680589|FG003|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||88
6754054|NCT03482011|7680590|FG004|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||86
6754055|NCT03482011|7680591|FG005|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||85
6754056|NCT03482011|7680592|FG006|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||87
6754057|NCT03482011|7680593|FG007|Roll Over to I6T-MC-AMAH (NCT03556202)|Maintenance Period (36 Weeks)||121
6754058|NCT03482011|7680586|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
6754059|NCT03482011|7680587|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
6754060|NCT03482011|7680588|FG002|COMPLETED|Maintenance Period (36 Weeks)||6
6754061|NCT03482011|7680589|FG003|COMPLETED|Maintenance Period (36 Weeks)||90
6754062|NCT03482011|7680590|FG004|COMPLETED|Maintenance Period (36 Weeks)||86
6754063|NCT03482011|7680591|FG005|COMPLETED|Maintenance Period (36 Weeks)||86
6754064|NCT03482011|7680592|FG006|COMPLETED|Maintenance Period (36 Weeks)||87
6754065|NCT03482011|7680593|FG007|COMPLETED|Maintenance Period (36 Weeks)||123
6754066|NCT03482011|7680586|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
6754067|NCT03482011|7680587|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
6754068|NCT03482011|7680588|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||1
6754069|NCT03482011|7680589|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6754070|NCT03482011|7680590|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||5
6754071|NCT03482011|7680591|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6754072|NCT03482011|7680592|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6754073|NCT03482011|7680593|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||17
6754074|NCT03482011|7680586|FG000|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
6754075|NCT03482011|7680587|FG001|STARTED|Follow-up Period (12 Weeks)|Participants were assigned to this arm during induction period.|0
6754076|NCT03482011|7680588|FG002|STARTED|Follow-up Period (12 Weeks)||1
6754077|NCT03482011|7680589|FG003|STARTED|Follow-up Period (12 Weeks)||10
6754078|NCT03482011|7680590|FG004|STARTED|Follow-up Period (12 Weeks)||2
6754079|NCT03482011|7680591|FG005|STARTED|Follow-up Period (12 Weeks)||4
6754080|NCT03482011|7680592|FG006|STARTED|Follow-up Period (12 Weeks)||4
6754081|NCT03482011|7680593|FG007|STARTED|Follow-up Period (12 Weeks)||21
6754082|NCT03482011|7680586|FG000|COMPLETED|Follow-up Period (12 Weeks)||0
6754083|NCT03482011|7680587|FG001|COMPLETED|Follow-up Period (12 Weeks)||0
6754084|NCT03482011|7680588|FG002|COMPLETED|Follow-up Period (12 Weeks)||0
6754085|NCT03482011|7680589|FG003|COMPLETED|Follow-up Period (12 Weeks)||5
6754086|NCT03482011|7680590|FG004|COMPLETED|Follow-up Period (12 Weeks)||2
6754087|NCT03482011|7680591|FG005|COMPLETED|Follow-up Period (12 Weeks)||3
6754088|NCT03482011|7680592|FG006|COMPLETED|Follow-up Period (12 Weeks)||2
6754089|NCT03482011|7680593|FG007|COMPLETED|Follow-up Period (12 Weeks)||4
6754090|NCT03482011|7680586|FG000|NOT COMPLETED|Follow-up Period (12 Weeks)||0
6754091|NCT03482011|7680587|FG001|NOT COMPLETED|Follow-up Period (12 Weeks)||0
6754092|NCT03482011|7680588|FG002|NOT COMPLETED|Follow-up Period (12 Weeks)||1
6754093|NCT03482011|7680589|FG003|NOT COMPLETED|Follow-up Period (12 Weeks)||5
6754094|NCT03482011|7680590|FG004|NOT COMPLETED|Follow-up Period (12 Weeks)||0
6754095|NCT03482011|7680591|FG005|NOT COMPLETED|Follow-up Period (12 Weeks)||1
6754096|NCT03482011|7680592|FG006|NOT COMPLETED|Follow-up Period (12 Weeks)||2
6754097|NCT03482011|7680593|FG007|NOT COMPLETED|Follow-up Period (12 Weeks)||17
6754098|NCT03482453|7680630|FG000|STARTED|Part 1 (1 Day)||10
6754099|NCT03482453|7680631|FG001|STARTED|Part 1 (1 Day)||6
6754100|NCT03482453|7680632|FG002|STARTED|Part 1 (1 Day)||6
6754101|NCT03482453|7680633|FG003|STARTED|Part 1 (1 Day)||6
6754102|NCT03482453|7680634|FG004|STARTED|Part 1 (1 Day)||6
6754103|NCT03482453|7680635|FG005|STARTED|Part 1 (1 Day)||6
6754104|NCT03482453|7680636|FG006|STARTED|Part 1 (1 Day)||0
6754105|NCT03482453|7680637|FG007|STARTED|Part 1 (1 Day)||0
6754106|NCT03482453|7680638|FG008|STARTED|Part 1 (1 Day)||0
6754107|NCT03482453|7680639|FG009|STARTED|Part 1 (1 Day)||0
6754108|NCT03482453|7680640|FG010|STARTED|Part 1 (1 Day)||0
6754109|NCT03482453|7680641|FG011|STARTED|Part 1 (1 Day)||0
6754110|NCT03482453|7680630|FG000|COMPLETED|Part 1 (1 Day)||10
6754111|NCT03482453|7680631|FG001|COMPLETED|Part 1 (1 Day)||6
6754112|NCT03482453|7680632|FG002|COMPLETED|Part 1 (1 Day)||6
6754113|NCT03482453|7680633|FG003|COMPLETED|Part 1 (1 Day)||6
6754114|NCT03482453|7680634|FG004|COMPLETED|Part 1 (1 Day)||6
6754115|NCT03482453|7680635|FG005|COMPLETED|Part 1 (1 Day)||6
6754116|NCT03482453|7680636|FG006|COMPLETED|Part 1 (1 Day)||0
6754117|NCT03482453|7680637|FG007|COMPLETED|Part 1 (1 Day)||0
6754118|NCT03482453|7680638|FG008|COMPLETED|Part 1 (1 Day)||0
6754119|NCT03482453|7680639|FG009|COMPLETED|Part 1 (1 Day)||0
6754120|NCT03482453|7680640|FG010|COMPLETED|Part 1 (1 Day)||0
6754121|NCT03482453|7680641|FG011|COMPLETED|Part 1 (1 Day)||0
6754122|NCT03482453|7680630|FG000|NOT COMPLETED|Part 1 (1 Day)||0
6754123|NCT03482453|7680631|FG001|NOT COMPLETED|Part 1 (1 Day)||0
6754124|NCT03482453|7680632|FG002|NOT COMPLETED|Part 1 (1 Day)||0
6754125|NCT03482453|7680633|FG003|NOT COMPLETED|Part 1 (1 Day)||0
6754126|NCT03482453|7680634|FG004|NOT COMPLETED|Part 1 (1 Day)||0
6754127|NCT03482453|7680635|FG005|NOT COMPLETED|Part 1 (1 Day)||0
6754128|NCT03482453|7680636|FG006|NOT COMPLETED|Part 1 (1 Day)||0
6754129|NCT03482453|7680637|FG007|NOT COMPLETED|Part 1 (1 Day)||0
6754130|NCT03482453|7680638|FG008|NOT COMPLETED|Part 1 (1 Day)||0
6754131|NCT03482453|7680639|FG009|NOT COMPLETED|Part 1 (1 Day)||0
6754132|NCT03482453|7680640|FG010|NOT COMPLETED|Part 1 (1 Day)||0
6754133|NCT03482453|7680641|FG011|NOT COMPLETED|Part 1 (1 Day)||0
6754134|NCT03482453|7680630|FG000|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754135|NCT03482453|7680631|FG001|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754136|NCT03482453|7680632|FG002|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754137|NCT03482453|7680633|FG003|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754138|NCT03482453|7680634|FG004|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754139|NCT03482453|7680635|FG005|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754140|NCT03482453|7680636|FG006|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
6754141|NCT03482453|7680637|FG007|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||3
6754142|NCT03482453|7680638|FG008|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
6754143|NCT03482453|7680639|FG009|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||5
6754144|NCT03482453|7680640|FG010|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||7
6754145|NCT03482453|7680641|FG011|STARTED|Parts 2, 3 Intervention Period 1 (1 Day)||6
6754146|NCT03482453|7680630|FG000|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754147|NCT03482453|7680631|FG001|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754148|NCT03482453|7680632|FG002|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754149|NCT03482453|7680633|FG003|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754150|NCT03482453|7680634|FG004|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754151|NCT03482453|7680635|FG005|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754152|NCT03482453|7680636|FG006|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
6754153|NCT03482453|7680637|FG007|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||3
6754154|NCT03482453|7680638|FG008|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
6754155|NCT03482453|7680639|FG009|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||5
6754156|NCT03482453|7680640|FG010|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
6754157|NCT03482453|7680641|FG011|COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||6
6754158|NCT03482453|7680630|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754159|NCT03482453|7680631|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754160|NCT03482453|7680632|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6555648|NCT01753401|7477807|FG001|mITT|Open Label Period (44 Weeks)||0
6555649|NCT01753401|7477808|FG002|mITT|Open Label Period (44 Weeks)||11
6555650|NCT01753401|7477809|FG003|mITT|Open Label Period (44 Weeks)||22
6754161|NCT03482453|7680633|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754162|NCT03482453|7680634|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754163|NCT03482453|7680635|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754164|NCT03482453|7680636|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754165|NCT03482453|7680637|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754166|NCT03482453|7680638|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754167|NCT03482453|7680639|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754168|NCT03482453|7680640|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||1
6754169|NCT03482453|7680641|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 1 (1 Day)||0
6754170|NCT03482453|7680630|FG000|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6754171|NCT03482453|7680631|FG001|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6754172|NCT03482453|7680632|FG002|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6754173|NCT03482453|7680633|FG003|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6754174|NCT03482453|7680634|FG004|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6754175|NCT03482453|7680635|FG005|STARTED|Parts 2, 3 Washout Period (7 Days)||0
6754176|NCT03482453|7680636|FG006|STARTED|Parts 2, 3 Washout Period (7 Days)||3
6754177|NCT03482453|7680637|FG007|STARTED|Parts 2, 3 Washout Period (7 Days)||3
6754178|NCT03482453|7680638|FG008|STARTED|Parts 2, 3 Washout Period (7 Days)||5
6754179|NCT03482453|7680639|FG009|STARTED|Parts 2, 3 Washout Period (7 Days)||5
6754180|NCT03482453|7680640|FG010|STARTED|Parts 2, 3 Washout Period (7 Days)||6
6754181|NCT03482453|7680641|FG011|STARTED|Parts 2, 3 Washout Period (7 Days)||6
6754182|NCT03482453|7680630|FG000|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754183|NCT03482453|7680631|FG001|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754184|NCT03482453|7680632|FG002|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754185|NCT03482453|7680633|FG003|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754186|NCT03482453|7680634|FG004|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754187|NCT03482453|7680635|FG005|COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754188|NCT03482453|7680636|FG006|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
6754189|NCT03482453|7680637|FG007|COMPLETED|Parts 2, 3 Washout Period (7 Days)||3
6754190|NCT03482453|7680638|FG008|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
6754191|NCT03482453|7680639|FG009|COMPLETED|Parts 2, 3 Washout Period (7 Days)||5
6754192|NCT03482453|7680640|FG010|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
6754193|NCT03482453|7680641|FG011|COMPLETED|Parts 2, 3 Washout Period (7 Days)||6
6754194|NCT03482453|7680630|FG000|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754195|NCT03482453|7680631|FG001|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754196|NCT03482453|7680632|FG002|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754197|NCT03482453|7680633|FG003|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754198|NCT03482453|7680634|FG004|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754199|NCT03482453|7680635|FG005|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754200|NCT03482453|7680636|FG006|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754201|NCT03482453|7680637|FG007|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754202|NCT03482453|7680638|FG008|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754203|NCT03482453|7680639|FG009|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754204|NCT03482453|7680640|FG010|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754205|NCT03482453|7680641|FG011|NOT COMPLETED|Parts 2, 3 Washout Period (7 Days)||0
6754206|NCT03482453|7680630|FG000|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754207|NCT03482453|7680631|FG001|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754208|NCT03482453|7680632|FG002|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6555651|NCT01753401|7477806|FG000|Safety Analysis Set|Open Label Period (44 Weeks)||0
6754209|NCT03482453|7680633|FG003|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754210|NCT03482453|7680634|FG004|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754211|NCT03482453|7680635|FG005|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754212|NCT03482453|7680636|FG006|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
6754213|NCT03482453|7680637|FG007|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||3
6754214|NCT03482453|7680638|FG008|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
6754215|NCT03482453|7680639|FG009|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||5
6754216|NCT03482453|7680640|FG010|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
6754217|NCT03482453|7680641|FG011|STARTED|Parts 2, 3 Intervention Period 2 (1 Day)||6
6754218|NCT03482453|7680630|FG000|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754219|NCT03482453|7680631|FG001|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754220|NCT03482453|7680632|FG002|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754221|NCT03482453|7680633|FG003|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754222|NCT03482453|7680634|FG004|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754223|NCT03482453|7680635|FG005|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754224|NCT03482453|7680636|FG006|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
6754225|NCT03482453|7680637|FG007|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||3
6754226|NCT03482453|7680638|FG008|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
6754227|NCT03482453|7680639|FG009|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||5
6754228|NCT03482453|7680640|FG010|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
6754229|NCT03482453|7680641|FG011|COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||6
6754230|NCT03482453|7680630|FG000|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754231|NCT03482453|7680631|FG001|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754232|NCT03482453|7680632|FG002|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754233|NCT03482453|7680633|FG003|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754234|NCT03482453|7680634|FG004|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754235|NCT03482453|7680635|FG005|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754236|NCT03482453|7680636|FG006|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754237|NCT03482453|7680637|FG007|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754238|NCT03482453|7680638|FG008|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754239|NCT03482453|7680639|FG009|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754240|NCT03482453|7680640|FG010|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754241|NCT03482453|7680641|FG011|NOT COMPLETED|Parts 2, 3 Intervention Period 2 (1 Day)||0
6754242|NCT03482583|7680680|FG000|STARTED|Overall Study||37
6754243|NCT03482583|7680681|FG001|STARTED|Overall Study||14
6754244|NCT03482583|7680682|FG002|STARTED|Overall Study||39
6754245|NCT03482583|7680680|FG000|COMPLETED|Overall Study||12
6754246|NCT03482583|7680681|FG001|COMPLETED|Overall Study||5
6754247|NCT03482583|7680682|FG002|COMPLETED|Overall Study||18
6754248|NCT03482583|7680680|FG000|NOT COMPLETED|Overall Study||25
6754249|NCT03482583|7680681|FG001|NOT COMPLETED|Overall Study||9
6754250|NCT03482583|7680682|FG002|NOT COMPLETED|Overall Study||21
6754251|NCT03482635|7680695|FG000|STARTED|Overall Study||23
6754252|NCT03482635|7680696|FG001|STARTED|Overall Study||24
6754253|NCT03482635|7680697|FG002|STARTED|Overall Study||23
6754254|NCT03482635|7680698|FG003|STARTED|Overall Study||28
6754255|NCT03482635|7680695|FG000|Treated|Overall Study||23
6754256|NCT03482635|7680696|FG001|Treated|Overall Study||24
6754257|NCT03482635|7680697|FG002|Treated|Overall Study||23
6754258|NCT03482635|7680698|FG003|Treated|Overall Study||27
6754259|NCT03482635|7680695|FG000|COMPLETED|Overall Study||18
6754260|NCT03482635|7680696|FG001|COMPLETED|Overall Study||21
6754261|NCT03482635|7680697|FG002|COMPLETED|Overall Study||22
6754262|NCT03482635|7680698|FG003|COMPLETED|Overall Study||20
6754263|NCT03482635|7680695|FG000|NOT COMPLETED|Overall Study||5
6754264|NCT03482635|7680696|FG001|NOT COMPLETED|Overall Study||3
6754265|NCT03482635|7680697|FG002|NOT COMPLETED|Overall Study||1
6754266|NCT03482635|7680698|FG003|NOT COMPLETED|Overall Study||8
6754267|NCT03482713|7680710|FG000|STARTED|Overall Study||11
6754268|NCT03482713|7680711|FG001|STARTED|Overall Study||12
6754269|NCT03482713|7680710|FG000|COMPLETED|Overall Study||11
6754270|NCT03482713|7680711|FG001|COMPLETED|Overall Study||12
6754271|NCT03482713|7680710|FG000|NOT COMPLETED|Overall Study||0
6754272|NCT03482713|7680711|FG001|NOT COMPLETED|Overall Study||0
6754273|NCT03482882|7680717|FG000|STARTED|Overall Study||47
6754274|NCT03482882|7680717|FG000|COMPLETED|Overall Study||40
6754275|NCT03482882|7680717|FG000|NOT COMPLETED|Overall Study||7
6754276|NCT03482973|7680723|FG000|STARTED|Overall Study||40
6754277|NCT03482973|7680724|FG001|STARTED|Overall Study||40
6754278|NCT03482973|7680723|FG000|COMPLETED|Overall Study||40
6754279|NCT03482973|7680724|FG001|COMPLETED|Overall Study||40
6754280|NCT03482973|7680723|FG000|NOT COMPLETED|Overall Study||0
6754281|NCT03482973|7680724|FG001|NOT COMPLETED|Overall Study||0
6754282|NCT03483506|7680730|FG000|STARTED|Overall Study||12
6754283|NCT03483506|7680730|FG000|COMPLETED|Overall Study||12
6754284|NCT03483506|7680730|FG000|NOT COMPLETED|Overall Study||0
6754285|NCT03483623|7680736|FG000|STARTED|Overall Study||44
6754286|NCT03483623|7680736|FG000|Started NATO WELP|Overall Study||44
6754287|NCT03483623|7680736|FG000|Completeded NATO WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6754288|NCT03483623|7680736|FG000|Started NATO FIS|Overall Study||44
6754289|NCT03483623|7680736|FG000|Completed NATO FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6754290|NCT03483623|7680736|FG000|Started RAVEN WELP|Overall Study||44
6754291|NCT03483623|7680736|FG000|Completed RAVEN WELP|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6754292|NCT03483623|7680736|FG000|Started RAVEN FIS|Overall Study||44
6754293|NCT03483623|7680736|FG000|Completed RAVEN FIS|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6754294|NCT03483623|7680736|FG000|COMPLETED|Overall Study|1 subject was withdrawn after the target of 43 complete sets was achieved|43
6754295|NCT03483623|7680736|FG000|NOT COMPLETED|Overall Study||1
6754296|NCT03483675|7680742|FG000|STARTED|Overall Study||9
6754297|NCT03483675|7680743|FG001|STARTED|Overall Study||8
6754298|NCT03483675|7680742|FG000|COMPLETED|Overall Study||9
6754299|NCT03483675|7680743|FG001|COMPLETED|Overall Study||8
6754300|NCT03483675|7680742|FG000|NOT COMPLETED|Overall Study||0
6754301|NCT03483675|7680743|FG001|NOT COMPLETED|Overall Study||0
6754302|NCT03483896|7680752|FG000|STARTED|Overall Study||33
6754303|NCT03483896|7680753|FG001|STARTED|Overall Study||50
6754304|NCT03483896|7680752|FG000|COMPLETED|Overall Study||31
6754305|NCT03483896|7680753|FG001|COMPLETED|Overall Study||46
6754306|NCT03483896|7680752|FG000|NOT COMPLETED|Overall Study||2
6754307|NCT03483896|7680753|FG001|NOT COMPLETED|Overall Study||4
6754308|NCT03483935|7680761|FG000|STARTED|Stage 1: Dose Setting Study||7
6754309|NCT03483935|7680761|FG000|COMPLETED|Stage 1: Dose Setting Study||7
6754310|NCT03483935|7680761|FG000|NOT COMPLETED|Stage 1: Dose Setting Study||0
6754311|NCT03483935|7680761|FG000|STARTED|Stage 2: Randomised Controlled Trial|Participants were randomised to receiving treatment on the left or right side.|11
6754312|NCT03483935|7680761|FG000|AKs Treated|Stage 2: Randomised Controlled Trial||11
6754313|NCT03483935|7680761|FG000|AKs Not Treated|Stage 2: Randomised Controlled Trial||11
6754314|NCT03483935|7680761|FG000|COMPLETED|Stage 2: Randomised Controlled Trial||11
6754315|NCT03483935|7680761|FG000|NOT COMPLETED|Stage 2: Randomised Controlled Trial||0
6754316|NCT03483961|7680779|FG000|STARTED|Overall Study||53
6754317|NCT03483961|7680780|FG001|STARTED|Overall Study||52
6754318|NCT03483961|7680781|FG002|STARTED|Overall Study||51
6754319|NCT03483961|7680782|FG003|STARTED|Overall Study||50
6754320|NCT03483961|7680783|FG004|STARTED|Overall Study||53
6754321|NCT03483961|7680784|FG005|STARTED|Overall Study||53
6754322|NCT03483961|7680785|FG006|STARTED|Overall Study||51
6754323|NCT03483961|7680786|FG007|STARTED|Overall Study||52
6754324|NCT03483961|7680787|FG008|STARTED|Overall Study||20
6754325|NCT03483961|7680788|FG009|STARTED|Overall Study||10
6754326|NCT03483961|7680779|FG000|Exposed / Safety|Overall Study||53
6754327|NCT03483961|7680780|FG001|Exposed / Safety|Overall Study||52
6754328|NCT03483961|7680781|FG002|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|50
6754329|NCT03483961|7680782|FG003|Exposed / Safety|Overall Study|One subject was randomized to Group 3 but treated in Group 4 due to a dispensing error.|51
6754330|NCT03483961|7680783|FG004|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|53
6754331|NCT03483961|7680784|FG005|Exposed / Safety|Overall Study||53
6754332|NCT03483961|7680785|FG006|Exposed / Safety|Overall Study|One subject did not receive PXVX0317 but is in the Exposed / Safety population because of receipt of placebo.|51
6754333|NCT03483961|7680786|FG007|Exposed / Safety|Overall Study|Two subjects did not receive PXVX0317 but are in the Exposed / Safety population because of receipt of placebo.|52
6754334|NCT03483961|7680787|FG008|Exposed / Safety|Overall Study||20
6754335|NCT03483961|7680788|FG009|Exposed / Safety|Overall Study||10
6754336|NCT03483961|7680779|FG000|Immunogenicity-evaluable|Overall Study||47
6754337|NCT03483961|7680780|FG001|Immunogenicity-evaluable|Overall Study||44
6754338|NCT03483961|7680781|FG002|Immunogenicity-evaluable|Overall Study||44
6754339|NCT03483961|7680782|FG003|Immunogenicity-evaluable|Overall Study||45
6754340|NCT03483961|7680783|FG004|Immunogenicity-evaluable|Overall Study||48
6754341|NCT03483961|7680784|FG005|Immunogenicity-evaluable|Overall Study||48
6754342|NCT03483961|7680785|FG006|Immunogenicity-evaluable|Overall Study||47
6754343|NCT03483961|7680786|FG007|Immunogenicity-evaluable|Overall Study||50
6754344|NCT03483961|7680787|FG008|Immunogenicity-evaluable|Overall Study||20
6754345|NCT03483961|7680788|FG009|Immunogenicity-evaluable|Overall Study||10
6754346|NCT03483961|7680779|FG000|COMPLETED|Overall Study||42
6754347|NCT03483961|7680780|FG001|COMPLETED|Overall Study||42
6754348|NCT03483961|7680781|FG002|COMPLETED|Overall Study||39
6754349|NCT03483961|7680782|FG003|COMPLETED|Overall Study||41
6754350|NCT03483961|7680783|FG004|COMPLETED|Overall Study||43
6754351|NCT03483961|7680784|FG005|COMPLETED|Overall Study||47
6754352|NCT03483961|7680785|FG006|COMPLETED|Overall Study||46
6754353|NCT03483961|7680786|FG007|COMPLETED|Overall Study||39
6754354|NCT03483961|7680787|FG008|COMPLETED|Overall Study||18
6754355|NCT03483961|7680788|FG009|COMPLETED|Overall Study||10
6754356|NCT03483961|7680779|FG000|NOT COMPLETED|Overall Study||11
6754357|NCT03483961|7680780|FG001|NOT COMPLETED|Overall Study||10
6754358|NCT03483961|7680781|FG002|NOT COMPLETED|Overall Study||12
6754359|NCT03483961|7680782|FG003|NOT COMPLETED|Overall Study||9
6754360|NCT03483961|7680783|FG004|NOT COMPLETED|Overall Study||10
6754361|NCT03483961|7680784|FG005|NOT COMPLETED|Overall Study||6
6754362|NCT03483961|7680785|FG006|NOT COMPLETED|Overall Study||5
6754363|NCT03483961|7680786|FG007|NOT COMPLETED|Overall Study||13
6754364|NCT03483961|7680787|FG008|NOT COMPLETED|Overall Study||2
6754365|NCT03483961|7680788|FG009|NOT COMPLETED|Overall Study||0
6754366|NCT03484273|7680809|FG000|STARTED|Overall Study|This was a crossover trial. A total of 32 participants were enrolled in this study.|32
6754367|NCT03484273|7680809|FG000|COMPLETED|Overall Study|This was a crossover trial. A total of 30 participants completed all 4 arms.|30
6754368|NCT03484273|7680809|FG000|NOT COMPLETED|Overall Study||2
6754369|NCT03484429|7680823|FG000|STARTED|Overall Study||8
6754370|NCT03484429|7680824|FG001|STARTED|Overall Study||8
6754371|NCT03484429|7680823|FG000|Postamputation Week 1-4|Overall Study||8
6754372|NCT03484429|7680824|FG001|Postamputation Week 1-4|Overall Study||8
6754373|NCT03484429|7680823|FG000|Postamputation Week 5-8|Overall Study||5
6754374|NCT03484429|7680824|FG001|Postamputation Week 5-8|Overall Study||8
6754375|NCT03484429|7680823|FG000|Postamputation Month 3|Overall Study||5
6754376|NCT03484429|7680824|FG001|Postamputation Month 3|Overall Study||7
6754377|NCT03484429|7680823|FG000|COMPLETED|Overall Study||5
6754378|NCT03484429|7680824|FG001|COMPLETED|Overall Study||8
6754379|NCT03484429|7680823|FG000|NOT COMPLETED|Overall Study||3
6754380|NCT03484429|7680824|FG001|NOT COMPLETED|Overall Study||0
6754381|NCT03485222|7680832|FG000|STARTED|Overall Study||42
6754382|NCT03485222|7680833|FG001|STARTED|Overall Study||42
6754383|NCT03485222|7680832|FG000|COMPLETED|Overall Study||40
6754384|NCT03485222|7680833|FG001|COMPLETED|Overall Study||40
6754385|NCT03485222|7680832|FG000|NOT COMPLETED|Overall Study||2
6754386|NCT03485222|7680833|FG001|NOT COMPLETED|Overall Study||2
6754387|NCT03485495|7680841|FG000|STARTED|Overall Study||65
6754388|NCT03485495|7680842|FG001|STARTED|Overall Study||59
6754389|NCT03485495|7680841|FG000|COMPLETED|Overall Study||64
6754390|NCT03485495|7680842|FG001|COMPLETED|Overall Study||59
6754391|NCT03485495|7680841|FG000|NOT COMPLETED|Overall Study||1
6754392|NCT03485495|7680842|FG001|NOT COMPLETED|Overall Study||0
6555652|NCT01753401|7477807|FG001|Safety Analysis Set|Open Label Period (44 Weeks)||0
6555653|NCT01753401|7477808|FG002|Safety Analysis Set|Open Label Period (44 Weeks)||11
6754393|NCT03485976|7680848|FG000|STARTED|Overall Study||12
6754394|NCT03485976|7680848|FG000|COMPLETED|Overall Study||11
6754395|NCT03485976|7680848|FG000|NOT COMPLETED|Overall Study||1
6754396|NCT03486392|7680857|FG000|STARTED|Overall Study||60
6754397|NCT03486392|7680858|FG001|STARTED|Overall Study||59
6754398|NCT03486392|7680859|FG002|STARTED|Overall Study||118
6754399|NCT03486392|7680860|FG003|STARTED|Overall Study||118
6754400|NCT03486392|7680861|FG004|STARTED|Overall Study||119
6754401|NCT03486392|7680857|FG000|COMPLETED|Overall Study||57
6754402|NCT03486392|7680858|FG001|COMPLETED|Overall Study||59
6754403|NCT03486392|7680859|FG002|COMPLETED|Overall Study||104
6754404|NCT03486392|7680860|FG003|COMPLETED|Overall Study||109
6754405|NCT03486392|7680861|FG004|COMPLETED|Overall Study||115
6754406|NCT03486392|7680857|FG000|NOT COMPLETED|Overall Study||3
6754407|NCT03486392|7680858|FG001|NOT COMPLETED|Overall Study||0
6754408|NCT03486392|7680859|FG002|NOT COMPLETED|Overall Study||14
6754409|NCT03486392|7680860|FG003|NOT COMPLETED|Overall Study||9
6754410|NCT03486392|7680861|FG004|NOT COMPLETED|Overall Study||4
6754411|NCT03486834|7680876|FG000|STARTED|Overall Study||733
6754412|NCT03486834|7680877|FG001|STARTED|Overall Study||733
6754413|NCT03486834|7680878|FG002|STARTED|Overall Study||734
6754414|NCT03486834|7680876|FG000|Treatment 1|Overall Study||729
6754415|NCT03486834|7680877|FG001|Treatment 1|Overall Study||729
6754416|NCT03486834|7680878|FG002|Treatment 1|Overall Study||733
6754417|NCT03486834|7680876|FG000|Treatment 2|Overall Study||680
6754418|NCT03486834|7680877|FG001|Treatment 2|Overall Study||680
6754419|NCT03486834|7680878|FG002|Treatment 2|Overall Study||679
6754420|NCT03486834|7680876|FG000|Treatment 3|Overall Study||614
6754421|NCT03486834|7680877|FG001|Treatment 3|Overall Study||631
6754422|NCT03486834|7680878|FG002|Treatment 3|Overall Study||622
6754423|NCT03486834|7680876|FG000|COMPLETED|Overall Study||614
6754424|NCT03486834|7680877|FG001|COMPLETED|Overall Study||631
6754425|NCT03486834|7680878|FG002|COMPLETED|Overall Study||622
6754426|NCT03486834|7680876|FG000|NOT COMPLETED|Overall Study||119
6754427|NCT03486834|7680877|FG001|NOT COMPLETED|Overall Study||102
6754428|NCT03486834|7680878|FG002|NOT COMPLETED|Overall Study||112
6754429|NCT03486990|7680897|FG000|STARTED|Overall Study||2
6754430|NCT03486990|7680898|FG001|STARTED|Overall Study||2
6754431|NCT03486990|7680899|FG002|STARTED|Overall Study||3
6754432|NCT03486990|7680900|FG003|STARTED|Overall Study||3
6754433|NCT03486990|7680901|FG004|STARTED|Overall Study||3
6754434|NCT03486990|7680902|FG005|STARTED|Overall Study||4
6754435|NCT03486990|7680903|FG006|STARTED|Overall Study||2
6754436|NCT03486990|7680904|FG007|STARTED|Overall Study||2
6754437|NCT03486990|7680905|FG008|STARTED|Overall Study||2
6754438|NCT03486990|7680897|FG000|COMPLETED|Overall Study||2
6754439|NCT03486990|7680898|FG001|COMPLETED|Overall Study||2
6754440|NCT03486990|7680899|FG002|COMPLETED|Overall Study||3
6754441|NCT03486990|7680900|FG003|COMPLETED|Overall Study||3
6754442|NCT03486990|7680901|FG004|COMPLETED|Overall Study||3
6754443|NCT03486990|7680902|FG005|COMPLETED|Overall Study||4
6754444|NCT03486990|7680903|FG006|COMPLETED|Overall Study||2
6754445|NCT03486990|7680904|FG007|COMPLETED|Overall Study||2
6754446|NCT03486990|7680905|FG008|COMPLETED|Overall Study||2
6754447|NCT03486990|7680897|FG000|NOT COMPLETED|Overall Study||0
6754448|NCT03486990|7680898|FG001|NOT COMPLETED|Overall Study||0
6754449|NCT03486990|7680899|FG002|NOT COMPLETED|Overall Study||0
6754450|NCT03486990|7680900|FG003|NOT COMPLETED|Overall Study||0
6754451|NCT03486990|7680901|FG004|NOT COMPLETED|Overall Study||0
6754452|NCT03486990|7680902|FG005|NOT COMPLETED|Overall Study||0
6754453|NCT03486990|7680903|FG006|NOT COMPLETED|Overall Study||0
6754454|NCT03486990|7680904|FG007|NOT COMPLETED|Overall Study||0
6754455|NCT03486990|7680905|FG008|NOT COMPLETED|Overall Study||0
6754456|NCT03487276|7680946|FG000|STARTED|Main Period (16 Weeks)||37
6754457|NCT03487276|7680947|FG001|STARTED|Main Period (16 Weeks)||34
6754458|NCT03487276|7680948|FG002|STARTED|Main Period (16 Weeks)||36
6754459|NCT03487276|7680949|FG003|STARTED|Main Period (16 Weeks)||36
6754460|NCT03487276|7680950|FG004|STARTED|Main Period (16 Weeks)||36
6754461|NCT03487276|7680946|FG000|COMPLETED|Main Period (16 Weeks)||34
6754462|NCT03487276|7680947|FG001|COMPLETED|Main Period (16 Weeks)||30
6754463|NCT03487276|7680948|FG002|COMPLETED|Main Period (16 Weeks)||32
6754464|NCT03487276|7680949|FG003|COMPLETED|Main Period (16 Weeks)||30
6754465|NCT03487276|7680950|FG004|COMPLETED|Main Period (16 Weeks)|One patient completed the Main Period but was lost to follow-up afterwards and not treated in the Extension Period|31
6754466|NCT03487276|7680946|FG000|NOT COMPLETED|Main Period (16 Weeks)||3
6754467|NCT03487276|7680947|FG001|NOT COMPLETED|Main Period (16 Weeks)||4
6754468|NCT03487276|7680948|FG002|NOT COMPLETED|Main Period (16 Weeks)||4
6754469|NCT03487276|7680949|FG003|NOT COMPLETED|Main Period (16 Weeks)||6
6754470|NCT03487276|7680950|FG004|NOT COMPLETED|Main Period (16 Weeks)||5
6754471|NCT03487276|7680946|FG000|STARTED|Extension Period (28 Weeks)||0
6754472|NCT03487276|7680947|FG001|STARTED|Extension Period (28 Weeks)||0
6754473|NCT03487276|7680948|FG002|STARTED|Extension Period (28 Weeks)||72
6754474|NCT03487276|7680949|FG003|STARTED|Extension Period (28 Weeks)||84
6754475|NCT03487276|7680950|FG004|STARTED|Extension Period (28 Weeks)||0
6754476|NCT03487276|7680946|FG000|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754477|NCT03487276|7680947|FG001|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754478|NCT03487276|7680948|FG002|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
6754479|NCT03487276|7680949|FG003|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
6754480|NCT03487276|7680950|FG004|Number of Patients in Cohort 1 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754481|NCT03487276|7680946|FG000|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754482|NCT03487276|7680947|FG001|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754483|NCT03487276|7680948|FG002|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
6754484|NCT03487276|7680949|FG003|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
6754485|NCT03487276|7680950|FG004|Number of Patients in Cohort 2 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754486|NCT03487276|7680946|FG000|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754487|NCT03487276|7680947|FG001|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754488|NCT03487276|7680948|FG002|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||17
6754489|NCT03487276|7680949|FG003|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
6754490|NCT03487276|7680950|FG004|Number of Patients in Cohort 3 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754491|NCT03487276|7680946|FG000|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754492|NCT03487276|7680947|FG001|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754493|NCT03487276|7680948|FG002|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||12
6754494|NCT03487276|7680949|FG003|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||18
6754495|NCT03487276|7680950|FG004|Number of Patients in Cohort 4 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754496|NCT03487276|7680946|FG000|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754497|NCT03487276|7680947|FG001|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754498|NCT03487276|7680948|FG002|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||15
6754499|NCT03487276|7680949|FG003|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||16
6754500|NCT03487276|7680950|FG004|Number of Patients in Cohort 5 (Main Period) Crossed Over to Cohort 3 or 4|Extension Period (28 Weeks)||0
6754501|NCT03487276|7680946|FG000|COMPLETED|Extension Period (28 Weeks)||0
6754502|NCT03487276|7680947|FG001|COMPLETED|Extension Period (28 Weeks)||0
6754503|NCT03487276|7680948|FG002|COMPLETED|Extension Period (28 Weeks)||67
6754504|NCT03487276|7680949|FG003|COMPLETED|Extension Period (28 Weeks)||54
6754505|NCT03487276|7680950|FG004|COMPLETED|Extension Period (28 Weeks)||0
6754506|NCT03487276|7680946|FG000|NOT COMPLETED|Extension Period (28 Weeks)||0
6754507|NCT03487276|7680947|FG001|NOT COMPLETED|Extension Period (28 Weeks)||0
6754508|NCT03487276|7680948|FG002|NOT COMPLETED|Extension Period (28 Weeks)||5
6754509|NCT03487276|7680949|FG003|NOT COMPLETED|Extension Period (28 Weeks)||30
6754510|NCT03487276|7680950|FG004|NOT COMPLETED|Extension Period (28 Weeks)||0
6754511|NCT03487445|7680973|FG000|STARTED|Randomization||25
6754512|NCT03487445|7680974|FG001|STARTED|Randomization||23
6754513|NCT03487445|7680973|FG000|COMPLETED|Randomization||24
6754514|NCT03487445|7680974|FG001|COMPLETED|Randomization||23
6754515|NCT03487445|7680973|FG000|NOT COMPLETED|Randomization||1
6754516|NCT03487445|7680974|FG001|NOT COMPLETED|Randomization||0
6754517|NCT03487445|7680973|FG000|STARTED|Treatment Period||24
6754518|NCT03487445|7680974|FG001|STARTED|Treatment Period||23
6754519|NCT03487445|7680973|FG000|Modified Full Analysis Set (mFAS)|Treatment Period||23
6754520|NCT03487445|7680974|FG001|Modified Full Analysis Set (mFAS)|Treatment Period||22
6754521|NCT03487445|7680973|FG000|Per Protocol Set|Treatment Period||20
6754522|NCT03487445|7680974|FG001|Per Protocol Set|Treatment Period||20
6754523|NCT03487445|7680973|FG000|COMPLETED|Treatment Period||24
6754524|NCT03487445|7680974|FG001|COMPLETED|Treatment Period||23
6754525|NCT03487445|7680973|FG000|NOT COMPLETED|Treatment Period||0
6754526|NCT03487445|7680974|FG001|NOT COMPLETED|Treatment Period||0
6754527|NCT03487549|7680982|FG000|STARTED|Overall Study||21
6754528|NCT03487549|7680983|FG001|STARTED|Overall Study||35
6754529|NCT03487549|7680982|FG000|COMPLETED|Overall Study||17
6754530|NCT03487549|7680983|FG001|COMPLETED|Overall Study||33
6754531|NCT03487549|7680982|FG000|NOT COMPLETED|Overall Study||4
6754532|NCT03487549|7680983|FG001|NOT COMPLETED|Overall Study||2
6754533|NCT03487588|7680989|FG000|STARTED|Overall Study||41
6754534|NCT03487588|7680989|FG000|COMPLETED|Overall Study||41
6754535|NCT03487588|7680989|FG000|NOT COMPLETED|Overall Study||0
6754536|NCT03487718|7680995|FG000|STARTED|Overall Study||12
6754537|NCT03487718|7680996|FG001|STARTED|Overall Study||15
6754538|NCT03487718|7680995|FG000|COMPLETED|Overall Study||11
6754539|NCT03487718|7680996|FG001|COMPLETED|Overall Study||11
6754540|NCT03487718|7680995|FG000|NOT COMPLETED|Overall Study||1
6754541|NCT03487718|7680996|FG001|NOT COMPLETED|Overall Study||4
6754542|NCT03487848|7681002|FG000|STARTED|Overall Study||5
6754543|NCT03487848|7681002|FG000|COMPLETED|Overall Study||4
6754544|NCT03487848|7681002|FG000|NOT COMPLETED|Overall Study||1
6754545|NCT03488108|7681008|FG000|STARTED|First Intervention (12 Weeks)||10
6754546|NCT03488108|7681009|FG001|STARTED|First Intervention (12 Weeks)||10
6754547|NCT03488108|7681008|FG000|COMPLETED|First Intervention (12 Weeks)||10
6754548|NCT03488108|7681009|FG001|COMPLETED|First Intervention (12 Weeks)||9
6754549|NCT03488108|7681008|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
6754550|NCT03488108|7681009|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
6754551|NCT03488108|7681008|FG000|STARTED|Washout (2 Months)||10
6754552|NCT03488108|7681009|FG001|STARTED|Washout (2 Months)||9
6754553|NCT03488108|7681008|FG000|COMPLETED|Washout (2 Months)||10
6754554|NCT03488108|7681009|FG001|COMPLETED|Washout (2 Months)||9
6754555|NCT03488108|7681008|FG000|NOT COMPLETED|Washout (2 Months)||0
6754556|NCT03488108|7681009|FG001|NOT COMPLETED|Washout (2 Months)||0
6754557|NCT03488108|7681008|FG000|STARTED|Second Intervention (12 Weeks)||10
6754558|NCT03488108|7681009|FG001|STARTED|Second Intervention (12 Weeks)||9
6754559|NCT03488108|7681008|FG000|COMPLETED|Second Intervention (12 Weeks)||9
6754560|NCT03488108|7681009|FG001|COMPLETED|Second Intervention (12 Weeks)||9
6754561|NCT03488108|7681008|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
6754562|NCT03488108|7681009|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
6754563|NCT03488225|7681017|FG000|STARTED|Overall Study||4
6754564|NCT03488225|7681017|FG000|COMPLETED|Overall Study||0
6754565|NCT03488225|7681017|FG000|NOT COMPLETED|Overall Study||4
6754566|NCT03488238|7681021|FG000|STARTED|Overall Study||31
6754567|NCT03488238|7681021|FG000|COMPLETED|Overall Study||29
6754568|NCT03488238|7681021|FG000|NOT COMPLETED|Overall Study||2
6754569|NCT03488849|7681028|FG000|STARTED|Overall Study||10
6754570|NCT03488849|7681029|FG001|STARTED|Overall Study||8
6754571|NCT03488849|7681030|FG002|STARTED|Overall Study||6
6754572|NCT03488849|7681028|FG000|COMPLETED|Overall Study||10
6754573|NCT03488849|7681029|FG001|COMPLETED|Overall Study||8
6754574|NCT03488849|7681030|FG002|COMPLETED|Overall Study||6
6754575|NCT03488849|7681028|FG000|NOT COMPLETED|Overall Study||0
6754576|NCT03488849|7681029|FG001|NOT COMPLETED|Overall Study||0
6754577|NCT03488849|7681030|FG002|NOT COMPLETED|Overall Study||0
6754578|NCT03488927|7681041|FG000|STARTED|Overall Study||305
6754579|NCT03488927|7681042|FG001|STARTED|Overall Study||432
6754580|NCT03488927|7681043|FG002|STARTED|Overall Study||531
6555654|NCT01753401|7477809|FG003|Safety Analysis Set|Open Label Period (44 Weeks)||22
6555655|NCT01753401|7477806|FG000|COMPLETED|Open Label Period (44 Weeks)||0
6555656|NCT01753401|7477807|FG001|COMPLETED|Open Label Period (44 Weeks)||0
6555657|NCT01753401|7477808|FG002|COMPLETED|Open Label Period (44 Weeks)||7
6555658|NCT01753401|7477809|FG003|COMPLETED|Open Label Period (44 Weeks)||13
6555659|NCT01753401|7477806|FG000|NOT COMPLETED|Open Label Period (44 Weeks)||0
6562915|NCT01803464|7485826|FG000|NOT COMPLETED|Overall Study||1
6754581|NCT03488927|7681041|FG000|COMPLETED|Overall Study||261
6754582|NCT03488927|7681042|FG001|COMPLETED|Overall Study||314
6754583|NCT03488927|7681043|FG002|COMPLETED|Overall Study||314
6754584|NCT03488927|7681041|FG000|NOT COMPLETED|Overall Study||44
6754585|NCT03488927|7681042|FG001|NOT COMPLETED|Overall Study||118
6754586|NCT03488927|7681043|FG002|NOT COMPLETED|Overall Study||217
6754587|NCT03489304|7681051|FG000|STARTED|Overall Study||20
6754588|NCT03489304|7681051|FG000|COMPLETED|Overall Study||16
6754589|NCT03489304|7681051|FG000|NOT COMPLETED|Overall Study||4
6754590|NCT03489343|7681062|FG000|STARTED|Overall Study||1
6754591|NCT03489343|7681063|FG001|STARTED|Overall Study||1
6754592|NCT03489343|7681064|FG002|STARTED|Overall Study||3
6754593|NCT03489343|7681065|FG003|STARTED|Overall Study||3
6754594|NCT03489343|7681066|FG004|STARTED|Overall Study||3
6754595|NCT03489343|7681067|FG005|STARTED|Overall Study||7
6754596|NCT03489343|7681068|FG006|STARTED|Overall Study||6
6754597|NCT03489343|7681062|FG000|COMPLETED|Overall Study||0
6754598|NCT03489343|7681063|FG001|COMPLETED|Overall Study||0
6754599|NCT03489343|7681064|FG002|COMPLETED|Overall Study||0
6754600|NCT03489343|7681065|FG003|COMPLETED|Overall Study||0
6754601|NCT03489343|7681066|FG004|COMPLETED|Overall Study||0
6754602|NCT03489343|7681067|FG005|COMPLETED|Overall Study||0
6754603|NCT03489343|7681068|FG006|COMPLETED|Overall Study||0
6754604|NCT03489343|7681062|FG000|NOT COMPLETED|Overall Study||1
6754605|NCT03489343|7681063|FG001|NOT COMPLETED|Overall Study||1
6754606|NCT03489343|7681064|FG002|NOT COMPLETED|Overall Study||3
6754607|NCT03489343|7681065|FG003|NOT COMPLETED|Overall Study||3
6754608|NCT03489343|7681066|FG004|NOT COMPLETED|Overall Study||3
6754609|NCT03489343|7681067|FG005|NOT COMPLETED|Overall Study||7
6754610|NCT03489343|7681068|FG006|NOT COMPLETED|Overall Study||6
6754611|NCT03489369|7681088|FG000|STARTED|Overall Study||3
6754612|NCT03489369|7681089|FG001|STARTED|Overall Study||3
6754613|NCT03489369|7681090|FG002|STARTED|Overall Study||3
6754614|NCT03489369|7681091|FG003|STARTED|Overall Study||6
6754615|NCT03489369|7681088|FG000|COMPLETED|Overall Study||0
6754616|NCT03489369|7681089|FG001|COMPLETED|Overall Study||0
6754617|NCT03489369|7681090|FG002|COMPLETED|Overall Study||0
6754618|NCT03489369|7681091|FG003|COMPLETED|Overall Study||0
6754619|NCT03489369|7681088|FG000|NOT COMPLETED|Overall Study||3
6754620|NCT03489369|7681089|FG001|NOT COMPLETED|Overall Study||3
6754621|NCT03489369|7681090|FG002|NOT COMPLETED|Overall Study||3
6754622|NCT03489369|7681091|FG003|NOT COMPLETED|Overall Study||6
6754623|NCT03489551|7681101|FG000|STARTED|Overall Study||17
6754624|NCT03489551|7681101|FG000|COMPLETED|Overall Study||15
6754625|NCT03489551|7681101|FG000|NOT COMPLETED|Overall Study||2
6754626|NCT03489720|7681107|FG000|STARTED|Overall Study||24
6754627|NCT03489720|7681108|FG001|STARTED|Overall Study||22
6754628|NCT03489720|7681107|FG000|COMPLETED|Overall Study||22
6754629|NCT03489720|7681108|FG001|COMPLETED|Overall Study||22
6754630|NCT03489720|7681107|FG000|NOT COMPLETED|Overall Study||2
6754631|NCT03489720|7681108|FG001|NOT COMPLETED|Overall Study||0
6754632|NCT03489850|7681120|FG000|STARTED|Overall Study||24
6754633|NCT03489850|7681121|FG001|STARTED|Overall Study||28
6754634|NCT03489850|7681120|FG000|COMPLETED|Overall Study||23
6754635|NCT03489850|7681121|FG001|COMPLETED|Overall Study||27
6754636|NCT03489850|7681120|FG000|NOT COMPLETED|Overall Study||1
6754637|NCT03489850|7681121|FG001|NOT COMPLETED|Overall Study||1
6754638|NCT03489863|7681129|FG000|STARTED|Overall Study||7
6754639|NCT03489863|7681130|FG001|STARTED|Overall Study||7
6754640|NCT03489863|7681129|FG000|COMPLETED|Overall Study||7
6754641|NCT03489863|7681130|FG001|COMPLETED|Overall Study||6
6754642|NCT03489863|7681129|FG000|NOT COMPLETED|Overall Study||0
6754643|NCT03489863|7681130|FG001|NOT COMPLETED|Overall Study||1
6754644|NCT03489941|7681136|FG000|STARTED|Overall Study||51
6754645|NCT03489941|7681137|FG001|STARTED|Overall Study||52
6754646|NCT03489941|7681138|FG002|STARTED|Overall Study||27
6754647|NCT03489941|7681136|FG000|COMPLETED|Overall Study||51
6754648|NCT03489941|7681137|FG001|COMPLETED|Overall Study||52
6754649|NCT03489941|7681138|FG002|COMPLETED|Overall Study||27
6754650|NCT03489941|7681136|FG000|NOT COMPLETED|Overall Study||0
6754651|NCT03489941|7681137|FG001|NOT COMPLETED|Overall Study||0
6754652|NCT03489941|7681138|FG002|NOT COMPLETED|Overall Study||0
6754653|NCT03490032|7681147|FG000|STARTED|Overall Study||6
6754654|NCT03490032|7681148|FG001|STARTED|Overall Study||12
6754655|NCT03490032|7681149|FG002|STARTED|Overall Study||12
6754656|NCT03490032|7681147|FG000|COMPLETED|Overall Study||5
6754657|NCT03490032|7681148|FG001|COMPLETED|Overall Study||12
6754658|NCT03490032|7681149|FG002|COMPLETED|Overall Study||12
6754659|NCT03490032|7681147|FG000|NOT COMPLETED|Overall Study||1
6754660|NCT03490032|7681148|FG001|NOT COMPLETED|Overall Study||0
6754661|NCT03490032|7681149|FG002|NOT COMPLETED|Overall Study||0
6754662|NCT03490110|7681160|FG000|STARTED|Overall Study||9
6754663|NCT03490110|7681161|FG001|STARTED|Overall Study||9
6754664|NCT03490110|7681160|FG000|COMPLETED|Overall Study||6
6754665|NCT03490110|7681161|FG001|COMPLETED|Overall Study||6
6754666|NCT03490110|7681160|FG000|NOT COMPLETED|Overall Study||3
6754667|NCT03490110|7681161|FG001|NOT COMPLETED|Overall Study||3
6754668|NCT03490942|7681170|FG000|STARTED|Overall Study||15
6754669|NCT03490942|7681171|FG001|STARTED|Overall Study||18
6754670|NCT03490942|7681172|FG002|STARTED|Overall Study||16
6754671|NCT03490942|7681170|FG000|COMPLETED|Overall Study||5
6754672|NCT03490942|7681171|FG001|COMPLETED|Overall Study||8
6754673|NCT03490942|7681172|FG002|COMPLETED|Overall Study||9
6754674|NCT03490942|7681170|FG000|NOT COMPLETED|Overall Study||10
6754675|NCT03490942|7681171|FG001|NOT COMPLETED|Overall Study||10
6754676|NCT03490942|7681172|FG002|NOT COMPLETED|Overall Study||7
6754677|NCT03490981|7681182|FG000|STARTED|Overall Study||15
6754678|NCT03490981|7681183|FG001|STARTED|Overall Study||15
6754679|NCT03490981|7681182|FG000|COMPLETED|Overall Study||14
6754680|NCT03490981|7681183|FG001|COMPLETED|Overall Study||13
6754681|NCT03490981|7681182|FG000|NOT COMPLETED|Overall Study||1
6754682|NCT03490981|7681183|FG001|NOT COMPLETED|Overall Study||2
6754683|NCT03491150|7681191|FG000|STARTED|Overall Study||76
6754684|NCT03491150|7681192|FG001|STARTED|Overall Study||73
6754685|NCT03491150|7681191|FG000|COMPLETED|Overall Study||0
6754686|NCT03491150|7681192|FG001|COMPLETED|Overall Study||0
6754687|NCT03491150|7681191|FG000|NOT COMPLETED|Overall Study||76
6754688|NCT03491150|7681192|FG001|NOT COMPLETED|Overall Study||73
6754689|NCT03491228|7681198|FG000|STARTED|Overall Study||107
6754690|NCT03491228|7681198|FG000|COMPLETED|Overall Study||107
6754691|NCT03491228|7681198|FG000|NOT COMPLETED|Overall Study||0
6754692|NCT03491553|7681208|FG000|STARTED|Main Study (Up to Week 48)||9
6754693|NCT03491553|7681209|FG001|STARTED|Main Study (Up to Week 48)||10
6754694|NCT03491553|7681210|FG002|STARTED|Main Study (Up to Week 48)||10
6754695|NCT03491553|7681211|FG003|STARTED|Main Study (Up to Week 48)||10
6754696|NCT03491553|7681212|FG004|STARTED|Main Study (Up to Week 48)||5
6754697|NCT03491553|7681213|FG005|STARTED|Main Study (Up to Week 48)||4
6754698|NCT03491553|7681208|FG000|COMPLETED|Main Study (Up to Week 48)||8
6754699|NCT03491553|7681209|FG001|COMPLETED|Main Study (Up to Week 48)||9
6754700|NCT03491553|7681210|FG002|COMPLETED|Main Study (Up to Week 48)||10
6555660|NCT01753401|7477807|FG001|NOT COMPLETED|Open Label Period (44 Weeks)||0
6555661|NCT01753401|7477808|FG002|NOT COMPLETED|Open Label Period (44 Weeks)||4
6555662|NCT01753401|7477809|FG003|NOT COMPLETED|Open Label Period (44 Weeks)||9
6555663|NCT01753518|7477821|FG000|STARTED|Intention-to-Treat Analysis||110
6555664|NCT01753518|7477822|FG001|STARTED|Intention-to-Treat Analysis||110
6555665|NCT01753518|7477821|FG000|COMPLETED|Intention-to-Treat Analysis||103
6555666|NCT01753518|7477822|FG001|COMPLETED|Intention-to-Treat Analysis||103
6555667|NCT01753518|7477821|FG000|NOT COMPLETED|Intention-to-Treat Analysis||7
6555668|NCT01753518|7477822|FG001|NOT COMPLETED|Intention-to-Treat Analysis||7
6555669|NCT01753518|7477821|FG000|STARTED|Postpartum Follow-up||103
6555670|NCT01753518|7477822|FG001|STARTED|Postpartum Follow-up||103
6555671|NCT01753518|7477821|FG000|COMPLETED|Postpartum Follow-up||81
6555672|NCT01753518|7477822|FG001|COMPLETED|Postpartum Follow-up||88
6555673|NCT01753518|7477821|FG000|NOT COMPLETED|Postpartum Follow-up||22
6754701|NCT03491553|7681211|FG003|COMPLETED|Main Study (Up to Week 48)||9
6754702|NCT03491553|7681212|FG004|COMPLETED|Main Study (Up to Week 48)||5
6754703|NCT03491553|7681213|FG005|COMPLETED|Main Study (Up to Week 48)||4
6754704|NCT03491553|7681208|FG000|NOT COMPLETED|Main Study (Up to Week 48)||1
6754705|NCT03491553|7681209|FG001|NOT COMPLETED|Main Study (Up to Week 48)||1
6754706|NCT03491553|7681210|FG002|NOT COMPLETED|Main Study (Up to Week 48)||0
6754707|NCT03491553|7681211|FG003|NOT COMPLETED|Main Study (Up to Week 48)||1
6754708|NCT03491553|7681212|FG004|NOT COMPLETED|Main Study (Up to Week 48)||0
6754709|NCT03491553|7681213|FG005|NOT COMPLETED|Main Study (Up to Week 48)||0
6754710|NCT03491553|7681208|FG000|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|8 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
6754711|NCT03491553|7681209|FG001|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but only 1 participant continued in the TFFU phase.|1
6754712|NCT03491553|7681210|FG002|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|10 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
6754713|NCT03491553|7681211|FG003|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|9 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
6754714|NCT03491553|7681212|FG004|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|5 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
6754715|NCT03491553|7681213|FG005|STARTED|TFFU (Week 49 up to Additional 48 Weeks)|4 participants completed the study period up to Week 48 but did not continue in the TFFU phase.|0
6754716|NCT03491553|7681208|FG000|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754717|NCT03491553|7681209|FG001|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||1
6754718|NCT03491553|7681210|FG002|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754719|NCT03491553|7681211|FG003|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754720|NCT03491553|7681212|FG004|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754721|NCT03491553|7681213|FG005|COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754722|NCT03491553|7681208|FG000|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754723|NCT03491553|7681209|FG001|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754724|NCT03491553|7681210|FG002|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754725|NCT03491553|7681211|FG003|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754726|NCT03491553|7681212|FG004|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754727|NCT03491553|7681213|FG005|NOT COMPLETED|TFFU (Week 49 up to Additional 48 Weeks)||0
6754728|NCT03491800|7681232|FG000|STARTED|Overall Study||23
6754729|NCT03491800|7681233|FG001|STARTED|Overall Study||23
6754730|NCT03491800|7681234|FG002|STARTED|Overall Study||7
6754731|NCT03491800|7681232|FG000|COMPLETED|Overall Study||23
6754732|NCT03491800|7681233|FG001|COMPLETED|Overall Study||23
6754733|NCT03491800|7681234|FG002|COMPLETED|Overall Study||7
6754734|NCT03491800|7681232|FG000|NOT COMPLETED|Overall Study||0
6754735|NCT03491800|7681233|FG001|NOT COMPLETED|Overall Study||0
6754736|NCT03491800|7681234|FG002|NOT COMPLETED|Overall Study||0
6754737|NCT03491891|7681245|FG000|STARTED|Overall Study||6038
6754738|NCT03491891|7681246|FG001|STARTED|Overall Study||2438
6754739|NCT03491891|7681245|FG000|COMPLETED|Overall Study||5185
6754740|NCT03491891|7681246|FG001|COMPLETED|Overall Study||2058
6754741|NCT03491891|7681245|FG000|NOT COMPLETED|Overall Study||853
6754742|NCT03491891|7681246|FG001|NOT COMPLETED|Overall Study||380
6754743|NCT03491917|7681252|FG000|STARTED|First Reading Session||50
6754744|NCT03491917|7681253|FG001|STARTED|First Reading Session||50
6754745|NCT03491917|7681252|FG000|COMPLETED|First Reading Session||50
6555674|NCT01753518|7477822|FG001|NOT COMPLETED|Postpartum Follow-up||15
6555675|NCT01753557|7477830|FG000|STARTED|Overall Study||35
6555676|NCT01753557|7477831|FG001|STARTED|Overall Study||19
6754746|NCT03491917|7681253|FG001|COMPLETED|First Reading Session||50
6555677|NCT01753557|7477830|FG000|COMPLETED|Overall Study||35
6754747|NCT03491917|7681252|FG000|NOT COMPLETED|First Reading Session||0
6754748|NCT03491917|7681253|FG001|NOT COMPLETED|First Reading Session||0
6754749|NCT03491917|7681252|FG000|STARTED|4 Week Memory Washout Period||50
6754750|NCT03491917|7681253|FG001|STARTED|4 Week Memory Washout Period||50
6754751|NCT03491917|7681252|FG000|COMPLETED|4 Week Memory Washout Period||50
6754752|NCT03491917|7681253|FG001|COMPLETED|4 Week Memory Washout Period||50
6754753|NCT03491917|7681252|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
6754754|NCT03491917|7681253|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
6754755|NCT03491917|7681252|FG000|STARTED|Second Reading Session||50
6754756|NCT03491917|7681253|FG001|STARTED|Second Reading Session||50
6754757|NCT03491917|7681252|FG000|COMPLETED|Second Reading Session||50
6754758|NCT03491917|7681253|FG001|COMPLETED|Second Reading Session||50
6754759|NCT03491917|7681252|FG000|NOT COMPLETED|Second Reading Session||0
6754760|NCT03491917|7681253|FG001|NOT COMPLETED|Second Reading Session||0
6754761|NCT03492281|7681262|FG000|STARTED|Overall Study||540
6754762|NCT03492281|7681263|FG001|STARTED|Overall Study||547
6754763|NCT03492281|7681264|FG002|STARTED|Overall Study||431
6754764|NCT03492281|7681262|FG000|COMPLETED|Overall Study||486
6754765|NCT03492281|7681263|FG001|COMPLETED|Overall Study||502
6754766|NCT03492281|7681264|FG002|COMPLETED|Overall Study||385
6754767|NCT03492281|7681262|FG000|NOT COMPLETED|Overall Study||54
6754768|NCT03492281|7681263|FG001|NOT COMPLETED|Overall Study||45
6754769|NCT03492281|7681264|FG002|NOT COMPLETED|Overall Study||46
6754770|NCT03492398|7681284|FG000|STARTED|Overall Study||8
6754771|NCT03492398|7681285|FG001|STARTED|Overall Study||6
6754772|NCT03492398|7681286|FG002|STARTED|Overall Study||6
6754773|NCT03492398|7681287|FG003|STARTED|Overall Study||6
6754774|NCT03492398|7681288|FG004|STARTED|Overall Study||6
6754775|NCT03492398|7681289|FG005|STARTED|Overall Study||6
6754776|NCT03492398|7681290|FG006|STARTED|Overall Study||6
6754777|NCT03492398|7681291|FG007|STARTED|Overall Study||6
6754778|NCT03492398|7681292|FG008|STARTED|Overall Study||6
6754779|NCT03492398|7681284|FG000|COMPLETED|Overall Study||8
6754780|NCT03492398|7681285|FG001|COMPLETED|Overall Study||6
6754781|NCT03492398|7681286|FG002|COMPLETED|Overall Study||6
6754782|NCT03492398|7681287|FG003|COMPLETED|Overall Study||6
6555678|NCT01753557|7477831|FG001|COMPLETED|Overall Study||19
6555679|NCT01753557|7477830|FG000|NOT COMPLETED|Overall Study||0
6555680|NCT01753557|7477831|FG001|NOT COMPLETED|Overall Study||0
6754783|NCT03492398|7681288|FG004|COMPLETED|Overall Study||6
6754784|NCT03492398|7681289|FG005|COMPLETED|Overall Study||6
6754785|NCT03492398|7681290|FG006|COMPLETED|Overall Study||5
6754786|NCT03492398|7681291|FG007|COMPLETED|Overall Study||5
6754787|NCT03492398|7681292|FG008|COMPLETED|Overall Study||6
6754788|NCT03492398|7681284|FG000|NOT COMPLETED|Overall Study||0
6754789|NCT03492398|7681285|FG001|NOT COMPLETED|Overall Study||0
6754790|NCT03492398|7681286|FG002|NOT COMPLETED|Overall Study||0
6754791|NCT03492398|7681287|FG003|NOT COMPLETED|Overall Study||0
6754792|NCT03492398|7681288|FG004|NOT COMPLETED|Overall Study||0
6754793|NCT03492398|7681289|FG005|NOT COMPLETED|Overall Study||0
6754794|NCT03492398|7681290|FG006|NOT COMPLETED|Overall Study||1
6754795|NCT03492398|7681291|FG007|NOT COMPLETED|Overall Study||1
6754796|NCT03492398|7681292|FG008|NOT COMPLETED|Overall Study||0
6754797|NCT03492554|7681314|FG000|STARTED|Overall Study||301
6754798|NCT03492554|7681315|FG001|STARTED|Overall Study||301
6754799|NCT03492554|7681314|FG000|COMPLETED|Overall Study||301
6754800|NCT03492554|7681315|FG001|COMPLETED|Overall Study||287
6754801|NCT03492554|7681314|FG000|NOT COMPLETED|Overall Study||0
6754802|NCT03492554|7681315|FG001|NOT COMPLETED|Overall Study||14
6754803|NCT03493386|7681324|FG000|STARTED|Part 1, Intervention Period 1 (2 Days)||26
6754804|NCT03493386|7681325|FG001|STARTED|Part 1, Intervention Period 1 (2 Days)||26
6754805|NCT03493386|7681326|FG002|STARTED|Part 1, Intervention Period 1 (2 Days)||0
6754806|NCT03493386|7681327|FG003|STARTED|Part 1, Intervention Period 1 (2 Days)||0
6754807|NCT03493386|7681324|FG000|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
6754808|NCT03493386|7681325|FG001|COMPLETED|Part 1, Intervention Period 1 (2 Days)||26
6754809|NCT03493386|7681326|FG002|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6754810|NCT03493386|7681327|FG003|COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6754811|NCT03493386|7681324|FG000|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6754812|NCT03493386|7681325|FG001|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6754813|NCT03493386|7681326|FG002|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6754814|NCT03493386|7681327|FG003|NOT COMPLETED|Part 1, Intervention Period 1 (2 Days)||0
6754815|NCT03493386|7681324|FG000|STARTED|Part 1, Washout Period (at Least 5 Days)||26
6754816|NCT03493386|7681325|FG001|STARTED|Part 1, Washout Period (at Least 5 Days)||26
6754817|NCT03493386|7681326|FG002|STARTED|Part 1, Washout Period (at Least 5 Days)||0
6754818|NCT03493386|7681327|FG003|STARTED|Part 1, Washout Period (at Least 5 Days)||0
6754819|NCT03493386|7681324|FG000|COMPLETED|Part 1, Washout Period (at Least 5 Days)||26
6754820|NCT03493386|7681325|FG001|COMPLETED|Part 1, Washout Period (at Least 5 Days)||25
6754821|NCT03493386|7681326|FG002|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6754822|NCT03493386|7681327|FG003|COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6754823|NCT03493386|7681324|FG000|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6754824|NCT03493386|7681325|FG001|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||1
6754825|NCT03493386|7681326|FG002|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6754826|NCT03493386|7681327|FG003|NOT COMPLETED|Part 1, Washout Period (at Least 5 Days)||0
6555681|NCT01753570|7477841|FG000|STARTED|Overall Study||30
6754827|NCT03493386|7681324|FG000|STARTED|Part 1, Intervention Period 2 (2 Days)||26
6754828|NCT03493386|7681325|FG001|STARTED|Part 1, Intervention Period 2 (2 Days)||25
6754829|NCT03493386|7681326|FG002|STARTED|Part 1, Intervention Period 2 (2 Days)||0
6754830|NCT03493386|7681327|FG003|STARTED|Part 1, Intervention Period 2 (2 Days)||0
6754831|NCT03493386|7681324|FG000|COMPLETED|Part 1, Intervention Period 2 (2 Days)||26
6754832|NCT03493386|7681325|FG001|COMPLETED|Part 1, Intervention Period 2 (2 Days)||25
6754833|NCT03493386|7681326|FG002|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6754834|NCT03493386|7681327|FG003|COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6754835|NCT03493386|7681324|FG000|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6555682|NCT01753570|7477842|FG001|STARTED|Overall Study||30
6555683|NCT01753570|7477843|FG002|STARTED|Overall Study||14
6555684|NCT01753570|7477841|FG000|COMPLETED|Overall Study||28
6555685|NCT01753570|7477842|FG001|COMPLETED|Overall Study||25
6754836|NCT03493386|7681325|FG001|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6754837|NCT03493386|7681326|FG002|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6754838|NCT03493386|7681327|FG003|NOT COMPLETED|Part 1, Intervention Period 2 (2 Days)||0
6754839|NCT03493386|7681324|FG000|STARTED|Part 2, Intervention Period 1 (2 Days)||0
6754840|NCT03493386|7681325|FG001|STARTED|Part 2, Intervention Period 1 (2 Days)||0
6754841|NCT03493386|7681326|FG002|STARTED|Part 2, Intervention Period 1 (2 Days)||6
6754842|NCT03493386|7681327|FG003|STARTED|Part 2, Intervention Period 1 (2 Days)||6
6754843|NCT03493386|7681324|FG000|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6754844|NCT03493386|7681325|FG001|COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6754845|NCT03493386|7681326|FG002|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
6754846|NCT03493386|7681327|FG003|COMPLETED|Part 2, Intervention Period 1 (2 Days)||6
6754847|NCT03493386|7681324|FG000|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6754848|NCT03493386|7681325|FG001|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6754849|NCT03493386|7681326|FG002|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6754850|NCT03493386|7681327|FG003|NOT COMPLETED|Part 2, Intervention Period 1 (2 Days)||0
6754851|NCT03493386|7681324|FG000|STARTED|Part 2, Washout Period (at Least 5 Days)||0
6754852|NCT03493386|7681325|FG001|STARTED|Part 2, Washout Period (at Least 5 Days)||0
6754853|NCT03493386|7681326|FG002|STARTED|Part 2, Washout Period (at Least 5 Days)||6
6754854|NCT03493386|7681327|FG003|STARTED|Part 2, Washout Period (at Least 5 Days)||6
6754855|NCT03493386|7681324|FG000|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6754856|NCT03493386|7681325|FG001|COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6754857|NCT03493386|7681326|FG002|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
6754858|NCT03493386|7681327|FG003|COMPLETED|Part 2, Washout Period (at Least 5 Days)||6
6754859|NCT03493386|7681324|FG000|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6754860|NCT03493386|7681325|FG001|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6754861|NCT03493386|7681326|FG002|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6754862|NCT03493386|7681327|FG003|NOT COMPLETED|Part 2, Washout Period (at Least 5 Days)||0
6754863|NCT03493386|7681324|FG000|STARTED|Part 2, Intervention Period 2 (2 Days)||0
6754864|NCT03493386|7681325|FG001|STARTED|Part 2, Intervention Period 2 (2 Days)||0
6754865|NCT03493386|7681326|FG002|STARTED|Part 2, Intervention Period 2 (2 Days)||6
6754866|NCT03493386|7681327|FG003|STARTED|Part 2, Intervention Period 2 (2 Days)||6
6754867|NCT03493386|7681324|FG000|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6754868|NCT03493386|7681325|FG001|COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6754869|NCT03493386|7681326|FG002|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
6754870|NCT03493386|7681327|FG003|COMPLETED|Part 2, Intervention Period 2 (2 Days)||6
6754871|NCT03493386|7681324|FG000|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6754872|NCT03493386|7681325|FG001|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6754873|NCT03493386|7681326|FG002|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6754874|NCT03493386|7681327|FG003|NOT COMPLETED|Part 2, Intervention Period 2 (2 Days)||0
6754875|NCT03493542|7681346|FG000|STARTED|Overall Study||383
6754876|NCT03493542|7681347|FG001|STARTED|Overall Study||383
6754877|NCT03493542|7681346|FG000|Vaccination 1|Overall Study||383
6754878|NCT03493542|7681347|FG001|Vaccination 1|Overall Study||383
6754879|NCT03493542|7681346|FG000|Vaccination 2|Overall Study||379
6754880|NCT03493542|7681347|FG001|Vaccination 2|Overall Study||378
6754881|NCT03493542|7681346|FG000|Vaccination 3|Overall Study||376
6754882|NCT03493542|7681347|FG001|Vaccination 3|Overall Study||374
6754883|NCT03493542|7681346|FG000|COMPLETED|Overall Study||376
6754884|NCT03493542|7681347|FG001|COMPLETED|Overall Study||374
6754885|NCT03493542|7681346|FG000|NOT COMPLETED|Overall Study||7
6754886|NCT03493542|7681347|FG001|NOT COMPLETED|Overall Study||9
6754887|NCT03493607|7681353|FG000|STARTED|Overall Study||6
6754888|NCT03493607|7681353|FG000|COMPLETED|Overall Study||6
6754889|NCT03493607|7681353|FG000|NOT COMPLETED|Overall Study||0
6754890|NCT03493698|7681357|FG000|STARTED|Treatment Period A||17
6754891|NCT03493698|7681357|FG000|COMPLETED|Treatment Period A||17
6754892|NCT03493698|7681357|FG000|NOT COMPLETED|Treatment Period A||0
6754893|NCT03493698|7681357|FG000|STARTED|Treatment Period B||17
6754894|NCT03493698|7681357|FG000|COMPLETED|Treatment Period B||17
6754895|NCT03493698|7681357|FG000|NOT COMPLETED|Treatment Period B||0
6754896|NCT03493698|7681357|FG000|STARTED|Treatment Period C||17
6754897|NCT03493698|7681357|FG000|COMPLETED|Treatment Period C||15
6754898|NCT03493698|7681357|FG000|NOT COMPLETED|Treatment Period C||2
6754899|NCT03493698|7681357|FG000|STARTED|Treatment Period D||15
6754900|NCT03493698|7681357|FG000|COMPLETED|Treatment Period D||15
6754901|NCT03493698|7681357|FG000|NOT COMPLETED|Treatment Period D||0
6754902|NCT03493815|7681373|FG000|STARTED|Overall Study||42
6754903|NCT03493815|7681374|FG001|STARTED|Overall Study||43
6754904|NCT03493815|7681373|FG000|COMPLETED|Overall Study||33
6754905|NCT03493815|7681374|FG001|COMPLETED|Overall Study||32
6754906|NCT03493815|7681373|FG000|NOT COMPLETED|Overall Study||9
6754907|NCT03493815|7681374|FG001|NOT COMPLETED|Overall Study||11
6754908|NCT03493828|7681383|FG000|STARTED|Overall Study||20
6754909|NCT03493828|7681384|FG001|STARTED|Overall Study||20
6754910|NCT03493828|7681385|FG002|STARTED|Overall Study||20
6754911|NCT03493828|7681383|FG000|COMPLETED|Overall Study||20
6754912|NCT03493828|7681384|FG001|COMPLETED|Overall Study||20
6754913|NCT03493828|7681385|FG002|COMPLETED|Overall Study||20
6754914|NCT03493828|7681383|FG000|NOT COMPLETED|Overall Study||0
6754915|NCT03493828|7681384|FG001|NOT COMPLETED|Overall Study||0
6754916|NCT03493828|7681385|FG002|NOT COMPLETED|Overall Study||0
6754917|NCT03494725|7681395|FG000|STARTED|Overall Study||60
6754918|NCT03494725|7681396|FG001|STARTED|Overall Study||60
6754919|NCT03494725|7681395|FG000|Intervention (Post 2 Weeks run-in)|Overall Study||59
6754920|NCT03494725|7681396|FG001|Intervention (Post 2 Weeks run-in)|Overall Study||59
6754921|NCT03494725|7681395|FG000|COMPLETED|Overall Study||59
6754922|NCT03494725|7681396|FG001|COMPLETED|Overall Study||58
6754923|NCT03494725|7681395|FG000|NOT COMPLETED|Overall Study||1
6754924|NCT03494725|7681396|FG001|NOT COMPLETED|Overall Study||2
6754925|NCT03494816|7681408|FG000|STARTED|Overall Study||24
6754926|NCT03494816|7681408|FG000|COMPLETED|Overall Study||18
6754927|NCT03494816|7681408|FG000|NOT COMPLETED|Overall Study||6
6754928|NCT03494985|7681420|FG000|STARTED|Overall Study||101
6754929|NCT03494985|7681421|FG001|STARTED|Overall Study||98
6754930|NCT03494985|7681422|FG002|STARTED|Overall Study||98
6754931|NCT03494985|7681423|FG003|STARTED|Overall Study||99
6754932|NCT03494985|7681420|FG000|COMPLETED|Overall Study||96
6754933|NCT03494985|7681421|FG001|COMPLETED|Overall Study||92
6754934|NCT03494985|7681422|FG002|COMPLETED|Overall Study||92
6754935|NCT03494985|7681423|FG003|COMPLETED|Overall Study||94
6754936|NCT03494985|7681420|FG000|NOT COMPLETED|Overall Study||5
6754937|NCT03494985|7681421|FG001|NOT COMPLETED|Overall Study||6
6754938|NCT03494985|7681422|FG002|NOT COMPLETED|Overall Study||6
6754939|NCT03494985|7681423|FG003|NOT COMPLETED|Overall Study||5
6754940|NCT03495102|7681436|FG000|STARTED|Overall Study||612
6754941|NCT03495102|7681437|FG001|STARTED|Overall Study||616
6754942|NCT03495102|7681438|FG002|STARTED|Overall Study||614
6754943|NCT03495102|7681436|FG000|Received at Least One Dose of Study Drug|Overall Study||612
6754944|NCT03495102|7681437|FG001|Received at Least One Dose of Study Drug|Overall Study||616
6754945|NCT03495102|7681438|FG002|Received at Least One Dose of Study Drug|Overall Study||614
6754946|NCT03495102|7681436|FG000|COMPLETED|Overall Study||556
6754947|NCT03495102|7681437|FG001|COMPLETED|Overall Study||549
6754948|NCT03495102|7681438|FG002|COMPLETED|Overall Study||560
6754949|NCT03495102|7681436|FG000|NOT COMPLETED|Overall Study||56
6754950|NCT03495102|7681437|FG001|NOT COMPLETED|Overall Study||67
6754951|NCT03495102|7681438|FG002|NOT COMPLETED|Overall Study||54
6754952|NCT03495648|7681448|FG000|STARTED|Overall Study||60
6754953|NCT03495648|7681449|FG001|STARTED|Overall Study||61
6754954|NCT03495648|7681448|FG000|COMPLETED|Overall Study||60
6754955|NCT03495648|7681449|FG001|COMPLETED|Overall Study||61
6754956|NCT03495648|7681448|FG000|NOT COMPLETED|Overall Study||0
6754957|NCT03495648|7681449|FG001|NOT COMPLETED|Overall Study||0
6754958|NCT03495817|7681455|FG000|STARTED|26 Week Open Label||31
6754959|NCT03495817|7681455|FG000|COMPLETED|26 Week Open Label||23
6754960|NCT03495817|7681455|FG000|NOT COMPLETED|26 Week Open Label||8
6754961|NCT03495817|7681455|FG000|STARTED|26 Week Extension||19
6754962|NCT03495817|7681455|FG000|COMPLETED|26 Week Extension||17
6754963|NCT03495817|7681455|FG000|NOT COMPLETED|26 Week Extension||2
6754964|NCT03495856|7681459|FG000|STARTED|Overall Study||23
6754965|NCT03495856|7681459|FG000|COMPLETED|Overall Study||22
6754966|NCT03495856|7681459|FG000|NOT COMPLETED|Overall Study||1
6754967|NCT03495869|7681467|FG000|STARTED|Overall Study||54
6754968|NCT03495869|7681468|FG001|STARTED|Overall Study||124
6754969|NCT03495869|7681469|FG002|STARTED|Overall Study||61
6754970|NCT03495869|7681470|FG003|STARTED|Overall Study||129
6754971|NCT03495869|7681467|FG000|COMPLETED|Overall Study||50
6754972|NCT03495869|7681468|FG001|COMPLETED|Overall Study||97
6754973|NCT03495869|7681469|FG002|COMPLETED|Overall Study||51
6754974|NCT03495869|7681470|FG003|COMPLETED|Overall Study||108
6754975|NCT03495869|7681467|FG000|NOT COMPLETED|Overall Study||4
6754976|NCT03495869|7681468|FG001|NOT COMPLETED|Overall Study||27
6754977|NCT03495869|7681469|FG002|NOT COMPLETED|Overall Study||10
6754978|NCT03495869|7681470|FG003|NOT COMPLETED|Overall Study||21
6754979|NCT03495908|7681482|FG000|STARTED|Overall Study||69
6754980|NCT03495908|7681483|FG001|STARTED|Overall Study||67
6754981|NCT03495908|7681482|FG000|COMPLETED|Overall Study||59
6754982|NCT03495908|7681483|FG001|COMPLETED|Overall Study||54
6754983|NCT03495908|7681482|FG000|NOT COMPLETED|Overall Study||10
6754984|NCT03495908|7681483|FG001|NOT COMPLETED|Overall Study||13
6754985|NCT03496220|7681491|FG000|STARTED|First Intervention||15
6754986|NCT03496220|7681492|FG001|STARTED|First Intervention||4
6754987|NCT03496220|7681493|FG002|STARTED|First Intervention||10
6754988|NCT03496220|7681491|FG000|COMPLETED|First Intervention||15
6754989|NCT03496220|7681492|FG001|COMPLETED|First Intervention||4
6754990|NCT03496220|7681493|FG002|COMPLETED|First Intervention||10
6754991|NCT03496220|7681491|FG000|NOT COMPLETED|First Intervention||0
6754992|NCT03496220|7681492|FG001|NOT COMPLETED|First Intervention||0
6754993|NCT03496220|7681493|FG002|NOT COMPLETED|First Intervention||0
6754994|NCT03496220|7681491|FG000|STARTED|Second Intervention||17
6754995|NCT03496220|7681492|FG001|STARTED|Second Intervention||9
6754996|NCT03496220|7681493|FG002|STARTED|Second Intervention||11
6754997|NCT03496220|7681491|FG000|COMPLETED|Second Intervention||17
6754998|NCT03496220|7681492|FG001|COMPLETED|Second Intervention||9
6555686|NCT01753570|7477843|FG002|COMPLETED|Overall Study||13
6555687|NCT01753570|7477841|FG000|NOT COMPLETED|Overall Study||2
6555688|NCT01753570|7477842|FG001|NOT COMPLETED|Overall Study||5
6555689|NCT01753570|7477843|FG002|NOT COMPLETED|Overall Study||1
6555690|NCT01753713|7477854|FG000|STARTED|Overall Study||14
6555691|NCT01753713|7477855|FG001|STARTED|Overall Study||19
6555692|NCT01753713|7477854|FG000|COMPLETED|Overall Study||14
6555693|NCT01753713|7477855|FG001|COMPLETED|Overall Study||19
6555694|NCT01753713|7477854|FG000|NOT COMPLETED|Overall Study||0
6555695|NCT01753713|7477855|FG001|NOT COMPLETED|Overall Study||0
6555696|NCT01753739|7477866|FG000|STARTED|Overall Study||124
6555697|NCT01753739|7477867|FG001|STARTED|Overall Study||123
6555698|NCT01753739|7477868|FG002|STARTED|Overall Study||123
6555699|NCT01753739|7477869|FG003|STARTED|Overall Study||124
6555700|NCT01753739|7477870|FG004|STARTED|Overall Study||123
6754999|NCT03496220|7681493|FG002|COMPLETED|Second Intervention||11
6755000|NCT03496220|7681491|FG000|NOT COMPLETED|Second Intervention||0
6755001|NCT03496220|7681492|FG001|NOT COMPLETED|Second Intervention||0
6755002|NCT03496220|7681493|FG002|NOT COMPLETED|Second Intervention||0
6755003|NCT03496220|7681491|FG000|STARTED|Third Intervention||11
6755004|NCT03496220|7681492|FG001|STARTED|Third Intervention||8
6755005|NCT03496220|7681493|FG002|STARTED|Third Intervention||5
6755006|NCT03496220|7681491|FG000|COMPLETED|Third Intervention||11
6755007|NCT03496220|7681492|FG001|COMPLETED|Third Intervention||8
6755008|NCT03496220|7681493|FG002|COMPLETED|Third Intervention||5
6755009|NCT03496220|7681491|FG000|NOT COMPLETED|Third Intervention||0
6755010|NCT03496220|7681492|FG001|NOT COMPLETED|Third Intervention||0
6755011|NCT03496220|7681493|FG002|NOT COMPLETED|Third Intervention||0
6755012|NCT03496298|7681502|FG000|STARTED|Overall Study||1359
6755013|NCT03496298|7681503|FG001|STARTED|Overall Study||1359
6755014|NCT03496298|7681504|FG002|STARTED|Overall Study||1358
6755015|NCT03496298|7681502|FG000|Randomized and Treated|Overall Study||1358
6755016|NCT03496298|7681503|FG001|Randomized and Treated|Overall Study||1358
6755017|NCT03496298|7681504|FG002|Randomized and Treated|Overall Study||1357
6755018|NCT03496298|7681502|FG000|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and 1 participant received Efpeglenatide 6 mg treatment. Hence, they were counted in the respective arm for safety analysis.|1355
6755019|NCT03496298|7681503|FG001|Safety Population|Overall Study|2 participants of Placebo arm received Efpeglenatide 4 mg treatment and thus counted in the 4 mg treatment arm for safety analysis.|1360
6755020|NCT03496298|7681504|FG002|Safety Population|Overall Study|1 participant of Placebo arm received Efpeglenatide 6 mg treatment and thus counted in the 6 mg treatment arm for safety analysis.|1358
6755021|NCT03496298|7681502|FG000|COMPLETED|Overall Study||42
6755022|NCT03496298|7681503|FG001|COMPLETED|Overall Study||36
6755023|NCT03496298|7681504|FG002|COMPLETED|Overall Study||23
6755024|NCT03496298|7681502|FG000|NOT COMPLETED|Overall Study||1317
6755025|NCT03496298|7681503|FG001|NOT COMPLETED|Overall Study||1323
6755026|NCT03496298|7681504|FG002|NOT COMPLETED|Overall Study||1335
6755027|NCT03496324|7681511|FG000|STARTED|Period 1||6
6755028|NCT03496324|7681512|FG001|STARTED|Period 1||6
6755029|NCT03496324|7681513|FG002|STARTED|Period 1||6
6755030|NCT03496324|7681514|FG003|STARTED|Period 1||6
6755031|NCT03496324|7681511|FG000|COMPLETED|Period 1||6
6755032|NCT03496324|7681512|FG001|COMPLETED|Period 1||6
6755033|NCT03496324|7681513|FG002|COMPLETED|Period 1||6
6755034|NCT03496324|7681514|FG003|COMPLETED|Period 1||6
6755035|NCT03496324|7681511|FG000|NOT COMPLETED|Period 1||0
6755036|NCT03496324|7681512|FG001|NOT COMPLETED|Period 1||0
6755037|NCT03496324|7681513|FG002|NOT COMPLETED|Period 1||0
6755038|NCT03496324|7681514|FG003|NOT COMPLETED|Period 1||0
6755039|NCT03496324|7681511|FG000|STARTED|Period 1: Washout (3 to 7 Days)||6
6755040|NCT03496324|7681512|FG001|STARTED|Period 1: Washout (3 to 7 Days)||6
6755041|NCT03496324|7681513|FG002|STARTED|Period 1: Washout (3 to 7 Days)||6
6755042|NCT03496324|7681514|FG003|STARTED|Period 1: Washout (3 to 7 Days)||6
6755043|NCT03496324|7681511|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||6
6755044|NCT03496324|7681512|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||6
6755045|NCT03496324|7681513|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||6
6755046|NCT03496324|7681514|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||6
6755047|NCT03496324|7681511|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6555701|NCT01753739|7477866|FG000|COMPLETED|Overall Study||120
6555702|NCT01753739|7477867|FG001|COMPLETED|Overall Study||118
6555703|NCT01753739|7477868|FG002|COMPLETED|Overall Study||118
6755048|NCT03496324|7681512|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6755049|NCT03496324|7681513|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6755050|NCT03496324|7681514|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6755051|NCT03496324|7681511|FG000|STARTED|Period 2||6
6755052|NCT03496324|7681512|FG001|STARTED|Period 2||6
6755053|NCT03496324|7681513|FG002|STARTED|Period 2||6
6755054|NCT03496324|7681514|FG003|STARTED|Period 2||6
6755055|NCT03496324|7681511|FG000|COMPLETED|Period 2||6
6555704|NCT01753739|7477869|FG003|COMPLETED|Overall Study||117
6555705|NCT01753739|7477870|FG004|COMPLETED|Overall Study||120
6555706|NCT01753739|7477866|FG000|NOT COMPLETED|Overall Study||4
6755056|NCT03496324|7681512|FG001|COMPLETED|Period 2||6
6755057|NCT03496324|7681513|FG002|COMPLETED|Period 2||6
6755058|NCT03496324|7681514|FG003|COMPLETED|Period 2||6
6755059|NCT03496324|7681511|FG000|NOT COMPLETED|Period 2||0
6755060|NCT03496324|7681512|FG001|NOT COMPLETED|Period 2||0
6755061|NCT03496324|7681513|FG002|NOT COMPLETED|Period 2||0
6755062|NCT03496324|7681514|FG003|NOT COMPLETED|Period 2||0
6755063|NCT03496324|7681511|FG000|STARTED|Period 2: Washout (3 to 7 Days)||6
6755064|NCT03496324|7681512|FG001|STARTED|Period 2: Washout (3 to 7 Days)||6
6755065|NCT03496324|7681513|FG002|STARTED|Period 2: Washout (3 to 7 Days)||6
6755066|NCT03496324|7681514|FG003|STARTED|Period 2: Washout (3 to 7 Days)||6
6755067|NCT03496324|7681511|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6755068|NCT03496324|7681512|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6755069|NCT03496324|7681513|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6755070|NCT03496324|7681514|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6755071|NCT03496324|7681511|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6755072|NCT03496324|7681512|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6755073|NCT03496324|7681513|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6755074|NCT03496324|7681514|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6755075|NCT03496324|7681511|FG000|STARTED|Period 3||6
6755076|NCT03496324|7681512|FG001|STARTED|Period 3||6
6755077|NCT03496324|7681513|FG002|STARTED|Period 3||6
6755078|NCT03496324|7681514|FG003|STARTED|Period 3||6
6755079|NCT03496324|7681511|FG000|COMPLETED|Period 3||6
6755080|NCT03496324|7681512|FG001|COMPLETED|Period 3||6
6755081|NCT03496324|7681513|FG002|COMPLETED|Period 3||6
6755082|NCT03496324|7681514|FG003|COMPLETED|Period 3||6
6755083|NCT03496324|7681511|FG000|NOT COMPLETED|Period 3||0
6755084|NCT03496324|7681512|FG001|NOT COMPLETED|Period 3||0
6755085|NCT03496324|7681513|FG002|NOT COMPLETED|Period 3||0
6755086|NCT03496324|7681514|FG003|NOT COMPLETED|Period 3||0
6755087|NCT03496324|7681511|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
6755088|NCT03496324|7681512|FG001|STARTED|Period 3: Washout (3 to 7 Days)||6
6755089|NCT03496324|7681513|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
6755090|NCT03496324|7681514|FG003|STARTED|Period 3: Washout (3 to 7 Days)||6
6755091|NCT03496324|7681511|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6755092|NCT03496324|7681512|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6755093|NCT03496324|7681513|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6755094|NCT03496324|7681514|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6755095|NCT03496324|7681511|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6755096|NCT03496324|7681512|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6755097|NCT03496324|7681513|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6755098|NCT03496324|7681514|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6755099|NCT03496324|7681511|FG000|STARTED|Period 7: Period 4||6
6755100|NCT03496324|7681512|FG001|STARTED|Period 7: Period 4||6
6755101|NCT03496324|7681513|FG002|STARTED|Period 7: Period 4||6
6755102|NCT03496324|7681514|FG003|STARTED|Period 7: Period 4||6
6755103|NCT03496324|7681511|FG000|COMPLETED|Period 7: Period 4||6
6755104|NCT03496324|7681512|FG001|COMPLETED|Period 7: Period 4||6
6755105|NCT03496324|7681513|FG002|COMPLETED|Period 7: Period 4||6
6755106|NCT03496324|7681514|FG003|COMPLETED|Period 7: Period 4||6
6755107|NCT03496324|7681511|FG000|NOT COMPLETED|Period 7: Period 4||0
6755108|NCT03496324|7681512|FG001|NOT COMPLETED|Period 7: Period 4||0
6755109|NCT03496324|7681513|FG002|NOT COMPLETED|Period 7: Period 4||0
6755110|NCT03496324|7681514|FG003|NOT COMPLETED|Period 7: Period 4||0
6755111|NCT03496428|7681524|FG000|STARTED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
6755112|NCT03496428|7681524|FG000|COMPLETED|Overall Study|304 locations distributed for the analyzed teeth 108 locations distributed for the implant spots|6
6755113|NCT03496428|7681524|FG000|NOT COMPLETED|Overall Study||0
6755114|NCT03496467|7681530|FG000|STARTED|Overall Study||38
6755115|NCT03496467|7681531|FG001|STARTED|Overall Study||18
6755116|NCT03496467|7681530|FG000|COMPLETED|Overall Study||34
6755117|NCT03496467|7681531|FG001|COMPLETED|Overall Study||14
6755118|NCT03496467|7681530|FG000|NOT COMPLETED|Overall Study||4
6755119|NCT03496467|7681531|FG001|NOT COMPLETED|Overall Study||4
6755120|NCT03496545|7681539|FG000|STARTED|Overall Study||21
6755121|NCT03496545|7681540|FG001|STARTED|Overall Study||26
6755122|NCT03496545|7681539|FG000|COMPLETED|Overall Study||20
6755123|NCT03496545|7681540|FG001|COMPLETED|Overall Study||24
6755124|NCT03496545|7681539|FG000|NOT COMPLETED|Overall Study||1
6755125|NCT03496545|7681540|FG001|NOT COMPLETED|Overall Study||2
6755126|NCT03496701|7681546|FG000|STARTED|Overall Study||77
6755127|NCT03496701|7681546|FG000|COMPLETED|Overall Study||77
6755128|NCT03496701|7681546|FG000|NOT COMPLETED|Overall Study||0
6755129|NCT03496974|7681554|FG000|STARTED|Overall Study||10
6755130|NCT03496974|7681555|FG001|STARTED|Overall Study||28
6755131|NCT03496974|7681554|FG000|COMPLETED|Overall Study||9
6755132|NCT03496974|7681555|FG001|COMPLETED|Overall Study||20
6755133|NCT03496974|7681554|FG000|NOT COMPLETED|Overall Study||1
6755134|NCT03496974|7681555|FG001|NOT COMPLETED|Overall Study||8
6755135|NCT03496987|7681563|FG000|STARTED|Overall Study||49
6755136|NCT03496987|7681564|FG001|STARTED|Overall Study||51
6755137|NCT03496987|7681563|FG000|COMPLETED|Overall Study||49
6755138|NCT03496987|7681564|FG001|COMPLETED|Overall Study||51
6755139|NCT03496987|7681563|FG000|NOT COMPLETED|Overall Study||0
6755140|NCT03496987|7681564|FG001|NOT COMPLETED|Overall Study||0
6755141|NCT03497026|7681570|FG000|STARTED|Overall Study||4
6755142|NCT03497026|7681570|FG000|COMPLETED|Overall Study||4
6755143|NCT03497026|7681570|FG000|NOT COMPLETED|Overall Study||0
6755144|NCT03497039|7681576|FG000|STARTED|Overall Study||30
6755145|NCT03497039|7681577|FG001|STARTED|Overall Study||17
6755146|NCT03497039|7681576|FG000|Treated|Overall Study||29
6755147|NCT03497039|7681577|FG001|Treated|Overall Study||17
6755148|NCT03497039|7681576|FG000|COMPLETED|Overall Study||29
6755149|NCT03497039|7681577|FG001|COMPLETED|Overall Study||16
6755150|NCT03497039|7681576|FG000|NOT COMPLETED|Overall Study||1
6755151|NCT03497039|7681577|FG001|NOT COMPLETED|Overall Study||1
6755152|NCT03497130|7681585|FG000|STARTED|Overall Study||40
6755153|NCT03497130|7681586|FG001|STARTED|Overall Study||14
6755154|NCT03497130|7681585|FG000|COMPLETED|Overall Study||39
6755155|NCT03497130|7681586|FG001|COMPLETED|Overall Study||13
6755156|NCT03497130|7681585|FG000|NOT COMPLETED|Overall Study||1
6755157|NCT03497130|7681586|FG001|NOT COMPLETED|Overall Study||1
6755158|NCT03497429|7681594|FG000|STARTED|Overall Study||3
6755159|NCT03497429|7681595|FG001|STARTED|Overall Study||6
6755160|NCT03497429|7681594|FG000|Started|Overall Study||3
6755161|NCT03497429|7681595|FG001|Started|Overall Study||6
6755162|NCT03497429|7681594|FG000|Completed|Overall Study||0
6755163|NCT03497429|7681595|FG001|Completed|Overall Study||0
6755164|NCT03497429|7681594|FG000|COMPLETED|Overall Study||0
6755165|NCT03497429|7681595|FG001|COMPLETED|Overall Study||0
6755166|NCT03497429|7681594|FG000|NOT COMPLETED|Overall Study||3
6755167|NCT03497429|7681595|FG001|NOT COMPLETED|Overall Study||6
6755168|NCT03497585|7681601|FG000|STARTED|Overall Study|112 participants were recruited: 107 patients, plus 5 HCPs for the acceptability interviews.|112
6755169|NCT03497585|7681601|FG000|COMPLETED|Overall Study||57
6755170|NCT03497585|7681601|FG000|NOT COMPLETED|Overall Study||55
6755171|NCT03497845|7681617|FG000|STARTED|Overall Study||60
6755172|NCT03497845|7681618|FG001|STARTED|Overall Study||58
6755173|NCT03497845|7681619|FG002|STARTED|Overall Study||61
6755174|NCT03497845|7681620|FG003|STARTED|Overall Study||60
6755175|NCT03497845|7681621|FG004|STARTED|Overall Study||59
6755176|NCT03497845|7681622|FG005|STARTED|Overall Study||62
6755177|NCT03497845|7681623|FG006|STARTED|Overall Study||59
6755178|NCT03497845|7681624|FG007|STARTED|Overall Study||60
6755179|NCT03497845|7681625|FG008|STARTED|Overall Study||61
6755180|NCT03497845|7681626|FG009|STARTED|Overall Study||59
6755181|NCT03497845|7681627|FG010|STARTED|Overall Study||61
6755182|NCT03497845|7681628|FG011|STARTED|Overall Study||60
6755183|NCT03497845|7681617|FG000|COMPLETED|Overall Study|Day 142|55
6755184|NCT03497845|7681618|FG001|COMPLETED|Overall Study|Day 142|45
6755185|NCT03497845|7681619|FG002|COMPLETED|Overall Study|Day 142|50
6755186|NCT03497845|7681620|FG003|COMPLETED|Overall Study|Day 142|50
6755187|NCT03497845|7681621|FG004|COMPLETED|Overall Study|Day 262|38
6755188|NCT03497845|7681622|FG005|COMPLETED|Overall Study|Day 262|44
6755189|NCT03497845|7681623|FG006|COMPLETED|Overall Study|Day 142|51
6755190|NCT03497845|7681624|FG007|COMPLETED|Overall Study|Day 142|50
6755191|NCT03497845|7681625|FG008|COMPLETED|Overall Study|Day 142|47
6755192|NCT03497845|7681626|FG009|COMPLETED|Overall Study|Day 142|53
6755193|NCT03497845|7681627|FG010|COMPLETED|Overall Study|Day 262|46
6755194|NCT03497845|7681628|FG011|COMPLETED|Overall Study|Day 262|38
6755195|NCT03497845|7681617|FG000|NOT COMPLETED|Overall Study||5
6755196|NCT03497845|7681618|FG001|NOT COMPLETED|Overall Study||13
6755197|NCT03497845|7681619|FG002|NOT COMPLETED|Overall Study||11
6755198|NCT03497845|7681620|FG003|NOT COMPLETED|Overall Study||10
6755199|NCT03497845|7681621|FG004|NOT COMPLETED|Overall Study||21
6755200|NCT03497845|7681622|FG005|NOT COMPLETED|Overall Study||18
6755201|NCT03497845|7681623|FG006|NOT COMPLETED|Overall Study||8
6755202|NCT03497845|7681624|FG007|NOT COMPLETED|Overall Study||10
6755203|NCT03497845|7681625|FG008|NOT COMPLETED|Overall Study||14
6755204|NCT03497845|7681626|FG009|NOT COMPLETED|Overall Study||6
6755205|NCT03497845|7681627|FG010|NOT COMPLETED|Overall Study||15
6755206|NCT03497845|7681628|FG011|NOT COMPLETED|Overall Study||22
6755207|NCT03498196|7681660|FG000|STARTED|Overall Study||1
6755208|NCT03498196|7681660|FG000|COMPLETED|Overall Study||1
6755209|NCT03498196|7681660|FG000|NOT COMPLETED|Overall Study||0
6755210|NCT03498287|7681666|FG000|STARTED|Overall Study||45
6755211|NCT03498287|7681667|FG001|STARTED|Overall Study||43
6755212|NCT03498287|7681666|FG000|COMPLETED|Overall Study||42
6755213|NCT03498287|7681667|FG001|COMPLETED|Overall Study||38
6755214|NCT03498287|7681666|FG000|NOT COMPLETED|Overall Study||3
6755215|NCT03498287|7681667|FG001|NOT COMPLETED|Overall Study||5
6755216|NCT03498300|7681675|FG000|STARTED|Overall Study||21
6755217|NCT03498300|7681676|FG001|STARTED|Overall Study||21
6755218|NCT03498300|7681675|FG000|COMPLETED|Overall Study||18
6755219|NCT03498300|7681676|FG001|COMPLETED|Overall Study||13
6755220|NCT03498300|7681675|FG000|NOT COMPLETED|Overall Study||3
6755221|NCT03498300|7681676|FG001|NOT COMPLETED|Overall Study||8
6755222|NCT03499028|7681685|FG000|STARTED|Overall Study||226
6755223|NCT03499028|7681686|FG001|STARTED|Overall Study||220
6755224|NCT03499028|7681685|FG000|COMPLETED|Overall Study||204
6755225|NCT03499028|7681686|FG001|COMPLETED|Overall Study||195
6755226|NCT03499028|7681685|FG000|NOT COMPLETED|Overall Study||22
6755227|NCT03499028|7681686|FG001|NOT COMPLETED|Overall Study||25
6755228|NCT03499067|7681694|FG000|STARTED|First Intervention||27
6755229|NCT03499067|7681695|FG001|STARTED|First Intervention||31
6755230|NCT03499067|7681694|FG000|COMPLETED|First Intervention||22
6755231|NCT03499067|7681695|FG001|COMPLETED|First Intervention||24
6755232|NCT03499067|7681694|FG000|NOT COMPLETED|First Intervention||5
6755233|NCT03499067|7681695|FG001|NOT COMPLETED|First Intervention||7
6755234|NCT03499067|7681694|FG000|STARTED|Second Intervention||22
6755235|NCT03499067|7681695|FG001|STARTED|Second Intervention||24
6755236|NCT03499067|7681694|FG000|COMPLETED|Second Intervention||22
6755237|NCT03499067|7681695|FG001|COMPLETED|Second Intervention||24
6755238|NCT03499067|7681694|FG000|NOT COMPLETED|Second Intervention||0
6755239|NCT03499067|7681695|FG001|NOT COMPLETED|Second Intervention||0
6755240|NCT03499353|7681701|FG000|STARTED|Treatment||61
6755241|NCT03499353|7681701|FG000|COMPLETED|Treatment||45
6755242|NCT03499353|7681701|FG000|NOT COMPLETED|Treatment||16
6755243|NCT03499353|7681701|FG000|STARTED|Safety Follow-up||49
6755244|NCT03499353|7681701|FG000|Received Treatment|Safety Follow-up||0
6755245|NCT03499353|7681701|FG000|COMPLETED|Safety Follow-up||49
6755246|NCT03499353|7681701|FG000|NOT COMPLETED|Safety Follow-up||0
6755247|NCT03499353|7681701|FG000|STARTED|Long-Term Follow-up||58
6755248|NCT03499353|7681701|FG000|Received Treatment|Long-Term Follow-up||0
6755249|NCT03499353|7681701|FG000|COMPLETED|Long-Term Follow-up||0
6755250|NCT03499353|7681701|FG000|NOT COMPLETED|Long-Term Follow-up||58
6755251|NCT03499873|7681708|FG000|STARTED|Overall Study||183
6755252|NCT03499873|7681709|FG001|STARTED|Overall Study||182
6755253|NCT03499873|7681710|FG002|STARTED|Overall Study||83
6755254|NCT03499873|7681708|FG000|Safety Population|Overall Study||175
6755255|NCT03499873|7681709|FG001|Safety Population|Overall Study||174
6755256|NCT03499873|7681710|FG002|Safety Population|Overall Study||80
6755257|NCT03499873|7681708|FG000|Per-Protocol Population|Overall Study||144
6755258|NCT03499873|7681709|FG001|Per-Protocol Population|Overall Study||143
6755259|NCT03499873|7681710|FG002|Per-Protocol Population|Overall Study||58
6755260|NCT03499873|7681708|FG000|Modified-Intent-to-Treat|Overall Study||170
6755261|NCT03499873|7681709|FG001|Modified-Intent-to-Treat|Overall Study||168
6755262|NCT03499873|7681710|FG002|Modified-Intent-to-Treat|Overall Study||77
6755263|NCT03499873|7681708|FG000|COMPLETED|Overall Study||163
6755264|NCT03499873|7681709|FG001|COMPLETED|Overall Study||162
6755265|NCT03499873|7681710|FG002|COMPLETED|Overall Study||56
6755266|NCT03499873|7681708|FG000|NOT COMPLETED|Overall Study||20
6755267|NCT03499873|7681709|FG001|NOT COMPLETED|Overall Study||20
6755268|NCT03499873|7681710|FG002|NOT COMPLETED|Overall Study||27
6755269|NCT03500094|7681718|FG000|STARTED|Overall Study||22
6755270|NCT03500094|7681718|FG000|Received At Least 1 Dose of Study Drug|Overall Study||21
6755271|NCT03500094|7681718|FG000|COMPLETED|Overall Study||19
6755272|NCT03500094|7681718|FG000|NOT COMPLETED|Overall Study||3
6755273|NCT03500198|7681726|FG000|STARTED|Overall Study||110
6755274|NCT03500198|7681727|FG001|STARTED|Overall Study||108
6755275|NCT03500198|7681726|FG000|First Eye|Overall Study||110
6755276|NCT03500198|7681727|FG001|First Eye|Overall Study||108
6755277|NCT03500198|7681726|FG000|Second Eye|Overall Study||109
6755278|NCT03500198|7681727|FG001|Second Eye|Overall Study||108
6755279|NCT03500198|7681726|FG000|COMPLETED|Overall Study||110
6755280|NCT03500198|7681727|FG001|COMPLETED|Overall Study||107
6755281|NCT03500198|7681726|FG000|NOT COMPLETED|Overall Study||0
6755282|NCT03500198|7681727|FG001|NOT COMPLETED|Overall Study||1
6755283|NCT03500211|7681737|FG000|STARTED|Overall Study||25
6755284|NCT03500211|7681738|FG001|STARTED|Overall Study||25
6755285|NCT03500211|7681737|FG000|COMPLETED|Overall Study||24
6755286|NCT03500211|7681738|FG001|COMPLETED|Overall Study||24
6755287|NCT03500211|7681737|FG000|NOT COMPLETED|Overall Study||1
6755288|NCT03500211|7681738|FG001|NOT COMPLETED|Overall Study||1
6755289|NCT03500224|7681744|FG000|STARTED|Overall Study||6
6755290|NCT03500224|7681744|FG000|COMPLETED|Overall Study||4
6755291|NCT03500224|7681744|FG000|NOT COMPLETED|Overall Study||2
6755292|NCT03500289|7681750|FG000|STARTED|Overall Study||12
6755293|NCT03500289|7681751|FG001|STARTED|Overall Study||6
6755294|NCT03500289|7681750|FG000|COMPLETED|Overall Study||12
6755295|NCT03500289|7681751|FG001|COMPLETED|Overall Study||6
6755296|NCT03500289|7681750|FG000|NOT COMPLETED|Overall Study||0
6755297|NCT03500289|7681751|FG001|NOT COMPLETED|Overall Study||0
6755298|NCT03500302|7681757|FG000|STARTED|Overall Study||19
6755299|NCT03500302|7681757|FG000|COMPLETED|Overall Study||19
6755300|NCT03500302|7681757|FG000|NOT COMPLETED|Overall Study||0
6755301|NCT03500419|7681763|FG000|STARTED|Overall Study||27
6755302|NCT03500419|7681764|FG001|STARTED|Overall Study||55
6755303|NCT03500419|7681763|FG000|COMPLETED|Overall Study||25
6755304|NCT03500419|7681764|FG001|COMPLETED|Overall Study||30
6755305|NCT03500419|7681763|FG000|NOT COMPLETED|Overall Study||2
6755306|NCT03500419|7681764|FG001|NOT COMPLETED|Overall Study||25
6755307|NCT03500679|7681772|FG000|STARTED|Overall Study||75
6755308|NCT03500679|7681773|FG001|STARTED|Overall Study||25
6755309|NCT03500679|7681772|FG000|COMPLETED|Overall Study||66
6755310|NCT03500679|7681773|FG001|COMPLETED|Overall Study||22
6755311|NCT03500679|7681772|FG000|NOT COMPLETED|Overall Study||9
6755312|NCT03500679|7681773|FG001|NOT COMPLETED|Overall Study||3
6779981|NCT03465735|7708275|FG000|STARTED|Overall Study||8
6779982|NCT03465735|7708276|FG001|STARTED|Overall Study||7
6779983|NCT03465735|7708275|FG000|COMPLETED|Overall Study||7
6779984|NCT03465735|7708276|FG001|COMPLETED|Overall Study||5
6779985|NCT03465735|7708275|FG000|NOT COMPLETED|Overall Study||1
6779986|NCT03465735|7708276|FG001|NOT COMPLETED|Overall Study||2
6779987|NCT03461705|7708282|FG000|STARTED|Overall Study||5
6779988|NCT03461705|7708282|FG000|COMPLETED|Overall Study||5
6779989|NCT03461705|7708282|FG000|NOT COMPLETED|Overall Study||0
6779990|NCT03457818|7708288|FG000|STARTED|Overall Study||4
6779991|NCT03457818|7708289|FG001|STARTED|Overall Study||4
6779992|NCT03457818|7708288|FG000|COMPLETED|Overall Study|Study terminated|0
6755313|NCT03500692|7681779|FG000|STARTED|Overall Study||500
6755314|NCT03500692|7681779|FG000|COMPLETED|Overall Study||391
6755315|NCT03500692|7681779|FG000|NOT COMPLETED|Overall Study||109
6755316|NCT03501043|7681783|FG000|STARTED|Overall Study||11
6755317|NCT03501043|7681783|FG000|COMPLETED|Overall Study||10
6755318|NCT03501043|7681783|FG000|NOT COMPLETED|Overall Study||1
6755319|NCT03501069|7681807|FG000|STARTED|Period A||2
6755320|NCT03501069|7681808|FG001|STARTED|Period A||4
6755321|NCT03501069|7681809|FG002|STARTED|Period A||2
6755322|NCT03501069|7681810|FG003|STARTED|Period A||5
6755323|NCT03501069|7681811|FG004|STARTED|Period A||1
6755324|NCT03501069|7681812|FG005|STARTED|Period A||6
6755325|NCT03501069|7681813|FG006|STARTED|Period A||6
6755326|NCT03501069|7681814|FG007|STARTED|Period A||3
6755327|NCT03501069|7681815|FG008|STARTED|Period A||3
6755328|NCT03501069|7681807|FG000|COMPLETED|Period A||2
6755329|NCT03501069|7681808|FG001|COMPLETED|Period A||4
6755330|NCT03501069|7681809|FG002|COMPLETED|Period A||2
6755331|NCT03501069|7681810|FG003|COMPLETED|Period A||5
6755332|NCT03501069|7681811|FG004|COMPLETED|Period A||1
6755333|NCT03501069|7681812|FG005|COMPLETED|Period A||6
6755334|NCT03501069|7681813|FG006|COMPLETED|Period A||6
6755335|NCT03501069|7681814|FG007|COMPLETED|Period A||3
6755336|NCT03501069|7681815|FG008|COMPLETED|Period A||3
6755337|NCT03501069|7681807|FG000|NOT COMPLETED|Period A||0
6755338|NCT03501069|7681808|FG001|NOT COMPLETED|Period A||0
6755339|NCT03501069|7681809|FG002|NOT COMPLETED|Period A||0
6755340|NCT03501069|7681810|FG003|NOT COMPLETED|Period A||0
6755341|NCT03501069|7681811|FG004|NOT COMPLETED|Period A||0
6755342|NCT03501069|7681812|FG005|NOT COMPLETED|Period A||0
6755343|NCT03501069|7681813|FG006|NOT COMPLETED|Period A||0
6755344|NCT03501069|7681814|FG007|NOT COMPLETED|Period A||0
6755345|NCT03501069|7681815|FG008|NOT COMPLETED|Period A||0
6755346|NCT03501069|7681807|FG000|STARTED|Washout Period (at Least 14 Days)||2
6755347|NCT03501069|7681808|FG001|STARTED|Washout Period (at Least 14 Days)||4
6755348|NCT03501069|7681809|FG002|STARTED|Washout Period (at Least 14 Days)||2
6755349|NCT03501069|7681810|FG003|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755350|NCT03501069|7681811|FG004|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755351|NCT03501069|7681812|FG005|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755352|NCT03501069|7681813|FG006|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755353|NCT03501069|7681814|FG007|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755354|NCT03501069|7681815|FG008|STARTED|Washout Period (at Least 14 Days)|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755355|NCT03501069|7681807|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
6755356|NCT03501069|7681808|FG001|COMPLETED|Washout Period (at Least 14 Days)||4
6755357|NCT03501069|7681809|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
6755358|NCT03501069|7681810|FG003|COMPLETED|Washout Period (at Least 14 Days)||0
6755359|NCT03501069|7681811|FG004|COMPLETED|Washout Period (at Least 14 Days)||0
6755360|NCT03501069|7681812|FG005|COMPLETED|Washout Period (at Least 14 Days)||0
6755361|NCT03501069|7681813|FG006|COMPLETED|Washout Period (at Least 14 Days)||0
6755362|NCT03501069|7681814|FG007|COMPLETED|Washout Period (at Least 14 Days)||0
6755363|NCT03501069|7681815|FG008|COMPLETED|Washout Period (at Least 14 Days)||0
6755364|NCT03501069|7681807|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755365|NCT03501069|7681808|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755366|NCT03501069|7681809|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755367|NCT03501069|7681810|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755368|NCT03501069|7681811|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755369|NCT03501069|7681812|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755370|NCT03501069|7681813|FG006|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755371|NCT03501069|7681814|FG007|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755372|NCT03501069|7681815|FG008|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6755373|NCT03501069|7681807|FG000|STARTED|Period B||2
6755374|NCT03501069|7681808|FG001|STARTED|Period B||4
6755375|NCT03501069|7681809|FG002|STARTED|Period B||2
6755376|NCT03501069|7681810|FG003|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755377|NCT03501069|7681811|FG004|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755378|NCT03501069|7681812|FG005|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755379|NCT03501069|7681813|FG006|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755380|NCT03501069|7681814|FG007|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755381|NCT03501069|7681815|FG008|STARTED|Period B|Participants other than Cohort 1 were not to continue in subsequent Periods after Period A.|0
6755382|NCT03501069|7681807|FG000|COMPLETED|Period B||2
6755383|NCT03501069|7681808|FG001|COMPLETED|Period B||4
6755384|NCT03501069|7681809|FG002|COMPLETED|Period B||2
6755385|NCT03501069|7681810|FG003|COMPLETED|Period B||0
6755386|NCT03501069|7681811|FG004|COMPLETED|Period B||0
6755387|NCT03501069|7681812|FG005|COMPLETED|Period B||0
6755388|NCT03501069|7681813|FG006|COMPLETED|Period B||0
6755389|NCT03501069|7681814|FG007|COMPLETED|Period B||0
6755390|NCT03501069|7681815|FG008|COMPLETED|Period B||0
6755391|NCT03501069|7681807|FG000|NOT COMPLETED|Period B||0
6755392|NCT03501069|7681808|FG001|NOT COMPLETED|Period B||0
6755393|NCT03501069|7681809|FG002|NOT COMPLETED|Period B||0
6755394|NCT03501069|7681810|FG003|NOT COMPLETED|Period B||0
6755395|NCT03501069|7681811|FG004|NOT COMPLETED|Period B||0
6755396|NCT03501069|7681812|FG005|NOT COMPLETED|Period B||0
6755397|NCT03501069|7681813|FG006|NOT COMPLETED|Period B||0
6755398|NCT03501069|7681814|FG007|NOT COMPLETED|Period B||0
6755399|NCT03501069|7681815|FG008|NOT COMPLETED|Period B||0
6755400|NCT03501264|7681845|FG000|STARTED|Overall Study||120
6755401|NCT03501264|7681846|FG001|STARTED|Overall Study||120
6755402|NCT03501264|7681845|FG000|COMPLETED|Overall Study||120
6755403|NCT03501264|7681846|FG001|COMPLETED|Overall Study||120
6755404|NCT03501264|7681845|FG000|NOT COMPLETED|Overall Study||0
6755405|NCT03501264|7681846|FG001|NOT COMPLETED|Overall Study||0
6755406|NCT03501277|7681856|FG000|STARTED|Intervention Period 1 (4 Days)||18
6755407|NCT03501277|7681857|FG001|STARTED|Intervention Period 1 (4 Days)||18
6755408|NCT03501277|7681858|FG002|STARTED|Intervention Period 1 (4 Days)||18
6755409|NCT03501277|7681859|FG003|STARTED|Intervention Period 1 (4 Days)||18
6755410|NCT03501277|7681856|FG000|Safety Analysis Set|Intervention Period 1 (4 Days)||18
6755411|NCT03501277|7681857|FG001|Safety Analysis Set|Intervention Period 1 (4 Days)||18
6755412|NCT03501277|7681858|FG002|Safety Analysis Set|Intervention Period 1 (4 Days)||17
6755413|NCT03501277|7681859|FG003|Safety Analysis Set|Intervention Period 1 (4 Days)||17
6755414|NCT03501277|7681856|FG000|COMPLETED|Intervention Period 1 (4 Days)||18
6755415|NCT03501277|7681857|FG001|COMPLETED|Intervention Period 1 (4 Days)||18
6755416|NCT03501277|7681858|FG002|COMPLETED|Intervention Period 1 (4 Days)||17
6755417|NCT03501277|7681859|FG003|COMPLETED|Intervention Period 1 (4 Days)||17
6755418|NCT03501277|7681856|FG000|NOT COMPLETED|Intervention Period 1 (4 Days)||0
6755419|NCT03501277|7681857|FG001|NOT COMPLETED|Intervention Period 1 (4 Days)||0
6755420|NCT03501277|7681858|FG002|NOT COMPLETED|Intervention Period 1 (4 Days)||1
6755421|NCT03501277|7681859|FG003|NOT COMPLETED|Intervention Period 1 (4 Days)||1
6755422|NCT03501277|7681856|FG000|STARTED|Washout Period 1 (7 Days)||18
6755423|NCT03501277|7681857|FG001|STARTED|Washout Period 1 (7 Days)||18
6755424|NCT03501277|7681858|FG002|STARTED|Washout Period 1 (7 Days)||17
6755425|NCT03501277|7681859|FG003|STARTED|Washout Period 1 (7 Days)||17
6755426|NCT03501277|7681856|FG000|COMPLETED|Washout Period 1 (7 Days)||18
6755427|NCT03501277|7681857|FG001|COMPLETED|Washout Period 1 (7 Days)||18
6755428|NCT03501277|7681858|FG002|COMPLETED|Washout Period 1 (7 Days)||17
6755429|NCT03501277|7681859|FG003|COMPLETED|Washout Period 1 (7 Days)||17
6755430|NCT03501277|7681856|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6755431|NCT03501277|7681857|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6755432|NCT03501277|7681858|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6755433|NCT03501277|7681859|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6755434|NCT03501277|7681856|FG000|STARTED|Intervention Period 2 (4 Days)||18
6755435|NCT03501277|7681857|FG001|STARTED|Intervention Period 2 (4 Days)||18
6755436|NCT03501277|7681858|FG002|STARTED|Intervention Period 2 (4 Days)||17
6755437|NCT03501277|7681859|FG003|STARTED|Intervention Period 2 (4 Days)||17
6755438|NCT03501277|7681856|FG000|COMPLETED|Intervention Period 2 (4 Days)||18
6755439|NCT03501277|7681857|FG001|COMPLETED|Intervention Period 2 (4 Days)||18
6755440|NCT03501277|7681858|FG002|COMPLETED|Intervention Period 2 (4 Days)||17
6755441|NCT03501277|7681859|FG003|COMPLETED|Intervention Period 2 (4 Days)||16
6755442|NCT03501277|7681856|FG000|NOT COMPLETED|Intervention Period 2 (4 Days)||0
6755443|NCT03501277|7681857|FG001|NOT COMPLETED|Intervention Period 2 (4 Days)||0
6755444|NCT03501277|7681858|FG002|NOT COMPLETED|Intervention Period 2 (4 Days)||0
6755445|NCT03501277|7681859|FG003|NOT COMPLETED|Intervention Period 2 (4 Days)||1
6755446|NCT03501277|7681856|FG000|STARTED|Washout Period 2 (7 Days)||18
6755447|NCT03501277|7681857|FG001|STARTED|Washout Period 2 (7 Days)||18
6755448|NCT03501277|7681858|FG002|STARTED|Washout Period 2 (7 Days)||17
6755449|NCT03501277|7681859|FG003|STARTED|Washout Period 2 (7 Days)||16
6755450|NCT03501277|7681856|FG000|COMPLETED|Washout Period 2 (7 Days)||18
6755451|NCT03501277|7681857|FG001|COMPLETED|Washout Period 2 (7 Days)||18
6755452|NCT03501277|7681858|FG002|COMPLETED|Washout Period 2 (7 Days)||17
6755453|NCT03501277|7681859|FG003|COMPLETED|Washout Period 2 (7 Days)||16
6755454|NCT03501277|7681856|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6755455|NCT03501277|7681857|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6755456|NCT03501277|7681858|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6755457|NCT03501277|7681859|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6755458|NCT03501277|7681856|FG000|STARTED|Intervention Period 3 (4 Days)||18
6755459|NCT03501277|7681857|FG001|STARTED|Intervention Period 3 (4 Days)||18
6755460|NCT03501277|7681858|FG002|STARTED|Intervention Period 3 (4 Days)||17
6755461|NCT03501277|7681859|FG003|STARTED|Intervention Period 3 (4 Days)||16
6755462|NCT03501277|7681856|FG000|COMPLETED|Intervention Period 3 (4 Days)||18
6755463|NCT03501277|7681857|FG001|COMPLETED|Intervention Period 3 (4 Days)||18
6755464|NCT03501277|7681858|FG002|COMPLETED|Intervention Period 3 (4 Days)||17
6755465|NCT03501277|7681859|FG003|COMPLETED|Intervention Period 3 (4 Days)||15
6755466|NCT03501277|7681856|FG000|NOT COMPLETED|Intervention Period 3 (4 Days)||0
6755467|NCT03501277|7681857|FG001|NOT COMPLETED|Intervention Period 3 (4 Days)||0
6755468|NCT03501277|7681858|FG002|NOT COMPLETED|Intervention Period 3 (4 Days)||0
6755469|NCT03501277|7681859|FG003|NOT COMPLETED|Intervention Period 3 (4 Days)||1
6755470|NCT03501277|7681856|FG000|STARTED|Washout Period 3 (7 Days)||18
6755471|NCT03501277|7681857|FG001|STARTED|Washout Period 3 (7 Days)||18
6755472|NCT03501277|7681858|FG002|STARTED|Washout Period 3 (7 Days)||17
6755473|NCT03501277|7681859|FG003|STARTED|Washout Period 3 (7 Days)||15
6755474|NCT03501277|7681856|FG000|COMPLETED|Washout Period 3 (7 Days)||18
6755475|NCT03501277|7681857|FG001|COMPLETED|Washout Period 3 (7 Days)||18
6755476|NCT03501277|7681858|FG002|COMPLETED|Washout Period 3 (7 Days)||17
6755477|NCT03501277|7681859|FG003|COMPLETED|Washout Period 3 (7 Days)||15
6755478|NCT03501277|7681856|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
6755479|NCT03501277|7681857|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
6755480|NCT03501277|7681858|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
6755481|NCT03501277|7681859|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
6755482|NCT03501277|7681856|FG000|STARTED|Intervention Period 4 (4 Days)||18
6755483|NCT03501277|7681857|FG001|STARTED|Intervention Period 4 (4 Days)||18
6755484|NCT03501277|7681858|FG002|STARTED|Intervention Period 4 (4 Days)||17
6755485|NCT03501277|7681859|FG003|STARTED|Intervention Period 4 (4 Days)||15
6755486|NCT03501277|7681856|FG000|COMPLETED|Intervention Period 4 (4 Days)||18
6755487|NCT03501277|7681857|FG001|COMPLETED|Intervention Period 4 (4 Days)||18
6755488|NCT03501277|7681858|FG002|COMPLETED|Intervention Period 4 (4 Days)||17
6755489|NCT03501277|7681859|FG003|COMPLETED|Intervention Period 4 (4 Days)||15
6755490|NCT03501277|7681856|FG000|NOT COMPLETED|Intervention Period 4 (4 Days)||0
6755491|NCT03501277|7681857|FG001|NOT COMPLETED|Intervention Period 4 (4 Days)||0
6755492|NCT03501277|7681858|FG002|NOT COMPLETED|Intervention Period 4 (4 Days)||0
6755493|NCT03501277|7681859|FG003|NOT COMPLETED|Intervention Period 4 (4 Days)||0
6755494|NCT03501550|7681869|FG000|STARTED|Overall Study||12
6755495|NCT03501550|7681869|FG000|COMPLETED|Overall Study||12
6755496|NCT03501550|7681869|FG000|NOT COMPLETED|Overall Study||0
6755497|NCT03501693|7681873|FG000|STARTED|First Reading Session||75
6755498|NCT03501693|7681874|FG001|STARTED|First Reading Session||75
6755499|NCT03501693|7681873|FG000|COMPLETED|First Reading Session||75
6755500|NCT03501693|7681874|FG001|COMPLETED|First Reading Session||75
6755501|NCT03501693|7681873|FG000|NOT COMPLETED|First Reading Session||0
6755502|NCT03501693|7681874|FG001|NOT COMPLETED|First Reading Session||0
6755503|NCT03501693|7681873|FG000|STARTED|4 Week Memory Washout Period||75
6755504|NCT03501693|7681874|FG001|STARTED|4 Week Memory Washout Period||75
6755505|NCT03501693|7681873|FG000|COMPLETED|4 Week Memory Washout Period||75
6755506|NCT03501693|7681874|FG001|COMPLETED|4 Week Memory Washout Period||75
6755507|NCT03501693|7681873|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
6755508|NCT03501693|7681874|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
6755509|NCT03501693|7681873|FG000|STARTED|Second Reading Session||75
6755510|NCT03501693|7681874|FG001|STARTED|Second Reading Session||75
6755511|NCT03501693|7681873|FG000|COMPLETED|Second Reading Session||75
6755512|NCT03501693|7681874|FG001|COMPLETED|Second Reading Session||75
6755513|NCT03501693|7681873|FG000|NOT COMPLETED|Second Reading Session||0
6755514|NCT03501693|7681874|FG001|NOT COMPLETED|Second Reading Session||0
6755515|NCT03502265|7681880|FG000|STARTED|Overall Study||4
6755516|NCT03502265|7681880|FG000|COMPLETED|Overall Study||4
6755517|NCT03502265|7681880|FG000|NOT COMPLETED|Overall Study||0
6755518|NCT03502616|7681886|FG000|STARTED|Up to Week 16||134
6755519|NCT03502616|7681887|FG001|STARTED|Up to Week 16||136
6755520|NCT03502616|7681886|FG000|Treated|Up to Week 16||133
6755521|NCT03502616|7681887|FG001|Treated|Up to Week 16||136
6755522|NCT03502616|7681886|FG000|COMPLETED|Up to Week 16||132
6755523|NCT03502616|7681887|FG001|COMPLETED|Up to Week 16||133
6755524|NCT03502616|7681886|FG000|NOT COMPLETED|Up to Week 16||2
6755525|NCT03502616|7681887|FG001|NOT COMPLETED|Up to Week 16||3
6755526|NCT03502616|7681886|FG000|STARTED|Week 16 to Week 48||132
6755527|NCT03502616|7681887|FG001|STARTED|Week 16 to Week 48||133
6755528|NCT03502616|7681886|FG000|Treated|Week 16 to Week 48||132
6755529|NCT03502616|7681887|FG001|Treated|Week 16 to Week 48||133
6755530|NCT03502616|7681886|FG000|COMPLETED|Week 16 to Week 48||125
6755531|NCT03502616|7681887|FG001|COMPLETED|Week 16 to Week 48||127
6755532|NCT03502616|7681886|FG000|NOT COMPLETED|Week 16 to Week 48||7
6755533|NCT03502616|7681887|FG001|NOT COMPLETED|Week 16 to Week 48||6
6755534|NCT03502681|7681897|FG000|STARTED|Overall Study||3
6755535|NCT03502681|7681898|FG001|STARTED|Overall Study||3
6755536|NCT03502681|7681897|FG000|COMPLETED|Overall Study||0
6755537|NCT03502681|7681898|FG001|COMPLETED|Overall Study||1
6755538|NCT03502681|7681897|FG000|NOT COMPLETED|Overall Study||3
6755539|NCT03502681|7681898|FG001|NOT COMPLETED|Overall Study||2
6755540|NCT03502798|7681905|FG000|STARTED|Overall Study||5
6755541|NCT03502798|7681906|FG001|STARTED|Overall Study||40
6755542|NCT03502798|7681905|FG000|COMPLETED|Overall Study||5
6755543|NCT03502798|7681906|FG001|COMPLETED|Overall Study||33
6755544|NCT03502798|7681905|FG000|NOT COMPLETED|Overall Study||0
6755545|NCT03502798|7681906|FG001|NOT COMPLETED|Overall Study||7
6755546|NCT03502915|7681914|FG000|STARTED|Overall Study||24
6555707|NCT01753739|7477867|FG001|NOT COMPLETED|Overall Study||5
6555708|NCT01753739|7477868|FG002|NOT COMPLETED|Overall Study||5
6555709|NCT01753739|7477869|FG003|NOT COMPLETED|Overall Study||7
6555710|NCT01753739|7477870|FG004|NOT COMPLETED|Overall Study||3
6555711|NCT01753830|7477884|FG000|STARTED|Overall Study||37
6555712|NCT01753830|7477885|FG001|STARTED|Overall Study||38
6755547|NCT03502915|7681915|FG001|STARTED|Overall Study||24
6755548|NCT03502915|7681914|FG000|COMPLETED|Overall Study||24
6755549|NCT03502915|7681915|FG001|COMPLETED|Overall Study||24
6755550|NCT03502915|7681914|FG000|NOT COMPLETED|Overall Study||0
6755551|NCT03502915|7681915|FG001|NOT COMPLETED|Overall Study||0
6755552|NCT03502941|7681924|FG000|STARTED|Overall Study||3
6755553|NCT03502941|7681925|FG001|STARTED|Overall Study||5
6755554|NCT03502941|7681926|FG002|STARTED|Overall Study||8
6755555|NCT03502941|7681924|FG000|COMPLETED|Overall Study||3
6755556|NCT03502941|7681925|FG001|COMPLETED|Overall Study||5
6755557|NCT03502941|7681926|FG002|COMPLETED|Overall Study||8
6755558|NCT03502941|7681924|FG000|NOT COMPLETED|Overall Study||0
6755559|NCT03502941|7681925|FG001|NOT COMPLETED|Overall Study||0
6755560|NCT03502941|7681926|FG002|NOT COMPLETED|Overall Study||0
6755561|NCT03503162|7681934|FG000|STARTED|Overall Study||95
6755562|NCT03503162|7681934|FG000|COMPLETED|Overall Study||94
6755563|NCT03503162|7681934|FG000|NOT COMPLETED|Overall Study||1
6755564|NCT03503188|7681940|FG000|STARTED|Overall Study||128
6755565|NCT03503188|7681941|FG001|STARTED|Overall Study||146
6755566|NCT03503188|7681940|FG000|Entered in the Entire Study|Overall Study||128
6755567|NCT03503188|7681941|FG001|Entered in the Entire Study|Overall Study||145
6755568|NCT03503188|7681940|FG000|Main Study|Overall Study||99
6755569|NCT03503188|7681941|FG001|Main Study|Overall Study||101
6755570|NCT03503188|7681940|FG000|Sub-study|Overall Study||29
6755571|NCT03503188|7681941|FG001|Sub-study|Overall Study||44
6755572|NCT03503188|7681940|FG000|COMPLETED|Overall Study||128
6755573|NCT03503188|7681941|FG001|COMPLETED|Overall Study||145
6755574|NCT03503188|7681940|FG000|NOT COMPLETED|Overall Study||0
6755575|NCT03503188|7681941|FG001|NOT COMPLETED|Overall Study||1
6755576|NCT03503292|7681949|FG000|STARTED|Overall Study||2
6755577|NCT03503292|7681950|FG001|STARTED|Overall Study||90
6755578|NCT03503292|7681949|FG000|COMPLETED|Overall Study||2
6755579|NCT03503292|7681950|FG001|COMPLETED|Overall Study||90
6555713|NCT01753830|7477884|FG000|COMPLETED|Overall Study||30
6755580|NCT03503292|7681949|FG000|NOT COMPLETED|Overall Study||0
6755581|NCT03503292|7681950|FG001|NOT COMPLETED|Overall Study||0
6755582|NCT03503565|7681958|FG000|STARTED|Overall Study||59
6755583|NCT03503565|7681959|FG001|STARTED|Overall Study||58
6755584|NCT03503565|7681958|FG000|COMPLETED|Overall Study||59
6755585|NCT03503565|7681959|FG001|COMPLETED|Overall Study||58
6755586|NCT03503565|7681958|FG000|NOT COMPLETED|Overall Study||0
6755587|NCT03503565|7681959|FG001|NOT COMPLETED|Overall Study||0
6755588|NCT03503578|7681965|FG000|STARTED|Overall Study||12
6755589|NCT03503578|7681965|FG000|COMPLETED|Overall Study||12
6755590|NCT03503578|7681965|FG000|NOT COMPLETED|Overall Study||0
6755591|NCT03504189|7681969|FG000|STARTED|Overall Study||151
6755592|NCT03504189|7681969|FG000|COMPLETED|Overall Study||147
6755593|NCT03504189|7681969|FG000|NOT COMPLETED|Overall Study||4
6755594|NCT03504839|7681978|FG000|STARTED|Overall Study||53
6755595|NCT03504839|7681978|FG000|COMPLETED|Overall Study||49
6755596|NCT03504839|7681978|FG000|NOT COMPLETED|Overall Study||4
6755597|NCT03504852|7681985|FG000|STARTED|Overall Study||165
6755598|NCT03504852|7681986|FG001|STARTED|Overall Study||135
6755599|NCT03504852|7681987|FG002|STARTED|Overall Study||31
6755600|NCT03504852|7681985|FG000|COMPLETED|Overall Study||148
6755601|NCT03504852|7681986|FG001|COMPLETED|Overall Study||117
6755602|NCT03504852|7681987|FG002|COMPLETED|Overall Study||28
6755603|NCT03504852|7681985|FG000|NOT COMPLETED|Overall Study||17
6755604|NCT03504852|7681986|FG001|NOT COMPLETED|Overall Study||18
6755605|NCT03504852|7681987|FG002|NOT COMPLETED|Overall Study||3
6755606|NCT03504917|7681999|FG000|STARTED|Blinded Treatment Period||163
6755607|NCT03504917|7682000|FG001|STARTED|Blinded Treatment Period||158
6755608|NCT03504917|7681999|FG000|COMPLETED|Blinded Treatment Period||103
6755609|NCT03504917|7682000|FG001|COMPLETED|Blinded Treatment Period||102
6755610|NCT03504917|7681999|FG000|NOT COMPLETED|Blinded Treatment Period||60
6755611|NCT03504917|7682000|FG001|NOT COMPLETED|Blinded Treatment Period||56
6755612|NCT03504917|7681999|FG000|STARTED|Open Label Extension Treatment Period||100
6755613|NCT03504917|7682000|FG001|STARTED|Open Label Extension Treatment Period||97
6755614|NCT03504917|7681999|FG000|COMPLETED|Open Label Extension Treatment Period||0
6755615|NCT03504917|7682000|FG001|COMPLETED|Open Label Extension Treatment Period||0
6755616|NCT03504917|7681999|FG000|NOT COMPLETED|Open Label Extension Treatment Period||100
6755617|NCT03504917|7682000|FG001|NOT COMPLETED|Open Label Extension Treatment Period||97
6755618|NCT03505021|7682014|FG000|STARTED|Overall Study||329
6755619|NCT03505021|7682015|FG001|STARTED|Overall Study||167
6755620|NCT03505021|7682014|FG000|COMPLETED|Overall Study||217
6755621|NCT03505021|7682015|FG001|COMPLETED|Overall Study||112
6755622|NCT03505021|7682014|FG000|NOT COMPLETED|Overall Study||112
6755623|NCT03505021|7682015|FG001|NOT COMPLETED|Overall Study||55
6755624|NCT03505190|7682026|FG000|STARTED|Overall Study||9
6755625|NCT03505190|7682027|FG001|STARTED|Overall Study||8
6755626|NCT03505190|7682028|FG002|STARTED|Overall Study||8
6755627|NCT03505190|7682029|FG003|STARTED|Overall Study||8
6755628|NCT03505190|7682030|FG004|STARTED|Overall Study||8
6755629|NCT03505190|7682026|FG000|COMPLETED|Overall Study||9
6755630|NCT03505190|7682027|FG001|COMPLETED|Overall Study||8
6755631|NCT03505190|7682028|FG002|COMPLETED|Overall Study||8
6755632|NCT03505190|7682029|FG003|COMPLETED|Overall Study||8
6755633|NCT03505190|7682030|FG004|COMPLETED|Overall Study||8
6755634|NCT03505190|7682026|FG000|NOT COMPLETED|Overall Study||0
6755635|NCT03505190|7682027|FG001|NOT COMPLETED|Overall Study||0
6755636|NCT03505190|7682028|FG002|NOT COMPLETED|Overall Study||0
6755637|NCT03505190|7682029|FG003|NOT COMPLETED|Overall Study||0
6755638|NCT03505190|7682030|FG004|NOT COMPLETED|Overall Study||0
6755639|NCT03505593|7682042|FG000|STARTED|Overall Study||48
6755640|NCT03505593|7682042|FG000|COMPLETED|Overall Study||43
6755641|NCT03505593|7682042|FG000|NOT COMPLETED|Overall Study||5
6755642|NCT03506295|7682046|FG000|STARTED|Overall Study||10
6755643|NCT03506295|7682046|FG000|COMPLETED|Overall Study||10
6755644|NCT03506295|7682046|FG000|NOT COMPLETED|Overall Study||0
6755645|NCT03506347|7682054|FG000|STARTED|Overall Study||12
6755646|NCT03506347|7682055|FG001|STARTED|Overall Study||12
6755647|NCT03506347|7682054|FG000|COMPLETED|Overall Study||12
6755648|NCT03506347|7682055|FG001|COMPLETED|Overall Study||12
6755649|NCT03506347|7682054|FG000|NOT COMPLETED|Overall Study||0
6755650|NCT03506347|7682055|FG001|NOT COMPLETED|Overall Study||0
6755651|NCT03506386|7682061|FG000|STARTED|Overall Study||943
6755652|NCT03506386|7682061|FG000|COMPLETED|Overall Study||943
6755653|NCT03506386|7682061|FG000|NOT COMPLETED|Overall Study||0
6755654|NCT03506425|7682068|FG000|STARTED|Overall Study||5
6755655|NCT03506425|7682069|FG001|STARTED|Overall Study||5
6755656|NCT03506425|7682070|FG002|STARTED|Overall Study||5
6755657|NCT03506425|7682068|FG000|COMPLETED|Overall Study||3
6755658|NCT03506425|7682069|FG001|COMPLETED|Overall Study||2
6755659|NCT03506425|7682070|FG002|COMPLETED|Overall Study||4
6755660|NCT03506425|7682068|FG000|NOT COMPLETED|Overall Study||2
6755661|NCT03506425|7682069|FG001|NOT COMPLETED|Overall Study||3
6755662|NCT03506425|7682070|FG002|NOT COMPLETED|Overall Study||1
6755663|NCT03506477|7682081|FG000|STARTED|Overall Study||20
6755664|NCT03506477|7682082|FG001|STARTED|Overall Study||5
6755665|NCT03506477|7682081|FG000|COMPLETED|Overall Study||19
6755666|NCT03506477|7682082|FG001|COMPLETED|Overall Study||5
6755667|NCT03506477|7682081|FG000|NOT COMPLETED|Overall Study||1
6755668|NCT03506477|7682082|FG001|NOT COMPLETED|Overall Study||0
6755669|NCT03506724|7682090|FG000|STARTED|Overall Study||54
6755670|NCT03506724|7682091|FG001|STARTED|Overall Study||55
6755671|NCT03506724|7682090|FG000|COMPLETED|Overall Study||54
6755672|NCT03506724|7682091|FG001|COMPLETED|Overall Study||55
6755673|NCT03506724|7682090|FG000|NOT COMPLETED|Overall Study||0
6755674|NCT03506724|7682091|FG001|NOT COMPLETED|Overall Study||0
6755675|NCT03507036|7682097|FG000|STARTED|Overall Study||20
6755676|NCT03507036|7682097|FG000|COMPLETED|Overall Study||15
6755677|NCT03507036|7682097|FG000|NOT COMPLETED|Overall Study||5
6755678|NCT03507569|7682108|FG000|STARTED|Overall Study||2
6755679|NCT03507569|7682109|FG001|STARTED|Overall Study||1
6755680|NCT03507569|7682110|FG002|STARTED|Overall Study||2
6755681|NCT03507569|7682111|FG003|STARTED|Overall Study||1
6755682|NCT03507569|7682108|FG000|COMPLETED|Overall Study||2
6755683|NCT03507569|7682109|FG001|COMPLETED|Overall Study||1
6755684|NCT03507569|7682110|FG002|COMPLETED|Overall Study||2
6755685|NCT03507569|7682111|FG003|COMPLETED|Overall Study||1
6755686|NCT03507569|7682108|FG000|NOT COMPLETED|Overall Study||0
6755687|NCT03507569|7682109|FG001|NOT COMPLETED|Overall Study||0
6755688|NCT03507569|7682110|FG002|NOT COMPLETED|Overall Study||0
6755689|NCT03507569|7682111|FG003|NOT COMPLETED|Overall Study||0
6755690|NCT03508050|7682123|FG000|STARTED|Overall Study||20
6755691|NCT03508050|7682124|FG001|STARTED|Overall Study||17
6755692|NCT03508050|7682123|FG000|COMPLETED|Overall Study||15
6755693|NCT03508050|7682124|FG001|COMPLETED|Overall Study||15
6755694|NCT03508050|7682123|FG000|NOT COMPLETED|Overall Study||5
6755695|NCT03508050|7682124|FG001|NOT COMPLETED|Overall Study||2
6755696|NCT03508609|7682131|FG000|STARTED|Overall Study||20
6755697|NCT03508609|7682131|FG000|COMPLETED|Overall Study||19
6755698|NCT03508609|7682131|FG000|NOT COMPLETED|Overall Study||1
6755699|NCT03508661|7682135|FG000|STARTED|Overall Study||10
6755700|NCT03508661|7682135|FG000|COMPLETED|Overall Study||10
6755701|NCT03508661|7682135|FG000|NOT COMPLETED|Overall Study||0
6755702|NCT03508687|7682141|FG000|STARTED|Overall Study||2
6755703|NCT03508687|7682142|FG001|STARTED|Overall Study||3
6755704|NCT03508687|7682141|FG000|COMPLETED|Overall Study||2
6755705|NCT03508687|7682142|FG001|COMPLETED|Overall Study||3
6755706|NCT03508687|7682141|FG000|NOT COMPLETED|Overall Study||0
6755707|NCT03508687|7682142|FG001|NOT COMPLETED|Overall Study||0
6755708|NCT03508830|7682152|FG000|STARTED|Overall Study||46
6755709|NCT03508830|7682153|FG001|STARTED|Overall Study||45
6755710|NCT03508830|7682152|FG000|COMPLETED|Overall Study||41
6755711|NCT03508830|7682153|FG001|COMPLETED|Overall Study||39
6755712|NCT03508830|7682152|FG000|NOT COMPLETED|Overall Study||5
6755713|NCT03508830|7682153|FG001|NOT COMPLETED|Overall Study||6
6755714|NCT03508843|7682159|FG000|STARTED|Overall Study||150
6755715|NCT03508843|7682159|FG000|COMPLETED|Overall Study||147
6755716|NCT03508843|7682159|FG000|NOT COMPLETED|Overall Study||3
6755717|NCT03509350|7682165|FG000|STARTED|Overall Study||252
6755718|NCT03509350|7682166|FG001|STARTED|Overall Study||249
6755719|NCT03509350|7682165|FG000|COMPLETED|Overall Study||252
6755720|NCT03509350|7682166|FG001|COMPLETED|Overall Study||247
6755721|NCT03509350|7682165|FG000|NOT COMPLETED|Overall Study||0
6755722|NCT03509350|7682166|FG001|NOT COMPLETED|Overall Study||2
6755723|NCT03509675|7682174|FG000|STARTED|First Intervention (7 Days)||11
6755724|NCT03509675|7682175|FG001|STARTED|First Intervention (7 Days)||12
6755725|NCT03509675|7682174|FG000|COMPLETED|First Intervention (7 Days)||6
6755726|NCT03509675|7682175|FG001|COMPLETED|First Intervention (7 Days)||8
6755727|NCT03509675|7682174|FG000|NOT COMPLETED|First Intervention (7 Days)||5
6755728|NCT03509675|7682175|FG001|NOT COMPLETED|First Intervention (7 Days)||4
6755729|NCT03509675|7682174|FG000|STARTED|Washout Period (7 Days)||6
6755730|NCT03509675|7682175|FG001|STARTED|Washout Period (7 Days)||8
6755731|NCT03509675|7682174|FG000|COMPLETED|Washout Period (7 Days)||6
6755732|NCT03509675|7682175|FG001|COMPLETED|Washout Period (7 Days)||8
6755733|NCT03509675|7682174|FG000|NOT COMPLETED|Washout Period (7 Days)||0
6755734|NCT03509675|7682175|FG001|NOT COMPLETED|Washout Period (7 Days)||0
6755735|NCT03509675|7682174|FG000|STARTED|Second Intervention )7 Days)||6
6755736|NCT03509675|7682175|FG001|STARTED|Second Intervention )7 Days)||8
6755737|NCT03509675|7682174|FG000|COMPLETED|Second Intervention )7 Days)||4
6755738|NCT03509675|7682175|FG001|COMPLETED|Second Intervention )7 Days)||8
6755739|NCT03509675|7682174|FG000|NOT COMPLETED|Second Intervention )7 Days)||2
6755740|NCT03509675|7682175|FG001|NOT COMPLETED|Second Intervention )7 Days)||0
6755741|NCT03509766|7682181|FG000|STARTED|Overall Study||24
6755742|NCT03509766|7682181|FG000|COMPLETED|Overall Study||24
6755743|NCT03509766|7682181|FG000|NOT COMPLETED|Overall Study||0
6755744|NCT03509883|7682188|FG000|STARTED|Initial Treatment||15
6755745|NCT03509883|7682189|FG001|STARTED|Initial Treatment||15
6755746|NCT03509883|7682188|FG000|COMPLETED|Initial Treatment||15
6755747|NCT03509883|7682189|FG001|COMPLETED|Initial Treatment||15
6755748|NCT03509883|7682188|FG000|NOT COMPLETED|Initial Treatment||0
6755749|NCT03509883|7682189|FG001|NOT COMPLETED|Initial Treatment||0
6755750|NCT03509883|7682188|FG000|STARTED|Initial Treatment Washout||15
6755751|NCT03509883|7682189|FG001|STARTED|Initial Treatment Washout||15
6755752|NCT03509883|7682188|FG000|COMPLETED|Initial Treatment Washout||15
6755753|NCT03509883|7682189|FG001|COMPLETED|Initial Treatment Washout||15
6755754|NCT03509883|7682188|FG000|NOT COMPLETED|Initial Treatment Washout||0
6755755|NCT03509883|7682189|FG001|NOT COMPLETED|Initial Treatment Washout||0
6755756|NCT03509883|7682188|FG000|STARTED|Cross-over and Treatment||15
6755757|NCT03509883|7682189|FG001|STARTED|Cross-over and Treatment||15
6755758|NCT03509883|7682188|FG000|COMPLETED|Cross-over and Treatment||15
6755759|NCT03509883|7682189|FG001|COMPLETED|Cross-over and Treatment||15
6755760|NCT03509883|7682188|FG000|NOT COMPLETED|Cross-over and Treatment||0
6755761|NCT03509883|7682189|FG001|NOT COMPLETED|Cross-over and Treatment||0
6755762|NCT03509948|7682196|FG000|STARTED|Overall Study||6
6755763|NCT03509948|7682197|FG001|STARTED|Overall Study||7
6755764|NCT03509948|7682196|FG000|COMPLETED|Overall Study||6
6755765|NCT03509948|7682197|FG001|COMPLETED|Overall Study||6
6755766|NCT03509948|7682196|FG000|NOT COMPLETED|Overall Study||0
6755767|NCT03509948|7682197|FG001|NOT COMPLETED|Overall Study||1
6755768|NCT03509974|7682203|FG000|STARTED|Overall Study||14
6755769|NCT03509974|7682203|FG000|COMPLETED|Overall Study||14
6755770|NCT03509974|7682203|FG000|NOT COMPLETED|Overall Study||0
6755771|NCT03510182|7682207|FG000|STARTED|Overall Study||25
6755772|NCT03510182|7682207|FG000|COMPLETED|Overall Study||23
6755773|NCT03510182|7682207|FG000|NOT COMPLETED|Overall Study||2
6755774|NCT03510195|7682211|FG000|STARTED|Overall Study||267
6755775|NCT03510195|7682211|FG000|COMPLETED|Overall Study||101
6755776|NCT03510195|7682211|FG000|NOT COMPLETED|Overall Study||166
6755777|NCT03510273|7682225|FG000|STARTED|Overall Study||319
6755778|NCT03510273|7682225|FG000|Treated With Thermal Coagulation|Overall Study||319
6755779|NCT03510273|7682225|FG000|Completed 1-mth Follow-up Visit & Exited|Overall Study||192
6755780|NCT03510273|7682225|FG000|Completed 1-mth Follow-up Visit & Cont'd|Overall Study||126
6755781|NCT03510273|7682225|FG000|Completed All One-year Follow up Visits|Overall Study||118
6755782|NCT03510273|7682225|FG000|COMPLETED|Overall Study||310
6755783|NCT03510273|7682225|FG000|NOT COMPLETED|Overall Study||9
6755784|NCT03510455|7682233|FG000|STARTED|Overall Study||4
6755785|NCT03510455|7682233|FG000|Treated|Overall Study||4
6755786|NCT03510455|7682233|FG000|Extension Phase|Overall Study||1
6755787|NCT03510455|7682233|FG000|Screening Failures|Overall Study||0
6755788|NCT03510455|7682233|FG000|COMPLETED|Overall Study|3 of 4 patients completed the 24 week treatment phase of the study|3
6755789|NCT03510455|7682233|FG000|NOT COMPLETED|Overall Study||1
6755790|NCT03510481|7682243|FG000|STARTED|Year 1||69
6755791|NCT03510481|7682244|FG001|STARTED|Year 1||70
6755792|NCT03510481|7682245|FG002|STARTED|Year 1||36
6755793|NCT03510481|7682246|FG003|STARTED|Year 1||35
6755794|NCT03510481|7682243|FG000|COMPLETED|Year 1||56
6755795|NCT03510481|7682244|FG001|COMPLETED|Year 1||61
6755796|NCT03510481|7682245|FG002|COMPLETED|Year 1||34
6755797|NCT03510481|7682246|FG003|COMPLETED|Year 1||31
6755798|NCT03510481|7682243|FG000|NOT COMPLETED|Year 1||13
6755799|NCT03510481|7682244|FG001|NOT COMPLETED|Year 1||9
6755800|NCT03510481|7682245|FG002|NOT COMPLETED|Year 1||2
6755801|NCT03510481|7682246|FG003|NOT COMPLETED|Year 1||4
6755802|NCT03510481|7682243|FG000|STARTED|Year 2 - Booster Dose|10 participants who completed Period 1 did not re-consent for Period 2.|46
6755803|NCT03510481|7682244|FG001|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|52
6755804|NCT03510481|7682245|FG002|STARTED|Year 2 - Booster Dose|9 participants who completed Period 1 did not re-consent for Period 2.|25
6755805|NCT03510481|7682246|FG003|STARTED|Year 2 - Booster Dose|12 participants who completed Period 1 did not re-consent for Period 2.|19
6755806|NCT03510481|7682243|FG000|COMPLETED|Year 2 - Booster Dose||42
6755807|NCT03510481|7682244|FG001|COMPLETED|Year 2 - Booster Dose||49
6755808|NCT03510481|7682245|FG002|COMPLETED|Year 2 - Booster Dose||23
6755809|NCT03510481|7682246|FG003|COMPLETED|Year 2 - Booster Dose||18
6755810|NCT03510481|7682243|FG000|NOT COMPLETED|Year 2 - Booster Dose||4
6755811|NCT03510481|7682244|FG001|NOT COMPLETED|Year 2 - Booster Dose||3
6755812|NCT03510481|7682245|FG002|NOT COMPLETED|Year 2 - Booster Dose||2
6755813|NCT03510481|7682246|FG003|NOT COMPLETED|Year 2 - Booster Dose||1
6755814|NCT03510663|7682266|FG000|STARTED|Overall Study||6
6755815|NCT03510663|7682267|FG001|STARTED|Overall Study||6
6755816|NCT03510663|7682268|FG002|STARTED|Overall Study||6
6755817|NCT03510663|7682269|FG003|STARTED|Overall Study||6
6755818|NCT03510663|7682270|FG004|STARTED|Overall Study||6
6755819|NCT03510663|7682271|FG005|STARTED|Overall Study||6
6755820|NCT03510663|7682272|FG006|STARTED|Overall Study||6
6755821|NCT03510663|7682273|FG007|STARTED|Overall Study||6
6755822|NCT03510663|7682266|FG000|COMPLETED|Overall Study||6
6755823|NCT03510663|7682267|FG001|COMPLETED|Overall Study||5
6755824|NCT03510663|7682268|FG002|COMPLETED|Overall Study||6
6755825|NCT03510663|7682269|FG003|COMPLETED|Overall Study||6
6755826|NCT03510663|7682270|FG004|COMPLETED|Overall Study||6
6755827|NCT03510663|7682271|FG005|COMPLETED|Overall Study||6
6755828|NCT03510663|7682272|FG006|COMPLETED|Overall Study||6
6755829|NCT03510663|7682273|FG007|COMPLETED|Overall Study||6
6755830|NCT03510663|7682266|FG000|NOT COMPLETED|Overall Study||0
6755831|NCT03510663|7682267|FG001|NOT COMPLETED|Overall Study||1
6755832|NCT03510663|7682268|FG002|NOT COMPLETED|Overall Study||0
6755833|NCT03510663|7682269|FG003|NOT COMPLETED|Overall Study||0
6755834|NCT03510663|7682270|FG004|NOT COMPLETED|Overall Study||0
6755835|NCT03510663|7682271|FG005|NOT COMPLETED|Overall Study||0
6755836|NCT03510663|7682272|FG006|NOT COMPLETED|Overall Study||0
6755837|NCT03510663|7682273|FG007|NOT COMPLETED|Overall Study||0
6755838|NCT03510715|7682285|FG000|STARTED|Overall Study||9
6755839|NCT03510715|7682286|FG001|STARTED|Overall Study||9
6755840|NCT03510715|7682285|FG000|COMPLETED|Overall Study||8
6755841|NCT03510715|7682286|FG001|COMPLETED|Overall Study||9
6755842|NCT03510715|7682285|FG000|NOT COMPLETED|Overall Study||1
6755843|NCT03510715|7682286|FG001|NOT COMPLETED|Overall Study||0
6755844|NCT03510910|7682295|FG000|STARTED|Overall Study||42
6755845|NCT03510910|7682296|FG001|STARTED|Overall Study||43
6755846|NCT03510910|7682295|FG000|COMPLETED|Overall Study||40
6755847|NCT03510910|7682296|FG001|COMPLETED|Overall Study||40
6755848|NCT03510910|7682295|FG000|NOT COMPLETED|Overall Study||2
6755849|NCT03510910|7682296|FG001|NOT COMPLETED|Overall Study||3
6755850|NCT03511001|7682304|FG000|STARTED|Overall Study||126
6755851|NCT03511001|7682305|FG001|STARTED|Overall Study||61
6755852|NCT03511001|7682304|FG000|Completers Analyzed|Overall Study|1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.|114
6755853|NCT03511001|7682305|FG001|Completers Analyzed|Overall Study||61
6755854|NCT03511001|7682304|FG000|COMPLETED|Overall Study||115
6755855|NCT03511001|7682305|FG001|COMPLETED|Overall Study||54
6755856|NCT03511001|7682304|FG000|NOT COMPLETED|Overall Study||11
6755857|NCT03511001|7682305|FG001|NOT COMPLETED|Overall Study||7
6755858|NCT03511053|7682311|FG000|STARTED|Overall Study||11
6755859|NCT03511053|7682311|FG000|COMPLETED|Overall Study||10
6755860|NCT03511053|7682311|FG000|NOT COMPLETED|Overall Study||1
6755861|NCT03511105|7682317|FG000|STARTED|Overall Study||25
6755862|NCT03511105|7682318|FG001|STARTED|Overall Study||22
6755863|NCT03511105|7682317|FG000|COMPLETED|Overall Study||23
6755864|NCT03511105|7682318|FG001|COMPLETED|Overall Study||22
6755865|NCT03511105|7682317|FG000|NOT COMPLETED|Overall Study||2
6755866|NCT03511105|7682318|FG001|NOT COMPLETED|Overall Study||0
6755867|NCT03511326|7682325|FG000|STARTED|Overall Study||50
6755868|NCT03511326|7682325|FG000|COMPLETED|Overall Study||49
6755869|NCT03511326|7682325|FG000|NOT COMPLETED|Overall Study||1
6755870|NCT03511378|7682331|FG000|STARTED|Overall Study||70
6755871|NCT03511378|7682332|FG001|STARTED|Overall Study||68
6755872|NCT03511378|7682331|FG000|COMPLETED|Overall Study||67
6755873|NCT03511378|7682332|FG001|COMPLETED|Overall Study||66
6755874|NCT03511378|7682331|FG000|NOT COMPLETED|Overall Study||3
6755875|NCT03511378|7682332|FG001|NOT COMPLETED|Overall Study||2
6755876|NCT03511521|7682340|FG000|STARTED|Overall Study||2
6755877|NCT03511521|7682341|FG001|STARTED|Overall Study||1
6755878|NCT03511521|7682340|FG000|COMPLETED|Overall Study||2
6755879|NCT03511521|7682341|FG001|COMPLETED|Overall Study||1
6755880|NCT03511521|7682340|FG000|NOT COMPLETED|Overall Study||0
6755881|NCT03511521|7682341|FG001|NOT COMPLETED|Overall Study||0
6755882|NCT03511638|7682349|FG000|STARTED|Overall Study||184
6755883|NCT03511638|7682350|FG001|STARTED|Overall Study||188
6755884|NCT03511638|7682349|FG000|COMPLETED|Overall Study||182
6755885|NCT03511638|7682350|FG001|COMPLETED|Overall Study||187
6755886|NCT03511638|7682349|FG000|NOT COMPLETED|Overall Study||2
6755887|NCT03511638|7682350|FG001|NOT COMPLETED|Overall Study||1
6755888|NCT03511937|7682358|FG000|STARTED|Overall Study||200
6755889|NCT03511937|7682359|FG001|STARTED|Overall Study||200
6755890|NCT03511937|7682358|FG000|COMPLETED|Overall Study||200
6755891|NCT03511937|7682359|FG001|COMPLETED|Overall Study||200
6755892|NCT03511937|7682358|FG000|NOT COMPLETED|Overall Study||0
6755893|NCT03511937|7682359|FG001|NOT COMPLETED|Overall Study||0
6755894|NCT03512028|7682369|FG000|STARTED|Overall Study||19
6755895|NCT03512028|7682370|FG001|STARTED|Overall Study||15
6755896|NCT03512028|7682369|FG000|COMPLETED|Overall Study||15
6755897|NCT03512028|7682370|FG001|COMPLETED|Overall Study||15
6755898|NCT03512028|7682369|FG000|NOT COMPLETED|Overall Study||4
6755899|NCT03512028|7682370|FG001|NOT COMPLETED|Overall Study||0
6755900|NCT03512041|7682380|FG000|STARTED|Overall Study||10
6755901|NCT03512041|7682381|FG001|STARTED|Overall Study||10
6755902|NCT03512041|7682382|FG002|STARTED|Overall Study||11
6755903|NCT03512041|7682383|FG003|STARTED|Overall Study||9
6755904|NCT03512041|7682380|FG000|COMPLETED|Overall Study||10
6755905|NCT03512041|7682381|FG001|COMPLETED|Overall Study||10
6755906|NCT03512041|7682382|FG002|COMPLETED|Overall Study||11
6755907|NCT03512041|7682383|FG003|COMPLETED|Overall Study||9
6755908|NCT03512041|7682380|FG000|NOT COMPLETED|Overall Study||0
6755909|NCT03512041|7682381|FG001|NOT COMPLETED|Overall Study||0
6755910|NCT03512041|7682382|FG002|NOT COMPLETED|Overall Study||0
6755911|NCT03512041|7682383|FG003|NOT COMPLETED|Overall Study||0
6755912|NCT03512067|7682393|FG000|STARTED|Overall Study||1
6755913|NCT03512067|7682393|FG000|COMPLETED|Overall Study||1
6755914|NCT03512067|7682393|FG000|NOT COMPLETED|Overall Study||0
6755915|NCT03512288|7682399|FG000|STARTED|Overall Study||232
6755916|NCT03512288|7682400|FG001|STARTED|Overall Study||228
6755917|NCT03512288|7682399|FG000|Vaccination 1|Overall Study||231
6755918|NCT03512288|7682400|FG001|Vaccination 1|Overall Study||227
6755919|NCT03512288|7682399|FG000|Vaccination 2|Overall Study||222
6755920|NCT03512288|7682400|FG001|Vaccination 2|Overall Study||213
6755921|NCT03512288|7682399|FG000|Vaccination 3|Overall Study||210
6755922|NCT03512288|7682400|FG001|Vaccination 3|Overall Study||206
6755923|NCT03512288|7682399|FG000|Vaccination 4|Overall Study||197
6755924|NCT03512288|7682400|FG001|Vaccination 4|Overall Study||194
6755925|NCT03512288|7682399|FG000|COMPLETED|Overall Study||191
6755926|NCT03512288|7682400|FG001|COMPLETED|Overall Study||185
6755927|NCT03512288|7682399|FG000|NOT COMPLETED|Overall Study||41
6755928|NCT03512288|7682400|FG001|NOT COMPLETED|Overall Study||43
6755929|NCT03512353|7682406|FG000|STARTED|Overall Study||7
6755930|NCT03512353|7682406|FG000|Received Treatment|Overall Study||6
6755931|NCT03512353|7682406|FG000|COMPLETED|Overall Study||3
6755932|NCT03512353|7682406|FG000|NOT COMPLETED|Overall Study||4
6755933|NCT03512457|7682414|FG000|STARTED|Overall Study||195
6755934|NCT03512457|7682415|FG001|STARTED|Overall Study||225
6755935|NCT03512457|7682414|FG000|COMPLETED|Overall Study||161
6755936|NCT03512457|7682415|FG001|COMPLETED|Overall Study||185
6755937|NCT03512457|7682414|FG000|NOT COMPLETED|Overall Study||34
6755938|NCT03512457|7682415|FG001|NOT COMPLETED|Overall Study||40
6755939|NCT03513588|7682426|FG000|STARTED|Overall Study||16
6755940|NCT03513588|7682427|FG001|STARTED|Overall Study||17
6755941|NCT03513588|7682428|FG002|STARTED|Overall Study||15
6755942|NCT03513588|7682426|FG000|COMPLETED|Overall Study||15
6755943|NCT03513588|7682427|FG001|COMPLETED|Overall Study||15
6755944|NCT03513588|7682428|FG002|COMPLETED|Overall Study||13
6755945|NCT03513588|7682426|FG000|NOT COMPLETED|Overall Study||1
6755946|NCT03513588|7682427|FG001|NOT COMPLETED|Overall Study||2
6755947|NCT03513588|7682428|FG002|NOT COMPLETED|Overall Study||2
6755948|NCT03513757|7682440|FG000|STARTED|Overall Study||22
6755949|NCT03513757|7682441|FG001|STARTED|Overall Study||18
6755950|NCT03513757|7682440|FG000|COMPLETED|Overall Study||22
6755951|NCT03513757|7682441|FG001|COMPLETED|Overall Study||18
6755952|NCT03513757|7682440|FG000|NOT COMPLETED|Overall Study||0
6755953|NCT03513757|7682441|FG001|NOT COMPLETED|Overall Study||0
6755954|NCT03513848|7682452|FG000|STARTED|Overall Study||9
6755955|NCT03513848|7682453|FG001|STARTED|Overall Study||6
6755956|NCT03513848|7682452|FG000|COMPLETED|Overall Study||9
6755957|NCT03513848|7682453|FG001|COMPLETED|Overall Study||6
6755958|NCT03513848|7682452|FG000|NOT COMPLETED|Overall Study||0
6755959|NCT03513848|7682453|FG001|NOT COMPLETED|Overall Study||0
6755960|NCT03514277|7682462|FG000|STARTED|Overall Study||11
6755961|NCT03514277|7682463|FG001|STARTED|Overall Study||4
6755962|NCT03514277|7682464|FG002|STARTED|Overall Study||4
6755963|NCT03514277|7682462|FG000|COMPLETED|Overall Study||11
6755964|NCT03514277|7682463|FG001|COMPLETED|Overall Study||4
6755965|NCT03514277|7682464|FG002|COMPLETED|Overall Study||4
6755966|NCT03514277|7682462|FG000|NOT COMPLETED|Overall Study||0
6755967|NCT03514277|7682463|FG001|NOT COMPLETED|Overall Study||0
6755968|NCT03514277|7682464|FG002|NOT COMPLETED|Overall Study||0
6755969|NCT03514420|7682472|FG000|STARTED|Overall Study||4
6755970|NCT03514420|7682472|FG000|COMPLETED|Overall Study||4
6755971|NCT03514420|7682472|FG000|NOT COMPLETED|Overall Study||0
6755972|NCT03514641|7682480|FG000|STARTED|603A: 0-12 Week Study Period||334
6755973|NCT03514641|7682481|FG001|STARTED|603A: 0-12 Week Study Period||339
6755974|NCT03514641|7682482|FG002|STARTED|603A: 0-12 Week Study Period||0
6755975|NCT03514641|7682483|FG003|STARTED|603A: 0-12 Week Study Period||0
6755976|NCT03514641|7682480|FG000|COMPLETED|603A: 0-12 Week Study Period||307
6755977|NCT03514641|7682481|FG001|COMPLETED|603A: 0-12 Week Study Period||319
6755978|NCT03514641|7682482|FG002|COMPLETED|603A: 0-12 Week Study Period||0
6755979|NCT03514641|7682483|FG003|COMPLETED|603A: 0-12 Week Study Period||0
6755980|NCT03514641|7682480|FG000|NOT COMPLETED|603A: 0-12 Week Study Period||27
6755981|NCT03514641|7682481|FG001|NOT COMPLETED|603A: 0-12 Week Study Period||20
6755982|NCT03514641|7682482|FG002|NOT COMPLETED|603A: 0-12 Week Study Period||0
6755983|NCT03514641|7682483|FG003|NOT COMPLETED|603A: 0-12 Week Study Period||0
6755984|NCT03514641|7682480|FG000|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
6755985|NCT03514641|7682481|FG001|STARTED|603B: 24-36 Week Study Period|The second part of study only applies to subjects in 603B|0
6755986|NCT03514641|7682482|FG002|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
6755987|NCT03514641|7682483|FG003|STARTED|603B: 24-36 Week Study Period|The subjects were re-randomized in 603B|281
6755988|NCT03514641|7682480|FG000|COMPLETED|603B: 24-36 Week Study Period||0
6755989|NCT03514641|7682481|FG001|COMPLETED|603B: 24-36 Week Study Period||0
6555714|NCT01753830|7477885|FG001|COMPLETED|Overall Study||35
6555715|NCT01753830|7477884|FG000|NOT COMPLETED|Overall Study||7
6555716|NCT01753830|7477885|FG001|NOT COMPLETED|Overall Study||3
6755990|NCT03514641|7682482|FG002|COMPLETED|603B: 24-36 Week Study Period||267
6755991|NCT03514641|7682483|FG003|COMPLETED|603B: 24-36 Week Study Period||266
6755992|NCT03514641|7682480|FG000|NOT COMPLETED|603B: 24-36 Week Study Period||0
6755993|NCT03514641|7682481|FG001|NOT COMPLETED|603B: 24-36 Week Study Period||0
6755994|NCT03514641|7682482|FG002|NOT COMPLETED|603B: 24-36 Week Study Period||14
6755995|NCT03514641|7682483|FG003|NOT COMPLETED|603B: 24-36 Week Study Period||15
6755996|NCT03514966|7682497|FG000|STARTED|Overall Study||40
6755997|NCT03514966|7682498|FG001|STARTED|Overall Study||43
6755998|NCT03514966|7682497|FG000|COMPLETED|Overall Study||40
6755999|NCT03514966|7682498|FG001|COMPLETED|Overall Study||43
6756000|NCT03514966|7682497|FG000|NOT COMPLETED|Overall Study||0
6756001|NCT03514966|7682498|FG001|NOT COMPLETED|Overall Study||0
6756002|NCT03515681|7682506|FG000|STARTED|Overall Study||70
6756003|NCT03515681|7682507|FG001|STARTED|Overall Study||70
6756004|NCT03515681|7682506|FG000|Randomized|Overall Study||70
6756005|NCT03515681|7682507|FG001|Randomized|Overall Study||70
6756006|NCT03515681|7682506|FG000|Completed at 6 Months|Overall Study||61
6756007|NCT03515681|7682507|FG001|Completed at 6 Months|Overall Study||62
6756008|NCT03515681|7682506|FG000|COMPLETED|Overall Study||37
6756009|NCT03515681|7682507|FG001|COMPLETED|Overall Study||25
6756010|NCT03515681|7682506|FG000|NOT COMPLETED|Overall Study||33
6756011|NCT03515681|7682507|FG001|NOT COMPLETED|Overall Study||45
6756012|NCT03515824|7682516|FG000|STARTED|Overall Study||3
6756013|NCT03515824|7682517|FG001|STARTED|Overall Study||4
6756014|NCT03515824|7682518|FG002|STARTED|Overall Study||15
6756015|NCT03515824|7682519|FG003|STARTED|Overall Study||0
6756016|NCT03515824|7682516|FG000|COMPLETED|Overall Study||0
6756017|NCT03515824|7682517|FG001|COMPLETED|Overall Study||0
6756018|NCT03515824|7682518|FG002|COMPLETED|Overall Study||0
6756019|NCT03515824|7682519|FG003|COMPLETED|Overall Study||0
6756020|NCT03515824|7682516|FG000|NOT COMPLETED|Overall Study||3
6756021|NCT03515824|7682517|FG001|NOT COMPLETED|Overall Study||4
6555717|NCT01753856|7477893|FG000|STARTED|Overall Study||33
6555718|NCT01753856|7477894|FG001|STARTED|Overall Study||36
6756022|NCT03515824|7682518|FG002|NOT COMPLETED|Overall Study||15
6756023|NCT03515824|7682519|FG003|NOT COMPLETED|Overall Study||0
6756024|NCT03515941|7682529|FG000|STARTED|Overall Study||4
6756025|NCT03515941|7682530|FG001|STARTED|Overall Study||2
6756026|NCT03515941|7682529|FG000|COMPLETED|Overall Study||3
6756027|NCT03515941|7682530|FG001|COMPLETED|Overall Study||2
6756028|NCT03515941|7682529|FG000|NOT COMPLETED|Overall Study||1
6756029|NCT03515941|7682530|FG001|NOT COMPLETED|Overall Study||0
6756030|NCT03516227|7682538|FG000|STARTED|Overall Study||20
6756031|NCT03516227|7682539|FG001|STARTED|Overall Study||20
6756032|NCT03516227|7682538|FG000|COMPLETED|Overall Study||19
6756033|NCT03516227|7682539|FG001|COMPLETED|Overall Study||16
6756034|NCT03516227|7682538|FG000|NOT COMPLETED|Overall Study||1
6756035|NCT03516227|7682539|FG001|NOT COMPLETED|Overall Study||4
6756036|NCT03517436|7682546|FG000|STARTED|Overall Study||101
6756037|NCT03517436|7682546|FG000|COMPLETED|Overall Study||93
6756038|NCT03517436|7682546|FG000|NOT COMPLETED|Overall Study||8
6756039|NCT03517566|7682555|FG000|STARTED|Overall Study||74
6756040|NCT03517566|7682556|FG001|STARTED|Overall Study||37
6756041|NCT03517566|7682557|FG002|STARTED|Overall Study||36
6756042|NCT03517566|7682558|FG003|STARTED|Overall Study||73
6756043|NCT03517566|7682559|FG004|STARTED|Overall Study||73
6756044|NCT03517566|7682555|FG000|COMPLETED|Overall Study||42
6756045|NCT03517566|7682556|FG001|COMPLETED|Overall Study||16
6756046|NCT03517566|7682557|FG002|COMPLETED|Overall Study||21
6756047|NCT03517566|7682558|FG003|COMPLETED|Overall Study||39
6756048|NCT03517566|7682559|FG004|COMPLETED|Overall Study||41
6756049|NCT03517566|7682555|FG000|NOT COMPLETED|Overall Study||32
6756050|NCT03517566|7682556|FG001|NOT COMPLETED|Overall Study||21
6756051|NCT03517566|7682557|FG002|NOT COMPLETED|Overall Study||15
6756052|NCT03517566|7682558|FG003|NOT COMPLETED|Overall Study||34
6756053|NCT03517566|7682559|FG004|NOT COMPLETED|Overall Study||32
6756054|NCT03518008|7682572|FG000|STARTED|Period 1, First Week of Wear||11
6756055|NCT03518008|7682573|FG001|STARTED|Period 1, First Week of Wear||11
6756056|NCT03518008|7682572|FG000|COMPLETED|Period 1, First Week of Wear||11
6756057|NCT03518008|7682573|FG001|COMPLETED|Period 1, First Week of Wear||11
6756058|NCT03518008|7682572|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
6756059|NCT03518008|7682573|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
6756060|NCT03518008|7682572|FG000|STARTED|Period 2, Second Week of Wear||11
6756061|NCT03518008|7682573|FG001|STARTED|Period 2, Second Week of Wear||11
6756062|NCT03518008|7682572|FG000|COMPLETED|Period 2, Second Week of Wear||11
6756063|NCT03518008|7682573|FG001|COMPLETED|Period 2, Second Week of Wear||10
6756064|NCT03518008|7682572|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
6756065|NCT03518008|7682573|FG001|NOT COMPLETED|Period 2, Second Week of Wear||1
6756066|NCT03518125|7682585|FG000|STARTED|Overall Study||50
6756067|NCT03518125|7682586|FG001|STARTED|Overall Study||50
6756068|NCT03518125|7682587|FG002|STARTED|Overall Study||49
6756069|NCT03518125|7682588|FG003|STARTED|Overall Study||52
6756070|NCT03518125|7682589|FG004|STARTED|Overall Study||52
6756071|NCT03518125|7682590|FG005|STARTED|Overall Study||52
6756072|NCT03518125|7682585|FG000|COMPLETED|Overall Study||48
6756073|NCT03518125|7682586|FG001|COMPLETED|Overall Study||46
6756074|NCT03518125|7682587|FG002|COMPLETED|Overall Study||49
6756075|NCT03518125|7682588|FG003|COMPLETED|Overall Study||51
6756076|NCT03518125|7682589|FG004|COMPLETED|Overall Study||48
6756077|NCT03518125|7682590|FG005|COMPLETED|Overall Study||44
6756078|NCT03518125|7682585|FG000|NOT COMPLETED|Overall Study||2
6756079|NCT03518125|7682586|FG001|NOT COMPLETED|Overall Study||4
6756080|NCT03518125|7682587|FG002|NOT COMPLETED|Overall Study||0
6756081|NCT03518125|7682588|FG003|NOT COMPLETED|Overall Study||1
6756082|NCT03518125|7682589|FG004|NOT COMPLETED|Overall Study||4
6756083|NCT03518125|7682590|FG005|NOT COMPLETED|Overall Study||8
6756084|NCT03518658|7682607|FG000|STARTED|Overall Study|Number of patients completing device pairing survey|257
6756085|NCT03518658|7682608|FG001|STARTED|Overall Study||128607
6756086|NCT03518658|7682607|FG000|COMPLETED|Overall Study|Number of patients completing annual survey|206
6756087|NCT03518658|7682608|FG001|COMPLETED|Overall Study||128607
6756088|NCT03518658|7682607|FG000|NOT COMPLETED|Overall Study||51
6756089|NCT03518658|7682608|FG001|NOT COMPLETED|Overall Study||0
6756090|NCT03518840|7682616|FG000|STARTED|Overall Study||63
6756091|NCT03518840|7682616|FG000|COMPLETED|Overall Study||57
6756092|NCT03518840|7682616|FG000|NOT COMPLETED|Overall Study||6
6756093|NCT03519087|7682625|FG000|STARTED|Clinic Evaluation||55
6756094|NCT03519087|7682626|FG001|STARTED|Clinic Evaluation||57
6756095|NCT03519087|7682627|FG002|STARTED|Clinic Evaluation||0
6756096|NCT03519087|7682628|FG003|STARTED|Clinic Evaluation||0
6756097|NCT03519087|7682629|FG004|STARTED|Clinic Evaluation||0
6756098|NCT03519087|7682625|FG000|Received Assigned Intervention|Clinic Evaluation||54
6756099|NCT03519087|7682626|FG001|Received Assigned Intervention|Clinic Evaluation||57
6756100|NCT03519087|7682627|FG002|Received Assigned Intervention|Clinic Evaluation||0
6756101|NCT03519087|7682628|FG003|Received Assigned Intervention|Clinic Evaluation||0
6756102|NCT03519087|7682629|FG004|Received Assigned Intervention|Clinic Evaluation||0
6756103|NCT03519087|7682625|FG000|Confirmed Diagnosis by Physician|Clinic Evaluation||39
6756104|NCT03519087|7682626|FG001|Confirmed Diagnosis by Physician|Clinic Evaluation||39
6756105|NCT03519087|7682627|FG002|Confirmed Diagnosis by Physician|Clinic Evaluation||0
6756106|NCT03519087|7682628|FG003|Confirmed Diagnosis by Physician|Clinic Evaluation||0
6779993|NCT03457818|7708289|FG001|COMPLETED|Overall Study|study terminated|0
6756107|NCT03519087|7682629|FG004|Confirmed Diagnosis by Physician|Clinic Evaluation||0
6756108|NCT03519087|7682625|FG000|COMPLETED|Clinic Evaluation||39
6756109|NCT03519087|7682626|FG001|COMPLETED|Clinic Evaluation||39
6756110|NCT03519087|7682627|FG002|COMPLETED|Clinic Evaluation||0
6756111|NCT03519087|7682628|FG003|COMPLETED|Clinic Evaluation||0
6756112|NCT03519087|7682629|FG004|COMPLETED|Clinic Evaluation||0
6756113|NCT03519087|7682625|FG000|NOT COMPLETED|Clinic Evaluation||16
6756114|NCT03519087|7682626|FG001|NOT COMPLETED|Clinic Evaluation||18
6756115|NCT03519087|7682627|FG002|NOT COMPLETED|Clinic Evaluation||0
6756116|NCT03519087|7682628|FG003|NOT COMPLETED|Clinic Evaluation||0
6756117|NCT03519087|7682629|FG004|NOT COMPLETED|Clinic Evaluation||0
6756118|NCT03519087|7682625|FG000|STARTED|Re-randomization for Treatment||39
6756119|NCT03519087|7682626|FG001|STARTED|Re-randomization for Treatment||39
6756120|NCT03519087|7682627|FG002|STARTED|Re-randomization for Treatment||0
6756121|NCT03519087|7682628|FG003|STARTED|Re-randomization for Treatment||0
6756122|NCT03519087|7682629|FG004|STARTED|Re-randomization for Treatment||0
6756123|NCT03519087|7682625|FG000|COMPLETED|Re-randomization for Treatment||12
6756124|NCT03519087|7682626|FG001|COMPLETED|Re-randomization for Treatment||7
6756125|NCT03519087|7682627|FG002|COMPLETED|Re-randomization for Treatment||0
6756126|NCT03519087|7682628|FG003|COMPLETED|Re-randomization for Treatment||0
6756127|NCT03519087|7682629|FG004|COMPLETED|Re-randomization for Treatment||0
6756128|NCT03519087|7682625|FG000|NOT COMPLETED|Re-randomization for Treatment||27
6756129|NCT03519087|7682626|FG001|NOT COMPLETED|Re-randomization for Treatment||32
6756130|NCT03519087|7682627|FG002|NOT COMPLETED|Re-randomization for Treatment||0
6756131|NCT03519087|7682628|FG003|NOT COMPLETED|Re-randomization for Treatment||0
6756132|NCT03519087|7682629|FG004|NOT COMPLETED|Re-randomization for Treatment||0
6756133|NCT03519087|7682625|FG000|STARTED|Laboratory Testing||0
6756134|NCT03519087|7682626|FG001|STARTED|Laboratory Testing||0
6756135|NCT03519087|7682627|FG002|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
6756136|NCT03519087|7682628|FG003|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (2) evaluation from Period 1|6
6756137|NCT03519087|7682629|FG004|STARTED|Laboratory Testing|From interdisciplinary (4) or standard (3) evaluation from Period 1|7
6756138|NCT03519087|7682625|FG000|Baseline Lab Testing|Laboratory Testing||0
6756139|NCT03519087|7682626|FG001|Baseline Lab Testing|Laboratory Testing||0
6756140|NCT03519087|7682627|FG002|Baseline Lab Testing|Laboratory Testing||5
6756141|NCT03519087|7682628|FG003|Baseline Lab Testing|Laboratory Testing||4
6756142|NCT03519087|7682629|FG004|Baseline Lab Testing|Laboratory Testing||3
6756143|NCT03519087|7682625|FG000|COMPLETED|Laboratory Testing||0
6756144|NCT03519087|7682626|FG001|COMPLETED|Laboratory Testing||0
6756145|NCT03519087|7682627|FG002|COMPLETED|Laboratory Testing||4
6756146|NCT03519087|7682628|FG003|COMPLETED|Laboratory Testing||2
6756147|NCT03519087|7682629|FG004|COMPLETED|Laboratory Testing||1
6756148|NCT03519087|7682625|FG000|NOT COMPLETED|Laboratory Testing||0
6756149|NCT03519087|7682626|FG001|NOT COMPLETED|Laboratory Testing||0
6756150|NCT03519087|7682627|FG002|NOT COMPLETED|Laboratory Testing||2
6756151|NCT03519087|7682628|FG003|NOT COMPLETED|Laboratory Testing||4
6756152|NCT03519087|7682629|FG004|NOT COMPLETED|Laboratory Testing||6
6756153|NCT03519204|7682647|FG000|STARTED|Overall Study|3 control participants were treated in error; 29 participants received treatment after 3 months.|43
6756154|NCT03519204|7682648|FG001|STARTED|Overall Study||133
6756155|NCT03519204|7682647|FG000|mITT Population|Overall Study||33
6756156|NCT03519204|7682648|FG001|mITT Population|Overall Study||130
6756157|NCT03519204|7682647|FG000|Safety Population|Overall Study||40
6756158|NCT03519204|7682648|FG001|Safety Population|Overall Study||136
6756159|NCT03519204|7682647|FG000|COMPLETED|Overall Study||30
6756160|NCT03519204|7682648|FG001|COMPLETED|Overall Study||118
6756161|NCT03519204|7682647|FG000|NOT COMPLETED|Overall Study||13
6756162|NCT03519204|7682648|FG001|NOT COMPLETED|Overall Study||15
6756163|NCT03519243|7682661|FG000|STARTED|Overall Study||25
6756164|NCT03519243|7682662|FG001|STARTED|Overall Study||25
6756165|NCT03519243|7682663|FG002|STARTED|Overall Study|The dose level was not studied due to the dose level l.7 µg/kg demonstrated the sufficient PD effect|0
6756166|NCT03519243|7682664|FG003|STARTED|Overall Study||25
6756167|NCT03519243|7682661|FG000|COMPLETED|Overall Study||20
6756168|NCT03519243|7682662|FG001|COMPLETED|Overall Study||21
6756169|NCT03519243|7682663|FG002|COMPLETED|Overall Study||0
6756170|NCT03519243|7682664|FG003|COMPLETED|Overall Study||24
6756171|NCT03519243|7682661|FG000|NOT COMPLETED|Overall Study||5
6756172|NCT03519243|7682662|FG001|NOT COMPLETED|Overall Study||4
6756173|NCT03519243|7682663|FG002|NOT COMPLETED|Overall Study||0
6756174|NCT03519243|7682664|FG003|NOT COMPLETED|Overall Study||1
6756175|NCT03519282|7682672|FG000|STARTED|First Intervention||5
6756176|NCT03519282|7682673|FG001|STARTED|First Intervention||5
6756177|NCT03519282|7682672|FG000|COMPLETED|First Intervention||5
6756178|NCT03519282|7682673|FG001|COMPLETED|First Intervention||5
6756179|NCT03519282|7682672|FG000|NOT COMPLETED|First Intervention||0
6756180|NCT03519282|7682673|FG001|NOT COMPLETED|First Intervention||0
6756181|NCT03519282|7682672|FG000|STARTED|Second Intervention||5
6756182|NCT03519282|7682673|FG001|STARTED|Second Intervention||5
6756183|NCT03519282|7682672|FG000|COMPLETED|Second Intervention||5
6756184|NCT03519282|7682673|FG001|COMPLETED|Second Intervention||5
6756185|NCT03519282|7682672|FG000|NOT COMPLETED|Second Intervention||0
6756186|NCT03519282|7682673|FG001|NOT COMPLETED|Second Intervention||0
6756187|NCT03519516|7682681|FG000|STARTED|Overall Study||15
6756188|NCT03519516|7682682|FG001|STARTED|Overall Study||15
6756189|NCT03519516|7682681|FG000|COMPLETED|Overall Study||15
6756190|NCT03519516|7682682|FG001|COMPLETED|Overall Study||14
6756191|NCT03519516|7682681|FG000|NOT COMPLETED|Overall Study||0
6756192|NCT03519516|7682682|FG001|NOT COMPLETED|Overall Study||1
6756193|NCT03519854|7682706|FG000|STARTED|Overall Study|N=3 randomized to Arm A. An additional N=1 (randomized to Arm C) is counted as Started in Arm A|4
6756194|NCT03519854|7682707|FG001|STARTED|Overall Study||6
6756195|NCT03519854|7682708|FG002|STARTED|Overall Study||5
6756196|NCT03519854|7682709|FG003|STARTED|Overall Study||6
6756197|NCT03519854|7682710|FG004|STARTED|Overall Study||6
6756198|NCT03519854|7682711|FG005|STARTED|Overall Study||6
6756199|NCT03519854|7682712|FG006|STARTED|Overall Study||3
6756200|NCT03519854|7682713|FG007|STARTED|Overall Study||6
6756201|NCT03519854|7682714|FG008|STARTED|Overall Study||6
6756202|NCT03519854|7682715|FG009|STARTED|Overall Study||6
6756203|NCT03519854|7682716|FG010|STARTED|Overall Study||6
6756204|NCT03519854|7682717|FG011|STARTED|Overall Study||6
6756205|NCT03519854|7682718|FG012|STARTED|Overall Study||3
6756206|NCT03519854|7682719|FG013|STARTED|Overall Study||6
6756207|NCT03519854|7682720|FG014|STARTED|Overall Study||6
6756208|NCT03519854|7682721|FG015|STARTED|Overall Study||6
6756209|NCT03519854|7682722|FG016|STARTED|Overall Study||6
6756210|NCT03519854|7682723|FG017|STARTED|Overall Study||6
6756211|NCT03519854|7682706|FG000|Treated|Overall Study|N=1 (randomized to Arm C) received placebo, 3 min after 1.2 mg/kg Esmeron®|4
6756212|NCT03519854|7682707|FG001|Treated|Overall Study||6
6756213|NCT03519854|7682708|FG002|Treated|Overall Study||4
6756214|NCT03519854|7682709|FG003|Treated|Overall Study||6
6756215|NCT03519854|7682710|FG004|Treated|Overall Study||6
6756216|NCT03519854|7682711|FG005|Treated|Overall Study||6
6756217|NCT03519854|7682712|FG006|Treated|Overall Study||3
6756218|NCT03519854|7682713|FG007|Treated|Overall Study||6
6756219|NCT03519854|7682714|FG008|Treated|Overall Study||6
6756220|NCT03519854|7682715|FG009|Treated|Overall Study||6
6756221|NCT03519854|7682716|FG010|Treated|Overall Study||6
6756222|NCT03519854|7682717|FG011|Treated|Overall Study||6
6756223|NCT03519854|7682718|FG012|Treated|Overall Study||3
6756224|NCT03519854|7682719|FG013|Treated|Overall Study||6
6756225|NCT03519854|7682720|FG014|Treated|Overall Study||6
6756226|NCT03519854|7682721|FG015|Treated|Overall Study||6
6756227|NCT03519854|7682722|FG016|Treated|Overall Study||6
6756228|NCT03519854|7682723|FG017|Treated|Overall Study||6
6756229|NCT03519854|7682706|FG000|COMPLETED|Overall Study||4
6756230|NCT03519854|7682707|FG001|COMPLETED|Overall Study||6
6756231|NCT03519854|7682708|FG002|COMPLETED|Overall Study||4
6756232|NCT03519854|7682709|FG003|COMPLETED|Overall Study||6
6756233|NCT03519854|7682710|FG004|COMPLETED|Overall Study||6
6756234|NCT03519854|7682711|FG005|COMPLETED|Overall Study||6
6756235|NCT03519854|7682712|FG006|COMPLETED|Overall Study||3
6756236|NCT03519854|7682713|FG007|COMPLETED|Overall Study||6
6756237|NCT03519854|7682714|FG008|COMPLETED|Overall Study||6
6756238|NCT03519854|7682715|FG009|COMPLETED|Overall Study||6
6756239|NCT03519854|7682716|FG010|COMPLETED|Overall Study||6
6756240|NCT03519854|7682717|FG011|COMPLETED|Overall Study||6
6756241|NCT03519854|7682718|FG012|COMPLETED|Overall Study||3
6756242|NCT03519854|7682719|FG013|COMPLETED|Overall Study||6
6756243|NCT03519854|7682720|FG014|COMPLETED|Overall Study||6
6756244|NCT03519854|7682721|FG015|COMPLETED|Overall Study||6
6756245|NCT03519854|7682722|FG016|COMPLETED|Overall Study||6
6756246|NCT03519854|7682723|FG017|COMPLETED|Overall Study||6
6756247|NCT03519854|7682706|FG000|NOT COMPLETED|Overall Study||0
6756248|NCT03519854|7682707|FG001|NOT COMPLETED|Overall Study||0
6756249|NCT03519854|7682708|FG002|NOT COMPLETED|Overall Study||1
6756250|NCT03519854|7682709|FG003|NOT COMPLETED|Overall Study||0
6756251|NCT03519854|7682710|FG004|NOT COMPLETED|Overall Study||0
6756252|NCT03519854|7682711|FG005|NOT COMPLETED|Overall Study||0
6756253|NCT03519854|7682712|FG006|NOT COMPLETED|Overall Study||0
6756254|NCT03519854|7682713|FG007|NOT COMPLETED|Overall Study||0
6756255|NCT03519854|7682714|FG008|NOT COMPLETED|Overall Study||0
6756256|NCT03519854|7682715|FG009|NOT COMPLETED|Overall Study||0
6756257|NCT03519854|7682716|FG010|NOT COMPLETED|Overall Study||0
6756258|NCT03519854|7682717|FG011|NOT COMPLETED|Overall Study||0
6756259|NCT03519854|7682718|FG012|NOT COMPLETED|Overall Study||0
6756260|NCT03519854|7682719|FG013|NOT COMPLETED|Overall Study||0
6756261|NCT03519854|7682720|FG014|NOT COMPLETED|Overall Study||0
6756262|NCT03519854|7682721|FG015|NOT COMPLETED|Overall Study||0
6756263|NCT03519854|7682722|FG016|NOT COMPLETED|Overall Study||0
6756264|NCT03519854|7682723|FG017|NOT COMPLETED|Overall Study||0
6756265|NCT03519867|7682771|FG000|STARTED|Overall Study||6
6756266|NCT03519867|7682772|FG001|STARTED|Overall Study|One participant randomized to receive MK-8616 8.0 mg/kg received MK-8616 0.8 mg/kg.|7
6756267|NCT03519867|7682773|FG002|STARTED|Overall Study||6
6756268|NCT03519867|7682774|FG003|STARTED|Overall Study||4
6756269|NCT03519867|7682775|FG004|STARTED|Overall Study||5
6756270|NCT03519867|7682776|FG005|STARTED|Overall Study||5
6756271|NCT03519867|7682777|FG006|STARTED|Overall Study||4
6756272|NCT03519867|7682778|FG007|STARTED|Overall Study||5
6756273|NCT03519867|7682779|FG008|STARTED|Overall Study||4
6756274|NCT03519867|7682780|FG009|STARTED|Overall Study||4
6756275|NCT03519867|7682771|FG000|Treated|Overall Study||5
6756276|NCT03519867|7682772|FG001|Treated|Overall Study||6
6756277|NCT03519867|7682773|FG002|Treated|Overall Study||5
6756278|NCT03519867|7682774|FG003|Treated|Overall Study||3
6756279|NCT03519867|7682775|FG004|Treated|Overall Study||5
6756280|NCT03519867|7682776|FG005|Treated|Overall Study||4
6756281|NCT03519867|7682777|FG006|Treated|Overall Study||4
6756282|NCT03519867|7682778|FG007|Treated|Overall Study||4
6756283|NCT03519867|7682779|FG008|Treated|Overall Study||3
6756284|NCT03519867|7682780|FG009|Treated|Overall Study||4
6756285|NCT03519867|7682771|FG000|COMPLETED|Overall Study||3
6756286|NCT03519867|7682772|FG001|COMPLETED|Overall Study||4
6756287|NCT03519867|7682773|FG002|COMPLETED|Overall Study||5
6756288|NCT03519867|7682774|FG003|COMPLETED|Overall Study||3
6555719|NCT01753856|7477893|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
6555720|NCT01753856|7477894|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
6555721|NCT01753856|7477893|FG000|Completed 3-Month Bone Biopsy|Overall Study||31
6756289|NCT03519867|7682775|FG004|COMPLETED|Overall Study||5
6756290|NCT03519867|7682776|FG005|COMPLETED|Overall Study||2
6756291|NCT03519867|7682777|FG006|COMPLETED|Overall Study||3
6756292|NCT03519867|7682778|FG007|COMPLETED|Overall Study||4
6756293|NCT03519867|7682779|FG008|COMPLETED|Overall Study||3
6756294|NCT03519867|7682780|FG009|COMPLETED|Overall Study||4
6756295|NCT03519867|7682771|FG000|NOT COMPLETED|Overall Study||3
6756296|NCT03519867|7682772|FG001|NOT COMPLETED|Overall Study||3
6756297|NCT03519867|7682773|FG002|NOT COMPLETED|Overall Study||1
6756298|NCT03519867|7682774|FG003|NOT COMPLETED|Overall Study||1
6756299|NCT03519867|7682775|FG004|NOT COMPLETED|Overall Study||0
6756300|NCT03519867|7682776|FG005|NOT COMPLETED|Overall Study||3
6756301|NCT03519867|7682777|FG006|NOT COMPLETED|Overall Study||1
6756302|NCT03519867|7682778|FG007|NOT COMPLETED|Overall Study||1
6756303|NCT03519867|7682779|FG008|NOT COMPLETED|Overall Study||1
6756304|NCT03519867|7682780|FG009|NOT COMPLETED|Overall Study||0
6756305|NCT03519919|7682802|FG000|STARTED|Overall Study||51
6756306|NCT03519919|7682802|FG000|COMPLETED|Overall Study||48
6756307|NCT03519919|7682802|FG000|NOT COMPLETED|Overall Study||3
6756308|NCT03519932|7682832|FG000|STARTED|First Intervention||24
6756309|NCT03519932|7682833|FG001|STARTED|First Intervention||25
6756310|NCT03519932|7682832|FG000|COMPLETED|First Intervention|One subject had non-significant adverse event and data not included in the analysis|23
6756311|NCT03519932|7682833|FG001|COMPLETED|First Intervention|3 subjects had non-significant adverse events and data not included in analysis.|22
6756312|NCT03519932|7682832|FG000|NOT COMPLETED|First Intervention||1
6756313|NCT03519932|7682833|FG001|NOT COMPLETED|First Intervention||3
6756314|NCT03519932|7682832|FG000|STARTED|Second Intervention|Subjects who wore samfilcon A toric at 1st intervention wear comfilcon A toric at 2nd intervention|22
6756315|NCT03519932|7682833|FG001|STARTED|Second Intervention|Subjects who wore comfilcon A toric at 1st intervention wear Samfilcon A toric at 2nd intervention|23
6756316|NCT03519932|7682832|FG000|COMPLETED|Second Intervention||22
6756317|NCT03519932|7682833|FG001|COMPLETED|Second Intervention||23
6756318|NCT03519932|7682832|FG000|NOT COMPLETED|Second Intervention||0
6756319|NCT03519932|7682833|FG001|NOT COMPLETED|Second Intervention||0
6756320|NCT03520283|7682846|FG000|STARTED|Overall Study||24
6756321|NCT03520283|7682847|FG001|STARTED|Overall Study||42
6756322|NCT03520283|7682846|FG000|COMPLETED|Overall Study||24
6756323|NCT03520283|7682847|FG001|COMPLETED|Overall Study||42
6756324|NCT03520283|7682846|FG000|NOT COMPLETED|Overall Study||0
6756325|NCT03520283|7682847|FG001|NOT COMPLETED|Overall Study||0
6756326|NCT03520348|7682864|FG000|STARTED|Overall Study||12
6756327|NCT03520348|7682865|FG001|STARTED|Overall Study||12
6756328|NCT03520348|7682864|FG000|COMPLETED|Overall Study||12
6756329|NCT03520348|7682865|FG001|COMPLETED|Overall Study||12
6756330|NCT03520348|7682864|FG000|NOT COMPLETED|Overall Study||0
6756331|NCT03520348|7682865|FG001|NOT COMPLETED|Overall Study||0
6756332|NCT03520387|7682876|FG000|STARTED|Pre-Randomization||16
6756333|NCT03520387|7682877|FG001|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
6756334|NCT03520387|7682878|FG002|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
6756335|NCT03520387|7682879|FG003|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
6756336|NCT03520387|7682880|FG004|STARTED|Pre-Randomization|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment. There are no participants in this group until the randomization period (until after the pre-randomization run-in period has ended).|0
6756337|NCT03520387|7682876|FG000|COMPLETED|Pre-Randomization||13
6756338|NCT03520387|7682877|FG001|COMPLETED|Pre-Randomization||0
6756339|NCT03520387|7682878|FG002|COMPLETED|Pre-Randomization||0
6756340|NCT03520387|7682879|FG003|COMPLETED|Pre-Randomization||0
6555722|NCT01753856|7477894|FG001|Completed 3-Month Bone Biopsy|Overall Study||35
6756341|NCT03520387|7682880|FG004|COMPLETED|Pre-Randomization||0
6756342|NCT03520387|7682876|FG000|NOT COMPLETED|Pre-Randomization||3
6756343|NCT03520387|7682877|FG001|NOT COMPLETED|Pre-Randomization||0
6756344|NCT03520387|7682878|FG002|NOT COMPLETED|Pre-Randomization||0
6756345|NCT03520387|7682879|FG003|NOT COMPLETED|Pre-Randomization||0
6756346|NCT03520387|7682880|FG004|NOT COMPLETED|Pre-Randomization||0
6756347|NCT03520387|7682876|FG000|STARTED|Randomized|There are no participants in this group during this period, because the pre-randomization run-in period has ended.|0
6756348|NCT03520387|7682877|FG001|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|4
6756349|NCT03520387|7682878|FG002|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
6756350|NCT03520387|7682879|FG003|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
6756351|NCT03520387|7682880|FG004|STARTED|Randomized|Although participant flow is presented for each cell of the 2 x 2 contingency table in this factorial pilot trial, the primary analysis as originally planned focused on the main effects of (1) LRFA vs. simulated LRFA and (2) AcTIVE-CBT vs. TBSCE, unless there were indications of strong interactions between the two types of treatment.|3
6756352|NCT03520387|7682876|FG000|COMPLETED|Randomized||0
6756353|NCT03520387|7682877|FG001|COMPLETED|Randomized||4
6756354|NCT03520387|7682878|FG002|COMPLETED|Randomized||3
6756355|NCT03520387|7682879|FG003|COMPLETED|Randomized||3
6756356|NCT03520387|7682880|FG004|COMPLETED|Randomized||3
6756357|NCT03520387|7682876|FG000|NOT COMPLETED|Randomized||0
6756358|NCT03520387|7682877|FG001|NOT COMPLETED|Randomized||0
6756359|NCT03520387|7682878|FG002|NOT COMPLETED|Randomized||0
6756360|NCT03520387|7682879|FG003|NOT COMPLETED|Randomized||0
6756361|NCT03520387|7682880|FG004|NOT COMPLETED|Randomized||0
6756362|NCT03520400|7682893|FG000|STARTED|Overall Study||37
6756363|NCT03520400|7682894|FG001|STARTED|Overall Study||14
6756364|NCT03520400|7682893|FG000|COMPLETED|Overall Study||22
6756365|NCT03520400|7682894|FG001|COMPLETED|Overall Study||7
6756366|NCT03520400|7682893|FG000|NOT COMPLETED|Overall Study||15
6756367|NCT03520400|7682894|FG001|NOT COMPLETED|Overall Study||7
6756368|NCT03520920|7682903|FG000|STARTED|Overall Study||20
6756369|NCT03520920|7682904|FG001|STARTED|Overall Study||16
6756370|NCT03520920|7682905|FG002|STARTED|Overall Study||5
6756371|NCT03520920|7682903|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
6756372|NCT03520920|7682904|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
6756373|NCT03520920|7682905|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
6756374|NCT03520920|7682903|FG000|COMPLETED|Overall Study||0
6756375|NCT03520920|7682904|FG001|COMPLETED|Overall Study||0
6756376|NCT03520920|7682905|FG002|COMPLETED|Overall Study||0
6756377|NCT03520920|7682903|FG000|NOT COMPLETED|Overall Study||20
6756378|NCT03520920|7682904|FG001|NOT COMPLETED|Overall Study||16
6756379|NCT03520920|7682905|FG002|NOT COMPLETED|Overall Study||5
6756380|NCT03520959|7682921|FG000|STARTED|Overall Study||0
6756381|NCT03520959|7682922|FG001|STARTED|Overall Study||1
6756382|NCT03520959|7682921|FG000|COMPLETED|Overall Study||0
6756383|NCT03520959|7682922|FG001|COMPLETED|Overall Study||0
6756384|NCT03520959|7682921|FG000|NOT COMPLETED|Overall Study||0
6756385|NCT03520959|7682922|FG001|NOT COMPLETED|Overall Study||1
6756386|NCT03520998|7682930|FG000|STARTED|Overall Study||24
6756387|NCT03520998|7682931|FG001|STARTED|Overall Study||23
6756388|NCT03520998|7682930|FG000|COMPLETED|Overall Study||18
6756389|NCT03520998|7682931|FG001|COMPLETED|Overall Study||21
6756390|NCT03520998|7682930|FG000|NOT COMPLETED|Overall Study||6
6756391|NCT03520998|7682931|FG001|NOT COMPLETED|Overall Study||2
6779994|NCT03457818|7708288|FG000|NOT COMPLETED|Overall Study||4
6779995|NCT03457818|7708289|FG001|NOT COMPLETED|Overall Study||4
6779996|NCT03455556|7708295|FG000|STARTED|Overall Study||1
6779997|NCT03455556|7708295|FG000|COMPLETED|Overall Study||1
6779998|NCT03455556|7708295|FG000|NOT COMPLETED|Overall Study||0
6779999|NCT03447639|7708301|FG000|STARTED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
6780000|NCT03447639|7708302|FG001|STARTED|Overall Study|3 patients were randomized to the Standard of Care arm.|3
6780001|NCT03447639|7708301|FG000|COMPLETED|Overall Study|No patients were randomized to the Povidone-Iodine irrigation arm|0
6780002|NCT03447639|7708302|FG001|COMPLETED|Overall Study|2 patients were withdrawn because their catheters had to be re-inserted.|1
6780003|NCT03447639|7708301|FG000|NOT COMPLETED|Overall Study||0
6780004|NCT03447639|7708302|FG001|NOT COMPLETED|Overall Study||2
6780005|NCT03429712|7708308|FG000|STARTED|Overall Study||19
6780006|NCT03429712|7708308|FG000|COMPLETED|Overall Study||10
6780007|NCT03429712|7708308|FG000|NOT COMPLETED|Overall Study||9
6780008|NCT03426137|7708315|FG000|STARTED|Overall Study||0
6780009|NCT03426137|7708316|FG001|STARTED|Overall Study||0
6780010|NCT03426137|7708317|FG002|STARTED|Overall Study||0
6780011|NCT03426137|7708315|FG000|COMPLETED|Overall Study||0
6780012|NCT03426137|7708316|FG001|COMPLETED|Overall Study||0
6780013|NCT03426137|7708317|FG002|COMPLETED|Overall Study||0
6780014|NCT03426137|7708315|FG000|NOT COMPLETED|Overall Study||0
6756392|NCT03521089|7682939|FG000|STARTED|Overall Study||8
6756393|NCT03521089|7682940|FG001|STARTED|Overall Study||8
6756394|NCT03521089|7682939|FG000|COMPLETED|Overall Study||8
6756395|NCT03521089|7682940|FG001|COMPLETED|Overall Study||8
6756396|NCT03521089|7682939|FG000|NOT COMPLETED|Overall Study||0
6756397|NCT03521089|7682940|FG001|NOT COMPLETED|Overall Study||0
6756398|NCT03521115|7682948|FG000|STARTED|Time 0 Baseline Surveys||206
6756399|NCT03521115|7682949|FG001|STARTED|Time 0 Baseline Surveys||205
6756400|NCT03521115|7682948|FG000|COMPLETED|Time 0 Baseline Surveys||206
6756401|NCT03521115|7682949|FG001|COMPLETED|Time 0 Baseline Surveys||205
6756402|NCT03521115|7682948|FG000|NOT COMPLETED|Time 0 Baseline Surveys||0
6756403|NCT03521115|7682949|FG001|NOT COMPLETED|Time 0 Baseline Surveys||0
6756404|NCT03521115|7682948|FG000|STARTED|Time 1 Survey (6 Months Post Baseline)||206
6756405|NCT03521115|7682949|FG001|STARTED|Time 1 Survey (6 Months Post Baseline)||205
6756406|NCT03521115|7682948|FG000|COMPLETED|Time 1 Survey (6 Months Post Baseline)||150
6756407|NCT03521115|7682949|FG001|COMPLETED|Time 1 Survey (6 Months Post Baseline)||165
6756408|NCT03521115|7682948|FG000|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||56
6756409|NCT03521115|7682949|FG001|NOT COMPLETED|Time 1 Survey (6 Months Post Baseline)||40
6756410|NCT03521115|7682948|FG000|STARTED|Time 2 Survey (12 Months Post Baseline)||150
6756411|NCT03521115|7682949|FG001|STARTED|Time 2 Survey (12 Months Post Baseline)||165
6756412|NCT03521115|7682948|FG000|COMPLETED|Time 2 Survey (12 Months Post Baseline)||147
6756413|NCT03521115|7682949|FG001|COMPLETED|Time 2 Survey (12 Months Post Baseline)||164
6756414|NCT03521115|7682948|FG000|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||3
6756415|NCT03521115|7682949|FG001|NOT COMPLETED|Time 2 Survey (12 Months Post Baseline)||1
6756416|NCT03521115|7682948|FG000|STARTED|Time 3 Survey (18 Months Post Baseline)||147
6756417|NCT03521115|7682949|FG001|STARTED|Time 3 Survey (18 Months Post Baseline)||164
6756418|NCT03521115|7682948|FG000|COMPLETED|Time 3 Survey (18 Months Post Baseline)||145
6756419|NCT03521115|7682949|FG001|COMPLETED|Time 3 Survey (18 Months Post Baseline)||164
6756420|NCT03521115|7682948|FG000|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||2
6756421|NCT03521115|7682949|FG001|NOT COMPLETED|Time 3 Survey (18 Months Post Baseline)||0
6756422|NCT03521141|7682964|FG000|STARTED|Overall Study||19
6756423|NCT03521141|7682965|FG001|STARTED|Overall Study||19
6756424|NCT03521141|7682966|FG002|STARTED|Overall Study||20
6756425|NCT03521141|7682964|FG000|COMPLETED|Overall Study||18
6756426|NCT03521141|7682965|FG001|COMPLETED|Overall Study||19
6756427|NCT03521141|7682966|FG002|COMPLETED|Overall Study||19
6756428|NCT03521141|7682964|FG000|NOT COMPLETED|Overall Study||1
6756429|NCT03521141|7682965|FG001|NOT COMPLETED|Overall Study||0
6756430|NCT03521141|7682966|FG002|NOT COMPLETED|Overall Study||1
6756431|NCT03521193|7682976|FG000|STARTED|Overall Study|enrolled on the PFO closure hospitalization|78
6756432|NCT03521193|7682977|FG001|STARTED|Overall Study||12
6756433|NCT03521193|7682976|FG000|COMPLETED|Overall Study|8 pts refused to continue the study; 8 patients were non compliant to ASA treatment|62
6756434|NCT03521193|7682977|FG001|COMPLETED|Overall Study||12
6756435|NCT03521193|7682976|FG000|NOT COMPLETED|Overall Study||16
6756436|NCT03521193|7682977|FG001|NOT COMPLETED|Overall Study||0
6756437|NCT03521479|7682988|FG000|STARTED|Overall Study||10
6756438|NCT03521479|7682989|FG001|STARTED|Overall Study||10
6756439|NCT03521479|7682990|FG002|STARTED|Overall Study||10
6756440|NCT03521479|7682991|FG003|STARTED|Overall Study||10
6756441|NCT03521479|7682988|FG000|COMPLETED|Overall Study||10
6756442|NCT03521479|7682989|FG001|COMPLETED|Overall Study||10
6756443|NCT03521479|7682990|FG002|COMPLETED|Overall Study||10
6756444|NCT03521479|7682991|FG003|COMPLETED|Overall Study||10
6756445|NCT03521479|7682988|FG000|NOT COMPLETED|Overall Study||0
6555723|NCT01753856|7477893|FG000|COMPLETED|Overall Study||30
6756446|NCT03521479|7682989|FG001|NOT COMPLETED|Overall Study||0
6555724|NCT01753856|7477894|FG001|COMPLETED|Overall Study||34
6555725|NCT01753856|7477893|FG000|NOT COMPLETED|Overall Study||3
6756447|NCT03521479|7682990|FG002|NOT COMPLETED|Overall Study||0
6756448|NCT03521479|7682991|FG003|NOT COMPLETED|Overall Study||0
6756449|NCT03521505|7683003|FG000|STARTED|Overall Study||25
6756450|NCT03521505|7683004|FG001|STARTED|Overall Study||25
6756451|NCT03521505|7683003|FG000|COMPLETED|Overall Study||25
6756452|NCT03521505|7683004|FG001|COMPLETED|Overall Study||25
6756453|NCT03521505|7683003|FG000|NOT COMPLETED|Overall Study||0
6756454|NCT03521505|7683004|FG001|NOT COMPLETED|Overall Study||0
6756455|NCT03521635|7683012|FG000|STARTED|Overall Study||49
6756456|NCT03521635|7683013|FG001|STARTED|Overall Study||49
6756457|NCT03521635|7683012|FG000|COMPLETED|Overall Study||45
6756458|NCT03521635|7683013|FG001|COMPLETED|Overall Study||43
6756459|NCT03521635|7683012|FG000|NOT COMPLETED|Overall Study||4
6756460|NCT03521635|7683013|FG001|NOT COMPLETED|Overall Study||6
6756461|NCT03521791|7683021|FG000|STARTED|Overall Study||76
6756462|NCT03521791|7683022|FG001|STARTED|Overall Study||90
6756463|NCT03521791|7683021|FG000|COMPLETED|Overall Study||69
6756464|NCT03521791|7683022|FG001|COMPLETED|Overall Study||73
6756465|NCT03521791|7683021|FG000|NOT COMPLETED|Overall Study||7
6756466|NCT03521791|7683022|FG001|NOT COMPLETED|Overall Study||17
6756467|NCT03521817|7683030|FG000|STARTED|Overall Study||7
6756468|NCT03521817|7683031|FG001|STARTED|Overall Study||5
6756469|NCT03521817|7683030|FG000|COMPLETED|Overall Study||7
6756470|NCT03521817|7683031|FG001|COMPLETED|Overall Study|1 completer was non adherent based on weekly intervention body weight|4
6756471|NCT03521817|7683030|FG000|NOT COMPLETED|Overall Study||0
6756472|NCT03521817|7683031|FG001|NOT COMPLETED|Overall Study||1
6756473|NCT03522350|7683037|FG000|STARTED|Overall Study||18
6756474|NCT03522350|7683038|FG001|STARTED|Overall Study||18
6756475|NCT03522350|7683037|FG000|COMPLETED|Overall Study||18
6756476|NCT03522350|7683038|FG001|COMPLETED|Overall Study||18
6756477|NCT03522350|7683037|FG000|NOT COMPLETED|Overall Study||0
6756478|NCT03522350|7683038|FG001|NOT COMPLETED|Overall Study||0
6756479|NCT03522441|7683046|FG000|STARTED|Overall Study||450
6756480|NCT03522441|7683047|FG001|STARTED|Overall Study||450
6756481|NCT03522441|7683048|FG002|STARTED|Overall Study||225
6756482|NCT03522441|7683046|FG000|COMPLETED|Overall Study||424
6756483|NCT03522441|7683047|FG001|COMPLETED|Overall Study||431
6756484|NCT03522441|7683048|FG002|COMPLETED|Overall Study||214
6756485|NCT03522441|7683046|FG000|NOT COMPLETED|Overall Study||26
6756486|NCT03522441|7683047|FG001|NOT COMPLETED|Overall Study||19
6756487|NCT03522441|7683048|FG002|NOT COMPLETED|Overall Study||11
6756488|NCT03522506|7683060|FG000|STARTED|Treatment Period 1 (2 Days)||5
6756489|NCT03522506|7683061|FG001|STARTED|Treatment Period 1 (2 Days)||5
6756490|NCT03522506|7683062|FG002|STARTED|Treatment Period 1 (2 Days)||5
6756491|NCT03522506|7683063|FG003|STARTED|Treatment Period 1 (2 Days)||5
6756492|NCT03522506|7683060|FG000|COMPLETED|Treatment Period 1 (2 Days)||5
6756493|NCT03522506|7683061|FG001|COMPLETED|Treatment Period 1 (2 Days)||5
6756494|NCT03522506|7683062|FG002|COMPLETED|Treatment Period 1 (2 Days)||5
6756495|NCT03522506|7683063|FG003|COMPLETED|Treatment Period 1 (2 Days)||5
6756496|NCT03522506|7683060|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6756497|NCT03522506|7683061|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6756498|NCT03522506|7683062|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6756499|NCT03522506|7683063|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6756500|NCT03522506|7683060|FG000|STARTED|Washout Period 1 (7 Days)||5
6756501|NCT03522506|7683061|FG001|STARTED|Washout Period 1 (7 Days)||5
6756502|NCT03522506|7683062|FG002|STARTED|Washout Period 1 (7 Days)||5
6756503|NCT03522506|7683063|FG003|STARTED|Washout Period 1 (7 Days)||5
6756504|NCT03522506|7683060|FG000|COMPLETED|Washout Period 1 (7 Days)||5
6756505|NCT03522506|7683061|FG001|COMPLETED|Washout Period 1 (7 Days)||5
6756506|NCT03522506|7683062|FG002|COMPLETED|Washout Period 1 (7 Days)||5
6756507|NCT03522506|7683063|FG003|COMPLETED|Washout Period 1 (7 Days)||4
6756508|NCT03522506|7683060|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6756509|NCT03522506|7683061|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6555726|NCT01753856|7477894|FG001|NOT COMPLETED|Overall Study||2
6555727|NCT01753999|7477903|FG000|STARTED|Period 1 - Initial Assignment||155
6756510|NCT03522506|7683062|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6756511|NCT03522506|7683063|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
6756512|NCT03522506|7683060|FG000|STARTED|Treatment Period 2 (2 Days)||5
6756513|NCT03522506|7683061|FG001|STARTED|Treatment Period 2 (2 Days)||5
6756514|NCT03522506|7683062|FG002|STARTED|Treatment Period 2 (2 Days)||5
6756515|NCT03522506|7683063|FG003|STARTED|Treatment Period 2 (2 Days)||4
6756516|NCT03522506|7683060|FG000|COMPLETED|Treatment Period 2 (2 Days)||5
6756517|NCT03522506|7683061|FG001|COMPLETED|Treatment Period 2 (2 Days)||5
6756518|NCT03522506|7683062|FG002|COMPLETED|Treatment Period 2 (2 Days)||5
6756519|NCT03522506|7683063|FG003|COMPLETED|Treatment Period 2 (2 Days)||4
6756520|NCT03522506|7683060|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6756521|NCT03522506|7683061|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6756522|NCT03522506|7683062|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6756523|NCT03522506|7683063|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6756524|NCT03522506|7683060|FG000|STARTED|Washout Period 2 (7 Days)||5
6756525|NCT03522506|7683061|FG001|STARTED|Washout Period 2 (7 Days)||5
6756526|NCT03522506|7683062|FG002|STARTED|Washout Period 2 (7 Days)||5
6756527|NCT03522506|7683063|FG003|STARTED|Washout Period 2 (7 Days)||4
6756528|NCT03522506|7683060|FG000|COMPLETED|Washout Period 2 (7 Days)||5
6756529|NCT03522506|7683061|FG001|COMPLETED|Washout Period 2 (7 Days)||5
6756530|NCT03522506|7683062|FG002|COMPLETED|Washout Period 2 (7 Days)||5
6756531|NCT03522506|7683063|FG003|COMPLETED|Washout Period 2 (7 Days)||3
6756532|NCT03522506|7683060|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6756533|NCT03522506|7683061|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6756534|NCT03522506|7683062|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6756535|NCT03522506|7683063|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||1
6756536|NCT03522506|7683060|FG000|STARTED|Treatment Period 3 (2 Days)||5
6756537|NCT03522506|7683061|FG001|STARTED|Treatment Period 3 (2 Days)||5
6756538|NCT03522506|7683062|FG002|STARTED|Treatment Period 3 (2 Days)||5
6756539|NCT03522506|7683063|FG003|STARTED|Treatment Period 3 (2 Days)||3
6756540|NCT03522506|7683060|FG000|COMPLETED|Treatment Period 3 (2 Days)||5
6756541|NCT03522506|7683061|FG001|COMPLETED|Treatment Period 3 (2 Days)||5
6756542|NCT03522506|7683062|FG002|COMPLETED|Treatment Period 3 (2 Days)||5
6756543|NCT03522506|7683063|FG003|COMPLETED|Treatment Period 3 (2 Days)||3
6756544|NCT03522506|7683060|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6756545|NCT03522506|7683061|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6756546|NCT03522506|7683062|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6756547|NCT03522506|7683063|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6756548|NCT03522506|7683060|FG000|STARTED|Washout Period 3 (7 Days)||5
6756549|NCT03522506|7683061|FG001|STARTED|Washout Period 3 (7 Days)||5
6756550|NCT03522506|7683062|FG002|STARTED|Washout Period 3 (7 Days)||5
6756551|NCT03522506|7683063|FG003|STARTED|Washout Period 3 (7 Days)||3
6756552|NCT03522506|7683060|FG000|COMPLETED|Washout Period 3 (7 Days)||5
6756553|NCT03522506|7683061|FG001|COMPLETED|Washout Period 3 (7 Days)||5
6756554|NCT03522506|7683062|FG002|COMPLETED|Washout Period 3 (7 Days)||5
6756555|NCT03522506|7683063|FG003|COMPLETED|Washout Period 3 (7 Days)||3
6756556|NCT03522506|7683060|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
6756557|NCT03522506|7683061|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
6756558|NCT03522506|7683062|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
6756559|NCT03522506|7683063|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
6756560|NCT03522506|7683060|FG000|STARTED|Treatment Period 4 (2 Days)||5
6756561|NCT03522506|7683061|FG001|STARTED|Treatment Period 4 (2 Days)||5
6756562|NCT03522506|7683062|FG002|STARTED|Treatment Period 4 (2 Days)||5
6756563|NCT03522506|7683063|FG003|STARTED|Treatment Period 4 (2 Days)||3
6756564|NCT03522506|7683060|FG000|COMPLETED|Treatment Period 4 (2 Days)||5
6756565|NCT03522506|7683061|FG001|COMPLETED|Treatment Period 4 (2 Days)||5
6756566|NCT03522506|7683062|FG002|COMPLETED|Treatment Period 4 (2 Days)||5
6756567|NCT03522506|7683063|FG003|COMPLETED|Treatment Period 4 (2 Days)||3
6756568|NCT03522506|7683060|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6555728|NCT01753999|7477904|FG001|STARTED|Period 1 - Initial Assignment||162
6555729|NCT01753999|7477903|FG000|Received Intervention|Period 1 - Initial Assignment||144
6555730|NCT01753999|7477904|FG001|Received Intervention|Period 1 - Initial Assignment||146
6555731|NCT01753999|7477903|FG000|COMPLETED|Period 1 - Initial Assignment||116
6555732|NCT01753999|7477904|FG001|COMPLETED|Period 1 - Initial Assignment||112
6555733|NCT01753999|7477903|FG000|NOT COMPLETED|Period 1 - Initial Assignment||39
6555734|NCT01753999|7477904|FG001|NOT COMPLETED|Period 1 - Initial Assignment||50
6555735|NCT01753999|7477903|FG000|STARTED|Period 2 -Cross to Alternate Arm||116
6756569|NCT03522506|7683061|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6756570|NCT03522506|7683062|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6756571|NCT03522506|7683063|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6756572|NCT03522675|7683077|FG000|STARTED|Overall Study||22
6756573|NCT03522675|7683077|FG000|COMPLETED|Overall Study||20
6756574|NCT03522675|7683077|FG000|NOT COMPLETED|Overall Study||2
6756575|NCT03522948|7683085|FG000|STARTED|Overall Study||8
6756576|NCT03522948|7683085|FG000|COMPLETED|Overall Study||7
6756577|NCT03522948|7683085|FG000|NOT COMPLETED|Overall Study||1
6756578|NCT03523715|7683091|FG000|STARTED|Overall Study||38
6756579|NCT03523715|7683092|FG001|STARTED|Overall Study||39
6756580|NCT03523715|7683091|FG000|COMPLETED|Overall Study||26
6555736|NCT01753999|7477904|FG001|STARTED|Period 2 -Cross to Alternate Arm||112
6562916|NCT01803464|7485827|FG001|NOT COMPLETED|Overall Study||0
6756581|NCT03523715|7683092|FG001|COMPLETED|Overall Study||23
6756582|NCT03523715|7683091|FG000|NOT COMPLETED|Overall Study||12
6756583|NCT03523715|7683092|FG001|NOT COMPLETED|Overall Study||16
6756584|NCT03523871|7683098|FG000|STARTED|Overall Study||20
6756585|NCT03523871|7683098|FG000|COMPLETED|Overall Study||19
6756586|NCT03523871|7683098|FG000|NOT COMPLETED|Overall Study||1
6756587|NCT03523988|7683105|FG000|STARTED|Overall Study||24
6756588|NCT03523988|7683106|FG001|STARTED|Overall Study||24
6756589|NCT03523988|7683107|FG002|STARTED|Overall Study||25
6756590|NCT03523988|7683105|FG000|COMPLETED|Overall Study||7
6756591|NCT03523988|7683106|FG001|COMPLETED|Overall Study||8
6756592|NCT03523988|7683107|FG002|COMPLETED|Overall Study||7
6756593|NCT03523988|7683105|FG000|NOT COMPLETED|Overall Study||17
6756594|NCT03523988|7683106|FG001|NOT COMPLETED|Overall Study||16
6756595|NCT03523988|7683107|FG002|NOT COMPLETED|Overall Study||18
6756596|NCT03524157|7683118|FG000|STARTED|Overall Study||10
6756597|NCT03524157|7683119|FG001|STARTED|Overall Study||10
6756598|NCT03524157|7683120|FG002|STARTED|Overall Study||10
6756599|NCT03524157|7683118|FG000|COMPLETED|Overall Study||10
6756600|NCT03524157|7683119|FG001|COMPLETED|Overall Study||10
6756601|NCT03524157|7683120|FG002|COMPLETED|Overall Study||9
6756602|NCT03524157|7683118|FG000|NOT COMPLETED|Overall Study||0
6756603|NCT03524157|7683119|FG001|NOT COMPLETED|Overall Study||0
6756604|NCT03524157|7683120|FG002|NOT COMPLETED|Overall Study||1
6756605|NCT03524339|7683130|FG000|STARTED|Overall Study||66
6756606|NCT03524339|7683131|FG001|STARTED|Overall Study||66
6756607|NCT03524339|7683130|FG000|COMPLETED|Overall Study||57
6756608|NCT03524339|7683131|FG001|COMPLETED|Overall Study||62
6756609|NCT03524339|7683130|FG000|NOT COMPLETED|Overall Study||9
6756610|NCT03524339|7683131|FG001|NOT COMPLETED|Overall Study||4
6756611|NCT03525119|7683140|FG000|STARTED|Overall Study||300
6756612|NCT03525119|7683141|FG001|STARTED|Overall Study||300
6756613|NCT03525119|7683142|FG002|STARTED|Overall Study||300
6756614|NCT03525119|7683140|FG000|Safety Population|Overall Study||299
6756615|NCT03525119|7683141|FG001|Safety Population|Overall Study||300
6756616|NCT03525119|7683142|FG002|Safety Population|Overall Study||298
6756617|NCT03525119|7683140|FG000|COMPLETED|Overall Study||260
6756618|NCT03525119|7683141|FG001|COMPLETED|Overall Study||261
6756619|NCT03525119|7683142|FG002|COMPLETED|Overall Study||257
6756620|NCT03525119|7683140|FG000|NOT COMPLETED|Overall Study||40
6756621|NCT03525119|7683141|FG001|NOT COMPLETED|Overall Study||39
6756622|NCT03525119|7683142|FG002|NOT COMPLETED|Overall Study||43
6756623|NCT03525210|7683152|FG000|STARTED|Overall Study||100
6756624|NCT03525210|7683153|FG001|STARTED|Overall Study||171
6756625|NCT03525210|7683152|FG000|COMPLETED|Overall Study||96
6756626|NCT03525210|7683153|FG001|COMPLETED|Overall Study||169
6756627|NCT03525210|7683152|FG000|NOT COMPLETED|Overall Study||4
6756628|NCT03525210|7683153|FG001|NOT COMPLETED|Overall Study||2
6756629|NCT03525444|7683163|FG000|STARTED|Overall Study||203
6756630|NCT03525444|7683164|FG001|STARTED|Overall Study||200
6756631|NCT03525444|7683163|FG000|Safety Set|Overall Study||201
6756632|NCT03525444|7683164|FG001|Safety Set|Overall Study||202
6756633|NCT03525444|7683163|FG000|COMPLETED|Overall Study||203
6756634|NCT03525444|7683164|FG001|COMPLETED|Overall Study||197
6756635|NCT03525444|7683163|FG000|NOT COMPLETED|Overall Study||0
6756636|NCT03525444|7683164|FG001|NOT COMPLETED|Overall Study||3
6756637|NCT03525548|7683173|FG000|STARTED|Overall Study||52
6756638|NCT03525548|7683174|FG001|STARTED|Overall Study||55
6756639|NCT03525548|7683173|FG000|COMPLETED|Overall Study||52
6756640|NCT03525548|7683174|FG001|COMPLETED|Overall Study||55
6756641|NCT03525548|7683173|FG000|NOT COMPLETED|Overall Study||0
6756642|NCT03525548|7683174|FG001|NOT COMPLETED|Overall Study||0
6756643|NCT03525834|7683180|FG000|STARTED|Overall Study||40
6756644|NCT03525834|7683180|FG000|COMPLETED|Overall Study||39
6756645|NCT03525834|7683180|FG000|NOT COMPLETED|Overall Study||1
6756646|NCT03526055|7683184|FG000|STARTED|Initial Program||5
6756647|NCT03526055|7683185|FG001|STARTED|Initial Program||5
6756648|NCT03526055|7683184|FG000|COMPLETED|Initial Program||5
6756649|NCT03526055|7683185|FG001|COMPLETED|Initial Program||5
6756650|NCT03526055|7683184|FG000|NOT COMPLETED|Initial Program||0
6756651|NCT03526055|7683185|FG001|NOT COMPLETED|Initial Program||0
6756652|NCT03526055|7683184|FG000|STARTED|Second Program||5
6756653|NCT03526055|7683185|FG001|STARTED|Second Program||5
6756654|NCT03526055|7683184|FG000|COMPLETED|Second Program||5
6756655|NCT03526055|7683185|FG001|COMPLETED|Second Program||5
6756656|NCT03526055|7683184|FG000|NOT COMPLETED|Second Program||0
6756657|NCT03526055|7683185|FG001|NOT COMPLETED|Second Program||0
6756658|NCT03526458|7683194|FG000|STARTED|Overall Study||20
6756659|NCT03526458|7683195|FG001|STARTED|Overall Study||20
6756660|NCT03526458|7683194|FG000|COMPLETED|Overall Study||12
6756661|NCT03526458|7683195|FG001|COMPLETED|Overall Study||15
6756662|NCT03526458|7683194|FG000|NOT COMPLETED|Overall Study||8
6756663|NCT03526458|7683195|FG001|NOT COMPLETED|Overall Study||5
6756664|NCT03526861|7683204|FG000|STARTED|Initial Treatment Period||101
6756665|NCT03526861|7683205|FG001|STARTED|Initial Treatment Period||100
6756666|NCT03526861|7683206|FG002|STARTED|Initial Treatment Period||100
6756667|NCT03526861|7683207|FG003|STARTED|Initial Treatment Period||0
6756668|NCT03526861|7683208|FG004|STARTED|Initial Treatment Period||0
6756669|NCT03526861|7683209|FG005|STARTED|Initial Treatment Period||0
6756670|NCT03526861|7683210|FG006|STARTED|Initial Treatment Period||0
6756671|NCT03526861|7683211|FG007|STARTED|Initial Treatment Period||0
6756672|NCT03526861|7683212|FG008|STARTED|Initial Treatment Period||0
6756673|NCT03526861|7683204|FG000|COMPLETED|Initial Treatment Period||94
6756674|NCT03526861|7683205|FG001|COMPLETED|Initial Treatment Period||93
6756675|NCT03526861|7683206|FG002|COMPLETED|Initial Treatment Period||86
6756676|NCT03526861|7683207|FG003|COMPLETED|Initial Treatment Period||0
6756677|NCT03526861|7683208|FG004|COMPLETED|Initial Treatment Period||0
6756678|NCT03526861|7683209|FG005|COMPLETED|Initial Treatment Period||0
6756679|NCT03526861|7683210|FG006|COMPLETED|Initial Treatment Period||0
6756680|NCT03526861|7683211|FG007|COMPLETED|Initial Treatment Period||0
6756681|NCT03526861|7683212|FG008|COMPLETED|Initial Treatment Period||0
6756682|NCT03526861|7683204|FG000|NOT COMPLETED|Initial Treatment Period||7
6756683|NCT03526861|7683205|FG001|NOT COMPLETED|Initial Treatment Period||7
6756684|NCT03526861|7683206|FG002|NOT COMPLETED|Initial Treatment Period||14
6756685|NCT03526861|7683207|FG003|NOT COMPLETED|Initial Treatment Period||0
6756686|NCT03526861|7683208|FG004|NOT COMPLETED|Initial Treatment Period||0
6756687|NCT03526861|7683209|FG005|NOT COMPLETED|Initial Treatment Period||0
6756688|NCT03526861|7683210|FG006|NOT COMPLETED|Initial Treatment Period||0
6756689|NCT03526861|7683211|FG007|NOT COMPLETED|Initial Treatment Period||0
6756690|NCT03526861|7683212|FG008|NOT COMPLETED|Initial Treatment Period||0
6756691|NCT03526861|7683204|FG000|STARTED|Maintenance Treatment Period||0
6756692|NCT03526861|7683205|FG001|STARTED|Maintenance Treatment Period||0
6756693|NCT03526861|7683206|FG002|STARTED|Maintenance Treatment Period||0
6756694|NCT03526861|7683207|FG003|STARTED|Maintenance Treatment Period||13
6756695|NCT03526861|7683208|FG004|STARTED|Maintenance Treatment Period||14
6756696|NCT03526861|7683209|FG005|STARTED|Maintenance Treatment Period||12
6756697|NCT03526861|7683210|FG006|STARTED|Maintenance Treatment Period||14
6756698|NCT03526861|7683211|FG007|STARTED|Maintenance Treatment Period||6
6756699|NCT03526861|7683212|FG008|STARTED|Maintenance Treatment Period||0
6756700|NCT03526861|7683204|FG000|COMPLETED|Maintenance Treatment Period||0
6756701|NCT03526861|7683205|FG001|COMPLETED|Maintenance Treatment Period||0
6756702|NCT03526861|7683206|FG002|COMPLETED|Maintenance Treatment Period||0
6756703|NCT03526861|7683207|FG003|COMPLETED|Maintenance Treatment Period||5
6756704|NCT03526861|7683208|FG004|COMPLETED|Maintenance Treatment Period||8
6756705|NCT03526861|7683209|FG005|COMPLETED|Maintenance Treatment Period||8
6756706|NCT03526861|7683210|FG006|COMPLETED|Maintenance Treatment Period||8
6756707|NCT03526861|7683211|FG007|COMPLETED|Maintenance Treatment Period||4
6756708|NCT03526861|7683212|FG008|COMPLETED|Maintenance Treatment Period||0
6756709|NCT03526861|7683204|FG000|NOT COMPLETED|Maintenance Treatment Period||0
6756710|NCT03526861|7683205|FG001|NOT COMPLETED|Maintenance Treatment Period||0
6756711|NCT03526861|7683206|FG002|NOT COMPLETED|Maintenance Treatment Period||0
6756712|NCT03526861|7683207|FG003|NOT COMPLETED|Maintenance Treatment Period||8
6756713|NCT03526861|7683208|FG004|NOT COMPLETED|Maintenance Treatment Period||6
6756714|NCT03526861|7683209|FG005|NOT COMPLETED|Maintenance Treatment Period||4
6756715|NCT03526861|7683210|FG006|NOT COMPLETED|Maintenance Treatment Period||6
6756716|NCT03526861|7683211|FG007|NOT COMPLETED|Maintenance Treatment Period||2
6756717|NCT03526861|7683212|FG008|NOT COMPLETED|Maintenance Treatment Period||0
6756718|NCT03526861|7683204|FG000|STARTED|Open-label Treatment Period||0
6756719|NCT03526861|7683205|FG001|STARTED|Open-label Treatment Period||0
6756720|NCT03526861|7683206|FG002|STARTED|Open-label Treatment Period||0
6756721|NCT03526861|7683207|FG003|STARTED|Open-label Treatment Period||0
6756722|NCT03526861|7683208|FG004|STARTED|Open-label Treatment Period||0
6756723|NCT03526861|7683209|FG005|STARTED|Open-label Treatment Period||0
6756724|NCT03526861|7683210|FG006|STARTED|Open-label Treatment Period||0
6756725|NCT03526861|7683211|FG007|STARTED|Open-label Treatment Period||0
6756726|NCT03526861|7683212|FG008|STARTED|Open-label Treatment Period|226 subjects transferred to open-label treatment at Week 16. 24 subjects transferred to open-label treatment between Week 16 and Week 52.|242
6756727|NCT03526861|7683204|FG000|COMPLETED|Open-label Treatment Period||0
6756728|NCT03526861|7683205|FG001|COMPLETED|Open-label Treatment Period||0
6756729|NCT03526861|7683206|FG002|COMPLETED|Open-label Treatment Period||0
6756730|NCT03526861|7683207|FG003|COMPLETED|Open-label Treatment Period||0
6756731|NCT03526861|7683208|FG004|COMPLETED|Open-label Treatment Period||0
6756732|NCT03526861|7683209|FG005|COMPLETED|Open-label Treatment Period||0
6756733|NCT03526861|7683210|FG006|COMPLETED|Open-label Treatment Period||0
6756734|NCT03526861|7683211|FG007|COMPLETED|Open-label Treatment Period||0
6756735|NCT03526861|7683212|FG008|COMPLETED|Open-label Treatment Period||214
6756736|NCT03526861|7683204|FG000|NOT COMPLETED|Open-label Treatment Period||0
6756737|NCT03526861|7683205|FG001|NOT COMPLETED|Open-label Treatment Period||0
6756738|NCT03526861|7683206|FG002|NOT COMPLETED|Open-label Treatment Period||0
6756739|NCT03526861|7683207|FG003|NOT COMPLETED|Open-label Treatment Period||0
6756740|NCT03526861|7683208|FG004|NOT COMPLETED|Open-label Treatment Period||0
6756741|NCT03526861|7683209|FG005|NOT COMPLETED|Open-label Treatment Period||0
6756742|NCT03526861|7683210|FG006|NOT COMPLETED|Open-label Treatment Period||0
6756743|NCT03526861|7683211|FG007|NOT COMPLETED|Open-label Treatment Period||0
6756744|NCT03526861|7683212|FG008|NOT COMPLETED|Open-label Treatment Period||28
6756745|NCT03527160|7683234|FG000|STARTED|Overall Study||134
6756746|NCT03527160|7683234|FG000|COMPLETED|Overall Study||113
6756747|NCT03527160|7683234|FG000|NOT COMPLETED|Overall Study||21
6756748|NCT03527173|7683243|FG000|STARTED|Overall Study||36
6756749|NCT03527173|7683244|FG001|STARTED|Overall Study||35
6756750|NCT03527173|7683243|FG000|COMPLETED|Overall Study||29
6756751|NCT03527173|7683244|FG001|COMPLETED|Overall Study||28
6756752|NCT03527173|7683243|FG000|NOT COMPLETED|Overall Study||7
6756753|NCT03527173|7683244|FG001|NOT COMPLETED|Overall Study||7
6756754|NCT03527550|7683252|FG000|STARTED|Overall Study||24
6756755|NCT03527550|7683253|FG001|STARTED|Overall Study||22
6756756|NCT03527550|7683252|FG000|COMPLETED|Overall Study||15
6756757|NCT03527550|7683253|FG001|COMPLETED|Overall Study||19
6756758|NCT03527550|7683252|FG000|NOT COMPLETED|Overall Study||9
6756759|NCT03527550|7683253|FG001|NOT COMPLETED|Overall Study||3
6756760|NCT03527745|7683287|FG000|STARTED|Overall Study||27
6756761|NCT03527745|7683288|FG001|STARTED|Overall Study||27
6756762|NCT03527745|7683289|FG002|STARTED|Overall Study||30
6756763|NCT03527745|7683290|FG003|STARTED|Overall Study||27
6756764|NCT03527745|7683291|FG004|STARTED|Overall Study||46
6756765|NCT03527745|7683292|FG005|STARTED|Overall Study||45
6756766|NCT03527745|7683293|FG006|STARTED|Overall Study||46
6756767|NCT03527745|7683294|FG007|STARTED|Overall Study||43
6756768|NCT03527745|7683295|FG008|STARTED|Overall Study||10
6756769|NCT03527745|7683296|FG009|STARTED|Overall Study||11
6756770|NCT03527745|7683297|FG010|STARTED|Overall Study||9
6756771|NCT03527745|7683298|FG011|STARTED|Overall Study||12
6756772|NCT03527745|7683299|FG012|STARTED|Overall Study|During screening, the principal investigator decided to remove the this arm due to recruitment.|0
6756773|NCT03527745|7683300|FG013|STARTED|Overall Study||13
6756774|NCT03527745|7683301|FG014|STARTED|Overall Study||13
6756775|NCT03527745|7683302|FG015|STARTED|Overall Study||12
6756776|NCT03527745|7683303|FG016|STARTED|Overall Study||24
6756777|NCT03527745|7683304|FG017|STARTED|Overall Study||27
6756778|NCT03527745|7683305|FG018|STARTED|Overall Study||27
6756779|NCT03527745|7683306|FG019|STARTED|Overall Study||29
6756780|NCT03527745|7683307|FG020|STARTED|Overall Study||26
6756781|NCT03527745|7683308|FG021|STARTED|Overall Study||40
6756782|NCT03527745|7683309|FG022|STARTED|Overall Study||41
6756783|NCT03527745|7683310|FG023|STARTED|Overall Study||38
6756784|NCT03527745|7683311|FG024|STARTED|Overall Study||40
6756785|NCT03527745|7683312|FG025|STARTED|Overall Study||37
6756786|NCT03527745|7683287|FG000|COMPLETED|Overall Study||24
6756787|NCT03527745|7683288|FG001|COMPLETED|Overall Study||21
6756788|NCT03527745|7683289|FG002|COMPLETED|Overall Study||23
6756789|NCT03527745|7683290|FG003|COMPLETED|Overall Study||18
6756790|NCT03527745|7683291|FG004|COMPLETED|Overall Study||46
6756791|NCT03527745|7683292|FG005|COMPLETED|Overall Study||43
6756792|NCT03527745|7683293|FG006|COMPLETED|Overall Study||43
6756793|NCT03527745|7683294|FG007|COMPLETED|Overall Study||41
6756794|NCT03527745|7683295|FG008|COMPLETED|Overall Study||7
6756795|NCT03527745|7683296|FG009|COMPLETED|Overall Study||9
6756796|NCT03527745|7683297|FG010|COMPLETED|Overall Study||8
6756797|NCT03527745|7683298|FG011|COMPLETED|Overall Study||11
6756798|NCT03527745|7683299|FG012|COMPLETED|Overall Study||0
6756799|NCT03527745|7683300|FG013|COMPLETED|Overall Study||13
6756800|NCT03527745|7683301|FG014|COMPLETED|Overall Study||13
6756801|NCT03527745|7683302|FG015|COMPLETED|Overall Study||12
6756802|NCT03527745|7683303|FG016|COMPLETED|Overall Study||23
6756803|NCT03527745|7683304|FG017|COMPLETED|Overall Study||27
6756804|NCT03527745|7683305|FG018|COMPLETED|Overall Study||27
6756805|NCT03527745|7683306|FG019|COMPLETED|Overall Study||28
6756806|NCT03527745|7683307|FG020|COMPLETED|Overall Study||25
6756807|NCT03527745|7683308|FG021|COMPLETED|Overall Study||35
6756808|NCT03527745|7683309|FG022|COMPLETED|Overall Study||35
6756809|NCT03527745|7683310|FG023|COMPLETED|Overall Study||30
6756810|NCT03527745|7683311|FG024|COMPLETED|Overall Study||39
6756811|NCT03527745|7683312|FG025|COMPLETED|Overall Study||34
6756812|NCT03527745|7683287|FG000|NOT COMPLETED|Overall Study||3
6756813|NCT03527745|7683288|FG001|NOT COMPLETED|Overall Study||6
6756814|NCT03527745|7683289|FG002|NOT COMPLETED|Overall Study||7
6756815|NCT03527745|7683290|FG003|NOT COMPLETED|Overall Study||9
6756816|NCT03527745|7683291|FG004|NOT COMPLETED|Overall Study||0
6756817|NCT03527745|7683292|FG005|NOT COMPLETED|Overall Study||2
6756818|NCT03527745|7683293|FG006|NOT COMPLETED|Overall Study||3
6756819|NCT03527745|7683294|FG007|NOT COMPLETED|Overall Study||2
6756820|NCT03527745|7683295|FG008|NOT COMPLETED|Overall Study||3
6756821|NCT03527745|7683296|FG009|NOT COMPLETED|Overall Study||2
6756822|NCT03527745|7683297|FG010|NOT COMPLETED|Overall Study||1
6756823|NCT03527745|7683298|FG011|NOT COMPLETED|Overall Study||1
6756824|NCT03527745|7683299|FG012|NOT COMPLETED|Overall Study||0
6756825|NCT03527745|7683300|FG013|NOT COMPLETED|Overall Study||0
6756826|NCT03527745|7683301|FG014|NOT COMPLETED|Overall Study||0
6756827|NCT03527745|7683302|FG015|NOT COMPLETED|Overall Study||0
6756828|NCT03527745|7683303|FG016|NOT COMPLETED|Overall Study||1
6756829|NCT03527745|7683304|FG017|NOT COMPLETED|Overall Study||0
6756830|NCT03527745|7683305|FG018|NOT COMPLETED|Overall Study||0
6756831|NCT03527745|7683306|FG019|NOT COMPLETED|Overall Study||1
6756832|NCT03527745|7683307|FG020|NOT COMPLETED|Overall Study||1
6756833|NCT03527745|7683308|FG021|NOT COMPLETED|Overall Study||5
6756834|NCT03527745|7683309|FG022|NOT COMPLETED|Overall Study||6
6756835|NCT03527745|7683310|FG023|NOT COMPLETED|Overall Study||8
6756836|NCT03527745|7683311|FG024|NOT COMPLETED|Overall Study||1
6756837|NCT03527745|7683312|FG025|NOT COMPLETED|Overall Study||3
6756838|NCT03527966|7683370|FG000|STARTED|Overall Study||3
6756839|NCT03527966|7683371|FG001|STARTED|Overall Study||0
6756840|NCT03527966|7683370|FG000|COMPLETED|Overall Study||0
6756841|NCT03527966|7683371|FG001|COMPLETED|Overall Study||0
6756842|NCT03527966|7683370|FG000|NOT COMPLETED|Overall Study||3
6756843|NCT03527966|7683371|FG001|NOT COMPLETED|Overall Study||0
6756844|NCT03528174|7683377|FG000|STARTED|Overall Study||10
6756845|NCT03528174|7683377|FG000|COMPLETED|Overall Study||8
6756846|NCT03528174|7683377|FG000|NOT COMPLETED|Overall Study||2
6756847|NCT03528369|7683384|FG000|STARTED|Overall Study||40
6756848|NCT03528369|7683385|FG001|STARTED|Overall Study||42
6756849|NCT03528369|7683386|FG002|STARTED|Overall Study||40
6756850|NCT03528369|7683384|FG000|COMPLETED|Overall Study||37
6756851|NCT03528369|7683385|FG001|COMPLETED|Overall Study||41
6756852|NCT03528369|7683386|FG002|COMPLETED|Overall Study||40
6756853|NCT03528369|7683384|FG000|NOT COMPLETED|Overall Study||3
6756854|NCT03528369|7683385|FG001|NOT COMPLETED|Overall Study||1
6756855|NCT03528369|7683386|FG002|NOT COMPLETED|Overall Study||0
6756856|NCT03528512|7683396|FG000|STARTED|Overall Study||3
6756857|NCT03528512|7683397|FG001|STARTED|Overall Study||2
6756858|NCT03528512|7683396|FG000|COMPLETED|Overall Study||3
6756859|NCT03528512|7683397|FG001|COMPLETED|Overall Study||2
6756860|NCT03528512|7683396|FG000|NOT COMPLETED|Overall Study||0
6756861|NCT03528512|7683397|FG001|NOT COMPLETED|Overall Study||0
6756862|NCT03528551|7683406|FG000|STARTED|Overall Study||25
6756863|NCT03528551|7683407|FG001|STARTED|Overall Study||133
6756864|NCT03528551|7683408|FG002|STARTED|Overall Study||2
6756865|NCT03528551|7683406|FG000|COMPLETED|Overall Study||23
6756866|NCT03528551|7683407|FG001|COMPLETED|Overall Study||114
6756867|NCT03528551|7683408|FG002|COMPLETED|Overall Study||2
6756868|NCT03528551|7683406|FG000|NOT COMPLETED|Overall Study||2
6756869|NCT03528551|7683407|FG001|NOT COMPLETED|Overall Study||19
6756870|NCT03528551|7683408|FG002|NOT COMPLETED|Overall Study||0
6756871|NCT03528577|7683417|FG000|STARTED|Sequence 1||128
6756872|NCT03528577|7683417|FG000|COMPLETED|Sequence 1|Per report, 119 completed the trial, and all 119 received Treatment A, B, C and D.|126
6756873|NCT03528577|7683417|FG000|NOT COMPLETED|Sequence 1||2
6756874|NCT03528577|7683417|FG000|STARTED|Sequence 2||128
6756875|NCT03528577|7683417|FG000|COMPLETED|Sequence 2||125
6756876|NCT03528577|7683417|FG000|NOT COMPLETED|Sequence 2||3
6756877|NCT03528577|7683417|FG000|STARTED|Sequence 3||128
6555737|NCT01753999|7477903|FG000|Received Intervention|Period 2 -Cross to Alternate Arm||103
6555738|NCT01753999|7477904|FG001|Received Intervention|Period 2 -Cross to Alternate Arm||95
6555739|NCT01753999|7477903|FG000|COMPLETED|Period 2 -Cross to Alternate Arm||99
6756878|NCT03528577|7683417|FG000|COMPLETED|Sequence 3||127
6756879|NCT03528577|7683417|FG000|NOT COMPLETED|Sequence 3||1
6756880|NCT03528577|7683417|FG000|STARTED|Sequence 4||128
6756881|NCT03528577|7683417|FG000|COMPLETED|Sequence 4||125
6756882|NCT03528577|7683417|FG000|NOT COMPLETED|Sequence 4||3
6756883|NCT03529162|7683426|FG000|STARTED|Overall Study||2
6756884|NCT03529162|7683427|FG001|STARTED|Overall Study||2
6756885|NCT03529162|7683426|FG000|COMPLETED|Overall Study||0
6756886|NCT03529162|7683427|FG001|COMPLETED|Overall Study||0
6756887|NCT03529162|7683426|FG000|NOT COMPLETED|Overall Study||2
6756888|NCT03529162|7683427|FG001|NOT COMPLETED|Overall Study||2
6756889|NCT03529409|7683438|FG000|STARTED|Randomized||30
6756890|NCT03529409|7683439|FG001|STARTED|Randomized||31
6756891|NCT03529409|7683440|FG002|STARTED|Randomized||5
6756892|NCT03529409|7683438|FG000|COMPLETED|Randomized||30
6756893|NCT03529409|7683439|FG001|COMPLETED|Randomized||31
6756894|NCT03529409|7683440|FG002|COMPLETED|Randomized||0
6756895|NCT03529409|7683438|FG000|NOT COMPLETED|Randomized||0
6756896|NCT03529409|7683439|FG001|NOT COMPLETED|Randomized||0
6756897|NCT03529409|7683440|FG002|NOT COMPLETED|Randomized||5
6756898|NCT03529409|7683438|FG000|STARTED|Post-treatment Assessment||30
6756899|NCT03529409|7683439|FG001|STARTED|Post-treatment Assessment||31
6756900|NCT03529409|7683440|FG002|STARTED|Post-treatment Assessment||0
6756901|NCT03529409|7683438|FG000|COMPLETED|Post-treatment Assessment||26
6756902|NCT03529409|7683439|FG001|COMPLETED|Post-treatment Assessment||26
6756903|NCT03529409|7683440|FG002|COMPLETED|Post-treatment Assessment||0
6756904|NCT03529409|7683438|FG000|NOT COMPLETED|Post-treatment Assessment||4
6756905|NCT03529409|7683439|FG001|NOT COMPLETED|Post-treatment Assessment||5
6756906|NCT03529409|7683440|FG002|NOT COMPLETED|Post-treatment Assessment||0
6756907|NCT03529409|7683438|FG000|STARTED|Follow-up Assessment|All participants were eligible for Follow-Up regardless of Post-Treatment attendance.|28
6756908|NCT03529409|7683439|FG001|STARTED|Follow-up Assessment|All participants (n=31) were eligible for Follow-Up regardless of Post-Treatment attendance|30
6756909|NCT03529409|7683440|FG002|STARTED|Follow-up Assessment||0
6756910|NCT03529409|7683438|FG000|COMPLETED|Follow-up Assessment||27
6756911|NCT03529409|7683439|FG001|COMPLETED|Follow-up Assessment||29
6756912|NCT03529409|7683440|FG002|COMPLETED|Follow-up Assessment||0
6756913|NCT03529409|7683438|FG000|NOT COMPLETED|Follow-up Assessment||1
6756914|NCT03529409|7683439|FG001|NOT COMPLETED|Follow-up Assessment||1
6756915|NCT03529409|7683440|FG002|NOT COMPLETED|Follow-up Assessment||0
6756916|NCT03529461|7683449|FG000|STARTED|Overall Study||28
6756917|NCT03529461|7683450|FG001|STARTED|Overall Study||28
6756918|NCT03529461|7683449|FG000|COMPLETED|Overall Study||28
6756919|NCT03529461|7683450|FG001|COMPLETED|Overall Study||28
6756920|NCT03529461|7683449|FG000|NOT COMPLETED|Overall Study||0
6756921|NCT03529461|7683450|FG001|NOT COMPLETED|Overall Study||0
6756922|NCT03530098|7683459|FG000|STARTED|Overall Study||939
6756923|NCT03530098|7683460|FG001|STARTED|Overall Study||964
6756924|NCT03530098|7683459|FG000|Ground-truth Labeled|Overall Study||741
6756925|NCT03530098|7683460|FG001|Ground-truth Labeled|Overall Study||794
6756926|NCT03530098|7683459|FG000|Primary Analysis Set|Overall Study||739
6756927|NCT03530098|7683460|FG001|Primary Analysis Set|Overall Study||792
6756928|NCT03530098|7683459|FG000|COMPLETED|Overall Study||939
6756929|NCT03530098|7683460|FG001|COMPLETED|Overall Study||964
6756930|NCT03530098|7683459|FG000|NOT COMPLETED|Overall Study||0
6756931|NCT03530098|7683460|FG001|NOT COMPLETED|Overall Study||0
6756932|NCT03530345|7683469|FG000|STARTED|Treatment Period A/Follow-up Period 1||28
6756933|NCT03530345|7683470|FG001|STARTED|Treatment Period A/Follow-up Period 1||29
6756934|NCT03530345|7683469|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||26
6756935|NCT03530345|7683470|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||27
6756936|NCT03530345|7683469|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||7
6756937|NCT03530345|7683470|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||7
6756938|NCT03530345|7683469|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||21
6756939|NCT03530345|7683470|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||22
6756940|NCT03530345|7683469|FG000|STARTED|Treatment Period B/Follow-up Period 2|2 participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|5
6756941|NCT03530345|7683470|FG001|STARTED|Treatment Period B/Follow-up Period 2||7
6756942|NCT03530345|7683469|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||4
6756943|NCT03530345|7683470|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||6
6555740|NCT01753999|7477904|FG001|COMPLETED|Period 2 -Cross to Alternate Arm||89
6756944|NCT03530345|7683469|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||0
6756945|NCT03530345|7683470|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
6756946|NCT03530345|7683469|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||5
6756947|NCT03530345|7683470|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||7
6756948|NCT03530631|7683482|FG000|STARTED|Adderall/Truth||4
6756949|NCT03530631|7683482|FG000|COMPLETED|Adderall/Truth||4
6756950|NCT03530631|7683482|FG000|NOT COMPLETED|Adderall/Truth||0
6756951|NCT03530631|7683482|FG000|STARTED|Placebo/Truth||4
6756952|NCT03530631|7683482|FG000|COMPLETED|Placebo/Truth||4
6756953|NCT03530631|7683482|FG000|NOT COMPLETED|Placebo/Truth||0
6756954|NCT03530631|7683482|FG000|STARTED|Adderall/Deception||4
6756955|NCT03530631|7683482|FG000|COMPLETED|Adderall/Deception||4
6756956|NCT03530631|7683482|FG000|NOT COMPLETED|Adderall/Deception||0
6756957|NCT03530631|7683482|FG000|STARTED|Placebo/Deception||4
6756958|NCT03530631|7683482|FG000|COMPLETED|Placebo/Deception||4
6756959|NCT03530631|7683482|FG000|NOT COMPLETED|Placebo/Deception||0
6756960|NCT03530917|7683500|FG000|STARTED|Overall Study||8
6756961|NCT03530917|7683501|FG001|STARTED|Overall Study||8
6756962|NCT03530917|7683502|FG002|STARTED|Overall Study||8
6756963|NCT03530917|7683503|FG003|STARTED|Overall Study||8
6756964|NCT03530917|7683504|FG004|STARTED|Overall Study||8
6756965|NCT03530917|7683505|FG005|STARTED|Overall Study||6
6756966|NCT03530917|7683506|FG006|STARTED|Overall Study||8
6756967|NCT03530917|7683507|FG007|STARTED|Overall Study||16
6756968|NCT03530917|7683500|FG000|COMPLETED|Overall Study||8
6756969|NCT03530917|7683501|FG001|COMPLETED|Overall Study||8
6756970|NCT03530917|7683502|FG002|COMPLETED|Overall Study||8
6756971|NCT03530917|7683503|FG003|COMPLETED|Overall Study||8
6756972|NCT03530917|7683504|FG004|COMPLETED|Overall Study||8
6756973|NCT03530917|7683505|FG005|COMPLETED|Overall Study||6
6756974|NCT03530917|7683506|FG006|COMPLETED|Overall Study||8
6756975|NCT03530917|7683507|FG007|COMPLETED|Overall Study||16
6756976|NCT03530917|7683500|FG000|NOT COMPLETED|Overall Study||0
6756977|NCT03530917|7683501|FG001|NOT COMPLETED|Overall Study||0
6756978|NCT03530917|7683502|FG002|NOT COMPLETED|Overall Study||0
6756979|NCT03530917|7683503|FG003|NOT COMPLETED|Overall Study||0
6756980|NCT03530917|7683504|FG004|NOT COMPLETED|Overall Study||0
6756981|NCT03530917|7683505|FG005|NOT COMPLETED|Overall Study||0
6756982|NCT03530917|7683506|FG006|NOT COMPLETED|Overall Study||0
6756983|NCT03530917|7683507|FG007|NOT COMPLETED|Overall Study||0
6756984|NCT03531710|7683537|FG000|STARTED|Overall Study||10
6756985|NCT03531710|7683538|FG001|STARTED|Overall Study||2
6756986|NCT03531710|7683539|FG002|STARTED|Overall Study||7
6756987|NCT03531710|7683540|FG003|STARTED|Overall Study||5
6756988|NCT03531710|7683541|FG004|STARTED|Overall Study||8
6756989|NCT03531710|7683542|FG005|STARTED|Overall Study||2
6756990|NCT03531710|7683537|FG000|COMPLETED|Overall Study||8
6756991|NCT03531710|7683538|FG001|COMPLETED|Overall Study||2
6756992|NCT03531710|7683539|FG002|COMPLETED|Overall Study||7
6756993|NCT03531710|7683540|FG003|COMPLETED|Overall Study||5
6756994|NCT03531710|7683541|FG004|COMPLETED|Overall Study||8
6756995|NCT03531710|7683542|FG005|COMPLETED|Overall Study||2
6756996|NCT03531710|7683537|FG000|NOT COMPLETED|Overall Study||2
6756997|NCT03531710|7683538|FG001|NOT COMPLETED|Overall Study||0
6756998|NCT03531710|7683539|FG002|NOT COMPLETED|Overall Study||0
6756999|NCT03531710|7683540|FG003|NOT COMPLETED|Overall Study||0
6757000|NCT03531710|7683541|FG004|NOT COMPLETED|Overall Study||0
6757001|NCT03531710|7683542|FG005|NOT COMPLETED|Overall Study||0
6757002|NCT03531840|7683560|FG000|STARTED|Overall Study||5
6757003|NCT03531840|7683561|FG001|STARTED|Overall Study||6
6757004|NCT03531840|7683562|FG002|STARTED|Overall Study||8
6757005|NCT03531840|7683563|FG003|STARTED|Overall Study||4
6757006|NCT03531840|7683560|FG000|COMPLETED|Overall Study||0
6757007|NCT03531840|7683561|FG001|COMPLETED|Overall Study||1
6757008|NCT03531840|7683562|FG002|COMPLETED|Overall Study||3
6757009|NCT03531840|7683563|FG003|COMPLETED|Overall Study||1
6757010|NCT03531840|7683560|FG000|NOT COMPLETED|Overall Study||5
6757011|NCT03531840|7683561|FG001|NOT COMPLETED|Overall Study||5
6757012|NCT03531840|7683562|FG002|NOT COMPLETED|Overall Study||5
6555741|NCT01753999|7477903|FG000|NOT COMPLETED|Period 2 -Cross to Alternate Arm||17
6555742|NCT01753999|7477904|FG001|NOT COMPLETED|Period 2 -Cross to Alternate Arm||23
6757013|NCT03531840|7683563|FG003|NOT COMPLETED|Overall Study||3
6757014|NCT03531905|7683581|FG000|STARTED|Overall Study||81
6757015|NCT03531905|7683582|FG001|STARTED|Overall Study||81
6757016|NCT03531905|7683583|FG002|STARTED|Overall Study||80
6757017|NCT03531905|7683581|FG000|COMPLETED|Overall Study||74
6757018|NCT03531905|7683582|FG001|COMPLETED|Overall Study||76
6757019|NCT03531905|7683583|FG002|COMPLETED|Overall Study||77
6757020|NCT03531905|7683581|FG000|NOT COMPLETED|Overall Study||7
6757021|NCT03531905|7683582|FG001|NOT COMPLETED|Overall Study||5
6757022|NCT03531905|7683583|FG002|NOT COMPLETED|Overall Study||3
6757023|NCT03532009|7683595|FG000|STARTED|Overall Study||92
6757024|NCT03532009|7683596|FG001|STARTED|Overall Study||90
6757025|NCT03532009|7683595|FG000|Received Treatment|Overall Study||91
6757026|NCT03532009|7683596|FG001|Received Treatment|Overall Study||90
6757027|NCT03532009|7683595|FG000|COMPLETED|Overall Study||90
6757028|NCT03532009|7683596|FG001|COMPLETED|Overall Study||86
6757029|NCT03532009|7683595|FG000|NOT COMPLETED|Overall Study||2
6757030|NCT03532009|7683596|FG001|NOT COMPLETED|Overall Study||4
6757031|NCT03532048|7683604|FG000|STARTED|Overall Study|68 individuals (19 fathers, 31 children & 18 mothers)|68
6757032|NCT03532048|7683605|FG001|STARTED|Overall Study|67 individuals (17 fathers, 33 children & 17 mothers)|67
6757033|NCT03532048|7683604|FG000|COMPLETED|Overall Study|49 individuals (14 fathers, 22 children, 13 mothers). 1 father only took part in interview|49
6757034|NCT03532048|7683605|FG001|COMPLETED|Overall Study|50 individuals (13 fathers, 24 children & 13 mothers)|50
6757035|NCT03532048|7683604|FG000|NOT COMPLETED|Overall Study||19
6757036|NCT03532048|7683605|FG001|NOT COMPLETED|Overall Study||17
6757037|NCT03532308|7683613|FG000|STARTED|Overall Study||10
6757038|NCT03532308|7683614|FG001|STARTED|Overall Study||9
6757039|NCT03532308|7683613|FG000|Completed Assessments|Overall Study||9
6757040|NCT03532308|7683614|FG001|Completed Assessments|Overall Study||7
6757041|NCT03532308|7683613|FG000|COMPLETED|Overall Study||10
6757042|NCT03532308|7683614|FG001|COMPLETED|Overall Study||8
6757043|NCT03532308|7683613|FG000|NOT COMPLETED|Overall Study||0
6757044|NCT03532308|7683614|FG001|NOT COMPLETED|Overall Study||1
6757045|NCT03532776|7683623|FG000|STARTED|Overall Study||201
6757046|NCT03532776|7683624|FG001|STARTED|Overall Study||198
6757047|NCT03532776|7683625|FG002|STARTED|Overall Study||67
6757048|NCT03532776|7683623|FG000|COMPLETED|Overall Study||196
6757049|NCT03532776|7683624|FG001|COMPLETED|Overall Study||194
6757050|NCT03532776|7683625|FG002|COMPLETED|Overall Study||63
6757051|NCT03532776|7683623|FG000|NOT COMPLETED|Overall Study||5
6757052|NCT03532776|7683624|FG001|NOT COMPLETED|Overall Study||4
6757053|NCT03532776|7683625|FG002|NOT COMPLETED|Overall Study||4
6757054|NCT03533036|7683636|FG000|STARTED|Overall Study||15
6757055|NCT03533036|7683637|FG001|STARTED|Overall Study||15
6757056|NCT03533036|7683636|FG000|COMPLETED|Overall Study||15
6757057|NCT03533036|7683637|FG001|COMPLETED|Overall Study||15
6757058|NCT03533036|7683636|FG000|NOT COMPLETED|Overall Study||0
6757059|NCT03533036|7683637|FG001|NOT COMPLETED|Overall Study||0
6757060|NCT03533114|7683645|FG000|STARTED|Overall||88
6757061|NCT03533114|7683646|FG001|STARTED|Overall||66
6757062|NCT03533114|7683645|FG000|COMPLETED|Overall||57
6757063|NCT03533114|7683646|FG001|COMPLETED|Overall||38
6757064|NCT03533114|7683645|FG000|NOT COMPLETED|Overall||31
6757065|NCT03533114|7683646|FG001|NOT COMPLETED|Overall||28
6757066|NCT03533114|7683645|FG000|STARTED|Open Label Titration and Optimization||88
6757067|NCT03533114|7683646|FG001|STARTED|Open Label Titration and Optimization||66
6757068|NCT03533114|7683645|FG000|COMPLETED|Open Label Titration and Optimization||72
6757069|NCT03533114|7683646|FG001|COMPLETED|Open Label Titration and Optimization||53
6757070|NCT03533114|7683645|FG000|NOT COMPLETED|Open Label Titration and Optimization||16
6757071|NCT03533114|7683646|FG001|NOT COMPLETED|Open Label Titration and Optimization||13
6757072|NCT03533114|7683645|FG000|STARTED|Stable Dose||71
6757073|NCT03533114|7683646|FG001|STARTED|Stable Dose||52
6555743|NCT01754129|7477915|FG000|STARTED|Overall Study||148
6555744|NCT01754129|7477915|FG000|Visit 1 (Enrollment Day)|Overall Study||145
6555745|NCT01754129|7477915|FG000|Visit 2 (Year 1)|Overall Study||129
6555746|NCT01754129|7477915|FG000|Visit 3 (Year 2)|Overall Study||115
6555747|NCT01754129|7477915|FG000|COMPLETED|Overall Study||115
6555748|NCT01754129|7477915|FG000|NOT COMPLETED|Overall Study||33
6555749|NCT01754194|7477928|FG000|STARTED|Overall Study||169
6555750|NCT01754194|7477929|FG001|STARTED|Overall Study||124
6555751|NCT01754194|7477928|FG000|COMPLETED|Overall Study||117
6757074|NCT03533114|7683645|FG000|COMPLETED|Stable Dose||69
6757075|NCT03533114|7683646|FG001|COMPLETED|Stable Dose||50
6757076|NCT03533114|7683645|FG000|NOT COMPLETED|Stable Dose||2
6757077|NCT03533114|7683646|FG001|NOT COMPLETED|Stable Dose||2
6757078|NCT03533114|7683645|FG000|STARTED|Double Blind Randomized-Withdrawal||69
6757079|NCT03533114|7683646|FG001|STARTED|Double Blind Randomized-Withdrawal||47
6757080|NCT03533114|7683645|FG000|JZP-258|Double Blind Randomized-Withdrawal||57
6757081|NCT03533114|7683646|FG001|JZP-258|Double Blind Randomized-Withdrawal||0
6757082|NCT03533114|7683645|FG000|Placebo|Double Blind Randomized-Withdrawal||0
6555752|NCT01754194|7477929|FG001|COMPLETED|Overall Study||97
6555753|NCT01754194|7477928|FG000|NOT COMPLETED|Overall Study||52
6555754|NCT01754194|7477929|FG001|NOT COMPLETED|Overall Study||27
6555755|NCT01754207|7477937|FG000|STARTED|Overall Study||20
6555756|NCT01754207|7477937|FG000|COMPLETED|Overall Study||17
6555757|NCT01754207|7477937|FG000|NOT COMPLETED|Overall Study||3
6555758|NCT01754259|7477943|FG000|STARTED|Overall Study||23
6555759|NCT01754259|7477944|FG001|STARTED|Overall Study||24
6555760|NCT01754259|7477943|FG000|COMPLETED|Overall Study||18
6555761|NCT01754259|7477944|FG001|COMPLETED|Overall Study||18
6555762|NCT01754259|7477943|FG000|NOT COMPLETED|Overall Study||5
6555763|NCT01754259|7477944|FG001|NOT COMPLETED|Overall Study||6
6555764|NCT01754350|7477952|FG000|STARTED|Overall Study||25
6555765|NCT01754350|7477953|FG001|STARTED|Overall Study||25
6555766|NCT01754350|7477952|FG000|COMPLETED|Overall Study||20
6555767|NCT01754350|7477953|FG001|COMPLETED|Overall Study||22
6555768|NCT01754350|7477952|FG000|NOT COMPLETED|Overall Study||5
6555769|NCT01754350|7477953|FG001|NOT COMPLETED|Overall Study||3
6555770|NCT01754376|7477959|FG000|STARTED|Overall Study||6
6555771|NCT01754376|7477959|FG000|Completed 2-week Lead in of Vemurafenib|Overall Study||6
6757083|NCT03533114|7683646|FG001|Placebo|Double Blind Randomized-Withdrawal||59
6757084|NCT03533114|7683645|FG000|COMPLETED|Double Blind Randomized-Withdrawal||67
6757085|NCT03533114|7683646|FG001|COMPLETED|Double Blind Randomized-Withdrawal||46
6757086|NCT03533114|7683645|FG000|NOT COMPLETED|Double Blind Randomized-Withdrawal||2
6757087|NCT03533114|7683646|FG001|NOT COMPLETED|Double Blind Randomized-Withdrawal||1
6757088|NCT03533114|7683645|FG000|STARTED|Open-Label Safety Extension||65
6757089|NCT03533114|7683646|FG001|STARTED|Open-Label Safety Extension||41
6757090|NCT03533114|7683645|FG000|COMPLETED|Open-Label Safety Extension||57
6555772|NCT01754376|7477959|FG000|COMPLETED|Overall Study||3
6555773|NCT01754376|7477959|FG000|NOT COMPLETED|Overall Study||3
6555774|NCT01754389|7477967|FG000|STARTED|Overall Study||46
6555775|NCT01754389|7477968|FG001|STARTED|Overall Study||45
6555776|NCT01754389|7477969|FG002|STARTED|Overall Study||47
6555777|NCT01754389|7477967|FG000|COMPLETED|Overall Study||46
6555778|NCT01754389|7477968|FG001|COMPLETED|Overall Study||45
6555779|NCT01754389|7477969|FG002|COMPLETED|Overall Study||47
6555780|NCT01754389|7477967|FG000|NOT COMPLETED|Overall Study||0
6555781|NCT01754389|7477968|FG001|NOT COMPLETED|Overall Study||0
6555782|NCT01754389|7477969|FG002|NOT COMPLETED|Overall Study||0
6555783|NCT01754402|7477980|FG000|STARTED|Overall Study||6
6555784|NCT01754402|7477981|FG001|STARTED|Overall Study||2
6555785|NCT01754402|7477982|FG002|STARTED|Overall Study||30
6555786|NCT01754402|7477980|FG000|COMPLETED|Overall Study||4
6555787|NCT01754402|7477981|FG001|COMPLETED|Overall Study||0
6555788|NCT01754402|7477982|FG002|COMPLETED|Overall Study||26
6555789|NCT01754402|7477980|FG000|NOT COMPLETED|Overall Study||2
6555790|NCT01754402|7477981|FG001|NOT COMPLETED|Overall Study||2
6555791|NCT01754402|7477982|FG002|NOT COMPLETED|Overall Study||4
6555792|NCT01754467|7477991|FG000|STARTED|Overall Study||9
6555793|NCT01754467|7477991|FG000|COMPLETED|Overall Study||8
6555794|NCT01754467|7477991|FG000|NOT COMPLETED|Overall Study||1
6555795|NCT01754480|7477997|FG000|STARTED|Part I + Part II (Overall Study)||163
6555796|NCT01754480|7477998|FG001|STARTED|Part I + Part II (Overall Study)||162
6555797|NCT01754480|7477997|FG000|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
6555798|NCT01754480|7477998|FG001|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
6555799|NCT01754480|7477997|FG000|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
6555800|NCT01754480|7477998|FG001|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
6555801|NCT01754480|7477997|FG000|NOT COMPLETED|Part I + Part II (Overall Study)||25
6555802|NCT01754480|7477998|FG001|NOT COMPLETED|Part I + Part II (Overall Study)||23
6555803|NCT01754480|7477997|FG000|STARTED|Primary Part II||111
6555804|NCT01754480|7477998|FG001|STARTED|Primary Part II||113
6555805|NCT01754480|7477997|FG000|Completed Study up to Week 6|Primary Part II||100
6555806|NCT01754480|7477998|FG001|Completed Study up to Week 6|Primary Part II||108
6555807|NCT01754480|7477997|FG000|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
6555808|NCT01754480|7477998|FG001|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
6555809|NCT01754480|7477997|FG000|NOT COMPLETED|Primary Part II||15
6555810|NCT01754480|7477998|FG001|NOT COMPLETED|Primary Part II||11
6555811|NCT01754493|7478005|FG000|STARTED|Overall Study||17
6555812|NCT01754493|7478005|FG000|COMPLETED|Overall Study||10
6555813|NCT01754493|7478005|FG000|NOT COMPLETED|Overall Study||7
6562791|NCT01803074|7485704|FG005|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562792|NCT01803074|7485705|FG006|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562793|NCT01803074|7485706|FG007|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
6562794|NCT01803074|7485707|FG008|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
6562795|NCT01803074|7485708|FG009|COMPLETED|Period 2: Part B (HIV-1 Clade B)||4
6562796|NCT01803074|7485709|FG010|COMPLETED|Period 2: Part B (HIV-1 Clade B)||8
6562797|NCT01803074|7485710|FG011|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562798|NCT01803074|7485711|FG012|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562799|NCT01803074|7485712|FG013|COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562800|NCT01803074|7485699|FG000|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562801|NCT01803074|7485700|FG001|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562802|NCT01803074|7485701|FG002|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562803|NCT01803074|7485702|FG003|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562804|NCT01803074|7485703|FG004|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562805|NCT01803074|7485704|FG005|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562806|NCT01803074|7485705|FG006|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562807|NCT01803074|7485706|FG007|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562808|NCT01803074|7485707|FG008|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562809|NCT01803074|7485708|FG009|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562810|NCT01803074|7485709|FG010|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562811|NCT01803074|7485710|FG011|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562812|NCT01803074|7485711|FG012|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562813|NCT01803074|7485712|FG013|NOT COMPLETED|Period 2: Part B (HIV-1 Clade B)||0
6562814|NCT01803074|7485699|FG000|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562815|NCT01803074|7485700|FG001|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562816|NCT01803074|7485701|FG002|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562817|NCT01803074|7485702|FG003|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562818|NCT01803074|7485703|FG004|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562819|NCT01803074|7485704|FG005|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562820|NCT01803074|7485705|FG006|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562821|NCT01803074|7485706|FG007|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562822|NCT01803074|7485707|FG008|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562823|NCT01803074|7485708|FG009|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562824|NCT01803074|7485709|FG010|STARTED|Period 3: Part C (HIV-1 Clade C Only)||0
6562825|NCT01803074|7485710|FG011|STARTED|Period 3: Part C (HIV-1 Clade C Only)||8
6555814|NCT01754519|7478009|FG000|STARTED|Overall Study||1
6555815|NCT01754519|7478009|FG000|COMPLETED|Overall Study||1
6555816|NCT01754519|7478009|FG000|NOT COMPLETED|Overall Study||0
6555817|NCT01754623|7478013|FG000|STARTED|Overall Study||9
6555818|NCT01754623|7478013|FG000|COMPLETED|Overall Study||9
6555819|NCT01754623|7478013|FG000|NOT COMPLETED|Overall Study||0
6555820|NCT01754688|7478019|FG000|STARTED|Overall Study||624
6555821|NCT01754688|7478019|FG000|COMPLETED|Overall Study||624
6555822|NCT01754688|7478019|FG000|NOT COMPLETED|Overall Study||0
6555823|NCT01754714|7478028|FG000|STARTED|Overall Study||27
6555824|NCT01754714|7478029|FG001|STARTED|Overall Study||27
6555825|NCT01754714|7478030|FG002|STARTED|Overall Study||26
6555826|NCT01754714|7478031|FG003|STARTED|Overall Study||28
6555827|NCT01754714|7478028|FG000|COMPLETED|Overall Study||27
6555828|NCT01754714|7478029|FG001|COMPLETED|Overall Study||26
6555829|NCT01754714|7478030|FG002|COMPLETED|Overall Study||24
6555830|NCT01754714|7478031|FG003|COMPLETED|Overall Study||27
6555831|NCT01754714|7478028|FG000|NOT COMPLETED|Overall Study||0
6555832|NCT01754714|7478029|FG001|NOT COMPLETED|Overall Study||1
6555833|NCT01754714|7478030|FG002|NOT COMPLETED|Overall Study||2
6555834|NCT01754714|7478031|FG003|NOT COMPLETED|Overall Study||1
6555835|NCT01754727|7478042|FG000|STARTED|Overall Study||452
6555836|NCT01754727|7478042|FG000|COMPLETED|Overall Study||450
6555837|NCT01754727|7478042|FG000|NOT COMPLETED|Overall Study||2
6555838|NCT01754753|7478048|FG000|STARTED|Overall Study||78
6555839|NCT01754753|7478049|FG001|STARTED|Overall Study||79
6757091|NCT03533114|7683646|FG001|COMPLETED|Open-Label Safety Extension||38
6757092|NCT03533114|7683645|FG000|NOT COMPLETED|Open-Label Safety Extension||8
6757093|NCT03533114|7683646|FG001|NOT COMPLETED|Open-Label Safety Extension||3
6757094|NCT03533244|7683657|FG000|STARTED|Overall Study||20
6757095|NCT03533244|7683658|FG001|STARTED|Overall Study||22
6757096|NCT03533244|7683659|FG002|STARTED|Overall Study||22
6757097|NCT03533244|7683657|FG000|COMPLETED|Overall Study||18
6757098|NCT03533244|7683658|FG001|COMPLETED|Overall Study||21
6757099|NCT03533244|7683659|FG002|COMPLETED|Overall Study||22
6757100|NCT03533244|7683657|FG000|NOT COMPLETED|Overall Study||2
6757101|NCT03533244|7683658|FG001|NOT COMPLETED|Overall Study||1
6757102|NCT03533244|7683659|FG002|NOT COMPLETED|Overall Study||0
6757103|NCT03533374|7683669|FG000|STARTED|Overall Study||54
6757104|NCT03533374|7683670|FG001|STARTED|Overall Study||46
6757105|NCT03533374|7683669|FG000|COMPLETED|Overall Study||54
6757106|NCT03533374|7683670|FG001|COMPLETED|Overall Study||46
6757107|NCT03533374|7683669|FG000|NOT COMPLETED|Overall Study||0
6757108|NCT03533374|7683670|FG001|NOT COMPLETED|Overall Study||0
6757109|NCT03533608|7683676|FG000|STARTED|Overall Study||39
6757110|NCT03533608|7683676|FG000|COMPLETED|Overall Study||34
6757111|NCT03533608|7683676|FG000|NOT COMPLETED|Overall Study||5
6757112|NCT03533829|7683684|FG000|STARTED|Overall Study||10
6757113|NCT03533829|7683685|FG001|STARTED|Overall Study||10
6757114|NCT03533829|7683686|FG002|STARTED|Overall Study||10
6757115|NCT03533829|7683684|FG000|COMPLETED|Overall Study||10
6757116|NCT03533829|7683685|FG001|COMPLETED|Overall Study||10
6757117|NCT03533829|7683686|FG002|COMPLETED|Overall Study||10
6757118|NCT03533829|7683684|FG000|NOT COMPLETED|Overall Study||0
6757119|NCT03533829|7683685|FG001|NOT COMPLETED|Overall Study||0
6757120|NCT03533829|7683686|FG002|NOT COMPLETED|Overall Study||0
6757121|NCT03534427|7683696|FG000|STARTED|Overall Study||20
6757122|NCT03534427|7683697|FG001|STARTED|Overall Study||20
6757123|NCT03534427|7683696|FG000|COMPLETED|Overall Study||20
6757124|NCT03534427|7683697|FG001|COMPLETED|Overall Study||20
6757125|NCT03534427|7683696|FG000|NOT COMPLETED|Overall Study||0
6757126|NCT03534427|7683697|FG001|NOT COMPLETED|Overall Study||0
6757127|NCT03534986|7683706|FG000|STARTED|Overall Study||10
6757128|NCT03534986|7683707|FG001|STARTED|Overall Study||10
6555840|NCT01754753|7478048|FG000|COMPLETED|Overall Study||26
6555841|NCT01754753|7478049|FG001|COMPLETED|Overall Study||30
6555842|NCT01754753|7478048|FG000|NOT COMPLETED|Overall Study||52
6555843|NCT01754753|7478049|FG001|NOT COMPLETED|Overall Study||49
6555844|NCT01754766|7478058|FG000|STARTED|Overall Study||31
6555845|NCT01754766|7478059|FG001|STARTED|Overall Study||29
6555846|NCT01754766|7478060|FG002|STARTED|Overall Study||30
6555847|NCT01754766|7478058|FG000|COMPLETED|Overall Study||30
6555848|NCT01754766|7478059|FG001|COMPLETED|Overall Study||28
6555849|NCT01754766|7478060|FG002|COMPLETED|Overall Study||30
6555850|NCT01754766|7478058|FG000|NOT COMPLETED|Overall Study||1
6555851|NCT01754766|7478059|FG001|NOT COMPLETED|Overall Study||1
6555852|NCT01754766|7478060|FG002|NOT COMPLETED|Overall Study||0
6757129|NCT03534986|7683708|FG002|STARTED|Overall Study||12
6757130|NCT03534986|7683706|FG000|COMPLETED|Overall Study||10
6757131|NCT03534986|7683707|FG001|COMPLETED|Overall Study||10
6757132|NCT03534986|7683708|FG002|COMPLETED|Overall Study||10
6757133|NCT03534986|7683706|FG000|NOT COMPLETED|Overall Study||0
6757134|NCT03534986|7683707|FG001|NOT COMPLETED|Overall Study||0
6757135|NCT03534986|7683708|FG002|NOT COMPLETED|Overall Study||2
6757136|NCT03535194|7683721|FG000|STARTED|Induction Period||454
6757137|NCT03535194|7683722|FG001|STARTED|Induction Period||451
6757138|NCT03535194|7683723|FG002|STARTED|Induction Period||112
6757139|NCT03535194|7683724|FG003|STARTED|Induction Period||448
6757140|NCT03535194|7683725|FG004|STARTED|Induction Period|A plaque psoriasis participant was misrandomized by the site.|19
6757141|NCT03535194|7683721|FG000|Received at Least One Dose of Study Drug|Induction Period||454
6757142|NCT03535194|7683722|FG001|Received at Least One Dose of Study Drug|Induction Period||450
6757143|NCT03535194|7683723|FG002|Received at Least One Dose of Study Drug|Induction Period||112
6555853|NCT01754909|7478070|FG000|STARTED|Overall Study||20
6555854|NCT01754909|7478071|FG001|STARTED|Overall Study||23
6757144|NCT03535194|7683724|FG003|Received at Least One Dose of Study Drug|Induction Period||448
6757145|NCT03535194|7683725|FG004|Received at Least One Dose of Study Drug|Induction Period||19
6757146|NCT03535194|7683721|FG000|COMPLETED|Induction Period||443
6757147|NCT03535194|7683722|FG001|COMPLETED|Induction Period||434
6757148|NCT03535194|7683723|FG002|COMPLETED|Induction Period||104
6757149|NCT03535194|7683724|FG003|COMPLETED|Induction Period||437
6757150|NCT03535194|7683725|FG004|COMPLETED|Induction Period||19
6757151|NCT03535194|7683721|FG000|NOT COMPLETED|Induction Period||11
6757152|NCT03535194|7683722|FG001|NOT COMPLETED|Induction Period||17
6757153|NCT03535194|7683723|FG002|NOT COMPLETED|Induction Period||8
6757154|NCT03535194|7683724|FG003|NOT COMPLETED|Induction Period||11
6757155|NCT03535194|7683725|FG004|NOT COMPLETED|Induction Period||0
6757156|NCT03535194|7683721|FG000|STARTED|Maintenance Period||443
6757157|NCT03535194|7683722|FG001|STARTED|Maintenance Period||434
6757158|NCT03535194|7683723|FG002|STARTED|Maintenance Period||104
6757159|NCT03535194|7683724|FG003|STARTED|Maintenance Period||437
6757160|NCT03535194|7683725|FG004|STARTED|Maintenance Period||19
6757161|NCT03535194|7683721|FG000|COMPLETED|Maintenance Period||421
6757162|NCT03535194|7683722|FG001|COMPLETED|Maintenance Period||418
6757163|NCT03535194|7683723|FG002|COMPLETED|Maintenance Period||96
6757164|NCT03535194|7683724|FG003|COMPLETED|Maintenance Period||400
6757165|NCT03535194|7683725|FG004|COMPLETED|Maintenance Period||13
6757166|NCT03535194|7683721|FG000|NOT COMPLETED|Maintenance Period||22
6757167|NCT03535194|7683722|FG001|NOT COMPLETED|Maintenance Period||16
6757168|NCT03535194|7683723|FG002|NOT COMPLETED|Maintenance Period||8
6757169|NCT03535194|7683724|FG003|NOT COMPLETED|Maintenance Period||37
6757170|NCT03535194|7683725|FG004|NOT COMPLETED|Maintenance Period||6
6757171|NCT03535194|7683721|FG000|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|38
6757172|NCT03535194|7683722|FG001|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|35
6757173|NCT03535194|7683723|FG002|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|18
6757174|NCT03535194|7683724|FG003|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|47
6757175|NCT03535194|7683725|FG004|STARTED|Post-Treatment Followup Period|Participants who discontinued/completed Induction/Maintenance had option to enter post-treatment|8
6757176|NCT03535194|7683721|FG000|COMPLETED|Post-Treatment Followup Period||27
6757177|NCT03535194|7683722|FG001|COMPLETED|Post-Treatment Followup Period||21
6757178|NCT03535194|7683723|FG002|COMPLETED|Post-Treatment Followup Period||7
6757179|NCT03535194|7683724|FG003|COMPLETED|Post-Treatment Followup Period||23
6757180|NCT03535194|7683725|FG004|COMPLETED|Post-Treatment Followup Period||8
6757181|NCT03535194|7683721|FG000|NOT COMPLETED|Post-Treatment Followup Period||11
6757182|NCT03535194|7683722|FG001|NOT COMPLETED|Post-Treatment Followup Period||14
6757183|NCT03535194|7683723|FG002|NOT COMPLETED|Post-Treatment Followup Period||11
6757184|NCT03535194|7683724|FG003|NOT COMPLETED|Post-Treatment Followup Period||24
6757185|NCT03535194|7683725|FG004|NOT COMPLETED|Post-Treatment Followup Period||0
6757186|NCT03535571|7683749|FG000|STARTED|Overall Study||20
6757187|NCT03535571|7683749|FG000|COMPLETED|Overall Study||19
6757188|NCT03535571|7683749|FG000|NOT COMPLETED|Overall Study||1
6757189|NCT03535649|7683755|FG000|STARTED|Overall Study||105
6757190|NCT03535649|7683755|FG000|COMPLETED|Overall Study||105
6757191|NCT03535649|7683755|FG000|NOT COMPLETED|Overall Study||0
6757192|NCT03535844|7683761|FG000|STARTED|Overall Study||22
6757193|NCT03535844|7683762|FG001|STARTED|Overall Study||19
6757194|NCT03535844|7683761|FG000|COMPLETED|Overall Study||22
6757195|NCT03535844|7683762|FG001|COMPLETED|Overall Study||18
6757196|NCT03535844|7683761|FG000|NOT COMPLETED|Overall Study||0
6757197|NCT03535844|7683762|FG001|NOT COMPLETED|Overall Study||1
6757198|NCT03535974|7683771|FG000|STARTED|First Intervention Weeks 0-6 (V1-V2)||14
6757199|NCT03535974|7683772|FG001|STARTED|First Intervention Weeks 0-6 (V1-V2)||19
6757200|NCT03535974|7683773|FG002|STARTED|First Intervention Weeks 0-6 (V1-V2)||5
6757201|NCT03535974|7683771|FG000|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||12
6757202|NCT03535974|7683772|FG001|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||17
6757203|NCT03535974|7683773|FG002|COMPLETED|First Intervention Weeks 0-6 (V1-V2)||5
6757204|NCT03535974|7683771|FG000|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
6757205|NCT03535974|7683772|FG001|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||2
6757206|NCT03535974|7683773|FG002|NOT COMPLETED|First Intervention Weeks 0-6 (V1-V2)||0
6757207|NCT03535974|7683771|FG000|STARTED|Second Intervention Weeks 6-12 (V2-V3)||12
6757208|NCT03535974|7683772|FG001|STARTED|Second Intervention Weeks 6-12 (V2-V3)||17
6757209|NCT03535974|7683773|FG002|STARTED|Second Intervention Weeks 6-12 (V2-V3)||5
6757210|NCT03535974|7683771|FG000|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||12
6757211|NCT03535974|7683772|FG001|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||17
6757212|NCT03535974|7683773|FG002|COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||5
6757213|NCT03535974|7683771|FG000|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
6555855|NCT01754909|7478070|FG000|COMPLETED|Overall Study||20
6757214|NCT03535974|7683772|FG001|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
6757215|NCT03535974|7683773|FG002|NOT COMPLETED|Second Intervention Weeks 6-12 (V2-V3)||0
6757216|NCT03536663|7683781|FG000|STARTED|Optiflux||23
6757217|NCT03536663|7683781|FG000|COMPLETED|Optiflux||19
6757218|NCT03536663|7683781|FG000|NOT COMPLETED|Optiflux||4
6757219|NCT03536663|7683781|FG000|STARTED|Endexo|One subject completed the Optiflux period but missed Visit 13 and was withdrawn per protocol.|18
6757220|NCT03536663|7683781|FG000|COMPLETED|Endexo||17
6757221|NCT03536663|7683781|FG000|NOT COMPLETED|Endexo||1
6757222|NCT03536702|7683792|FG000|STARTED|Overall Study||40
6757223|NCT03536702|7683793|FG001|STARTED|Overall Study||20
6757224|NCT03536702|7683792|FG000|COMPLETED|Overall Study||26
6757225|NCT03536702|7683793|FG001|COMPLETED|Overall Study||8
6757226|NCT03536702|7683792|FG000|NOT COMPLETED|Overall Study||14
6757227|NCT03536702|7683793|FG001|NOT COMPLETED|Overall Study||12
6757228|NCT03536819|7683799|FG000|STARTED|Overall Study||20
6757229|NCT03536819|7683799|FG000|COMPLETED|Overall Study||15
6757230|NCT03536819|7683799|FG000|NOT COMPLETED|Overall Study||5
6757231|NCT03536923|7683803|FG000|STARTED|Overall Study||23
6757232|NCT03536923|7683803|FG000|COMPLETED|Overall Study||23
6757233|NCT03536923|7683803|FG000|NOT COMPLETED|Overall Study||0
6757234|NCT03536949|7683809|FG000|STARTED|Overall Study||157
6757235|NCT03536949|7683810|FG001|STARTED|Overall Study||77
6757236|NCT03536949|7683809|FG000|COMPLETED|Overall Study||143
6757237|NCT03536949|7683810|FG001|COMPLETED|Overall Study||75
6757238|NCT03536949|7683809|FG000|NOT COMPLETED|Overall Study||14
6757239|NCT03536949|7683810|FG001|NOT COMPLETED|Overall Study||2
6757240|NCT03537014|7683818|FG000|STARTED|Overall Study||46
6757241|NCT03537014|7683819|FG001|STARTED|Overall Study||45
6757242|NCT03537014|7683818|FG000|Withdrew Consent Before Dosing|Overall Study||0
6757243|NCT03537014|7683819|FG001|Withdrew Consent Before Dosing|Overall Study||1
6757244|NCT03537014|7683818|FG000|Completed First Experimental Session|Overall Study||46
6757245|NCT03537014|7683819|FG001|Completed First Experimental Session|Overall Study||44
6757246|NCT03537014|7683818|FG000|Completed Second Experimental Session|Overall Study||43
6757247|NCT03537014|7683819|FG001|Completed Second Experimental Session|Overall Study||41
6757248|NCT03537014|7683818|FG000|COMPLETED|Overall Study||42
6757249|NCT03537014|7683819|FG001|COMPLETED|Overall Study||40
6757250|NCT03537014|7683818|FG000|NOT COMPLETED|Overall Study||4
6757251|NCT03537014|7683819|FG001|NOT COMPLETED|Overall Study||5
6757252|NCT03537092|7683825|FG000|STARTED|Overall Study||64
6757253|NCT03537092|7683825|FG000|COMPLETED|Overall Study||64
6757254|NCT03537092|7683825|FG000|NOT COMPLETED|Overall Study||0
6757255|NCT03537261|7683831|FG000|STARTED|Overall Study||41
6757256|NCT03537261|7683832|FG001|STARTED|Overall Study||39
6757257|NCT03537261|7683831|FG000|Completed Baseline Assessment|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|35
6757258|NCT03537261|7683832|FG001|Completed Baseline Assessment|Overall Study||28
6757259|NCT03537261|7683831|FG000|COMPLETED|Overall Study|One participant did not attend the CPI-Parent training but remained in the study.|33
6757260|NCT03537261|7683832|FG001|COMPLETED|Overall Study||27
6757261|NCT03537261|7683831|FG000|NOT COMPLETED|Overall Study||8
6757262|NCT03537261|7683832|FG001|NOT COMPLETED|Overall Study||12
6757263|NCT03537274|7683842|FG000|STARTED|Overall Study||315
6757264|NCT03537274|7683843|FG001|STARTED|Overall Study||298
6757265|NCT03537274|7683844|FG002|STARTED|Overall Study||304
6757266|NCT03537274|7683845|FG003|STARTED|Overall Study||307
6757267|NCT03537274|7683842|FG000|Treated|Overall Study||315
6757268|NCT03537274|7683843|FG001|Treated|Overall Study||297
6757269|NCT03537274|7683844|FG002|Treated|Overall Study||304
6757270|NCT03537274|7683845|FG003|Treated|Overall Study||303
6757271|NCT03537274|7683842|FG000|COMPLETED|Overall Study||255
6757272|NCT03537274|7683843|FG001|COMPLETED|Overall Study||229
6757273|NCT03537274|7683844|FG002|COMPLETED|Overall Study||228
6757274|NCT03537274|7683845|FG003|COMPLETED|Overall Study||231
6555856|NCT01754909|7478071|FG001|COMPLETED|Overall Study||23
6555857|NCT01754909|7478070|FG000|NOT COMPLETED|Overall Study||0
6555858|NCT01754909|7478071|FG001|NOT COMPLETED|Overall Study||0
6555859|NCT01754922|7478079|FG000|STARTED|Overall Study||32
6555860|NCT01754922|7478080|FG001|STARTED|Overall Study||18
6555861|NCT01754922|7478079|FG000|COMPLETED|Overall Study||32
6555862|NCT01754922|7478080|FG001|COMPLETED|Overall Study||17
6555863|NCT01754922|7478079|FG000|NOT COMPLETED|Overall Study||0
6555864|NCT01754922|7478080|FG001|NOT COMPLETED|Overall Study||1
6555865|NCT01755026|7478089|FG000|STARTED|Overall Study||11
6555866|NCT01755026|7478090|FG001|STARTED|Overall Study||12
6555867|NCT01755026|7478089|FG000|COMPLETED|Overall Study||9
6555868|NCT01755026|7478090|FG001|COMPLETED|Overall Study||11
6555869|NCT01755026|7478089|FG000|NOT COMPLETED|Overall Study||2
6555870|NCT01755026|7478090|FG001|NOT COMPLETED|Overall Study||1
6757275|NCT03537274|7683842|FG000|NOT COMPLETED|Overall Study||60
6757276|NCT03537274|7683843|FG001|NOT COMPLETED|Overall Study||69
6757277|NCT03537274|7683844|FG002|NOT COMPLETED|Overall Study||76
6757278|NCT03537274|7683845|FG003|NOT COMPLETED|Overall Study||76
6757279|NCT03537404|7683858|FG000|STARTED|First Intervention (A or B or C)||18
6757280|NCT03537404|7683859|FG001|STARTED|First Intervention (A or B or C)||18
6757281|NCT03537404|7683858|FG000|COMPLETED|First Intervention (A or B or C)||18
6757282|NCT03537404|7683859|FG001|COMPLETED|First Intervention (A or B or C)||18
6757283|NCT03537404|7683858|FG000|NOT COMPLETED|First Intervention (A or B or C)||0
6757284|NCT03537404|7683859|FG001|NOT COMPLETED|First Intervention (A or B or C)||0
6757285|NCT03537404|7683858|FG000|STARTED|First Washout Period (8 Days)||18
6757286|NCT03537404|7683859|FG001|STARTED|First Washout Period (8 Days)||18
6757287|NCT03537404|7683858|FG000|COMPLETED|First Washout Period (8 Days)||18
6757288|NCT03537404|7683859|FG001|COMPLETED|First Washout Period (8 Days)||18
6757289|NCT03537404|7683858|FG000|NOT COMPLETED|First Washout Period (8 Days)||0
6757290|NCT03537404|7683859|FG001|NOT COMPLETED|First Washout Period (8 Days)||0
6757291|NCT03537404|7683858|FG000|STARTED|Second Intervention (A or B or C)||18
6757292|NCT03537404|7683859|FG001|STARTED|Second Intervention (A or B or C)||18
6757293|NCT03537404|7683858|FG000|COMPLETED|Second Intervention (A or B or C)||18
6757294|NCT03537404|7683859|FG001|COMPLETED|Second Intervention (A or B or C)||18
6757295|NCT03537404|7683858|FG000|NOT COMPLETED|Second Intervention (A or B or C)||0
6757296|NCT03537404|7683859|FG001|NOT COMPLETED|Second Intervention (A or B or C)||0
6757297|NCT03537404|7683858|FG000|STARTED|Second Washout Period (8 Days)||18
6757298|NCT03537404|7683859|FG001|STARTED|Second Washout Period (8 Days)||18
6757299|NCT03537404|7683858|FG000|COMPLETED|Second Washout Period (8 Days)||18
6757300|NCT03537404|7683859|FG001|COMPLETED|Second Washout Period (8 Days)||18
6757301|NCT03537404|7683858|FG000|NOT COMPLETED|Second Washout Period (8 Days)||0
6757302|NCT03537404|7683859|FG001|NOT COMPLETED|Second Washout Period (8 Days)||0
6757303|NCT03537404|7683858|FG000|STARTED|Third Intervention (A or B or C)||18
6757304|NCT03537404|7683859|FG001|STARTED|Third Intervention (A or B or C)||18
6757305|NCT03537404|7683858|FG000|COMPLETED|Third Intervention (A or B or C)||18
6757306|NCT03537404|7683859|FG001|COMPLETED|Third Intervention (A or B or C)||18
6757307|NCT03537404|7683858|FG000|NOT COMPLETED|Third Intervention (A or B or C)||0
6757308|NCT03537404|7683859|FG001|NOT COMPLETED|Third Intervention (A or B or C)||0
6757309|NCT03537651|7683883|FG000|STARTED|Overall Study||130
6757310|NCT03537651|7683883|FG000|113B/116 FAS|Overall Study||64
6757311|NCT03537651|7683883|FG000|113B/116 LCI FAS|Overall Study||30
6757312|NCT03537651|7683883|FG000|115/116 FAS|Overall Study||66
6757313|NCT03537651|7683883|FG000|115/116 FAS (TEZ/IVA Group)|Overall Study||53
6757314|NCT03537651|7683883|FG000|COMPLETED|Overall Study||69
6757315|NCT03537651|7683883|FG000|NOT COMPLETED|Overall Study||61
6757316|NCT03537664|7683890|FG000|STARTED|Overall Study||20
6757317|NCT03537664|7683891|FG001|STARTED|Overall Study||25
6757318|NCT03537664|7683890|FG000|Metabolic Activity of Bacteria|Overall Study|5 patients were excluded from metabolic activity analysis (lost of RNA)|15
6757319|NCT03537664|7683891|FG001|Metabolic Activity of Bacteria|Overall Study||25
6757320|NCT03537664|7683890|FG000|Bacterial Levels|Overall Study||20
6757321|NCT03537664|7683891|FG001|Bacterial Levels|Overall Study||25
6757322|NCT03537664|7683890|FG000|Bacterial Community Diversity|Overall Study||10
6757323|NCT03537664|7683891|FG001|Bacterial Community Diversity|Overall Study||0
6757324|NCT03537664|7683890|FG000|Endodontic Success|Overall Study||20
6757325|NCT03537664|7683891|FG001|Endodontic Success|Overall Study||10
6757326|NCT03537664|7683890|FG000|COMPLETED|Overall Study||20
6757327|NCT03537664|7683891|FG001|COMPLETED|Overall Study||25
6757328|NCT03537664|7683890|FG000|NOT COMPLETED|Overall Study||0
6757329|NCT03537664|7683891|FG001|NOT COMPLETED|Overall Study||0
6757330|NCT03538431|7683902|FG000|STARTED|Overall Study||13
6757331|NCT03538431|7683903|FG001|STARTED|Overall Study||13
6757332|NCT03538431|7683902|FG000|COMPLETED|Overall Study||12
6757333|NCT03538431|7683903|FG001|COMPLETED|Overall Study||12
6757334|NCT03538431|7683902|FG000|NOT COMPLETED|Overall Study||1
6757335|NCT03538431|7683903|FG001|NOT COMPLETED|Overall Study||1
6757336|NCT03538678|7683913|FG000|STARTED|Overall Study||20
6757337|NCT03538678|7683914|FG001|STARTED|Overall Study||20
6757338|NCT03538678|7683913|FG000|COMPLETED|Overall Study||5
6757339|NCT03538678|7683914|FG001|COMPLETED|Overall Study||9
6757340|NCT03538678|7683913|FG000|NOT COMPLETED|Overall Study||15
6757341|NCT03538678|7683914|FG001|NOT COMPLETED|Overall Study||11
6757342|NCT03538743|7683929|FG000|STARTED|Overall Study||25
6757343|NCT03538743|7683930|FG001|STARTED|Overall Study||9
6757344|NCT03538743|7683931|FG002|STARTED|Overall Study||9
6757345|NCT03538743|7683932|FG003|STARTED|Overall Study||10
6555871|NCT01755091|7478099|FG000|STARTED|Overall Study||26
6555872|NCT01755091|7478100|FG001|STARTED|Overall Study||22
6555873|NCT01755091|7478101|FG002|STARTED|Overall Study||27
6555874|NCT01755091|7478099|FG000|COMPLETED|Overall Study||17
6555875|NCT01755091|7478100|FG001|COMPLETED|Overall Study||19
6555876|NCT01755091|7478101|FG002|COMPLETED|Overall Study||20
6555877|NCT01755091|7478099|FG000|NOT COMPLETED|Overall Study||9
6555878|NCT01755091|7478100|FG001|NOT COMPLETED|Overall Study||3
6555879|NCT01755091|7478101|FG002|NOT COMPLETED|Overall Study||7
6555880|NCT01755143|7478111|FG000|STARTED|Overall Study||177
6555881|NCT01755143|7478112|FG001|STARTED|Overall Study||89
6555882|NCT01755143|7478111|FG000|COMPLETED|Overall Study||166
6555883|NCT01755143|7478112|FG001|COMPLETED|Overall Study||86
6555884|NCT01755143|7478111|FG000|NOT COMPLETED|Overall Study||11
6757346|NCT03538743|7683933|FG004|STARTED|Overall Study||9
6757347|NCT03538743|7683934|FG005|STARTED|Overall Study||9
6757348|NCT03538743|7683935|FG006|STARTED|Overall Study||9
6757349|NCT03538743|7683936|FG007|STARTED|Overall Study||8
6757350|NCT03538743|7683937|FG008|STARTED|Overall Study||10
6757351|NCT03538743|7683929|FG000|Received Treatment|Overall Study||25
6757352|NCT03538743|7683930|FG001|Received Treatment|Overall Study||9
6757353|NCT03538743|7683931|FG002|Received Treatment|Overall Study||9
6757354|NCT03538743|7683932|FG003|Received Treatment|Overall Study||10
6757355|NCT03538743|7683933|FG004|Received Treatment|Overall Study||9
6757356|NCT03538743|7683934|FG005|Received Treatment|Overall Study||9
6757357|NCT03538743|7683935|FG006|Received Treatment|Overall Study||9
6757358|NCT03538743|7683936|FG007|Received Treatment|Overall Study||8
6757359|NCT03538743|7683937|FG008|Received Treatment|Overall Study||10
6757360|NCT03538743|7683929|FG000|COMPLETED|Overall Study||25
6757361|NCT03538743|7683930|FG001|COMPLETED|Overall Study||9
6757362|NCT03538743|7683931|FG002|COMPLETED|Overall Study||8
6757363|NCT03538743|7683932|FG003|COMPLETED|Overall Study||8
6757364|NCT03538743|7683933|FG004|COMPLETED|Overall Study||9
6757365|NCT03538743|7683934|FG005|COMPLETED|Overall Study||9
6757366|NCT03538743|7683935|FG006|COMPLETED|Overall Study||9
6757367|NCT03538743|7683936|FG007|COMPLETED|Overall Study||8
6757368|NCT03538743|7683937|FG008|COMPLETED|Overall Study||7
6757369|NCT03538743|7683929|FG000|NOT COMPLETED|Overall Study||0
6757370|NCT03538743|7683930|FG001|NOT COMPLETED|Overall Study||0
6757371|NCT03538743|7683931|FG002|NOT COMPLETED|Overall Study||1
6757372|NCT03538743|7683932|FG003|NOT COMPLETED|Overall Study||2
6757373|NCT03538743|7683933|FG004|NOT COMPLETED|Overall Study||0
6757374|NCT03538743|7683934|FG005|NOT COMPLETED|Overall Study||0
6757375|NCT03538743|7683935|FG006|NOT COMPLETED|Overall Study||0
6757376|NCT03538743|7683936|FG007|NOT COMPLETED|Overall Study||0
6757377|NCT03538743|7683937|FG008|NOT COMPLETED|Overall Study||3
6757378|NCT03538795|7683965|FG000|STARTED|Overall Study||3
6555885|NCT01755143|7478112|FG001|NOT COMPLETED|Overall Study||3
6555886|NCT01755156|7478120|FG000|STARTED|Phase A (Weeks 0-24)||201
6555887|NCT01755156|7478121|FG001|STARTED|Phase A (Weeks 0-24)||201
6757379|NCT03538795|7683965|FG000|COMPLETED|Overall Study||3
6757380|NCT03538795|7683965|FG000|NOT COMPLETED|Overall Study||0
6757381|NCT03538808|7683973|FG000|STARTED|Overall Study||20
6757382|NCT03538808|7683974|FG001|STARTED|Overall Study||20
6757383|NCT03538808|7683975|FG002|STARTED|Overall Study||20
6757384|NCT03538808|7683976|FG003|STARTED|Overall Study||20
6757385|NCT03538808|7683973|FG000|COMPLETED|Overall Study||18
6757386|NCT03538808|7683974|FG001|COMPLETED|Overall Study||20
6757387|NCT03538808|7683975|FG002|COMPLETED|Overall Study||16
6757388|NCT03538808|7683976|FG003|COMPLETED|Overall Study||18
6757389|NCT03538808|7683973|FG000|NOT COMPLETED|Overall Study||2
6757390|NCT03538808|7683974|FG001|NOT COMPLETED|Overall Study||0
6757391|NCT03538808|7683975|FG002|NOT COMPLETED|Overall Study||4
6757392|NCT03538808|7683976|FG003|NOT COMPLETED|Overall Study||2
6757393|NCT03539211|7683988|FG000|STARTED|Overall Study||16
6757394|NCT03539211|7683989|FG001|STARTED|Overall Study||15
6757395|NCT03539211|7683988|FG000|COMPLETED|Overall Study||16
6757396|NCT03539211|7683989|FG001|COMPLETED|Overall Study||15
6757397|NCT03539211|7683988|FG000|NOT COMPLETED|Overall Study||0
6757398|NCT03539211|7683989|FG001|NOT COMPLETED|Overall Study||0
6555888|NCT01755156|7478120|FG000|COMPLETED|Phase A (Weeks 0-24)||184
6555889|NCT01755156|7478121|FG001|COMPLETED|Phase A (Weeks 0-24)||177
6555890|NCT01755156|7478120|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||17
6555891|NCT01755156|7478121|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||24
6555892|NCT01755156|7478120|FG000|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
6555893|NCT01755156|7478121|FG001|STARTED|Phase B (Weeks 24-104)||177
6555894|NCT01755156|7478120|FG000|COMPLETED|Phase B (Weeks 24-104)||144
6555895|NCT01755156|7478121|FG001|COMPLETED|Phase B (Weeks 24-104)||141
6555896|NCT01755156|7478120|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||39
6555897|NCT01755156|7478121|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||36
6757399|NCT03539432|7683997|FG000|STARTED|Overall Study||2
6757400|NCT03539432|7683998|FG001|STARTED|Overall Study||1
6757401|NCT03539432|7683997|FG000|COMPLETED|Overall Study||2
6757402|NCT03539432|7683998|FG001|COMPLETED|Overall Study||0
6757403|NCT03539432|7683997|FG000|NOT COMPLETED|Overall Study||0
6757404|NCT03539432|7683998|FG001|NOT COMPLETED|Overall Study||1
6757405|NCT03539484|7684011|FG000|STARTED|Overall Study||1
6757406|NCT03539484|7684012|FG001|STARTED|Overall Study||1
6757407|NCT03539484|7684013|FG002|STARTED|Overall Study||1
6757408|NCT03539484|7684014|FG003|STARTED|Overall Study||3
6757409|NCT03539484|7684015|FG004|STARTED|Overall Study||13
6757410|NCT03539484|7684016|FG005|STARTED|Overall Study||5
6757411|NCT03539484|7684017|FG006|STARTED|Overall Study||2
6757412|NCT03539484|7684011|FG000|COMPLETED|Overall Study||0
6757413|NCT03539484|7684012|FG001|COMPLETED|Overall Study||0
6757414|NCT03539484|7684013|FG002|COMPLETED|Overall Study||0
6757415|NCT03539484|7684014|FG003|COMPLETED|Overall Study||0
6757416|NCT03539484|7684015|FG004|COMPLETED|Overall Study||0
6757417|NCT03539484|7684016|FG005|COMPLETED|Overall Study||0
6757418|NCT03539484|7684017|FG006|COMPLETED|Overall Study||0
6757419|NCT03539484|7684011|FG000|NOT COMPLETED|Overall Study||1
6757420|NCT03539484|7684012|FG001|NOT COMPLETED|Overall Study||1
6757421|NCT03539484|7684013|FG002|NOT COMPLETED|Overall Study||1
6555898|NCT01755169|7478135|FG000|STARTED|Overall Study||2
6757422|NCT03539484|7684014|FG003|NOT COMPLETED|Overall Study||3
6757423|NCT03539484|7684015|FG004|NOT COMPLETED|Overall Study||13
6757424|NCT03539484|7684016|FG005|NOT COMPLETED|Overall Study||5
6757425|NCT03539484|7684017|FG006|NOT COMPLETED|Overall Study||2
6757426|NCT03539549|7684038|FG000|STARTED|Overall Study||123
6757427|NCT03539549|7684038|FG000|COMPLETED|Overall Study||106
6757428|NCT03539549|7684038|FG000|NOT COMPLETED|Overall Study||17
6757429|NCT03540030|7684044|FG000|STARTED|Overall Study||48
6757430|NCT03540030|7684045|FG001|STARTED|Overall Study||38
6757431|NCT03540030|7684044|FG000|COMPLETED|Overall Study||30
6757432|NCT03540030|7684045|FG001|COMPLETED|Overall Study||35
6757433|NCT03540030|7684044|FG000|NOT COMPLETED|Overall Study||18
6757434|NCT03540030|7684045|FG001|NOT COMPLETED|Overall Study||3
6757435|NCT03540134|7684051|FG000|STARTED|Overall Study||4
6757436|NCT03540134|7684051|FG000|COMPLETED|Overall Study||4
6757437|NCT03540134|7684051|FG000|NOT COMPLETED|Overall Study||0
6757438|NCT03540147|7684055|FG000|STARTED|Overall Study||20
6757439|NCT03540147|7684055|FG000|COMPLETED|Overall Study||20
6757440|NCT03540147|7684055|FG000|NOT COMPLETED|Overall Study||0
6757441|NCT03540160|7684067|FG000|STARTED|Overall Study||558
6757442|NCT03540160|7684067|FG000|COMPLETED|Overall Study||179
6757443|NCT03540160|7684067|FG000|NOT COMPLETED|Overall Study||379
6757444|NCT03541044|7684071|FG000|STARTED|Study Period 1: Up to Day 1||23
6757445|NCT03541044|7684072|FG001|STARTED|Study Period 1: Up to Day 1||23
6757446|NCT03541044|7684071|FG000|COMPLETED|Study Period 1: Up to Day 1||23
6757447|NCT03541044|7684072|FG001|COMPLETED|Study Period 1: Up to Day 1||23
6757448|NCT03541044|7684071|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
6757449|NCT03541044|7684072|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
6555899|NCT01755169|7478136|FG001|STARTED|Overall Study||1
6555900|NCT01755169|7478137|FG002|STARTED|Overall Study||0
6555901|NCT01755169|7478138|FG003|STARTED|Overall Study||1
6555902|NCT01755169|7478135|FG000|COMPLETED|Overall Study||2
6757450|NCT03541044|7684071|FG000|STARTED|Washout Period: 5 to 7 Days||23
6757451|NCT03541044|7684072|FG001|STARTED|Washout Period: 5 to 7 Days||23
6757452|NCT03541044|7684071|FG000|COMPLETED|Washout Period: 5 to 7 Days||23
6757453|NCT03541044|7684072|FG001|COMPLETED|Washout Period: 5 to 7 Days||23
6757454|NCT03541044|7684071|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
6757455|NCT03541044|7684072|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
6757456|NCT03541044|7684071|FG000|STARTED|Study Period 2: Up to Day 8||23
6757457|NCT03541044|7684072|FG001|STARTED|Study Period 2: Up to Day 8||23
6757458|NCT03541044|7684071|FG000|COMPLETED|Study Period 2: Up to Day 8||21
6757459|NCT03541044|7684072|FG001|COMPLETED|Study Period 2: Up to Day 8||23
6757460|NCT03541044|7684071|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
6757461|NCT03541044|7684072|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||0
6757462|NCT03541356|7684085|FG000|STARTED|Overall Study||8
6757463|NCT03541356|7684086|FG001|STARTED|Overall Study||6
6757464|NCT03541356|7684087|FG002|STARTED|Overall Study||6
6757465|NCT03541356|7684088|FG003|STARTED|Overall Study||6
6757466|NCT03541356|7684089|FG004|STARTED|Overall Study||6
6757467|NCT03541356|7684085|FG000|COMPLETED|Overall Study||8
6757468|NCT03541356|7684086|FG001|COMPLETED|Overall Study||6
6757469|NCT03541356|7684087|FG002|COMPLETED|Overall Study||6
6757470|NCT03541356|7684088|FG003|COMPLETED|Overall Study||6
6757471|NCT03541356|7684089|FG004|COMPLETED|Overall Study||6
6757472|NCT03541356|7684085|FG000|NOT COMPLETED|Overall Study||0
6757473|NCT03541356|7684086|FG001|NOT COMPLETED|Overall Study||0
6757474|NCT03541356|7684087|FG002|NOT COMPLETED|Overall Study||0
6757475|NCT03541356|7684088|FG003|NOT COMPLETED|Overall Study||0
6757476|NCT03541356|7684089|FG004|NOT COMPLETED|Overall Study||0
6757477|NCT03541941|7684109|FG000|STARTED|Overall Study||57
6757478|NCT03541941|7684110|FG001|STARTED|Overall Study||55
6757479|NCT03541941|7684111|FG002|STARTED|Overall Study||52
6757480|NCT03541941|7684109|FG000|COMPLETED|Overall Study||57
6757481|NCT03541941|7684110|FG001|COMPLETED|Overall Study||55
6757482|NCT03541941|7684111|FG002|COMPLETED|Overall Study||52
6757483|NCT03541941|7684109|FG000|NOT COMPLETED|Overall Study||0
6757484|NCT03541941|7684110|FG001|NOT COMPLETED|Overall Study||0
6757485|NCT03541941|7684111|FG002|NOT COMPLETED|Overall Study||0
6757486|NCT03541980|7684121|FG000|STARTED|Overall Study||35
6757487|NCT03541980|7684122|FG001|STARTED|Overall Study||36
6757488|NCT03541980|7684121|FG000|COMPLETED|Overall Study||35
6757489|NCT03541980|7684122|FG001|COMPLETED|Overall Study||36
6757490|NCT03541980|7684121|FG000|NOT COMPLETED|Overall Study||0
6757491|NCT03541980|7684122|FG001|NOT COMPLETED|Overall Study||0
6757492|NCT03542019|7684137|FG000|STARTED|Overall Study||20
6757493|NCT03542019|7684138|FG001|STARTED|Overall Study||20
6757494|NCT03542019|7684139|FG002|STARTED|Overall Study||20
6757495|NCT03542019|7684137|FG000|COMPLETED|Overall Study||19
6757496|NCT03542019|7684138|FG001|COMPLETED|Overall Study||17
6757497|NCT03542019|7684139|FG002|COMPLETED|Overall Study||19
6757498|NCT03542019|7684137|FG000|NOT COMPLETED|Overall Study||1
6757499|NCT03542019|7684138|FG001|NOT COMPLETED|Overall Study||3
6757500|NCT03542019|7684139|FG002|NOT COMPLETED|Overall Study||1
6757501|NCT03542266|7684147|FG000|STARTED|Treatment Phase||21
6757502|NCT03542266|7684147|FG000|COMPLETED|Treatment Phase||18
6757503|NCT03542266|7684147|FG000|NOT COMPLETED|Treatment Phase||3
6757504|NCT03542266|7684147|FG000|STARTED|Post-treatment Follow-up Phase|Three subjects did not enter follow-up: 1 had PD at EOT, 2 withdrew consent|15
6757505|NCT03542266|7684147|FG000|COMPLETED|Post-treatment Follow-up Phase||0
6757506|NCT03542266|7684147|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||15
6757507|NCT03542305|7684155|FG000|STARTED|Overall Study||8
6757508|NCT03542305|7684156|FG001|STARTED|Overall Study||8
6757509|NCT03542305|7684157|FG002|STARTED|Overall Study||8
6757510|NCT03542305|7684158|FG003|STARTED|Overall Study||5
6757511|NCT03542305|7684155|FG000|COMPLETED|Overall Study||8
6757512|NCT03542305|7684156|FG001|COMPLETED|Overall Study||8
6757513|NCT03542305|7684157|FG002|COMPLETED|Overall Study||8
6757514|NCT03542305|7684158|FG003|COMPLETED|Overall Study||5
6757515|NCT03542305|7684155|FG000|NOT COMPLETED|Overall Study||0
6757516|NCT03542305|7684156|FG001|NOT COMPLETED|Overall Study||0
6757517|NCT03542305|7684157|FG002|NOT COMPLETED|Overall Study||0
6757518|NCT03542305|7684158|FG003|NOT COMPLETED|Overall Study||0
6757519|NCT03542474|7684168|FG000|STARTED|Overall Study||8
6757520|NCT03542474|7684168|FG000|COMPLETED|Overall Study||8
6757521|NCT03542474|7684168|FG000|NOT COMPLETED|Overall Study||0
6757522|NCT03543085|7684172|FG000|STARTED|Overall Study||10
6757523|NCT03543085|7684172|FG000|COMPLETED|Overall Study||10
6757524|NCT03543085|7684172|FG000|NOT COMPLETED|Overall Study||0
6757525|NCT03543137|7684176|FG000|STARTED|Study Period 1: Up to Day 1||18
6757526|NCT03543137|7684177|FG001|STARTED|Study Period 1: Up to Day 1||19
6757527|NCT03543137|7684176|FG000|COMPLETED|Study Period 1: Up to Day 1||18
6757528|NCT03543137|7684177|FG001|COMPLETED|Study Period 1: Up to Day 1||19
6757529|NCT03543137|7684176|FG000|NOT COMPLETED|Study Period 1: Up to Day 1||0
6757530|NCT03543137|7684177|FG001|NOT COMPLETED|Study Period 1: Up to Day 1||0
6757531|NCT03543137|7684176|FG000|STARTED|Washout Period: 5 to 7 Days||18
6757532|NCT03543137|7684177|FG001|STARTED|Washout Period: 5 to 7 Days||19
6757533|NCT03543137|7684176|FG000|COMPLETED|Washout Period: 5 to 7 Days||18
6757534|NCT03543137|7684177|FG001|COMPLETED|Washout Period: 5 to 7 Days||19
6757535|NCT03543137|7684176|FG000|NOT COMPLETED|Washout Period: 5 to 7 Days||0
6757536|NCT03543137|7684177|FG001|NOT COMPLETED|Washout Period: 5 to 7 Days||0
6757537|NCT03543137|7684176|FG000|STARTED|Study Period 2: Up to Day 8||18
6757538|NCT03543137|7684177|FG001|STARTED|Study Period 2: Up to Day 8||19
6757539|NCT03543137|7684176|FG000|Treated|Study Period 2: Up to Day 8||16
6757540|NCT03543137|7684177|FG001|Treated|Study Period 2: Up to Day 8||18
6757541|NCT03543137|7684176|FG000|COMPLETED|Study Period 2: Up to Day 8||16
6757542|NCT03543137|7684177|FG001|COMPLETED|Study Period 2: Up to Day 8||18
6757543|NCT03543137|7684176|FG000|NOT COMPLETED|Study Period 2: Up to Day 8||2
6757544|NCT03543137|7684177|FG001|NOT COMPLETED|Study Period 2: Up to Day 8||1
6757545|NCT03543176|7684187|FG000|STARTED|Overall Study||392
6757546|NCT03543176|7684188|FG001|STARTED|Overall Study||397
6757547|NCT03543176|7684187|FG000|COMPLETED|Overall Study||392
6757548|NCT03543176|7684188|FG001|COMPLETED|Overall Study||397
6757549|NCT03543176|7684187|FG000|NOT COMPLETED|Overall Study||0
6757550|NCT03543176|7684188|FG001|NOT COMPLETED|Overall Study||0
6780015|NCT03426137|7708316|FG001|NOT COMPLETED|Overall Study||0
6780016|NCT03426137|7708317|FG002|NOT COMPLETED|Overall Study||0
6780017|NCT03425799|7708327|FG000|STARTED|Overall Study|Study terminated due to low recruitment|0
6780018|NCT03425799|7708328|FG001|STARTED|Overall Study|Study terminated due to low recruitment|0
6780019|NCT03425799|7708327|FG000|COMPLETED|Overall Study|Study terminated due to low recruitment|0
6780020|NCT03425799|7708328|FG001|COMPLETED|Overall Study|Study terminated due to low recruitment|0
6780021|NCT03425799|7708327|FG000|NOT COMPLETED|Overall Study||0
6780022|NCT03425799|7708328|FG001|NOT COMPLETED|Overall Study||0
6780023|NCT03423654|7708336|FG000|STARTED|Overall Study||3
6780024|NCT03423654|7708337|FG001|STARTED|Overall Study||3
6780025|NCT03423654|7708336|FG000|COMPLETED|Overall Study||3
6780026|NCT03423654|7708337|FG001|COMPLETED|Overall Study||3
6780027|NCT03423654|7708336|FG000|NOT COMPLETED|Overall Study||0
6780028|NCT03423654|7708337|FG001|NOT COMPLETED|Overall Study||0
6780029|NCT03387059|7708345|FG000|STARTED|Overall Study||5
6780030|NCT03387059|7708346|FG001|STARTED|Overall Study||4
6780031|NCT03387059|7708345|FG000|COMPLETED|Overall Study||0
6780032|NCT03387059|7708346|FG001|COMPLETED|Overall Study||0
6780033|NCT03387059|7708345|FG000|NOT COMPLETED|Overall Study||5
6780034|NCT03387059|7708346|FG001|NOT COMPLETED|Overall Study||4
6780035|NCT03382925|7708354|FG000|STARTED|Overall Study||10
6780036|NCT03382925|7708355|FG001|STARTED|Overall Study||6
6780037|NCT03382925|7708354|FG000|COMPLETED|Overall Study||10
6780038|NCT03382925|7708355|FG001|COMPLETED|Overall Study||6
6780039|NCT03382925|7708354|FG000|NOT COMPLETED|Overall Study||0
6780040|NCT03382925|7708355|FG001|NOT COMPLETED|Overall Study||0
6780041|NCT03379233|7708363|FG000|STARTED|Overall Study||1
6780042|NCT03379233|7708364|FG001|STARTED|Overall Study||6
6780043|NCT03379233|7708363|FG000|COMPLETED|Overall Study||0
6780044|NCT03379233|7708364|FG001|COMPLETED|Overall Study||0
6780045|NCT03379233|7708363|FG000|NOT COMPLETED|Overall Study||1
6780046|NCT03379233|7708364|FG001|NOT COMPLETED|Overall Study||6
6780047|NCT03370536|7708370|FG000|STARTED|Overall Study||1
6780048|NCT03370536|7708370|FG000|COMPLETED|Overall Study||0
6780049|NCT03370536|7708370|FG000|NOT COMPLETED|Overall Study||1
6780050|NCT03363633|7708374|FG000|STARTED|Overall Study||12
6780051|NCT03363633|7708374|FG000|COMPLETED|Overall Study|See note in Pre-Assignment Details|0
6780052|NCT03363633|7708374|FG000|NOT COMPLETED|Overall Study||12
6780053|NCT03361228|7708380|FG000|STARTED|Overall Study||4
6780054|NCT03361228|7708381|FG001|STARTED|Overall Study||1
6780055|NCT03361228|7708380|FG000|COMPLETED|Overall Study||0
6780056|NCT03361228|7708381|FG001|COMPLETED|Overall Study||0
6780057|NCT03361228|7708380|FG000|NOT COMPLETED|Overall Study||4
6305856|NCT00371150|7209242|FG001|Discontinued at or After Week 48 Visit|Overall Study||1
6305857|NCT00371150|7209241|FG000|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|37
6780058|NCT03361228|7708381|FG001|NOT COMPLETED|Overall Study||1
6780059|NCT03360903|7708389|FG000|STARTED|First Intervention||4
6780060|NCT03360903|7708390|FG001|STARTED|First Intervention||4
6780061|NCT03360903|7708389|FG000|COMPLETED|First Intervention||4
6780062|NCT03360903|7708390|FG001|COMPLETED|First Intervention||4
6780063|NCT03360903|7708389|FG000|NOT COMPLETED|First Intervention||0
6780064|NCT03360903|7708390|FG001|NOT COMPLETED|First Intervention||0
6780065|NCT03360903|7708389|FG000|STARTED|Washout (2 Weeks)||4
6780066|NCT03360903|7708390|FG001|STARTED|Washout (2 Weeks)||4
6780067|NCT03360903|7708389|FG000|COMPLETED|Washout (2 Weeks)||4
6780068|NCT03360903|7708390|FG001|COMPLETED|Washout (2 Weeks)||4
6780069|NCT03360903|7708389|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6780070|NCT03360903|7708390|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6780071|NCT03360903|7708389|FG000|STARTED|Second Intervention||4
6780072|NCT03360903|7708390|FG001|STARTED|Second Intervention||4
6780073|NCT03360903|7708389|FG000|COMPLETED|Second Intervention||4
6780074|NCT03360903|7708390|FG001|COMPLETED|Second Intervention||4
6780075|NCT03360903|7708389|FG000|NOT COMPLETED|Second Intervention||0
6780076|NCT03360903|7708390|FG001|NOT COMPLETED|Second Intervention||0
6780077|NCT03359174|7708396|FG000|STARTED|Overall Study||2
6780078|NCT03359174|7708396|FG000|COMPLETED|Overall Study||1
6780079|NCT03359174|7708396|FG000|NOT COMPLETED|Overall Study||1
6780080|NCT03352882|7708400|FG000|STARTED|Overall Study||1
6780081|NCT03352882|7708400|FG000|COMPLETED|Overall Study||1
6780082|NCT03352882|7708400|FG000|NOT COMPLETED|Overall Study||0
6780083|NCT03348904|7708407|FG000|STARTED|Overall Study||0
6780084|NCT03348904|7708408|FG001|STARTED|Overall Study||2
6780085|NCT03348904|7708409|FG002|STARTED|Overall Study||0
6780086|NCT03348904|7708407|FG000|COMPLETED|Overall Study||0
6780087|NCT03348904|7708408|FG001|COMPLETED|Overall Study||1
6757551|NCT03543878|7684196|FG000|STARTED|Overall Study||5
6757552|NCT03543878|7684197|FG001|STARTED|Overall Study||5
6757553|NCT03543878|7684196|FG000|COMPLETED|Overall Study||5
6757554|NCT03543878|7684197|FG001|COMPLETED|Overall Study||5
6757555|NCT03543878|7684196|FG000|NOT COMPLETED|Overall Study||0
6757556|NCT03543878|7684197|FG001|NOT COMPLETED|Overall Study||0
6757557|NCT03544216|7684206|FG000|STARTED|Overall Study||42
6757558|NCT03544216|7684207|FG001|STARTED|Overall Study||42
6757559|NCT03544216|7684206|FG000|COMPLETED|Overall Study||42
6757560|NCT03544216|7684207|FG001|COMPLETED|Overall Study||42
6757561|NCT03544216|7684206|FG000|NOT COMPLETED|Overall Study||0
6757562|NCT03544216|7684207|FG001|NOT COMPLETED|Overall Study||0
6757563|NCT03544307|7684216|FG000|STARTED|Overall Study||10
6757564|NCT03544307|7684217|FG001|STARTED|Overall Study||10
6757565|NCT03544307|7684216|FG000|COMPLETED|Overall Study||10
6757566|NCT03544307|7684217|FG001|COMPLETED|Overall Study||10
6757567|NCT03544307|7684216|FG000|NOT COMPLETED|Overall Study||0
6757568|NCT03544307|7684217|FG001|NOT COMPLETED|Overall Study||0
6757569|NCT03544333|7684225|FG000|STARTED|Overall Study||3
6757570|NCT03544333|7684226|FG001|STARTED|Overall Study||2
6757571|NCT03544333|7684225|FG000|COMPLETED|Overall Study||2
6757572|NCT03544333|7684226|FG001|COMPLETED|Overall Study||2
6757573|NCT03544333|7684225|FG000|NOT COMPLETED|Overall Study||1
6757574|NCT03544333|7684226|FG001|NOT COMPLETED|Overall Study||0
6757575|NCT03544879|7684234|FG000|STARTED|Overall Study||22
6757576|NCT03544879|7684235|FG001|STARTED|Overall Study||24
6757577|NCT03544879|7684234|FG000|Completed Follow-up Physical Assessment|Overall Study||20
6757578|NCT03544879|7684235|FG001|Completed Follow-up Physical Assessment|Overall Study||21
6757579|NCT03544879|7684234|FG000|COMPLETED|Overall Study||22
6757580|NCT03544879|7684235|FG001|COMPLETED|Overall Study||23
6757581|NCT03544879|7684234|FG000|NOT COMPLETED|Overall Study||0
6757582|NCT03544879|7684235|FG001|NOT COMPLETED|Overall Study||1
6757583|NCT03545165|7684243|FG000|STARTED|Overall Study||6
6757584|NCT03545165|7684243|FG000|COMPLETED|Overall Study||6
6757585|NCT03545165|7684243|FG000|NOT COMPLETED|Overall Study||0
6757586|NCT03545412|7684247|FG000|STARTED|Overall Study||25
6757587|NCT03545412|7684247|FG000|COMPLETED|Overall Study||25
6757588|NCT03545412|7684247|FG000|NOT COMPLETED|Overall Study||0
6757589|NCT03545503|7684253|FG000|STARTED|Overall Study||208
6757590|NCT03545503|7684254|FG001|STARTED|Overall Study||220
6757591|NCT03545503|7684253|FG000|COMPLETED|Overall Study||194
6757592|NCT03545503|7684254|FG001|COMPLETED|Overall Study||204
6757593|NCT03545503|7684253|FG000|NOT COMPLETED|Overall Study||14
6757594|NCT03545503|7684254|FG001|NOT COMPLETED|Overall Study||16
6757595|NCT03545893|7684262|FG000|STARTED|Overall Study||35
6757596|NCT03545893|7684263|FG001|STARTED|Overall Study||35
6757597|NCT03545893|7684262|FG000|COMPLETED|Overall Study||35
6757598|NCT03545893|7684263|FG001|COMPLETED|Overall Study||35
6757599|NCT03545893|7684262|FG000|NOT COMPLETED|Overall Study||0
6757600|NCT03545893|7684263|FG001|NOT COMPLETED|Overall Study||0
6757601|NCT03545984|7684271|FG000|STARTED|Overall Study||24
6757602|NCT03545984|7684272|FG001|STARTED|Overall Study||24
6757603|NCT03545984|7684271|FG000|COMPLETED|Overall Study||13
6757604|NCT03545984|7684272|FG001|COMPLETED|Overall Study||15
6757605|NCT03545984|7684271|FG000|NOT COMPLETED|Overall Study||11
6555903|NCT01755169|7478136|FG001|COMPLETED|Overall Study||1
6555904|NCT01755169|7478137|FG002|COMPLETED|Overall Study||0
6555905|NCT01755169|7478138|FG003|COMPLETED|Overall Study||1
6757606|NCT03545984|7684272|FG001|NOT COMPLETED|Overall Study||9
6757607|NCT03546270|7684280|FG000|STARTED|Overall Study||52
6757608|NCT03546270|7684281|FG001|STARTED|Overall Study||48
6757609|NCT03546270|7684280|FG000|COMPLETED|Overall Study||52
6757610|NCT03546270|7684281|FG001|COMPLETED|Overall Study||48
6757611|NCT03546270|7684280|FG000|NOT COMPLETED|Overall Study||0
6757612|NCT03546270|7684281|FG001|NOT COMPLETED|Overall Study||0
6757613|NCT03546491|7684287|FG000|STARTED|Overall Study||32
6757614|NCT03546491|7684287|FG000|Recieved Test Product 1|Overall Study||32
6757615|NCT03546491|7684287|FG000|Received Test Product 2|Overall Study||32
6757616|NCT03546491|7684287|FG000|COMPLETED|Overall Study||30
6757617|NCT03546491|7684287|FG000|NOT COMPLETED|Overall Study||2
6757618|NCT03546621|7684301|FG000|STARTED|Overall Study||28
6757619|NCT03546621|7684302|FG001|STARTED|Overall Study||32
6757620|NCT03546621|7684303|FG002|STARTED|Overall Study||30
6757621|NCT03546621|7684304|FG003|STARTED|Overall Study|2 patients from Tenofovir only group withdrew from the study before treatment.|28
6757622|NCT03546621|7684301|FG000|COMPLETED|Overall Study||28
6757623|NCT03546621|7684302|FG001|COMPLETED|Overall Study||29
6757624|NCT03546621|7684303|FG002|COMPLETED|Overall Study||28
6757625|NCT03546621|7684304|FG003|COMPLETED|Overall Study||25
6757626|NCT03546621|7684301|FG000|NOT COMPLETED|Overall Study||0
6757627|NCT03546621|7684302|FG001|NOT COMPLETED|Overall Study||3
6757628|NCT03546621|7684303|FG002|NOT COMPLETED|Overall Study||2
6757629|NCT03546621|7684304|FG003|NOT COMPLETED|Overall Study||3
6757630|NCT03546647|7684314|FG000|STARTED|Overall Study||18
6757631|NCT03546647|7684315|FG001|STARTED|Overall Study|34|17
6757632|NCT03546647|7684314|FG000|COMPLETED|Overall Study||17
6757633|NCT03546647|7684315|FG001|COMPLETED|Overall Study||17
6757634|NCT03546647|7684314|FG000|NOT COMPLETED|Overall Study||1
6757635|NCT03546647|7684315|FG001|NOT COMPLETED|Overall Study||0
6757636|NCT03546816|7684323|FG000|STARTED|Overall Study||142
6757637|NCT03546816|7684324|FG001|STARTED|Overall Study||143
6757638|NCT03546816|7684323|FG000|COMPLETED|Overall Study||121
6757639|NCT03546816|7684324|FG001|COMPLETED|Overall Study||124
6757640|NCT03546816|7684323|FG000|NOT COMPLETED|Overall Study||21
6757641|NCT03546816|7684324|FG001|NOT COMPLETED|Overall Study||19
6757642|NCT03546842|7684332|FG000|STARTED|Overall Study||201
6757643|NCT03546842|7684332|FG000|Vaccination 1|Overall Study||200
6757644|NCT03546842|7684332|FG000|Vaccination 2|Overall Study||200
6757645|NCT03546842|7684332|FG000|Vaccination 3|Overall Study||198
6757646|NCT03546842|7684332|FG000|COMPLETED|Overall Study||198
6757647|NCT03546842|7684332|FG000|NOT COMPLETED|Overall Study||3
6757648|NCT03547154|7684338|FG000|STARTED|Overall Study||173
6757649|NCT03547154|7684339|FG001|STARTED|Overall Study||171
6757650|NCT03547154|7684338|FG000|COMPLETED|Overall Study||50
6757651|NCT03547154|7684339|FG001|COMPLETED|Overall Study||55
6757652|NCT03547154|7684338|FG000|NOT COMPLETED|Overall Study||123
6757653|NCT03547154|7684339|FG001|NOT COMPLETED|Overall Study||116
6757654|NCT03547167|7684347|FG000|STARTED|Overall Study||1135
6757655|NCT03547167|7684348|FG001|STARTED|Overall Study||380
6757656|NCT03547167|7684347|FG000|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||1133
6757657|NCT03547167|7684348|FG001|Vaccination 1 - (V114 or Prevnar 13™, Day 1)|Overall Study||379
6757658|NCT03547167|7684347|FG000|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||1035
6757659|NCT03547167|7684348|FG001|Vaccination 2 - (PNEUMOVAX™23, Month 6)|Overall Study||346
6757660|NCT03547167|7684347|FG000|COMPLETED|Overall Study||1038
6757661|NCT03547167|7684348|FG001|COMPLETED|Overall Study||350
6757662|NCT03547167|7684347|FG000|NOT COMPLETED|Overall Study||97
6757663|NCT03547167|7684348|FG001|NOT COMPLETED|Overall Study||30
6757664|NCT03547531|7684360|FG000|STARTED|Overall Study||62
6757665|NCT03547531|7684361|FG001|STARTED|Overall Study||62
6757666|NCT03547531|7684360|FG000|COMPLETED|Overall Study||60
6757667|NCT03547531|7684361|FG001|COMPLETED|Overall Study||58
6757668|NCT03547531|7684360|FG000|NOT COMPLETED|Overall Study||2
6757669|NCT03547531|7684361|FG001|NOT COMPLETED|Overall Study||4
6757670|NCT03547583|7684370|FG000|STARTED|Overall Study||263
6757671|NCT03547583|7684371|FG001|STARTED|Overall Study||264
6757672|NCT03547583|7684372|FG002|STARTED|Overall Study||262
6757673|NCT03547583|7684370|FG000|Treated|Overall Study||262
6757674|NCT03547583|7684371|FG001|Treated|Overall Study||264
6757675|NCT03547583|7684372|FG002|Treated|Overall Study||262
6757676|NCT03547583|7684370|FG000|COMPLETED|Overall Study||218
6757677|NCT03547583|7684371|FG001|COMPLETED|Overall Study||224
6757678|NCT03547583|7684372|FG002|COMPLETED|Overall Study||230
6757679|NCT03547583|7684370|FG000|NOT COMPLETED|Overall Study||45
6757680|NCT03547583|7684371|FG001|NOT COMPLETED|Overall Study||40
6757681|NCT03547583|7684372|FG002|NOT COMPLETED|Overall Study||32
6757682|NCT03547635|7684386|FG000|STARTED|Overall Study||41
6757683|NCT03547635|7684387|FG001|STARTED|Overall Study||38
6757684|NCT03547635|7684388|FG002|STARTED|Overall Study||37
6757685|NCT03547635|7684386|FG000|COMPLETED|Overall Study||33
6757686|NCT03547635|7684387|FG001|COMPLETED|Overall Study||31
6757687|NCT03547635|7684388|FG002|COMPLETED|Overall Study||29
6757688|NCT03547635|7684386|FG000|NOT COMPLETED|Overall Study||8
6757689|NCT03547635|7684387|FG001|NOT COMPLETED|Overall Study||7
6757690|NCT03547635|7684388|FG002|NOT COMPLETED|Overall Study||8
6757691|NCT03547687|7684396|FG000|STARTED|Overall Study||9
6757692|NCT03547687|7684396|FG000|COMPLETED|Overall Study||7
6757693|NCT03547687|7684396|FG000|NOT COMPLETED|Overall Study||2
6757694|NCT03548337|7684402|FG000|STARTED|Infant Series||151
6757695|NCT03548337|7684403|FG001|STARTED|Infant Series||150
6757696|NCT03548337|7684402|FG000|Vaccination 1|Infant Series||150
6757697|NCT03548337|7684403|FG001|Vaccination 1|Infant Series||150
6757698|NCT03548337|7684402|FG000|Vaccination 2|Infant Series||144
6757699|NCT03548337|7684403|FG001|Vaccination 2|Infant Series||144
6757700|NCT03548337|7684402|FG000|Vaccination 3|Infant Series||144
6757701|NCT03548337|7684403|FG001|Vaccination 3|Infant Series||141
6757702|NCT03548337|7684402|FG000|COMPLETED|Infant Series||139
6757703|NCT03548337|7684403|FG001|COMPLETED|Infant Series||139
6757704|NCT03548337|7684402|FG000|NOT COMPLETED|Infant Series||12
6757705|NCT03548337|7684403|FG001|NOT COMPLETED|Infant Series||11
6757706|NCT03548337|7684402|FG000|STARTED|Toddler Dose||139
6757707|NCT03548337|7684403|FG001|STARTED|Toddler Dose||139
6757708|NCT03548337|7684402|FG000|Vaccination 4|Toddler Dose||139
6757709|NCT03548337|7684403|FG001|Vaccination 4|Toddler Dose||139
6757710|NCT03548337|7684402|FG000|COMPLETED|Toddler Dose||138
6757711|NCT03548337|7684403|FG001|COMPLETED|Toddler Dose||138
6757712|NCT03548337|7684402|FG000|NOT COMPLETED|Toddler Dose||1
6757713|NCT03548337|7684403|FG001|NOT COMPLETED|Toddler Dose||1
6757714|NCT03548935|7684417|FG000|STARTED|Overall Study||1306
6757715|NCT03548935|7684418|FG001|STARTED|Overall Study||655
6757716|NCT03548935|7684417|FG000|Full Analysis Set (FAS)|Overall Study||1306
6757717|NCT03548935|7684418|FG001|Full Analysis Set (FAS)|Overall Study||655
6757718|NCT03548935|7684417|FG000|Safety Analysis Set (SAS)|Overall Study||1306
6757719|NCT03548935|7684418|FG001|Safety Analysis Set (SAS)|Overall Study||655
6757720|NCT03548935|7684417|FG000|COMPLETED|Overall Study||1240
6757721|NCT03548935|7684418|FG001|COMPLETED|Overall Study||609
6757722|NCT03548935|7684417|FG000|NOT COMPLETED|Overall Study||66
6757723|NCT03548935|7684418|FG001|NOT COMPLETED|Overall Study||46
6757724|NCT03549117|7684426|FG000|STARTED|Overall Study||70
6757725|NCT03549117|7684427|FG001|STARTED|Overall Study||70
6757726|NCT03549117|7684426|FG000|COMPLETED|Overall Study||69
6757727|NCT03549117|7684427|FG001|COMPLETED|Overall Study||70
6757728|NCT03549117|7684426|FG000|NOT COMPLETED|Overall Study||1
6757729|NCT03549117|7684427|FG001|NOT COMPLETED|Overall Study||0
6757730|NCT03549130|7684435|FG000|STARTED|Overall Study||64
6757731|NCT03549130|7684436|FG001|STARTED|Overall Study||66
6757732|NCT03549130|7684435|FG000|COMPLETED|Overall Study||64
6757733|NCT03549130|7684436|FG001|COMPLETED|Overall Study||64
6757734|NCT03549130|7684435|FG000|NOT COMPLETED|Overall Study||0
6757735|NCT03549130|7684436|FG001|NOT COMPLETED|Overall Study||2
6757736|NCT03549234|7684446|FG000|STARTED|Overall Study||50
6757737|NCT03549234|7684447|FG001|STARTED|Overall Study||50
6757738|NCT03549234|7684446|FG000|COMPLETED|Overall Study||50
6757739|NCT03549234|7684447|FG001|COMPLETED|Overall Study||50
6757740|NCT03549234|7684446|FG000|NOT COMPLETED|Overall Study||0
6757741|NCT03549234|7684447|FG001|NOT COMPLETED|Overall Study||0
6757742|NCT03549338|7684456|FG000|STARTED|Overall Study||1
6757743|NCT03549338|7684457|FG001|STARTED|Overall Study||1
6757744|NCT03549338|7684458|FG002|STARTED|Overall Study||0
6757745|NCT03549338|7684456|FG000|COMPLETED|Overall Study||0
6757746|NCT03549338|7684457|FG001|COMPLETED|Overall Study|Patient crossed-over to Sym004 at the EOC1 per Sponsor decision following trial termination.|0
6757747|NCT03549338|7684458|FG002|COMPLETED|Overall Study||0
6757748|NCT03549338|7684456|FG000|NOT COMPLETED|Overall Study||1
6757749|NCT03549338|7684457|FG001|NOT COMPLETED|Overall Study||1
6757750|NCT03549338|7684458|FG002|NOT COMPLETED|Overall Study||0
6757751|NCT03549429|7684466|FG000|STARTED|Overall Study||81
6757752|NCT03549429|7684467|FG001|STARTED|Overall Study||78
6757753|NCT03549429|7684466|FG000|COMPLETED|Overall Study||76
6757754|NCT03549429|7684467|FG001|COMPLETED|Overall Study||75
6757755|NCT03549429|7684466|FG000|NOT COMPLETED|Overall Study||5
6757756|NCT03549429|7684467|FG001|NOT COMPLETED|Overall Study||3
6757757|NCT03549598|7684475|FG000|STARTED|Overall Study||15
6757758|NCT03549598|7684475|FG000|COMPLETED|Overall Study||15
6757759|NCT03549598|7684475|FG000|NOT COMPLETED|Overall Study||0
6757760|NCT03550066|7684483|FG000|STARTED|Overall Study||49
6757761|NCT03550066|7684484|FG001|STARTED|Overall Study||41
6757762|NCT03550066|7684483|FG000|COMPLETED|Overall Study||49
6757763|NCT03550066|7684484|FG001|COMPLETED|Overall Study||41
6757764|NCT03550066|7684483|FG000|NOT COMPLETED|Overall Study||0
6757765|NCT03550066|7684484|FG001|NOT COMPLETED|Overall Study||0
6757766|NCT03550209|7684494|FG000|STARTED|Overall Study||12
6757767|NCT03550209|7684495|FG001|STARTED|Overall Study||12
6757768|NCT03550209|7684496|FG002|STARTED|Overall Study||13
6757769|NCT03550209|7684497|FG003|STARTED|Overall Study||35
6555906|NCT01755169|7478135|FG000|NOT COMPLETED|Overall Study||0
6555907|NCT01755169|7478136|FG001|NOT COMPLETED|Overall Study||0
6555908|NCT01755169|7478137|FG002|NOT COMPLETED|Overall Study||0
6757770|NCT03550209|7684494|FG000|COMPLETED|Overall Study||11
6757771|NCT03550209|7684495|FG001|COMPLETED|Overall Study||9
6757772|NCT03550209|7684496|FG002|COMPLETED|Overall Study||11
6757773|NCT03550209|7684497|FG003|COMPLETED|Overall Study||31
6757774|NCT03550209|7684494|FG000|NOT COMPLETED|Overall Study||1
6757775|NCT03550209|7684495|FG001|NOT COMPLETED|Overall Study||3
6757776|NCT03550209|7684496|FG002|NOT COMPLETED|Overall Study||2
6757777|NCT03550209|7684497|FG003|NOT COMPLETED|Overall Study||4
6757778|NCT03550313|7684510|FG000|STARTED|Overall Study||192
6757779|NCT03550313|7684511|FG001|STARTED|Overall Study||187
6757780|NCT03550313|7684512|FG002|STARTED|Overall Study||186
6757781|NCT03550313|7684510|FG000|Vaccinated for Dose 1|Overall Study||171
6757782|NCT03550313|7684511|FG001|Vaccinated for Dose 1|Overall Study||147
6757783|NCT03550313|7684512|FG002|Vaccinated for Dose 1|Overall Study||166
6757784|NCT03550313|7684510|FG000|Vaccinated for Dose 2|Overall Study||159
6757785|NCT03550313|7684511|FG001|Vaccinated for Dose 2|Overall Study||135
6757786|NCT03550313|7684512|FG002|Vaccinated for Dose 2|Overall Study||153
6757787|NCT03550313|7684510|FG000|Vaccinated for Dose 3|Overall Study||151
6757788|NCT03550313|7684511|FG001|Vaccinated for Dose 3|Overall Study||127
6757789|NCT03550313|7684512|FG002|Vaccinated for Dose 3|Overall Study||146
6757790|NCT03550313|7684510|FG000|COMPLETED|Overall Study||95
6757791|NCT03550313|7684511|FG001|COMPLETED|Overall Study||77
6757792|NCT03550313|7684512|FG002|COMPLETED|Overall Study||72
6757793|NCT03550313|7684510|FG000|NOT COMPLETED|Overall Study||97
6757794|NCT03550313|7684511|FG001|NOT COMPLETED|Overall Study||110
6757795|NCT03550313|7684512|FG002|NOT COMPLETED|Overall Study||114
6757796|NCT03550378|7684523|FG000|STARTED|Overall Study||20
6757797|NCT03550378|7684524|FG001|STARTED|Overall Study||21
6757798|NCT03550378|7684523|FG000|COMPLETED|Overall Study||20
6555909|NCT01755169|7478138|FG003|NOT COMPLETED|Overall Study||0
6555910|NCT01755195|7478148|FG000|STARTED|Overall Study||55
6555911|NCT01755195|7478148|FG000|COMPLETED|Overall Study||42
6555912|NCT01755195|7478148|FG000|NOT COMPLETED|Overall Study||13
6555913|NCT01755234|7478154|FG000|STARTED|Overall Study||45
6757799|NCT03550378|7684524|FG001|COMPLETED|Overall Study||20
6757800|NCT03550378|7684523|FG000|NOT COMPLETED|Overall Study||0
6757801|NCT03550378|7684524|FG001|NOT COMPLETED|Overall Study||1
6757802|NCT03550989|7684535|FG000|STARTED|Overall Study||190
6757803|NCT03550989|7684536|FG001|STARTED|Overall Study||74
6757804|NCT03550989|7684537|FG002|STARTED|Overall Study||77
6757805|NCT03550989|7684538|FG003|STARTED|Overall Study||60
6757806|NCT03550989|7684535|FG000|COMPLETED|Overall Study||188
6757807|NCT03550989|7684536|FG001|COMPLETED|Overall Study||73
6757808|NCT03550989|7684537|FG002|COMPLETED|Overall Study||76
6757809|NCT03550989|7684538|FG003|COMPLETED|Overall Study||60
6757810|NCT03550989|7684535|FG000|NOT COMPLETED|Overall Study||2
6555914|NCT01755234|7478155|FG001|STARTED|Overall Study||45
6757811|NCT03550989|7684536|FG001|NOT COMPLETED|Overall Study||1
6757812|NCT03550989|7684537|FG002|NOT COMPLETED|Overall Study||1
6757813|NCT03550989|7684538|FG003|NOT COMPLETED|Overall Study||0
6757814|NCT03551730|7684556|FG000|STARTED|Overall Study||9
6757815|NCT03551730|7684557|FG001|STARTED|Overall Study||6
6757816|NCT03551730|7684558|FG002|STARTED|Overall Study||6
6757817|NCT03551730|7684559|FG003|STARTED|Overall Study||6
6757818|NCT03551730|7684556|FG000|COMPLETED|Overall Study||8
6757819|NCT03551730|7684557|FG001|COMPLETED|Overall Study||6
6757820|NCT03551730|7684558|FG002|COMPLETED|Overall Study||6
6757821|NCT03551730|7684559|FG003|COMPLETED|Overall Study||6
6757822|NCT03551730|7684556|FG000|NOT COMPLETED|Overall Study||1
6757823|NCT03551730|7684557|FG001|NOT COMPLETED|Overall Study||0
6757824|NCT03551730|7684558|FG002|NOT COMPLETED|Overall Study||0
6757825|NCT03551730|7684559|FG003|NOT COMPLETED|Overall Study||0
6757826|NCT03551743|7684573|FG000|STARTED|Overall Study||10
6757827|NCT03551743|7684574|FG001|STARTED|Overall Study||6
6757828|NCT03551743|7684575|FG002|STARTED|Overall Study||6
6757829|NCT03551743|7684576|FG003|STARTED|Overall Study||6
6757830|NCT03551743|7684573|FG000|COMPLETED|Overall Study||8
6757831|NCT03551743|7684574|FG001|COMPLETED|Overall Study||6
6757832|NCT03551743|7684575|FG002|COMPLETED|Overall Study||6
6757833|NCT03551743|7684576|FG003|COMPLETED|Overall Study||6
6757834|NCT03551743|7684573|FG000|NOT COMPLETED|Overall Study||2
6757835|NCT03551743|7684574|FG001|NOT COMPLETED|Overall Study||0
6757836|NCT03551743|7684575|FG002|NOT COMPLETED|Overall Study||0
6757837|NCT03551743|7684576|FG003|NOT COMPLETED|Overall Study||0
6757838|NCT03551821|7684586|FG000|STARTED|Overall Study||1
6757839|NCT03551821|7684586|FG000|COMPLETED|Overall Study||1
6757840|NCT03551821|7684586|FG000|NOT COMPLETED|Overall Study||0
6757841|NCT03552198|7684594|FG000|STARTED|Overall Study||83
6757842|NCT03552198|7684595|FG001|STARTED|Overall Study||84
6757843|NCT03552198|7684596|FG002|STARTED|Overall Study||24
6757844|NCT03552198|7684597|FG003|STARTED|Overall Study||34
6757845|NCT03552198|7684594|FG000|Final Questionnaire 4 Weeks Follow-up|Overall Study||34
6757846|NCT03552198|7684595|FG001|Final Questionnaire 4 Weeks Follow-up|Overall Study||29
6757847|NCT03552198|7684596|FG002|Final Questionnaire 4 Weeks Follow-up|Overall Study||7
6757848|NCT03552198|7684597|FG003|Final Questionnaire 4 Weeks Follow-up|Overall Study||12
6757849|NCT03552198|7684594|FG000|COMPLETED|Overall Study||34
6757850|NCT03552198|7684595|FG001|COMPLETED|Overall Study||29
6757851|NCT03552198|7684596|FG002|COMPLETED|Overall Study||7
6757852|NCT03552198|7684597|FG003|COMPLETED|Overall Study||12
6757853|NCT03552198|7684594|FG000|NOT COMPLETED|Overall Study||49
6757854|NCT03552198|7684595|FG001|NOT COMPLETED|Overall Study||55
6757855|NCT03552198|7684596|FG002|NOT COMPLETED|Overall Study||17
6757856|NCT03552198|7684597|FG003|NOT COMPLETED|Overall Study||22
6757857|NCT03552289|7684609|FG000|STARTED|Overall Study||102
6757858|NCT03552289|7684610|FG001|STARTED|Overall Study||109
6757859|NCT03552289|7684609|FG000|COMPLETED|Overall Study||101
6757860|NCT03552289|7684610|FG001|COMPLETED|Overall Study||106
6757861|NCT03552289|7684609|FG000|NOT COMPLETED|Overall Study||1
6757862|NCT03552289|7684610|FG001|NOT COMPLETED|Overall Study||3
6757863|NCT03552523|7684616|FG000|STARTED|Overall Study||5
6757864|NCT03552523|7684617|FG001|STARTED|Overall Study||2
6757865|NCT03552523|7684616|FG000|COMPLETED|Overall Study||4
6757866|NCT03552523|7684617|FG001|COMPLETED|Overall Study||1
6757867|NCT03552523|7684616|FG000|NOT COMPLETED|Overall Study||1
6757868|NCT03552523|7684617|FG001|NOT COMPLETED|Overall Study||1
6757869|NCT03552536|7684626|FG000|STARTED|Overall Study||5
6757870|NCT03552536|7684627|FG001|STARTED|Overall Study||0
6757871|NCT03552536|7684628|FG002|STARTED|Overall Study||0
6757872|NCT03552536|7684626|FG000|COMPLETED|Overall Study||5
6757873|NCT03552536|7684627|FG001|COMPLETED|Overall Study||0
6757874|NCT03552536|7684628|FG002|COMPLETED|Overall Study||0
6757875|NCT03552536|7684626|FG000|NOT COMPLETED|Overall Study||0
6757876|NCT03552536|7684627|FG001|NOT COMPLETED|Overall Study||0
6757877|NCT03552536|7684628|FG002|NOT COMPLETED|Overall Study||0
6757878|NCT03552549|7684636|FG000|STARTED|Overall Study||63
6757879|NCT03552549|7684637|FG001|STARTED|Overall Study||63
6757880|NCT03552549|7684636|FG000|Treated|Overall Study||62
6757881|NCT03552549|7684637|FG001|Treated|Overall Study||62
6757882|NCT03552549|7684636|FG000|COMPLETED|Overall Study||10
6757883|NCT03552549|7684637|FG001|COMPLETED|Overall Study||11
6757884|NCT03552549|7684636|FG000|NOT COMPLETED|Overall Study||53
6757885|NCT03552549|7684637|FG001|NOT COMPLETED|Overall Study||52
6757886|NCT03552757|7684646|FG000|STARTED|Overall Study||403
6757887|NCT03552757|7684647|FG001|STARTED|Overall Study||404
6757888|NCT03552757|7684648|FG002|STARTED|Overall Study||403
6757889|NCT03552757|7684646|FG000|Exposed|Overall Study||402
6757890|NCT03552757|7684647|FG001|Exposed|Overall Study||403
6757891|NCT03552757|7684648|FG002|Exposed|Overall Study||402
6757892|NCT03552757|7684646|FG000|Full Analysis Set (FAS)|Overall Study||403
6757893|NCT03552757|7684647|FG001|Full Analysis Set (FAS)|Overall Study||404
6757894|NCT03552757|7684648|FG002|Full Analysis Set (FAS)|Overall Study||403
6757895|NCT03552757|7684646|FG000|Safety Analysis Set (SAS)|Overall Study||402
6757896|NCT03552757|7684647|FG001|Safety Analysis Set (SAS)|Overall Study||403
6757897|NCT03552757|7684648|FG002|Safety Analysis Set (SAS)|Overall Study||402
6757898|NCT03552757|7684646|FG000|COMPLETED|Overall Study||390
6757899|NCT03552757|7684647|FG001|COMPLETED|Overall Study||391
6757900|NCT03552757|7684648|FG002|COMPLETED|Overall Study||383
6757901|NCT03552757|7684646|FG000|NOT COMPLETED|Overall Study||13
6757902|NCT03552757|7684647|FG001|NOT COMPLETED|Overall Study||13
6757903|NCT03552757|7684648|FG002|NOT COMPLETED|Overall Study||20
6757904|NCT03553758|7684659|FG000|STARTED|Overall Study||16
6757905|NCT03553758|7684659|FG000|Completed Screening Visit|Overall Study||16
6757906|NCT03553758|7684659|FG000|COMPLETED|Overall Study||15
6757907|NCT03553758|7684659|FG000|NOT COMPLETED|Overall Study||1
6757908|NCT03553823|7684667|FG000|STARTED|Overall Study||20
6757909|NCT03553823|7684668|FG001|STARTED|Overall Study||20
6757910|NCT03553823|7684667|FG000|COMPLETED|Overall Study||20
6757911|NCT03553823|7684668|FG001|COMPLETED|Overall Study||19
6757912|NCT03553823|7684667|FG000|NOT COMPLETED|Overall Study||0
6757913|NCT03553823|7684668|FG001|NOT COMPLETED|Overall Study||1
6757914|NCT03553940|7684676|FG000|STARTED|Overall Study||22
6757915|NCT03553940|7684677|FG001|STARTED|Overall Study||21
6757916|NCT03553940|7684676|FG000|COMPLETED|Overall Study||22
6757917|NCT03553940|7684677|FG001|COMPLETED|Overall Study||21
6757918|NCT03553940|7684676|FG000|NOT COMPLETED|Overall Study||0
6757919|NCT03553940|7684677|FG001|NOT COMPLETED|Overall Study||0
6757920|NCT03554005|7684689|FG000|STARTED|Overall Study||1
6757921|NCT03554005|7684690|FG001|STARTED|Overall Study||2
6757922|NCT03554005|7684691|FG002|STARTED|Overall Study||2
6757923|NCT03554005|7684692|FG003|STARTED|Overall Study||2
6757924|NCT03554005|7684693|FG004|STARTED|Overall Study||11
6757925|NCT03554005|7684694|FG005|STARTED|Overall Study||11
6757926|NCT03554005|7684689|FG000|COMPLETED|Overall Study||0
6757927|NCT03554005|7684690|FG001|COMPLETED|Overall Study||1
6757928|NCT03554005|7684691|FG002|COMPLETED|Overall Study||1
6757929|NCT03554005|7684692|FG003|COMPLETED|Overall Study||1
6757930|NCT03554005|7684693|FG004|COMPLETED|Overall Study||5
6757931|NCT03554005|7684694|FG005|COMPLETED|Overall Study||0
6757932|NCT03554005|7684689|FG000|NOT COMPLETED|Overall Study||1
6757933|NCT03554005|7684690|FG001|NOT COMPLETED|Overall Study||1
6757934|NCT03554005|7684691|FG002|NOT COMPLETED|Overall Study||1
6757935|NCT03554005|7684692|FG003|NOT COMPLETED|Overall Study||1
6757936|NCT03554005|7684693|FG004|NOT COMPLETED|Overall Study||6
6757937|NCT03554005|7684694|FG005|NOT COMPLETED|Overall Study||11
6757938|NCT03554018|7684710|FG000|STARTED|Overall Study||60
6757939|NCT03554018|7684711|FG001|STARTED|Overall Study||60
6757940|NCT03554018|7684710|FG000|COMPLETED|Overall Study||57
6757941|NCT03554018|7684711|FG001|COMPLETED|Overall Study||53
6757942|NCT03554018|7684710|FG000|NOT COMPLETED|Overall Study||3
6757943|NCT03554018|7684711|FG001|NOT COMPLETED|Overall Study||7
6757944|NCT03554486|7684719|FG000|STARTED|Run-in Period (2 Weeks)||24
6757945|NCT03554486|7684720|FG001|STARTED|Run-in Period (2 Weeks)||0
6757946|NCT03554486|7684721|FG002|STARTED|Run-in Period (2 Weeks)||0
6757947|NCT03554486|7684719|FG000|COMPLETED|Run-in Period (2 Weeks)||21
6757948|NCT03554486|7684720|FG001|COMPLETED|Run-in Period (2 Weeks)||0
6757949|NCT03554486|7684721|FG002|COMPLETED|Run-in Period (2 Weeks)||0
6757950|NCT03554486|7684719|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||3
6757951|NCT03554486|7684720|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
6757952|NCT03554486|7684721|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
6757953|NCT03554486|7684719|FG000|STARTED|Treatment Period 1 (2 Weeks)||0
6757954|NCT03554486|7684720|FG001|STARTED|Treatment Period 1 (2 Weeks)||11
6757955|NCT03554486|7684721|FG002|STARTED|Treatment Period 1 (2 Weeks)||10
6757956|NCT03554486|7684719|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||0
6757957|NCT03554486|7684720|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||10
6757958|NCT03554486|7684721|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||9
6555915|NCT01755234|7478154|FG000|COMPLETED|Overall Study||30
6555916|NCT01755234|7478155|FG001|COMPLETED|Overall Study||37
6555917|NCT01755234|7478154|FG000|NOT COMPLETED|Overall Study||15
6555918|NCT01755234|7478155|FG001|NOT COMPLETED|Overall Study||8
6555919|NCT01755416|7478161|FG000|STARTED|First Intervention ( Upto 2 Days)||9
6555920|NCT01755416|7478162|FG001|STARTED|First Intervention ( Upto 2 Days)||9
6555921|NCT01755416|7478161|FG000|COMPLETED|First Intervention ( Upto 2 Days)||8
6555922|NCT01755416|7478162|FG001|COMPLETED|First Intervention ( Upto 2 Days)||7
6555923|NCT01755416|7478161|FG000|NOT COMPLETED|First Intervention ( Upto 2 Days)||1
6555924|NCT01755416|7478162|FG001|NOT COMPLETED|First Intervention ( Upto 2 Days)||2
6555925|NCT01755416|7478161|FG000|STARTED|Second Intervention (Upto 2 Days)||8
6555926|NCT01755416|7478162|FG001|STARTED|Second Intervention (Upto 2 Days)||7
6555927|NCT01755416|7478161|FG000|COMPLETED|Second Intervention (Upto 2 Days)||8
6555928|NCT01755416|7478162|FG001|COMPLETED|Second Intervention (Upto 2 Days)||7
6555929|NCT01755416|7478161|FG000|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
6555930|NCT01755416|7478162|FG001|NOT COMPLETED|Second Intervention (Upto 2 Days)||0
6555931|NCT01755455|7478168|FG000|STARTED|First Intervention (6 Weeks)||11
6555932|NCT01755455|7478169|FG001|STARTED|First Intervention (6 Weeks)||11
6555933|NCT01755455|7478168|FG000|COMPLETED|First Intervention (6 Weeks)||11
6757959|NCT03554486|7684719|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6757960|NCT03554486|7684720|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
6757961|NCT03554486|7684721|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
6757962|NCT03554486|7684719|FG000|STARTED|Treatment Period 2 (2 Weeks)||0
6757963|NCT03554486|7684720|FG001|STARTED|Treatment Period 2 (2 Weeks)||10
6757964|NCT03554486|7684721|FG002|STARTED|Treatment Period 2 (2 Weeks)||9
6757965|NCT03554486|7684719|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||0
6757966|NCT03554486|7684720|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||10
6757967|NCT03554486|7684721|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||9
6757968|NCT03554486|7684719|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6757969|NCT03554486|7684720|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6757970|NCT03554486|7684721|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6555934|NCT01755455|7478169|FG001|COMPLETED|First Intervention (6 Weeks)||11
6757971|NCT03554629|7684728|FG000|STARTED|Overall Study|8 filterlines per participant for four scripted activities with supplemental oxygen|29
6757972|NCT03554629|7684728|FG000|COMPLETED|Overall Study|8 filterlines (CCSF) per participate for four scripted activities with supplemental oxygen.|23
6757973|NCT03554629|7684728|FG000|NOT COMPLETED|Overall Study||6
6757974|NCT03554746|7684758|FG000|STARTED|Overall Study||24
6757975|NCT03554746|7684759|FG001|STARTED|Overall Study||24
6757976|NCT03554746|7684758|FG000|COMPLETED|Overall Study||24
6757977|NCT03554746|7684759|FG001|COMPLETED|Overall Study||24
6757978|NCT03554746|7684758|FG000|NOT COMPLETED|Overall Study||0
6757979|NCT03554746|7684759|FG001|NOT COMPLETED|Overall Study||0
6757980|NCT03554772|7684769|FG000|STARTED|Overall Study||30
6757981|NCT03554772|7684770|FG001|STARTED|Overall Study||30
6757982|NCT03554772|7684771|FG002|STARTED|Overall Study||29
6757983|NCT03554772|7684772|FG003|STARTED|Overall Study||31
6757984|NCT03554772|7684769|FG000|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
6757985|NCT03554772|7684770|FG001|Completed Treatment Period (8 Hours Post Dose)|Overall Study||30
6757986|NCT03554772|7684771|FG002|Completed Treatment Period (8 Hours Post Dose)|Overall Study||29
6757987|NCT03554772|7684772|FG003|Completed Treatment Period (8 Hours Post Dose)|Overall Study||31
6757988|NCT03554772|7684769|FG000|COMPLETED|Overall Study||30
6757989|NCT03554772|7684770|FG001|COMPLETED|Overall Study||30
6757990|NCT03554772|7684771|FG002|COMPLETED|Overall Study||29
6757991|NCT03554772|7684772|FG003|COMPLETED|Overall Study||29
6757992|NCT03554772|7684769|FG000|NOT COMPLETED|Overall Study||0
6757993|NCT03554772|7684770|FG001|NOT COMPLETED|Overall Study||0
6757994|NCT03554772|7684771|FG002|NOT COMPLETED|Overall Study||0
6757995|NCT03554772|7684772|FG003|NOT COMPLETED|Overall Study||2
6757996|NCT03554954|7684782|FG000|STARTED|Overall Study||108
6757997|NCT03554954|7684782|FG000|COMPLETED|Overall Study||108
6757998|NCT03554954|7684782|FG000|NOT COMPLETED|Overall Study||0
6757999|NCT03555266|7684792|FG000|STARTED|Overall Study||32
6758000|NCT03555266|7684793|FG001|STARTED|Overall Study||31
6758001|NCT03555266|7684792|FG000|COMPLETED|Overall Study||26
6758002|NCT03555266|7684793|FG001|COMPLETED|Overall Study||27
6758003|NCT03555266|7684792|FG000|NOT COMPLETED|Overall Study||6
6758004|NCT03555266|7684793|FG001|NOT COMPLETED|Overall Study||4
6758005|NCT03555305|7684799|FG000|STARTED|Period 1||29
6758006|NCT03555305|7684800|FG001|STARTED|Period 1||29
6758007|NCT03555305|7684799|FG000|Received at Least 1 Dose of Study Drug|Period 1||29
6758008|NCT03555305|7684800|FG001|Received at Least 1 Dose of Study Drug|Period 1||29
6758009|NCT03555305|7684799|FG000|COMPLETED|Period 1||29
6758010|NCT03555305|7684800|FG001|COMPLETED|Period 1||27
6758011|NCT03555305|7684799|FG000|NOT COMPLETED|Period 1||0
6758012|NCT03555305|7684800|FG001|NOT COMPLETED|Period 1||2
6758013|NCT03555305|7684799|FG000|STARTED|Period 2||29
6758014|NCT03555305|7684800|FG001|STARTED|Period 2||27
6758015|NCT03555305|7684799|FG000|COMPLETED|Period 2||29
6758016|NCT03555305|7684800|FG001|COMPLETED|Period 2||27
6758017|NCT03555305|7684799|FG000|NOT COMPLETED|Period 2||0
6758018|NCT03555305|7684800|FG001|NOT COMPLETED|Period 2||0
6758019|NCT03555435|7684809|FG000|STARTED|Overall Study||28
6758020|NCT03555435|7684810|FG001|STARTED|Overall Study||27
6758021|NCT03555435|7684811|FG002|STARTED|Overall Study||26
6758022|NCT03555435|7684809|FG000|COMPLETED|Overall Study||11
6758023|NCT03555435|7684810|FG001|COMPLETED|Overall Study||8
6758024|NCT03555435|7684811|FG002|COMPLETED|Overall Study||18
6758025|NCT03555435|7684809|FG000|NOT COMPLETED|Overall Study||17
6758026|NCT03555435|7684810|FG001|NOT COMPLETED|Overall Study||19
6758027|NCT03555435|7684811|FG002|NOT COMPLETED|Overall Study||8
6758028|NCT03555565|7684819|FG000|STARTED|Overall Study||1026
6758029|NCT03555565|7684819|FG000|COMPLETED|Overall Study||1011
6758030|NCT03555565|7684819|FG000|NOT COMPLETED|Overall Study||15
6758031|NCT03555890|7684827|FG000|STARTED|Part 1:Treatment Period 1 (3 Days)||12
6758032|NCT03555890|7684828|FG001|STARTED|Part 1:Treatment Period 1 (3 Days)||12
6758033|NCT03555890|7684829|FG002|STARTED|Part 1:Treatment Period 1 (3 Days)||0
6758034|NCT03555890|7684830|FG003|STARTED|Part 1:Treatment Period 1 (3 Days)||0
6758035|NCT03555890|7684827|FG000|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
6758036|NCT03555890|7684828|FG001|COMPLETED|Part 1:Treatment Period 1 (3 Days)||12
6758037|NCT03555890|7684829|FG002|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6758038|NCT03555890|7684830|FG003|COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6758039|NCT03555890|7684827|FG000|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6758040|NCT03555890|7684828|FG001|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6758041|NCT03555890|7684829|FG002|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6758042|NCT03555890|7684830|FG003|NOT COMPLETED|Part 1:Treatment Period 1 (3 Days)||0
6758043|NCT03555890|7684827|FG000|STARTED|Part 1:Washout Period (at Least 5 Days)||12
6758044|NCT03555890|7684828|FG001|STARTED|Part 1:Washout Period (at Least 5 Days)||12
6758045|NCT03555890|7684829|FG002|STARTED|Part 1:Washout Period (at Least 5 Days)||0
6758046|NCT03555890|7684830|FG003|STARTED|Part 1:Washout Period (at Least 5 Days)||0
6758047|NCT03555890|7684827|FG000|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
6758048|NCT03555890|7684828|FG001|COMPLETED|Part 1:Washout Period (at Least 5 Days)||12
6758049|NCT03555890|7684829|FG002|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6758050|NCT03555890|7684830|FG003|COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6758051|NCT03555890|7684827|FG000|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6758052|NCT03555890|7684828|FG001|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6758053|NCT03555890|7684829|FG002|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6758054|NCT03555890|7684830|FG003|NOT COMPLETED|Part 1:Washout Period (at Least 5 Days)||0
6758055|NCT03555890|7684827|FG000|STARTED|Part 1:Treatment Period 2 (10 Days)||12
6758056|NCT03555890|7684828|FG001|STARTED|Part 1:Treatment Period 2 (10 Days)||12
6758057|NCT03555890|7684829|FG002|STARTED|Part 1:Treatment Period 2 (10 Days)||0
6758058|NCT03555890|7684830|FG003|STARTED|Part 1:Treatment Period 2 (10 Days)||0
6758059|NCT03555890|7684827|FG000|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
6758060|NCT03555890|7684828|FG001|COMPLETED|Part 1:Treatment Period 2 (10 Days)||12
6758061|NCT03555890|7684829|FG002|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6758062|NCT03555890|7684830|FG003|COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6758063|NCT03555890|7684827|FG000|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6758064|NCT03555890|7684828|FG001|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6758065|NCT03555890|7684829|FG002|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6758066|NCT03555890|7684830|FG003|NOT COMPLETED|Part 1:Treatment Period 2 (10 Days)||0
6758067|NCT03555890|7684827|FG000|STARTED|Part 2:Treatment Period 1 (3 Days)||0
6758068|NCT03555890|7684828|FG001|STARTED|Part 2:Treatment Period 1 (3 Days)||0
6758069|NCT03555890|7684829|FG002|STARTED|Part 2:Treatment Period 1 (3 Days)||24
6758070|NCT03555890|7684830|FG003|STARTED|Part 2:Treatment Period 1 (3 Days)||24
6758071|NCT03555890|7684827|FG000|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6758072|NCT03555890|7684828|FG001|COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6758073|NCT03555890|7684829|FG002|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
6758074|NCT03555890|7684830|FG003|COMPLETED|Part 2:Treatment Period 1 (3 Days)||24
6758075|NCT03555890|7684827|FG000|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6758076|NCT03555890|7684828|FG001|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6758077|NCT03555890|7684829|FG002|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6758078|NCT03555890|7684830|FG003|NOT COMPLETED|Part 2:Treatment Period 1 (3 Days)||0
6758079|NCT03555890|7684827|FG000|STARTED|Part 2:Washout Period (at Least 5 Days)||0
6758080|NCT03555890|7684828|FG001|STARTED|Part 2:Washout Period (at Least 5 Days)||0
6758081|NCT03555890|7684829|FG002|STARTED|Part 2:Washout Period (at Least 5 Days)||24
6758082|NCT03555890|7684830|FG003|STARTED|Part 2:Washout Period (at Least 5 Days)||24
6758083|NCT03555890|7684827|FG000|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6758084|NCT03555890|7684828|FG001|COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6758085|NCT03555890|7684829|FG002|COMPLETED|Part 2:Washout Period (at Least 5 Days)||24
6758086|NCT03555890|7684830|FG003|COMPLETED|Part 2:Washout Period (at Least 5 Days)||23
6758087|NCT03555890|7684827|FG000|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6758088|NCT03555890|7684828|FG001|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6758089|NCT03555890|7684829|FG002|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||0
6758090|NCT03555890|7684830|FG003|NOT COMPLETED|Part 2:Washout Period (at Least 5 Days)||1
6758091|NCT03555890|7684827|FG000|STARTED|Part 2:Treatment Period 2 (10 Days)||0
6758092|NCT03555890|7684828|FG001|STARTED|Part 2:Treatment Period 2 (10 Days)||0
6758093|NCT03555890|7684829|FG002|STARTED|Part 2:Treatment Period 2 (10 Days)||24
6758094|NCT03555890|7684830|FG003|STARTED|Part 2:Treatment Period 2 (10 Days)||23
6758095|NCT03555890|7684827|FG000|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6758096|NCT03555890|7684828|FG001|COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6758097|NCT03555890|7684829|FG002|COMPLETED|Part 2:Treatment Period 2 (10 Days)||24
6758098|NCT03555890|7684830|FG003|COMPLETED|Part 2:Treatment Period 2 (10 Days)||23
6758099|NCT03555890|7684827|FG000|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6758100|NCT03555890|7684828|FG001|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6758101|NCT03555890|7684829|FG002|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6758102|NCT03555890|7684830|FG003|NOT COMPLETED|Part 2:Treatment Period 2 (10 Days)||0
6758103|NCT03556579|7684840|FG000|STARTED|Visit 1||16
6758104|NCT03556579|7684841|FG001|STARTED|Visit 1||14
6758105|NCT03556579|7684842|FG002|STARTED|Visit 1||14
6758106|NCT03556579|7684843|FG003|STARTED|Visit 1||16
6758107|NCT03556579|7684840|FG000|COMPLETED|Visit 1||16
6758108|NCT03556579|7684841|FG001|COMPLETED|Visit 1||14
6758109|NCT03556579|7684842|FG002|COMPLETED|Visit 1||14
6758110|NCT03556579|7684843|FG003|COMPLETED|Visit 1||16
6555935|NCT01755455|7478168|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
6555936|NCT01755455|7478169|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
6555937|NCT01755455|7478168|FG000|STARTED|Washout (4 Weeks)||11
6555938|NCT01755455|7478169|FG001|STARTED|Washout (4 Weeks)||11
6555939|NCT01755455|7478168|FG000|COMPLETED|Washout (4 Weeks)||11
6555940|NCT01755455|7478169|FG001|COMPLETED|Washout (4 Weeks)||11
6555941|NCT01755455|7478168|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6758111|NCT03556579|7684840|FG000|NOT COMPLETED|Visit 1||0
6758112|NCT03556579|7684841|FG001|NOT COMPLETED|Visit 1||0
6758113|NCT03556579|7684842|FG002|NOT COMPLETED|Visit 1||0
6758114|NCT03556579|7684843|FG003|NOT COMPLETED|Visit 1||0
6758115|NCT03556579|7684840|FG000|STARTED|Visit 2||16
6758116|NCT03556579|7684841|FG001|STARTED|Visit 2||14
6758117|NCT03556579|7684842|FG002|STARTED|Visit 2||14
6758118|NCT03556579|7684843|FG003|STARTED|Visit 2||16
6758119|NCT03556579|7684840|FG000|COMPLETED|Visit 2||16
6758120|NCT03556579|7684841|FG001|COMPLETED|Visit 2||14
6758121|NCT03556579|7684842|FG002|COMPLETED|Visit 2||14
6758122|NCT03556579|7684843|FG003|COMPLETED|Visit 2||16
6758123|NCT03556579|7684840|FG000|NOT COMPLETED|Visit 2||0
6758124|NCT03556579|7684841|FG001|NOT COMPLETED|Visit 2||0
6758125|NCT03556579|7684842|FG002|NOT COMPLETED|Visit 2||0
6758126|NCT03556579|7684843|FG003|NOT COMPLETED|Visit 2||0
6758127|NCT03556761|7684855|FG000|STARTED|Overall Study||192
6758128|NCT03556761|7684856|FG001|STARTED|Overall Study||192
6758129|NCT03556761|7684855|FG000|COMPLETED|Overall Study||168
6555942|NCT01755455|7478169|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6758130|NCT03556761|7684856|FG001|COMPLETED|Overall Study||163
6758131|NCT03556761|7684855|FG000|NOT COMPLETED|Overall Study||24
6758132|NCT03556761|7684856|FG001|NOT COMPLETED|Overall Study||29
6758133|NCT03556891|7684862|FG000|STARTED|Overall Study||133
6758134|NCT03556891|7684862|FG000|COMPLETED|Overall Study||120
6758135|NCT03556891|7684862|FG000|NOT COMPLETED|Overall Study||13
6758136|NCT03557034|7684868|FG000|STARTED|Overall Study||49
6758137|NCT03557034|7684869|FG001|STARTED|Overall Study||51
6758138|NCT03557034|7684868|FG000|Randomization|Overall Study||49
6758139|NCT03557034|7684869|FG001|Randomization|Overall Study||51
6758140|NCT03557034|7684868|FG000|COMPLETED|Overall Study||48
6758141|NCT03557034|7684869|FG001|COMPLETED|Overall Study||51
6758142|NCT03557034|7684868|FG000|NOT COMPLETED|Overall Study||1
6758143|NCT03557034|7684869|FG001|NOT COMPLETED|Overall Study||0
6758144|NCT03557086|7684877|FG000|STARTED|Overall Study||26
6758145|NCT03557086|7684878|FG001|STARTED|Overall Study||24
6758146|NCT03557086|7684877|FG000|COMPLETED|Overall Study||26
6758147|NCT03557086|7684878|FG001|COMPLETED|Overall Study||24
6758148|NCT03557086|7684877|FG000|NOT COMPLETED|Overall Study||0
6758149|NCT03557086|7684878|FG001|NOT COMPLETED|Overall Study||0
6758150|NCT03557125|7684888|FG000|STARTED|Overall Study||22
6758151|NCT03557125|7684889|FG001|STARTED|Overall Study||24
6758152|NCT03557125|7684888|FG000|COMPLETED|Overall Study||22
6758153|NCT03557125|7684889|FG001|COMPLETED|Overall Study||24
6758154|NCT03557125|7684888|FG000|NOT COMPLETED|Overall Study||0
6758155|NCT03557125|7684889|FG001|NOT COMPLETED|Overall Study||0
6758156|NCT03557333|7684895|FG000|STARTED|Overall Study||354
6758157|NCT03557333|7684895|FG000|COMPLETED|Overall Study||262
6758158|NCT03557333|7684895|FG000|NOT COMPLETED|Overall Study||92
6758159|NCT03557372|7684901|FG000|STARTED|Overall Study||14
6758160|NCT03557372|7684901|FG000|COMPLETED|Overall Study||14
6758161|NCT03557372|7684901|FG000|NOT COMPLETED|Overall Study||0
6758162|NCT03557476|7684907|FG000|STARTED|Overall Study||13
6758163|NCT03557476|7684908|FG001|STARTED|Overall Study||13
6758164|NCT03557476|7684907|FG000|COMPLETED|Overall Study||13
6758165|NCT03557476|7684908|FG001|COMPLETED|Overall Study||13
6758166|NCT03557476|7684907|FG000|NOT COMPLETED|Overall Study||0
6758167|NCT03557476|7684908|FG001|NOT COMPLETED|Overall Study||0
6758168|NCT03557658|7684916|FG000|STARTED|Overall Study||8
6758169|NCT03557658|7684917|FG001|STARTED|Overall Study||8
6758170|NCT03557658|7684916|FG000|COMPLETED|Overall Study||8
6758171|NCT03557658|7684917|FG001|COMPLETED|Overall Study||8
6758172|NCT03557658|7684916|FG000|NOT COMPLETED|Overall Study||0
6758173|NCT03557658|7684917|FG001|NOT COMPLETED|Overall Study||0
6758174|NCT03557775|7684926|FG000|STARTED|Overall Study||5
6758175|NCT03557775|7684927|FG001|STARTED|Overall Study||7
6758176|NCT03557775|7684928|FG002|STARTED|Overall Study||8
6758177|NCT03557775|7684926|FG000|COMPLETED|Overall Study||4
6758178|NCT03557775|7684927|FG001|COMPLETED|Overall Study||4
6758179|NCT03557775|7684928|FG002|COMPLETED|Overall Study||4
6758180|NCT03557775|7684926|FG000|NOT COMPLETED|Overall Study||1
6758181|NCT03557775|7684927|FG001|NOT COMPLETED|Overall Study||3
6758182|NCT03557775|7684928|FG002|NOT COMPLETED|Overall Study||4
6758183|NCT03557801|7684939|FG000|STARTED|Overall Study||34
6758184|NCT03557801|7684940|FG001|STARTED|Overall Study||33
6758185|NCT03557801|7684941|FG002|STARTED|Overall Study||33
6758186|NCT03557801|7684939|FG000|COMPLETED|Overall Study||32
6758187|NCT03557801|7684940|FG001|COMPLETED|Overall Study||32
6758188|NCT03557801|7684941|FG002|COMPLETED|Overall Study||30
6758189|NCT03557801|7684939|FG000|NOT COMPLETED|Overall Study||2
6758190|NCT03557801|7684940|FG001|NOT COMPLETED|Overall Study||1
6758191|NCT03557801|7684941|FG002|NOT COMPLETED|Overall Study||3
6758192|NCT03557931|7684952|FG000|STARTED|Overall Study||100
6555943|NCT01755455|7478168|FG000|STARTED|Second Intervention (6 Weeks)||11
6555944|NCT01755455|7478169|FG001|STARTED|Second Intervention (6 Weeks)||11
6555945|NCT01755455|7478168|FG000|COMPLETED|Second Intervention (6 Weeks)||11
6555946|NCT01755455|7478169|FG001|COMPLETED|Second Intervention (6 Weeks)||11
6555947|NCT01755455|7478168|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6555948|NCT01755455|7478169|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6555949|NCT01755546|7478175|FG000|STARTED|Screened and Taper (Rollover and DeNovo)||304
6555950|NCT01755546|7478175|FG000|COMPLETED|Screened and Taper (Rollover and DeNovo)||294
6555951|NCT01755546|7478175|FG000|NOT COMPLETED|Screened and Taper (Rollover and DeNovo)||10
6555952|NCT01755546|7478175|FG000|STARTED|Titration Phase||294
6555953|NCT01755546|7478175|FG000|COMPLETED|Titration Phase||224
6555954|NCT01755546|7478175|FG000|NOT COMPLETED|Titration Phase||70
6758193|NCT03557931|7684953|FG001|STARTED|Overall Study||65
6758194|NCT03557931|7684954|FG002|STARTED|Overall Study||68
6758195|NCT03557931|7684952|FG000|COMPLETED|Overall Study||69
6758196|NCT03557931|7684953|FG001|COMPLETED|Overall Study||46
6758197|NCT03557931|7684954|FG002|COMPLETED|Overall Study||55
6758198|NCT03557931|7684952|FG000|NOT COMPLETED|Overall Study||31
6758199|NCT03557931|7684953|FG001|NOT COMPLETED|Overall Study||19
6758200|NCT03557931|7684954|FG002|NOT COMPLETED|Overall Study||13
6758201|NCT03558061|7684964|FG000|STARTED|Overall Study||30
6758202|NCT03558061|7684964|FG000|COMPLETED|Overall Study||29
6758203|NCT03558061|7684964|FG000|NOT COMPLETED|Overall Study||1
6758204|NCT03558074|7684968|FG000|STARTED|Overall Study||26
6758205|NCT03558074|7684968|FG000|COMPLETED|Overall Study||24
6555955|NCT01755546|7478175|FG000|STARTED|Long Term Treatment||224
6555956|NCT01755546|7478175|FG000|COMPLETED|Long Term Treatment||103
6555957|NCT01755546|7478175|FG000|NOT COMPLETED|Long Term Treatment||121
6555958|NCT01755598|7478181|FG000|STARTED|Overall Study||1786
6555959|NCT01755598|7478182|FG001|STARTED|Overall Study||1787
6555960|NCT01755598|7478181|FG000|COMPLETED|Overall Study||1521
6555961|NCT01755598|7478182|FG001|COMPLETED|Overall Study||1504
6555962|NCT01755598|7478181|FG000|NOT COMPLETED|Overall Study||265
6555963|NCT01755598|7478182|FG001|NOT COMPLETED|Overall Study||283
6555964|NCT01755637|7478188|FG000|STARTED|Period 1||28
6555965|NCT01755637|7478189|FG001|STARTED|Period 1||28
6555966|NCT01755637|7478188|FG000|COMPLETED|Period 1||28
6555967|NCT01755637|7478189|FG001|COMPLETED|Period 1||27
6555968|NCT01755637|7478188|FG000|NOT COMPLETED|Period 1||0
6555969|NCT01755637|7478189|FG001|NOT COMPLETED|Period 1||1
6555970|NCT01755637|7478188|FG000|STARTED|Period 2||28
6555971|NCT01755637|7478189|FG001|STARTED|Period 2||27
6555972|NCT01755637|7478188|FG000|COMPLETED|Period 2||28
6555973|NCT01755637|7478189|FG001|COMPLETED|Period 2||27
6555974|NCT01755637|7478188|FG000|NOT COMPLETED|Period 2||0
6555975|NCT01755637|7478189|FG001|NOT COMPLETED|Period 2||0
6555976|NCT01755702|7478201|FG000|STARTED|Period I||66
6555977|NCT01755702|7478201|FG000|Received Paracetamol|Period I||16
6758206|NCT03558074|7684968|FG000|NOT COMPLETED|Overall Study||2
6758207|NCT03558230|7684975|FG000|STARTED|Overall Study||7
6758208|NCT03558230|7684976|FG001|STARTED|Overall Study||6
6758209|NCT03558230|7684975|FG000|COMPLETED|Overall Study||7
6758210|NCT03558230|7684976|FG001|COMPLETED|Overall Study||6
6758211|NCT03558230|7684975|FG000|NOT COMPLETED|Overall Study||0
6555978|NCT01755702|7478201|FG000|Received Placebo|Period I||17
6758212|NCT03558230|7684976|FG001|NOT COMPLETED|Overall Study||0
6555979|NCT01755702|7478201|FG000|Received Ibuprofen|Period I||16
6555980|NCT01755702|7478201|FG000|Received Paracetamol/Caffeine|Period I||17
6555981|NCT01755702|7478201|FG000|COMPLETED|Period I||66
6555982|NCT01755702|7478201|FG000|NOT COMPLETED|Period I||0
6758213|NCT03558516|7684984|FG000|STARTED|Overall Study||40
6758214|NCT03558516|7684985|FG001|STARTED|Overall Study||40
6758215|NCT03558516|7684984|FG000|COMPLETED|Overall Study||38
6758216|NCT03558516|7684985|FG001|COMPLETED|Overall Study||38
6758217|NCT03558516|7684984|FG000|NOT COMPLETED|Overall Study||2
6758218|NCT03558516|7684985|FG001|NOT COMPLETED|Overall Study||2
6758219|NCT03558555|7684993|FG000|STARTED|Overall Study||58
6758220|NCT03558555|7684994|FG001|STARTED|Overall Study||45
6758221|NCT03558555|7684993|FG000|COMPLETED|Overall Study||56
6758222|NCT03558555|7684994|FG001|COMPLETED|Overall Study||44
6758223|NCT03558555|7684993|FG000|NOT COMPLETED|Overall Study||2
6758224|NCT03558555|7684994|FG001|NOT COMPLETED|Overall Study||1
6758225|NCT03558672|7685000|FG000|STARTED|Overall Study||18
6758226|NCT03558672|7685000|FG000|COMPLETED|Overall Study||8
6758227|NCT03558672|7685000|FG000|NOT COMPLETED|Overall Study||10
6758228|NCT03558997|7685008|FG000|STARTED|Overall Study||25
6758229|NCT03558997|7685009|FG001|STARTED|Overall Study||26
6758230|NCT03558997|7685010|FG002|STARTED|Overall Study||26
6758231|NCT03558997|7685011|FG003|STARTED|Overall Study||26
6758232|NCT03558997|7685008|FG000|COMPLETED|Overall Study||24
6758233|NCT03558997|7685009|FG001|COMPLETED|Overall Study||24
6758234|NCT03558997|7685010|FG002|COMPLETED|Overall Study||18
6758235|NCT03558997|7685011|FG003|COMPLETED|Overall Study||24
6758236|NCT03558997|7685008|FG000|NOT COMPLETED|Overall Study||1
6758237|NCT03558997|7685009|FG001|NOT COMPLETED|Overall Study||2
6758238|NCT03558997|7685010|FG002|NOT COMPLETED|Overall Study||8
6758239|NCT03558997|7685011|FG003|NOT COMPLETED|Overall Study||2
6758240|NCT03559062|7685027|FG000|STARTED|Overall Study||10
6758241|NCT03559062|7685028|FG001|STARTED|Overall Study||54
6758242|NCT03559062|7685029|FG002|STARTED|Overall Study||3
6758243|NCT03559062|7685027|FG000|COMPLETED|Overall Study||10
6758244|NCT03559062|7685028|FG001|COMPLETED|Overall Study||53
6758245|NCT03559062|7685029|FG002|COMPLETED|Overall Study||3
6758246|NCT03559062|7685027|FG000|NOT COMPLETED|Overall Study||0
6758247|NCT03559062|7685028|FG001|NOT COMPLETED|Overall Study||1
6758248|NCT03559062|7685029|FG002|NOT COMPLETED|Overall Study||0
6758249|NCT03559179|7685041|FG000|STARTED|Overall Study||8
6758250|NCT03559179|7685042|FG001|STARTED|Overall Study||24
6758251|NCT03559179|7685043|FG002|STARTED|Overall Study||23
6758252|NCT03559179|7685041|FG000|COMPLETED|Overall Study||8
6758253|NCT03559179|7685042|FG001|COMPLETED|Overall Study||23
6758254|NCT03559179|7685043|FG002|COMPLETED|Overall Study||23
6758255|NCT03559179|7685041|FG000|NOT COMPLETED|Overall Study||0
6758256|NCT03559179|7685042|FG001|NOT COMPLETED|Overall Study||1
6758257|NCT03559179|7685043|FG002|NOT COMPLETED|Overall Study||0
6758258|NCT03559205|7685062|FG000|STARTED|Overall Study||177
6758259|NCT03559205|7685063|FG001|STARTED|Overall Study||144
6758260|NCT03559205|7685062|FG000|Baseline Data|Overall Study||141
6758261|NCT03559205|7685063|FG001|Baseline Data|Overall Study||132
6758262|NCT03559205|7685062|FG000|COMPLETED|Overall Study||65
6758263|NCT03559205|7685063|FG001|COMPLETED|Overall Study||57
6758264|NCT03559205|7685062|FG000|NOT COMPLETED|Overall Study||112
6758265|NCT03559205|7685063|FG001|NOT COMPLETED|Overall Study||87
6758266|NCT03559218|7685071|FG000|STARTED|Overall Study||12
6758267|NCT03559218|7685072|FG001|STARTED|Overall Study||13
6758268|NCT03559218|7685071|FG000|COMPLETED|Overall Study||11
6758269|NCT03559218|7685072|FG001|COMPLETED|Overall Study||13
6758270|NCT03559218|7685071|FG000|NOT COMPLETED|Overall Study||1
6758271|NCT03559218|7685072|FG001|NOT COMPLETED|Overall Study||0
6758272|NCT03559257|7685080|FG000|STARTED|Double Blind Treatment Period||230
6758273|NCT03559257|7685081|FG001|STARTED|Double Blind Treatment Period||233
6758274|NCT03559257|7685080|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||230
6758275|NCT03559257|7685081|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||232
6758276|NCT03559257|7685080|FG000|COMPLETED|Double Blind Treatment Period||226
6758277|NCT03559257|7685081|FG001|COMPLETED|Double Blind Treatment Period||225
6758278|NCT03559257|7685080|FG000|NOT COMPLETED|Double Blind Treatment Period||4
6758279|NCT03559257|7685081|FG001|NOT COMPLETED|Double Blind Treatment Period||8
6758280|NCT03559257|7685080|FG000|STARTED|Open-label Treatment Period|One participant who completed double blind period has withdrawn from the study.|225
6758281|NCT03559257|7685081|FG001|STARTED|Open-label Treatment Period|One participant who completed double blind period had discontinued due to adverse event.|224
6758282|NCT03559257|7685080|FG000|COMPLETED|Open-label Treatment Period||215
6758283|NCT03559257|7685081|FG001|COMPLETED|Open-label Treatment Period||217
6758284|NCT03559257|7685080|FG000|NOT COMPLETED|Open-label Treatment Period||10
6758285|NCT03559257|7685081|FG001|NOT COMPLETED|Open-label Treatment Period||7
6758286|NCT03559517|7685093|FG000|STARTED|Overall Study||8
6758287|NCT03559517|7685094|FG001|STARTED|Overall Study||9
6758288|NCT03559517|7685095|FG002|STARTED|Overall Study||12
6758289|NCT03559517|7685093|FG000|COMPLETED|Overall Study||7
6758290|NCT03559517|7685094|FG001|COMPLETED|Overall Study||9
6758291|NCT03559517|7685095|FG002|COMPLETED|Overall Study||12
6758292|NCT03559517|7685093|FG000|NOT COMPLETED|Overall Study||1
6758293|NCT03559517|7685094|FG001|NOT COMPLETED|Overall Study||0
6758294|NCT03559517|7685095|FG002|NOT COMPLETED|Overall Study||0
6758295|NCT03559530|7685103|FG000|STARTED|Overall Study||197
6758296|NCT03559530|7685104|FG001|STARTED|Overall Study||65
6758297|NCT03559530|7685103|FG000|COMPLETED|Overall Study||106
6758298|NCT03559530|7685104|FG001|COMPLETED|Overall Study||65
6758299|NCT03559530|7685103|FG000|NOT COMPLETED|Overall Study||91
6758300|NCT03559530|7685104|FG001|NOT COMPLETED|Overall Study||0
6758301|NCT03559829|7685109|FG000|STARTED|Overall Study||20
6758302|NCT03559829|7685109|FG000|COMPLETED|Overall Study||20
6758303|NCT03559829|7685109|FG000|NOT COMPLETED|Overall Study||0
6758304|NCT03559933|7685113|FG000|STARTED|Overall Study||12
6758305|NCT03559933|7685113|FG000|COMPLETED|Overall Study||12
6758306|NCT03559933|7685113|FG000|NOT COMPLETED|Overall Study||0
6758307|NCT03560102|7685118|FG000|STARTED|Overall Study||1
6758308|NCT03560102|7685118|FG000|COMPLETED|Overall Study||1
6758309|NCT03560102|7685118|FG000|NOT COMPLETED|Overall Study||0
6758310|NCT03560128|7685124|FG000|STARTED|Overall Study||306
6758311|NCT03560128|7685125|FG001|STARTED|Overall Study||306
6758312|NCT03560128|7685124|FG000|COMPLETED|Overall Study||294
6758313|NCT03560128|7685125|FG001|COMPLETED|Overall Study||298
6758314|NCT03560128|7685124|FG000|NOT COMPLETED|Overall Study||12
6758315|NCT03560128|7685125|FG001|NOT COMPLETED|Overall Study||8
6758316|NCT03560141|7685133|FG000|STARTED|Overall Study||6
6758317|NCT03560141|7685134|FG001|STARTED|Overall Study||5
6758318|NCT03560141|7685133|FG000|COMPLETED|Overall Study||6
6758319|NCT03560141|7685134|FG001|COMPLETED|Overall Study||5
6758320|NCT03560141|7685133|FG000|NOT COMPLETED|Overall Study||0
6758321|NCT03560141|7685134|FG001|NOT COMPLETED|Overall Study||0
6758322|NCT03560245|7685144|FG000|STARTED|Overall Study||53
6758323|NCT03560245|7685145|FG001|STARTED|Overall Study||55
6758324|NCT03560245|7685144|FG000|COMPLETED|Overall Study||48
6758325|NCT03560245|7685145|FG001|COMPLETED|Overall Study||48
6758326|NCT03560245|7685144|FG000|NOT COMPLETED|Overall Study||5
6758327|NCT03560245|7685145|FG001|NOT COMPLETED|Overall Study||7
6758328|NCT03560518|7685156|FG000|STARTED|Double Blind Treatment Period||147
6758329|NCT03560518|7685157|FG001|STARTED|Double Blind Treatment Period||145
6758330|NCT03560518|7685158|FG002|STARTED|Double Blind Treatment Period||147
6758331|NCT03560518|7685156|FG000|COMPLETED|Double Blind Treatment Period||122
6758332|NCT03560518|7685157|FG001|COMPLETED|Double Blind Treatment Period||116
6758333|NCT03560518|7685158|FG002|COMPLETED|Double Blind Treatment Period||124
6758334|NCT03560518|7685156|FG000|NOT COMPLETED|Double Blind Treatment Period||25
6758335|NCT03560518|7685157|FG001|NOT COMPLETED|Double Blind Treatment Period||29
6758336|NCT03560518|7685158|FG002|NOT COMPLETED|Double Blind Treatment Period||23
6758337|NCT03560518|7685156|FG000|STARTED|Safety Follow-Up Period||10
6758338|NCT03560518|7685157|FG001|STARTED|Safety Follow-Up Period||17
6758339|NCT03560518|7685158|FG002|STARTED|Safety Follow-Up Period||22
6758340|NCT03560518|7685156|FG000|COMPLETED|Safety Follow-Up Period||10
6758341|NCT03560518|7685157|FG001|COMPLETED|Safety Follow-Up Period||17
6758342|NCT03560518|7685158|FG002|COMPLETED|Safety Follow-Up Period||22
6758343|NCT03560518|7685156|FG000|NOT COMPLETED|Safety Follow-Up Period||0
6758344|NCT03560518|7685157|FG001|NOT COMPLETED|Safety Follow-Up Period||0
6758345|NCT03560518|7685158|FG002|NOT COMPLETED|Safety Follow-Up Period||0
6758346|NCT03560739|7685170|FG000|STARTED|Overall Study||128
6498119|NCT01408719|7416837|FG011|STARTED|Third Intervention (35 Days)||2
6498120|NCT01408719|7416838|FG012|STARTED|Third Intervention (35 Days)||2
6498121|NCT01408719|7416839|FG013|STARTED|Third Intervention (35 Days)||3
6498122|NCT01408719|7416840|FG014|STARTED|Third Intervention (35 Days)||1
6758347|NCT03560739|7685171|FG001|STARTED|Overall Study||130
6758348|NCT03560739|7685172|FG002|STARTED|Overall Study||13
6758349|NCT03560739|7685173|FG003|STARTED|Overall Study||13
6758350|NCT03560739|7685170|FG000|COMPLETED|Overall Study||128
6758351|NCT03560739|7685171|FG001|COMPLETED|Overall Study||129
6758352|NCT03560739|7685172|FG002|COMPLETED|Overall Study||13
6758353|NCT03560739|7685173|FG003|COMPLETED|Overall Study||13
6758354|NCT03560739|7685170|FG000|NOT COMPLETED|Overall Study||0
6758355|NCT03560739|7685171|FG001|NOT COMPLETED|Overall Study||1
6758356|NCT03560739|7685172|FG002|NOT COMPLETED|Overall Study||0
6758357|NCT03560739|7685173|FG003|NOT COMPLETED|Overall Study||0
6758358|NCT03560869|7685183|FG000|STARTED|Overall Study||14
6758359|NCT03560869|7685184|FG001|STARTED|Overall Study||21
6758360|NCT03560869|7685183|FG000|COMPLETED|Overall Study||7
6758361|NCT03560869|7685184|FG001|COMPLETED|Overall Study||12
6758362|NCT03560869|7685183|FG000|NOT COMPLETED|Overall Study||7
6758363|NCT03560869|7685184|FG001|NOT COMPLETED|Overall Study||9
6758364|NCT03560986|7685192|FG000|STARTED|Treatment Period A/Follow-up Period 1||48
6758365|NCT03560986|7685193|FG001|STARTED|Treatment Period A/Follow-up Period 1|One additional participant was allocated to placebo but not treated.|51
6758366|NCT03560986|7685192|FG000|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
6758367|NCT03560986|7685193|FG001|Treatment Period A Completers|Treatment Period A/Follow-up Period 1||45
6758368|NCT03560986|7685192|FG000|COMPLETED|Treatment Period A/Follow-up Period 1||12
6758369|NCT03560986|7685193|FG001|COMPLETED|Treatment Period A/Follow-up Period 1||13
6758370|NCT03560986|7685192|FG000|NOT COMPLETED|Treatment Period A/Follow-up Period 1||36
6758371|NCT03560986|7685193|FG001|NOT COMPLETED|Treatment Period A/Follow-up Period 1||38
6758372|NCT03560986|7685192|FG000|STARTED|Treatment Period B/Follow-up Period 2|3 Participants completed Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|9
6758373|NCT03560986|7685193|FG001|STARTED|Treatment Period B/Follow-up Period 2|5 Part. completed Placebo Treatment Period A/Follow-up Period 1 but were not allocated in Period B.|8
6758374|NCT03560986|7685192|FG000|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
6758375|NCT03560986|7685193|FG001|Treatment Period B Completers|Treatment Period B/Follow-up Period 2||8
6758376|NCT03560986|7685192|FG000|COMPLETED|Treatment Period B/Follow-up Period 2||1
6758377|NCT03560986|7685193|FG001|COMPLETED|Treatment Period B/Follow-up Period 2||0
6758378|NCT03560986|7685192|FG000|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
6758379|NCT03560986|7685193|FG001|NOT COMPLETED|Treatment Period B/Follow-up Period 2||8
6758380|NCT03561090|7685207|FG000|STARTED|Overall Study||247
6758381|NCT03561090|7685208|FG001|STARTED|Overall Study||248
6758382|NCT03561090|7685207|FG000|Randomized and Treated|Overall Study||246
6758383|NCT03561090|7685208|FG001|Randomized and Treated|Overall Study||247
6758384|NCT03561090|7685207|FG000|COMPLETED|Overall Study||207
6498123|NCT01408719|7416841|FG015|STARTED|Third Intervention (35 Days)||1
6498124|NCT01408719|7416842|FG016|STARTED|Third Intervention (35 Days)||2
6758385|NCT03561090|7685208|FG001|COMPLETED|Overall Study||212
6758386|NCT03561090|7685207|FG000|NOT COMPLETED|Overall Study||40
6758387|NCT03561090|7685208|FG001|NOT COMPLETED|Overall Study||36
6758388|NCT03561883|7685218|FG000|STARTED|Overall Study||305
6758389|NCT03561883|7685219|FG001|STARTED|Overall Study||304
6758390|NCT03561883|7685218|FG000|COMPLETED|Overall Study||259
6758391|NCT03561883|7685219|FG001|COMPLETED|Overall Study||261
6758392|NCT03561883|7685218|FG000|NOT COMPLETED|Overall Study||46
6758393|NCT03561883|7685219|FG001|NOT COMPLETED|Overall Study||43
6758394|NCT03562117|7685228|FG000|STARTED|Part 1, Up to 3 Days||8
6758395|NCT03562117|7685229|FG001|STARTED|Part 1, Up to 3 Days||8
6758396|NCT03562117|7685230|FG002|STARTED|Part 1, Up to 3 Days||0
6758397|NCT03562117|7685228|FG000|COMPLETED|Part 1, Up to 3 Days||7
6758398|NCT03562117|7685229|FG001|COMPLETED|Part 1, Up to 3 Days||8
6758399|NCT03562117|7685230|FG002|COMPLETED|Part 1, Up to 3 Days||0
6758400|NCT03562117|7685228|FG000|NOT COMPLETED|Part 1, Up to 3 Days||1
6758401|NCT03562117|7685229|FG001|NOT COMPLETED|Part 1, Up to 3 Days||0
6758402|NCT03562117|7685230|FG002|NOT COMPLETED|Part 1, Up to 3 Days||0
6758403|NCT03562117|7685228|FG000|STARTED|Part 2, Up to 3 Days|Only 1 additional participant with normal hepatic function enrolled in Part 2 received dosing|8
6758404|NCT03562117|7685229|FG001|STARTED|Part 2, Up to 3 Days||0
6758405|NCT03562117|7685230|FG002|STARTED|Part 2, Up to 3 Days||8
6758406|NCT03562117|7685228|FG000|COMPLETED|Part 2, Up to 3 Days||8
6758407|NCT03562117|7685229|FG001|COMPLETED|Part 2, Up to 3 Days||0
6758408|NCT03562117|7685230|FG002|COMPLETED|Part 2, Up to 3 Days||8
6758409|NCT03562117|7685228|FG000|NOT COMPLETED|Part 2, Up to 3 Days||0
6758410|NCT03562117|7685229|FG001|NOT COMPLETED|Part 2, Up to 3 Days||0
6758411|NCT03562117|7685230|FG002|NOT COMPLETED|Part 2, Up to 3 Days||0
6758412|NCT03562377|7685240|FG000|STARTED|Treatment Period|Number of participants assigned to treatment|107
6758413|NCT03562377|7685241|FG001|STARTED|Treatment Period|Number of participants assigned to treatment|108
6758414|NCT03562377|7685240|FG000|Safety Analysis Set|Treatment Period||107
6758415|NCT03562377|7685241|FG001|Safety Analysis Set|Treatment Period||107
6758416|NCT03562377|7685240|FG000|Per Protocol Anaysis Set|Treatment Period||88
6758417|NCT03562377|7685241|FG001|Per Protocol Anaysis Set|Treatment Period||78
6758418|NCT03562377|7685240|FG000|Full Analysis Set|Treatment Period||106
6758419|NCT03562377|7685241|FG001|Full Analysis Set|Treatment Period||108
6758420|NCT03562377|7685240|FG000|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|100
6758421|NCT03562377|7685241|FG001|COMPLETED|Treatment Period|Number of participants attending the Week 16 visit (end of treatment visit)|89
6758422|NCT03562377|7685240|FG000|NOT COMPLETED|Treatment Period||7
6758423|NCT03562377|7685241|FG001|NOT COMPLETED|Treatment Period||19
6758424|NCT03562377|7685240|FG000|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
6758425|NCT03562377|7685241|FG001|STARTED|Safety Follow-up Period|Last contact after exposure end. Main reason for not entering follow-up: transfer to extension trial|75
6758426|NCT03562377|7685240|FG000|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|16
6758427|NCT03562377|7685241|FG001|COMPLETED|Safety Follow-up Period|Attended Week 30 visit. Main reason for not attending was transfer to long-term extension trial.|18
6758428|NCT03562377|7685240|FG000|NOT COMPLETED|Safety Follow-up Period||59
6758429|NCT03562377|7685241|FG001|NOT COMPLETED|Safety Follow-up Period||57
6780088|NCT03348904|7708409|FG002|COMPLETED|Overall Study||0
6780089|NCT03348904|7708407|FG000|NOT COMPLETED|Overall Study||0
6780090|NCT03348904|7708408|FG001|NOT COMPLETED|Overall Study||1
6780091|NCT03348904|7708409|FG002|NOT COMPLETED|Overall Study||0
6780092|NCT03345901|7708417|FG000|STARTED|Overall Study||18
6780093|NCT03345901|7708417|FG000|COMPLETED|Overall Study||0
6780094|NCT03345901|7708417|FG000|NOT COMPLETED|Overall Study||18
6780095|NCT03344562|7708424|FG000|STARTED|Overall Study||10
6780096|NCT03344562|7708425|FG001|STARTED|Overall Study||9
6780097|NCT03344562|7708424|FG000|COMPLETED|Overall Study||8
6780098|NCT03344562|7708425|FG001|COMPLETED|Overall Study||9
6780099|NCT03344562|7708424|FG000|NOT COMPLETED|Overall Study||2
6780100|NCT03344562|7708425|FG001|NOT COMPLETED|Overall Study||0
6780101|NCT03342638|7708433|FG000|STARTED|Overall Study||34
6780102|NCT03342638|7708434|FG001|STARTED|Overall Study||32
6780103|NCT03342638|7708433|FG000|COMPLETED|Overall Study||33
6780104|NCT03342638|7708434|FG001|COMPLETED|Overall Study||31
6780105|NCT03342638|7708433|FG000|NOT COMPLETED|Overall Study||1
6780106|NCT03342638|7708434|FG001|NOT COMPLETED|Overall Study||1
6780107|NCT03342157|7708442|FG000|STARTED|Overall Study||1
6780108|NCT03342157|7708443|FG001|STARTED|Overall Study||1
6780109|NCT03342157|7708442|FG000|COMPLETED|Overall Study||1
6780110|NCT03342157|7708443|FG001|COMPLETED|Overall Study||1
6780111|NCT03342157|7708442|FG000|NOT COMPLETED|Overall Study||0
6780112|NCT03342157|7708443|FG001|NOT COMPLETED|Overall Study||0
6780113|NCT03339401|7708451|FG000|STARTED|Overall Study||20
6780114|NCT03339401|7708452|FG001|STARTED|Overall Study||9
6780115|NCT03339401|7708451|FG000|COMPLETED|Overall Study||11
6780116|NCT03339401|7708452|FG001|COMPLETED|Overall Study||5
6780117|NCT03339401|7708451|FG000|NOT COMPLETED|Overall Study||9
6780118|NCT03339401|7708452|FG001|NOT COMPLETED|Overall Study||4
6780119|NCT03339245|7708460|FG000|STARTED|Overall Study||6
6780120|NCT03339245|7708461|FG001|STARTED|Overall Study||7
6780121|NCT03339245|7708460|FG000|COMPLETED|Overall Study|"1 withdrawn due to elevated glucose during pre-intervention testing~1 withdrawn for personal reason"|4
6780122|NCT03339245|7708461|FG001|COMPLETED|Overall Study|1 withdrawn due to elevated glucose on baseline testing|6
6758430|NCT03562481|7685249|FG000|STARTED|First Intervention||12
6758431|NCT03562481|7685250|FG001|STARTED|First Intervention||14
6758432|NCT03562481|7685249|FG000|COMPLETED|First Intervention||11
6758433|NCT03562481|7685250|FG001|COMPLETED|First Intervention||14
6758434|NCT03562481|7685249|FG000|NOT COMPLETED|First Intervention||1
6758435|NCT03562481|7685250|FG001|NOT COMPLETED|First Intervention||0
6758436|NCT03562481|7685249|FG000|STARTED|Washout||11
6758437|NCT03562481|7685250|FG001|STARTED|Washout||14
6758438|NCT03562481|7685249|FG000|COMPLETED|Washout||11
6758439|NCT03562481|7685250|FG001|COMPLETED|Washout||14
6758440|NCT03562481|7685249|FG000|NOT COMPLETED|Washout||0
6758441|NCT03562481|7685250|FG001|NOT COMPLETED|Washout||0
6758442|NCT03562481|7685249|FG000|STARTED|Second Intervention||11
6758443|NCT03562481|7685250|FG001|STARTED|Second Intervention||14
6758444|NCT03562481|7685249|FG000|COMPLETED|Second Intervention||11
6758445|NCT03562481|7685250|FG001|COMPLETED|Second Intervention||14
6758446|NCT03562481|7685249|FG000|NOT COMPLETED|Second Intervention||0
6758447|NCT03562481|7685250|FG001|NOT COMPLETED|Second Intervention||0
6758448|NCT03562559|7685260|FG000|STARTED|Overall Study||40
6758449|NCT03562559|7685260|FG000|COMPLETED|Overall Study||40
6758450|NCT03562559|7685260|FG000|NOT COMPLETED|Overall Study||0
6758451|NCT03562663|7685266|FG000|STARTED|Overall Study||41
6758452|NCT03562663|7685267|FG001|STARTED|Overall Study||41
6758453|NCT03562663|7685266|FG000|COMPLETED|Overall Study||34
6758454|NCT03562663|7685267|FG001|COMPLETED|Overall Study||35
6758455|NCT03562663|7685266|FG000|NOT COMPLETED|Overall Study||7
6758456|NCT03562663|7685267|FG001|NOT COMPLETED|Overall Study||6
6758457|NCT03562988|7685273|FG000|STARTED|Overall Study||17
6758458|NCT03562988|7685274|FG001|STARTED|Overall Study||18
6758459|NCT03562988|7685273|FG000|COMPLETED|Overall Study||15
6758460|NCT03562988|7685274|FG001|COMPLETED|Overall Study||15
6758461|NCT03562988|7685273|FG000|NOT COMPLETED|Overall Study||2
6758462|NCT03562988|7685274|FG001|NOT COMPLETED|Overall Study||3
6758463|NCT03563027|7685287|FG000|STARTED|Overall Study||60
6758464|NCT03563027|7685288|FG001|STARTED|Overall Study||60
6758465|NCT03563027|7685289|FG002|STARTED|Overall Study||60
6758466|NCT03563027|7685287|FG000|COMPLETED|Overall Study||60
6758467|NCT03563027|7685288|FG001|COMPLETED|Overall Study||60
6758468|NCT03563027|7685289|FG002|COMPLETED|Overall Study||58
6758469|NCT03563027|7685287|FG000|NOT COMPLETED|Overall Study||0
6758470|NCT03563027|7685288|FG001|NOT COMPLETED|Overall Study||0
6758471|NCT03563027|7685289|FG002|NOT COMPLETED|Overall Study||2
6758472|NCT03563183|7685297|FG000|STARTED|Overall Study||26976
6758473|NCT03563183|7685297|FG000|COMPLETED|Overall Study||26976
6758474|NCT03563183|7685297|FG000|NOT COMPLETED|Overall Study||0
6758475|NCT03563209|7685316|FG000|STARTED|Overall Study||60
6758476|NCT03563209|7685316|FG000|COMPLETED|Overall Study||60
6758477|NCT03563209|7685316|FG000|NOT COMPLETED|Overall Study||0
6758478|NCT03563313|7685324|FG000|STARTED|Overall Study||112
6758479|NCT03563313|7685325|FG001|STARTED|Overall Study||56
6758480|NCT03563313|7685324|FG000|COMPLETED|Overall Study||112
6758481|NCT03563313|7685325|FG001|COMPLETED|Overall Study||56
6758482|NCT03563313|7685324|FG000|NOT COMPLETED|Overall Study||0
6758483|NCT03563313|7685325|FG001|NOT COMPLETED|Overall Study||0
6758484|NCT03564444|7685339|FG000|STARTED|Overall Study||60
6758485|NCT03564444|7685340|FG001|STARTED|Overall Study||240
6758486|NCT03564444|7685339|FG000|COMPLETED|Overall Study||60
6758487|NCT03564444|7685340|FG001|COMPLETED|Overall Study||240
6758488|NCT03564444|7685339|FG000|NOT COMPLETED|Overall Study||0
6758489|NCT03564444|7685340|FG001|NOT COMPLETED|Overall Study||0
6758490|NCT03564886|7685348|FG000|STARTED|Overall Study||24
6758491|NCT03564886|7685349|FG001|STARTED|Overall Study||24
6758492|NCT03564886|7685348|FG000|COMPLETED|Overall Study||23
6758493|NCT03564886|7685349|FG001|COMPLETED|Overall Study||23
6758494|NCT03564886|7685348|FG000|NOT COMPLETED|Overall Study||1
6758495|NCT03564886|7685349|FG001|NOT COMPLETED|Overall Study||1
6758496|NCT03565068|7685364|FG000|STARTED|Overall Study||12
6758497|NCT03565068|7685365|FG001|STARTED|Overall Study||4
6758498|NCT03565068|7685366|FG002|STARTED|Overall Study||12
6758499|NCT03565068|7685367|FG003|STARTED|Overall Study||4
6758500|NCT03565068|7685368|FG004|STARTED|Overall Study||12
6758501|NCT03565068|7685369|FG005|STARTED|Overall Study||1
6758502|NCT03565068|7685370|FG006|STARTED|Overall Study||4
6758503|NCT03565068|7685371|FG007|STARTED|Overall Study||17
6758504|NCT03565068|7685372|FG008|STARTED|Overall Study||9
6758505|NCT03565068|7685364|FG000|COMPLETED|Overall Study||12
6758506|NCT03565068|7685365|FG001|COMPLETED|Overall Study||4
6758507|NCT03565068|7685366|FG002|COMPLETED|Overall Study||11
6758508|NCT03565068|7685367|FG003|COMPLETED|Overall Study||4
6758509|NCT03565068|7685368|FG004|COMPLETED|Overall Study||8
6758510|NCT03565068|7685369|FG005|COMPLETED|Overall Study||0
6758511|NCT03565068|7685370|FG006|COMPLETED|Overall Study||3
6758512|NCT03565068|7685371|FG007|COMPLETED|Overall Study||9
6758513|NCT03565068|7685372|FG008|COMPLETED|Overall Study||8
6758514|NCT03565068|7685364|FG000|NOT COMPLETED|Overall Study||0
6758515|NCT03565068|7685365|FG001|NOT COMPLETED|Overall Study||0
6758516|NCT03565068|7685366|FG002|NOT COMPLETED|Overall Study||1
6758517|NCT03565068|7685367|FG003|NOT COMPLETED|Overall Study||0
6758518|NCT03565068|7685368|FG004|NOT COMPLETED|Overall Study||4
6758519|NCT03565068|7685369|FG005|NOT COMPLETED|Overall Study||1
6758520|NCT03565068|7685370|FG006|NOT COMPLETED|Overall Study||1
6758521|NCT03565068|7685371|FG007|NOT COMPLETED|Overall Study||8
6758522|NCT03565068|7685372|FG008|NOT COMPLETED|Overall Study||1
6758523|NCT03565211|7685429|FG000|STARTED|Overall Study||254
6758524|NCT03565211|7685429|FG000|Modified Intention-to-treat (mITT)|Overall Study|Had successful oocyte retrieval, received >=1 dose of IMP, and completed fresh embryo transfer|243
6758525|NCT03565211|7685429|FG000|COMPLETED|Overall Study||206
6758526|NCT03565211|7685429|FG000|NOT COMPLETED|Overall Study||48
6758527|NCT03565315|7685437|FG000|STARTED|Overall Study||3
6758528|NCT03565315|7685438|FG001|STARTED|Overall Study||3
6758529|NCT03565315|7685439|FG002|STARTED|Overall Study||1
6758530|NCT03565315|7685440|FG003|STARTED|Overall Study||2
6758531|NCT03565315|7685437|FG000|Product Administration Completed|Overall Study||3
6758532|NCT03565315|7685438|FG001|Product Administration Completed|Overall Study||0
6758533|NCT03565315|7685439|FG002|Product Administration Completed|Overall Study||1
6758534|NCT03565315|7685440|FG003|Product Administration Completed|Overall Study||0
6758535|NCT03565315|7685437|FG000|Discontinued Product Administrations|Overall Study||0
6758536|NCT03565315|7685438|FG001|Discontinued Product Administrations|Overall Study||3
6758537|NCT03565315|7685439|FG002|Discontinued Product Administrations|Overall Study||0
6758538|NCT03565315|7685440|FG003|Discontinued Product Administrations|Overall Study|One Group 4 participant enrolled but did not receive product due to IND/PI voluntary study pause.|2
6758539|NCT03565315|7685437|FG000|COMPLETED|Overall Study||3
6758540|NCT03565315|7685438|FG001|COMPLETED|Overall Study||3
6758541|NCT03565315|7685439|FG002|COMPLETED|Overall Study||1
6758542|NCT03565315|7685440|FG003|COMPLETED|Overall Study||1
6758543|NCT03565315|7685437|FG000|NOT COMPLETED|Overall Study||0
6758544|NCT03565315|7685438|FG001|NOT COMPLETED|Overall Study||0
6758545|NCT03565315|7685439|FG002|NOT COMPLETED|Overall Study||0
6758546|NCT03565315|7685440|FG003|NOT COMPLETED|Overall Study||1
6758547|NCT03565666|7685463|FG000|STARTED|Overall Study||12
6758548|NCT03565666|7685464|FG001|STARTED|Overall Study||12
6758549|NCT03565666|7685465|FG002|STARTED|Overall Study||12
6758550|NCT03565666|7685463|FG000|COMPLETED|Overall Study||12
6758551|NCT03565666|7685464|FG001|COMPLETED|Overall Study||12
6758552|NCT03565666|7685465|FG002|COMPLETED|Overall Study||11
6758553|NCT03565666|7685463|FG000|NOT COMPLETED|Overall Study||0
6758554|NCT03565666|7685464|FG001|NOT COMPLETED|Overall Study||0
6758555|NCT03565666|7685465|FG002|NOT COMPLETED|Overall Study||1
6758556|NCT03565679|7685476|FG000|STARTED|Overall Study||10
6758557|NCT03565679|7685476|FG000|COMPLETED|Overall Study||10
6758558|NCT03565679|7685476|FG000|NOT COMPLETED|Overall Study||0
6758559|NCT03565874|7685483|FG000|STARTED|Overall Study||6
6758560|NCT03565874|7685483|FG000|COMPLETED|Overall Study||4
6758561|NCT03565874|7685483|FG000|NOT COMPLETED|Overall Study||2
6758562|NCT03565887|7685489|FG000|STARTED|Overall Study||109
6758563|NCT03565887|7685490|FG001|STARTED|Overall Study||55
6758564|NCT03565887|7685489|FG000|COMPLETED|Overall Study||108
6758565|NCT03565887|7685490|FG001|COMPLETED|Overall Study||53
6758566|NCT03565887|7685489|FG000|NOT COMPLETED|Overall Study||1
6758567|NCT03565887|7685490|FG001|NOT COMPLETED|Overall Study||2
6758568|NCT03566238|7685499|FG000|STARTED|Overall Study||23
6758569|NCT03566238|7685500|FG001|STARTED|Overall Study||19
6758570|NCT03566238|7685501|FG002|STARTED|Overall Study||20
6758571|NCT03566238|7685499|FG000|Received Treatment|Overall Study||23
6758572|NCT03566238|7685500|FG001|Received Treatment|Overall Study||19
6758573|NCT03566238|7685501|FG002|Received Treatment|Overall Study||20
6758574|NCT03566238|7685499|FG000|COMPLETED|Overall Study||18
6758575|NCT03566238|7685500|FG001|COMPLETED|Overall Study||16
6758576|NCT03566238|7685501|FG002|COMPLETED|Overall Study||15
6758577|NCT03566238|7685499|FG000|NOT COMPLETED|Overall Study||5
6758578|NCT03566238|7685500|FG001|NOT COMPLETED|Overall Study||3
6758579|NCT03566238|7685501|FG002|NOT COMPLETED|Overall Study||5
6758580|NCT03566485|7685511|FG000|STARTED|Overall Study||5
6758581|NCT03566485|7685512|FG001|STARTED|Overall Study|Dose level 1 (Idasanutlin 100mg PO)|7
6758582|NCT03566485|7685511|FG000|COMPLETED|Overall Study||0
6758583|NCT03566485|7685512|FG001|COMPLETED|Overall Study||0
6758584|NCT03566485|7685511|FG000|NOT COMPLETED|Overall Study||5
6758585|NCT03566485|7685512|FG001|NOT COMPLETED|Overall Study||7
6758586|NCT03566550|7685520|FG000|STARTED|Overall Study||12
6758587|NCT03566550|7685521|FG001|STARTED|Overall Study||13
6758588|NCT03566550|7685520|FG000|COMPLETED|Overall Study||12
6758589|NCT03566550|7685521|FG001|COMPLETED|Overall Study||12
6758590|NCT03566550|7685520|FG000|NOT COMPLETED|Overall Study||0
6758591|NCT03566550|7685521|FG001|NOT COMPLETED|Overall Study||1
6758592|NCT03566680|7685527|FG000|STARTED|Overall Study||46
6758593|NCT03566680|7685527|FG000|COMPLETED|Overall Study||29
6758594|NCT03566680|7685527|FG000|NOT COMPLETED|Overall Study||17
6758595|NCT03566810|7685535|FG000|STARTED|Treatment Period 1 (Day 1-Day 3)||19
6758596|NCT03566810|7685536|FG001|STARTED|Treatment Period 1 (Day 1-Day 3)||19
6758597|NCT03566810|7685537|FG002|STARTED|Treatment Period 1 (Day 1-Day 3)||8
6758598|NCT03566810|7685538|FG003|STARTED|Treatment Period 1 (Day 1-Day 3)||8
6758599|NCT03566810|7685535|FG000|Treated|Treatment Period 1 (Day 1-Day 3)||19
6758600|NCT03566810|7685536|FG001|Treated|Treatment Period 1 (Day 1-Day 3)||18
6758601|NCT03566810|7685537|FG002|Treated|Treatment Period 1 (Day 1-Day 3)||8
6758602|NCT03566810|7685538|FG003|Treated|Treatment Period 1 (Day 1-Day 3)||8
6758603|NCT03566810|7685535|FG000|COMPLETED|Treatment Period 1 (Day 1-Day 3)||19
6758604|NCT03566810|7685536|FG001|COMPLETED|Treatment Period 1 (Day 1-Day 3)||18
6758605|NCT03566810|7685537|FG002|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
6758606|NCT03566810|7685538|FG003|COMPLETED|Treatment Period 1 (Day 1-Day 3)||8
6758607|NCT03566810|7685535|FG000|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6758608|NCT03566810|7685536|FG001|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||1
6758609|NCT03566810|7685537|FG002|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6758610|NCT03566810|7685538|FG003|NOT COMPLETED|Treatment Period 1 (Day 1-Day 3)||0
6758611|NCT03566810|7685535|FG000|STARTED|Treatment Period 2 (Day 8- Day 10)||19
6758612|NCT03566810|7685536|FG001|STARTED|Treatment Period 2 (Day 8- Day 10)||18
6758613|NCT03566810|7685537|FG002|STARTED|Treatment Period 2 (Day 8- Day 10)||8
6758614|NCT03566810|7685538|FG003|STARTED|Treatment Period 2 (Day 8- Day 10)||8
6758615|NCT03566810|7685535|FG000|COMPLETED|Treatment Period 2 (Day 8- Day 10)||19
6758616|NCT03566810|7685536|FG001|COMPLETED|Treatment Period 2 (Day 8- Day 10)||18
6758617|NCT03566810|7685537|FG002|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
6758618|NCT03566810|7685538|FG003|COMPLETED|Treatment Period 2 (Day 8- Day 10)||8
6758619|NCT03566810|7685535|FG000|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6758620|NCT03566810|7685536|FG001|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6758621|NCT03566810|7685537|FG002|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6758622|NCT03566810|7685538|FG003|NOT COMPLETED|Treatment Period 2 (Day 8- Day 10)||0
6758623|NCT03566823|7685551|FG000|STARTED|Overall Study||6
6758624|NCT03566823|7685552|FG001|STARTED|Overall Study||15
6758625|NCT03566823|7685553|FG002|STARTED|Overall Study||13
6758626|NCT03566823|7685551|FG000|COMPLETED|Overall Study||4
6758627|NCT03566823|7685552|FG001|COMPLETED|Overall Study||12
6758628|NCT03566823|7685553|FG002|COMPLETED|Overall Study||11
6758629|NCT03566823|7685551|FG000|NOT COMPLETED|Overall Study||2
6758630|NCT03566823|7685552|FG001|NOT COMPLETED|Overall Study||3
6758631|NCT03566823|7685553|FG002|NOT COMPLETED|Overall Study||2
6758632|NCT03566979|7685565|FG000|STARTED|Overall Study||58
6758633|NCT03566979|7685566|FG001|STARTED|Overall Study||152
6758634|NCT03566979|7685567|FG002|STARTED|Overall Study||142
6758635|NCT03566979|7685568|FG003|STARTED|Overall Study||149
6758636|NCT03566979|7685565|FG000|COMPLETED|Overall Study||53
6758637|NCT03566979|7685566|FG001|COMPLETED|Overall Study||145
6758638|NCT03566979|7685567|FG002|COMPLETED|Overall Study||132
6758639|NCT03566979|7685568|FG003|COMPLETED|Overall Study||143
6758640|NCT03566979|7685565|FG000|NOT COMPLETED|Overall Study||5
6758641|NCT03566979|7685566|FG001|NOT COMPLETED|Overall Study||7
6758642|NCT03566979|7685567|FG002|NOT COMPLETED|Overall Study||10
6758643|NCT03566979|7685568|FG003|NOT COMPLETED|Overall Study||6
6758644|NCT03567005|7685578|FG000|STARTED|Period 1, First 7 Days of Wear||29
6758645|NCT03567005|7685579|FG001|STARTED|Period 1, First 7 Days of Wear||31
6758646|NCT03567005|7685578|FG000|COMPLETED|Period 1, First 7 Days of Wear||29
6758647|NCT03567005|7685579|FG001|COMPLETED|Period 1, First 7 Days of Wear||31
6758648|NCT03567005|7685578|FG000|NOT COMPLETED|Period 1, First 7 Days of Wear||0
6758649|NCT03567005|7685579|FG001|NOT COMPLETED|Period 1, First 7 Days of Wear||0
6758650|NCT03567005|7685578|FG000|STARTED|Period 2, Second 7 Days of Wear||29
6758651|NCT03567005|7685579|FG001|STARTED|Period 2, Second 7 Days of Wear||31
6758652|NCT03567005|7685578|FG000|COMPLETED|Period 2, Second 7 Days of Wear||29
6758653|NCT03567005|7685579|FG001|COMPLETED|Period 2, Second 7 Days of Wear||31
6555983|NCT01755702|7478201|FG000|STARTED|Wash Out Period I||66
6555984|NCT01755702|7478201|FG000|COMPLETED|Wash Out Period I||63
6555985|NCT01755702|7478201|FG000|NOT COMPLETED|Wash Out Period I||3
6555986|NCT01755702|7478201|FG000|STARTED|Period II||63
6555987|NCT01755702|7478201|FG000|Received Ibuprofen|Period II||11
6555988|NCT01755702|7478201|FG000|Received Placebo|Period II||15
6555989|NCT01755702|7478201|FG000|Received Paracetamol/Caffeine|Period II||20
6758654|NCT03567005|7685578|FG000|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
6758655|NCT03567005|7685579|FG001|NOT COMPLETED|Period 2, Second 7 Days of Wear||0
6758656|NCT03567252|7685587|FG000|STARTED|Overall Study||48
6758657|NCT03567252|7685588|FG001|STARTED|Overall Study||19
6758658|NCT03567252|7685587|FG000|COMPLETED|Overall Study||48
6758659|NCT03567252|7685588|FG001|COMPLETED|Overall Study||19
6758660|NCT03567252|7685587|FG000|NOT COMPLETED|Overall Study||0
6758661|NCT03567252|7685588|FG001|NOT COMPLETED|Overall Study||0
6758662|NCT03567291|7685594|FG000|STARTED|Period I||228
6758663|NCT03567291|7685595|FG001|STARTED|Period I||0
6758664|NCT03567291|7685596|FG002|STARTED|Period I||0
6758665|NCT03567291|7685597|FG003|STARTED|Period I||0
6758666|NCT03567291|7685594|FG000|Safety Set|Period I||227
6758667|NCT03567291|7685595|FG001|Safety Set|Period I||0
6758668|NCT03567291|7685596|FG002|Safety Set|Period I||0
6758669|NCT03567291|7685597|FG003|Safety Set|Period I||0
6758670|NCT03567291|7685594|FG000|Intent to Treat Set|Period I||228
6758671|NCT03567291|7685595|FG001|Intent to Treat Set|Period I||0
6758672|NCT03567291|7685596|FG002|Intent to Treat Set|Period I||0
6758673|NCT03567291|7685597|FG003|Intent to Treat Set|Period I||0
6758674|NCT03567291|7685594|FG000|COMPLETED|Period I||137
6758675|NCT03567291|7685595|FG001|COMPLETED|Period I||0
6758676|NCT03567291|7685596|FG002|COMPLETED|Period I||0
6758677|NCT03567291|7685597|FG003|COMPLETED|Period I||0
6758678|NCT03567291|7685594|FG000|NOT COMPLETED|Period I||91
6555990|NCT01755702|7478201|FG000|Received Paracetamol|Period II||17
6555991|NCT01755702|7478201|FG000|COMPLETED|Period II||63
6758679|NCT03567291|7685595|FG001|NOT COMPLETED|Period I||0
6758680|NCT03567291|7685596|FG002|NOT COMPLETED|Period I||0
6758681|NCT03567291|7685597|FG003|NOT COMPLETED|Period I||0
6758682|NCT03567291|7685594|FG000|STARTED|Period II||0
6758683|NCT03567291|7685595|FG001|STARTED|Period II||91
6758684|NCT03567291|7685596|FG002|STARTED|Period II||46
6758685|NCT03567291|7685597|FG003|STARTED|Period II||0
6555992|NCT01755702|7478201|FG000|NOT COMPLETED|Period II||0
6758686|NCT03567291|7685594|FG000|COMPLETED|Period II||0
6758687|NCT03567291|7685595|FG001|COMPLETED|Period II||88
6758688|NCT03567291|7685596|FG002|COMPLETED|Period II||45
6758689|NCT03567291|7685597|FG003|COMPLETED|Period II||0
6758690|NCT03567291|7685594|FG000|NOT COMPLETED|Period II||0
6758691|NCT03567291|7685595|FG001|NOT COMPLETED|Period II||3
6758692|NCT03567291|7685596|FG002|NOT COMPLETED|Period II||1
6758693|NCT03567291|7685597|FG003|NOT COMPLETED|Period II||0
6758694|NCT03567291|7685594|FG000|STARTED|Period III||0
6758695|NCT03567291|7685595|FG001|STARTED|Period III||0
6758696|NCT03567291|7685596|FG002|STARTED|Period III||0
6758697|NCT03567291|7685597|FG003|STARTED|Period III||133
6758698|NCT03567291|7685594|FG000|COMPLETED|Period III||0
6758699|NCT03567291|7685595|FG001|COMPLETED|Period III||0
6758700|NCT03567291|7685596|FG002|COMPLETED|Period III||0
6758701|NCT03567291|7685597|FG003|COMPLETED|Period III||48
6758702|NCT03567291|7685594|FG000|NOT COMPLETED|Period III||0
6758703|NCT03567291|7685595|FG001|NOT COMPLETED|Period III||0
6758704|NCT03567291|7685596|FG002|NOT COMPLETED|Period III||0
6758705|NCT03567291|7685597|FG003|NOT COMPLETED|Period III||85
6758706|NCT03567382|7685605|FG000|STARTED|Overall Study||10
6758707|NCT03567382|7685606|FG001|STARTED|Overall Study||81
6758708|NCT03567382|7685607|FG002|STARTED|Overall Study||9
6758709|NCT03567382|7685608|FG003|STARTED|Overall Study||79
6758710|NCT03567382|7685605|FG000|Received Tenofovir|Overall Study||9
6758711|NCT03567382|7685606|FG001|Received Tenofovir|Overall Study||0
6758712|NCT03567382|7685607|FG002|Received Tenofovir|Overall Study||0
6758713|NCT03567382|7685608|FG003|Received Tenofovir|Overall Study||0
6758714|NCT03567382|7685605|FG000|COMPLETED|Overall Study||7
6758715|NCT03567382|7685606|FG001|COMPLETED|Overall Study||46
6758716|NCT03567382|7685607|FG002|COMPLETED|Overall Study||7
6758717|NCT03567382|7685608|FG003|COMPLETED|Overall Study||46
6758718|NCT03567382|7685605|FG000|NOT COMPLETED|Overall Study||3
6758719|NCT03567382|7685606|FG001|NOT COMPLETED|Overall Study||35
6758720|NCT03567382|7685607|FG002|NOT COMPLETED|Overall Study||2
6758721|NCT03567382|7685608|FG003|NOT COMPLETED|Overall Study||33
6758722|NCT03567616|7685621|FG000|STARTED|Overall Study||8
6758723|NCT03567616|7685621|FG000|COMPLETED|Overall Study||0
6758724|NCT03567616|7685621|FG000|NOT COMPLETED|Overall Study||8
6758725|NCT03567980|7685628|FG000|STARTED|Overall Study||30
6758726|NCT03567980|7685628|FG000|COMPLETED|Overall Study||29
6758727|NCT03567980|7685628|FG000|NOT COMPLETED|Overall Study||1
6758728|NCT03568500|7685635|FG000|STARTED|Overall Study||18
6758729|NCT03568500|7685636|FG001|STARTED|Overall Study||20
6758730|NCT03568500|7685637|FG002|STARTED|Overall Study||6
6758731|NCT03568500|7685635|FG000|Received At Least 1 Dose of Study Drug|Overall Study||18
6758732|NCT03568500|7685636|FG001|Received At Least 1 Dose of Study Drug|Overall Study||19
6758733|NCT03568500|7685637|FG002|Received At Least 1 Dose of Study Drug|Overall Study||6
6758734|NCT03568500|7685635|FG000|COMPLETED|Overall Study||8
6758735|NCT03568500|7685636|FG001|COMPLETED|Overall Study||14
6758736|NCT03568500|7685637|FG002|COMPLETED|Overall Study||2
6758737|NCT03568500|7685635|FG000|NOT COMPLETED|Overall Study||10
6758738|NCT03568500|7685636|FG001|NOT COMPLETED|Overall Study||6
6758739|NCT03568500|7685637|FG002|NOT COMPLETED|Overall Study||4
6758740|NCT03568539|7685652|FG000|STARTED|Overall Study||3
6758741|NCT03568539|7685653|FG001|STARTED|Overall Study||36
6758742|NCT03568539|7685652|FG000|COMPLETED|Overall Study||3
6758743|NCT03568539|7685653|FG001|COMPLETED|Overall Study||36
6758744|NCT03568539|7685652|FG000|NOT COMPLETED|Overall Study||0
6758745|NCT03568539|7685653|FG001|NOT COMPLETED|Overall Study||0
6758746|NCT03568942|7685660|FG000|STARTED|Overall Study||22
6758747|NCT03568942|7685660|FG000|COMPLETED|Overall Study||20
6758748|NCT03568942|7685660|FG000|NOT COMPLETED|Overall Study||2
6758749|NCT03569020|7685666|FG000|STARTED|Period 1||22
6758750|NCT03569020|7685667|FG001|STARTED|Period 1||21
6758751|NCT03569020|7685666|FG000|COMPLETED|Period 1||22
6758752|NCT03569020|7685667|FG001|COMPLETED|Period 1||21
6758753|NCT03569020|7685666|FG000|NOT COMPLETED|Period 1||0
6758754|NCT03569020|7685667|FG001|NOT COMPLETED|Period 1||0
6758755|NCT03569020|7685666|FG000|STARTED|Period 2||22
6758756|NCT03569020|7685667|FG001|STARTED|Period 2||21
6758757|NCT03569020|7685666|FG000|COMPLETED|Period 2||22
6758758|NCT03569020|7685667|FG001|COMPLETED|Period 2||21
6758759|NCT03569020|7685666|FG000|NOT COMPLETED|Period 2||0
6758760|NCT03569020|7685667|FG001|NOT COMPLETED|Period 2||0
6758761|NCT03569033|7685679|FG000|STARTED|Overall Study||23
6758762|NCT03569033|7685680|FG001|STARTED|Overall Study||23
6758763|NCT03569033|7685679|FG000|COMPLETED|Overall Study||23
6758764|NCT03569033|7685680|FG001|COMPLETED|Overall Study||23
6758765|NCT03569033|7685679|FG000|NOT COMPLETED|Overall Study||0
6758766|NCT03569033|7685680|FG001|NOT COMPLETED|Overall Study||0
6758767|NCT03569098|7685689|FG000|STARTED|Double-Blind Treatment Cycle 1||63
6758768|NCT03569098|7685690|FG001|STARTED|Double-Blind Treatment Cycle 1||63
6758769|NCT03569098|7685691|FG002|STARTED|Double-Blind Treatment Cycle 1||60
6758770|NCT03569098|7685689|FG000|Received Study Medication|Double-Blind Treatment Cycle 1||61
6758771|NCT03569098|7685690|FG001|Received Study Medication|Double-Blind Treatment Cycle 1||63
6758772|NCT03569098|7685691|FG002|Received Study Medication|Double-Blind Treatment Cycle 1||56
6758773|NCT03569098|7685689|FG000|COMPLETED|Double-Blind Treatment Cycle 1||55
6758774|NCT03569098|7685690|FG001|COMPLETED|Double-Blind Treatment Cycle 1||53
6758775|NCT03569098|7685691|FG002|COMPLETED|Double-Blind Treatment Cycle 1||49
6758776|NCT03569098|7685689|FG000|NOT COMPLETED|Double-Blind Treatment Cycle 1||8
6758777|NCT03569098|7685690|FG001|NOT COMPLETED|Double-Blind Treatment Cycle 1||10
6758778|NCT03569098|7685691|FG002|NOT COMPLETED|Double-Blind Treatment Cycle 1||11
6758779|NCT03569098|7685689|FG000|STARTED|Open-Label Treatment Cycle 2|No participants were treated with placebo during the open-label treatment cycle 2.|0
6758780|NCT03569098|7685690|FG001|STARTED|Open-Label Treatment Cycle 2|All participants who met retreatment criteria were treated with Dysport 300 U during the open-label treatment cycle 2.|146
6758781|NCT03569098|7685691|FG002|STARTED|Open-Label Treatment Cycle 2|No participants were treated with Dysport 500 U during the open-label treatment cycle 2.|0
6758782|NCT03569098|7685689|FG000|COMPLETED|Open-Label Treatment Cycle 2||0
6758783|NCT03569098|7685690|FG001|COMPLETED|Open-Label Treatment Cycle 2||111
6758784|NCT03569098|7685691|FG002|COMPLETED|Open-Label Treatment Cycle 2||0
6758785|NCT03569098|7685689|FG000|NOT COMPLETED|Open-Label Treatment Cycle 2||0
6758786|NCT03569098|7685690|FG001|NOT COMPLETED|Open-Label Treatment Cycle 2||35
6758787|NCT03569098|7685691|FG002|NOT COMPLETED|Open-Label Treatment Cycle 2||0
6758788|NCT03569098|7685689|FG000|STARTED|Open-Label Treatment Cycle 3||0
6758789|NCT03569098|7685690|FG001|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 300 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|8
6758790|NCT03569098|7685691|FG002|STARTED|Open-Label Treatment Cycle 3|Participants were treated with Dysport 500 U during open-label treatment cycle 3 based on investigator judgment following clinical evaluation of the participant at the time of retreatment.|56
6758791|NCT03569098|7685689|FG000|COMPLETED|Open-Label Treatment Cycle 3||0
6758792|NCT03569098|7685690|FG001|COMPLETED|Open-Label Treatment Cycle 3||7
6758793|NCT03569098|7685691|FG002|COMPLETED|Open-Label Treatment Cycle 3||50
6758794|NCT03569098|7685689|FG000|NOT COMPLETED|Open-Label Treatment Cycle 3||0
6758795|NCT03569098|7685690|FG001|NOT COMPLETED|Open-Label Treatment Cycle 3||1
6758796|NCT03569098|7685691|FG002|NOT COMPLETED|Open-Label Treatment Cycle 3||6
6758797|NCT03569202|7685704|FG000|STARTED|Part 1|Emulsion Eye Drops were used on one eye only.|3
6758798|NCT03569202|7685705|FG001|STARTED|Part 1|Control Eye Drops were not used for Part 1.|0
6758799|NCT03569202|7685704|FG000|COMPLETED|Part 1|No participant completing Part 1 was allowed to continue to Parts 2 or 3.|3
6758800|NCT03569202|7685705|FG001|COMPLETED|Part 1||0
6758801|NCT03569202|7685704|FG000|NOT COMPLETED|Part 1||0
6758802|NCT03569202|7685705|FG001|NOT COMPLETED|Part 1||0
6758803|NCT03569202|7685704|FG000|STARTED|Part 2|Emulsion Eye Drops were used on one randomized eye. Participants were different from Part 1.|9
6758804|NCT03569202|7685705|FG001|STARTED|Part 2|Control Eye Drops were used on contralateral eye. Participants were different from Part 1.|9
6758805|NCT03569202|7685704|FG000|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
6758806|NCT03569202|7685705|FG001|COMPLETED|Part 2|No participant completing Part 2 was allowed to continue to Part 3.|9
6758807|NCT03569202|7685704|FG000|NOT COMPLETED|Part 2||0
6758808|NCT03569202|7685705|FG001|NOT COMPLETED|Part 2||0
6758809|NCT03569202|7685704|FG000|STARTED|Part 3|Emulsion Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
6758810|NCT03569202|7685705|FG001|STARTED|Part 3|Control Eye Drops were used on both eyes. Participants were different from Parts 1 and 2.|26
6758811|NCT03569202|7685704|FG000|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|24
6758812|NCT03569202|7685705|FG001|COMPLETED|Part 3|Per-protocol (PP) dataset. 'Not Completed' participants are included in safety and ITT datasets.|25
6758813|NCT03569202|7685704|FG000|NOT COMPLETED|Part 3||2
6758814|NCT03569202|7685705|FG001|NOT COMPLETED|Part 3||1
6758815|NCT03569371|7685711|FG000|STARTED|Overall Study||10
6758816|NCT03569371|7685711|FG000|COMPLETED|Overall Study||7
6758817|NCT03569371|7685711|FG000|NOT COMPLETED|Overall Study||3
6758818|NCT03569397|7685717|FG000|STARTED|Overall Study||29
6758819|NCT03569397|7685718|FG001|STARTED|Overall Study||28
6758820|NCT03569397|7685717|FG000|COMPLETED|Overall Study||29
6758821|NCT03569397|7685718|FG001|COMPLETED|Overall Study||28
6758822|NCT03569397|7685717|FG000|NOT COMPLETED|Overall Study||0
6758823|NCT03569397|7685718|FG001|NOT COMPLETED|Overall Study||0
6758824|NCT03569618|7685725|FG000|STARTED|Overall Study||23
6758825|NCT03569618|7685726|FG001|STARTED|Overall Study||21
6758826|NCT03569618|7685725|FG000|COMPLETED|Overall Study||20
6758827|NCT03569618|7685726|FG001|COMPLETED|Overall Study||20
6758828|NCT03569618|7685725|FG000|NOT COMPLETED|Overall Study||3
6758829|NCT03569618|7685726|FG001|NOT COMPLETED|Overall Study||1
6758830|NCT03569748|7685735|FG000|STARTED|Overall Study||110
6758831|NCT03569748|7685736|FG001|STARTED|Overall Study||110
6758832|NCT03569748|7685735|FG000|COMPLETED|Overall Study||110
6758833|NCT03569748|7685736|FG001|COMPLETED|Overall Study||101
6758834|NCT03569748|7685735|FG000|NOT COMPLETED|Overall Study||0
6758835|NCT03569748|7685736|FG001|NOT COMPLETED|Overall Study||9
6758836|NCT03570047|7685753|FG000|STARTED|Overall Study||15902
6758837|NCT03570047|7685754|FG001|STARTED|Overall Study||22336
6758838|NCT03570047|7685755|FG002|STARTED|Overall Study||6925
6758839|NCT03570047|7685756|FG003|STARTED|Overall Study||16564
6758840|NCT03570047|7685757|FG004|STARTED|Overall Study||12262
6758841|NCT03570047|7685753|FG000|COMPLETED|Overall Study||15902
6758842|NCT03570047|7685754|FG001|COMPLETED|Overall Study||22336
6758843|NCT03570047|7685755|FG002|COMPLETED|Overall Study||6925
6758844|NCT03570047|7685756|FG003|COMPLETED|Overall Study||16564
6758845|NCT03570047|7685757|FG004|COMPLETED|Overall Study||12262
6758846|NCT03570047|7685753|FG000|NOT COMPLETED|Overall Study||0
6758847|NCT03570047|7685754|FG001|NOT COMPLETED|Overall Study||0
6758848|NCT03570047|7685755|FG002|NOT COMPLETED|Overall Study||0
6758849|NCT03570047|7685756|FG003|NOT COMPLETED|Overall Study||0
6758850|NCT03570047|7685757|FG004|NOT COMPLETED|Overall Study||0
6758851|NCT03570255|7685769|FG000|STARTED|Overall Study||28
6758852|NCT03570255|7685769|FG000|COMPLETED|Overall Study||28
6758853|NCT03570255|7685769|FG000|NOT COMPLETED|Overall Study||0
6758854|NCT03570476|7685773|FG000|STARTED|Overall Study||2
6758855|NCT03570476|7685773|FG000|COMPLETED|Overall Study||2
6758856|NCT03570476|7685773|FG000|NOT COMPLETED|Overall Study||0
6758857|NCT03570554|7685782|FG000|STARTED|Overall Study||10
6758858|NCT03570554|7685783|FG001|STARTED|Overall Study||10
6758859|NCT03570554|7685784|FG002|STARTED|Overall Study||11
6758860|NCT03570554|7685785|FG003|STARTED|Overall Study||10
6758861|NCT03570554|7685782|FG000|COMPLETED|Overall Study||10
6758862|NCT03570554|7685783|FG001|COMPLETED|Overall Study||10
6758863|NCT03570554|7685784|FG002|COMPLETED|Overall Study||10
6758864|NCT03570554|7685785|FG003|COMPLETED|Overall Study||9
6758865|NCT03570554|7685782|FG000|NOT COMPLETED|Overall Study||0
6758866|NCT03570554|7685783|FG001|NOT COMPLETED|Overall Study||0
6758867|NCT03570554|7685784|FG002|NOT COMPLETED|Overall Study||1
6758868|NCT03570554|7685785|FG003|NOT COMPLETED|Overall Study||1
6758869|NCT03570658|7685799|FG000|STARTED|Single Ascending Dose (SAD)||6
6758870|NCT03570658|7685800|FG001|STARTED|Single Ascending Dose (SAD)||2
6758871|NCT03570658|7685801|FG002|STARTED|Single Ascending Dose (SAD)||10
6758872|NCT03570658|7685802|FG003|STARTED|Single Ascending Dose (SAD)||10
6758873|NCT03570658|7685799|FG000|COMPLETED|Single Ascending Dose (SAD)||6
6758874|NCT03570658|7685800|FG001|COMPLETED|Single Ascending Dose (SAD)||2
6758875|NCT03570658|7685801|FG002|COMPLETED|Single Ascending Dose (SAD)||10
6758876|NCT03570658|7685802|FG003|COMPLETED|Single Ascending Dose (SAD)||10
6758877|NCT03570658|7685799|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
6758878|NCT03570658|7685800|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
6758879|NCT03570658|7685801|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
6758880|NCT03570658|7685802|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
6758881|NCT03570658|7685799|FG000|STARTED|Multiple Ascending Dose (MAD)||4
6758882|NCT03570658|7685800|FG001|STARTED|Multiple Ascending Dose (MAD)||0
6758883|NCT03570658|7685801|FG002|STARTED|Multiple Ascending Dose (MAD)||10
6758884|NCT03570658|7685802|FG003|STARTED|Multiple Ascending Dose (MAD)||10
6758885|NCT03570658|7685799|FG000|COMPLETED|Multiple Ascending Dose (MAD)||4
6758886|NCT03570658|7685800|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
6758887|NCT03570658|7685801|FG002|COMPLETED|Multiple Ascending Dose (MAD)||10
6758888|NCT03570658|7685802|FG003|COMPLETED|Multiple Ascending Dose (MAD)||10
6758889|NCT03570658|7685799|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6758890|NCT03570658|7685800|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6758891|NCT03570658|7685801|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6758892|NCT03570658|7685802|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6758893|NCT03570697|7685828|FG000|STARTED|Overall Study||82
6758894|NCT03570697|7685829|FG001|STARTED|Overall Study||82
6758895|NCT03570697|7685828|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
6758896|NCT03570697|7685829|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
6758897|NCT03570697|7685828|FG000|COMPLETED|Overall Study||76
6758898|NCT03570697|7685829|FG001|COMPLETED|Overall Study||79
6758899|NCT03570697|7685828|FG000|NOT COMPLETED|Overall Study||6
6758900|NCT03570697|7685829|FG001|NOT COMPLETED|Overall Study||3
6758901|NCT03571256|7685838|FG000|STARTED|Overall Study||52
6758902|NCT03571256|7685839|FG001|STARTED|Overall Study||54
6758903|NCT03571256|7685840|FG002|STARTED|Overall Study||52
6758904|NCT03571256|7685838|FG000|Safety Analysis Set|Overall Study||52
6758905|NCT03571256|7685839|FG001|Safety Analysis Set|Overall Study||54
6758906|NCT03571256|7685840|FG002|Safety Analysis Set|Overall Study||51
6758907|NCT03571256|7685838|FG000|Modified ITT (mITT) Analysis Set|Overall Study||49
6758908|NCT03571256|7685839|FG001|Modified ITT (mITT) Analysis Set|Overall Study||53
6758909|NCT03571256|7685840|FG002|Modified ITT (mITT) Analysis Set|Overall Study||51
6758910|NCT03571256|7685838|FG000|COMPLETED|Overall Study||46
6758911|NCT03571256|7685839|FG001|COMPLETED|Overall Study||51
6758912|NCT03571256|7685840|FG002|COMPLETED|Overall Study||48
6758913|NCT03571256|7685838|FG000|NOT COMPLETED|Overall Study||6
6758914|NCT03571256|7685839|FG001|NOT COMPLETED|Overall Study||3
6758915|NCT03571256|7685840|FG002|NOT COMPLETED|Overall Study||4
6758916|NCT03571516|7685852|FG000|STARTED|Overall Study||5
6758917|NCT03571516|7685853|FG001|STARTED|Overall Study||5
6758918|NCT03571516|7685852|FG000|COMPLETED|Overall Study||4
6758919|NCT03571516|7685853|FG001|COMPLETED|Overall Study||4
6758920|NCT03571516|7685852|FG000|NOT COMPLETED|Overall Study||1
6758921|NCT03571516|7685853|FG001|NOT COMPLETED|Overall Study||1
6758922|NCT03571555|7685861|FG000|STARTED|Overall Study||252
6758923|NCT03571555|7685862|FG001|STARTED|Overall Study||263
6758924|NCT03571555|7685861|FG000|COMPLETED|Overall Study||177
6758925|NCT03571555|7685862|FG001|COMPLETED|Overall Study||195
6758926|NCT03571555|7685861|FG000|NOT COMPLETED|Overall Study||75
6758927|NCT03571555|7685862|FG001|NOT COMPLETED|Overall Study||68
6758928|NCT03571607|7685870|FG000|STARTED|Overall Study||53
6758929|NCT03571607|7685871|FG001|STARTED|Overall Study||153
6758930|NCT03571607|7685870|FG000|Vaccinated|Overall Study||53
6758931|NCT03571607|7685871|FG001|Vaccinated|Overall Study||153
6758932|NCT03571607|7685870|FG000|COMPLETED|Overall Study||53
6758933|NCT03571607|7685871|FG001|COMPLETED|Overall Study||153
6758934|NCT03571607|7685870|FG000|NOT COMPLETED|Overall Study||0
6758935|NCT03571607|7685871|FG001|NOT COMPLETED|Overall Study||0
6758936|NCT03571672|7685879|FG000|STARTED|Overall Study||153
6758937|NCT03571672|7685879|FG000|COMPLETED|Overall Study||148
6758938|NCT03571672|7685879|FG000|NOT COMPLETED|Overall Study||5
6758939|NCT03571724|7685889|FG000|STARTED|Week -1 (Prior to Switching)||0
6758940|NCT03571724|7685890|FG001|STARTED|Week -1 (Prior to Switching)||0
6758941|NCT03571724|7685891|FG002|STARTED|Week -1 (Prior to Switching)||72
6758942|NCT03571724|7685892|FG003|STARTED|Week -1 (Prior to Switching)||70
6758943|NCT03571724|7685889|FG000|Topography|Week -1 (Prior to Switching)||0
6758944|NCT03571724|7685890|FG001|Topography|Week -1 (Prior to Switching)||0
6758945|NCT03571724|7685891|FG002|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
6758946|NCT03571724|7685892|FG003|Topography|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|18
6758947|NCT03571724|7685889|FG000|PK Nicotine|Week -1 (Prior to Switching)||0
6758948|NCT03571724|7685890|FG001|PK Nicotine|Week -1 (Prior to Switching)||0
6758949|NCT03571724|7685891|FG002|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
6758950|NCT03571724|7685892|FG003|PK Nicotine|Week -1 (Prior to Switching)|These subjects switched into VLN arms.|12
6758951|NCT03571724|7685889|FG000|COMPLETED|Week -1 (Prior to Switching)||0
6758952|NCT03571724|7685890|FG001|COMPLETED|Week -1 (Prior to Switching)||0
6758953|NCT03571724|7685891|FG002|COMPLETED|Week -1 (Prior to Switching)||72
6758954|NCT03571724|7685892|FG003|COMPLETED|Week -1 (Prior to Switching)||70
6758955|NCT03571724|7685889|FG000|NOT COMPLETED|Week -1 (Prior to Switching)||0
6758956|NCT03571724|7685890|FG001|NOT COMPLETED|Week -1 (Prior to Switching)||0
6758957|NCT03571724|7685891|FG002|NOT COMPLETED|Week -1 (Prior to Switching)||0
6758958|NCT03571724|7685892|FG003|NOT COMPLETED|Week -1 (Prior to Switching)||0
6758959|NCT03571724|7685889|FG000|STARTED|Week 1-6|Non-menthol VLN subjects were assigned to this arm after randomization at week 1|50
6758960|NCT03571724|7685890|FG001|STARTED|Week 1-6|Menthol VLN subjects were assigned to this arm after randomization at week 1|50
6758961|NCT03571724|7685891|FG002|STARTED|Week 1-6||22
6758962|NCT03571724|7685892|FG003|STARTED|Week 1-6||20
6758963|NCT03571724|7685889|FG000|COMPLETED|Week 1-6||43
6758964|NCT03571724|7685890|FG001|COMPLETED|Week 1-6||42
6758965|NCT03571724|7685891|FG002|COMPLETED|Week 1-6||19
6758966|NCT03571724|7685892|FG003|COMPLETED|Week 1-6||20
6758967|NCT03571724|7685889|FG000|NOT COMPLETED|Week 1-6||7
6758968|NCT03571724|7685890|FG001|NOT COMPLETED|Week 1-6||8
6758969|NCT03571724|7685891|FG002|NOT COMPLETED|Week 1-6||3
6758970|NCT03571724|7685892|FG003|NOT COMPLETED|Week 1-6||0
6758971|NCT03572062|7685923|FG000|STARTED|Overall Study||32
6758972|NCT03572062|7685924|FG001|STARTED|Overall Study||32
6758973|NCT03572062|7685925|FG002|STARTED|Overall Study||32
6758974|NCT03572062|7685926|FG003|STARTED|Overall Study||31
6758975|NCT03572062|7685927|FG004|STARTED|Overall Study||32
6758976|NCT03572062|7685928|FG005|STARTED|Overall Study||32
6758977|NCT03572062|7685929|FG006|STARTED|Overall Study||32
6758978|NCT03572062|7685930|FG007|STARTED|Overall Study||31
6758979|NCT03572062|7685931|FG008|STARTED|Overall Study||32
6758980|NCT03572062|7685932|FG009|STARTED|Overall Study||31
6758981|NCT03572062|7685923|FG000|Treated|Overall Study||32
6758982|NCT03572062|7685924|FG001|Treated|Overall Study||32
6758983|NCT03572062|7685925|FG002|Treated|Overall Study||32
6758984|NCT03572062|7685926|FG003|Treated|Overall Study||31
6758985|NCT03572062|7685927|FG004|Treated|Overall Study||31
6758986|NCT03572062|7685928|FG005|Treated|Overall Study||30
6758987|NCT03572062|7685929|FG006|Treated|Overall Study||32
6758988|NCT03572062|7685930|FG007|Treated|Overall Study||30
6758989|NCT03572062|7685931|FG008|Treated|Overall Study||32
6758990|NCT03572062|7685932|FG009|Treated|Overall Study||31
6758991|NCT03572062|7685923|FG000|COMPLETED|Overall Study||32
6758992|NCT03572062|7685924|FG001|COMPLETED|Overall Study||32
6758993|NCT03572062|7685925|FG002|COMPLETED|Overall Study||32
6758994|NCT03572062|7685926|FG003|COMPLETED|Overall Study||31
6758995|NCT03572062|7685927|FG004|COMPLETED|Overall Study||31
6758996|NCT03572062|7685928|FG005|COMPLETED|Overall Study||28
6758997|NCT03572062|7685929|FG006|COMPLETED|Overall Study||31
6758998|NCT03572062|7685930|FG007|COMPLETED|Overall Study||30
6758999|NCT03572062|7685931|FG008|COMPLETED|Overall Study||0
6759000|NCT03572062|7685932|FG009|COMPLETED|Overall Study||0
6759001|NCT03572062|7685923|FG000|NOT COMPLETED|Overall Study||0
6759002|NCT03572062|7685924|FG001|NOT COMPLETED|Overall Study||0
6759003|NCT03572062|7685925|FG002|NOT COMPLETED|Overall Study||0
6759004|NCT03572062|7685926|FG003|NOT COMPLETED|Overall Study||0
6759005|NCT03572062|7685927|FG004|NOT COMPLETED|Overall Study||1
6759006|NCT03572062|7685928|FG005|NOT COMPLETED|Overall Study||4
6759007|NCT03572062|7685929|FG006|NOT COMPLETED|Overall Study||1
6759008|NCT03572062|7685930|FG007|NOT COMPLETED|Overall Study||1
6759009|NCT03572062|7685931|FG008|NOT COMPLETED|Overall Study||32
6759010|NCT03572062|7685932|FG009|NOT COMPLETED|Overall Study||31
6759011|NCT03572218|7685954|FG000|STARTED|Overall Study||36
6759012|NCT03572218|7685955|FG001|STARTED|Overall Study||36
6759013|NCT03572218|7685954|FG000|Week 12|Overall Study||30
6759014|NCT03572218|7685955|FG001|Week 12|Overall Study||31
6759015|NCT03572218|7685954|FG000|Week 26|Overall Study||30
6759016|NCT03572218|7685955|FG001|Week 26|Overall Study||31
6759017|NCT03572218|7685954|FG000|COMPLETED|Overall Study||30
6759018|NCT03572218|7685955|FG001|COMPLETED|Overall Study||31
6759019|NCT03572218|7685954|FG000|NOT COMPLETED|Overall Study||6
6759020|NCT03572218|7685955|FG001|NOT COMPLETED|Overall Study||5
6759021|NCT03572478|7685961|FG000|STARTED|Overall Study||12
6759022|NCT03572478|7685961|FG000|COMPLETED|Overall Study||12
6759023|NCT03572478|7685961|FG000|NOT COMPLETED|Overall Study||0
6759024|NCT03572972|7685970|FG000|STARTED|Overall Study||10548
6759025|NCT03572972|7685971|FG001|STARTED|Overall Study||11414
6759026|NCT03572972|7685972|FG002|STARTED|Overall Study||17779
6759027|NCT03572972|7685973|FG003|STARTED|Overall Study||8648
6759028|NCT03572972|7685974|FG004|STARTED|Overall Study||16295
6759029|NCT03572972|7685970|FG000|COMPLETED|Overall Study||10548
6759030|NCT03572972|7685971|FG001|COMPLETED|Overall Study||11414
6759031|NCT03572972|7685972|FG002|COMPLETED|Overall Study||17779
6759032|NCT03572972|7685973|FG003|COMPLETED|Overall Study||8648
6759033|NCT03572972|7685974|FG004|COMPLETED|Overall Study||16295
6759034|NCT03572972|7685970|FG000|NOT COMPLETED|Overall Study||0
6759035|NCT03572972|7685971|FG001|NOT COMPLETED|Overall Study||0
6759036|NCT03572972|7685972|FG002|NOT COMPLETED|Overall Study||0
6759037|NCT03572972|7685973|FG003|NOT COMPLETED|Overall Study||0
6759038|NCT03572972|7685974|FG004|NOT COMPLETED|Overall Study||0
6759039|NCT03573206|7685994|FG000|STARTED|Overall Study||168
6759040|NCT03573206|7685994|FG000|COMPLETED|Overall Study||168
6759041|NCT03573206|7685994|FG000|NOT COMPLETED|Overall Study||0
6759042|NCT03573323|7686000|FG000|STARTED|Blinded Treatment Period (Weeks 0-24)||520
6759043|NCT03573323|7686001|FG001|STARTED|Blinded Treatment Period (Weeks 0-24)||507
6759044|NCT03573323|7686000|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||519
6759045|NCT03573323|7686001|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period (Weeks 0-24)||506
6759046|NCT03573323|7686000|FG000|COMPLETED|Blinded Treatment Period (Weeks 0-24)||465
6759047|NCT03573323|7686001|FG001|COMPLETED|Blinded Treatment Period (Weeks 0-24)||459
6759048|NCT03573323|7686000|FG000|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||55
6759049|NCT03573323|7686001|FG001|NOT COMPLETED|Blinded Treatment Period (Weeks 0-24)||48
6759050|NCT03573323|7686000|FG000|STARTED|Post-Treatment Follow Up (Weeks 25-36)||465
6759051|NCT03573323|7686001|FG001|STARTED|Post-Treatment Follow Up (Weeks 25-36)|Excludes participants who completed treatment and did not enter the PTFU.|456
6759052|NCT03573323|7686000|FG000|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||406
6759053|NCT03573323|7686001|FG001|COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||399
6759054|NCT03573323|7686000|FG000|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||59
6759055|NCT03573323|7686001|FG001|NOT COMPLETED|Post-Treatment Follow Up (Weeks 25-36)||57
6759056|NCT03573505|7686013|FG000|STARTED|Overall Study||52
6759057|NCT03573505|7686014|FG001|STARTED|Overall Study||54
6759058|NCT03573505|7686013|FG000|COMPLETED|Overall Study||0
6759059|NCT03573505|7686014|FG001|COMPLETED|Overall Study||0
6759060|NCT03573505|7686013|FG000|NOT COMPLETED|Overall Study||52
6759061|NCT03573505|7686014|FG001|NOT COMPLETED|Overall Study||54
6759062|NCT03573804|7686021|FG000|STARTED|Overall Study||72
6759063|NCT03573804|7686021|FG000|COMPLETED|Overall Study||62
6759064|NCT03573804|7686021|FG000|NOT COMPLETED|Overall Study||10
6759065|NCT03573830|7686033|FG000|STARTED|Overall Study||364
6759066|NCT03573830|7686034|FG001|STARTED|Overall Study||367
6759067|NCT03573830|7686033|FG000|Reviewed Assigned Material|Overall Study|All participants assigned to this arm reviewed their assigned material.|364
6759068|NCT03573830|7686034|FG001|Reviewed Assigned Material|Overall Study|360 reviewed their assigned material:Transport Canada information plus the enhanced material.|360
6759069|NCT03573830|7686033|FG000|COMPLETED|Overall Study||360
6759070|NCT03573830|7686034|FG001|COMPLETED|Overall Study||360
6759071|NCT03573830|7686033|FG000|NOT COMPLETED|Overall Study||4
6759072|NCT03573830|7686034|FG001|NOT COMPLETED|Overall Study||7
6759073|NCT03573908|7686041|FG000|STARTED|Treatment Period||308
6759074|NCT03573908|7686042|FG001|STARTED|Treatment Period||306
6759075|NCT03573908|7686043|FG002|STARTED|Treatment Period||0
6759076|NCT03573908|7686044|FG003|STARTED|Treatment Period||0
6759077|NCT03573908|7686045|FG004|STARTED|Treatment Period||0
6759078|NCT03573908|7686041|FG000|COMPLETED|Treatment Period||284
6759079|NCT03573908|7686042|FG001|COMPLETED|Treatment Period||280
6759080|NCT03573908|7686043|FG002|COMPLETED|Treatment Period||0
6759081|NCT03573908|7686044|FG003|COMPLETED|Treatment Period||0
6759082|NCT03573908|7686045|FG004|COMPLETED|Treatment Period||0
6759083|NCT03573908|7686041|FG000|NOT COMPLETED|Treatment Period||24
6759084|NCT03573908|7686042|FG001|NOT COMPLETED|Treatment Period||26
6759085|NCT03573908|7686043|FG002|NOT COMPLETED|Treatment Period||0
6759086|NCT03573908|7686044|FG003|NOT COMPLETED|Treatment Period||0
6759087|NCT03573908|7686045|FG004|NOT COMPLETED|Treatment Period||0
6759088|NCT03573908|7686041|FG000|STARTED|Randomized Withdrawal Period||0
6759089|NCT03573908|7686042|FG001|STARTED|Randomized Withdrawal Period||0
6759090|NCT03573908|7686043|FG002|STARTED|Randomized Withdrawal Period||280
6759091|NCT03573908|7686044|FG003|STARTED|Randomized Withdrawal Period||138
6759092|NCT03573908|7686045|FG004|STARTED|Randomized Withdrawal Period||139
6759093|NCT03573908|7686041|FG000|COMPLETED|Randomized Withdrawal Period||0
6759094|NCT03573908|7686042|FG001|COMPLETED|Randomized Withdrawal Period||0
6759095|NCT03573908|7686043|FG002|COMPLETED|Randomized Withdrawal Period||272
6759096|NCT03573908|7686044|FG003|COMPLETED|Randomized Withdrawal Period||136
6759097|NCT03573908|7686045|FG004|COMPLETED|Randomized Withdrawal Period||137
6759098|NCT03573908|7686041|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
6759099|NCT03573908|7686042|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
6759100|NCT03573908|7686043|FG002|NOT COMPLETED|Randomized Withdrawal Period||8
6759101|NCT03573908|7686044|FG003|NOT COMPLETED|Randomized Withdrawal Period||2
6759102|NCT03573908|7686045|FG004|NOT COMPLETED|Randomized Withdrawal Period||2
6759103|NCT03574181|7686054|FG000|STARTED|Overall Study||9
6759104|NCT03574181|7686054|FG000|COMPLETED|Overall Study||0
6759105|NCT03574181|7686054|FG000|NOT COMPLETED|Overall Study||9
6759106|NCT03574441|7686061|FG000|STARTED|Overall Study||31
6759107|NCT03574441|7686062|FG001|STARTED|Overall Study||30
6759108|NCT03574441|7686063|FG002|STARTED|Overall Study||30
6759109|NCT03574441|7686061|FG000|COMPLETED|Overall Study||31
6759110|NCT03574441|7686062|FG001|COMPLETED|Overall Study||30
6759111|NCT03574441|7686063|FG002|COMPLETED|Overall Study||30
6759112|NCT03574441|7686061|FG000|NOT COMPLETED|Overall Study||0
6759113|NCT03574441|7686062|FG001|NOT COMPLETED|Overall Study||0
6759114|NCT03574441|7686063|FG002|NOT COMPLETED|Overall Study||0
6759115|NCT03574753|7686071|FG000|STARTED|Overall Study||23
6759116|NCT03574753|7686071|FG000|COMPLETED|Overall Study||0
6759117|NCT03574753|7686071|FG000|NOT COMPLETED|Overall Study||23
6759118|NCT03574818|7686076|FG000|STARTED|Overall Study||1
6759119|NCT03574818|7686076|FG000|COMPLETED|Overall Study||1
6759120|NCT03574818|7686076|FG000|NOT COMPLETED|Overall Study||0
6759121|NCT03575702|7686082|FG000|STARTED|Overall Study||149
6759122|NCT03575702|7686083|FG001|STARTED|Overall Study||150
6759123|NCT03575702|7686082|FG000|COMPLETED|Overall Study||143
6759124|NCT03575702|7686083|FG001|COMPLETED|Overall Study||146
6759125|NCT03575702|7686082|FG000|NOT COMPLETED|Overall Study||6
6759126|NCT03575702|7686083|FG001|NOT COMPLETED|Overall Study||4
6759127|NCT03575754|7686091|FG000|STARTED|Overall Study||25
6759128|NCT03575754|7686092|FG001|STARTED|Overall Study||25
6759129|NCT03575754|7686091|FG000|COMPLETED|Overall Study||25
6759130|NCT03575754|7686092|FG001|COMPLETED|Overall Study||25
6759131|NCT03575754|7686091|FG000|NOT COMPLETED|Overall Study||0
6759132|NCT03575754|7686092|FG001|NOT COMPLETED|Overall Study||0
6759133|NCT03575806|7686100|FG000|STARTED|Overall Study||25
6759134|NCT03575806|7686101|FG001|STARTED|Overall Study||27
6759135|NCT03575806|7686100|FG000|COMPLETED|Overall Study||25
6759136|NCT03575806|7686101|FG001|COMPLETED|Overall Study||23
6759137|NCT03575806|7686100|FG000|NOT COMPLETED|Overall Study||0
6759138|NCT03575806|7686101|FG001|NOT COMPLETED|Overall Study||4
6759139|NCT03575871|7686110|FG000|STARTED|Overall Study||158
6759140|NCT03575871|7686111|FG001|STARTED|Overall Study||155
6759141|NCT03575871|7686112|FG002|STARTED|Overall Study||78
6759142|NCT03575871|7686110|FG000|COMPLETED|Overall Study||137
6759143|NCT03575871|7686111|FG001|COMPLETED|Overall Study||141
6759144|NCT03575871|7686112|FG002|COMPLETED|Overall Study||52
6759145|NCT03575871|7686110|FG000|NOT COMPLETED|Overall Study||21
6759146|NCT03575871|7686111|FG001|NOT COMPLETED|Overall Study||14
6759147|NCT03575871|7686112|FG002|NOT COMPLETED|Overall Study||26
6759148|NCT03575962|7686120|FG000|STARTED|Treatment Period 1 (4 Days)||7
6759149|NCT03575962|7686121|FG001|STARTED|Treatment Period 1 (4 Days)||7
6759150|NCT03575962|7686120|FG000|COMPLETED|Treatment Period 1 (4 Days)||7
6759151|NCT03575962|7686121|FG001|COMPLETED|Treatment Period 1 (4 Days)||7
6759152|NCT03575962|7686120|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6759153|NCT03575962|7686121|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6759154|NCT03575962|7686120|FG000|STARTED|Washout Period (7 Days)||7
6759155|NCT03575962|7686121|FG001|STARTED|Washout Period (7 Days)||7
6759156|NCT03575962|7686120|FG000|COMPLETED|Washout Period (7 Days)||7
6759157|NCT03575962|7686121|FG001|COMPLETED|Washout Period (7 Days)||7
6759158|NCT03575962|7686120|FG000|NOT COMPLETED|Washout Period (7 Days)||0
6759159|NCT03575962|7686121|FG001|NOT COMPLETED|Washout Period (7 Days)||0
6759160|NCT03575962|7686120|FG000|STARTED|Treatment Period 2 (4 Days)||7
6759161|NCT03575962|7686121|FG001|STARTED|Treatment Period 2 (4 Days)||7
6759162|NCT03575962|7686120|FG000|COMPLETED|Treatment Period 2 (4 Days)||7
6759163|NCT03575962|7686121|FG001|COMPLETED|Treatment Period 2 (4 Days)||7
6759164|NCT03575962|7686120|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6759165|NCT03575962|7686121|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6759166|NCT03575975|7686130|FG000|STARTED|Overall Study||4
6759167|NCT03575975|7686131|FG001|STARTED|Overall Study||5
6759168|NCT03575975|7686132|FG002|STARTED|Overall Study||0
6759169|NCT03575975|7686130|FG000|COMPLETED|Overall Study||3
6759170|NCT03575975|7686131|FG001|COMPLETED|Overall Study||5
6759171|NCT03575975|7686132|FG002|COMPLETED|Overall Study||0
6759172|NCT03575975|7686130|FG000|NOT COMPLETED|Overall Study||1
6759173|NCT03575975|7686131|FG001|NOT COMPLETED|Overall Study||0
6759174|NCT03575975|7686132|FG002|NOT COMPLETED|Overall Study||0
6759175|NCT03576066|7686140|FG000|STARTED|Overall Study||45
6759176|NCT03576066|7686141|FG001|STARTED|Overall Study||28
6759177|NCT03576066|7686140|FG000|COMPLETED|Overall Study||45
6759178|NCT03576066|7686141|FG001|COMPLETED|Overall Study||27
6759179|NCT03576066|7686140|FG000|NOT COMPLETED|Overall Study||0
6759180|NCT03576066|7686141|FG001|NOT COMPLETED|Overall Study||1
6759181|NCT03576118|7686153|FG000|STARTED|Overall Study||37
6759182|NCT03576118|7686154|FG001|STARTED|Overall Study||37
6759183|NCT03576118|7686153|FG000|COMPLETED|Overall Study||34
6759184|NCT03576118|7686154|FG001|COMPLETED|Overall Study||33
6759185|NCT03576118|7686153|FG000|NOT COMPLETED|Overall Study||3
6759186|NCT03576118|7686154|FG001|NOT COMPLETED|Overall Study||4
6759187|NCT03576183|7686162|FG000|STARTED|Overall Study||17
6759188|NCT03576183|7686163|FG001|STARTED|Overall Study||17
6759189|NCT03576183|7686162|FG000|COMPLETED|Overall Study||15
6759190|NCT03576183|7686163|FG001|COMPLETED|Overall Study||16
6759191|NCT03576183|7686162|FG000|NOT COMPLETED|Overall Study||2
6759192|NCT03576183|7686163|FG001|NOT COMPLETED|Overall Study||1
6759193|NCT03576716|7686171|FG000|STARTED|Overall Study||10
6759194|NCT03576716|7686172|FG001|STARTED|Overall Study||9
6759195|NCT03576716|7686171|FG000|COMPLETED|Overall Study||10
6759196|NCT03576716|7686172|FG001|COMPLETED|Overall Study||8
6759197|NCT03576716|7686171|FG000|NOT COMPLETED|Overall Study||0
6759198|NCT03576716|7686172|FG001|NOT COMPLETED|Overall Study||1
6759199|NCT03576768|7686182|FG000|STARTED|Overall Study||13
6759200|NCT03576768|7686183|FG001|STARTED|Overall Study||12
6759201|NCT03576768|7686184|FG002|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
6759202|NCT03576768|7686185|FG003|STARTED|Overall Study|The study was ended before recruitment into this arm started.|0
6759203|NCT03576768|7686182|FG000|COMPLETED|Overall Study||10
6759204|NCT03576768|7686183|FG001|COMPLETED|Overall Study||9
6759205|NCT03576768|7686184|FG002|COMPLETED|Overall Study||0
6759206|NCT03576768|7686185|FG003|COMPLETED|Overall Study||0
6759207|NCT03576768|7686182|FG000|NOT COMPLETED|Overall Study||3
6759208|NCT03576768|7686183|FG001|NOT COMPLETED|Overall Study||3
6759209|NCT03576768|7686184|FG002|NOT COMPLETED|Overall Study||0
6759210|NCT03576768|7686185|FG003|NOT COMPLETED|Overall Study||0
6759211|NCT03577171|7686197|FG000|STARTED|Overall Study||13
6759212|NCT03577171|7686198|FG001|STARTED|Overall Study||12
6759213|NCT03577171|7686197|FG000|COMPLETED|Overall Study||13
6759214|NCT03577171|7686198|FG001|COMPLETED|Overall Study||12
6759215|NCT03577171|7686197|FG000|NOT COMPLETED|Overall Study||0
6759216|NCT03577171|7686198|FG001|NOT COMPLETED|Overall Study||0
6759217|NCT03577275|7686204|FG000|STARTED|Overall Study|All participants received all of the 4 interventions|32
6759218|NCT03577275|7686204|FG000|Placebo|Overall Study||32
6759219|NCT03577275|7686204|FG000|Moxifloxacin 400mg|Overall Study||32
6759220|NCT03577275|7686204|FG000|NST-4016 600mg|Overall Study||32
6759221|NCT03577275|7686204|FG000|NST-4016 2000mg|Overall Study||32
6759222|NCT03577275|7686204|FG000|COMPLETED|Overall Study||32
6759223|NCT03577275|7686204|FG000|NOT COMPLETED|Overall Study||0
6759224|NCT03577730|7686220|FG000|STARTED|Overall Study||34
6759225|NCT03577730|7686221|FG001|STARTED|Overall Study||31
6759226|NCT03577730|7686220|FG000|Received Treatment|Overall Study||33
6759227|NCT03577730|7686221|FG001|Received Treatment|Overall Study||31
6759228|NCT03577730|7686220|FG000|COMPLETED|Overall Study||30
6759229|NCT03577730|7686221|FG001|COMPLETED|Overall Study||30
6759230|NCT03577730|7686220|FG000|NOT COMPLETED|Overall Study||4
6759231|NCT03577730|7686221|FG001|NOT COMPLETED|Overall Study||1
6759232|NCT03578146|7686233|FG000|STARTED|Overall Study||16
6759233|NCT03578146|7686234|FG001|STARTED|Overall Study||6
6759234|NCT03578146|7686235|FG002|STARTED|Overall Study||6
6759235|NCT03578146|7686236|FG003|STARTED|Overall Study||6
6759236|NCT03578146|7686237|FG004|STARTED|Overall Study||6
6759237|NCT03578146|7686238|FG005|STARTED|Overall Study||8
6759238|NCT03578146|7686233|FG000|COMPLETED|Overall Study||15
6759239|NCT03578146|7686234|FG001|COMPLETED|Overall Study||5
6759240|NCT03578146|7686235|FG002|COMPLETED|Overall Study||5
6759241|NCT03578146|7686236|FG003|COMPLETED|Overall Study||6
6759242|NCT03578146|7686237|FG004|COMPLETED|Overall Study||6
6759243|NCT03578146|7686238|FG005|COMPLETED|Overall Study||5
6759244|NCT03578146|7686233|FG000|NOT COMPLETED|Overall Study||1
6759245|NCT03578146|7686234|FG001|NOT COMPLETED|Overall Study||1
6759246|NCT03578146|7686235|FG002|NOT COMPLETED|Overall Study||1
6759247|NCT03578146|7686236|FG003|NOT COMPLETED|Overall Study||0
6759248|NCT03578146|7686237|FG004|NOT COMPLETED|Overall Study||0
6759249|NCT03578146|7686238|FG005|NOT COMPLETED|Overall Study||3
6759250|NCT03578549|7686252|FG000|STARTED|Overall Study||30
6759251|NCT03578549|7686252|FG000|COMPLETED|Overall Study||29
6759252|NCT03578549|7686252|FG000|NOT COMPLETED|Overall Study||1
6759253|NCT03578926|7686256|FG000|STARTED|First Intervention||21
6759254|NCT03578926|7686257|FG001|STARTED|First Intervention||23
6759255|NCT03578926|7686256|FG000|COMPLETED|First Intervention||21
6759256|NCT03578926|7686257|FG001|COMPLETED|First Intervention||23
6759257|NCT03578926|7686256|FG000|NOT COMPLETED|First Intervention||0
6759258|NCT03578926|7686257|FG001|NOT COMPLETED|First Intervention||0
6759259|NCT03578926|7686256|FG000|STARTED|Second Intervention||23
6759260|NCT03578926|7686257|FG001|STARTED|Second Intervention||21
6759261|NCT03578926|7686256|FG000|COMPLETED|Second Intervention||23
6759262|NCT03578926|7686257|FG001|COMPLETED|Second Intervention||21
6759263|NCT03578926|7686256|FG000|NOT COMPLETED|Second Intervention||0
6759264|NCT03578926|7686257|FG001|NOT COMPLETED|Second Intervention||0
6759265|NCT03579290|7686265|FG000|STARTED|Overall Study||40
6759266|NCT03579290|7686265|FG000|COMPLETED|Overall Study||31
6759267|NCT03579290|7686265|FG000|NOT COMPLETED|Overall Study||9
6759268|NCT03579433|7686269|FG000|STARTED|Overall Study||104
6759269|NCT03579433|7686269|FG000|ORA With VerifEye+|Overall Study||96
6759270|NCT03579433|7686269|FG000|Barrett Calculator|Overall Study||102
6759271|NCT03579433|7686269|FG000|COMPLETED|Overall Study||98
6555993|NCT01755702|7478201|FG000|STARTED|Washout Period II||63
6759272|NCT03579433|7686269|FG000|NOT COMPLETED|Overall Study||6
6759273|NCT03579719|7686277|FG000|STARTED|Overall Study||15
6759274|NCT03579719|7686277|FG000|COMPLETED|Overall Study||14
6759275|NCT03579719|7686277|FG000|NOT COMPLETED|Overall Study||1
6759276|NCT03579940|7686292|FG000|STARTED|Period 1||3
6759277|NCT03579940|7686293|FG001|STARTED|Period 1||2
6759278|NCT03579940|7686294|FG002|STARTED|Period 1||2
6759279|NCT03579940|7686295|FG003|STARTED|Period 1||2
6759280|NCT03579940|7686296|FG004|STARTED|Period 1||2
6759281|NCT03579940|7686297|FG005|STARTED|Period 1||2
6759282|NCT03579940|7686298|FG006|STARTED|Period 1||3
6759283|NCT03579940|7686299|FG007|STARTED|Period 1||3
6759284|NCT03579940|7686300|FG008|STARTED|Period 1||3
6759285|NCT03579940|7686301|FG009|STARTED|Period 1||2
6759286|NCT03579940|7686302|FG010|STARTED|Period 1||3
6759287|NCT03579940|7686292|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
6759288|NCT03579940|7686293|FG001|Received at Least 1 Dose of Study Drug|Period 1||2
6759289|NCT03579940|7686294|FG002|Received at Least 1 Dose of Study Drug|Period 1||2
6759290|NCT03579940|7686295|FG003|Received at Least 1 Dose of Study Drug|Period 1||2
6759291|NCT03579940|7686296|FG004|Received at Least 1 Dose of Study Drug|Period 1||2
6759292|NCT03579940|7686297|FG005|Received at Least 1 Dose of Study Drug|Period 1||2
6759293|NCT03579940|7686298|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
6759294|NCT03579940|7686299|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
6759295|NCT03579940|7686300|FG008|Received at Least 1 Dose of Study Drug|Period 1||3
6759296|NCT03579940|7686301|FG009|Received at Least 1 Dose of Study Drug|Period 1||2
6759297|NCT03579940|7686302|FG010|Received at Least 1 Dose of Study Drug|Period 1||3
6759298|NCT03579940|7686292|FG000|COMPLETED|Period 1||3
6759299|NCT03579940|7686293|FG001|COMPLETED|Period 1||2
6759300|NCT03579940|7686294|FG002|COMPLETED|Period 1||2
6759301|NCT03579940|7686295|FG003|COMPLETED|Period 1||2
6759302|NCT03579940|7686296|FG004|COMPLETED|Period 1||2
6759303|NCT03579940|7686297|FG005|COMPLETED|Period 1||2
6759304|NCT03579940|7686298|FG006|COMPLETED|Period 1||3
6759305|NCT03579940|7686299|FG007|COMPLETED|Period 1||3
6759306|NCT03579940|7686300|FG008|COMPLETED|Period 1||3
6759307|NCT03579940|7686301|FG009|COMPLETED|Period 1||2
6759308|NCT03579940|7686302|FG010|COMPLETED|Period 1||3
6759309|NCT03579940|7686292|FG000|NOT COMPLETED|Period 1||0
6759310|NCT03579940|7686293|FG001|NOT COMPLETED|Period 1||0
6759311|NCT03579940|7686294|FG002|NOT COMPLETED|Period 1||0
6759312|NCT03579940|7686295|FG003|NOT COMPLETED|Period 1||0
6759313|NCT03579940|7686296|FG004|NOT COMPLETED|Period 1||0
6759314|NCT03579940|7686297|FG005|NOT COMPLETED|Period 1||0
6759315|NCT03579940|7686298|FG006|NOT COMPLETED|Period 1||0
6759316|NCT03579940|7686299|FG007|NOT COMPLETED|Period 1||0
6759317|NCT03579940|7686300|FG008|NOT COMPLETED|Period 1||0
6759318|NCT03579940|7686301|FG009|NOT COMPLETED|Period 1||0
6759319|NCT03579940|7686302|FG010|NOT COMPLETED|Period 1||0
6759320|NCT03579940|7686292|FG000|STARTED|Period 2||3
6759321|NCT03579940|7686293|FG001|STARTED|Period 2||2
6759322|NCT03579940|7686294|FG002|STARTED|Period 2||2
6759323|NCT03579940|7686295|FG003|STARTED|Period 2||2
6759324|NCT03579940|7686296|FG004|STARTED|Period 2||2
6759325|NCT03579940|7686297|FG005|STARTED|Period 2||2
6759326|NCT03579940|7686298|FG006|STARTED|Period 2||3
6759327|NCT03579940|7686299|FG007|STARTED|Period 2||3
6759328|NCT03579940|7686300|FG008|STARTED|Period 2||3
6759329|NCT03579940|7686301|FG009|STARTED|Period 2||2
6759330|NCT03579940|7686302|FG010|STARTED|Period 2||3
6759331|NCT03579940|7686292|FG000|COMPLETED|Period 2||3
6759332|NCT03579940|7686293|FG001|COMPLETED|Period 2||2
6759333|NCT03579940|7686294|FG002|COMPLETED|Period 2||1
6305858|NCT00371150|7209242|FG001|COMPLETED|Overall Study|"Completion of treatment means received treatment through Week 52"|4
6305859|NCT00371150|7209241|FG000|NOT COMPLETED|Overall Study||3
6555994|NCT01755702|7478201|FG000|COMPLETED|Washout Period II||58
6759334|NCT03579940|7686295|FG003|COMPLETED|Period 2||2
6759335|NCT03579940|7686296|FG004|COMPLETED|Period 2||2
6759336|NCT03579940|7686297|FG005|COMPLETED|Period 2||2
6759337|NCT03579940|7686298|FG006|COMPLETED|Period 2||3
6759338|NCT03579940|7686299|FG007|COMPLETED|Period 2||3
6759339|NCT03579940|7686300|FG008|COMPLETED|Period 2||3
6759340|NCT03579940|7686301|FG009|COMPLETED|Period 2||2
6759341|NCT03579940|7686302|FG010|COMPLETED|Period 2||3
6759342|NCT03579940|7686292|FG000|NOT COMPLETED|Period 2||0
6759343|NCT03579940|7686293|FG001|NOT COMPLETED|Period 2||0
6759344|NCT03579940|7686294|FG002|NOT COMPLETED|Period 2||1
6759345|NCT03579940|7686295|FG003|NOT COMPLETED|Period 2||0
6759346|NCT03579940|7686296|FG004|NOT COMPLETED|Period 2||0
6759347|NCT03579940|7686297|FG005|NOT COMPLETED|Period 2||0
6759348|NCT03579940|7686298|FG006|NOT COMPLETED|Period 2||0
6759349|NCT03579940|7686299|FG007|NOT COMPLETED|Period 2||0
6759350|NCT03579940|7686300|FG008|NOT COMPLETED|Period 2||0
6759351|NCT03579940|7686301|FG009|NOT COMPLETED|Period 2||0
6759352|NCT03579940|7686302|FG010|NOT COMPLETED|Period 2||0
6759353|NCT03579940|7686292|FG000|STARTED|Period 3||3
6759354|NCT03579940|7686293|FG001|STARTED|Period 3||2
6759355|NCT03579940|7686294|FG002|STARTED|Period 3||1
6759356|NCT03579940|7686295|FG003|STARTED|Period 3||2
6759357|NCT03579940|7686296|FG004|STARTED|Period 3||2
6759358|NCT03579940|7686297|FG005|STARTED|Period 3||2
6759359|NCT03579940|7686298|FG006|STARTED|Period 3||3
6759360|NCT03579940|7686299|FG007|STARTED|Period 3||3
6759361|NCT03579940|7686300|FG008|STARTED|Period 3||3
6759362|NCT03579940|7686301|FG009|STARTED|Period 3||2
6759363|NCT03579940|7686302|FG010|STARTED|Period 3||3
6759364|NCT03579940|7686292|FG000|COMPLETED|Period 3||3
6759365|NCT03579940|7686293|FG001|COMPLETED|Period 3||2
6759366|NCT03579940|7686294|FG002|COMPLETED|Period 3||1
6759367|NCT03579940|7686295|FG003|COMPLETED|Period 3||2
6759368|NCT03579940|7686296|FG004|COMPLETED|Period 3||2
6759369|NCT03579940|7686297|FG005|COMPLETED|Period 3||2
6759370|NCT03579940|7686298|FG006|COMPLETED|Period 3||3
6759371|NCT03579940|7686299|FG007|COMPLETED|Period 3||3
6759372|NCT03579940|7686300|FG008|COMPLETED|Period 3||3
6759373|NCT03579940|7686301|FG009|COMPLETED|Period 3||2
6759374|NCT03579940|7686302|FG010|COMPLETED|Period 3||3
6759375|NCT03579940|7686292|FG000|NOT COMPLETED|Period 3||0
6759376|NCT03579940|7686293|FG001|NOT COMPLETED|Period 3||0
6759377|NCT03579940|7686294|FG002|NOT COMPLETED|Period 3||0
6759378|NCT03579940|7686295|FG003|NOT COMPLETED|Period 3||0
6759379|NCT03579940|7686296|FG004|NOT COMPLETED|Period 3||0
6759380|NCT03579940|7686297|FG005|NOT COMPLETED|Period 3||0
6759381|NCT03579940|7686298|FG006|NOT COMPLETED|Period 3||0
6759382|NCT03579940|7686299|FG007|NOT COMPLETED|Period 3||0
6759383|NCT03579940|7686300|FG008|NOT COMPLETED|Period 3||0
6759384|NCT03579940|7686301|FG009|NOT COMPLETED|Period 3||0
6759385|NCT03579940|7686302|FG010|NOT COMPLETED|Period 3||0
6759386|NCT03580343|7686334|FG000|STARTED|Overall Study||5
6759387|NCT03580343|7686334|FG000|COMPLETED|Overall Study||4
6759388|NCT03580343|7686334|FG000|NOT COMPLETED|Overall Study||1
6555995|NCT01755702|7478201|FG000|NOT COMPLETED|Washout Period II||5
6555996|NCT01755702|7478201|FG000|STARTED|Period III||58
6555997|NCT01755702|7478201|FG000|Received Paracetamol|Period III||17
6555998|NCT01755702|7478201|FG000|Received Placebo|Period III||13
6555999|NCT01755702|7478201|FG000|Received Paracetamol/Caffeine|Period III||10
6759389|NCT03581084|7686338|FG000|STARTED|Overall Study||1
6759390|NCT03581084|7686338|FG000|COMPLETED|Overall Study||1
6759391|NCT03581084|7686338|FG000|NOT COMPLETED|Overall Study||0
6759392|NCT03581097|7686344|FG000|STARTED|Overall Study||46
6759393|NCT03581097|7686345|FG001|STARTED|Overall Study||47
6759394|NCT03581097|7686344|FG000|COMPLETED|Overall Study||46
6759395|NCT03581097|7686345|FG001|COMPLETED|Overall Study||47
6759396|NCT03581097|7686344|FG000|NOT COMPLETED|Overall Study||0
6759397|NCT03581097|7686345|FG001|NOT COMPLETED|Overall Study||0
6759398|NCT03581474|7686353|FG000|STARTED|Overall Study||12
6759399|NCT03581474|7686353|FG000|COMPLETED|Overall Study||12
6759400|NCT03581474|7686353|FG000|NOT COMPLETED|Overall Study||0
6759401|NCT03581825|7686357|FG000|STARTED|Period 1||31
6759402|NCT03581825|7686358|FG001|STARTED|Period 1||31
6759403|NCT03581825|7686357|FG000|COMPLETED|Period 1||30
6759404|NCT03581825|7686358|FG001|COMPLETED|Period 1||31
6759405|NCT03581825|7686357|FG000|NOT COMPLETED|Period 1||1
6759406|NCT03581825|7686358|FG001|NOT COMPLETED|Period 1||0
6759407|NCT03581825|7686357|FG000|STARTED|Period 2||30
6759408|NCT03581825|7686358|FG001|STARTED|Period 2||31
6759409|NCT03581825|7686357|FG000|COMPLETED|Period 2||30
6759410|NCT03581825|7686358|FG001|COMPLETED|Period 2||30
6759411|NCT03581825|7686357|FG000|NOT COMPLETED|Period 2||0
6759412|NCT03581825|7686358|FG001|NOT COMPLETED|Period 2||1
6759413|NCT03582215|7686372|FG000|STARTED|Overall Study||6
6759414|NCT03582215|7686373|FG001|STARTED|Overall Study||6
6759415|NCT03582215|7686374|FG002|STARTED|Overall Study||6
6759416|NCT03582215|7686375|FG003|STARTED|Overall Study||6
6759417|NCT03582215|7686376|FG004|STARTED|Overall Study||12
6759418|NCT03582215|7686377|FG005|STARTED|Overall Study||12
6759419|NCT03582215|7686378|FG006|STARTED|Overall Study||12
6759420|NCT03582215|7686379|FG007|STARTED|Overall Study||12
6759421|NCT03582215|7686372|FG000|COMPLETED|Overall Study||5
6759422|NCT03582215|7686373|FG001|COMPLETED|Overall Study||6
6759423|NCT03582215|7686374|FG002|COMPLETED|Overall Study||6
6759424|NCT03582215|7686375|FG003|COMPLETED|Overall Study||6
6759425|NCT03582215|7686376|FG004|COMPLETED|Overall Study||12
6759426|NCT03582215|7686377|FG005|COMPLETED|Overall Study||12
6759427|NCT03582215|7686378|FG006|COMPLETED|Overall Study||10
6759428|NCT03582215|7686379|FG007|COMPLETED|Overall Study||10
6759429|NCT03582215|7686372|FG000|NOT COMPLETED|Overall Study||1
6759430|NCT03582215|7686373|FG001|NOT COMPLETED|Overall Study||0
6759431|NCT03582215|7686374|FG002|NOT COMPLETED|Overall Study||0
6759432|NCT03582215|7686375|FG003|NOT COMPLETED|Overall Study||0
6759433|NCT03582215|7686376|FG004|NOT COMPLETED|Overall Study||0
6759434|NCT03582215|7686377|FG005|NOT COMPLETED|Overall Study||0
6759435|NCT03582215|7686378|FG006|NOT COMPLETED|Overall Study||2
6759436|NCT03582215|7686379|FG007|NOT COMPLETED|Overall Study||2
6759437|NCT03582553|7686414|FG000|STARTED|Intervention 1/Visit 1||3
6759438|NCT03582553|7686415|FG001|STARTED|Intervention 1/Visit 1||3
6759439|NCT03582553|7686416|FG002|STARTED|Intervention 1/Visit 1||3
6759440|NCT03582553|7686417|FG003|STARTED|Intervention 1/Visit 1||3
6759441|NCT03582553|7686418|FG004|STARTED|Intervention 1/Visit 1||3
6759442|NCT03582553|7686419|FG005|STARTED|Intervention 1/Visit 1||3
6759443|NCT03582553|7686414|FG000|COMPLETED|Intervention 1/Visit 1||3
6556000|NCT01755702|7478201|FG000|Received Ibuprofen|Period III||18
6556001|NCT01755702|7478201|FG000|COMPLETED|Period III||58
6556002|NCT01755702|7478201|FG000|NOT COMPLETED|Period III||0
6556003|NCT01755767|7478215|FG000|STARTED|Overall Study||28
6759444|NCT03582553|7686415|FG001|COMPLETED|Intervention 1/Visit 1||3
6759445|NCT03582553|7686416|FG002|COMPLETED|Intervention 1/Visit 1||3
6759446|NCT03582553|7686417|FG003|COMPLETED|Intervention 1/Visit 1||3
6759447|NCT03582553|7686418|FG004|COMPLETED|Intervention 1/Visit 1||3
6759448|NCT03582553|7686419|FG005|COMPLETED|Intervention 1/Visit 1||3
6759449|NCT03582553|7686414|FG000|NOT COMPLETED|Intervention 1/Visit 1||0
6759450|NCT03582553|7686415|FG001|NOT COMPLETED|Intervention 1/Visit 1||0
6759451|NCT03582553|7686416|FG002|NOT COMPLETED|Intervention 1/Visit 1||0
6759452|NCT03582553|7686417|FG003|NOT COMPLETED|Intervention 1/Visit 1||0
6759453|NCT03582553|7686418|FG004|NOT COMPLETED|Intervention 1/Visit 1||0
6759454|NCT03582553|7686419|FG005|NOT COMPLETED|Intervention 1/Visit 1||0
6759455|NCT03582553|7686414|FG000|STARTED|Washout Period ( At Least 1 Week)||3
6759456|NCT03582553|7686415|FG001|STARTED|Washout Period ( At Least 1 Week)||3
6759457|NCT03582553|7686416|FG002|STARTED|Washout Period ( At Least 1 Week)||3
6759458|NCT03582553|7686417|FG003|STARTED|Washout Period ( At Least 1 Week)||3
6759459|NCT03582553|7686418|FG004|STARTED|Washout Period ( At Least 1 Week)||3
6759460|NCT03582553|7686419|FG005|STARTED|Washout Period ( At Least 1 Week)||3
6759461|NCT03582553|7686414|FG000|COMPLETED|Washout Period ( At Least 1 Week)||3
6759462|NCT03582553|7686415|FG001|COMPLETED|Washout Period ( At Least 1 Week)||3
6759463|NCT03582553|7686416|FG002|COMPLETED|Washout Period ( At Least 1 Week)||3
6759464|NCT03582553|7686417|FG003|COMPLETED|Washout Period ( At Least 1 Week)||3
6759465|NCT03582553|7686418|FG004|COMPLETED|Washout Period ( At Least 1 Week)||3
6759466|NCT03582553|7686419|FG005|COMPLETED|Washout Period ( At Least 1 Week)||3
6759467|NCT03582553|7686414|FG000|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6759468|NCT03582553|7686415|FG001|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6759469|NCT03582553|7686416|FG002|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6759470|NCT03582553|7686417|FG003|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6759471|NCT03582553|7686418|FG004|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6759472|NCT03582553|7686419|FG005|NOT COMPLETED|Washout Period ( At Least 1 Week)||0
6759473|NCT03582553|7686414|FG000|STARTED|Intervention 2/Visit 2||3
6759474|NCT03582553|7686415|FG001|STARTED|Intervention 2/Visit 2||3
6759475|NCT03582553|7686416|FG002|STARTED|Intervention 2/Visit 2||3
6759476|NCT03582553|7686417|FG003|STARTED|Intervention 2/Visit 2||3
6759477|NCT03582553|7686418|FG004|STARTED|Intervention 2/Visit 2||3
6759478|NCT03582553|7686419|FG005|STARTED|Intervention 2/Visit 2||3
6759479|NCT03582553|7686414|FG000|COMPLETED|Intervention 2/Visit 2||3
6759480|NCT03582553|7686415|FG001|COMPLETED|Intervention 2/Visit 2||3
6759481|NCT03582553|7686416|FG002|COMPLETED|Intervention 2/Visit 2||3
6759482|NCT03582553|7686417|FG003|COMPLETED|Intervention 2/Visit 2||3
6759483|NCT03582553|7686418|FG004|COMPLETED|Intervention 2/Visit 2||3
6759484|NCT03582553|7686419|FG005|COMPLETED|Intervention 2/Visit 2||3
6759485|NCT03582553|7686414|FG000|NOT COMPLETED|Intervention 2/Visit 2||0
6759486|NCT03582553|7686415|FG001|NOT COMPLETED|Intervention 2/Visit 2||0
6759487|NCT03582553|7686416|FG002|NOT COMPLETED|Intervention 2/Visit 2||0
6759488|NCT03582553|7686417|FG003|NOT COMPLETED|Intervention 2/Visit 2||0
6759489|NCT03582553|7686418|FG004|NOT COMPLETED|Intervention 2/Visit 2||0
6759490|NCT03582553|7686419|FG005|NOT COMPLETED|Intervention 2/Visit 2||0
6759491|NCT03582553|7686414|FG000|STARTED|Washout Period (At Least 1 Week)||3
6759492|NCT03582553|7686415|FG001|STARTED|Washout Period (At Least 1 Week)||3
6759493|NCT03582553|7686416|FG002|STARTED|Washout Period (At Least 1 Week)||3
6759494|NCT03582553|7686417|FG003|STARTED|Washout Period (At Least 1 Week)||3
6759495|NCT03582553|7686418|FG004|STARTED|Washout Period (At Least 1 Week)||3
6759496|NCT03582553|7686419|FG005|STARTED|Washout Period (At Least 1 Week)||3
6759497|NCT03582553|7686414|FG000|COMPLETED|Washout Period (At Least 1 Week)||3
6759498|NCT03582553|7686415|FG001|COMPLETED|Washout Period (At Least 1 Week)||3
6759499|NCT03582553|7686416|FG002|COMPLETED|Washout Period (At Least 1 Week)||3
6759500|NCT03582553|7686417|FG003|COMPLETED|Washout Period (At Least 1 Week)||3
6759501|NCT03582553|7686418|FG004|COMPLETED|Washout Period (At Least 1 Week)||3
6759502|NCT03582553|7686419|FG005|COMPLETED|Washout Period (At Least 1 Week)||3
6759503|NCT03582553|7686414|FG000|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6759504|NCT03582553|7686415|FG001|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6759505|NCT03582553|7686416|FG002|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6759506|NCT03582553|7686417|FG003|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6759507|NCT03582553|7686418|FG004|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6759508|NCT03582553|7686419|FG005|NOT COMPLETED|Washout Period (At Least 1 Week)||0
6759509|NCT03582553|7686414|FG000|STARTED|Intervention 3/Visit 3||3
6759510|NCT03582553|7686415|FG001|STARTED|Intervention 3/Visit 3||3
6759511|NCT03582553|7686416|FG002|STARTED|Intervention 3/Visit 3||3
6759512|NCT03582553|7686417|FG003|STARTED|Intervention 3/Visit 3||3
6759513|NCT03582553|7686418|FG004|STARTED|Intervention 3/Visit 3||3
6759514|NCT03582553|7686419|FG005|STARTED|Intervention 3/Visit 3||3
6759515|NCT03582553|7686414|FG000|COMPLETED|Intervention 3/Visit 3||3
6759516|NCT03582553|7686415|FG001|COMPLETED|Intervention 3/Visit 3||3
6759517|NCT03582553|7686416|FG002|COMPLETED|Intervention 3/Visit 3||3
6759518|NCT03582553|7686417|FG003|COMPLETED|Intervention 3/Visit 3||3
6759519|NCT03582553|7686418|FG004|COMPLETED|Intervention 3/Visit 3||3
6759520|NCT03582553|7686419|FG005|COMPLETED|Intervention 3/Visit 3||3
6759521|NCT03582553|7686414|FG000|NOT COMPLETED|Intervention 3/Visit 3||0
6759522|NCT03582553|7686415|FG001|NOT COMPLETED|Intervention 3/Visit 3||0
6759523|NCT03582553|7686416|FG002|NOT COMPLETED|Intervention 3/Visit 3||0
6759524|NCT03582553|7686417|FG003|NOT COMPLETED|Intervention 3/Visit 3||0
6759525|NCT03582553|7686418|FG004|NOT COMPLETED|Intervention 3/Visit 3||0
6759526|NCT03582553|7686419|FG005|NOT COMPLETED|Intervention 3/Visit 3||0
6759527|NCT03582813|7686439|FG000|STARTED|Overall Study||114
6759528|NCT03582813|7686440|FG001|STARTED|Overall Study||102
6759529|NCT03582813|7686439|FG000|COMPLETED|Overall Study||95
6759530|NCT03582813|7686440|FG001|COMPLETED|Overall Study||81
6759531|NCT03582813|7686439|FG000|NOT COMPLETED|Overall Study||19
6759532|NCT03582813|7686440|FG001|NOT COMPLETED|Overall Study||21
6759533|NCT03582826|7686448|FG000|STARTED|Overall Study||119
6759534|NCT03582826|7686449|FG001|STARTED|Overall Study||6
6759535|NCT03582826|7686448|FG000|COMPLETED|Overall Study||78
6759536|NCT03582826|7686449|FG001|COMPLETED|Overall Study||6
6759537|NCT03582826|7686448|FG000|NOT COMPLETED|Overall Study||41
6759538|NCT03582826|7686449|FG001|NOT COMPLETED|Overall Study||0
6759539|NCT03582943|7686466|FG000|STARTED|Allocated to Groups||42
6759540|NCT03582943|7686467|FG001|STARTED|Allocated to Groups||40
6759541|NCT03582943|7686466|FG000|COMPLETED|Allocated to Groups||41
6759542|NCT03582943|7686467|FG001|COMPLETED|Allocated to Groups||39
6759543|NCT03582943|7686466|FG000|NOT COMPLETED|Allocated to Groups||1
6759544|NCT03582943|7686467|FG001|NOT COMPLETED|Allocated to Groups||1
6759545|NCT03582943|7686466|FG000|STARTED|Intervention and Follow up||41
6759546|NCT03582943|7686467|FG001|STARTED|Intervention and Follow up||39
6759547|NCT03582943|7686466|FG000|COMPLETED|Intervention and Follow up||37
6759548|NCT03582943|7686467|FG001|COMPLETED|Intervention and Follow up||37
6759549|NCT03582943|7686466|FG000|NOT COMPLETED|Intervention and Follow up||4
6759550|NCT03582943|7686467|FG001|NOT COMPLETED|Intervention and Follow up||2
6759551|NCT03582943|7686466|FG000|STARTED|Analyzed||37
6759552|NCT03582943|7686467|FG001|STARTED|Analyzed||37
6759553|NCT03582943|7686466|FG000|COMPLETED|Analyzed||33
6759554|NCT03582943|7686467|FG001|COMPLETED|Analyzed||36
6759555|NCT03582943|7686466|FG000|NOT COMPLETED|Analyzed||4
6759556|NCT03582943|7686467|FG001|NOT COMPLETED|Analyzed||1
6759557|NCT03583372|7686477|FG000|STARTED|Overall Study||92
6759558|NCT03583372|7686478|FG001|STARTED|Overall Study||182
6759559|NCT03583372|7686479|FG002|STARTED|Overall Study||91
6759560|NCT03583372|7686480|FG003|STARTED|Overall Study||141
6759561|NCT03583372|7686477|FG000|COMPLETED|Overall Study||79
6759562|NCT03583372|7686478|FG001|COMPLETED|Overall Study||156
6759563|NCT03583372|7686479|FG002|COMPLETED|Overall Study||72
6759564|NCT03583372|7686480|FG003|COMPLETED|Overall Study||123
6759565|NCT03583372|7686477|FG000|NOT COMPLETED|Overall Study||13
6759566|NCT03583372|7686478|FG001|NOT COMPLETED|Overall Study||26
6759567|NCT03583372|7686479|FG002|NOT COMPLETED|Overall Study||19
6759568|NCT03583372|7686480|FG003|NOT COMPLETED|Overall Study||18
6759569|NCT03583385|7686490|FG000|STARTED|Treatment Period 1||24
6759570|NCT03583385|7686491|FG001|STARTED|Treatment Period 1||24
6759571|NCT03583385|7686490|FG000|COMPLETED|Treatment Period 1||23
6759572|NCT03583385|7686491|FG001|COMPLETED|Treatment Period 1||23
6759573|NCT03583385|7686490|FG000|NOT COMPLETED|Treatment Period 1||1
6759574|NCT03583385|7686491|FG001|NOT COMPLETED|Treatment Period 1||1
6759575|NCT03583385|7686490|FG000|STARTED|Treatment Period 2|Of 46 participants who completed period 1, 45 entered period2 & 1 participant didn't attend period2.|22
6759576|NCT03583385|7686491|FG001|STARTED|Treatment Period 2||23
6759577|NCT03583385|7686490|FG000|COMPLETED|Treatment Period 2||21
6759578|NCT03583385|7686491|FG001|COMPLETED|Treatment Period 2||23
6759579|NCT03583385|7686490|FG000|NOT COMPLETED|Treatment Period 2||1
6759580|NCT03583385|7686491|FG001|NOT COMPLETED|Treatment Period 2||0
6780123|NCT03339245|7708460|FG000|NOT COMPLETED|Overall Study||2
6780124|NCT03339245|7708461|FG001|NOT COMPLETED|Overall Study||1
6780125|NCT03333746|7708467|FG000|STARTED|Overall Study||1
6780126|NCT03333746|7708467|FG000|COMPLETED|Overall Study||0
6780127|NCT03333746|7708467|FG000|NOT COMPLETED|Overall Study||1
6780128|NCT03329404|7708473|FG000|STARTED|Overall Study||4
6780129|NCT03329404|7708474|FG001|STARTED|Overall Study||5
6780130|NCT03329404|7708473|FG000|COMPLETED|Overall Study||3
6780131|NCT03329404|7708474|FG001|COMPLETED|Overall Study||1
6780132|NCT03329404|7708473|FG000|NOT COMPLETED|Overall Study||1
6780133|NCT03329404|7708474|FG001|NOT COMPLETED|Overall Study||4
6780134|NCT03326869|7708482|FG000|STARTED|Overall Study||1
6780135|NCT03326869|7708483|FG001|STARTED|Overall Study||1
6780136|NCT03326869|7708482|FG000|COMPLETED|Overall Study||0
6780137|NCT03326869|7708483|FG001|COMPLETED|Overall Study||0
6780138|NCT03326869|7708482|FG000|NOT COMPLETED|Overall Study||1
6780139|NCT03326869|7708483|FG001|NOT COMPLETED|Overall Study||1
6780140|NCT03325114|7708489|FG000|STARTED|Overall Study||1
6780141|NCT03325114|7708489|FG000|COMPLETED|Overall Study||0
6780142|NCT03325114|7708489|FG000|NOT COMPLETED|Overall Study||1
6780143|NCT03319407|7708493|FG000|STARTED|Overall Study||21
6780144|NCT03319407|7708493|FG000|COMPLETED|Overall Study||0
6780145|NCT03319407|7708493|FG000|NOT COMPLETED|Overall Study||21
6780146|NCT03316105|7708499|FG000|STARTED|Overall Study||9
6780147|NCT03316105|7708500|FG001|STARTED|Overall Study||7
6780148|NCT03316105|7708499|FG000|COMPLETED|Overall Study||9
6780149|NCT03316105|7708500|FG001|COMPLETED|Overall Study||7
6780150|NCT03316105|7708499|FG000|NOT COMPLETED|Overall Study||0
6780151|NCT03316105|7708500|FG001|NOT COMPLETED|Overall Study||0
6780152|NCT03305055|7708508|FG000|STARTED|Overall Study||2
6780153|NCT03305055|7708509|FG001|STARTED|Overall Study||2
6780154|NCT03305055|7708508|FG000|COMPLETED|Overall Study||1
6780155|NCT03305055|7708509|FG001|COMPLETED|Overall Study||0
6780156|NCT03305055|7708508|FG000|NOT COMPLETED|Overall Study||1
6780157|NCT03305055|7708509|FG001|NOT COMPLETED|Overall Study||2
6780158|NCT03303469|7708515|FG000|STARTED|Overall Study||3
6780159|NCT03303469|7708515|FG000|COMPLETED|Overall Study||1
6780160|NCT03303469|7708515|FG000|NOT COMPLETED|Overall Study||2
6780161|NCT03302247|7708519|FG000|STARTED|Overall Study||3
6780162|NCT03302247|7708519|FG000|COMPLETED|Overall Study||0
6759581|NCT03583450|7686499|FG000|STARTED|Overall Study||34
6759582|NCT03583450|7686500|FG001|STARTED|Overall Study||37
6759583|NCT03583450|7686499|FG000|COMPLETED|Overall Study||33
6759584|NCT03583450|7686500|FG001|COMPLETED|Overall Study||37
6759585|NCT03583450|7686499|FG000|NOT COMPLETED|Overall Study||1
6759586|NCT03583450|7686500|FG001|NOT COMPLETED|Overall Study||0
6759587|NCT03583606|7686511|FG000|STARTED|Overall Study||22
6759588|NCT03583606|7686512|FG001|STARTED|Overall Study||20
6759589|NCT03583606|7686513|FG002|STARTED|Overall Study||19
6759590|NCT03583606|7686511|FG000|COMPLETED|Overall Study||21
6759591|NCT03583606|7686512|FG001|COMPLETED|Overall Study||19
6759592|NCT03583606|7686513|FG002|COMPLETED|Overall Study||19
6759593|NCT03583606|7686511|FG000|NOT COMPLETED|Overall Study||1
6759594|NCT03583606|7686512|FG001|NOT COMPLETED|Overall Study||1
6759595|NCT03583606|7686513|FG002|NOT COMPLETED|Overall Study||0
6759596|NCT03584009|7686524|FG000|STARTED|Overall Study||51
6759597|NCT03584009|7686525|FG001|STARTED|Overall Study||52
6759598|NCT03584009|7686524|FG000|COMPLETED|Overall Study||0
6759599|NCT03584009|7686525|FG001|COMPLETED|Overall Study||0
6759600|NCT03584009|7686524|FG000|NOT COMPLETED|Overall Study||51
6759601|NCT03584009|7686525|FG001|NOT COMPLETED|Overall Study||52
6759602|NCT03584100|7686531|FG000|STARTED|Overall Study||12
6759603|NCT03584100|7686531|FG000|COMPLETED|Overall Study||12
6759604|NCT03584100|7686531|FG000|NOT COMPLETED|Overall Study||0
6759605|NCT03585244|7686538|FG000|STARTED|Overall Study||180
6759606|NCT03585244|7686538|FG000|COMPLETED|Overall Study||165
6759607|NCT03585244|7686538|FG000|NOT COMPLETED|Overall Study||15
6759608|NCT03585296|7686542|FG000|STARTED|Overall Study||22
6759609|NCT03585296|7686542|FG000|COMPLETED|Overall Study||17
6759610|NCT03585296|7686542|FG000|NOT COMPLETED|Overall Study||5
6759611|NCT03585504|7686548|FG000|STARTED|Overall Study||41
6759612|NCT03585504|7686549|FG001|STARTED|Overall Study||40
6759613|NCT03585504|7686548|FG000|COMPLETED|Overall Study||15
6759614|NCT03585504|7686549|FG001|COMPLETED|Overall Study||11
6759615|NCT03585504|7686548|FG000|NOT COMPLETED|Overall Study||26
6759616|NCT03585504|7686549|FG001|NOT COMPLETED|Overall Study||29
6759617|NCT03585543|7686555|FG000|STARTED|Overall Study||30
6759618|NCT03585543|7686555|FG000|Mid-intervention Assessment (6-weeks)|Overall Study||25
6759619|NCT03585543|7686555|FG000|End-of-intervention Assessment (12 Weeks|Overall Study||22
6759620|NCT03585543|7686555|FG000|3-month Post-intervention Follow-up (6 m|Overall Study||15
6759621|NCT03585543|7686555|FG000|COMPLETED|Overall Study||15
6759622|NCT03585543|7686555|FG000|NOT COMPLETED|Overall Study||15
6759623|NCT03585712|7686560|FG000|STARTED|Treatment Period 1||52
6759624|NCT03585712|7686561|FG001|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
6759625|NCT03585712|7686562|FG002|STARTED|Treatment Period 1|Randomization in Treatment Period 2|0
6759626|NCT03585712|7686560|FG000|COMPLETED|Treatment Period 1||51
6759627|NCT03585712|7686561|FG001|COMPLETED|Treatment Period 1||0
6759628|NCT03585712|7686562|FG002|COMPLETED|Treatment Period 1||0
6759629|NCT03585712|7686560|FG000|NOT COMPLETED|Treatment Period 1||1
6759630|NCT03585712|7686561|FG001|NOT COMPLETED|Treatment Period 1||0
6759631|NCT03585712|7686562|FG002|NOT COMPLETED|Treatment Period 1||0
6556004|NCT01755767|7478216|FG001|STARTED|Overall Study||15
6759632|NCT03585712|7686560|FG000|STARTED|Treatment Periods 2 and 3|Subjects having completed Treatment Period 1 randomized in Arm A or Arm B|0
6759633|NCT03585712|7686561|FG001|STARTED|Treatment Periods 2 and 3||26
6759634|NCT03585712|7686562|FG002|STARTED|Treatment Periods 2 and 3||25
6759635|NCT03585712|7686560|FG000|COMPLETED|Treatment Periods 2 and 3||0
6759636|NCT03585712|7686561|FG001|COMPLETED|Treatment Periods 2 and 3||23
6759637|NCT03585712|7686562|FG002|COMPLETED|Treatment Periods 2 and 3||22
6759638|NCT03585712|7686560|FG000|NOT COMPLETED|Treatment Periods 2 and 3||0
6759639|NCT03585712|7686561|FG001|NOT COMPLETED|Treatment Periods 2 and 3||3
6759640|NCT03585712|7686562|FG002|NOT COMPLETED|Treatment Periods 2 and 3||3
6759641|NCT03585790|7686581|FG000|STARTED|First Intervention (1 Week)||23
6759642|NCT03585790|7686582|FG001|STARTED|First Intervention (1 Week)||22
6498125|NCT01408719|7416843|FG017|STARTED|Third Intervention (35 Days)||2
6498126|NCT01408719|7416844|FG018|STARTED|Third Intervention (35 Days)||0
6498127|NCT01408719|7416845|FG019|STARTED|Third Intervention (35 Days)||1
6498128|NCT01408719|7416826|FG000|COMPLETED|Third Intervention (35 Days)||2
6498129|NCT01408719|7416827|FG001|COMPLETED|Third Intervention (35 Days)||3
6498130|NCT01408719|7416828|FG002|COMPLETED|Third Intervention (35 Days)||1
6498131|NCT01408719|7416829|FG003|COMPLETED|Third Intervention (35 Days)||2
6498132|NCT01408719|7416830|FG004|COMPLETED|Third Intervention (35 Days)||3
6498133|NCT01408719|7416831|FG005|COMPLETED|Third Intervention (35 Days)||3
6498134|NCT01408719|7416832|FG006|COMPLETED|Third Intervention (35 Days)||2
6556005|NCT01755767|7478217|FG002|STARTED|Overall Study||226
6759643|NCT03585790|7686581|FG000|COMPLETED|First Intervention (1 Week)||23
6759644|NCT03585790|7686582|FG001|COMPLETED|First Intervention (1 Week)||22
6759645|NCT03585790|7686581|FG000|NOT COMPLETED|First Intervention (1 Week)||0
6759646|NCT03585790|7686582|FG001|NOT COMPLETED|First Intervention (1 Week)||0
6759647|NCT03585790|7686581|FG000|STARTED|Second Intervention (1 Week)||23
6759648|NCT03585790|7686582|FG001|STARTED|Second Intervention (1 Week)||22
6759649|NCT03585790|7686581|FG000|COMPLETED|Second Intervention (1 Week)||23
6759650|NCT03585790|7686582|FG001|COMPLETED|Second Intervention (1 Week)||22
6759651|NCT03585790|7686581|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6759652|NCT03585790|7686582|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6759653|NCT03585959|7686589|FG000|STARTED|Overall Study||50
6759654|NCT03585959|7686589|FG000|COMPLETED|Overall Study||47
6759655|NCT03585959|7686589|FG000|NOT COMPLETED|Overall Study||3
6759656|NCT03586167|7686597|FG000|STARTED|Overall Study||58
6759657|NCT03586167|7686598|FG001|STARTED|Overall Study||28
6759658|NCT03586167|7686597|FG000|COMPLETED|Overall Study||57
6759659|NCT03586167|7686598|FG001|COMPLETED|Overall Study||28
6759660|NCT03586167|7686597|FG000|NOT COMPLETED|Overall Study||1
6759661|NCT03586167|7686598|FG001|NOT COMPLETED|Overall Study||0
6759662|NCT03586544|7686606|FG000|STARTED|First Intervention||6
6759663|NCT03586544|7686607|FG001|STARTED|First Intervention||12
6759664|NCT03586544|7686606|FG000|COMPLETED|First Intervention||6
6759665|NCT03586544|7686607|FG001|COMPLETED|First Intervention||11
6759666|NCT03586544|7686606|FG000|NOT COMPLETED|First Intervention||0
6759667|NCT03586544|7686607|FG001|NOT COMPLETED|First Intervention||1
6759668|NCT03586544|7686606|FG000|STARTED|Second Intervention||6
6759669|NCT03586544|7686607|FG001|STARTED|Second Intervention||11
6759670|NCT03586544|7686606|FG000|COMPLETED|Second Intervention||6
6759671|NCT03586544|7686607|FG001|COMPLETED|Second Intervention||10
6759672|NCT03586544|7686606|FG000|NOT COMPLETED|Second Intervention||0
6759673|NCT03586544|7686607|FG001|NOT COMPLETED|Second Intervention||1
6759674|NCT03586583|7686613|FG000|STARTED|Overall Study||600
6759675|NCT03586583|7686613|FG000|COMPLETED|Overall Study||600
6759676|NCT03586583|7686613|FG000|NOT COMPLETED|Overall Study||0
6759677|NCT03586648|7686618|FG000|STARTED|Period 1||36
6759678|NCT03586648|7686619|FG001|STARTED|Period 1||34
6759679|NCT03586648|7686618|FG000|COMPLETED|Period 1||32
6759680|NCT03586648|7686619|FG001|COMPLETED|Period 1||30
6759681|NCT03586648|7686618|FG000|NOT COMPLETED|Period 1||4
6759682|NCT03586648|7686619|FG001|NOT COMPLETED|Period 1||4
6759683|NCT03586648|7686618|FG000|STARTED|Period 2||32
6759684|NCT03586648|7686619|FG001|STARTED|Period 2||30
6759685|NCT03586648|7686618|FG000|COMPLETED|Period 2||31
6759686|NCT03586648|7686619|FG001|COMPLETED|Period 2||30
6759687|NCT03586648|7686618|FG000|NOT COMPLETED|Period 2||1
6759688|NCT03586648|7686619|FG001|NOT COMPLETED|Period 2||0
6759689|NCT03586726|7686625|FG000|STARTED|Overall Study||16
6759690|NCT03586726|7686625|FG000|COMPLETED|Overall Study||15
6759691|NCT03586726|7686625|FG000|NOT COMPLETED|Overall Study||1
6759692|NCT03586830|7686633|FG000|STARTED|Overall Study||50
6759693|NCT03586830|7686634|FG001|STARTED|Overall Study||48
6759694|NCT03586830|7686635|FG002|STARTED|Overall Study||49
6759695|NCT03586830|7686636|FG003|STARTED|Overall Study||49
6759696|NCT03586830|7686633|FG000|Treated|Overall Study||49
6759697|NCT03586830|7686634|FG001|Treated|Overall Study||48
6759698|NCT03586830|7686635|FG002|Treated|Overall Study||49
6759699|NCT03586830|7686636|FG003|Treated|Overall Study||49
6556006|NCT01755767|7478218|FG003|STARTED|Overall Study||114
6556007|NCT01755767|7478215|FG000|COMPLETED|Overall Study||0
6556008|NCT01755767|7478216|FG001|COMPLETED|Overall Study||0
6556009|NCT01755767|7478217|FG002|COMPLETED|Overall Study||0
6556010|NCT01755767|7478218|FG003|COMPLETED|Overall Study||0
6759700|NCT03586830|7686633|FG000|COMPLETED|Overall Study||48
6759701|NCT03586830|7686634|FG001|COMPLETED|Overall Study||42
6759702|NCT03586830|7686635|FG002|COMPLETED|Overall Study||41
6759703|NCT03586830|7686636|FG003|COMPLETED|Overall Study||44
6759704|NCT03586830|7686633|FG000|NOT COMPLETED|Overall Study||2
6759705|NCT03586830|7686634|FG001|NOT COMPLETED|Overall Study||6
6759706|NCT03586830|7686635|FG002|NOT COMPLETED|Overall Study||8
6759707|NCT03586830|7686636|FG003|NOT COMPLETED|Overall Study||5
6759708|NCT03587207|7686651|FG000|STARTED|Overall Study||100
6759709|NCT03587207|7686652|FG001|STARTED|Overall Study||104
6759710|NCT03587207|7686653|FG002|STARTED|Overall Study||100
6759711|NCT03587207|7686654|FG003|STARTED|Overall Study||94
6759712|NCT03587207|7686655|FG004|STARTED|Overall Study||102
6759713|NCT03587207|7686651|FG000|COMPLETED|Overall Study||100
6759714|NCT03587207|7686652|FG001|COMPLETED|Overall Study||104
6759715|NCT03587207|7686653|FG002|COMPLETED|Overall Study||100
6556011|NCT01755767|7478215|FG000|NOT COMPLETED|Overall Study||28
6556012|NCT01755767|7478216|FG001|NOT COMPLETED|Overall Study||15
6556013|NCT01755767|7478217|FG002|NOT COMPLETED|Overall Study||226
6759716|NCT03587207|7686654|FG003|COMPLETED|Overall Study||94
6759717|NCT03587207|7686655|FG004|COMPLETED|Overall Study||102
6759718|NCT03587207|7686651|FG000|NOT COMPLETED|Overall Study||0
6759719|NCT03587207|7686652|FG001|NOT COMPLETED|Overall Study||0
6759720|NCT03587207|7686653|FG002|NOT COMPLETED|Overall Study||0
6759721|NCT03587207|7686654|FG003|NOT COMPLETED|Overall Study||0
6759722|NCT03587207|7686655|FG004|NOT COMPLETED|Overall Study||0
6759723|NCT03587428|7686667|FG000|STARTED|Period 1||3
6759724|NCT03587428|7686668|FG001|STARTED|Period 1||2
6759725|NCT03587428|7686669|FG002|STARTED|Period 1||3
6759726|NCT03587428|7686670|FG003|STARTED|Period 1||3
6759727|NCT03587428|7686671|FG004|STARTED|Period 1||2
6759728|NCT03587428|7686672|FG005|STARTED|Period 1||2
6759729|NCT03587428|7686667|FG000|COMPLETED|Period 1||3
6759730|NCT03587428|7686668|FG001|COMPLETED|Period 1||2
6759731|NCT03587428|7686669|FG002|COMPLETED|Period 1||3
6759732|NCT03587428|7686670|FG003|COMPLETED|Period 1||3
6759733|NCT03587428|7686671|FG004|COMPLETED|Period 1||2
6759734|NCT03587428|7686672|FG005|COMPLETED|Period 1||2
6759735|NCT03587428|7686667|FG000|NOT COMPLETED|Period 1||0
6759736|NCT03587428|7686668|FG001|NOT COMPLETED|Period 1||0
6759737|NCT03587428|7686669|FG002|NOT COMPLETED|Period 1||0
6759738|NCT03587428|7686670|FG003|NOT COMPLETED|Period 1||0
6759739|NCT03587428|7686671|FG004|NOT COMPLETED|Period 1||0
6759740|NCT03587428|7686672|FG005|NOT COMPLETED|Period 1||0
6759741|NCT03587428|7686667|FG000|STARTED|Period 2||3
6759742|NCT03587428|7686668|FG001|STARTED|Period 2||2
6759743|NCT03587428|7686669|FG002|STARTED|Period 2||3
6759744|NCT03587428|7686670|FG003|STARTED|Period 2||3
6759745|NCT03587428|7686671|FG004|STARTED|Period 2||2
6759746|NCT03587428|7686672|FG005|STARTED|Period 2||2
6759747|NCT03587428|7686667|FG000|COMPLETED|Period 2||3
6759748|NCT03587428|7686668|FG001|COMPLETED|Period 2||2
6759749|NCT03587428|7686669|FG002|COMPLETED|Period 2||3
6759750|NCT03587428|7686670|FG003|COMPLETED|Period 2||3
6759751|NCT03587428|7686671|FG004|COMPLETED|Period 2||2
6759752|NCT03587428|7686672|FG005|COMPLETED|Period 2||2
6759753|NCT03587428|7686667|FG000|NOT COMPLETED|Period 2||0
6759754|NCT03587428|7686668|FG001|NOT COMPLETED|Period 2||0
6759755|NCT03587428|7686669|FG002|NOT COMPLETED|Period 2||0
6759756|NCT03587428|7686670|FG003|NOT COMPLETED|Period 2||0
6759757|NCT03587428|7686671|FG004|NOT COMPLETED|Period 2||0
6759758|NCT03587428|7686672|FG005|NOT COMPLETED|Period 2||0
6759759|NCT03587428|7686667|FG000|STARTED|Period 3||3
6759760|NCT03587428|7686668|FG001|STARTED|Period 3||2
6759761|NCT03587428|7686669|FG002|STARTED|Period 3||3
6759762|NCT03587428|7686670|FG003|STARTED|Period 3||3
6759763|NCT03587428|7686671|FG004|STARTED|Period 3||2
6759764|NCT03587428|7686672|FG005|STARTED|Period 3||2
6759765|NCT03587428|7686667|FG000|COMPLETED|Period 3||3
6759766|NCT03587428|7686668|FG001|COMPLETED|Period 3||2
6759767|NCT03587428|7686669|FG002|COMPLETED|Period 3||3
6759768|NCT03587428|7686670|FG003|COMPLETED|Period 3||3
6759769|NCT03587428|7686671|FG004|COMPLETED|Period 3||2
6759770|NCT03587428|7686672|FG005|COMPLETED|Period 3||2
6759771|NCT03587428|7686667|FG000|NOT COMPLETED|Period 3||0
6759772|NCT03587428|7686668|FG001|NOT COMPLETED|Period 3||0
6759773|NCT03587428|7686669|FG002|NOT COMPLETED|Period 3||0
6759774|NCT03587428|7686670|FG003|NOT COMPLETED|Period 3||0
6759775|NCT03587428|7686671|FG004|NOT COMPLETED|Period 3||0
6759776|NCT03587428|7686672|FG005|NOT COMPLETED|Period 3||0
6759777|NCT03587974|7686682|FG000|STARTED|Overall Study||30
6759778|NCT03587974|7686683|FG001|STARTED|Overall Study||30
6759779|NCT03587974|7686682|FG000|COMPLETED|Overall Study||25
6759780|NCT03587974|7686683|FG001|COMPLETED|Overall Study||26
6759781|NCT03587974|7686682|FG000|NOT COMPLETED|Overall Study||5
6759782|NCT03587974|7686683|FG001|NOT COMPLETED|Overall Study||4
6759783|NCT03588572|7686691|FG000|STARTED|Visitation 1||22
6759784|NCT03588572|7686692|FG001|STARTED|Visitation 1||21
6759785|NCT03588572|7686691|FG000|COMPLETED|Visitation 1||21
6759786|NCT03588572|7686692|FG001|COMPLETED|Visitation 1||20
6759787|NCT03588572|7686691|FG000|NOT COMPLETED|Visitation 1||1
6759788|NCT03588572|7686692|FG001|NOT COMPLETED|Visitation 1||1
6759789|NCT03588572|7686691|FG000|STARTED|Visitation 2||21
6759790|NCT03588572|7686692|FG001|STARTED|Visitation 2||20
6759791|NCT03588572|7686691|FG000|COMPLETED|Visitation 2||19
6759792|NCT03588572|7686692|FG001|COMPLETED|Visitation 2||18
6759793|NCT03588572|7686691|FG000|NOT COMPLETED|Visitation 2||2
6759794|NCT03588572|7686692|FG001|NOT COMPLETED|Visitation 2||2
6759795|NCT03588572|7686691|FG000|STARTED|Visitation 3||19
6759796|NCT03588572|7686692|FG001|STARTED|Visitation 3||18
6759797|NCT03588572|7686691|FG000|COMPLETED|Visitation 3||16
6759798|NCT03588572|7686692|FG001|COMPLETED|Visitation 3||16
6759799|NCT03588572|7686691|FG000|NOT COMPLETED|Visitation 3||3
6759800|NCT03588572|7686692|FG001|NOT COMPLETED|Visitation 3||2
6759801|NCT03588741|7686698|FG000|STARTED|Overall Study||1
6759802|NCT03588741|7686698|FG000|COMPLETED|Overall Study||0
6759803|NCT03588741|7686698|FG000|NOT COMPLETED|Overall Study||1
6759804|NCT03588806|7686702|FG000|STARTED|Overall Study||11
6759805|NCT03588806|7686702|FG000|COMPLETED|Overall Study||11
6759806|NCT03588806|7686702|FG000|NOT COMPLETED|Overall Study||0
6759807|NCT03588910|7686708|FG000|STARTED|Overall Study||60
6759808|NCT03588910|7686709|FG001|STARTED|Overall Study||60
6759809|NCT03588910|7686708|FG000|Post Op Day 1 Survey|Overall Study||52
6759810|NCT03588910|7686709|FG001|Post Op Day 1 Survey|Overall Study||47
6759811|NCT03588910|7686708|FG000|COMPLETED|Overall Study||47
6759812|NCT03588910|7686709|FG001|COMPLETED|Overall Study||45
6759813|NCT03588910|7686708|FG000|NOT COMPLETED|Overall Study||13
6759814|NCT03588910|7686709|FG001|NOT COMPLETED|Overall Study||15
6759815|NCT03589469|7686715|FG000|STARTED|Overall Study||145
6759816|NCT03589469|7686715|FG000|Received Treatment|Overall Study||145
6759817|NCT03589469|7686715|FG000|COMPLETED|Overall Study||0
6759818|NCT03589469|7686715|FG000|NOT COMPLETED|Overall Study||145
6759819|NCT03589807|7686725|FG000|STARTED|Overall Study||27
6759820|NCT03589807|7686726|FG001|STARTED|Overall Study||30
6759821|NCT03589807|7686727|FG002|STARTED|Overall Study||33
6759822|NCT03589807|7686728|FG003|STARTED|Overall Study||32
6759823|NCT03589807|7686729|FG004|STARTED|Overall Study||28
6759824|NCT03589807|7686730|FG005|STARTED|Overall Study||30
6759825|NCT03589807|7686725|FG000|COMPLETED|Overall Study||27
6759826|NCT03589807|7686726|FG001|COMPLETED|Overall Study||23
6759827|NCT03589807|7686727|FG002|COMPLETED|Overall Study||31
6759828|NCT03589807|7686728|FG003|COMPLETED|Overall Study||28
6759829|NCT03589807|7686729|FG004|COMPLETED|Overall Study||26
6759830|NCT03589807|7686730|FG005|COMPLETED|Overall Study||29
6759831|NCT03589807|7686725|FG000|NOT COMPLETED|Overall Study||0
6759832|NCT03589807|7686726|FG001|NOT COMPLETED|Overall Study||7
6759833|NCT03589807|7686727|FG002|NOT COMPLETED|Overall Study||2
6759834|NCT03589807|7686728|FG003|NOT COMPLETED|Overall Study||4
6759835|NCT03589807|7686729|FG004|NOT COMPLETED|Overall Study||2
6759836|NCT03589807|7686730|FG005|NOT COMPLETED|Overall Study||1
6759837|NCT03589885|7686750|FG000|STARTED|Treatment Period 1-Randomized Set||41
6759838|NCT03589885|7686751|FG001|STARTED|Treatment Period 1-Randomized Set||41
6759839|NCT03589885|7686752|FG002|STARTED|Treatment Period 1-Randomized Set||40
6759840|NCT03589885|7686753|FG003|STARTED|Treatment Period 1-Randomized Set||0
6759841|NCT03589885|7686754|FG004|STARTED|Treatment Period 1-Randomized Set||0
6759842|NCT03589885|7686750|FG000|COMPLETED|Treatment Period 1-Randomized Set||41
6759843|NCT03589885|7686751|FG001|COMPLETED|Treatment Period 1-Randomized Set||39
6759844|NCT03589885|7686752|FG002|COMPLETED|Treatment Period 1-Randomized Set||37
6759845|NCT03589885|7686753|FG003|COMPLETED|Treatment Period 1-Randomized Set||0
6759846|NCT03589885|7686754|FG004|COMPLETED|Treatment Period 1-Randomized Set||0
6759847|NCT03589885|7686750|FG000|NOT COMPLETED|Treatment Period 1-Randomized Set||0
6759848|NCT03589885|7686751|FG001|NOT COMPLETED|Treatment Period 1-Randomized Set||2
6759849|NCT03589885|7686752|FG002|NOT COMPLETED|Treatment Period 1-Randomized Set||3
6759850|NCT03589885|7686753|FG003|NOT COMPLETED|Treatment Period 1-Randomized Set||0
6759851|NCT03589885|7686754|FG004|NOT COMPLETED|Treatment Period 1-Randomized Set||0
6759852|NCT03589885|7686750|FG000|STARTED|Treatment Period 2-Randomized Set||41
6759853|NCT03589885|7686751|FG001|STARTED|Treatment Period 2-Randomized Set||39
6759854|NCT03589885|7686752|FG002|STARTED|Treatment Period 2-Randomized Set||4
6759855|NCT03589885|7686753|FG003|STARTED|Treatment Period 2-Randomized Set||16
6759856|NCT03589885|7686754|FG004|STARTED|Treatment Period 2-Randomized Set||17
6759857|NCT03589885|7686750|FG000|COMPLETED|Treatment Period 2-Randomized Set||40
6759858|NCT03589885|7686751|FG001|COMPLETED|Treatment Period 2-Randomized Set||34
6759859|NCT03589885|7686752|FG002|COMPLETED|Treatment Period 2-Randomized Set||3
6759860|NCT03589885|7686753|FG003|COMPLETED|Treatment Period 2-Randomized Set||16
6759861|NCT03589885|7686754|FG004|COMPLETED|Treatment Period 2-Randomized Set||16
6759862|NCT03589885|7686750|FG000|NOT COMPLETED|Treatment Period 2-Randomized Set||1
6759863|NCT03589885|7686751|FG001|NOT COMPLETED|Treatment Period 2-Randomized Set||5
6759864|NCT03589885|7686752|FG002|NOT COMPLETED|Treatment Period 2-Randomized Set||1
6759865|NCT03589885|7686753|FG003|NOT COMPLETED|Treatment Period 2-Randomized Set||0
6759866|NCT03589885|7686754|FG004|NOT COMPLETED|Treatment Period 2-Randomized Set||1
6759867|NCT03590613|7686772|FG000|STARTED|Period 1, 4 Days||3
6759868|NCT03590613|7686773|FG001|STARTED|Period 1, 4 Days||3
6759869|NCT03590613|7686774|FG002|STARTED|Period 1, 4 Days||3
6759870|NCT03590613|7686775|FG003|STARTED|Period 1, 4 Days||3
6759871|NCT03590613|7686772|FG000|COMPLETED|Period 1, 4 Days||3
6759872|NCT03590613|7686773|FG001|COMPLETED|Period 1, 4 Days||3
6759873|NCT03590613|7686774|FG002|COMPLETED|Period 1, 4 Days||3
6759874|NCT03590613|7686775|FG003|COMPLETED|Period 1, 4 Days||3
6759875|NCT03590613|7686772|FG000|NOT COMPLETED|Period 1, 4 Days||0
6759876|NCT03590613|7686773|FG001|NOT COMPLETED|Period 1, 4 Days||0
6759877|NCT03590613|7686774|FG002|NOT COMPLETED|Period 1, 4 Days||0
6759878|NCT03590613|7686775|FG003|NOT COMPLETED|Period 1, 4 Days||0
6759879|NCT03590613|7686772|FG000|STARTED|Period 1, Wash-out, at Least 3 Days||3
6759880|NCT03590613|7686773|FG001|STARTED|Period 1, Wash-out, at Least 3 Days||3
6759881|NCT03590613|7686774|FG002|STARTED|Period 1, Wash-out, at Least 3 Days||3
6759882|NCT03590613|7686775|FG003|STARTED|Period 1, Wash-out, at Least 3 Days||3
6759883|NCT03590613|7686772|FG000|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
6759884|NCT03590613|7686773|FG001|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
6759885|NCT03590613|7686774|FG002|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
6759886|NCT03590613|7686775|FG003|COMPLETED|Period 1, Wash-out, at Least 3 Days||3
6759887|NCT03590613|7686772|FG000|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
6759888|NCT03590613|7686773|FG001|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
6759889|NCT03590613|7686774|FG002|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
6759890|NCT03590613|7686775|FG003|NOT COMPLETED|Period 1, Wash-out, at Least 3 Days||0
6759891|NCT03590613|7686772|FG000|STARTED|Period 2, 4 Days||3
6759892|NCT03590613|7686773|FG001|STARTED|Period 2, 4 Days||3
6759893|NCT03590613|7686774|FG002|STARTED|Period 2, 4 Days||3
6759894|NCT03590613|7686775|FG003|STARTED|Period 2, 4 Days|One additional participant was enrolled in Period 2.|4
6759895|NCT03590613|7686772|FG000|COMPLETED|Period 2, 4 Days||3
6759896|NCT03590613|7686773|FG001|COMPLETED|Period 2, 4 Days||3
6759897|NCT03590613|7686774|FG002|COMPLETED|Period 2, 4 Days||3
6759898|NCT03590613|7686775|FG003|COMPLETED|Period 2, 4 Days||3
6759899|NCT03590613|7686772|FG000|NOT COMPLETED|Period 2, 4 Days||0
6759900|NCT03590613|7686773|FG001|NOT COMPLETED|Period 2, 4 Days||0
6759901|NCT03590613|7686774|FG002|NOT COMPLETED|Period 2, 4 Days||0
6759902|NCT03590613|7686775|FG003|NOT COMPLETED|Period 2, 4 Days||1
6759903|NCT03590613|7686772|FG000|STARTED|Period 2, Wash-out, at Least 3 Days||3
6759904|NCT03590613|7686773|FG001|STARTED|Period 2, Wash-out, at Least 3 Days||3
6759905|NCT03590613|7686774|FG002|STARTED|Period 2, Wash-out, at Least 3 Days||3
6759906|NCT03590613|7686775|FG003|STARTED|Period 2, Wash-out, at Least 3 Days||3
6759907|NCT03590613|7686772|FG000|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
6759908|NCT03590613|7686773|FG001|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
6759909|NCT03590613|7686774|FG002|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
6759910|NCT03590613|7686775|FG003|COMPLETED|Period 2, Wash-out, at Least 3 Days||3
6759911|NCT03590613|7686772|FG000|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
6759912|NCT03590613|7686773|FG001|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
6759913|NCT03590613|7686774|FG002|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
6759914|NCT03590613|7686775|FG003|NOT COMPLETED|Period 2, Wash-out, at Least 3 Days||0
6759915|NCT03590613|7686772|FG000|STARTED|Period 3, 4 Days||3
6759916|NCT03590613|7686773|FG001|STARTED|Period 3, 4 Days||3
6759917|NCT03590613|7686774|FG002|STARTED|Period 3, 4 Days||3
6759918|NCT03590613|7686775|FG003|STARTED|Period 3, 4 Days||3
6759919|NCT03590613|7686772|FG000|COMPLETED|Period 3, 4 Days||3
6759920|NCT03590613|7686773|FG001|COMPLETED|Period 3, 4 Days||3
6759921|NCT03590613|7686774|FG002|COMPLETED|Period 3, 4 Days||3
6759922|NCT03590613|7686775|FG003|COMPLETED|Period 3, 4 Days||3
6759923|NCT03590613|7686772|FG000|NOT COMPLETED|Period 3, 4 Days||0
6759924|NCT03590613|7686773|FG001|NOT COMPLETED|Period 3, 4 Days||0
6759925|NCT03590613|7686774|FG002|NOT COMPLETED|Period 3, 4 Days||0
6759926|NCT03590613|7686775|FG003|NOT COMPLETED|Period 3, 4 Days||0
6759927|NCT03590613|7686772|FG000|STARTED|Period 3,Wash-out, at Least 3 Days||3
6759928|NCT03590613|7686773|FG001|STARTED|Period 3,Wash-out, at Least 3 Days||3
6759929|NCT03590613|7686774|FG002|STARTED|Period 3,Wash-out, at Least 3 Days||3
6759930|NCT03590613|7686775|FG003|STARTED|Period 3,Wash-out, at Least 3 Days||3
6759931|NCT03590613|7686772|FG000|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
6759932|NCT03590613|7686773|FG001|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
6759933|NCT03590613|7686774|FG002|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
6759934|NCT03590613|7686775|FG003|COMPLETED|Period 3,Wash-out, at Least 3 Days||3
6759935|NCT03590613|7686772|FG000|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
6759936|NCT03590613|7686773|FG001|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
6759937|NCT03590613|7686774|FG002|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
6759938|NCT03590613|7686775|FG003|NOT COMPLETED|Period 3,Wash-out, at Least 3 Days||0
6759939|NCT03590613|7686772|FG000|STARTED|Period 4, 4 Days||3
6759940|NCT03590613|7686773|FG001|STARTED|Period 4, 4 Days||3
6759941|NCT03590613|7686774|FG002|STARTED|Period 4, 4 Days||3
6759942|NCT03590613|7686775|FG003|STARTED|Period 4, 4 Days||3
6759943|NCT03590613|7686772|FG000|COMPLETED|Period 4, 4 Days||3
6759944|NCT03590613|7686773|FG001|COMPLETED|Period 4, 4 Days||3
6759945|NCT03590613|7686774|FG002|COMPLETED|Period 4, 4 Days||3
6759946|NCT03590613|7686775|FG003|COMPLETED|Period 4, 4 Days||3
6759947|NCT03590613|7686772|FG000|NOT COMPLETED|Period 4, 4 Days||0
6759948|NCT03590613|7686773|FG001|NOT COMPLETED|Period 4, 4 Days||0
6759949|NCT03590613|7686774|FG002|NOT COMPLETED|Period 4, 4 Days||0
6759950|NCT03590613|7686775|FG003|NOT COMPLETED|Period 4, 4 Days||0
6759951|NCT03591068|7686788|FG000|STARTED|Overall Study||11
6759952|NCT03591068|7686788|FG000|COMPLETED|Overall Study||9
6759953|NCT03591068|7686788|FG000|NOT COMPLETED|Overall Study||2
6759954|NCT03591146|7686799|FG000|STARTED|TLC590 190mg and Naropin 150mg||12
6759955|NCT03591146|7686800|FG001|STARTED|TLC590 190mg and Naropin 150mg||0
6759956|NCT03591146|7686801|FG002|STARTED|TLC590 190mg and Naropin 150mg||0
6759957|NCT03591146|7686802|FG003|STARTED|TLC590 190mg and Naropin 150mg||0
6759958|NCT03591146|7686803|FG004|STARTED|TLC590 190mg and Naropin 150mg||4
6759959|NCT03591146|7686799|FG000|COMPLETED|TLC590 190mg and Naropin 150mg||12
6759960|NCT03591146|7686800|FG001|COMPLETED|TLC590 190mg and Naropin 150mg||0
6759961|NCT03591146|7686801|FG002|COMPLETED|TLC590 190mg and Naropin 150mg||0
6759962|NCT03591146|7686802|FG003|COMPLETED|TLC590 190mg and Naropin 150mg||0
6759963|NCT03591146|7686803|FG004|COMPLETED|TLC590 190mg and Naropin 150mg||3
6759964|NCT03591146|7686799|FG000|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
6759965|NCT03591146|7686800|FG001|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
6759966|NCT03591146|7686801|FG002|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
6759967|NCT03591146|7686802|FG003|NOT COMPLETED|TLC590 190mg and Naropin 150mg||0
6759968|NCT03591146|7686803|FG004|NOT COMPLETED|TLC590 190mg and Naropin 150mg||1
6759969|NCT03591146|7686799|FG000|STARTED|TLC590 380mg and Naropin 150mg||0
6759970|NCT03591146|7686800|FG001|STARTED|TLC590 380mg and Naropin 150mg||12
6759971|NCT03591146|7686801|FG002|STARTED|TLC590 380mg and Naropin 150mg||0
6759972|NCT03591146|7686802|FG003|STARTED|TLC590 380mg and Naropin 150mg||0
6759973|NCT03591146|7686803|FG004|STARTED|TLC590 380mg and Naropin 150mg||5
6759974|NCT03591146|7686799|FG000|COMPLETED|TLC590 380mg and Naropin 150mg||0
6759975|NCT03591146|7686800|FG001|COMPLETED|TLC590 380mg and Naropin 150mg||11
6759976|NCT03591146|7686801|FG002|COMPLETED|TLC590 380mg and Naropin 150mg||0
6759977|NCT03591146|7686802|FG003|COMPLETED|TLC590 380mg and Naropin 150mg||0
6759978|NCT03591146|7686803|FG004|COMPLETED|TLC590 380mg and Naropin 150mg||4
6759979|NCT03591146|7686799|FG000|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
6759980|NCT03591146|7686800|FG001|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
6759981|NCT03591146|7686801|FG002|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
6759982|NCT03591146|7686802|FG003|NOT COMPLETED|TLC590 380mg and Naropin 150mg||0
6759983|NCT03591146|7686803|FG004|NOT COMPLETED|TLC590 380mg and Naropin 150mg||1
6759984|NCT03591146|7686799|FG000|STARTED|TLC590 570mg and Naropin 150mg||0
6759985|NCT03591146|7686800|FG001|STARTED|TLC590 570mg and Naropin 150mg||0
6759986|NCT03591146|7686801|FG002|STARTED|TLC590 570mg and Naropin 150mg||12
6759987|NCT03591146|7686802|FG003|STARTED|TLC590 570mg and Naropin 150mg||0
6759988|NCT03591146|7686803|FG004|STARTED|TLC590 570mg and Naropin 150mg||4
6759989|NCT03591146|7686799|FG000|COMPLETED|TLC590 570mg and Naropin 150mg||0
6759990|NCT03591146|7686800|FG001|COMPLETED|TLC590 570mg and Naropin 150mg||0
6759991|NCT03591146|7686801|FG002|COMPLETED|TLC590 570mg and Naropin 150mg||11
6759992|NCT03591146|7686802|FG003|COMPLETED|TLC590 570mg and Naropin 150mg||0
6759993|NCT03591146|7686803|FG004|COMPLETED|TLC590 570mg and Naropin 150mg||3
6759994|NCT03591146|7686799|FG000|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
6759995|NCT03591146|7686800|FG001|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
6759996|NCT03591146|7686801|FG002|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
6759997|NCT03591146|7686802|FG003|NOT COMPLETED|TLC590 570mg and Naropin 150mg||0
6759998|NCT03591146|7686803|FG004|NOT COMPLETED|TLC590 570mg and Naropin 150mg||1
6759999|NCT03591146|7686799|FG000|STARTED|TLC590 475mg and Naropin 150mg||0
6760000|NCT03591146|7686800|FG001|STARTED|TLC590 475mg and Naropin 150mg||0
6760001|NCT03591146|7686801|FG002|STARTED|TLC590 475mg and Naropin 150mg||0
6760002|NCT03591146|7686802|FG003|STARTED|TLC590 475mg and Naropin 150mg||12
6760003|NCT03591146|7686803|FG004|STARTED|TLC590 475mg and Naropin 150mg||4
6760004|NCT03591146|7686799|FG000|COMPLETED|TLC590 475mg and Naropin 150mg||0
6760005|NCT03591146|7686800|FG001|COMPLETED|TLC590 475mg and Naropin 150mg||0
6760006|NCT03591146|7686801|FG002|COMPLETED|TLC590 475mg and Naropin 150mg||0
6760007|NCT03591146|7686802|FG003|COMPLETED|TLC590 475mg and Naropin 150mg||12
6760008|NCT03591146|7686803|FG004|COMPLETED|TLC590 475mg and Naropin 150mg||4
6760009|NCT03591146|7686799|FG000|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
6760010|NCT03591146|7686800|FG001|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
6760011|NCT03591146|7686801|FG002|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
6760012|NCT03591146|7686802|FG003|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
6760013|NCT03591146|7686803|FG004|NOT COMPLETED|TLC590 475mg and Naropin 150mg||0
6760014|NCT03591406|7686817|FG000|STARTED|Overall Study||188
6760015|NCT03591406|7686818|FG001|STARTED|Overall Study||183
6760016|NCT03591406|7686817|FG000|COMPLETED|Overall Study||181
6760017|NCT03591406|7686818|FG001|COMPLETED|Overall Study||174
6760018|NCT03591406|7686817|FG000|NOT COMPLETED|Overall Study||7
6760019|NCT03591406|7686818|FG001|NOT COMPLETED|Overall Study||9
6760020|NCT03592121|7686826|FG000|STARTED|Overall Study||3
6760021|NCT03592121|7686827|FG001|STARTED|Overall Study||0
6760022|NCT03592121|7686826|FG000|COMPLETED|Overall Study||3
6760023|NCT03592121|7686827|FG001|COMPLETED|Overall Study||0
6760024|NCT03592121|7686826|FG000|NOT COMPLETED|Overall Study||0
6760025|NCT03592121|7686827|FG001|NOT COMPLETED|Overall Study||0
6760026|NCT03592745|7686835|FG000|STARTED|Overall Study||18
6760027|NCT03592745|7686836|FG001|STARTED|Overall Study||18
6760028|NCT03592745|7686835|FG000|COMPLETED|Overall Study||15
6760029|NCT03592745|7686836|FG001|COMPLETED|Overall Study||15
6760030|NCT03592745|7686835|FG000|NOT COMPLETED|Overall Study||3
6760031|NCT03592745|7686836|FG001|NOT COMPLETED|Overall Study||3
6760032|NCT03593200|7686842|FG000|STARTED|Overall Study||4
6760033|NCT03593200|7686842|FG000|COMPLETED|Overall Study||4
6760034|NCT03593200|7686842|FG000|NOT COMPLETED|Overall Study||0
6760035|NCT03593538|7686849|FG000|STARTED|Overall Study||26
6760036|NCT03593538|7686850|FG001|STARTED|Overall Study||21
6760037|NCT03593538|7686851|FG002|STARTED|Overall Study||22
6760038|NCT03593538|7686849|FG000|COMPLETED|Overall Study||15
6760039|NCT03593538|7686850|FG001|COMPLETED|Overall Study||15
6760040|NCT03593538|7686851|FG002|COMPLETED|Overall Study||11
6760041|NCT03593538|7686849|FG000|NOT COMPLETED|Overall Study||11
6760042|NCT03593538|7686850|FG001|NOT COMPLETED|Overall Study||6
6760043|NCT03593538|7686851|FG002|NOT COMPLETED|Overall Study||11
6760044|NCT03593681|7686859|FG000|STARTED|Overall Study||150
6760045|NCT03593681|7686859|FG000|COMPLETED|Overall Study||115
6760046|NCT03593681|7686859|FG000|NOT COMPLETED|Overall Study||35
6760047|NCT03593876|7686880|FG000|STARTED|Overall Study||16
6760048|NCT03593876|7686880|FG000|COMPLETED|Overall Study||13
6760049|NCT03593876|7686880|FG000|NOT COMPLETED|Overall Study||3
6760050|NCT03593902|7686884|FG000|STARTED|Overall Study||9
6760051|NCT03593902|7686884|FG000|COMPLETED|Overall Study||9
6760052|NCT03593902|7686884|FG000|NOT COMPLETED|Overall Study||0
6760053|NCT03594045|7686890|FG000|STARTED|Overall Study||0
6760054|NCT03594045|7686891|FG001|STARTED|Overall Study||5
6760055|NCT03594045|7686890|FG000|COMPLETED|Overall Study||0
6760056|NCT03594045|7686891|FG001|COMPLETED|Overall Study||5
6760057|NCT03594045|7686890|FG000|NOT COMPLETED|Overall Study||0
6760058|NCT03594045|7686891|FG001|NOT COMPLETED|Overall Study||0
6760059|NCT03594071|7686897|FG000|STARTED|Overall Study||294
6760060|NCT03594071|7686897|FG000|COMPLETED|Overall Study||289
6760061|NCT03594071|7686897|FG000|NOT COMPLETED|Overall Study||5
6760062|NCT03594227|7686905|FG000|STARTED|Overall Study||23
6760063|NCT03594227|7686906|FG001|STARTED|Overall Study||23
6760064|NCT03594227|7686907|FG002|STARTED|Overall Study||22
6760065|NCT03594227|7686908|FG003|STARTED|Overall Study||19
6760066|NCT03594227|7686905|FG000|COMPLETED|Overall Study||18
6760067|NCT03594227|7686906|FG001|COMPLETED|Overall Study||19
6760068|NCT03594227|7686907|FG002|COMPLETED|Overall Study||19
6760069|NCT03594227|7686908|FG003|COMPLETED|Overall Study||14
6760070|NCT03594227|7686905|FG000|NOT COMPLETED|Overall Study||5
6760071|NCT03594227|7686906|FG001|NOT COMPLETED|Overall Study||4
6760072|NCT03594227|7686907|FG002|NOT COMPLETED|Overall Study||3
6760073|NCT03594227|7686908|FG003|NOT COMPLETED|Overall Study||5
6760074|NCT03594500|7686931|FG000|STARTED|Overall Study||66
6760075|NCT03594500|7686932|FG001|STARTED|Overall Study||67
6760076|NCT03594500|7686931|FG000|COMPLETED|Overall Study||60
6760077|NCT03594500|7686932|FG001|COMPLETED|Overall Study||63
6760078|NCT03594500|7686931|FG000|NOT COMPLETED|Overall Study||6
6760079|NCT03594500|7686932|FG001|NOT COMPLETED|Overall Study||4
6760080|NCT03595176|7686943|FG000|STARTED|Overall Study||47
6760081|NCT03595176|7686944|FG001|STARTED|Overall Study||384
6760082|NCT03595176|7686943|FG000|COMPLETED|Overall Study||47
6760083|NCT03595176|7686944|FG001|COMPLETED|Overall Study||381
6760084|NCT03595176|7686943|FG000|NOT COMPLETED|Overall Study||0
6760085|NCT03595176|7686944|FG001|NOT COMPLETED|Overall Study||3
6760086|NCT03595215|7686949|FG000|STARTED|Overall Study||18
6760087|NCT03595215|7686949|FG000|COMPLETED|Overall Study||10
6760088|NCT03595215|7686949|FG000|NOT COMPLETED|Overall Study||8
6760089|NCT03595280|7686956|FG000|STARTED|Overall Study||119
6760090|NCT03595280|7686957|FG001|STARTED|Overall Study||117
6760091|NCT03595280|7686958|FG002|STARTED|Overall Study||113
6760092|NCT03595280|7686956|FG000|COMPLETED|Overall Study||113
6760093|NCT03595280|7686957|FG001|COMPLETED|Overall Study||108
6760094|NCT03595280|7686958|FG002|COMPLETED|Overall Study||98
6760095|NCT03595280|7686956|FG000|NOT COMPLETED|Overall Study||6
6760096|NCT03595280|7686957|FG001|NOT COMPLETED|Overall Study||9
6760097|NCT03595280|7686958|FG002|NOT COMPLETED|Overall Study||15
6760098|NCT03595449|7686968|FG000|STARTED|Overall Study||118
6760099|NCT03595449|7686969|FG001|STARTED|Overall Study||115
6760100|NCT03595449|7686968|FG000|COMPLETED|Overall Study||118
6760101|NCT03595449|7686969|FG001|COMPLETED|Overall Study||115
6760102|NCT03595449|7686968|FG000|NOT COMPLETED|Overall Study||0
6760103|NCT03595449|7686969|FG001|NOT COMPLETED|Overall Study||0
6760104|NCT03595579|7686977|FG000|STARTED|Overall Study||48
6760105|NCT03595579|7686978|FG001|STARTED|Overall Study||49
6760106|NCT03595579|7686977|FG000|mITT Population|Overall Study||43
6760107|NCT03595579|7686978|FG001|mITT Population|Overall Study||37
6760108|NCT03595579|7686977|FG000|Safety Population|Overall Study||48
6760109|NCT03595579|7686978|FG001|Safety Population|Overall Study||48
6760110|NCT03595579|7686977|FG000|COMPLETED|Overall Study||38
6760111|NCT03595579|7686978|FG001|COMPLETED|Overall Study||35
6760112|NCT03595579|7686977|FG000|NOT COMPLETED|Overall Study||10
6760113|NCT03595579|7686978|FG001|NOT COMPLETED|Overall Study||14
6760114|NCT03595618|7686988|FG000|STARTED|Overall Study||234
6760115|NCT03595618|7686989|FG001|STARTED|Overall Study||231
6760116|NCT03595618|7686990|FG002|STARTED|Overall Study||233
6760117|NCT03595618|7686991|FG003|STARTED|Overall Study||234
6760118|NCT03595618|7686988|FG000|Treated|Overall Study||234
6760119|NCT03595618|7686989|FG001|Treated|Overall Study||231
6760120|NCT03595618|7686990|FG002|Treated|Overall Study||232
6760121|NCT03595618|7686991|FG003|Treated|Overall Study||234
6760122|NCT03595618|7686988|FG000|COMPLETED|Overall Study||191
6760123|NCT03595618|7686989|FG001|COMPLETED|Overall Study||191
6760124|NCT03595618|7686990|FG002|COMPLETED|Overall Study||177
6760125|NCT03595618|7686991|FG003|COMPLETED|Overall Study||200
6760126|NCT03595618|7686988|FG000|NOT COMPLETED|Overall Study||43
6760127|NCT03595618|7686989|FG001|NOT COMPLETED|Overall Study||40
6760128|NCT03595618|7686990|FG002|NOT COMPLETED|Overall Study||56
6760129|NCT03595618|7686991|FG003|NOT COMPLETED|Overall Study||34
6760130|NCT03595904|7687003|FG000|STARTED|Overall Study||39
6760131|NCT03595904|7687004|FG001|STARTED|Overall Study||39
6760132|NCT03595904|7687003|FG000|COMPLETED|Overall Study||29
6760133|NCT03595904|7687004|FG001|COMPLETED|Overall Study||34
6760134|NCT03595904|7687003|FG000|NOT COMPLETED|Overall Study||10
6760135|NCT03595904|7687004|FG001|NOT COMPLETED|Overall Study||5
6760136|NCT03596151|7687010|FG000|STARTED|Overall Study||295
6760137|NCT03596151|7687010|FG000|COMPLETED|Overall Study||294
6760138|NCT03596151|7687010|FG000|NOT COMPLETED|Overall Study||1
6760139|NCT03596177|7687016|FG000|STARTED|Single Blind Period||9
6760140|NCT03596177|7687017|FG001|STARTED|Single Blind Period||19
6760141|NCT03596177|7687016|FG000|COMPLETED|Single Blind Period||7
6760142|NCT03596177|7687017|FG001|COMPLETED|Single Blind Period||18
6760143|NCT03596177|7687016|FG000|NOT COMPLETED|Single Blind Period||2
6760144|NCT03596177|7687017|FG001|NOT COMPLETED|Single Blind Period||1
6760145|NCT03596177|7687016|FG000|STARTED|Double Blind Period||7
6760146|NCT03596177|7687017|FG001|STARTED|Double Blind Period||18
6760147|NCT03596177|7687016|FG000|COMPLETED|Double Blind Period||7
6760148|NCT03596177|7687017|FG001|COMPLETED|Double Blind Period||12
6760149|NCT03596177|7687016|FG000|NOT COMPLETED|Double Blind Period||0
6760150|NCT03596177|7687017|FG001|NOT COMPLETED|Double Blind Period||6
6760151|NCT03596723|7687025|FG000|STARTED|Overall Study||1
6760152|NCT03596723|7687026|FG001|STARTED|Overall Study||1
6760153|NCT03596723|7687025|FG000|COMPLETED|Overall Study||1
6760154|NCT03596723|7687026|FG001|COMPLETED|Overall Study||1
6760155|NCT03596723|7687025|FG000|NOT COMPLETED|Overall Study||0
6760156|NCT03596723|7687026|FG001|NOT COMPLETED|Overall Study||0
6760157|NCT03597009|7687032|FG000|STARTED|Overall Study||1
6760158|NCT03597009|7687032|FG000|COMPLETED|Overall Study||1
6760159|NCT03597009|7687032|FG000|NOT COMPLETED|Overall Study||0
6760160|NCT03597022|7687039|FG000|STARTED|Overall Study||8
6760161|NCT03597022|7687040|FG001|STARTED|Overall Study||8
6760162|NCT03597022|7687041|FG002|STARTED|Overall Study||8
6760163|NCT03597022|7687039|FG000|COMPLETED|Overall Study||0
6760164|NCT03597022|7687040|FG001|COMPLETED|Overall Study||0
6760165|NCT03597022|7687041|FG002|COMPLETED|Overall Study||0
6760166|NCT03597022|7687039|FG000|NOT COMPLETED|Overall Study||8
6760167|NCT03597022|7687040|FG001|NOT COMPLETED|Overall Study||8
6760168|NCT03597022|7687041|FG002|NOT COMPLETED|Overall Study||8
6760169|NCT03597061|7687051|FG000|STARTED|Overall Study||17
6760170|NCT03597061|7687052|FG001|STARTED|Overall Study||17
6760171|NCT03597061|7687051|FG000|COMPLETED|Overall Study||16
6760172|NCT03597061|7687052|FG001|COMPLETED|Overall Study||16
6760173|NCT03597061|7687051|FG000|NOT COMPLETED|Overall Study||1
6760174|NCT03597061|7687052|FG001|NOT COMPLETED|Overall Study||1
6760175|NCT03597139|7687060|FG000|STARTED|Overall Study||51
6760176|NCT03597139|7687061|FG001|STARTED|Overall Study||49
6760177|NCT03597139|7687060|FG000|COMPLETED|Overall Study||47
6760178|NCT03597139|7687061|FG001|COMPLETED|Overall Study||49
6760179|NCT03597139|7687060|FG000|NOT COMPLETED|Overall Study||4
6760180|NCT03597139|7687061|FG001|NOT COMPLETED|Overall Study||0
6760181|NCT03597178|7687067|FG000|STARTED|Overall Study||14
6760182|NCT03597178|7687067|FG000|COMPLETED|Overall Study||14
6760183|NCT03597178|7687067|FG000|NOT COMPLETED|Overall Study||0
6760184|NCT03597347|7687074|FG000|STARTED|Overall Study||7
6760185|NCT03597347|7687075|FG001|STARTED|Overall Study||3
6760186|NCT03597347|7687076|FG002|STARTED|Overall Study||4
6760187|NCT03597347|7687074|FG000|COMPLETED|Overall Study||0
6760188|NCT03597347|7687075|FG001|COMPLETED|Overall Study||0
6760189|NCT03597347|7687076|FG002|COMPLETED|Overall Study||0
6760190|NCT03597347|7687074|FG000|NOT COMPLETED|Overall Study||7
6760191|NCT03597347|7687075|FG001|NOT COMPLETED|Overall Study||3
6760192|NCT03597347|7687076|FG002|NOT COMPLETED|Overall Study||4
6760193|NCT03597529|7687086|FG000|STARTED|Overall Study||42
6760194|NCT03597529|7687087|FG001|STARTED|Overall Study||42
6760195|NCT03597529|7687086|FG000|Follow-up|Overall Study||22
6760196|NCT03597529|7687087|FG001|Follow-up|Overall Study||24
6760197|NCT03597529|7687086|FG000|COMPLETED|Overall Study||22
6760198|NCT03597529|7687087|FG001|COMPLETED|Overall Study||24
6760199|NCT03597529|7687086|FG000|NOT COMPLETED|Overall Study||20
6760200|NCT03597529|7687087|FG001|NOT COMPLETED|Overall Study||18
6760201|NCT03597789|7687093|FG000|STARTED|Overall Study||45
6760202|NCT03597789|7687093|FG000|COMPLETED|Overall Study||10
6760203|NCT03597789|7687093|FG000|NOT COMPLETED|Overall Study||35
6760204|NCT03598647|7687099|FG000|STARTED|Exercisers vs. Non-exercisers||30
6760205|NCT03598647|7687100|FG001|STARTED|Exercisers vs. Non-exercisers||30
6760206|NCT03598647|7687101|FG002|STARTED|Exercisers vs. Non-exercisers||0
6760207|NCT03598647|7687102|FG003|STARTED|Exercisers vs. Non-exercisers||0
6760208|NCT03598647|7687099|FG000|COMPLETED|Exercisers vs. Non-exercisers||29
6760209|NCT03598647|7687100|FG001|COMPLETED|Exercisers vs. Non-exercisers||30
6760210|NCT03598647|7687101|FG002|COMPLETED|Exercisers vs. Non-exercisers||0
6760211|NCT03598647|7687102|FG003|COMPLETED|Exercisers vs. Non-exercisers||0
6760212|NCT03598647|7687099|FG000|NOT COMPLETED|Exercisers vs. Non-exercisers||1
6760213|NCT03598647|7687100|FG001|NOT COMPLETED|Exercisers vs. Non-exercisers||0
6760214|NCT03598647|7687101|FG002|NOT COMPLETED|Exercisers vs. Non-exercisers||0
6760215|NCT03598647|7687102|FG003|NOT COMPLETED|Exercisers vs. Non-exercisers||0
6760216|NCT03598647|7687099|FG000|STARTED|Interventions for Non-exercisers||0
6760217|NCT03598647|7687100|FG001|STARTED|Interventions for Non-exercisers||0
6760218|NCT03598647|7687101|FG002|STARTED|Interventions for Non-exercisers||14
6760219|NCT03598647|7687102|FG003|STARTED|Interventions for Non-exercisers||16
6760220|NCT03598647|7687099|FG000|COMPLETED|Interventions for Non-exercisers||0
6760221|NCT03598647|7687100|FG001|COMPLETED|Interventions for Non-exercisers||0
6760222|NCT03598647|7687101|FG002|COMPLETED|Interventions for Non-exercisers||14
6760223|NCT03598647|7687102|FG003|COMPLETED|Interventions for Non-exercisers||16
6760224|NCT03598647|7687099|FG000|NOT COMPLETED|Interventions for Non-exercisers||0
6760225|NCT03598647|7687100|FG001|NOT COMPLETED|Interventions for Non-exercisers||0
6760226|NCT03598647|7687101|FG002|NOT COMPLETED|Interventions for Non-exercisers||0
6760227|NCT03598647|7687102|FG003|NOT COMPLETED|Interventions for Non-exercisers||0
6760228|NCT03599089|7687116|FG000|STARTED|Overall Study||36
6760229|NCT03599089|7687117|FG001|STARTED|Overall Study||36
6760230|NCT03599089|7687118|FG002|STARTED|Overall Study||38
6760231|NCT03599089|7687119|FG003|STARTED|Overall Study||37
6760232|NCT03599089|7687116|FG000|COMPLETED|Overall Study||33
6760233|NCT03599089|7687117|FG001|COMPLETED|Overall Study||35
6760234|NCT03599089|7687118|FG002|COMPLETED|Overall Study||37
6760235|NCT03599089|7687119|FG003|COMPLETED|Overall Study||35
6760236|NCT03599089|7687116|FG000|NOT COMPLETED|Overall Study||3
6760237|NCT03599089|7687117|FG001|NOT COMPLETED|Overall Study||1
6760238|NCT03599089|7687118|FG002|NOT COMPLETED|Overall Study||1
6760239|NCT03599089|7687119|FG003|NOT COMPLETED|Overall Study||2
6760240|NCT03599193|7687131|FG000|STARTED|Overall Study||34
6760241|NCT03599193|7687132|FG001|STARTED|Overall Study||24
6760242|NCT03599193|7687131|FG000|COMPLETED|Overall Study||32
6760243|NCT03599193|7687132|FG001|COMPLETED|Overall Study||21
6760244|NCT03599193|7687131|FG000|NOT COMPLETED|Overall Study||2
6760245|NCT03599193|7687132|FG001|NOT COMPLETED|Overall Study||3
6760246|NCT03599271|7687141|FG000|STARTED|Overall Study||70
6760247|NCT03599271|7687142|FG001|STARTED|Overall Study||5
6760248|NCT03599271|7687141|FG000|Drug-Coated Device|Overall Study||70
6760249|NCT03599271|7687142|FG001|Drug-Coated Device|Overall Study||5
6760250|NCT03599271|7687141|FG000|Control Device|Overall Study||70
6760251|NCT03599271|7687142|FG001|Control Device|Overall Study||0
6760252|NCT03599271|7687141|FG000|COMPLETED|Overall Study||70
6760253|NCT03599271|7687142|FG001|COMPLETED|Overall Study||5
6760254|NCT03599271|7687141|FG000|NOT COMPLETED|Overall Study||0
6760255|NCT03599271|7687142|FG001|NOT COMPLETED|Overall Study||0
6760256|NCT03599349|7687150|FG000|STARTED|Overall Study||20
6760257|NCT03599349|7687150|FG000|Treated|Overall Study||20
6760258|NCT03599349|7687150|FG000|COMPLETED|Overall Study||19
6760259|NCT03599349|7687150|FG000|NOT COMPLETED|Overall Study||1
6760260|NCT03599362|7687154|FG000|STARTED|Overall Study||7
6760261|NCT03599362|7687154|FG000|COMPLETED|Overall Study||4
6760262|NCT03599362|7687154|FG000|NOT COMPLETED|Overall Study||3
6760263|NCT03599687|7687160|FG000|STARTED|Overall Study||82
6760264|NCT03599687|7687161|FG001|STARTED|Overall Study||82
6760265|NCT03599687|7687160|FG000|COMPLETED|Overall Study||82
6760266|NCT03599687|7687161|FG001|COMPLETED|Overall Study||82
6760267|NCT03599687|7687160|FG000|NOT COMPLETED|Overall Study||0
6760268|NCT03599687|7687161|FG001|NOT COMPLETED|Overall Study||0
6760269|NCT03599986|7687167|FG000|STARTED|Overall Study||398
6760270|NCT03599986|7687167|FG000|COMPLETED|Overall Study||366
6760271|NCT03599986|7687167|FG000|NOT COMPLETED|Overall Study||32
6760272|NCT03600194|7687172|FG000|STARTED|Screening||38
6760273|NCT03600194|7687173|FG001|STARTED|Screening||0
6760274|NCT03600194|7687174|FG002|STARTED|Screening||0
6760275|NCT03600194|7687172|FG000|COMPLETED|Screening||11
6760276|NCT03600194|7687173|FG001|COMPLETED|Screening||0
6760277|NCT03600194|7687174|FG002|COMPLETED|Screening||0
6760278|NCT03600194|7687172|FG000|NOT COMPLETED|Screening||27
6760279|NCT03600194|7687173|FG001|NOT COMPLETED|Screening||0
6760280|NCT03600194|7687174|FG002|NOT COMPLETED|Screening||0
6760281|NCT03600194|7687172|FG000|STARTED|In Lab Phase||0
6760282|NCT03600194|7687173|FG001|STARTED|In Lab Phase||5
6760283|NCT03600194|7687174|FG002|STARTED|In Lab Phase||6
6760284|NCT03600194|7687172|FG000|COMPLETED|In Lab Phase||0
6760285|NCT03600194|7687173|FG001|COMPLETED|In Lab Phase||5
6760286|NCT03600194|7687174|FG002|COMPLETED|In Lab Phase||6
6760287|NCT03600194|7687172|FG000|NOT COMPLETED|In Lab Phase||0
6760288|NCT03600194|7687173|FG001|NOT COMPLETED|In Lab Phase||0
6760289|NCT03600194|7687174|FG002|NOT COMPLETED|In Lab Phase||0
6760290|NCT03600376|7687187|FG000|STARTED|Overall Study||9
6760291|NCT03600376|7687188|FG001|STARTED|Overall Study||8
6760292|NCT03600376|7687187|FG000|COMPLETED|Overall Study||7
6760293|NCT03600376|7687188|FG001|COMPLETED|Overall Study||2
6760294|NCT03600376|7687187|FG000|NOT COMPLETED|Overall Study||2
6760295|NCT03600376|7687188|FG001|NOT COMPLETED|Overall Study||6
6760296|NCT03600428|7687196|FG000|STARTED|Overall Study||79
6760297|NCT03600428|7687197|FG001|STARTED|Overall Study||73
6760298|NCT03600428|7687196|FG000|15-day Follow-up|Overall Study||76
6760299|NCT03600428|7687197|FG001|15-day Follow-up|Overall Study||70
6760300|NCT03600428|7687196|FG000|43-day Follow-up|Overall Study||74
6760301|NCT03600428|7687197|FG001|43-day Follow-up|Overall Study||68
6760302|NCT03600428|7687196|FG000|COMPLETED|Overall Study||74
6760303|NCT03600428|7687197|FG001|COMPLETED|Overall Study||68
6760304|NCT03600428|7687196|FG000|NOT COMPLETED|Overall Study||5
6760305|NCT03600428|7687197|FG001|NOT COMPLETED|Overall Study||5
6760306|NCT03601052|7687203|FG000|STARTED|Overall Study||14
6760307|NCT03601052|7687203|FG000|COMPLETED|Overall Study||12
6760308|NCT03601052|7687203|FG000|NOT COMPLETED|Overall Study||2
6760309|NCT03601117|7687214|FG000|STARTED|Overall Study||20
6760310|NCT03601117|7687215|FG001|STARTED|Overall Study||2
6760311|NCT03601117|7687214|FG000|COMPLETED|Overall Study||17
6760312|NCT03601117|7687215|FG001|COMPLETED|Overall Study||1
6760313|NCT03601117|7687214|FG000|NOT COMPLETED|Overall Study||3
6760314|NCT03601117|7687215|FG001|NOT COMPLETED|Overall Study||1
6760315|NCT03601715|7687226|FG000|STARTED|First Intervention||7
6760316|NCT03601715|7687227|FG001|STARTED|First Intervention||7
6760317|NCT03601715|7687228|FG002|STARTED|First Intervention||6
6760318|NCT03601715|7687226|FG000|COMPLETED|First Intervention||7
6760319|NCT03601715|7687227|FG001|COMPLETED|First Intervention||7
6760320|NCT03601715|7687228|FG002|COMPLETED|First Intervention||6
6760321|NCT03601715|7687226|FG000|NOT COMPLETED|First Intervention||0
6760322|NCT03601715|7687227|FG001|NOT COMPLETED|First Intervention||0
6760323|NCT03601715|7687228|FG002|NOT COMPLETED|First Intervention||0
6760324|NCT03601715|7687226|FG000|STARTED|Washout 1 (at Least 24 Hours)||7
6760325|NCT03601715|7687227|FG001|STARTED|Washout 1 (at Least 24 Hours)||7
6760326|NCT03601715|7687228|FG002|STARTED|Washout 1 (at Least 24 Hours)||6
6760327|NCT03601715|7687226|FG000|COMPLETED|Washout 1 (at Least 24 Hours)||7
6760328|NCT03601715|7687227|FG001|COMPLETED|Washout 1 (at Least 24 Hours)||7
6760329|NCT03601715|7687228|FG002|COMPLETED|Washout 1 (at Least 24 Hours)||6
6760330|NCT03601715|7687226|FG000|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
6760331|NCT03601715|7687227|FG001|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
6760332|NCT03601715|7687228|FG002|NOT COMPLETED|Washout 1 (at Least 24 Hours)||0
6760333|NCT03601715|7687226|FG000|STARTED|Second Intervention||7
6760334|NCT03601715|7687227|FG001|STARTED|Second Intervention||7
6760335|NCT03601715|7687228|FG002|STARTED|Second Intervention||6
6760336|NCT03601715|7687226|FG000|COMPLETED|Second Intervention||6
6760337|NCT03601715|7687227|FG001|COMPLETED|Second Intervention||6
6760338|NCT03601715|7687228|FG002|COMPLETED|Second Intervention||6
6760339|NCT03601715|7687226|FG000|NOT COMPLETED|Second Intervention||1
6760340|NCT03601715|7687227|FG001|NOT COMPLETED|Second Intervention||1
6760341|NCT03601715|7687228|FG002|NOT COMPLETED|Second Intervention||0
6760342|NCT03601715|7687226|FG000|STARTED|Wash Out 2 (at Least 24 Hours)||6
6760343|NCT03601715|7687227|FG001|STARTED|Wash Out 2 (at Least 24 Hours)||6
6760344|NCT03601715|7687228|FG002|STARTED|Wash Out 2 (at Least 24 Hours)||6
6760345|NCT03601715|7687226|FG000|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
6760346|NCT03601715|7687227|FG001|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
6760347|NCT03601715|7687228|FG002|COMPLETED|Wash Out 2 (at Least 24 Hours)||6
6760348|NCT03601715|7687226|FG000|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
6760349|NCT03601715|7687227|FG001|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
6760350|NCT03601715|7687228|FG002|NOT COMPLETED|Wash Out 2 (at Least 24 Hours)||0
6760351|NCT03601715|7687226|FG000|STARTED|Third Intervention||6
6760352|NCT03601715|7687227|FG001|STARTED|Third Intervention||6
6760353|NCT03601715|7687228|FG002|STARTED|Third Intervention||6
6760354|NCT03601715|7687226|FG000|COMPLETED|Third Intervention||6
6760355|NCT03601715|7687227|FG001|COMPLETED|Third Intervention||6
6760356|NCT03601715|7687228|FG002|COMPLETED|Third Intervention||6
6760357|NCT03601715|7687226|FG000|NOT COMPLETED|Third Intervention||0
6760358|NCT03601715|7687227|FG001|NOT COMPLETED|Third Intervention||0
6760359|NCT03601715|7687228|FG002|NOT COMPLETED|Third Intervention||0
6760360|NCT03602053|7687239|FG000|STARTED|Overall Study||150
6760361|NCT03602053|7687240|FG001|STARTED|Overall Study||150
6760362|NCT03602053|7687241|FG002|STARTED|Overall Study||150
6760363|NCT03602053|7687239|FG000|COMPLETED|Overall Study||131
6760364|NCT03602053|7687240|FG001|COMPLETED|Overall Study||132
6760365|NCT03602053|7687241|FG002|COMPLETED|Overall Study||139
6760366|NCT03602053|7687239|FG000|NOT COMPLETED|Overall Study||19
6760367|NCT03602053|7687240|FG001|NOT COMPLETED|Overall Study||18
6760368|NCT03602053|7687241|FG002|NOT COMPLETED|Overall Study||11
6760369|NCT03602339|7687253|FG000|STARTED|Overall Study||157
6760370|NCT03602339|7687253|FG000|Completed Period 1 (Gadoterate)|Overall Study||155
6760371|NCT03602339|7687253|FG000|Started Period 2 (Gadobutrol)|Overall Study||142
6760372|NCT03602339|7687253|FG000|COMPLETED|Overall Study||142
6760373|NCT03602339|7687253|FG000|NOT COMPLETED|Overall Study||15
6760374|NCT03602482|7687262|FG000|STARTED|Overall Study||50
6760375|NCT03602482|7687263|FG001|STARTED|Overall Study||50
6760376|NCT03602482|7687264|FG002|STARTED|Overall Study||20
6760377|NCT03602482|7687265|FG003|STARTED|Overall Study||19
6760378|NCT03602482|7687262|FG000|COMPLETED|Overall Study||44
6760379|NCT03602482|7687263|FG001|COMPLETED|Overall Study||43
6760380|NCT03602482|7687264|FG002|COMPLETED|Overall Study||20
6760381|NCT03602482|7687265|FG003|COMPLETED|Overall Study||19
6760382|NCT03602482|7687262|FG000|NOT COMPLETED|Overall Study||6
6760383|NCT03602482|7687263|FG001|NOT COMPLETED|Overall Study||7
6760384|NCT03602482|7687264|FG002|NOT COMPLETED|Overall Study||0
6760385|NCT03602482|7687265|FG003|NOT COMPLETED|Overall Study||0
6556014|NCT01755767|7478218|FG003|NOT COMPLETED|Overall Study||114
6556015|NCT01755858|7478230|FG000|STARTED|Overall Study||7
6556016|NCT01755858|7478231|FG001|STARTED|Overall Study||9
6556017|NCT01755858|7478230|FG000|COMPLETED|Overall Study||6
6556018|NCT01755858|7478231|FG001|COMPLETED|Overall Study||8
6556019|NCT01755858|7478230|FG000|NOT COMPLETED|Overall Study||1
6760386|NCT03603028|7687278|FG000|STARTED|Overall Study||13
6760387|NCT03603028|7687278|FG000|COMPLETED|Overall Study||12
6760388|NCT03603028|7687278|FG000|NOT COMPLETED|Overall Study||1
6760389|NCT03603106|7687293|FG000|STARTED|Overall Study||6
6760390|NCT03603106|7687294|FG001|STARTED|Overall Study||6
6556020|NCT01755858|7478231|FG001|NOT COMPLETED|Overall Study||1
6556021|NCT01755949|7478245|FG000|STARTED|Overall Study||5
6556022|NCT01755949|7478246|FG001|STARTED|Overall Study||5
6556023|NCT01755949|7478247|FG002|STARTED|Overall Study||4
6556024|NCT01755949|7478248|FG003|STARTED|Overall Study||5
6556025|NCT01755949|7478249|FG004|STARTED|Overall Study||4
6760391|NCT03603106|7687295|FG002|STARTED|Overall Study||6
6760392|NCT03603106|7687296|FG003|STARTED|Overall Study||6
6760393|NCT03603106|7687297|FG004|STARTED|Overall Study||6
6760394|NCT03603106|7687298|FG005|STARTED|Overall Study||6
6760395|NCT03603106|7687299|FG006|STARTED|Overall Study||18
6760396|NCT03603106|7687300|FG007|STARTED|Overall Study||3
6760397|NCT03603106|7687301|FG008|STARTED|Overall Study||3
6556026|NCT01755949|7478250|FG005|STARTED|Overall Study||3
6556027|NCT01755949|7478245|FG000|COMPLETED|Overall Study||5
6760398|NCT03603106|7687302|FG009|STARTED|Overall Study||3
6760399|NCT03603106|7687303|FG010|STARTED|Overall Study||3
6760400|NCT03603106|7687293|FG000|COMPLETED|Overall Study||6
6760401|NCT03603106|7687294|FG001|COMPLETED|Overall Study||6
6760402|NCT03603106|7687295|FG002|COMPLETED|Overall Study||6
6760403|NCT03603106|7687296|FG003|COMPLETED|Overall Study||6
6760404|NCT03603106|7687297|FG004|COMPLETED|Overall Study||6
6760405|NCT03603106|7687298|FG005|COMPLETED|Overall Study||6
6760406|NCT03603106|7687299|FG006|COMPLETED|Overall Study||18
6760407|NCT03603106|7687300|FG007|COMPLETED|Overall Study||3
6760408|NCT03603106|7687301|FG008|COMPLETED|Overall Study||3
6760409|NCT03603106|7687302|FG009|COMPLETED|Overall Study||3
6760410|NCT03603106|7687303|FG010|COMPLETED|Overall Study||3
6760411|NCT03603106|7687293|FG000|NOT COMPLETED|Overall Study||0
6760412|NCT03603106|7687294|FG001|NOT COMPLETED|Overall Study||0
6760413|NCT03603106|7687295|FG002|NOT COMPLETED|Overall Study||0
6760414|NCT03603106|7687296|FG003|NOT COMPLETED|Overall Study||0
6760415|NCT03603106|7687297|FG004|NOT COMPLETED|Overall Study||0
6760416|NCT03603106|7687298|FG005|NOT COMPLETED|Overall Study||0
6760417|NCT03603106|7687299|FG006|NOT COMPLETED|Overall Study||0
6760418|NCT03603106|7687300|FG007|NOT COMPLETED|Overall Study||0
6760419|NCT03603106|7687301|FG008|NOT COMPLETED|Overall Study||0
6760420|NCT03603106|7687302|FG009|NOT COMPLETED|Overall Study||0
6760421|NCT03603106|7687303|FG010|NOT COMPLETED|Overall Study||0
6760422|NCT03603652|7687336|FG000|STARTED|Overall Study||10
6760423|NCT03603652|7687336|FG000|COMPLETED|Overall Study||8
6760424|NCT03603652|7687336|FG000|NOT COMPLETED|Overall Study||2
6760425|NCT03604263|7687340|FG000|STARTED|Overall Study||17
6760426|NCT03604263|7687340|FG000|COMPLETED|Overall Study||15
6760427|NCT03604263|7687340|FG000|NOT COMPLETED|Overall Study||2
6760428|NCT03604341|7687346|FG000|STARTED|Overall Study||35
6760429|NCT03604341|7687347|FG001|STARTED|Overall Study||35
6760430|NCT03604341|7687346|FG000|COMPLETED|Overall Study||33
6760431|NCT03604341|7687347|FG001|COMPLETED|Overall Study||33
6760432|NCT03604341|7687346|FG000|NOT COMPLETED|Overall Study||2
6760433|NCT03604341|7687347|FG001|NOT COMPLETED|Overall Study||2
6760434|NCT03604497|7687353|FG000|STARTED|Overall Study||437
6556028|NCT01755949|7478246|FG001|COMPLETED|Overall Study||5
6556029|NCT01755949|7478247|FG002|COMPLETED|Overall Study||4
6556030|NCT01755949|7478248|FG003|COMPLETED|Overall Study||5
6556031|NCT01755949|7478249|FG004|COMPLETED|Overall Study||4
6760435|NCT03604497|7687353|FG000|COMPLETED|Overall Study||385
6760436|NCT03604497|7687353|FG000|NOT COMPLETED|Overall Study||52
6556032|NCT01755949|7478250|FG005|COMPLETED|Overall Study||3
6760437|NCT03604523|7687363|FG000|STARTED|Overall Study||5
6760438|NCT03604523|7687364|FG001|STARTED|Overall Study||5
6760439|NCT03604523|7687363|FG000|COMPLETED|Overall Study||4
6760440|NCT03604523|7687364|FG001|COMPLETED|Overall Study||5
6760441|NCT03604523|7687363|FG000|NOT COMPLETED|Overall Study||1
6760442|NCT03604523|7687364|FG001|NOT COMPLETED|Overall Study||0
6760443|NCT03604705|7687370|FG000|STARTED|Overall Study||21
6760444|NCT03604705|7687370|FG000|COMPLETED|Overall Study||20
6760445|NCT03604705|7687370|FG000|NOT COMPLETED|Overall Study||1
6760446|NCT03605212|7687387|FG000|STARTED|Baseline Period||3
6760447|NCT03605212|7687388|FG001|STARTED|Baseline Period||0
6760448|NCT03605212|7687389|FG002|STARTED|Baseline Period||3
6760449|NCT03605212|7687390|FG003|STARTED|Baseline Period||0
6760450|NCT03605212|7687391|FG004|STARTED|Baseline Period||24
6760451|NCT03605212|7687387|FG000|COMPLETED|Baseline Period||3
6760452|NCT03605212|7687388|FG001|COMPLETED|Baseline Period||0
6760453|NCT03605212|7687389|FG002|COMPLETED|Baseline Period||3
6760454|NCT03605212|7687390|FG003|COMPLETED|Baseline Period||0
6760455|NCT03605212|7687391|FG004|COMPLETED|Baseline Period||24
6760456|NCT03605212|7687387|FG000|NOT COMPLETED|Baseline Period||0
6760457|NCT03605212|7687388|FG001|NOT COMPLETED|Baseline Period||0
6760458|NCT03605212|7687389|FG002|NOT COMPLETED|Baseline Period||0
6760459|NCT03605212|7687390|FG003|NOT COMPLETED|Baseline Period||0
6760460|NCT03605212|7687391|FG004|NOT COMPLETED|Baseline Period||0
6760461|NCT03605212|7687387|FG000|STARTED|Treatment Period||3
6760462|NCT03605212|7687388|FG001|STARTED|Treatment Period||0
6760463|NCT03605212|7687389|FG002|STARTED|Treatment Period||3
6760464|NCT03605212|7687390|FG003|STARTED|Treatment Period||0
6760465|NCT03605212|7687391|FG004|STARTED|Treatment Period||24
6760466|NCT03605212|7687387|FG000|COMPLETED|Treatment Period||2
6760467|NCT03605212|7687388|FG001|COMPLETED|Treatment Period||0
6760468|NCT03605212|7687389|FG002|COMPLETED|Treatment Period||3
6760469|NCT03605212|7687390|FG003|COMPLETED|Treatment Period||0
6760470|NCT03605212|7687391|FG004|COMPLETED|Treatment Period||23
6760471|NCT03605212|7687387|FG000|NOT COMPLETED|Treatment Period||1
6760472|NCT03605212|7687388|FG001|NOT COMPLETED|Treatment Period||0
6760473|NCT03605212|7687389|FG002|NOT COMPLETED|Treatment Period||0
6760474|NCT03605212|7687390|FG003|NOT COMPLETED|Treatment Period||0
6760475|NCT03605212|7687391|FG004|NOT COMPLETED|Treatment Period||1
6760476|NCT03605693|7687406|FG000|STARTED|Overall Study||5
6760477|NCT03605693|7687407|FG001|STARTED|Overall Study||5
6760478|NCT03605693|7687406|FG000|COMPLETED|Overall Study||0
6760479|NCT03605693|7687407|FG001|COMPLETED|Overall Study||5
6760480|NCT03605693|7687406|FG000|NOT COMPLETED|Overall Study||5
6760481|NCT03605693|7687407|FG001|NOT COMPLETED|Overall Study||0
6760482|NCT03605745|7687413|FG000|STARTED|Overall Study||47
6760483|NCT03605745|7687413|FG000|2 Weeks|Overall Study||47
6760484|NCT03605745|7687413|FG000|6 Weeks|Overall Study||47
6760485|NCT03605745|7687413|FG000|3 Months|Overall Study||47
6760486|NCT03605745|7687413|FG000|6 Months|Overall Study||47
6760487|NCT03605745|7687413|FG000|12 Months|Overall Study||40
6760488|NCT03605745|7687413|FG000|24 Months|Overall Study||1
6760489|NCT03605745|7687413|FG000|COMPLETED|Overall Study||0
6760490|NCT03605745|7687413|FG000|NOT COMPLETED|Overall Study||47
6760491|NCT03605836|7687421|FG000|STARTED|OL Placebo Run-in Period [1 Week]||590
6760492|NCT03605836|7687422|FG001|STARTED|OL Placebo Run-in Period [1 Week]||0
6760493|NCT03605836|7687423|FG002|STARTED|OL Placebo Run-in Period [1 Week]||0
6760494|NCT03605836|7687424|FG003|STARTED|OL Placebo Run-in Period [1 Week]||0
6760495|NCT03605836|7687421|FG000|Treated|OL Placebo Run-in Period [1 Week]||579
6760496|NCT03605836|7687422|FG001|Treated|OL Placebo Run-in Period [1 Week]||0
6760497|NCT03605836|7687423|FG002|Treated|OL Placebo Run-in Period [1 Week]||0
6760498|NCT03605836|7687424|FG003|Treated|OL Placebo Run-in Period [1 Week]||0
6760499|NCT03605836|7687421|FG000|COMPLETED|OL Placebo Run-in Period [1 Week]||440
6760500|NCT03605836|7687422|FG001|COMPLETED|OL Placebo Run-in Period [1 Week]||0
6760501|NCT03605836|7687423|FG002|COMPLETED|OL Placebo Run-in Period [1 Week]||0
6760502|NCT03605836|7687424|FG003|COMPLETED|OL Placebo Run-in Period [1 Week]||0
6760503|NCT03605836|7687421|FG000|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||150
6760504|NCT03605836|7687422|FG001|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
6760505|NCT03605836|7687423|FG002|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
6760506|NCT03605836|7687424|FG003|NOT COMPLETED|OL Placebo Run-in Period [1 Week]||0
6760507|NCT03605836|7687421|FG000|STARTED|Double-blind Treatment Period [6 Weeks]||0
6760508|NCT03605836|7687422|FG001|STARTED|Double-blind Treatment Period [6 Weeks]||147
6760509|NCT03605836|7687423|FG002|STARTED|Double-blind Treatment Period [6 Weeks]||147
6760510|NCT03605836|7687424|FG003|STARTED|Double-blind Treatment Period [6 Weeks]||146
6760511|NCT03605836|7687421|FG000|Treated|Double-blind Treatment Period [6 Weeks]||0
6760512|NCT03605836|7687422|FG001|Treated|Double-blind Treatment Period [6 Weeks]||145
6760513|NCT03605836|7687423|FG002|Treated|Double-blind Treatment Period [6 Weeks]||143
6760514|NCT03605836|7687424|FG003|Treated|Double-blind Treatment Period [6 Weeks]||142
6760515|NCT03605836|7687421|FG000|COMPLETED|Double-blind Treatment Period [6 Weeks]||0
6760516|NCT03605836|7687422|FG001|COMPLETED|Double-blind Treatment Period [6 Weeks]||111
6760517|NCT03605836|7687423|FG002|COMPLETED|Double-blind Treatment Period [6 Weeks]||102
6760518|NCT03605836|7687424|FG003|COMPLETED|Double-blind Treatment Period [6 Weeks]||123
6760519|NCT03605836|7687421|FG000|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||0
6760520|NCT03605836|7687422|FG001|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||36
6760521|NCT03605836|7687423|FG002|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||45
6760522|NCT03605836|7687424|FG003|NOT COMPLETED|Double-blind Treatment Period [6 Weeks]||23
6760523|NCT03605914|7687435|FG000|STARTED|Overall Study||57
6760524|NCT03605914|7687436|FG001|STARTED|Overall Study||43
6760525|NCT03605914|7687435|FG000|Completed Day 1 Assessment|Overall Study||31
6760526|NCT03605914|7687436|FG001|Completed Day 1 Assessment|Overall Study||26
6760527|NCT03605914|7687435|FG000|Completed Day 2 Assessment|Overall Study||32
6760528|NCT03605914|7687436|FG001|Completed Day 2 Assessment|Overall Study||27
6760529|NCT03605914|7687435|FG000|Completed Day 3 Assessment|Overall Study||31
6760530|NCT03605914|7687436|FG001|Completed Day 3 Assessment|Overall Study||28
6760531|NCT03605914|7687435|FG000|Completed Day 5 Assessment|Overall Study||30
6760532|NCT03605914|7687436|FG001|Completed Day 5 Assessment|Overall Study||24
6760533|NCT03605914|7687435|FG000|COMPLETED|Overall Study||30
6760534|NCT03605914|7687436|FG001|COMPLETED|Overall Study||24
6760535|NCT03605914|7687435|FG000|NOT COMPLETED|Overall Study||27
6760536|NCT03605914|7687436|FG001|NOT COMPLETED|Overall Study||19
6760537|NCT03606187|7687444|FG000|STARTED|Overall Study||67
6760538|NCT03606187|7687445|FG001|STARTED|Overall Study||61
6760539|NCT03606187|7687444|FG000|COMPLETED|Overall Study||67
6760540|NCT03606187|7687445|FG001|COMPLETED|Overall Study||61
6760541|NCT03606187|7687444|FG000|NOT COMPLETED|Overall Study||0
6760542|NCT03606187|7687445|FG001|NOT COMPLETED|Overall Study||0
6760543|NCT03606343|7687451|FG000|STARTED|Overall Study||21
6760544|NCT03606343|7687451|FG000|COMPLETED|Overall Study||21
6760545|NCT03606343|7687451|FG000|NOT COMPLETED|Overall Study||0
6760546|NCT03606460|7687457|FG000|STARTED|Overall Study||95
6760547|NCT03606460|7687458|FG001|STARTED|Overall Study||46
6760548|NCT03606460|7687457|FG000|COMPLETED|Overall Study||94
6760549|NCT03606460|7687458|FG001|COMPLETED|Overall Study||38
6760550|NCT03606460|7687457|FG000|NOT COMPLETED|Overall Study||1
6760551|NCT03606460|7687458|FG001|NOT COMPLETED|Overall Study||8
6760552|NCT03607539|7687467|FG000|STARTED|Overall Study||266
6760553|NCT03607539|7687468|FG001|STARTED|Overall Study||131
6760554|NCT03607539|7687467|FG000|COMPLETED|Overall Study||0
6760555|NCT03607539|7687468|FG001|COMPLETED|Overall Study||0
6760556|NCT03607539|7687467|FG000|NOT COMPLETED|Overall Study||266
6760557|NCT03607539|7687468|FG001|NOT COMPLETED|Overall Study||131
6760558|NCT03607682|7687474|FG000|STARTED|Overall Study||2
6760559|NCT03607682|7687474|FG000|COMPLETED|Overall Study||0
6760560|NCT03607682|7687474|FG000|NOT COMPLETED|Overall Study||2
6760561|NCT03607695|7687478|FG000|STARTED|2 Week||19
6760562|NCT03607695|7687478|FG000|COMPLETED|2 Week||19
6760563|NCT03607695|7687478|FG000|NOT COMPLETED|2 Week||0
6760564|NCT03607695|7687478|FG000|STARTED|10 Week||19
6760565|NCT03607695|7687478|FG000|COMPLETED|10 Week||18
6760566|NCT03607695|7687478|FG000|NOT COMPLETED|10 Week||1
6760567|NCT03607695|7687478|FG000|STARTED|16 Week||18
6760568|NCT03607695|7687478|FG000|COMPLETED|16 Week||16
6760569|NCT03607695|7687478|FG000|NOT COMPLETED|16 Week||2
6760570|NCT03608488|7687486|FG000|STARTED|Overall Study||22
6760571|NCT03608488|7687487|FG001|STARTED|Overall Study||21
6760572|NCT03608488|7687488|FG002|STARTED|Overall Study||22
6760573|NCT03608488|7687489|FG003|STARTED|Overall Study||45
6760574|NCT03608488|7687486|FG000|COMPLETED|Overall Study||21
6760575|NCT03608488|7687487|FG001|COMPLETED|Overall Study||18
6760576|NCT03608488|7687488|FG002|COMPLETED|Overall Study||20
6760577|NCT03608488|7687489|FG003|COMPLETED|Overall Study||40
6760578|NCT03608488|7687486|FG000|NOT COMPLETED|Overall Study||1
6760579|NCT03608488|7687487|FG001|NOT COMPLETED|Overall Study||3
6760580|NCT03608488|7687488|FG002|NOT COMPLETED|Overall Study||2
6760581|NCT03608488|7687489|FG003|NOT COMPLETED|Overall Study||5
6760582|NCT03608774|7687501|FG000|STARTED|Overall Study||89
6760583|NCT03608774|7687502|FG001|STARTED|Overall Study||88
6760584|NCT03608774|7687501|FG000|COMPLETED|Overall Study||82
6760585|NCT03608774|7687502|FG001|COMPLETED|Overall Study||81
6760586|NCT03608774|7687501|FG000|NOT COMPLETED|Overall Study||7
6760587|NCT03608774|7687502|FG001|NOT COMPLETED|Overall Study||7
6760588|NCT03608839|7687511|FG000|STARTED|Overall Study||9
6760589|NCT03608839|7687512|FG001|STARTED|Overall Study||9
6760590|NCT03608839|7687513|FG002|STARTED|Overall Study||9
6760591|NCT03608839|7687511|FG000|COMPLETED|Overall Study||9
6760592|NCT03608839|7687512|FG001|COMPLETED|Overall Study||9
6760593|NCT03608839|7687513|FG002|COMPLETED|Overall Study||9
6760594|NCT03608839|7687511|FG000|NOT COMPLETED|Overall Study||0
6760595|NCT03608839|7687512|FG001|NOT COMPLETED|Overall Study||0
6760596|NCT03608839|7687513|FG002|NOT COMPLETED|Overall Study||0
6760597|NCT03609619|7687523|FG000|STARTED|Overall Study||54
6760598|NCT03609619|7687524|FG001|STARTED|Overall Study||55
6760599|NCT03609619|7687523|FG000|COMPLETED|Overall Study||44
6760600|NCT03609619|7687524|FG001|COMPLETED|Overall Study||49
6760601|NCT03609619|7687523|FG000|NOT COMPLETED|Overall Study||10
6760602|NCT03609619|7687524|FG001|NOT COMPLETED|Overall Study||6
6780163|NCT03302247|7708519|FG000|NOT COMPLETED|Overall Study||3
6780164|NCT03300024|7708525|FG000|STARTED|Overall Study||4
6780165|NCT03300024|7708526|FG001|STARTED|Overall Study||6
6780166|NCT03300024|7708525|FG000|COMPLETED|Overall Study||0
6780167|NCT03300024|7708526|FG001|COMPLETED|Overall Study||0
6780168|NCT03300024|7708525|FG000|NOT COMPLETED|Overall Study||4
6780169|NCT03300024|7708526|FG001|NOT COMPLETED|Overall Study||6
6780170|NCT03283709|7708536|FG000|STARTED|Overall Study||0
6780171|NCT03283709|7708537|FG001|STARTED|Overall Study||1
6780172|NCT03283709|7708536|FG000|COMPLETED|Overall Study||0
6780173|NCT03283709|7708537|FG001|COMPLETED|Overall Study||0
6780174|NCT03283709|7708536|FG000|NOT COMPLETED|Overall Study||0
6780175|NCT03283709|7708537|FG001|NOT COMPLETED|Overall Study||1
6780176|NCT03277183|7708545|FG000|STARTED|Overall Study||3
6780177|NCT03277183|7708546|FG001|STARTED|Overall Study||2
6780178|NCT03277183|7708545|FG000|COMPLETED|Overall Study||0
6780179|NCT03277183|7708546|FG001|COMPLETED|Overall Study||0
6760603|NCT03609658|7687532|FG000|STARTED|Overall Study||379
6760604|NCT03609658|7687533|FG001|STARTED|Overall Study||380
6760605|NCT03609658|7687532|FG000|COMPLETED|Overall Study||379
6760606|NCT03609658|7687533|FG001|COMPLETED|Overall Study||380
6760607|NCT03609658|7687532|FG000|NOT COMPLETED|Overall Study||0
6760608|NCT03609658|7687533|FG001|NOT COMPLETED|Overall Study||0
6760609|NCT03610048|7687539|FG000|STARTED|Overall Study||175
6760610|NCT03610048|7687539|FG000|Completed Treatment|Overall Study||15
6760611|NCT03610048|7687539|FG000|COMPLETED|Overall Study||14
6760612|NCT03610048|7687539|FG000|NOT COMPLETED|Overall Study||161
6760613|NCT03610165|7687545|FG000|STARTED|Overall Study||108
6760614|NCT03610165|7687546|FG001|STARTED|Overall Study||106
6760615|NCT03610165|7687545|FG000|COMPLETED|Overall Study||108
6760616|NCT03610165|7687546|FG001|COMPLETED|Overall Study||105
6760617|NCT03610165|7687545|FG000|NOT COMPLETED|Overall Study||0
6760618|NCT03610165|7687546|FG001|NOT COMPLETED|Overall Study||1
6760619|NCT03610269|7687552|FG000|STARTED|Overall Study||143
6760620|NCT03610269|7687552|FG000|COMPLETED|Overall Study||127
6760621|NCT03610269|7687552|FG000|NOT COMPLETED|Overall Study||16
6760622|NCT03610399|7687559|FG000|STARTED|Overall Study||63
6760623|NCT03610399|7687560|FG001|STARTED|Overall Study||96
6760624|NCT03610399|7687561|FG002|STARTED|Overall Study||95
6760625|NCT03610399|7687559|FG000|COMPLETED|Overall Study||53
6760626|NCT03610399|7687560|FG001|COMPLETED|Overall Study||78
6760627|NCT03610399|7687561|FG002|COMPLETED|Overall Study||79
6760628|NCT03610399|7687559|FG000|NOT COMPLETED|Overall Study||10
6760629|NCT03610399|7687560|FG001|NOT COMPLETED|Overall Study||18
6760630|NCT03610399|7687561|FG002|NOT COMPLETED|Overall Study||16
6760631|NCT03610464|7687569|FG000|STARTED|Overall Study||5
6760632|NCT03610464|7687569|FG000|COMPLETED|Overall Study||5
6760633|NCT03610464|7687569|FG000|NOT COMPLETED|Overall Study||0
6760634|NCT03610581|7687576|FG000|STARTED|Overall Study||5
6760635|NCT03610581|7687577|FG001|STARTED|Overall Study||4
6760636|NCT03610581|7687576|FG000|Vaccinated|Overall Study||4
6760637|NCT03610581|7687577|FG001|Vaccinated|Overall Study||4
6760638|NCT03610581|7687576|FG000|COMPLETED|Overall Study||2
6760639|NCT03610581|7687577|FG001|COMPLETED|Overall Study||3
6760640|NCT03610581|7687576|FG000|NOT COMPLETED|Overall Study||3
6760641|NCT03610581|7687577|FG001|NOT COMPLETED|Overall Study||1
6760642|NCT03610633|7687585|FG000|STARTED|Overall Study||5
6760643|NCT03610633|7687586|FG001|STARTED|Overall Study||6
6760644|NCT03610633|7687585|FG000|COMPLETED|Overall Study||5
6760645|NCT03610633|7687586|FG001|COMPLETED|Overall Study||5
6760646|NCT03610633|7687585|FG000|NOT COMPLETED|Overall Study||0
6760647|NCT03610633|7687586|FG001|NOT COMPLETED|Overall Study||1
6760648|NCT03611062|7687594|FG000|STARTED|Overall Study||14
6760649|NCT03611062|7687595|FG001|STARTED|Overall Study||13
6760650|NCT03611062|7687594|FG000|COMPLETED|Overall Study||13
6760651|NCT03611062|7687595|FG001|COMPLETED|Overall Study||12
6760652|NCT03611062|7687594|FG000|NOT COMPLETED|Overall Study||1
6760653|NCT03611062|7687595|FG001|NOT COMPLETED|Overall Study||1
6760654|NCT03611075|7687610|FG000|STARTED|Overall Study||16
6760655|NCT03611075|7687611|FG001|STARTED|Overall Study||15
6760656|NCT03611075|7687612|FG002|STARTED|Overall Study||16
6760657|NCT03611075|7687613|FG003|STARTED|Overall Study||17
6760658|NCT03611075|7687614|FG004|STARTED|Overall Study||13
6760659|NCT03611075|7687615|FG005|STARTED|Overall Study||18
6760660|NCT03611075|7687616|FG006|STARTED|Overall Study||15
6760661|NCT03611075|7687617|FG007|STARTED|Overall Study||17
6760662|NCT03611075|7687618|FG008|STARTED|Overall Study||17
6760663|NCT03611075|7687610|FG000|COMPLETED|Overall Study||15
6760664|NCT03611075|7687611|FG001|COMPLETED|Overall Study||13
6760665|NCT03611075|7687612|FG002|COMPLETED|Overall Study||14
6760666|NCT03611075|7687613|FG003|COMPLETED|Overall Study||13
6760667|NCT03611075|7687614|FG004|COMPLETED|Overall Study||13
6760668|NCT03611075|7687615|FG005|COMPLETED|Overall Study||18
6760669|NCT03611075|7687616|FG006|COMPLETED|Overall Study||13
6556033|NCT01755949|7478245|FG000|NOT COMPLETED|Overall Study||0
6556034|NCT01755949|7478246|FG001|NOT COMPLETED|Overall Study||0
6556035|NCT01755949|7478247|FG002|NOT COMPLETED|Overall Study||0
6556036|NCT01755949|7478248|FG003|NOT COMPLETED|Overall Study||0
6556037|NCT01755949|7478249|FG004|NOT COMPLETED|Overall Study||0
6760670|NCT03611075|7687617|FG007|COMPLETED|Overall Study||17
6760671|NCT03611075|7687618|FG008|COMPLETED|Overall Study||17
6760672|NCT03611075|7687610|FG000|NOT COMPLETED|Overall Study||1
6760673|NCT03611075|7687611|FG001|NOT COMPLETED|Overall Study||2
6760674|NCT03611075|7687612|FG002|NOT COMPLETED|Overall Study||2
6760675|NCT03611075|7687613|FG003|NOT COMPLETED|Overall Study||4
6760676|NCT03611075|7687614|FG004|NOT COMPLETED|Overall Study||0
6760677|NCT03611075|7687615|FG005|NOT COMPLETED|Overall Study||0
6760678|NCT03611075|7687616|FG006|NOT COMPLETED|Overall Study||2
6760679|NCT03611075|7687617|FG007|NOT COMPLETED|Overall Study||0
6760680|NCT03611075|7687618|FG008|NOT COMPLETED|Overall Study||0
6760681|NCT03611582|7687663|FG000|STARTED|Overall Study||407
6760682|NCT03611582|7687664|FG001|STARTED|Overall Study||204
6760683|NCT03611582|7687663|FG000|Full Analysis Set (FAS)|Overall Study||407
6760684|NCT03611582|7687664|FG001|Full Analysis Set (FAS)|Overall Study||204
6760685|NCT03611582|7687663|FG000|Safety Analysis Set (SAS)|Overall Study||407
6760686|NCT03611582|7687664|FG001|Safety Analysis Set (SAS)|Overall Study||204
6760687|NCT03611582|7687663|FG000|COMPLETED|Overall Study||339
6760688|NCT03611582|7687664|FG001|COMPLETED|Overall Study||166
6760689|NCT03611582|7687663|FG000|NOT COMPLETED|Overall Study||68
6760690|NCT03611582|7687664|FG001|NOT COMPLETED|Overall Study||38
6760691|NCT03611777|7687672|FG000|STARTED|Overall Study||432
6760692|NCT03611777|7687673|FG001|STARTED|Overall Study||469
6760693|NCT03611777|7687672|FG000|COMPLETED|Overall Study||432
6760694|NCT03611777|7687673|FG001|COMPLETED|Overall Study||469
6760695|NCT03611777|7687672|FG000|NOT COMPLETED|Overall Study||0
6760696|NCT03611777|7687673|FG001|NOT COMPLETED|Overall Study||0
6760697|NCT03611829|7687684|FG000|STARTED|Overall Study||43
6760698|NCT03611829|7687685|FG001|STARTED|Overall Study||44
6760699|NCT03611829|7687684|FG000|COMPLETED|Overall Study||21
6760700|NCT03611829|7687685|FG001|COMPLETED|Overall Study||19
6760701|NCT03611829|7687684|FG000|NOT COMPLETED|Overall Study||22
6760702|NCT03611829|7687685|FG001|NOT COMPLETED|Overall Study||25
6760703|NCT03613129|7687696|FG000|STARTED|Pre-treatment Assessment||3
6760704|NCT03613129|7687697|FG001|STARTED|Pre-treatment Assessment||3
6760705|NCT03613129|7687698|FG002|STARTED|Pre-treatment Assessment||7
6760706|NCT03613129|7687699|FG003|STARTED|Pre-treatment Assessment||2
6760707|NCT03613129|7687700|FG004|STARTED|Pre-treatment Assessment||2
6760708|NCT03613129|7687696|FG000|COMPLETED|Pre-treatment Assessment||0
6760709|NCT03613129|7687697|FG001|COMPLETED|Pre-treatment Assessment||3
6760710|NCT03613129|7687698|FG002|COMPLETED|Pre-treatment Assessment||7
6760711|NCT03613129|7687699|FG003|COMPLETED|Pre-treatment Assessment||2
6760712|NCT03613129|7687700|FG004|COMPLETED|Pre-treatment Assessment||2
6760713|NCT03613129|7687696|FG000|NOT COMPLETED|Pre-treatment Assessment||3
6760714|NCT03613129|7687697|FG001|NOT COMPLETED|Pre-treatment Assessment||0
6760715|NCT03613129|7687698|FG002|NOT COMPLETED|Pre-treatment Assessment||0
6760716|NCT03613129|7687699|FG003|NOT COMPLETED|Pre-treatment Assessment||0
6760717|NCT03613129|7687700|FG004|NOT COMPLETED|Pre-treatment Assessment||0
6760718|NCT03613129|7687696|FG000|STARTED|Treatment||0
6760719|NCT03613129|7687697|FG001|STARTED|Treatment||3
6760720|NCT03613129|7687698|FG002|STARTED|Treatment||7
6760721|NCT03613129|7687699|FG003|STARTED|Treatment||2
6760722|NCT03613129|7687700|FG004|STARTED|Treatment||2
6760723|NCT03613129|7687696|FG000|COMPLETED|Treatment||0
6760724|NCT03613129|7687697|FG001|COMPLETED|Treatment|ID35 received only 1 infusion (due to symptom worsening)|3
6760725|NCT03613129|7687698|FG002|COMPLETED|Treatment||7
6760726|NCT03613129|7687699|FG003|COMPLETED|Treatment|ID34 did not receive 3rd infusion (for lack of venous access)|2
6760727|NCT03613129|7687700|FG004|COMPLETED|Treatment||2
6760728|NCT03613129|7687696|FG000|NOT COMPLETED|Treatment||0
6760729|NCT03613129|7687697|FG001|NOT COMPLETED|Treatment||0
6760730|NCT03613129|7687698|FG002|NOT COMPLETED|Treatment||0
6760731|NCT03613129|7687699|FG003|NOT COMPLETED|Treatment||0
6760732|NCT03613129|7687700|FG004|NOT COMPLETED|Treatment||0
6760733|NCT03613129|7687696|FG000|STARTED|Post-treatment Assessment||0
6760734|NCT03613129|7687697|FG001|STARTED|Post-treatment Assessment||3
6760735|NCT03613129|7687698|FG002|STARTED|Post-treatment Assessment||7
6760736|NCT03613129|7687699|FG003|STARTED|Post-treatment Assessment||2
6760737|NCT03613129|7687700|FG004|STARTED|Post-treatment Assessment||2
6760738|NCT03613129|7687696|FG000|COMPLETED|Post-treatment Assessment||0
6760739|NCT03613129|7687697|FG001|COMPLETED|Post-treatment Assessment||3
6760740|NCT03613129|7687698|FG002|COMPLETED|Post-treatment Assessment||7
6760741|NCT03613129|7687699|FG003|COMPLETED|Post-treatment Assessment||2
6760742|NCT03613129|7687700|FG004|COMPLETED|Post-treatment Assessment||2
6760743|NCT03613129|7687696|FG000|NOT COMPLETED|Post-treatment Assessment||0
6760744|NCT03613129|7687697|FG001|NOT COMPLETED|Post-treatment Assessment||0
6760745|NCT03613129|7687698|FG002|NOT COMPLETED|Post-treatment Assessment||0
6760746|NCT03613129|7687699|FG003|NOT COMPLETED|Post-treatment Assessment||0
6760747|NCT03613129|7687700|FG004|NOT COMPLETED|Post-treatment Assessment||0
6760748|NCT03613454|7687714|FG000|STARTED|Overall Study||24
6760749|NCT03613454|7687715|FG001|STARTED|Overall Study||24
6760750|NCT03613454|7687714|FG000|COMPLETED|Overall Study||23
6760751|NCT03613454|7687715|FG001|COMPLETED|Overall Study||23
6760752|NCT03613454|7687714|FG000|NOT COMPLETED|Overall Study||1
6760753|NCT03613454|7687715|FG001|NOT COMPLETED|Overall Study||1
6760754|NCT03613493|7687725|FG000|STARTED|Overall Study||10
6760755|NCT03613493|7687726|FG001|STARTED|Overall Study||75
6760756|NCT03613493|7687727|FG002|STARTED|Overall Study||0
6760757|NCT03613493|7687728|FG003|STARTED|Overall Study||90
6760758|NCT03613493|7687725|FG000|Enrollment Criteria Met|Overall Study||10
6760759|NCT03613493|7687726|FG001|Enrollment Criteria Met|Overall Study||74
6760760|NCT03613493|7687727|FG002|Enrollment Criteria Met|Overall Study||0
6760761|NCT03613493|7687728|FG003|Enrollment Criteria Met|Overall Study||89
6760762|NCT03613493|7687725|FG000|COMPLETED|Overall Study||10
6760763|NCT03613493|7687726|FG001|COMPLETED|Overall Study||73
6760764|NCT03613493|7687727|FG002|COMPLETED|Overall Study||0
6760765|NCT03613493|7687728|FG003|COMPLETED|Overall Study||83
6760766|NCT03613493|7687725|FG000|NOT COMPLETED|Overall Study||0
6760767|NCT03613493|7687726|FG001|NOT COMPLETED|Overall Study||2
6760768|NCT03613493|7687727|FG002|NOT COMPLETED|Overall Study||0
6760769|NCT03613493|7687728|FG003|NOT COMPLETED|Overall Study||7
6760770|NCT03613649|7687749|FG000|STARTED|First Treatment||6
6760771|NCT03613649|7687750|FG001|STARTED|First Treatment||6
6760772|NCT03613649|7687751|FG002|STARTED|First Treatment||6
6760773|NCT03613649|7687752|FG003|STARTED|First Treatment||6
6760774|NCT03613649|7687753|FG004|STARTED|First Treatment||6
6760775|NCT03613649|7687754|FG005|STARTED|First Treatment||6
6760776|NCT03613649|7687755|FG006|STARTED|First Treatment||6
6760777|NCT03613649|7687756|FG007|STARTED|First Treatment||6
6760778|NCT03613649|7687757|FG008|STARTED|First Treatment||6
6760779|NCT03613649|7687758|FG009|STARTED|First Treatment||6
6760780|NCT03613649|7687759|FG010|STARTED|First Treatment||6
6760781|NCT03613649|7687760|FG011|STARTED|First Treatment||6
6760782|NCT03613649|7687749|FG000|Received Treatment|First Treatment||6
6760783|NCT03613649|7687750|FG001|Received Treatment|First Treatment||6
6760784|NCT03613649|7687751|FG002|Received Treatment|First Treatment||6
6760785|NCT03613649|7687752|FG003|Received Treatment|First Treatment||6
6760786|NCT03613649|7687753|FG004|Received Treatment|First Treatment||6
6760787|NCT03613649|7687754|FG005|Received Treatment|First Treatment||6
6760788|NCT03613649|7687755|FG006|Received Treatment|First Treatment||6
6760789|NCT03613649|7687756|FG007|Received Treatment|First Treatment||6
6760790|NCT03613649|7687757|FG008|Received Treatment|First Treatment||6
6760791|NCT03613649|7687758|FG009|Received Treatment|First Treatment||6
6760792|NCT03613649|7687759|FG010|Received Treatment|First Treatment||6
6760793|NCT03613649|7687760|FG011|Received Treatment|First Treatment||6
6760794|NCT03613649|7687749|FG000|COMPLETED|First Treatment||6
6760795|NCT03613649|7687750|FG001|COMPLETED|First Treatment||6
6760796|NCT03613649|7687751|FG002|COMPLETED|First Treatment||6
6760797|NCT03613649|7687752|FG003|COMPLETED|First Treatment||6
6760798|NCT03613649|7687753|FG004|COMPLETED|First Treatment||6
6760799|NCT03613649|7687754|FG005|COMPLETED|First Treatment||6
6760800|NCT03613649|7687755|FG006|COMPLETED|First Treatment||6
6760801|NCT03613649|7687756|FG007|COMPLETED|First Treatment||6
6760802|NCT03613649|7687757|FG008|COMPLETED|First Treatment||6
6760803|NCT03613649|7687758|FG009|COMPLETED|First Treatment||6
6760804|NCT03613649|7687759|FG010|COMPLETED|First Treatment||6
6760805|NCT03613649|7687760|FG011|COMPLETED|First Treatment||6
6760806|NCT03613649|7687749|FG000|NOT COMPLETED|First Treatment||0
6760807|NCT03613649|7687750|FG001|NOT COMPLETED|First Treatment||0
6760808|NCT03613649|7687751|FG002|NOT COMPLETED|First Treatment||0
6760809|NCT03613649|7687752|FG003|NOT COMPLETED|First Treatment||0
6760810|NCT03613649|7687753|FG004|NOT COMPLETED|First Treatment||0
6760811|NCT03613649|7687754|FG005|NOT COMPLETED|First Treatment||0
6760812|NCT03613649|7687755|FG006|NOT COMPLETED|First Treatment||0
6760813|NCT03613649|7687756|FG007|NOT COMPLETED|First Treatment||0
6760814|NCT03613649|7687757|FG008|NOT COMPLETED|First Treatment||0
6760815|NCT03613649|7687758|FG009|NOT COMPLETED|First Treatment||0
6760816|NCT03613649|7687759|FG010|NOT COMPLETED|First Treatment||0
6760817|NCT03613649|7687760|FG011|NOT COMPLETED|First Treatment||0
6760818|NCT03613649|7687749|FG000|STARTED|Second Treatment||6
6760819|NCT03613649|7687750|FG001|STARTED|Second Treatment||6
6760820|NCT03613649|7687751|FG002|STARTED|Second Treatment||6
6760821|NCT03613649|7687752|FG003|STARTED|Second Treatment||6
6760822|NCT03613649|7687753|FG004|STARTED|Second Treatment||6
6760823|NCT03613649|7687754|FG005|STARTED|Second Treatment||6
6760824|NCT03613649|7687755|FG006|STARTED|Second Treatment||6
6760825|NCT03613649|7687756|FG007|STARTED|Second Treatment||6
6760826|NCT03613649|7687757|FG008|STARTED|Second Treatment||6
6760827|NCT03613649|7687758|FG009|STARTED|Second Treatment||6
6760828|NCT03613649|7687759|FG010|STARTED|Second Treatment||6
6760829|NCT03613649|7687760|FG011|STARTED|Second Treatment||6
6760830|NCT03613649|7687749|FG000|Received Treatment|Second Treatment||6
6760831|NCT03613649|7687750|FG001|Received Treatment|Second Treatment||6
6760832|NCT03613649|7687751|FG002|Received Treatment|Second Treatment||6
6760833|NCT03613649|7687752|FG003|Received Treatment|Second Treatment||6
6760834|NCT03613649|7687753|FG004|Received Treatment|Second Treatment||6
6760835|NCT03613649|7687754|FG005|Received Treatment|Second Treatment||6
6760836|NCT03613649|7687755|FG006|Received Treatment|Second Treatment||6
6760837|NCT03613649|7687756|FG007|Received Treatment|Second Treatment||6
6760838|NCT03613649|7687757|FG008|Received Treatment|Second Treatment||6
6760839|NCT03613649|7687758|FG009|Received Treatment|Second Treatment||6
6760840|NCT03613649|7687759|FG010|Received Treatment|Second Treatment||6
6760841|NCT03613649|7687760|FG011|Received Treatment|Second Treatment||6
6760842|NCT03613649|7687749|FG000|COMPLETED|Second Treatment||6
6760843|NCT03613649|7687750|FG001|COMPLETED|Second Treatment||6
6760844|NCT03613649|7687751|FG002|COMPLETED|Second Treatment||5
6760845|NCT03613649|7687752|FG003|COMPLETED|Second Treatment||6
6760846|NCT03613649|7687753|FG004|COMPLETED|Second Treatment||5
6760847|NCT03613649|7687754|FG005|COMPLETED|Second Treatment||6
6760848|NCT03613649|7687755|FG006|COMPLETED|Second Treatment||6
6760849|NCT03613649|7687756|FG007|COMPLETED|Second Treatment||6
6760850|NCT03613649|7687757|FG008|COMPLETED|Second Treatment||6
6760851|NCT03613649|7687758|FG009|COMPLETED|Second Treatment||6
6760852|NCT03613649|7687759|FG010|COMPLETED|Second Treatment||6
6760853|NCT03613649|7687760|FG011|COMPLETED|Second Treatment||6
6760854|NCT03613649|7687749|FG000|NOT COMPLETED|Second Treatment||0
6760855|NCT03613649|7687750|FG001|NOT COMPLETED|Second Treatment||0
6760856|NCT03613649|7687751|FG002|NOT COMPLETED|Second Treatment||1
6760857|NCT03613649|7687752|FG003|NOT COMPLETED|Second Treatment||0
6760858|NCT03613649|7687753|FG004|NOT COMPLETED|Second Treatment||1
6760859|NCT03613649|7687754|FG005|NOT COMPLETED|Second Treatment||0
6760860|NCT03613649|7687755|FG006|NOT COMPLETED|Second Treatment||0
6760861|NCT03613649|7687756|FG007|NOT COMPLETED|Second Treatment||0
6760862|NCT03613649|7687757|FG008|NOT COMPLETED|Second Treatment||0
6760863|NCT03613649|7687758|FG009|NOT COMPLETED|Second Treatment||0
6760864|NCT03613649|7687759|FG010|NOT COMPLETED|Second Treatment||0
6760865|NCT03613649|7687760|FG011|NOT COMPLETED|Second Treatment||0
6760866|NCT03613649|7687749|FG000|STARTED|Third Treatment||6
6760867|NCT03613649|7687750|FG001|STARTED|Third Treatment||6
6760868|NCT03613649|7687751|FG002|STARTED|Third Treatment||5
6760869|NCT03613649|7687752|FG003|STARTED|Third Treatment||6
6760870|NCT03613649|7687753|FG004|STARTED|Third Treatment||5
6760871|NCT03613649|7687754|FG005|STARTED|Third Treatment||6
6760872|NCT03613649|7687755|FG006|STARTED|Third Treatment||6
6760873|NCT03613649|7687756|FG007|STARTED|Third Treatment||6
6760874|NCT03613649|7687757|FG008|STARTED|Third Treatment||6
6760875|NCT03613649|7687758|FG009|STARTED|Third Treatment||6
6760876|NCT03613649|7687759|FG010|STARTED|Third Treatment||6
6760877|NCT03613649|7687760|FG011|STARTED|Third Treatment||6
6760878|NCT03613649|7687749|FG000|Received Treatment|Third Treatment||6
6760879|NCT03613649|7687750|FG001|Received Treatment|Third Treatment||6
6760880|NCT03613649|7687751|FG002|Received Treatment|Third Treatment||5
6760881|NCT03613649|7687752|FG003|Received Treatment|Third Treatment||6
6760882|NCT03613649|7687753|FG004|Received Treatment|Third Treatment||5
6760883|NCT03613649|7687754|FG005|Received Treatment|Third Treatment||6
6760884|NCT03613649|7687755|FG006|Received Treatment|Third Treatment||5
6760885|NCT03613649|7687756|FG007|Received Treatment|Third Treatment||6
6760886|NCT03613649|7687757|FG008|Received Treatment|Third Treatment||6
6760887|NCT03613649|7687758|FG009|Received Treatment|Third Treatment||6
6760888|NCT03613649|7687759|FG010|Received Treatment|Third Treatment||6
6760889|NCT03613649|7687760|FG011|Received Treatment|Third Treatment||6
6760890|NCT03613649|7687749|FG000|COMPLETED|Third Treatment||6
6760891|NCT03613649|7687750|FG001|COMPLETED|Third Treatment||6
6760892|NCT03613649|7687751|FG002|COMPLETED|Third Treatment||5
6760893|NCT03613649|7687752|FG003|COMPLETED|Third Treatment||6
6760894|NCT03613649|7687753|FG004|COMPLETED|Third Treatment||4
6760895|NCT03613649|7687754|FG005|COMPLETED|Third Treatment||6
6760896|NCT03613649|7687755|FG006|COMPLETED|Third Treatment||5
6760897|NCT03613649|7687756|FG007|COMPLETED|Third Treatment||6
6760898|NCT03613649|7687757|FG008|COMPLETED|Third Treatment||6
6760899|NCT03613649|7687758|FG009|COMPLETED|Third Treatment||6
6760900|NCT03613649|7687759|FG010|COMPLETED|Third Treatment||6
6760901|NCT03613649|7687760|FG011|COMPLETED|Third Treatment||4
6760902|NCT03613649|7687749|FG000|NOT COMPLETED|Third Treatment||0
6760903|NCT03613649|7687750|FG001|NOT COMPLETED|Third Treatment||0
6760904|NCT03613649|7687751|FG002|NOT COMPLETED|Third Treatment||0
6760905|NCT03613649|7687752|FG003|NOT COMPLETED|Third Treatment||0
6760906|NCT03613649|7687753|FG004|NOT COMPLETED|Third Treatment||1
6760907|NCT03613649|7687754|FG005|NOT COMPLETED|Third Treatment||0
6760908|NCT03613649|7687755|FG006|NOT COMPLETED|Third Treatment||1
6760909|NCT03613649|7687756|FG007|NOT COMPLETED|Third Treatment||0
6760910|NCT03613649|7687757|FG008|NOT COMPLETED|Third Treatment||0
6760911|NCT03613649|7687758|FG009|NOT COMPLETED|Third Treatment||0
6760912|NCT03613649|7687759|FG010|NOT COMPLETED|Third Treatment||0
6760913|NCT03613649|7687760|FG011|NOT COMPLETED|Third Treatment||2
6760914|NCT03613649|7687749|FG000|STARTED|Fourth Treatment||6
6760915|NCT03613649|7687750|FG001|STARTED|Fourth Treatment||6
6760916|NCT03613649|7687751|FG002|STARTED|Fourth Treatment||5
6760917|NCT03613649|7687752|FG003|STARTED|Fourth Treatment||6
6760918|NCT03613649|7687753|FG004|STARTED|Fourth Treatment||4
6760919|NCT03613649|7687754|FG005|STARTED|Fourth Treatment||6
6760920|NCT03613649|7687755|FG006|STARTED|Fourth Treatment||5
6760921|NCT03613649|7687756|FG007|STARTED|Fourth Treatment||6
6760922|NCT03613649|7687757|FG008|STARTED|Fourth Treatment||6
6760923|NCT03613649|7687758|FG009|STARTED|Fourth Treatment||6
6760924|NCT03613649|7687759|FG010|STARTED|Fourth Treatment||6
6760925|NCT03613649|7687760|FG011|STARTED|Fourth Treatment||4
6760926|NCT03613649|7687749|FG000|Received Treatment|Fourth Treatment||5
6760927|NCT03613649|7687750|FG001|Received Treatment|Fourth Treatment||6
6760928|NCT03613649|7687751|FG002|Received Treatment|Fourth Treatment||5
6760929|NCT03613649|7687752|FG003|Received Treatment|Fourth Treatment||6
6760930|NCT03613649|7687753|FG004|Received Treatment|Fourth Treatment||4
6760931|NCT03613649|7687754|FG005|Received Treatment|Fourth Treatment||6
6760932|NCT03613649|7687755|FG006|Received Treatment|Fourth Treatment||4
6760933|NCT03613649|7687756|FG007|Received Treatment|Fourth Treatment||6
6760934|NCT03613649|7687757|FG008|Received Treatment|Fourth Treatment||6
6760935|NCT03613649|7687758|FG009|Received Treatment|Fourth Treatment||6
6760936|NCT03613649|7687759|FG010|Received Treatment|Fourth Treatment||6
6760937|NCT03613649|7687760|FG011|Received Treatment|Fourth Treatment||4
6760938|NCT03613649|7687749|FG000|COMPLETED|Fourth Treatment||5
6760939|NCT03613649|7687750|FG001|COMPLETED|Fourth Treatment||6
6760940|NCT03613649|7687751|FG002|COMPLETED|Fourth Treatment||5
6760941|NCT03613649|7687752|FG003|COMPLETED|Fourth Treatment||6
6760942|NCT03613649|7687753|FG004|COMPLETED|Fourth Treatment||3
6760943|NCT03613649|7687754|FG005|COMPLETED|Fourth Treatment||6
6760944|NCT03613649|7687755|FG006|COMPLETED|Fourth Treatment||4
6760945|NCT03613649|7687756|FG007|COMPLETED|Fourth Treatment||6
6760946|NCT03613649|7687757|FG008|COMPLETED|Fourth Treatment||6
6760947|NCT03613649|7687758|FG009|COMPLETED|Fourth Treatment||6
6760948|NCT03613649|7687759|FG010|COMPLETED|Fourth Treatment||6
6760949|NCT03613649|7687760|FG011|COMPLETED|Fourth Treatment||4
6760950|NCT03613649|7687749|FG000|NOT COMPLETED|Fourth Treatment||1
6760951|NCT03613649|7687750|FG001|NOT COMPLETED|Fourth Treatment||0
6760952|NCT03613649|7687751|FG002|NOT COMPLETED|Fourth Treatment||0
6760953|NCT03613649|7687752|FG003|NOT COMPLETED|Fourth Treatment||0
6760954|NCT03613649|7687753|FG004|NOT COMPLETED|Fourth Treatment||1
6760955|NCT03613649|7687754|FG005|NOT COMPLETED|Fourth Treatment||0
6760956|NCT03613649|7687755|FG006|NOT COMPLETED|Fourth Treatment||1
6760957|NCT03613649|7687756|FG007|NOT COMPLETED|Fourth Treatment||0
6760958|NCT03613649|7687757|FG008|NOT COMPLETED|Fourth Treatment||0
6760959|NCT03613649|7687758|FG009|NOT COMPLETED|Fourth Treatment||0
6760960|NCT03613649|7687759|FG010|NOT COMPLETED|Fourth Treatment||0
6760961|NCT03613649|7687760|FG011|NOT COMPLETED|Fourth Treatment||0
6760962|NCT03613818|7687780|FG000|STARTED|Overall Study||174
6760963|NCT03613818|7687781|FG001|STARTED|Overall Study||137
6760964|NCT03613818|7687780|FG000|COMPLETED|Overall Study||137
6760965|NCT03613818|7687781|FG001|COMPLETED|Overall Study||110
6760966|NCT03613818|7687780|FG000|NOT COMPLETED|Overall Study||37
6760967|NCT03613818|7687781|FG001|NOT COMPLETED|Overall Study||27
6760968|NCT03614078|7687790|FG000|STARTED|Overall Study||31
6760969|NCT03614078|7687791|FG001|STARTED|Overall Study||30
6760970|NCT03614078|7687792|FG002|STARTED|Overall Study||31
6760971|NCT03614078|7687790|FG000|COMPLETED|Overall Study||28
6760972|NCT03614078|7687791|FG001|COMPLETED|Overall Study||23
6760973|NCT03614078|7687792|FG002|COMPLETED|Overall Study||26
6760974|NCT03614078|7687790|FG000|NOT COMPLETED|Overall Study||3
6760975|NCT03614078|7687791|FG001|NOT COMPLETED|Overall Study||7
6760976|NCT03614078|7687792|FG002|NOT COMPLETED|Overall Study||5
6760977|NCT03614130|7687802|FG000|STARTED|Overall Study||10
6760978|NCT03614130|7687803|FG001|STARTED|Overall Study||12
6760979|NCT03614130|7687802|FG000|COMPLETED|Overall Study||10
6760980|NCT03614130|7687803|FG001|COMPLETED|Overall Study||12
6760981|NCT03614130|7687802|FG000|NOT COMPLETED|Overall Study||0
6760982|NCT03614130|7687803|FG001|NOT COMPLETED|Overall Study||0
6760983|NCT03614156|7687814|FG000|STARTED|Open-Label Treatment Period||363
6760984|NCT03614156|7687815|FG001|STARTED|Open-Label Treatment Period||0
6760985|NCT03614156|7687816|FG002|STARTED|Open-Label Treatment Period||0
6760986|NCT03614156|7687817|FG003|STARTED|Open-Label Treatment Period||0
6760987|NCT03614156|7687814|FG000|COMPLETED|Open-Label Treatment Period||209
6760988|NCT03614156|7687815|FG001|COMPLETED|Open-Label Treatment Period||0
6760989|NCT03614156|7687816|FG002|COMPLETED|Open-Label Treatment Period||0
6760990|NCT03614156|7687817|FG003|COMPLETED|Open-Label Treatment Period||0
6760991|NCT03614156|7687814|FG000|NOT COMPLETED|Open-Label Treatment Period||154
6760992|NCT03614156|7687815|FG001|NOT COMPLETED|Open-Label Treatment Period||0
6760993|NCT03614156|7687816|FG002|NOT COMPLETED|Open-Label Treatment Period||0
6760994|NCT03614156|7687817|FG003|NOT COMPLETED|Open-Label Treatment Period||0
6760995|NCT03614156|7687814|FG000|STARTED|Double-Blind Treatment Period (DBTP)||0
6760996|NCT03614156|7687815|FG001|STARTED|Double-Blind Treatment Period (DBTP)||40
6760997|NCT03614156|7687816|FG002|STARTED|Double-Blind Treatment Period (DBTP)||42
6760998|NCT03614156|7687817|FG003|STARTED|Double-Blind Treatment Period (DBTP)||55
6760999|NCT03614156|7687814|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||0
6761000|NCT03614156|7687815|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||10
6761001|NCT03614156|7687816|FG002|COMPLETED|Double-Blind Treatment Period (DBTP)||11
6761002|NCT03614156|7687817|FG003|COMPLETED|Double-Blind Treatment Period (DBTP)||10
6761003|NCT03614156|7687814|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
6761004|NCT03614156|7687815|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||30
6761005|NCT03614156|7687816|FG002|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||31
6761006|NCT03614156|7687817|FG003|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||45
6761007|NCT03614156|7687814|FG000|STARTED|Safety Follow-Up Period||165
6761008|NCT03614156|7687815|FG001|STARTED|Safety Follow-Up Period||26
6761009|NCT03614156|7687816|FG002|STARTED|Safety Follow-Up Period||30
6761010|NCT03614156|7687817|FG003|STARTED|Safety Follow-Up Period||35
6761011|NCT03614156|7687814|FG000|COMPLETED|Safety Follow-Up Period||162
6761012|NCT03614156|7687815|FG001|COMPLETED|Safety Follow-Up Period||26
6761013|NCT03614156|7687816|FG002|COMPLETED|Safety Follow-Up Period||29
6761014|NCT03614156|7687817|FG003|COMPLETED|Safety Follow-Up Period||34
6761015|NCT03614156|7687814|FG000|NOT COMPLETED|Safety Follow-Up Period||3
6761016|NCT03614156|7687815|FG001|NOT COMPLETED|Safety Follow-Up Period||0
6761017|NCT03614156|7687816|FG002|NOT COMPLETED|Safety Follow-Up Period||1
6761018|NCT03614156|7687817|FG003|NOT COMPLETED|Safety Follow-Up Period||1
6761019|NCT03614416|7687826|FG000|STARTED|Overall Study||13
6761020|NCT03614416|7687826|FG000|COMPLETED|Overall Study||13
6761021|NCT03614416|7687826|FG000|NOT COMPLETED|Overall Study||0
6761022|NCT03614975|7687834|FG000|STARTED|Overall Study||85
6761023|NCT03614975|7687835|FG001|STARTED|Overall Study||81
6761024|NCT03614975|7687834|FG000|COMPLETED|Overall Study||75
6761025|NCT03614975|7687835|FG001|COMPLETED|Overall Study||73
6761026|NCT03614975|7687834|FG000|NOT COMPLETED|Overall Study||10
6761027|NCT03614975|7687835|FG001|NOT COMPLETED|Overall Study||8
6761028|NCT03615001|7687841|FG000|STARTED|Overall Study||20
6761029|NCT03615001|7687841|FG000|COMPLETED|Overall Study||20
6761030|NCT03615001|7687841|FG000|NOT COMPLETED|Overall Study||0
6761031|NCT03615066|7687848|FG000|STARTED|Overall Study||26
6761032|NCT03615066|7687849|FG001|STARTED|Overall Study||28
6761033|NCT03615066|7687850|FG002|STARTED|Overall Study||13
6761034|NCT03615066|7687848|FG000|COMPLETED|Overall Study||17
6761035|NCT03615066|7687849|FG001|COMPLETED|Overall Study||20
6761036|NCT03615066|7687850|FG002|COMPLETED|Overall Study||9
6761037|NCT03615066|7687848|FG000|NOT COMPLETED|Overall Study||9
6761038|NCT03615066|7687849|FG001|NOT COMPLETED|Overall Study||8
6761039|NCT03615066|7687850|FG002|NOT COMPLETED|Overall Study||4
6761040|NCT03615079|7687862|FG000|STARTED|Overall Study||28
6761041|NCT03615079|7687862|FG000|COMPLETED|Overall Study||11
6761042|NCT03615079|7687862|FG000|NOT COMPLETED|Overall Study||17
6761043|NCT03615183|7687871|FG000|STARTED|Overall Study||6
6761044|NCT03615183|7687872|FG001|STARTED|Overall Study||6
6761045|NCT03615183|7687873|FG002|STARTED|Overall Study||5
6761046|NCT03615183|7687874|FG003|STARTED|Overall Study|Panel D was not conducted as the scientific study objectives were met in the conducted panels.|0
6761047|NCT03615183|7687875|FG004|STARTED|Overall Study|Panel E was not conducted as the scientific study objectives were met in the conducted panels.|0
6761048|NCT03615183|7687871|FG000|COMPLETED|Overall Study||6
6761049|NCT03615183|7687872|FG001|COMPLETED|Overall Study||6
6761050|NCT03615183|7687873|FG002|COMPLETED|Overall Study||5
6761051|NCT03615183|7687874|FG003|COMPLETED|Overall Study||0
6761052|NCT03615183|7687875|FG004|COMPLETED|Overall Study||0
6556038|NCT01755949|7478250|FG005|NOT COMPLETED|Overall Study||0
6556039|NCT01756053|7478264|FG000|STARTED|Period 1 (10 Days)||8
6556040|NCT01756053|7478265|FG001|STARTED|Period 1 (10 Days)||9
6556041|NCT01756053|7478264|FG000|COMPLETED|Period 1 (10 Days)||7
6556042|NCT01756053|7478265|FG001|COMPLETED|Period 1 (10 Days)||8
6556043|NCT01756053|7478264|FG000|NOT COMPLETED|Period 1 (10 Days)||1
6761053|NCT03615183|7687871|FG000|NOT COMPLETED|Overall Study||0
6761054|NCT03615183|7687872|FG001|NOT COMPLETED|Overall Study||0
6761055|NCT03615183|7687873|FG002|NOT COMPLETED|Overall Study||0
6761056|NCT03615183|7687874|FG003|NOT COMPLETED|Overall Study||0
6761057|NCT03615183|7687875|FG004|NOT COMPLETED|Overall Study||0
6761058|NCT03615404|7687883|FG000|STARTED|Overall Study||11
6761059|NCT03615404|7687883|FG000|COMPLETED|Overall Study||9
6761060|NCT03615404|7687883|FG000|NOT COMPLETED|Overall Study||2
6761061|NCT03615482|7687889|FG000|STARTED|Overall Study||600
6761062|NCT03615482|7687890|FG001|STARTED|Overall Study||600
6761063|NCT03615482|7687889|FG000|Vaccinated|Overall Study||599
6761064|NCT03615482|7687890|FG001|Vaccinated|Overall Study||598
6761065|NCT03615482|7687889|FG000|COMPLETED|Overall Study||583
6761066|NCT03615482|7687890|FG001|COMPLETED|Overall Study||583
6761067|NCT03615482|7687889|FG000|NOT COMPLETED|Overall Study||17
6761068|NCT03615482|7687890|FG001|NOT COMPLETED|Overall Study||17
6761069|NCT03615534|7687900|FG000|STARTED|Overall Study||14
6761070|NCT03615534|7687901|FG001|STARTED|Overall Study||15
6761071|NCT03615534|7687902|FG002|STARTED|Overall Study||14
6761072|NCT03615534|7687903|FG003|STARTED|Overall Study||14
6761073|NCT03615534|7687900|FG000|COMPLETED|Overall Study||12
6761074|NCT03615534|7687901|FG001|COMPLETED|Overall Study||15
6761075|NCT03615534|7687902|FG002|COMPLETED|Overall Study||14
6761076|NCT03615534|7687903|FG003|COMPLETED|Overall Study||13
6761077|NCT03615534|7687900|FG000|NOT COMPLETED|Overall Study||2
6761078|NCT03615534|7687901|FG001|NOT COMPLETED|Overall Study||0
6761079|NCT03615534|7687902|FG002|NOT COMPLETED|Overall Study||0
6761080|NCT03615534|7687903|FG003|NOT COMPLETED|Overall Study||1
6761081|NCT03615807|7687915|FG000|STARTED|Overall Study||91
6556044|NCT01756053|7478265|FG001|NOT COMPLETED|Period 1 (10 Days)||1
6556045|NCT01756053|7478264|FG000|STARTED|Washout Period (~21 Days)||7
6761082|NCT03615807|7687916|FG001|STARTED|Overall Study||91
6761083|NCT03615807|7687915|FG000|COMPLETED|Overall Study||79
6761084|NCT03615807|7687916|FG001|COMPLETED|Overall Study||80
6761085|NCT03615807|7687915|FG000|NOT COMPLETED|Overall Study||12
6761086|NCT03615807|7687916|FG001|NOT COMPLETED|Overall Study||11
6761087|NCT03615911|7687924|FG000|STARTED|Overall Study||14
6761088|NCT03615911|7687925|FG001|STARTED|Overall Study||12
6761089|NCT03615911|7687924|FG000|Received Late Booster Immunization|Overall Study||3
6556046|NCT01756053|7478265|FG001|STARTED|Washout Period (~21 Days)||8
6556047|NCT01756053|7478264|FG000|COMPLETED|Washout Period (~21 Days)||7
6761090|NCT03615911|7687925|FG001|Received Late Booster Immunization|Overall Study||7
6761091|NCT03615911|7687924|FG000|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|12
6761092|NCT03615911|7687925|FG001|COMPLETED|Overall Study|A subgroup received an additional booster of 1x10^8 PFU MVA-MERS-S 12 (+/-4) months after prime.|11
6761093|NCT03615911|7687924|FG000|NOT COMPLETED|Overall Study||2
6761094|NCT03615911|7687925|FG001|NOT COMPLETED|Overall Study||1
6761095|NCT03615924|7687935|FG000|STARTED|Overall Study||101
6761096|NCT03615924|7687936|FG001|STARTED|Overall Study||92
6761097|NCT03615924|7687935|FG000|Received Treatment|Overall Study||101
6761098|NCT03615924|7687936|FG001|Received Treatment|Overall Study||92
6761099|NCT03615924|7687935|FG000|COMPLETED|Overall Study||0
6761100|NCT03615924|7687936|FG001|COMPLETED|Overall Study||0
6761101|NCT03615924|7687935|FG000|NOT COMPLETED|Overall Study||101
6761102|NCT03615924|7687936|FG001|NOT COMPLETED|Overall Study||92
6761103|NCT03616106|7687944|FG000|STARTED|Overall Study||56
6761104|NCT03616106|7687945|FG001|STARTED|Overall Study||3
6761105|NCT03616106|7687944|FG000|COMPLETED|Overall Study||42
6761106|NCT03616106|7687945|FG001|COMPLETED|Overall Study||2
6761107|NCT03616106|7687944|FG000|NOT COMPLETED|Overall Study||14
6761108|NCT03616106|7687945|FG001|NOT COMPLETED|Overall Study||1
6761109|NCT03616171|7687952|FG000|STARTED|Overall Study||4
6761110|NCT03616171|7687953|FG001|STARTED|Overall Study||2
6761111|NCT03616171|7687952|FG000|COMPLETED|Overall Study||4
6761112|NCT03616171|7687953|FG001|COMPLETED|Overall Study||2
6761113|NCT03616171|7687952|FG000|NOT COMPLETED|Overall Study||0
6761114|NCT03616171|7687953|FG001|NOT COMPLETED|Overall Study||0
6761115|NCT03616600|7687962|FG000|STARTED|Overall Study||16
6761116|NCT03616600|7687963|FG001|STARTED|Overall Study||15
6761117|NCT03616600|7687962|FG000|COMPLETED|Overall Study||15
6761118|NCT03616600|7687963|FG001|COMPLETED|Overall Study||15
6761119|NCT03616600|7687962|FG000|NOT COMPLETED|Overall Study||1
6761120|NCT03616600|7687963|FG001|NOT COMPLETED|Overall Study||0
6761121|NCT03616899|7687972|FG000|STARTED|Overall Study||447
6761122|NCT03616899|7687973|FG001|STARTED|Overall Study||454
6761123|NCT03616899|7687972|FG000|COMPLETED|Overall Study||437
6761124|NCT03616899|7687973|FG001|COMPLETED|Overall Study||453
6761125|NCT03616899|7687972|FG000|NOT COMPLETED|Overall Study||10
6761126|NCT03616899|7687973|FG001|NOT COMPLETED|Overall Study||1
6761127|NCT03616977|7687979|FG000|STARTED|Period 1||34
6761128|NCT03616977|7687980|FG001|STARTED|Period 1||35
6761129|NCT03616977|7687979|FG000|Received at Least One Dose of Study Drug|Period 1||34
6761130|NCT03616977|7687980|FG001|Received at Least One Dose of Study Drug|Period 1||34
6761131|NCT03616977|7687979|FG000|COMPLETED|Period 1||34
6761132|NCT03616977|7687980|FG001|COMPLETED|Period 1||34
6761133|NCT03616977|7687979|FG000|NOT COMPLETED|Period 1||0
6761134|NCT03616977|7687980|FG001|NOT COMPLETED|Period 1||1
6761135|NCT03616977|7687979|FG000|STARTED|Period 2||34
6761136|NCT03616977|7687980|FG001|STARTED|Period 2||34
6761137|NCT03616977|7687979|FG000|COMPLETED|Period 2||34
6761138|NCT03616977|7687980|FG001|COMPLETED|Period 2||34
6761139|NCT03616977|7687979|FG000|NOT COMPLETED|Period 2||0
6761140|NCT03616977|7687980|FG001|NOT COMPLETED|Period 2||0
6761141|NCT03616977|7687979|FG000|STARTED|Period 3||34
6761142|NCT03616977|7687980|FG001|STARTED|Period 3|Participant completed Period 2 and withdrew from the study.|33
6761143|NCT03616977|7687979|FG000|Received Study Drug|Period 3|Participant not dosed due to adverse event.|33
6761144|NCT03616977|7687980|FG001|Received Study Drug|Period 3|Participant not dosed due to adverse event.|32
6761145|NCT03616977|7687979|FG000|COMPLETED|Period 3||33
6761146|NCT03616977|7687980|FG001|COMPLETED|Period 3||32
6761147|NCT03616977|7687979|FG000|NOT COMPLETED|Period 3||1
6761148|NCT03616977|7687980|FG001|NOT COMPLETED|Period 3||1
6761149|NCT03616977|7687979|FG000|STARTED|Period 4||33
6761150|NCT03616977|7687980|FG001|STARTED|Period 4||32
6761151|NCT03616977|7687979|FG000|COMPLETED|Period 4||33
6761152|NCT03616977|7687980|FG001|COMPLETED|Period 4||32
6761153|NCT03616977|7687979|FG000|NOT COMPLETED|Period 4||0
6761154|NCT03616977|7687980|FG001|NOT COMPLETED|Period 4||0
6761155|NCT03617419|7687987|FG000|STARTED|Part 1||2
6761156|NCT03617419|7687987|FG000|COMPLETED|Part 1||2
6761157|NCT03617419|7687987|FG000|NOT COMPLETED|Part 1||0
6761158|NCT03617419|7687987|FG000|STARTED|Part 2||14
6761159|NCT03617419|7687987|FG000|COMPLETED|Part 2||14
6761160|NCT03617419|7687987|FG000|NOT COMPLETED|Part 2||0
6761161|NCT03617588|7687993|FG000|STARTED|Overall Study||20
6761162|NCT03617588|7687994|FG001|STARTED|Overall Study||29
6761163|NCT03617588|7687993|FG000|COMPLETED|Overall Study||19
6761164|NCT03617588|7687994|FG001|COMPLETED|Overall Study||29
6761165|NCT03617588|7687993|FG000|NOT COMPLETED|Overall Study||1
6761166|NCT03617588|7687994|FG001|NOT COMPLETED|Overall Study||0
6761167|NCT03617770|7688006|FG000|STARTED|Overall Study|9|9
6761168|NCT03617770|7688007|FG001|STARTED|Overall Study|5|5
6761169|NCT03617770|7688006|FG000|COMPLETED|Overall Study|8|8
6761170|NCT03617770|7688007|FG001|COMPLETED|Overall Study||5
6761171|NCT03617770|7688006|FG000|NOT COMPLETED|Overall Study||1
6761172|NCT03617770|7688007|FG001|NOT COMPLETED|Overall Study||0
6761173|NCT03617861|7688015|FG000|STARTED|First Intervention (1 Day)||5
6761174|NCT03617861|7688016|FG001|STARTED|First Intervention (1 Day)||5
6761175|NCT03617861|7688017|FG002|STARTED|First Intervention (1 Day)||5
6761176|NCT03617861|7688018|FG003|STARTED|First Intervention (1 Day)||5
6761177|NCT03617861|7688015|FG000|COMPLETED|First Intervention (1 Day)||5
6761178|NCT03617861|7688016|FG001|COMPLETED|First Intervention (1 Day)||5
6761179|NCT03617861|7688017|FG002|COMPLETED|First Intervention (1 Day)||5
6761180|NCT03617861|7688018|FG003|COMPLETED|First Intervention (1 Day)||5
6761181|NCT03617861|7688015|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6761182|NCT03617861|7688016|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6761183|NCT03617861|7688017|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6761184|NCT03617861|7688018|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6761185|NCT03617861|7688015|FG000|STARTED|Washout (1 to 4 Weeks)||5
6761186|NCT03617861|7688016|FG001|STARTED|Washout (1 to 4 Weeks)||5
6761187|NCT03617861|7688017|FG002|STARTED|Washout (1 to 4 Weeks)||5
6761188|NCT03617861|7688018|FG003|STARTED|Washout (1 to 4 Weeks)||5
6761189|NCT03617861|7688015|FG000|COMPLETED|Washout (1 to 4 Weeks)||5
6761190|NCT03617861|7688016|FG001|COMPLETED|Washout (1 to 4 Weeks)||5
6761191|NCT03617861|7688017|FG002|COMPLETED|Washout (1 to 4 Weeks)||5
6761192|NCT03617861|7688018|FG003|COMPLETED|Washout (1 to 4 Weeks)||5
6761193|NCT03617861|7688015|FG000|NOT COMPLETED|Washout (1 to 4 Weeks)||0
6761194|NCT03617861|7688016|FG001|NOT COMPLETED|Washout (1 to 4 Weeks)||0
6761195|NCT03617861|7688017|FG002|NOT COMPLETED|Washout (1 to 4 Weeks)||0
6761196|NCT03617861|7688018|FG003|NOT COMPLETED|Washout (1 to 4 Weeks)||0
6761197|NCT03617861|7688015|FG000|STARTED|Second Intervention (1 Day)||5
6761198|NCT03617861|7688016|FG001|STARTED|Second Intervention (1 Day)||5
6761199|NCT03617861|7688017|FG002|STARTED|Second Intervention (1 Day)||5
6761200|NCT03617861|7688018|FG003|STARTED|Second Intervention (1 Day)||5
6761201|NCT03617861|7688015|FG000|COMPLETED|Second Intervention (1 Day)||5
6761202|NCT03617861|7688016|FG001|COMPLETED|Second Intervention (1 Day)||5
6761203|NCT03617861|7688017|FG002|COMPLETED|Second Intervention (1 Day)||4
6761204|NCT03617861|7688018|FG003|COMPLETED|Second Intervention (1 Day)||5
6761205|NCT03617861|7688015|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6761206|NCT03617861|7688016|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6761207|NCT03617861|7688017|FG002|NOT COMPLETED|Second Intervention (1 Day)||1
6761208|NCT03617861|7688018|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6761209|NCT03617913|7688028|FG000|STARTED|Overall Study||2
6761210|NCT03617913|7688028|FG000|COMPLETED|Overall Study||2
6761211|NCT03617913|7688028|FG000|NOT COMPLETED|Overall Study||0
6761212|NCT03618017|7688034|FG000|STARTED|Overall Study||33
6761213|NCT03618017|7688035|FG001|STARTED|Overall Study||33
6761214|NCT03618017|7688034|FG000|COMPLETED|Overall Study||26
6761215|NCT03618017|7688035|FG001|COMPLETED|Overall Study||28
6761216|NCT03618017|7688034|FG000|NOT COMPLETED|Overall Study||7
6761217|NCT03618017|7688035|FG001|NOT COMPLETED|Overall Study||5
6761218|NCT03618030|7688045|FG000|STARTED|Overall Study||15
6761219|NCT03618030|7688046|FG001|STARTED|Overall Study||14
6761220|NCT03618030|7688047|FG002|STARTED|Overall Study||21
6761221|NCT03618030|7688048|FG003|STARTED|Overall Study||39
6761222|NCT03618030|7688049|FG004|STARTED|Overall Study||36
6761223|NCT03618030|7688050|FG005|STARTED|Overall Study||27
6556048|NCT01756053|7478265|FG001|COMPLETED|Washout Period (~21 Days)||8
6556049|NCT01756053|7478264|FG000|NOT COMPLETED|Washout Period (~21 Days)||0
6556050|NCT01756053|7478265|FG001|NOT COMPLETED|Washout Period (~21 Days)||0
6556051|NCT01756053|7478264|FG000|STARTED|Period 2 (10 Days)||7
6556052|NCT01756053|7478265|FG001|STARTED|Period 2 (10 Days)||8
6761224|NCT03618030|7688051|FG006|STARTED|Overall Study||18
6761225|NCT03618030|7688052|FG007|STARTED|Overall Study||118
6761226|NCT03618030|7688045|FG000|COMPLETED|Overall Study||3
6761227|NCT03618030|7688046|FG001|COMPLETED|Overall Study||3
6761228|NCT03618030|7688047|FG002|COMPLETED|Overall Study||13
6761229|NCT03618030|7688048|FG003|COMPLETED|Overall Study||30
6761230|NCT03618030|7688049|FG004|COMPLETED|Overall Study||29
6761231|NCT03618030|7688050|FG005|COMPLETED|Overall Study||21
6761232|NCT03618030|7688051|FG006|COMPLETED|Overall Study||14
6761233|NCT03618030|7688052|FG007|COMPLETED|Overall Study||108
6761234|NCT03618030|7688045|FG000|NOT COMPLETED|Overall Study||12
6761235|NCT03618030|7688046|FG001|NOT COMPLETED|Overall Study||11
6761236|NCT03618030|7688047|FG002|NOT COMPLETED|Overall Study||8
6761237|NCT03618030|7688048|FG003|NOT COMPLETED|Overall Study||9
6761238|NCT03618030|7688049|FG004|NOT COMPLETED|Overall Study||7
6761239|NCT03618030|7688050|FG005|NOT COMPLETED|Overall Study||6
6761240|NCT03618030|7688051|FG006|NOT COMPLETED|Overall Study||4
6761241|NCT03618030|7688052|FG007|NOT COMPLETED|Overall Study||10
6761242|NCT03618147|7688065|FG000|STARTED|Overall Study||314
6761243|NCT03618147|7688065|FG000|COMPLETED|Overall Study||314
6761244|NCT03618147|7688065|FG000|NOT COMPLETED|Overall Study||0
6761245|NCT03618628|7688070|FG000|STARTED|Overall Study||3
6761246|NCT03618628|7688070|FG000|COMPLETED|Overall Study||1
6761247|NCT03618628|7688070|FG000|NOT COMPLETED|Overall Study||2
6761248|NCT03618823|7688076|FG000|STARTED|Overall Study||132
6761249|NCT03618823|7688077|FG001|STARTED|Overall Study||136
6761250|NCT03618823|7688076|FG000|COMPLETED|Overall Study||69
6761251|NCT03618823|7688077|FG001|COMPLETED|Overall Study||75
6761252|NCT03618823|7688076|FG000|NOT COMPLETED|Overall Study||63
6761253|NCT03618823|7688077|FG001|NOT COMPLETED|Overall Study||61
6761254|NCT03619135|7688088|FG000|STARTED|Overall Study||50
6761255|NCT03619135|7688089|FG001|STARTED|Overall Study||50
6761256|NCT03619135|7688088|FG000|COMPLETED|Overall Study||50
6761257|NCT03619135|7688089|FG001|COMPLETED|Overall Study||50
6761258|NCT03619135|7688088|FG000|NOT COMPLETED|Overall Study||0
6761259|NCT03619135|7688089|FG001|NOT COMPLETED|Overall Study||0
6761260|NCT03619590|7688095|FG000|STARTED|Overall Study||103
6761261|NCT03619590|7688095|FG000|COMPLETED|Overall Study||103
6761262|NCT03619590|7688095|FG000|NOT COMPLETED|Overall Study||0
6761263|NCT03619811|7688099|FG000|STARTED|Overall Study||43
6761264|NCT03619811|7688099|FG000|COMPLETED|Overall Study||31
6761265|NCT03619811|7688099|FG000|NOT COMPLETED|Overall Study||12
6761266|NCT03619837|7688103|FG000|STARTED|Screening||122
6761267|NCT03619837|7688103|FG000|COMPLETED|Screening||24
6761268|NCT03619837|7688103|FG000|NOT COMPLETED|Screening||98
6761269|NCT03619837|7688103|FG000|STARTED|Main Study||24
6761270|NCT03619837|7688103|FG000|COMPLETED|Main Study||24
6761271|NCT03619837|7688103|FG000|NOT COMPLETED|Main Study||0
6761272|NCT03619889|7688109|FG000|STARTED|Overall Study||37
6761273|NCT03619889|7688110|FG001|STARTED|Overall Study||37
6761274|NCT03619889|7688109|FG000|COMPLETED|Overall Study||35
6761275|NCT03619889|7688110|FG001|COMPLETED|Overall Study||37
6761276|NCT03619889|7688109|FG000|NOT COMPLETED|Overall Study||2
6761277|NCT03619889|7688110|FG001|NOT COMPLETED|Overall Study||0
6761278|NCT03620162|7688121|FG000|STARTED|Overall Study||179
6761279|NCT03620162|7688122|FG001|STARTED|Overall Study||181
6761280|NCT03620162|7688123|FG002|STARTED|Overall Study||180
6761281|NCT03620162|7688124|FG003|STARTED|Overall Study||180
6761282|NCT03620162|7688125|FG004|STARTED|Overall Study||180
6761283|NCT03620162|7688121|FG000|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
6761284|NCT03620162|7688122|FG001|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||181
6761285|NCT03620162|7688123|FG002|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||178
6761286|NCT03620162|7688124|FG003|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
6761287|NCT03620162|7688125|FG004|Vaccination 1 (V114 or Prevnar 13™)|Overall Study||179
6761288|NCT03620162|7688121|FG000|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||176
6761289|NCT03620162|7688122|FG001|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||175
6761290|NCT03620162|7688123|FG002|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||166
6761291|NCT03620162|7688124|FG003|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||169
6761292|NCT03620162|7688125|FG004|Vaccination 2 (V114 or Prevnar 13™)|Overall Study||173
6761293|NCT03620162|7688121|FG000|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||175
6761294|NCT03620162|7688122|FG001|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||174
6761295|NCT03620162|7688123|FG002|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||161
6761296|NCT03620162|7688124|FG003|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||167
6761297|NCT03620162|7688125|FG004|Vaccination 3 (V114 or Prevnar 13™)|Overall Study||173
6761298|NCT03620162|7688121|FG000|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||165
6761299|NCT03620162|7688122|FG001|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
6761300|NCT03620162|7688123|FG002|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||150
6761301|NCT03620162|7688124|FG003|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||162
6761302|NCT03620162|7688125|FG004|Vaccination 4 (V114 or Prevnar 13™)|Overall Study||168
6761303|NCT03620162|7688121|FG000|COMPLETED|Overall Study||164
6761304|NCT03620162|7688122|FG001|COMPLETED|Overall Study||167
6761305|NCT03620162|7688123|FG002|COMPLETED|Overall Study||147
6761306|NCT03620162|7688124|FG003|COMPLETED|Overall Study||160
6761307|NCT03620162|7688125|FG004|COMPLETED|Overall Study||167
6761308|NCT03620162|7688121|FG000|NOT COMPLETED|Overall Study||15
6761309|NCT03620162|7688122|FG001|NOT COMPLETED|Overall Study||14
6761310|NCT03620162|7688123|FG002|NOT COMPLETED|Overall Study||33
6761311|NCT03620162|7688124|FG003|NOT COMPLETED|Overall Study||20
6761312|NCT03620162|7688125|FG004|NOT COMPLETED|Overall Study||13
6761313|NCT03620383|7688141|FG000|STARTED|Overall Study||30
6761314|NCT03620383|7688142|FG001|STARTED|Overall Study||15
6761315|NCT03620383|7688141|FG000|COMPLETED|Overall Study||30
6761316|NCT03620383|7688142|FG001|COMPLETED|Overall Study||15
6761317|NCT03620383|7688141|FG000|NOT COMPLETED|Overall Study||0
6761318|NCT03620383|7688142|FG001|NOT COMPLETED|Overall Study||0
6761319|NCT03620708|7688151|FG000|STARTED|Overall Study||19
6761320|NCT03620708|7688152|FG001|STARTED|Overall Study||19
6761321|NCT03620708|7688153|FG002|STARTED|Overall Study||20
6761322|NCT03620708|7688151|FG000|COMPLETED|Overall Study||18
6761323|NCT03620708|7688152|FG001|COMPLETED|Overall Study||18
6761324|NCT03620708|7688153|FG002|COMPLETED|Overall Study||17
6761325|NCT03620708|7688151|FG000|NOT COMPLETED|Overall Study||1
6761326|NCT03620708|7688152|FG001|NOT COMPLETED|Overall Study||1
6761327|NCT03620708|7688153|FG002|NOT COMPLETED|Overall Study||3
6761328|NCT03620890|7688163|FG000|STARTED|Overall Study||57
6761329|NCT03620890|7688164|FG001|STARTED|Overall Study||51
6761330|NCT03620890|7688163|FG000|First Trimester Miscarriage|Overall Study||2
6761331|NCT03620890|7688164|FG001|First Trimester Miscarriage|Overall Study||1
6761332|NCT03620890|7688163|FG000|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||1
6761333|NCT03620890|7688164|FG001|Major Fetal Anomalies (Hypoplastic Left Heart and Sacral Agenesis) With 2nd Trimester Stillbirth|Overall Study||0
6761334|NCT03620890|7688163|FG000|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||1
6761335|NCT03620890|7688164|FG001|Major Fetal Anomaly (Holoprosencephaly) With 2nd Trimester Pregnancy Termination|Overall Study||0
6761336|NCT03620890|7688163|FG000|COMPLETED|Overall Study||53
6761337|NCT03620890|7688164|FG001|COMPLETED|Overall Study||50
6761338|NCT03620890|7688163|FG000|NOT COMPLETED|Overall Study||4
6761339|NCT03620890|7688164|FG001|NOT COMPLETED|Overall Study||1
6761340|NCT03621085|7688170|FG000|STARTED|Enrollment||22
6761341|NCT03621085|7688171|FG001|STARTED|Enrollment||21
6761342|NCT03621085|7688170|FG000|COMPLETED|Enrollment||16
6761343|NCT03621085|7688171|FG001|COMPLETED|Enrollment||14
6761344|NCT03621085|7688170|FG000|NOT COMPLETED|Enrollment||6
6761345|NCT03621085|7688171|FG001|NOT COMPLETED|Enrollment||7
6761346|NCT03621085|7688170|FG000|STARTED|First Visit||16
6761347|NCT03621085|7688171|FG001|STARTED|First Visit||14
6761348|NCT03621085|7688170|FG000|COMPLETED|First Visit||16
6761349|NCT03621085|7688171|FG001|COMPLETED|First Visit||14
6761350|NCT03621085|7688170|FG000|NOT COMPLETED|First Visit||0
6761351|NCT03621085|7688171|FG001|NOT COMPLETED|First Visit||0
6761352|NCT03621085|7688170|FG000|STARTED|Washout (at Least 48 Hours)||16
6761353|NCT03621085|7688171|FG001|STARTED|Washout (at Least 48 Hours)||14
6761354|NCT03621085|7688170|FG000|COMPLETED|Washout (at Least 48 Hours)||16
6761355|NCT03621085|7688171|FG001|COMPLETED|Washout (at Least 48 Hours)||14
6761356|NCT03621085|7688170|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
6761357|NCT03621085|7688171|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
6761358|NCT03621085|7688170|FG000|STARTED|Second Visit||16
6761359|NCT03621085|7688171|FG001|STARTED|Second Visit||14
6761360|NCT03621085|7688170|FG000|COMPLETED|Second Visit||16
6761361|NCT03621085|7688171|FG001|COMPLETED|Second Visit||14
6761362|NCT03621085|7688170|FG000|NOT COMPLETED|Second Visit||0
6761363|NCT03621085|7688171|FG001|NOT COMPLETED|Second Visit||0
6761364|NCT03621189|7688179|FG000|STARTED|Overall Study||40
6761365|NCT03621189|7688180|FG001|STARTED|Overall Study||40
6761366|NCT03621189|7688179|FG000|COMPLETED|Overall Study||40
6761367|NCT03621189|7688180|FG001|COMPLETED|Overall Study||35
6761368|NCT03621189|7688179|FG000|NOT COMPLETED|Overall Study||0
6761369|NCT03621189|7688180|FG001|NOT COMPLETED|Overall Study||5
6761370|NCT03621202|7688187|FG000|STARTED|Overall Study||66
6761371|NCT03621202|7688187|FG000|COMPLETED|Overall Study||60
6761372|NCT03621202|7688187|FG000|NOT COMPLETED|Overall Study||6
6761373|NCT03621787|7688191|FG000|STARTED|Overall Study||9
6761374|NCT03621787|7688191|FG000|COMPLETED|Overall Study||9
6761375|NCT03621787|7688191|FG000|NOT COMPLETED|Overall Study||0
6761376|NCT03621878|7688198|FG000|STARTED|Overall Study||17
6761377|NCT03621878|7688199|FG001|STARTED|Overall Study||17
6761378|NCT03621878|7688200|FG002|STARTED|Overall Study||17
6761379|NCT03621878|7688198|FG000|COMPLETED|Overall Study||17
6761380|NCT03621878|7688199|FG001|COMPLETED|Overall Study||17
6761381|NCT03621878|7688200|FG002|COMPLETED|Overall Study||17
6761382|NCT03621878|7688198|FG000|NOT COMPLETED|Overall Study||0
6761383|NCT03621878|7688199|FG001|NOT COMPLETED|Overall Study||0
6761384|NCT03621878|7688200|FG002|NOT COMPLETED|Overall Study||0
6761385|NCT03622112|7688215|FG000|STARTED|Overall Study||110
6761386|NCT03622112|7688216|FG001|STARTED|Overall Study||112
6761387|NCT03622112|7688217|FG002|STARTED|Overall Study||111
6761388|NCT03622112|7688218|FG003|STARTED|Overall Study||113
6761389|NCT03622112|7688219|FG004|STARTED|Overall Study||134
6761390|NCT03622112|7688220|FG005|STARTED|Overall Study||113
6761391|NCT03622112|7688221|FG006|STARTED|Overall Study||112
6761392|NCT03622112|7688215|FG000|COMPLETED|Overall Study||85
6761393|NCT03622112|7688216|FG001|COMPLETED|Overall Study||92
6761394|NCT03622112|7688217|FG002|COMPLETED|Overall Study||95
6761395|NCT03622112|7688218|FG003|COMPLETED|Overall Study||91
6761396|NCT03622112|7688219|FG004|COMPLETED|Overall Study||124
6761397|NCT03622112|7688220|FG005|COMPLETED|Overall Study||71
6761398|NCT03622112|7688221|FG006|COMPLETED|Overall Study||103
6761399|NCT03622112|7688215|FG000|NOT COMPLETED|Overall Study||25
6761400|NCT03622112|7688216|FG001|NOT COMPLETED|Overall Study||20
6761401|NCT03622112|7688217|FG002|NOT COMPLETED|Overall Study||16
6761402|NCT03622112|7688218|FG003|NOT COMPLETED|Overall Study||22
6761403|NCT03622112|7688219|FG004|NOT COMPLETED|Overall Study||10
6761404|NCT03622112|7688220|FG005|NOT COMPLETED|Overall Study||42
6761405|NCT03622112|7688221|FG006|NOT COMPLETED|Overall Study||9
6761406|NCT03622619|7688239|FG000|STARTED|Overall Study||23
6761407|NCT03622619|7688240|FG001|STARTED|Overall Study||23
6761408|NCT03622619|7688239|FG000|COMPLETED|Overall Study||21
6761409|NCT03622619|7688240|FG001|COMPLETED|Overall Study||21
6761410|NCT03622619|7688239|FG000|NOT COMPLETED|Overall Study||2
6761411|NCT03622619|7688240|FG001|NOT COMPLETED|Overall Study||2
6761412|NCT03623035|7688246|FG000|STARTED|Overall Study||10
6761413|NCT03623035|7688246|FG000|COMPLETED|Overall Study||10
6761414|NCT03623035|7688246|FG000|NOT COMPLETED|Overall Study||0
6761415|NCT03623334|7688253|FG000|STARTED|Overall Study||15
6761416|NCT03623334|7688254|FG001|STARTED|Overall Study||21
6761417|NCT03623334|7688255|FG002|STARTED|Overall Study||19
6761418|NCT03623334|7688253|FG000|COMPLETED|Overall Study||15
6761419|NCT03623334|7688254|FG001|COMPLETED|Overall Study||21
6761420|NCT03623334|7688255|FG002|COMPLETED|Overall Study||19
6761421|NCT03623334|7688253|FG000|NOT COMPLETED|Overall Study||0
6761422|NCT03623334|7688254|FG001|NOT COMPLETED|Overall Study||0
6761423|NCT03623334|7688255|FG002|NOT COMPLETED|Overall Study||0
6761424|NCT03623698|7688263|FG000|STARTED|Overall Study||24
6761425|NCT03623698|7688263|FG000|COMPLETED|Overall Study||24
6761426|NCT03623698|7688263|FG000|NOT COMPLETED|Overall Study||0
6761427|NCT03624192|7688274|FG000|STARTED|Overall Study||3
6761428|NCT03624192|7688275|FG001|STARTED|Overall Study||3
6761429|NCT03624192|7688274|FG000|COMPLETED|Overall Study||2
6761430|NCT03624192|7688275|FG001|COMPLETED|Overall Study||2
6761431|NCT03624192|7688274|FG000|NOT COMPLETED|Overall Study||1
6761432|NCT03624192|7688275|FG001|NOT COMPLETED|Overall Study||1
6761433|NCT03624504|7688283|FG000|STARTED|Overall Study||82
6761434|NCT03624504|7688283|FG000|COMPLETED|Overall Study||81
6761435|NCT03624504|7688283|FG000|NOT COMPLETED|Overall Study||1
6761436|NCT03624920|7688293|FG000|STARTED|Overall Study||14
6761437|NCT03624920|7688294|FG001|STARTED|Overall Study||14
6761438|NCT03624920|7688295|FG002|STARTED|Overall Study||13
6761439|NCT03624920|7688296|FG003|STARTED|Overall Study||13
6761440|NCT03624920|7688297|FG004|STARTED|Overall Study||11
6761441|NCT03624920|7688298|FG005|STARTED|Overall Study||12
6761442|NCT03624920|7688293|FG000|COMPLETED|Overall Study||13
6761443|NCT03624920|7688294|FG001|COMPLETED|Overall Study||12
6761444|NCT03624920|7688295|FG002|COMPLETED|Overall Study||12
6761445|NCT03624920|7688296|FG003|COMPLETED|Overall Study||12
6761446|NCT03624920|7688297|FG004|COMPLETED|Overall Study||7
6761447|NCT03624920|7688298|FG005|COMPLETED|Overall Study||11
6761448|NCT03624920|7688293|FG000|NOT COMPLETED|Overall Study||1
6761449|NCT03624920|7688294|FG001|NOT COMPLETED|Overall Study||2
6761450|NCT03624920|7688295|FG002|NOT COMPLETED|Overall Study||1
6761451|NCT03624920|7688296|FG003|NOT COMPLETED|Overall Study||1
6761452|NCT03624920|7688297|FG004|NOT COMPLETED|Overall Study||4
6761453|NCT03624920|7688298|FG005|NOT COMPLETED|Overall Study||1
6761454|NCT03624946|7688308|FG000|STARTED|Overall Study||19
6761455|NCT03624946|7688309|FG001|STARTED|Overall Study||11
6761456|NCT03624946|7688308|FG000|COMPLETED|Overall Study||19
6761457|NCT03624946|7688309|FG001|COMPLETED|Overall Study||10
6761458|NCT03624946|7688308|FG000|NOT COMPLETED|Overall Study||0
6761459|NCT03624946|7688309|FG001|NOT COMPLETED|Overall Study||1
6761460|NCT03624972|7688322|FG000|STARTED|Overall Study||71
6761461|NCT03624972|7688323|FG001|STARTED|Overall Study||73
6761462|NCT03624972|7688324|FG002|STARTED|Overall Study||9
6761463|NCT03624972|7688322|FG000|COMPLETED|Overall Study||69
6761464|NCT03624972|7688323|FG001|COMPLETED|Overall Study||71
6761465|NCT03624972|7688324|FG002|COMPLETED|Overall Study||9
6761466|NCT03624972|7688322|FG000|NOT COMPLETED|Overall Study||2
6761467|NCT03624972|7688323|FG001|NOT COMPLETED|Overall Study||2
6761468|NCT03624972|7688324|FG002|NOT COMPLETED|Overall Study||0
6761469|NCT03626415|7688336|FG000|STARTED|Overall Study||8
6761470|NCT03626415|7688337|FG001|STARTED|Overall Study||8
6761471|NCT03626415|7688338|FG002|STARTED|Overall Study||8
6761472|NCT03626415|7688336|FG000|COMPLETED|Overall Study||8
6761473|NCT03626415|7688337|FG001|COMPLETED|Overall Study||8
6761474|NCT03626415|7688338|FG002|COMPLETED|Overall Study||8
6761475|NCT03626415|7688336|FG000|NOT COMPLETED|Overall Study||0
6761476|NCT03626415|7688337|FG001|NOT COMPLETED|Overall Study||0
6761477|NCT03626415|7688338|FG002|NOT COMPLETED|Overall Study||0
6761478|NCT03626623|7688348|FG000|STARTED|Overall Study||5
6761479|NCT03626623|7688349|FG001|STARTED|Overall Study||10
6761480|NCT03626623|7688348|FG000|COMPLETED|Overall Study||0
6761481|NCT03626623|7688349|FG001|COMPLETED|Overall Study||0
6761482|NCT03626623|7688348|FG000|NOT COMPLETED|Overall Study||5
6761483|NCT03626623|7688349|FG001|NOT COMPLETED|Overall Study||10
6761484|NCT03626714|7688355|FG000|STARTED|Overall Study||8
6761485|NCT03626714|7688355|FG000|COMPLETED|Overall Study||8
6761486|NCT03626714|7688355|FG000|NOT COMPLETED|Overall Study||0
6761487|NCT03627065|7688359|FG000|STARTED|Overall Study||10
6761488|NCT03627065|7688359|FG000|COMPLETED|Overall Study||7
6761489|NCT03627065|7688359|FG000|NOT COMPLETED|Overall Study||3
6761490|NCT03627195|7688369|FG000|STARTED|Overall Study||6
6761491|NCT03627195|7688370|FG001|STARTED|Overall Study||6
6761492|NCT03627195|7688371|FG002|STARTED|Overall Study||6
6761493|NCT03627195|7688372|FG003|STARTED|Overall Study||6
6761494|NCT03627195|7688373|FG004|STARTED|Overall Study||6
6761495|NCT03627195|7688374|FG005|STARTED|Overall Study||10
6761496|NCT03627195|7688369|FG000|COMPLETED|Overall Study||5
6761497|NCT03627195|7688370|FG001|COMPLETED|Overall Study||6
6761498|NCT03627195|7688371|FG002|COMPLETED|Overall Study||6
6761499|NCT03627195|7688372|FG003|COMPLETED|Overall Study||6
6761500|NCT03627195|7688373|FG004|COMPLETED|Overall Study||6
6761501|NCT03627195|7688374|FG005|COMPLETED|Overall Study||10
6761502|NCT03627195|7688369|FG000|NOT COMPLETED|Overall Study||1
6761503|NCT03627195|7688370|FG001|NOT COMPLETED|Overall Study||0
6761504|NCT03627195|7688371|FG002|NOT COMPLETED|Overall Study||0
6761505|NCT03627195|7688372|FG003|NOT COMPLETED|Overall Study||0
6761506|NCT03627195|7688373|FG004|NOT COMPLETED|Overall Study||0
6761507|NCT03627195|7688374|FG005|NOT COMPLETED|Overall Study||0
6761508|NCT03627299|7688388|FG000|STARTED|Overall Study||10
6761509|NCT03627299|7688388|FG000|COMPLETED|Overall Study||10
6761510|NCT03627299|7688388|FG000|NOT COMPLETED|Overall Study||0
6761511|NCT03627416|7688394|FG000|STARTED|Overall Study||8
6761512|NCT03627416|7688395|FG001|STARTED|Overall Study||7
6761513|NCT03627416|7688394|FG000|COMPLETED|Overall Study||8
6761514|NCT03627416|7688395|FG001|COMPLETED|Overall Study||6
6761515|NCT03627416|7688394|FG000|NOT COMPLETED|Overall Study||0
6761516|NCT03627416|7688395|FG001|NOT COMPLETED|Overall Study||1
6761517|NCT03627494|7688413|FG000|STARTED|Part A Period 1 (4 Days)||3
6761518|NCT03627494|7688414|FG001|STARTED|Part A Period 1 (4 Days)||3
6761519|NCT03627494|7688415|FG002|STARTED|Part A Period 1 (4 Days)||3
6761520|NCT03627494|7688416|FG003|STARTED|Part A Period 1 (4 Days)||3
6761521|NCT03627494|7688417|FG004|STARTED|Part A Period 1 (4 Days)||3
6761522|NCT03627494|7688418|FG005|STARTED|Part A Period 1 (4 Days)||3
6761523|NCT03627494|7688419|FG006|STARTED|Part A Period 1 (4 Days)||0
6761524|NCT03627494|7688420|FG007|STARTED|Part A Period 1 (4 Days)||0
6761525|NCT03627494|7688421|FG008|STARTED|Part A Period 1 (4 Days)||0
6761526|NCT03627494|7688422|FG009|STARTED|Part A Period 1 (4 Days)||0
6761527|NCT03627494|7688423|FG010|STARTED|Part A Period 1 (4 Days)||0
6761528|NCT03627494|7688424|FG011|STARTED|Part A Period 1 (4 Days)||0
6761529|NCT03627494|7688413|FG000|COMPLETED|Part A Period 1 (4 Days)||3
6761530|NCT03627494|7688414|FG001|COMPLETED|Part A Period 1 (4 Days)||3
6761531|NCT03627494|7688415|FG002|COMPLETED|Part A Period 1 (4 Days)||3
6761532|NCT03627494|7688416|FG003|COMPLETED|Part A Period 1 (4 Days)||3
6761533|NCT03627494|7688417|FG004|COMPLETED|Part A Period 1 (4 Days)||3
6761534|NCT03627494|7688418|FG005|COMPLETED|Part A Period 1 (4 Days)||3
6761535|NCT03627494|7688419|FG006|COMPLETED|Part A Period 1 (4 Days)||0
6761536|NCT03627494|7688420|FG007|COMPLETED|Part A Period 1 (4 Days)||0
6761537|NCT03627494|7688421|FG008|COMPLETED|Part A Period 1 (4 Days)||0
6761538|NCT03627494|7688422|FG009|COMPLETED|Part A Period 1 (4 Days)||0
6761539|NCT03627494|7688423|FG010|COMPLETED|Part A Period 1 (4 Days)||0
6761540|NCT03627494|7688424|FG011|COMPLETED|Part A Period 1 (4 Days)||0
6761541|NCT03627494|7688413|FG000|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761542|NCT03627494|7688414|FG001|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761543|NCT03627494|7688415|FG002|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761544|NCT03627494|7688416|FG003|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761545|NCT03627494|7688417|FG004|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761546|NCT03627494|7688418|FG005|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761547|NCT03627494|7688419|FG006|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761548|NCT03627494|7688420|FG007|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761549|NCT03627494|7688421|FG008|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761550|NCT03627494|7688422|FG009|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761551|NCT03627494|7688423|FG010|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761552|NCT03627494|7688424|FG011|NOT COMPLETED|Part A Period 1 (4 Days)||0
6761553|NCT03627494|7688413|FG000|STARTED|Part A Washout 1 (7 Days)||3
6761554|NCT03627494|7688414|FG001|STARTED|Part A Washout 1 (7 Days)||3
6761555|NCT03627494|7688415|FG002|STARTED|Part A Washout 1 (7 Days)||3
6761556|NCT03627494|7688416|FG003|STARTED|Part A Washout 1 (7 Days)||3
6761557|NCT03627494|7688417|FG004|STARTED|Part A Washout 1 (7 Days)||3
6761558|NCT03627494|7688418|FG005|STARTED|Part A Washout 1 (7 Days)||3
6761559|NCT03627494|7688419|FG006|STARTED|Part A Washout 1 (7 Days)||0
6761560|NCT03627494|7688420|FG007|STARTED|Part A Washout 1 (7 Days)||0
6761561|NCT03627494|7688421|FG008|STARTED|Part A Washout 1 (7 Days)||0
6761562|NCT03627494|7688422|FG009|STARTED|Part A Washout 1 (7 Days)||0
6761563|NCT03627494|7688423|FG010|STARTED|Part A Washout 1 (7 Days)||0
6761564|NCT03627494|7688424|FG011|STARTED|Part A Washout 1 (7 Days)||0
6761565|NCT03627494|7688413|FG000|COMPLETED|Part A Washout 1 (7 Days)||3
6761566|NCT03627494|7688414|FG001|COMPLETED|Part A Washout 1 (7 Days)||3
6761567|NCT03627494|7688415|FG002|COMPLETED|Part A Washout 1 (7 Days)||3
6761568|NCT03627494|7688416|FG003|COMPLETED|Part A Washout 1 (7 Days)||3
6761569|NCT03627494|7688417|FG004|COMPLETED|Part A Washout 1 (7 Days)||3
6761570|NCT03627494|7688418|FG005|COMPLETED|Part A Washout 1 (7 Days)||3
6761571|NCT03627494|7688419|FG006|COMPLETED|Part A Washout 1 (7 Days)||0
6761572|NCT03627494|7688420|FG007|COMPLETED|Part A Washout 1 (7 Days)||0
6761573|NCT03627494|7688421|FG008|COMPLETED|Part A Washout 1 (7 Days)||0
6761574|NCT03627494|7688422|FG009|COMPLETED|Part A Washout 1 (7 Days)||0
6761575|NCT03627494|7688423|FG010|COMPLETED|Part A Washout 1 (7 Days)||0
6761576|NCT03627494|7688424|FG011|COMPLETED|Part A Washout 1 (7 Days)||0
6761577|NCT03627494|7688413|FG000|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761578|NCT03627494|7688414|FG001|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761579|NCT03627494|7688415|FG002|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761580|NCT03627494|7688416|FG003|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761581|NCT03627494|7688417|FG004|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761582|NCT03627494|7688418|FG005|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761583|NCT03627494|7688419|FG006|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761584|NCT03627494|7688420|FG007|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761585|NCT03627494|7688421|FG008|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761586|NCT03627494|7688422|FG009|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761587|NCT03627494|7688423|FG010|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761588|NCT03627494|7688424|FG011|NOT COMPLETED|Part A Washout 1 (7 Days)||0
6761589|NCT03627494|7688413|FG000|STARTED|Part A Period 2 (4 Days)||3
6761590|NCT03627494|7688414|FG001|STARTED|Part A Period 2 (4 Days)||3
6761591|NCT03627494|7688415|FG002|STARTED|Part A Period 2 (4 Days)||3
6761592|NCT03627494|7688416|FG003|STARTED|Part A Period 2 (4 Days)||3
6761593|NCT03627494|7688417|FG004|STARTED|Part A Period 2 (4 Days)||3
6761594|NCT03627494|7688418|FG005|STARTED|Part A Period 2 (4 Days)||3
6761595|NCT03627494|7688419|FG006|STARTED|Part A Period 2 (4 Days)||0
6761596|NCT03627494|7688420|FG007|STARTED|Part A Period 2 (4 Days)||0
6761597|NCT03627494|7688421|FG008|STARTED|Part A Period 2 (4 Days)||0
6761598|NCT03627494|7688422|FG009|STARTED|Part A Period 2 (4 Days)||0
6761599|NCT03627494|7688423|FG010|STARTED|Part A Period 2 (4 Days)||0
6761600|NCT03627494|7688424|FG011|STARTED|Part A Period 2 (4 Days)||0
6761601|NCT03627494|7688413|FG000|COMPLETED|Part A Period 2 (4 Days)||3
6761602|NCT03627494|7688414|FG001|COMPLETED|Part A Period 2 (4 Days)||3
6761603|NCT03627494|7688415|FG002|COMPLETED|Part A Period 2 (4 Days)||3
6761604|NCT03627494|7688416|FG003|COMPLETED|Part A Period 2 (4 Days)||3
6761605|NCT03627494|7688417|FG004|COMPLETED|Part A Period 2 (4 Days)||3
6761606|NCT03627494|7688418|FG005|COMPLETED|Part A Period 2 (4 Days)||3
6761607|NCT03627494|7688419|FG006|COMPLETED|Part A Period 2 (4 Days)||0
6761608|NCT03627494|7688420|FG007|COMPLETED|Part A Period 2 (4 Days)||0
6761609|NCT03627494|7688421|FG008|COMPLETED|Part A Period 2 (4 Days)||0
6761610|NCT03627494|7688422|FG009|COMPLETED|Part A Period 2 (4 Days)||0
6761611|NCT03627494|7688423|FG010|COMPLETED|Part A Period 2 (4 Days)||0
6761612|NCT03627494|7688424|FG011|COMPLETED|Part A Period 2 (4 Days)||0
6761613|NCT03627494|7688413|FG000|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761614|NCT03627494|7688414|FG001|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761615|NCT03627494|7688415|FG002|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761616|NCT03627494|7688416|FG003|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761617|NCT03627494|7688417|FG004|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761618|NCT03627494|7688418|FG005|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761619|NCT03627494|7688419|FG006|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761620|NCT03627494|7688420|FG007|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761621|NCT03627494|7688421|FG008|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761622|NCT03627494|7688422|FG009|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761623|NCT03627494|7688423|FG010|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761624|NCT03627494|7688424|FG011|NOT COMPLETED|Part A Period 2 (4 Days)||0
6761625|NCT03627494|7688413|FG000|STARTED|Part A Washout 2 (7 Days)||3
6761626|NCT03627494|7688414|FG001|STARTED|Part A Washout 2 (7 Days)||3
6761627|NCT03627494|7688415|FG002|STARTED|Part A Washout 2 (7 Days)||3
6761628|NCT03627494|7688416|FG003|STARTED|Part A Washout 2 (7 Days)||3
6761629|NCT03627494|7688417|FG004|STARTED|Part A Washout 2 (7 Days)||3
6761630|NCT03627494|7688418|FG005|STARTED|Part A Washout 2 (7 Days)||3
6761631|NCT03627494|7688419|FG006|STARTED|Part A Washout 2 (7 Days)||0
6761632|NCT03627494|7688420|FG007|STARTED|Part A Washout 2 (7 Days)||0
6761633|NCT03627494|7688421|FG008|STARTED|Part A Washout 2 (7 Days)||0
6761634|NCT03627494|7688422|FG009|STARTED|Part A Washout 2 (7 Days)||0
6761635|NCT03627494|7688423|FG010|STARTED|Part A Washout 2 (7 Days)||0
6761636|NCT03627494|7688424|FG011|STARTED|Part A Washout 2 (7 Days)||0
6761637|NCT03627494|7688413|FG000|COMPLETED|Part A Washout 2 (7 Days)||2
6761638|NCT03627494|7688414|FG001|COMPLETED|Part A Washout 2 (7 Days)||3
6761639|NCT03627494|7688415|FG002|COMPLETED|Part A Washout 2 (7 Days)||2
6761640|NCT03627494|7688416|FG003|COMPLETED|Part A Washout 2 (7 Days)||3
6761641|NCT03627494|7688417|FG004|COMPLETED|Part A Washout 2 (7 Days)||3
6761642|NCT03627494|7688418|FG005|COMPLETED|Part A Washout 2 (7 Days)||3
6761643|NCT03627494|7688419|FG006|COMPLETED|Part A Washout 2 (7 Days)||0
6761644|NCT03627494|7688420|FG007|COMPLETED|Part A Washout 2 (7 Days)||0
6761645|NCT03627494|7688421|FG008|COMPLETED|Part A Washout 2 (7 Days)||0
6761646|NCT03627494|7688422|FG009|COMPLETED|Part A Washout 2 (7 Days)||0
6761647|NCT03627494|7688423|FG010|COMPLETED|Part A Washout 2 (7 Days)||0
6761648|NCT03627494|7688424|FG011|COMPLETED|Part A Washout 2 (7 Days)||0
6761649|NCT03627494|7688413|FG000|NOT COMPLETED|Part A Washout 2 (7 Days)||1
6761650|NCT03627494|7688414|FG001|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761651|NCT03627494|7688415|FG002|NOT COMPLETED|Part A Washout 2 (7 Days)||1
6761652|NCT03627494|7688416|FG003|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761653|NCT03627494|7688417|FG004|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761654|NCT03627494|7688418|FG005|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761655|NCT03627494|7688419|FG006|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761656|NCT03627494|7688420|FG007|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761657|NCT03627494|7688421|FG008|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761658|NCT03627494|7688422|FG009|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761659|NCT03627494|7688423|FG010|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761660|NCT03627494|7688424|FG011|NOT COMPLETED|Part A Washout 2 (7 Days)||0
6761661|NCT03627494|7688413|FG000|STARTED|Part A Period3(4days)+Follow-up(14days)||2
6761662|NCT03627494|7688414|FG001|STARTED|Part A Period3(4days)+Follow-up(14days)||3
6761663|NCT03627494|7688415|FG002|STARTED|Part A Period3(4days)+Follow-up(14days)||2
6761664|NCT03627494|7688416|FG003|STARTED|Part A Period3(4days)+Follow-up(14days)||3
6761665|NCT03627494|7688417|FG004|STARTED|Part A Period3(4days)+Follow-up(14days)||3
6761666|NCT03627494|7688418|FG005|STARTED|Part A Period3(4days)+Follow-up(14days)||3
6761667|NCT03627494|7688419|FG006|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6761668|NCT03627494|7688420|FG007|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6761669|NCT03627494|7688421|FG008|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6761670|NCT03627494|7688422|FG009|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6556053|NCT01756053|7478264|FG000|COMPLETED|Period 2 (10 Days)||7
6556054|NCT01756053|7478265|FG001|COMPLETED|Period 2 (10 Days)||6
6556055|NCT01756053|7478264|FG000|NOT COMPLETED|Period 2 (10 Days)||0
6556056|NCT01756053|7478265|FG001|NOT COMPLETED|Period 2 (10 Days)||2
6556057|NCT01756079|7478271|FG000|STARTED|Lead-in: Day 0 to Week 4||58
6556058|NCT01756079|7478271|FG000|COMPLETED|Lead-in: Day 0 to Week 4||58
6556059|NCT01756079|7478271|FG000|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
6556060|NCT01756079|7478271|FG000|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
6761671|NCT03627494|7688423|FG010|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6761672|NCT03627494|7688424|FG011|STARTED|Part A Period3(4days)+Follow-up(14days)||0
6761673|NCT03627494|7688413|FG000|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
6761674|NCT03627494|7688414|FG001|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
6562917|NCT01803464|7485828|FG002|NOT COMPLETED|Overall Study||4
6761675|NCT03627494|7688415|FG002|COMPLETED|Part A Period3(4days)+Follow-up(14days)||2
6761676|NCT03627494|7688416|FG003|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
6761677|NCT03627494|7688417|FG004|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
6761678|NCT03627494|7688418|FG005|COMPLETED|Part A Period3(4days)+Follow-up(14days)||3
6761679|NCT03627494|7688419|FG006|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761680|NCT03627494|7688420|FG007|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761681|NCT03627494|7688421|FG008|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761682|NCT03627494|7688422|FG009|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761683|NCT03627494|7688423|FG010|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761684|NCT03627494|7688424|FG011|COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761685|NCT03627494|7688413|FG000|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761686|NCT03627494|7688414|FG001|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761687|NCT03627494|7688415|FG002|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761688|NCT03627494|7688416|FG003|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761689|NCT03627494|7688417|FG004|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761690|NCT03627494|7688418|FG005|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761691|NCT03627494|7688419|FG006|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761692|NCT03627494|7688420|FG007|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761693|NCT03627494|7688421|FG008|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761694|NCT03627494|7688422|FG009|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761695|NCT03627494|7688423|FG010|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761696|NCT03627494|7688424|FG011|NOT COMPLETED|Part A Period3(4days)+Follow-up(14days)||0
6761697|NCT03627494|7688413|FG000|STARTED|Part B (Maximum of 34 Days)||0
6761698|NCT03627494|7688414|FG001|STARTED|Part B (Maximum of 34 Days)||0
6761699|NCT03627494|7688415|FG002|STARTED|Part B (Maximum of 34 Days)||0
6761700|NCT03627494|7688416|FG003|STARTED|Part B (Maximum of 34 Days)||0
6761701|NCT03627494|7688417|FG004|STARTED|Part B (Maximum of 34 Days)||0
6761702|NCT03627494|7688418|FG005|STARTED|Part B (Maximum of 34 Days)||0
6761703|NCT03627494|7688419|FG006|STARTED|Part B (Maximum of 34 Days)||9
6761704|NCT03627494|7688420|FG007|STARTED|Part B (Maximum of 34 Days)||9
6761705|NCT03627494|7688421|FG008|STARTED|Part B (Maximum of 34 Days)||9
6761706|NCT03627494|7688422|FG009|STARTED|Part B (Maximum of 34 Days)||9
6761707|NCT03627494|7688423|FG010|STARTED|Part B (Maximum of 34 Days)||0
6761708|NCT03627494|7688424|FG011|STARTED|Part B (Maximum of 34 Days)||0
6761709|NCT03627494|7688413|FG000|COMPLETED|Part B (Maximum of 34 Days)||0
6761710|NCT03627494|7688414|FG001|COMPLETED|Part B (Maximum of 34 Days)||0
6761711|NCT03627494|7688415|FG002|COMPLETED|Part B (Maximum of 34 Days)||0
6761712|NCT03627494|7688416|FG003|COMPLETED|Part B (Maximum of 34 Days)||0
6761713|NCT03627494|7688417|FG004|COMPLETED|Part B (Maximum of 34 Days)||0
6761714|NCT03627494|7688418|FG005|COMPLETED|Part B (Maximum of 34 Days)||0
6761715|NCT03627494|7688419|FG006|COMPLETED|Part B (Maximum of 34 Days)||9
6761716|NCT03627494|7688420|FG007|COMPLETED|Part B (Maximum of 34 Days)||9
6761717|NCT03627494|7688421|FG008|COMPLETED|Part B (Maximum of 34 Days)||7
6761718|NCT03627494|7688422|FG009|COMPLETED|Part B (Maximum of 34 Days)||9
6761719|NCT03627494|7688423|FG010|COMPLETED|Part B (Maximum of 34 Days)||0
6761720|NCT03627494|7688424|FG011|COMPLETED|Part B (Maximum of 34 Days)||0
6761721|NCT03627494|7688413|FG000|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761722|NCT03627494|7688414|FG001|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761723|NCT03627494|7688415|FG002|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761724|NCT03627494|7688416|FG003|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761725|NCT03627494|7688417|FG004|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761726|NCT03627494|7688418|FG005|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761727|NCT03627494|7688419|FG006|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761728|NCT03627494|7688420|FG007|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761729|NCT03627494|7688421|FG008|NOT COMPLETED|Part B (Maximum of 34 Days)||2
6761730|NCT03627494|7688422|FG009|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761731|NCT03627494|7688423|FG010|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761732|NCT03627494|7688424|FG011|NOT COMPLETED|Part B (Maximum of 34 Days)||0
6761733|NCT03627494|7688413|FG000|STARTED|Part C Period 1 (4 Days)||0
6761734|NCT03627494|7688414|FG001|STARTED|Part C Period 1 (4 Days)||0
6761735|NCT03627494|7688415|FG002|STARTED|Part C Period 1 (4 Days)||0
6761736|NCT03627494|7688416|FG003|STARTED|Part C Period 1 (4 Days)||0
6761737|NCT03627494|7688417|FG004|STARTED|Part C Period 1 (4 Days)||0
6761738|NCT03627494|7688418|FG005|STARTED|Part C Period 1 (4 Days)||0
6761739|NCT03627494|7688419|FG006|STARTED|Part C Period 1 (4 Days)||0
6761740|NCT03627494|7688420|FG007|STARTED|Part C Period 1 (4 Days)||0
6761741|NCT03627494|7688421|FG008|STARTED|Part C Period 1 (4 Days)||0
6761742|NCT03627494|7688422|FG009|STARTED|Part C Period 1 (4 Days)||0
6761743|NCT03627494|7688423|FG010|STARTED|Part C Period 1 (4 Days)||6
6761744|NCT03627494|7688424|FG011|STARTED|Part C Period 1 (4 Days)||6
6761745|NCT03627494|7688413|FG000|COMPLETED|Part C Period 1 (4 Days)||0
6761746|NCT03627494|7688414|FG001|COMPLETED|Part C Period 1 (4 Days)||0
6761747|NCT03627494|7688415|FG002|COMPLETED|Part C Period 1 (4 Days)||0
6761748|NCT03627494|7688416|FG003|COMPLETED|Part C Period 1 (4 Days)||0
6761749|NCT03627494|7688417|FG004|COMPLETED|Part C Period 1 (4 Days)||0
6761750|NCT03627494|7688418|FG005|COMPLETED|Part C Period 1 (4 Days)||0
6761751|NCT03627494|7688419|FG006|COMPLETED|Part C Period 1 (4 Days)||0
6761752|NCT03627494|7688420|FG007|COMPLETED|Part C Period 1 (4 Days)||0
6761753|NCT03627494|7688421|FG008|COMPLETED|Part C Period 1 (4 Days)||0
6761754|NCT03627494|7688422|FG009|COMPLETED|Part C Period 1 (4 Days)||0
6761755|NCT03627494|7688423|FG010|COMPLETED|Part C Period 1 (4 Days)||6
6761756|NCT03627494|7688424|FG011|COMPLETED|Part C Period 1 (4 Days)||6
6761757|NCT03627494|7688413|FG000|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761758|NCT03627494|7688414|FG001|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761759|NCT03627494|7688415|FG002|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761760|NCT03627494|7688416|FG003|NOT COMPLETED|Part C Period 1 (4 Days)||0
6556061|NCT01756079|7478271|FG000|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
6556062|NCT01756079|7478271|FG000|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
6556063|NCT01756079|7478271|FG000|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
6556064|NCT01756157|7478276|FG000|STARTED|First Intervention Period||23
6556065|NCT01756157|7478277|FG001|STARTED|First Intervention Period||24
6556066|NCT01756157|7478276|FG000|COMPLETED|First Intervention Period||22
6761761|NCT03627494|7688417|FG004|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761762|NCT03627494|7688418|FG005|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761763|NCT03627494|7688419|FG006|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761764|NCT03627494|7688420|FG007|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761765|NCT03627494|7688421|FG008|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761766|NCT03627494|7688422|FG009|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761767|NCT03627494|7688423|FG010|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761768|NCT03627494|7688424|FG011|NOT COMPLETED|Part C Period 1 (4 Days)||0
6761769|NCT03627494|7688413|FG000|STARTED|Part C Washout 1 (7 Days)||0
6761770|NCT03627494|7688414|FG001|STARTED|Part C Washout 1 (7 Days)||0
6761771|NCT03627494|7688415|FG002|STARTED|Part C Washout 1 (7 Days)||0
6761772|NCT03627494|7688416|FG003|STARTED|Part C Washout 1 (7 Days)||0
6761773|NCT03627494|7688417|FG004|STARTED|Part C Washout 1 (7 Days)||0
6761774|NCT03627494|7688418|FG005|STARTED|Part C Washout 1 (7 Days)||0
6761775|NCT03627494|7688419|FG006|STARTED|Part C Washout 1 (7 Days)||0
6761776|NCT03627494|7688420|FG007|STARTED|Part C Washout 1 (7 Days)||0
6761777|NCT03627494|7688421|FG008|STARTED|Part C Washout 1 (7 Days)||0
6761778|NCT03627494|7688422|FG009|STARTED|Part C Washout 1 (7 Days)||0
6761779|NCT03627494|7688423|FG010|STARTED|Part C Washout 1 (7 Days)||6
6761780|NCT03627494|7688424|FG011|STARTED|Part C Washout 1 (7 Days)||6
6761781|NCT03627494|7688413|FG000|COMPLETED|Part C Washout 1 (7 Days)||0
6761782|NCT03627494|7688414|FG001|COMPLETED|Part C Washout 1 (7 Days)||0
6761783|NCT03627494|7688415|FG002|COMPLETED|Part C Washout 1 (7 Days)||0
6761784|NCT03627494|7688416|FG003|COMPLETED|Part C Washout 1 (7 Days)||0
6761785|NCT03627494|7688417|FG004|COMPLETED|Part C Washout 1 (7 Days)||0
6761786|NCT03627494|7688418|FG005|COMPLETED|Part C Washout 1 (7 Days)||0
6761787|NCT03627494|7688419|FG006|COMPLETED|Part C Washout 1 (7 Days)||0
6761788|NCT03627494|7688420|FG007|COMPLETED|Part C Washout 1 (7 Days)||0
6761789|NCT03627494|7688421|FG008|COMPLETED|Part C Washout 1 (7 Days)||0
6761790|NCT03627494|7688422|FG009|COMPLETED|Part C Washout 1 (7 Days)||0
6761791|NCT03627494|7688423|FG010|COMPLETED|Part C Washout 1 (7 Days)||5
6761792|NCT03627494|7688424|FG011|COMPLETED|Part C Washout 1 (7 Days)||5
6761793|NCT03627494|7688413|FG000|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761794|NCT03627494|7688414|FG001|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6556067|NCT01756157|7478277|FG001|COMPLETED|First Intervention Period||22
6556068|NCT01756157|7478276|FG000|NOT COMPLETED|First Intervention Period||1
6556069|NCT01756157|7478277|FG001|NOT COMPLETED|First Intervention Period||2
6556070|NCT01756157|7478276|FG000|STARTED|Washout Period (at Least 7 Days)||22
6556071|NCT01756157|7478277|FG001|STARTED|Washout Period (at Least 7 Days)||22
6761795|NCT03627494|7688415|FG002|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761796|NCT03627494|7688416|FG003|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761797|NCT03627494|7688417|FG004|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761798|NCT03627494|7688418|FG005|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761799|NCT03627494|7688419|FG006|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761800|NCT03627494|7688420|FG007|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761801|NCT03627494|7688421|FG008|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761802|NCT03627494|7688422|FG009|NOT COMPLETED|Part C Washout 1 (7 Days)||0
6761803|NCT03627494|7688423|FG010|NOT COMPLETED|Part C Washout 1 (7 Days)||1
6761804|NCT03627494|7688424|FG011|NOT COMPLETED|Part C Washout 1 (7 Days)||1
6761805|NCT03627494|7688413|FG000|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761806|NCT03627494|7688414|FG001|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761807|NCT03627494|7688415|FG002|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761808|NCT03627494|7688416|FG003|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761809|NCT03627494|7688417|FG004|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761810|NCT03627494|7688418|FG005|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761811|NCT03627494|7688419|FG006|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761812|NCT03627494|7688420|FG007|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761813|NCT03627494|7688421|FG008|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761814|NCT03627494|7688422|FG009|STARTED|Part C Period2(4days)+Follow-up(14days)||0
6761815|NCT03627494|7688423|FG010|STARTED|Part C Period2(4days)+Follow-up(14days)||5
6761816|NCT03627494|7688424|FG011|STARTED|Part C Period2(4days)+Follow-up(14days)||5
6761817|NCT03627494|7688413|FG000|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761818|NCT03627494|7688414|FG001|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761819|NCT03627494|7688415|FG002|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761820|NCT03627494|7688416|FG003|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761821|NCT03627494|7688417|FG004|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761822|NCT03627494|7688418|FG005|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761823|NCT03627494|7688419|FG006|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6305860|NCT00371150|7209242|FG001|NOT COMPLETED|Overall Study||2
6305861|NCT00371176|7209254|FG000|STARTED|Overall Study||13
6305862|NCT00371176|7209255|FG001|STARTED|Overall Study||13
6305863|NCT00371176|7209254|FG000|Completed Treatment|Overall Study||10
6305864|NCT00371176|7209255|FG001|Completed Treatment|Overall Study||9
6305865|NCT00371176|7209254|FG000|COMPLETED|Overall Study||8
6305866|NCT00371176|7209255|FG001|COMPLETED|Overall Study||5
6305867|NCT00371176|7209254|FG000|NOT COMPLETED|Overall Study||5
6305868|NCT00371176|7209255|FG001|NOT COMPLETED|Overall Study||8
6305869|NCT00371254|7209263|FG000|STARTED|Overall Study|Number of participants treated|23
6305870|NCT00371254|7209264|FG001|STARTED|Overall Study|Number of participants treated|21
6305871|NCT00371254|7209263|FG000|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
6305872|NCT00371254|7209264|FG001|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
6305873|NCT00371254|7209263|FG000|NOT COMPLETED|Overall Study||23
6305874|NCT00371254|7209264|FG001|NOT COMPLETED|Overall Study||21
6305875|NCT00371267|7209272|FG000|STARTED|Overall Study||48
6305876|NCT00371267|7209273|FG001|STARTED|Overall Study||50
6305877|NCT00371267|7209272|FG000|COMPLETED|Overall Study||39
6305878|NCT00371267|7209273|FG001|COMPLETED|Overall Study||32
6305879|NCT00371267|7209272|FG000|NOT COMPLETED|Overall Study||9
6761824|NCT03627494|7688420|FG007|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761825|NCT03627494|7688421|FG008|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761826|NCT03627494|7688422|FG009|COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761827|NCT03627494|7688423|FG010|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
6305880|NCT00371267|7209273|FG001|NOT COMPLETED|Overall Study||18
6305881|NCT00371293|7209282|FG000|STARTED|Overall Study||58
6305882|NCT00371293|7209283|FG001|STARTED|Overall Study||61
6305883|NCT00371293|7209284|FG002|STARTED|Overall Study||62
6556072|NCT01756157|7478276|FG000|COMPLETED|Washout Period (at Least 7 Days)||22
6556073|NCT01756157|7478277|FG001|COMPLETED|Washout Period (at Least 7 Days)||22
6761828|NCT03627494|7688424|FG011|COMPLETED|Part C Period2(4days)+Follow-up(14days)||5
6761829|NCT03627494|7688413|FG000|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761830|NCT03627494|7688414|FG001|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761831|NCT03627494|7688415|FG002|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761832|NCT03627494|7688416|FG003|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761833|NCT03627494|7688417|FG004|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761834|NCT03627494|7688418|FG005|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761835|NCT03627494|7688419|FG006|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761836|NCT03627494|7688420|FG007|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761837|NCT03627494|7688421|FG008|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761838|NCT03627494|7688422|FG009|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761839|NCT03627494|7688423|FG010|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761840|NCT03627494|7688424|FG011|NOT COMPLETED|Part C Period2(4days)+Follow-up(14days)||0
6761841|NCT03627767|7688466|FG000|STARTED|Open-label (OL) Run-in Period (12 Weeks)||1235
6761842|NCT03627767|7688467|FG001|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
6761843|NCT03627767|7688468|FG002|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
6761844|NCT03627767|7688469|FG003|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
6761845|NCT03627767|7688470|FG004|STARTED|Open-label (OL) Run-in Period (12 Weeks)||0
6761846|NCT03627767|7688466|FG000|Treated|Open-label (OL) Run-in Period (12 Weeks)||1233
6761847|NCT03627767|7688467|FG001|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
6761848|NCT03627767|7688468|FG002|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
6761849|NCT03627767|7688469|FG003|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
6761850|NCT03627767|7688470|FG004|Treated|Open-label (OL) Run-in Period (12 Weeks)||0
6761851|NCT03627767|7688466|FG000|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||798
6761852|NCT03627767|7688467|FG001|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
6761853|NCT03627767|7688468|FG002|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
6761854|NCT03627767|7688469|FG003|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
6761855|NCT03627767|7688470|FG004|COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
6761856|NCT03627767|7688466|FG000|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||437
6761857|NCT03627767|7688467|FG001|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
6761858|NCT03627767|7688468|FG002|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
6761859|NCT03627767|7688469|FG003|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
6761860|NCT03627767|7688470|FG004|NOT COMPLETED|Open-label (OL) Run-in Period (12 Weeks)||0
6761861|NCT03627767|7688466|FG000|STARTED|Double-blind Treatment Period (40 Weeks)|Participants did not enter into the DB period.|0
6761862|NCT03627767|7688467|FG001|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|267
6761863|NCT03627767|7688468|FG002|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|265
6761864|NCT03627767|7688469|FG003|STARTED|Double-blind Treatment Period (40 Weeks)|Participants who met the pre-defined criteria for DB.|266
6761865|NCT03627767|7688470|FG004|STARTED|Double-blind Treatment Period (40 Weeks)||0
6761866|NCT03627767|7688466|FG000|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
6761867|NCT03627767|7688467|FG001|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||208
6761868|NCT03627767|7688468|FG002|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||109
6761869|NCT03627767|7688469|FG003|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||44
6761870|NCT03627767|7688470|FG004|Participants Entered Rescue Period|Double-blind Treatment Period (40 Weeks)||0
6761871|NCT03627767|7688466|FG000|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
6761872|NCT03627767|7688467|FG001|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||201
6761873|NCT03627767|7688468|FG002|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||99
6761874|NCT03627767|7688469|FG003|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||41
6761875|NCT03627767|7688470|FG004|Completed After Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
6761876|NCT03627767|7688466|FG000|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
6761877|NCT03627767|7688467|FG001|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||43
6761878|NCT03627767|7688468|FG002|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||134
6761879|NCT03627767|7688469|FG003|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||187
6761880|NCT03627767|7688470|FG004|Completed Without Entering Rescue Period|Double-blind Treatment Period (40 Weeks)||0
6761881|NCT03627767|7688466|FG000|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
6761882|NCT03627767|7688467|FG001|COMPLETED|Double-blind Treatment Period (40 Weeks)|208 entered RP+43 completed study in DB period|251
6761883|NCT03627767|7688468|FG002|COMPLETED|Double-blind Treatment Period (40 Weeks)|109 entered RP+134 completed study in DB period|243
6761884|NCT03627767|7688469|FG003|COMPLETED|Double-blind Treatment Period (40 Weeks)|44 entered RP+187 completed study in DB period|231
6761885|NCT03627767|7688470|FG004|COMPLETED|Double-blind Treatment Period (40 Weeks)||0
6761886|NCT03627767|7688466|FG000|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
6761887|NCT03627767|7688467|FG001|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||16
6761888|NCT03627767|7688468|FG002|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||22
6761889|NCT03627767|7688469|FG003|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||35
6761890|NCT03627767|7688470|FG004|NOT COMPLETED|Double-blind Treatment Period (40 Weeks)||0
6761891|NCT03627767|7688466|FG000|STARTED|Open-label Rescue Period (12 Weeks)||0
6761892|NCT03627767|7688467|FG001|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
6761893|NCT03627767|7688468|FG002|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
6761894|NCT03627767|7688469|FG003|STARTED|Open-label Rescue Period (12 Weeks)|Participants did not enter into the OL- Rescue Period.|0
6761895|NCT03627767|7688470|FG004|STARTED|Open-label Rescue Period (12 Weeks)|Participants who met the pre-defined criteria for OL- Rescue Period.|361
6761896|NCT03627767|7688466|FG000|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
6761897|NCT03627767|7688467|FG001|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
6761898|NCT03627767|7688468|FG002|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
6761899|NCT03627767|7688469|FG003|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||0
6761900|NCT03627767|7688470|FG004|Met Protocol-defined Flare Criteria|Open-label Rescue Period (12 Weeks)||351
6761901|NCT03627767|7688466|FG000|COMPLETED|Open-label Rescue Period (12 Weeks)||0
6761902|NCT03627767|7688467|FG001|COMPLETED|Open-label Rescue Period (12 Weeks)||0
6761903|NCT03627767|7688468|FG002|COMPLETED|Open-label Rescue Period (12 Weeks)||0
6761904|NCT03627767|7688469|FG003|COMPLETED|Open-label Rescue Period (12 Weeks)||0
6761905|NCT03627767|7688470|FG004|COMPLETED|Open-label Rescue Period (12 Weeks)||341
6761906|NCT03627767|7688466|FG000|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
6761907|NCT03627767|7688467|FG001|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
6761908|NCT03627767|7688468|FG002|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
6761909|NCT03627767|7688469|FG003|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||0
6761910|NCT03627767|7688470|FG004|NOT COMPLETED|Open-label Rescue Period (12 Weeks)||20
6761911|NCT03627832|7688483|FG000|STARTED|Overall Study||28
6761912|NCT03627832|7688484|FG001|STARTED|Overall Study||28
6761913|NCT03627832|7688483|FG000|COMPLETED|Overall Study||18
6761914|NCT03627832|7688484|FG001|COMPLETED|Overall Study||27
6761915|NCT03627832|7688483|FG000|NOT COMPLETED|Overall Study||10
6761916|NCT03627832|7688484|FG001|NOT COMPLETED|Overall Study||1
6761917|NCT03628417|7688490|FG000|STARTED|Overall Study||7
6761918|NCT03628417|7688491|FG001|STARTED|Overall Study||7
6761919|NCT03628417|7688490|FG000|Day 0|Overall Study||7
6761920|NCT03628417|7688491|FG001|Day 0|Overall Study||7
6761921|NCT03628417|7688490|FG000|Day 7|Overall Study||7
6761922|NCT03628417|7688491|FG001|Day 7|Overall Study||7
6761923|NCT03628417|7688490|FG000|Day 15|Overall Study||7
6761924|NCT03628417|7688491|FG001|Day 15|Overall Study||7
6761925|NCT03628417|7688490|FG000|Day 30|Overall Study||7
6761926|NCT03628417|7688491|FG001|Day 30|Overall Study||7
6761927|NCT03628417|7688490|FG000|Day 60|Overall Study||7
6761928|NCT03628417|7688491|FG001|Day 60|Overall Study||7
6761929|NCT03628417|7688490|FG000|Day 90|Overall Study||7
6761930|NCT03628417|7688491|FG001|Day 90|Overall Study||7
6761931|NCT03628417|7688490|FG000|Day 180|Overall Study||7
6761932|NCT03628417|7688491|FG001|Day 180|Overall Study||7
6761933|NCT03628417|7688490|FG000|COMPLETED|Overall Study|One patient died and 3 more Ca electroporated lesions were removed before the one-year closing visit|6
6761934|NCT03628417|7688491|FG001|COMPLETED|Overall Study|One patient died before the one-year closing visit,this is why decreased the number of metastases|6
6761935|NCT03628417|7688490|FG000|NOT COMPLETED|Overall Study||1
6761936|NCT03628417|7688491|FG001|NOT COMPLETED|Overall Study||1
6761937|NCT03628456|7688501|FG000|STARTED|Overall Study||10
6761938|NCT03628456|7688501|FG000|COMPLETED|Overall Study||10
6761939|NCT03628456|7688501|FG000|NOT COMPLETED|Overall Study||0
6761940|NCT03628508|7688509|FG000|STARTED|Overall Study||40
6761941|NCT03628508|7688509|FG000|COMPLETED|Overall Study||39
6556074|NCT01756157|7478276|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6556075|NCT01756157|7478277|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6556076|NCT01756157|7478276|FG000|STARTED|Second Intervention Period||22
6556077|NCT01756157|7478277|FG001|STARTED|Second Intervention Period||22
6761942|NCT03628508|7688509|FG000|NOT COMPLETED|Overall Study||1
6761943|NCT03628599|7688515|FG000|STARTED|Overall Study||18
6761944|NCT03628599|7688516|FG001|STARTED|Overall Study||19
6761945|NCT03628599|7688515|FG000|COMPLETED|Overall Study||18
6761946|NCT03628599|7688516|FG001|COMPLETED|Overall Study||18
6761947|NCT03628599|7688515|FG000|NOT COMPLETED|Overall Study||0
6761948|NCT03628599|7688516|FG001|NOT COMPLETED|Overall Study||1
6761949|NCT03628885|7688529|FG000|STARTED|Overall Study||306
6761950|NCT03628885|7688530|FG001|STARTED|Overall Study||299
6761951|NCT03628885|7688531|FG002|STARTED|Overall Study||303
6761952|NCT03628885|7688529|FG000|COMPLETED|Overall Study||267
6761953|NCT03628885|7688530|FG001|COMPLETED|Overall Study||252
6761954|NCT03628885|7688531|FG002|COMPLETED|Overall Study||243
6761955|NCT03628885|7688529|FG000|NOT COMPLETED|Overall Study||39
6761956|NCT03628885|7688530|FG001|NOT COMPLETED|Overall Study||47
6761957|NCT03628885|7688531|FG002|NOT COMPLETED|Overall Study||60
6761958|NCT03628898|7688539|FG000|STARTED|Overall Study||27
6761959|NCT03628898|7688539|FG000|COMPLETED|Overall Study||26
6761960|NCT03628898|7688539|FG000|NOT COMPLETED|Overall Study||1
6761961|NCT03628924|7688546|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||62
6761962|NCT03628924|7688547|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||59
6761963|NCT03628924|7688548|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||60
6761964|NCT03628924|7688549|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||0
6761965|NCT03628924|7688550|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||0
6761966|NCT03628924|7688551|FG005|STARTED|Placebo Controlled Period (Week 0 - 16)||0
6556078|NCT01756157|7478276|FG000|COMPLETED|Second Intervention Period||22
6761967|NCT03628924|7688552|FG006|STARTED|Placebo Controlled Period (Week 0 - 16)||0
6761968|NCT03628924|7688546|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
6761969|NCT03628924|7688547|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||56
6761970|NCT03628924|7688548|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||57
6761971|NCT03628924|7688549|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6761972|NCT03628924|7688550|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6761973|NCT03628924|7688551|FG005|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6761974|NCT03628924|7688552|FG006|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6761975|NCT03628924|7688546|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||6
6761976|NCT03628924|7688547|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
6761977|NCT03628924|7688548|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||3
6761978|NCT03628924|7688549|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6761979|NCT03628924|7688550|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6761980|NCT03628924|7688551|FG005|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6761981|NCT03628924|7688552|FG006|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6761982|NCT03628924|7688546|FG000|STARTED|Active Treatment Period (Week 16-48)||0
6761983|NCT03628924|7688547|FG001|STARTED|Active Treatment Period (Week 16-48)||0
6761984|NCT03628924|7688548|FG002|STARTED|Active Treatment Period (Week 16-48)||0
6761985|NCT03628924|7688549|FG003|STARTED|Active Treatment Period (Week 16-48)||28
6761986|NCT03628924|7688550|FG004|STARTED|Active Treatment Period (Week 16-48)||28
6761987|NCT03628924|7688551|FG005|STARTED|Active Treatment Period (Week 16-48)||56
6761988|NCT03628924|7688552|FG006|STARTED|Active Treatment Period (Week 16-48)||57
6761989|NCT03628924|7688546|FG000|COMPLETED|Active Treatment Period (Week 16-48)||0
6761990|NCT03628924|7688547|FG001|COMPLETED|Active Treatment Period (Week 16-48)||0
6761991|NCT03628924|7688548|FG002|COMPLETED|Active Treatment Period (Week 16-48)||0
6761992|NCT03628924|7688549|FG003|COMPLETED|Active Treatment Period (Week 16-48)||20
6761993|NCT03628924|7688550|FG004|COMPLETED|Active Treatment Period (Week 16-48)||24
6761994|NCT03628924|7688551|FG005|COMPLETED|Active Treatment Period (Week 16-48)||43
6761995|NCT03628924|7688552|FG006|COMPLETED|Active Treatment Period (Week 16-48)||46
6761996|NCT03628924|7688546|FG000|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
6761997|NCT03628924|7688547|FG001|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
6761998|NCT03628924|7688548|FG002|NOT COMPLETED|Active Treatment Period (Week 16-48)||0
6761999|NCT03628924|7688549|FG003|NOT COMPLETED|Active Treatment Period (Week 16-48)||8
6762000|NCT03628924|7688550|FG004|NOT COMPLETED|Active Treatment Period (Week 16-48)||4
6762001|NCT03628924|7688551|FG005|NOT COMPLETED|Active Treatment Period (Week 16-48)||13
6762002|NCT03628924|7688552|FG006|NOT COMPLETED|Active Treatment Period (Week 16-48)||11
6762003|NCT03629028|7688566|FG000|STARTED|Overall Study||141
6762004|NCT03629028|7688567|FG001|STARTED|Overall Study||141
6762005|NCT03629028|7688566|FG000|COMPLETED|Overall Study||109
6762006|NCT03629028|7688567|FG001|COMPLETED|Overall Study||116
6762007|NCT03629028|7688566|FG000|NOT COMPLETED|Overall Study||32
6762008|NCT03629028|7688567|FG001|NOT COMPLETED|Overall Study||25
6762009|NCT03629041|7688583|FG000|STARTED|Visit 1||4
6762010|NCT03629041|7688584|FG001|STARTED|Visit 1||4
6762011|NCT03629041|7688585|FG002|STARTED|Visit 1||4
6762012|NCT03629041|7688586|FG003|STARTED|Visit 1||4
6762013|NCT03629041|7688583|FG000|COMPLETED|Visit 1||4
6762014|NCT03629041|7688584|FG001|COMPLETED|Visit 1||4
6762015|NCT03629041|7688585|FG002|COMPLETED|Visit 1||4
6762016|NCT03629041|7688586|FG003|COMPLETED|Visit 1||4
6762017|NCT03629041|7688583|FG000|NOT COMPLETED|Visit 1||0
6762018|NCT03629041|7688584|FG001|NOT COMPLETED|Visit 1||0
6762019|NCT03629041|7688585|FG002|NOT COMPLETED|Visit 1||0
6762020|NCT03629041|7688586|FG003|NOT COMPLETED|Visit 1||0
6762021|NCT03629041|7688583|FG000|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6762022|NCT03629041|7688584|FG001|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6762023|NCT03629041|7688585|FG002|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6762024|NCT03629041|7688586|FG003|STARTED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6762025|NCT03629041|7688583|FG000|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6762026|NCT03629041|7688584|FG001|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||3
6762027|NCT03629041|7688585|FG002|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6762028|NCT03629041|7688586|FG003|COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||4
6762029|NCT03629041|7688583|FG000|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
6762030|NCT03629041|7688584|FG001|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||1
6762031|NCT03629041|7688585|FG002|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
6762032|NCT03629041|7688586|FG003|NOT COMPLETED|Visit 2 (2 Weeks ± 3 Days From Visit 1)||0
6762033|NCT03629054|7688606|FG000|STARTED|Period 1 (4 Days)|Started this period|15
6762034|NCT03629054|7688607|FG001|STARTED|Period 1 (4 Days)|Started this period|15
6762035|NCT03629054|7688606|FG000|COMPLETED|Period 1 (4 Days)||15
6762036|NCT03629054|7688607|FG001|COMPLETED|Period 1 (4 Days)||15
6762037|NCT03629054|7688606|FG000|NOT COMPLETED|Period 1 (4 Days)||0
6762038|NCT03629054|7688607|FG001|NOT COMPLETED|Period 1 (4 Days)||0
6762039|NCT03629054|7688606|FG000|STARTED|Wasout Period (35 Days)|Started this period|15
6762040|NCT03629054|7688607|FG001|STARTED|Wasout Period (35 Days)|Started this period|15
6762041|NCT03629054|7688606|FG000|COMPLETED|Wasout Period (35 Days)||15
6762042|NCT03629054|7688607|FG001|COMPLETED|Wasout Period (35 Days)||15
6762043|NCT03629054|7688606|FG000|NOT COMPLETED|Wasout Period (35 Days)||0
6762044|NCT03629054|7688607|FG001|NOT COMPLETED|Wasout Period (35 Days)||0
6762045|NCT03629054|7688606|FG000|STARTED|Period 2 (4 Days)|Started this period|15
6762046|NCT03629054|7688607|FG001|STARTED|Period 2 (4 Days)|Started this period|15
6762047|NCT03629054|7688606|FG000|Treated|Period 2 (4 Days)||15
6762048|NCT03629054|7688607|FG001|Treated|Period 2 (4 Days)||14
6762049|NCT03629054|7688606|FG000|COMPLETED|Period 2 (4 Days)||15
6762050|NCT03629054|7688607|FG001|COMPLETED|Period 2 (4 Days)||14
6762051|NCT03629054|7688606|FG000|NOT COMPLETED|Period 2 (4 Days)||0
6762052|NCT03629054|7688607|FG001|NOT COMPLETED|Period 2 (4 Days)||1
6762053|NCT03629184|7688615|FG000|STARTED|Overall Study||115
6762054|NCT03629184|7688616|FG001|STARTED|Overall Study||58
6762055|NCT03629184|7688615|FG000|COMPLETED|Overall Study||112
6762056|NCT03629184|7688616|FG001|COMPLETED|Overall Study||57
6762057|NCT03629184|7688615|FG000|NOT COMPLETED|Overall Study||3
6762058|NCT03629184|7688616|FG001|NOT COMPLETED|Overall Study||1
6762059|NCT03629249|7688625|FG000|STARTED|Overall Study||201
6762060|NCT03629249|7688626|FG001|STARTED|Overall Study||201
6762061|NCT03629249|7688627|FG002|STARTED|Overall Study||202
6762062|NCT03629249|7688625|FG000|Full Analysis Set (FAS)|Overall Study||201
6762063|NCT03629249|7688626|FG001|Full Analysis Set (FAS)|Overall Study||200
6762064|NCT03629249|7688627|FG002|Full Analysis Set (FAS)|Overall Study||201
6762065|NCT03629249|7688625|FG000|Safety Set (SAF)|Overall Study||201
6762066|NCT03629249|7688626|FG001|Safety Set (SAF)|Overall Study||200
6762067|NCT03629249|7688627|FG002|Safety Set (SAF)|Overall Study||201
6762068|NCT03629249|7688625|FG000|COMPLETED|Overall Study||0
6762069|NCT03629249|7688626|FG001|COMPLETED|Overall Study||0
6762070|NCT03629249|7688627|FG002|COMPLETED|Overall Study||0
6762071|NCT03629249|7688625|FG000|NOT COMPLETED|Overall Study||201
6762072|NCT03629249|7688626|FG001|NOT COMPLETED|Overall Study||201
6762073|NCT03629249|7688627|FG002|NOT COMPLETED|Overall Study||202
6762074|NCT03629535|7688635|FG000|STARTED|Overall Study||8
6762075|NCT03629535|7688635|FG000|COMPLETED|Overall Study||8
6762076|NCT03629535|7688635|FG000|NOT COMPLETED|Overall Study||0
6762077|NCT03629886|7688641|FG000|STARTED|Overall Study||1671
6762078|NCT03629886|7688642|FG001|STARTED|Overall Study||1866
6762079|NCT03629886|7688641|FG000|COMPLETED|Overall Study||1671
6762080|NCT03629886|7688642|FG001|COMPLETED|Overall Study||1686
6762081|NCT03629886|7688641|FG000|NOT COMPLETED|Overall Study||0
6762082|NCT03629886|7688642|FG001|NOT COMPLETED|Overall Study||180
6762083|NCT03629925|7688651|FG000|STARTED|Overall Study||179
6762084|NCT03629925|7688652|FG001|STARTED|Overall Study||178
6762085|NCT03629925|7688651|FG000|COMPLETED|Overall Study||0
6762086|NCT03629925|7688652|FG001|COMPLETED|Overall Study||0
6762087|NCT03629925|7688651|FG000|NOT COMPLETED|Overall Study||179
6762088|NCT03629925|7688652|FG001|NOT COMPLETED|Overall Study||178
6762089|NCT03630016|7688658|FG000|STARTED|Overall Study||11
6762090|NCT03630016|7688658|FG000|COMPLETED|Overall Study||10
6762091|NCT03630016|7688658|FG000|NOT COMPLETED|Overall Study||1
6762092|NCT03630185|7688664|FG000|STARTED|Overall Study||4
6762093|NCT03630185|7688665|FG001|STARTED|Overall Study||4
6762094|NCT03630185|7688664|FG000|30 Day Follow up|Overall Study||1
6762095|NCT03630185|7688665|FG001|30 Day Follow up|Overall Study||1
6762096|NCT03630185|7688664|FG000|90 Day Follow up|Overall Study||0
6762097|NCT03630185|7688665|FG001|90 Day Follow up|Overall Study||1
6762098|NCT03630185|7688664|FG000|6 Month Follow up|Overall Study||0
6762099|NCT03630185|7688665|FG001|6 Month Follow up|Overall Study||0
6556079|NCT01756157|7478277|FG001|COMPLETED|Second Intervention Period||22
6556080|NCT01756157|7478276|FG000|NOT COMPLETED|Second Intervention Period||0
6556081|NCT01756157|7478277|FG001|NOT COMPLETED|Second Intervention Period||0
6556082|NCT01756209|7478287|FG000|STARTED|Overall Study||40
6556083|NCT01756209|7478288|FG001|STARTED|Overall Study||40
6556084|NCT01756209|7478289|FG002|STARTED|Overall Study||40
6556085|NCT01756209|7478290|FG003|STARTED|Overall Study||40
6556086|NCT01756209|7478287|FG000|COMPLETED|Overall Study||40
6556087|NCT01756209|7478288|FG001|COMPLETED|Overall Study||40
6556088|NCT01756209|7478289|FG002|COMPLETED|Overall Study||40
6556089|NCT01756209|7478290|FG003|COMPLETED|Overall Study||40
6556090|NCT01756209|7478287|FG000|NOT COMPLETED|Overall Study||0
6556091|NCT01756209|7478288|FG001|NOT COMPLETED|Overall Study||0
6556092|NCT01756209|7478289|FG002|NOT COMPLETED|Overall Study||0
6556093|NCT01756209|7478290|FG003|NOT COMPLETED|Overall Study||0
6762100|NCT03630185|7688664|FG000|COMPLETED|Overall Study||0
6762101|NCT03630185|7688665|FG001|COMPLETED|Overall Study||0
6762102|NCT03630185|7688664|FG000|NOT COMPLETED|Overall Study||4
6762103|NCT03630185|7688665|FG001|NOT COMPLETED|Overall Study||4
6762104|NCT03630198|7688673|FG000|STARTED|Overall Study||13
6762105|NCT03630198|7688674|FG001|STARTED|Overall Study||18
6762106|NCT03630198|7688673|FG000|COMPLETED|Overall Study||13
6762107|NCT03630198|7688674|FG001|COMPLETED|Overall Study||18
6762108|NCT03630198|7688673|FG000|NOT COMPLETED|Overall Study||0
6556094|NCT01756235|7478300|FG000|STARTED|Overall Study||462
6556095|NCT01756235|7478300|FG000|COMPLETED|Overall Study||460
6556096|NCT01756235|7478300|FG000|NOT COMPLETED|Overall Study||2
6762109|NCT03630198|7688674|FG001|NOT COMPLETED|Overall Study||0
6780180|NCT03277183|7708545|FG000|NOT COMPLETED|Overall Study||3
6780181|NCT03277183|7708546|FG001|NOT COMPLETED|Overall Study||2
6780182|NCT03269968|7708554|FG000|STARTED|Overall Study||0
6780183|NCT03269968|7708555|FG001|STARTED|Overall Study||0
6780184|NCT03269968|7708554|FG000|COMPLETED|Overall Study||0
6780185|NCT03269968|7708555|FG001|COMPLETED|Overall Study||0
6780186|NCT03269968|7708554|FG000|NOT COMPLETED|Overall Study||0
6780187|NCT03269968|7708555|FG001|NOT COMPLETED|Overall Study||0
6762110|NCT03630302|7688680|FG000|STARTED|Surgery||10
6762111|NCT03630302|7688680|FG000|COMPLETED|Surgery||9
6762112|NCT03630302|7688680|FG000|NOT COMPLETED|Surgery||1
6762113|NCT03630302|7688680|FG000|STARTED|3 Month Visit||9
6762114|NCT03630302|7688680|FG000|COMPLETED|3 Month Visit||7
6762115|NCT03630302|7688680|FG000|NOT COMPLETED|3 Month Visit||2
6762116|NCT03630302|7688680|FG000|STARTED|Data Post Analyses||7
6762117|NCT03630302|7688680|FG000|COMPLETED|Data Post Analyses||5
6762118|NCT03630302|7688680|FG000|NOT COMPLETED|Data Post Analyses||2
6762119|NCT03630679|7688686|FG000|STARTED|Overall Study||20
6762120|NCT03630679|7688687|FG001|STARTED|Overall Study||25
6762121|NCT03630679|7688686|FG000|COMPLETED|Overall Study||13
6762122|NCT03630679|7688687|FG001|COMPLETED|Overall Study||13
6762123|NCT03630679|7688686|FG000|NOT COMPLETED|Overall Study||7
6762124|NCT03630679|7688687|FG001|NOT COMPLETED|Overall Study||12
6762125|NCT03631355|7688695|FG000|STARTED|Overall Study||55
6762126|NCT03631355|7688696|FG001|STARTED|Overall Study||55
6762127|NCT03631355|7688695|FG000|COMPLETED|Overall Study||54
6762128|NCT03631355|7688696|FG001|COMPLETED|Overall Study||53
6762129|NCT03631355|7688695|FG000|NOT COMPLETED|Overall Study||1
6762130|NCT03631355|7688696|FG001|NOT COMPLETED|Overall Study||2
6762131|NCT03631433|7688704|FG000|STARTED|Overall Study||49
6762132|NCT03631433|7688705|FG001|STARTED|Overall Study||53
6762133|NCT03631433|7688704|FG000|COMPLETED|Overall Study||49
6762134|NCT03631433|7688705|FG001|COMPLETED|Overall Study||53
6762135|NCT03631433|7688704|FG000|NOT COMPLETED|Overall Study||0
6762136|NCT03631433|7688705|FG001|NOT COMPLETED|Overall Study||0
6762137|NCT03631732|7688713|FG000|STARTED|Randomized Phase Up to Week 24||331
6762138|NCT03631732|7688714|FG001|STARTED|Randomized Phase Up to Week 24||165
6762139|NCT03631732|7688713|FG000|COMPLETED|Randomized Phase Up to Week 24||324
6762140|NCT03631732|7688714|FG001|COMPLETED|Randomized Phase Up to Week 24||163
6762141|NCT03631732|7688713|FG000|NOT COMPLETED|Randomized Phase Up to Week 24||7
6762142|NCT03631732|7688714|FG001|NOT COMPLETED|Randomized Phase Up to Week 24||2
6762143|NCT03631732|7688713|FG000|STARTED|B/F/TAF Treatment Phase (After Week 24)|5 participants completed 24 weeks of the study, but did not receive study treatment after Week 24.|319
6762144|NCT03631732|7688714|FG001|STARTED|B/F/TAF Treatment Phase (After Week 24)||163
6762145|NCT03631732|7688713|FG000|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||303
6762146|NCT03631732|7688714|FG001|COMPLETED|B/F/TAF Treatment Phase (After Week 24)||158
6762147|NCT03631732|7688713|FG000|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||16
6556097|NCT01756274|7478304|FG000|STARTED|Overall Study||162
6556098|NCT01756274|7478304|FG000|COMPLETED|Overall Study||159
6556099|NCT01756274|7478304|FG000|NOT COMPLETED|Overall Study||3
6556100|NCT01756300|7478309|FG000|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
6762148|NCT03631732|7688714|FG001|NOT COMPLETED|B/F/TAF Treatment Phase (After Week 24)||5
6762149|NCT03631927|7688724|FG000|STARTED|Overall Study||5094
6762150|NCT03631927|7688724|FG000|COMPLETED|Overall Study||4669
6762151|NCT03631927|7688724|FG000|NOT COMPLETED|Overall Study||425
6762152|NCT03632083|7688728|FG000|STARTED|First Intervention||5
6762153|NCT03632083|7688729|FG001|STARTED|First Intervention||5
6762154|NCT03632083|7688730|FG002|STARTED|First Intervention||7
6762155|NCT03632083|7688731|FG003|STARTED|First Intervention||7
6762156|NCT03632083|7688732|FG004|STARTED|First Intervention||9
6762157|NCT03632083|7688733|FG005|STARTED|First Intervention||9
6762158|NCT03632083|7688734|FG006|STARTED|First Intervention||7
6762159|NCT03632083|7688735|FG007|STARTED|First Intervention||7
6762160|NCT03632083|7688728|FG000|COMPLETED|First Intervention||5
6762161|NCT03632083|7688729|FG001|COMPLETED|First Intervention||5
6762162|NCT03632083|7688730|FG002|COMPLETED|First Intervention||7
6762163|NCT03632083|7688731|FG003|COMPLETED|First Intervention||7
6762164|NCT03632083|7688732|FG004|COMPLETED|First Intervention||9
6762165|NCT03632083|7688733|FG005|COMPLETED|First Intervention||9
6762166|NCT03632083|7688734|FG006|COMPLETED|First Intervention||7
6762167|NCT03632083|7688735|FG007|COMPLETED|First Intervention||7
6762168|NCT03632083|7688728|FG000|NOT COMPLETED|First Intervention||0
6762169|NCT03632083|7688729|FG001|NOT COMPLETED|First Intervention||0
6762170|NCT03632083|7688730|FG002|NOT COMPLETED|First Intervention||0
6762171|NCT03632083|7688731|FG003|NOT COMPLETED|First Intervention||0
6762172|NCT03632083|7688732|FG004|NOT COMPLETED|First Intervention||0
6762173|NCT03632083|7688733|FG005|NOT COMPLETED|First Intervention||0
6762174|NCT03632083|7688734|FG006|NOT COMPLETED|First Intervention||0
6762175|NCT03632083|7688735|FG007|NOT COMPLETED|First Intervention||0
6762176|NCT03632083|7688728|FG000|STARTED|Second Intervention||5
6762177|NCT03632083|7688729|FG001|STARTED|Second Intervention||5
6762178|NCT03632083|7688730|FG002|STARTED|Second Intervention||7
6762179|NCT03632083|7688731|FG003|STARTED|Second Intervention||7
6762180|NCT03632083|7688732|FG004|STARTED|Second Intervention||9
6762181|NCT03632083|7688733|FG005|STARTED|Second Intervention||9
6762182|NCT03632083|7688734|FG006|STARTED|Second Intervention||7
6762183|NCT03632083|7688735|FG007|STARTED|Second Intervention||7
6762184|NCT03632083|7688728|FG000|COMPLETED|Second Intervention||5
6762185|NCT03632083|7688729|FG001|COMPLETED|Second Intervention||5
6762186|NCT03632083|7688730|FG002|COMPLETED|Second Intervention||7
6556101|NCT01756300|7478309|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
6762187|NCT03632083|7688731|FG003|COMPLETED|Second Intervention||7
6762188|NCT03632083|7688732|FG004|COMPLETED|Second Intervention||9
6762189|NCT03632083|7688733|FG005|COMPLETED|Second Intervention||9
6762190|NCT03632083|7688734|FG006|COMPLETED|Second Intervention||7
6762191|NCT03632083|7688735|FG007|COMPLETED|Second Intervention||5
6762192|NCT03632083|7688728|FG000|NOT COMPLETED|Second Intervention||0
6762193|NCT03632083|7688729|FG001|NOT COMPLETED|Second Intervention||0
6762194|NCT03632083|7688730|FG002|NOT COMPLETED|Second Intervention||0
6762195|NCT03632083|7688731|FG003|NOT COMPLETED|Second Intervention||0
6762196|NCT03632083|7688732|FG004|NOT COMPLETED|Second Intervention||0
6762197|NCT03632083|7688733|FG005|NOT COMPLETED|Second Intervention||0
6762198|NCT03632083|7688734|FG006|NOT COMPLETED|Second Intervention||0
6762199|NCT03632083|7688735|FG007|NOT COMPLETED|Second Intervention||2
6762200|NCT03632109|7688747|FG000|STARTED|Overall Study||13
6762201|NCT03632109|7688747|FG000|COMPLETED|Overall Study||13
6762202|NCT03632109|7688747|FG000|NOT COMPLETED|Overall Study||0
6762203|NCT03632954|7688753|FG000|STARTED|Overall Study||37
6762204|NCT03632954|7688753|FG000|COMPLETED|Overall Study||3
6762205|NCT03632954|7688753|FG000|NOT COMPLETED|Overall Study||34
6762206|NCT03633084|7688760|FG000|STARTED|Overall Study||3
6762207|NCT03633084|7688761|FG001|STARTED|Overall Study||3
6762208|NCT03633084|7688762|FG002|STARTED|Overall Study||3
6762209|NCT03633084|7688760|FG000|COMPLETED|Overall Study||3
6762210|NCT03633084|7688761|FG001|COMPLETED|Overall Study||3
6762211|NCT03633084|7688762|FG002|COMPLETED|Overall Study||3
6762212|NCT03633084|7688760|FG000|NOT COMPLETED|Overall Study||0
6762213|NCT03633084|7688761|FG001|NOT COMPLETED|Overall Study||0
6762214|NCT03633084|7688762|FG002|NOT COMPLETED|Overall Study||0
6762215|NCT03633331|7688771|FG000|STARTED|Overall Study||93
6762216|NCT03633331|7688771|FG000|COMPLETED|Overall Study||92
6762217|NCT03633331|7688771|FG000|NOT COMPLETED|Overall Study||1
6762218|NCT03633344|7688777|FG000|STARTED|Overall Study||120
6762219|NCT03633344|7688778|FG001|STARTED|Overall Study||24
6762220|NCT03633344|7688777|FG000|COMPLETED|Overall Study||120
6762221|NCT03633344|7688778|FG001|COMPLETED|Overall Study||24
6762222|NCT03633344|7688777|FG000|NOT COMPLETED|Overall Study||0
6762223|NCT03633344|7688778|FG001|NOT COMPLETED|Overall Study||0
6762224|NCT03633448|7688788|FG000|STARTED|Period 1 (1 Day)||12
6762225|NCT03633448|7688789|FG001|STARTED|Period 1 (1 Day)||12
6762226|NCT03633448|7688788|FG000|COMPLETED|Period 1 (1 Day)||12
6762227|NCT03633448|7688789|FG001|COMPLETED|Period 1 (1 Day)||12
6762228|NCT03633448|7688788|FG000|NOT COMPLETED|Period 1 (1 Day)||0
6762229|NCT03633448|7688789|FG001|NOT COMPLETED|Period 1 (1 Day)||0
6762230|NCT03633448|7688788|FG000|STARTED|Washout (7 Days)||12
6762231|NCT03633448|7688789|FG001|STARTED|Washout (7 Days)||12
6762232|NCT03633448|7688788|FG000|COMPLETED|Washout (7 Days)||12
6762233|NCT03633448|7688789|FG001|COMPLETED|Washout (7 Days)||12
6762234|NCT03633448|7688788|FG000|NOT COMPLETED|Washout (7 Days)||0
6762235|NCT03633448|7688789|FG001|NOT COMPLETED|Washout (7 Days)||0
6762236|NCT03633448|7688788|FG000|STARTED|Period 2 (1 Day)||12
6762237|NCT03633448|7688789|FG001|STARTED|Period 2 (1 Day)||12
6762238|NCT03633448|7688788|FG000|COMPLETED|Period 2 (1 Day)||12
6762239|NCT03633448|7688789|FG001|COMPLETED|Period 2 (1 Day)||12
6762240|NCT03633448|7688788|FG000|NOT COMPLETED|Period 2 (1 Day)||0
6762241|NCT03633448|7688789|FG001|NOT COMPLETED|Period 2 (1 Day)||0
6762242|NCT03633487|7688799|FG000|STARTED|Overall Study||24
6762243|NCT03633487|7688799|FG000|COMPLETED|Overall Study||24
6762244|NCT03633487|7688799|FG000|NOT COMPLETED|Overall Study||0
6762245|NCT03633526|7688803|FG000|STARTED|Overall Study||16
6762246|NCT03633526|7688803|FG000|COMPLETED|Overall Study||16
6762247|NCT03633526|7688803|FG000|NOT COMPLETED|Overall Study||0
6762248|NCT03633825|7688809|FG000|STARTED|Enrollment||19838
6762249|NCT03633825|7688810|FG001|STARTED|Enrollment||19612
6762250|NCT03633825|7688809|FG000|COMPLETED|Enrollment||805
6762251|NCT03633825|7688810|FG001|COMPLETED|Enrollment||775
6762252|NCT03633825|7688809|FG000|NOT COMPLETED|Enrollment||19033
6762253|NCT03633825|7688810|FG001|NOT COMPLETED|Enrollment||18837
6762254|NCT03633825|7688809|FG000|STARTED|Allocation||805
6762255|NCT03633825|7688810|FG001|STARTED|Allocation||775
6762256|NCT03633825|7688809|FG000|COMPLETED|Allocation||805
6762257|NCT03633825|7688810|FG001|COMPLETED|Allocation||775
6762258|NCT03633825|7688809|FG000|NOT COMPLETED|Allocation||0
6762259|NCT03633825|7688810|FG001|NOT COMPLETED|Allocation||0
6762260|NCT03633825|7688809|FG000|STARTED|Follow up||805
6762261|NCT03633825|7688810|FG001|STARTED|Follow up||775
6762262|NCT03633825|7688809|FG000|COMPLETED|Follow up||327
6762263|NCT03633825|7688810|FG001|COMPLETED|Follow up||325
6762264|NCT03633825|7688809|FG000|NOT COMPLETED|Follow up||478
6762265|NCT03633825|7688810|FG001|NOT COMPLETED|Follow up||450
6762266|NCT03633825|7688809|FG000|STARTED|Analysis||327
6762267|NCT03633825|7688810|FG001|STARTED|Analysis||325
6762268|NCT03633825|7688809|FG000|COMPLETED|Analysis||327
6762269|NCT03633825|7688810|FG001|COMPLETED|Analysis||325
6762270|NCT03633825|7688809|FG000|NOT COMPLETED|Analysis||0
6762271|NCT03633825|7688810|FG001|NOT COMPLETED|Analysis||0
6762272|NCT03633903|7688818|FG000|STARTED|Overall Study||22
6762273|NCT03633903|7688819|FG001|STARTED|Overall Study||18
6762274|NCT03633903|7688818|FG000|Intent to Treat|Overall Study||0
6762275|NCT03633903|7688819|FG001|Intent to Treat|Overall Study||18
6762276|NCT03633903|7688818|FG000|COMPLETED|Overall Study||16
6762277|NCT03633903|7688819|FG001|COMPLETED|Overall Study||11
6762278|NCT03633903|7688818|FG000|NOT COMPLETED|Overall Study||6
6762279|NCT03633903|7688819|FG001|NOT COMPLETED|Overall Study||7
6762280|NCT03633929|7688825|FG000|STARTED|Overall Study||19
6762281|NCT03633929|7688825|FG000|COMPLETED|Overall Study||15
6762282|NCT03633929|7688825|FG000|NOT COMPLETED|Overall Study||4
6762283|NCT03634085|7688831|FG000|STARTED|Overall Study||8
6762284|NCT03634085|7688832|FG001|STARTED|Overall Study||8
6762285|NCT03634085|7688831|FG000|Period 1|Overall Study|8 subjects started BDM2-50 mg and 8 subjects completed BDM2-50 mg including matching placebo.|8
6762286|NCT03634085|7688832|FG001|Period 1|Overall Study|8 subjects started BDM2 - 150mg and 8 subjects completed BDM2 - 150 mg including matching placebo|8
6762287|NCT03634085|7688831|FG000|Period 2|Overall Study|8 subjects started BDM2 - 450 mg and 7 subjects completed BDM2 - 450 mg (drop out; 1 active)|8
6762288|NCT03634085|7688832|FG001|Period 2|Overall Study|8 subjects started BDM2 - 900 mg fasted and 8 subjects completed BDM2 - 900 mg fasted|8
6762289|NCT03634085|7688831|FG000|Period 3|Overall Study|8 subjects started BDM2 - 1800 mg and 7 subjects completed BDM2 - 1800 mg (drop out; 1 active)|8
6762290|NCT03634085|7688832|FG001|Period 3|Overall Study|8 subjects started and 6 subjects completed BDM2 - 900 mg fed (dropout; 1 active 1 placebo)|8
6762291|NCT03634085|7688831|FG000|Period 4|Overall Study|8 subjects started BDM2 - 3100 mg and 7 subjects completed BDM2 - 3100 mg (drop out; 1 active)|8
6762292|NCT03634085|7688832|FG001|Period 4|Overall Study|this period is not applicable for Cohort B|0
6762293|NCT03634085|7688831|FG000|COMPLETED|Overall Study|1 subject dropped out due to car accident|7
6762294|NCT03634085|7688832|FG001|COMPLETED|Overall Study|"1 subject dropped out due to personal emergency~1 subject dropped out due to personal circumstances"|6
6762295|NCT03634085|7688831|FG000|NOT COMPLETED|Overall Study||1
6762296|NCT03634085|7688832|FG001|NOT COMPLETED|Overall Study||2
6762297|NCT03634306|7688848|FG000|STARTED|Overall Study||15
6762298|NCT03634306|7688849|FG001|STARTED|Overall Study||15
6762299|NCT03634306|7688850|FG002|STARTED|Overall Study||5
6762300|NCT03634306|7688848|FG000|COMPLETED|Overall Study||15
6762301|NCT03634306|7688849|FG001|COMPLETED|Overall Study||15
6762302|NCT03634306|7688850|FG002|COMPLETED|Overall Study||5
6762303|NCT03634306|7688848|FG000|NOT COMPLETED|Overall Study||0
6762304|NCT03634306|7688849|FG001|NOT COMPLETED|Overall Study||0
6762305|NCT03634306|7688850|FG002|NOT COMPLETED|Overall Study||0
6762306|NCT03634579|7688858|FG000|STARTED|Overall Study||9
6762307|NCT03634579|7688858|FG000|COMPLETED|Overall Study||0
6762308|NCT03634579|7688858|FG000|NOT COMPLETED|Overall Study||9
6762309|NCT03634800|7688862|FG000|STARTED|Overall Study||6
6762310|NCT03634800|7688862|FG000|COMPLETED|Overall Study||0
6762311|NCT03634800|7688862|FG000|NOT COMPLETED|Overall Study||6
6762312|NCT03634813|7688868|FG000|STARTED|Overall Study||49
6762313|NCT03634813|7688869|FG001|STARTED|Overall Study||51
6762314|NCT03634813|7688868|FG000|COMPLETED|Overall Study||49
6762315|NCT03634813|7688869|FG001|COMPLETED|Overall Study||51
6762316|NCT03634813|7688868|FG000|NOT COMPLETED|Overall Study||0
6762317|NCT03634813|7688869|FG001|NOT COMPLETED|Overall Study||0
6762318|NCT03635086|7688881|FG000|STARTED|Overall Study||12
6762319|NCT03635086|7688882|FG001|STARTED|Overall Study||12
6762320|NCT03635086|7688883|FG002|STARTED|Overall Study||12
6762321|NCT03635086|7688884|FG003|STARTED|Overall Study||12
6762322|NCT03635086|7688885|FG004|STARTED|Overall Study||12
6762323|NCT03635086|7688881|FG000|COMPLETED|Overall Study||11
6762324|NCT03635086|7688882|FG001|COMPLETED|Overall Study||11
6762325|NCT03635086|7688883|FG002|COMPLETED|Overall Study||11
6762326|NCT03635086|7688884|FG003|COMPLETED|Overall Study||12
6762327|NCT03635086|7688885|FG004|COMPLETED|Overall Study||12
6762328|NCT03635086|7688881|FG000|NOT COMPLETED|Overall Study||1
6762329|NCT03635086|7688882|FG001|NOT COMPLETED|Overall Study||1
6762330|NCT03635086|7688883|FG002|NOT COMPLETED|Overall Study||1
6762331|NCT03635086|7688884|FG003|NOT COMPLETED|Overall Study||0
6762332|NCT03635086|7688885|FG004|NOT COMPLETED|Overall Study||0
6762333|NCT03635320|7688900|FG000|STARTED|Overall Study||94
6762334|NCT03635320|7688901|FG001|STARTED|Overall Study||94
6762335|NCT03635320|7688900|FG000|FAS|Overall Study|1 subject was not implanted the device|93
6762336|NCT03635320|7688901|FG001|FAS|Overall Study|2 subjects were not implant the device|92
6762337|NCT03635320|7688900|FG000|PPS|Overall Study|11 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject had a risk of unblinding, which was excluded from the PPS.|81
6762338|NCT03635320|7688901|FG001|PPS|Overall Study|6 subjects early discontinued and didn't complete the trial which were excluded from PPS, 1 subject didn't undergo the evaluation or laboratory examination required by the clinical trial, 1 subject violated the inclusion/exclusion criteria and 1 subject used the device beyond the scope of the specifications, which were excluded from the PPS.|83
6762339|NCT03635320|7688900|FG000|COMPLETED|Overall Study||82
6762340|NCT03635320|7688901|FG001|COMPLETED|Overall Study||86
6762341|NCT03635320|7688900|FG000|NOT COMPLETED|Overall Study||12
6762342|NCT03635320|7688901|FG001|NOT COMPLETED|Overall Study||8
6762346|NCT03635775|7688915|FG000|STARTED|Overall Study||5
6762347|NCT03635775|7688916|FG001|STARTED|Overall Study||0
6762348|NCT03635775|7688917|FG002|STARTED|Overall Study||5
6762349|NCT03635775|7688918|FG003|STARTED|Overall Study||10
6762350|NCT03635775|7688915|FG000|COMPLETED|Overall Study||5
6762351|NCT03635775|7688916|FG001|COMPLETED|Overall Study||0
6762352|NCT03635775|7688917|FG002|COMPLETED|Overall Study||5
6762353|NCT03635775|7688918|FG003|COMPLETED|Overall Study||9
6762354|NCT03635775|7688915|FG000|NOT COMPLETED|Overall Study||0
6762355|NCT03635775|7688916|FG001|NOT COMPLETED|Overall Study||0
6762356|NCT03635775|7688917|FG002|NOT COMPLETED|Overall Study||0
6762357|NCT03635775|7688918|FG003|NOT COMPLETED|Overall Study||1
6762358|NCT03635957|7688928|FG000|STARTED|Run-In Period||15
6762359|NCT03635957|7688928|FG000|COMPLETED|Run-In Period||14
6762360|NCT03635957|7688928|FG000|NOT COMPLETED|Run-In Period||1
6762361|NCT03635957|7688928|FG000|STARTED|Pegloticase + IMM Period||14
6762362|NCT03635957|7688928|FG000|Completed Study at 24 Weeks-Amendment 1|Pegloticase + IMM Period||1
6762363|NCT03635957|7688928|FG000|Completed Study at 52 Weeks-Amendment 2|Pegloticase + IMM Period||10
6762364|NCT03635957|7688928|FG000|Discontinued Study Treatment Early|Pegloticase + IMM Period||5
6762365|NCT03635957|7688928|FG000|Had 3-Month Follow-up|Pegloticase + IMM Period||7
6762366|NCT03635957|7688928|FG000|Had 6-Month Follow-up|Pegloticase + IMM Period||6
6762367|NCT03635957|7688928|FG000|COMPLETED|Pegloticase + IMM Period||11
6762368|NCT03635957|7688928|FG000|NOT COMPLETED|Pegloticase + IMM Period||3
6762369|NCT03636061|7688937|FG000|STARTED|Overall Study||47
6762370|NCT03636061|7688938|FG001|STARTED|Overall Study||48
6762371|NCT03636061|7688939|FG002|STARTED|Overall Study||44
6762372|NCT03636061|7688940|FG003|STARTED|Overall Study||43
6762373|NCT03636061|7688937|FG000|COMPLETED|Overall Study||47
6762374|NCT03636061|7688938|FG001|COMPLETED|Overall Study||46
6762375|NCT03636061|7688939|FG002|COMPLETED|Overall Study||40
6762376|NCT03636061|7688940|FG003|COMPLETED|Overall Study||43
6762377|NCT03636061|7688937|FG000|NOT COMPLETED|Overall Study||0
6762378|NCT03636061|7688938|FG001|NOT COMPLETED|Overall Study||2
6762379|NCT03636061|7688939|FG002|NOT COMPLETED|Overall Study||4
6762380|NCT03636061|7688940|FG003|NOT COMPLETED|Overall Study||0
6762381|NCT03636386|7688955|FG000|STARTED|Overall Study||24
6762382|NCT03636386|7688956|FG001|STARTED|Overall Study||24
6762383|NCT03636386|7688955|FG000|COMPLETED|Overall Study||24
6762384|NCT03636386|7688956|FG001|COMPLETED|Overall Study||24
6762385|NCT03636386|7688955|FG000|NOT COMPLETED|Overall Study||0
6762386|NCT03636386|7688956|FG001|NOT COMPLETED|Overall Study||0
6762387|NCT03636893|7688964|FG000|STARTED|Overall Study||40
6762388|NCT03636893|7688965|FG001|STARTED|Overall Study||34
6762389|NCT03636893|7688964|FG000|COMPLETED|Overall Study||31
6762390|NCT03636893|7688965|FG001|COMPLETED|Overall Study||24
6762391|NCT03636893|7688964|FG000|NOT COMPLETED|Overall Study||9
6762392|NCT03636893|7688965|FG001|NOT COMPLETED|Overall Study||10
6762393|NCT03637296|7688973|FG000|STARTED|Overall Study||10
6762394|NCT03637296|7688974|FG001|STARTED|Overall Study||5
6762395|NCT03637296|7688973|FG000|COMPLETED|Overall Study||10
6762396|NCT03637296|7688974|FG001|COMPLETED|Overall Study||5
6762397|NCT03637296|7688973|FG000|NOT COMPLETED|Overall Study||0
6762398|NCT03637296|7688974|FG001|NOT COMPLETED|Overall Study||0
6762399|NCT03637348|7688980|FG000|STARTED|Overall Study||45
6762400|NCT03637348|7688980|FG000|COMPLETED|Overall Study||45
6762401|NCT03637348|7688980|FG000|NOT COMPLETED|Overall Study||0
6762402|NCT03637517|7688988|FG000|STARTED|Overall Study||14
6762403|NCT03637517|7688989|FG001|STARTED|Overall Study||14
6762404|NCT03637517|7688990|FG002|STARTED|Overall Study||14
6762405|NCT03637517|7688988|FG000|COMPLETED|Overall Study||14
6762406|NCT03637517|7688989|FG001|COMPLETED|Overall Study||14
6762407|NCT03637517|7688990|FG002|COMPLETED|Overall Study||14
6762408|NCT03637517|7688988|FG000|NOT COMPLETED|Overall Study||0
6762409|NCT03637517|7688989|FG001|NOT COMPLETED|Overall Study||0
6762410|NCT03637517|7688990|FG002|NOT COMPLETED|Overall Study||0
6762411|NCT03637699|7689000|FG000|STARTED|Overall Study||15
6762412|NCT03637699|7689001|FG001|STARTED|Overall Study||15
6762413|NCT03637699|7689000|FG000|COMPLETED|Overall Study||14
6762414|NCT03637699|7689001|FG001|COMPLETED|Overall Study||14
6762415|NCT03637699|7689000|FG000|NOT COMPLETED|Overall Study||1
6762416|NCT03637699|7689001|FG001|NOT COMPLETED|Overall Study||1
6762417|NCT03637842|7689010|FG000|STARTED|Overall Study||2
6762418|NCT03637842|7689011|FG001|STARTED|Overall Study||2
6762419|NCT03637842|7689010|FG000|COMPLETED|Overall Study||2
6762420|NCT03637842|7689011|FG001|COMPLETED|Overall Study||2
6762421|NCT03637842|7689010|FG000|NOT COMPLETED|Overall Study||0
6762422|NCT03637842|7689011|FG001|NOT COMPLETED|Overall Study||0
6762423|NCT03638011|7689019|FG000|STARTED|Overall Study||38
6762424|NCT03638011|7689020|FG001|STARTED|Overall Study||33
6762425|NCT03638011|7689019|FG000|COMPLETED|Overall Study||38
6762426|NCT03638011|7689020|FG001|COMPLETED|Overall Study||33
6762427|NCT03638011|7689019|FG000|NOT COMPLETED|Overall Study||0
6762428|NCT03638011|7689020|FG001|NOT COMPLETED|Overall Study||0
6762429|NCT03638323|7689028|FG000|STARTED|Overall Study||38
6762430|NCT03638323|7689028|FG000|COMPLETED|Overall Study||37
6762431|NCT03638323|7689028|FG000|NOT COMPLETED|Overall Study||1
6762432|NCT03638622|7689035|FG000|STARTED|Overall Study||30
6762433|NCT03638622|7689035|FG000|COMPLETED|Overall Study||29
6762434|NCT03638622|7689035|FG000|NOT COMPLETED|Overall Study||1
6762435|NCT03638635|7689041|FG000|STARTED|Initial Hospitalization||39
6762436|NCT03638635|7689042|FG001|STARTED|Initial Hospitalization||24
6762437|NCT03638635|7689041|FG000|COMPLETED|Initial Hospitalization||39
6762438|NCT03638635|7689042|FG001|COMPLETED|Initial Hospitalization||22
6762439|NCT03638635|7689041|FG000|NOT COMPLETED|Initial Hospitalization||0
6762440|NCT03638635|7689042|FG001|NOT COMPLETED|Initial Hospitalization||2
6762441|NCT03638635|7689041|FG000|STARTED|Follow-Up (30 Days After Discharge)||39
6762442|NCT03638635|7689042|FG001|STARTED|Follow-Up (30 Days After Discharge)||22
6762443|NCT03638635|7689041|FG000|COMPLETED|Follow-Up (30 Days After Discharge)||0
6762444|NCT03638635|7689042|FG001|COMPLETED|Follow-Up (30 Days After Discharge)||0
6762445|NCT03638635|7689041|FG000|NOT COMPLETED|Follow-Up (30 Days After Discharge)||39
6762446|NCT03638635|7689042|FG001|NOT COMPLETED|Follow-Up (30 Days After Discharge)||22
6762447|NCT03638908|7689048|FG000|STARTED|Overall Study||8
6762448|NCT03638908|7689048|FG000|COMPLETED|Overall Study||7
6762449|NCT03638908|7689048|FG000|NOT COMPLETED|Overall Study||1
6762450|NCT03639675|7689056|FG000|STARTED|Overall Study||16
6762451|NCT03639675|7689056|FG000|Received Treatment|Overall Study||16
6762452|NCT03639675|7689056|FG000|COMPLETED|Overall Study||15
6762453|NCT03639675|7689056|FG000|NOT COMPLETED|Overall Study||1
6762454|NCT03639766|7689060|FG000|STARTED|Overall Study||3
6762455|NCT03639766|7689060|FG000|COMPLETED|Overall Study||3
6762456|NCT03639766|7689060|FG000|NOT COMPLETED|Overall Study||0
6762457|NCT03639779|7689066|FG000|STARTED|Overall Study||5
6762458|NCT03639779|7689066|FG000|Baseline|Overall Study||5
6762459|NCT03639779|7689066|FG000|Month 1|Overall Study||5
6762460|NCT03639779|7689066|FG000|Month 2|Overall Study||4
6762461|NCT03639779|7689066|FG000|Month 3|Overall Study||4
6762462|NCT03639779|7689066|FG000|COMPLETED|Overall Study||4
6762463|NCT03639779|7689066|FG000|NOT COMPLETED|Overall Study||1
6762464|NCT03639857|7689072|FG000|STARTED|Overall Study||1
6762465|NCT03639857|7689073|FG001|STARTED|Overall Study||3
6762466|NCT03639857|7689074|FG002|STARTED|Overall Study||3
6762467|NCT03639857|7689072|FG000|COMPLETED|Overall Study||1
6762468|NCT03639857|7689073|FG001|COMPLETED|Overall Study||3
6762469|NCT03639857|7689074|FG002|COMPLETED|Overall Study||3
6762470|NCT03639857|7689072|FG000|NOT COMPLETED|Overall Study||0
6556102|NCT01756300|7478309|FG000|NOT COMPLETED|Overall Study||2
6556103|NCT01756352|7478330|FG000|STARTED|Overall Study||13
6556104|NCT01756352|7478330|FG000|COMPLETED|Overall Study||12
6556105|NCT01756352|7478330|FG000|NOT COMPLETED|Overall Study||1
6556106|NCT01756391|7478334|FG000|STARTED|Overall Study||351
6556107|NCT01756391|7478334|FG000|COMPLETED|Overall Study||319
6556108|NCT01756391|7478334|FG000|NOT COMPLETED|Overall Study||32
6556109|NCT01756456|7478344|FG000|STARTED|Treatment Period: Phase I/II||7
6556110|NCT01756456|7478345|FG001|STARTED|Treatment Period: Phase I/II||7
6556111|NCT01756456|7478346|FG002|STARTED|Treatment Period: Phase I/II||4
6556112|NCT01756456|7478347|FG003|STARTED|Treatment Period: Phase I/II||52
6556113|NCT01756456|7478348|FG004|STARTED|Treatment Period: Phase I/II||52
6556114|NCT01756456|7478349|FG005|STARTED|Treatment Period: Phase I/II||52
6556115|NCT01756456|7478344|FG000|COMPLETED|Treatment Period: Phase I/II||6
6556116|NCT01756456|7478345|FG001|COMPLETED|Treatment Period: Phase I/II||6
6556117|NCT01756456|7478346|FG002|COMPLETED|Treatment Period: Phase I/II||2
6556118|NCT01756456|7478347|FG003|COMPLETED|Treatment Period: Phase I/II||45
6556119|NCT01756456|7478348|FG004|COMPLETED|Treatment Period: Phase I/II||39
6556120|NCT01756456|7478349|FG005|COMPLETED|Treatment Period: Phase I/II||48
6556121|NCT01756456|7478344|FG000|NOT COMPLETED|Treatment Period: Phase I/II||1
6556122|NCT01756456|7478345|FG001|NOT COMPLETED|Treatment Period: Phase I/II||1
6556123|NCT01756456|7478346|FG002|NOT COMPLETED|Treatment Period: Phase I/II||2
6556124|NCT01756456|7478347|FG003|NOT COMPLETED|Treatment Period: Phase I/II||7
6556125|NCT01756456|7478348|FG004|NOT COMPLETED|Treatment Period: Phase I/II||13
6556126|NCT01756456|7478349|FG005|NOT COMPLETED|Treatment Period: Phase I/II||4
6556127|NCT01756456|7478344|FG000|STARTED|Follow Up Period Phase I/II||6
6556128|NCT01756456|7478345|FG001|STARTED|Follow Up Period Phase I/II||6
6556129|NCT01756456|7478346|FG002|STARTED|Follow Up Period Phase I/II||2
6556130|NCT01756456|7478347|FG003|STARTED|Follow Up Period Phase I/II||45
6556131|NCT01756456|7478348|FG004|STARTED|Follow Up Period Phase I/II||39
6556132|NCT01756456|7478349|FG005|STARTED|Follow Up Period Phase I/II||48
6556133|NCT01756456|7478344|FG000|COMPLETED|Follow Up Period Phase I/II||5
6762471|NCT03639857|7689073|FG001|NOT COMPLETED|Overall Study||0
6762472|NCT03639857|7689074|FG002|NOT COMPLETED|Overall Study||0
6762473|NCT03639987|7689084|FG000|STARTED|Overall Study||26
6762474|NCT03639987|7689085|FG001|STARTED|Overall Study||26
6762475|NCT03639987|7689084|FG000|COMPLETED|Overall Study||0
6762476|NCT03639987|7689085|FG001|COMPLETED|Overall Study||0
6762477|NCT03639987|7689084|FG000|NOT COMPLETED|Overall Study||26
6762478|NCT03639987|7689085|FG001|NOT COMPLETED|Overall Study||26
6762479|NCT03640052|7689091|FG000|STARTED|Overall Study||2
6762480|NCT03640052|7689092|FG001|STARTED|Overall Study||1
6762481|NCT03640052|7689093|FG002|STARTED|Overall Study||1
6762482|NCT03640052|7689094|FG003|STARTED|Overall Study||1
6762483|NCT03640052|7689095|FG004|STARTED|Overall Study||1
6762484|NCT03640052|7689091|FG000|COMPLETED|Overall Study||2
6762485|NCT03640052|7689092|FG001|COMPLETED|Overall Study|the patient performed 4 out of 5 nights|0
6762486|NCT03640052|7689093|FG002|COMPLETED|Overall Study||1
6762487|NCT03640052|7689094|FG003|COMPLETED|Overall Study||1
6762488|NCT03640052|7689095|FG004|COMPLETED|Overall Study||1
6762489|NCT03640052|7689091|FG000|NOT COMPLETED|Overall Study||0
6762490|NCT03640052|7689092|FG001|NOT COMPLETED|Overall Study||1
6762491|NCT03640052|7689093|FG002|NOT COMPLETED|Overall Study||0
6762492|NCT03640052|7689094|FG003|NOT COMPLETED|Overall Study||0
6556134|NCT01756456|7478345|FG001|COMPLETED|Follow Up Period Phase I/II||5
6556135|NCT01756456|7478346|FG002|COMPLETED|Follow Up Period Phase I/II||1
6556136|NCT01756456|7478347|FG003|COMPLETED|Follow Up Period Phase I/II||12
6556137|NCT01756456|7478348|FG004|COMPLETED|Follow Up Period Phase I/II||13
6556138|NCT01756456|7478349|FG005|COMPLETED|Follow Up Period Phase I/II||15
6762493|NCT03640052|7689095|FG004|NOT COMPLETED|Overall Study||0
6762494|NCT03640507|7689110|FG000|STARTED|Overall Study||10
6762495|NCT03640507|7689111|FG001|STARTED|Overall Study||9
6762496|NCT03640507|7689112|FG002|STARTED|Overall Study||11
6762497|NCT03640507|7689110|FG000|COMPLETED|Overall Study||10
6762498|NCT03640507|7689111|FG001|COMPLETED|Overall Study||9
6762499|NCT03640507|7689112|FG002|COMPLETED|Overall Study||10
6762500|NCT03640507|7689110|FG000|NOT COMPLETED|Overall Study||0
6762501|NCT03640507|7689111|FG001|NOT COMPLETED|Overall Study||0
6762502|NCT03640507|7689112|FG002|NOT COMPLETED|Overall Study||1
6556139|NCT01756456|7478344|FG000|NOT COMPLETED|Follow Up Period Phase I/II||1
6556140|NCT01756456|7478345|FG001|NOT COMPLETED|Follow Up Period Phase I/II||1
6762503|NCT03640559|7689122|FG000|STARTED|Overall Study||25
6762504|NCT03640559|7689123|FG001|STARTED|Overall Study||25
6762505|NCT03640559|7689122|FG000|COMPLETED|Overall Study||23
6762506|NCT03640559|7689123|FG001|COMPLETED|Overall Study||24
6762507|NCT03640559|7689122|FG000|NOT COMPLETED|Overall Study||2
6762508|NCT03640559|7689123|FG001|NOT COMPLETED|Overall Study||1
6762509|NCT03640832|7689131|FG000|STARTED|Overall Study||44
6762510|NCT03640832|7689132|FG001|STARTED|Overall Study||46
6762511|NCT03640832|7689131|FG000|COMPLETED|Overall Study||44
6762512|NCT03640832|7689132|FG001|COMPLETED|Overall Study||46
6762513|NCT03640832|7689131|FG000|NOT COMPLETED|Overall Study||0
6762514|NCT03640832|7689132|FG001|NOT COMPLETED|Overall Study||0
6762515|NCT03641508|7689140|FG000|STARTED|First Injection||37
6762516|NCT03641508|7689141|FG001|STARTED|First Injection||32
6762517|NCT03641508|7689140|FG000|COMPLETED|First Injection||35
6762518|NCT03641508|7689141|FG001|COMPLETED|First Injection||32
6762519|NCT03641508|7689140|FG000|NOT COMPLETED|First Injection||2
6762520|NCT03641508|7689141|FG001|NOT COMPLETED|First Injection||0
6762521|NCT03641508|7689140|FG000|STARTED|Follow-up/Second Injection||2
6762522|NCT03641508|7689141|FG001|STARTED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
6762523|NCT03641508|7689140|FG000|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|2
6762524|NCT03641508|7689141|FG001|COMPLETED|Follow-up/Second Injection|Only those who had symptoms at the six-week follow-up received the second injection|10
6762525|NCT03641508|7689140|FG000|NOT COMPLETED|Follow-up/Second Injection||0
6762526|NCT03641508|7689141|FG001|NOT COMPLETED|Follow-up/Second Injection||0
6762527|NCT03641716|7689147|FG000|STARTED|Overall Study||20
6762528|NCT03641716|7689147|FG000|COMPLETED|Overall Study||15
6762529|NCT03641716|7689147|FG000|NOT COMPLETED|Overall Study||5
6762530|NCT03642262|7689151|FG000|STARTED|Period 1||12
6762531|NCT03642262|7689152|FG001|STARTED|Period 1||18
6762532|NCT03642262|7689151|FG000|COMPLETED|Period 1||11
6762533|NCT03642262|7689152|FG001|COMPLETED|Period 1||16
6556141|NCT01756456|7478346|FG002|NOT COMPLETED|Follow Up Period Phase I/II||1
6556142|NCT01756456|7478347|FG003|NOT COMPLETED|Follow Up Period Phase I/II||33
6556143|NCT01756456|7478348|FG004|NOT COMPLETED|Follow Up Period Phase I/II||26
6556144|NCT01756456|7478349|FG005|NOT COMPLETED|Follow Up Period Phase I/II||33
6556145|NCT01756833|7478374|FG000|STARTED|Overall Study||133
6556146|NCT01756833|7478375|FG001|STARTED|Overall Study||128
6762534|NCT03642262|7689151|FG000|NOT COMPLETED|Period 1||1
6762535|NCT03642262|7689152|FG001|NOT COMPLETED|Period 1||2
6762536|NCT03642262|7689151|FG000|STARTED|Washout: 7 Days||11
6762537|NCT03642262|7689152|FG001|STARTED|Washout: 7 Days||16
6762538|NCT03642262|7689151|FG000|COMPLETED|Washout: 7 Days||11
6762539|NCT03642262|7689152|FG001|COMPLETED|Washout: 7 Days||16
6762540|NCT03642262|7689151|FG000|NOT COMPLETED|Washout: 7 Days||0
6762541|NCT03642262|7689152|FG001|NOT COMPLETED|Washout: 7 Days||0
6762542|NCT03642262|7689151|FG000|STARTED|Period 2||11
6762543|NCT03642262|7689152|FG001|STARTED|Period 2||16
6762544|NCT03642262|7689151|FG000|COMPLETED|Period 2||11
6762545|NCT03642262|7689152|FG001|COMPLETED|Period 2||16
6762546|NCT03642262|7689151|FG000|NOT COMPLETED|Period 2||0
6762547|NCT03642262|7689152|FG001|NOT COMPLETED|Period 2||0
6762548|NCT03642457|7689161|FG000|STARTED|Overall Study||35
6762549|NCT03642457|7689162|FG001|STARTED|Overall Study||30
6762550|NCT03642457|7689161|FG000|COMPLETED|Overall Study||35
6762551|NCT03642457|7689162|FG001|COMPLETED|Overall Study||30
6762552|NCT03642457|7689161|FG000|NOT COMPLETED|Overall Study||0
6762553|NCT03642457|7689162|FG001|NOT COMPLETED|Overall Study||0
6762554|NCT03642717|7689168|FG000|STARTED|Overall Study||658
6762555|NCT03642717|7689168|FG000|COMPLETED|Overall Study||620
6762556|NCT03642717|7689168|FG000|NOT COMPLETED|Overall Study||38
6762557|NCT03642873|7689173|FG000|STARTED|First Intervention (1 Day)||4
6762558|NCT03642873|7689174|FG001|STARTED|First Intervention (1 Day)||4
6762559|NCT03642873|7689175|FG002|STARTED|First Intervention (1 Day)||4
6762560|NCT03642873|7689176|FG003|STARTED|First Intervention (1 Day)||4
6762561|NCT03642873|7689177|FG004|STARTED|First Intervention (1 Day)||4
6762562|NCT03642873|7689178|FG005|STARTED|First Intervention (1 Day)||4
6762563|NCT03642873|7689173|FG000|COMPLETED|First Intervention (1 Day)||4
6762564|NCT03642873|7689174|FG001|COMPLETED|First Intervention (1 Day)||4
6762565|NCT03642873|7689175|FG002|COMPLETED|First Intervention (1 Day)||4
6762566|NCT03642873|7689176|FG003|COMPLETED|First Intervention (1 Day)||4
6762567|NCT03642873|7689177|FG004|COMPLETED|First Intervention (1 Day)||4
6762568|NCT03642873|7689178|FG005|COMPLETED|First Intervention (1 Day)||4
6762569|NCT03642873|7689173|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6762570|NCT03642873|7689174|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6762571|NCT03642873|7689175|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6762572|NCT03642873|7689176|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6762573|NCT03642873|7689177|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6762574|NCT03642873|7689178|FG005|NOT COMPLETED|First Intervention (1 Day)||0
6762575|NCT03642873|7689173|FG000|STARTED|Washout (7 Days)||4
6762576|NCT03642873|7689174|FG001|STARTED|Washout (7 Days)||4
6762577|NCT03642873|7689175|FG002|STARTED|Washout (7 Days)||4
6762578|NCT03642873|7689176|FG003|STARTED|Washout (7 Days)||4
6762579|NCT03642873|7689177|FG004|STARTED|Washout (7 Days)||4
6556147|NCT01756833|7478374|FG000|COMPLETED|Overall Study||129
6556148|NCT01756833|7478375|FG001|COMPLETED|Overall Study||125
6762580|NCT03642873|7689178|FG005|STARTED|Washout (7 Days)||4
6762581|NCT03642873|7689173|FG000|COMPLETED|Washout (7 Days)||4
6762582|NCT03642873|7689174|FG001|COMPLETED|Washout (7 Days)||4
6762583|NCT03642873|7689175|FG002|COMPLETED|Washout (7 Days)||4
6762584|NCT03642873|7689176|FG003|COMPLETED|Washout (7 Days)||4
6762585|NCT03642873|7689177|FG004|COMPLETED|Washout (7 Days)||4
6762586|NCT03642873|7689178|FG005|COMPLETED|Washout (7 Days)||4
6762587|NCT03642873|7689173|FG000|NOT COMPLETED|Washout (7 Days)||0
6762588|NCT03642873|7689174|FG001|NOT COMPLETED|Washout (7 Days)||0
6762589|NCT03642873|7689175|FG002|NOT COMPLETED|Washout (7 Days)||0
6762590|NCT03642873|7689176|FG003|NOT COMPLETED|Washout (7 Days)||0
6762591|NCT03642873|7689177|FG004|NOT COMPLETED|Washout (7 Days)||0
6762592|NCT03642873|7689178|FG005|NOT COMPLETED|Washout (7 Days)||0
6762593|NCT03642873|7689173|FG000|STARTED|Second Intervention (1 Day)||4
6762594|NCT03642873|7689174|FG001|STARTED|Second Intervention (1 Day)||4
6762595|NCT03642873|7689175|FG002|STARTED|Second Intervention (1 Day)||4
6762596|NCT03642873|7689176|FG003|STARTED|Second Intervention (1 Day)||4
6762597|NCT03642873|7689177|FG004|STARTED|Second Intervention (1 Day)||4
6762598|NCT03642873|7689178|FG005|STARTED|Second Intervention (1 Day)||4
6762599|NCT03642873|7689173|FG000|COMPLETED|Second Intervention (1 Day)||4
6762600|NCT03642873|7689174|FG001|COMPLETED|Second Intervention (1 Day)||4
6762601|NCT03642873|7689175|FG002|COMPLETED|Second Intervention (1 Day)||4
6762602|NCT03642873|7689176|FG003|COMPLETED|Second Intervention (1 Day)||4
6762603|NCT03642873|7689177|FG004|COMPLETED|Second Intervention (1 Day)||4
6762604|NCT03642873|7689178|FG005|COMPLETED|Second Intervention (1 Day)||4
6762605|NCT03642873|7689173|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6762606|NCT03642873|7689174|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6762607|NCT03642873|7689175|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6762608|NCT03642873|7689176|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6762609|NCT03642873|7689177|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6762610|NCT03642873|7689178|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
6762611|NCT03642873|7689173|FG000|STARTED|Washout (7 Days)||4
6762612|NCT03642873|7689174|FG001|STARTED|Washout (7 Days)||4
6762613|NCT03642873|7689175|FG002|STARTED|Washout (7 Days)||4
6762614|NCT03642873|7689176|FG003|STARTED|Washout (7 Days)||4
6762615|NCT03642873|7689177|FG004|STARTED|Washout (7 Days)||4
6762616|NCT03642873|7689178|FG005|STARTED|Washout (7 Days)||4
6762617|NCT03642873|7689173|FG000|COMPLETED|Washout (7 Days)||4
6762618|NCT03642873|7689174|FG001|COMPLETED|Washout (7 Days)||4
6762619|NCT03642873|7689175|FG002|COMPLETED|Washout (7 Days)||4
6762620|NCT03642873|7689176|FG003|COMPLETED|Washout (7 Days)||4
6762621|NCT03642873|7689177|FG004|COMPLETED|Washout (7 Days)||4
6762622|NCT03642873|7689178|FG005|COMPLETED|Washout (7 Days)||4
6762623|NCT03642873|7689173|FG000|NOT COMPLETED|Washout (7 Days)||0
6762624|NCT03642873|7689174|FG001|NOT COMPLETED|Washout (7 Days)||0
6762625|NCT03642873|7689175|FG002|NOT COMPLETED|Washout (7 Days)||0
6762626|NCT03642873|7689176|FG003|NOT COMPLETED|Washout (7 Days)||0
6762627|NCT03642873|7689177|FG004|NOT COMPLETED|Washout (7 Days)||0
6762628|NCT03642873|7689178|FG005|NOT COMPLETED|Washout (7 Days)||0
6762629|NCT03642873|7689173|FG000|STARTED|Third Intervention (1 Day)||4
6762630|NCT03642873|7689174|FG001|STARTED|Third Intervention (1 Day)||4
6762631|NCT03642873|7689175|FG002|STARTED|Third Intervention (1 Day)||4
6762632|NCT03642873|7689176|FG003|STARTED|Third Intervention (1 Day)||4
6762633|NCT03642873|7689177|FG004|STARTED|Third Intervention (1 Day)||4
6762634|NCT03642873|7689178|FG005|STARTED|Third Intervention (1 Day)||4
6762635|NCT03642873|7689173|FG000|COMPLETED|Third Intervention (1 Day)||4
6762636|NCT03642873|7689174|FG001|COMPLETED|Third Intervention (1 Day)||4
6762637|NCT03642873|7689175|FG002|COMPLETED|Third Intervention (1 Day)||4
6762638|NCT03642873|7689176|FG003|COMPLETED|Third Intervention (1 Day)||4
6762639|NCT03642873|7689177|FG004|COMPLETED|Third Intervention (1 Day)||3
6762640|NCT03642873|7689178|FG005|COMPLETED|Third Intervention (1 Day)||4
6762641|NCT03642873|7689173|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6762642|NCT03642873|7689174|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6762643|NCT03642873|7689175|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6762644|NCT03642873|7689176|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6762645|NCT03642873|7689177|FG004|NOT COMPLETED|Third Intervention (1 Day)||1
6762646|NCT03642873|7689178|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
6762647|NCT03643432|7689192|FG000|STARTED|Overall Study||27
6762648|NCT03643432|7689193|FG001|STARTED|Overall Study||21
6762649|NCT03643432|7689192|FG000|COMPLETED|Overall Study||26
6762650|NCT03643432|7689193|FG001|COMPLETED|Overall Study||21
6762651|NCT03643432|7689192|FG000|NOT COMPLETED|Overall Study||1
6762652|NCT03643432|7689193|FG001|NOT COMPLETED|Overall Study||0
6762653|NCT03643575|7689199|FG000|STARTED|Period 1||5
6762654|NCT03643575|7689200|FG001|STARTED|Period 1||5
6762655|NCT03643575|7689201|FG002|STARTED|Period 1||5
6762656|NCT03643575|7689202|FG003|STARTED|Period 1||5
6762657|NCT03643575|7689203|FG004|STARTED|Period 1||5
6762658|NCT03643575|7689204|FG005|STARTED|Period 1||5
6762659|NCT03643575|7689199|FG000|COMPLETED|Period 1||5
6762660|NCT03643575|7689200|FG001|COMPLETED|Period 1||5
6762661|NCT03643575|7689201|FG002|COMPLETED|Period 1||5
6762662|NCT03643575|7689202|FG003|COMPLETED|Period 1||5
6762663|NCT03643575|7689203|FG004|COMPLETED|Period 1||5
6762664|NCT03643575|7689204|FG005|COMPLETED|Period 1||5
6762665|NCT03643575|7689199|FG000|NOT COMPLETED|Period 1||0
6762666|NCT03643575|7689200|FG001|NOT COMPLETED|Period 1||0
6762667|NCT03643575|7689201|FG002|NOT COMPLETED|Period 1||0
6762668|NCT03643575|7689202|FG003|NOT COMPLETED|Period 1||0
6762669|NCT03643575|7689203|FG004|NOT COMPLETED|Period 1||0
6762670|NCT03643575|7689204|FG005|NOT COMPLETED|Period 1||0
6762671|NCT03643575|7689199|FG000|STARTED|Washout: 7 Days||5
6762672|NCT03643575|7689200|FG001|STARTED|Washout: 7 Days||5
6762673|NCT03643575|7689201|FG002|STARTED|Washout: 7 Days||5
6762674|NCT03643575|7689202|FG003|STARTED|Washout: 7 Days||5
6762675|NCT03643575|7689203|FG004|STARTED|Washout: 7 Days||5
6762676|NCT03643575|7689204|FG005|STARTED|Washout: 7 Days||5
6762677|NCT03643575|7689199|FG000|COMPLETED|Washout: 7 Days||4
6762678|NCT03643575|7689200|FG001|COMPLETED|Washout: 7 Days||5
6762679|NCT03643575|7689201|FG002|COMPLETED|Washout: 7 Days||5
6762680|NCT03643575|7689202|FG003|COMPLETED|Washout: 7 Days||4
6762681|NCT03643575|7689203|FG004|COMPLETED|Washout: 7 Days||5
6762682|NCT03643575|7689204|FG005|COMPLETED|Washout: 7 Days||5
6762683|NCT03643575|7689199|FG000|NOT COMPLETED|Washout: 7 Days||1
6762684|NCT03643575|7689200|FG001|NOT COMPLETED|Washout: 7 Days||0
6762685|NCT03643575|7689201|FG002|NOT COMPLETED|Washout: 7 Days||0
6762686|NCT03643575|7689202|FG003|NOT COMPLETED|Washout: 7 Days||1
6762687|NCT03643575|7689203|FG004|NOT COMPLETED|Washout: 7 Days||0
6762688|NCT03643575|7689204|FG005|NOT COMPLETED|Washout: 7 Days||0
6762689|NCT03643575|7689199|FG000|STARTED|Period 2||4
6762690|NCT03643575|7689200|FG001|STARTED|Period 2||5
6762691|NCT03643575|7689201|FG002|STARTED|Period 2||5
6762692|NCT03643575|7689202|FG003|STARTED|Period 2||4
6762693|NCT03643575|7689203|FG004|STARTED|Period 2||5
6762694|NCT03643575|7689204|FG005|STARTED|Period 2||5
6762695|NCT03643575|7689199|FG000|COMPLETED|Period 2||4
6762696|NCT03643575|7689200|FG001|COMPLETED|Period 2||5
6762697|NCT03643575|7689201|FG002|COMPLETED|Period 2||5
6762698|NCT03643575|7689202|FG003|COMPLETED|Period 2||4
6762699|NCT03643575|7689203|FG004|COMPLETED|Period 2||5
6762700|NCT03643575|7689204|FG005|COMPLETED|Period 2||5
6762701|NCT03643575|7689199|FG000|NOT COMPLETED|Period 2||0
6762702|NCT03643575|7689200|FG001|NOT COMPLETED|Period 2||0
6762703|NCT03643575|7689201|FG002|NOT COMPLETED|Period 2||0
6762704|NCT03643575|7689202|FG003|NOT COMPLETED|Period 2||0
6762705|NCT03643575|7689203|FG004|NOT COMPLETED|Period 2||0
6762706|NCT03643575|7689204|FG005|NOT COMPLETED|Period 2||0
6762707|NCT03643575|7689199|FG000|STARTED|Washout: 7 Days||4
6762708|NCT03643575|7689200|FG001|STARTED|Washout: 7 Days||5
6762709|NCT03643575|7689201|FG002|STARTED|Washout: 7 Days||5
6762710|NCT03643575|7689202|FG003|STARTED|Washout: 7 Days||4
6762711|NCT03643575|7689203|FG004|STARTED|Washout: 7 Days||5
6762712|NCT03643575|7689204|FG005|STARTED|Washout: 7 Days||5
6762713|NCT03643575|7689199|FG000|COMPLETED|Washout: 7 Days||4
6762714|NCT03643575|7689200|FG001|COMPLETED|Washout: 7 Days||4
6762715|NCT03643575|7689201|FG002|COMPLETED|Washout: 7 Days||5
6762716|NCT03643575|7689202|FG003|COMPLETED|Washout: 7 Days||4
6762717|NCT03643575|7689203|FG004|COMPLETED|Washout: 7 Days||5
6762718|NCT03643575|7689204|FG005|COMPLETED|Washout: 7 Days||5
6762719|NCT03643575|7689199|FG000|NOT COMPLETED|Washout: 7 Days||0
6762720|NCT03643575|7689200|FG001|NOT COMPLETED|Washout: 7 Days||1
6762721|NCT03643575|7689201|FG002|NOT COMPLETED|Washout: 7 Days||0
6762722|NCT03643575|7689202|FG003|NOT COMPLETED|Washout: 7 Days||0
6762723|NCT03643575|7689203|FG004|NOT COMPLETED|Washout: 7 Days||0
6762724|NCT03643575|7689204|FG005|NOT COMPLETED|Washout: 7 Days||0
6762725|NCT03643575|7689199|FG000|STARTED|Period 3||4
6762726|NCT03643575|7689200|FG001|STARTED|Period 3||4
6762727|NCT03643575|7689201|FG002|STARTED|Period 3||5
6762728|NCT03643575|7689202|FG003|STARTED|Period 3||4
6762729|NCT03643575|7689203|FG004|STARTED|Period 3||5
6762730|NCT03643575|7689204|FG005|STARTED|Period 3||5
6762731|NCT03643575|7689199|FG000|COMPLETED|Period 3||4
6762732|NCT03643575|7689200|FG001|COMPLETED|Period 3||4
6762733|NCT03643575|7689201|FG002|COMPLETED|Period 3||5
6762734|NCT03643575|7689202|FG003|COMPLETED|Period 3||4
6762735|NCT03643575|7689203|FG004|COMPLETED|Period 3||5
6762736|NCT03643575|7689204|FG005|COMPLETED|Period 3||5
6762737|NCT03643575|7689199|FG000|NOT COMPLETED|Period 3||0
6762738|NCT03643575|7689200|FG001|NOT COMPLETED|Period 3||0
6762739|NCT03643575|7689201|FG002|NOT COMPLETED|Period 3||0
6762740|NCT03643575|7689202|FG003|NOT COMPLETED|Period 3||0
6762741|NCT03643575|7689203|FG004|NOT COMPLETED|Period 3||0
6762742|NCT03643575|7689204|FG005|NOT COMPLETED|Period 3||0
6762743|NCT03643692|7689212|FG000|STARTED|Overall Study||12
6762744|NCT03643692|7689212|FG000|COMPLETED|Overall Study||12
6762745|NCT03643692|7689212|FG000|NOT COMPLETED|Overall Study||0
6762746|NCT03643952|7689216|FG000|STARTED|Overall Study||18
6762747|NCT03643952|7689216|FG000|COMPLETED|Overall Study||17
6762748|NCT03643952|7689216|FG000|NOT COMPLETED|Overall Study||1
6762749|NCT03644095|7689228|FG000|STARTED|Period 1||15
6762750|NCT03644095|7689229|FG001|STARTED|Period 1||15
6762751|NCT03644095|7689228|FG000|COMPLETED|Period 1||15
6762752|NCT03644095|7689229|FG001|COMPLETED|Period 1||15
6762753|NCT03644095|7689228|FG000|NOT COMPLETED|Period 1||0
6762754|NCT03644095|7689229|FG001|NOT COMPLETED|Period 1||0
6762755|NCT03644095|7689228|FG000|STARTED|Washout (7 Days)||15
6762756|NCT03644095|7689229|FG001|STARTED|Washout (7 Days)||15
6762757|NCT03644095|7689228|FG000|COMPLETED|Washout (7 Days)||15
6762758|NCT03644095|7689229|FG001|COMPLETED|Washout (7 Days)||15
6762759|NCT03644095|7689228|FG000|NOT COMPLETED|Washout (7 Days)||0
6762760|NCT03644095|7689229|FG001|NOT COMPLETED|Washout (7 Days)||0
6762761|NCT03644095|7689228|FG000|STARTED|Period 2||15
6762762|NCT03644095|7689229|FG001|STARTED|Period 2||15
6762763|NCT03644095|7689228|FG000|COMPLETED|Period 2||15
6762764|NCT03644095|7689229|FG001|COMPLETED|Period 2||15
6762765|NCT03644095|7689228|FG000|NOT COMPLETED|Period 2||0
6762766|NCT03644095|7689229|FG001|NOT COMPLETED|Period 2||0
6762767|NCT03644108|7689235|FG000|STARTED|Overall Study||30
6762768|NCT03644108|7689235|FG000|COMPLETED|Overall Study||30
6762769|NCT03644108|7689235|FG000|NOT COMPLETED|Overall Study||0
6762770|NCT03644173|7689239|FG000|STARTED|Participants at Last Visit (Pre-surveys)||37
6762771|NCT03644173|7689239|FG000|COMPLETED|Participants at Last Visit (Pre-surveys)||16
6762772|NCT03644173|7689239|FG000|NOT COMPLETED|Participants at Last Visit (Pre-surveys)||21
6762773|NCT03644173|7689239|FG000|STARTED|Participants at the 1-month Follow up||16
6762774|NCT03644173|7689239|FG000|COMPLETED|Participants at the 1-month Follow up||12
6762775|NCT03644173|7689239|FG000|NOT COMPLETED|Participants at the 1-month Follow up||4
6762776|NCT03644173|7689239|FG000|STARTED|Participants at the 3-month Follow up||12
6762777|NCT03644173|7689239|FG000|COMPLETED|Participants at the 3-month Follow up||10
6762778|NCT03644173|7689239|FG000|NOT COMPLETED|Participants at the 3-month Follow up||2
6762779|NCT03644212|7689246|FG000|STARTED|Overall Study||63
6762780|NCT03644212|7689247|FG001|STARTED|Overall Study||16
6762781|NCT03644212|7689246|FG000|COMPLETED|Overall Study||63
6762782|NCT03644212|7689247|FG001|COMPLETED|Overall Study||16
6762783|NCT03644212|7689246|FG000|NOT COMPLETED|Overall Study||0
6762784|NCT03644212|7689247|FG001|NOT COMPLETED|Overall Study||0
6762785|NCT03645421|7689257|FG000|STARTED|Overall Study||16
6762786|NCT03645421|7689258|FG001|STARTED|Overall Study||15
6762787|NCT03645421|7689259|FG002|STARTED|Overall Study||15
6762788|NCT03645421|7689260|FG003|STARTED|Overall Study||15
6762789|NCT03645421|7689257|FG000|Received Investigational Product (IP)|Overall Study||16
6762790|NCT03645421|7689258|FG001|Received Investigational Product (IP)|Overall Study||15
6762791|NCT03645421|7689259|FG002|Received Investigational Product (IP)|Overall Study||15
6762792|NCT03645421|7689260|FG003|Received Investigational Product (IP)|Overall Study||15
6762793|NCT03645421|7689257|FG000|COMPLETED|Overall Study||16
6762794|NCT03645421|7689258|FG001|COMPLETED|Overall Study||15
6762795|NCT03645421|7689259|FG002|COMPLETED|Overall Study||10
6762796|NCT03645421|7689260|FG003|COMPLETED|Overall Study||11
6762797|NCT03645421|7689257|FG000|NOT COMPLETED|Overall Study||0
6762798|NCT03645421|7689258|FG001|NOT COMPLETED|Overall Study||0
6762799|NCT03645421|7689259|FG002|NOT COMPLETED|Overall Study||5
6762800|NCT03645421|7689260|FG003|NOT COMPLETED|Overall Study||4
6762801|NCT03645434|7689273|FG000|STARTED|Period 1||12
6762802|NCT03645434|7689274|FG001|STARTED|Period 1||13
6762803|NCT03645434|7689275|FG002|STARTED|Period 1||13
6762804|NCT03645434|7689276|FG003|STARTED|Period 1||11
6762805|NCT03645434|7689277|FG004|STARTED|Period 1||12
6762806|NCT03645434|7689278|FG005|STARTED|Period 1||12
6762807|NCT03645434|7689273|FG000|COMPLETED|Period 1||12
6762808|NCT03645434|7689274|FG001|COMPLETED|Period 1||13
6762809|NCT03645434|7689275|FG002|COMPLETED|Period 1||13
6762810|NCT03645434|7689276|FG003|COMPLETED|Period 1||10
6762811|NCT03645434|7689277|FG004|COMPLETED|Period 1||11
6762812|NCT03645434|7689278|FG005|COMPLETED|Period 1||12
6762813|NCT03645434|7689273|FG000|NOT COMPLETED|Period 1||0
6762814|NCT03645434|7689274|FG001|NOT COMPLETED|Period 1||0
6762815|NCT03645434|7689275|FG002|NOT COMPLETED|Period 1||0
6762816|NCT03645434|7689276|FG003|NOT COMPLETED|Period 1||1
6762817|NCT03645434|7689277|FG004|NOT COMPLETED|Period 1||1
6762818|NCT03645434|7689278|FG005|NOT COMPLETED|Period 1||0
6762819|NCT03645434|7689273|FG000|STARTED|Period 2|2 subject discontinued as they did not meet stability or FEV1 variability.|10
6762820|NCT03645434|7689274|FG001|STARTED|Period 2||13
6762821|NCT03645434|7689275|FG002|STARTED|Period 2||13
6762822|NCT03645434|7689276|FG003|STARTED|Period 2||10
6762823|NCT03645434|7689277|FG004|STARTED|Period 2||11
6762824|NCT03645434|7689278|FG005|STARTED|Period 2|1 subject completed Period 1 but not allowed to enter Period 2 due to physician decision.|11
6762825|NCT03645434|7689273|FG000|COMPLETED|Period 2||10
6762826|NCT03645434|7689274|FG001|COMPLETED|Period 2||13
6762827|NCT03645434|7689275|FG002|COMPLETED|Period 2||13
6762828|NCT03645434|7689276|FG003|COMPLETED|Period 2||10
6762829|NCT03645434|7689277|FG004|COMPLETED|Period 2||11
6762830|NCT03645434|7689278|FG005|COMPLETED|Period 2||11
6762831|NCT03645434|7689273|FG000|NOT COMPLETED|Period 2||0
6762832|NCT03645434|7689274|FG001|NOT COMPLETED|Period 2||0
6762833|NCT03645434|7689275|FG002|NOT COMPLETED|Period 2||0
6762834|NCT03645434|7689276|FG003|NOT COMPLETED|Period 2||0
6762835|NCT03645434|7689277|FG004|NOT COMPLETED|Period 2||0
6762836|NCT03645434|7689278|FG005|NOT COMPLETED|Period 2||0
6762837|NCT03645434|7689273|FG000|STARTED|Period 3||10
6762838|NCT03645434|7689274|FG001|STARTED|Period 3||13
6762839|NCT03645434|7689275|FG002|STARTED|Period 3|2 subjects discontinued as they did not meet FEV1 stability criteria or pfts variability criteria.|11
6762840|NCT03645434|7689276|FG003|STARTED|Period 3||10
6762841|NCT03645434|7689277|FG004|STARTED|Period 3||11
6762842|NCT03645434|7689278|FG005|STARTED|Period 3||11
6762843|NCT03645434|7689273|FG000|COMPLETED|Period 3||10
6762844|NCT03645434|7689274|FG001|COMPLETED|Period 3||13
6762845|NCT03645434|7689275|FG002|COMPLETED|Period 3||11
6762846|NCT03645434|7689276|FG003|COMPLETED|Period 3||10
6762847|NCT03645434|7689277|FG004|COMPLETED|Period 3||11
6762848|NCT03645434|7689278|FG005|COMPLETED|Period 3||11
6762849|NCT03645434|7689273|FG000|NOT COMPLETED|Period 3||0
6762850|NCT03645434|7689274|FG001|NOT COMPLETED|Period 3||0
6762851|NCT03645434|7689275|FG002|NOT COMPLETED|Period 3||0
6762852|NCT03645434|7689276|FG003|NOT COMPLETED|Period 3||0
6762853|NCT03645434|7689277|FG004|NOT COMPLETED|Period 3||0
6762854|NCT03645434|7689278|FG005|NOT COMPLETED|Period 3||0
6762855|NCT03645785|7689286|FG000|STARTED|Day 1 (Normal Fluid Intake and Diet)||23
6762856|NCT03645785|7689286|FG000|COMPLETED|Day 1 (Normal Fluid Intake and Diet)||23
6762857|NCT03645785|7689286|FG000|NOT COMPLETED|Day 1 (Normal Fluid Intake and Diet)||0
6762858|NCT03645785|7689286|FG000|STARTED|Day 2-4 (Double Fluid and Add Citrate)||23
6762859|NCT03645785|7689286|FG000|COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||23
6762860|NCT03645785|7689286|FG000|NOT COMPLETED|Day 2-4 (Double Fluid and Add Citrate)||0
6762861|NCT03645811|7689305|FG000|STARTED|Overall Study||32
6762862|NCT03645811|7689306|FG001|STARTED|Overall Study||32
6762863|NCT03645811|7689307|FG002|STARTED|Overall Study||32
6762864|NCT03645811|7689305|FG000|COMPLETED|Overall Study||30
6762865|NCT03645811|7689306|FG001|COMPLETED|Overall Study||30
6762866|NCT03645811|7689307|FG002|COMPLETED|Overall Study||30
6762867|NCT03645811|7689305|FG000|NOT COMPLETED|Overall Study||2
6762868|NCT03645811|7689306|FG001|NOT COMPLETED|Overall Study||2
6762869|NCT03645811|7689307|FG002|NOT COMPLETED|Overall Study||2
6556149|NCT01756833|7478374|FG000|NOT COMPLETED|Overall Study||4
6556150|NCT01756833|7478375|FG001|NOT COMPLETED|Overall Study||3
6556151|NCT01756846|7478383|FG000|STARTED|Overall Study||1833
6556152|NCT01756846|7478384|FG001|STARTED|Overall Study||1833
6556153|NCT01756846|7478383|FG000|COMPLETED|Overall Study||1827
6762870|NCT03645954|7689317|FG000|STARTED|Overall Study||40
6762871|NCT03645954|7689318|FG001|STARTED|Overall Study||40
6762872|NCT03645954|7689317|FG000|COMPLETED|Overall Study||37
6762873|NCT03645954|7689318|FG001|COMPLETED|Overall Study||40
6762874|NCT03645954|7689317|FG000|NOT COMPLETED|Overall Study||3
6762875|NCT03645954|7689318|FG001|NOT COMPLETED|Overall Study||0
6556154|NCT01756846|7478384|FG001|COMPLETED|Overall Study||1821
6556155|NCT01756846|7478383|FG000|NOT COMPLETED|Overall Study||6
6762876|NCT03646305|7689328|FG000|STARTED|Overall Study||32
6762877|NCT03646305|7689329|FG001|STARTED|Overall Study||35
6762878|NCT03646305|7689330|FG002|STARTED|Overall Study||33
6762879|NCT03646305|7689331|FG003|STARTED|Overall Study||33
6762880|NCT03646305|7689328|FG000|Received Treatment|Overall Study||31
6762881|NCT03646305|7689329|FG001|Received Treatment|Overall Study||35
6762882|NCT03646305|7689330|FG002|Received Treatment|Overall Study||32
6762883|NCT03646305|7689331|FG003|Received Treatment|Overall Study||32
6762884|NCT03646305|7689328|FG000|No Treatment Recieved|Overall Study||1
6762885|NCT03646305|7689329|FG001|No Treatment Recieved|Overall Study||0
6762886|NCT03646305|7689330|FG002|No Treatment Recieved|Overall Study||1
6762887|NCT03646305|7689331|FG003|No Treatment Recieved|Overall Study||1
6762888|NCT03646305|7689328|FG000|COMPLETED|Overall Study||27
6762889|NCT03646305|7689329|FG001|COMPLETED|Overall Study||33
6762890|NCT03646305|7689330|FG002|COMPLETED|Overall Study||31
6762891|NCT03646305|7689331|FG003|COMPLETED|Overall Study||31
6762892|NCT03646305|7689328|FG000|NOT COMPLETED|Overall Study||5
6762893|NCT03646305|7689329|FG001|NOT COMPLETED|Overall Study||2
6762894|NCT03646305|7689330|FG002|NOT COMPLETED|Overall Study||2
6762895|NCT03646305|7689331|FG003|NOT COMPLETED|Overall Study||2
6762896|NCT03646656|7689347|FG000|STARTED|Overall Study||12
6762897|NCT03646656|7689348|FG001|STARTED|Overall Study||3
6762898|NCT03646656|7689347|FG000|Attended 1st Group Session|Overall Study||10
6762899|NCT03646656|7689348|FG001|Attended 1st Group Session|Overall Study||3
6762900|NCT03646656|7689347|FG000|COMPLETED|Overall Study||9
6762901|NCT03646656|7689348|FG001|COMPLETED|Overall Study||3
6762902|NCT03646656|7689347|FG000|NOT COMPLETED|Overall Study||3
6762903|NCT03646656|7689348|FG001|NOT COMPLETED|Overall Study||0
6762904|NCT03647033|7689360|FG000|STARTED|Overall Study||16
6762905|NCT03647033|7689361|FG001|STARTED|Overall Study||16
6762906|NCT03647033|7689360|FG000|COMPLETED|Overall Study||16
6762907|NCT03647033|7689361|FG001|COMPLETED|Overall Study||16
6762908|NCT03647033|7689360|FG000|NOT COMPLETED|Overall Study||0
6762909|NCT03647033|7689361|FG001|NOT COMPLETED|Overall Study||0
6762910|NCT03647046|7689367|FG000|STARTED|Overall Study||12
6762911|NCT03647046|7689367|FG000|COMPLETED|Overall Study||8
6762912|NCT03647046|7689367|FG000|NOT COMPLETED|Overall Study||4
6762913|NCT03647267|7689373|FG000|STARTED|Overall Study||24
6762914|NCT03647267|7689374|FG001|STARTED|Overall Study||22
6762915|NCT03647267|7689373|FG000|COMPLETED|Overall Study||23
6762916|NCT03647267|7689374|FG001|COMPLETED|Overall Study||22
6762917|NCT03647267|7689373|FG000|NOT COMPLETED|Overall Study||1
6762918|NCT03647267|7689374|FG001|NOT COMPLETED|Overall Study||0
6762919|NCT03647475|7689382|FG000|STARTED|Overall Study||752
6762920|NCT03647475|7689382|FG000|NCT03647475 - Included in One Month Clear Analysis Population|Overall Study||601
6762921|NCT03647475|7689382|FG000|NCT03344653- Included in One Month Clear Analysis Population|Overall Study||905
6762922|NCT03647475|7689382|FG000|COMPLETED|Overall Study||75
6762923|NCT03647475|7689382|FG000|NOT COMPLETED|Overall Study||677
6762924|NCT03647709|7689386|FG000|STARTED|Overall Study||400
6762925|NCT03647709|7689386|FG000|COMPLETED|Overall Study||386
6762926|NCT03647709|7689386|FG000|NOT COMPLETED|Overall Study||14
6762927|NCT03648853|7689392|FG000|STARTED|Overall Study||12
6762928|NCT03648853|7689392|FG000|COMPLETED|Overall Study||12
6762929|NCT03648853|7689392|FG000|NOT COMPLETED|Overall Study||0
6762930|NCT03648879|7689396|FG000|STARTED|Overall Study||37
6762931|NCT03648879|7689396|FG000|COMPLETED|Overall Study||36
6762932|NCT03648879|7689396|FG000|NOT COMPLETED|Overall Study||1
6762933|NCT03649412|7689402|FG000|STARTED|Part A, Period 1 (4 Days)||16
6762934|NCT03649412|7689403|FG001|STARTED|Part A, Period 1 (4 Days)||0
6762935|NCT03649412|7689402|FG000|COMPLETED|Part A, Period 1 (4 Days)||16
6762936|NCT03649412|7689403|FG001|COMPLETED|Part A, Period 1 (4 Days)||0
6762937|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Period 1 (4 Days)||0
6762938|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Period 1 (4 Days)||0
6762939|NCT03649412|7689402|FG000|STARTED|Part A, Washout Period 1 (7 Days)||16
6762940|NCT03649412|7689403|FG001|STARTED|Part A, Washout Period 1 (7 Days)||0
6762941|NCT03649412|7689402|FG000|COMPLETED|Part A, Washout Period 1 (7 Days)||15
6762942|NCT03649412|7689403|FG001|COMPLETED|Part A, Washout Period 1 (7 Days)||0
6762943|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||1
6762944|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Washout Period 1 (7 Days)||0
6762945|NCT03649412|7689402|FG000|STARTED|Part A, Period 2 (3 Days)|1 Replacement par. was enrolled & dosed|16
6762946|NCT03649412|7689403|FG001|STARTED|Part A, Period 2 (3 Days)||0
6762947|NCT03649412|7689402|FG000|COMPLETED|Part A, Period 2 (3 Days)||16
6762948|NCT03649412|7689403|FG001|COMPLETED|Part A, Period 2 (3 Days)||0
6762949|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Period 2 (3 Days)||0
6762950|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Period 2 (3 Days)||0
6762951|NCT03649412|7689402|FG000|STARTED|Part A, Washout Period 2 (7 Days)||16
6762952|NCT03649412|7689403|FG001|STARTED|Part A, Washout Period 2 (7 Days)||0
6762953|NCT03649412|7689402|FG000|COMPLETED|Part A, Washout Period 2 (7 Days)||16
6762954|NCT03649412|7689403|FG001|COMPLETED|Part A, Washout Period 2 (7 Days)||0
6762955|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
6762956|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Washout Period 2 (7 Days)||0
6762957|NCT03649412|7689402|FG000|STARTED|Part A, Period 3 (4 Days)||16
6762958|NCT03649412|7689403|FG001|STARTED|Part A, Period 3 (4 Days)||0
6762959|NCT03649412|7689402|FG000|COMPLETED|Part A, Period 3 (4 Days)||16
6762960|NCT03649412|7689403|FG001|COMPLETED|Part A, Period 3 (4 Days)||0
6762961|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Period 3 (4 Days)||0
6762962|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Period 3 (4 Days)||0
6762963|NCT03649412|7689402|FG000|STARTED|Part A, Washout Period 3 (7 Days)||16
6762964|NCT03649412|7689403|FG001|STARTED|Part A, Washout Period 3 (7 Days)||0
6762965|NCT03649412|7689402|FG000|COMPLETED|Part A, Washout Period 3 (7 Days)||16
6762966|NCT03649412|7689403|FG001|COMPLETED|Part A, Washout Period 3 (7 Days)||0
6762967|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
6762968|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Washout Period 3 (7 Days)||0
6762969|NCT03649412|7689402|FG000|STARTED|Part A, Period 4 (4 Days)||16
6762970|NCT03649412|7689403|FG001|STARTED|Part A, Period 4 (4 Days)||0
6762971|NCT03649412|7689402|FG000|COMPLETED|Part A, Period 4 (4 Days)||16
6762972|NCT03649412|7689403|FG001|COMPLETED|Part A, Period 4 (4 Days)||0
6762973|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Period 4 (4 Days)||0
6762974|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Period 4 (4 Days)||0
6762975|NCT03649412|7689402|FG000|STARTED|Part A, Washout Period 4 (7 Days)||16
6762976|NCT03649412|7689403|FG001|STARTED|Part A, Washout Period 4 (7 Days)||0
6762977|NCT03649412|7689402|FG000|COMPLETED|Part A, Washout Period 4 (7 Days)||14
6762978|NCT03649412|7689403|FG001|COMPLETED|Part A, Washout Period 4 (7 Days)||0
6762979|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||2
6762980|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Washout Period 4 (7 Days)||0
6762981|NCT03649412|7689402|FG000|STARTED|Part A, Period 5 (4 Days)|Two participant did not start in Period 5|12
6762982|NCT03649412|7689403|FG001|STARTED|Part A, Period 5 (4 Days)||0
6556156|NCT01756846|7478384|FG001|NOT COMPLETED|Overall Study||12
6556157|NCT01756885|7478392|FG000|STARTED|Overall Study||102
6556158|NCT01756885|7478393|FG001|STARTED|Overall Study||105
6762983|NCT03649412|7689402|FG000|COMPLETED|Part A, Period 5 (4 Days)||12
6762984|NCT03649412|7689403|FG001|COMPLETED|Part A, Period 5 (4 Days)||0
6762985|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Period 5 (4 Days)||0
6762986|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Period 5 (4 Days)||0
6762987|NCT03649412|7689402|FG000|STARTED|Part A, Washout Period 5 (7 Days)||12
6762988|NCT03649412|7689403|FG001|STARTED|Part A, Washout Period 5 (7 Days)||0
6762989|NCT03649412|7689402|FG000|COMPLETED|Part A, Washout Period 5 (7 Days)||11
6762990|NCT03649412|7689403|FG001|COMPLETED|Part A, Washout Period 5 (7 Days)||0
6762991|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||1
6762992|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Washout Period 5 (7 Days)||0
6762993|NCT03649412|7689402|FG000|STARTED|Part A, Period 6 (4 Days)|1 of the participant who did not start Period 5 directly joined into Period 6|12
6762994|NCT03649412|7689403|FG001|STARTED|Part A, Period 6 (4 Days)||0
6762995|NCT03649412|7689402|FG000|COMPLETED|Part A, Period 6 (4 Days)||12
6762996|NCT03649412|7689403|FG001|COMPLETED|Part A, Period 6 (4 Days)||0
6762997|NCT03649412|7689402|FG000|NOT COMPLETED|Part A, Period 6 (4 Days)||0
6762998|NCT03649412|7689403|FG001|NOT COMPLETED|Part A, Period 6 (4 Days)||0
6762999|NCT03649412|7689402|FG000|STARTED|Part B, Period 1 (4 Days)|Participants in Part A did not enter Part B|0
6763000|NCT03649412|7689403|FG001|STARTED|Part B, Period 1 (4 Days)|16 new participants enrolled in Part B|16
6763001|NCT03649412|7689402|FG000|COMPLETED|Part B, Period 1 (4 Days)||0
6763002|NCT03649412|7689403|FG001|COMPLETED|Part B, Period 1 (4 Days)||16
6763003|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Period 1 (4 Days)||0
6763004|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Period 1 (4 Days)||0
6763005|NCT03649412|7689402|FG000|STARTED|Part B, Washout Period 1 (7 Days)||0
6763006|NCT03649412|7689403|FG001|STARTED|Part B, Washout Period 1 (7 Days)||16
6763007|NCT03649412|7689402|FG000|COMPLETED|Part B, Washout Period 1 (7 Days)||0
6763008|NCT03649412|7689403|FG001|COMPLETED|Part B, Washout Period 1 (7 Days)||15
6763009|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||0
6763010|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Washout Period 1 (7 Days)||1
6556159|NCT01756885|7478392|FG000|COMPLETED|Overall Study||79
6556160|NCT01756885|7478393|FG001|COMPLETED|Overall Study||79
6556161|NCT01756885|7478392|FG000|NOT COMPLETED|Overall Study||23
6556162|NCT01756885|7478393|FG001|NOT COMPLETED|Overall Study||26
6556163|NCT01756898|7478403|FG000|STARTED|Overall Study||92
6556164|NCT01756898|7478404|FG001|STARTED|Overall Study||92
6556165|NCT01756898|7478405|FG002|STARTED|Overall Study||93
6556166|NCT01756898|7478406|FG003|STARTED|Overall Study||93
6763011|NCT03649412|7689402|FG000|STARTED|Part B, Period 2 (4 Days)||0
6763012|NCT03649412|7689403|FG001|STARTED|Part B, Period 2 (4 Days)||15
6763013|NCT03649412|7689402|FG000|COMPLETED|Part B, Period 2 (4 Days)||0
6763014|NCT03649412|7689403|FG001|COMPLETED|Part B, Period 2 (4 Days)||15
6763015|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Period 2 (4 Days)||0
6763016|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Period 2 (4 Days)||0
6556167|NCT01756898|7478403|FG000|COMPLETED|Overall Study||73
6556168|NCT01756898|7478404|FG001|COMPLETED|Overall Study||73
6556169|NCT01756898|7478405|FG002|COMPLETED|Overall Study||76
6556170|NCT01756898|7478406|FG003|COMPLETED|Overall Study||77
6556171|NCT01756898|7478403|FG000|NOT COMPLETED|Overall Study||19
6556172|NCT01756898|7478404|FG001|NOT COMPLETED|Overall Study||19
6556173|NCT01756898|7478405|FG002|NOT COMPLETED|Overall Study||17
6556174|NCT01756898|7478406|FG003|NOT COMPLETED|Overall Study||16
6556175|NCT01756976|7478421|FG000|STARTED|Overall Study||76
6556176|NCT01756976|7478422|FG001|STARTED|Overall Study||8
6556177|NCT01756976|7478421|FG000|COMPLETED|Overall Study||73
6556178|NCT01756976|7478422|FG001|COMPLETED|Overall Study||8
6556179|NCT01756976|7478421|FG000|NOT COMPLETED|Overall Study||3
6763017|NCT03649412|7689402|FG000|STARTED|Part B, Washout Period 2 (7 Days)||0
6763018|NCT03649412|7689403|FG001|STARTED|Part B, Washout Period 2 (7 Days)||15
6763019|NCT03649412|7689402|FG000|COMPLETED|Part B, Washout Period 2 (7 Days)||0
6763020|NCT03649412|7689403|FG001|COMPLETED|Part B, Washout Period 2 (7 Days)||15
6556180|NCT01756976|7478422|FG001|NOT COMPLETED|Overall Study||0
6556181|NCT01757067|7478430|FG000|STARTED|Overall Study||2
6556182|NCT01757067|7478431|FG001|STARTED|Overall Study|The study was closed due to low enrollment.|1
6763021|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
6763022|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Washout Period 2 (7 Days)||0
6763023|NCT03649412|7689402|FG000|STARTED|Part B, Period 3 (4 Days)||0
6763024|NCT03649412|7689403|FG001|STARTED|Part B, Period 3 (4 Days)||15
6763025|NCT03649412|7689402|FG000|COMPLETED|Part B, Period 3 (4 Days)||0
6763026|NCT03649412|7689403|FG001|COMPLETED|Part B, Period 3 (4 Days)||15
6763027|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Period 3 (4 Days)||0
6763028|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Period 3 (4 Days)||0
6763029|NCT03649412|7689402|FG000|STARTED|Part B, Washout Period 3 (7 Days)||0
6763030|NCT03649412|7689403|FG001|STARTED|Part B, Washout Period 3 (7 Days)||15
6763031|NCT03649412|7689402|FG000|COMPLETED|Part B, Washout Period 3 (7 Days)||0
6763032|NCT03649412|7689403|FG001|COMPLETED|Part B, Washout Period 3 (7 Days)||15
6763033|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
6763034|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Washout Period 3 (7 Days)||0
6763035|NCT03649412|7689402|FG000|STARTED|Part B, Period 4 (4 Days)||0
6763036|NCT03649412|7689403|FG001|STARTED|Part B, Period 4 (4 Days)||15
6763037|NCT03649412|7689402|FG000|COMPLETED|Part B, Period 4 (4 Days)||0
6763038|NCT03649412|7689403|FG001|COMPLETED|Part B, Period 4 (4 Days)||15
6763039|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Period 4 (4 Days)||0
6763040|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Period 4 (4 Days)||0
6763041|NCT03649412|7689402|FG000|STARTED|Part B, Washout Period 4 (7 Days)||0
6763042|NCT03649412|7689403|FG001|STARTED|Part B, Washout Period 4 (7 Days)||15
6763043|NCT03649412|7689402|FG000|COMPLETED|Part B, Washout Period 4 (7 Days)||0
6763044|NCT03649412|7689403|FG001|COMPLETED|Part B, Washout Period 4 (7 Days)||15
6763045|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
6763046|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Washout Period 4 (7 Days)||0
6763047|NCT03649412|7689402|FG000|STARTED|Part B, Period 5 (4 Days)||0
6763048|NCT03649412|7689403|FG001|STARTED|Part B, Period 5 (4 Days)|One participant did not start in Period 5|14
6763049|NCT03649412|7689402|FG000|COMPLETED|Part B, Period 5 (4 Days)||0
6763050|NCT03649412|7689403|FG001|COMPLETED|Part B, Period 5 (4 Days)||14
6763051|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Period 5 (4 Days)||0
6763052|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Period 5 (4 Days)||0
6763053|NCT03649412|7689402|FG000|STARTED|Part B, Washout Period 5 (7 Days)||0
6763054|NCT03649412|7689403|FG001|STARTED|Part B, Washout Period 5 (7 Days)||14
6763055|NCT03649412|7689402|FG000|COMPLETED|Part B, Washout Period 5 (7 Days)||0
6763056|NCT03649412|7689403|FG001|COMPLETED|Part B, Washout Period 5 (7 Days)||13
6763057|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||0
6763058|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Washout Period 5 (7 Days)||1
6763059|NCT03649412|7689402|FG000|STARTED|Part B, Period 6 (4days)||0
6763060|NCT03649412|7689403|FG001|STARTED|Part B, Period 6 (4days)|Participant who did not start Period 5 directly joined into Period 6|14
6763061|NCT03649412|7689402|FG000|COMPLETED|Part B, Period 6 (4days)||0
6763062|NCT03649412|7689403|FG001|COMPLETED|Part B, Period 6 (4days)||14
6763063|NCT03649412|7689402|FG000|NOT COMPLETED|Part B, Period 6 (4days)||0
6763064|NCT03649412|7689403|FG001|NOT COMPLETED|Part B, Period 6 (4days)||0
6763065|NCT03649477|7689449|FG000|STARTED|Overall Study||44
6763066|NCT03649477|7689450|FG001|STARTED|Overall Study||43
6763067|NCT03649477|7689451|FG002|STARTED|Overall Study||43
6763068|NCT03649477|7689449|FG000|COMPLETED|Overall Study||42
6763069|NCT03649477|7689450|FG001|COMPLETED|Overall Study||43
6763070|NCT03649477|7689451|FG002|COMPLETED|Overall Study||43
6763071|NCT03649477|7689449|FG000|NOT COMPLETED|Overall Study||2
6763072|NCT03649477|7689450|FG001|NOT COMPLETED|Overall Study||0
6763073|NCT03649477|7689451|FG002|NOT COMPLETED|Overall Study||0
6763074|NCT03649646|7689459|FG000|STARTED|Overall Study||4542
6763075|NCT03649646|7689459|FG000|COMPLETED|Overall Study||4075
6763076|NCT03649646|7689459|FG000|NOT COMPLETED|Overall Study||467
6763077|NCT03649750|7689463|FG000|STARTED|Period 1||12
6763078|NCT03649750|7689464|FG001|STARTED|Period 1||24
6763079|NCT03649750|7689463|FG000|COMPLETED|Period 1||12
6763080|NCT03649750|7689464|FG001|COMPLETED|Period 1||24
6763081|NCT03649750|7689463|FG000|NOT COMPLETED|Period 1||0
6763082|NCT03649750|7689464|FG001|NOT COMPLETED|Period 1||0
6763083|NCT03649750|7689463|FG000|STARTED|Washout: 7 Days||12
6763084|NCT03649750|7689464|FG001|STARTED|Washout: 7 Days||24
6763085|NCT03649750|7689463|FG000|COMPLETED|Washout: 7 Days||12
6763086|NCT03649750|7689464|FG001|COMPLETED|Washout: 7 Days||24
6763087|NCT03649750|7689463|FG000|NOT COMPLETED|Washout: 7 Days||0
6763088|NCT03649750|7689464|FG001|NOT COMPLETED|Washout: 7 Days||0
6763089|NCT03649750|7689463|FG000|STARTED|Period 2||12
6763090|NCT03649750|7689464|FG001|STARTED|Period 2||24
6763091|NCT03649750|7689463|FG000|COMPLETED|Period 2||12
6763092|NCT03649750|7689464|FG001|COMPLETED|Period 2||24
6763093|NCT03649750|7689463|FG000|NOT COMPLETED|Period 2||0
6763094|NCT03649750|7689464|FG001|NOT COMPLETED|Period 2||0
6763095|NCT03649815|7689471|FG000|STARTED|Overall Study||38
6763096|NCT03649815|7689471|FG000|COMPLETED|Overall Study||38
6763097|NCT03649815|7689471|FG000|NOT COMPLETED|Overall Study||0
6763098|NCT03649867|7689475|FG000|STARTED|Overall Study||13
6763099|NCT03649867|7689475|FG000|COMPLETED|Overall Study||13
6763100|NCT03649867|7689475|FG000|NOT COMPLETED|Overall Study||0
6763101|NCT03649932|7689482|FG000|STARTED|Overall Study||14
6763102|NCT03649932|7689483|FG001|STARTED|Overall Study||14
6763103|NCT03649932|7689484|FG002|STARTED|Overall Study||14
6763104|NCT03649932|7689482|FG000|COMPLETED|Overall Study||14
6763105|NCT03649932|7689483|FG001|COMPLETED|Overall Study||13
6763106|NCT03649932|7689484|FG002|COMPLETED|Overall Study||13
6763107|NCT03649932|7689482|FG000|NOT COMPLETED|Overall Study||0
6763108|NCT03649932|7689483|FG001|NOT COMPLETED|Overall Study||1
6763109|NCT03649932|7689484|FG002|NOT COMPLETED|Overall Study||1
6763110|NCT03650192|7689492|FG000|STARTED|Overall Study||40
6763111|NCT03650192|7689492|FG000|COMPLETED|Overall Study||40
6763112|NCT03650192|7689492|FG000|NOT COMPLETED|Overall Study||0
6763113|NCT03650387|7689496|FG000|STARTED|Overall Study||207
6763114|NCT03650387|7689496|FG000|COMPLETED|Overall Study||173
6763115|NCT03650387|7689496|FG000|NOT COMPLETED|Overall Study||34
6763116|NCT03650400|7689511|FG000|STARTED|Overall Study||6
6763117|NCT03650400|7689512|FG001|STARTED|Overall Study||5
6763118|NCT03650400|7689511|FG000|COMPLETED|Overall Study||6
6763119|NCT03650400|7689512|FG001|COMPLETED|Overall Study||0
6763120|NCT03650400|7689511|FG000|NOT COMPLETED|Overall Study||0
6763121|NCT03650400|7689512|FG001|NOT COMPLETED|Overall Study||5
6763122|NCT03650452|7689520|FG000|STARTED|Overall Study||70
6763123|NCT03650452|7689521|FG001|STARTED|Overall Study||71
6763124|NCT03650452|7689520|FG000|COMPLETED|Overall Study||60
6556183|NCT01757067|7478430|FG000|COMPLETED|Overall Study|The study was closed due to low enrollment.|2
6556184|NCT01757067|7478431|FG001|COMPLETED|Overall Study|The study was closed due to low enrollment.|1
6556185|NCT01757067|7478430|FG000|NOT COMPLETED|Overall Study||0
6556186|NCT01757067|7478431|FG001|NOT COMPLETED|Overall Study||0
6556187|NCT01757171|7478439|FG000|STARTED|Overall Study||61
6556188|NCT01757171|7478440|FG001|STARTED|Overall Study||24
6556189|NCT01757171|7478439|FG000|COMPLETED|Overall Study||53
6556190|NCT01757171|7478440|FG001|COMPLETED|Overall Study||23
6556191|NCT01757171|7478439|FG000|NOT COMPLETED|Overall Study||8
6763125|NCT03650452|7689521|FG001|COMPLETED|Overall Study||66
6763126|NCT03650452|7689520|FG000|NOT COMPLETED|Overall Study||10
6763127|NCT03650452|7689521|FG001|NOT COMPLETED|Overall Study||5
6763128|NCT03650842|7689527|FG000|STARTED|Overall Study||25
6763129|NCT03650842|7689527|FG000|COMPLETED|Overall Study||25
6556192|NCT01757171|7478440|FG001|NOT COMPLETED|Overall Study||1
6556193|NCT01757184|7478448|FG000|STARTED|Double-blind Period||36
6763130|NCT03650842|7689527|FG000|NOT COMPLETED|Overall Study||0
6763131|NCT03651479|7689533|FG000|STARTED|Overall Study||20
6763132|NCT03651479|7689534|FG001|STARTED|Overall Study||20
6763133|NCT03651479|7689533|FG000|COMPLETED|Overall Study||20
6763134|NCT03651479|7689534|FG001|COMPLETED|Overall Study||20
6763135|NCT03651479|7689533|FG000|NOT COMPLETED|Overall Study||0
6763136|NCT03651479|7689534|FG001|NOT COMPLETED|Overall Study||0
6763137|NCT03651856|7689540|FG000|STARTED|Overall Study||10
6763138|NCT03651856|7689540|FG000|COMPLETED|Overall Study||10
6763139|NCT03651856|7689540|FG000|NOT COMPLETED|Overall Study||0
6763140|NCT03652610|7689546|FG000|STARTED|Overall Study||490
6763141|NCT03652610|7689547|FG001|STARTED|Overall Study||489
6763142|NCT03652610|7689546|FG000|COMPLETED|Overall Study||486
6763143|NCT03652610|7689547|FG001|COMPLETED|Overall Study||484
6763144|NCT03652610|7689546|FG000|NOT COMPLETED|Overall Study||4
6763145|NCT03652610|7689547|FG001|NOT COMPLETED|Overall Study||5
6763146|NCT03652662|7689555|FG000|STARTED|Overall Study||18
6763147|NCT03652662|7689556|FG001|STARTED|Overall Study||16
6763148|NCT03652662|7689555|FG000|COMPLETED|Overall Study||15
6763149|NCT03652662|7689556|FG001|COMPLETED|Overall Study||15
6763150|NCT03652662|7689555|FG000|NOT COMPLETED|Overall Study||3
6763151|NCT03652662|7689556|FG001|NOT COMPLETED|Overall Study||1
6763152|NCT03652675|7689564|FG000|STARTED|Overall Study||16
6763153|NCT03652675|7689565|FG001|STARTED|Overall Study||15
6763154|NCT03652675|7689564|FG000|COMPLETED|Overall Study||12
6763155|NCT03652675|7689565|FG001|COMPLETED|Overall Study||11
6763156|NCT03652675|7689564|FG000|NOT COMPLETED|Overall Study||4
6763157|NCT03652675|7689565|FG001|NOT COMPLETED|Overall Study||4
6763158|NCT03652818|7689576|FG000|STARTED|Overall Study||24
6763159|NCT03652818|7689577|FG001|STARTED|Overall Study||23
6763160|NCT03652818|7689578|FG002|STARTED|Overall Study||22
6763161|NCT03652818|7689579|FG003|STARTED|Overall Study||23
6763162|NCT03652818|7689580|FG004|STARTED|Overall Study||23
6763163|NCT03652818|7689576|FG000|COMPLETED|Overall Study||22
6763164|NCT03652818|7689577|FG001|COMPLETED|Overall Study||22
6763165|NCT03652818|7689578|FG002|COMPLETED|Overall Study||20
6763166|NCT03652818|7689579|FG003|COMPLETED|Overall Study||22
6763167|NCT03652818|7689580|FG004|COMPLETED|Overall Study||22
6763168|NCT03652818|7689576|FG000|NOT COMPLETED|Overall Study||2
6763169|NCT03652818|7689577|FG001|NOT COMPLETED|Overall Study||1
6763170|NCT03652818|7689578|FG002|NOT COMPLETED|Overall Study||2
6763171|NCT03652818|7689579|FG003|NOT COMPLETED|Overall Study||1
6763172|NCT03652818|7689580|FG004|NOT COMPLETED|Overall Study||1
6763173|NCT03653208|7689601|FG000|STARTED|Overall Study||3
6763174|NCT03653208|7689602|FG001|STARTED|Overall Study||3
6763175|NCT03653208|7689603|FG002|STARTED|Overall Study||6
6763176|NCT03653208|7689604|FG003|STARTED|Overall Study||6
6763177|NCT03653208|7689605|FG004|STARTED|Overall Study||6
6763178|NCT03653208|7689606|FG005|STARTED|Overall Study||6
6763179|NCT03653208|7689607|FG006|STARTED|Overall Study||6
6763180|NCT03653208|7689608|FG007|STARTED|Overall Study||6
6763181|NCT03653208|7689609|FG008|STARTED|Overall Study||14
6556194|NCT01757184|7478449|FG001|STARTED|Double-blind Period||30
6556195|NCT01757184|7478450|FG002|STARTED|Double-blind Period||0
6763182|NCT03653208|7689601|FG000|COMPLETED|Overall Study||3
6763183|NCT03653208|7689602|FG001|COMPLETED|Overall Study||3
6763184|NCT03653208|7689603|FG002|COMPLETED|Overall Study||6
6763185|NCT03653208|7689604|FG003|COMPLETED|Overall Study||6
6763186|NCT03653208|7689605|FG004|COMPLETED|Overall Study||5
6763187|NCT03653208|7689606|FG005|COMPLETED|Overall Study||6
6763188|NCT03653208|7689607|FG006|COMPLETED|Overall Study||6
6763189|NCT03653208|7689608|FG007|COMPLETED|Overall Study||5
6763190|NCT03653208|7689609|FG008|COMPLETED|Overall Study||13
6763191|NCT03653208|7689601|FG000|NOT COMPLETED|Overall Study||0
6763192|NCT03653208|7689602|FG001|NOT COMPLETED|Overall Study||0
6763193|NCT03653208|7689603|FG002|NOT COMPLETED|Overall Study||0
6763194|NCT03653208|7689604|FG003|NOT COMPLETED|Overall Study||0
6763195|NCT03653208|7689605|FG004|NOT COMPLETED|Overall Study||1
6763196|NCT03653208|7689606|FG005|NOT COMPLETED|Overall Study||0
6763197|NCT03653208|7689607|FG006|NOT COMPLETED|Overall Study||0
6763198|NCT03653208|7689608|FG007|NOT COMPLETED|Overall Study||1
6763199|NCT03653208|7689609|FG008|NOT COMPLETED|Overall Study||1
6763200|NCT03653351|7689631|FG000|STARTED|Overall Study||14
6763201|NCT03653351|7689632|FG001|STARTED|Overall Study||12
6763202|NCT03653351|7689631|FG000|COMPLETED|Overall Study||13
6763203|NCT03653351|7689632|FG001|COMPLETED|Overall Study||10
6763204|NCT03653351|7689631|FG000|NOT COMPLETED|Overall Study||1
6763205|NCT03653351|7689632|FG001|NOT COMPLETED|Overall Study||2
6763206|NCT03653416|7689640|FG000|STARTED|Overall Study||52
6763207|NCT03653416|7689641|FG001|STARTED|Overall Study||47
6763208|NCT03653416|7689640|FG000|COMPLETED|Overall Study||46
6763209|NCT03653416|7689641|FG001|COMPLETED|Overall Study||46
6763210|NCT03653416|7689640|FG000|NOT COMPLETED|Overall Study||6
6763211|NCT03653416|7689641|FG001|NOT COMPLETED|Overall Study||1
6763212|NCT03653429|7689649|FG000|STARTED|Overall Study||49
6763213|NCT03653429|7689650|FG001|STARTED|Overall Study||51
6763214|NCT03653429|7689649|FG000|COMPLETED|Overall Study||45
6763215|NCT03653429|7689650|FG001|COMPLETED|Overall Study||41
6763216|NCT03653429|7689649|FG000|NOT COMPLETED|Overall Study||4
6763217|NCT03653429|7689650|FG001|NOT COMPLETED|Overall Study||10
6780188|NCT03248141|7708563|FG000|STARTED|Overall Study||11
6780189|NCT03248141|7708564|FG001|STARTED|Overall Study|No enrollment occurred in this arm prior to study termination.|0
6780190|NCT03248141|7708563|FG000|COMPLETED|Overall Study|Participants who were present in the study till termination were considered as completed.|11
6780191|NCT03248141|7708564|FG001|COMPLETED|Overall Study||0
6780192|NCT03248141|7708563|FG000|NOT COMPLETED|Overall Study||0
6780193|NCT03248141|7708564|FG001|NOT COMPLETED|Overall Study||0
6780194|NCT03263806|7708572|FG000|STARTED|Overall Study||6
6780195|NCT03263806|7708573|FG001|STARTED|Overall Study||7
6780196|NCT03263806|7708572|FG000|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
6780197|NCT03263806|7708573|FG001|COMPLETED|Overall Study|Study Terminated due to lack of enrollment|0
6780198|NCT03263806|7708572|FG000|NOT COMPLETED|Overall Study||6
6780199|NCT03263806|7708573|FG001|NOT COMPLETED|Overall Study||7
6780200|NCT03261531|7708579|FG000|STARTED|Overall Study||7
6780201|NCT03261531|7708579|FG000|COMPLETED|Overall Study||3
6780202|NCT03261531|7708579|FG000|NOT COMPLETED|Overall Study||4
6780203|NCT03251326|7708583|FG000|STARTED|Overall Study||0
6780204|NCT03251326|7708584|FG001|STARTED|Overall Study||0
6780205|NCT03251326|7708585|FG002|STARTED|Overall Study||0
6780206|NCT03251326|7708586|FG003|STARTED|Overall Study||0
6780207|NCT03251326|7708583|FG000|COMPLETED|Overall Study||0
6780208|NCT03251326|7708584|FG001|COMPLETED|Overall Study||0
6780209|NCT03251326|7708585|FG002|COMPLETED|Overall Study||0
6780210|NCT03251326|7708586|FG003|COMPLETED|Overall Study||0
6780211|NCT03251326|7708583|FG000|NOT COMPLETED|Overall Study||0
6780212|NCT03251326|7708584|FG001|NOT COMPLETED|Overall Study||0
6780213|NCT03251326|7708585|FG002|NOT COMPLETED|Overall Study||0
6780214|NCT03251326|7708586|FG003|NOT COMPLETED|Overall Study||0
6780215|NCT03219372|7708598|FG000|STARTED|Overall Study||1
6780216|NCT03219372|7708599|FG001|STARTED|Overall Study||0
6780217|NCT03219372|7708598|FG000|COMPLETED|Overall Study||0
6780218|NCT03219372|7708599|FG001|COMPLETED|Overall Study||0
6780219|NCT03219372|7708598|FG000|NOT COMPLETED|Overall Study||1
6780220|NCT03219372|7708599|FG001|NOT COMPLETED|Overall Study||0
6780221|NCT03217175|7708605|FG000|STARTED|Overall Study||4
6780222|NCT03217175|7708606|FG001|STARTED|Overall Study||1
6780223|NCT03217175|7708605|FG000|COMPLETED|Overall Study||0
6780224|NCT03217175|7708606|FG001|COMPLETED|Overall Study||0
6780225|NCT03217175|7708605|FG000|NOT COMPLETED|Overall Study||4
6780226|NCT03217175|7708606|FG001|NOT COMPLETED|Overall Study||1
6780227|NCT03231397|7708616|FG000|STARTED|Overall Study||0
6780228|NCT03231397|7708617|FG001|STARTED|Overall Study||1
6780229|NCT03231397|7708618|FG002|STARTED|Overall Study||1
6780230|NCT03231397|7708619|FG003|STARTED|Overall Study||0
6780231|NCT03231397|7708616|FG000|COMPLETED|Overall Study||0
6780232|NCT03231397|7708617|FG001|COMPLETED|Overall Study||1
6780233|NCT03231397|7708618|FG002|COMPLETED|Overall Study||1
6780234|NCT03231397|7708619|FG003|COMPLETED|Overall Study||0
6780235|NCT03231397|7708616|FG000|NOT COMPLETED|Overall Study||0
6780236|NCT03231397|7708617|FG001|NOT COMPLETED|Overall Study||0
6780237|NCT03231397|7708618|FG002|NOT COMPLETED|Overall Study||0
6780238|NCT03231397|7708619|FG003|NOT COMPLETED|Overall Study||0
6780239|NCT03232892|7708629|FG000|STARTED|Overall Study||1
6780240|NCT03232892|7708629|FG000|COMPLETED|Overall Study||1
6780241|NCT03232892|7708629|FG000|NOT COMPLETED|Overall Study||0
6780242|NCT03223662|7708633|FG000|STARTED|Overall Study||2
6780243|NCT03223662|7708633|FG000|COMPLETED|Overall Study||0
6780244|NCT03223662|7708633|FG000|NOT COMPLETED|Overall Study||2
6780245|NCT03212144|7708639|FG000|STARTED|First Sequence (4 Weeks)||2
6780246|NCT03212144|7708640|FG001|STARTED|First Sequence (4 Weeks)||1
6763218|NCT03654326|7689658|FG000|STARTED|Overall Study||94
6763219|NCT03654326|7689659|FG001|STARTED|Overall Study||93
6763220|NCT03654326|7689658|FG000|COMPLETED|Overall Study||88
6763221|NCT03654326|7689659|FG001|COMPLETED|Overall Study||87
6763222|NCT03654326|7689658|FG000|NOT COMPLETED|Overall Study||6
6763223|NCT03654326|7689659|FG001|NOT COMPLETED|Overall Study||6
6763224|NCT03654417|7689667|FG000|STARTED|Overall Study||19
6763225|NCT03654417|7689668|FG001|STARTED|Overall Study||18
6763226|NCT03654417|7689667|FG000|COMPLETED|Overall Study||19
6763227|NCT03654417|7689668|FG001|COMPLETED|Overall Study||18
6763228|NCT03654417|7689667|FG000|NOT COMPLETED|Overall Study||0
6763229|NCT03654417|7689668|FG001|NOT COMPLETED|Overall Study||0
6763230|NCT03654560|7689676|FG000|STARTED|Overall Study||118
6763231|NCT03654560|7689677|FG001|STARTED|Overall Study||118
6763232|NCT03654560|7689676|FG000|COMPLETED|Overall Study||114
6763233|NCT03654560|7689677|FG001|COMPLETED|Overall Study||117
6763234|NCT03654560|7689676|FG000|NOT COMPLETED|Overall Study||4
6763235|NCT03654560|7689677|FG001|NOT COMPLETED|Overall Study||1
6763236|NCT03655054|7689683|FG000|STARTED|Overall Study||23
6763237|NCT03655054|7689683|FG000|COMPLETED|Overall Study||22
6763238|NCT03655054|7689683|FG000|NOT COMPLETED|Overall Study||1
6763239|NCT03655080|7689687|FG000|STARTED|Overall Study||2
6763240|NCT03655080|7689687|FG000|COMPLETED|Overall Study||2
6763241|NCT03655080|7689687|FG000|NOT COMPLETED|Overall Study||0
6763242|NCT03655106|7689693|FG000|STARTED|Overall Study||135
6763243|NCT03655106|7689694|FG001|STARTED|Overall Study||135
6763244|NCT03655106|7689693|FG000|COMPLETED|Overall Study||126
6763245|NCT03655106|7689694|FG001|COMPLETED|Overall Study||131
6763246|NCT03655106|7689693|FG000|NOT COMPLETED|Overall Study||9
6763247|NCT03655106|7689694|FG001|NOT COMPLETED|Overall Study||4
6763248|NCT03655301|7689700|FG000|STARTED|Overall Study||13
6763249|NCT03655301|7689700|FG000|COMPLETED|Overall Study||13
6763250|NCT03655301|7689700|FG000|NOT COMPLETED|Overall Study||0
6763251|NCT03655405|7689706|FG000|STARTED|Overall Study||32
6763252|NCT03655405|7689707|FG001|STARTED|Overall Study||30
6763253|NCT03655405|7689706|FG000|COMPLETED|Overall Study||27
6763254|NCT03655405|7689707|FG001|COMPLETED|Overall Study||25
6763255|NCT03655405|7689706|FG000|NOT COMPLETED|Overall Study||5
6763256|NCT03655405|7689707|FG001|NOT COMPLETED|Overall Study||5
6763257|NCT03655444|7689715|FG000|STARTED|Overall Study||3
6763258|NCT03655444|7689716|FG001|STARTED|Overall Study||3
6763259|NCT03655444|7689715|FG000|COMPLETED|Overall Study||3
6763260|NCT03655444|7689716|FG001|COMPLETED|Overall Study||3
6763261|NCT03655444|7689715|FG000|NOT COMPLETED|Overall Study||0
6763262|NCT03655444|7689716|FG001|NOT COMPLETED|Overall Study||0
6763263|NCT03655951|7689724|FG000|STARTED|Overall Study||358
6763264|NCT03655951|7689725|FG001|STARTED|Overall Study||372
6763265|NCT03655951|7689724|FG000|Completed Pretest|Overall Study||344
6763266|NCT03655951|7689725|FG001|Completed Pretest|Overall Study||366
6763267|NCT03655951|7689724|FG000|COMPLETED|Overall Study||319
6763268|NCT03655951|7689725|FG001|COMPLETED|Overall Study||351
6763269|NCT03655951|7689724|FG000|NOT COMPLETED|Overall Study||39
6763270|NCT03655951|7689725|FG001|NOT COMPLETED|Overall Study||21
6763271|NCT03656939|7689731|FG000|STARTED|Overall Study||21240
6763272|NCT03656939|7689731|FG000|Main Study Cohort|Overall Study||21240
6763273|NCT03656939|7689731|FG000|Main Study Cohort: Participants Who Received Dose 1|Overall Study||20318
6763274|NCT03656939|7689731|FG000|Main Study Cohort: Participants Who Received Dose 2|Overall Study||19387
6763275|NCT03656939|7689731|FG000|Main Study Cohort: Participants Who Received Dose 3|Overall Study||18415
6763276|NCT03656939|7689731|FG000|Main Study Cohort: Participants Who Received Dose 4|Overall Study||12944
6763277|NCT03656939|7689731|FG000|Prospective Study Cohort|Overall Study||2300
6763278|NCT03656939|7689731|FG000|Prospective Study Cohort: Participants Who Received Dose 1|Overall Study||2300
6763279|NCT03656939|7689731|FG000|Prospective Study Cohort: Participants Who Received Dose 2|Overall Study||2203
6763280|NCT03656939|7689731|FG000|Prospective Study Cohort: Participants Who Received Dose 3|Overall Study||2047
6763281|NCT03656939|7689731|FG000|Prospective Study Cohort: Participants Who Received Dose 4|Overall Study||1291
6763282|NCT03656939|7689731|FG000|COMPLETED|Overall Study||21240
6763283|NCT03656939|7689731|FG000|NOT COMPLETED|Overall Study||0
6763284|NCT03657095|7689739|FG000|STARTED|Overall Study||59
6763285|NCT03657095|7689740|FG001|STARTED|Overall Study||53
6763286|NCT03657095|7689739|FG000|Received at Least 1 Dose of Study Drug|Overall Study||59
6763287|NCT03657095|7689740|FG001|Received at Least 1 Dose of Study Drug|Overall Study||53
6763288|NCT03657095|7689739|FG000|COMPLETED|Overall Study||0
6763289|NCT03657095|7689740|FG001|COMPLETED|Overall Study||0
6763290|NCT03657095|7689739|FG000|NOT COMPLETED|Overall Study||59
6763291|NCT03657095|7689740|FG001|NOT COMPLETED|Overall Study||53
6763292|NCT03657134|7689746|FG000|STARTED|Overall Study||20
6763293|NCT03657134|7689746|FG000|COMPLETED|Overall Study||20
6763294|NCT03657134|7689746|FG000|NOT COMPLETED|Overall Study||0
6763295|NCT03657264|7689755|FG000|STARTED|Overall Study||12
6763296|NCT03657264|7689756|FG001|STARTED|Overall Study||12
6763297|NCT03657264|7689757|FG002|STARTED|Overall Study||12
6763298|NCT03657264|7689758|FG003|STARTED|Overall Study||12
6763299|NCT03657264|7689755|FG000|COMPLETED|Overall Study||12
6763300|NCT03657264|7689756|FG001|COMPLETED|Overall Study||12
6763301|NCT03657264|7689757|FG002|COMPLETED|Overall Study||12
6763302|NCT03657264|7689758|FG003|COMPLETED|Overall Study||12
6763303|NCT03657264|7689755|FG000|NOT COMPLETED|Overall Study||0
6763304|NCT03657264|7689756|FG001|NOT COMPLETED|Overall Study||0
6763305|NCT03657264|7689757|FG002|NOT COMPLETED|Overall Study||0
6763306|NCT03657264|7689758|FG003|NOT COMPLETED|Overall Study||0
6763307|NCT03657277|7689769|FG000|STARTED|Overall Study||46
6763308|NCT03657277|7689769|FG000|COMPLETED|Overall Study||35
6763309|NCT03657277|7689769|FG000|NOT COMPLETED|Overall Study||11
6763310|NCT03657407|7689775|FG000|STARTED|Overall Study||29
6763311|NCT03657407|7689776|FG001|STARTED|Overall Study||27
6763312|NCT03657407|7689775|FG000|COMPLETED|Overall Study||29
6763313|NCT03657407|7689776|FG001|COMPLETED|Overall Study||27
6763314|NCT03657407|7689775|FG000|NOT COMPLETED|Overall Study||0
6763315|NCT03657407|7689776|FG001|NOT COMPLETED|Overall Study||0
6763316|NCT03658811|7689782|FG000|STARTED|Overall Study||19
6763317|NCT03658811|7689782|FG000|COMPLETED|Overall Study||16
6763318|NCT03658811|7689782|FG000|NOT COMPLETED|Overall Study||3
6763319|NCT03658876|7689788|FG000|STARTED|Overall Study||88
6763320|NCT03658876|7689789|FG001|STARTED|Overall Study||96
6763321|NCT03658876|7689788|FG000|COMPLETED|Overall Study||76
6763322|NCT03658876|7689789|FG001|COMPLETED|Overall Study||84
6763323|NCT03658876|7689788|FG000|NOT COMPLETED|Overall Study||12
6763324|NCT03658876|7689789|FG001|NOT COMPLETED|Overall Study||12
6763325|NCT03658889|7689797|FG000|STARTED|Overall Study|Enrolled population|308
6763326|NCT03658889|7689798|FG001|STARTED|Overall Study||69
6763327|NCT03658889|7689797|FG000|COMPLETED|Overall Study|Analysis population|306
6763328|NCT03658889|7689798|FG001|COMPLETED|Overall Study||69
6556196|NCT01757184|7478451|FG003|STARTED|Double-blind Period||0
6556197|NCT01757184|7478448|FG000|Received at Least 1 Dose of Study Drug|Double-blind Period||36
6556198|NCT01757184|7478449|FG001|Received at Least 1 Dose of Study Drug|Double-blind Period||30
6556199|NCT01757184|7478450|FG002|Received at Least 1 Dose of Study Drug|Double-blind Period||0
6763329|NCT03658889|7689797|FG000|NOT COMPLETED|Overall Study||2
6763330|NCT03658889|7689798|FG001|NOT COMPLETED|Overall Study||0
6763331|NCT03660787|7689807|FG000|STARTED|Overall Study||26
6763332|NCT03660787|7689808|FG001|STARTED|Overall Study||26
6763333|NCT03660787|7689809|FG002|STARTED|Overall Study||26
6763334|NCT03660787|7689810|FG003|STARTED|Overall Study||26
6763335|NCT03660787|7689807|FG000|COMPLETED|Overall Study||25
6763336|NCT03660787|7689808|FG001|COMPLETED|Overall Study||25
6763337|NCT03660787|7689809|FG002|COMPLETED|Overall Study||25
6763338|NCT03660787|7689810|FG003|COMPLETED|Overall Study||26
6763339|NCT03660787|7689807|FG000|NOT COMPLETED|Overall Study||1
6763340|NCT03660787|7689808|FG001|NOT COMPLETED|Overall Study||1
6763341|NCT03660787|7689809|FG002|NOT COMPLETED|Overall Study||1
6763342|NCT03660787|7689810|FG003|NOT COMPLETED|Overall Study||0
6763343|NCT03661346|7689822|FG000|STARTED|Overall Study|Esmolol administration|13
6562918|NCT01803464|7485829|FG003|NOT COMPLETED|Overall Study||0
6763344|NCT03661346|7689823|FG001|STARTED|Overall Study||15
6763345|NCT03661346|7689822|FG000|COMPLETED|Overall Study||13
6763346|NCT03661346|7689823|FG001|COMPLETED|Overall Study||15
6763347|NCT03661346|7689822|FG000|NOT COMPLETED|Overall Study||0
6763348|NCT03661346|7689823|FG001|NOT COMPLETED|Overall Study||0
6763349|NCT03661541|7689832|FG000|STARTED|Overall Study||12
6763350|NCT03661541|7689833|FG001|STARTED|Overall Study||12
6763351|NCT03661541|7689834|FG002|STARTED|Overall Study||12
6763352|NCT03661541|7689832|FG000|COMPLETED|Overall Study||10
6763353|NCT03661541|7689833|FG001|COMPLETED|Overall Study||10
6763354|NCT03661541|7689834|FG002|COMPLETED|Overall Study||10
6763355|NCT03661541|7689832|FG000|NOT COMPLETED|Overall Study||2
6763356|NCT03661541|7689833|FG001|NOT COMPLETED|Overall Study||2
6763357|NCT03661541|7689834|FG002|NOT COMPLETED|Overall Study||2
6763358|NCT03661697|7689848|FG000|STARTED|Overall Study||7
6763359|NCT03661697|7689849|FG001|STARTED|Overall Study||7
6763360|NCT03661697|7689848|FG000|COMPLETED|Overall Study||7
6763361|NCT03661697|7689849|FG001|COMPLETED|Overall Study||7
6763362|NCT03661697|7689848|FG000|NOT COMPLETED|Overall Study||0
6763363|NCT03661697|7689849|FG001|NOT COMPLETED|Overall Study||0
6763364|NCT03661762|7689855|FG000|STARTED|Overall Study||18
6763365|NCT03661762|7689855|FG000|COMPLETED|Overall Study||10
6763366|NCT03661762|7689855|FG000|NOT COMPLETED|Overall Study||8
6763367|NCT03661814|7689862|FG000|STARTED|Overall Study||2
6763368|NCT03661814|7689863|FG001|STARTED|Overall Study||5
6763369|NCT03661814|7689862|FG000|COMPLETED|Overall Study||2
6763370|NCT03661814|7689863|FG001|COMPLETED|Overall Study||5
6763371|NCT03661814|7689862|FG000|NOT COMPLETED|Overall Study||0
6763372|NCT03661814|7689863|FG001|NOT COMPLETED|Overall Study||0
6763373|NCT03661983|7689869|FG000|STARTED|Open Label Stabilization Phase||36
6763374|NCT03661983|7689870|FG001|STARTED|Open Label Stabilization Phase||0
6763375|NCT03661983|7689871|FG002|STARTED|Open Label Stabilization Phase||0
6763376|NCT03661983|7689872|FG003|STARTED|Open Label Stabilization Phase||0
6763377|NCT03661983|7689869|FG000|COMPLETED|Open Label Stabilization Phase||25
6763378|NCT03661983|7689870|FG001|COMPLETED|Open Label Stabilization Phase||0
6763379|NCT03661983|7689871|FG002|COMPLETED|Open Label Stabilization Phase||0
6763380|NCT03661983|7689872|FG003|COMPLETED|Open Label Stabilization Phase||0
6763381|NCT03661983|7689869|FG000|NOT COMPLETED|Open Label Stabilization Phase||11
6763382|NCT03661983|7689870|FG001|NOT COMPLETED|Open Label Stabilization Phase||0
6763383|NCT03661983|7689871|FG002|NOT COMPLETED|Open Label Stabilization Phase||0
6763384|NCT03661983|7689872|FG003|NOT COMPLETED|Open Label Stabilization Phase||0
6763385|NCT03661983|7689869|FG000|STARTED|Double-blind Randomized Phase||0
6763386|NCT03661983|7689870|FG001|STARTED|Double-blind Randomized Phase||9
6763387|NCT03661983|7689871|FG002|STARTED|Double-blind Randomized Phase||8
6763388|NCT03661983|7689872|FG003|STARTED|Double-blind Randomized Phase||8
6763389|NCT03661983|7689869|FG000|COMPLETED|Double-blind Randomized Phase||0
6763390|NCT03661983|7689870|FG001|COMPLETED|Double-blind Randomized Phase||7
6763391|NCT03661983|7689871|FG002|COMPLETED|Double-blind Randomized Phase||7
6763392|NCT03661983|7689872|FG003|COMPLETED|Double-blind Randomized Phase||0
6763393|NCT03661983|7689869|FG000|NOT COMPLETED|Double-blind Randomized Phase||0
6763394|NCT03661983|7689870|FG001|NOT COMPLETED|Double-blind Randomized Phase||2
6763395|NCT03661983|7689871|FG002|NOT COMPLETED|Double-blind Randomized Phase||1
6763396|NCT03661983|7689872|FG003|NOT COMPLETED|Double-blind Randomized Phase||8
6763397|NCT03662074|7689881|FG000|STARTED|Overall Study||14
6763398|NCT03662074|7689881|FG000|COMPLETED|Overall Study||14
6763399|NCT03662074|7689881|FG000|NOT COMPLETED|Overall Study||0
6763400|NCT03662139|7689887|FG000|STARTED|Overall Study||16
6763401|NCT03662139|7689888|FG001|STARTED|Overall Study||16
6763402|NCT03662139|7689887|FG000|COMPLETED|Overall Study||16
6763403|NCT03662139|7689888|FG001|COMPLETED|Overall Study||16
6763404|NCT03662139|7689887|FG000|NOT COMPLETED|Overall Study||0
6763405|NCT03662139|7689888|FG001|NOT COMPLETED|Overall Study||0
6763406|NCT03662282|7689896|FG000|STARTED|Overall Study||2
6763407|NCT03662282|7689896|FG000|COMPLETED|Overall Study||2
6763408|NCT03662282|7689896|FG000|NOT COMPLETED|Overall Study||0
6763409|NCT03662334|7689902|FG000|STARTED|Part 1: Treatment Period 1||0
6763410|NCT03662334|7689903|FG001|STARTED|Part 1: Treatment Period 1||0
6556200|NCT01757184|7478451|FG003|Received at Least 1 Dose of Study Drug|Double-blind Period||0
6556201|NCT01757184|7478448|FG000|COMPLETED|Double-blind Period||35
6556202|NCT01757184|7478449|FG001|COMPLETED|Double-blind Period||30
6556203|NCT01757184|7478450|FG002|COMPLETED|Double-blind Period||0
6556204|NCT01757184|7478451|FG003|COMPLETED|Double-blind Period||0
6556205|NCT01757184|7478448|FG000|NOT COMPLETED|Double-blind Period||1
6556206|NCT01757184|7478449|FG001|NOT COMPLETED|Double-blind Period||0
6556207|NCT01757184|7478450|FG002|NOT COMPLETED|Double-blind Period||0
6556208|NCT01757184|7478451|FG003|NOT COMPLETED|Double-blind Period||0
6556209|NCT01757184|7478448|FG000|STARTED|Open-label Period||0
6556210|NCT01757184|7478449|FG001|STARTED|Open-label Period||0
6556211|NCT01757184|7478450|FG002|STARTED|Open-label Period|1 participant who did not complete Double-blind Period due to AE rechallenged for Open-label Period|36
6556212|NCT01757184|7478451|FG003|STARTED|Open-label Period||30
6556213|NCT01757184|7478448|FG000|Received at Least 1 Dose of Study Drug|Open-label Period||0
6556214|NCT01757184|7478449|FG001|Received at Least 1 Dose of Study Drug|Open-label Period||0
6556215|NCT01757184|7478450|FG002|Received at Least 1 Dose of Study Drug|Open-label Period||36
6556216|NCT01757184|7478451|FG003|Received at Least 1 Dose of Study Drug|Open-label Period||30
6763411|NCT03662334|7689902|FG000|COMPLETED|Part 1: Treatment Period 1||0
6763412|NCT03662334|7689903|FG001|COMPLETED|Part 1: Treatment Period 1||0
6763413|NCT03662334|7689902|FG000|NOT COMPLETED|Part 1: Treatment Period 1||0
6763414|NCT03662334|7689903|FG001|NOT COMPLETED|Part 1: Treatment Period 1||0
6763415|NCT03662334|7689902|FG000|STARTED|Part 1: Treatment Period 2||0
6763416|NCT03662334|7689903|FG001|STARTED|Part 1: Treatment Period 2||0
6763417|NCT03662334|7689902|FG000|COMPLETED|Part 1: Treatment Period 2||0
6763418|NCT03662334|7689903|FG001|COMPLETED|Part 1: Treatment Period 2||0
6763419|NCT03662334|7689902|FG000|NOT COMPLETED|Part 1: Treatment Period 2||0
6763420|NCT03662334|7689903|FG001|NOT COMPLETED|Part 1: Treatment Period 2||0
6763421|NCT03662334|7689902|FG000|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
6763422|NCT03662334|7689903|FG001|STARTED|Part 2: Treatment Period 1 (2 Days)|Part 1 of the study was not conducted. Participants were enrolled starting with Part 2.|7
6763423|NCT03662334|7689902|FG000|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
6763424|NCT03662334|7689903|FG001|COMPLETED|Part 2: Treatment Period 1 (2 Days)||7
6763425|NCT03662334|7689902|FG000|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
6763426|NCT03662334|7689903|FG001|NOT COMPLETED|Part 2: Treatment Period 1 (2 Days)||0
6763427|NCT03662334|7689902|FG000|STARTED|Part 2: Treatment Period 2 (2 Days)||7
6763428|NCT03662334|7689903|FG001|STARTED|Part 2: Treatment Period 2 (2 Days)||7
6763429|NCT03662334|7689902|FG000|COMPLETED|Part 2: Treatment Period 2 (2 Days)||6
6763430|NCT03662334|7689903|FG001|COMPLETED|Part 2: Treatment Period 2 (2 Days)||7
6763431|NCT03662334|7689902|FG000|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||1
6763432|NCT03662334|7689903|FG001|NOT COMPLETED|Part 2: Treatment Period 2 (2 Days)||0
6763433|NCT03662334|7689902|FG000|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
6763434|NCT03662334|7689903|FG001|STARTED|Part 3: Treatment Period 1|Part 3 of the study was not conducted. No participants were enrolled in this part of the study.|0
6763435|NCT03662334|7689902|FG000|COMPLETED|Part 3: Treatment Period 1||0
6763436|NCT03662334|7689903|FG001|COMPLETED|Part 3: Treatment Period 1||0
6763437|NCT03662334|7689902|FG000|NOT COMPLETED|Part 3: Treatment Period 1||0
6763438|NCT03662334|7689903|FG001|NOT COMPLETED|Part 3: Treatment Period 1||0
6763439|NCT03662334|7689902|FG000|STARTED|Part 3: Treatment Period 2||0
6763440|NCT03662334|7689903|FG001|STARTED|Part 3: Treatment Period 2||0
6763441|NCT03662334|7689902|FG000|COMPLETED|Part 3: Treatment Period 2||0
6763442|NCT03662334|7689903|FG001|COMPLETED|Part 3: Treatment Period 2||0
6763443|NCT03662334|7689902|FG000|NOT COMPLETED|Part 3: Treatment Period 2||0
6763444|NCT03662334|7689903|FG001|NOT COMPLETED|Part 3: Treatment Period 2||0
6763445|NCT03662360|7689911|FG000|STARTED|Overall Study||16
6556217|NCT01757184|7478448|FG000|COMPLETED|Open-label Period||0
6556218|NCT01757184|7478449|FG001|COMPLETED|Open-label Period||0
6556219|NCT01757184|7478450|FG002|COMPLETED|Open-label Period||32
6556220|NCT01757184|7478451|FG003|COMPLETED|Open-label Period||27
6556221|NCT01757184|7478448|FG000|NOT COMPLETED|Open-label Period||0
6556222|NCT01757184|7478449|FG001|NOT COMPLETED|Open-label Period||0
6556223|NCT01757184|7478450|FG002|NOT COMPLETED|Open-label Period||4
6556224|NCT01757184|7478451|FG003|NOT COMPLETED|Open-label Period||3
6556225|NCT01757197|7478465|FG000|STARTED|Overall Study||2
6556226|NCT01757197|7478465|FG000|COMPLETED|Overall Study||0
6556227|NCT01757197|7478465|FG000|NOT COMPLETED|Overall Study||2
6556228|NCT01757275|7478471|FG000|STARTED|Overall Study||111
6556229|NCT01757275|7478472|FG001|STARTED|Overall Study||111
6556230|NCT01757275|7478471|FG000|COMPLETED|Overall Study||102
6556231|NCT01757275|7478472|FG001|COMPLETED|Overall Study||98
6556232|NCT01757275|7478471|FG000|NOT COMPLETED|Overall Study||9
6556233|NCT01757275|7478472|FG001|NOT COMPLETED|Overall Study||13
6556234|NCT01757288|7478481|FG000|STARTED|Overall Study||6
6556235|NCT01757288|7478482|FG001|STARTED|Overall Study||46
6556236|NCT01757288|7478483|FG002|STARTED|Overall Study||46
6556237|NCT01757288|7478481|FG000|COMPLETED|Overall Study||6
6556238|NCT01757288|7478482|FG001|COMPLETED|Overall Study||38
6556239|NCT01757288|7478483|FG002|COMPLETED|Overall Study||37
6556240|NCT01757288|7478481|FG000|NOT COMPLETED|Overall Study||0
6763446|NCT03662360|7689912|FG001|STARTED|Overall Study||16
6763447|NCT03662360|7689911|FG000|COMPLETED|Overall Study||16
6763448|NCT03662360|7689912|FG001|COMPLETED|Overall Study||14
6763449|NCT03662360|7689911|FG000|NOT COMPLETED|Overall Study||0
6763450|NCT03662360|7689912|FG001|NOT COMPLETED|Overall Study||2
6763451|NCT03662750|7689919|FG000|STARTED|Overall Study||3
6763452|NCT03662750|7689919|FG000|COMPLETED|Overall Study||2
6763453|NCT03662750|7689919|FG000|NOT COMPLETED|Overall Study||1
6763454|NCT03662789|7689925|FG000|STARTED|Overall Study|Baseline|52
6763455|NCT03662789|7689926|FG001|STARTED|Overall Study|Baseline|50
6763456|NCT03662789|7689925|FG000|COMPLETED|Overall Study|Follow-up at 6 months|47
6763457|NCT03662789|7689926|FG001|COMPLETED|Overall Study|Follow-up at 6 months|43
6763458|NCT03662789|7689925|FG000|NOT COMPLETED|Overall Study||5
6763459|NCT03662789|7689926|FG001|NOT COMPLETED|Overall Study||7
6763460|NCT03662997|7689936|FG000|STARTED|Overall Study||11
6763461|NCT03662997|7689937|FG001|STARTED|Overall Study||10
6763462|NCT03662997|7689938|FG002|STARTED|Overall Study||11
6763463|NCT03662997|7689939|FG003|STARTED|Overall Study||8
6763464|NCT03662997|7689936|FG000|COMPLETED|Overall Study||11
6763465|NCT03662997|7689937|FG001|COMPLETED|Overall Study||8
6763466|NCT03662997|7689938|FG002|COMPLETED|Overall Study||11
6763467|NCT03662997|7689939|FG003|COMPLETED|Overall Study||8
6763468|NCT03662997|7689936|FG000|NOT COMPLETED|Overall Study||0
6763469|NCT03662997|7689937|FG001|NOT COMPLETED|Overall Study||2
6763470|NCT03662997|7689938|FG002|NOT COMPLETED|Overall Study||0
6763471|NCT03662997|7689939|FG003|NOT COMPLETED|Overall Study||0
6763472|NCT03663101|7689955|FG000|STARTED|Overall Study||4
6763473|NCT03663101|7689956|FG001|STARTED|Overall Study||3
6763474|NCT03663101|7689957|FG002|STARTED|Overall Study||5
6763475|NCT03663101|7689958|FG003|STARTED|Overall Study||4
6763476|NCT03663101|7689955|FG000|COMPLETED|Overall Study||4
6763477|NCT03663101|7689956|FG001|COMPLETED|Overall Study||3
6763478|NCT03663101|7689957|FG002|COMPLETED|Overall Study||5
6763479|NCT03663101|7689958|FG003|COMPLETED|Overall Study||4
6763480|NCT03663101|7689955|FG000|NOT COMPLETED|Overall Study||0
6763481|NCT03663101|7689956|FG001|NOT COMPLETED|Overall Study||0
6763482|NCT03663101|7689957|FG002|NOT COMPLETED|Overall Study||0
6763483|NCT03663101|7689958|FG003|NOT COMPLETED|Overall Study||0
6763484|NCT03663179|7689970|FG000|STARTED|Overall Study||18
6763485|NCT03663179|7689971|FG001|STARTED|Overall Study||14
6763486|NCT03663179|7689970|FG000|COMPLETED|Overall Study||14
6763487|NCT03663179|7689971|FG001|COMPLETED|Overall Study||13
6763488|NCT03663179|7689970|FG000|NOT COMPLETED|Overall Study||4
6763489|NCT03663179|7689971|FG001|NOT COMPLETED|Overall Study||1
6763490|NCT03663231|7689979|FG000|STARTED|First Intervention||16
6763491|NCT03663231|7689980|FG001|STARTED|First Intervention||13
6763492|NCT03663231|7689979|FG000|COMPLETED|First Intervention||14
6763493|NCT03663231|7689980|FG001|COMPLETED|First Intervention||12
6763494|NCT03663231|7689979|FG000|NOT COMPLETED|First Intervention||2
6763495|NCT03663231|7689980|FG001|NOT COMPLETED|First Intervention||1
6763496|NCT03663231|7689979|FG000|STARTED|Washout||14
6763497|NCT03663231|7689980|FG001|STARTED|Washout||12
6763498|NCT03663231|7689979|FG000|COMPLETED|Washout||14
6763499|NCT03663231|7689980|FG001|COMPLETED|Washout||12
6763500|NCT03663231|7689979|FG000|NOT COMPLETED|Washout||0
6763501|NCT03663231|7689980|FG001|NOT COMPLETED|Washout||0
6763502|NCT03663231|7689979|FG000|STARTED|Second Intervention||14
6763503|NCT03663231|7689980|FG001|STARTED|Second Intervention||12
6556241|NCT01757288|7478482|FG001|NOT COMPLETED|Overall Study||8
6556242|NCT01757288|7478483|FG002|NOT COMPLETED|Overall Study||9
6556243|NCT01757301|7478494|FG000|STARTED|Overall Study||147
6556244|NCT01757301|7478495|FG001|STARTED|Overall Study||147
6556245|NCT01757301|7478494|FG000|COMPLETED|Overall Study||134
6763504|NCT03663231|7689979|FG000|COMPLETED|Second Intervention||14
6763505|NCT03663231|7689980|FG001|COMPLETED|Second Intervention||12
6763506|NCT03663231|7689979|FG000|NOT COMPLETED|Second Intervention||0
6763507|NCT03663231|7689980|FG001|NOT COMPLETED|Second Intervention||0
6763508|NCT03663283|7689988|FG000|STARTED|Overall Study||52
6763509|NCT03663283|7689989|FG001|STARTED|Overall Study||52
6763510|NCT03663283|7689988|FG000|COMPLETED|Overall Study||52
6763511|NCT03663283|7689989|FG001|COMPLETED|Overall Study||52
6763512|NCT03663283|7689988|FG000|NOT COMPLETED|Overall Study||0
6763513|NCT03663283|7689989|FG001|NOT COMPLETED|Overall Study||0
6763514|NCT03663569|7689995|FG000|STARTED|Overall Study||4819
6763515|NCT03663569|7689995|FG000|COMPLETED|Overall Study||4756
6763516|NCT03663569|7689995|FG000|NOT COMPLETED|Overall Study||63
6763517|NCT03663582|7689999|FG000|STARTED|Overall Study||7
6763518|NCT03663582|7689999|FG000|COMPLETED|Overall Study||6
6763519|NCT03663582|7689999|FG000|NOT COMPLETED|Overall Study||1
6763520|NCT03663816|7690003|FG000|STARTED|Overall Study||15
6763521|NCT03663816|7690003|FG000|COMPLETED|Overall Study||15
6763522|NCT03663816|7690003|FG000|NOT COMPLETED|Overall Study||0
6763523|NCT03664193|7690007|FG000|STARTED|Overall Study||30
6763524|NCT03664193|7690007|FG000|COMPLETED|Overall Study||30
6763525|NCT03664193|7690007|FG000|NOT COMPLETED|Overall Study||0
6763526|NCT03664544|7690013|FG000|STARTED|Overall Study||6
6763527|NCT03664544|7690014|FG001|STARTED|Overall Study||6
6763528|NCT03664544|7690013|FG000|COMPLETED|Overall Study||6
6763529|NCT03664544|7690014|FG001|COMPLETED|Overall Study||6
6763530|NCT03664544|7690013|FG000|NOT COMPLETED|Overall Study||0
6763531|NCT03664544|7690014|FG001|NOT COMPLETED|Overall Study||0
6763532|NCT03665155|7690023|FG000|STARTED|Overall Study||3
6763533|NCT03665155|7690024|FG001|STARTED|Overall Study||7
6763534|NCT03665155|7690025|FG002|STARTED|Overall Study||1
6763535|NCT03665155|7690023|FG000|COMPLETED|Overall Study||3
6763536|NCT03665155|7690024|FG001|COMPLETED|Overall Study||7
6763537|NCT03665155|7690025|FG002|COMPLETED|Overall Study||1
6763538|NCT03665155|7690023|FG000|NOT COMPLETED|Overall Study||0
6763539|NCT03665155|7690024|FG001|NOT COMPLETED|Overall Study||0
6763540|NCT03665155|7690025|FG002|NOT COMPLETED|Overall Study||0
6763541|NCT03666026|7690035|FG000|STARTED|Overall Study||41070
6763542|NCT03666026|7690036|FG001|STARTED|Overall Study||41055
6763543|NCT03666026|7690037|FG002|STARTED|Overall Study||41046
6763544|NCT03666026|7690038|FG003|STARTED|Overall Study||41034
6763545|NCT03666026|7690035|FG000|COMPLETED|Overall Study||41070
6763546|NCT03666026|7690036|FG001|COMPLETED|Overall Study||41055
6763547|NCT03666026|7690037|FG002|COMPLETED|Overall Study||41046
6763548|NCT03666026|7690038|FG003|COMPLETED|Overall Study||41034
6763549|NCT03666026|7690035|FG000|NOT COMPLETED|Overall Study||0
6763550|NCT03666026|7690036|FG001|NOT COMPLETED|Overall Study||0
6763551|NCT03666026|7690037|FG002|NOT COMPLETED|Overall Study||0
6763552|NCT03666026|7690038|FG003|NOT COMPLETED|Overall Study||0
6763553|NCT03666663|7690052|FG000|STARTED|Overall Study||3
6763554|NCT03666663|7690053|FG001|STARTED|Overall Study||1
6763555|NCT03666663|7690054|FG002|STARTED|Overall Study||3
6763556|NCT03666663|7690055|FG003|STARTED|Overall Study||3
6763557|NCT03666663|7690052|FG000|COMPLETED|Overall Study||3
6763558|NCT03666663|7690053|FG001|COMPLETED|Overall Study||1
6763559|NCT03666663|7690054|FG002|COMPLETED|Overall Study||1
6763560|NCT03666663|7690055|FG003|COMPLETED|Overall Study||1
6763561|NCT03666663|7690052|FG000|NOT COMPLETED|Overall Study||0
6763562|NCT03666663|7690053|FG001|NOT COMPLETED|Overall Study||0
6763563|NCT03666663|7690054|FG002|NOT COMPLETED|Overall Study||2
6763564|NCT03666663|7690055|FG003|NOT COMPLETED|Overall Study||2
6763565|NCT03666858|7690065|FG000|STARTED|Cohort 1|All participants with TTH who had reported at least one headache and Neosaldina intake.|216
6763566|NCT03666858|7690066|FG001|STARTED|Cohort 1||0
6763567|NCT03666858|7690065|FG000|COMPLETED|Cohort 1||215
6763568|NCT03666858|7690066|FG001|COMPLETED|Cohort 1||0
6763569|NCT03666858|7690065|FG000|NOT COMPLETED|Cohort 1||1
6763570|NCT03666858|7690066|FG001|NOT COMPLETED|Cohort 1||0
6763571|NCT03666858|7690065|FG000|STARTED|Cohort 2||0
6763572|NCT03666858|7690066|FG001|STARTED|Cohort 2|Cohort 1 participants with pain intensity at 0,120minutes after Neosaldina/0 pain before 120minutes.|138
6763573|NCT03666858|7690065|FG000|COMPLETED|Cohort 2||0
6763574|NCT03666858|7690066|FG001|COMPLETED|Cohort 2||137
6763575|NCT03666858|7690065|FG000|NOT COMPLETED|Cohort 2||0
6763576|NCT03666858|7690066|FG001|NOT COMPLETED|Cohort 2||1
6763577|NCT03667053|7690075|FG000|STARTED|Overall Study||21
6763578|NCT03667053|7690076|FG001|STARTED|Overall Study||11
6763579|NCT03667053|7690077|FG002|STARTED|Overall Study||10
6763580|NCT03667053|7690075|FG000|Randomized and Treated|Overall Study||20
6763581|NCT03667053|7690076|FG001|Randomized and Treated|Overall Study||11
6763582|NCT03667053|7690077|FG002|Randomized and Treated|Overall Study||10
6763583|NCT03667053|7690075|FG000|COMPLETED|Overall Study||20
6763584|NCT03667053|7690076|FG001|COMPLETED|Overall Study||11
6763585|NCT03667053|7690077|FG002|COMPLETED|Overall Study||10
6763586|NCT03667053|7690075|FG000|NOT COMPLETED|Overall Study||1
6763587|NCT03667053|7690076|FG001|NOT COMPLETED|Overall Study||0
6763588|NCT03667053|7690077|FG002|NOT COMPLETED|Overall Study||0
6763589|NCT03667547|7690092|FG000|STARTED|Overall Study||12
6763590|NCT03667547|7690092|FG000|COMPLETED|Overall Study||12
6763591|NCT03667547|7690092|FG000|NOT COMPLETED|Overall Study||0
6763592|NCT03668600|7690096|FG000|STARTED|Overall Study||230
6763593|NCT03668600|7690096|FG000|COMPLETED|Overall Study||0
6763594|NCT03668600|7690096|FG000|NOT COMPLETED|Overall Study||230
6763595|NCT03668613|7690102|FG000|STARTED|Overall Study||42
6763596|NCT03668613|7690103|FG001|STARTED|Overall Study||42
6763597|NCT03668613|7690102|FG000|COMPLETED|Overall Study||42
6763598|NCT03668613|7690103|FG001|COMPLETED|Overall Study||39
6763599|NCT03668613|7690102|FG000|NOT COMPLETED|Overall Study||0
6763600|NCT03668613|7690103|FG001|NOT COMPLETED|Overall Study||3
6763601|NCT03669081|7690112|FG000|STARTED|Overall Study||34
6763602|NCT03669081|7690113|FG001|STARTED|Overall Study||30
6763603|NCT03669081|7690112|FG000|COMPLETED|Overall Study||33
6763604|NCT03669081|7690113|FG001|COMPLETED|Overall Study||29
6763605|NCT03669081|7690112|FG000|NOT COMPLETED|Overall Study||1
6763606|NCT03669081|7690113|FG001|NOT COMPLETED|Overall Study||1
6763607|NCT03669354|7690123|FG000|STARTED|Overall Study||73
6763608|NCT03669354|7690124|FG001|STARTED|Overall Study||22
6763609|NCT03669354|7690125|FG002|STARTED|Overall Study||47
6763610|NCT03669354|7690126|FG003|STARTED|Overall Study||53
6763611|NCT03669354|7690123|FG000|COMPLETED|Overall Study||73
6763612|NCT03669354|7690124|FG001|COMPLETED|Overall Study||22
6763613|NCT03669354|7690125|FG002|COMPLETED|Overall Study||47
6763614|NCT03669354|7690126|FG003|COMPLETED|Overall Study||53
6763615|NCT03669354|7690123|FG000|NOT COMPLETED|Overall Study||0
6763616|NCT03669354|7690124|FG001|NOT COMPLETED|Overall Study||0
6763617|NCT03669354|7690125|FG002|NOT COMPLETED|Overall Study||0
6763618|NCT03669354|7690126|FG003|NOT COMPLETED|Overall Study||0
6763619|NCT03669549|7690137|FG000|STARTED|Overall Study||15
6763620|NCT03669549|7690137|FG000|COMPLETED|Overall Study||9
6763621|NCT03669549|7690137|FG000|NOT COMPLETED|Overall Study||6
6763622|NCT03669861|7690145|FG000|STARTED|Overall Study||10
6763623|NCT03669861|7690145|FG000|COMPLETED|Overall Study||3
6763624|NCT03669861|7690145|FG000|NOT COMPLETED|Overall Study||7
6763625|NCT03670017|7690149|FG000|STARTED|Overall Study||68
6763626|NCT03670017|7690149|FG000|COMPLETED|Overall Study||50
6763627|NCT03670017|7690149|FG000|NOT COMPLETED|Overall Study||18
6763628|NCT03670030|7690153|FG000|STARTED|Overall Study||5
6763629|NCT03670030|7690153|FG000|COMPLETED|Overall Study||5
6763630|NCT03670030|7690153|FG000|NOT COMPLETED|Overall Study||0
6763631|NCT03670160|7690159|FG000|STARTED|Overall Study||11
6763632|NCT03670160|7690160|FG001|STARTED|Overall Study||14
6763633|NCT03670160|7690159|FG000|COMPLETED|Overall Study||11
6763634|NCT03670160|7690160|FG001|COMPLETED|Overall Study||14
6763635|NCT03670160|7690159|FG000|NOT COMPLETED|Overall Study||0
6763636|NCT03670160|7690160|FG001|NOT COMPLETED|Overall Study||0
6763637|NCT03670264|7690169|FG000|STARTED|Overall Study||5
6763638|NCT03670264|7690170|FG001|STARTED|Overall Study||5
6763639|NCT03670264|7690171|FG002|STARTED|Overall Study||5
6763640|NCT03670264|7690169|FG000|COMPLETED|Overall Study||5
6763641|NCT03670264|7690170|FG001|COMPLETED|Overall Study||5
6763642|NCT03670264|7690171|FG002|COMPLETED|Overall Study||5
6763643|NCT03670264|7690169|FG000|NOT COMPLETED|Overall Study||0
6763644|NCT03670264|7690170|FG001|NOT COMPLETED|Overall Study||0
6763645|NCT03670264|7690171|FG002|NOT COMPLETED|Overall Study||0
6763646|NCT03670537|7690179|FG000|STARTED|Overall Study||102
6763647|NCT03670537|7690179|FG000|COMPLETED|Overall Study||101
6763648|NCT03670537|7690179|FG000|NOT COMPLETED|Overall Study||1
6763649|NCT03670641|7690183|FG000|STARTED|Overall Study||10
6763650|NCT03670641|7690183|FG000|COMPLETED|Overall Study|3 participants were lost to follow up by 12 months|7
6763651|NCT03670641|7690183|FG000|NOT COMPLETED|Overall Study||3
6763652|NCT03670810|7690193|FG000|STARTED|Overall Study||485
6763653|NCT03670810|7690194|FG001|STARTED|Overall Study||486
6763654|NCT03670810|7690195|FG002|STARTED|Overall Study||249
6763655|NCT03670810|7690196|FG003|STARTED|Overall Study||251
6763656|NCT03670810|7690193|FG000|Treated at Least One Migraine Attack|Overall Study||485
6763657|NCT03670810|7690194|FG001|Treated at Least One Migraine Attack|Overall Study||486
6763658|NCT03670810|7690195|FG002|Treated at Least One Migraine Attack|Overall Study||249
6763659|NCT03670810|7690196|FG003|Treated at Least One Migraine Attack|Overall Study||251
6763660|NCT03670810|7690193|FG000|COMPLETED|Overall Study||381
6763661|NCT03670810|7690194|FG001|COMPLETED|Overall Study||369
6763662|NCT03670810|7690195|FG002|COMPLETED|Overall Study||208
6763663|NCT03670810|7690196|FG003|COMPLETED|Overall Study||213
6763664|NCT03670810|7690193|FG000|NOT COMPLETED|Overall Study||104
6763665|NCT03670810|7690194|FG001|NOT COMPLETED|Overall Study||117
6763666|NCT03670810|7690195|FG002|NOT COMPLETED|Overall Study||41
6763667|NCT03670810|7690196|FG003|NOT COMPLETED|Overall Study||38
6763668|NCT03672006|7690208|FG000|STARTED|Overall Study||10
6763669|NCT03672006|7690209|FG001|STARTED|Overall Study||10
6763670|NCT03672006|7690208|FG000|COMPLETED|Overall Study||10
6763671|NCT03672006|7690209|FG001|COMPLETED|Overall Study||9
6763672|NCT03672006|7690208|FG000|NOT COMPLETED|Overall Study||0
6763673|NCT03672006|7690209|FG001|NOT COMPLETED|Overall Study||1
6763674|NCT03672032|7690219|FG000|STARTED|Overall Study||67
6763675|NCT03672032|7690220|FG001|STARTED|Overall Study||67
6763676|NCT03672032|7690219|FG000|COMPLETED|Overall Study||67
6763677|NCT03672032|7690220|FG001|COMPLETED|Overall Study||67
6763678|NCT03672032|7690219|FG000|NOT COMPLETED|Overall Study||0
6763679|NCT03672032|7690220|FG001|NOT COMPLETED|Overall Study||0
6763680|NCT03672097|7690226|FG000|STARTED|Period 1||204
6763681|NCT03672097|7690226|FG000|COMPLETED|Period 1||200
6763682|NCT03672097|7690226|FG000|NOT COMPLETED|Period 1||4
6763683|NCT03672097|7690226|FG000|STARTED|Period 2||200
6763684|NCT03672097|7690226|FG000|COMPLETED|Period 2||196
6763685|NCT03672097|7690226|FG000|NOT COMPLETED|Period 2||4
6763686|NCT03672370|7690230|FG000|STARTED|Overall Study|11 hips did not receive the study devices acc. to the protocol and therefore had to be excluded.|89
6763687|NCT03672370|7690230|FG000|COMPLETED|Overall Study||42
6763688|NCT03672370|7690230|FG000|NOT COMPLETED|Overall Study||47
6763689|NCT03672396|7690234|FG000|STARTED|Overall Study||22
6763690|NCT03672396|7690234|FG000|COMPLETED|Overall Study||16
6763691|NCT03672396|7690234|FG000|NOT COMPLETED|Overall Study||6
6763692|NCT03673670|7690244|FG000|STARTED|Treatment Period 1 (3 Days)||14
6763693|NCT03673670|7690245|FG001|STARTED|Treatment Period 1 (3 Days)||14
6763694|NCT03673670|7690246|FG002|STARTED|Treatment Period 1 (3 Days)||13
6763695|NCT03673670|7690247|FG003|STARTED|Treatment Period 1 (3 Days)||12
6763696|NCT03673670|7690248|FG004|STARTED|Treatment Period 1 (3 Days)||13
6763697|NCT03673670|7690249|FG005|STARTED|Treatment Period 1 (3 Days)||13
6763698|NCT03673670|7690244|FG000|COMPLETED|Treatment Period 1 (3 Days)||13
6763699|NCT03673670|7690245|FG001|COMPLETED|Treatment Period 1 (3 Days)||14
6763700|NCT03673670|7690246|FG002|COMPLETED|Treatment Period 1 (3 Days)||12
6763701|NCT03673670|7690247|FG003|COMPLETED|Treatment Period 1 (3 Days)||12
6763702|NCT03673670|7690248|FG004|COMPLETED|Treatment Period 1 (3 Days)||13
6763703|NCT03673670|7690249|FG005|COMPLETED|Treatment Period 1 (3 Days)||11
6763704|NCT03673670|7690244|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||1
6763705|NCT03673670|7690245|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6763706|NCT03673670|7690246|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||1
6763707|NCT03673670|7690247|FG003|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6763708|NCT03673670|7690248|FG004|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6763709|NCT03673670|7690249|FG005|NOT COMPLETED|Treatment Period 1 (3 Days)||2
6763710|NCT03673670|7690244|FG000|STARTED|Washout Period 1 (7-14 Days)||13
6763711|NCT03673670|7690245|FG001|STARTED|Washout Period 1 (7-14 Days)||14
6763712|NCT03673670|7690246|FG002|STARTED|Washout Period 1 (7-14 Days)||12
6763713|NCT03673670|7690247|FG003|STARTED|Washout Period 1 (7-14 Days)||12
6763714|NCT03673670|7690248|FG004|STARTED|Washout Period 1 (7-14 Days)||13
6763715|NCT03673670|7690249|FG005|STARTED|Washout Period 1 (7-14 Days)||11
6763716|NCT03673670|7690244|FG000|COMPLETED|Washout Period 1 (7-14 Days)||13
6763717|NCT03673670|7690245|FG001|COMPLETED|Washout Period 1 (7-14 Days)||14
6763718|NCT03673670|7690246|FG002|COMPLETED|Washout Period 1 (7-14 Days)||12
6763719|NCT03673670|7690247|FG003|COMPLETED|Washout Period 1 (7-14 Days)||12
6763720|NCT03673670|7690248|FG004|COMPLETED|Washout Period 1 (7-14 Days)||13
6763721|NCT03673670|7690249|FG005|COMPLETED|Washout Period 1 (7-14 Days)||11
6763722|NCT03673670|7690244|FG000|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6763723|NCT03673670|7690245|FG001|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6763724|NCT03673670|7690246|FG002|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6763725|NCT03673670|7690247|FG003|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6763726|NCT03673670|7690248|FG004|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6763727|NCT03673670|7690249|FG005|NOT COMPLETED|Washout Period 1 (7-14 Days)||0
6763728|NCT03673670|7690244|FG000|STARTED|Treatment Period 2 (3 Days)||13
6763729|NCT03673670|7690245|FG001|STARTED|Treatment Period 2 (3 Days)||14
6763730|NCT03673670|7690246|FG002|STARTED|Treatment Period 2 (3 Days)||12
6763731|NCT03673670|7690247|FG003|STARTED|Treatment Period 2 (3 Days)||12
6763732|NCT03673670|7690248|FG004|STARTED|Treatment Period 2 (3 Days)||13
6763733|NCT03673670|7690249|FG005|STARTED|Treatment Period 2 (3 Days)||11
6763734|NCT03673670|7690244|FG000|COMPLETED|Treatment Period 2 (3 Days)||13
6763735|NCT03673670|7690245|FG001|COMPLETED|Treatment Period 2 (3 Days)||14
6763736|NCT03673670|7690246|FG002|COMPLETED|Treatment Period 2 (3 Days)||11
6763737|NCT03673670|7690247|FG003|COMPLETED|Treatment Period 2 (3 Days)||12
6763738|NCT03673670|7690248|FG004|COMPLETED|Treatment Period 2 (3 Days)||12
6763739|NCT03673670|7690249|FG005|COMPLETED|Treatment Period 2 (3 Days)||11
6763740|NCT03673670|7690244|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6763741|NCT03673670|7690245|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6763742|NCT03673670|7690246|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||1
6763743|NCT03673670|7690247|FG003|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6763744|NCT03673670|7690248|FG004|NOT COMPLETED|Treatment Period 2 (3 Days)||1
6763745|NCT03673670|7690249|FG005|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6763746|NCT03673670|7690244|FG000|STARTED|Washout Period 2 (7-14 Days)||13
6763747|NCT03673670|7690245|FG001|STARTED|Washout Period 2 (7-14 Days)||14
6763748|NCT03673670|7690246|FG002|STARTED|Washout Period 2 (7-14 Days)||11
6763749|NCT03673670|7690247|FG003|STARTED|Washout Period 2 (7-14 Days)||12
6763750|NCT03673670|7690248|FG004|STARTED|Washout Period 2 (7-14 Days)||12
6763751|NCT03673670|7690249|FG005|STARTED|Washout Period 2 (7-14 Days)||11
6763752|NCT03673670|7690244|FG000|COMPLETED|Washout Period 2 (7-14 Days)||13
6763753|NCT03673670|7690245|FG001|COMPLETED|Washout Period 2 (7-14 Days)||14
6763754|NCT03673670|7690246|FG002|COMPLETED|Washout Period 2 (7-14 Days)||11
6763755|NCT03673670|7690247|FG003|COMPLETED|Washout Period 2 (7-14 Days)||12
6763756|NCT03673670|7690248|FG004|COMPLETED|Washout Period 2 (7-14 Days)||11
6763757|NCT03673670|7690249|FG005|COMPLETED|Washout Period 2 (7-14 Days)||11
6763758|NCT03673670|7690244|FG000|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6763759|NCT03673670|7690245|FG001|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6763760|NCT03673670|7690246|FG002|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6763761|NCT03673670|7690247|FG003|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6763762|NCT03673670|7690248|FG004|NOT COMPLETED|Washout Period 2 (7-14 Days)||1
6763763|NCT03673670|7690249|FG005|NOT COMPLETED|Washout Period 2 (7-14 Days)||0
6763764|NCT03673670|7690244|FG000|STARTED|Treatment Period 3 (3 Days)||13
6763765|NCT03673670|7690245|FG001|STARTED|Treatment Period 3 (3 Days)||14
6763766|NCT03673670|7690246|FG002|STARTED|Treatment Period 3 (3 Days)||11
6763767|NCT03673670|7690247|FG003|STARTED|Treatment Period 3 (3 Days)||12
6763768|NCT03673670|7690248|FG004|STARTED|Treatment Period 3 (3 Days)||11
6763769|NCT03673670|7690249|FG005|STARTED|Treatment Period 3 (3 Days)||11
6763770|NCT03673670|7690244|FG000|COMPLETED|Treatment Period 3 (3 Days)||13
6763771|NCT03673670|7690245|FG001|COMPLETED|Treatment Period 3 (3 Days)||14
6763772|NCT03673670|7690246|FG002|COMPLETED|Treatment Period 3 (3 Days)||11
6763773|NCT03673670|7690247|FG003|COMPLETED|Treatment Period 3 (3 Days)||12
6763774|NCT03673670|7690248|FG004|COMPLETED|Treatment Period 3 (3 Days)||10
6763775|NCT03673670|7690249|FG005|COMPLETED|Treatment Period 3 (3 Days)||11
6763776|NCT03673670|7690244|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6763777|NCT03673670|7690245|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6763778|NCT03673670|7690246|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6763779|NCT03673670|7690247|FG003|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6763780|NCT03673670|7690248|FG004|NOT COMPLETED|Treatment Period 3 (3 Days)||1
6763781|NCT03673670|7690249|FG005|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6763782|NCT03674177|7690270|FG000|STARTED|Overall Study||124
6763783|NCT03674177|7690271|FG001|STARTED|Overall Study||126
6763784|NCT03674177|7690272|FG002|STARTED|Overall Study||126
6763785|NCT03674177|7690273|FG003|STARTED|Overall Study||126
6763786|NCT03674177|7690270|FG000|COMPLETED|Overall Study||122
6763787|NCT03674177|7690271|FG001|COMPLETED|Overall Study||125
6763788|NCT03674177|7690272|FG002|COMPLETED|Overall Study||126
6556246|NCT01757301|7478495|FG001|COMPLETED|Overall Study||133
6556247|NCT01757301|7478494|FG000|NOT COMPLETED|Overall Study||13
6556248|NCT01757301|7478495|FG001|NOT COMPLETED|Overall Study||14
6763789|NCT03674177|7690273|FG003|COMPLETED|Overall Study||124
6763790|NCT03674177|7690270|FG000|NOT COMPLETED|Overall Study||2
6763791|NCT03674177|7690271|FG001|NOT COMPLETED|Overall Study||1
6763792|NCT03674177|7690272|FG002|NOT COMPLETED|Overall Study||0
6763793|NCT03674177|7690273|FG003|NOT COMPLETED|Overall Study||2
6763794|NCT03674281|7690286|FG000|STARTED|Overall Study||18
6763795|NCT03674281|7690287|FG001|STARTED|Overall Study||16
6763796|NCT03674281|7690288|FG002|STARTED|Overall Study||16
6763797|NCT03674281|7690286|FG000|COMPLETED|Overall Study||15
6763798|NCT03674281|7690287|FG001|COMPLETED|Overall Study||13
6763799|NCT03674281|7690288|FG002|COMPLETED|Overall Study||13
6763800|NCT03674281|7690286|FG000|NOT COMPLETED|Overall Study||3
6763801|NCT03674281|7690287|FG001|NOT COMPLETED|Overall Study||3
6763802|NCT03674281|7690288|FG002|NOT COMPLETED|Overall Study||3
6763803|NCT03674970|7690307|FG000|STARTED|Overall Study||15
6763804|NCT03674970|7690308|FG001|STARTED|Overall Study||15
6763805|NCT03674970|7690309|FG002|STARTED|Overall Study||15
6763806|NCT03674970|7690307|FG000|COMPLETED|Overall Study||12
6763807|NCT03674970|7690308|FG001|COMPLETED|Overall Study||8
6763808|NCT03674970|7690309|FG002|COMPLETED|Overall Study||12
6763809|NCT03674970|7690307|FG000|NOT COMPLETED|Overall Study||3
6763810|NCT03674970|7690308|FG001|NOT COMPLETED|Overall Study||7
6763811|NCT03674970|7690309|FG002|NOT COMPLETED|Overall Study||3
6763812|NCT03675451|7690317|FG000|STARTED|Overall Study||20
6763813|NCT03675451|7690317|FG000|COMPLETED|Overall Study||20
6763814|NCT03675451|7690317|FG000|NOT COMPLETED|Overall Study||0
6763815|NCT03675581|7690328|FG000|STARTED|Period 1: Microgynon Alone||17
6763816|NCT03675581|7690328|FG000|COMPLETED|Period 1: Microgynon Alone||17
6763817|NCT03675581|7690328|FG000|NOT COMPLETED|Period 1: Microgynon Alone||0
6763818|NCT03675581|7690328|FG000|STARTED|Period 2: Microgynon + Nintedanib||17
6763819|NCT03675581|7690328|FG000|COMPLETED|Period 2: Microgynon + Nintedanib||17
6763820|NCT03675581|7690328|FG000|NOT COMPLETED|Period 2: Microgynon + Nintedanib||0
6763821|NCT03675685|7690336|FG000|STARTED|Overall Study||12
6763822|NCT03675685|7690336|FG000|COMPLETED|Overall Study||12
6763823|NCT03675685|7690336|FG000|NOT COMPLETED|Overall Study||0
6763824|NCT03675776|7690347|FG000|STARTED|Double Blind Treatment Period||15
6763825|NCT03675776|7690348|FG001|STARTED|Double Blind Treatment Period||17
6763826|NCT03675776|7690349|FG002|STARTED|Double Blind Treatment Period||18
6763827|NCT03675776|7690347|FG000|COMPLETED|Double Blind Treatment Period||9
6763828|NCT03675776|7690348|FG001|COMPLETED|Double Blind Treatment Period||11
6763829|NCT03675776|7690349|FG002|COMPLETED|Double Blind Treatment Period||10
6763830|NCT03675776|7690347|FG000|NOT COMPLETED|Double Blind Treatment Period||6
6763831|NCT03675776|7690348|FG001|NOT COMPLETED|Double Blind Treatment Period||6
6763832|NCT03675776|7690349|FG002|NOT COMPLETED|Double Blind Treatment Period||8
6763833|NCT03675776|7690347|FG000|STARTED|Safety Follow-up Period||6
6763834|NCT03675776|7690348|FG001|STARTED|Safety Follow-up Period||8
6763835|NCT03675776|7690349|FG002|STARTED|Safety Follow-up Period||7
6763836|NCT03675776|7690347|FG000|COMPLETED|Safety Follow-up Period||6
6763837|NCT03675776|7690348|FG001|COMPLETED|Safety Follow-up Period||8
6763838|NCT03675776|7690349|FG002|COMPLETED|Safety Follow-up Period||7
6763839|NCT03675776|7690347|FG000|NOT COMPLETED|Safety Follow-up Period||0
6763840|NCT03675776|7690348|FG001|NOT COMPLETED|Safety Follow-up Period||0
6763841|NCT03675776|7690349|FG002|NOT COMPLETED|Safety Follow-up Period||0
6763842|NCT03676270|7690357|FG000|STARTED|Overall Study||6915
6763843|NCT03676270|7690357|FG000|COMPLETED|Overall Study||6915
6763844|NCT03676270|7690357|FG000|NOT COMPLETED|Overall Study||0
6763845|NCT03676634|7690361|FG000|STARTED|Overall Study||32
6556249|NCT01757392|7478503|FG000|STARTED|Overall Study||39
6556250|NCT01757392|7478503|FG000|COMPLETED|Overall Study||35
6763846|NCT03676634|7690361|FG000|Screening|Overall Study||32
6763847|NCT03676634|7690361|FG000|Participants Received rBV A/B Injection|Overall Study||32
6763848|NCT03676634|7690361|FG000|Participants Included in the Plasma-donating Population|Overall Study||32
6763849|NCT03676634|7690361|FG000|Participants Completed Follow up|Overall Study||32
6763850|NCT03676634|7690361|FG000|COMPLETED|Overall Study||29
6763851|NCT03676634|7690361|FG000|NOT COMPLETED|Overall Study||3
6763852|NCT03676725|7690371|FG000|STARTED|Overall Study||23
6763853|NCT03676725|7690372|FG001|STARTED|Overall Study||14
6763854|NCT03676725|7690373|FG002|STARTED|Overall Study||22
6763855|NCT03676725|7690374|FG003|STARTED|Overall Study||5
6763856|NCT03676725|7690375|FG004|STARTED|Overall Study||15
6763857|NCT03676725|7690376|FG005|STARTED|Overall Study||11
6763858|NCT03676725|7690371|FG000|COMPLETED|Overall Study||23
6763859|NCT03676725|7690372|FG001|COMPLETED|Overall Study||14
6763860|NCT03676725|7690373|FG002|COMPLETED|Overall Study||22
6763861|NCT03676725|7690374|FG003|COMPLETED|Overall Study||5
6763862|NCT03676725|7690375|FG004|COMPLETED|Overall Study||15
6763863|NCT03676725|7690376|FG005|COMPLETED|Overall Study||11
6763864|NCT03676725|7690371|FG000|NOT COMPLETED|Overall Study||0
6763865|NCT03676725|7690372|FG001|NOT COMPLETED|Overall Study||0
6763866|NCT03676725|7690373|FG002|NOT COMPLETED|Overall Study||0
6763867|NCT03676725|7690374|FG003|NOT COMPLETED|Overall Study||0
6763868|NCT03676725|7690375|FG004|NOT COMPLETED|Overall Study||0
6763869|NCT03676725|7690376|FG005|NOT COMPLETED|Overall Study||0
6763870|NCT03676803|7690387|FG000|STARTED|Overall Study||15
6763871|NCT03676803|7690388|FG001|STARTED|Overall Study||16
6763872|NCT03676803|7690387|FG000|COMPLETED|Overall Study||15
6763873|NCT03676803|7690388|FG001|COMPLETED|Overall Study||16
6763874|NCT03676803|7690387|FG000|NOT COMPLETED|Overall Study||0
6763875|NCT03676803|7690388|FG001|NOT COMPLETED|Overall Study||0
6763876|NCT03676972|7690396|FG000|STARTED|Overall Study||60
6763877|NCT03676972|7690396|FG000|COMPLETED|Overall Study||58
6763878|NCT03676972|7690396|FG000|NOT COMPLETED|Overall Study||2
6763879|NCT03677089|7690400|FG000|STARTED|Overall Study||148
6763880|NCT03677089|7690400|FG000|Baseline/Pre-Intervention|Overall Study||137
6763881|NCT03677089|7690400|FG000|Mid-Intervention|Overall Study||120
6763882|NCT03677089|7690400|FG000|Post-Intervention|Overall Study||117
6763883|NCT03677089|7690400|FG000|Follow-Up|Overall Study||114
6763884|NCT03677089|7690400|FG000|COMPLETED|Overall Study||114
6763885|NCT03677089|7690400|FG000|NOT COMPLETED|Overall Study||34
6763886|NCT03677245|7690408|FG000|STARTED|Overall Study||8
6763887|NCT03677245|7690408|FG000|COMPLETED|Overall Study||8
6763888|NCT03677245|7690408|FG000|NOT COMPLETED|Overall Study||0
6763889|NCT03677375|7690413|FG000|STARTED|Overall Study||93
6763890|NCT03677375|7690413|FG000|COMPLETED|Overall Study||81
6763891|NCT03677375|7690413|FG000|NOT COMPLETED|Overall Study||12
6763892|NCT03677401|7690419|FG000|STARTED|Overall Study||148
6763893|NCT03677401|7690420|FG001|STARTED|Overall Study||147
6763894|NCT03677401|7690419|FG000|COMPLETED|Overall Study||138
6763895|NCT03677401|7690420|FG001|COMPLETED|Overall Study||129
6763896|NCT03677401|7690419|FG000|NOT COMPLETED|Overall Study||10
6763897|NCT03677401|7690420|FG001|NOT COMPLETED|Overall Study||18
6763898|NCT03677869|7690426|FG000|STARTED|Overall Study||35
6763899|NCT03677869|7690426|FG000|COMPLETED|Overall Study||34
6763900|NCT03677869|7690426|FG000|NOT COMPLETED|Overall Study||1
6763901|NCT03678103|7690430|FG000|STARTED|Overall Study||30
6763902|NCT03678103|7690430|FG000|COMPLETED|Overall Study||26
6763903|NCT03678103|7690430|FG000|NOT COMPLETED|Overall Study||4
6763904|NCT03678285|7690434|FG000|STARTED|Overall Study||42
6763905|NCT03678285|7690434|FG000|Started Workout|Overall Study||40
6763906|NCT03678285|7690434|FG000|COMPLETED|Overall Study||38
6763907|NCT03678285|7690434|FG000|NOT COMPLETED|Overall Study||4
6763908|NCT03678311|7690438|FG000|STARTED|Overall Study||9
6763909|NCT03678311|7690438|FG000|COMPLETED|Overall Study||9
6763910|NCT03678311|7690438|FG000|NOT COMPLETED|Overall Study||0
6763911|NCT03678870|7690444|FG000|STARTED|Overall Study||97
6763912|NCT03678870|7690445|FG001|STARTED|Overall Study||99
6763913|NCT03678870|7690444|FG000|COMPLETED|Overall Study||84
6763914|NCT03678870|7690445|FG001|COMPLETED|Overall Study||91
6763915|NCT03678870|7690444|FG000|NOT COMPLETED|Overall Study||13
6763916|NCT03678870|7690445|FG001|NOT COMPLETED|Overall Study||8
6763917|NCT03679494|7690453|FG000|STARTED|Overall Study||67
6763918|NCT03679494|7690454|FG001|STARTED|Overall Study||63
6763919|NCT03679494|7690453|FG000|COMPLETED|Overall Study||67
6763920|NCT03679494|7690454|FG001|COMPLETED|Overall Study||63
6763921|NCT03679494|7690453|FG000|NOT COMPLETED|Overall Study||0
6763922|NCT03679494|7690454|FG001|NOT COMPLETED|Overall Study||0
6763923|NCT03679741|7690460|FG000|STARTED|Period 1||59
6763924|NCT03679741|7690461|FG001|STARTED|Period 1||61
6763925|NCT03679741|7690460|FG000|COMPLETED|Period 1||57
6763926|NCT03679741|7690461|FG001|COMPLETED|Period 1||58
6763927|NCT03679741|7690460|FG000|NOT COMPLETED|Period 1||2
6763928|NCT03679741|7690461|FG001|NOT COMPLETED|Period 1||3
6763929|NCT03679741|7690460|FG000|STARTED|Period 2||57
6763930|NCT03679741|7690461|FG001|STARTED|Period 2||58
6763931|NCT03679741|7690460|FG000|COMPLETED|Period 2||54
6763932|NCT03679741|7690461|FG001|COMPLETED|Period 2||56
6763933|NCT03679741|7690460|FG000|NOT COMPLETED|Period 2||3
6763934|NCT03679741|7690461|FG001|NOT COMPLETED|Period 2||2
6763935|NCT03679741|7690460|FG000|STARTED|Period 3||54
6763936|NCT03679741|7690461|FG001|STARTED|Period 3||56
6763937|NCT03679741|7690460|FG000|COMPLETED|Period 3||54
6763938|NCT03679741|7690461|FG001|COMPLETED|Period 3||56
6763939|NCT03679741|7690460|FG000|NOT COMPLETED|Period 3||0
6763940|NCT03679741|7690461|FG001|NOT COMPLETED|Period 3||0
6763941|NCT03679975|7690467|FG000|STARTED|Overall Study||9
6763942|NCT03679975|7690467|FG000|COMPLETED|Overall Study||9
6763943|NCT03679975|7690467|FG000|NOT COMPLETED|Overall Study||0
6763944|NCT03680105|7690480|FG000|STARTED|Overall Study||8
6763945|NCT03680105|7690481|FG001|STARTED|Overall Study||8
6763946|NCT03680105|7690482|FG002|STARTED|Overall Study||8
6763947|NCT03680105|7690483|FG003|STARTED|Overall Study||8
6763948|NCT03680105|7690484|FG004|STARTED|Overall Study||8
6763949|NCT03680105|7690485|FG005|STARTED|Overall Study||12
6763950|NCT03680105|7690486|FG006|STARTED|Overall Study||8
6763951|NCT03680105|7690487|FG007|STARTED|Overall Study||8
6763952|NCT03680105|7690488|FG008|STARTED|Overall Study||8
6763953|NCT03680105|7690480|FG000|COMPLETED|Overall Study||8
6763954|NCT03680105|7690481|FG001|COMPLETED|Overall Study||8
6763955|NCT03680105|7690482|FG002|COMPLETED|Overall Study||8
6763956|NCT03680105|7690483|FG003|COMPLETED|Overall Study||8
6763957|NCT03680105|7690484|FG004|COMPLETED|Overall Study||8
6763958|NCT03680105|7690485|FG005|COMPLETED|Overall Study||12
6763959|NCT03680105|7690486|FG006|COMPLETED|Overall Study||8
6763960|NCT03680105|7690487|FG007|COMPLETED|Overall Study||8
6763961|NCT03680105|7690488|FG008|COMPLETED|Overall Study||8
6763962|NCT03680105|7690480|FG000|NOT COMPLETED|Overall Study||0
6763963|NCT03680105|7690481|FG001|NOT COMPLETED|Overall Study||0
6763964|NCT03680105|7690482|FG002|NOT COMPLETED|Overall Study||0
6763965|NCT03680105|7690483|FG003|NOT COMPLETED|Overall Study||0
6763966|NCT03680105|7690484|FG004|NOT COMPLETED|Overall Study||0
6763967|NCT03680105|7690485|FG005|NOT COMPLETED|Overall Study||0
6763968|NCT03680105|7690486|FG006|NOT COMPLETED|Overall Study||0
6763969|NCT03680105|7690487|FG007|NOT COMPLETED|Overall Study||0
6763970|NCT03680105|7690488|FG008|NOT COMPLETED|Overall Study||0
6763971|NCT03680521|7690514|FG000|STARTED|Overall Study||7
6763972|NCT03680521|7690515|FG001|STARTED|Overall Study||13
6763973|NCT03680521|7690514|FG000|COMPLETED|Overall Study||0
6763974|NCT03680521|7690515|FG001|COMPLETED|Overall Study||2
6763975|NCT03680521|7690514|FG000|NOT COMPLETED|Overall Study||7
6763976|NCT03680521|7690515|FG001|NOT COMPLETED|Overall Study||11
6763977|NCT03680742|7690524|FG000|STARTED|Overall Study||34
6763978|NCT03680742|7690524|FG000|COMPLETED|Overall Study||32
6763979|NCT03680742|7690524|FG000|NOT COMPLETED|Overall Study||2
6763980|NCT03681093|7690531|FG000|STARTED|Overall Study||32
6763981|NCT03681093|7690532|FG001|STARTED|Overall Study||34
6763982|NCT03681093|7690533|FG002|STARTED|Overall Study||32
6763983|NCT03681093|7690531|FG000|Full Analysis Set (FAS)|Overall Study||31
6763984|NCT03681093|7690532|FG001|Full Analysis Set (FAS)|Overall Study||32
6763985|NCT03681093|7690533|FG002|Full Analysis Set (FAS)|Overall Study||28
6763986|NCT03681093|7690531|FG000|Safety Analysis Set (SAF)|Overall Study||32
6763987|NCT03681093|7690532|FG001|Safety Analysis Set (SAF)|Overall Study||34
6763988|NCT03681093|7690533|FG002|Safety Analysis Set (SAF)|Overall Study||32
6763989|NCT03681093|7690531|FG000|COMPLETED|Overall Study||32
6763990|NCT03681093|7690532|FG001|COMPLETED|Overall Study||32
6763991|NCT03681093|7690533|FG002|COMPLETED|Overall Study||31
6763992|NCT03681093|7690531|FG000|NOT COMPLETED|Overall Study||0
6763993|NCT03681093|7690532|FG001|NOT COMPLETED|Overall Study||2
6763994|NCT03681093|7690533|FG002|NOT COMPLETED|Overall Study||1
6763995|NCT03681119|7690543|FG000|STARTED|Overall Study||72
6763996|NCT03681119|7690544|FG001|STARTED|Overall Study||11
6763997|NCT03681119|7690543|FG000|COMPLETED|Overall Study||66
6763998|NCT03681119|7690544|FG001|COMPLETED|Overall Study||11
6763999|NCT03681119|7690543|FG000|NOT COMPLETED|Overall Study||6
6764000|NCT03681119|7690544|FG001|NOT COMPLETED|Overall Study||0
6764001|NCT03681353|7690548|FG000|STARTED|Overall Study||25
6764002|NCT03681353|7690548|FG000|COMPLETED|Overall Study||18
6764003|NCT03681353|7690548|FG000|NOT COMPLETED|Overall Study||7
6764004|NCT03681405|7690554|FG000|STARTED|Overall Study||14
6764005|NCT03681405|7690555|FG001|STARTED|Overall Study||17
6764006|NCT03681405|7690554|FG000|COMPLETED|Overall Study||13
6764007|NCT03681405|7690555|FG001|COMPLETED|Overall Study||17
6764008|NCT03681405|7690554|FG000|NOT COMPLETED|Overall Study||1
6764009|NCT03681405|7690555|FG001|NOT COMPLETED|Overall Study||0
6764010|NCT03681808|7690565|FG000|STARTED|Overall Study||123
6764011|NCT03681808|7690566|FG001|STARTED|Overall Study||119
6764012|NCT03681808|7690565|FG000|COMPLETED|Overall Study||109
6764013|NCT03681808|7690566|FG001|COMPLETED|Overall Study||102
6764014|NCT03681808|7690565|FG000|NOT COMPLETED|Overall Study||14
6764015|NCT03681808|7690566|FG001|NOT COMPLETED|Overall Study||17
6780247|NCT03212144|7708639|FG000|COMPLETED|First Sequence (4 Weeks)||1
6780248|NCT03212144|7708640|FG001|COMPLETED|First Sequence (4 Weeks)||1
6780249|NCT03212144|7708639|FG000|NOT COMPLETED|First Sequence (4 Weeks)||1
6780250|NCT03212144|7708640|FG001|NOT COMPLETED|First Sequence (4 Weeks)||0
6780251|NCT03212144|7708639|FG000|STARTED|Washout (4 Weeks)||1
6780252|NCT03212144|7708640|FG001|STARTED|Washout (4 Weeks)||1
6780253|NCT03212144|7708639|FG000|COMPLETED|Washout (4 Weeks)||1
6780254|NCT03212144|7708640|FG001|COMPLETED|Washout (4 Weeks)||1
6780255|NCT03212144|7708639|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6780256|NCT03212144|7708640|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6780257|NCT03212144|7708639|FG000|STARTED|Second Sequence (4 Weeks)||1
6780258|NCT03212144|7708640|FG001|STARTED|Second Sequence (4 Weeks)||1
6780259|NCT03212144|7708639|FG000|COMPLETED|Second Sequence (4 Weeks)||0
6764016|NCT03681886|7690572|FG000|STARTED|Overall Study||78
6764017|NCT03681886|7690572|FG000|Successful Implantation|Overall Study||76
6764018|NCT03681886|7690572|FG000|Failed Implantation|Overall Study||2
6764019|NCT03681886|7690572|FG000|Underwent Optic Exchange|Overall Study||4
6764020|NCT03681886|7690572|FG000|COMPLETED|Overall Study||76
6764021|NCT03681886|7690572|FG000|NOT COMPLETED|Overall Study||2
6764022|NCT03681951|7690601|FG000|STARTED|Part1: Monotherapy DE (Up to Day 95)||8
6764023|NCT03681951|7690602|FG001|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
6764024|NCT03681951|7690603|FG002|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID."|0
6764025|NCT03681951|7690604|FG003|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
6764026|NCT03681951|7690605|FG004|STARTED|Part1: Monotherapy DE (Up to Day 95)|"No participant was enrolled in this arm as study was terminated during cohort GSK3145095 50mg BID"|0
6764027|NCT03681951|7690606|FG005|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 2 was not initiated as this study was terminated during Part 1|0
6764028|NCT03681951|7690607|FG006|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 3 was not initiated as this study was terminated during Part 1|0
6764029|NCT03681951|7690608|FG007|STARTED|Part1: Monotherapy DE (Up to Day 95)|Part 4 was not initiated as this study was terminated during Part 1|0
6764030|NCT03681951|7690601|FG000|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764031|NCT03681951|7690602|FG001|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764032|NCT03681951|7690603|FG002|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764033|NCT03681951|7690604|FG003|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764034|NCT03681951|7690605|FG004|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764035|NCT03681951|7690606|FG005|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764036|NCT03681951|7690607|FG006|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764037|NCT03681951|7690608|FG007|COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764038|NCT03681951|7690601|FG000|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||8
6764039|NCT03681951|7690602|FG001|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764040|NCT03681951|7690603|FG002|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764041|NCT03681951|7690604|FG003|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764042|NCT03681951|7690605|FG004|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764043|NCT03681951|7690606|FG005|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764044|NCT03681951|7690607|FG006|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764045|NCT03681951|7690608|FG007|NOT COMPLETED|Part1: Monotherapy DE (Up to Day 95)||0
6764046|NCT03681951|7690601|FG000|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6764047|NCT03681951|7690602|FG001|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6764048|NCT03681951|7690603|FG002|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6764049|NCT03681951|7690604|FG003|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6764050|NCT03681951|7690605|FG004|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6764051|NCT03681951|7690606|FG005|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6764052|NCT03681951|7690607|FG006|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6764053|NCT03681951|7690608|FG007|STARTED|Part2:Combination Therapy(Upto 2yr90day)||0
6764054|NCT03681951|7690601|FG000|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764055|NCT03681951|7690602|FG001|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764056|NCT03681951|7690603|FG002|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764057|NCT03681951|7690604|FG003|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764058|NCT03681951|7690605|FG004|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764059|NCT03681951|7690606|FG005|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764060|NCT03681951|7690607|FG006|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764061|NCT03681951|7690608|FG007|COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764062|NCT03681951|7690601|FG000|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764063|NCT03681951|7690602|FG001|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764064|NCT03681951|7690603|FG002|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764065|NCT03681951|7690604|FG003|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764066|NCT03681951|7690605|FG004|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764067|NCT03681951|7690606|FG005|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764068|NCT03681951|7690607|FG006|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764069|NCT03681951|7690608|FG007|NOT COMPLETED|Part2:Combination Therapy(Upto 2yr90day)||0
6764070|NCT03681951|7690601|FG000|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764071|NCT03681951|7690602|FG001|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764072|NCT03681951|7690603|FG002|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764073|NCT03681951|7690604|FG003|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764074|NCT03681951|7690605|FG004|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764075|NCT03681951|7690606|FG005|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764076|NCT03681951|7690607|FG006|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764077|NCT03681951|7690608|FG007|STARTED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764078|NCT03681951|7690601|FG000|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764079|NCT03681951|7690602|FG001|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764080|NCT03681951|7690603|FG002|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764081|NCT03681951|7690604|FG003|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764082|NCT03681951|7690605|FG004|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764083|NCT03681951|7690606|FG005|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764084|NCT03681951|7690607|FG006|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764085|NCT03681951|7690608|FG007|COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764086|NCT03681951|7690601|FG000|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764087|NCT03681951|7690602|FG001|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764088|NCT03681951|7690603|FG002|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764089|NCT03681951|7690604|FG003|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764090|NCT03681951|7690605|FG004|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764091|NCT03681951|7690606|FG005|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764092|NCT03681951|7690607|FG006|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764093|NCT03681951|7690608|FG007|NOT COMPLETED|Part 3:Dose Expansion (Up to 2yr90day)||0
6764094|NCT03681951|7690601|FG000|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764095|NCT03681951|7690602|FG001|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764096|NCT03681951|7690603|FG002|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764097|NCT03681951|7690604|FG003|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764098|NCT03681951|7690605|FG004|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764099|NCT03681951|7690606|FG005|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764100|NCT03681951|7690607|FG006|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764101|NCT03681951|7690608|FG007|STARTED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764102|NCT03681951|7690601|FG000|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764103|NCT03681951|7690602|FG001|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764104|NCT03681951|7690603|FG002|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764105|NCT03681951|7690604|FG003|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764106|NCT03681951|7690605|FG004|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764107|NCT03681951|7690606|FG005|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764108|NCT03681951|7690607|FG006|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764109|NCT03681951|7690608|FG007|COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764110|NCT03681951|7690601|FG000|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764111|NCT03681951|7690602|FG001|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764112|NCT03681951|7690603|FG002|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764113|NCT03681951|7690604|FG003|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764114|NCT03681951|7690605|FG004|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764115|NCT03681951|7690606|FG005|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764116|NCT03681951|7690607|FG006|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764117|NCT03681951|7690608|FG007|NOT COMPLETED|Part 4: Dose Expansion(Up to 2 yr90day)||0
6764118|NCT03682107|7690636|FG000|STARTED|Overall Study||10
6764119|NCT03682107|7690637|FG001|STARTED|Overall Study||10
6764120|NCT03682107|7690638|FG002|STARTED|Overall Study||10
6764121|NCT03682107|7690639|FG003|STARTED|Overall Study||10
6764122|NCT03682107|7690640|FG004|STARTED|Overall Study||8
6764123|NCT03682107|7690636|FG000|COMPLETED|Overall Study||10
6764124|NCT03682107|7690637|FG001|COMPLETED|Overall Study||9
6764125|NCT03682107|7690638|FG002|COMPLETED|Overall Study||10
6764126|NCT03682107|7690639|FG003|COMPLETED|Overall Study||10
6764127|NCT03682107|7690640|FG004|COMPLETED|Overall Study||8
6764128|NCT03682107|7690636|FG000|NOT COMPLETED|Overall Study||0
6764129|NCT03682107|7690637|FG001|NOT COMPLETED|Overall Study||1
6764130|NCT03682107|7690638|FG002|NOT COMPLETED|Overall Study||0
6764131|NCT03682107|7690639|FG003|NOT COMPLETED|Overall Study||0
6764132|NCT03682107|7690640|FG004|NOT COMPLETED|Overall Study||0
6764133|NCT03682120|7690656|FG000|STARTED|Overall Study||105
6764134|NCT03682120|7690657|FG001|STARTED|Overall Study||105
6764135|NCT03682120|7690658|FG002|STARTED|Overall Study||105
6764136|NCT03682120|7690659|FG003|STARTED|Overall Study||57
6764137|NCT03682120|7690656|FG000|COMPLETED|Overall Study||92
6764138|NCT03682120|7690657|FG001|COMPLETED|Overall Study||97
6764139|NCT03682120|7690658|FG002|COMPLETED|Overall Study||97
6764140|NCT03682120|7690659|FG003|COMPLETED|Overall Study||55
6764141|NCT03682120|7690656|FG000|NOT COMPLETED|Overall Study||13
6764142|NCT03682120|7690657|FG001|NOT COMPLETED|Overall Study||8
6764143|NCT03682120|7690658|FG002|NOT COMPLETED|Overall Study||8
6764144|NCT03682120|7690659|FG003|NOT COMPLETED|Overall Study||2
6764145|NCT03682302|7690675|FG000|STARTED|Overall Study||31
6764146|NCT03682302|7690676|FG001|STARTED|Overall Study||30
6764147|NCT03682302|7690677|FG002|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|6
6764148|NCT03682302|7690678|FG003|STARTED|Overall Study|1 subject enrolled in Group 2, not treated, and surgery type unknown. Subject is not counted here.|30
6764149|NCT03682302|7690675|FG000|COMPLETED|Overall Study||30
6764150|NCT03682302|7690676|FG001|COMPLETED|Overall Study||28
6764151|NCT03682302|7690677|FG002|COMPLETED|Overall Study||5
6764152|NCT03682302|7690678|FG003|COMPLETED|Overall Study||28
6764153|NCT03682302|7690675|FG000|NOT COMPLETED|Overall Study||1
6764154|NCT03682302|7690676|FG001|NOT COMPLETED|Overall Study||2
6764155|NCT03682302|7690677|FG002|NOT COMPLETED|Overall Study||1
6764156|NCT03682302|7690678|FG003|NOT COMPLETED|Overall Study||2
6764157|NCT03682705|7690694|FG000|STARTED|Overall Study||19
6764158|NCT03682705|7690695|FG001|STARTED|Overall Study||62
6764159|NCT03682705|7690696|FG002|STARTED|Overall Study||41
6764160|NCT03682705|7690697|FG003|STARTED|Overall Study||39
6764161|NCT03682705|7690698|FG004|STARTED|Overall Study||41
6764162|NCT03682705|7690699|FG005|STARTED|Overall Study||40
6764163|NCT03682705|7690694|FG000|COMPLETED|Overall Study||17
6764164|NCT03682705|7690695|FG001|COMPLETED|Overall Study||58
6764165|NCT03682705|7690696|FG002|COMPLETED|Overall Study||38
6764166|NCT03682705|7690697|FG003|COMPLETED|Overall Study||34
6764167|NCT03682705|7690698|FG004|COMPLETED|Overall Study||35
6764168|NCT03682705|7690699|FG005|COMPLETED|Overall Study||38
6764169|NCT03682705|7690694|FG000|NOT COMPLETED|Overall Study||2
6764170|NCT03682705|7690695|FG001|NOT COMPLETED|Overall Study||4
6764171|NCT03682705|7690696|FG002|NOT COMPLETED|Overall Study||3
6764172|NCT03682705|7690697|FG003|NOT COMPLETED|Overall Study||5
6764173|NCT03682705|7690698|FG004|NOT COMPLETED|Overall Study||6
6764174|NCT03682705|7690699|FG005|NOT COMPLETED|Overall Study||2
6764175|NCT03682809|7690715|FG000|STARTED|Overall Study||22
6764176|NCT03682809|7690716|FG001|STARTED|Overall Study||24
6764177|NCT03682809|7690715|FG000|COMPLETED|Overall Study||22
6764178|NCT03682809|7690716|FG001|COMPLETED|Overall Study||24
6764179|NCT03682809|7690715|FG000|NOT COMPLETED|Overall Study||0
6764180|NCT03682809|7690716|FG001|NOT COMPLETED|Overall Study||0
6764181|NCT03682965|7690724|FG000|STARTED|Overall Study||11
6764182|NCT03682965|7690725|FG001|STARTED|Overall Study||10
6764183|NCT03682965|7690724|FG000|COMPLETED|Overall Study||11
6764184|NCT03682965|7690725|FG001|COMPLETED|Overall Study||10
6764185|NCT03682965|7690724|FG000|NOT COMPLETED|Overall Study||0
6764186|NCT03682965|7690725|FG001|NOT COMPLETED|Overall Study||0
6764187|NCT03683576|7690735|FG000|STARTED|Overall Study||120
6764188|NCT03683576|7690736|FG001|STARTED|Overall Study||120
6764189|NCT03683576|7690737|FG002|STARTED|Overall Study||118
6764190|NCT03683576|7690738|FG003|STARTED|Overall Study||122
6764191|NCT03683576|7690735|FG000|COMPLETED|Overall Study||114
6764192|NCT03683576|7690736|FG001|COMPLETED|Overall Study||116
6764193|NCT03683576|7690737|FG002|COMPLETED|Overall Study||106
6764194|NCT03683576|7690738|FG003|COMPLETED|Overall Study||114
6764195|NCT03683576|7690735|FG000|NOT COMPLETED|Overall Study||6
6764196|NCT03683576|7690736|FG001|NOT COMPLETED|Overall Study||4
6764197|NCT03683576|7690737|FG002|NOT COMPLETED|Overall Study||12
6764198|NCT03683576|7690738|FG003|NOT COMPLETED|Overall Study||8
6764199|NCT03683719|7690753|FG000|STARTED|Overall Study||52
6764200|NCT03683719|7690754|FG001|STARTED|Overall Study||51
6764201|NCT03683719|7690755|FG002|STARTED|Overall Study||52
6764202|NCT03683719|7690756|FG003|STARTED|Overall Study||53
6764203|NCT03683719|7690757|FG004|STARTED|Overall Study||50
6764204|NCT03683719|7690753|FG000|COMPLETED|Overall Study||40
6764205|NCT03683719|7690754|FG001|COMPLETED|Overall Study||38
6764206|NCT03683719|7690755|FG002|COMPLETED|Overall Study||44
6764207|NCT03683719|7690756|FG003|COMPLETED|Overall Study||46
6764208|NCT03683719|7690757|FG004|COMPLETED|Overall Study||36
6764209|NCT03683719|7690753|FG000|NOT COMPLETED|Overall Study||12
6764210|NCT03683719|7690754|FG001|NOT COMPLETED|Overall Study||13
6764211|NCT03683719|7690755|FG002|NOT COMPLETED|Overall Study||8
6764212|NCT03683719|7690756|FG003|NOT COMPLETED|Overall Study||7
6764213|NCT03683719|7690757|FG004|NOT COMPLETED|Overall Study||14
6764214|NCT03683758|7690771|FG000|STARTED|Overall Study||11
6764215|NCT03683758|7690772|FG001|STARTED|Overall Study||10
6764216|NCT03683758|7690771|FG000|COMPLETED|Overall Study||8
6764217|NCT03683758|7690772|FG001|COMPLETED|Overall Study||7
6764218|NCT03683758|7690771|FG000|NOT COMPLETED|Overall Study||3
6764219|NCT03683758|7690772|FG001|NOT COMPLETED|Overall Study||3
6764220|NCT03683901|7690778|FG000|STARTED|Overall Study||10
6764221|NCT03683901|7690778|FG000|COMPLETED|Overall Study||10
6764222|NCT03683901|7690778|FG000|NOT COMPLETED|Overall Study||0
6764223|NCT03684044|7690786|FG000|STARTED|Overall Study||239
6764224|NCT03684044|7690787|FG001|STARTED|Overall Study||124
6764225|NCT03684044|7690786|FG000|COMPLETED|Overall Study||217
6764226|NCT03684044|7690787|FG001|COMPLETED|Overall Study||104
6764227|NCT03684044|7690786|FG000|NOT COMPLETED|Overall Study||22
6764228|NCT03684044|7690787|FG001|NOT COMPLETED|Overall Study||20
6764229|NCT03684265|7690795|FG000|STARTED|Treatment Period 1||13
6764230|NCT03684265|7690796|FG001|STARTED|Treatment Period 1||13
6764231|NCT03684265|7690795|FG000|COMPLETED|Treatment Period 1||13
6764232|NCT03684265|7690796|FG001|COMPLETED|Treatment Period 1||13
6764233|NCT03684265|7690795|FG000|NOT COMPLETED|Treatment Period 1||0
6764234|NCT03684265|7690796|FG001|NOT COMPLETED|Treatment Period 1||0
6764235|NCT03684265|7690795|FG000|STARTED|Washout Period of 1 Week||13
6764236|NCT03684265|7690796|FG001|STARTED|Washout Period of 1 Week||13
6764237|NCT03684265|7690795|FG000|COMPLETED|Washout Period of 1 Week||13
6764238|NCT03684265|7690796|FG001|COMPLETED|Washout Period of 1 Week||13
6764239|NCT03684265|7690795|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6764240|NCT03684265|7690796|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6764241|NCT03684265|7690795|FG000|STARTED|Treatment Period 2||13
6764242|NCT03684265|7690796|FG001|STARTED|Treatment Period 2||13
6764243|NCT03684265|7690795|FG000|COMPLETED|Treatment Period 2||13
6764244|NCT03684265|7690796|FG001|COMPLETED|Treatment Period 2||13
6764245|NCT03684265|7690795|FG000|NOT COMPLETED|Treatment Period 2||0
6764246|NCT03684265|7690796|FG001|NOT COMPLETED|Treatment Period 2||0
6764247|NCT03684642|7690805|FG000|STARTED|Overall Study||303
6764248|NCT03684642|7690806|FG001|STARTED|Overall Study||302
6764249|NCT03684642|7690807|FG002|STARTED|Overall Study||303
6764250|NCT03684642|7690805|FG000|Treated|Overall Study||303
6764251|NCT03684642|7690806|FG001|Treated|Overall Study||302
6764252|NCT03684642|7690807|FG002|Treated|Overall Study||302
6764253|NCT03684642|7690805|FG000|Safety Population|Overall Study|For safety analysis participants are included in the treatment group that they are exposed for longer duration. 10 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration, and considered in the Efpeglenatide 4 mg group for safety analysis.|313
6764254|NCT03684642|7690806|FG001|Safety Population|Overall Study||292
6764255|NCT03684642|7690807|FG002|Safety Population|Overall Study||302
6764256|NCT03684642|7690805|FG000|COMPLETED|Overall Study||200
6764257|NCT03684642|7690806|FG001|COMPLETED|Overall Study||169
6764258|NCT03684642|7690807|FG002|COMPLETED|Overall Study||197
6764259|NCT03684642|7690805|FG000|NOT COMPLETED|Overall Study||103
6764260|NCT03684642|7690806|FG001|NOT COMPLETED|Overall Study||133
6764261|NCT03684642|7690807|FG002|NOT COMPLETED|Overall Study||106
6764262|NCT03684928|7690815|FG000|STARTED|First Intervention||23
6764263|NCT03684928|7690816|FG001|STARTED|First Intervention||22
6764264|NCT03684928|7690815|FG000|COMPLETED|First Intervention||23
6764265|NCT03684928|7690816|FG001|COMPLETED|First Intervention||19
6764266|NCT03684928|7690815|FG000|NOT COMPLETED|First Intervention||0
6764267|NCT03684928|7690816|FG001|NOT COMPLETED|First Intervention||3
6764268|NCT03684928|7690815|FG000|STARTED|Second Intervention|Two participants discontinued between the first intervention and second intervention.|21
6764269|NCT03684928|7690816|FG001|STARTED|Second Intervention||19
6764270|NCT03684928|7690815|FG000|COMPLETED|Second Intervention||20
6764271|NCT03684928|7690816|FG001|COMPLETED|Second Intervention||19
6764272|NCT03684928|7690815|FG000|NOT COMPLETED|Second Intervention||1
6764273|NCT03684928|7690816|FG001|NOT COMPLETED|Second Intervention||0
6764274|NCT03685344|7690826|FG000|STARTED|Overall Study||3
6764275|NCT03685344|7690827|FG001|STARTED|Overall Study||3
6764276|NCT03685344|7690828|FG002|STARTED|Overall Study||7
6764277|NCT03685344|7690829|FG003|STARTED|Overall Study||0
6764278|NCT03685344|7690826|FG000|Received Treatment|Overall Study||3
6764279|NCT03685344|7690827|FG001|Received Treatment|Overall Study||3
6764280|NCT03685344|7690828|FG002|Received Treatment|Overall Study||7
6764281|NCT03685344|7690829|FG003|Received Treatment|Overall Study||0
6764282|NCT03685344|7690826|FG000|COMPLETED|Overall Study||0
6764283|NCT03685344|7690827|FG001|COMPLETED|Overall Study||0
6764284|NCT03685344|7690828|FG002|COMPLETED|Overall Study||0
6764285|NCT03685344|7690829|FG003|COMPLETED|Overall Study||0
6764286|NCT03685344|7690826|FG000|NOT COMPLETED|Overall Study||3
6764287|NCT03685344|7690827|FG001|NOT COMPLETED|Overall Study||3
6764288|NCT03685344|7690828|FG002|NOT COMPLETED|Overall Study||7
6764289|NCT03685344|7690829|FG003|NOT COMPLETED|Overall Study||0
6764290|NCT03685396|7690841|FG000|STARTED|Overall Study||21
6764291|NCT03685396|7690842|FG001|STARTED|Overall Study||21
6764292|NCT03685396|7690841|FG000|COMPLETED|Overall Study||21
6764293|NCT03685396|7690842|FG001|COMPLETED|Overall Study||21
6764294|NCT03685396|7690841|FG000|NOT COMPLETED|Overall Study||0
6764295|NCT03685396|7690842|FG001|NOT COMPLETED|Overall Study||0
6764296|NCT03685643|7690850|FG000|STARTED|Overall Study||290
6764297|NCT03685643|7690851|FG001|STARTED|Overall Study||288
6764298|NCT03685643|7690850|FG000|COMPLETED|Overall Study||276
6764299|NCT03685643|7690851|FG001|COMPLETED|Overall Study||266
6764300|NCT03685643|7690850|FG000|NOT COMPLETED|Overall Study||14
6764301|NCT03685643|7690851|FG001|NOT COMPLETED|Overall Study||22
6764302|NCT03685968|7690860|FG000|STARTED|Overall Study||75
6764303|NCT03685968|7690861|FG001|STARTED|Overall Study||75
6764304|NCT03685968|7690862|FG002|STARTED|Overall Study||75
6764305|NCT03685968|7690860|FG000|COMPLETED|Overall Study||75
6764306|NCT03685968|7690861|FG001|COMPLETED|Overall Study||75
6764307|NCT03685968|7690862|FG002|COMPLETED|Overall Study||75
6764308|NCT03685968|7690860|FG000|NOT COMPLETED|Overall Study||0
6764309|NCT03685968|7690861|FG001|NOT COMPLETED|Overall Study||0
6764310|NCT03685968|7690862|FG002|NOT COMPLETED|Overall Study||0
6764311|NCT03686033|7690870|FG000|STARTED|Treatment Period 1 (1 Day)||1
6764312|NCT03686033|7690871|FG001|STARTED|Treatment Period 1 (1 Day)||1
6764313|NCT03686033|7690872|FG002|STARTED|Treatment Period 1 (1 Day)||1
6764314|NCT03686033|7690873|FG003|STARTED|Treatment Period 1 (1 Day)||1
6764315|NCT03686033|7690874|FG004|STARTED|Treatment Period 1 (1 Day)||1
6764316|NCT03686033|7690875|FG005|STARTED|Treatment Period 1 (1 Day)||0
6764317|NCT03686033|7690870|FG000|COMPLETED|Treatment Period 1 (1 Day)||1
6764318|NCT03686033|7690871|FG001|COMPLETED|Treatment Period 1 (1 Day)||1
6764319|NCT03686033|7690872|FG002|COMPLETED|Treatment Period 1 (1 Day)||1
6764320|NCT03686033|7690873|FG003|COMPLETED|Treatment Period 1 (1 Day)||1
6764321|NCT03686033|7690874|FG004|COMPLETED|Treatment Period 1 (1 Day)||1
6764322|NCT03686033|7690875|FG005|COMPLETED|Treatment Period 1 (1 Day)||0
6764323|NCT03686033|7690870|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6764324|NCT03686033|7690871|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6764325|NCT03686033|7690872|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6764326|NCT03686033|7690873|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6764327|NCT03686033|7690874|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6764328|NCT03686033|7690875|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6764329|NCT03686033|7690870|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
6764330|NCT03686033|7690871|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
6764331|NCT03686033|7690872|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
6764332|NCT03686033|7690873|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
6764333|NCT03686033|7690874|FG004|STARTED|Washout Phase (at Least 2 Weeks)||1
6764334|NCT03686033|7690875|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
6764335|NCT03686033|7690870|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764336|NCT03686033|7690871|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764337|NCT03686033|7690872|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764338|NCT03686033|7690873|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764339|NCT03686033|7690874|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764340|NCT03686033|7690875|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764341|NCT03686033|7690870|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764342|NCT03686033|7690871|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764343|NCT03686033|7690872|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764344|NCT03686033|7690873|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764345|NCT03686033|7690874|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764346|NCT03686033|7690875|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764347|NCT03686033|7690870|FG000|STARTED|Treatment Period 2 (1 Day)||1
6764348|NCT03686033|7690871|FG001|STARTED|Treatment Period 2 (1 Day)||1
6764349|NCT03686033|7690872|FG002|STARTED|Treatment Period 2 (1 Day)||1
6764350|NCT03686033|7690873|FG003|STARTED|Treatment Period 2 (1 Day)||1
6764351|NCT03686033|7690874|FG004|STARTED|Treatment Period 2 (1 Day)||1
6764352|NCT03686033|7690875|FG005|STARTED|Treatment Period 2 (1 Day)||0
6764353|NCT03686033|7690870|FG000|COMPLETED|Treatment Period 2 (1 Day)||1
6764354|NCT03686033|7690871|FG001|COMPLETED|Treatment Period 2 (1 Day)||1
6764355|NCT03686033|7690872|FG002|COMPLETED|Treatment Period 2 (1 Day)||1
6764356|NCT03686033|7690873|FG003|COMPLETED|Treatment Period 2 (1 Day)||1
6764357|NCT03686033|7690874|FG004|COMPLETED|Treatment Period 2 (1 Day)||0
6764358|NCT03686033|7690875|FG005|COMPLETED|Treatment Period 2 (1 Day)||0
6764359|NCT03686033|7690870|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6764360|NCT03686033|7690871|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6764361|NCT03686033|7690872|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6764362|NCT03686033|7690873|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6764363|NCT03686033|7690874|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||1
6764364|NCT03686033|7690875|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6764365|NCT03686033|7690870|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
6764366|NCT03686033|7690871|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
6764367|NCT03686033|7690872|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
6764368|NCT03686033|7690873|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
6764369|NCT03686033|7690874|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
6764370|NCT03686033|7690875|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
6764371|NCT03686033|7690870|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764372|NCT03686033|7690871|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764373|NCT03686033|7690872|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764374|NCT03686033|7690873|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764375|NCT03686033|7690874|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764376|NCT03686033|7690875|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764377|NCT03686033|7690870|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764378|NCT03686033|7690871|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764379|NCT03686033|7690872|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764380|NCT03686033|7690873|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764381|NCT03686033|7690874|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764382|NCT03686033|7690875|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764383|NCT03686033|7690870|FG000|STARTED|Treatment Period 3 (1 Day)||1
6764384|NCT03686033|7690871|FG001|STARTED|Treatment Period 3 (1 Day)||1
6764385|NCT03686033|7690872|FG002|STARTED|Treatment Period 3 (1 Day)||1
6764386|NCT03686033|7690873|FG003|STARTED|Treatment Period 3 (1 Day)||1
6764387|NCT03686033|7690874|FG004|STARTED|Treatment Period 3 (1 Day)||0
6764388|NCT03686033|7690875|FG005|STARTED|Treatment Period 3 (1 Day)||0
6764389|NCT03686033|7690870|FG000|COMPLETED|Treatment Period 3 (1 Day)||1
6764390|NCT03686033|7690871|FG001|COMPLETED|Treatment Period 3 (1 Day)||1
6764391|NCT03686033|7690872|FG002|COMPLETED|Treatment Period 3 (1 Day)||1
6764392|NCT03686033|7690873|FG003|COMPLETED|Treatment Period 3 (1 Day)||1
6764393|NCT03686033|7690874|FG004|COMPLETED|Treatment Period 3 (1 Day)||0
6764394|NCT03686033|7690875|FG005|COMPLETED|Treatment Period 3 (1 Day)||0
6764395|NCT03686033|7690870|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6764396|NCT03686033|7690871|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6764397|NCT03686033|7690872|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6764398|NCT03686033|7690873|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6764399|NCT03686033|7690874|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6764400|NCT03686033|7690875|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6764401|NCT03686033|7690870|FG000|STARTED|Washout Phase (at Least 2 Weeks)||1
6764402|NCT03686033|7690871|FG001|STARTED|Washout Phase (at Least 2 Weeks)||1
6764403|NCT03686033|7690872|FG002|STARTED|Washout Phase (at Least 2 Weeks)||1
6764404|NCT03686033|7690873|FG003|STARTED|Washout Phase (at Least 2 Weeks)||1
6764405|NCT03686033|7690874|FG004|STARTED|Washout Phase (at Least 2 Weeks)||0
6764406|NCT03686033|7690875|FG005|STARTED|Washout Phase (at Least 2 Weeks)||0
6764407|NCT03686033|7690870|FG000|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764408|NCT03686033|7690871|FG001|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764409|NCT03686033|7690872|FG002|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764410|NCT03686033|7690873|FG003|COMPLETED|Washout Phase (at Least 2 Weeks)||1
6764411|NCT03686033|7690874|FG004|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764412|NCT03686033|7690875|FG005|COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764413|NCT03686033|7690870|FG000|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764414|NCT03686033|7690871|FG001|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764415|NCT03686033|7690872|FG002|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764416|NCT03686033|7690873|FG003|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764417|NCT03686033|7690874|FG004|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764418|NCT03686033|7690875|FG005|NOT COMPLETED|Washout Phase (at Least 2 Weeks)||0
6764419|NCT03686033|7690870|FG000|STARTED|Treatment Period 4 (1 Day)||1
6764420|NCT03686033|7690871|FG001|STARTED|Treatment Period 4 (1 Day)||1
6764421|NCT03686033|7690872|FG002|STARTED|Treatment Period 4 (1 Day)||1
6764422|NCT03686033|7690873|FG003|STARTED|Treatment Period 4 (1 Day)||1
6764423|NCT03686033|7690874|FG004|STARTED|Treatment Period 4 (1 Day)||0
6764424|NCT03686033|7690875|FG005|STARTED|Treatment Period 4 (1 Day)||0
6764425|NCT03686033|7690870|FG000|COMPLETED|Treatment Period 4 (1 Day)||1
6764426|NCT03686033|7690871|FG001|COMPLETED|Treatment Period 4 (1 Day)||1
6764427|NCT03686033|7690872|FG002|COMPLETED|Treatment Period 4 (1 Day)||1
6764428|NCT03686033|7690873|FG003|COMPLETED|Treatment Period 4 (1 Day)||1
6764429|NCT03686033|7690874|FG004|COMPLETED|Treatment Period 4 (1 Day)||0
6764430|NCT03686033|7690875|FG005|COMPLETED|Treatment Period 4 (1 Day)||0
6764431|NCT03686033|7690870|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6764432|NCT03686033|7690871|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6764433|NCT03686033|7690872|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6764434|NCT03686033|7690873|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6764435|NCT03686033|7690874|FG004|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6764436|NCT03686033|7690875|FG005|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6764437|NCT03686176|7690892|FG000|STARTED|Overall Study||19
6764438|NCT03686176|7690893|FG001|STARTED|Overall Study||25
6764439|NCT03686176|7690894|FG002|STARTED|Overall Study||20
6764440|NCT03686176|7690892|FG000|COMPLETED|Overall Study||17
6764441|NCT03686176|7690893|FG001|COMPLETED|Overall Study||25
6764442|NCT03686176|7690894|FG002|COMPLETED|Overall Study||20
6764443|NCT03686176|7690892|FG000|NOT COMPLETED|Overall Study||2
6764444|NCT03686176|7690893|FG001|NOT COMPLETED|Overall Study||0
6764445|NCT03686176|7690894|FG002|NOT COMPLETED|Overall Study||0
6764446|NCT03687125|7690904|FG000|STARTED|Overall Study||3
6764447|NCT03687125|7690905|FG001|STARTED|Overall Study||3
6764448|NCT03687125|7690904|FG000|COMPLETED|Overall Study||0
6764449|NCT03687125|7690905|FG001|COMPLETED|Overall Study||2
6764450|NCT03687125|7690904|FG000|NOT COMPLETED|Overall Study||3
6764451|NCT03687125|7690905|FG001|NOT COMPLETED|Overall Study||1
6764452|NCT03687372|7690915|FG000|STARTED|Overall Study||254
6764453|NCT03687372|7690916|FG001|STARTED|Overall Study||249
6764454|NCT03687372|7690915|FG000|COMPLETED|Overall Study||237
6764455|NCT03687372|7690916|FG001|COMPLETED|Overall Study||210
6764456|NCT03687372|7690915|FG000|NOT COMPLETED|Overall Study||17
6764457|NCT03687372|7690916|FG001|NOT COMPLETED|Overall Study||39
6764458|NCT03687450|7690926|FG000|STARTED|Overall Study||38
6764459|NCT03687450|7690927|FG001|STARTED|Overall Study||18
6764460|NCT03687450|7690926|FG000|Post-Program Follow-Up|Overall Study|1 withdrew, 9 lost to follow-up|28
6556251|NCT01757392|7478503|FG000|NOT COMPLETED|Overall Study||4
6556252|NCT01757405|7478509|FG000|STARTED|Overall Study||18
6556253|NCT01757405|7478510|FG001|STARTED|Overall Study||20
6556254|NCT01757405|7478509|FG000|COMPLETED|Overall Study||17
6556255|NCT01757405|7478510|FG001|COMPLETED|Overall Study||18
6556256|NCT01757405|7478509|FG000|NOT COMPLETED|Overall Study||1
6556257|NCT01757405|7478510|FG001|NOT COMPLETED|Overall Study||2
6556258|NCT01757561|7478520|FG000|STARTED|Overall Study||38
6556259|NCT01757561|7478521|FG001|STARTED|Overall Study||34
6556260|NCT01757561|7478522|FG002|STARTED|Overall Study||38
6556261|NCT01757561|7478523|FG003|STARTED|Overall Study||34
6556262|NCT01757561|7478520|FG000|COMPLETED|Overall Study||32
6556263|NCT01757561|7478521|FG001|COMPLETED|Overall Study||28
6556264|NCT01757561|7478522|FG002|COMPLETED|Overall Study||31
6556265|NCT01757561|7478523|FG003|COMPLETED|Overall Study||25
6764461|NCT03687450|7690927|FG001|Post-Program Follow-Up|Overall Study|3 lost to follow-up|15
6764462|NCT03687450|7690926|FG000|Two-month Follow-up|Overall Study|2 lost to follow-up|26
6764463|NCT03687450|7690927|FG001|Two-month Follow-up|Overall Study|2 lost to follow-up (N.B. 1 participant completed 2-month follow-up but not post-program follow-up)|16
6764464|NCT03687450|7690926|FG000|COMPLETED|Overall Study||26
6764465|NCT03687450|7690927|FG001|COMPLETED|Overall Study||16
6764466|NCT03687450|7690926|FG000|NOT COMPLETED|Overall Study||12
6764467|NCT03687450|7690927|FG001|NOT COMPLETED|Overall Study||2
6764468|NCT03687684|7690942|FG000|STARTED|Overall Study||4
6764469|NCT03687684|7690943|FG001|STARTED|Overall Study||2
6764470|NCT03687684|7690944|FG002|STARTED|Overall Study||2
6764471|NCT03687684|7690945|FG003|STARTED|Overall Study||6
6764472|NCT03687684|7690946|FG004|STARTED|Overall Study||6
6764473|NCT03687684|7690947|FG005|STARTED|Overall Study||6
6764474|NCT03687684|7690948|FG006|STARTED|Overall Study||6
6764475|NCT03687684|7690949|FG007|STARTED|Overall Study||2
6764476|NCT03687684|7690950|FG008|STARTED|Overall Study||6
6764477|NCT03687684|7690942|FG000|COMPLETED|Overall Study||4
6764478|NCT03687684|7690943|FG001|COMPLETED|Overall Study||2
6764479|NCT03687684|7690944|FG002|COMPLETED|Overall Study||2
6764480|NCT03687684|7690945|FG003|COMPLETED|Overall Study||6
6764481|NCT03687684|7690946|FG004|COMPLETED|Overall Study||6
6556266|NCT01757561|7478520|FG000|NOT COMPLETED|Overall Study||6
6556267|NCT01757561|7478521|FG001|NOT COMPLETED|Overall Study||6
6556268|NCT01757561|7478522|FG002|NOT COMPLETED|Overall Study||7
6556269|NCT01757561|7478523|FG003|NOT COMPLETED|Overall Study||9
6556270|NCT01757678|7478533|FG000|STARTED|Overall Study||276
6556271|NCT01757678|7478533|FG000|COMPLETED|Overall Study||276
6764482|NCT03687684|7690947|FG005|COMPLETED|Overall Study||6
6764483|NCT03687684|7690948|FG006|COMPLETED|Overall Study||6
6556272|NCT01757678|7478533|FG000|NOT COMPLETED|Overall Study||0
6556273|NCT01757691|7478541|FG000|STARTED|Overall Study||2
6764484|NCT03687684|7690949|FG007|COMPLETED|Overall Study||2
6764485|NCT03687684|7690950|FG008|COMPLETED|Overall Study||6
6764486|NCT03687684|7690942|FG000|NOT COMPLETED|Overall Study||0
6764487|NCT03687684|7690943|FG001|NOT COMPLETED|Overall Study||0
6556274|NCT01757691|7478542|FG001|STARTED|Overall Study||0
6556275|NCT01757691|7478541|FG000|COMPLETED|Overall Study||0
6764488|NCT03687684|7690944|FG002|NOT COMPLETED|Overall Study||0
6764489|NCT03687684|7690945|FG003|NOT COMPLETED|Overall Study||0
6764490|NCT03687684|7690946|FG004|NOT COMPLETED|Overall Study||0
6556276|NCT01757691|7478542|FG001|COMPLETED|Overall Study||0
6556277|NCT01757691|7478541|FG000|NOT COMPLETED|Overall Study||2
6556278|NCT01757691|7478542|FG001|NOT COMPLETED|Overall Study||0
6556279|NCT01757704|7478550|FG000|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
6556280|NCT01757704|7478551|FG001|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
6556281|NCT01757704|7478550|FG000|COMPLETED|Overall Study||10
6556282|NCT01757704|7478551|FG001|COMPLETED|Overall Study||10
6556283|NCT01757704|7478550|FG000|NOT COMPLETED|Overall Study||1
6556284|NCT01757704|7478551|FG001|NOT COMPLETED|Overall Study||3
6556285|NCT01757717|7478557|FG000|STARTED|Overall Study||3
6556286|NCT01757717|7478557|FG000|COMPLETED|Overall Study||3
6556287|NCT01757717|7478557|FG000|NOT COMPLETED|Overall Study||0
6764491|NCT03687684|7690947|FG005|NOT COMPLETED|Overall Study||0
6764492|NCT03687684|7690948|FG006|NOT COMPLETED|Overall Study||0
6764493|NCT03687684|7690949|FG007|NOT COMPLETED|Overall Study||0
6764494|NCT03687684|7690950|FG008|NOT COMPLETED|Overall Study||0
6764495|NCT03687736|7690980|FG000|STARTED|Overall Study||120
6764496|NCT03687736|7690980|FG000|COMPLETED|Overall Study||110
6764497|NCT03687736|7690980|FG000|NOT COMPLETED|Overall Study||10
6764498|NCT03687827|7690986|FG000|STARTED|Treatment Period 1||249
6764499|NCT03687827|7690987|FG001|STARTED|Treatment Period 1||249
6764500|NCT03687827|7690986|FG000|Full Analysis Set (FAS)|Treatment Period 1||249
6764501|NCT03687827|7690987|FG001|Full Analysis Set (FAS)|Treatment Period 1||249
6764502|NCT03687827|7690986|FG000|Safety Analysis Set (SAS)|Treatment Period 1||249
6556288|NCT01757821|7478561|FG000|STARTED|Overall Study|11 subjects|11
6556289|NCT01757821|7478561|FG000|COMPLETED|Overall Study|10 subjects|10
6556290|NCT01757821|7478561|FG000|NOT COMPLETED|Overall Study||1
6556291|NCT01757847|7478571|FG000|STARTED|Overall Study||44
6556292|NCT01757847|7478572|FG001|STARTED|Overall Study||46
6556293|NCT01757847|7478571|FG000|COMPLETED|Overall Study||41
6556294|NCT01757847|7478572|FG001|COMPLETED|Overall Study||42
6556295|NCT01757847|7478571|FG000|NOT COMPLETED|Overall Study||3
6556296|NCT01757847|7478572|FG001|NOT COMPLETED|Overall Study||4
6556297|NCT01757964|7478580|FG000|STARTED|Overall Study||9
6556298|NCT01757964|7478581|FG001|STARTED|Overall Study||4
6556299|NCT01757964|7478580|FG000|COMPLETED|Overall Study||9
6556300|NCT01757964|7478581|FG001|COMPLETED|Overall Study||4
6556301|NCT01757964|7478580|FG000|NOT COMPLETED|Overall Study||0
6556302|NCT01757964|7478581|FG001|NOT COMPLETED|Overall Study||0
6556303|NCT01758289|7478585|FG000|STARTED|Overall Study||105
6764503|NCT03687827|7690987|FG001|Safety Analysis Set (SAS)|Treatment Period 1||249
6764504|NCT03687827|7690986|FG000|Per Protocol Set|Treatment Period 1||219
6764505|NCT03687827|7690987|FG001|Per Protocol Set|Treatment Period 1||229
6764506|NCT03687827|7690986|FG000|COMPLETED|Treatment Period 1||235
6764507|NCT03687827|7690987|FG001|COMPLETED|Treatment Period 1||241
6764508|NCT03687827|7690986|FG000|NOT COMPLETED|Treatment Period 1||14
6764509|NCT03687827|7690987|FG001|NOT COMPLETED|Treatment Period 1||8
6764510|NCT03687827|7690986|FG000|STARTED|Treatment Period 2||235
6764511|NCT03687827|7690987|FG001|STARTED|Treatment Period 2||241
6764512|NCT03687827|7690986|FG000|COMPLETED|Treatment Period 2||230
6764513|NCT03687827|7690987|FG001|COMPLETED|Treatment Period 2||238
6764514|NCT03687827|7690986|FG000|NOT COMPLETED|Treatment Period 2||5
6764515|NCT03687827|7690987|FG001|NOT COMPLETED|Treatment Period 2||3
6764516|NCT03687970|7690995|FG000|STARTED|Overall Study||22
6556304|NCT01758289|7478585|FG000|COMPLETED|Overall Study||52
6556305|NCT01758289|7478585|FG000|NOT COMPLETED|Overall Study||53
6556306|NCT01758432|7478600|FG000|STARTED|Overall Study||18
6556307|NCT01758432|7478601|FG001|STARTED|Overall Study||6
6556308|NCT01758432|7478602|FG002|STARTED|Overall Study||6
6556309|NCT01758432|7478603|FG003|STARTED|Overall Study||6
6556310|NCT01758432|7478604|FG004|STARTED|Overall Study||6
6556311|NCT01758432|7478605|FG005|STARTED|Overall Study||6
6556312|NCT01758432|7478606|FG006|STARTED|Overall Study||6
6556313|NCT01758432|7478600|FG000|COMPLETED|Overall Study||18
6556314|NCT01758432|7478601|FG001|COMPLETED|Overall Study||6
6556315|NCT01758432|7478602|FG002|COMPLETED|Overall Study||6
6556316|NCT01758432|7478603|FG003|COMPLETED|Overall Study||6
6764517|NCT03687970|7690996|FG001|STARTED|Overall Study||20
6764518|NCT03687970|7690995|FG000|COMPLETED|Overall Study||20
6764519|NCT03687970|7690996|FG001|COMPLETED|Overall Study||20
6764520|NCT03687970|7690995|FG000|NOT COMPLETED|Overall Study||2
6764521|NCT03687970|7690996|FG001|NOT COMPLETED|Overall Study||0
6764522|NCT03688282|7691004|FG000|STARTED|Sham Treatment for 30 Minutes||18
6764523|NCT03688282|7691004|FG000|COMPLETED|Sham Treatment for 30 Minutes||17
6764524|NCT03688282|7691004|FG000|NOT COMPLETED|Sham Treatment for 30 Minutes||1
6556317|NCT01758432|7478604|FG004|COMPLETED|Overall Study||6
6556318|NCT01758432|7478605|FG005|COMPLETED|Overall Study||6
6764525|NCT03688282|7691004|FG000|STARTED|Washout (7 Days)||17
6764526|NCT03688282|7691004|FG000|COMPLETED|Washout (7 Days)||17
6764527|NCT03688282|7691004|FG000|NOT COMPLETED|Washout (7 Days)||0
6556319|NCT01758432|7478606|FG006|COMPLETED|Overall Study||6
6556320|NCT01758432|7478600|FG000|NOT COMPLETED|Overall Study||0
6556321|NCT01758432|7478601|FG001|NOT COMPLETED|Overall Study||0
6556322|NCT01758432|7478602|FG002|NOT COMPLETED|Overall Study||0
6556323|NCT01758432|7478603|FG003|NOT COMPLETED|Overall Study||0
6556324|NCT01758432|7478604|FG004|NOT COMPLETED|Overall Study||0
6556325|NCT01758432|7478605|FG005|NOT COMPLETED|Overall Study||0
6556326|NCT01758432|7478606|FG006|NOT COMPLETED|Overall Study||0
6556327|NCT01758523|7478624|FG000|STARTED|Overall Study||74
6556328|NCT01758523|7478625|FG001|STARTED|Overall Study||68
6556329|NCT01758523|7478624|FG000|Attended >/= 1 Visit Post-randomization|Overall Study||68
6556330|NCT01758523|7478625|FG001|Attended >/= 1 Visit Post-randomization|Overall Study||67
6556331|NCT01758523|7478624|FG000|COMPLETED|Overall Study||53
6764528|NCT03688282|7691004|FG000|STARTED|Active Treatment for 30 Minutes||17
6764529|NCT03688282|7691004|FG000|COMPLETED|Active Treatment for 30 Minutes||17
6764530|NCT03688282|7691004|FG000|NOT COMPLETED|Active Treatment for 30 Minutes||0
6764531|NCT03688542|7691012|FG000|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
6764532|NCT03688542|7691013|FG001|STARTED|Overall Study|No individual participants were recruited, only nursing homes.|
6764533|NCT03688542|7691012|FG000|COMPLETED|Overall Study|No individual participants were recruited, only nursing homes.|
6764534|NCT03688542|7691013|FG001|COMPLETED|Overall Study|"1 nursing home withdrew from the study.~No individual participants were recruited, only nursing homes."|
6764535|NCT03688542|7691012|FG000|NOT COMPLETED|Overall Study||
6764536|NCT03688542|7691013|FG001|NOT COMPLETED|Overall Study||
6764537|NCT03688620|7691022|FG000|STARTED|Overall Study||329
6764538|NCT03688620|7691023|FG001|STARTED|Overall Study||278
6764539|NCT03688620|7691024|FG002|STARTED|Overall Study||453
6764540|NCT03688620|7691022|FG000|COMPLETED|Overall Study||313
6764541|NCT03688620|7691023|FG001|COMPLETED|Overall Study||277
6764542|NCT03688620|7691024|FG002|COMPLETED|Overall Study||445
6764543|NCT03688620|7691022|FG000|NOT COMPLETED|Overall Study||16
6764544|NCT03688620|7691023|FG001|NOT COMPLETED|Overall Study||1
6764545|NCT03688620|7691024|FG002|NOT COMPLETED|Overall Study||8
6764546|NCT03688685|7691034|FG000|STARTED|Overall Study||25
6764547|NCT03688685|7691034|FG000|COMPLETED|Overall Study||21
6764548|NCT03688685|7691034|FG000|NOT COMPLETED|Overall Study||4
6764549|NCT03688711|7691040|FG000|STARTED|Overall Study||34
6764550|NCT03688711|7691041|FG001|STARTED|Overall Study||11
6764551|NCT03688711|7691040|FG000|COMPLETED|Overall Study||34
6764552|NCT03688711|7691041|FG001|COMPLETED|Overall Study||10
6764553|NCT03688711|7691040|FG000|NOT COMPLETED|Overall Study||0
6764554|NCT03688711|7691041|FG001|NOT COMPLETED|Overall Study||1
6764555|NCT03688880|7691049|FG000|STARTED|Overall Study||29
6764556|NCT03688880|7691050|FG001|STARTED|Overall Study||60
6764557|NCT03688880|7691049|FG000|COMPLETED|Overall Study||15
6764558|NCT03688880|7691050|FG001|COMPLETED|Overall Study||29
6764559|NCT03688880|7691049|FG000|NOT COMPLETED|Overall Study||14
6764560|NCT03688880|7691050|FG001|NOT COMPLETED|Overall Study||31
6764561|NCT03689452|7691058|FG000|STARTED|Overall Study||15
6764562|NCT03689452|7691059|FG001|STARTED|Overall Study||15
6764563|NCT03689452|7691058|FG000|COMPLETED|Overall Study||14
6764564|NCT03689452|7691059|FG001|COMPLETED|Overall Study||14
6764565|NCT03689452|7691058|FG000|NOT COMPLETED|Overall Study||1
6764566|NCT03689452|7691059|FG001|NOT COMPLETED|Overall Study||1
6764567|NCT03689504|7691067|FG000|STARTED|Overall Study||70
6764568|NCT03689504|7691068|FG001|STARTED|Overall Study||70
6764569|NCT03689504|7691067|FG000|COMPLETED|Overall Study||65
6764570|NCT03689504|7691068|FG001|COMPLETED|Overall Study||70
6764571|NCT03689504|7691067|FG000|NOT COMPLETED|Overall Study||5
6764572|NCT03689504|7691068|FG001|NOT COMPLETED|Overall Study||0
6764573|NCT03690375|7691076|FG000|STARTED|Overall Study||10
6764574|NCT03690375|7691077|FG001|STARTED|Overall Study||10
6556332|NCT01758523|7478625|FG001|COMPLETED|Overall Study||54
6556333|NCT01758523|7478624|FG000|NOT COMPLETED|Overall Study||21
6764575|NCT03690375|7691076|FG000|COMPLETED|Overall Study||10
6764576|NCT03690375|7691077|FG001|COMPLETED|Overall Study||10
6764577|NCT03690375|7691076|FG000|NOT COMPLETED|Overall Study||0
6764578|NCT03690375|7691077|FG001|NOT COMPLETED|Overall Study||0
6764579|NCT03691779|7691086|FG000|STARTED|Part A (15 Days)||16
6764580|NCT03691779|7691087|FG001|STARTED|Part A (15 Days)||0
6764581|NCT03691779|7691086|FG000|COMPLETED|Part A (15 Days)||16
6764582|NCT03691779|7691087|FG001|COMPLETED|Part A (15 Days)||0
6764583|NCT03691779|7691086|FG000|NOT COMPLETED|Part A (15 Days)||0
6764584|NCT03691779|7691087|FG001|NOT COMPLETED|Part A (15 Days)||0
6764585|NCT03691779|7691086|FG000|STARTED|Part B (24 Weeks)||0
6764586|NCT03691779|7691087|FG001|STARTED|Part B (24 Weeks)|Out of the 16 participants from Part A, 11 participants also participated in Part B of the study.|66
6764587|NCT03691779|7691086|FG000|COMPLETED|Part B (24 Weeks)||0
6764588|NCT03691779|7691087|FG001|COMPLETED|Part B (24 Weeks)||64
6764589|NCT03691779|7691086|FG000|NOT COMPLETED|Part B (24 Weeks)||0
6764590|NCT03691779|7691087|FG001|NOT COMPLETED|Part B (24 Weeks)||2
6764591|NCT03691831|7691096|FG000|STARTED|Overall Study||251
6764592|NCT03691831|7691097|FG001|STARTED|Overall Study||251
6764593|NCT03691831|7691096|FG000|COMPLETED|Overall Study||224
6764594|NCT03691831|7691097|FG001|COMPLETED|Overall Study||220
6764595|NCT03691831|7691096|FG000|NOT COMPLETED|Overall Study||27
6764596|NCT03691831|7691097|FG001|NOT COMPLETED|Overall Study||31
6556334|NCT01758523|7478625|FG001|NOT COMPLETED|Overall Study||14
6764597|NCT03691844|7691107|FG000|STARTED|Overall Study||121
6764598|NCT03691844|7691108|FG001|STARTED|Overall Study||121
6764599|NCT03691844|7691109|FG002|STARTED|Overall Study||121
6764600|NCT03691844|7691110|FG003|STARTED|Overall Study||81
6764601|NCT03691844|7691107|FG000|COMPLETED|Overall Study||114
6764602|NCT03691844|7691108|FG001|COMPLETED|Overall Study||109
6764603|NCT03691844|7691109|FG002|COMPLETED|Overall Study||108
6764604|NCT03691844|7691110|FG003|COMPLETED|Overall Study||70
6764605|NCT03691844|7691107|FG000|NOT COMPLETED|Overall Study||7
6764606|NCT03691844|7691108|FG001|NOT COMPLETED|Overall Study||12
6764607|NCT03691844|7691109|FG002|NOT COMPLETED|Overall Study||13
6764608|NCT03691844|7691110|FG003|NOT COMPLETED|Overall Study||11
6764609|NCT03691948|7691124|FG000|STARTED|Overall Study||27
6764610|NCT03691948|7691125|FG001|STARTED|Overall Study||33
6764611|NCT03691948|7691124|FG000|COMPLETED|Overall Study||26
6764612|NCT03691948|7691125|FG001|COMPLETED|Overall Study||30
6764613|NCT03691948|7691124|FG000|NOT COMPLETED|Overall Study||1
6764614|NCT03691948|7691125|FG001|NOT COMPLETED|Overall Study||3
6764615|NCT03692676|7691136|FG000|STARTED|Overall Study||10365
6764616|NCT03692676|7691137|FG001|STARTED|Overall Study||51142
6764617|NCT03692676|7691138|FG002|STARTED|Overall Study||49479
6764618|NCT03692676|7691139|FG003|STARTED|Overall Study||5147
6764619|NCT03692676|7691136|FG000|COMPLETED|Overall Study||940
6764620|NCT03692676|7691137|FG001|COMPLETED|Overall Study||3704
6764621|NCT03692676|7691138|FG002|COMPLETED|Overall Study||11135
6764622|NCT03692676|7691139|FG003|COMPLETED|Overall Study||1561
6764623|NCT03692676|7691136|FG000|NOT COMPLETED|Overall Study||9425
6764624|NCT03692676|7691137|FG001|NOT COMPLETED|Overall Study||47438
6764625|NCT03692676|7691138|FG002|NOT COMPLETED|Overall Study||38344
6764626|NCT03692676|7691139|FG003|NOT COMPLETED|Overall Study||3586
6764627|NCT03693625|7691151|FG000|STARTED|Overall Study||23
6764628|NCT03693625|7691152|FG001|STARTED|Overall Study||8
6764629|NCT03693625|7691151|FG000|COMPLETED|Overall Study||0
6764630|NCT03693625|7691152|FG001|COMPLETED|Overall Study||0
6764631|NCT03693625|7691151|FG000|NOT COMPLETED|Overall Study||23
6764632|NCT03693625|7691152|FG001|NOT COMPLETED|Overall Study||8
6764633|NCT03693742|7691160|FG000|STARTED|Overall Study||7
6764634|NCT03693742|7691161|FG001|STARTED|Overall Study||3
6764635|NCT03693742|7691160|FG000|COMPLETED|Overall Study||7
6764636|NCT03693742|7691161|FG001|COMPLETED|Overall Study||3
6764637|NCT03693742|7691160|FG000|NOT COMPLETED|Overall Study||0
6764638|NCT03693742|7691161|FG001|NOT COMPLETED|Overall Study||0
6764639|NCT03693937|7691169|FG000|STARTED|Overall Study||776
6764640|NCT03693937|7691169|FG000|COMPLETED|Overall Study||776
6764641|NCT03693937|7691169|FG000|NOT COMPLETED|Overall Study||0
6764642|NCT03693950|7691175|FG000|STARTED|Overall Study||29
6764643|NCT03693950|7691176|FG001|STARTED|Overall Study||28
6764644|NCT03693950|7691175|FG000|COMPLETED|Overall Study||28
6764645|NCT03693950|7691176|FG001|COMPLETED|Overall Study||28
6764646|NCT03693950|7691175|FG000|NOT COMPLETED|Overall Study||1
6764647|NCT03693950|7691176|FG001|NOT COMPLETED|Overall Study||0
6764648|NCT03693989|7691184|FG000|STARTED|Overall Study||88
6764649|NCT03693989|7691185|FG001|STARTED|Overall Study||90
6764650|NCT03693989|7691184|FG000|COMPLETED|Overall Study||85
6764651|NCT03693989|7691185|FG001|COMPLETED|Overall Study||86
6764652|NCT03693989|7691184|FG000|NOT COMPLETED|Overall Study||3
6764653|NCT03693989|7691185|FG001|NOT COMPLETED|Overall Study||4
6764654|NCT03694197|7691191|FG000|STARTED|Overall Study||1385
6764655|NCT03694197|7691191|FG000|COMPLETED|Overall Study||0
6764656|NCT03694197|7691191|FG000|NOT COMPLETED|Overall Study||1385
6764657|NCT03694210|7691195|FG000|STARTED|Overall Study||37
6764658|NCT03694210|7691195|FG000|COMPLETED|Overall Study||29
6764659|NCT03694210|7691195|FG000|NOT COMPLETED|Overall Study||8
6764660|NCT03694275|7691203|FG000|STARTED|Overall Study||8
6764661|NCT03694275|7691204|FG001|STARTED|Overall Study||12
6764662|NCT03694275|7691203|FG000|COMPLETED|Overall Study||8
6764663|NCT03694275|7691204|FG001|COMPLETED|Overall Study||10
6764664|NCT03694275|7691203|FG000|NOT COMPLETED|Overall Study||0
6764665|NCT03694275|7691204|FG001|NOT COMPLETED|Overall Study||2
6764666|NCT03694548|7691213|FG000|STARTED|Part A Survey||18
6764667|NCT03694548|7691214|FG001|STARTED|Part A Survey||17
6764668|NCT03694548|7691215|FG002|STARTED|Part A Survey||0
6764669|NCT03694548|7691213|FG000|COMPLETED|Part A Survey||15
6764670|NCT03694548|7691214|FG001|COMPLETED|Part A Survey||14
6764671|NCT03694548|7691215|FG002|COMPLETED|Part A Survey||0
6764672|NCT03694548|7691213|FG000|NOT COMPLETED|Part A Survey||3
6764673|NCT03694548|7691214|FG001|NOT COMPLETED|Part A Survey||3
6764674|NCT03694548|7691215|FG002|NOT COMPLETED|Part A Survey||0
6764675|NCT03694548|7691213|FG000|STARTED|Part B Yoga Program||0
6764676|NCT03694548|7691214|FG001|STARTED|Part B Yoga Program||0
6764677|NCT03694548|7691215|FG002|STARTED|Part B Yoga Program||12
6764678|NCT03694548|7691213|FG000|COMPLETED|Part B Yoga Program||0
6764679|NCT03694548|7691214|FG001|COMPLETED|Part B Yoga Program||0
6764680|NCT03694548|7691215|FG002|COMPLETED|Part B Yoga Program||1
6764681|NCT03694548|7691213|FG000|NOT COMPLETED|Part B Yoga Program||0
6764682|NCT03694548|7691214|FG001|NOT COMPLETED|Part B Yoga Program||0
6764683|NCT03694548|7691215|FG002|NOT COMPLETED|Part B Yoga Program||11
6764684|NCT03694613|7691225|FG000|STARTED|Overall Study||65
6764685|NCT03694613|7691225|FG000|COMPLETED|Overall Study|65 samples were collected and analyzed. at least 3 ml were collected.|65
6764686|NCT03694613|7691225|FG000|NOT COMPLETED|Overall Study||0
6764687|NCT03694925|7691241|FG000|STARTED|Overall Study||30
6764688|NCT03694925|7691242|FG001|STARTED|Overall Study||73
6764689|NCT03694925|7691243|FG002|STARTED|Overall Study||53
6764690|NCT03694925|7691241|FG000|COMPLETED|Overall Study||30
6764691|NCT03694925|7691242|FG001|COMPLETED|Overall Study||70
6764692|NCT03694925|7691243|FG002|COMPLETED|Overall Study||53
6764693|NCT03694925|7691241|FG000|NOT COMPLETED|Overall Study||0
6764694|NCT03694925|7691242|FG001|NOT COMPLETED|Overall Study||3
6764695|NCT03694925|7691243|FG002|NOT COMPLETED|Overall Study||0
6764696|NCT03695094|7691255|FG000|STARTED|Overall Study||16
6764697|NCT03695094|7691256|FG001|STARTED|Overall Study||15
6764698|NCT03695094|7691255|FG000|COMPLETED|Overall Study||14
6764699|NCT03695094|7691256|FG001|COMPLETED|Overall Study||14
6764700|NCT03695094|7691255|FG000|NOT COMPLETED|Overall Study||2
6764701|NCT03695094|7691256|FG001|NOT COMPLETED|Overall Study||1
6764702|NCT03695367|7691266|FG000|STARTED|Overall Study||33
6764703|NCT03695367|7691267|FG001|STARTED|Overall Study||30
6764704|NCT03695367|7691266|FG000|COMPLETED|Overall Study||32
6764705|NCT03695367|7691267|FG001|COMPLETED|Overall Study||26
6764706|NCT03695367|7691266|FG000|NOT COMPLETED|Overall Study||1
6764707|NCT03695367|7691267|FG001|NOT COMPLETED|Overall Study||4
6764708|NCT03695393|7691275|FG000|STARTED|Overall Study||67
6764709|NCT03695393|7691276|FG001|STARTED|Overall Study||33
6764710|NCT03695393|7691275|FG000|1-month|Overall Study||66
6764711|NCT03695393|7691276|FG001|1-month|Overall Study||32
6764712|NCT03695393|7691275|FG000|6-month|Overall Study||64
6764713|NCT03695393|7691276|FG001|6-month|Overall Study||31
6764714|NCT03695393|7691275|FG000|COMPLETED|Overall Study||64
6764715|NCT03695393|7691276|FG001|COMPLETED|Overall Study||31
6764716|NCT03695393|7691275|FG000|NOT COMPLETED|Overall Study||3
6764717|NCT03695393|7691276|FG001|NOT COMPLETED|Overall Study||2
6764718|NCT03695913|7691282|FG000|STARTED|Overall Study||15
6764719|NCT03695913|7691282|FG000|COMPLETED|Overall Study||15
6764720|NCT03695913|7691282|FG000|NOT COMPLETED|Overall Study||0
6764721|NCT03696108|7691288|FG000|STARTED|Overall Study||84
6764722|NCT03696108|7691289|FG001|STARTED|Overall Study||85
6764723|NCT03696108|7691288|FG000|COMPLETED|Overall Study||80
6764724|NCT03696108|7691289|FG001|COMPLETED|Overall Study||79
6764725|NCT03696108|7691288|FG000|NOT COMPLETED|Overall Study||4
6764726|NCT03696108|7691289|FG001|NOT COMPLETED|Overall Study||6
6764727|NCT03696342|7691297|FG000|STARTED|Overall Study||23
6764728|NCT03696342|7691298|FG001|STARTED|Overall Study||23
6764729|NCT03696342|7691297|FG000|COMPLETED|Overall Study||22
6764730|NCT03696342|7691298|FG001|COMPLETED|Overall Study||23
6764731|NCT03696342|7691297|FG000|NOT COMPLETED|Overall Study||1
6764732|NCT03696342|7691298|FG001|NOT COMPLETED|Overall Study||0
6764733|NCT03696576|7691306|FG000|STARTED|Overall Study||13
6764734|NCT03696576|7691307|FG001|STARTED|Overall Study||11
6764735|NCT03696576|7691306|FG000|COMPLETED|Overall Study||10
6764736|NCT03696576|7691307|FG001|COMPLETED|Overall Study||6
6764737|NCT03696576|7691306|FG000|NOT COMPLETED|Overall Study||3
6764738|NCT03696576|7691307|FG001|NOT COMPLETED|Overall Study||5
6764739|NCT03696589|7691313|FG000|STARTED|Overall Study||13
6764740|NCT03696589|7691313|FG000|COMPLETED|Overall Study||12
6764741|NCT03696589|7691313|FG000|NOT COMPLETED|Overall Study||1
6764742|NCT03696758|7691326|FG000|STARTED|First Intervention||3
6764743|NCT03696758|7691327|FG001|STARTED|First Intervention||6
6764744|NCT03696758|7691326|FG000|COMPLETED|First Intervention||3
6764745|NCT03696758|7691327|FG001|COMPLETED|First Intervention||6
6764746|NCT03696758|7691326|FG000|NOT COMPLETED|First Intervention||0
6764747|NCT03696758|7691327|FG001|NOT COMPLETED|First Intervention||0
6764748|NCT03696758|7691326|FG000|STARTED|Wash Out>12 Hours||3
6764749|NCT03696758|7691327|FG001|STARTED|Wash Out>12 Hours||6
6764750|NCT03696758|7691326|FG000|COMPLETED|Wash Out>12 Hours||3
6764751|NCT03696758|7691327|FG001|COMPLETED|Wash Out>12 Hours||6
6764752|NCT03696758|7691326|FG000|NOT COMPLETED|Wash Out>12 Hours||0
6764753|NCT03696758|7691327|FG001|NOT COMPLETED|Wash Out>12 Hours||0
6764754|NCT03696758|7691326|FG000|STARTED|Second Intervention||3
6556335|NCT01758588|7478637|FG000|STARTED|Overall Study||5
6556336|NCT01758588|7478638|FG001|STARTED|Overall Study||3
6556337|NCT01758588|7478637|FG000|COMPLETED|Overall Study||5
6556338|NCT01758588|7478638|FG001|COMPLETED|Overall Study||3
6556339|NCT01758588|7478637|FG000|NOT COMPLETED|Overall Study||0
6556340|NCT01758588|7478638|FG001|NOT COMPLETED|Overall Study||0
6556341|NCT01758731|7478646|FG000|STARTED|Overall Study||17
6556342|NCT01758731|7478646|FG000|COMPLETED|Overall Study||16
6556343|NCT01758731|7478646|FG000|NOT COMPLETED|Overall Study||1
6556344|NCT01758900|7478652|FG000|STARTED|Overall Study||106
6764755|NCT03696758|7691327|FG001|STARTED|Second Intervention||6
6764756|NCT03696758|7691326|FG000|COMPLETED|Second Intervention||3
6764757|NCT03696758|7691327|FG001|COMPLETED|Second Intervention||6
6764758|NCT03696758|7691326|FG000|NOT COMPLETED|Second Intervention||0
6764759|NCT03696758|7691327|FG001|NOT COMPLETED|Second Intervention||0
6764760|NCT03697083|7691336|FG000|STARTED|Overall Study||262
6764761|NCT03697083|7691337|FG001|STARTED|Overall Study||260
6764762|NCT03697083|7691338|FG002|STARTED|Overall Study||255
6764763|NCT03697083|7691336|FG000|COMPLETED|Overall Study||262
6764764|NCT03697083|7691337|FG001|COMPLETED|Overall Study||250
6764765|NCT03697083|7691338|FG002|COMPLETED|Overall Study||255
6764766|NCT03697083|7691336|FG000|NOT COMPLETED|Overall Study||0
6764767|NCT03697083|7691337|FG001|NOT COMPLETED|Overall Study||10
6764768|NCT03697083|7691338|FG002|NOT COMPLETED|Overall Study||0
6764769|NCT03697122|7691346|FG000|STARTED|Overall Study||14
6764770|NCT03697122|7691346|FG000|COMPLETED|Overall Study||14
6764771|NCT03697122|7691346|FG000|NOT COMPLETED|Overall Study||0
6764772|NCT03697252|7691352|FG000|STARTED|Overall Study||90
6764773|NCT03697252|7691353|FG001|STARTED|Overall Study||92
6764774|NCT03697252|7691352|FG000|COMPLETED|Overall Study||72
6764775|NCT03697252|7691353|FG001|COMPLETED|Overall Study||73
6764776|NCT03697252|7691352|FG000|NOT COMPLETED|Overall Study||18
6764777|NCT03697252|7691353|FG001|NOT COMPLETED|Overall Study||19
6764778|NCT03697460|7691359|FG000|STARTED|Overall Study||12
6764779|NCT03697460|7691359|FG000|COMPLETED|Overall Study||9
6764780|NCT03697460|7691359|FG000|NOT COMPLETED|Overall Study||3
6764781|NCT03697993|7691365|FG000|STARTED|Overall Study||32
6764782|NCT03697993|7691366|FG001|STARTED|Overall Study||30
6764783|NCT03697993|7691365|FG000|Initiated Treatment|Overall Study||30
6764784|NCT03697993|7691366|FG001|Initiated Treatment|Overall Study||28
6764785|NCT03697993|7691365|FG000|Switched Treatment|Overall Study||0
6764786|NCT03697993|7691366|FG001|Switched Treatment|Overall Study|Five (5) participants switched to Fosfomycin; 1 participant switched to Cefixime.|6
6764787|NCT03697993|7691365|FG000|Treated With at Least Two Dose of Fosfomycin|Overall Study||27
6764788|NCT03697993|7691366|FG001|Treated With at Least Two Dose of Fosfomycin|Overall Study||4
6764789|NCT03697993|7691365|FG000|COMPLETED|Overall Study||22
6764790|NCT03697993|7691366|FG001|COMPLETED|Overall Study||25
6764791|NCT03697993|7691365|FG000|NOT COMPLETED|Overall Study||10
6764792|NCT03697993|7691366|FG001|NOT COMPLETED|Overall Study||5
6764793|NCT03698331|7691375|FG000|STARTED|Overall Study||44
6764794|NCT03698331|7691376|FG001|STARTED|Overall Study||45
6764795|NCT03698331|7691375|FG000|Entered Withdrawal Period|Overall Study||42
6764796|NCT03698331|7691376|FG001|Entered Withdrawal Period|Overall Study||39
6764797|NCT03698331|7691375|FG000|COMPLETED|Overall Study||40
6764798|NCT03698331|7691376|FG001|COMPLETED|Overall Study||39
6764799|NCT03698331|7691375|FG000|NOT COMPLETED|Overall Study||4
6764800|NCT03698331|7691376|FG001|NOT COMPLETED|Overall Study||6
6764801|NCT03698591|7691384|FG000|STARTED|Overall Study||20
6764802|NCT03698591|7691385|FG001|STARTED|Overall Study||20
6764803|NCT03698591|7691384|FG000|COMPLETED|Overall Study||15
6764804|NCT03698591|7691385|FG001|COMPLETED|Overall Study||15
6764805|NCT03698591|7691384|FG000|NOT COMPLETED|Overall Study||5
6764806|NCT03698591|7691385|FG001|NOT COMPLETED|Overall Study||5
6764807|NCT03699124|7691394|FG000|STARTED|Overall Study||377
6764808|NCT03699124|7691395|FG001|STARTED|Overall Study||375
6764809|NCT03699124|7691396|FG002|STARTED|Overall Study||377
6764810|NCT03699124|7691394|FG000|COMPLETED|Overall Study||332
6764811|NCT03699124|7691395|FG001|COMPLETED|Overall Study||335
6764812|NCT03699124|7691396|FG002|COMPLETED|Overall Study||337
6764813|NCT03699124|7691394|FG000|NOT COMPLETED|Overall Study||45
6764814|NCT03699124|7691395|FG001|NOT COMPLETED|Overall Study||40
6764815|NCT03699124|7691396|FG002|NOT COMPLETED|Overall Study||40
6764816|NCT03700320|7691406|FG000|STARTED|Overall Study||198
6764817|NCT03700320|7691407|FG001|STARTED|Overall Study||546
6764818|NCT03700320|7691406|FG000|Safety Population; Received Treatment|Overall Study||196
6764819|NCT03700320|7691407|FG001|Safety Population; Received Treatment|Overall Study||543
6764820|NCT03700320|7691406|FG000|Entered Safety Follow-up|Overall Study||159
6764821|NCT03700320|7691407|FG001|Entered Safety Follow-up|Overall Study||472
6764822|NCT03700320|7691406|FG000|COMPLETED|Overall Study||136
6764823|NCT03700320|7691407|FG001|COMPLETED|Overall Study||373
6764824|NCT03700320|7691406|FG000|NOT COMPLETED|Overall Study||62
6764825|NCT03700320|7691407|FG001|NOT COMPLETED|Overall Study||173
6764826|NCT03700372|7691413|FG000|STARTED|Overall Study||7
6764827|NCT03700372|7691413|FG000|COMPLETED|Overall Study||7
6764828|NCT03700372|7691413|FG000|NOT COMPLETED|Overall Study||0
6764829|NCT03700385|7691417|FG000|STARTED|Overall Study||40
6764830|NCT03700385|7691417|FG000|COMPLETED|Overall Study||39
6764831|NCT03700385|7691417|FG000|NOT COMPLETED|Overall Study||1
6764832|NCT03700671|7691423|FG000|STARTED|Overall Study||21
6764833|NCT03700671|7691424|FG001|STARTED|Overall Study||21
6764834|NCT03700671|7691423|FG000|COMPLETED|Overall Study||20
6764835|NCT03700671|7691424|FG001|COMPLETED|Overall Study||19
6764836|NCT03700671|7691423|FG000|NOT COMPLETED|Overall Study||1
6764837|NCT03700671|7691424|FG001|NOT COMPLETED|Overall Study||2
6764838|NCT03700736|7691434|FG000|STARTED|Overall Study||30
6764839|NCT03700736|7691435|FG001|STARTED|Overall Study||32
6556345|NCT01758900|7478653|FG001|STARTED|Overall Study||108
6556346|NCT01758900|7478652|FG000|COMPLETED|Overall Study||99
6556347|NCT01758900|7478653|FG001|COMPLETED|Overall Study||100
6556348|NCT01758900|7478652|FG000|NOT COMPLETED|Overall Study||7
6556349|NCT01758900|7478653|FG001|NOT COMPLETED|Overall Study||8
6764840|NCT03700736|7691434|FG000|COMPLETED|Overall Study||27
6764841|NCT03700736|7691435|FG001|COMPLETED|Overall Study||25
6764842|NCT03700736|7691434|FG000|NOT COMPLETED|Overall Study||3
6764843|NCT03700736|7691435|FG001|NOT COMPLETED|Overall Study||7
6556350|NCT01759160|7478661|FG000|STARTED|Overall Study||30
6764844|NCT03700892|7691446|FG000|STARTED|Baseline||15
6764845|NCT03700892|7691447|FG001|STARTED|Baseline||0
6764846|NCT03700892|7691448|FG002|STARTED|Baseline||4
6764847|NCT03700892|7691446|FG000|COMPLETED|Baseline||15
6764848|NCT03700892|7691447|FG001|COMPLETED|Baseline||0
6764849|NCT03700892|7691448|FG002|COMPLETED|Baseline||4
6764850|NCT03700892|7691446|FG000|NOT COMPLETED|Baseline||0
6764851|NCT03700892|7691447|FG001|NOT COMPLETED|Baseline||0
6764852|NCT03700892|7691448|FG002|NOT COMPLETED|Baseline||0
6764853|NCT03700892|7691446|FG000|STARTED|First Intervention (Single 1-Day Visit)||1
6764854|NCT03700892|7691447|FG001|STARTED|First Intervention (Single 1-Day Visit)||4
6556351|NCT01759160|7478662|FG001|STARTED|Overall Study||30
6556352|NCT01759160|7478661|FG000|COMPLETED|Overall Study||30
6764855|NCT03700892|7691448|FG002|STARTED|First Intervention (Single 1-Day Visit)||0
6764856|NCT03700892|7691446|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||1
6764857|NCT03700892|7691447|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||4
6764858|NCT03700892|7691448|FG002|COMPLETED|First Intervention (Single 1-Day Visit)||0
6764859|NCT03700892|7691446|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
6764860|NCT03700892|7691447|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
6764861|NCT03700892|7691448|FG002|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
6764862|NCT03700892|7691446|FG000|STARTED|Washout (2-3 Weeks)||1
6764863|NCT03700892|7691447|FG001|STARTED|Washout (2-3 Weeks)||4
6764864|NCT03700892|7691448|FG002|STARTED|Washout (2-3 Weeks)||0
6764865|NCT03700892|7691446|FG000|COMPLETED|Washout (2-3 Weeks)||1
6764866|NCT03700892|7691447|FG001|COMPLETED|Washout (2-3 Weeks)||4
6764867|NCT03700892|7691448|FG002|COMPLETED|Washout (2-3 Weeks)||0
6764868|NCT03700892|7691446|FG000|NOT COMPLETED|Washout (2-3 Weeks)||0
6764869|NCT03700892|7691447|FG001|NOT COMPLETED|Washout (2-3 Weeks)||0
6764870|NCT03700892|7691448|FG002|NOT COMPLETED|Washout (2-3 Weeks)||0
6764871|NCT03700892|7691446|FG000|STARTED|Second Intervention (Single 1-Day Visit)||1
6764872|NCT03700892|7691447|FG001|STARTED|Second Intervention (Single 1-Day Visit)||4
6764873|NCT03700892|7691448|FG002|STARTED|Second Intervention (Single 1-Day Visit)||0
6764874|NCT03700892|7691446|FG000|Received Intervention|Second Intervention (Single 1-Day Visit)||1
6764875|NCT03700892|7691447|FG001|Received Intervention|Second Intervention (Single 1-Day Visit)||3
6764876|NCT03700892|7691448|FG002|Received Intervention|Second Intervention (Single 1-Day Visit)||0
6764877|NCT03700892|7691446|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||1
6764878|NCT03700892|7691447|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
6764879|NCT03700892|7691448|FG002|COMPLETED|Second Intervention (Single 1-Day Visit)||0
6764880|NCT03700892|7691446|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
6764881|NCT03700892|7691447|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||1
6764882|NCT03700892|7691448|FG002|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
6556353|NCT01759160|7478662|FG001|COMPLETED|Overall Study||30
6556354|NCT01759160|7478661|FG000|NOT COMPLETED|Overall Study||0
6556355|NCT01759160|7478662|FG001|NOT COMPLETED|Overall Study||0
6556356|NCT01759251|7478668|FG000|STARTED|30 Days Treatment Period||309
6764883|NCT03701061|7691459|FG000|STARTED|Overall Study||9
6764884|NCT03701061|7691460|FG001|STARTED|Overall Study||3
6764885|NCT03701061|7691459|FG000|COMPLETED|Overall Study||9
6764886|NCT03701061|7691460|FG001|COMPLETED|Overall Study||3
6764887|NCT03701061|7691459|FG000|NOT COMPLETED|Overall Study||0
6764888|NCT03701061|7691460|FG001|NOT COMPLETED|Overall Study||0
6764889|NCT03701074|7691468|FG000|STARTED|Overall Study||1
6764890|NCT03701074|7691469|FG001|STARTED|Overall Study||0
6764891|NCT03701074|7691468|FG000|COMPLETED|Overall Study|Treatment was withdrawn after the 10th dose of oral medication (acetaminophen), on day 3 of treatment, as the infant developed mild abdominal distension which was as per the study protocol|0
6764892|NCT03701074|7691469|FG001|COMPLETED|Overall Study||0
6764893|NCT03701074|7691468|FG000|NOT COMPLETED|Overall Study||1
6764894|NCT03701074|7691469|FG001|NOT COMPLETED|Overall Study||0
6764895|NCT03702010|7691477|FG000|STARTED|First Stimulation (5 Days)||13
6764896|NCT03702010|7691478|FG001|STARTED|First Stimulation (5 Days)||14
6764897|NCT03702010|7691477|FG000|COMPLETED|First Stimulation (5 Days)||13
6764898|NCT03702010|7691478|FG001|COMPLETED|First Stimulation (5 Days)||14
6764899|NCT03702010|7691477|FG000|NOT COMPLETED|First Stimulation (5 Days)||0
6764900|NCT03702010|7691478|FG001|NOT COMPLETED|First Stimulation (5 Days)||0
6764901|NCT03702010|7691477|FG000|STARTED|Washout + Second Stimulation (2+5days)||13
6764902|NCT03702010|7691478|FG001|STARTED|Washout + Second Stimulation (2+5days)||14
6764903|NCT03702010|7691477|FG000|COMPLETED|Washout + Second Stimulation (2+5days)||13
6764904|NCT03702010|7691478|FG001|COMPLETED|Washout + Second Stimulation (2+5days)||14
6764905|NCT03702010|7691477|FG000|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
6764906|NCT03702010|7691478|FG001|NOT COMPLETED|Washout + Second Stimulation (2+5days)||0
6764907|NCT03702010|7691477|FG000|STARTED|Follow-up (30days)||13
6764908|NCT03702010|7691478|FG001|STARTED|Follow-up (30days)||14
6764909|NCT03702010|7691477|FG000|COMPLETED|Follow-up (30days)||11
6764910|NCT03702010|7691478|FG001|COMPLETED|Follow-up (30days)||12
6764911|NCT03702010|7691477|FG000|NOT COMPLETED|Follow-up (30days)||2
6764912|NCT03702010|7691478|FG001|NOT COMPLETED|Follow-up (30days)||2
6764913|NCT03702166|7691490|FG000|STARTED|Overall Study||10
6764914|NCT03702166|7691490|FG000|COMPLETED|Overall Study||8
6764915|NCT03702166|7691490|FG000|NOT COMPLETED|Overall Study||2
6764916|NCT03702608|7691495|FG000|STARTED|Overall Study||50
6764917|NCT03702608|7691495|FG000|COMPLETED|Overall Study||50
6764918|NCT03702608|7691495|FG000|NOT COMPLETED|Overall Study||0
6764919|NCT03703336|7691501|FG000|STARTED|Overall Study||552
6764920|NCT03703336|7691502|FG001|STARTED|Overall Study||273
6764921|NCT03703336|7691501|FG000|Received Dose 1|Overall Study||552
6764922|NCT03703336|7691502|FG001|Received Dose 1|Overall Study||273
6764923|NCT03703336|7691501|FG000|Received Dose 2|Overall Study||518
6764924|NCT03703336|7691502|FG001|Received Dose 2|Overall Study||263
6764925|NCT03703336|7691501|FG000|Safety Population|Overall Study||551
6764926|NCT03703336|7691502|FG001|Safety Population|Overall Study||274
6764927|NCT03703336|7691501|FG000|COMPLETED|Overall Study||514
6764928|NCT03703336|7691502|FG001|COMPLETED|Overall Study||259
6764929|NCT03703336|7691501|FG000|NOT COMPLETED|Overall Study||38
6764930|NCT03703336|7691502|FG001|NOT COMPLETED|Overall Study||14
6556357|NCT01759251|7478668|FG000|COMPLETED|30 Days Treatment Period||305
6764931|NCT03703466|7691511|FG000|STARTED|Overall Study||24
6764932|NCT03703466|7691512|FG001|STARTED|Overall Study||24
6764933|NCT03703466|7691513|FG002|STARTED|Overall Study||24
6764934|NCT03703466|7691511|FG000|Received at Least One Dose of Study Drug|Overall Study||24
6764935|NCT03703466|7691512|FG001|Received at Least One Dose of Study Drug|Overall Study||23
6764936|NCT03703466|7691513|FG002|Received at Least One Dose of Study Drug|Overall Study||24
6764937|NCT03703466|7691511|FG000|COMPLETED|Overall Study||20
6764938|NCT03703466|7691512|FG001|COMPLETED|Overall Study||18
6764939|NCT03703466|7691513|FG002|COMPLETED|Overall Study||22
6764940|NCT03703466|7691511|FG000|NOT COMPLETED|Overall Study||4
6764941|NCT03703466|7691512|FG001|NOT COMPLETED|Overall Study||6
6764942|NCT03703466|7691513|FG002|NOT COMPLETED|Overall Study||2
6764943|NCT03703817|7691524|FG000|STARTED|Overall Study||288
6764944|NCT03703817|7691525|FG001|STARTED|Overall Study||133
6764945|NCT03703817|7691524|FG000|COMPLETED|Overall Study||281
6764946|NCT03703817|7691525|FG001|COMPLETED|Overall Study||129
6764947|NCT03703817|7691524|FG000|NOT COMPLETED|Overall Study||7
6764948|NCT03703817|7691525|FG001|NOT COMPLETED|Overall Study||4
6764949|NCT03704194|7691533|FG000|STARTED|Overall Study||8
6764950|NCT03704194|7691534|FG001|STARTED|Overall Study||9
6764951|NCT03704194|7691533|FG000|COMPLETED|Overall Study||8
6764952|NCT03704194|7691534|FG001|COMPLETED|Overall Study||8
6764953|NCT03704194|7691533|FG000|NOT COMPLETED|Overall Study||0
6764954|NCT03704194|7691534|FG001|NOT COMPLETED|Overall Study||1
6764955|NCT03704376|7691544|FG000|STARTED|Overall Study||42
6764956|NCT03704376|7691545|FG001|STARTED|Overall Study||44
6764957|NCT03704376|7691544|FG000|COMPLETED|Overall Study||38
6764958|NCT03704376|7691545|FG001|COMPLETED|Overall Study||40
6764959|NCT03704376|7691544|FG000|NOT COMPLETED|Overall Study||4
6764960|NCT03704376|7691545|FG001|NOT COMPLETED|Overall Study||4
6764961|NCT03704467|7691551|FG000|STARTED|Overall Study||3
6764962|NCT03704467|7691551|FG000|COMPLETED|Overall Study||3
6764963|NCT03704467|7691551|FG000|NOT COMPLETED|Overall Study||0
6764964|NCT03705273|7691557|FG000|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
6764965|NCT03705273|7691558|FG001|STARTED|Overall Study|Planned enrollment of 110 participants in the arm was not achieved due to lack of study personnel.|20
6764966|NCT03705273|7691557|FG000|COMPLETED|Overall Study||20
6764967|NCT03705273|7691558|FG001|COMPLETED|Overall Study||20
6764968|NCT03705273|7691557|FG000|NOT COMPLETED|Overall Study||0
6764969|NCT03705273|7691558|FG001|NOT COMPLETED|Overall Study||0
6764970|NCT03705481|7691564|FG000|STARTED|Overall Study||5
6764971|NCT03705481|7691564|FG000|COMPLETED|Overall Study||5
6764972|NCT03705481|7691564|FG000|NOT COMPLETED|Overall Study||0
6764973|NCT03705494|7691573|FG000|STARTED|Overall Study||10
6764974|NCT03705494|7691574|FG001|STARTED|Overall Study||10
6764975|NCT03705494|7691573|FG000|COMPLETED|Overall Study||3
6764976|NCT03705494|7691574|FG001|COMPLETED|Overall Study||7
6764977|NCT03705494|7691573|FG000|NOT COMPLETED|Overall Study||7
6764978|NCT03705494|7691574|FG001|NOT COMPLETED|Overall Study||3
6764979|NCT03705793|7691582|FG000|STARTED|Overall Study||27
6764980|NCT03705793|7691583|FG001|STARTED|Overall Study||26
6764981|NCT03705793|7691582|FG000|COMPLETED|Overall Study||22
6764982|NCT03705793|7691583|FG001|COMPLETED|Overall Study||21
6764983|NCT03705793|7691582|FG000|NOT COMPLETED|Overall Study||5
6764984|NCT03705793|7691583|FG001|NOT COMPLETED|Overall Study||5
6764985|NCT03706040|7691592|FG000|STARTED|Period A (Week 0 to Week 16)||34
6764986|NCT03706040|7691593|FG001|STARTED|Period A (Week 0 to Week 16)||69
6764987|NCT03706040|7691594|FG002|STARTED|Period A (Week 0 to Week 16)||69
6764988|NCT03706040|7691595|FG003|STARTED|Period A (Week 0 to Week 16)||0
6764989|NCT03706040|7691596|FG004|STARTED|Period A (Week 0 to Week 16)||0
6764990|NCT03706040|7691597|FG005|STARTED|Period A (Week 0 to Week 16)||0
6764991|NCT03706040|7691598|FG006|STARTED|Period A (Week 0 to Week 16)||0
6764992|NCT03706040|7691592|FG000|Received Study Drug|Period A (Week 0 to Week 16)||34
6764993|NCT03706040|7691593|FG001|Received Study Drug|Period A (Week 0 to Week 16)||69
6764994|NCT03706040|7691594|FG002|Received Study Drug|Period A (Week 0 to Week 16)||69
6764995|NCT03706040|7691595|FG003|Received Study Drug|Period A (Week 0 to Week 16)||0
6764996|NCT03706040|7691596|FG004|Received Study Drug|Period A (Week 0 to Week 16)||0
6556358|NCT01759251|7478668|FG000|NOT COMPLETED|30 Days Treatment Period||4
6556359|NCT01759251|7478668|FG000|STARTED|60 Days Treatment Period||305
6556360|NCT01759251|7478668|FG000|COMPLETED|60 Days Treatment Period||305
6556361|NCT01759251|7478668|FG000|NOT COMPLETED|60 Days Treatment Period||0
6556362|NCT01759251|7478668|FG000|STARTED|Follow-up Period||305
6556363|NCT01759251|7478668|FG000|COMPLETED|Follow-up Period||305
6556364|NCT01759251|7478668|FG000|NOT COMPLETED|Follow-up Period||0
6556365|NCT01759264|7478672|FG000|STARTED|Overall Study||101
6556366|NCT01759264|7478672|FG000|COMPLETED|Overall Study||91
6556367|NCT01759264|7478672|FG000|NOT COMPLETED|Overall Study||10
6556368|NCT01759277|7478679|FG000|STARTED|Overall Study||41
6556369|NCT01759277|7478680|FG001|STARTED|Overall Study||39
6764997|NCT03706040|7691597|FG005|Received Study Drug|Period A (Week 0 to Week 16)||0
6764998|NCT03706040|7691598|FG006|Received Study Drug|Period A (Week 0 to Week 16)||0
6556370|NCT01759277|7478679|FG000|COMPLETED|Overall Study||41
6764999|NCT03706040|7691592|FG000|COMPLETED|Period A (Week 0 to Week 16)||25
6765000|NCT03706040|7691593|FG001|COMPLETED|Period A (Week 0 to Week 16)||61
6765001|NCT03706040|7691594|FG002|COMPLETED|Period A (Week 0 to Week 16)||58
6765002|NCT03706040|7691595|FG003|COMPLETED|Period A (Week 0 to Week 16)||0
6765003|NCT03706040|7691596|FG004|COMPLETED|Period A (Week 0 to Week 16)||0
6765004|NCT03706040|7691597|FG005|COMPLETED|Period A (Week 0 to Week 16)||0
6765005|NCT03706040|7691598|FG006|COMPLETED|Period A (Week 0 to Week 16)||0
6765006|NCT03706040|7691592|FG000|NOT COMPLETED|Period A (Week 0 to Week 16)||9
6765007|NCT03706040|7691593|FG001|NOT COMPLETED|Period A (Week 0 to Week 16)||8
6765008|NCT03706040|7691594|FG002|NOT COMPLETED|Period A (Week 0 to Week 16)||11
6765009|NCT03706040|7691595|FG003|NOT COMPLETED|Period A (Week 0 to Week 16)||0
6765010|NCT03706040|7691596|FG004|NOT COMPLETED|Period A (Week 0 to Week 16)||0
6765011|NCT03706040|7691597|FG005|NOT COMPLETED|Period A (Week 0 to Week 16)||0
6765012|NCT03706040|7691598|FG006|NOT COMPLETED|Period A (Week 0 to Week 16)||0
6765013|NCT03706040|7691592|FG000|STARTED|Period B (Week 16 to Week 52)||0
6765014|NCT03706040|7691593|FG001|STARTED|Period B (Week 16 to Week 52)||0
6765015|NCT03706040|7691594|FG002|STARTED|Period B (Week 16 to Week 52)||0
6765016|NCT03706040|7691595|FG003|STARTED|Period B (Week 16 to Week 52)||13
6765017|NCT03706040|7691596|FG004|STARTED|Period B (Week 16 to Week 52)||12
6765018|NCT03706040|7691597|FG005|STARTED|Period B (Week 16 to Week 52)||61
6765019|NCT03706040|7691598|FG006|STARTED|Period B (Week 16 to Week 52)||58
6765020|NCT03706040|7691592|FG000|Received Study Drug|Period B (Week 16 to Week 52)||0
6765021|NCT03706040|7691593|FG001|Received Study Drug|Period B (Week 16 to Week 52)||0
6765022|NCT03706040|7691594|FG002|Received Study Drug|Period B (Week 16 to Week 52)||0
6765023|NCT03706040|7691595|FG003|Received Study Drug|Period B (Week 16 to Week 52)||13
6765024|NCT03706040|7691596|FG004|Received Study Drug|Period B (Week 16 to Week 52)||11
6765025|NCT03706040|7691597|FG005|Received Study Drug|Period B (Week 16 to Week 52)||61
6765026|NCT03706040|7691598|FG006|Received Study Drug|Period B (Week 16 to Week 52)||57
6765027|NCT03706040|7691592|FG000|COMPLETED|Period B (Week 16 to Week 52)||0
6765028|NCT03706040|7691593|FG001|COMPLETED|Period B (Week 16 to Week 52)||0
6765029|NCT03706040|7691594|FG002|COMPLETED|Period B (Week 16 to Week 52)||0
6765030|NCT03706040|7691595|FG003|COMPLETED|Period B (Week 16 to Week 52)||5
6765031|NCT03706040|7691596|FG004|COMPLETED|Period B (Week 16 to Week 52)||3
6765032|NCT03706040|7691597|FG005|COMPLETED|Period B (Week 16 to Week 52)||33
6765033|NCT03706040|7691598|FG006|COMPLETED|Period B (Week 16 to Week 52)||30
6765034|NCT03706040|7691592|FG000|NOT COMPLETED|Period B (Week 16 to Week 52)||0
6765035|NCT03706040|7691593|FG001|NOT COMPLETED|Period B (Week 16 to Week 52)||0
6765036|NCT03706040|7691594|FG002|NOT COMPLETED|Period B (Week 16 to Week 52)||0
6765037|NCT03706040|7691595|FG003|NOT COMPLETED|Period B (Week 16 to Week 52)||8
6765038|NCT03706040|7691596|FG004|NOT COMPLETED|Period B (Week 16 to Week 52)||9
6765039|NCT03706040|7691597|FG005|NOT COMPLETED|Period B (Week 16 to Week 52)||28
6765040|NCT03706040|7691598|FG006|NOT COMPLETED|Period B (Week 16 to Week 52)||28
6765041|NCT03706313|7691616|FG000|STARTED|Overall Study||20
6765042|NCT03706313|7691617|FG001|STARTED|Overall Study||20
6765043|NCT03706313|7691616|FG000|COMPLETED|Overall Study||20
6765044|NCT03706313|7691617|FG001|COMPLETED|Overall Study||20
6765045|NCT03706313|7691616|FG000|NOT COMPLETED|Overall Study||0
6765046|NCT03706313|7691617|FG001|NOT COMPLETED|Overall Study||0
6765047|NCT03706456|7691623|FG000|STARTED|Overall Study||22
6765048|NCT03706456|7691623|FG000|Started|Overall Study||22
6765049|NCT03706456|7691623|FG000|Completed|Overall Study||0
6765050|NCT03706456|7691623|FG000|COMPLETED|Overall Study||0
6765051|NCT03706456|7691623|FG000|NOT COMPLETED|Overall Study||22
6765052|NCT03706469|7691631|FG000|STARTED|Overall Study||4
6765053|NCT03706469|7691632|FG001|STARTED|Overall Study||4
6765054|NCT03706469|7691633|FG002|STARTED|Overall Study||4
6765055|NCT03706469|7691634|FG003|STARTED|Overall Study||4
6765056|NCT03706469|7691631|FG000|COMPLETED|Overall Study||4
6765057|NCT03706469|7691632|FG001|COMPLETED|Overall Study||4
6765058|NCT03706469|7691633|FG002|COMPLETED|Overall Study||4
6765059|NCT03706469|7691634|FG003|COMPLETED|Overall Study||4
6765060|NCT03706469|7691631|FG000|NOT COMPLETED|Overall Study||0
6765061|NCT03706469|7691632|FG001|NOT COMPLETED|Overall Study||0
6765062|NCT03706469|7691633|FG002|NOT COMPLETED|Overall Study||0
6765063|NCT03706469|7691634|FG003|NOT COMPLETED|Overall Study||0
6765064|NCT03707041|7691651|FG000|STARTED|Overall Study||6
6765065|NCT03707041|7691652|FG001|STARTED|Overall Study||2
6765066|NCT03707041|7691653|FG002|STARTED|Overall Study||9
6765067|NCT03707041|7691654|FG003|STARTED|Overall Study||3
6765068|NCT03707041|7691655|FG004|STARTED|Overall Study||9
6765069|NCT03707041|7691656|FG005|STARTED|Overall Study||3
6765070|NCT03707041|7691651|FG000|COMPLETED|Overall Study||6
6765071|NCT03707041|7691652|FG001|COMPLETED|Overall Study||2
6765072|NCT03707041|7691653|FG002|COMPLETED|Overall Study||9
6765073|NCT03707041|7691654|FG003|COMPLETED|Overall Study||3
6765074|NCT03707041|7691655|FG004|COMPLETED|Overall Study||9
6765075|NCT03707041|7691656|FG005|COMPLETED|Overall Study||3
6765076|NCT03707041|7691651|FG000|NOT COMPLETED|Overall Study||0
6765077|NCT03707041|7691652|FG001|NOT COMPLETED|Overall Study||0
6765078|NCT03707041|7691653|FG002|NOT COMPLETED|Overall Study||0
6765079|NCT03707041|7691654|FG003|NOT COMPLETED|Overall Study||0
6765080|NCT03707041|7691655|FG004|NOT COMPLETED|Overall Study||0
6765081|NCT03707041|7691656|FG005|NOT COMPLETED|Overall Study||0
6765082|NCT03707522|7691675|FG000|STARTED|Overall Study||31
6765083|NCT03707522|7691676|FG001|STARTED|Overall Study||36
6765084|NCT03707522|7691677|FG002|STARTED|Overall Study||52
6765085|NCT03707522|7691678|FG003|STARTED|Overall Study||43
6765086|NCT03707522|7691675|FG000|COMPLETED|Overall Study||7
6765087|NCT03707522|7691676|FG001|COMPLETED|Overall Study||9
6765088|NCT03707522|7691677|FG002|COMPLETED|Overall Study||11
6765089|NCT03707522|7691678|FG003|COMPLETED|Overall Study||7
6765090|NCT03707522|7691675|FG000|NOT COMPLETED|Overall Study||24
6765091|NCT03707522|7691676|FG001|NOT COMPLETED|Overall Study||27
6765092|NCT03707522|7691677|FG002|NOT COMPLETED|Overall Study||41
6765093|NCT03707522|7691678|FG003|NOT COMPLETED|Overall Study||36
6765094|NCT03707587|7691690|FG000|STARTED|Overall Study||7
6765095|NCT03707587|7691691|FG001|STARTED|Overall Study||2
6765096|NCT03707587|7691690|FG000|COMPLETED|Overall Study||7
6765097|NCT03707587|7691691|FG001|COMPLETED|Overall Study||1
6765098|NCT03707587|7691690|FG000|NOT COMPLETED|Overall Study||0
6765099|NCT03707587|7691691|FG001|NOT COMPLETED|Overall Study||1
6765100|NCT03707821|7691699|FG000|STARTED|Overall Study||125
6765101|NCT03707821|7691700|FG001|STARTED|Overall Study||126
6765102|NCT03707821|7691699|FG000|COMPLETED|Overall Study||123
6765103|NCT03707821|7691700|FG001|COMPLETED|Overall Study||125
6765104|NCT03707821|7691699|FG000|NOT COMPLETED|Overall Study||2
6765105|NCT03707821|7691700|FG001|NOT COMPLETED|Overall Study||1
6780260|NCT03212144|7708640|FG001|COMPLETED|Second Sequence (4 Weeks)||0
6780261|NCT03212144|7708639|FG000|NOT COMPLETED|Second Sequence (4 Weeks)||1
6780262|NCT03212144|7708640|FG001|NOT COMPLETED|Second Sequence (4 Weeks)||1
6780263|NCT03218163|7708646|FG000|STARTED|Overall Study||0
6780264|NCT03218163|7708646|FG000|COMPLETED|Overall Study||0
6780265|NCT03218163|7708646|FG000|NOT COMPLETED|Overall Study||0
6780266|NCT03172520|7708650|FG000|STARTED|Overall Study||10
6780267|NCT03172520|7708650|FG000|COMPLETED|Overall Study||0
6780268|NCT03172520|7708650|FG000|NOT COMPLETED|Overall Study||10
6780269|NCT03204539|7708656|FG000|STARTED|Overall Study||0
6780270|NCT03204539|7708657|FG001|STARTED|Overall Study||1
6780271|NCT03204539|7708656|FG000|COMPLETED|Overall Study||0
6780272|NCT03204539|7708657|FG001|COMPLETED|Overall Study||0
6780273|NCT03204539|7708656|FG000|NOT COMPLETED|Overall Study||0
6780274|NCT03204539|7708657|FG001|NOT COMPLETED|Overall Study||1
6780275|NCT03206216|7708665|FG000|STARTED|Overall Study||0
6780276|NCT03206216|7708666|FG001|STARTED|Overall Study||1
6780277|NCT03206216|7708665|FG000|COMPLETED|Overall Study||0
6780278|NCT03206216|7708666|FG001|COMPLETED|Overall Study||0
6780279|NCT03206216|7708665|FG000|NOT COMPLETED|Overall Study||0
6780280|NCT03206216|7708666|FG001|NOT COMPLETED|Overall Study||1
6780281|NCT03195660|7708672|FG000|STARTED|Overall Study||2
6780282|NCT03195660|7708672|FG000|COMPLETED|Overall Study||0
6780283|NCT03195660|7708672|FG000|NOT COMPLETED|Overall Study||2
6780284|NCT03195465|7708676|FG000|STARTED|Overall Study||0
6780285|NCT03195465|7708676|FG000|COMPLETED|Overall Study||0
6780286|NCT03195465|7708676|FG000|NOT COMPLETED|Overall Study||0
6780287|NCT03166618|7708682|FG000|STARTED|Overall Study||0
6780288|NCT03166618|7708683|FG001|STARTED|Overall Study||1
6780289|NCT03166618|7708682|FG000|COMPLETED|Overall Study||0
6780290|NCT03166618|7708683|FG001|COMPLETED|Overall Study||0
6780291|NCT03166618|7708682|FG000|NOT COMPLETED|Overall Study||0
6780292|NCT03166618|7708683|FG001|NOT COMPLETED|Overall Study||1
6780293|NCT03169530|7708691|FG000|STARTED|Overall Study||15
6780294|NCT03169530|7708692|FG001|STARTED|Overall Study||17
6780295|NCT03169530|7708691|FG000|COMPLETED|Overall Study||0
6780296|NCT03169530|7708692|FG001|COMPLETED|Overall Study||0
6780297|NCT03169530|7708691|FG000|NOT COMPLETED|Overall Study||15
6780298|NCT03169530|7708692|FG001|NOT COMPLETED|Overall Study||17
6780299|NCT03189433|7708700|FG000|STARTED|Overall Study||2
6780300|NCT03189433|7708701|FG001|STARTED|Overall Study||0
6780301|NCT03189433|7708700|FG000|COMPLETED|Overall Study||0
6780302|NCT03189433|7708701|FG001|COMPLETED|Overall Study||0
6780303|NCT03189433|7708700|FG000|NOT COMPLETED|Overall Study||2
6780304|NCT03189433|7708701|FG001|NOT COMPLETED|Overall Study||0
6780305|NCT03151226|7708707|FG000|STARTED|Overall Study||3
6780306|NCT03151226|7708707|FG000|COMPLETED|Overall Study||0
6780307|NCT03151226|7708707|FG000|NOT COMPLETED|Overall Study||3
6780308|NCT03165747|7708713|FG000|STARTED|Overall Study||0
6780309|NCT03165747|7708714|FG001|STARTED|Overall Study||0
6780310|NCT03165747|7708713|FG000|COMPLETED|Overall Study||0
6780311|NCT03165747|7708714|FG001|COMPLETED|Overall Study||0
6780312|NCT03165747|7708713|FG000|NOT COMPLETED|Overall Study||0
6780313|NCT03165747|7708714|FG001|NOT COMPLETED|Overall Study||0
6780314|NCT03168906|7708722|FG000|STARTED|Overall Study||6
6780315|NCT03168906|7708723|FG001|STARTED|Overall Study||6
6780316|NCT03168906|7708722|FG000|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
6780317|NCT03168906|7708723|FG001|COMPLETED|Overall Study|Study discontinued due to futile nature of drug|0
6780318|NCT03168906|7708722|FG000|NOT COMPLETED|Overall Study||6
6780319|NCT03168906|7708723|FG001|NOT COMPLETED|Overall Study||6
6780320|NCT03178201|7708730|FG000|STARTED|Overall Study||5
6780321|NCT03178201|7708730|FG000|COMPLETED|Overall Study||0
6780322|NCT03178201|7708730|FG000|NOT COMPLETED|Overall Study||5
6780323|NCT03172026|7708736|FG000|STARTED|Overall Study||2
6780324|NCT03172026|7708737|FG001|STARTED|Overall Study||0
6780325|NCT03172026|7708736|FG000|8 Week Assessment|Overall Study||0
6780326|NCT03172026|7708737|FG001|8 Week Assessment|Overall Study||0
6780327|NCT03172026|7708736|FG000|6 Month Assessment|Overall Study||0
6780328|NCT03172026|7708737|FG001|6 Month Assessment|Overall Study||0
6780329|NCT03172026|7708736|FG000|COMPLETED|Overall Study||0
6780330|NCT03172026|7708737|FG001|COMPLETED|Overall Study||0
6780331|NCT03172026|7708736|FG000|NOT COMPLETED|Overall Study||2
6780332|NCT03172026|7708737|FG001|NOT COMPLETED|Overall Study||0
6780333|NCT03152526|7708746|FG000|STARTED|Overall Study|No participants were enrolled on this arm.|0
6780334|NCT03152526|7708747|FG001|STARTED|Overall Study|One participant was enrolled on this arm.|1
6765106|NCT03707912|7691708|FG000|STARTED|Overall Study||104
6765107|NCT03707912|7691709|FG001|STARTED|Overall Study||100
6765108|NCT03707912|7691708|FG000|COMPLETED|Overall Study||103
6765109|NCT03707912|7691709|FG001|COMPLETED|Overall Study||100
6765110|NCT03707912|7691708|FG000|NOT COMPLETED|Overall Study||1
6765111|NCT03707912|7691709|FG001|NOT COMPLETED|Overall Study||0
6765112|NCT03708211|7691717|FG000|STARTED|Overall Study||12
6765113|NCT03708211|7691718|FG001|STARTED|Overall Study||8
6765114|NCT03708211|7691717|FG000|COMPLETED|Overall Study||0
6765115|NCT03708211|7691718|FG001|COMPLETED|Overall Study||0
6765116|NCT03708211|7691717|FG000|NOT COMPLETED|Overall Study||12
6765117|NCT03708211|7691718|FG001|NOT COMPLETED|Overall Study||8
6765118|NCT03708367|7691728|FG000|STARTED|Overall Study||59
6765119|NCT03708367|7691729|FG001|STARTED|Overall Study||58
6765120|NCT03708367|7691728|FG000|COMPLETED|Overall Study||58
6765121|NCT03708367|7691729|FG001|COMPLETED|Overall Study||57
6765122|NCT03708367|7691728|FG000|NOT COMPLETED|Overall Study||1
6765123|NCT03708367|7691729|FG001|NOT COMPLETED|Overall Study||1
6765124|NCT03708393|7691736|FG000|STARTED|Overall Study||155
6765125|NCT03708393|7691736|FG000|COMPLETED|Overall Study||155
6765126|NCT03708393|7691736|FG000|NOT COMPLETED|Overall Study||0
6765127|NCT03708562|7691745|FG000|STARTED|Overall Study||24
6765128|NCT03708562|7691745|FG000|COMPLETED|Overall Study||12
6765129|NCT03708562|7691745|FG000|NOT COMPLETED|Overall Study||12
6765130|NCT03708744|7691749|FG000|STARTED|Overall Study||7
6765131|NCT03708744|7691750|FG001|STARTED|Overall Study||6
6765132|NCT03708744|7691751|FG002|STARTED|Overall Study||5
6765133|NCT03708744|7691752|FG003|STARTED|Overall Study||6
6765134|NCT03708744|7691749|FG000|COMPLETED|Overall Study||7
6765135|NCT03708744|7691750|FG001|COMPLETED|Overall Study||6
6765136|NCT03708744|7691751|FG002|COMPLETED|Overall Study||4
6765137|NCT03708744|7691752|FG003|COMPLETED|Overall Study||6
6765138|NCT03708744|7691749|FG000|NOT COMPLETED|Overall Study||0
6765139|NCT03708744|7691750|FG001|NOT COMPLETED|Overall Study||0
6765140|NCT03708744|7691751|FG002|NOT COMPLETED|Overall Study||1
6765141|NCT03708744|7691752|FG003|NOT COMPLETED|Overall Study||0
6765142|NCT03708770|7691762|FG000|STARTED|Overall Study||32
6765143|NCT03708770|7691762|FG000|COMPLETED|Overall Study||22
6765144|NCT03708770|7691762|FG000|NOT COMPLETED|Overall Study||10
6765145|NCT03709602|7691769|FG000|STARTED|Overall Study|Adolescents recruited for qualitative interviews.|16
6765146|NCT03709602|7691770|FG001|STARTED|Overall Study|Parents recruited for qualitative interviews.|16
6765147|NCT03709602|7691771|FG002|STARTED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
6765148|NCT03709602|7691769|FG000|COMPLETED|Overall Study|Adolescents recruited for qualitative interviews.|16
6765149|NCT03709602|7691770|FG001|COMPLETED|Overall Study|Parents recruited for qualitative interviews.|16
6765150|NCT03709602|7691771|FG002|COMPLETED|Overall Study|Cohort of adolescents created from the EHR data for the quantitative portion of the study.|3044
6765151|NCT03709602|7691769|FG000|NOT COMPLETED|Overall Study||0
6765152|NCT03709602|7691770|FG001|NOT COMPLETED|Overall Study||0
6765153|NCT03709602|7691771|FG002|NOT COMPLETED|Overall Study||0
6765154|NCT03709654|7691779|FG000|STARTED|Overall Study||23
6765155|NCT03709654|7691780|FG001|STARTED|Overall Study||13
6765156|NCT03709654|7691779|FG000|COMPLETED|Overall Study||20
6765157|NCT03709654|7691780|FG001|COMPLETED|Overall Study||11
6765158|NCT03709654|7691779|FG000|NOT COMPLETED|Overall Study||3
6765159|NCT03709654|7691780|FG001|NOT COMPLETED|Overall Study||2
6765160|NCT03709810|7691786|FG000|STARTED|Treatment Period 1 (Visit 2)||24
6765161|NCT03709810|7691787|FG001|STARTED|Treatment Period 1 (Visit 2)||24
6765162|NCT03709810|7691786|FG000|COMPLETED|Treatment Period 1 (Visit 2)||24
6765163|NCT03709810|7691787|FG001|COMPLETED|Treatment Period 1 (Visit 2)||24
6765164|NCT03709810|7691786|FG000|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
6765165|NCT03709810|7691787|FG001|NOT COMPLETED|Treatment Period 1 (Visit 2)||0
6765166|NCT03709810|7691786|FG000|STARTED|Treatment Period 2 (Visit 3)||24
6765167|NCT03709810|7691787|FG001|STARTED|Treatment Period 2 (Visit 3)||24
6765168|NCT03709810|7691786|FG000|COMPLETED|Treatment Period 2 (Visit 3)||24
6765169|NCT03709810|7691787|FG001|COMPLETED|Treatment Period 2 (Visit 3)||24
6765170|NCT03709810|7691786|FG000|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
6765171|NCT03709810|7691787|FG001|NOT COMPLETED|Treatment Period 2 (Visit 3)||0
6765172|NCT03709823|7691799|FG000|STARTED|Overall Study||51
6765173|NCT03709823|7691800|FG001|STARTED|Overall Study||50
6765174|NCT03709823|7691801|FG002|STARTED|Overall Study||25
6765175|NCT03709823|7691802|FG003|STARTED|Overall Study||52
6765176|NCT03709823|7691803|FG004|STARTED|Overall Study||50
6765177|NCT03709823|7691804|FG005|STARTED|Overall Study||26
6765178|NCT03709823|7691799|FG000|COMPLETED|Overall Study||48
6765179|NCT03709823|7691800|FG001|COMPLETED|Overall Study||45
6765180|NCT03709823|7691801|FG002|COMPLETED|Overall Study||22
6765181|NCT03709823|7691802|FG003|COMPLETED|Overall Study||50
6765182|NCT03709823|7691803|FG004|COMPLETED|Overall Study||49
6765183|NCT03709823|7691804|FG005|COMPLETED|Overall Study||26
6765184|NCT03709823|7691799|FG000|NOT COMPLETED|Overall Study||3
6765185|NCT03709823|7691800|FG001|NOT COMPLETED|Overall Study||5
6765186|NCT03709823|7691801|FG002|NOT COMPLETED|Overall Study||3
6765187|NCT03709823|7691802|FG003|NOT COMPLETED|Overall Study||2
6765188|NCT03709823|7691803|FG004|NOT COMPLETED|Overall Study||1
6765189|NCT03709823|7691804|FG005|NOT COMPLETED|Overall Study||0
6765190|NCT03710083|7691821|FG000|STARTED|Overall Study||66
6765191|NCT03710083|7691821|FG000|COMPLETED|Overall Study||63
6765192|NCT03710083|7691821|FG000|NOT COMPLETED|Overall Study||3
6765193|NCT03710161|7691827|FG000|STARTED|Overall Study||3
6765194|NCT03710161|7691828|FG001|STARTED|Overall Study||2
6765195|NCT03710161|7691827|FG000|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
6765196|NCT03710161|7691828|FG001|COMPLETED|Overall Study|Study halted due to COVID pandemic|0
6765197|NCT03710161|7691827|FG000|NOT COMPLETED|Overall Study||3
6765198|NCT03710161|7691828|FG001|NOT COMPLETED|Overall Study||2
6765199|NCT03710187|7691836|FG000|STARTED|Overall Study||41
6765200|NCT03710187|7691837|FG001|STARTED|Overall Study||43
6765201|NCT03710187|7691836|FG000|COMPLETED|Overall Study||41
6765202|NCT03710187|7691837|FG001|COMPLETED|Overall Study||43
6765203|NCT03710187|7691836|FG000|NOT COMPLETED|Overall Study||0
6765204|NCT03710187|7691837|FG001|NOT COMPLETED|Overall Study||0
6765205|NCT03710577|7691845|FG000|STARTED|First Intervention||8
6765206|NCT03710577|7691846|FG001|STARTED|First Intervention||4
6765207|NCT03710577|7691845|FG000|COMPLETED|First Intervention||8
6765208|NCT03710577|7691846|FG001|COMPLETED|First Intervention||4
6765209|NCT03710577|7691845|FG000|NOT COMPLETED|First Intervention||0
6765210|NCT03710577|7691846|FG001|NOT COMPLETED|First Intervention||0
6765211|NCT03710577|7691845|FG000|STARTED|Time Between Sessions (2-5 Days)||8
6765212|NCT03710577|7691846|FG001|STARTED|Time Between Sessions (2-5 Days)||4
6765213|NCT03710577|7691845|FG000|COMPLETED|Time Between Sessions (2-5 Days)||8
6765214|NCT03710577|7691846|FG001|COMPLETED|Time Between Sessions (2-5 Days)||4
6765215|NCT03710577|7691845|FG000|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
6765216|NCT03710577|7691846|FG001|NOT COMPLETED|Time Between Sessions (2-5 Days)||0
6765217|NCT03710577|7691845|FG000|STARTED|Second Intervention||8
6765218|NCT03710577|7691846|FG001|STARTED|Second Intervention||4
6765219|NCT03710577|7691845|FG000|COMPLETED|Second Intervention||8
6765220|NCT03710577|7691846|FG001|COMPLETED|Second Intervention||4
6765221|NCT03710577|7691845|FG000|NOT COMPLETED|Second Intervention||0
6765222|NCT03710577|7691846|FG001|NOT COMPLETED|Second Intervention||0
6765223|NCT03710590|7691854|FG000|STARTED|Overall Study||22
6765224|NCT03710590|7691855|FG001|STARTED|Overall Study||23
6765225|NCT03710590|7691854|FG000|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||12
6765226|NCT03710590|7691855|FG001|Session 1: ECIG Lab Session 15 Watts, 10 mg Nicotine|Overall Study||15
6765227|NCT03710590|7691854|FG000|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||12
6765228|NCT03710590|7691855|FG001|Session 2: ECIG Lab Session 15 Watts, 15 mg Nicotine|Overall Study||15
6765229|NCT03710590|7691854|FG000|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||12
6765230|NCT03710590|7691855|FG001|Session 3: ECIG Lab Session 15 Watts, 30 mg Nicotine|Overall Study||15
6765231|NCT03710590|7691854|FG000|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||12
6765232|NCT03710590|7691855|FG001|Session 4: ECIG Lab Session 30 Watts, 10 mg Nicotine|Overall Study||15
6765233|NCT03710590|7691854|FG000|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||12
6765234|NCT03710590|7691855|FG001|Session 5: ECIG Lab Session 30 Watts, 15 mg Nicotine|Overall Study||15
6765235|NCT03710590|7691854|FG000|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||12
6765236|NCT03710590|7691855|FG001|Session 6: ECIG Lab Session 30 Watts, 30 mg Nicotine|Overall Study||15
6765237|NCT03710590|7691854|FG000|COMPLETED|Overall Study||12
6765238|NCT03710590|7691855|FG001|COMPLETED|Overall Study||15
6765239|NCT03710590|7691854|FG000|NOT COMPLETED|Overall Study||10
6765240|NCT03710590|7691855|FG001|NOT COMPLETED|Overall Study||8
6765241|NCT03710889|7691861|FG000|STARTED|Overall Study||23
6765242|NCT03710889|7691861|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
6765243|NCT03710889|7691861|FG000|Bone-Biopsy Population|Overall Study||19
6765244|NCT03710889|7691861|FG000|COMPLETED|Overall Study||20
6765245|NCT03710889|7691861|FG000|NOT COMPLETED|Overall Study||3
6765246|NCT03711396|7691865|FG000|STARTED|Overall Study||13
6765247|NCT03711396|7691866|FG001|STARTED|Overall Study||13
6765248|NCT03711396|7691865|FG000|COMPLETED|Overall Study||13
6765249|NCT03711396|7691866|FG001|COMPLETED|Overall Study||13
6765250|NCT03711396|7691865|FG000|NOT COMPLETED|Overall Study||0
6765251|NCT03711396|7691866|FG001|NOT COMPLETED|Overall Study||0
6765252|NCT03711578|7691873|FG000|STARTED|Overall Study||20
6765253|NCT03711578|7691873|FG000|COMPLETED|Overall Study||20
6765254|NCT03711578|7691873|FG000|NOT COMPLETED|Overall Study||0
6765255|NCT03712189|7691879|FG000|STARTED|Overall Study||15
6765256|NCT03712189|7691880|FG001|STARTED|Overall Study||15
6765257|NCT03712189|7691879|FG000|COMPLETED|Overall Study||15
6765258|NCT03712189|7691880|FG001|COMPLETED|Overall Study||15
6765259|NCT03712189|7691879|FG000|NOT COMPLETED|Overall Study||0
6765260|NCT03712189|7691880|FG001|NOT COMPLETED|Overall Study||0
6765261|NCT03712280|7691890|FG000|STARTED|Overall Study||12
6765262|NCT03712280|7691891|FG001|STARTED|Overall Study||12
6765263|NCT03712280|7691892|FG002|STARTED|Overall Study||13
6765264|NCT03712280|7691893|FG003|STARTED|Overall Study||13
6765265|NCT03712280|7691890|FG000|Safety Population|Overall Study||12
6765266|NCT03712280|7691891|FG001|Safety Population|Overall Study||11
6765267|NCT03712280|7691892|FG002|Safety Population|Overall Study||13
6765268|NCT03712280|7691893|FG003|Safety Population|Overall Study||12
6765269|NCT03712280|7691890|FG000|Modified Intent to Treat Population|Overall Study||12
6765270|NCT03712280|7691891|FG001|Modified Intent to Treat Population|Overall Study||11
6765271|NCT03712280|7691892|FG002|Modified Intent to Treat Population|Overall Study||13
6765272|NCT03712280|7691893|FG003|Modified Intent to Treat Population|Overall Study||12
6765273|NCT03712280|7691890|FG000|Completed 5 Day Treatment|Overall Study||11
6765274|NCT03712280|7691891|FG001|Completed 5 Day Treatment|Overall Study||11
6765275|NCT03712280|7691892|FG002|Completed 5 Day Treatment|Overall Study||12
6765276|NCT03712280|7691893|FG003|Completed 5 Day Treatment|Overall Study||12
6765277|NCT03712280|7691890|FG000|COMPLETED|Overall Study||11
6765278|NCT03712280|7691891|FG001|COMPLETED|Overall Study||11
6765279|NCT03712280|7691892|FG002|COMPLETED|Overall Study||12
6765280|NCT03712280|7691893|FG003|COMPLETED|Overall Study||12
6765281|NCT03712280|7691890|FG000|NOT COMPLETED|Overall Study||1
6765282|NCT03712280|7691891|FG001|NOT COMPLETED|Overall Study||1
6765283|NCT03712280|7691892|FG002|NOT COMPLETED|Overall Study||1
6765284|NCT03712280|7691893|FG003|NOT COMPLETED|Overall Study||1
6765285|NCT03712449|7691905|FG000|STARTED|Overall Study||13
6765286|NCT03712449|7691906|FG001|STARTED|Overall Study||46
6765287|NCT03712449|7691905|FG000|Full Analysis Population|Overall Study||13
6765288|NCT03712449|7691906|FG001|Full Analysis Population|Overall Study||45
6765289|NCT03712449|7691905|FG000|COMPLETED|Overall Study||13
6765290|NCT03712449|7691906|FG001|COMPLETED|Overall Study||45
6765291|NCT03712449|7691905|FG000|NOT COMPLETED|Overall Study||0
6765292|NCT03712449|7691906|FG001|NOT COMPLETED|Overall Study||1
6765293|NCT03712852|7691915|FG000|STARTED|Overall Study||20
6765294|NCT03712852|7691916|FG001|STARTED|Overall Study||20
6765295|NCT03712852|7691917|FG002|STARTED|Overall Study||20
6765296|NCT03712852|7691915|FG000|COMPLETED|Overall Study||20
6765297|NCT03712852|7691916|FG001|COMPLETED|Overall Study||20
6765298|NCT03712852|7691917|FG002|COMPLETED|Overall Study||20
6765299|NCT03712852|7691915|FG000|NOT COMPLETED|Overall Study||0
6765300|NCT03712852|7691916|FG001|NOT COMPLETED|Overall Study||0
6765301|NCT03712852|7691917|FG002|NOT COMPLETED|Overall Study||0
6765302|NCT03712917|7691928|FG000|STARTED|Overall Study||40
6765303|NCT03712917|7691929|FG001|STARTED|Overall Study||40
6765304|NCT03712917|7691930|FG002|STARTED|Overall Study||40
6765305|NCT03712917|7691928|FG000|COMPLETED|Overall Study||31
6765306|NCT03712917|7691929|FG001|COMPLETED|Overall Study||32
6765307|NCT03712917|7691930|FG002|COMPLETED|Overall Study||31
6765308|NCT03712917|7691928|FG000|NOT COMPLETED|Overall Study||9
6765309|NCT03712917|7691929|FG001|NOT COMPLETED|Overall Study||8
6765310|NCT03712917|7691930|FG002|NOT COMPLETED|Overall Study||9
6765311|NCT03712930|7691938|FG000|STARTED|Overall Study||13
6765312|NCT03712930|7691938|FG000|COMPLETED|Overall Study||0
6765313|NCT03712930|7691938|FG000|NOT COMPLETED|Overall Study||13
6765314|NCT03713398|7691944|FG000|STARTED|Overall Study||50
6765315|NCT03713398|7691945|FG001|STARTED|Overall Study||50
6765316|NCT03713398|7691944|FG000|COMPLETED|Overall Study||24
6765317|NCT03713398|7691945|FG001|COMPLETED|Overall Study||23
6765318|NCT03713398|7691944|FG000|NOT COMPLETED|Overall Study||26
6765319|NCT03713398|7691945|FG001|NOT COMPLETED|Overall Study||27
6765320|NCT03714022|7691953|FG000|STARTED|Overall Study||70
6765321|NCT03714022|7691954|FG001|STARTED|Overall Study||70
6765322|NCT03714022|7691953|FG000|COMPLETED|Overall Study||66
6765323|NCT03714022|7691954|FG001|COMPLETED|Overall Study||67
6765324|NCT03714022|7691953|FG000|NOT COMPLETED|Overall Study||4
6765325|NCT03714022|7691954|FG001|NOT COMPLETED|Overall Study||3
6765326|NCT03714256|7691962|FG000|STARTED|Overall Study||14
6765327|NCT03714256|7691963|FG001|STARTED|Overall Study||19
6765328|NCT03714256|7691962|FG000|COMPLETED|Overall Study||14
6765329|NCT03714256|7691963|FG001|COMPLETED|Overall Study||19
6765330|NCT03714256|7691962|FG000|NOT COMPLETED|Overall Study||0
6765331|NCT03714256|7691963|FG001|NOT COMPLETED|Overall Study||0
6765332|NCT03714659|7691969|FG000|STARTED|Overall Study||20
6765333|NCT03714659|7691969|FG000|COMPLETED|Overall Study||19
6765334|NCT03714659|7691969|FG000|NOT COMPLETED|Overall Study||1
6765335|NCT03714672|7691977|FG000|STARTED|Overall Study||209
6765336|NCT03714672|7691978|FG001|STARTED|Overall Study||206
6765337|NCT03714672|7691979|FG002|STARTED|Overall Study||206
6765338|NCT03714672|7691980|FG003|STARTED|Overall Study||208
6765339|NCT03714672|7691977|FG000|Safety Set|Overall Study||208
6765340|NCT03714672|7691978|FG001|Safety Set|Overall Study||205
6765341|NCT03714672|7691979|FG002|Safety Set|Overall Study||206
6765342|NCT03714672|7691980|FG003|Safety Set|Overall Study||207
6765343|NCT03714672|7691977|FG000|COMPLETED|Overall Study||207
6765344|NCT03714672|7691978|FG001|COMPLETED|Overall Study||202
6765345|NCT03714672|7691979|FG002|COMPLETED|Overall Study||202
6765346|NCT03714672|7691980|FG003|COMPLETED|Overall Study||207
6765347|NCT03714672|7691977|FG000|NOT COMPLETED|Overall Study||2
6765348|NCT03714672|7691978|FG001|NOT COMPLETED|Overall Study||4
6765349|NCT03714672|7691979|FG002|NOT COMPLETED|Overall Study||4
6765350|NCT03714672|7691980|FG003|NOT COMPLETED|Overall Study||1
6765351|NCT03714919|7691991|FG000|STARTED|Overall Study||10
6765352|NCT03714919|7691991|FG000|COMPLETED|Overall Study||10
6765353|NCT03714919|7691991|FG000|NOT COMPLETED|Overall Study||0
6765354|NCT03715426|7691997|FG000|STARTED|Overall Study||133
6765355|NCT03715426|7691998|FG001|STARTED|Overall Study||117
6765356|NCT03715426|7691997|FG000|1-Month Follow-Up Survey|Overall Study||113
6765357|NCT03715426|7691998|FG001|1-Month Follow-Up Survey|Overall Study||97
6765358|NCT03715426|7691997|FG000|4-Month Follow-Up Survey|Overall Study||112
6765359|NCT03715426|7691998|FG001|4-Month Follow-Up Survey|Overall Study||92
6765360|NCT03715426|7691997|FG000|COMPLETED|Overall Study||112
6765361|NCT03715426|7691998|FG001|COMPLETED|Overall Study||92
6765362|NCT03715426|7691997|FG000|NOT COMPLETED|Overall Study||21
6765363|NCT03715426|7691998|FG001|NOT COMPLETED|Overall Study||25
6765364|NCT03715452|7692004|FG000|STARTED|Overall Study||114
6765365|NCT03715452|7692004|FG000|COMPLETED|Overall Study||114
6765366|NCT03715452|7692004|FG000|NOT COMPLETED|Overall Study||0
6765367|NCT03715530|7692011|FG000|STARTED|Overall Study||33
6765368|NCT03715530|7692012|FG001|STARTED|Overall Study||42
6765369|NCT03715530|7692013|FG002|STARTED|Overall Study||87
6765370|NCT03715530|7692011|FG000|COMPLETED|Overall Study||30
6765371|NCT03715530|7692012|FG001|COMPLETED|Overall Study||41
6765372|NCT03715530|7692013|FG002|COMPLETED|Overall Study||85
6765373|NCT03715530|7692011|FG000|NOT COMPLETED|Overall Study||3
6765374|NCT03715530|7692012|FG001|NOT COMPLETED|Overall Study||1
6765375|NCT03715530|7692013|FG002|NOT COMPLETED|Overall Study||2
6765376|NCT03715803|7692023|FG000|STARTED|Overall Study||91
6765377|NCT03715803|7692024|FG001|STARTED|Overall Study||126
6765378|NCT03715803|7692023|FG000|COMPLETED|Overall Study||91
6765379|NCT03715803|7692024|FG001|COMPLETED|Overall Study||126
6765380|NCT03715803|7692023|FG000|NOT COMPLETED|Overall Study||0
6765381|NCT03715803|7692024|FG001|NOT COMPLETED|Overall Study||0
6765382|NCT03716024|7692032|FG000|STARTED|Overall Study||118
6765383|NCT03716024|7692033|FG001|STARTED|Overall Study||116
6765384|NCT03716024|7692032|FG000|COMPLETED|Overall Study||107
6765385|NCT03716024|7692033|FG001|COMPLETED|Overall Study||98
6765386|NCT03716024|7692032|FG000|NOT COMPLETED|Overall Study||11
6765387|NCT03716024|7692033|FG001|NOT COMPLETED|Overall Study||18
6765388|NCT03716050|7692047|FG000|STARTED|Overall Study||2
6765389|NCT03716050|7692048|FG001|STARTED|Overall Study||4
6765390|NCT03716050|7692049|FG002|STARTED|Overall Study||1
6765391|NCT03716050|7692050|FG003|STARTED|Overall Study||3
6765392|NCT03716050|7692051|FG004|STARTED|Overall Study||1
6765393|NCT03716050|7692052|FG005|STARTED|Overall Study||0
6765394|NCT03716050|7692053|FG006|STARTED|Overall Study||4
6765395|NCT03716050|7692054|FG007|STARTED|Overall Study||2
6765396|NCT03716050|7692047|FG000|COMPLETED|Overall Study||2
6765397|NCT03716050|7692048|FG001|COMPLETED|Overall Study||4
6765398|NCT03716050|7692049|FG002|COMPLETED|Overall Study||0
6765399|NCT03716050|7692050|FG003|COMPLETED|Overall Study||1
6765400|NCT03716050|7692051|FG004|COMPLETED|Overall Study||1
6765401|NCT03716050|7692052|FG005|COMPLETED|Overall Study||0
6765402|NCT03716050|7692053|FG006|COMPLETED|Overall Study||4
6765403|NCT03716050|7692054|FG007|COMPLETED|Overall Study||0
6765404|NCT03716050|7692047|FG000|NOT COMPLETED|Overall Study||0
6765405|NCT03716050|7692048|FG001|NOT COMPLETED|Overall Study||0
6765406|NCT03716050|7692049|FG002|NOT COMPLETED|Overall Study||1
6765407|NCT03716050|7692050|FG003|NOT COMPLETED|Overall Study||2
6765408|NCT03716050|7692051|FG004|NOT COMPLETED|Overall Study||0
6765409|NCT03716050|7692052|FG005|NOT COMPLETED|Overall Study||0
6765410|NCT03716050|7692053|FG006|NOT COMPLETED|Overall Study||0
6765411|NCT03716050|7692054|FG007|NOT COMPLETED|Overall Study||2
6765412|NCT03716076|7692073|FG000|STARTED|Overall Study||25
6765413|NCT03716076|7692074|FG001|STARTED|Overall Study||25
6765414|NCT03716076|7692073|FG000|COMPLETED|Overall Study||22
6765415|NCT03716076|7692074|FG001|COMPLETED|Overall Study||19
6765416|NCT03716076|7692073|FG000|NOT COMPLETED|Overall Study||3
6765417|NCT03716076|7692074|FG001|NOT COMPLETED|Overall Study||6
6765418|NCT03717012|7692082|FG000|STARTED|Overall Study||9
6765419|NCT03717012|7692083|FG001|STARTED|Overall Study||10
6765420|NCT03717012|7692082|FG000|COMPLETED|Overall Study||8
6765421|NCT03717012|7692083|FG001|COMPLETED|Overall Study||4
6765422|NCT03717012|7692082|FG000|NOT COMPLETED|Overall Study||1
6765423|NCT03717012|7692083|FG001|NOT COMPLETED|Overall Study||6
6765424|NCT03717051|7692091|FG000|STARTED|Overall Study||352
6765425|NCT03717051|7692092|FG001|STARTED|Overall Study||482
6765426|NCT03717051|7692091|FG000|COMPLETED|Overall Study||352
6765427|NCT03717051|7692092|FG001|COMPLETED|Overall Study||482
6765428|NCT03717051|7692091|FG000|NOT COMPLETED|Overall Study||0
6765429|NCT03717051|7692092|FG001|NOT COMPLETED|Overall Study||0
6765430|NCT03717064|7692098|FG000|STARTED|Period 1||18
6765431|NCT03717064|7692098|FG000|COMPLETED|Period 1||18
6765432|NCT03717064|7692098|FG000|NOT COMPLETED|Period 1||0
6765433|NCT03717064|7692098|FG000|STARTED|Period 2||18
6765434|NCT03717064|7692098|FG000|COMPLETED|Period 2||17
6765435|NCT03717064|7692098|FG000|NOT COMPLETED|Period 2||1
6765436|NCT03717155|7692102|FG000|STARTED|Overall Study||43
6765437|NCT03717155|7692102|FG000|COMPLETED|Overall Study||43
6765438|NCT03717155|7692102|FG000|NOT COMPLETED|Overall Study||0
6765439|NCT03717506|7692109|FG000|STARTED|Overall Study||496
6765440|NCT03717506|7692110|FG001|STARTED|Overall Study||491
6765441|NCT03717506|7692111|FG002|STARTED|Overall Study||249
6765442|NCT03717506|7692109|FG000|COMPLETED|Overall Study||447
6765443|NCT03717506|7692110|FG001|COMPLETED|Overall Study||441
6765444|NCT03717506|7692111|FG002|COMPLETED|Overall Study||222
6765445|NCT03717506|7692109|FG000|NOT COMPLETED|Overall Study||49
6765446|NCT03717506|7692110|FG001|NOT COMPLETED|Overall Study||50
6765447|NCT03717506|7692111|FG002|NOT COMPLETED|Overall Study||27
6765448|NCT03718000|7692121|FG000|STARTED|Overall Study||55
6765449|NCT03718000|7692122|FG001|STARTED|Overall Study||56
6765450|NCT03718000|7692121|FG000|COMPLETED|Overall Study||53
6765451|NCT03718000|7692122|FG001|COMPLETED|Overall Study||51
6765452|NCT03718000|7692121|FG000|NOT COMPLETED|Overall Study||2
6765453|NCT03718000|7692122|FG001|NOT COMPLETED|Overall Study||5
6765454|NCT03718871|7692131|FG000|STARTED|Overall Study||250
6765455|NCT03718871|7692132|FG001|STARTED|Overall Study||250
6765456|NCT03718871|7692131|FG000|COMPLETED|Overall Study||250
6765457|NCT03718871|7692132|FG001|COMPLETED|Overall Study||250
6765458|NCT03718871|7692131|FG000|NOT COMPLETED|Overall Study||0
6765459|NCT03718871|7692132|FG001|NOT COMPLETED|Overall Study||0
6765460|NCT03719300|7692139|FG000|STARTED|Overall Study||32
6765461|NCT03719300|7692139|FG000|COMPLETED|Overall Study||32
6765462|NCT03719300|7692139|FG000|NOT COMPLETED|Overall Study||0
6765463|NCT03719378|7692145|FG000|STARTED|Overall Study||75
6765464|NCT03719378|7692146|FG001|STARTED|Overall Study||75
6765465|NCT03719378|7692145|FG000|COMPLETED|Overall Study||65
6765466|NCT03719378|7692146|FG001|COMPLETED|Overall Study||65
6765467|NCT03719378|7692145|FG000|NOT COMPLETED|Overall Study||10
6765468|NCT03719378|7692146|FG001|NOT COMPLETED|Overall Study||10
6765469|NCT03719586|7692156|FG000|STARTED|Overall Study||177
6765470|NCT03719586|7692157|FG001|STARTED|Overall Study||176
6765471|NCT03719586|7692158|FG002|STARTED|Overall Study|The REGN-EB3 arm was added in 1/2019 after the trial had initially begun in November 2018.|158
6765472|NCT03719586|7692159|FG003|STARTED|Overall Study||169
6765473|NCT03719586|7692156|FG000|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
6765474|NCT03719586|7692157|FG001|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
6765475|NCT03719586|7692158|FG002|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|154
6765476|NCT03719586|7692159|FG003|COMPLETED|Overall Study|in 8/2019 the DSMB recommended further randomization only occur to the MAb114 and REGN-EB3 arms.|169
6765477|NCT03719586|7692156|FG000|NOT COMPLETED|Overall Study||8
6765478|NCT03719586|7692157|FG001|NOT COMPLETED|Overall Study||7
6765479|NCT03719586|7692158|FG002|NOT COMPLETED|Overall Study||4
6765480|NCT03719586|7692159|FG003|NOT COMPLETED|Overall Study||0
6765481|NCT03719612|7692169|FG000|STARTED|Overall Study||160
6765482|NCT03719612|7692169|FG000|COMPLETED|Overall Study||148
6765483|NCT03719612|7692169|FG000|NOT COMPLETED|Overall Study||12
6765484|NCT03719677|7692175|FG000|STARTED|Overall Study||7
6765485|NCT03719677|7692175|FG000|COMPLETED|Overall Study||7
6765486|NCT03719677|7692175|FG000|NOT COMPLETED|Overall Study||0
6765487|NCT03719885|7692179|FG000|STARTED|Overall Study||55
6765488|NCT03719885|7692179|FG000|COMPLETED|Overall Study||35
6765489|NCT03719885|7692179|FG000|NOT COMPLETED|Overall Study||20
6765490|NCT03720119|7692185|FG000|STARTED|Overall Study||78
6765491|NCT03720119|7692185|FG000|COMPLETED|Overall Study||69
6765492|NCT03720119|7692185|FG000|NOT COMPLETED|Overall Study||9
6765493|NCT03720470|7692193|FG000|STARTED|Treatment Period: First Part 16 Weeks||131
6765494|NCT03720470|7692194|FG001|STARTED|Treatment Period: First Part 16 Weeks||0
6765495|NCT03720470|7692195|FG002|STARTED|Treatment Period: First Part 16 Weeks||0
6765496|NCT03720470|7692196|FG003|STARTED|Treatment Period: First Part 16 Weeks||238
6765497|NCT03720470|7692197|FG004|STARTED|Treatment Period: First Part 16 Weeks||226
6765498|NCT03720470|7692198|FG005|STARTED|Treatment Period: First Part 16 Weeks||243
6765499|NCT03720470|7692193|FG000|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||131
6765500|NCT03720470|7692194|FG001|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
6765501|NCT03720470|7692195|FG002|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||0
6765502|NCT03720470|7692196|FG003|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||238
6765503|NCT03720470|7692197|FG004|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||226
6781040|NCT02708849|7709646|FG001|COMPLETED|Overall Study||1
6765504|NCT03720470|7692198|FG005|Treated/ Safety Analysis Set|Treatment Period: First Part 16 Weeks||242
6765505|NCT03720470|7692193|FG000|Full Analysis Set|Treatment Period: First Part 16 Weeks||131
6765506|NCT03720470|7692194|FG001|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
6765507|NCT03720470|7692195|FG002|Full Analysis Set|Treatment Period: First Part 16 Weeks||0
6765508|NCT03720470|7692196|FG003|Full Analysis Set|Treatment Period: First Part 16 Weeks||238
6765509|NCT03720470|7692197|FG004|Full Analysis Set|Treatment Period: First Part 16 Weeks||226
6765510|NCT03720470|7692198|FG005|Full Analysis Set|Treatment Period: First Part 16 Weeks||242
6765511|NCT03720470|7692193|FG000|COMPLETED|Treatment Period: First Part 16 Weeks||117
6765512|NCT03720470|7692194|FG001|COMPLETED|Treatment Period: First Part 16 Weeks||0
6765513|NCT03720470|7692195|FG002|COMPLETED|Treatment Period: First Part 16 Weeks||0
6765514|NCT03720470|7692196|FG003|COMPLETED|Treatment Period: First Part 16 Weeks||217
6765515|NCT03720470|7692197|FG004|COMPLETED|Treatment Period: First Part 16 Weeks||208
6765516|NCT03720470|7692198|FG005|COMPLETED|Treatment Period: First Part 16 Weeks||223
6765517|NCT03720470|7692193|FG000|NOT COMPLETED|Treatment Period: First Part 16 Weeks||14
6765518|NCT03720470|7692194|FG001|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
6765519|NCT03720470|7692195|FG002|NOT COMPLETED|Treatment Period: First Part 16 Weeks||0
6765520|NCT03720470|7692196|FG003|NOT COMPLETED|Treatment Period: First Part 16 Weeks||21
6765521|NCT03720470|7692197|FG004|NOT COMPLETED|Treatment Period: First Part 16 Weeks||18
6765522|NCT03720470|7692198|FG005|NOT COMPLETED|Treatment Period: First Part 16 Weeks||20
6765523|NCT03720470|7692193|FG000|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|0
6765524|NCT03720470|7692194|FG001|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|60
6765525|NCT03720470|7692195|FG002|STARTED|Treatment Period: Final 4 Weeks|Participants received placebo till Week 16 then allocated to receive PF-04965842 post Week 16.|57
6765526|NCT03720470|7692196|FG003|STARTED|Treatment Period: Final 4 Weeks||217
6765527|NCT03720470|7692197|FG004|STARTED|Treatment Period: Final 4 Weeks||208
6765528|NCT03720470|7692198|FG005|STARTED|Treatment Period: Final 4 Weeks||223
6765529|NCT03720470|7692193|FG000|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||0
6765530|NCT03720470|7692194|FG001|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||60
6765531|NCT03720470|7692195|FG002|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||57
6765532|NCT03720470|7692196|FG003|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||217
6765533|NCT03720470|7692197|FG004|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||208
6765534|NCT03720470|7692198|FG005|Treated/ Safety Analysis Set|Treatment Period: Final 4 Weeks||223
6765535|NCT03720470|7692193|FG000|Full Analysis Set|Treatment Period: Final 4 Weeks||0
6765536|NCT03720470|7692194|FG001|Full Analysis Set|Treatment Period: Final 4 Weeks||60
6765537|NCT03720470|7692195|FG002|Full Analysis Set|Treatment Period: Final 4 Weeks||57
6765538|NCT03720470|7692196|FG003|Full Analysis Set|Treatment Period: Final 4 Weeks||217
6765539|NCT03720470|7692197|FG004|Full Analysis Set|Treatment Period: Final 4 Weeks||208
6765540|NCT03720470|7692198|FG005|Full Analysis Set|Treatment Period: Final 4 Weeks||223
6765541|NCT03720470|7692193|FG000|COMPLETED|Treatment Period: Final 4 Weeks||0
6765542|NCT03720470|7692194|FG001|COMPLETED|Treatment Period: Final 4 Weeks||58
6765543|NCT03720470|7692195|FG002|COMPLETED|Treatment Period: Final 4 Weeks||55
6765544|NCT03720470|7692196|FG003|COMPLETED|Treatment Period: Final 4 Weeks||210
6765545|NCT03720470|7692197|FG004|COMPLETED|Treatment Period: Final 4 Weeks||204
6765546|NCT03720470|7692198|FG005|COMPLETED|Treatment Period: Final 4 Weeks||218
6765547|NCT03720470|7692193|FG000|NOT COMPLETED|Treatment Period: Final 4 Weeks||0
6765548|NCT03720470|7692194|FG001|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
6765549|NCT03720470|7692195|FG002|NOT COMPLETED|Treatment Period: Final 4 Weeks||2
6765550|NCT03720470|7692196|FG003|NOT COMPLETED|Treatment Period: Final 4 Weeks||7
6765551|NCT03720470|7692197|FG004|NOT COMPLETED|Treatment Period: Final 4 Weeks||4
6765552|NCT03720470|7692198|FG005|NOT COMPLETED|Treatment Period: Final 4 Weeks||5
6765553|NCT03720652|7692220|FG000|STARTED|Overall Study||12
6765554|NCT03720652|7692221|FG001|STARTED|Overall Study||27
6765555|NCT03720652|7692220|FG000|Baseline Interview|Overall Study||12
6765556|NCT03720652|7692221|FG001|Baseline Interview|Overall Study||22
6765557|NCT03720652|7692220|FG000|Start Intervention|Overall Study||11
6765558|NCT03720652|7692221|FG001|Start Intervention|Overall Study||21
6765559|NCT03720652|7692220|FG000|Complete Intervention|Overall Study||10
6765560|NCT03720652|7692221|FG001|Complete Intervention|Overall Study||20
6765561|NCT03720652|7692220|FG000|3-Month Follow Up Interview|Overall Study||10
6765562|NCT03720652|7692221|FG001|3-Month Follow Up Interview|Overall Study||19
6765563|NCT03720652|7692220|FG000|6-Month Follow Up Interview|Overall Study||10
6765564|NCT03720652|7692221|FG001|6-Month Follow Up Interview|Overall Study||16
6765565|NCT03720652|7692220|FG000|COMPLETED|Overall Study||10
6765566|NCT03720652|7692221|FG001|COMPLETED|Overall Study||16
6765567|NCT03720652|7692220|FG000|NOT COMPLETED|Overall Study||2
6765568|NCT03720652|7692221|FG001|NOT COMPLETED|Overall Study||11
6765569|NCT03720847|7692229|FG000|STARTED|Condition 1||15
6765570|NCT03720847|7692230|FG001|STARTED|Condition 1||15
6765571|NCT03720847|7692229|FG000|COMPLETED|Condition 1||15
6765572|NCT03720847|7692230|FG001|COMPLETED|Condition 1||15
6765573|NCT03720847|7692229|FG000|NOT COMPLETED|Condition 1||0
6765574|NCT03720847|7692230|FG001|NOT COMPLETED|Condition 1||0
6765575|NCT03720847|7692229|FG000|STARTED|Washout||15
6765576|NCT03720847|7692230|FG001|STARTED|Washout||15
6765577|NCT03720847|7692229|FG000|COMPLETED|Washout||14
6765578|NCT03720847|7692230|FG001|COMPLETED|Washout||13
6765579|NCT03720847|7692229|FG000|NOT COMPLETED|Washout||1
6765580|NCT03720847|7692230|FG001|NOT COMPLETED|Washout||2
6765581|NCT03720847|7692229|FG000|STARTED|Condition 2||14
6765582|NCT03720847|7692230|FG001|STARTED|Condition 2||13
6765583|NCT03720847|7692229|FG000|COMPLETED|Condition 2||14
6765584|NCT03720847|7692230|FG001|COMPLETED|Condition 2||13
6765585|NCT03720847|7692229|FG000|NOT COMPLETED|Condition 2||0
6765586|NCT03720847|7692230|FG001|NOT COMPLETED|Condition 2||0
6765587|NCT03720938|7692239|FG000|STARTED|Overall Study||242
6765588|NCT03720938|7692240|FG001|STARTED|Overall Study||676
6765589|NCT03720938|7692239|FG000|COMPLETED|Overall Study||53
6765590|NCT03720938|7692240|FG001|COMPLETED|Overall Study||53
6765591|NCT03720938|7692239|FG000|NOT COMPLETED|Overall Study||189
6765592|NCT03720938|7692240|FG001|NOT COMPLETED|Overall Study||623
6765593|NCT03721172|7692259|FG000|STARTED|Placebo-controlled Phase||298
6556371|NCT01759277|7478680|FG001|COMPLETED|Overall Study||39
6556372|NCT01759277|7478679|FG000|NOT COMPLETED|Overall Study||0
6556373|NCT01759277|7478680|FG001|NOT COMPLETED|Overall Study||0
6556374|NCT01759290|7478688|FG000|STARTED|Overall Study||1800
6765594|NCT03721172|7692260|FG001|STARTED|Placebo-controlled Phase||297
6765595|NCT03721172|7692261|FG002|STARTED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
6765596|NCT03721172|7692259|FG000|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
6765597|NCT03721172|7692260|FG001|Received at Least 1 Dose of Treatment|Placebo-controlled Phase||297
6765598|NCT03721172|7692261|FG002|Received at Least 1 Dose of Treatment|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
6765599|NCT03721172|7692259|FG000|COMPLETED|Placebo-controlled Phase||246
6765600|NCT03721172|7692260|FG001|COMPLETED|Placebo-controlled Phase||258
6765601|NCT03721172|7692261|FG002|COMPLETED|Placebo-controlled Phase|This arm was not included in the placebo-controlled phase.|0
6765602|NCT03721172|7692259|FG000|NOT COMPLETED|Placebo-controlled Phase||52
6765603|NCT03721172|7692260|FG001|NOT COMPLETED|Placebo-controlled Phase||39
6765604|NCT03721172|7692261|FG002|NOT COMPLETED|Placebo-controlled Phase||0
6765605|NCT03721172|7692259|FG000|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
6765606|NCT03721172|7692260|FG001|STARTED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
6765607|NCT03721172|7692261|FG002|STARTED|Apremilast Extension Phase|1 participant did not enter the extension phase due to physician decision.|503
6765608|NCT03721172|7692259|FG000|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
6765609|NCT03721172|7692260|FG001|Received at Least 1 Dose|Apremilast Extension Phase|This arm was not included in the extension phase.|0
6765610|NCT03721172|7692261|FG002|Received at Least 1 Dose|Apremilast Extension Phase||503
6765611|NCT03721172|7692259|FG000|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
6765612|NCT03721172|7692260|FG001|COMPLETED|Apremilast Extension Phase|This arm was not included in the extension phase.|0
6765613|NCT03721172|7692261|FG002|COMPLETED|Apremilast Extension Phase||437
6765614|NCT03721172|7692259|FG000|NOT COMPLETED|Apremilast Extension Phase||0
6765615|NCT03721172|7692260|FG001|NOT COMPLETED|Apremilast Extension Phase||0
6765616|NCT03721172|7692261|FG002|NOT COMPLETED|Apremilast Extension Phase||66
6765617|NCT03721549|7692271|FG000|STARTED|Overall Study||8
6765618|NCT03721549|7692272|FG001|STARTED|Overall Study||8
6765619|NCT03721549|7692271|FG000|COMPLETED|Overall Study||7
6765620|NCT03721549|7692272|FG001|COMPLETED|Overall Study||8
6765621|NCT03721549|7692271|FG000|NOT COMPLETED|Overall Study||1
6765622|NCT03721549|7692272|FG001|NOT COMPLETED|Overall Study||0
6765623|NCT03722030|7692280|FG000|STARTED|Overall Study||20
6765624|NCT03722030|7692281|FG001|STARTED|Overall Study||20
6765625|NCT03722030|7692280|FG000|COMPLETED|Overall Study||19
6765626|NCT03722030|7692281|FG001|COMPLETED|Overall Study||20
6765627|NCT03722030|7692280|FG000|NOT COMPLETED|Overall Study||1
6765628|NCT03722030|7692281|FG001|NOT COMPLETED|Overall Study||0
6765629|NCT03722238|7692290|FG000|STARTED|Overall Study||608
6765630|NCT03722238|7692291|FG001|STARTED|Overall Study||5
6765631|NCT03722238|7692290|FG000|Safety Set|Overall Study||198
6765632|NCT03722238|7692291|FG001|Safety Set|Overall Study||5
6765633|NCT03722238|7692290|FG000|Actual Drug Users|Overall Study||179
6765634|NCT03722238|7692291|FG001|Actual Drug Users|Overall Study||5
6765635|NCT03722238|7692290|FG000|COMPLETED|Overall Study||143
6765636|NCT03722238|7692291|FG001|COMPLETED|Overall Study||4
6765637|NCT03722238|7692290|FG000|NOT COMPLETED|Overall Study||465
6765638|NCT03722238|7692291|FG001|NOT COMPLETED|Overall Study||1
6765639|NCT03722264|7692297|FG000|STARTED|Overall Study||12
6765640|NCT03722264|7692297|FG000|COMPLETED|Overall Study||9
6765641|NCT03722264|7692297|FG000|NOT COMPLETED|Overall Study||3
6765642|NCT03722446|7692305|FG000|STARTED|Overall Study||135
6765643|NCT03722446|7692306|FG001|STARTED|Overall Study||122
6765644|NCT03722446|7692305|FG000|COMPLETED|Overall Study||120
6765645|NCT03722446|7692306|FG001|COMPLETED|Overall Study||120
6765646|NCT03722446|7692305|FG000|NOT COMPLETED|Overall Study||15
6765647|NCT03722446|7692306|FG001|NOT COMPLETED|Overall Study||2
6765648|NCT03722524|7692312|FG000|STARTED|Overall Study||1247
6765649|NCT03722524|7692312|FG000|COMPLETED|Overall Study||1148
6765650|NCT03722524|7692312|FG000|NOT COMPLETED|Overall Study||99
6765651|NCT03722576|7692316|FG000|STARTED|Overall Study||18
6765652|NCT03722576|7692316|FG000|COMPLETED|Overall Study||11
6765653|NCT03722576|7692316|FG000|NOT COMPLETED|Overall Study||7
6765654|NCT03722784|7692322|FG000|STARTED|Overall Study||58
6765655|NCT03722784|7692323|FG001|STARTED|Overall Study||30
6556375|NCT01759290|7478688|FG000|COMPLETED|Overall Study||1719
6556376|NCT01759290|7478688|FG000|NOT COMPLETED|Overall Study||81
6765656|NCT03722784|7692322|FG000|COMPLETED|Overall Study||56
6765657|NCT03722784|7692323|FG001|COMPLETED|Overall Study||28
6765658|NCT03722784|7692322|FG000|NOT COMPLETED|Overall Study||2
6765659|NCT03722784|7692323|FG001|NOT COMPLETED|Overall Study||2
6765660|NCT03723915|7692330|FG000|STARTED|Screening||17
6765661|NCT03723915|7692330|FG000|COMPLETED|Screening||15
6765662|NCT03723915|7692330|FG000|NOT COMPLETED|Screening||2
6765663|NCT03723915|7692330|FG000|STARTED|On Treatment||15
6765664|NCT03723915|7692330|FG000|Registered on Study|On Treatment||15
6765665|NCT03723915|7692330|FG000|Received First Dose of Study Drugs|On Treatment||13
6765666|NCT03723915|7692330|FG000|COMPLETED|On Treatment||13
6765667|NCT03723915|7692330|FG000|NOT COMPLETED|On Treatment||2
6765668|NCT03723915|7692330|FG000|STARTED|Survival Follow-up||13
6765669|NCT03723915|7692330|FG000|COMPLETED|Survival Follow-up||13
6765670|NCT03723915|7692330|FG000|NOT COMPLETED|Survival Follow-up||0
6765671|NCT03724812|7692334|FG000|STARTED|Overall Study||46
6765672|NCT03724812|7692334|FG000|Discharge|Overall Study||46
6765673|NCT03724812|7692334|FG000|30 Day Follow-Up|Overall Study||45
6765674|NCT03724812|7692334|FG000|6 Month Follow-Up|Overall Study||42
6765675|NCT03724812|7692334|FG000|12-Month Follow-Up|Overall Study||42
6765676|NCT03724812|7692334|FG000|COMPLETED|Overall Study||42
6765677|NCT03724812|7692334|FG000|NOT COMPLETED|Overall Study||4
6765678|NCT03725982|7692341|FG000|STARTED|First Intervention||20
6765679|NCT03725982|7692342|FG001|STARTED|First Intervention||19
6765680|NCT03725982|7692341|FG000|COMPLETED|First Intervention||19
6765681|NCT03725982|7692342|FG001|COMPLETED|First Intervention||17
6765682|NCT03725982|7692341|FG000|NOT COMPLETED|First Intervention||1
6765683|NCT03725982|7692342|FG001|NOT COMPLETED|First Intervention||2
6765684|NCT03725982|7692341|FG000|STARTED|Second Intervention||19
6765685|NCT03725982|7692342|FG001|STARTED|Second Intervention||17
6765686|NCT03725982|7692341|FG000|COMPLETED|Second Intervention||19
6765687|NCT03725982|7692342|FG001|COMPLETED|Second Intervention||17
6765688|NCT03725982|7692341|FG000|NOT COMPLETED|Second Intervention||0
6765689|NCT03725982|7692342|FG001|NOT COMPLETED|Second Intervention||0
6765690|NCT03727841|7692356|FG000|STARTED|Overall Study||3
6765691|NCT03727841|7692357|FG001|STARTED|Overall Study||1
6765692|NCT03727841|7692356|FG000|COMPLETED|Overall Study||1
6765693|NCT03727841|7692357|FG001|COMPLETED|Overall Study||0
6765694|NCT03727841|7692356|FG000|NOT COMPLETED|Overall Study||2
6765695|NCT03727841|7692357|FG001|NOT COMPLETED|Overall Study||1
6765696|NCT03736967|7692367|FG000|STARTED|Overall Study||51
6765697|NCT03736967|7692368|FG001|STARTED|Overall Study||52
6765698|NCT03736967|7692369|FG002|STARTED|Overall Study||51
6765699|NCT03736967|7692370|FG003|STARTED|Overall Study||52
6765700|NCT03736967|7692367|FG000|Treated|Overall Study||50
6765701|NCT03736967|7692368|FG001|Treated|Overall Study||52
6765702|NCT03736967|7692369|FG002|Treated|Overall Study||51
6765703|NCT03736967|7692370|FG003|Treated|Overall Study||52
6765704|NCT03736967|7692367|FG000|COMPLETED|Overall Study||20
6765705|NCT03736967|7692368|FG001|COMPLETED|Overall Study||24
6765706|NCT03736967|7692369|FG002|COMPLETED|Overall Study||27
6765707|NCT03736967|7692370|FG003|COMPLETED|Overall Study||22
6765708|NCT03736967|7692367|FG000|NOT COMPLETED|Overall Study||31
6765709|NCT03736967|7692368|FG001|NOT COMPLETED|Overall Study||28
6765710|NCT03736967|7692369|FG002|NOT COMPLETED|Overall Study||24
6765711|NCT03736967|7692370|FG003|NOT COMPLETED|Overall Study||30
6765712|NCT03739840|7692387|FG000|STARTED|Treatment Period: Wk0-16||56
6765713|NCT03739840|7692388|FG001|STARTED|Treatment Period: Wk0-16||60
6765714|NCT03739840|7692389|FG002|STARTED|Treatment Period: Wk0-16||57
6765715|NCT03739840|7692390|FG003|STARTED|Treatment Period: Wk0-16||59
6765716|NCT03739840|7692387|FG000|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
6765717|NCT03739840|7692388|FG001|Completed Titration and Stabilization|Treatment Period: Wk0-16||58
6765718|NCT03739840|7692389|FG002|Completed Titration and Stabilization|Treatment Period: Wk0-16||51
6765719|NCT03739840|7692390|FG003|Completed Titration and Stabilization|Treatment Period: Wk0-16||54
6765720|NCT03739840|7692387|FG000|Completed Maintenance Period|Treatment Period: Wk0-16||46
6765721|NCT03739840|7692388|FG001|Completed Maintenance Period|Treatment Period: Wk0-16||44
6765722|NCT03739840|7692389|FG002|Completed Maintenance Period|Treatment Period: Wk0-16||44
6765723|NCT03739840|7692390|FG003|Completed Maintenance Period|Treatment Period: Wk0-16||36
6765724|NCT03739840|7692387|FG000|COMPLETED|Treatment Period: Wk0-16||46
6765725|NCT03739840|7692388|FG001|COMPLETED|Treatment Period: Wk0-16||44
6765726|NCT03739840|7692389|FG002|COMPLETED|Treatment Period: Wk0-16||44
6765727|NCT03739840|7692390|FG003|COMPLETED|Treatment Period: Wk0-16||36
6765728|NCT03739840|7692387|FG000|NOT COMPLETED|Treatment Period: Wk0-16||10
6765729|NCT03739840|7692388|FG001|NOT COMPLETED|Treatment Period: Wk0-16||16
6765730|NCT03739840|7692389|FG002|NOT COMPLETED|Treatment Period: Wk0-16||13
6765731|NCT03739840|7692390|FG003|NOT COMPLETED|Treatment Period: Wk0-16||23
6765732|NCT03739840|7692387|FG000|STARTED|Post-Treatment Period: Wk16-23||46
6765733|NCT03739840|7692388|FG001|STARTED|Post-Treatment Period: Wk16-23||44
6765734|NCT03739840|7692389|FG002|STARTED|Post-Treatment Period: Wk16-23||44
6765735|NCT03739840|7692390|FG003|STARTED|Post-Treatment Period: Wk16-23||36
6765736|NCT03739840|7692387|FG000|Started Conversion Period|Post-Treatment Period: Wk16-23||33
6765737|NCT03739840|7692388|FG001|Started Conversion Period|Post-Treatment Period: Wk16-23||31
6765738|NCT03739840|7692389|FG002|Started Conversion Period|Post-Treatment Period: Wk16-23||29
6765739|NCT03739840|7692390|FG003|Started Conversion Period|Post-Treatment Period: Wk16-23||28
6765740|NCT03739840|7692387|FG000|Completed Conversion Period|Post-Treatment Period: Wk16-23||33
6765741|NCT03739840|7692388|FG001|Completed Conversion Period|Post-Treatment Period: Wk16-23||31
6765742|NCT03739840|7692389|FG002|Completed Conversion Period|Post-Treatment Period: Wk16-23||29
6765743|NCT03739840|7692390|FG003|Completed Conversion Period|Post-Treatment Period: Wk16-23||28
6765744|NCT03739840|7692387|FG000|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||19
6765745|NCT03739840|7692388|FG001|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
6765746|NCT03739840|7692389|FG002|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||21
6765747|NCT03739840|7692390|FG003|Started Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||13
6765748|NCT03739840|7692387|FG000|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||15
6765749|NCT03739840|7692388|FG001|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||16
6765750|NCT03739840|7692389|FG002|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||18
6765751|NCT03739840|7692390|FG003|Completed Taper and Safety Follow-up|Post-Treatment Period: Wk16-23||12
6765752|NCT03739840|7692387|FG000|Enrolled in EP0093|Post-Treatment Period: Wk16-23||27
6765753|NCT03739840|7692388|FG001|Enrolled in EP0093|Post-Treatment Period: Wk16-23||26
6765754|NCT03739840|7692389|FG002|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
6765755|NCT03739840|7692390|FG003|Enrolled in EP0093|Post-Treatment Period: Wk16-23||23
6765756|NCT03739840|7692387|FG000|COMPLETED|Post-Treatment Period: Wk16-23||42
6765757|NCT03739840|7692388|FG001|COMPLETED|Post-Treatment Period: Wk16-23||42
6765758|NCT03739840|7692389|FG002|COMPLETED|Post-Treatment Period: Wk16-23||41
6765759|NCT03739840|7692390|FG003|COMPLETED|Post-Treatment Period: Wk16-23||35
6765760|NCT03739840|7692387|FG000|NOT COMPLETED|Post-Treatment Period: Wk16-23||4
6765761|NCT03739840|7692388|FG001|NOT COMPLETED|Post-Treatment Period: Wk16-23||2
6765762|NCT03739840|7692389|FG002|NOT COMPLETED|Post-Treatment Period: Wk16-23||3
6765763|NCT03739840|7692390|FG003|NOT COMPLETED|Post-Treatment Period: Wk16-23||1
6765764|NCT03739983|7692412|FG000|STARTED|Overall Study||2
6765765|NCT03739983|7692412|FG000|COMPLETED|Overall Study||2
6765766|NCT03739983|7692412|FG000|NOT COMPLETED|Overall Study||0
6765767|NCT03746002|7692418|FG000|STARTED|Overall Study||1
6765768|NCT03746002|7692419|FG001|STARTED|Overall Study||2
6765769|NCT03746002|7692418|FG000|COMPLETED|Overall Study||1
6765770|NCT03746002|7692419|FG001|COMPLETED|Overall Study||2
6765771|NCT03746002|7692418|FG000|NOT COMPLETED|Overall Study||0
6765772|NCT03746002|7692419|FG001|NOT COMPLETED|Overall Study||0
6765773|NCT03748771|7692425|FG000|STARTED|Overall Study||20
6765774|NCT03748771|7692425|FG000|COMPLETED|Overall Study||20
6765775|NCT03748771|7692425|FG000|NOT COMPLETED|Overall Study||0
6765776|NCT03752177|7692433|FG000|STARTED|Overall Study||3
6765777|NCT03752177|7692434|FG001|STARTED|Overall Study||3
6765778|NCT03752177|7692435|FG002|STARTED|Overall Study||3
6765779|NCT03752177|7692436|FG003|STARTED|Overall Study||3
6765780|NCT03752177|7692433|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6765781|NCT03752177|7692434|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6765782|NCT03752177|7692435|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6765783|NCT03752177|7692436|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6765784|NCT03752177|7692433|FG000|COMPLETED|Overall Study||3
6765785|NCT03752177|7692434|FG001|COMPLETED|Overall Study||3
6765786|NCT03752177|7692435|FG002|COMPLETED|Overall Study||3
6765787|NCT03752177|7692436|FG003|COMPLETED|Overall Study||3
6765788|NCT03752177|7692433|FG000|NOT COMPLETED|Overall Study||0
6765789|NCT03752177|7692434|FG001|NOT COMPLETED|Overall Study||0
6765790|NCT03752177|7692435|FG002|NOT COMPLETED|Overall Study||0
6765791|NCT03752177|7692436|FG003|NOT COMPLETED|Overall Study||0
6765792|NCT03753763|7692449|FG000|STARTED|Overall Study||32
6765793|NCT03753763|7692450|FG001|STARTED|Overall Study||17
6765794|NCT03753763|7692449|FG000|COMPLETED|Overall Study||26
6765795|NCT03753763|7692450|FG001|COMPLETED|Overall Study||16
6765796|NCT03753763|7692449|FG000|NOT COMPLETED|Overall Study||6
6765797|NCT03753763|7692450|FG001|NOT COMPLETED|Overall Study||1
6765798|NCT03756571|7692458|FG000|STARTED|Overall Study||10
6765799|NCT03756571|7692459|FG001|STARTED|Overall Study||11
6765800|NCT03756571|7692458|FG000|COMPLETED|Overall Study||9
6765801|NCT03756571|7692459|FG001|COMPLETED|Overall Study||10
6765802|NCT03756571|7692458|FG000|NOT COMPLETED|Overall Study||1
6765803|NCT03756571|7692459|FG001|NOT COMPLETED|Overall Study||1
6765804|NCT03761537|7692467|FG000|STARTED|Overall Study||140
6765805|NCT03761537|7692468|FG001|STARTED|Overall Study||137
6765806|NCT03761537|7692467|FG000|COMPLETED|Overall Study||125
6765807|NCT03761537|7692468|FG001|COMPLETED|Overall Study||120
6765808|NCT03761537|7692467|FG000|NOT COMPLETED|Overall Study||15
6765809|NCT03761537|7692468|FG001|NOT COMPLETED|Overall Study||17
6765810|NCT03763877|7692486|FG000|STARTED|Overall Study||31
6765811|NCT03763877|7692487|FG001|STARTED|Overall Study||30
6765812|NCT03763877|7692488|FG002|STARTED|Overall Study||31
6765813|NCT03763877|7692489|FG003|STARTED|Overall Study||29
6765814|NCT03763877|7692486|FG000|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||31
6765815|NCT03763877|7692487|FG001|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
6765816|NCT03763877|7692488|FG002|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||30
6765817|NCT03763877|7692489|FG003|Received at Least 1 Dose of Double-blind Study Treatment|Overall Study||29
6765818|NCT03763877|7692486|FG000|Completed the Double-blind Period|Overall Study||27
6765819|NCT03763877|7692487|FG001|Completed the Double-blind Period|Overall Study||26
6765820|NCT03763877|7692488|FG002|Completed the Double-blind Period|Overall Study||25
6765821|NCT03763877|7692489|FG003|Completed the Double-blind Period|Overall Study||24
6765822|NCT03763877|7692486|FG000|COMPLETED|Overall Study||26
6765823|NCT03763877|7692487|FG001|COMPLETED|Overall Study||26
6765824|NCT03763877|7692488|FG002|COMPLETED|Overall Study||24
6765825|NCT03763877|7692489|FG003|COMPLETED|Overall Study||24
6765826|NCT03763877|7692486|FG000|NOT COMPLETED|Overall Study||5
6765827|NCT03763877|7692487|FG001|NOT COMPLETED|Overall Study||4
6556377|NCT01759368|7478694|FG000|STARTED|Overall Study||47
6556378|NCT01759368|7478695|FG001|STARTED|Overall Study||47
6765828|NCT03763877|7692488|FG002|NOT COMPLETED|Overall Study||7
6765829|NCT03763877|7692489|FG003|NOT COMPLETED|Overall Study||5
6765830|NCT03764007|7692503|FG000|STARTED|Overall Study||98
6765831|NCT03764007|7692503|FG000|Imaging Completed|Overall Study||98
6765832|NCT03764007|7692503|FG000|Underwent Parathyroidectomy Surgery|Overall Study||77
6765833|NCT03764007|7692503|FG000|COMPLETED|Overall Study||77
6765834|NCT03764007|7692503|FG000|NOT COMPLETED|Overall Study||21
6765835|NCT03772587|7692512|FG000|STARTED|Overall Study||14
6765836|NCT03772587|7692513|FG001|STARTED|Overall Study||14
6765837|NCT03772587|7692514|FG002|STARTED|Overall Study||13
6765838|NCT03772587|7692515|FG003|STARTED|Overall Study||13
6765839|NCT03772587|7692516|FG004|STARTED|Overall Study||14
6765840|NCT03772587|7692512|FG000|COMPLETED|Overall Study||13
6765841|NCT03772587|7692513|FG001|COMPLETED|Overall Study||14
6765842|NCT03772587|7692514|FG002|COMPLETED|Overall Study||12
6765843|NCT03772587|7692515|FG003|COMPLETED|Overall Study||12
6765844|NCT03772587|7692516|FG004|COMPLETED|Overall Study||14
6765845|NCT03772587|7692512|FG000|NOT COMPLETED|Overall Study||1
6765846|NCT03772587|7692513|FG001|NOT COMPLETED|Overall Study||0
6765847|NCT03772587|7692514|FG002|NOT COMPLETED|Overall Study||1
6765848|NCT03772587|7692515|FG003|NOT COMPLETED|Overall Study||1
6765849|NCT03772587|7692516|FG004|NOT COMPLETED|Overall Study||0
6765850|NCT03789292|7692540|FG000|STARTED|Treatment Period I (Week 0 to Week 26)||324
6765851|NCT03789292|7692541|FG001|STARTED|Treatment Period I (Week 0 to Week 26)||324
6765852|NCT03789292|7692542|FG002|STARTED|Treatment Period I (Week 0 to Week 26)||0
6765853|NCT03789292|7692540|FG000|COMPLETED|Treatment Period I (Week 0 to Week 26)||303
6765854|NCT03789292|7692541|FG001|COMPLETED|Treatment Period I (Week 0 to Week 26)||305
6765855|NCT03789292|7692542|FG002|COMPLETED|Treatment Period I (Week 0 to Week 26)||0
6765856|NCT03789292|7692540|FG000|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||21
6765857|NCT03789292|7692541|FG001|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||19
6765858|NCT03789292|7692542|FG002|NOT COMPLETED|Treatment Period I (Week 0 to Week 26)||0
6765859|NCT03789292|7692540|FG000|STARTED|Treatment Period II (Week 26 to Week 52)||303
6765860|NCT03789292|7692541|FG001|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|153
6765861|NCT03789292|7692542|FG002|STARTED|Treatment Period II (Week 26 to Week 52)|Patients who had administrated Humira SC during Treatment Period 1 has been devided into 2 groups - maintaining Humira SC and switched to CT-P17.|152
6765862|NCT03789292|7692540|FG000|COMPLETED|Treatment Period II (Week 26 to Week 52)||287
6765863|NCT03789292|7692541|FG001|COMPLETED|Treatment Period II (Week 26 to Week 52)||147
6765864|NCT03789292|7692542|FG002|COMPLETED|Treatment Period II (Week 26 to Week 52)||143
6765865|NCT03789292|7692540|FG000|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||16
6765866|NCT03789292|7692541|FG001|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||6
6765867|NCT03789292|7692542|FG002|NOT COMPLETED|Treatment Period II (Week 26 to Week 52)||9
6765868|NCT03799289|7692558|FG000|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
6765869|NCT03799289|7692559|FG001|STARTED|Initial Weight Loss Program (Weeks 1-12)||30
6765870|NCT03799289|7692558|FG000|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||24
6765871|NCT03799289|7692559|FG001|COMPLETED|Initial Weight Loss Program (Weeks 1-12)||27
6765872|NCT03799289|7692558|FG000|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||6
6765873|NCT03799289|7692559|FG001|NOT COMPLETED|Initial Weight Loss Program (Weeks 1-12)||3
6765874|NCT03799289|7692558|FG000|STARTED|Maintenance Intervention (Weeks 13-24)||24
6765875|NCT03799289|7692559|FG001|STARTED|Maintenance Intervention (Weeks 13-24)||27
6765876|NCT03799289|7692558|FG000|COMPLETED|Maintenance Intervention (Weeks 13-24)||24
6765877|NCT03799289|7692559|FG001|COMPLETED|Maintenance Intervention (Weeks 13-24)||27
6765878|NCT03799289|7692558|FG000|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
6765879|NCT03799289|7692559|FG001|NOT COMPLETED|Maintenance Intervention (Weeks 13-24)||0
6765880|NCT03801408|7692565|FG000|STARTED|Overall Study||145
6765881|NCT03801408|7692565|FG000|COMPLETED|Overall Study||145
6765882|NCT03801408|7692565|FG000|NOT COMPLETED|Overall Study||0
6765883|NCT03805438|7692569|FG000|STARTED|Overall Study||47
6765884|NCT03805438|7692569|FG000|COMPLETED|Overall Study||45
6765885|NCT03805438|7692569|FG000|NOT COMPLETED|Overall Study||2
6765886|NCT03808948|7692573|FG000|STARTED|Overall Study||50
6765887|NCT03808948|7692573|FG000|COMPLETED|Overall Study||50
6765888|NCT03808948|7692573|FG000|NOT COMPLETED|Overall Study||0
6765889|NCT03810053|7692577|FG000|STARTED|Overall Study||290
6556379|NCT01759368|7478694|FG000|COMPLETED|Overall Study||46
6765890|NCT03810053|7692577|FG000|COMPLETED|Overall Study||290
6765891|NCT03810053|7692577|FG000|NOT COMPLETED|Overall Study||0
6765892|NCT03812224|7692583|FG000|STARTED|Double-blind Treatment Period||131
6765893|NCT03812224|7692584|FG001|STARTED|Double-blind Treatment Period||130
6765894|NCT03812224|7692583|FG000|COMPLETED|Double-blind Treatment Period||127
6765895|NCT03812224|7692584|FG001|COMPLETED|Double-blind Treatment Period||127
6765896|NCT03812224|7692583|FG000|NOT COMPLETED|Double-blind Treatment Period||4
6765897|NCT03812224|7692584|FG001|NOT COMPLETED|Double-blind Treatment Period||3
6765898|NCT03812224|7692583|FG000|STARTED|Open-label Treatment Period||127
6765899|NCT03812224|7692584|FG001|STARTED|Open-label Treatment Period||127
6765900|NCT03812224|7692583|FG000|COMPLETED|Open-label Treatment Period||125
6765901|NCT03812224|7692584|FG001|COMPLETED|Open-label Treatment Period||124
6765902|NCT03812224|7692583|FG000|NOT COMPLETED|Open-label Treatment Period||2
6765903|NCT03812224|7692584|FG001|NOT COMPLETED|Open-label Treatment Period||3
6765904|NCT03817528|7692591|FG000|STARTED|Overall Study||4
6765905|NCT03817528|7692591|FG000|COMPLETED|Overall Study||1
6765906|NCT03817528|7692591|FG000|NOT COMPLETED|Overall Study||3
6765907|NCT03817580|7692598|FG000|STARTED|Overall Study||57
6765908|NCT03817580|7692599|FG001|STARTED|Overall Study||56
6765909|NCT03817580|7692600|FG002|STARTED|Overall Study||57
6765910|NCT03817580|7692598|FG000|COMPLETED|Overall Study||57
6765911|NCT03817580|7692599|FG001|COMPLETED|Overall Study||56
6765912|NCT03817580|7692600|FG002|COMPLETED|Overall Study||57
6765913|NCT03817580|7692598|FG000|NOT COMPLETED|Overall Study||0
6765914|NCT03817580|7692599|FG001|NOT COMPLETED|Overall Study||0
6765915|NCT03817580|7692600|FG002|NOT COMPLETED|Overall Study||0
6765916|NCT03828422|7692610|FG000|STARTED|Overall Study||40
6765917|NCT03828422|7692611|FG001|STARTED|Overall Study||42
6765918|NCT03828422|7692610|FG000|COMPLETED|Overall Study||36
6765919|NCT03828422|7692611|FG001|COMPLETED|Overall Study||38
6765920|NCT03828422|7692610|FG000|NOT COMPLETED|Overall Study||4
6765921|NCT03828422|7692611|FG001|NOT COMPLETED|Overall Study||4
6765922|NCT03829228|7692618|FG000|STARTED|Overall Study||30
6765923|NCT03829228|7692618|FG000|COMPLETED|Overall Study||29
6765924|NCT03829228|7692618|FG000|NOT COMPLETED|Overall Study||1
6765925|NCT03829618|7692625|FG000|STARTED|Overall Study||15
6765926|NCT03829618|7692626|FG001|STARTED|Overall Study||7
6765927|NCT03829618|7692627|FG002|STARTED|Overall Study||7
6765928|NCT03829618|7692625|FG000|COMPLETED|Overall Study||15
6765929|NCT03829618|7692626|FG001|COMPLETED|Overall Study||7
6765930|NCT03829618|7692627|FG002|COMPLETED|Overall Study||7
6765931|NCT03829618|7692625|FG000|NOT COMPLETED|Overall Study||0
6765932|NCT03829618|7692626|FG001|NOT COMPLETED|Overall Study||0
6765933|NCT03829618|7692627|FG002|NOT COMPLETED|Overall Study||0
6765934|NCT03830333|7692637|FG000|STARTED|Overall Study||134
6765935|NCT03830333|7692638|FG001|STARTED|Overall Study||134
6765936|NCT03830333|7692637|FG000|Clinically Evaluable Population|Overall Study||105
6765937|NCT03830333|7692638|FG001|Clinically Evaluable Population|Overall Study||116
6765938|NCT03830333|7692637|FG000|COMPLETED|Overall Study||126
6765939|NCT03830333|7692638|FG001|COMPLETED|Overall Study||130
6765940|NCT03830333|7692637|FG000|NOT COMPLETED|Overall Study||8
6765941|NCT03830333|7692638|FG001|NOT COMPLETED|Overall Study||4
6765942|NCT03831880|7692646|FG000|STARTED|Period 1 (12 Weeks)||43
6765943|NCT03831880|7692647|FG001|STARTED|Period 1 (12 Weeks)||44
6765944|NCT03831880|7692646|FG000|COMPLETED|Period 1 (12 Weeks)||43
6765945|NCT03831880|7692647|FG001|COMPLETED|Period 1 (12 Weeks)||43
6765946|NCT03831880|7692646|FG000|NOT COMPLETED|Period 1 (12 Weeks)||0
6765947|NCT03831880|7692647|FG001|NOT COMPLETED|Period 1 (12 Weeks)||1
6765948|NCT03831880|7692646|FG000|STARTED|Period 2 (12 Weeks)||43
6765949|NCT03831880|7692647|FG001|STARTED|Period 2 (12 Weeks)||43
6765950|NCT03831880|7692646|FG000|COMPLETED|Period 2 (12 Weeks)||43
6765951|NCT03831880|7692647|FG001|COMPLETED|Period 2 (12 Weeks)||42
6765952|NCT03831880|7692646|FG000|NOT COMPLETED|Period 2 (12 Weeks)||0
6765953|NCT03831880|7692647|FG001|NOT COMPLETED|Period 2 (12 Weeks)||1
6765954|NCT03831880|7692646|FG000|STARTED|Follow-up (5 Weeks)||43
6765955|NCT03831880|7692647|FG001|STARTED|Follow-up (5 Weeks)|1 participant who discontinued from Period 1 completed follow-up visit.|43
6765956|NCT03831880|7692646|FG000|COMPLETED|Follow-up (5 Weeks)||43
6765957|NCT03831880|7692647|FG001|COMPLETED|Follow-up (5 Weeks)||43
6765958|NCT03831880|7692646|FG000|NOT COMPLETED|Follow-up (5 Weeks)||0
6765959|NCT03831880|7692647|FG001|NOT COMPLETED|Follow-up (5 Weeks)||0
6765960|NCT03831945|7692657|FG000|STARTED|Overall Study||10
6765961|NCT03831945|7692658|FG001|STARTED|Overall Study||10
6765962|NCT03831945|7692657|FG000|COMPLETED|Overall Study||3
6765963|NCT03831945|7692658|FG001|COMPLETED|Overall Study||4
6765964|NCT03831945|7692657|FG000|NOT COMPLETED|Overall Study||7
6765965|NCT03831945|7692658|FG001|NOT COMPLETED|Overall Study||6
6765966|NCT03835728|7692666|FG000|STARTED|Overall Study||2
6765967|NCT03835728|7692667|FG001|STARTED|Overall Study||1
6765968|NCT03835728|7692666|FG000|COMPLETED|Overall Study||2
6765969|NCT03835728|7692667|FG001|COMPLETED|Overall Study||1
6765970|NCT03835728|7692666|FG000|NOT COMPLETED|Overall Study||0
6765971|NCT03835728|7692667|FG001|NOT COMPLETED|Overall Study||0
6765972|NCT03840174|7692677|FG000|STARTED|Overall Study||6
6765973|NCT03840174|7692678|FG001|STARTED|Overall Study||6
6765974|NCT03840174|7692679|FG002|STARTED|Overall Study||3
6765975|NCT03840174|7692680|FG003|STARTED|Overall Study||3
6765976|NCT03840174|7692677|FG000|Vaccination 1|Overall Study||6
6765977|NCT03840174|7692678|FG001|Vaccination 1|Overall Study||6
6765978|NCT03840174|7692679|FG002|Vaccination 1|Overall Study||3
6765979|NCT03840174|7692680|FG003|Vaccination 1|Overall Study||3
6765980|NCT03840174|7692677|FG000|Vaccination 2|Overall Study||5
6765981|NCT03840174|7692678|FG001|Vaccination 2|Overall Study||6
6765982|NCT03840174|7692679|FG002|Vaccination 2|Overall Study||3
6765983|NCT03840174|7692680|FG003|Vaccination 2|Overall Study||3
6765984|NCT03840174|7692677|FG000|Vaccination 3|Overall Study||5
6765985|NCT03840174|7692678|FG001|Vaccination 3|Overall Study||6
6765986|NCT03840174|7692679|FG002|Vaccination 3|Overall Study||3
6765987|NCT03840174|7692680|FG003|Vaccination 3|Overall Study||3
6556380|NCT01759368|7478695|FG001|COMPLETED|Overall Study||47
6556381|NCT01759368|7478694|FG000|NOT COMPLETED|Overall Study||1
6556382|NCT01759368|7478695|FG001|NOT COMPLETED|Overall Study||0
6765988|NCT03840174|7692677|FG000|COMPLETED|Overall Study||5
6765989|NCT03840174|7692678|FG001|COMPLETED|Overall Study||6
6765990|NCT03840174|7692679|FG002|COMPLETED|Overall Study||3
6765991|NCT03840174|7692680|FG003|COMPLETED|Overall Study||3
6765992|NCT03840174|7692677|FG000|NOT COMPLETED|Overall Study||1
6765993|NCT03840174|7692678|FG001|NOT COMPLETED|Overall Study||0
6765994|NCT03840174|7692679|FG002|NOT COMPLETED|Overall Study||0
6765995|NCT03840174|7692680|FG003|NOT COMPLETED|Overall Study||0
6765996|NCT03848910|7692691|FG000|STARTED|Overall Study||11
6765997|NCT03848910|7692691|FG000|COMPLETED|Overall Study||11
6765998|NCT03848910|7692691|FG000|NOT COMPLETED|Overall Study||0
6765999|NCT03852524|7692698|FG000|STARTED|Overall Study||41
6766000|NCT03852524|7692699|FG001|STARTED|Overall Study||41
6766001|NCT03852524|7692698|FG000|COMPLETED|Overall Study||41
6766002|NCT03852524|7692699|FG001|COMPLETED|Overall Study||41
6766003|NCT03852524|7692698|FG000|NOT COMPLETED|Overall Study||0
6766004|NCT03852524|7692699|FG001|NOT COMPLETED|Overall Study||0
6780335|NCT03152526|7708746|FG000|COMPLETED|Overall Study|No participants were enrolled on this arm.|0
6780336|NCT03152526|7708747|FG001|COMPLETED|Overall Study|The one participant enrolled on this arm withdrew from the study early.|0
6780337|NCT03152526|7708746|FG000|NOT COMPLETED|Overall Study||0
6780338|NCT03152526|7708747|FG001|NOT COMPLETED|Overall Study||1
6780339|NCT03161964|7708755|FG000|STARTED|Overall Study||1
6780340|NCT03161964|7708756|FG001|STARTED|Overall Study||1
6780341|NCT03161964|7708755|FG000|COMPLETED|Overall Study||1
6780342|NCT03161964|7708756|FG001|COMPLETED|Overall Study||0
6780343|NCT03161964|7708755|FG000|NOT COMPLETED|Overall Study||0
6780344|NCT03161964|7708756|FG001|NOT COMPLETED|Overall Study||1
6780345|NCT03150160|7708764|FG000|STARTED|Overall Study||0
6780346|NCT03150160|7708765|FG001|STARTED|Overall Study||1
6780347|NCT03150160|7708764|FG000|COMPLETED|Overall Study||0
6780348|NCT03150160|7708765|FG001|COMPLETED|Overall Study||1
6780349|NCT03150160|7708764|FG000|NOT COMPLETED|Overall Study||0
6780350|NCT03150160|7708765|FG001|NOT COMPLETED|Overall Study||0
6780351|NCT03137225|7708773|FG000|STARTED|First 4 Hour Measurement Period||1
6780352|NCT03137225|7708774|FG001|STARTED|First 4 Hour Measurement Period||0
6780353|NCT03137225|7708773|FG000|COMPLETED|First 4 Hour Measurement Period||1
6780354|NCT03137225|7708774|FG001|COMPLETED|First 4 Hour Measurement Period||0
6780355|NCT03137225|7708773|FG000|NOT COMPLETED|First 4 Hour Measurement Period||0
6780356|NCT03137225|7708774|FG001|NOT COMPLETED|First 4 Hour Measurement Period||0
6780357|NCT03137225|7708773|FG000|STARTED|Second 4 Hour Measurement Period||1
6780358|NCT03137225|7708774|FG001|STARTED|Second 4 Hour Measurement Period||0
6780359|NCT03137225|7708773|FG000|COMPLETED|Second 4 Hour Measurement Period||1
6780360|NCT03137225|7708774|FG001|COMPLETED|Second 4 Hour Measurement Period||0
6780361|NCT03137225|7708773|FG000|NOT COMPLETED|Second 4 Hour Measurement Period||0
6780362|NCT03137225|7708774|FG001|NOT COMPLETED|Second 4 Hour Measurement Period||0
6556383|NCT01759381|7478705|FG000|STARTED|Overall Study||8
6556384|NCT01759381|7478706|FG001|STARTED|Overall Study||11
6556385|NCT01759381|7478705|FG000|COMPLETED|Overall Study||7
6556386|NCT01759381|7478706|FG001|COMPLETED|Overall Study||11
6556387|NCT01759381|7478705|FG000|NOT COMPLETED|Overall Study||1
6556388|NCT01759381|7478706|FG001|NOT COMPLETED|Overall Study||0
6780363|NCT03123393|7708782|FG000|STARTED|Overall Study||24
6780364|NCT03123393|7708783|FG001|STARTED|Overall Study||25
6780365|NCT03123393|7708782|FG000|COMPLETED|Overall Study||3
6556389|NCT01759407|7478714|FG000|STARTED|Overall Study||10
6556390|NCT01759407|7478715|FG001|STARTED|Overall Study||9
6556391|NCT01759407|7478714|FG000|COMPLETED|Overall Study||10
6780366|NCT03123393|7708783|FG001|COMPLETED|Overall Study||2
6780367|NCT03123393|7708782|FG000|NOT COMPLETED|Overall Study||21
6780368|NCT03123393|7708783|FG001|NOT COMPLETED|Overall Study||23
6780369|NCT03123328|7708789|FG000|STARTED|Overall Study||380
6780370|NCT03123328|7708789|FG000|COMPLETED|Overall Study||351
6780371|NCT03123328|7708789|FG000|NOT COMPLETED|Overall Study||29
6780372|NCT03119662|7708795|FG000|STARTED|Overall Study||2
6780373|NCT03119662|7708796|FG001|STARTED|Overall Study||2
6780374|NCT03119662|7708795|FG000|COMPLETED|Overall Study||2
6780375|NCT03119662|7708796|FG001|COMPLETED|Overall Study||1
6780376|NCT03119662|7708795|FG000|NOT COMPLETED|Overall Study||0
6780377|NCT03119662|7708796|FG001|NOT COMPLETED|Overall Study||1
6780378|NCT03109418|7708804|FG000|STARTED|Overall Study||2
6780379|NCT03109418|7708805|FG001|STARTED|Overall Study||4
6780380|NCT03109418|7708804|FG000|COMPLETED|Overall Study||2
6780381|NCT03109418|7708805|FG001|COMPLETED|Overall Study||3
6780382|NCT03109418|7708804|FG000|NOT COMPLETED|Overall Study||0
6780383|NCT03109418|7708805|FG001|NOT COMPLETED|Overall Study||1
6780384|NCT03120676|7708811|FG000|STARTED|Overall Study||3
6780385|NCT03120676|7708811|FG000|COMPLETED|Overall Study||2
6556392|NCT01759407|7478715|FG001|COMPLETED|Overall Study||7
6556393|NCT01759407|7478714|FG000|NOT COMPLETED|Overall Study||0
6556394|NCT01759407|7478715|FG001|NOT COMPLETED|Overall Study||2
6780386|NCT03120676|7708811|FG000|NOT COMPLETED|Overall Study||1
6780387|NCT03109873|7708817|FG000|STARTED|Overall Study||5
6780388|NCT03109873|7708818|FG001|STARTED|Overall Study||4
6780389|NCT03109873|7708817|FG000|COMPLETED|Overall Study||5
6780390|NCT03109873|7708818|FG001|COMPLETED|Overall Study||4
6780391|NCT03109873|7708817|FG000|NOT COMPLETED|Overall Study||0
6766005|NCT03857841|7692709|FG000|STARTED|Overall Study||2
6766006|NCT03857841|7692710|FG001|STARTED|Overall Study||0
6766007|NCT03857841|7692711|FG002|STARTED|Overall Study||0
6766008|NCT03857841|7692712|FG003|STARTED|Overall Study||1
6766009|NCT03857841|7692709|FG000|COMPLETED|Overall Study||0
6766010|NCT03857841|7692710|FG001|COMPLETED|Overall Study||0
6766011|NCT03857841|7692711|FG002|COMPLETED|Overall Study||0
6766012|NCT03857841|7692712|FG003|COMPLETED|Overall Study||1
6766013|NCT03857841|7692709|FG000|NOT COMPLETED|Overall Study||2
6766014|NCT03857841|7692710|FG001|NOT COMPLETED|Overall Study||0
6766015|NCT03857841|7692711|FG002|NOT COMPLETED|Overall Study||0
6766016|NCT03857841|7692712|FG003|NOT COMPLETED|Overall Study||0
6766017|NCT03861780|7692725|FG000|STARTED|Overall Study||51
6766018|NCT03861780|7692726|FG001|STARTED|Overall Study||50
6766019|NCT03861780|7692727|FG002|STARTED|Overall Study||51
6766020|NCT03861780|7692725|FG000|COMPLETED|Overall Study||51
6766021|NCT03861780|7692726|FG001|COMPLETED|Overall Study||50
6766022|NCT03861780|7692727|FG002|COMPLETED|Overall Study||51
6766023|NCT03861780|7692725|FG000|NOT COMPLETED|Overall Study||0
6766024|NCT03861780|7692726|FG001|NOT COMPLETED|Overall Study||0
6766025|NCT03861780|7692727|FG002|NOT COMPLETED|Overall Study||0
6766026|NCT03862625|7692737|FG000|STARTED|Overall Study||15
6766027|NCT03862625|7692738|FG001|STARTED|Overall Study||15
6766028|NCT03862625|7692737|FG000|COMPLETED|Overall Study||15
6766029|NCT03862625|7692738|FG001|COMPLETED|Overall Study||14
6766030|NCT03862625|7692737|FG000|NOT COMPLETED|Overall Study||0
6766031|NCT03862625|7692738|FG001|NOT COMPLETED|Overall Study||1
6766032|NCT03862755|7692744|FG000|STARTED|Overall Study||581
6766033|NCT03862755|7692744|FG000|COMPLETED|Overall Study||581
6766034|NCT03862755|7692744|FG000|NOT COMPLETED|Overall Study||0
6766035|NCT03869541|7692751|FG000|STARTED|Overall Study||40
6766036|NCT03869541|7692752|FG001|STARTED|Overall Study||50
6766037|NCT03869541|7692753|FG002|STARTED|Overall Study||10
6766038|NCT03869541|7692751|FG000|COMPLETED|Overall Study||40
6766039|NCT03869541|7692752|FG001|COMPLETED|Overall Study||50
6766040|NCT03869541|7692753|FG002|COMPLETED|Overall Study||10
6766041|NCT03869541|7692751|FG000|NOT COMPLETED|Overall Study||0
6766042|NCT03869541|7692752|FG001|NOT COMPLETED|Overall Study||0
6766043|NCT03869541|7692753|FG002|NOT COMPLETED|Overall Study||0
6766044|NCT03877224|7692766|FG000|STARTED|Overall Study||253
6766045|NCT03877224|7692767|FG001|STARTED|Overall Study||251
6766046|NCT03877224|7692766|FG000|Treated|Overall Study||252
6766047|NCT03877224|7692767|FG001|Treated|Overall Study||249
6766048|NCT03877224|7692766|FG000|COMPLETED|Overall Study||248
6766049|NCT03877224|7692767|FG001|COMPLETED|Overall Study||243
6766050|NCT03877224|7692766|FG000|NOT COMPLETED|Overall Study||5
6766051|NCT03877224|7692767|FG001|NOT COMPLETED|Overall Study||8
6766052|NCT03883607|7692775|FG000|STARTED|Overall Study||5
6766053|NCT03883607|7692776|FG001|STARTED|Overall Study||5
6766054|NCT03883607|7692775|FG000|COMPLETED|Overall Study||5
6766055|NCT03883607|7692776|FG001|COMPLETED|Overall Study||5
6766056|NCT03883607|7692775|FG000|NOT COMPLETED|Overall Study||0
6766057|NCT03883607|7692776|FG001|NOT COMPLETED|Overall Study||0
6766058|NCT03885596|7692786|FG000|STARTED|Overall Study||9
6766059|NCT03885596|7692787|FG001|STARTED|Overall Study||9
6766060|NCT03885596|7692788|FG002|STARTED|Overall Study||9
6766061|NCT03885596|7692789|FG003|STARTED|Overall Study||9
6766062|NCT03885596|7692786|FG000|COMPLETED|Overall Study||7
6766063|NCT03885596|7692787|FG001|COMPLETED|Overall Study||8
6766064|NCT03885596|7692788|FG002|COMPLETED|Overall Study||9
6766065|NCT03885596|7692789|FG003|COMPLETED|Overall Study||9
6766066|NCT03885596|7692786|FG000|NOT COMPLETED|Overall Study||2
6766067|NCT03885596|7692787|FG001|NOT COMPLETED|Overall Study||1
6766068|NCT03885596|7692788|FG002|NOT COMPLETED|Overall Study||0
6766069|NCT03885596|7692789|FG003|NOT COMPLETED|Overall Study||0
6766070|NCT03885661|7692804|FG000|STARTED|Overall Study||12
6766071|NCT03885661|7692805|FG001|STARTED|Overall Study||8
6766072|NCT03885661|7692804|FG000|Baseline|Overall Study||12
6766073|NCT03885661|7692805|FG001|Baseline|Overall Study||8
6766074|NCT03885661|7692804|FG000|Treatment Visit (12 Week)|Overall Study||11
6766075|NCT03885661|7692805|FG001|Treatment Visit (12 Week)|Overall Study||7
6766076|NCT03885661|7692804|FG000|COMPLETED|Overall Study||11
6766077|NCT03885661|7692805|FG001|COMPLETED|Overall Study||7
6766078|NCT03885661|7692804|FG000|NOT COMPLETED|Overall Study||1
6766079|NCT03885661|7692805|FG001|NOT COMPLETED|Overall Study||1
6766080|NCT03886493|7692811|FG000|STARTED|Overall Study||7
6766081|NCT03886493|7692811|FG000|COMPLETED|Overall Study||6
6766082|NCT03886493|7692811|FG000|NOT COMPLETED|Overall Study||1
6766083|NCT03888235|7692818|FG000|STARTED|Overall Study|1 Participant dropped out after the first visit and was replaced.|21
6766084|NCT03888235|7692819|FG001|STARTED|Overall Study|1 participants dropped out after the first visit and was replaced|21
6766085|NCT03888235|7692820|FG002|STARTED|Overall Study||20
6766086|NCT03888235|7692818|FG000|COMPLETED|Overall Study||20
6766087|NCT03888235|7692819|FG001|COMPLETED|Overall Study||20
6766088|NCT03888235|7692820|FG002|COMPLETED|Overall Study||20
6766089|NCT03888235|7692818|FG000|NOT COMPLETED|Overall Study||1
6766090|NCT03888235|7692819|FG001|NOT COMPLETED|Overall Study||1
6766091|NCT03888235|7692820|FG002|NOT COMPLETED|Overall Study||0
6766092|NCT03889158|7692853|FG000|STARTED|Overall Study||20
6766093|NCT03889158|7692854|FG001|STARTED|Overall Study||15
6766094|NCT03889158|7692853|FG000|COMPLETED|Overall Study||16
6766095|NCT03889158|7692854|FG001|COMPLETED|Overall Study||9
6766096|NCT03889158|7692853|FG000|NOT COMPLETED|Overall Study||4
6766097|NCT03889158|7692854|FG001|NOT COMPLETED|Overall Study||6
6766098|NCT03890419|7692864|FG000|STARTED|Overall Study||34
6766099|NCT03890419|7692865|FG001|STARTED|Overall Study||30
6766100|NCT03890419|7692866|FG002|STARTED|Overall Study||30
6766101|NCT03890419|7692864|FG000|COMPLETED|Overall Study||27
6766102|NCT03890419|7692865|FG001|COMPLETED|Overall Study||27
6766103|NCT03890419|7692866|FG002|COMPLETED|Overall Study||25
6766104|NCT03890419|7692864|FG000|NOT COMPLETED|Overall Study||7
6766105|NCT03890419|7692865|FG001|NOT COMPLETED|Overall Study||3
6766106|NCT03890419|7692866|FG002|NOT COMPLETED|Overall Study||5
6766107|NCT03897348|7692878|FG000|STARTED|ADP Session 1||1
6766108|NCT03897348|7692879|FG001|STARTED|ADP Session 1||1
6766109|NCT03897348|7692880|FG002|STARTED|ADP Session 1||1
6766110|NCT03897348|7692881|FG003|STARTED|ADP Session 1||1
6766111|NCT03897348|7692878|FG000|COMPLETED|ADP Session 1||1
6766112|NCT03897348|7692879|FG001|COMPLETED|ADP Session 1||1
6766113|NCT03897348|7692880|FG002|COMPLETED|ADP Session 1||1
6766114|NCT03897348|7692881|FG003|COMPLETED|ADP Session 1||1
6766115|NCT03897348|7692878|FG000|NOT COMPLETED|ADP Session 1||0
6766116|NCT03897348|7692879|FG001|NOT COMPLETED|ADP Session 1||0
6766117|NCT03897348|7692880|FG002|NOT COMPLETED|ADP Session 1||0
6766118|NCT03897348|7692881|FG003|NOT COMPLETED|ADP Session 1||0
6766119|NCT03897348|7692878|FG000|STARTED|ADP Session 2||1
6766120|NCT03897348|7692879|FG001|STARTED|ADP Session 2||1
6766121|NCT03897348|7692880|FG002|STARTED|ADP Session 2||1
6766122|NCT03897348|7692881|FG003|STARTED|ADP Session 2||1
6766123|NCT03897348|7692878|FG000|COMPLETED|ADP Session 2||1
6766124|NCT03897348|7692879|FG001|COMPLETED|ADP Session 2||1
6766125|NCT03897348|7692880|FG002|COMPLETED|ADP Session 2||1
6766126|NCT03897348|7692881|FG003|COMPLETED|ADP Session 2||1
6766127|NCT03897348|7692878|FG000|NOT COMPLETED|ADP Session 2||0
6766128|NCT03897348|7692879|FG001|NOT COMPLETED|ADP Session 2||0
6766129|NCT03897348|7692880|FG002|NOT COMPLETED|ADP Session 2||0
6766130|NCT03897348|7692881|FG003|NOT COMPLETED|ADP Session 2||0
6766131|NCT03897348|7692878|FG000|STARTED|ADP Session 3||1
6766132|NCT03897348|7692879|FG001|STARTED|ADP Session 3||1
6766133|NCT03897348|7692880|FG002|STARTED|ADP Session 3||0
6766134|NCT03897348|7692881|FG003|STARTED|ADP Session 3||1
6766135|NCT03897348|7692878|FG000|COMPLETED|ADP Session 3||1
6766136|NCT03897348|7692879|FG001|COMPLETED|ADP Session 3||1
6766137|NCT03897348|7692880|FG002|COMPLETED|ADP Session 3||0
6766138|NCT03897348|7692881|FG003|COMPLETED|ADP Session 3||1
6766139|NCT03897348|7692878|FG000|NOT COMPLETED|ADP Session 3||0
6766140|NCT03897348|7692879|FG001|NOT COMPLETED|ADP Session 3||0
6766141|NCT03897348|7692880|FG002|NOT COMPLETED|ADP Session 3||0
6766142|NCT03897348|7692881|FG003|NOT COMPLETED|ADP Session 3||0
6766143|NCT03900416|7692892|FG000|STARTED|Baseline||72
6766144|NCT03900416|7692893|FG001|STARTED|Baseline||80
6766145|NCT03900416|7692892|FG000|COMPLETED|Baseline||72
6766146|NCT03900416|7692893|FG001|COMPLETED|Baseline||80
6766147|NCT03900416|7692892|FG000|NOT COMPLETED|Baseline||0
6766148|NCT03900416|7692893|FG001|NOT COMPLETED|Baseline||0
6766149|NCT03900416|7692892|FG000|STARTED|Post||72
6766150|NCT03900416|7692893|FG001|STARTED|Post||80
6766151|NCT03900416|7692892|FG000|COMPLETED|Post||72
6766152|NCT03900416|7692893|FG001|COMPLETED|Post||80
6766153|NCT03900416|7692892|FG000|NOT COMPLETED|Post||0
6766154|NCT03900416|7692893|FG001|NOT COMPLETED|Post||0
6766155|NCT03900416|7692892|FG000|STARTED|Six Week Follow-up||72
6766156|NCT03900416|7692893|FG001|STARTED|Six Week Follow-up||80
6766157|NCT03900416|7692892|FG000|COMPLETED|Six Week Follow-up||70
6766158|NCT03900416|7692893|FG001|COMPLETED|Six Week Follow-up||80
6766159|NCT03900416|7692892|FG000|NOT COMPLETED|Six Week Follow-up||2
6766160|NCT03900416|7692893|FG001|NOT COMPLETED|Six Week Follow-up||0
6766161|NCT03900416|7692892|FG000|STARTED|Twelve Week Follow-up||70
6766162|NCT03900416|7692893|FG001|STARTED|Twelve Week Follow-up||80
6766163|NCT03900416|7692892|FG000|COMPLETED|Twelve Week Follow-up||69
6766164|NCT03900416|7692893|FG001|COMPLETED|Twelve Week Follow-up||76
6766165|NCT03900416|7692892|FG000|NOT COMPLETED|Twelve Week Follow-up||1
6766166|NCT03900416|7692893|FG001|NOT COMPLETED|Twelve Week Follow-up||4
6766167|NCT03900416|7692892|FG000|STARTED|Six Month Follow-up||69
6766168|NCT03900416|7692893|FG001|STARTED|Six Month Follow-up||76
6766169|NCT03900416|7692892|FG000|COMPLETED|Six Month Follow-up||64
6766170|NCT03900416|7692893|FG001|COMPLETED|Six Month Follow-up||72
6766171|NCT03900416|7692892|FG000|NOT COMPLETED|Six Month Follow-up||5
6766172|NCT03900416|7692893|FG001|NOT COMPLETED|Six Month Follow-up||4
6766173|NCT03905863|7692901|FG000|STARTED|Overall Study||64
6766174|NCT03905863|7692902|FG001|STARTED|Overall Study||81
6766175|NCT03905863|7692901|FG000|COMPLETED|Overall Study||59
6766176|NCT03905863|7692902|FG001|COMPLETED|Overall Study||69
6766177|NCT03905863|7692901|FG000|NOT COMPLETED|Overall Study||5
6766178|NCT03905863|7692902|FG001|NOT COMPLETED|Overall Study||12
6766179|NCT03907033|7692910|FG000|STARTED|Overall Study||14
6766180|NCT03907033|7692911|FG001|STARTED|Overall Study||14
6766181|NCT03907033|7692910|FG000|COMPLETED|Overall Study||14
6766182|NCT03907033|7692911|FG001|COMPLETED|Overall Study||14
6766183|NCT03907033|7692910|FG000|NOT COMPLETED|Overall Study||0
6766184|NCT03907033|7692911|FG001|NOT COMPLETED|Overall Study||0
6766185|NCT03909178|7692919|FG000|STARTED|Overall Study||46
6766186|NCT03909178|7692920|FG001|STARTED|Overall Study||44
6766187|NCT03909178|7692919|FG000|COMPLETED|Overall Study||42
6766188|NCT03909178|7692920|FG001|COMPLETED|Overall Study||39
6766189|NCT03909178|7692919|FG000|NOT COMPLETED|Overall Study||4
6766190|NCT03909178|7692920|FG001|NOT COMPLETED|Overall Study||5
6766191|NCT03909971|7692930|FG000|STARTED|Overall Study||67
6766192|NCT03909971|7692931|FG001|STARTED|Overall Study||42
6766193|NCT03909971|7692930|FG000|COMPLETED|Overall Study||57
6766194|NCT03909971|7692931|FG001|COMPLETED|Overall Study||20
6766195|NCT03909971|7692930|FG000|NOT COMPLETED|Overall Study||10
6766196|NCT03909971|7692931|FG001|NOT COMPLETED|Overall Study||22
6766197|NCT03920215|7692942|FG000|STARTED|Overall Study||26
6766198|NCT03920215|7692943|FG001|STARTED|Overall Study||29
6766199|NCT03920215|7692944|FG002|STARTED|Overall Study||23
6766200|NCT03920215|7692945|FG003|STARTED|Overall Study||23
6766201|NCT03920215|7692942|FG000|COMPLETED|Overall Study||25
6766202|NCT03920215|7692943|FG001|COMPLETED|Overall Study||27
6766203|NCT03920215|7692944|FG002|COMPLETED|Overall Study||23
6766204|NCT03920215|7692945|FG003|COMPLETED|Overall Study||22
6766205|NCT03920215|7692942|FG000|NOT COMPLETED|Overall Study||1
6766206|NCT03920215|7692943|FG001|NOT COMPLETED|Overall Study||2
6766207|NCT03920215|7692944|FG002|NOT COMPLETED|Overall Study||0
6766208|NCT03920215|7692945|FG003|NOT COMPLETED|Overall Study||1
6766209|NCT03921151|7692957|FG000|STARTED|Overall Study||46
6766210|NCT03921151|7692958|FG001|STARTED|Overall Study||44
6766211|NCT03921151|7692957|FG000|COMPLETED|Overall Study||35
6766212|NCT03921151|7692958|FG001|COMPLETED|Overall Study||28
6766213|NCT03921151|7692957|FG000|NOT COMPLETED|Overall Study||11
6766214|NCT03921151|7692958|FG001|NOT COMPLETED|Overall Study||16
6766215|NCT03926039|7692966|FG000|STARTED|Overall Study||35
6766216|NCT03926039|7692967|FG001|STARTED|Overall Study||35
6766217|NCT03926039|7692966|FG000|COMPLETED|Overall Study||35
6766218|NCT03926039|7692967|FG001|COMPLETED|Overall Study||34
6766219|NCT03926039|7692966|FG000|NOT COMPLETED|Overall Study||0
6766220|NCT03926039|7692967|FG001|NOT COMPLETED|Overall Study||1
6766221|NCT03927911|7692979|FG000|STARTED|Overall Study||0
6766222|NCT03927911|7692980|FG001|STARTED|Overall Study||17
6766223|NCT03927911|7692981|FG002|STARTED|Overall Study||0
6766224|NCT03927911|7692982|FG003|STARTED|Overall Study||3
6766225|NCT03927911|7692983|FG004|STARTED|Overall Study||13
6766226|NCT03927911|7692984|FG005|STARTED|Overall Study||32
6766227|NCT03927911|7692979|FG000|COMPLETED|Overall Study||0
6766228|NCT03927911|7692980|FG001|COMPLETED|Overall Study||15
6766229|NCT03927911|7692981|FG002|COMPLETED|Overall Study||0
6766230|NCT03927911|7692982|FG003|COMPLETED|Overall Study||1
6766231|NCT03927911|7692983|FG004|COMPLETED|Overall Study||13
6766232|NCT03927911|7692984|FG005|COMPLETED|Overall Study||25
6766233|NCT03927911|7692979|FG000|NOT COMPLETED|Overall Study||0
6766234|NCT03927911|7692980|FG001|NOT COMPLETED|Overall Study||2
6766235|NCT03927911|7692981|FG002|NOT COMPLETED|Overall Study||0
6766236|NCT03927911|7692982|FG003|NOT COMPLETED|Overall Study||2
6766237|NCT03927911|7692983|FG004|NOT COMPLETED|Overall Study||0
6766238|NCT03927911|7692984|FG005|NOT COMPLETED|Overall Study||7
6766239|NCT03937570|7693000|FG000|STARTED|Overall Study||13
6766240|NCT03937570|7693001|FG001|STARTED|Overall Study||14
6766241|NCT03937570|7693000|FG000|COMPLETED|Overall Study||13
6766242|NCT03937570|7693001|FG001|COMPLETED|Overall Study||14
6766243|NCT03937570|7693000|FG000|NOT COMPLETED|Overall Study||0
6766244|NCT03937570|7693001|FG001|NOT COMPLETED|Overall Study||0
6766245|NCT03938857|7693011|FG000|STARTED|Overall Study||6
6766246|NCT03938857|7693012|FG001|STARTED|Overall Study||12
6766247|NCT03938857|7693013|FG002|STARTED|Overall Study||12
6766248|NCT03938857|7693014|FG003|STARTED|Overall Study||0
6766249|NCT03938857|7693011|FG000|COMPLETED|Overall Study||5
6766250|NCT03938857|7693012|FG001|COMPLETED|Overall Study||12
6766251|NCT03938857|7693013|FG002|COMPLETED|Overall Study||12
6766252|NCT03938857|7693014|FG003|COMPLETED|Overall Study||0
6766253|NCT03938857|7693011|FG000|NOT COMPLETED|Overall Study||1
6766254|NCT03938857|7693012|FG001|NOT COMPLETED|Overall Study||0
6766255|NCT03938857|7693013|FG002|NOT COMPLETED|Overall Study||0
6766256|NCT03938857|7693014|FG003|NOT COMPLETED|Overall Study||0
6766257|NCT03941912|7693024|FG000|STARTED|Overall Study||44
6766258|NCT03941912|7693024|FG000|COMPLETED|Overall Study||44
6766259|NCT03941912|7693024|FG000|NOT COMPLETED|Overall Study||0
6766260|NCT03945981|7693028|FG000|STARTED|Overall Study||131
6766261|NCT03945981|7693028|FG000|COMPLETED|Overall Study||108
6766262|NCT03945981|7693028|FG000|NOT COMPLETED|Overall Study||23
6766263|NCT03950167|7693034|FG000|STARTED|Overall Study||25
6766264|NCT03950167|7693035|FG001|STARTED|Overall Study||25
6766265|NCT03950167|7693034|FG000|COMPLETED|Overall Study||24
6766266|NCT03950167|7693035|FG001|COMPLETED|Overall Study||22
6766267|NCT03950167|7693034|FG000|NOT COMPLETED|Overall Study||1
6766268|NCT03950167|7693035|FG001|NOT COMPLETED|Overall Study||3
6766269|NCT03954834|7693045|FG000|STARTED|Overall Study||121
6766270|NCT03954834|7693046|FG001|STARTED|Overall Study||121
6766271|NCT03954834|7693047|FG002|STARTED|Overall Study||121
6766272|NCT03954834|7693048|FG003|STARTED|Overall Study||115
6766273|NCT03954834|7693045|FG000|Received at Least One Dose of Study Drug|Overall Study||121
6766274|NCT03954834|7693046|FG001|Received at Least One Dose of Study Drug|Overall Study||121
6766275|NCT03954834|7693047|FG002|Received at Least One Dose of Study Drug|Overall Study||121
6766276|NCT03954834|7693048|FG003|Received at Least One Dose of Study Drug|Overall Study||115
6766277|NCT03954834|7693045|FG000|COMPLETED|Overall Study||114
6766278|NCT03954834|7693046|FG001|COMPLETED|Overall Study||112
6766279|NCT03954834|7693047|FG002|COMPLETED|Overall Study||103
6766280|NCT03954834|7693048|FG003|COMPLETED|Overall Study||99
6766281|NCT03954834|7693045|FG000|NOT COMPLETED|Overall Study||7
6766282|NCT03954834|7693046|FG001|NOT COMPLETED|Overall Study||9
6766283|NCT03954834|7693047|FG002|NOT COMPLETED|Overall Study||18
6766284|NCT03954834|7693048|FG003|NOT COMPLETED|Overall Study||16
6766285|NCT03958071|7693061|FG000|STARTED|Overall Study||347
6766286|NCT03958071|7693062|FG001|STARTED|Overall Study||423
6766287|NCT03958071|7693063|FG002|STARTED|Overall Study||12494
6766288|NCT03958071|7693061|FG000|COMPLETED|Overall Study||347
6766289|NCT03958071|7693062|FG001|COMPLETED|Overall Study||423
6766290|NCT03958071|7693063|FG002|COMPLETED|Overall Study||12494
6766291|NCT03958071|7693061|FG000|NOT COMPLETED|Overall Study||0
6766292|NCT03958071|7693062|FG001|NOT COMPLETED|Overall Study||0
6766293|NCT03958071|7693063|FG002|NOT COMPLETED|Overall Study||0
6766294|NCT03961529|7693075|FG000|STARTED|Overall Study||166
6766295|NCT03961529|7693076|FG001|STARTED|Overall Study||144
6766296|NCT03961529|7693077|FG002|STARTED|Overall Study||56
6766297|NCT03961529|7693075|FG000|COMPLETED|Overall Study||124
6766298|NCT03961529|7693076|FG001|COMPLETED|Overall Study||127
6766299|NCT03961529|7693077|FG002|COMPLETED|Overall Study||51
6766300|NCT03961529|7693075|FG000|NOT COMPLETED|Overall Study||42
6766301|NCT03961529|7693076|FG001|NOT COMPLETED|Overall Study||17
6766302|NCT03961529|7693077|FG002|NOT COMPLETED|Overall Study||5
6766303|NCT03968159|7693087|FG000|STARTED|Overall Study||148
6766304|NCT03968159|7693088|FG001|STARTED|Overall Study||150
6766305|NCT03968159|7693087|FG000|COMPLETED|Overall Study||135
6766306|NCT03968159|7693088|FG001|COMPLETED|Overall Study||135
6766307|NCT03968159|7693087|FG000|NOT COMPLETED|Overall Study||13
6766308|NCT03968159|7693088|FG001|NOT COMPLETED|Overall Study||15
6766309|NCT03968965|7693096|FG000|STARTED|Overall Study||32
6766310|NCT03968965|7693097|FG001|STARTED|Overall Study||32
6766311|NCT03968965|7693096|FG000|COMPLETED|Overall Study||32
6766312|NCT03968965|7693097|FG001|COMPLETED|Overall Study||30
6766313|NCT03968965|7693096|FG000|NOT COMPLETED|Overall Study||0
6766314|NCT03968965|7693097|FG001|NOT COMPLETED|Overall Study||2
6766315|NCT03970824|7693106|FG000|STARTED|Overall Study||103
6766316|NCT03970824|7693107|FG001|STARTED|Overall Study||103
6766317|NCT03970824|7693108|FG002|STARTED|Overall Study||106
6766318|NCT03970824|7693106|FG000|COMPLETED|Overall Study||101
6766319|NCT03970824|7693107|FG001|COMPLETED|Overall Study||100
6766320|NCT03970824|7693108|FG002|COMPLETED|Overall Study||102
6766321|NCT03970824|7693106|FG000|NOT COMPLETED|Overall Study||2
6766322|NCT03970824|7693107|FG001|NOT COMPLETED|Overall Study||3
6766323|NCT03970824|7693108|FG002|NOT COMPLETED|Overall Study||4
6766324|NCT03978403|7693120|FG000|STARTED|Overall Study||6
6766325|NCT03978403|7693121|FG001|STARTED|Overall Study||6
6766326|NCT03978403|7693122|FG002|STARTED|Overall Study||6
6766327|NCT03978403|7693123|FG003|STARTED|Overall Study||6
6766328|NCT03978403|7693120|FG000|COMPLETED|Overall Study||6
6766329|NCT03978403|7693121|FG001|COMPLETED|Overall Study||6
6766330|NCT03978403|7693122|FG002|COMPLETED|Overall Study||6
6766331|NCT03978403|7693123|FG003|COMPLETED|Overall Study||6
6766332|NCT03978403|7693120|FG000|NOT COMPLETED|Overall Study||0
6766333|NCT03978403|7693121|FG001|NOT COMPLETED|Overall Study||0
6766334|NCT03978403|7693122|FG002|NOT COMPLETED|Overall Study||0
6766335|NCT03978403|7693123|FG003|NOT COMPLETED|Overall Study||0
6766336|NCT03979807|7693136|FG000|STARTED|Overall Study||3876
6556395|NCT01759420|7478721|FG000|STARTED|Overall Study||28
6556396|NCT01759420|7478721|FG000|COMPLETED|Overall Study||22
6556397|NCT01759420|7478721|FG000|NOT COMPLETED|Overall Study||6
6766337|NCT03979807|7693137|FG001|STARTED|Overall Study||7420
6766338|NCT03979807|7693136|FG000|COMPLETED|Overall Study||3876
6766339|NCT03979807|7693137|FG001|COMPLETED|Overall Study||7420
6766340|NCT03979807|7693136|FG000|NOT COMPLETED|Overall Study||0
6766341|NCT03979807|7693137|FG001|NOT COMPLETED|Overall Study||0
6766342|NCT03980470|7693143|FG000|STARTED|Overall Study||50
6766343|NCT03980470|7693143|FG000|COMPLETED|Overall Study||50
6766344|NCT03980470|7693143|FG000|NOT COMPLETED|Overall Study||0
6766345|NCT03982069|7693154|FG000|STARTED|Overall Study||108
6766346|NCT03982069|7693155|FG001|STARTED|Overall Study||110
6766347|NCT03982069|7693156|FG002|STARTED|Overall Study||127
6766348|NCT03982069|7693157|FG003|STARTED|Overall Study||120
6766349|NCT03982069|7693154|FG000|COMPLETED|Overall Study||98
6766350|NCT03982069|7693155|FG001|COMPLETED|Overall Study||100
6766351|NCT03982069|7693156|FG002|COMPLETED|Overall Study||118
6766352|NCT03982069|7693157|FG003|COMPLETED|Overall Study||112
6766353|NCT03982069|7693154|FG000|NOT COMPLETED|Overall Study||10
6766354|NCT03982069|7693155|FG001|NOT COMPLETED|Overall Study||10
6766355|NCT03982069|7693156|FG002|NOT COMPLETED|Overall Study||9
6766356|NCT03982069|7693157|FG003|NOT COMPLETED|Overall Study||8
6766357|NCT03984812|7693176|FG000|STARTED|Part 1 (Up to Day 28)||6
6766358|NCT03984812|7693177|FG001|STARTED|Part 1 (Up to Day 28)||6
6766359|NCT03984812|7693178|FG002|STARTED|Part 1 (Up to Day 28)||6
6766360|NCT03984812|7693179|FG003|STARTED|Part 1 (Up to Day 28)||6
6556398|NCT01759446|7478730|FG000|STARTED|Overall Study||9
6556399|NCT01759446|7478731|FG001|STARTED|Overall Study||9
6766361|NCT03984812|7693180|FG004|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
6766362|NCT03984812|7693181|FG005|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
6766363|NCT03984812|7693182|FG006|STARTED|Part 1 (Up to Day 28)|No participants were enrolled in this arm as the study was terminated due to non-safety reasons.|0
6766364|NCT03984812|7693183|FG007|STARTED|Part 1 (Up to Day 28)||0
6766365|NCT03984812|7693184|FG008|STARTED|Part 1 (Up to Day 28)||0
6766366|NCT03984812|7693185|FG009|STARTED|Part 1 (Up to Day 28)||0
6766367|NCT03984812|7693186|FG010|STARTED|Part 1 (Up to Day 28)||0
6766368|NCT03984812|7693176|FG000|COMPLETED|Part 1 (Up to Day 28)||6
6766369|NCT03984812|7693177|FG001|COMPLETED|Part 1 (Up to Day 28)||6
6766370|NCT03984812|7693178|FG002|COMPLETED|Part 1 (Up to Day 28)||5
6766371|NCT03984812|7693179|FG003|COMPLETED|Part 1 (Up to Day 28)||6
6766372|NCT03984812|7693180|FG004|COMPLETED|Part 1 (Up to Day 28)||0
6766373|NCT03984812|7693181|FG005|COMPLETED|Part 1 (Up to Day 28)||0
6766374|NCT03984812|7693182|FG006|COMPLETED|Part 1 (Up to Day 28)||0
6766375|NCT03984812|7693183|FG007|COMPLETED|Part 1 (Up to Day 28)||0
6766376|NCT03984812|7693184|FG008|COMPLETED|Part 1 (Up to Day 28)||0
6766377|NCT03984812|7693185|FG009|COMPLETED|Part 1 (Up to Day 28)||0
6766378|NCT03984812|7693186|FG010|COMPLETED|Part 1 (Up to Day 28)||0
6766379|NCT03984812|7693176|FG000|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766380|NCT03984812|7693177|FG001|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766381|NCT03984812|7693178|FG002|NOT COMPLETED|Part 1 (Up to Day 28)||1
6766382|NCT03984812|7693179|FG003|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766383|NCT03984812|7693180|FG004|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766384|NCT03984812|7693181|FG005|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766385|NCT03984812|7693182|FG006|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766386|NCT03984812|7693183|FG007|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766387|NCT03984812|7693184|FG008|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766388|NCT03984812|7693185|FG009|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766389|NCT03984812|7693186|FG010|NOT COMPLETED|Part 1 (Up to Day 28)||0
6766390|NCT03984812|7693176|FG000|STARTED|Part 2 (Up to Day 49)||0
6766391|NCT03984812|7693177|FG001|STARTED|Part 2 (Up to Day 49)||0
6766392|NCT03984812|7693178|FG002|STARTED|Part 2 (Up to Day 49)||0
6766393|NCT03984812|7693179|FG003|STARTED|Part 2 (Up to Day 49)||0
6766394|NCT03984812|7693180|FG004|STARTED|Part 2 (Up to Day 49)||0
6766395|NCT03984812|7693181|FG005|STARTED|Part 2 (Up to Day 49)||0
6766396|NCT03984812|7693182|FG006|STARTED|Part 2 (Up to Day 49)||0
6766397|NCT03984812|7693183|FG007|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
6766398|NCT03984812|7693184|FG008|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
6766399|NCT03984812|7693185|FG009|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
6766400|NCT03984812|7693186|FG010|STARTED|Part 2 (Up to Day 49)|No participants were enrolled in Part 2 as the study was terminated due to non-safety reasons.|0
6766401|NCT03984812|7693176|FG000|COMPLETED|Part 2 (Up to Day 49)||0
6766402|NCT03984812|7693177|FG001|COMPLETED|Part 2 (Up to Day 49)||0
6766403|NCT03984812|7693178|FG002|COMPLETED|Part 2 (Up to Day 49)||0
6766404|NCT03984812|7693179|FG003|COMPLETED|Part 2 (Up to Day 49)||0
6766405|NCT03984812|7693180|FG004|COMPLETED|Part 2 (Up to Day 49)||0
6766406|NCT03984812|7693181|FG005|COMPLETED|Part 2 (Up to Day 49)||0
6766407|NCT03984812|7693182|FG006|COMPLETED|Part 2 (Up to Day 49)||0
6766408|NCT03984812|7693183|FG007|COMPLETED|Part 2 (Up to Day 49)||0
6766409|NCT03984812|7693184|FG008|COMPLETED|Part 2 (Up to Day 49)||0
6766410|NCT03984812|7693185|FG009|COMPLETED|Part 2 (Up to Day 49)||0
6766411|NCT03984812|7693186|FG010|COMPLETED|Part 2 (Up to Day 49)||0
6766412|NCT03984812|7693176|FG000|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766413|NCT03984812|7693177|FG001|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766414|NCT03984812|7693178|FG002|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766415|NCT03984812|7693179|FG003|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766416|NCT03984812|7693180|FG004|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766417|NCT03984812|7693181|FG005|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766418|NCT03984812|7693182|FG006|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766419|NCT03984812|7693183|FG007|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766420|NCT03984812|7693184|FG008|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766421|NCT03984812|7693185|FG009|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766422|NCT03984812|7693186|FG010|NOT COMPLETED|Part 2 (Up to Day 49)||0
6766423|NCT03985813|7693215|FG000|STARTED|Overall Study||27
6766424|NCT03985813|7693216|FG001|STARTED|Overall Study||26
6766425|NCT03985813|7693215|FG000|COMPLETED|Overall Study||27
6766426|NCT03985813|7693216|FG001|COMPLETED|Overall Study||26
6766427|NCT03985813|7693215|FG000|NOT COMPLETED|Overall Study||0
6766428|NCT03985813|7693216|FG001|NOT COMPLETED|Overall Study||0
6766429|NCT03998163|7693222|FG000|STARTED|Overall Study||222
6766430|NCT03998163|7693222|FG000|COMPLETED|Overall Study||197
6766431|NCT03998163|7693222|FG000|NOT COMPLETED|Overall Study||25
6766432|NCT04000373|7693226|FG000|STARTED|Overall Study||5
6766433|NCT04000373|7693226|FG000|COMPLETED|Overall Study||5
6766434|NCT04000373|7693226|FG000|NOT COMPLETED|Overall Study||0
6766435|NCT04001517|7693233|FG000|STARTED|Overall Study||20
6766436|NCT04001517|7693234|FG001|STARTED|Overall Study||26
6766437|NCT04001517|7693235|FG002|STARTED|Overall Study||27
6766438|NCT04001517|7693236|FG003|STARTED|Overall Study||18
6766439|NCT04001517|7693233|FG000|COMPLETED|Overall Study||20
6766440|NCT04001517|7693234|FG001|COMPLETED|Overall Study||20
6766441|NCT04001517|7693235|FG002|COMPLETED|Overall Study||26
6766442|NCT04001517|7693236|FG003|COMPLETED|Overall Study||15
6766443|NCT04001517|7693233|FG000|NOT COMPLETED|Overall Study||0
6766444|NCT04001517|7693234|FG001|NOT COMPLETED|Overall Study||6
6766445|NCT04001517|7693235|FG002|NOT COMPLETED|Overall Study||1
6766446|NCT04001517|7693236|FG003|NOT COMPLETED|Overall Study||3
6766447|NCT04006171|7693249|FG000|STARTED|Overall Study||48
6766448|NCT04006171|7693250|FG001|STARTED|Overall Study||42
6766449|NCT04006171|7693249|FG000|COMPLETED|Overall Study||36
6766450|NCT04006171|7693250|FG001|COMPLETED|Overall Study||30
6766451|NCT04006171|7693249|FG000|NOT COMPLETED|Overall Study||12
6766452|NCT04006171|7693250|FG001|NOT COMPLETED|Overall Study||12
6766453|NCT04011436|7693259|FG000|STARTED|Overall Study||20
6766454|NCT04011436|7693260|FG001|STARTED|Overall Study||20
6766455|NCT04011436|7693259|FG000|COMPLETED|Overall Study||19
6766456|NCT04011436|7693260|FG001|COMPLETED|Overall Study||19
6766457|NCT04011436|7693259|FG000|NOT COMPLETED|Overall Study||1
6766458|NCT04011436|7693260|FG001|NOT COMPLETED|Overall Study||1
6766459|NCT04011592|7693268|FG000|STARTED|Overall Study||1
6766460|NCT04011592|7693269|FG001|STARTED|Overall Study||0
6766461|NCT04011592|7693268|FG000|COMPLETED|Overall Study||1
6766462|NCT04011592|7693269|FG001|COMPLETED|Overall Study||0
6766463|NCT04011592|7693268|FG000|NOT COMPLETED|Overall Study||0
6766464|NCT04011592|7693269|FG001|NOT COMPLETED|Overall Study||0
6766465|NCT04013529|7693277|FG000|STARTED|Overall Study||20
6766466|NCT04013529|7693278|FG001|STARTED|Overall Study||20
6766467|NCT04013529|7693277|FG000|COMPLETED|Overall Study||19
6766468|NCT04013529|7693278|FG001|COMPLETED|Overall Study||19
6766469|NCT04013529|7693277|FG000|NOT COMPLETED|Overall Study||1
6766470|NCT04013529|7693278|FG001|NOT COMPLETED|Overall Study||1
6766471|NCT04016324|7693284|FG000|STARTED|Overall Study||110
6766472|NCT04016324|7693284|FG000|COMPLETED|Overall Study||107
6766473|NCT04016324|7693284|FG000|NOT COMPLETED|Overall Study||3
6766474|NCT04017910|7693289|FG000|STARTED|Overall Study||17
6766475|NCT04017910|7693289|FG000|COMPLETED|Overall Study||17
6766476|NCT04017910|7693289|FG000|NOT COMPLETED|Overall Study||0
6766477|NCT04018066|7693293|FG000|STARTED|Overall Study|34 participants were enrolled in the study|34
6766478|NCT04018066|7693293|FG000|COMPLETED|Overall Study|30 participants completed the study protocol.|30
6766479|NCT04018066|7693293|FG000|NOT COMPLETED|Overall Study||4
6766480|NCT04018794|7693298|FG000|STARTED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
6766481|NCT04018794|7693298|FG000|COMPLETED|Overall Study|N=15 students participants completed the open trial of usability/feasibility of the intervention and completed quantitative ratings of usability before and after using the program.|15
6766482|NCT04018794|7693298|FG000|NOT COMPLETED|Overall Study||0
6766483|NCT04032327|7693304|FG000|STARTED|Overall Study||60
6766484|NCT04032327|7693305|FG001|STARTED|Overall Study||60
6766485|NCT04032327|7693304|FG000|COMPLETED|Overall Study||60
6766486|NCT04032327|7693305|FG001|COMPLETED|Overall Study||60
6766487|NCT04032327|7693304|FG000|NOT COMPLETED|Overall Study||0
6766488|NCT04032327|7693305|FG001|NOT COMPLETED|Overall Study||0
6766489|NCT04033640|7693313|FG000|STARTED|Overall Study||1736
6766490|NCT04033640|7693314|FG001|STARTED|Overall Study||18
6766491|NCT04033640|7693313|FG000|COMPLETED|Overall Study||1736
6766492|NCT04033640|7693314|FG001|COMPLETED|Overall Study||18
6766493|NCT04033640|7693313|FG000|NOT COMPLETED|Overall Study||0
6766494|NCT04033640|7693314|FG001|NOT COMPLETED|Overall Study||0
6766495|NCT04036292|7693323|FG000|STARTED|Overall Study||260
6766496|NCT04036292|7693324|FG001|STARTED|Overall Study||246
6766497|NCT04036292|7693325|FG002|STARTED|Overall Study||252
6766498|NCT04036292|7693323|FG000|COMPLETED|Overall Study||239
6766499|NCT04036292|7693324|FG001|COMPLETED|Overall Study||212
6766500|NCT04036292|7693325|FG002|COMPLETED|Overall Study||228
6766501|NCT04036292|7693323|FG000|NOT COMPLETED|Overall Study||21
6766502|NCT04036292|7693324|FG001|NOT COMPLETED|Overall Study||34
6766503|NCT04036292|7693325|FG002|NOT COMPLETED|Overall Study||24
6766504|NCT04041440|7693338|FG000|STARTED|Overall Study||12
6766505|NCT04041440|7693339|FG001|STARTED|Overall Study||22
6766506|NCT04041440|7693338|FG000|COMPLETED|Overall Study||12
6766507|NCT04041440|7693339|FG001|COMPLETED|Overall Study||20
6766508|NCT04041440|7693338|FG000|NOT COMPLETED|Overall Study||0
6766509|NCT04041440|7693339|FG001|NOT COMPLETED|Overall Study||2
6766510|NCT04041570|7693348|FG000|STARTED|Overall Study||20
6766511|NCT04041570|7693349|FG001|STARTED|Overall Study||20
6766512|NCT04041570|7693348|FG000|COMPLETED|Overall Study||20
6766513|NCT04041570|7693349|FG001|COMPLETED|Overall Study||18
6766514|NCT04041570|7693348|FG000|NOT COMPLETED|Overall Study||0
6766515|NCT04041570|7693349|FG001|NOT COMPLETED|Overall Study||2
6766516|NCT04043143|7693358|FG000|STARTED|Overall Study||29
6766517|NCT04043143|7693359|FG001|STARTED|Overall Study||27
6766518|NCT04043143|7693358|FG000|COMPLETED|Overall Study||23
6766519|NCT04043143|7693359|FG001|COMPLETED|Overall Study||22
6766520|NCT04043143|7693358|FG000|NOT COMPLETED|Overall Study||6
6766521|NCT04043143|7693359|FG001|NOT COMPLETED|Overall Study||5
6766522|NCT04049123|7693365|FG000|STARTED|Period 1||5
6766523|NCT04049123|7693366|FG001|STARTED|Period 1||5
6766524|NCT04049123|7693367|FG002|STARTED|Period 1||5
6766525|NCT04049123|7693365|FG000|Received at Least One Dose of Study Drug|Period 1||5
6766526|NCT04049123|7693366|FG001|Received at Least One Dose of Study Drug|Period 1||5
6766527|NCT04049123|7693367|FG002|Received at Least One Dose of Study Drug|Period 1||5
6766528|NCT04049123|7693365|FG000|COMPLETED|Period 1||5
6766529|NCT04049123|7693366|FG001|COMPLETED|Period 1||5
6766530|NCT04049123|7693367|FG002|COMPLETED|Period 1||5
6766531|NCT04049123|7693365|FG000|NOT COMPLETED|Period 1||0
6766532|NCT04049123|7693366|FG001|NOT COMPLETED|Period 1||0
6766533|NCT04049123|7693367|FG002|NOT COMPLETED|Period 1||0
6766534|NCT04049123|7693365|FG000|STARTED|Period 2||5
6766535|NCT04049123|7693366|FG001|STARTED|Period 2||5
6766536|NCT04049123|7693367|FG002|STARTED|Period 2||5
6766537|NCT04049123|7693365|FG000|COMPLETED|Period 2||5
6766538|NCT04049123|7693366|FG001|COMPLETED|Period 2||5
6766539|NCT04049123|7693367|FG002|COMPLETED|Period 2||5
6766540|NCT04049123|7693365|FG000|NOT COMPLETED|Period 2||0
6766541|NCT04049123|7693366|FG001|NOT COMPLETED|Period 2||0
6766542|NCT04049123|7693367|FG002|NOT COMPLETED|Period 2||0
6766543|NCT04049123|7693365|FG000|STARTED|Period 3||5
6766544|NCT04049123|7693366|FG001|STARTED|Period 3||5
6766545|NCT04049123|7693367|FG002|STARTED|Period 3||5
6766546|NCT04049123|7693365|FG000|COMPLETED|Period 3||5
6766547|NCT04049123|7693366|FG001|COMPLETED|Period 3||5
6766548|NCT04049123|7693367|FG002|COMPLETED|Period 3||5
6766549|NCT04049123|7693365|FG000|NOT COMPLETED|Period 3||0
6766550|NCT04049123|7693366|FG001|NOT COMPLETED|Period 3||0
6766551|NCT04049123|7693367|FG002|NOT COMPLETED|Period 3||0
6766552|NCT04051463|7693377|FG000|STARTED|Overall Study||15
6766553|NCT04051463|7693378|FG001|STARTED|Overall Study||14
6766554|NCT04051463|7693377|FG000|COMPLETED|Overall Study||13
6766555|NCT04051463|7693378|FG001|COMPLETED|Overall Study||13
6766556|NCT04051463|7693377|FG000|NOT COMPLETED|Overall Study||2
6766557|NCT04051463|7693378|FG001|NOT COMPLETED|Overall Study||1
6766558|NCT04052204|7693384|FG000|STARTED|Overall Study||3
6766559|NCT04052204|7693385|FG001|STARTED|Overall Study|Arm was not tested due to study termination.|0
6766560|NCT04052204|7693386|FG002|STARTED|Overall Study|Arm was not tested due to study termination.|0
6766561|NCT04052204|7693384|FG000|COMPLETED|Overall Study||0
6766562|NCT04052204|7693385|FG001|COMPLETED|Overall Study||0
6766563|NCT04052204|7693386|FG002|COMPLETED|Overall Study||0
6766564|NCT04052204|7693384|FG000|NOT COMPLETED|Overall Study||3
6766565|NCT04052204|7693385|FG001|NOT COMPLETED|Overall Study||0
6766566|NCT04052204|7693386|FG002|NOT COMPLETED|Overall Study||0
6766567|NCT04054661|7693390|FG000|STARTED|Overall Study||229
6766568|NCT04054661|7693390|FG000|Enrolled in Repeatability Sub-study|Overall Study||15
6766569|NCT04054661|7693390|FG000|Enrolled in Sample Stability Sub-study|Overall Study||3
6766570|NCT04054661|7693390|FG000|COMPLETED|Overall Study||229
6766571|NCT04054661|7693390|FG000|NOT COMPLETED|Overall Study||0
6766572|NCT04067011|7693406|FG000|STARTED|Overall Study||70
6766573|NCT04067011|7693407|FG001|STARTED|Overall Study||71
6766574|NCT04067011|7693408|FG002|STARTED|Overall Study||69
6766575|NCT04067011|7693406|FG000|COMPLETED|Overall Study||51
6766576|NCT04067011|7693407|FG001|COMPLETED|Overall Study||58
6766577|NCT04067011|7693408|FG002|COMPLETED|Overall Study||61
6766578|NCT04067011|7693406|FG000|NOT COMPLETED|Overall Study||19
6766579|NCT04067011|7693407|FG001|NOT COMPLETED|Overall Study||13
6766580|NCT04067011|7693408|FG002|NOT COMPLETED|Overall Study||8
6766581|NCT04072159|7693420|FG000|STARTED|Overall Study||16
6766582|NCT04072159|7693421|FG001|STARTED|Overall Study||17
6766583|NCT04072159|7693420|FG000|COMPLETED|Overall Study||8
6766584|NCT04072159|7693421|FG001|COMPLETED|Overall Study||11
6766585|NCT04072159|7693420|FG000|NOT COMPLETED|Overall Study||8
6766586|NCT04072159|7693421|FG001|NOT COMPLETED|Overall Study||6
6766587|NCT04085341|7693431|FG000|STARTED|Overall Study||10
6766588|NCT04085341|7693432|FG001|STARTED|Overall Study||11
6766589|NCT04085341|7693431|FG000|COMPLETED|Overall Study||10
6766590|NCT04085341|7693432|FG001|COMPLETED|Overall Study||11
6766591|NCT04085341|7693431|FG000|NOT COMPLETED|Overall Study||0
6766592|NCT04085341|7693432|FG001|NOT COMPLETED|Overall Study||0
6766593|NCT04094870|7693440|FG000|STARTED|Overall Study||40
6766594|NCT04094870|7693441|FG001|STARTED|Overall Study||40
6766595|NCT04094870|7693440|FG000|COMPLETED|Overall Study||39
6766596|NCT04094870|7693441|FG001|COMPLETED|Overall Study||39
6766597|NCT04094870|7693440|FG000|NOT COMPLETED|Overall Study||1
6766598|NCT04094870|7693441|FG001|NOT COMPLETED|Overall Study||1
6766599|NCT04096482|7693454|FG000|STARTED|Overall Study||6
6766600|NCT04096482|7693454|FG000|COMPLETED|Overall Study||6
6766601|NCT04096482|7693454|FG000|NOT COMPLETED|Overall Study||0
6766602|NCT04098172|7693460|FG000|STARTED|Overall Study||39
6766603|NCT04098172|7693460|FG000|COMPLETED|Overall Study||39
6766604|NCT04098172|7693460|FG000|NOT COMPLETED|Overall Study||0
6766605|NCT04103515|7693467|FG000|STARTED|Overall Study||25
6766606|NCT04103515|7693468|FG001|STARTED|Overall Study||25
6766607|NCT04103515|7693467|FG000|COMPLETED|Overall Study||25
6766608|NCT04103515|7693468|FG001|COMPLETED|Overall Study||25
6766609|NCT04103515|7693467|FG000|NOT COMPLETED|Overall Study||0
6766610|NCT04103515|7693468|FG001|NOT COMPLETED|Overall Study||0
6766611|NCT04111276|7693474|FG000|STARTED|Overall Study||23
6766612|NCT04111276|7693474|FG000|COMPLETED|Overall Study||20
6766613|NCT04111276|7693474|FG000|NOT COMPLETED|Overall Study||3
6766614|NCT04123405|7693482|FG000|STARTED|Overall Study||235
6766615|NCT04123405|7693483|FG001|STARTED|Overall Study||238
6766616|NCT04123405|7693484|FG002|STARTED|Overall Study||238
6766617|NCT04123405|7693485|FG003|STARTED|Overall Study||233
6766618|NCT04123405|7693482|FG000|Full Analysis Set|Overall Study||235
6766619|NCT04123405|7693483|FG001|Full Analysis Set|Overall Study||236
6766620|NCT04123405|7693484|FG002|Full Analysis Set|Overall Study||238
6766621|NCT04123405|7693485|FG003|Full Analysis Set|Overall Study||230
6766622|NCT04123405|7693482|FG000|Per-protocol Set|Overall Study||213
6766623|NCT04123405|7693483|FG001|Per-protocol Set|Overall Study||215
6766624|NCT04123405|7693484|FG002|Per-protocol Set|Overall Study||212
6766625|NCT04123405|7693485|FG003|Per-protocol Set|Overall Study||207
6766626|NCT04123405|7693482|FG000|Safety Set|Overall Study||235
6766627|NCT04123405|7693483|FG001|Safety Set|Overall Study||238
6766628|NCT04123405|7693484|FG002|Safety Set|Overall Study||238
6766629|NCT04123405|7693485|FG003|Safety Set|Overall Study||233
6766630|NCT04123405|7693482|FG000|COMPLETED|Overall Study||231
6766631|NCT04123405|7693483|FG001|COMPLETED|Overall Study||231
6766632|NCT04123405|7693484|FG002|COMPLETED|Overall Study||235
6766633|NCT04123405|7693485|FG003|COMPLETED|Overall Study||225
6766634|NCT04123405|7693482|FG000|NOT COMPLETED|Overall Study||4
6766635|NCT04123405|7693483|FG001|NOT COMPLETED|Overall Study||7
6766636|NCT04123405|7693484|FG002|NOT COMPLETED|Overall Study||3
6766637|NCT04123405|7693485|FG003|NOT COMPLETED|Overall Study||8
6766638|NCT04128527|7693495|FG000|STARTED|Overall Study||16
6766639|NCT04128527|7693495|FG000|COMPLETED|Overall Study||16
6766640|NCT04128527|7693495|FG000|NOT COMPLETED|Overall Study||0
6766641|NCT04132973|7693499|FG000|STARTED|Overall Study||34
6766642|NCT04132973|7693499|FG000|Completed Intervention|Overall Study||11
6766643|NCT04132973|7693499|FG000|COMPLETED|Overall Study||8
6766644|NCT04132973|7693499|FG000|NOT COMPLETED|Overall Study||26
6766645|NCT04133415|7693503|FG000|STARTED|Overall Study||20
6766646|NCT04133415|7693503|FG000|COMPLETED|Overall Study||20
6766647|NCT04133415|7693503|FG000|NOT COMPLETED|Overall Study||0
6766648|NCT04138758|7693509|FG000|STARTED|Overall Study||2600
6766649|NCT04138758|7693510|FG001|STARTED|Overall Study||40353
6766650|NCT04138758|7693509|FG000|COMPLETED|Overall Study||2600
6766651|NCT04138758|7693510|FG001|COMPLETED|Overall Study||40353
6766652|NCT04138758|7693509|FG000|NOT COMPLETED|Overall Study||0
6766653|NCT04138758|7693510|FG001|NOT COMPLETED|Overall Study||0
6766654|NCT04147715|7693528|FG000|STARTED|Overall Study||12
6766655|NCT04147715|7693529|FG001|STARTED|Overall Study||6
6766656|NCT04147715|7693530|FG002|STARTED|Overall Study||6
6766657|NCT04147715|7693531|FG003|STARTED|Overall Study||8
6766658|NCT04147715|7693532|FG004|STARTED|Overall Study||6
6766659|NCT04147715|7693533|FG005|STARTED|Overall Study||6
6766660|NCT04147715|7693534|FG006|STARTED|Overall Study||6
6766661|NCT04147715|7693535|FG007|STARTED|Overall Study||4
6766662|NCT04147715|7693536|FG008|STARTED|Overall Study||8
6766663|NCT04147715|7693537|FG009|STARTED|Overall Study||8
6766664|NCT04147715|7693538|FG010|STARTED|Overall Study||14
6766665|NCT04147715|7693539|FG011|STARTED|Overall Study||14
6766666|NCT04147715|7693528|FG000|COMPLETED|Overall Study||12
6766667|NCT04147715|7693529|FG001|COMPLETED|Overall Study||6
6766668|NCT04147715|7693530|FG002|COMPLETED|Overall Study||6
6766669|NCT04147715|7693531|FG003|COMPLETED|Overall Study||8
6766670|NCT04147715|7693532|FG004|COMPLETED|Overall Study||6
6766671|NCT04147715|7693533|FG005|COMPLETED|Overall Study||6
6766672|NCT04147715|7693534|FG006|COMPLETED|Overall Study||6
6766673|NCT04147715|7693535|FG007|COMPLETED|Overall Study||2
6766674|NCT04147715|7693536|FG008|COMPLETED|Overall Study||7
6766675|NCT04147715|7693537|FG009|COMPLETED|Overall Study||8
6766676|NCT04147715|7693538|FG010|COMPLETED|Overall Study||14
6766677|NCT04147715|7693539|FG011|COMPLETED|Overall Study||14
6766678|NCT04147715|7693528|FG000|NOT COMPLETED|Overall Study||0
6766679|NCT04147715|7693529|FG001|NOT COMPLETED|Overall Study||0
6766680|NCT04147715|7693530|FG002|NOT COMPLETED|Overall Study||0
6766681|NCT04147715|7693531|FG003|NOT COMPLETED|Overall Study||0
6766682|NCT04147715|7693532|FG004|NOT COMPLETED|Overall Study||0
6766683|NCT04147715|7693533|FG005|NOT COMPLETED|Overall Study||0
6766684|NCT04147715|7693534|FG006|NOT COMPLETED|Overall Study||0
6766685|NCT04147715|7693535|FG007|NOT COMPLETED|Overall Study||2
6766686|NCT04147715|7693536|FG008|NOT COMPLETED|Overall Study||1
6766687|NCT04147715|7693537|FG009|NOT COMPLETED|Overall Study||0
6766688|NCT04147715|7693538|FG010|NOT COMPLETED|Overall Study||0
6766689|NCT04147715|7693539|FG011|NOT COMPLETED|Overall Study||0
6766690|NCT04150068|7693614|FG000|STARTED|Overall Study||24
6766691|NCT04150068|7693615|FG001|STARTED|Overall Study||12
6766692|NCT04150068|7693616|FG002|STARTED|Overall Study||16
6766693|NCT04150068|7693614|FG000|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||24
6766694|NCT04150068|7693615|FG001|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||12
6556400|NCT01759446|7478732|FG002|STARTED|Overall Study||9
6556401|NCT01759446|7478733|FG003|STARTED|Overall Study||9
6556402|NCT01759446|7478734|FG004|STARTED|Overall Study||8
6556403|NCT01759446|7478730|FG000|COMPLETED|Overall Study||8
6556404|NCT01759446|7478731|FG001|COMPLETED|Overall Study||8
6766695|NCT04150068|7693616|FG002|Completed Functional Monotherapy/Oral Lead-in (14 Days) Period|Overall Study||16
6766696|NCT04150068|7693614|FG000|COMPLETED|Overall Study||0
6766697|NCT04150068|7693615|FG001|COMPLETED|Overall Study||0
6766698|NCT04150068|7693616|FG002|COMPLETED|Overall Study||0
6766699|NCT04150068|7693614|FG000|NOT COMPLETED|Overall Study||24
6766700|NCT04150068|7693615|FG001|NOT COMPLETED|Overall Study||12
6766701|NCT04150068|7693616|FG002|NOT COMPLETED|Overall Study||16
6766702|NCT04154605|7693625|FG000|STARTED|Overall Study||68
6766703|NCT04154605|7693626|FG001|STARTED|Overall Study||65
6766704|NCT04154605|7693625|FG000|COMPLETED|Overall Study||65
6766705|NCT04154605|7693626|FG001|COMPLETED|Overall Study||63
6766706|NCT04154605|7693625|FG000|NOT COMPLETED|Overall Study||3
6766707|NCT04154605|7693626|FG001|NOT COMPLETED|Overall Study||2
6766708|NCT04160091|7693636|FG000|STARTED|Overall Study||7
6766709|NCT04160091|7693637|FG001|STARTED|Overall Study||3
6766710|NCT04160091|7693638|FG002|STARTED|Overall Study||5
6766711|NCT04160091|7693639|FG003|STARTED|Overall Study||4
6766712|NCT04160091|7693636|FG000|COMPLETED|Overall Study||0
6766713|NCT04160091|7693637|FG001|COMPLETED|Overall Study||0
6766714|NCT04160091|7693638|FG002|COMPLETED|Overall Study||0
6766715|NCT04160091|7693639|FG003|COMPLETED|Overall Study||0
6766716|NCT04160091|7693636|FG000|NOT COMPLETED|Overall Study||7
6766717|NCT04160091|7693637|FG001|NOT COMPLETED|Overall Study||3
6766718|NCT04160091|7693638|FG002|NOT COMPLETED|Overall Study||5
6766719|NCT04160091|7693639|FG003|NOT COMPLETED|Overall Study||4
6766720|NCT04160260|7693649|FG000|STARTED|Overall Study||18
6766721|NCT04160260|7693649|FG000|COMPLETED|Overall Study||18
6766722|NCT04160260|7693649|FG000|NOT COMPLETED|Overall Study||0
6766723|NCT04164758|7693656|FG000|STARTED|Overall Study||4
6766724|NCT04164758|7693657|FG001|STARTED|Overall Study||4
6766725|NCT04164758|7693658|FG002|STARTED|Overall Study||3
6556405|NCT01759446|7478732|FG002|COMPLETED|Overall Study||8
6766726|NCT04164758|7693656|FG000|COMPLETED|Overall Study||3
6766727|NCT04164758|7693657|FG001|COMPLETED|Overall Study||3
6766728|NCT04164758|7693658|FG002|COMPLETED|Overall Study||3
6766729|NCT04164758|7693656|FG000|NOT COMPLETED|Overall Study||1
6766730|NCT04164758|7693657|FG001|NOT COMPLETED|Overall Study||1
6766731|NCT04164758|7693658|FG002|NOT COMPLETED|Overall Study||0
6766732|NCT04165031|7693672|FG000|STARTED|Overall Study||2
6766733|NCT04165031|7693673|FG001|STARTED|Overall Study||1
6766734|NCT04165031|7693674|FG002|STARTED|Overall Study||2
6766735|NCT04165031|7693675|FG003|STARTED|Overall Study||0
6766736|NCT04165031|7693676|FG004|STARTED|Overall Study||0
6766737|NCT04165031|7693677|FG005|STARTED|Overall Study||0
6766738|NCT04165031|7693672|FG000|Received at Least One Dose of Study Drug|Overall Study||2
6766739|NCT04165031|7693673|FG001|Received at Least One Dose of Study Drug|Overall Study||1
6766740|NCT04165031|7693674|FG002|Received at Least One Dose of Study Drug|Overall Study||2
6766741|NCT04165031|7693675|FG003|Received at Least One Dose of Study Drug|Overall Study||0
6766742|NCT04165031|7693676|FG004|Received at Least One Dose of Study Drug|Overall Study||0
6766743|NCT04165031|7693677|FG005|Received at Least One Dose of Study Drug|Overall Study||0
6766744|NCT04165031|7693672|FG000|COMPLETED|Overall Study||1
6766745|NCT04165031|7693673|FG001|COMPLETED|Overall Study||0
6766746|NCT04165031|7693674|FG002|COMPLETED|Overall Study||1
6766747|NCT04165031|7693675|FG003|COMPLETED|Overall Study||0
6766748|NCT04165031|7693676|FG004|COMPLETED|Overall Study||0
6766749|NCT04165031|7693677|FG005|COMPLETED|Overall Study||0
6766750|NCT04165031|7693672|FG000|NOT COMPLETED|Overall Study||1
6766751|NCT04165031|7693673|FG001|NOT COMPLETED|Overall Study||1
6766752|NCT04165031|7693674|FG002|NOT COMPLETED|Overall Study||1
6766753|NCT04165031|7693675|FG003|NOT COMPLETED|Overall Study||0
6766754|NCT04165031|7693676|FG004|NOT COMPLETED|Overall Study||0
6766755|NCT04165031|7693677|FG005|NOT COMPLETED|Overall Study||0
6766756|NCT04166032|7693692|FG000|STARTED|Overall Study||15
6766757|NCT04166032|7693692|FG000|COMPLETED|Overall Study||14
6766758|NCT04166032|7693692|FG000|NOT COMPLETED|Overall Study||1
6766759|NCT04171414|7693696|FG000|STARTED|Overall Study||62
6766760|NCT04171414|7693696|FG000|COMPLETED|Overall Study||60
6766761|NCT04171414|7693696|FG000|NOT COMPLETED|Overall Study||2
6766762|NCT04175808|7693700|FG000|STARTED|Part A||70
6766763|NCT04175808|7693701|FG001|STARTED|Part A||0
6766764|NCT04175808|7693702|FG002|STARTED|Part A||0
6766765|NCT04175808|7693703|FG003|STARTED|Part A||0
6766766|NCT04175808|7693704|FG004|STARTED|Part A||0
6766767|NCT04175808|7693705|FG005|STARTED|Part A||0
6766768|NCT04175808|7693706|FG006|STARTED|Part A||0
6766769|NCT04175808|7693700|FG000|COMPLETED|Part A||68
6766770|NCT04175808|7693701|FG001|COMPLETED|Part A||0
6766771|NCT04175808|7693702|FG002|COMPLETED|Part A||0
6766772|NCT04175808|7693703|FG003|COMPLETED|Part A||0
6766773|NCT04175808|7693704|FG004|COMPLETED|Part A||0
6766774|NCT04175808|7693705|FG005|COMPLETED|Part A||0
6766775|NCT04175808|7693706|FG006|COMPLETED|Part A||0
6766776|NCT04175808|7693700|FG000|NOT COMPLETED|Part A||2
6766777|NCT04175808|7693701|FG001|NOT COMPLETED|Part A||0
6766778|NCT04175808|7693702|FG002|NOT COMPLETED|Part A||0
6766779|NCT04175808|7693703|FG003|NOT COMPLETED|Part A||0
6766780|NCT04175808|7693704|FG004|NOT COMPLETED|Part A||0
6766781|NCT04175808|7693705|FG005|NOT COMPLETED|Part A||0
6766782|NCT04175808|7693706|FG006|NOT COMPLETED|Part A||0
6766783|NCT04175808|7693700|FG000|STARTED|Part B||0
6766784|NCT04175808|7693701|FG001|STARTED|Part B||10
6766785|NCT04175808|7693702|FG002|STARTED|Part B||10
6766786|NCT04175808|7693703|FG003|STARTED|Part B||10
6766787|NCT04175808|7693704|FG004|STARTED|Part B||10
6766788|NCT04175808|7693705|FG005|STARTED|Part B||10
6766789|NCT04175808|7693706|FG006|STARTED|Part B||10
6766790|NCT04175808|7693700|FG000|COMPLETED|Part B||0
6766791|NCT04175808|7693701|FG001|COMPLETED|Part B||10
6766792|NCT04175808|7693702|FG002|COMPLETED|Part B||10
6766793|NCT04175808|7693703|FG003|COMPLETED|Part B||10
6766794|NCT04175808|7693704|FG004|COMPLETED|Part B||10
6766795|NCT04175808|7693705|FG005|COMPLETED|Part B||10
6766796|NCT04175808|7693706|FG006|COMPLETED|Part B||10
6766797|NCT04175808|7693700|FG000|NOT COMPLETED|Part B||0
6766798|NCT04175808|7693701|FG001|NOT COMPLETED|Part B||0
6766799|NCT04175808|7693702|FG002|NOT COMPLETED|Part B||0
6766800|NCT04175808|7693703|FG003|NOT COMPLETED|Part B||0
6766801|NCT04175808|7693704|FG004|NOT COMPLETED|Part B||0
6766802|NCT04175808|7693705|FG005|NOT COMPLETED|Part B||0
6766803|NCT04175808|7693706|FG006|NOT COMPLETED|Part B||0
6766804|NCT04178720|7693724|FG000|STARTED|Overall Study||40
6766805|NCT04178720|7693725|FG001|STARTED|Overall Study||78
6766806|NCT04178720|7693724|FG000|COMPLETED|Overall Study||38
6766807|NCT04178720|7693725|FG001|COMPLETED|Overall Study||77
6766808|NCT04178720|7693724|FG000|NOT COMPLETED|Overall Study||2
6766809|NCT04178720|7693725|FG001|NOT COMPLETED|Overall Study||1
6766810|NCT04184297|7693736|FG000|STARTED|Overall Study||2864
6766811|NCT04184297|7693737|FG001|STARTED|Overall Study||24326
6766812|NCT04184297|7693736|FG000|COMPLETED|Overall Study||2864
6766813|NCT04184297|7693737|FG001|COMPLETED|Overall Study||24326
6766814|NCT04184297|7693736|FG000|NOT COMPLETED|Overall Study||0
6766815|NCT04184297|7693737|FG001|NOT COMPLETED|Overall Study||0
6766816|NCT04189848|7693743|FG000|STARTED|Treatment Period 1 (Day 1)||26
6766817|NCT04189848|7693744|FG001|STARTED|Treatment Period 1 (Day 1)||26
6766818|NCT04189848|7693745|FG002|STARTED|Treatment Period 1 (Day 1)||25
6766819|NCT04189848|7693746|FG003|STARTED|Treatment Period 1 (Day 1)||27
6766820|NCT04189848|7693743|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
6766821|NCT04189848|7693744|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
6766822|NCT04189848|7693745|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
6766823|NCT04189848|7693746|FG003|COMPLETED|Treatment Period 1 (Day 1)||27
6766824|NCT04189848|7693743|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6766825|NCT04189848|7693744|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6766826|NCT04189848|7693745|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6766827|NCT04189848|7693746|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6766828|NCT04189848|7693743|FG000|STARTED|Treatment Period 2 (Day 1)||26
6766829|NCT04189848|7693744|FG001|STARTED|Treatment Period 2 (Day 1)||26
6766830|NCT04189848|7693745|FG002|STARTED|Treatment Period 2 (Day 1)||25
6766831|NCT04189848|7693746|FG003|STARTED|Treatment Period 2 (Day 1)||27
6766832|NCT04189848|7693743|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
6766833|NCT04189848|7693744|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
6766834|NCT04189848|7693745|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
6766835|NCT04189848|7693746|FG003|COMPLETED|Treatment Period 2 (Day 1)||27
6766836|NCT04189848|7693743|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6766837|NCT04189848|7693744|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6766838|NCT04189848|7693745|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6766839|NCT04189848|7693746|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6766840|NCT04210232|7693751|FG000|STARTED|Overall Study||54
6766841|NCT04210232|7693751|FG000|COMPLETED|Overall Study||54
6766842|NCT04210232|7693751|FG000|NOT COMPLETED|Overall Study||0
6766843|NCT04211909|7693757|FG000|STARTED|Overall Study||54
6766844|NCT04211909|7693758|FG001|STARTED|Overall Study||33
6766845|NCT04211909|7693757|FG000|COMPLETED|Overall Study||54
6766846|NCT04211909|7693758|FG001|COMPLETED|Overall Study||33
6766847|NCT04211909|7693757|FG000|NOT COMPLETED|Overall Study||0
6766848|NCT04211909|7693758|FG001|NOT COMPLETED|Overall Study||0
6766849|NCT04218110|7693768|FG000|STARTED|Overall Study||82
6766850|NCT04218110|7693769|FG001|STARTED|Overall Study||81
6766851|NCT04218110|7693770|FG002|STARTED|Overall Study||83
6766852|NCT04218110|7693771|FG003|STARTED|Overall Study||83
6766853|NCT04218110|7693768|FG000|Received Treatment|Overall Study||82
6766854|NCT04218110|7693769|FG001|Received Treatment|Overall Study||81
6766855|NCT04218110|7693770|FG002|Received Treatment|Overall Study||83
6766856|NCT04218110|7693771|FG003|Received Treatment|Overall Study||82
6766857|NCT04218110|7693768|FG000|COMPLETED|Overall Study||82
6766858|NCT04218110|7693769|FG001|COMPLETED|Overall Study||81
6766859|NCT04218110|7693770|FG002|COMPLETED|Overall Study||83
6766860|NCT04218110|7693771|FG003|COMPLETED|Overall Study||82
6766861|NCT04218110|7693768|FG000|NOT COMPLETED|Overall Study||0
6766862|NCT04218110|7693769|FG001|NOT COMPLETED|Overall Study||0
6766863|NCT04218110|7693770|FG002|NOT COMPLETED|Overall Study||0
6766864|NCT04218110|7693771|FG003|NOT COMPLETED|Overall Study||1
6766865|NCT04222725|7693785|FG000|STARTED|Overall Study||8
6766866|NCT04222725|7693786|FG001|STARTED|Overall Study||10
6766867|NCT04222725|7693787|FG002|STARTED|Overall Study||9
6766868|NCT04222725|7693788|FG003|STARTED|Overall Study||10
6766869|NCT04222725|7693785|FG000|COMPLETED|Overall Study||8
6766870|NCT04222725|7693786|FG001|COMPLETED|Overall Study||9
6766871|NCT04222725|7693787|FG002|COMPLETED|Overall Study||9
6766872|NCT04222725|7693788|FG003|COMPLETED|Overall Study||10
6766873|NCT04222725|7693785|FG000|NOT COMPLETED|Overall Study||0
6766874|NCT04222725|7693786|FG001|NOT COMPLETED|Overall Study||1
6766875|NCT04222725|7693787|FG002|NOT COMPLETED|Overall Study||0
6766876|NCT04222725|7693788|FG003|NOT COMPLETED|Overall Study||0
6766877|NCT04223843|7693802|FG000|STARTED|Overall Study||55
6766878|NCT04223843|7693803|FG001|STARTED|Overall Study||55
6766879|NCT04223843|7693804|FG002|STARTED|Overall Study||51
6556406|NCT01759446|7478733|FG003|COMPLETED|Overall Study||8
6556407|NCT01759446|7478734|FG004|COMPLETED|Overall Study||8
6556408|NCT01759446|7478730|FG000|NOT COMPLETED|Overall Study||1
6556409|NCT01759446|7478731|FG001|NOT COMPLETED|Overall Study||1
6556410|NCT01759446|7478732|FG002|NOT COMPLETED|Overall Study||1
6556411|NCT01759446|7478733|FG003|NOT COMPLETED|Overall Study||1
6556412|NCT01759446|7478734|FG004|NOT COMPLETED|Overall Study||0
6556413|NCT01759511|7478746|FG000|STARTED|Overall Study||34
6556414|NCT01759511|7478746|FG000|COMPLETED|Overall Study||0
6556415|NCT01759511|7478746|FG000|NOT COMPLETED|Overall Study||34
6766880|NCT04223843|7693805|FG003|STARTED|Overall Study||52
6766881|NCT04223843|7693802|FG000|COMPLETED|Overall Study||55
6766882|NCT04223843|7693803|FG001|COMPLETED|Overall Study||55
6766883|NCT04223843|7693804|FG002|COMPLETED|Overall Study||51
6766884|NCT04223843|7693805|FG003|COMPLETED|Overall Study||52
6766885|NCT04223843|7693802|FG000|NOT COMPLETED|Overall Study||0
6556416|NCT01759602|7478750|FG000|STARTED|Overall Study||10
6766886|NCT04223843|7693803|FG001|NOT COMPLETED|Overall Study||0
6766887|NCT04223843|7693804|FG002|NOT COMPLETED|Overall Study||0
6766888|NCT04223843|7693805|FG003|NOT COMPLETED|Overall Study||0
6766889|NCT04229303|7693822|FG000|STARTED|Overall Study||6
6766890|NCT04229303|7693823|FG001|STARTED|Overall Study||6
6766891|NCT04229303|7693824|FG002|STARTED|Overall Study||6
6766892|NCT04229303|7693825|FG003|STARTED|Overall Study||6
6766893|NCT04229303|7693826|FG004|STARTED|Overall Study||6
6766894|NCT04229303|7693827|FG005|STARTED|Overall Study||6
6766895|NCT04229303|7693828|FG006|STARTED|Overall Study||6
6766896|NCT04229303|7693829|FG007|STARTED|Overall Study||8
6766897|NCT04229303|7693830|FG008|STARTED|Overall Study||8
6766898|NCT04229303|7693822|FG000|COMPLETED|Overall Study||6
6766899|NCT04229303|7693823|FG001|COMPLETED|Overall Study||6
6766900|NCT04229303|7693824|FG002|COMPLETED|Overall Study||6
6766901|NCT04229303|7693825|FG003|COMPLETED|Overall Study||6
6766902|NCT04229303|7693826|FG004|COMPLETED|Overall Study||6
6766903|NCT04229303|7693827|FG005|COMPLETED|Overall Study||6
6766904|NCT04229303|7693828|FG006|COMPLETED|Overall Study||6
6766905|NCT04229303|7693829|FG007|COMPLETED|Overall Study||8
6766906|NCT04229303|7693830|FG008|COMPLETED|Overall Study||8
6766907|NCT04229303|7693822|FG000|NOT COMPLETED|Overall Study||0
6766908|NCT04229303|7693823|FG001|NOT COMPLETED|Overall Study||0
6766909|NCT04229303|7693824|FG002|NOT COMPLETED|Overall Study||0
6766910|NCT04229303|7693825|FG003|NOT COMPLETED|Overall Study||0
6766911|NCT04229303|7693826|FG004|NOT COMPLETED|Overall Study||0
6766912|NCT04229303|7693827|FG005|NOT COMPLETED|Overall Study||0
6766913|NCT04229303|7693828|FG006|NOT COMPLETED|Overall Study||0
6766914|NCT04229303|7693829|FG007|NOT COMPLETED|Overall Study||0
6766915|NCT04229303|7693830|FG008|NOT COMPLETED|Overall Study||0
6766916|NCT04243421|7693858|FG000|STARTED|Overall Study||30
6766917|NCT04243421|7693858|FG000|COMPLETED|Overall Study||30
6766918|NCT04243421|7693858|FG000|NOT COMPLETED|Overall Study||0
6766919|NCT04244084|7693865|FG000|STARTED|Overall Study||118
6766920|NCT04244084|7693866|FG001|STARTED|Overall Study||122
6766921|NCT04244084|7693865|FG000|COMPLETED|Overall Study||118
6766922|NCT04244084|7693866|FG001|COMPLETED|Overall Study||122
6766923|NCT04244084|7693865|FG000|NOT COMPLETED|Overall Study||0
6766924|NCT04244084|7693866|FG001|NOT COMPLETED|Overall Study||0
6766925|NCT04256603|7693874|FG000|STARTED|Overall Study||21
6766926|NCT04256603|7693875|FG001|STARTED|Overall Study||6
6766927|NCT04256603|7693874|FG000|COMPLETED|Overall Study||21
6766928|NCT04256603|7693875|FG001|COMPLETED|Overall Study||6
6766929|NCT04256603|7693874|FG000|NOT COMPLETED|Overall Study||0
6766930|NCT04256603|7693875|FG001|NOT COMPLETED|Overall Study||0
6766931|NCT04258995|7693883|FG000|STARTED|Overall Study||76
6766932|NCT04258995|7693884|FG001|STARTED|Overall Study||75
6766933|NCT04258995|7693883|FG000|Vaccinated|Overall Study||76
6766934|NCT04258995|7693884|FG001|Vaccinated|Overall Study||75
6766935|NCT04258995|7693883|FG000|COMPLETED|Overall Study||75
6766936|NCT04258995|7693884|FG001|COMPLETED|Overall Study||74
6766937|NCT04258995|7693883|FG000|NOT COMPLETED|Overall Study||1
6766938|NCT04258995|7693884|FG001|NOT COMPLETED|Overall Study||1
6766939|NCT04280445|7693890|FG000|STARTED|Overall Study||3
6766940|NCT04280445|7693890|FG000|COMPLETED|Overall Study||3
6766941|NCT04280445|7693890|FG000|NOT COMPLETED|Overall Study||0
6780392|NCT03109873|7708818|FG001|NOT COMPLETED|Overall Study||0
6780393|NCT03100617|7708824|FG000|STARTED|Overall Study||6
6780394|NCT03100617|7708824|FG000|COMPLETED|Overall Study||6
6780395|NCT03100617|7708824|FG000|NOT COMPLETED|Overall Study||0
6780396|NCT03115853|7708828|FG000|STARTED|Overall Study||31
6780397|NCT03115853|7708828|FG000|COMPLETED|Overall Study||31
6780398|NCT03115853|7708828|FG000|NOT COMPLETED|Overall Study||0
6780399|NCT03113071|7708836|FG000|STARTED|Overall Study||1
6780400|NCT03113071|7708837|FG001|STARTED|Overall Study||0
6780401|NCT03113071|7708836|FG000|COMPLETED|Overall Study||0
6780402|NCT03113071|7708837|FG001|COMPLETED|Overall Study||0
6780403|NCT03113071|7708836|FG000|NOT COMPLETED|Overall Study||1
6780404|NCT03113071|7708837|FG001|NOT COMPLETED|Overall Study||0
6780405|NCT03110900|7708845|FG000|STARTED|Overall Study||1
6780406|NCT03110900|7708846|FG001|STARTED|Overall Study||1
6780407|NCT03110900|7708845|FG000|COMPLETED|Overall Study||0
6780408|NCT03110900|7708846|FG001|COMPLETED|Overall Study||0
6780409|NCT03110900|7708845|FG000|NOT COMPLETED|Overall Study||1
6780410|NCT03110900|7708846|FG001|NOT COMPLETED|Overall Study||1
6780411|NCT03078868|7708852|FG000|STARTED|Overall Study||3
6780412|NCT03078868|7708852|FG000|COMPLETED|Overall Study||0
6780413|NCT03078868|7708852|FG000|NOT COMPLETED|Overall Study||3
6780414|NCT03078270|7708858|FG000|STARTED|Overall Study||4
6780415|NCT03078270|7708859|FG001|STARTED|Overall Study||0
6780416|NCT03078270|7708858|FG000|COMPLETED|Overall Study||0
6780417|NCT03078270|7708859|FG001|COMPLETED|Overall Study||0
6780418|NCT03078270|7708858|FG000|NOT COMPLETED|Overall Study||4
6780419|NCT03078270|7708859|FG001|NOT COMPLETED|Overall Study||0
6780420|NCT03065933|7708865|FG000|STARTED|Overall Study||5
6780421|NCT03065933|7708865|FG000|COMPLETED|Overall Study||0
6780422|NCT03065933|7708865|FG000|NOT COMPLETED|Overall Study||5
6780423|NCT03070002|7708869|FG000|STARTED|3 Cycles of Treatment||1
6780424|NCT03070002|7708869|FG000|COMPLETED|3 Cycles of Treatment||1
6780425|NCT03070002|7708869|FG000|NOT COMPLETED|3 Cycles of Treatment||0
6780426|NCT03070002|7708869|FG000|STARTED|Follow up for 2 Years||1
6780427|NCT03070002|7708869|FG000|COMPLETED|Follow up for 2 Years||0
6780428|NCT03070002|7708869|FG000|NOT COMPLETED|Follow up for 2 Years||1
6780429|NCT03058705|7708873|FG000|STARTED|Overall Study||10
6780430|NCT03058705|7708873|FG000|COMPLETED|Overall Study||6
6780431|NCT03058705|7708873|FG000|NOT COMPLETED|Overall Study||4
6780432|NCT03061279|7708879|FG000|STARTED|Overall Study||0
6780433|NCT03061279|7708880|FG001|STARTED|Overall Study||1
6780434|NCT03061279|7708879|FG000|COMPLETED|Overall Study||0
6780435|NCT03061279|7708880|FG001|COMPLETED|Overall Study||0
6780436|NCT03061279|7708879|FG000|NOT COMPLETED|Overall Study||0
6780437|NCT03061279|7708880|FG001|NOT COMPLETED|Overall Study||1
6780438|NCT03040323|7708888|FG000|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
6780439|NCT03040323|7708889|FG001|STARTED|Overall Study|No information available regarding how many participants Started and Completed the study in each arm|0
6780440|NCT03040323|7708888|FG000|COMPLETED|Overall Study||0
6780441|NCT03040323|7708889|FG001|COMPLETED|Overall Study||0
6780442|NCT03040323|7708888|FG000|NOT COMPLETED|Overall Study||0
6766942|NCT04285489|7693894|FG000|STARTED|Overall Study||130
6766943|NCT04285489|7693894|FG000|COMPLETED|Overall Study|all subjects finished the study before Jul 1, 2020.|130
6766944|NCT04285489|7693894|FG000|NOT COMPLETED|Overall Study||0
6766945|NCT04290494|7693901|FG000|STARTED|Overall Study||10968
6766946|NCT04290494|7693902|FG001|STARTED|Overall Study||17823
6766947|NCT04290494|7693903|FG002|STARTED|Overall Study||13397
6766948|NCT04290494|7693901|FG000|COMPLETED|Overall Study||10968
6766949|NCT04290494|7693902|FG001|COMPLETED|Overall Study||17823
6766950|NCT04290494|7693903|FG002|COMPLETED|Overall Study||13397
6766951|NCT04290494|7693901|FG000|NOT COMPLETED|Overall Study||0
6766952|NCT04290494|7693902|FG001|NOT COMPLETED|Overall Study||0
6766953|NCT04290494|7693903|FG002|NOT COMPLETED|Overall Study||0
6780443|NCT03040323|7708889|FG001|NOT COMPLETED|Overall Study||0
6780444|NCT03053518|7708895|FG000|STARTED|Overall Study||22
6780445|NCT03053518|7708895|FG000|COMPLETED|Overall Study||12
6780446|NCT03053518|7708895|FG000|NOT COMPLETED|Overall Study||10
6780447|NCT03050398|7708899|FG000|STARTED|Overall Study||8
6780448|NCT03050398|7708899|FG000|COMPLETED|Overall Study||0
6780449|NCT03050398|7708899|FG000|NOT COMPLETED|Overall Study||8
6780450|NCT03042780|7708903|FG000|STARTED|Overall Study||2
6780451|NCT03042780|7708903|FG000|COMPLETED|Overall Study||2
6780452|NCT03042780|7708903|FG000|NOT COMPLETED|Overall Study||0
6780453|NCT03053960|7708907|FG000|STARTED|Overall Study||8
6780454|NCT03053960|7708907|FG000|COMPLETED|Overall Study||8
6780455|NCT03053960|7708907|FG000|NOT COMPLETED|Overall Study||0
6780456|NCT03036735|7708911|FG000|STARTED|Overall Study||10
6780457|NCT03036735|7708911|FG000|COMPLETED|Overall Study||0
6780458|NCT03036735|7708911|FG000|NOT COMPLETED|Overall Study||10
6780459|NCT03029832|7708917|FG000|STARTED|Overall Study||4
6780460|NCT03029832|7708918|FG001|STARTED|Overall Study||1
6780461|NCT03029832|7708917|FG000|COMPLETED|Overall Study||0
6780462|NCT03029832|7708918|FG001|COMPLETED|Overall Study||0
6780463|NCT03029832|7708917|FG000|NOT COMPLETED|Overall Study||4
6780464|NCT03029832|7708918|FG001|NOT COMPLETED|Overall Study||1
6780465|NCT03020446|7708924|FG000|STARTED|Overall Study||3
6780466|NCT03020446|7708924|FG000|COMPLETED|Overall Study||0
6780467|NCT03020446|7708924|FG000|NOT COMPLETED|Overall Study||3
6780468|NCT03031340|7708930|FG000|STARTED|Overall Study||2
6780469|NCT03031340|7708931|FG001|STARTED|Overall Study||1
6780470|NCT03031340|7708930|FG000|COMPLETED|Overall Study||0
6780471|NCT03031340|7708931|FG001|COMPLETED|Overall Study||0
6780472|NCT03031340|7708930|FG000|NOT COMPLETED|Overall Study||2
6780473|NCT03031340|7708931|FG001|NOT COMPLETED|Overall Study||1
6780474|NCT03017040|7708937|FG000|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
6780475|NCT03017040|7708938|FG001|STARTED|Overall Study|Participants enroll one wrist into each group,thus, one participant flows into both groups.|1
6780476|NCT03017040|7708937|FG000|COMPLETED|Overall Study||0
6780477|NCT03017040|7708938|FG001|COMPLETED|Overall Study||0
6780478|NCT03017040|7708937|FG000|NOT COMPLETED|Overall Study||1
6780479|NCT03017040|7708938|FG001|NOT COMPLETED|Overall Study||1
6780480|NCT03007719|7708946|FG000|STARTED|Overall Study||0
6780481|NCT03007719|7708947|FG001|STARTED|Overall Study||4
6780482|NCT03007719|7708946|FG000|COMPLETED|Overall Study||0
6780483|NCT03007719|7708947|FG001|COMPLETED|Overall Study||4
6780484|NCT03007719|7708946|FG000|NOT COMPLETED|Overall Study||0
6780485|NCT03007719|7708947|FG001|NOT COMPLETED|Overall Study||0
6780486|NCT03010423|7708953|FG000|STARTED|Overall Study||8
6780487|NCT03010423|7708953|FG000|COMPLETED|Overall Study||0
6780488|NCT03010423|7708953|FG000|NOT COMPLETED|Overall Study||8
6780489|NCT02985801|7708959|FG000|STARTED|Overall Study||8
6780490|NCT02985801|7708960|FG001|STARTED|Overall Study||8
6780491|NCT02985801|7708959|FG000|COMPLETED|Overall Study||8
6780492|NCT02985801|7708960|FG001|COMPLETED|Overall Study||8
6780493|NCT02985801|7708959|FG000|NOT COMPLETED|Overall Study||0
6780494|NCT02985801|7708960|FG001|NOT COMPLETED|Overall Study||0
6781041|NCT02708849|7709645|FG000|NOT COMPLETED|Overall Study||1
6781042|NCT02708849|7709646|FG001|NOT COMPLETED|Overall Study||0
6781043|NCT02693717|7709652|FG000|STARTED|Overall Study||7
6781044|NCT02693717|7709652|FG000|COMPLETED|Overall Study||7
6781045|NCT02693717|7709652|FG000|NOT COMPLETED|Overall Study||0
6781046|NCT02694757|7709656|FG000|STARTED|Overall Study||3
6781047|NCT02694757|7709656|FG000|COMPLETED|Overall Study||0
6781048|NCT02694757|7709656|FG000|NOT COMPLETED|Overall Study||3
6781049|NCT02693002|7709662|FG000|STARTED|Overall Study||2
6781050|NCT02693002|7709663|FG001|STARTED|Overall Study||2
6781051|NCT02693002|7709662|FG000|COMPLETED|Overall Study||1
6781052|NCT02693002|7709663|FG001|COMPLETED|Overall Study||2
6781053|NCT02693002|7709662|FG000|NOT COMPLETED|Overall Study||1
6781054|NCT02693002|7709663|FG001|NOT COMPLETED|Overall Study||0
6781055|NCT02689518|7709669|FG000|STARTED|Overall Study||49
6781056|NCT02689518|7709669|FG000|COMPLETED|Overall Study||46
6781057|NCT02689518|7709669|FG000|NOT COMPLETED|Overall Study||3
6781058|NCT02687165|7709673|FG000|STARTED|Overall Study||0
6781059|NCT02687165|7709674|FG001|STARTED|Overall Study||0
6781060|NCT02687165|7709673|FG000|COMPLETED|Overall Study||0
6781061|NCT02687165|7709674|FG001|COMPLETED|Overall Study||0
6781062|NCT02687165|7709673|FG000|NOT COMPLETED|Overall Study||0
6781063|NCT02687165|7709674|FG001|NOT COMPLETED|Overall Study||0
6781064|NCT02679560|7709682|FG000|STARTED|Overall Study||1
6781065|NCT02679560|7709683|FG001|STARTED|Overall Study||2
6781066|NCT02679560|7709682|FG000|COMPLETED|Overall Study||1
6781067|NCT02679560|7709683|FG001|COMPLETED|Overall Study||2
6766954|NCT04303156|7693913|FG000|STARTED|Overall Study||6
6766955|NCT04303156|7693914|FG001|STARTED|Overall Study||6
6766956|NCT04303156|7693913|FG000|COMPLETED|Overall Study||6
6766957|NCT04303156|7693914|FG001|COMPLETED|Overall Study||6
6766958|NCT04303156|7693913|FG000|NOT COMPLETED|Overall Study||0
6766959|NCT04303156|7693914|FG001|NOT COMPLETED|Overall Study||0
6766960|NCT04317040|7693923|FG000|STARTED|Overall Study||116
6766961|NCT04317040|7693924|FG001|STARTED|Overall Study||118
6766962|NCT04317040|7693923|FG000|Treated|Overall Study||114
6766963|NCT04317040|7693924|FG001|Treated|Overall Study||115
6766964|NCT04317040|7693923|FG000|COMPLETED|Overall Study||98
6766965|NCT04317040|7693924|FG001|COMPLETED|Overall Study||98
6766966|NCT04317040|7693923|FG000|NOT COMPLETED|Overall Study||18
6766967|NCT04317040|7693924|FG001|NOT COMPLETED|Overall Study||20
6766968|NCT04317313|7693932|FG000|STARTED|Overall Study||100
6766969|NCT04317313|7693933|FG001|STARTED|Overall Study||52
6766970|NCT04317313|7693932|FG000|COMPLETED|Overall Study||100
6766971|NCT04317313|7693933|FG001|COMPLETED|Overall Study||52
6766972|NCT04317313|7693932|FG000|NOT COMPLETED|Overall Study||0
6766973|NCT04317313|7693933|FG001|NOT COMPLETED|Overall Study||0
6766974|NCT04319159|7693941|FG000|STARTED|Overall Study||48
6766975|NCT04319159|7693941|FG000|COMPLETED|Overall Study||32
6766976|NCT04319159|7693941|FG000|NOT COMPLETED|Overall Study||16
6766977|NCT04321239|7693949|FG000|STARTED|Overall Study||25
6766978|NCT04321239|7693950|FG001|STARTED|Overall Study||26
6766979|NCT04321239|7693949|FG000|COMPLETED|Overall Study||22
6766980|NCT04321239|7693950|FG001|COMPLETED|Overall Study||24
6766981|NCT04321239|7693949|FG000|NOT COMPLETED|Overall Study||3
6766982|NCT04321239|7693950|FG001|NOT COMPLETED|Overall Study||2
6766983|NCT04323852|7693958|FG000|STARTED|Overall Study||35
6766984|NCT04323852|7693959|FG001|STARTED|Overall Study||35
6766985|NCT04323852|7693958|FG000|COMPLETED|Overall Study||35
6766986|NCT04323852|7693959|FG001|COMPLETED|Overall Study||35
6766987|NCT04323852|7693958|FG000|NOT COMPLETED|Overall Study||0
6766988|NCT04323852|7693959|FG001|NOT COMPLETED|Overall Study||0
6766989|NCT04327843|7693965|FG000|STARTED|Baseline Assessment||19
6766990|NCT04327843|7693965|FG000|COMPLETED|Baseline Assessment||19
6766991|NCT04327843|7693965|FG000|NOT COMPLETED|Baseline Assessment||0
6766992|NCT04327843|7693965|FG000|STARTED|Week 13 Assessment||19
6766993|NCT04327843|7693965|FG000|COMPLETED|Week 13 Assessment||19
6766994|NCT04327843|7693965|FG000|NOT COMPLETED|Week 13 Assessment||0
6766995|NCT04327843|7693965|FG000|STARTED|Week 25 Assessment||19
6766996|NCT04327843|7693965|FG000|COMPLETED|Week 25 Assessment||18
6766997|NCT04327843|7693965|FG000|NOT COMPLETED|Week 25 Assessment||1
6766998|NCT04331899|7693971|FG000|STARTED|Trial Period (28 Days)||60
6766999|NCT04331899|7693972|FG001|STARTED|Trial Period (28 Days)||60
6767000|NCT04331899|7693971|FG000|COMPLETED|Trial Period (28 Days)||58
6767001|NCT04331899|7693972|FG001|COMPLETED|Trial Period (28 Days)||58
6767002|NCT04331899|7693971|FG000|NOT COMPLETED|Trial Period (28 Days)||2
6767003|NCT04331899|7693972|FG001|NOT COMPLETED|Trial Period (28 Days)||2
6767004|NCT04331899|7693971|FG000|STARTED|Follow-up Period (10 Months)|16 participants who completed the trial period did not continue in the follow-up period.|42
6767005|NCT04331899|7693972|FG001|STARTED|Follow-up Period (10 Months)|15 participants who completed the trial period did not continue in the follow-up period.|43
6767006|NCT04331899|7693971|FG000|COMPLETED|Follow-up Period (10 Months)||42
6767007|NCT04331899|7693972|FG001|COMPLETED|Follow-up Period (10 Months)||43
6767008|NCT04331899|7693971|FG000|NOT COMPLETED|Follow-up Period (10 Months)||0
6767009|NCT04331899|7693972|FG001|NOT COMPLETED|Follow-up Period (10 Months)||0
6767010|NCT04334148|7693980|FG000|STARTED|Overall Study||683
6767011|NCT04334148|7693981|FG001|STARTED|Overall Study||677
6767012|NCT04334148|7693980|FG000|COMPLETED|Overall Study||683
6767013|NCT04334148|7693981|FG001|COMPLETED|Overall Study||676
6767014|NCT04334148|7693980|FG000|NOT COMPLETED|Overall Study||0
6767015|NCT04334148|7693981|FG001|NOT COMPLETED|Overall Study||1
6767016|NCT04343287|7693989|FG000|STARTED|Overall Study||108
6767017|NCT04343287|7693990|FG001|STARTED|Overall Study||112
6767018|NCT04343287|7693989|FG000|COMPLETED|Overall Study||108
6767019|NCT04343287|7693990|FG001|COMPLETED|Overall Study||111
6767020|NCT04343287|7693989|FG000|NOT COMPLETED|Overall Study||0
6767021|NCT04343287|7693990|FG001|NOT COMPLETED|Overall Study||1
6767022|NCT04347954|7694001|FG000|STARTED|Overall Study||15
6767023|NCT04347954|7694002|FG001|STARTED|Overall Study||15
6767024|NCT04347954|7694003|FG002|STARTED|Overall Study||17
6767025|NCT04347954|7694001|FG000|Received Allocated Intervention|Overall Study||12
6767026|NCT04347954|7694002|FG001|Received Allocated Intervention|Overall Study||15
6767027|NCT04347954|7694003|FG002|Received Allocated Intervention|Overall Study||14
6767028|NCT04347954|7694001|FG000|Negative PCR Swab at Baseline|Overall Study||1
6767029|NCT04347954|7694002|FG001|Negative PCR Swab at Baseline|Overall Study||3
6767030|NCT04347954|7694003|FG002|Negative PCR Swab at Baseline|Overall Study||1
6767031|NCT04347954|7694001|FG000|COMPLETED|Overall Study||12
6767032|NCT04347954|7694002|FG001|COMPLETED|Overall Study||14
6767033|NCT04347954|7694003|FG002|COMPLETED|Overall Study||14
6767034|NCT04347954|7694001|FG000|NOT COMPLETED|Overall Study||3
6767035|NCT04347954|7694002|FG001|NOT COMPLETED|Overall Study||1
6767036|NCT04347954|7694003|FG002|NOT COMPLETED|Overall Study||3
6767037|NCT04349098|7694013|FG000|STARTED|Overall Study||103
6767038|NCT04349098|7694014|FG001|STARTED|Overall Study||87
6767039|NCT04349098|7694013|FG000|Treated|Overall Study||102
6767040|NCT04349098|7694014|FG001|Treated|Overall Study||86
6767041|NCT04349098|7694013|FG000|COMPLETED|Overall Study||65
6767042|NCT04349098|7694014|FG001|COMPLETED|Overall Study||61
6556417|NCT01759602|7478750|FG000|COMPLETED|Overall Study||10
6556418|NCT01759602|7478750|FG000|NOT COMPLETED|Overall Study||0
6556419|NCT01759862|7478756|FG000|STARTED|Overall Study||23
6556420|NCT01759862|7478757|FG001|STARTED|Overall Study||27
6556421|NCT01759862|7478756|FG000|COMPLETED|Overall Study||20
6556422|NCT01759862|7478757|FG001|COMPLETED|Overall Study||25
6556423|NCT01759862|7478756|FG000|NOT COMPLETED|Overall Study||3
6556424|NCT01759862|7478757|FG001|NOT COMPLETED|Overall Study||2
6556425|NCT01760187|7478773|FG000|STARTED|Overall Study||20
6556426|NCT01760187|7478774|FG001|STARTED|Overall Study||12
6556427|NCT01760187|7478775|FG002|STARTED|Overall Study||12
6556428|NCT01760187|7478776|FG003|STARTED|Overall Study||12
6556429|NCT01760187|7478777|FG004|STARTED|Overall Study||16
6556430|NCT01760187|7478773|FG000|COMPLETED|Overall Study||19
6556431|NCT01760187|7478774|FG001|COMPLETED|Overall Study||12
6556432|NCT01760187|7478775|FG002|COMPLETED|Overall Study||12
6556433|NCT01760187|7478776|FG003|COMPLETED|Overall Study||10
6556434|NCT01760187|7478777|FG004|COMPLETED|Overall Study||16
6556435|NCT01760187|7478773|FG000|NOT COMPLETED|Overall Study||1
6556436|NCT01760187|7478774|FG001|NOT COMPLETED|Overall Study||0
6556437|NCT01760187|7478775|FG002|NOT COMPLETED|Overall Study||0
6556438|NCT01760187|7478776|FG003|NOT COMPLETED|Overall Study||2
6556439|NCT01760187|7478777|FG004|NOT COMPLETED|Overall Study||0
6556440|NCT01760239|7478799|FG000|STARTED|Overall Study||17037
6556441|NCT01760239|7478800|FG001|STARTED|Overall Study||14542
6556442|NCT01760239|7478799|FG000|COMPLETED|Overall Study||296
6556443|NCT01760239|7478800|FG001|COMPLETED|Overall Study||226
6556444|NCT01760239|7478799|FG000|NOT COMPLETED|Overall Study||16741
6556445|NCT01760239|7478800|FG001|NOT COMPLETED|Overall Study||14316
6556446|NCT01760304|7478809|FG000|STARTED|Overall Study||2
6556447|NCT01760304|7478810|FG001|STARTED|Overall Study||3
6556448|NCT01760304|7478809|FG000|COMPLETED|Overall Study||2
6767043|NCT04349098|7694013|FG000|NOT COMPLETED|Overall Study||38
6767044|NCT04349098|7694014|FG001|NOT COMPLETED|Overall Study||26
6767045|NCT04353037|7694024|FG000|STARTED|Overall Study||6
6767046|NCT04353037|7694025|FG001|STARTED|Overall Study||3
6767047|NCT04353037|7694026|FG002|STARTED|Overall Study||13
6767048|NCT04353037|7694027|FG003|STARTED|Overall Study||17
6767049|NCT04353037|7694024|FG000|COMPLETED|Overall Study||6
6767050|NCT04353037|7694025|FG001|COMPLETED|Overall Study||0
6767051|NCT04353037|7694026|FG002|COMPLETED|Overall Study||6
6767052|NCT04353037|7694027|FG003|COMPLETED|Overall Study||7
6767053|NCT04353037|7694024|FG000|NOT COMPLETED|Overall Study||0
6767054|NCT04353037|7694025|FG001|NOT COMPLETED|Overall Study||3
6767055|NCT04353037|7694026|FG002|NOT COMPLETED|Overall Study||7
6767056|NCT04353037|7694027|FG003|NOT COMPLETED|Overall Study||10
6767057|NCT04355117|7694039|FG000|STARTED|Overall Study||71
6767058|NCT04355117|7694039|FG000|COMPLETED|Overall Study||71
6767059|NCT04355117|7694039|FG000|NOT COMPLETED|Overall Study||0
6767060|NCT04355767|7694047|FG000|STARTED|Overall Study||257
6767061|NCT04355767|7694048|FG001|STARTED|Overall Study||254
6767062|NCT04355767|7694047|FG000|Intention-to-treat Population|Overall Study||257
6767063|NCT04355767|7694048|FG001|Intention-to-treat Population|Overall Study||254
6767064|NCT04355767|7694047|FG000|Had Data for 15-day Outcome|Overall Study||257
6767065|NCT04355767|7694048|FG001|Had Data for 15-day Outcome|Overall Study||254
6767066|NCT04355767|7694047|FG000|COMPLETED|Overall Study||250
6767067|NCT04355767|7694048|FG001|COMPLETED|Overall Study||251
6767068|NCT04355767|7694047|FG000|NOT COMPLETED|Overall Study||7
6767069|NCT04355767|7694048|FG001|NOT COMPLETED|Overall Study||3
6767070|NCT04356573|7694056|FG000|STARTED|Overall Study||7
6767071|NCT04356573|7694057|FG001|STARTED|Overall Study||6
6767072|NCT04356573|7694056|FG000|COMPLETED|Overall Study||6
6767073|NCT04356573|7694057|FG001|COMPLETED|Overall Study||6
6767074|NCT04356573|7694056|FG000|NOT COMPLETED|Overall Study||1
6767075|NCT04356573|7694057|FG001|NOT COMPLETED|Overall Study||0
6767076|NCT04357379|7694063|FG000|STARTED|Overall Study||10
6767077|NCT04357379|7694063|FG000|COMPLETED|Overall Study||10
6767078|NCT04357379|7694063|FG000|NOT COMPLETED|Overall Study||0
6767079|NCT04358068|7694069|FG000|STARTED|Overall Study||9
6767080|NCT04358068|7694070|FG001|STARTED|Overall Study||11
6767081|NCT04358068|7694069|FG000|COMPLETED|Overall Study||7
6556449|NCT01760304|7478810|FG001|COMPLETED|Overall Study||3
6556450|NCT01760304|7478809|FG000|NOT COMPLETED|Overall Study||0
6556451|NCT01760304|7478810|FG001|NOT COMPLETED|Overall Study||0
6556452|NCT01760447|7478824|FG000|STARTED|Weeks 0-20|The first randomization for the participant who withdrew and re-randomized is not counted in the 62.|62
6556453|NCT01760447|7478825|FG001|STARTED|Weeks 0-20||62
6556454|NCT01760447|7478826|FG002|STARTED|Weeks 0-20||47
6767082|NCT04358068|7694070|FG001|COMPLETED|Overall Study||9
6767083|NCT04358068|7694069|FG000|NOT COMPLETED|Overall Study||2
6767084|NCT04358068|7694070|FG001|NOT COMPLETED|Overall Study||2
6767085|NCT04366349|7694082|FG000|STARTED|Overall Study||13
6767086|NCT04366349|7694083|FG001|STARTED|Overall Study||18
6556455|NCT01760447|7478827|FG003|STARTED|Weeks 0-20||51
6556456|NCT01760447|7478824|FG000|Treated|Weeks 0-20||62
6556457|NCT01760447|7478825|FG001|Treated|Weeks 0-20||62
6556458|NCT01760447|7478826|FG002|Treated|Weeks 0-20||45
6556459|NCT01760447|7478827|FG003|Treated|Weeks 0-20||51
6556460|NCT01760447|7478824|FG000|COMPLETED|Weeks 0-20||59
6767087|NCT04366349|7694084|FG002|STARTED|Overall Study||18
6767088|NCT04366349|7694085|FG003|STARTED|Overall Study||4
6767089|NCT04366349|7694086|FG004|STARTED|Overall Study||6
6556461|NCT01760447|7478825|FG001|COMPLETED|Weeks 0-20||62
6556462|NCT01760447|7478826|FG002|COMPLETED|Weeks 0-20||42
6556463|NCT01760447|7478827|FG003|COMPLETED|Weeks 0-20||47
6556464|NCT01760447|7478824|FG000|NOT COMPLETED|Weeks 0-20||3
6556465|NCT01760447|7478825|FG001|NOT COMPLETED|Weeks 0-20||0
6556466|NCT01760447|7478826|FG002|NOT COMPLETED|Weeks 0-20||5
6767090|NCT04366349|7694087|FG005|STARTED|Overall Study||6
6767091|NCT04366349|7694082|FG000|COMPLETED|Overall Study||12
6767092|NCT04366349|7694083|FG001|COMPLETED|Overall Study||18
6767093|NCT04366349|7694084|FG002|COMPLETED|Overall Study||18
6767094|NCT04366349|7694085|FG003|COMPLETED|Overall Study||4
6767095|NCT04366349|7694086|FG004|COMPLETED|Overall Study||6
6767096|NCT04366349|7694087|FG005|COMPLETED|Overall Study||6
6767097|NCT04366349|7694082|FG000|NOT COMPLETED|Overall Study||1
6767098|NCT04366349|7694083|FG001|NOT COMPLETED|Overall Study||0
6767099|NCT04366349|7694084|FG002|NOT COMPLETED|Overall Study||0
6767100|NCT04366349|7694085|FG003|NOT COMPLETED|Overall Study||0
6767101|NCT04366349|7694086|FG004|NOT COMPLETED|Overall Study||0
6767102|NCT04366349|7694087|FG005|NOT COMPLETED|Overall Study||0
6767103|NCT04369885|7694105|FG000|STARTED|Overall Study||12
6767104|NCT04369885|7694105|FG000|COMPLETED|Overall Study||10
6767105|NCT04369885|7694105|FG000|NOT COMPLETED|Overall Study||2
6767106|NCT04373421|7694112|FG000|STARTED|Overall Study||30
6767107|NCT04373421|7694113|FG001|STARTED|Overall Study||30
6767108|NCT04373421|7694114|FG002|STARTED|Overall Study||30
6767109|NCT04373421|7694112|FG000|COMPLETED|Overall Study||26
6767110|NCT04373421|7694113|FG001|COMPLETED|Overall Study||26
6767111|NCT04373421|7694114|FG002|COMPLETED|Overall Study||29
6767112|NCT04373421|7694112|FG000|NOT COMPLETED|Overall Study||4
6767113|NCT04373421|7694113|FG001|NOT COMPLETED|Overall Study||4
6767114|NCT04373421|7694114|FG002|NOT COMPLETED|Overall Study||1
6767115|NCT04381728|7694125|FG000|STARTED|Overall Study||23
6767116|NCT04381728|7694125|FG000|COMPLETED|Overall Study||23
6767117|NCT04381728|7694125|FG000|NOT COMPLETED|Overall Study||0
6767118|NCT04382053|7694131|FG000|STARTED|Overall Study||71
6767119|NCT04382053|7694132|FG001|STARTED|Overall Study||72
6767120|NCT04382053|7694131|FG000|Safety Analysis Set|Overall Study|One participant that was randomized to the DFV890 + SoC arm did not attend any post-baseline visit|70
6767121|NCT04382053|7694132|FG001|Safety Analysis Set|Overall Study||72
6767122|NCT04382053|7694131|FG000|PD Analysis Set|Overall Study||62
6767123|NCT04382053|7694132|FG001|PD Analysis Set|Overall Study||68
6767124|NCT04382053|7694131|FG000|COMPLETED|Overall Study||62
6767125|NCT04382053|7694132|FG001|COMPLETED|Overall Study||59
6767126|NCT04382053|7694131|FG000|NOT COMPLETED|Overall Study||9
6767127|NCT04382053|7694132|FG001|NOT COMPLETED|Overall Study||13
6767128|NCT04388826|7694141|FG000|STARTED|Overall Study||19
6767129|NCT04388826|7694142|FG001|STARTED|Overall Study||20
6767130|NCT04388826|7694141|FG000|COMPLETED|Overall Study||15
6767131|NCT04388826|7694142|FG001|COMPLETED|Overall Study||18
6767132|NCT04388826|7694141|FG000|NOT COMPLETED|Overall Study||4
6767133|NCT04388826|7694142|FG001|NOT COMPLETED|Overall Study||2
6767134|NCT04394845|7694148|FG000|STARTED|Overall Study||6
6767135|NCT04394845|7694148|FG000|COMPLETED|Overall Study||6
6767136|NCT04394845|7694148|FG000|NOT COMPLETED|Overall Study||0
6767137|NCT04398732|7694154|FG000|STARTED|Overall Study||486
6767138|NCT04398732|7694154|FG000|COMPLETED|Overall Study||436
6767139|NCT04398732|7694154|FG000|NOT COMPLETED|Overall Study||50
6767140|NCT04401293|7694162|FG000|STARTED|Overall Study||130
6767141|NCT04401293|7694163|FG001|STARTED|Overall Study||127
6767142|NCT04401293|7694162|FG000|COMPLETED|Overall Study||129
6767143|NCT04401293|7694163|FG001|COMPLETED|Overall Study||124
6767144|NCT04401293|7694162|FG000|NOT COMPLETED|Overall Study||1
6767145|NCT04401293|7694163|FG001|NOT COMPLETED|Overall Study||3
6767146|NCT04411628|7694173|FG000|STARTED|Overall Study||7
6767147|NCT04411628|7694174|FG001|STARTED|Overall Study||6
6767148|NCT04411628|7694175|FG002|STARTED|Overall Study||7
6767149|NCT04411628|7694176|FG003|STARTED|Overall Study||6
6767150|NCT04411628|7694173|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6767151|NCT04411628|7694174|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6767152|NCT04411628|7694175|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6767153|NCT04411628|7694176|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6767154|NCT04411628|7694173|FG000|COMPLETED|Overall Study||6
6767155|NCT04411628|7694174|FG001|COMPLETED|Overall Study||4
6767156|NCT04411628|7694175|FG002|COMPLETED|Overall Study||5
6767157|NCT04411628|7694176|FG003|COMPLETED|Overall Study||6
6767158|NCT04411628|7694173|FG000|NOT COMPLETED|Overall Study||1
6767159|NCT04411628|7694174|FG001|NOT COMPLETED|Overall Study||2
6767160|NCT04411628|7694175|FG002|NOT COMPLETED|Overall Study||2
6767161|NCT04411628|7694176|FG003|NOT COMPLETED|Overall Study||0
6767162|NCT04418947|7694194|FG000|STARTED|Overall Study||1108
6767163|NCT04418947|7694195|FG001|STARTED|Overall Study||1351
6767164|NCT04418947|7694196|FG002|STARTED|Overall Study||1351
6556467|NCT01760447|7478827|FG003|NOT COMPLETED|Weeks 0-20||4
6767165|NCT04418947|7694197|FG003|STARTED|Overall Study||3655
6767166|NCT04418947|7694198|FG004|STARTED|Overall Study||3655
6562919|NCT01803607|7485845|FG000|STARTED|Overall Study||68
6767167|NCT04418947|7694194|FG000|COMPLETED|Overall Study||1108
6767168|NCT04418947|7694195|FG001|COMPLETED|Overall Study||1351
6767169|NCT04418947|7694196|FG002|COMPLETED|Overall Study||1351
6767170|NCT04418947|7694197|FG003|COMPLETED|Overall Study||3655
6767171|NCT04418947|7694198|FG004|COMPLETED|Overall Study||3655
6767172|NCT04418947|7694194|FG000|NOT COMPLETED|Overall Study||0
6767173|NCT04418947|7694195|FG001|NOT COMPLETED|Overall Study||0
6767174|NCT04418947|7694196|FG002|NOT COMPLETED|Overall Study||0
6767175|NCT04418947|7694197|FG003|NOT COMPLETED|Overall Study||0
6767176|NCT04418947|7694198|FG004|NOT COMPLETED|Overall Study||0
6767177|NCT04420273|7694212|FG000|STARTED|Overall Study||501
6767178|NCT04420273|7694213|FG001|STARTED|Overall Study||499
6767179|NCT04420273|7694212|FG000|COMPLETED|Overall Study||390
6767180|NCT04420273|7694213|FG001|COMPLETED|Overall Study||414
6767181|NCT04420273|7694212|FG000|NOT COMPLETED|Overall Study||111
6767182|NCT04420273|7694213|FG001|NOT COMPLETED|Overall Study||85
6767183|NCT04420572|7694221|FG000|STARTED|Overall Study||33
6767184|NCT04420572|7694222|FG001|STARTED|Overall Study||30
6767185|NCT04420572|7694221|FG000|COMPLETED|Overall Study||33
6767186|NCT04420572|7694222|FG001|COMPLETED|Overall Study||30
6767187|NCT04420572|7694221|FG000|NOT COMPLETED|Overall Study||0
6767188|NCT04420572|7694222|FG001|NOT COMPLETED|Overall Study||0
6767189|NCT04428411|7694228|FG000|STARTED|Overall Study||486
6767190|NCT04428411|7694228|FG000|Participants With Difficult to Treat Sites|Overall Study||397
6767191|NCT04428411|7694228|FG000|Participants Without Difficulty to Treat Sites|Overall Study||89
6767192|NCT04428411|7694228|FG000|Participants Adherent to Treatment|Overall Study||417
6767193|NCT04428411|7694228|FG000|Participants Not Adherent to Treatment|Overall Study||69
6767194|NCT04428411|7694228|FG000|COMPLETED|Overall Study||372
6767195|NCT04428411|7694228|FG000|NOT COMPLETED|Overall Study||114
6767196|NCT04435184|7694237|FG000|STARTED|Overall Study||25
6767197|NCT04435184|7694238|FG001|STARTED|Overall Study||25
6767198|NCT04435184|7694237|FG000|COMPLETED|Overall Study||22
6767199|NCT04435184|7694238|FG001|COMPLETED|Overall Study||20
6767200|NCT04435184|7694237|FG000|NOT COMPLETED|Overall Study||3
6767201|NCT04435184|7694238|FG001|NOT COMPLETED|Overall Study||5
6767202|NCT04476784|7694246|FG000|STARTED|First Wear Period (30 Days ± 2 Days)||31
6767203|NCT04476784|7694247|FG001|STARTED|First Wear Period (30 Days ± 2 Days)||35
6767204|NCT04476784|7694246|FG000|COMPLETED|First Wear Period (30 Days ± 2 Days)||30
6767205|NCT04476784|7694247|FG001|COMPLETED|First Wear Period (30 Days ± 2 Days)||35
6767206|NCT04476784|7694246|FG000|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||1
6767207|NCT04476784|7694247|FG001|NOT COMPLETED|First Wear Period (30 Days ± 2 Days)||0
6767208|NCT04476784|7694246|FG000|STARTED|Second Wear Period (30 Days ± 2 Days)||30
6767209|NCT04476784|7694247|FG001|STARTED|Second Wear Period (30 Days ± 2 Days)||35
6767210|NCT04476784|7694246|FG000|COMPLETED|Second Wear Period (30 Days ± 2 Days)||30
6767211|NCT04476784|7694247|FG001|COMPLETED|Second Wear Period (30 Days ± 2 Days)||35
6767212|NCT04476784|7694246|FG000|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
6767213|NCT04476784|7694247|FG001|NOT COMPLETED|Second Wear Period (30 Days ± 2 Days)||0
6767214|NCT04484207|7694259|FG000|STARTED|Overall Study||86
6767215|NCT04484207|7694260|FG001|STARTED|Overall Study||44
6767216|NCT04484207|7694261|FG002|STARTED|Overall Study||42
6767217|NCT04484207|7694259|FG000|14-Day Follow-Up|Overall Study||69
6767218|NCT04484207|7694260|FG001|14-Day Follow-Up|Overall Study||40
6767219|NCT04484207|7694261|FG002|14-Day Follow-Up|Overall Study||33
6767220|NCT04484207|7694259|FG000|30-Day Follow-Up|Overall Study||65
6767221|NCT04484207|7694260|FG001|30-Day Follow-Up|Overall Study||34
6767222|NCT04484207|7694261|FG002|30-Day Follow-Up|Overall Study||31
6767223|NCT04484207|7694259|FG000|COMPLETED|Overall Study||65
6767224|NCT04484207|7694260|FG001|COMPLETED|Overall Study||34
6767225|NCT04484207|7694261|FG002|COMPLETED|Overall Study||31
6767226|NCT04484207|7694259|FG000|NOT COMPLETED|Overall Study||21
6767227|NCT04484207|7694260|FG001|NOT COMPLETED|Overall Study||10
6767228|NCT04484207|7694261|FG002|NOT COMPLETED|Overall Study||11
6767229|NCT04485455|7694272|FG000|STARTED|Overall Study||5
6767230|NCT04485455|7694272|FG000|COMPLETED|Overall Study||5
6767231|NCT04485455|7694272|FG000|NOT COMPLETED|Overall Study||0
6767232|NCT04495283|7694279|FG000|STARTED|Overall Study||35
6767233|NCT04495283|7694280|FG001|STARTED|Overall Study||35
6767234|NCT04495283|7694281|FG002|STARTED|Overall Study||17
6767235|NCT04495283|7694279|FG000|COMPLETED|Overall Study||34
6767236|NCT04495283|7694280|FG001|COMPLETED|Overall Study||34
6767237|NCT04495283|7694281|FG002|COMPLETED|Overall Study||14
6767238|NCT04495283|7694279|FG000|NOT COMPLETED|Overall Study||1
6767239|NCT04495283|7694280|FG001|NOT COMPLETED|Overall Study||1
6767240|NCT04495283|7694281|FG002|NOT COMPLETED|Overall Study||3
6767241|NCT04497948|7694292|FG000|STARTED|Overall Study||9
6767242|NCT04497948|7694292|FG000|COMPLETED|Overall Study||7
6767243|NCT04497948|7694292|FG000|NOT COMPLETED|Overall Study||2
6767244|NCT04501640|7694304|FG000|STARTED|Period 1 (5 Days)||6
6767245|NCT04501640|7694305|FG001|STARTED|Period 1 (5 Days)||6
6767246|NCT04501640|7694306|FG002|STARTED|Period 1 (5 Days)||6
6767247|NCT04501640|7694307|FG003|STARTED|Period 1 (5 Days)||6
6767248|NCT04501640|7694304|FG000|COMPLETED|Period 1 (5 Days)||6
6767249|NCT04501640|7694305|FG001|COMPLETED|Period 1 (5 Days)||6
6767250|NCT04501640|7694306|FG002|COMPLETED|Period 1 (5 Days)||6
6767251|NCT04501640|7694307|FG003|COMPLETED|Period 1 (5 Days)||6
6767252|NCT04501640|7694304|FG000|NOT COMPLETED|Period 1 (5 Days)||0
6767253|NCT04501640|7694305|FG001|NOT COMPLETED|Period 1 (5 Days)||0
6767254|NCT04501640|7694306|FG002|NOT COMPLETED|Period 1 (5 Days)||0
6767255|NCT04501640|7694307|FG003|NOT COMPLETED|Period 1 (5 Days)||0
6767256|NCT04501640|7694304|FG000|STARTED|Washout Period (10 Days)||6
6767257|NCT04501640|7694305|FG001|STARTED|Washout Period (10 Days)||6
6767258|NCT04501640|7694306|FG002|STARTED|Washout Period (10 Days)||6
6767259|NCT04501640|7694307|FG003|STARTED|Washout Period (10 Days)||6
6767260|NCT04501640|7694304|FG000|COMPLETED|Washout Period (10 Days)||6
6767261|NCT04501640|7694305|FG001|COMPLETED|Washout Period (10 Days)||6
6767262|NCT04501640|7694306|FG002|COMPLETED|Washout Period (10 Days)||6
6767263|NCT04501640|7694307|FG003|COMPLETED|Washout Period (10 Days)||6
6767264|NCT04501640|7694304|FG000|NOT COMPLETED|Washout Period (10 Days)||0
6767265|NCT04501640|7694305|FG001|NOT COMPLETED|Washout Period (10 Days)||0
6767266|NCT04501640|7694306|FG002|NOT COMPLETED|Washout Period (10 Days)||0
6767267|NCT04501640|7694307|FG003|NOT COMPLETED|Washout Period (10 Days)||0
6767268|NCT04501640|7694304|FG000|STARTED|Period 2 (5 Days)||6
6767269|NCT04501640|7694305|FG001|STARTED|Period 2 (5 Days)||6
6767270|NCT04501640|7694306|FG002|STARTED|Period 2 (5 Days)||6
6767271|NCT04501640|7694307|FG003|STARTED|Period 2 (5 Days)||6
6767272|NCT04501640|7694304|FG000|COMPLETED|Period 2 (5 Days)||6
6767273|NCT04501640|7694305|FG001|COMPLETED|Period 2 (5 Days)||6
6767274|NCT04501640|7694306|FG002|COMPLETED|Period 2 (5 Days)||6
6767275|NCT04501640|7694307|FG003|COMPLETED|Period 2 (5 Days)||6
6767276|NCT04501640|7694304|FG000|NOT COMPLETED|Period 2 (5 Days)||0
6767277|NCT04501640|7694305|FG001|NOT COMPLETED|Period 2 (5 Days)||0
6767278|NCT04501640|7694306|FG002|NOT COMPLETED|Period 2 (5 Days)||0
6767279|NCT04501640|7694307|FG003|NOT COMPLETED|Period 2 (5 Days)||0
6767280|NCT04501952|7694319|FG000|STARTED|Overall Study||292
6767281|NCT04501952|7694320|FG001|STARTED|Overall Study||292
6767282|NCT04501952|7694319|FG000|COMPLETED|Overall Study||266
6767283|NCT04501952|7694320|FG001|COMPLETED|Overall Study||272
6556468|NCT01760447|7478824|FG000|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|28
6556469|NCT01760447|7478825|FG001|STARTED|Weeks 20-54|MK-0431A-170 added Weeks 20-54 via amendment, but not all participants were eligible for this period|30
6767284|NCT04501952|7694319|FG000|NOT COMPLETED|Overall Study||26
6767285|NCT04501952|7694320|FG001|NOT COMPLETED|Overall Study||20
6767286|NCT04504032|7694329|FG000|STARTED|Overall Study||246
6767287|NCT04504032|7694330|FG001|STARTED|Overall Study||251
6767288|NCT04504032|7694329|FG000|COMPLETED|Overall Study||210
6767289|NCT04504032|7694330|FG001|COMPLETED|Overall Study||223
6767290|NCT04504032|7694329|FG000|NOT COMPLETED|Overall Study||36
6767291|NCT04504032|7694330|FG001|NOT COMPLETED|Overall Study||28
6767292|NCT04507763|7694336|FG000|STARTED|Overall Study||763
6767293|NCT04507763|7694336|FG000|COMPLETED|Overall Study||562
6767294|NCT04507763|7694336|FG000|NOT COMPLETED|Overall Study||201
6767295|NCT04507867|7694345|FG000|STARTED|Overall Study||40
6767296|NCT04507867|7694346|FG001|STARTED|Overall Study||40
6767297|NCT04507867|7694345|FG000|COMPLETED|Overall Study||33
6767298|NCT04507867|7694346|FG001|COMPLETED|Overall Study||39
6767299|NCT04507867|7694345|FG000|NOT COMPLETED|Overall Study||7
6767300|NCT04507867|7694346|FG001|NOT COMPLETED|Overall Study||1
6767301|NCT04525079|7694373|FG000|STARTED|Overall Study||6
6767302|NCT04525079|7694374|FG001|STARTED|Overall Study||6
6767303|NCT04525079|7694375|FG002|STARTED|Overall Study||6
6767304|NCT04525079|7694376|FG003|STARTED|Overall Study||6
6767305|NCT04525079|7694377|FG004|STARTED|Overall Study||8
6767306|NCT04525079|7694373|FG000|COMPLETED|Overall Study||6
6767307|NCT04525079|7694374|FG001|COMPLETED|Overall Study||6
6767308|NCT04525079|7694375|FG002|COMPLETED|Overall Study||6
6767309|NCT04525079|7694376|FG003|COMPLETED|Overall Study||6
6767310|NCT04525079|7694377|FG004|COMPLETED|Overall Study||8
6767311|NCT04525079|7694373|FG000|NOT COMPLETED|Overall Study||0
6767312|NCT04525079|7694374|FG001|NOT COMPLETED|Overall Study||0
6767313|NCT04525079|7694375|FG002|NOT COMPLETED|Overall Study||0
6767314|NCT04525079|7694376|FG003|NOT COMPLETED|Overall Study||0
6767315|NCT04525079|7694377|FG004|NOT COMPLETED|Overall Study||0
6767316|NCT04527978|7694391|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
6767317|NCT04527978|7694392|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
6767318|NCT04527978|7694391|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||26
6767319|NCT04527978|7694392|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
6767320|NCT04527978|7694391|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||1
6767321|NCT04527978|7694392|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
6767322|NCT04527978|7694391|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||26
6767323|NCT04527978|7694392|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
6767324|NCT04527978|7694391|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||26
6767325|NCT04527978|7694392|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
6767326|NCT04527978|7694391|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
6767327|NCT04527978|7694392|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
6767328|NCT04528017|7694403|FG000|STARTED|First Wear Period (8 -0/+3 Days)||27
6767329|NCT04528017|7694404|FG001|STARTED|First Wear Period (8 -0/+3 Days)||28
6767330|NCT04528017|7694403|FG000|COMPLETED|First Wear Period (8 -0/+3 Days)||27
6767331|NCT04528017|7694404|FG001|COMPLETED|First Wear Period (8 -0/+3 Days)||28
6767332|NCT04528017|7694403|FG000|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
6767333|NCT04528017|7694404|FG001|NOT COMPLETED|First Wear Period (8 -0/+3 Days)||0
6767334|NCT04528017|7694403|FG000|STARTED|Second Wear Period (8 -0/+3 Days)||27
6767335|NCT04528017|7694404|FG001|STARTED|Second Wear Period (8 -0/+3 Days)||28
6767336|NCT04528017|7694403|FG000|COMPLETED|Second Wear Period (8 -0/+3 Days)||27
6767337|NCT04528017|7694404|FG001|COMPLETED|Second Wear Period (8 -0/+3 Days)||28
6767338|NCT04528017|7694403|FG000|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
6767339|NCT04528017|7694404|FG001|NOT COMPLETED|Second Wear Period (8 -0/+3 Days)||0
6767340|NCT04529109|7694413|FG000|STARTED|Period 1||27
6767341|NCT04529109|7694414|FG001|STARTED|Period 1||29
6767342|NCT04529109|7694413|FG000|COMPLETED|Period 1||27
6767343|NCT04529109|7694414|FG001|COMPLETED|Period 1||28
6767344|NCT04529109|7694413|FG000|NOT COMPLETED|Period 1||0
6767345|NCT04529109|7694414|FG001|NOT COMPLETED|Period 1||1
6767346|NCT04529109|7694413|FG000|STARTED|Period 2||27
6767347|NCT04529109|7694414|FG001|STARTED|Period 2||28
6767348|NCT04529109|7694413|FG000|COMPLETED|Period 2||27
6767349|NCT04529109|7694414|FG001|COMPLETED|Period 2||28
6767350|NCT04529109|7694413|FG000|NOT COMPLETED|Period 2||0
6767351|NCT04529109|7694414|FG001|NOT COMPLETED|Period 2||0
6767352|NCT04536571|7694420|FG000|STARTED|First Intervention||11
6767353|NCT04536571|7694421|FG001|STARTED|First Intervention||16
6767354|NCT04536571|7694420|FG000|COMPLETED|First Intervention||11
6767355|NCT04536571|7694421|FG001|COMPLETED|First Intervention||16
6767356|NCT04536571|7694420|FG000|NOT COMPLETED|First Intervention||0
6767357|NCT04536571|7694421|FG001|NOT COMPLETED|First Intervention||0
6767358|NCT04536571|7694420|FG000|STARTED|Second Intervention||11
6767359|NCT04536571|7694421|FG001|STARTED|Second Intervention||16
6767360|NCT04536571|7694420|FG000|COMPLETED|Second Intervention||11
6767361|NCT04536571|7694421|FG001|COMPLETED|Second Intervention||16
6767362|NCT04536571|7694420|FG000|NOT COMPLETED|Second Intervention||0
6767363|NCT04536571|7694421|FG001|NOT COMPLETED|Second Intervention||0
6767364|NCT04544787|7694438|FG000|STARTED|Overall Study||50
6767365|NCT04544787|7694439|FG001|STARTED|Overall Study||50
6767366|NCT04544787|7694440|FG002|STARTED|Overall Study||50
6767367|NCT04544787|7694441|FG003|STARTED|Overall Study||50
6767368|NCT04544787|7694442|FG004|STARTED|Overall Study||17
6767369|NCT04544787|7694443|FG005|STARTED|Overall Study||16
6767370|NCT04544787|7694444|FG006|STARTED|Overall Study||17
6767371|NCT04544787|7694438|FG000|Received First Dose of Vaccine|Overall Study||50
6767372|NCT04544787|7694439|FG001|Received First Dose of Vaccine|Overall Study||50
6767373|NCT04544787|7694440|FG002|Received First Dose of Vaccine|Overall Study||50
6767374|NCT04544787|7694441|FG003|Received First Dose of Vaccine|Overall Study||50
6767375|NCT04544787|7694442|FG004|Received First Dose of Vaccine|Overall Study||17
6767376|NCT04544787|7694443|FG005|Received First Dose of Vaccine|Overall Study||16
6767377|NCT04544787|7694444|FG006|Received First Dose of Vaccine|Overall Study||17
6767378|NCT04544787|7694438|FG000|Received Second Dose of Vaccine|Overall Study||0
6767379|NCT04544787|7694439|FG001|Received Second Dose of Vaccine|Overall Study||49
6767380|NCT04544787|7694440|FG002|Received Second Dose of Vaccine|Overall Study||0
6767381|NCT04544787|7694441|FG003|Received Second Dose of Vaccine|Overall Study||49
6767382|NCT04544787|7694442|FG004|Received Second Dose of Vaccine|Overall Study||17
6767383|NCT04544787|7694443|FG005|Received Second Dose of Vaccine|Overall Study||15
6767384|NCT04544787|7694444|FG006|Received Second Dose of Vaccine|Overall Study||16
6767385|NCT04544787|7694438|FG000|COMPLETED|Overall Study||50
6767386|NCT04544787|7694439|FG001|COMPLETED|Overall Study||50
6767387|NCT04544787|7694440|FG002|COMPLETED|Overall Study||50
6767388|NCT04544787|7694441|FG003|COMPLETED|Overall Study||50
6767389|NCT04544787|7694442|FG004|COMPLETED|Overall Study||17
6767390|NCT04544787|7694443|FG005|COMPLETED|Overall Study||16
6767391|NCT04544787|7694444|FG006|COMPLETED|Overall Study||17
6767392|NCT04544787|7694438|FG000|NOT COMPLETED|Overall Study||0
6767393|NCT04544787|7694439|FG001|NOT COMPLETED|Overall Study||0
6767394|NCT04544787|7694440|FG002|NOT COMPLETED|Overall Study||0
6767395|NCT04544787|7694441|FG003|NOT COMPLETED|Overall Study||0
6767396|NCT04544787|7694442|FG004|NOT COMPLETED|Overall Study||0
6767397|NCT04544787|7694443|FG005|NOT COMPLETED|Overall Study||0
6767398|NCT04544787|7694444|FG006|NOT COMPLETED|Overall Study||0
6767399|NCT04555031|7694483|FG000|STARTED|Overall Study||10
6767400|NCT04555031|7694483|FG000|COMPLETED|Overall Study||10
6767401|NCT04555031|7694483|FG000|NOT COMPLETED|Overall Study||0
6767402|NCT04559282|7694490|FG000|STARTED|Intervention 1 (Day 0)||8
6767403|NCT04559282|7694491|FG001|STARTED|Intervention 1 (Day 0)||8
6767404|NCT04559282|7694490|FG000|COMPLETED|Intervention 1 (Day 0)||8
6767405|NCT04559282|7694491|FG001|COMPLETED|Intervention 1 (Day 0)||8
6767406|NCT04559282|7694490|FG000|NOT COMPLETED|Intervention 1 (Day 0)||0
6767407|NCT04559282|7694491|FG001|NOT COMPLETED|Intervention 1 (Day 0)||0
6767408|NCT04559282|7694490|FG000|STARTED|Intervention 2 (Day 7)||8
6767409|NCT04559282|7694491|FG001|STARTED|Intervention 2 (Day 7)||8
6767410|NCT04559282|7694490|FG000|COMPLETED|Intervention 2 (Day 7)||8
6767411|NCT04559282|7694491|FG001|COMPLETED|Intervention 2 (Day 7)||8
6767412|NCT04559282|7694490|FG000|NOT COMPLETED|Intervention 2 (Day 7)||0
6767413|NCT04559282|7694491|FG001|NOT COMPLETED|Intervention 2 (Day 7)||0
6767414|NCT04559282|7694490|FG000|STARTED|Intervention 3 (Day 14)||8
6767415|NCT04559282|7694491|FG001|STARTED|Intervention 3 (Day 14)||8
6767416|NCT04559282|7694490|FG000|COMPLETED|Intervention 3 (Day 14)||8
6767417|NCT04559282|7694491|FG001|COMPLETED|Intervention 3 (Day 14)||8
6767418|NCT04559282|7694490|FG000|NOT COMPLETED|Intervention 3 (Day 14)||0
6767419|NCT04559282|7694491|FG001|NOT COMPLETED|Intervention 3 (Day 14)||0
6767420|NCT04574297|7694504|FG000|STARTED|Overall Study||180
6767421|NCT04574297|7694505|FG001|STARTED|Overall Study||263
6767422|NCT04574297|7694506|FG002|STARTED|Overall Study||230
6767423|NCT04574297|7694507|FG003|STARTED|Overall Study||125
6767424|NCT04574297|7694504|FG000|COMPLETED|Overall Study||180
6767425|NCT04574297|7694505|FG001|COMPLETED|Overall Study||263
6767426|NCT04574297|7694506|FG002|COMPLETED|Overall Study||230
6767427|NCT04574297|7694507|FG003|COMPLETED|Overall Study||125
6767428|NCT04574297|7694504|FG000|NOT COMPLETED|Overall Study||0
6767429|NCT04574297|7694505|FG001|NOT COMPLETED|Overall Study||0
6767430|NCT04574297|7694506|FG002|NOT COMPLETED|Overall Study||0
6767431|NCT04574297|7694507|FG003|NOT COMPLETED|Overall Study||0
6767432|NCT04580290|7694519|FG000|STARTED|Overall Study||88
6767433|NCT04580290|7694520|FG001|STARTED|Overall Study||32
6767434|NCT04580290|7694519|FG000|COMPLETED|Overall Study||88
6767435|NCT04580290|7694520|FG001|COMPLETED|Overall Study||32
6767436|NCT04580290|7694519|FG000|NOT COMPLETED|Overall Study||0
6556470|NCT01760447|7478826|FG002|STARTED|Weeks 20-54||42
6556471|NCT01760447|7478827|FG003|STARTED|Weeks 20-54||47
6556472|NCT01760447|7478824|FG000|COMPLETED|Weeks 20-54||25
6556473|NCT01760447|7478825|FG001|COMPLETED|Weeks 20-54||28
6767437|NCT04580290|7694520|FG001|NOT COMPLETED|Overall Study||0
6767438|NCT04601103|7694529|FG000|STARTED|Overall Study||18
6767439|NCT04601103|7694530|FG001|STARTED|Overall Study||18
6767440|NCT04601103|7694531|FG002|STARTED|Overall Study||17
6767441|NCT04601103|7694529|FG000|COMPLETED|Overall Study||0
6767442|NCT04601103|7694530|FG001|COMPLETED|Overall Study||0
6767443|NCT04601103|7694531|FG002|COMPLETED|Overall Study||0
6767444|NCT04601103|7694529|FG000|NOT COMPLETED|Overall Study||18
6767445|NCT04601103|7694530|FG001|NOT COMPLETED|Overall Study||18
6767446|NCT04601103|7694531|FG002|NOT COMPLETED|Overall Study||17
6767447|NCT04617574|7694541|FG000|STARTED|Overall Study||30
6767448|NCT04617574|7694542|FG001|STARTED|Overall Study||30
6767449|NCT04617574|7694541|FG000|COMPLETED|Overall Study||30
6767450|NCT04617574|7694542|FG001|COMPLETED|Overall Study||30
6767451|NCT04617574|7694541|FG000|NOT COMPLETED|Overall Study||0
6767452|NCT04617574|7694542|FG001|NOT COMPLETED|Overall Study||0
6767453|NCT04658797|7694550|FG000|STARTED|Overall Study||15
6767454|NCT04658797|7694551|FG001|STARTED|Overall Study||15
6767455|NCT04658797|7694550|FG000|COMPLETED|Overall Study||15
6767456|NCT04658797|7694551|FG001|COMPLETED|Overall Study||15
6767457|NCT04658797|7694550|FG000|NOT COMPLETED|Overall Study||0
6767458|NCT04658797|7694551|FG001|NOT COMPLETED|Overall Study||0
6767459|NCT04664855|7694559|FG000|STARTED|Overall Study||23
6767460|NCT04664855|7694560|FG001|STARTED|Overall Study||24
6767461|NCT04664855|7694559|FG000|COMPLETED|Overall Study||23
6767462|NCT04664855|7694560|FG001|COMPLETED|Overall Study||22
6767463|NCT04664855|7694559|FG000|NOT COMPLETED|Overall Study||0
6767464|NCT04664855|7694560|FG001|NOT COMPLETED|Overall Study||2
6767465|NCT04701658|7694566|FG000|STARTED|Overall Study||109
6767466|NCT04701658|7694566|FG000|Received Single Dose of Bamlanivimab|Overall Study||109
6767467|NCT04701658|7694566|FG000|COMPLETED|Overall Study||103
6767468|NCT04701658|7694566|FG000|NOT COMPLETED|Overall Study||6
6767469|NCT04706416|7694572|FG000|STARTED|Overall Study||50
6767470|NCT04706416|7694573|FG001|STARTED|Overall Study||100
6767471|NCT04706416|7694572|FG000|COMPLETED|Overall Study||48
6767472|NCT04706416|7694573|FG001|COMPLETED|Overall Study||100
6556474|NCT01760447|7478826|FG002|COMPLETED|Weeks 20-54||39
6767473|NCT04706416|7694572|FG000|NOT COMPLETED|Overall Study||2
6767474|NCT04706416|7694573|FG001|NOT COMPLETED|Overall Study||0
6767475|NCT04709484|7694584|FG000|STARTED|Overall Study||34
6767476|NCT04709484|7694585|FG001|STARTED|Overall Study||32
6767477|NCT04709484|7694584|FG000|COMPLETED|Overall Study||34
6767478|NCT04709484|7694585|FG001|COMPLETED|Overall Study||32
6767479|NCT04709484|7694584|FG000|NOT COMPLETED|Overall Study||0
6767480|NCT04709484|7694585|FG001|NOT COMPLETED|Overall Study||0
6767481|NCT04727749|7694593|FG000|STARTED|Overall Study||107
6767482|NCT04727749|7694594|FG001|STARTED|Overall Study||104
6767483|NCT04727749|7694593|FG000|COMPLETED|Overall Study||97
6767484|NCT04727749|7694594|FG001|COMPLETED|Overall Study||101
6767485|NCT04727749|7694593|FG000|NOT COMPLETED|Overall Study||10
6767486|NCT04727749|7694594|FG001|NOT COMPLETED|Overall Study||3
6767487|NCT04777214|7694604|FG000|STARTED|Initial Randomization||5
6767488|NCT04777214|7694605|FG001|STARTED|Initial Randomization||5
6767489|NCT04777214|7694604|FG000|COMPLETED|Initial Randomization||5
6767490|NCT04777214|7694605|FG001|COMPLETED|Initial Randomization||5
6767491|NCT04777214|7694604|FG000|NOT COMPLETED|Initial Randomization||0
6767492|NCT04777214|7694605|FG001|NOT COMPLETED|Initial Randomization||0
6767493|NCT04777214|7694604|FG000|STARTED|Sham Crossover to Active TMS Arm||0
6767494|NCT04777214|7694605|FG001|STARTED|Sham Crossover to Active TMS Arm||5
6767495|NCT04777214|7694604|FG000|COMPLETED|Sham Crossover to Active TMS Arm||0
6767496|NCT04777214|7694605|FG001|COMPLETED|Sham Crossover to Active TMS Arm||5
6767497|NCT04777214|7694604|FG000|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
6767498|NCT04777214|7694605|FG001|NOT COMPLETED|Sham Crossover to Active TMS Arm||0
6767499|NCT04854707|7694616|FG000|STARTED|Overall Study||2625
6767500|NCT04854707|7694617|FG001|STARTED|Overall Study||2183
6767501|NCT04854707|7694618|FG002|STARTED|Overall Study||676
6767502|NCT04854707|7694616|FG000|COMPLETED|Overall Study||2547
6767503|NCT04854707|7694617|FG001|COMPLETED|Overall Study||2124
6767504|NCT04854707|7694618|FG002|COMPLETED|Overall Study||646
6767505|NCT04854707|7694616|FG000|NOT COMPLETED|Overall Study||78
6767506|NCT04854707|7694617|FG001|NOT COMPLETED|Overall Study||59
6767507|NCT04854707|7694618|FG002|NOT COMPLETED|Overall Study||30
6767508|NCT04898166|7694632|FG000|STARTED|Overall Study||220
6767509|NCT04898166|7694633|FG001|STARTED|Overall Study||80
6767510|NCT04898166|7694632|FG000|COMPLETED|Overall Study||220
6767511|NCT04898166|7694633|FG001|COMPLETED|Overall Study||80
6767512|NCT04898166|7694632|FG000|NOT COMPLETED|Overall Study||0
6767513|NCT04898166|7694633|FG001|NOT COMPLETED|Overall Study||0
6767514|NCT04926233|7694653|FG000|STARTED|Overall Study||1280486
6767515|NCT04926233|7694654|FG001|STARTED|Overall Study||90660
6767516|NCT04926233|7694653|FG000|COMPLETED|Overall Study||1280486
6767517|NCT04926233|7694654|FG001|COMPLETED|Overall Study||90660
6767518|NCT04926233|7694653|FG000|NOT COMPLETED|Overall Study||0
6767519|NCT04926233|7694654|FG001|NOT COMPLETED|Overall Study||0
6767520|NCT04943159|7694706|FG000|STARTED|Overall Study||3
6767521|NCT04943159|7694706|FG000|COMPLETED|Overall Study||3
6767522|NCT04943159|7694706|FG000|NOT COMPLETED|Overall Study||0
6767523|NCT04947436|7694713|FG000|STARTED|Overall Study||7
6767524|NCT04947436|7694714|FG001|STARTED|Overall Study||10
6767525|NCT04947436|7694715|FG002|STARTED|Overall Study||11
6767526|NCT04947436|7694713|FG000|COMPLETED|Overall Study||3
6767527|NCT04947436|7694714|FG001|COMPLETED|Overall Study||2
6767528|NCT04947436|7694715|FG002|COMPLETED|Overall Study||5
6767529|NCT04947436|7694713|FG000|NOT COMPLETED|Overall Study||4
6767530|NCT04947436|7694714|FG001|NOT COMPLETED|Overall Study||8
6767531|NCT04947436|7694715|FG002|NOT COMPLETED|Overall Study||6
6767532|NCT05002972|7694723|FG000|STARTED|Overall Study||63
6767533|NCT05002972|7694723|FG000|COMPLETED|Overall Study||61
6767534|NCT05002972|7694723|FG000|NOT COMPLETED|Overall Study||2
6767535|NCT05002985|7694727|FG000|STARTED|Overall Study||49
6767536|NCT05002985|7694727|FG000|COMPLETED|Overall Study||48
6767537|NCT05002985|7694727|FG000|NOT COMPLETED|Overall Study||1
6767538|NCT04512482|7694733|FG000|STARTED|First Intervention (1 Day)||24
6767539|NCT04512482|7694734|FG001|STARTED|First Intervention (1 Day)||21
6767540|NCT04512482|7694733|FG000|Baseline Plaque Assessment|First Intervention (1 Day)||24
6767541|NCT04512482|7694734|FG001|Baseline Plaque Assessment|First Intervention (1 Day)||21
6767542|NCT04512482|7694733|FG000|Baseline Photographs|First Intervention (1 Day)||24
6767543|NCT04512482|7694734|FG001|Baseline Photographs|First Intervention (1 Day)||21
6767544|NCT04512482|7694733|FG000|Received Rinse Intervention|First Intervention (1 Day)||24
6767545|NCT04512482|7694734|FG001|Received Rinse Intervention|First Intervention (1 Day)||21
6767546|NCT04512482|7694733|FG000|Post-rinse Photographs|First Intervention (1 Day)||24
6767547|NCT04512482|7694734|FG001|Post-rinse Photographs|First Intervention (1 Day)||21
6767548|NCT04512482|7694733|FG000|Toothbrush Utilization|First Intervention (1 Day)||24
6767549|NCT04512482|7694734|FG001|Toothbrush Utilization|First Intervention (1 Day)||21
6767550|NCT04512482|7694733|FG000|Post-toothbrush Photographs|First Intervention (1 Day)||24
6767551|NCT04512482|7694734|FG001|Post-toothbrush Photographs|First Intervention (1 Day)||21
6767552|NCT04512482|7694733|FG000|Waterpik Utilization|First Intervention (1 Day)||24
6767553|NCT04512482|7694734|FG001|Waterpik Utilization|First Intervention (1 Day)||21
6767554|NCT04512482|7694733|FG000|Post-Waterpik Photographs|First Intervention (1 Day)||24
6767555|NCT04512482|7694734|FG001|Post-Waterpik Photographs|First Intervention (1 Day)||21
6767556|NCT04512482|7694733|FG000|COMPLETED|First Intervention (1 Day)||24
6767557|NCT04512482|7694734|FG001|COMPLETED|First Intervention (1 Day)||21
6767558|NCT04512482|7694733|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6767559|NCT04512482|7694734|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6767560|NCT04512482|7694733|FG000|STARTED|Washout (1 Week)||24
6767561|NCT04512482|7694734|FG001|STARTED|Washout (1 Week)||21
6767562|NCT04512482|7694733|FG000|COMPLETED|Washout (1 Week)||24
6767563|NCT04512482|7694734|FG001|COMPLETED|Washout (1 Week)||21
6767564|NCT04512482|7694733|FG000|NOT COMPLETED|Washout (1 Week)||0
6767565|NCT04512482|7694734|FG001|NOT COMPLETED|Washout (1 Week)||0
6767566|NCT04512482|7694733|FG000|STARTED|Second Intervention (1 Day)||24
6556475|NCT01760447|7478827|FG003|COMPLETED|Weeks 20-54||43
6556476|NCT01760447|7478824|FG000|NOT COMPLETED|Weeks 20-54||3
6556477|NCT01760447|7478825|FG001|NOT COMPLETED|Weeks 20-54||2
6767567|NCT04512482|7694734|FG001|STARTED|Second Intervention (1 Day)||21
6767568|NCT04512482|7694733|FG000|Baseline Plaque Assessment|Second Intervention (1 Day)||22
6767569|NCT04512482|7694734|FG001|Baseline Plaque Assessment|Second Intervention (1 Day)||20
6767570|NCT04512482|7694733|FG000|Baseline Photographs|Second Intervention (1 Day)||22
6767571|NCT04512482|7694734|FG001|Baseline Photographs|Second Intervention (1 Day)||20
6767572|NCT04512482|7694733|FG000|Received Intervention|Second Intervention (1 Day)||22
6767573|NCT04512482|7694734|FG001|Received Intervention|Second Intervention (1 Day)||20
6767574|NCT04512482|7694733|FG000|Post-rinse Photographs|Second Intervention (1 Day)||22
6767575|NCT04512482|7694734|FG001|Post-rinse Photographs|Second Intervention (1 Day)||20
6767576|NCT04512482|7694733|FG000|Toothbrush Utilization|Second Intervention (1 Day)||22
6767577|NCT04512482|7694734|FG001|Toothbrush Utilization|Second Intervention (1 Day)||20
6767578|NCT04512482|7694733|FG000|Post-toothbrush Photographs|Second Intervention (1 Day)||22
6767579|NCT04512482|7694734|FG001|Post-toothbrush Photographs|Second Intervention (1 Day)||20
6767580|NCT04512482|7694733|FG000|Waterpik Utilization|Second Intervention (1 Day)||22
6767581|NCT04512482|7694734|FG001|Waterpik Utilization|Second Intervention (1 Day)||20
6767582|NCT04512482|7694733|FG000|Post-Waterpik Photographs|Second Intervention (1 Day)||22
6556478|NCT01760447|7478826|FG002|NOT COMPLETED|Weeks 20-54||3
6556479|NCT01760447|7478827|FG003|NOT COMPLETED|Weeks 20-54||4
6556480|NCT01760473|7478843|FG000|STARTED|Overall Study||27
6767583|NCT04512482|7694734|FG001|Post-Waterpik Photographs|Second Intervention (1 Day)||20
6767584|NCT04512482|7694733|FG000|COMPLETED|Second Intervention (1 Day)||22
6767585|NCT04512482|7694734|FG001|COMPLETED|Second Intervention (1 Day)||20
6767586|NCT04512482|7694733|FG000|NOT COMPLETED|Second Intervention (1 Day)||2
6767587|NCT04512482|7694734|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
6767588|NCT04499599|7694743|FG000|STARTED|Overall Study||35
6767589|NCT04499599|7694744|FG001|STARTED|Overall Study||35
6767590|NCT04499599|7694745|FG002|STARTED|Overall Study||35
6767591|NCT04499599|7694743|FG000|COMPLETED|Overall Study||35
6767592|NCT04499599|7694744|FG001|COMPLETED|Overall Study||35
6767593|NCT04499599|7694745|FG002|COMPLETED|Overall Study||35
6767594|NCT04499599|7694743|FG000|NOT COMPLETED|Overall Study||0
6767595|NCT04499599|7694744|FG001|NOT COMPLETED|Overall Study||0
6767596|NCT04499599|7694745|FG002|NOT COMPLETED|Overall Study||0
6767597|NCT04525157|7694753|FG000|STARTED|Overall Study||18
6767598|NCT04525157|7694753|FG000|COMPLETED|Overall Study||15
6767599|NCT04525157|7694753|FG000|NOT COMPLETED|Overall Study||3
6767600|NCT04523831|7694759|FG000|STARTED|Overall Study||200
6767601|NCT04523831|7694760|FG001|STARTED|Overall Study||200
6767602|NCT04523831|7694759|FG000|COMPLETED|Overall Study||183
6767603|NCT04523831|7694760|FG001|COMPLETED|Overall Study||180
6767604|NCT04523831|7694759|FG000|NOT COMPLETED|Overall Study||17
6767605|NCT04523831|7694760|FG001|NOT COMPLETED|Overall Study||20
6767606|NCT04521777|7694769|FG000|STARTED|Overall Study||24
6767607|NCT04521777|7694769|FG000|COMPLETED|Overall Study||20
6767608|NCT04521777|7694769|FG000|NOT COMPLETED|Overall Study||4
6767609|NCT04512703|7694775|FG000|STARTED|Within 7 Days From Start of Device Wear||6
6767610|NCT04512703|7694776|FG001|STARTED|Within 7 Days From Start of Device Wear||45
6767611|NCT04512703|7694775|FG000|Wore Front Position|Within 7 Days From Start of Device Wear||6
6767612|NCT04512703|7694776|FG001|Wore Front Position|Within 7 Days From Start of Device Wear||45
6767613|NCT04512703|7694775|FG000|Wore Side Position|Within 7 Days From Start of Device Wear||6
6767614|NCT04512703|7694776|FG001|Wore Side Position|Within 7 Days From Start of Device Wear||45
6767615|NCT04512703|7694775|FG000|COMPLETED|Within 7 Days From Start of Device Wear||6
6767616|NCT04512703|7694776|FG001|COMPLETED|Within 7 Days From Start of Device Wear||45
6767617|NCT04512703|7694775|FG000|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
6767618|NCT04512703|7694776|FG001|NOT COMPLETED|Within 7 Days From Start of Device Wear||0
6767619|NCT04512703|7694775|FG000|STARTED|Between 7th and 90th Day of Device Wear||6
6767620|NCT04512703|7694776|FG001|STARTED|Between 7th and 90th Day of Device Wear||45
6767621|NCT04512703|7694775|FG000|Wore Side Position Device|Between 7th and 90th Day of Device Wear||3
6767622|NCT04512703|7694776|FG001|Wore Side Position Device|Between 7th and 90th Day of Device Wear||23
6767623|NCT04512703|7694775|FG000|Wore Front Position Device|Between 7th and 90th Day of Device Wear||3
6767624|NCT04512703|7694776|FG001|Wore Front Position Device|Between 7th and 90th Day of Device Wear||22
6767625|NCT04512703|7694775|FG000|COMPLETED|Between 7th and 90th Day of Device Wear||6
6767626|NCT04512703|7694776|FG001|COMPLETED|Between 7th and 90th Day of Device Wear||45
6767627|NCT04512703|7694775|FG000|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
6767628|NCT04512703|7694776|FG001|NOT COMPLETED|Between 7th and 90th Day of Device Wear||0
6767629|NCT04511520|7694788|FG000|STARTED|Overall Study||24
6767630|NCT04511520|7694789|FG001|STARTED|Overall Study||24
6767631|NCT04511520|7694790|FG002|STARTED|Overall Study||24
6767632|NCT04511520|7694788|FG000|COMPLETED|Overall Study||24
6767633|NCT04511520|7694789|FG001|COMPLETED|Overall Study||24
6767634|NCT04511520|7694790|FG002|COMPLETED|Overall Study||24
6767635|NCT04511520|7694788|FG000|NOT COMPLETED|Overall Study||0
6767636|NCT04511520|7694789|FG001|NOT COMPLETED|Overall Study||0
6767637|NCT04511520|7694790|FG002|NOT COMPLETED|Overall Study||0
6767638|NCT04507776|7694799|FG000|STARTED|Overall Study||763
6767639|NCT04507776|7694799|FG000|COMPLETED|Overall Study||562
6767640|NCT04507776|7694799|FG000|NOT COMPLETED|Overall Study||201
6767641|NCT04502979|7694810|FG000|STARTED|Overall Study||37
6767642|NCT04502979|7694811|FG001|STARTED|Overall Study||34
6767643|NCT04502979|7694810|FG000|COMPLETED|Overall Study||34
6767644|NCT04502979|7694811|FG001|COMPLETED|Overall Study||30
6767645|NCT04502979|7694810|FG000|NOT COMPLETED|Overall Study||3
6767646|NCT04502979|7694811|FG001|NOT COMPLETED|Overall Study||4
6767647|NCT04502056|7694819|FG000|STARTED|Overall Study||2046
6767648|NCT04502056|7694820|FG001|STARTED|Overall Study||2044
6767649|NCT04502056|7694821|FG002|STARTED|Overall Study||2045
6767650|NCT04502056|7694822|FG003|STARTED|Overall Study||2046
6767651|NCT04502056|7694823|FG004|STARTED|Overall Study||2044
6767652|NCT04502056|7694824|FG005|STARTED|Overall Study||2052
6767653|NCT04502056|7694825|FG006|STARTED|Overall Study||2046
6767654|NCT04502056|7694826|FG007|STARTED|Overall Study||2043
6767655|NCT04502056|7694827|FG008|STARTED|Overall Study||1026
6767656|NCT04502056|7694828|FG009|STARTED|Overall Study||1025
6767657|NCT04502056|7694829|FG010|STARTED|Overall Study||1023
6767658|NCT04502056|7694830|FG011|STARTED|Overall Study||1020
6767659|NCT04502056|7694819|FG000|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1859
6767660|NCT04502056|7694820|FG001|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1881
6767661|NCT04502056|7694821|FG002|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1879
6767662|NCT04502056|7694822|FG003|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1886
6767663|NCT04502056|7694823|FG004|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1846
6780495|NCT02991430|7708969|FG000|STARTED|Treatment Period 1||14
6767664|NCT04502056|7694824|FG005|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1877
6767665|NCT04502056|7694825|FG006|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1888
6767666|NCT04502056|7694826|FG007|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||1883
6767667|NCT04502056|7694827|FG008|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||947
6767668|NCT04502056|7694828|FG009|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||942
6767669|NCT04502056|7694829|FG010|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||946
6767670|NCT04502056|7694830|FG011|Completed the Knowledge Questions, Included for the Knowledge Gaps Analysis|Overall Study||928
6767671|NCT04502056|7694819|FG000|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1799
6767672|NCT04502056|7694820|FG001|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1828
6767673|NCT04502056|7694821|FG002|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1830
6767674|NCT04502056|7694822|FG003|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1835
6767675|NCT04502056|7694823|FG004|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1792
6767676|NCT04502056|7694824|FG005|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1820
6767677|NCT04502056|7694825|FG006|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1821
6767678|NCT04502056|7694826|FG007|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||1844
6767679|NCT04502056|7694827|FG008|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||914
6767680|NCT04502056|7694828|FG009|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||912
6767681|NCT04502056|7694829|FG010|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||928
6767682|NCT04502056|7694830|FG011|Completed the Entire Survey, Included for All Analysis Besides Knowledge Gaps, Except Follow-up|Overall Study||900
6767683|NCT04502056|7694819|FG000|Completed the Follow-up Survey|Overall Study||608
6767684|NCT04502056|7694820|FG001|Completed the Follow-up Survey|Overall Study||607
6767685|NCT04502056|7694821|FG002|Completed the Follow-up Survey|Overall Study||591
6767686|NCT04502056|7694822|FG003|Completed the Follow-up Survey|Overall Study||601
6767687|NCT04502056|7694823|FG004|Completed the Follow-up Survey|Overall Study||631
6767688|NCT04502056|7694824|FG005|Completed the Follow-up Survey|Overall Study||598
6767689|NCT04502056|7694825|FG006|Completed the Follow-up Survey|Overall Study||607
6767690|NCT04502056|7694826|FG007|Completed the Follow-up Survey|Overall Study||607
6767691|NCT04502056|7694827|FG008|Completed the Follow-up Survey|Overall Study||301
6767692|NCT04502056|7694828|FG009|Completed the Follow-up Survey|Overall Study||313
6767693|NCT04502056|7694829|FG010|Completed the Follow-up Survey|Overall Study||291
6767694|NCT04502056|7694830|FG011|Completed the Follow-up Survey|Overall Study||316
6767695|NCT04502056|7694819|FG000|COMPLETED|Overall Study||604
6767696|NCT04502056|7694820|FG001|COMPLETED|Overall Study||602
6767697|NCT04502056|7694821|FG002|COMPLETED|Overall Study||586
6767698|NCT04502056|7694822|FG003|COMPLETED|Overall Study||597
6767699|NCT04502056|7694823|FG004|COMPLETED|Overall Study||626
6767700|NCT04502056|7694824|FG005|COMPLETED|Overall Study||596
6767701|NCT04502056|7694825|FG006|COMPLETED|Overall Study||605
6767702|NCT04502056|7694826|FG007|COMPLETED|Overall Study||603
6767703|NCT04502056|7694827|FG008|COMPLETED|Overall Study||298
6767704|NCT04502056|7694828|FG009|COMPLETED|Overall Study||311
6767705|NCT04502056|7694829|FG010|COMPLETED|Overall Study||288
6767706|NCT04502056|7694830|FG011|COMPLETED|Overall Study||614
6767707|NCT04502056|7694819|FG000|NOT COMPLETED|Overall Study||1442
6767708|NCT04502056|7694820|FG001|NOT COMPLETED|Overall Study||1442
6767709|NCT04502056|7694821|FG002|NOT COMPLETED|Overall Study||1459
6767710|NCT04502056|7694822|FG003|NOT COMPLETED|Overall Study||1449
6767711|NCT04502056|7694823|FG004|NOT COMPLETED|Overall Study||1418
6767712|NCT04502056|7694824|FG005|NOT COMPLETED|Overall Study||1456
6767713|NCT04502056|7694825|FG006|NOT COMPLETED|Overall Study||1441
6767714|NCT04502056|7694826|FG007|NOT COMPLETED|Overall Study||1440
6767715|NCT04502056|7694827|FG008|NOT COMPLETED|Overall Study||728
6767716|NCT04502056|7694828|FG009|NOT COMPLETED|Overall Study||714
6767717|NCT04502056|7694829|FG010|NOT COMPLETED|Overall Study||735
6767718|NCT04502056|7694830|FG011|NOT COMPLETED|Overall Study||406
6767719|NCT04498403|7694854|FG000|STARTED|Overall Study||30
6767720|NCT04498403|7694855|FG001|STARTED|Overall Study||10
6767721|NCT04498403|7694854|FG000|Completed Follow up|Overall Study||30
6767722|NCT04498403|7694855|FG001|Completed Follow up|Overall Study||10
6767723|NCT04498403|7694854|FG000|COMPLETED|Overall Study||0
6767724|NCT04498403|7694855|FG001|COMPLETED|Overall Study||0
6767725|NCT04498403|7694854|FG000|NOT COMPLETED|Overall Study||30
6767726|NCT04498403|7694855|FG001|NOT COMPLETED|Overall Study||10
6767727|NCT04495374|7694863|FG000|STARTED|Overall Study||30
6767728|NCT04495374|7694864|FG001|STARTED|Overall Study||28
6767729|NCT04495374|7694863|FG000|COMPLETED|Overall Study||28
6767730|NCT04495374|7694864|FG001|COMPLETED|Overall Study||27
6767731|NCT04495374|7694863|FG000|NOT COMPLETED|Overall Study||2
6767732|NCT04495374|7694864|FG001|NOT COMPLETED|Overall Study||1
6767733|NCT04495712|7694872|FG000|STARTED|Overall Study||44
6767734|NCT04495712|7694873|FG001|STARTED|Overall Study||46
6767735|NCT04495712|7694872|FG000|COMPLETED|Overall Study||44
6767736|NCT04495712|7694873|FG001|COMPLETED|Overall Study||46
6767737|NCT04495712|7694872|FG000|NOT COMPLETED|Overall Study||0
6767738|NCT04495712|7694873|FG001|NOT COMPLETED|Overall Study||0
6767739|NCT04492397|7694879|FG000|STARTED|First Intervention||17
6767740|NCT04492397|7694880|FG001|STARTED|First Intervention||18
6767741|NCT04492397|7694879|FG000|COMPLETED|First Intervention||17
6767742|NCT04492397|7694880|FG001|COMPLETED|First Intervention||18
6767743|NCT04492397|7694879|FG000|NOT COMPLETED|First Intervention||0
6767744|NCT04492397|7694880|FG001|NOT COMPLETED|First Intervention||0
6767745|NCT04492397|7694879|FG000|STARTED|Second Intervention||17
6767746|NCT04492397|7694880|FG001|STARTED|Second Intervention||18
6767747|NCT04492397|7694879|FG000|COMPLETED|Second Intervention||17
6767748|NCT04492397|7694880|FG001|COMPLETED|Second Intervention||18
6767749|NCT04492397|7694879|FG000|NOT COMPLETED|Second Intervention||0
6767750|NCT04492397|7694880|FG001|NOT COMPLETED|Second Intervention||0
6767751|NCT04491994|7694888|FG000|STARTED|Overall Study||180
6767752|NCT04491994|7694889|FG001|STARTED|Overall Study||360
6767753|NCT04491994|7694888|FG000|COMPLETED|Overall Study||151
6767754|NCT04491994|7694889|FG001|COMPLETED|Overall Study||349
6767755|NCT04491994|7694888|FG000|NOT COMPLETED|Overall Study||29
6767756|NCT04491994|7694889|FG001|NOT COMPLETED|Overall Study||11
6767757|NCT04491240|7694898|FG000|STARTED|Overall Study||10
6767758|NCT04491240|7694899|FG001|STARTED|Overall Study||10
6767759|NCT04491240|7694900|FG002|STARTED|Overall Study||10
6767760|NCT04491240|7694898|FG000|COMPLETED|Overall Study||10
6767761|NCT04491240|7694899|FG001|COMPLETED|Overall Study||10
6767762|NCT04491240|7694900|FG002|COMPLETED|Overall Study||10
6767763|NCT04491240|7694898|FG000|NOT COMPLETED|Overall Study||0
6767764|NCT04491240|7694899|FG001|NOT COMPLETED|Overall Study||0
6767765|NCT04491240|7694900|FG002|NOT COMPLETED|Overall Study||0
6767766|NCT04490863|7694908|FG000|STARTED|Overall Study||26
6767767|NCT04490863|7694908|FG000|COMPLETED|Overall Study||26
6767768|NCT04490863|7694908|FG000|NOT COMPLETED|Overall Study||0
6767769|NCT04490499|7694912|FG000|STARTED|Overall Study||207
6767770|NCT04490499|7694912|FG000|Vaccinated|Overall Study||205
6767771|NCT04490499|7694912|FG000|COMPLETED|Overall Study||205
6767772|NCT04490499|7694912|FG000|NOT COMPLETED|Overall Study||2
6767773|NCT04490239|7694916|FG000|STARTED|1000 U Acute (One Dose, Day 1)||6
6767774|NCT04490239|7694916|FG000|COMPLETED|1000 U Acute (One Dose, Day 1)||6
6767775|NCT04490239|7694916|FG000|NOT COMPLETED|1000 U Acute (One Dose, Day 1)||0
6767776|NCT04490239|7694916|FG000|STARTED|2000 U Acute (One Dose, Day 3)||6
6767777|NCT04490239|7694916|FG000|COMPLETED|2000 U Acute (One Dose, Day 3)||6
6767778|NCT04490239|7694916|FG000|NOT COMPLETED|2000 U Acute (One Dose, Day 3)||0
6767779|NCT04490239|7694916|FG000|STARTED|2000 U Chronic (Daily, 14 Days)||6
6767780|NCT04490239|7694916|FG000|COMPLETED|2000 U Chronic (Daily, 14 Days)||6
6767781|NCT04490239|7694916|FG000|NOT COMPLETED|2000 U Chronic (Daily, 14 Days)||0
6767782|NCT04486235|7694922|FG000|STARTED|Overall Study||32
6767783|NCT04486235|7694923|FG001|STARTED|Overall Study||30
6767784|NCT04486235|7694922|FG000|Analysis|Overall Study||30
6767785|NCT04486235|7694923|FG001|Analysis|Overall Study||30
6767786|NCT04486235|7694922|FG000|COMPLETED|Overall Study||30
6767787|NCT04486235|7694923|FG001|COMPLETED|Overall Study||30
6767788|NCT04486235|7694922|FG000|NOT COMPLETED|Overall Study||2
6767789|NCT04486235|7694923|FG001|NOT COMPLETED|Overall Study||0
6767790|NCT04483011|7694932|FG000|STARTED|Intervention Period 1 (8 Days)||9
6767791|NCT04483011|7694933|FG001|STARTED|Intervention Period 1 (8 Days)||9
6767792|NCT04483011|7694932|FG000|COMPLETED|Intervention Period 1 (8 Days)||9
6767793|NCT04483011|7694933|FG001|COMPLETED|Intervention Period 1 (8 Days)||9
6767794|NCT04483011|7694932|FG000|NOT COMPLETED|Intervention Period 1 (8 Days)||0
6767795|NCT04483011|7694933|FG001|NOT COMPLETED|Intervention Period 1 (8 Days)||0
6767796|NCT04483011|7694932|FG000|STARTED|Washout (7 Days)||9
6767797|NCT04483011|7694933|FG001|STARTED|Washout (7 Days)||9
6767798|NCT04483011|7694932|FG000|COMPLETED|Washout (7 Days)||9
6767799|NCT04483011|7694933|FG001|COMPLETED|Washout (7 Days)||8
6767800|NCT04483011|7694932|FG000|NOT COMPLETED|Washout (7 Days)||0
6767801|NCT04483011|7694933|FG001|NOT COMPLETED|Washout (7 Days)||1
6767802|NCT04483011|7694932|FG000|STARTED|Intervention Period 2 (8 Days)||9
6767803|NCT04483011|7694933|FG001|STARTED|Intervention Period 2 (8 Days)||8
6767804|NCT04483011|7694932|FG000|COMPLETED|Intervention Period 2 (8 Days)||9
6767805|NCT04483011|7694933|FG001|COMPLETED|Intervention Period 2 (8 Days)||8
6767806|NCT04483011|7694932|FG000|NOT COMPLETED|Intervention Period 2 (8 Days)||0
6767807|NCT04483011|7694933|FG001|NOT COMPLETED|Intervention Period 2 (8 Days)||0
6767808|NCT04475588|7694943|FG000|STARTED|Overall Study|Stated in protocol apriori, patient not completing 1st infusion were not evaluable & were replaced.|22
6767809|NCT04475588|7694944|FG001|STARTED|Overall Study||10
6767810|NCT04475588|7694943|FG000|COMPLETED|Overall Study||20
6767811|NCT04475588|7694944|FG001|COMPLETED|Overall Study||10
6767812|NCT04475588|7694943|FG000|NOT COMPLETED|Overall Study||2
6767813|NCT04475588|7694944|FG001|NOT COMPLETED|Overall Study||0
6767814|NCT04474496|7694951|FG000|STARTED|Overall Study||120
6767815|NCT04474496|7694951|FG000|COMPLETED|Overall Study|120 individuals were deemed eligible based on inclusion criteria, completed at least 10 survey items, and were included in the final analytical sample|120
6767816|NCT04474496|7694951|FG000|NOT COMPLETED|Overall Study||0
6767817|NCT04448210|7694957|FG000|STARTED|Overall Study||22
6767818|NCT04448210|7694958|FG001|STARTED|Overall Study||20
6767819|NCT04448210|7694957|FG000|COMPLETED|Overall Study||22
6767820|NCT04448210|7694958|FG001|COMPLETED|Overall Study||20
6767821|NCT04448210|7694957|FG000|NOT COMPLETED|Overall Study||0
6767822|NCT04448210|7694958|FG001|NOT COMPLETED|Overall Study||0
6767823|NCT04474405|7694970|FG000|STARTED|Overall Study||4
6767824|NCT04474405|7694971|FG001|STARTED|Overall Study||3
6767825|NCT04474405|7694972|FG002|STARTED|Overall Study||5
6767826|NCT04474405|7694973|FG003|STARTED|Overall Study||4
6767827|NCT04474405|7694974|FG004|STARTED|Overall Study||13
6767828|NCT04474405|7694975|FG005|STARTED|Overall Study||7
6767829|NCT04474405|7694970|FG000|Flortaucipir PET Scan|Overall Study||4
6767830|NCT04474405|7694971|FG001|Flortaucipir PET Scan|Overall Study||3
6767831|NCT04474405|7694972|FG002|Flortaucipir PET Scan|Overall Study||4
6767832|NCT04474405|7694973|FG003|Flortaucipir PET Scan|Overall Study||4
6767833|NCT04474405|7694974|FG004|Flortaucipir PET Scan|Overall Study||9
6767834|NCT04474405|7694975|FG005|Flortaucipir PET Scan|Overall Study||0
6767835|NCT04474405|7694970|FG000|Florbetapir PET Scan|Overall Study||4
6767836|NCT04474405|7694971|FG001|Florbetapir PET Scan|Overall Study||3
6767837|NCT04474405|7694972|FG002|Florbetapir PET Scan|Overall Study||0
6767838|NCT04474405|7694973|FG003|Florbetapir PET Scan|Overall Study||4
6767839|NCT04474405|7694974|FG004|Florbetapir PET Scan|Overall Study||0
6767840|NCT04474405|7694975|FG005|Florbetapir PET Scan|Overall Study||4
6767841|NCT04474405|7694970|FG000|COMPLETED|Overall Study||4
6767842|NCT04474405|7694971|FG001|COMPLETED|Overall Study||3
6767843|NCT04474405|7694972|FG002|COMPLETED|Overall Study||4
6767844|NCT04474405|7694973|FG003|COMPLETED|Overall Study||4
6767845|NCT04474405|7694974|FG004|COMPLETED|Overall Study||9
6767846|NCT04474405|7694975|FG005|COMPLETED|Overall Study||7
6767847|NCT04474405|7694970|FG000|NOT COMPLETED|Overall Study||0
6767848|NCT04474405|7694971|FG001|NOT COMPLETED|Overall Study||0
6767849|NCT04474405|7694972|FG002|NOT COMPLETED|Overall Study||1
6767850|NCT04474405|7694973|FG003|NOT COMPLETED|Overall Study||0
6767851|NCT04474405|7694974|FG004|NOT COMPLETED|Overall Study||4
6767852|NCT04474405|7694975|FG005|NOT COMPLETED|Overall Study||0
6767853|NCT04470375|7694989|FG000|STARTED|Overall Study||20
6767854|NCT04470375|7694989|FG000|COMPLETED|Overall Study||20
6767855|NCT04470375|7694989|FG000|NOT COMPLETED|Overall Study||0
6767856|NCT04468347|7694997|FG000|STARTED|Overall Study||6
6767857|NCT04468347|7694998|FG001|STARTED|Overall Study||11
6767858|NCT04468347|7694999|FG002|STARTED|Overall Study||47
6767859|NCT04468347|7695000|FG003|STARTED|Overall Study||25
6767860|NCT04468347|7694997|FG000|Baseline Flortacuipir PET Scan|Overall Study||5
6767861|NCT04468347|7694998|FG001|Baseline Flortacuipir PET Scan|Overall Study||11
6767862|NCT04468347|7694999|FG002|Baseline Flortacuipir PET Scan|Overall Study||45
6767863|NCT04468347|7695000|FG003|Baseline Flortacuipir PET Scan|Overall Study||25
6767864|NCT04468347|7694997|FG000|COMPLETED|Overall Study||4
6767865|NCT04468347|7694998|FG001|COMPLETED|Overall Study||10
6767866|NCT04468347|7694999|FG002|COMPLETED|Overall Study||41
6767867|NCT04468347|7695000|FG003|COMPLETED|Overall Study||21
6767868|NCT04468347|7694997|FG000|NOT COMPLETED|Overall Study||2
6767869|NCT04468347|7694998|FG001|NOT COMPLETED|Overall Study||1
6767870|NCT04468347|7694999|FG002|NOT COMPLETED|Overall Study||6
6767871|NCT04468347|7695000|FG003|NOT COMPLETED|Overall Study||4
6767872|NCT04467424|7695016|FG000|STARTED|Overall Study||100
6767873|NCT04467424|7695017|FG001|STARTED|Overall Study||100
6767874|NCT04467424|7695016|FG000|COMPLETED|Overall Study||100
6767875|NCT04467424|7695017|FG001|COMPLETED|Overall Study||100
6767876|NCT04467424|7695016|FG000|NOT COMPLETED|Overall Study||0
6767877|NCT04467424|7695017|FG001|NOT COMPLETED|Overall Study||0
6767878|NCT04465422|7695025|FG000|STARTED|Overall Study||17
6767879|NCT04465422|7695026|FG001|STARTED|Overall Study||16
6767880|NCT04465422|7695025|FG000|COMPLETED|Overall Study||17
6767881|NCT04465422|7695026|FG001|COMPLETED|Overall Study||14
6767882|NCT04465422|7695025|FG000|NOT COMPLETED|Overall Study||0
6767883|NCT04465422|7695026|FG001|NOT COMPLETED|Overall Study||2
6767884|NCT04463004|7695036|FG000|STARTED|Overall Study||1
6767885|NCT04463004|7695037|FG001|STARTED|Overall Study||1
6767886|NCT04463004|7695036|FG000|COMPLETED|Overall Study||1
6767887|NCT04463004|7695037|FG001|COMPLETED|Overall Study||1
6767888|NCT04463004|7695036|FG000|NOT COMPLETED|Overall Study||0
6767889|NCT04463004|7695037|FG001|NOT COMPLETED|Overall Study||0
6767890|NCT04463069|7695045|FG000|STARTED|Overall Study||41
6767891|NCT04463069|7695046|FG001|STARTED|Overall Study||45
6767892|NCT04463069|7695045|FG000|COMPLETED|Overall Study||39
6767893|NCT04463069|7695046|FG001|COMPLETED|Overall Study||22
6767894|NCT04463069|7695045|FG000|NOT COMPLETED|Overall Study||2
6767895|NCT04463069|7695046|FG001|NOT COMPLETED|Overall Study||23
6780496|NCT02991430|7708970|FG001|STARTED|Treatment Period 1||15
6780497|NCT02991430|7708971|FG002|STARTED|Treatment Period 1||16
6780498|NCT02991430|7708969|FG000|COMPLETED|Treatment Period 1||13
6780499|NCT02991430|7708970|FG001|COMPLETED|Treatment Period 1||11
6780500|NCT02991430|7708971|FG002|COMPLETED|Treatment Period 1||14
6780501|NCT02991430|7708969|FG000|NOT COMPLETED|Treatment Period 1||1
6780502|NCT02991430|7708970|FG001|NOT COMPLETED|Treatment Period 1||4
6780503|NCT02991430|7708971|FG002|NOT COMPLETED|Treatment Period 1||2
6780504|NCT02991430|7708969|FG000|STARTED|Treatment Period 2||13
6780505|NCT02991430|7708970|FG001|STARTED|Treatment Period 2||11
6780506|NCT02991430|7708971|FG002|STARTED|Treatment Period 2||14
6780507|NCT02991430|7708969|FG000|COMPLETED|Treatment Period 2||7
6780508|NCT02991430|7708970|FG001|COMPLETED|Treatment Period 2||8
6780509|NCT02991430|7708971|FG002|COMPLETED|Treatment Period 2||10
6780510|NCT02991430|7708969|FG000|NOT COMPLETED|Treatment Period 2||6
6780511|NCT02991430|7708970|FG001|NOT COMPLETED|Treatment Period 2||3
6767896|NCT04448561|7695054|FG000|STARTED|Overall Study||16
6767897|NCT04448561|7695055|FG001|STARTED|Overall Study||8
6767898|NCT04448561|7695054|FG000|COMPLETED|Overall Study||15
6767899|NCT04448561|7695055|FG001|COMPLETED|Overall Study||8
6767900|NCT04448561|7695054|FG000|NOT COMPLETED|Overall Study||1
6767901|NCT04448561|7695055|FG001|NOT COMPLETED|Overall Study||0
6767902|NCT04462731|7695071|FG000|STARTED|Overall Study||97
6767903|NCT04462731|7695072|FG001|STARTED|Overall Study||97
6767904|NCT04462731|7695071|FG000|COMPLETED|Overall Study||41
6767905|NCT04462731|7695072|FG001|COMPLETED|Overall Study||51
6767906|NCT04462731|7695071|FG000|NOT COMPLETED|Overall Study||56
6767907|NCT04462731|7695072|FG001|NOT COMPLETED|Overall Study||46
6498135|NCT01408719|7416833|FG007|COMPLETED|Third Intervention (35 Days)||2
6498136|NCT01408719|7416834|FG008|COMPLETED|Third Intervention (35 Days)||1
6498137|NCT01408719|7416835|FG009|COMPLETED|Third Intervention (35 Days)||1
6498138|NCT01408719|7416836|FG010|COMPLETED|Third Intervention (35 Days)||2
6498139|NCT01408719|7416837|FG011|COMPLETED|Third Intervention (35 Days)||2
6498140|NCT01408719|7416838|FG012|COMPLETED|Third Intervention (35 Days)||2
6767908|NCT04459585|7695078|FG000|STARTED|Period 1 (Day 1 to Day 5)||20
6767909|NCT04459585|7695078|FG000|COMPLETED|Period 1 (Day 1 to Day 5)||20
6767910|NCT04459585|7695078|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 5)||0
6498141|NCT01408719|7416839|FG013|COMPLETED|Third Intervention (35 Days)||3
6498142|NCT01408719|7416840|FG014|COMPLETED|Third Intervention (35 Days)||1
6498143|NCT01408719|7416841|FG015|COMPLETED|Third Intervention (35 Days)||1
6498144|NCT01408719|7416842|FG016|COMPLETED|Third Intervention (35 Days)||2
6498145|NCT01408719|7416843|FG017|COMPLETED|Third Intervention (35 Days)||2
6498146|NCT01408719|7416844|FG018|COMPLETED|Third Intervention (35 Days)||0
6498147|NCT01408719|7416845|FG019|COMPLETED|Third Intervention (35 Days)||1
6498148|NCT01408719|7416826|FG000|NOT COMPLETED|Third Intervention (35 Days)||0
6498149|NCT01408719|7416827|FG001|NOT COMPLETED|Third Intervention (35 Days)||0
6498150|NCT01408719|7416828|FG002|NOT COMPLETED|Third Intervention (35 Days)||0
6556481|NCT01760473|7478843|FG000|COMPLETED|Overall Study||12
6556482|NCT01760473|7478843|FG000|NOT COMPLETED|Overall Study||15
6767911|NCT04459585|7695078|FG000|STARTED|Period 2 (Day 5 to Day 12)||20
6767912|NCT04459585|7695078|FG000|COMPLETED|Period 2 (Day 5 to Day 12)||20
6767913|NCT04459585|7695078|FG000|NOT COMPLETED|Period 2 (Day 5 to Day 12)||0
6767914|NCT04458818|7695085|FG000|STARTED|Overall Study|May 01 2020|39
6767915|NCT04458818|7695085|FG000|COMPLETED|Overall Study|Jan 30 2021|39
6767916|NCT04458818|7695085|FG000|NOT COMPLETED|Overall Study||0
6767917|NCT04456634|7695091|FG000|STARTED|Overall Study||6
6767918|NCT04456634|7695092|FG001|STARTED|Overall Study||2
6767919|NCT04456634|7695091|FG000|COMPLETED|Overall Study||5
6767920|NCT04456634|7695092|FG001|COMPLETED|Overall Study||2
6767921|NCT04456634|7695091|FG000|NOT COMPLETED|Overall Study||1
6767922|NCT04456634|7695092|FG001|NOT COMPLETED|Overall Study||0
6767923|NCT04454138|7695100|FG000|STARTED|Overall Study||65
6767924|NCT04454138|7695101|FG001|STARTED|Overall Study||77
6767925|NCT04454138|7695100|FG000|COMPLETED|Overall Study||65
6767926|NCT04454138|7695101|FG001|COMPLETED|Overall Study||77
6767927|NCT04454138|7695100|FG000|NOT COMPLETED|Overall Study||0
6767928|NCT04454138|7695101|FG001|NOT COMPLETED|Overall Study||0
6767929|NCT04452435|7695109|FG000|STARTED|Screening||51
6767930|NCT04452435|7695110|FG001|STARTED|Screening||55
6767931|NCT04452435|7695109|FG000|COMPLETED|Screening||51
6556483|NCT01760733|7478855|FG000|STARTED|Waiting List|All patients included started in the waiting list group.|289
6767932|NCT04452435|7695110|FG001|COMPLETED|Screening||55
6767933|NCT04452435|7695109|FG000|NOT COMPLETED|Screening||0
6767934|NCT04452435|7695110|FG001|NOT COMPLETED|Screening||0
6767935|NCT04452435|7695109|FG000|STARTED|Treatment Period||51
6767936|NCT04452435|7695110|FG001|STARTED|Treatment Period||55
6767937|NCT04452435|7695109|FG000|COMPLETED|Treatment Period||45
6767938|NCT04452435|7695110|FG001|COMPLETED|Treatment Period||43
6767939|NCT04452435|7695109|FG000|NOT COMPLETED|Treatment Period||6
6767940|NCT04452435|7695110|FG001|NOT COMPLETED|Treatment Period||12
6767941|NCT04452435|7695109|FG000|STARTED|Follow-up||45
6767942|NCT04452435|7695110|FG001|STARTED|Follow-up||43
6767943|NCT04452435|7695109|FG000|COMPLETED|Follow-up||45
6767944|NCT04452435|7695110|FG001|COMPLETED|Follow-up||42
6767945|NCT04452435|7695109|FG000|NOT COMPLETED|Follow-up||0
6767946|NCT04452435|7695110|FG001|NOT COMPLETED|Follow-up||1
6767947|NCT04451707|7695117|FG000|STARTED|Overall Study||67
6767948|NCT04451707|7695117|FG000|COMPLETED|Overall Study||67
6767949|NCT04451707|7695117|FG000|NOT COMPLETED|Overall Study||0
6767950|NCT04449263|7695121|FG000|STARTED|First Intervention||29
6767951|NCT04449263|7695122|FG001|STARTED|First Intervention||30
6767952|NCT04449263|7695121|FG000|COMPLETED|First Intervention||29
6767953|NCT04449263|7695122|FG001|COMPLETED|First Intervention||30
6501984|NCT01432171|7420647|FG001|NOT COMPLETED|Overall Study||11
6556484|NCT01760733|7478855|FG000|COMPLETED|Waiting List|217 patients have been transplanted|217
6556485|NCT01760733|7478855|FG000|NOT COMPLETED|Waiting List||72
6767954|NCT04449263|7695121|FG000|NOT COMPLETED|First Intervention||0
6767955|NCT04449263|7695122|FG001|NOT COMPLETED|First Intervention||0
6767956|NCT04449263|7695121|FG000|STARTED|Second Intervention||29
6767957|NCT04449263|7695122|FG001|STARTED|Second Intervention||30
6767958|NCT04449263|7695121|FG000|COMPLETED|Second Intervention||29
6767959|NCT04449263|7695122|FG001|COMPLETED|Second Intervention||30
6767960|NCT04449263|7695121|FG000|NOT COMPLETED|Second Intervention||0
6767961|NCT04449263|7695122|FG001|NOT COMPLETED|Second Intervention||0
6767962|NCT04449263|7695121|FG000|STARTED|Third Intervention||29
6767963|NCT04449263|7695122|FG001|STARTED|Third Intervention||30
6767964|NCT04449263|7695121|FG000|COMPLETED|Third Intervention||29
6767965|NCT04449263|7695122|FG001|COMPLETED|Third Intervention||30
6767966|NCT04449263|7695121|FG000|NOT COMPLETED|Third Intervention||0
6767967|NCT04449263|7695122|FG001|NOT COMPLETED|Third Intervention||0
6767968|NCT04450381|7695130|FG000|STARTED|Overall Study||131
6767969|NCT04450381|7695130|FG000|COMPLETED|Overall Study||125
6767970|NCT04450381|7695130|FG000|NOT COMPLETED|Overall Study||6
6767971|NCT04449341|7695136|FG000|STARTED|Overall Study||31
6767972|NCT04449341|7695137|FG001|STARTED|Overall Study||28
6767973|NCT04449341|7695136|FG000|COMPLETED|Overall Study||30
6767974|NCT04449341|7695137|FG001|COMPLETED|Overall Study||28
6767975|NCT04449341|7695136|FG000|NOT COMPLETED|Overall Study||1
6767976|NCT04449341|7695137|FG001|NOT COMPLETED|Overall Study||0
6767977|NCT04441255|7695145|FG000|STARTED|Period 1 (1 Day)||7
6767978|NCT04441255|7695146|FG001|STARTED|Period 1 (1 Day)||7
6767979|NCT04441255|7695145|FG000|COMPLETED|Period 1 (1 Day)||7
6767980|NCT04441255|7695146|FG001|COMPLETED|Period 1 (1 Day)||7
6767981|NCT04441255|7695145|FG000|NOT COMPLETED|Period 1 (1 Day)||0
6767982|NCT04441255|7695146|FG001|NOT COMPLETED|Period 1 (1 Day)||0
6767983|NCT04441255|7695145|FG000|STARTED|Washout Period (10 Days)||7
6767984|NCT04441255|7695146|FG001|STARTED|Washout Period (10 Days)||7
6767985|NCT04441255|7695145|FG000|COMPLETED|Washout Period (10 Days)||7
6767986|NCT04441255|7695146|FG001|COMPLETED|Washout Period (10 Days)||7
6767987|NCT04441255|7695145|FG000|NOT COMPLETED|Washout Period (10 Days)||0
6767988|NCT04441255|7695146|FG001|NOT COMPLETED|Washout Period (10 Days)||0
6767989|NCT04441255|7695145|FG000|STARTED|Period 2 (1 Day)||7
6767990|NCT04441255|7695146|FG001|STARTED|Period 2 (1 Day)||7
6767991|NCT04441255|7695145|FG000|COMPLETED|Period 2 (1 Day)||7
6767992|NCT04441255|7695146|FG001|COMPLETED|Period 2 (1 Day)||7
6767993|NCT04441255|7695145|FG000|NOT COMPLETED|Period 2 (1 Day)||0
6767994|NCT04441255|7695146|FG001|NOT COMPLETED|Period 2 (1 Day)||0
6767995|NCT04440449|7695154|FG000|STARTED|Overall Study||20
6767996|NCT04440449|7695155|FG001|STARTED|Overall Study||0
6767997|NCT04440449|7695154|FG000|COMPLETED|Overall Study||18
6767998|NCT04440449|7695155|FG001|COMPLETED|Overall Study||0
6767999|NCT04440449|7695154|FG000|NOT COMPLETED|Overall Study||2
6768000|NCT04440449|7695155|FG001|NOT COMPLETED|Overall Study||0
6768001|NCT04439214|7695162|FG000|STARTED|Overall Study||47
6768002|NCT04439214|7695162|FG000|Eligible|Overall Study||42
6768003|NCT04439214|7695162|FG000|Treated|Overall Study||47
6768004|NCT04439214|7695162|FG000|Treated and Reported Adverse Event Data|Overall Study|One patient experienced disease progression in cycle 1 and an AE form was not submitted.|46
6768005|NCT04439214|7695162|FG000|Eligible and Treated|Overall Study||42
6768006|NCT04439214|7695162|FG000|COMPLETED|Overall Study||0
6768007|NCT04439214|7695162|FG000|NOT COMPLETED|Overall Study||47
6768008|NCT04439240|7695166|FG000|STARTED|Overall Study||52
6768009|NCT04439240|7695166|FG000|Started Protocol Therapy|Overall Study||50
6768010|NCT04439240|7695166|FG000|Eligible|Overall Study||49
6768011|NCT04439240|7695166|FG000|Eligible and Started Protocol Therapy|Overall Study||48
6768012|NCT04439240|7695166|FG000|Reported Adverse Events Data|Overall Study||49
6768013|NCT04439240|7695166|FG000|COMPLETED|Overall Study||0
6768014|NCT04439240|7695166|FG000|NOT COMPLETED|Overall Study||52
6768015|NCT04438785|7695172|FG000|STARTED|Overall Study||20
6768016|NCT04438785|7695173|FG001|STARTED|Overall Study||20
6768017|NCT04438785|7695172|FG000|COMPLETED|Overall Study||18
6768018|NCT04438785|7695173|FG001|COMPLETED|Overall Study||10
6768019|NCT04438785|7695172|FG000|NOT COMPLETED|Overall Study||2
6768020|NCT04438785|7695173|FG001|NOT COMPLETED|Overall Study||10
6768021|NCT04431908|7695181|FG000|STARTED|Overall Study||1042
6768022|NCT04431908|7695182|FG001|STARTED|Overall Study||278
6768023|NCT04431908|7695181|FG000|COMPLETED|Overall Study||1042
6768024|NCT04431908|7695182|FG001|COMPLETED|Overall Study||278
6768025|NCT04431908|7695181|FG000|NOT COMPLETED|Overall Study||0
6768026|NCT04431908|7695182|FG001|NOT COMPLETED|Overall Study||0
6768027|NCT04413929|7695189|FG000|STARTED|Overall Study||8411
6768028|NCT04413929|7695189|FG000|COMPLETED|Overall Study||8411
6768029|NCT04413929|7695189|FG000|NOT COMPLETED|Overall Study||0
6768030|NCT04430634|7695202|FG000|STARTED|Overall Study||5
6768031|NCT04430634|7695203|FG001|STARTED|Overall Study||5
6768032|NCT04430634|7695204|FG002|STARTED|Overall Study||5
6768033|NCT04430634|7695205|FG003|STARTED|Overall Study||5
6768034|NCT04430634|7695206|FG004|STARTED|Overall Study||5
6768035|NCT04430634|7695207|FG005|STARTED|Overall Study||5
6768036|NCT04430634|7695208|FG006|STARTED|Overall Study||5
6768037|NCT04430634|7695209|FG007|STARTED|Overall Study||5
6768038|NCT04430634|7695202|FG000|COMPLETED|Overall Study||5
6768039|NCT04430634|7695203|FG001|COMPLETED|Overall Study||5
6768040|NCT04430634|7695204|FG002|COMPLETED|Overall Study||5
6768041|NCT04430634|7695205|FG003|COMPLETED|Overall Study||4
6768042|NCT04430634|7695206|FG004|COMPLETED|Overall Study||5
6768043|NCT04430634|7695207|FG005|COMPLETED|Overall Study||5
6768044|NCT04430634|7695208|FG006|COMPLETED|Overall Study||4
6768045|NCT04430634|7695209|FG007|COMPLETED|Overall Study||5
6768046|NCT04430634|7695202|FG000|NOT COMPLETED|Overall Study||0
6768047|NCT04430634|7695203|FG001|NOT COMPLETED|Overall Study||0
6768048|NCT04430634|7695204|FG002|NOT COMPLETED|Overall Study||0
6768049|NCT04430634|7695205|FG003|NOT COMPLETED|Overall Study||1
6768050|NCT04430634|7695206|FG004|NOT COMPLETED|Overall Study||0
6768051|NCT04430634|7695207|FG005|NOT COMPLETED|Overall Study||0
6768052|NCT04430634|7695208|FG006|NOT COMPLETED|Overall Study||1
6768053|NCT04430634|7695209|FG007|NOT COMPLETED|Overall Study||0
6768054|NCT04429932|7695236|FG000|STARTED|Overall Study||4
6768055|NCT04429932|7695237|FG001|STARTED|Overall Study||5
6768056|NCT04429932|7695238|FG002|STARTED|Overall Study||5
6768057|NCT04429932|7695239|FG003|STARTED|Overall Study||5
6768058|NCT04429932|7695240|FG004|STARTED|Overall Study||5
6768059|NCT04429932|7695241|FG005|STARTED|Overall Study||5
6768060|NCT04429932|7695242|FG006|STARTED|Overall Study||5
6768061|NCT04429932|7695243|FG007|STARTED|Overall Study||5
6768062|NCT04429932|7695236|FG000|COMPLETED|Overall Study||3
6768063|NCT04429932|7695237|FG001|COMPLETED|Overall Study||5
6768064|NCT04429932|7695238|FG002|COMPLETED|Overall Study||5
6768065|NCT04429932|7695239|FG003|COMPLETED|Overall Study||2
6768066|NCT04429932|7695240|FG004|COMPLETED|Overall Study||5
6768067|NCT04429932|7695241|FG005|COMPLETED|Overall Study||5
6768068|NCT04429932|7695242|FG006|COMPLETED|Overall Study||5
6768069|NCT04429932|7695243|FG007|COMPLETED|Overall Study||5
6768070|NCT04429932|7695236|FG000|NOT COMPLETED|Overall Study||1
6768071|NCT04429932|7695237|FG001|NOT COMPLETED|Overall Study||0
6768072|NCT04429932|7695238|FG002|NOT COMPLETED|Overall Study||0
6768073|NCT04429932|7695239|FG003|NOT COMPLETED|Overall Study||3
6768074|NCT04429932|7695240|FG004|NOT COMPLETED|Overall Study||0
6768075|NCT04429932|7695241|FG005|NOT COMPLETED|Overall Study||0
6768076|NCT04429932|7695242|FG006|NOT COMPLETED|Overall Study||0
6768077|NCT04429932|7695243|FG007|NOT COMPLETED|Overall Study||0
6768078|NCT04428502|7695262|FG000|STARTED|Overall Study||127
6768079|NCT04428502|7695262|FG000|COMPLETED|Overall Study||113
6768080|NCT04428502|7695262|FG000|NOT COMPLETED|Overall Study||14
6768081|NCT04428424|7695267|FG000|STARTED|Overall Study||1493
6768082|NCT04428424|7695267|FG000|COMPLETED|Overall Study||1246
6768083|NCT04428424|7695267|FG000|NOT COMPLETED|Overall Study||247
6768084|NCT04428359|7695273|FG000|STARTED|Overall Study||33
6768085|NCT04428359|7695274|FG001|STARTED|Overall Study||33
6768086|NCT04428359|7695273|FG000|COMPLETED|Overall Study||31
6768087|NCT04428359|7695274|FG001|COMPLETED|Overall Study||30
6768088|NCT04428359|7695273|FG000|NOT COMPLETED|Overall Study||2
6768089|NCT04428359|7695274|FG001|NOT COMPLETED|Overall Study||3
6768090|NCT04410159|7695284|FG000|STARTED|Overall Study||5
6768091|NCT04410159|7695285|FG001|STARTED|Overall Study||5
6768092|NCT04410159|7695286|FG002|STARTED|Overall Study||5
6768093|NCT04410159|7695287|FG003|STARTED|Overall Study||5
6768094|NCT04410159|7695284|FG000|COMPLETED|Overall Study||5
6768095|NCT04410159|7695285|FG001|COMPLETED|Overall Study||5
6768096|NCT04410159|7695286|FG002|COMPLETED|Overall Study||5
6556486|NCT01760733|7478855|FG000|STARTED|Transplanted||217
6556487|NCT01760733|7478855|FG000|COMPLETED|Transplanted||0
6556488|NCT01760733|7478855|FG000|NOT COMPLETED|Transplanted||217
6556489|NCT01760785|7478862|FG000|STARTED|Overall Study||23
6556490|NCT01760785|7478863|FG001|STARTED|Overall Study||27
6556491|NCT01760785|7478862|FG000|COMPLETED|Overall Study||23
6556492|NCT01760785|7478863|FG001|COMPLETED|Overall Study||27
6556493|NCT01760785|7478862|FG000|NOT COMPLETED|Overall Study||0
6556494|NCT01760785|7478863|FG001|NOT COMPLETED|Overall Study||0
6556495|NCT01760876|7478869|FG000|STARTED|Overall Study||106
6556496|NCT01760876|7478869|FG000|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
6556497|NCT01760876|7478869|FG000|NOT COMPLETED|Overall Study||6
6556498|NCT01760954|7478877|FG000|STARTED|Treatment Period (6 Months)||149
6556499|NCT01760954|7478878|FG001|STARTED|Treatment Period (6 Months)||138
6556500|NCT01760954|7478879|FG002|STARTED|Treatment Period (6 Months)||108
6556501|NCT01760954|7478880|FG003|STARTED|Treatment Period (6 Months)||109
6556502|NCT01760954|7478877|FG000|COMPLETED|Treatment Period (6 Months)||116
6556503|NCT01760954|7478878|FG001|COMPLETED|Treatment Period (6 Months)||110
6556504|NCT01760954|7478879|FG002|COMPLETED|Treatment Period (6 Months)||87
6556505|NCT01760954|7478880|FG003|COMPLETED|Treatment Period (6 Months)||83
6556506|NCT01760954|7478877|FG000|NOT COMPLETED|Treatment Period (6 Months)||33
6556507|NCT01760954|7478878|FG001|NOT COMPLETED|Treatment Period (6 Months)||28
6556508|NCT01760954|7478879|FG002|NOT COMPLETED|Treatment Period (6 Months)||21
6556509|NCT01760954|7478880|FG003|NOT COMPLETED|Treatment Period (6 Months)||26
6768097|NCT04410159|7695287|FG003|COMPLETED|Overall Study||5
6768098|NCT04410159|7695284|FG000|NOT COMPLETED|Overall Study||0
6768099|NCT04410159|7695285|FG001|NOT COMPLETED|Overall Study||0
6768100|NCT04410159|7695286|FG002|NOT COMPLETED|Overall Study||0
6768101|NCT04410159|7695287|FG003|NOT COMPLETED|Overall Study||0
6768102|NCT04425850|7695299|FG000|STARTED|Overall Study|Standard prophylactic measures and PPE + iota carrageenan (nasal and buccal) and ivermectin (buccal)|131
6768103|NCT04425850|7695300|FG001|STARTED|Overall Study|Standard prophylactic measures and PPE only|98
6768104|NCT04425850|7695299|FG000|COMPLETED|Overall Study||131
6768105|NCT04425850|7695300|FG001|COMPLETED|Overall Study||98
6768106|NCT04425850|7695299|FG000|NOT COMPLETED|Overall Study||0
6768107|NCT04425850|7695300|FG001|NOT COMPLETED|Overall Study||0
6768108|NCT04425863|7695311|FG000|STARTED|Overall Study||135
6556510|NCT01760954|7478877|FG000|STARTED|Post-treatment Follow-up (12 Months)||126
6556511|NCT01760954|7478878|FG001|STARTED|Post-treatment Follow-up (12 Months)||118
6556512|NCT01760954|7478879|FG002|STARTED|Post-treatment Follow-up (12 Months)||86
6556513|NCT01760954|7478880|FG003|STARTED|Post-treatment Follow-up (12 Months)||87
6768109|NCT04425863|7695312|FG001|STARTED|Overall Study||12
6768110|NCT04425863|7695313|FG002|STARTED|Overall Study||20
6768111|NCT04425863|7695311|FG000|COMPLETED|Overall Study||135
6768112|NCT04425863|7695312|FG001|COMPLETED|Overall Study||12
6768113|NCT04425863|7695313|FG002|COMPLETED|Overall Study||19
6768114|NCT04425863|7695311|FG000|NOT COMPLETED|Overall Study||0
6768115|NCT04425863|7695312|FG001|NOT COMPLETED|Overall Study||0
6768116|NCT04425863|7695313|FG002|NOT COMPLETED|Overall Study||1
6768117|NCT04425746|7695335|FG000|STARTED|Overall Study||9
6768118|NCT04425746|7695336|FG001|STARTED|Overall Study||7
6768119|NCT04425746|7695335|FG000|COMPLETED|Overall Study||9
6768120|NCT04425746|7695336|FG001|COMPLETED|Overall Study||6
6768121|NCT04425746|7695335|FG000|NOT COMPLETED|Overall Study||0
6768122|NCT04425746|7695336|FG001|NOT COMPLETED|Overall Study||1
6768123|NCT04422561|7695346|FG000|STARTED|Overall Study||228
6768124|NCT04422561|7695347|FG001|STARTED|Overall Study||112
6768125|NCT04422561|7695346|FG000|COMPLETED|Overall Study||203
6768126|NCT04422561|7695347|FG001|COMPLETED|Overall Study||101
6768127|NCT04422561|7695346|FG000|NOT COMPLETED|Overall Study||25
6768128|NCT04422561|7695347|FG001|NOT COMPLETED|Overall Study||11
6768129|NCT04421404|7695355|FG000|STARTED|Overall Study||16
6768130|NCT04421404|7695356|FG001|STARTED|Overall Study||18
6768131|NCT04421404|7695355|FG000|COMPLETED|Overall Study||16
6768132|NCT04421404|7695356|FG001|COMPLETED|Overall Study||18
6768133|NCT04421404|7695355|FG000|NOT COMPLETED|Overall Study||0
6768134|NCT04421404|7695356|FG001|NOT COMPLETED|Overall Study||0
6768135|NCT04419311|7695364|FG000|STARTED|Overall Study||33
6768136|NCT04419311|7695365|FG001|STARTED|Overall Study||33
6768137|NCT04419311|7695364|FG000|COMPLETED|Overall Study||32
6768138|NCT04419311|7695365|FG001|COMPLETED|Overall Study||33
6768139|NCT04419311|7695364|FG000|NOT COMPLETED|Overall Study||1
6768140|NCT04419311|7695365|FG001|NOT COMPLETED|Overall Study||0
6768141|NCT04415489|7695375|FG000|STARTED|Overall Study||50
6768142|NCT04415489|7695376|FG001|STARTED|Overall Study||50
6768143|NCT04415489|7695375|FG000|COMPLETED|Overall Study||50
6768144|NCT04415489|7695376|FG001|COMPLETED|Overall Study||50
6768145|NCT04415489|7695375|FG000|NOT COMPLETED|Overall Study||0
6768146|NCT04415489|7695376|FG001|NOT COMPLETED|Overall Study||0
6768147|NCT04411667|7695385|FG000|STARTED|Overall Study||17
6768148|NCT04411667|7695386|FG001|STARTED|Overall Study||17
6768149|NCT04411667|7695385|FG000|COMPLETED|Overall Study||16
6768150|NCT04411667|7695386|FG001|COMPLETED|Overall Study||17
6768151|NCT04411667|7695385|FG000|NOT COMPLETED|Overall Study||1
6768152|NCT04411667|7695386|FG001|NOT COMPLETED|Overall Study||0
6556514|NCT01760954|7478877|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||96
6556515|NCT01760954|7478878|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||83
6768153|NCT04409886|7695392|FG000|STARTED|Overall Study||1
6768154|NCT04409886|7695392|FG000|COMPLETED|Overall Study||1
6768155|NCT04409886|7695392|FG000|NOT COMPLETED|Overall Study||0
6768156|NCT04407507|7695398|FG000|STARTED|Overall Study||33
6768157|NCT04407507|7695399|FG001|STARTED|Overall Study||33
6768158|NCT04407507|7695398|FG000|COMPLETED|Overall Study||33
6768159|NCT04407507|7695399|FG001|COMPLETED|Overall Study||32
6768160|NCT04407507|7695398|FG000|NOT COMPLETED|Overall Study||0
6768161|NCT04407507|7695399|FG001|NOT COMPLETED|Overall Study||1
6768162|NCT04406194|7695407|FG000|STARTED|Period 1||15
6768163|NCT04406194|7695408|FG001|STARTED|Period 1||15
6768164|NCT04406194|7695407|FG000|COMPLETED|Period 1||15
6768165|NCT04406194|7695408|FG001|COMPLETED|Period 1||14
6768166|NCT04406194|7695407|FG000|NOT COMPLETED|Period 1||0
6768167|NCT04406194|7695408|FG001|NOT COMPLETED|Period 1||1
6768168|NCT04406194|7695407|FG000|STARTED|Period 2||15
6768169|NCT04406194|7695408|FG001|STARTED|Period 2||14
6768170|NCT04406194|7695407|FG000|COMPLETED|Period 2||15
6768171|NCT04406194|7695408|FG001|COMPLETED|Period 2||14
6768172|NCT04406194|7695407|FG000|NOT COMPLETED|Period 2||0
6768173|NCT04406194|7695408|FG001|NOT COMPLETED|Period 2||0
6768174|NCT04404907|7695419|FG000|STARTED|Overall Study||442
6768175|NCT04404907|7695420|FG001|STARTED|Overall Study||95
6768176|NCT04404907|7695419|FG000|Occasional Tan|Overall Study||0
6768177|NCT04404907|7695420|FG001|Occasional Tan|Overall Study||88
6768178|NCT04404907|7695419|FG000|Frequent Tan|Overall Study||0
6768179|NCT04404907|7695420|FG001|Frequent Tan|Overall Study||7
6768180|NCT04404907|7695419|FG000|COMPLETED|Overall Study||442
6768181|NCT04404907|7695420|FG001|COMPLETED|Overall Study||95
6768182|NCT04404907|7695419|FG000|NOT COMPLETED|Overall Study||0
6768183|NCT04404907|7695420|FG001|NOT COMPLETED|Overall Study||0
6768184|NCT04404010|7695428|FG000|STARTED|Overall Study|1 participant was mistakenly consented, enrolled and randomized as part of study. After randomization, but prior to study testing we realized the participant was not eligible (they were not a PGY4 or 5), therefore they were excluded prior to any further study procedures commenced. Therefore, only 9 participants completed all study procedures/were followed for purposes of study.|10
6768185|NCT04404010|7695429|FG001|STARTED|Overall Study||9
6768186|NCT04404010|7695428|FG000|COMPLETED|Overall Study||9
6768187|NCT04404010|7695429|FG001|COMPLETED|Overall Study||9
6768188|NCT04404010|7695428|FG000|NOT COMPLETED|Overall Study||1
6768189|NCT04404010|7695429|FG001|NOT COMPLETED|Overall Study||0
6768190|NCT04403399|7695439|FG000|STARTED|Period 1||18
6768191|NCT04403399|7695440|FG001|STARTED|Period 1||16
6768192|NCT04403399|7695439|FG000|COMPLETED|Period 1||18
6768193|NCT04403399|7695440|FG001|COMPLETED|Period 1||16
6556516|NCT01760954|7478879|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||65
6768194|NCT04403399|7695439|FG000|NOT COMPLETED|Period 1||0
6768195|NCT04403399|7695440|FG001|NOT COMPLETED|Period 1||0
6768196|NCT04403399|7695439|FG000|STARTED|Period 2||18
6768197|NCT04403399|7695440|FG001|STARTED|Period 2||16
6768198|NCT04403399|7695439|FG000|COMPLETED|Period 2||18
6768199|NCT04403399|7695440|FG001|COMPLETED|Period 2||15
6768200|NCT04403399|7695439|FG000|NOT COMPLETED|Period 2||0
6768201|NCT04403399|7695440|FG001|NOT COMPLETED|Period 2||1
6768202|NCT04402970|7695448|FG000|STARTED|Overall Study||10
6768203|NCT04402970|7695449|FG001|STARTED|Overall Study||20
6768204|NCT04402970|7695448|FG000|COMPLETED|Overall Study||10
6768205|NCT04402970|7695449|FG001|COMPLETED|Overall Study||20
6768206|NCT04402970|7695448|FG000|NOT COMPLETED|Overall Study||0
6768207|NCT04402970|7695449|FG001|NOT COMPLETED|Overall Study||0
6768208|NCT04403113|7695457|FG000|STARTED|Overall Study||20
6768209|NCT04403113|7695458|FG001|STARTED|Overall Study||20
6768210|NCT04403113|7695457|FG000|COMPLETED|Overall Study||20
6768211|NCT04403113|7695458|FG001|COMPLETED|Overall Study||20
6768212|NCT04403113|7695457|FG000|NOT COMPLETED|Overall Study||0
6768213|NCT04403113|7695458|FG001|NOT COMPLETED|Overall Study||0
6768214|NCT04401202|7695470|FG000|STARTED|Overall Study||92
6768215|NCT04401202|7695471|FG001|STARTED|Overall Study||91
6768216|NCT04401202|7695470|FG000|COMPLETED|Overall Study||86
6768217|NCT04401202|7695471|FG001|COMPLETED|Overall Study||87
6768218|NCT04401202|7695470|FG000|NOT COMPLETED|Overall Study||6
6768219|NCT04401202|7695471|FG001|NOT COMPLETED|Overall Study||4
6768220|NCT04400682|7695480|FG000|STARTED|Period 1||15
6768221|NCT04400682|7695481|FG001|STARTED|Period 1||15
6768222|NCT04400682|7695480|FG000|COMPLETED|Period 1||14
6768223|NCT04400682|7695481|FG001|COMPLETED|Period 1||11
6768224|NCT04400682|7695480|FG000|NOT COMPLETED|Period 1||1
6768225|NCT04400682|7695481|FG001|NOT COMPLETED|Period 1||4
6768226|NCT04400682|7695480|FG000|STARTED|Period 2||14
6768227|NCT04400682|7695481|FG001|STARTED|Period 2||11
6768228|NCT04400682|7695480|FG000|COMPLETED|Period 2||14
6768229|NCT04400682|7695481|FG001|COMPLETED|Period 2||11
6768230|NCT04400682|7695480|FG000|NOT COMPLETED|Period 2||0
6768231|NCT04400682|7695481|FG001|NOT COMPLETED|Period 2||0
6768232|NCT04399161|7695490|FG000|STARTED|Overall Study||20
6768233|NCT04399161|7695491|FG001|STARTED|Overall Study||20
6768234|NCT04399161|7695492|FG002|STARTED|Overall Study||20
6768235|NCT04399161|7695490|FG000|COMPLETED|Overall Study||18
6768236|NCT04399161|7695491|FG001|COMPLETED|Overall Study||18
6768237|NCT04399161|7695492|FG002|COMPLETED|Overall Study||18
6768238|NCT04399161|7695490|FG000|NOT COMPLETED|Overall Study||2
6768239|NCT04399161|7695491|FG001|NOT COMPLETED|Overall Study||2
6768240|NCT04399161|7695492|FG002|NOT COMPLETED|Overall Study||2
6768241|NCT04399980|7695502|FG000|STARTED|Overall Study||21
6768242|NCT04399980|7695503|FG001|STARTED|Overall Study||19
6768243|NCT04399980|7695502|FG000|COMPLETED|Overall Study||21
6768244|NCT04399980|7695503|FG001|COMPLETED|Overall Study||19
6768245|NCT04399980|7695502|FG000|NOT COMPLETED|Overall Study||0
6768246|NCT04399980|7695503|FG001|NOT COMPLETED|Overall Study||0
6768247|NCT04399122|7695511|FG000|STARTED|Overall Study||100
6768248|NCT04399122|7695512|FG001|STARTED|Overall Study||100
6768249|NCT04399122|7695511|FG000|COMPLETED|Overall Study||97
6768250|NCT04399122|7695512|FG001|COMPLETED|Overall Study||100
6768251|NCT04399122|7695511|FG000|NOT COMPLETED|Overall Study||3
6768252|NCT04399122|7695512|FG001|NOT COMPLETED|Overall Study||0
6768253|NCT04397445|7695518|FG000|STARTED|Overall Study||5
6768254|NCT04397445|7695519|FG001|STARTED|Overall Study||5
6768255|NCT04397445|7695520|FG002|STARTED|Overall Study||4
6768256|NCT04397445|7695521|FG003|STARTED|Overall Study||4
6768257|NCT04397445|7695518|FG000|COMPLETED|Overall Study||4
6768258|NCT04397445|7695519|FG001|COMPLETED|Overall Study||5
6768259|NCT04397445|7695520|FG002|COMPLETED|Overall Study||4
6768260|NCT04397445|7695521|FG003|COMPLETED|Overall Study||4
6768261|NCT04397445|7695518|FG000|NOT COMPLETED|Overall Study||1
6768262|NCT04397445|7695519|FG001|NOT COMPLETED|Overall Study||0
6768263|NCT04397445|7695520|FG002|NOT COMPLETED|Overall Study||0
6768264|NCT04397445|7695521|FG003|NOT COMPLETED|Overall Study||0
6768265|NCT04397094|7695538|FG000|STARTED|Overall Study||30
6768266|NCT04397094|7695539|FG001|STARTED|Overall Study||30
6768267|NCT04397094|7695538|FG000|COMPLETED|Overall Study||30
6768268|NCT04397094|7695539|FG001|COMPLETED|Overall Study||30
6768269|NCT04397094|7695538|FG000|NOT COMPLETED|Overall Study||0
6768270|NCT04397094|7695539|FG001|NOT COMPLETED|Overall Study||0
6768271|NCT04396639|7695547|FG000|STARTED|Overall Study||50
6768272|NCT04396639|7695547|FG000|Completed Follow up|Overall Study||48
6768273|NCT04396639|7695547|FG000|COMPLETED|Overall Study||48
6768274|NCT04396639|7695547|FG000|NOT COMPLETED|Overall Study||2
6768275|NCT04396665|7695553|FG000|STARTED|Overall Study||134
6768276|NCT04396665|7695554|FG001|STARTED|Overall Study||90
6768277|NCT04396665|7695553|FG000|COMPLETED|Overall Study||99
6768278|NCT04396665|7695554|FG001|COMPLETED|Overall Study||83
6768279|NCT04396665|7695553|FG000|NOT COMPLETED|Overall Study||35
6768280|NCT04396665|7695554|FG001|NOT COMPLETED|Overall Study||7
6768281|NCT04393493|7695566|FG000|STARTED|Follow up||40
6768282|NCT04393493|7695567|FG001|STARTED|Follow up||40
6768283|NCT04393493|7695566|FG000|COMPLETED|Follow up||40
6768284|NCT04393493|7695567|FG001|COMPLETED|Follow up||40
6768285|NCT04393493|7695566|FG000|NOT COMPLETED|Follow up||0
6768286|NCT04393493|7695567|FG001|NOT COMPLETED|Follow up||0
6768287|NCT04393493|7695566|FG000|STARTED|First 4 Days of Intervention||40
6768288|NCT04393493|7695567|FG001|STARTED|First 4 Days of Intervention||40
6768289|NCT04393493|7695566|FG000|COMPLETED|First 4 Days of Intervention||35
6768290|NCT04393493|7695567|FG001|COMPLETED|First 4 Days of Intervention||33
6768291|NCT04393493|7695566|FG000|NOT COMPLETED|First 4 Days of Intervention||5
6768292|NCT04393493|7695567|FG001|NOT COMPLETED|First 4 Days of Intervention||7
6768293|NCT04392362|7695577|FG000|STARTED|Overall Study||23
6768294|NCT04392362|7695578|FG001|STARTED|Overall Study||7
6768295|NCT04392362|7695577|FG000|COMPLETED|Overall Study||23
6768296|NCT04392362|7695578|FG001|COMPLETED|Overall Study||7
6768297|NCT04392362|7695577|FG000|NOT COMPLETED|Overall Study||0
6768298|NCT04392362|7695578|FG001|NOT COMPLETED|Overall Study||0
6768299|NCT04392141|7695586|FG000|STARTED|Overall Study||60
6768300|NCT04392141|7695587|FG001|STARTED|Overall Study||60
6768301|NCT04392141|7695586|FG000|COMPLETED|Overall Study||60
6768302|NCT04392141|7695587|FG001|COMPLETED|Overall Study||60
6768303|NCT04392141|7695586|FG000|NOT COMPLETED|Overall Study||0
6768304|NCT04392141|7695587|FG001|NOT COMPLETED|Overall Study||0
6768305|NCT04392219|7695611|FG000|STARTED|Overall Study||16
6768306|NCT04392219|7695612|FG001|STARTED|Overall Study||6
6768307|NCT04392219|7695613|FG002|STARTED|Overall Study||6
6768308|NCT04392219|7695614|FG003|STARTED|Overall Study||6
6768309|NCT04392219|7695615|FG004|STARTED|Overall Study||6
6768310|NCT04392219|7695616|FG005|STARTED|Overall Study||6
6768311|NCT04392219|7695617|FG006|STARTED|Overall Study||6
6768312|NCT04392219|7695618|FG007|STARTED|Overall Study||6
6768313|NCT04392219|7695619|FG008|STARTED|Overall Study||6
6768314|NCT04392219|7695620|FG009|STARTED|Overall Study||10
6768315|NCT04392219|7695621|FG010|STARTED|Overall Study||14
6768316|NCT04392219|7695622|FG011|STARTED|Overall Study||6
6768317|NCT04392219|7695623|FG012|STARTED|Overall Study||6
6768318|NCT04392219|7695624|FG013|STARTED|Overall Study||6
6768319|NCT04392219|7695625|FG014|STARTED|Overall Study||6
6768320|NCT04392219|7695626|FG015|STARTED|Overall Study||6
6768321|NCT04392219|7695627|FG016|STARTED|Overall Study||6
6768322|NCT04392219|7695628|FG017|STARTED|Overall Study||6
6768323|NCT04392219|7695611|FG000|COMPLETED|Overall Study||16
6768324|NCT04392219|7695612|FG001|COMPLETED|Overall Study||6
6768325|NCT04392219|7695613|FG002|COMPLETED|Overall Study||6
6768326|NCT04392219|7695614|FG003|COMPLETED|Overall Study||6
6768327|NCT04392219|7695615|FG004|COMPLETED|Overall Study||6
6768328|NCT04392219|7695616|FG005|COMPLETED|Overall Study||6
6768329|NCT04392219|7695617|FG006|COMPLETED|Overall Study||6
6768330|NCT04392219|7695618|FG007|COMPLETED|Overall Study||6
6768331|NCT04392219|7695619|FG008|COMPLETED|Overall Study||6
6768332|NCT04392219|7695620|FG009|COMPLETED|Overall Study||10
6768333|NCT04392219|7695621|FG010|COMPLETED|Overall Study||14
6768334|NCT04392219|7695622|FG011|COMPLETED|Overall Study||6
6768335|NCT04392219|7695623|FG012|COMPLETED|Overall Study||6
6768336|NCT04392219|7695624|FG013|COMPLETED|Overall Study||6
6768337|NCT04392219|7695625|FG014|COMPLETED|Overall Study||6
6768338|NCT04392219|7695626|FG015|COMPLETED|Overall Study||6
6768339|NCT04392219|7695627|FG016|COMPLETED|Overall Study||6
6768340|NCT04392219|7695628|FG017|COMPLETED|Overall Study||6
6768341|NCT04392219|7695611|FG000|NOT COMPLETED|Overall Study||0
6768342|NCT04392219|7695612|FG001|NOT COMPLETED|Overall Study||0
6768343|NCT04392219|7695613|FG002|NOT COMPLETED|Overall Study||0
6768344|NCT04392219|7695614|FG003|NOT COMPLETED|Overall Study||0
6768345|NCT04392219|7695615|FG004|NOT COMPLETED|Overall Study||0
6768346|NCT04392219|7695616|FG005|NOT COMPLETED|Overall Study||0
6768347|NCT04392219|7695617|FG006|NOT COMPLETED|Overall Study||0
6768348|NCT04392219|7695618|FG007|NOT COMPLETED|Overall Study||0
6768349|NCT04392219|7695619|FG008|NOT COMPLETED|Overall Study||0
6768350|NCT04392219|7695620|FG009|NOT COMPLETED|Overall Study||0
6768351|NCT04392219|7695621|FG010|NOT COMPLETED|Overall Study||0
6768352|NCT04392219|7695622|FG011|NOT COMPLETED|Overall Study||0
6768353|NCT04392219|7695623|FG012|NOT COMPLETED|Overall Study||0
6768354|NCT04392219|7695624|FG013|NOT COMPLETED|Overall Study||0
6768355|NCT04392219|7695625|FG014|NOT COMPLETED|Overall Study||0
6768356|NCT04392219|7695626|FG015|NOT COMPLETED|Overall Study||0
6768357|NCT04392219|7695627|FG016|NOT COMPLETED|Overall Study||0
6768358|NCT04392219|7695628|FG017|NOT COMPLETED|Overall Study||0
6768359|NCT04391842|7695666|FG000|STARTED|Overall Study||34
6768360|NCT04391842|7695666|FG000|COMPLETED|Overall Study||32
6768361|NCT04391842|7695666|FG000|NOT COMPLETED|Overall Study||2
6768362|NCT04390022|7695672|FG000|STARTED|Overall Study||12
6768363|NCT04390022|7695673|FG001|STARTED|Overall Study||12
6768364|NCT04390022|7695672|FG000|COMPLETED|Overall Study||12
6768365|NCT04390022|7695673|FG001|COMPLETED|Overall Study||12
6768366|NCT04390022|7695672|FG000|NOT COMPLETED|Overall Study||0
6768367|NCT04390022|7695673|FG001|NOT COMPLETED|Overall Study||0
6768368|NCT04386902|7695679|FG000|STARTED|Overall Study||60
6556517|NCT01760954|7478880|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||67
6556518|NCT01760954|7478877|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||30
6556519|NCT01760954|7478878|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||35
6768369|NCT04386902|7695679|FG000|COMPLETED|Overall Study||50
6768370|NCT04386902|7695679|FG000|NOT COMPLETED|Overall Study||10
6768371|NCT04385238|7695685|FG000|STARTED|Overall Study||5712
6768372|NCT04385238|7695686|FG001|STARTED|Overall Study||1182
6768373|NCT04385238|7695685|FG000|COMPLETED|Overall Study||5712
6768374|NCT04385238|7695686|FG001|COMPLETED|Overall Study||1182
6768375|NCT04385238|7695685|FG000|NOT COMPLETED|Overall Study||0
6768376|NCT04385238|7695686|FG001|NOT COMPLETED|Overall Study||0
6768377|NCT04384523|7695698|FG000|STARTED|Overall Study||10
6768378|NCT04384523|7695699|FG001|STARTED|Overall Study||6
6768379|NCT04384523|7695700|FG002|STARTED|Overall Study||6
6768380|NCT04384523|7695701|FG003|STARTED|Overall Study||6
6768381|NCT04384523|7695702|FG004|STARTED|Overall Study||7
6768382|NCT04384523|7695703|FG005|STARTED|Overall Study||6
6768383|NCT04384523|7695698|FG000|COMPLETED|Overall Study||9
6768384|NCT04384523|7695699|FG001|COMPLETED|Overall Study||5
6768385|NCT04384523|7695700|FG002|COMPLETED|Overall Study||6
6768386|NCT04384523|7695701|FG003|COMPLETED|Overall Study||6
6768387|NCT04384523|7695702|FG004|COMPLETED|Overall Study||7
6768388|NCT04384523|7695703|FG005|COMPLETED|Overall Study||5
6768389|NCT04384523|7695698|FG000|NOT COMPLETED|Overall Study||1
6768390|NCT04384523|7695699|FG001|NOT COMPLETED|Overall Study||1
6768391|NCT04384523|7695700|FG002|NOT COMPLETED|Overall Study||0
6768392|NCT04384523|7695701|FG003|NOT COMPLETED|Overall Study||0
6768393|NCT04384523|7695702|FG004|NOT COMPLETED|Overall Study||0
6768394|NCT04384523|7695703|FG005|NOT COMPLETED|Overall Study||1
6768395|NCT04383665|7695723|FG000|STARTED|Overall Study||2
6768396|NCT04383665|7695724|FG001|STARTED|Overall Study||2
6768397|NCT04383665|7695725|FG002|STARTED|Overall Study||2
6768398|NCT04383665|7695726|FG003|STARTED|Overall Study||2
6768399|NCT04383665|7695727|FG004|STARTED|Overall Study||2
6768400|NCT04383665|7695728|FG005|STARTED|Overall Study||2
6768401|NCT04383665|7695723|FG000|COMPLETED|Overall Study||2
6768402|NCT04383665|7695724|FG001|COMPLETED|Overall Study||2
6768403|NCT04383665|7695725|FG002|COMPLETED|Overall Study||2
6768404|NCT04383665|7695726|FG003|COMPLETED|Overall Study||2
6768405|NCT04383665|7695727|FG004|COMPLETED|Overall Study||2
6768406|NCT04383665|7695728|FG005|COMPLETED|Overall Study||2
6768407|NCT04383665|7695723|FG000|NOT COMPLETED|Overall Study||0
6768408|NCT04383665|7695724|FG001|NOT COMPLETED|Overall Study||0
6768409|NCT04383665|7695725|FG002|NOT COMPLETED|Overall Study||0
6768410|NCT04383665|7695726|FG003|NOT COMPLETED|Overall Study||0
6768411|NCT04383665|7695727|FG004|NOT COMPLETED|Overall Study||0
6768412|NCT04383665|7695728|FG005|NOT COMPLETED|Overall Study||0
6768413|NCT04383132|7695738|FG000|STARTED|Overall Study||173
6768414|NCT04383132|7695739|FG001|STARTED|Overall Study||173
6768415|NCT04383132|7695738|FG000|COMPLETED|Overall Study||173
6768416|NCT04383132|7695739|FG001|COMPLETED|Overall Study||173
6768417|NCT04383132|7695738|FG000|NOT COMPLETED|Overall Study||0
6768418|NCT04383132|7695739|FG001|NOT COMPLETED|Overall Study||0
6768419|NCT04382066|7695748|FG000|STARTED|Overall Study||15
6768420|NCT04382066|7695749|FG001|STARTED|Overall Study||15
6768421|NCT04382066|7695750|FG002|STARTED|Overall Study||15
6768422|NCT04382066|7695748|FG000|Completed 3-day Treatment|Overall Study||14
6768423|NCT04382066|7695749|FG001|Completed 3-day Treatment|Overall Study||15
6768424|NCT04382066|7695750|FG002|Completed 3-day Treatment|Overall Study||15
6768425|NCT04382066|7695748|FG000|COMPLETED|Overall Study||13
6768426|NCT04382066|7695749|FG001|COMPLETED|Overall Study||15
6768427|NCT04382066|7695750|FG002|COMPLETED|Overall Study||14
6768428|NCT04382066|7695748|FG000|NOT COMPLETED|Overall Study||2
6768429|NCT04382066|7695749|FG001|NOT COMPLETED|Overall Study||0
6768430|NCT04382066|7695750|FG002|NOT COMPLETED|Overall Study||1
6768431|NCT04381481|7695772|FG000|STARTED|Overall Study||200
6768432|NCT04381481|7695773|FG001|STARTED|Overall Study||205
6768433|NCT04381481|7695774|FG002|STARTED|Overall Study||199
6768434|NCT04381481|7695775|FG003|STARTED|Overall Study||197
6768435|NCT04381481|7695776|FG004|STARTED|Overall Study||199
6768436|NCT04381481|7695777|FG005|STARTED|Overall Study||195
6768437|NCT04381481|7695778|FG006|STARTED|Overall Study||194
6768438|NCT04381481|7695779|FG007|STARTED|Overall Study||193
6768439|NCT04381481|7695780|FG008|STARTED|Overall Study||214
6768440|NCT04381481|7695781|FG009|STARTED|Overall Study||198
6768441|NCT04381481|7695782|FG010|STARTED|Overall Study||192
6768442|NCT04381481|7695783|FG011|STARTED|Overall Study||188
6768443|NCT04381481|7695772|FG000|COMPLETED|Overall Study||185
6768444|NCT04381481|7695773|FG001|COMPLETED|Overall Study||190
6768445|NCT04381481|7695774|FG002|COMPLETED|Overall Study||190
6768446|NCT04381481|7695775|FG003|COMPLETED|Overall Study||183
6768447|NCT04381481|7695776|FG004|COMPLETED|Overall Study||191
6768448|NCT04381481|7695777|FG005|COMPLETED|Overall Study||180
6768449|NCT04381481|7695778|FG006|COMPLETED|Overall Study||184
6768450|NCT04381481|7695779|FG007|COMPLETED|Overall Study||177
6768451|NCT04381481|7695780|FG008|COMPLETED|Overall Study||195
6768452|NCT04381481|7695781|FG009|COMPLETED|Overall Study||188
6768453|NCT04381481|7695782|FG010|COMPLETED|Overall Study||183
6768454|NCT04381481|7695783|FG011|COMPLETED|Overall Study||173
6768455|NCT04381481|7695772|FG000|NOT COMPLETED|Overall Study||15
6768456|NCT04381481|7695773|FG001|NOT COMPLETED|Overall Study||15
6768457|NCT04381481|7695774|FG002|NOT COMPLETED|Overall Study||9
6768458|NCT04381481|7695775|FG003|NOT COMPLETED|Overall Study||14
6768459|NCT04381481|7695776|FG004|NOT COMPLETED|Overall Study||8
6768460|NCT04381481|7695777|FG005|NOT COMPLETED|Overall Study||15
6768461|NCT04381481|7695778|FG006|NOT COMPLETED|Overall Study||10
6768462|NCT04381481|7695779|FG007|NOT COMPLETED|Overall Study||16
6768463|NCT04381481|7695780|FG008|NOT COMPLETED|Overall Study||19
6768464|NCT04381481|7695781|FG009|NOT COMPLETED|Overall Study||10
6768465|NCT04381481|7695782|FG010|NOT COMPLETED|Overall Study||9
6768466|NCT04381481|7695783|FG011|NOT COMPLETED|Overall Study||15
6768467|NCT04380688|7695811|FG000|STARTED|Overall Study||31
6768468|NCT04380688|7695812|FG001|STARTED|Overall Study||31
6768469|NCT04380688|7695811|FG000|COMPLETED|Overall Study||24
6768470|NCT04380688|7695812|FG001|COMPLETED|Overall Study||22
6768471|NCT04380688|7695811|FG000|NOT COMPLETED|Overall Study||7
6768472|NCT04380688|7695812|FG001|NOT COMPLETED|Overall Study||9
6768473|NCT04376060|7695818|FG000|STARTED|Overall Study||15
6768474|NCT04376060|7695818|FG000|COMPLETED|Overall Study||14
6768475|NCT04376060|7695818|FG000|NOT COMPLETED|Overall Study||1
6768476|NCT04374500|7695822|FG000|STARTED|Overall Study||10
6768477|NCT04374500|7695823|FG001|STARTED|Overall Study||10
6768478|NCT04374500|7695824|FG002|STARTED|Overall Study||83
6768479|NCT04374500|7695822|FG000|COMPLETED|Overall Study||10
6768480|NCT04374500|7695823|FG001|COMPLETED|Overall Study||10
6768481|NCT04374500|7695824|FG002|COMPLETED|Overall Study||83
6768482|NCT04374500|7695822|FG000|NOT COMPLETED|Overall Study||0
6768483|NCT04374500|7695823|FG001|NOT COMPLETED|Overall Study||0
6768484|NCT04374500|7695824|FG002|NOT COMPLETED|Overall Study||0
6768485|NCT04372186|7695837|FG000|STARTED|Overall Study||249
6768486|NCT04372186|7695838|FG001|STARTED|Overall Study||128
6768487|NCT04372186|7695837|FG000|COMPLETED|Overall Study||225
6768488|NCT04372186|7695838|FG001|COMPLETED|Overall Study||115
6768489|NCT04372186|7695837|FG000|NOT COMPLETED|Overall Study||24
6768490|NCT04372186|7695838|FG001|NOT COMPLETED|Overall Study||13
6768491|NCT04371419|7695846|FG000|STARTED|Overall Study||784
6768492|NCT04371419|7695847|FG001|STARTED|Overall Study||791
6768493|NCT04371419|7695848|FG002|STARTED|Overall Study||780
6768494|NCT04371419|7695849|FG003|STARTED|Overall Study||778
6768495|NCT04371419|7695850|FG004|STARTED|Overall Study||777
6768496|NCT04371419|7695851|FG005|STARTED|Overall Study||788
6768497|NCT04371419|7695852|FG006|STARTED|Overall Study||783
6768498|NCT04371419|7695853|FG007|STARTED|Overall Study||788
6768499|NCT04371419|7695854|FG008|STARTED|Overall Study||779
6768500|NCT04371419|7695855|FG009|STARTED|Overall Study||780
6768501|NCT04371419|7695856|FG010|STARTED|Overall Study||782
6768502|NCT04371419|7695857|FG011|STARTED|Overall Study||790
6768503|NCT04371419|7695858|FG012|STARTED|Overall Study||779
6768504|NCT04371419|7695859|FG013|STARTED|Overall Study||786
6768505|NCT04371419|7695860|FG014|STARTED|Overall Study||781
6768506|NCT04371419|7695861|FG015|STARTED|Overall Study||781
6768507|NCT04371419|7695862|FG016|STARTED|Overall Study||1617
6768508|NCT04371419|7695846|FG000|Completed the Knowledge Questions|Overall Study||663
6768509|NCT04371419|7695847|FG001|Completed the Knowledge Questions|Overall Study||669
6768510|NCT04371419|7695848|FG002|Completed the Knowledge Questions|Overall Study||673
6768511|NCT04371419|7695849|FG003|Completed the Knowledge Questions|Overall Study||664
6768512|NCT04371419|7695850|FG004|Completed the Knowledge Questions|Overall Study||666
6768513|NCT04371419|7695851|FG005|Completed the Knowledge Questions|Overall Study||683
6768514|NCT04371419|7695852|FG006|Completed the Knowledge Questions|Overall Study||664
6768515|NCT04371419|7695853|FG007|Completed the Knowledge Questions|Overall Study||679
6768516|NCT04371419|7695854|FG008|Completed the Knowledge Questions|Overall Study||670
6768517|NCT04371419|7695855|FG009|Completed the Knowledge Questions|Overall Study||655
6768518|NCT04371419|7695856|FG010|Completed the Knowledge Questions|Overall Study||656
6768519|NCT04371419|7695857|FG011|Completed the Knowledge Questions|Overall Study||692
6768520|NCT04371419|7695858|FG012|Completed the Knowledge Questions|Overall Study||664
6768521|NCT04371419|7695859|FG013|Completed the Knowledge Questions|Overall Study||687
6768522|NCT04371419|7695860|FG014|Completed the Knowledge Questions|Overall Study||652
6768523|NCT04371419|7695861|FG015|Completed the Knowledge Questions|Overall Study||652
6768524|NCT04371419|7695862|FG016|Completed the Knowledge Questions|Overall Study||1526
6768525|NCT04371419|7695846|FG000|COMPLETED|Overall Study||641
6768526|NCT04371419|7695847|FG001|COMPLETED|Overall Study||636
6562920|NCT01803607|7485846|FG001|STARTED|Overall Study||67
6768527|NCT04371419|7695848|FG002|COMPLETED|Overall Study||639
6768528|NCT04371419|7695849|FG003|COMPLETED|Overall Study||631
6768529|NCT04371419|7695850|FG004|COMPLETED|Overall Study||644
6768530|NCT04371419|7695851|FG005|COMPLETED|Overall Study||654
6768531|NCT04371419|7695852|FG006|COMPLETED|Overall Study||639
6768532|NCT04371419|7695853|FG007|COMPLETED|Overall Study||658
6768533|NCT04371419|7695854|FG008|COMPLETED|Overall Study||649
6768534|NCT04371419|7695855|FG009|COMPLETED|Overall Study||621
6768535|NCT04371419|7695856|FG010|COMPLETED|Overall Study||626
6768536|NCT04371419|7695857|FG011|COMPLETED|Overall Study||662
6768537|NCT04371419|7695858|FG012|COMPLETED|Overall Study||633
6768538|NCT04371419|7695859|FG013|COMPLETED|Overall Study||660
6768539|NCT04371419|7695860|FG014|COMPLETED|Overall Study||626
6768540|NCT04371419|7695861|FG015|COMPLETED|Overall Study||625
6768541|NCT04371419|7695862|FG016|COMPLETED|Overall Study||1450
6768542|NCT04371419|7695846|FG000|NOT COMPLETED|Overall Study||143
6768543|NCT04371419|7695847|FG001|NOT COMPLETED|Overall Study||155
6768544|NCT04371419|7695848|FG002|NOT COMPLETED|Overall Study||141
6768545|NCT04371419|7695849|FG003|NOT COMPLETED|Overall Study||147
6768546|NCT04371419|7695850|FG004|NOT COMPLETED|Overall Study||133
6768547|NCT04371419|7695851|FG005|NOT COMPLETED|Overall Study||134
6768548|NCT04371419|7695852|FG006|NOT COMPLETED|Overall Study||144
6768549|NCT04371419|7695853|FG007|NOT COMPLETED|Overall Study||130
6768550|NCT04371419|7695854|FG008|NOT COMPLETED|Overall Study||130
6768551|NCT04371419|7695855|FG009|NOT COMPLETED|Overall Study||159
6768552|NCT04371419|7695856|FG010|NOT COMPLETED|Overall Study||156
6768553|NCT04371419|7695857|FG011|NOT COMPLETED|Overall Study||128
6768554|NCT04371419|7695858|FG012|NOT COMPLETED|Overall Study||146
6768555|NCT04371419|7695859|FG013|NOT COMPLETED|Overall Study||126
6768556|NCT04371419|7695860|FG014|NOT COMPLETED|Overall Study||155
6768557|NCT04371419|7695861|FG015|NOT COMPLETED|Overall Study||156
6768558|NCT04371419|7695862|FG016|NOT COMPLETED|Overall Study||167
6768559|NCT04370834|7695893|FG000|STARTED|Overall Study||1
6768560|NCT04370834|7695893|FG000|COMPLETED|Overall Study||1
6768561|NCT04370834|7695893|FG000|NOT COMPLETED|Overall Study||0
6768562|NCT04370548|7695905|FG000|STARTED|Overall Study||204
6768563|NCT04370548|7695906|FG001|STARTED|Overall Study||103
6768564|NCT04370548|7695905|FG000|COMPLETED|Overall Study||190
6768565|NCT04370548|7695906|FG001|COMPLETED|Overall Study||100
6768566|NCT04370548|7695905|FG000|NOT COMPLETED|Overall Study||14
6768567|NCT04370548|7695906|FG001|NOT COMPLETED|Overall Study||3
6768568|NCT04370028|7695912|FG000|STARTED|Overall Study||2583
6768569|NCT04370028|7695912|FG000|COMPLETED|Overall Study||1876
6768570|NCT04370028|7695912|FG000|NOT COMPLETED|Overall Study||707
6768571|NCT04363736|7695925|FG000|STARTED|Overall Study||49
6768572|NCT04363736|7695926|FG001|STARTED|Overall Study||48
6768573|NCT04363736|7695925|FG000|COMPLETED|Overall Study||30
6768574|NCT04363736|7695926|FG001|COMPLETED|Overall Study||35
6768575|NCT04363736|7695925|FG000|NOT COMPLETED|Overall Study||19
6768576|NCT04363736|7695926|FG001|NOT COMPLETED|Overall Study||13
6768577|NCT04366583|7695934|FG000|STARTED|Overall Study||82
6768578|NCT04366583|7695935|FG001|STARTED|Overall Study||84
6768579|NCT04366583|7695934|FG000|COMPLETED|Overall Study||82
6768580|NCT04366583|7695935|FG001|COMPLETED|Overall Study||84
6768581|NCT04366583|7695934|FG000|NOT COMPLETED|Overall Study||0
6768582|NCT04366583|7695935|FG001|NOT COMPLETED|Overall Study||0
6768583|NCT04365699|7695944|FG000|STARTED|Overall Study||10
6768584|NCT04365699|7695945|FG001|STARTED|Overall Study||16
6768585|NCT04365699|7695946|FG002|STARTED|Overall Study||55
6768586|NCT04365699|7695944|FG000|COMPLETED|Overall Study||8
6768587|NCT04365699|7695945|FG001|COMPLETED|Overall Study||11
6768588|NCT04365699|7695946|FG002|COMPLETED|Overall Study||40
6768589|NCT04365699|7695944|FG000|NOT COMPLETED|Overall Study||2
6768590|NCT04365699|7695945|FG001|NOT COMPLETED|Overall Study||5
6768591|NCT04365699|7695946|FG002|NOT COMPLETED|Overall Study||15
6768592|NCT04365153|7695957|FG000|STARTED|Overall Study||15
6768593|NCT04365153|7695958|FG001|STARTED|Overall Study||14
6768594|NCT04365153|7695959|FG002|STARTED|Overall Study||16
6768595|NCT04365153|7695957|FG000|COMPLETED|Overall Study||15
6768596|NCT04365153|7695958|FG001|COMPLETED|Overall Study||14
6768597|NCT04365153|7695959|FG002|COMPLETED|Overall Study||16
6768598|NCT04365153|7695957|FG000|NOT COMPLETED|Overall Study||0
6768599|NCT04365153|7695958|FG001|NOT COMPLETED|Overall Study||0
6768600|NCT04365153|7695959|FG002|NOT COMPLETED|Overall Study||0
6768601|NCT04363879|7695970|FG000|STARTED|Overall Study||78
6768602|NCT04363879|7695971|FG001|STARTED|Overall Study||92
6768603|NCT04363879|7695970|FG000|COMPLETED|Overall Study||78
6768604|NCT04363879|7695971|FG001|COMPLETED|Overall Study||92
6768605|NCT04363879|7695970|FG000|NOT COMPLETED|Overall Study||0
6768606|NCT04363879|7695971|FG001|NOT COMPLETED|Overall Study||0
6768607|NCT04362137|7695979|FG000|STARTED|Overall Study||287
6768608|NCT04362137|7695980|FG001|STARTED|Overall Study||145
6768609|NCT04362137|7695979|FG000|Safety Set|Overall Study||281
6768610|NCT04362137|7695980|FG001|Safety Set|Overall Study||143
6768611|NCT04362137|7695979|FG000|COMPLETED|Overall Study||269
6768612|NCT04362137|7695980|FG001|COMPLETED|Overall Study||139
6768613|NCT04362137|7695979|FG000|NOT COMPLETED|Overall Study||18
6768614|NCT04362137|7695980|FG001|NOT COMPLETED|Overall Study||6
6768615|NCT04359771|7695988|FG000|STARTED|Overall Study|Right eye of every participant was assigned to the diode MPL group|15
6768616|NCT04359771|7695989|FG001|STARTED|Overall Study|Left eye of every participant was assigned to the diode MPL group|15
6768617|NCT04359771|7695988|FG000|COMPLETED|Overall Study|The right eye of each participant was assigned to the diode MPL group|13
6768618|NCT04359771|7695989|FG001|COMPLETED|Overall Study|The left eye of every participant was assigned to the diode MPL group|13
6768619|NCT04359771|7695988|FG000|NOT COMPLETED|Overall Study||2
6768620|NCT04359771|7695989|FG001|NOT COMPLETED|Overall Study||2
6768621|NCT04358991|7695995|FG000|STARTED|Overall Study||20
6768622|NCT04358991|7695995|FG000|COMPLETED|Overall Study||20
6768623|NCT04358991|7695995|FG000|NOT COMPLETED|Overall Study||0
6768624|NCT04358081|7696002|FG000|STARTED|Treatment Phase of Study||7
6768625|NCT04358081|7696003|FG001|STARTED|Treatment Phase of Study||7
6768626|NCT04358081|7696004|FG002|STARTED|Treatment Phase of Study||5
6768627|NCT04358081|7696002|FG000|COMPLETED|Treatment Phase of Study||3
6768628|NCT04358081|7696003|FG001|COMPLETED|Treatment Phase of Study||6
6768629|NCT04358081|7696004|FG002|COMPLETED|Treatment Phase of Study||2
6768630|NCT04358081|7696002|FG000|NOT COMPLETED|Treatment Phase of Study||4
6768631|NCT04358081|7696003|FG001|NOT COMPLETED|Treatment Phase of Study||1
6768632|NCT04358081|7696004|FG002|NOT COMPLETED|Treatment Phase of Study||3
6768633|NCT04358081|7696002|FG000|STARTED|Study Completion Phase||7
6768634|NCT04358081|7696003|FG001|STARTED|Study Completion Phase||7
6768635|NCT04358081|7696004|FG002|STARTED|Study Completion Phase||5
6768636|NCT04358081|7696002|FG000|COMPLETED|Study Completion Phase||6
6768637|NCT04358081|7696003|FG001|COMPLETED|Study Completion Phase||7
6768638|NCT04358081|7696004|FG002|COMPLETED|Study Completion Phase||3
6768639|NCT04358081|7696002|FG000|NOT COMPLETED|Study Completion Phase||1
6768640|NCT04358081|7696003|FG001|NOT COMPLETED|Study Completion Phase||0
6768641|NCT04358081|7696004|FG002|NOT COMPLETED|Study Completion Phase||2
6768642|NCT04356937|7696016|FG000|STARTED|Randomization (Safety Population)||161
6768643|NCT04356937|7696017|FG001|STARTED|Randomization (Safety Population)||82
6768644|NCT04356937|7696016|FG000|COMPLETED|Randomization (Safety Population)||161
6768645|NCT04356937|7696017|FG001|COMPLETED|Randomization (Safety Population)||82
6768646|NCT04356937|7696016|FG000|NOT COMPLETED|Randomization (Safety Population)||0
6768647|NCT04356937|7696017|FG001|NOT COMPLETED|Randomization (Safety Population)||0
6768648|NCT04356937|7696016|FG000|STARTED|Treatment (mITT Population)||161
6768649|NCT04356937|7696017|FG001|STARTED|Treatment (mITT Population)||82
6768650|NCT04356937|7696016|FG000|COMPLETED|Treatment (mITT Population)||161
6768651|NCT04356937|7696017|FG001|COMPLETED|Treatment (mITT Population)||81
6768652|NCT04356937|7696016|FG000|NOT COMPLETED|Treatment (mITT Population)||0
6768653|NCT04356937|7696017|FG001|NOT COMPLETED|Treatment (mITT Population)||1
6768654|NCT04355663|7696026|FG000|STARTED|Overall Study||42
6768655|NCT04355663|7696027|FG001|STARTED|Overall Study||29
6768656|NCT04355663|7696028|FG002|STARTED|Overall Study||21
6768657|NCT04355663|7696026|FG000|COMPLETED|Overall Study||40
6768658|NCT04355663|7696027|FG001|COMPLETED|Overall Study||14
6768659|NCT04355663|7696028|FG002|COMPLETED|Overall Study||17
6768660|NCT04355663|7696026|FG000|NOT COMPLETED|Overall Study||2
6768661|NCT04355663|7696027|FG001|NOT COMPLETED|Overall Study||15
6768662|NCT04355663|7696028|FG002|NOT COMPLETED|Overall Study||4
6768663|NCT04354870|7696038|FG000|STARTED|Overall Study||83
6768664|NCT04354870|7696039|FG001|STARTED|Overall Study||47
6768665|NCT04354870|7696038|FG000|COMPLETED|Overall Study||35
6768666|NCT04354870|7696039|FG001|COMPLETED|Overall Study||14
6768667|NCT04354870|7696038|FG000|NOT COMPLETED|Overall Study||48
6768668|NCT04354870|7696039|FG001|NOT COMPLETED|Overall Study||33
6768669|NCT04350307|7696047|FG000|STARTED|Overall Study||84
6768670|NCT04350307|7696048|FG001|STARTED|Overall Study||78
6768671|NCT04350307|7696047|FG000|COMPLETED|Overall Study||84
6768672|NCT04350307|7696048|FG001|COMPLETED|Overall Study||78
6768673|NCT04350307|7696047|FG000|NOT COMPLETED|Overall Study||0
6768674|NCT04350307|7696048|FG001|NOT COMPLETED|Overall Study||0
6768675|NCT04352660|7696056|FG000|STARTED|Overall Study||50
6768676|NCT04352660|7696057|FG001|STARTED|Overall Study||50
6768677|NCT04352660|7696056|FG000|COMPLETED|Overall Study||36
6768678|NCT04352660|7696057|FG001|COMPLETED|Overall Study||40
6768679|NCT04352660|7696056|FG000|NOT COMPLETED|Overall Study||14
6768680|NCT04352660|7696057|FG001|NOT COMPLETED|Overall Study||10
6768681|NCT04350788|7696065|FG000|STARTED|Overall Study||62
6768682|NCT04350788|7696066|FG001|STARTED|Overall Study||62
6768683|NCT04350788|7696065|FG000|COMPLETED|Overall Study||50
6768684|NCT04350788|7696066|FG001|COMPLETED|Overall Study||56
6768685|NCT04350788|7696065|FG000|NOT COMPLETED|Overall Study||12
6768686|NCT04350788|7696066|FG001|NOT COMPLETED|Overall Study||6
6768687|NCT04349917|7696079|FG000|STARTED|First Intervention (2-4 Hours)||19
6556520|NCT01760954|7478879|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||21
6556521|NCT01760954|7478880|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||20
6556522|NCT01761019|7478890|FG000|STARTED|Overall Study||8
6768688|NCT04349917|7696080|FG001|STARTED|First Intervention (2-4 Hours)||18
6768689|NCT04349917|7696079|FG000|Received Intervention|First Intervention (2-4 Hours)||19
6768690|NCT04349917|7696080|FG001|Received Intervention|First Intervention (2-4 Hours)||17
6768691|NCT04349917|7696079|FG000|COMPLETED|First Intervention (2-4 Hours)||19
6768692|NCT04349917|7696080|FG001|COMPLETED|First Intervention (2-4 Hours)||16
6768693|NCT04349917|7696079|FG000|NOT COMPLETED|First Intervention (2-4 Hours)||0
6768694|NCT04349917|7696080|FG001|NOT COMPLETED|First Intervention (2-4 Hours)||2
6768695|NCT04349917|7696079|FG000|STARTED|Washout Period (4-20 Days)||19
6768696|NCT04349917|7696080|FG001|STARTED|Washout Period (4-20 Days)||16
6768697|NCT04349917|7696079|FG000|COMPLETED|Washout Period (4-20 Days)||19
6768698|NCT04349917|7696080|FG001|COMPLETED|Washout Period (4-20 Days)||16
6768699|NCT04349917|7696079|FG000|NOT COMPLETED|Washout Period (4-20 Days)||0
6768700|NCT04349917|7696080|FG001|NOT COMPLETED|Washout Period (4-20 Days)||0
6768701|NCT04349917|7696079|FG000|STARTED|Second Intervention (2-4 Hours)||19
6768702|NCT04349917|7696080|FG001|STARTED|Second Intervention (2-4 Hours)||16
6768703|NCT04349917|7696079|FG000|Received Intervention|Second Intervention (2-4 Hours)||19
6768704|NCT04349917|7696080|FG001|Received Intervention|Second Intervention (2-4 Hours)||16
6768705|NCT04349917|7696079|FG000|COMPLETED|Second Intervention (2-4 Hours)||19
6768706|NCT04349917|7696080|FG001|COMPLETED|Second Intervention (2-4 Hours)||16
6768707|NCT04349917|7696079|FG000|NOT COMPLETED|Second Intervention (2-4 Hours)||0
6768708|NCT04349917|7696080|FG001|NOT COMPLETED|Second Intervention (2-4 Hours)||0
6768709|NCT04348851|7696091|FG000|STARTED|Post-Test 1||13
6768710|NCT04348851|7696092|FG001|STARTED|Post-Test 1||13
6768711|NCT04348851|7696093|FG002|STARTED|Post-Test 1||13
6768712|NCT04348851|7696094|FG003|STARTED|Post-Test 1||14
6768713|NCT04348851|7696091|FG000|COMPLETED|Post-Test 1||13
6768714|NCT04348851|7696092|FG001|COMPLETED|Post-Test 1||11
6768715|NCT04348851|7696093|FG002|COMPLETED|Post-Test 1||13
6768716|NCT04348851|7696094|FG003|COMPLETED|Post-Test 1||14
6768717|NCT04348851|7696091|FG000|NOT COMPLETED|Post-Test 1||0
6768718|NCT04348851|7696092|FG001|NOT COMPLETED|Post-Test 1||2
6768719|NCT04348851|7696093|FG002|NOT COMPLETED|Post-Test 1||0
6768720|NCT04348851|7696094|FG003|NOT COMPLETED|Post-Test 1||0
6768721|NCT04348851|7696091|FG000|STARTED|Post-Test 2||13
6768722|NCT04348851|7696092|FG001|STARTED|Post-Test 2||11
6768723|NCT04348851|7696093|FG002|STARTED|Post-Test 2||13
6768724|NCT04348851|7696094|FG003|STARTED|Post-Test 2||14
6768725|NCT04348851|7696091|FG000|COMPLETED|Post-Test 2||13
6768726|NCT04348851|7696092|FG001|COMPLETED|Post-Test 2||10
6768727|NCT04348851|7696093|FG002|COMPLETED|Post-Test 2||13
6768728|NCT04348851|7696094|FG003|COMPLETED|Post-Test 2||13
6768729|NCT04348851|7696091|FG000|NOT COMPLETED|Post-Test 2||0
6768730|NCT04348851|7696092|FG001|NOT COMPLETED|Post-Test 2||1
6768731|NCT04348851|7696093|FG002|NOT COMPLETED|Post-Test 2||0
6768732|NCT04348851|7696094|FG003|NOT COMPLETED|Post-Test 2||1
6768733|NCT04348357|7696106|FG000|STARTED|Overall Study||25
6768734|NCT04348357|7696107|FG001|STARTED|Overall Study||28
6768735|NCT04348357|7696106|FG000|COMPLETED|Overall Study||25
6556523|NCT01761019|7478890|FG000|COMPLETED|Overall Study||8
6556524|NCT01761019|7478890|FG000|NOT COMPLETED|Overall Study||0
6768736|NCT04348357|7696107|FG001|COMPLETED|Overall Study||16
6768737|NCT04348357|7696106|FG000|NOT COMPLETED|Overall Study||0
6768738|NCT04348357|7696107|FG001|NOT COMPLETED|Overall Study||12
6768739|NCT04346199|7696115|FG000|STARTED|Overall Study||89
6768740|NCT04346199|7696116|FG001|STARTED|Overall Study||88
6768741|NCT04346199|7696115|FG000|COMPLETED|Overall Study||74
6768742|NCT04346199|7696116|FG001|COMPLETED|Overall Study||77
6768743|NCT04346199|7696115|FG000|NOT COMPLETED|Overall Study||15
6768744|NCT04346199|7696116|FG001|NOT COMPLETED|Overall Study||11
6768745|NCT04345653|7696122|FG000|STARTED|Overall Study||48
6768746|NCT04345653|7696122|FG000|COMPLETED|Overall Study||46
6768747|NCT04345653|7696122|FG000|NOT COMPLETED|Overall Study||2
6768748|NCT04343261|7696127|FG000|STARTED|Overall Study||48
6768749|NCT04343261|7696127|FG000|COMPLETED|Overall Study||40
6768750|NCT04343261|7696127|FG000|NOT COMPLETED|Overall Study||8
6768751|NCT04343222|7696134|FG000|STARTED|Overall Study||16
6768752|NCT04343222|7696135|FG001|STARTED|Overall Study||15
6768753|NCT04343222|7696136|FG002|STARTED|Overall Study||15
6768754|NCT04343222|7696134|FG000|COMPLETED|Overall Study||16
6768755|NCT04343222|7696135|FG001|COMPLETED|Overall Study||15
6768756|NCT04343222|7696136|FG002|COMPLETED|Overall Study||15
6768757|NCT04343222|7696134|FG000|NOT COMPLETED|Overall Study||0
6768758|NCT04343222|7696135|FG001|NOT COMPLETED|Overall Study||0
6768759|NCT04343222|7696136|FG002|NOT COMPLETED|Overall Study||0
6768760|NCT04343092|7696144|FG000|STARTED|Overall Study||16
6768761|NCT04343092|7696144|FG000|COMPLETED|Overall Study||16
6768762|NCT04343092|7696144|FG000|NOT COMPLETED|Overall Study||0
6768763|NCT04342663|7696150|FG000|STARTED|Overall Study||80
6768764|NCT04342663|7696151|FG001|STARTED|Overall Study||72
6768765|NCT04342663|7696150|FG000|COMPLETED|Overall Study||62
6768766|NCT04342663|7696151|FG001|COMPLETED|Overall Study||53
6768767|NCT04342663|7696150|FG000|NOT COMPLETED|Overall Study||18
6768768|NCT04342663|7696151|FG001|NOT COMPLETED|Overall Study||19
6768769|NCT04342897|7696159|FG000|STARTED|Overall Study||47
6768770|NCT04342897|7696160|FG001|STARTED|Overall Study||48
6768771|NCT04342897|7696159|FG000|Received at Least One Dose of Study Drug|Overall Study||47
6768772|NCT04342897|7696160|FG001|Received at Least One Dose of Study Drug|Overall Study||48
6768773|NCT04342897|7696159|FG000|COMPLETED|Overall Study||33
6768774|NCT04342897|7696160|FG001|COMPLETED|Overall Study||36
6768775|NCT04342897|7696159|FG000|NOT COMPLETED|Overall Study||14
6768776|NCT04342897|7696160|FG001|NOT COMPLETED|Overall Study||12
6768777|NCT04342130|7696166|FG000|STARTED|Overall Study||10
6768778|NCT04342130|7696166|FG000|COMPLETED|Overall Study||10
6768779|NCT04342130|7696166|FG000|NOT COMPLETED|Overall Study||0
6768780|NCT04340557|7696172|FG000|STARTED|Overall Study||16
6768781|NCT04340557|7696173|FG001|STARTED|Overall Study||15
6556525|NCT01761084|7478896|FG000|STARTED|Overall Study||71
6768782|NCT04340557|7696172|FG000|COMPLETED|Overall Study||15
6768783|NCT04340557|7696173|FG001|COMPLETED|Overall Study||13
6768784|NCT04340557|7696172|FG000|NOT COMPLETED|Overall Study||1
6768785|NCT04340557|7696173|FG001|NOT COMPLETED|Overall Study||2
6768786|NCT04339972|7696181|FG000|STARTED|Overall Study||15
6768787|NCT04339972|7696182|FG001|STARTED|Overall Study||14
6768788|NCT04339972|7696181|FG000|COMPLETED|Overall Study||10
6768789|NCT04339972|7696182|FG001|COMPLETED|Overall Study||9
6768790|NCT04339972|7696181|FG000|NOT COMPLETED|Overall Study||5
6768791|NCT04339972|7696182|FG001|NOT COMPLETED|Overall Study||5
6768792|NCT04339296|7696190|FG000|STARTED|Overall Study||24
6768793|NCT04339296|7696191|FG001|STARTED|Overall Study||26
6768794|NCT04339296|7696190|FG000|Completed Baseline|Overall Study||23
6768795|NCT04339296|7696191|FG001|Completed Baseline|Overall Study||25
6768796|NCT04339296|7696190|FG000|Received Allocated Intervention|Overall Study||21
6768797|NCT04339296|7696191|FG001|Received Allocated Intervention|Overall Study||24
6768798|NCT04339296|7696190|FG000|COMPLETED|Overall Study||16
6768799|NCT04339296|7696191|FG001|COMPLETED|Overall Study||17
6768800|NCT04339296|7696190|FG000|NOT COMPLETED|Overall Study||8
6768801|NCT04339296|7696191|FG001|NOT COMPLETED|Overall Study||9
6768802|NCT04338009|7696199|FG000|STARTED|Overall Study||77
6768803|NCT04338009|7696200|FG001|STARTED|Overall Study||75
6768804|NCT04338009|7696199|FG000|COMPLETED|Overall Study||77
6768805|NCT04338009|7696200|FG001|COMPLETED|Overall Study||75
6768806|NCT04338009|7696199|FG000|NOT COMPLETED|Overall Study||0
6768807|NCT04338009|7696200|FG001|NOT COMPLETED|Overall Study||0
6780512|NCT02991430|7708971|FG002|NOT COMPLETED|Treatment Period 2||4
6780513|NCT02991430|7708969|FG000|STARTED|Post-treatment Observation Period||7
6780514|NCT02991430|7708970|FG001|STARTED|Post-treatment Observation Period||8
6780515|NCT02991430|7708971|FG002|STARTED|Post-treatment Observation Period||10
6556526|NCT01761084|7478897|FG001|STARTED|Overall Study||70
6556527|NCT01761084|7478896|FG000|COMPLETED|Overall Study||66
6556528|NCT01761084|7478897|FG001|COMPLETED|Overall Study||64
6556529|NCT01761084|7478896|FG000|NOT COMPLETED|Overall Study||5
6780516|NCT02991430|7708969|FG000|COMPLETED|Post-treatment Observation Period||4
6780517|NCT02991430|7708970|FG001|COMPLETED|Post-treatment Observation Period||2
6780518|NCT02991430|7708971|FG002|COMPLETED|Post-treatment Observation Period||5
6780519|NCT02991430|7708969|FG000|NOT COMPLETED|Post-treatment Observation Period||3
6780520|NCT02991430|7708970|FG001|NOT COMPLETED|Post-treatment Observation Period||6
6780521|NCT02991430|7708971|FG002|NOT COMPLETED|Post-treatment Observation Period||5
6780522|NCT02995967|7708981|FG000|STARTED|Overall Study||1
6780523|NCT02995967|7708982|FG001|STARTED|Overall Study||2
6780524|NCT02995967|7708981|FG000|COMPLETED|Overall Study||1
6780525|NCT02995967|7708982|FG001|COMPLETED|Overall Study||2
6780526|NCT02995967|7708981|FG000|NOT COMPLETED|Overall Study||0
6780527|NCT02995967|7708982|FG001|NOT COMPLETED|Overall Study||0
6780528|NCT02994251|7708989|FG000|STARTED|Overall Study||0
6780529|NCT02994251|7708989|FG000|COMPLETED|Overall Study||0
6780530|NCT02994251|7708989|FG000|NOT COMPLETED|Overall Study||0
6780531|NCT02978885|7708995|FG000|STARTED|Overall Study||0
6780532|NCT02978885|7708996|FG001|STARTED|Overall Study||1
6780533|NCT02978885|7708995|FG000|COMPLETED|Overall Study||0
6780534|NCT02978885|7708996|FG001|COMPLETED|Overall Study||1
6780535|NCT02978885|7708995|FG000|NOT COMPLETED|Overall Study||0
6780536|NCT02978885|7708996|FG001|NOT COMPLETED|Overall Study||0
6780537|NCT02978833|7709004|FG000|STARTED|Overall Study||1
6780538|NCT02978833|7709005|FG001|STARTED|Overall Study||1
6780539|NCT02978833|7709004|FG000|COMPLETED|Overall Study||0
6780540|NCT02978833|7709005|FG001|COMPLETED|Overall Study||0
6780541|NCT02978833|7709004|FG000|NOT COMPLETED|Overall Study||1
6780542|NCT02978833|7709005|FG001|NOT COMPLETED|Overall Study||1
6780543|NCT02971839|7709017|FG000|STARTED|Overall Study||2
6780544|NCT02971839|7709018|FG001|STARTED|Overall Study||2
6780545|NCT02971839|7709019|FG002|STARTED|Overall Study||2
6780546|NCT02971839|7709020|FG003|STARTED|Overall Study||2
6780547|NCT02971839|7709021|FG004|STARTED|Overall Study||3
6780548|NCT02971839|7709017|FG000|COMPLETED|Overall Study||2
6780549|NCT02971839|7709018|FG001|COMPLETED|Overall Study||2
6780550|NCT02971839|7709019|FG002|COMPLETED|Overall Study||2
6780551|NCT02971839|7709020|FG003|COMPLETED|Overall Study||2
6780552|NCT02971839|7709021|FG004|COMPLETED|Overall Study||3
6780553|NCT02971839|7709017|FG000|NOT COMPLETED|Overall Study||0
6780554|NCT02971839|7709018|FG001|NOT COMPLETED|Overall Study||0
6780555|NCT02971839|7709019|FG002|NOT COMPLETED|Overall Study||0
6780556|NCT02971839|7709020|FG003|NOT COMPLETED|Overall Study||0
6780557|NCT02971839|7709021|FG004|NOT COMPLETED|Overall Study||0
6780558|NCT02985840|7709035|FG000|STARTED|Overall Study||64
6780559|NCT02985840|7709036|FG001|STARTED|Overall Study||63
6780560|NCT02985840|7709035|FG000|COMPLETED|Overall Study||64
6780561|NCT02985840|7709036|FG001|COMPLETED|Overall Study||63
6780562|NCT02985840|7709035|FG000|NOT COMPLETED|Overall Study||0
6780563|NCT02985840|7709036|FG001|NOT COMPLETED|Overall Study||0
6780564|NCT02966223|7709042|FG000|STARTED|Overall Study||20
6780565|NCT02966223|7709042|FG000|COMPLETED|Overall Study||5
6780566|NCT02966223|7709042|FG000|NOT COMPLETED|Overall Study||15
6780567|NCT02965846|7709049|FG000|STARTED|Overall Study||5
6780568|NCT02965846|7709050|FG001|STARTED|Overall Study||5
6780569|NCT02965846|7709051|FG002|STARTED|Overall Study||33
6780570|NCT02965846|7709049|FG000|COMPLETED|Overall Study||0
6780571|NCT02965846|7709050|FG001|COMPLETED|Overall Study||0
6780572|NCT02965846|7709051|FG002|COMPLETED|Overall Study||0
6556530|NCT01761084|7478897|FG001|NOT COMPLETED|Overall Study||6
6780573|NCT02965846|7709049|FG000|NOT COMPLETED|Overall Study||5
6780574|NCT02965846|7709050|FG001|NOT COMPLETED|Overall Study||5
6780575|NCT02965846|7709051|FG002|NOT COMPLETED|Overall Study||33
6780576|NCT02974803|7709057|FG000|STARTED|Overall Study||6
6780577|NCT02974803|7709057|FG000|COMPLETED|Overall Study||6
6780578|NCT02974803|7709057|FG000|NOT COMPLETED|Overall Study||0
6780579|NCT02974686|7709063|FG000|STARTED|Overall Study||0
6780580|NCT02974686|7709064|FG001|STARTED|Overall Study||0
6768808|NCT04338074|7696208|FG000|STARTED|Overall Study||3
6768809|NCT04338074|7696209|FG001|STARTED|Overall Study||2
6768810|NCT04338074|7696208|FG000|COMPLETED|Overall Study||3
6768811|NCT04338074|7696209|FG001|COMPLETED|Overall Study||2
6768812|NCT04338074|7696208|FG000|NOT COMPLETED|Overall Study||0
6768813|NCT04338074|7696209|FG001|NOT COMPLETED|Overall Study||0
6768814|NCT04337138|7696215|FG000|STARTED|Overall Study||32
6768815|NCT04337138|7696215|FG000|COMPLETED|Overall Study||32
6768816|NCT04337138|7696215|FG000|NOT COMPLETED|Overall Study||0
6768817|NCT04336475|7696221|FG000|STARTED|Overall Study||30
6768818|NCT04336475|7696222|FG001|STARTED|Overall Study||30
6768819|NCT04336475|7696221|FG000|COMPLETED|Overall Study||28
6768820|NCT04336475|7696222|FG001|COMPLETED|Overall Study||28
6768821|NCT04336475|7696221|FG000|NOT COMPLETED|Overall Study||2
6768822|NCT04336475|7696222|FG001|NOT COMPLETED|Overall Study||2
6768823|NCT04335929|7696228|FG000|STARTED|Overall Study||32
6768824|NCT04335929|7696228|FG000|COMPLETED|Overall Study||22
6768825|NCT04335929|7696228|FG000|NOT COMPLETED|Overall Study||10
6768826|NCT04335812|7696234|FG000|STARTED|Overall Study||63
6768827|NCT04335812|7696235|FG001|STARTED|Overall Study||63
6768828|NCT04335812|7696234|FG000|COMPLETED|Overall Study||28
6768829|NCT04335812|7696235|FG001|COMPLETED|Overall Study||30
6768830|NCT04335812|7696234|FG000|NOT COMPLETED|Overall Study||35
6768831|NCT04335812|7696235|FG001|NOT COMPLETED|Overall Study||33
6768832|NCT04335136|7696243|FG000|STARTED|Overall Study||91
6768833|NCT04335136|7696244|FG001|STARTED|Overall Study||90
6768834|NCT04335136|7696243|FG000|Treated|Overall Study||88
6768835|NCT04335136|7696244|FG001|Treated|Overall Study||90
6768836|NCT04335136|7696243|FG000|COMPLETED|Overall Study||77
6768837|NCT04335136|7696244|FG001|COMPLETED|Overall Study||83
6768838|NCT04335136|7696243|FG000|NOT COMPLETED|Overall Study||14
6768839|NCT04335136|7696244|FG001|NOT COMPLETED|Overall Study||7
6768840|NCT04335552|7696254|FG000|STARTED|Overall Study||2
6768841|NCT04335552|7696255|FG001|STARTED|Overall Study||4
6768842|NCT04335552|7696256|FG002|STARTED|Overall Study||3
6768843|NCT04335552|7696257|FG003|STARTED|Overall Study||2
6768844|NCT04335552|7696254|FG000|COMPLETED|Overall Study||1
6768845|NCT04335552|7696255|FG001|COMPLETED|Overall Study||4
6768846|NCT04335552|7696256|FG002|COMPLETED|Overall Study||3
6768847|NCT04335552|7696257|FG003|COMPLETED|Overall Study||2
6768848|NCT04335552|7696254|FG000|NOT COMPLETED|Overall Study||1
6768849|NCT04335552|7696255|FG001|NOT COMPLETED|Overall Study||0
6768850|NCT04335552|7696256|FG002|NOT COMPLETED|Overall Study||0
6768851|NCT04335552|7696257|FG003|NOT COMPLETED|Overall Study||0
6768852|NCT04334876|7696267|FG000|STARTED|Overall Study||571
6768853|NCT04334876|7696267|FG000|COMPLETED|Overall Study||500
6768854|NCT04334876|7696267|FG000|NOT COMPLETED|Overall Study||71
6768855|NCT04334681|7696273|FG000|STARTED|Overall Study||135
6768856|NCT04334681|7696274|FG001|STARTED|Overall Study||143
6768857|NCT04334681|7696273|FG000|COMPLETED|Overall Study||135
6768858|NCT04334681|7696274|FG001|COMPLETED|Overall Study||143
6768859|NCT04334681|7696273|FG000|NOT COMPLETED|Overall Study||0
6768860|NCT04334681|7696274|FG001|NOT COMPLETED|Overall Study||0
6768861|NCT04333225|7696284|FG000|STARTED|Overall Study||101
6768862|NCT04333225|7696285|FG001|STARTED|Overall Study||120
6768863|NCT04333225|7696284|FG000|COMPLETED|Overall Study||98
6768864|NCT04333225|7696285|FG001|COMPLETED|Overall Study||115
6768865|NCT04333225|7696284|FG000|NOT COMPLETED|Overall Study||3
6768866|NCT04333225|7696285|FG001|NOT COMPLETED|Overall Study||5
6768867|NCT04333199|7696294|FG000|STARTED|Evaluated Patients||1669
6768868|NCT04333199|7696295|FG001|STARTED|Evaluated Patients||1672
6768869|NCT04333199|7696296|FG002|STARTED|Evaluated Patients||1671
6768870|NCT04333199|7696294|FG000|COMPLETED|Evaluated Patients||1669
6768871|NCT04333199|7696295|FG001|COMPLETED|Evaluated Patients||1671
6768872|NCT04333199|7696296|FG002|COMPLETED|Evaluated Patients||1669
6768873|NCT04333199|7696294|FG000|NOT COMPLETED|Evaluated Patients||0
6768874|NCT04333199|7696295|FG001|NOT COMPLETED|Evaluated Patients||1
6768875|NCT04333199|7696296|FG002|NOT COMPLETED|Evaluated Patients||2
6768876|NCT04333199|7696294|FG000|STARTED|Emailed Patients|Patients in this group were not emailed|0
6768877|NCT04333199|7696295|FG001|STARTED|Emailed Patients||1671
6768878|NCT04333199|7696296|FG002|STARTED|Emailed Patients||1669
6768879|NCT04333199|7696294|FG000|Valid Email Address|Emailed Patients|Patients in this group were not emailed|0
6768880|NCT04333199|7696295|FG001|Valid Email Address|Emailed Patients||1495
6768881|NCT04333199|7696296|FG002|Valid Email Address|Emailed Patients||1441
6768882|NCT04333199|7696294|FG000|COMPLETED|Emailed Patients|Patients in this group were not emailed|0
6768883|NCT04333199|7696295|FG001|COMPLETED|Emailed Patients||1399
6768884|NCT04333199|7696296|FG002|COMPLETED|Emailed Patients||1351
6768885|NCT04333199|7696294|FG000|NOT COMPLETED|Emailed Patients||0
6768886|NCT04333199|7696295|FG001|NOT COMPLETED|Emailed Patients||272
6768887|NCT04333199|7696296|FG002|NOT COMPLETED|Emailed Patients||318
6768888|NCT04332991|7696307|FG000|STARTED|Overall Study||242
6768889|NCT04332991|7696308|FG001|STARTED|Overall Study||237
6768890|NCT04332991|7696307|FG000|COMPLETED|Overall Study||242
6768891|NCT04332991|7696308|FG001|COMPLETED|Overall Study||237
6768892|NCT04332991|7696307|FG000|NOT COMPLETED|Overall Study||0
6768893|NCT04332991|7696308|FG001|NOT COMPLETED|Overall Study||0
6768894|NCT04332614|7696320|FG000|STARTED|~1 Week After Study Launch||2350
6768895|NCT04332614|7696321|FG001|STARTED|~1 Week After Study Launch||2350
6768896|NCT04332614|7696322|FG002|STARTED|~1 Week After Study Launch||2350
6768897|NCT04332614|7696323|FG003|STARTED|~1 Week After Study Launch||2350
6768898|NCT04332614|7696324|FG004|STARTED|~1 Week After Study Launch||2350
6768899|NCT04332614|7696325|FG005|STARTED|~1 Week After Study Launch||2349
6768900|NCT04332614|7696320|FG000|Data in EHR|~1 Week After Study Launch||2245
6768901|NCT04332614|7696321|FG001|Data in EHR|~1 Week After Study Launch||2273
6768902|NCT04332614|7696322|FG002|Data in EHR|~1 Week After Study Launch||2251
6768903|NCT04332614|7696323|FG003|Data in EHR|~1 Week After Study Launch||2254
6768904|NCT04332614|7696324|FG004|Data in EHR|~1 Week After Study Launch||2251
6768905|NCT04332614|7696325|FG005|Data in EHR|~1 Week After Study Launch||2249
6768906|NCT04332614|7696320|FG000|COMPLETED|~1 Week After Study Launch||2117
6768907|NCT04332614|7696321|FG001|COMPLETED|~1 Week After Study Launch||2129
6768908|NCT04332614|7696322|FG002|COMPLETED|~1 Week After Study Launch||2124
6768909|NCT04332614|7696323|FG003|COMPLETED|~1 Week After Study Launch||2131
6768910|NCT04332614|7696324|FG004|COMPLETED|~1 Week After Study Launch||2127
6768911|NCT04332614|7696325|FG005|COMPLETED|~1 Week After Study Launch||2115
6768912|NCT04332614|7696320|FG000|NOT COMPLETED|~1 Week After Study Launch||233
6768913|NCT04332614|7696321|FG001|NOT COMPLETED|~1 Week After Study Launch||221
6768914|NCT04332614|7696322|FG002|NOT COMPLETED|~1 Week After Study Launch||226
6768915|NCT04332614|7696323|FG003|NOT COMPLETED|~1 Week After Study Launch||219
6768916|NCT04332614|7696324|FG004|NOT COMPLETED|~1 Week After Study Launch||223
6768917|NCT04332614|7696325|FG005|NOT COMPLETED|~1 Week After Study Launch||234
6768918|NCT04332614|7696320|FG000|STARTED|~1 Month After Study Launch||2117
6768919|NCT04332614|7696321|FG001|STARTED|~1 Month After Study Launch||2129
6768920|NCT04332614|7696322|FG002|STARTED|~1 Month After Study Launch||2124
6768921|NCT04332614|7696323|FG003|STARTED|~1 Month After Study Launch||2131
6768922|NCT04332614|7696324|FG004|STARTED|~1 Month After Study Launch||2127
6768923|NCT04332614|7696325|FG005|STARTED|~1 Month After Study Launch||2115
6768924|NCT04332614|7696320|FG000|COMPLETED|~1 Month After Study Launch||2095
6768925|NCT04332614|7696321|FG001|COMPLETED|~1 Month After Study Launch||2107
6556531|NCT01761162|7478904|FG000|STARTED|Overall Study||229
6556532|NCT01761162|7478904|FG000|COMPLETED|Overall Study||226
6556533|NCT01761162|7478904|FG000|NOT COMPLETED|Overall Study||3
6556534|NCT01761175|7478910|FG000|STARTED|Overall Study||112
6556535|NCT01761175|7478911|FG001|STARTED|Overall Study||112
6556536|NCT01761175|7478910|FG000|COMPLETED|Overall Study||112
6556537|NCT01761175|7478911|FG001|COMPLETED|Overall Study||112
6556538|NCT01761175|7478910|FG000|NOT COMPLETED|Overall Study||0
6556539|NCT01761175|7478911|FG001|NOT COMPLETED|Overall Study||0
6556540|NCT01761279|7478918|FG000|STARTED|Overall Study||84
6556541|NCT01761279|7478918|FG000|COMPLETED|Overall Study||84
6556542|NCT01761279|7478918|FG000|NOT COMPLETED|Overall Study||0
6556543|NCT01761292|7478926|FG000|STARTED|Part 1||20
6556544|NCT01761292|7478926|FG000|Patients Receiving Drug in Part 1|Part 1|One patient was enrolled in Part 1 and started treatment in Part 2.|19
6556545|NCT01761292|7478926|FG000|COMPLETED|Part 1||18
6556546|NCT01761292|7478926|FG000|NOT COMPLETED|Part 1||2
6556547|NCT01761292|7478926|FG000|STARTED|Part 2|1 pt was enrolled in Part 1 but started the treatment in Part 2. So 19 pts started Part 2.|19
6556548|NCT01761292|7478926|FG000|COMPLETED|Part 2||19
6556549|NCT01761292|7478926|FG000|NOT COMPLETED|Part 2||0
6556550|NCT01761292|7478926|FG000|STARTED|Extension 1||19
6556551|NCT01761292|7478926|FG000|COMPLETED|Extension 1||18
6556552|NCT01761292|7478926|FG000|NOT COMPLETED|Extension 1||1
6556553|NCT01761292|7478926|FG000|STARTED|Extension 2||18
6556554|NCT01761292|7478926|FG000|COMPLETED|Extension 2||18
6556555|NCT01761292|7478926|FG000|NOT COMPLETED|Extension 2||0
6556556|NCT01761292|7478926|FG000|STARTED|Extension 3||18
6556557|NCT01761292|7478926|FG000|COMPLETED|Extension 3||18
6556558|NCT01761292|7478926|FG000|NOT COMPLETED|Extension 3||0
6556559|NCT01761565|7478937|FG000|STARTED|Single Dose of SUF NT 15 mcg||40
6556560|NCT01761565|7478937|FG000|COMPLETED|Single Dose of SUF NT 15 mcg||40
6556561|NCT01761565|7478937|FG000|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
6556562|NCT01761565|7478937|FG000|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
6556563|NCT01761565|7478937|FG000|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
6556564|NCT01761565|7478937|FG000|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
6556565|NCT01761643|7478947|FG000|STARTED|Overall Study||198
6556566|NCT01761643|7478948|FG001|STARTED|Overall Study||200
6556567|NCT01761643|7478947|FG000|COMPLETED|Overall Study||166
6556568|NCT01761643|7478948|FG001|COMPLETED|Overall Study||158
6556569|NCT01761643|7478947|FG000|NOT COMPLETED|Overall Study||32
6556570|NCT01761643|7478948|FG001|NOT COMPLETED|Overall Study||42
6556571|NCT01761747|7478954|FG000|STARTED|Overall Study||3
6556572|NCT01761747|7478954|FG000|COMPLETED|Overall Study||2
6556573|NCT01761747|7478954|FG000|NOT COMPLETED|Overall Study||1
6556574|NCT01762059|7478958|FG000|STARTED|Overall Study||20
6556575|NCT01762059|7478958|FG000|COMPLETED|Overall Study||20
6768926|NCT04332614|7696322|FG002|COMPLETED|~1 Month After Study Launch||2094
6768927|NCT04332614|7696323|FG003|COMPLETED|~1 Month After Study Launch||2107
6768928|NCT04332614|7696324|FG004|COMPLETED|~1 Month After Study Launch||2107
6556576|NCT01762059|7478958|FG000|NOT COMPLETED|Overall Study||0
6556577|NCT01762345|7478967|FG000|STARTED|Overall Study||83
6556578|NCT01762345|7478967|FG000|COMPLETED|Overall Study||76
6556579|NCT01762345|7478967|FG000|NOT COMPLETED|Overall Study||7
6556580|NCT01762501|7478974|FG000|STARTED|Overall Study||359
6556581|NCT01762501|7478975|FG001|STARTED|Overall Study||359
6556582|NCT01762501|7478974|FG000|COMPLETED|Overall Study||332
6556583|NCT01762501|7478975|FG001|COMPLETED|Overall Study||336
6768929|NCT04332614|7696325|FG005|COMPLETED|~1 Month After Study Launch||2096
6768930|NCT04332614|7696320|FG000|NOT COMPLETED|~1 Month After Study Launch||22
6768931|NCT04332614|7696321|FG001|NOT COMPLETED|~1 Month After Study Launch||22
6768932|NCT04332614|7696322|FG002|NOT COMPLETED|~1 Month After Study Launch||30
6768933|NCT04332614|7696323|FG003|NOT COMPLETED|~1 Month After Study Launch||24
6768934|NCT04332614|7696324|FG004|NOT COMPLETED|~1 Month After Study Launch||20
6768935|NCT04332614|7696325|FG005|NOT COMPLETED|~1 Month After Study Launch||19
6768936|NCT04322968|7696344|FG000|STARTED|Overall Study||11
6768937|NCT04322968|7696345|FG001|STARTED|Overall Study||10
6768938|NCT04322968|7696346|FG002|STARTED|Overall Study||10
6768939|NCT04322968|7696347|FG003|STARTED|Overall Study||10
6768940|NCT04322968|7696344|FG000|COMPLETED|Overall Study||10
6768941|NCT04322968|7696345|FG001|COMPLETED|Overall Study||9
6768942|NCT04322968|7696346|FG002|COMPLETED|Overall Study||10
6768943|NCT04322968|7696347|FG003|COMPLETED|Overall Study||10
6768944|NCT04322968|7696344|FG000|NOT COMPLETED|Overall Study||1
6768945|NCT04322968|7696345|FG001|NOT COMPLETED|Overall Study||1
6768946|NCT04322968|7696346|FG002|NOT COMPLETED|Overall Study||0
6768947|NCT04322968|7696347|FG003|NOT COMPLETED|Overall Study||0
6768948|NCT04332419|7696357|FG000|STARTED|Overall Study||11
6768949|NCT04332419|7696357|FG000|COMPLETED|Overall Study||10
6768950|NCT04332419|7696357|FG000|NOT COMPLETED|Overall Study||1
6768951|NCT04332081|7696363|FG000|STARTED|Overall Study||20
6768952|NCT04332081|7696364|FG001|STARTED|Overall Study||60
6768953|NCT04332081|7696363|FG000|COMPLETED|Overall Study||20
6768954|NCT04332081|7696364|FG001|COMPLETED|Overall Study||60
6768955|NCT04332081|7696363|FG000|NOT COMPLETED|Overall Study||0
6768956|NCT04332081|7696364|FG001|NOT COMPLETED|Overall Study||0
6768957|NCT04332107|7696372|FG000|STARTED|Day 3||171
6768958|NCT04332107|7696373|FG001|STARTED|Day 3||92
6768959|NCT04332107|7696372|FG000|COMPLETED|Day 3||145
6768960|NCT04332107|7696373|FG001|COMPLETED|Day 3||72
6768961|NCT04332107|7696372|FG000|NOT COMPLETED|Day 3||26
6768962|NCT04332107|7696373|FG001|NOT COMPLETED|Day 3||20
6768963|NCT04332107|7696372|FG000|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|148
6768964|NCT04332107|7696373|FG001|STARTED|Day 14|Those who had missing measurements at Day 3 but were not completely lost-to-followup were allowed to continue with the trial.|78
6768965|NCT04332107|7696372|FG000|COMPLETED|Day 14||131
6768966|NCT04332107|7696373|FG001|COMPLETED|Day 14||70
6768967|NCT04332107|7696372|FG000|NOT COMPLETED|Day 14||17
6768968|NCT04332107|7696373|FG001|NOT COMPLETED|Day 14||8
6768969|NCT04332107|7696372|FG000|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|135
6768970|NCT04332107|7696373|FG001|STARTED|Day 21|Those who had missing measurements at Day 14 but were not completely lost-to-followup were allowed to continue with the trial.|74
6768971|NCT04332107|7696372|FG000|COMPLETED|Day 21||125
6768972|NCT04332107|7696373|FG001|COMPLETED|Day 21||72
6768973|NCT04332107|7696372|FG000|NOT COMPLETED|Day 21||10
6768974|NCT04332107|7696373|FG001|NOT COMPLETED|Day 21||2
6768975|NCT04323592|7696381|FG000|STARTED|Overall Study||83
6768976|NCT04323592|7696382|FG001|STARTED|Overall Study||90
6768977|NCT04323592|7696381|FG000|COMPLETED|Overall Study||83
6768978|NCT04323592|7696382|FG001|COMPLETED|Overall Study||90
6768979|NCT04323592|7696381|FG000|NOT COMPLETED|Overall Study||0
6768980|NCT04323592|7696382|FG001|NOT COMPLETED|Overall Study||0
6768981|NCT04326842|7696390|FG000|STARTED|Overall Study||40
6768982|NCT04326842|7696391|FG001|STARTED|Overall Study||89
6768983|NCT04326842|7696390|FG000|COMPLETED|Overall Study||31
6768984|NCT04326842|7696391|FG001|COMPLETED|Overall Study||31
6768985|NCT04326842|7696390|FG000|NOT COMPLETED|Overall Study||9
6768986|NCT04326842|7696391|FG001|NOT COMPLETED|Overall Study||58
6768987|NCT04325542|7696397|FG000|STARTED|Overall Study|one participant withdraw consent during the study|743
6768988|NCT04325542|7696397|FG000|COMPLETED|Overall Study||742
6768989|NCT04325542|7696397|FG000|NOT COMPLETED|Overall Study||1
6768990|NCT04329923|7696407|FG000|STARTED|Overall Study||17
6768991|NCT04329923|7696408|FG001|STARTED|Overall Study||17
6768992|NCT04329923|7696409|FG002|STARTED|Overall Study||4
6768993|NCT04329923|7696410|FG003|STARTED|Overall Study||3
6768994|NCT04329923|7696411|FG004|STARTED|Overall Study||66
6768995|NCT04329923|7696412|FG005|STARTED|Overall Study||66
6768996|NCT04329923|7696407|FG000|COMPLETED|Overall Study||16
6768997|NCT04329923|7696408|FG001|COMPLETED|Overall Study||13
6768998|NCT04329923|7696409|FG002|COMPLETED|Overall Study||3
6768999|NCT04329923|7696410|FG003|COMPLETED|Overall Study||2
6769000|NCT04329923|7696411|FG004|COMPLETED|Overall Study||64
6769001|NCT04329923|7696412|FG005|COMPLETED|Overall Study||61
6769002|NCT04329923|7696407|FG000|NOT COMPLETED|Overall Study||1
6769003|NCT04329923|7696408|FG001|NOT COMPLETED|Overall Study||4
6769004|NCT04329923|7696409|FG002|NOT COMPLETED|Overall Study||1
6769005|NCT04329923|7696410|FG003|NOT COMPLETED|Overall Study||1
6769006|NCT04329923|7696411|FG004|NOT COMPLETED|Overall Study||2
6769007|NCT04329923|7696412|FG005|NOT COMPLETED|Overall Study||5
6769008|NCT04328467|7696429|FG000|STARTED|Overall Study||494
6769009|NCT04328467|7696430|FG001|STARTED|Overall Study||495
6769010|NCT04328467|7696431|FG002|STARTED|Overall Study||494
6769011|NCT04328467|7696429|FG000|COMPLETED|Overall Study||490
6769012|NCT04328467|7696430|FG001|COMPLETED|Overall Study||493
6769013|NCT04328467|7696431|FG002|COMPLETED|Overall Study||493
6769014|NCT04328467|7696429|FG000|NOT COMPLETED|Overall Study||4
6769015|NCT04328467|7696430|FG001|NOT COMPLETED|Overall Study||2
6769016|NCT04328467|7696431|FG002|NOT COMPLETED|Overall Study||1
6769017|NCT04322526|7696441|FG000|STARTED|First Intervention (1 Day)||13
6769018|NCT04322526|7696442|FG001|STARTED|First Intervention (1 Day)||12
6769019|NCT04322526|7696441|FG000|COMPLETED|First Intervention (1 Day)||12
6769020|NCT04322526|7696442|FG001|COMPLETED|First Intervention (1 Day)||11
6769021|NCT04322526|7696441|FG000|NOT COMPLETED|First Intervention (1 Day)||1
6769022|NCT04322526|7696442|FG001|NOT COMPLETED|First Intervention (1 Day)||1
6769023|NCT04322526|7696441|FG000|STARTED|Washout (1 Week)||12
6769024|NCT04322526|7696442|FG001|STARTED|Washout (1 Week)||11
6769025|NCT04322526|7696441|FG000|COMPLETED|Washout (1 Week)||11
6769026|NCT04322526|7696442|FG001|COMPLETED|Washout (1 Week)||9
6769027|NCT04322526|7696441|FG000|NOT COMPLETED|Washout (1 Week)||1
6769028|NCT04322526|7696442|FG001|NOT COMPLETED|Washout (1 Week)||2
6769029|NCT04322526|7696441|FG000|STARTED|Second Intervention (1day)||11
6769030|NCT04322526|7696442|FG001|STARTED|Second Intervention (1day)||9
6769031|NCT04322526|7696441|FG000|COMPLETED|Second Intervention (1day)||11
6769032|NCT04322526|7696442|FG001|COMPLETED|Second Intervention (1day)||9
6769033|NCT04322526|7696441|FG000|NOT COMPLETED|Second Intervention (1day)||0
6769034|NCT04322526|7696442|FG001|NOT COMPLETED|Second Intervention (1day)||0
6769035|NCT04322500|7696450|FG000|STARTED|Overall Study||13
6769036|NCT04322500|7696451|FG001|STARTED|Overall Study||13
6769037|NCT04322500|7696450|FG000|COMPLETED|Overall Study||13
6769038|NCT04322500|7696451|FG001|COMPLETED|Overall Study||13
6769039|NCT04322500|7696450|FG000|NOT COMPLETED|Overall Study||0
6769040|NCT04322500|7696451|FG001|NOT COMPLETED|Overall Study||0
6769041|NCT04322682|7696459|FG000|STARTED|Overall Study||2235
6769042|NCT04322682|7696460|FG001|STARTED|Overall Study||2253
6769043|NCT04322682|7696459|FG000|COMPLETED|Overall Study||2192
6769044|NCT04322682|7696460|FG001|COMPLETED|Overall Study||2189
6769045|NCT04322682|7696459|FG000|NOT COMPLETED|Overall Study||43
6769046|NCT04322682|7696460|FG001|NOT COMPLETED|Overall Study||64
6769047|NCT04321980|7696468|FG000|STARTED|Overall Study||4
6769048|NCT04321980|7696469|FG001|STARTED|Overall Study||4
6769049|NCT04321980|7696468|FG000|COMPLETED|Overall Study||4
6769050|NCT04321980|7696469|FG001|COMPLETED|Overall Study||4
6769051|NCT04321980|7696468|FG000|NOT COMPLETED|Overall Study||0
6769052|NCT04321980|7696469|FG001|NOT COMPLETED|Overall Study||0
6769053|NCT04322396|7696477|FG000|STARTED|Overall Study||56
6769054|NCT04322396|7696478|FG001|STARTED|Overall Study||61
6769055|NCT04322396|7696477|FG000|COMPLETED|Overall Study||56
6769056|NCT04322396|7696478|FG001|COMPLETED|Overall Study||61
6769057|NCT04322396|7696477|FG000|NOT COMPLETED|Overall Study||0
6769058|NCT04322396|7696478|FG001|NOT COMPLETED|Overall Study||0
6769059|NCT04320823|7696486|FG000|STARTED|Overall Study||1717
6769060|NCT04320823|7696487|FG001|STARTED|Overall Study||1726
6769061|NCT04320823|7696486|FG000|COMPLETED|Overall Study|Includes 47 donors who withdrew from the study after one or more donations.|1717
6769062|NCT04320823|7696487|FG001|COMPLETED|Overall Study|Includes 38 donors who withdrew from the study after one or more donations.|1726
6769063|NCT04320823|7696486|FG000|NOT COMPLETED|Overall Study||0
6769064|NCT04320823|7696487|FG001|NOT COMPLETED|Overall Study||0
6769065|NCT04320615|7696511|FG000|STARTED|Overall Study||144
6769066|NCT04320615|7696512|FG001|STARTED|Overall Study||294
6769067|NCT04320615|7696511|FG000|COMPLETED|Overall Study||96
6769068|NCT04320615|7696512|FG001|COMPLETED|Overall Study||190
6769069|NCT04320615|7696511|FG000|NOT COMPLETED|Overall Study||48
6769070|NCT04320615|7696512|FG001|NOT COMPLETED|Overall Study||104
6769071|NCT04318535|7696522|FG000|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
6769072|NCT04318535|7696523|FG001|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
6769073|NCT04318535|7696524|FG002|STARTED|Treatment Period 1 (Day -1 to Day 5)||12
6769074|NCT04318535|7696522|FG000|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
6769075|NCT04318535|7696523|FG001|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
6769076|NCT04318535|7696524|FG002|COMPLETED|Treatment Period 1 (Day -1 to Day 5)||12
6769077|NCT04318535|7696522|FG000|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
6769078|NCT04318535|7696523|FG001|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
6769079|NCT04318535|7696524|FG002|NOT COMPLETED|Treatment Period 1 (Day -1 to Day 5)||0
6769080|NCT04318535|7696522|FG000|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
6769081|NCT04318535|7696523|FG001|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
6769082|NCT04318535|7696524|FG002|STARTED|Period1washout(Atleast 7 Days Post-dose)||12
6769083|NCT04318535|7696522|FG000|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
6769084|NCT04318535|7696523|FG001|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
6769085|NCT04318535|7696524|FG002|COMPLETED|Period1washout(Atleast 7 Days Post-dose)||12
6769086|NCT04318535|7696522|FG000|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
6769087|NCT04318535|7696523|FG001|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
6769088|NCT04318535|7696524|FG002|NOT COMPLETED|Period1washout(Atleast 7 Days Post-dose)||0
6769089|NCT04318535|7696522|FG000|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
6769090|NCT04318535|7696523|FG001|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
6769091|NCT04318535|7696524|FG002|STARTED|Treatment Period 2 (Day 7 to Day 12)||12
6769092|NCT04318535|7696522|FG000|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
6769093|NCT04318535|7696523|FG001|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
6769094|NCT04318535|7696524|FG002|COMPLETED|Treatment Period 2 (Day 7 to Day 12)||12
6769095|NCT04318535|7696522|FG000|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
6769096|NCT04318535|7696523|FG001|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
6769097|NCT04318535|7696524|FG002|NOT COMPLETED|Treatment Period 2 (Day 7 to Day 12)||0
6769098|NCT04318535|7696522|FG000|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
6769099|NCT04318535|7696523|FG001|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
6769100|NCT04318535|7696524|FG002|STARTED|Period2washout(Atleast 7 Days Post-dose)||12
6769101|NCT04318535|7696522|FG000|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
6769102|NCT04318535|7696523|FG001|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||11
6769103|NCT04318535|7696524|FG002|COMPLETED|Period2washout(Atleast 7 Days Post-dose)||12
6769104|NCT04318535|7696522|FG000|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
6769105|NCT04318535|7696523|FG001|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||1
6769106|NCT04318535|7696524|FG002|NOT COMPLETED|Period2washout(Atleast 7 Days Post-dose)||0
6769107|NCT04318535|7696522|FG000|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
6769108|NCT04318535|7696523|FG001|STARTED|Treatment Period 3 (Day 17 to Day 22)||11
6769109|NCT04318535|7696524|FG002|STARTED|Treatment Period 3 (Day 17 to Day 22)||12
6769110|NCT04318535|7696522|FG000|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
6769111|NCT04318535|7696523|FG001|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||11
6769112|NCT04318535|7696524|FG002|COMPLETED|Treatment Period 3 (Day 17 to Day 22)||12
6769113|NCT04318535|7696522|FG000|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
6769114|NCT04318535|7696523|FG001|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
6769115|NCT04318535|7696524|FG002|NOT COMPLETED|Treatment Period 3 (Day 17 to Day 22)||0
6769116|NCT04316260|7696535|FG000|STARTED|Overall Study||34
6769117|NCT04316260|7696536|FG001|STARTED|Overall Study||17
6769118|NCT04316260|7696535|FG000|COMPLETED|Overall Study||34
6769119|NCT04316260|7696536|FG001|COMPLETED|Overall Study||17
6769120|NCT04316260|7696535|FG000|NOT COMPLETED|Overall Study||0
6769121|NCT04316260|7696536|FG001|NOT COMPLETED|Overall Study||0
6769122|NCT04314037|7696545|FG000|STARTED|Treatment Period 1||18
6769123|NCT04314037|7696546|FG001|STARTED|Treatment Period 1||18
6769124|NCT04314037|7696545|FG000|COMPLETED|Treatment Period 1||18
6769125|NCT04314037|7696546|FG001|COMPLETED|Treatment Period 1||18
6769126|NCT04314037|7696545|FG000|NOT COMPLETED|Treatment Period 1||0
6769127|NCT04314037|7696546|FG001|NOT COMPLETED|Treatment Period 1||0
6769128|NCT04314037|7696545|FG000|STARTED|Treatment Period 2||18
6769129|NCT04314037|7696546|FG001|STARTED|Treatment Period 2||18
6769130|NCT04314037|7696545|FG000|COMPLETED|Treatment Period 2||17
6769131|NCT04314037|7696546|FG001|COMPLETED|Treatment Period 2||18
6769132|NCT04314037|7696545|FG000|NOT COMPLETED|Treatment Period 2||1
6769133|NCT04314037|7696546|FG001|NOT COMPLETED|Treatment Period 2||0
6769134|NCT04314037|7696545|FG000|STARTED|Treatment Period 3||17
6769135|NCT04314037|7696546|FG001|STARTED|Treatment Period 3||18
6769136|NCT04314037|7696545|FG000|COMPLETED|Treatment Period 3||16
6769137|NCT04314037|7696546|FG001|COMPLETED|Treatment Period 3||17
6769138|NCT04314037|7696545|FG000|NOT COMPLETED|Treatment Period 3||1
6769139|NCT04314037|7696546|FG001|NOT COMPLETED|Treatment Period 3||1
6769140|NCT04314037|7696545|FG000|STARTED|Treatment Period 4||16
6769141|NCT04314037|7696546|FG001|STARTED|Treatment Period 4||17
6769142|NCT04314037|7696545|FG000|COMPLETED|Treatment Period 4||16
6769143|NCT04314037|7696546|FG001|COMPLETED|Treatment Period 4||17
6769144|NCT04314037|7696545|FG000|NOT COMPLETED|Treatment Period 4||0
6769145|NCT04314037|7696546|FG001|NOT COMPLETED|Treatment Period 4||0
6769146|NCT04315298|7696577|FG000|STARTED|Overall Study||90
6769147|NCT04315298|7696578|FG001|STARTED|Overall Study||187
6769148|NCT04315298|7696579|FG002|STARTED|Overall Study||180
6769149|NCT04315298|7696580|FG003|STARTED|Overall Study||170
6769150|NCT04315298|7696581|FG004|STARTED|Overall Study||242
6769151|NCT04315298|7696582|FG005|STARTED|Overall Study||338
6769152|NCT04315298|7696583|FG006|STARTED|Overall Study||70
6769153|NCT04315298|7696584|FG007|STARTED|Overall Study||140
6769154|NCT04315298|7696585|FG008|STARTED|Overall Study||137
6769155|NCT04315298|7696586|FG009|STARTED|Overall Study||46
6769156|NCT04315298|7696587|FG010|STARTED|Overall Study||95
6769157|NCT04315298|7696588|FG011|STARTED|Overall Study||92
6769158|NCT04315298|7696589|FG012|STARTED|Overall Study||8
6769159|NCT04315298|7696590|FG013|STARTED|Overall Study||12
6769160|NCT04315298|7696591|FG014|STARTED|Overall Study||15
6769161|NCT04315298|7696592|FG015|STARTED|Overall Study||15
6769162|NCT04315298|7696593|FG016|STARTED|Overall Study||16
6769163|NCT04315298|7696594|FG017|STARTED|Overall Study||6
6769164|NCT04315298|7696595|FG018|STARTED|Overall Study||2
6769165|NCT04315298|7696577|FG000|COMPLETED|Overall Study||61
6769166|NCT04315298|7696578|FG001|COMPLETED|Overall Study||117
6769167|NCT04315298|7696579|FG002|COMPLETED|Overall Study||125
6769168|NCT04315298|7696580|FG003|COMPLETED|Overall Study||101
6769169|NCT04315298|7696581|FG004|COMPLETED|Overall Study||157
6769170|NCT04315298|7696582|FG005|COMPLETED|Overall Study||209
6769171|NCT04315298|7696583|FG006|COMPLETED|Overall Study||52
6769172|NCT04315298|7696584|FG007|COMPLETED|Overall Study||111
6769173|NCT04315298|7696585|FG008|COMPLETED|Overall Study||101
6769174|NCT04315298|7696586|FG009|COMPLETED|Overall Study||29
6769175|NCT04315298|7696587|FG010|COMPLETED|Overall Study||53
6556584|NCT01762501|7478974|FG000|NOT COMPLETED|Overall Study||27
6556585|NCT01762501|7478975|FG001|NOT COMPLETED|Overall Study||23
6556586|NCT01762631|7478983|FG000|STARTED|Overall Study||53
6556587|NCT01762631|7478984|FG001|STARTED|Overall Study||22
6556588|NCT01762631|7478983|FG000|COMPLETED|Overall Study||53
6769176|NCT04315298|7696588|FG011|COMPLETED|Overall Study||51
6769177|NCT04315298|7696589|FG012|COMPLETED|Overall Study||5
6769178|NCT04315298|7696590|FG013|COMPLETED|Overall Study||8
6769179|NCT04315298|7696591|FG014|COMPLETED|Overall Study||9
6769180|NCT04315298|7696592|FG015|COMPLETED|Overall Study||9
6769181|NCT04315298|7696593|FG016|COMPLETED|Overall Study||13
6769182|NCT04315298|7696594|FG017|COMPLETED|Overall Study||5
6769183|NCT04315298|7696595|FG018|COMPLETED|Overall Study||2
6769184|NCT04315298|7696577|FG000|NOT COMPLETED|Overall Study||29
6769185|NCT04315298|7696578|FG001|NOT COMPLETED|Overall Study||70
6769186|NCT04315298|7696579|FG002|NOT COMPLETED|Overall Study||55
6769187|NCT04315298|7696580|FG003|NOT COMPLETED|Overall Study||69
6769188|NCT04315298|7696581|FG004|NOT COMPLETED|Overall Study||85
6769189|NCT04315298|7696582|FG005|NOT COMPLETED|Overall Study||129
6769190|NCT04315298|7696583|FG006|NOT COMPLETED|Overall Study||18
6769191|NCT04315298|7696584|FG007|NOT COMPLETED|Overall Study||29
6769192|NCT04315298|7696585|FG008|NOT COMPLETED|Overall Study||36
6769193|NCT04315298|7696586|FG009|NOT COMPLETED|Overall Study||17
6769194|NCT04315298|7696587|FG010|NOT COMPLETED|Overall Study||42
6769195|NCT04315298|7696588|FG011|NOT COMPLETED|Overall Study||41
6769196|NCT04315298|7696589|FG012|NOT COMPLETED|Overall Study||3
6769197|NCT04315298|7696590|FG013|NOT COMPLETED|Overall Study||4
6769198|NCT04315298|7696591|FG014|NOT COMPLETED|Overall Study||6
6769199|NCT04315298|7696592|FG015|NOT COMPLETED|Overall Study||6
6769200|NCT04315298|7696593|FG016|NOT COMPLETED|Overall Study||3
6769201|NCT04315298|7696594|FG017|NOT COMPLETED|Overall Study||1
6769202|NCT04315298|7696595|FG018|NOT COMPLETED|Overall Study||0
6769203|NCT04313647|7696667|FG000|STARTED|Overall Study||3
6769204|NCT04313647|7696668|FG001|STARTED|Overall Study||3
6769205|NCT04313647|7696669|FG002|STARTED|Overall Study||6
6769206|NCT04313647|7696670|FG003|STARTED|Overall Study||6
6769207|NCT04313647|7696671|FG004|STARTED|Overall Study||6
6769208|NCT04313647|7696667|FG000|COMPLETED|Overall Study||3
6769209|NCT04313647|7696668|FG001|COMPLETED|Overall Study||3
6769210|NCT04313647|7696669|FG002|COMPLETED|Overall Study||6
6769211|NCT04313647|7696670|FG003|COMPLETED|Overall Study||6
6769212|NCT04313647|7696671|FG004|COMPLETED|Overall Study||6
6769213|NCT04313647|7696667|FG000|NOT COMPLETED|Overall Study||0
6769214|NCT04313647|7696668|FG001|NOT COMPLETED|Overall Study||0
6769215|NCT04313647|7696669|FG002|NOT COMPLETED|Overall Study||0
6769216|NCT04313647|7696670|FG003|NOT COMPLETED|Overall Study||0
6769217|NCT04313647|7696671|FG004|NOT COMPLETED|Overall Study||0
6769218|NCT04310085|7696690|FG000|STARTED|Overall Study||8
6769219|NCT04310085|7696691|FG001|STARTED|Overall Study||8
6769220|NCT04310085|7696690|FG000|COMPLETED|Overall Study||8
6769221|NCT04310085|7696691|FG001|COMPLETED|Overall Study||8
6769222|NCT04310085|7696690|FG000|NOT COMPLETED|Overall Study||0
6769223|NCT04310085|7696691|FG001|NOT COMPLETED|Overall Study||0
6769224|NCT04309617|7696697|FG000|STARTED|Overall Study||618
6769225|NCT04309617|7696697|FG000|Modified High Risk of Recurrence|Overall Study||136
6769226|NCT04309617|7696697|FG000|COMPLETED|Overall Study||618
6769227|NCT04309617|7696697|FG000|NOT COMPLETED|Overall Study||0
6769228|NCT04308239|7696705|FG000|STARTED|Pre-intervention Evaluation (1 Week)||20
6769229|NCT04308239|7696706|FG001|STARTED|Pre-intervention Evaluation (1 Week)||14
6769230|NCT04308239|7696705|FG000|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|17
6769231|NCT04308239|7696706|FG001|COMPLETED|Pre-intervention Evaluation (1 Week)|No withdrawals. These participants just missed this evaluation but stayed in study.|11
6769232|NCT04308239|7696705|FG000|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
6769233|NCT04308239|7696706|FG001|NOT COMPLETED|Pre-intervention Evaluation (1 Week)||3
6769234|NCT04308239|7696705|FG000|STARTED|Intervention (2 Weeks)||20
6769235|NCT04308239|7696706|FG001|STARTED|Intervention (2 Weeks)||14
6769236|NCT04308239|7696705|FG000|COMPLETED|Intervention (2 Weeks)||20
6769237|NCT04308239|7696706|FG001|COMPLETED|Intervention (2 Weeks)||14
6769238|NCT04308239|7696705|FG000|NOT COMPLETED|Intervention (2 Weeks)||0
6769239|NCT04308239|7696706|FG001|NOT COMPLETED|Intervention (2 Weeks)||0
6769240|NCT04308239|7696705|FG000|STARTED|Post-intervention Evaluation (1 Week)||20
6769241|NCT04308239|7696706|FG001|STARTED|Post-intervention Evaluation (1 Week)||14
6769242|NCT04308239|7696705|FG000|COMPLETED|Post-intervention Evaluation (1 Week)||19
6769243|NCT04308239|7696706|FG001|COMPLETED|Post-intervention Evaluation (1 Week)||10
6769244|NCT04308239|7696705|FG000|NOT COMPLETED|Post-intervention Evaluation (1 Week)||1
6769245|NCT04308239|7696706|FG001|NOT COMPLETED|Post-intervention Evaluation (1 Week)||4
6769246|NCT04308668|7696718|FG000|STARTED|Overall Study||658
6769247|NCT04308668|7696719|FG001|STARTED|Overall Study||654
6769248|NCT04308668|7696718|FG000|COMPLETED|Overall Study||622
6769249|NCT04308668|7696719|FG001|COMPLETED|Overall Study||612
6769250|NCT04308668|7696718|FG000|NOT COMPLETED|Overall Study||36
6769251|NCT04308668|7696719|FG001|NOT COMPLETED|Overall Study||42
6769252|NCT04307940|7696728|FG000|STARTED|Overall Study||90
6769253|NCT04307940|7696729|FG001|STARTED|Overall Study||87
6769254|NCT04307940|7696730|FG002|STARTED|Overall Study||44
6769255|NCT04307940|7696728|FG000|COMPLETED|Overall Study||85
6769256|NCT04307940|7696729|FG001|COMPLETED|Overall Study||84
6769257|NCT04307940|7696730|FG002|COMPLETED|Overall Study||42
6769258|NCT04307940|7696728|FG000|NOT COMPLETED|Overall Study||5
6769259|NCT04307940|7696729|FG001|NOT COMPLETED|Overall Study||3
6769260|NCT04307940|7696730|FG002|NOT COMPLETED|Overall Study||2
6769261|NCT04302545|7696740|FG000|STARTED|Overall Study||107
6769262|NCT04302545|7696741|FG001|STARTED|Overall Study||107
6769263|NCT04302545|7696740|FG000|COMPLETED|Overall Study||104
6769264|NCT04302545|7696741|FG001|COMPLETED|Overall Study||103
6769265|NCT04302545|7696740|FG000|NOT COMPLETED|Overall Study||3
6769266|NCT04302545|7696741|FG001|NOT COMPLETED|Overall Study||4
6769267|NCT04297631|7696758|FG000|STARTED|Overall Study||20
6769268|NCT04297631|7696758|FG000|COMPLETED|Overall Study||20
6769269|NCT04297631|7696758|FG000|NOT COMPLETED|Overall Study||0
6769270|NCT04297241|7696763|FG000|STARTED|Overall Study||20
6769271|NCT04297241|7696763|FG000|COMPLETED|Overall Study||15
6769272|NCT04297241|7696763|FG000|NOT COMPLETED|Overall Study||5
6769273|NCT04296448|7696779|FG000|STARTED|Overall Study||98
6769274|NCT04296448|7696780|FG001|STARTED|Overall Study||99
6769275|NCT04296448|7696779|FG000|COMPLETED|Overall Study||98
6769276|NCT04296448|7696780|FG001|COMPLETED|Overall Study||99
6769277|NCT04296448|7696779|FG000|NOT COMPLETED|Overall Study||0
6769278|NCT04296448|7696780|FG001|NOT COMPLETED|Overall Study||0
6769279|NCT04296227|7696786|FG000|STARTED|Overall Study||85
6769280|NCT04296227|7696786|FG000|COMPLETED|Overall Study||85
6769281|NCT04296227|7696786|FG000|NOT COMPLETED|Overall Study||0
6769282|NCT04295356|7696792|FG000|STARTED|Overall Study||93
6769283|NCT04295356|7696793|FG001|STARTED|Overall Study||87
6769284|NCT04295356|7696792|FG000|COMPLETED|Overall Study||92
6769285|NCT04295356|7696793|FG001|COMPLETED|Overall Study||83
6769286|NCT04295356|7696792|FG000|NOT COMPLETED|Overall Study||1
6769287|NCT04295356|7696793|FG001|NOT COMPLETED|Overall Study||4
6769288|NCT04292639|7696799|FG000|STARTED|Overall Study||20
6769289|NCT04292639|7696799|FG000|COMPLETED|Overall Study||20
6769290|NCT04292639|7696799|FG000|NOT COMPLETED|Overall Study||0
6769291|NCT04292535|7696817|FG000|STARTED|Overall Study||8
6769292|NCT04292535|7696818|FG001|STARTED|Overall Study||8
6769293|NCT04292535|7696819|FG002|STARTED|Overall Study||9
6769294|NCT04292535|7696820|FG003|STARTED|Overall Study||8
6769295|NCT04292535|7696821|FG004|STARTED|Overall Study||8
6769296|NCT04292535|7696822|FG005|STARTED|Overall Study||9
6769297|NCT04292535|7696823|FG006|STARTED|Overall Study||8
6769298|NCT04292535|7696824|FG007|STARTED|Overall Study||10
6769299|NCT04292535|7696825|FG008|STARTED|Overall Study||8
6769300|NCT04292535|7696826|FG009|STARTED|Overall Study||8
6769301|NCT04292535|7696827|FG010|STARTED|Overall Study||7
6769302|NCT04292535|7696828|FG011|STARTED|Overall Study||7
6769303|NCT04292535|7696829|FG012|STARTED|Overall Study||9
6769304|NCT04292535|7696830|FG013|STARTED|Overall Study||9
6769305|NCT04292535|7696817|FG000|COMPLETED|Overall Study||8
6769306|NCT04292535|7696818|FG001|COMPLETED|Overall Study||8
6769307|NCT04292535|7696819|FG002|COMPLETED|Overall Study||9
6769308|NCT04292535|7696820|FG003|COMPLETED|Overall Study||8
6769309|NCT04292535|7696821|FG004|COMPLETED|Overall Study||8
6769310|NCT04292535|7696822|FG005|COMPLETED|Overall Study||9
6769311|NCT04292535|7696823|FG006|COMPLETED|Overall Study||8
6769312|NCT04292535|7696824|FG007|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
6769313|NCT04292535|7696825|FG008|COMPLETED|Overall Study||8
6769314|NCT04292535|7696826|FG009|COMPLETED|Overall Study||8
6769315|NCT04292535|7696827|FG010|COMPLETED|Overall Study||7
6769316|NCT04292535|7696828|FG011|COMPLETED|Overall Study||6
6769317|NCT04292535|7696829|FG012|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1)|8
6769318|NCT04292535|7696830|FG013|COMPLETED|Overall Study|Condition stopped due to Blood Sugar Below 70 mg/dL (n = 1) Condition stopped due to Report of Dizziness (n = 1)|7
6769319|NCT04292535|7696817|FG000|NOT COMPLETED|Overall Study||0
6769320|NCT04292535|7696818|FG001|NOT COMPLETED|Overall Study||0
6769321|NCT04292535|7696819|FG002|NOT COMPLETED|Overall Study||0
6769322|NCT04292535|7696820|FG003|NOT COMPLETED|Overall Study||0
6769323|NCT04292535|7696821|FG004|NOT COMPLETED|Overall Study||0
6769324|NCT04292535|7696822|FG005|NOT COMPLETED|Overall Study||0
6769325|NCT04292535|7696823|FG006|NOT COMPLETED|Overall Study||0
6769326|NCT04292535|7696824|FG007|NOT COMPLETED|Overall Study||2
6769327|NCT04292535|7696825|FG008|NOT COMPLETED|Overall Study||0
6769328|NCT04292535|7696826|FG009|NOT COMPLETED|Overall Study||0
6769329|NCT04292535|7696827|FG010|NOT COMPLETED|Overall Study||0
6769330|NCT04292535|7696828|FG011|NOT COMPLETED|Overall Study||1
6769331|NCT04292535|7696829|FG012|NOT COMPLETED|Overall Study||1
6769332|NCT04292535|7696830|FG013|NOT COMPLETED|Overall Study||2
6769333|NCT04292171|7696862|FG000|STARTED|Overall Study||109
6769334|NCT04292171|7696863|FG001|STARTED|Overall Study||110
6769335|NCT04292171|7696862|FG000|COMPLETED|Overall Study||107
6769336|NCT04292171|7696863|FG001|COMPLETED|Overall Study||109
6769337|NCT04292171|7696862|FG000|NOT COMPLETED|Overall Study||2
6769338|NCT04292171|7696863|FG001|NOT COMPLETED|Overall Study||1
6769339|NCT04292899|7696873|FG000|STARTED|Overall Study||200
6769340|NCT04292899|7696874|FG001|STARTED|Overall Study||197
6769341|NCT04292899|7696875|FG002|STARTED|Overall Study||844
6769342|NCT04292899|7696876|FG003|STARTED|Overall Study||3597
6769343|NCT04292899|7696873|FG000|COMPLETED|Overall Study||168
6769344|NCT04292899|7696874|FG001|COMPLETED|Overall Study||164
6769345|NCT04292899|7696875|FG002|COMPLETED|Overall Study||621
6769346|NCT04292899|7696876|FG003|COMPLETED|Overall Study||2952
6769347|NCT04292899|7696873|FG000|NOT COMPLETED|Overall Study||32
6769348|NCT04292899|7696874|FG001|NOT COMPLETED|Overall Study||33
6769349|NCT04292899|7696875|FG002|NOT COMPLETED|Overall Study||223
6769350|NCT04292899|7696876|FG003|NOT COMPLETED|Overall Study||645
6769351|NCT04292730|7696888|FG000|STARTED|Overall Study||199
6769352|NCT04292730|7696889|FG001|STARTED|Overall Study||197
6769353|NCT04292730|7696890|FG002|STARTED|Overall Study||200
6769354|NCT04292730|7696891|FG003|STARTED|Overall Study||517
6769355|NCT04292730|7696888|FG000|COMPLETED|Overall Study||179
6769356|NCT04292730|7696889|FG001|COMPLETED|Overall Study||176
6769357|NCT04292730|7696890|FG002|COMPLETED|Overall Study||178
6769358|NCT04292730|7696891|FG003|COMPLETED|Overall Study||437
6769359|NCT04292730|7696888|FG000|NOT COMPLETED|Overall Study||20
6769360|NCT04292730|7696889|FG001|NOT COMPLETED|Overall Study||21
6769361|NCT04292730|7696890|FG002|NOT COMPLETED|Overall Study||22
6769362|NCT04292730|7696891|FG003|NOT COMPLETED|Overall Study||80
6769363|NCT04290676|7696900|FG000|STARTED|Overall Study||527
6769364|NCT04290676|7696900|FG000|COMPLETED|Overall Study||527
6769365|NCT04290676|7696900|FG000|NOT COMPLETED|Overall Study||0
6769366|NCT04290039|7696907|FG000|STARTED|Period 1 (Visit 1; Day 1)||5
6769367|NCT04290039|7696908|FG001|STARTED|Period 1 (Visit 1; Day 1)||5
6769368|NCT04290039|7696909|FG002|STARTED|Period 1 (Visit 1; Day 1)||5
6769369|NCT04290039|7696907|FG000|COMPLETED|Period 1 (Visit 1; Day 1)||5
6769370|NCT04290039|7696908|FG001|COMPLETED|Period 1 (Visit 1; Day 1)||5
6769371|NCT04290039|7696909|FG002|COMPLETED|Period 1 (Visit 1; Day 1)||5
6769372|NCT04290039|7696907|FG000|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
6769373|NCT04290039|7696908|FG001|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
6769374|NCT04290039|7696909|FG002|NOT COMPLETED|Period 1 (Visit 1; Day 1)||0
6769375|NCT04290039|7696907|FG000|STARTED|Period 2 (Visit 2; Day 8)||5
6769376|NCT04290039|7696908|FG001|STARTED|Period 2 (Visit 2; Day 8)||5
6769377|NCT04290039|7696909|FG002|STARTED|Period 2 (Visit 2; Day 8)||5
6769378|NCT04290039|7696907|FG000|COMPLETED|Period 2 (Visit 2; Day 8)||5
6769379|NCT04290039|7696908|FG001|COMPLETED|Period 2 (Visit 2; Day 8)||5
6769380|NCT04290039|7696909|FG002|COMPLETED|Period 2 (Visit 2; Day 8)||5
6769381|NCT04290039|7696907|FG000|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
6769382|NCT04290039|7696908|FG001|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
6769383|NCT04290039|7696909|FG002|NOT COMPLETED|Period 2 (Visit 2; Day 8)||0
6769384|NCT04290039|7696907|FG000|STARTED|Period 3 (Visit 3; Day 15)||5
6769385|NCT04290039|7696908|FG001|STARTED|Period 3 (Visit 3; Day 15)||4
6769386|NCT04290039|7696909|FG002|STARTED|Period 3 (Visit 3; Day 15)||5
6769387|NCT04290039|7696907|FG000|COMPLETED|Period 3 (Visit 3; Day 15)||5
6769388|NCT04290039|7696908|FG001|COMPLETED|Period 3 (Visit 3; Day 15)||4
6769389|NCT04290039|7696909|FG002|COMPLETED|Period 3 (Visit 3; Day 15)||5
6769390|NCT04290039|7696907|FG000|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
6769391|NCT04290039|7696908|FG001|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
6769392|NCT04290039|7696909|FG002|NOT COMPLETED|Period 3 (Visit 3; Day 15)||0
6769393|NCT04289623|7696924|FG000|STARTED|Wave 1 Emails||6782
6769394|NCT04289623|7696925|FG001|STARTED|Wave 1 Emails||6764
6769395|NCT04289623|7696926|FG002|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (rank-and-file) email in Wave 2.|0
6769396|NCT04289623|7696927|FG003|STARTED|Wave 1 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to this intervention or the testimonial (medical expert) email in Wave 2.|0
6769397|NCT04289623|7696928|FG004|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
6769398|NCT04289623|7696929|FG005|STARTED|Wave 1 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
6769399|NCT04289623|7696924|FG000|COMPLETED|Wave 1 Emails||6514
6769400|NCT04289623|7696925|FG001|COMPLETED|Wave 1 Emails||6507
6769401|NCT04289623|7696926|FG002|COMPLETED|Wave 1 Emails||0
6769402|NCT04289623|7696927|FG003|COMPLETED|Wave 1 Emails||0
6769403|NCT04289623|7696928|FG004|COMPLETED|Wave 1 Emails||0
6769404|NCT04289623|7696929|FG005|COMPLETED|Wave 1 Emails||0
6769405|NCT04289623|7696924|FG000|NOT COMPLETED|Wave 1 Emails||268
6769406|NCT04289623|7696925|FG001|NOT COMPLETED|Wave 1 Emails||257
6769407|NCT04289623|7696926|FG002|NOT COMPLETED|Wave 1 Emails||0
6769408|NCT04289623|7696927|FG003|NOT COMPLETED|Wave 1 Emails||0
6769409|NCT04289623|7696928|FG004|NOT COMPLETED|Wave 1 Emails||0
6769410|NCT04289623|7696929|FG005|NOT COMPLETED|Wave 1 Emails||0
6769411|NCT04289623|7696924|FG000|STARTED|Wave 2 Emails|Participants were already sent this intervention or the loss frame email in Wave 1.|0
6769412|NCT04289623|7696925|FG001|STARTED|Wave 2 Emails|Participants were already sent this intervention or the standard email in Wave 1.|0
6769413|NCT04289623|7696926|FG002|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6099
6769414|NCT04289623|7696927|FG003|STARTED|Wave 2 Emails|Participants who did not respond to the intervention in Wave 1 were randomly assigned to these groups in Wave 2.|6117
6769415|NCT04289623|7696928|FG004|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
6769416|NCT04289623|7696929|FG005|STARTED|Wave 2 Emails|A planned Wave 3 of the study was not conducted due to COVID-19-related changes in the program being offered as part of the intervention.|0
6769417|NCT04289623|7696924|FG000|COMPLETED|Wave 2 Emails||0
6769418|NCT04289623|7696925|FG001|COMPLETED|Wave 2 Emails||0
6769419|NCT04289623|7696926|FG002|COMPLETED|Wave 2 Emails||6099
6769420|NCT04289623|7696927|FG003|COMPLETED|Wave 2 Emails||6117
6769421|NCT04289623|7696928|FG004|COMPLETED|Wave 2 Emails||0
6769422|NCT04289623|7696929|FG005|COMPLETED|Wave 2 Emails||0
6769423|NCT04289623|7696924|FG000|NOT COMPLETED|Wave 2 Emails||0
6769424|NCT04289623|7696925|FG001|NOT COMPLETED|Wave 2 Emails||0
6769425|NCT04289623|7696926|FG002|NOT COMPLETED|Wave 2 Emails||0
6769426|NCT04289623|7696927|FG003|NOT COMPLETED|Wave 2 Emails||0
6769427|NCT04289623|7696928|FG004|NOT COMPLETED|Wave 2 Emails||0
6769428|NCT04289623|7696929|FG005|NOT COMPLETED|Wave 2 Emails||0
6769429|NCT04276207|7696943|FG000|STARTED|Period 1||15
6769430|NCT04276207|7696944|FG001|STARTED|Period 1||17
6769431|NCT04276207|7696943|FG000|Received at Least One Dose of Study Drug|Period 1||15
6769432|NCT04276207|7696944|FG001|Received at Least One Dose of Study Drug|Period 1||17
6769433|NCT04276207|7696943|FG000|COMPLETED|Period 1||15
6769434|NCT04276207|7696944|FG001|COMPLETED|Period 1||16
6769435|NCT04276207|7696943|FG000|NOT COMPLETED|Period 1||0
6769436|NCT04276207|7696944|FG001|NOT COMPLETED|Period 1||1
6769437|NCT04276207|7696943|FG000|STARTED|Washout (3- 14 Days)||15
6769438|NCT04276207|7696944|FG001|STARTED|Washout (3- 14 Days)||16
6769439|NCT04276207|7696943|FG000|COMPLETED|Washout (3- 14 Days)||15
6769440|NCT04276207|7696944|FG001|COMPLETED|Washout (3- 14 Days)||16
6769441|NCT04276207|7696943|FG000|NOT COMPLETED|Washout (3- 14 Days)||0
6769442|NCT04276207|7696944|FG001|NOT COMPLETED|Washout (3- 14 Days)||0
6769443|NCT04276207|7696943|FG000|STARTED|Period 2||15
6769444|NCT04276207|7696944|FG001|STARTED|Period 2||16
6769445|NCT04276207|7696943|FG000|COMPLETED|Period 2||15
6769446|NCT04276207|7696944|FG001|COMPLETED|Period 2||16
6769447|NCT04276207|7696943|FG000|NOT COMPLETED|Period 2||0
6769448|NCT04276207|7696944|FG001|NOT COMPLETED|Period 2||0
6769449|NCT04289714|7696953|FG000|STARTED|Overall Study||14
6769450|NCT04289714|7696954|FG001|STARTED|Overall Study||11
6769451|NCT04289714|7696955|FG002|STARTED|Overall Study||10
6769452|NCT04289714|7696953|FG000|COMPLETED|Overall Study||8
6769453|NCT04289714|7696954|FG001|COMPLETED|Overall Study||6
6769454|NCT04289714|7696955|FG002|COMPLETED|Overall Study||4
6769455|NCT04289714|7696953|FG000|NOT COMPLETED|Overall Study||6
6769456|NCT04289714|7696954|FG001|NOT COMPLETED|Overall Study||5
6769457|NCT04289714|7696955|FG002|NOT COMPLETED|Overall Study||6
6769458|NCT04288752|7696965|FG000|STARTED|Overall Study|88 Participants were randomized to the VR101 group. However, one randomized participant (AR33) was unable to place the device and was immediately terminated from the study, prior to any post-randomization data collection. Therefore, 87 participants assigned to the VR101 group entered the treatment phase.|87
6769459|NCT04288752|7696966|FG001|STARTED|Overall Study||88
6769460|NCT04288752|7696965|FG000|COMPLETED|Overall Study||81
6769461|NCT04288752|7696966|FG001|COMPLETED|Overall Study||85
6769462|NCT04288752|7696965|FG000|NOT COMPLETED|Overall Study||6
6769463|NCT04288752|7696966|FG001|NOT COMPLETED|Overall Study||3
6769464|NCT04287517|7696974|FG000|STARTED|Overall Study||19
6769465|NCT04287517|7696975|FG001|STARTED|Overall Study||19
6769466|NCT04287517|7696974|FG000|COMPLETED|Overall Study||18
6769467|NCT04287517|7696975|FG001|COMPLETED|Overall Study||18
6769468|NCT04287517|7696974|FG000|NOT COMPLETED|Overall Study||1
6769469|NCT04287517|7696975|FG001|NOT COMPLETED|Overall Study||1
6769470|NCT04287036|7696981|FG000|STARTED|Period 1||13
6769471|NCT04287036|7696982|FG001|STARTED|Period 1||12
6769472|NCT04287036|7696981|FG000|COMPLETED|Period 1||13
6769473|NCT04287036|7696982|FG001|COMPLETED|Period 1||12
6769474|NCT04287036|7696981|FG000|NOT COMPLETED|Period 1||0
6769475|NCT04287036|7696982|FG001|NOT COMPLETED|Period 1||0
6769476|NCT04287036|7696981|FG000|STARTED|Period 2||13
6769477|NCT04287036|7696982|FG001|STARTED|Period 2||12
6769478|NCT04287036|7696981|FG000|COMPLETED|Period 2||13
6769479|NCT04287036|7696982|FG001|COMPLETED|Period 2||12
6769480|NCT04287036|7696981|FG000|NOT COMPLETED|Period 2||0
6769481|NCT04287036|7696982|FG001|NOT COMPLETED|Period 2||0
6769482|NCT04286412|7696988|FG000|STARTED|Overall Study||25
6769483|NCT04286412|7696988|FG000|COMPLETED|Overall Study||25
6769484|NCT04286412|7696988|FG000|NOT COMPLETED|Overall Study||0
6769485|NCT04285411|7696992|FG000|STARTED|Overall Study||10
6556589|NCT01762631|7478984|FG001|COMPLETED|Overall Study||22
6556590|NCT01762631|7478983|FG000|NOT COMPLETED|Overall Study||0
6556591|NCT01762631|7478984|FG001|NOT COMPLETED|Overall Study||0
6556592|NCT01762722|7478992|FG000|STARTED|Overall Study||12
6556593|NCT01762722|7478993|FG001|STARTED|Overall Study||11
6556594|NCT01762722|7478992|FG000|COMPLETED|Overall Study||12
6556595|NCT01762722|7478993|FG001|COMPLETED|Overall Study||11
6556596|NCT01762722|7478992|FG000|NOT COMPLETED|Overall Study||0
6556597|NCT01762722|7478993|FG001|NOT COMPLETED|Overall Study||0
6769486|NCT04285411|7696992|FG000|COMPLETED|Overall Study||10
6769487|NCT04285411|7696992|FG000|NOT COMPLETED|Overall Study||0
6769488|NCT04284930|7697000|FG000|STARTED|Overall Study||8
6769489|NCT04284930|7697001|FG001|STARTED|Overall Study||5
6769490|NCT04284930|7697002|FG002|STARTED|Overall Study||8
6769491|NCT04284930|7697000|FG000|COMPLETED|Overall Study||8
6769492|NCT04284930|7697001|FG001|COMPLETED|Overall Study||5
6769493|NCT04284930|7697002|FG002|COMPLETED|Overall Study||8
6769494|NCT04284930|7697000|FG000|NOT COMPLETED|Overall Study||0
6769495|NCT04284930|7697001|FG001|NOT COMPLETED|Overall Study||0
6769496|NCT04284930|7697002|FG002|NOT COMPLETED|Overall Study||0
6769497|NCT04283773|7697013|FG000|STARTED|Overall Study||22
6769498|NCT04283773|7697014|FG001|STARTED|Overall Study||20
6769499|NCT04283773|7697015|FG002|STARTED|Overall Study||20
6769500|NCT04283773|7697013|FG000|COMPLETED|Overall Study||22
6769501|NCT04283773|7697014|FG001|COMPLETED|Overall Study||20
6769502|NCT04283773|7697015|FG002|COMPLETED|Overall Study||20
6769503|NCT04283773|7697013|FG000|NOT COMPLETED|Overall Study||0
6769504|NCT04283773|7697014|FG001|NOT COMPLETED|Overall Study||0
6769505|NCT04283773|7697015|FG002|NOT COMPLETED|Overall Study||0
6769506|NCT04281901|7697027|FG000|STARTED|Overall Study||12
6769507|NCT04281901|7697028|FG001|STARTED|Overall Study||12
6769508|NCT04281901|7697027|FG000|2. Check-up|Overall Study||11
6769509|NCT04281901|7697028|FG001|2. Check-up|Overall Study||11
6769510|NCT04281901|7697027|FG000|3. Check-up|Overall Study||11
6769511|NCT04281901|7697028|FG001|3. Check-up|Overall Study||11
6769512|NCT04281901|7697027|FG000|COMPLETED|Overall Study||11
6769513|NCT04281901|7697028|FG001|COMPLETED|Overall Study||11
6769514|NCT04281901|7697027|FG000|NOT COMPLETED|Overall Study||1
6769515|NCT04281901|7697028|FG001|NOT COMPLETED|Overall Study||1
6769516|NCT04280653|7697034|FG000|STARTED|Overall Study||15
6769517|NCT04280653|7697034|FG000|COMPLETED|Overall Study||15
6769518|NCT04280653|7697034|FG000|NOT COMPLETED|Overall Study||0
6769519|NCT04277936|7697038|FG000|STARTED|Overall Study||1
6769520|NCT04277936|7697038|FG000|COMPLETED|Overall Study||1
6769521|NCT04277936|7697038|FG000|NOT COMPLETED|Overall Study||0
6769522|NCT04275336|7697045|FG000|STARTED|Overall Study||120
6769523|NCT04275336|7697046|FG001|STARTED|Overall Study||118
6769524|NCT04275336|7697047|FG002|STARTED|Overall Study||116
6769525|NCT04275336|7697045|FG000|COMPLETED|Overall Study||103
6769526|NCT04275336|7697046|FG001|COMPLETED|Overall Study||96
6769527|NCT04275336|7697047|FG002|COMPLETED|Overall Study||100
6769528|NCT04275336|7697045|FG000|NOT COMPLETED|Overall Study||17
6769529|NCT04275336|7697046|FG001|NOT COMPLETED|Overall Study||22
6769530|NCT04275336|7697047|FG002|NOT COMPLETED|Overall Study||16
6769531|NCT04272775|7697060|FG000|STARTED|Overall Study||7
6769532|NCT04272775|7697061|FG001|STARTED|Overall Study||7
6769533|NCT04272775|7697060|FG000|COMPLETED|Overall Study||0
6769534|NCT04272775|7697061|FG001|COMPLETED|Overall Study||0
6769535|NCT04272775|7697060|FG000|NOT COMPLETED|Overall Study||7
6769536|NCT04272775|7697061|FG001|NOT COMPLETED|Overall Study||7
6769537|NCT04271020|7697067|FG000|STARTED|Overall Study||12
6769538|NCT04271020|7697067|FG000|COMPLETED|Overall Study||12
6769539|NCT04271020|7697067|FG000|NOT COMPLETED|Overall Study||0
6769540|NCT04274075|7697077|FG000|STARTED|Overall Study||3
6769541|NCT04274075|7697078|FG001|STARTED|Overall Study||3
6769542|NCT04274075|7697079|FG002|STARTED|Overall Study||3
6769543|NCT04274075|7697080|FG003|STARTED|Overall Study||3
6769544|NCT04274075|7697081|FG004|STARTED|Overall Study||3
6769545|NCT04274075|7697082|FG005|STARTED|Overall Study||3
6769546|NCT04274075|7697077|FG000|Completed Treatment Period 1 (9 Days)|Overall Study||3
6769547|NCT04274075|7697078|FG001|Completed Treatment Period 1 (9 Days)|Overall Study||3
6769548|NCT04274075|7697079|FG002|Completed Treatment Period 1 (9 Days)|Overall Study||3
6769549|NCT04274075|7697080|FG003|Completed Treatment Period 1 (9 Days)|Overall Study||3
6769550|NCT04274075|7697081|FG004|Completed Treatment Period 1 (9 Days)|Overall Study||3
6769551|NCT04274075|7697082|FG005|Completed Treatment Period 1 (9 Days)|Overall Study||3
6769552|NCT04274075|7697077|FG000|Completed Treatment Period 2 (9 Days)|Overall Study||3
6769553|NCT04274075|7697078|FG001|Completed Treatment Period 2 (9 Days)|Overall Study||3
6769554|NCT04274075|7697079|FG002|Completed Treatment Period 2 (9 Days)|Overall Study||3
6769555|NCT04274075|7697080|FG003|Completed Treatment Period 2 (9 Days)|Overall Study||3
6769556|NCT04274075|7697081|FG004|Completed Treatment Period 2 (9 Days)|Overall Study||3
6769557|NCT04274075|7697082|FG005|Completed Treatment Period 2 (9 Days)|Overall Study||3
6769558|NCT04274075|7697077|FG000|Completed Treatment Period 3 (9 Days)|Overall Study||3
6769559|NCT04274075|7697078|FG001|Completed Treatment Period 3 (9 Days)|Overall Study||3
6769560|NCT04274075|7697079|FG002|Completed Treatment Period 3 (9 Days)|Overall Study||3
6769561|NCT04274075|7697080|FG003|Completed Treatment Period 3 (9 Days)|Overall Study||3
6769562|NCT04274075|7697081|FG004|Completed Treatment Period 3 (9 Days)|Overall Study||3
6769563|NCT04274075|7697082|FG005|Completed Treatment Period 3 (9 Days)|Overall Study||3
6769564|NCT04274075|7697077|FG000|Completed Follow-up Visit|Overall Study||3
6769565|NCT04274075|7697078|FG001|Completed Follow-up Visit|Overall Study||3
6769566|NCT04274075|7697079|FG002|Completed Follow-up Visit|Overall Study||3
6769567|NCT04274075|7697080|FG003|Completed Follow-up Visit|Overall Study||3
6769568|NCT04274075|7697081|FG004|Completed Follow-up Visit|Overall Study||3
6769569|NCT04274075|7697082|FG005|Completed Follow-up Visit|Overall Study||3
6769570|NCT04274075|7697077|FG000|COMPLETED|Overall Study||3
6769571|NCT04274075|7697078|FG001|COMPLETED|Overall Study||3
6769572|NCT04274075|7697079|FG002|COMPLETED|Overall Study||3
6769573|NCT04274075|7697080|FG003|COMPLETED|Overall Study||3
6769574|NCT04274075|7697081|FG004|COMPLETED|Overall Study||3
6769575|NCT04274075|7697082|FG005|COMPLETED|Overall Study||3
6769576|NCT04274075|7697077|FG000|NOT COMPLETED|Overall Study||0
6769577|NCT04274075|7697078|FG001|NOT COMPLETED|Overall Study||0
6769578|NCT04274075|7697079|FG002|NOT COMPLETED|Overall Study||0
6769579|NCT04274075|7697080|FG003|NOT COMPLETED|Overall Study||0
6769580|NCT04274075|7697081|FG004|NOT COMPLETED|Overall Study||0
6769581|NCT04274075|7697082|FG005|NOT COMPLETED|Overall Study||0
6769582|NCT04271605|7697093|FG000|STARTED|Overall Study|Baseline questionnaire and examination were done after enrollment.|5
6769583|NCT04271605|7697093|FG000|COMPLETED|Overall Study||0
6769584|NCT04271605|7697093|FG000|NOT COMPLETED|Overall Study||5
6769585|NCT04271761|7697097|FG000|STARTED|Overall Study||14
6769586|NCT04271761|7697097|FG000|COMPLETED|Overall Study||14
6769587|NCT04271761|7697097|FG000|NOT COMPLETED|Overall Study||0
6769588|NCT04268316|7697104|FG000|STARTED|Overall Study||5
6769589|NCT04268316|7697105|FG001|STARTED|Overall Study||4
6769590|NCT04268316|7697106|FG002|STARTED|Overall Study||4
6769591|NCT04268316|7697104|FG000|COMPLETED|Overall Study||3
6769592|NCT04268316|7697105|FG001|COMPLETED|Overall Study||3
6769593|NCT04268316|7697106|FG002|COMPLETED|Overall Study||4
6769594|NCT04268316|7697104|FG000|NOT COMPLETED|Overall Study||2
6769595|NCT04268316|7697105|FG001|NOT COMPLETED|Overall Study||1
6769596|NCT04268316|7697106|FG002|NOT COMPLETED|Overall Study||0
6769597|NCT04269629|7697114|FG000|STARTED|Overall Study|1425 patients were included in the study (=Visit 1)|1425
6769598|NCT04269629|7697114|FG000|Number of Patients Who Performed VIT|Overall Study|Visit 2 was performed with 1342 patients|1342
6769599|NCT04269629|7697114|FG000|COMPLETED|Overall Study|Visit 3 was performed with 1186 patients|1186
6769600|NCT04269629|7697114|FG000|NOT COMPLETED|Overall Study||239
6769601|NCT04267575|7697122|FG000|STARTED|Overall Study||20
6769602|NCT04267575|7697122|FG000|COMPLETED|Overall Study||20
6769603|NCT04267575|7697122|FG000|NOT COMPLETED|Overall Study||0
6769604|NCT04267770|7697128|FG000|STARTED|Overall Study||9
6556598|NCT01762800|7479001|FG000|STARTED|Overall Study||202
6556599|NCT01762800|7479002|FG001|STARTED|Overall Study||204
6556600|NCT01762800|7479001|FG000|COMPLETED|Overall Study||183
6556601|NCT01762800|7479002|FG001|COMPLETED|Overall Study||183
6769605|NCT04267770|7697129|FG001|STARTED|Overall Study||8
6769606|NCT04267770|7697128|FG000|COMPLETED|Overall Study||9
6769607|NCT04267770|7697129|FG001|COMPLETED|Overall Study||8
6769608|NCT04267770|7697128|FG000|NOT COMPLETED|Overall Study||0
6769609|NCT04267770|7697129|FG001|NOT COMPLETED|Overall Study||0
6769610|NCT04266925|7697137|FG000|STARTED|1 Referee Game (~1 Hour)||23
6769611|NCT04266925|7697138|FG001|STARTED|1 Referee Game (~1 Hour)||26
6769612|NCT04266925|7697137|FG000|COMPLETED|1 Referee Game (~1 Hour)||23
6769613|NCT04266925|7697138|FG001|COMPLETED|1 Referee Game (~1 Hour)||26
6769614|NCT04266925|7697137|FG000|NOT COMPLETED|1 Referee Game (~1 Hour)||0
6769615|NCT04266925|7697138|FG001|NOT COMPLETED|1 Referee Game (~1 Hour)||0
6769616|NCT04266925|7697137|FG000|STARTED|3 Referee Game (~1 Hour)||23
6769617|NCT04266925|7697138|FG001|STARTED|3 Referee Game (~1 Hour)||26
6769618|NCT04266925|7697137|FG000|COMPLETED|3 Referee Game (~1 Hour)||23
6769619|NCT04266925|7697138|FG001|COMPLETED|3 Referee Game (~1 Hour)||26
6769620|NCT04266925|7697137|FG000|NOT COMPLETED|3 Referee Game (~1 Hour)||0
6769621|NCT04266925|7697138|FG001|NOT COMPLETED|3 Referee Game (~1 Hour)||0
6769622|NCT04263142|7697149|FG000|STARTED|Part 1 Period 1 (Day 1)||9
6769623|NCT04263142|7697150|FG001|STARTED|Part 1 Period 1 (Day 1)||9
6769624|NCT04263142|7697151|FG002|STARTED|Part 1 Period 1 (Day 1)||0
6769625|NCT04263142|7697152|FG003|STARTED|Part 1 Period 1 (Day 1)||0
6769626|NCT04263142|7697153|FG004|STARTED|Part 1 Period 1 (Day 1)||0
6769627|NCT04263142|7697149|FG000|COMPLETED|Part 1 Period 1 (Day 1)||9
6769628|NCT04263142|7697150|FG001|COMPLETED|Part 1 Period 1 (Day 1)||9
6769629|NCT04263142|7697151|FG002|COMPLETED|Part 1 Period 1 (Day 1)||0
6769630|NCT04263142|7697152|FG003|COMPLETED|Part 1 Period 1 (Day 1)||0
6769631|NCT04263142|7697153|FG004|COMPLETED|Part 1 Period 1 (Day 1)||0
6769632|NCT04263142|7697149|FG000|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
6769633|NCT04263142|7697150|FG001|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
6769634|NCT04263142|7697151|FG002|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
6769635|NCT04263142|7697152|FG003|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
6769636|NCT04263142|7697153|FG004|NOT COMPLETED|Part 1 Period 1 (Day 1)||0
6769637|NCT04263142|7697149|FG000|STARTED|Part 1 Period 2 (Up to Day 5)||9
6769638|NCT04263142|7697150|FG001|STARTED|Part 1 Period 2 (Up to Day 5)||9
6769639|NCT04263142|7697151|FG002|STARTED|Part 1 Period 2 (Up to Day 5)||0
6769640|NCT04263142|7697152|FG003|STARTED|Part 1 Period 2 (Up to Day 5)||0
6769641|NCT04263142|7697153|FG004|STARTED|Part 1 Period 2 (Up to Day 5)||0
6769642|NCT04263142|7697149|FG000|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
6769643|NCT04263142|7697150|FG001|COMPLETED|Part 1 Period 2 (Up to Day 5)||9
6769644|NCT04263142|7697151|FG002|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
6769645|NCT04263142|7697152|FG003|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
6769646|NCT04263142|7697153|FG004|COMPLETED|Part 1 Period 2 (Up to Day 5)||0
6769647|NCT04263142|7697149|FG000|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
6769648|NCT04263142|7697150|FG001|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
6769649|NCT04263142|7697151|FG002|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
6769650|NCT04263142|7697152|FG003|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
6769651|NCT04263142|7697153|FG004|NOT COMPLETED|Part 1 Period 2 (Up to Day 5)||0
6769652|NCT04263142|7697149|FG000|STARTED|Part 2 Period 1 (Day 1)||0
6769653|NCT04263142|7697150|FG001|STARTED|Part 2 Period 1 (Day 1)||0
6769654|NCT04263142|7697151|FG002|STARTED|Part 2 Period 1 (Day 1)||7
6769655|NCT04263142|7697152|FG003|STARTED|Part 2 Period 1 (Day 1)||7
6769656|NCT04263142|7697153|FG004|STARTED|Part 2 Period 1 (Day 1)||7
6769657|NCT04263142|7697149|FG000|COMPLETED|Part 2 Period 1 (Day 1)||0
6769658|NCT04263142|7697150|FG001|COMPLETED|Part 2 Period 1 (Day 1)||0
6769659|NCT04263142|7697151|FG002|COMPLETED|Part 2 Period 1 (Day 1)||7
6769660|NCT04263142|7697152|FG003|COMPLETED|Part 2 Period 1 (Day 1)||7
6769661|NCT04263142|7697153|FG004|COMPLETED|Part 2 Period 1 (Day 1)||6
6769662|NCT04263142|7697149|FG000|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
6769663|NCT04263142|7697150|FG001|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
6769664|NCT04263142|7697151|FG002|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
6769665|NCT04263142|7697152|FG003|NOT COMPLETED|Part 2 Period 1 (Day 1)||0
6769666|NCT04263142|7697153|FG004|NOT COMPLETED|Part 2 Period 1 (Day 1)||1
6769667|NCT04263142|7697149|FG000|STARTED|Part 2 Period 2 (Day 1)||0
6769668|NCT04263142|7697150|FG001|STARTED|Part 2 Period 2 (Day 1)||0
6769669|NCT04263142|7697151|FG002|STARTED|Part 2 Period 2 (Day 1)||7
6769670|NCT04263142|7697152|FG003|STARTED|Part 2 Period 2 (Day 1)||7
6769671|NCT04263142|7697153|FG004|STARTED|Part 2 Period 2 (Day 1)||6
6769672|NCT04263142|7697149|FG000|COMPLETED|Part 2 Period 2 (Day 1)||0
6769673|NCT04263142|7697150|FG001|COMPLETED|Part 2 Period 2 (Day 1)||0
6769674|NCT04263142|7697151|FG002|COMPLETED|Part 2 Period 2 (Day 1)||7
6769675|NCT04263142|7697152|FG003|COMPLETED|Part 2 Period 2 (Day 1)||7
6769676|NCT04263142|7697153|FG004|COMPLETED|Part 2 Period 2 (Day 1)||5
6769677|NCT04263142|7697149|FG000|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
6769678|NCT04263142|7697150|FG001|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
6769679|NCT04263142|7697151|FG002|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
6769680|NCT04263142|7697152|FG003|NOT COMPLETED|Part 2 Period 2 (Day 1)||0
6769681|NCT04263142|7697153|FG004|NOT COMPLETED|Part 2 Period 2 (Day 1)||1
6769682|NCT04263142|7697149|FG000|STARTED|Part 2 Period 3 (Up to Day 5)||0
6769683|NCT04263142|7697150|FG001|STARTED|Part 2 Period 3 (Up to Day 5)||0
6769684|NCT04263142|7697151|FG002|STARTED|Part 2 Period 3 (Up to Day 5)||7
6769685|NCT04263142|7697152|FG003|STARTED|Part 2 Period 3 (Up to Day 5)||7
6769686|NCT04263142|7697153|FG004|STARTED|Part 2 Period 3 (Up to Day 5)||5
6769687|NCT04263142|7697149|FG000|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
6769688|NCT04263142|7697150|FG001|COMPLETED|Part 2 Period 3 (Up to Day 5)||0
6769689|NCT04263142|7697151|FG002|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
6769690|NCT04263142|7697152|FG003|COMPLETED|Part 2 Period 3 (Up to Day 5)||7
6769691|NCT04263142|7697153|FG004|COMPLETED|Part 2 Period 3 (Up to Day 5)||5
6556602|NCT01762800|7479001|FG000|NOT COMPLETED|Overall Study||19
6556603|NCT01762800|7479002|FG001|NOT COMPLETED|Overall Study||21
6562826|NCT01803074|7485711|FG012|STARTED|Period 3: Part C (HIV-1 Clade C Only)||7
6562827|NCT01803074|7485712|FG013|STARTED|Period 3: Part C (HIV-1 Clade C Only)||4
6769692|NCT04263142|7697149|FG000|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
6769693|NCT04263142|7697150|FG001|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
6769694|NCT04263142|7697151|FG002|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
6769695|NCT04263142|7697152|FG003|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
6769696|NCT04263142|7697153|FG004|NOT COMPLETED|Part 2 Period 3 (Up to Day 5)||0
6769697|NCT04256785|7697168|FG000|STARTED|Overall Study||54
6769698|NCT04256785|7697169|FG001|STARTED|Overall Study||56
6769699|NCT04256785|7697168|FG000|COMPLETED|Overall Study||26
6769700|NCT04256785|7697169|FG001|COMPLETED|Overall Study||31
6769701|NCT04256785|7697168|FG000|NOT COMPLETED|Overall Study||28
6769702|NCT04256785|7697169|FG001|NOT COMPLETED|Overall Study||25
6769703|NCT04252092|7697179|FG000|STARTED|Overall Study||15
6769704|NCT04252092|7697180|FG001|STARTED|Overall Study||15
6769705|NCT04252092|7697179|FG000|COMPLETED|Overall Study||15
6769706|NCT04252092|7697180|FG001|COMPLETED|Overall Study||15
6769707|NCT04252092|7697179|FG000|NOT COMPLETED|Overall Study||0
6769708|NCT04252092|7697180|FG001|NOT COMPLETED|Overall Study||0
6769709|NCT04250987|7697186|FG000|STARTED|Overall Study||12
6769710|NCT04250987|7697186|FG000|COMPLETED|Overall Study||12
6769711|NCT04250987|7697186|FG000|NOT COMPLETED|Overall Study||0
6769712|NCT04249336|7697194|FG000|STARTED|Overall Study||35
6769713|NCT04249336|7697195|FG001|STARTED|Overall Study||35
6769714|NCT04249336|7697196|FG002|STARTED|Overall Study||35
6769715|NCT04249336|7697197|FG003|STARTED|Overall Study||35
6769716|NCT04249336|7697194|FG000|Per Protocol Population Day 3|Overall Study||32
6769717|NCT04249336|7697195|FG001|Per Protocol Population Day 3|Overall Study||32
6769718|NCT04249336|7697196|FG002|Per Protocol Population Day 3|Overall Study||32
6769719|NCT04249336|7697197|FG003|Per Protocol Population Day 3|Overall Study||32
6769720|NCT04249336|7697194|FG000|Per Protocol Population Week 4|Overall Study||33
6769721|NCT04249336|7697195|FG001|Per Protocol Population Week 4|Overall Study||35
6769722|NCT04249336|7697196|FG002|Per Protocol Population Week 4|Overall Study||33
6769723|NCT04249336|7697197|FG003|Per Protocol Population Week 4|Overall Study||34
6769724|NCT04249336|7697194|FG000|COMPLETED|Overall Study||32
6769725|NCT04249336|7697195|FG001|COMPLETED|Overall Study||32
6769726|NCT04249336|7697196|FG002|COMPLETED|Overall Study||32
6769727|NCT04249336|7697197|FG003|COMPLETED|Overall Study||32
6769728|NCT04249336|7697194|FG000|NOT COMPLETED|Overall Study||3
6769729|NCT04249336|7697195|FG001|NOT COMPLETED|Overall Study||3
6769730|NCT04249336|7697196|FG002|NOT COMPLETED|Overall Study||3
6769731|NCT04249336|7697197|FG003|NOT COMPLETED|Overall Study||3
6769732|NCT04249310|7697209|FG000|STARTED|Overall Study||1436
6769733|NCT04249310|7697210|FG001|STARTED|Overall Study||5352
6769734|NCT04249310|7697209|FG000|PS-matched Cohort|Overall Study||1412
6769735|NCT04249310|7697210|FG001|PS-matched Cohort|Overall Study||1412
6769736|NCT04249310|7697209|FG000|hdPS-matched Cohort|Overall Study||1302
6769737|NCT04249310|7697210|FG001|hdPS-matched Cohort|Overall Study||1302
6769738|NCT04249310|7697209|FG000|COMPLETED|Overall Study||1436
6769739|NCT04249310|7697210|FG001|COMPLETED|Overall Study||5352
6769740|NCT04249310|7697209|FG000|NOT COMPLETED|Overall Study||0
6769741|NCT04249310|7697210|FG001|NOT COMPLETED|Overall Study||0
6769742|NCT04247581|7697218|FG000|STARTED|Overall Study||241
6769743|NCT04247581|7697219|FG001|STARTED|Overall Study||305
6769744|NCT04247581|7697218|FG000|COMPLETED|Overall Study||241
6769745|NCT04247581|7697219|FG001|COMPLETED|Overall Study||293
6769746|NCT04247581|7697218|FG000|NOT COMPLETED|Overall Study||0
6769747|NCT04247581|7697219|FG001|NOT COMPLETED|Overall Study||12
6769748|NCT04247061|7697225|FG000|STARTED|Overall Study|13 Subjects completed the required pre-dental appointment study activities and were scheduled to attend the dental clinic|13
6769749|NCT04247061|7697225|FG000|COMPLETED|Overall Study||4
6769750|NCT04247061|7697225|FG000|NOT COMPLETED|Overall Study||9
6769751|NCT04245202|7697231|FG000|STARTED|Overall Study|After getting consent.|48
6769752|NCT04245202|7697232|FG001|STARTED|Overall Study|After getting consent|39
6769753|NCT04245202|7697231|FG000|COMPLETED|Overall Study||38
6769754|NCT04245202|7697232|FG001|COMPLETED|Overall Study||38
6769755|NCT04245202|7697231|FG000|NOT COMPLETED|Overall Study||10
6769756|NCT04245202|7697232|FG001|NOT COMPLETED|Overall Study||1
6769757|NCT04243369|7697239|FG000|STARTED|Overall Study||30
6769758|NCT04243369|7697239|FG000|COMPLETED|Overall Study||30
6769759|NCT04243369|7697239|FG000|NOT COMPLETED|Overall Study||0
6769760|NCT04241146|7697245|FG000|STARTED|Overall Study||24
6769761|NCT04241146|7697246|FG001|STARTED|Overall Study||28
6769762|NCT04241146|7697245|FG000|COMPLETED|Overall Study||24
6769763|NCT04241146|7697246|FG001|COMPLETED|Overall Study||28
6769764|NCT04241146|7697245|FG000|NOT COMPLETED|Overall Study||0
6769765|NCT04241146|7697246|FG001|NOT COMPLETED|Overall Study||0
6769766|NCT04240678|7697254|FG000|STARTED|Overall Study||4141
6769767|NCT04240678|7697255|FG001|STARTED|Overall Study||4158
6769768|NCT04240678|7697254|FG000|COMPLETED|Overall Study||4141
6769769|NCT04240678|7697255|FG001|COMPLETED|Overall Study||4158
6769770|NCT04240678|7697254|FG000|NOT COMPLETED|Overall Study||0
6769771|NCT04240678|7697255|FG001|NOT COMPLETED|Overall Study||0
6769772|NCT04238650|7697263|FG000|STARTED|Overall Study||24
6769773|NCT04238650|7697264|FG001|STARTED|Overall Study|One subject was enrolled and randomized to EU Avastin® but the subject was not dosed (subject withdrawal before study drug administration)|25
6769774|NCT04238650|7697263|FG000|COMPLETED|Overall Study||24
6769775|NCT04238650|7697264|FG001|COMPLETED|Overall Study||24
6769776|NCT04238650|7697263|FG000|NOT COMPLETED|Overall Study||0
6769777|NCT04238650|7697264|FG001|NOT COMPLETED|Overall Study||1
6769778|NCT04238663|7697273|FG000|STARTED|Overall Study||38
6769779|NCT04238663|7697274|FG001|STARTED|Overall Study||38
6769780|NCT04238663|7697275|FG002|STARTED|Overall Study||38
6769781|NCT04238663|7697273|FG000|COMPLETED|Overall Study||38
6769782|NCT04238663|7697274|FG001|COMPLETED|Overall Study||37
6769783|NCT04238663|7697275|FG002|COMPLETED|Overall Study||38
6769784|NCT04238663|7697273|FG000|NOT COMPLETED|Overall Study||0
6769785|NCT04238663|7697274|FG001|NOT COMPLETED|Overall Study||1
6769786|NCT04238663|7697275|FG002|NOT COMPLETED|Overall Study||0
6769787|NCT04235582|7697286|FG000|STARTED|Overall Study||12
6769788|NCT04235582|7697287|FG001|STARTED|Overall Study||13
6769789|NCT04235582|7697288|FG002|STARTED|Overall Study||11
6769790|NCT04235582|7697286|FG000|COMPLETED|Overall Study||12
6769791|NCT04235582|7697287|FG001|COMPLETED|Overall Study||12
6769792|NCT04235582|7697288|FG002|COMPLETED|Overall Study||8
6769793|NCT04235582|7697286|FG000|NOT COMPLETED|Overall Study||0
6769794|NCT04235582|7697287|FG001|NOT COMPLETED|Overall Study||1
6769795|NCT04235582|7697288|FG002|NOT COMPLETED|Overall Study||3
6769796|NCT04203225|7697298|FG000|STARTED|Overall Study||21
6769797|NCT04203225|7697299|FG001|STARTED|Overall Study||27
6769798|NCT04203225|7697298|FG000|COMPLETED|Overall Study||21
6769799|NCT04203225|7697299|FG001|COMPLETED|Overall Study||27
6769800|NCT04203225|7697298|FG000|NOT COMPLETED|Overall Study||0
6769801|NCT04203225|7697299|FG001|NOT COMPLETED|Overall Study||0
6769802|NCT04234672|7697305|FG000|STARTED|Treatment Period 1 (Day 1)||6
6769803|NCT04234672|7697305|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
6769804|NCT04234672|7697305|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6769805|NCT04234672|7697305|FG000|STARTED|Washout Period (Day 2 to 8)||6
6769806|NCT04234672|7697305|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
6769807|NCT04234672|7697305|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
6769808|NCT04234672|7697305|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
6769809|NCT04234672|7697305|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
6769810|NCT04234672|7697305|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
6769811|NCT04223635|7697318|FG000|STARTED|Overall Study||8
6769812|NCT04223635|7697319|FG001|STARTED|Overall Study||8
6769813|NCT04223635|7697318|FG000|COMPLETED|Overall Study||8
6769814|NCT04223635|7697319|FG001|COMPLETED|Overall Study||8
6769815|NCT04223635|7697318|FG000|NOT COMPLETED|Overall Study||0
6769816|NCT04223635|7697319|FG001|NOT COMPLETED|Overall Study||0
6769817|NCT04214951|7697327|FG000|STARTED|Overall Study||50
6769818|NCT04214951|7697328|FG001|STARTED|Overall Study||50
6769819|NCT04214951|7697327|FG000|COMPLETED|Overall Study||10
6769820|NCT04214951|7697328|FG001|COMPLETED|Overall Study||10
6769821|NCT04214951|7697327|FG000|NOT COMPLETED|Overall Study||40
6769822|NCT04214951|7697328|FG001|NOT COMPLETED|Overall Study||40
6769823|NCT04234425|7697334|FG000|STARTED|Overall Study||18
6769824|NCT04234425|7697334|FG000|Midpoint-Week 4|Overall Study||18
6769825|NCT04234425|7697334|FG000|COMPLETED|Overall Study||18
6769826|NCT04234425|7697334|FG000|NOT COMPLETED|Overall Study||0
6769827|NCT04232137|7697342|FG000|STARTED|Overall Study||254
6769828|NCT04232137|7697343|FG001|STARTED|Overall Study||185
6769829|NCT04232137|7697342|FG000|COMPLETED|Overall Study||254
6769830|NCT04232137|7697343|FG001|COMPLETED|Overall Study||185
6769831|NCT04232137|7697342|FG000|NOT COMPLETED|Overall Study||0
6769832|NCT04232137|7697343|FG001|NOT COMPLETED|Overall Study||0
6769833|NCT04222699|7697349|FG000|STARTED|Overall Study||28
6769834|NCT04222699|7697349|FG000|COMPLETED|Overall Study||26
6769835|NCT04222699|7697349|FG000|NOT COMPLETED|Overall Study||2
6769836|NCT04208698|7697358|FG000|STARTED|Overall Study||2
6769837|NCT04208698|7697359|FG001|STARTED|Overall Study||0
6769838|NCT04208698|7697360|FG002|STARTED|Overall Study||0
6769839|NCT04208698|7697361|FG003|STARTED|Overall Study||0
6769840|NCT04208698|7697362|FG004|STARTED|Overall Study||0
6769841|NCT04208698|7697358|FG000|COMPLETED|Overall Study||0
6769842|NCT04208698|7697359|FG001|COMPLETED|Overall Study||0
6769843|NCT04208698|7697360|FG002|COMPLETED|Overall Study||0
6769844|NCT04208698|7697361|FG003|COMPLETED|Overall Study||0
6769845|NCT04208698|7697362|FG004|COMPLETED|Overall Study||0
6769846|NCT04208698|7697358|FG000|NOT COMPLETED|Overall Study||2
6769847|NCT04208698|7697359|FG001|NOT COMPLETED|Overall Study||0
6769848|NCT04208698|7697360|FG002|NOT COMPLETED|Overall Study||0
6769849|NCT04208698|7697361|FG003|NOT COMPLETED|Overall Study||0
6769850|NCT04208698|7697362|FG004|NOT COMPLETED|Overall Study||0
6769851|NCT04206293|7697372|FG000|STARTED|Overall Study||11
6769852|NCT04206293|7697372|FG000|COMPLETED|Overall Study||10
6769853|NCT04206293|7697372|FG000|NOT COMPLETED|Overall Study||1
6780581|NCT02974686|7709063|FG000|COMPLETED|Overall Study||0
6780582|NCT02974686|7709064|FG001|COMPLETED|Overall Study||0
6780583|NCT02974686|7709063|FG000|NOT COMPLETED|Overall Study||0
6780584|NCT02974686|7709064|FG001|NOT COMPLETED|Overall Study||0
6780585|NCT02956005|7709072|FG000|STARTED|Overall Study||18
6780586|NCT02956005|7709072|FG000|COMPLETED|Overall Study||2
6780587|NCT02956005|7709072|FG000|NOT COMPLETED|Overall Study||16
6780588|NCT02966184|7709078|FG000|STARTED|Overall Study||0
6780589|NCT02966184|7709079|FG001|STARTED|Overall Study||8
6780590|NCT02966184|7709078|FG000|COMPLETED|Overall Study||0
6780591|NCT02966184|7709079|FG001|COMPLETED|Overall Study||0
6780592|NCT02966184|7709078|FG000|NOT COMPLETED|Overall Study||0
6780593|NCT02966184|7709079|FG001|NOT COMPLETED|Overall Study||8
6780594|NCT02940223|7709087|FG000|STARTED|Overall Study||2
6780595|NCT02940223|7709088|FG001|STARTED|Overall Study||0
6780596|NCT02940223|7709087|FG000|COMPLETED|Overall Study||0
6780597|NCT02940223|7709088|FG001|COMPLETED|Overall Study||0
6780598|NCT02940223|7709087|FG000|NOT COMPLETED|Overall Study||2
6780599|NCT02940223|7709088|FG001|NOT COMPLETED|Overall Study||0
6780600|NCT02954159|7709096|FG000|STARTED|Overall Study||2
6780601|NCT02954159|7709097|FG001|STARTED|Overall Study||2
6780602|NCT02954159|7709096|FG000|COMPLETED|Overall Study||1
6780603|NCT02954159|7709097|FG001|COMPLETED|Overall Study||1
6780604|NCT02954159|7709096|FG000|NOT COMPLETED|Overall Study||1
6780605|NCT02954159|7709097|FG001|NOT COMPLETED|Overall Study||1
6780606|NCT02954952|7709106|FG000|STARTED|Overall Study||36
6780607|NCT02954952|7709107|FG001|STARTED|Overall Study||5
6780608|NCT02954952|7709108|FG002|STARTED|Overall Study||3
6780609|NCT02954952|7709106|FG000|COMPLETED|Overall Study||35
6780610|NCT02954952|7709107|FG001|COMPLETED|Overall Study||4
6780611|NCT02954952|7709108|FG002|COMPLETED|Overall Study||3
6780612|NCT02954952|7709106|FG000|NOT COMPLETED|Overall Study||1
6780613|NCT02954952|7709107|FG001|NOT COMPLETED|Overall Study||1
6780614|NCT02954952|7709108|FG002|NOT COMPLETED|Overall Study||0
6780615|NCT02950896|7709116|FG000|STARTED|Overall Study||4
6780616|NCT02950896|7709116|FG000|COMPLETED|Overall Study||4
6780617|NCT02950896|7709116|FG000|NOT COMPLETED|Overall Study||0
6780618|NCT02947022|7709120|FG000|STARTED|Overall Study||1
6780619|NCT02947022|7709120|FG000|COMPLETED|Overall Study||0
6780620|NCT02947022|7709120|FG000|NOT COMPLETED|Overall Study||1
6780621|NCT02936999|7709127|FG000|STARTED|Overall Study||8
6780622|NCT02936999|7709127|FG000|COMPLETED|Overall Study||8
6780623|NCT02936999|7709127|FG000|NOT COMPLETED|Overall Study||0
6780624|NCT02950480|7709135|FG000|STARTED|Overall Study||2
6780625|NCT02950480|7709136|FG001|STARTED|Overall Study||2
6780626|NCT02950480|7709135|FG000|COMPLETED|Overall Study||1
6780627|NCT02950480|7709136|FG001|COMPLETED|Overall Study||2
6780628|NCT02950480|7709135|FG000|NOT COMPLETED|Overall Study||1
6780629|NCT02950480|7709136|FG001|NOT COMPLETED|Overall Study||0
6780630|NCT02949947|7709144|FG000|STARTED|Overall Study||1
6780631|NCT02949947|7709145|FG001|STARTED|Overall Study||2
6780632|NCT02949947|7709144|FG000|COMPLETED|Overall Study||0
6780633|NCT02949947|7709145|FG001|COMPLETED|Overall Study||1
6780634|NCT02949947|7709144|FG000|NOT COMPLETED|Overall Study||1
6780635|NCT02949947|7709145|FG001|NOT COMPLETED|Overall Study||1
6780636|NCT02947100|7709151|FG000|STARTED|Overall Study||4
6780637|NCT02947100|7709151|FG000|COMPLETED|Overall Study||0
6780638|NCT02947100|7709151|FG000|NOT COMPLETED|Overall Study||4
6780639|NCT02936206|7709157|FG000|STARTED|Overall Study||0
6780640|NCT02936206|7709158|FG001|STARTED|Overall Study||2
6780641|NCT02936206|7709157|FG000|COMPLETED|Overall Study||0
6780642|NCT02936206|7709158|FG001|COMPLETED|Overall Study||2
6780643|NCT02936206|7709157|FG000|NOT COMPLETED|Overall Study||0
6780644|NCT02936206|7709158|FG001|NOT COMPLETED|Overall Study||0
6780645|NCT02934932|7709164|FG000|STARTED|Overall Study||9
6780646|NCT02934932|7709164|FG000|COMPLETED|Overall Study||6
6780647|NCT02934932|7709164|FG000|NOT COMPLETED|Overall Study||3
6780648|NCT02908516|7709172|FG000|STARTED|Overall Study||3
6769854|NCT04228302|7697383|FG000|STARTED|Overall Study||6
6769855|NCT04228302|7697384|FG001|STARTED|Overall Study||6
6769856|NCT04228302|7697385|FG002|STARTED|Overall Study||6
6769857|NCT04228302|7697386|FG003|STARTED|Overall Study||6
6769858|NCT04228302|7697387|FG004|STARTED|Overall Study||6
6769859|NCT04228302|7697388|FG005|STARTED|Overall Study||10
6769860|NCT04228302|7697383|FG000|COMPLETED|Overall Study||6
6769861|NCT04228302|7697384|FG001|COMPLETED|Overall Study||6
6769862|NCT04228302|7697385|FG002|COMPLETED|Overall Study||6
6769863|NCT04228302|7697386|FG003|COMPLETED|Overall Study||6
6769864|NCT04228302|7697387|FG004|COMPLETED|Overall Study||5
6769865|NCT04228302|7697388|FG005|COMPLETED|Overall Study||10
6769866|NCT04228302|7697383|FG000|NOT COMPLETED|Overall Study||0
6769867|NCT04228302|7697384|FG001|NOT COMPLETED|Overall Study||0
6769868|NCT04228302|7697385|FG002|NOT COMPLETED|Overall Study||0
6769869|NCT04228302|7697386|FG003|NOT COMPLETED|Overall Study||0
6769870|NCT04228302|7697387|FG004|NOT COMPLETED|Overall Study||1
6769871|NCT04228302|7697388|FG005|NOT COMPLETED|Overall Study||0
6769872|NCT04227119|7697402|FG000|STARTED|Overall Study||11
6769873|NCT04227119|7697402|FG000|COMPLETED|Overall Study||11
6769874|NCT04227119|7697402|FG000|NOT COMPLETED|Overall Study||0
6769875|NCT04224753|7697408|FG000|STARTED|Overall Study||51
6769876|NCT04224753|7697408|FG000|COMPLETED|Overall Study||51
6769877|NCT04224753|7697408|FG000|NOT COMPLETED|Overall Study||0
6769878|NCT04218799|7697412|FG000|STARTED|Overall Study||7
6769879|NCT04218799|7697412|FG000|COMPLETED|Overall Study||7
6556604|NCT01762904|7479014|FG000|STARTED|Overall Study|January, 2013|135
6556605|NCT01762904|7479014|FG000|COMPLETED|Overall Study|October, 2013|135
6556606|NCT01762904|7479014|FG000|NOT COMPLETED|Overall Study||0
6556607|NCT01762943|7479023|FG000|STARTED|Overall Study||19
6556608|NCT01762943|7479024|FG001|STARTED|Overall Study||17
6556609|NCT01762943|7479023|FG000|Hypogonadism|Overall Study||18
6556610|NCT01762943|7479024|FG001|Hypogonadism|Overall Study||15
6556611|NCT01762943|7479023|FG000|Addback|Overall Study||16
6556612|NCT01762943|7479024|FG001|Addback|Overall Study||15
6556613|NCT01762943|7479023|FG000|Withdrawal|Overall Study||15
6556614|NCT01762943|7479024|FG001|Withdrawal|Overall Study||15
6556615|NCT01762943|7479023|FG000|COMPLETED|Overall Study||15
6556616|NCT01762943|7479024|FG001|COMPLETED|Overall Study||15
6556617|NCT01762943|7479023|FG000|NOT COMPLETED|Overall Study||4
6556618|NCT01762943|7479024|FG001|NOT COMPLETED|Overall Study||2
6556619|NCT01762982|7479030|FG000|STARTED|Overall Study||36
6556620|NCT01762982|7479030|FG000|Received Saline Water|Overall Study||36
6556621|NCT01762982|7479030|FG000|Received Benzalkonium Chloride|Overall Study||36
6556622|NCT01762982|7479030|FG000|Received SLS|Overall Study||36
6556623|NCT01762982|7479030|FG000|Received Empty Finn Chamber|Overall Study||36
6556624|NCT01762982|7479030|FG000|COMPLETED|Overall Study||36
6556625|NCT01762982|7479030|FG000|NOT COMPLETED|Overall Study||0
6769880|NCT04218799|7697412|FG000|NOT COMPLETED|Overall Study||0
6769881|NCT04204057|7697416|FG000|STARTED|Overall Study||21
6769882|NCT04204057|7697416|FG000|COMPLETED|Overall Study||21
6769883|NCT04204057|7697416|FG000|NOT COMPLETED|Overall Study||0
6769884|NCT04195594|7697420|FG000|STARTED|Overall Study||14
6769885|NCT04195594|7697420|FG000|COMPLETED|Overall Study||11
6769886|NCT04195594|7697420|FG000|NOT COMPLETED|Overall Study||3
6769887|NCT04223687|7697426|FG000|STARTED|Overall Study||163
6769888|NCT04223687|7697427|FG001|STARTED|Overall Study||163
6769889|NCT04223687|7697426|FG000|COMPLETED|Overall Study||162
6769890|NCT04223687|7697427|FG001|COMPLETED|Overall Study||163
6769891|NCT04223687|7697426|FG000|NOT COMPLETED|Overall Study||1
6769892|NCT04223687|7697427|FG001|NOT COMPLETED|Overall Study||0
6769893|NCT04223232|7697433|FG000|STARTED|Overall Study||6
6769894|NCT04223232|7697433|FG000|COMPLETED|Overall Study||5
6769895|NCT04223232|7697433|FG000|NOT COMPLETED|Overall Study||1
6769896|NCT04189224|7697437|FG000|STARTED|Period 1||23
6769897|NCT04189224|7697438|FG001|STARTED|Period 1||21
6769898|NCT04189224|7697437|FG000|COMPLETED|Period 1||23
6769899|NCT04189224|7697438|FG001|COMPLETED|Period 1||21
6769900|NCT04189224|7697437|FG000|NOT COMPLETED|Period 1||0
6769901|NCT04189224|7697438|FG001|NOT COMPLETED|Period 1||0
6769902|NCT04189224|7697437|FG000|STARTED|Period 2||23
6769903|NCT04189224|7697438|FG001|STARTED|Period 2||21
6769904|NCT04189224|7697437|FG000|COMPLETED|Period 2||23
6769905|NCT04189224|7697438|FG001|COMPLETED|Period 2||20
6769906|NCT04189224|7697437|FG000|NOT COMPLETED|Period 2||0
6556626|NCT01763047|7479040|FG000|STARTED|Period 1||139
6769907|NCT04189224|7697438|FG001|NOT COMPLETED|Period 2||1
6769908|NCT04214600|7697446|FG000|STARTED|Overall Study||50
6769909|NCT04214600|7697447|FG001|STARTED|Overall Study||50
6769910|NCT04214600|7697446|FG000|COMPLETED|Overall Study||41
6769911|NCT04214600|7697447|FG001|COMPLETED|Overall Study||36
6769912|NCT04214600|7697446|FG000|NOT COMPLETED|Overall Study||9
6769913|NCT04214600|7697447|FG001|NOT COMPLETED|Overall Study||14
6769914|NCT04202497|7697454|FG000|STARTED|Baseline Scan (Day-1)||7
6769915|NCT04202497|7697455|FG001|STARTED|Baseline Scan (Day-1)||0
6769916|NCT04202497|7697456|FG002|STARTED|Baseline Scan (Day-1)||0
6769917|NCT04202497|7697457|FG003|STARTED|Baseline Scan (Day-1)||0
6769918|NCT04202497|7697454|FG000|COMPLETED|Baseline Scan (Day-1)||6
6769919|NCT04202497|7697455|FG001|COMPLETED|Baseline Scan (Day-1)||0
6769920|NCT04202497|7697456|FG002|COMPLETED|Baseline Scan (Day-1)||0
6769921|NCT04202497|7697457|FG003|COMPLETED|Baseline Scan (Day-1)||0
6769922|NCT04202497|7697454|FG000|NOT COMPLETED|Baseline Scan (Day-1)||1
6769923|NCT04202497|7697455|FG001|NOT COMPLETED|Baseline Scan (Day-1)||0
6769924|NCT04202497|7697456|FG002|NOT COMPLETED|Baseline Scan (Day-1)||0
6769925|NCT04202497|7697457|FG003|NOT COMPLETED|Baseline Scan (Day-1)||0
6769926|NCT04202497|7697454|FG000|STARTED|Treatment Period (Day 1 Through Day 2-3)||0
6769927|NCT04202497|7697455|FG001|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
6769928|NCT04202497|7697456|FG002|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
6769929|NCT04202497|7697457|FG003|STARTED|Treatment Period (Day 1 Through Day 2-3)|Eligible participants from Baseline Period who received 10 mCi of [18F]MNI-1054 on Day -1.|2
6769930|NCT04202497|7697454|FG000|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
6769931|NCT04202497|7697455|FG001|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
6769932|NCT04202497|7697456|FG002|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
6769933|NCT04202497|7697457|FG003|COMPLETED|Treatment Period (Day 1 Through Day 2-3)||2
6769934|NCT04202497|7697454|FG000|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
6769935|NCT04202497|7697455|FG001|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
6769936|NCT04202497|7697456|FG002|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
6769937|NCT04202497|7697457|FG003|NOT COMPLETED|Treatment Period (Day 1 Through Day 2-3)||0
6769938|NCT04214080|7697473|FG000|STARTED|Overall Study||20
6769939|NCT04214080|7697474|FG001|STARTED|Overall Study||20
6769940|NCT04214080|7697473|FG000|COMPLETED|Overall Study||20
6769941|NCT04214080|7697474|FG001|COMPLETED|Overall Study||20
6769942|NCT04214080|7697473|FG000|NOT COMPLETED|Overall Study||0
6769943|NCT04214080|7697474|FG001|NOT COMPLETED|Overall Study||0
6769944|NCT04209530|7697484|FG000|STARTED|Overall Study||4
6769945|NCT04209530|7697485|FG001|STARTED|Overall Study||3
6769946|NCT04209530|7697484|FG000|COMPLETED|Overall Study||0
6769947|NCT04209530|7697485|FG001|COMPLETED|Overall Study||0
6769948|NCT04209530|7697484|FG000|NOT COMPLETED|Overall Study||4
6769949|NCT04209530|7697485|FG001|NOT COMPLETED|Overall Study||3
6769950|NCT04209335|7697491|FG000|STARTED|Overall Study||48
6769951|NCT04209335|7697491|FG000|COMPLETED|Overall Study||48
6769952|NCT04209335|7697491|FG000|NOT COMPLETED|Overall Study||0
6769953|NCT04207333|7697498|FG000|STARTED|First Intervention (Single 1-Day Visit)||3
6769954|NCT04207333|7697499|FG001|STARTED|First Intervention (Single 1-Day Visit)||3
6769955|NCT04207333|7697498|FG000|COMPLETED|First Intervention (Single 1-Day Visit)||3
6769956|NCT04207333|7697499|FG001|COMPLETED|First Intervention (Single 1-Day Visit)||3
6769957|NCT04207333|7697498|FG000|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
6769958|NCT04207333|7697499|FG001|NOT COMPLETED|First Intervention (Single 1-Day Visit)||0
6769959|NCT04207333|7697498|FG000|STARTED|Washout (2-7 Days)||3
6769960|NCT04207333|7697499|FG001|STARTED|Washout (2-7 Days)||3
6769961|NCT04207333|7697498|FG000|COMPLETED|Washout (2-7 Days)||3
6769962|NCT04207333|7697499|FG001|COMPLETED|Washout (2-7 Days)||3
6769963|NCT04207333|7697498|FG000|NOT COMPLETED|Washout (2-7 Days)||0
6769964|NCT04207333|7697499|FG001|NOT COMPLETED|Washout (2-7 Days)||0
6769965|NCT04207333|7697498|FG000|STARTED|Second Intervention (Single 1-Day Visit)||3
6769966|NCT04207333|7697499|FG001|STARTED|Second Intervention (Single 1-Day Visit)||3
6769967|NCT04207333|7697498|FG000|COMPLETED|Second Intervention (Single 1-Day Visit)||3
6769968|NCT04207333|7697499|FG001|COMPLETED|Second Intervention (Single 1-Day Visit)||3
6769969|NCT04207333|7697498|FG000|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
6769970|NCT04207333|7697499|FG001|NOT COMPLETED|Second Intervention (Single 1-Day Visit)||0
6769971|NCT04207840|7697505|FG000|STARTED|Treatment Period 1||9
6769972|NCT04207840|7697506|FG001|STARTED|Treatment Period 1||10
6769973|NCT04207840|7697507|FG002|STARTED|Treatment Period 1||9
6769974|NCT04207840|7697505|FG000|COMPLETED|Treatment Period 1||9
6769975|NCT04207840|7697506|FG001|COMPLETED|Treatment Period 1||10
6769976|NCT04207840|7697507|FG002|COMPLETED|Treatment Period 1||9
6769977|NCT04207840|7697505|FG000|NOT COMPLETED|Treatment Period 1||0
6769978|NCT04207840|7697506|FG001|NOT COMPLETED|Treatment Period 1||0
6769979|NCT04207840|7697507|FG002|NOT COMPLETED|Treatment Period 1||0
6769980|NCT04207840|7697505|FG000|STARTED|Washout Period 1 (2-7 Days)||9
6769981|NCT04207840|7697506|FG001|STARTED|Washout Period 1 (2-7 Days)||10
6769982|NCT04207840|7697507|FG002|STARTED|Washout Period 1 (2-7 Days)||9
6769983|NCT04207840|7697505|FG000|COMPLETED|Washout Period 1 (2-7 Days)||9
6769984|NCT04207840|7697506|FG001|COMPLETED|Washout Period 1 (2-7 Days)||10
6769985|NCT04207840|7697507|FG002|COMPLETED|Washout Period 1 (2-7 Days)||8
6769986|NCT04207840|7697505|FG000|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
6769987|NCT04207840|7697506|FG001|NOT COMPLETED|Washout Period 1 (2-7 Days)||0
6769988|NCT04207840|7697507|FG002|NOT COMPLETED|Washout Period 1 (2-7 Days)||1
6769989|NCT04207840|7697505|FG000|STARTED|Treatment Period 2||9
6769990|NCT04207840|7697506|FG001|STARTED|Treatment Period 2||10
6769991|NCT04207840|7697507|FG002|STARTED|Treatment Period 2||8
6769992|NCT04207840|7697505|FG000|COMPLETED|Treatment Period 2||9
6769993|NCT04207840|7697506|FG001|COMPLETED|Treatment Period 2||10
6769994|NCT04207840|7697507|FG002|COMPLETED|Treatment Period 2||8
6769995|NCT04207840|7697505|FG000|NOT COMPLETED|Treatment Period 2||0
6769996|NCT04207840|7697506|FG001|NOT COMPLETED|Treatment Period 2||0
6769997|NCT04207840|7697507|FG002|NOT COMPLETED|Treatment Period 2||0
6769998|NCT04207840|7697505|FG000|STARTED|Washout Period 2 (2-7 Days)||9
6769999|NCT04207840|7697506|FG001|STARTED|Washout Period 2 (2-7 Days)||10
6770000|NCT04207840|7697507|FG002|STARTED|Washout Period 2 (2-7 Days)||8
6770001|NCT04207840|7697505|FG000|COMPLETED|Washout Period 2 (2-7 Days)||9
6770002|NCT04207840|7697506|FG001|COMPLETED|Washout Period 2 (2-7 Days)||10
6770003|NCT04207840|7697507|FG002|COMPLETED|Washout Period 2 (2-7 Days)||7
6770004|NCT04207840|7697505|FG000|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
6770005|NCT04207840|7697506|FG001|NOT COMPLETED|Washout Period 2 (2-7 Days)||0
6770006|NCT04207840|7697507|FG002|NOT COMPLETED|Washout Period 2 (2-7 Days)||1
6770007|NCT04207840|7697505|FG000|STARTED|Treatment Period 3||9
6770008|NCT04207840|7697506|FG001|STARTED|Treatment Period 3||10
6770009|NCT04207840|7697507|FG002|STARTED|Treatment Period 3||7
6770010|NCT04207840|7697505|FG000|COMPLETED|Treatment Period 3||9
6770011|NCT04207840|7697506|FG001|COMPLETED|Treatment Period 3||10
6770012|NCT04207840|7697507|FG002|COMPLETED|Treatment Period 3||7
6770013|NCT04207840|7697505|FG000|NOT COMPLETED|Treatment Period 3||0
6770014|NCT04207840|7697506|FG001|NOT COMPLETED|Treatment Period 3||0
6770015|NCT04207840|7697507|FG002|NOT COMPLETED|Treatment Period 3||0
6770016|NCT04206800|7697517|FG000|STARTED|Overall Study||4
6770017|NCT04206800|7697518|FG001|STARTED|Overall Study||1
6770018|NCT04206800|7697517|FG000|COMPLETED|Overall Study||4
6770019|NCT04206800|7697518|FG001|COMPLETED|Overall Study||1
6770020|NCT04206800|7697517|FG000|NOT COMPLETED|Overall Study||0
6770021|NCT04206800|7697518|FG001|NOT COMPLETED|Overall Study||0
6770022|NCT04205669|7697526|FG000|STARTED|Overall Study||47
6770023|NCT04205669|7697527|FG001|STARTED|Overall Study||57
6770024|NCT04205669|7697526|FG000|COMPLETED|Overall Study||34
6770025|NCT04205669|7697527|FG001|COMPLETED|Overall Study||45
6770026|NCT04205669|7697526|FG000|NOT COMPLETED|Overall Study||13
6770027|NCT04205669|7697527|FG001|NOT COMPLETED|Overall Study||12
6770028|NCT04198948|7697535|FG000|STARTED|First Period||7
6770029|NCT04198948|7697536|FG001|STARTED|First Period||8
6770030|NCT04198948|7697535|FG000|COMPLETED|First Period||7
6770031|NCT04198948|7697536|FG001|COMPLETED|First Period||8
6770032|NCT04198948|7697535|FG000|NOT COMPLETED|First Period||0
6770033|NCT04198948|7697536|FG001|NOT COMPLETED|First Period||0
6770034|NCT04198948|7697535|FG000|STARTED|Wash-out (10 Days)||7
6770035|NCT04198948|7697536|FG001|STARTED|Wash-out (10 Days)||8
6770036|NCT04198948|7697535|FG000|COMPLETED|Wash-out (10 Days)||7
6770037|NCT04198948|7697536|FG001|COMPLETED|Wash-out (10 Days)||8
6770038|NCT04198948|7697535|FG000|NOT COMPLETED|Wash-out (10 Days)||0
6770039|NCT04198948|7697536|FG001|NOT COMPLETED|Wash-out (10 Days)||0
6770040|NCT04198948|7697535|FG000|STARTED|Second Period||7
6770041|NCT04198948|7697536|FG001|STARTED|Second Period||8
6770042|NCT04198948|7697535|FG000|COMPLETED|Second Period||7
6770043|NCT04198948|7697536|FG001|COMPLETED|Second Period||7
6770044|NCT04198948|7697535|FG000|NOT COMPLETED|Second Period||0
6770045|NCT04198948|7697536|FG001|NOT COMPLETED|Second Period||1
6770046|NCT04206384|7697542|FG000|STARTED|Overall Study||52
6770047|NCT04206384|7697542|FG000|COMPLETED|Overall Study||42
6770048|NCT04206384|7697542|FG000|NOT COMPLETED|Overall Study||10
6770049|NCT04204200|7697549|FG000|STARTED|Overall Study||22
6770050|NCT04204200|7697550|FG001|STARTED|Overall Study||22
6770051|NCT04204200|7697551|FG002|STARTED|Overall Study||22
6770052|NCT04204200|7697549|FG000|COMPLETED|Overall Study||22
6770053|NCT04204200|7697550|FG001|COMPLETED|Overall Study||22
6770054|NCT04204200|7697551|FG002|COMPLETED|Overall Study||22
6770055|NCT04204200|7697549|FG000|NOT COMPLETED|Overall Study||0
6770056|NCT04204200|7697550|FG001|NOT COMPLETED|Overall Study||0
6770057|NCT04204200|7697551|FG002|NOT COMPLETED|Overall Study||0
6770058|NCT04196907|7697559|FG000|STARTED|Overall Study||20
6770059|NCT04196907|7697559|FG000|COMPLETED|Overall Study||20
6770060|NCT04196907|7697559|FG000|NOT COMPLETED|Overall Study||0
6770061|NCT04195893|7697563|FG000|STARTED|First Intervention||27
6770062|NCT04195893|7697564|FG001|STARTED|First Intervention||29
6770063|NCT04195893|7697563|FG000|COMPLETED|First Intervention||27
6770064|NCT04195893|7697564|FG001|COMPLETED|First Intervention||29
6770065|NCT04195893|7697563|FG000|NOT COMPLETED|First Intervention||0
6770066|NCT04195893|7697564|FG001|NOT COMPLETED|First Intervention||0
6770067|NCT04195893|7697563|FG000|STARTED|Second Intervention||27
6770068|NCT04195893|7697564|FG001|STARTED|Second Intervention||29
6770069|NCT04195893|7697563|FG000|COMPLETED|Second Intervention||26
6770070|NCT04195893|7697564|FG001|COMPLETED|Second Intervention||29
6770071|NCT04195893|7697563|FG000|NOT COMPLETED|Second Intervention||1
6770072|NCT04195893|7697564|FG001|NOT COMPLETED|Second Intervention||0
6770073|NCT04195880|7697572|FG000|STARTED|Overall Study||3205
6770074|NCT04195880|7697573|FG001|STARTED|Overall Study||3338
6770075|NCT04195880|7697572|FG000|COMPLETED|Overall Study||3205
6770076|NCT04195880|7697573|FG001|COMPLETED|Overall Study||3338
6770077|NCT04195880|7697572|FG000|NOT COMPLETED|Overall Study||0
6770078|NCT04195880|7697573|FG001|NOT COMPLETED|Overall Study||0
6770079|NCT04195581|7697579|FG000|STARTED|Comfilcon A With All in One Light||28
6770080|NCT04195581|7697579|FG000|COMPLETED|Comfilcon A With All in One Light||24
6770081|NCT04195581|7697579|FG000|NOT COMPLETED|Comfilcon A With All in One Light||4
6770082|NCT04195581|7697579|FG000|STARTED|Comfilcon A With Hy-Care||30
6770083|NCT04195581|7697579|FG000|COMPLETED|Comfilcon A With Hy-Care||25
6770084|NCT04195581|7697579|FG000|NOT COMPLETED|Comfilcon A With Hy-Care||5
6770085|NCT04195581|7697579|FG000|STARTED|Comfilcon A With Refine One Step||25
6770086|NCT04195581|7697579|FG000|COMPLETED|Comfilcon A With Refine One Step||24
6770087|NCT04195581|7697579|FG000|NOT COMPLETED|Comfilcon A With Refine One Step||1
6770088|NCT04195581|7697579|FG000|STARTED|Fanfilcon A With All in One Light||28
6770089|NCT04195581|7697579|FG000|COMPLETED|Fanfilcon A With All in One Light||27
6770090|NCT04195581|7697579|FG000|NOT COMPLETED|Fanfilcon A With All in One Light||1
6770091|NCT04195581|7697579|FG000|STARTED|Fanfilcon A With Hy-Care||28
6770092|NCT04195581|7697579|FG000|COMPLETED|Fanfilcon A With Hy-Care||25
6770093|NCT04195581|7697579|FG000|NOT COMPLETED|Fanfilcon A With Hy-Care||3
6770094|NCT04195581|7697579|FG000|STARTED|Fanfilcon A With Refine One Step||29
6770095|NCT04195581|7697579|FG000|COMPLETED|Fanfilcon A With Refine One Step||27
6770096|NCT04195581|7697579|FG000|NOT COMPLETED|Fanfilcon A With Refine One Step||2
6770097|NCT04194151|7697603|FG000|STARTED|Overall Study||32
6770098|NCT04194151|7697604|FG001|STARTED|Overall Study||32
6770099|NCT04194151|7697605|FG002|STARTED|Overall Study||32
6770100|NCT04194151|7697606|FG003|STARTED|Overall Study||32
6770101|NCT04194151|7697607|FG004|STARTED|Overall Study||32
6770102|NCT04194151|7697608|FG005|STARTED|Overall Study||32
6770103|NCT04194151|7697603|FG000|COMPLETED|Overall Study||31
6770104|NCT04194151|7697604|FG001|COMPLETED|Overall Study||30
6770105|NCT04194151|7697605|FG002|COMPLETED|Overall Study||31
6770106|NCT04194151|7697606|FG003|COMPLETED|Overall Study||31
6770107|NCT04194151|7697607|FG004|COMPLETED|Overall Study||32
6770108|NCT04194151|7697608|FG005|COMPLETED|Overall Study||31
6770109|NCT04194151|7697603|FG000|NOT COMPLETED|Overall Study||1
6770110|NCT04194151|7697604|FG001|NOT COMPLETED|Overall Study||2
6770111|NCT04194151|7697605|FG002|NOT COMPLETED|Overall Study||1
6770112|NCT04194151|7697606|FG003|NOT COMPLETED|Overall Study||1
6770113|NCT04194151|7697607|FG004|NOT COMPLETED|Overall Study||0
6770114|NCT04194151|7697608|FG005|NOT COMPLETED|Overall Study||1
6770115|NCT04194008|7697622|FG000|STARTED|Baseline (Run-in) Phase||126
6770116|NCT04194008|7697622|FG000|COMPLETED|Baseline (Run-in) Phase||99
6770117|NCT04194008|7697622|FG000|NOT COMPLETED|Baseline (Run-in) Phase||27
6770118|NCT04194008|7697622|FG000|STARTED|Treatment Phase With Nerivio||99
6770119|NCT04194008|7697622|FG000|COMPLETED|Treatment Phase With Nerivio||91
6770120|NCT04194008|7697622|FG000|NOT COMPLETED|Treatment Phase With Nerivio||8
6770121|NCT04191668|7697626|FG000|STARTED|Overall Study||106
6770122|NCT04191668|7697626|FG000|COMPLETED|Overall Study||106
6770123|NCT04191668|7697626|FG000|NOT COMPLETED|Overall Study||0
6770124|NCT04189081|7697633|FG000|STARTED|Overall Study||46
6770125|NCT04189081|7697634|FG001|STARTED|Overall Study||45
6770126|NCT04189081|7697635|FG002|STARTED|Overall Study||46
6770127|NCT04189081|7697633|FG000|COMPLETED|Overall Study||45
6770128|NCT04189081|7697634|FG001|COMPLETED|Overall Study||45
6770129|NCT04189081|7697635|FG002|COMPLETED|Overall Study||45
6770130|NCT04189081|7697633|FG000|NOT COMPLETED|Overall Study||1
6770131|NCT04189081|7697634|FG001|NOT COMPLETED|Overall Study||0
6770132|NCT04189081|7697635|FG002|NOT COMPLETED|Overall Study||1
6770133|NCT04186780|7697645|FG000|STARTED|Overall Study||36
6770134|NCT04186780|7697646|FG001|STARTED|Overall Study||32
6770135|NCT04186780|7697645|FG000|COMPLETED|Overall Study||22
6770136|NCT04186780|7697646|FG001|COMPLETED|Overall Study||25
6770137|NCT04186780|7697645|FG000|NOT COMPLETED|Overall Study||14
6770138|NCT04186780|7697646|FG001|NOT COMPLETED|Overall Study||7
6770139|NCT04186806|7697656|FG000|STARTED|Period 1: 7 Days||20
6770140|NCT04186806|7697657|FG001|STARTED|Period 1: 7 Days||20
6770141|NCT04186806|7697656|FG000|COMPLETED|Period 1: 7 Days||19
6770142|NCT04186806|7697657|FG001|COMPLETED|Period 1: 7 Days||20
6770143|NCT04186806|7697656|FG000|NOT COMPLETED|Period 1: 7 Days||1
6770144|NCT04186806|7697657|FG001|NOT COMPLETED|Period 1: 7 Days||0
6770145|NCT04186806|7697656|FG000|STARTED|Washout Period: at Least 2 Days||19
6770146|NCT04186806|7697657|FG001|STARTED|Washout Period: at Least 2 Days||20
6770147|NCT04186806|7697656|FG000|COMPLETED|Washout Period: at Least 2 Days||19
6770148|NCT04186806|7697657|FG001|COMPLETED|Washout Period: at Least 2 Days||20
6770149|NCT04186806|7697656|FG000|NOT COMPLETED|Washout Period: at Least 2 Days||0
6770150|NCT04186806|7697657|FG001|NOT COMPLETED|Washout Period: at Least 2 Days||0
6770151|NCT04186806|7697656|FG000|STARTED|Period 2: 7 Days||19
6770152|NCT04186806|7697657|FG001|STARTED|Period 2: 7 Days||20
6770153|NCT04186806|7697656|FG000|COMPLETED|Period 2: 7 Days||19
6770154|NCT04186806|7697657|FG001|COMPLETED|Period 2: 7 Days||20
6770155|NCT04186806|7697656|FG000|NOT COMPLETED|Period 2: 7 Days||0
6770156|NCT04186806|7697657|FG001|NOT COMPLETED|Period 2: 7 Days||0
6770157|NCT04186481|7697664|FG000|STARTED|Overall Study||32
6770158|NCT04186481|7697664|FG000|Completed 6 Month Visit|Overall Study||31
6770159|NCT04186481|7697664|FG000|Completed 12 Month Visit|Overall Study||4
6770160|NCT04186481|7697664|FG000|COMPLETED|Overall Study||32
6770161|NCT04186481|7697664|FG000|NOT COMPLETED|Overall Study||0
6770162|NCT04184999|7697670|FG000|STARTED|Overall Study||40
6770163|NCT04184999|7697671|FG001|STARTED|Overall Study||40
6770164|NCT04184999|7697670|FG000|3 Week Tear Film Osmolarity Testing|Overall Study||40
6770165|NCT04184999|7697671|FG001|3 Week Tear Film Osmolarity Testing|Overall Study||40
6770166|NCT04184999|7697670|FG000|COMPLETED|Overall Study||40
6556627|NCT01763047|7479041|FG001|STARTED|Period 1||137
6556628|NCT01763047|7479040|FG000|Myopes|Period 1||77
6556629|NCT01763047|7479041|FG001|Myopes|Period 1||76
6556630|NCT01763047|7479040|FG000|Hyperopes|Period 1||62
6556631|NCT01763047|7479041|FG001|Hyperopes|Period 1||61
6770167|NCT04184999|7697671|FG001|COMPLETED|Overall Study||40
6770168|NCT04184999|7697670|FG000|NOT COMPLETED|Overall Study||0
6770169|NCT04184999|7697671|FG001|NOT COMPLETED|Overall Study||0
6770170|NCT04184271|7697677|FG000|STARTED|Overall Study||16
6770171|NCT04184271|7697677|FG000|COMPLETED|Overall Study||16
6770172|NCT04184271|7697677|FG000|NOT COMPLETED|Overall Study||0
6556632|NCT01763047|7479040|FG000|COMPLETED|Period 1||130
6556633|NCT01763047|7479041|FG001|COMPLETED|Period 1||126
6770173|NCT04183231|7697681|FG000|STARTED|Overall Study||16
6770174|NCT04183231|7697681|FG000|COMPLETED|Overall Study||16
6770175|NCT04183231|7697681|FG000|NOT COMPLETED|Overall Study||0
6770176|NCT04182958|7697685|FG000|STARTED|Overall Study||8
6770177|NCT04182958|7697685|FG000|COMPLETED|Overall Study||8
6770178|NCT04182958|7697685|FG000|NOT COMPLETED|Overall Study||0
6770179|NCT04179838|7697691|FG000|STARTED|First Intervention (1 Day)||13
6770180|NCT04179838|7697692|FG001|STARTED|First Intervention (1 Day)||16
6770181|NCT04179838|7697691|FG000|COMPLETED|First Intervention (1 Day)||13
6770182|NCT04179838|7697692|FG001|COMPLETED|First Intervention (1 Day)||13
6770183|NCT04179838|7697691|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6770184|NCT04179838|7697692|FG001|NOT COMPLETED|First Intervention (1 Day)||3
6770185|NCT04179838|7697691|FG000|STARTED|Washout (4 Weeks)||13
6770186|NCT04179838|7697692|FG001|STARTED|Washout (4 Weeks)||13
6770187|NCT04179838|7697691|FG000|COMPLETED|Washout (4 Weeks)||13
6770188|NCT04179838|7697692|FG001|COMPLETED|Washout (4 Weeks)||13
6770189|NCT04179838|7697691|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6770190|NCT04179838|7697692|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6770191|NCT04179838|7697691|FG000|STARTED|Second Intervention (1 Day)||13
6770192|NCT04179838|7697692|FG001|STARTED|Second Intervention (1 Day)||13
6770193|NCT04179838|7697691|FG000|COMPLETED|Second Intervention (1 Day)||13
6770194|NCT04179838|7697692|FG001|COMPLETED|Second Intervention (1 Day)||12
6770195|NCT04179838|7697691|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6770196|NCT04179838|7697692|FG001|NOT COMPLETED|Second Intervention (1 Day)||1
6770197|NCT04179461|7697698|FG000|STARTED|Overall Study||21
6770198|NCT04179461|7697698|FG000|COMPLETED|Overall Study||17
6770199|NCT04179461|7697698|FG000|NOT COMPLETED|Overall Study||4
6770200|NCT04179474|7697704|FG000|STARTED|Treatment Period 1 (First Intervention)||20
6770201|NCT04179474|7697705|FG001|STARTED|Treatment Period 1 (First Intervention)||20
6770202|NCT04179474|7697704|FG000|COMPLETED|Treatment Period 1 (First Intervention)||20
6770203|NCT04179474|7697705|FG001|COMPLETED|Treatment Period 1 (First Intervention)||20
6770204|NCT04179474|7697704|FG000|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
6770205|NCT04179474|7697705|FG001|NOT COMPLETED|Treatment Period 1 (First Intervention)||0
6770206|NCT04179474|7697704|FG000|STARTED|Treatment Period 2 (Second Intervention)|1 participant did not receive Intervention B.|19
6770207|NCT04179474|7697705|FG001|STARTED|Treatment Period 2 (Second Intervention)||20
6770208|NCT04179474|7697704|FG000|COMPLETED|Treatment Period 2 (Second Intervention)||19
6770209|NCT04179474|7697705|FG001|COMPLETED|Treatment Period 2 (Second Intervention)||20
6770210|NCT04179474|7697704|FG000|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
6770211|NCT04179474|7697705|FG001|NOT COMPLETED|Treatment Period 2 (Second Intervention)||0
6770212|NCT04179474|7697704|FG000|STARTED|Treatment Period 3 (Third Intervention)||19
6770213|NCT04179474|7697705|FG001|STARTED|Treatment Period 3 (Third Intervention)|1 participant did not receive Intervention D.|19
6770214|NCT04179474|7697704|FG000|COMPLETED|Treatment Period 3 (Third Intervention)||19
6770215|NCT04179474|7697705|FG001|COMPLETED|Treatment Period 3 (Third Intervention)||19
6770216|NCT04179474|7697704|FG000|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
6770217|NCT04179474|7697705|FG001|NOT COMPLETED|Treatment Period 3 (Third Intervention)||0
6770218|NCT04178590|7697726|FG000|STARTED|Overall Study||32
6770219|NCT04178590|7697726|FG000|COMPLETED|Overall Study||30
6770220|NCT04178590|7697726|FG000|NOT COMPLETED|Overall Study||2
6770221|NCT04177862|7697754|FG000|STARTED|Overall Study||35
6770222|NCT04177862|7697755|FG001|STARTED|Overall Study||40
6770223|NCT04177862|7697754|FG000|COMPLETED|Overall Study||33
6770224|NCT04177862|7697755|FG001|COMPLETED|Overall Study||33
6770225|NCT04177862|7697754|FG000|NOT COMPLETED|Overall Study||2
6770226|NCT04177862|7697755|FG001|NOT COMPLETED|Overall Study||7
6770227|NCT04176406|7697762|FG000|STARTED|Overall Study||0
6770228|NCT04176406|7697763|FG001|STARTED|Overall Study||0
6770229|NCT04176406|7697764|FG002|STARTED|Overall Study||0
6770230|NCT04176406|7697765|FG003|STARTED|Overall Study||0
6770231|NCT04176406|7697762|FG000|COMPLETED|Overall Study||0
6770232|NCT04176406|7697763|FG001|COMPLETED|Overall Study||0
6770233|NCT04176406|7697764|FG002|COMPLETED|Overall Study||0
6770234|NCT04176406|7697765|FG003|COMPLETED|Overall Study||0
6770235|NCT04176406|7697762|FG000|NOT COMPLETED|Overall Study||0
6770236|NCT04176406|7697763|FG001|NOT COMPLETED|Overall Study||0
6770237|NCT04176406|7697764|FG002|NOT COMPLETED|Overall Study||0
6770238|NCT04176406|7697765|FG003|NOT COMPLETED|Overall Study||0
6770239|NCT04175262|7697776|FG000|STARTED|Overall Study||102
6770240|NCT04175262|7697776|FG000|COMPLETED|Overall Study||102
6770241|NCT04175262|7697776|FG000|NOT COMPLETED|Overall Study||0
6770242|NCT04171102|7697783|FG000|STARTED|Overall Study||4
6770243|NCT04171102|7697784|FG001|STARTED|Overall Study||5
6770244|NCT04171102|7697785|FG002|STARTED|Overall Study||6
6770245|NCT04171102|7697783|FG000|COMPLETED|Overall Study||4
6770246|NCT04171102|7697784|FG001|COMPLETED|Overall Study||5
6770247|NCT04171102|7697785|FG002|COMPLETED|Overall Study||6
6770248|NCT04171102|7697783|FG000|NOT COMPLETED|Overall Study||0
6770249|NCT04171102|7697784|FG001|NOT COMPLETED|Overall Study||0
6770250|NCT04171102|7697785|FG002|NOT COMPLETED|Overall Study||0
6770251|NCT04174638|7697795|FG000|STARTED|Overall Study||32
6770252|NCT04174638|7697796|FG001|STARTED|Overall Study||28
6770253|NCT04174638|7697795|FG000|COMPLETED|Overall Study||32
6770254|NCT04174638|7697796|FG001|COMPLETED|Overall Study||28
6770255|NCT04174638|7697795|FG000|NOT COMPLETED|Overall Study||0
6770256|NCT04174638|7697796|FG001|NOT COMPLETED|Overall Study||0
6770257|NCT04174313|7697807|FG000|STARTED|Overall Study||15
6770258|NCT04174313|7697808|FG001|STARTED|Overall Study||50
6770259|NCT04174313|7697807|FG000|COMPLETED|Overall Study||15
6770260|NCT04174313|7697808|FG001|COMPLETED|Overall Study||50
6770261|NCT04174313|7697807|FG000|NOT COMPLETED|Overall Study||0
6770262|NCT04174313|7697808|FG001|NOT COMPLETED|Overall Study||0
6770263|NCT04173429|7697820|FG000|STARTED|Overall Study||32
6770264|NCT04173429|7697821|FG001|STARTED|Overall Study||32
6770265|NCT04173429|7697820|FG000|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||32
6770266|NCT04173429|7697821|FG001|Completed the Nadroparin Calcium Therapy and Received Warfarin|Overall Study||0
6770267|NCT04173429|7697820|FG000|COMPLETED|Overall Study||30
6770268|NCT04173429|7697821|FG001|COMPLETED|Overall Study||30
6770269|NCT04173429|7697820|FG000|NOT COMPLETED|Overall Study||2
6770270|NCT04173429|7697821|FG001|NOT COMPLETED|Overall Study||2
6770271|NCT04173741|7697830|FG000|STARTED|Overall Study||23
6770272|NCT04173741|7697831|FG001|STARTED|Overall Study||23
6770273|NCT04173741|7697830|FG000|COMPLETED|Overall Study||22
6770274|NCT04173741|7697831|FG001|COMPLETED|Overall Study||22
6770275|NCT04173741|7697830|FG000|NOT COMPLETED|Overall Study||1
6770276|NCT04173741|7697831|FG001|NOT COMPLETED|Overall Study||1
6770277|NCT04169061|7697837|FG000|STARTED|Overall Study||36
6770278|NCT04169061|7697837|FG000|Safety Population|Overall Study||36
6770279|NCT04169061|7697837|FG000|Modified Intent to Treat (mITT) Population|Overall Study||34
6770280|NCT04169061|7697837|FG000|COMPLETED|Overall Study||31
6770281|NCT04169061|7697837|FG000|NOT COMPLETED|Overall Study||5
6770282|NCT04157738|7697843|FG000|STARTED|Overall Study||12
6770283|NCT04157738|7697844|FG001|STARTED|Overall Study||12
6770284|NCT04157738|7697843|FG000|COMPLETED|Overall Study||11
6770285|NCT04157738|7697844|FG001|COMPLETED|Overall Study||10
6770286|NCT04157738|7697843|FG000|NOT COMPLETED|Overall Study||1
6770287|NCT04157738|7697844|FG001|NOT COMPLETED|Overall Study||2
6770288|NCT04156646|7697852|FG000|STARTED|Treatment Period 1 (6 Days)||8
6770289|NCT04156646|7697853|FG001|STARTED|Treatment Period 1 (6 Days)||8
6770290|NCT04156646|7697852|FG000|COMPLETED|Treatment Period 1 (6 Days)||8
6556634|NCT01763047|7479040|FG000|NOT COMPLETED|Period 1||9
6556635|NCT01763047|7479041|FG001|NOT COMPLETED|Period 1||11
6770291|NCT04156646|7697853|FG001|COMPLETED|Treatment Period 1 (6 Days)||8
6770292|NCT04156646|7697852|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6770293|NCT04156646|7697853|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6770294|NCT04156646|7697852|FG000|STARTED|Wash-out Period (12- to 21-days)||8
6770295|NCT04156646|7697853|FG001|STARTED|Wash-out Period (12- to 21-days)||8
6770296|NCT04156646|7697852|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
6770297|NCT04156646|7697853|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
6770298|NCT04156646|7697852|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
6770299|NCT04156646|7697853|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
6770300|NCT04156646|7697852|FG000|STARTED|Treatment Period 2 (6 Days)||8
6770301|NCT04156646|7697853|FG001|STARTED|Treatment Period 2 (6 Days)||8
6770302|NCT04156646|7697852|FG000|COMPLETED|Treatment Period 2 (6 Days)||8
6770303|NCT04156646|7697853|FG001|COMPLETED|Treatment Period 2 (6 Days)||8
6770304|NCT04156646|7697852|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6770305|NCT04156646|7697853|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6770306|NCT04156646|7697852|FG000|STARTED|Wash-out Period (12- to 21-days)||8
6770307|NCT04156646|7697853|FG001|STARTED|Wash-out Period (12- to 21-days)||8
6770308|NCT04156646|7697852|FG000|COMPLETED|Wash-out Period (12- to 21-days)||8
6770309|NCT04156646|7697853|FG001|COMPLETED|Wash-out Period (12- to 21-days)||8
6770310|NCT04156646|7697852|FG000|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
6770311|NCT04156646|7697853|FG001|NOT COMPLETED|Wash-out Period (12- to 21-days)||0
6770312|NCT04156646|7697852|FG000|STARTED|Treatment Period 3 (6 Days)||8
6770313|NCT04156646|7697853|FG001|STARTED|Treatment Period 3 (6 Days)||8
6770314|NCT04156646|7697852|FG000|COMPLETED|Treatment Period 3 (6 Days)||8
6770315|NCT04156646|7697853|FG001|COMPLETED|Treatment Period 3 (6 Days)||7
6770316|NCT04156646|7697852|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6770317|NCT04156646|7697853|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||1
6770318|NCT04170686|7697864|FG000|STARTED|Screening||74
6770319|NCT04170686|7697865|FG001|STARTED|Screening||72
6770320|NCT04170686|7697864|FG000|COMPLETED|Screening||62
6770321|NCT04170686|7697865|FG001|COMPLETED|Screening||59
6770322|NCT04170686|7697864|FG000|NOT COMPLETED|Screening||12
6770323|NCT04170686|7697865|FG001|NOT COMPLETED|Screening||13
6770324|NCT04170686|7697864|FG000|STARTED|Randomization and Treatment||62
6770325|NCT04170686|7697865|FG001|STARTED|Randomization and Treatment||59
6770326|NCT04170686|7697864|FG000|COMPLETED|Randomization and Treatment||36
6770327|NCT04170686|7697865|FG001|COMPLETED|Randomization and Treatment||44
6770328|NCT04170686|7697864|FG000|NOT COMPLETED|Randomization and Treatment||26
6770329|NCT04170686|7697865|FG001|NOT COMPLETED|Randomization and Treatment||15
6770330|NCT04169113|7697873|FG000|STARTED|Overall Study||52
6770331|NCT04169113|7697874|FG001|STARTED|Overall Study||59
6770332|NCT04169113|7697873|FG000|COMPLETED|Overall Study||47
6770333|NCT04169113|7697874|FG001|COMPLETED|Overall Study||53
6770334|NCT04169113|7697873|FG000|NOT COMPLETED|Overall Study||5
6770335|NCT04169113|7697874|FG001|NOT COMPLETED|Overall Study||6
6770336|NCT04160975|7697886|FG000|STARTED|Overall Study||479
6770337|NCT04160975|7697887|FG001|STARTED|Overall Study||496
6770338|NCT04160975|7697888|FG002|STARTED|Overall Study||478
6770339|NCT04160975|7697889|FG003|STARTED|Overall Study||485
6770340|NCT04160975|7697890|FG004|STARTED|Overall Study||649
6770341|NCT04160975|7697891|FG005|STARTED|Overall Study||658
6556636|NCT01763047|7479040|FG000|STARTED|Period 2||130
6770342|NCT04160975|7697886|FG000|COMPLETED|Overall Study||415
6770343|NCT04160975|7697887|FG001|COMPLETED|Overall Study||430
6770344|NCT04160975|7697888|FG002|COMPLETED|Overall Study||417
6770345|NCT04160975|7697889|FG003|COMPLETED|Overall Study||410
6770346|NCT04160975|7697890|FG004|COMPLETED|Overall Study||614
6770347|NCT04160975|7697891|FG005|COMPLETED|Overall Study||607
6770348|NCT04160975|7697886|FG000|NOT COMPLETED|Overall Study||64
6770349|NCT04160975|7697887|FG001|NOT COMPLETED|Overall Study||66
6770350|NCT04160975|7697888|FG002|NOT COMPLETED|Overall Study||61
6770351|NCT04160975|7697889|FG003|NOT COMPLETED|Overall Study||75
6770352|NCT04160975|7697890|FG004|NOT COMPLETED|Overall Study||35
6770353|NCT04160975|7697891|FG005|NOT COMPLETED|Overall Study||51
6770354|NCT04153409|7697906|FG000|STARTED|Overall Study||10
6770355|NCT04153409|7697907|FG001|STARTED|Overall Study||11
6770356|NCT04153409|7697906|FG000|COMPLETED|Overall Study||8
6770357|NCT04153409|7697907|FG001|COMPLETED|Overall Study||9
6770358|NCT04153409|7697906|FG000|NOT COMPLETED|Overall Study||2
6770359|NCT04153409|7697907|FG001|NOT COMPLETED|Overall Study||2
6770360|NCT04167189|7697913|FG000|STARTED|Overall Study||28
6770361|NCT04167189|7697913|FG000|COMPLETED|Overall Study||28
6770362|NCT04167189|7697913|FG000|NOT COMPLETED|Overall Study||0
6770363|NCT04162795|7697917|FG000|STARTED|Overall Study||468
6770364|NCT04162795|7697917|FG000|COMPLETED|Overall Study||442
6770365|NCT04162795|7697917|FG000|NOT COMPLETED|Overall Study||26
6770366|NCT04161807|7697921|FG000|STARTED|Overall Study||42
6770367|NCT04161807|7697921|FG000|COMPLETED|Overall Study||38
6770368|NCT04161807|7697921|FG000|NOT COMPLETED|Overall Study||4
6770369|NCT04161144|7697927|FG000|STARTED|Overall Study||12
6770370|NCT04161144|7697928|FG001|STARTED|Overall Study||10
6770371|NCT04161144|7697927|FG000|COMPLETED|Overall Study||11
6770372|NCT04161144|7697928|FG001|COMPLETED|Overall Study||9
6770373|NCT04161144|7697927|FG000|NOT COMPLETED|Overall Study||1
6770374|NCT04161144|7697928|FG001|NOT COMPLETED|Overall Study||1
6770375|NCT04161131|7697934|FG000|STARTED|Overall Study||28
6770376|NCT04161131|7697934|FG000|Completed Baseline Surveys|Overall Study||27
6770377|NCT04161131|7697934|FG000|Received Intervention|Overall Study||22
6770378|NCT04161131|7697934|FG000|COMPLETED|Overall Study||22
6770379|NCT04161131|7697934|FG000|NOT COMPLETED|Overall Study||6
6770380|NCT04161079|7697938|FG000|STARTED|Clinical Investigation 2010-040||12
6770381|NCT04161079|7697938|FG000|COMPLETED|Clinical Investigation 2010-040||11
6770382|NCT04161079|7697938|FG000|NOT COMPLETED|Clinical Investigation 2010-040||1
6770383|NCT04161079|7697938|FG000|STARTED|2010-040FU5 >5 Years Follow-up|Of 11 subjects 3 refused to participate and 1 died.|7
6770384|NCT04161079|7697938|FG000|COMPLETED|2010-040FU5 >5 Years Follow-up|Timepoint distribution for individual patients ranged approximately 6-8 yrs after MAR implantation.|7
6770385|NCT04161079|7697938|FG000|NOT COMPLETED|2010-040FU5 >5 Years Follow-up||0
6770386|NCT04158466|7697948|FG000|STARTED|Overall Study||124
6770387|NCT04158466|7697949|FG001|STARTED|Overall Study||127
6770388|NCT04158466|7697948|FG000|COMPLETED|Overall Study||121
6770389|NCT04158466|7697949|FG001|COMPLETED|Overall Study||126
6770390|NCT04158466|7697948|FG000|NOT COMPLETED|Overall Study||3
6770391|NCT04158466|7697949|FG001|NOT COMPLETED|Overall Study||1
6770392|NCT04152083|7697957|FG000|STARTED|Overall Study||241
6770393|NCT04152083|7697958|FG001|STARTED|Overall Study||244
6770394|NCT04152083|7697957|FG000|Received at Least 1 Dose of Study Drug|Overall Study||238
6770395|NCT04152083|7697958|FG001|Received at Least 1 Dose of Study Drug|Overall Study||242
6770396|NCT04152083|7697957|FG000|COMPLETED|Overall Study||235
6770397|NCT04152083|7697958|FG001|COMPLETED|Overall Study||241
6770398|NCT04152083|7697957|FG000|NOT COMPLETED|Overall Study||6
6770399|NCT04152083|7697958|FG001|NOT COMPLETED|Overall Study||3
6770400|NCT04155567|7697964|FG000|STARTED|Overall Study||10
6770401|NCT04155567|7697964|FG000|COMPLETED|Overall Study||10
6770402|NCT04155567|7697964|FG000|NOT COMPLETED|Overall Study||0
6770403|NCT04155047|7697970|FG000|STARTED|Overall Study||11
6770404|NCT04155047|7697971|FG001|STARTED|Overall Study||11
6770405|NCT04155047|7697970|FG000|COMPLETED|Overall Study||9
6770406|NCT04155047|7697971|FG001|COMPLETED|Overall Study||11
6770407|NCT04155047|7697970|FG000|NOT COMPLETED|Overall Study||2
6770408|NCT04155047|7697971|FG001|NOT COMPLETED|Overall Study||0
6770409|NCT04152642|7697977|FG000|STARTED|Overall Study||22
6770410|NCT04152642|7697977|FG000|C (Water/Negative) Control|Overall Study||20
6770411|NCT04152642|7697977|FG000|A (Marketed Rinse)|Overall Study||19
6770412|NCT04152642|7697977|FG000|B (Experimental Rinse)|Overall Study||19
6770413|NCT04152642|7697977|FG000|COMPLETED|Overall Study||15
6770414|NCT04152642|7697977|FG000|NOT COMPLETED|Overall Study||7
6770415|NCT04150861|7697988|FG000|STARTED|Overall Study||8
6770416|NCT04150861|7697989|FG001|STARTED|Overall Study||8
6770417|NCT04150861|7697990|FG002|STARTED|Overall Study||8
6770418|NCT04150861|7697988|FG000|COMPLETED|Overall Study||8
6770419|NCT04150861|7697989|FG001|COMPLETED|Overall Study||8
6770420|NCT04150861|7697990|FG002|COMPLETED|Overall Study||8
6770421|NCT04150861|7697988|FG000|NOT COMPLETED|Overall Study||0
6770422|NCT04150861|7697989|FG001|NOT COMPLETED|Overall Study||0
6770423|NCT04150861|7697990|FG002|NOT COMPLETED|Overall Study||0
6770424|NCT04150250|7698000|FG000|STARTED|Overall Study||23
6770425|NCT04150250|7698001|FG001|STARTED|Overall Study||24
6770426|NCT04150250|7698000|FG000|COMPLETED|Overall Study||23
6770427|NCT04150250|7698001|FG001|COMPLETED|Overall Study||22
6770428|NCT04150250|7698000|FG000|NOT COMPLETED|Overall Study||0
6770429|NCT04150250|7698001|FG001|NOT COMPLETED|Overall Study||2
6770430|NCT04149925|7698009|FG000|STARTED|Overall Study||30
6770431|NCT04149925|7698010|FG001|STARTED|Overall Study||30
6770432|NCT04149925|7698009|FG000|COMPLETED|Overall Study||30
6770433|NCT04149925|7698010|FG001|COMPLETED|Overall Study||30
6770434|NCT04149925|7698009|FG000|NOT COMPLETED|Overall Study||0
6770435|NCT04149925|7698010|FG001|NOT COMPLETED|Overall Study||0
6770436|NCT04150224|7698022|FG000|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6770437|NCT04150224|7698023|FG001|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6770438|NCT04150224|7698024|FG002|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6770439|NCT04150224|7698025|FG003|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6770440|NCT04150224|7698026|FG004|STARTED|Overall Study|10 healthy volunteers receiving PBTZ169 + 1 backup volunteer|10
6770441|NCT04150224|7698027|FG005|STARTED|Overall Study|Period 2: Multple Dosing|10
6770442|NCT04150224|7698022|FG000|COMPLETED|Overall Study||10
6770443|NCT04150224|7698023|FG001|COMPLETED|Overall Study||10
6770444|NCT04150224|7698024|FG002|COMPLETED|Overall Study||10
6770445|NCT04150224|7698025|FG003|COMPLETED|Overall Study||10
6770446|NCT04150224|7698026|FG004|COMPLETED|Overall Study||10
6770447|NCT04150224|7698027|FG005|COMPLETED|Overall Study|Period 2: Multple Dosing|10
6770448|NCT04150224|7698022|FG000|NOT COMPLETED|Overall Study||0
6770449|NCT04150224|7698023|FG001|NOT COMPLETED|Overall Study||0
6770450|NCT04150224|7698024|FG002|NOT COMPLETED|Overall Study||0
6770451|NCT04150224|7698025|FG003|NOT COMPLETED|Overall Study||0
6770452|NCT04150224|7698026|FG004|NOT COMPLETED|Overall Study||0
6770453|NCT04150224|7698027|FG005|NOT COMPLETED|Overall Study||0
6770454|NCT04149405|7698054|FG000|STARTED|Overall Study||12
6770455|NCT04149405|7698055|FG001|STARTED|Overall Study||10
6770456|NCT04149405|7698056|FG002|STARTED|Overall Study||11
6770457|NCT04149405|7698057|FG003|STARTED|Overall Study||10
6770458|NCT04149405|7698054|FG000|COMPLETED|Overall Study||12
6770459|NCT04149405|7698055|FG001|COMPLETED|Overall Study||10
6770460|NCT04149405|7698056|FG002|COMPLETED|Overall Study||11
6770461|NCT04149405|7698057|FG003|COMPLETED|Overall Study||10
6770462|NCT04149405|7698054|FG000|NOT COMPLETED|Overall Study||0
6770463|NCT04149405|7698055|FG001|NOT COMPLETED|Overall Study||0
6770464|NCT04149405|7698056|FG002|NOT COMPLETED|Overall Study||0
6770465|NCT04149405|7698057|FG003|NOT COMPLETED|Overall Study||0
6498151|NCT01408719|7416829|FG003|NOT COMPLETED|Third Intervention (35 Days)||0
6498152|NCT01408719|7416830|FG004|NOT COMPLETED|Third Intervention (35 Days)||0
6498153|NCT01408719|7416831|FG005|NOT COMPLETED|Third Intervention (35 Days)||0
6498154|NCT01408719|7416832|FG006|NOT COMPLETED|Third Intervention (35 Days)||0
6498155|NCT01408719|7416833|FG007|NOT COMPLETED|Third Intervention (35 Days)||1
6498156|NCT01408719|7416834|FG008|NOT COMPLETED|Third Intervention (35 Days)||0
6498157|NCT01408719|7416835|FG009|NOT COMPLETED|Third Intervention (35 Days)||0
6498158|NCT01408719|7416836|FG010|NOT COMPLETED|Third Intervention (35 Days)||0
6498159|NCT01408719|7416837|FG011|NOT COMPLETED|Third Intervention (35 Days)||0
6498160|NCT01408719|7416838|FG012|NOT COMPLETED|Third Intervention (35 Days)||0
6770466|NCT04144088|7698076|FG000|STARTED|Overall Study||20
6770467|NCT04144088|7698077|FG001|STARTED|Overall Study||20
6770468|NCT04144088|7698078|FG002|STARTED|Overall Study||20
6770469|NCT04144088|7698076|FG000|COMPLETED|Overall Study||14
6770470|NCT04144088|7698077|FG001|COMPLETED|Overall Study||15
6770471|NCT04144088|7698078|FG002|COMPLETED|Overall Study||13
6770472|NCT04144088|7698076|FG000|NOT COMPLETED|Overall Study||6
6770473|NCT04144088|7698077|FG001|NOT COMPLETED|Overall Study||5
6770474|NCT04144088|7698078|FG002|NOT COMPLETED|Overall Study||7
6770475|NCT04149353|7698086|FG000|STARTED|Overall Study|The study was terminated for low recruitment before this subject's second imaging scan was due.|1
6770476|NCT04149353|7698086|FG000|COMPLETED|Overall Study||0
6770477|NCT04149353|7698086|FG000|NOT COMPLETED|Overall Study||1
6770478|NCT04137783|7698094|FG000|STARTED|Overall Study||7
6770479|NCT04137783|7698095|FG001|STARTED|Overall Study||10
6770480|NCT04137783|7698096|FG002|STARTED|Overall Study||22
6770481|NCT04137783|7698094|FG000|COMPLETED|Overall Study||7
6770482|NCT04137783|7698095|FG001|COMPLETED|Overall Study||10
6770483|NCT04137783|7698096|FG002|COMPLETED|Overall Study||22
6770484|NCT04137783|7698094|FG000|NOT COMPLETED|Overall Study||0
6770485|NCT04137783|7698095|FG001|NOT COMPLETED|Overall Study||0
6770486|NCT04137783|7698096|FG002|NOT COMPLETED|Overall Study||0
6770487|NCT04136444|7698106|FG000|STARTED|Overall Study||3
6770488|NCT04136444|7698107|FG001|STARTED|Overall Study||9
6770489|NCT04136444|7698106|FG000|COMPLETED|Overall Study|The cohort was not completely recruited, as the study was stopped/terminated due to COVID-19.|3
6770490|NCT04136444|7698107|FG001|COMPLETED|Overall Study||8
6770491|NCT04136444|7698106|FG000|NOT COMPLETED|Overall Study||0
6770492|NCT04136444|7698107|FG001|NOT COMPLETED|Overall Study||1
6770493|NCT04124536|7698124|FG000|STARTED|Overall Study||58
6770494|NCT04124536|7698125|FG001|STARTED|Overall Study||58
6770495|NCT04124536|7698126|FG002|STARTED|Overall Study||105
6770496|NCT04124536|7698127|FG003|STARTED|Overall Study||105
6770497|NCT04124536|7698128|FG004|STARTED|Overall Study||15
6770498|NCT04124536|7698124|FG000|COMPLETED|Overall Study||47
6770499|NCT04124536|7698125|FG001|COMPLETED|Overall Study||53
6770500|NCT04124536|7698126|FG002|COMPLETED|Overall Study||102
6770501|NCT04124536|7698127|FG003|COMPLETED|Overall Study||98
6770502|NCT04124536|7698128|FG004|COMPLETED|Overall Study||15
6770503|NCT04124536|7698124|FG000|NOT COMPLETED|Overall Study||11
6770504|NCT04124536|7698125|FG001|NOT COMPLETED|Overall Study||5
6770505|NCT04124536|7698126|FG002|NOT COMPLETED|Overall Study||3
6770506|NCT04124536|7698127|FG003|NOT COMPLETED|Overall Study||7
6770507|NCT04124536|7698128|FG004|NOT COMPLETED|Overall Study||0
6770508|NCT04147611|7698141|FG000|STARTED|Overall Study||9
6770509|NCT04147611|7698142|FG001|STARTED|Overall Study||13
6770510|NCT04147611|7698141|FG000|COMPLETED|Overall Study||9
6770511|NCT04147611|7698142|FG001|COMPLETED|Overall Study||12
6770512|NCT04147611|7698141|FG000|NOT COMPLETED|Overall Study||0
6770513|NCT04147611|7698142|FG001|NOT COMPLETED|Overall Study||1
6770514|NCT04147442|7698148|FG000|STARTED|Overall Study||20
6770515|NCT04147442|7698148|FG000|COMPLETED|Overall Study||20
6770516|NCT04147442|7698148|FG000|NOT COMPLETED|Overall Study||0
6770517|NCT04147455|7698162|FG000|STARTED|Overall Study||397
6770518|NCT04147455|7698163|FG001|STARTED|Overall Study||396
6770519|NCT04147455|7698162|FG000|COMPLETED|Overall Study||375
6770520|NCT04147455|7698163|FG001|COMPLETED|Overall Study||364
6770521|NCT04147455|7698162|FG000|NOT COMPLETED|Overall Study||22
6770522|NCT04147455|7698163|FG001|NOT COMPLETED|Overall Study||32
6770523|NCT04146272|7698173|FG000|STARTED|First Intervention||11
6770524|NCT04146272|7698174|FG001|STARTED|First Intervention||11
6770525|NCT04146272|7698175|FG002|STARTED|First Intervention||6
6770526|NCT04146272|7698176|FG003|STARTED|First Intervention||5
6770527|NCT04146272|7698173|FG000|COMPLETED|First Intervention||11
6770528|NCT04146272|7698174|FG001|COMPLETED|First Intervention||11
6770529|NCT04146272|7698175|FG002|COMPLETED|First Intervention||6
6770530|NCT04146272|7698176|FG003|COMPLETED|First Intervention||5
6770531|NCT04146272|7698173|FG000|NOT COMPLETED|First Intervention||0
6770532|NCT04146272|7698174|FG001|NOT COMPLETED|First Intervention||0
6770533|NCT04146272|7698175|FG002|NOT COMPLETED|First Intervention||0
6770534|NCT04146272|7698176|FG003|NOT COMPLETED|First Intervention||0
6770535|NCT04146272|7698173|FG000|STARTED|Second Intervention||11
6770536|NCT04146272|7698174|FG001|STARTED|Second Intervention||11
6770537|NCT04146272|7698175|FG002|STARTED|Second Intervention||6
6770538|NCT04146272|7698176|FG003|STARTED|Second Intervention||5
6770539|NCT04146272|7698173|FG000|COMPLETED|Second Intervention||11
6770540|NCT04146272|7698174|FG001|COMPLETED|Second Intervention||11
6770541|NCT04146272|7698175|FG002|COMPLETED|Second Intervention||6
6770542|NCT04146272|7698176|FG003|COMPLETED|Second Intervention||5
6770543|NCT04146272|7698173|FG000|NOT COMPLETED|Second Intervention||0
6770544|NCT04146272|7698174|FG001|NOT COMPLETED|Second Intervention||0
6770545|NCT04146272|7698175|FG002|NOT COMPLETED|Second Intervention||0
6770546|NCT04146272|7698176|FG003|NOT COMPLETED|Second Intervention||0
6770547|NCT04143945|7698195|FG000|STARTED|Treatment Period 1 (Day 1)||26
6770548|NCT04143945|7698196|FG001|STARTED|Treatment Period 1 (Day 1)||26
6770549|NCT04143945|7698197|FG002|STARTED|Treatment Period 1 (Day 1)||26
6770550|NCT04143945|7698198|FG003|STARTED|Treatment Period 1 (Day 1)||26
6770551|NCT04143945|7698195|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6770552|NCT04143945|7698196|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6770553|NCT04143945|7698197|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6770554|NCT04143945|7698198|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6770555|NCT04143945|7698195|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6770556|NCT04143945|7698196|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6770557|NCT04143945|7698197|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6770558|NCT04143945|7698198|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6770559|NCT04143945|7698195|FG000|Per Protocol Set|Treatment Period 1 (Day 1)||26
6770560|NCT04143945|7698196|FG001|Per Protocol Set|Treatment Period 1 (Day 1)||26
6770561|NCT04143945|7698197|FG002|Per Protocol Set|Treatment Period 1 (Day 1)||26
6770562|NCT04143945|7698198|FG003|Per Protocol Set|Treatment Period 1 (Day 1)||26
6770563|NCT04143945|7698195|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
6770564|NCT04143945|7698196|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
6770565|NCT04143945|7698197|FG002|COMPLETED|Treatment Period 1 (Day 1)||26
6770566|NCT04143945|7698198|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
6770567|NCT04143945|7698195|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6770568|NCT04143945|7698196|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6770569|NCT04143945|7698197|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6770570|NCT04143945|7698198|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6770571|NCT04143945|7698195|FG000|STARTED|Treatment Period 2 (Day 1)||26
6770572|NCT04143945|7698196|FG001|STARTED|Treatment Period 2 (Day 1)||26
6770573|NCT04143945|7698197|FG002|STARTED|Treatment Period 2 (Day 1)||26
6770574|NCT04143945|7698198|FG003|STARTED|Treatment Period 2 (Day 1)||26
6770575|NCT04143945|7698195|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
6770576|NCT04143945|7698196|FG001|COMPLETED|Treatment Period 2 (Day 1)||26
6770577|NCT04143945|7698197|FG002|COMPLETED|Treatment Period 2 (Day 1)||26
6770578|NCT04143945|7698198|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
6770579|NCT04143945|7698195|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6770580|NCT04143945|7698196|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6770581|NCT04143945|7698197|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6770582|NCT04143945|7698198|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6770583|NCT04143373|7698203|FG000|STARTED|Overall Study||20
6770584|NCT04143373|7698204|FG001|STARTED|Overall Study||20
6770585|NCT04143373|7698203|FG000|COMPLETED|Overall Study||20
6770586|NCT04143373|7698204|FG001|COMPLETED|Overall Study||20
6770587|NCT04143373|7698203|FG000|NOT COMPLETED|Overall Study||0
6770588|NCT04143373|7698204|FG001|NOT COMPLETED|Overall Study||0
6770589|NCT04142216|7698211|FG000|STARTED|Overall Study||28
6770590|NCT04142216|7698212|FG001|STARTED|Overall Study||28
6770591|NCT04142216|7698211|FG000|COMPLETED|Overall Study||22
6770592|NCT04142216|7698212|FG001|COMPLETED|Overall Study||22
6770593|NCT04142216|7698211|FG000|NOT COMPLETED|Overall Study||6
6770594|NCT04142216|7698212|FG001|NOT COMPLETED|Overall Study||6
6770595|NCT04141930|7698218|FG000|STARTED|Overall Study||302
6770596|NCT04141930|7698219|FG001|STARTED|Overall Study|The 179 individuals that were not eligible to receive the study drug, participated in an observation portion of the study where all study procedures were the same excluding telehealth visit and an antiviral delivery.|179
6770597|NCT04141930|7698218|FG000|COMPLETED|Overall Study||302
6770598|NCT04141930|7698219|FG001|COMPLETED|Overall Study||179
6770599|NCT04141930|7698218|FG000|NOT COMPLETED|Overall Study||0
6770600|NCT04141930|7698219|FG001|NOT COMPLETED|Overall Study||0
6770601|NCT04142450|7698223|FG000|STARTED|Overall Study||50
6770602|NCT04142450|7698223|FG000|Safety Population|Overall Study||49
6770603|NCT04142450|7698223|FG000|COMPLETED|Overall Study||48
6770604|NCT04142450|7698223|FG000|NOT COMPLETED|Overall Study||2
6770605|NCT04142242|7698233|FG000|STARTED|Overall Study||139
6770606|NCT04142242|7698234|FG001|STARTED|Overall Study||176
6770607|NCT04142242|7698235|FG002|STARTED|Overall Study||31
6770608|NCT04142242|7698236|FG003|STARTED|Overall Study||39
6770609|NCT04142242|7698237|FG004|STARTED|Overall Study||26
6770610|NCT04142242|7698238|FG005|STARTED|Overall Study||60
6770611|NCT04142242|7698233|FG000|Vaccinated|Overall Study||138
6770612|NCT04142242|7698234|FG001|Vaccinated|Overall Study||175
6770613|NCT04142242|7698235|FG002|Vaccinated|Overall Study||0
6770614|NCT04142242|7698236|FG003|Vaccinated|Overall Study||0
6770615|NCT04142242|7698237|FG004|Vaccinated|Overall Study||0
6770616|NCT04142242|7698238|FG005|Vaccinated|Overall Study||0
6770617|NCT04142242|7698233|FG000|Full Analysis Set (FAS)|Overall Study||138
6770618|NCT04142242|7698234|FG001|Full Analysis Set (FAS)|Overall Study||175
6770619|NCT04142242|7698235|FG002|Full Analysis Set (FAS)|Overall Study||31
6770620|NCT04142242|7698236|FG003|Full Analysis Set (FAS)|Overall Study||39
6770621|NCT04142242|7698237|FG004|Full Analysis Set (FAS)|Overall Study||26
6770622|NCT04142242|7698238|FG005|Full Analysis Set (FAS)|Overall Study||59
6770623|NCT04142242|7698233|FG000|Safety Analysis Set (SAfAS)|Overall Study|1 MenACYW Conjugate vaccine-primed participant was erroneously assigned by Investigator to Group 1 but per planned analysis was counted in Group 2 for safety analysis.|151
6770624|NCT04142242|7698234|FG001|Safety Analysis Set (SAfAS)|Overall Study|14 Menomune-primed participants were erroneously assigned by Investigator to Group 2 but per planned analysis they were counted in Group 1 for safety analysis.|162
6770625|NCT04142242|7698235|FG002|Safety Analysis Set (SAfAS)|Overall Study||0
6770626|NCT04142242|7698236|FG003|Safety Analysis Set (SAfAS)|Overall Study||0
6770627|NCT04142242|7698237|FG004|Safety Analysis Set (SAfAS)|Overall Study||0
6770628|NCT04142242|7698238|FG005|Safety Analysis Set (SAfAS)|Overall Study||0
6770629|NCT04142242|7698233|FG000|COMPLETED|Overall Study||138
6770630|NCT04142242|7698234|FG001|COMPLETED|Overall Study||175
6770631|NCT04142242|7698235|FG002|COMPLETED|Overall Study||0
6770632|NCT04142242|7698236|FG003|COMPLETED|Overall Study||0
6770633|NCT04142242|7698237|FG004|COMPLETED|Overall Study||26
6770634|NCT04142242|7698238|FG005|COMPLETED|Overall Study||59
6770635|NCT04142242|7698233|FG000|NOT COMPLETED|Overall Study||1
6770636|NCT04142242|7698234|FG001|NOT COMPLETED|Overall Study||1
6770637|NCT04142242|7698235|FG002|NOT COMPLETED|Overall Study||31
6770638|NCT04142242|7698236|FG003|NOT COMPLETED|Overall Study||39
6770639|NCT04142242|7698237|FG004|NOT COMPLETED|Overall Study||0
6770640|NCT04142242|7698238|FG005|NOT COMPLETED|Overall Study||1
6770641|NCT04140890|7698253|FG000|STARTED|Overall Study||9
6770642|NCT04140890|7698254|FG001|STARTED|Overall Study||12
6770643|NCT04140890|7698253|FG000|COMPLETED|Overall Study||9
6770644|NCT04140890|7698254|FG001|COMPLETED|Overall Study||11
6770645|NCT04140890|7698253|FG000|NOT COMPLETED|Overall Study||0
6770646|NCT04140890|7698254|FG001|NOT COMPLETED|Overall Study||1
6770647|NCT04139018|7698265|FG000|STARTED|Overall Study||14
6770648|NCT04139018|7698266|FG001|STARTED|Overall Study||13
6770649|NCT04139018|7698265|FG000|COMPLETED|Overall Study||11
6770650|NCT04139018|7698266|FG001|COMPLETED|Overall Study||12
6770651|NCT04139018|7698265|FG000|NOT COMPLETED|Overall Study||3
6770652|NCT04139018|7698266|FG001|NOT COMPLETED|Overall Study||1
6770653|NCT04138810|7698274|FG000|STARTED|Overall Study||27
6770654|NCT04138810|7698275|FG001|STARTED|Overall Study||27
6770655|NCT04138810|7698274|FG000|COMPLETED|Overall Study||26
6770656|NCT04138810|7698275|FG001|COMPLETED|Overall Study||26
6770657|NCT04138810|7698274|FG000|NOT COMPLETED|Overall Study||1
6770658|NCT04138810|7698275|FG001|NOT COMPLETED|Overall Study||1
6770659|NCT04131556|7698281|FG000|STARTED|Overall Study||20
6770660|NCT04131556|7698281|FG000|COMPLETED|Overall Study||18
6770661|NCT04131556|7698281|FG000|NOT COMPLETED|Overall Study||2
6770662|NCT04126174|7698288|FG000|STARTED|Overall Study||41
6770663|NCT04126174|7698289|FG001|STARTED|Overall Study||41
6770664|NCT04126174|7698288|FG000|COMPLETED|Overall Study||38
6770665|NCT04126174|7698289|FG001|COMPLETED|Overall Study||38
6770666|NCT04126174|7698288|FG000|NOT COMPLETED|Overall Study||3
6770667|NCT04126174|7698289|FG001|NOT COMPLETED|Overall Study||3
6770668|NCT04134429|7698295|FG000|STARTED|Overall Study||20
6770669|NCT04134429|7698295|FG000|COMPLETED|Overall Study||19
6770670|NCT04134429|7698295|FG000|NOT COMPLETED|Overall Study||1
6770671|NCT04130425|7698299|FG000|STARTED|Overall Study||30
6770672|NCT04130425|7698299|FG000|COMPLETED|Overall Study||30
6770673|NCT04130425|7698299|FG000|NOT COMPLETED|Overall Study||0
6770674|NCT04138498|7698314|FG000|STARTED|Overall Study||11
6770675|NCT04138498|7698315|FG001|STARTED|Overall Study||10
6770676|NCT04138498|7698316|FG002|STARTED|Overall Study||12
6770677|NCT04138498|7698317|FG003|STARTED|Overall Study||12
6770678|NCT04138498|7698314|FG000|COMPLETED|Overall Study||10
6770679|NCT04138498|7698315|FG001|COMPLETED|Overall Study||10
6770680|NCT04138498|7698316|FG002|COMPLETED|Overall Study||10
6770681|NCT04138498|7698317|FG003|COMPLETED|Overall Study||9
6770682|NCT04138498|7698314|FG000|NOT COMPLETED|Overall Study||1
6770683|NCT04138498|7698315|FG001|NOT COMPLETED|Overall Study||0
6770684|NCT04138498|7698316|FG002|NOT COMPLETED|Overall Study||2
6770685|NCT04138498|7698317|FG003|NOT COMPLETED|Overall Study||3
6770686|NCT04138043|7698333|FG000|STARTED|Overall Study||2
6770687|NCT04138043|7698334|FG001|STARTED|Overall Study||7
6770688|NCT04138043|7698333|FG000|COMPLETED|Overall Study||2
6770689|NCT04138043|7698334|FG001|COMPLETED|Overall Study||6
6770690|NCT04138043|7698333|FG000|NOT COMPLETED|Overall Study||0
6770691|NCT04138043|7698334|FG001|NOT COMPLETED|Overall Study||1
6770692|NCT04137627|7698343|FG000|STARTED|Overall Study||25
6770693|NCT04137627|7698344|FG001|STARTED|Overall Study||25
6770694|NCT04137627|7698343|FG000|COMPLETED|Overall Study||13
6770695|NCT04137627|7698344|FG001|COMPLETED|Overall Study||12
6770696|NCT04137627|7698343|FG000|NOT COMPLETED|Overall Study||12
6770697|NCT04137627|7698344|FG001|NOT COMPLETED|Overall Study||13
6770698|NCT04136145|7698352|FG000|STARTED|Overall Study||12
6770699|NCT04136145|7698353|FG001|STARTED|Overall Study||24
6770700|NCT04136145|7698352|FG000|COMPLETED|Overall Study||12
6770701|NCT04136145|7698353|FG001|COMPLETED|Overall Study||24
6770702|NCT04136145|7698352|FG000|NOT COMPLETED|Overall Study||0
6770703|NCT04136145|7698353|FG001|NOT COMPLETED|Overall Study||0
6770704|NCT04132336|7698367|FG000|STARTED|Overall Study||32
6770705|NCT04132336|7698368|FG001|STARTED|Overall Study||32
6770706|NCT04132336|7698369|FG002|STARTED|Overall Study||32
6770707|NCT04132336|7698370|FG003|STARTED|Overall Study||32
6770708|NCT04132336|7698371|FG004|STARTED|Overall Study||32
6770709|NCT04132336|7698372|FG005|STARTED|Overall Study||16
6770710|NCT04132336|7698373|FG006|STARTED|Overall Study||17
6770711|NCT04132336|7698367|FG000|COMPLETED|Overall Study||32
6770712|NCT04132336|7698368|FG001|COMPLETED|Overall Study||31
6770713|NCT04132336|7698369|FG002|COMPLETED|Overall Study||32
6770714|NCT04132336|7698370|FG003|COMPLETED|Overall Study||32
6770715|NCT04132336|7698371|FG004|COMPLETED|Overall Study||32
6770716|NCT04132336|7698372|FG005|COMPLETED|Overall Study||16
6770717|NCT04132336|7698373|FG006|COMPLETED|Overall Study||17
6770718|NCT04132336|7698367|FG000|NOT COMPLETED|Overall Study||0
6770719|NCT04132336|7698368|FG001|NOT COMPLETED|Overall Study||1
6770720|NCT04132336|7698369|FG002|NOT COMPLETED|Overall Study||0
6770721|NCT04132336|7698370|FG003|NOT COMPLETED|Overall Study||0
6770722|NCT04132336|7698371|FG004|NOT COMPLETED|Overall Study||0
6770723|NCT04132336|7698372|FG005|NOT COMPLETED|Overall Study||0
6770724|NCT04132336|7698373|FG006|NOT COMPLETED|Overall Study||0
6770725|NCT04131517|7698391|FG000|STARTED|Overall Study||7
6770726|NCT04131517|7698392|FG001|STARTED|Overall Study||7
6770727|NCT04131517|7698391|FG000|COMPLETED|Overall Study||7
6770728|NCT04131517|7698392|FG001|COMPLETED|Overall Study||7
6770729|NCT04131517|7698391|FG000|NOT COMPLETED|Overall Study||0
6770730|NCT04131517|7698392|FG001|NOT COMPLETED|Overall Study||0
6770731|NCT04128293|7698413|FG000|STARTED|Treatment Period 1 (1 Day)||4
6770732|NCT04128293|7698414|FG001|STARTED|Treatment Period 1 (1 Day)||4
6770733|NCT04128293|7698415|FG002|STARTED|Treatment Period 1 (1 Day)||4
6770734|NCT04128293|7698416|FG003|STARTED|Treatment Period 1 (1 Day)||4
6770735|NCT04128293|7698413|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
6770736|NCT04128293|7698414|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
6770737|NCT04128293|7698415|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
6770738|NCT04128293|7698416|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
6770739|NCT04128293|7698413|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6770740|NCT04128293|7698414|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6770741|NCT04128293|7698415|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6770742|NCT04128293|7698416|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6770743|NCT04128293|7698413|FG000|STARTED|Washout Period 1 (Up to 7 Days)||4
6770744|NCT04128293|7698414|FG001|STARTED|Washout Period 1 (Up to 7 Days)||4
6770745|NCT04128293|7698415|FG002|STARTED|Washout Period 1 (Up to 7 Days)||4
6770746|NCT04128293|7698416|FG003|STARTED|Washout Period 1 (Up to 7 Days)||4
6770747|NCT04128293|7698413|FG000|COMPLETED|Washout Period 1 (Up to 7 Days)||4
6770748|NCT04128293|7698414|FG001|COMPLETED|Washout Period 1 (Up to 7 Days)||4
6770749|NCT04128293|7698415|FG002|COMPLETED|Washout Period 1 (Up to 7 Days)||4
6770750|NCT04128293|7698416|FG003|COMPLETED|Washout Period 1 (Up to 7 Days)||4
6770751|NCT04128293|7698413|FG000|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
6770752|NCT04128293|7698414|FG001|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
6770753|NCT04128293|7698415|FG002|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
6770754|NCT04128293|7698416|FG003|NOT COMPLETED|Washout Period 1 (Up to 7 Days)||0
6770755|NCT04128293|7698413|FG000|STARTED|Treatment Period 2 (1 Day)||4
6770756|NCT04128293|7698414|FG001|STARTED|Treatment Period 2 (1 Day)||4
6770757|NCT04128293|7698415|FG002|STARTED|Treatment Period 2 (1 Day)||4
6770758|NCT04128293|7698416|FG003|STARTED|Treatment Period 2 (1 Day)||4
6770759|NCT04128293|7698413|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
6770760|NCT04128293|7698414|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
6770761|NCT04128293|7698415|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
6770762|NCT04128293|7698416|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
6770763|NCT04128293|7698413|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6770764|NCT04128293|7698414|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6770765|NCT04128293|7698415|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6770766|NCT04128293|7698416|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6770767|NCT04128293|7698413|FG000|STARTED|Washout Period 2 (Up to 7 Days)||4
6770768|NCT04128293|7698414|FG001|STARTED|Washout Period 2 (Up to 7 Days)||4
6770769|NCT04128293|7698415|FG002|STARTED|Washout Period 2 (Up to 7 Days)||4
6770770|NCT04128293|7698416|FG003|STARTED|Washout Period 2 (Up to 7 Days)||4
6770771|NCT04128293|7698413|FG000|COMPLETED|Washout Period 2 (Up to 7 Days)||0
6770772|NCT04128293|7698414|FG001|COMPLETED|Washout Period 2 (Up to 7 Days)||0
6770773|NCT04128293|7698415|FG002|COMPLETED|Washout Period 2 (Up to 7 Days)||0
6770774|NCT04128293|7698416|FG003|COMPLETED|Washout Period 2 (Up to 7 Days)||0
6770775|NCT04128293|7698413|FG000|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
6770776|NCT04128293|7698414|FG001|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
6770777|NCT04128293|7698415|FG002|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
6770778|NCT04128293|7698416|FG003|NOT COMPLETED|Washout Period 2 (Up to 7 Days)||4
6770779|NCT04128293|7698413|FG000|STARTED|Treatment Period 3 (1 Day)||0
6770780|NCT04128293|7698414|FG001|STARTED|Treatment Period 3 (1 Day)||0
6770781|NCT04128293|7698415|FG002|STARTED|Treatment Period 3 (1 Day)||0
6770782|NCT04128293|7698416|FG003|STARTED|Treatment Period 3 (1 Day)||0
6770783|NCT04128293|7698413|FG000|COMPLETED|Treatment Period 3 (1 Day)||0
6770784|NCT04128293|7698414|FG001|COMPLETED|Treatment Period 3 (1 Day)||0
6770785|NCT04128293|7698415|FG002|COMPLETED|Treatment Period 3 (1 Day)||0
6770786|NCT04128293|7698416|FG003|COMPLETED|Treatment Period 3 (1 Day)||0
6770787|NCT04128293|7698413|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6770788|NCT04128293|7698414|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6770789|NCT04128293|7698415|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6770790|NCT04128293|7698416|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6770791|NCT04128293|7698413|FG000|STARTED|Washout Period 3 (Up to 7 Days)||0
6770792|NCT04128293|7698414|FG001|STARTED|Washout Period 3 (Up to 7 Days)||0
6770793|NCT04128293|7698415|FG002|STARTED|Washout Period 3 (Up to 7 Days)||0
6770794|NCT04128293|7698416|FG003|STARTED|Washout Period 3 (Up to 7 Days)||0
6770795|NCT04128293|7698413|FG000|COMPLETED|Washout Period 3 (Up to 7 Days)||0
6770796|NCT04128293|7698414|FG001|COMPLETED|Washout Period 3 (Up to 7 Days)||0
6770797|NCT04128293|7698415|FG002|COMPLETED|Washout Period 3 (Up to 7 Days)||0
6770798|NCT04128293|7698416|FG003|COMPLETED|Washout Period 3 (Up to 7 Days)||0
6770799|NCT04128293|7698413|FG000|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
6770800|NCT04128293|7698414|FG001|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
6770801|NCT04128293|7698415|FG002|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
6770802|NCT04128293|7698416|FG003|NOT COMPLETED|Washout Period 3 (Up to 7 Days)||0
6770803|NCT04128293|7698413|FG000|STARTED|Treatment Period 4 (1 Day)||0
6770804|NCT04128293|7698414|FG001|STARTED|Treatment Period 4 (1 Day)||0
6770805|NCT04128293|7698415|FG002|STARTED|Treatment Period 4 (1 Day)||0
6770806|NCT04128293|7698416|FG003|STARTED|Treatment Period 4 (1 Day)||0
6770807|NCT04128293|7698413|FG000|COMPLETED|Treatment Period 4 (1 Day)||0
6770808|NCT04128293|7698414|FG001|COMPLETED|Treatment Period 4 (1 Day)||0
6770809|NCT04128293|7698415|FG002|COMPLETED|Treatment Period 4 (1 Day)||0
6770810|NCT04128293|7698416|FG003|COMPLETED|Treatment Period 4 (1 Day)||0
6770811|NCT04128293|7698413|FG000|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6770812|NCT04128293|7698414|FG001|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6770813|NCT04128293|7698415|FG002|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6770814|NCT04128293|7698416|FG003|NOT COMPLETED|Treatment Period 4 (1 Day)||0
6780649|NCT02908516|7709173|FG001|STARTED|Overall Study||3
6780650|NCT02908516|7709172|FG000|COMPLETED|Overall Study||0
6780651|NCT02908516|7709173|FG001|COMPLETED|Overall Study||0
6780652|NCT02908516|7709172|FG000|NOT COMPLETED|Overall Study||3
6780653|NCT02908516|7709173|FG001|NOT COMPLETED|Overall Study||3
6780654|NCT02923830|7709181|FG000|STARTED|Overall Study||13
6780655|NCT02923830|7709182|FG001|STARTED|Overall Study||15
6780656|NCT02923830|7709181|FG000|COMPLETED|Overall Study|Study terminated|0
6780657|NCT02923830|7709182|FG001|COMPLETED|Overall Study|Study terminated|0
6780658|NCT02923830|7709181|FG000|NOT COMPLETED|Overall Study||13
6780659|NCT02923830|7709182|FG001|NOT COMPLETED|Overall Study||15
6780660|NCT02920450|7709188|FG000|STARTED|Overall Study||3
6780661|NCT02920450|7709189|FG001|STARTED|Overall Study||0
6780662|NCT02920450|7709190|FG002|STARTED|Overall Study||0
6780663|NCT02920450|7709191|FG003|STARTED|Overall Study||0
6780664|NCT02920450|7709188|FG000|COMPLETED|Overall Study||1
6780665|NCT02920450|7709189|FG001|COMPLETED|Overall Study||0
6780666|NCT02920450|7709190|FG002|COMPLETED|Overall Study||0
6780667|NCT02920450|7709191|FG003|COMPLETED|Overall Study||0
6780668|NCT02920450|7709188|FG000|NOT COMPLETED|Overall Study||2
6780669|NCT02920450|7709189|FG001|NOT COMPLETED|Overall Study||0
6780670|NCT02920450|7709190|FG002|NOT COMPLETED|Overall Study||0
6780671|NCT02920450|7709191|FG003|NOT COMPLETED|Overall Study||0
6780672|NCT02920177|7709200|FG000|STARTED|Overall Study||2
6780673|NCT02920177|7709201|FG001|STARTED|Overall Study||2
6780674|NCT02920177|7709200|FG000|COMPLETED|Overall Study||0
6780675|NCT02920177|7709201|FG001|COMPLETED|Overall Study||0
6780676|NCT02920177|7709200|FG000|NOT COMPLETED|Overall Study||2
6780677|NCT02920177|7709201|FG001|NOT COMPLETED|Overall Study||2
6780678|NCT02926638|7709209|FG000|STARTED|Overall Study||4
6780679|NCT02926638|7709210|FG001|STARTED|Overall Study||5
6780680|NCT02926638|7709209|FG000|Eligible|Overall Study||3
6780681|NCT02926638|7709210|FG001|Eligible|Overall Study||5
6780682|NCT02926638|7709209|FG000|COMPLETED|Overall Study||0
6780683|NCT02926638|7709210|FG001|COMPLETED|Overall Study||0
6780684|NCT02926638|7709209|FG000|NOT COMPLETED|Overall Study||4
6780685|NCT02926638|7709210|FG001|NOT COMPLETED|Overall Study||5
6780686|NCT02920242|7709219|FG000|STARTED|Overall Study||13
6780687|NCT02920242|7709220|FG001|STARTED|Overall Study||11
6780688|NCT02920242|7709221|FG002|STARTED|Overall Study||4
6780689|NCT02920242|7709219|FG000|Safety Set|Overall Study||12
6780690|NCT02920242|7709220|FG001|Safety Set|Overall Study||11
6780691|NCT02920242|7709221|FG002|Safety Set|Overall Study||4
6780692|NCT02920242|7709219|FG000|COMPLETED|Overall Study||11
6780693|NCT02920242|7709220|FG001|COMPLETED|Overall Study||11
6780694|NCT02920242|7709221|FG002|COMPLETED|Overall Study||3
6780695|NCT02920242|7709219|FG000|NOT COMPLETED|Overall Study||2
6780696|NCT02920242|7709220|FG001|NOT COMPLETED|Overall Study||0
6780697|NCT02920242|7709221|FG002|NOT COMPLETED|Overall Study||1
6780698|NCT02900781|7709231|FG000|STARTED|Overall Study||4
6780699|NCT02900781|7709232|FG001|STARTED|Overall Study||5
6780700|NCT02900781|7709231|FG000|COMPLETED|Overall Study||0
6780701|NCT02900781|7709232|FG001|COMPLETED|Overall Study||0
6780702|NCT02900781|7709231|FG000|NOT COMPLETED|Overall Study||4
6780703|NCT02900781|7709232|FG001|NOT COMPLETED|Overall Study||5
6780704|NCT02892500|7709240|FG000|STARTED|Overall Study||0
6780705|NCT02892500|7709241|FG001|STARTED|Overall Study||0
6770815|NCT04126343|7698437|FG000|STARTED|Overall Study||9
6770816|NCT04126343|7698438|FG001|STARTED|Overall Study||9
6770817|NCT04126343|7698439|FG002|STARTED|Overall Study||9
6770818|NCT04126343|7698440|FG003|STARTED|Overall Study||9
6770819|NCT04126343|7698441|FG004|STARTED|Overall Study||9
6770820|NCT04126343|7698442|FG005|STARTED|Overall Study||9
6770821|NCT04126343|7698437|FG000|Completed Padsevonil Period|Overall Study||9
6770822|NCT04126343|7698438|FG001|Completed Padsevonil Period|Overall Study||9
6770823|NCT04126343|7698439|FG002|Completed Padsevonil Period|Overall Study||9
6770824|NCT04126343|7698440|FG003|Completed Padsevonil Period|Overall Study||7
6770825|NCT04126343|7698441|FG004|Completed Padsevonil Period|Overall Study||9
6770826|NCT04126343|7698442|FG005|Completed Padsevonil Period|Overall Study||8
6770827|NCT04126343|7698437|FG000|Completed Placebo Period|Overall Study||9
6770828|NCT04126343|7698438|FG001|Completed Placebo Period|Overall Study||7
6770829|NCT04126343|7698439|FG002|Completed Placebo Period|Overall Study||9
6770830|NCT04126343|7698440|FG003|Completed Placebo Period|Overall Study||9
6770831|NCT04126343|7698441|FG004|Completed Placebo Period|Overall Study||7
6770832|NCT04126343|7698442|FG005|Completed Placebo Period|Overall Study||9
6770833|NCT04126343|7698437|FG000|Completed Moxifloxacin Period|Overall Study||8
6770834|NCT04126343|7698438|FG001|Completed Moxifloxacin Period|Overall Study||9
6770835|NCT04126343|7698439|FG002|Completed Moxifloxacin Period|Overall Study||7
6770836|NCT04126343|7698440|FG003|Completed Moxifloxacin Period|Overall Study||9
6770837|NCT04126343|7698441|FG004|Completed Moxifloxacin Period|Overall Study||9
6770838|NCT04126343|7698442|FG005|Completed Moxifloxacin Period|Overall Study||9
6770839|NCT04126343|7698437|FG000|COMPLETED|Overall Study||6
6770840|NCT04126343|7698438|FG001|COMPLETED|Overall Study||5
6770841|NCT04126343|7698439|FG002|COMPLETED|Overall Study||6
6770842|NCT04126343|7698440|FG003|COMPLETED|Overall Study||5
6770843|NCT04126343|7698441|FG004|COMPLETED|Overall Study||6
6770844|NCT04126343|7698442|FG005|COMPLETED|Overall Study||5
6770845|NCT04126343|7698437|FG000|NOT COMPLETED|Overall Study||3
6770846|NCT04126343|7698438|FG001|NOT COMPLETED|Overall Study||4
6770847|NCT04126343|7698439|FG002|NOT COMPLETED|Overall Study||3
6770848|NCT04126343|7698440|FG003|NOT COMPLETED|Overall Study||4
6770849|NCT04126343|7698441|FG004|NOT COMPLETED|Overall Study||3
6770850|NCT04126343|7698442|FG005|NOT COMPLETED|Overall Study||4
6770851|NCT04126187|7698457|FG000|STARTED|Overall Study||30
6770852|NCT04126187|7698457|FG000|COMPLETED|Overall Study||30
6770853|NCT04126187|7698457|FG000|NOT COMPLETED|Overall Study||0
6770854|NCT04124952|7698461|FG000|STARTED|Overall Study||30
6770855|NCT04124952|7698461|FG000|COMPLETED|Overall Study||29
6770856|NCT04124952|7698461|FG000|NOT COMPLETED|Overall Study||1
6770857|NCT04123665|7698467|FG000|STARTED|Overall Study||50
6770858|NCT04123665|7698468|FG001|STARTED|Overall Study||48
6770859|NCT04123665|7698467|FG000|COMPLETED|Overall Study||42
6770860|NCT04123665|7698468|FG001|COMPLETED|Overall Study||48
6770861|NCT04123665|7698467|FG000|NOT COMPLETED|Overall Study||8
6770862|NCT04123665|7698468|FG001|NOT COMPLETED|Overall Study||0
6770863|NCT04122534|7698474|FG000|STARTED|Overall Study||48
6770864|NCT04122534|7698474|FG000|COMPLETED|Overall Study||44
6770865|NCT04122534|7698474|FG000|NOT COMPLETED|Overall Study||4
6770866|NCT04121078|7698480|FG000|STARTED|Study Period 1 (1 Day)||6
6770867|NCT04121078|7698481|FG001|STARTED|Study Period 1 (1 Day)||6
6770868|NCT04121078|7698480|FG000|COMPLETED|Study Period 1 (1 Day)||6
6770869|NCT04121078|7698481|FG001|COMPLETED|Study Period 1 (1 Day)||6
6770870|NCT04121078|7698480|FG000|NOT COMPLETED|Study Period 1 (1 Day)||0
6770871|NCT04121078|7698481|FG001|NOT COMPLETED|Study Period 1 (1 Day)||0
6770872|NCT04121078|7698480|FG000|STARTED|Washout Period (at Least 7 Days)||6
6770873|NCT04121078|7698481|FG001|STARTED|Washout Period (at Least 7 Days)||6
6770874|NCT04121078|7698480|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
6770875|NCT04121078|7698481|FG001|COMPLETED|Washout Period (at Least 7 Days)||6
6770876|NCT04121078|7698480|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6770877|NCT04121078|7698481|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6770878|NCT04121078|7698480|FG000|STARTED|Study Period 2 (1 Day)||6
6770879|NCT04121078|7698481|FG001|STARTED|Study Period 2 (1 Day)||6
6770880|NCT04121078|7698480|FG000|COMPLETED|Study Period 2 (1 Day)||6
6770881|NCT04121078|7698481|FG001|COMPLETED|Study Period 2 (1 Day)||6
6770882|NCT04121078|7698480|FG000|NOT COMPLETED|Study Period 2 (1 Day)||0
6770883|NCT04121078|7698481|FG001|NOT COMPLETED|Study Period 2 (1 Day)||0
6770884|NCT04117607|7698490|FG000|STARTED|Overall Study||3
6770885|NCT04117607|7698491|FG001|STARTED|Overall Study||7
6770886|NCT04117607|7698492|FG002|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770887|NCT04117607|7698493|FG003|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770888|NCT04117607|7698494|FG004|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770889|NCT04117607|7698495|FG005|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770890|NCT04117607|7698496|FG006|STARTED|Overall Study||4
6780706|NCT02892500|7709240|FG000|COMPLETED|Overall Study||0
6780707|NCT02892500|7709241|FG001|COMPLETED|Overall Study||0
6556637|NCT01763047|7479041|FG001|STARTED|Period 2||126
6556638|NCT01763047|7479040|FG000|Myopes|Period 2||74
6556639|NCT01763047|7479041|FG001|Myopes|Period 2||72
6556640|NCT01763047|7479040|FG000|Hyperopes|Period 2||56
6556641|NCT01763047|7479041|FG001|Hyperopes|Period 2||54
6556642|NCT01763047|7479040|FG000|COMPLETED|Period 2||126
6770891|NCT04117607|7698497|FG007|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770892|NCT04117607|7698498|FG008|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770893|NCT04117607|7698499|FG009|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770894|NCT04117607|7698500|FG010|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770895|NCT04117607|7698501|FG011|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770896|NCT04117607|7698502|FG012|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770897|NCT04117607|7698503|FG013|STARTED|Overall Study|The study was terminated on 27APR2020 due to safety concerns. No subjects were enrolled into this group.|0
6770898|NCT04117607|7698490|FG000|Received Study Product|Overall Study||3
6770899|NCT04117607|7698491|FG001|Received Study Product|Overall Study||6
6770900|NCT04117607|7698492|FG002|Received Study Product|Overall Study||0
6770901|NCT04117607|7698493|FG003|Received Study Product|Overall Study||0
6770902|NCT04117607|7698494|FG004|Received Study Product|Overall Study||0
6770903|NCT04117607|7698495|FG005|Received Study Product|Overall Study||0
6770904|NCT04117607|7698496|FG006|Received Study Product|Overall Study||3
6770905|NCT04117607|7698497|FG007|Received Study Product|Overall Study||0
6770906|NCT04117607|7698498|FG008|Received Study Product|Overall Study||0
6770907|NCT04117607|7698499|FG009|Received Study Product|Overall Study||0
6770908|NCT04117607|7698500|FG010|Received Study Product|Overall Study||0
6770909|NCT04117607|7698501|FG011|Received Study Product|Overall Study||0
6770910|NCT04117607|7698502|FG012|Received Study Product|Overall Study||0
6770911|NCT04117607|7698503|FG013|Received Study Product|Overall Study||0
6770912|NCT04117607|7698490|FG000|Completed All PK Blood Draws|Overall Study||0
6770913|NCT04117607|7698491|FG001|Completed All PK Blood Draws|Overall Study||6
6770914|NCT04117607|7698492|FG002|Completed All PK Blood Draws|Overall Study||0
6770915|NCT04117607|7698493|FG003|Completed All PK Blood Draws|Overall Study||0
6770916|NCT04117607|7698494|FG004|Completed All PK Blood Draws|Overall Study||0
6770917|NCT04117607|7698495|FG005|Completed All PK Blood Draws|Overall Study||0
6770918|NCT04117607|7698496|FG006|Completed All PK Blood Draws|Overall Study||1
6770919|NCT04117607|7698497|FG007|Completed All PK Blood Draws|Overall Study||0
6770920|NCT04117607|7698498|FG008|Completed All PK Blood Draws|Overall Study||0
6770921|NCT04117607|7698499|FG009|Completed All PK Blood Draws|Overall Study||0
6770922|NCT04117607|7698500|FG010|Completed All PK Blood Draws|Overall Study||0
6770923|NCT04117607|7698501|FG011|Completed All PK Blood Draws|Overall Study||0
6770924|NCT04117607|7698502|FG012|Completed All PK Blood Draws|Overall Study||0
6770925|NCT04117607|7698503|FG013|Completed All PK Blood Draws|Overall Study||0
6770926|NCT04117607|7698490|FG000|COMPLETED|Overall Study||3
6770927|NCT04117607|7698491|FG001|COMPLETED|Overall Study||6
6770928|NCT04117607|7698492|FG002|COMPLETED|Overall Study||0
6770929|NCT04117607|7698493|FG003|COMPLETED|Overall Study||0
6770930|NCT04117607|7698494|FG004|COMPLETED|Overall Study||0
6770931|NCT04117607|7698495|FG005|COMPLETED|Overall Study||0
6770932|NCT04117607|7698496|FG006|COMPLETED|Overall Study||3
6770933|NCT04117607|7698497|FG007|COMPLETED|Overall Study||0
6770934|NCT04117607|7698498|FG008|COMPLETED|Overall Study||0
6770935|NCT04117607|7698499|FG009|COMPLETED|Overall Study||0
6770936|NCT04117607|7698500|FG010|COMPLETED|Overall Study||0
6770937|NCT04117607|7698501|FG011|COMPLETED|Overall Study||0
6770938|NCT04117607|7698502|FG012|COMPLETED|Overall Study||0
6770939|NCT04117607|7698503|FG013|COMPLETED|Overall Study||0
6770940|NCT04117607|7698490|FG000|NOT COMPLETED|Overall Study||0
6770941|NCT04117607|7698491|FG001|NOT COMPLETED|Overall Study||1
6770942|NCT04117607|7698492|FG002|NOT COMPLETED|Overall Study||0
6770943|NCT04117607|7698493|FG003|NOT COMPLETED|Overall Study||0
6770944|NCT04117607|7698494|FG004|NOT COMPLETED|Overall Study||0
6770945|NCT04117607|7698495|FG005|NOT COMPLETED|Overall Study||0
6770946|NCT04117607|7698496|FG006|NOT COMPLETED|Overall Study||1
6770947|NCT04117607|7698497|FG007|NOT COMPLETED|Overall Study||0
6770948|NCT04117607|7698498|FG008|NOT COMPLETED|Overall Study||0
6770949|NCT04117607|7698499|FG009|NOT COMPLETED|Overall Study||0
6770950|NCT04117607|7698500|FG010|NOT COMPLETED|Overall Study||0
6770951|NCT04117607|7698501|FG011|NOT COMPLETED|Overall Study||0
6770952|NCT04117607|7698502|FG012|NOT COMPLETED|Overall Study||0
6770953|NCT04117607|7698503|FG013|NOT COMPLETED|Overall Study||0
6770954|NCT04116684|7698521|FG000|STARTED|Overall Study||3
6770955|NCT04116684|7698522|FG001|STARTED|Overall Study||1
6770956|NCT04116684|7698521|FG000|COMPLETED|Overall Study||1
6770957|NCT04116684|7698522|FG001|COMPLETED|Overall Study||1
6770958|NCT04116684|7698521|FG000|NOT COMPLETED|Overall Study||2
6770959|NCT04116684|7698522|FG001|NOT COMPLETED|Overall Study||0
6770960|NCT04096365|7698528|FG000|STARTED|Overall Study||12
6770961|NCT04096365|7698528|FG000|COMPLETED|Overall Study||11
6770962|NCT04096365|7698528|FG000|NOT COMPLETED|Overall Study||1
6770963|NCT04080297|7698534|FG000|STARTED|Overall Study||10
6770964|NCT04080297|7698535|FG001|STARTED|Overall Study||11
6770965|NCT04080297|7698534|FG000|COMPLETED|Overall Study||8
6770966|NCT04080297|7698535|FG001|COMPLETED|Overall Study||8
6770967|NCT04080297|7698534|FG000|NOT COMPLETED|Overall Study||2
6770968|NCT04080297|7698535|FG001|NOT COMPLETED|Overall Study||3
6770969|NCT04115358|7698544|FG000|STARTED|Overall Study||34
6770970|NCT04115358|7698545|FG001|STARTED|Overall Study||33
6770971|NCT04115358|7698546|FG002|STARTED|Overall Study||34
6770972|NCT04115358|7698544|FG000|COMPLETED|Overall Study|34 participants 48 teeth for clinical assessment, 28 participants 35 teeth for radiographic assessment.|34
6770973|NCT04115358|7698545|FG001|COMPLETED|Overall Study|33 participants 40 teeth for clinical assessment, 26 participants 32 teeth for radiographic assessment.|33
6770974|NCT04115358|7698546|FG002|COMPLETED|Overall Study|34 participants 38 teeth for clinical assessment, 26 participants 31 teeth for radiographic assessment.|33
6770975|NCT04115358|7698544|FG000|NOT COMPLETED|Overall Study||0
6770976|NCT04115358|7698545|FG001|NOT COMPLETED|Overall Study||0
6770977|NCT04115358|7698546|FG002|NOT COMPLETED|Overall Study||1
6770978|NCT04114058|7698557|FG000|STARTED|Overall Study||20
6770979|NCT04114058|7698558|FG001|STARTED|Overall Study||17
6770980|NCT04114058|7698557|FG000|COMPLETED|Overall Study||20
6770981|NCT04114058|7698558|FG001|COMPLETED|Overall Study||17
6770982|NCT04114058|7698557|FG000|NOT COMPLETED|Overall Study||0
6770983|NCT04114058|7698558|FG001|NOT COMPLETED|Overall Study||0
6770984|NCT04113785|7698564|FG000|STARTED|Overall Study||21
6770985|NCT04113785|7698564|FG000|COMPLETED|Overall Study||21
6770986|NCT04113785|7698564|FG000|NOT COMPLETED|Overall Study||0
6770987|NCT04113694|7698570|FG000|STARTED|Overall Study||259
6770988|NCT04113694|7698570|FG000|COMPLETED|Overall Study||248
6770989|NCT04113694|7698570|FG000|NOT COMPLETED|Overall Study||11
6770990|NCT04112160|7698579|FG000|STARTED|Overall Study||63
6770991|NCT04112160|7698580|FG001|STARTED|Overall Study||62
6770992|NCT04112160|7698579|FG000|COMPLETED|Overall Study||62
6770993|NCT04112160|7698580|FG001|COMPLETED|Overall Study||62
6770994|NCT04112160|7698579|FG000|NOT COMPLETED|Overall Study||1
6770995|NCT04112160|7698580|FG001|NOT COMPLETED|Overall Study||0
6770996|NCT04112069|7698586|FG000|STARTED|Overall Study||10
6770997|NCT04112069|7698587|FG001|STARTED|Overall Study||10
6770998|NCT04112069|7698586|FG000|COMPLETED|Overall Study||10
6770999|NCT04112069|7698587|FG001|COMPLETED|Overall Study||10
6771000|NCT04112069|7698586|FG000|NOT COMPLETED|Overall Study||0
6771001|NCT04112069|7698587|FG001|NOT COMPLETED|Overall Study||0
6771002|NCT04109703|7698595|FG000|STARTED|Overall Study||49
6771003|NCT04109703|7698596|FG001|STARTED|Overall Study||51
6771004|NCT04109703|7698595|FG000|COMPLETED|Overall Study||49
6771005|NCT04109703|7698596|FG001|COMPLETED|Overall Study||51
6771006|NCT04109703|7698595|FG000|NOT COMPLETED|Overall Study||0
6771007|NCT04109703|7698596|FG001|NOT COMPLETED|Overall Study||0
6771008|NCT04109443|7698606|FG000|STARTED|Overall Study||77
6771009|NCT04109443|7698607|FG001|STARTED|Overall Study||77
6771010|NCT04109443|7698606|FG000|COMPLETED|Overall Study||67
6771011|NCT04109443|7698607|FG001|COMPLETED|Overall Study||65
6771012|NCT04109443|7698606|FG000|NOT COMPLETED|Overall Study||10
6771013|NCT04109443|7698607|FG001|NOT COMPLETED|Overall Study||12
6771014|NCT04107493|7698616|FG000|STARTED|First Intervention (1 Hour)||16
6771015|NCT04107493|7698617|FG001|STARTED|First Intervention (1 Hour)||17
6771016|NCT04107493|7698616|FG000|COMPLETED|First Intervention (1 Hour)||16
6771017|NCT04107493|7698617|FG001|COMPLETED|First Intervention (1 Hour)||17
6771018|NCT04107493|7698616|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
6771019|NCT04107493|7698617|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
6771020|NCT04107493|7698616|FG000|STARTED|Washout (One Hour)||16
6771021|NCT04107493|7698617|FG001|STARTED|Washout (One Hour)||17
6771022|NCT04107493|7698616|FG000|COMPLETED|Washout (One Hour)||16
6771023|NCT04107493|7698617|FG001|COMPLETED|Washout (One Hour)||17
6771024|NCT04107493|7698616|FG000|NOT COMPLETED|Washout (One Hour)||0
6771025|NCT04107493|7698617|FG001|NOT COMPLETED|Washout (One Hour)||0
6771026|NCT04107493|7698616|FG000|STARTED|Second Intervention||16
6771027|NCT04107493|7698617|FG001|STARTED|Second Intervention||17
6771028|NCT04107493|7698616|FG000|COMPLETED|Second Intervention||16
6771029|NCT04107493|7698617|FG001|COMPLETED|Second Intervention||17
6771030|NCT04107493|7698616|FG000|NOT COMPLETED|Second Intervention||0
6771031|NCT04107493|7698617|FG001|NOT COMPLETED|Second Intervention||0
6771032|NCT04106817|7698626|FG000|STARTED|Overall Study||12
6771033|NCT04106817|7698627|FG001|STARTED|Overall Study||11
6771034|NCT04106817|7698628|FG002|STARTED|Overall Study||12
6771035|NCT04106817|7698626|FG000|COMPLETED|Overall Study||11
6771036|NCT04106817|7698627|FG001|COMPLETED|Overall Study||11
6771037|NCT04106817|7698628|FG002|COMPLETED|Overall Study||12
6771038|NCT04106817|7698626|FG000|NOT COMPLETED|Overall Study||1
6771039|NCT04106817|7698627|FG001|NOT COMPLETED|Overall Study||0
6771040|NCT04106817|7698628|FG002|NOT COMPLETED|Overall Study||0
6771041|NCT04105972|7698638|FG000|STARTED|Overall Study||88
6771042|NCT04105972|7698639|FG001|STARTED|Overall Study||87
6771043|NCT04105972|7698638|FG000|COMPLETED|Overall Study||86
6771044|NCT04105972|7698639|FG001|COMPLETED|Overall Study||86
6771045|NCT04105972|7698638|FG000|NOT COMPLETED|Overall Study||2
6771046|NCT04105972|7698639|FG001|NOT COMPLETED|Overall Study||1
6771047|NCT04105218|7698647|FG000|STARTED|Overall Study||6
6771048|NCT04105218|7698648|FG001|STARTED|Overall Study||6
6771049|NCT04105218|7698647|FG000|Completed First Condition|Overall Study||0
6771050|NCT04105218|7698648|FG001|Completed First Condition|Overall Study||1
6771051|NCT04105218|7698647|FG000|Completed Second Condition|Overall Study||0
6771052|NCT04105218|7698648|FG001|Completed Second Condition|Overall Study||0
6771053|NCT04105218|7698647|FG000|COMPLETED|Overall Study||0
6771054|NCT04105218|7698648|FG001|COMPLETED|Overall Study||0
6771055|NCT04105218|7698647|FG000|NOT COMPLETED|Overall Study||6
6771056|NCT04105218|7698648|FG001|NOT COMPLETED|Overall Study||6
6771057|NCT04102956|7698656|FG000|STARTED|Overall Study||42
6556643|NCT01763047|7479041|FG001|COMPLETED|Period 2||121
6771058|NCT04102956|7698657|FG001|STARTED|Overall Study||38
6771059|NCT04102956|7698656|FG000|COMPLETED|Overall Study||42
6771060|NCT04102956|7698657|FG001|COMPLETED|Overall Study||38
6771061|NCT04102956|7698656|FG000|NOT COMPLETED|Overall Study||0
6771062|NCT04102956|7698657|FG001|NOT COMPLETED|Overall Study||0
6771063|NCT04102540|7698663|FG000|STARTED|Overall Study||32
6771064|NCT04102540|7698663|FG000|COMPLETED|Overall Study||24
6771065|NCT04102540|7698663|FG000|NOT COMPLETED|Overall Study||8
6771066|NCT04102345|7698669|FG000|STARTED|Overall Study||26
6771067|NCT04102345|7698670|FG001|STARTED|Overall Study||32
6771068|NCT04102345|7698669|FG000|COMPLETED|Overall Study||25
6771069|NCT04102345|7698670|FG001|COMPLETED|Overall Study||32
6771070|NCT04102345|7698669|FG000|NOT COMPLETED|Overall Study||1
6771071|NCT04102345|7698670|FG001|NOT COMPLETED|Overall Study||0
6771072|NCT04092907|7698678|FG000|STARTED|Overall Study||50
6771073|NCT04092907|7698679|FG001|STARTED|Overall Study||50
6771074|NCT04092907|7698678|FG000|COMPLETED|Overall Study||48
6771075|NCT04092907|7698679|FG001|COMPLETED|Overall Study||50
6771076|NCT04092907|7698678|FG000|NOT COMPLETED|Overall Study||2
6771077|NCT04092907|7698679|FG001|NOT COMPLETED|Overall Study||0
6771078|NCT04089982|7698687|FG000|STARTED|Overall Study||6
6771079|NCT04089982|7698688|FG001|STARTED|Overall Study||5
6771080|NCT04089982|7698687|FG000|COMPLETED|Overall Study||6
6771081|NCT04089982|7698688|FG001|COMPLETED|Overall Study||5
6771082|NCT04089982|7698687|FG000|NOT COMPLETED|Overall Study||0
6771083|NCT04089982|7698688|FG001|NOT COMPLETED|Overall Study||0
6771084|NCT04086433|7698696|FG000|STARTED|Overall Study||17
6771085|NCT04086433|7698697|FG001|STARTED|Overall Study||18
6771086|NCT04086433|7698696|FG000|COMPLETED|Overall Study||17
6771087|NCT04086433|7698697|FG001|COMPLETED|Overall Study||18
6771088|NCT04086433|7698696|FG000|NOT COMPLETED|Overall Study||0
6771089|NCT04086433|7698697|FG001|NOT COMPLETED|Overall Study||0
6771090|NCT04086407|7698703|FG000|STARTED|Overall Study||8
6771091|NCT04086407|7698703|FG000|COMPLETED|Overall Study||8
6771092|NCT04086407|7698703|FG000|NOT COMPLETED|Overall Study||0
6771093|NCT04099277|7698710|FG000|STARTED|Overall Study||2
6771094|NCT04099277|7698710|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
6771095|NCT04099277|7698710|FG000|COMPLETED|Overall Study||0
6771096|NCT04099277|7698710|FG000|NOT COMPLETED|Overall Study||2
6771097|NCT04098809|7698716|FG000|STARTED|Overall Study||27
6771098|NCT04098809|7698717|FG001|STARTED|Overall Study||25
6771099|NCT04098809|7698716|FG000|COMPLETED|Overall Study||24
6771100|NCT04098809|7698717|FG001|COMPLETED|Overall Study||21
6771101|NCT04098809|7698716|FG000|NOT COMPLETED|Overall Study||3
6771102|NCT04098809|7698717|FG001|NOT COMPLETED|Overall Study||4
6771103|NCT04098575|7698726|FG000|STARTED|Overall Study||505
6771104|NCT04098575|7698727|FG001|STARTED|Overall Study||2961
6771105|NCT04098575|7698728|FG002|STARTED|Overall Study||6105
6771106|NCT04098575|7698726|FG000|COMPLETED|Overall Study||505
6771107|NCT04098575|7698727|FG001|COMPLETED|Overall Study||2961
6771108|NCT04098575|7698728|FG002|COMPLETED|Overall Study||6105
6771109|NCT04098575|7698726|FG000|NOT COMPLETED|Overall Study||0
6771110|NCT04098575|7698727|FG001|NOT COMPLETED|Overall Study||0
6771111|NCT04098575|7698728|FG002|NOT COMPLETED|Overall Study||0
6771112|NCT04098458|7698736|FG000|STARTED|Overall Study||18
6771113|NCT04098458|7698736|FG000|COMPLETED|Overall Study||14
6771114|NCT04098458|7698736|FG000|NOT COMPLETED|Overall Study||4
6771115|NCT04095286|7698741|FG000|STARTED|Period 1 (4 Days) + Washout (7days)||4
6771116|NCT04095286|7698742|FG001|STARTED|Period 1 (4 Days) + Washout (7days)||5
6771117|NCT04095286|7698743|FG002|STARTED|Period 1 (4 Days) + Washout (7days)||5
6771118|NCT04095286|7698744|FG003|STARTED|Period 1 (4 Days) + Washout (7days)||5
6771119|NCT04095286|7698745|FG004|STARTED|Period 1 (4 Days) + Washout (7days)||5
6771120|NCT04095286|7698746|FG005|STARTED|Period 1 (4 Days) + Washout (7days)||5
6771121|NCT04095286|7698741|FG000|COMPLETED|Period 1 (4 Days) + Washout (7days)||3
6771122|NCT04095286|7698742|FG001|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
6771123|NCT04095286|7698743|FG002|COMPLETED|Period 1 (4 Days) + Washout (7days)||4
6771124|NCT04095286|7698744|FG003|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
6771125|NCT04095286|7698745|FG004|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
6771126|NCT04095286|7698746|FG005|COMPLETED|Period 1 (4 Days) + Washout (7days)||5
6771127|NCT04095286|7698741|FG000|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
6771128|NCT04095286|7698742|FG001|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
6771129|NCT04095286|7698743|FG002|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||1
6771130|NCT04095286|7698744|FG003|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
6771131|NCT04095286|7698745|FG004|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
6771132|NCT04095286|7698746|FG005|NOT COMPLETED|Period 1 (4 Days) + Washout (7days)||0
6771133|NCT04095286|7698741|FG000|STARTED|Period 2 (4 Days) + Washout (7days)||3
6771134|NCT04095286|7698742|FG001|STARTED|Period 2 (4 Days) + Washout (7days)||4
6771135|NCT04095286|7698743|FG002|STARTED|Period 2 (4 Days) + Washout (7days)||4
6771136|NCT04095286|7698744|FG003|STARTED|Period 2 (4 Days) + Washout (7days)||5
6771137|NCT04095286|7698745|FG004|STARTED|Period 2 (4 Days) + Washout (7days)||5
6771138|NCT04095286|7698746|FG005|STARTED|Period 2 (4 Days) + Washout (7days)||5
6771139|NCT04095286|7698741|FG000|COMPLETED|Period 2 (4 Days) + Washout (7days)||3
6771140|NCT04095286|7698742|FG001|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
6780708|NCT02892500|7709240|FG000|NOT COMPLETED|Overall Study||0
6556644|NCT01763047|7479040|FG000|NOT COMPLETED|Period 2||4
6556645|NCT01763047|7479041|FG001|NOT COMPLETED|Period 2||5
6771141|NCT04095286|7698743|FG002|COMPLETED|Period 2 (4 Days) + Washout (7days)||2
6771142|NCT04095286|7698744|FG003|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
6771143|NCT04095286|7698745|FG004|COMPLETED|Period 2 (4 Days) + Washout (7days)||4
6771144|NCT04095286|7698746|FG005|COMPLETED|Period 2 (4 Days) + Washout (7days)||5
6771145|NCT04095286|7698741|FG000|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
6771146|NCT04095286|7698742|FG001|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
6771147|NCT04095286|7698743|FG002|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||2
6771148|NCT04095286|7698744|FG003|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
6771149|NCT04095286|7698745|FG004|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||1
6771150|NCT04095286|7698746|FG005|NOT COMPLETED|Period 2 (4 Days) + Washout (7days)||0
6771151|NCT04095286|7698741|FG000|STARTED|Period 3 (4 Days) + Follow up (14 Days)||3
6771152|NCT04095286|7698742|FG001|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
6771153|NCT04095286|7698743|FG002|STARTED|Period 3 (4 Days) + Follow up (14 Days)||2
6771154|NCT04095286|7698744|FG003|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
6771155|NCT04095286|7698745|FG004|STARTED|Period 3 (4 Days) + Follow up (14 Days)||4
6771156|NCT04095286|7698746|FG005|STARTED|Period 3 (4 Days) + Follow up (14 Days)||5
6771157|NCT04095286|7698741|FG000|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||3
6771158|NCT04095286|7698742|FG001|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
6771159|NCT04095286|7698743|FG002|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||2
6771160|NCT04095286|7698744|FG003|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
6771161|NCT04095286|7698745|FG004|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||4
6771162|NCT04095286|7698746|FG005|COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||5
6771163|NCT04095286|7698741|FG000|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6771164|NCT04095286|7698742|FG001|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6771165|NCT04095286|7698743|FG002|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6771166|NCT04095286|7698744|FG003|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6771167|NCT04095286|7698745|FG004|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6771168|NCT04095286|7698746|FG005|NOT COMPLETED|Period 3 (4 Days) + Follow up (14 Days)||0
6771169|NCT04094883|7698754|FG000|STARTED|Overall Study||11
6771170|NCT04094883|7698754|FG000|COMPLETED|Overall Study||10
6771171|NCT04094883|7698754|FG000|NOT COMPLETED|Overall Study||1
6771172|NCT04091659|7698760|FG000|STARTED|Overall Study||40
6771173|NCT04091659|7698761|FG001|STARTED|Overall Study||58
6771174|NCT04091659|7698760|FG000|COMPLETED|Overall Study||37
6771175|NCT04091659|7698761|FG001|COMPLETED|Overall Study||57
6771176|NCT04091659|7698760|FG000|NOT COMPLETED|Overall Study||3
6771177|NCT04091659|7698761|FG001|NOT COMPLETED|Overall Study||1
6771178|NCT04091061|7698771|FG000|STARTED|Overall Study||6
6771179|NCT04091061|7698772|FG001|STARTED|Overall Study||6
6771180|NCT04091061|7698773|FG002|STARTED|Overall Study||6
6771181|NCT04091061|7698774|FG003|STARTED|Overall Study||6
6771182|NCT04091061|7698771|FG000|COMPLETED|Overall Study||6
6771183|NCT04091061|7698772|FG001|COMPLETED|Overall Study||6
6771184|NCT04091061|7698773|FG002|COMPLETED|Overall Study||6
6771185|NCT04091061|7698774|FG003|COMPLETED|Overall Study||6
6771186|NCT04091061|7698771|FG000|NOT COMPLETED|Overall Study||0
6771187|NCT04091061|7698772|FG001|NOT COMPLETED|Overall Study||0
6771188|NCT04091061|7698773|FG002|NOT COMPLETED|Overall Study||0
6771189|NCT04091061|7698774|FG003|NOT COMPLETED|Overall Study||0
6771190|NCT04090242|7698786|FG000|STARTED|Overall Study||28
6771191|NCT04090242|7698787|FG001|STARTED|Overall Study||30
6771192|NCT04090242|7698786|FG000|COMPLETED|Overall Study||27
6771193|NCT04090242|7698787|FG001|COMPLETED|Overall Study||30
6771194|NCT04090242|7698786|FG000|NOT COMPLETED|Overall Study||1
6771195|NCT04090242|7698787|FG001|NOT COMPLETED|Overall Study||0
6771196|NCT04089761|7698794|FG000|STARTED|"Run In Phase"||60
6771197|NCT04089761|7698794|FG000|COMPLETED|"Run In Phase"||45
6771198|NCT04089761|7698794|FG000|NOT COMPLETED|"Run In Phase"||15
6771199|NCT04089761|7698794|FG000|STARTED|"Treatment Phase"||45
6771200|NCT04089761|7698794|FG000|COMPLETED|"Treatment Phase"||39
6771201|NCT04089761|7698794|FG000|NOT COMPLETED|"Treatment Phase"||6
6771202|NCT04089761|7698794|FG000|STARTED|"Follow Up Phase (Optional)"|"Due to the COVID-19 pandemic, Only 27 participants were able to continue to the folllow Up phase"|27
6771203|NCT04089761|7698794|FG000|COMPLETED|"Follow Up Phase (Optional)"||27
6771204|NCT04089761|7698794|FG000|NOT COMPLETED|"Follow Up Phase (Optional)"||0
6771205|NCT04079803|7698801|FG000|STARTED|Overall Study||22
6771206|NCT04079803|7698802|FG001|STARTED|Overall Study||21
6771207|NCT04079803|7698803|FG002|STARTED|Overall Study||21
6771208|NCT04079803|7698801|FG000|COMPLETED|Overall Study||22
6771209|NCT04079803|7698802|FG001|COMPLETED|Overall Study||21
6771210|NCT04079803|7698803|FG002|COMPLETED|Overall Study||20
6771211|NCT04079803|7698801|FG000|NOT COMPLETED|Overall Study||0
6771212|NCT04079803|7698802|FG001|NOT COMPLETED|Overall Study||0
6771213|NCT04079803|7698803|FG002|NOT COMPLETED|Overall Study||1
6771214|NCT04087343|7698827|FG000|STARTED|Overall Study||4
6771215|NCT04087343|7698828|FG001|STARTED|Overall Study||5
6771216|NCT04087343|7698827|FG000|COMPLETED|Overall Study||4
6771217|NCT04087343|7698828|FG001|COMPLETED|Overall Study||5
6771218|NCT04087343|7698827|FG000|NOT COMPLETED|Overall Study||0
6771219|NCT04087343|7698828|FG001|NOT COMPLETED|Overall Study||0
6771220|NCT04087122|7698834|FG000|STARTED|Overall Study||20
6771221|NCT04087122|7698834|FG000|COMPLETED|Overall Study||20
6771222|NCT04087122|7698834|FG000|NOT COMPLETED|Overall Study||0
6771223|NCT04086576|7698840|FG000|STARTED|Overall Study||10
6771224|NCT04086576|7698841|FG001|STARTED|Overall Study||10
6771225|NCT04086576|7698840|FG000|COMPLETED|Overall Study||10
6771226|NCT04086576|7698841|FG001|COMPLETED|Overall Study||10
6771227|NCT04086576|7698840|FG000|NOT COMPLETED|Overall Study||0
6771228|NCT04086576|7698841|FG001|NOT COMPLETED|Overall Study||0
6771229|NCT04086641|7698859|FG000|STARTED|Foot 1 (Two Week Utilization)||2
6771230|NCT04086641|7698860|FG001|STARTED|Foot 1 (Two Week Utilization)||3
6771231|NCT04086641|7698859|FG000|COMPLETED|Foot 1 (Two Week Utilization)||1
6771232|NCT04086641|7698860|FG001|COMPLETED|Foot 1 (Two Week Utilization)||1
6771233|NCT04086641|7698859|FG000|NOT COMPLETED|Foot 1 (Two Week Utilization)||1
6771234|NCT04086641|7698860|FG001|NOT COMPLETED|Foot 1 (Two Week Utilization)||2
6771235|NCT04086641|7698859|FG000|STARTED|Foot 2 (Two Week Utilization)||1
6771236|NCT04086641|7698860|FG001|STARTED|Foot 2 (Two Week Utilization)||1
6771237|NCT04086641|7698859|FG000|COMPLETED|Foot 2 (Two Week Utilization)||1
6771238|NCT04086641|7698860|FG001|COMPLETED|Foot 2 (Two Week Utilization)||1
6771239|NCT04086641|7698859|FG000|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
6771240|NCT04086641|7698860|FG001|NOT COMPLETED|Foot 2 (Two Week Utilization)||0
6771241|NCT04080882|7698868|FG000|STARTED|Overall Study||20
6771242|NCT04080882|7698869|FG001|STARTED|Overall Study||60
6771243|NCT04080882|7698868|FG000|COMPLETED|Overall Study||18
6771244|NCT04080882|7698869|FG001|COMPLETED|Overall Study||58
6771245|NCT04080882|7698868|FG000|NOT COMPLETED|Overall Study||2
6771246|NCT04080882|7698869|FG001|NOT COMPLETED|Overall Study||2
6771247|NCT04086472|7698880|FG000|STARTED|Overall Study||16
6771248|NCT04086472|7698881|FG001|STARTED|Overall Study||16
6771249|NCT04086472|7698882|FG002|STARTED|Overall Study||16
6771250|NCT04086472|7698883|FG003|STARTED|Overall Study||16
6771251|NCT04086472|7698884|FG004|STARTED|Overall Study||16
6771252|NCT04086472|7698880|FG000|Received MK-1654 or Placebo|Overall Study||16
6771253|NCT04086472|7698881|FG001|Received MK-1654 or Placebo|Overall Study||16
6771254|NCT04086472|7698882|FG002|Received MK-1654 or Placebo|Overall Study||16
6771255|NCT04086472|7698883|FG003|Received MK-1654 or Placebo|Overall Study||16
6771256|NCT04086472|7698884|FG004|Received MK-1654 or Placebo|Overall Study||16
6771257|NCT04086472|7698880|FG000|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
6771258|NCT04086472|7698881|FG001|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
6771259|NCT04086472|7698882|FG002|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||14
6771260|NCT04086472|7698883|FG003|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||13
6771261|NCT04086472|7698884|FG004|Inoculated With Respiratory Syncytial Virus (RSV) A Memphis 37b|Overall Study||15
6771262|NCT04086472|7698880|FG000|Not Inoculated|Overall Study||2
6771263|NCT04086472|7698881|FG001|Not Inoculated|Overall Study||2
6771264|NCT04086472|7698882|FG002|Not Inoculated|Overall Study||2
6771265|NCT04086472|7698883|FG003|Not Inoculated|Overall Study||3
6771266|NCT04086472|7698884|FG004|Not Inoculated|Overall Study||1
6771267|NCT04086472|7698880|FG000|COMPLETED|Overall Study||12
6771268|NCT04086472|7698881|FG001|COMPLETED|Overall Study||14
6771269|NCT04086472|7698882|FG002|COMPLETED|Overall Study||14
6771270|NCT04086472|7698883|FG003|COMPLETED|Overall Study||13
6771271|NCT04086472|7698884|FG004|COMPLETED|Overall Study||14
6771272|NCT04086472|7698880|FG000|NOT COMPLETED|Overall Study||4
6771273|NCT04086472|7698881|FG001|NOT COMPLETED|Overall Study||2
6771274|NCT04086472|7698882|FG002|NOT COMPLETED|Overall Study||2
6771275|NCT04086472|7698883|FG003|NOT COMPLETED|Overall Study||3
6771276|NCT04086472|7698884|FG004|NOT COMPLETED|Overall Study||2
6771277|NCT04085289|7698899|FG000|STARTED|Overall Study||6
6771278|NCT04085289|7698900|FG001|STARTED|Overall Study||12
6771279|NCT04085289|7698901|FG002|STARTED|Overall Study||12
6771280|NCT04085289|7698899|FG000|Received at Least One Dose of Study Drug|Overall Study||6
6771281|NCT04085289|7698900|FG001|Received at Least One Dose of Study Drug|Overall Study||12
6771282|NCT04085289|7698901|FG002|Received at Least One Dose of Study Drug|Overall Study||12
6771283|NCT04085289|7698899|FG000|COMPLETED|Overall Study||6
6771284|NCT04085289|7698900|FG001|COMPLETED|Overall Study||12
6771285|NCT04085289|7698901|FG002|COMPLETED|Overall Study||11
6771286|NCT04085289|7698899|FG000|NOT COMPLETED|Overall Study||0
6771287|NCT04085289|7698900|FG001|NOT COMPLETED|Overall Study||0
6771288|NCT04085289|7698901|FG002|NOT COMPLETED|Overall Study||1
6771289|NCT04084015|7698908|FG000|STARTED|Overall Study||2
6771290|NCT04084015|7698908|FG000|COMPLETED|Overall Study||2
6771291|NCT04084015|7698908|FG000|NOT COMPLETED|Overall Study||0
6771292|NCT04082663|7698912|FG000|STARTED|Overall Study||20
6771293|NCT04082663|7698912|FG000|COMPLETED|Overall Study||13
6771294|NCT04082663|7698912|FG000|NOT COMPLETED|Overall Study||7
6771295|NCT04084028|7698920|FG000|STARTED|Overall Study||18
6771296|NCT04084028|7698921|FG001|STARTED|Overall Study||16
6771297|NCT04084028|7698922|FG002|STARTED|Overall Study||9
6771298|NCT04084028|7698923|FG003|STARTED|Overall Study||10
6771299|NCT04084028|7698920|FG000|COMPLETED|Overall Study||18
6771300|NCT04084028|7698921|FG001|COMPLETED|Overall Study||16
6771301|NCT04084028|7698922|FG002|COMPLETED|Overall Study||9
6771302|NCT04084028|7698923|FG003|COMPLETED|Overall Study||10
6771303|NCT04084028|7698920|FG000|NOT COMPLETED|Overall Study||0
6771304|NCT04084028|7698921|FG001|NOT COMPLETED|Overall Study||0
6771305|NCT04084028|7698922|FG002|NOT COMPLETED|Overall Study||0
6771306|NCT04084028|7698923|FG003|NOT COMPLETED|Overall Study||0
6771307|NCT04082819|7698938|FG000|STARTED|Overall Study||37
6771308|NCT04082819|7698939|FG001|STARTED|Overall Study||54
6771309|NCT04082819|7698940|FG002|STARTED|Overall Study||3
6771310|NCT04082819|7698938|FG000|COMPLETED|Overall Study||37
6771311|NCT04082819|7698939|FG001|COMPLETED|Overall Study||54
6771312|NCT04082819|7698940|FG002|COMPLETED|Overall Study||3
6771313|NCT04082819|7698938|FG000|NOT COMPLETED|Overall Study||0
6771314|NCT04082819|7698939|FG001|NOT COMPLETED|Overall Study||0
6771315|NCT04082819|7698940|FG002|NOT COMPLETED|Overall Study||0
6771316|NCT04081961|7698954|FG000|STARTED|Overall Study||9
6771317|NCT04081961|7698955|FG001|STARTED|Overall Study||9
6771318|NCT04081961|7698956|FG002|STARTED|Overall Study||9
6771319|NCT04081961|7698954|FG000|COMPLETED|Overall Study||9
6771320|NCT04081961|7698955|FG001|COMPLETED|Overall Study||9
6771321|NCT04081961|7698956|FG002|COMPLETED|Overall Study||9
6771322|NCT04081961|7698954|FG000|NOT COMPLETED|Overall Study||0
6771323|NCT04081961|7698955|FG001|NOT COMPLETED|Overall Study||0
6771324|NCT04081961|7698956|FG002|NOT COMPLETED|Overall Study||0
6771325|NCT04081610|7698966|FG000|STARTED|Overall Study||16
6771326|NCT04081610|7698967|FG001|STARTED|Overall Study||18
6771327|NCT04081610|7698966|FG000|COMPLETED|Overall Study||16
6771328|NCT04081610|7698967|FG001|COMPLETED|Overall Study||18
6771329|NCT04081610|7698966|FG000|NOT COMPLETED|Overall Study||0
6771330|NCT04081610|7698967|FG001|NOT COMPLETED|Overall Study||0
6771331|NCT04081324|7698977|FG000|STARTED|Overall Study||6
6771332|NCT04081324|7698978|FG001|STARTED|Overall Study||10
6771333|NCT04081324|7698979|FG002|STARTED|Overall Study||10
6771334|NCT04081324|7698980|FG003|STARTED|Overall Study||10
6771335|NCT04081324|7698977|FG000|Received At Least One Dose of Study Drug|Overall Study||6
6771336|NCT04081324|7698978|FG001|Received At Least One Dose of Study Drug|Overall Study||10
6771337|NCT04081324|7698979|FG002|Received At Least One Dose of Study Drug|Overall Study||10
6771338|NCT04081324|7698980|FG003|Received At Least One Dose of Study Drug|Overall Study||10
6771339|NCT04081324|7698977|FG000|COMPLETED|Overall Study||6
6771340|NCT04081324|7698978|FG001|COMPLETED|Overall Study||10
6771341|NCT04081324|7698979|FG002|COMPLETED|Overall Study||10
6771342|NCT04081324|7698980|FG003|COMPLETED|Overall Study||10
6771343|NCT04081324|7698977|FG000|NOT COMPLETED|Overall Study||0
6771344|NCT04081324|7698978|FG001|NOT COMPLETED|Overall Study||0
6771345|NCT04081324|7698979|FG002|NOT COMPLETED|Overall Study||0
6771346|NCT04081324|7698980|FG003|NOT COMPLETED|Overall Study||0
6771347|NCT04079790|7698993|FG000|STARTED|Part 1, Period 1(Day 1 to Day 4)||14
6771348|NCT04079790|7698994|FG001|STARTED|Part 1, Period 1(Day 1 to Day 4)||2
6771349|NCT04079790|7698995|FG002|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
6771350|NCT04079790|7698996|FG003|STARTED|Part 1, Period 1(Day 1 to Day 4)||0
6771351|NCT04079790|7698993|FG000|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||13
6771352|NCT04079790|7698994|FG001|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||2
6771353|NCT04079790|7698995|FG002|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6771354|NCT04079790|7698996|FG003|COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6771355|NCT04079790|7698993|FG000|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||1
6771356|NCT04079790|7698994|FG001|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6771357|NCT04079790|7698995|FG002|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6771358|NCT04079790|7698996|FG003|NOT COMPLETED|Part 1, Period 1(Day 1 to Day 4)||0
6771359|NCT04079790|7698993|FG000|STARTED|Part 1, Period 2 (Day 5 to Day 8)||13
6771360|NCT04079790|7698994|FG001|STARTED|Part 1, Period 2 (Day 5 to Day 8)||2
6771361|NCT04079790|7698995|FG002|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
6771362|NCT04079790|7698996|FG003|STARTED|Part 1, Period 2 (Day 5 to Day 8)||0
6771363|NCT04079790|7698993|FG000|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||13
6771364|NCT04079790|7698994|FG001|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||2
6771365|NCT04079790|7698995|FG002|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6771366|NCT04079790|7698996|FG003|COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6771367|NCT04079790|7698993|FG000|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6771368|NCT04079790|7698994|FG001|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6771369|NCT04079790|7698995|FG002|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6771370|NCT04079790|7698996|FG003|NOT COMPLETED|Part 1, Period 2 (Day 5 to Day 8)||0
6771371|NCT04079790|7698993|FG000|STARTED|Part 1, Period 3 (Day 9 to Day 11)||13
6771372|NCT04079790|7698994|FG001|STARTED|Part 1, Period 3 (Day 9 to Day 11)||2
6771373|NCT04079790|7698995|FG002|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
6771374|NCT04079790|7698996|FG003|STARTED|Part 1, Period 3 (Day 9 to Day 11)||0
6771375|NCT04079790|7698993|FG000|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||13
6771376|NCT04079790|7698994|FG001|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||2
6771377|NCT04079790|7698995|FG002|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6771378|NCT04079790|7698996|FG003|COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6771379|NCT04079790|7698993|FG000|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6771380|NCT04079790|7698994|FG001|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6771381|NCT04079790|7698995|FG002|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6771382|NCT04079790|7698996|FG003|NOT COMPLETED|Part 1, Period 3 (Day 9 to Day 11)||0
6771383|NCT04079790|7698993|FG000|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
6771384|NCT04079790|7698994|FG001|STARTED|Part 2, Period 1 (Day 1 to Day 3)||0
6771385|NCT04079790|7698995|FG002|STARTED|Part 2, Period 1 (Day 1 to Day 3)||15
6771386|NCT04079790|7698996|FG003|STARTED|Part 2, Period 1 (Day 1 to Day 3)||3
6771387|NCT04079790|7698993|FG000|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6771388|NCT04079790|7698994|FG001|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6771389|NCT04079790|7698995|FG002|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||12
6771390|NCT04079790|7698996|FG003|COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
6771391|NCT04079790|7698993|FG000|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6771392|NCT04079790|7698994|FG001|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6771393|NCT04079790|7698995|FG002|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||3
6771394|NCT04079790|7698996|FG003|NOT COMPLETED|Part 2, Period 1 (Day 1 to Day 3)||0
6771395|NCT04079790|7698993|FG000|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
6771396|NCT04079790|7698994|FG001|STARTED|Part 2, Period 2 (Day 1 to Day 3)||0
6771397|NCT04079790|7698995|FG002|STARTED|Part 2, Period 2 (Day 1 to Day 3)||12
6771398|NCT04079790|7698996|FG003|STARTED|Part 2, Period 2 (Day 1 to Day 3)||3
6771399|NCT04079790|7698993|FG000|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6771400|NCT04079790|7698994|FG001|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6771401|NCT04079790|7698995|FG002|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||12
6771402|NCT04079790|7698996|FG003|COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||3
6771403|NCT04079790|7698993|FG000|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6771404|NCT04079790|7698994|FG001|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6771405|NCT04079790|7698995|FG002|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6771406|NCT04079790|7698996|FG003|NOT COMPLETED|Part 2, Period 2 (Day 1 to Day 3)||0
6771407|NCT04079127|7699022|FG000|STARTED|Overall Study|hips (in 141 patients)|150
6771408|NCT04079127|7699022|FG000|COMPLETED|Overall Study|89 hips have completed the study, and all 10 year data of 81 were available for analysis.|89
6771409|NCT04079127|7699022|FG000|NOT COMPLETED|Overall Study||61
6771410|NCT04076787|7699029|FG000|STARTED|Overall Study||318
6771411|NCT04076787|7699030|FG001|STARTED|Overall Study||1031
6771412|NCT04076787|7699031|FG002|STARTED|Overall Study||420
6771413|NCT04076787|7699029|FG000|COMPLETED|Overall Study||318
6771414|NCT04076787|7699030|FG001|COMPLETED|Overall Study||1031
6771415|NCT04076787|7699031|FG002|COMPLETED|Overall Study||420
6771416|NCT04076787|7699029|FG000|NOT COMPLETED|Overall Study||0
6771417|NCT04076787|7699030|FG001|NOT COMPLETED|Overall Study||0
6771418|NCT04076787|7699031|FG002|NOT COMPLETED|Overall Study||0
6771419|NCT04075812|7699039|FG000|STARTED|Overall Study||2
6771420|NCT04075812|7699039|FG000|COMPLETED|Overall Study||2
6771421|NCT04075812|7699039|FG000|NOT COMPLETED|Overall Study||0
6771422|NCT04075409|7699046|FG000|STARTED|Overall Study||13
6771423|NCT04075409|7699047|FG001|STARTED|Overall Study||13
6771424|NCT04075409|7699048|FG002|STARTED|Overall Study||13
6771425|NCT04075409|7699046|FG000|COMPLETED|Overall Study||13
6771426|NCT04075409|7699047|FG001|COMPLETED|Overall Study||13
6771427|NCT04075409|7699048|FG002|COMPLETED|Overall Study||13
6771428|NCT04075409|7699046|FG000|NOT COMPLETED|Overall Study||0
6771429|NCT04075409|7699047|FG001|NOT COMPLETED|Overall Study||0
6771430|NCT04075409|7699048|FG002|NOT COMPLETED|Overall Study||0
6771431|NCT04074941|7699069|FG000|STARTED|Overall Study||11
6771432|NCT04074941|7699070|FG001|STARTED|Overall Study||9
6771433|NCT04074941|7699069|FG000|COMPLETED|Overall Study||11
6771434|NCT04074941|7699070|FG001|COMPLETED|Overall Study||9
6771435|NCT04074941|7699069|FG000|NOT COMPLETED|Overall Study||0
6771436|NCT04074941|7699070|FG001|NOT COMPLETED|Overall Study||0
6771437|NCT04073823|7699078|FG000|STARTED|Overall Study||1
6771438|NCT04073823|7699079|FG001|STARTED|Overall Study||1
6771439|NCT04073823|7699078|FG000|COMPLETED|Overall Study||1
6771440|NCT04073823|7699079|FG001|COMPLETED|Overall Study||1
6771441|NCT04073823|7699078|FG000|NOT COMPLETED|Overall Study||0
6771442|NCT04073823|7699079|FG001|NOT COMPLETED|Overall Study||0
6771443|NCT04073407|7699087|FG000|STARTED|Part 1||6
6771444|NCT04073407|7699088|FG001|STARTED|Part 1||3
6771445|NCT04073407|7699087|FG000|COMPLETED|Part 1||1
6771446|NCT04073407|7699088|FG001|COMPLETED|Part 1||2
6771447|NCT04073407|7699087|FG000|NOT COMPLETED|Part 1||5
6771448|NCT04073407|7699088|FG001|NOT COMPLETED|Part 1||1
6771449|NCT04073407|7699087|FG000|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|0
6771450|NCT04073407|7699088|FG001|STARTED|Part 2|Following Part 1, all subjects (including those randomly assigned to the placebo arm in Part 1) were given the option to continue in Part 2 to receive the study food product twice daily for an additional 12 weeks. If the subject chose to not take part in Part 2, the subject underwent a safety follow-up visit approximately 2 weeks after Week13 (Visit 6).|1
6771451|NCT04073407|7699087|FG000|COMPLETED|Part 2||0
6771452|NCT04073407|7699088|FG001|COMPLETED|Part 2||0
6771453|NCT04073407|7699087|FG000|NOT COMPLETED|Part 2||0
6771454|NCT04073407|7699088|FG001|NOT COMPLETED|Part 2||1
6771455|NCT04073368|7699098|FG000|STARTED|Overall Study||32
6771456|NCT04073368|7699099|FG001|STARTED|Overall Study||26
6771457|NCT04073368|7699100|FG002|STARTED|Overall Study||29
6771458|NCT04073368|7699101|FG003|STARTED|Overall Study||15
6771459|NCT04073368|7699098|FG000|COMPLETED|Overall Study||20
6771460|NCT04073368|7699099|FG001|COMPLETED|Overall Study||18
6771461|NCT04073368|7699100|FG002|COMPLETED|Overall Study||26
6771462|NCT04073368|7699101|FG003|COMPLETED|Overall Study||13
6771463|NCT04073368|7699098|FG000|NOT COMPLETED|Overall Study||12
6771464|NCT04073368|7699099|FG001|NOT COMPLETED|Overall Study||8
6771465|NCT04073368|7699100|FG002|NOT COMPLETED|Overall Study||3
6771466|NCT04073368|7699101|FG003|NOT COMPLETED|Overall Study||2
6771467|NCT04073186|7699111|FG000|STARTED|First Wearing Cycle||86
6771468|NCT04073186|7699111|FG000|COMPLETED|First Wearing Cycle||80
6771469|NCT04073186|7699111|FG000|NOT COMPLETED|First Wearing Cycle||6
6771470|NCT04073186|7699111|FG000|STARTED|Second Wearing Cycle||80
6771471|NCT04073186|7699111|FG000|COMPLETED|Second Wearing Cycle||79
6771472|NCT04073186|7699111|FG000|NOT COMPLETED|Second Wearing Cycle||1
6771473|NCT04072237|7699116|FG000|STARTED|Stage I: MarzAA 18 µg/kg IV||11
6771474|NCT04072237|7699116|FG000|COMPLETED|Stage I: MarzAA 18 µg/kg IV||10
6771475|NCT04072237|7699116|FG000|NOT COMPLETED|Stage I: MarzAA 18 µg/kg IV||1
6771476|NCT04072237|7699116|FG000|STARTED|Stage 2: MarzAA 30 µg/kg SC||8
6771477|NCT04072237|7699116|FG000|COMPLETED|Stage 2: MarzAA 30 µg/kg SC||8
6771478|NCT04072237|7699116|FG000|NOT COMPLETED|Stage 2: MarzAA 30 µg/kg SC||0
6771479|NCT04072237|7699116|FG000|STARTED|Stage 3: MarzAA 45 µg/kg SC||8
6771480|NCT04072237|7699116|FG000|COMPLETED|Stage 3: MarzAA 45 µg/kg SC||8
6771481|NCT04072237|7699116|FG000|NOT COMPLETED|Stage 3: MarzAA 45 µg/kg SC||0
6771482|NCT04072237|7699116|FG000|STARTED|Stage 4: MarzAA 60 µg/kg SC||8
6771483|NCT04072237|7699116|FG000|COMPLETED|Stage 4: MarzAA 60 µg/kg SC||8
6771484|NCT04072237|7699116|FG000|NOT COMPLETED|Stage 4: MarzAA 60 µg/kg SC||0
6771485|NCT04072237|7699116|FG000|STARTED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
6771486|NCT04072237|7699116|FG000|COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||8
6771487|NCT04072237|7699116|FG000|NOT COMPLETED|Stage 5: MarzAA 2 x 30 ug/kg SC||0
6771488|NCT04072237|7699116|FG000|STARTED|Stage 6: MarzAA 90 µg/kg SC||8
6771489|NCT04072237|7699116|FG000|COMPLETED|Stage 6: MarzAA 90 µg/kg SC||8
6771490|NCT04072237|7699116|FG000|NOT COMPLETED|Stage 6: MarzAA 90 µg/kg SC||0
6771491|NCT04072237|7699116|FG000|STARTED|Stage 7: MarzAA 120 µg/kg SC||8
6771492|NCT04072237|7699116|FG000|COMPLETED|Stage 7: MarzAA 120 µg/kg SC||8
6771493|NCT04072237|7699116|FG000|NOT COMPLETED|Stage 7: MarzAA 120 µg/kg SC||0
6771494|NCT04072237|7699116|FG000|STARTED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
6771495|NCT04072237|7699116|FG000|COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||8
6771496|NCT04072237|7699116|FG000|NOT COMPLETED|Stage 8: MarzAA 2 x 60 µg/kg Q3H SC||0
6771497|NCT04072237|7699116|FG000|STARTED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
6771498|NCT04072237|7699116|FG000|COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||8
6771499|NCT04072237|7699116|FG000|NOT COMPLETED|Stage 9: MarzAA 3 x 60 µg/kg Q3H SC||0
6771500|NCT04063371|7699146|FG000|STARTED|Overall Study||100
6771501|NCT04063371|7699147|FG001|STARTED|Overall Study||100
6556646|NCT01763164|7479052|FG000|STARTED|Treatment Phase||269
6556647|NCT01763164|7479053|FG001|STARTED|Treatment Phase||133
6556648|NCT01763164|7479052|FG000|Treated/Safety Set|Treatment Phase||269
6771502|NCT04063371|7699148|FG002|STARTED|Overall Study||100
6771503|NCT04063371|7699146|FG000|COMPLETED|Overall Study||100
6556649|NCT01763164|7479053|FG001|Treated/Safety Set|Treatment Phase||114
6771504|NCT04063371|7699147|FG001|COMPLETED|Overall Study||100
6771505|NCT04063371|7699148|FG002|COMPLETED|Overall Study||100
6771506|NCT04063371|7699146|FG000|NOT COMPLETED|Overall Study||0
6771507|NCT04063371|7699147|FG001|NOT COMPLETED|Overall Study||0
6771508|NCT04063371|7699148|FG002|NOT COMPLETED|Overall Study||0
6771509|NCT04042324|7699158|FG000|STARTED|UFH and Triferic Admixture (Day 1)||12
6771510|NCT04042324|7699159|FG001|STARTED|UFH and Triferic Admixture (Day 1)||0
6771511|NCT04042324|7699160|FG002|STARTED|UFH and Triferic Admixture (Day 1)||0
6771512|NCT04042324|7699158|FG000|COMPLETED|UFH and Triferic Admixture (Day 1)||12
6771513|NCT04042324|7699159|FG001|COMPLETED|UFH and Triferic Admixture (Day 1)||0
6771514|NCT04042324|7699160|FG002|COMPLETED|UFH and Triferic Admixture (Day 1)||0
6771515|NCT04042324|7699158|FG000|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
6771516|NCT04042324|7699159|FG001|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
6771517|NCT04042324|7699160|FG002|NOT COMPLETED|UFH and Triferic Admixture (Day 1)||0
6771518|NCT04042324|7699158|FG000|STARTED|Triferic Post-dialyzer (Day 3)||0
6771519|NCT04042324|7699159|FG001|STARTED|Triferic Post-dialyzer (Day 3)||12
6771520|NCT04042324|7699160|FG002|STARTED|Triferic Post-dialyzer (Day 3)||0
6771521|NCT04042324|7699158|FG000|COMPLETED|Triferic Post-dialyzer (Day 3)||0
6771522|NCT04042324|7699159|FG001|COMPLETED|Triferic Post-dialyzer (Day 3)||12
6771523|NCT04042324|7699160|FG002|COMPLETED|Triferic Post-dialyzer (Day 3)||0
6771524|NCT04042324|7699158|FG000|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
6771525|NCT04042324|7699159|FG001|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
6771526|NCT04042324|7699160|FG002|NOT COMPLETED|Triferic Post-dialyzer (Day 3)||0
6771527|NCT04042324|7699158|FG000|STARTED|Triferic Pre-dialyzer (Day 5)||0
6771528|NCT04042324|7699159|FG001|STARTED|Triferic Pre-dialyzer (Day 5)||0
6771529|NCT04042324|7699160|FG002|STARTED|Triferic Pre-dialyzer (Day 5)||12
6771530|NCT04042324|7699158|FG000|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
6771531|NCT04042324|7699159|FG001|COMPLETED|Triferic Pre-dialyzer (Day 5)||0
6771532|NCT04042324|7699160|FG002|COMPLETED|Triferic Pre-dialyzer (Day 5)||12
6771533|NCT04042324|7699158|FG000|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
6771534|NCT04042324|7699159|FG001|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
6771535|NCT04042324|7699160|FG002|NOT COMPLETED|Triferic Pre-dialyzer (Day 5)||0
6771536|NCT04071392|7699172|FG000|STARTED|Overall Study||12
6771537|NCT04071392|7699173|FG001|STARTED|Overall Study||12
6771538|NCT04071392|7699172|FG000|COMPLETED|Overall Study||10
6771539|NCT04071392|7699173|FG001|COMPLETED|Overall Study||10
6771540|NCT04071392|7699172|FG000|NOT COMPLETED|Overall Study||2
6771541|NCT04071392|7699173|FG001|NOT COMPLETED|Overall Study||2
6771542|NCT04071301|7699179|FG000|STARTED|Overall Study||15
6771543|NCT04071301|7699179|FG000|COMPLETED|Overall Study||8
6771544|NCT04071301|7699179|FG000|NOT COMPLETED|Overall Study||7
6771545|NCT04071158|7699188|FG000|STARTED|Overall Study||143
6771546|NCT04071158|7699189|FG001|STARTED|Overall Study||143
6771547|NCT04071158|7699190|FG002|STARTED|Overall Study||143
6771548|NCT04071158|7699191|FG003|STARTED|Overall Study||143
6771549|NCT04071158|7699192|FG004|STARTED|Overall Study||141
6771550|NCT04071158|7699188|FG000|Treated|Overall Study||141
6771551|NCT04071158|7699189|FG001|Treated|Overall Study||141
6771552|NCT04071158|7699190|FG002|Treated|Overall Study||143
6771553|NCT04071158|7699191|FG003|Treated|Overall Study||143
6771554|NCT04071158|7699192|FG004|Treated|Overall Study||141
6771555|NCT04071158|7699188|FG000|Safety Population|Overall Study||141
6771556|NCT04071158|7699189|FG001|Safety Population|Overall Study||141
6771557|NCT04071158|7699190|FG002|Safety Population|Overall Study|1 participant randomized to this arm received RSV vaccine 240 mcg with aluminum hydroxide withTdap|142
6771558|NCT04071158|7699191|FG003|Safety Population|Overall Study|1 participant of this arm actually received RSV vaccine 240 mcg with aluminum hydroxide with Tdap|144
6771559|NCT04071158|7699192|FG004|Safety Population|Overall Study||141
6771560|NCT04071158|7699188|FG000|COMPLETED|Overall Study||140
6771561|NCT04071158|7699189|FG001|COMPLETED|Overall Study||139
6771562|NCT04071158|7699190|FG002|COMPLETED|Overall Study||140
6771563|NCT04071158|7699191|FG003|COMPLETED|Overall Study||140
6771564|NCT04071158|7699192|FG004|COMPLETED|Overall Study||136
6771565|NCT04071158|7699188|FG000|NOT COMPLETED|Overall Study||3
6771566|NCT04071158|7699189|FG001|NOT COMPLETED|Overall Study||4
6771567|NCT04071158|7699190|FG002|NOT COMPLETED|Overall Study||3
6771568|NCT04071158|7699191|FG003|NOT COMPLETED|Overall Study||3
6771569|NCT04071158|7699192|FG004|NOT COMPLETED|Overall Study||5
6771570|NCT04070287|7699215|FG000|STARTED|Overall Study||114
6771571|NCT04070287|7699216|FG001|STARTED|Overall Study||86
6771572|NCT04070287|7699217|FG002|STARTED|Overall Study||81
6771573|NCT04070287|7699218|FG003|STARTED|Overall Study||11
6771574|NCT04070287|7699219|FG004|STARTED|Overall Study||96
6771575|NCT04070287|7699215|FG000|COMPLETED|Overall Study||103
6771576|NCT04070287|7699216|FG001|COMPLETED|Overall Study||44
6771577|NCT04070287|7699217|FG002|COMPLETED|Overall Study||75
6771578|NCT04070287|7699218|FG003|COMPLETED|Overall Study||7
6771579|NCT04070287|7699219|FG004|COMPLETED|Overall Study||95
6771580|NCT04070287|7699215|FG000|NOT COMPLETED|Overall Study||11
6771581|NCT04070287|7699216|FG001|NOT COMPLETED|Overall Study||42
6771582|NCT04070287|7699217|FG002|NOT COMPLETED|Overall Study||6
6771583|NCT04070287|7699218|FG003|NOT COMPLETED|Overall Study||4
6771584|NCT04070287|7699219|FG004|NOT COMPLETED|Overall Study||1
6771585|NCT04069715|7699233|FG000|STARTED|Overall Study||47
6771586|NCT04069715|7699234|FG001|STARTED|Overall Study||48
6771587|NCT04069715|7699233|FG000|COMPLETED|Overall Study||42
6771588|NCT04069715|7699234|FG001|COMPLETED|Overall Study||43
6771589|NCT04069715|7699233|FG000|NOT COMPLETED|Overall Study||5
6771590|NCT04069715|7699234|FG001|NOT COMPLETED|Overall Study||5
6771591|NCT04050722|7699242|FG000|STARTED|Overall Study||65
6771592|NCT04050722|7699243|FG001|STARTED|Overall Study||65
6771593|NCT04050722|7699242|FG000|COMPLETED|Overall Study||64
6771594|NCT04050722|7699243|FG001|COMPLETED|Overall Study||65
6771595|NCT04050722|7699242|FG000|NOT COMPLETED|Overall Study||1
6771596|NCT04050722|7699243|FG001|NOT COMPLETED|Overall Study||0
6771597|NCT04069221|7699251|FG000|STARTED|Overall Study||8
6771598|NCT04069221|7699252|FG001|STARTED|Overall Study||6
6771599|NCT04069221|7699253|FG002|STARTED|Overall Study||6
6771600|NCT04069221|7699254|FG003|STARTED|Overall Study||6
6771601|NCT04069221|7699251|FG000|COMPLETED|Overall Study||8
6771602|NCT04069221|7699252|FG001|COMPLETED|Overall Study||6
6771603|NCT04069221|7699253|FG002|COMPLETED|Overall Study||6
6771604|NCT04069221|7699254|FG003|COMPLETED|Overall Study||6
6771605|NCT04069221|7699251|FG000|NOT COMPLETED|Overall Study||0
6771606|NCT04069221|7699252|FG001|NOT COMPLETED|Overall Study||0
6771607|NCT04069221|7699253|FG002|NOT COMPLETED|Overall Study||0
6771608|NCT04069221|7699254|FG003|NOT COMPLETED|Overall Study||0
6771609|NCT04067141|7699264|FG000|STARTED|First Intervention||35
6771610|NCT04067141|7699265|FG001|STARTED|First Intervention||35
6771611|NCT04067141|7699264|FG000|COMPLETED|First Intervention||35
6771612|NCT04067141|7699265|FG001|COMPLETED|First Intervention||34
6771613|NCT04067141|7699264|FG000|NOT COMPLETED|First Intervention||0
6771614|NCT04067141|7699265|FG001|NOT COMPLETED|First Intervention||1
6771615|NCT04067141|7699264|FG000|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject.|34
6771616|NCT04067141|7699265|FG001|STARTED|Second Intervention|Unacceptable lens fit at dispense. One withdrawal by subject|33
6771617|NCT04067141|7699264|FG000|COMPLETED|Second Intervention||34
6771618|NCT04067141|7699265|FG001|COMPLETED|Second Intervention||31
6771619|NCT04067141|7699264|FG000|NOT COMPLETED|Second Intervention||0
6556650|NCT01763164|7479052|FG000|Full Analysis Set|Treatment Phase||269
6556651|NCT01763164|7479053|FG001|Full Analysis Set|Treatment Phase||133
6556652|NCT01763164|7479052|FG000|COMPLETED|Treatment Phase||0
6556653|NCT01763164|7479053|FG001|COMPLETED|Treatment Phase||0
6556654|NCT01763164|7479052|FG000|NOT COMPLETED|Treatment Phase||269
6556655|NCT01763164|7479053|FG001|NOT COMPLETED|Treatment Phase||133
6556656|NCT01763164|7479052|FG000|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|200
6556657|NCT01763164|7479053|FG001|STARTED|Follow up Phase|Participants were followed up after completion or discontinuation of treatment.|78
6556658|NCT01763164|7479052|FG000|COMPLETED|Follow up Phase||3
6556659|NCT01763164|7479053|FG001|COMPLETED|Follow up Phase||3
6556660|NCT01763164|7479052|FG000|NOT COMPLETED|Follow up Phase||197
6556661|NCT01763164|7479053|FG001|NOT COMPLETED|Follow up Phase||75
6556662|NCT01763203|7479061|FG000|STARTED|Overall Study||241
6556663|NCT01763203|7479062|FG001|STARTED|Overall Study||246
6556664|NCT01763203|7479061|FG000|COMPLETED|Overall Study||208
6556665|NCT01763203|7479062|FG001|COMPLETED|Overall Study||204
6556666|NCT01763203|7479061|FG000|NOT COMPLETED|Overall Study||33
6556667|NCT01763203|7479062|FG001|NOT COMPLETED|Overall Study||42
6771620|NCT04067141|7699265|FG001|NOT COMPLETED|Second Intervention||2
6771621|NCT04049578|7699271|FG000|STARTED|Overall Study||2
6771622|NCT04049578|7699271|FG000|COMPLETED|Overall Study||1
6771623|NCT04049578|7699271|FG000|NOT COMPLETED|Overall Study||1
6771624|NCT04067401|7699277|FG000|STARTED|Overall Study||748
6771625|NCT04067401|7699278|FG001|STARTED|Overall Study||737
6771626|NCT04067401|7699277|FG000|Baseline Survey Completion|Overall Study||746
6771627|NCT04067401|7699278|FG001|Baseline Survey Completion|Overall Study||735
6771628|NCT04067401|7699277|FG000|1 Month Survey Completion|Overall Study||697
6771629|NCT04067401|7699278|FG001|1 Month Survey Completion|Overall Study||694
6771630|NCT04067401|7699277|FG000|6 Month Survey Completion|Overall Study||629
6771631|NCT04067401|7699278|FG001|6 Month Survey Completion|Overall Study||618
6771632|NCT04067401|7699277|FG000|COMPLETED|Overall Study||740
6771633|NCT04067401|7699278|FG001|COMPLETED|Overall Study||737
6771634|NCT04067401|7699277|FG000|NOT COMPLETED|Overall Study||8
6771635|NCT04067401|7699278|FG001|NOT COMPLETED|Overall Study||0
6771636|NCT04067050|7699286|FG000|STARTED|One Month||32
6771637|NCT04067050|7699287|FG001|STARTED|One Month||29
6771638|NCT04067050|7699286|FG000|COMPLETED|One Month||28
6771639|NCT04067050|7699287|FG001|COMPLETED|One Month||29
6771640|NCT04067050|7699286|FG000|NOT COMPLETED|One Month||4
6771641|NCT04067050|7699287|FG001|NOT COMPLETED|One Month||0
6771642|NCT04067050|7699286|FG000|STARTED|Two Month|6 subjects discontinued after 1 month visit. 22 Subjects continued the study.|22
6771643|NCT04067050|7699287|FG001|STARTED|Two Month||29
6771644|NCT04067050|7699286|FG000|COMPLETED|Two Month||20
6771645|NCT04067050|7699287|FG001|COMPLETED|Two Month||29
6771646|NCT04067050|7699286|FG000|NOT COMPLETED|Two Month||2
6771647|NCT04067050|7699287|FG001|NOT COMPLETED|Two Month||0
6771648|NCT04066647|7699293|FG000|STARTED|Overall Study||7
6556668|NCT01763333|7479082|FG000|STARTED|Overall Study||6
6556669|NCT01763333|7479083|FG001|STARTED|Overall Study||6
6771649|NCT04066647|7699293|FG000|COMPLETED|Overall Study||7
6771650|NCT04066647|7699293|FG000|NOT COMPLETED|Overall Study||0
6771651|NCT04066426|7699301|FG000|STARTED|Overall Study||50
6771652|NCT04066426|7699302|FG001|STARTED|Overall Study||50
6771653|NCT04066426|7699303|FG002|STARTED|Overall Study||50
6771654|NCT04066426|7699304|FG003|STARTED|Overall Study||50
6771655|NCT04066426|7699301|FG000|COMPLETED|Overall Study||40
6771656|NCT04066426|7699302|FG001|COMPLETED|Overall Study||40
6771657|NCT04066426|7699303|FG002|COMPLETED|Overall Study||42
6771658|NCT04066426|7699304|FG003|COMPLETED|Overall Study||47
6771659|NCT04066426|7699301|FG000|NOT COMPLETED|Overall Study||10
6771660|NCT04066426|7699302|FG001|NOT COMPLETED|Overall Study||10
6771661|NCT04066426|7699303|FG002|NOT COMPLETED|Overall Study||8
6771662|NCT04066426|7699304|FG003|NOT COMPLETED|Overall Study||3
6771663|NCT04061694|7699316|FG000|STARTED|Overall Study||21
6771664|NCT04061694|7699317|FG001|STARTED|Overall Study||25
6771665|NCT04061694|7699316|FG000|COMPLETED|Overall Study||19
6771666|NCT04061694|7699317|FG001|COMPLETED|Overall Study||25
6771667|NCT04061694|7699316|FG000|NOT COMPLETED|Overall Study||2
6771668|NCT04061694|7699317|FG001|NOT COMPLETED|Overall Study||0
6771669|NCT04060654|7699323|FG000|STARTED|Overall Study||17
6771670|NCT04060654|7699323|FG000|COMPLETED|Overall Study||11
6771671|NCT04060654|7699323|FG000|NOT COMPLETED|Overall Study||6
6771672|NCT04059250|7699327|FG000|STARTED|Overall Study||25
6771673|NCT04059250|7699328|FG001|STARTED|Overall Study||25
6771674|NCT04059250|7699327|FG000|COMPLETED|Overall Study||25
6771675|NCT04059250|7699328|FG001|COMPLETED|Overall Study||25
6771676|NCT04059250|7699327|FG000|NOT COMPLETED|Overall Study||0
6771677|NCT04059250|7699328|FG001|NOT COMPLETED|Overall Study||0
6771678|NCT04058353|7699336|FG000|STARTED|Overall Study||126
6556670|NCT01763333|7479084|FG002|STARTED|Overall Study||6
6556671|NCT01763333|7479085|FG003|STARTED|Overall Study||6
6556672|NCT01763333|7479086|FG004|STARTED|Overall Study||4
6556673|NCT01763333|7479087|FG005|STARTED|Overall Study||6
6556674|NCT01763333|7479088|FG006|STARTED|Overall Study||5
6556675|NCT01763333|7479089|FG007|STARTED|Overall Study||6
6556676|NCT01763333|7479090|FG008|STARTED|Overall Study||5
6556677|NCT01763333|7479091|FG009|STARTED|Overall Study||18
6556678|NCT01763333|7479092|FG010|STARTED|Overall Study||3
6771679|NCT04058353|7699337|FG001|STARTED|Overall Study||132
6771680|NCT04058353|7699336|FG000|COMPLETED|Overall Study||122
6771681|NCT04058353|7699337|FG001|COMPLETED|Overall Study||131
6771682|NCT04058353|7699336|FG000|NOT COMPLETED|Overall Study||4
6771683|NCT04058353|7699337|FG001|NOT COMPLETED|Overall Study||1
6771684|NCT04057248|7699344|FG000|STARTED|Overall Study||14
6771685|NCT04057248|7699344|FG000|COMPLETED|Overall Study||12
6771686|NCT04057248|7699344|FG000|NOT COMPLETED|Overall Study||2
6771687|NCT04055519|7699348|FG000|STARTED|First Wear Period (30 Days)||16
6771688|NCT04055519|7699349|FG001|STARTED|First Wear Period (30 Days)||20
6771689|NCT04055519|7699348|FG000|COMPLETED|First Wear Period (30 Days)||16
6771690|NCT04055519|7699349|FG001|COMPLETED|First Wear Period (30 Days)||20
6771691|NCT04055519|7699348|FG000|NOT COMPLETED|First Wear Period (30 Days)||0
6771692|NCT04055519|7699349|FG001|NOT COMPLETED|First Wear Period (30 Days)||0
6771693|NCT04055519|7699348|FG000|STARTED|Second Wear Period (30 Days)||16
6771694|NCT04055519|7699349|FG001|STARTED|Second Wear Period (30 Days)||20
6771695|NCT04055519|7699348|FG000|COMPLETED|Second Wear Period (30 Days)||16
6771696|NCT04055519|7699349|FG001|COMPLETED|Second Wear Period (30 Days)||20
6771697|NCT04055519|7699348|FG000|NOT COMPLETED|Second Wear Period (30 Days)||0
6771698|NCT04055519|7699349|FG001|NOT COMPLETED|Second Wear Period (30 Days)||0
6771699|NCT04055675|7699360|FG000|STARTED|Overall Study||96
6771700|NCT04055675|7699361|FG001|STARTED|Overall Study||104
6771701|NCT04055675|7699360|FG000|COMPLETED|Overall Study||96
6771702|NCT04055675|7699361|FG001|COMPLETED|Overall Study||104
6771703|NCT04055675|7699360|FG000|NOT COMPLETED|Overall Study||0
6771704|NCT04055675|7699361|FG001|NOT COMPLETED|Overall Study||0
6771705|NCT04054765|7699369|FG000|STARTED|Baseline||155
6771706|NCT04054765|7699370|FG001|STARTED|Baseline||132
6771707|NCT04054765|7699369|FG000|COMPLETED|Baseline||150
6771708|NCT04054765|7699370|FG001|COMPLETED|Baseline||129
6771709|NCT04054765|7699369|FG000|NOT COMPLETED|Baseline||5
6771710|NCT04054765|7699370|FG001|NOT COMPLETED|Baseline||3
6771711|NCT04054765|7699369|FG000|STARTED|Post-Gameplay / 1-week Follow up||150
6771712|NCT04054765|7699370|FG001|STARTED|Post-Gameplay / 1-week Follow up||129
6771713|NCT04054765|7699369|FG000|COMPLETED|Post-Gameplay / 1-week Follow up||142
6771714|NCT04054765|7699370|FG001|COMPLETED|Post-Gameplay / 1-week Follow up||126
6771715|NCT04054765|7699369|FG000|NOT COMPLETED|Post-Gameplay / 1-week Follow up||8
6771716|NCT04054765|7699370|FG001|NOT COMPLETED|Post-Gameplay / 1-week Follow up||3
6771717|NCT04054765|7699369|FG000|STARTED|3-month Follow up||142
6771718|NCT04054765|7699370|FG001|STARTED|3-month Follow up||126
6771719|NCT04054765|7699369|FG000|COMPLETED|3-month Follow up||142
6771720|NCT04054765|7699370|FG001|COMPLETED|3-month Follow up||123
6771721|NCT04054765|7699369|FG000|NOT COMPLETED|3-month Follow up||0
6771722|NCT04054765|7699370|FG001|NOT COMPLETED|3-month Follow up||3
6771723|NCT04054765|7699369|FG000|STARTED|6-month Follow up||142
6771724|NCT04054765|7699370|FG001|STARTED|6-month Follow up||123
6556679|NCT01763333|7479093|FG011|STARTED|Overall Study||3
6556680|NCT01763333|7479094|FG012|STARTED|Overall Study||3
6556681|NCT01763333|7479095|FG013|STARTED|Overall Study||3
6771725|NCT04054765|7699369|FG000|COMPLETED|6-month Follow up||110
6771726|NCT04054765|7699370|FG001|COMPLETED|6-month Follow up||91
6771727|NCT04054765|7699369|FG000|NOT COMPLETED|6-month Follow up||32
6771728|NCT04054765|7699370|FG001|NOT COMPLETED|6-month Follow up||32
6556682|NCT01763333|7479082|FG000|COMPLETED|Overall Study||6
6771729|NCT04054011|7699376|FG000|STARTED|Overall Study||15
6771730|NCT04054011|7699376|FG000|COMPLETED|Overall Study||12
6771731|NCT04054011|7699376|FG000|NOT COMPLETED|Overall Study||3
6771732|NCT04059094|7699387|FG000|STARTED|Overall Study||18
6771733|NCT04059094|7699388|FG001|STARTED|Overall Study||6
6771734|NCT04059094|7699389|FG002|STARTED|Overall Study||5
6771735|NCT04059094|7699390|FG003|STARTED|Overall Study||5
6771736|NCT04059094|7699391|FG004|STARTED|Overall Study||18
6771737|NCT04059094|7699387|FG000|COMPLETED|Overall Study||18
6771738|NCT04059094|7699388|FG001|COMPLETED|Overall Study||4
6771739|NCT04059094|7699389|FG002|COMPLETED|Overall Study||5
6771740|NCT04059094|7699390|FG003|COMPLETED|Overall Study||5
6771741|NCT04059094|7699391|FG004|COMPLETED|Overall Study||17
6771742|NCT04059094|7699387|FG000|NOT COMPLETED|Overall Study||0
6771743|NCT04059094|7699388|FG001|NOT COMPLETED|Overall Study||2
6771744|NCT04059094|7699389|FG002|NOT COMPLETED|Overall Study||0
6771745|NCT04059094|7699390|FG003|NOT COMPLETED|Overall Study||0
6771746|NCT04059094|7699391|FG004|NOT COMPLETED|Overall Study||1
6771747|NCT04051684|7699409|FG000|STARTED|Overall Study||12
6771748|NCT04051684|7699410|FG001|STARTED|Overall Study||11
6771749|NCT04051684|7699409|FG000|COMPLETED|Overall Study||12
6771750|NCT04051684|7699410|FG001|COMPLETED|Overall Study||11
6771751|NCT04051684|7699409|FG000|NOT COMPLETED|Overall Study||0
6771752|NCT04051684|7699410|FG001|NOT COMPLETED|Overall Study||0
6771753|NCT04046341|7699416|FG000|STARTED|Overall Study||15
6771754|NCT04046341|7699416|FG000|COMPLETED|Overall Study||12
6771755|NCT04046341|7699416|FG000|NOT COMPLETED|Overall Study||3
6771756|NCT04045964|7699422|FG000|STARTED|Overall Study||16
6771757|NCT04045964|7699423|FG001|STARTED|Overall Study||16
6771758|NCT04045964|7699422|FG000|Intervention Visit(s)|Overall Study||15
6771759|NCT04045964|7699423|FG001|Intervention Visit(s)|Overall Study||16
6771760|NCT04045964|7699422|FG000|Follow up Visit 1|Overall Study||15
6771761|NCT04045964|7699423|FG001|Follow up Visit 1|Overall Study||15
6771762|NCT04045964|7699422|FG000|Follow up Visit 2|Overall Study||15
6771763|NCT04045964|7699423|FG001|Follow up Visit 2|Overall Study||15
6771764|NCT04045964|7699422|FG000|COMPLETED|Overall Study||15
6771765|NCT04045964|7699423|FG001|COMPLETED|Overall Study||15
6771766|NCT04045964|7699422|FG000|NOT COMPLETED|Overall Study||1
6771767|NCT04045964|7699423|FG001|NOT COMPLETED|Overall Study||1
6771768|NCT04043416|7699431|FG000|STARTED|Campaign 1||14
6771769|NCT04043416|7699432|FG001|STARTED|Campaign 1||14
6771770|NCT04043416|7699431|FG000|COMPLETED|Campaign 1||14
6771771|NCT04043416|7699432|FG001|COMPLETED|Campaign 1||14
6771772|NCT04043416|7699431|FG000|NOT COMPLETED|Campaign 1||0
6771773|NCT04043416|7699432|FG001|NOT COMPLETED|Campaign 1||0
6771774|NCT04043416|7699431|FG000|STARTED|Washout||14
6771775|NCT04043416|7699432|FG001|STARTED|Washout||14
6771776|NCT04043416|7699431|FG000|COMPLETED|Washout||14
6771777|NCT04043416|7699432|FG001|COMPLETED|Washout||13
6771778|NCT04043416|7699431|FG000|NOT COMPLETED|Washout||0
6771779|NCT04043416|7699432|FG001|NOT COMPLETED|Washout||1
6771780|NCT04043416|7699431|FG000|STARTED|Campaign 2||14
6771781|NCT04043416|7699432|FG001|STARTED|Campaign 2||13
6771782|NCT04043416|7699431|FG000|COMPLETED|Campaign 2||14
6771783|NCT04043416|7699432|FG001|COMPLETED|Campaign 2||13
6771784|NCT04043416|7699431|FG000|NOT COMPLETED|Campaign 2||0
6771785|NCT04043416|7699432|FG001|NOT COMPLETED|Campaign 2||0
6771786|NCT04057768|7699441|FG000|STARTED|Overall Study||10
6771787|NCT04057768|7699441|FG000|COMPLETED|Overall Study||10
6771788|NCT04057768|7699441|FG000|NOT COMPLETED|Overall Study||0
6771789|NCT04052542|7699457|FG000|STARTED|Overall Study||116
6771790|NCT04052542|7699458|FG001|STARTED|Overall Study||28
6498161|NCT01408719|7416839|FG013|NOT COMPLETED|Third Intervention (35 Days)||0
6498162|NCT01408719|7416840|FG014|NOT COMPLETED|Third Intervention (35 Days)||0
6498163|NCT01408719|7416841|FG015|NOT COMPLETED|Third Intervention (35 Days)||0
6498164|NCT01408719|7416842|FG016|NOT COMPLETED|Third Intervention (35 Days)||0
6498165|NCT01408719|7416843|FG017|NOT COMPLETED|Third Intervention (35 Days)||0
6498166|NCT01408719|7416844|FG018|NOT COMPLETED|Third Intervention (35 Days)||0
6498167|NCT01408719|7416845|FG019|NOT COMPLETED|Third Intervention (35 Days)||0
6498168|NCT01408719|7416826|FG000|STARTED|Washout Period (28 Days)||2
6498169|NCT01408719|7416827|FG001|STARTED|Washout Period (28 Days)||3
6498170|NCT01408719|7416828|FG002|STARTED|Washout Period (28 Days)||1
6498171|NCT01408719|7416829|FG003|STARTED|Washout Period (28 Days)||2
6498172|NCT01408719|7416830|FG004|STARTED|Washout Period (28 Days)||3
6498173|NCT01408719|7416831|FG005|STARTED|Washout Period (28 Days)||3
6498174|NCT01408719|7416832|FG006|STARTED|Washout Period (28 Days)||2
6498175|NCT01408719|7416833|FG007|STARTED|Washout Period (28 Days)||2
6498176|NCT01408719|7416834|FG008|STARTED|Washout Period (28 Days)||1
6498177|NCT01408719|7416835|FG009|STARTED|Washout Period (28 Days)||1
6498178|NCT01408719|7416836|FG010|STARTED|Washout Period (28 Days)||2
6771791|NCT04052542|7699459|FG002|STARTED|Overall Study||146
6771792|NCT04052542|7699460|FG003|STARTED|Overall Study||188
6771793|NCT04052542|7699461|FG004|STARTED|Overall Study||24
6498179|NCT01408719|7416837|FG011|STARTED|Washout Period (28 Days)||2
6498180|NCT01408719|7416838|FG012|STARTED|Washout Period (28 Days)||1
6771794|NCT04052542|7699462|FG005|STARTED|Overall Study||183
6771795|NCT04052542|7699463|FG006|STARTED|Overall Study||275
6771796|NCT04052542|7699464|FG007|STARTED|Overall Study||27
6771797|NCT04052542|7699465|FG008|STARTED|Overall Study||276
6771798|NCT04052542|7699466|FG009|STARTED|Overall Study||22
6771799|NCT04052542|7699467|FG010|STARTED|Overall Study||31
6771800|NCT04052542|7699468|FG011|STARTED|Overall Study||12
6771801|NCT04052542|7699457|FG000|COMPLETED|Overall Study||116
6771802|NCT04052542|7699458|FG001|COMPLETED|Overall Study||28
6771803|NCT04052542|7699459|FG002|COMPLETED|Overall Study||146
6556683|NCT01763333|7479083|FG001|COMPLETED|Overall Study||6
6556684|NCT01763333|7479084|FG002|COMPLETED|Overall Study||6
6556685|NCT01763333|7479085|FG003|COMPLETED|Overall Study||6
6556686|NCT01763333|7479086|FG004|COMPLETED|Overall Study||4
6556687|NCT01763333|7479087|FG005|COMPLETED|Overall Study||6
6556688|NCT01763333|7479088|FG006|COMPLETED|Overall Study||5
6556689|NCT01763333|7479089|FG007|COMPLETED|Overall Study||6
6556690|NCT01763333|7479090|FG008|COMPLETED|Overall Study||5
6556691|NCT01763333|7479091|FG009|COMPLETED|Overall Study||18
6556692|NCT01763333|7479092|FG010|COMPLETED|Overall Study||3
6556693|NCT01763333|7479093|FG011|COMPLETED|Overall Study||3
6556694|NCT01763333|7479094|FG012|COMPLETED|Overall Study||3
6556695|NCT01763333|7479095|FG013|COMPLETED|Overall Study||3
6556696|NCT01763333|7479082|FG000|NOT COMPLETED|Overall Study||0
6771804|NCT04052542|7699460|FG003|COMPLETED|Overall Study||188
6771805|NCT04052542|7699461|FG004|COMPLETED|Overall Study||24
6771806|NCT04052542|7699462|FG005|COMPLETED|Overall Study||183
6771807|NCT04052542|7699463|FG006|COMPLETED|Overall Study||275
6771808|NCT04052542|7699464|FG007|COMPLETED|Overall Study||27
6771809|NCT04052542|7699465|FG008|COMPLETED|Overall Study||276
6771810|NCT04052542|7699466|FG009|COMPLETED|Overall Study||22
6771811|NCT04052542|7699467|FG010|COMPLETED|Overall Study||31
6771812|NCT04052542|7699468|FG011|COMPLETED|Overall Study||12
6771813|NCT04052542|7699457|FG000|NOT COMPLETED|Overall Study||0
6498181|NCT01408719|7416839|FG013|STARTED|Washout Period (28 Days)||3
6498182|NCT01408719|7416840|FG014|STARTED|Washout Period (28 Days)||1
6498183|NCT01408719|7416841|FG015|STARTED|Washout Period (28 Days)||1
6498184|NCT01408719|7416842|FG016|STARTED|Washout Period (28 Days)||2
6498185|NCT01408719|7416843|FG017|STARTED|Washout Period (28 Days)||2
6498186|NCT01408719|7416844|FG018|STARTED|Washout Period (28 Days)||0
6498187|NCT01408719|7416845|FG019|STARTED|Washout Period (28 Days)||1
6498188|NCT01408719|7416826|FG000|COMPLETED|Washout Period (28 Days)||2
6498189|NCT01408719|7416827|FG001|COMPLETED|Washout Period (28 Days)||3
6498190|NCT01408719|7416828|FG002|COMPLETED|Washout Period (28 Days)||1
6498191|NCT01408719|7416829|FG003|COMPLETED|Washout Period (28 Days)||2
6556697|NCT01763333|7479083|FG001|NOT COMPLETED|Overall Study||0
6771814|NCT04052542|7699458|FG001|NOT COMPLETED|Overall Study||0
6771815|NCT04052542|7699459|FG002|NOT COMPLETED|Overall Study||0
6771816|NCT04052542|7699460|FG003|NOT COMPLETED|Overall Study||0
6771817|NCT04052542|7699461|FG004|NOT COMPLETED|Overall Study||0
6771818|NCT04052542|7699462|FG005|NOT COMPLETED|Overall Study||0
6771819|NCT04052542|7699463|FG006|NOT COMPLETED|Overall Study||0
6771820|NCT04052542|7699464|FG007|NOT COMPLETED|Overall Study||0
6771821|NCT04052542|7699465|FG008|NOT COMPLETED|Overall Study||0
6771822|NCT04052542|7699466|FG009|NOT COMPLETED|Overall Study||0
6771823|NCT04052542|7699467|FG010|NOT COMPLETED|Overall Study||0
6771824|NCT04052542|7699468|FG011|NOT COMPLETED|Overall Study||0
6771825|NCT04054193|7699494|FG000|STARTED|Cycle 1||103
6771826|NCT04054193|7699494|FG000|Treated (≥1 Dose)|Cycle 1||100
6771827|NCT04054193|7699494|FG000|COMPLETED|Cycle 1||98
6771828|NCT04054193|7699494|FG000|NOT COMPLETED|Cycle 1||5
6771829|NCT04054193|7699494|FG000|STARTED|Cycles 2-3|Participation in Cycles 2-3 was optional after completing Cycle 1.|69
6771830|NCT04054193|7699494|FG000|COMPLETED|Cycles 2-3||48
6771831|NCT04054193|7699494|FG000|NOT COMPLETED|Cycles 2-3||21
6771832|NCT04050618|7699501|FG000|STARTED|First Intervention||58
6771833|NCT04050618|7699502|FG001|STARTED|First Intervention||56
6771834|NCT04050618|7699501|FG000|COMPLETED|First Intervention||56
6771835|NCT04050618|7699502|FG001|COMPLETED|First Intervention||56
6771836|NCT04050618|7699501|FG000|NOT COMPLETED|First Intervention||2
6771837|NCT04050618|7699502|FG001|NOT COMPLETED|First Intervention||0
6771838|NCT04050618|7699501|FG000|STARTED|Second Intervention||56
6771839|NCT04050618|7699502|FG001|STARTED|Second Intervention||56
6771840|NCT04050618|7699501|FG000|COMPLETED|Second Intervention||55
6771841|NCT04050618|7699502|FG001|COMPLETED|Second Intervention||56
6771842|NCT04050618|7699501|FG000|NOT COMPLETED|Second Intervention||1
6771843|NCT04050618|7699502|FG001|NOT COMPLETED|Second Intervention||0
6771844|NCT04053465|7699515|FG000|STARTED|Overall Study||22
6771845|NCT04053465|7699516|FG001|STARTED|Overall Study||12
6771846|NCT04053465|7699515|FG000|COMPLETED|Overall Study||18
6771847|NCT04053465|7699516|FG001|COMPLETED|Overall Study||8
6771848|NCT04053465|7699515|FG000|NOT COMPLETED|Overall Study||4
6771849|NCT04053465|7699516|FG001|NOT COMPLETED|Overall Study||4
6771850|NCT04053270|7699524|FG000|STARTED|Overall Study||49
6556698|NCT01763333|7479084|FG002|NOT COMPLETED|Overall Study||0
6556699|NCT01763333|7479085|FG003|NOT COMPLETED|Overall Study||0
6556700|NCT01763333|7479086|FG004|NOT COMPLETED|Overall Study||0
6556701|NCT01763333|7479087|FG005|NOT COMPLETED|Overall Study||0
6556702|NCT01763333|7479088|FG006|NOT COMPLETED|Overall Study||0
6556703|NCT01763333|7479089|FG007|NOT COMPLETED|Overall Study||0
6556704|NCT01763333|7479090|FG008|NOT COMPLETED|Overall Study||0
6556705|NCT01763333|7479091|FG009|NOT COMPLETED|Overall Study||0
6556706|NCT01763333|7479092|FG010|NOT COMPLETED|Overall Study||0
6556707|NCT01763333|7479093|FG011|NOT COMPLETED|Overall Study||0
6498192|NCT01408719|7416830|FG004|COMPLETED|Washout Period (28 Days)||3
6556708|NCT01763333|7479094|FG012|NOT COMPLETED|Overall Study||0
6771851|NCT04053270|7699525|FG001|STARTED|Overall Study||51
6771852|NCT04053270|7699524|FG000|COMPLETED|Overall Study||47
6771853|NCT04053270|7699525|FG001|COMPLETED|Overall Study||46
6771854|NCT04053270|7699524|FG000|NOT COMPLETED|Overall Study||2
6771855|NCT04053270|7699525|FG001|NOT COMPLETED|Overall Study||5
6771856|NCT04049552|7699535|FG000|STARTED|Overall Study||4
6771857|NCT04049552|7699535|FG000|COMPLETED|Overall Study||3
6771858|NCT04049552|7699535|FG000|NOT COMPLETED|Overall Study||1
6771859|NCT04053023|7699543|FG000|STARTED|Part A: Period 1 (Day 1 to Day 19)||19
6771860|NCT04053023|7699544|FG001|STARTED|Part A: Period 1 (Day 1 to Day 19)||0
6771861|NCT04053023|7699543|FG000|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||19
6771862|NCT04053023|7699544|FG001|COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
6771863|NCT04053023|7699543|FG000|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
6771864|NCT04053023|7699544|FG001|NOT COMPLETED|Part A: Period 1 (Day 1 to Day 19)||0
6771865|NCT04053023|7699543|FG000|STARTED|Part A: Period 2 (Day 20 to Day 38)||19
6771866|NCT04053023|7699544|FG001|STARTED|Part A: Period 2 (Day 20 to Day 38)||0
6771867|NCT04053023|7699543|FG000|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||18
6771868|NCT04053023|7699544|FG001|COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
6771869|NCT04053023|7699543|FG000|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||1
6771870|NCT04053023|7699544|FG001|NOT COMPLETED|Part A: Period 2 (Day 20 to Day 38)||0
6771871|NCT04053023|7699543|FG000|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
6771872|NCT04053023|7699544|FG001|STARTED|Part B: Period 1 (Day 1 to Day 19)||0
6771873|NCT04053023|7699543|FG000|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
6771874|NCT04053023|7699544|FG001|COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
6771875|NCT04053023|7699543|FG000|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
6771876|NCT04053023|7699544|FG001|NOT COMPLETED|Part B: Period 1 (Day 1 to Day 19)||0
6771877|NCT04053023|7699543|FG000|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
6771878|NCT04053023|7699544|FG001|STARTED|Part B: Period 2 (Day 20 to Day 38)||0
6771879|NCT04053023|7699543|FG000|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
6771880|NCT04053023|7699544|FG001|COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
6771881|NCT04053023|7699543|FG000|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
6771882|NCT04053023|7699544|FG001|NOT COMPLETED|Part B: Period 2 (Day 20 to Day 38)||0
6771883|NCT04051710|7699557|FG000|STARTED|Overall Study||620
6771884|NCT04051710|7699558|FG001|STARTED|Overall Study||620
6771885|NCT04051710|7699559|FG002|STARTED|Overall Study||310
6771886|NCT04051710|7699557|FG000|COMPLETED|Overall Study||616
6771887|NCT04051710|7699558|FG001|COMPLETED|Overall Study||612
6771888|NCT04051710|7699559|FG002|COMPLETED|Overall Study||306
6771889|NCT04051710|7699557|FG000|NOT COMPLETED|Overall Study||4
6771890|NCT04051710|7699558|FG001|NOT COMPLETED|Overall Study||8
6771891|NCT04051710|7699559|FG002|NOT COMPLETED|Overall Study||4
6771892|NCT04050865|7699569|FG000|STARTED|Overall Study||48
6771893|NCT04050865|7699570|FG001|STARTED|Overall Study||48
6771894|NCT04050865|7699569|FG000|COMPLETED|Overall Study||44
6771895|NCT04050865|7699570|FG001|COMPLETED|Overall Study||43
6771896|NCT04050865|7699569|FG000|NOT COMPLETED|Overall Study||4
6771897|NCT04050865|7699570|FG001|NOT COMPLETED|Overall Study||5
6771898|NCT04050605|7699576|FG000|STARTED|Overall Study||40
6771899|NCT04050605|7699576|FG000|COMPLETED|Overall Study||40
6771900|NCT04050605|7699576|FG000|NOT COMPLETED|Overall Study||0
6771901|NCT04050371|7699588|FG000|STARTED|Overall Study||24
6771902|NCT04050371|7699589|FG001|STARTED|Overall Study||24
6771903|NCT04050371|7699588|FG000|COMPLETED|Overall Study||23
6771904|NCT04050371|7699589|FG001|COMPLETED|Overall Study||24
6771905|NCT04050371|7699588|FG000|NOT COMPLETED|Overall Study||1
6771906|NCT04050371|7699589|FG001|NOT COMPLETED|Overall Study||0
6771907|NCT04048460|7699595|FG000|STARTED|Overall Study||10
6771908|NCT04048460|7699595|FG000|COMPLETED|Overall Study||10
6771909|NCT04048460|7699595|FG000|NOT COMPLETED|Overall Study||0
6771910|NCT04048681|7699599|FG000|STARTED|Overall Study||1
6771911|NCT04048681|7699600|FG001|STARTED|Overall Study||1
6771912|NCT04048681|7699601|FG002|STARTED|Overall Study||1
6771913|NCT04048681|7699602|FG003|STARTED|Overall Study||1
6771914|NCT04048681|7699603|FG004|STARTED|Overall Study||1
6771915|NCT04048681|7699599|FG000|COMPLETED|Overall Study||1
6771916|NCT04048681|7699600|FG001|COMPLETED|Overall Study||1
6771917|NCT04048681|7699601|FG002|COMPLETED|Overall Study||1
6771918|NCT04048681|7699602|FG003|COMPLETED|Overall Study||0
6771919|NCT04048681|7699603|FG004|COMPLETED|Overall Study||1
6771920|NCT04048681|7699599|FG000|NOT COMPLETED|Overall Study||0
6771921|NCT04048681|7699600|FG001|NOT COMPLETED|Overall Study||0
6771922|NCT04048681|7699601|FG002|NOT COMPLETED|Overall Study||0
6771923|NCT04048681|7699602|FG003|NOT COMPLETED|Overall Study||1
6771924|NCT04048681|7699603|FG004|NOT COMPLETED|Overall Study||0
6556709|NCT01763333|7479095|FG013|NOT COMPLETED|Overall Study||0
6556710|NCT01763346|7479131|FG000|STARTED|Overall Study|"Five subjects who enrolled in the study refused to initiate metformin therapy, thus did not start"|44
6556711|NCT01763346|7479132|FG001|STARTED|Overall Study|"Six subjects randomized to gastric banding refused the banding surgery and, thus, did not start"|44
6556712|NCT01763346|7479131|FG000|Received Intervention|Overall Study||39
6556713|NCT01763346|7479132|FG001|Received Intervention|Overall Study||38
6771925|NCT04046250|7699613|FG000|STARTED|Overall Study||11
6771926|NCT04046250|7699614|FG001|STARTED|Overall Study||11
6771927|NCT04046250|7699613|FG000|COMPLETED|Overall Study|Four Methotrexate + TK-112690 Treatments|8
6771928|NCT04046250|7699614|FG001|COMPLETED|Overall Study|Four Methotrexate + TK-12260 Placebo Treatments|7
6771929|NCT04046250|7699613|FG000|NOT COMPLETED|Overall Study||3
6771930|NCT04046250|7699614|FG001|NOT COMPLETED|Overall Study||4
6771931|NCT04047342|7699622|FG000|STARTED|Overall Study||409
6556714|NCT01763346|7479131|FG000|COMPLETED|Overall Study||34
6556715|NCT01763346|7479132|FG001|COMPLETED|Overall Study||36
6771932|NCT04047342|7699623|FG001|STARTED|Overall Study||415
6771933|NCT04047342|7699622|FG000|COMPLETED|Overall Study||409
6771934|NCT04047342|7699623|FG001|COMPLETED|Overall Study||415
6771935|NCT04047342|7699622|FG000|NOT COMPLETED|Overall Study||0
6771936|NCT04047342|7699623|FG001|NOT COMPLETED|Overall Study||0
6771937|NCT04044352|7699629|FG000|STARTED|Overall Study||76
6771938|NCT04044352|7699629|FG000|COMPLETED|Overall Study||65
6771939|NCT04044352|7699629|FG000|NOT COMPLETED|Overall Study||11
6771940|NCT04043728|7699637|FG000|STARTED|Overall Study||6
6771941|NCT04043728|7699638|FG001|STARTED|Overall Study||6
6771942|NCT04043728|7699639|FG002|STARTED|Overall Study||6
6771943|NCT04043728|7699637|FG000|COMPLETED|Overall Study||5
6771944|NCT04043728|7699638|FG001|COMPLETED|Overall Study||4
6771945|NCT04043728|7699639|FG002|COMPLETED|Overall Study||6
6771946|NCT04043728|7699637|FG000|NOT COMPLETED|Overall Study||1
6771947|NCT04043728|7699638|FG001|NOT COMPLETED|Overall Study||2
6771948|NCT04043728|7699639|FG002|NOT COMPLETED|Overall Study||0
6771949|NCT04041453|7699651|FG000|STARTED|Overall Study||38
6771950|NCT04041453|7699652|FG001|STARTED|Overall Study||57
6771951|NCT04041453|7699653|FG002|STARTED|Overall Study||23
6771952|NCT04041453|7699654|FG003|STARTED|Overall Study||58
6771953|NCT04041453|7699651|FG000|Safety Population|Overall Study||38
6771954|NCT04041453|7699652|FG001|Safety Population|Overall Study||56
6771955|NCT04041453|7699653|FG002|Safety Population|Overall Study||23
6771956|NCT04041453|7699654|FG003|Safety Population|Overall Study||58
6771957|NCT04041453|7699651|FG000|COMPLETED|Overall Study||24
6771958|NCT04041453|7699652|FG001|COMPLETED|Overall Study||35
6771959|NCT04041453|7699653|FG002|COMPLETED|Overall Study||18
6771960|NCT04041453|7699654|FG003|COMPLETED|Overall Study||40
6771961|NCT04041453|7699651|FG000|NOT COMPLETED|Overall Study||14
6771962|NCT04041453|7699652|FG001|NOT COMPLETED|Overall Study||22
6771963|NCT04041453|7699653|FG002|NOT COMPLETED|Overall Study||5
6771964|NCT04041453|7699654|FG003|NOT COMPLETED|Overall Study||18
6771965|NCT04041414|7699668|FG000|STARTED|Overall Study||27
6771966|NCT04041414|7699669|FG001|STARTED|Overall Study||20
6771967|NCT04041414|7699668|FG000|COMPLETED|Overall Study||26
6771968|NCT04041414|7699669|FG001|COMPLETED|Overall Study||18
6771969|NCT04041414|7699668|FG000|NOT COMPLETED|Overall Study||1
6771970|NCT04041414|7699669|FG001|NOT COMPLETED|Overall Study||2
6771971|NCT04041219|7699678|FG000|STARTED|Overall Study||10
6771972|NCT04041219|7699678|FG000|COMPLETED|Overall Study||10
6771973|NCT04041219|7699678|FG000|NOT COMPLETED|Overall Study||0
6771974|NCT04041700|7699682|FG000|STARTED|Overall Study||29
6771975|NCT04041700|7699682|FG000|COMPLETED|Overall Study||27
6771976|NCT04041700|7699682|FG000|NOT COMPLETED|Overall Study||2
6771977|NCT04040933|7699686|FG000|STARTED|Overall Study||36
6771978|NCT04040933|7699686|FG000|Treated|Overall Study||36
6771979|NCT04040933|7699686|FG000|COMPLETED|Overall Study||33
6771980|NCT04040933|7699686|FG000|NOT COMPLETED|Overall Study||3
6771981|NCT04039867|7699697|FG000|STARTED|Overall Study||17
6771982|NCT04039867|7699697|FG000|COMPLETED|Overall Study||17
6771983|NCT04039867|7699697|FG000|NOT COMPLETED|Overall Study||0
6771984|NCT04039412|7699704|FG000|STARTED|Overall Study||110
6771985|NCT04039412|7699705|FG001|STARTED|Overall Study||110
6771986|NCT04039412|7699706|FG002|STARTED|Overall Study||110
6771987|NCT04039412|7699704|FG000|COMPLETED|Overall Study||109
6771988|NCT04039412|7699705|FG001|COMPLETED|Overall Study||107
6771989|NCT04039412|7699706|FG002|COMPLETED|Overall Study||108
6771990|NCT04039412|7699704|FG000|NOT COMPLETED|Overall Study||1
6771991|NCT04039412|7699705|FG001|NOT COMPLETED|Overall Study||3
6771992|NCT04039412|7699706|FG002|NOT COMPLETED|Overall Study||2
6771993|NCT04035161|7699717|FG000|STARTED|Overall Study||1121
6771994|NCT04035161|7699717|FG000|Treated With Investigational Product|Overall Study||609
6771995|NCT04035161|7699717|FG000|Treated With Reference Standard|Overall Study||419
6771996|NCT04035161|7699717|FG000|Treated With Active Control|Overall Study||609
6771997|NCT04035161|7699717|FG000|Treated With Negative Control|Overall Study||605
6771998|NCT04035161|7699717|FG000|COMPLETED|Overall Study||1121
6771999|NCT04035161|7699717|FG000|NOT COMPLETED|Overall Study||0
6772000|NCT04029519|7699727|FG000|STARTED|Overall Study||84
6772001|NCT04029519|7699727|FG000|COMPLETED|Overall Study||79
6772002|NCT04029519|7699727|FG000|NOT COMPLETED|Overall Study||5
6772003|NCT04039919|7699736|FG000|STARTED|Treatment Period 1||7
6772004|NCT04039919|7699737|FG001|STARTED|Treatment Period 1||6
6772005|NCT04039919|7699738|FG002|STARTED|Treatment Period 1||5
6772006|NCT04039919|7699739|FG003|STARTED|Treatment Period 1||6
6772007|NCT04039919|7699740|FG004|STARTED|Treatment Period 1||16
6772008|NCT04039919|7699736|FG000|COMPLETED|Treatment Period 1||6
6772009|NCT04039919|7699737|FG001|COMPLETED|Treatment Period 1||6
6772010|NCT04039919|7699738|FG002|COMPLETED|Treatment Period 1||5
6772011|NCT04039919|7699739|FG003|COMPLETED|Treatment Period 1||6
6772012|NCT04039919|7699740|FG004|COMPLETED|Treatment Period 1||0
6772013|NCT04039919|7699736|FG000|NOT COMPLETED|Treatment Period 1||1
6772014|NCT04039919|7699737|FG001|NOT COMPLETED|Treatment Period 1||0
6772015|NCT04039919|7699738|FG002|NOT COMPLETED|Treatment Period 1||0
6772016|NCT04039919|7699739|FG003|NOT COMPLETED|Treatment Period 1||0
6772017|NCT04039919|7699740|FG004|NOT COMPLETED|Treatment Period 1||16
6772018|NCT04039919|7699736|FG000|STARTED|Treatment Period 2||6
6772019|NCT04039919|7699737|FG001|STARTED|Treatment Period 2||6
6772020|NCT04039919|7699738|FG002|STARTED|Treatment Period 2||5
6772021|NCT04039919|7699739|FG003|STARTED|Treatment Period 2||6
6772022|NCT04039919|7699740|FG004|STARTED|Treatment Period 2||0
6772023|NCT04039919|7699736|FG000|COMPLETED|Treatment Period 2||6
6772024|NCT04039919|7699737|FG001|COMPLETED|Treatment Period 2||6
6772025|NCT04039919|7699738|FG002|COMPLETED|Treatment Period 2||5
6772026|NCT04039919|7699739|FG003|COMPLETED|Treatment Period 2||6
6772027|NCT04039919|7699740|FG004|COMPLETED|Treatment Period 2||0
6772028|NCT04039919|7699736|FG000|NOT COMPLETED|Treatment Period 2||0
6772029|NCT04039919|7699737|FG001|NOT COMPLETED|Treatment Period 2||0
6772030|NCT04039919|7699738|FG002|NOT COMPLETED|Treatment Period 2||0
6772031|NCT04039919|7699739|FG003|NOT COMPLETED|Treatment Period 2||0
6772032|NCT04039919|7699740|FG004|NOT COMPLETED|Treatment Period 2||0
6772033|NCT04039919|7699736|FG000|STARTED|Treatment Period 3||6
6772034|NCT04039919|7699737|FG001|STARTED|Treatment Period 3||6
6772035|NCT04039919|7699738|FG002|STARTED|Treatment Period 3||5
6772036|NCT04039919|7699739|FG003|STARTED|Treatment Period 3||6
6772037|NCT04039919|7699740|FG004|STARTED|Treatment Period 3||0
6772038|NCT04039919|7699736|FG000|COMPLETED|Treatment Period 3||6
6772039|NCT04039919|7699737|FG001|COMPLETED|Treatment Period 3||6
6772040|NCT04039919|7699738|FG002|COMPLETED|Treatment Period 3||5
6772041|NCT04039919|7699739|FG003|COMPLETED|Treatment Period 3||6
6772042|NCT04039919|7699740|FG004|COMPLETED|Treatment Period 3||0
6772043|NCT04039919|7699736|FG000|NOT COMPLETED|Treatment Period 3||0
6772044|NCT04039919|7699737|FG001|NOT COMPLETED|Treatment Period 3||0
6772045|NCT04039919|7699738|FG002|NOT COMPLETED|Treatment Period 3||0
6772046|NCT04039919|7699739|FG003|NOT COMPLETED|Treatment Period 3||0
6772047|NCT04039919|7699740|FG004|NOT COMPLETED|Treatment Period 3||0
6772048|NCT04039919|7699736|FG000|STARTED|Treatment Period 4||6
6772049|NCT04039919|7699737|FG001|STARTED|Treatment Period 4||6
6772050|NCT04039919|7699738|FG002|STARTED|Treatment Period 4||5
6772051|NCT04039919|7699739|FG003|STARTED|Treatment Period 4||6
6772052|NCT04039919|7699740|FG004|STARTED|Treatment Period 4||0
6772053|NCT04039919|7699736|FG000|COMPLETED|Treatment Period 4||6
6772054|NCT04039919|7699737|FG001|COMPLETED|Treatment Period 4||6
6772055|NCT04039919|7699738|FG002|COMPLETED|Treatment Period 4||5
6772056|NCT04039919|7699739|FG003|COMPLETED|Treatment Period 4||6
6772057|NCT04039919|7699740|FG004|COMPLETED|Treatment Period 4||0
6772058|NCT04039919|7699736|FG000|NOT COMPLETED|Treatment Period 4||0
6772059|NCT04039919|7699737|FG001|NOT COMPLETED|Treatment Period 4||0
6772060|NCT04039919|7699738|FG002|NOT COMPLETED|Treatment Period 4||0
6772061|NCT04039919|7699739|FG003|NOT COMPLETED|Treatment Period 4||0
6772062|NCT04039919|7699740|FG004|NOT COMPLETED|Treatment Period 4||0
6772063|NCT04039919|7699736|FG000|STARTED|Treatment Period 5||6
6772064|NCT04039919|7699737|FG001|STARTED|Treatment Period 5||6
6556716|NCT01763346|7479131|FG000|NOT COMPLETED|Overall Study||10
6556717|NCT01763346|7479132|FG001|NOT COMPLETED|Overall Study||8
6556718|NCT01763567|7479138|FG000|STARTED|Overall Study||19
6556719|NCT01763567|7479138|FG000|COMPLETED|Overall Study||19
6556720|NCT01763567|7479138|FG000|NOT COMPLETED|Overall Study||0
6772065|NCT04039919|7699738|FG002|STARTED|Treatment Period 5||5
6772066|NCT04039919|7699739|FG003|STARTED|Treatment Period 5||6
6772067|NCT04039919|7699740|FG004|STARTED|Treatment Period 5||0
6772068|NCT04039919|7699736|FG000|COMPLETED|Treatment Period 5||5
6772069|NCT04039919|7699737|FG001|COMPLETED|Treatment Period 5||6
6772070|NCT04039919|7699738|FG002|COMPLETED|Treatment Period 5||5
6772071|NCT04039919|7699739|FG003|COMPLETED|Treatment Period 5||6
6772072|NCT04039919|7699740|FG004|COMPLETED|Treatment Period 5||0
6772073|NCT04039919|7699736|FG000|NOT COMPLETED|Treatment Period 5||1
6772074|NCT04039919|7699737|FG001|NOT COMPLETED|Treatment Period 5||0
6772075|NCT04039919|7699738|FG002|NOT COMPLETED|Treatment Period 5||0
6772076|NCT04039919|7699739|FG003|NOT COMPLETED|Treatment Period 5||0
6772077|NCT04039919|7699740|FG004|NOT COMPLETED|Treatment Period 5||0
6772078|NCT04039919|7699736|FG000|STARTED|Treatment Period 6||5
6772079|NCT04039919|7699737|FG001|STARTED|Treatment Period 6||6
6772080|NCT04039919|7699738|FG002|STARTED|Treatment Period 6||5
6772081|NCT04039919|7699739|FG003|STARTED|Treatment Period 6||6
6772082|NCT04039919|7699740|FG004|STARTED|Treatment Period 6||0
6772083|NCT04039919|7699736|FG000|COMPLETED|Treatment Period 6||5
6772084|NCT04039919|7699737|FG001|COMPLETED|Treatment Period 6||6
6772085|NCT04039919|7699738|FG002|COMPLETED|Treatment Period 6||5
6772086|NCT04039919|7699739|FG003|COMPLETED|Treatment Period 6||6
6772087|NCT04039919|7699740|FG004|COMPLETED|Treatment Period 6||0
6772088|NCT04039919|7699736|FG000|NOT COMPLETED|Treatment Period 6||0
6772089|NCT04039919|7699737|FG001|NOT COMPLETED|Treatment Period 6||0
6772090|NCT04039919|7699738|FG002|NOT COMPLETED|Treatment Period 6||0
6772091|NCT04039919|7699739|FG003|NOT COMPLETED|Treatment Period 6||0
6772092|NCT04039919|7699740|FG004|NOT COMPLETED|Treatment Period 6||0
6772093|NCT04037969|7699776|FG000|STARTED|Overall Study||10
6772094|NCT04037969|7699777|FG001|STARTED|Overall Study||10
6772095|NCT04037969|7699776|FG000|COMPLETED|Overall Study||10
6556721|NCT01763606|7479144|FG000|STARTED|Overall Study||10
6556722|NCT01763606|7479145|FG001|STARTED|Overall Study||10
6772096|NCT04037969|7699777|FG001|COMPLETED|Overall Study||10
6772097|NCT04037969|7699776|FG000|NOT COMPLETED|Overall Study||0
6772098|NCT04037969|7699777|FG001|NOT COMPLETED|Overall Study||0
6772099|NCT04037865|7699782|FG000|STARTED|Overall Study||8
6772100|NCT04037865|7699782|FG000|COMPLETED|Overall Study||8
6772101|NCT04037865|7699782|FG000|NOT COMPLETED|Overall Study||0
6772102|NCT04037748|7699789|FG000|STARTED|Treatment Period 1||36
6772103|NCT04037748|7699790|FG001|STARTED|Treatment Period 1||36
6556723|NCT01763606|7479144|FG000|COMPLETED|Overall Study||10
6556724|NCT01763606|7479145|FG001|COMPLETED|Overall Study||10
6772104|NCT04037748|7699789|FG000|COMPLETED|Treatment Period 1||28
6772105|NCT04037748|7699790|FG001|COMPLETED|Treatment Period 1||30
6772106|NCT04037748|7699789|FG000|NOT COMPLETED|Treatment Period 1||8
6772107|NCT04037748|7699790|FG001|NOT COMPLETED|Treatment Period 1||6
6772108|NCT04037748|7699789|FG000|STARTED|Treatment Period 2||28
6772109|NCT04037748|7699790|FG001|STARTED|Treatment Period 2||30
6772110|NCT04037748|7699789|FG000|COMPLETED|Treatment Period 2||26
6772111|NCT04037748|7699790|FG001|COMPLETED|Treatment Period 2||29
6772112|NCT04037748|7699789|FG000|NOT COMPLETED|Treatment Period 2||2
6772113|NCT04037748|7699790|FG001|NOT COMPLETED|Treatment Period 2||1
6772114|NCT04036838|7699796|FG000|STARTED|Overall Study||415
6772115|NCT04036838|7699796|FG000|COMPLETED|Overall Study||324
6772116|NCT04036838|7699796|FG000|NOT COMPLETED|Overall Study||91
6772117|NCT04034121|7699800|FG000|STARTED|European Cohort|The European Cohort enrolled 30 patients|30
6772118|NCT04034121|7699800|FG000|COMPLETED|European Cohort||30
6772119|NCT04034121|7699800|FG000|NOT COMPLETED|European Cohort||0
6772120|NCT04034121|7699800|FG000|STARTED|Brazil Cohort|The Brazil Cohort enrolled 20 patients|20
6772121|NCT04034121|7699800|FG000|COMPLETED|Brazil Cohort||20
6772122|NCT04034121|7699800|FG000|NOT COMPLETED|Brazil Cohort||0
6772123|NCT04027686|7699807|FG000|STARTED|Overall Study||17
6772124|NCT04027686|7699808|FG001|STARTED|Overall Study||6
6498193|NCT01408719|7416831|FG005|COMPLETED|Washout Period (28 Days)||3
6498194|NCT01408719|7416832|FG006|COMPLETED|Washout Period (28 Days)||2
6498195|NCT01408719|7416833|FG007|COMPLETED|Washout Period (28 Days)||2
6498196|NCT01408719|7416834|FG008|COMPLETED|Washout Period (28 Days)||1
6498197|NCT01408719|7416835|FG009|COMPLETED|Washout Period (28 Days)||1
6498198|NCT01408719|7416836|FG010|COMPLETED|Washout Period (28 Days)||2
6498199|NCT01408719|7416837|FG011|COMPLETED|Washout Period (28 Days)||2
6498200|NCT01408719|7416838|FG012|COMPLETED|Washout Period (28 Days)||1
6498201|NCT01408719|7416839|FG013|COMPLETED|Washout Period (28 Days)||3
6498202|NCT01408719|7416840|FG014|COMPLETED|Washout Period (28 Days)||1
6498203|NCT01408719|7416841|FG015|COMPLETED|Washout Period (28 Days)||1
6498204|NCT01408719|7416842|FG016|COMPLETED|Washout Period (28 Days)||2
6772125|NCT04027686|7699807|FG000|COMPLETED|Overall Study||15
6772126|NCT04027686|7699808|FG001|COMPLETED|Overall Study||5
6772127|NCT04027686|7699807|FG000|NOT COMPLETED|Overall Study||2
6772128|NCT04027686|7699808|FG001|NOT COMPLETED|Overall Study||1
6772129|NCT04022694|7699820|FG000|STARTED|Overall Study||167
6772130|NCT04022694|7699821|FG001|STARTED|Overall Study||145
6772131|NCT04022694|7699822|FG002|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|143
6772132|NCT04022694|7699823|FG003|STARTED|Overall Study|This was a cross-sectional study, so participants at baseline -- were not the same as exposure.|173
6772133|NCT04022694|7699820|FG000|COMPLETED|Overall Study||167
6772134|NCT04022694|7699821|FG001|COMPLETED|Overall Study||145
6772135|NCT04022694|7699822|FG002|COMPLETED|Overall Study||143
6772136|NCT04022694|7699823|FG003|COMPLETED|Overall Study||173
6498205|NCT01408719|7416843|FG017|COMPLETED|Washout Period (28 Days)||2
6498206|NCT01408719|7416844|FG018|COMPLETED|Washout Period (28 Days)||0
6498207|NCT01408719|7416845|FG019|COMPLETED|Washout Period (28 Days)||1
6498208|NCT01408719|7416826|FG000|NOT COMPLETED|Washout Period (28 Days)||0
6498209|NCT01408719|7416827|FG001|NOT COMPLETED|Washout Period (28 Days)||0
6498210|NCT01408719|7416828|FG002|NOT COMPLETED|Washout Period (28 Days)||0
6498211|NCT01408719|7416829|FG003|NOT COMPLETED|Washout Period (28 Days)||0
6654850|NCT02448706|7584803|FG000|Completed Baseline Testing|Overall Study||24
6654851|NCT02448706|7584804|FG001|Completed Baseline Testing|Overall Study||23
6498212|NCT01408719|7416830|FG004|NOT COMPLETED|Washout Period (28 Days)||0
6498213|NCT01408719|7416831|FG005|NOT COMPLETED|Washout Period (28 Days)||0
6654852|NCT02448706|7584803|FG000|COMPLETED|Overall Study||20
6654853|NCT02448706|7584804|FG001|COMPLETED|Overall Study||20
6654854|NCT02448706|7584803|FG000|NOT COMPLETED|Overall Study||5
6654855|NCT02448706|7584804|FG001|NOT COMPLETED|Overall Study||4
6654856|NCT02448719|7584823|FG000|STARTED|Overall Study||12
6654857|NCT02448719|7584824|FG001|STARTED|Overall Study||6
6654858|NCT02448719|7584825|FG002|STARTED|Overall Study||6
6654859|NCT02448719|7584826|FG003|STARTED|Overall Study||6
6654860|NCT02448719|7584827|FG004|STARTED|Overall Study||6
6654861|NCT02448719|7584828|FG005|STARTED|Overall Study||6
6654862|NCT02448719|7584829|FG006|STARTED|Overall Study||6
6654863|NCT02448719|7584830|FG007|STARTED|Overall Study||6
6654864|NCT02448719|7584831|FG008|STARTED|Overall Study||6
6654865|NCT02448719|7584832|FG009|STARTED|Overall Study||6
6654866|NCT02448719|7584833|FG010|STARTED|Overall Study||6
6654867|NCT02448719|7584823|FG000|COMPLETED|Overall Study||12
6654868|NCT02448719|7584824|FG001|COMPLETED|Overall Study||6
6654869|NCT02448719|7584825|FG002|COMPLETED|Overall Study||6
6654870|NCT02448719|7584826|FG003|COMPLETED|Overall Study||6
6654871|NCT02448719|7584827|FG004|COMPLETED|Overall Study||5
6654872|NCT02448719|7584828|FG005|COMPLETED|Overall Study||6
6654873|NCT02448719|7584829|FG006|COMPLETED|Overall Study||6
6654874|NCT02448719|7584830|FG007|COMPLETED|Overall Study||6
6654875|NCT02448719|7584831|FG008|COMPLETED|Overall Study||6
6654876|NCT02448719|7584832|FG009|COMPLETED|Overall Study||6
6654877|NCT02448719|7584833|FG010|COMPLETED|Overall Study||6
6654878|NCT02448719|7584823|FG000|NOT COMPLETED|Overall Study||0
6654879|NCT02448719|7584824|FG001|NOT COMPLETED|Overall Study||0
6654880|NCT02448719|7584825|FG002|NOT COMPLETED|Overall Study||0
6654881|NCT02448719|7584826|FG003|NOT COMPLETED|Overall Study||0
6654882|NCT02448719|7584827|FG004|NOT COMPLETED|Overall Study||1
6654883|NCT02448719|7584828|FG005|NOT COMPLETED|Overall Study||0
6654884|NCT02448719|7584829|FG006|NOT COMPLETED|Overall Study||0
6654885|NCT02448719|7584830|FG007|NOT COMPLETED|Overall Study||0
6498214|NCT01408719|7416832|FG006|NOT COMPLETED|Washout Period (28 Days)||0
6498215|NCT01408719|7416833|FG007|NOT COMPLETED|Washout Period (28 Days)||0
6498216|NCT01408719|7416834|FG008|NOT COMPLETED|Washout Period (28 Days)||0
6772137|NCT04022694|7699820|FG000|NOT COMPLETED|Overall Study||0
6772138|NCT04022694|7699821|FG001|NOT COMPLETED|Overall Study||0
6772139|NCT04022694|7699822|FG002|NOT COMPLETED|Overall Study||0
6772140|NCT04022694|7699823|FG003|NOT COMPLETED|Overall Study||0
6772141|NCT04036110|7699838|FG000|STARTED|Overall Study||12
6772142|NCT04036110|7699839|FG001|STARTED|Overall Study||12
6772143|NCT04036110|7699840|FG002|STARTED|Overall Study||12
6772144|NCT04036110|7699838|FG000|COMPLETED|Overall Study||5
6772145|NCT04036110|7699839|FG001|COMPLETED|Overall Study||5
6772146|NCT04036110|7699840|FG002|COMPLETED|Overall Study||10
6772147|NCT04036110|7699838|FG000|NOT COMPLETED|Overall Study||7
6772148|NCT04036110|7699839|FG001|NOT COMPLETED|Overall Study||7
6772149|NCT04036110|7699840|FG002|NOT COMPLETED|Overall Study||2
6772150|NCT04035694|7699850|FG000|STARTED|Overall Study||374
6772151|NCT04035694|7699851|FG001|STARTED|Overall Study||216
6772152|NCT04035694|7699850|FG000|COMPLETED|Overall Study||374
6772153|NCT04035694|7699851|FG001|COMPLETED|Overall Study||216
6772154|NCT04035694|7699850|FG000|NOT COMPLETED|Overall Study||0
6772155|NCT04035694|7699851|FG001|NOT COMPLETED|Overall Study||0
6772156|NCT04035577|7699857|FG000|STARTED|Overall Study|One participant withdrew after signing the consent but before initiating any study activities.|21
6772157|NCT04035577|7699857|FG000|COMPLETED|Overall Study||19
6772158|NCT04035577|7699857|FG000|NOT COMPLETED|Overall Study||2
6772159|NCT04035564|7699865|FG000|STARTED|Overall Study||27
6772160|NCT04035564|7699866|FG001|STARTED|Overall Study||25
6772161|NCT04035564|7699865|FG000|COMPLETED|Overall Study||23
6772162|NCT04035564|7699866|FG001|COMPLETED|Overall Study||19
6772163|NCT04035564|7699865|FG000|NOT COMPLETED|Overall Study||4
6772164|NCT04035564|7699866|FG001|NOT COMPLETED|Overall Study||6
6772165|NCT04032977|7699874|FG000|STARTED|Overall Study||80
6772166|NCT04032977|7699875|FG001|STARTED|Overall Study||78
6772167|NCT04032977|7699874|FG000|COMPLETED|Overall Study||71
6772168|NCT04032977|7699875|FG001|COMPLETED|Overall Study||70
6772169|NCT04032977|7699874|FG000|NOT COMPLETED|Overall Study||9
6772170|NCT04032977|7699875|FG001|NOT COMPLETED|Overall Study||8
6772171|NCT04032652|7699883|FG000|STARTED|Overall Study||1
6772172|NCT04032652|7699884|FG001|STARTED|Overall Study||1
6772173|NCT04032652|7699883|FG000|COMPLETED|Overall Study||0
6772174|NCT04032652|7699884|FG001|COMPLETED|Overall Study||0
6772175|NCT04032652|7699883|FG000|NOT COMPLETED|Overall Study||1
6772176|NCT04032652|7699884|FG001|NOT COMPLETED|Overall Study||1
6772177|NCT04024501|7699890|FG000|STARTED|Overall Study||25
6772178|NCT04024501|7699890|FG000|COMPLETED|Overall Study||25
6772179|NCT04024501|7699890|FG000|NOT COMPLETED|Overall Study||0
6772180|NCT04032613|7699904|FG000|STARTED|Overall Study||21
6772181|NCT04032613|7699905|FG001|STARTED|Overall Study||25
6772182|NCT04032613|7699904|FG000|COMPLETED|Overall Study||16
6772183|NCT04032613|7699905|FG001|COMPLETED|Overall Study||23
6772184|NCT04032613|7699904|FG000|NOT COMPLETED|Overall Study||5
6772185|NCT04032613|7699905|FG001|NOT COMPLETED|Overall Study||2
6772186|NCT04032171|7699913|FG000|STARTED|Overall Study||1
6772187|NCT04032171|7699914|FG001|STARTED|Overall Study||0
6556725|NCT01763606|7479144|FG000|NOT COMPLETED|Overall Study||0
6556726|NCT01763606|7479145|FG001|NOT COMPLETED|Overall Study||0
6772188|NCT04032171|7699913|FG000|COMPLETED|Overall Study||0
6772189|NCT04032171|7699914|FG001|COMPLETED|Overall Study||0
6772190|NCT04032171|7699913|FG000|NOT COMPLETED|Overall Study||1
6772191|NCT04032171|7699914|FG001|NOT COMPLETED|Overall Study||0
6498217|NCT01408719|7416835|FG009|NOT COMPLETED|Washout Period (28 Days)||0
6498218|NCT01408719|7416836|FG010|NOT COMPLETED|Washout Period (28 Days)||0
6498219|NCT01408719|7416837|FG011|NOT COMPLETED|Washout Period (28 Days)||0
6498220|NCT01408719|7416838|FG012|NOT COMPLETED|Washout Period (28 Days)||0
6498221|NCT01408719|7416839|FG013|NOT COMPLETED|Washout Period (28 Days)||0
6498222|NCT01408719|7416840|FG014|NOT COMPLETED|Washout Period (28 Days)||0
6498223|NCT01408719|7416841|FG015|NOT COMPLETED|Washout Period (28 Days)||0
6654886|NCT02448719|7584831|FG008|NOT COMPLETED|Overall Study||0
6654887|NCT02448719|7584832|FG009|NOT COMPLETED|Overall Study||0
6654888|NCT02448719|7584833|FG010|NOT COMPLETED|Overall Study||0
6654889|NCT02448771|7584894|FG000|STARTED|Overall Study||36
6654890|NCT02448771|7584894|FG000|COMPLETED|Overall Study||0
6654891|NCT02448771|7584894|FG000|NOT COMPLETED|Overall Study||36
6654892|NCT02448810|7584907|FG000|STARTED|Overall Study||3
6654893|NCT02448810|7584908|FG001|STARTED|Overall Study||3
6654894|NCT02448810|7584909|FG002|STARTED|Overall Study||3
6654895|NCT02448810|7584910|FG003|STARTED|Overall Study||3
6654896|NCT02448810|7584911|FG004|STARTED|Overall Study||31
6654897|NCT02448810|7584912|FG005|STARTED|Overall Study||16
6654898|NCT02448810|7584913|FG006|STARTED|Overall Study||18
6654899|NCT02448810|7584914|FG007|STARTED|Overall Study||8
6654900|NCT02448810|7584907|FG000|Treated|Overall Study||3
6654901|NCT02448810|7584908|FG001|Treated|Overall Study||3
6654902|NCT02448810|7584909|FG002|Treated|Overall Study||3
6654903|NCT02448810|7584910|FG003|Treated|Overall Study||3
6772192|NCT04032158|7699922|FG000|STARTED|Overall Study||2
6772193|NCT04032158|7699923|FG001|STARTED|Overall Study||1
6772194|NCT04032158|7699922|FG000|COMPLETED|Overall Study||0
6772195|NCT04032158|7699923|FG001|COMPLETED|Overall Study||0
6772196|NCT04032158|7699922|FG000|NOT COMPLETED|Overall Study||2
6772197|NCT04032158|7699923|FG001|NOT COMPLETED|Overall Study||1
6772198|NCT04031404|7699929|FG000|STARTED|Baseline||10
6772199|NCT04031404|7699930|FG001|STARTED|Baseline||13
6772200|NCT04031404|7699929|FG000|COMPLETED|Baseline||8
6772201|NCT04031404|7699930|FG001|COMPLETED|Baseline||8
6772202|NCT04031404|7699929|FG000|NOT COMPLETED|Baseline||2
6772203|NCT04031404|7699930|FG001|NOT COMPLETED|Baseline||5
6772204|NCT04031404|7699929|FG000|STARTED|Pre-randomization||8
6772205|NCT04031404|7699930|FG001|STARTED|Pre-randomization||8
6772206|NCT04031404|7699929|FG000|COMPLETED|Pre-randomization||6
6772207|NCT04031404|7699930|FG001|COMPLETED|Pre-randomization||5
6772208|NCT04031404|7699929|FG000|NOT COMPLETED|Pre-randomization||2
6772209|NCT04031404|7699930|FG001|NOT COMPLETED|Pre-randomization||3
6772210|NCT04031404|7699929|FG000|STARTED|First Drink Visit||6
6772211|NCT04031404|7699930|FG001|STARTED|First Drink Visit||5
6772212|NCT04031404|7699929|FG000|COMPLETED|First Drink Visit||6
6772213|NCT04031404|7699930|FG001|COMPLETED|First Drink Visit||5
6772214|NCT04031404|7699929|FG000|NOT COMPLETED|First Drink Visit||0
6772215|NCT04031404|7699930|FG001|NOT COMPLETED|First Drink Visit||0
6772216|NCT04031404|7699929|FG000|STARTED|Washout (5 Day Min)||6
6772217|NCT04031404|7699930|FG001|STARTED|Washout (5 Day Min)||5
6772218|NCT04031404|7699929|FG000|COMPLETED|Washout (5 Day Min)||5
6772219|NCT04031404|7699930|FG001|COMPLETED|Washout (5 Day Min)||5
6772220|NCT04031404|7699929|FG000|NOT COMPLETED|Washout (5 Day Min)||1
6772221|NCT04031404|7699930|FG001|NOT COMPLETED|Washout (5 Day Min)||0
6772222|NCT04031404|7699929|FG000|STARTED|Second Drink Visit||5
6772223|NCT04031404|7699930|FG001|STARTED|Second Drink Visit||5
6772224|NCT04031404|7699929|FG000|COMPLETED|Second Drink Visit||5
6772225|NCT04031404|7699930|FG001|COMPLETED|Second Drink Visit||5
6772226|NCT04031404|7699929|FG000|NOT COMPLETED|Second Drink Visit||0
6772227|NCT04031404|7699930|FG001|NOT COMPLETED|Second Drink Visit||0
6772228|NCT04031885|7699946|FG000|STARTED|Overall Study||1
6772229|NCT04031885|7699947|FG001|STARTED|Overall Study||3
6772230|NCT04031885|7699946|FG000|Received Any Quantity of Study Treatment|Overall Study||1
6772231|NCT04031885|7699947|FG001|Received Any Quantity of Study Treatment|Overall Study||1
6772232|NCT04031885|7699946|FG000|COMPLETED|Overall Study||1
6772233|NCT04031885|7699947|FG001|COMPLETED|Overall Study||3
6772234|NCT04031885|7699946|FG000|NOT COMPLETED|Overall Study||0
6772235|NCT04031885|7699947|FG001|NOT COMPLETED|Overall Study||0
6772236|NCT04018924|7699953|FG000|STARTED|Overall Study|The total number of participants is 90 and the patient is control of themselves.|90
6772237|NCT04018924|7699953|FG000|Standard Of Care Intervention|Overall Study||90
6772238|NCT04018924|7699953|FG000|EmoLED Intervention|Overall Study||90
6772239|NCT04018924|7699953|FG000|COMPLETED|Overall Study||84
6772240|NCT04018924|7699953|FG000|NOT COMPLETED|Overall Study||6
6772241|NCT04015440|7699959|FG000|STARTED|Overall Study||117
6772242|NCT04015440|7699960|FG001|STARTED|Overall Study||112
6772243|NCT04015440|7699959|FG000|COMPLETED|Overall Study||109
6772244|NCT04015440|7699960|FG001|COMPLETED|Overall Study||108
6772245|NCT04015440|7699959|FG000|NOT COMPLETED|Overall Study||8
6772246|NCT04015440|7699960|FG001|NOT COMPLETED|Overall Study||4
6772247|NCT04030104|7699966|FG000|STARTED|Overall Study||480
6772248|NCT04030104|7699966|FG000|COMPLETED|Overall Study||480
6772249|NCT04030104|7699966|FG000|NOT COMPLETED|Overall Study||0
6772250|NCT04029961|7699975|FG000|STARTED|Overall Study||13
6772251|NCT04029961|7699976|FG001|STARTED|Overall Study||13
6772252|NCT04029961|7699975|FG000|COMPLETED|Overall Study||12
6772253|NCT04029961|7699976|FG001|COMPLETED|Overall Study||12
6772254|NCT04029961|7699975|FG000|NOT COMPLETED|Overall Study||1
6772255|NCT04029961|7699976|FG001|NOT COMPLETED|Overall Study||1
6772256|NCT04025684|7699986|FG000|STARTED|Overall Study||20
6772257|NCT04025684|7699987|FG001|STARTED|Overall Study||19
6772258|NCT04025684|7699988|FG002|STARTED|Overall Study||20
6772259|NCT04025684|7699989|FG003|STARTED|Overall Study||21
6772260|NCT04025684|7699986|FG000|COMPLETED|Overall Study||18
6772261|NCT04025684|7699987|FG001|COMPLETED|Overall Study||15
6772262|NCT04025684|7699988|FG002|COMPLETED|Overall Study||20
6772263|NCT04025684|7699989|FG003|COMPLETED|Overall Study||20
6772264|NCT04025684|7699986|FG000|NOT COMPLETED|Overall Study||2
6772265|NCT04025684|7699987|FG001|NOT COMPLETED|Overall Study||4
6772266|NCT04025684|7699988|FG002|NOT COMPLETED|Overall Study||0
6772267|NCT04025684|7699989|FG003|NOT COMPLETED|Overall Study||1
6772268|NCT04019054|7700001|FG000|STARTED|Overall Study||11
6772269|NCT04019054|7700002|FG001|STARTED|Overall Study||11
6772270|NCT04019054|7700001|FG000|COMPLETED|Overall Study||8
6772271|NCT04019054|7700002|FG001|COMPLETED|Overall Study||9
6772272|NCT04019054|7700001|FG000|NOT COMPLETED|Overall Study||3
6772273|NCT04019054|7700002|FG001|NOT COMPLETED|Overall Study||2
6772274|NCT04029545|7700011|FG000|STARTED|Overall Study||2
6772275|NCT04029545|7700012|FG001|STARTED|Overall Study||1
6772276|NCT04029545|7700013|FG002|STARTED|Overall Study||2
6772277|NCT04029545|7700011|FG000|COMPLETED|Overall Study||2
6772278|NCT04029545|7700012|FG001|COMPLETED|Overall Study||1
6772279|NCT04029545|7700013|FG002|COMPLETED|Overall Study||2
6772280|NCT04029545|7700011|FG000|NOT COMPLETED|Overall Study||0
6772281|NCT04029545|7700012|FG001|NOT COMPLETED|Overall Study||0
6772282|NCT04029545|7700013|FG002|NOT COMPLETED|Overall Study||0
6772283|NCT04029584|7700021|FG000|STARTED|Uninduced Study 1st Intervention (1 Day)||4
6772284|NCT04029584|7700022|FG001|STARTED|Uninduced Study 1st Intervention (1 Day)||6
6772285|NCT04029584|7700021|FG000|COMPLETED|Uninduced Study 1st Intervention (1 Day)||4
6772286|NCT04029584|7700022|FG001|COMPLETED|Uninduced Study 1st Intervention (1 Day)||6
6772287|NCT04029584|7700021|FG000|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
6772288|NCT04029584|7700022|FG001|NOT COMPLETED|Uninduced Study 1st Intervention (1 Day)||0
6772289|NCT04029584|7700021|FG000|STARTED|Uninduced Washout (1 Day)||4
6772290|NCT04029584|7700022|FG001|STARTED|Uninduced Washout (1 Day)||6
6772291|NCT04029584|7700021|FG000|COMPLETED|Uninduced Washout (1 Day)||4
6772292|NCT04029584|7700022|FG001|COMPLETED|Uninduced Washout (1 Day)||6
6772293|NCT04029584|7700021|FG000|NOT COMPLETED|Uninduced Washout (1 Day)||0
6772294|NCT04029584|7700022|FG001|NOT COMPLETED|Uninduced Washout (1 Day)||0
6772295|NCT04029584|7700021|FG000|STARTED|Uninduced Study 2nd Intervention (1 Day)||4
6772296|NCT04029584|7700022|FG001|STARTED|Uninduced Study 2nd Intervention (1 Day)||6
6772297|NCT04029584|7700021|FG000|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||4
6772298|NCT04029584|7700022|FG001|COMPLETED|Uninduced Study 2nd Intervention (1 Day)||6
6772299|NCT04029584|7700021|FG000|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
6772300|NCT04029584|7700022|FG001|NOT COMPLETED|Uninduced Study 2nd Intervention (1 Day)||0
6772301|NCT04029584|7700021|FG000|STARTED|Washout Between (>1 Week)||4
6772302|NCT04029584|7700022|FG001|STARTED|Washout Between (>1 Week)||6
6498224|NCT01408719|7416842|FG016|NOT COMPLETED|Washout Period (28 Days)||0
6498225|NCT01408719|7416843|FG017|NOT COMPLETED|Washout Period (28 Days)||0
6498226|NCT01408719|7416844|FG018|NOT COMPLETED|Washout Period (28 Days)||0
6498227|NCT01408719|7416845|FG019|NOT COMPLETED|Washout Period (28 Days)||0
6498228|NCT01408719|7416826|FG000|STARTED|Fourth Intervention (35 Days)||2
6498229|NCT01408719|7416827|FG001|STARTED|Fourth Intervention (35 Days)||3
6498230|NCT01408719|7416828|FG002|STARTED|Fourth Intervention (35 Days)||1
6498231|NCT01408719|7416829|FG003|STARTED|Fourth Intervention (35 Days)||2
6498232|NCT01408719|7416830|FG004|STARTED|Fourth Intervention (35 Days)||3
6498233|NCT01408719|7416831|FG005|STARTED|Fourth Intervention (35 Days)||3
6498234|NCT01408719|7416832|FG006|STARTED|Fourth Intervention (35 Days)||2
6772303|NCT04029584|7700021|FG000|COMPLETED|Washout Between (>1 Week)||4
6772304|NCT04029584|7700022|FG001|COMPLETED|Washout Between (>1 Week)||6
6772305|NCT04029584|7700021|FG000|NOT COMPLETED|Washout Between (>1 Week)||0
6772306|NCT04029584|7700022|FG001|NOT COMPLETED|Washout Between (>1 Week)||0
6772307|NCT04029584|7700021|FG000|STARTED|Induced Study 1st Intervention (1 Day)||2
6772308|NCT04029584|7700022|FG001|STARTED|Induced Study 1st Intervention (1 Day)||8
6772309|NCT04029584|7700021|FG000|COMPLETED|Induced Study 1st Intervention (1 Day)||2
6772310|NCT04029584|7700022|FG001|COMPLETED|Induced Study 1st Intervention (1 Day)||8
6772311|NCT04029584|7700021|FG000|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
6772312|NCT04029584|7700022|FG001|NOT COMPLETED|Induced Study 1st Intervention (1 Day)||0
6772313|NCT04029584|7700021|FG000|STARTED|Induced Washout (1 Day)||2
6772314|NCT04029584|7700022|FG001|STARTED|Induced Washout (1 Day)||8
6772315|NCT04029584|7700021|FG000|COMPLETED|Induced Washout (1 Day)||2
6772316|NCT04029584|7700022|FG001|COMPLETED|Induced Washout (1 Day)||8
6772317|NCT04029584|7700021|FG000|NOT COMPLETED|Induced Washout (1 Day)||0
6772318|NCT04029584|7700022|FG001|NOT COMPLETED|Induced Washout (1 Day)||0
6772319|NCT04029584|7700021|FG000|STARTED|Induced Study 2nd Intervention (1 Day)||2
6772320|NCT04029584|7700022|FG001|STARTED|Induced Study 2nd Intervention (1 Day)||8
6772321|NCT04029584|7700021|FG000|COMPLETED|Induced Study 2nd Intervention (1 Day)||2
6772322|NCT04029584|7700022|FG001|COMPLETED|Induced Study 2nd Intervention (1 Day)||8
6772323|NCT04029584|7700021|FG000|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
6772324|NCT04029584|7700022|FG001|NOT COMPLETED|Induced Study 2nd Intervention (1 Day)||0
6772325|NCT04029311|7700034|FG000|STARTED|Overall Study||15
6772326|NCT04029311|7700035|FG001|STARTED|Overall Study||13
6772327|NCT04029311|7700034|FG000|COMPLETED|Overall Study||12
6772328|NCT04029311|7700035|FG001|COMPLETED|Overall Study||13
6772329|NCT04029311|7700034|FG000|NOT COMPLETED|Overall Study||3
6772330|NCT04029311|7700035|FG001|NOT COMPLETED|Overall Study||0
6772331|NCT04028960|7700043|FG000|STARTED|Overall Study||2
6772332|NCT04028960|7700044|FG001|STARTED|Overall Study||2
6772333|NCT04028960|7700043|FG000|COMPLETED|Overall Study||2
6772334|NCT04028960|7700044|FG001|COMPLETED|Overall Study||2
6772335|NCT04028960|7700043|FG000|NOT COMPLETED|Overall Study||0
6772336|NCT04028960|7700044|FG001|NOT COMPLETED|Overall Study||0
6772337|NCT04026399|7700052|FG000|STARTED|Overall Study||6
6772338|NCT04026399|7700053|FG001|STARTED|Overall Study||6
6772339|NCT04026399|7700052|FG000|COMPLETED|Overall Study||1
6772340|NCT04026399|7700053|FG001|COMPLETED|Overall Study||3
6772341|NCT04026399|7700052|FG000|NOT COMPLETED|Overall Study||5
6772342|NCT04026399|7700053|FG001|NOT COMPLETED|Overall Study||3
6772343|NCT04023578|7700059|FG000|STARTED|Overall Study||15
6772344|NCT04023578|7700059|FG000|COMPLETED|Overall Study||13
6772345|NCT04023578|7700059|FG000|NOT COMPLETED|Overall Study||2
6772346|NCT04023695|7700066|FG000|STARTED|Overall Study||57
6772347|NCT04023695|7700067|FG001|STARTED|Overall Study||53
6772348|NCT04023695|7700066|FG000|COMPLETED|Overall Study||57
6772349|NCT04023695|7700067|FG001|COMPLETED|Overall Study||53
6772350|NCT04023695|7700066|FG000|NOT COMPLETED|Overall Study||0
6772351|NCT04023695|7700067|FG001|NOT COMPLETED|Overall Study||0
6772352|NCT04018664|7700081|FG000|STARTED|Overall Study||14
6772353|NCT04018664|7700082|FG001|STARTED|Overall Study||6
6772354|NCT04018664|7700083|FG002|STARTED|Overall Study||6
6772355|NCT04018664|7700084|FG003|STARTED|Overall Study||6
6772356|NCT04018664|7700085|FG004|STARTED|Overall Study||6
6772357|NCT04018664|7700086|FG005|STARTED|Overall Study||6
6498235|NCT01408719|7416833|FG007|STARTED|Fourth Intervention (35 Days)||2
6498236|NCT01408719|7416834|FG008|STARTED|Fourth Intervention (35 Days)||1
6498237|NCT01408719|7416835|FG009|STARTED|Fourth Intervention (35 Days)||1
6498238|NCT01408719|7416836|FG010|STARTED|Fourth Intervention (35 Days)||2
6772358|NCT04018664|7700087|FG006|STARTED|Overall Study||6
6772359|NCT04018664|7700088|FG007|STARTED|Overall Study||6
6772360|NCT04018664|7700081|FG000|COMPLETED|Overall Study||14
6498239|NCT01408719|7416837|FG011|STARTED|Fourth Intervention (35 Days)||2
6498240|NCT01408719|7416838|FG012|STARTED|Fourth Intervention (35 Days)||1
6498241|NCT01408719|7416839|FG013|STARTED|Fourth Intervention (35 Days)||3
6498242|NCT01408719|7416840|FG014|STARTED|Fourth Intervention (35 Days)||1
6498243|NCT01408719|7416841|FG015|STARTED|Fourth Intervention (35 Days)||1
6498244|NCT01408719|7416842|FG016|STARTED|Fourth Intervention (35 Days)||2
6498245|NCT01408719|7416843|FG017|STARTED|Fourth Intervention (35 Days)||2
6498246|NCT01408719|7416844|FG018|STARTED|Fourth Intervention (35 Days)||0
6772361|NCT04018664|7700082|FG001|COMPLETED|Overall Study||6
6772362|NCT04018664|7700083|FG002|COMPLETED|Overall Study||6
6772363|NCT04018664|7700084|FG003|COMPLETED|Overall Study||6
6772364|NCT04018664|7700085|FG004|COMPLETED|Overall Study||6
6772365|NCT04018664|7700086|FG005|COMPLETED|Overall Study||6
6772366|NCT04018664|7700087|FG006|COMPLETED|Overall Study||6
6498247|NCT01408719|7416845|FG019|STARTED|Fourth Intervention (35 Days)||1
6498248|NCT01408719|7416826|FG000|COMPLETED|Fourth Intervention (35 Days)||2
6498249|NCT01408719|7416827|FG001|COMPLETED|Fourth Intervention (35 Days)||3
6498250|NCT01408719|7416828|FG002|COMPLETED|Fourth Intervention (35 Days)||1
6498251|NCT01408719|7416829|FG003|COMPLETED|Fourth Intervention (35 Days)||2
6498252|NCT01408719|7416830|FG004|COMPLETED|Fourth Intervention (35 Days)||3
6498253|NCT01408719|7416831|FG005|COMPLETED|Fourth Intervention (35 Days)||3
6498254|NCT01408719|7416832|FG006|COMPLETED|Fourth Intervention (35 Days)||2
6498255|NCT01408719|7416833|FG007|COMPLETED|Fourth Intervention (35 Days)||2
6498256|NCT01408719|7416834|FG008|COMPLETED|Fourth Intervention (35 Days)||1
6498257|NCT01408719|7416835|FG009|COMPLETED|Fourth Intervention (35 Days)||1
6498258|NCT01408719|7416836|FG010|COMPLETED|Fourth Intervention (35 Days)||2
6498259|NCT01408719|7416837|FG011|COMPLETED|Fourth Intervention (35 Days)||2
6498260|NCT01408719|7416838|FG012|COMPLETED|Fourth Intervention (35 Days)||1
6498261|NCT01408719|7416839|FG013|COMPLETED|Fourth Intervention (35 Days)||3
6498262|NCT01408719|7416840|FG014|COMPLETED|Fourth Intervention (35 Days)||1
6498263|NCT01408719|7416841|FG015|COMPLETED|Fourth Intervention (35 Days)||1
6498264|NCT01408719|7416842|FG016|COMPLETED|Fourth Intervention (35 Days)||2
6498265|NCT01408719|7416843|FG017|COMPLETED|Fourth Intervention (35 Days)||2
6498266|NCT01408719|7416844|FG018|COMPLETED|Fourth Intervention (35 Days)||0
6498267|NCT01408719|7416845|FG019|COMPLETED|Fourth Intervention (35 Days)||1
6556727|NCT01763645|7479154|FG000|STARTED|Overall Study||69
6556728|NCT01763645|7479155|FG001|STARTED|Overall Study||69
6556729|NCT01763645|7479154|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
6772367|NCT04018664|7700088|FG007|COMPLETED|Overall Study||6
6772368|NCT04018664|7700081|FG000|NOT COMPLETED|Overall Study||0
6772369|NCT04018664|7700082|FG001|NOT COMPLETED|Overall Study||0
6772370|NCT04018664|7700083|FG002|NOT COMPLETED|Overall Study||0
6772371|NCT04018664|7700084|FG003|NOT COMPLETED|Overall Study||0
6556730|NCT01763645|7479155|FG001|Received at Least 1 Dose of Study Drug|Overall Study||66
6772372|NCT04018664|7700085|FG004|NOT COMPLETED|Overall Study||0
6772373|NCT04018664|7700086|FG005|NOT COMPLETED|Overall Study||0
6772374|NCT04018664|7700087|FG006|NOT COMPLETED|Overall Study||0
6772375|NCT04018664|7700088|FG007|NOT COMPLETED|Overall Study||0
6772376|NCT04016259|7700108|FG000|STARTED|Overall Study||15
6772377|NCT04016259|7700109|FG001|STARTED|Overall Study||15
6772378|NCT04016259|7700108|FG000|COMPLETED|Overall Study||15
6772379|NCT04016259|7700109|FG001|COMPLETED|Overall Study||15
6772380|NCT04016259|7700108|FG000|NOT COMPLETED|Overall Study||0
6772381|NCT04016259|7700109|FG001|NOT COMPLETED|Overall Study||0
6772382|NCT04016077|7700117|FG000|STARTED|Overall Study||10
6772383|NCT04016077|7700118|FG001|STARTED|Overall Study||8
6772384|NCT04016077|7700117|FG000|COMPLETED|Overall Study||10
6772385|NCT04016077|7700118|FG001|COMPLETED|Overall Study||8
6772386|NCT04016077|7700117|FG000|NOT COMPLETED|Overall Study||0
6772387|NCT04016077|7700118|FG001|NOT COMPLETED|Overall Study||0
6772388|NCT04027803|7700126|FG000|STARTED|Overall Study||39
6772389|NCT04027803|7700127|FG001|STARTED|Overall Study||39
6772390|NCT04027803|7700126|FG000|COMPLETED|Overall Study||39
6772391|NCT04027803|7700127|FG001|COMPLETED|Overall Study||39
6772392|NCT04027803|7700126|FG000|NOT COMPLETED|Overall Study||0
6772393|NCT04027803|7700127|FG001|NOT COMPLETED|Overall Study||0
6772394|NCT04016311|7700135|FG000|STARTED|Overall Study||18
6772395|NCT04016311|7700136|FG001|STARTED|Overall Study||20
6772396|NCT04016311|7700135|FG000|COMPLETED|Overall Study||17
6772397|NCT04016311|7700136|FG001|COMPLETED|Overall Study||20
6772398|NCT04016311|7700135|FG000|NOT COMPLETED|Overall Study||1
6772399|NCT04016311|7700136|FG001|NOT COMPLETED|Overall Study||0
6772400|NCT04027439|7700150|FG000|STARTED|Part A (R, PC, PG) Single Dose||6
6772401|NCT04027439|7700151|FG001|STARTED|Part A (R, PC, PG) Single Dose||6
6772402|NCT04027439|7700152|FG002|STARTED|Part A (R, PC, PG) Single Dose||7
6772403|NCT04027439|7700153|FG003|STARTED|Part A (R, PC, PG) Single Dose||6
6772404|NCT04027439|7700154|FG004|STARTED|Part A (R, PC, PG) Single Dose||6
6772405|NCT04027439|7700155|FG005|STARTED|Part A (R, PC, PG) Single Dose||6
6772406|NCT04027439|7700156|FG006|STARTED|Part A (R, PC, PG) Single Dose||0
6772407|NCT04027439|7700157|FG007|STARTED|Part A (R, PC, PG) Single Dose||0
6772408|NCT04027439|7700158|FG008|STARTED|Part A (R, PC, PG) Single Dose||0
6772409|NCT04027439|7700159|FG009|STARTED|Part A (R, PC, PG) Single Dose||0
6772410|NCT04027439|7700160|FG010|STARTED|Part A (R, PC, PG) Single Dose||0
6772411|NCT04027439|7700161|FG011|STARTED|Part A (R, PC, PG) Single Dose||0
6772412|NCT04027439|7700162|FG012|STARTED|Part A (R, PC, PG) Single Dose||0
6772413|NCT04027439|7700163|FG013|STARTED|Part A (R, PC, PG) Single Dose||0
6772414|NCT04027439|7700164|FG014|STARTED|Part A (R, PC, PG) Single Dose||0
6772415|NCT04027439|7700165|FG015|STARTED|Part A (R, PC, PG) Single Dose||0
6772416|NCT04027439|7700150|FG000|COMPLETED|Part A (R, PC, PG) Single Dose||6
6772417|NCT04027439|7700151|FG001|COMPLETED|Part A (R, PC, PG) Single Dose||6
6772418|NCT04027439|7700152|FG002|COMPLETED|Part A (R, PC, PG) Single Dose||7
6772419|NCT04027439|7700153|FG003|COMPLETED|Part A (R, PC, PG) Single Dose||6
6772420|NCT04027439|7700154|FG004|COMPLETED|Part A (R, PC, PG) Single Dose||6
6772421|NCT04027439|7700155|FG005|COMPLETED|Part A (R, PC, PG) Single Dose||6
6772422|NCT04027439|7700156|FG006|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772423|NCT04027439|7700157|FG007|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772424|NCT04027439|7700158|FG008|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772425|NCT04027439|7700159|FG009|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772426|NCT04027439|7700160|FG010|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772427|NCT04027439|7700161|FG011|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772428|NCT04027439|7700162|FG012|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772429|NCT04027439|7700163|FG013|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772430|NCT04027439|7700164|FG014|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772431|NCT04027439|7700165|FG015|COMPLETED|Part A (R, PC, PG) Single Dose||0
6772432|NCT04027439|7700150|FG000|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772433|NCT04027439|7700151|FG001|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772434|NCT04027439|7700152|FG002|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772435|NCT04027439|7700153|FG003|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772436|NCT04027439|7700154|FG004|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772437|NCT04027439|7700155|FG005|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772438|NCT04027439|7700156|FG006|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772439|NCT04027439|7700157|FG007|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772440|NCT04027439|7700158|FG008|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772441|NCT04027439|7700159|FG009|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772442|NCT04027439|7700160|FG010|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772443|NCT04027439|7700161|FG011|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772444|NCT04027439|7700162|FG012|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772445|NCT04027439|7700163|FG013|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772446|NCT04027439|7700164|FG014|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772447|NCT04027439|7700165|FG015|NOT COMPLETED|Part A (R, PC, PG) Single Dose||0
6772448|NCT04027439|7700150|FG000|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772449|NCT04027439|7700151|FG001|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772450|NCT04027439|7700152|FG002|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772451|NCT04027439|7700153|FG003|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772452|NCT04027439|7700154|FG004|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772453|NCT04027439|7700155|FG005|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772454|NCT04027439|7700156|FG006|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772455|NCT04027439|7700157|FG007|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772456|NCT04027439|7700158|FG008|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772457|NCT04027439|7700159|FG009|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772458|NCT04027439|7700160|FG010|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772459|NCT04027439|7700161|FG011|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772460|NCT04027439|7700162|FG012|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772461|NCT04027439|7700163|FG013|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772462|NCT04027439|7700164|FG014|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772463|NCT04027439|7700165|FG015|STARTED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772464|NCT04027439|7700150|FG000|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772465|NCT04027439|7700151|FG001|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772466|NCT04027439|7700152|FG002|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6498268|NCT01408719|7416826|FG000|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498269|NCT01408719|7416827|FG001|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498270|NCT01408719|7416828|FG002|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498271|NCT01408719|7416829|FG003|NOT COMPLETED|Fourth Intervention (35 Days)||0
6772467|NCT04027439|7700153|FG003|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772468|NCT04027439|7700154|FG004|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772469|NCT04027439|7700155|FG005|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6498272|NCT01408719|7416830|FG004|NOT COMPLETED|Fourth Intervention (35 Days)||0
6501985|NCT01432236|7420655|FG000|STARTED|Overall Study||96
6772470|NCT04027439|7700156|FG006|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772471|NCT04027439|7700157|FG007|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day|1 patient discontinued in part b/period 2 and another in part b/period 3.|1
6772472|NCT04027439|7700158|FG008|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772473|NCT04027439|7700159|FG009|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772474|NCT04027439|7700160|FG010|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772475|NCT04027439|7700161|FG011|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772476|NCT04027439|7700162|FG012|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772477|NCT04027439|7700163|FG013|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772478|NCT04027439|7700164|FG014|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||4
6772479|NCT04027439|7700165|FG015|COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||3
6772480|NCT04027439|7700150|FG000|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772481|NCT04027439|7700151|FG001|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772482|NCT04027439|7700152|FG002|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772483|NCT04027439|7700153|FG003|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6498273|NCT01408719|7416831|FG005|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498274|NCT01408719|7416832|FG006|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498275|NCT01408719|7416833|FG007|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498276|NCT01408719|7416834|FG008|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498277|NCT01408719|7416835|FG009|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498278|NCT01408719|7416836|FG010|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498279|NCT01408719|7416837|FG011|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498280|NCT01408719|7416838|FG012|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498281|NCT01408719|7416839|FG013|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498282|NCT01408719|7416840|FG014|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498283|NCT01408719|7416841|FG015|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498284|NCT01408719|7416842|FG016|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498285|NCT01408719|7416843|FG017|NOT COMPLETED|Fourth Intervention (35 Days)||0
6772484|NCT04027439|7700154|FG004|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772485|NCT04027439|7700155|FG005|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772486|NCT04027439|7700156|FG006|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772487|NCT04027439|7700157|FG007|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||2
6772488|NCT04027439|7700158|FG008|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772489|NCT04027439|7700159|FG009|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772490|NCT04027439|7700160|FG010|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772491|NCT04027439|7700161|FG011|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772492|NCT04027439|7700162|FG012|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772493|NCT04027439|7700163|FG013|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772494|NCT04027439|7700164|FG014|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772495|NCT04027439|7700165|FG015|NOT COMPLETED|Part B (R, PC, CO) Twice Daily for 7 Day||0
6772496|NCT04027218|7700195|FG000|STARTED|Overall Study||10
6772497|NCT04027218|7700196|FG001|STARTED|Overall Study||11
6772498|NCT04027218|7700197|FG002|STARTED|Overall Study||9
6772499|NCT04027218|7700198|FG003|STARTED|Overall Study||11
6772500|NCT04027218|7700199|FG004|STARTED|Overall Study||10
6772501|NCT04027218|7700200|FG005|STARTED|Overall Study||11
6772502|NCT04027218|7700195|FG000|COMPLETED|Overall Study||10
6772503|NCT04027218|7700196|FG001|COMPLETED|Overall Study||8
6772504|NCT04027218|7700197|FG002|COMPLETED|Overall Study||9
6772505|NCT04027218|7700198|FG003|COMPLETED|Overall Study||11
6772506|NCT04027218|7700199|FG004|COMPLETED|Overall Study||10
6772507|NCT04027218|7700200|FG005|COMPLETED|Overall Study||11
6772508|NCT04027218|7700195|FG000|NOT COMPLETED|Overall Study||0
6772509|NCT04027218|7700196|FG001|NOT COMPLETED|Overall Study||3
6772510|NCT04027218|7700197|FG002|NOT COMPLETED|Overall Study||0
6772511|NCT04027218|7700198|FG003|NOT COMPLETED|Overall Study||0
6772512|NCT04027218|7700199|FG004|NOT COMPLETED|Overall Study||0
6772513|NCT04027218|7700200|FG005|NOT COMPLETED|Overall Study||0
6772514|NCT04026750|7700212|FG000|STARTED|Overall Study||3
6772515|NCT04026750|7700213|FG001|STARTED|Overall Study||2
6772516|NCT04026750|7700212|FG000|COMPLETED|Overall Study||3
6772517|NCT04026750|7700213|FG001|COMPLETED|Overall Study||2
6772518|NCT04026750|7700212|FG000|NOT COMPLETED|Overall Study||0
6772519|NCT04026750|7700213|FG001|NOT COMPLETED|Overall Study||0
6772520|NCT04026308|7700222|FG000|STARTED|Overall Study||14
6772521|NCT04026308|7700223|FG001|STARTED|Overall Study||16
6772522|NCT04026308|7700222|FG000|COMPLETED|Overall Study||14
6772523|NCT04026308|7700223|FG001|COMPLETED|Overall Study||16
6772524|NCT04026308|7700222|FG000|NOT COMPLETED|Overall Study||0
6772525|NCT04026308|7700223|FG001|NOT COMPLETED|Overall Study||0
6772526|NCT04023682|7700229|FG000|STARTED|Overall Study||31
6772527|NCT04023682|7700229|FG000|COMPLETED|Overall Study||25
6772528|NCT04023682|7700229|FG000|NOT COMPLETED|Overall Study||6
6772529|NCT04021771|7700239|FG000|STARTED|Overall Study||55
6772530|NCT04021771|7700240|FG001|STARTED|Overall Study||54
6772531|NCT04021771|7700239|FG000|COMPLETED|Overall Study||55
6772532|NCT04021771|7700240|FG001|COMPLETED|Overall Study||54
6772533|NCT04021771|7700239|FG000|NOT COMPLETED|Overall Study||0
6772534|NCT04021771|7700240|FG001|NOT COMPLETED|Overall Study||0
6772535|NCT04019626|7700251|FG000|STARTED|Overall Study||42
6772536|NCT04019626|7700252|FG001|STARTED|Overall Study||42
6772537|NCT04019626|7700253|FG002|STARTED|Overall Study||45
6772538|NCT04019626|7700254|FG003|STARTED|Overall Study||46
6772539|NCT04019626|7700255|FG004|STARTED|Overall Study||44
6772540|NCT04019626|7700256|FG005|STARTED|Overall Study||21
6772541|NCT04019626|7700251|FG000|COMPLETED|Overall Study||36
6772542|NCT04019626|7700252|FG001|COMPLETED|Overall Study||32
6772543|NCT04019626|7700253|FG002|COMPLETED|Overall Study||37
6772544|NCT04019626|7700254|FG003|COMPLETED|Overall Study||39
6772545|NCT04019626|7700255|FG004|COMPLETED|Overall Study||38
6772546|NCT04019626|7700256|FG005|COMPLETED|Overall Study||20
6772547|NCT04019626|7700251|FG000|NOT COMPLETED|Overall Study||6
6772548|NCT04019626|7700252|FG001|NOT COMPLETED|Overall Study||10
6772549|NCT04019626|7700253|FG002|NOT COMPLETED|Overall Study||8
6772550|NCT04019626|7700254|FG003|NOT COMPLETED|Overall Study||7
6772551|NCT04019626|7700255|FG004|NOT COMPLETED|Overall Study||6
6772552|NCT04019626|7700256|FG005|NOT COMPLETED|Overall Study||1
6772553|NCT04023994|7700276|FG000|STARTED|Overall Study||10
6772554|NCT04023994|7700277|FG001|STARTED|Overall Study||4
6772555|NCT04023994|7700278|FG002|STARTED|Overall Study||4
6772556|NCT04023994|7700279|FG003|STARTED|Overall Study||6
6772557|NCT04023994|7700280|FG004|STARTED|Overall Study||6
6772558|NCT04023994|7700281|FG005|STARTED|Overall Study||6
6772559|NCT04023994|7700276|FG000|COMPLETED|Overall Study||10
6772560|NCT04023994|7700277|FG001|COMPLETED|Overall Study||3
6772561|NCT04023994|7700278|FG002|COMPLETED|Overall Study||2
6772562|NCT04023994|7700279|FG003|COMPLETED|Overall Study||5
6772563|NCT04023994|7700280|FG004|COMPLETED|Overall Study||6
6772564|NCT04023994|7700281|FG005|COMPLETED|Overall Study||6
6772565|NCT04023994|7700276|FG000|NOT COMPLETED|Overall Study||0
6772566|NCT04023994|7700277|FG001|NOT COMPLETED|Overall Study||1
6772567|NCT04023994|7700278|FG002|NOT COMPLETED|Overall Study||2
6772568|NCT04023994|7700279|FG003|NOT COMPLETED|Overall Study||1
6772569|NCT04023994|7700280|FG004|NOT COMPLETED|Overall Study||0
6772570|NCT04023994|7700281|FG005|NOT COMPLETED|Overall Study||0
6772571|NCT04022668|7700303|FG000|STARTED|Overall Study||1000
6772572|NCT04022668|7700304|FG001|STARTED|Overall Study||1000
6772573|NCT04022668|7700305|FG002|STARTED|Overall Study||1000
6772574|NCT04022668|7700303|FG000|COMPLETED|Overall Study||986
6772575|NCT04022668|7700304|FG001|COMPLETED|Overall Study||973
6772576|NCT04022668|7700305|FG002|COMPLETED|Overall Study||1000
6772577|NCT04022668|7700303|FG000|NOT COMPLETED|Overall Study||14
6772578|NCT04022668|7700304|FG001|NOT COMPLETED|Overall Study||27
6772579|NCT04022668|7700305|FG002|NOT COMPLETED|Overall Study||0
6772580|NCT04020822|7700313|FG000|STARTED|Overall Study||19
6772581|NCT04020822|7700313|FG000|COMPLETED|Overall Study||19
6772582|NCT04020822|7700313|FG000|NOT COMPLETED|Overall Study||0
6772583|NCT04019990|7700317|FG000|STARTED|Overall Study||13
6772584|NCT04019990|7700318|FG001|STARTED|Overall Study||15
6772585|NCT04019990|7700317|FG000|COMPLETED|Overall Study||12
6772586|NCT04019990|7700318|FG001|COMPLETED|Overall Study||12
6772587|NCT04019990|7700317|FG000|NOT COMPLETED|Overall Study||1
6772588|NCT04019990|7700318|FG001|NOT COMPLETED|Overall Study||3
6772589|NCT04017611|7700324|FG000|STARTED|Overall Study||13
6772590|NCT04017611|7700324|FG000|COMPLETED|Overall Study||12
6772591|NCT04017611|7700324|FG000|NOT COMPLETED|Overall Study||1
6772592|NCT04015232|7700330|FG000|STARTED|Overall Study||100
6772593|NCT04015232|7700331|FG001|STARTED|Overall Study||100
6772594|NCT04015232|7700330|FG000|COMPLETED|Overall Study||89
6772595|NCT04015232|7700331|FG001|COMPLETED|Overall Study||93
6772596|NCT04015232|7700330|FG000|NOT COMPLETED|Overall Study||11
6772597|NCT04015232|7700331|FG001|NOT COMPLETED|Overall Study||7
6772598|NCT04016623|7700341|FG000|STARTED|Pair 1 Test / Control Dispense||10
6772599|NCT04016623|7700341|FG000|COMPLETED|Pair 1 Test / Control Dispense||10
6772600|NCT04016623|7700341|FG000|NOT COMPLETED|Pair 1 Test / Control Dispense||0
6772601|NCT04016623|7700341|FG000|STARTED|Pair 1 Test /Control Follow up||10
6772602|NCT04016623|7700341|FG000|COMPLETED|Pair 1 Test /Control Follow up||10
6772603|NCT04016623|7700341|FG000|NOT COMPLETED|Pair 1 Test /Control Follow up||0
6772604|NCT04016623|7700341|FG000|STARTED|Pair 2 Test / Control Dispense||10
6772605|NCT04016623|7700341|FG000|COMPLETED|Pair 2 Test / Control Dispense||10
6772606|NCT04016623|7700341|FG000|NOT COMPLETED|Pair 2 Test / Control Dispense||0
6772607|NCT04016623|7700341|FG000|STARTED|Pair 2 Test /Control Follow up||10
6772608|NCT04016623|7700341|FG000|COMPLETED|Pair 2 Test /Control Follow up||10
6772609|NCT04016623|7700341|FG000|NOT COMPLETED|Pair 2 Test /Control Follow up||0
6772610|NCT04016623|7700341|FG000|STARTED|Pair 3 Test / Control Dispense||10
6772611|NCT04016623|7700341|FG000|COMPLETED|Pair 3 Test / Control Dispense||10
6772612|NCT04016623|7700341|FG000|NOT COMPLETED|Pair 3 Test / Control Dispense||0
6772613|NCT04016623|7700341|FG000|STARTED|Pair 3 Test /Control Follow up||10
6772614|NCT04016623|7700341|FG000|COMPLETED|Pair 3 Test /Control Follow up||10
6772615|NCT04016623|7700341|FG000|NOT COMPLETED|Pair 3 Test /Control Follow up||0
6772616|NCT04016623|7700341|FG000|STARTED|Pair 4 Test / Control Dispense||10
6772617|NCT04016623|7700341|FG000|COMPLETED|Pair 4 Test / Control Dispense||10
6772618|NCT04016623|7700341|FG000|NOT COMPLETED|Pair 4 Test / Control Dispense||0
6772619|NCT04016623|7700341|FG000|STARTED|Pair 4 Test /Control Follow up||10
6772620|NCT04016623|7700341|FG000|COMPLETED|Pair 4 Test /Control Follow up||10
6772621|NCT04016623|7700341|FG000|NOT COMPLETED|Pair 4 Test /Control Follow up||0
6772622|NCT04013737|7700363|FG000|STARTED|Overall Study||18
6772623|NCT04013737|7700364|FG001|STARTED|Overall Study||15
6772624|NCT04013737|7700363|FG000|COMPLETED|Overall Study|12 participants declined to participate in the study|18
6772625|NCT04013737|7700364|FG001|COMPLETED|Overall Study||15
6772626|NCT04013737|7700363|FG000|NOT COMPLETED|Overall Study||0
6772627|NCT04013737|7700364|FG001|NOT COMPLETED|Overall Study||0
6772628|NCT04014062|7700371|FG000|STARTED|Period I: Dosing||71
6772629|NCT04014062|7700372|FG001|STARTED|Period I: Dosing||71
6772630|NCT04014062|7700371|FG000|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|64
6772631|NCT04014062|7700372|FG001|COMPLETED|Period I: Dosing|Period I: Dosing, includes a washout period of 42 days before starting Period II: Crossover Dosing|65
6772632|NCT04014062|7700371|FG000|NOT COMPLETED|Period I: Dosing||7
6772633|NCT04014062|7700372|FG001|NOT COMPLETED|Period I: Dosing||6
6772634|NCT04014062|7700371|FG000|STARTED|Period II: Crossover Dosing||64
6772635|NCT04014062|7700372|FG001|STARTED|Period II: Crossover Dosing||65
6772636|NCT04014062|7700371|FG000|COMPLETED|Period II: Crossover Dosing||64
6772637|NCT04014062|7700372|FG001|COMPLETED|Period II: Crossover Dosing||65
6772638|NCT04014062|7700371|FG000|NOT COMPLETED|Period II: Crossover Dosing||0
6772639|NCT04014062|7700372|FG001|NOT COMPLETED|Period II: Crossover Dosing||0
6772640|NCT04013789|7700383|FG000|STARTED|First Wear Period (1 Week)||33
6772641|NCT04013789|7700384|FG001|STARTED|First Wear Period (1 Week)||34
6772642|NCT04013789|7700383|FG000|COMPLETED|First Wear Period (1 Week)||33
6772643|NCT04013789|7700384|FG001|COMPLETED|First Wear Period (1 Week)||34
6772644|NCT04013789|7700383|FG000|NOT COMPLETED|First Wear Period (1 Week)||0
6772645|NCT04013789|7700384|FG001|NOT COMPLETED|First Wear Period (1 Week)||0
6772646|NCT04013789|7700383|FG000|STARTED|Second Wear Period (1 Week)|One subject withdrew from the study between the first wear period and the second wear period.|32
6772647|NCT04013789|7700384|FG001|STARTED|Second Wear Period (1 Week)||34
6772648|NCT04013789|7700383|FG000|COMPLETED|Second Wear Period (1 Week)||32
6772649|NCT04013789|7700384|FG001|COMPLETED|Second Wear Period (1 Week)||34
6772650|NCT04013789|7700383|FG000|NOT COMPLETED|Second Wear Period (1 Week)||0
6772651|NCT04013789|7700384|FG001|NOT COMPLETED|Second Wear Period (1 Week)||0
6772652|NCT04012970|7700394|FG000|STARTED|Intervention Session, 30 Minutes||26
6772653|NCT04012970|7700395|FG001|STARTED|Intervention Session, 30 Minutes||14
6772654|NCT04012970|7700394|FG000|COMPLETED|Intervention Session, 30 Minutes||26
6772655|NCT04012970|7700395|FG001|COMPLETED|Intervention Session, 30 Minutes||14
6772656|NCT04012970|7700394|FG000|NOT COMPLETED|Intervention Session, 30 Minutes||0
6772657|NCT04012970|7700395|FG001|NOT COMPLETED|Intervention Session, 30 Minutes||0
6772658|NCT04012970|7700394|FG000|STARTED|Control Session, 30 Minutes||26
6772659|NCT04012970|7700395|FG001|STARTED|Control Session, 30 Minutes||14
6772660|NCT04012970|7700394|FG000|COMPLETED|Control Session, 30 Minutes||26
6772661|NCT04012970|7700395|FG001|COMPLETED|Control Session, 30 Minutes||14
6772662|NCT04012970|7700394|FG000|NOT COMPLETED|Control Session, 30 Minutes||0
6772663|NCT04012970|7700395|FG001|NOT COMPLETED|Control Session, 30 Minutes||0
6772664|NCT04013191|7700409|FG000|STARTED|Overall Study||10
6772665|NCT04013191|7700410|FG001|STARTED|Overall Study||18
6772666|NCT04013191|7700409|FG000|Completed Period 1A (Single Dose)|Overall Study||10
6772667|NCT04013191|7700410|FG001|Completed Period 1A (Single Dose)|Overall Study||18
6772668|NCT04013191|7700409|FG000|Completed Period 1B (Multiple Dose)|Overall Study||9
6772669|NCT04013191|7700410|FG001|Completed Period 1B (Multiple Dose)|Overall Study||18
6772670|NCT04013191|7700409|FG000|COMPLETED|Overall Study||9
6772671|NCT04013191|7700410|FG001|COMPLETED|Overall Study||18
6772672|NCT04013191|7700409|FG000|NOT COMPLETED|Overall Study||1
6772673|NCT04013191|7700410|FG001|NOT COMPLETED|Overall Study||0
6772674|NCT04011631|7700420|FG000|STARTED|Overall Study||100
6772675|NCT04011631|7700420|FG000|COMPLETED|Overall Study||100
6772676|NCT04011631|7700420|FG000|NOT COMPLETED|Overall Study||0
6772677|NCT04011735|7700427|FG000|STARTED|Overall Study||133
6772678|NCT04011735|7700428|FG001|STARTED|Overall Study||71
6772679|NCT04011735|7700429|FG002|STARTED|Overall Study||56
6772680|NCT04011735|7700427|FG000|COMPLETED|Overall Study||132
6772681|NCT04011735|7700428|FG001|COMPLETED|Overall Study||70
6772682|NCT04011735|7700429|FG002|COMPLETED|Overall Study||55
6772683|NCT04011735|7700427|FG000|NOT COMPLETED|Overall Study||1
6772684|NCT04011735|7700428|FG001|NOT COMPLETED|Overall Study||1
6772685|NCT04011735|7700429|FG002|NOT COMPLETED|Overall Study||1
6772686|NCT04010695|7700439|FG000|STARTED|Overall Study||250
6772687|NCT04010695|7700439|FG000|COMPLETED|Overall Study||250
6772688|NCT04010695|7700439|FG000|NOT COMPLETED|Overall Study||0
6772689|NCT04009577|7700448|FG000|STARTED|Core Study||7
6772690|NCT04009577|7700449|FG001|STARTED|Core Study||3
6772691|NCT04009577|7700450|FG002|STARTED|Core Study||21
6772692|NCT04009577|7700451|FG003|STARTED|Core Study||22
6772693|NCT04009577|7700448|FG000|LEM5|Core Study||7
6772694|NCT04009577|7700449|FG001|LEM5|Core Study||3
6772695|NCT04009577|7700450|FG002|LEM5|Core Study||21
6772696|NCT04009577|7700451|FG003|LEM5|Core Study||5
6772697|NCT04009577|7700448|FG000|LEM10|Core Study||3
6772698|NCT04009577|7700449|FG001|LEM10|Core Study||2
6772699|NCT04009577|7700450|FG002|LEM10|Core Study||10
6772700|NCT04009577|7700451|FG003|LEM10|Core Study||22
6772701|NCT04009577|7700448|FG000|COMPLETED|Core Study||6
6772702|NCT04009577|7700449|FG001|COMPLETED|Core Study||3
6772703|NCT04009577|7700450|FG002|COMPLETED|Core Study||17
6772704|NCT04009577|7700451|FG003|COMPLETED|Core Study||17
6772705|NCT04009577|7700448|FG000|NOT COMPLETED|Core Study||1
6772706|NCT04009577|7700449|FG001|NOT COMPLETED|Core Study||0
6772707|NCT04009577|7700450|FG002|NOT COMPLETED|Core Study||4
6772708|NCT04009577|7700451|FG003|NOT COMPLETED|Core Study||5
6772709|NCT04009577|7700448|FG000|STARTED|Extension Phase||6
6772710|NCT04009577|7700449|FG001|STARTED|Extension Phase||3
6772711|NCT04009577|7700450|FG002|STARTED|Extension Phase||17
6772712|NCT04009577|7700451|FG003|STARTED|Extension Phase||17
6772713|NCT04009577|7700448|FG000|Treated|Extension Phase||6
6772714|NCT04009577|7700449|FG001|Treated|Extension Phase||3
6772715|NCT04009577|7700450|FG002|Treated|Extension Phase||15
6772716|NCT04009577|7700451|FG003|Treated|Extension Phase||17
6772717|NCT04009577|7700448|FG000|LEM5|Extension Phase||6
6772718|NCT04009577|7700449|FG001|LEM5|Extension Phase||3
6772719|NCT04009577|7700450|FG002|LEM5|Extension Phase||15
6772720|NCT04009577|7700451|FG003|LEM5|Extension Phase||8
6772721|NCT04009577|7700448|FG000|LEM10|Extension Phase||5
6772722|NCT04009577|7700449|FG001|LEM10|Extension Phase||3
6772723|NCT04009577|7700450|FG002|LEM10|Extension Phase||12
6772724|NCT04009577|7700451|FG003|LEM10|Extension Phase||17
6772725|NCT04009577|7700448|FG000|COMPLETED|Extension Phase||6
6772726|NCT04009577|7700449|FG001|COMPLETED|Extension Phase||3
6772727|NCT04009577|7700450|FG002|COMPLETED|Extension Phase||13
6772728|NCT04009577|7700451|FG003|COMPLETED|Extension Phase||16
6772729|NCT04009577|7700448|FG000|NOT COMPLETED|Extension Phase||0
6772730|NCT04009577|7700449|FG001|NOT COMPLETED|Extension Phase||0
6772731|NCT04009577|7700450|FG002|NOT COMPLETED|Extension Phase||4
6772732|NCT04009577|7700451|FG003|NOT COMPLETED|Extension Phase||1
6772733|NCT04007159|7700477|FG000|STARTED|Induction Phase||280
6772734|NCT04007159|7700477|FG000|COMPLETED|Induction Phase||258
6772735|NCT04007159|7700477|FG000|NOT COMPLETED|Induction Phase||22
6772736|NCT04007159|7700477|FG000|STARTED|Rest Phase||258
6772737|NCT04007159|7700477|FG000|COMPLETED|Rest Phase||258
6772738|NCT04007159|7700477|FG000|NOT COMPLETED|Rest Phase||0
6772739|NCT04007159|7700477|FG000|STARTED|Challenge Phase||258
6772740|NCT04007159|7700477|FG000|COMPLETED|Challenge Phase||255
6772741|NCT04007159|7700477|FG000|NOT COMPLETED|Challenge Phase||3
6772742|NCT04007107|7700488|FG000|STARTED|Treatment Period 1 (Day 1)||26
6772743|NCT04007107|7700489|FG001|STARTED|Treatment Period 1 (Day 1)||26
6772744|NCT04007107|7700490|FG002|STARTED|Treatment Period 1 (Day 1)||25
6556731|NCT01763645|7479154|FG000|COMPLETED|Overall Study|Completed the study according the protocol.|43
6556732|NCT01763645|7479155|FG001|COMPLETED|Overall Study|Completed the study according the protocol.|45
6556733|NCT01763645|7479154|FG000|NOT COMPLETED|Overall Study||26
6556734|NCT01763645|7479155|FG001|NOT COMPLETED|Overall Study||24
6556735|NCT01763684|7479164|FG000|STARTED|Overall Study||133
6556736|NCT01763684|7479165|FG001|STARTED|Overall Study||133
6556737|NCT01763684|7479164|FG000|Completed Surgery|Overall Study||126
6556738|NCT01763684|7479165|FG001|Completed Surgery|Overall Study||127
6556739|NCT01763684|7479164|FG000|COMPLETED|Overall Study||0
6556740|NCT01763684|7479165|FG001|COMPLETED|Overall Study||0
6556741|NCT01763684|7479164|FG000|NOT COMPLETED|Overall Study||133
6556742|NCT01763684|7479165|FG001|NOT COMPLETED|Overall Study||133
6772745|NCT04007107|7700491|FG003|STARTED|Treatment Period 1 (Day 1)||26
6305884|NCT00371293|7209282|FG000|COMPLETED|Overall Study||48
6305885|NCT00371293|7209283|FG001|COMPLETED|Overall Study||42
6305886|NCT00371293|7209284|FG002|COMPLETED|Overall Study||46
6305887|NCT00371293|7209282|FG000|NOT COMPLETED|Overall Study||10
6305888|NCT00371293|7209283|FG001|NOT COMPLETED|Overall Study||19
6305889|NCT00371293|7209284|FG002|NOT COMPLETED|Overall Study||16
6305890|NCT00371345|7209295|FG000|STARTED|Overall Study||24
6305891|NCT00371345|7209296|FG001|STARTED|Overall Study||46
6305892|NCT00371345|7209295|FG000|COMPLETED|Overall Study||0
6305893|NCT00371345|7209296|FG001|COMPLETED|Overall Study||0
6305894|NCT00371345|7209295|FG000|NOT COMPLETED|Overall Study||24
6305895|NCT00371345|7209296|FG001|NOT COMPLETED|Overall Study||46
6305896|NCT00371397|7209316|FG000|STARTED|Session 1||5
6305897|NCT00371397|7209317|FG001|STARTED|Session 1||7
6305898|NCT00371397|7209318|FG002|STARTED|Session 1||5
6305899|NCT00371397|7209319|FG003|STARTED|Session 1||2
6305900|NCT00371397|7209320|FG004|STARTED|Session 1||3
6305901|NCT00371397|7209321|FG005|STARTED|Session 1||4
6305902|NCT00371397|7209322|FG006|STARTED|Session 1||4
6305903|NCT00371397|7209323|FG007|STARTED|Session 1||5
6772746|NCT04007107|7700488|FG000|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6772747|NCT04007107|7700489|FG001|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6772748|NCT04007107|7700490|FG002|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||25
6772749|NCT04007107|7700491|FG003|Full Analysis Set (FAS)|Treatment Period 1 (Day 1)||26
6772750|NCT04007107|7700488|FG000|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6772751|NCT04007107|7700489|FG001|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6772752|NCT04007107|7700490|FG002|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||25
6772753|NCT04007107|7700491|FG003|Safety Analysis Set (SAS)|Treatment Period 1 (Day 1)||26
6556743|NCT01763827|7479177|FG000|STARTED|Overall Study||77
6556744|NCT01763827|7479178|FG001|STARTED|Overall Study||78
6772754|NCT04007107|7700488|FG000|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
6772755|NCT04007107|7700489|FG001|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
6772756|NCT04007107|7700490|FG002|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||25
6772757|NCT04007107|7700491|FG003|Per Protocol (PP) Set|Treatment Period 1 (Day 1)||26
6772758|NCT04007107|7700488|FG000|COMPLETED|Treatment Period 1 (Day 1)||26
6772759|NCT04007107|7700489|FG001|COMPLETED|Treatment Period 1 (Day 1)||26
6556745|NCT01763827|7479179|FG002|STARTED|Overall Study||77
6556746|NCT01763827|7479180|FG003|STARTED|Overall Study||77
6305904|NCT00371397|7209324|FG008|STARTED|Session 1||6
6305905|NCT00371397|7209325|FG009|STARTED|Session 1||5
6305906|NCT00371397|7209326|FG010|STARTED|Session 1||4
6305907|NCT00371397|7209327|FG011|STARTED|Session 1||2
6772760|NCT04007107|7700490|FG002|COMPLETED|Treatment Period 1 (Day 1)||25
6772761|NCT04007107|7700491|FG003|COMPLETED|Treatment Period 1 (Day 1)||26
6772762|NCT04007107|7700488|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6772763|NCT04007107|7700489|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6772764|NCT04007107|7700490|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6772765|NCT04007107|7700491|FG003|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6772766|NCT04007107|7700488|FG000|STARTED|Treatment Period 2 (Day 1)||26
6772767|NCT04007107|7700489|FG001|STARTED|Treatment Period 2 (Day 1)||26
6772768|NCT04007107|7700490|FG002|STARTED|Treatment Period 2 (Day 1)||25
6772769|NCT04007107|7700491|FG003|STARTED|Treatment Period 2 (Day 1)||26
6772770|NCT04007107|7700488|FG000|COMPLETED|Treatment Period 2 (Day 1)||26
6772771|NCT04007107|7700489|FG001|COMPLETED|Treatment Period 2 (Day 1)||25
6772772|NCT04007107|7700490|FG002|COMPLETED|Treatment Period 2 (Day 1)||25
6772773|NCT04007107|7700491|FG003|COMPLETED|Treatment Period 2 (Day 1)||26
6772774|NCT04007107|7700488|FG000|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6772775|NCT04007107|7700489|FG001|NOT COMPLETED|Treatment Period 2 (Day 1)||1
6772776|NCT04007107|7700490|FG002|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6772777|NCT04007107|7700491|FG003|NOT COMPLETED|Treatment Period 2 (Day 1)||0
6772778|NCT04006795|7700496|FG000|STARTED|Induction Phase||37
6772779|NCT04006795|7700496|FG000|COMPLETED|Induction Phase||37
6772780|NCT04006795|7700496|FG000|NOT COMPLETED|Induction Phase||0
6772781|NCT04006795|7700496|FG000|STARTED|Rest Phase||37
6772782|NCT04006795|7700496|FG000|COMPLETED|Rest Phase||37
6772783|NCT04006795|7700496|FG000|NOT COMPLETED|Rest Phase||0
6772784|NCT04006795|7700496|FG000|STARTED|Challenge Phase||37
6772785|NCT04006795|7700496|FG000|COMPLETED|Challenge Phase||37
6772786|NCT04006795|7700496|FG000|NOT COMPLETED|Challenge Phase||0
6772787|NCT04005885|7700507|FG000|STARTED|First Intervention||26
6772788|NCT04005885|7700508|FG001|STARTED|First Intervention||29
6772789|NCT04005885|7700507|FG000|COMPLETED|First Intervention||25
6772790|NCT04005885|7700508|FG001|COMPLETED|First Intervention||28
6772791|NCT04005885|7700507|FG000|NOT COMPLETED|First Intervention||1
6772792|NCT04005885|7700508|FG001|NOT COMPLETED|First Intervention||1
6772793|NCT04005885|7700507|FG000|STARTED|Second Intervention||25
6772794|NCT04005885|7700508|FG001|STARTED|Second Intervention||28
6772795|NCT04005885|7700507|FG000|COMPLETED|Second Intervention||25
6772796|NCT04005885|7700508|FG001|COMPLETED|Second Intervention||26
6772797|NCT04005885|7700507|FG000|NOT COMPLETED|Second Intervention||0
6772798|NCT04005885|7700508|FG001|NOT COMPLETED|Second Intervention||2
6772799|NCT04005885|7700507|FG000|STARTED|Third Intervention||25
6772800|NCT04005885|7700508|FG001|STARTED|Third Intervention||26
6772801|NCT04005885|7700507|FG000|COMPLETED|Third Intervention||25
6772802|NCT04005885|7700508|FG001|COMPLETED|Third Intervention||26
6772803|NCT04005885|7700507|FG000|NOT COMPLETED|Third Intervention||0
6772804|NCT04005885|7700508|FG001|NOT COMPLETED|Third Intervention||0
6772805|NCT04000815|7700522|FG000|STARTED|Overall Study||29
6772806|NCT04000815|7700523|FG001|STARTED|Overall Study||20
6772807|NCT04000815|7700524|FG002|STARTED|Overall Study||22
6772808|NCT04000815|7700522|FG000|COMPLETED|Overall Study||15
6772809|NCT04000815|7700523|FG001|COMPLETED|Overall Study||15
6772810|NCT04000815|7700524|FG002|COMPLETED|Overall Study||15
6772811|NCT04000815|7700522|FG000|NOT COMPLETED|Overall Study||14
6772812|NCT04000815|7700523|FG001|NOT COMPLETED|Overall Study||5
6772813|NCT04000815|7700524|FG002|NOT COMPLETED|Overall Study||7
6772814|NCT03999944|7700532|FG000|STARTED|First Sleep Night||26
6772815|NCT03999944|7700533|FG001|STARTED|First Sleep Night||26
6772816|NCT03999944|7700532|FG000|COMPLETED|First Sleep Night||22
6772817|NCT03999944|7700533|FG001|COMPLETED|First Sleep Night||24
6772818|NCT03999944|7700532|FG000|NOT COMPLETED|First Sleep Night||4
6772819|NCT03999944|7700533|FG001|NOT COMPLETED|First Sleep Night||2
6772820|NCT03999944|7700532|FG000|STARTED|Second Sleep Night||22
6772821|NCT03999944|7700533|FG001|STARTED|Second Sleep Night||24
6772822|NCT03999944|7700532|FG000|COMPLETED|Second Sleep Night||22
6772823|NCT03999944|7700533|FG001|COMPLETED|Second Sleep Night||20
6772824|NCT03999944|7700532|FG000|NOT COMPLETED|Second Sleep Night||0
6772825|NCT03999944|7700533|FG001|NOT COMPLETED|Second Sleep Night||4
6772826|NCT03995680|7700542|FG000|STARTED|Overall Study||199
6772827|NCT03995680|7700543|FG001|STARTED|Overall Study||198
6772828|NCT03995680|7700542|FG000|COMPLETED|Overall Study||197
6772829|NCT03995680|7700543|FG001|COMPLETED|Overall Study||196
6556747|NCT01763827|7479181|FG004|STARTED|Overall Study||153
6556748|NCT01763827|7479182|FG005|STARTED|Overall Study||153
6772830|NCT03995680|7700542|FG000|NOT COMPLETED|Overall Study||2
6772831|NCT03995680|7700543|FG001|NOT COMPLETED|Overall Study||2
6772832|NCT04006366|7700549|FG000|STARTED|Overall Study||6
6772833|NCT04006366|7700549|FG000|COMPLETED|Overall Study||5
6772834|NCT04006366|7700549|FG000|NOT COMPLETED|Overall Study||1
6772835|NCT04006145|7700555|FG000|STARTED|Overall Study||23
6772836|NCT04006145|7700556|FG001|STARTED|Overall Study||24
6772837|NCT04006145|7700555|FG000|Received Treatment|Overall Study||23
6772838|NCT04006145|7700556|FG001|Received Treatment|Overall Study||24
6772839|NCT04006145|7700555|FG000|COMPLETED|Overall Study||22
6772840|NCT04006145|7700556|FG001|COMPLETED|Overall Study||21
6772841|NCT04006145|7700555|FG000|NOT COMPLETED|Overall Study||1
6772842|NCT04006145|7700556|FG001|NOT COMPLETED|Overall Study||3
6772843|NCT04005755|7700562|FG000|STARTED|Overall Study||232
6772844|NCT04005755|7700562|FG000|COMPLETED|Overall Study||215
6772845|NCT04005755|7700562|FG000|NOT COMPLETED|Overall Study||17
6772846|NCT04005586|7700566|FG000|STARTED|Overall Study||25
6772847|NCT04005586|7700566|FG000|COMPLETED|Overall Study||25
6772848|NCT04005586|7700566|FG000|NOT COMPLETED|Overall Study||0
6772849|NCT04005404|7700573|FG000|STARTED|Overall Study||43
6772850|NCT04005404|7700574|FG001|STARTED|Overall Study||34
6772851|NCT04005404|7700575|FG002|STARTED|Overall Study||3
6772852|NCT04005404|7700573|FG000|COMPLETED|Overall Study||42
6772853|NCT04005404|7700574|FG001|COMPLETED|Overall Study||33
6772854|NCT04005404|7700575|FG002|COMPLETED|Overall Study||3
6772855|NCT04005404|7700573|FG000|NOT COMPLETED|Overall Study||1
6772856|NCT04005404|7700574|FG001|NOT COMPLETED|Overall Study||1
6772857|NCT04005404|7700575|FG002|NOT COMPLETED|Overall Study||0
6772858|NCT03993288|7700585|FG000|STARTED|Overall Study||133
6772859|NCT03993288|7700586|FG001|STARTED|Overall Study||134
6772860|NCT03993288|7700585|FG000|Intention-to-treat (ITT) Population|Overall Study||123
6772861|NCT03993288|7700586|FG001|Intention-to-treat (ITT) Population|Overall Study||129
6772862|NCT03993288|7700585|FG000|Safety Analysis Set|Overall Study||133
6772863|NCT03993288|7700586|FG001|Safety Analysis Set|Overall Study||134
6772864|NCT03993288|7700585|FG000|COMPLETED|Overall Study||123
6772865|NCT03993288|7700586|FG001|COMPLETED|Overall Study||129
6772866|NCT03993288|7700585|FG000|NOT COMPLETED|Overall Study||10
6772867|NCT03993288|7700586|FG001|NOT COMPLETED|Overall Study||5
6772868|NCT03990298|7700592|FG000|STARTED|Overall Study||16
6772869|NCT03990298|7700592|FG000|COMPLETED|Overall Study||16
6772870|NCT03990298|7700592|FG000|NOT COMPLETED|Overall Study||0
6772871|NCT03988647|7700596|FG000|STARTED|Overall Study||1
6772872|NCT03988647|7700596|FG000|COMPLETED|Overall Study||1
6772873|NCT03988647|7700596|FG000|NOT COMPLETED|Overall Study||0
6772874|NCT03979872|7700604|FG000|STARTED|Overall Study||22
6772875|NCT03979872|7700605|FG001|STARTED|Overall Study||23
6772876|NCT03979872|7700606|FG002|STARTED|Overall Study||24
6772877|NCT03979872|7700607|FG003|STARTED|Overall Study||23
6772878|NCT03979872|7700604|FG000|COMPLETED|Overall Study||19
6772879|NCT03979872|7700605|FG001|COMPLETED|Overall Study||15
6772880|NCT03979872|7700606|FG002|COMPLETED|Overall Study||18
6772881|NCT03979872|7700607|FG003|COMPLETED|Overall Study||19
6772882|NCT03979872|7700604|FG000|NOT COMPLETED|Overall Study||3
6772883|NCT03979872|7700605|FG001|NOT COMPLETED|Overall Study||8
6772884|NCT03979872|7700606|FG002|NOT COMPLETED|Overall Study||6
6772885|NCT03979872|7700607|FG003|NOT COMPLETED|Overall Study||4
6772886|NCT03978832|7700617|FG000|STARTED|Overall Study|69 participants signed the ICF and entered screening; 25 met eligibility criteria and were enrolled.|69
6772887|NCT03978832|7700617|FG000|Stabilization Period|Overall Study||25
6772888|NCT03978832|7700617|FG000|Treatment Period|Overall Study||23
6772889|NCT03978832|7700617|FG000|COMPLETED|Overall Study||15
6772890|NCT03978832|7700617|FG000|NOT COMPLETED|Overall Study||54
6772891|NCT04005391|7700623|FG000|STARTED|Overall Study|10/23/18|108
6772892|NCT04005391|7700624|FG001|STARTED|Overall Study|10/23/18|100
6772893|NCT04005391|7700623|FG000|COMPLETED|Overall Study||101
6772894|NCT04005391|7700624|FG001|COMPLETED|Overall Study||100
6772895|NCT04005391|7700623|FG000|NOT COMPLETED|Overall Study||7
6772896|NCT04005391|7700624|FG001|NOT COMPLETED|Overall Study||0
6780709|NCT02892500|7709241|FG001|NOT COMPLETED|Overall Study||0
6780710|NCT02904356|7709247|FG000|STARTED|Overall Study||2
6780711|NCT02904356|7709247|FG000|COMPLETED|Overall Study||2
6780712|NCT02904356|7709247|FG000|NOT COMPLETED|Overall Study||0
6780713|NCT02899728|7709253|FG000|STARTED|Overall Study|0|5
6780714|NCT02899728|7709254|FG001|STARTED|Overall Study||3
6780715|NCT02899728|7709253|FG000|COMPLETED|Overall Study||4
6780716|NCT02899728|7709254|FG001|COMPLETED|Overall Study||2
6780717|NCT02899728|7709253|FG000|NOT COMPLETED|Overall Study||1
6780718|NCT02899728|7709254|FG001|NOT COMPLETED|Overall Study||1
6780719|NCT02875067|7709260|FG000|STARTED|Overall Study||6
6780720|NCT02875067|7709260|FG000|COMPLETED|Overall Study||0
6780721|NCT02875067|7709260|FG000|NOT COMPLETED|Overall Study||6
6780722|NCT02877732|7709266|FG000|STARTED|Overall Study||6
6780723|NCT02877732|7709267|FG001|STARTED|Overall Study||6
6780724|NCT02877732|7709266|FG000|COMPLETED|Overall Study||0
6780725|NCT02877732|7709267|FG001|COMPLETED|Overall Study||0
6780726|NCT02877732|7709266|FG000|NOT COMPLETED|Overall Study||6
6780727|NCT02877732|7709267|FG001|NOT COMPLETED|Overall Study||6
6780728|NCT02860169|7709275|FG000|STARTED|Part A||46
6780729|NCT02860169|7709275|FG000|Healthy Participants|Part A||46
6780730|NCT02860169|7709275|FG000|Participants With Cold and Flu|Part A||0
6780731|NCT02860169|7709275|FG000|COMPLETED|Part A||35
6780732|NCT02860169|7709275|FG000|NOT COMPLETED|Part A||11
6780733|NCT02860169|7709275|FG000|STARTED|Part B||20
6780734|NCT02860169|7709275|FG000|Healthy Participants|Part B||10
6780735|NCT02860169|7709275|FG000|Participants With Cold and Flu|Part B||10
6780736|NCT02860169|7709275|FG000|COMPLETED|Part B||9
6780737|NCT02860169|7709275|FG000|NOT COMPLETED|Part B||11
6780738|NCT02860169|7709275|FG000|STARTED|Part C||48
6780739|NCT02860169|7709275|FG000|Healthy Participants|Part C||6
6780740|NCT02860169|7709275|FG000|Participants With Cold and Flu|Part C||42
6780741|NCT02860169|7709275|FG000|COMPLETED|Part C||47
6780742|NCT02860169|7709275|FG000|NOT COMPLETED|Part C||1
6780743|NCT02865395|7709284|FG000|STARTED|Overall Study||6
6780744|NCT02865395|7709285|FG001|STARTED|Overall Study||10
6780745|NCT02865395|7709286|FG002|STARTED|Overall Study||7
6780746|NCT02865395|7709284|FG000|COMPLETED|Overall Study|Data Not Collected|0
6780747|NCT02865395|7709285|FG001|COMPLETED|Overall Study|Data Not Collected|0
6780748|NCT02865395|7709286|FG002|COMPLETED|Overall Study|Data Not Collected|0
6780749|NCT02865395|7709284|FG000|NOT COMPLETED|Overall Study||6
6772897|NCT04004481|7700634|FG000|STARTED|Overall Study||50
6772898|NCT04004481|7700634|FG000|COMPLETED|Overall Study||47
6772899|NCT04004481|7700634|FG000|NOT COMPLETED|Overall Study||3
6772900|NCT04004260|7700658|FG000|STARTED|Overall Study||79
6772901|NCT04004260|7700659|FG001|STARTED|Overall Study||79
6772902|NCT04004260|7700658|FG000|COMPLETED|Overall Study||37
6772903|NCT04004260|7700659|FG001|COMPLETED|Overall Study||47
6772904|NCT04004260|7700658|FG000|NOT COMPLETED|Overall Study||42
6772905|NCT04004260|7700659|FG001|NOT COMPLETED|Overall Study||32
6772906|NCT03997851|7700665|FG000|STARTED|Overall Study||17
6772907|NCT03997851|7700665|FG000|COMPLETED|Overall Study||17
6772908|NCT03997851|7700665|FG000|NOT COMPLETED|Overall Study||0
6772909|NCT03991715|7700675|FG000|STARTED|Overall Study||5
6772910|NCT03991715|7700675|FG000|COMPLETED|Overall Study||5
6772911|NCT03991715|7700675|FG000|NOT COMPLETED|Overall Study||0
6772912|NCT03990415|7700682|FG000|STARTED|Overall Study||19
6772913|NCT03990415|7700683|FG001|STARTED|Overall Study||19
6772914|NCT03990415|7700684|FG002|STARTED|Overall Study||14
6772915|NCT03990415|7700682|FG000|COMPLETED|Overall Study||15
6772916|NCT03990415|7700683|FG001|COMPLETED|Overall Study||17
6772917|NCT03990415|7700684|FG002|COMPLETED|Overall Study||14
6772918|NCT03990415|7700682|FG000|NOT COMPLETED|Overall Study||4
6772919|NCT03990415|7700683|FG001|NOT COMPLETED|Overall Study||2
6772920|NCT03990415|7700684|FG002|NOT COMPLETED|Overall Study||0
6772921|NCT04002960|7700692|FG000|STARTED|Overall Study||23
6772922|NCT04002960|7700692|FG000|COMPLETED|Overall Study||21
6772923|NCT04002960|7700692|FG000|NOT COMPLETED|Overall Study||2
6772924|NCT04002973|7700696|FG000|STARTED|Overall Study||11
6772925|NCT04002973|7700696|FG000|COMPLETED|Overall Study||11
6772926|NCT04002973|7700696|FG000|NOT COMPLETED|Overall Study||0
6772927|NCT04002648|7700702|FG000|STARTED|Overall Study||104
6772928|NCT04002648|7700703|FG001|STARTED|Overall Study||104
6772929|NCT04002648|7700702|FG000|COMPLETED|Overall Study||102
6772930|NCT04002648|7700703|FG001|COMPLETED|Overall Study||104
6772931|NCT04002648|7700702|FG000|NOT COMPLETED|Overall Study||2
6772932|NCT04002648|7700703|FG001|NOT COMPLETED|Overall Study||0
6772933|NCT03993210|7700711|FG000|STARTED|Overall Study||1
6772934|NCT03993210|7700712|FG001|STARTED|Overall Study||0
6772935|NCT03993210|7700711|FG000|COMPLETED|Overall Study||1
6772936|NCT03993210|7700712|FG001|COMPLETED|Overall Study||0
6772937|NCT03993210|7700711|FG000|NOT COMPLETED|Overall Study||0
6772938|NCT03993210|7700712|FG001|NOT COMPLETED|Overall Study||0
6772939|NCT03992014|7700722|FG000|STARTED|Treatment Period 1 (8 Days)||6
6772940|NCT03992014|7700722|FG000|COMPLETED|Treatment Period 1 (8 Days)||6
6772941|NCT03992014|7700722|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6772942|NCT03992014|7700722|FG000|STARTED|Washout Period (7 Days)||6
6772943|NCT03992014|7700722|FG000|COMPLETED|Washout Period (7 Days)||6
6772944|NCT03992014|7700722|FG000|NOT COMPLETED|Washout Period (7 Days)||0
6772945|NCT03992014|7700722|FG000|STARTED|Treatment Period 2 (8 Days)||6
6772946|NCT03992014|7700722|FG000|COMPLETED|Treatment Period 2 (8 Days)||6
6772947|NCT03992014|7700722|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6772948|NCT03990649|7700732|FG000|STARTED|Part A: DB Treatment Period (15 Weeks)||9
6772949|NCT03990649|7700733|FG001|STARTED|Part A: DB Treatment Period (15 Weeks)||15
6772950|NCT03990649|7700734|FG002|STARTED|Part A: DB Treatment Period (15 Weeks)||0
6772951|NCT03990649|7700732|FG000|COMPLETED|Part A: DB Treatment Period (15 Weeks)||6
6772952|NCT03990649|7700733|FG001|COMPLETED|Part A: DB Treatment Period (15 Weeks)||12
6772953|NCT03990649|7700734|FG002|COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
6772954|NCT03990649|7700732|FG000|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
6772955|NCT03990649|7700733|FG001|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||3
6772956|NCT03990649|7700734|FG002|NOT COMPLETED|Part A: DB Treatment Period (15 Weeks)||0
6772957|NCT03990649|7700732|FG000|STARTED|Part B: OL Extension Period (14 Weeks)||0
6772958|NCT03990649|7700733|FG001|STARTED|Part B: OL Extension Period (14 Weeks)||0
6772959|NCT03990649|7700734|FG002|STARTED|Part B: OL Extension Period (14 Weeks)||18
6772960|NCT03990649|7700732|FG000|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
6772961|NCT03990649|7700733|FG001|COMPLETED|Part B: OL Extension Period (14 Weeks)||0
6772962|NCT03990649|7700734|FG002|COMPLETED|Part B: OL Extension Period (14 Weeks)||14
6772963|NCT03990649|7700732|FG000|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
6772964|NCT03990649|7700733|FG001|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||0
6772965|NCT03990649|7700734|FG002|NOT COMPLETED|Part B: OL Extension Period (14 Weeks)||4
6772966|NCT04002791|7700743|FG000|STARTED|Overall Study||127
6772967|NCT04002791|7700744|FG001|STARTED|Overall Study||126
6772968|NCT04002791|7700743|FG000|COMPLETED|Overall Study||127
6772969|NCT04002791|7700744|FG001|COMPLETED|Overall Study||126
6772970|NCT04002791|7700743|FG000|NOT COMPLETED|Overall Study||0
6772971|NCT04002791|7700744|FG001|NOT COMPLETED|Overall Study||0
6772972|NCT04000581|7700752|FG000|STARTED|Overall Study||5
6772973|NCT04000581|7700753|FG001|STARTED|Overall Study||12
6772974|NCT04000581|7700752|FG000|COMPLETED|Overall Study||5
6772975|NCT04000581|7700753|FG001|COMPLETED|Overall Study||11
6772976|NCT04000581|7700752|FG000|NOT COMPLETED|Overall Study||0
6772977|NCT04000581|7700753|FG001|NOT COMPLETED|Overall Study||1
6772978|NCT03996694|7700759|FG000|STARTED|First Intervention (1 Day)||3
6772979|NCT03996694|7700760|FG001|STARTED|First Intervention (1 Day)||3
6772980|NCT03996694|7700761|FG002|STARTED|First Intervention (1 Day)||4
6772981|NCT03996694|7700762|FG003|STARTED|First Intervention (1 Day)||3
6772982|NCT03996694|7700763|FG004|STARTED|First Intervention (1 Day)||3
6772983|NCT03996694|7700764|FG005|STARTED|First Intervention (1 Day)||3
6772984|NCT03996694|7700759|FG000|COMPLETED|First Intervention (1 Day)||3
6772985|NCT03996694|7700760|FG001|COMPLETED|First Intervention (1 Day)||3
6772986|NCT03996694|7700761|FG002|COMPLETED|First Intervention (1 Day)||4
6772987|NCT03996694|7700762|FG003|COMPLETED|First Intervention (1 Day)||3
6772988|NCT03996694|7700763|FG004|COMPLETED|First Intervention (1 Day)||3
6772989|NCT03996694|7700764|FG005|COMPLETED|First Intervention (1 Day)||3
6772990|NCT03996694|7700759|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6772991|NCT03996694|7700760|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6772992|NCT03996694|7700761|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6556749|NCT01763827|7479177|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
6556750|NCT01763827|7479178|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
6556751|NCT01763827|7479179|FG002|Received at Least 1 Dose of Study Drug|Overall Study||77
6556752|NCT01763827|7479180|FG003|Received at Least 1 Dose of Study Drug|Overall Study||77
6556753|NCT01763827|7479181|FG004|Received at Least 1 Dose of Study Drug|Overall Study||153
6556754|NCT01763827|7479182|FG005|Received at Least 1 Dose of Study Drug|Overall Study||153
6556755|NCT01763827|7479177|FG000|COMPLETED|Overall Study||74
6772993|NCT03996694|7700762|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6772994|NCT03996694|7700763|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6772995|NCT03996694|7700764|FG005|NOT COMPLETED|First Intervention (1 Day)||0
6772996|NCT03996694|7700759|FG000|STARTED|First Washout (7 Days)||3
6772997|NCT03996694|7700760|FG001|STARTED|First Washout (7 Days)||3
6772998|NCT03996694|7700761|FG002|STARTED|First Washout (7 Days)||4
6772999|NCT03996694|7700762|FG003|STARTED|First Washout (7 Days)||3
6773000|NCT03996694|7700763|FG004|STARTED|First Washout (7 Days)||3
6773001|NCT03996694|7700764|FG005|STARTED|First Washout (7 Days)||3
6773002|NCT03996694|7700759|FG000|COMPLETED|First Washout (7 Days)||3
6773003|NCT03996694|7700760|FG001|COMPLETED|First Washout (7 Days)||2
6773004|NCT03996694|7700761|FG002|COMPLETED|First Washout (7 Days)||2
6773005|NCT03996694|7700762|FG003|COMPLETED|First Washout (7 Days)||3
6773006|NCT03996694|7700763|FG004|COMPLETED|First Washout (7 Days)||3
6773007|NCT03996694|7700764|FG005|COMPLETED|First Washout (7 Days)||3
6773008|NCT03996694|7700759|FG000|NOT COMPLETED|First Washout (7 Days)||0
6773009|NCT03996694|7700760|FG001|NOT COMPLETED|First Washout (7 Days)||1
6773010|NCT03996694|7700761|FG002|NOT COMPLETED|First Washout (7 Days)||2
6773011|NCT03996694|7700762|FG003|NOT COMPLETED|First Washout (7 Days)||0
6773012|NCT03996694|7700763|FG004|NOT COMPLETED|First Washout (7 Days)||0
6773013|NCT03996694|7700764|FG005|NOT COMPLETED|First Washout (7 Days)||0
6773014|NCT03996694|7700759|FG000|STARTED|Second Intervention (1 Day)||3
6773015|NCT03996694|7700760|FG001|STARTED|Second Intervention (1 Day)||2
6773016|NCT03996694|7700761|FG002|STARTED|Second Intervention (1 Day)||2
6773017|NCT03996694|7700762|FG003|STARTED|Second Intervention (1 Day)||3
6773018|NCT03996694|7700763|FG004|STARTED|Second Intervention (1 Day)||3
6773019|NCT03996694|7700764|FG005|STARTED|Second Intervention (1 Day)||3
6773020|NCT03996694|7700759|FG000|COMPLETED|Second Intervention (1 Day)||3
6773021|NCT03996694|7700760|FG001|COMPLETED|Second Intervention (1 Day)||2
6773022|NCT03996694|7700761|FG002|COMPLETED|Second Intervention (1 Day)||2
6773023|NCT03996694|7700762|FG003|COMPLETED|Second Intervention (1 Day)||3
6773024|NCT03996694|7700763|FG004|COMPLETED|Second Intervention (1 Day)||3
6773025|NCT03996694|7700764|FG005|COMPLETED|Second Intervention (1 Day)||3
6773026|NCT03996694|7700759|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6773027|NCT03996694|7700760|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6773028|NCT03996694|7700761|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6773029|NCT03996694|7700762|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6773030|NCT03996694|7700763|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6773031|NCT03996694|7700764|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
6773032|NCT03996694|7700759|FG000|STARTED|Second Washout (7 Days)||3
6773033|NCT03996694|7700760|FG001|STARTED|Second Washout (7 Days)||2
6773034|NCT03996694|7700761|FG002|STARTED|Second Washout (7 Days)||2
6773035|NCT03996694|7700762|FG003|STARTED|Second Washout (7 Days)||3
6773036|NCT03996694|7700763|FG004|STARTED|Second Washout (7 Days)||3
6773037|NCT03996694|7700764|FG005|STARTED|Second Washout (7 Days)||3
6773038|NCT03996694|7700759|FG000|COMPLETED|Second Washout (7 Days)||3
6773039|NCT03996694|7700760|FG001|COMPLETED|Second Washout (7 Days)||2
6773040|NCT03996694|7700761|FG002|COMPLETED|Second Washout (7 Days)||2
6773041|NCT03996694|7700762|FG003|COMPLETED|Second Washout (7 Days)||3
6773042|NCT03996694|7700763|FG004|COMPLETED|Second Washout (7 Days)||3
6773043|NCT03996694|7700764|FG005|COMPLETED|Second Washout (7 Days)||3
6773044|NCT03996694|7700759|FG000|NOT COMPLETED|Second Washout (7 Days)||0
6773045|NCT03996694|7700760|FG001|NOT COMPLETED|Second Washout (7 Days)||0
6773046|NCT03996694|7700761|FG002|NOT COMPLETED|Second Washout (7 Days)||0
6773047|NCT03996694|7700762|FG003|NOT COMPLETED|Second Washout (7 Days)||0
6773048|NCT03996694|7700763|FG004|NOT COMPLETED|Second Washout (7 Days)||0
6773049|NCT03996694|7700764|FG005|NOT COMPLETED|Second Washout (7 Days)||0
6773050|NCT03996694|7700759|FG000|STARTED|Third Intervention (1 Day)||3
6773051|NCT03996694|7700760|FG001|STARTED|Third Intervention (1 Day)||2
6773052|NCT03996694|7700761|FG002|STARTED|Third Intervention (1 Day)||2
6773053|NCT03996694|7700762|FG003|STARTED|Third Intervention (1 Day)||3
6773054|NCT03996694|7700763|FG004|STARTED|Third Intervention (1 Day)||3
6773055|NCT03996694|7700764|FG005|STARTED|Third Intervention (1 Day)||3
6773056|NCT03996694|7700759|FG000|COMPLETED|Third Intervention (1 Day)||3
6773057|NCT03996694|7700760|FG001|COMPLETED|Third Intervention (1 Day)||2
6773058|NCT03996694|7700761|FG002|COMPLETED|Third Intervention (1 Day)||2
6773059|NCT03996694|7700762|FG003|COMPLETED|Third Intervention (1 Day)||3
6773060|NCT03996694|7700763|FG004|COMPLETED|Third Intervention (1 Day)||3
6773061|NCT03996694|7700764|FG005|COMPLETED|Third Intervention (1 Day)||3
6773062|NCT03996694|7700759|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6773063|NCT03996694|7700760|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6773064|NCT03996694|7700761|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6773065|NCT03996694|7700762|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6773066|NCT03996694|7700763|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
6773067|NCT03996694|7700764|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
6773068|NCT03996694|7700759|FG000|STARTED|Third Washout (7 Days)||3
6773069|NCT03996694|7700760|FG001|STARTED|Third Washout (7 Days)||2
6773070|NCT03996694|7700761|FG002|STARTED|Third Washout (7 Days)||2
6773071|NCT03996694|7700762|FG003|STARTED|Third Washout (7 Days)||3
6773072|NCT03996694|7700763|FG004|STARTED|Third Washout (7 Days)||3
6773073|NCT03996694|7700764|FG005|STARTED|Third Washout (7 Days)||3
6773074|NCT03996694|7700759|FG000|COMPLETED|Third Washout (7 Days)||3
6773075|NCT03996694|7700760|FG001|COMPLETED|Third Washout (7 Days)||2
6773076|NCT03996694|7700761|FG002|COMPLETED|Third Washout (7 Days)||2
6773077|NCT03996694|7700762|FG003|COMPLETED|Third Washout (7 Days)||3
6773078|NCT03996694|7700763|FG004|COMPLETED|Third Washout (7 Days)||2
6773079|NCT03996694|7700764|FG005|COMPLETED|Third Washout (7 Days)||3
6773080|NCT03996694|7700759|FG000|NOT COMPLETED|Third Washout (7 Days)||0
6773081|NCT03996694|7700760|FG001|NOT COMPLETED|Third Washout (7 Days)||0
6773082|NCT03996694|7700761|FG002|NOT COMPLETED|Third Washout (7 Days)||0
6773083|NCT03996694|7700762|FG003|NOT COMPLETED|Third Washout (7 Days)||0
6773084|NCT03996694|7700763|FG004|NOT COMPLETED|Third Washout (7 Days)||1
6773085|NCT03996694|7700764|FG005|NOT COMPLETED|Third Washout (7 Days)||0
6773086|NCT03996694|7700759|FG000|STARTED|Fourth Intervention (1 Day)||3
6773087|NCT03996694|7700760|FG001|STARTED|Fourth Intervention (1 Day)||2
6773088|NCT03996694|7700761|FG002|STARTED|Fourth Intervention (1 Day)||2
6773089|NCT03996694|7700762|FG003|STARTED|Fourth Intervention (1 Day)||3
6773090|NCT03996694|7700763|FG004|STARTED|Fourth Intervention (1 Day)||2
6773091|NCT03996694|7700764|FG005|STARTED|Fourth Intervention (1 Day)||3
6773092|NCT03996694|7700759|FG000|COMPLETED|Fourth Intervention (1 Day)||3
6773093|NCT03996694|7700760|FG001|COMPLETED|Fourth Intervention (1 Day)||2
6773094|NCT03996694|7700761|FG002|COMPLETED|Fourth Intervention (1 Day)||2
6773095|NCT03996694|7700762|FG003|COMPLETED|Fourth Intervention (1 Day)||3
6773096|NCT03996694|7700763|FG004|COMPLETED|Fourth Intervention (1 Day)||2
6773097|NCT03996694|7700764|FG005|COMPLETED|Fourth Intervention (1 Day)||3
6773098|NCT03996694|7700759|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
6773099|NCT03996694|7700760|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
6773100|NCT03996694|7700761|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
6773101|NCT03996694|7700762|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
6773102|NCT03996694|7700763|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
6773103|NCT03996694|7700764|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
6773104|NCT03996694|7700759|FG000|STARTED|Fourth Washout (7 Days)||3
6773105|NCT03996694|7700760|FG001|STARTED|Fourth Washout (7 Days)||2
6773106|NCT03996694|7700761|FG002|STARTED|Fourth Washout (7 Days)||2
6773107|NCT03996694|7700762|FG003|STARTED|Fourth Washout (7 Days)||3
6773108|NCT03996694|7700763|FG004|STARTED|Fourth Washout (7 Days)||2
6773109|NCT03996694|7700764|FG005|STARTED|Fourth Washout (7 Days)||3
6773110|NCT03996694|7700759|FG000|COMPLETED|Fourth Washout (7 Days)||3
6773111|NCT03996694|7700760|FG001|COMPLETED|Fourth Washout (7 Days)||2
6773112|NCT03996694|7700761|FG002|COMPLETED|Fourth Washout (7 Days)||2
6773113|NCT03996694|7700762|FG003|COMPLETED|Fourth Washout (7 Days)||3
6773114|NCT03996694|7700763|FG004|COMPLETED|Fourth Washout (7 Days)||2
6773115|NCT03996694|7700764|FG005|COMPLETED|Fourth Washout (7 Days)||3
6773116|NCT03996694|7700759|FG000|NOT COMPLETED|Fourth Washout (7 Days)||0
6773117|NCT03996694|7700760|FG001|NOT COMPLETED|Fourth Washout (7 Days)||0
6773118|NCT03996694|7700761|FG002|NOT COMPLETED|Fourth Washout (7 Days)||0
6773119|NCT03996694|7700762|FG003|NOT COMPLETED|Fourth Washout (7 Days)||0
6773120|NCT03996694|7700763|FG004|NOT COMPLETED|Fourth Washout (7 Days)||0
6773121|NCT03996694|7700764|FG005|NOT COMPLETED|Fourth Washout (7 Days)||0
6773122|NCT03996694|7700759|FG000|STARTED|Fifth Intervention (1 Day)||3
6773123|NCT03996694|7700760|FG001|STARTED|Fifth Intervention (1 Day)||2
6773124|NCT03996694|7700761|FG002|STARTED|Fifth Intervention (1 Day)||2
6773125|NCT03996694|7700762|FG003|STARTED|Fifth Intervention (1 Day)||3
6773126|NCT03996694|7700763|FG004|STARTED|Fifth Intervention (1 Day)||2
6773127|NCT03996694|7700764|FG005|STARTED|Fifth Intervention (1 Day)||3
6773128|NCT03996694|7700759|FG000|COMPLETED|Fifth Intervention (1 Day)||3
6773129|NCT03996694|7700760|FG001|COMPLETED|Fifth Intervention (1 Day)||2
6773130|NCT03996694|7700761|FG002|COMPLETED|Fifth Intervention (1 Day)||2
6773131|NCT03996694|7700762|FG003|COMPLETED|Fifth Intervention (1 Day)||3
6773132|NCT03996694|7700763|FG004|COMPLETED|Fifth Intervention (1 Day)||2
6773133|NCT03996694|7700764|FG005|COMPLETED|Fifth Intervention (1 Day)||3
6773134|NCT03996694|7700759|FG000|NOT COMPLETED|Fifth Intervention (1 Day)||0
6773135|NCT03996694|7700760|FG001|NOT COMPLETED|Fifth Intervention (1 Day)||0
6773136|NCT03996694|7700761|FG002|NOT COMPLETED|Fifth Intervention (1 Day)||0
6773137|NCT03996694|7700762|FG003|NOT COMPLETED|Fifth Intervention (1 Day)||0
6773138|NCT03996694|7700763|FG004|NOT COMPLETED|Fifth Intervention (1 Day)||0
6773139|NCT03996694|7700764|FG005|NOT COMPLETED|Fifth Intervention (1 Day)||0
6773140|NCT03996694|7700759|FG000|STARTED|Fifth Washout (7 Days)||3
6773141|NCT03996694|7700760|FG001|STARTED|Fifth Washout (7 Days)||2
6773142|NCT03996694|7700761|FG002|STARTED|Fifth Washout (7 Days)||2
6773143|NCT03996694|7700762|FG003|STARTED|Fifth Washout (7 Days)||3
6773144|NCT03996694|7700763|FG004|STARTED|Fifth Washout (7 Days)||2
6773145|NCT03996694|7700764|FG005|STARTED|Fifth Washout (7 Days)||3
6773146|NCT03996694|7700759|FG000|COMPLETED|Fifth Washout (7 Days)||3
6773147|NCT03996694|7700760|FG001|COMPLETED|Fifth Washout (7 Days)||2
6773148|NCT03996694|7700761|FG002|COMPLETED|Fifth Washout (7 Days)||2
6773149|NCT03996694|7700762|FG003|COMPLETED|Fifth Washout (7 Days)||3
6773150|NCT03996694|7700763|FG004|COMPLETED|Fifth Washout (7 Days)||2
6773151|NCT03996694|7700764|FG005|COMPLETED|Fifth Washout (7 Days)||3
6773152|NCT03996694|7700759|FG000|NOT COMPLETED|Fifth Washout (7 Days)||0
6773153|NCT03996694|7700760|FG001|NOT COMPLETED|Fifth Washout (7 Days)||0
6773154|NCT03996694|7700761|FG002|NOT COMPLETED|Fifth Washout (7 Days)||0
6773155|NCT03996694|7700762|FG003|NOT COMPLETED|Fifth Washout (7 Days)||0
6773156|NCT03996694|7700763|FG004|NOT COMPLETED|Fifth Washout (7 Days)||0
6773157|NCT03996694|7700764|FG005|NOT COMPLETED|Fifth Washout (7 Days)||0
6773158|NCT03996694|7700759|FG000|STARTED|Sixth Intervention (1 Day)||3
6773159|NCT03996694|7700760|FG001|STARTED|Sixth Intervention (1 Day)||2
6773160|NCT03996694|7700761|FG002|STARTED|Sixth Intervention (1 Day)||2
6773161|NCT03996694|7700762|FG003|STARTED|Sixth Intervention (1 Day)||3
6773162|NCT03996694|7700763|FG004|STARTED|Sixth Intervention (1 Day)||2
6773163|NCT03996694|7700764|FG005|STARTED|Sixth Intervention (1 Day)||3
6773164|NCT03996694|7700759|FG000|COMPLETED|Sixth Intervention (1 Day)||3
6773165|NCT03996694|7700760|FG001|COMPLETED|Sixth Intervention (1 Day)||2
6773166|NCT03996694|7700761|FG002|COMPLETED|Sixth Intervention (1 Day)||2
6773167|NCT03996694|7700762|FG003|COMPLETED|Sixth Intervention (1 Day)||3
6773168|NCT03996694|7700763|FG004|COMPLETED|Sixth Intervention (1 Day)||2
6773169|NCT03996694|7700764|FG005|COMPLETED|Sixth Intervention (1 Day)||3
6773170|NCT03996694|7700759|FG000|NOT COMPLETED|Sixth Intervention (1 Day)||0
6773171|NCT03996694|7700760|FG001|NOT COMPLETED|Sixth Intervention (1 Day)||0
6773172|NCT03996694|7700761|FG002|NOT COMPLETED|Sixth Intervention (1 Day)||0
6773173|NCT03996694|7700762|FG003|NOT COMPLETED|Sixth Intervention (1 Day)||0
6773174|NCT03996694|7700763|FG004|NOT COMPLETED|Sixth Intervention (1 Day)||0
6773175|NCT03996694|7700764|FG005|NOT COMPLETED|Sixth Intervention (1 Day)||0
6773176|NCT03988907|7700780|FG000|STARTED|Overall Study||8
6773177|NCT03988907|7700781|FG001|STARTED|Overall Study||27
6773178|NCT03988907|7700780|FG000|COMPLETED|Overall Study||8
6773179|NCT03988907|7700781|FG001|COMPLETED|Overall Study||26
6773180|NCT03988907|7700780|FG000|NOT COMPLETED|Overall Study||0
6773181|NCT03988907|7700781|FG001|NOT COMPLETED|Overall Study||1
6773182|NCT03988088|7700795|FG000|STARTED|Single-Dose Pharmacokinetic Study||11
6773183|NCT03988088|7700796|FG001|STARTED|Single-Dose Pharmacokinetic Study||7
6773184|NCT03988088|7700797|FG002|STARTED|Single-Dose Pharmacokinetic Study||0
6773185|NCT03988088|7700798|FG003|STARTED|Single-Dose Pharmacokinetic Study||0
6773186|NCT03988088|7700795|FG000|COMPLETED|Single-Dose Pharmacokinetic Study||11
6773187|NCT03988088|7700796|FG001|COMPLETED|Single-Dose Pharmacokinetic Study||6
6773188|NCT03988088|7700797|FG002|COMPLETED|Single-Dose Pharmacokinetic Study||0
6773189|NCT03988088|7700798|FG003|COMPLETED|Single-Dose Pharmacokinetic Study||0
6773190|NCT03988088|7700795|FG000|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
6773191|NCT03988088|7700796|FG001|NOT COMPLETED|Single-Dose Pharmacokinetic Study||1
6773192|NCT03988088|7700797|FG002|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
6773193|NCT03988088|7700798|FG003|NOT COMPLETED|Single-Dose Pharmacokinetic Study||0
6773194|NCT03988088|7700795|FG000|STARTED|Open-Label Addendum||0
6773195|NCT03988088|7700796|FG001|STARTED|Open-Label Addendum||0
6773196|NCT03988088|7700797|FG002|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
6556756|NCT01763827|7479178|FG001|COMPLETED|Overall Study||77
6556757|NCT01763827|7479179|FG002|COMPLETED|Overall Study||73
6773197|NCT03988088|7700798|FG003|STARTED|Open-Label Addendum|The US participants had the option to enter this optional 3-month open-label extension addendum.|2
6773198|NCT03988088|7700795|FG000|COMPLETED|Open-Label Addendum||0
6773199|NCT03988088|7700796|FG001|COMPLETED|Open-Label Addendum||0
6773200|NCT03988088|7700797|FG002|COMPLETED|Open-Label Addendum||1
6773201|NCT03988088|7700798|FG003|COMPLETED|Open-Label Addendum||2
6773202|NCT03988088|7700795|FG000|NOT COMPLETED|Open-Label Addendum||0
6773203|NCT03988088|7700796|FG001|NOT COMPLETED|Open-Label Addendum||0
6773204|NCT03988088|7700797|FG002|NOT COMPLETED|Open-Label Addendum||1
6773205|NCT03988088|7700798|FG003|NOT COMPLETED|Open-Label Addendum||0
6773206|NCT03980522|7700811|FG000|STARTED|Treatment Period||13
6773207|NCT03980522|7700812|FG001|STARTED|Treatment Period||3
6773208|NCT03980522|7700813|FG002|STARTED|Treatment Period||6
6773209|NCT03980522|7700814|FG003|STARTED|Treatment Period||1
6773210|NCT03980522|7700815|FG004|STARTED|Treatment Period||3
6773211|NCT03980522|7700811|FG000|COMPLETED|Treatment Period||12
6773212|NCT03980522|7700812|FG001|COMPLETED|Treatment Period||3
6556758|NCT01763827|7479180|FG003|COMPLETED|Overall Study||76
6556759|NCT01763827|7479181|FG004|COMPLETED|Overall Study||147
6556760|NCT01763827|7479182|FG005|COMPLETED|Overall Study||151
6773213|NCT03980522|7700813|FG002|COMPLETED|Treatment Period||6
6773214|NCT03980522|7700814|FG003|COMPLETED|Treatment Period||1
6773215|NCT03980522|7700815|FG004|COMPLETED|Treatment Period||3
6773216|NCT03980522|7700811|FG000|NOT COMPLETED|Treatment Period||1
6773217|NCT03980522|7700812|FG001|NOT COMPLETED|Treatment Period||0
6773218|NCT03980522|7700813|FG002|NOT COMPLETED|Treatment Period||0
6773219|NCT03980522|7700814|FG003|NOT COMPLETED|Treatment Period||0
6773220|NCT03980522|7700815|FG004|NOT COMPLETED|Treatment Period||0
6773221|NCT03980522|7700811|FG000|STARTED|Extension Period||12
6773222|NCT03980522|7700812|FG001|STARTED|Extension Period||3
6773223|NCT03980522|7700813|FG002|STARTED|Extension Period|1 participant did not sign the optional Extension Period consent form.|5
6773224|NCT03980522|7700814|FG003|STARTED|Extension Period||1
6773225|NCT03980522|7700815|FG004|STARTED|Extension Period||3
6773226|NCT03980522|7700811|FG000|COMPLETED|Extension Period||12
6773227|NCT03980522|7700812|FG001|COMPLETED|Extension Period||3
6773228|NCT03980522|7700813|FG002|COMPLETED|Extension Period||5
6773229|NCT03980522|7700814|FG003|COMPLETED|Extension Period||1
6773230|NCT03980522|7700815|FG004|COMPLETED|Extension Period||3
6773231|NCT03980522|7700811|FG000|NOT COMPLETED|Extension Period||0
6773232|NCT03980522|7700812|FG001|NOT COMPLETED|Extension Period||0
6773233|NCT03980522|7700813|FG002|NOT COMPLETED|Extension Period||0
6773234|NCT03980522|7700814|FG003|NOT COMPLETED|Extension Period||0
6773235|NCT03980522|7700815|FG004|NOT COMPLETED|Extension Period||0
6773236|NCT03999684|7700827|FG000|STARTED|Overall Study||18
6773237|NCT03999684|7700827|FG000|COMPLETED|Overall Study||18
6773238|NCT03999684|7700827|FG000|NOT COMPLETED|Overall Study||0
6773239|NCT03995784|7700831|FG000|STARTED|Overall Study||6
6773240|NCT03995784|7700831|FG000|COMPLETED|Overall Study||5
6773241|NCT03995784|7700831|FG000|NOT COMPLETED|Overall Study||1
6773242|NCT03993392|7700842|FG000|STARTED|Overall Study||26
6773243|NCT03993392|7700842|FG000|Treated With SUBLOCADE|Overall Study||24
6773244|NCT03993392|7700842|FG000|COMPLETED|Overall Study||20
6773245|NCT03993392|7700842|FG000|NOT COMPLETED|Overall Study||6
6773246|NCT03989427|7700849|FG000|STARTED|First Intervention (2 Weeks)||15
6773247|NCT03989427|7700850|FG001|STARTED|First Intervention (2 Weeks)||15
6773248|NCT03989427|7700849|FG000|COMPLETED|First Intervention (2 Weeks)||15
6773249|NCT03989427|7700850|FG001|COMPLETED|First Intervention (2 Weeks)||15
6773250|NCT03989427|7700849|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6773251|NCT03989427|7700850|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
6773252|NCT03989427|7700849|FG000|STARTED|Washout (1 Week)||15
6773253|NCT03989427|7700850|FG001|STARTED|Washout (1 Week)||15
6773254|NCT03989427|7700849|FG000|COMPLETED|Washout (1 Week)||15
6773255|NCT03989427|7700850|FG001|COMPLETED|Washout (1 Week)||15
6773256|NCT03989427|7700849|FG000|NOT COMPLETED|Washout (1 Week)||0
6773257|NCT03989427|7700850|FG001|NOT COMPLETED|Washout (1 Week)||0
6773258|NCT03989427|7700849|FG000|STARTED|Second Intervention (2 Weeks)||15
6773259|NCT03989427|7700850|FG001|STARTED|Second Intervention (2 Weeks)||15
6773260|NCT03989427|7700849|FG000|COMPLETED|Second Intervention (2 Weeks)||15
6773261|NCT03989427|7700850|FG001|COMPLETED|Second Intervention (2 Weeks)||15
6773262|NCT03989427|7700849|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6773263|NCT03989427|7700850|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6773264|NCT03981822|7700865|FG000|STARTED|Overall Study||5
6773265|NCT03981822|7700866|FG001|STARTED|Overall Study||5
6556761|NCT01763827|7479177|FG000|NOT COMPLETED|Overall Study||3
6556762|NCT01763827|7479178|FG001|NOT COMPLETED|Overall Study||1
6773266|NCT03981822|7700867|FG002|STARTED|Overall Study||5
6773267|NCT03981822|7700868|FG003|STARTED|Overall Study||3
6773268|NCT03981822|7700869|FG004|STARTED|Overall Study||25
6773269|NCT03981822|7700870|FG005|STARTED|Overall Study||23
6773270|NCT03981822|7700871|FG006|STARTED|Overall Study||22
6773271|NCT03981822|7700872|FG007|STARTED|Overall Study||17
6773272|NCT03981822|7700865|FG000|COMPLETED|Overall Study||5
6773273|NCT03981822|7700866|FG001|COMPLETED|Overall Study||3
6773274|NCT03981822|7700867|FG002|COMPLETED|Overall Study||4
6773275|NCT03981822|7700868|FG003|COMPLETED|Overall Study||3
6773276|NCT03981822|7700869|FG004|COMPLETED|Overall Study||17
6773277|NCT03981822|7700870|FG005|COMPLETED|Overall Study||17
6773278|NCT03981822|7700871|FG006|COMPLETED|Overall Study||16
6773279|NCT03981822|7700872|FG007|COMPLETED|Overall Study||12
6773280|NCT03981822|7700865|FG000|NOT COMPLETED|Overall Study||0
6773281|NCT03981822|7700866|FG001|NOT COMPLETED|Overall Study||2
6556763|NCT01763827|7479179|FG002|NOT COMPLETED|Overall Study||4
6773282|NCT03981822|7700867|FG002|NOT COMPLETED|Overall Study||1
6773283|NCT03981822|7700868|FG003|NOT COMPLETED|Overall Study||0
6773284|NCT03981822|7700869|FG004|NOT COMPLETED|Overall Study||8
6773285|NCT03981822|7700870|FG005|NOT COMPLETED|Overall Study||6
6773286|NCT03981822|7700871|FG006|NOT COMPLETED|Overall Study||6
6773287|NCT03981822|7700872|FG007|NOT COMPLETED|Overall Study||5
6773288|NCT03992482|7700886|FG000|STARTED|Overall Study||13
6773289|NCT03992482|7700887|FG001|STARTED|Overall Study||14
6773290|NCT03992482|7700886|FG000|COMPLETED|Overall Study||13
6773291|NCT03992482|7700887|FG001|COMPLETED|Overall Study||14
6773292|NCT03992482|7700886|FG000|NOT COMPLETED|Overall Study||0
6773293|NCT03992482|7700887|FG001|NOT COMPLETED|Overall Study||0
6773294|NCT03993119|7700897|FG000|STARTED|Overall Study||192
6773295|NCT03993119|7700898|FG001|STARTED|Overall Study||76
6773296|NCT03993119|7700899|FG002|STARTED|Overall Study||166
6773297|NCT03993119|7700900|FG003|STARTED|Overall Study||66
6773298|NCT03993119|7700897|FG000|COMPLETED|Overall Study||192
6773299|NCT03993119|7700898|FG001|COMPLETED|Overall Study||76
6773300|NCT03993119|7700899|FG002|COMPLETED|Overall Study||166
6773301|NCT03993119|7700900|FG003|COMPLETED|Overall Study||66
6773302|NCT03993119|7700897|FG000|NOT COMPLETED|Overall Study||0
6773303|NCT03993119|7700898|FG001|NOT COMPLETED|Overall Study||0
6773304|NCT03993119|7700899|FG002|NOT COMPLETED|Overall Study||0
6773305|NCT03993119|7700900|FG003|NOT COMPLETED|Overall Study||0
6773306|NCT03991494|7700925|FG000|STARTED|Overall Study||4
6773307|NCT03991494|7700925|FG000|COMPLETED|Overall Study||0
6773308|NCT03991494|7700925|FG000|NOT COMPLETED|Overall Study||4
6773309|NCT03989570|7700934|FG000|STARTED|Overall Study||31
6773310|NCT03989570|7700935|FG001|STARTED|Overall Study||31
6773311|NCT03989570|7700936|FG002|STARTED|Overall Study||31
6773312|NCT03989570|7700934|FG000|COMPLETED|Overall Study||31
6773313|NCT03989570|7700935|FG001|COMPLETED|Overall Study||31
6773314|NCT03989570|7700936|FG002|COMPLETED|Overall Study||31
6773315|NCT03989570|7700934|FG000|NOT COMPLETED|Overall Study||0
6773316|NCT03989570|7700935|FG001|NOT COMPLETED|Overall Study||0
6773317|NCT03989570|7700936|FG002|NOT COMPLETED|Overall Study||0
6773318|NCT03988803|7700944|FG000|STARTED|Screening||16
6773319|NCT03988803|7700944|FG000|COMPLETED|Screening||16
6773320|NCT03988803|7700944|FG000|NOT COMPLETED|Screening||0
6773321|NCT03988803|7700944|FG000|STARTED|Period 1||16
6773322|NCT03988803|7700944|FG000|COMPLETED|Period 1||16
6773323|NCT03988803|7700944|FG000|NOT COMPLETED|Period 1||0
6556764|NCT01763827|7479180|FG003|NOT COMPLETED|Overall Study||1
6556765|NCT01763827|7479181|FG004|NOT COMPLETED|Overall Study||6
6556766|NCT01763827|7479182|FG005|NOT COMPLETED|Overall Study||2
6556767|NCT01763866|7479220|FG000|STARTED|Overall Study||56
6556768|NCT01763866|7479221|FG001|STARTED|Overall Study||55
6556769|NCT01763866|7479222|FG002|STARTED|Overall Study||56
6556770|NCT01763866|7479223|FG003|STARTED|Overall Study||55
6556771|NCT01763866|7479224|FG004|STARTED|Overall Study||110
6556772|NCT01763866|7479225|FG005|STARTED|Overall Study||110
6556773|NCT01763866|7479226|FG006|STARTED|Overall Study||55
6556774|NCT01763866|7479227|FG007|STARTED|Overall Study||55
6556775|NCT01763866|7479228|FG008|STARTED|Overall Study||56
6556776|NCT01763866|7479229|FG009|STARTED|Overall Study||54
6556777|NCT01763866|7479230|FG010|STARTED|Overall Study||110
6556778|NCT01763866|7479231|FG011|STARTED|Overall Study||110
6556779|NCT01763866|7479232|FG012|STARTED|Overall Study||58
6556780|NCT01763866|7479233|FG013|STARTED|Overall Study||57
6556781|NCT01763866|7479234|FG014|STARTED|Overall Study||114
6556782|NCT01763866|7479235|FG015|STARTED|Overall Study||115
6556783|NCT01763866|7479236|FG016|STARTED|Overall Study||56
6556784|NCT01763866|7479237|FG017|STARTED|Overall Study||56
6556785|NCT01763866|7479238|FG018|STARTED|Overall Study||111
6556786|NCT01763866|7479239|FG019|STARTED|Overall Study||112
6556787|NCT01763866|7479240|FG020|STARTED|Overall Study||56
6556788|NCT01763866|7479241|FG021|STARTED|Overall Study||55
6556789|NCT01763866|7479242|FG022|STARTED|Overall Study||112
6556790|NCT01763866|7479243|FG023|STARTED|Overall Study||115
6556791|NCT01763866|7479220|FG000|Received Treatment|Overall Study||56
6556792|NCT01763866|7479221|FG001|Received Treatment|Overall Study||55
6556793|NCT01763866|7479222|FG002|Received Treatment|Overall Study||56
6556794|NCT01763866|7479223|FG003|Received Treatment|Overall Study||55
6556795|NCT01763866|7479224|FG004|Received Treatment|Overall Study||110
6556796|NCT01763866|7479225|FG005|Received Treatment|Overall Study||110
6556797|NCT01763866|7479226|FG006|Received Treatment|Overall Study||55
6556798|NCT01763866|7479227|FG007|Received Treatment|Overall Study||55
6556799|NCT01763866|7479228|FG008|Received Treatment|Overall Study||56
6556800|NCT01763866|7479229|FG009|Received Treatment|Overall Study||54
6556801|NCT01763866|7479230|FG010|Received Treatment|Overall Study||109
6773324|NCT03988803|7700944|FG000|STARTED|Period 2||16
6773325|NCT03988803|7700944|FG000|Treated|Period 2||15
6773326|NCT03988803|7700944|FG000|Started Days 1 - 7: Multiple Doses of 5 mg Memantine qd|Period 2||15
6773327|NCT03988803|7700944|FG000|Started Days 8 - 14: Multiple Doses of 10 mg Memantine qd|Period 2||14
6773328|NCT03988803|7700944|FG000|Started Days 15 - 21: Multiple Doses of 15 mg Memantine qd|Period 2||13
6773329|NCT03988803|7700944|FG000|Started Days 22 - 35: Multiple Doses of 20 mg Memantine qd|Period 2||13
6556802|NCT01763866|7479231|FG011|Received Treatment|Overall Study||110
6556803|NCT01763866|7479232|FG012|Received Treatment|Overall Study||58
6556804|NCT01763866|7479233|FG013|Received Treatment|Overall Study||57
6556805|NCT01763866|7479234|FG014|Received Treatment|Overall Study||113
6773330|NCT03988803|7700944|FG000|COMPLETED|Period 2||13
6773331|NCT03988803|7700944|FG000|NOT COMPLETED|Period 2||3
6556806|NCT01763866|7479235|FG015|Received Treatment|Overall Study||115
6556807|NCT01763866|7479236|FG016|Received Treatment|Overall Study||56
6556808|NCT01763866|7479237|FG017|Received Treatment|Overall Study||55
6556809|NCT01763866|7479238|FG018|Received Treatment|Overall Study||111
6556810|NCT01763866|7479239|FG019|Received Treatment|Overall Study||112
6556811|NCT01763866|7479240|FG020|Received Treatment|Overall Study||56
6556812|NCT01763866|7479241|FG021|Received Treatment|Overall Study||55
6773332|NCT03988803|7700944|FG000|STARTED|Period 3||13
6773333|NCT03988803|7700944|FG000|COMPLETED|Period 3||13
6773334|NCT03988803|7700944|FG000|NOT COMPLETED|Period 3||0
6773335|NCT03987932|7700955|FG000|STARTED|Overall Study||4
6773336|NCT03987932|7700956|FG001|STARTED|Overall Study||3
6773337|NCT03987932|7700957|FG002|STARTED|Overall Study||4
6773338|NCT03987932|7700955|FG000|1 Month|Overall Study||4
6773339|NCT03987932|7700956|FG001|1 Month|Overall Study||2
6773340|NCT03987932|7700957|FG002|1 Month|Overall Study||3
6773341|NCT03987932|7700955|FG000|3 Months|Overall Study||4
6773342|NCT03987932|7700956|FG001|3 Months|Overall Study||2
6773343|NCT03987932|7700957|FG002|3 Months|Overall Study||3
6773344|NCT03987932|7700955|FG000|6 Months|Overall Study||2
6773345|NCT03987932|7700956|FG001|6 Months|Overall Study||2
6773346|NCT03987932|7700957|FG002|6 Months|Overall Study||2
6773347|NCT03987932|7700955|FG000|COMPLETED|Overall Study||2
6773348|NCT03987932|7700956|FG001|COMPLETED|Overall Study||2
6773349|NCT03987932|7700957|FG002|COMPLETED|Overall Study||2
6773350|NCT03987932|7700955|FG000|NOT COMPLETED|Overall Study||2
6773351|NCT03987932|7700956|FG001|NOT COMPLETED|Overall Study||1
6773352|NCT03987932|7700957|FG002|NOT COMPLETED|Overall Study||2
6773353|NCT03987191|7700967|FG000|STARTED|Overall Study||17
6773354|NCT03987191|7700968|FG001|STARTED|Overall Study||15
6773355|NCT03987191|7700967|FG000|Data Collected|Overall Study||17
6773356|NCT03987191|7700968|FG001|Data Collected|Overall Study||13
6773357|NCT03987191|7700967|FG000|COMPLETED|Overall Study||17
6773358|NCT03987191|7700968|FG001|COMPLETED|Overall Study||13
6773359|NCT03987191|7700967|FG000|NOT COMPLETED|Overall Study||0
6773360|NCT03987191|7700968|FG001|NOT COMPLETED|Overall Study||2
6773361|NCT03988842|7700974|FG000|STARTED|Overall Study||4
6773362|NCT03988842|7700974|FG000|COMPLETED|Overall Study||3
6773363|NCT03988842|7700974|FG000|NOT COMPLETED|Overall Study||1
6773364|NCT03981861|7700979|FG000|STARTED|Overall Study||12
6773365|NCT03981861|7700979|FG000|COMPLETED|Overall Study||9
6773366|NCT03981861|7700979|FG000|NOT COMPLETED|Overall Study||3
6773367|NCT03974334|7700983|FG000|STARTED|Overall Study||25
6773368|NCT03974334|7700983|FG000|COMPLETED|Overall Study||24
6773369|NCT03974334|7700983|FG000|NOT COMPLETED|Overall Study||1
6773370|NCT03988426|7700987|FG000|STARTED|Overall Study||25
6773371|NCT03988426|7700987|FG000|COMPLETED|Overall Study||24
6773372|NCT03988426|7700987|FG000|NOT COMPLETED|Overall Study||1
6773373|NCT03988374|7700996|FG000|STARTED|Overall Study||104
6773374|NCT03988374|7700997|FG001|STARTED|Overall Study||107
6773375|NCT03988374|7700998|FG002|STARTED|Overall Study||108
6773376|NCT03988374|7700996|FG000|COMPLETED|Overall Study||103
6773377|NCT03988374|7700997|FG001|COMPLETED|Overall Study||105
6773378|NCT03988374|7700998|FG002|COMPLETED|Overall Study||107
6773379|NCT03988374|7700996|FG000|NOT COMPLETED|Overall Study||1
6556813|NCT01763866|7479242|FG022|Received Treatment|Overall Study||112
6556814|NCT01763866|7479243|FG023|Received Treatment|Overall Study||115
6556815|NCT01763866|7479220|FG000|COMPLETED|Overall Study||54
6773380|NCT03988374|7700997|FG001|NOT COMPLETED|Overall Study||2
6773381|NCT03988374|7700998|FG002|NOT COMPLETED|Overall Study||1
6556816|NCT01763866|7479221|FG001|COMPLETED|Overall Study||54
6654904|NCT02448810|7584911|FG004|Treated|Overall Study||29
6654905|NCT02448810|7584912|FG005|Treated|Overall Study||13
6654906|NCT02448810|7584913|FG006|Treated|Overall Study||18
6654907|NCT02448810|7584914|FG007|Treated|Overall Study||7
6654908|NCT02448810|7584907|FG000|COMPLETED|Overall Study||0
6305908|NCT00371397|7209316|FG000|COMPLETED|Session 1||4
6305909|NCT00371397|7209317|FG001|COMPLETED|Session 1||7
6556817|NCT01763866|7479222|FG002|COMPLETED|Overall Study||51
6556818|NCT01763866|7479223|FG003|COMPLETED|Overall Study||55
6556819|NCT01763866|7479224|FG004|COMPLETED|Overall Study||108
6556820|NCT01763866|7479225|FG005|COMPLETED|Overall Study||107
6556821|NCT01763866|7479226|FG006|COMPLETED|Overall Study||48
6556822|NCT01763866|7479227|FG007|COMPLETED|Overall Study||55
6556823|NCT01763866|7479228|FG008|COMPLETED|Overall Study||53
6556824|NCT01763866|7479229|FG009|COMPLETED|Overall Study||53
6556825|NCT01763866|7479230|FG010|COMPLETED|Overall Study||102
6556826|NCT01763866|7479231|FG011|COMPLETED|Overall Study||108
6556827|NCT01763866|7479232|FG012|COMPLETED|Overall Study||54
6556828|NCT01763866|7479233|FG013|COMPLETED|Overall Study||57
6556829|NCT01763866|7479234|FG014|COMPLETED|Overall Study||102
6556830|NCT01763866|7479235|FG015|COMPLETED|Overall Study||112
6556831|NCT01763866|7479236|FG016|COMPLETED|Overall Study||55
6556832|NCT01763866|7479237|FG017|COMPLETED|Overall Study||55
6305910|NCT00371397|7209318|FG002|COMPLETED|Session 1||5
6305911|NCT00371397|7209319|FG003|COMPLETED|Session 1||2
6498286|NCT01408719|7416844|FG018|NOT COMPLETED|Fourth Intervention (35 Days)||0
6498287|NCT01408719|7416845|FG019|NOT COMPLETED|Fourth Intervention (35 Days)||0
6305912|NCT00371397|7209320|FG004|COMPLETED|Session 1||3
6305913|NCT00371397|7209321|FG005|COMPLETED|Session 1||4
6305914|NCT00371397|7209322|FG006|COMPLETED|Session 1||4
6305915|NCT00371397|7209323|FG007|COMPLETED|Session 1||4
6305916|NCT00371397|7209324|FG008|COMPLETED|Session 1||6
6305917|NCT00371397|7209325|FG009|COMPLETED|Session 1||5
6305918|NCT00371397|7209326|FG010|COMPLETED|Session 1||4
6305919|NCT00371397|7209327|FG011|COMPLETED|Session 1||2
6305920|NCT00371397|7209316|FG000|NOT COMPLETED|Session 1||1
6305921|NCT00371397|7209317|FG001|NOT COMPLETED|Session 1||0
6305922|NCT00371397|7209318|FG002|NOT COMPLETED|Session 1||0
6305923|NCT00371397|7209319|FG003|NOT COMPLETED|Session 1||0
6305924|NCT00371397|7209320|FG004|NOT COMPLETED|Session 1||0
6305925|NCT00371397|7209321|FG005|NOT COMPLETED|Session 1||0
6305926|NCT00371397|7209322|FG006|NOT COMPLETED|Session 1||0
6305927|NCT00371397|7209323|FG007|NOT COMPLETED|Session 1||1
6305928|NCT00371397|7209324|FG008|NOT COMPLETED|Session 1||0
6305929|NCT00371397|7209325|FG009|NOT COMPLETED|Session 1||0
6305930|NCT00371397|7209326|FG010|NOT COMPLETED|Session 1||0
6305931|NCT00371397|7209327|FG011|NOT COMPLETED|Session 1||0
6305932|NCT00371397|7209316|FG000|STARTED|Session 2||4
6305933|NCT00371397|7209317|FG001|STARTED|Session 2||7
6305934|NCT00371397|7209318|FG002|STARTED|Session 2||5
6305935|NCT00371397|7209319|FG003|STARTED|Session 2||2
6305936|NCT00371397|7209320|FG004|STARTED|Session 2||3
6305937|NCT00371397|7209321|FG005|STARTED|Session 2||4
6305938|NCT00371397|7209322|FG006|STARTED|Session 2||4
6305939|NCT00371397|7209323|FG007|STARTED|Session 2||4
6305940|NCT00371397|7209324|FG008|STARTED|Session 2||6
6305941|NCT00371397|7209325|FG009|STARTED|Session 2||5
6305942|NCT00371397|7209326|FG010|STARTED|Session 2||4
6305943|NCT00371397|7209327|FG011|STARTED|Session 2||2
6305944|NCT00371397|7209316|FG000|COMPLETED|Session 2||4
6305945|NCT00371397|7209317|FG001|COMPLETED|Session 2||7
6305946|NCT00371397|7209318|FG002|COMPLETED|Session 2||5
6305947|NCT00371397|7209319|FG003|COMPLETED|Session 2||2
6305948|NCT00371397|7209320|FG004|COMPLETED|Session 2||3
6305949|NCT00371397|7209321|FG005|COMPLETED|Session 2||4
6305950|NCT00371397|7209322|FG006|COMPLETED|Session 2||4
6305951|NCT00371397|7209323|FG007|COMPLETED|Session 2||4
6305952|NCT00371397|7209324|FG008|COMPLETED|Session 2||6
6305953|NCT00371397|7209325|FG009|COMPLETED|Session 2||5
6305954|NCT00371397|7209326|FG010|COMPLETED|Session 2||4
6305955|NCT00371397|7209327|FG011|COMPLETED|Session 2||2
6305956|NCT00371397|7209316|FG000|NOT COMPLETED|Session 2||0
6305957|NCT00371397|7209317|FG001|NOT COMPLETED|Session 2||0
6305958|NCT00371397|7209318|FG002|NOT COMPLETED|Session 2||0
6305959|NCT00371397|7209319|FG003|NOT COMPLETED|Session 2||0
6305960|NCT00371397|7209320|FG004|NOT COMPLETED|Session 2||0
6305961|NCT00371397|7209321|FG005|NOT COMPLETED|Session 2||0
6305962|NCT00371397|7209322|FG006|NOT COMPLETED|Session 2||0
6305963|NCT00371397|7209323|FG007|NOT COMPLETED|Session 2||0
6305964|NCT00371397|7209324|FG008|NOT COMPLETED|Session 2||0
6305965|NCT00371397|7209325|FG009|NOT COMPLETED|Session 2||0
6305966|NCT00371397|7209326|FG010|NOT COMPLETED|Session 2||0
6305967|NCT00371397|7209327|FG011|NOT COMPLETED|Session 2||0
6305968|NCT00371397|7209316|FG000|STARTED|Session 3||4
6305969|NCT00371397|7209317|FG001|STARTED|Session 3||7
6305970|NCT00371397|7209318|FG002|STARTED|Session 3||5
6305971|NCT00371397|7209319|FG003|STARTED|Session 3||2
6305972|NCT00371397|7209320|FG004|STARTED|Session 3||3
6305973|NCT00371397|7209321|FG005|STARTED|Session 3||4
6305974|NCT00371397|7209322|FG006|STARTED|Session 3||4
6305975|NCT00371397|7209323|FG007|STARTED|Session 3||4
6305976|NCT00371397|7209324|FG008|STARTED|Session 3||6
6305977|NCT00371397|7209325|FG009|STARTED|Session 3||5
6305978|NCT00371397|7209326|FG010|STARTED|Session 3||4
6305979|NCT00371397|7209327|FG011|STARTED|Session 3||2
6305980|NCT00371397|7209316|FG000|COMPLETED|Session 3||4
6305981|NCT00371397|7209317|FG001|COMPLETED|Session 3||7
6305982|NCT00371397|7209318|FG002|COMPLETED|Session 3||5
6305983|NCT00371397|7209319|FG003|COMPLETED|Session 3||2
6305984|NCT00371397|7209320|FG004|COMPLETED|Session 3||3
6305985|NCT00371397|7209321|FG005|COMPLETED|Session 3||4
6305986|NCT00371397|7209322|FG006|COMPLETED|Session 3||4
6305987|NCT00371397|7209323|FG007|COMPLETED|Session 3||4
6305988|NCT00371397|7209324|FG008|COMPLETED|Session 3||6
6305989|NCT00371397|7209325|FG009|COMPLETED|Session 3||5
6305990|NCT00371397|7209326|FG010|COMPLETED|Session 3||4
6305991|NCT00371397|7209327|FG011|COMPLETED|Session 3||2
6305992|NCT00371397|7209316|FG000|NOT COMPLETED|Session 3||0
6305993|NCT00371397|7209317|FG001|NOT COMPLETED|Session 3||0
6305994|NCT00371397|7209318|FG002|NOT COMPLETED|Session 3||0
6305995|NCT00371397|7209319|FG003|NOT COMPLETED|Session 3||0
6305996|NCT00371397|7209320|FG004|NOT COMPLETED|Session 3||0
6305997|NCT00371397|7209321|FG005|NOT COMPLETED|Session 3||0
6305998|NCT00371397|7209322|FG006|NOT COMPLETED|Session 3||0
6305999|NCT00371397|7209323|FG007|NOT COMPLETED|Session 3||0
6306000|NCT00371397|7209324|FG008|NOT COMPLETED|Session 3||0
6306001|NCT00371397|7209325|FG009|NOT COMPLETED|Session 3||0
6306002|NCT00371397|7209326|FG010|NOT COMPLETED|Session 3||0
6556833|NCT01763866|7479238|FG018|COMPLETED|Overall Study||105
6556834|NCT01763866|7479239|FG019|COMPLETED|Overall Study||110
6556835|NCT01763866|7479240|FG020|COMPLETED|Overall Study||52
6556836|NCT01763866|7479241|FG021|COMPLETED|Overall Study||54
6556837|NCT01763866|7479242|FG022|COMPLETED|Overall Study||109
6556838|NCT01763866|7479243|FG023|COMPLETED|Overall Study||113
6556839|NCT01763866|7479220|FG000|NOT COMPLETED|Overall Study||2
6556840|NCT01763866|7479221|FG001|NOT COMPLETED|Overall Study||1
6556841|NCT01763866|7479222|FG002|NOT COMPLETED|Overall Study||5
6556842|NCT01763866|7479223|FG003|NOT COMPLETED|Overall Study||0
6654909|NCT02448810|7584908|FG001|COMPLETED|Overall Study||0
6654910|NCT02448810|7584909|FG002|COMPLETED|Overall Study||0
6654911|NCT02448810|7584910|FG003|COMPLETED|Overall Study||0
6654912|NCT02448810|7584911|FG004|COMPLETED|Overall Study||0
6654913|NCT02448810|7584912|FG005|COMPLETED|Overall Study||0
6654914|NCT02448810|7584913|FG006|COMPLETED|Overall Study||0
6654915|NCT02448810|7584914|FG007|COMPLETED|Overall Study||0
6556843|NCT01763866|7479224|FG004|NOT COMPLETED|Overall Study||2
6556844|NCT01763866|7479225|FG005|NOT COMPLETED|Overall Study||3
6556845|NCT01763866|7479226|FG006|NOT COMPLETED|Overall Study||7
6556846|NCT01763866|7479227|FG007|NOT COMPLETED|Overall Study||0
6556847|NCT01763866|7479228|FG008|NOT COMPLETED|Overall Study||3
6556848|NCT01763866|7479229|FG009|NOT COMPLETED|Overall Study||1
6556849|NCT01763866|7479230|FG010|NOT COMPLETED|Overall Study||8
6556850|NCT01763866|7479231|FG011|NOT COMPLETED|Overall Study||2
6556851|NCT01763866|7479232|FG012|NOT COMPLETED|Overall Study||4
6556852|NCT01763866|7479233|FG013|NOT COMPLETED|Overall Study||0
6556853|NCT01763866|7479234|FG014|NOT COMPLETED|Overall Study||12
6556854|NCT01763866|7479235|FG015|NOT COMPLETED|Overall Study||3
6556855|NCT01763866|7479236|FG016|NOT COMPLETED|Overall Study||1
6556856|NCT01763866|7479237|FG017|NOT COMPLETED|Overall Study||1
6556857|NCT01763866|7479238|FG018|NOT COMPLETED|Overall Study||6
6556858|NCT01763866|7479239|FG019|NOT COMPLETED|Overall Study||2
6556859|NCT01763866|7479240|FG020|NOT COMPLETED|Overall Study||4
6556860|NCT01763866|7479241|FG021|NOT COMPLETED|Overall Study||1
6556861|NCT01763866|7479242|FG022|NOT COMPLETED|Overall Study||3
6556862|NCT01763866|7479243|FG023|NOT COMPLETED|Overall Study||2
6556863|NCT01763905|7479297|FG000|STARTED|Overall Study||51
6556864|NCT01763905|7479298|FG001|STARTED|Overall Study||51
6556865|NCT01763905|7479299|FG002|STARTED|Overall Study||103
6556866|NCT01763905|7479300|FG003|STARTED|Overall Study||102
6556867|NCT01763905|7479297|FG000|COMPLETED|Overall Study||45
6556868|NCT01763905|7479298|FG001|COMPLETED|Overall Study||50
6556869|NCT01763905|7479299|FG002|COMPLETED|Overall Study||94
6556870|NCT01763905|7479300|FG003|COMPLETED|Overall Study||101
6556871|NCT01763905|7479297|FG000|NOT COMPLETED|Overall Study||6
6556872|NCT01763905|7479298|FG001|NOT COMPLETED|Overall Study||1
6556873|NCT01763905|7479299|FG002|NOT COMPLETED|Overall Study||9
6306003|NCT00371397|7209327|FG011|NOT COMPLETED|Session 3||0
6306004|NCT00371436|7209335|FG000|STARTED|Overall Study||92
6306005|NCT00371436|7209336|FG001|STARTED|Overall Study||89
6306006|NCT00371436|7209335|FG000|COMPLETED|Overall Study||58
6306007|NCT00371436|7209336|FG001|COMPLETED|Overall Study||68
6306008|NCT00371436|7209335|FG000|NOT COMPLETED|Overall Study||34
6306009|NCT00371436|7209336|FG001|NOT COMPLETED|Overall Study||21
6306010|NCT00371449|7209342|FG000|STARTED|Overall Study||120
6306011|NCT00371449|7209342|FG000|COMPLETED|Overall Study||120
6306012|NCT00371449|7209342|FG000|NOT COMPLETED|Overall Study||0
6306013|NCT00371540|7209350|FG000|STARTED|Overall Study||112
6306014|NCT00371540|7209351|FG001|STARTED|Overall Study||96
6306015|NCT00371540|7209350|FG000|COMPLETED|Overall Study||102
6306016|NCT00371540|7209351|FG001|COMPLETED|Overall Study||87
6306017|NCT00371540|7209350|FG000|NOT COMPLETED|Overall Study||10
6306018|NCT00371540|7209351|FG001|NOT COMPLETED|Overall Study||9
6306019|NCT00371566|7209359|FG000|STARTED|Treatment Phase||36
6306020|NCT00371566|7209360|FG001|STARTED|Treatment Phase||71
6306021|NCT00371566|7209359|FG000|COMPLETED|Treatment Phase||36
6306022|NCT00371566|7209360|FG001|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
6306023|NCT00371566|7209359|FG000|NOT COMPLETED|Treatment Phase||0
6306024|NCT00371566|7209360|FG001|NOT COMPLETED|Treatment Phase||3
6306025|NCT00371566|7209359|FG000|STARTED|Chemoradiation Phase||36
6306026|NCT00371566|7209360|FG001|STARTED|Chemoradiation Phase||68
6306027|NCT00371566|7209359|FG000|COMPLETED|Chemoradiation Phase||31
6306028|NCT00371566|7209360|FG001|COMPLETED|Chemoradiation Phase||65
6306029|NCT00371566|7209359|FG000|NOT COMPLETED|Chemoradiation Phase||5
6306030|NCT00371566|7209360|FG001|NOT COMPLETED|Chemoradiation Phase||3
6306031|NCT00371566|7209359|FG000|STARTED|Follow Up Phase||31
6306032|NCT00371566|7209360|FG001|STARTED|Follow Up Phase||65
6306033|NCT00371566|7209359|FG000|COMPLETED|Follow Up Phase||28
6306034|NCT00371566|7209360|FG001|COMPLETED|Follow Up Phase||58
6306035|NCT00371566|7209359|FG000|NOT COMPLETED|Follow Up Phase||3
6306036|NCT00371566|7209360|FG001|NOT COMPLETED|Follow Up Phase||7
6306037|NCT00371631|7209366|FG000|STARTED|Overall Study||13
6306038|NCT00371631|7209366|FG000|COMPLETED|Overall Study||13
6306039|NCT00371631|7209366|FG000|NOT COMPLETED|Overall Study||0
6306040|NCT00371644|7209372|FG000|STARTED|Overall Study||72
6306041|NCT00371644|7209373|FG001|STARTED|Overall Study||57
6306042|NCT00371644|7209372|FG000|COMPLETED|Overall Study||44
6306043|NCT00371644|7209373|FG001|COMPLETED|Overall Study||44
6306044|NCT00371644|7209372|FG000|NOT COMPLETED|Overall Study||28
6306045|NCT00371644|7209373|FG001|NOT COMPLETED|Overall Study||13
6306046|NCT00371683|7209381|FG000|STARTED|DB Treatment Period-Randomized Patients||1599
6306047|NCT00371683|7209382|FG001|STARTED|DB Treatment Period-Randomized Patients||1596
6306048|NCT00371683|7209381|FG000|COMPLETED|DB Treatment Period-Randomized Patients||1509
6306049|NCT00371683|7209382|FG001|COMPLETED|DB Treatment Period-Randomized Patients||1489
6306050|NCT00371683|7209381|FG000|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
6306051|NCT00371683|7209382|FG001|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
6306052|NCT00371683|7209381|FG000|STARTED|Follow-Up Period - Randomized Patients||1553
6306053|NCT00371683|7209382|FG001|STARTED|Follow-Up Period - Randomized Patients||1533
6306054|NCT00371683|7209381|FG000|COMPLETED|Follow-Up Period - Randomized Patients||1492
6306055|NCT00371683|7209382|FG001|COMPLETED|Follow-Up Period - Randomized Patients||1461
6306056|NCT00371683|7209381|FG000|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
6306057|NCT00371683|7209382|FG001|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
6306058|NCT00371761|7209400|FG000|STARTED|Overall Study||13
6306059|NCT00371761|7209401|FG001|STARTED|Overall Study||12
6306060|NCT00371761|7209400|FG000|COMPLETED|Overall Study||5
6306061|NCT00371761|7209401|FG001|COMPLETED|Overall Study||2
6306062|NCT00371761|7209400|FG000|NOT COMPLETED|Overall Study||8
6306063|NCT00371761|7209401|FG001|NOT COMPLETED|Overall Study||10
6306064|NCT00371787|7209409|FG000|STARTED|Overall Study||26
6556874|NCT01763905|7479300|FG003|NOT COMPLETED|Overall Study||1
6773382|NCT03987074|7701011|FG000|STARTED|Overall Study||21
6773383|NCT03987074|7701012|FG001|STARTED|Overall Study||22
6773384|NCT03987074|7701013|FG002|STARTED|Overall Study||22
6773385|NCT03987074|7701014|FG003|STARTED|Overall Study||22
6773386|NCT03987074|7701015|FG004|STARTED|Overall Study||21
6773387|NCT03987074|7701011|FG000|COMPLETED|Overall Study||18
6773388|NCT03987074|7701012|FG001|COMPLETED|Overall Study||20
6773389|NCT03987074|7701013|FG002|COMPLETED|Overall Study||21
6773390|NCT03987074|7701014|FG003|COMPLETED|Overall Study||18
6773391|NCT03987074|7701015|FG004|COMPLETED|Overall Study||19
6773392|NCT03987074|7701011|FG000|NOT COMPLETED|Overall Study||3
6773393|NCT03987074|7701012|FG001|NOT COMPLETED|Overall Study||2
6773394|NCT03987074|7701013|FG002|NOT COMPLETED|Overall Study||1
6773395|NCT03987074|7701014|FG003|NOT COMPLETED|Overall Study||4
6773396|NCT03987074|7701015|FG004|NOT COMPLETED|Overall Study||2
6773397|NCT03977935|7701029|FG000|STARTED|Overall Study||40
6773398|NCT03977935|7701030|FG001|STARTED|Overall Study||40
6773399|NCT03977935|7701029|FG000|COMPLETED|Overall Study||40
6773400|NCT03977935|7701030|FG001|COMPLETED|Overall Study||40
6773401|NCT03977935|7701029|FG000|NOT COMPLETED|Overall Study||0
6773402|NCT03977935|7701030|FG001|NOT COMPLETED|Overall Study||0
6773403|NCT03988049|7701038|FG000|STARTED|Overall Study||22
6773404|NCT03988049|7701039|FG001|STARTED|Overall Study||22
6773405|NCT03988049|7701038|FG000|COMPLETED|Overall Study||22
6773406|NCT03988049|7701039|FG001|COMPLETED|Overall Study||22
6773407|NCT03988049|7701038|FG000|NOT COMPLETED|Overall Study||0
6773408|NCT03988049|7701039|FG001|NOT COMPLETED|Overall Study||0
6773409|NCT03979820|7701049|FG000|STARTED|Overall Study||13
6773410|NCT03979820|7701050|FG001|STARTED|Overall Study||14
6773411|NCT03979820|7701051|FG002|STARTED|Overall Study||16
6773412|NCT03979820|7701052|FG003|STARTED|Overall Study||10
6556875|NCT01763918|7479314|FG000|STARTED|Overall Study||55
6556876|NCT01763918|7479315|FG001|STARTED|Overall Study||55
6556877|NCT01763918|7479316|FG002|STARTED|Overall Study||111
6556878|NCT01763918|7479317|FG003|STARTED|Overall Study||110
6556879|NCT01763918|7479314|FG000|Received Treatment|Overall Study||54
6556880|NCT01763918|7479315|FG001|Received Treatment|Overall Study||55
6556881|NCT01763918|7479316|FG002|Received Treatment|Overall Study||110
6556882|NCT01763918|7479317|FG003|Received Treatment|Overall Study||110
6556883|NCT01763918|7479314|FG000|COMPLETED|Overall Study||49
6556884|NCT01763918|7479315|FG001|COMPLETED|Overall Study||54
6556885|NCT01763918|7479316|FG002|COMPLETED|Overall Study||101
6556886|NCT01763918|7479317|FG003|COMPLETED|Overall Study||108
6556887|NCT01763918|7479314|FG000|NOT COMPLETED|Overall Study||6
6556888|NCT01763918|7479315|FG001|NOT COMPLETED|Overall Study||1
6556889|NCT01763918|7479316|FG002|NOT COMPLETED|Overall Study||10
6556890|NCT01763918|7479317|FG003|NOT COMPLETED|Overall Study||2
6556891|NCT01763931|7479329|FG000|STARTED|Overall Study||2
6556892|NCT01763931|7479330|FG001|STARTED|Overall Study||4
6556893|NCT01763931|7479329|FG000|COMPLETED|Overall Study||2
6556894|NCT01763931|7479330|FG001|COMPLETED|Overall Study||3
6556895|NCT01763931|7479329|FG000|NOT COMPLETED|Overall Study||0
6556896|NCT01763931|7479330|FG001|NOT COMPLETED|Overall Study||1
6556897|NCT01763970|7479336|FG000|STARTED|Overall Study||14
6556898|NCT01763970|7479336|FG000|COMPLETED|Overall Study||14
6556899|NCT01763970|7479336|FG000|NOT COMPLETED|Overall Study||0
6556900|NCT01763996|7479343|FG000|STARTED|Treatment Period 1||15
6556901|NCT01763996|7479344|FG001|STARTED|Treatment Period 1||15
6556902|NCT01763996|7479343|FG000|COMPLETED|Treatment Period 1||15
6556903|NCT01763996|7479344|FG001|COMPLETED|Treatment Period 1||15
6556904|NCT01763996|7479343|FG000|NOT COMPLETED|Treatment Period 1||0
6556905|NCT01763996|7479344|FG001|NOT COMPLETED|Treatment Period 1||0
6556906|NCT01763996|7479343|FG000|STARTED|Treatment Period 2||15
6556907|NCT01763996|7479344|FG001|STARTED|Treatment Period 2||15
6556908|NCT01763996|7479343|FG000|COMPLETED|Treatment Period 2||15
6556909|NCT01763996|7479344|FG001|COMPLETED|Treatment Period 2||14
6556910|NCT01763996|7479343|FG000|NOT COMPLETED|Treatment Period 2||0
6556911|NCT01763996|7479344|FG001|NOT COMPLETED|Treatment Period 2||1
6556912|NCT01764022|7479352|FG000|STARTED|Overall Study||115
6556913|NCT01764022|7479353|FG001|STARTED|Overall Study||110
6498288|NCT01408732|7416855|FG000|STARTED|Overall Study||9
6498289|NCT01408732|7416856|FG001|STARTED|Overall Study||9
6498290|NCT01408732|7416855|FG000|COMPLETED|Overall Study||7
6498291|NCT01408732|7416856|FG001|COMPLETED|Overall Study||7
6498292|NCT01408732|7416855|FG000|NOT COMPLETED|Overall Study||2
6498293|NCT01408732|7416856|FG001|NOT COMPLETED|Overall Study||2
6556914|NCT01764022|7479352|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
6562921|NCT01803607|7485845|FG000|COMPLETED|Overall Study||0
6498294|NCT01408862|7416862|FG000|STARTED|Overall Study||20
6498295|NCT01408862|7416862|FG000|COMPLETED|Overall Study||20
6498296|NCT01408862|7416862|FG000|NOT COMPLETED|Overall Study||0
6556915|NCT01764022|7479353|FG001|Received at Least 1 Dose of Study Drug|Overall Study||110
6556916|NCT01764022|7479352|FG000|COMPLETED|Overall Study||107
6556917|NCT01764022|7479353|FG001|COMPLETED|Overall Study||96
6556918|NCT01764022|7479352|FG000|NOT COMPLETED|Overall Study||8
6556919|NCT01764022|7479353|FG001|NOT COMPLETED|Overall Study||14
6556920|NCT01764256|7479365|FG000|STARTED|Received All Vaccinations||12
6556921|NCT01764256|7479366|FG001|STARTED|Received All Vaccinations||12
6556922|NCT01764256|7479367|FG002|STARTED|Received All Vaccinations||12
6556923|NCT01764256|7479368|FG003|STARTED|Received All Vaccinations||12
6306065|NCT00371787|7209410|FG001|STARTED|Overall Study||12
6306066|NCT00371787|7209409|FG000|COMPLETED|Overall Study||23
6306067|NCT00371787|7209410|FG001|COMPLETED|Overall Study||11
6306068|NCT00371787|7209409|FG000|NOT COMPLETED|Overall Study||3
6306069|NCT00371787|7209410|FG001|NOT COMPLETED|Overall Study||1
6306070|NCT00371826|7209419|FG000|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
6306071|NCT00371826|7209420|FG001|STARTED|Core Phase (12 Months)||47
6306072|NCT00371826|7209421|FG002|STARTED|Core Phase (12 Months)||30
6306073|NCT00371826|7209419|FG000|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
6306074|NCT00371826|7209420|FG001|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
6306075|NCT00371826|7209421|FG002|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
6306076|NCT00371826|7209419|FG000|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
6306077|NCT00371826|7209420|FG001|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
6306078|NCT00371826|7209421|FG002|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
6306079|NCT00371826|7209419|FG000|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
6306080|NCT00371826|7209420|FG001|COMPLETED|Core Phase (12 Months)||39
6306081|NCT00371826|7209421|FG002|COMPLETED|Core Phase (12 Months)||6
6306082|NCT00371826|7209419|FG000|NOT COMPLETED|Core Phase (12 Months)||24
6306083|NCT00371826|7209420|FG001|NOT COMPLETED|Core Phase (12 Months)||8
6306084|NCT00371826|7209421|FG002|NOT COMPLETED|Core Phase (12 Months)||24
6306085|NCT00371826|7209419|FG000|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
6306086|NCT00371826|7209420|FG001|STARTED|Extension Phase (24 Months)||39
6306087|NCT00371826|7209421|FG002|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
6306088|NCT00371826|7209419|FG000|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
6306089|NCT00371826|7209420|FG001|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
6306090|NCT00371826|7209421|FG002|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
6306091|NCT00371826|7209419|FG000|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
6306092|NCT00371826|7209420|FG001|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
6306093|NCT00371826|7209421|FG002|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
6306094|NCT00371826|7209419|FG000|COMPLETED|Extension Phase (24 Months)||18
6306095|NCT00371826|7209420|FG001|COMPLETED|Extension Phase (24 Months)||29
6556924|NCT01764256|7479365|FG000|COMPLETED|Received All Vaccinations||10
6556925|NCT01764256|7479366|FG001|COMPLETED|Received All Vaccinations||11
6556926|NCT01764256|7479367|FG002|COMPLETED|Received All Vaccinations||11
6556927|NCT01764256|7479368|FG003|COMPLETED|Received All Vaccinations||12
6556928|NCT01764256|7479365|FG000|NOT COMPLETED|Received All Vaccinations||2
6306096|NCT00371826|7209421|FG002|COMPLETED|Extension Phase (24 Months)||3
6306097|NCT00371826|7209419|FG000|NOT COMPLETED|Extension Phase (24 Months)||5
6306098|NCT00371826|7209420|FG001|NOT COMPLETED|Extension Phase (24 Months)||10
6306099|NCT00371826|7209421|FG002|NOT COMPLETED|Extension Phase (24 Months)||2
6306100|NCT00371839|7209432|FG000|STARTED|Overall Study||49
6306101|NCT00371839|7209433|FG001|STARTED|Overall Study||20
6306102|NCT00371839|7209434|FG002|STARTED|Overall Study||9
6306103|NCT00371839|7209432|FG000|COMPLETED|Overall Study||32
6306104|NCT00371839|7209433|FG001|COMPLETED|Overall Study||13
6306105|NCT00371839|7209434|FG002|COMPLETED|Overall Study||7
6306106|NCT00371839|7209432|FG000|NOT COMPLETED|Overall Study||17
6306107|NCT00371839|7209433|FG001|NOT COMPLETED|Overall Study||7
6306108|NCT00371839|7209434|FG002|NOT COMPLETED|Overall Study||2
6306109|NCT00371865|7209442|FG000|STARTED|Overall Study||57
6306110|NCT00371865|7209443|FG001|STARTED|Overall Study||57
6306111|NCT00371865|7209442|FG000|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
6374945|NCT00753337|7285545|FG000|COMPLETED|Overall Study||123
6556929|NCT01764256|7479366|FG001|NOT COMPLETED|Received All Vaccinations||1
6556930|NCT01764256|7479367|FG002|NOT COMPLETED|Received All Vaccinations||1
6556931|NCT01764256|7479368|FG003|NOT COMPLETED|Received All Vaccinations||0
6556932|NCT01764256|7479365|FG000|STARTED|Completed Study||10
6556933|NCT01764256|7479366|FG001|STARTED|Completed Study||11
6556934|NCT01764256|7479367|FG002|STARTED|Completed Study||11
6556935|NCT01764256|7479368|FG003|STARTED|Completed Study||12
6556936|NCT01764256|7479365|FG000|COMPLETED|Completed Study||10
6556937|NCT01764256|7479366|FG001|COMPLETED|Completed Study||11
6556938|NCT01764256|7479367|FG002|COMPLETED|Completed Study||11
6556939|NCT01764256|7479368|FG003|COMPLETED|Completed Study||11
6556940|NCT01764256|7479365|FG000|NOT COMPLETED|Completed Study||0
6556941|NCT01764256|7479366|FG001|NOT COMPLETED|Completed Study||0
6556942|NCT01764256|7479367|FG002|NOT COMPLETED|Completed Study||0
6556943|NCT01764256|7479368|FG003|NOT COMPLETED|Completed Study||1
6556944|NCT01764386|7479384|FG000|STARTED|Controlled Treatment Period (CTP)||153
6556945|NCT01764386|7479385|FG001|STARTED|Controlled Treatment Period (CTP)||89
6556946|NCT01764386|7479384|FG000|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
6556947|NCT01764386|7479385|FG001|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
6556948|NCT01764386|7479384|FG000|NOT COMPLETED|Controlled Treatment Period (CTP)||82
6556949|NCT01764386|7479385|FG001|NOT COMPLETED|Controlled Treatment Period (CTP)||7
6556950|NCT01764386|7479384|FG000|STARTED|Uncontrolled Treatment Period (UTP)||71
6556951|NCT01764386|7479385|FG001|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
6556952|NCT01764386|7479384|FG000|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
6556953|NCT01764386|7479385|FG001|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
6556954|NCT01764386|7479384|FG000|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
6556955|NCT01764386|7479385|FG001|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
6556956|NCT01764386|7479384|FG000|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
6556957|NCT01764386|7479385|FG001|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
6556958|NCT01764464|7479394|FG000|STARTED|First Intervention|Started Gralise|16
6556959|NCT01764464|7479395|FG001|STARTED|First Intervention|Started Placebo|16
6556960|NCT01764464|7479394|FG000|COMPLETED|First Intervention|Completed Gralise|14
6556961|NCT01764464|7479395|FG001|COMPLETED|First Intervention|Completed Placebo|13
6556962|NCT01764464|7479394|FG000|NOT COMPLETED|First Intervention||2
6556963|NCT01764464|7479395|FG001|NOT COMPLETED|First Intervention||3
6556964|NCT01764464|7479394|FG000|STARTED|Second Intervention (Cross-over)|Started Placebo|14
6556965|NCT01764464|7479395|FG001|STARTED|Second Intervention (Cross-over)|Started Gralise|13
6556966|NCT01764464|7479394|FG000|COMPLETED|Second Intervention (Cross-over)|Completed Placebo|12
6556967|NCT01764464|7479395|FG001|COMPLETED|Second Intervention (Cross-over)|Completed Gralise|13
6556968|NCT01764464|7479394|FG000|NOT COMPLETED|Second Intervention (Cross-over)||2
6556969|NCT01764464|7479395|FG001|NOT COMPLETED|Second Intervention (Cross-over)||0
6556970|NCT01764607|7479401|FG000|STARTED|Overall Study||1
6556971|NCT01764607|7479401|FG000|COMPLETED|Overall Study||1
6556972|NCT01764607|7479401|FG000|NOT COMPLETED|Overall Study||0
6556973|NCT01764633|7479407|FG000|STARTED|Overall Study||13780
6556974|NCT01764633|7479408|FG001|STARTED|Overall Study||13784
6556975|NCT01764633|7479407|FG000|Received Treatment|Overall Study||13756
6556976|NCT01764633|7479408|FG001|Received Treatment|Overall Study||13769
6556977|NCT01764633|7479407|FG000|COMPLETED|Overall Study||13662
6556978|NCT01764633|7479408|FG001|COMPLETED|Overall Study||13691
6556979|NCT01764633|7479407|FG000|NOT COMPLETED|Overall Study||118
6556980|NCT01764633|7479408|FG001|NOT COMPLETED|Overall Study||93
6556981|NCT01764659|7479414|FG000|STARTED|Overall Study||14
6556982|NCT01764659|7479414|FG000|COMPLETED|Overall Study||12
6556983|NCT01764659|7479414|FG000|NOT COMPLETED|Overall Study||2
6556984|NCT01764685|7479422|FG000|STARTED|Overall Study||0
6556985|NCT01764685|7479423|FG001|STARTED|Overall Study||4
6556986|NCT01764685|7479422|FG000|COMPLETED|Overall Study||0
6556987|NCT01764685|7479423|FG001|COMPLETED|Overall Study||3
6556988|NCT01764685|7479422|FG000|NOT COMPLETED|Overall Study||0
6556989|NCT01764685|7479423|FG001|NOT COMPLETED|Overall Study||1
6556990|NCT01764841|7479433|FG000|STARTED|Overall Study||141
6556991|NCT01764841|7479434|FG001|STARTED|Overall Study||137
6556992|NCT01764841|7479435|FG002|STARTED|Overall Study||70
6556993|NCT01764841|7479436|FG003|STARTED|Overall Study||68
6556994|NCT01764841|7479433|FG000|Participants Received Treatment|Overall Study|safety population|141
6556995|NCT01764841|7479434|FG001|Participants Received Treatment|Overall Study|safety population|136
6556996|NCT01764841|7479435|FG002|Participants Received Treatment|Overall Study|safety population|69
6556997|NCT01764841|7479436|FG003|Participants Received Treatment|Overall Study|safety population|68
6556998|NCT01764841|7479433|FG000|COMPLETED|Overall Study||118
6556999|NCT01764841|7479434|FG001|COMPLETED|Overall Study||111
6557000|NCT01764841|7479435|FG002|COMPLETED|Overall Study||56
6557001|NCT01764841|7479436|FG003|COMPLETED|Overall Study||49
6557002|NCT01764841|7479433|FG000|NOT COMPLETED|Overall Study||23
6557003|NCT01764841|7479434|FG001|NOT COMPLETED|Overall Study||26
6557004|NCT01764841|7479435|FG002|NOT COMPLETED|Overall Study||14
6557005|NCT01764841|7479436|FG003|NOT COMPLETED|Overall Study||19
6557006|NCT01764854|7479450|FG000|STARTED|Overall Study||8
6557007|NCT01764854|7479451|FG001|STARTED|Overall Study||8
6557008|NCT01764854|7479452|FG002|STARTED|Overall Study||37
6557009|NCT01764854|7479453|FG003|STARTED|Overall Study||35
6557010|NCT01764854|7479450|FG000|COMPLETED|Overall Study||8
6557011|NCT01764854|7479451|FG001|COMPLETED|Overall Study||8
6557012|NCT01764854|7479452|FG002|COMPLETED|Overall Study||31
6557013|NCT01764854|7479453|FG003|COMPLETED|Overall Study||33
6557014|NCT01764854|7479450|FG000|NOT COMPLETED|Overall Study||0
6557015|NCT01764854|7479451|FG001|NOT COMPLETED|Overall Study||0
6557016|NCT01764854|7479452|FG002|NOT COMPLETED|Overall Study||6
6557017|NCT01764854|7479453|FG003|NOT COMPLETED|Overall Study||2
6557018|NCT01764919|7479463|FG000|STARTED|Overall Study||4
6557019|NCT01764919|7479463|FG000|COMPLETED|Overall Study||4
6557020|NCT01764919|7479463|FG000|NOT COMPLETED|Overall Study||0
6557021|NCT01764945|7479475|FG000|STARTED|Overall Study||5
6557022|NCT01764945|7479476|FG001|STARTED|Overall Study||5
6557023|NCT01764945|7479477|FG002|STARTED|Overall Study||5
6557024|NCT01764945|7479478|FG003|STARTED|Overall Study||5
6557025|NCT01764945|7479479|FG004|STARTED|Overall Study||10
6557026|NCT01764945|7479480|FG005|STARTED|Overall Study||8
6557027|NCT01764945|7479481|FG006|STARTED|Overall Study||9
6557028|NCT01764945|7479482|FG007|STARTED|Overall Study||9
6557029|NCT01764945|7479475|FG000|COMPLETED|Overall Study||5
6557030|NCT01764945|7479476|FG001|COMPLETED|Overall Study||4
6557031|NCT01764945|7479477|FG002|COMPLETED|Overall Study||5
6557032|NCT01764945|7479478|FG003|COMPLETED|Overall Study||5
6557033|NCT01764945|7479479|FG004|COMPLETED|Overall Study||10
6557034|NCT01764945|7479480|FG005|COMPLETED|Overall Study||8
6557035|NCT01764945|7479481|FG006|COMPLETED|Overall Study||8
6557036|NCT01764945|7479482|FG007|COMPLETED|Overall Study||9
6557037|NCT01764945|7479475|FG000|NOT COMPLETED|Overall Study||0
6557038|NCT01764945|7479476|FG001|NOT COMPLETED|Overall Study||1
6557039|NCT01764945|7479477|FG002|NOT COMPLETED|Overall Study||0
6557040|NCT01764945|7479478|FG003|NOT COMPLETED|Overall Study||0
6557041|NCT01764945|7479479|FG004|NOT COMPLETED|Overall Study||0
6557042|NCT01764945|7479480|FG005|NOT COMPLETED|Overall Study||0
6557043|NCT01764945|7479481|FG006|NOT COMPLETED|Overall Study||1
6557044|NCT01764945|7479482|FG007|NOT COMPLETED|Overall Study||0
6557045|NCT01765153|7479502|FG000|STARTED|Training Phase 1||10
6557046|NCT01765153|7479503|FG001|STARTED|Training Phase 1||11
6557047|NCT01765153|7479502|FG000|COMPLETED|Training Phase 1||9
6557048|NCT01765153|7479503|FG001|COMPLETED|Training Phase 1||10
6557049|NCT01765153|7479502|FG000|NOT COMPLETED|Training Phase 1||1
6557050|NCT01765153|7479503|FG001|NOT COMPLETED|Training Phase 1||1
6557051|NCT01765153|7479502|FG000|STARTED|Rest Phase 1||9
6557052|NCT01765153|7479503|FG001|STARTED|Rest Phase 1||10
6557053|NCT01765153|7479502|FG000|COMPLETED|Rest Phase 1||9
6557054|NCT01765153|7479503|FG001|COMPLETED|Rest Phase 1||9
6557055|NCT01765153|7479502|FG000|NOT COMPLETED|Rest Phase 1||0
6557056|NCT01765153|7479503|FG001|NOT COMPLETED|Rest Phase 1||1
6557057|NCT01765153|7479502|FG000|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
6557058|NCT01765153|7479503|FG001|STARTED|Training Phase 2||9
6498297|NCT01408888|7416867|FG000|STARTED|First Intervention||18
6498298|NCT01408888|7416868|FG001|STARTED|First Intervention||11
6498299|NCT01408888|7416867|FG000|Received at Least 1 Dose of Drug|First Intervention||18
6498300|NCT01408888|7416868|FG001|Received at Least 1 Dose of Drug|First Intervention||11
6498301|NCT01408888|7416867|FG000|COMPLETED|First Intervention||18
6498302|NCT01408888|7416868|FG001|COMPLETED|First Intervention||8
6498303|NCT01408888|7416867|FG000|NOT COMPLETED|First Intervention||0
6498304|NCT01408888|7416868|FG001|NOT COMPLETED|First Intervention||3
6498305|NCT01408888|7416867|FG000|STARTED|Washout of at Least 21 Days||18
6498306|NCT01408888|7416868|FG001|STARTED|Washout of at Least 21 Days||8
6498307|NCT01408888|7416867|FG000|COMPLETED|Washout of at Least 21 Days||18
6498308|NCT01408888|7416868|FG001|COMPLETED|Washout of at Least 21 Days||8
6773413|NCT03979820|7701049|FG000|COMPLETED|Overall Study||7
6773414|NCT03979820|7701050|FG001|COMPLETED|Overall Study||14
6773415|NCT03979820|7701051|FG002|COMPLETED|Overall Study||15
6773416|NCT03979820|7701052|FG003|COMPLETED|Overall Study||0
6773417|NCT03979820|7701049|FG000|NOT COMPLETED|Overall Study||6
6773418|NCT03979820|7701050|FG001|NOT COMPLETED|Overall Study||0
6773419|NCT03979820|7701051|FG002|NOT COMPLETED|Overall Study||1
6773420|NCT03979820|7701052|FG003|NOT COMPLETED|Overall Study||10
6773421|NCT03972137|7701066|FG000|STARTED|Overall Study||10
6773422|NCT03972137|7701066|FG000|Enrolled|Overall Study||10
6773423|NCT03972137|7701066|FG000|Treatment Completed|Overall Study||6
6773424|NCT03972137|7701066|FG000|Follow-up Completed|Overall Study||4
6557059|NCT01765153|7479502|FG000|COMPLETED|Training Phase 2||10
6557060|NCT01765153|7479503|FG001|COMPLETED|Training Phase 2||8
6557061|NCT01765153|7479502|FG000|NOT COMPLETED|Training Phase 2||0
6557062|NCT01765153|7479503|FG001|NOT COMPLETED|Training Phase 2||1
6557063|NCT01765153|7479502|FG000|STARTED|Rest Phase 2||10
6557064|NCT01765153|7479503|FG001|STARTED|Rest Phase 2||8
6557065|NCT01765153|7479502|FG000|COMPLETED|Rest Phase 2||8
6557066|NCT01765153|7479503|FG001|COMPLETED|Rest Phase 2||7
6557067|NCT01765153|7479502|FG000|NOT COMPLETED|Rest Phase 2||2
6557068|NCT01765153|7479503|FG001|NOT COMPLETED|Rest Phase 2||1
6557069|NCT01765179|7479513|FG000|STARTED|Overall Study||144
6557070|NCT01765179|7479513|FG000|COMPLETED|Overall Study||117
6557071|NCT01765179|7479513|FG000|NOT COMPLETED|Overall Study||27
6557072|NCT01765192|7479519|FG000|STARTED|Treatment Period 1||32
6557073|NCT01765192|7479520|FG001|STARTED|Treatment Period 1||32
6557074|NCT01765192|7479519|FG000|COMPLETED|Treatment Period 1||32
6557075|NCT01765192|7479520|FG001|COMPLETED|Treatment Period 1||31
6557076|NCT01765192|7479519|FG000|NOT COMPLETED|Treatment Period 1||0
6557077|NCT01765192|7479520|FG001|NOT COMPLETED|Treatment Period 1||1
6557078|NCT01765192|7479519|FG000|STARTED|Washout Period||32
6557079|NCT01765192|7479520|FG001|STARTED|Washout Period||31
6557080|NCT01765192|7479519|FG000|COMPLETED|Washout Period||30
6557081|NCT01765192|7479520|FG001|COMPLETED|Washout Period||30
6557082|NCT01765192|7479519|FG000|NOT COMPLETED|Washout Period||2
6557083|NCT01765192|7479520|FG001|NOT COMPLETED|Washout Period||1
6557084|NCT01765192|7479519|FG000|STARTED|Treatment Period 2||30
6557085|NCT01765192|7479520|FG001|STARTED|Treatment Period 2||30
6557086|NCT01765192|7479519|FG000|COMPLETED|Treatment Period 2||30
6557087|NCT01765192|7479520|FG001|COMPLETED|Treatment Period 2||28
6557088|NCT01765192|7479519|FG000|NOT COMPLETED|Treatment Period 2||0
6557089|NCT01765192|7479520|FG001|NOT COMPLETED|Treatment Period 2||2
6557090|NCT01765192|7479519|FG000|STARTED|End of Treatment Period 2 to Final Visit||30
6557091|NCT01765192|7479520|FG001|STARTED|End of Treatment Period 2 to Final Visit||28
6557092|NCT01765192|7479519|FG000|COMPLETED|End of Treatment Period 2 to Final Visit||30
6557093|NCT01765192|7479520|FG001|COMPLETED|End of Treatment Period 2 to Final Visit||27
6557094|NCT01765192|7479519|FG000|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
6557095|NCT01765192|7479520|FG001|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
6557096|NCT01765270|7479528|FG000|STARTED|Overall Study||5
6557097|NCT01765270|7479529|FG001|STARTED|Overall Study||7
6557098|NCT01765270|7479528|FG000|COMPLETED|Overall Study||4
6557099|NCT01765270|7479529|FG001|COMPLETED|Overall Study||6
6557100|NCT01765270|7479528|FG000|NOT COMPLETED|Overall Study||1
6557101|NCT01765270|7479529|FG001|NOT COMPLETED|Overall Study||1
6557102|NCT01765426|7479540|FG000|STARTED|Overall Study||18
6557103|NCT01765426|7479541|FG001|STARTED|Overall Study||17
6557104|NCT01765426|7479542|FG002|STARTED|Overall Study||17
6557105|NCT01765426|7479543|FG003|STARTED|Overall Study||15
6557106|NCT01765426|7479540|FG000|Completed All Vaccinations|Overall Study||17
6557107|NCT01765426|7479541|FG001|Completed All Vaccinations|Overall Study||16
6557108|NCT01765426|7479542|FG002|Completed All Vaccinations|Overall Study||17
6557109|NCT01765426|7479543|FG003|Completed All Vaccinations|Overall Study||15
6557110|NCT01765426|7479540|FG000|COMPLETED|Overall Study||18
6557111|NCT01765426|7479541|FG001|COMPLETED|Overall Study||16
6557112|NCT01765426|7479542|FG002|COMPLETED|Overall Study||17
6557113|NCT01765426|7479543|FG003|COMPLETED|Overall Study||15
6557114|NCT01765426|7479540|FG000|NOT COMPLETED|Overall Study||0
6557115|NCT01765426|7479541|FG001|NOT COMPLETED|Overall Study||1
6557116|NCT01765426|7479542|FG002|NOT COMPLETED|Overall Study||0
6557117|NCT01765426|7479543|FG003|NOT COMPLETED|Overall Study||0
6557118|NCT01765465|7479555|FG000|STARTED|Overall Study||71
6557119|NCT01765465|7479556|FG001|STARTED|Overall Study||67
6557120|NCT01765465|7479555|FG000|COMPLETED|Overall Study||64
6557121|NCT01765465|7479556|FG001|COMPLETED|Overall Study||63
6557122|NCT01765465|7479555|FG000|NOT COMPLETED|Overall Study||7
6557123|NCT01765465|7479556|FG001|NOT COMPLETED|Overall Study||4
6557124|NCT01765530|7479566|FG000|STARTED|Overall Study||37
6557125|NCT01765530|7479567|FG001|STARTED|Overall Study||37
6557126|NCT01765530|7479566|FG000|COMPLETED|Overall Study||36
6557127|NCT01765530|7479567|FG001|COMPLETED|Overall Study||36
6557128|NCT01765530|7479566|FG000|NOT COMPLETED|Overall Study||1
6557129|NCT01765530|7479567|FG001|NOT COMPLETED|Overall Study||1
6557130|NCT01765543|7479573|FG000|STARTED|Overall Study||27
6557131|NCT01765543|7479573|FG000|COMPLETED|Overall Study||24
6557132|NCT01765543|7479573|FG000|NOT COMPLETED|Overall Study||3
6557133|NCT01765569|7479581|FG000|STARTED|Period A||29
6557134|NCT01765569|7479581|FG000|COMPLETED|Period A||29
6557135|NCT01765569|7479581|FG000|NOT COMPLETED|Period A||0
6557136|NCT01765569|7479581|FG000|STARTED|Period B||29
6557137|NCT01765569|7479581|FG000|COMPLETED|Period B||28
6557138|NCT01765569|7479581|FG000|NOT COMPLETED|Period B||1
6557139|NCT01765569|7479581|FG000|STARTED|Period C||28
6557140|NCT01765569|7479581|FG000|COMPLETED|Period C||27
6557141|NCT01765569|7479581|FG000|NOT COMPLETED|Period C||1
6557142|NCT01765582|7479591|FG000|STARTED|Overall Study||93
6557143|NCT01765582|7479592|FG001|STARTED|Overall Study||92
6557144|NCT01765582|7479593|FG002|STARTED|Overall Study||95
6557145|NCT01765582|7479591|FG000|COMPLETED|Overall Study||0
6557146|NCT01765582|7479592|FG001|COMPLETED|Overall Study||0
6557147|NCT01765582|7479593|FG002|COMPLETED|Overall Study||0
6557148|NCT01765582|7479591|FG000|NOT COMPLETED|Overall Study||93
6557149|NCT01765582|7479592|FG001|NOT COMPLETED|Overall Study||92
6557150|NCT01765582|7479593|FG002|NOT COMPLETED|Overall Study||95
6557151|NCT01765647|7479602|FG000|STARTED|Overall Study|One began the run-in period, but was withdrawn prior to beginning treatment with AGY|10
6557152|NCT01765647|7479602|FG000|COMPLETED|Overall Study|10 entered the AGY treatment phase and all 10 completed treatment.|10
6557153|NCT01765647|7479602|FG000|NOT COMPLETED|Overall Study||0
6557154|NCT01765673|7479606|FG000|STARTED|Overall Study||12
6557155|NCT01765673|7479606|FG000|COMPLETED|Overall Study||11
6557156|NCT01765673|7479606|FG000|NOT COMPLETED|Overall Study||1
6557157|NCT01765712|7479615|FG000|STARTED|Overall Study||27
6557158|NCT01765712|7479616|FG001|STARTED|Overall Study||23
6557159|NCT01765712|7479615|FG000|COMPLETED|Overall Study||27
6557160|NCT01765712|7479616|FG001|COMPLETED|Overall Study||23
6557161|NCT01765712|7479615|FG000|NOT COMPLETED|Overall Study||0
6557162|NCT01765712|7479616|FG001|NOT COMPLETED|Overall Study||0
6557163|NCT01765751|7479625|FG000|STARTED|Overall Study||16
6557164|NCT01765751|7479626|FG001|STARTED|Overall Study||16
6557165|NCT01765751|7479627|FG002|STARTED|Overall Study||16
6557166|NCT01765751|7479625|FG000|COMPLETED|Overall Study||16
6557167|NCT01765751|7479626|FG001|COMPLETED|Overall Study||14
6557168|NCT01765751|7479627|FG002|COMPLETED|Overall Study||15
6557169|NCT01765751|7479625|FG000|NOT COMPLETED|Overall Study||0
6557170|NCT01765751|7479626|FG001|NOT COMPLETED|Overall Study||2
6557171|NCT01765751|7479627|FG002|NOT COMPLETED|Overall Study||1
6557172|NCT01765764|7479641|FG000|STARTED|Treatment Period||118
6557173|NCT01765764|7479642|FG001|STARTED|Treatment Period||118
6557174|NCT01765764|7479643|FG002|STARTED|Treatment Period||121
6557175|NCT01765764|7479641|FG000|COMPLETED|Treatment Period||115
6557176|NCT01765764|7479642|FG001|COMPLETED|Treatment Period||109
6557177|NCT01765764|7479643|FG002|COMPLETED|Treatment Period||115
6557178|NCT01765764|7479641|FG000|NOT COMPLETED|Treatment Period||3
6557179|NCT01765764|7479642|FG001|NOT COMPLETED|Treatment Period||9
6557180|NCT01765764|7479643|FG002|NOT COMPLETED|Treatment Period||6
6557181|NCT01765764|7479641|FG000|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
6557182|NCT01765764|7479642|FG001|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
6557183|NCT01765764|7479643|FG002|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
6557184|NCT01765764|7479641|FG000|COMPLETED|Post-treatment Period||114
6557185|NCT01765764|7479642|FG001|COMPLETED|Post-treatment Period||107
6557186|NCT01765764|7479643|FG002|COMPLETED|Post-treatment Period||112
6557187|NCT01765764|7479641|FG000|NOT COMPLETED|Post-treatment Period||0
6557188|NCT01765764|7479642|FG001|NOT COMPLETED|Post-treatment Period||0
6557189|NCT01765764|7479643|FG002|NOT COMPLETED|Post-treatment Period||0
6557190|NCT01765803|7479651|FG000|STARTED|Overall Study||6
6557191|NCT01765803|7479651|FG000|COMPLETED|Overall Study||6
6557192|NCT01765803|7479651|FG000|NOT COMPLETED|Overall Study||0
6557193|NCT01765920|7479657|FG000|STARTED|Overall Study||169
6557194|NCT01765920|7479658|FG001|STARTED|Overall Study||173
6557195|NCT01765920|7479657|FG000|COMPLETED|Overall Study||167
6557196|NCT01765920|7479658|FG001|COMPLETED|Overall Study||167
6557197|NCT01765920|7479657|FG000|NOT COMPLETED|Overall Study||2
6557198|NCT01765920|7479658|FG001|NOT COMPLETED|Overall Study||6
6557199|NCT01765972|7479664|FG000|STARTED|Overall Study||6
6557200|NCT01765972|7479665|FG001|STARTED|Overall Study||6
6557201|NCT01765972|7479666|FG002|STARTED|Overall Study||6
6557202|NCT01765972|7479667|FG003|STARTED|Overall Study||6
6557203|NCT01765972|7479664|FG000|COMPLETED|Overall Study||6
6557204|NCT01765972|7479665|FG001|COMPLETED|Overall Study||6
6557205|NCT01765972|7479666|FG002|COMPLETED|Overall Study||6
6557206|NCT01765972|7479667|FG003|COMPLETED|Overall Study||6
6557207|NCT01765972|7479664|FG000|NOT COMPLETED|Overall Study||0
6557208|NCT01765972|7479665|FG001|NOT COMPLETED|Overall Study||0
6557209|NCT01765972|7479666|FG002|NOT COMPLETED|Overall Study||0
6557210|NCT01765972|7479667|FG003|NOT COMPLETED|Overall Study||0
6557211|NCT01766024|7479679|FG000|STARTED|Overall Study||16
6557212|NCT01766024|7479680|FG001|STARTED|Overall Study||16
6557213|NCT01766024|7479679|FG000|COMPLETED|Overall Study||16
6557214|NCT01766024|7479680|FG001|COMPLETED|Overall Study||16
6557215|NCT01766024|7479679|FG000|NOT COMPLETED|Overall Study||0
6557216|NCT01766024|7479680|FG001|NOT COMPLETED|Overall Study||0
6557217|NCT01766037|7479690|FG000|STARTED|Overall Study||111
6557218|NCT01766037|7479691|FG001|STARTED|Overall Study||60
6557219|NCT01766037|7479690|FG000|COMPLETED|Overall Study||82
6557220|NCT01766037|7479691|FG001|COMPLETED|Overall Study||31
6557221|NCT01766037|7479690|FG000|NOT COMPLETED|Overall Study||29
6557222|NCT01766037|7479691|FG001|NOT COMPLETED|Overall Study||29
6557223|NCT01766050|7479697|FG000|STARTED|Overall Study||22
6557224|NCT01766050|7479697|FG000|COMPLETED|Overall Study||18
6557225|NCT01766050|7479697|FG000|NOT COMPLETED|Overall Study||4
6557226|NCT01766076|7479717|FG000|STARTED|Overall Study||15
6557227|NCT01766076|7479718|FG001|STARTED|Overall Study||15
6557228|NCT01766076|7479717|FG000|COMPLETED|Overall Study||15
6557229|NCT01766076|7479718|FG001|COMPLETED|Overall Study||15
6557230|NCT01766076|7479717|FG000|NOT COMPLETED|Overall Study||0
6557231|NCT01766076|7479718|FG001|NOT COMPLETED|Overall Study||0
6557232|NCT01766102|7479726|FG000|STARTED|Overall Study||36
6557233|NCT01766102|7479727|FG001|STARTED|Overall Study||36
6557234|NCT01766102|7479726|FG000|COMPLETED|Overall Study||36
6557235|NCT01766102|7479727|FG001|COMPLETED|Overall Study||36
6557236|NCT01766102|7479726|FG000|NOT COMPLETED|Overall Study||0
6557237|NCT01766102|7479727|FG001|NOT COMPLETED|Overall Study||0
6557238|NCT01766206|7479733|FG000|STARTED|Overall Study||3939
6557239|NCT01766206|7479733|FG000|COMPLETED|Overall Study||3888
6557240|NCT01766206|7479733|FG000|NOT COMPLETED|Overall Study||51
6557241|NCT01766219|7479740|FG000|STARTED|Overall Study||4
6557242|NCT01766219|7479741|FG001|STARTED|Overall Study||2
6557243|NCT01766219|7479742|FG002|STARTED|Overall Study||11
6557244|NCT01766219|7479740|FG000|COMPLETED|Overall Study||4
6557245|NCT01766219|7479741|FG001|COMPLETED|Overall Study||2
6557246|NCT01766219|7479742|FG002|COMPLETED|Overall Study||11
6557247|NCT01766219|7479740|FG000|NOT COMPLETED|Overall Study||0
6557248|NCT01766219|7479741|FG001|NOT COMPLETED|Overall Study||0
6557249|NCT01766219|7479742|FG002|NOT COMPLETED|Overall Study||0
6557250|NCT01766310|7479753|FG000|STARTED|Overall Study||24
6557251|NCT01766310|7479754|FG001|STARTED|Overall Study||26
6557252|NCT01766310|7479753|FG000|COMPLETED|Overall Study||23
6557253|NCT01766310|7479754|FG001|COMPLETED|Overall Study||23
6557254|NCT01766310|7479753|FG000|NOT COMPLETED|Overall Study||1
6557255|NCT01766310|7479754|FG001|NOT COMPLETED|Overall Study||3
6557256|NCT01766336|7479762|FG000|STARTED|Overall Study||150
6557257|NCT01766336|7479763|FG001|STARTED|Overall Study||146
6557258|NCT01766336|7479762|FG000|COMPLETED|Overall Study||60
6557259|NCT01766336|7479763|FG001|COMPLETED|Overall Study||71
6557260|NCT01766336|7479762|FG000|NOT COMPLETED|Overall Study||90
6557261|NCT01766336|7479763|FG001|NOT COMPLETED|Overall Study||75
6557262|NCT01766401|7479771|FG000|STARTED|Overall Study||198
6557263|NCT01766401|7479772|FG001|STARTED|Overall Study||200
6557264|NCT01766401|7479771|FG000|COMPLETED|Overall Study||161
6557265|NCT01766401|7479772|FG001|COMPLETED|Overall Study||144
6557266|NCT01766401|7479771|FG000|NOT COMPLETED|Overall Study||37
6557267|NCT01766401|7479772|FG001|NOT COMPLETED|Overall Study||56
6557268|NCT01766440|7479778|FG000|STARTED|Overall Study||18
6557269|NCT01766440|7479778|FG000|COMPLETED|Overall Study||17
6557270|NCT01766440|7479778|FG000|NOT COMPLETED|Overall Study||1
6557271|NCT01766466|7479784|FG000|STARTED|Day 1||6
6557272|NCT01766466|7479785|FG001|STARTED|Day 1||0
6557273|NCT01766466|7479786|FG002|STARTED|Day 1||6
6557274|NCT01766466|7479787|FG003|STARTED|Day 1||0
6557275|NCT01766466|7479784|FG000|COMPLETED|Day 1||6
6557276|NCT01766466|7479785|FG001|COMPLETED|Day 1||0
6557277|NCT01766466|7479786|FG002|COMPLETED|Day 1||6
6557278|NCT01766466|7479787|FG003|COMPLETED|Day 1||0
6557279|NCT01766466|7479784|FG000|NOT COMPLETED|Day 1||0
6557280|NCT01766466|7479785|FG001|NOT COMPLETED|Day 1||0
6557281|NCT01766466|7479786|FG002|NOT COMPLETED|Day 1||0
6557282|NCT01766466|7479787|FG003|NOT COMPLETED|Day 1||0
6557283|NCT01766466|7479784|FG000|STARTED|Day 5||0
6557284|NCT01766466|7479785|FG001|STARTED|Day 5||6
6557285|NCT01766466|7479786|FG002|STARTED|Day 5||0
6557286|NCT01766466|7479787|FG003|STARTED|Day 5||6
6557287|NCT01766466|7479784|FG000|COMPLETED|Day 5||0
6557288|NCT01766466|7479785|FG001|COMPLETED|Day 5||6
6557289|NCT01766466|7479786|FG002|COMPLETED|Day 5||0
6557290|NCT01766466|7479787|FG003|COMPLETED|Day 5||6
6557291|NCT01766466|7479784|FG000|NOT COMPLETED|Day 5||0
6557292|NCT01766466|7479785|FG001|NOT COMPLETED|Day 5||0
6557293|NCT01766466|7479786|FG002|NOT COMPLETED|Day 5||0
6557294|NCT01766466|7479787|FG003|NOT COMPLETED|Day 5||0
6557295|NCT01766713|7479798|FG000|STARTED|Overall Study||25
6557296|NCT01766713|7479799|FG001|STARTED|Overall Study||25
6557297|NCT01766713|7479798|FG000|COMPLETED|Overall Study||23
6557298|NCT01766713|7479799|FG001|COMPLETED|Overall Study||22
6557299|NCT01766713|7479798|FG000|NOT COMPLETED|Overall Study||2
6557300|NCT01766713|7479799|FG001|NOT COMPLETED|Overall Study||3
6557301|NCT01766778|7479807|FG000|STARTED|Overall Study|Intent to treat population|56
6557302|NCT01766778|7479808|FG001|STARTED|Overall Study||61
6557303|NCT01766778|7479807|FG000|COMPLETED|Overall Study||51
6557304|NCT01766778|7479808|FG001|COMPLETED|Overall Study||57
6557305|NCT01766778|7479807|FG000|NOT COMPLETED|Overall Study||5
6557306|NCT01766778|7479808|FG001|NOT COMPLETED|Overall Study||4
6557307|NCT01766817|7479817|FG000|STARTED|Overall Study||48
6557308|NCT01766817|7479818|FG001|STARTED|Overall Study||48
6557309|NCT01766817|7479819|FG002|STARTED|Overall Study||47
6557310|NCT01766817|7479817|FG000|COMPLETED|Overall Study||37
6557311|NCT01766817|7479818|FG001|COMPLETED|Overall Study||37
6557312|NCT01766817|7479819|FG002|COMPLETED|Overall Study||34
6557313|NCT01766817|7479817|FG000|NOT COMPLETED|Overall Study||11
6557314|NCT01766817|7479818|FG001|NOT COMPLETED|Overall Study||11
6557315|NCT01766817|7479819|FG002|NOT COMPLETED|Overall Study||13
6557316|NCT01766921|7479829|FG000|STARTED|Overall Study||700
6557317|NCT01766921|7479830|FG001|STARTED|Overall Study||693
6557318|NCT01766921|7479829|FG000|COMPLETED|Overall Study||676
6557319|NCT01766921|7479830|FG001|COMPLETED|Overall Study||676
6557320|NCT01766921|7479829|FG000|NOT COMPLETED|Overall Study||24
6557321|NCT01766921|7479830|FG001|NOT COMPLETED|Overall Study||17
6557322|NCT01766986|7479840|FG000|STARTED|Overall Study||41
6557323|NCT01766986|7479841|FG001|STARTED|Overall Study||51
6557324|NCT01766986|7479842|FG002|STARTED|Overall Study||38
6557325|NCT01766986|7479840|FG000|COMPLETED|Overall Study||41
6557326|NCT01766986|7479841|FG001|COMPLETED|Overall Study||51
6557327|NCT01766986|7479842|FG002|COMPLETED|Overall Study||38
6557328|NCT01766986|7479840|FG000|NOT COMPLETED|Overall Study||0
6557329|NCT01766986|7479841|FG001|NOT COMPLETED|Overall Study||0
6557330|NCT01766986|7479842|FG002|NOT COMPLETED|Overall Study||0
6557331|NCT01767064|7479852|FG000|STARTED|Overall Study||7
6557332|NCT01767064|7479853|FG001|STARTED|Overall Study||7
6557333|NCT01767064|7479852|FG000|COMPLETED|Overall Study||7
6557334|NCT01767064|7479853|FG001|COMPLETED|Overall Study||7
6557335|NCT01767064|7479852|FG000|NOT COMPLETED|Overall Study||0
6557336|NCT01767064|7479853|FG001|NOT COMPLETED|Overall Study||0
6557337|NCT01767103|7479862|FG000|STARTED|Overall Study||7
6557338|NCT01767103|7479863|FG001|STARTED|Overall Study||7
6557339|NCT01767103|7479864|FG002|STARTED|Overall Study||7
6557340|NCT01767103|7479862|FG000|COMPLETED|Overall Study||7
6557341|NCT01767103|7479863|FG001|COMPLETED|Overall Study||7
6557342|NCT01767103|7479864|FG002|COMPLETED|Overall Study||7
6557343|NCT01767103|7479862|FG000|NOT COMPLETED|Overall Study||0
6557344|NCT01767103|7479863|FG001|NOT COMPLETED|Overall Study||0
6557345|NCT01767103|7479864|FG002|NOT COMPLETED|Overall Study||0
6557346|NCT01767116|7479875|FG000|STARTED|Overall Study||210
6557347|NCT01767116|7479876|FG001|STARTED|Overall Study||209
6306112|NCT00371865|7209443|FG001|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
6306113|NCT00371865|7209442|FG000|NOT COMPLETED|Overall Study||15
6306114|NCT00371865|7209443|FG001|NOT COMPLETED|Overall Study||14
6306115|NCT00372060|7209451|FG000|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
6306116|NCT00372060|7209452|FG001|STARTED|Period I - Double-blind (Weeks 0-12)||68
6306117|NCT00372060|7209451|FG000|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
6306118|NCT00372060|7209452|FG001|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
6306119|NCT00372060|7209451|FG000|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
6306120|NCT00372060|7209452|FG001|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
6306121|NCT00372060|7209451|FG000|STARTED|Period II - Open-label (Weeks 12-52)||63
6306122|NCT00372060|7209452|FG001|STARTED|Period II - Open-label (Weeks 12-52)||67
6306123|NCT00372060|7209451|FG000|COMPLETED|Period II - Open-label (Weeks 12-52)||49
6306124|NCT00372060|7209452|FG001|COMPLETED|Period II - Open-label (Weeks 12-52)||59
6306125|NCT00372060|7209451|FG000|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
6306126|NCT00372060|7209452|FG001|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
6306127|NCT00372112|7209465|FG000|STARTED|Overall Study||17
6306128|NCT00372112|7209466|FG001|STARTED|Overall Study||16
6306129|NCT00372112|7209467|FG002|STARTED|Overall Study||17
6306130|NCT00372112|7209468|FG003|STARTED|Overall Study||18
6306131|NCT00372112|7209465|FG000|COMPLETED|Overall Study||16
6306132|NCT00372112|7209466|FG001|COMPLETED|Overall Study||15
6306133|NCT00372112|7209467|FG002|COMPLETED|Overall Study||13
6306134|NCT00372112|7209468|FG003|COMPLETED|Overall Study||14
6306135|NCT00372112|7209465|FG000|NOT COMPLETED|Overall Study||1
6306136|NCT00372112|7209466|FG001|NOT COMPLETED|Overall Study||1
6306137|NCT00372112|7209467|FG002|NOT COMPLETED|Overall Study||4
6654916|NCT02448810|7584907|FG000|NOT COMPLETED|Overall Study||3
6654917|NCT02448810|7584908|FG001|NOT COMPLETED|Overall Study||3
6654918|NCT02448810|7584909|FG002|NOT COMPLETED|Overall Study||3
6654919|NCT02448810|7584910|FG003|NOT COMPLETED|Overall Study||3
6654920|NCT02448810|7584911|FG004|NOT COMPLETED|Overall Study||31
6654921|NCT02448810|7584912|FG005|NOT COMPLETED|Overall Study||16
6654922|NCT02448810|7584913|FG006|NOT COMPLETED|Overall Study||18
6654923|NCT02448810|7584914|FG007|NOT COMPLETED|Overall Study||8
6654924|NCT02448862|7584938|FG000|STARTED|Overall Study||4525
6654925|NCT02448862|7584939|FG001|STARTED|Overall Study||6050
6654926|NCT02448862|7584938|FG000|COMPLETED|Overall Study||4525
6654927|NCT02448862|7584939|FG001|COMPLETED|Overall Study||6050
6654928|NCT02448862|7584938|FG000|NOT COMPLETED|Overall Study||0
6654929|NCT02448862|7584939|FG001|NOT COMPLETED|Overall Study||0
6306138|NCT00372112|7209468|FG003|NOT COMPLETED|Overall Study||4
6374946|NCT00753337|7285545|FG000|NOT COMPLETED|Overall Study||0
6306139|NCT00372190|7209483|FG000|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
6306140|NCT00372190|7209484|FG001|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
6306141|NCT00372190|7209483|FG000|COMPLETED|Overall Study||90
6306142|NCT00372190|7209484|FG001|COMPLETED|Overall Study||96
6306143|NCT00372190|7209483|FG000|NOT COMPLETED|Overall Study||3
6306144|NCT00372190|7209484|FG001|NOT COMPLETED|Overall Study||1
6306145|NCT00372255|7209494|FG000|STARTED|Overall Study||110
6306146|NCT00372255|7209495|FG001|STARTED|Overall Study||114
6306147|NCT00372255|7209494|FG000|COMPLETED|Overall Study||108
6306148|NCT00372255|7209495|FG001|COMPLETED|Overall Study||113
6306149|NCT00372255|7209494|FG000|NOT COMPLETED|Overall Study||2
6306150|NCT00372255|7209495|FG001|NOT COMPLETED|Overall Study||1
6306151|NCT00372385|7209506|FG000|STARTED|Overall Study||82
6306152|NCT00372385|7209507|FG001|STARTED|Overall Study||81
6306153|NCT00372385|7209508|FG002|STARTED|Overall Study||82
6306154|NCT00372385|7209509|FG003|STARTED|Overall Study||78
6306155|NCT00372385|7209506|FG000|COMPLETED|Overall Study||49
6306156|NCT00372385|7209507|FG001|COMPLETED|Overall Study||61
6306157|NCT00372385|7209508|FG002|COMPLETED|Overall Study||72
6306158|NCT00372385|7209509|FG003|COMPLETED|Overall Study||70
6306159|NCT00372385|7209506|FG000|NOT COMPLETED|Overall Study||33
6306160|NCT00372385|7209507|FG001|NOT COMPLETED|Overall Study||20
6306161|NCT00372385|7209508|FG002|NOT COMPLETED|Overall Study||10
6306162|NCT00372385|7209509|FG003|NOT COMPLETED|Overall Study||8
6306163|NCT00372411|7209523|FG000|STARTED|Overall Study||49
6306164|NCT00372411|7209524|FG001|STARTED|Overall Study||50
6306165|NCT00372411|7209525|FG002|STARTED|Overall Study||28
6306166|NCT00372411|7209523|FG000|COMPLETED|Overall Study||44
6306167|NCT00372411|7209524|FG001|COMPLETED|Overall Study||42
6306168|NCT00372411|7209525|FG002|COMPLETED|Overall Study||25
6306169|NCT00372411|7209523|FG000|NOT COMPLETED|Overall Study||5
6306170|NCT00372411|7209524|FG001|NOT COMPLETED|Overall Study||8
6306171|NCT00372411|7209525|FG002|NOT COMPLETED|Overall Study||3
6306172|NCT00372424|7209533|FG000|STARTED|Overall Study||26
6306173|NCT00372424|7209533|FG000|Treated|Overall Study||25
6306174|NCT00372424|7209533|FG000|COMPLETED|Overall Study||0
6306175|NCT00372424|7209533|FG000|NOT COMPLETED|Overall Study||26
6306176|NCT00372489|7209537|FG000|STARTED|Overall Study||81
6306177|NCT00372489|7209537|FG000|COMPLETED|Overall Study||2
6306178|NCT00372489|7209537|FG000|NOT COMPLETED|Overall Study||79
6306179|NCT00372528|7209541|FG000|STARTED|Overall Study||21
6306180|NCT00372528|7209541|FG000|COMPLETED|Overall Study||0
6306181|NCT00372528|7209541|FG000|NOT COMPLETED|Overall Study||21
6306182|NCT00372567|7209548|FG000|STARTED|Phase 1 Sub-study||0
6306183|NCT00372567|7209549|FG001|STARTED|Phase 1 Sub-study||0
6306184|NCT00372567|7209550|FG002|STARTED|Phase 1 Sub-study||12
6306185|NCT00372567|7209548|FG000|COMPLETED|Phase 1 Sub-study||0
6306186|NCT00372567|7209549|FG001|COMPLETED|Phase 1 Sub-study||0
6306187|NCT00372567|7209550|FG002|COMPLETED|Phase 1 Sub-study||12
6306188|NCT00372567|7209548|FG000|NOT COMPLETED|Phase 1 Sub-study||0
6306189|NCT00372567|7209549|FG001|NOT COMPLETED|Phase 1 Sub-study||0
6306190|NCT00372567|7209550|FG002|NOT COMPLETED|Phase 1 Sub-study||0
6306191|NCT00372567|7209548|FG000|STARTED|Phase 3 Study||31
6306192|NCT00372567|7209549|FG001|STARTED|Phase 3 Study||26
6306193|NCT00372567|7209550|FG002|STARTED|Phase 3 Study||12
6306194|NCT00372567|7209548|FG000|Received Treatment|Phase 3 Study||31
6306195|NCT00372567|7209549|FG001|Received Treatment|Phase 3 Study||25
6306196|NCT00372567|7209550|FG002|Received Treatment|Phase 3 Study||12
6306197|NCT00372567|7209548|FG000|COMPLETED|Phase 3 Study||0
6306198|NCT00372567|7209549|FG001|COMPLETED|Phase 3 Study||0
6306199|NCT00372567|7209550|FG002|COMPLETED|Phase 3 Study||0
6306200|NCT00372567|7209548|FG000|NOT COMPLETED|Phase 3 Study||31
6306201|NCT00372567|7209549|FG001|NOT COMPLETED|Phase 3 Study||26
6306202|NCT00372567|7209550|FG002|NOT COMPLETED|Phase 3 Study||12
6306203|NCT00372593|7209561|FG000|STARTED|Overall Study||531
6306204|NCT00372593|7209562|FG001|STARTED|Overall Study||532
6306205|NCT00372593|7209563|FG002|STARTED|Overall Study||7
6306206|NCT00372593|7209561|FG000|COMPLETED|Overall Study||327
6306207|NCT00372593|7209562|FG001|COMPLETED|Overall Study||334
6306208|NCT00372593|7209563|FG002|COMPLETED|Overall Study||3
6306209|NCT00372593|7209561|FG000|NOT COMPLETED|Overall Study||204
6306210|NCT00372593|7209562|FG001|NOT COMPLETED|Overall Study||198
6306211|NCT00372593|7209563|FG002|NOT COMPLETED|Overall Study||4
6306212|NCT00372619|7209579|FG000|STARTED|Overall Study||8
6306213|NCT00372619|7209580|FG001|STARTED|Overall Study||2
6306214|NCT00372619|7209581|FG002|STARTED|Overall Study||3
6306215|NCT00372619|7209582|FG003|STARTED|Overall Study||10
6306216|NCT00372619|7209583|FG004|STARTED|Overall Study||7
6306217|NCT00372619|7209584|FG005|STARTED|Overall Study||42
6306218|NCT00372619|7209585|FG006|STARTED|Overall Study||2
6306219|NCT00372619|7209579|FG000|COMPLETED|Overall Study||8
6306220|NCT00372619|7209580|FG001|COMPLETED|Overall Study||2
6306221|NCT00372619|7209581|FG002|COMPLETED|Overall Study||3
6306222|NCT00372619|7209582|FG003|COMPLETED|Overall Study||10
6306223|NCT00372619|7209583|FG004|COMPLETED|Overall Study||7
6306224|NCT00372619|7209584|FG005|COMPLETED|Overall Study||39
6306225|NCT00372619|7209585|FG006|COMPLETED|Overall Study||2
6306226|NCT00372619|7209579|FG000|NOT COMPLETED|Overall Study||0
6306227|NCT00372619|7209580|FG001|NOT COMPLETED|Overall Study||0
6306228|NCT00372619|7209581|FG002|NOT COMPLETED|Overall Study||0
6306229|NCT00372619|7209582|FG003|NOT COMPLETED|Overall Study||0
6306230|NCT00372619|7209583|FG004|NOT COMPLETED|Overall Study||0
6306231|NCT00372619|7209584|FG005|NOT COMPLETED|Overall Study||3
6306232|NCT00372619|7209585|FG006|NOT COMPLETED|Overall Study||0
6306233|NCT00372697|7209603|FG000|STARTED|Overall Study||16
6306234|NCT00372697|7209604|FG001|STARTED|Overall Study||12
6306235|NCT00372697|7209603|FG000|COMPLETED|Overall Study||15
6306236|NCT00372697|7209604|FG001|COMPLETED|Overall Study||11
6306237|NCT00372697|7209603|FG000|NOT COMPLETED|Overall Study||1
6306238|NCT00372697|7209604|FG001|NOT COMPLETED|Overall Study||1
6306239|NCT00372775|7209610|FG000|STARTED|Overall Study||66
6306240|NCT00372775|7209610|FG000|Received Treatment|Overall Study||64
6306241|NCT00372775|7209610|FG000|COMPLETED|Overall Study||3
6306242|NCT00372775|7209610|FG000|NOT COMPLETED|Overall Study||63
6306243|NCT00372905|7209614|FG000|STARTED|Cohort 1: Dose Level 1.0mg/m2||3
6306244|NCT00372905|7209615|FG001|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
6306245|NCT00372905|7209616|FG002|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
6306246|NCT00372905|7209617|FG003|STARTED|Cohort 1: Dose Level 1.0mg/m2||0
6306247|NCT00372905|7209614|FG000|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||3
6306248|NCT00372905|7209615|FG001|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
6306249|NCT00372905|7209616|FG002|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
6306250|NCT00372905|7209617|FG003|Registered to Study|Cohort 1: Dose Level 1.0mg/m2||0
6306251|NCT00372905|7209614|FG000|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||3
6306252|NCT00372905|7209615|FG001|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
6306253|NCT00372905|7209616|FG002|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
6306254|NCT00372905|7209617|FG003|Treated 1 Cycle of Induction Therapy|Cohort 1: Dose Level 1.0mg/m2||0
6306255|NCT00372905|7209614|FG000|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||1
6306256|NCT00372905|7209615|FG001|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
6306257|NCT00372905|7209616|FG002|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
6306258|NCT00372905|7209617|FG003|Completed 3 Cycles of Consolidation|Cohort 1: Dose Level 1.0mg/m2||0
6306259|NCT00372905|7209614|FG000|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||1
6306260|NCT00372905|7209615|FG001|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6306261|NCT00372905|7209616|FG002|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6306262|NCT00372905|7209617|FG003|COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6306263|NCT00372905|7209614|FG000|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||2
6306264|NCT00372905|7209615|FG001|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6306265|NCT00372905|7209616|FG002|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6306266|NCT00372905|7209617|FG003|NOT COMPLETED|Cohort 1: Dose Level 1.0mg/m2||0
6306267|NCT00372905|7209614|FG000|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
6306268|NCT00372905|7209615|FG001|STARTED|Cohort 2: Dose Level 1.3mg/m2||3
6306269|NCT00372905|7209616|FG002|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
6306270|NCT00372905|7209617|FG003|STARTED|Cohort 2: Dose Level 1.3mg/m2||0
6306271|NCT00372905|7209614|FG000|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
6306272|NCT00372905|7209615|FG001|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||3
6306273|NCT00372905|7209616|FG002|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
6306274|NCT00372905|7209617|FG003|Registered to Study|Cohort 2: Dose Level 1.3mg/m2||0
6306275|NCT00372905|7209614|FG000|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
6306276|NCT00372905|7209615|FG001|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||3
6306277|NCT00372905|7209616|FG002|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
6306278|NCT00372905|7209617|FG003|Treated 1 Cycle of Induction Therapy|Cohort 2: Dose Level 1.3mg/m2||0
6306279|NCT00372905|7209614|FG000|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
6306280|NCT00372905|7209615|FG001|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||3
6306281|NCT00372905|7209616|FG002|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
6306282|NCT00372905|7209617|FG003|Completed 3 Cycles of Consolidation|Cohort 2: Dose Level 1.3mg/m2||0
6306283|NCT00372905|7209614|FG000|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6306284|NCT00372905|7209615|FG001|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||3
6306285|NCT00372905|7209616|FG002|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6306286|NCT00372905|7209617|FG003|COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6306287|NCT00372905|7209614|FG000|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6306288|NCT00372905|7209615|FG001|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6306289|NCT00372905|7209616|FG002|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6306290|NCT00372905|7209617|FG003|NOT COMPLETED|Cohort 2: Dose Level 1.3mg/m2||0
6306291|NCT00372905|7209614|FG000|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
6306292|NCT00372905|7209615|FG001|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
6306293|NCT00372905|7209616|FG002|STARTED|Cohort 3: Dose Level 1.6mg/m2||4
6306294|NCT00372905|7209617|FG003|STARTED|Cohort 3: Dose Level 1.6mg/m2||0
6306295|NCT00372905|7209614|FG000|Registered|Cohort 3: Dose Level 1.6mg/m2||0
6306296|NCT00372905|7209615|FG001|Registered|Cohort 3: Dose Level 1.6mg/m2||0
6306297|NCT00372905|7209616|FG002|Registered|Cohort 3: Dose Level 1.6mg/m2||4
6306298|NCT00372905|7209617|FG003|Registered|Cohort 3: Dose Level 1.6mg/m2||0
6306299|NCT00372905|7209614|FG000|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
6306300|NCT00372905|7209615|FG001|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
6306301|NCT00372905|7209616|FG002|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||3
6306302|NCT00372905|7209617|FG003|Treated 1 Cycle of Induction Therapy|Cohort 3: Dose Level 1.6mg/m2||0
6306303|NCT00372905|7209614|FG000|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
6306304|NCT00372905|7209615|FG001|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
6306305|NCT00372905|7209616|FG002|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||1
6306306|NCT00372905|7209617|FG003|Completed 3 Cycles of Consolidation|Cohort 3: Dose Level 1.6mg/m2||0
6306307|NCT00372905|7209614|FG000|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6306308|NCT00372905|7209615|FG001|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6306309|NCT00372905|7209616|FG002|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||1
6306310|NCT00372905|7209617|FG003|COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6306311|NCT00372905|7209614|FG000|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6306312|NCT00372905|7209615|FG001|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6306313|NCT00372905|7209616|FG002|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||3
6306314|NCT00372905|7209617|FG003|NOT COMPLETED|Cohort 3: Dose Level 1.6mg/m2||0
6306315|NCT00372905|7209614|FG000|STARTED|Expansion Phase at Dose 1.3mg/m2||0
6306316|NCT00372905|7209615|FG001|STARTED|Expansion Phase at Dose 1.3mg/m2||0
6306317|NCT00372905|7209616|FG002|STARTED|Expansion Phase at Dose 1.3mg/m2||0
6306318|NCT00372905|7209617|FG003|STARTED|Expansion Phase at Dose 1.3mg/m2||8
6306319|NCT00372905|7209614|FG000|Registration|Expansion Phase at Dose 1.3mg/m2||0
6306320|NCT00372905|7209615|FG001|Registration|Expansion Phase at Dose 1.3mg/m2||0
6306321|NCT00372905|7209616|FG002|Registration|Expansion Phase at Dose 1.3mg/m2||0
6306322|NCT00372905|7209617|FG003|Registration|Expansion Phase at Dose 1.3mg/m2||8
6306323|NCT00372905|7209614|FG000|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
6306324|NCT00372905|7209615|FG001|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
6306325|NCT00372905|7209616|FG002|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||0
6306326|NCT00372905|7209617|FG003|Treated 1 Cycle Induction Therapy|Expansion Phase at Dose 1.3mg/m2||8
6306327|NCT00372905|7209614|FG000|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
6306328|NCT00372905|7209615|FG001|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
6306329|NCT00372905|7209616|FG002|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||0
6306330|NCT00372905|7209617|FG003|Completed 3 Cycles of Consolidation|Expansion Phase at Dose 1.3mg/m2||6
6306331|NCT00372905|7209614|FG000|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6306332|NCT00372905|7209615|FG001|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6306333|NCT00372905|7209616|FG002|COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6306334|NCT00372905|7209617|FG003|COMPLETED|Expansion Phase at Dose 1.3mg/m2||6
6306335|NCT00372905|7209614|FG000|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6306336|NCT00372905|7209615|FG001|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6306337|NCT00372905|7209616|FG002|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||0
6306338|NCT00372905|7209617|FG003|NOT COMPLETED|Expansion Phase at Dose 1.3mg/m2||2
6306339|NCT00372905|7209614|FG000|STARTED|Follow up Until Relapse or Progression|All patients that are treated on study move into the follow up phase at the completion of therapy.|3
6306340|NCT00372905|7209615|FG001|STARTED|Follow up Until Relapse or Progression||3
6306341|NCT00372905|7209616|FG002|STARTED|Follow up Until Relapse or Progression||3
6306342|NCT00372905|7209617|FG003|STARTED|Follow up Until Relapse or Progression||8
6306343|NCT00372905|7209614|FG000|COMPLETED|Follow up Until Relapse or Progression||3
6306344|NCT00372905|7209615|FG001|COMPLETED|Follow up Until Relapse or Progression||2
6306345|NCT00372905|7209616|FG002|COMPLETED|Follow up Until Relapse or Progression||3
6306346|NCT00372905|7209617|FG003|COMPLETED|Follow up Until Relapse or Progression||5
6306347|NCT00372905|7209614|FG000|NOT COMPLETED|Follow up Until Relapse or Progression||0
6306348|NCT00372905|7209615|FG001|NOT COMPLETED|Follow up Until Relapse or Progression||1
6306349|NCT00372905|7209616|FG002|NOT COMPLETED|Follow up Until Relapse or Progression||0
6306350|NCT00372905|7209617|FG003|NOT COMPLETED|Follow up Until Relapse or Progression||3
6306351|NCT00372957|7209630|FG000|STARTED|Overall Study||10
6306352|NCT00372957|7209631|FG001|STARTED|Overall Study||10
6306353|NCT00372957|7209632|FG002|STARTED|Overall Study||10
6306354|NCT00372957|7209630|FG000|COMPLETED|Overall Study||10
6306355|NCT00372957|7209631|FG001|COMPLETED|Overall Study||10
6306356|NCT00372957|7209632|FG002|COMPLETED|Overall Study||10
6306357|NCT00372957|7209630|FG000|NOT COMPLETED|Overall Study||0
6306358|NCT00372957|7209631|FG001|NOT COMPLETED|Overall Study||0
6306359|NCT00372957|7209632|FG002|NOT COMPLETED|Overall Study||0
6306360|NCT00372970|7209644|FG000|STARTED|Overall Study||16
6306361|NCT00372970|7209645|FG001|STARTED|Overall Study||16
6306362|NCT00372970|7209644|FG000|COMPLETED|Overall Study||16
6306363|NCT00372970|7209645|FG001|COMPLETED|Overall Study||16
6306364|NCT00372970|7209644|FG000|NOT COMPLETED|Overall Study||0
6306365|NCT00372970|7209645|FG001|NOT COMPLETED|Overall Study||0
6306366|NCT00372996|7209653|FG000|STARTED|Overall Study||79
6306367|NCT00372996|7209654|FG001|STARTED|Overall Study||36
6306368|NCT00372996|7209655|FG002|STARTED|Overall Study||61
6306369|NCT00372996|7209656|FG003|STARTED|Overall Study||43
6306370|NCT00372996|7209653|FG000|COMPLETED|Overall Study||42
6306371|NCT00372996|7209654|FG001|COMPLETED|Overall Study||22
6306372|NCT00372996|7209655|FG002|COMPLETED|Overall Study||33
6306373|NCT00372996|7209656|FG003|COMPLETED|Overall Study||23
6306374|NCT00372996|7209653|FG000|NOT COMPLETED|Overall Study||37
6306375|NCT00372996|7209654|FG001|NOT COMPLETED|Overall Study||14
6306376|NCT00372996|7209655|FG002|NOT COMPLETED|Overall Study||28
6306377|NCT00372996|7209656|FG003|NOT COMPLETED|Overall Study||20
6306378|NCT00373113|7209668|FG000|STARTED|Overall Study||238
6557348|NCT01767116|7479875|FG000|COMPLETED|Overall Study||208
6557349|NCT01767116|7479876|FG001|COMPLETED|Overall Study||207
6557350|NCT01767116|7479875|FG000|NOT COMPLETED|Overall Study||2
6557351|NCT01767116|7479876|FG001|NOT COMPLETED|Overall Study||2
6306379|NCT00373113|7209669|FG001|STARTED|Overall Study||244
6306380|NCT00373113|7209668|FG000|Received Treatment|Overall Study||238
6306381|NCT00373113|7209669|FG001|Received Treatment|Overall Study||240
6306382|NCT00373113|7209668|FG000|COMPLETED|Overall Study||0
6306383|NCT00373113|7209669|FG001|COMPLETED|Overall Study||0
6306384|NCT00373113|7209668|FG000|NOT COMPLETED|Overall Study||238
6306385|NCT00373113|7209669|FG001|NOT COMPLETED|Overall Study||244
6306386|NCT00373256|7209677|FG000|STARTED|Overall Study||241
6306387|NCT00373256|7209678|FG001|STARTED|Overall Study||247
6306388|NCT00373256|7209677|FG000|Treated|Overall Study||235
6306389|NCT00373256|7209678|FG001|Treated|Overall Study||236
6306390|NCT00373256|7209677|FG000|COMPLETED|Overall Study||0
6306391|NCT00373256|7209678|FG001|COMPLETED|Overall Study||0
6306392|NCT00373256|7209677|FG000|NOT COMPLETED|Overall Study||241
6306393|NCT00373256|7209678|FG001|NOT COMPLETED|Overall Study||247
6306394|NCT00373269|7209686|FG000|STARTED|Overall Study||11
6306395|NCT00373269|7209687|FG001|STARTED|Overall Study||10
6306396|NCT00373269|7209686|FG000|COMPLETED|Overall Study||11
6306397|NCT00373269|7209687|FG001|COMPLETED|Overall Study||10
6306398|NCT00373269|7209686|FG000|NOT COMPLETED|Overall Study||0
6306399|NCT00373269|7209687|FG001|NOT COMPLETED|Overall Study||0
6306400|NCT00373295|7209693|FG000|STARTED|Intervention 1 (8 Days)||2
6306401|NCT00373295|7209694|FG001|STARTED|Intervention 1 (8 Days)||3
6306402|NCT00373295|7209695|FG002|STARTED|Intervention 1 (8 Days)||1
6306403|NCT00373295|7209696|FG003|STARTED|Intervention 1 (8 Days)||2
6306404|NCT00373295|7209697|FG004|STARTED|Intervention 1 (8 Days)||3
6306405|NCT00373295|7209698|FG005|STARTED|Intervention 1 (8 Days)||2
6306406|NCT00373295|7209693|FG000|COMPLETED|Intervention 1 (8 Days)||2
6306407|NCT00373295|7209694|FG001|COMPLETED|Intervention 1 (8 Days)||1
6306408|NCT00373295|7209695|FG002|COMPLETED|Intervention 1 (8 Days)||1
6306409|NCT00373295|7209696|FG003|COMPLETED|Intervention 1 (8 Days)||2
6306410|NCT00373295|7209697|FG004|COMPLETED|Intervention 1 (8 Days)||2
6306411|NCT00373295|7209698|FG005|COMPLETED|Intervention 1 (8 Days)||2
6306412|NCT00373295|7209693|FG000|NOT COMPLETED|Intervention 1 (8 Days)||0
6306413|NCT00373295|7209694|FG001|NOT COMPLETED|Intervention 1 (8 Days)||2
6306414|NCT00373295|7209695|FG002|NOT COMPLETED|Intervention 1 (8 Days)||0
6306415|NCT00373295|7209696|FG003|NOT COMPLETED|Intervention 1 (8 Days)||0
6306416|NCT00373295|7209697|FG004|NOT COMPLETED|Intervention 1 (8 Days)||1
6306417|NCT00373295|7209698|FG005|NOT COMPLETED|Intervention 1 (8 Days)||0
6306418|NCT00373295|7209693|FG000|STARTED|Intervention 2 (8 Days)||2
6306419|NCT00373295|7209694|FG001|STARTED|Intervention 2 (8 Days)||1
6306420|NCT00373295|7209695|FG002|STARTED|Intervention 2 (8 Days)||1
6306421|NCT00373295|7209696|FG003|STARTED|Intervention 2 (8 Days)||2
6306422|NCT00373295|7209697|FG004|STARTED|Intervention 2 (8 Days)||2
6306423|NCT00373295|7209698|FG005|STARTED|Intervention 2 (8 Days)||2
6306424|NCT00373295|7209693|FG000|COMPLETED|Intervention 2 (8 Days)||2
6306425|NCT00373295|7209694|FG001|COMPLETED|Intervention 2 (8 Days)||1
6306426|NCT00373295|7209695|FG002|COMPLETED|Intervention 2 (8 Days)||1
6306427|NCT00373295|7209696|FG003|COMPLETED|Intervention 2 (8 Days)||2
6306428|NCT00373295|7209697|FG004|COMPLETED|Intervention 2 (8 Days)||2
6306429|NCT00373295|7209698|FG005|COMPLETED|Intervention 2 (8 Days)||2
6306430|NCT00373295|7209693|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
6306431|NCT00373295|7209694|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
6306432|NCT00373295|7209695|FG002|NOT COMPLETED|Intervention 2 (8 Days)||0
6306433|NCT00373295|7209696|FG003|NOT COMPLETED|Intervention 2 (8 Days)||0
6306434|NCT00373295|7209697|FG004|NOT COMPLETED|Intervention 2 (8 Days)||0
6306435|NCT00373295|7209698|FG005|NOT COMPLETED|Intervention 2 (8 Days)||0
6306436|NCT00373295|7209693|FG000|STARTED|Intervention 3 (8 Days)||2
6306437|NCT00373295|7209694|FG001|STARTED|Intervention 3 (8 Days)||1
6306438|NCT00373295|7209695|FG002|STARTED|Intervention 3 (8 Days)||1
6306439|NCT00373295|7209696|FG003|STARTED|Intervention 3 (8 Days)||2
6306440|NCT00373295|7209697|FG004|STARTED|Intervention 3 (8 Days)||2
6306441|NCT00373295|7209698|FG005|STARTED|Intervention 3 (8 Days)||2
6306442|NCT00373295|7209693|FG000|COMPLETED|Intervention 3 (8 Days)||2
6306443|NCT00373295|7209694|FG001|COMPLETED|Intervention 3 (8 Days)||1
6306444|NCT00373295|7209695|FG002|COMPLETED|Intervention 3 (8 Days)||1
6306445|NCT00373295|7209696|FG003|COMPLETED|Intervention 3 (8 Days)||2
6306446|NCT00373295|7209697|FG004|COMPLETED|Intervention 3 (8 Days)||2
6306447|NCT00373295|7209698|FG005|COMPLETED|Intervention 3 (8 Days)||2
6306448|NCT00373295|7209693|FG000|NOT COMPLETED|Intervention 3 (8 Days)||0
6306449|NCT00373295|7209694|FG001|NOT COMPLETED|Intervention 3 (8 Days)||0
6773425|NCT03972137|7701066|FG000|COMPLETED|Overall Study||4
6773426|NCT03972137|7701066|FG000|NOT COMPLETED|Overall Study||6
6773427|NCT03970395|7701084|FG000|STARTED|Overall Study||48
6773428|NCT03970395|7701085|FG001|STARTED|Overall Study||48
6773429|NCT03970395|7701084|FG000|COMPLETED|Overall Study||41
6773430|NCT03970395|7701085|FG001|COMPLETED|Overall Study||36
6773431|NCT03970395|7701084|FG000|NOT COMPLETED|Overall Study||7
6306450|NCT00373295|7209695|FG002|NOT COMPLETED|Intervention 3 (8 Days)||0
6306451|NCT00373295|7209696|FG003|NOT COMPLETED|Intervention 3 (8 Days)||0
6306452|NCT00373295|7209697|FG004|NOT COMPLETED|Intervention 3 (8 Days)||0
6306453|NCT00373295|7209698|FG005|NOT COMPLETED|Intervention 3 (8 Days)||0
6306454|NCT00373334|7209709|FG000|STARTED|Overall Study||43
6306455|NCT00373334|7209710|FG001|STARTED|Overall Study||50
6306456|NCT00373334|7209711|FG002|STARTED|Overall Study||45
6306457|NCT00373334|7209709|FG000|COMPLETED|Overall Study||33
6773432|NCT03970395|7701085|FG001|NOT COMPLETED|Overall Study||12
6773433|NCT03987620|7701097|FG000|STARTED|Overall Study||303
6306458|NCT00373334|7209710|FG001|COMPLETED|Overall Study||32
6306459|NCT00373334|7209711|FG002|COMPLETED|Overall Study||32
6306460|NCT00373334|7209709|FG000|NOT COMPLETED|Overall Study||10
6306461|NCT00373334|7209710|FG001|NOT COMPLETED|Overall Study||18
6306462|NCT00373334|7209711|FG002|NOT COMPLETED|Overall Study||13
6306463|NCT00373360|7209719|FG000|STARTED|Overall Study||10
6306464|NCT00373360|7209719|FG000|COMPLETED|Overall Study||10
6306465|NCT00373360|7209719|FG000|NOT COMPLETED|Overall Study||0
6306466|NCT00373386|7209723|FG000|STARTED|Overall Study||9
6306467|NCT00373386|7209723|FG000|COMPLETED|Overall Study||9
6306468|NCT00373386|7209723|FG000|NOT COMPLETED|Overall Study||0
6306469|NCT00373399|7209729|FG000|STARTED|Overall Study||5
6306470|NCT00373399|7209730|FG001|STARTED|Overall Study||7
6306471|NCT00373399|7209731|FG002|STARTED|Overall Study||4
6306472|NCT00373399|7209732|FG003|STARTED|Overall Study||6
6306473|NCT00373399|7209733|FG004|STARTED|Overall Study||7
6306474|NCT00373399|7209734|FG005|STARTED|Overall Study||7
6306475|NCT00373399|7209729|FG000|COMPLETED|Overall Study||5
6306476|NCT00373399|7209730|FG001|COMPLETED|Overall Study||7
6306477|NCT00373399|7209731|FG002|COMPLETED|Overall Study||4
6306478|NCT00373399|7209732|FG003|COMPLETED|Overall Study||6
6306479|NCT00373399|7209733|FG004|COMPLETED|Overall Study||7
6306480|NCT00373399|7209734|FG005|COMPLETED|Overall Study||7
6306481|NCT00373399|7209729|FG000|NOT COMPLETED|Overall Study||0
6306482|NCT00373399|7209730|FG001|NOT COMPLETED|Overall Study||0
6306483|NCT00373399|7209731|FG002|NOT COMPLETED|Overall Study||0
6306484|NCT00373399|7209732|FG003|NOT COMPLETED|Overall Study||0
6306485|NCT00373399|7209733|FG004|NOT COMPLETED|Overall Study||0
6306486|NCT00373399|7209734|FG005|NOT COMPLETED|Overall Study||0
6306487|NCT00373425|7209747|FG000|STARTED|Overall Study||623
6306488|NCT00373425|7209748|FG001|STARTED|Overall Study||350
6306489|NCT00373425|7209749|FG002|STARTED|Overall Study||134
6306490|NCT00373425|7209750|FG003|STARTED|Overall Study||11
6306491|NCT00373425|7209751|FG004|STARTED|Overall Study||132
6306492|NCT00373425|7209747|FG000|Received Treatment|Overall Study||612
6306493|NCT00373425|7209748|FG001|Received Treatment|Overall Study||342
6306494|NCT00373425|7209749|FG002|Received Treatment|Overall Study||134
6306495|NCT00373425|7209750|FG003|Received Treatment|Overall Study||7
6306496|NCT00373425|7209751|FG004|Received Treatment|Overall Study||132
6306497|NCT00373425|7209747|FG000|COMPLETED|Overall Study|Completed 2 years of study treatment|253
6306498|NCT00373425|7209748|FG001|COMPLETED|Overall Study|Completed 2 years of study treatment|197
6306499|NCT00373425|7209749|FG002|COMPLETED|Overall Study|Completed 2 years of study treatment|0
6306500|NCT00373425|7209750|FG003|COMPLETED|Overall Study|Completed 2 years of study treatment|0
6306501|NCT00373425|7209751|FG004|COMPLETED|Overall Study|Completed 2 years of study treatment|60
6306502|NCT00373425|7209747|FG000|NOT COMPLETED|Overall Study||370
6306503|NCT00373425|7209748|FG001|NOT COMPLETED|Overall Study||153
6306504|NCT00373425|7209749|FG002|NOT COMPLETED|Overall Study||134
6306505|NCT00373425|7209750|FG003|NOT COMPLETED|Overall Study||11
6306506|NCT00373425|7209751|FG004|NOT COMPLETED|Overall Study||72
6306507|NCT00373490|7209762|FG000|STARTED|Overall Study||10
6306508|NCT00373490|7209763|FG001|STARTED|Overall Study||6
6306509|NCT00373490|7209762|FG000|COMPLETED|Overall Study||1
6306510|NCT00373490|7209763|FG001|COMPLETED|Overall Study||0
6306511|NCT00373490|7209762|FG000|NOT COMPLETED|Overall Study||9
6306512|NCT00373490|7209763|FG001|NOT COMPLETED|Overall Study||6
6306513|NCT00373529|7209769|FG000|STARTED|Overall Study||116
6306514|NCT00373529|7209769|FG000|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
6306515|NCT00373529|7209769|FG000|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
6306516|NCT00373529|7209769|FG000|NOT COMPLETED|Overall Study||108
6306517|NCT00373685|7209775|FG000|STARTED|Overall Study||4035
6306518|NCT00373685|7209776|FG001|STARTED|Overall Study||4032
6306519|NCT00373685|7209775|FG000|Treated|Overall Study||3984
6306520|NCT00373685|7209776|FG001|Treated|Overall Study||3955
6306521|NCT00373685|7209775|FG000|COMPLETED|Overall Study||2596
6306522|NCT00373685|7209776|FG001|COMPLETED|Overall Study||2611
6306523|NCT00373685|7209775|FG000|NOT COMPLETED|Overall Study||1439
6306524|NCT00373685|7209776|FG001|NOT COMPLETED|Overall Study||1421
6306525|NCT00373698|7209784|FG000|STARTED|Overall Study||96
6306526|NCT00373698|7209785|FG001|STARTED|Overall Study||99
6306527|NCT00373698|7209784|FG000|COMPLETED|Overall Study||85
6306528|NCT00373698|7209785|FG001|COMPLETED|Overall Study||99
6306529|NCT00373698|7209784|FG000|NOT COMPLETED|Overall Study||11
6306530|NCT00373698|7209785|FG001|NOT COMPLETED|Overall Study||0
6306531|NCT00373880|7209793|FG000|STARTED|Overall Study||26
6306532|NCT00373880|7209793|FG000|COMPLETED|Overall Study||8
6306533|NCT00373880|7209793|FG000|NOT COMPLETED|Overall Study||18
6306534|NCT00373958|7209807|FG000|STARTED|Infant Series|One participant was prerandomized but not consented.|334
6306535|NCT00373958|7209808|FG001|STARTED|Infant Series||332
6306536|NCT00373958|7209807|FG000|Vaccinated Dose 1|Infant Series||332
6306537|NCT00373958|7209808|FG001|Vaccinated Dose 1|Infant Series||331
6306538|NCT00373958|7209807|FG000|Vaccinated Dose 2|Infant Series||309
6306539|NCT00373958|7209808|FG001|Vaccinated Dose 2|Infant Series||305
6306540|NCT00373958|7209807|FG000|Vaccinated Dose 3|Infant Series||298
6306541|NCT00373958|7209808|FG001|Vaccinated Dose 3|Infant Series||300
6306542|NCT00373958|7209807|FG000|COMPLETED|Infant Series||294
6306543|NCT00373958|7209808|FG001|COMPLETED|Infant Series||290
6306544|NCT00373958|7209807|FG000|NOT COMPLETED|Infant Series||40
6306545|NCT00373958|7209808|FG001|NOT COMPLETED|Infant Series||42
6306546|NCT00373958|7209807|FG000|STARTED|Toddler Dose||294
6306547|NCT00373958|7209808|FG001|STARTED|Toddler Dose||290
6306548|NCT00373958|7209807|FG000|Withdrawn After Infant Series|Toddler Dose||22
6306549|NCT00373958|7209808|FG001|Withdrawn After Infant Series|Toddler Dose||25
6306550|NCT00373958|7209807|FG000|Vaccinated Toddler Dose|Toddler Dose||272
6306551|NCT00373958|7209808|FG001|Vaccinated Toddler Dose|Toddler Dose||265
6306552|NCT00373958|7209807|FG000|COMPLETED|Toddler Dose||264
6306553|NCT00373958|7209808|FG001|COMPLETED|Toddler Dose||252
6306554|NCT00373958|7209807|FG000|NOT COMPLETED|Toddler Dose||30
6306555|NCT00373958|7209808|FG001|NOT COMPLETED|Toddler Dose||38
6306556|NCT00374088|7209839|FG000|STARTED|Overall Study||10
6306557|NCT00374088|7209840|FG001|STARTED|Overall Study||11
6306558|NCT00374088|7209839|FG000|COMPLETED|Overall Study||9
6306559|NCT00374088|7209840|FG001|COMPLETED|Overall Study||10
6306560|NCT00374088|7209839|FG000|NOT COMPLETED|Overall Study||1
6306561|NCT00374088|7209840|FG001|NOT COMPLETED|Overall Study||1
6306562|NCT00374127|7209846|FG000|STARTED|Overall Study||35
6306563|NCT00374127|7209846|FG000|COMPLETED|Overall Study||24
6306564|NCT00374127|7209846|FG000|NOT COMPLETED|Overall Study||11
6306565|NCT00374140|7209856|FG000|STARTED|Overall Study||40
6306566|NCT00374140|7209856|FG000|COMPLETED|Overall Study||38
6306567|NCT00374140|7209856|FG000|NOT COMPLETED|Overall Study||2
6306568|NCT00374231|7209860|FG000|STARTED|Overall Study||40
6306569|NCT00374231|7209860|FG000|COMPLETED|Overall Study||40
6306570|NCT00374231|7209860|FG000|NOT COMPLETED|Overall Study||0
6306571|NCT00374244|7209867|FG000|STARTED|Overall Study||14
6306572|NCT00374244|7209868|FG001|STARTED|Overall Study||14
6306573|NCT00374244|7209867|FG000|COMPLETED|Overall Study||14
6306574|NCT00374244|7209868|FG001|COMPLETED|Overall Study||14
6306575|NCT00374244|7209867|FG000|NOT COMPLETED|Overall Study||0
6306576|NCT00374244|7209868|FG001|NOT COMPLETED|Overall Study||0
6306577|NCT00374322|7209876|FG000|STARTED|Overall Study||1579
6306578|NCT00374322|7209877|FG001|STARTED|Overall Study||1582
6306579|NCT00374322|7209876|FG000|Received >=1 Dose of Study Treatment|Overall Study||1571
6306580|NCT00374322|7209877|FG001|Received >=1 Dose of Study Treatment|Overall Study||1576
6306581|NCT00374322|7209876|FG000|COMPLETED|Overall Study||322
6306582|NCT00374322|7209877|FG001|COMPLETED|Overall Study||278
6306583|NCT00374322|7209876|FG000|NOT COMPLETED|Overall Study||1257
6306584|NCT00374322|7209877|FG001|NOT COMPLETED|Overall Study||1304
6306585|NCT00374335|7209884|FG000|STARTED|Overall Study||261
6306586|NCT00374335|7209884|FG000|COMPLETED|Overall Study||261
6306587|NCT00374335|7209884|FG000|NOT COMPLETED|Overall Study||0
6306588|NCT00374452|7209890|FG000|STARTED|Overall Study||34
6306589|NCT00374452|7209891|FG001|STARTED|Overall Study||48
6306590|NCT00374452|7209890|FG000|Intervention Started|Overall Study||30
6306591|NCT00374452|7209891|FG001|Intervention Started|Overall Study||46
6306592|NCT00374452|7209890|FG000|COMPLETED|Overall Study||29
6306593|NCT00374452|7209891|FG001|COMPLETED|Overall Study||43
6306594|NCT00374452|7209890|FG000|NOT COMPLETED|Overall Study||5
6306595|NCT00374452|7209891|FG001|NOT COMPLETED|Overall Study||5
6306596|NCT00374556|7209899|FG000|STARTED|Overall Study||14
6306597|NCT00374556|7209900|FG001|STARTED|Overall Study||16
6306598|NCT00374556|7209899|FG000|COMPLETED|Overall Study||13
6306599|NCT00374556|7209900|FG001|COMPLETED|Overall Study||15
6306600|NCT00374556|7209899|FG000|NOT COMPLETED|Overall Study||1
6306601|NCT00374556|7209900|FG001|NOT COMPLETED|Overall Study||1
6306602|NCT00374803|7209908|FG000|STARTED|Overall Study||22
6306603|NCT00374803|7209909|FG001|STARTED|Overall Study||23
6306604|NCT00374803|7209908|FG000|COMPLETED|Overall Study||22
6306605|NCT00374803|7209909|FG001|COMPLETED|Overall Study||23
6306606|NCT00374803|7209908|FG000|NOT COMPLETED|Overall Study||0
6306607|NCT00374803|7209909|FG001|NOT COMPLETED|Overall Study||0
6306608|NCT00374842|7209920|FG000|STARTED|Overall Study||100
6306609|NCT00374842|7209921|FG001|STARTED|Overall Study||100
6306610|NCT00374842|7209922|FG002|STARTED|Overall Study||100
6306611|NCT00374842|7209920|FG000|COMPLETED|Overall Study||100
6306612|NCT00374842|7209921|FG001|COMPLETED|Overall Study||100
6306613|NCT00374842|7209922|FG002|COMPLETED|Overall Study||100
6306614|NCT00374842|7209920|FG000|NOT COMPLETED|Overall Study||0
6306615|NCT00374842|7209921|FG001|NOT COMPLETED|Overall Study||0
6306616|NCT00374842|7209922|FG002|NOT COMPLETED|Overall Study||0
6306617|NCT00374868|7209932|FG000|STARTED|Overall Study||38
6306618|NCT00374868|7209932|FG000|COMPLETED|Overall Study||2
6306619|NCT00374868|7209932|FG000|NOT COMPLETED|Overall Study||36
6306620|NCT00374907|7209938|FG000|STARTED|12-Week Short-term Period||20
6306621|NCT00374907|7209939|FG001|STARTED|12-Week Short-term Period||16
6306622|NCT00374907|7209938|FG000|COMPLETED|12-Week Short-term Period||17
6306623|NCT00374907|7209939|FG001|COMPLETED|12-Week Short-term Period||15
6306624|NCT00374907|7209938|FG000|NOT COMPLETED|12-Week Short-term Period||3
6306625|NCT00374907|7209939|FG001|NOT COMPLETED|12-Week Short-term Period||1
6306626|NCT00374907|7209938|FG000|STARTED|116-Week Short-term + Long-term Period||20
6306627|NCT00374907|7209939|FG001|STARTED|116-Week Short-term + Long-term Period||16
6306628|NCT00374907|7209938|FG000|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
6306629|NCT00374907|7209939|FG001|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
6306630|NCT00374907|7209938|FG000|COMPLETED|116-Week Short-term + Long-term Period||7
6306631|NCT00374907|7209939|FG001|COMPLETED|116-Week Short-term + Long-term Period||2
6306632|NCT00374907|7209938|FG000|NOT COMPLETED|116-Week Short-term + Long-term Period||13
6306633|NCT00374907|7209939|FG001|NOT COMPLETED|116-Week Short-term + Long-term Period||14
6306634|NCT00375167|7209949|FG000|STARTED|Overall Study|Clients were already receiving ACT services and this continued after study completion|16
6306635|NCT00375167|7209950|FG001|STARTED|Overall Study|Participants were already clients of ACT and continued receiving services following this period|17
6306636|NCT00375167|7209949|FG000|COMPLETED|Overall Study||16
6306637|NCT00375167|7209950|FG001|COMPLETED|Overall Study||17
6306638|NCT00375167|7209949|FG000|NOT COMPLETED|Overall Study||0
6306639|NCT00375167|7209950|FG001|NOT COMPLETED|Overall Study||0
6306640|NCT00375219|7209961|FG000|STARTED|Overall Study||62
6306641|NCT00375219|7209962|FG001|STARTED|Overall Study||20
6306642|NCT00375219|7209963|FG002|STARTED|Overall Study||21
6306643|NCT00375219|7209961|FG000|COMPLETED|Overall Study||3
6306644|NCT00375219|7209962|FG001|COMPLETED|Overall Study||0
6306645|NCT00375219|7209963|FG002|COMPLETED|Overall Study||0
6306646|NCT00375219|7209961|FG000|NOT COMPLETED|Overall Study||59
6306647|NCT00375219|7209962|FG001|NOT COMPLETED|Overall Study||20
6306648|NCT00375219|7209963|FG002|NOT COMPLETED|Overall Study||21
6306649|NCT00375427|7209972|FG000|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
6306650|NCT00375427|7209973|FG001|STARTED|Overall Study||216
6306651|NCT00375427|7209972|FG000|COMPLETED|Overall Study||149
6306652|NCT00375427|7209973|FG001|COMPLETED|Overall Study||142
6306653|NCT00375427|7209972|FG000|NOT COMPLETED|Overall Study||60
6306654|NCT00375427|7209973|FG001|NOT COMPLETED|Overall Study||74
6306655|NCT00375492|7209981|FG000|STARTED|Overall Study||96
6306656|NCT00375492|7209982|FG001|STARTED|Overall Study||98
6306657|NCT00375492|7209981|FG000|COMPLETED|Overall Study||70
6306658|NCT00375492|7209982|FG001|COMPLETED|Overall Study||72
6306659|NCT00375492|7209981|FG000|NOT COMPLETED|Overall Study||26
6306660|NCT00375492|7209982|FG001|NOT COMPLETED|Overall Study||26
6306661|NCT00375505|7209990|FG000|STARTED|Overall Study||36
6306662|NCT00375505|7209991|FG001|STARTED|Overall Study||34
6306663|NCT00375505|7209990|FG000|COMPLETED|Overall Study||35
6306664|NCT00375505|7209991|FG001|COMPLETED|Overall Study||32
6306665|NCT00375505|7209990|FG000|NOT COMPLETED|Overall Study||1
6306666|NCT00375505|7209991|FG001|NOT COMPLETED|Overall Study||2
6306667|NCT00375518|7209999|FG000|STARTED|Overall Study||80
6306668|NCT00375518|7210000|FG001|STARTED|Overall Study||82
6306669|NCT00375518|7209999|FG000|COMPLETED|Overall Study||72
6306670|NCT00375518|7210000|FG001|COMPLETED|Overall Study||65
6306671|NCT00375518|7209999|FG000|NOT COMPLETED|Overall Study||8
6306672|NCT00375518|7210000|FG001|NOT COMPLETED|Overall Study||17
6306673|NCT00375609|7210009|FG000|STARTED|Overall Study||88
6306674|NCT00375609|7210010|FG001|STARTED|Overall Study||84
6306675|NCT00375609|7210011|FG002|STARTED|Overall Study||43
6306676|NCT00375609|7210009|FG000|COMPLETED|Overall Study||84
6306677|NCT00375609|7210010|FG001|COMPLETED|Overall Study||77
6306678|NCT00375609|7210011|FG002|COMPLETED|Overall Study||42
6306679|NCT00375609|7210009|FG000|NOT COMPLETED|Overall Study||4
6306680|NCT00375609|7210010|FG001|NOT COMPLETED|Overall Study||7
6306681|NCT00375609|7210011|FG002|NOT COMPLETED|Overall Study||1
6306682|NCT00375674|7210021|FG000|STARTED|Overall Study||309
6306683|NCT00375674|7210022|FG001|STARTED|Overall Study||306
6306684|NCT00375674|7210021|FG000|Intent-to-Treat Population|Overall Study||309
6306685|NCT00375674|7210022|FG001|Intent-to-Treat Population|Overall Study||306
6306686|NCT00375674|7210021|FG000|As-Treated Population|Overall Study|3 were randomized but not treated: 2 refused treatment & 1 withdrew before receiving study drug|306
6306687|NCT00375674|7210022|FG001|As-Treated Population|Overall Study|2 were randomized but not treated: 1 was screening failure & 1 discontinued due to new liver lesions|304
6306688|NCT00375674|7210021|FG000|COMPLETED|Overall Study||165
6306689|NCT00375674|7210022|FG001|COMPLETED|Overall Study||165
6306690|NCT00375674|7210021|FG000|NOT COMPLETED|Overall Study||144
6306691|NCT00375674|7210022|FG001|NOT COMPLETED|Overall Study||141
6306692|NCT00375713|7210030|FG000|STARTED|Overall Study|Randomized population (N=232).|232
6306693|NCT00375713|7210031|FG001|STARTED|Overall Study|Randomized population (N=234).|234
6306694|NCT00375713|7210030|FG000|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
6306695|NCT00375713|7210031|FG001|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
6306696|NCT00375713|7210030|FG000|NOT COMPLETED|Overall Study||20
6306697|NCT00375713|7210031|FG001|NOT COMPLETED|Overall Study||23
6306698|NCT00375752|7210039|FG000|STARTED|Overall Study||79
6306699|NCT00375752|7210040|FG001|STARTED|Overall Study||89
6306700|NCT00375752|7210039|FG000|COMPLETED|Overall Study||67
6306701|NCT00375752|7210040|FG001|COMPLETED|Overall Study||74
6306702|NCT00375752|7210039|FG000|NOT COMPLETED|Overall Study||12
6773434|NCT03987620|7701098|FG001|STARTED|Overall Study||152
6773435|NCT03987620|7701097|FG000|Withdrawn Before Treatment|Overall Study||5
6773436|NCT03987620|7701098|FG001|Withdrawn Before Treatment|Overall Study||1
6306703|NCT00375752|7210040|FG001|NOT COMPLETED|Overall Study||15
6306704|NCT00375830|7210049|FG000|STARTED|Overall Study||10
6306705|NCT00375830|7210050|FG001|STARTED|Overall Study||30
6306706|NCT00375830|7210051|FG002|STARTED|Overall Study||74
6306707|NCT00375830|7210049|FG000|COMPLETED|Overall Study||10
6306708|NCT00375830|7210050|FG001|COMPLETED|Overall Study||30
6306709|NCT00375830|7210051|FG002|COMPLETED|Overall Study||74
6306710|NCT00375830|7210049|FG000|NOT COMPLETED|Overall Study||0
6306711|NCT00375830|7210050|FG001|NOT COMPLETED|Overall Study||0
6306712|NCT00375830|7210051|FG002|NOT COMPLETED|Overall Study||0
6306713|NCT00375934|7210073|FG000|STARTED|Overall Study||99
6306714|NCT00375934|7210074|FG001|STARTED|Overall Study||101
6306715|NCT00375934|7210073|FG000|COMPLETED|Overall Study||96
6306716|NCT00375934|7210074|FG001|COMPLETED|Overall Study||95
6306717|NCT00375934|7210073|FG000|NOT COMPLETED|Overall Study||3
6306718|NCT00375934|7210074|FG001|NOT COMPLETED|Overall Study||6
6374947|NCT00753363|7285552|FG000|STARTED|Overall Study||59
6374948|NCT00753363|7285553|FG001|STARTED|Overall Study||60
6374949|NCT00753363|7285552|FG000|COMPLETED|Overall Study||19
6374950|NCT00753363|7285553|FG001|COMPLETED|Overall Study||21
6374951|NCT00753363|7285552|FG000|NOT COMPLETED|Overall Study||40
6374952|NCT00753363|7285553|FG001|NOT COMPLETED|Overall Study||39
6374953|NCT00753415|7285564|FG000|STARTED|Part A||3
6374954|NCT00753415|7285565|FG001|STARTED|Part A||3
6374955|NCT00753415|7285566|FG002|STARTED|Part A||10
6374956|NCT00753415|7285567|FG003|STARTED|Part A||11
6374957|NCT00753415|7285568|FG004|STARTED|Part A||10
6374958|NCT00753415|7285569|FG005|STARTED|Part A||0
6374959|NCT00753415|7285570|FG006|STARTED|Part A||0
6374960|NCT00753415|7285571|FG007|STARTED|Part A||0
6374961|NCT00753415|7285572|FG008|STARTED|Part A||0
6374962|NCT00753415|7285573|FG009|STARTED|Part A||0
6374963|NCT00753415|7285564|FG000|COMPLETED|Part A||2
6374964|NCT00753415|7285565|FG001|COMPLETED|Part A||3
6374965|NCT00753415|7285566|FG002|COMPLETED|Part A||8
6374966|NCT00753415|7285567|FG003|COMPLETED|Part A||9
6374967|NCT00753415|7285568|FG004|COMPLETED|Part A||10
6374968|NCT00753415|7285569|FG005|COMPLETED|Part A||0
6374969|NCT00753415|7285570|FG006|COMPLETED|Part A||0
6374970|NCT00753415|7285571|FG007|COMPLETED|Part A||0
6374971|NCT00753415|7285572|FG008|COMPLETED|Part A||0
6374972|NCT00753415|7285573|FG009|COMPLETED|Part A||0
6374973|NCT00753415|7285564|FG000|NOT COMPLETED|Part A||1
6374974|NCT00753415|7285565|FG001|NOT COMPLETED|Part A||0
6374975|NCT00753415|7285566|FG002|NOT COMPLETED|Part A||2
6374976|NCT00753415|7285567|FG003|NOT COMPLETED|Part A||2
6374977|NCT00753415|7285568|FG004|NOT COMPLETED|Part A||0
6374978|NCT00753415|7285569|FG005|NOT COMPLETED|Part A||0
6374979|NCT00753415|7285570|FG006|NOT COMPLETED|Part A||0
6374980|NCT00753415|7285571|FG007|NOT COMPLETED|Part A||0
6374981|NCT00753415|7285572|FG008|NOT COMPLETED|Part A||0
6374982|NCT00753415|7285573|FG009|NOT COMPLETED|Part A||0
6374983|NCT00753415|7285564|FG000|STARTED|Part B||0
6374984|NCT00753415|7285565|FG001|STARTED|Part B||0
6374985|NCT00753415|7285566|FG002|STARTED|Part B||0
6374986|NCT00753415|7285567|FG003|STARTED|Part B||0
6374987|NCT00753415|7285568|FG004|STARTED|Part B||0
6374988|NCT00753415|7285569|FG005|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
6374989|NCT00753415|7285570|FG006|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
6374990|NCT00753415|7285571|FG007|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
6374991|NCT00753415|7285572|FG008|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
6374992|NCT00753415|7285573|FG009|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
6374993|NCT00753415|7285564|FG000|COMPLETED|Part B||0
6374994|NCT00753415|7285565|FG001|COMPLETED|Part B||0
6374995|NCT00753415|7285566|FG002|COMPLETED|Part B||0
6374996|NCT00753415|7285567|FG003|COMPLETED|Part B||0
6374997|NCT00753415|7285568|FG004|COMPLETED|Part B||0
6374998|NCT00753415|7285569|FG005|COMPLETED|Part B||1
6374999|NCT00753415|7285570|FG006|COMPLETED|Part B||2
6375000|NCT00753415|7285571|FG007|COMPLETED|Part B||6
6375001|NCT00753415|7285572|FG008|COMPLETED|Part B||6
6375002|NCT00753415|7285573|FG009|COMPLETED|Part B||8
6375003|NCT00753415|7285564|FG000|NOT COMPLETED|Part B||0
6375004|NCT00753415|7285565|FG001|NOT COMPLETED|Part B||0
6375005|NCT00753415|7285566|FG002|NOT COMPLETED|Part B||0
6375006|NCT00753415|7285567|FG003|NOT COMPLETED|Part B||0
6375007|NCT00753415|7285568|FG004|NOT COMPLETED|Part B||0
6375008|NCT00753415|7285569|FG005|NOT COMPLETED|Part B||0
6375009|NCT00753415|7285570|FG006|NOT COMPLETED|Part B||0
6375010|NCT00753415|7285571|FG007|NOT COMPLETED|Part B||1
6375011|NCT00753415|7285572|FG008|NOT COMPLETED|Part B||3
6375012|NCT00753415|7285573|FG009|NOT COMPLETED|Part B||1
6375013|NCT00753454|7285597|FG000|STARTED|Overall Study||168
6557352|NCT01767142|7479882|FG000|STARTED|Overall Study|Each subject was treated on a single thigh. therefore the number of units is 40.|40
6557353|NCT01767142|7479882|FG000|COMPLETED|Overall Study||37
6375014|NCT00753454|7285597|FG000|COMPLETED|Overall Study||154
6375015|NCT00753454|7285597|FG000|NOT COMPLETED|Overall Study||14
6375016|NCT00753506|7285603|FG000|STARTED|Overall Study||33
6375017|NCT00753506|7285604|FG001|STARTED|Overall Study||33
6375018|NCT00753506|7285603|FG000|COMPLETED|Overall Study||26
6375019|NCT00753506|7285604|FG001|COMPLETED|Overall Study||31
6375020|NCT00753506|7285603|FG000|NOT COMPLETED|Overall Study||7
6375021|NCT00753506|7285604|FG001|NOT COMPLETED|Overall Study||2
6375022|NCT00753519|7285612|FG000|STARTED|Overall Study||13
6375023|NCT00753519|7285613|FG001|STARTED|Overall Study||15
6375024|NCT00753519|7285612|FG000|COMPLETED|Overall Study||13
6375025|NCT00753519|7285613|FG001|COMPLETED|Overall Study||13
6375026|NCT00753519|7285612|FG000|NOT COMPLETED|Overall Study||0
6375027|NCT00753519|7285613|FG001|NOT COMPLETED|Overall Study||2
6375028|NCT00753623|7285623|FG000|STARTED|Phase I (14 Days)||11
6375029|NCT00753623|7285624|FG001|STARTED|Phase I (14 Days)||12
6375030|NCT00753623|7285623|FG000|COMPLETED|Phase I (14 Days)||9
6375031|NCT00753623|7285624|FG001|COMPLETED|Phase I (14 Days)||8
6375032|NCT00753623|7285623|FG000|NOT COMPLETED|Phase I (14 Days)||2
6375033|NCT00753623|7285624|FG001|NOT COMPLETED|Phase I (14 Days)||4
6375034|NCT00753623|7285623|FG000|STARTED|Washout (7 Days)||9
6306719|NCT00375973|7210082|FG000|STARTED|Overall Study||30
6306720|NCT00375973|7210083|FG001|STARTED|Overall Study||30
6306721|NCT00375973|7210082|FG000|COMPLETED|Overall Study||20
6306722|NCT00375973|7210083|FG001|COMPLETED|Overall Study||28
6306723|NCT00375973|7210082|FG000|NOT COMPLETED|Overall Study||10
6306724|NCT00375973|7210083|FG001|NOT COMPLETED|Overall Study||2
6306725|NCT00375999|7210089|FG000|STARTED|Overall Study||34
6306726|NCT00375999|7210089|FG000|COMPLETED|Overall Study||32
6306727|NCT00375999|7210089|FG000|NOT COMPLETED|Overall Study||2
6306728|NCT00376168|7210095|FG000|STARTED|Overall Study||16
6306729|NCT00376168|7210096|FG001|STARTED|Overall Study|One patient randomized but not treated|16
6306730|NCT00376168|7210095|FG000|COMPLETED|Overall Study||14
6306731|NCT00376168|7210096|FG001|COMPLETED|Overall Study||15
6306732|NCT00376168|7210095|FG000|NOT COMPLETED|Overall Study||2
6306733|NCT00376168|7210096|FG001|NOT COMPLETED|Overall Study||1
6306734|NCT00376220|7210104|FG000|STARTED|Overall Study||47
6306735|NCT00376220|7210105|FG001|STARTED|Overall Study||47
6306736|NCT00376220|7210104|FG000|COMPLETED|Overall Study||37
6306737|NCT00376220|7210105|FG001|COMPLETED|Overall Study||35
6306738|NCT00376220|7210104|FG000|NOT COMPLETED|Overall Study||10
6306739|NCT00376220|7210105|FG001|NOT COMPLETED|Overall Study||12
6306740|NCT00376246|7210111|FG000|STARTED|First Intervention (2 Weeks)||14
6306741|NCT00376246|7210112|FG001|STARTED|First Intervention (2 Weeks)||14
6306742|NCT00376246|7210111|FG000|COMPLETED|First Intervention (2 Weeks)||10
6306743|NCT00376246|7210112|FG001|COMPLETED|First Intervention (2 Weeks)||12
6306744|NCT00376246|7210111|FG000|NOT COMPLETED|First Intervention (2 Weeks)||4
6306745|NCT00376246|7210112|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
6306746|NCT00376246|7210111|FG000|STARTED|Washout (2 Weeks)||10
6306747|NCT00376246|7210112|FG001|STARTED|Washout (2 Weeks)||12
6306748|NCT00376246|7210111|FG000|COMPLETED|Washout (2 Weeks)||10
6306749|NCT00376246|7210112|FG001|COMPLETED|Washout (2 Weeks)||12
6306750|NCT00376246|7210111|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6306751|NCT00376246|7210112|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6306752|NCT00376246|7210111|FG000|STARTED|Second Intervention (2 Weeks)||10
6306753|NCT00376246|7210112|FG001|STARTED|Second Intervention (2 Weeks)||12
6306754|NCT00376246|7210111|FG000|COMPLETED|Second Intervention (2 Weeks)||10
6306755|NCT00376246|7210112|FG001|COMPLETED|Second Intervention (2 Weeks)||12
6306756|NCT00376246|7210111|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6306757|NCT00376246|7210112|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6306758|NCT00376259|7210122|FG000|STARTED|Overall Study||22
6306759|NCT00376259|7210123|FG001|STARTED|Overall Study||21
6306760|NCT00376259|7210122|FG000|Received Study Drug|Overall Study||21
6306761|NCT00376259|7210123|FG001|Received Study Drug|Overall Study||21
6306762|NCT00376259|7210122|FG000|COMPLETED|Overall Study||0
6306763|NCT00376259|7210123|FG001|COMPLETED|Overall Study||0
6306764|NCT00376259|7210122|FG000|NOT COMPLETED|Overall Study||22
6306765|NCT00376259|7210123|FG001|NOT COMPLETED|Overall Study||21
6306766|NCT00376363|7210131|FG000|STARTED|Overall Study||143
6306767|NCT00376363|7210132|FG001|STARTED|Overall Study||133
6306768|NCT00376363|7210131|FG000|COMPLETED|Overall Study||87
6306769|NCT00376363|7210132|FG001|COMPLETED|Overall Study||87
6306770|NCT00376363|7210131|FG000|NOT COMPLETED|Overall Study||56
6306771|NCT00376363|7210132|FG001|NOT COMPLETED|Overall Study||46
6306772|NCT00376506|7210140|FG000|STARTED|Overall Study||4
6306773|NCT00376506|7210141|FG001|STARTED|Overall Study||6
6306774|NCT00376506|7210140|FG000|COMPLETED|Overall Study||4
6306775|NCT00376506|7210141|FG001|COMPLETED|Overall Study||4
6306776|NCT00376506|7210140|FG000|NOT COMPLETED|Overall Study||0
6306777|NCT00376506|7210141|FG001|NOT COMPLETED|Overall Study||2
6306778|NCT00376532|7210152|FG000|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
6306779|NCT00376532|7210153|FG001|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
6306780|NCT00376532|7210152|FG000|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
6306781|NCT00376532|7210153|FG001|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
6306782|NCT00376532|7210152|FG000|NOT COMPLETED|Overall Study||6
6306783|NCT00376532|7210153|FG001|NOT COMPLETED|Overall Study||6
6306784|NCT00376558|7210161|FG000|STARTED|Overall Study||25
6306785|NCT00376558|7210162|FG001|STARTED|Overall Study||25
6306786|NCT00376558|7210161|FG000|COMPLETED|Overall Study||25
6306787|NCT00376558|7210162|FG001|COMPLETED|Overall Study||25
6306788|NCT00376558|7210161|FG000|NOT COMPLETED|Overall Study||0
6306789|NCT00376558|7210162|FG001|NOT COMPLETED|Overall Study||0
6306790|NCT00376597|7210171|FG000|STARTED|Overall Study||253
6306791|NCT00376597|7210172|FG001|STARTED|Overall Study||315
6306792|NCT00376597|7210171|FG000|COMPLETED|Overall Study||242
6306793|NCT00376597|7210172|FG001|COMPLETED|Overall Study||312
6306794|NCT00376597|7210171|FG000|NOT COMPLETED|Overall Study||11
6306795|NCT00376597|7210172|FG001|NOT COMPLETED|Overall Study||3
6306796|NCT00376675|7210182|FG000|STARTED|Overall Study||69
6306797|NCT00376675|7210183|FG001|STARTED|Overall Study||70
6306798|NCT00376675|7210182|FG000|COMPLETED|Overall Study||49
6306799|NCT00376675|7210183|FG001|COMPLETED|Overall Study||56
6306800|NCT00376675|7210182|FG000|NOT COMPLETED|Overall Study||20
6306801|NCT00376675|7210183|FG001|NOT COMPLETED|Overall Study||14
6306802|NCT00376688|7210189|FG000|STARTED|Overall Study||31
6306803|NCT00376688|7210189|FG000|COMPLETED|Overall Study||27
6306804|NCT00376688|7210189|FG000|NOT COMPLETED|Overall Study||4
6306805|NCT00376805|7210193|FG000|STARTED|Overall Study||6
6306806|NCT00376805|7210193|FG000|COMPLETED|Overall Study||6
6306807|NCT00376805|7210193|FG000|NOT COMPLETED|Overall Study||0
6306808|NCT00376935|7210201|FG000|STARTED|Overall Study||25
6306809|NCT00376935|7210202|FG001|STARTED|Overall Study||25
6306810|NCT00376935|7210203|FG002|STARTED|Overall Study||25
6306811|NCT00376935|7210204|FG003|STARTED|Overall Study||24
6306812|NCT00376935|7210201|FG000|COMPLETED|Overall Study||25
6306813|NCT00376935|7210202|FG001|COMPLETED|Overall Study||25
6306814|NCT00376935|7210203|FG002|COMPLETED|Overall Study||25
6306815|NCT00376935|7210204|FG003|COMPLETED|Overall Study||24
6306816|NCT00376935|7210201|FG000|NOT COMPLETED|Overall Study||0
6306817|NCT00376935|7210202|FG001|NOT COMPLETED|Overall Study||0
6306818|NCT00376935|7210203|FG002|NOT COMPLETED|Overall Study||0
6306819|NCT00376935|7210204|FG003|NOT COMPLETED|Overall Study||0
6306820|NCT00376948|7210214|FG000|STARTED|Overall Study||20
6306821|NCT00376948|7210214|FG000|COMPLETED|Overall Study||20
6306822|NCT00376948|7210214|FG000|NOT COMPLETED|Overall Study||0
6306823|NCT00376961|7210218|FG000|STARTED|Initial Registration||68
6306824|NCT00376961|7210219|FG001|STARTED|Initial Registration||0
6306825|NCT00376961|7210218|FG000|Eligible|Initial Registration||65
6306826|NCT00376961|7210219|FG001|Eligible|Initial Registration||0
6306827|NCT00376961|7210218|FG000|COMPLETED|Initial Registration||61
6306828|NCT00376961|7210219|FG001|COMPLETED|Initial Registration||0
6306829|NCT00376961|7210218|FG000|NOT COMPLETED|Initial Registration||7
6306830|NCT00376961|7210219|FG001|NOT COMPLETED|Initial Registration||0
6306831|NCT00376961|7210218|FG000|STARTED|Maintenance||0
6306832|NCT00376961|7210219|FG001|STARTED|Maintenance||50
6306833|NCT00376961|7210218|FG000|Eligible|Maintenance||0
6306834|NCT00376961|7210219|FG001|Eligible|Maintenance||47
6306835|NCT00376961|7210218|FG000|COMPLETED|Maintenance||0
6306836|NCT00376961|7210219|FG001|COMPLETED|Maintenance||27
6306837|NCT00376961|7210218|FG000|NOT COMPLETED|Maintenance||0
6306838|NCT00376961|7210219|FG001|NOT COMPLETED|Maintenance||23
6306839|NCT00377156|7210229|FG000|STARTED|Overall Study||111
6306840|NCT00377156|7210230|FG001|STARTED|Overall Study||102
6306841|NCT00377156|7210229|FG000|COMPLETED|Overall Study||63
6306842|NCT00377156|7210230|FG001|COMPLETED|Overall Study||48
6306843|NCT00377156|7210229|FG000|NOT COMPLETED|Overall Study||48
6306844|NCT00377156|7210230|FG001|NOT COMPLETED|Overall Study||54
6306845|NCT00377234|7210240|FG000|STARTED|Overall Study||180
6306846|NCT00377234|7210241|FG001|STARTED|Overall Study||176
6306847|NCT00377234|7210240|FG000|Randomized|Overall Study||180
6306848|NCT00377234|7210241|FG001|Randomized|Overall Study||176
6306849|NCT00377234|7210240|FG000|Did Not Receive Study Treatment|Overall Study||3
6306850|NCT00377234|7210241|FG001|Did Not Receive Study Treatment|Overall Study||2
6306851|NCT00377234|7210240|FG000|Received Treatment|Overall Study||177
6306852|NCT00377234|7210241|FG001|Received Treatment|Overall Study||174
6306853|NCT00377234|7210240|FG000|Safety Analysis Set: Period 1|Overall Study||177
6773437|NCT03987620|7701097|FG000|Withdrawn Before TOC|Overall Study||48
6773438|NCT03987620|7701098|FG001|Withdrawn Before TOC|Overall Study||45
6306854|NCT00377234|7210241|FG001|Safety Analysis Set: Period 1|Overall Study||174
6306855|NCT00377234|7210240|FG000|Safety Analysis Set: Period 2|Overall Study||153
6306856|NCT00377234|7210241|FG001|Safety Analysis Set: Period 2|Overall Study||150
6306857|NCT00377234|7210240|FG000|Safety Analysis Set: Ibandronate|Overall Study||177
6306858|NCT00377234|7210241|FG001|Safety Analysis Set: Ibandronate|Overall Study||150
6306859|NCT00377234|7210240|FG000|Safety Analysis Set: Risedronate|Overall Study||153
6306860|NCT00377234|7210241|FG001|Safety Analysis Set: Risedronate|Overall Study||174
6306861|NCT00377234|7210240|FG000|COMPLETED|Overall Study||146
6306862|NCT00377234|7210241|FG001|COMPLETED|Overall Study||145
6306863|NCT00377234|7210240|FG000|NOT COMPLETED|Overall Study||34
6306864|NCT00377234|7210241|FG001|NOT COMPLETED|Overall Study||31
6306865|NCT00377260|7210255|FG000|STARTED|Overall Study||144
6306866|NCT00377260|7210256|FG001|STARTED|Overall Study||147
6306867|NCT00377260|7210255|FG000|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
6306868|NCT00377260|7210256|FG001|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
6306869|NCT00377260|7210255|FG000|NOT COMPLETED|Overall Study||2
6306870|NCT00377260|7210256|FG001|NOT COMPLETED|Overall Study||5
6306871|NCT00377299|7210264|FG000|STARTED|Overall Study||32
6306872|NCT00377299|7210265|FG001|STARTED|Overall Study||28
6306873|NCT00377299|7210264|FG000|COMPLETED|Overall Study||13
6306874|NCT00377299|7210265|FG001|COMPLETED|Overall Study||4
6306875|NCT00377299|7210264|FG000|NOT COMPLETED|Overall Study||19
6306876|NCT00377299|7210265|FG001|NOT COMPLETED|Overall Study||24
6306877|NCT00377312|7210274|FG000|STARTED|Overall Study||6
6306878|NCT00377312|7210275|FG001|STARTED|Overall Study||5
6306879|NCT00377312|7210274|FG000|COMPLETED|Overall Study||5
6306880|NCT00377312|7210275|FG001|COMPLETED|Overall Study||4
6306881|NCT00377312|7210274|FG000|NOT COMPLETED|Overall Study||1
6306882|NCT00377312|7210275|FG001|NOT COMPLETED|Overall Study||1
6306883|NCT00377364|7210283|FG000|STARTED|Overall Study||16
6306884|NCT00377364|7210284|FG001|STARTED|Overall Study||14
6306885|NCT00377364|7210283|FG000|COMPLETED|Overall Study||14
6306886|NCT00377364|7210284|FG001|COMPLETED|Overall Study||14
6306887|NCT00377364|7210283|FG000|NOT COMPLETED|Overall Study||2
6306888|NCT00377364|7210284|FG001|NOT COMPLETED|Overall Study||0
6306889|NCT00377403|7210294|FG000|STARTED|Overall Study||85
6306890|NCT00377403|7210295|FG001|STARTED|Overall Study||81
6306891|NCT00377403|7210294|FG000|Day -3 Assessment|Overall Study||81
6306892|NCT00377403|7210295|FG001|Day -3 Assessment|Overall Study||74
6306893|NCT00377403|7210294|FG000|Day 7 Assessment|Overall Study||80
6306894|NCT00377403|7210295|FG001|Day 7 Assessment|Overall Study||75
6306895|NCT00377403|7210294|FG000|Day 10 Assessment|Overall Study||81
6306896|NCT00377403|7210295|FG001|Day 10 Assessment|Overall Study||71
6306897|NCT00377403|7210294|FG000|Day 28 Assessment|Overall Study||82
6306898|NCT00377403|7210295|FG001|Day 28 Assessment|Overall Study||77
6306899|NCT00377403|7210294|FG000|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
6306900|NCT00377403|7210295|FG001|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
6306901|NCT00377403|7210294|FG000|NOT COMPLETED|Overall Study||4
6306902|NCT00377403|7210295|FG001|NOT COMPLETED|Overall Study||7
6306903|NCT00377429|7210301|FG000|STARTED|Overall Study|Treated|47
6306904|NCT00377429|7210301|FG000|COMPLETED|Overall Study|Completed main study|32
6306905|NCT00377429|7210301|FG000|NOT COMPLETED|Overall Study||15
6306906|NCT00377520|7210305|FG000|STARTED|Overall Study||27
6306907|NCT00377520|7210305|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
6306908|NCT00377520|7210305|FG000|NOT COMPLETED|Overall Study||1
6306909|NCT00377572|7210311|FG000|STARTED|Overall Study||208
6306910|NCT00377572|7210312|FG001|STARTED|Overall Study||211
6306911|NCT00377572|7210311|FG000|COMPLETED|Overall Study||155
6306912|NCT00377572|7210312|FG001|COMPLETED|Overall Study||157
6306913|NCT00377572|7210311|FG000|NOT COMPLETED|Overall Study||53
6306914|NCT00377572|7210312|FG001|NOT COMPLETED|Overall Study||54
6306915|NCT00377611|7210320|FG000|STARTED|Overall Study||1047
6306916|NCT00377611|7210321|FG001|STARTED|Overall Study||2007
6306917|NCT00377611|7210320|FG000|COMPLETED|Overall Study||1025
6306918|NCT00377611|7210321|FG001|COMPLETED|Overall Study||1974
6306919|NCT00377611|7210320|FG000|NOT COMPLETED|Overall Study||22
6306920|NCT00377611|7210321|FG001|NOT COMPLETED|Overall Study||33
6306921|NCT00377637|7210332|FG000|STARTED|Induction Phase|Intent-To-Treat|185
6306922|NCT00377637|7210333|FG001|STARTED|Induction Phase|Intent-To-Treat|185
6306923|NCT00377637|7210334|FG002|STARTED|Induction Phase||0
6306924|NCT00377637|7210335|FG003|STARTED|Induction Phase||0
6306925|NCT00377637|7210332|FG000|Safety Population|Induction Phase||180
6306926|NCT00377637|7210333|FG001|Safety Population|Induction Phase||184
6306927|NCT00377637|7210334|FG002|Safety Population|Induction Phase||0
6306928|NCT00377637|7210335|FG003|Safety Population|Induction Phase||0
6306929|NCT00377637|7210332|FG000|COMPLETED|Induction Phase||156
6306930|NCT00377637|7210333|FG001|COMPLETED|Induction Phase||150
6306931|NCT00377637|7210334|FG002|COMPLETED|Induction Phase||0
6306932|NCT00377637|7210335|FG003|COMPLETED|Induction Phase||0
6306933|NCT00377637|7210332|FG000|NOT COMPLETED|Induction Phase||29
6306934|NCT00377637|7210333|FG001|NOT COMPLETED|Induction Phase||35
6306935|NCT00377637|7210334|FG002|NOT COMPLETED|Induction Phase||0
6306936|NCT00377637|7210335|FG003|NOT COMPLETED|Induction Phase||0
6306937|NCT00377637|7210332|FG000|STARTED|Maintenance Phase||0
6306938|NCT00377637|7210333|FG001|STARTED|Maintenance Phase||0
6306939|NCT00377637|7210334|FG002|STARTED|Maintenance Phase||116
6306940|NCT00377637|7210335|FG003|STARTED|Maintenance Phase||111
6306941|NCT00377637|7210332|FG000|COMPLETED|Maintenance Phase||0
6306942|NCT00377637|7210333|FG001|COMPLETED|Maintenance Phase||0
6306943|NCT00377637|7210334|FG002|COMPLETED|Maintenance Phase||73
6306944|NCT00377637|7210335|FG003|COMPLETED|Maintenance Phase||54
6306945|NCT00377637|7210332|FG000|NOT COMPLETED|Maintenance Phase||0
6306946|NCT00377637|7210333|FG001|NOT COMPLETED|Maintenance Phase||0
6306947|NCT00377637|7210334|FG002|NOT COMPLETED|Maintenance Phase||43
6306948|NCT00377637|7210335|FG003|NOT COMPLETED|Maintenance Phase||57
6306949|NCT00377676|7210351|FG000|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
6306950|NCT00377676|7210352|FG001|STARTED|Overall Study||1016
6306951|NCT00377676|7210351|FG000|COMPLETED|Overall Study||1093
6306952|NCT00377676|7210352|FG001|COMPLETED|Overall Study||694
6306953|NCT00377676|7210351|FG000|NOT COMPLETED|Overall Study||961
6306954|NCT00377676|7210352|FG001|NOT COMPLETED|Overall Study||322
6306955|NCT00377741|7210360|FG000|STARTED|Overall Study||16
6306956|NCT00377741|7210361|FG001|STARTED|Overall Study||15
6306957|NCT00377741|7210360|FG000|COMPLETED|Overall Study||16
6306958|NCT00377741|7210361|FG001|COMPLETED|Overall Study||15
6306959|NCT00377741|7210360|FG000|NOT COMPLETED|Overall Study||0
6306960|NCT00377741|7210361|FG001|NOT COMPLETED|Overall Study||0
6306961|NCT00377819|7210369|FG000|STARTED|Overall Study||251
6306962|NCT00377819|7210370|FG001|STARTED|Overall Study||253
6306963|NCT00377819|7210369|FG000|Received Study Medication|Overall Study||249
6306964|NCT00377819|7210370|FG001|Received Study Medication|Overall Study||253
6306965|NCT00377819|7210369|FG000|COMPLETED|Overall Study||238
6306966|NCT00377819|7210370|FG001|COMPLETED|Overall Study||243
6306967|NCT00377819|7210369|FG000|NOT COMPLETED|Overall Study||13
6306968|NCT00377819|7210370|FG001|NOT COMPLETED|Overall Study||10
6306969|NCT00377832|7210378|FG000|STARTED|Overall Study||7
6306970|NCT00377832|7210379|FG001|STARTED|Overall Study||6
6306971|NCT00377832|7210378|FG000|COMPLETED|Overall Study||7
6306972|NCT00377832|7210379|FG001|COMPLETED|Overall Study||6
6306973|NCT00377832|7210378|FG000|NOT COMPLETED|Overall Study||0
6306974|NCT00377832|7210379|FG001|NOT COMPLETED|Overall Study||0
6306975|NCT00377858|7210390|FG000|STARTED|Overall Study||242
6306976|NCT00377858|7210391|FG001|STARTED|Overall Study||242
6306977|NCT00377858|7210390|FG000|Had at Least One Post-Baseline Value|Overall Study||239
6306978|NCT00377858|7210391|FG001|Had at Least One Post-Baseline Value|Overall Study||240
6306979|NCT00377858|7210390|FG000|COMPLETED|Overall Study||211
6306980|NCT00377858|7210391|FG001|COMPLETED|Overall Study||215
6306981|NCT00377858|7210390|FG000|NOT COMPLETED|Overall Study||31
6306982|NCT00377858|7210391|FG001|NOT COMPLETED|Overall Study||27
6306983|NCT00377962|7210399|FG000|STARTED|Core Study: 0-12 Months||140
6306984|NCT00377962|7210400|FG001|STARTED|Core Study: 0-12 Months||142
6306985|NCT00377962|7210399|FG000|COMPLETED|Core Study: 0-12 Months||112
6306986|NCT00377962|7210400|FG001|COMPLETED|Core Study: 0-12 Months||133
6306987|NCT00377962|7210399|FG000|NOT COMPLETED|Core Study: 0-12 Months||28
6306988|NCT00377962|7210400|FG001|NOT COMPLETED|Core Study: 0-12 Months||9
6306989|NCT00377962|7210399|FG000|STARTED|Extension Study: 12-24 Months||108
6306990|NCT00377962|7210400|FG001|STARTED|Extension Study: 12-24 Months||127
6306991|NCT00377962|7210399|FG000|COMPLETED|Extension Study: 12-24 Months||98
6306992|NCT00377962|7210400|FG001|COMPLETED|Extension Study: 12-24 Months||123
6306993|NCT00377962|7210399|FG000|NOT COMPLETED|Extension Study: 12-24 Months||10
6306994|NCT00377962|7210400|FG001|NOT COMPLETED|Extension Study: 12-24 Months||4
6306995|NCT00378014|7210414|FG000|STARTED|Core (Randomization to Month 11)||101
6306996|NCT00378014|7210415|FG001|STARTED|Core (Randomization to Month 11)||102
6306997|NCT00378014|7210414|FG000|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
6306998|NCT00378014|7210415|FG001|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
6306999|NCT00378014|7210414|FG000|COMPLETED|Core (Randomization to Month 11)||87
6307000|NCT00378014|7210415|FG001|COMPLETED|Core (Randomization to Month 11)||90
6307001|NCT00378014|7210414|FG000|NOT COMPLETED|Core (Randomization to Month 11)||14
6307002|NCT00378014|7210415|FG001|NOT COMPLETED|Core (Randomization to Month 11)||12
6307003|NCT00378014|7210414|FG000|STARTED|Extension (Month 12 to Month 59)||41
6307004|NCT00378014|7210415|FG001|STARTED|Extension (Month 12 to Month 59)||40
6307005|NCT00378014|7210414|FG000|COMPLETED|Extension (Month 12 to Month 59)||27
6307006|NCT00378014|7210415|FG001|COMPLETED|Extension (Month 12 to Month 59)||26
6307007|NCT00378014|7210414|FG000|NOT COMPLETED|Extension (Month 12 to Month 59)||14
6307008|NCT00378014|7210415|FG001|NOT COMPLETED|Extension (Month 12 to Month 59)||14
6307009|NCT00378079|7210426|FG000|STARTED|Overall Study||70
6307010|NCT00378079|7210427|FG001|STARTED|Overall Study||70
6307011|NCT00378079|7210428|FG002|STARTED|Overall Study||71
6307012|NCT00378079|7210426|FG000|COMPLETED|Overall Study||64
6307013|NCT00378079|7210427|FG001|COMPLETED|Overall Study||69
6307014|NCT00378079|7210428|FG002|COMPLETED|Overall Study||71
6307015|NCT00378079|7210426|FG000|NOT COMPLETED|Overall Study||6
6307016|NCT00378079|7210427|FG001|NOT COMPLETED|Overall Study||1
6307017|NCT00378079|7210428|FG002|NOT COMPLETED|Overall Study||0
6307018|NCT00378105|7210438|FG000|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
6307019|NCT00378105|7210439|FG001|STARTED|Overall Study||35
6307020|NCT00378105|7210438|FG000|COMPLETED|Overall Study||11
6307021|NCT00378105|7210439|FG001|COMPLETED|Overall Study||5
6307022|NCT00378105|7210438|FG000|NOT COMPLETED|Overall Study||20
6307023|NCT00378105|7210439|FG001|NOT COMPLETED|Overall Study||30
6307024|NCT00378209|7210446|FG000|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
6307025|NCT00378209|7210446|FG000|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
6557354|NCT01767142|7479882|FG000|NOT COMPLETED|Overall Study||3
6557355|NCT01767155|7479888|FG000|STARTED|Overall Study|Patients allocated to AEZS-108|256
6557356|NCT01767155|7479889|FG001|STARTED|Overall Study|Patients allocated to doxorubicin|255
6307026|NCT00378209|7210446|FG000|NOT COMPLETED|Overall Study||22
6307027|NCT00378326|7210451|FG000|STARTED|Overall Study||26
6307028|NCT00378326|7210451|FG000|COMPLETED|Overall Study||26
6307029|NCT00378326|7210451|FG000|NOT COMPLETED|Overall Study||0
6307030|NCT00378352|7210459|FG000|STARTED|Dose Escalation 15,000 Units||20
6307031|NCT00378352|7210460|FG001|STARTED|Dose Escalation 15,000 Units||0
6307032|NCT00378352|7210461|FG002|STARTED|Dose Escalation 15,000 Units||0
6307033|NCT00378352|7210462|FG003|STARTED|Dose Escalation 15,000 Units||11
6307034|NCT00378352|7210463|FG004|STARTED|Dose Escalation 15,000 Units||0
6307035|NCT00378352|7210464|FG005|STARTED|Dose Escalation 15,000 Units||0
6307036|NCT00378352|7210459|FG000|Safety Analysis|Dose Escalation 15,000 Units||19
6307037|NCT00378352|7210460|FG001|Safety Analysis|Dose Escalation 15,000 Units||0
6307038|NCT00378352|7210461|FG002|Safety Analysis|Dose Escalation 15,000 Units||0
6307039|NCT00378352|7210462|FG003|Safety Analysis|Dose Escalation 15,000 Units||11
6307040|NCT00378352|7210463|FG004|Safety Analysis|Dose Escalation 15,000 Units||0
6307041|NCT00378352|7210464|FG005|Safety Analysis|Dose Escalation 15,000 Units||0
6307042|NCT00378352|7210459|FG000|COMPLETED|Dose Escalation 15,000 Units||15
6307043|NCT00378352|7210460|FG001|COMPLETED|Dose Escalation 15,000 Units||0
6307044|NCT00378352|7210461|FG002|COMPLETED|Dose Escalation 15,000 Units||0
6307045|NCT00378352|7210462|FG003|COMPLETED|Dose Escalation 15,000 Units||10
6307046|NCT00378352|7210463|FG004|COMPLETED|Dose Escalation 15,000 Units||0
6307047|NCT00378352|7210464|FG005|COMPLETED|Dose Escalation 15,000 Units||0
6307048|NCT00378352|7210459|FG000|NOT COMPLETED|Dose Escalation 15,000 Units||5
6307049|NCT00378352|7210460|FG001|NOT COMPLETED|Dose Escalation 15,000 Units||0
6307050|NCT00378352|7210461|FG002|NOT COMPLETED|Dose Escalation 15,000 Units||0
6307051|NCT00378352|7210462|FG003|NOT COMPLETED|Dose Escalation 15,000 Units||1
6307052|NCT00378352|7210463|FG004|NOT COMPLETED|Dose Escalation 15,000 Units||0
6307053|NCT00378352|7210464|FG005|NOT COMPLETED|Dose Escalation 15,000 Units||0
6307054|NCT00378352|7210459|FG000|STARTED|Dose Escalation 30,000 Units||0
6307055|NCT00378352|7210460|FG001|STARTED|Dose Escalation 30,000 Units||19
6307056|NCT00378352|7210461|FG002|STARTED|Dose Escalation 30,000 Units||0
6307057|NCT00378352|7210462|FG003|STARTED|Dose Escalation 30,000 Units||11
6307058|NCT00378352|7210463|FG004|STARTED|Dose Escalation 30,000 Units||0
6307059|NCT00378352|7210464|FG005|STARTED|Dose Escalation 30,000 Units||0
6307060|NCT00378352|7210459|FG000|Safety Analysis|Dose Escalation 30,000 Units||0
6307061|NCT00378352|7210460|FG001|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
6307062|NCT00378352|7210461|FG002|Safety Analysis|Dose Escalation 30,000 Units||0
6307063|NCT00378352|7210462|FG003|Safety Analysis|Dose Escalation 30,000 Units||11
6307064|NCT00378352|7210463|FG004|Safety Analysis|Dose Escalation 30,000 Units||0
6307065|NCT00378352|7210464|FG005|Safety Analysis|Dose Escalation 30,000 Units||0
6307066|NCT00378352|7210459|FG000|COMPLETED|Dose Escalation 30,000 Units||0
6307067|NCT00378352|7210460|FG001|COMPLETED|Dose Escalation 30,000 Units||16
6307068|NCT00378352|7210461|FG002|COMPLETED|Dose Escalation 30,000 Units||0
6307069|NCT00378352|7210462|FG003|COMPLETED|Dose Escalation 30,000 Units||9
6307070|NCT00378352|7210463|FG004|COMPLETED|Dose Escalation 30,000 Units||0
6307071|NCT00378352|7210464|FG005|COMPLETED|Dose Escalation 30,000 Units||0
6307072|NCT00378352|7210459|FG000|NOT COMPLETED|Dose Escalation 30,000 Units||0
6307073|NCT00378352|7210460|FG001|NOT COMPLETED|Dose Escalation 30,000 Units||3
6307074|NCT00378352|7210461|FG002|NOT COMPLETED|Dose Escalation 30,000 Units||0
6307075|NCT00378352|7210462|FG003|NOT COMPLETED|Dose Escalation 30,000 Units||2
6307076|NCT00378352|7210463|FG004|NOT COMPLETED|Dose Escalation 30,000 Units||0
6307077|NCT00378352|7210464|FG005|NOT COMPLETED|Dose Escalation 30,000 Units||0
6307078|NCT00378352|7210459|FG000|STARTED|Dose Escalation 60,000 Units||0
6307079|NCT00378352|7210460|FG001|STARTED|Dose Escalation 60,000 Units||0
6307080|NCT00378352|7210461|FG002|STARTED|Dose Escalation 60,000 Units||20
6307081|NCT00378352|7210462|FG003|STARTED|Dose Escalation 60,000 Units||11
6307082|NCT00378352|7210463|FG004|STARTED|Dose Escalation 60,000 Units||0
6307083|NCT00378352|7210464|FG005|STARTED|Dose Escalation 60,000 Units||0
6307084|NCT00378352|7210459|FG000|Safety Analysis|Dose Escalation 60,000 Units||0
6307085|NCT00378352|7210460|FG001|Safety Analysis|Dose Escalation 60,000 Units||0
6307086|NCT00378352|7210461|FG002|Safety Analysis|Dose Escalation 60,000 Units||19
6307087|NCT00378352|7210462|FG003|Safety Analysis|Dose Escalation 60,000 Units||11
6307088|NCT00378352|7210463|FG004|Safety Analysis|Dose Escalation 60,000 Units||0
6307089|NCT00378352|7210464|FG005|Safety Analysis|Dose Escalation 60,000 Units||0
6307090|NCT00378352|7210459|FG000|COMPLETED|Dose Escalation 60,000 Units||0
6307091|NCT00378352|7210460|FG001|COMPLETED|Dose Escalation 60,000 Units||0
6307092|NCT00378352|7210461|FG002|COMPLETED|Dose Escalation 60,000 Units||17
6307093|NCT00378352|7210462|FG003|COMPLETED|Dose Escalation 60,000 Units||10
6307094|NCT00378352|7210463|FG004|COMPLETED|Dose Escalation 60,000 Units||0
6307095|NCT00378352|7210464|FG005|COMPLETED|Dose Escalation 60,000 Units||0
6307096|NCT00378352|7210459|FG000|NOT COMPLETED|Dose Escalation 60,000 Units||0
6307097|NCT00378352|7210460|FG001|NOT COMPLETED|Dose Escalation 60,000 Units||0
6307098|NCT00378352|7210461|FG002|NOT COMPLETED|Dose Escalation 60,000 Units||3
6307099|NCT00378352|7210462|FG003|NOT COMPLETED|Dose Escalation 60,000 Units||1
6307100|NCT00378352|7210463|FG004|NOT COMPLETED|Dose Escalation 60,000 Units||0
6307101|NCT00378352|7210464|FG005|NOT COMPLETED|Dose Escalation 60,000 Units||0
6307102|NCT00378352|7210459|FG000|STARTED|Efficacy Phase||0
6307103|NCT00378352|7210460|FG001|STARTED|Efficacy Phase||0
6307104|NCT00378352|7210461|FG002|STARTED|Efficacy Phase||0
6307105|NCT00378352|7210462|FG003|STARTED|Efficacy Phase||0
6307106|NCT00378352|7210463|FG004|STARTED|Efficacy Phase||65
6307107|NCT00378352|7210464|FG005|STARTED|Efficacy Phase||66
6307108|NCT00378352|7210459|FG000|Safety Analysis|Efficacy Phase||0
6307109|NCT00378352|7210460|FG001|Safety Analysis|Efficacy Phase||0
6307110|NCT00378352|7210461|FG002|Safety Analysis|Efficacy Phase||0
6307111|NCT00378352|7210462|FG003|Safety Analysis|Efficacy Phase||0
6307112|NCT00378352|7210463|FG004|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
6307113|NCT00378352|7210464|FG005|Safety Analysis|Efficacy Phase||64
6307114|NCT00378352|7210459|FG000|COMPLETED|Efficacy Phase||0
6307115|NCT00378352|7210460|FG001|COMPLETED|Efficacy Phase||0
6307116|NCT00378352|7210461|FG002|COMPLETED|Efficacy Phase||0
6307117|NCT00378352|7210462|FG003|COMPLETED|Efficacy Phase||0
6307118|NCT00378352|7210463|FG004|COMPLETED|Efficacy Phase||54
6307119|NCT00378352|7210464|FG005|COMPLETED|Efficacy Phase||59
6307120|NCT00378352|7210459|FG000|NOT COMPLETED|Efficacy Phase||0
6307121|NCT00378352|7210460|FG001|NOT COMPLETED|Efficacy Phase||0
6307122|NCT00378352|7210461|FG002|NOT COMPLETED|Efficacy Phase||0
6307123|NCT00378352|7210462|FG003|NOT COMPLETED|Efficacy Phase||0
6307124|NCT00378352|7210463|FG004|NOT COMPLETED|Efficacy Phase||11
6307125|NCT00378352|7210464|FG005|NOT COMPLETED|Efficacy Phase||7
6307126|NCT00378508|7210474|FG000|STARTED|Overall Study||29
6307127|NCT00378508|7210475|FG001|STARTED|Overall Study||34
6307128|NCT00378508|7210474|FG000|Randomized|Overall Study||29
6307129|NCT00378508|7210475|FG001|Randomized|Overall Study||34
6307130|NCT00378508|7210474|FG000|Received Intervention/Placebo|Overall Study||28
6307131|NCT00378508|7210475|FG001|Received Intervention/Placebo|Overall Study||31
6307132|NCT00378508|7210474|FG000|COMPLETED|Overall Study||27
6307133|NCT00378508|7210475|FG001|COMPLETED|Overall Study||31
6307134|NCT00378508|7210474|FG000|NOT COMPLETED|Overall Study||2
6307135|NCT00378508|7210475|FG001|NOT COMPLETED|Overall Study||3
6307136|NCT00378534|7210484|FG000|STARTED|Overall Study||58
6307137|NCT00378534|7210485|FG001|STARTED|Overall Study||58
6307138|NCT00378534|7210484|FG000|COMPLETED|Overall Study||55
6307139|NCT00378534|7210485|FG001|COMPLETED|Overall Study||58
6307140|NCT00378534|7210484|FG000|NOT COMPLETED|Overall Study||3
6307141|NCT00378534|7210485|FG001|NOT COMPLETED|Overall Study||0
6307142|NCT00378560|7210492|FG000|STARTED|Overall Study||509
6307143|NCT00378560|7210493|FG001|STARTED|Overall Study||512
6307144|NCT00378560|7210492|FG000|Vaccinated|Overall Study||509
6307145|NCT00378560|7210493|FG001|Vaccinated|Overall Study||512
6307146|NCT00378560|7210492|FG000|COMPLETED|Overall Study||453
6307147|NCT00378560|7210493|FG001|COMPLETED|Overall Study||454
6307148|NCT00378560|7210492|FG000|NOT COMPLETED|Overall Study||56
6307149|NCT00378560|7210493|FG001|NOT COMPLETED|Overall Study||58
6307150|NCT00378573|7210499|FG000|STARTED|Treatment Period||17
6307151|NCT00378573|7210499|FG000|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
6307152|NCT00378573|7210499|FG000|NOT COMPLETED|Treatment Period||17
6307153|NCT00378573|7210499|FG000|STARTED|Follow-up||17
6307154|NCT00378573|7210499|FG000|COMPLETED|Follow-up||3
6307155|NCT00378573|7210499|FG000|NOT COMPLETED|Follow-up||14
6307156|NCT00378599|7210503|FG000|STARTED|Overall Study||125
6307157|NCT00378599|7210503|FG000|COMPLETED|Overall Study||73
6307158|NCT00378599|7210503|FG000|NOT COMPLETED|Overall Study||52
6307159|NCT00378703|7210511|FG000|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
6307160|NCT00378703|7210512|FG001|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
6307161|NCT00378703|7210513|FG002|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
6307162|NCT00378703|7210514|FG003|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
6307163|NCT00378703|7210511|FG000|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
6307164|NCT00378703|7210512|FG001|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
6307165|NCT00378703|7210513|FG002|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
6307166|NCT00378703|7210514|FG003|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
6307167|NCT00378703|7210511|FG000|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
6307168|NCT00378703|7210512|FG001|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
6307169|NCT00378703|7210513|FG002|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
6307170|NCT00378703|7210514|FG003|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
6307171|NCT00378703|7210511|FG000|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
6307172|NCT00378703|7210512|FG001|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
6307173|NCT00378703|7210513|FG002|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
6307174|NCT00378703|7210514|FG003|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
6307175|NCT00378703|7210511|FG000|NOT COMPLETED|Overall Study||89
6307176|NCT00378703|7210512|FG001|NOT COMPLETED|Overall Study||91
6307177|NCT00378703|7210513|FG002|NOT COMPLETED|Overall Study||90
6307178|NCT00378703|7210514|FG003|NOT COMPLETED|Overall Study||91
6307179|NCT00378898|7210526|FG000|STARTED|Overall Study||22
6307180|NCT00378898|7210527|FG001|STARTED|Overall Study||17
6307181|NCT00378898|7210526|FG000|COMPLETED|Overall Study||11
6307182|NCT00378898|7210527|FG001|COMPLETED|Overall Study||11
6307183|NCT00378898|7210526|FG000|NOT COMPLETED|Overall Study||11
6307184|NCT00378898|7210527|FG001|NOT COMPLETED|Overall Study||6
6307185|NCT00379080|7210538|FG000|STARTED|Overall Study||6
6307186|NCT00379080|7210539|FG001|STARTED|Overall Study||19
6307187|NCT00379080|7210540|FG002|STARTED|Overall Study||31
6307188|NCT00379080|7210538|FG000|COMPLETED|Overall Study||6
6307189|NCT00379080|7210539|FG001|COMPLETED|Overall Study||15
6307190|NCT00379080|7210540|FG002|COMPLETED|Overall Study||31
6307191|NCT00379080|7210538|FG000|NOT COMPLETED|Overall Study||0
6307192|NCT00379080|7210539|FG001|NOT COMPLETED|Overall Study||4
6307193|NCT00379080|7210540|FG002|NOT COMPLETED|Overall Study||0
6307194|NCT00379145|7210563|FG000|STARTED|Overall Study||20
6307195|NCT00379145|7210563|FG000|COMPLETED|Overall Study||20
6307196|NCT00379145|7210563|FG000|NOT COMPLETED|Overall Study||0
6307197|NCT00379197|7210572|FG000|STARTED|Overall Study||13
6307198|NCT00379197|7210572|FG000|COMPLETED|Overall Study||8
6307199|NCT00379197|7210572|FG000|NOT COMPLETED|Overall Study||5
6307200|NCT00379210|7210579|FG000|STARTED|Overall Study||30
6307201|NCT00379210|7210580|FG001|STARTED|Overall Study||30
6307202|NCT00379210|7210579|FG000|COMPLETED|Overall Study||20
6307203|NCT00379210|7210580|FG001|COMPLETED|Overall Study||23
6307204|NCT00379210|7210579|FG000|NOT COMPLETED|Overall Study||10
6307205|NCT00379210|7210580|FG001|NOT COMPLETED|Overall Study||7
6307206|NCT00379236|7210588|FG000|STARTED|Double-blind||293
6307207|NCT00379236|7210589|FG001|STARTED|Double-blind||295
6307208|NCT00379236|7210590|FG002|STARTED|Double-blind||0
6307209|NCT00379236|7210588|FG000|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
6307210|NCT00379236|7210589|FG001|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
6307211|NCT00379236|7210590|FG002|COMPLETED|Double-blind||0
6307212|NCT00379236|7210588|FG000|NOT COMPLETED|Double-blind||36
6307213|NCT00379236|7210589|FG001|NOT COMPLETED|Double-blind||36
6307214|NCT00379236|7210590|FG002|NOT COMPLETED|Double-blind||0
6307215|NCT00379236|7210588|FG000|STARTED|Open-label Extension||0
6307216|NCT00379236|7210589|FG001|STARTED|Open-label Extension||0
6307217|NCT00379236|7210590|FG002|STARTED|Open-label Extension||433
6307218|NCT00379236|7210588|FG000|COMPLETED|Open-label Extension||0
6307219|NCT00379236|7210589|FG001|COMPLETED|Open-label Extension||0
6307220|NCT00379236|7210590|FG002|COMPLETED|Open-label Extension||378
6307221|NCT00379236|7210588|FG000|NOT COMPLETED|Open-label Extension||0
6307222|NCT00379236|7210589|FG001|NOT COMPLETED|Open-label Extension||0
6307223|NCT00379236|7210590|FG002|NOT COMPLETED|Open-label Extension||55
6307224|NCT00379353|7210604|FG000|STARTED|Overall Study||16
6307225|NCT00379353|7210605|FG001|STARTED|Overall Study||15
6307226|NCT00379353|7210604|FG000|COMPLETED|Overall Study||5
6307227|NCT00379353|7210605|FG001|COMPLETED|Overall Study||9
6307228|NCT00379353|7210604|FG000|NOT COMPLETED|Overall Study||11
6307229|NCT00379353|7210605|FG001|NOT COMPLETED|Overall Study||6
6307230|NCT00379574|7210621|FG000|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
6307231|NCT00379574|7210621|FG000|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
6307232|NCT00379574|7210621|FG000|NOT COMPLETED|Overall Study||0
6307233|NCT00379587|7210625|FG000|STARTED|Overall Study||65
6307234|NCT00379587|7210625|FG000|COMPLETED|Overall Study||63
6307235|NCT00379587|7210625|FG000|NOT COMPLETED|Overall Study||2
6307236|NCT00379639|7210634|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
6307237|NCT00379639|7210635|FG001|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
6307238|NCT00379639|7210636|FG002|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
6307239|NCT00379639|7210637|FG003|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
6307240|NCT00379639|7210638|FG004|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
6307241|NCT00379639|7210634|FG000|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
6307242|NCT00379639|7210635|FG001|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
6307243|NCT00379639|7210636|FG002|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
6307244|NCT00379639|7210637|FG003|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
6307245|NCT00379639|7210638|FG004|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
6307246|NCT00379639|7210634|FG000|Completed 6 Cycles of Therapy|Overall Study||4
6307247|NCT00379639|7210635|FG001|Completed 6 Cycles of Therapy|Overall Study||2
6307248|NCT00379639|7210636|FG002|Completed 6 Cycles of Therapy|Overall Study||1
6307249|NCT00379639|7210637|FG003|Completed 6 Cycles of Therapy|Overall Study||0
6307250|NCT00379639|7210638|FG004|Completed 6 Cycles of Therapy|Overall Study||0
6307251|NCT00379639|7210634|FG000|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
6307252|NCT00379639|7210635|FG001|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
6307253|NCT00379639|7210636|FG002|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
6307254|NCT00379639|7210637|FG003|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
6307255|NCT00379639|7210638|FG004|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
6307256|NCT00379639|7210634|FG000|NOT COMPLETED|Overall Study||3
6307257|NCT00379639|7210635|FG001|NOT COMPLETED|Overall Study||5
6307258|NCT00379639|7210636|FG002|NOT COMPLETED|Overall Study||9
6307259|NCT00379639|7210637|FG003|NOT COMPLETED|Overall Study||6
6307260|NCT00379639|7210638|FG004|NOT COMPLETED|Overall Study||6
6307261|NCT00379769|7210654|FG000|STARTED|Main Study||1117
6307262|NCT00379769|7210655|FG001|STARTED|Main Study||1105
6307263|NCT00379769|7210656|FG002|STARTED|Main Study||1103
6307264|NCT00379769|7210657|FG003|STARTED|Main Study||1122
6307265|NCT00379769|7210658|FG004|STARTED|Main Study||0
6307266|NCT00379769|7210659|FG005|STARTED|Main Study||0
6307267|NCT00379769|7210654|FG000|COMPLETED|Main Study||939
6307268|NCT00379769|7210655|FG001|COMPLETED|Main Study||906
6307269|NCT00379769|7210656|FG002|COMPLETED|Main Study||896
6307270|NCT00379769|7210657|FG003|COMPLETED|Main Study||892
6307271|NCT00379769|7210658|FG004|COMPLETED|Main Study||0
6307272|NCT00379769|7210659|FG005|COMPLETED|Main Study||0
6307273|NCT00379769|7210654|FG000|NOT COMPLETED|Main Study||178
6307274|NCT00379769|7210655|FG001|NOT COMPLETED|Main Study||199
6307275|NCT00379769|7210656|FG002|NOT COMPLETED|Main Study||207
6307276|NCT00379769|7210657|FG003|NOT COMPLETED|Main Study||230
6307277|NCT00379769|7210658|FG004|NOT COMPLETED|Main Study||0
6307278|NCT00379769|7210659|FG005|NOT COMPLETED|Main Study||0
6307279|NCT00379769|7210654|FG000|STARTED|Observational Follow-up||0
6307280|NCT00379769|7210655|FG001|STARTED|Observational Follow-up||0
6307281|NCT00379769|7210656|FG002|STARTED|Observational Follow-up||0
6307282|NCT00379769|7210657|FG003|STARTED|Observational Follow-up||0
6307283|NCT00379769|7210658|FG004|STARTED|Observational Follow-up|"665 from RSG in Addition to Background MET arm; 615 from RGS in Addition to Background SU arm."|1280
6307284|NCT00379769|7210659|FG005|STARTED|Observational Follow-up|"647 from SU in Addition to Background MET arm; 603 from MET in Addition to Background SU arm."|1250
6307285|NCT00379769|7210654|FG000|COMPLETED|Observational Follow-up||0
6307286|NCT00379769|7210655|FG001|COMPLETED|Observational Follow-up||0
6307287|NCT00379769|7210656|FG002|COMPLETED|Observational Follow-up||0
6307288|NCT00379769|7210657|FG003|COMPLETED|Observational Follow-up||0
6307289|NCT00379769|7210658|FG004|COMPLETED|Observational Follow-up||1131
6307290|NCT00379769|7210659|FG005|COMPLETED|Observational Follow-up||1102
6307291|NCT00379769|7210654|FG000|NOT COMPLETED|Observational Follow-up||0
6307292|NCT00379769|7210655|FG001|NOT COMPLETED|Observational Follow-up||0
6307293|NCT00379769|7210656|FG002|NOT COMPLETED|Observational Follow-up||0
6307294|NCT00379769|7210657|FG003|NOT COMPLETED|Observational Follow-up||0
6307295|NCT00379769|7210658|FG004|NOT COMPLETED|Observational Follow-up||149
6307296|NCT00379769|7210659|FG005|NOT COMPLETED|Observational Follow-up||148
6307297|NCT00379795|7210691|FG000|STARTED|Overall Study||526
6307298|NCT00379795|7210692|FG001|STARTED|Overall Study||74
6307299|NCT00379795|7210693|FG002|STARTED|Overall Study||116
6307300|NCT00379795|7210694|FG003|STARTED|Overall Study||74
6307301|NCT00379795|7210695|FG004|STARTED|Overall Study||63
6307302|NCT00379795|7210691|FG000|Received Ranibizumab in Extension Study|Overall Study||377
6307303|NCT00379795|7210692|FG001|Received Ranibizumab in Extension Study|Overall Study||41
6307304|NCT00379795|7210693|FG002|Received Ranibizumab in Extension Study|Overall Study||113
6307305|NCT00379795|7210694|FG003|Received Ranibizumab in Extension Study|Overall Study||55
6307306|NCT00379795|7210695|FG004|Received Ranibizumab in Extension Study|Overall Study||0
6307307|NCT00379795|7210691|FG000|COMPLETED|Overall Study||50
6307308|NCT00379795|7210692|FG001|COMPLETED|Overall Study||23
6307309|NCT00379795|7210693|FG002|COMPLETED|Overall Study||23
6307310|NCT00379795|7210694|FG003|COMPLETED|Overall Study||6
6307311|NCT00379795|7210695|FG004|COMPLETED|Overall Study||14
6307312|NCT00379795|7210691|FG000|NOT COMPLETED|Overall Study||476
6307313|NCT00379795|7210692|FG001|NOT COMPLETED|Overall Study||51
6307314|NCT00379795|7210693|FG002|NOT COMPLETED|Overall Study||93
6307315|NCT00379795|7210694|FG003|NOT COMPLETED|Overall Study||68
6307316|NCT00379795|7210695|FG004|NOT COMPLETED|Overall Study||49
6307317|NCT00379808|7210710|FG000|STARTED|Intervention Period 1 (4 Weeks)||11
6307318|NCT00379808|7210711|FG001|STARTED|Intervention Period 1 (4 Weeks)||11
6307319|NCT00379808|7210710|FG000|COMPLETED|Intervention Period 1 (4 Weeks)||11
6307320|NCT00379808|7210711|FG001|COMPLETED|Intervention Period 1 (4 Weeks)||11
6307321|NCT00379808|7210710|FG000|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
6307322|NCT00379808|7210711|FG001|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
6307323|NCT00379808|7210710|FG000|STARTED|Intervention Period 2 (4 Weeks)||11
6307324|NCT00379808|7210711|FG001|STARTED|Intervention Period 2 (4 Weeks)||11
6307325|NCT00379808|7210710|FG000|COMPLETED|Intervention Period 2 (4 Weeks)||11
6307326|NCT00379808|7210711|FG001|COMPLETED|Intervention Period 2 (4 Weeks)||10
6307327|NCT00379808|7210710|FG000|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
6307328|NCT00379808|7210711|FG001|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
6307329|NCT00379821|7210721|FG000|STARTED|Overall Study||160
6307330|NCT00379821|7210722|FG001|STARTED|Overall Study||160
6307331|NCT00379821|7210723|FG002|STARTED|Overall Study||160
6307332|NCT00379821|7210724|FG003|STARTED|Overall Study||160
6307333|NCT00379821|7210721|FG000|COMPLETED|Overall Study||87
6307334|NCT00379821|7210722|FG001|COMPLETED|Overall Study||71
6307335|NCT00379821|7210723|FG002|COMPLETED|Overall Study||93
6307336|NCT00379821|7210724|FG003|COMPLETED|Overall Study||81
6557357|NCT01767155|7479888|FG000|Modified ITT (mITT)|Overall Study||252
6557358|NCT01767155|7479889|FG001|Modified ITT (mITT)|Overall Study||249
6557359|NCT01767155|7479888|FG000|Safety Population (SAF)|Overall Study||252
6557360|NCT01767155|7479889|FG001|Safety Population (SAF)|Overall Study||249
6557361|NCT01767155|7479888|FG000|COMPLETED|Overall Study||243
6557362|NCT01767155|7479889|FG001|COMPLETED|Overall Study||240
6557363|NCT01767155|7479888|FG000|NOT COMPLETED|Overall Study||13
6307337|NCT00379821|7210721|FG000|NOT COMPLETED|Overall Study||73
6307338|NCT00379821|7210722|FG001|NOT COMPLETED|Overall Study||89
6307339|NCT00379821|7210723|FG002|NOT COMPLETED|Overall Study||67
6307340|NCT00379821|7210724|FG003|NOT COMPLETED|Overall Study||79
6307341|NCT00379834|7210741|FG000|STARTED|Overall Study||10
6307342|NCT00379834|7210741|FG000|COMPLETED|Overall Study||8
6307343|NCT00379834|7210741|FG000|NOT COMPLETED|Overall Study||2
6307344|NCT00379899|7210747|FG000|STARTED|Overall Study||180
6307345|NCT00379899|7210748|FG001|STARTED|Overall Study||180
6307346|NCT00379899|7210747|FG000|COMPLETED|Overall Study||140
6307347|NCT00379899|7210748|FG001|COMPLETED|Overall Study||140
6307348|NCT00379899|7210747|FG000|NOT COMPLETED|Overall Study||40
6307349|NCT00379899|7210748|FG001|NOT COMPLETED|Overall Study||40
6307350|NCT00379912|7210756|FG000|STARTED|Overall Study||7
6307351|NCT00379912|7210757|FG001|STARTED|Overall Study||8
6307352|NCT00379912|7210756|FG000|COMPLETED|Overall Study||6
6307353|NCT00379912|7210757|FG001|COMPLETED|Overall Study||8
6307354|NCT00379912|7210756|FG000|NOT COMPLETED|Overall Study||1
6307355|NCT00379912|7210757|FG001|NOT COMPLETED|Overall Study||0
6307356|NCT00380029|7210769|FG000|STARTED|Overall Study||20
6307357|NCT00380029|7210769|FG000|COMPLETED|Overall Study||20
6307358|NCT00380029|7210769|FG000|NOT COMPLETED|Overall Study||0
6307359|NCT00380068|7210777|FG000|STARTED|Overall Study||224
6307360|NCT00380068|7210777|FG000|COMPLETED|Overall Study||155
6307361|NCT00380068|7210777|FG000|NOT COMPLETED|Overall Study||69
6307362|NCT00380081|7210787|FG000|STARTED|Overall Study||14
6307363|NCT00380081|7210788|FG001|STARTED|Overall Study||13
6307364|NCT00380081|7210789|FG002|STARTED|Overall Study||13
6557364|NCT01767155|7479889|FG001|NOT COMPLETED|Overall Study||15
6557365|NCT01767285|7479897|FG000|STARTED|Overall Study||29
6557366|NCT01767285|7479898|FG001|STARTED|Overall Study||30
6307365|NCT00380081|7210790|FG003|STARTED|Overall Study||15
6307366|NCT00380081|7210791|FG004|STARTED|Overall Study||13
6307367|NCT00380081|7210792|FG005|STARTED|Overall Study||14
6307368|NCT00380081|7210787|FG000|COMPLETED|Overall Study||14
6307369|NCT00380081|7210788|FG001|COMPLETED|Overall Study||13
6307370|NCT00380081|7210789|FG002|COMPLETED|Overall Study||13
6307371|NCT00380081|7210790|FG003|COMPLETED|Overall Study||15
6307372|NCT00380081|7210791|FG004|COMPLETED|Overall Study||12
6307373|NCT00380081|7210792|FG005|COMPLETED|Overall Study||13
6307374|NCT00380081|7210787|FG000|NOT COMPLETED|Overall Study||0
6307375|NCT00380081|7210788|FG001|NOT COMPLETED|Overall Study||0
6307376|NCT00380081|7210789|FG002|NOT COMPLETED|Overall Study||0
6307377|NCT00380081|7210790|FG003|NOT COMPLETED|Overall Study||0
6307378|NCT00380081|7210791|FG004|NOT COMPLETED|Overall Study||1
6307379|NCT00380081|7210792|FG005|NOT COMPLETED|Overall Study||1
6307380|NCT00380250|7210802|FG000|STARTED|Overall Study||396
6307381|NCT00380250|7210803|FG001|STARTED|Overall Study||194
6307382|NCT00380250|7210802|FG000|COMPLETED|Overall Study||297
6307383|NCT00380250|7210803|FG001|COMPLETED|Overall Study||139
6307384|NCT00380250|7210802|FG000|NOT COMPLETED|Overall Study||99
6307385|NCT00380250|7210803|FG001|NOT COMPLETED|Overall Study||55
6307386|NCT00380367|7210809|FG000|STARTED|Overall Study||110
6557367|NCT01767285|7479897|FG000|COMPLETED|Overall Study||22
6557368|NCT01767285|7479898|FG001|COMPLETED|Overall Study||24
6557369|NCT01767285|7479897|FG000|NOT COMPLETED|Overall Study||7
6557370|NCT01767285|7479898|FG001|NOT COMPLETED|Overall Study||6
6557371|NCT01767376|7479907|FG000|STARTED|Overall Study||231
6557372|NCT01767376|7479908|FG001|STARTED|Overall Study||228
6307387|NCT00380367|7210809|FG000|COMPLETED|Overall Study||108
6307388|NCT00380367|7210809|FG000|NOT COMPLETED|Overall Study||2
6307389|NCT00380393|7210815|FG000|STARTED|Month 8 (Cross-sectional Visit)||447
6307390|NCT00380393|7210816|FG001|STARTED|Month 8 (Cross-sectional Visit)||447
6307391|NCT00380393|7210815|FG000|COMPLETED|Month 8 (Cross-sectional Visit)||398
6307392|NCT00380393|7210816|FG001|COMPLETED|Month 8 (Cross-sectional Visit)||407
6307393|NCT00380393|7210815|FG000|NOT COMPLETED|Month 8 (Cross-sectional Visit)||49
6307394|NCT00380393|7210816|FG001|NOT COMPLETED|Month 8 (Cross-sectional Visit)||40
6307395|NCT00380393|7210815|FG000|STARTED|Month 14||447
6307396|NCT00380393|7210816|FG001|STARTED|Month 14||447
6307397|NCT00380393|7210815|FG000|COMPLETED|Month 14||390
6307398|NCT00380393|7210816|FG001|COMPLETED|Month 14||391
6307399|NCT00380393|7210815|FG000|NOT COMPLETED|Month 14||57
6307400|NCT00380393|7210816|FG001|NOT COMPLETED|Month 14||56
6307401|NCT00380588|7210824|FG000|STARTED|Overall Study||42
6307402|NCT00380588|7210825|FG001|STARTED|Overall Study||42
6307403|NCT00380588|7210824|FG000|Received at Least One Dose of Study Drug|Overall Study||41
6307404|NCT00380588|7210825|FG001|Received at Least One Dose of Study Drug|Overall Study||42
6307405|NCT00380588|7210824|FG000|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
6307406|NCT00380588|7210825|FG001|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
6307407|NCT00380588|7210824|FG000|NOT COMPLETED|Overall Study||39
6307408|NCT00380588|7210825|FG001|NOT COMPLETED|Overall Study||40
6307409|NCT00380692|7210833|FG000|STARTED|Study Period II - Double Blind||48
6307410|NCT00380692|7210834|FG001|STARTED|Study Period II - Double Blind||49
6307411|NCT00380692|7210833|FG000|COMPLETED|Study Period II - Double Blind||43
6307412|NCT00380692|7210834|FG001|COMPLETED|Study Period II - Double Blind||46
6307413|NCT00380692|7210833|FG000|NOT COMPLETED|Study Period II - Double Blind||5
6307414|NCT00380692|7210834|FG001|NOT COMPLETED|Study Period II - Double Blind||3
6307415|NCT00380692|7210833|FG000|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
6307416|NCT00380692|7210834|FG001|STARTED|Study Period III - Open Label||46
6307417|NCT00380692|7210833|FG000|COMPLETED|Study Period III - Open Label||36
6307418|NCT00380692|7210834|FG001|COMPLETED|Study Period III - Open Label||34
6307419|NCT00380692|7210833|FG000|NOT COMPLETED|Study Period III - Open Label||6
6307420|NCT00380692|7210834|FG001|NOT COMPLETED|Study Period III - Open Label||12
6307421|NCT00380718|7210840|FG000|STARTED|Overall Study||33
6307422|NCT00380718|7210840|FG000|Received at Least One Dose of Study Drug|Overall Study||33
6307423|NCT00380718|7210840|FG000|Received Escalated Dose in Cycle 2|Overall Study||25
6307424|NCT00380718|7210840|FG000|COMPLETED|Overall Study||15
6307425|NCT00380718|7210840|FG000|NOT COMPLETED|Overall Study||18
6307426|NCT00380744|7210851|FG000|STARTED|Overall Study||20
6307427|NCT00380744|7210852|FG001|STARTED|Overall Study||4
6307428|NCT00380744|7210853|FG002|STARTED|Overall Study||20
6307429|NCT00380744|7210854|FG003|STARTED|Overall Study||4
6307430|NCT00380744|7210855|FG004|STARTED|Overall Study||23
6307431|NCT00380744|7210856|FG005|STARTED|Overall Study||25
6307432|NCT00380744|7210857|FG006|STARTED|Overall Study||25
6307433|NCT00380744|7210851|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
6307434|NCT00380744|7210852|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
6307435|NCT00380744|7210853|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
6307436|NCT00380744|7210854|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
6307437|NCT00380744|7210855|FG004|Received at Least 1 Dose of Study Drug|Overall Study||23
6307438|NCT00380744|7210856|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
6307439|NCT00380744|7210857|FG006|Received at Least 1 Dose of Study Drug|Overall Study||25
6307440|NCT00380744|7210851|FG000|COMPLETED|Overall Study||19
6307441|NCT00380744|7210852|FG001|COMPLETED|Overall Study||4
6307442|NCT00380744|7210853|FG002|COMPLETED|Overall Study||20
6557373|NCT01767376|7479909|FG002|STARTED|Overall Study||232
6307443|NCT00380744|7210854|FG003|COMPLETED|Overall Study||4
6307444|NCT00380744|7210855|FG004|COMPLETED|Overall Study||23
6307445|NCT00380744|7210856|FG005|COMPLETED|Overall Study||25
6307446|NCT00380744|7210857|FG006|COMPLETED|Overall Study||24
6307447|NCT00380744|7210851|FG000|NOT COMPLETED|Overall Study||1
6307448|NCT00380744|7210852|FG001|NOT COMPLETED|Overall Study||0
6307449|NCT00380744|7210853|FG002|NOT COMPLETED|Overall Study||0
6307450|NCT00380744|7210854|FG003|NOT COMPLETED|Overall Study||0
6307451|NCT00380744|7210855|FG004|NOT COMPLETED|Overall Study||0
6307452|NCT00380744|7210856|FG005|NOT COMPLETED|Overall Study||0
6307453|NCT00380744|7210857|FG006|NOT COMPLETED|Overall Study||1
6307454|NCT00380861|7210876|FG000|STARTED|Overall Study||93
6307455|NCT00380861|7210877|FG001|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
6307456|NCT00380861|7210876|FG000|COMPLETED|Overall Study||75
6307457|NCT00380861|7210877|FG001|COMPLETED|Overall Study||74
6307458|NCT00380861|7210876|FG000|NOT COMPLETED|Overall Study||18
6307459|NCT00380861|7210877|FG001|NOT COMPLETED|Overall Study||17
6307460|NCT00380874|7210885|FG000|STARTED|Overall Study||32
6307461|NCT00380874|7210886|FG001|STARTED|Overall Study||29
6307462|NCT00380874|7210885|FG000|COMPLETED|Overall Study||19
6307463|NCT00380874|7210886|FG001|COMPLETED|Overall Study||19
6307464|NCT00380874|7210885|FG000|NOT COMPLETED|Overall Study||13
6307465|NCT00380874|7210886|FG001|NOT COMPLETED|Overall Study||10
6307466|NCT00380978|7210894|FG000|STARTED|Overall Study||408
6307467|NCT00380978|7210895|FG001|STARTED|Overall Study||410
6307468|NCT00380978|7210894|FG000|COMPLETED|Overall Study||406
6307469|NCT00380978|7210895|FG001|COMPLETED|Overall Study||400
6307470|NCT00380978|7210894|FG000|NOT COMPLETED|Overall Study||2
6307471|NCT00380978|7210895|FG001|NOT COMPLETED|Overall Study||10
6307472|NCT00381004|7210901|FG000|STARTED|Overall Study||60
6307473|NCT00381004|7210901|FG000|COMPLETED|Overall Study||60
6307474|NCT00381004|7210901|FG000|NOT COMPLETED|Overall Study||0
6307475|NCT00381043|7210907|FG000|STARTED|Overall Study||51
6307476|NCT00381043|7210908|FG001|STARTED|Overall Study||49
6307477|NCT00381043|7210907|FG000|COMPLETED|Overall Study||39
6307478|NCT00381043|7210908|FG001|COMPLETED|Overall Study||41
6307479|NCT00381043|7210907|FG000|NOT COMPLETED|Overall Study||12
6307480|NCT00381043|7210908|FG001|NOT COMPLETED|Overall Study||8
6307481|NCT00381095|7210916|FG000|STARTED|Overall Study||72
6307482|NCT00381095|7210917|FG001|STARTED|Overall Study||80
6307483|NCT00381095|7210916|FG000|COMPLETED|Overall Study||59
6307484|NCT00381095|7210917|FG001|COMPLETED|Overall Study||59
6307485|NCT00381095|7210916|FG000|NOT COMPLETED|Overall Study||13
6307486|NCT00381095|7210917|FG001|NOT COMPLETED|Overall Study||21
6307487|NCT00381238|7210923|FG000|STARTED|Overall Study||33
6307488|NCT00381238|7210923|FG000|COMPLETED|Overall Study||21
6307489|NCT00381238|7210923|FG000|NOT COMPLETED|Overall Study||12
6307490|NCT00381303|7210929|FG000|STARTED|Overall Study||287
6307491|NCT00381303|7210930|FG001|STARTED|Overall Study||142
6307492|NCT00381303|7210929|FG000|COMPLETED|Overall Study||193
6307493|NCT00381303|7210930|FG001|COMPLETED|Overall Study||109
6307494|NCT00381303|7210929|FG000|NOT COMPLETED|Overall Study||94
6307495|NCT00381303|7210930|FG001|NOT COMPLETED|Overall Study||33
6307496|NCT00381550|7210948|FG000|STARTED|Overall Study||35
6307497|NCT00381550|7210948|FG000|COMPLETED|Overall Study||35
6307498|NCT00381550|7210948|FG000|NOT COMPLETED|Overall Study||0
6307499|NCT00381563|7210954|FG000|STARTED|Overall Study||41
6307500|NCT00381563|7210955|FG001|STARTED|Overall Study||39
6307501|NCT00381563|7210954|FG000|COMPLETED|Overall Study||34
6307502|NCT00381563|7210955|FG001|COMPLETED|Overall Study||33
6307503|NCT00381563|7210954|FG000|NOT COMPLETED|Overall Study||7
6307504|NCT00381563|7210955|FG001|NOT COMPLETED|Overall Study||6
6307505|NCT00381615|7210964|FG000|STARTED|Overall Study||48
6307506|NCT00381615|7210965|FG001|STARTED|Overall Study||50
6307507|NCT00381615|7210966|FG002|STARTED|Overall Study||25
6307508|NCT00381615|7210967|FG003|STARTED|Overall Study||24
6307509|NCT00381615|7210964|FG000|COMPLETED|Overall Study||44
6307510|NCT00381615|7210965|FG001|COMPLETED|Overall Study||45
6307511|NCT00381615|7210966|FG002|COMPLETED|Overall Study||24
6307512|NCT00381615|7210967|FG003|COMPLETED|Overall Study||22
6307513|NCT00381615|7210964|FG000|NOT COMPLETED|Overall Study||4
6307514|NCT00381615|7210965|FG001|NOT COMPLETED|Overall Study||5
6307515|NCT00381615|7210966|FG002|NOT COMPLETED|Overall Study||1
6307516|NCT00381615|7210967|FG003|NOT COMPLETED|Overall Study||2
6307517|NCT00381628|7210983|FG000|STARTED|Overall Study||18
6307518|NCT00381628|7210984|FG001|STARTED|Overall Study||27
6307519|NCT00381628|7210985|FG002|STARTED|Overall Study||0
6307520|NCT00381628|7210986|FG003|STARTED|Overall Study||14
6307521|NCT00381628|7210983|FG000|COMPLETED|Overall Study||18
6307522|NCT00381628|7210984|FG001|COMPLETED|Overall Study||27
6307523|NCT00381628|7210985|FG002|COMPLETED|Overall Study||0
6307524|NCT00381628|7210986|FG003|COMPLETED|Overall Study||14
6307525|NCT00381628|7210983|FG000|NOT COMPLETED|Overall Study||0
6307526|NCT00381628|7210984|FG001|NOT COMPLETED|Overall Study||0
6307527|NCT00381628|7210985|FG002|NOT COMPLETED|Overall Study||0
6307528|NCT00381628|7210986|FG003|NOT COMPLETED|Overall Study||0
6307529|NCT00381680|7210998|FG000|STARTED|Overall Study||206
6307530|NCT00381680|7210999|FG001|STARTED|Overall Study||69
6307531|NCT00381680|7210998|FG000|COMPLETED|Overall Study||81
6307532|NCT00381680|7210999|FG001|COMPLETED|Overall Study||19
6307533|NCT00381680|7210998|FG000|NOT COMPLETED|Overall Study||125
6307534|NCT00381680|7210999|FG001|NOT COMPLETED|Overall Study||50
6307535|NCT00381693|7211009|FG000|STARTED|Overall Study||10
6307536|NCT00381693|7211009|FG000|COMPLETED|Overall Study||2
6307537|NCT00381693|7211009|FG000|NOT COMPLETED|Overall Study||8
6307538|NCT00381706|7211019|FG000|STARTED|Overall Study||82
6307539|NCT00381706|7211020|FG001|STARTED|Overall Study||83
6307540|NCT00381706|7211021|FG002|STARTED|Overall Study||80
6307541|NCT00381706|7211019|FG000|COMPLETED|Overall Study||75
6307542|NCT00381706|7211020|FG001|COMPLETED|Overall Study||81
6307543|NCT00381706|7211021|FG002|COMPLETED|Overall Study||79
6307544|NCT00381706|7211019|FG000|NOT COMPLETED|Overall Study||7
6307545|NCT00381706|7211020|FG001|NOT COMPLETED|Overall Study||2
6307546|NCT00381706|7211021|FG002|NOT COMPLETED|Overall Study||1
6307547|NCT00381797|7211040|FG000|STARTED|Overall Study||18
6307548|NCT00381797|7211041|FG001|STARTED|Overall Study||17
6307549|NCT00381797|7211042|FG002|STARTED|Overall Study||10
6307550|NCT00381797|7211043|FG003|STARTED|Overall Study||15
6307551|NCT00381797|7211044|FG004|STARTED|Overall Study||37
6307552|NCT00381797|7211040|FG000|COMPLETED|Overall Study||17
6307553|NCT00381797|7211041|FG001|COMPLETED|Overall Study||16
6307554|NCT00381797|7211042|FG002|COMPLETED|Overall Study||10
6307555|NCT00381797|7211043|FG003|COMPLETED|Overall Study||14
6307556|NCT00381797|7211044|FG004|COMPLETED|Overall Study||35
6307557|NCT00381797|7211040|FG000|NOT COMPLETED|Overall Study||1
6307558|NCT00381797|7211041|FG001|NOT COMPLETED|Overall Study||1
6307559|NCT00381797|7211042|FG002|NOT COMPLETED|Overall Study||0
6307560|NCT00381797|7211043|FG003|NOT COMPLETED|Overall Study||1
6307561|NCT00381797|7211044|FG004|NOT COMPLETED|Overall Study||2
6307562|NCT00381810|7211077|FG000|STARTED|Treatment and Safety Follow-up||31
6307563|NCT00381810|7211077|FG000|COMPLETED|Treatment and Safety Follow-up||16
6307564|NCT00381810|7211077|FG000|NOT COMPLETED|Treatment and Safety Follow-up||15
6307565|NCT00381810|7211077|FG000|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
6307566|NCT00381810|7211077|FG000|COMPLETED|B Cell Follow-up||0
6307567|NCT00381810|7211077|FG000|NOT COMPLETED|B Cell Follow-up||7
6307568|NCT00381849|7211083|FG000|STARTED|First Intervention||10
6307569|NCT00381849|7211084|FG001|STARTED|First Intervention||10
6307570|NCT00381849|7211083|FG000|COMPLETED|First Intervention||10
6307571|NCT00381849|7211084|FG001|COMPLETED|First Intervention||10
6307572|NCT00381849|7211083|FG000|NOT COMPLETED|First Intervention||0
6307573|NCT00381849|7211084|FG001|NOT COMPLETED|First Intervention||0
6307574|NCT00381849|7211083|FG000|STARTED|Wash Out||10
6307575|NCT00381849|7211084|FG001|STARTED|Wash Out||10
6307576|NCT00381849|7211083|FG000|COMPLETED|Wash Out||10
6307577|NCT00381849|7211084|FG001|COMPLETED|Wash Out||9
6307578|NCT00381849|7211083|FG000|NOT COMPLETED|Wash Out||0
6307579|NCT00381849|7211084|FG001|NOT COMPLETED|Wash Out||1
6307580|NCT00381849|7211083|FG000|STARTED|Second Intervention||10
6307581|NCT00381849|7211084|FG001|STARTED|Second Intervention||9
6307582|NCT00381849|7211083|FG000|COMPLETED|Second Intervention||10
6307583|NCT00381849|7211084|FG001|COMPLETED|Second Intervention||9
6307584|NCT00381849|7211083|FG000|NOT COMPLETED|Second Intervention||0
6307585|NCT00381849|7211084|FG001|NOT COMPLETED|Second Intervention||0
6307586|NCT00381849|7211083|FG000|STARTED|Open-label||10
6307587|NCT00381849|7211084|FG001|STARTED|Open-label||9
6307588|NCT00381849|7211083|FG000|COMPLETED|Open-label||10
6307589|NCT00381849|7211084|FG001|COMPLETED|Open-label||9
6307590|NCT00381849|7211083|FG000|NOT COMPLETED|Open-label||0
6307591|NCT00381849|7211084|FG001|NOT COMPLETED|Open-label||0
6307592|NCT00381862|7211090|FG000|STARTED|Overall Study||54
6307593|NCT00381862|7211090|FG000|COMPLETED|Overall Study||44
6307594|NCT00381862|7211090|FG000|NOT COMPLETED|Overall Study||10
6307595|NCT00381888|7211094|FG000|STARTED|Overall Study||44
6307596|NCT00381888|7211094|FG000|COMPLETED|Overall Study||27
6307597|NCT00381888|7211094|FG000|NOT COMPLETED|Overall Study||17
6307598|NCT00381940|7211098|FG000|STARTED|Overall Study||26
6307599|NCT00381940|7211098|FG000|COMPLETED|Overall Study||21
6307600|NCT00381940|7211098|FG000|NOT COMPLETED|Overall Study||5
6307601|NCT00381966|7211102|FG000|STARTED|Overall Study||5
6307602|NCT00381966|7211102|FG000|COMPLETED|Overall Study||5
6307603|NCT00381966|7211102|FG000|NOT COMPLETED|Overall Study||0
6307604|NCT00382018|7211110|FG000|STARTED|Overall Study||276
6307605|NCT00382018|7211111|FG001|STARTED|Overall Study||165
6307606|NCT00382018|7211112|FG002|STARTED|Overall Study||64
6307607|NCT00382018|7211113|FG003|STARTED|Overall Study||59
6307608|NCT00382018|7211110|FG000|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
6307609|NCT00382018|7211111|FG001|COMPLETED|Overall Study||0
6307610|NCT00382018|7211112|FG002|COMPLETED|Overall Study||0
6307611|NCT00382018|7211113|FG003|COMPLETED|Overall Study||0
6307612|NCT00382018|7211110|FG000|NOT COMPLETED|Overall Study||0
6307613|NCT00382018|7211111|FG001|NOT COMPLETED|Overall Study||165
6307614|NCT00382018|7211112|FG002|NOT COMPLETED|Overall Study||64
6307615|NCT00382018|7211113|FG003|NOT COMPLETED|Overall Study||59
6307616|NCT00382031|7211128|FG000|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
6307617|NCT00382031|7211129|FG001|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
6307618|NCT00382031|7211128|FG000|COMPLETED|Overall Study||191
6307619|NCT00382031|7211129|FG001|COMPLETED|Overall Study||95
6307620|NCT00382031|7211128|FG000|NOT COMPLETED|Overall Study||0
6307621|NCT00382031|7211129|FG001|NOT COMPLETED|Overall Study||0
6307622|NCT00382070|7211137|FG000|STARTED|Overall Study||1983
6307623|NCT00382070|7211138|FG001|STARTED|Overall Study||1983
6307624|NCT00382070|7211137|FG000|COMPLETED|Overall Study||1950
6307625|NCT00382070|7211138|FG001|COMPLETED|Overall Study||1953
6307626|NCT00382070|7211137|FG000|NOT COMPLETED|Overall Study||33
6307627|NCT00382070|7211138|FG001|NOT COMPLETED|Overall Study||30
6307628|NCT00382109|7211146|FG000|STARTED|Overall Study||76
6307629|NCT00382109|7211147|FG001|STARTED|Overall Study||70
6307630|NCT00382109|7211146|FG000|COMPLETED|Overall Study||64
6307631|NCT00382109|7211147|FG001|COMPLETED|Overall Study||66
6307632|NCT00382109|7211146|FG000|NOT COMPLETED|Overall Study||12
6307633|NCT00382109|7211147|FG001|NOT COMPLETED|Overall Study||4
6375035|NCT00753623|7285624|FG001|STARTED|Washout (7 Days)||8
6375036|NCT00753623|7285623|FG000|COMPLETED|Washout (7 Days)||8
6375037|NCT00753623|7285624|FG001|COMPLETED|Washout (7 Days)||8
6375038|NCT00753623|7285623|FG000|NOT COMPLETED|Washout (7 Days)||1
6375039|NCT00753623|7285624|FG001|NOT COMPLETED|Washout (7 Days)||0
6375040|NCT00753623|7285623|FG000|STARTED|Phase II (14 Days)||8
6375041|NCT00753623|7285624|FG001|STARTED|Phase II (14 Days)||8
6375042|NCT00753623|7285623|FG000|COMPLETED|Phase II (14 Days)||8
6375043|NCT00753623|7285624|FG001|COMPLETED|Phase II (14 Days)||7
6375044|NCT00753623|7285623|FG000|NOT COMPLETED|Phase II (14 Days)||0
6375045|NCT00753623|7285624|FG001|NOT COMPLETED|Phase II (14 Days)||1
6375046|NCT00753636|7285630|FG000|STARTED|Overall Study||31
6375047|NCT00753636|7285630|FG000|COMPLETED|Overall Study||25
6375048|NCT00753636|7285630|FG000|NOT COMPLETED|Overall Study||6
6375049|NCT00753649|7285636|FG000|STARTED|Overall Study||112
6375050|NCT00753649|7285637|FG001|STARTED|Overall Study||112
6375051|NCT00753649|7285636|FG000|COMPLETED|Overall Study||105
6375052|NCT00753649|7285637|FG001|COMPLETED|Overall Study||112
6375053|NCT00753649|7285636|FG000|NOT COMPLETED|Overall Study||7
6375054|NCT00753649|7285637|FG001|NOT COMPLETED|Overall Study||0
6375055|NCT00753675|7285646|FG000|STARTED|Overall Study||59
6375056|NCT00753675|7285647|FG001|STARTED|Overall Study||59
6375057|NCT00753675|7285648|FG002|STARTED|Overall Study||56
6375058|NCT00753675|7285646|FG000|COMPLETED|Overall Study||0
6557374|NCT01767376|7479907|FG000|COMPLETED|Overall Study||227
6557375|NCT01767376|7479908|FG001|COMPLETED|Overall Study||225
6557376|NCT01767376|7479909|FG002|COMPLETED|Overall Study||232
6557377|NCT01767376|7479907|FG000|NOT COMPLETED|Overall Study||4
6557378|NCT01767376|7479908|FG001|NOT COMPLETED|Overall Study||3
6557379|NCT01767376|7479909|FG002|NOT COMPLETED|Overall Study||0
6557380|NCT01767415|7479919|FG000|STARTED|Overall Study||10
6375059|NCT00753675|7285647|FG001|COMPLETED|Overall Study||0
6375060|NCT00753675|7285648|FG002|COMPLETED|Overall Study||0
6375061|NCT00753675|7285646|FG000|NOT COMPLETED|Overall Study||59
6375062|NCT00753675|7285647|FG001|NOT COMPLETED|Overall Study||59
6375063|NCT00753675|7285648|FG002|NOT COMPLETED|Overall Study||56
6375064|NCT00753688|7285658|FG000|STARTED|Overall Study||123
6375065|NCT00753688|7285659|FG001|STARTED|Overall Study||246
6557381|NCT01767415|7479919|FG000|COMPLETED|Overall Study||10
6557382|NCT01767415|7479919|FG000|NOT COMPLETED|Overall Study||0
6557383|NCT01767467|7479925|FG000|STARTED|Vaccination Phase (up to Month 2)||283
6557384|NCT01767467|7479926|FG001|STARTED|Vaccination Phase (up to Month 2)||279
6557385|NCT01767467|7479925|FG000|COMPLETED|Vaccination Phase (up to Month 2)||266
6557386|NCT01767467|7479926|FG001|COMPLETED|Vaccination Phase (up to Month 2)||259
6557387|NCT01767467|7479925|FG000|NOT COMPLETED|Vaccination Phase (up to Month 2)||17
6557388|NCT01767467|7479926|FG001|NOT COMPLETED|Vaccination Phase (up to Month 2)||20
6654930|NCT02448875|7584948|FG000|STARTED|Overall Study||60
6654931|NCT02448875|7584949|FG001|STARTED|Overall Study||21
6654932|NCT02448875|7584950|FG002|STARTED|Overall Study||61
6654933|NCT02448875|7584948|FG000|Completed Dose Selection Phase|Overall Study||20
6654934|NCT02448875|7584949|FG001|Completed Dose Selection Phase|Overall Study||21
6654935|NCT02448875|7584950|FG002|Completed Dose Selection Phase|Overall Study||20
6654936|NCT02448875|7584948|FG000|Full Analysis Set|Overall Study||60
6654937|NCT02448875|7584949|FG001|Full Analysis Set|Overall Study||21
6654938|NCT02448875|7584950|FG002|Full Analysis Set|Overall Study||61
6654939|NCT02448875|7584948|FG000|Safety Analysis Set|Overall Study||60
6654940|NCT02448875|7584949|FG001|Safety Analysis Set|Overall Study||21
6654941|NCT02448875|7584950|FG002|Safety Analysis Set|Overall Study||61
6654942|NCT02448875|7584948|FG000|COMPLETED|Overall Study||53
6654943|NCT02448875|7584949|FG001|COMPLETED|Overall Study||20
6654944|NCT02448875|7584950|FG002|COMPLETED|Overall Study||60
6654945|NCT02448875|7584948|FG000|NOT COMPLETED|Overall Study||7
6654946|NCT02448875|7584949|FG001|NOT COMPLETED|Overall Study||1
6654947|NCT02448875|7584950|FG002|NOT COMPLETED|Overall Study||1
6654948|NCT02448914|7584961|FG000|STARTED|First Intervention (1 Day)||6
6654949|NCT02448914|7584962|FG001|STARTED|First Intervention (1 Day)||5
6375066|NCT00753688|7285658|FG000|Ongoing - in Follow-up|Overall Study||15
6557389|NCT01767467|7479925|FG000|STARTED|End of Study Phase (up to Month 13)||283
6557390|NCT01767467|7479926|FG001|STARTED|End of Study Phase (up to Month 13)||279
6375067|NCT00753688|7285659|FG001|Ongoing - in Follow-up|Overall Study||31
6375068|NCT00753688|7285658|FG000|COMPLETED|Overall Study||0
6375069|NCT00753688|7285659|FG001|COMPLETED|Overall Study||0
6375070|NCT00753688|7285658|FG000|NOT COMPLETED|Overall Study||123
6375071|NCT00753688|7285659|FG001|NOT COMPLETED|Overall Study||246
6375072|NCT00753714|7285667|FG000|STARTED|Overall Study||61
6375073|NCT00753714|7285668|FG001|STARTED|Overall Study||63
6375074|NCT00753714|7285667|FG000|COMPLETED|Overall Study||1
6557391|NCT01767467|7479925|FG000|COMPLETED|End of Study Phase (up to Month 13)||236
6557392|NCT01767467|7479926|FG001|COMPLETED|End of Study Phase (up to Month 13)||216
6307634|NCT00382148|7211158|FG000|STARTED|Overall Study||4
6307635|NCT00382148|7211159|FG001|STARTED|Overall Study||7
6307636|NCT00382148|7211158|FG000|COMPLETED|Overall Study||3
6307637|NCT00382148|7211159|FG001|COMPLETED|Overall Study||7
6307638|NCT00382148|7211158|FG000|NOT COMPLETED|Overall Study||1
6307639|NCT00382148|7211159|FG001|NOT COMPLETED|Overall Study||0
6307640|NCT00382174|7211167|FG000|STARTED|Overall Study||18
6307641|NCT00382174|7211168|FG001|STARTED|Overall Study||54
6307642|NCT00382174|7211169|FG002|STARTED|Overall Study||72
6307643|NCT00382174|7211167|FG000|COMPLETED|Overall Study||14
6307644|NCT00382174|7211168|FG001|COMPLETED|Overall Study||37
6307645|NCT00382174|7211169|FG002|COMPLETED|Overall Study||51
6307646|NCT00382174|7211167|FG000|NOT COMPLETED|Overall Study||4
6307647|NCT00382174|7211168|FG001|NOT COMPLETED|Overall Study||17
6307648|NCT00382174|7211169|FG002|NOT COMPLETED|Overall Study||21
6307649|NCT00382265|7211179|FG000|STARTED|Overall Study||267
6307650|NCT00382265|7211180|FG001|STARTED|Overall Study||245
6307651|NCT00382265|7211179|FG000|COMPLETED|Overall Study||258
6307652|NCT00382265|7211180|FG001|COMPLETED|Overall Study||239
6307653|NCT00382265|7211179|FG000|NOT COMPLETED|Overall Study||9
6307654|NCT00382265|7211180|FG001|NOT COMPLETED|Overall Study||6
6307655|NCT00382291|7211193|FG000|STARTED|Overall Study||18
6307656|NCT00382291|7211194|FG001|STARTED|Overall Study||17
6307657|NCT00382291|7211195|FG002|STARTED|Overall Study||21
6307658|NCT00382291|7211193|FG000|COMPLETED|Overall Study||14
6307659|NCT00382291|7211194|FG001|COMPLETED|Overall Study||10
6307660|NCT00382291|7211195|FG002|COMPLETED|Overall Study||13
6307661|NCT00382291|7211193|FG000|NOT COMPLETED|Overall Study||4
6307662|NCT00382291|7211194|FG001|NOT COMPLETED|Overall Study||7
6307663|NCT00382291|7211195|FG002|NOT COMPLETED|Overall Study||8
6307664|NCT00382408|7211207|FG000|STARTED|Overall Study||3031
6307665|NCT00382408|7211208|FG001|STARTED|Overall Study||1009
6307666|NCT00382408|7211207|FG000|COMPLETED|Overall Study||2887
6307667|NCT00382408|7211208|FG001|COMPLETED|Overall Study||955
6307668|NCT00382408|7211207|FG000|NOT COMPLETED|Overall Study||144
6307669|NCT00382408|7211208|FG001|NOT COMPLETED|Overall Study||54
6307670|NCT00382590|7211216|FG000|STARTED|Overall Study||4
6307671|NCT00382590|7211217|FG001|STARTED|Overall Study||6
6307672|NCT00382590|7211216|FG000|COMPLETED|Overall Study||4
6307673|NCT00382590|7211217|FG001|COMPLETED|Overall Study||6
6307674|NCT00382590|7211216|FG000|NOT COMPLETED|Overall Study||0
6307675|NCT00382590|7211217|FG001|NOT COMPLETED|Overall Study||0
6307676|NCT00382720|7211226|FG000|STARTED|Overall Study||79
6307677|NCT00382720|7211227|FG001|STARTED|Overall Study||89
6307678|NCT00382720|7211228|FG002|STARTED|Overall Study||86
6307679|NCT00382720|7211226|FG000|Administered Non-Optimal Dose (Part I)|Overall Study||10
6307680|NCT00382720|7211227|FG001|Administered Non-Optimal Dose (Part I)|Overall Study||11
6307681|NCT00382720|7211228|FG002|Administered Non-Optimal Dose (Part I)|Overall Study||0
6307682|NCT00382720|7211226|FG000|Administered Optimal Dose (Parts I & II)|Overall Study||78
6307683|NCT00382720|7211227|FG001|Administered Optimal Dose (Parts I & II)|Overall Study||88
6307684|NCT00382720|7211228|FG002|Administered Optimal Dose (Parts I & II)|Overall Study||82
6307685|NCT00382720|7211226|FG000|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
6307686|NCT00382720|7211227|FG001|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
6307687|NCT00382720|7211228|FG002|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
6307688|NCT00382720|7211226|FG000|COMPLETED|Overall Study||0
6307689|NCT00382720|7211227|FG001|COMPLETED|Overall Study||0
6307690|NCT00382720|7211228|FG002|COMPLETED|Overall Study||0
6307691|NCT00382720|7211226|FG000|NOT COMPLETED|Overall Study||79
6307692|NCT00382720|7211227|FG001|NOT COMPLETED|Overall Study||89
6307693|NCT00382720|7211228|FG002|NOT COMPLETED|Overall Study||86
6307694|NCT00382733|7211236|FG000|STARTED|Overall Study||3
6307695|NCT00382733|7211237|FG001|STARTED|Overall Study||4
6307696|NCT00382733|7211238|FG002|STARTED|Overall Study||3
6307697|NCT00382733|7211239|FG003|STARTED|Overall Study||14
6307698|NCT00382733|7211240|FG004|STARTED|Overall Study||2
6307699|NCT00382733|7211236|FG000|COMPLETED|Overall Study||3
6307700|NCT00382733|7211237|FG001|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
6307701|NCT00382733|7211238|FG002|COMPLETED|Overall Study||3
6307702|NCT00382733|7211239|FG003|COMPLETED|Overall Study||14
6307703|NCT00382733|7211240|FG004|COMPLETED|Overall Study||2
6307704|NCT00382733|7211236|FG000|NOT COMPLETED|Overall Study||0
6307705|NCT00382733|7211237|FG001|NOT COMPLETED|Overall Study||1
6307706|NCT00382733|7211238|FG002|NOT COMPLETED|Overall Study||0
6307707|NCT00382733|7211239|FG003|NOT COMPLETED|Overall Study||0
6307708|NCT00382733|7211240|FG004|NOT COMPLETED|Overall Study||0
6307709|NCT00382785|7211255|FG000|STARTED|Overall Study||25
6307710|NCT00382785|7211256|FG001|STARTED|Overall Study||26
6307711|NCT00382785|7211255|FG000|COMPLETED|Overall Study||25
6307712|NCT00382785|7211256|FG001|COMPLETED|Overall Study||26
6307713|NCT00382785|7211255|FG000|NOT COMPLETED|Overall Study||0
6307714|NCT00382785|7211256|FG001|NOT COMPLETED|Overall Study||0
6307715|NCT00382824|7211264|FG000|STARTED|Overall Study||32
6307716|NCT00382824|7211265|FG001|STARTED|Overall Study||29
6307717|NCT00382824|7211264|FG000|COMPLETED|Overall Study||20
6307718|NCT00382824|7211265|FG001|COMPLETED|Overall Study||16
6307719|NCT00382824|7211264|FG000|NOT COMPLETED|Overall Study||12
6307720|NCT00382824|7211265|FG001|NOT COMPLETED|Overall Study||13
6307721|NCT00382863|7211273|FG000|STARTED|Overall Study||96
6307722|NCT00382863|7211274|FG001|STARTED|Overall Study||114
6307723|NCT00382863|7211273|FG000|COMPLETED|Overall Study||81
6307724|NCT00382863|7211274|FG001|COMPLETED|Overall Study||78
6307725|NCT00382863|7211273|FG000|NOT COMPLETED|Overall Study||15
6307726|NCT00382863|7211274|FG001|NOT COMPLETED|Overall Study||36
6307727|NCT00382928|7211282|FG000|STARTED|Overall Study||97
6307728|NCT00382928|7211283|FG001|STARTED|Overall Study||95
6307729|NCT00382928|7211282|FG000|COMPLETED|Overall Study||97
6307730|NCT00382928|7211283|FG001|COMPLETED|Overall Study||95
6307731|NCT00382928|7211282|FG000|NOT COMPLETED|Overall Study||0
6307732|NCT00382928|7211283|FG001|NOT COMPLETED|Overall Study||0
6307733|NCT00382967|7211296|FG000|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
6307734|NCT00382967|7211297|FG001|STARTED|Overall Study||138
6307735|NCT00382967|7211296|FG000|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
6307736|NCT00382967|7211297|FG001|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
6307737|NCT00382967|7211296|FG000|NOT COMPLETED|Overall Study||1
6307738|NCT00382967|7211297|FG001|NOT COMPLETED|Overall Study||1
6307739|NCT00382993|7211303|FG000|STARTED|Migraine Attack 1 (Period 1)||84
6307740|NCT00382993|7211304|FG001|STARTED|Migraine Attack 1 (Period 1)||85
6307741|NCT00382993|7211303|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
6307742|NCT00382993|7211304|FG001|COMPLETED|Migraine Attack 1 (Period 1)||67
6307743|NCT00382993|7211303|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
6307744|NCT00382993|7211304|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
6307745|NCT00382993|7211303|FG000|STARTED|Migraine Attack 2 (Period 2)||70
6307746|NCT00382993|7211304|FG001|STARTED|Migraine Attack 2 (Period 2)||67
6307747|NCT00382993|7211303|FG000|COMPLETED|Migraine Attack 2 (Period 2)||68
6307748|NCT00382993|7211304|FG001|COMPLETED|Migraine Attack 2 (Period 2)||63
6307749|NCT00382993|7211303|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
6307750|NCT00382993|7211304|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
6307751|NCT00383019|7211312|FG000|STARTED|Overall Study||144
6307752|NCT00383019|7211313|FG001|STARTED|Overall Study||145
6307753|NCT00383019|7211312|FG000|COMPLETED|Overall Study||139
6307754|NCT00383019|7211313|FG001|COMPLETED|Overall Study||143
6307755|NCT00383019|7211312|FG000|NOT COMPLETED|Overall Study||5
6307756|NCT00383019|7211313|FG001|NOT COMPLETED|Overall Study||2
6307757|NCT00383071|7211323|FG000|STARTED|Overall Study||25
6307758|NCT00383071|7211324|FG001|STARTED|Overall Study||25
6307759|NCT00383071|7211325|FG002|STARTED|Overall Study||51
6307760|NCT00383071|7211326|FG003|STARTED|Overall Study||25
6307761|NCT00383071|7211323|FG000|COMPLETED|Overall Study||25
6307762|NCT00383071|7211324|FG001|COMPLETED|Overall Study||21
6307763|NCT00383071|7211325|FG002|COMPLETED|Overall Study||44
6307764|NCT00383071|7211326|FG003|COMPLETED|Overall Study||22
6307765|NCT00383071|7211323|FG000|NOT COMPLETED|Overall Study||0
6307766|NCT00383071|7211324|FG001|NOT COMPLETED|Overall Study||4
6307767|NCT00383071|7211325|FG002|NOT COMPLETED|Overall Study||7
6307768|NCT00383071|7211326|FG003|NOT COMPLETED|Overall Study||3
6307769|NCT00383084|7211338|FG000|STARTED|Overall Study||46
6307770|NCT00383084|7211339|FG001|STARTED|Overall Study||38
6307771|NCT00383084|7211338|FG000|COMPLETED|Overall Study||34
6307772|NCT00383084|7211339|FG001|COMPLETED|Overall Study||28
6307773|NCT00383084|7211338|FG000|NOT COMPLETED|Overall Study||12
6307774|NCT00383084|7211339|FG001|NOT COMPLETED|Overall Study||10
6307775|NCT00383110|7211347|FG000|STARTED|Overall Study||150
6307776|NCT00383110|7211348|FG001|STARTED|Overall Study||150
6307777|NCT00383110|7211347|FG000|COMPLETED|Overall Study||150
6307778|NCT00383110|7211348|FG001|COMPLETED|Overall Study||150
6307779|NCT00383110|7211347|FG000|NOT COMPLETED|Overall Study||0
6307780|NCT00383110|7211348|FG001|NOT COMPLETED|Overall Study||0
6307781|NCT00383123|7211357|FG000|STARTED|Overall Study||2115
6307782|NCT00383123|7211358|FG001|STARTED|Overall Study||1210
6307783|NCT00383123|7211357|FG000|COMPLETED|Overall Study||2004
6307784|NCT00383123|7211358|FG001|COMPLETED|Overall Study||1124
6307785|NCT00383123|7211357|FG000|NOT COMPLETED|Overall Study||111
6307786|NCT00383123|7211358|FG001|NOT COMPLETED|Overall Study||86
6307787|NCT00383149|7211364|FG000|STARTED|Overall Study||54
6307788|NCT00383149|7211364|FG000|COMPLETED|Overall Study||0
6307789|NCT00383149|7211364|FG000|NOT COMPLETED|Overall Study||54
6307790|NCT00383162|7211370|FG000|STARTED|Migraine Attack 1 (Period 1)||87
6307791|NCT00383162|7211371|FG001|STARTED|Migraine Attack 1 (Period 1)||86
6307792|NCT00383162|7211370|FG000|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
6307793|NCT00383162|7211371|FG001|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
6307794|NCT00383162|7211370|FG000|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
6307795|NCT00383162|7211371|FG001|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
6307796|NCT00383162|7211370|FG000|STARTED|Migraine Attack 2 (Period 2)||67
6307797|NCT00383162|7211371|FG001|STARTED|Migraine Attack 2 (Period 2)||73
6307798|NCT00383162|7211370|FG000|COMPLETED|Migraine Attack 2 (Period 2)||65
6307799|NCT00383162|7211371|FG001|COMPLETED|Migraine Attack 2 (Period 2)||66
6307800|NCT00383162|7211370|FG000|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
6307801|NCT00383162|7211371|FG001|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
6307802|NCT00383188|7211382|FG000|STARTED|Overall Study||69
6307803|NCT00383188|7211383|FG001|STARTED|Overall Study||74
6307804|NCT00383188|7211384|FG002|STARTED|Overall Study||44
6307805|NCT00383188|7211385|FG003|STARTED|Overall Study||40
6307806|NCT00383188|7211386|FG004|STARTED|Overall Study||75
6307807|NCT00383188|7211382|FG000|COMPLETED|Overall Study||52
6307808|NCT00383188|7211383|FG001|COMPLETED|Overall Study||63
6307809|NCT00383188|7211384|FG002|COMPLETED|Overall Study||31
6307810|NCT00383188|7211385|FG003|COMPLETED|Overall Study||28
6307811|NCT00383188|7211386|FG004|COMPLETED|Overall Study||52
6307812|NCT00383188|7211382|FG000|NOT COMPLETED|Overall Study||17
6307813|NCT00383188|7211383|FG001|NOT COMPLETED|Overall Study||11
6307814|NCT00383188|7211384|FG002|NOT COMPLETED|Overall Study||13
6307815|NCT00383188|7211385|FG003|NOT COMPLETED|Overall Study||12
6307816|NCT00383188|7211386|FG004|NOT COMPLETED|Overall Study||23
6307817|NCT00383266|7211400|FG000|STARTED|Overall Study||9
6307818|NCT00383266|7211400|FG000|COMPLETED|Overall Study||9
6307819|NCT00383266|7211400|FG000|NOT COMPLETED|Overall Study||0
6307820|NCT00383292|7211407|FG000|STARTED|Overall Study||68
6307821|NCT00383292|7211408|FG001|STARTED|Overall Study||32
6307822|NCT00383292|7211409|FG002|STARTED|Overall Study||30
6307823|NCT00383292|7211407|FG000|Received at Least One Dose of Study Drug|Overall Study||68
6307824|NCT00383292|7211408|FG001|Received at Least One Dose of Study Drug|Overall Study||32
6307825|NCT00383292|7211409|FG002|Received at Least One Dose of Study Drug|Overall Study||30
6307826|NCT00383292|7211407|FG000|COMPLETED|Overall Study||53
6307827|NCT00383292|7211408|FG001|COMPLETED|Overall Study||26
6307828|NCT00383292|7211409|FG002|COMPLETED|Overall Study||22
6307829|NCT00383292|7211407|FG000|NOT COMPLETED|Overall Study||15
6307830|NCT00383292|7211408|FG001|NOT COMPLETED|Overall Study||6
6307831|NCT00383292|7211409|FG002|NOT COMPLETED|Overall Study||8
6307832|NCT00383331|7211420|FG000|STARTED|Overall Study||10
6307833|NCT00383331|7211421|FG001|STARTED|Overall Study||9
6307834|NCT00383331|7211420|FG000|COMPLETED|Overall Study||10
6307835|NCT00383331|7211421|FG001|COMPLETED|Overall Study||8
6307836|NCT00383331|7211420|FG000|NOT COMPLETED|Overall Study||0
6307837|NCT00383331|7211421|FG001|NOT COMPLETED|Overall Study||1
6307838|NCT00383448|7211427|FG000|STARTED|Overall Study||38
6307839|NCT00383448|7211427|FG000|COMPLETED|Overall Study||38
6307840|NCT00383448|7211427|FG000|NOT COMPLETED|Overall Study||0
6307841|NCT00383500|7211435|FG000|STARTED|Overall Study||27
6307842|NCT00383500|7211436|FG001|STARTED|Overall Study||24
6307843|NCT00383500|7211437|FG002|STARTED|Overall Study||24
6307844|NCT00383500|7211435|FG000|COMPLETED|Overall Study||19
6307845|NCT00383500|7211436|FG001|COMPLETED|Overall Study||21
6307846|NCT00383500|7211437|FG002|COMPLETED|Overall Study||22
6307847|NCT00383500|7211435|FG000|NOT COMPLETED|Overall Study||8
6307848|NCT00383500|7211436|FG001|NOT COMPLETED|Overall Study||3
6307849|NCT00383500|7211437|FG002|NOT COMPLETED|Overall Study||2
6307850|NCT00383565|7211446|FG000|STARTED|Overall Study||9
6307851|NCT00383565|7211446|FG000|COMPLETED|Overall Study||9
6307852|NCT00383565|7211446|FG000|NOT COMPLETED|Overall Study||0
6307853|NCT00383643|7211453|FG000|STARTED|Overall Study||18
6307854|NCT00383643|7211454|FG001|STARTED|Overall Study||16
6307855|NCT00383643|7211455|FG002|STARTED|Overall Study||14
6307856|NCT00383643|7211453|FG000|COMPLETED|Overall Study||17
6307857|NCT00383643|7211454|FG001|COMPLETED|Overall Study||15
6307858|NCT00383643|7211455|FG002|COMPLETED|Overall Study||13
6307859|NCT00383643|7211453|FG000|NOT COMPLETED|Overall Study||1
6307860|NCT00383643|7211454|FG001|NOT COMPLETED|Overall Study||1
6307861|NCT00383643|7211455|FG002|NOT COMPLETED|Overall Study||1
6307862|NCT00383747|7211465|FG000|STARTED|Visit 1||14
6307863|NCT00383747|7211466|FG001|STARTED|Visit 1||14
6307864|NCT00383747|7211467|FG002|STARTED|Visit 1||16
6307865|NCT00383747|7211468|FG003|STARTED|Visit 1||16
6307866|NCT00383747|7211465|FG000|COMPLETED|Visit 1||14
6307867|NCT00383747|7211466|FG001|COMPLETED|Visit 1||14
6307868|NCT00383747|7211467|FG002|COMPLETED|Visit 1||16
6307869|NCT00383747|7211468|FG003|COMPLETED|Visit 1||16
6307870|NCT00383747|7211465|FG000|NOT COMPLETED|Visit 1||0
6307871|NCT00383747|7211466|FG001|NOT COMPLETED|Visit 1||0
6307872|NCT00383747|7211467|FG002|NOT COMPLETED|Visit 1||0
6307873|NCT00383747|7211468|FG003|NOT COMPLETED|Visit 1||0
6307874|NCT00383747|7211465|FG000|STARTED|Visit 2||14
6307875|NCT00383747|7211466|FG001|STARTED|Visit 2||14
6307876|NCT00383747|7211467|FG002|STARTED|Visit 2||16
6307877|NCT00383747|7211468|FG003|STARTED|Visit 2||16
6307878|NCT00383747|7211465|FG000|COMPLETED|Visit 2||14
6307879|NCT00383747|7211466|FG001|COMPLETED|Visit 2||14
6307880|NCT00383747|7211467|FG002|COMPLETED|Visit 2||16
6307881|NCT00383747|7211468|FG003|COMPLETED|Visit 2||16
6307882|NCT00383747|7211465|FG000|NOT COMPLETED|Visit 2||0
6307883|NCT00383747|7211466|FG001|NOT COMPLETED|Visit 2||0
6307884|NCT00383747|7211467|FG002|NOT COMPLETED|Visit 2||0
6307885|NCT00383747|7211468|FG003|NOT COMPLETED|Visit 2||0
6307886|NCT00383760|7211481|FG000|STARTED|Overall Study||15
6307887|NCT00383760|7211481|FG000|COMPLETED|Overall Study||15
6307888|NCT00383760|7211481|FG000|NOT COMPLETED|Overall Study||0
6307889|NCT00383786|7211488|FG000|STARTED|Overall Study||22
6307890|NCT00383786|7211489|FG001|STARTED|Overall Study||25
6307891|NCT00383786|7211488|FG000|COMPLETED|Overall Study||18
6307892|NCT00383786|7211489|FG001|COMPLETED|Overall Study||13
6307893|NCT00383786|7211488|FG000|NOT COMPLETED|Overall Study||4
6307894|NCT00383786|7211489|FG001|NOT COMPLETED|Overall Study||12
6307895|NCT00383942|7211497|FG000|STARTED|Overall Study||40
6307896|NCT00383942|7211498|FG001|STARTED|Overall Study||40
6307897|NCT00383942|7211497|FG000|COMPLETED|Overall Study||40
6307898|NCT00383942|7211498|FG001|COMPLETED|Overall Study||40
6307899|NCT00383942|7211497|FG000|NOT COMPLETED|Overall Study||0
6307900|NCT00383942|7211498|FG001|NOT COMPLETED|Overall Study||0
6307901|NCT00384033|7211508|FG000|STARTED|Overall Study||164
6307902|NCT00384033|7211509|FG001|STARTED|Overall Study||155
6307903|NCT00384033|7211510|FG002|STARTED|Overall Study||160
6307904|NCT00384033|7211511|FG003|STARTED|Overall Study||159
6307905|NCT00384033|7211508|FG000|Treated|Overall Study||161
6307906|NCT00384033|7211509|FG001|Treated|Overall Study||148
6307907|NCT00384033|7211510|FG002|Treated|Overall Study||150
6307908|NCT00384033|7211511|FG003|Treated|Overall Study||157
6307909|NCT00384033|7211508|FG000|COMPLETED|Overall Study||123
6307910|NCT00384033|7211509|FG001|COMPLETED|Overall Study||120
6307911|NCT00384033|7211510|FG002|COMPLETED|Overall Study||117
6307912|NCT00384033|7211511|FG003|COMPLETED|Overall Study||119
6307913|NCT00384033|7211508|FG000|NOT COMPLETED|Overall Study||41
6307914|NCT00384033|7211509|FG001|NOT COMPLETED|Overall Study||35
6307915|NCT00384033|7211510|FG002|NOT COMPLETED|Overall Study||43
6307916|NCT00384033|7211511|FG003|NOT COMPLETED|Overall Study||40
6307917|NCT00384059|7211523|FG000|STARTED|Infant Series||141
6307918|NCT00384059|7211524|FG001|STARTED|Infant Series||145
6307919|NCT00384059|7211523|FG000|Vaccinated Dose 1|Infant Series||139
6307920|NCT00384059|7211524|FG001|Vaccinated Dose 1|Infant Series||139
6307921|NCT00384059|7211523|FG000|Vaccinated Dose 2|Infant Series||136
6307922|NCT00384059|7211524|FG001|Vaccinated Dose 2|Infant Series||135
6307923|NCT00384059|7211523|FG000|COMPLETED|Infant Series||135
6307924|NCT00384059|7211524|FG001|COMPLETED|Infant Series||132
6307925|NCT00384059|7211523|FG000|NOT COMPLETED|Infant Series||6
6307926|NCT00384059|7211524|FG001|NOT COMPLETED|Infant Series||13
6307927|NCT00384059|7211523|FG000|STARTED|After Infant Series||135
6307928|NCT00384059|7211524|FG001|STARTED|After Infant Series||132
6307929|NCT00384059|7211523|FG000|COMPLETED|After Infant Series||131
6307930|NCT00384059|7211524|FG001|COMPLETED|After Infant Series||122
6307931|NCT00384059|7211523|FG000|NOT COMPLETED|After Infant Series||4
6307932|NCT00384059|7211524|FG001|NOT COMPLETED|After Infant Series||10
6307933|NCT00384059|7211523|FG000|STARTED|Toddler Dose||131
6307934|NCT00384059|7211524|FG001|STARTED|Toddler Dose||122
6307935|NCT00384059|7211523|FG000|COMPLETED|Toddler Dose||130
6307936|NCT00384059|7211524|FG001|COMPLETED|Toddler Dose||120
6307937|NCT00384059|7211523|FG000|NOT COMPLETED|Toddler Dose||1
6307938|NCT00384059|7211524|FG001|NOT COMPLETED|Toddler Dose||2
6307939|NCT00384085|7211554|FG000|STARTED|Overall Study|Randomized|195
6307940|NCT00384085|7211555|FG001|STARTED|Overall Study|Randomized|196
6307941|NCT00384085|7211556|FG002|STARTED|Overall Study|Randomized|197
6307942|NCT00384085|7211554|FG000|Intent-To-Treat (ITT)|Overall Study||195
6307943|NCT00384085|7211555|FG001|Intent-To-Treat (ITT)|Overall Study||196
6307944|NCT00384085|7211556|FG002|Intent-To-Treat (ITT)|Overall Study||197
6307945|NCT00384085|7211554|FG000|Treated (Safety Population)|Overall Study||194
6307946|NCT00384085|7211555|FG001|Treated (Safety Population)|Overall Study||194
6307947|NCT00384085|7211556|FG002|Treated (Safety Population)|Overall Study||194
6307948|NCT00384085|7211554|FG000|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
6307949|NCT00384085|7211555|FG001|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
6307950|NCT00384085|7211556|FG002|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
6307951|NCT00384085|7211554|FG000|COMPLETED|Overall Study|Based on the entire ITT population|156
6307952|NCT00384085|7211555|FG001|COMPLETED|Overall Study|Based on the entire ITT population|150
6307953|NCT00384085|7211556|FG002|COMPLETED|Overall Study|Based on the entire ITT population|141
6307954|NCT00384085|7211554|FG000|NOT COMPLETED|Overall Study||39
6307955|NCT00384085|7211555|FG001|NOT COMPLETED|Overall Study||46
6307956|NCT00384085|7211556|FG002|NOT COMPLETED|Overall Study||56
6307957|NCT00384176|7211569|FG000|STARTED|Overall Study||709
6307958|NCT00384176|7211570|FG001|STARTED|Overall Study||713
6307959|NCT00384176|7211571|FG002|STARTED|Overall Study||192
6307960|NCT00384176|7211569|FG000|COMPLETED|Overall Study||397
6307961|NCT00384176|7211570|FG001|COMPLETED|Overall Study||394
6307962|NCT00384176|7211571|FG002|COMPLETED|Overall Study||60
6307963|NCT00384176|7211569|FG000|NOT COMPLETED|Overall Study||312
6307964|NCT00384176|7211570|FG001|NOT COMPLETED|Overall Study||319
6307965|NCT00384176|7211571|FG002|NOT COMPLETED|Overall Study||132
6307966|NCT00384189|7211583|FG000|STARTED|Overall Study||305
6307967|NCT00384189|7211584|FG001|STARTED|Overall Study||312
6307968|NCT00384189|7211585|FG002|STARTED|Overall Study||313
6307969|NCT00384189|7211586|FG003|STARTED|Overall Study||150
6307970|NCT00384189|7211583|FG000|Randomized, Not Treated|Overall Study||1
6307971|NCT00384189|7211584|FG001|Randomized, Not Treated|Overall Study||0
6307972|NCT00384189|7211585|FG002|Randomized, Not Treated|Overall Study||2
6307973|NCT00384189|7211586|FG003|Randomized, Not Treated|Overall Study||4
6307974|NCT00384189|7211583|FG000|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
6307975|NCT00384189|7211584|FG001|Actual Treatment Received|Overall Study||312
6307976|NCT00384189|7211585|FG002|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
6307977|NCT00384189|7211586|FG003|Actual Treatment Received|Overall Study||146
6307978|NCT00384189|7211583|FG000|COMPLETED|Overall Study||255
6307979|NCT00384189|7211584|FG001|COMPLETED|Overall Study||255
6307980|NCT00384189|7211585|FG002|COMPLETED|Overall Study||255
6307981|NCT00384189|7211586|FG003|COMPLETED|Overall Study||110
6307982|NCT00384189|7211583|FG000|NOT COMPLETED|Overall Study||50
6307983|NCT00384189|7211584|FG001|NOT COMPLETED|Overall Study||57
6307984|NCT00384189|7211585|FG002|NOT COMPLETED|Overall Study||58
6307985|NCT00384189|7211586|FG003|NOT COMPLETED|Overall Study||40
6307986|NCT00384241|7211598|FG000|STARTED|Overall Study||500
6307987|NCT00384241|7211599|FG001|STARTED|Overall Study||599
6307988|NCT00384241|7211598|FG000|COMPLETED|Overall Study||500
6307989|NCT00384241|7211599|FG001|COMPLETED|Overall Study||599
6307990|NCT00384241|7211598|FG000|NOT COMPLETED|Overall Study||0
6307991|NCT00384241|7211599|FG001|NOT COMPLETED|Overall Study||0
6307992|NCT00384332|7211606|FG000|STARTED|Overall Study||13
6307993|NCT00384332|7211607|FG001|STARTED|Overall Study||10
6307994|NCT00384332|7211606|FG000|COMPLETED|Overall Study||9
6307995|NCT00384332|7211607|FG001|COMPLETED|Overall Study||10
6307996|NCT00384332|7211606|FG000|NOT COMPLETED|Overall Study||4
6307997|NCT00384332|7211607|FG001|NOT COMPLETED|Overall Study||0
6307998|NCT00384397|7211618|FG000|STARTED|Overall Study||407
6307999|NCT00384397|7211619|FG001|STARTED|Overall Study||293
6308000|NCT00384397|7211620|FG002|STARTED|Overall Study||418
6308001|NCT00384397|7211618|FG000|COMPLETED|Overall Study||375
6308002|NCT00384397|7211619|FG001|COMPLETED|Overall Study||247
6308003|NCT00384397|7211620|FG002|COMPLETED|Overall Study||385
6308004|NCT00384397|7211618|FG000|NOT COMPLETED|Overall Study||32
6308005|NCT00384397|7211619|FG001|NOT COMPLETED|Overall Study||46
6308006|NCT00384397|7211620|FG002|NOT COMPLETED|Overall Study||33
6308007|NCT00384449|7211628|FG000|STARTED|Overall Study||1
6308008|NCT00384449|7211628|FG000|COMPLETED|Overall Study||1
6308009|NCT00384449|7211628|FG000|NOT COMPLETED|Overall Study||0
6308010|NCT00384670|7211632|FG000|STARTED|Overall Study||7
6308011|NCT00384670|7211632|FG000|COMPLETED|Overall Study||7
6308012|NCT00384670|7211632|FG000|NOT COMPLETED|Overall Study||0
6308013|NCT00384748|7211638|FG000|STARTED|Overall Study||25
6308014|NCT00384748|7211639|FG001|STARTED|Overall Study||23
6308015|NCT00384748|7211638|FG000|COMPLETED|Overall Study||25
6308016|NCT00384748|7211639|FG001|COMPLETED|Overall Study||23
6308017|NCT00384748|7211638|FG000|NOT COMPLETED|Overall Study||0
6308018|NCT00384748|7211639|FG001|NOT COMPLETED|Overall Study||0
6308019|NCT00384774|7211652|FG000|STARTED|Overall Study||42
6308020|NCT00384774|7211653|FG001|STARTED|Overall Study||4
6308021|NCT00384774|7211654|FG002|STARTED|Overall Study||12
6308022|NCT00384774|7211655|FG003|STARTED|Overall Study||24
6308023|NCT00384774|7211656|FG004|STARTED|Overall Study||28
6308024|NCT00384774|7211657|FG005|STARTED|Overall Study||16
6308025|NCT00384774|7211658|FG006|STARTED|Overall Study||4
6308026|NCT00384774|7211652|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
6308027|NCT00384774|7211653|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
6308028|NCT00384774|7211654|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
6308029|NCT00384774|7211655|FG003|Received at Least 1 Dose of Study Drug|Overall Study||24
6308030|NCT00384774|7211656|FG004|Received at Least 1 Dose of Study Drug|Overall Study||28
6308031|NCT00384774|7211657|FG005|Received at Least 1 Dose of Study Drug|Overall Study||16
6308032|NCT00384774|7211658|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
6308033|NCT00384774|7211652|FG000|COMPLETED|Overall Study||42
6308034|NCT00384774|7211653|FG001|COMPLETED|Overall Study||4
6308035|NCT00384774|7211654|FG002|COMPLETED|Overall Study||12
6308036|NCT00384774|7211655|FG003|COMPLETED|Overall Study||24
6308037|NCT00384774|7211656|FG004|COMPLETED|Overall Study||28
6308038|NCT00384774|7211657|FG005|COMPLETED|Overall Study||16
6308039|NCT00384774|7211658|FG006|COMPLETED|Overall Study||4
6308040|NCT00384774|7211652|FG000|NOT COMPLETED|Overall Study||0
6308041|NCT00384774|7211653|FG001|NOT COMPLETED|Overall Study||0
6308042|NCT00384774|7211654|FG002|NOT COMPLETED|Overall Study||0
6308043|NCT00384774|7211655|FG003|NOT COMPLETED|Overall Study||0
6308044|NCT00384774|7211656|FG004|NOT COMPLETED|Overall Study||0
6308045|NCT00384774|7211657|FG005|NOT COMPLETED|Overall Study||0
6308046|NCT00384774|7211658|FG006|NOT COMPLETED|Overall Study||0
6308047|NCT00384813|7211676|FG000|STARTED|Overall Study||23
6308048|NCT00384813|7211677|FG001|STARTED|Overall Study||20
6308049|NCT00384813|7211676|FG000|COMPLETED|Overall Study||21
6308050|NCT00384813|7211677|FG001|COMPLETED|Overall Study||20
6308051|NCT00384813|7211676|FG000|NOT COMPLETED|Overall Study||2
6308052|NCT00384813|7211677|FG001|NOT COMPLETED|Overall Study||0
6308053|NCT00384839|7211683|FG000|STARTED|Overall Study||36
6308054|NCT00384839|7211683|FG000|COMPLETED|Overall Study||28
6308055|NCT00384839|7211683|FG000|NOT COMPLETED|Overall Study||8
6308056|NCT00384865|7211691|FG000|STARTED|Overall Study||16
6308057|NCT00384865|7211692|FG001|STARTED|Overall Study||16
6308058|NCT00384865|7211693|FG002|STARTED|Overall Study||16
6308059|NCT00384865|7211694|FG003|STARTED|Overall Study||16
6308060|NCT00384865|7211691|FG000|Completed Six Month Assessment|Overall Study||11
6308061|NCT00384865|7211692|FG001|Completed Six Month Assessment|Overall Study||12
6308062|NCT00384865|7211693|FG002|Completed Six Month Assessment|Overall Study||15
6308063|NCT00384865|7211694|FG003|Completed Six Month Assessment|Overall Study||11
6308064|NCT00384865|7211691|FG000|COMPLETED|Overall Study||16
6308065|NCT00384865|7211692|FG001|COMPLETED|Overall Study||16
6308066|NCT00384865|7211693|FG002|COMPLETED|Overall Study||16
6308067|NCT00384865|7211694|FG003|COMPLETED|Overall Study||16
6308068|NCT00384865|7211691|FG000|NOT COMPLETED|Overall Study||0
6308069|NCT00384865|7211692|FG001|NOT COMPLETED|Overall Study||0
6308070|NCT00384865|7211693|FG002|NOT COMPLETED|Overall Study||0
6308071|NCT00384865|7211694|FG003|NOT COMPLETED|Overall Study||0
6308072|NCT00384930|7211709|FG000|STARTED|Overall Study||212
6308073|NCT00384930|7211710|FG001|STARTED|Overall Study||209
6308074|NCT00384930|7211711|FG002|STARTED|Overall Study||212
6308075|NCT00384930|7211712|FG003|STARTED|Overall Study||216
6308076|NCT00384930|7211713|FG004|STARTED|Overall Study||209
6308077|NCT00384930|7211709|FG000|Received Double-Blind Study Drug|Overall Study||211
6308078|NCT00384930|7211710|FG001|Received Double-Blind Study Drug|Overall Study||208
6308079|NCT00384930|7211711|FG002|Received Double-Blind Study Drug|Overall Study||212
6308080|NCT00384930|7211712|FG003|Received Double-Blind Study Drug|Overall Study||216
6308081|NCT00384930|7211713|FG004|Received Double-Blind Study Drug|Overall Study||209
6308082|NCT00384930|7211709|FG000|COMPLETED|Overall Study||185
6308083|NCT00384930|7211710|FG001|COMPLETED|Overall Study||182
6308084|NCT00384930|7211711|FG002|COMPLETED|Overall Study||182
6308085|NCT00384930|7211712|FG003|COMPLETED|Overall Study||175
6308086|NCT00384930|7211713|FG004|COMPLETED|Overall Study||162
6308087|NCT00384930|7211709|FG000|NOT COMPLETED|Overall Study||27
6308088|NCT00384930|7211710|FG001|NOT COMPLETED|Overall Study||27
6308089|NCT00384930|7211711|FG002|NOT COMPLETED|Overall Study||30
6308090|NCT00384930|7211712|FG003|NOT COMPLETED|Overall Study||41
6308091|NCT00384930|7211713|FG004|NOT COMPLETED|Overall Study||47
6308092|NCT00384956|7211728|FG000|STARTED|Overall Study||25
6308093|NCT00384956|7211728|FG000|COMPLETED|Overall Study||22
6308094|NCT00384956|7211728|FG000|NOT COMPLETED|Overall Study||3
6308095|NCT00385008|7211734|FG000|STARTED|Overall Study||10
6308096|NCT00385008|7211735|FG001|STARTED|Overall Study||10
6308097|NCT00385008|7211734|FG000|In Absence of Migraine|Overall Study||10
6308098|NCT00385008|7211735|FG001|In Absence of Migraine|Overall Study||10
6308099|NCT00385008|7211734|FG000|In Presence of Migraine|Overall Study||5
6308100|NCT00385008|7211735|FG001|In Presence of Migraine|Overall Study||5
6308101|NCT00385008|7211734|FG000|COMPLETED|Overall Study||10
6308102|NCT00385008|7211735|FG001|COMPLETED|Overall Study||10
6308103|NCT00385008|7211734|FG000|NOT COMPLETED|Overall Study||0
6308104|NCT00385008|7211735|FG001|NOT COMPLETED|Overall Study||0
6308105|NCT00385138|7211744|FG000|STARTED|Overall Study||2695
6308106|NCT00385138|7211745|FG001|STARTED|Overall Study||2669
6308107|NCT00385138|7211744|FG000|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
6308108|NCT00385138|7211745|FG001|Intent-to-treat (ITT)|Overall Study||2669
6308109|NCT00385138|7211744|FG000|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
6308110|NCT00385138|7211745|FG001|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
6308111|NCT00385138|7211744|FG000|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
6308112|NCT00385138|7211745|FG001|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
6308113|NCT00385138|7211744|FG000|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
6308114|NCT00385138|7211745|FG001|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
6308115|NCT00385138|7211744|FG000|NOT COMPLETED|Overall Study||30
6308116|NCT00385138|7211745|FG001|NOT COMPLETED|Overall Study||28
6308117|NCT00385203|7211753|FG000|STARTED|Overall Study||26
6308118|NCT00385203|7211754|FG001|STARTED|Overall Study||10
6308119|NCT00385203|7211753|FG000|COMPLETED|Overall Study||0
6308120|NCT00385203|7211754|FG001|COMPLETED|Overall Study||3
6308121|NCT00385203|7211753|FG000|NOT COMPLETED|Overall Study||26
6308122|NCT00385203|7211754|FG001|NOT COMPLETED|Overall Study||7
6308123|NCT00385216|7211761|FG000|STARTED|First Intervention||11
6308124|NCT00385216|7211762|FG001|STARTED|First Intervention||9
6308125|NCT00385216|7211761|FG000|COMPLETED|First Intervention||11
6308126|NCT00385216|7211762|FG001|COMPLETED|First Intervention||9
6308127|NCT00385216|7211761|FG000|NOT COMPLETED|First Intervention||0
6308128|NCT00385216|7211762|FG001|NOT COMPLETED|First Intervention||0
6308129|NCT00385216|7211761|FG000|STARTED|Second Intervention||11
6308130|NCT00385216|7211762|FG001|STARTED|Second Intervention||9
6308131|NCT00385216|7211761|FG000|COMPLETED|Second Intervention||11
6308132|NCT00385216|7211762|FG001|COMPLETED|Second Intervention||9
6557393|NCT01767467|7479925|FG000|NOT COMPLETED|End of Study Phase (up to Month 13)||47
6557394|NCT01767467|7479926|FG001|NOT COMPLETED|End of Study Phase (up to Month 13)||63
6557395|NCT01767493|7479939|FG000|STARTED|Overall Study||19
6308133|NCT00385216|7211761|FG000|NOT COMPLETED|Second Intervention||0
6308134|NCT00385216|7211762|FG001|NOT COMPLETED|Second Intervention||0
6308135|NCT00385255|7211770|FG000|STARTED|Overall Study||860
6308136|NCT00385255|7211771|FG001|STARTED|Overall Study||858
6308137|NCT00385255|7211770|FG000|≥ 65 Years of Age (YOA) Cohort|Overall Study||112
6308138|NCT00385255|7211771|FG001|≥ 65 Years of Age (YOA) Cohort|Overall Study||109
6308139|NCT00385255|7211770|FG000|19-64 Years of Age (YOA) Cohort|Overall Study||748
6308140|NCT00385255|7211771|FG001|19-64 Years of Age (YOA) Cohort|Overall Study||749
6308141|NCT00385255|7211770|FG000|COMPLETED|Overall Study||839
6308142|NCT00385255|7211771|FG001|COMPLETED|Overall Study||785
6308143|NCT00385255|7211770|FG000|NOT COMPLETED|Overall Study||21
6308144|NCT00385255|7211771|FG001|NOT COMPLETED|Overall Study||73
6308145|NCT00385268|7211783|FG000|STARTED|Overall Study||34
6308146|NCT00385268|7211784|FG001|STARTED|Overall Study||26
6308147|NCT00385268|7211783|FG000|COMPLETED|Overall Study||18
6308148|NCT00385268|7211784|FG001|COMPLETED|Overall Study||18
6308149|NCT00385268|7211783|FG000|NOT COMPLETED|Overall Study||16
6308150|NCT00385268|7211784|FG001|NOT COMPLETED|Overall Study||8
6308151|NCT00385541|7211792|FG000|STARTED|Overall Study||25
6557396|NCT01767493|7479939|FG000|COMPLETED|Overall Study||16
6557397|NCT01767493|7479939|FG000|NOT COMPLETED|Overall Study||3
6308152|NCT00385541|7211793|FG001|STARTED|Overall Study||25
6308153|NCT00385541|7211792|FG000|COMPLETED|Overall Study||25
6308154|NCT00385541|7211793|FG001|COMPLETED|Overall Study||24
6308155|NCT00385541|7211792|FG000|NOT COMPLETED|Overall Study||0
6308156|NCT00385541|7211793|FG001|NOT COMPLETED|Overall Study||1
6308157|NCT00385580|7211801|FG000|STARTED|Overall Study|Number of participants treated.|48
6308158|NCT00385580|7211802|FG001|STARTED|Overall Study|Number of participants treated.|47
6308159|NCT00385580|7211801|FG000|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
6308160|NCT00385580|7211802|FG001|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
6308161|NCT00385580|7211801|FG000|NOT COMPLETED|Overall Study||0
6308162|NCT00385580|7211802|FG001|NOT COMPLETED|Overall Study||0
6308163|NCT00385593|7211820|FG000|STARTED|Overall Study||328
6308164|NCT00385593|7211821|FG001|STARTED|Overall Study||326
6308165|NCT00385593|7211820|FG000|COMPLETED|Overall Study||270
6308166|NCT00385593|7211821|FG001|COMPLETED|Overall Study||289
6308167|NCT00385593|7211820|FG000|NOT COMPLETED|Overall Study||58
6308168|NCT00385593|7211821|FG001|NOT COMPLETED|Overall Study||37
6308169|NCT00385671|7211830|FG000|STARTED|Overall Study||134
6308170|NCT00385671|7211831|FG001|STARTED|Overall Study||138
6308171|NCT00385671|7211832|FG002|STARTED|Overall Study||135
6308172|NCT00385671|7211830|FG000|COMPLETED|Overall Study||96
6308173|NCT00385671|7211831|FG001|COMPLETED|Overall Study||87
6308174|NCT00385671|7211832|FG002|COMPLETED|Overall Study||99
6308175|NCT00385671|7211830|FG000|NOT COMPLETED|Overall Study||38
6308176|NCT00385671|7211831|FG001|NOT COMPLETED|Overall Study||51
6308177|NCT00385671|7211832|FG002|NOT COMPLETED|Overall Study||36
6308178|NCT00385684|7211842|FG000|STARTED|FIRST INTERVENTION OF PHASE A||6
6308179|NCT00385684|7211843|FG001|STARTED|FIRST INTERVENTION OF PHASE A||5
6308180|NCT00385684|7211842|FG000|COMPLETED|FIRST INTERVENTION OF PHASE A||5
6308181|NCT00385684|7211843|FG001|COMPLETED|FIRST INTERVENTION OF PHASE A||5
6308182|NCT00385684|7211842|FG000|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
6308183|NCT00385684|7211843|FG001|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
6308184|NCT00385684|7211842|FG000|STARTED|SECOND INTERVENTION OF PHASE A||5
6308185|NCT00385684|7211843|FG001|STARTED|SECOND INTERVENTION OF PHASE A||5
6308186|NCT00385684|7211842|FG000|COMPLETED|SECOND INTERVENTION OF PHASE A||5
6308187|NCT00385684|7211843|FG001|COMPLETED|SECOND INTERVENTION OF PHASE A||3
6308188|NCT00385684|7211842|FG000|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
6308189|NCT00385684|7211843|FG001|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
6308190|NCT00385684|7211842|FG000|STARTED|PHASE B||5
6308191|NCT00385684|7211843|FG001|STARTED|PHASE B||3
6308192|NCT00385684|7211842|FG000|COMPLETED|PHASE B||5
6308193|NCT00385684|7211843|FG001|COMPLETED|PHASE B||3
6308194|NCT00385684|7211842|FG000|NOT COMPLETED|PHASE B||0
6308195|NCT00385684|7211843|FG001|NOT COMPLETED|PHASE B||0
6308196|NCT00385723|7211852|FG000|STARTED|Overall Study||46
6308197|NCT00385723|7211853|FG001|STARTED|Overall Study||46
6308198|NCT00385723|7211854|FG002|STARTED|Overall Study||46
6308199|NCT00385723|7211852|FG000|COMPLETED|Overall Study||44
6308200|NCT00385723|7211853|FG001|COMPLETED|Overall Study||45
6308201|NCT00385723|7211854|FG002|COMPLETED|Overall Study||44
6308202|NCT00385723|7211852|FG000|NOT COMPLETED|Overall Study||2
6308203|NCT00385723|7211853|FG001|NOT COMPLETED|Overall Study||1
6308204|NCT00385723|7211854|FG002|NOT COMPLETED|Overall Study||2
6308205|NCT00385736|7211865|FG000|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
6308206|NCT00385736|7211866|FG001|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
6308207|NCT00385736|7211867|FG002|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
6308208|NCT00385736|7211865|FG000|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
6308209|NCT00385736|7211866|FG001|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
6308210|NCT00385736|7211867|FG002|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
6308211|NCT00385736|7211865|FG000|NOT COMPLETED|Efficacy Analysis Set - Induction||9
6308212|NCT00385736|7211866|FG001|NOT COMPLETED|Efficacy Analysis Set - Induction||12
6308213|NCT00385736|7211867|FG002|NOT COMPLETED|Efficacy Analysis Set - Induction||9
6308214|NCT00385736|7211865|FG000|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
6308215|NCT00385736|7211866|FG001|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
6308216|NCT00385736|7211867|FG002|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
6308217|NCT00385736|7211865|FG000|COMPLETED|Efficacy Analysis Set - Maintenance||153
6308218|NCT00385736|7211866|FG001|COMPLETED|Efficacy Analysis Set - Maintenance||86
6308219|NCT00385736|7211867|FG002|COMPLETED|Efficacy Analysis Set - Maintenance||143
6308220|NCT00385736|7211865|FG000|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
6308221|NCT00385736|7211866|FG001|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
6308222|NCT00385736|7211867|FG002|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
6308223|NCT00385736|7211865|FG000|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
6308224|NCT00385736|7211866|FG001|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
6308225|NCT00385736|7211867|FG002|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
6308226|NCT00385736|7211865|FG000|COMPLETED|Safety Analysis Set||153
6308227|NCT00385736|7211866|FG001|COMPLETED|Safety Analysis Set||86
6308228|NCT00385736|7211867|FG002|COMPLETED|Safety Analysis Set||143
6308229|NCT00385736|7211865|FG000|NOT COMPLETED|Safety Analysis Set||70
6308230|NCT00385736|7211866|FG001|NOT COMPLETED|Safety Analysis Set||44
6308231|NCT00385736|7211867|FG002|NOT COMPLETED|Safety Analysis Set||80
6308232|NCT00385762|7211878|FG000|STARTED|Overall Study||35
6308233|NCT00385762|7211878|FG000|COMPLETED|Overall Study||33
6308234|NCT00385762|7211878|FG000|NOT COMPLETED|Overall Study||2
6308235|NCT00385788|7211884|FG000|STARTED|Overall Study||12
6308236|NCT00385788|7211885|FG001|STARTED|Overall Study||40
6308237|NCT00385788|7211884|FG000|COMPLETED|Overall Study||12
6308238|NCT00385788|7211885|FG001|COMPLETED|Overall Study||40
6308239|NCT00385788|7211884|FG000|NOT COMPLETED|Overall Study||0
6308240|NCT00385788|7211885|FG001|NOT COMPLETED|Overall Study||0
6308241|NCT00385801|7211893|FG000|STARTED|Overall Study||15
6308242|NCT00385801|7211894|FG001|STARTED|Overall Study||16
6308243|NCT00385801|7211893|FG000|COMPLETED|Overall Study||6
6308244|NCT00385801|7211894|FG001|COMPLETED|Overall Study||8
6308245|NCT00385801|7211893|FG000|NOT COMPLETED|Overall Study||9
6308246|NCT00385801|7211894|FG001|NOT COMPLETED|Overall Study||8
6308247|NCT00385827|7211904|FG000|STARTED|Part 1||9
6308248|NCT00385827|7211905|FG001|STARTED|Part 1||0
6308249|NCT00385827|7211906|FG002|STARTED|Part 1||0
6308250|NCT00385827|7211904|FG000|Treated|Part 1||9
6308251|NCT00385827|7211905|FG001|Treated|Part 1||0
6308252|NCT00385827|7211906|FG002|Treated|Part 1||0
6308253|NCT00385827|7211904|FG000|COMPLETED|Part 1||0
6308254|NCT00385827|7211905|FG001|COMPLETED|Part 1||0
6308255|NCT00385827|7211906|FG002|COMPLETED|Part 1||0
6308256|NCT00385827|7211904|FG000|NOT COMPLETED|Part 1||9
6308257|NCT00385827|7211905|FG001|NOT COMPLETED|Part 1||0
6308258|NCT00385827|7211906|FG002|NOT COMPLETED|Part 1||0
6308259|NCT00385827|7211904|FG000|STARTED|Part 2||0
6308260|NCT00385827|7211905|FG001|STARTED|Part 2||49
6308261|NCT00385827|7211906|FG002|STARTED|Part 2||48
6308262|NCT00385827|7211904|FG000|Treated|Part 2||0
6308263|NCT00385827|7211905|FG001|Treated|Part 2||47
6308264|NCT00385827|7211906|FG002|Treated|Part 2||46
6308265|NCT00385827|7211904|FG000|COMPLETED|Part 2||0
6308266|NCT00385827|7211905|FG001|COMPLETED|Part 2||16
6308267|NCT00385827|7211906|FG002|COMPLETED|Part 2||0
6308268|NCT00385827|7211904|FG000|NOT COMPLETED|Part 2||0
6308269|NCT00385827|7211905|FG001|NOT COMPLETED|Part 2||33
6308270|NCT00385827|7211906|FG002|NOT COMPLETED|Part 2||48
6308271|NCT00385840|7211918|FG000|STARTED|Overall Study||133
6308272|NCT00385840|7211919|FG001|STARTED|Overall Study||545
6308273|NCT00385840|7211918|FG000|COMPLETED|Overall Study||129
6308274|NCT00385840|7211919|FG001|COMPLETED|Overall Study||531
6308275|NCT00385840|7211918|FG000|NOT COMPLETED|Overall Study||4
6308276|NCT00385840|7211919|FG001|NOT COMPLETED|Overall Study||14
6308277|NCT00385918|7211927|FG000|STARTED|Feasibility & Baseline Measurement Phase||0
6308278|NCT00385918|7211928|FG001|STARTED|Feasibility & Baseline Measurement Phase||0
6308279|NCT00385918|7211929|FG002|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
6308280|NCT00385918|7211927|FG000|Number Eligible|Feasibility & Baseline Measurement Phase||0
6308281|NCT00385918|7211928|FG001|Number Eligible|Feasibility & Baseline Measurement Phase||0
6308282|NCT00385918|7211929|FG002|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
6308283|NCT00385918|7211927|FG000|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
6308284|NCT00385918|7211928|FG001|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
6308285|NCT00385918|7211929|FG002|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
6308286|NCT00385918|7211927|FG000|COMPLETED|Feasibility & Baseline Measurement Phase||0
6308287|NCT00385918|7211928|FG001|COMPLETED|Feasibility & Baseline Measurement Phase||0
6308288|NCT00385918|7211929|FG002|COMPLETED|Feasibility & Baseline Measurement Phase||21
6308289|NCT00385918|7211927|FG000|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
6308290|NCT00385918|7211928|FG001|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
6308291|NCT00385918|7211929|FG002|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
6308292|NCT00385918|7211927|FG000|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
6308293|NCT00385918|7211928|FG001|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
6308294|NCT00385918|7211929|FG002|STARTED|Intervention Phase After Randomization||0
6308295|NCT00385918|7211927|FG000|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
6308296|NCT00385918|7211928|FG001|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
6308297|NCT00385918|7211929|FG002|COMPLETED|Intervention Phase After Randomization||0
6308298|NCT00385918|7211927|FG000|NOT COMPLETED|Intervention Phase After Randomization||3
6308299|NCT00385918|7211928|FG001|NOT COMPLETED|Intervention Phase After Randomization||0
6308300|NCT00385918|7211929|FG002|NOT COMPLETED|Intervention Phase After Randomization||0
6308301|NCT00385944|7211938|FG000|STARTED|Loading Dose||0
6308302|NCT00385944|7211939|FG001|STARTED|Loading Dose||0
6308303|NCT00385944|7211940|FG002|STARTED|Loading Dose||56
6308304|NCT00385944|7211938|FG000|COMPLETED|Loading Dose||0
6308305|NCT00385944|7211939|FG001|COMPLETED|Loading Dose||0
6308306|NCT00385944|7211940|FG002|COMPLETED|Loading Dose||56
6308307|NCT00385944|7211938|FG000|NOT COMPLETED|Loading Dose||0
6308308|NCT00385944|7211939|FG001|NOT COMPLETED|Loading Dose||0
6308309|NCT00385944|7211940|FG002|NOT COMPLETED|Loading Dose||0
6308310|NCT00385944|7211938|FG000|STARTED|1st Maintenance Dose Period||29
6308311|NCT00385944|7211939|FG001|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
6308312|NCT00385944|7211940|FG002|STARTED|1st Maintenance Dose Period||0
6308313|NCT00385944|7211938|FG000|COMPLETED|1st Maintenance Dose Period||25
6308314|NCT00385944|7211939|FG001|COMPLETED|1st Maintenance Dose Period||24
6308315|NCT00385944|7211940|FG002|COMPLETED|1st Maintenance Dose Period||0
6308316|NCT00385944|7211938|FG000|NOT COMPLETED|1st Maintenance Dose Period||4
6308317|NCT00385944|7211939|FG001|NOT COMPLETED|1st Maintenance Dose Period||1
6308318|NCT00385944|7211940|FG002|NOT COMPLETED|1st Maintenance Dose Period||0
6308319|NCT00385944|7211938|FG000|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
6308320|NCT00385944|7211939|FG001|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
6308321|NCT00385944|7211940|FG002|STARTED|2nd Maintenance Dose Period||0
6773439|NCT03987620|7701097|FG000|Completed the TOC Visit|Overall Study||250
6773440|NCT03987620|7701098|FG001|Completed the TOC Visit|Overall Study||106
6773441|NCT03987620|7701097|FG000|Withdrawn At or After the TOC Visit|Overall Study||4
6773442|NCT03987620|7701098|FG001|Withdrawn At or After the TOC Visit|Overall Study||4
6308322|NCT00385944|7211938|FG000|COMPLETED|2nd Maintenance Dose Period||22
6308323|NCT00385944|7211939|FG001|COMPLETED|2nd Maintenance Dose Period||19
6308324|NCT00385944|7211940|FG002|COMPLETED|2nd Maintenance Dose Period||0
6308325|NCT00385944|7211938|FG000|NOT COMPLETED|2nd Maintenance Dose Period||2
6308326|NCT00385944|7211939|FG001|NOT COMPLETED|2nd Maintenance Dose Period||3
6308327|NCT00385944|7211940|FG002|NOT COMPLETED|2nd Maintenance Dose Period||0
6308328|NCT00385996|7211955|FG000|STARTED|Overall Study||22
6308329|NCT00385996|7211955|FG000|COMPLETED|Overall Study||22
6308330|NCT00385996|7211955|FG000|NOT COMPLETED|Overall Study||0
6308331|NCT00386009|7211962|FG000|STARTED|Overall Study||101
6308332|NCT00386009|7211963|FG001|STARTED|Overall Study||99
6308333|NCT00386009|7211962|FG000|COMPLETED|Overall Study||92
6308334|NCT00386009|7211963|FG001|COMPLETED|Overall Study||89
6308335|NCT00386009|7211962|FG000|NOT COMPLETED|Overall Study||9
6308336|NCT00386009|7211963|FG001|NOT COMPLETED|Overall Study||10
6308337|NCT00386022|7211971|FG000|STARTED|Baseline||10
6308338|NCT00386022|7211972|FG001|STARTED|Baseline||9
6308339|NCT00386022|7211971|FG000|All Doses of GnRH|Baseline||10
6308340|NCT00386022|7211972|FG001|All Doses of GnRH|Baseline||9
6308341|NCT00386022|7211971|FG000|COMPLETED|Baseline||10
6308342|NCT00386022|7211972|FG001|COMPLETED|Baseline||9
6308343|NCT00386022|7211971|FG000|NOT COMPLETED|Baseline||0
6308344|NCT00386022|7211972|FG001|NOT COMPLETED|Baseline||0
6308345|NCT00386022|7211971|FG000|STARTED|Plus Estrogen||10
6308346|NCT00386022|7211972|FG001|STARTED|Plus Estrogen||9
6308347|NCT00386022|7211971|FG000|Estrogen Patch|Plus Estrogen||8
6308348|NCT00386022|7211972|FG001|Estrogen Patch|Plus Estrogen||9
6308349|NCT00386022|7211971|FG000|All Doses GnRH|Plus Estrogen||8
6308350|NCT00386022|7211972|FG001|All Doses GnRH|Plus Estrogen||8
6308351|NCT00386022|7211971|FG000|COMPLETED|Plus Estrogen||8
6308352|NCT00386022|7211972|FG001|COMPLETED|Plus Estrogen||8
6308353|NCT00386022|7211971|FG000|NOT COMPLETED|Plus Estrogen||2
6308354|NCT00386022|7211972|FG001|NOT COMPLETED|Plus Estrogen||1
6308355|NCT00386100|7211982|FG000|STARTED|Overall Study||340
6308356|NCT00386100|7211983|FG001|STARTED|Overall Study||348
6308357|NCT00386100|7211982|FG000|COMPLETED|Overall Study||186
6308358|NCT00386100|7211983|FG001|COMPLETED|Overall Study||217
6308359|NCT00386100|7211982|FG000|NOT COMPLETED|Overall Study||154
6308360|NCT00386100|7211983|FG001|NOT COMPLETED|Overall Study||131
6308361|NCT00386152|7211992|FG000|STARTED|Overall Study|number of subjects treated|75
6308362|NCT00386152|7211993|FG001|STARTED|Overall Study|number of subjects treated|77
6308363|NCT00386152|7211994|FG002|STARTED|Overall Study|number of subjects treated|75
6308364|NCT00386152|7211992|FG000|COMPLETED|Overall Study||31
6308365|NCT00386152|7211993|FG001|COMPLETED|Overall Study||37
6308366|NCT00386152|7211994|FG002|COMPLETED|Overall Study||42
6308367|NCT00386152|7211992|FG000|NOT COMPLETED|Overall Study||44
6308368|NCT00386152|7211993|FG001|NOT COMPLETED|Overall Study||40
6308369|NCT00386152|7211994|FG002|NOT COMPLETED|Overall Study||33
6308370|NCT00386243|7212004|FG000|STARTED|Overall Study||121
6308371|NCT00386243|7212005|FG001|STARTED|Overall Study||121
6308372|NCT00386243|7212004|FG000|COMPLETED|Overall Study||114
6308373|NCT00386243|7212005|FG001|COMPLETED|Overall Study||108
6308374|NCT00386243|7212004|FG000|NOT COMPLETED|Overall Study||7
6308375|NCT00386243|7212005|FG001|NOT COMPLETED|Overall Study||13
6308376|NCT00386256|7212015|FG000|STARTED|Overall Study||16
6308377|NCT00386256|7212016|FG001|STARTED|Overall Study||15
6308378|NCT00386256|7212017|FG002|STARTED|Overall Study||4
6308379|NCT00386256|7212018|FG003|STARTED|Overall Study||3
6308380|NCT00386256|7212015|FG000|COMPLETED|Overall Study||16
6308381|NCT00386256|7212016|FG001|COMPLETED|Overall Study||15
6308382|NCT00386256|7212017|FG002|COMPLETED|Overall Study||4
6308383|NCT00386256|7212018|FG003|COMPLETED|Overall Study||3
6308384|NCT00386256|7212015|FG000|NOT COMPLETED|Overall Study||0
6308385|NCT00386256|7212016|FG001|NOT COMPLETED|Overall Study||0
6308386|NCT00386256|7212017|FG002|NOT COMPLETED|Overall Study||0
6308387|NCT00386256|7212018|FG003|NOT COMPLETED|Overall Study||0
6308388|NCT00386308|7212030|FG000|STARTED|Overall Study||123
6308389|NCT00386308|7212031|FG001|STARTED|Overall Study||73
6308390|NCT00386308|7212030|FG000|Intent to Treat Population|Overall Study||117
6308391|NCT00386308|7212031|FG001|Intent to Treat Population|Overall Study||72
6308392|NCT00386308|7212030|FG000|Modified Intent to Treat Population|Overall Study||115
6308393|NCT00386308|7212031|FG001|Modified Intent to Treat Population|Overall Study||72
6308394|NCT00386308|7212030|FG000|COMPLETED|Overall Study||94
6308395|NCT00386308|7212031|FG001|COMPLETED|Overall Study||54
6308396|NCT00386308|7212030|FG000|NOT COMPLETED|Overall Study||29
6308397|NCT00386308|7212031|FG001|NOT COMPLETED|Overall Study||19
6308398|NCT00386334|7212039|FG000|STARTED|Double Blind Period||194
6308399|NCT00386334|7212040|FG001|STARTED|Double Blind Period||194
6308400|NCT00386334|7212039|FG000|COMPLETED|Double Blind Period||148
6308401|NCT00386334|7212040|FG001|COMPLETED|Double Blind Period||147
6308402|NCT00386334|7212039|FG000|NOT COMPLETED|Double Blind Period||46
6308403|NCT00386334|7212040|FG001|NOT COMPLETED|Double Blind Period||47
6308404|NCT00386334|7212039|FG000|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
6308405|NCT00386334|7212040|FG001|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
6308406|NCT00386334|7212039|FG000|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
6308407|NCT00386334|7212040|FG001|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
6308408|NCT00386334|7212039|FG000|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
6308409|NCT00386334|7212040|FG001|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
6308410|NCT00386360|7212048|FG000|STARTED|Overall Study||49
6308411|NCT00386360|7212049|FG001|STARTED|Overall Study||112
6308412|NCT00386360|7212048|FG000|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
6308413|NCT00386360|7212049|FG001|Intent to Treat Population (ITT)|Overall Study||110
6308414|NCT00386360|7212048|FG000|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
6308415|NCT00386360|7212049|FG001|Primary Efficacy|Overall Study||77
6308416|NCT00386360|7212048|FG000|COMPLETED|Overall Study||40
6308417|NCT00386360|7212049|FG001|COMPLETED|Overall Study||95
6308418|NCT00386360|7212048|FG000|NOT COMPLETED|Overall Study||9
6308419|NCT00386360|7212049|FG001|NOT COMPLETED|Overall Study||17
6308420|NCT00386425|7212058|FG000|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
6308421|NCT00386425|7212059|FG001|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
6308422|NCT00386425|7212060|FG002|STARTED|Overall Study||53
6308423|NCT00386425|7212058|FG000|Received Study Drug|Overall Study||227
6308424|NCT00386425|7212059|FG001|Received Study Drug|Overall Study||206
6308425|NCT00386425|7212060|FG002|Received Study Drug|Overall Study||53
6308426|NCT00386425|7212058|FG000|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
6308427|NCT00386425|7212059|FG001|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
6308428|NCT00386425|7212060|FG002|COMPLETED|Overall Study||53
6308429|NCT00386425|7212058|FG000|NOT COMPLETED|Overall Study||3
6308430|NCT00386425|7212059|FG001|NOT COMPLETED|Overall Study||1
6308431|NCT00386425|7212060|FG002|NOT COMPLETED|Overall Study||0
6308432|NCT00386477|7212074|FG000|STARTED|Overall Study||155
6308433|NCT00386477|7212075|FG001|STARTED|Overall Study||145
6308434|NCT00386477|7212074|FG000|COMPLETED|Overall Study||155
6308435|NCT00386477|7212075|FG001|COMPLETED|Overall Study||145
6308436|NCT00386477|7212074|FG000|NOT COMPLETED|Overall Study||0
6308437|NCT00386477|7212075|FG001|NOT COMPLETED|Overall Study||0
6308438|NCT00386607|7212081|FG000|STARTED|Core||601
6308439|NCT00386607|7212082|FG001|STARTED|Core||0
6308440|NCT00386607|7212081|FG000|COMPLETED|Core||486
6308441|NCT00386607|7212082|FG001|COMPLETED|Core||0
6308442|NCT00386607|7212081|FG000|NOT COMPLETED|Core||115
6308443|NCT00386607|7212082|FG001|NOT COMPLETED|Core||0
6308444|NCT00386607|7212081|FG000|STARTED|Extension||0
6308445|NCT00386607|7212082|FG001|STARTED|Extension||162
6308446|NCT00386607|7212081|FG000|COMPLETED|Extension||0
6308447|NCT00386607|7212082|FG001|COMPLETED|Extension||145
6308448|NCT00386607|7212081|FG000|NOT COMPLETED|Extension||0
6308449|NCT00386607|7212082|FG001|NOT COMPLETED|Extension||17
6308450|NCT00386776|7212094|FG000|STARTED|Overall Study||40
6308451|NCT00386776|7212094|FG000|COMPLETED|Overall Study||32
6308452|NCT00386776|7212094|FG000|NOT COMPLETED|Overall Study||8
6308453|NCT00386880|7212100|FG000|STARTED|Overall Study||30
6308454|NCT00386880|7212101|FG001|STARTED|Overall Study||8
6308455|NCT00386880|7212100|FG000|COMPLETED|Overall Study||30
6308456|NCT00386880|7212101|FG001|COMPLETED|Overall Study||8
6308457|NCT00386880|7212100|FG000|NOT COMPLETED|Overall Study||0
6308458|NCT00386880|7212101|FG001|NOT COMPLETED|Overall Study||0
6308459|NCT00387010|7212106|FG000|STARTED|Dose Titration Period||218
6308460|NCT00387010|7212106|FG000|COMPLETED|Dose Titration Period||180
6308461|NCT00387010|7212106|FG000|NOT COMPLETED|Dose Titration Period||38
6308462|NCT00387010|7212106|FG000|STARTED|Treatment Period||180
6308463|NCT00387010|7212106|FG000|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
6308464|NCT00387010|7212106|FG000|COMPLETED|Treatment Period||169
6308465|NCT00387010|7212106|FG000|NOT COMPLETED|Treatment Period||11
6308466|NCT00387023|7212110|FG000|STARTED|Overall Study||12
6308467|NCT00387023|7212110|FG000|COMPLETED|Overall Study||12
6557398|NCT01767506|7479945|FG000|STARTED|Overall Study|"26 communities were randomized to intervention group~The study was conducted at the community level."|
6557399|NCT01767506|7479946|FG001|STARTED|Overall Study|"26 communities were randomized to control group~The study was conducted at the community level."|
6557400|NCT01767506|7479945|FG000|COMPLETED|Overall Study|The study was conducted at the community level.|
6308468|NCT00387023|7212110|FG000|NOT COMPLETED|Overall Study||0
6308469|NCT00387036|7212114|FG000|STARTED|2-Week First Intervention||6
6308470|NCT00387036|7212115|FG001|STARTED|2-Week First Intervention||6
6308471|NCT00387036|7212114|FG000|COMPLETED|2-Week First Intervention||6
6308472|NCT00387036|7212115|FG001|COMPLETED|2-Week First Intervention||6
6308473|NCT00387036|7212114|FG000|NOT COMPLETED|2-Week First Intervention||0
6308474|NCT00387036|7212115|FG001|NOT COMPLETED|2-Week First Intervention||0
6308475|NCT00387036|7212114|FG000|STARTED|2-Week Placebo Washout||6
6308476|NCT00387036|7212115|FG001|STARTED|2-Week Placebo Washout||6
6308477|NCT00387036|7212114|FG000|COMPLETED|2-Week Placebo Washout||6
6308478|NCT00387036|7212115|FG001|COMPLETED|2-Week Placebo Washout||6
6308479|NCT00387036|7212114|FG000|NOT COMPLETED|2-Week Placebo Washout||0
6308480|NCT00387036|7212115|FG001|NOT COMPLETED|2-Week Placebo Washout||0
6308481|NCT00387036|7212114|FG000|STARTED|2-Week Crossover Second Intervention||6
6308482|NCT00387036|7212115|FG001|STARTED|2-Week Crossover Second Intervention||6
6308483|NCT00387036|7212114|FG000|COMPLETED|2-Week Crossover Second Intervention||6
6308484|NCT00387036|7212115|FG001|COMPLETED|2-Week Crossover Second Intervention||6
6308485|NCT00387036|7212114|FG000|NOT COMPLETED|2-Week Crossover Second Intervention||0
6308486|NCT00387036|7212115|FG001|NOT COMPLETED|2-Week Crossover Second Intervention||0
6308487|NCT00387088|7212123|FG000|STARTED|Overall Study||1989
6308488|NCT00387088|7212124|FG001|STARTED|Overall Study||2002
6308489|NCT00387088|7212123|FG000|COMPLETED|Overall Study||1671
6308490|NCT00387088|7212124|FG001|COMPLETED|Overall Study||1629
6308491|NCT00387088|7212123|FG000|NOT COMPLETED|Overall Study||318
6308492|NCT00387088|7212124|FG001|NOT COMPLETED|Overall Study||373
6308493|NCT00387127|7212132|FG000|STARTED|Overall Study||33
6308494|NCT00387127|7212133|FG001|STARTED|Overall Study||34
6308495|NCT00387127|7212132|FG000|COMPLETED|Overall Study||0
6308496|NCT00387127|7212133|FG001|COMPLETED|Overall Study||0
6308497|NCT00387127|7212132|FG000|NOT COMPLETED|Overall Study||33
6308498|NCT00387127|7212133|FG001|NOT COMPLETED|Overall Study||34
6308499|NCT00387153|7212141|FG000|STARTED|Overall Study||8
6308500|NCT00387153|7212141|FG000|COMPLETED|Overall Study||0
6308501|NCT00387153|7212141|FG000|NOT COMPLETED|Overall Study||8
6308502|NCT00387335|7212147|FG000|STARTED|Overall Study||15
6308503|NCT00387335|7212148|FG001|STARTED|Overall Study||7
6308504|NCT00387335|7212147|FG000|COMPLETED|Overall Study||15
6308505|NCT00387335|7212148|FG001|COMPLETED|Overall Study||7
6308506|NCT00387335|7212147|FG000|NOT COMPLETED|Overall Study||0
6308507|NCT00387335|7212148|FG001|NOT COMPLETED|Overall Study||0
6557401|NCT01767506|7479946|FG001|COMPLETED|Overall Study|The study was conducted at the community level.|
6557402|NCT01767506|7479945|FG000|NOT COMPLETED|Overall Study||
6557403|NCT01767506|7479946|FG001|NOT COMPLETED|Overall Study||
6557404|NCT01767519|7479955|FG000|STARTED|Overall Study||145
6557405|NCT01767519|7479956|FG001|STARTED|Overall Study||151
6557406|NCT01767519|7479957|FG002|STARTED|Overall Study||60
6557407|NCT01767519|7479955|FG000|COMPLETED|Overall Study||131
6557408|NCT01767519|7479956|FG001|COMPLETED|Overall Study||138
6557409|NCT01767519|7479957|FG002|COMPLETED|Overall Study||55
6557410|NCT01767519|7479955|FG000|NOT COMPLETED|Overall Study||14
6557411|NCT01767519|7479956|FG001|NOT COMPLETED|Overall Study||13
6557412|NCT01767519|7479957|FG002|NOT COMPLETED|Overall Study||5
6557413|NCT01767597|7479967|FG000|STARTED|Overall Study||500
6557414|NCT01767597|7479968|FG001|STARTED|Overall Study||500
6557415|NCT01767597|7479967|FG000|COMPLETED|Overall Study||496
6557416|NCT01767597|7479968|FG001|COMPLETED|Overall Study||499
6557417|NCT01767597|7479967|FG000|NOT COMPLETED|Overall Study||4
6557418|NCT01767597|7479968|FG001|NOT COMPLETED|Overall Study||1
6557419|NCT01767636|7479974|FG000|STARTED|Overall Study||38
6557420|NCT01767636|7479974|FG000|COMPLETED|Overall Study||35
6557421|NCT01767636|7479974|FG000|NOT COMPLETED|Overall Study||3
6557422|NCT01767688|7479980|FG000|STARTED|Overall Study||8
6557423|NCT01767688|7479981|FG001|STARTED|Overall Study||8
6557424|NCT01767688|7479980|FG000|COMPLETED|Overall Study||8
6557425|NCT01767688|7479981|FG001|COMPLETED|Overall Study||8
6557426|NCT01767688|7479980|FG000|NOT COMPLETED|Overall Study||0
6557427|NCT01767688|7479981|FG001|NOT COMPLETED|Overall Study||0
6557428|NCT01767701|7479987|FG000|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
6557429|NCT01767701|7479987|FG000|COMPLETED|Overall Study||20
6557430|NCT01767701|7479987|FG000|NOT COMPLETED|Overall Study||0
6557431|NCT01767792|7479992|FG000|STARTED|Overall Study||22
6557432|NCT01767792|7479992|FG000|COMPLETED|Overall Study||20
6557433|NCT01767792|7479992|FG000|NOT COMPLETED|Overall Study||2
6557434|NCT01767857|7479999|FG000|STARTED|Overall Study||430
6557435|NCT01767857|7480000|FG001|STARTED|Overall Study||213
6557436|NCT01767857|7479999|FG000|Treated|Overall Study||411
6557437|NCT01767857|7480000|FG001|Treated|Overall Study||200
6557438|NCT01767857|7479999|FG000|COMPLETED|Overall Study||0
6557439|NCT01767857|7480000|FG001|COMPLETED|Overall Study||0
6557440|NCT01767857|7479999|FG000|NOT COMPLETED|Overall Study||430
6557441|NCT01767857|7480000|FG001|NOT COMPLETED|Overall Study||213
6557442|NCT01767909|7480009|FG000|STARTED|Overall Study||121
6557443|NCT01767909|7480010|FG001|STARTED|Overall Study||119
6557444|NCT01767909|7480009|FG000|COMPLETED|Overall Study||108
6557445|NCT01767909|7480010|FG001|COMPLETED|Overall Study||107
6308508|NCT00387348|7212157|FG000|STARTED|Overall Study||8
6308509|NCT00387348|7212158|FG001|STARTED|Overall Study||5
6308510|NCT00387348|7212159|FG002|STARTED|Overall Study||11
6308511|NCT00387348|7212157|FG000|COMPLETED|Overall Study||5
6557446|NCT01767909|7480009|FG000|NOT COMPLETED|Overall Study||13
6557447|NCT01767909|7480010|FG001|NOT COMPLETED|Overall Study||12
6557448|NCT01767935|7480018|FG000|STARTED|Overall Study||1
6557449|NCT01767935|7480018|FG000|COMPLETED|Overall Study||1
6557450|NCT01767935|7480018|FG000|NOT COMPLETED|Overall Study||0
6557451|NCT01767987|7480024|FG000|STARTED|Overall Study||4
6557452|NCT01767987|7480025|FG001|STARTED|Overall Study||2
6308512|NCT00387348|7212158|FG001|COMPLETED|Overall Study||2
6308513|NCT00387348|7212159|FG002|COMPLETED|Overall Study||7
6308514|NCT00387348|7212157|FG000|NOT COMPLETED|Overall Study||3
6308515|NCT00387348|7212158|FG001|NOT COMPLETED|Overall Study||3
6308516|NCT00387348|7212159|FG002|NOT COMPLETED|Overall Study||4
6308517|NCT00387426|7212172|FG000|STARTED|Overall Study||14
6308518|NCT00387426|7212172|FG000|COMPLETED|Overall Study||0
6308519|NCT00387426|7212172|FG000|NOT COMPLETED|Overall Study||14
6308520|NCT00387465|7212179|FG000|STARTED|Overall Study||3
6308521|NCT00387465|7212180|FG001|STARTED|Overall Study||7
6308522|NCT00387465|7212181|FG002|STARTED|Overall Study||35
6308523|NCT00387465|7212179|FG000|COMPLETED|Overall Study||3
6308524|NCT00387465|7212180|FG001|COMPLETED|Overall Study||6
6308525|NCT00387465|7212181|FG002|COMPLETED|Overall Study||35
6308526|NCT00387465|7212179|FG000|NOT COMPLETED|Overall Study||0
6308527|NCT00387465|7212180|FG001|NOT COMPLETED|Overall Study||1
6308528|NCT00387465|7212181|FG002|NOT COMPLETED|Overall Study||0
6308529|NCT00387621|7212192|FG000|STARTED|First Intervention||29
6308530|NCT00387621|7212193|FG001|STARTED|First Intervention||29
6308531|NCT00387621|7212192|FG000|COMPLETED|First Intervention||29
6308532|NCT00387621|7212193|FG001|COMPLETED|First Intervention||29
6308533|NCT00387621|7212192|FG000|NOT COMPLETED|First Intervention||0
6308534|NCT00387621|7212193|FG001|NOT COMPLETED|First Intervention||0
6308535|NCT00387621|7212192|FG000|STARTED|Washout Period of 2 Weeks||29
6308536|NCT00387621|7212193|FG001|STARTED|Washout Period of 2 Weeks||29
6308537|NCT00387621|7212192|FG000|COMPLETED|Washout Period of 2 Weeks||29
6308538|NCT00387621|7212193|FG001|COMPLETED|Washout Period of 2 Weeks||29
6308539|NCT00387621|7212192|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6308540|NCT00387621|7212193|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6308541|NCT00387621|7212192|FG000|STARTED|Second Intervention||29
6308542|NCT00387621|7212193|FG001|STARTED|Second Intervention||29
6308543|NCT00387621|7212192|FG000|COMPLETED|Second Intervention||29
6308544|NCT00387621|7212193|FG001|COMPLETED|Second Intervention||29
6308545|NCT00387621|7212192|FG000|NOT COMPLETED|Second Intervention||0
6308546|NCT00387621|7212193|FG001|NOT COMPLETED|Second Intervention||0
6308547|NCT00387647|7212205|FG000|STARTED|Overall Study||24
6308548|NCT00387647|7212205|FG000|COMPLETED|Overall Study||6
6308549|NCT00387647|7212205|FG000|NOT COMPLETED|Overall Study||18
6308550|NCT00387660|7212211|FG000|STARTED|Overall Study||40
6308551|NCT00387660|7212212|FG001|STARTED|Overall Study||40
6308552|NCT00387660|7212211|FG000|COMPLETED|Overall Study||40
6308553|NCT00387660|7212212|FG001|COMPLETED|Overall Study||40
6308554|NCT00387660|7212211|FG000|NOT COMPLETED|Overall Study||0
6308555|NCT00387660|7212212|FG001|NOT COMPLETED|Overall Study||0
6308556|NCT00387712|7212220|FG000|STARTED|Overall Study||47
6308557|NCT00387712|7212221|FG001|STARTED|Overall Study||52
6308558|NCT00387712|7212220|FG000|COMPLETED|Overall Study||18
6308559|NCT00387712|7212221|FG001|COMPLETED|Overall Study||16
6308560|NCT00387712|7212220|FG000|NOT COMPLETED|Overall Study||29
6308561|NCT00387712|7212221|FG001|NOT COMPLETED|Overall Study||36
6308562|NCT00387725|7212231|FG000|STARTED|Overall Study||21
6308563|NCT00387725|7212232|FG001|STARTED|Overall Study||16
6308564|NCT00387725|7212233|FG002|STARTED|Overall Study||45
6308565|NCT00387725|7212234|FG003|STARTED|Overall Study||45
6308566|NCT00387725|7212231|FG000|COMPLETED|Overall Study||20
6308567|NCT00387725|7212232|FG001|COMPLETED|Overall Study||15
6308568|NCT00387725|7212233|FG002|COMPLETED|Overall Study||43
6308569|NCT00387725|7212234|FG003|COMPLETED|Overall Study||43
6308570|NCT00387725|7212231|FG000|NOT COMPLETED|Overall Study||1
6308571|NCT00387725|7212232|FG001|NOT COMPLETED|Overall Study||1
6308572|NCT00387725|7212233|FG002|NOT COMPLETED|Overall Study||2
6308573|NCT00387725|7212234|FG003|NOT COMPLETED|Overall Study||2
6375075|NCT00753714|7285668|FG001|COMPLETED|Overall Study||1
6375076|NCT00753714|7285667|FG000|NOT COMPLETED|Overall Study||60
6375077|NCT00753714|7285668|FG001|NOT COMPLETED|Overall Study||62
6375078|NCT00753766|7285679|FG000|STARTED|Overall Study||1
6375079|NCT00753766|7285680|FG001|STARTED|Overall Study||0
6375080|NCT00753766|7285679|FG000|COMPLETED|Overall Study||0
6375081|NCT00753766|7285680|FG001|COMPLETED|Overall Study||0
6375082|NCT00753766|7285679|FG000|NOT COMPLETED|Overall Study||1
6375083|NCT00753766|7285680|FG001|NOT COMPLETED|Overall Study||0
6375084|NCT00753896|7285687|FG000|STARTED|Overall Study||134
6375085|NCT00753896|7285687|FG000|COMPLETED|Overall Study||118
6557453|NCT01767987|7480024|FG000|COMPLETED|Overall Study||0
6557454|NCT01767987|7480025|FG001|COMPLETED|Overall Study||1
6557455|NCT01767987|7480024|FG000|NOT COMPLETED|Overall Study||4
6375086|NCT00753896|7285687|FG000|NOT COMPLETED|Overall Study||16
6375087|NCT00753922|7285695|FG000|STARTED|Overall Study||552
6375088|NCT00753922|7285696|FG001|STARTED|Overall Study||251
6375089|NCT00753922|7285697|FG002|STARTED|Overall Study||145
6375090|NCT00753922|7285698|FG003|STARTED|Overall Study||60
6375091|NCT00753922|7285695|FG000|COMPLETED|Overall Study||306
6375092|NCT00753922|7285696|FG001|COMPLETED|Overall Study||157
6375093|NCT00753922|7285697|FG002|COMPLETED|Overall Study||82
6375094|NCT00753922|7285698|FG003|COMPLETED|Overall Study||37
6308574|NCT00387751|7212244|FG000|STARTED|Overall Study||14
6308575|NCT00387751|7212244|FG000|COMPLETED|Overall Study||14
6308576|NCT00387751|7212244|FG000|NOT COMPLETED|Overall Study||0
6308577|NCT00387764|7212250|FG000|STARTED|Overall Study||80
6308578|NCT00387764|7212250|FG000|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
6308579|NCT00387764|7212250|FG000|NOT COMPLETED|Overall Study||31
6308580|NCT00387790|7212254|FG000|STARTED|Overall Study||64
6308581|NCT00387790|7212254|FG000|COMPLETED|Overall Study||50
6308582|NCT00387790|7212254|FG000|NOT COMPLETED|Overall Study||14
6308583|NCT00387829|7212260|FG000|STARTED|Safety Population||178
6308584|NCT00387829|7212261|FG001|STARTED|Safety Population||169
6308585|NCT00387829|7212260|FG000|COMPLETED|Safety Population||139
6308586|NCT00387829|7212261|FG001|COMPLETED|Safety Population||136
6308587|NCT00387829|7212260|FG000|NOT COMPLETED|Safety Population||39
6308588|NCT00387829|7212261|FG001|NOT COMPLETED|Safety Population||33
6308589|NCT00387829|7212260|FG000|STARTED|Intent-to-treat Population||177
6308590|NCT00387829|7212261|FG001|STARTED|Intent-to-treat Population||166
6308591|NCT00387829|7212260|FG000|COMPLETED|Intent-to-treat Population||139
6308592|NCT00387829|7212261|FG001|COMPLETED|Intent-to-treat Population||136
6308593|NCT00387829|7212260|FG000|NOT COMPLETED|Intent-to-treat Population||38
6308594|NCT00387829|7212261|FG001|NOT COMPLETED|Intent-to-treat Population||30
6308595|NCT00387881|7212269|FG000|STARTED|Overall Study||334
6308596|NCT00387881|7212270|FG001|STARTED|Overall Study||345
6308597|NCT00387881|7212269|FG000|COMPLETED|Overall Study||245
6308598|NCT00387881|7212270|FG001|COMPLETED|Overall Study||243
6308599|NCT00387881|7212269|FG000|NOT COMPLETED|Overall Study||89
6308600|NCT00387881|7212270|FG001|NOT COMPLETED|Overall Study||102
6308601|NCT00387894|7212276|FG000|STARTED|Overall Study||6
6308602|NCT00387894|7212276|FG000|COMPLETED|Overall Study||5
6308603|NCT00387894|7212276|FG000|NOT COMPLETED|Overall Study||1
6308604|NCT00387959|7212280|FG000|STARTED|Overall Study||17
6308605|NCT00387959|7212280|FG000|COMPLETED|Overall Study||16
6308606|NCT00387959|7212280|FG000|NOT COMPLETED|Overall Study||1
6308607|NCT00388037|7212284|FG000|STARTED|Overall Study||31
6308608|NCT00388037|7212284|FG000|COMPLETED|Overall Study||30
6308609|NCT00388037|7212284|FG000|NOT COMPLETED|Overall Study||1
6308610|NCT00388154|7212288|FG000|STARTED|Overall Study||21
6308611|NCT00388154|7212288|FG000|COMPLETED|Overall Study||20
6308612|NCT00388154|7212288|FG000|NOT COMPLETED|Overall Study||1
6308613|NCT00388297|7212296|FG000|STARTED|Overall Study||339
6308614|NCT00388297|7212297|FG001|STARTED|Overall Study||338
6308615|NCT00388297|7212298|FG002|STARTED|Overall Study||265
6308616|NCT00388297|7212299|FG003|STARTED|Overall Study||261
6308617|NCT00388297|7212296|FG000|COMPLETED|Overall Study||323
6308618|NCT00388297|7212297|FG001|COMPLETED|Overall Study||326
6308619|NCT00388297|7212298|FG002|COMPLETED|Overall Study||254
6308620|NCT00388297|7212299|FG003|COMPLETED|Overall Study||253
6308621|NCT00388297|7212296|FG000|NOT COMPLETED|Overall Study||16
6308622|NCT00388297|7212297|FG001|NOT COMPLETED|Overall Study||12
6308623|NCT00388297|7212298|FG002|NOT COMPLETED|Overall Study||11
6308624|NCT00388297|7212299|FG003|NOT COMPLETED|Overall Study||8
6308625|NCT00388349|7212309|FG000|STARTED|Phase I Dose Escalation||3
6308626|NCT00388349|7212310|FG001|STARTED|Phase I Dose Escalation||4
6308627|NCT00388349|7212309|FG000|COMPLETED|Phase I Dose Escalation||3
6308628|NCT00388349|7212310|FG001|COMPLETED|Phase I Dose Escalation||1
6308629|NCT00388349|7212309|FG000|NOT COMPLETED|Phase I Dose Escalation||0
6308630|NCT00388349|7212310|FG001|NOT COMPLETED|Phase I Dose Escalation||3
6308631|NCT00388349|7212309|FG000|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
6308632|NCT00388349|7212310|FG001|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
6308633|NCT00388349|7212309|FG000|COMPLETED|Phase 2 Dose Expansion||139
6308634|NCT00388349|7212310|FG001|COMPLETED|Phase 2 Dose Expansion||0
6308635|NCT00388349|7212309|FG000|NOT COMPLETED|Phase 2 Dose Expansion||0
6308636|NCT00388349|7212310|FG001|NOT COMPLETED|Phase 2 Dose Expansion||0
6308637|NCT00388362|7212318|FG000|STARTED|Enrolled||36
6308638|NCT00388362|7212318|FG000|COMPLETED|Enrolled||23
6308639|NCT00388362|7212318|FG000|NOT COMPLETED|Enrolled||13
6308640|NCT00388362|7212318|FG000|STARTED|Remained on Study Median of 514 Days||23
6308641|NCT00388362|7212318|FG000|COMPLETED|Remained on Study Median of 514 Days||21
6308642|NCT00388362|7212318|FG000|NOT COMPLETED|Remained on Study Median of 514 Days||2
6308643|NCT00388414|7212324|FG000|STARTED|First Intervention (8 Weeks)||7
6308644|NCT00388414|7212325|FG001|STARTED|First Intervention (8 Weeks)||7
6308645|NCT00388414|7212324|FG000|COMPLETED|First Intervention (8 Weeks)||7
6308646|NCT00388414|7212325|FG001|COMPLETED|First Intervention (8 Weeks)||7
6308647|NCT00388414|7212324|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
6308648|NCT00388414|7212325|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
6308649|NCT00388414|7212324|FG000|STARTED|Washout (1 Week)||7
6308650|NCT00388414|7212325|FG001|STARTED|Washout (1 Week)||7
6308651|NCT00388414|7212324|FG000|COMPLETED|Washout (1 Week)||7
6308652|NCT00388414|7212325|FG001|COMPLETED|Washout (1 Week)||7
6308653|NCT00388414|7212324|FG000|NOT COMPLETED|Washout (1 Week)||0
6308654|NCT00388414|7212325|FG001|NOT COMPLETED|Washout (1 Week)||0
6308655|NCT00388414|7212324|FG000|STARTED|Second Intervention (8 Weeks)||7
6308656|NCT00388414|7212325|FG001|STARTED|Second Intervention (8 Weeks)||7
6308657|NCT00388414|7212324|FG000|COMPLETED|Second Intervention (8 Weeks)||7
6308658|NCT00388414|7212325|FG001|COMPLETED|Second Intervention (8 Weeks)||7
6308659|NCT00388414|7212324|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
6308660|NCT00388414|7212325|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
6308661|NCT00388453|7212336|FG000|STARTED|Overall Study||20
6308662|NCT00388453|7212337|FG001|STARTED|Overall Study||17
6308663|NCT00388453|7212338|FG002|STARTED|Overall Study||10
6308664|NCT00388453|7212336|FG000|COMPLETED|Overall Study||20
6308665|NCT00388453|7212337|FG001|COMPLETED|Overall Study||17
6308666|NCT00388453|7212338|FG002|COMPLETED|Overall Study||10
6308667|NCT00388453|7212336|FG000|NOT COMPLETED|Overall Study||0
6308668|NCT00388453|7212337|FG001|NOT COMPLETED|Overall Study||0
6308669|NCT00388453|7212338|FG002|NOT COMPLETED|Overall Study||0
6308670|NCT00388505|7212348|FG000|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
6308671|NCT00388505|7212349|FG001|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
6308672|NCT00388505|7212348|FG000|COMPLETED|Overall Study||225
6308673|NCT00388505|7212349|FG001|COMPLETED|Overall Study||171
6308674|NCT00388505|7212348|FG000|NOT COMPLETED|Overall Study||83
6308675|NCT00388505|7212349|FG001|NOT COMPLETED|Overall Study||38
6308676|NCT00388583|7212357|FG000|STARTED|Overall Study||407
6308677|NCT00388583|7212358|FG001|STARTED|Overall Study||410
6308678|NCT00388583|7212357|FG000|COMPLETED|Overall Study||401
6308679|NCT00388583|7212358|FG001|COMPLETED|Overall Study||406
6308680|NCT00388583|7212357|FG000|NOT COMPLETED|Overall Study||6
6308681|NCT00388583|7212358|FG001|NOT COMPLETED|Overall Study||4
6308682|NCT00388674|7212366|FG000|STARTED|Initial Treatment||6216
6308683|NCT00388674|7212367|FG001|STARTED|Initial Treatment||6162
6308684|NCT00388674|7212366|FG000|COMPLETED|Initial Treatment|Completed=Reason of 'successful treatment', 'other: successful treatment' or 'other: end of study'|4388
6308685|NCT00388674|7212367|FG001|COMPLETED|Initial Treatment|"Completed=discontinued initial treatment reason of successful treatment or end of study"|3576
6308686|NCT00388674|7212366|FG000|NOT COMPLETED|Initial Treatment||1828
6308687|NCT00388674|7212367|FG001|NOT COMPLETED|Initial Treatment||2586
6308688|NCT00388674|7212366|FG000|STARTED|End of Study||6216
6308689|NCT00388674|7212367|FG001|STARTED|End of Study||6162
6308690|NCT00388674|7212366|FG000|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|4482
6308691|NCT00388674|7212367|FG001|COMPLETED|End of Study|Completed=Reason of 'other: end of study'|3993
6308692|NCT00388674|7212366|FG000|NOT COMPLETED|End of Study||1734
6308693|NCT00388674|7212367|FG001|NOT COMPLETED|End of Study||2169
6308694|NCT00388726|7212375|FG000|STARTED|Overall Study||508
6308695|NCT00388726|7212376|FG001|STARTED|Overall Study||254
6308696|NCT00388726|7212375|FG000|COMPLETED|Overall Study||24
6308697|NCT00388726|7212376|FG001|COMPLETED|Overall Study||10
6308698|NCT00388726|7212375|FG000|NOT COMPLETED|Overall Study||484
6308699|NCT00388726|7212376|FG001|NOT COMPLETED|Overall Study||244
6308700|NCT00388804|7212384|FG000|STARTED|Overall Study||17
6308701|NCT00388804|7212385|FG001|STARTED|Overall Study||21
6308702|NCT00388804|7212384|FG000|COMPLETED|Overall Study||17
6308703|NCT00388804|7212385|FG001|COMPLETED|Overall Study||21
6308704|NCT00388804|7212384|FG000|NOT COMPLETED|Overall Study||0
6308705|NCT00388804|7212385|FG001|NOT COMPLETED|Overall Study||0
6308706|NCT00388947|7212391|FG000|STARTED|Overall Study||1590
6308707|NCT00388947|7212391|FG000|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
6308708|NCT00388947|7212391|FG000|NOT COMPLETED|Overall Study||47
6308709|NCT00388973|7212397|FG000|STARTED|Overall Study|Randomized|166
6308710|NCT00388973|7212398|FG001|STARTED|Overall Study|Randomized|172
6308711|NCT00388973|7212397|FG000|Completed Study|Overall Study||110
6308712|NCT00388973|7212398|FG001|Completed Study|Overall Study||114
6308713|NCT00388973|7212397|FG000|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
6308714|NCT00388973|7212398|FG001|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
6308715|NCT00388973|7212397|FG000|NOT COMPLETED|Overall Study||56
6308716|NCT00388973|7212398|FG001|NOT COMPLETED|Overall Study||58
6308717|NCT00389064|7212406|FG000|STARTED|Overall Study||223
6308718|NCT00389064|7212407|FG001|STARTED|Overall Study||227
6308719|NCT00389064|7212406|FG000|COMPLETED|Overall Study||178
6308720|NCT00389064|7212407|FG001|COMPLETED|Overall Study||168
6308721|NCT00389064|7212406|FG000|NOT COMPLETED|Overall Study||45
6308722|NCT00389064|7212407|FG001|NOT COMPLETED|Overall Study||59
6308723|NCT00389168|7212415|FG000|STARTED|Overall Study||56
6308724|NCT00389168|7212416|FG001|STARTED|Overall Study||58
6308725|NCT00389168|7212415|FG000|COMPLETED|Overall Study||47
6308726|NCT00389168|7212416|FG001|COMPLETED|Overall Study||53
6308727|NCT00389168|7212415|FG000|NOT COMPLETED|Overall Study||9
6308728|NCT00389168|7212416|FG001|NOT COMPLETED|Overall Study||5
6308729|NCT00389207|7212425|FG000|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
6308730|NCT00389207|7212426|FG001|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
6308731|NCT00389207|7212427|FG002|STARTED|Overall Study||193
6308732|NCT00389207|7212425|FG000|COMPLETED|Overall Study||125
6308733|NCT00389207|7212426|FG001|COMPLETED|Overall Study||116
6308734|NCT00389207|7212427|FG002|COMPLETED|Overall Study||152
6308735|NCT00389207|7212425|FG000|NOT COMPLETED|Overall Study||63
6308736|NCT00389207|7212426|FG001|NOT COMPLETED|Overall Study||72
6308737|NCT00389207|7212427|FG002|NOT COMPLETED|Overall Study||41
6308738|NCT00389324|7212440|FG000|STARTED|Run-In Phase||21
6308739|NCT00389324|7212440|FG000|COMPLETED|Run-In Phase||18
6308740|NCT00389324|7212440|FG000|NOT COMPLETED|Run-In Phase||3
6308741|NCT00389324|7212440|FG000|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
6308742|NCT00389324|7212440|FG000|COMPLETED|Intravenous Phase||32
6308743|NCT00389324|7212440|FG000|NOT COMPLETED|Intravenous Phase||0
6308744|NCT00389324|7212440|FG000|STARTED|Subcutaneous Phase||32
6308745|NCT00389324|7212440|FG000|COMPLETED|Subcutaneous Phase||25
6308746|NCT00389324|7212440|FG000|NOT COMPLETED|Subcutaneous Phase||7
6308747|NCT00389441|7212447|FG000|STARTED|Overall Study||52
6308748|NCT00389441|7212447|FG000|COMPLETED|Overall Study||0
6308749|NCT00389441|7212447|FG000|NOT COMPLETED|Overall Study||52
6308750|NCT00389467|7212455|FG000|STARTED|Overall Study||34
6308751|NCT00389467|7212456|FG001|STARTED|Overall Study||34
6308752|NCT00389467|7212457|FG002|STARTED|Overall Study||30
6308753|NCT00389467|7212458|FG003|STARTED|Overall Study||20
6308754|NCT00389467|7212455|FG000|COMPLETED|Overall Study||34
6308755|NCT00389467|7212456|FG001|COMPLETED|Overall Study||34
6308756|NCT00389467|7212457|FG002|COMPLETED|Overall Study||30
6308757|NCT00389467|7212458|FG003|COMPLETED|Overall Study||20
6308758|NCT00389467|7212455|FG000|NOT COMPLETED|Overall Study||0
6308759|NCT00389467|7212456|FG001|NOT COMPLETED|Overall Study||0
6308760|NCT00389467|7212457|FG002|NOT COMPLETED|Overall Study||0
6308761|NCT00389467|7212458|FG003|NOT COMPLETED|Overall Study||0
6308762|NCT00389493|7212472|FG000|STARTED|Overall Study||40
6308763|NCT00389493|7212473|FG001|STARTED|Overall Study||40
6308764|NCT00389493|7212474|FG002|STARTED|Overall Study||20
6308765|NCT00389493|7212472|FG000|COMPLETED|Overall Study||37
6308766|NCT00389493|7212473|FG001|COMPLETED|Overall Study||32
6308767|NCT00389493|7212474|FG002|COMPLETED|Overall Study||17
6308768|NCT00389493|7212472|FG000|NOT COMPLETED|Overall Study||3
6308769|NCT00389493|7212473|FG001|NOT COMPLETED|Overall Study||8
6308770|NCT00389493|7212474|FG002|NOT COMPLETED|Overall Study||3
6308771|NCT00389519|7212489|FG000|STARTED|Placebo Run-In||422
6308772|NCT00389519|7212490|FG001|STARTED|Placebo Run-In||0
6308773|NCT00389519|7212491|FG002|STARTED|Placebo Run-In||0
6308774|NCT00389519|7212492|FG003|STARTED|Placebo Run-In||0
6308775|NCT00389519|7212489|FG000|COMPLETED|Placebo Run-In||244
6308776|NCT00389519|7212490|FG001|COMPLETED|Placebo Run-In||0
6308777|NCT00389519|7212491|FG002|COMPLETED|Placebo Run-In||0
6308778|NCT00389519|7212492|FG003|COMPLETED|Placebo Run-In||0
6308779|NCT00389519|7212489|FG000|NOT COMPLETED|Placebo Run-In||178
6308780|NCT00389519|7212490|FG001|NOT COMPLETED|Placebo Run-In||0
6308781|NCT00389519|7212491|FG002|NOT COMPLETED|Placebo Run-In||0
6308782|NCT00389519|7212492|FG003|NOT COMPLETED|Placebo Run-In||0
6308783|NCT00389519|7212489|FG000|STARTED|Randomized||83
6308784|NCT00389519|7212490|FG001|STARTED|Randomized||41
6308785|NCT00389519|7212491|FG002|STARTED|Randomized||40
6308786|NCT00389519|7212492|FG003|STARTED|Randomized||80
6308787|NCT00389519|7212489|FG000|COMPLETED|Randomized||81
6308788|NCT00389519|7212490|FG001|COMPLETED|Randomized||41
6308789|NCT00389519|7212491|FG002|COMPLETED|Randomized||40
6308790|NCT00389519|7212492|FG003|COMPLETED|Randomized||80
6308791|NCT00389519|7212489|FG000|NOT COMPLETED|Randomized||2
6308792|NCT00389519|7212490|FG001|NOT COMPLETED|Randomized||0
6308793|NCT00389519|7212491|FG002|NOT COMPLETED|Randomized||0
6308794|NCT00389519|7212492|FG003|NOT COMPLETED|Randomized||0
6308795|NCT00389519|7212489|FG000|STARTED|Treated||81
6308796|NCT00389519|7212490|FG001|STARTED|Treated||41
6308797|NCT00389519|7212491|FG002|STARTED|Treated||40
6308798|NCT00389519|7212492|FG003|STARTED|Treated||80
6308799|NCT00389519|7212489|FG000|COMPLETED|Treated||79
6308800|NCT00389519|7212490|FG001|COMPLETED|Treated||40
6308801|NCT00389519|7212491|FG002|COMPLETED|Treated||40
6308802|NCT00389519|7212492|FG003|COMPLETED|Treated||76
6308803|NCT00389519|7212489|FG000|NOT COMPLETED|Treated||2
6308804|NCT00389519|7212490|FG001|NOT COMPLETED|Treated||1
6308805|NCT00389519|7212491|FG002|NOT COMPLETED|Treated||0
6308806|NCT00389519|7212492|FG003|NOT COMPLETED|Treated||4
6308807|NCT00389532|7212504|FG000|STARTED|Overall Study||60
6308808|NCT00389532|7212505|FG001|STARTED|Overall Study||56
6308809|NCT00389532|7212504|FG000|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
6308810|NCT00389532|7212505|FG001|COMPLETED|Overall Study||56
6308811|NCT00389532|7212504|FG000|NOT COMPLETED|Overall Study||0
6308812|NCT00389532|7212505|FG001|NOT COMPLETED|Overall Study||0
6308813|NCT00389597|7212515|FG000|STARTED|Overall Study||164
6308814|NCT00389597|7212516|FG001|STARTED|Overall Study||81
6308815|NCT00389597|7212517|FG002|STARTED|Overall Study||225
6308816|NCT00389597|7212518|FG003|STARTED|Overall Study||105
6308817|NCT00389597|7212515|FG000|24 mo|Overall Study||156
6308818|NCT00389597|7212516|FG001|24 mo|Overall Study||75
6308819|NCT00389597|7212517|FG002|24 mo|Overall Study||221
6308820|NCT00389597|7212518|FG003|24 mo|Overall Study||99
6308821|NCT00389597|7212515|FG000|COMPLETED|Overall Study||156
6308822|NCT00389597|7212516|FG001|COMPLETED|Overall Study||75
6308823|NCT00389597|7212517|FG002|COMPLETED|Overall Study||221
6308824|NCT00389597|7212518|FG003|COMPLETED|Overall Study||99
6308825|NCT00389597|7212515|FG000|NOT COMPLETED|Overall Study||8
6308826|NCT00389597|7212516|FG001|NOT COMPLETED|Overall Study||6
6308827|NCT00389597|7212517|FG002|NOT COMPLETED|Overall Study||4
6308828|NCT00389597|7212518|FG003|NOT COMPLETED|Overall Study||6
6308829|NCT00389805|7212530|FG000|STARTED|Phase I||15
6308830|NCT00389805|7212531|FG001|STARTED|Phase I||12
6308831|NCT00389805|7212530|FG000|COMPLETED|Phase I||15
6308832|NCT00389805|7212531|FG001|COMPLETED|Phase I||12
6308833|NCT00389805|7212530|FG000|NOT COMPLETED|Phase I||0
6308834|NCT00389805|7212531|FG001|NOT COMPLETED|Phase I||0
6308835|NCT00389805|7212530|FG000|STARTED|Phase II|The Phase II study was not conducted.|0
6308836|NCT00389805|7212531|FG001|STARTED|Phase II|The Phase II study was not conducted.|0
6308837|NCT00389805|7212530|FG000|COMPLETED|Phase II||0
6308838|NCT00389805|7212531|FG001|COMPLETED|Phase II||0
6308839|NCT00389805|7212530|FG000|NOT COMPLETED|Phase II||0
6308840|NCT00389805|7212531|FG001|NOT COMPLETED|Phase II||0
6308841|NCT00389818|7212537|FG000|STARTED|Overall Study||43
6308842|NCT00389818|7212537|FG000|COMPLETED|Overall Study||40
6308843|NCT00389818|7212537|FG000|NOT COMPLETED|Overall Study||3
6308844|NCT00389831|7212543|FG000|STARTED|Overall Study||10
6308845|NCT00389831|7212544|FG001|STARTED|Overall Study||34
6308846|NCT00389831|7212543|FG000|COMPLETED|Overall Study||10
6308847|NCT00389831|7212544|FG001|COMPLETED|Overall Study||27
6308848|NCT00389831|7212543|FG000|NOT COMPLETED|Overall Study||0
6308849|NCT00389831|7212544|FG001|NOT COMPLETED|Overall Study||7
6308850|NCT00389857|7212564|FG000|STARTED|Overall Study||14
6308851|NCT00389857|7212565|FG001|STARTED|Overall Study||17
6308852|NCT00389857|7212564|FG000|COMPLETED|Overall Study||14
6308853|NCT00389857|7212565|FG001|COMPLETED|Overall Study||17
6308854|NCT00389857|7212564|FG000|NOT COMPLETED|Overall Study||0
6308855|NCT00389857|7212565|FG001|NOT COMPLETED|Overall Study||0
6308856|NCT00389974|7212571|FG000|STARTED|Overall Study||19
6308857|NCT00389974|7212571|FG000|COMPLETED|Overall Study||19
6308858|NCT00389974|7212571|FG000|NOT COMPLETED|Overall Study||0
6308859|NCT00390013|7212578|FG000|STARTED|Phase 1||0
6308860|NCT00390013|7212579|FG001|STARTED|Phase 1||0
6308861|NCT00390013|7212580|FG002|STARTED|Phase 1||2
6308862|NCT00390013|7212581|FG003|STARTED|Phase 1||2
6308863|NCT00390013|7212578|FG000|COMPLETED|Phase 1||0
6308864|NCT00390013|7212579|FG001|COMPLETED|Phase 1||0
6308865|NCT00390013|7212580|FG002|COMPLETED|Phase 1||2
6308866|NCT00390013|7212581|FG003|COMPLETED|Phase 1||1
6308867|NCT00390013|7212578|FG000|NOT COMPLETED|Phase 1||0
6308868|NCT00390013|7212579|FG001|NOT COMPLETED|Phase 1||0
6308869|NCT00390013|7212580|FG002|NOT COMPLETED|Phase 1||0
6308870|NCT00390013|7212581|FG003|NOT COMPLETED|Phase 1||1
6308871|NCT00390013|7212578|FG000|STARTED|Phase 2 First Treatment||3
6308872|NCT00390013|7212579|FG001|STARTED|Phase 2 First Treatment||2
6308873|NCT00390013|7212580|FG002|STARTED|Phase 2 First Treatment||0
6308874|NCT00390013|7212581|FG003|STARTED|Phase 2 First Treatment||0
6308875|NCT00390013|7212578|FG000|COMPLETED|Phase 2 First Treatment||2
6308876|NCT00390013|7212579|FG001|COMPLETED|Phase 2 First Treatment||1
6308877|NCT00390013|7212580|FG002|COMPLETED|Phase 2 First Treatment||0
6308878|NCT00390013|7212581|FG003|COMPLETED|Phase 2 First Treatment||0
6308879|NCT00390013|7212578|FG000|NOT COMPLETED|Phase 2 First Treatment||1
6308880|NCT00390013|7212579|FG001|NOT COMPLETED|Phase 2 First Treatment||1
6308881|NCT00390013|7212580|FG002|NOT COMPLETED|Phase 2 First Treatment||0
6308882|NCT00390013|7212581|FG003|NOT COMPLETED|Phase 2 First Treatment||0
6308883|NCT00390013|7212578|FG000|STARTED|Phase 2 Second Treatment||2
6308884|NCT00390013|7212579|FG001|STARTED|Phase 2 Second Treatment||1
6308885|NCT00390013|7212580|FG002|STARTED|Phase 2 Second Treatment||0
6308886|NCT00390013|7212581|FG003|STARTED|Phase 2 Second Treatment||0
6308887|NCT00390013|7212578|FG000|COMPLETED|Phase 2 Second Treatment||2
6308888|NCT00390013|7212579|FG001|COMPLETED|Phase 2 Second Treatment||1
6308889|NCT00390013|7212580|FG002|COMPLETED|Phase 2 Second Treatment||0
6308890|NCT00390013|7212581|FG003|COMPLETED|Phase 2 Second Treatment||0
6308891|NCT00390013|7212578|FG000|NOT COMPLETED|Phase 2 Second Treatment||0
6308892|NCT00390013|7212579|FG001|NOT COMPLETED|Phase 2 Second Treatment||0
6308893|NCT00390013|7212580|FG002|NOT COMPLETED|Phase 2 Second Treatment||0
6308894|NCT00390013|7212581|FG003|NOT COMPLETED|Phase 2 Second Treatment||0
6308895|NCT00390182|7212587|FG000|STARTED|Overall Study||38
6308896|NCT00390182|7212587|FG000|COMPLETED|Overall Study||33
6308897|NCT00390182|7212587|FG000|NOT COMPLETED|Overall Study||5
6308898|NCT00390221|7212594|FG000|STARTED|Overall Study||204
6308899|NCT00390221|7212595|FG001|STARTED|Overall Study||208
6308900|NCT00390221|7212596|FG002|STARTED|Overall Study||209
6308901|NCT00390221|7212594|FG000|COMPLETED|Overall Study||186
6308902|NCT00390221|7212595|FG001|COMPLETED|Overall Study||188
6308903|NCT00390221|7212596|FG002|COMPLETED|Overall Study||194
6308904|NCT00390221|7212594|FG000|NOT COMPLETED|Overall Study||18
6308905|NCT00390221|7212595|FG001|NOT COMPLETED|Overall Study||20
6308906|NCT00390221|7212596|FG002|NOT COMPLETED|Overall Study||15
6308907|NCT00390234|7212605|FG000|STARTED|Overall Study||63
6308908|NCT00390234|7212605|FG000|COMPLETED|Overall Study||63
6308909|NCT00390234|7212605|FG000|NOT COMPLETED|Overall Study||0
6308910|NCT00390299|7212615|FG000|STARTED|Overall Study||4
6308911|NCT00390299|7212616|FG001|STARTED|Overall Study||3
6308912|NCT00390299|7212617|FG002|STARTED|Overall Study||3
6308913|NCT00390299|7212618|FG003|STARTED|Overall Study||3
6308914|NCT00390299|7212619|FG004|STARTED|Overall Study||10
6308915|NCT00390299|7212615|FG000|COMPLETED|Overall Study||3
6308916|NCT00390299|7212616|FG001|COMPLETED|Overall Study||3
6308917|NCT00390299|7212617|FG002|COMPLETED|Overall Study||3
6308918|NCT00390299|7212618|FG003|COMPLETED|Overall Study||3
6308919|NCT00390299|7212619|FG004|COMPLETED|Overall Study||10
6308920|NCT00390299|7212615|FG000|NOT COMPLETED|Overall Study||1
6308921|NCT00390299|7212616|FG001|NOT COMPLETED|Overall Study||0
6308922|NCT00390299|7212617|FG002|NOT COMPLETED|Overall Study||0
6308923|NCT00390299|7212618|FG003|NOT COMPLETED|Overall Study||0
6308924|NCT00390299|7212619|FG004|NOT COMPLETED|Overall Study||0
6308925|NCT00390325|7212635|FG000|STARTED|Overall Study||5
6308926|NCT00390325|7212636|FG001|STARTED|Overall Study||16
6308927|NCT00390325|7212635|FG000|COMPLETED|Overall Study||5
6308928|NCT00390325|7212636|FG001|COMPLETED|Overall Study||16
6308929|NCT00390325|7212635|FG000|NOT COMPLETED|Overall Study||0
6308930|NCT00390325|7212636|FG001|NOT COMPLETED|Overall Study||0
6308931|NCT00390364|7212646|FG000|STARTED|Overall Study||1
6308932|NCT00390364|7212646|FG000|COMPLETED|Overall Study||1
6308933|NCT00390364|7212646|FG000|NOT COMPLETED|Overall Study||0
6308934|NCT00390416|7212650|FG000|STARTED|Overall Study||48
6308935|NCT00390416|7212650|FG000|COMPLETED|Overall Study||44
6308936|NCT00390416|7212650|FG000|NOT COMPLETED|Overall Study||4
6308937|NCT00390429|7212657|FG000|STARTED|Overall Study||5
6308938|NCT00390429|7212658|FG001|STARTED|Overall Study||12
6308939|NCT00390429|7212659|FG002|STARTED|Overall Study||25
6308940|NCT00390429|7212660|FG003|STARTED|Overall Study||39
6308941|NCT00390429|7212657|FG000|COMPLETED|Overall Study||5
6308942|NCT00390429|7212658|FG001|COMPLETED|Overall Study||12
6308943|NCT00390429|7212659|FG002|COMPLETED|Overall Study||25
6308944|NCT00390429|7212660|FG003|COMPLETED|Overall Study||39
6308945|NCT00390429|7212657|FG000|NOT COMPLETED|Overall Study||0
6308946|NCT00390429|7212658|FG001|NOT COMPLETED|Overall Study||0
6308947|NCT00390429|7212659|FG002|NOT COMPLETED|Overall Study||0
6308948|NCT00390429|7212660|FG003|NOT COMPLETED|Overall Study||0
6308949|NCT00390455|7212673|FG000|STARTED|Overall Study||148
6308950|NCT00390455|7212674|FG001|STARTED|Overall Study||147
6308951|NCT00390455|7212673|FG000|COMPLETED|Overall Study||116
6308952|NCT00390455|7212674|FG001|COMPLETED|Overall Study||124
6308953|NCT00390455|7212673|FG000|NOT COMPLETED|Overall Study||32
6308954|NCT00390455|7212674|FG001|NOT COMPLETED|Overall Study||23
6308955|NCT00390468|7212680|FG000|STARTED|Overall Study||18
6308956|NCT00390468|7212680|FG000|COMPLETED|Overall Study||15
6308957|NCT00390468|7212680|FG000|NOT COMPLETED|Overall Study||3
6308958|NCT00390546|7212686|FG000|STARTED|Overall Study||33
6308959|NCT00390546|7212687|FG001|STARTED|Overall Study||39
6308960|NCT00390546|7212686|FG000|COMPLETED|Overall Study||27
6308961|NCT00390546|7212687|FG001|COMPLETED|Overall Study||34
6308962|NCT00390546|7212686|FG000|NOT COMPLETED|Overall Study||6
6308963|NCT00390546|7212687|FG001|NOT COMPLETED|Overall Study||5
6308964|NCT00390559|7212694|FG000|STARTED|Overall Study||124
6308965|NCT00390559|7212694|FG000|Received PlaceboP/Active C|Overall Study||93
6308966|NCT00390559|7212694|FG000|ActiveP/ActiveC|Overall Study||87
6308967|NCT00390559|7212694|FG000|PlaceboP/PlaceboC|Overall Study||93
6308968|NCT00390559|7212694|FG000|ActiveP/PlaceboC|Overall Study||90
6308969|NCT00390559|7212694|FG000|COMPLETED|Overall Study||80
6308970|NCT00390559|7212694|FG000|NOT COMPLETED|Overall Study||44
6308971|NCT00390572|7212706|FG000|STARTED|Overall Study||68
6308972|NCT00390572|7212707|FG001|STARTED|Overall Study||69
6308973|NCT00390572|7212706|FG000|COMPLETED|Overall Study||60
6308974|NCT00390572|7212707|FG001|COMPLETED|Overall Study||64
6308975|NCT00390572|7212706|FG000|NOT COMPLETED|Overall Study||8
6308976|NCT00390572|7212707|FG001|NOT COMPLETED|Overall Study||5
6308977|NCT00390611|7212715|FG000|STARTED|6 Cycles of Study Treatment||43
6308978|NCT00390611|7212716|FG001|STARTED|6 Cycles of Study Treatment||42
6308979|NCT00390611|7212715|FG000|COMPLETED|6 Cycles of Study Treatment||34
6308980|NCT00390611|7212716|FG001|COMPLETED|6 Cycles of Study Treatment||37
6308981|NCT00390611|7212715|FG000|NOT COMPLETED|6 Cycles of Study Treatment||9
6308982|NCT00390611|7212716|FG001|NOT COMPLETED|6 Cycles of Study Treatment||5
6308983|NCT00390611|7212715|FG000|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
6308984|NCT00390611|7212716|FG001|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
6308985|NCT00390611|7212715|FG000|COMPLETED|Maintenance Sorafenib to Month 12||13
6308986|NCT00390611|7212716|FG001|COMPLETED|Maintenance Sorafenib to Month 12||0
6308987|NCT00390611|7212715|FG000|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
6308988|NCT00390611|7212716|FG001|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
6308989|NCT00390689|7212727|FG000|STARTED|Overall Study||48
6308990|NCT00390689|7212728|FG001|STARTED|Overall Study||53
6308991|NCT00390689|7212729|FG002|STARTED|Overall Study||53
6308992|NCT00390689|7212727|FG000|COMPLETED|Overall Study||43
6308993|NCT00390689|7212728|FG001|COMPLETED|Overall Study||48
6308994|NCT00390689|7212729|FG002|COMPLETED|Overall Study||50
6308995|NCT00390689|7212727|FG000|NOT COMPLETED|Overall Study||5
6308996|NCT00390689|7212728|FG001|NOT COMPLETED|Overall Study||5
6308997|NCT00390689|7212729|FG002|NOT COMPLETED|Overall Study||3
6308998|NCT00390780|7212748|FG000|STARTED|Overall Study||291
6308999|NCT00390780|7212749|FG001|STARTED|Overall Study||287
6309000|NCT00390780|7212748|FG000|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
6309001|NCT00390780|7212749|FG001|Treatment|Overall Study||287
6309002|NCT00390780|7212748|FG000|COMPLETED|Overall Study||268
6309003|NCT00390780|7212749|FG001|COMPLETED|Overall Study||260
6309004|NCT00390780|7212748|FG000|NOT COMPLETED|Overall Study||23
6309005|NCT00390780|7212749|FG001|NOT COMPLETED|Overall Study||27
6309006|NCT00390806|7212757|FG000|STARTED|Overall Study||236
6309007|NCT00390806|7212758|FG001|STARTED|Overall Study||236
6309008|NCT00390806|7212757|FG000|Ongoing|Overall Study||4
6309009|NCT00390806|7212758|FG001|Ongoing|Overall Study||2
6309010|NCT00390806|7212757|FG000|COMPLETED|Overall Study||206
6309011|NCT00390806|7212758|FG001|COMPLETED|Overall Study||204
6309012|NCT00390806|7212757|FG000|NOT COMPLETED|Overall Study||30
6309013|NCT00390806|7212758|FG001|NOT COMPLETED|Overall Study||32
6309014|NCT00390858|7212766|FG000|STARTED|Overall Study|20 participants started the Core Study|20
6309015|NCT00390858|7212767|FG001|STARTED|Overall Study|20 Participants started the Core Study|20
6309016|NCT00390858|7212766|FG000|Completed Core & Entered Extension Study|Overall Study||19
6309017|NCT00390858|7212767|FG001|Completed Core & Entered Extension Study|Overall Study||20
6309018|NCT00390858|7212766|FG000|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
6309019|NCT00390858|7212767|FG001|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
6309020|NCT00390858|7212766|FG000|NOT COMPLETED|Overall Study||9
6557456|NCT01767987|7480025|FG001|NOT COMPLETED|Overall Study||1
6557457|NCT01768000|7480035|FG000|STARTED|Overall Study||10
6557458|NCT01768000|7480036|FG001|STARTED|Overall Study||10
6557459|NCT01768000|7480037|FG002|STARTED|Overall Study||10
6557460|NCT01768000|7480038|FG003|STARTED|Overall Study||10
6309021|NCT00390858|7212767|FG001|NOT COMPLETED|Overall Study||7
6309022|NCT00390884|7212775|FG000|STARTED|Overall Study||116
6309023|NCT00390884|7212776|FG001|STARTED|Overall Study||57
6309024|NCT00390884|7212775|FG000|COMPLETED|Overall Study||114
6309025|NCT00390884|7212776|FG001|COMPLETED|Overall Study||55
6309026|NCT00390884|7212775|FG000|NOT COMPLETED|Overall Study||2
6309027|NCT00390884|7212776|FG001|NOT COMPLETED|Overall Study||2
6309028|NCT00390910|7212785|FG000|STARTED|Overall Study||50
6309029|NCT00390910|7212786|FG001|STARTED|Overall Study||87
6309030|NCT00390910|7212787|FG002|STARTED|Overall Study||149
6309031|NCT00390910|7212785|FG000|COMPLETED|Overall Study||48
6309032|NCT00390910|7212786|FG001|COMPLETED|Overall Study||83
6309033|NCT00390910|7212787|FG002|COMPLETED|Overall Study||139
6309034|NCT00390910|7212785|FG000|NOT COMPLETED|Overall Study||2
6309035|NCT00390910|7212786|FG001|NOT COMPLETED|Overall Study||4
6309036|NCT00390910|7212787|FG002|NOT COMPLETED|Overall Study||10
6309037|NCT00390949|7212799|FG000|STARTED|Overall Study||4662
6309038|NCT00390949|7212800|FG001|STARTED|Overall Study||4792
6309039|NCT00390949|7212799|FG000|COMPLETED|Overall Study||2564
6309040|NCT00390949|7212800|FG001|COMPLETED|Overall Study||2664
6309041|NCT00390949|7212799|FG000|NOT COMPLETED|Overall Study||2098
6309042|NCT00390949|7212800|FG001|NOT COMPLETED|Overall Study||2128
6309043|NCT00391027|7212808|FG000|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
6309044|NCT00391027|7212809|FG001|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
6309045|NCT00391027|7212808|FG000|COMPLETED|Overall Study||110
6309046|NCT00391027|7212809|FG001|COMPLETED|Overall Study||110
6309047|NCT00391027|7212808|FG000|NOT COMPLETED|Overall Study||25
6309048|NCT00391027|7212809|FG001|NOT COMPLETED|Overall Study||12
6309049|NCT00391053|7212819|FG000|STARTED|Overall Study||857
6309050|NCT00391053|7212820|FG001|STARTED|Overall Study||848
6309051|NCT00391053|7212821|FG002|STARTED|Overall Study||870
6309052|NCT00391053|7212822|FG003|STARTED|Overall Study||1262
6309053|NCT00391053|7212819|FG000|COMPLETED|Overall Study||848
6309054|NCT00391053|7212820|FG001|COMPLETED|Overall Study||847
6309055|NCT00391053|7212821|FG002|COMPLETED|Overall Study||868
6309056|NCT00391053|7212822|FG003|COMPLETED|Overall Study||1252
6309057|NCT00391053|7212819|FG000|NOT COMPLETED|Overall Study||9
6309058|NCT00391053|7212820|FG001|NOT COMPLETED|Overall Study||1
6309059|NCT00391053|7212821|FG002|NOT COMPLETED|Overall Study||2
6309060|NCT00391053|7212822|FG003|NOT COMPLETED|Overall Study||10
6557461|NCT01768000|7480035|FG000|COMPLETED|Overall Study||9
6309061|NCT00391079|7212834|FG000|STARTED|Overall Study||167
6309062|NCT00391079|7212835|FG001|STARTED|Overall Study||172
6309063|NCT00391079|7212834|FG000|COMPLETED|Overall Study||141
6309064|NCT00391079|7212835|FG001|COMPLETED|Overall Study||156
6309065|NCT00391079|7212834|FG000|NOT COMPLETED|Overall Study||26
6309066|NCT00391079|7212835|FG001|NOT COMPLETED|Overall Study||16
6309067|NCT00391092|7212843|FG000|STARTED|Overall Study||208
6309068|NCT00391092|7212844|FG001|STARTED|Overall Study||216
6309069|NCT00391092|7212843|FG000|Received Treatment|Overall Study||206
6309070|NCT00391092|7212844|FG001|Received Treatment|Overall Study||215
6309071|NCT00391092|7212843|FG000|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
6309072|NCT00391092|7212844|FG001|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
6309073|NCT00391092|7212843|FG000|NOT COMPLETED|Overall Study||208
6309074|NCT00391092|7212844|FG001|NOT COMPLETED|Overall Study||216
6309075|NCT00391118|7212853|FG000|STARTED|Overall Study||11
6309076|NCT00391118|7212854|FG001|STARTED|Overall Study||69
6309077|NCT00391118|7212855|FG002|STARTED|Overall Study||73
6309078|NCT00391118|7212853|FG000|Received ≥1 Dose of Assigned Study Drug|Overall Study||11
6309079|NCT00391118|7212854|FG001|Received ≥1 Dose of Assigned Study Drug|Overall Study||67
6309080|NCT00391118|7212855|FG002|Received ≥1 Dose of Assigned Study Drug|Overall Study||72
6309081|NCT00391118|7212853|FG000|COMPLETED|Overall Study||0
6309082|NCT00391118|7212854|FG001|COMPLETED|Overall Study||14
6309083|NCT00391118|7212855|FG002|COMPLETED|Overall Study||15
6309084|NCT00391118|7212853|FG000|NOT COMPLETED|Overall Study||11
6309085|NCT00391118|7212854|FG001|NOT COMPLETED|Overall Study||55
6557462|NCT01768000|7480036|FG001|COMPLETED|Overall Study||8
6309086|NCT00391118|7212855|FG002|NOT COMPLETED|Overall Study||58
6309087|NCT00391222|7212869|FG000|STARTED|Period II (Open-label Risperidone LAI)||0
6309088|NCT00391222|7212870|FG001|STARTED|Period II (Open-label Risperidone LAI)||0
6309089|NCT00391222|7212871|FG002|STARTED|Period II (Open-label Risperidone LAI)||0
6309090|NCT00391222|7212872|FG003|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
6309091|NCT00391222|7212869|FG000|COMPLETED|Period II (Open-label Risperidone LAI)||0
6309092|NCT00391222|7212870|FG001|COMPLETED|Period II (Open-label Risperidone LAI)||0
6309093|NCT00391222|7212871|FG002|COMPLETED|Period II (Open-label Risperidone LAI)||0
6309094|NCT00391222|7212872|FG003|COMPLETED|Period II (Open-label Risperidone LAI)||398
6309095|NCT00391222|7212869|FG000|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
6309096|NCT00391222|7212870|FG001|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
6309097|NCT00391222|7212871|FG002|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
6309098|NCT00391222|7212872|FG003|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
6309099|NCT00391222|7212869|FG000|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
6309100|NCT00391222|7212870|FG001|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
6309101|NCT00391222|7212871|FG002|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
6309102|NCT00391222|7212872|FG003|STARTED|Period III (Double-Blind Treatment)||0
6309103|NCT00391222|7212869|FG000|COMPLETED|Period III (Double-Blind Treatment)||104
6309104|NCT00391222|7212870|FG001|COMPLETED|Period III (Double-Blind Treatment)||113
6309105|NCT00391222|7212871|FG002|COMPLETED|Period III (Double-Blind Treatment)||108
6309106|NCT00391222|7212872|FG003|COMPLETED|Period III (Double-Blind Treatment)||0
6309107|NCT00391222|7212869|FG000|NOT COMPLETED|Period III (Double-Blind Treatment)||28
6309108|NCT00391222|7212870|FG001|NOT COMPLETED|Period III (Double-Blind Treatment)||22
6309109|NCT00391222|7212871|FG002|NOT COMPLETED|Period III (Double-Blind Treatment)||23
6309110|NCT00391222|7212872|FG003|NOT COMPLETED|Period III (Double-Blind Treatment)||0
6309111|NCT00391274|7212884|FG000|STARTED|Overall Study||107
6309112|NCT00391274|7212885|FG001|STARTED|Overall Study||104
6309113|NCT00391274|7212884|FG000|Received at Least One Dose of Study Drug|Overall Study||106
6309114|NCT00391274|7212885|FG001|Received at Least One Dose of Study Drug|Overall Study||102
6309115|NCT00391274|7212884|FG000|COMPLETED|Overall Study||46
6309116|NCT00391274|7212885|FG001|COMPLETED|Overall Study||47
6309117|NCT00391274|7212884|FG000|NOT COMPLETED|Overall Study||61
6309118|NCT00391274|7212885|FG001|NOT COMPLETED|Overall Study||57
6309119|NCT00391365|7212893|FG000|STARTED|Overall Study||103
6309120|NCT00391365|7212894|FG001|STARTED|Overall Study||170
6309121|NCT00391365|7212893|FG000|COMPLETED|Overall Study||78
6309122|NCT00391365|7212894|FG001|COMPLETED|Overall Study||151
6309123|NCT00391365|7212893|FG000|NOT COMPLETED|Overall Study||25
6309124|NCT00391365|7212894|FG001|NOT COMPLETED|Overall Study||19
6309125|NCT00391391|7212905|FG000|STARTED|Overall Study|1 participant was not vaccinated.|98
6309126|NCT00391391|7212906|FG001|STARTED|Overall Study||97
6309127|NCT00391391|7212907|FG002|STARTED|Overall Study|1 participant was not vaccinated.|161
6309128|NCT00391391|7212908|FG003|STARTED|Overall Study|1 participant was not vaccinated.|164
6309129|NCT00391391|7212905|FG000|COMPLETED|Overall Study||89
6309130|NCT00391391|7212906|FG001|COMPLETED|Overall Study||87
6309131|NCT00391391|7212907|FG002|COMPLETED|Overall Study||138
6309132|NCT00391391|7212908|FG003|COMPLETED|Overall Study||145
6309133|NCT00391391|7212905|FG000|NOT COMPLETED|Overall Study||9
6309134|NCT00391391|7212906|FG001|NOT COMPLETED|Overall Study||10
6309135|NCT00391391|7212907|FG002|NOT COMPLETED|Overall Study||23
6309136|NCT00391391|7212908|FG003|NOT COMPLETED|Overall Study||19
6309137|NCT00391443|7212920|FG000|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
6309138|NCT00391443|7212921|FG001|STARTED|Overall Study||407
6309139|NCT00391443|7212920|FG000|COMPLETED|Overall Study||209
6309140|NCT00391443|7212921|FG001|COMPLETED|Overall Study||407
6309141|NCT00391443|7212920|FG000|NOT COMPLETED|Overall Study||0
6309142|NCT00391443|7212921|FG001|NOT COMPLETED|Overall Study||0
6309143|NCT00391469|7212931|FG000|STARTED|Overall Study||688
6309144|NCT00391469|7212932|FG001|STARTED|Overall Study||671
6309145|NCT00391469|7212931|FG000|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
6309146|NCT00391469|7212932|FG001|COMPLETED|Overall Study||671
6309147|NCT00391469|7212931|FG000|NOT COMPLETED|Overall Study||0
6309148|NCT00391469|7212932|FG001|NOT COMPLETED|Overall Study||0
6309149|NCT00391586|7212940|FG000|STARTED|Overall Study||45
6309150|NCT00391586|7212940|FG000|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
6309151|NCT00391586|7212940|FG000|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
6309152|NCT00391586|7212940|FG000|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
6309153|NCT00391586|7212940|FG000|NOT COMPLETED|Overall Study||24
6309154|NCT00391599|7212946|FG000|STARTED|Overall Study||65
6309155|NCT00391599|7212947|FG001|STARTED|Overall Study||65
6309156|NCT00391599|7212946|FG000|COMPLETED|Overall Study||65
6309157|NCT00391599|7212947|FG001|COMPLETED|Overall Study||65
6309158|NCT00391599|7212946|FG000|NOT COMPLETED|Overall Study||0
6309159|NCT00391599|7212947|FG001|NOT COMPLETED|Overall Study||0
6309160|NCT00391625|7212955|FG000|STARTED|Baseline||10
6309161|NCT00391625|7212955|FG000|COMPLETED|Baseline||10
6309162|NCT00391625|7212955|FG000|NOT COMPLETED|Baseline||0
6309163|NCT00391625|7212955|FG000|STARTED|Month 14||10
6309164|NCT00391625|7212955|FG000|COMPLETED|Month 14||9
6309165|NCT00391625|7212955|FG000|NOT COMPLETED|Month 14||1
6309166|NCT00391625|7212955|FG000|STARTED|Month 50||9
6309167|NCT00391625|7212955|FG000|COMPLETED|Month 50||8
6309168|NCT00391625|7212955|FG000|NOT COMPLETED|Month 50||1
6309169|NCT00391625|7212955|FG000|STARTED|Month 84||8
6309170|NCT00391625|7212955|FG000|COMPLETED|Month 84||8
6309171|NCT00391625|7212955|FG000|NOT COMPLETED|Month 84||0
6309172|NCT00391716|7212985|FG000|STARTED|Overall Study||54
6309173|NCT00391716|7212986|FG001|STARTED|Overall Study||47
6309174|NCT00391716|7212987|FG002|STARTED|Overall Study||49
6309175|NCT00391716|7212985|FG000|COMPLETED|Overall Study||27
6309176|NCT00391716|7212986|FG001|COMPLETED|Overall Study||28
6309177|NCT00391716|7212987|FG002|COMPLETED|Overall Study||30
6309178|NCT00391716|7212985|FG000|NOT COMPLETED|Overall Study||27
6309179|NCT00391716|7212986|FG001|NOT COMPLETED|Overall Study||19
6309180|NCT00391716|7212987|FG002|NOT COMPLETED|Overall Study||19
6309181|NCT00391768|7213002|FG000|STARTED|Overall Study||12
6309182|NCT00391768|7213003|FG001|STARTED|Overall Study||3
6309183|NCT00391768|7213004|FG002|STARTED|Overall Study||7
6309184|NCT00391768|7213005|FG003|STARTED|Overall Study||8
6309185|NCT00391768|7213006|FG004|STARTED|Overall Study||24
6309186|NCT00391768|7213007|FG005|STARTED|Overall Study||10
6309187|NCT00391768|7213008|FG006|STARTED|Overall Study||23
6309188|NCT00391768|7213002|FG000|COMPLETED|Overall Study||12
6557463|NCT01768000|7480037|FG002|COMPLETED|Overall Study||9
6557464|NCT01768000|7480038|FG003|COMPLETED|Overall Study||8
6309189|NCT00391768|7213003|FG001|COMPLETED|Overall Study||3
6309190|NCT00391768|7213004|FG002|COMPLETED|Overall Study||6
6309191|NCT00391768|7213005|FG003|COMPLETED|Overall Study||7
6309192|NCT00391768|7213006|FG004|COMPLETED|Overall Study||22
6309193|NCT00391768|7213007|FG005|COMPLETED|Overall Study||7
6309194|NCT00391768|7213008|FG006|COMPLETED|Overall Study||19
6309195|NCT00391768|7213002|FG000|NOT COMPLETED|Overall Study||0
6309196|NCT00391768|7213003|FG001|NOT COMPLETED|Overall Study||0
6309197|NCT00391768|7213004|FG002|NOT COMPLETED|Overall Study||1
6309198|NCT00391768|7213005|FG003|NOT COMPLETED|Overall Study||1
6309199|NCT00391768|7213006|FG004|NOT COMPLETED|Overall Study||2
6309200|NCT00391768|7213007|FG005|NOT COMPLETED|Overall Study||3
6309201|NCT00391768|7213008|FG006|NOT COMPLETED|Overall Study||4
6309202|NCT00391807|7213042|FG000|STARTED|Overall Study||1683
6309203|NCT00391807|7213042|FG000|COMPLETED|Overall Study||968
6309204|NCT00391807|7213042|FG000|NOT COMPLETED|Overall Study||715
6309205|NCT00391846|7213048|FG000|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
6309206|NCT00391846|7213049|FG001|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
6309207|NCT00391846|7213048|FG000|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
6309208|NCT00391846|7213049|FG001|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
6309209|NCT00391846|7213048|FG000|NOT COMPLETED|Overall Study||8
6309210|NCT00391846|7213049|FG001|NOT COMPLETED|Overall Study||7
6309211|NCT00391872|7213057|FG000|STARTED|Overall Study||9333
6309212|NCT00391872|7213058|FG001|STARTED|Overall Study||9291
6309213|NCT00391872|7213057|FG000|COMPLETED|Overall Study||9026
6309214|NCT00391872|7213058|FG001|COMPLETED|Overall Study||9036
6309215|NCT00391872|7213057|FG000|NOT COMPLETED|Overall Study||307
6309216|NCT00391872|7213058|FG001|NOT COMPLETED|Overall Study||255
6309217|NCT00391898|7213066|FG000|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
6309218|NCT00391898|7213067|FG001|STARTED|Overall Study||49
6309219|NCT00391898|7213066|FG000|COMPLETED|Overall Study||35
6309220|NCT00391898|7213067|FG001|COMPLETED|Overall Study||39
6309221|NCT00391898|7213066|FG000|NOT COMPLETED|Overall Study||11
6309222|NCT00391898|7213067|FG001|NOT COMPLETED|Overall Study||10
6309223|NCT00391976|7213076|FG000|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
6309224|NCT00391976|7213077|FG001|STARTED|Overall Study||43
6309225|NCT00391976|7213078|FG002|STARTED|Overall Study||35
6309226|NCT00391976|7213076|FG000|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
6309227|NCT00391976|7213077|FG001|Randomized|Overall Study||43
6309228|NCT00391976|7213078|FG002|Randomized|Overall Study||0
6309229|NCT00391976|7213076|FG000|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
6309230|NCT00391976|7213077|FG001|Safety Population|Overall Study||43
6309231|NCT00391976|7213078|FG002|Safety Population|Overall Study||35
6309232|NCT00391976|7213076|FG000|COMPLETED|Overall Study||18
6309233|NCT00391976|7213077|FG001|COMPLETED|Overall Study||18
6309234|NCT00391976|7213078|FG002|COMPLETED|Overall Study||0
6309235|NCT00391976|7213076|FG000|NOT COMPLETED|Overall Study||27
6309236|NCT00391976|7213077|FG001|NOT COMPLETED|Overall Study||25
6309237|NCT00391976|7213078|FG002|NOT COMPLETED|Overall Study||35
6309238|NCT00391989|7213088|FG000|STARTED|Overall Study||55
6309239|NCT00391989|7213088|FG000|COMPLETED|Overall Study||53
6309240|NCT00391989|7213088|FG000|NOT COMPLETED|Overall Study||2
6309241|NCT00392015|7213098|FG000|STARTED|Overall Study||6
6309242|NCT00392015|7213099|FG001|STARTED|Overall Study||6
6309243|NCT00392015|7213100|FG002|STARTED|Overall Study||20
6309244|NCT00392015|7213101|FG003|STARTED|Overall Study||6
6309245|NCT00392015|7213102|FG004|STARTED|Overall Study||15
6309246|NCT00392015|7213103|FG005|STARTED|Overall Study||6
6309247|NCT00392015|7213098|FG000|COMPLETED|Overall Study||4
6309248|NCT00392015|7213099|FG001|COMPLETED|Overall Study||6
6309249|NCT00392015|7213100|FG002|COMPLETED|Overall Study||16
6309250|NCT00392015|7213101|FG003|COMPLETED|Overall Study||5
6309251|NCT00392015|7213102|FG004|COMPLETED|Overall Study||12
6309252|NCT00392015|7213103|FG005|COMPLETED|Overall Study||6
6557465|NCT01768000|7480035|FG000|NOT COMPLETED|Overall Study||1
6309253|NCT00392015|7213098|FG000|NOT COMPLETED|Overall Study||2
6309254|NCT00392015|7213099|FG001|NOT COMPLETED|Overall Study||0
6309255|NCT00392015|7213100|FG002|NOT COMPLETED|Overall Study||4
6309256|NCT00392015|7213101|FG003|NOT COMPLETED|Overall Study||1
6309257|NCT00392015|7213102|FG004|NOT COMPLETED|Overall Study||3
6309258|NCT00392015|7213103|FG005|NOT COMPLETED|Overall Study||0
6309259|NCT00392041|7213124|FG000|STARTED|First 4 Weeks||19
6309260|NCT00392041|7213125|FG001|STARTED|First 4 Weeks||17
6309261|NCT00392041|7213124|FG000|COMPLETED|First 4 Weeks||11
6309262|NCT00392041|7213125|FG001|COMPLETED|First 4 Weeks||14
6309263|NCT00392041|7213124|FG000|NOT COMPLETED|First 4 Weeks||8
6309264|NCT00392041|7213125|FG001|NOT COMPLETED|First 4 Weeks||3
6309265|NCT00392041|7213124|FG000|STARTED|Weeks 5 - 12||11
6309266|NCT00392041|7213125|FG001|STARTED|Weeks 5 - 12||14
6309267|NCT00392041|7213124|FG000|COMPLETED|Weeks 5 - 12||7
6309268|NCT00392041|7213125|FG001|COMPLETED|Weeks 5 - 12||9
6309269|NCT00392041|7213124|FG000|NOT COMPLETED|Weeks 5 - 12||4
6309270|NCT00392041|7213125|FG001|NOT COMPLETED|Weeks 5 - 12||5
6309271|NCT00392054|7213133|FG000|STARTED|Overall Study|All participants randomized are included in final analysis|66
6309272|NCT00392054|7213134|FG001|STARTED|Overall Study|All participants randomized are included in final analysis|61
6309273|NCT00392054|7213133|FG000|Received Allocated Intervention|Overall Study||65
6309274|NCT00392054|7213134|FG001|Received Allocated Intervention|Overall Study||60
6309275|NCT00392054|7213133|FG000|COMPLETED|Overall Study||66
6309276|NCT00392054|7213134|FG001|COMPLETED|Overall Study||61
6309277|NCT00392054|7213133|FG000|NOT COMPLETED|Overall Study||0
6309278|NCT00392054|7213134|FG001|NOT COMPLETED|Overall Study||0
6309279|NCT00392171|7213144|FG000|STARTED|Overall Study||120
6309280|NCT00392171|7213144|FG000|COMPLETED|Overall Study||15
6309281|NCT00392171|7213144|FG000|NOT COMPLETED|Overall Study||105
6309282|NCT00392197|7213150|FG000|STARTED|Overall Study||48
6309283|NCT00392197|7213151|FG001|STARTED|Overall Study||63
6309284|NCT00392197|7213150|FG000|COMPLETED|Overall Study||27
6309285|NCT00392197|7213151|FG001|COMPLETED|Overall Study||33
6309286|NCT00392197|7213150|FG000|NOT COMPLETED|Overall Study||21
6309287|NCT00392197|7213151|FG001|NOT COMPLETED|Overall Study||30
6309288|NCT00392210|7213159|FG000|STARTED|First Voiding Trial||36
6309289|NCT00392210|7213160|FG001|STARTED|First Voiding Trial||33
6309290|NCT00392210|7213159|FG000|COMPLETED|First Voiding Trial||34
6309291|NCT00392210|7213160|FG001|COMPLETED|First Voiding Trial||31
6309292|NCT00392210|7213159|FG000|NOT COMPLETED|First Voiding Trial||2
6309293|NCT00392210|7213160|FG001|NOT COMPLETED|First Voiding Trial||2
6309294|NCT00392210|7213159|FG000|STARTED|Second Voiding Trial||34
6309295|NCT00392210|7213160|FG001|STARTED|Second Voiding Trial||31
6309296|NCT00392210|7213159|FG000|COMPLETED|Second Voiding Trial||34
6309297|NCT00392210|7213160|FG001|COMPLETED|Second Voiding Trial||31
6309298|NCT00392210|7213159|FG000|NOT COMPLETED|Second Voiding Trial||0
6309299|NCT00392210|7213160|FG001|NOT COMPLETED|Second Voiding Trial||0
6309300|NCT00392223|7213168|FG000|STARTED|Overall Study||58
6309301|NCT00392223|7213169|FG001|STARTED|Overall Study||60
6309302|NCT00392223|7213168|FG000|COMPLETED|Overall Study||49
6309303|NCT00392223|7213169|FG001|COMPLETED|Overall Study||47
6309304|NCT00392223|7213168|FG000|NOT COMPLETED|Overall Study||9
6309305|NCT00392223|7213169|FG001|NOT COMPLETED|Overall Study||13
6309306|NCT00392236|7213177|FG000|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
6309307|NCT00392236|7213178|FG001|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
6309308|NCT00392236|7213177|FG000|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
6309309|NCT00392236|7213178|FG001|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
6309310|NCT00392236|7213177|FG000|NOT COMPLETED|Overall Study||12
6309311|NCT00392236|7213178|FG001|NOT COMPLETED|Overall Study||6
6309312|NCT00392288|7213187|FG000|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
6309313|NCT00392288|7213188|FG001|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
6309314|NCT00392288|7213189|FG002|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
6309315|NCT00392288|7213187|FG000|Treatment Period|Overall Study||172
6309316|NCT00392288|7213188|FG001|Treatment Period|Overall Study||174
6309317|NCT00392288|7213189|FG002|Treatment Period|Overall Study||175
6309318|NCT00392288|7213187|FG000|COMPLETED|Overall Study|ITT set = 163 patients|143
6309319|NCT00392288|7213188|FG001|COMPLETED|Overall Study|ITT set = 166 patients|155
6309320|NCT00392288|7213189|FG002|COMPLETED|Overall Study|ITT set = 172 patients|159
6309321|NCT00392288|7213187|FG000|NOT COMPLETED|Overall Study||32
6309322|NCT00392288|7213188|FG001|NOT COMPLETED|Overall Study||22
6309323|NCT00392288|7213189|FG002|NOT COMPLETED|Overall Study||17
6309324|NCT00392379|7213199|FG000|STARTED|Overall Study|Medication period|136
6309325|NCT00392379|7213200|FG001|STARTED|Overall Study|Medication period|134
6309326|NCT00392379|7213199|FG000|COMPLETED|Overall Study|Medication period|114
6309327|NCT00392379|7213200|FG001|COMPLETED|Overall Study|Medication period|96
6309328|NCT00392379|7213199|FG000|NOT COMPLETED|Overall Study||22
6309329|NCT00392379|7213200|FG001|NOT COMPLETED|Overall Study||38
6309330|NCT00392392|7213206|FG000|STARTED|Overall Study||29
6309331|NCT00392392|7213206|FG000|COMPLETED|Overall Study||9
6309332|NCT00392392|7213206|FG000|NOT COMPLETED|Overall Study||20
6309333|NCT00392444|7213210|FG000|STARTED|Overall Study||39
6309334|NCT00392444|7213210|FG000|COMPLETED|Overall Study||39
6309335|NCT00392444|7213210|FG000|NOT COMPLETED|Overall Study||0
6773443|NCT03987620|7701097|FG000|COMPLETED|Overall Study||246
6773444|NCT03987620|7701098|FG001|COMPLETED|Overall Study||102
6773445|NCT03987620|7701097|FG000|NOT COMPLETED|Overall Study||57
6773446|NCT03987620|7701098|FG001|NOT COMPLETED|Overall Study||50
6309336|NCT00392496|7213214|FG000|STARTED|Overall Study||19
6309337|NCT00392496|7213214|FG000|COMPLETED|Overall Study||19
6309338|NCT00392496|7213214|FG000|NOT COMPLETED|Overall Study||0
6309339|NCT00392665|7213220|FG000|STARTED|Overall Study||18
6309340|NCT00392665|7213221|FG001|STARTED|Overall Study||18
6309341|NCT00392665|7213220|FG000|COMPLETED|Overall Study||1
6309342|NCT00392665|7213221|FG001|COMPLETED|Overall Study||3
6309343|NCT00392665|7213220|FG000|NOT COMPLETED|Overall Study||17
6309344|NCT00392665|7213221|FG001|NOT COMPLETED|Overall Study||15
6309345|NCT00392678|7213231|FG000|STARTED|Overall Study||27
6309346|NCT00392678|7213232|FG001|STARTED|Overall Study||27
6309347|NCT00392678|7213233|FG002|STARTED|Overall Study||27
6309348|NCT00392678|7213234|FG003|STARTED|Overall Study||27
6309349|NCT00392678|7213231|FG000|COMPLETED|Overall Study||27
6309350|NCT00392678|7213232|FG001|COMPLETED|Overall Study||26
6309351|NCT00392678|7213233|FG002|COMPLETED|Overall Study||25
6309352|NCT00392678|7213234|FG003|COMPLETED|Overall Study||26
6309353|NCT00392678|7213231|FG000|NOT COMPLETED|Overall Study||0
6309354|NCT00392678|7213232|FG001|NOT COMPLETED|Overall Study||1
6309355|NCT00392678|7213233|FG002|NOT COMPLETED|Overall Study||2
6309356|NCT00392678|7213234|FG003|NOT COMPLETED|Overall Study||1
6309357|NCT00392704|7213253|FG000|STARTED|Neoadjuvant Chemotherapy||60
6309358|NCT00392704|7213253|FG000|COMPLETED|Neoadjuvant Chemotherapy||54
6309359|NCT00392704|7213253|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||6
6309360|NCT00392704|7213253|FG000|STARTED|Combined Modality Therapy||54
6309361|NCT00392704|7213253|FG000|COMPLETED|Combined Modality Therapy||49
6309362|NCT00392704|7213253|FG000|NOT COMPLETED|Combined Modality Therapy||5
6309363|NCT00392769|7213257|FG000|STARTED|Overall Study||33
6309364|NCT00392769|7213257|FG000|COMPLETED|Overall Study||23
6309365|NCT00392769|7213257|FG000|NOT COMPLETED|Overall Study||10
6309366|NCT00392782|7213261|FG000|STARTED|Overall Study||24
6309367|NCT00392782|7213261|FG000|COMPLETED|Overall Study||24
6309368|NCT00392782|7213261|FG000|NOT COMPLETED|Overall Study||0
6309369|NCT00392808|7213269|FG000|STARTED|Overall Study||87
6309370|NCT00392808|7213270|FG001|STARTED|Overall Study||89
6309371|NCT00392808|7213271|FG002|STARTED|Overall Study||109
6309372|NCT00392808|7213272|FG003|STARTED|Overall Study||104
6309373|NCT00392808|7213269|FG000|COMPLETED|Overall Study||81
6309374|NCT00392808|7213270|FG001|COMPLETED|Overall Study||86
6309375|NCT00392808|7213271|FG002|COMPLETED|Overall Study||107
6309376|NCT00392808|7213272|FG003|COMPLETED|Overall Study||100
6309377|NCT00392808|7213269|FG000|NOT COMPLETED|Overall Study||6
6309378|NCT00392808|7213270|FG001|NOT COMPLETED|Overall Study||3
6309379|NCT00392808|7213271|FG002|NOT COMPLETED|Overall Study||2
6309380|NCT00392808|7213272|FG003|NOT COMPLETED|Overall Study||4
6375095|NCT00753922|7285695|FG000|NOT COMPLETED|Overall Study||246
6375096|NCT00753922|7285696|FG001|NOT COMPLETED|Overall Study||94
6557466|NCT01768000|7480036|FG001|NOT COMPLETED|Overall Study||2
6557467|NCT01768000|7480037|FG002|NOT COMPLETED|Overall Study||1
6375097|NCT00753922|7285697|FG002|NOT COMPLETED|Overall Study||63
6375098|NCT00753922|7285698|FG003|NOT COMPLETED|Overall Study||23
6375099|NCT00753935|7285710|FG000|STARTED|Overall Study||45
6375100|NCT00753935|7285711|FG001|STARTED|Overall Study||47
6375101|NCT00753935|7285710|FG000|COMPLETED|Overall Study||45
6375102|NCT00753935|7285711|FG001|COMPLETED|Overall Study||47
6375103|NCT00753935|7285710|FG000|NOT COMPLETED|Overall Study||0
6375104|NCT00753935|7285711|FG001|NOT COMPLETED|Overall Study||0
6375105|NCT00753948|7285720|FG000|STARTED|Overall Study||9
6375106|NCT00753948|7285721|FG001|STARTED|Overall Study||7
6375107|NCT00753948|7285722|FG002|STARTED|Overall Study||7
6375108|NCT00753948|7285720|FG000|COMPLETED|Overall Study||9
6375109|NCT00753948|7285721|FG001|COMPLETED|Overall Study||7
6375110|NCT00753948|7285722|FG002|COMPLETED|Overall Study||7
6375111|NCT00753948|7285720|FG000|NOT COMPLETED|Overall Study||0
6375112|NCT00753948|7285721|FG001|NOT COMPLETED|Overall Study||0
6375113|NCT00753948|7285722|FG002|NOT COMPLETED|Overall Study||0
6375114|NCT00754065|7285732|FG000|STARTED|Overall Study||203
6375115|NCT00754065|7285733|FG001|STARTED|Overall Study||206
6375116|NCT00754065|7285732|FG000|Participants Received Treatment|Overall Study||191
6375117|NCT00754065|7285733|FG001|Participants Received Treatment|Overall Study||204
6375118|NCT00754065|7285732|FG000|Cycle 6|Overall Study||141
6375119|NCT00754065|7285733|FG001|Cycle 6|Overall Study||153
6375120|NCT00754065|7285732|FG000|COMPLETED|Overall Study||122
6375121|NCT00754065|7285733|FG001|COMPLETED|Overall Study||126
6375122|NCT00754065|7285732|FG000|NOT COMPLETED|Overall Study||81
6375123|NCT00754065|7285733|FG001|NOT COMPLETED|Overall Study||80
6375124|NCT00754130|7285745|FG000|STARTED|Period 1 (5 Days)||2
6375125|NCT00754130|7285746|FG001|STARTED|Period 1 (5 Days)||2
6375126|NCT00754130|7285747|FG002|STARTED|Period 1 (5 Days)||4
6375127|NCT00754130|7285748|FG003|STARTED|Period 1 (5 Days)||2
6375128|NCT00754130|7285749|FG004|STARTED|Period 1 (5 Days)||2
6375129|NCT00754130|7285750|FG005|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
6375130|NCT00754130|7285745|FG000|COMPLETED|Period 1 (5 Days)||2
6773447|NCT03983317|7701104|FG000|STARTED|Overall Study||25
6309384|NCT00392834|7213288|FG000|STARTED|Overall Study||2
6309385|NCT00392834|7213289|FG001|STARTED|Overall Study||32
6309386|NCT00392834|7213288|FG000|COMPLETED|Overall Study||2
6309387|NCT00392834|7213289|FG001|COMPLETED|Overall Study||32
6309388|NCT00392834|7213288|FG000|NOT COMPLETED|Overall Study||0
6309389|NCT00392834|7213289|FG001|NOT COMPLETED|Overall Study||0
6309390|NCT00392925|7213299|FG000|STARTED|4 Week Lead-In Period - Non-Randomized||177
6309391|NCT00392925|7213300|FG001|STARTED|4 Week Lead-In Period - Non-Randomized||0
6309392|NCT00392925|7213301|FG002|STARTED|4 Week Lead-In Period - Non-Randomized||0
6309393|NCT00392925|7213302|FG003|STARTED|4 Week Lead-In Period - Non-Randomized||0
6309394|NCT00392925|7213299|FG000|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
6309395|NCT00392925|7213300|FG001|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6309396|NCT00392925|7213301|FG002|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6309397|NCT00392925|7213302|FG003|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6309398|NCT00392925|7213299|FG000|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
6309399|NCT00392925|7213300|FG001|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6309400|NCT00392925|7213301|FG002|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6309401|NCT00392925|7213302|FG003|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
6309402|NCT00392925|7213299|FG000|STARTED|Randomization to Treatment Group Period||0
6309403|NCT00392925|7213300|FG001|STARTED|Randomization to Treatment Group Period||27
6309404|NCT00392925|7213301|FG002|STARTED|Randomization to Treatment Group Period||56
6309405|NCT00392925|7213302|FG003|STARTED|Randomization to Treatment Group Period||56
6309406|NCT00392925|7213299|FG000|COMPLETED|Randomization to Treatment Group Period||0
6309407|NCT00392925|7213300|FG001|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
6309408|NCT00392925|7213301|FG002|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
6309409|NCT00392925|7213302|FG003|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
6309410|NCT00392925|7213299|FG000|NOT COMPLETED|Randomization to Treatment Group Period||0
6309411|NCT00392925|7213300|FG001|NOT COMPLETED|Randomization to Treatment Group Period||8
6309412|NCT00392925|7213301|FG002|NOT COMPLETED|Randomization to Treatment Group Period||19
6309413|NCT00392925|7213302|FG003|NOT COMPLETED|Randomization to Treatment Group Period||18
6309414|NCT00392951|7213318|FG000|STARTED|Overall Study||30
6309415|NCT00392951|7213318|FG000|COMPLETED|Overall Study||30
6309416|NCT00392951|7213318|FG000|NOT COMPLETED|Overall Study||0
6309417|NCT00392990|7213324|FG000|STARTED|Treatment on Study||20
6309418|NCT00392990|7213325|FG001|STARTED|Treatment on Study||5
6309419|NCT00392990|7213324|FG000|COMPLETED|Treatment on Study||17
6309420|NCT00392990|7213325|FG001|COMPLETED|Treatment on Study||4
6309421|NCT00392990|7213324|FG000|NOT COMPLETED|Treatment on Study||3
6309422|NCT00392990|7213325|FG001|NOT COMPLETED|Treatment on Study||1
6309423|NCT00392990|7213324|FG000|STARTED|Follow up for 2 Years||20
6309424|NCT00392990|7213325|FG001|STARTED|Follow up for 2 Years||5
6309425|NCT00392990|7213324|FG000|COMPLETED|Follow up for 2 Years||16
6309426|NCT00392990|7213325|FG001|COMPLETED|Follow up for 2 Years||5
6309427|NCT00392990|7213324|FG000|NOT COMPLETED|Follow up for 2 Years||4
6309428|NCT00392990|7213325|FG001|NOT COMPLETED|Follow up for 2 Years||0
6309429|NCT00393029|7213333|FG000|STARTED|Overall Study||2
6309430|NCT00393029|7213334|FG001|STARTED|Overall Study||10
6309431|NCT00393029|7213333|FG000|COMPLETED|Overall Study||2
6309432|NCT00393029|7213334|FG001|COMPLETED|Overall Study||9
6309433|NCT00393029|7213333|FG000|NOT COMPLETED|Overall Study||0
6309434|NCT00393029|7213334|FG001|NOT COMPLETED|Overall Study||1
6309435|NCT00393042|7213341|FG000|STARTED|First Intervention||31
6309436|NCT00393042|7213342|FG001|STARTED|First Intervention||33
6309437|NCT00393042|7213341|FG000|Completed the Placebo Dosage|First Intervention||27
6309438|NCT00393042|7213342|FG001|Completed the Placebo Dosage|First Intervention||29
6309439|NCT00393042|7213341|FG000|Completed 10mg Dosage|First Intervention||29
6309440|NCT00393042|7213342|FG001|Completed 10mg Dosage|First Intervention||29
6309441|NCT00393042|7213341|FG000|Completed 20 mg Dosage|First Intervention||26
6309442|NCT00393042|7213342|FG001|Completed 20 mg Dosage|First Intervention||28
6309443|NCT00393042|7213341|FG000|Completed 25/30mg Dosage|First Intervention||27
6309444|NCT00393042|7213342|FG001|Completed 25/30mg Dosage|First Intervention||27
6309445|NCT00393042|7213341|FG000|COMPLETED|First Intervention||26
6309446|NCT00393042|7213342|FG001|COMPLETED|First Intervention||27
6309447|NCT00393042|7213341|FG000|NOT COMPLETED|First Intervention||5
6309448|NCT00393042|7213342|FG001|NOT COMPLETED|First Intervention||6
6309449|NCT00393042|7213341|FG000|STARTED|Second Intervetion||26
6309450|NCT00393042|7213342|FG001|STARTED|Second Intervetion||27
6309451|NCT00393042|7213341|FG000|Completed Placebo Dosage|Second Intervetion||25
6309452|NCT00393042|7213342|FG001|Completed Placebo Dosage|Second Intervetion||21
6309453|NCT00393042|7213341|FG000|Completed 10 mg Dosage|Second Intervetion||26
6309454|NCT00393042|7213342|FG001|Completed 10 mg Dosage|Second Intervetion||24
6309455|NCT00393042|7213341|FG000|Completed the 20mg Dosage|Second Intervetion||24
6309456|NCT00393042|7213342|FG001|Completed the 20mg Dosage|Second Intervetion||21
6309457|NCT00393042|7213341|FG000|Completed 25/30 mg Dosage|Second Intervetion||24
6309458|NCT00393042|7213342|FG001|Completed 25/30 mg Dosage|Second Intervetion||20
6309459|NCT00393042|7213341|FG000|COMPLETED|Second Intervetion||24
6309460|NCT00393042|7213342|FG001|COMPLETED|Second Intervetion||19
6309461|NCT00393042|7213341|FG000|NOT COMPLETED|Second Intervetion||2
6309462|NCT00393042|7213342|FG001|NOT COMPLETED|Second Intervetion||8
6309463|NCT00393094|7213396|FG000|STARTED|Period1Bevacizumab & Irinotecan Patients||31
6309464|NCT00393094|7213396|FG000|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
6309465|NCT00393094|7213396|FG000|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
6309466|NCT00393094|7213396|FG000|STARTED|Disease Progression After Trtmt: Onstudy||30
6309467|NCT00393094|7213396|FG000|COMPLETED|Disease Progression After Trtmt: Onstudy||29
6309468|NCT00393094|7213396|FG000|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
6309469|NCT00393367|7213404|FG000|STARTED|Overall Study||91
6309470|NCT00393367|7213405|FG001|STARTED|Overall Study||88
6309471|NCT00393367|7213404|FG000|COMPLETED|Overall Study||89
6309472|NCT00393367|7213405|FG001|COMPLETED|Overall Study||81
6309473|NCT00393367|7213404|FG000|NOT COMPLETED|Overall Study||2
6309474|NCT00393367|7213405|FG001|NOT COMPLETED|Overall Study||7
6309475|NCT00393380|7213413|FG000|STARTED|Overall Study||13
6309476|NCT00393380|7213413|FG000|COMPLETED|Overall Study||13
6309477|NCT00393380|7213413|FG000|NOT COMPLETED|Overall Study||0
6309478|NCT00393458|7213421|FG000|STARTED|Overall Study||437
6309479|NCT00393458|7213422|FG001|STARTED|Overall Study||428
6309480|NCT00393458|7213423|FG002|STARTED|Overall Study||435
6309481|NCT00393458|7213424|FG003|STARTED|Overall Study||432
6309482|NCT00393458|7213421|FG000|Exposed to Study Medication or Placebo|Overall Study||437
6309483|NCT00393458|7213422|FG001|Exposed to Study Medication or Placebo|Overall Study||425
6309484|NCT00393458|7213423|FG002|Exposed to Study Medication or Placebo|Overall Study||434
6309485|NCT00393458|7213424|FG003|Exposed to Study Medication or Placebo|Overall Study||432
6309486|NCT00393458|7213421|FG000|COMPLETED|Overall Study||338
6309487|NCT00393458|7213422|FG001|COMPLETED|Overall Study||326
6309488|NCT00393458|7213423|FG002|COMPLETED|Overall Study||323
6309489|NCT00393458|7213424|FG003|COMPLETED|Overall Study||295
6309490|NCT00393458|7213421|FG000|NOT COMPLETED|Overall Study||99
6309491|NCT00393458|7213422|FG001|NOT COMPLETED|Overall Study||102
6309492|NCT00393458|7213423|FG002|NOT COMPLETED|Overall Study||112
6309493|NCT00393458|7213424|FG003|NOT COMPLETED|Overall Study||137
6309494|NCT00393484|7213436|FG000|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
6309495|NCT00393484|7213437|FG001|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
6309496|NCT00393484|7213436|FG000|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
6309497|NCT00393484|7213437|FG001|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
6309498|NCT00393484|7213436|FG000|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
6309499|NCT00393484|7213437|FG001|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
6309500|NCT00393484|7213436|FG000|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
6309501|NCT00393484|7213437|FG001|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
6309502|NCT00393484|7213436|FG000|STARTED|Open-label Period (Weeks 96 to 240)||48
6309503|NCT00393484|7213437|FG001|STARTED|Open-label Period (Weeks 96 to 240)||44
6309504|NCT00393484|7213436|FG000|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
6309505|NCT00393484|7213437|FG001|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
6309506|NCT00393484|7213436|FG000|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
6309507|NCT00393484|7213437|FG001|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
6309508|NCT00393484|7213436|FG000|COMPLETED|Open-label Period (Weeks 96 to 240)||40
6309509|NCT00393484|7213437|FG001|COMPLETED|Open-label Period (Weeks 96 to 240)||21
6309510|NCT00393484|7213436|FG000|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
6309511|NCT00393484|7213437|FG001|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
6309512|NCT00393510|7213447|FG000|STARTED|Overall Study||40
6309513|NCT00393510|7213448|FG001|STARTED|Overall Study||40
6309514|NCT00393510|7213447|FG000|COMPLETED|Overall Study||37
6309515|NCT00393510|7213448|FG001|COMPLETED|Overall Study||31
6309516|NCT00393510|7213447|FG000|NOT COMPLETED|Overall Study||3
6309517|NCT00393510|7213448|FG001|NOT COMPLETED|Overall Study||9
6309518|NCT00393523|7213459|FG000|STARTED|Overall Study||376
6309519|NCT00393523|7213460|FG001|STARTED|Overall Study||375
6309520|NCT00393523|7213461|FG002|STARTED|Overall Study||353
6309521|NCT00393523|7213462|FG003|STARTED|Overall Study||354
6309522|NCT00393523|7213463|FG004|STARTED|Overall Study||20
6309523|NCT00393523|7213459|FG000|Vaccination Visit 1|Overall Study||374
6309524|NCT00393523|7213460|FG001|Vaccination Visit 1|Overall Study||375
6309525|NCT00393523|7213461|FG002|Vaccination Visit 1|Overall Study||349
6309526|NCT00393523|7213462|FG003|Vaccination Visit 1|Overall Study||352
6309527|NCT00393523|7213463|FG004|Vaccination Visit 1|Overall Study||20
6309528|NCT00393523|7213459|FG000|COMPLETED|Overall Study||364
6309529|NCT00393523|7213460|FG001|COMPLETED|Overall Study||366
6309530|NCT00393523|7213461|FG002|COMPLETED|Overall Study||349
6309531|NCT00393523|7213462|FG003|COMPLETED|Overall Study||348
6309532|NCT00393523|7213463|FG004|COMPLETED|Overall Study||19
6309533|NCT00393523|7213459|FG000|NOT COMPLETED|Overall Study||12
6309534|NCT00393523|7213460|FG001|NOT COMPLETED|Overall Study||9
6309535|NCT00393523|7213461|FG002|NOT COMPLETED|Overall Study||4
6309536|NCT00393523|7213462|FG003|NOT COMPLETED|Overall Study||6
6309537|NCT00393523|7213463|FG004|NOT COMPLETED|Overall Study||1
6309538|NCT00393705|7213476|FG000|STARTED|Overall Study||151
6309539|NCT00393705|7213477|FG001|STARTED|Overall Study||151
6309540|NCT00393705|7213476|FG000|Received at Least One Dose of Study Drug|Overall Study||139
6309541|NCT00393705|7213477|FG001|Received at Least One Dose of Study Drug|Overall Study||139
6309542|NCT00393705|7213476|FG000|COMPLETED|Overall Study||128
6309543|NCT00393705|7213477|FG001|COMPLETED|Overall Study||128
6309544|NCT00393705|7213476|FG000|NOT COMPLETED|Overall Study||23
6309545|NCT00393705|7213477|FG001|NOT COMPLETED|Overall Study||23
6309546|NCT00393718|7213485|FG000|STARTED|Overall Study||268
6309547|NCT00393718|7213486|FG001|STARTED|Overall Study||132
6309548|NCT00393718|7213485|FG000|COMPLETED|Overall Study||225
6309549|NCT00393718|7213486|FG001|COMPLETED|Overall Study||110
6309550|NCT00393718|7213485|FG000|NOT COMPLETED|Overall Study||43
6309551|NCT00393718|7213486|FG001|NOT COMPLETED|Overall Study||22
6309552|NCT00393796|7213494|FG000|STARTED|Double Blind Period||26
6309553|NCT00393796|7213495|FG001|STARTED|Double Blind Period||28
6309554|NCT00393796|7213494|FG000|COMPLETED|Double Blind Period||26
6309555|NCT00393796|7213495|FG001|COMPLETED|Double Blind Period||28
6309556|NCT00393796|7213494|FG000|NOT COMPLETED|Double Blind Period||0
6309557|NCT00393796|7213495|FG001|NOT COMPLETED|Double Blind Period||0
6309558|NCT00393796|7213494|FG000|STARTED|Open Label Period - Placebo to SUTENT||0
6309559|NCT00393796|7213495|FG001|STARTED|Open Label Period - Placebo to SUTENT||16
6309560|NCT00393796|7213494|FG000|COMPLETED|Open Label Period - Placebo to SUTENT||0
6309561|NCT00393796|7213495|FG001|COMPLETED|Open Label Period - Placebo to SUTENT||16
6309562|NCT00393796|7213494|FG000|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
6309563|NCT00393796|7213495|FG001|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
6309564|NCT00393848|7213505|FG000|STARTED|Overall Study||16
6309565|NCT00393848|7213506|FG001|STARTED|Overall Study||9
6309566|NCT00393848|7213507|FG002|STARTED|Overall Study||6
6309567|NCT00393848|7213508|FG003|STARTED|Overall Study||9
6309568|NCT00393848|7213505|FG000|COMPLETED|Overall Study||16
6309569|NCT00393848|7213506|FG001|COMPLETED|Overall Study||9
6309570|NCT00393848|7213507|FG002|COMPLETED|Overall Study||4
6309571|NCT00393848|7213508|FG003|COMPLETED|Overall Study||8
6309572|NCT00393848|7213505|FG000|NOT COMPLETED|Overall Study||0
6309573|NCT00393848|7213506|FG001|NOT COMPLETED|Overall Study||0
6309574|NCT00393848|7213507|FG002|NOT COMPLETED|Overall Study||2
6309575|NCT00393848|7213508|FG003|NOT COMPLETED|Overall Study||1
6309576|NCT00393861|7213519|FG000|STARTED|Overall Study||29
6309577|NCT00393861|7213519|FG000|COMPLETED|Overall Study||3
6309578|NCT00393861|7213519|FG000|NOT COMPLETED|Overall Study||26
6309579|NCT00393874|7213526|FG000|STARTED|Overall Study||18
6309580|NCT00393874|7213527|FG001|STARTED|Overall Study||17
6309581|NCT00393874|7213528|FG002|STARTED|Overall Study||15
6309582|NCT00393874|7213526|FG000|COMPLETED|Overall Study||15
6309583|NCT00393874|7213527|FG001|COMPLETED|Overall Study||13
6309584|NCT00393874|7213528|FG002|COMPLETED|Overall Study||13
6309585|NCT00393874|7213526|FG000|NOT COMPLETED|Overall Study||3
6309586|NCT00393874|7213527|FG001|NOT COMPLETED|Overall Study||4
6309587|NCT00393874|7213528|FG002|NOT COMPLETED|Overall Study||2
6309588|NCT00393887|7213541|FG000|STARTED|Overall Study||50
6309589|NCT00393887|7213542|FG001|STARTED|Overall Study||50
6309590|NCT00393887|7213541|FG000|1 Year|Overall Study||45
6309591|NCT00393887|7213542|FG001|1 Year|Overall Study||50
6309592|NCT00393887|7213541|FG000|COMPLETED|Overall Study||34
6309593|NCT00393887|7213542|FG001|COMPLETED|Overall Study||41
6309594|NCT00393887|7213541|FG000|NOT COMPLETED|Overall Study||16
6557468|NCT01768000|7480038|FG003|NOT COMPLETED|Overall Study||2
6557469|NCT01768013|7480050|FG000|STARTED|Overall Study||13
6557470|NCT01768013|7480050|FG000|COMPLETED|Overall Study||13
6557471|NCT01768013|7480050|FG000|NOT COMPLETED|Overall Study||0
6557472|NCT01768117|7480054|FG000|STARTED|Overall Study||13
6309595|NCT00393887|7213542|FG001|NOT COMPLETED|Overall Study||9
6309596|NCT00393913|7213548|FG000|STARTED|Initial Assessment||144
6309597|NCT00393913|7213548|FG000|COMPLETED|Initial Assessment||107
6309598|NCT00393913|7213548|FG000|NOT COMPLETED|Initial Assessment||37
6309599|NCT00393913|7213548|FG000|STARTED|CPAP|Excludes normal volunteers without OSA|100
6309600|NCT00393913|7213548|FG000|COMPLETED|CPAP||93
6309601|NCT00393913|7213548|FG000|NOT COMPLETED|CPAP||7
6309602|NCT00393913|7213548|FG000|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
6309603|NCT00393913|7213548|FG000|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
6309604|NCT00393913|7213548|FG000|COMPLETED|CPAP Withdrawal||42
6309605|NCT00393913|7213548|FG000|NOT COMPLETED|CPAP Withdrawal||0
6309606|NCT00393939|7213555|FG000|STARTED|Overall Study||296
6309607|NCT00393939|7213556|FG001|STARTED|Overall Study||297
6309608|NCT00393939|7213555|FG000|Treated|Overall Study||295
6309609|NCT00393939|7213556|FG001|Treated|Overall Study||293
6309610|NCT00393939|7213555|FG000|COMPLETED|Overall Study||0
6309611|NCT00393939|7213556|FG001|COMPLETED|Overall Study||0
6309612|NCT00393939|7213555|FG000|NOT COMPLETED|Overall Study||296
6309613|NCT00393939|7213556|FG001|NOT COMPLETED|Overall Study||297
6309614|NCT00393978|7213564|FG000|STARTED|Overall Study||37
6309615|NCT00393978|7213565|FG001|STARTED|Overall Study||38
6309616|NCT00393978|7213564|FG000|COMPLETED|Overall Study||21
6309617|NCT00393978|7213565|FG001|COMPLETED|Overall Study||18
6557473|NCT01768117|7480054|FG000|COMPLETED|Overall Study||7
6557474|NCT01768117|7480054|FG000|NOT COMPLETED|Overall Study||6
6309618|NCT00393978|7213564|FG000|NOT COMPLETED|Overall Study||16
6309619|NCT00393978|7213565|FG001|NOT COMPLETED|Overall Study||20
6309620|NCT00394082|7213571|FG000|STARTED|Overall Study||50
6309621|NCT00394082|7213571|FG000|At Least One Response Assessment|Overall Study||43
6309622|NCT00394082|7213571|FG000|COMPLETED|Overall Study|Treatment completed upon disease progression|24
6309623|NCT00394082|7213571|FG000|NOT COMPLETED|Overall Study||26
6309624|NCT00394095|7213577|FG000|STARTED|Overall Study||17
6309625|NCT00394095|7213578|FG001|STARTED|Overall Study||14
6309626|NCT00394095|7213577|FG000|Screened|Overall Study||17
6309627|NCT00394095|7213578|FG001|Screened|Overall Study||14
6309628|NCT00394095|7213577|FG000|COMPLETED|Overall Study||16
6309629|NCT00394095|7213578|FG001|COMPLETED|Overall Study||14
6309630|NCT00394095|7213577|FG000|NOT COMPLETED|Overall Study||1
6309631|NCT00394095|7213578|FG001|NOT COMPLETED|Overall Study||0
6309632|NCT00394212|7213587|FG000|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
6309633|NCT00394212|7213588|FG001|STARTED|Overall Study||27
6309634|NCT00394212|7213587|FG000|6 Week Follow-up|Overall Study||45
6309635|NCT00394212|7213588|FG001|6 Week Follow-up|Overall Study||26
6309636|NCT00394212|7213587|FG000|3 Month Follow-up|Overall Study||45
6309637|NCT00394212|7213588|FG001|3 Month Follow-up|Overall Study||26
6309638|NCT00394212|7213587|FG000|6 Month Follow-up|Overall Study||43
6309639|NCT00394212|7213588|FG001|6 Month Follow-up|Overall Study||26
6309640|NCT00394212|7213587|FG000|COMPLETED|Overall Study||43
6309641|NCT00394212|7213588|FG001|COMPLETED|Overall Study||26
6309642|NCT00394212|7213587|FG000|NOT COMPLETED|Overall Study||7
6309643|NCT00394212|7213588|FG001|NOT COMPLETED|Overall Study||1
6309644|NCT00394251|7213596|FG000|STARTED|Overall Study||98
6309645|NCT00394251|7213597|FG001|STARTED|Overall Study||99
6309646|NCT00394251|7213596|FG000|At Least One Dose of Taxane|Overall Study||93
6309647|NCT00394251|7213597|FG001|At Least One Dose of Taxane|Overall Study||93
6309648|NCT00394251|7213596|FG000|COMPLETED|Overall Study||61
6309649|NCT00394251|7213597|FG001|COMPLETED|Overall Study||61
6309650|NCT00394251|7213596|FG000|NOT COMPLETED|Overall Study||37
6309651|NCT00394251|7213597|FG001|NOT COMPLETED|Overall Study||38
6309652|NCT00394277|7213611|FG000|STARTED|Overall Study||195
6309653|NCT00394277|7213612|FG001|STARTED|Overall Study||196
6309654|NCT00394277|7213613|FG002|STARTED|Overall Study||393
6309655|NCT00394277|7213614|FG003|STARTED|Overall Study||391
6309656|NCT00394277|7213611|FG000|COMPLETED|Overall Study||137
6309657|NCT00394277|7213612|FG001|COMPLETED|Overall Study||136
6309658|NCT00394277|7213613|FG002|COMPLETED|Overall Study||273
6309659|NCT00394277|7213614|FG003|COMPLETED|Overall Study||266
6309660|NCT00394277|7213611|FG000|NOT COMPLETED|Overall Study||58
6309661|NCT00394277|7213612|FG001|NOT COMPLETED|Overall Study||60
6309662|NCT00394277|7213613|FG002|NOT COMPLETED|Overall Study||120
6309663|NCT00394277|7213614|FG003|NOT COMPLETED|Overall Study||125
6309664|NCT00394329|7213628|FG000|STARTED|Overall Study||71
6309665|NCT00394329|7213629|FG001|STARTED|Overall Study||72
6309666|NCT00394329|7213630|FG002|STARTED|Overall Study||71
6309667|NCT00394329|7213631|FG003|STARTED|Overall Study||74
6309668|NCT00394329|7213628|FG000|COMPLETED|Overall Study||63
6309669|NCT00394329|7213629|FG001|COMPLETED|Overall Study||63
6309670|NCT00394329|7213630|FG002|COMPLETED|Overall Study||58
6309671|NCT00394329|7213631|FG003|COMPLETED|Overall Study||50
6309672|NCT00394329|7213628|FG000|NOT COMPLETED|Overall Study||8
6309673|NCT00394329|7213629|FG001|NOT COMPLETED|Overall Study||9
6309674|NCT00394329|7213630|FG002|NOT COMPLETED|Overall Study||13
6309675|NCT00394329|7213631|FG003|NOT COMPLETED|Overall Study||24
6309676|NCT00394433|7213647|FG000|STARTED|Overall Study||38
6309677|NCT00394433|7213647|FG000|Evaluable and Treated|Overall Study||35
6309678|NCT00394433|7213647|FG000|COMPLETED|Overall Study||35
6309679|NCT00394433|7213647|FG000|NOT COMPLETED|Overall Study||3
6309680|NCT00394472|7213653|FG000|STARTED|Overall Study||122
6309681|NCT00394472|7213654|FG001|STARTED|Overall Study||122
6309682|NCT00394472|7213653|FG000|COMPLETED|Overall Study||113
6309683|NCT00394472|7213654|FG001|COMPLETED|Overall Study||111
6309684|NCT00394472|7213653|FG000|NOT COMPLETED|Overall Study||9
6309685|NCT00394472|7213654|FG001|NOT COMPLETED|Overall Study||11
6309686|NCT00394524|7213662|FG000|STARTED|Overall Study||80
6309687|NCT00394524|7213663|FG001|STARTED|Overall Study||80
6309688|NCT00394524|7213662|FG000|COMPLETED|Overall Study||77
6309689|NCT00394524|7213663|FG001|COMPLETED|Overall Study||76
6309690|NCT00394524|7213662|FG000|NOT COMPLETED|Overall Study||3
6309691|NCT00394524|7213663|FG001|NOT COMPLETED|Overall Study||4
6309692|NCT00394589|7213674|FG000|STARTED|Overall Study||14
6309693|NCT00394589|7213675|FG001|STARTED|Overall Study||11
6309694|NCT00394589|7213676|FG002|STARTED|Overall Study||18
6309695|NCT00394589|7213674|FG000|COMPLETED|Overall Study||6
6309696|NCT00394589|7213675|FG001|COMPLETED|Overall Study||8
6309697|NCT00394589|7213676|FG002|COMPLETED|Overall Study||11
6309698|NCT00394589|7213674|FG000|NOT COMPLETED|Overall Study||8
6309699|NCT00394589|7213675|FG001|NOT COMPLETED|Overall Study||3
6309700|NCT00394589|7213676|FG002|NOT COMPLETED|Overall Study||7
6309701|NCT00394654|7213686|FG000|STARTED|Overall Study||15
6309702|NCT00394654|7213687|FG001|STARTED|Overall Study||15
6309703|NCT00394654|7213686|FG000|COMPLETED|Overall Study||13
6309704|NCT00394654|7213687|FG001|COMPLETED|Overall Study||15
6309705|NCT00394654|7213686|FG000|NOT COMPLETED|Overall Study||2
6309706|NCT00394654|7213687|FG001|NOT COMPLETED|Overall Study||0
6309707|NCT00394706|7213701|FG000|STARTED|Overall Study||1819
6309708|NCT00394706|7213702|FG001|STARTED|Overall Study||1862
6309709|NCT00394706|7213703|FG002|STARTED|Overall Study||1624
6309710|NCT00394706|7213704|FG003|STARTED|Overall Study||1633
6309711|NCT00394706|7213705|FG004|STARTED|Overall Study||1636
6309712|NCT00394706|7213706|FG005|STARTED|Overall Study||1384
6309713|NCT00394706|7213707|FG006|STARTED|Overall Study||929
6309714|NCT00394706|7213708|FG007|STARTED|Overall Study||851
6309715|NCT00394706|7213701|FG000|COMPLETED|Overall Study||1815
6309716|NCT00394706|7213702|FG001|COMPLETED|Overall Study||1860
6309717|NCT00394706|7213703|FG002|COMPLETED|Overall Study||1615
6309718|NCT00394706|7213704|FG003|COMPLETED|Overall Study||1632
6309719|NCT00394706|7213705|FG004|COMPLETED|Overall Study||1634
6309720|NCT00394706|7213706|FG005|COMPLETED|Overall Study||1377
6309721|NCT00394706|7213707|FG006|COMPLETED|Overall Study||926
6309722|NCT00394706|7213708|FG007|COMPLETED|Overall Study||851
6309723|NCT00394706|7213701|FG000|NOT COMPLETED|Overall Study||4
6309724|NCT00394706|7213702|FG001|NOT COMPLETED|Overall Study||2
6309725|NCT00394706|7213703|FG002|NOT COMPLETED|Overall Study||9
6309726|NCT00394706|7213704|FG003|NOT COMPLETED|Overall Study||1
6309727|NCT00394706|7213705|FG004|NOT COMPLETED|Overall Study||2
6309728|NCT00394706|7213706|FG005|NOT COMPLETED|Overall Study||7
6309729|NCT00394706|7213707|FG006|NOT COMPLETED|Overall Study||3
6309730|NCT00394706|7213708|FG007|NOT COMPLETED|Overall Study||0
6309731|NCT00394771|7213726|FG000|STARTED|Overall Study|Safety population of treated participants|140
6309732|NCT00394771|7213727|FG001|STARTED|Overall Study|Safety population of treated participants|136
6309733|NCT00394771|7213728|FG002|STARTED|Overall Study|Safety population of treated participants|143
6309734|NCT00394771|7213729|FG003|STARTED|Overall Study|Safety population of treated participants|148
6309735|NCT00394771|7213726|FG000|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
6309736|NCT00394771|7213727|FG001|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
6309737|NCT00394771|7213728|FG002|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
6309738|NCT00394771|7213729|FG003|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
6309739|NCT00394771|7213726|FG000|COMPLETED|Overall Study||99
6309740|NCT00394771|7213727|FG001|COMPLETED|Overall Study||102
6309741|NCT00394771|7213728|FG002|COMPLETED|Overall Study||96
6309742|NCT00394771|7213729|FG003|COMPLETED|Overall Study||109
6309743|NCT00394771|7213726|FG000|NOT COMPLETED|Overall Study||41
6309744|NCT00394771|7213727|FG001|NOT COMPLETED|Overall Study||34
6309745|NCT00394771|7213728|FG002|NOT COMPLETED|Overall Study||47
6309746|NCT00394771|7213729|FG003|NOT COMPLETED|Overall Study||39
6309747|NCT00394836|7213741|FG000|STARTED|Teatment or Follow-up Phase||30
6309748|NCT00394836|7213742|FG001|STARTED|Teatment or Follow-up Phase||86
6309749|NCT00394836|7213741|FG000|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
6309750|NCT00394836|7213742|FG001|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
6309751|NCT00394836|7213741|FG000|COMPLETED|Teatment or Follow-up Phase||2
6309752|NCT00394836|7213742|FG001|COMPLETED|Teatment or Follow-up Phase||8
6309753|NCT00394836|7213741|FG000|NOT COMPLETED|Teatment or Follow-up Phase||28
6309754|NCT00394836|7213742|FG001|NOT COMPLETED|Teatment or Follow-up Phase||78
6309755|NCT00394836|7213741|FG000|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
6309756|NCT00394836|7213742|FG001|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
6309757|NCT00394836|7213741|FG000|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
6309758|NCT00394836|7213742|FG001|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
6309759|NCT00394836|7213741|FG000|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
6309760|NCT00394836|7213742|FG001|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
6309761|NCT00394888|7213753|FG000|STARTED|Overall Study||108
6309762|NCT00394888|7213754|FG001|STARTED|Overall Study||48
6309763|NCT00394888|7213755|FG002|STARTED|Overall Study||201
6309764|NCT00394888|7213753|FG000|COMPLETED|Overall Study||108
6309765|NCT00394888|7213754|FG001|COMPLETED|Overall Study||48
6309766|NCT00394888|7213755|FG002|COMPLETED|Overall Study||201
6309767|NCT00394888|7213753|FG000|NOT COMPLETED|Overall Study||0
6309768|NCT00394888|7213754|FG001|NOT COMPLETED|Overall Study||0
6309769|NCT00394888|7213755|FG002|NOT COMPLETED|Overall Study||0
6309770|NCT00394901|7213765|FG000|STARTED|Baseline Phase|Subjects randomized|98
6309771|NCT00394901|7213766|FG001|STARTED|Baseline Phase|Subjects randomized|87
6309772|NCT00394901|7213767|FG002|STARTED|Baseline Phase|Subjects randomized|90
6309773|NCT00394901|7213768|FG003|STARTED|Baseline Phase|Subjects randomized|97
6309774|NCT00394901|7213765|FG000|COMPLETED|Baseline Phase||98
6309775|NCT00394901|7213766|FG001|COMPLETED|Baseline Phase||87
6309776|NCT00394901|7213767|FG002|COMPLETED|Baseline Phase||89
6309777|NCT00394901|7213768|FG003|COMPLETED|Baseline Phase||97
6309778|NCT00394901|7213765|FG000|NOT COMPLETED|Baseline Phase||0
6309779|NCT00394901|7213766|FG001|NOT COMPLETED|Baseline Phase||0
6309780|NCT00394901|7213767|FG002|NOT COMPLETED|Baseline Phase||1
6309781|NCT00394901|7213768|FG003|NOT COMPLETED|Baseline Phase||0
6309782|NCT00394901|7213765|FG000|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
6309783|NCT00394901|7213766|FG001|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
6309784|NCT00394901|7213767|FG002|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
6309785|NCT00394901|7213768|FG003|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
6309786|NCT00394901|7213765|FG000|COMPLETED|Double-blind Phase||83
6309787|NCT00394901|7213766|FG001|COMPLETED|Double-blind Phase||73
6309788|NCT00394901|7213767|FG002|COMPLETED|Double-blind Phase||71
6309789|NCT00394901|7213768|FG003|COMPLETED|Double-blind Phase||70
6309790|NCT00394901|7213765|FG000|NOT COMPLETED|Double-blind Phase||15
6309791|NCT00394901|7213766|FG001|NOT COMPLETED|Double-blind Phase||14
6309792|NCT00394901|7213767|FG002|NOT COMPLETED|Double-blind Phase||18
6309793|NCT00394901|7213768|FG003|NOT COMPLETED|Double-blind Phase||27
6309794|NCT00394914|7213783|FG000|STARTED|Screening Period||311
6309795|NCT00394914|7213784|FG001|STARTED|Screening Period||0
6309796|NCT00394914|7213785|FG002|STARTED|Screening Period||0
6309797|NCT00394914|7213783|FG000|COMPLETED|Screening Period||311
6309798|NCT00394914|7213784|FG001|COMPLETED|Screening Period||0
6309799|NCT00394914|7213785|FG002|COMPLETED|Screening Period||0
6309800|NCT00394914|7213783|FG000|NOT COMPLETED|Screening Period||0
6309801|NCT00394914|7213784|FG001|NOT COMPLETED|Screening Period||0
6309802|NCT00394914|7213785|FG002|NOT COMPLETED|Screening Period||0
6309803|NCT00394914|7213783|FG000|STARTED|Pre-exposure Period||311
6309804|NCT00394914|7213784|FG001|STARTED|Pre-exposure Period||0
6309805|NCT00394914|7213785|FG002|STARTED|Pre-exposure Period||0
6309806|NCT00394914|7213783|FG000|COMPLETED|Pre-exposure Period||311
6309807|NCT00394914|7213784|FG001|COMPLETED|Pre-exposure Period||0
6309808|NCT00394914|7213785|FG002|COMPLETED|Pre-exposure Period||0
6309809|NCT00394914|7213783|FG000|NOT COMPLETED|Pre-exposure Period||0
6309810|NCT00394914|7213784|FG001|NOT COMPLETED|Pre-exposure Period||0
6309811|NCT00394914|7213785|FG002|NOT COMPLETED|Pre-exposure Period||0
6309812|NCT00394914|7213783|FG000|STARTED|Treatment Period||0
6309813|NCT00394914|7213784|FG001|STARTED|Treatment Period||154
6309814|NCT00394914|7213785|FG002|STARTED|Treatment Period||157
6309815|NCT00394914|7213783|FG000|COMPLETED|Treatment Period||0
6309816|NCT00394914|7213784|FG001|COMPLETED|Treatment Period||144
6309817|NCT00394914|7213785|FG002|COMPLETED|Treatment Period||151
6309818|NCT00394914|7213783|FG000|NOT COMPLETED|Treatment Period||0
6309819|NCT00394914|7213784|FG001|NOT COMPLETED|Treatment Period||10
6309820|NCT00394914|7213785|FG002|NOT COMPLETED|Treatment Period||6
6309821|NCT00394953|7213793|FG000|STARTED|First Treatment Period||245
6309822|NCT00394953|7213794|FG001|STARTED|First Treatment Period||244
6309823|NCT00394953|7213793|FG000|COMPLETED|First Treatment Period||216
6309824|NCT00394953|7213794|FG001|COMPLETED|First Treatment Period||222
6309825|NCT00394953|7213793|FG000|NOT COMPLETED|First Treatment Period||29
6309826|NCT00394953|7213794|FG001|NOT COMPLETED|First Treatment Period||22
6309827|NCT00394953|7213793|FG000|STARTED|Second Treatment Period||216
6309828|NCT00394953|7213794|FG001|STARTED|Second Treatment Period||222
6309829|NCT00394953|7213793|FG000|COMPLETED|Second Treatment Period||187
6309830|NCT00394953|7213794|FG001|COMPLETED|Second Treatment Period||148
6309831|NCT00394953|7213793|FG000|NOT COMPLETED|Second Treatment Period||29
6309832|NCT00394953|7213794|FG001|NOT COMPLETED|Second Treatment Period||74
6309833|NCT00395018|7213800|FG000|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
6309834|NCT00395018|7213800|FG000|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
6309835|NCT00395018|7213800|FG000|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
6309836|NCT00395018|7213800|FG000|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
6309837|NCT00395018|7213800|FG000|NOT COMPLETED|On-Treatment||10
6309838|NCT00395018|7213800|FG000|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
6309839|NCT00395018|7213800|FG000|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
6309840|NCT00395018|7213800|FG000|NOT COMPLETED|Off-Treatment Follow-up||4
6309841|NCT00395044|7213806|FG000|STARTED|Overall Study||25
6309842|NCT00395044|7213807|FG001|STARTED|Overall Study||25
6309843|NCT00395044|7213806|FG000|COMPLETED|Overall Study||7
6309844|NCT00395044|7213807|FG001|COMPLETED|Overall Study||11
6309845|NCT00395044|7213806|FG000|NOT COMPLETED|Overall Study||18
6309846|NCT00395044|7213807|FG001|NOT COMPLETED|Overall Study||14
6309847|NCT00395057|7213817|FG000|STARTED|Overall Study||34
6309848|NCT00395057|7213818|FG001|STARTED|Overall Study||35
6309849|NCT00395057|7213819|FG002|STARTED|Overall Study||35
6309850|NCT00395057|7213820|FG003|STARTED|Overall Study||34
6309851|NCT00395057|7213817|FG000|COMPLETED|Overall Study||2
6309852|NCT00395057|7213818|FG001|COMPLETED|Overall Study||1
6309853|NCT00395057|7213819|FG002|COMPLETED|Overall Study||2
6309854|NCT00395057|7213820|FG003|COMPLETED|Overall Study||1
6309855|NCT00395057|7213817|FG000|NOT COMPLETED|Overall Study||32
6309856|NCT00395057|7213818|FG001|NOT COMPLETED|Overall Study||34
6309857|NCT00395057|7213819|FG002|NOT COMPLETED|Overall Study||33
6309858|NCT00395057|7213820|FG003|NOT COMPLETED|Overall Study||33
6309859|NCT00395083|7213832|FG000|STARTED|Overall Study||217
6309860|NCT00395083|7213833|FG001|STARTED|Overall Study||209
6309861|NCT00395083|7213832|FG000|COMPLETED|Overall Study||207
6309862|NCT00395083|7213833|FG001|COMPLETED|Overall Study||201
6309863|NCT00395083|7213832|FG000|NOT COMPLETED|Overall Study||10
6309864|NCT00395083|7213833|FG001|NOT COMPLETED|Overall Study||8
6309865|NCT00395135|7213841|FG000|STARTED|Year 1||1595
6309866|NCT00395135|7213842|FG001|STARTED|Year 1||1587
6309867|NCT00395135|7213843|FG002|STARTED|Year 1||0
6309868|NCT00395135|7213844|FG003|STARTED|Year 1||0
6309869|NCT00395135|7213845|FG004|STARTED|Year 1||0
6309870|NCT00395135|7213841|FG000|COMPLETED|Year 1||883
6309871|NCT00395135|7213842|FG001|COMPLETED|Year 1||716
6309872|NCT00395135|7213843|FG002|COMPLETED|Year 1||0
6309873|NCT00395135|7213844|FG003|COMPLETED|Year 1||0
6309874|NCT00395135|7213845|FG004|COMPLETED|Year 1||0
6309875|NCT00395135|7213841|FG000|NOT COMPLETED|Year 1||712
6309876|NCT00395135|7213842|FG001|NOT COMPLETED|Year 1||871
6309877|NCT00395135|7213843|FG002|NOT COMPLETED|Year 1||0
6309878|NCT00395135|7213844|FG003|NOT COMPLETED|Year 1||0
6309879|NCT00395135|7213845|FG004|NOT COMPLETED|Year 1||0
6309880|NCT00395135|7213841|FG000|STARTED|Year 2||0
6309881|NCT00395135|7213842|FG001|STARTED|Year 2||0
6309882|NCT00395135|7213843|FG002|STARTED|Year 2||573
6309883|NCT00395135|7213844|FG003|STARTED|Year 2||283
6309884|NCT00395135|7213845|FG004|STARTED|Year 2||697
6309885|NCT00395135|7213841|FG000|COMPLETED|Year 2||0
6309886|NCT00395135|7213842|FG001|COMPLETED|Year 2||0
6309887|NCT00395135|7213843|FG002|COMPLETED|Year 2||426
6309888|NCT00395135|7213844|FG003|COMPLETED|Year 2||195
6309889|NCT00395135|7213845|FG004|COMPLETED|Year 2||507
6309890|NCT00395135|7213841|FG000|NOT COMPLETED|Year 2||0
6309891|NCT00395135|7213842|FG001|NOT COMPLETED|Year 2||0
6309892|NCT00395135|7213843|FG002|NOT COMPLETED|Year 2||147
6309893|NCT00395135|7213844|FG003|NOT COMPLETED|Year 2||88
6309894|NCT00395135|7213845|FG004|NOT COMPLETED|Year 2||190
6309895|NCT00395161|7213861|FG000|STARTED|Overall Study||149
6309896|NCT00395161|7213862|FG001|STARTED|Overall Study||144
6309897|NCT00395161|7213861|FG000|COMPLETED|Overall Study||149
6309898|NCT00395161|7213862|FG001|COMPLETED|Overall Study||144
6309899|NCT00395161|7213861|FG000|NOT COMPLETED|Overall Study||0
6309900|NCT00395161|7213862|FG001|NOT COMPLETED|Overall Study||0
6309901|NCT00395226|7213872|FG000|STARTED|Overall Study||26
6309902|NCT00395226|7213873|FG001|STARTED|Overall Study||27
6309903|NCT00395226|7213872|FG000|COMPLETED|Overall Study||22
6309904|NCT00395226|7213873|FG001|COMPLETED|Overall Study||22
6309905|NCT00395226|7213872|FG000|NOT COMPLETED|Overall Study||4
6309906|NCT00395226|7213873|FG001|NOT COMPLETED|Overall Study||5
6309907|NCT00395291|7213879|FG000|STARTED|First Intervention||17
6309908|NCT00395291|7213880|FG001|STARTED|First Intervention||9
6309909|NCT00395291|7213879|FG000|COMPLETED|First Intervention||15
6309910|NCT00395291|7213880|FG001|COMPLETED|First Intervention||9
6309911|NCT00395291|7213879|FG000|NOT COMPLETED|First Intervention||2
6309912|NCT00395291|7213880|FG001|NOT COMPLETED|First Intervention||0
6309913|NCT00395291|7213879|FG000|STARTED|Washout Period for 30 Days||15
6309914|NCT00395291|7213880|FG001|STARTED|Washout Period for 30 Days||9
6309915|NCT00395291|7213879|FG000|COMPLETED|Washout Period for 30 Days||13
6309916|NCT00395291|7213880|FG001|COMPLETED|Washout Period for 30 Days||9
6309917|NCT00395291|7213879|FG000|NOT COMPLETED|Washout Period for 30 Days||2
6309918|NCT00395291|7213880|FG001|NOT COMPLETED|Washout Period for 30 Days||0
6309919|NCT00395291|7213879|FG000|STARTED|Second Intervention||13
6309920|NCT00395291|7213880|FG001|STARTED|Second Intervention||9
6309921|NCT00395291|7213879|FG000|COMPLETED|Second Intervention||13
6309922|NCT00395291|7213880|FG001|COMPLETED|Second Intervention||9
6309923|NCT00395291|7213879|FG000|NOT COMPLETED|Second Intervention||0
6309924|NCT00395291|7213880|FG001|NOT COMPLETED|Second Intervention||0
6309925|NCT00395304|7213886|FG000|STARTED|Treatment Period 1||31
6309926|NCT00395304|7213887|FG001|STARTED|Treatment Period 1||30
6309927|NCT00395304|7213888|FG002|STARTED|Treatment Period 1||30
6309928|NCT00395304|7213889|FG003|STARTED|Treatment Period 1||31
6309929|NCT00395304|7213890|FG004|STARTED|Treatment Period 1||28
6309930|NCT00395304|7213891|FG005|STARTED|Treatment Period 1||32
6309931|NCT00395304|7213886|FG000|COMPLETED|Treatment Period 1||30
6309932|NCT00395304|7213887|FG001|COMPLETED|Treatment Period 1||26
6309933|NCT00395304|7213888|FG002|COMPLETED|Treatment Period 1||30
6309934|NCT00395304|7213889|FG003|COMPLETED|Treatment Period 1||28
6309935|NCT00395304|7213890|FG004|COMPLETED|Treatment Period 1||27
6309936|NCT00395304|7213891|FG005|COMPLETED|Treatment Period 1||30
6309937|NCT00395304|7213886|FG000|NOT COMPLETED|Treatment Period 1||1
6309938|NCT00395304|7213887|FG001|NOT COMPLETED|Treatment Period 1||4
6309939|NCT00395304|7213888|FG002|NOT COMPLETED|Treatment Period 1||0
6309940|NCT00395304|7213889|FG003|NOT COMPLETED|Treatment Period 1||3
6309941|NCT00395304|7213890|FG004|NOT COMPLETED|Treatment Period 1||1
6309942|NCT00395304|7213891|FG005|NOT COMPLETED|Treatment Period 1||2
6309943|NCT00395304|7213886|FG000|STARTED|Treatment Period 2||30
6309944|NCT00395304|7213887|FG001|STARTED|Treatment Period 2||26
6309945|NCT00395304|7213888|FG002|STARTED|Treatment Period 2||30
6309946|NCT00395304|7213889|FG003|STARTED|Treatment Period 2||28
6309947|NCT00395304|7213890|FG004|STARTED|Treatment Period 2||27
6309948|NCT00395304|7213891|FG005|STARTED|Treatment Period 2||30
6309949|NCT00395304|7213886|FG000|COMPLETED|Treatment Period 2||30
6309950|NCT00395304|7213887|FG001|COMPLETED|Treatment Period 2||22
6309951|NCT00395304|7213888|FG002|COMPLETED|Treatment Period 2||29
6309952|NCT00395304|7213889|FG003|COMPLETED|Treatment Period 2||27
6309953|NCT00395304|7213890|FG004|COMPLETED|Treatment Period 2||27
6309954|NCT00395304|7213891|FG005|COMPLETED|Treatment Period 2||28
6309955|NCT00395304|7213886|FG000|NOT COMPLETED|Treatment Period 2||0
6309956|NCT00395304|7213887|FG001|NOT COMPLETED|Treatment Period 2||4
6309957|NCT00395304|7213888|FG002|NOT COMPLETED|Treatment Period 2||1
6309958|NCT00395304|7213889|FG003|NOT COMPLETED|Treatment Period 2||1
6309959|NCT00395304|7213890|FG004|NOT COMPLETED|Treatment Period 2||0
6309960|NCT00395304|7213891|FG005|NOT COMPLETED|Treatment Period 2||2
6309961|NCT00395304|7213886|FG000|STARTED|Treatment Period 3||30
6309962|NCT00395304|7213887|FG001|STARTED|Treatment Period 3||22
6309963|NCT00395304|7213888|FG002|STARTED|Treatment Period 3||29
6309964|NCT00395304|7213889|FG003|STARTED|Treatment Period 3||27
6309965|NCT00395304|7213890|FG004|STARTED|Treatment Period 3||27
6309966|NCT00395304|7213891|FG005|STARTED|Treatment Period 3||28
6309967|NCT00395304|7213886|FG000|COMPLETED|Treatment Period 3||29
6309968|NCT00395304|7213887|FG001|COMPLETED|Treatment Period 3||20
6309969|NCT00395304|7213888|FG002|COMPLETED|Treatment Period 3||29
6309970|NCT00395304|7213889|FG003|COMPLETED|Treatment Period 3||25
6309971|NCT00395304|7213890|FG004|COMPLETED|Treatment Period 3||27
6309972|NCT00395304|7213891|FG005|COMPLETED|Treatment Period 3||27
6309973|NCT00395304|7213886|FG000|NOT COMPLETED|Treatment Period 3||1
6309974|NCT00395304|7213887|FG001|NOT COMPLETED|Treatment Period 3||2
6309975|NCT00395304|7213888|FG002|NOT COMPLETED|Treatment Period 3||0
6309976|NCT00395304|7213889|FG003|NOT COMPLETED|Treatment Period 3||2
6309977|NCT00395304|7213890|FG004|NOT COMPLETED|Treatment Period 3||0
6309978|NCT00395304|7213891|FG005|NOT COMPLETED|Treatment Period 3||1
6309979|NCT00395343|7213900|FG000|STARTED|Overall Study||322
6309980|NCT00395343|7213901|FG001|STARTED|Overall Study||319
6309981|NCT00395343|7213900|FG000|COMPLETED|Overall Study||281
6309982|NCT00395343|7213901|FG001|COMPLETED|Overall Study||283
6309983|NCT00395343|7213900|FG000|NOT COMPLETED|Overall Study||41
6309984|NCT00395343|7213901|FG001|NOT COMPLETED|Overall Study||36
6309985|NCT00395447|7213909|FG000|STARTED|Overall Study||1031
6309986|NCT00395447|7213910|FG001|STARTED|Overall Study||713
6309987|NCT00395447|7213909|FG000|COMPLETED|Overall Study||910
6309988|NCT00395447|7213910|FG001|COMPLETED|Overall Study||602
6309989|NCT00395447|7213909|FG000|NOT COMPLETED|Overall Study||121
6309990|NCT00395447|7213910|FG001|NOT COMPLETED|Overall Study||111
6309991|NCT00395460|7213918|FG000|STARTED|Overall Study||72
6309992|NCT00395460|7213919|FG001|STARTED|Overall Study||75
6309993|NCT00395460|7213918|FG000|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
6309994|NCT00395460|7213919|FG001|Received Treatment|Overall Study||75
6309995|NCT00395460|7213918|FG000|COMPLETED|Overall Study||71
6309996|NCT00395460|7213919|FG001|COMPLETED|Overall Study||75
6309997|NCT00395460|7213918|FG000|NOT COMPLETED|Overall Study||1
6309998|NCT00395460|7213919|FG001|NOT COMPLETED|Overall Study||0
6309999|NCT00395486|7213927|FG000|STARTED|Overall Study|Randomized subjects|132
6310000|NCT00395486|7213928|FG001|STARTED|Overall Study|Randomized subjects|126
6310001|NCT00395486|7213927|FG000|COMPLETED|Overall Study|Completed subjects|126
6310002|NCT00395486|7213928|FG001|COMPLETED|Overall Study|Completed subjects|121
6310003|NCT00395486|7213927|FG000|NOT COMPLETED|Overall Study||6
6310004|NCT00395486|7213928|FG001|NOT COMPLETED|Overall Study||5
6310005|NCT00395512|7213938|FG000|STARTED|Overall Study||164
6310006|NCT00395512|7213939|FG001|STARTED|Overall Study||163
6310007|NCT00395512|7213940|FG002|STARTED|Overall Study||164
6310008|NCT00395512|7213941|FG003|STARTED|Overall Study||164
6310009|NCT00395512|7213938|FG000|Safety Set|Overall Study||164
6310010|NCT00395512|7213939|FG001|Safety Set|Overall Study||163
6310011|NCT00395512|7213940|FG002|Safety Set|Overall Study||164
6310012|NCT00395512|7213941|FG003|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
6310013|NCT00395512|7213938|FG000|COMPLETED|Overall Study||126
6310014|NCT00395512|7213939|FG001|COMPLETED|Overall Study||126
6310015|NCT00395512|7213940|FG002|COMPLETED|Overall Study||136
6310016|NCT00395512|7213941|FG003|COMPLETED|Overall Study||126
6310017|NCT00395512|7213938|FG000|NOT COMPLETED|Overall Study||38
6310018|NCT00395512|7213939|FG001|NOT COMPLETED|Overall Study||37
6310019|NCT00395512|7213940|FG002|NOT COMPLETED|Overall Study||28
6310020|NCT00395512|7213941|FG003|NOT COMPLETED|Overall Study||38
6310021|NCT00395538|7213954|FG000|STARTED|Overall Study||8
6310022|NCT00395538|7213955|FG001|STARTED|Overall Study||15
6310023|NCT00395538|7213956|FG002|STARTED|Overall Study||23
6310024|NCT00395538|7213954|FG000|Signed Consent to the New Protocol|Overall Study||7
6310025|NCT00395538|7213955|FG001|Signed Consent to the New Protocol|Overall Study||5
6310026|NCT00395538|7213956|FG002|Signed Consent to the New Protocol|Overall Study||23
6310027|NCT00395538|7213954|FG000|Received HPTH on New Protocol|Overall Study||7
6310028|NCT00395538|7213955|FG001|Received HPTH on New Protocol|Overall Study||5
6310029|NCT00395538|7213956|FG002|Received HPTH on New Protocol|Overall Study||19
6310030|NCT00395538|7213954|FG000|Randomized to Bone Biopsy Year 1|Overall Study||0
6310031|NCT00395538|7213955|FG001|Randomized to Bone Biopsy Year 1|Overall Study||1
6310032|NCT00395538|7213956|FG002|Randomized to Bone Biopsy Year 1|Overall Study||5
6310033|NCT00395538|7213954|FG000|Randomized to Bone Biopsy Year 2|Overall Study||0
6310034|NCT00395538|7213955|FG001|Randomized to Bone Biopsy Year 2|Overall Study||2
6310035|NCT00395538|7213956|FG002|Randomized to Bone Biopsy Year 2|Overall Study||6
6310036|NCT00395538|7213954|FG000|Randomized to Bone Biospy Year 4|Overall Study||0
6310037|NCT00395538|7213955|FG001|Randomized to Bone Biospy Year 4|Overall Study||2
6310038|NCT00395538|7213956|FG002|Randomized to Bone Biospy Year 4|Overall Study||8
6310039|NCT00395538|7213954|FG000|Completed Bone Biopsy Year 1|Overall Study||0
6310040|NCT00395538|7213955|FG001|Completed Bone Biopsy Year 1|Overall Study||1
6310041|NCT00395538|7213956|FG002|Completed Bone Biopsy Year 1|Overall Study||4
6310042|NCT00395538|7213954|FG000|Completed Bone Biopsy Year 2|Overall Study||0
6310043|NCT00395538|7213955|FG001|Completed Bone Biopsy Year 2|Overall Study||2
6310044|NCT00395538|7213956|FG002|Completed Bone Biopsy Year 2|Overall Study||3
6310045|NCT00395538|7213954|FG000|Completed Bone Biopsy Year 4|Overall Study||0
6310046|NCT00395538|7213955|FG001|Completed Bone Biopsy Year 4|Overall Study||1
6310047|NCT00395538|7213956|FG002|Completed Bone Biopsy Year 4|Overall Study||1
6310048|NCT00395538|7213954|FG000|COMPLETED|Overall Study||5
6310049|NCT00395538|7213955|FG001|COMPLETED|Overall Study||2
6310050|NCT00395538|7213956|FG002|COMPLETED|Overall Study||0
6310051|NCT00395538|7213954|FG000|NOT COMPLETED|Overall Study||3
6310052|NCT00395538|7213955|FG001|NOT COMPLETED|Overall Study||13
6310053|NCT00395538|7213956|FG002|NOT COMPLETED|Overall Study||23
6310054|NCT00395629|7213967|FG000|STARTED|Core Study||11
6310055|NCT00395629|7213968|FG001|STARTED|Core Study||15
6310056|NCT00395629|7213969|FG002|STARTED|Core Study||23
6310057|NCT00395629|7213967|FG000|COMPLETED|Core Study||10
6310058|NCT00395629|7213968|FG001|COMPLETED|Core Study||11
6310059|NCT00395629|7213969|FG002|COMPLETED|Core Study||16
6310060|NCT00395629|7213967|FG000|NOT COMPLETED|Core Study||1
6310061|NCT00395629|7213968|FG001|NOT COMPLETED|Core Study||4
6310062|NCT00395629|7213969|FG002|NOT COMPLETED|Core Study||7
6310063|NCT00395629|7213967|FG000|STARTED|Extension Study||9
6310064|NCT00395629|7213968|FG001|STARTED|Extension Study||6
6310065|NCT00395629|7213969|FG002|STARTED|Extension Study||11
6310066|NCT00395629|7213967|FG000|COMPLETED|Extension Study||9
6310067|NCT00395629|7213968|FG001|COMPLETED|Extension Study||6
6310068|NCT00395629|7213969|FG002|COMPLETED|Extension Study||8
6310069|NCT00395629|7213967|FG000|NOT COMPLETED|Extension Study||0
6310070|NCT00395629|7213968|FG001|NOT COMPLETED|Extension Study||0
6310071|NCT00395629|7213969|FG002|NOT COMPLETED|Extension Study||3
6310072|NCT00395642|7213980|FG000|STARTED|Overall Study||66
6310073|NCT00395642|7213980|FG000|COMPLETED|Overall Study||53
6310074|NCT00395642|7213980|FG000|NOT COMPLETED|Overall Study||13
6310075|NCT00395694|7213986|FG000|STARTED|Escalation Phase + Maintenance Phase||51
6310076|NCT00395694|7213987|FG001|STARTED|Escalation Phase + Maintenance Phase||51
6310077|NCT00395694|7213986|FG000|COMPLETED|Escalation Phase + Maintenance Phase||50
6310078|NCT00395694|7213987|FG001|COMPLETED|Escalation Phase + Maintenance Phase||49
6310079|NCT00395694|7213986|FG000|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
6310080|NCT00395694|7213987|FG001|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
6310081|NCT00395694|7213986|FG000|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
6310082|NCT00395694|7213987|FG001|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
6310083|NCT00395694|7213986|FG000|COMPLETED|Continuation Phase||34
6310084|NCT00395694|7213987|FG001|COMPLETED|Continuation Phase||35
6310085|NCT00395694|7213986|FG000|NOT COMPLETED|Continuation Phase||15
6310086|NCT00395694|7213987|FG001|NOT COMPLETED|Continuation Phase||13
6310087|NCT00395733|7213998|FG000|STARTED|Period 1||41
6310088|NCT00395733|7213999|FG001|STARTED|Period 1||42
6310089|NCT00395733|7213998|FG000|COMPLETED|Period 1||41
6310090|NCT00395733|7213999|FG001|COMPLETED|Period 1||42
6310091|NCT00395733|7213998|FG000|NOT COMPLETED|Period 1||0
6310092|NCT00395733|7213999|FG001|NOT COMPLETED|Period 1||0
6310093|NCT00395733|7213998|FG000|STARTED|Period 2||41
6310094|NCT00395733|7213999|FG001|STARTED|Period 2||42
6310095|NCT00395733|7213998|FG000|COMPLETED|Period 2||39
6310096|NCT00395733|7213999|FG001|COMPLETED|Period 2||37
6310097|NCT00395733|7213998|FG000|NOT COMPLETED|Period 2||2
6310098|NCT00395733|7213999|FG001|NOT COMPLETED|Period 2||5
6310099|NCT00395746|7214008|FG000|STARTED|Overall Study|Exposed to study drug|88
6310100|NCT00395746|7214009|FG001|STARTED|Overall Study|Exposed to study drug|88
6310101|NCT00395746|7214010|FG002|STARTED|Overall Study|Exposed to study drug|88
6310102|NCT00395746|7214008|FG000|COMPLETED|Overall Study|Completed 52 weeks treatment|78
6310103|NCT00395746|7214009|FG001|COMPLETED|Overall Study|Completed 52 weeks treatment|84
6310104|NCT00395746|7214010|FG002|COMPLETED|Overall Study|Completed 52 weeks treatment|66
6310105|NCT00395746|7214008|FG000|NOT COMPLETED|Overall Study||10
6310106|NCT00395746|7214009|FG001|NOT COMPLETED|Overall Study||4
6310107|NCT00395746|7214010|FG002|NOT COMPLETED|Overall Study||22
6310108|NCT00395850|7214022|FG000|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
6310109|NCT00395850|7214023|FG001|STARTED|Pre-randomization Baseline/Induction||0
6310110|NCT00395850|7214024|FG002|STARTED|Pre-randomization Baseline/Induction||0
6310111|NCT00395850|7214025|FG003|STARTED|Pre-randomization Baseline/Induction||0
6310112|NCT00395850|7214022|FG000|COMPLETED|Pre-randomization Baseline/Induction||107
6310113|NCT00395850|7214023|FG001|COMPLETED|Pre-randomization Baseline/Induction||0
6310114|NCT00395850|7214024|FG002|COMPLETED|Pre-randomization Baseline/Induction||0
6310115|NCT00395850|7214025|FG003|COMPLETED|Pre-randomization Baseline/Induction||0
6310116|NCT00395850|7214022|FG000|NOT COMPLETED|Pre-randomization Baseline/Induction||11
6310117|NCT00395850|7214023|FG001|NOT COMPLETED|Pre-randomization Baseline/Induction||0
6310118|NCT00395850|7214024|FG002|NOT COMPLETED|Pre-randomization Baseline/Induction||0
6310119|NCT00395850|7214025|FG003|NOT COMPLETED|Pre-randomization Baseline/Induction||0
6310120|NCT00395850|7214022|FG000|STARTED|Randomization to Disulfiram/ Pre-admin||27
6310121|NCT00395850|7214023|FG001|STARTED|Randomization to Disulfiram/ Pre-admin||25
6310122|NCT00395850|7214024|FG002|STARTED|Randomization to Disulfiram/ Pre-admin||30
6310123|NCT00395850|7214025|FG003|STARTED|Randomization to Disulfiram/ Pre-admin||25
6310124|NCT00395850|7214022|FG000|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
6310125|NCT00395850|7214023|FG001|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
6310126|NCT00395850|7214024|FG002|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
6310127|NCT00395850|7214025|FG003|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
6310128|NCT00395850|7214022|FG000|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
6310129|NCT00395850|7214023|FG001|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
6310130|NCT00395850|7214024|FG002|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
6310131|NCT00395850|7214025|FG003|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
6310132|NCT00395850|7214022|FG000|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
6310133|NCT00395850|7214023|FG001|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
6310134|NCT00395850|7214024|FG002|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
6310135|NCT00395850|7214025|FG003|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
6310136|NCT00395850|7214022|FG000|COMPLETED|Disulfiram/Placebo Treatment||11
6310137|NCT00395850|7214023|FG001|COMPLETED|Disulfiram/Placebo Treatment||9
6310138|NCT00395850|7214024|FG002|COMPLETED|Disulfiram/Placebo Treatment||5
6310139|NCT00395850|7214025|FG003|COMPLETED|Disulfiram/Placebo Treatment||8
6310140|NCT00395850|7214022|FG000|NOT COMPLETED|Disulfiram/Placebo Treatment||9
6310141|NCT00395850|7214023|FG001|NOT COMPLETED|Disulfiram/Placebo Treatment||14
6310142|NCT00395850|7214024|FG002|NOT COMPLETED|Disulfiram/Placebo Treatment||19
6310143|NCT00395850|7214025|FG003|NOT COMPLETED|Disulfiram/Placebo Treatment||13
6310144|NCT00395863|7214037|FG000|STARTED|Overall Study||23
6310145|NCT00395863|7214038|FG001|STARTED|Overall Study||23
6310146|NCT00395863|7214037|FG000|COMPLETED|Overall Study||21
6310147|NCT00395863|7214038|FG001|COMPLETED|Overall Study||20
6310148|NCT00395863|7214037|FG000|NOT COMPLETED|Overall Study||2
6310149|NCT00395863|7214038|FG001|NOT COMPLETED|Overall Study||3
6310150|NCT00395876|7214049|FG000|STARTED|Overall Study||50
6310151|NCT00395876|7214050|FG001|STARTED|Overall Study||50
6310152|NCT00395876|7214049|FG000|COMPLETED|Overall Study||47
6310153|NCT00395876|7214050|FG001|COMPLETED|Overall Study||50
6310154|NCT00395876|7214049|FG000|NOT COMPLETED|Overall Study||3
6310155|NCT00395876|7214050|FG001|NOT COMPLETED|Overall Study||0
6310156|NCT00395967|7214056|FG000|STARTED|Treatment Period||5
6310157|NCT00395967|7214056|FG000|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
6310158|NCT00395967|7214056|FG000|NOT COMPLETED|Treatment Period||1
6310159|NCT00395967|7214056|FG000|STARTED|Follow-up Period|Participants who had transplants.|5
6310160|NCT00395967|7214056|FG000|COMPLETED|Follow-up Period||3
6310161|NCT00395967|7214056|FG000|NOT COMPLETED|Follow-up Period||2
6310162|NCT00395993|7214062|FG000|STARTED|Overall Study||246
6310163|NCT00395993|7214063|FG001|STARTED|Overall Study||231
6310164|NCT00395993|7214062|FG000|COMPLETED|Overall Study||211
6310165|NCT00395993|7214063|FG001|COMPLETED|Overall Study||212
6310166|NCT00395993|7214062|FG000|NOT COMPLETED|Overall Study||35
6310167|NCT00395993|7214063|FG001|NOT COMPLETED|Overall Study||19
6310168|NCT00396006|7214069|FG000|STARTED|Overall Study||13
6310169|NCT00396006|7214069|FG000|COMPLETED|Overall Study||13
6310170|NCT00396006|7214069|FG000|NOT COMPLETED|Overall Study||0
6310171|NCT00396019|7214077|FG000|STARTED|Overall Study||27
6310172|NCT00396019|7214078|FG001|STARTED|Overall Study||29
6310173|NCT00396019|7214079|FG002|STARTED|Overall Study||30
6310174|NCT00396019|7214077|FG000|COMPLETED|Overall Study||27
6310175|NCT00396019|7214078|FG001|COMPLETED|Overall Study||26
6310176|NCT00396019|7214079|FG002|COMPLETED|Overall Study||29
6310177|NCT00396019|7214077|FG000|NOT COMPLETED|Overall Study||0
6310178|NCT00396019|7214078|FG001|NOT COMPLETED|Overall Study||3
6310179|NCT00396019|7214079|FG002|NOT COMPLETED|Overall Study||1
6310180|NCT00396032|7214090|FG000|STARTED|Overall Study||74
6310181|NCT00396032|7214091|FG001|STARTED|Overall Study||76
6310182|NCT00396032|7214090|FG000|COMPLETED|Overall Study||70
6310183|NCT00396032|7214091|FG001|COMPLETED|Overall Study||71
6310184|NCT00396032|7214090|FG000|NOT COMPLETED|Overall Study||4
6310185|NCT00396032|7214091|FG001|NOT COMPLETED|Overall Study||5
6310186|NCT00396084|7214103|FG000|STARTED|Overall Study||10
6310187|NCT00396084|7214104|FG001|STARTED|Overall Study||10
6310188|NCT00396084|7214105|FG002|STARTED|Overall Study||10
6310189|NCT00396084|7214106|FG003|STARTED|Overall Study||10
6310190|NCT00396084|7214107|FG004|STARTED|Overall Study||10
6310191|NCT00396084|7214108|FG005|STARTED|Overall Study||20
6310192|NCT00396084|7214103|FG000|COMPLETED|Overall Study||10
6310193|NCT00396084|7214104|FG001|COMPLETED|Overall Study||10
6310194|NCT00396084|7214105|FG002|COMPLETED|Overall Study||10
6310195|NCT00396084|7214106|FG003|COMPLETED|Overall Study||9
6310196|NCT00396084|7214107|FG004|COMPLETED|Overall Study||9
6310197|NCT00396084|7214108|FG005|COMPLETED|Overall Study||18
6310198|NCT00396084|7214103|FG000|NOT COMPLETED|Overall Study||0
6310199|NCT00396084|7214104|FG001|NOT COMPLETED|Overall Study||0
6310200|NCT00396084|7214105|FG002|NOT COMPLETED|Overall Study||0
6310201|NCT00396084|7214106|FG003|NOT COMPLETED|Overall Study||1
6310202|NCT00396084|7214107|FG004|NOT COMPLETED|Overall Study||1
6310203|NCT00396084|7214108|FG005|NOT COMPLETED|Overall Study||2
6310204|NCT00396097|7214128|FG000|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
6310205|NCT00396097|7214129|FG001|STARTED|Overall Study||202
6310206|NCT00396097|7214128|FG000|COMPLETED|Overall Study||88
6310207|NCT00396097|7214129|FG001|COMPLETED|Overall Study||156
6310208|NCT00396097|7214128|FG000|NOT COMPLETED|Overall Study||26
6310209|NCT00396097|7214129|FG001|NOT COMPLETED|Overall Study||46
6310210|NCT00396136|7214139|FG000|STARTED|Overall Study||221
6310211|NCT00396136|7214139|FG000|COMPLETED|Overall Study||96
6310212|NCT00396136|7214139|FG000|NOT COMPLETED|Overall Study||125
6310213|NCT00396162|7214145|FG000|STARTED|Overall Study||39
6310214|NCT00396162|7214146|FG001|STARTED|Overall Study||38
6310215|NCT00396162|7214145|FG000|COMPLETED|Overall Study||37
6310216|NCT00396162|7214146|FG001|COMPLETED|Overall Study||35
6310217|NCT00396162|7214145|FG000|NOT COMPLETED|Overall Study||2
6310218|NCT00396162|7214146|FG001|NOT COMPLETED|Overall Study||3
6310219|NCT00396201|7214156|FG000|STARTED|Treatment Period||22
6310220|NCT00396201|7214156|FG000|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
6310221|NCT00396201|7214156|FG000|NOT COMPLETED|Treatment Period||0
6310222|NCT00396201|7214156|FG000|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
6310223|NCT00396201|7214156|FG000|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
6310224|NCT00396201|7214156|FG000|NOT COMPLETED|Follow-up Period||0
6310225|NCT00396253|7214161|FG000|STARTED|Overall Study||223
6557475|NCT01768286|7480062|FG000|STARTED|Overall Study||109
6557476|NCT01768286|7480063|FG001|STARTED|Overall Study||111
6557477|NCT01768286|7480064|FG002|STARTED|Overall Study||110
6310226|NCT00396253|7214161|FG000|COMPLETED|Overall Study||210
6310227|NCT00396253|7214161|FG000|NOT COMPLETED|Overall Study||13
6310228|NCT00396266|7214167|FG000|STARTED|Overall Study||8
6310229|NCT00396266|7214168|FG001|STARTED|Overall Study||14
6310230|NCT00396266|7214167|FG000|COMPLETED|Overall Study||8
6310231|NCT00396266|7214168|FG001|COMPLETED|Overall Study||14
6310232|NCT00396266|7214167|FG000|NOT COMPLETED|Overall Study||0
6310233|NCT00396266|7214168|FG001|NOT COMPLETED|Overall Study||0
6310234|NCT00396279|7214178|FG000|STARTED|Overall Study||37
6310235|NCT00396279|7214178|FG000|COMPLETED|Overall Study|Defined as participants with a complete resection|7
6310236|NCT00396279|7214178|FG000|NOT COMPLETED|Overall Study||30
6310237|NCT00396292|7214184|FG000|STARTED|Overall Study||174
6310238|NCT00396292|7214185|FG001|STARTED|Overall Study||178
6310239|NCT00396292|7214184|FG000|COMPLETED|Overall Study||165
6310240|NCT00396292|7214185|FG001|COMPLETED|Overall Study||162
6310241|NCT00396292|7214184|FG000|NOT COMPLETED|Overall Study||9
6310242|NCT00396292|7214185|FG001|NOT COMPLETED|Overall Study||16
6310243|NCT00396318|7214191|FG000|STARTED|At Least One Dose of Tenecteplase (MITT)||246
6310244|NCT00396318|7214191|FG000|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
6310245|NCT00396318|7214191|FG000|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
6310246|NCT00396318|7214191|FG000|STARTED|48- to 96-Hour Follow-Up Period||246
6310247|NCT00396318|7214191|FG000|COMPLETED|48- to 96-Hour Follow-Up Period||241
6310248|NCT00396318|7214191|FG000|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
6310249|NCT00396318|7214191|FG000|STARTED|7-Day Post-Treatment Contact||241
6310250|NCT00396318|7214191|FG000|COMPLETED|7-Day Post-Treatment Contact||240
6310251|NCT00396318|7214191|FG000|NOT COMPLETED|7-Day Post-Treatment Contact||1
6310252|NCT00396331|7214199|FG000|STARTED|Overall Study||100
6310253|NCT00396331|7214199|FG000|Number of Participants Treated|Overall Study||100
6310254|NCT00396331|7214199|FG000|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
6310255|NCT00396331|7214199|FG000|COMPLETED|Overall Study||68
6310256|NCT00396331|7214199|FG000|NOT COMPLETED|Overall Study||32
6310257|NCT00396383|7214211|FG000|STARTED|Overall Study||9
6310258|NCT00396383|7214211|FG000|COMPLETED|Overall Study||6
6310259|NCT00396383|7214211|FG000|NOT COMPLETED|Overall Study||3
6310260|NCT00396409|7214217|FG000|STARTED|Period 1 - 2007||65
6310261|NCT00396409|7214218|FG001|STARTED|Period 1 - 2007||63
6310262|NCT00396409|7214217|FG000|COMPLETED|Period 1 - 2007||62
6310263|NCT00396409|7214218|FG001|COMPLETED|Period 1 - 2007||57
6310264|NCT00396409|7214217|FG000|NOT COMPLETED|Period 1 - 2007||3
6310265|NCT00396409|7214218|FG001|NOT COMPLETED|Period 1 - 2007||6
6310266|NCT00396409|7214217|FG000|STARTED|Between Period 1 and Period 2||62
6310267|NCT00396409|7214218|FG001|STARTED|Between Period 1 and Period 2||57
6310268|NCT00396409|7214217|FG000|COMPLETED|Between Period 1 and Period 2||59
6310269|NCT00396409|7214218|FG001|COMPLETED|Between Period 1 and Period 2||55
6310270|NCT00396409|7214217|FG000|NOT COMPLETED|Between Period 1 and Period 2||3
6310271|NCT00396409|7214218|FG001|NOT COMPLETED|Between Period 1 and Period 2||2
6310272|NCT00396409|7214217|FG000|STARTED|Period 2 - 2008||59
6310273|NCT00396409|7214218|FG001|STARTED|Period 2 - 2008||55
6310274|NCT00396409|7214217|FG000|COMPLETED|Period 2 - 2008||52
6310275|NCT00396409|7214218|FG001|COMPLETED|Period 2 - 2008||53
6310276|NCT00396409|7214217|FG000|NOT COMPLETED|Period 2 - 2008||7
6310277|NCT00396409|7214218|FG001|NOT COMPLETED|Period 2 - 2008||2
6310278|NCT00396565|7214229|FG000|STARTED|Overall Study||136
6310279|NCT00396565|7214230|FG001|STARTED|Overall Study||138
6310280|NCT00396565|7214231|FG002|STARTED|Overall Study||47
6310281|NCT00396565|7214229|FG000|COMPLETED|Overall Study||88
6310282|NCT00396565|7214230|FG001|COMPLETED|Overall Study||47
6310283|NCT00396565|7214231|FG002|COMPLETED|Overall Study||30
6310284|NCT00396565|7214229|FG000|NOT COMPLETED|Overall Study||48
6310285|NCT00396565|7214230|FG001|NOT COMPLETED|Overall Study||91
6310286|NCT00396565|7214231|FG002|NOT COMPLETED|Overall Study||17
6310287|NCT00396591|7214239|FG000|STARTED|Overall Study||16
6310288|NCT00396591|7214239|FG000|COMPLETED|Overall Study||0
6310289|NCT00396591|7214239|FG000|NOT COMPLETED|Overall Study||16
6310290|NCT00396630|7214245|FG000|STARTED|Overall Study||100
6310291|NCT00396630|7214246|FG001|STARTED|Overall Study||100
6310292|NCT00396630|7214245|FG000|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
6310293|NCT00396630|7214246|FG001|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
6310294|NCT00396630|7214245|FG000|NOT COMPLETED|Overall Study||5
6310295|NCT00396630|7214246|FG001|NOT COMPLETED|Overall Study||5
6310296|NCT00396656|7214253|FG000|STARTED|First Treatment Period||15
6310297|NCT00396656|7214254|FG001|STARTED|First Treatment Period||15
6310298|NCT00396656|7214253|FG000|COMPLETED|First Treatment Period||15
6310299|NCT00396656|7214254|FG001|COMPLETED|First Treatment Period||13
6310300|NCT00396656|7214253|FG000|NOT COMPLETED|First Treatment Period||0
6310301|NCT00396656|7214254|FG001|NOT COMPLETED|First Treatment Period||2
6310302|NCT00396656|7214253|FG000|STARTED|Second Treatment Period||15
6310303|NCT00396656|7214254|FG001|STARTED|Second Treatment Period||13
6310304|NCT00396656|7214253|FG000|COMPLETED|Second Treatment Period||15
6310305|NCT00396656|7214254|FG001|COMPLETED|Second Treatment Period||12
6310306|NCT00396656|7214253|FG000|NOT COMPLETED|Second Treatment Period||0
6557478|NCT01768286|7480065|FG003|STARTED|Overall Study||111
6557479|NCT01768286|7480062|FG000|COMPLETED|Overall Study||102
6310307|NCT00396656|7214254|FG001|NOT COMPLETED|Second Treatment Period||1
6310308|NCT00396812|7214260|FG000|STARTED|Overall Study||4
6310309|NCT00396812|7214260|FG000|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
6310310|NCT00396812|7214260|FG000|NOT COMPLETED|Overall Study||1
6310311|NCT00396877|7214266|FG000|STARTED|Overall Study|Randomized|439
6310312|NCT00396877|7214267|FG001|STARTED|Overall Study|Randomized|467
6310313|NCT00396877|7214266|FG000|Treated|Overall Study||436
6310314|NCT00396877|7214267|FG001|Treated|Overall Study||464
6310315|NCT00396877|7214266|FG000|Completed Treatment|Overall Study||356
6310316|NCT00396877|7214267|FG001|Completed Treatment|Overall Study||352
6310317|NCT00396877|7214266|FG000|COMPLETED|Overall Study|Completed follow-up|433
6310318|NCT00396877|7214267|FG001|COMPLETED|Overall Study|Completed follow-up|459
6310319|NCT00396877|7214266|FG000|NOT COMPLETED|Overall Study||6
6310320|NCT00396877|7214267|FG001|NOT COMPLETED|Overall Study||8
6310321|NCT00396981|7214275|FG000|STARTED|Overall Study||311
6310322|NCT00396981|7214276|FG001|STARTED|Overall Study||315
6310323|NCT00396981|7214275|FG000|COMPLETED|Overall Study||296
6310324|NCT00396981|7214276|FG001|COMPLETED|Overall Study||306
6310325|NCT00396981|7214275|FG000|NOT COMPLETED|Overall Study||15
6310326|NCT00396981|7214276|FG001|NOT COMPLETED|Overall Study||9
6310327|NCT00397020|7214284|FG000|STARTED|Overall Study||14
6310328|NCT00397020|7214285|FG001|STARTED|Overall Study||16
6310329|NCT00397020|7214284|FG000|COMPLETED|Overall Study||13
6310330|NCT00397020|7214285|FG001|COMPLETED|Overall Study||15
6557480|NCT01768286|7480063|FG001|COMPLETED|Overall Study||107
6557481|NCT01768286|7480064|FG002|COMPLETED|Overall Study||108
6557482|NCT01768286|7480065|FG003|COMPLETED|Overall Study||110
6557483|NCT01768286|7480062|FG000|NOT COMPLETED|Overall Study||7
6557484|NCT01768286|7480063|FG001|NOT COMPLETED|Overall Study||4
6557485|NCT01768286|7480064|FG002|NOT COMPLETED|Overall Study||2
6557486|NCT01768286|7480065|FG003|NOT COMPLETED|Overall Study||1
6557487|NCT01768325|7480077|FG000|STARTED|Overall Study||37
6557488|NCT01768325|7480078|FG001|STARTED|Overall Study||41
6557489|NCT01768325|7480077|FG000|COMPLETED|Overall Study||37
6557490|NCT01768325|7480078|FG001|COMPLETED|Overall Study||41
6557491|NCT01768325|7480077|FG000|NOT COMPLETED|Overall Study||0
6310331|NCT00397020|7214284|FG000|NOT COMPLETED|Overall Study||1
6310332|NCT00397020|7214285|FG001|NOT COMPLETED|Overall Study||1
6310333|NCT00397033|7214294|FG000|STARTED|Overall Study||107
6310334|NCT00397033|7214295|FG001|STARTED|Overall Study||109
6310335|NCT00397033|7214296|FG002|STARTED|Overall Study||100
6310336|NCT00397033|7214294|FG000|Safety Population: >= 1 Dose of Drug|Overall Study||107
6310337|NCT00397033|7214295|FG001|Safety Population: >= 1 Dose of Drug|Overall Study||108
6310338|NCT00397033|7214296|FG002|Safety Population: >= 1 Dose of Drug|Overall Study||98
6310339|NCT00397033|7214294|FG000|ITT Population|Overall Study||107
6310340|NCT00397033|7214295|FG001|ITT Population|Overall Study||105
6557492|NCT01768325|7480078|FG001|NOT COMPLETED|Overall Study||0
6557493|NCT01768520|7480089|FG000|STARTED|Overall Study||152
6557494|NCT01768520|7480090|FG001|STARTED|Overall Study||147
6557495|NCT01768520|7480091|FG002|STARTED|Overall Study||39
6557496|NCT01768520|7480089|FG000|COMPLETED|Overall Study||120
6557497|NCT01768520|7480090|FG001|COMPLETED|Overall Study||121
6557498|NCT01768520|7480091|FG002|COMPLETED|Overall Study||30
6557499|NCT01768520|7480089|FG000|NOT COMPLETED|Overall Study||32
6557500|NCT01768520|7480090|FG001|NOT COMPLETED|Overall Study||26
6557501|NCT01768520|7480091|FG002|NOT COMPLETED|Overall Study||9
6557502|NCT01768559|7480102|FG000|STARTED|Overall Study||298
6557503|NCT01768559|7480103|FG001|STARTED|Overall Study||298
6557504|NCT01768559|7480104|FG002|STARTED|Overall Study||298
6557505|NCT01768559|7480102|FG000|Treated|Overall Study||298
6557506|NCT01768559|7480103|FG001|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
6557507|NCT01768559|7480104|FG002|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
6557508|NCT01768559|7480102|FG000|COMPLETED|Overall Study||268
6557509|NCT01768559|7480103|FG001|COMPLETED|Overall Study||281
6557510|NCT01768559|7480104|FG002|COMPLETED|Overall Study||285
6557511|NCT01768559|7480102|FG000|NOT COMPLETED|Overall Study||30
6557512|NCT01768559|7480103|FG001|NOT COMPLETED|Overall Study||17
6557513|NCT01768559|7480104|FG002|NOT COMPLETED|Overall Study||13
6557514|NCT01768572|7480119|FG000|STARTED|Overall Study||49
6557515|NCT01768572|7480120|FG001|STARTED|Overall Study||51
6557516|NCT01768572|7480121|FG002|STARTED|Overall Study||102
6557517|NCT01768572|7480119|FG000|COMPLETED|Overall Study||40
6557518|NCT01768572|7480120|FG001|COMPLETED|Overall Study||39
6557519|NCT01768572|7480121|FG002|COMPLETED|Overall Study||96
6557520|NCT01768572|7480119|FG000|NOT COMPLETED|Overall Study||9
6557521|NCT01768572|7480120|FG001|NOT COMPLETED|Overall Study||12
6557522|NCT01768572|7480121|FG002|NOT COMPLETED|Overall Study||6
6557523|NCT01768637|7480131|FG000|STARTED|Overall Study||29
6557524|NCT01768637|7480132|FG001|STARTED|Overall Study||19
6310341|NCT00397033|7214296|FG002|ITT Population|Overall Study||98
6310342|NCT00397033|7214294|FG000|COMPLETED|Overall Study||63
6310343|NCT00397033|7214295|FG001|COMPLETED|Overall Study||72
6310344|NCT00397033|7214296|FG002|COMPLETED|Overall Study||77
6557525|NCT01768637|7480131|FG000|Completed Visit 1|Overall Study||28
6310345|NCT00397033|7214294|FG000|NOT COMPLETED|Overall Study||44
6310346|NCT00397033|7214295|FG001|NOT COMPLETED|Overall Study||37
6557526|NCT01768637|7480132|FG001|Completed Visit 1|Overall Study||16
6557527|NCT01768637|7480131|FG000|Completed Visit 2|Overall Study||26
6557528|NCT01768637|7480132|FG001|Completed Visit 2|Overall Study||13
6557529|NCT01768637|7480131|FG000|COMPLETED|Overall Study||26
6557530|NCT01768637|7480132|FG001|COMPLETED|Overall Study||12
6557531|NCT01768637|7480131|FG000|NOT COMPLETED|Overall Study||3
6557532|NCT01768637|7480132|FG001|NOT COMPLETED|Overall Study||7
6557533|NCT01768676|7480140|FG000|STARTED|Overall Study||90
6557534|NCT01768676|7480141|FG001|STARTED|Overall Study||91
6557535|NCT01768676|7480140|FG000|COMPLETED|Overall Study||66
6557536|NCT01768676|7480141|FG001|COMPLETED|Overall Study||60
6557537|NCT01768676|7480140|FG000|NOT COMPLETED|Overall Study||24
6557538|NCT01768676|7480141|FG001|NOT COMPLETED|Overall Study||31
6557539|NCT01768832|7480150|FG000|STARTED|Overall Study||41
6557540|NCT01768832|7480151|FG001|STARTED|Overall Study||43
6557541|NCT01768832|7480152|FG002|STARTED|Overall Study||35
6557542|NCT01768832|7480150|FG000|COMPLETED|Overall Study||31
6557543|NCT01768832|7480151|FG001|COMPLETED|Overall Study||39
6557544|NCT01768832|7480152|FG002|COMPLETED|Overall Study||26
6557545|NCT01768832|7480150|FG000|NOT COMPLETED|Overall Study||10
6557546|NCT01768832|7480151|FG001|NOT COMPLETED|Overall Study||4
6557547|NCT01768832|7480152|FG002|NOT COMPLETED|Overall Study||9
6557548|NCT01768845|7480160|FG000|STARTED|Overall Study||34
6557549|NCT01768845|7480160|FG000|COMPLETED|Overall Study||11
6557550|NCT01768845|7480160|FG000|NOT COMPLETED|Overall Study||23
6557551|NCT01768858|7480164|FG000|STARTED|Overall Study||96
6557552|NCT01768858|7480164|FG000|COMPLETED|Overall Study||74
6557553|NCT01768858|7480164|FG000|NOT COMPLETED|Overall Study||22
6562828|NCT01803074|7485699|FG000|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562829|NCT01803074|7485700|FG001|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562830|NCT01803074|7485701|FG002|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562831|NCT01803074|7485702|FG003|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562832|NCT01803074|7485703|FG004|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562833|NCT01803074|7485704|FG005|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562834|NCT01803074|7485705|FG006|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562835|NCT01803074|7485706|FG007|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562836|NCT01803074|7485707|FG008|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562837|NCT01803074|7485708|FG009|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562838|NCT01803074|7485709|FG010|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562839|NCT01803074|7485710|FG011|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||8
6562840|NCT01803074|7485711|FG012|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||7
6562841|NCT01803074|7485712|FG013|COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||4
6562842|NCT01803074|7485699|FG000|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562843|NCT01803074|7485700|FG001|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562844|NCT01803074|7485701|FG002|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562845|NCT01803074|7485702|FG003|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562846|NCT01803074|7485703|FG004|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6310347|NCT00397033|7214296|FG002|NOT COMPLETED|Overall Study||23
6310348|NCT00397046|7214308|FG000|STARTED|Overall Study||3
6310349|NCT00397046|7214309|FG001|STARTED|Overall Study||3
6310350|NCT00397046|7214310|FG002|STARTED|Overall Study||10
6310351|NCT00397046|7214311|FG003|STARTED|Overall Study||5
6310352|NCT00397046|7214308|FG000|COMPLETED|Overall Study||0
6310353|NCT00397046|7214309|FG001|COMPLETED|Overall Study||0
6310354|NCT00397046|7214310|FG002|COMPLETED|Overall Study||0
6310355|NCT00397046|7214311|FG003|COMPLETED|Overall Study||0
6310356|NCT00397046|7214308|FG000|NOT COMPLETED|Overall Study||3
6310357|NCT00397046|7214309|FG001|NOT COMPLETED|Overall Study||3
6310358|NCT00397046|7214310|FG002|NOT COMPLETED|Overall Study||10
6310359|NCT00397046|7214311|FG003|NOT COMPLETED|Overall Study||5
6310360|NCT00397150|7214324|FG000|STARTED|Overall Study||1323
6310361|NCT00397150|7214325|FG001|STARTED|Overall Study||1256
6310362|NCT00397150|7214324|FG000|COMPLETED|Overall Study||1188
6310363|NCT00397150|7214325|FG001|COMPLETED|Overall Study||1111
6562847|NCT01803074|7485704|FG005|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562848|NCT01803074|7485705|FG006|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562849|NCT01803074|7485706|FG007|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562850|NCT01803074|7485707|FG008|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562851|NCT01803074|7485708|FG009|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562852|NCT01803074|7485709|FG010|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6310364|NCT00397150|7214324|FG000|NOT COMPLETED|Overall Study||135
6310365|NCT00397150|7214325|FG001|NOT COMPLETED|Overall Study||145
6310366|NCT00397189|7214333|FG000|STARTED|3 Weeks Period||394
6310367|NCT00397189|7214334|FG001|STARTED|3 Weeks Period||395
6310368|NCT00397189|7214333|FG000|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
6310369|NCT00397189|7214334|FG001|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
6310370|NCT00397189|7214333|FG000|NOT COMPLETED|3 Weeks Period||21
6310371|NCT00397189|7214334|FG001|NOT COMPLETED|3 Weeks Period||22
6375131|NCT00754130|7285746|FG001|COMPLETED|Period 1 (5 Days)||2
6375132|NCT00754130|7285747|FG002|COMPLETED|Period 1 (5 Days)||4
6562853|NCT01803074|7485710|FG011|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562854|NCT01803074|7485711|FG012|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562855|NCT01803074|7485712|FG013|NOT COMPLETED|Period 3: Part C (HIV-1 Clade C Only)||0
6562856|NCT01803204|7485753|FG000|STARTED|Overall Study||20
6562857|NCT01803204|7485754|FG001|STARTED|Overall Study||20
6310372|NCT00397189|7214333|FG000|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
6310373|NCT00397189|7214334|FG001|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
6310374|NCT00397189|7214333|FG000|COMPLETED|Extension Period||421
6310375|NCT00397189|7214334|FG001|COMPLETED|Extension Period||134
6310376|NCT00397189|7214333|FG000|NOT COMPLETED|Extension Period||113
6310377|NCT00397189|7214334|FG001|NOT COMPLETED|Extension Period||43
6310378|NCT00397215|7214346|FG000|STARTED|Month 0 (Day 0)||165
6310379|NCT00397215|7214347|FG001|STARTED|Month 0 (Day 0)||61
6310380|NCT00397215|7214348|FG002|STARTED|Month 0 (Day 0)||159
6310381|NCT00397215|7214349|FG003|STARTED|Month 0 (Day 0)||52
6310382|NCT00397215|7214346|FG000|COMPLETED|Month 0 (Day 0)||158
6310383|NCT00397215|7214347|FG001|COMPLETED|Month 0 (Day 0)||56
6310384|NCT00397215|7214348|FG002|COMPLETED|Month 0 (Day 0)||153
6310385|NCT00397215|7214349|FG003|COMPLETED|Month 0 (Day 0)||48
6310386|NCT00397215|7214346|FG000|NOT COMPLETED|Month 0 (Day 0)||7
6310387|NCT00397215|7214347|FG001|NOT COMPLETED|Month 0 (Day 0)||5
6310388|NCT00397215|7214348|FG002|NOT COMPLETED|Month 0 (Day 0)||6
6310389|NCT00397215|7214349|FG003|NOT COMPLETED|Month 0 (Day 0)||4
6310390|NCT00397215|7214346|FG000|STARTED|Month 6 (Day 180)||164
6310391|NCT00397215|7214347|FG001|STARTED|Month 6 (Day 180)||58
6310392|NCT00397215|7214348|FG002|STARTED|Month 6 (Day 180)||158
6310393|NCT00397215|7214349|FG003|STARTED|Month 6 (Day 180)||51
6310394|NCT00397215|7214346|FG000|COMPLETED|Month 6 (Day 180)||162
6310395|NCT00397215|7214347|FG001|COMPLETED|Month 6 (Day 180)||55
6310396|NCT00397215|7214348|FG002|COMPLETED|Month 6 (Day 180)||153
6310397|NCT00397215|7214349|FG003|COMPLETED|Month 6 (Day 180)||51
6310398|NCT00397215|7214346|FG000|NOT COMPLETED|Month 6 (Day 180)||2
6310399|NCT00397215|7214347|FG001|NOT COMPLETED|Month 6 (Day 180)||3
6310400|NCT00397215|7214348|FG002|NOT COMPLETED|Month 6 (Day 180)||5
6310401|NCT00397215|7214349|FG003|NOT COMPLETED|Month 6 (Day 180)||0
6310402|NCT00397215|7214346|FG000|STARTED|Month 12 (Day 360)||130
6310403|NCT00397215|7214347|FG001|STARTED|Month 12 (Day 360)||48
6310404|NCT00397215|7214348|FG002|STARTED|Month 12 (Day 360)||125
6310405|NCT00397215|7214349|FG003|STARTED|Month 12 (Day 360)||42
6310406|NCT00397215|7214346|FG000|COMPLETED|Month 12 (Day 360)||130
6310407|NCT00397215|7214347|FG001|COMPLETED|Month 12 (Day 360)||48
6310408|NCT00397215|7214348|FG002|COMPLETED|Month 12 (Day 360)||125
6310409|NCT00397215|7214349|FG003|COMPLETED|Month 12 (Day 360)||42
6310410|NCT00397215|7214346|FG000|NOT COMPLETED|Month 12 (Day 360)||0
6310411|NCT00397215|7214347|FG001|NOT COMPLETED|Month 12 (Day 360)||0
6310412|NCT00397215|7214348|FG002|NOT COMPLETED|Month 12 (Day 360)||0
6310413|NCT00397215|7214349|FG003|NOT COMPLETED|Month 12 (Day 360)||0
6310414|NCT00397215|7214346|FG000|STARTED|Month 24 (Day 720)||122
6310415|NCT00397215|7214347|FG001|STARTED|Month 24 (Day 720)||45
6310416|NCT00397215|7214348|FG002|STARTED|Month 24 (Day 720)||117
6310417|NCT00397215|7214349|FG003|STARTED|Month 24 (Day 720)||36
6310418|NCT00397215|7214346|FG000|COMPLETED|Month 24 (Day 720)||122
6310419|NCT00397215|7214347|FG001|COMPLETED|Month 24 (Day 720)||45
6310420|NCT00397215|7214348|FG002|COMPLETED|Month 24 (Day 720)||117
6310421|NCT00397215|7214349|FG003|COMPLETED|Month 24 (Day 720)||36
6310422|NCT00397215|7214346|FG000|NOT COMPLETED|Month 24 (Day 720)||0
6310423|NCT00397215|7214347|FG001|NOT COMPLETED|Month 24 (Day 720)||0
6310424|NCT00397215|7214348|FG002|NOT COMPLETED|Month 24 (Day 720)||0
6310425|NCT00397215|7214349|FG003|NOT COMPLETED|Month 24 (Day 720)||0
6310426|NCT00397462|7214365|FG000|STARTED|Overall Study||16
6557554|NCT01769105|7480170|FG000|STARTED|First Intervention||16
6557555|NCT01769105|7480171|FG001|STARTED|First Intervention||19
6557556|NCT01769105|7480170|FG000|COMPLETED|First Intervention||14
6557557|NCT01769105|7480171|FG001|COMPLETED|First Intervention||17
6310427|NCT00397462|7214366|FG001|STARTED|Overall Study||13
6310428|NCT00397462|7214367|FG002|STARTED|Overall Study||15
6310429|NCT00397462|7214365|FG000|COMPLETED|Overall Study||16
6310430|NCT00397462|7214366|FG001|COMPLETED|Overall Study||13
6310431|NCT00397462|7214367|FG002|COMPLETED|Overall Study||15
6310432|NCT00397462|7214365|FG000|NOT COMPLETED|Overall Study||0
6310433|NCT00397462|7214366|FG001|NOT COMPLETED|Overall Study||0
6310434|NCT00397462|7214367|FG002|NOT COMPLETED|Overall Study||0
6310435|NCT00397488|7214375|FG000|STARTED|Overall Study||78
6310436|NCT00397488|7214375|FG000|COMPLETED|Overall Study||71
6310437|NCT00397488|7214375|FG000|NOT COMPLETED|Overall Study||7
6310438|NCT00397514|7214379|FG000|STARTED|Overall Study||34
6310439|NCT00397514|7214379|FG000|COMPLETED|Overall Study||25
6310440|NCT00397514|7214379|FG000|NOT COMPLETED|Overall Study||9
6310441|NCT00397540|7214391|FG000|STARTED|Overall Study||60
6310442|NCT00397540|7214392|FG001|STARTED|Overall Study||85
6310443|NCT00397540|7214391|FG000|COMPLETED|Overall Study||59
6310444|NCT00397540|7214392|FG001|COMPLETED|Overall Study||85
6310445|NCT00397540|7214391|FG000|NOT COMPLETED|Overall Study||1
6310446|NCT00397540|7214392|FG001|NOT COMPLETED|Overall Study||0
6310447|NCT00397579|7214399|FG000|STARTED|Overall Study||11
6310448|NCT00397579|7214399|FG000|COMPLETED|Overall Study||11
6310449|NCT00397579|7214399|FG000|NOT COMPLETED|Overall Study||0
6375133|NCT00754130|7285748|FG003|COMPLETED|Period 1 (5 Days)||2
6375134|NCT00754130|7285749|FG004|COMPLETED|Period 1 (5 Days)||2
6375135|NCT00754130|7285750|FG005|COMPLETED|Period 1 (5 Days)||4
6375136|NCT00754130|7285745|FG000|NOT COMPLETED|Period 1 (5 Days)||0
6375137|NCT00754130|7285746|FG001|NOT COMPLETED|Period 1 (5 Days)||0
6375138|NCT00754130|7285747|FG002|NOT COMPLETED|Period 1 (5 Days)||0
6557558|NCT01769105|7480170|FG000|NOT COMPLETED|First Intervention||2
6310450|NCT00397631|7214405|FG000|STARTED|Overall Study|Randomization ratio was 1:1|261
6310451|NCT00397631|7214406|FG001|STARTED|Overall Study||259
6310452|NCT00397631|7214405|FG000|COMPLETED|Overall Study||231
6310453|NCT00397631|7214406|FG001|COMPLETED|Overall Study||215
6310454|NCT00397631|7214405|FG000|NOT COMPLETED|Overall Study||30
6310455|NCT00397631|7214406|FG001|NOT COMPLETED|Overall Study||44
6310456|NCT00397813|7214418|FG000|STARTED|Overall Study||36
6310457|NCT00397813|7214419|FG001|STARTED|Overall Study||0
6310458|NCT00397813|7214420|FG002|STARTED|Overall Study||0
6310459|NCT00397813|7214421|FG003|STARTED|Overall Study||12
6310460|NCT00397813|7214422|FG004|STARTED|Overall Study||5
6310461|NCT00397813|7214423|FG005|STARTED|Overall Study||24
6310462|NCT00397813|7214418|FG000|COMPLETED|Overall Study||36
6310463|NCT00397813|7214419|FG001|COMPLETED|Overall Study||0
6310464|NCT00397813|7214420|FG002|COMPLETED|Overall Study||0
6310465|NCT00397813|7214421|FG003|COMPLETED|Overall Study||12
6310466|NCT00397813|7214422|FG004|COMPLETED|Overall Study||5
6310467|NCT00397813|7214423|FG005|COMPLETED|Overall Study||24
6310468|NCT00397813|7214418|FG000|NOT COMPLETED|Overall Study||0
6310469|NCT00397813|7214419|FG001|NOT COMPLETED|Overall Study||0
6310470|NCT00397813|7214420|FG002|NOT COMPLETED|Overall Study||0
6310471|NCT00397813|7214421|FG003|NOT COMPLETED|Overall Study||0
6310472|NCT00397813|7214422|FG004|NOT COMPLETED|Overall Study||0
6310473|NCT00397813|7214423|FG005|NOT COMPLETED|Overall Study||0
6310474|NCT00397839|7214439|FG000|STARTED|Overall Study||48
6310475|NCT00397839|7214440|FG001|STARTED|Overall Study||87
6310476|NCT00397839|7214439|FG000|COMPLETED|Overall Study||41
6310477|NCT00397839|7214440|FG001|COMPLETED|Overall Study||69
6310478|NCT00397839|7214439|FG000|NOT COMPLETED|Overall Study||7
6310479|NCT00397839|7214440|FG001|NOT COMPLETED|Overall Study||18
6310480|NCT00397878|7214446|FG000|STARTED|Overall Study||10
6310481|NCT00397878|7214446|FG000|COMPLETED|Overall Study||10
6310482|NCT00397878|7214446|FG000|NOT COMPLETED|Overall Study||0
6310483|NCT00397891|7214455|FG000|STARTED|Overall Study||6
6310484|NCT00397891|7214456|FG001|STARTED|Overall Study||6
6310485|NCT00397891|7214457|FG002|STARTED|Overall Study||6
6310486|NCT00397891|7214458|FG003|STARTED|Overall Study||6
6310487|NCT00397891|7214459|FG004|STARTED|Overall Study||8
6310488|NCT00397891|7214455|FG000|COMPLETED|Overall Study||5
6310489|NCT00397891|7214456|FG001|COMPLETED|Overall Study||6
6310490|NCT00397891|7214457|FG002|COMPLETED|Overall Study||6
6310491|NCT00397891|7214458|FG003|COMPLETED|Overall Study||6
6310492|NCT00397891|7214459|FG004|COMPLETED|Overall Study||7
6310493|NCT00397891|7214455|FG000|NOT COMPLETED|Overall Study||1
6310494|NCT00397891|7214456|FG001|NOT COMPLETED|Overall Study||0
6310495|NCT00397891|7214457|FG002|NOT COMPLETED|Overall Study||0
6310496|NCT00397891|7214458|FG003|NOT COMPLETED|Overall Study||0
6310497|NCT00397891|7214459|FG004|NOT COMPLETED|Overall Study||1
6310498|NCT00397904|7214471|FG000|STARTED|Overall Study||16
6310499|NCT00397904|7214471|FG000|COMPLETED|Overall Study||16
6310500|NCT00397904|7214471|FG000|NOT COMPLETED|Overall Study||0
6310501|NCT00397930|7214477|FG000|STARTED|Overall Study||206
6310502|NCT00397930|7214478|FG001|STARTED|Overall Study||204
6310503|NCT00397930|7214477|FG000|COMPLETED|Overall Study||168
6310504|NCT00397930|7214478|FG001|COMPLETED|Overall Study||153
6310505|NCT00397930|7214477|FG000|NOT COMPLETED|Overall Study||38
6310506|NCT00397930|7214478|FG001|NOT COMPLETED|Overall Study||51
6310507|NCT00397943|7214489|FG000|STARTED|Overall Study||40
6310508|NCT00397943|7214490|FG001|STARTED|Overall Study||40
6310509|NCT00397943|7214491|FG002|STARTED|Overall Study||10
6310510|NCT00397943|7214492|FG003|STARTED|Overall Study||10
6310511|NCT00397943|7214493|FG004|STARTED|Overall Study||10
6310512|NCT00397943|7214489|FG000|COMPLETED|Overall Study||28
6310513|NCT00397943|7214490|FG001|COMPLETED|Overall Study||31
6310514|NCT00397943|7214491|FG002|COMPLETED|Overall Study||10
6310515|NCT00397943|7214492|FG003|COMPLETED|Overall Study||10
6310516|NCT00397943|7214493|FG004|COMPLETED|Overall Study||10
6310517|NCT00397943|7214489|FG000|NOT COMPLETED|Overall Study||12
6310518|NCT00397943|7214490|FG001|NOT COMPLETED|Overall Study||9
6310519|NCT00397943|7214491|FG002|NOT COMPLETED|Overall Study||0
6310520|NCT00397943|7214492|FG003|NOT COMPLETED|Overall Study||0
6310521|NCT00397943|7214493|FG004|NOT COMPLETED|Overall Study||0
6557559|NCT01769105|7480171|FG001|NOT COMPLETED|First Intervention||2
6557560|NCT01769105|7480170|FG000|STARTED|Cross-over||14
6557561|NCT01769105|7480171|FG001|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
6557562|NCT01769105|7480170|FG000|COMPLETED|Cross-over||9
6310522|NCT00397982|7214505|FG000|STARTED|Overall Study||17
6310523|NCT00397982|7214505|FG000|COMPLETED|Overall Study||13
6310524|NCT00397982|7214505|FG000|NOT COMPLETED|Overall Study||4
6310525|NCT00398047|7214510|FG000|STARTED|Overall Study||3
6310526|NCT00398047|7214510|FG000|COMPLETED|Overall Study|all three patients progressed before completing|0
6310527|NCT00398047|7214510|FG000|NOT COMPLETED|Overall Study||3
6310528|NCT00398073|7214517|FG000|STARTED|Overall Study||18
6310529|NCT00398073|7214518|FG001|STARTED|Overall Study||17
6310530|NCT00398073|7214517|FG000|COMPLETED|Overall Study||17
6310531|NCT00398073|7214518|FG001|COMPLETED|Overall Study||17
6310532|NCT00398073|7214517|FG000|NOT COMPLETED|Overall Study||1
6310533|NCT00398073|7214518|FG001|NOT COMPLETED|Overall Study||0
6310534|NCT00398086|7214527|FG000|STARTED|Overall Study||20
6310535|NCT00398086|7214528|FG001|STARTED|Overall Study||44
6310536|NCT00398086|7214529|FG002|STARTED|Overall Study||3
6310537|NCT00398086|7214527|FG000|Phase 1, Dose Escalation Population|Overall Study||20
6310538|NCT00398086|7214528|FG001|Phase 1, Dose Escalation Population|Overall Study||7
6310539|NCT00398086|7214529|FG002|Phase 1, Dose Escalation Population|Overall Study||3
6310540|NCT00398086|7214527|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
6310541|NCT00398086|7214528|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
6310542|NCT00398086|7214529|FG002|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
6310543|NCT00398086|7214527|FG000|NOT COMPLETED|Overall Study||9
6310544|NCT00398086|7214528|FG001|NOT COMPLETED|Overall Study||23
6310545|NCT00398086|7214529|FG002|NOT COMPLETED|Overall Study||2
6310546|NCT00398112|7214537|FG000|STARTED|Overall Study||18
6310547|NCT00398112|7214537|FG000|COMPLETED|Overall Study||0
6310548|NCT00398112|7214537|FG000|NOT COMPLETED|Overall Study||18
6310549|NCT00398138|7214541|FG000|STARTED|Overall Study||12
6310550|NCT00398138|7214541|FG000|COMPLETED|Overall Study||10
6310551|NCT00398138|7214541|FG000|NOT COMPLETED|Overall Study||2
6310552|NCT00398216|7214550|FG000|STARTED|Overall Study||192
6310553|NCT00398216|7214551|FG001|STARTED|Overall Study||170
6310554|NCT00398216|7214552|FG002|STARTED|Overall Study||185
6498309|NCT01408888|7416867|FG000|NOT COMPLETED|Washout of at Least 21 Days||0
6498310|NCT01408888|7416868|FG001|NOT COMPLETED|Washout of at Least 21 Days||0
6498311|NCT01408888|7416867|FG000|STARTED|Second Intervention||18
6498312|NCT01408888|7416868|FG001|STARTED|Second Intervention||8
6498313|NCT01408888|7416867|FG000|COMPLETED|Second Intervention||16
6498314|NCT01408888|7416868|FG001|COMPLETED|Second Intervention||8
6310555|NCT00398216|7214553|FG003|STARTED|Overall Study||177
6310556|NCT00398216|7214554|FG004|STARTED|Overall Study||172
6310557|NCT00398216|7214550|FG000|COMPLETED|Overall Study||181
6310558|NCT00398216|7214551|FG001|COMPLETED|Overall Study||151
6310559|NCT00398216|7214552|FG002|COMPLETED|Overall Study||164
6310560|NCT00398216|7214553|FG003|COMPLETED|Overall Study||155
6310561|NCT00398216|7214554|FG004|COMPLETED|Overall Study||157
6310562|NCT00398216|7214550|FG000|NOT COMPLETED|Overall Study||11
6310563|NCT00398216|7214551|FG001|NOT COMPLETED|Overall Study||19
6310564|NCT00398216|7214552|FG002|NOT COMPLETED|Overall Study||21
6310565|NCT00398216|7214553|FG003|NOT COMPLETED|Overall Study||22
6310566|NCT00398216|7214554|FG004|NOT COMPLETED|Overall Study||15
6310567|NCT00398320|7214566|FG000|STARTED|Overall Study||40
6310568|NCT00398320|7214566|FG000|COMPLETED|Overall Study||34
6310569|NCT00398320|7214566|FG000|NOT COMPLETED|Overall Study||6
6310570|NCT00398398|7214570|FG000|STARTED|Overall Study||44
6310571|NCT00398398|7214570|FG000|COMPLETED|Overall Study||44
6310572|NCT00398398|7214570|FG000|NOT COMPLETED|Overall Study||0
6310573|NCT00398411|7214576|FG000|STARTED|Overall Study||34
6310574|NCT00398411|7214577|FG001|STARTED|Overall Study||32
6310575|NCT00398411|7214576|FG000|COMPLETED|Overall Study||34
6310576|NCT00398411|7214577|FG001|COMPLETED|Overall Study||31
6310577|NCT00398411|7214576|FG000|NOT COMPLETED|Overall Study||0
6310578|NCT00398411|7214577|FG001|NOT COMPLETED|Overall Study||1
6310579|NCT00398476|7214583|FG000|STARTED|Treatment Period 1||63
6310580|NCT00398476|7214584|FG001|STARTED|Treatment Period 1||64
6310581|NCT00398476|7214583|FG000|COMPLETED|Treatment Period 1||63
6310582|NCT00398476|7214584|FG001|COMPLETED|Treatment Period 1||64
6310583|NCT00398476|7214583|FG000|NOT COMPLETED|Treatment Period 1||0
6310584|NCT00398476|7214584|FG001|NOT COMPLETED|Treatment Period 1||0
6310585|NCT00398476|7214583|FG000|STARTED|Washout Period (20 Minutes)||63
6310586|NCT00398476|7214584|FG001|STARTED|Washout Period (20 Minutes)||64
6310587|NCT00398476|7214583|FG000|COMPLETED|Washout Period (20 Minutes)||63
6310588|NCT00398476|7214584|FG001|COMPLETED|Washout Period (20 Minutes)||64
6310589|NCT00398476|7214583|FG000|NOT COMPLETED|Washout Period (20 Minutes)||0
6310590|NCT00398476|7214584|FG001|NOT COMPLETED|Washout Period (20 Minutes)||0
6310591|NCT00398476|7214583|FG000|STARTED|Treatment Period 2||63
6310592|NCT00398476|7214584|FG001|STARTED|Treatment Period 2||64
6310593|NCT00398476|7214583|FG000|COMPLETED|Treatment Period 2||63
6310594|NCT00398476|7214584|FG001|COMPLETED|Treatment Period 2||64
6310595|NCT00398476|7214583|FG000|NOT COMPLETED|Treatment Period 2||0
6310596|NCT00398476|7214584|FG001|NOT COMPLETED|Treatment Period 2||0
6310597|NCT00398567|7214595|FG000|STARTED|Overall Study||4
6310598|NCT00398567|7214596|FG001|STARTED|Overall Study||4
6310599|NCT00398567|7214597|FG002|STARTED|Overall Study||37
6310600|NCT00398567|7214595|FG000|COMPLETED|Overall Study||0
6310601|NCT00398567|7214596|FG001|COMPLETED|Overall Study||0
6310602|NCT00398567|7214597|FG002|COMPLETED|Overall Study||3
6310603|NCT00398567|7214595|FG000|NOT COMPLETED|Overall Study||4
6310604|NCT00398567|7214596|FG001|NOT COMPLETED|Overall Study||4
6310605|NCT00398567|7214597|FG002|NOT COMPLETED|Overall Study||34
6310606|NCT00398632|7214603|FG000|STARTED|Overall Study||6
6310607|NCT00398632|7214603|FG000|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
6310608|NCT00398632|7214603|FG000|NOT COMPLETED|Overall Study||2
6310609|NCT00398866|7214611|FG000|STARTED|Overall Study||66
6310610|NCT00398866|7214612|FG001|STARTED|Overall Study||68
6310611|NCT00398866|7214613|FG002|STARTED|Overall Study||66
6310612|NCT00398866|7214611|FG000|COMPLETED|Overall Study||52
6310613|NCT00398866|7214612|FG001|COMPLETED|Overall Study||60
6310614|NCT00398866|7214613|FG002|COMPLETED|Overall Study||58
6310615|NCT00398866|7214611|FG000|NOT COMPLETED|Overall Study||14
6310616|NCT00398866|7214612|FG001|NOT COMPLETED|Overall Study||8
6310617|NCT00398866|7214613|FG002|NOT COMPLETED|Overall Study||8
6310618|NCT00398918|7214622|FG000|STARTED|Overall Study||10
6310619|NCT00398918|7214622|FG000|COMPLETED|Overall Study||10
6310620|NCT00398918|7214622|FG000|NOT COMPLETED|Overall Study||0
6310621|NCT00398983|7214628|FG000|STARTED|Overall Study||20
6310622|NCT00398983|7214629|FG001|STARTED|Overall Study||25
6310623|NCT00398983|7214628|FG000|COMPLETED|Overall Study||20
6310624|NCT00398983|7214629|FG001|COMPLETED|Overall Study||25
6310625|NCT00398983|7214628|FG000|NOT COMPLETED|Overall Study||0
6310626|NCT00398983|7214629|FG001|NOT COMPLETED|Overall Study||0
6310627|NCT00399035|7214638|FG000|STARTED|Overall Study||502
6310628|NCT00399035|7214639|FG001|STARTED|Overall Study||216
6310629|NCT00399035|7214640|FG002|STARTED|Overall Study||358
6310630|NCT00399035|7214638|FG000|COMPLETED|Overall Study||189
6310631|NCT00399035|7214639|FG001|COMPLETED|Overall Study||58
6310632|NCT00399035|7214640|FG002|COMPLETED|Overall Study||106
6310633|NCT00399035|7214638|FG000|NOT COMPLETED|Overall Study||313
6310634|NCT00399035|7214639|FG001|NOT COMPLETED|Overall Study||158
6310635|NCT00399035|7214640|FG002|NOT COMPLETED|Overall Study||252
6310636|NCT00399308|7214650|FG000|STARTED|Overall Study||13
6310637|NCT00399308|7214651|FG001|STARTED|Overall Study||15
6310638|NCT00399308|7214652|FG002|STARTED|Overall Study||12
6310639|NCT00399308|7214650|FG000|COMPLETED|Overall Study||13
6310640|NCT00399308|7214651|FG001|COMPLETED|Overall Study||15
6310641|NCT00399308|7214652|FG002|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
6310642|NCT00399308|7214650|FG000|NOT COMPLETED|Overall Study||0
6310643|NCT00399308|7214651|FG001|NOT COMPLETED|Overall Study||0
6310644|NCT00399308|7214652|FG002|NOT COMPLETED|Overall Study||1
6310645|NCT00399360|7214664|FG000|STARTED|Overall Study||11
6310646|NCT00399360|7214665|FG001|STARTED|Overall Study||11
6310647|NCT00399360|7214666|FG002|STARTED|Overall Study||13
6310648|NCT00399360|7214667|FG003|STARTED|Overall Study||15
6310649|NCT00399360|7214664|FG000|COMPLETED|Overall Study||9
6310650|NCT00399360|7214665|FG001|COMPLETED|Overall Study||8
6310651|NCT00399360|7214666|FG002|COMPLETED|Overall Study||10
6310652|NCT00399360|7214667|FG003|COMPLETED|Overall Study||9
6310653|NCT00399360|7214664|FG000|NOT COMPLETED|Overall Study||2
6310654|NCT00399360|7214665|FG001|NOT COMPLETED|Overall Study||3
6310655|NCT00399360|7214666|FG002|NOT COMPLETED|Overall Study||3
6310656|NCT00399360|7214667|FG003|NOT COMPLETED|Overall Study||6
6310657|NCT00399490|7214682|FG000|STARTED|Overall Study||281
6310658|NCT00399490|7214682|FG000|COMPLETED|Overall Study||183
6310659|NCT00399490|7214682|FG000|NOT COMPLETED|Overall Study||98
6310660|NCT00399516|7214688|FG000|STARTED|Overall Study||21
6310661|NCT00399516|7214688|FG000|COMPLETED|Overall Study||19
6310662|NCT00399516|7214688|FG000|NOT COMPLETED|Overall Study||2
6310663|NCT00399529|7214692|FG000|STARTED|Overall Study||22
6310664|NCT00399529|7214692|FG000|COMPLETED|Overall Study||20
6310665|NCT00399529|7214692|FG000|NOT COMPLETED|Overall Study||2
6310666|NCT00399542|7214699|FG000|STARTED|Overall Study||387
6310667|NCT00399542|7214700|FG001|STARTED|Overall Study||194
6310668|NCT00399542|7214699|FG000|COMPLETED|Overall Study||303
6310669|NCT00399542|7214700|FG001|COMPLETED|Overall Study||151
6310670|NCT00399542|7214699|FG000|NOT COMPLETED|Overall Study||84
6310671|NCT00399542|7214700|FG001|NOT COMPLETED|Overall Study||43
6310672|NCT00399568|7214708|FG000|STARTED|Overall Study||166
6310673|NCT00399568|7214709|FG001|STARTED|Overall Study||165
6310674|NCT00399568|7214708|FG000|COMPLETED|Overall Study||154
6310675|NCT00399568|7214709|FG001|COMPLETED|Overall Study||156
6310676|NCT00399568|7214708|FG000|NOT COMPLETED|Overall Study||12
6310677|NCT00399568|7214709|FG001|NOT COMPLETED|Overall Study||9
6310678|NCT00399763|7214719|FG000|STARTED|Overall Study||35
6310679|NCT00399763|7214720|FG001|STARTED|Overall Study||35
6310680|NCT00399763|7214719|FG000|COMPLETED|Overall Study||33
6310681|NCT00399763|7214720|FG001|COMPLETED|Overall Study||32
6310682|NCT00399763|7214719|FG000|NOT COMPLETED|Overall Study||2
6310683|NCT00399763|7214720|FG001|NOT COMPLETED|Overall Study||3
6310684|NCT00399802|7214728|FG000|STARTED|Overall Study||14
6310685|NCT00399802|7214729|FG001|STARTED|Overall Study||29
6310686|NCT00399802|7214728|FG000|COMPLETED|Overall Study||14
6310687|NCT00399802|7214729|FG001|COMPLETED|Overall Study||26
6310688|NCT00399802|7214728|FG000|NOT COMPLETED|Overall Study||0
6310689|NCT00399802|7214729|FG001|NOT COMPLETED|Overall Study||3
6310690|NCT00399880|7214737|FG000|STARTED|Overall Study||65
6310691|NCT00399880|7214738|FG001|STARTED|Overall Study||65
6310692|NCT00399880|7214737|FG000|COMPLETED|Overall Study||65
6310693|NCT00399880|7214738|FG001|COMPLETED|Overall Study||65
6310694|NCT00399880|7214737|FG000|NOT COMPLETED|Overall Study||0
6310695|NCT00399880|7214738|FG001|NOT COMPLETED|Overall Study||0
6310696|NCT00399893|7214746|FG000|STARTED|Overall Study||2
6310697|NCT00399893|7214747|FG001|STARTED|Overall Study||3
6310698|NCT00399893|7214746|FG000|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
6310699|NCT00399893|7214747|FG001|COMPLETED|Overall Study||3
6310700|NCT00399893|7214746|FG000|NOT COMPLETED|Overall Study||1
6310701|NCT00399893|7214747|FG001|NOT COMPLETED|Overall Study||0
6310702|NCT00400153|7214756|FG000|STARTED|Overall Study||486
6310703|NCT00400153|7214757|FG001|STARTED|Overall Study||491
6310704|NCT00400153|7214758|FG002|STARTED|Overall Study||483
6310705|NCT00400153|7214756|FG000|COMPLETED|Overall Study||438
6310706|NCT00400153|7214757|FG001|COMPLETED|Overall Study||436
6310707|NCT00400153|7214758|FG002|COMPLETED|Overall Study||422
6310708|NCT00400153|7214756|FG000|NOT COMPLETED|Overall Study||48
6310709|NCT00400153|7214757|FG001|NOT COMPLETED|Overall Study||55
6310710|NCT00400153|7214758|FG002|NOT COMPLETED|Overall Study||61
6310711|NCT00400179|7214773|FG000|STARTED|Overall Study|Signed informed consent form and randomized|527
6310712|NCT00400179|7214774|FG001|STARTED|Overall Study||526
6310713|NCT00400179|7214773|FG000|COMPLETED|Overall Study|Received Treatment|521
6310714|NCT00400179|7214774|FG001|COMPLETED|Overall Study||508
6310715|NCT00400179|7214773|FG000|NOT COMPLETED|Overall Study||6
6310716|NCT00400179|7214774|FG001|NOT COMPLETED|Overall Study||18
6310717|NCT00400205|7214780|FG000|STARTED|Overall Study||14
6557563|NCT01769105|7480171|FG001|COMPLETED|Cross-over|Was not intended by the study protocol|0
6557564|NCT01769105|7480170|FG000|NOT COMPLETED|Cross-over||5
6557565|NCT01769105|7480171|FG001|NOT COMPLETED|Cross-over||0
6557566|NCT01769170|7480181|FG000|STARTED|Overall Study||303
6557567|NCT01769170|7480182|FG001|STARTED|Overall Study||149
6310718|NCT00400205|7214780|FG000|COMPLETED|Overall Study||9
6310719|NCT00400205|7214780|FG000|NOT COMPLETED|Overall Study||5
6310720|NCT00400400|7214787|FG000|STARTED|Overall Study||200
6310721|NCT00400400|7214788|FG001|STARTED|Overall Study||200
6310722|NCT00400400|7214787|FG000|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
6310723|NCT00400400|7214788|FG001|Intent-to-Treat Population|Overall Study||197
6310724|NCT00400400|7214787|FG000|COMPLETED|Overall Study||186
6310725|NCT00400400|7214788|FG001|COMPLETED|Overall Study||185
6310726|NCT00400400|7214787|FG000|NOT COMPLETED|Overall Study||14
6310727|NCT00400400|7214788|FG001|NOT COMPLETED|Overall Study||15
6310728|NCT00400439|7214796|FG000|STARTED|Overall Study||52
6310729|NCT00400439|7214797|FG001|STARTED|Overall Study||25
6310730|NCT00400439|7214796|FG000|COMPLETED|Overall Study||47
6310731|NCT00400439|7214797|FG001|COMPLETED|Overall Study||23
6310732|NCT00400439|7214796|FG000|NOT COMPLETED|Overall Study||5
6310733|NCT00400439|7214797|FG001|NOT COMPLETED|Overall Study||2
6310734|NCT00400517|7214803|FG000|STARTED|Overall Study|1 pt w/d consent. 1 pt found to have unresectable dx at time of sx and is exc. in tissue analysis.|28
6310735|NCT00400517|7214803|FG000|COMPLETED|Overall Study||26
6310736|NCT00400517|7214803|FG000|NOT COMPLETED|Overall Study||2
6310737|NCT00400569|7214807|FG000|STARTED|Overall Study||48
6310738|NCT00400569|7214807|FG000|COMPLETED|Overall Study||47
6310739|NCT00400569|7214807|FG000|NOT COMPLETED|Overall Study||1
6310740|NCT00400634|7214816|FG000|STARTED|Overall Study||38
6310741|NCT00400634|7214817|FG001|STARTED|Overall Study||20
6310742|NCT00400634|7214816|FG000|COMPLETED|Overall Study||34
6310743|NCT00400634|7214817|FG001|COMPLETED|Overall Study||19
6310744|NCT00400634|7214816|FG000|NOT COMPLETED|Overall Study||4
6310745|NCT00400634|7214817|FG001|NOT COMPLETED|Overall Study||1
6310746|NCT00400686|7214823|FG000|STARTED|Overall Study||31
6310747|NCT00400686|7214823|FG000|COMPLETED|Overall Study||31
6310748|NCT00400686|7214823|FG000|NOT COMPLETED|Overall Study||0
6310749|NCT00400712|7214829|FG000|STARTED|Overall Study||52
6310750|NCT00400712|7214830|FG001|STARTED|Overall Study||51
6310751|NCT00400712|7214829|FG000|COMPLETED|Overall Study||35
6310752|NCT00400712|7214830|FG001|COMPLETED|Overall Study||35
6310753|NCT00400712|7214829|FG000|NOT COMPLETED|Overall Study||17
6310754|NCT00400712|7214830|FG001|NOT COMPLETED|Overall Study||16
6310755|NCT00400764|7214843|FG000|STARTED|Phase Ib||6
6310756|NCT00400764|7214844|FG001|STARTED|Phase Ib||6
6310757|NCT00400764|7214845|FG002|STARTED|Phase Ib||0
6310758|NCT00400764|7214846|FG003|STARTED|Phase Ib||0
6310759|NCT00400764|7214847|FG004|STARTED|Phase Ib||0
6310760|NCT00400764|7214843|FG000|Treated|Phase Ib||6
6310761|NCT00400764|7214844|FG001|Treated|Phase Ib||6
6310762|NCT00400764|7214845|FG002|Treated|Phase Ib||0
6310763|NCT00400764|7214846|FG003|Treated|Phase Ib||0
6310764|NCT00400764|7214847|FG004|Treated|Phase Ib||0
6310765|NCT00400764|7214843|FG000|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
6310766|NCT00400764|7214844|FG001|COMPLETED|Phase Ib||2
6310767|NCT00400764|7214845|FG002|COMPLETED|Phase Ib||0
6310768|NCT00400764|7214846|FG003|COMPLETED|Phase Ib||0
6310769|NCT00400764|7214847|FG004|COMPLETED|Phase Ib||0
6310770|NCT00400764|7214843|FG000|NOT COMPLETED|Phase Ib||6
6310771|NCT00400764|7214844|FG001|NOT COMPLETED|Phase Ib||4
6310772|NCT00400764|7214845|FG002|NOT COMPLETED|Phase Ib||0
6310773|NCT00400764|7214846|FG003|NOT COMPLETED|Phase Ib||0
6310774|NCT00400764|7214847|FG004|NOT COMPLETED|Phase Ib||0
6310775|NCT00400764|7214843|FG000|STARTED|Phase II||0
6310776|NCT00400764|7214844|FG001|STARTED|Phase II||0
6310777|NCT00400764|7214845|FG002|STARTED|Phase II||23
6310778|NCT00400764|7214846|FG003|STARTED|Phase II||26
6310779|NCT00400764|7214847|FG004|STARTED|Phase II||11
6310780|NCT00400764|7214843|FG000|Treated|Phase II||0
6310781|NCT00400764|7214844|FG001|Treated|Phase II||0
6310782|NCT00400764|7214845|FG002|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
6498315|NCT01408888|7416867|FG000|NOT COMPLETED|Second Intervention||2
6310783|NCT00400764|7214846|FG003|Treated|Phase II||26
6310784|NCT00400764|7214847|FG004|Treated|Phase II||11
6310785|NCT00400764|7214843|FG000|COMPLETED|Phase II||0
6498316|NCT01408888|7416868|FG001|NOT COMPLETED|Second Intervention||0
6498317|NCT01408901|7416888|FG000|STARTED|6-Week Follow-Up||53
6498318|NCT01408901|7416889|FG001|STARTED|6-Week Follow-Up||53
6498319|NCT01408901|7416890|FG002|STARTED|6-Week Follow-Up||53
6498320|NCT01408901|7416891|FG003|STARTED|6-Week Follow-Up||51
6498321|NCT01408901|7416888|FG000|COMPLETED|6-Week Follow-Up||50
6498322|NCT01408901|7416889|FG001|COMPLETED|6-Week Follow-Up||51
6498323|NCT01408901|7416890|FG002|COMPLETED|6-Week Follow-Up||50
6498324|NCT01408901|7416891|FG003|COMPLETED|6-Week Follow-Up||47
6557568|NCT01769170|7480181|FG000|COMPLETED|Overall Study||232
6310786|NCT00400764|7214844|FG001|COMPLETED|Phase II||0
6310787|NCT00400764|7214845|FG002|COMPLETED|Phase II||0
6310788|NCT00400764|7214846|FG003|COMPLETED|Phase II||0
6310789|NCT00400764|7214847|FG004|COMPLETED|Phase II||0
6310790|NCT00400764|7214843|FG000|NOT COMPLETED|Phase II||0
6310791|NCT00400764|7214844|FG001|NOT COMPLETED|Phase II||0
6310792|NCT00400764|7214845|FG002|NOT COMPLETED|Phase II||23
6310793|NCT00400764|7214846|FG003|NOT COMPLETED|Phase II||26
6310794|NCT00400764|7214847|FG004|NOT COMPLETED|Phase II||11
6310795|NCT00400803|7214864|FG000|STARTED|Overall Study||35
6310796|NCT00400803|7214864|FG000|COMPLETED|Overall Study||35
6310797|NCT00400803|7214864|FG000|NOT COMPLETED|Overall Study||0
6310798|NCT00400829|7214872|FG000|STARTED|Overall Study||66
6310799|NCT00400829|7214872|FG000|COMPLETED|Overall Study||66
6310800|NCT00400829|7214872|FG000|NOT COMPLETED|Overall Study||0
6310801|NCT00400881|7214878|FG000|STARTED|Overall Study||62
6310802|NCT00400881|7214879|FG001|STARTED|Overall Study||60
6310803|NCT00400881|7214878|FG000|COMPLETED|Overall Study||62
6310804|NCT00400881|7214879|FG001|COMPLETED|Overall Study||60
6310805|NCT00400881|7214878|FG000|NOT COMPLETED|Overall Study||0
6310806|NCT00400881|7214879|FG001|NOT COMPLETED|Overall Study||0
6310807|NCT00400946|7214891|FG000|STARTED|Overall Study||231
6310808|NCT00400946|7214892|FG001|STARTED|Overall Study||232
6310809|NCT00400946|7214893|FG002|STARTED|Overall Study||42
6310810|NCT00400946|7214894|FG003|STARTED|Overall Study||51
6310811|NCT00400946|7214895|FG004|STARTED|Overall Study||244
6310812|NCT00400946|7214891|FG000|Evaluable for CNS Directed-Treatment|Overall Study||231
6310813|NCT00400946|7214892|FG001|Evaluable for CNS Directed-Treatment|Overall Study||232
6310814|NCT00400946|7214893|FG002|Evaluable for CNS Directed-Treatment|Overall Study||42
6310815|NCT00400946|7214894|FG003|Evaluable for CNS Directed-Treatment|Overall Study||21
6310816|NCT00400946|7214895|FG004|Evaluable for CNS Directed-Treatment|Overall Study||227
6310817|NCT00400946|7214891|FG000|Evaluable for Day 18 Marrow Morphology|Overall Study||158
6310818|NCT00400946|7214892|FG001|Evaluable for Day 18 Marrow Morphology|Overall Study||161
6310819|NCT00400946|7214893|FG002|Evaluable for Day 18 Marrow Morphology|Overall Study||19
6310820|NCT00400946|7214894|FG003|Evaluable for Day 18 Marrow Morphology|Overall Study||13
6310821|NCT00400946|7214895|FG004|Evaluable for Day 18 Marrow Morphology|Overall Study||152
6310822|NCT00400946|7214891|FG000|Evaluable for Day 32 MRD|Overall Study||166
6310823|NCT00400946|7214892|FG001|Evaluable for Day 32 MRD|Overall Study||167
6310824|NCT00400946|7214893|FG002|Evaluable for Day 32 MRD|Overall Study||33
6310825|NCT00400946|7214894|FG003|Evaluable for Day 32 MRD|Overall Study||12
6310826|NCT00400946|7214895|FG004|Evaluable for Day 32 MRD|Overall Study||168
6310827|NCT00400946|7214891|FG000|Eligible and Treated|Overall Study||231
6310828|NCT00400946|7214892|FG001|Eligible and Treated|Overall Study||232
6310829|NCT00400946|7214893|FG002|Eligible and Treated|Overall Study||42
6310830|NCT00400946|7214894|FG003|Eligible and Treated|Overall Study||46
6310831|NCT00400946|7214895|FG004|Eligible and Treated|Overall Study||243
6310832|NCT00400946|7214891|FG000|COMPLETED|Overall Study||217
6310833|NCT00400946|7214892|FG001|COMPLETED|Overall Study||221
6310834|NCT00400946|7214893|FG002|COMPLETED|Overall Study||40
6310835|NCT00400946|7214894|FG003|COMPLETED|Overall Study||4
6310836|NCT00400946|7214895|FG004|COMPLETED|Overall Study||206
6310837|NCT00400946|7214891|FG000|NOT COMPLETED|Overall Study||14
6310838|NCT00400946|7214892|FG001|NOT COMPLETED|Overall Study||11
6310839|NCT00400946|7214893|FG002|NOT COMPLETED|Overall Study||2
6310840|NCT00400946|7214894|FG003|NOT COMPLETED|Overall Study||47
6310841|NCT00400946|7214895|FG004|NOT COMPLETED|Overall Study||38
6310842|NCT00400985|7214913|FG000|STARTED|Overall Study||501
6310843|NCT00400985|7214913|FG000|COMPLETED|Overall Study||449
6310844|NCT00400985|7214913|FG000|NOT COMPLETED|Overall Study||52
6310845|NCT00401102|7214917|FG000|STARTED|Overall Study||12
6310846|NCT00401102|7214917|FG000|COMPLETED|Overall Study||5
6310847|NCT00401102|7214917|FG000|NOT COMPLETED|Overall Study||7
6310848|NCT00401193|7214924|FG000|STARTED|Overall Study||118
6310849|NCT00401193|7214925|FG001|STARTED|Overall Study||117
6310850|NCT00401193|7214926|FG002|STARTED|Overall Study||69
6310851|NCT00401193|7214924|FG000|Intent to Treat Population|Overall Study||115
6310852|NCT00401193|7214925|FG001|Intent to Treat Population|Overall Study||115
6310853|NCT00401193|7214926|FG002|Intent to Treat Population|Overall Study||67
6310854|NCT00401193|7214924|FG000|Modified Intent to Treat Population|Overall Study||112
6310855|NCT00401193|7214925|FG001|Modified Intent to Treat Population|Overall Study||115
6310856|NCT00401193|7214926|FG002|Modified Intent to Treat Population|Overall Study||67
6310857|NCT00401193|7214924|FG000|COMPLETED|Overall Study||103
6310858|NCT00401193|7214925|FG001|COMPLETED|Overall Study||106
6310859|NCT00401193|7214926|FG002|COMPLETED|Overall Study||63
6773448|NCT03983317|7701104|FG000|COMPLETED|Overall Study||20
6773449|NCT03983317|7701104|FG000|NOT COMPLETED|Overall Study||5
6773450|NCT03985657|7701108|FG000|STARTED|Intervention 1 (One Night)||20
6773451|NCT03985657|7701109|FG001|STARTED|Intervention 1 (One Night)||11
6773452|NCT03985657|7701108|FG000|COMPLETED|Intervention 1 (One Night)||20
6310860|NCT00401193|7214924|FG000|NOT COMPLETED|Overall Study||15
6310861|NCT00401193|7214925|FG001|NOT COMPLETED|Overall Study||11
6310862|NCT00401193|7214926|FG002|NOT COMPLETED|Overall Study||6
6310863|NCT00401245|7214939|FG000|STARTED|Double Blind Titration Phase||126
6310864|NCT00401245|7214940|FG001|STARTED|Double Blind Titration Phase||121
6310865|NCT00401245|7214941|FG002|STARTED|Double Blind Titration Phase||124
6773453|NCT03985657|7701109|FG001|COMPLETED|Intervention 1 (One Night)||10
6310866|NCT00401245|7214942|FG003|STARTED|Double Blind Titration Phase||122
6310867|NCT00401245|7214943|FG004|STARTED|Double Blind Titration Phase||0
6310868|NCT00401245|7214944|FG005|STARTED|Double Blind Titration Phase||0
6310869|NCT00401245|7214945|FG006|STARTED|Double Blind Titration Phase||0
6310870|NCT00401245|7214946|FG007|STARTED|Double Blind Titration Phase||0
6310871|NCT00401245|7214939|FG000|COMPLETED|Double Blind Titration Phase||122
6310872|NCT00401245|7214940|FG001|COMPLETED|Double Blind Titration Phase||118
6310873|NCT00401245|7214941|FG002|COMPLETED|Double Blind Titration Phase||118
6310874|NCT00401245|7214942|FG003|COMPLETED|Double Blind Titration Phase||107
6310875|NCT00401245|7214943|FG004|COMPLETED|Double Blind Titration Phase||0
6310876|NCT00401245|7214944|FG005|COMPLETED|Double Blind Titration Phase||0
6310877|NCT00401245|7214945|FG006|COMPLETED|Double Blind Titration Phase||0
6310878|NCT00401245|7214946|FG007|COMPLETED|Double Blind Titration Phase||0
6310879|NCT00401245|7214939|FG000|NOT COMPLETED|Double Blind Titration Phase||4
6310880|NCT00401245|7214940|FG001|NOT COMPLETED|Double Blind Titration Phase||3
6310881|NCT00401245|7214941|FG002|NOT COMPLETED|Double Blind Titration Phase||6
6310882|NCT00401245|7214942|FG003|NOT COMPLETED|Double Blind Titration Phase||15
6310883|NCT00401245|7214943|FG004|NOT COMPLETED|Double Blind Titration Phase||0
6310884|NCT00401245|7214944|FG005|NOT COMPLETED|Double Blind Titration Phase||0
6310885|NCT00401245|7214945|FG006|NOT COMPLETED|Double Blind Titration Phase||0
6310886|NCT00401245|7214946|FG007|NOT COMPLETED|Double Blind Titration Phase||0
6310887|NCT00401245|7214939|FG000|STARTED|Between Titration and Open Label Phase||122
6310888|NCT00401245|7214940|FG001|STARTED|Between Titration and Open Label Phase||118
6310889|NCT00401245|7214941|FG002|STARTED|Between Titration and Open Label Phase||118
6310890|NCT00401245|7214942|FG003|STARTED|Between Titration and Open Label Phase||107
6310891|NCT00401245|7214943|FG004|STARTED|Between Titration and Open Label Phase||0
6310892|NCT00401245|7214944|FG005|STARTED|Between Titration and Open Label Phase||0
6310893|NCT00401245|7214945|FG006|STARTED|Between Titration and Open Label Phase||0
6310894|NCT00401245|7214946|FG007|STARTED|Between Titration and Open Label Phase||0
6310895|NCT00401245|7214939|FG000|COMPLETED|Between Titration and Open Label Phase||122
6310896|NCT00401245|7214940|FG001|COMPLETED|Between Titration and Open Label Phase||116
6310897|NCT00401245|7214941|FG002|COMPLETED|Between Titration and Open Label Phase||118
6310898|NCT00401245|7214942|FG003|COMPLETED|Between Titration and Open Label Phase||105
6310899|NCT00401245|7214943|FG004|COMPLETED|Between Titration and Open Label Phase||0
6310900|NCT00401245|7214944|FG005|COMPLETED|Between Titration and Open Label Phase||0
6310901|NCT00401245|7214945|FG006|COMPLETED|Between Titration and Open Label Phase||0
6310902|NCT00401245|7214946|FG007|COMPLETED|Between Titration and Open Label Phase||0
6310903|NCT00401245|7214939|FG000|NOT COMPLETED|Between Titration and Open Label Phase||0
6310904|NCT00401245|7214940|FG001|NOT COMPLETED|Between Titration and Open Label Phase||2
6310905|NCT00401245|7214941|FG002|NOT COMPLETED|Between Titration and Open Label Phase||0
6310906|NCT00401245|7214942|FG003|NOT COMPLETED|Between Titration and Open Label Phase||2
6310907|NCT00401245|7214943|FG004|NOT COMPLETED|Between Titration and Open Label Phase||0
6310908|NCT00401245|7214944|FG005|NOT COMPLETED|Between Titration and Open Label Phase||0
6310909|NCT00401245|7214945|FG006|NOT COMPLETED|Between Titration and Open Label Phase||0
6310910|NCT00401245|7214946|FG007|NOT COMPLETED|Between Titration and Open Label Phase||0
6310911|NCT00401245|7214939|FG000|STARTED|Open Label Phase||122
6310912|NCT00401245|7214940|FG001|STARTED|Open Label Phase||116
6310913|NCT00401245|7214941|FG002|STARTED|Open Label Phase||118
6310914|NCT00401245|7214942|FG003|STARTED|Open Label Phase||105
6310915|NCT00401245|7214943|FG004|STARTED|Open Label Phase||0
6310916|NCT00401245|7214944|FG005|STARTED|Open Label Phase||0
6310917|NCT00401245|7214945|FG006|STARTED|Open Label Phase||0
6310918|NCT00401245|7214946|FG007|STARTED|Open Label Phase||0
6310919|NCT00401245|7214939|FG000|COMPLETED|Open Label Phase||101
6310920|NCT00401245|7214940|FG001|COMPLETED|Open Label Phase||81
6310921|NCT00401245|7214941|FG002|COMPLETED|Open Label Phase||95
6310922|NCT00401245|7214942|FG003|COMPLETED|Open Label Phase||84
6310923|NCT00401245|7214943|FG004|COMPLETED|Open Label Phase||0
6310924|NCT00401245|7214944|FG005|COMPLETED|Open Label Phase||0
6310925|NCT00401245|7214945|FG006|COMPLETED|Open Label Phase||0
6310926|NCT00401245|7214946|FG007|COMPLETED|Open Label Phase||0
6310927|NCT00401245|7214939|FG000|NOT COMPLETED|Open Label Phase||21
6310928|NCT00401245|7214940|FG001|NOT COMPLETED|Open Label Phase||35
6310929|NCT00401245|7214941|FG002|NOT COMPLETED|Open Label Phase||23
6310930|NCT00401245|7214942|FG003|NOT COMPLETED|Open Label Phase||21
6310931|NCT00401245|7214943|FG004|NOT COMPLETED|Open Label Phase||0
6310932|NCT00401245|7214944|FG005|NOT COMPLETED|Open Label Phase||0
6310933|NCT00401245|7214945|FG006|NOT COMPLETED|Open Label Phase||0
6310934|NCT00401245|7214946|FG007|NOT COMPLETED|Open Label Phase||0
6310935|NCT00401245|7214939|FG000|STARTED|Double Blind Tapering Phase||0
6310936|NCT00401245|7214940|FG001|STARTED|Double Blind Tapering Phase||0
6310937|NCT00401245|7214941|FG002|STARTED|Double Blind Tapering Phase||0
6310938|NCT00401245|7214942|FG003|STARTED|Double Blind Tapering Phase||0
6310939|NCT00401245|7214943|FG004|STARTED|Double Blind Tapering Phase||101
6310940|NCT00401245|7214944|FG005|STARTED|Double Blind Tapering Phase||94
6310941|NCT00401245|7214945|FG006|STARTED|Double Blind Tapering Phase||87
6310942|NCT00401245|7214946|FG007|STARTED|Double Blind Tapering Phase||102
6310943|NCT00401245|7214939|FG000|COMPLETED|Double Blind Tapering Phase||0
6310944|NCT00401245|7214940|FG001|COMPLETED|Double Blind Tapering Phase||0
6310945|NCT00401245|7214941|FG002|COMPLETED|Double Blind Tapering Phase||0
6310946|NCT00401245|7214942|FG003|COMPLETED|Double Blind Tapering Phase||0
6310947|NCT00401245|7214943|FG004|COMPLETED|Double Blind Tapering Phase||97
6310948|NCT00401245|7214944|FG005|COMPLETED|Double Blind Tapering Phase||90
6310949|NCT00401245|7214945|FG006|COMPLETED|Double Blind Tapering Phase||80
6310950|NCT00401245|7214946|FG007|COMPLETED|Double Blind Tapering Phase||95
6310951|NCT00401245|7214939|FG000|NOT COMPLETED|Double Blind Tapering Phase||0
6310952|NCT00401245|7214940|FG001|NOT COMPLETED|Double Blind Tapering Phase||0
6310953|NCT00401245|7214941|FG002|NOT COMPLETED|Double Blind Tapering Phase||0
6310954|NCT00401245|7214942|FG003|NOT COMPLETED|Double Blind Tapering Phase||0
6310955|NCT00401245|7214943|FG004|NOT COMPLETED|Double Blind Tapering Phase||4
6310956|NCT00401245|7214944|FG005|NOT COMPLETED|Double Blind Tapering Phase||4
6310957|NCT00401245|7214945|FG006|NOT COMPLETED|Double Blind Tapering Phase||7
6310958|NCT00401245|7214946|FG007|NOT COMPLETED|Double Blind Tapering Phase||7
6310959|NCT00401258|7214966|FG000|STARTED|Overall Study||15
6310960|NCT00401258|7214966|FG000|COMPLETED|Overall Study||8
6310961|NCT00401258|7214966|FG000|NOT COMPLETED|Overall Study||7
6557569|NCT01769170|7480182|FG001|COMPLETED|Overall Study||122
6557570|NCT01769170|7480181|FG000|NOT COMPLETED|Overall Study||71
6557571|NCT01769170|7480182|FG001|NOT COMPLETED|Overall Study||27
6557572|NCT01769196|7480190|FG000|STARTED|Overall Study||272
6557573|NCT01769196|7480191|FG001|STARTED|Overall Study||272
6557574|NCT01769196|7480190|FG000|COMPLETED|Overall Study||0
6557575|NCT01769196|7480191|FG001|COMPLETED|Overall Study||0
6557576|NCT01769196|7480190|FG000|NOT COMPLETED|Overall Study||272
6557577|NCT01769196|7480191|FG001|NOT COMPLETED|Overall Study||272
6557578|NCT01769209|7480197|FG000|STARTED|Overall Study||18
6557579|NCT01769209|7480197|FG000|COMPLETED|Overall Study||18
6557580|NCT01769209|7480197|FG000|NOT COMPLETED|Overall Study||0
6557581|NCT01769222|7480203|FG000|STARTED|Overall Study||3
6773454|NCT03985657|7701108|FG000|NOT COMPLETED|Intervention 1 (One Night)||0
6773455|NCT03985657|7701109|FG001|NOT COMPLETED|Intervention 1 (One Night)||1
6310962|NCT00401375|7214973|FG000|STARTED|Overall Study||174
6310963|NCT00401375|7214974|FG001|STARTED|Overall Study||176
6310964|NCT00401375|7214975|FG002|STARTED|Overall Study||174
6310965|NCT00401375|7214973|FG000|Received at Least 1 Dose of Study Drug|Overall Study||171
6310966|NCT00401375|7214974|FG001|Received at Least 1 Dose of Study Drug|Overall Study||173
6310967|NCT00401375|7214975|FG002|Received at Least 1 Dose of Study Drug|Overall Study||171
6310968|NCT00401375|7214973|FG000|COMPLETED|Overall Study||152
6310969|NCT00401375|7214974|FG001|COMPLETED|Overall Study||151
6310970|NCT00401375|7214975|FG002|COMPLETED|Overall Study||149
6310971|NCT00401375|7214973|FG000|NOT COMPLETED|Overall Study||22
6310972|NCT00401375|7214974|FG001|NOT COMPLETED|Overall Study||25
6310973|NCT00401375|7214975|FG002|NOT COMPLETED|Overall Study||25
6310974|NCT00401401|7214987|FG000|STARTED|Overall Study||6
6310975|NCT00401401|7214988|FG001|STARTED|Overall Study||6
6310976|NCT00401401|7214989|FG002|STARTED|Overall Study||6
6310977|NCT00401401|7214990|FG003|STARTED|Overall Study||12
6310978|NCT00401401|7214987|FG000|COMPLETED|Overall Study||6
6310979|NCT00401401|7214988|FG001|COMPLETED|Overall Study||6
6310980|NCT00401401|7214989|FG002|COMPLETED|Overall Study||5
6310981|NCT00401401|7214990|FG003|COMPLETED|Overall Study||9
6310982|NCT00401401|7214987|FG000|NOT COMPLETED|Overall Study||0
6310983|NCT00401401|7214988|FG001|NOT COMPLETED|Overall Study||0
6310984|NCT00401401|7214989|FG002|NOT COMPLETED|Overall Study||1
6310985|NCT00401401|7214990|FG003|NOT COMPLETED|Overall Study||3
6310986|NCT00401414|7215007|FG000|STARTED|Overall Study||118
6310987|NCT00401414|7215008|FG001|STARTED|Overall Study||147
6310988|NCT00401414|7215009|FG002|STARTED|Overall Study||79
6310989|NCT00401414|7215007|FG000|COMPLETED|Overall Study||118
6310990|NCT00401414|7215008|FG001|COMPLETED|Overall Study||147
6310991|NCT00401414|7215009|FG002|COMPLETED|Overall Study||79
6310992|NCT00401414|7215007|FG000|NOT COMPLETED|Overall Study||0
6310993|NCT00401414|7215008|FG001|NOT COMPLETED|Overall Study||0
6310994|NCT00401414|7215009|FG002|NOT COMPLETED|Overall Study||0
6310995|NCT00401518|7215022|FG000|STARTED|Overall Study||46
6310996|NCT00401518|7215023|FG001|STARTED|Overall Study||227
6310997|NCT00401518|7215024|FG002|STARTED|Overall Study||117
6310998|NCT00401518|7215022|FG000|COMPLETED|Overall Study||40
6310999|NCT00401518|7215023|FG001|COMPLETED|Overall Study||190
6311000|NCT00401518|7215024|FG002|COMPLETED|Overall Study||94
6311001|NCT00401518|7215022|FG000|NOT COMPLETED|Overall Study||6
6311002|NCT00401518|7215023|FG001|NOT COMPLETED|Overall Study||37
6311003|NCT00401518|7215024|FG002|NOT COMPLETED|Overall Study||23
6311004|NCT00401531|7215034|FG000|STARTED|Overall Study||206
6311005|NCT00401531|7215035|FG001|STARTED|Overall Study||206
6311006|NCT00401531|7215034|FG000|COMPLETED|Overall Study||197
6311007|NCT00401531|7215035|FG001|COMPLETED|Overall Study||196
6311008|NCT00401531|7215034|FG000|NOT COMPLETED|Overall Study||9
6311009|NCT00401531|7215035|FG001|NOT COMPLETED|Overall Study||10
6311010|NCT00401544|7215045|FG000|STARTED|Overall Study|Randomized and treated|56
6311011|NCT00401544|7215046|FG001|STARTED|Overall Study|Randomized and treated|62
6557582|NCT01769222|7480204|FG001|STARTED|Overall Study||0
6311012|NCT00401544|7215047|FG002|STARTED|Overall Study|Randomized and treated|60
6311013|NCT00401544|7215048|FG003|STARTED|Overall Study|Randomized and treated|60
6311014|NCT00401544|7215045|FG000|COMPLETED|Overall Study||38
6557583|NCT01769222|7480203|FG000|COMPLETED|Overall Study||3
6311015|NCT00401544|7215046|FG001|COMPLETED|Overall Study||44
6557584|NCT01769222|7480204|FG001|COMPLETED|Overall Study||0
6557585|NCT01769222|7480203|FG000|NOT COMPLETED|Overall Study||0
6311016|NCT00401544|7215047|FG002|COMPLETED|Overall Study||48
6311017|NCT00401544|7215048|FG003|COMPLETED|Overall Study||44
6311018|NCT00401544|7215045|FG000|NOT COMPLETED|Overall Study||18
6311019|NCT00401544|7215046|FG001|NOT COMPLETED|Overall Study||18
6311020|NCT00401544|7215047|FG002|NOT COMPLETED|Overall Study||12
6311021|NCT00401544|7215048|FG003|NOT COMPLETED|Overall Study||16
6311022|NCT00401622|7215065|FG000|STARTED|Overall Study||160
6311023|NCT00401622|7215066|FG001|STARTED|Overall Study||160
6311024|NCT00401622|7215065|FG000|COMPLETED|Overall Study||126
6311025|NCT00401622|7215066|FG001|COMPLETED|Overall Study||117
6311026|NCT00401622|7215065|FG000|NOT COMPLETED|Overall Study||34
6311027|NCT00401622|7215066|FG001|NOT COMPLETED|Overall Study||43
6311028|NCT00401726|7215074|FG000|STARTED|Overall Study||269
6311029|NCT00401726|7215075|FG001|STARTED|Overall Study||268
6311030|NCT00401726|7215074|FG000|COMPLETED|Overall Study||172
6311031|NCT00401726|7215075|FG001|COMPLETED|Overall Study||156
6311032|NCT00401726|7215074|FG000|NOT COMPLETED|Overall Study||97
6311033|NCT00401726|7215075|FG001|NOT COMPLETED|Overall Study||112
6311034|NCT00401752|7215083|FG000|STARTED|Overall Study||107
6311035|NCT00401752|7215084|FG001|STARTED|Overall Study||112
6311036|NCT00401752|7215083|FG000|Number of Patients Received Treatment|Overall Study||107
6311037|NCT00401752|7215084|FG001|Number of Patients Received Treatment|Overall Study||111
6311038|NCT00401752|7215083|FG000|Patients Included in ITT Population|Overall Study||106
6311039|NCT00401752|7215084|FG001|Patients Included in ITT Population|Overall Study||111
6311040|NCT00401752|7215083|FG000|Patients Included in Safety Population|Overall Study||107
6311041|NCT00401752|7215084|FG001|Patients Included in Safety Population|Overall Study||110
6311042|NCT00401752|7215083|FG000|Patients Included in Per-Protocol Popula|Overall Study||100
6311043|NCT00401752|7215084|FG001|Patients Included in Per-Protocol Popula|Overall Study||99
6311044|NCT00401752|7215083|FG000|COMPLETED|Overall Study||97
6311045|NCT00401752|7215084|FG001|COMPLETED|Overall Study||94
6311046|NCT00401752|7215083|FG000|NOT COMPLETED|Overall Study||10
6311047|NCT00401752|7215084|FG001|NOT COMPLETED|Overall Study||18
6311048|NCT00401778|7215093|FG000|STARTED|Overall Study||10
6311049|NCT00401778|7215094|FG001|STARTED|Overall Study||12
6311050|NCT00401778|7215095|FG002|STARTED|Overall Study||11
6311051|NCT00401778|7215093|FG000|COMPLETED|Overall Study||9
6311052|NCT00401778|7215094|FG001|COMPLETED|Overall Study||11
6311053|NCT00401778|7215095|FG002|COMPLETED|Overall Study||10
6311054|NCT00401778|7215093|FG000|NOT COMPLETED|Overall Study||1
6311055|NCT00401778|7215094|FG001|NOT COMPLETED|Overall Study||1
6311056|NCT00401778|7215095|FG002|NOT COMPLETED|Overall Study||1
6311057|NCT00401817|7215103|FG000|STARTED|Overall Study||11
6311058|NCT00401817|7215103|FG000|COMPLETED|Overall Study||11
6311059|NCT00401817|7215103|FG000|NOT COMPLETED|Overall Study||0
6311060|NCT00401830|7215110|FG000|STARTED|Overall Study||81
6311061|NCT00401830|7215111|FG001|STARTED|Overall Study||78
6311062|NCT00401830|7215110|FG000|COMPLETED|Overall Study||50
6311063|NCT00401830|7215111|FG001|COMPLETED|Overall Study||46
6311064|NCT00401830|7215110|FG000|NOT COMPLETED|Overall Study||31
6311065|NCT00401830|7215111|FG001|NOT COMPLETED|Overall Study||32
6311066|NCT00401843|7215120|FG000|STARTED|Overall Study||21
6311067|NCT00401843|7215121|FG001|STARTED|Overall Study||144
6311068|NCT00401843|7215122|FG002|STARTED|Overall Study||142
6311069|NCT00401843|7215120|FG000|Treated|Overall Study||21
6311070|NCT00401843|7215121|FG001|Treated|Overall Study||142
6311071|NCT00401843|7215122|FG002|Treated|Overall Study||139
6311072|NCT00401843|7215120|FG000|COMPLETED|Overall Study||0
6311073|NCT00401843|7215121|FG001|COMPLETED|Overall Study||0
6311074|NCT00401843|7215122|FG002|COMPLETED|Overall Study||0
6311075|NCT00401843|7215120|FG000|NOT COMPLETED|Overall Study||21
6311076|NCT00401843|7215121|FG001|NOT COMPLETED|Overall Study||144
6311077|NCT00401843|7215122|FG002|NOT COMPLETED|Overall Study||142
6311078|NCT00401882|7215134|FG000|STARTED|Overall Study||2
6311079|NCT00401882|7215135|FG001|STARTED|Overall Study||5
6311080|NCT00401882|7215134|FG000|COMPLETED|Overall Study||2
6311081|NCT00401882|7215135|FG001|COMPLETED|Overall Study||5
6311082|NCT00401882|7215134|FG000|NOT COMPLETED|Overall Study||0
6311083|NCT00401882|7215135|FG001|NOT COMPLETED|Overall Study||0
6311084|NCT00401960|7215149|FG000|STARTED|Overall Study||5
6311085|NCT00401960|7215150|FG001|STARTED|Overall Study||1
6311086|NCT00401960|7215149|FG000|COMPLETED|Overall Study||0
6311087|NCT00401960|7215150|FG001|COMPLETED|Overall Study||1
6311088|NCT00401960|7215149|FG000|NOT COMPLETED|Overall Study||5
6311089|NCT00401960|7215150|FG001|NOT COMPLETED|Overall Study||0
6311090|NCT00401973|7215161|FG000|STARTED|Overall Study||50
6311091|NCT00401973|7215162|FG001|STARTED|Overall Study||76
6311092|NCT00401973|7215163|FG002|STARTED|Overall Study||73
6311093|NCT00401973|7215161|FG000|COMPLETED|Overall Study||39
6311094|NCT00401973|7215162|FG001|COMPLETED|Overall Study||50
6311095|NCT00401973|7215163|FG002|COMPLETED|Overall Study||50
6311096|NCT00401973|7215161|FG000|NOT COMPLETED|Overall Study||11
6311097|NCT00401973|7215162|FG001|NOT COMPLETED|Overall Study||26
6311098|NCT00401973|7215163|FG002|NOT COMPLETED|Overall Study||23
6311099|NCT00401986|7215173|FG000|STARTED|Overall Study||14
6311100|NCT00401986|7215173|FG000|COMPLETED|Overall Study||12
6311101|NCT00401986|7215173|FG000|NOT COMPLETED|Overall Study||2
6311102|NCT00402025|7215185|FG000|STARTED|Overall Study||3
6311103|NCT00402025|7215186|FG001|STARTED|Overall Study||4
6311104|NCT00402025|7215187|FG002|STARTED|Overall Study||10
6311105|NCT00402025|7215185|FG000|COMPLETED|Overall Study||1
6311106|NCT00402025|7215186|FG001|COMPLETED|Overall Study||1
6311107|NCT00402025|7215187|FG002|COMPLETED|Overall Study||0
6311108|NCT00402025|7215185|FG000|NOT COMPLETED|Overall Study||2
6311109|NCT00402025|7215186|FG001|NOT COMPLETED|Overall Study||3
6311110|NCT00402025|7215187|FG002|NOT COMPLETED|Overall Study||10
6311111|NCT00402051|7215197|FG000|STARTED|Overall Study||66
6311112|NCT00402051|7215198|FG001|STARTED|Overall Study||67
6311113|NCT00402051|7215197|FG000|Received Treatment|Overall Study||65
6311114|NCT00402051|7215198|FG001|Received Treatment|Overall Study||65
6311115|NCT00402051|7215197|FG000|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
6311116|NCT00402051|7215198|FG001|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
6311117|NCT00402051|7215197|FG000|NOT COMPLETED|Overall Study||38
6311118|NCT00402051|7215198|FG001|NOT COMPLETED|Overall Study||35
6311119|NCT00402103|7215206|FG000|STARTED|Overall Study||470
6311120|NCT00402103|7215207|FG001|STARTED|Overall Study||86
6311121|NCT00402103|7215206|FG000|COMPLETED|Overall Study||379
6311122|NCT00402103|7215207|FG001|COMPLETED|Overall Study||73
6311123|NCT00402103|7215206|FG000|NOT COMPLETED|Overall Study||91
6311124|NCT00402103|7215207|FG001|NOT COMPLETED|Overall Study||13
6311125|NCT00402116|7215220|FG000|STARTED|Overall Study||6
6311126|NCT00402116|7215221|FG001|STARTED|Overall Study||6
6311127|NCT00402116|7215222|FG002|STARTED|Overall Study||60
6311128|NCT00402116|7215220|FG000|COMPLETED|Overall Study||3
6311129|NCT00402116|7215221|FG001|COMPLETED|Overall Study||0
6311130|NCT00402116|7215222|FG002|COMPLETED|Overall Study||5
6311131|NCT00402116|7215220|FG000|NOT COMPLETED|Overall Study||3
6311132|NCT00402116|7215221|FG001|NOT COMPLETED|Overall Study||6
6311133|NCT00402116|7215222|FG002|NOT COMPLETED|Overall Study||55
6311134|NCT00402168|7215252|FG000|STARTED|Randomized||84
6311135|NCT00402168|7215253|FG001|STARTED|Randomized||89
6311136|NCT00402168|7215252|FG000|COMPLETED|Randomized||83
6311137|NCT00402168|7215253|FG001|COMPLETED|Randomized||88
6311138|NCT00402168|7215252|FG000|NOT COMPLETED|Randomized||1
6311139|NCT00402168|7215253|FG001|NOT COMPLETED|Randomized||1
6311140|NCT00402168|7215252|FG000|STARTED|Treatment (up to 12 Months)||83
6311141|NCT00402168|7215253|FG001|STARTED|Treatment (up to 12 Months)||88
6311142|NCT00402168|7215252|FG000|COMPLETED|Treatment (up to 12 Months)||81
6311143|NCT00402168|7215253|FG001|COMPLETED|Treatment (up to 12 Months)||86
6311144|NCT00402168|7215252|FG000|NOT COMPLETED|Treatment (up to 12 Months)||2
6311145|NCT00402168|7215253|FG001|NOT COMPLETED|Treatment (up to 12 Months)||2
6311146|NCT00402168|7215252|FG000|STARTED|Long Term (LT)||81
6311147|NCT00402168|7215253|FG001|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
6311148|NCT00402168|7215252|FG000|COMPLETED|Long Term (LT)||70
6311149|NCT00402168|7215253|FG001|COMPLETED|Long Term (LT)||64
6311150|NCT00402168|7215252|FG000|NOT COMPLETED|Long Term (LT)||11
6311151|NCT00402168|7215253|FG001|NOT COMPLETED|Long Term (LT)||17
6311152|NCT00402168|7215252|FG000|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
6311153|NCT00402168|7215253|FG001|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
6311154|NCT00402168|7215252|FG000|COMPLETED|Switched From CNI to Belatacept in LT||32
6311155|NCT00402168|7215253|FG001|COMPLETED|Switched From CNI to Belatacept in LT||0
6311156|NCT00402168|7215252|FG000|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
6311157|NCT00402168|7215253|FG001|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
6311158|NCT00402194|7215269|FG000|STARTED|Overall Study||9
6311159|NCT00402194|7215270|FG001|STARTED|Overall Study||8
6311160|NCT00402194|7215269|FG000|COMPLETED|Overall Study||9
6311161|NCT00402194|7215270|FG001|COMPLETED|Overall Study||8
6311162|NCT00402194|7215269|FG000|NOT COMPLETED|Overall Study||0
6311163|NCT00402194|7215270|FG001|NOT COMPLETED|Overall Study||0
6311164|NCT00402233|7215280|FG000|STARTED|Overall Study||77
6311165|NCT00402233|7215281|FG001|STARTED|Overall Study||80
6311166|NCT00402233|7215282|FG002|STARTED|Overall Study||81
6311167|NCT00402233|7215283|FG003|STARTED|Overall Study||73
6311168|NCT00402233|7215280|FG000|COMPLETED|Overall Study||72
6311169|NCT00402233|7215281|FG001|COMPLETED|Overall Study||70
6311170|NCT00402233|7215282|FG002|COMPLETED|Overall Study||70
6311171|NCT00402233|7215283|FG003|COMPLETED|Overall Study||62
6311172|NCT00402233|7215280|FG000|NOT COMPLETED|Overall Study||5
6311173|NCT00402233|7215281|FG001|NOT COMPLETED|Overall Study||10
6311174|NCT00402233|7215282|FG002|NOT COMPLETED|Overall Study||11
6311175|NCT00402233|7215283|FG003|NOT COMPLETED|Overall Study||11
6311176|NCT00402246|7215295|FG000|STARTED|Overall Study||1014
6311177|NCT00402246|7215296|FG001|STARTED|Overall Study||983
6311178|NCT00402246|7215295|FG000|COMPLETED|Overall Study||794
6311179|NCT00402246|7215296|FG001|COMPLETED|Overall Study||749
6311180|NCT00402246|7215295|FG000|NOT COMPLETED|Overall Study||220
6311181|NCT00402246|7215296|FG001|NOT COMPLETED|Overall Study||234
6311182|NCT00402285|7215307|FG000|STARTED|Overall Study||29
6311183|NCT00402285|7215308|FG001|STARTED|Overall Study||27
6311184|NCT00402285|7215309|FG002|STARTED|Overall Study||28
6311185|NCT00402285|7215307|FG000|COMPLETED|Overall Study||22
6311186|NCT00402285|7215308|FG001|COMPLETED|Overall Study||21
6311187|NCT00402285|7215309|FG002|COMPLETED|Overall Study||26
6311188|NCT00402285|7215307|FG000|NOT COMPLETED|Overall Study||7
6311189|NCT00402285|7215308|FG001|NOT COMPLETED|Overall Study||6
6311190|NCT00402285|7215309|FG002|NOT COMPLETED|Overall Study||2
6311191|NCT00402298|7215317|FG000|STARTED|Overall Study||3
6311192|NCT00402298|7215318|FG001|STARTED|Overall Study||2
6311193|NCT00402298|7215317|FG000|COMPLETED|Overall Study||2
6311194|NCT00402298|7215318|FG001|COMPLETED|Overall Study||2
6311195|NCT00402298|7215317|FG000|NOT COMPLETED|Overall Study||1
6311196|NCT00402298|7215318|FG001|NOT COMPLETED|Overall Study||0
6311197|NCT00402324|7215326|FG000|STARTED|Overall Study||101
6311198|NCT00402324|7215327|FG001|STARTED|Overall Study||101
6311199|NCT00402324|7215326|FG000|COMPLETED|Overall Study||58
6311200|NCT00402324|7215327|FG001|COMPLETED|Overall Study||60
6311201|NCT00402324|7215326|FG000|NOT COMPLETED|Overall Study||43
6311202|NCT00402324|7215327|FG001|NOT COMPLETED|Overall Study||41
6311203|NCT00402337|7215338|FG000|STARTED|Overall Study||59
6311204|NCT00402337|7215339|FG001|STARTED|Overall Study||57
6311205|NCT00402337|7215340|FG002|STARTED|Overall Study||62
6311206|NCT00402337|7215341|FG003|STARTED|Overall Study||63
6311207|NCT00402337|7215342|FG004|STARTED|Overall Study||69
6311208|NCT00402337|7215338|FG000|COMPLETED|Overall Study||54
6311209|NCT00402337|7215339|FG001|COMPLETED|Overall Study||51
6311210|NCT00402337|7215340|FG002|COMPLETED|Overall Study||58
6311211|NCT00402337|7215341|FG003|COMPLETED|Overall Study||51
6311212|NCT00402337|7215342|FG004|COMPLETED|Overall Study||61
6311213|NCT00402337|7215338|FG000|NOT COMPLETED|Overall Study||5
6311214|NCT00402337|7215339|FG001|NOT COMPLETED|Overall Study||6
6311215|NCT00402337|7215340|FG002|NOT COMPLETED|Overall Study||4
6311216|NCT00402337|7215341|FG003|NOT COMPLETED|Overall Study||12
6311217|NCT00402337|7215342|FG004|NOT COMPLETED|Overall Study||8
6311218|NCT00402363|7215358|FG000|STARTED|Overall Study||266
6311219|NCT00402363|7215359|FG001|STARTED|Overall Study||276
6311220|NCT00402363|7215360|FG002|STARTED|Overall Study||66
6311221|NCT00402363|7215361|FG003|STARTED|Overall Study||55
6311222|NCT00402363|7215358|FG000|COMPLETED|Overall Study||233
6311223|NCT00402363|7215359|FG001|COMPLETED|Overall Study||246
6311224|NCT00402363|7215360|FG002|COMPLETED|Overall Study||60
6311225|NCT00402363|7215361|FG003|COMPLETED|Overall Study||45
6311226|NCT00402363|7215358|FG000|NOT COMPLETED|Overall Study||33
6311227|NCT00402363|7215359|FG001|NOT COMPLETED|Overall Study||30
6311228|NCT00402363|7215360|FG002|NOT COMPLETED|Overall Study||6
6311229|NCT00402363|7215361|FG003|NOT COMPLETED|Overall Study||10
6311230|NCT00402597|7215382|FG000|STARTED|Overall Study||1153
6311231|NCT00402597|7215383|FG001|STARTED|Overall Study||307
6311232|NCT00402597|7215384|FG002|STARTED|Overall Study||1046
6311233|NCT00402597|7215385|FG003|STARTED|Overall Study||353
6311234|NCT00402597|7215386|FG004|STARTED|Overall Study||603
6311235|NCT00402597|7215382|FG000|COMPLETED|Overall Study||962
6311236|NCT00402597|7215383|FG001|COMPLETED|Overall Study||261
6311237|NCT00402597|7215384|FG002|COMPLETED|Overall Study||834
6311238|NCT00402597|7215385|FG003|COMPLETED|Overall Study||279
6311239|NCT00402597|7215386|FG004|COMPLETED|Overall Study||479
6311240|NCT00402597|7215382|FG000|NOT COMPLETED|Overall Study||191
6311241|NCT00402597|7215383|FG001|NOT COMPLETED|Overall Study||46
6311242|NCT00402597|7215384|FG002|NOT COMPLETED|Overall Study||212
6311243|NCT00402597|7215385|FG003|NOT COMPLETED|Overall Study||74
6311244|NCT00402597|7215386|FG004|NOT COMPLETED|Overall Study||124
6311245|NCT00402649|7215398|FG000|STARTED|Overall Study||35
6311246|NCT00402649|7215398|FG000|COMPLETED|Overall Study||33
6311247|NCT00402649|7215398|FG000|NOT COMPLETED|Overall Study||2
6311248|NCT00402688|7215405|FG000|STARTED|Overall Study||81
6311249|NCT00402688|7215406|FG001|STARTED|Overall Study||81
6311250|NCT00402688|7215407|FG002|STARTED|Overall Study||80
6311251|NCT00402688|7215405|FG000|COMPLETED|Overall Study||60
6311252|NCT00402688|7215406|FG001|COMPLETED|Overall Study||65
6311253|NCT00402688|7215407|FG002|COMPLETED|Overall Study||65
6311254|NCT00402688|7215405|FG000|NOT COMPLETED|Overall Study||21
6311255|NCT00402688|7215406|FG001|NOT COMPLETED|Overall Study||16
6311256|NCT00402688|7215407|FG002|NOT COMPLETED|Overall Study||15
6311257|NCT00402714|7215417|FG000|STARTED|Overall Study||3
6311258|NCT00402714|7215418|FG001|STARTED|Overall Study||11
6311259|NCT00402714|7215417|FG000|COMPLETED|Overall Study||3
6311260|NCT00402714|7215418|FG001|COMPLETED|Overall Study||11
6311261|NCT00402714|7215417|FG000|NOT COMPLETED|Overall Study||0
6311262|NCT00402714|7215418|FG001|NOT COMPLETED|Overall Study||0
6311263|NCT00402727|7215428|FG000|STARTED|Overall Study||432
6311264|NCT00402727|7215429|FG001|STARTED|Overall Study||381
6311265|NCT00402727|7215428|FG000|Achieving End Of Treatment (EOT)|Overall Study||408
6311266|NCT00402727|7215429|FG001|Achieving End Of Treatment (EOT)|Overall Study||355
6311267|NCT00402727|7215428|FG000|Achieving Test Of Cure (TOC)|Overall Study||390
6311268|NCT00402727|7215429|FG001|Achieving Test Of Cure (TOC)|Overall Study||347
6311269|NCT00402727|7215428|FG000|COMPLETED|Overall Study||390
6311270|NCT00402727|7215429|FG001|COMPLETED|Overall Study||347
6311271|NCT00402727|7215428|FG000|NOT COMPLETED|Overall Study||42
6311272|NCT00402727|7215429|FG001|NOT COMPLETED|Overall Study||34
6773456|NCT03985657|7701108|FG000|STARTED|Washout (Up to 1 Week)||20
6311273|NCT00402740|7215435|FG000|STARTED|Overall Study||322
6311274|NCT00402740|7215435|FG000|COMPLETED|Overall Study||242
6311275|NCT00402740|7215435|FG000|NOT COMPLETED|Overall Study||80
6311276|NCT00402779|7215445|FG000|STARTED|Overall Study||152
6311277|NCT00402779|7215446|FG001|STARTED|Overall Study||151
6311278|NCT00402779|7215445|FG000|COMPLETED|Overall Study||75
6311279|NCT00402779|7215446|FG001|COMPLETED|Overall Study||75
6311280|NCT00402779|7215445|FG000|NOT COMPLETED|Overall Study||77
6311281|NCT00402779|7215446|FG001|NOT COMPLETED|Overall Study||76
6311282|NCT00402831|7215454|FG000|STARTED|Overall Study||202
6311283|NCT00402831|7215455|FG001|STARTED|Overall Study||203
6773457|NCT03985657|7701109|FG001|STARTED|Washout (Up to 1 Week)||10
6311284|NCT00402831|7215454|FG000|ProQuad® Dose 1 (Day 1)|Overall Study||202
6311285|NCT00402831|7215455|FG001|ProQuad® Dose 1 (Day 1)|Overall Study||203
6311286|NCT00402831|7215454|FG000|ProQuad® Dose 1 (Day 30)|Overall Study||202
6311287|NCT00402831|7215455|FG001|ProQuad® Dose 1 (Day 30)|Overall Study||203
6311288|NCT00402831|7215454|FG000|COMPLETED|Overall Study||201
6311289|NCT00402831|7215455|FG001|COMPLETED|Overall Study||200
6311290|NCT00402831|7215454|FG000|NOT COMPLETED|Overall Study||1
6311291|NCT00402831|7215455|FG001|NOT COMPLETED|Overall Study||3
6311292|NCT00402896|7215463|FG000|STARTED|Overall Study||20
6311293|NCT00402896|7215463|FG000|COMPLETED|Overall Study||20
6311294|NCT00402896|7215463|FG000|NOT COMPLETED|Overall Study||0
6311295|NCT00402987|7215471|FG000|STARTED|Overall Study||90
6311296|NCT00402987|7215472|FG001|STARTED|Overall Study||45
6311297|NCT00402987|7215473|FG002|STARTED|Overall Study||45
6311298|NCT00402987|7215474|FG003|STARTED|Overall Study||89
6311299|NCT00402987|7215471|FG000|COMPLETED|Overall Study||90
6311300|NCT00402987|7215472|FG001|COMPLETED|Overall Study||45
6311301|NCT00402987|7215473|FG002|COMPLETED|Overall Study||44
6311302|NCT00402987|7215474|FG003|COMPLETED|Overall Study||89
6311303|NCT00402987|7215471|FG000|NOT COMPLETED|Overall Study||0
6311304|NCT00402987|7215472|FG001|NOT COMPLETED|Overall Study||0
6311305|NCT00402987|7215473|FG002|NOT COMPLETED|Overall Study||1
6311306|NCT00402987|7215474|FG003|NOT COMPLETED|Overall Study||0
6311307|NCT00403117|7215498|FG000|STARTED|Overall Study||49
6311308|NCT00403117|7215498|FG000|COMPLETED|Overall Study||29
6311309|NCT00403117|7215498|FG000|NOT COMPLETED|Overall Study||20
6311310|NCT00403130|7215529|FG000|STARTED|2 Years From Start of Treatment||31
6311311|NCT00403130|7215529|FG000|COMPLETED|2 Years From Start of Treatment||26
6311312|NCT00403130|7215529|FG000|NOT COMPLETED|2 Years From Start of Treatment||5
6311313|NCT00403130|7215529|FG000|STARTED|Survival Follow-up up to 6 Years||26
6311314|NCT00403130|7215529|FG000|COMPLETED|Survival Follow-up up to 6 Years||16
6311315|NCT00403130|7215529|FG000|NOT COMPLETED|Survival Follow-up up to 6 Years||10
6311316|NCT00403234|7215537|FG000|STARTED|Overall Study||2
6311317|NCT00403234|7215538|FG001|STARTED|Overall Study||3
6311318|NCT00403234|7215539|FG002|STARTED|Overall Study||3
6311319|NCT00403234|7215540|FG003|STARTED|Overall Study||2
6311320|NCT00403234|7215537|FG000|COMPLETED|Overall Study||1
6311321|NCT00403234|7215538|FG001|COMPLETED|Overall Study||2
6311322|NCT00403234|7215539|FG002|COMPLETED|Overall Study||2
6311323|NCT00403234|7215540|FG003|COMPLETED|Overall Study||2
6311324|NCT00403234|7215537|FG000|NOT COMPLETED|Overall Study||1
6311325|NCT00403234|7215538|FG001|NOT COMPLETED|Overall Study||1
6311326|NCT00403234|7215539|FG002|NOT COMPLETED|Overall Study||1
6311327|NCT00403234|7215540|FG003|NOT COMPLETED|Overall Study||0
6311328|NCT00403260|7215552|FG000|STARTED|Overall Study|Patients randomized and treated.|848
6311329|NCT00403260|7215553|FG001|STARTED|Overall Study|Patients randomized and treated.|423
6311330|NCT00403260|7215552|FG000|COMPLETED|Overall Study||723
6311331|NCT00403260|7215553|FG001|COMPLETED|Overall Study||357
6311332|NCT00403260|7215552|FG000|NOT COMPLETED|Overall Study||125
6311333|NCT00403260|7215553|FG001|NOT COMPLETED|Overall Study||66
6375139|NCT00754130|7285748|FG003|NOT COMPLETED|Period 1 (5 Days)||0
6375140|NCT00754130|7285749|FG004|NOT COMPLETED|Period 1 (5 Days)||0
6375141|NCT00754130|7285750|FG005|NOT COMPLETED|Period 1 (5 Days)||0
6375142|NCT00754130|7285745|FG000|STARTED|Washout Period (>=8 Days)||2
6375143|NCT00754130|7285746|FG001|STARTED|Washout Period (>=8 Days)||2
6375144|NCT00754130|7285747|FG002|STARTED|Washout Period (>=8 Days)||4
6375145|NCT00754130|7285748|FG003|STARTED|Washout Period (>=8 Days)||2
6375146|NCT00754130|7285749|FG004|STARTED|Washout Period (>=8 Days)||2
6375147|NCT00754130|7285750|FG005|STARTED|Washout Period (>=8 Days)||4
6375148|NCT00754130|7285745|FG000|COMPLETED|Washout Period (>=8 Days)||2
6375149|NCT00754130|7285746|FG001|COMPLETED|Washout Period (>=8 Days)||2
6375150|NCT00754130|7285747|FG002|COMPLETED|Washout Period (>=8 Days)||4
6375151|NCT00754130|7285748|FG003|COMPLETED|Washout Period (>=8 Days)||2
6375152|NCT00754130|7285749|FG004|COMPLETED|Washout Period (>=8 Days)||2
6375153|NCT00754130|7285750|FG005|COMPLETED|Washout Period (>=8 Days)||4
6375154|NCT00754130|7285745|FG000|NOT COMPLETED|Washout Period (>=8 Days)||0
6375155|NCT00754130|7285746|FG001|NOT COMPLETED|Washout Period (>=8 Days)||0
6375156|NCT00754130|7285747|FG002|NOT COMPLETED|Washout Period (>=8 Days)||0
6375157|NCT00754130|7285748|FG003|NOT COMPLETED|Washout Period (>=8 Days)||0
6375158|NCT00754130|7285749|FG004|NOT COMPLETED|Washout Period (>=8 Days)||0
6375159|NCT00754130|7285750|FG005|NOT COMPLETED|Washout Period (>=8 Days)||0
6375160|NCT00754130|7285745|FG000|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
6375161|NCT00754130|7285746|FG001|STARTED|Period 2 (5 Days)||2
6375162|NCT00754130|7285747|FG002|STARTED|Period 2 (5 Days)||4
6375163|NCT00754130|7285748|FG003|STARTED|Period 2 (5 Days)||2
6375164|NCT00754130|7285749|FG004|STARTED|Period 2 (5 Days)||2
6375165|NCT00754130|7285750|FG005|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
6375166|NCT00754130|7285745|FG000|COMPLETED|Period 2 (5 Days)||2
6375167|NCT00754130|7285746|FG001|COMPLETED|Period 2 (5 Days)||2
6375168|NCT00754130|7285747|FG002|COMPLETED|Period 2 (5 Days)||4
6375169|NCT00754130|7285748|FG003|COMPLETED|Period 2 (5 Days)||2
6375170|NCT00754130|7285749|FG004|COMPLETED|Period 2 (5 Days)||2
6375171|NCT00754130|7285750|FG005|COMPLETED|Period 2 (5 Days)||4
6375172|NCT00754130|7285745|FG000|NOT COMPLETED|Period 2 (5 Days)||0
6375173|NCT00754130|7285746|FG001|NOT COMPLETED|Period 2 (5 Days)||0
6375174|NCT00754130|7285747|FG002|NOT COMPLETED|Period 2 (5 Days)||0
6311334|NCT00403273|7215561|FG000|STARTED|Overall Study||25
6311335|NCT00403273|7215562|FG001|STARTED|Overall Study||29
6311336|NCT00403273|7215561|FG000|COMPLETED|Overall Study||22
6311337|NCT00403273|7215562|FG001|COMPLETED|Overall Study||25
6311338|NCT00403273|7215561|FG000|NOT COMPLETED|Overall Study||3
6311339|NCT00403273|7215562|FG001|NOT COMPLETED|Overall Study||4
6311340|NCT00403390|7215572|FG000|STARTED|Overall Study||16
6311341|NCT00403390|7215573|FG001|STARTED|Overall Study||18
6311342|NCT00403390|7215572|FG000|COMPLETED|Overall Study||13
6311343|NCT00403390|7215573|FG001|COMPLETED|Overall Study||18
6311344|NCT00403390|7215572|FG000|NOT COMPLETED|Overall Study||3
6311345|NCT00403390|7215573|FG001|NOT COMPLETED|Overall Study||0
6311346|NCT00403403|7215581|FG000|STARTED|Overall Study||50
6311347|NCT00403403|7215582|FG001|STARTED|Overall Study||52
6311348|NCT00403403|7215581|FG000|Safety-Evaluable Patients|Overall Study||47
6311349|NCT00403403|7215582|FG001|Safety-Evaluable Patients|Overall Study||51
6311350|NCT00403403|7215581|FG000|COMPLETED|Overall Study||50
6311351|NCT00403403|7215582|FG001|COMPLETED|Overall Study||52
6311352|NCT00403403|7215581|FG000|NOT COMPLETED|Overall Study||0
6311353|NCT00403403|7215582|FG001|NOT COMPLETED|Overall Study||0
6311354|NCT00403455|7215588|FG000|STARTED|Overall Study||38
6311355|NCT00403455|7215588|FG000|COMPLETED|Overall Study||37
6311356|NCT00403455|7215588|FG000|NOT COMPLETED|Overall Study||1
6311357|NCT00403481|7215592|FG000|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
6311358|NCT00403481|7215592|FG000|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
6311359|NCT00403481|7215592|FG000|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
6311360|NCT00403481|7215592|FG000|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
6311361|NCT00403481|7215592|FG000|COMPLETED|Olm 40 mg||177
6311362|NCT00403481|7215592|FG000|NOT COMPLETED|Olm 40 mg||5
6311363|NCT00403481|7215592|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
6311364|NCT00403481|7215592|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
6311365|NCT00403481|7215592|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
6311366|NCT00403481|7215592|FG000|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
6311367|NCT00403481|7215592|FG000|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
6311368|NCT00403481|7215592|FG000|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
6311369|NCT00403494|7215601|FG000|STARTED|Overall Study||96
6311370|NCT00403494|7215602|FG001|STARTED|Overall Study||94
6311371|NCT00403494|7215601|FG000|Intent to Treat|Overall Study||87
6311372|NCT00403494|7215602|FG001|Intent to Treat|Overall Study||83
6311373|NCT00403494|7215601|FG000|Per-protocol|Overall Study||69
6311374|NCT00403494|7215602|FG001|Per-protocol|Overall Study||69
6311375|NCT00403494|7215601|FG000|Safety Population|Overall Study||97
6311376|NCT00403494|7215602|FG001|Safety Population|Overall Study||91
6311377|NCT00403494|7215601|FG000|COMPLETED|Overall Study||81
6311378|NCT00403494|7215602|FG001|COMPLETED|Overall Study||80
6311379|NCT00403494|7215601|FG000|NOT COMPLETED|Overall Study||15
6311380|NCT00403494|7215602|FG001|NOT COMPLETED|Overall Study||14
6311381|NCT00403546|7215612|FG000|STARTED|Signed Informed Consent/Open-Label||131
6311382|NCT00403546|7215613|FG001|STARTED|Signed Informed Consent/Open-Label||0
6311383|NCT00403546|7215614|FG002|STARTED|Signed Informed Consent/Open-Label||0
6311384|NCT00403546|7215612|FG000|COMPLETED|Signed Informed Consent/Open-Label||103
6311385|NCT00403546|7215613|FG001|COMPLETED|Signed Informed Consent/Open-Label||0
6311386|NCT00403546|7215614|FG002|COMPLETED|Signed Informed Consent/Open-Label||0
6311387|NCT00403546|7215612|FG000|NOT COMPLETED|Signed Informed Consent/Open-Label||28
6311388|NCT00403546|7215613|FG001|NOT COMPLETED|Signed Informed Consent/Open-Label||0
6311389|NCT00403546|7215614|FG002|NOT COMPLETED|Signed Informed Consent/Open-Label||0
6311390|NCT00403546|7215612|FG000|STARTED|Screening Phase||103
6311391|NCT00403546|7215613|FG001|STARTED|Screening Phase||0
6311392|NCT00403546|7215614|FG002|STARTED|Screening Phase||0
6311393|NCT00403546|7215612|FG000|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
6311394|NCT00403546|7215613|FG001|COMPLETED|Screening Phase||0
6311395|NCT00403546|7215614|FG002|COMPLETED|Screening Phase||0
6311396|NCT00403546|7215612|FG000|NOT COMPLETED|Screening Phase||28
6311397|NCT00403546|7215613|FG001|NOT COMPLETED|Screening Phase||0
6311398|NCT00403546|7215614|FG002|NOT COMPLETED|Screening Phase||0
6311399|NCT00403546|7215612|FG000|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
6311400|NCT00403546|7215613|FG001|STARTED|Randomized Trial||38
6311401|NCT00403546|7215614|FG002|STARTED|Randomized Trial||37
6311402|NCT00403546|7215612|FG000|COMPLETED|Randomized Trial||0
6311403|NCT00403546|7215613|FG001|COMPLETED|Randomized Trial||21
6311404|NCT00403546|7215614|FG002|COMPLETED|Randomized Trial||21
6311405|NCT00403546|7215612|FG000|NOT COMPLETED|Randomized Trial||0
6311406|NCT00403546|7215613|FG001|NOT COMPLETED|Randomized Trial||17
6311407|NCT00403546|7215614|FG002|NOT COMPLETED|Randomized Trial||16
6311408|NCT00403585|7215623|FG000|STARTED|Initial Treatment Phase||104
6311409|NCT00403585|7215623|FG000|COMPLETED|Initial Treatment Phase||102
6311410|NCT00403585|7215623|FG000|NOT COMPLETED|Initial Treatment Phase||2
6311411|NCT00403585|7215623|FG000|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
6311412|NCT00403585|7215623|FG000|COMPLETED|Open-Label Phase; Extension Study||74
6311413|NCT00403585|7215623|FG000|NOT COMPLETED|Open-Label Phase; Extension Study||6
6311414|NCT00403754|7215627|FG000|STARTED|Core Treatment Period 1||11
6311415|NCT00403754|7215628|FG001|STARTED|Core Treatment Period 1||10
6311416|NCT00403754|7215629|FG002|STARTED|Core Treatment Period 1||9
6311417|NCT00403754|7215630|FG003|STARTED|Core Treatment Period 1||11
6311418|NCT00403754|7215627|FG000|COMPLETED|Core Treatment Period 1||11
6311419|NCT00403754|7215628|FG001|COMPLETED|Core Treatment Period 1||9
6311420|NCT00403754|7215629|FG002|COMPLETED|Core Treatment Period 1||9
6311421|NCT00403754|7215630|FG003|COMPLETED|Core Treatment Period 1||11
6311422|NCT00403754|7215627|FG000|NOT COMPLETED|Core Treatment Period 1||0
6311423|NCT00403754|7215628|FG001|NOT COMPLETED|Core Treatment Period 1||1
6311424|NCT00403754|7215629|FG002|NOT COMPLETED|Core Treatment Period 1||0
6311425|NCT00403754|7215630|FG003|NOT COMPLETED|Core Treatment Period 1||0
6311426|NCT00403754|7215627|FG000|STARTED|Core Treatment Period 2||11
6311427|NCT00403754|7215628|FG001|STARTED|Core Treatment Period 2||9
6311428|NCT00403754|7215629|FG002|STARTED|Core Treatment Period 2||9
6311429|NCT00403754|7215630|FG003|STARTED|Core Treatment Period 2||11
6311430|NCT00403754|7215627|FG000|COMPLETED|Core Treatment Period 2||11
6311431|NCT00403754|7215628|FG001|COMPLETED|Core Treatment Period 2||9
6311432|NCT00403754|7215629|FG002|COMPLETED|Core Treatment Period 2||8
6311433|NCT00403754|7215630|FG003|COMPLETED|Core Treatment Period 2||11
6311434|NCT00403754|7215627|FG000|NOT COMPLETED|Core Treatment Period 2||0
6311435|NCT00403754|7215628|FG001|NOT COMPLETED|Core Treatment Period 2||0
6311436|NCT00403754|7215629|FG002|NOT COMPLETED|Core Treatment Period 2||1
6311437|NCT00403754|7215630|FG003|NOT COMPLETED|Core Treatment Period 2||0
6311438|NCT00403754|7215627|FG000|STARTED|Core Treatment Period 3||11
6311439|NCT00403754|7215628|FG001|STARTED|Core Treatment Period 3||9
6311440|NCT00403754|7215629|FG002|STARTED|Core Treatment Period 3||8
6311441|NCT00403754|7215630|FG003|STARTED|Core Treatment Period 3||11
6311442|NCT00403754|7215627|FG000|COMPLETED|Core Treatment Period 3||11
6311443|NCT00403754|7215628|FG001|COMPLETED|Core Treatment Period 3||9
6311444|NCT00403754|7215629|FG002|COMPLETED|Core Treatment Period 3||8
6311445|NCT00403754|7215630|FG003|COMPLETED|Core Treatment Period 3||11
6311446|NCT00403754|7215627|FG000|NOT COMPLETED|Core Treatment Period 3||0
6311447|NCT00403754|7215628|FG001|NOT COMPLETED|Core Treatment Period 3||0
6311448|NCT00403754|7215629|FG002|NOT COMPLETED|Core Treatment Period 3||0
6311449|NCT00403754|7215630|FG003|NOT COMPLETED|Core Treatment Period 3||0
6311450|NCT00403754|7215627|FG000|STARTED|Core Treatment Period 4||11
6311451|NCT00403754|7215628|FG001|STARTED|Core Treatment Period 4||9
6311452|NCT00403754|7215629|FG002|STARTED|Core Treatment Period 4||8
6311453|NCT00403754|7215630|FG003|STARTED|Core Treatment Period 4||11
6311454|NCT00403754|7215627|FG000|COMPLETED|Core Treatment Period 4||11
6311455|NCT00403754|7215628|FG001|COMPLETED|Core Treatment Period 4||9
6311456|NCT00403754|7215629|FG002|COMPLETED|Core Treatment Period 4||8
6311457|NCT00403754|7215630|FG003|COMPLETED|Core Treatment Period 4||11
6311458|NCT00403754|7215627|FG000|NOT COMPLETED|Core Treatment Period 4||0
6311459|NCT00403754|7215628|FG001|NOT COMPLETED|Core Treatment Period 4||0
6311460|NCT00403754|7215629|FG002|NOT COMPLETED|Core Treatment Period 4||0
6311461|NCT00403754|7215630|FG003|NOT COMPLETED|Core Treatment Period 4||0
6311462|NCT00403754|7215627|FG000|STARTED|Open Label: Salmeterol||11
6311463|NCT00403754|7215628|FG001|STARTED|Open Label: Salmeterol||9
6311464|NCT00403754|7215629|FG002|STARTED|Open Label: Salmeterol||8
6311465|NCT00403754|7215630|FG003|STARTED|Open Label: Salmeterol||11
6311466|NCT00403754|7215627|FG000|COMPLETED|Open Label: Salmeterol||11
6311467|NCT00403754|7215628|FG001|COMPLETED|Open Label: Salmeterol||9
6311468|NCT00403754|7215629|FG002|COMPLETED|Open Label: Salmeterol||8
6311469|NCT00403754|7215630|FG003|COMPLETED|Open Label: Salmeterol||11
6311470|NCT00403754|7215627|FG000|NOT COMPLETED|Open Label: Salmeterol||0
6311471|NCT00403754|7215628|FG001|NOT COMPLETED|Open Label: Salmeterol||0
6311472|NCT00403754|7215629|FG002|NOT COMPLETED|Open Label: Salmeterol||0
6311473|NCT00403754|7215630|FG003|NOT COMPLETED|Open Label: Salmeterol||0
6311474|NCT00403767|7215644|FG000|STARTED|Overall Study||7111
6311475|NCT00403767|7215645|FG001|STARTED|Overall Study||7125
6311476|NCT00403767|7215644|FG000|COMPLETED|Overall Study||4591
6311477|NCT00403767|7215645|FG001|COMPLETED|Overall Study||4657
6311478|NCT00403767|7215644|FG000|NOT COMPLETED|Overall Study||2520
6557586|NCT01769222|7480204|FG001|NOT COMPLETED|Overall Study||0
6557587|NCT01769248|7480212|FG000|STARTED|Overall Study||70
6557588|NCT01769248|7480213|FG001|STARTED|Overall Study||70
6557589|NCT01769248|7480212|FG000|Participants Who Crossed-over|Overall Study||28
6557590|NCT01769248|7480213|FG001|Participants Who Crossed-over|Overall Study||12
6557591|NCT01769248|7480212|FG000|COMPLETED|Overall Study||42
6557592|NCT01769248|7480213|FG001|COMPLETED|Overall Study||58
6557593|NCT01769248|7480212|FG000|NOT COMPLETED|Overall Study||28
6557594|NCT01769248|7480213|FG001|NOT COMPLETED|Overall Study||12
6557595|NCT01769274|7480221|FG000|STARTED|Part A||5
6557596|NCT01769274|7480222|FG001|STARTED|Part A||0
6311479|NCT00403767|7215645|FG001|NOT COMPLETED|Overall Study||2468
6311480|NCT00403845|7215651|FG000|STARTED|Treatment Period 1||12
6311481|NCT00403845|7215652|FG001|STARTED|Treatment Period 1||13
6311482|NCT00403845|7215653|FG002|STARTED|Treatment Period 1||11
6311483|NCT00403845|7215654|FG003|STARTED|Treatment Period 1||14
6311484|NCT00403845|7215651|FG000|COMPLETED|Treatment Period 1||11
6311485|NCT00403845|7215652|FG001|COMPLETED|Treatment Period 1||13
6311486|NCT00403845|7215653|FG002|COMPLETED|Treatment Period 1||11
6311487|NCT00403845|7215654|FG003|COMPLETED|Treatment Period 1||13
6311488|NCT00403845|7215651|FG000|NOT COMPLETED|Treatment Period 1||1
6557597|NCT01769274|7480223|FG002|STARTED|Part A||0
6557598|NCT01769274|7480221|FG000|COMPLETED|Part A||5
6311489|NCT00403845|7215652|FG001|NOT COMPLETED|Treatment Period 1||0
6311490|NCT00403845|7215653|FG002|NOT COMPLETED|Treatment Period 1||0
6311491|NCT00403845|7215654|FG003|NOT COMPLETED|Treatment Period 1||1
6311492|NCT00403845|7215651|FG000|STARTED|Treatment Period 2||11
6311493|NCT00403845|7215652|FG001|STARTED|Treatment Period 2||13
6311494|NCT00403845|7215653|FG002|STARTED|Treatment Period 2||11
6311495|NCT00403845|7215654|FG003|STARTED|Treatment Period 2||13
6311496|NCT00403845|7215651|FG000|COMPLETED|Treatment Period 2||10
6311497|NCT00403845|7215652|FG001|COMPLETED|Treatment Period 2||13
6311498|NCT00403845|7215653|FG002|COMPLETED|Treatment Period 2||11
6311499|NCT00403845|7215654|FG003|COMPLETED|Treatment Period 2||13
6311500|NCT00403845|7215651|FG000|NOT COMPLETED|Treatment Period 2||1
6311501|NCT00403845|7215652|FG001|NOT COMPLETED|Treatment Period 2||0
6311502|NCT00403845|7215653|FG002|NOT COMPLETED|Treatment Period 2||0
6311503|NCT00403845|7215654|FG003|NOT COMPLETED|Treatment Period 2||0
6311504|NCT00403845|7215651|FG000|STARTED|Treatment Period 3||10
6311505|NCT00403845|7215652|FG001|STARTED|Treatment Period 3||13
6311506|NCT00403845|7215653|FG002|STARTED|Treatment Period 3||11
6311507|NCT00403845|7215654|FG003|STARTED|Treatment Period 3||13
6311508|NCT00403845|7215651|FG000|COMPLETED|Treatment Period 3||10
6311509|NCT00403845|7215652|FG001|COMPLETED|Treatment Period 3||13
6311510|NCT00403845|7215653|FG002|COMPLETED|Treatment Period 3||11
6311511|NCT00403845|7215654|FG003|COMPLETED|Treatment Period 3||11
6311512|NCT00403845|7215651|FG000|NOT COMPLETED|Treatment Period 3||0
6311513|NCT00403845|7215652|FG001|NOT COMPLETED|Treatment Period 3||0
6311514|NCT00403845|7215653|FG002|NOT COMPLETED|Treatment Period 3||0
6311515|NCT00403845|7215654|FG003|NOT COMPLETED|Treatment Period 3||2
6311516|NCT00403845|7215651|FG000|STARTED|Treatment Period 4||10
6311517|NCT00403845|7215652|FG001|STARTED|Treatment Period 4||13
6311518|NCT00403845|7215653|FG002|STARTED|Treatment Period 4||11
6311519|NCT00403845|7215654|FG003|STARTED|Treatment Period 4||11
6311520|NCT00403845|7215651|FG000|COMPLETED|Treatment Period 4||10
6311521|NCT00403845|7215652|FG001|COMPLETED|Treatment Period 4||13
6311522|NCT00403845|7215653|FG002|COMPLETED|Treatment Period 4||11
6311523|NCT00403845|7215654|FG003|COMPLETED|Treatment Period 4||11
6311524|NCT00403845|7215651|FG000|NOT COMPLETED|Treatment Period 4||0
6311525|NCT00403845|7215652|FG001|NOT COMPLETED|Treatment Period 4||0
6311526|NCT00403845|7215653|FG002|NOT COMPLETED|Treatment Period 4||0
6311527|NCT00403845|7215654|FG003|NOT COMPLETED|Treatment Period 4||0
6311528|NCT00404066|7215664|FG000|STARTED|Overall Study|1 subject started but withdrew after adriamycin+cytoxan, but before study drugs lapatinib+docetaxel.|21
6311529|NCT00404066|7215664|FG000|COMPLETED|Overall Study||18
6311530|NCT00404066|7215664|FG000|NOT COMPLETED|Overall Study||3
6311531|NCT00404079|7215670|FG000|STARTED|Overall Study||125
6311532|NCT00404079|7215671|FG001|STARTED|Overall Study||125
6311533|NCT00404079|7215670|FG000|COMPLETED|Overall Study||103
6311534|NCT00404079|7215671|FG001|COMPLETED|Overall Study||105
6311535|NCT00404079|7215670|FG000|NOT COMPLETED|Overall Study||22
6311536|NCT00404079|7215671|FG001|NOT COMPLETED|Overall Study||20
6311537|NCT00404092|7215681|FG000|STARTED|Overall Study||9
6311538|NCT00404092|7215682|FG001|STARTED|Overall Study||8
6311539|NCT00404092|7215683|FG002|STARTED|Overall Study||9
6311540|NCT00404092|7215684|FG003|STARTED|Overall Study||20
6311541|NCT00404092|7215681|FG000|COMPLETED|Overall Study||8
6311542|NCT00404092|7215682|FG001|COMPLETED|Overall Study||8
6311543|NCT00404092|7215683|FG002|COMPLETED|Overall Study||8
6311544|NCT00404092|7215684|FG003|COMPLETED|Overall Study||20
6311545|NCT00404092|7215681|FG000|NOT COMPLETED|Overall Study||1
6311546|NCT00404092|7215682|FG001|NOT COMPLETED|Overall Study||0
6311547|NCT00404092|7215683|FG002|NOT COMPLETED|Overall Study||1
6311548|NCT00404092|7215684|FG003|NOT COMPLETED|Overall Study||0
6311549|NCT00404235|7215696|FG000|STARTED|Overall Study||35
6311550|NCT00404235|7215697|FG001|STARTED|Overall Study||41
6311551|NCT00404235|7215696|FG000|COMPLETED|Overall Study||34
6311552|NCT00404235|7215697|FG001|COMPLETED|Overall Study||39
6311553|NCT00404235|7215696|FG000|NOT COMPLETED|Overall Study||1
6311554|NCT00404235|7215697|FG001|NOT COMPLETED|Overall Study||2
6311555|NCT00404248|7215706|FG000|STARTED|Overall Study||3
6311556|NCT00404248|7215707|FG001|STARTED|Overall Study||4
6311557|NCT00404248|7215708|FG002|STARTED|Overall Study||5
6311558|NCT00404248|7215709|FG003|STARTED|Overall Study||2
6311559|NCT00404248|7215710|FG004|STARTED|Overall Study||3
6557599|NCT01769274|7480222|FG001|COMPLETED|Part A||0
6557600|NCT01769274|7480223|FG002|COMPLETED|Part A||0
6557601|NCT01769274|7480221|FG000|NOT COMPLETED|Part A||0
6311560|NCT00404248|7215711|FG005|STARTED|Overall Study||3
6311561|NCT00404248|7215712|FG006|STARTED|Overall Study||6
6311562|NCT00404248|7215713|FG007|STARTED|Overall Study||6
6311563|NCT00404248|7215714|FG008|STARTED|Overall Study||3
6557602|NCT01769274|7480222|FG001|NOT COMPLETED|Part A||0
6311564|NCT00404248|7215706|FG000|COMPLETED|Overall Study||3
6311565|NCT00404248|7215707|FG001|COMPLETED|Overall Study||3
6311566|NCT00404248|7215708|FG002|COMPLETED|Overall Study||5
6311567|NCT00404248|7215709|FG003|COMPLETED|Overall Study||2
6311568|NCT00404248|7215710|FG004|COMPLETED|Overall Study||3
6311569|NCT00404248|7215711|FG005|COMPLETED|Overall Study||3
6311570|NCT00404248|7215712|FG006|COMPLETED|Overall Study||6
6311571|NCT00404248|7215713|FG007|COMPLETED|Overall Study||6
6311572|NCT00404248|7215714|FG008|COMPLETED|Overall Study||3
6311573|NCT00404248|7215706|FG000|NOT COMPLETED|Overall Study||0
6557603|NCT01769274|7480223|FG002|NOT COMPLETED|Part A||0
6557604|NCT01769274|7480221|FG000|STARTED|Part B:Treatment Session1-Period1||0
6311574|NCT00404248|7215707|FG001|NOT COMPLETED|Overall Study||1
6311575|NCT00404248|7215708|FG002|NOT COMPLETED|Overall Study||0
6311576|NCT00404248|7215709|FG003|NOT COMPLETED|Overall Study||0
6311577|NCT00404248|7215710|FG004|NOT COMPLETED|Overall Study||0
6311578|NCT00404248|7215711|FG005|NOT COMPLETED|Overall Study||0
6311579|NCT00404248|7215712|FG006|NOT COMPLETED|Overall Study||0
6311580|NCT00404248|7215713|FG007|NOT COMPLETED|Overall Study||0
6311581|NCT00404248|7215714|FG008|NOT COMPLETED|Overall Study||0
6311582|NCT00404352|7215743|FG000|STARTED|Double Blind (up to 24 Month)||171
6311583|NCT00404352|7215744|FG001|STARTED|Double Blind (up to 24 Month)||175
6311584|NCT00404352|7215745|FG002|STARTED|Double Blind (up to 24 Month)||171
6311585|NCT00404352|7215746|FG003|STARTED|Double Blind (up to 24 Month)||0
6311586|NCT00404352|7215747|FG004|STARTED|Double Blind (up to 24 Month)||0
6311587|NCT00404352|7215748|FG005|STARTED|Double Blind (up to 24 Month)||0
6311588|NCT00404352|7215749|FG006|STARTED|Double Blind (up to 24 Month)||0
6311589|NCT00404352|7215750|FG007|STARTED|Double Blind (up to 24 Month)||0
6311590|NCT00404352|7215751|FG008|STARTED|Double Blind (up to 24 Month)||0
6311591|NCT00404352|7215743|FG000|Treated|Double Blind (up to 24 Month)||171
6311592|NCT00404352|7215744|FG001|Treated|Double Blind (up to 24 Month)||173
6311593|NCT00404352|7215745|FG002|Treated|Double Blind (up to 24 Month)||171
6311594|NCT00404352|7215746|FG003|Treated|Double Blind (up to 24 Month)||0
6311595|NCT00404352|7215747|FG004|Treated|Double Blind (up to 24 Month)||0
6311596|NCT00404352|7215748|FG005|Treated|Double Blind (up to 24 Month)||0
6311597|NCT00404352|7215749|FG006|Treated|Double Blind (up to 24 Month)||0
6311598|NCT00404352|7215750|FG007|Treated|Double Blind (up to 24 Month)||0
6311599|NCT00404352|7215751|FG008|Treated|Double Blind (up to 24 Month)||0
6311600|NCT00404352|7215743|FG000|COMPLETED|Double Blind (up to 24 Month)||119
6311601|NCT00404352|7215744|FG001|COMPLETED|Double Blind (up to 24 Month)||128
6311602|NCT00404352|7215745|FG002|COMPLETED|Double Blind (up to 24 Month)||92
6311603|NCT00404352|7215746|FG003|COMPLETED|Double Blind (up to 24 Month)||0
6311604|NCT00404352|7215747|FG004|COMPLETED|Double Blind (up to 24 Month)||0
6311605|NCT00404352|7215748|FG005|COMPLETED|Double Blind (up to 24 Month)||0
6311606|NCT00404352|7215749|FG006|COMPLETED|Double Blind (up to 24 Month)||0
6311607|NCT00404352|7215750|FG007|COMPLETED|Double Blind (up to 24 Month)||0
6311608|NCT00404352|7215751|FG008|COMPLETED|Double Blind (up to 24 Month)||0
6311609|NCT00404352|7215743|FG000|NOT COMPLETED|Double Blind (up to 24 Month)||52
6311610|NCT00404352|7215744|FG001|NOT COMPLETED|Double Blind (up to 24 Month)||47
6311611|NCT00404352|7215745|FG002|NOT COMPLETED|Double Blind (up to 24 Month)||79
6311612|NCT00404352|7215746|FG003|NOT COMPLETED|Double Blind (up to 24 Month)||0
6557605|NCT01769274|7480222|FG001|STARTED|Part B:Treatment Session1-Period1||2
6311613|NCT00404352|7215747|FG004|NOT COMPLETED|Double Blind (up to 24 Month)||0
6311614|NCT00404352|7215748|FG005|NOT COMPLETED|Double Blind (up to 24 Month)||0
6311615|NCT00404352|7215749|FG006|NOT COMPLETED|Double Blind (up to 24 Month)||0
6311616|NCT00404352|7215750|FG007|NOT COMPLETED|Double Blind (up to 24 Month)||0
6311617|NCT00404352|7215751|FG008|NOT COMPLETED|Double Blind (up to 24 Month)||0
6311618|NCT00404352|7215743|FG000|STARTED|Open Label (up to 24 Month)||0
6311619|NCT00404352|7215744|FG001|STARTED|Open Label (up to 24 Month)||0
6311620|NCT00404352|7215745|FG002|STARTED|Open Label (up to 24 Month)||0
6311621|NCT00404352|7215746|FG003|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
6311622|NCT00404352|7215747|FG004|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
6311623|NCT00404352|7215748|FG005|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
6311624|NCT00404352|7215749|FG006|STARTED|Open Label (up to 24 Month)||0
6311625|NCT00404352|7215750|FG007|STARTED|Open Label (up to 24 Month)||0
6311626|NCT00404352|7215751|FG008|STARTED|Open Label (up to 24 Month)||0
6311627|NCT00404352|7215743|FG000|COMPLETED|Open Label (up to 24 Month)||0
6311628|NCT00404352|7215744|FG001|COMPLETED|Open Label (up to 24 Month)||0
6311629|NCT00404352|7215745|FG002|COMPLETED|Open Label (up to 24 Month)||0
6311630|NCT00404352|7215746|FG003|COMPLETED|Open Label (up to 24 Month)||28
6311631|NCT00404352|7215747|FG004|COMPLETED|Open Label (up to 24 Month)||28
6311632|NCT00404352|7215748|FG005|COMPLETED|Open Label (up to 24 Month)||52
6311633|NCT00404352|7215749|FG006|COMPLETED|Open Label (up to 24 Month)||0
6311634|NCT00404352|7215750|FG007|COMPLETED|Open Label (up to 24 Month)||0
6311635|NCT00404352|7215751|FG008|COMPLETED|Open Label (up to 24 Month)||0
6311636|NCT00404352|7215743|FG000|NOT COMPLETED|Open Label (up to 24 Month)||0
6311637|NCT00404352|7215744|FG001|NOT COMPLETED|Open Label (up to 24 Month)||0
6311638|NCT00404352|7215745|FG002|NOT COMPLETED|Open Label (up to 24 Month)||0
6311639|NCT00404352|7215746|FG003|NOT COMPLETED|Open Label (up to 24 Month)||3
6311640|NCT00404352|7215747|FG004|NOT COMPLETED|Open Label (up to 24 Month)||2
6311641|NCT00404352|7215748|FG005|NOT COMPLETED|Open Label (up to 24 Month)||7
6311642|NCT00404352|7215749|FG006|NOT COMPLETED|Open Label (up to 24 Month)||0
6311643|NCT00404352|7215750|FG007|NOT COMPLETED|Open Label (up to 24 Month)||0
6311644|NCT00404352|7215751|FG008|NOT COMPLETED|Open Label (up to 24 Month)||0
6311645|NCT00404352|7215743|FG000|STARTED|Open Label Extension (up to 36 Months)||0
6311646|NCT00404352|7215744|FG001|STARTED|Open Label Extension (up to 36 Months)||0
6311647|NCT00404352|7215745|FG002|STARTED|Open Label Extension (up to 36 Months)||0
6311648|NCT00404352|7215746|FG003|STARTED|Open Label Extension (up to 36 Months)||0
6311649|NCT00404352|7215747|FG004|STARTED|Open Label Extension (up to 36 Months)||0
6311650|NCT00404352|7215748|FG005|STARTED|Open Label Extension (up to 36 Months)||0
6311651|NCT00404352|7215749|FG006|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
6311652|NCT00404352|7215750|FG007|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
6311653|NCT00404352|7215751|FG008|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
6311654|NCT00404352|7215743|FG000|COMPLETED|Open Label Extension (up to 36 Months)||0
6311655|NCT00404352|7215744|FG001|COMPLETED|Open Label Extension (up to 36 Months)||0
6311656|NCT00404352|7215745|FG002|COMPLETED|Open Label Extension (up to 36 Months)||0
6311657|NCT00404352|7215746|FG003|COMPLETED|Open Label Extension (up to 36 Months)||0
6311658|NCT00404352|7215747|FG004|COMPLETED|Open Label Extension (up to 36 Months)||0
6311659|NCT00404352|7215748|FG005|COMPLETED|Open Label Extension (up to 36 Months)||0
6311660|NCT00404352|7215749|FG006|COMPLETED|Open Label Extension (up to 36 Months)||3
6311661|NCT00404352|7215750|FG007|COMPLETED|Open Label Extension (up to 36 Months)||4
6311662|NCT00404352|7215751|FG008|COMPLETED|Open Label Extension (up to 36 Months)||9
6311663|NCT00404352|7215743|FG000|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6311664|NCT00404352|7215744|FG001|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6311665|NCT00404352|7215745|FG002|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6311666|NCT00404352|7215746|FG003|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6311667|NCT00404352|7215747|FG004|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6311668|NCT00404352|7215748|FG005|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
6311669|NCT00404352|7215749|FG006|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
6311670|NCT00404352|7215750|FG007|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
6311671|NCT00404352|7215751|FG008|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
6311672|NCT00404495|7215770|FG000|STARTED|Overall Study||66
6311673|NCT00404495|7215771|FG001|STARTED|Overall Study||17
6311674|NCT00404495|7215770|FG000|COMPLETED|Overall Study||22
6311675|NCT00404495|7215771|FG001|COMPLETED|Overall Study||6
6311676|NCT00404495|7215770|FG000|NOT COMPLETED|Overall Study||44
6311677|NCT00404495|7215771|FG001|NOT COMPLETED|Overall Study||11
6311678|NCT00404547|7215779|FG000|STARTED|Overall Study||762
6311679|NCT00404547|7215780|FG001|STARTED|Overall Study||359
6311680|NCT00404547|7215779|FG000|COMPLETED|Overall Study||672
6311681|NCT00404547|7215780|FG001|COMPLETED|Overall Study||334
6311682|NCT00404547|7215779|FG000|NOT COMPLETED|Overall Study||90
6311683|NCT00404547|7215780|FG001|NOT COMPLETED|Overall Study||25
6311684|NCT00404651|7215790|FG000|STARTED|Overall Study||340
6311685|NCT00404651|7215791|FG001|STARTED|Overall Study||343
6311686|NCT00404651|7215792|FG002|STARTED|Overall Study||339
6311687|NCT00404651|7215793|FG003|STARTED|Overall Study||167
6311688|NCT00404651|7215790|FG000|COMPLETED|Overall Study||301
6311689|NCT00404651|7215791|FG001|COMPLETED|Overall Study||315
6311690|NCT00404651|7215792|FG002|COMPLETED|Overall Study||294
6311691|NCT00404651|7215793|FG003|COMPLETED|Overall Study||146
6311692|NCT00404651|7215790|FG000|NOT COMPLETED|Overall Study||39
6311693|NCT00404651|7215791|FG001|NOT COMPLETED|Overall Study||28
6311694|NCT00404651|7215792|FG002|NOT COMPLETED|Overall Study||45
6311695|NCT00404651|7215793|FG003|NOT COMPLETED|Overall Study||21
6311696|NCT00404755|7215803|FG000|STARTED|Phase I (Bupropion)|3 went directly into Phase II (intolerant of bupropion), 1 withdrew consent and 4 did not return|17
6311697|NCT00404755|7215803|FG000|COMPLETED|Phase I (Bupropion)||13
6311698|NCT00404755|7215803|FG000|NOT COMPLETED|Phase I (Bupropion)||4
6311699|NCT00404755|7215803|FG000|STARTED|Phase II (Escitalopram)||11
6311700|NCT00404755|7215803|FG000|COMPLETED|Phase II (Escitalopram)||9
6311701|NCT00404755|7215803|FG000|NOT COMPLETED|Phase II (Escitalopram)||2
6311702|NCT00404755|7215803|FG000|STARTED|Phase III (Imipramine)||3
6311703|NCT00404755|7215803|FG000|COMPLETED|Phase III (Imipramine)||3
6311704|NCT00404755|7215803|FG000|NOT COMPLETED|Phase III (Imipramine)||0
6311705|NCT00404768|7215815|FG000|STARTED|Part A and B||20
6311706|NCT00404768|7215816|FG001|STARTED|Part A and B||9
6311707|NCT00404768|7215817|FG002|STARTED|Part A and B||0
6311708|NCT00404768|7215818|FG003|STARTED|Part A and B||0
6311709|NCT00404768|7215815|FG000|COMPLETED|Part A and B||19
6311710|NCT00404768|7215816|FG001|COMPLETED|Part A and B||8
6311711|NCT00404768|7215817|FG002|COMPLETED|Part A and B||0
6311712|NCT00404768|7215818|FG003|COMPLETED|Part A and B||0
6311713|NCT00404768|7215815|FG000|NOT COMPLETED|Part A and B||1
6311714|NCT00404768|7215816|FG001|NOT COMPLETED|Part A and B||1
6311715|NCT00404768|7215817|FG002|NOT COMPLETED|Part A and B||0
6311716|NCT00404768|7215818|FG003|NOT COMPLETED|Part A and B||0
6311717|NCT00404768|7215815|FG000|STARTED|Part C||0
6311718|NCT00404768|7215816|FG001|STARTED|Part C||0
6311719|NCT00404768|7215817|FG002|STARTED|Part C||30
6311720|NCT00404768|7215818|FG003|STARTED|Part C||34
6311721|NCT00404768|7215815|FG000|COMPLETED|Part C||0
6311722|NCT00404768|7215816|FG001|COMPLETED|Part C||0
6311723|NCT00404768|7215817|FG002|COMPLETED|Part C||22
6311724|NCT00404768|7215818|FG003|COMPLETED|Part C||20
6311725|NCT00404768|7215815|FG000|NOT COMPLETED|Part C||0
6311726|NCT00404768|7215816|FG001|NOT COMPLETED|Part C||0
6311727|NCT00404768|7215817|FG002|NOT COMPLETED|Part C||8
6311728|NCT00404768|7215818|FG003|NOT COMPLETED|Part C||14
6311729|NCT00404820|7215835|FG000|STARTED|Overall Study||408
6311730|NCT00404820|7215836|FG001|STARTED|Overall Study||196
6311731|NCT00404820|7215835|FG000|Started Treatment|Overall Study||408
6375175|NCT00754130|7285748|FG003|NOT COMPLETED|Period 2 (5 Days)||0
6311732|NCT00404820|7215836|FG001|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
6311733|NCT00404820|7215835|FG000|COMPLETED|Overall Study||389
6311734|NCT00404820|7215836|FG001|COMPLETED|Overall Study||172
6311735|NCT00404820|7215835|FG000|NOT COMPLETED|Overall Study||19
6311736|NCT00404820|7215836|FG001|NOT COMPLETED|Overall Study||24
6311737|NCT00404924|7215844|FG000|STARTED|Overall Study|randomised patients|617
6311738|NCT00404924|7215845|FG001|STARTED|Overall Study|randomised patients|307
6311739|NCT00404924|7215844|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
6311740|NCT00404924|7215845|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
6311741|NCT00404924|7215844|FG000|NOT COMPLETED|Overall Study||603
6311742|NCT00404924|7215845|FG001|NOT COMPLETED|Overall Study||306
6311743|NCT00405067|7215854|FG000|STARTED|Overall Study||28
6311744|NCT00405067|7215855|FG001|STARTED|Overall Study||28
6311745|NCT00405067|7215856|FG002|STARTED|Overall Study||29
6311746|NCT00405067|7215854|FG000|COMPLETED|Overall Study||24
6311747|NCT00405067|7215855|FG001|COMPLETED|Overall Study||19
6311748|NCT00405067|7215856|FG002|COMPLETED|Overall Study||24
6311749|NCT00405067|7215854|FG000|NOT COMPLETED|Overall Study||4
6311750|NCT00405067|7215855|FG001|NOT COMPLETED|Overall Study||9
6311751|NCT00405067|7215856|FG002|NOT COMPLETED|Overall Study||5
6311752|NCT00405275|7215866|FG000|STARTED|Overall Study||178
6311753|NCT00405275|7215867|FG001|STARTED|Overall Study||175
6311754|NCT00405275|7215866|FG000|24 Weeks (Total)|Overall Study||163
6311755|NCT00405275|7215867|FG001|24 Weeks (Total)|Overall Study||165
6311756|NCT00405275|7215866|FG000|24 Week (no Switch)|Overall Study||119
6311757|NCT00405275|7215867|FG001|24 Week (no Switch)|Overall Study||121
6311758|NCT00405275|7215866|FG000|24 Week (Switch)|Overall Study||44
6311759|NCT00405275|7215867|FG001|24 Week (Switch)|Overall Study||44
6311760|NCT00405275|7215866|FG000|COMPLETED|Overall Study||155
6311761|NCT00405275|7215867|FG001|COMPLETED|Overall Study||156
6311762|NCT00405275|7215866|FG000|NOT COMPLETED|Overall Study||23
6311763|NCT00405275|7215867|FG001|NOT COMPLETED|Overall Study||19
6311764|NCT00405288|7215875|FG000|STARTED|Overall Study||204
6311765|NCT00405288|7215876|FG001|STARTED|Overall Study||204
6311766|NCT00405288|7215875|FG000|COMPLETED|Overall Study||204
6311767|NCT00405288|7215876|FG001|COMPLETED|Overall Study||204
6311768|NCT00405288|7215875|FG000|NOT COMPLETED|Overall Study||0
6311769|NCT00405288|7215876|FG001|NOT COMPLETED|Overall Study||0
6311770|NCT00405353|7215882|FG000|STARTED|Overall Study||10
6311771|NCT00405353|7215882|FG000|COMPLETED|Overall Study||10
6311772|NCT00405353|7215882|FG000|NOT COMPLETED|Overall Study||0
6311773|NCT00405392|7215888|FG000|STARTED|Overall Study||183
6311774|NCT00405392|7215889|FG001|STARTED|Overall Study||182
6311775|NCT00405392|7215888|FG000|COMPLETED|Overall Study||153
6311776|NCT00405392|7215889|FG001|COMPLETED|Overall Study||155
6311777|NCT00405392|7215888|FG000|NOT COMPLETED|Overall Study||30
6311778|NCT00405392|7215889|FG001|NOT COMPLETED|Overall Study||27
6311779|NCT00405509|7215897|FG000|STARTED|Overall Study||11
6311780|NCT00405509|7215898|FG001|STARTED|Overall Study||22
6311781|NCT00405509|7215897|FG000|COMPLETED|Overall Study||11
6311782|NCT00405509|7215898|FG001|COMPLETED|Overall Study||22
6311783|NCT00405509|7215897|FG000|NOT COMPLETED|Overall Study||0
6311784|NCT00405509|7215898|FG001|NOT COMPLETED|Overall Study||0
6311785|NCT00405522|7215906|FG000|STARTED|Overall Study||17
6311786|NCT00405522|7215907|FG001|STARTED|Overall Study||17
6311787|NCT00405522|7215906|FG000|COMPLETED|Overall Study||17
6311788|NCT00405522|7215907|FG001|COMPLETED|Overall Study||17
6311789|NCT00405522|7215906|FG000|NOT COMPLETED|Overall Study||0
6311790|NCT00405522|7215907|FG001|NOT COMPLETED|Overall Study||0
6311791|NCT00405548|7215915|FG000|STARTED|Overall Study||28
6311792|NCT00405548|7215916|FG001|STARTED|Overall Study||13
6311793|NCT00405548|7215915|FG000|COMPLETED|Overall Study||24
6311794|NCT00405548|7215916|FG001|COMPLETED|Overall Study||12
6311795|NCT00405548|7215915|FG000|NOT COMPLETED|Overall Study||4
6311796|NCT00405548|7215916|FG001|NOT COMPLETED|Overall Study||1
6311797|NCT00405587|7215926|FG000|STARTED|Overall Study||26
6311798|NCT00405587|7215927|FG001|STARTED|Overall Study||30
6311799|NCT00405587|7215928|FG002|STARTED|Overall Study||32
6311800|NCT00405587|7215929|FG003|STARTED|Overall Study||21
6311801|NCT00405587|7215926|FG000|COMPLETED|Overall Study||0
6311802|NCT00405587|7215927|FG001|COMPLETED|Overall Study||2
6311803|NCT00405587|7215928|FG002|COMPLETED|Overall Study||10
6311804|NCT00405587|7215929|FG003|COMPLETED|Overall Study||1
6311805|NCT00405587|7215926|FG000|NOT COMPLETED|Overall Study||26
6311806|NCT00405587|7215927|FG001|NOT COMPLETED|Overall Study||28
6311807|NCT00405587|7215928|FG002|NOT COMPLETED|Overall Study||22
6311808|NCT00405587|7215929|FG003|NOT COMPLETED|Overall Study||20
6311809|NCT00405639|7215967|FG000|STARTED|Overall Study||25
6311810|NCT00405639|7215968|FG001|STARTED|Overall Study||12
6311811|NCT00405639|7215967|FG000|COMPLETED|Overall Study||22
6311812|NCT00405639|7215968|FG001|COMPLETED|Overall Study||12
6311813|NCT00405639|7215967|FG000|NOT COMPLETED|Overall Study||3
6311814|NCT00405639|7215968|FG001|NOT COMPLETED|Overall Study||0
6311815|NCT00405652|7215974|FG000|STARTED|Overall Study||34
6311816|NCT00405652|7215974|FG000|COMPLETED|Overall Study||30
6311817|NCT00405652|7215974|FG000|NOT COMPLETED|Overall Study||4
6311818|NCT00405704|7215980|FG000|STARTED|Overall Study||302
6311819|NCT00405704|7215981|FG001|STARTED|Overall Study||305
6311820|NCT00405704|7215980|FG000|Completed Outcome Renal Scan|Overall Study||227
6311821|NCT00405704|7215981|FG001|Completed Outcome Renal Scan|Overall Study||235
6375176|NCT00754130|7285749|FG004|NOT COMPLETED|Period 2 (5 Days)||0
6311822|NCT00405704|7215980|FG000|Completed Assessments for New Scarring|Overall Study||220
6311823|NCT00405704|7215981|FG001|Completed Assessments for New Scarring|Overall Study||227
6311824|NCT00405704|7215980|FG000|Outcome Stool Assessed|Overall Study||203
6311825|NCT00405704|7215981|FG001|Outcome Stool Assessed|Overall Study||210
6311826|NCT00405704|7215980|FG000|Recurrent UTI With E. Coli|Overall Study||30
6311827|NCT00405704|7215981|FG001|Recurrent UTI With E. Coli|Overall Study||57
6311828|NCT00405704|7215980|FG000|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
6311829|NCT00405704|7215981|FG001|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
6311830|NCT00405704|7215980|FG000|COMPLETED|Overall Study||261
6311831|NCT00405704|7215981|FG001|COMPLETED|Overall Study||259
6311832|NCT00405704|7215980|FG000|NOT COMPLETED|Overall Study||41
6311833|NCT00405704|7215981|FG001|NOT COMPLETED|Overall Study||46
6311834|NCT00405756|7215991|FG000|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
6311835|NCT00405756|7215992|FG001|STARTED|Double-blind Treatment||153
6311836|NCT00405756|7215993|FG002|STARTED|Double-blind Treatment||154
6311837|NCT00405756|7215991|FG000|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
6311838|NCT00405756|7215992|FG001|Safety Population|Double-blind Treatment||152
6311839|NCT00405756|7215993|FG002|Safety Population|Double-blind Treatment||153
6311840|NCT00405756|7215991|FG000|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
6311841|NCT00405756|7215992|FG001|COMPLETED|Double-blind Treatment||0
6311842|NCT00405756|7215993|FG002|COMPLETED|Double-blind Treatment||0
6311843|NCT00405756|7215991|FG000|NOT COMPLETED|Double-blind Treatment||152
6311844|NCT00405756|7215992|FG001|NOT COMPLETED|Double-blind Treatment||153
6311845|NCT00405756|7215993|FG002|NOT COMPLETED|Double-blind Treatment||154
6311846|NCT00405756|7215991|FG000|STARTED|Open-label Extension||19
6311847|NCT00405756|7215992|FG001|STARTED|Open-label Extension||47
6311848|NCT00405756|7215993|FG002|STARTED|Open-label Extension||72
6311849|NCT00405756|7215991|FG000|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
6311850|NCT00405756|7215992|FG001|COMPLETED|Open-label Extension||0
6311851|NCT00405756|7215993|FG002|COMPLETED|Open-label Extension||0
6311852|NCT00405756|7215991|FG000|NOT COMPLETED|Open-label Extension||19
6311853|NCT00405756|7215992|FG001|NOT COMPLETED|Open-label Extension||47
6311854|NCT00405756|7215993|FG002|NOT COMPLETED|Open-label Extension||72
6311855|NCT00405756|7215991|FG000|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
6311856|NCT00405756|7215992|FG001|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
6311857|NCT00405756|7215993|FG002|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
6311858|NCT00405756|7215991|FG000|COMPLETED|Follow-up||0
6311859|NCT00405756|7215992|FG001|COMPLETED|Follow-up||0
6311860|NCT00405756|7215993|FG002|COMPLETED|Follow-up||0
6311861|NCT00405756|7215991|FG000|NOT COMPLETED|Follow-up||75
6311862|NCT00405756|7215992|FG001|NOT COMPLETED|Follow-up||90
6311863|NCT00405756|7215993|FG002|NOT COMPLETED|Follow-up||88
6311864|NCT00405821|7216003|FG000|STARTED|Overall Study||220
6311865|NCT00405821|7216004|FG001|STARTED|Overall Study||220
6311866|NCT00405821|7216003|FG000|COMPLETED|Overall Study||198
6311867|NCT00405821|7216004|FG001|COMPLETED|Overall Study||198
6311868|NCT00405821|7216003|FG000|NOT COMPLETED|Overall Study||22
6311869|NCT00405821|7216004|FG001|NOT COMPLETED|Overall Study||22
6311870|NCT00405912|7216013|FG000|STARTED|Overall Study||39
6311871|NCT00405912|7216014|FG001|STARTED|Overall Study||40
6311872|NCT00405912|7216015|FG002|STARTED|Overall Study||39
6311873|NCT00405912|7216013|FG000|COMPLETED|Overall Study||23
6311874|NCT00405912|7216014|FG001|COMPLETED|Overall Study||21
6311875|NCT00405912|7216015|FG002|COMPLETED|Overall Study||23
6311876|NCT00405912|7216013|FG000|NOT COMPLETED|Overall Study||16
6311877|NCT00405912|7216014|FG001|NOT COMPLETED|Overall Study||19
6557606|NCT01769274|7480223|FG002|STARTED|Part B:Treatment Session1-Period1||3
6557607|NCT01769274|7480221|FG000|COMPLETED|Part B:Treatment Session1-Period1||0
6557608|NCT01769274|7480222|FG001|COMPLETED|Part B:Treatment Session1-Period1||2
6557609|NCT01769274|7480223|FG002|COMPLETED|Part B:Treatment Session1-Period1||3
6557610|NCT01769274|7480221|FG000|NOT COMPLETED|Part B:Treatment Session1-Period1||0
6557611|NCT01769274|7480222|FG001|NOT COMPLETED|Part B:Treatment Session1-Period1||0
6557612|NCT01769274|7480223|FG002|NOT COMPLETED|Part B:Treatment Session1-Period1||0
6557613|NCT01769274|7480221|FG000|STARTED|Washout Period||0
6557614|NCT01769274|7480222|FG001|STARTED|Washout Period||2
6557615|NCT01769274|7480223|FG002|STARTED|Washout Period||3
6311878|NCT00405912|7216015|FG002|NOT COMPLETED|Overall Study||16
6311879|NCT00405938|7216025|FG000|STARTED|Overall Study||38
6311880|NCT00405938|7216026|FG001|STARTED|Overall Study||41
6311881|NCT00405938|7216025|FG000|COMPLETED|Overall Study||38
6311882|NCT00405938|7216026|FG001|COMPLETED|Overall Study||41
6311883|NCT00405938|7216025|FG000|NOT COMPLETED|Overall Study||0
6311884|NCT00405938|7216026|FG001|NOT COMPLETED|Overall Study||0
6311885|NCT00406029|7216037|FG000|STARTED|Overall Study||49
6311886|NCT00406029|7216038|FG001|STARTED|Overall Study||49
6311887|NCT00406029|7216039|FG002|STARTED|Overall Study||49
6311888|NCT00406029|7216040|FG003|STARTED|Overall Study||57
6311889|NCT00406029|7216041|FG004|STARTED|Overall Study||49
6311890|NCT00406029|7216037|FG000|Treated|Overall Study||49
6311891|NCT00406029|7216038|FG001|Treated|Overall Study||49
6311892|NCT00406029|7216039|FG002|Treated|Overall Study||47
6557616|NCT01769274|7480221|FG000|COMPLETED|Washout Period||0
6557617|NCT01769274|7480222|FG001|COMPLETED|Washout Period||2
6311893|NCT00406029|7216040|FG003|Treated|Overall Study||54
6311894|NCT00406029|7216041|FG004|Treated|Overall Study||47
6311895|NCT00406029|7216037|FG000|COMPLETED|Overall Study||33
6311896|NCT00406029|7216038|FG001|COMPLETED|Overall Study||41
6311897|NCT00406029|7216039|FG002|COMPLETED|Overall Study||39
6311898|NCT00406029|7216040|FG003|COMPLETED|Overall Study||40
6311899|NCT00406029|7216041|FG004|COMPLETED|Overall Study||41
6311900|NCT00406029|7216037|FG000|NOT COMPLETED|Overall Study||16
6311901|NCT00406029|7216038|FG001|NOT COMPLETED|Overall Study||8
6311902|NCT00406029|7216039|FG002|NOT COMPLETED|Overall Study||10
6311903|NCT00406029|7216040|FG003|NOT COMPLETED|Overall Study||17
6311904|NCT00406029|7216041|FG004|NOT COMPLETED|Overall Study||8
6311905|NCT00406107|7216055|FG000|STARTED|Overall Study||15
6311906|NCT00406107|7216056|FG001|STARTED|Overall Study||5
6311907|NCT00406107|7216055|FG000|COMPLETED|Overall Study||14
6311908|NCT00406107|7216056|FG001|COMPLETED|Overall Study||4
6311909|NCT00406107|7216055|FG000|NOT COMPLETED|Overall Study||1
6311910|NCT00406107|7216056|FG001|NOT COMPLETED|Overall Study||1
6311911|NCT00406133|7216067|FG000|STARTED|Phase 1 (First 26 Week Period)||165
6311912|NCT00406133|7216068|FG001|STARTED|Phase 1 (First 26 Week Period)||157
6311913|NCT00406133|7216069|FG002|STARTED|Phase 1 (First 26 Week Period)||67
6311914|NCT00406133|7216070|FG003|STARTED|Phase 1 (First 26 Week Period)||62
6311915|NCT00406133|7216067|FG000|COMPLETED|Phase 1 (First 26 Week Period)||162
6311916|NCT00406133|7216068|FG001|COMPLETED|Phase 1 (First 26 Week Period)||155
6311917|NCT00406133|7216069|FG002|COMPLETED|Phase 1 (First 26 Week Period)||67
6311918|NCT00406133|7216070|FG003|COMPLETED|Phase 1 (First 26 Week Period)||60
6311919|NCT00406133|7216067|FG000|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
6311920|NCT00406133|7216068|FG001|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
6311921|NCT00406133|7216069|FG002|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
6311922|NCT00406133|7216070|FG003|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
6311923|NCT00406133|7216067|FG000|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
6311924|NCT00406133|7216068|FG001|STARTED|Phase 2 (Second 26 Week Period)||155
6311925|NCT00406133|7216069|FG002|STARTED|Phase 2 (Second 26 Week Period)||67
6311926|NCT00406133|7216070|FG003|STARTED|Phase 2 (Second 26 Week Period)||60
6311927|NCT00406133|7216067|FG000|COMPLETED|Phase 2 (Second 26 Week Period)||157
6311928|NCT00406133|7216068|FG001|COMPLETED|Phase 2 (Second 26 Week Period)||152
6311929|NCT00406133|7216069|FG002|COMPLETED|Phase 2 (Second 26 Week Period)||67
6311930|NCT00406133|7216070|FG003|COMPLETED|Phase 2 (Second 26 Week Period)||60
6311931|NCT00406133|7216067|FG000|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
6311932|NCT00406133|7216068|FG001|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
6311933|NCT00406133|7216069|FG002|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
6311934|NCT00406133|7216070|FG003|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
6557618|NCT01769274|7480223|FG002|COMPLETED|Washout Period||3
6557619|NCT01769274|7480221|FG000|NOT COMPLETED|Washout Period||0
6557620|NCT01769274|7480222|FG001|NOT COMPLETED|Washout Period||0
6557621|NCT01769274|7480223|FG002|NOT COMPLETED|Washout Period||0
6557622|NCT01769274|7480221|FG000|STARTED|Part B:Treatment Session1-Period2||0
6557623|NCT01769274|7480222|FG001|STARTED|Part B:Treatment Session1-Period2||2
6557624|NCT01769274|7480223|FG002|STARTED|Part B:Treatment Session1-Period2||3
6557625|NCT01769274|7480221|FG000|COMPLETED|Part B:Treatment Session1-Period2||0
6557626|NCT01769274|7480222|FG001|COMPLETED|Part B:Treatment Session1-Period2||2
6311935|NCT00406276|7216085|FG000|STARTED|Overall Study||28
6311936|NCT00406276|7216085|FG000|COMPLETED|Overall Study||24
6311937|NCT00406276|7216085|FG000|NOT COMPLETED|Overall Study||4
6311938|NCT00406315|7216090|FG000|STARTED|Overall Study|Started = Treated|241
6311939|NCT00406315|7216090|FG000|COMPLETED|Overall Study||100
6311940|NCT00406315|7216090|FG000|NOT COMPLETED|Overall Study||141
6311941|NCT00406354|7216097|FG000|STARTED|All Randomized Patients||60
6311942|NCT00406354|7216098|FG001|STARTED|All Randomized Patients||61
6311943|NCT00406354|7216099|FG002|STARTED|All Randomized Patients||60
6311944|NCT00406354|7216097|FG000|COMPLETED|All Randomized Patients||60
6311945|NCT00406354|7216098|FG001|COMPLETED|All Randomized Patients||61
6311946|NCT00406354|7216099|FG002|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
6311947|NCT00406354|7216097|FG000|NOT COMPLETED|All Randomized Patients||0
6311948|NCT00406354|7216098|FG001|NOT COMPLETED|All Randomized Patients||0
6311949|NCT00406354|7216099|FG002|NOT COMPLETED|All Randomized Patients||1
6311950|NCT00406354|7216097|FG000|STARTED|All Randomized and Treated Patients||60
6311951|NCT00406354|7216098|FG001|STARTED|All Randomized and Treated Patients||61
6311952|NCT00406354|7216099|FG002|STARTED|All Randomized and Treated Patients||59
6311953|NCT00406354|7216097|FG000|COMPLETED|All Randomized and Treated Patients||44
6311954|NCT00406354|7216098|FG001|COMPLETED|All Randomized and Treated Patients||48
6311955|NCT00406354|7216099|FG002|COMPLETED|All Randomized and Treated Patients||37
6311956|NCT00406354|7216097|FG000|NOT COMPLETED|All Randomized and Treated Patients||16
6311957|NCT00406354|7216098|FG001|NOT COMPLETED|All Randomized and Treated Patients||13
6311958|NCT00406354|7216099|FG002|NOT COMPLETED|All Randomized and Treated Patients||22
6311959|NCT00406367|7216109|FG000|STARTED|Main Period - 6 to 20 Weeks||75
6311960|NCT00406367|7216110|FG001|STARTED|Main Period - 6 to 20 Weeks||34
6311961|NCT00406367|7216109|FG000|COMPLETED|Main Period - 6 to 20 Weeks||70
6311962|NCT00406367|7216110|FG001|COMPLETED|Main Period - 6 to 20 Weeks||32
6311963|NCT00406367|7216109|FG000|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
6311964|NCT00406367|7216110|FG001|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
6557627|NCT01769274|7480223|FG002|COMPLETED|Part B:Treatment Session1-Period2||3
6311965|NCT00406367|7216109|FG000|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
6311966|NCT00406367|7216110|FG001|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
6311967|NCT00406367|7216109|FG000|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
6311968|NCT00406367|7216110|FG001|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
6311969|NCT00406367|7216109|FG000|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
6311970|NCT00406367|7216110|FG001|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
6311971|NCT00406393|7216118|FG000|STARTED|Overall Study||151
6311972|NCT00406393|7216119|FG001|STARTED|Overall Study||153
6311973|NCT00406393|7216118|FG000|COMPLETED|Overall Study||149
6311974|NCT00406393|7216119|FG001|COMPLETED|Overall Study||152
6311975|NCT00406393|7216118|FG000|NOT COMPLETED|Overall Study||2
6311976|NCT00406393|7216119|FG001|NOT COMPLETED|Overall Study||1
6311977|NCT00406419|7216128|FG000|STARTED|Overall Study||324
6311978|NCT00406419|7216129|FG001|STARTED|Overall Study||344
6311979|NCT00406419|7216130|FG002|STARTED|Overall Study||347
6311980|NCT00406419|7216128|FG000|COMPLETED|Overall Study||0
6311981|NCT00406419|7216129|FG001|COMPLETED|Overall Study||0
6311982|NCT00406419|7216130|FG002|COMPLETED|Overall Study||0
6311983|NCT00406419|7216128|FG000|NOT COMPLETED|Overall Study||324
6311984|NCT00406419|7216129|FG001|NOT COMPLETED|Overall Study||344
6311985|NCT00406419|7216130|FG002|NOT COMPLETED|Overall Study||347
6311986|NCT00406640|7216140|FG000|STARTED|Acute Phase||296
6311987|NCT00406640|7216141|FG001|STARTED|Acute Phase||299
6311988|NCT00406640|7216140|FG000|COMPLETED|Acute Phase||245
6311989|NCT00406640|7216141|FG001|COMPLETED|Acute Phase||256
6311990|NCT00406640|7216140|FG000|NOT COMPLETED|Acute Phase||51
6311991|NCT00406640|7216141|FG001|NOT COMPLETED|Acute Phase||43
6311992|NCT00406640|7216140|FG000|STARTED|DB Continuation Phase for Responders||172
6311993|NCT00406640|7216141|FG001|STARTED|DB Continuation Phase for Responders||188
6311994|NCT00406640|7216140|FG000|COMPLETED|DB Continuation Phase for Responders||139
6311995|NCT00406640|7216141|FG001|COMPLETED|DB Continuation Phase for Responders||151
6311996|NCT00406640|7216140|FG000|NOT COMPLETED|DB Continuation Phase for Responders||33
6311997|NCT00406640|7216141|FG001|NOT COMPLETED|DB Continuation Phase for Responders||37
6311998|NCT00406640|7216140|FG000|STARTED|OL Extension Phase for Non-Responders||69
6311999|NCT00406640|7216141|FG001|STARTED|OL Extension Phase for Non-Responders||60
6312000|NCT00406640|7216140|FG000|COMPLETED|OL Extension Phase for Non-Responders||47
6312001|NCT00406640|7216141|FG001|COMPLETED|OL Extension Phase for Non-Responders||36
6312002|NCT00406640|7216140|FG000|NOT COMPLETED|OL Extension Phase for Non-Responders||22
6312003|NCT00406640|7216141|FG001|NOT COMPLETED|OL Extension Phase for Non-Responders||24
6312004|NCT00406653|7216157|FG000|STARTED|Induction Period||65
6312005|NCT00406653|7216158|FG001|STARTED|Induction Period||128
6312006|NCT00406653|7216159|FG002|STARTED|Induction Period||130
6312007|NCT00406653|7216160|FG003|STARTED|Induction Period||128
6312008|NCT00406653|7216161|FG004|STARTED|Induction Period||0
6312009|NCT00406653|7216162|FG005|STARTED|Induction Period||0
6312010|NCT00406653|7216163|FG006|STARTED|Induction Period||0
6312011|NCT00406653|7216157|FG000|COMPLETED|Induction Period||50
6312012|NCT00406653|7216158|FG001|COMPLETED|Induction Period||94
6312013|NCT00406653|7216159|FG002|COMPLETED|Induction Period||112
6312014|NCT00406653|7216160|FG003|COMPLETED|Induction Period||102
6312015|NCT00406653|7216161|FG004|COMPLETED|Induction Period||0
6312016|NCT00406653|7216162|FG005|COMPLETED|Induction Period||0
6312017|NCT00406653|7216163|FG006|COMPLETED|Induction Period||0
6312018|NCT00406653|7216157|FG000|NOT COMPLETED|Induction Period||15
6312019|NCT00406653|7216158|FG001|NOT COMPLETED|Induction Period||34
6312020|NCT00406653|7216159|FG002|NOT COMPLETED|Induction Period||18
6312021|NCT00406653|7216160|FG003|NOT COMPLETED|Induction Period||26
6312022|NCT00406653|7216161|FG004|NOT COMPLETED|Induction Period||0
6312023|NCT00406653|7216162|FG005|NOT COMPLETED|Induction Period||0
6312024|NCT00406653|7216163|FG006|NOT COMPLETED|Induction Period||0
6312025|NCT00406653|7216157|FG000|STARTED|Maintenance Period||0
6312026|NCT00406653|7216158|FG001|STARTED|Maintenance Period||0
6312027|NCT00406653|7216159|FG002|STARTED|Maintenance Period||0
6312028|NCT00406653|7216160|FG003|STARTED|Maintenance Period||0
6312029|NCT00406653|7216161|FG004|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
6312030|NCT00406653|7216162|FG005|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
6312031|NCT00406653|7216163|FG006|STARTED|Maintenance Period||0
6312032|NCT00406653|7216157|FG000|COMPLETED|Maintenance Period||0
6312033|NCT00406653|7216158|FG001|COMPLETED|Maintenance Period||0
6312034|NCT00406653|7216159|FG002|COMPLETED|Maintenance Period||0
6312035|NCT00406653|7216160|FG003|COMPLETED|Maintenance Period||0
6312036|NCT00406653|7216161|FG004|COMPLETED|Maintenance Period||14
6312037|NCT00406653|7216162|FG005|COMPLETED|Maintenance Period||10
6312038|NCT00406653|7216163|FG006|COMPLETED|Maintenance Period||0
6312039|NCT00406653|7216157|FG000|NOT COMPLETED|Maintenance Period||0
6312040|NCT00406653|7216158|FG001|NOT COMPLETED|Maintenance Period||0
6312041|NCT00406653|7216159|FG002|NOT COMPLETED|Maintenance Period||0
6312042|NCT00406653|7216160|FG003|NOT COMPLETED|Maintenance Period||0
6312043|NCT00406653|7216161|FG004|NOT COMPLETED|Maintenance Period||30
6312044|NCT00406653|7216162|FG005|NOT COMPLETED|Maintenance Period||36
6312045|NCT00406653|7216163|FG006|NOT COMPLETED|Maintenance Period||0
6312046|NCT00406653|7216157|FG000|STARTED|Open-Label Period||0
6312047|NCT00406653|7216158|FG001|STARTED|Open-Label Period||0
6312048|NCT00406653|7216159|FG002|STARTED|Open-Label Period||0
6312049|NCT00406653|7216160|FG003|STARTED|Open-Label Period||0
6312050|NCT00406653|7216161|FG004|STARTED|Open-Label Period||0
6312051|NCT00406653|7216162|FG005|STARTED|Open-Label Period||0
6312052|NCT00406653|7216163|FG006|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
6312053|NCT00406653|7216157|FG000|COMPLETED|Open-Label Period||0
6312054|NCT00406653|7216158|FG001|COMPLETED|Open-Label Period||0
6312055|NCT00406653|7216159|FG002|COMPLETED|Open-Label Period||0
6312056|NCT00406653|7216160|FG003|COMPLETED|Open-Label Period||0
6312057|NCT00406653|7216161|FG004|COMPLETED|Open-Label Period||0
6312058|NCT00406653|7216162|FG005|COMPLETED|Open-Label Period||0
6312059|NCT00406653|7216163|FG006|COMPLETED|Open-Label Period||0
6312060|NCT00406653|7216157|FG000|NOT COMPLETED|Open-Label Period||0
6312061|NCT00406653|7216158|FG001|NOT COMPLETED|Open-Label Period||0
6312062|NCT00406653|7216159|FG002|NOT COMPLETED|Open-Label Period||0
6312063|NCT00406653|7216160|FG003|NOT COMPLETED|Open-Label Period||0
6312064|NCT00406653|7216161|FG004|NOT COMPLETED|Open-Label Period||0
6312065|NCT00406653|7216162|FG005|NOT COMPLETED|Open-Label Period||0
6312066|NCT00406653|7216163|FG006|NOT COMPLETED|Open-Label Period||324
6312067|NCT00406692|7216183|FG000|STARTED|Overall Study||16
6312068|NCT00406692|7216183|FG000|COMPLETED|Overall Study||9
6312069|NCT00406692|7216183|FG000|NOT COMPLETED|Overall Study||7
6312070|NCT00406718|7216190|FG000|STARTED|Overall Study||47
6312071|NCT00406718|7216191|FG001|STARTED|Overall Study||48
6312072|NCT00406718|7216192|FG002|STARTED|Overall Study||47
6312073|NCT00406718|7216190|FG000|COMPLETED|Overall Study||43
6312074|NCT00406718|7216191|FG001|COMPLETED|Overall Study||34
6312075|NCT00406718|7216192|FG002|COMPLETED|Overall Study||39
6312076|NCT00406718|7216190|FG000|NOT COMPLETED|Overall Study||4
6312077|NCT00406718|7216191|FG001|NOT COMPLETED|Overall Study||14
6312078|NCT00406718|7216192|FG002|NOT COMPLETED|Overall Study||8
6312079|NCT00406848|7216204|FG000|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
6312080|NCT00406848|7216205|FG001|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
6312081|NCT00406848|7216204|FG000|COMPLETED|Overall Study||156
6312082|NCT00406848|7216205|FG001|COMPLETED|Overall Study||67
6312083|NCT00406848|7216204|FG000|NOT COMPLETED|Overall Study||93
6312084|NCT00406848|7216205|FG001|NOT COMPLETED|Overall Study||54
6312085|NCT00407030|7216217|FG000|STARTED|Main Period - 8 to 20 Weeks||81
6312086|NCT00407030|7216218|FG001|STARTED|Main Period - 8 to 20 Weeks||78
6312087|NCT00407030|7216219|FG002|STARTED|Main Period - 8 to 20 Weeks||74
6312088|NCT00407030|7216217|FG000|COMPLETED|Main Period - 8 to 20 Weeks||76
6312089|NCT00407030|7216218|FG001|COMPLETED|Main Period - 8 to 20 Weeks||75
6312090|NCT00407030|7216219|FG002|COMPLETED|Main Period - 8 to 20 Weeks||68
6312091|NCT00407030|7216217|FG000|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
6312092|NCT00407030|7216218|FG001|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
6312093|NCT00407030|7216219|FG002|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
6312094|NCT00407030|7216217|FG000|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
6312095|NCT00407030|7216218|FG001|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
6312096|NCT00407030|7216219|FG002|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
6312097|NCT00407030|7216217|FG000|COMPLETED|Extension Period - up to 68 Weeks||84
6312098|NCT00407030|7216218|FG001|COMPLETED|Extension Period - up to 68 Weeks||74
6312099|NCT00407030|7216219|FG002|COMPLETED|Extension Period - up to 68 Weeks||0
6312100|NCT00407030|7216217|FG000|NOT COMPLETED|Extension Period - up to 68 Weeks||27
6312101|NCT00407030|7216218|FG001|NOT COMPLETED|Extension Period - up to 68 Weeks||29
6312102|NCT00407030|7216219|FG002|NOT COMPLETED|Extension Period - up to 68 Weeks||0
6312103|NCT00407355|7216231|FG000|STARTED|Overall Study||20
6312104|NCT00407355|7216232|FG001|STARTED|Overall Study||20
6312105|NCT00407355|7216231|FG000|COMPLETED|Overall Study||10
6312106|NCT00407355|7216232|FG001|COMPLETED|Overall Study||9
6312107|NCT00407355|7216231|FG000|NOT COMPLETED|Overall Study||10
6312108|NCT00407355|7216232|FG001|NOT COMPLETED|Overall Study||11
6312109|NCT00407381|7216241|FG000|STARTED|Overall Study||42
6312110|NCT00407381|7216242|FG001|STARTED|Overall Study||42
6312111|NCT00407381|7216243|FG002|STARTED|Overall Study||42
6312112|NCT00407381|7216241|FG000|COMPLETED|Overall Study||39
6312113|NCT00407381|7216242|FG001|COMPLETED|Overall Study||38
6312114|NCT00407381|7216243|FG002|COMPLETED|Overall Study||40
6312115|NCT00407381|7216241|FG000|NOT COMPLETED|Overall Study||3
6312116|NCT00407381|7216242|FG001|NOT COMPLETED|Overall Study||4
6312117|NCT00407381|7216243|FG002|NOT COMPLETED|Overall Study||2
6312118|NCT00407420|7216253|FG000|STARTED|Overall Study||54
6312119|NCT00407420|7216254|FG001|STARTED|Overall Study||52
6312120|NCT00407420|7216253|FG000|COMPLETED|Overall Study||45
6312121|NCT00407420|7216254|FG001|COMPLETED|Overall Study||46
6312122|NCT00407420|7216253|FG000|NOT COMPLETED|Overall Study||9
6312123|NCT00407420|7216254|FG001|NOT COMPLETED|Overall Study||6
6312124|NCT00407485|7216262|FG000|STARTED|Overall Study||22
6312125|NCT00407485|7216262|FG000|COMPLETED|Overall Study||22
6312126|NCT00407485|7216262|FG000|NOT COMPLETED|Overall Study||0
6312127|NCT00407511|7216267|FG000|STARTED|Overall Study||121
6312128|NCT00407511|7216267|FG000|COMPLETED|Overall Study||99
6312129|NCT00407511|7216267|FG000|NOT COMPLETED|Overall Study||22
6312130|NCT00407537|7216273|FG000|STARTED|Overall Study||779
6312131|NCT00407537|7216274|FG001|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
6312132|NCT00407537|7216273|FG000|Eligible for Efficacy Analysis|Overall Study||760
6312133|NCT00407537|7216274|FG001|Eligible for Efficacy Analysis|Overall Study||657
6312134|NCT00407537|7216273|FG000|COMPLETED|Overall Study||686
6312135|NCT00407537|7216274|FG001|COMPLETED|Overall Study||638
6312136|NCT00407537|7216273|FG000|NOT COMPLETED|Overall Study||93
6312137|NCT00407537|7216274|FG001|NOT COMPLETED|Overall Study||44
6312138|NCT00407550|7216282|FG000|STARTED|Overall Study||10
6312139|NCT00407550|7216283|FG001|STARTED|Overall Study||9
6312140|NCT00407550|7216282|FG000|COMPLETED|Overall Study||7
6312141|NCT00407550|7216283|FG001|COMPLETED|Overall Study||5
6312142|NCT00407550|7216282|FG000|NOT COMPLETED|Overall Study||3
6312143|NCT00407550|7216283|FG001|NOT COMPLETED|Overall Study||4
6312144|NCT00407563|7216289|FG000|STARTED|Overall Study||48
6312145|NCT00407563|7216289|FG000|COMPLETED|Overall Study|One patient remains on study treatment.|47
6312146|NCT00407563|7216289|FG000|NOT COMPLETED|Overall Study||1
6312147|NCT00407654|7216293|FG000|STARTED|Overall Study||75
6312148|NCT00407654|7216293|FG000|COMPLETED|Overall Study||75
6312149|NCT00407654|7216293|FG000|NOT COMPLETED|Overall Study||0
6312150|NCT00407745|7216300|FG000|STARTED|Overall Study||112
6312151|NCT00407745|7216301|FG001|STARTED|Overall Study||108
6312152|NCT00407745|7216300|FG000|Treated|Overall Study||112
6312153|NCT00407745|7216301|FG001|Treated|Overall Study||107
6312154|NCT00407745|7216300|FG000|COMPLETED|Overall Study||93
6312155|NCT00407745|7216301|FG001|COMPLETED|Overall Study||91
6312156|NCT00407745|7216300|FG000|NOT COMPLETED|Overall Study||19
6312157|NCT00407745|7216301|FG001|NOT COMPLETED|Overall Study||17
6312158|NCT00407758|7216307|FG000|STARTED|Overall Study||28
6312159|NCT00407758|7216307|FG000|COMPLETED|Overall Study||27
6312160|NCT00407758|7216307|FG000|NOT COMPLETED|Overall Study||1
6312161|NCT00407797|7216311|FG000|STARTED|Overall Study||136
6312162|NCT00407797|7216311|FG000|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
6312163|NCT00407797|7216311|FG000|COMPLETED|Overall Study||118
6312164|NCT00407797|7216311|FG000|NOT COMPLETED|Overall Study||18
6312165|NCT00407888|7216315|FG000|STARTED|Overall Study||60
6312166|NCT00407888|7216315|FG000|COMPLETED|Overall Study||60
6312167|NCT00407888|7216315|FG000|NOT COMPLETED|Overall Study||0
6312168|NCT00407966|7216319|FG000|STARTED|Overall Study||45
6312169|NCT00407966|7216319|FG000|CR|Overall Study||30
6312170|NCT00407966|7216319|FG000|COMPLETED|Overall Study||45
6312171|NCT00407966|7216319|FG000|NOT COMPLETED|Overall Study||0
6312172|NCT00408070|7216323|FG000|STARTED|Overall Study||5
6312173|NCT00408070|7216323|FG000|COMPLETED|Overall Study||5
6312174|NCT00408070|7216323|FG000|NOT COMPLETED|Overall Study||0
6312175|NCT00408200|7216329|FG000|STARTED|Overall Study||57
6312176|NCT00408200|7216330|FG001|STARTED|Overall Study||53
6312177|NCT00408200|7216329|FG000|COMPLETED|Overall Study||57
6312178|NCT00408200|7216330|FG001|COMPLETED|Overall Study||53
6312179|NCT00408200|7216329|FG000|NOT COMPLETED|Overall Study||0
6312180|NCT00408200|7216330|FG001|NOT COMPLETED|Overall Study||0
6312181|NCT00408317|7216336|FG000|STARTED|First Intervention Period||14
6312182|NCT00408317|7216337|FG001|STARTED|First Intervention Period||17
6312183|NCT00408317|7216336|FG000|COMPLETED|First Intervention Period||14
6312184|NCT00408317|7216337|FG001|COMPLETED|First Intervention Period||16
6312185|NCT00408317|7216336|FG000|NOT COMPLETED|First Intervention Period||0
6312186|NCT00408317|7216337|FG001|NOT COMPLETED|First Intervention Period||1
6312187|NCT00408317|7216336|FG000|STARTED|Second Intervention Period||14
6312188|NCT00408317|7216337|FG001|STARTED|Second Intervention Period||16
6312189|NCT00408317|7216336|FG000|COMPLETED|Second Intervention Period||12
6312190|NCT00408317|7216337|FG001|COMPLETED|Second Intervention Period||14
6312191|NCT00408317|7216336|FG000|NOT COMPLETED|Second Intervention Period||2
6312192|NCT00408317|7216337|FG001|NOT COMPLETED|Second Intervention Period||2
6312193|NCT00408408|7216349|FG000|STARTED|Overall Study||201
6312194|NCT00408408|7216350|FG001|STARTED|Overall Study||199
6312195|NCT00408408|7216351|FG002|STARTED|Overall Study||204
6312196|NCT00408408|7216352|FG003|STARTED|Overall Study||201
6312197|NCT00408408|7216353|FG004|STARTED|Overall Study||197
6312198|NCT00408408|7216354|FG005|STARTED|Overall Study||204
6312199|NCT00408408|7216349|FG000|COMPLETED|Overall Study||199
6312200|NCT00408408|7216350|FG001|COMPLETED|Overall Study||196
6312201|NCT00408408|7216351|FG002|COMPLETED|Overall Study||204
6312202|NCT00408408|7216352|FG003|COMPLETED|Overall Study||194
6312203|NCT00408408|7216353|FG004|COMPLETED|Overall Study||192
6312204|NCT00408408|7216354|FG005|COMPLETED|Overall Study||201
6312205|NCT00408408|7216349|FG000|NOT COMPLETED|Overall Study||2
6312206|NCT00408408|7216350|FG001|NOT COMPLETED|Overall Study||3
6312207|NCT00408408|7216351|FG002|NOT COMPLETED|Overall Study||0
6312208|NCT00408408|7216352|FG003|NOT COMPLETED|Overall Study||7
6312209|NCT00408408|7216353|FG004|NOT COMPLETED|Overall Study||5
6312210|NCT00408408|7216354|FG005|NOT COMPLETED|Overall Study||3
6312211|NCT00408421|7216370|FG000|STARTED|Treatment Initial Randomization||120
6312212|NCT00408421|7216371|FG001|STARTED|Treatment Initial Randomization||111
6312213|NCT00408421|7216372|FG002|STARTED|Treatment Initial Randomization||0
6312214|NCT00408421|7216370|FG000|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
6312215|NCT00408421|7216371|FG001|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
6312216|NCT00408421|7216372|FG002|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
6312217|NCT00408421|7216370|FG000|NOT COMPLETED|Treatment Initial Randomization||17
6312218|NCT00408421|7216371|FG001|NOT COMPLETED|Treatment Initial Randomization||22
6312219|NCT00408421|7216372|FG002|NOT COMPLETED|Treatment Initial Randomization||0
6312220|NCT00408421|7216370|FG000|STARTED|Treatment Re-Randomization||103
6312221|NCT00408421|7216371|FG001|STARTED|Treatment Re-Randomization||46
6312222|NCT00408421|7216372|FG002|STARTED|Treatment Re-Randomization||43
6312223|NCT00408421|7216370|FG000|COMPLETED|Treatment Re-Randomization||96
6312224|NCT00408421|7216371|FG001|COMPLETED|Treatment Re-Randomization||39
6312225|NCT00408421|7216372|FG002|COMPLETED|Treatment Re-Randomization||38
6312226|NCT00408421|7216370|FG000|NOT COMPLETED|Treatment Re-Randomization||7
6312227|NCT00408421|7216371|FG001|NOT COMPLETED|Treatment Re-Randomization||7
6312228|NCT00408421|7216372|FG002|NOT COMPLETED|Treatment Re-Randomization||5
6312229|NCT00408434|7216387|FG000|STARTED|Overall Study||6
6312230|NCT00408434|7216388|FG001|STARTED|Overall Study||3
6312231|NCT00408434|7216389|FG002|STARTED|Overall Study||6
6312232|NCT00408434|7216390|FG003|STARTED|Overall Study||3
6312233|NCT00408434|7216391|FG004|STARTED|Overall Study||6
6312234|NCT00408434|7216392|FG005|STARTED|Overall Study||3
6312235|NCT00408434|7216393|FG006|STARTED|Overall Study||4
6312236|NCT00408434|7216387|FG000|COMPLETED|Overall Study||0
6312237|NCT00408434|7216388|FG001|COMPLETED|Overall Study||0
6312238|NCT00408434|7216389|FG002|COMPLETED|Overall Study||0
6312239|NCT00408434|7216390|FG003|COMPLETED|Overall Study||0
6312240|NCT00408434|7216391|FG004|COMPLETED|Overall Study||0
6312241|NCT00408434|7216392|FG005|COMPLETED|Overall Study||0
6312242|NCT00408434|7216393|FG006|COMPLETED|Overall Study||0
6312243|NCT00408434|7216387|FG000|NOT COMPLETED|Overall Study||6
6312244|NCT00408434|7216388|FG001|NOT COMPLETED|Overall Study||3
6312245|NCT00408434|7216389|FG002|NOT COMPLETED|Overall Study||6
6312246|NCT00408434|7216390|FG003|NOT COMPLETED|Overall Study||3
6312247|NCT00408434|7216391|FG004|NOT COMPLETED|Overall Study||6
6312248|NCT00408434|7216392|FG005|NOT COMPLETED|Overall Study||3
6312249|NCT00408434|7216393|FG006|NOT COMPLETED|Overall Study||4
6312250|NCT00408460|7216410|FG000|STARTED|Overall Study||34
6312251|NCT00408460|7216410|FG000|COMPLETED|Overall Study||34
6312252|NCT00408460|7216410|FG000|NOT COMPLETED|Overall Study||0
6312253|NCT00408499|7216414|FG000|STARTED|Phase 1: Dose Levels 1-4||4
6312254|NCT00408499|7216415|FG001|STARTED|Phase 1: Dose Levels 1-4||7
6312255|NCT00408499|7216416|FG002|STARTED|Phase 1: Dose Levels 1-4||3
6312256|NCT00408499|7216417|FG003|STARTED|Phase 1: Dose Levels 1-4||6
6312257|NCT00408499|7216418|FG004|STARTED|Phase 1: Dose Levels 1-4||0
6312258|NCT00408499|7216414|FG000|COMPLETED|Phase 1: Dose Levels 1-4||2
6312259|NCT00408499|7216415|FG001|COMPLETED|Phase 1: Dose Levels 1-4||5
6312260|NCT00408499|7216416|FG002|COMPLETED|Phase 1: Dose Levels 1-4||2
6557628|NCT01769274|7480221|FG000|NOT COMPLETED|Part B:Treatment Session1-Period2||0
6557629|NCT01769274|7480222|FG001|NOT COMPLETED|Part B:Treatment Session1-Period2||0
6557630|NCT01769274|7480223|FG002|NOT COMPLETED|Part B:Treatment Session1-Period2||0
6557631|NCT01769274|7480221|FG000|STARTED|Washout Period||0
6557632|NCT01769274|7480222|FG001|STARTED|Washout Period||2
6557633|NCT01769274|7480223|FG002|STARTED|Washout Period||3
6312261|NCT00408499|7216417|FG003|COMPLETED|Phase 1: Dose Levels 1-4||6
6312262|NCT00408499|7216418|FG004|COMPLETED|Phase 1: Dose Levels 1-4||0
6312263|NCT00408499|7216414|FG000|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
6312264|NCT00408499|7216415|FG001|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
6312265|NCT00408499|7216416|FG002|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
6312266|NCT00408499|7216417|FG003|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
6312267|NCT00408499|7216418|FG004|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
6312268|NCT00408499|7216414|FG000|STARTED|Phase II- MTD Expansion||0
6312269|NCT00408499|7216415|FG001|STARTED|Phase II- MTD Expansion||0
6312270|NCT00408499|7216416|FG002|STARTED|Phase II- MTD Expansion||0
6312271|NCT00408499|7216417|FG003|STARTED|Phase II- MTD Expansion||0
6312272|NCT00408499|7216418|FG004|STARTED|Phase II- MTD Expansion||44
6312273|NCT00408499|7216414|FG000|COMPLETED|Phase II- MTD Expansion||0
6312274|NCT00408499|7216415|FG001|COMPLETED|Phase II- MTD Expansion||0
6312275|NCT00408499|7216416|FG002|COMPLETED|Phase II- MTD Expansion||0
6312276|NCT00408499|7216417|FG003|COMPLETED|Phase II- MTD Expansion||0
6312277|NCT00408499|7216418|FG004|COMPLETED|Phase II- MTD Expansion||24
6312278|NCT00408499|7216414|FG000|NOT COMPLETED|Phase II- MTD Expansion||0
6312279|NCT00408499|7216415|FG001|NOT COMPLETED|Phase II- MTD Expansion||0
6312280|NCT00408499|7216416|FG002|NOT COMPLETED|Phase II- MTD Expansion||0
6312281|NCT00408499|7216417|FG003|NOT COMPLETED|Phase II- MTD Expansion||0
6312282|NCT00408499|7216418|FG004|NOT COMPLETED|Phase II- MTD Expansion||20
6312283|NCT00408564|7216427|FG000|STARTED|Overall Study||39
6312284|NCT00408564|7216427|FG000|COMPLETED|Overall Study||39
6312285|NCT00408564|7216427|FG000|NOT COMPLETED|Overall Study||0
6312286|NCT00408590|7216434|FG000|STARTED|Overall Study||3
6312287|NCT00408590|7216435|FG001|STARTED|Overall Study||3
6312288|NCT00408590|7216436|FG002|STARTED|Overall Study||3
6312289|NCT00408590|7216437|FG003|STARTED|Overall Study||3
6312290|NCT00408590|7216438|FG004|STARTED|Overall Study||3
6312291|NCT00408590|7216439|FG005|STARTED|Overall Study||3
6312292|NCT00408590|7216440|FG006|STARTED|Overall Study||3
6312293|NCT00408590|7216441|FG007|STARTED|Overall Study||3
6312294|NCT00408590|7216442|FG008|STARTED|Overall Study||13
6312295|NCT00408590|7216434|FG000|COMPLETED|Overall Study||3
6312296|NCT00408590|7216435|FG001|COMPLETED|Overall Study||3
6557634|NCT01769274|7480221|FG000|COMPLETED|Washout Period||0
6557635|NCT01769274|7480222|FG001|COMPLETED|Washout Period||2
6312297|NCT00408590|7216436|FG002|COMPLETED|Overall Study||3
6312298|NCT00408590|7216437|FG003|COMPLETED|Overall Study||3
6312299|NCT00408590|7216438|FG004|COMPLETED|Overall Study||3
6312300|NCT00408590|7216439|FG005|COMPLETED|Overall Study||3
6312301|NCT00408590|7216440|FG006|COMPLETED|Overall Study||3
6312302|NCT00408590|7216441|FG007|COMPLETED|Overall Study||3
6312303|NCT00408590|7216442|FG008|COMPLETED|Overall Study||13
6312304|NCT00408590|7216434|FG000|NOT COMPLETED|Overall Study||0
6312305|NCT00408590|7216435|FG001|NOT COMPLETED|Overall Study||0
6312306|NCT00408590|7216436|FG002|NOT COMPLETED|Overall Study||0
6312307|NCT00408590|7216437|FG003|NOT COMPLETED|Overall Study||0
6312308|NCT00408590|7216438|FG004|NOT COMPLETED|Overall Study||0
6312309|NCT00408590|7216439|FG005|NOT COMPLETED|Overall Study||0
6312310|NCT00408590|7216440|FG006|NOT COMPLETED|Overall Study||0
6312311|NCT00408590|7216441|FG007|NOT COMPLETED|Overall Study||0
6312312|NCT00408590|7216442|FG008|NOT COMPLETED|Overall Study||0
6312313|NCT00408603|7216460|FG000|STARTED|Overall Study||69
6312314|NCT00408603|7216461|FG001|STARTED|Overall Study||39
6312315|NCT00408603|7216462|FG002|STARTED|Overall Study||75
6312316|NCT00408603|7216460|FG000|COMPLETED|Overall Study||65
6312317|NCT00408603|7216461|FG001|COMPLETED|Overall Study||37
6312318|NCT00408603|7216462|FG002|COMPLETED|Overall Study||35
6312319|NCT00408603|7216460|FG000|NOT COMPLETED|Overall Study||4
6312320|NCT00408603|7216461|FG001|NOT COMPLETED|Overall Study||2
6312321|NCT00408603|7216462|FG002|NOT COMPLETED|Overall Study||40
6312322|NCT00408629|7216474|FG000|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
6312323|NCT00408629|7216475|FG001|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
6312324|NCT00408629|7216474|FG000|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
6312325|NCT00408629|7216475|FG001|COMPLETED|Overall Study||135
6312326|NCT00408629|7216474|FG000|NOT COMPLETED|Overall Study||97
6312327|NCT00408629|7216475|FG001|NOT COMPLETED|Overall Study||125
6312328|NCT00408681|7216482|FG000|STARTED|Overall Study||20
6312329|NCT00408681|7216482|FG000|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
6312330|NCT00408681|7216482|FG000|NOT COMPLETED|Overall Study||9
6312331|NCT00408694|7216487|FG000|STARTED|Overall Study||46
6312332|NCT00408694|7216487|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
6312333|NCT00408694|7216487|FG000|NOT COMPLETED|Overall Study||2
6312334|NCT00408876|7216495|FG000|STARTED|Overall Study||59
6312335|NCT00408876|7216496|FG001|STARTED|Overall Study||116
6312336|NCT00408876|7216497|FG002|STARTED|Overall Study||112
6312337|NCT00408876|7216498|FG003|STARTED|Overall Study||117
6312338|NCT00408876|7216495|FG000|COMPLETED|Overall Study||43
6312339|NCT00408876|7216496|FG001|COMPLETED|Overall Study||80
6312340|NCT00408876|7216497|FG002|COMPLETED|Overall Study||62
6312341|NCT00408876|7216498|FG003|COMPLETED|Overall Study||82
6312342|NCT00408876|7216495|FG000|NOT COMPLETED|Overall Study||16
6312343|NCT00408876|7216496|FG001|NOT COMPLETED|Overall Study||36
6312344|NCT00408876|7216497|FG002|NOT COMPLETED|Overall Study||50
6312345|NCT00408876|7216498|FG003|NOT COMPLETED|Overall Study||35
6312346|NCT00408902|7216508|FG000|STARTED|Overall Study||10
6312347|NCT00408902|7216508|FG000|COMPLETED|Overall Study||0
6312348|NCT00408902|7216508|FG000|NOT COMPLETED|Overall Study||10
6312349|NCT00408928|7216513|FG000|STARTED|Overall Study||11
6312350|NCT00408928|7216513|FG000|COMPLETED|Overall Study||8
6312351|NCT00408928|7216513|FG000|NOT COMPLETED|Overall Study||3
6312352|NCT00408993|7216519|FG000|STARTED|Overall Study||106
6312353|NCT00408993|7216520|FG001|STARTED|Overall Study||109
6312354|NCT00408993|7216519|FG000|COMPLETED|Overall Study||87
6312355|NCT00408993|7216520|FG001|COMPLETED|Overall Study||92
6312356|NCT00408993|7216519|FG000|NOT COMPLETED|Overall Study||19
6312357|NCT00408993|7216520|FG001|NOT COMPLETED|Overall Study||17
6312358|NCT00409006|7216532|FG000|STARTED|Overall Study||39
6312359|NCT00409006|7216533|FG001|STARTED|Overall Study||31
6312360|NCT00409006|7216532|FG000|COMPLETED|Overall Study||19
6312361|NCT00409006|7216533|FG001|COMPLETED|Overall Study||19
6312362|NCT00409006|7216532|FG000|NOT COMPLETED|Overall Study||20
6312363|NCT00409006|7216533|FG001|NOT COMPLETED|Overall Study||12
6312364|NCT00409175|7216541|FG000|STARTED|Overall Study||65
6312365|NCT00409175|7216542|FG001|STARTED|Overall Study||63
6312366|NCT00409175|7216541|FG000|COMPLETED|Overall Study||47
6312367|NCT00409175|7216542|FG001|COMPLETED|Overall Study||44
6312368|NCT00409175|7216541|FG000|NOT COMPLETED|Overall Study||18
6312369|NCT00409175|7216542|FG001|NOT COMPLETED|Overall Study||19
6312370|NCT00409188|7216550|FG000|STARTED|Overall Study||1006
6312371|NCT00409188|7216551|FG001|STARTED|Overall Study||507
6312372|NCT00409188|7216550|FG000|COMPLETED|Overall Study||623
6312373|NCT00409188|7216551|FG001|COMPLETED|Overall Study||332
6312374|NCT00409188|7216550|FG000|NOT COMPLETED|Overall Study||383
6312375|NCT00409188|7216551|FG001|NOT COMPLETED|Overall Study||175
6312376|NCT00409240|7216559|FG000|STARTED|Overall Study||53
6312377|NCT00409240|7216560|FG001|STARTED|Overall Study||50
6312378|NCT00409240|7216559|FG000|COMPLETED|Overall Study||50
6312379|NCT00409240|7216560|FG001|COMPLETED|Overall Study||49
6312380|NCT00409240|7216559|FG000|NOT COMPLETED|Overall Study||3
6312381|NCT00409240|7216560|FG001|NOT COMPLETED|Overall Study||1
6312382|NCT00409292|7216566|FG000|STARTED|Overall Study||33
6312383|NCT00409292|7216566|FG000|COMPLETED|Overall Study||33
6312384|NCT00409292|7216566|FG000|NOT COMPLETED|Overall Study||0
6312385|NCT00409409|7216574|FG000|STARTED|Overall Study||139
6312386|NCT00409409|7216575|FG001|STARTED|Overall Study||139
6312387|NCT00409409|7216574|FG000|COMPLETED|Overall Study||131
6312388|NCT00409409|7216575|FG001|COMPLETED|Overall Study||135
6312389|NCT00409409|7216574|FG000|NOT COMPLETED|Overall Study||8
6312390|NCT00409409|7216575|FG001|NOT COMPLETED|Overall Study||4
6312391|NCT00409539|7216586|FG000|STARTED|Overall Study||111
6312392|NCT00409539|7216587|FG001|STARTED|Overall Study||111
6312393|NCT00409539|7216588|FG002|STARTED|Overall Study||109
6312394|NCT00409539|7216589|FG003|STARTED|Overall Study||109
6312395|NCT00409539|7216590|FG004|STARTED|Overall Study||110
6312396|NCT00409539|7216586|FG000|COMPLETED|Overall Study||100
6312397|NCT00409539|7216587|FG001|COMPLETED|Overall Study||100
6312398|NCT00409539|7216588|FG002|COMPLETED|Overall Study||95
6312399|NCT00409539|7216589|FG003|COMPLETED|Overall Study||97
6312400|NCT00409539|7216590|FG004|COMPLETED|Overall Study||85
6312401|NCT00409539|7216586|FG000|NOT COMPLETED|Overall Study||11
6312402|NCT00409539|7216587|FG001|NOT COMPLETED|Overall Study||11
6312403|NCT00409539|7216588|FG002|NOT COMPLETED|Overall Study||14
6312404|NCT00409539|7216589|FG003|NOT COMPLETED|Overall Study||12
6312405|NCT00409539|7216590|FG004|NOT COMPLETED|Overall Study||25
6312406|NCT00409565|7216602|FG000|STARTED|Overall Study||46
6312407|NCT00409565|7216602|FG000|Overall Response Rate|Overall Study||7
6312408|NCT00409565|7216602|FG000|COMPLETED|Overall Study||45
6312409|NCT00409565|7216602|FG000|NOT COMPLETED|Overall Study||1
6312410|NCT00409578|7216610|FG000|STARTED|Overall Study||280
6312411|NCT00409578|7216611|FG001|STARTED|Overall Study||271
6312412|NCT00409578|7216612|FG002|STARTED|Overall Study||269
6312413|NCT00409578|7216613|FG003|STARTED|Overall Study||281
6312414|NCT00409578|7216610|FG000|COMPLETED|Overall Study||228
6312415|NCT00409578|7216611|FG001|COMPLETED|Overall Study||201
6312416|NCT00409578|7216612|FG002|COMPLETED|Overall Study||215
6312417|NCT00409578|7216613|FG003|COMPLETED|Overall Study||214
6312418|NCT00409578|7216610|FG000|NOT COMPLETED|Overall Study||52
6312419|NCT00409578|7216611|FG001|NOT COMPLETED|Overall Study||70
6312420|NCT00409578|7216612|FG002|NOT COMPLETED|Overall Study||54
6312421|NCT00409578|7216613|FG003|NOT COMPLETED|Overall Study||67
6312422|NCT00409617|7216623|FG000|STARTED|Overall Study||945
6312423|NCT00409617|7216623|FG000|COMPLETED|Overall Study||785
6312424|NCT00409617|7216623|FG000|NOT COMPLETED|Overall Study||160
6312425|NCT00409682|7216630|FG000|STARTED|Open-label Induction Period||192
6312426|NCT00409682|7216631|FG001|STARTED|Open-label Induction Period||0
6312427|NCT00409682|7216632|FG002|STARTED|Open-label Induction Period||0
6312428|NCT00409682|7216630|FG000|COMPLETED|Open-label Induction Period||188
6312429|NCT00409682|7216631|FG001|COMPLETED|Open-label Induction Period||0
6312430|NCT00409682|7216632|FG002|COMPLETED|Open-label Induction Period||0
6312431|NCT00409682|7216630|FG000|NOT COMPLETED|Open-label Induction Period||4
6312432|NCT00409682|7216631|FG001|NOT COMPLETED|Open-label Induction Period||0
6312433|NCT00409682|7216632|FG002|NOT COMPLETED|Open-label Induction Period||0
6312434|NCT00409682|7216630|FG000|STARTED|EOW Double-blind Maintenance Period||0
6312435|NCT00409682|7216631|FG001|STARTED|EOW Double-blind Maintenance Period||95
6312436|NCT00409682|7216632|FG002|STARTED|EOW Double-blind Maintenance Period||93
6312437|NCT00409682|7216630|FG000|COMPLETED|EOW Double-blind Maintenance Period||0
6312438|NCT00409682|7216631|FG001|COMPLETED|EOW Double-blind Maintenance Period||58
6312439|NCT00409682|7216632|FG002|COMPLETED|EOW Double-blind Maintenance Period||66
6312440|NCT00409682|7216630|FG000|NOT COMPLETED|EOW Double-blind Maintenance Period||0
6312441|NCT00409682|7216631|FG001|NOT COMPLETED|EOW Double-blind Maintenance Period||37
6312442|NCT00409682|7216632|FG002|NOT COMPLETED|EOW Double-blind Maintenance Period||27
6312443|NCT00409708|7216641|FG000|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
6312444|NCT00409708|7216642|FG001|STARTED|Treatment||56
6312445|NCT00409708|7216641|FG000|COMPLETED|Treatment||38
6312446|NCT00409708|7216642|FG001|COMPLETED|Treatment||39
6312447|NCT00409708|7216641|FG000|NOT COMPLETED|Treatment||15
6312448|NCT00409708|7216642|FG001|NOT COMPLETED|Treatment||17
6312449|NCT00409708|7216641|FG000|STARTED|Washout||38
6312450|NCT00409708|7216642|FG001|STARTED|Washout||39
6312451|NCT00409708|7216641|FG000|COMPLETED|Washout||17
6312452|NCT00409708|7216642|FG001|COMPLETED|Washout||29
6312453|NCT00409708|7216641|FG000|NOT COMPLETED|Washout||21
6312454|NCT00409708|7216642|FG001|NOT COMPLETED|Washout||10
6312455|NCT00409747|7216648|FG000|STARTED|Overall Study||11
6312456|NCT00409747|7216648|FG000|COMPLETED|Overall Study||10
6312457|NCT00409747|7216648|FG000|NOT COMPLETED|Overall Study||1
6375177|NCT00754130|7285750|FG005|NOT COMPLETED|Period 2 (5 Days)||0
6375178|NCT00754156|7285768|FG000|STARTED|Overall Study||8
6375179|NCT00754156|7285769|FG001|STARTED|Overall Study||6
6375180|NCT00754156|7285768|FG000|COMPLETED|Overall Study||8
6375181|NCT00754156|7285769|FG001|COMPLETED|Overall Study||6
6375182|NCT00754156|7285768|FG000|NOT COMPLETED|Overall Study||0
6375183|NCT00754156|7285769|FG001|NOT COMPLETED|Overall Study||0
6375184|NCT00754208|7285781|FG000|STARTED|Overall Study||7
6375185|NCT00754208|7285781|FG000|COMPLETED|Overall Study||7
6375186|NCT00754208|7285781|FG000|NOT COMPLETED|Overall Study||0
6375187|NCT00754234|7285786|FG000|STARTED|Overall Study|7 Menus were consumed in randomized order|16
6375188|NCT00754234|7285786|FG000|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
6375189|NCT00754234|7285786|FG000|NOT COMPLETED|Overall Study||3
6375190|NCT00754247|7285793|FG000|STARTED|Overall Study||10
6375191|NCT00754247|7285794|FG001|STARTED|Overall Study||10
6312458|NCT00409786|7216652|FG000|STARTED|Overall Study||50
6312459|NCT00409786|7216652|FG000|COMPLETED|Overall Study||47
6312460|NCT00409786|7216652|FG000|NOT COMPLETED|Overall Study||3
6312461|NCT00409825|7216656|FG000|STARTED|Overall Study||61
6312462|NCT00409825|7216656|FG000|COMPLETED|Overall Study||61
6312463|NCT00409825|7216656|FG000|NOT COMPLETED|Overall Study||0
6312464|NCT00409838|7216662|FG000|STARTED|Short-term Period|Randomized|56
6312465|NCT00409838|7216663|FG001|STARTED|Short-term Period|Randomized|57
6312466|NCT00409838|7216662|FG000|Treated (Baseline) Population|Short-term Period||55
6312467|NCT00409838|7216663|FG001|Treated (Baseline) Population|Short-term Period||57
6312468|NCT00409838|7216662|FG000|COMPLETED|Short-term Period||53
6312469|NCT00409838|7216663|FG001|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
6312470|NCT00409838|7216662|FG000|NOT COMPLETED|Short-term Period||3
6312471|NCT00409838|7216663|FG001|NOT COMPLETED|Short-term Period||5
6312472|NCT00409838|7216662|FG000|STARTED|Long-term Extension Period||105
6312473|NCT00409838|7216663|FG001|STARTED|Long-term Extension Period||0
6557636|NCT01769274|7480223|FG002|COMPLETED|Washout Period||3
6557637|NCT01769274|7480221|FG000|NOT COMPLETED|Washout Period||0
6557638|NCT01769274|7480222|FG001|NOT COMPLETED|Washout Period||0
6557639|NCT01769274|7480223|FG002|NOT COMPLETED|Washout Period||0
6557640|NCT01769274|7480221|FG000|STARTED|Part B:Treatment Session2-Period3||0
6557641|NCT01769274|7480222|FG001|STARTED|Part B:Treatment Session2-Period3||2
6557642|NCT01769274|7480223|FG002|STARTED|Part B:Treatment Session2-Period3||3
6557643|NCT01769274|7480221|FG000|COMPLETED|Part B:Treatment Session2-Period3||0
6557644|NCT01769274|7480222|FG001|COMPLETED|Part B:Treatment Session2-Period3||2
6557645|NCT01769274|7480223|FG002|COMPLETED|Part B:Treatment Session2-Period3||3
6557646|NCT01769274|7480221|FG000|NOT COMPLETED|Part B:Treatment Session2-Period3||0
6557647|NCT01769274|7480222|FG001|NOT COMPLETED|Part B:Treatment Session2-Period3||0
6557648|NCT01769274|7480223|FG002|NOT COMPLETED|Part B:Treatment Session2-Period3||0
6557649|NCT01769274|7480221|FG000|STARTED|Washout Period||0
6557650|NCT01769274|7480222|FG001|STARTED|Washout Period||2
6557651|NCT01769274|7480223|FG002|STARTED|Washout Period||3
6557652|NCT01769274|7480221|FG000|COMPLETED|Washout Period||0
6557653|NCT01769274|7480222|FG001|COMPLETED|Washout Period||2
6557654|NCT01769274|7480223|FG002|COMPLETED|Washout Period||3
6557655|NCT01769274|7480221|FG000|NOT COMPLETED|Washout Period||0
6557656|NCT01769274|7480222|FG001|NOT COMPLETED|Washout Period||0
6773458|NCT03985657|7701108|FG000|COMPLETED|Washout (Up to 1 Week)||20
6773459|NCT03985657|7701109|FG001|COMPLETED|Washout (Up to 1 Week)||10
6773460|NCT03985657|7701108|FG000|NOT COMPLETED|Washout (Up to 1 Week)||0
6312474|NCT00409838|7216662|FG000|COMPLETED|Long-term Extension Period||87
6312475|NCT00409838|7216663|FG001|COMPLETED|Long-term Extension Period||0
6312476|NCT00409838|7216662|FG000|NOT COMPLETED|Long-term Extension Period||18
6312477|NCT00409838|7216663|FG001|NOT COMPLETED|Long-term Extension Period||0
6312478|NCT00410046|7216686|FG000|STARTED|Overall Study||84
6312479|NCT00410046|7216686|FG000|COMPLETED|Overall Study||79
6312480|NCT00410046|7216686|FG000|NOT COMPLETED|Overall Study||5
6312481|NCT00410059|7216691|FG000|STARTED|Overall Study||59
6312482|NCT00410059|7216691|FG000|COMPLETED|Overall Study||59
6312483|NCT00410059|7216691|FG000|NOT COMPLETED|Overall Study||0
6312484|NCT00410072|7216697|FG000|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
6312485|NCT00410072|7216698|FG001|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
6312486|NCT00410072|7216697|FG000|COMPLETED|Day 1 to Week 48||176
6312487|NCT00410072|7216698|FG001|COMPLETED|Day 1 to Week 48||185
6312488|NCT00410072|7216697|FG000|NOT COMPLETED|Day 1 to Week 48||6
6312489|NCT00410072|7216698|FG001|NOT COMPLETED|Day 1 to Week 48||12
6312490|NCT00410072|7216697|FG000|STARTED|After Week 48 to Week 96||176
6312491|NCT00410072|7216698|FG001|STARTED|After Week 48 to Week 96||185
6312492|NCT00410072|7216697|FG000|COMPLETED|After Week 48 to Week 96||170
6312493|NCT00410072|7216698|FG001|COMPLETED|After Week 48 to Week 96||174
6312494|NCT00410072|7216697|FG000|NOT COMPLETED|After Week 48 to Week 96||6
6312495|NCT00410072|7216698|FG001|NOT COMPLETED|After Week 48 to Week 96||11
6312496|NCT00410124|7216706|FG000|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
6312497|NCT00410124|7216707|FG001|STARTED|Core Phase Double Blind (15 Months)||139
6312498|NCT00410124|7216706|FG000|Ongoing|Core Phase Double Blind (15 Months)||13
6312499|NCT00410124|7216707|FG001|Ongoing|Core Phase Double Blind (15 Months)||4
6557657|NCT01769274|7480223|FG002|NOT COMPLETED|Washout Period||0
6557658|NCT01769274|7480221|FG000|STARTED|Part B:Treatment Session2-Period4||0
6557659|NCT01769274|7480222|FG001|STARTED|Part B:Treatment Session2-Period4||2
6557660|NCT01769274|7480223|FG002|STARTED|Part B:Treatment Session2-Period4||3
6773461|NCT03985657|7701109|FG001|NOT COMPLETED|Washout (Up to 1 Week)||0
6773462|NCT03985657|7701108|FG000|STARTED|Intervention 2 (One Night)||20
6773463|NCT03985657|7701109|FG001|STARTED|Intervention 2 (One Night)||10
6773464|NCT03985657|7701108|FG000|COMPLETED|Intervention 2 (One Night)||20
6773465|NCT03985657|7701109|FG001|COMPLETED|Intervention 2 (One Night)||10
6312500|NCT00410124|7216706|FG000|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
6312501|NCT00410124|7216707|FG001|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
6312502|NCT00410124|7216706|FG000|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
6375192|NCT00754247|7285795|FG002|STARTED|Overall Study||10
6312503|NCT00410124|7216707|FG001|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
6312504|NCT00410124|7216706|FG000|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
6312505|NCT00410124|7216707|FG001|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
6312506|NCT00410124|7216706|FG000|STARTED|Extension Phase - Open Label (45 Months)||67
6312507|NCT00410124|7216707|FG001|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
6312508|NCT00410124|7216706|FG000|COMPLETED|Extension Phase - Open Label (45 Months)||0
6312509|NCT00410124|7216707|FG001|COMPLETED|Extension Phase - Open Label (45 Months)||0
6312510|NCT00410124|7216706|FG000|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
6312511|NCT00410124|7216707|FG001|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
6312512|NCT00410150|7216719|FG000|STARTED|Overall Study||22
6312513|NCT00410150|7216720|FG001|STARTED|Overall Study||20
6312514|NCT00410150|7216719|FG000|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
6312515|NCT00410150|7216720|FG001|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
6312516|NCT00410150|7216719|FG000|NOT COMPLETED|Overall Study||2
6312517|NCT00410150|7216720|FG001|NOT COMPLETED|Overall Study||3
6312518|NCT00410163|7216728|FG000|STARTED|Treatment and Follow-up Phase (2 Years)||31
6312519|NCT00410163|7216729|FG001|STARTED|Treatment and Follow-up Phase (2 Years)||30
6312520|NCT00410163|7216728|FG000|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
6312521|NCT00410163|7216729|FG001|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
6312522|NCT00410163|7216728|FG000|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
6312523|NCT00410163|7216729|FG001|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
6312524|NCT00410163|7216728|FG000|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
6557661|NCT01769274|7480221|FG000|COMPLETED|Part B:Treatment Session2-Period4||0
6557662|NCT01769274|7480222|FG001|COMPLETED|Part B:Treatment Session2-Period4||2
6557663|NCT01769274|7480223|FG002|COMPLETED|Part B:Treatment Session2-Period4||3
6557664|NCT01769274|7480221|FG000|NOT COMPLETED|Part B:Treatment Session2-Period4||0
6557665|NCT01769274|7480222|FG001|NOT COMPLETED|Part B:Treatment Session2-Period4||0
6773466|NCT03985657|7701108|FG000|NOT COMPLETED|Intervention 2 (One Night)||0
6773467|NCT03985657|7701109|FG001|NOT COMPLETED|Intervention 2 (One Night)||0
6773468|NCT03981939|7701118|FG000|STARTED|Overall Study||549
6773469|NCT03981939|7701119|FG001|STARTED|Overall Study||1902
6773470|NCT03981939|7701120|FG002|STARTED|Overall Study||581
6773471|NCT03981939|7701118|FG000|COMPLETED|Overall Study||549
6773472|NCT03981939|7701119|FG001|COMPLETED|Overall Study||1902
6773473|NCT03981939|7701120|FG002|COMPLETED|Overall Study||581
6773474|NCT03981939|7701118|FG000|NOT COMPLETED|Overall Study||0
6773475|NCT03981939|7701119|FG001|NOT COMPLETED|Overall Study||0
6773476|NCT03981939|7701120|FG002|NOT COMPLETED|Overall Study||0
6773477|NCT03973905|7701133|FG000|STARTED|Overall Study||107
6773478|NCT03973905|7701134|FG001|STARTED|Overall Study||183
6773479|NCT03973905|7701133|FG000|COMPLETED|Overall Study||107
6773480|NCT03973905|7701134|FG001|COMPLETED|Overall Study||183
6773481|NCT03973905|7701133|FG000|NOT COMPLETED|Overall Study||0
6773482|NCT03973905|7701134|FG001|NOT COMPLETED|Overall Study||0
6773483|NCT03984838|7701140|FG000|STARTED|Overall Study||16
6773484|NCT03984838|7701140|FG000|COMPLETED|Overall Study||16
6773485|NCT03984838|7701140|FG000|NOT COMPLETED|Overall Study||0
6773486|NCT03983941|7701146|FG000|STARTED|Overall Study||2
6773487|NCT03983941|7701147|FG001|STARTED|Overall Study||5
6773488|NCT03983941|7701146|FG000|COMPLETED|Overall Study||2
6773489|NCT03983941|7701147|FG001|COMPLETED|Overall Study||5
6773490|NCT03983941|7701146|FG000|NOT COMPLETED|Overall Study||0
6773491|NCT03983941|7701147|FG001|NOT COMPLETED|Overall Study||0
6773492|NCT03976752|7701155|FG000|STARTED|Overall Study||4
6773493|NCT03976752|7701156|FG001|STARTED|Overall Study||37
6773494|NCT03976752|7701155|FG000|Started Study Arm A|Overall Study||0
6773495|NCT03976752|7701156|FG001|Started Study Arm A|Overall Study||14
6773496|NCT03976752|7701155|FG000|Completed Study Arm A|Overall Study||0
6773497|NCT03976752|7701156|FG001|Completed Study Arm A|Overall Study||8
6773498|NCT03976752|7701155|FG000|Started Study Arm B|Overall Study||0
6773499|NCT03976752|7701156|FG001|Started Study Arm B|Overall Study||8
6773500|NCT03976752|7701155|FG000|Completed Study Arm B|Overall Study||0
6773501|NCT03976752|7701156|FG001|Completed Study Arm B|Overall Study||8
6773502|NCT03976752|7701155|FG000|Started Study Arm C|Overall Study||0
6773503|NCT03976752|7701156|FG001|Started Study Arm C|Overall Study||11
6773504|NCT03976752|7701155|FG000|Completed Study Arm C|Overall Study||0
6773505|NCT03976752|7701156|FG001|Completed Study Arm C|Overall Study||8
6773506|NCT03976752|7701155|FG000|Started Study Arm D|Overall Study||0
6773507|NCT03976752|7701156|FG001|Started Study Arm D|Overall Study||6
6773508|NCT03976752|7701155|FG000|Completed Study Arm D|Overall Study||0
6773509|NCT03976752|7701156|FG001|Completed Study Arm D|Overall Study||4
6773510|NCT03976752|7701155|FG000|COMPLETED|Overall Study||3
6773511|NCT03976752|7701156|FG001|COMPLETED|Overall Study||28
6773512|NCT03976752|7701155|FG000|NOT COMPLETED|Overall Study||1
6773513|NCT03976752|7701156|FG001|NOT COMPLETED|Overall Study||9
6773514|NCT03984825|7701167|FG000|STARTED|Run-in Period (Day -3 to -1)||23
6773515|NCT03984825|7701167|FG000|COMPLETED|Run-in Period (Day -3 to -1)||23
6773516|NCT03984825|7701167|FG000|NOT COMPLETED|Run-in Period (Day -3 to -1)||0
6773517|NCT03984825|7701167|FG000|STARTED|Treatment Period 1 (Day 1 to 10)||23
6773518|NCT03984825|7701167|FG000|COMPLETED|Treatment Period 1 (Day 1 to 10)||21
6312525|NCT00410163|7216729|FG001|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
6312526|NCT00410163|7216728|FG000|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
6312527|NCT00410163|7216729|FG001|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
6312528|NCT00410163|7216728|FG000|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
6312529|NCT00410163|7216729|FG001|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
6312530|NCT00410189|7216739|FG000|STARTED|Overall Study||54
6312531|NCT00410189|7216739|FG000|COMPLETED|Overall Study||54
6312532|NCT00410189|7216739|FG000|NOT COMPLETED|Overall Study||0
6312533|NCT00410202|7216746|FG000|STARTED|On-Treatment||138
6312534|NCT00410202|7216747|FG001|STARTED|On-Treatment||140
6312535|NCT00410202|7216748|FG002|STARTED|On-Treatment||137
6312536|NCT00410202|7216746|FG000|Discontinued Prior to Week 48 Visit|On-Treatment||4
6312537|NCT00410202|7216747|FG001|Discontinued Prior to Week 48 Visit|On-Treatment||2
6312538|NCT00410202|7216748|FG002|Discontinued Prior to Week 48 Visit|On-Treatment||2
6312539|NCT00410202|7216746|FG000|Discontinued at or After Week 48 Visit|On-Treatment||2
6312540|NCT00410202|7216747|FG001|Discontinued at or After Week 48 Visit|On-Treatment||6
6312541|NCT00410202|7216748|FG002|Discontinued at or After Week 48 Visit|On-Treatment||3
6312542|NCT00410202|7216746|FG000|COMPLETED|On-Treatment|Completed the 100 week dosing|63
6312543|NCT00410202|7216747|FG001|COMPLETED|On-Treatment|Completed the 100 week dosing|61
6312544|NCT00410202|7216748|FG002|COMPLETED|On-Treatment|Completed the 100 week dosing|66
6312545|NCT00410202|7216746|FG000|NOT COMPLETED|On-Treatment||75
6312546|NCT00410202|7216747|FG001|NOT COMPLETED|On-Treatment||79
6312547|NCT00410202|7216748|FG002|NOT COMPLETED|On-Treatment||71
6312548|NCT00410202|7216746|FG000|STARTED|Off-treatment Follow up||15
6312549|NCT00410202|7216747|FG001|STARTED|Off-treatment Follow up||8
6312550|NCT00410202|7216748|FG002|STARTED|Off-treatment Follow up||14
6312551|NCT00410202|7216746|FG000|COMPLETED|Off-treatment Follow up||1
6312552|NCT00410202|7216747|FG001|COMPLETED|Off-treatment Follow up||0
6312553|NCT00410202|7216748|FG002|COMPLETED|Off-treatment Follow up||2
6312554|NCT00410202|7216746|FG000|NOT COMPLETED|Off-treatment Follow up||14
6312555|NCT00410202|7216747|FG001|NOT COMPLETED|Off-treatment Follow up||8
6312556|NCT00410202|7216748|FG002|NOT COMPLETED|Off-treatment Follow up||12
6773519|NCT03984825|7701167|FG000|NOT COMPLETED|Treatment Period 1 (Day 1 to 10)||2
6773520|NCT03984825|7701167|FG000|STARTED|Treatment Period 2 (Day 11 to 21)||21
6773521|NCT03984825|7701167|FG000|COMPLETED|Treatment Period 2 (Day 11 to 21)||17
6773522|NCT03984825|7701167|FG000|NOT COMPLETED|Treatment Period 2 (Day 11 to 21)||4
6773523|NCT03971721|7701176|FG000|STARTED|Overall Study||3
6773524|NCT03971721|7701176|FG000|COMPLETED|Overall Study||3
6773525|NCT03971721|7701176|FG000|NOT COMPLETED|Overall Study||0
6773526|NCT03982433|7701180|FG000|STARTED|Overall Study||8
6773527|NCT03982433|7701180|FG000|COMPLETED|Overall Study||7
6773528|NCT03982433|7701180|FG000|NOT COMPLETED|Overall Study||1
6773529|NCT03979677|7701184|FG000|STARTED|Overall Study|Participants enrolled|41
6773530|NCT03979677|7701184|FG000|COMPLETED|Overall Study|participants completed|28
6773531|NCT03979677|7701184|FG000|NOT COMPLETED|Overall Study||13
6773532|NCT03976466|7701190|FG000|STARTED|Overall Study||44
6773533|NCT03976466|7701191|FG001|STARTED|Overall Study||43
6773534|NCT03976466|7701190|FG000|COMPLETED|Overall Study||43
6773535|NCT03976466|7701191|FG001|COMPLETED|Overall Study||40
6773536|NCT03976466|7701190|FG000|NOT COMPLETED|Overall Study||1
6773537|NCT03976466|7701191|FG001|NOT COMPLETED|Overall Study||3
6773538|NCT03979638|7701201|FG000|STARTED|Period 1||33
6773539|NCT03979638|7701202|FG001|STARTED|Period 1||35
6773540|NCT03979638|7701201|FG000|COMPLETED|Period 1||26
6773541|NCT03979638|7701202|FG001|COMPLETED|Period 1||28
6773542|NCT03979638|7701201|FG000|NOT COMPLETED|Period 1||7
6773543|NCT03979638|7701202|FG001|NOT COMPLETED|Period 1||7
6773544|NCT03979638|7701201|FG000|STARTED|Period 2||26
6773545|NCT03979638|7701202|FG001|STARTED|Period 2||28
6773546|NCT03979638|7701201|FG000|COMPLETED|Period 2||25
6773547|NCT03979638|7701202|FG001|COMPLETED|Period 2||27
6773548|NCT03979638|7701201|FG000|NOT COMPLETED|Period 2||1
6773549|NCT03979638|7701202|FG001|NOT COMPLETED|Period 2||1
6773550|NCT03979274|7701217|FG000|STARTED|Treatment Period 1||22
6773551|NCT03979274|7701218|FG001|STARTED|Treatment Period 1||22
6773552|NCT03979274|7701217|FG000|COMPLETED|Treatment Period 1||22
6773553|NCT03979274|7701218|FG001|COMPLETED|Treatment Period 1||22
6773554|NCT03979274|7701217|FG000|NOT COMPLETED|Treatment Period 1||0
6773555|NCT03979274|7701218|FG001|NOT COMPLETED|Treatment Period 1||0
6773556|NCT03979274|7701217|FG000|STARTED|Treatment Period 2||22
6773557|NCT03979274|7701218|FG001|STARTED|Treatment Period 2||22
6773558|NCT03979274|7701217|FG000|COMPLETED|Treatment Period 2||22
6773559|NCT03979274|7701218|FG001|COMPLETED|Treatment Period 2||21
6773560|NCT03979274|7701217|FG000|NOT COMPLETED|Treatment Period 2||0
6773561|NCT03979274|7701218|FG001|NOT COMPLETED|Treatment Period 2||1
6773562|NCT03979066|7701226|FG000|STARTED|Overall Study||0
6773563|NCT03979066|7701227|FG001|STARTED|Overall Study||0
6773564|NCT03979066|7701226|FG000|COMPLETED|Overall Study||0
6773565|NCT03979066|7701227|FG001|COMPLETED|Overall Study||0
6773566|NCT03979066|7701226|FG000|NOT COMPLETED|Overall Study||0
6773567|NCT03979066|7701227|FG001|NOT COMPLETED|Overall Study||0
6773568|NCT03977727|7701235|FG000|STARTED|First Treatment||20
6773569|NCT03977727|7701236|FG001|STARTED|First Treatment||20
6773570|NCT03977727|7701235|FG000|Received Treatment|First Treatment||20
6773571|NCT03977727|7701236|FG001|Received Treatment|First Treatment||20
6312557|NCT00410280|7216759|FG000|STARTED|Overall Study||14
6312558|NCT00410280|7216760|FG001|STARTED|Overall Study||13
6312559|NCT00410280|7216759|FG000|COMPLETED|Overall Study||14
6312560|NCT00410280|7216760|FG001|COMPLETED|Overall Study||13
6312561|NCT00410280|7216759|FG000|NOT COMPLETED|Overall Study||0
6312562|NCT00410280|7216760|FG001|NOT COMPLETED|Overall Study||0
6312563|NCT00410384|7216769|FG000|STARTED|Overall Study||275
6312564|NCT00410384|7216770|FG001|STARTED|Overall Study||271
6312565|NCT00410384|7216771|FG002|STARTED|Overall Study||273
6312566|NCT00410384|7216769|FG000|COMPLETED|Overall Study||186
6312567|NCT00410384|7216770|FG001|COMPLETED|Overall Study||199
6312568|NCT00410384|7216771|FG002|COMPLETED|Overall Study||191
6312569|NCT00410384|7216769|FG000|NOT COMPLETED|Overall Study||89
6312570|NCT00410384|7216770|FG001|NOT COMPLETED|Overall Study||72
6312571|NCT00410384|7216771|FG002|NOT COMPLETED|Overall Study||82
6312572|NCT00410410|7216785|FG000|STARTED|Induction Period (IP)||141
6312573|NCT00410410|7216786|FG001|STARTED|Induction Period (IP)||139
6312574|NCT00410410|7216787|FG002|STARTED|Induction Period (IP)||70
6312575|NCT00410410|7216788|FG003|STARTED|Induction Period (IP)||140
6312576|NCT00410410|7216789|FG004|STARTED|Induction Period (IP)||51
6312577|NCT00410410|7216790|FG005|STARTED|Induction Period (IP)||50
6312578|NCT00410410|7216791|FG006|STARTED|Induction Period (IP)||0
6312579|NCT00410410|7216792|FG007|STARTED|Induction Period (IP)||0
6312580|NCT00410410|7216793|FG008|STARTED|Induction Period (IP)||0
6312581|NCT00410410|7216785|FG000|COMPLETED|Induction Period (IP)||106
6312582|NCT00410410|7216786|FG001|COMPLETED|Induction Period (IP)||104
6312583|NCT00410410|7216787|FG002|COMPLETED|Induction Period (IP)||53
6312584|NCT00410410|7216788|FG003|COMPLETED|Induction Period (IP)||120
6312585|NCT00410410|7216789|FG004|COMPLETED|Induction Period (IP)||19
6312586|NCT00410410|7216790|FG005|COMPLETED|Induction Period (IP)||21
6312587|NCT00410410|7216791|FG006|COMPLETED|Induction Period (IP)||0
6312588|NCT00410410|7216792|FG007|COMPLETED|Induction Period (IP)||0
6312589|NCT00410410|7216793|FG008|COMPLETED|Induction Period (IP)||0
6312590|NCT00410410|7216785|FG000|NOT COMPLETED|Induction Period (IP)||35
6312591|NCT00410410|7216786|FG001|NOT COMPLETED|Induction Period (IP)||35
6312592|NCT00410410|7216787|FG002|NOT COMPLETED|Induction Period (IP)||17
6312593|NCT00410410|7216788|FG003|NOT COMPLETED|Induction Period (IP)||20
6312594|NCT00410410|7216789|FG004|NOT COMPLETED|Induction Period (IP)||32
6312595|NCT00410410|7216790|FG005|NOT COMPLETED|Induction Period (IP)||29
6312596|NCT00410410|7216791|FG006|NOT COMPLETED|Induction Period (IP)||0
6312597|NCT00410410|7216792|FG007|NOT COMPLETED|Induction Period (IP)||0
6312598|NCT00410410|7216793|FG008|NOT COMPLETED|Induction Period (IP)||0
6312599|NCT00410410|7216785|FG000|STARTED|Maintenance Period (MP)||0
6312600|NCT00410410|7216786|FG001|STARTED|Maintenance Period (MP)||0
6312601|NCT00410410|7216787|FG002|STARTED|Maintenance Period (MP)||0
6312602|NCT00410410|7216788|FG003|STARTED|Maintenance Period (MP)||0
6312603|NCT00410410|7216789|FG004|STARTED|Maintenance Period (MP)||0
6312604|NCT00410410|7216790|FG005|STARTED|Maintenance Period (MP)||0
6312605|NCT00410410|7216791|FG006|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
6312606|NCT00410410|7216792|FG007|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
6312607|NCT00410410|7216793|FG008|STARTED|Maintenance Period (MP)||0
6312608|NCT00410410|7216785|FG000|COMPLETED|Maintenance Period (MP)||0
6312609|NCT00410410|7216786|FG001|COMPLETED|Maintenance Period (MP)||0
6312610|NCT00410410|7216787|FG002|COMPLETED|Maintenance Period (MP)||0
6312611|NCT00410410|7216788|FG003|COMPLETED|Maintenance Period (MP)||0
6312612|NCT00410410|7216789|FG004|COMPLETED|Maintenance Period (MP)||0
6312613|NCT00410410|7216790|FG005|COMPLETED|Maintenance Period (MP)||0
6312614|NCT00410410|7216791|FG006|COMPLETED|Maintenance Period (MP)||15
6312615|NCT00410410|7216792|FG007|COMPLETED|Maintenance Period (MP)||11
6312616|NCT00410410|7216793|FG008|COMPLETED|Maintenance Period (MP)||0
6312617|NCT00410410|7216785|FG000|NOT COMPLETED|Maintenance Period (MP)||0
6312618|NCT00410410|7216786|FG001|NOT COMPLETED|Maintenance Period (MP)||0
6312619|NCT00410410|7216787|FG002|NOT COMPLETED|Maintenance Period (MP)||0
6312620|NCT00410410|7216788|FG003|NOT COMPLETED|Maintenance Period (MP)||0
6312621|NCT00410410|7216789|FG004|NOT COMPLETED|Maintenance Period (MP)||0
6312622|NCT00410410|7216790|FG005|NOT COMPLETED|Maintenance Period (MP)||0
6312623|NCT00410410|7216791|FG006|NOT COMPLETED|Maintenance Period (MP)||50
6312624|NCT00410410|7216792|FG007|NOT COMPLETED|Maintenance Period (MP)||55
6312625|NCT00410410|7216793|FG008|NOT COMPLETED|Maintenance Period (MP)||0
6312626|NCT00410410|7216785|FG000|STARTED|Open-Label Period (OL)||0
6312627|NCT00410410|7216786|FG001|STARTED|Open-Label Period (OL)||0
6312628|NCT00410410|7216787|FG002|STARTED|Open-Label Period (OL)||0
6312629|NCT00410410|7216788|FG003|STARTED|Open-Label Period (OL)||0
6312630|NCT00410410|7216789|FG004|STARTED|Open-Label Period (OL)||0
6312631|NCT00410410|7216790|FG005|STARTED|Open-Label Period (OL)||0
6312632|NCT00410410|7216791|FG006|STARTED|Open-Label Period (OL)||0
6312633|NCT00410410|7216792|FG007|STARTED|Open-Label Period (OL)||0
6312634|NCT00410410|7216793|FG008|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
6312635|NCT00410410|7216785|FG000|COMPLETED|Open-Label Period (OL)||0
6312636|NCT00410410|7216786|FG001|COMPLETED|Open-Label Period (OL)||0
6312637|NCT00410410|7216787|FG002|COMPLETED|Open-Label Period (OL)||0
6312638|NCT00410410|7216788|FG003|COMPLETED|Open-Label Period (OL)||0
6312639|NCT00410410|7216789|FG004|COMPLETED|Open-Label Period (OL)||0
6312640|NCT00410410|7216790|FG005|COMPLETED|Open-Label Period (OL)||0
6312641|NCT00410410|7216791|FG006|COMPLETED|Open-Label Period (OL)||0
6312642|NCT00410410|7216792|FG007|COMPLETED|Open-Label Period (OL)||0
6312643|NCT00410410|7216793|FG008|COMPLETED|Open-Label Period (OL)||0
6312644|NCT00410410|7216785|FG000|NOT COMPLETED|Open-Label Period (OL)||0
6312645|NCT00410410|7216786|FG001|NOT COMPLETED|Open-Label Period (OL)||0
6312646|NCT00410410|7216787|FG002|NOT COMPLETED|Open-Label Period (OL)||0
6312647|NCT00410410|7216788|FG003|NOT COMPLETED|Open-Label Period (OL)||0
6312648|NCT00410410|7216789|FG004|NOT COMPLETED|Open-Label Period (OL)||0
6312649|NCT00410410|7216790|FG005|NOT COMPLETED|Open-Label Period (OL)||0
6312650|NCT00410410|7216791|FG006|NOT COMPLETED|Open-Label Period (OL)||0
6312651|NCT00410410|7216792|FG007|NOT COMPLETED|Open-Label Period (OL)||0
6312652|NCT00410410|7216793|FG008|NOT COMPLETED|Open-Label Period (OL)||349
6312653|NCT00410423|7216828|FG000|STARTED|Phase 1 - Dose Level 1||3
6312654|NCT00410423|7216829|FG001|STARTED|Phase 1 - Dose Level 1||0
6312655|NCT00410423|7216830|FG002|STARTED|Phase 1 - Dose Level 1||0
6312656|NCT00410423|7216831|FG003|STARTED|Phase 1 - Dose Level 1||0
6312657|NCT00410423|7216828|FG000|COMPLETED|Phase 1 - Dose Level 1||3
6312658|NCT00410423|7216829|FG001|COMPLETED|Phase 1 - Dose Level 1||0
6312659|NCT00410423|7216830|FG002|COMPLETED|Phase 1 - Dose Level 1||0
6312660|NCT00410423|7216831|FG003|COMPLETED|Phase 1 - Dose Level 1||0
6312661|NCT00410423|7216828|FG000|NOT COMPLETED|Phase 1 - Dose Level 1||0
6312662|NCT00410423|7216829|FG001|NOT COMPLETED|Phase 1 - Dose Level 1||0
6312663|NCT00410423|7216830|FG002|NOT COMPLETED|Phase 1 - Dose Level 1||0
6312664|NCT00410423|7216831|FG003|NOT COMPLETED|Phase 1 - Dose Level 1||0
6312665|NCT00410423|7216828|FG000|STARTED|Phase 1 - Dose Level 2||0
6312666|NCT00410423|7216829|FG001|STARTED|Phase 1 - Dose Level 2||5
6312667|NCT00410423|7216830|FG002|STARTED|Phase 1 - Dose Level 2||0
6312668|NCT00410423|7216831|FG003|STARTED|Phase 1 - Dose Level 2||0
6312669|NCT00410423|7216828|FG000|COMPLETED|Phase 1 - Dose Level 2||0
6773572|NCT03977727|7701235|FG000|COMPLETED|First Treatment||20
6773573|NCT03977727|7701236|FG001|COMPLETED|First Treatment||20
6773574|NCT03977727|7701235|FG000|NOT COMPLETED|First Treatment||0
6773575|NCT03977727|7701236|FG001|NOT COMPLETED|First Treatment||0
6773576|NCT03977727|7701235|FG000|STARTED|Second Treatment||20
6773577|NCT03977727|7701236|FG001|STARTED|Second Treatment||20
6773578|NCT03977727|7701235|FG000|COMPLETED|Second Treatment||20
6773579|NCT03977727|7701236|FG001|COMPLETED|Second Treatment||17
6773580|NCT03977727|7701235|FG000|NOT COMPLETED|Second Treatment||0
6773581|NCT03977727|7701236|FG001|NOT COMPLETED|Second Treatment||3
6773582|NCT03977155|7701245|FG000|STARTED|Overall Study||43
6773583|NCT03977155|7701246|FG001|STARTED|Overall Study||48
6773584|NCT03977155|7701247|FG002|STARTED|Overall Study||42
6773585|NCT03977155|7701245|FG000|COMPLETED|Overall Study||38
6773586|NCT03977155|7701246|FG001|COMPLETED|Overall Study||46
6773587|NCT03977155|7701247|FG002|COMPLETED|Overall Study||40
6773588|NCT03977155|7701245|FG000|NOT COMPLETED|Overall Study||5
6773589|NCT03977155|7701246|FG001|NOT COMPLETED|Overall Study||2
6773590|NCT03977155|7701247|FG002|NOT COMPLETED|Overall Study||2
6773591|NCT03974802|7701257|FG000|STARTED|Overall Study||41
6773592|NCT03974802|7701257|FG000|COMPLETED|Overall Study||41
6773593|NCT03974802|7701257|FG000|NOT COMPLETED|Overall Study||0
6773594|NCT03970733|7701269|FG000|STARTED|Overall Study||97
6773595|NCT03970733|7701270|FG001|STARTED|Overall Study||98
6773596|NCT03970733|7701271|FG002|STARTED|Overall Study||51
6773597|NCT03970733|7701269|FG000|COMPLETED|Overall Study||93
6773598|NCT03970733|7701270|FG001|COMPLETED|Overall Study||92
6773599|NCT03970733|7701271|FG002|COMPLETED|Overall Study||49
6773600|NCT03970733|7701269|FG000|NOT COMPLETED|Overall Study||4
6773601|NCT03970733|7701270|FG001|NOT COMPLETED|Overall Study||6
6773602|NCT03970733|7701271|FG002|NOT COMPLETED|Overall Study||2
6773603|NCT03968978|7701281|FG000|STARTED|Overall Study||111
6773604|NCT03968978|7701282|FG001|STARTED|Overall Study||105
6773605|NCT03968978|7701281|FG000|COMPLETED|Overall Study||110
6773606|NCT03968978|7701282|FG001|COMPLETED|Overall Study||105
6773607|NCT03968978|7701281|FG000|NOT COMPLETED|Overall Study||1
6773608|NCT03968978|7701282|FG001|NOT COMPLETED|Overall Study||0
6773609|NCT03968848|7701290|FG000|STARTED|Overall Study||8
6773610|NCT03968848|7701291|FG001|STARTED|Overall Study||8
6773611|NCT03968848|7701290|FG000|COMPLETED|Overall Study||8
6773612|NCT03968848|7701291|FG001|COMPLETED|Overall Study||8
6773613|NCT03968848|7701290|FG000|NOT COMPLETED|Overall Study||0
6773614|NCT03968848|7701291|FG001|NOT COMPLETED|Overall Study||0
6312670|NCT00410423|7216829|FG001|COMPLETED|Phase 1 - Dose Level 2||5
6312671|NCT00410423|7216830|FG002|COMPLETED|Phase 1 - Dose Level 2||0
6312672|NCT00410423|7216831|FG003|COMPLETED|Phase 1 - Dose Level 2||0
6312673|NCT00410423|7216828|FG000|NOT COMPLETED|Phase 1 - Dose Level 2||0
6773615|NCT03967444|7701299|FG000|STARTED|Overall Study||19
6773616|NCT03967444|7701300|FG001|STARTED|Overall Study||40
6773617|NCT03967444|7701299|FG000|COMPLETED|Overall Study||18
6773618|NCT03967444|7701300|FG001|COMPLETED|Overall Study||38
6773619|NCT03967444|7701299|FG000|NOT COMPLETED|Overall Study||1
6773620|NCT03967444|7701300|FG001|NOT COMPLETED|Overall Study||2
6773621|NCT03966924|7701306|FG000|STARTED|Overall Study||2
6773622|NCT03966924|7701306|FG000|COMPLETED|Overall Study||2
6773623|NCT03966924|7701306|FG000|NOT COMPLETED|Overall Study||0
6773624|NCT03966911|7701312|FG000|STARTED|Overall Study||169
6773625|NCT03966911|7701313|FG001|STARTED|Overall Study||142
6773626|NCT03966911|7701312|FG000|COMPLETED|Overall Study||160
6773627|NCT03966911|7701313|FG001|COMPLETED|Overall Study||126
6773628|NCT03966911|7701312|FG000|NOT COMPLETED|Overall Study||9
6312674|NCT00410423|7216829|FG001|NOT COMPLETED|Phase 1 - Dose Level 2||0
6312675|NCT00410423|7216830|FG002|NOT COMPLETED|Phase 1 - Dose Level 2||0
6312676|NCT00410423|7216831|FG003|NOT COMPLETED|Phase 1 - Dose Level 2||0
6312677|NCT00410423|7216828|FG000|STARTED|Phase 1 - Dose Level 3||0
6312678|NCT00410423|7216829|FG001|STARTED|Phase 1 - Dose Level 3||0
6312679|NCT00410423|7216830|FG002|STARTED|Phase 1 - Dose Level 3||3
6312680|NCT00410423|7216831|FG003|STARTED|Phase 1 - Dose Level 3||0
6312681|NCT00410423|7216828|FG000|COMPLETED|Phase 1 - Dose Level 3||0
6312682|NCT00410423|7216829|FG001|COMPLETED|Phase 1 - Dose Level 3||0
6312683|NCT00410423|7216830|FG002|COMPLETED|Phase 1 - Dose Level 3||3
6312684|NCT00410423|7216831|FG003|COMPLETED|Phase 1 - Dose Level 3||0
6312685|NCT00410423|7216828|FG000|NOT COMPLETED|Phase 1 - Dose Level 3||0
6312686|NCT00410423|7216829|FG001|NOT COMPLETED|Phase 1 - Dose Level 3||0
6312687|NCT00410423|7216830|FG002|NOT COMPLETED|Phase 1 - Dose Level 3||0
6312688|NCT00410423|7216831|FG003|NOT COMPLETED|Phase 1 - Dose Level 3||0
6312689|NCT00410423|7216828|FG000|STARTED|Phase 2||0
6312690|NCT00410423|7216829|FG001|STARTED|Phase 2||0
6312691|NCT00410423|7216830|FG002|STARTED|Phase 2||0
6312692|NCT00410423|7216831|FG003|STARTED|Phase 2||44
6312693|NCT00410423|7216828|FG000|COMPLETED|Phase 2||0
6312694|NCT00410423|7216829|FG001|COMPLETED|Phase 2||0
6312695|NCT00410423|7216830|FG002|COMPLETED|Phase 2||0
6312696|NCT00410423|7216831|FG003|COMPLETED|Phase 2||44
6312697|NCT00410423|7216828|FG000|NOT COMPLETED|Phase 2||0
6312698|NCT00410423|7216829|FG001|NOT COMPLETED|Phase 2||0
6312699|NCT00410423|7216830|FG002|NOT COMPLETED|Phase 2||0
6312700|NCT00410423|7216831|FG003|NOT COMPLETED|Phase 2||0
6312701|NCT00410488|7216840|FG000|STARTED|Overall Study||16
6312702|NCT00410488|7216841|FG001|STARTED|Overall Study||34
6312703|NCT00410488|7216840|FG000|COMPLETED|Overall Study||16
6312704|NCT00410488|7216841|FG001|COMPLETED|Overall Study||34
6312705|NCT00410488|7216840|FG000|NOT COMPLETED|Overall Study||0
6312706|NCT00410488|7216841|FG001|NOT COMPLETED|Overall Study||0
6312707|NCT00410514|7216849|FG000|STARTED|Overall Study||65
6312708|NCT00410514|7216850|FG001|STARTED|Overall Study||70
6312709|NCT00410514|7216851|FG002|STARTED|Overall Study||65
6312710|NCT00410514|7216849|FG000|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
6312711|NCT00410514|7216850|FG001|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
6312712|NCT00410514|7216851|FG002|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
6312713|NCT00410514|7216849|FG000|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
6312714|NCT00410514|7216850|FG001|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
6312715|NCT00410514|7216851|FG002|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
6312716|NCT00410514|7216849|FG000|COMPLETED|Overall Study||63
6312717|NCT00410514|7216850|FG001|COMPLETED|Overall Study||67
6312718|NCT00410514|7216851|FG002|COMPLETED|Overall Study||58
6312719|NCT00410514|7216849|FG000|NOT COMPLETED|Overall Study||2
6773629|NCT03966911|7701313|FG001|NOT COMPLETED|Overall Study||16
6773630|NCT03966365|7701323|FG000|STARTED|Overall Study||12
6773631|NCT03966365|7701324|FG001|STARTED|Overall Study||12
6773632|NCT03966365|7701323|FG000|COMPLETED|Overall Study||11
6773633|NCT03966365|7701324|FG001|COMPLETED|Overall Study||12
6773634|NCT03966365|7701323|FG000|NOT COMPLETED|Overall Study||1
6773635|NCT03966365|7701324|FG001|NOT COMPLETED|Overall Study||0
6773636|NCT03965403|7701330|FG000|STARTED|Overall Study||7
6773637|NCT03965403|7701330|FG000|COMPLETED|Overall Study||6
6773638|NCT03965403|7701330|FG000|NOT COMPLETED|Overall Study||1
6773639|NCT03965754|7701338|FG000|STARTED|Overall Study||1422
6773640|NCT03965754|7701339|FG001|STARTED|Overall Study||1425
6773641|NCT03965754|7701340|FG002|STARTED|Overall Study||1425
6773642|NCT03965754|7701341|FG003|STARTED|Overall Study||1425
6773643|NCT03965754|7701338|FG000|COMPLETED|Overall Study||1422
6773644|NCT03965754|7701339|FG001|COMPLETED|Overall Study||1425
6773645|NCT03965754|7701340|FG002|COMPLETED|Overall Study||1425
6773646|NCT03965754|7701341|FG003|COMPLETED|Overall Study||1425
6773647|NCT03965754|7701338|FG000|NOT COMPLETED|Overall Study||0
6773648|NCT03965754|7701339|FG001|NOT COMPLETED|Overall Study||0
6773649|NCT03965754|7701340|FG002|NOT COMPLETED|Overall Study||0
6773650|NCT03965754|7701341|FG003|NOT COMPLETED|Overall Study||0
6773651|NCT03965533|7701358|FG000|STARTED|Part A (112 Days)||2
6773652|NCT03965533|7701359|FG001|STARTED|Part A (112 Days)||6
6773653|NCT03965533|7701360|FG002|STARTED|Part A (112 Days)||2
6773654|NCT03965533|7701361|FG003|STARTED|Part A (112 Days)||6
6773655|NCT03965533|7701362|FG004|STARTED|Part A (112 Days)||0
6773656|NCT03965533|7701363|FG005|STARTED|Part A (112 Days)||0
6773657|NCT03965533|7701364|FG006|STARTED|Part A (112 Days)||0
6773658|NCT03965533|7701358|FG000|COMPLETED|Part A (112 Days)||2
6773659|NCT03965533|7701359|FG001|COMPLETED|Part A (112 Days)||6
6773660|NCT03965533|7701360|FG002|COMPLETED|Part A (112 Days)||2
6773661|NCT03965533|7701361|FG003|COMPLETED|Part A (112 Days)||6
6773662|NCT03965533|7701362|FG004|COMPLETED|Part A (112 Days)||0
6773663|NCT03965533|7701363|FG005|COMPLETED|Part A (112 Days)||0
6773664|NCT03965533|7701364|FG006|COMPLETED|Part A (112 Days)||0
6773665|NCT03965533|7701358|FG000|NOT COMPLETED|Part A (112 Days)||0
6773666|NCT03965533|7701359|FG001|NOT COMPLETED|Part A (112 Days)||0
6773667|NCT03965533|7701360|FG002|NOT COMPLETED|Part A (112 Days)||0
6773668|NCT03965533|7701361|FG003|NOT COMPLETED|Part A (112 Days)||0
6312720|NCT00410514|7216850|FG001|NOT COMPLETED|Overall Study||3
6312721|NCT00410514|7216851|FG002|NOT COMPLETED|Overall Study||7
6312722|NCT00410605|7216859|FG000|STARTED|Overall Study||39
6312723|NCT00410605|7216859|FG000|COMPLETED|Overall Study||14
6312724|NCT00410605|7216859|FG000|NOT COMPLETED|Overall Study||25
6312725|NCT00410761|7216865|FG000|STARTED|Overall Study|randomised patients|231
6312726|NCT00410761|7216866|FG001|STARTED|Overall Study|randomised patients|100
6312727|NCT00410761|7216865|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
6312728|NCT00410761|7216866|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
6312729|NCT00410761|7216865|FG000|NOT COMPLETED|Overall Study||120
6312730|NCT00410761|7216866|FG001|NOT COMPLETED|Overall Study||72
6312731|NCT00410813|7216874|FG000|STARTED|Overall Study||43
6312732|NCT00410813|7216875|FG001|STARTED|Overall Study||42
6312733|NCT00410813|7216874|FG000|Eligible|Overall Study||41
6312734|NCT00410813|7216875|FG001|Eligible|Overall Study||38
6312735|NCT00410813|7216874|FG000|COMPLETED|Overall Study|Patients treated until progression.|0
6312736|NCT00410813|7216875|FG001|COMPLETED|Overall Study||0
6312737|NCT00410813|7216874|FG000|NOT COMPLETED|Overall Study||43
6312738|NCT00410813|7216875|FG001|NOT COMPLETED|Overall Study||42
6312739|NCT00410826|7216906|FG000|STARTED|Overall Study||105
6312740|NCT00410826|7216907|FG001|STARTED|Overall Study||99
6312741|NCT00410826|7216906|FG000|COMPLETED|Overall Study||96
6312742|NCT00410826|7216907|FG001|COMPLETED|Overall Study||95
6312743|NCT00410826|7216906|FG000|NOT COMPLETED|Overall Study||9
6312744|NCT00410826|7216907|FG001|NOT COMPLETED|Overall Study||4
6312745|NCT00410891|7216913|FG000|STARTED|Overall Study||129
6312746|NCT00410891|7216913|FG000|COMPLETED|Overall Study||129
6312747|NCT00410891|7216913|FG000|NOT COMPLETED|Overall Study||0
6312748|NCT00410904|7216919|FG000|STARTED|Overall Study||40
6312749|NCT00410904|7216920|FG001|STARTED|Overall Study||20
6312750|NCT00410904|7216919|FG000|COMPLETED|Overall Study||40
6312751|NCT00410904|7216920|FG001|COMPLETED|Overall Study||20
6312752|NCT00410904|7216919|FG000|NOT COMPLETED|Overall Study||0
6312753|NCT00410904|7216920|FG001|NOT COMPLETED|Overall Study||0
6312754|NCT00411086|7216927|FG000|STARTED|Overall Study||52
6312755|NCT00411086|7216927|FG000|COMPLETED|Overall Study||52
6312756|NCT00411086|7216927|FG000|NOT COMPLETED|Overall Study||0
6312757|NCT00411151|7216931|FG000|STARTED|Overall Study||52
6312758|NCT00411151|7216931|FG000|COMPLETED|Overall Study||5
6312759|NCT00411151|7216931|FG000|NOT COMPLETED|Overall Study||47
6312760|NCT00411216|7216937|FG000|STARTED|Overall Study||13
6312761|NCT00411216|7216938|FG001|STARTED|Overall Study||10
6312762|NCT00411216|7216937|FG000|COMPLETED|Overall Study||13
6312763|NCT00411216|7216938|FG001|COMPLETED|Overall Study||8
6312764|NCT00411216|7216937|FG000|NOT COMPLETED|Overall Study||0
6312765|NCT00411216|7216938|FG001|NOT COMPLETED|Overall Study||2
6312766|NCT00411398|7216944|FG000|STARTED|Overall Study||15
6312767|NCT00411398|7216944|FG000|COMPLETED|Overall Study||10
6312768|NCT00411398|7216944|FG000|NOT COMPLETED|Overall Study||5
6312769|NCT00411411|7216950|FG000|STARTED|Overall Study||24
6312770|NCT00411411|7216951|FG001|STARTED|Overall Study||25
6312771|NCT00411411|7216950|FG000|COMPLETED|Overall Study||24
6312772|NCT00411411|7216951|FG001|COMPLETED|Overall Study||25
6312773|NCT00411411|7216950|FG000|NOT COMPLETED|Overall Study||0
6312774|NCT00411411|7216951|FG001|NOT COMPLETED|Overall Study||0
6312775|NCT00411450|7216958|FG000|STARTED|Overall Study||116
6312776|NCT00411450|7216958|FG000|Received Treatment|Overall Study||115
6312777|NCT00411450|7216958|FG000|COMPLETED|Overall Study|Ended second-line treatment|113
6557666|NCT01769274|7480223|FG002|NOT COMPLETED|Part B:Treatment Session2-Period4||0
6557667|NCT01769326|7480238|FG000|STARTED|Overall Study||11
6312778|NCT00411450|7216958|FG000|NOT COMPLETED|Overall Study||3
6312779|NCT00411463|7216966|FG000|STARTED|Overall Study||14
6312780|NCT00411463|7216967|FG001|STARTED|Overall Study||11
6312781|NCT00411463|7216966|FG000|COMPLETED|Overall Study||11
6312782|NCT00411463|7216967|FG001|COMPLETED|Overall Study||8
6312783|NCT00411463|7216966|FG000|NOT COMPLETED|Overall Study||3
6312784|NCT00411463|7216967|FG001|NOT COMPLETED|Overall Study||3
6312785|NCT00411554|7216978|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
6312786|NCT00411554|7216979|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
6312787|NCT00411554|7216978|FG000|COMPLETED|Overall Study||155
6312788|NCT00411554|7216979|FG001|COMPLETED|Overall Study||147
6312789|NCT00411554|7216978|FG000|NOT COMPLETED|Overall Study||8
6312790|NCT00411554|7216979|FG001|NOT COMPLETED|Overall Study||9
6312791|NCT00411619|7216985|FG000|STARTED|Overall Study||28
6312792|NCT00411619|7216985|FG000|COMPLETED|Overall Study||22
6312793|NCT00411619|7216985|FG000|NOT COMPLETED|Overall Study||6
6312794|NCT00411632|7216990|FG000|STARTED|Overall Study||37
6312795|NCT00411632|7216990|FG000|COMPLETED|Overall Study||36
6312796|NCT00411632|7216990|FG000|NOT COMPLETED|Overall Study||1
6312797|NCT00411645|7216996|FG000|STARTED|Overall Study||227
6312798|NCT00411645|7216997|FG001|STARTED|Overall Study||454
6312799|NCT00411645|7216996|FG000|COMPLETED|Overall Study||146
6312800|NCT00411645|7216997|FG001|COMPLETED|Overall Study||290
6312801|NCT00411645|7216996|FG000|NOT COMPLETED|Overall Study||81
6312802|NCT00411645|7216997|FG001|NOT COMPLETED|Overall Study||164
6312803|NCT00411671|7217004|FG000|STARTED|Overall Study||105
6312804|NCT00411671|7217004|FG000|COMPLETED|Overall Study||85
6312805|NCT00411671|7217004|FG000|NOT COMPLETED|Overall Study||20
6312806|NCT00411684|7217008|FG000|STARTED|Overall Study||1533
6312807|NCT00411684|7217008|FG000|COMPLETED|Overall Study||1241
6312808|NCT00411684|7217008|FG000|NOT COMPLETED|Overall Study||292
6312809|NCT00411749|7217014|FG000|STARTED|Overall Study||82
6312810|NCT00411749|7217015|FG001|STARTED|Overall Study||25
6312811|NCT00411749|7217014|FG000|Vaccinated|Overall Study||82
6312812|NCT00411749|7217015|FG001|Vaccinated|Overall Study||25
6312813|NCT00411749|7217014|FG000|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
6312814|NCT00411749|7217015|FG001|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
6312815|NCT00411749|7217014|FG000|NOT COMPLETED|Overall Study||0
6312816|NCT00411749|7217015|FG001|NOT COMPLETED|Overall Study||0
6312817|NCT00411762|7217025|FG000|STARTED|Overall Study||25
6312818|NCT00411762|7217025|FG000|COMPLETED|Overall Study||20
6312819|NCT00411762|7217025|FG000|NOT COMPLETED|Overall Study||5
6312820|NCT00411788|7217029|FG000|STARTED|Overall Study||11
6312821|NCT00411788|7217029|FG000|COMPLETED|Overall Study||9
6312822|NCT00411788|7217029|FG000|NOT COMPLETED|Overall Study||2
6312823|NCT00412061|7217035|FG000|STARTED|Double Blind Phase||216
6312824|NCT00412061|7217036|FG001|STARTED|Double Blind Phase||213
6312825|NCT00412061|7217035|FG000|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
6312826|NCT00412061|7217036|FG001|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
6312827|NCT00412061|7217035|FG000|COMPLETED|Double Blind Phase||0
6312828|NCT00412061|7217036|FG001|COMPLETED|Double Blind Phase||0
6312829|NCT00412061|7217035|FG000|NOT COMPLETED|Double Blind Phase||216
6312830|NCT00412061|7217036|FG001|NOT COMPLETED|Double Blind Phase||213
6312831|NCT00412061|7217035|FG000|STARTED|Open Label Phase||0
6312832|NCT00412061|7217036|FG001|STARTED|Open Label Phase||170
6312833|NCT00412061|7217035|FG000|COMPLETED|Open Label Phase||0
6312834|NCT00412061|7217036|FG001|COMPLETED|Open Label Phase||0
6312835|NCT00412061|7217035|FG000|NOT COMPLETED|Open Label Phase||0
6312836|NCT00412061|7217036|FG001|NOT COMPLETED|Open Label Phase||170
6312837|NCT00412074|7217048|FG000|STARTED|Overall Study||199
6312838|NCT00412074|7217049|FG001|STARTED|Overall Study||66
6312839|NCT00412074|7217050|FG002|STARTED|Overall Study||195
6312840|NCT00412074|7217048|FG000|COMPLETED|Overall Study||122
6312841|NCT00412074|7217049|FG001|COMPLETED|Overall Study||44
6312842|NCT00412074|7217050|FG002|COMPLETED|Overall Study||128
6312843|NCT00412074|7217048|FG000|NOT COMPLETED|Overall Study||77
6312844|NCT00412074|7217049|FG001|NOT COMPLETED|Overall Study||22
6312845|NCT00412074|7217050|FG002|NOT COMPLETED|Overall Study||67
6312846|NCT00412087|7217063|FG000|STARTED|Overall Study||134
6312847|NCT00412087|7217064|FG001|STARTED|Overall Study||131
6312848|NCT00412087|7217063|FG000|COMPLETED|Overall Study||72
6312849|NCT00412087|7217064|FG001|COMPLETED|Overall Study||66
6312850|NCT00412087|7217063|FG000|NOT COMPLETED|Overall Study||62
6312851|NCT00412087|7217064|FG001|NOT COMPLETED|Overall Study||65
6312852|NCT00412113|7217072|FG000|STARTED|Overall Study|15-January-2007|123
6312853|NCT00412113|7217073|FG001|STARTED|Overall Study|15-January-2007|122
6375193|NCT00754247|7285793|FG000|COMPLETED|Overall Study||5
6773669|NCT03965533|7701362|FG004|NOT COMPLETED|Part A (112 Days)||0
6773670|NCT03965533|7701363|FG005|NOT COMPLETED|Part A (112 Days)||0
6773671|NCT03965533|7701364|FG006|NOT COMPLETED|Part A (112 Days)||0
6773672|NCT03965533|7701358|FG000|STARTED|Part B (112 Days)||0
6773673|NCT03965533|7701359|FG001|STARTED|Part B (112 Days)||0
6773674|NCT03965533|7701360|FG002|STARTED|Part B (112 Days)||0
6773675|NCT03965533|7701361|FG003|STARTED|Part B (112 Days)||0
6773676|NCT03965533|7701362|FG004|STARTED|Part B (112 Days)||4
6773677|NCT03965533|7701363|FG005|STARTED|Part B (112 Days)||8
6773678|NCT03965533|7701364|FG006|STARTED|Part B (112 Days)||8
6773679|NCT03965533|7701358|FG000|COMPLETED|Part B (112 Days)||0
6773680|NCT03965533|7701359|FG001|COMPLETED|Part B (112 Days)||0
6773681|NCT03965533|7701360|FG002|COMPLETED|Part B (112 Days)||0
6773682|NCT03965533|7701361|FG003|COMPLETED|Part B (112 Days)||0
6773683|NCT03965533|7701362|FG004|COMPLETED|Part B (112 Days)||4
6773684|NCT03965533|7701363|FG005|COMPLETED|Part B (112 Days)||8
6773685|NCT03965533|7701364|FG006|COMPLETED|Part B (112 Days)||8
6773686|NCT03965533|7701358|FG000|NOT COMPLETED|Part B (112 Days)||0
6773687|NCT03965533|7701359|FG001|NOT COMPLETED|Part B (112 Days)||0
6773688|NCT03965533|7701360|FG002|NOT COMPLETED|Part B (112 Days)||0
6773689|NCT03965533|7701361|FG003|NOT COMPLETED|Part B (112 Days)||0
6773690|NCT03965533|7701362|FG004|NOT COMPLETED|Part B (112 Days)||0
6773691|NCT03965533|7701363|FG005|NOT COMPLETED|Part B (112 Days)||0
6773692|NCT03965533|7701364|FG006|NOT COMPLETED|Part B (112 Days)||0
6773693|NCT03965351|7701387|FG000|STARTED|First Intervention (4 Weeks)||3
6773694|NCT03965351|7701388|FG001|STARTED|First Intervention (4 Weeks)||5
6773695|NCT03965351|7701387|FG000|COMPLETED|First Intervention (4 Weeks)||3
6773696|NCT03965351|7701388|FG001|COMPLETED|First Intervention (4 Weeks)||4
6773697|NCT03965351|7701387|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6773698|NCT03965351|7701388|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
6773699|NCT03965351|7701387|FG000|STARTED|Wash Out Period (4 Weeks)||3
6773700|NCT03965351|7701388|FG001|STARTED|Wash Out Period (4 Weeks)||4
6773701|NCT03965351|7701387|FG000|COMPLETED|Wash Out Period (4 Weeks)||3
6773702|NCT03965351|7701388|FG001|COMPLETED|Wash Out Period (4 Weeks)||4
6773703|NCT03965351|7701387|FG000|NOT COMPLETED|Wash Out Period (4 Weeks)||0
6773704|NCT03965351|7701388|FG001|NOT COMPLETED|Wash Out Period (4 Weeks)||0
6773705|NCT03965351|7701387|FG000|STARTED|Second Intervention (4 Weeks)||3
6773706|NCT03965351|7701388|FG001|STARTED|Second Intervention (4 Weeks)||4
6312854|NCT00412113|7217072|FG000|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
6312855|NCT00412113|7217073|FG001|Received Treatment|Overall Study||122
6312856|NCT00412113|7217072|FG000|COMPLETED|Overall Study|15-April-2008|111
6312857|NCT00412113|7217073|FG001|COMPLETED|Overall Study|15-April-2008|107
6312858|NCT00412113|7217072|FG000|NOT COMPLETED|Overall Study||12
6312859|NCT00412113|7217073|FG001|NOT COMPLETED|Overall Study||15
6312860|NCT00412217|7217081|FG000|STARTED|Overall Study||46
6312861|NCT00412217|7217082|FG001|STARTED|Overall Study||48
6312862|NCT00412217|7217081|FG000|COMPLETED|Overall Study||0
6312863|NCT00412217|7217082|FG001|COMPLETED|Overall Study||0
6312864|NCT00412217|7217081|FG000|NOT COMPLETED|Overall Study||46
6312865|NCT00412217|7217082|FG001|NOT COMPLETED|Overall Study||48
6312866|NCT00412243|7217088|FG000|STARTED|Overall Study||50
6312867|NCT00412243|7217088|FG000|COMPLETED|Overall Study||50
6312868|NCT00412243|7217088|FG000|NOT COMPLETED|Overall Study||0
6312869|NCT00412360|7217094|FG000|STARTED|Overall Study||113
6312870|NCT00412360|7217095|FG001|STARTED|Overall Study||111
6312871|NCT00412360|7217094|FG000|COMPLETED|Overall Study||112
6312872|NCT00412360|7217095|FG001|COMPLETED|Overall Study||108
6312873|NCT00412360|7217094|FG000|NOT COMPLETED|Overall Study||1
6312874|NCT00412360|7217095|FG001|NOT COMPLETED|Overall Study||3
6312875|NCT00412373|7217103|FG000|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
6312876|NCT00412373|7217104|FG001|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
6312877|NCT00412373|7217103|FG000|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
6312878|NCT00412373|7217104|FG001|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
6312879|NCT00412373|7217103|FG000|NOT COMPLETED|Overall Study||41
6312880|NCT00412373|7217104|FG001|NOT COMPLETED|Overall Study||77
6312881|NCT00412425|7217112|FG000|STARTED|Overall Study||15
6312882|NCT00412425|7217113|FG001|STARTED|Overall Study||15
6312883|NCT00412425|7217112|FG000|COMPLETED|Overall Study||15
6312884|NCT00412425|7217113|FG001|COMPLETED|Overall Study||15
6312885|NCT00412425|7217112|FG000|NOT COMPLETED|Overall Study||0
6312886|NCT00412425|7217113|FG001|NOT COMPLETED|Overall Study||0
6312887|NCT00412451|7217123|FG000|STARTED|Overall Study||8
6312888|NCT00412451|7217124|FG001|STARTED|Overall Study||15
6312889|NCT00412451|7217125|FG002|STARTED|Overall Study||15
6312890|NCT00412451|7217126|FG003|STARTED|Overall Study||13
6312891|NCT00412451|7217123|FG000|COMPLETED|Overall Study||8
6312892|NCT00412451|7217124|FG001|COMPLETED|Overall Study||15
6312893|NCT00412451|7217125|FG002|COMPLETED|Overall Study||14
6312894|NCT00412451|7217126|FG003|COMPLETED|Overall Study||11
6312895|NCT00412451|7217123|FG000|NOT COMPLETED|Overall Study||0
6312896|NCT00412451|7217124|FG001|NOT COMPLETED|Overall Study||0
6773707|NCT03965351|7701387|FG000|COMPLETED|Second Intervention (4 Weeks)||3
6773708|NCT03965351|7701388|FG001|COMPLETED|Second Intervention (4 Weeks)||3
6773709|NCT03965351|7701387|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6773710|NCT03965351|7701388|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
6773711|NCT03964220|7701396|FG000|STARTED|Overall Study||2619
6773712|NCT03964220|7701397|FG001|STARTED|Overall Study||5238
6773713|NCT03964220|7701396|FG000|COMPLETED|Overall Study||2619
6773714|NCT03964220|7701397|FG001|COMPLETED|Overall Study||5238
6773715|NCT03964220|7701396|FG000|NOT COMPLETED|Overall Study||0
6773716|NCT03964220|7701397|FG001|NOT COMPLETED|Overall Study||0
6773717|NCT03958955|7701403|FG000|STARTED|Overall Study||27
6773718|NCT03958955|7701403|FG000|Lesions Treated With Delgocitinib Cream|Overall Study||27
6773719|NCT03958955|7701403|FG000|Lesions Treated With Delgocitinib Cream Vehicle|Overall Study||27
6773720|NCT03958955|7701403|FG000|COMPLETED|Overall Study||26
6773721|NCT03958955|7701403|FG000|NOT COMPLETED|Overall Study||1
6773722|NCT03965052|7701411|FG000|STARTED|Overall Study||12
6773723|NCT03965052|7701412|FG001|STARTED|Overall Study||12
6773724|NCT03965052|7701411|FG000|COMPLETED|Overall Study||11
6773725|NCT03965052|7701412|FG001|COMPLETED|Overall Study||12
6773726|NCT03965052|7701411|FG000|NOT COMPLETED|Overall Study||1
6773727|NCT03965052|7701412|FG001|NOT COMPLETED|Overall Study||0
6773728|NCT03965039|7701422|FG000|STARTED|Overall Study||30
6773729|NCT03965039|7701423|FG001|STARTED|Overall Study||30
6773730|NCT03965039|7701424|FG002|STARTED|Overall Study||30
6773731|NCT03965039|7701425|FG003|STARTED|Overall Study||30
6773732|NCT03965039|7701422|FG000|COMPLETED|Overall Study||30
6773733|NCT03965039|7701423|FG001|COMPLETED|Overall Study||29
6773734|NCT03965039|7701424|FG002|COMPLETED|Overall Study||30
6773735|NCT03965039|7701425|FG003|COMPLETED|Overall Study||29
6312897|NCT00412451|7217125|FG002|NOT COMPLETED|Overall Study||1
6312898|NCT00412451|7217126|FG003|NOT COMPLETED|Overall Study||2
6312899|NCT00412464|7217136|FG000|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
6312900|NCT00412464|7217136|FG000|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
6312901|NCT00412464|7217136|FG000|NOT COMPLETED|Overall Study||0
6312902|NCT00412516|7217143|FG000|STARTED|Overall Study||93
6312903|NCT00412516|7217144|FG001|STARTED|Overall Study||212
6312904|NCT00412516|7217145|FG002|STARTED|Overall Study||214
6312905|NCT00412516|7217143|FG000|COMPLETED|Overall Study||93
6312906|NCT00412516|7217144|FG001|COMPLETED|Overall Study||212
6312907|NCT00412516|7217145|FG002|COMPLETED|Overall Study||214
6773736|NCT03965039|7701422|FG000|NOT COMPLETED|Overall Study||0
6773737|NCT03965039|7701423|FG001|NOT COMPLETED|Overall Study||1
6773738|NCT03965039|7701424|FG002|NOT COMPLETED|Overall Study||0
6773739|NCT03965039|7701425|FG003|NOT COMPLETED|Overall Study||1
6312908|NCT00412516|7217143|FG000|NOT COMPLETED|Overall Study||0
6312909|NCT00412516|7217144|FG001|NOT COMPLETED|Overall Study||0
6312910|NCT00412516|7217145|FG002|NOT COMPLETED|Overall Study||0
6312911|NCT00412529|7217155|FG000|STARTED|Overall Study||23
6312912|NCT00412529|7217156|FG001|STARTED|Overall Study||21
6312913|NCT00412529|7217155|FG000|COMPLETED|Overall Study||23
6312914|NCT00412529|7217156|FG001|COMPLETED|Overall Study||21
6312915|NCT00412529|7217155|FG000|NOT COMPLETED|Overall Study||0
6312916|NCT00412529|7217156|FG001|NOT COMPLETED|Overall Study||0
6312917|NCT00412542|7217164|FG000|STARTED|Overall Study||33
6312918|NCT00412542|7217165|FG001|STARTED|Overall Study||45
6312919|NCT00412542|7217164|FG000|COMPLETED|Overall Study||33
6312920|NCT00412542|7217165|FG001|COMPLETED|Overall Study||42
6312921|NCT00412542|7217164|FG000|NOT COMPLETED|Overall Study||0
6312922|NCT00412542|7217165|FG001|NOT COMPLETED|Overall Study||3
6312923|NCT00412607|7217169|FG000|STARTED|Overall Study||249
6312924|NCT00412607|7217169|FG000|Started Study Catheter|Overall Study||233
6312925|NCT00412607|7217169|FG000|COMPLETED|Overall Study||145
6312926|NCT00412607|7217169|FG000|NOT COMPLETED|Overall Study||104
6312927|NCT00412737|7217178|FG000|STARTED|Overall Study||237
6312928|NCT00412737|7217179|FG001|STARTED|Overall Study||238
6312929|NCT00412737|7217178|FG000|COMPLETED|Overall Study||221
6312930|NCT00412737|7217179|FG001|COMPLETED|Overall Study||232
6312931|NCT00412737|7217178|FG000|NOT COMPLETED|Overall Study||16
6312932|NCT00412737|7217179|FG001|NOT COMPLETED|Overall Study||6
6312933|NCT00412750|7217188|FG000|STARTED|Overall Study||50
6312934|NCT00412750|7217189|FG001|STARTED|Overall Study||55
6312935|NCT00412750|7217190|FG002|STARTED|Overall Study||54
6312936|NCT00412750|7217188|FG000|COMPLETED|Overall Study||19
6312937|NCT00412750|7217189|FG001|COMPLETED|Overall Study||34
6312938|NCT00412750|7217190|FG002|COMPLETED|Overall Study||31
6312939|NCT00412750|7217188|FG000|NOT COMPLETED|Overall Study||31
6312940|NCT00412750|7217189|FG001|NOT COMPLETED|Overall Study||21
6312941|NCT00412750|7217190|FG002|NOT COMPLETED|Overall Study||23
6312942|NCT00412841|7217202|FG000|STARTED|Overall Study||22
6312943|NCT00412841|7217203|FG001|STARTED|Overall Study||21
6312944|NCT00412841|7217202|FG000|COMPLETED|Overall Study||12
6312945|NCT00412841|7217203|FG001|COMPLETED|Overall Study||16
6312946|NCT00412841|7217202|FG000|NOT COMPLETED|Overall Study||10
6312947|NCT00412841|7217203|FG001|NOT COMPLETED|Overall Study||5
6312948|NCT00412854|7217212|FG000|STARTED|Overall Study||330
6312949|NCT00412854|7217213|FG001|STARTED|Overall Study||330
6312950|NCT00412854|7217212|FG000|COMPLETED|Overall Study||316
6312951|NCT00412854|7217213|FG001|COMPLETED|Overall Study||314
6312952|NCT00412854|7217212|FG000|NOT COMPLETED|Overall Study||14
6312953|NCT00412854|7217213|FG001|NOT COMPLETED|Overall Study||16
6312954|NCT00412867|7217219|FG000|STARTED|Overall Study||58
6312955|NCT00412867|7217219|FG000|COMPLETED|Overall Study||58
6312956|NCT00412867|7217219|FG000|NOT COMPLETED|Overall Study||0
6312957|NCT00412893|7217226|FG000|STARTED|Overall Study||263
6773740|NCT03963401|7701441|FG000|STARTED|Initial Period (Day 1 - Week 16)||60
6773741|NCT03963401|7701442|FG001|STARTED|Initial Period (Day 1 - Week 16)||61
6773742|NCT03963401|7701443|FG002|STARTED|Initial Period (Day 1 - Week 16)||16
6773743|NCT03963401|7701444|FG003|STARTED|Initial Period (Day 1 - Week 16)||15
6773744|NCT03963401|7701445|FG004|STARTED|Initial Period (Day 1 - Week 16)||34
6773745|NCT03963401|7701446|FG005|STARTED|Initial Period (Day 1 - Week 16)||33
6773746|NCT03963401|7701441|FG000|Treated|Initial Period (Day 1 - Week 16)||60
6773747|NCT03963401|7701442|FG001|Treated|Initial Period (Day 1 - Week 16)||60
6773748|NCT03963401|7701443|FG002|Treated|Initial Period (Day 1 - Week 16)||16
6773749|NCT03963401|7701444|FG003|Treated|Initial Period (Day 1 - Week 16)||15
6773750|NCT03963401|7701445|FG004|Treated|Initial Period (Day 1 - Week 16)||34
6773751|NCT03963401|7701446|FG005|Treated|Initial Period (Day 1 - Week 16)||33
6773752|NCT03963401|7701441|FG000|COMPLETED|Initial Period (Day 1 - Week 16)||57
6773753|NCT03963401|7701442|FG001|COMPLETED|Initial Period (Day 1 - Week 16)||57
6773754|NCT03963401|7701443|FG002|COMPLETED|Initial Period (Day 1 - Week 16)||14
6773755|NCT03963401|7701444|FG003|COMPLETED|Initial Period (Day 1 - Week 16)||13
6773756|NCT03963401|7701445|FG004|COMPLETED|Initial Period (Day 1 - Week 16)||31
6773757|NCT03963401|7701446|FG005|COMPLETED|Initial Period (Day 1 - Week 16)||31
6773758|NCT03963401|7701441|FG000|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
6773759|NCT03963401|7701442|FG001|NOT COMPLETED|Initial Period (Day 1 - Week 16)||4
6773760|NCT03963401|7701443|FG002|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
6773761|NCT03963401|7701444|FG003|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
6773762|NCT03963401|7701445|FG004|NOT COMPLETED|Initial Period (Day 1 - Week 16)||3
6773763|NCT03963401|7701446|FG005|NOT COMPLETED|Initial Period (Day 1 - Week 16)||2
6773764|NCT03963401|7701441|FG000|STARTED|Extension Period (Week 17 - Week 52)||57
6773765|NCT03963401|7701442|FG001|STARTED|Extension Period (Week 17 - Week 52)||57
6773766|NCT03963401|7701443|FG002|STARTED|Extension Period (Week 17 - Week 52)||14
6773767|NCT03963401|7701444|FG003|STARTED|Extension Period (Week 17 - Week 52)||13
6312958|NCT00412893|7217227|FG001|STARTED|Overall Study||264
6312959|NCT00412893|7217226|FG000|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
6312960|NCT00412893|7217227|FG001|Received Treatment|Overall Study||258
6312961|NCT00412893|7217226|FG000|COMPLETED|Overall Study|Defined as completed treatment|118
6312962|NCT00412893|7217227|FG001|COMPLETED|Overall Study|Defined as completed treatment|120
6773768|NCT03963401|7701445|FG004|STARTED|Extension Period (Week 17 - Week 52)||31
6312963|NCT00412893|7217226|FG000|NOT COMPLETED|Overall Study||145
6312964|NCT00412893|7217227|FG001|NOT COMPLETED|Overall Study||144
6312965|NCT00412958|7217237|FG000|STARTED|Overall Study||29
6312966|NCT00412958|7217238|FG001|STARTED|Overall Study||33
6312967|NCT00412958|7217239|FG002|STARTED|Overall Study||32
6312968|NCT00412958|7217240|FG003|STARTED|Overall Study||31
6312969|NCT00412958|7217237|FG000|COMPLETED|Overall Study||26
6312970|NCT00412958|7217238|FG001|COMPLETED|Overall Study||29
6312971|NCT00412958|7217239|FG002|COMPLETED|Overall Study||32
6312972|NCT00412958|7217240|FG003|COMPLETED|Overall Study||30
6312973|NCT00412958|7217237|FG000|NOT COMPLETED|Overall Study||3
6312974|NCT00412958|7217238|FG001|NOT COMPLETED|Overall Study||4
6312975|NCT00412958|7217239|FG002|NOT COMPLETED|Overall Study||0
6312976|NCT00412958|7217240|FG003|NOT COMPLETED|Overall Study||1
6312977|NCT00412971|7217252|FG000|STARTED|Overall Study||115
6312978|NCT00412971|7217253|FG001|STARTED|Overall Study||118
6312979|NCT00412971|7217252|FG000|COMPLETED|Overall Study||85
6312980|NCT00412971|7217253|FG001|COMPLETED|Overall Study||108
6312981|NCT00412971|7217252|FG000|NOT COMPLETED|Overall Study||30
6312982|NCT00412971|7217253|FG001|NOT COMPLETED|Overall Study||10
6312983|NCT00412984|7217261|FG000|STARTED|Overall Study|Randomized participants|9120
6312984|NCT00412984|7217262|FG001|STARTED|Overall Study|Randomized participants|9081
6312985|NCT00412984|7217261|FG000|COMPLETED|Overall Study||6810
6312986|NCT00412984|7217262|FG001|COMPLETED|Overall Study||6588
6312987|NCT00412984|7217261|FG000|NOT COMPLETED|Overall Study||2310
6312988|NCT00412984|7217262|FG001|NOT COMPLETED|Overall Study||2493
6312989|NCT00413010|7217270|FG000|STARTED|Overall Study||180
6312990|NCT00413010|7217271|FG001|STARTED|Overall Study||176
6312991|NCT00413010|7217270|FG000|COMPLETED|Overall Study||108
6312992|NCT00413010|7217271|FG001|COMPLETED|Overall Study||113
6312993|NCT00413010|7217270|FG000|NOT COMPLETED|Overall Study||72
6312994|NCT00413010|7217271|FG001|NOT COMPLETED|Overall Study||63
6312995|NCT00413036|7217277|FG000|STARTED|Overall Study||217
6312996|NCT00413036|7217277|FG000|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
6312997|NCT00413036|7217277|FG000|NOT COMPLETED|Overall Study||217
6312998|NCT00413049|7217283|FG000|STARTED|Overall Study||349
6312999|NCT00413049|7217284|FG001|STARTED|Overall Study||349
6313000|NCT00413049|7217283|FG000|COMPLETED|Overall Study||325
6313001|NCT00413049|7217284|FG001|COMPLETED|Overall Study||331
6313002|NCT00413049|7217283|FG000|NOT COMPLETED|Overall Study||24
6313003|NCT00413049|7217284|FG001|NOT COMPLETED|Overall Study||18
6313004|NCT00413153|7217292|FG000|STARTED|Overall Study||7
6313005|NCT00413153|7217293|FG001|STARTED|Overall Study||8
6313006|NCT00413153|7217292|FG000|COMPLETED|Overall Study||5
6313007|NCT00413153|7217293|FG001|COMPLETED|Overall Study||7
6313008|NCT00413153|7217292|FG000|NOT COMPLETED|Overall Study||2
6313009|NCT00413153|7217293|FG001|NOT COMPLETED|Overall Study||1
6313010|NCT00413166|7217302|FG000|STARTED|Overall Study||57
6313011|NCT00413166|7217303|FG001|STARTED|Overall Study||5
6313012|NCT00413166|7217304|FG002|STARTED|Overall Study||16
6313013|NCT00413166|7217302|FG000|COMPLETED|Overall Study||57
6313014|NCT00413166|7217303|FG001|COMPLETED|Overall Study||5
6313015|NCT00413166|7217304|FG002|COMPLETED|Overall Study||16
6313016|NCT00413166|7217302|FG000|NOT COMPLETED|Overall Study||0
6313017|NCT00413166|7217303|FG001|NOT COMPLETED|Overall Study||0
6313018|NCT00413166|7217304|FG002|NOT COMPLETED|Overall Study||0
6313019|NCT00413192|7217316|FG000|STARTED|Overall Study||37
6313020|NCT00413192|7217317|FG001|STARTED|Overall Study||40
6313021|NCT00413192|7217318|FG002|STARTED|Overall Study||19
6313022|NCT00413192|7217319|FG003|STARTED|Overall Study||32
6313023|NCT00413192|7217316|FG000|COMPLETED|Overall Study||0
6313024|NCT00413192|7217317|FG001|COMPLETED|Overall Study||0
6313025|NCT00413192|7217318|FG002|COMPLETED|Overall Study||0
6313026|NCT00413192|7217319|FG003|COMPLETED|Overall Study||0
6313027|NCT00413192|7217316|FG000|NOT COMPLETED|Overall Study||37
6313028|NCT00413192|7217317|FG001|NOT COMPLETED|Overall Study||40
6313029|NCT00413192|7217318|FG002|NOT COMPLETED|Overall Study||19
6313030|NCT00413192|7217319|FG003|NOT COMPLETED|Overall Study||32
6313031|NCT00413218|7217331|FG000|STARTED|Overall Study||223
6313032|NCT00413218|7217332|FG001|STARTED|Overall Study||227
6313033|NCT00413218|7217331|FG000|Intent to Treat Population (ITT)|Overall Study||221
6313034|NCT00413218|7217332|FG001|Intent to Treat Population (ITT)|Overall Study||219
6313035|NCT00413218|7217331|FG000|COMPLETED|Overall Study||120
6313036|NCT00413218|7217332|FG001|COMPLETED|Overall Study||131
6313037|NCT00413218|7217331|FG000|NOT COMPLETED|Overall Study||103
6313038|NCT00413218|7217332|FG001|NOT COMPLETED|Overall Study||96
6313039|NCT00413231|7217339|FG000|STARTED|0 to 30-day Post Treatment||160
6313040|NCT00413231|7217339|FG000|COMPLETED|0 to 30-day Post Treatment||152
6313041|NCT00413231|7217339|FG000|NOT COMPLETED|0 to 30-day Post Treatment||8
6313042|NCT00413231|7217339|FG000|STARTED|30-day to 365-day Post Treatment||152
6313043|NCT00413231|7217339|FG000|COMPLETED|30-day to 365-day Post Treatment||139
6313044|NCT00413231|7217339|FG000|NOT COMPLETED|30-day to 365-day Post Treatment||13
6313045|NCT00413231|7217339|FG000|STARTED|365-day to 60-month Post Treatment||139
6313046|NCT00413231|7217339|FG000|COMPLETED|365-day to 60-month Post Treatment||93
6313047|NCT00413231|7217339|FG000|NOT COMPLETED|365-day to 60-month Post Treatment||46
6313048|NCT00413244|7217346|FG000|STARTED|Overall Study||31
6313049|NCT00413244|7217347|FG001|STARTED|Overall Study||20
6313050|NCT00413244|7217346|FG000|COMPLETED|Overall Study||21
6313051|NCT00413244|7217347|FG001|COMPLETED|Overall Study||19
6313052|NCT00413244|7217346|FG000|NOT COMPLETED|Overall Study||10
6313053|NCT00413244|7217347|FG001|NOT COMPLETED|Overall Study||1
6313054|NCT00413283|7217357|FG000|STARTED|Overall Study||12
6313055|NCT00413283|7217358|FG001|STARTED|Overall Study||16
6313056|NCT00413283|7217359|FG002|STARTED|Overall Study||18
6313057|NCT00413283|7217360|FG003|STARTED|Overall Study||17
6313058|NCT00413283|7217357|FG000|Received Study Drug|Overall Study||12
6313059|NCT00413283|7217358|FG001|Received Study Drug|Overall Study||16
6313060|NCT00413283|7217359|FG002|Received Study Drug|Overall Study||18
6313061|NCT00413283|7217360|FG003|Received Study Drug|Overall Study||16
6313062|NCT00413283|7217357|FG000|COMPLETED|Overall Study||11
6313063|NCT00413283|7217358|FG001|COMPLETED|Overall Study||13
6313064|NCT00413283|7217359|FG002|COMPLETED|Overall Study||16
6313065|NCT00413283|7217360|FG003|COMPLETED|Overall Study||13
6313066|NCT00413283|7217357|FG000|NOT COMPLETED|Overall Study||1
6313067|NCT00413283|7217358|FG001|NOT COMPLETED|Overall Study||3
6313068|NCT00413283|7217359|FG002|NOT COMPLETED|Overall Study||2
6313069|NCT00413283|7217360|FG003|NOT COMPLETED|Overall Study||4
6313070|NCT00413335|7217372|FG000|STARTED|Overall Study||12
6313071|NCT00413335|7217373|FG001|STARTED|Overall Study||9
6313072|NCT00413335|7217372|FG000|COMPLETED|Overall Study||12
6313073|NCT00413335|7217373|FG001|COMPLETED|Overall Study||9
6313074|NCT00413335|7217372|FG000|NOT COMPLETED|Overall Study||0
6313075|NCT00413335|7217373|FG001|NOT COMPLETED|Overall Study||0
6313076|NCT00413374|7217381|FG000|STARTED|Overall Study||40
6313077|NCT00413374|7217382|FG001|STARTED|Overall Study||80
6313078|NCT00413374|7217381|FG000|COMPLETED|Overall Study||34
6313079|NCT00413374|7217382|FG001|COMPLETED|Overall Study||80
6313080|NCT00413374|7217381|FG000|NOT COMPLETED|Overall Study||6
6313081|NCT00413374|7217382|FG001|NOT COMPLETED|Overall Study||0
6313082|NCT00413400|7217393|FG000|STARTED|Overall Study||24
6313083|NCT00413400|7217394|FG001|STARTED|Overall Study||16
6313084|NCT00413400|7217393|FG000|3 Month Visit|Overall Study||22
6313085|NCT00413400|7217394|FG001|3 Month Visit|Overall Study||12
6313086|NCT00413400|7217393|FG000|COMPLETED|Overall Study||22
6313087|NCT00413400|7217394|FG001|COMPLETED|Overall Study||12
6313088|NCT00413400|7217393|FG000|NOT COMPLETED|Overall Study||2
6313089|NCT00413400|7217394|FG001|NOT COMPLETED|Overall Study||4
6557668|NCT01769326|7480239|FG001|STARTED|Overall Study||12
6557669|NCT01769326|7480240|FG002|STARTED|Overall Study||9
6313090|NCT00413413|7217403|FG000|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
6313091|NCT00413413|7217404|FG001|STARTED|Single-Blind||1134
6313092|NCT00413413|7217405|FG002|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
6313093|NCT00413413|7217403|FG000|COMPLETED|Single-Blind||0
6313094|NCT00413413|7217404|FG001|COMPLETED|Single-Blind||918
6313095|NCT00413413|7217405|FG002|COMPLETED|Single-Blind||0
6313096|NCT00413413|7217403|FG000|NOT COMPLETED|Single-Blind||0
6313097|NCT00413413|7217404|FG001|NOT COMPLETED|Single-Blind||216
6313098|NCT00413413|7217405|FG002|NOT COMPLETED|Single-Blind||0
6313099|NCT00413413|7217403|FG000|STARTED|Double-Blind||308
6313100|NCT00413413|7217404|FG001|STARTED|Double-Blind||307
6313101|NCT00413413|7217405|FG002|STARTED|Double-Blind||303
6313102|NCT00413413|7217403|FG000|COMPLETED|Double-Blind||293
6313103|NCT00413413|7217404|FG001|COMPLETED|Double-Blind||293
6313104|NCT00413413|7217405|FG002|COMPLETED|Double-Blind||285
6313105|NCT00413413|7217403|FG000|NOT COMPLETED|Double-Blind||15
6313106|NCT00413413|7217404|FG001|NOT COMPLETED|Double-Blind||14
6313107|NCT00413413|7217405|FG002|NOT COMPLETED|Double-Blind||18
6313108|NCT00413478|7217413|FG000|STARTED|Overall Study||9
6313109|NCT00413478|7217413|FG000|COMPLETED|Overall Study||9
6313110|NCT00413478|7217413|FG000|NOT COMPLETED|Overall Study||0
6313111|NCT00413582|7217419|FG000|STARTED|Overall Study|all enrolled completed|55
6313112|NCT00413582|7217420|FG001|STARTED|Overall Study|all enrolled completed|55
6313113|NCT00413582|7217419|FG000|Completion of Study|Overall Study|all enrolled completed|55
6313114|NCT00413582|7217420|FG001|Completion of Study|Overall Study|all enrolled completed|55
6313115|NCT00413582|7217419|FG000|COMPLETED|Overall Study|all enrolled completed|55
6313116|NCT00413582|7217420|FG001|COMPLETED|Overall Study|all enrolled completed|55
6313117|NCT00413582|7217419|FG000|NOT COMPLETED|Overall Study||0
6313118|NCT00413582|7217420|FG001|NOT COMPLETED|Overall Study||0
6313119|NCT00413634|7217428|FG000|STARTED|Overall Study||12
6313120|NCT00413634|7217429|FG001|STARTED|Overall Study||12
6313121|NCT00413634|7217428|FG000|COMPLETED|Overall Study||12
6313122|NCT00413634|7217429|FG001|COMPLETED|Overall Study||12
6313123|NCT00413634|7217428|FG000|NOT COMPLETED|Overall Study||0
6313124|NCT00413634|7217429|FG001|NOT COMPLETED|Overall Study||0
6313125|NCT00413660|7217444|FG000|STARTED|Up To Week 12||71
6557670|NCT01769326|7480241|FG003|STARTED|Overall Study||8
6313126|NCT00413660|7217445|FG001|STARTED|Up To Week 12||68
6313127|NCT00413660|7217446|FG002|STARTED|Up To Week 12||71
6313128|NCT00413660|7217447|FG003|STARTED|Up To Week 12||75
6313129|NCT00413660|7217448|FG004|STARTED|Up To Week 12||75
6313130|NCT00413660|7217449|FG005|STARTED|Up To Week 12||80
6313131|NCT00413660|7217450|FG006|STARTED|Up To Week 12||69
6313132|NCT00413660|7217451|FG007|STARTED|Up To Week 12||0
6313133|NCT00413660|7217452|FG008|STARTED|Up To Week 12||0
6313134|NCT00413660|7217453|FG009|STARTED|Up To Week 12||0
6313135|NCT00413660|7217454|FG010|STARTED|Up To Week 12||0
6313136|NCT00413660|7217444|FG000|Treated|Up To Week 12||70
6313137|NCT00413660|7217445|FG001|Treated|Up To Week 12||68
6313138|NCT00413660|7217446|FG002|Treated|Up To Week 12||71
6557671|NCT01769326|7480238|FG000|COMPLETED|Overall Study||9
6313139|NCT00413660|7217447|FG003|Treated|Up To Week 12||74
6313140|NCT00413660|7217448|FG004|Treated|Up To Week 12||75
6313141|NCT00413660|7217449|FG005|Treated|Up To Week 12||80
6313142|NCT00413660|7217450|FG006|Treated|Up To Week 12||69
6313143|NCT00413660|7217451|FG007|Treated|Up To Week 12||0
6313144|NCT00413660|7217452|FG008|Treated|Up To Week 12||0
6313145|NCT00413660|7217453|FG009|Treated|Up To Week 12||0
6313146|NCT00413660|7217454|FG010|Treated|Up To Week 12||0
6313147|NCT00413660|7217444|FG000|COMPLETED|Up To Week 12||64
6313148|NCT00413660|7217445|FG001|COMPLETED|Up To Week 12||61
6313149|NCT00413660|7217446|FG002|COMPLETED|Up To Week 12||64
6313150|NCT00413660|7217447|FG003|COMPLETED|Up To Week 12||67
6313151|NCT00413660|7217448|FG004|COMPLETED|Up To Week 12||66
6313152|NCT00413660|7217449|FG005|COMPLETED|Up To Week 12||70
6313153|NCT00413660|7217450|FG006|COMPLETED|Up To Week 12||58
6313154|NCT00413660|7217451|FG007|COMPLETED|Up To Week 12||0
6313155|NCT00413660|7217452|FG008|COMPLETED|Up To Week 12||0
6313156|NCT00413660|7217453|FG009|COMPLETED|Up To Week 12||0
6313157|NCT00413660|7217454|FG010|COMPLETED|Up To Week 12||0
6313158|NCT00413660|7217444|FG000|NOT COMPLETED|Up To Week 12||7
6313159|NCT00413660|7217445|FG001|NOT COMPLETED|Up To Week 12||7
6313160|NCT00413660|7217446|FG002|NOT COMPLETED|Up To Week 12||7
6313161|NCT00413660|7217447|FG003|NOT COMPLETED|Up To Week 12||8
6313162|NCT00413660|7217448|FG004|NOT COMPLETED|Up To Week 12||9
6313163|NCT00413660|7217449|FG005|NOT COMPLETED|Up To Week 12||10
6313164|NCT00413660|7217450|FG006|NOT COMPLETED|Up To Week 12||11
6313165|NCT00413660|7217451|FG007|NOT COMPLETED|Up To Week 12||0
6313166|NCT00413660|7217452|FG008|NOT COMPLETED|Up To Week 12||0
6313167|NCT00413660|7217453|FG009|NOT COMPLETED|Up To Week 12||0
6313168|NCT00413660|7217454|FG010|NOT COMPLETED|Up To Week 12||0
6313169|NCT00413660|7217444|FG000|STARTED|Post Week 12||43
6313170|NCT00413660|7217445|FG001|STARTED|Post Week 12||48
6313171|NCT00413660|7217446|FG002|STARTED|Post Week 12||64
6313172|NCT00413660|7217447|FG003|STARTED|Post Week 12||67
6313173|NCT00413660|7217448|FG004|STARTED|Post Week 12||66
6313174|NCT00413660|7217449|FG005|STARTED|Post Week 12||57
6313175|NCT00413660|7217450|FG006|STARTED|Post Week 12||40
6313176|NCT00413660|7217451|FG007|STARTED|Post Week 12||21
6313177|NCT00413660|7217452|FG008|STARTED|Post Week 12||13
6313178|NCT00413660|7217453|FG009|STARTED|Post Week 12||13
6313179|NCT00413660|7217454|FG010|STARTED|Post Week 12||18
6313180|NCT00413660|7217444|FG000|COMPLETED|Post Week 12||40
6313181|NCT00413660|7217445|FG001|COMPLETED|Post Week 12||44
6313182|NCT00413660|7217446|FG002|COMPLETED|Post Week 12||56
6313183|NCT00413660|7217447|FG003|COMPLETED|Post Week 12||66
6313184|NCT00413660|7217448|FG004|COMPLETED|Post Week 12||60
6313185|NCT00413660|7217449|FG005|COMPLETED|Post Week 12||54
6313186|NCT00413660|7217450|FG006|COMPLETED|Post Week 12||37
6313187|NCT00413660|7217451|FG007|COMPLETED|Post Week 12||21
6313188|NCT00413660|7217452|FG008|COMPLETED|Post Week 12||13
6313189|NCT00413660|7217453|FG009|COMPLETED|Post Week 12||12
6313190|NCT00413660|7217454|FG010|COMPLETED|Post Week 12||17
6313191|NCT00413660|7217444|FG000|NOT COMPLETED|Post Week 12||3
6313192|NCT00413660|7217445|FG001|NOT COMPLETED|Post Week 12||4
6313193|NCT00413660|7217446|FG002|NOT COMPLETED|Post Week 12||8
6313194|NCT00413660|7217447|FG003|NOT COMPLETED|Post Week 12||1
6313195|NCT00413660|7217448|FG004|NOT COMPLETED|Post Week 12||6
6313196|NCT00413660|7217449|FG005|NOT COMPLETED|Post Week 12||3
6313197|NCT00413660|7217450|FG006|NOT COMPLETED|Post Week 12||3
6773769|NCT03963401|7701446|FG005|STARTED|Extension Period (Week 17 - Week 52)||31
6773770|NCT03963401|7701441|FG000|COMPLETED|Extension Period (Week 17 - Week 52)||43
6773771|NCT03963401|7701442|FG001|COMPLETED|Extension Period (Week 17 - Week 52)||52
6773772|NCT03963401|7701443|FG002|COMPLETED|Extension Period (Week 17 - Week 52)||10
6773773|NCT03963401|7701444|FG003|COMPLETED|Extension Period (Week 17 - Week 52)||12
6773774|NCT03963401|7701445|FG004|COMPLETED|Extension Period (Week 17 - Week 52)||25
6773775|NCT03963401|7701446|FG005|COMPLETED|Extension Period (Week 17 - Week 52)||26
6773776|NCT03963401|7701441|FG000|NOT COMPLETED|Extension Period (Week 17 - Week 52)||14
6773777|NCT03963401|7701442|FG001|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
6773778|NCT03963401|7701443|FG002|NOT COMPLETED|Extension Period (Week 17 - Week 52)||4
6773779|NCT03963401|7701444|FG003|NOT COMPLETED|Extension Period (Week 17 - Week 52)||1
6773780|NCT03963401|7701445|FG004|NOT COMPLETED|Extension Period (Week 17 - Week 52)||6
6773781|NCT03963401|7701446|FG005|NOT COMPLETED|Extension Period (Week 17 - Week 52)||5
6773782|NCT03962634|7701466|FG000|STARTED|Overall Study||1
6773783|NCT03962634|7701467|FG001|STARTED|Overall Study||2
6773784|NCT03962634|7701466|FG000|COMPLETED|Overall Study||1
6773785|NCT03962634|7701467|FG001|COMPLETED|Overall Study||2
6773786|NCT03962634|7701466|FG000|NOT COMPLETED|Overall Study||0
6773787|NCT03962634|7701467|FG001|NOT COMPLETED|Overall Study||0
6773788|NCT03962790|7701473|FG000|STARTED|Period 1||48
6773789|NCT03962790|7701474|FG001|STARTED|Period 1||46
6773790|NCT03962790|7701473|FG000|COMPLETED|Period 1||45
6773791|NCT03962790|7701474|FG001|COMPLETED|Period 1||44
6313198|NCT00413660|7217451|FG007|NOT COMPLETED|Post Week 12||0
6773792|NCT03962790|7701473|FG000|NOT COMPLETED|Period 1||3
6313199|NCT00413660|7217452|FG008|NOT COMPLETED|Post Week 12||0
6313200|NCT00413660|7217453|FG009|NOT COMPLETED|Post Week 12||1
6313201|NCT00413660|7217454|FG010|NOT COMPLETED|Post Week 12||1
6313202|NCT00413777|7217486|FG000|STARTED|Fixed-dose Period||22
6313203|NCT00413777|7217487|FG001|STARTED|Fixed-dose Period||24
6313204|NCT00413777|7217486|FG000|COMPLETED|Fixed-dose Period||18
6313205|NCT00413777|7217487|FG001|COMPLETED|Fixed-dose Period||21
6313206|NCT00413777|7217486|FG000|NOT COMPLETED|Fixed-dose Period||4
6313207|NCT00413777|7217487|FG001|NOT COMPLETED|Fixed-dose Period||3
6313208|NCT00413777|7217486|FG000|STARTED|Extension Period||17
6313209|NCT00413777|7217487|FG001|STARTED|Extension Period||18
6313210|NCT00413777|7217486|FG000|COMPLETED|Extension Period||17
6313211|NCT00413777|7217487|FG001|COMPLETED|Extension Period||18
6313212|NCT00413777|7217486|FG000|NOT COMPLETED|Extension Period||0
6313213|NCT00413777|7217487|FG001|NOT COMPLETED|Extension Period||0
6313214|NCT00413894|7217493|FG000|STARTED|Overall Study||424
6313215|NCT00413894|7217493|FG000|COMPLETED|Overall Study||344
6313216|NCT00413894|7217493|FG000|NOT COMPLETED|Overall Study||80
6313217|NCT00413920|7217502|FG000|STARTED|Overall Study||112
6313218|NCT00413920|7217503|FG001|STARTED|Overall Study||110
6313219|NCT00413920|7217502|FG000|COMPLETED|Overall Study||84
6313220|NCT00413920|7217503|FG001|COMPLETED|Overall Study||82
6313221|NCT00413920|7217502|FG000|NOT COMPLETED|Overall Study||28
6313222|NCT00413920|7217503|FG001|NOT COMPLETED|Overall Study||28
6313223|NCT00413959|7217509|FG000|STARTED|Overall Study||12
6313224|NCT00413959|7217509|FG000|COMPLETED|Overall Study||11
6313225|NCT00413959|7217509|FG000|NOT COMPLETED|Overall Study||1
6313226|NCT00414011|7217513|FG000|STARTED|Overall Study||40
6313227|NCT00414011|7217513|FG000|COMPLETED|Overall Study||35
6313228|NCT00414011|7217513|FG000|NOT COMPLETED|Overall Study||5
6313229|NCT00414050|7217522|FG000|STARTED|Overall Study||431
6773793|NCT03962790|7701474|FG001|NOT COMPLETED|Period 1||2
6773794|NCT03962790|7701473|FG000|STARTED|Period 2||45
6773795|NCT03962790|7701474|FG001|STARTED|Period 2||44
6773796|NCT03962790|7701473|FG000|COMPLETED|Period 2||45
6773797|NCT03962790|7701474|FG001|COMPLETED|Period 2||44
6773798|NCT03962790|7701473|FG000|NOT COMPLETED|Period 2||0
6773799|NCT03962790|7701474|FG001|NOT COMPLETED|Period 2||0
6773800|NCT03956225|7701482|FG000|STARTED|Overall Study||119
6773801|NCT03956225|7701483|FG001|STARTED|Overall Study||117
6773802|NCT03956225|7701482|FG000|COMPLETED|Overall Study||114
6773803|NCT03956225|7701483|FG001|COMPLETED|Overall Study||113
6773804|NCT03956225|7701482|FG000|NOT COMPLETED|Overall Study||5
6773805|NCT03956225|7701483|FG001|NOT COMPLETED|Overall Study||4
6773806|NCT03951610|7701492|FG000|STARTED|First Intervention||27
6773807|NCT03951610|7701493|FG001|STARTED|First Intervention||25
6773808|NCT03951610|7701492|FG000|COMPLETED|First Intervention||27
6773809|NCT03951610|7701493|FG001|COMPLETED|First Intervention||25
6773810|NCT03951610|7701492|FG000|NOT COMPLETED|First Intervention||0
6773811|NCT03951610|7701493|FG001|NOT COMPLETED|First Intervention||0
6773812|NCT03951610|7701492|FG000|STARTED|Second Intervention||27
6773813|NCT03951610|7701493|FG001|STARTED|Second Intervention||25
6773814|NCT03951610|7701492|FG000|COMPLETED|Second Intervention||27
6773815|NCT03951610|7701493|FG001|COMPLETED|Second Intervention||25
6773816|NCT03951610|7701492|FG000|NOT COMPLETED|Second Intervention||0
6773817|NCT03951610|7701493|FG001|NOT COMPLETED|Second Intervention||0
6773818|NCT03958149|7701501|FG000|STARTED|Overall Study||20
6773819|NCT03958149|7701502|FG001|STARTED|Overall Study||18
6773820|NCT03958149|7701501|FG000|COMPLETED|Overall Study||20
6773821|NCT03958149|7701502|FG001|COMPLETED|Overall Study||17
6773822|NCT03958149|7701501|FG000|NOT COMPLETED|Overall Study||0
6773823|NCT03958149|7701502|FG001|NOT COMPLETED|Overall Study||1
6773824|NCT03953183|7701514|FG000|STARTED|Overall Study||30
6773825|NCT03953183|7701515|FG001|STARTED|Overall Study||30
6773826|NCT03953183|7701514|FG000|COMPLETED|Overall Study||30
6773827|NCT03953183|7701515|FG001|COMPLETED|Overall Study||28
6773828|NCT03953183|7701514|FG000|NOT COMPLETED|Overall Study||0
6773829|NCT03953183|7701515|FG001|NOT COMPLETED|Overall Study||2
6773830|NCT03949335|7701523|FG000|STARTED|Overall Study||135
6773831|NCT03949335|7701524|FG001|STARTED|Overall Study||137
6773832|NCT03949335|7701523|FG000|COMPLETED|Overall Study||132
6773833|NCT03949335|7701524|FG001|COMPLETED|Overall Study||131
6773834|NCT03949335|7701523|FG000|NOT COMPLETED|Overall Study||3
6773835|NCT03949335|7701524|FG001|NOT COMPLETED|Overall Study||6
6773836|NCT03962738|7701536|FG000|STARTED|Overall Study||258
6773837|NCT03962738|7701537|FG001|STARTED|Overall Study||109
6773838|NCT03962738|7701538|FG002|STARTED|Overall Study||261
6773839|NCT03962738|7701539|FG003|STARTED|Overall Study||218
6773840|NCT03962738|7701536|FG000|Received At Least One Dose of Study Drug|Overall Study||214
6773841|NCT03962738|7701537|FG001|Received At Least One Dose of Study Drug|Overall Study||87
6773842|NCT03962738|7701538|FG002|Received At Least One Dose of Study Drug|Overall Study||208
6773843|NCT03962738|7701539|FG003|Received At Least One Dose of Study Drug|Overall Study||182
6773844|NCT03962738|7701536|FG000|COMPLETED|Overall Study||251
6773845|NCT03962738|7701537|FG001|COMPLETED|Overall Study||109
6313230|NCT00414050|7217523|FG001|STARTED|Overall Study||427
6313231|NCT00414050|7217524|FG002|STARTED|Overall Study||429
6313232|NCT00414050|7217525|FG003|STARTED|Overall Study||431
6313233|NCT00414050|7217522|FG000|Received Vaccination 1|Overall Study||431
6313234|NCT00414050|7217523|FG001|Received Vaccination 1|Overall Study||426
6313235|NCT00414050|7217524|FG002|Received Vaccination 1|Overall Study||429
6773846|NCT03962738|7701538|FG002|COMPLETED|Overall Study||259
6773847|NCT03962738|7701539|FG003|COMPLETED|Overall Study||217
6773848|NCT03962738|7701536|FG000|NOT COMPLETED|Overall Study||7
6773849|NCT03962738|7701537|FG001|NOT COMPLETED|Overall Study||0
6773850|NCT03962738|7701538|FG002|NOT COMPLETED|Overall Study||2
6773851|NCT03962738|7701539|FG003|NOT COMPLETED|Overall Study||1
6773852|NCT03962101|7701557|FG000|STARTED|Overall Study||45
6313236|NCT00414050|7217525|FG003|Received Vaccination 1|Overall Study||431
6313237|NCT00414050|7217522|FG000|Received Vaccination 2|Overall Study||425
6313238|NCT00414050|7217523|FG001|Received Vaccination 2|Overall Study||421
6313239|NCT00414050|7217524|FG002|Received Vaccination 2|Overall Study||425
6313240|NCT00414050|7217525|FG003|Received Vaccination 2|Overall Study||425
6313241|NCT00414050|7217522|FG000|Received Vaccination 3|Overall Study||424
6313242|NCT00414050|7217523|FG001|Received Vaccination 3|Overall Study||419
6313243|NCT00414050|7217524|FG002|Received Vaccination 3|Overall Study||425
6313244|NCT00414050|7217525|FG003|Received Vaccination 3|Overall Study||424
6313245|NCT00414050|7217522|FG000|COMPLETED|Overall Study||422
6313246|NCT00414050|7217523|FG001|COMPLETED|Overall Study||419
6313247|NCT00414050|7217524|FG002|COMPLETED|Overall Study||423
6313248|NCT00414050|7217525|FG003|COMPLETED|Overall Study||423
6313249|NCT00414050|7217522|FG000|NOT COMPLETED|Overall Study||9
6313250|NCT00414050|7217523|FG001|NOT COMPLETED|Overall Study||8
6313251|NCT00414050|7217524|FG002|NOT COMPLETED|Overall Study||6
6313252|NCT00414050|7217525|FG003|NOT COMPLETED|Overall Study||8
6313253|NCT00414076|7217537|FG000|STARTED|Overall Study||4
6313254|NCT00414076|7217538|FG001|STARTED|Overall Study||5
6313255|NCT00414076|7217537|FG000|COMPLETED|Overall Study||1
6313256|NCT00414076|7217538|FG001|COMPLETED|Overall Study||0
6313257|NCT00414076|7217537|FG000|NOT COMPLETED|Overall Study||3
6313258|NCT00414076|7217538|FG001|NOT COMPLETED|Overall Study||5
6313259|NCT00414167|7217546|FG000|STARTED|Overall Study||31
6313260|NCT00414167|7217547|FG001|STARTED|Overall Study||30
6313261|NCT00414167|7217546|FG000|COMPLETED|Overall Study||27
6313262|NCT00414167|7217547|FG001|COMPLETED|Overall Study||27
6313263|NCT00414167|7217546|FG000|NOT COMPLETED|Overall Study||4
6313264|NCT00414167|7217547|FG001|NOT COMPLETED|Overall Study||3
6313265|NCT00414206|7217558|FG000|STARTED|Overall Study||115
6313266|NCT00414206|7217559|FG001|STARTED|Overall Study||114
6313267|NCT00414206|7217560|FG002|STARTED|Overall Study||114
6313268|NCT00414206|7217558|FG000|COMPLETED|Overall Study||57
6313269|NCT00414206|7217559|FG001|COMPLETED|Overall Study||58
6773853|NCT03962101|7701557|FG000|COMPLETED|Overall Study||41
6773854|NCT03962101|7701557|FG000|NOT COMPLETED|Overall Study||4
6773855|NCT03959137|7701562|FG000|STARTED|Overall Study||215
6773856|NCT03959137|7701562|FG000|COMPLETED|Overall Study||209
6773857|NCT03959137|7701562|FG000|NOT COMPLETED|Overall Study||6
6773858|NCT03946124|7701566|FG000|STARTED|Overall Study||74
6773859|NCT03946124|7701566|FG000|COMPLETED|Overall Study||55
6773860|NCT03946124|7701566|FG000|NOT COMPLETED|Overall Study||19
6773861|NCT03961308|7701572|FG000|STARTED|Overall Study||102
6773862|NCT03961308|7701573|FG001|STARTED|Overall Study||102
6773863|NCT03961308|7701572|FG000|COMPLETED|Overall Study||100
6773864|NCT03961308|7701573|FG001|COMPLETED|Overall Study||100
6773865|NCT03961308|7701572|FG000|NOT COMPLETED|Overall Study||2
6773866|NCT03961308|7701573|FG001|NOT COMPLETED|Overall Study||2
6773867|NCT03961295|7701581|FG000|STARTED|Overall Study||12
6773868|NCT03961295|7701582|FG001|STARTED|Overall Study||12
6773869|NCT03961295|7701581|FG000|COMPLETED|Overall Study||12
6773870|NCT03961295|7701582|FG001|COMPLETED|Overall Study||12
6773871|NCT03961295|7701581|FG000|NOT COMPLETED|Overall Study||0
6773872|NCT03961295|7701582|FG001|NOT COMPLETED|Overall Study||0
6773873|NCT03960957|7701590|FG000|STARTED|Overall Study||224
6773874|NCT03960957|7701591|FG001|STARTED|Overall Study||77
6773875|NCT03960957|7701590|FG000|COMPLETED|Overall Study||216
6773876|NCT03960957|7701591|FG001|COMPLETED|Overall Study||71
6773877|NCT03960957|7701590|FG000|NOT COMPLETED|Overall Study||8
6773878|NCT03960957|7701591|FG001|NOT COMPLETED|Overall Study||6
6773879|NCT03956862|7701599|FG000|STARTED|Overall Study||50
6773880|NCT03956862|7701600|FG001|STARTED|Overall Study||47
6773881|NCT03956862|7701599|FG000|COMPLETED|Overall Study||48
6773882|NCT03956862|7701600|FG001|COMPLETED|Overall Study||45
6773883|NCT03956862|7701599|FG000|NOT COMPLETED|Overall Study||2
6773884|NCT03956862|7701600|FG001|NOT COMPLETED|Overall Study||2
6773885|NCT03954444|7701609|FG000|STARTED|Overall Study||379
6773886|NCT03954444|7701610|FG001|STARTED|Overall Study||382
6313270|NCT00414206|7217560|FG002|COMPLETED|Overall Study||59
6313271|NCT00414206|7217558|FG000|NOT COMPLETED|Overall Study||58
6313272|NCT00414206|7217559|FG001|NOT COMPLETED|Overall Study||56
6313273|NCT00414206|7217560|FG002|NOT COMPLETED|Overall Study||55
6313274|NCT00414271|7217568|FG000|STARTED|Overall Study||18
6313275|NCT00414271|7217568|FG000|COMPLETED|Overall Study||18
6773887|NCT03954444|7701611|FG002|STARTED|Overall Study||344
6773888|NCT03954444|7701609|FG000|COMPLETED|Overall Study||366
6313276|NCT00414271|7217568|FG000|NOT COMPLETED|Overall Study||0
6313277|NCT00414310|7217574|FG000|STARTED|Overall Study||71
6773889|NCT03954444|7701610|FG001|COMPLETED|Overall Study||366
6773890|NCT03954444|7701611|FG002|COMPLETED|Overall Study||327
6773891|NCT03954444|7701609|FG000|NOT COMPLETED|Overall Study||13
6773892|NCT03954444|7701610|FG001|NOT COMPLETED|Overall Study||16
6773893|NCT03954444|7701611|FG002|NOT COMPLETED|Overall Study||17
6773894|NCT03953820|7701619|FG000|STARTED|Two-Sequence, Two-Way Crossover||15
6773895|NCT03953820|7701620|FG001|STARTED|Two-Sequence, Two-Way Crossover||16
6773896|NCT03953820|7701621|FG002|STARTED|Two-Sequence, Two-Way Crossover||0
6773897|NCT03953820|7701619|FG000|COMPLETED|Two-Sequence, Two-Way Crossover||13
6313278|NCT00414310|7217575|FG001|STARTED|Overall Study||79
6313279|NCT00414310|7217574|FG000|COMPLETED|Overall Study||70
6313280|NCT00414310|7217575|FG001|COMPLETED|Overall Study||79
6313281|NCT00414310|7217574|FG000|NOT COMPLETED|Overall Study||1
6313282|NCT00414310|7217575|FG001|NOT COMPLETED|Overall Study||0
6313283|NCT00414388|7217583|FG000|STARTED|Overall Study||22
6313284|NCT00414388|7217583|FG000|COMPLETED|Overall Study||21
6313285|NCT00414388|7217583|FG000|NOT COMPLETED|Overall Study||1
6313286|NCT00414440|7217590|FG000|STARTED|Core Period|Core period|214
6313287|NCT00414440|7217591|FG001|STARTED|Core Period|Core period|217
6313288|NCT00414440|7217590|FG000|COMPLETED|Core Period|Core period|144
6313289|NCT00414440|7217591|FG001|COMPLETED|Core Period|Core period|185
6313290|NCT00414440|7217590|FG000|NOT COMPLETED|Core Period||70
6313291|NCT00414440|7217591|FG001|NOT COMPLETED|Core Period||32
6313292|NCT00414440|7217590|FG000|STARTED|Extension Period|Extension|214
6313293|NCT00414440|7217591|FG001|STARTED|Extension Period|Extension|217
6313294|NCT00414440|7217590|FG000|COMPLETED|Extension Period|Extension|64
6313295|NCT00414440|7217591|FG001|COMPLETED|Extension Period|Extension|77
6313296|NCT00414440|7217590|FG000|NOT COMPLETED|Extension Period||150
6557672|NCT01769326|7480239|FG001|COMPLETED|Overall Study||8
6313297|NCT00414440|7217591|FG001|NOT COMPLETED|Extension Period||140
6313298|NCT00414466|7217601|FG000|STARTED|Overall Study||44
6313299|NCT00414466|7217602|FG001|STARTED|Overall Study||42
6313300|NCT00414466|7217603|FG002|STARTED|Overall Study||41
6313301|NCT00414466|7217604|FG003|STARTED|Overall Study||43
6313302|NCT00414466|7217601|FG000|COMPLETED|Overall Study||42
6313303|NCT00414466|7217602|FG001|COMPLETED|Overall Study||42
6313304|NCT00414466|7217603|FG002|COMPLETED|Overall Study||40
6313305|NCT00414466|7217604|FG003|COMPLETED|Overall Study||42
6313306|NCT00414466|7217601|FG000|NOT COMPLETED|Overall Study||2
6773898|NCT03953820|7701620|FG001|COMPLETED|Two-Sequence, Two-Way Crossover||16
6773899|NCT03953820|7701621|FG002|COMPLETED|Two-Sequence, Two-Way Crossover||0
6773900|NCT03953820|7701619|FG000|NOT COMPLETED|Two-Sequence, Two-Way Crossover||2
6773901|NCT03953820|7701620|FG001|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
6773902|NCT03953820|7701621|FG002|NOT COMPLETED|Two-Sequence, Two-Way Crossover||0
6773903|NCT03953820|7701619|FG000|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
6773904|NCT03953820|7701620|FG001|STARTED|DBF Following High-Fat Meal|This arm did not continue in Period 2.|0
6773905|NCT03953820|7701621|FG002|STARTED|DBF Following High-Fat Meal|Participants in Period 2 completed 1 of the 2 arms in Period 1 and volunteered to continue.|10
6773906|NCT03953820|7701619|FG000|COMPLETED|DBF Following High-Fat Meal||0
6773907|NCT03953820|7701620|FG001|COMPLETED|DBF Following High-Fat Meal||0
6773908|NCT03953820|7701621|FG002|COMPLETED|DBF Following High-Fat Meal||10
6773909|NCT03953820|7701619|FG000|NOT COMPLETED|DBF Following High-Fat Meal||0
6773910|NCT03953820|7701620|FG001|NOT COMPLETED|DBF Following High-Fat Meal||0
6773911|NCT03953820|7701621|FG002|NOT COMPLETED|DBF Following High-Fat Meal||0
6773912|NCT03951766|7701634|FG000|STARTED|Treatment Phase||100
6773913|NCT03951766|7701634|FG000|COMPLETED|Treatment Phase||99
6773914|NCT03951766|7701634|FG000|NOT COMPLETED|Treatment Phase||1
6773915|NCT03951766|7701634|FG000|STARTED|Follow-up Phase||99
6773916|NCT03951766|7701634|FG000|COMPLETED|Follow-up Phase||89
6773917|NCT03951766|7701634|FG000|NOT COMPLETED|Follow-up Phase||10
6773918|NCT03961100|7701644|FG000|STARTED|Part 1||5
6773919|NCT03961100|7701645|FG001|STARTED|Part 1||5
6773920|NCT03961100|7701646|FG002|STARTED|Part 1||5
6773921|NCT03961100|7701647|FG003|STARTED|Part 1||0
6773922|NCT03961100|7701648|FG004|STARTED|Part 1||0
6773923|NCT03961100|7701644|FG000|COMPLETED|Part 1||5
6773924|NCT03961100|7701645|FG001|COMPLETED|Part 1||5
6773925|NCT03961100|7701646|FG002|COMPLETED|Part 1||5
6773926|NCT03961100|7701647|FG003|COMPLETED|Part 1||0
6773927|NCT03961100|7701648|FG004|COMPLETED|Part 1||0
6773928|NCT03961100|7701644|FG000|NOT COMPLETED|Part 1||0
6773929|NCT03961100|7701645|FG001|NOT COMPLETED|Part 1||0
6773930|NCT03961100|7701646|FG002|NOT COMPLETED|Part 1||0
6773931|NCT03961100|7701647|FG003|NOT COMPLETED|Part 1||0
6773932|NCT03961100|7701648|FG004|NOT COMPLETED|Part 1||0
6773933|NCT03961100|7701644|FG000|STARTED|Part 2||0
6773934|NCT03961100|7701645|FG001|STARTED|Part 2||0
6773935|NCT03961100|7701646|FG002|STARTED|Part 2||0
6773936|NCT03961100|7701647|FG003|STARTED|Part 2||8
6773937|NCT03961100|7701648|FG004|STARTED|Part 2||8
6773938|NCT03961100|7701644|FG000|COMPLETED|Part 2||0
6773939|NCT03961100|7701645|FG001|COMPLETED|Part 2||0
6773940|NCT03961100|7701646|FG002|COMPLETED|Part 2||0
6313307|NCT00414466|7217602|FG001|NOT COMPLETED|Overall Study||0
6313308|NCT00414466|7217603|FG002|NOT COMPLETED|Overall Study||1
6313309|NCT00414466|7217604|FG003|NOT COMPLETED|Overall Study||1
6313310|NCT00414518|7217619|FG000|STARTED|Overall Study||7
6313311|NCT00414518|7217620|FG001|STARTED|Overall Study||9
6557673|NCT01769326|7480240|FG002|COMPLETED|Overall Study||8
6557674|NCT01769326|7480241|FG003|COMPLETED|Overall Study||8
6773941|NCT03961100|7701647|FG003|COMPLETED|Part 2||8
6773942|NCT03961100|7701648|FG004|COMPLETED|Part 2||8
6773943|NCT03961100|7701644|FG000|NOT COMPLETED|Part 2||0
6773944|NCT03961100|7701645|FG001|NOT COMPLETED|Part 2||0
6773945|NCT03961100|7701646|FG002|NOT COMPLETED|Part 2||0
6773946|NCT03961100|7701647|FG003|NOT COMPLETED|Part 2||0
6773947|NCT03961100|7701648|FG004|NOT COMPLETED|Part 2||0
6773948|NCT03950856|7701664|FG000|STARTED|Overall Study||702
6773949|NCT03950856|7701665|FG001|STARTED|Overall Study||704
6773950|NCT03950856|7701666|FG002|STARTED|Overall Study||701
6773951|NCT03950856|7701667|FG003|STARTED|Overall Study||233
6773952|NCT03950856|7701664|FG000|Vaccinated|Overall Study||698
6773953|NCT03950856|7701665|FG001|Vaccinated|Overall Study||704
6773954|NCT03950856|7701666|FG002|Vaccinated|Overall Study||700
6773955|NCT03950856|7701667|FG003|Vaccinated|Overall Study||231
6773956|NCT03950856|7701664|FG000|COMPLETED|Overall Study||683
6313312|NCT00414518|7217619|FG000|COMPLETED|Overall Study||7
6313313|NCT00414518|7217620|FG001|COMPLETED|Overall Study||9
6313314|NCT00414518|7217619|FG000|NOT COMPLETED|Overall Study||0
6313315|NCT00414518|7217620|FG001|NOT COMPLETED|Overall Study||0
6313316|NCT00414544|7217630|FG000|STARTED|Overall Study||145
6313317|NCT00414544|7217630|FG000|COMPLETED|Overall Study||131
6313318|NCT00414544|7217630|FG000|NOT COMPLETED|Overall Study||14
6313319|NCT00414596|7217636|FG000|STARTED|Overall Study|December 2006|20
6313320|NCT00414596|7217636|FG000|COMPLETED|Overall Study|April 2007|18
6313321|NCT00414596|7217636|FG000|NOT COMPLETED|Overall Study||2
6313322|NCT00414609|7217642|FG000|STARTED|Core Study||397
6313323|NCT00414609|7217643|FG001|STARTED|Core Study||423
6313324|NCT00414609|7217644|FG002|STARTED|Core Study||0
6313325|NCT00414609|7217642|FG000|Received Study Drug|Core Study||397
6313326|NCT00414609|7217643|FG001|Received Study Drug|Core Study||422
6313327|NCT00414609|7217644|FG002|Received Study Drug|Core Study||0
6313328|NCT00414609|7217642|FG000|Echocardiogram Evaluable Set|Core Study||330
6313329|NCT00414609|7217643|FG001|Echocardiogram Evaluable Set|Core Study||343
6313330|NCT00414609|7217644|FG002|Echocardiogram Evaluable Set|Core Study||0
6313331|NCT00414609|7217642|FG000|COMPLETED|Core Study||363
6313332|NCT00414609|7217643|FG001|COMPLETED|Core Study||378
6313333|NCT00414609|7217644|FG002|COMPLETED|Core Study||0
6313334|NCT00414609|7217642|FG000|NOT COMPLETED|Core Study||34
6313335|NCT00414609|7217643|FG001|NOT COMPLETED|Core Study||45
6313336|NCT00414609|7217644|FG002|NOT COMPLETED|Core Study||0
6313337|NCT00414609|7217642|FG000|STARTED|Extension Study||0
6313338|NCT00414609|7217643|FG001|STARTED|Extension Study||0
6313339|NCT00414609|7217644|FG002|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
6313340|NCT00414609|7217642|FG000|Echocardiogram (ECHO) Analysis Set|Extension Study||0
6313341|NCT00414609|7217643|FG001|Echocardiogram (ECHO) Analysis Set|Extension Study||0
6313342|NCT00414609|7217644|FG002|Echocardiogram (ECHO) Analysis Set|Extension Study||400
6313343|NCT00414609|7217642|FG000|COMPLETED|Extension Study||0
6773957|NCT03950856|7701665|FG001|COMPLETED|Overall Study||689
6773958|NCT03950856|7701666|FG002|COMPLETED|Overall Study||683
6773959|NCT03950856|7701667|FG003|COMPLETED|Overall Study||227
6773960|NCT03950856|7701664|FG000|NOT COMPLETED|Overall Study||19
6773961|NCT03950856|7701665|FG001|NOT COMPLETED|Overall Study||15
6773962|NCT03950856|7701666|FG002|NOT COMPLETED|Overall Study||18
6773963|NCT03950856|7701667|FG003|NOT COMPLETED|Overall Study||6
6773964|NCT03947983|7701681|FG000|STARTED|Overall Study||19
6773965|NCT03947983|7701682|FG001|STARTED|Overall Study||19
6773966|NCT03947983|7701681|FG000|12 Weeks|Overall Study||15
6773967|NCT03947983|7701682|FG001|12 Weeks|Overall Study||17
6773968|NCT03947983|7701681|FG000|COMPLETED|Overall Study||14
6773969|NCT03947983|7701682|FG001|COMPLETED|Overall Study||13
6773970|NCT03947983|7701681|FG000|NOT COMPLETED|Overall Study||5
6773971|NCT03947983|7701682|FG001|NOT COMPLETED|Overall Study||6
6773972|NCT03960658|7701688|FG000|STARTED|Overall Study||12
6773973|NCT03960658|7701688|FG000|COMPLETED|Overall Study||10
6773974|NCT03960658|7701688|FG000|NOT COMPLETED|Overall Study||2
6773975|NCT03959332|7701694|FG000|STARTED|Overall Study||16
6773976|NCT03959332|7701695|FG001|STARTED|Overall Study||16
6773977|NCT03959332|7701694|FG000|COMPLETED|Overall Study||16
6773978|NCT03959332|7701695|FG001|COMPLETED|Overall Study||16
6773979|NCT03959332|7701694|FG000|NOT COMPLETED|Overall Study||0
6773980|NCT03959332|7701695|FG001|NOT COMPLETED|Overall Study||0
6773981|NCT03959189|7701703|FG000|STARTED|Overall Study||7
6773982|NCT03959189|7701704|FG001|STARTED|Overall Study||5
6773983|NCT03959189|7701703|FG000|COMPLETED|Overall Study||7
6773984|NCT03959189|7701704|FG001|COMPLETED|Overall Study||5
6773985|NCT03959189|7701703|FG000|NOT COMPLETED|Overall Study||0
6773986|NCT03959189|7701704|FG001|NOT COMPLETED|Overall Study||0
6773987|NCT03956550|7701720|FG000|STARTED|Overall Study||88
6773988|NCT03956550|7701721|FG001|STARTED|Overall Study||86
6773989|NCT03956550|7701722|FG002|STARTED|Overall Study||85
6773990|NCT03956550|7701720|FG000|COMPLETED|Overall Study||18
6773991|NCT03956550|7701721|FG001|COMPLETED|Overall Study||14
6773992|NCT03956550|7701722|FG002|COMPLETED|Overall Study||15
6773993|NCT03956550|7701720|FG000|NOT COMPLETED|Overall Study||70
6773994|NCT03956550|7701721|FG001|NOT COMPLETED|Overall Study||72
6773995|NCT03956550|7701722|FG002|NOT COMPLETED|Overall Study||70
6780750|NCT02865395|7709285|FG001|NOT COMPLETED|Overall Study||10
6780751|NCT02865395|7709286|FG002|NOT COMPLETED|Overall Study||7
6780752|NCT02868892|7709294|FG000|STARTED|Overall Study||6
6780753|NCT02868892|7709294|FG000|COMPLETED|Overall Study||0
6780754|NCT02868892|7709294|FG000|NOT COMPLETED|Overall Study||6
6313344|NCT00414609|7217643|FG001|COMPLETED|Extension Study||0
6313345|NCT00414609|7217644|FG002|COMPLETED|Extension Study||365
6313346|NCT00414609|7217642|FG000|NOT COMPLETED|Extension Study||0
6313347|NCT00414609|7217643|FG001|NOT COMPLETED|Extension Study||0
6313348|NCT00414609|7217644|FG002|NOT COMPLETED|Extension Study||57
6313349|NCT00414635|7217655|FG000|STARTED|Overall Study||30
6313350|NCT00414635|7217656|FG001|STARTED|Overall Study||30
6313351|NCT00414635|7217655|FG000|COMPLETED|Overall Study||25
6313352|NCT00414635|7217656|FG001|COMPLETED|Overall Study||28
6780755|NCT02865083|7709300|FG000|STARTED|Overall Study||3
6780756|NCT02865083|7709301|FG001|STARTED|Overall Study||1
6780757|NCT02865083|7709300|FG000|COMPLETED|Overall Study||0
6780758|NCT02865083|7709301|FG001|COMPLETED|Overall Study||0
6780759|NCT02865083|7709300|FG000|NOT COMPLETED|Overall Study||3
6780760|NCT02865083|7709301|FG001|NOT COMPLETED|Overall Study||1
6313353|NCT00414635|7217655|FG000|NOT COMPLETED|Overall Study||5
6313354|NCT00414635|7217656|FG001|NOT COMPLETED|Overall Study||2
6375194|NCT00754247|7285794|FG001|COMPLETED|Overall Study||5
6375195|NCT00754247|7285795|FG002|COMPLETED|Overall Study||5
6375196|NCT00754247|7285793|FG000|NOT COMPLETED|Overall Study||5
6375197|NCT00754247|7285794|FG001|NOT COMPLETED|Overall Study||5
6375198|NCT00754247|7285795|FG002|NOT COMPLETED|Overall Study||5
6375199|NCT00754325|7285805|FG000|STARTED|Initial Treatment||50
6375200|NCT00754325|7285806|FG001|STARTED|Initial Treatment||49
6375201|NCT00754325|7285805|FG000|COMPLETED|Initial Treatment||0
6375202|NCT00754325|7285806|FG001|COMPLETED|Initial Treatment||0
6375203|NCT00754325|7285805|FG000|NOT COMPLETED|Initial Treatment||50
6375204|NCT00754325|7285806|FG001|NOT COMPLETED|Initial Treatment||49
6375205|NCT00754325|7285805|FG000|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
6375206|NCT00754325|7285806|FG001|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
6375207|NCT00754325|7285805|FG000|COMPLETED|Progression and Cross-over||0
6375208|NCT00754325|7285806|FG001|COMPLETED|Progression and Cross-over||0
6375209|NCT00754325|7285805|FG000|NOT COMPLETED|Progression and Cross-over||0
6375210|NCT00754325|7285806|FG001|NOT COMPLETED|Progression and Cross-over||21
6375211|NCT00754338|7285817|FG000|STARTED|First Intervention for Phase1&Phase2||17
6375212|NCT00754338|7285818|FG001|STARTED|First Intervention for Phase1&Phase2||21
6375213|NCT00754338|7285819|FG002|STARTED|First Intervention for Phase1&Phase2||19
6375214|NCT00754338|7285820|FG003|STARTED|First Intervention for Phase1&Phase2||19
6375215|NCT00754338|7285817|FG000|COMPLETED|First Intervention for Phase1&Phase2||17
6375216|NCT00754338|7285818|FG001|COMPLETED|First Intervention for Phase1&Phase2||18
6375217|NCT00754338|7285819|FG002|COMPLETED|First Intervention for Phase1&Phase2||16
6375218|NCT00754338|7285820|FG003|COMPLETED|First Intervention for Phase1&Phase2||19
6375219|NCT00754338|7285817|FG000|NOT COMPLETED|First Intervention for Phase1&Phase2||0
6375220|NCT00754338|7285818|FG001|NOT COMPLETED|First Intervention for Phase1&Phase2||3
6375221|NCT00754338|7285819|FG002|NOT COMPLETED|First Intervention for Phase1&Phase2||3
6375222|NCT00754338|7285820|FG003|NOT COMPLETED|First Intervention for Phase1&Phase2||0
6375223|NCT00754338|7285817|FG000|STARTED|Second Intervention for Phase1&Phase2||17
6375224|NCT00754338|7285818|FG001|STARTED|Second Intervention for Phase1&Phase2||18
6773996|NCT03954158|7701734|FG000|STARTED|Overall Study||20
6773997|NCT03954158|7701735|FG001|STARTED|Overall Study||21
6773998|NCT03954158|7701736|FG002|STARTED|Overall Study||20
6773999|NCT03954158|7701737|FG003|STARTED|Overall Study||20
6774000|NCT03954158|7701734|FG000|COMPLETED|Overall Study||20
6774001|NCT03954158|7701735|FG001|COMPLETED|Overall Study||21
6774002|NCT03954158|7701736|FG002|COMPLETED|Overall Study||20
6774003|NCT03954158|7701737|FG003|COMPLETED|Overall Study||20
6774004|NCT03954158|7701734|FG000|NOT COMPLETED|Overall Study||0
6774005|NCT03954158|7701735|FG001|NOT COMPLETED|Overall Study||0
6774006|NCT03954158|7701736|FG002|NOT COMPLETED|Overall Study||0
6774007|NCT03954158|7701737|FG003|NOT COMPLETED|Overall Study||0
6774008|NCT03958656|7701774|FG000|STARTED|Overall Study||3
6774009|NCT03958656|7701775|FG001|STARTED|Overall Study||4
6774010|NCT03958656|7701776|FG002|STARTED|Overall Study||5
6774011|NCT03958656|7701777|FG003|STARTED|Overall Study||1
6774012|NCT03958656|7701774|FG000|COMPLETED|Overall Study||3
6774013|NCT03958656|7701775|FG001|COMPLETED|Overall Study||3
6774014|NCT03958656|7701776|FG002|COMPLETED|Overall Study||3
6774015|NCT03958656|7701777|FG003|COMPLETED|Overall Study||1
6774016|NCT03958656|7701774|FG000|NOT COMPLETED|Overall Study||0
6774017|NCT03958656|7701775|FG001|NOT COMPLETED|Overall Study||1
6774018|NCT03958656|7701776|FG002|NOT COMPLETED|Overall Study||2
6774019|NCT03958656|7701777|FG003|NOT COMPLETED|Overall Study||0
6774020|NCT03955133|7701787|FG000|STARTED|Overall Study|participants recruited from 3 care homes|19
6774021|NCT03955133|7701787|FG000|COMPLETED|Overall Study|End of study funding|19
6774022|NCT03955133|7701787|FG000|NOT COMPLETED|Overall Study||0
6774023|NCT03954626|7701792|FG000|STARTED|Overall Study||14
6774024|NCT03954626|7701792|FG000|COMPLETED|Overall Study||14
6774025|NCT03954626|7701792|FG000|NOT COMPLETED|Overall Study||0
6774026|NCT03951805|7701800|FG000|STARTED|Overall Study||51
6774027|NCT03951805|7701801|FG001|STARTED|Overall Study||51
6774028|NCT03951805|7701802|FG002|STARTED|Overall Study||52
6774029|NCT03951805|7701803|FG003|STARTED|Overall Study||51
6774030|NCT03951805|7701800|FG000|Full Analysis Set (FAS)|Overall Study||51
6774031|NCT03951805|7701801|FG001|Full Analysis Set (FAS)|Overall Study||51
6774032|NCT03951805|7701802|FG002|Full Analysis Set (FAS)|Overall Study||52
6774033|NCT03951805|7701803|FG003|Full Analysis Set (FAS)|Overall Study||51
6774034|NCT03951805|7701800|FG000|Safety Analysis Set (SAS)|Overall Study||51
6774035|NCT03951805|7701801|FG001|Safety Analysis Set (SAS)|Overall Study||51
6774036|NCT03951805|7701802|FG002|Safety Analysis Set (SAS)|Overall Study||52
6774037|NCT03951805|7701803|FG003|Safety Analysis Set (SAS)|Overall Study||51
6774038|NCT03951805|7701800|FG000|COMPLETED|Overall Study||50
6774039|NCT03951805|7701801|FG001|COMPLETED|Overall Study||51
6774040|NCT03951805|7701802|FG002|COMPLETED|Overall Study||52
6774041|NCT03951805|7701803|FG003|COMPLETED|Overall Study||51
6375225|NCT00754338|7285819|FG002|STARTED|Second Intervention for Phase1&Phase2||16
6375226|NCT00754338|7285820|FG003|STARTED|Second Intervention for Phase1&Phase2||19
6774042|NCT03951805|7701800|FG000|NOT COMPLETED|Overall Study||1
6774043|NCT03951805|7701801|FG001|NOT COMPLETED|Overall Study||0
6774044|NCT03951805|7701802|FG002|NOT COMPLETED|Overall Study||0
6313355|NCT00414661|7217666|FG000|STARTED|Overall Study||48
6313356|NCT00414661|7217667|FG001|STARTED|Overall Study||89
6313357|NCT00414661|7217668|FG002|STARTED|Overall Study||22
6313358|NCT00414661|7217669|FG003|STARTED|Overall Study||3
6313359|NCT00414661|7217666|FG000|COMPLETED|Overall Study||34
6313360|NCT00414661|7217667|FG001|COMPLETED|Overall Study||75
6313361|NCT00414661|7217668|FG002|COMPLETED|Overall Study||20
6313362|NCT00414661|7217669|FG003|COMPLETED|Overall Study||0
6313363|NCT00414661|7217666|FG000|NOT COMPLETED|Overall Study||14
6313364|NCT00414661|7217667|FG001|NOT COMPLETED|Overall Study||14
6313365|NCT00414661|7217668|FG002|NOT COMPLETED|Overall Study||2
6313366|NCT00414661|7217669|FG003|NOT COMPLETED|Overall Study||3
6313367|NCT00414700|7217681|FG000|STARTED|Overall Study||57
6313368|NCT00414700|7217682|FG001|STARTED|Overall Study||61
6313369|NCT00414700|7217681|FG000|COMPLETED|Overall Study||51
6313370|NCT00414700|7217682|FG001|COMPLETED|Overall Study||58
6313371|NCT00414700|7217681|FG000|NOT COMPLETED|Overall Study||6
6774045|NCT03951805|7701803|FG003|NOT COMPLETED|Overall Study||0
6774046|NCT03944785|7701816|FG000|STARTED|2 Month Study Completion||2
6774047|NCT03944785|7701817|FG001|STARTED|2 Month Study Completion||34
6774048|NCT03944785|7701818|FG002|STARTED|2 Month Study Completion||128
6774049|NCT03944785|7701816|FG000|COMPLETED|2 Month Study Completion||2
6774050|NCT03944785|7701817|FG001|COMPLETED|2 Month Study Completion||30
6774051|NCT03944785|7701818|FG002|COMPLETED|2 Month Study Completion||123
6774052|NCT03944785|7701816|FG000|NOT COMPLETED|2 Month Study Completion||0
6774053|NCT03944785|7701817|FG001|NOT COMPLETED|2 Month Study Completion||4
6774054|NCT03944785|7701818|FG002|NOT COMPLETED|2 Month Study Completion||5
6774055|NCT03944785|7701816|FG000|STARTED|4 Month Study Optional Extension||1
6774056|NCT03944785|7701817|FG001|STARTED|4 Month Study Optional Extension||10
6774057|NCT03944785|7701818|FG002|STARTED|4 Month Study Optional Extension||64
6774058|NCT03944785|7701816|FG000|COMPLETED|4 Month Study Optional Extension||0
6774059|NCT03944785|7701817|FG001|COMPLETED|4 Month Study Optional Extension||8
6774060|NCT03944785|7701818|FG002|COMPLETED|4 Month Study Optional Extension||41
6774061|NCT03944785|7701816|FG000|NOT COMPLETED|4 Month Study Optional Extension||1
6774062|NCT03944785|7701817|FG001|NOT COMPLETED|4 Month Study Optional Extension||2
6774063|NCT03944785|7701818|FG002|NOT COMPLETED|4 Month Study Optional Extension||23
6774064|NCT03950622|7701828|FG000|STARTED|Overall Study||604
6774065|NCT03950622|7701829|FG001|STARTED|Overall Study||601
6774066|NCT03950622|7701828|FG000|Vaccinated|Overall Study||602
6774067|NCT03950622|7701829|FG001|Vaccinated|Overall Study||600
6774068|NCT03950622|7701828|FG000|COMPLETED|Overall Study||596
6774069|NCT03950622|7701829|FG001|COMPLETED|Overall Study||594
6774070|NCT03950622|7701828|FG000|NOT COMPLETED|Overall Study||8
6774071|NCT03950622|7701829|FG001|NOT COMPLETED|Overall Study||7
6774072|NCT03949621|7701837|FG000|STARTED|Overall Study||12
6774073|NCT03949621|7701838|FG001|STARTED|Overall Study||12
6774074|NCT03949621|7701837|FG000|COMPLETED|Overall Study||12
6774075|NCT03949621|7701838|FG001|COMPLETED|Overall Study||12
6774076|NCT03949621|7701837|FG000|NOT COMPLETED|Overall Study||0
6774077|NCT03949621|7701838|FG001|NOT COMPLETED|Overall Study||0
6774078|NCT03949244|7701847|FG000|STARTED|Overall Study||12
6774079|NCT03949244|7701848|FG001|STARTED|Overall Study||21
6774080|NCT03949244|7701849|FG002|STARTED|Overall Study||14
6774081|NCT03949244|7701847|FG000|COMPLETED|Overall Study||12
6774082|NCT03949244|7701848|FG001|COMPLETED|Overall Study||21
6774083|NCT03949244|7701849|FG002|COMPLETED|Overall Study||14
6774084|NCT03949244|7701847|FG000|NOT COMPLETED|Overall Study||0
6774085|NCT03949244|7701848|FG001|NOT COMPLETED|Overall Study||0
6774086|NCT03949244|7701849|FG002|NOT COMPLETED|Overall Study||0
6774087|NCT03948581|7701859|FG000|STARTED|Overall Study||51
6774088|NCT03948581|7701860|FG001|STARTED|Overall Study||51
6774089|NCT03948581|7701859|FG000|COMPLETED|Overall Study||51
6774090|NCT03948581|7701860|FG001|COMPLETED|Overall Study||50
6774091|NCT03948581|7701859|FG000|NOT COMPLETED|Overall Study||0
6774092|NCT03948581|7701860|FG001|NOT COMPLETED|Overall Study||1
6774093|NCT03948386|7701869|FG000|STARTED|Overall Study||52
6774094|NCT03948386|7701870|FG001|STARTED|Overall Study||54
6774095|NCT03948386|7701871|FG002|STARTED|Overall Study||53
6774096|NCT03948386|7701869|FG000|COMPLETED|Overall Study||51
6774097|NCT03948386|7701870|FG001|COMPLETED|Overall Study||53
6774098|NCT03948386|7701871|FG002|COMPLETED|Overall Study||50
6774099|NCT03948386|7701869|FG000|NOT COMPLETED|Overall Study||1
6774100|NCT03948386|7701870|FG001|NOT COMPLETED|Overall Study||1
6774101|NCT03948386|7701871|FG002|NOT COMPLETED|Overall Study||3
6774102|NCT03948334|7701881|FG000|STARTED|Overall Study||60
6774103|NCT03948334|7701882|FG001|STARTED|Overall Study||63
6774104|NCT03948334|7701881|FG000|COMPLETED|Overall Study||0
6774105|NCT03948334|7701882|FG001|COMPLETED|Overall Study||0
6774106|NCT03948334|7701881|FG000|NOT COMPLETED|Overall Study||60
6774107|NCT03948334|7701882|FG001|NOT COMPLETED|Overall Study||63
6774108|NCT03946059|7701898|FG000|STARTED|Overall Study||13
6774109|NCT03946059|7701899|FG001|STARTED|Overall Study||12
6313372|NCT00414700|7217682|FG001|NOT COMPLETED|Overall Study||3
6774110|NCT03946059|7701898|FG000|COMPLETED|Overall Study||13
6774111|NCT03946059|7701899|FG001|COMPLETED|Overall Study||11
6774112|NCT03946059|7701898|FG000|NOT COMPLETED|Overall Study||0
6774113|NCT03946059|7701899|FG001|NOT COMPLETED|Overall Study||1
6313373|NCT00414726|7217690|FG000|STARTED|Overall Study||43
6313374|NCT00414726|7217691|FG001|STARTED|Overall Study||42
6313375|NCT00414726|7217690|FG000|COMPLETED|Overall Study||43
6313376|NCT00414726|7217691|FG001|COMPLETED|Overall Study||41
6313377|NCT00414726|7217690|FG000|NOT COMPLETED|Overall Study||0
6313378|NCT00414726|7217691|FG001|NOT COMPLETED|Overall Study||1
6313379|NCT00414765|7217699|FG000|STARTED|Overall Study||7
6313380|NCT00414765|7217700|FG001|STARTED|Overall Study||19
6313381|NCT00414765|7217699|FG000|Completed Study|Overall Study||7
6313382|NCT00414765|7217700|FG001|Completed Study|Overall Study||18
6313383|NCT00414765|7217699|FG000|Completed Cycle 1|Overall Study||7
6313384|NCT00414765|7217700|FG001|Completed Cycle 1|Overall Study||19
6313385|NCT00414765|7217699|FG000|Completed Cycle 2|Overall Study||4
6313386|NCT00414765|7217700|FG001|Completed Cycle 2|Overall Study||16
6313387|NCT00414765|7217699|FG000|COMPLETED|Overall Study||1
6313388|NCT00414765|7217700|FG001|COMPLETED|Overall Study||8
6313389|NCT00414765|7217699|FG000|NOT COMPLETED|Overall Study||6
6313390|NCT00414765|7217700|FG001|NOT COMPLETED|Overall Study||11
6313391|NCT00414817|7217708|FG000|STARTED|Overall Study||7033
6313392|NCT00414817|7217709|FG001|STARTED|Overall Study||7031
6313393|NCT00414817|7217708|FG000|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
6313394|NCT00414817|7217709|FG001|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
6313395|NCT00414817|7217708|FG000|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
6313396|NCT00414817|7217709|FG001|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
6313397|NCT00414817|7217708|FG000|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
6313398|NCT00414817|7217709|FG001|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
6313399|NCT00414817|7217708|FG000|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
6313400|NCT00414817|7217709|FG001|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
6313401|NCT00414817|7217708|FG000|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
6313402|NCT00414817|7217709|FG001|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
6313403|NCT00414817|7217708|FG000|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
6313404|NCT00414817|7217709|FG001|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
6313405|NCT00414817|7217708|FG000|NOT COMPLETED|Overall Study||3130
6313406|NCT00414817|7217709|FG001|NOT COMPLETED|Overall Study||3016
6313407|NCT00414908|7217717|FG000|STARTED|Overall Study||25
6313408|NCT00414908|7217718|FG001|STARTED|Overall Study||29
6313409|NCT00414908|7217717|FG000|COMPLETED|Overall Study||24
6313410|NCT00414908|7217718|FG001|COMPLETED|Overall Study||28
6498325|NCT01408901|7416888|FG000|NOT COMPLETED|6-Week Follow-Up||3
6498326|NCT01408901|7416889|FG001|NOT COMPLETED|6-Week Follow-Up||2
6498327|NCT01408901|7416890|FG002|NOT COMPLETED|6-Week Follow-Up||3
6774114|NCT03944707|7701909|FG000|STARTED|Overall Study||47
6774115|NCT03944707|7701910|FG001|STARTED|Overall Study||29
6774116|NCT03944707|7701909|FG000|PK Analysis Set|Overall Study||33
6774117|NCT03944707|7701910|FG001|PK Analysis Set|Overall Study||0
6774118|NCT03944707|7701909|FG000|PD Analysis Set|Overall Study||47
6774119|NCT03944707|7701910|FG001|PD Analysis Set|Overall Study||29
6774120|NCT03944707|7701909|FG000|COMPLETED|Overall Study||35
6774121|NCT03944707|7701910|FG001|COMPLETED|Overall Study||19
6774122|NCT03944707|7701909|FG000|NOT COMPLETED|Overall Study||12
6774123|NCT03944707|7701910|FG001|NOT COMPLETED|Overall Study||10
6774124|NCT03944668|7701916|FG000|STARTED|Overall Study|Enrolled in Study|17
6774125|NCT03944668|7701916|FG000|Able to Use Patient Data|Overall Study|3 Patient's Data Unusable|14
6774126|NCT03944668|7701916|FG000|Participated in Intervention|Overall Study|Started Cardiac Rehabilitation|10
6774127|NCT03944668|7701916|FG000|COMPLETED|Overall Study|Completed 75% of Comprehensive Cardiac Rehabilitation Sessions|8
6774128|NCT03944668|7701916|FG000|NOT COMPLETED|Overall Study||9
6774129|NCT03943160|7701921|FG000|STARTED|Overall Study||50
6774130|NCT03943160|7701921|FG000|COMPLETED|Overall Study||50
6774131|NCT03943160|7701921|FG000|NOT COMPLETED|Overall Study||0
6774132|NCT03943095|7701927|FG000|STARTED|Overall Study||52
6774133|NCT03943095|7701928|FG001|STARTED|Overall Study||52
6774134|NCT03943095|7701927|FG000|COMPLETED|Overall Study||51
6774135|NCT03943095|7701928|FG001|COMPLETED|Overall Study||51
6774136|NCT03943095|7701927|FG000|NOT COMPLETED|Overall Study||1
6774137|NCT03943095|7701928|FG001|NOT COMPLETED|Overall Study||1
6774138|NCT03943290|7701944|FG000|STARTED|Overall Study||7
6313411|NCT00414908|7217717|FG000|NOT COMPLETED|Overall Study||1
6313412|NCT00414908|7217718|FG001|NOT COMPLETED|Overall Study||1
6313413|NCT00414960|7217728|FG000|STARTED|Overall Study||25
6313414|NCT00414960|7217729|FG001|STARTED|Overall Study||15
6313415|NCT00414960|7217728|FG000|Received at Least One Dose of Study Drug|Overall Study||24
6313416|NCT00414960|7217729|FG001|Received at Least One Dose of Study Drug|Overall Study||15
6313417|NCT00414960|7217728|FG000|COMPLETED|Overall Study||18
6774139|NCT03943290|7701945|FG001|STARTED|Overall Study||1
6774140|NCT03943290|7701946|FG002|STARTED|Overall Study||13
6774141|NCT03943290|7701947|FG003|STARTED|Overall Study||6
6774142|NCT03943290|7701948|FG004|STARTED|Overall Study||7
6774143|NCT03943290|7701949|FG005|STARTED|Overall Study||6
6774144|NCT03943290|7701950|FG006|STARTED|Overall Study||6
6313418|NCT00414960|7217729|FG001|COMPLETED|Overall Study||14
6313419|NCT00414960|7217728|FG000|NOT COMPLETED|Overall Study||7
6313420|NCT00414960|7217729|FG001|NOT COMPLETED|Overall Study||1
6313421|NCT00414973|7217739|FG000|STARTED|Overall Study||218
6313422|NCT00414973|7217740|FG001|STARTED|Overall Study||109
6313423|NCT00414973|7217741|FG002|STARTED|Overall Study||24
6313424|NCT00414973|7217742|FG003|STARTED|Overall Study||11
6774145|NCT03943290|7701951|FG007|STARTED|Overall Study||8
6774146|NCT03943290|7701952|FG008|STARTED|Overall Study||8
6774147|NCT03943290|7701944|FG000|COMPLETED|Overall Study||0
6774148|NCT03943290|7701945|FG001|COMPLETED|Overall Study||0
6774149|NCT03943290|7701946|FG002|COMPLETED|Overall Study||0
6774150|NCT03943290|7701947|FG003|COMPLETED|Overall Study||0
6774151|NCT03943290|7701948|FG004|COMPLETED|Overall Study||0
6774152|NCT03943290|7701949|FG005|COMPLETED|Overall Study||0
6774153|NCT03943290|7701950|FG006|COMPLETED|Overall Study||0
6774154|NCT03943290|7701951|FG007|COMPLETED|Overall Study||0
6774155|NCT03943290|7701952|FG008|COMPLETED|Overall Study||0
6774156|NCT03943290|7701944|FG000|NOT COMPLETED|Overall Study||7
6774157|NCT03943290|7701945|FG001|NOT COMPLETED|Overall Study||1
6774158|NCT03943290|7701946|FG002|NOT COMPLETED|Overall Study||13
6774159|NCT03943290|7701947|FG003|NOT COMPLETED|Overall Study||6
6774160|NCT03943290|7701948|FG004|NOT COMPLETED|Overall Study||7
6774161|NCT03943290|7701949|FG005|NOT COMPLETED|Overall Study||6
6774162|NCT03943290|7701950|FG006|NOT COMPLETED|Overall Study||6
6774163|NCT03943290|7701951|FG007|NOT COMPLETED|Overall Study||8
6774164|NCT03943290|7701952|FG008|NOT COMPLETED|Overall Study||8
6774165|NCT03942042|7701987|FG000|STARTED|Induction Dosing Period (12 Weeks)||7
6774166|NCT03942042|7701988|FG001|STARTED|Induction Dosing Period (12 Weeks)||5
6774167|NCT03942042|7701987|FG000|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||7
6774168|NCT03942042|7701988|FG001|Received at Least One Dose of Study Drug|Induction Dosing Period (12 Weeks)||5
6774169|NCT03942042|7701987|FG000|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||4
6774170|NCT03942042|7701988|FG001|Participants With GIS=1 at Week 12|Induction Dosing Period (12 Weeks)||0
6774171|NCT03942042|7701987|FG000|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||2
6774172|NCT03942042|7701988|FG001|Participants Who Completed Week 12 With GIS >= 2|Induction Dosing Period (12 Weeks)||4
6774173|NCT03942042|7701987|FG000|COMPLETED|Induction Dosing Period (12 Weeks)||6
6774174|NCT03942042|7701988|FG001|COMPLETED|Induction Dosing Period (12 Weeks)||4
6774175|NCT03942042|7701987|FG000|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
6774176|NCT03942042|7701988|FG001|NOT COMPLETED|Induction Dosing Period (12 Weeks)||1
6774177|NCT03942042|7701987|FG000|STARTED|Maintenance Dosing Period (8 Weeks)|Only participants with GIS ≥2 at Week 12 and based on investigators' discretion continued to maintenance dosing period.|2
6774178|NCT03942042|7701988|FG001|STARTED|Maintenance Dosing Period (8 Weeks)||4
6774179|NCT03942042|7701987|FG000|COMPLETED|Maintenance Dosing Period (8 Weeks)||2
6774180|NCT03942042|7701988|FG001|COMPLETED|Maintenance Dosing Period (8 Weeks)||4
6774181|NCT03942042|7701987|FG000|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
6774182|NCT03942042|7701988|FG001|NOT COMPLETED|Maintenance Dosing Period (8 Weeks)||0
6774183|NCT03938337|7702000|FG000|STARTED|Overall Study||1
6774184|NCT03938337|7702001|FG001|STARTED|Overall Study||0
6774185|NCT03938337|7702000|FG000|COMPLETED|Overall Study||1
6774186|NCT03938337|7702001|FG001|COMPLETED|Overall Study||0
6774187|NCT03938337|7702000|FG000|NOT COMPLETED|Overall Study||0
6774188|NCT03938337|7702001|FG001|NOT COMPLETED|Overall Study||0
6774189|NCT03923530|7702007|FG000|STARTED|Overall Study||12
6774190|NCT03923530|7702007|FG000|COMPLETED|Overall Study||8
6774191|NCT03923530|7702007|FG000|NOT COMPLETED|Overall Study||4
6774192|NCT03914417|7702011|FG000|STARTED|Overall Study||21
6774193|NCT03914417|7702011|FG000|COMPLETED|Overall Study||19
6774194|NCT03914417|7702011|FG000|NOT COMPLETED|Overall Study||2
6774195|NCT03913377|7702017|FG000|STARTED|Period 1||21
6774196|NCT03913377|7702018|FG001|STARTED|Period 1||22
6774197|NCT03913377|7702019|FG002|STARTED|Period 1||22
6774198|NCT03913377|7702017|FG000|COMPLETED|Period 1||21
6774199|NCT03913377|7702018|FG001|COMPLETED|Period 1||21
6774200|NCT03913377|7702019|FG002|COMPLETED|Period 1||21
6774201|NCT03913377|7702017|FG000|NOT COMPLETED|Period 1||0
6774202|NCT03913377|7702018|FG001|NOT COMPLETED|Period 1||1
6774203|NCT03913377|7702019|FG002|NOT COMPLETED|Period 1||1
6774204|NCT03913377|7702017|FG000|STARTED|Period 2||0
6774205|NCT03913377|7702018|FG001|STARTED|Period 2||21
6774206|NCT03913377|7702019|FG002|STARTED|Period 2||21
6774207|NCT03913377|7702017|FG000|COMPLETED|Period 2||0
6774208|NCT03913377|7702018|FG001|COMPLETED|Period 2||21
6774209|NCT03913377|7702019|FG002|COMPLETED|Period 2||21
6774210|NCT03913377|7702017|FG000|NOT COMPLETED|Period 2||0
6774211|NCT03913377|7702018|FG001|NOT COMPLETED|Period 2||0
6774212|NCT03913377|7702019|FG002|NOT COMPLETED|Period 2||0
6774213|NCT03937791|7702026|FG000|STARTED|Overall Study||1
6313425|NCT00414973|7217739|FG000|COMPLETED|Overall Study||190
6313426|NCT00414973|7217740|FG001|COMPLETED|Overall Study||99
6313427|NCT00414973|7217741|FG002|COMPLETED|Overall Study||21
6774214|NCT03937791|7702026|FG000|COMPLETED|Overall Study||1
6774215|NCT03937791|7702026|FG000|NOT COMPLETED|Overall Study||0
6774216|NCT03937778|7702030|FG000|STARTED|Overall Study||7
6774217|NCT03937778|7702030|FG000|COMPLETED|Overall Study||5
6774218|NCT03937778|7702030|FG000|NOT COMPLETED|Overall Study||2
6774219|NCT03937479|7702039|FG000|STARTED|Overall Study||83
6774220|NCT03937479|7702040|FG001|STARTED|Overall Study||85
6313428|NCT00414973|7217742|FG003|COMPLETED|Overall Study||11
6313429|NCT00414973|7217739|FG000|NOT COMPLETED|Overall Study||28
6313430|NCT00414973|7217740|FG001|NOT COMPLETED|Overall Study||10
6313431|NCT00414973|7217741|FG002|NOT COMPLETED|Overall Study||3
6313432|NCT00414973|7217742|FG003|NOT COMPLETED|Overall Study||0
6313433|NCT00415051|7217752|FG000|STARTED|Overall Study||20
6313434|NCT00415051|7217752|FG000|COMPLETED|Overall Study||19
6313435|NCT00415051|7217752|FG000|NOT COMPLETED|Overall Study||1
6313436|NCT00415168|7217756|FG000|STARTED|Overall Study||53
6313437|NCT00415168|7217756|FG000|Completed Treatment|Overall Study||15
6313438|NCT00415168|7217756|FG000|COMPLETED|Overall Study||1
6313439|NCT00415168|7217756|FG000|NOT COMPLETED|Overall Study||52
6313440|NCT00415194|7217762|FG000|STARTED|Overall Study||398
6313441|NCT00415194|7217763|FG001|STARTED|Overall Study||397
6313442|NCT00415194|7217762|FG000|Received at Least 1 Dose of Study Drug|Overall Study||392
6313443|NCT00415194|7217763|FG001|Received at Least 1 Dose of Study Drug|Overall Study||385
6313444|NCT00415194|7217762|FG000|COMPLETED|Overall Study||70
6313445|NCT00415194|7217763|FG001|COMPLETED|Overall Study||55
6313446|NCT00415194|7217762|FG000|NOT COMPLETED|Overall Study||328
6313447|NCT00415194|7217763|FG001|NOT COMPLETED|Overall Study||342
6313448|NCT00415363|7217771|FG000|STARTED|Overall Study||55
6313449|NCT00415363|7217772|FG001|STARTED|Overall Study||54
6313450|NCT00415363|7217771|FG000|Safety Population|Overall Study||54
6313451|NCT00415363|7217772|FG001|Safety Population|Overall Study||53
6313452|NCT00415363|7217771|FG000|COMPLETED|Overall Study||0
6313453|NCT00415363|7217772|FG001|COMPLETED|Overall Study||0
6313454|NCT00415363|7217771|FG000|NOT COMPLETED|Overall Study||55
6313455|NCT00415363|7217772|FG001|NOT COMPLETED|Overall Study||54
6313456|NCT00415493|7217781|FG000|STARTED|Overall Study||12
6313457|NCT00415493|7217782|FG001|STARTED|Overall Study||12
6313458|NCT00415493|7217781|FG000|COMPLETED|Overall Study||12
6313459|NCT00415493|7217782|FG001|COMPLETED|Overall Study||12
6313460|NCT00415493|7217781|FG000|NOT COMPLETED|Overall Study||0
6774221|NCT03937479|7702041|FG002|STARTED|Overall Study||82
6774222|NCT03937479|7702042|FG003|STARTED|Overall Study||82
6774223|NCT03937479|7702043|FG004|STARTED|Overall Study||84
6774224|NCT03937479|7702039|FG000|Received Treatment|Overall Study||83
6774225|NCT03937479|7702040|FG001|Received Treatment|Overall Study||83
6774226|NCT03937479|7702041|FG002|Received Treatment|Overall Study||81
6774227|NCT03937479|7702042|FG003|Received Treatment|Overall Study||82
6774228|NCT03937479|7702043|FG004|Received Treatment|Overall Study||84
6774229|NCT03937479|7702039|FG000|COMPLETED|Overall Study||73
6774230|NCT03937479|7702040|FG001|COMPLETED|Overall Study||70
6774231|NCT03937479|7702041|FG002|COMPLETED|Overall Study||75
6774232|NCT03937479|7702042|FG003|COMPLETED|Overall Study||76
6774233|NCT03937479|7702043|FG004|COMPLETED|Overall Study||79
6774234|NCT03937479|7702039|FG000|NOT COMPLETED|Overall Study||10
6774235|NCT03937479|7702040|FG001|NOT COMPLETED|Overall Study||15
6774236|NCT03937479|7702041|FG002|NOT COMPLETED|Overall Study||7
6774237|NCT03937479|7702042|FG003|NOT COMPLETED|Overall Study||6
6774238|NCT03937479|7702043|FG004|NOT COMPLETED|Overall Study||5
6774239|NCT03936387|7702055|FG000|STARTED|Overall Study||10
6774240|NCT03936387|7702055|FG000|COMPLETED|Overall Study||10
6774241|NCT03936387|7702055|FG000|NOT COMPLETED|Overall Study||0
6774242|NCT03935399|7702061|FG000|STARTED|First Study Day||5
6774243|NCT03935399|7702062|FG001|STARTED|First Study Day||5
6774244|NCT03935399|7702061|FG000|COMPLETED|First Study Day||5
6774245|NCT03935399|7702062|FG001|COMPLETED|First Study Day||5
6774246|NCT03935399|7702061|FG000|NOT COMPLETED|First Study Day||0
6774247|NCT03935399|7702062|FG001|NOT COMPLETED|First Study Day||0
6774248|NCT03935399|7702061|FG000|STARTED|Second Study Day||5
6774249|NCT03935399|7702062|FG001|STARTED|Second Study Day||5
6774250|NCT03935399|7702061|FG000|COMPLETED|Second Study Day||5
6774251|NCT03935399|7702062|FG001|COMPLETED|Second Study Day||5
6774252|NCT03935399|7702061|FG000|NOT COMPLETED|Second Study Day||0
6774253|NCT03935399|7702062|FG001|NOT COMPLETED|Second Study Day||0
6774254|NCT03936608|7702070|FG000|STARTED|Overall Study||2
6774255|NCT03936608|7702071|FG001|STARTED|Overall Study||2
6774256|NCT03936608|7702070|FG000|COMPLETED|Overall Study||0
6774257|NCT03936608|7702071|FG001|COMPLETED|Overall Study||0
6774258|NCT03936608|7702070|FG000|NOT COMPLETED|Overall Study||2
6774259|NCT03936608|7702071|FG001|NOT COMPLETED|Overall Study||2
6774260|NCT03936244|7702079|FG000|STARTED|Overall Study||57
6774261|NCT03936244|7702080|FG001|STARTED|Overall Study||43
6774262|NCT03936244|7702079|FG000|COMPLETED|Overall Study||45
6774263|NCT03936244|7702080|FG001|COMPLETED|Overall Study||39
6774264|NCT03936244|7702079|FG000|NOT COMPLETED|Overall Study||12
6774265|NCT03936244|7702080|FG001|NOT COMPLETED|Overall Study||4
6774266|NCT03935126|7702087|FG000|STARTED|Overall Study||3
6774267|NCT03935126|7702087|FG000|COMPLETED|Overall Study||0
6313461|NCT00415493|7217782|FG001|NOT COMPLETED|Overall Study||0
6313462|NCT00415506|7217790|FG000|STARTED|Overall Study||12
6313463|NCT00415506|7217791|FG001|STARTED|Overall Study||10
6774268|NCT03935126|7702087|FG000|NOT COMPLETED|Overall Study||3
6774269|NCT03928327|7702093|FG000|STARTED|Period 1||12
6774270|NCT03928327|7702094|FG001|STARTED|Period 1||12
6774271|NCT03928327|7702093|FG000|COMPLETED|Period 1||12
6313464|NCT00415506|7217790|FG000|COMPLETED|Overall Study||9
6313465|NCT00415506|7217791|FG001|COMPLETED|Overall Study||9
6313466|NCT00415506|7217790|FG000|NOT COMPLETED|Overall Study||3
6313467|NCT00415506|7217791|FG001|NOT COMPLETED|Overall Study||1
6313468|NCT00415519|7217799|FG000|STARTED|Overall Study||13
6313469|NCT00415519|7217800|FG001|STARTED|Overall Study||12
6313470|NCT00415519|7217799|FG000|COMPLETED|Overall Study||9
6313471|NCT00415519|7217800|FG001|COMPLETED|Overall Study||12
6313472|NCT00415519|7217799|FG000|NOT COMPLETED|Overall Study||4
6313473|NCT00415519|7217800|FG001|NOT COMPLETED|Overall Study||0
6313474|NCT00415532|7217808|FG000|STARTED|Treatment Period||77
6313475|NCT00415532|7217809|FG001|STARTED|Treatment Period||157
6313476|NCT00415532|7217808|FG000|Received Treatment|Treatment Period||75
6313477|NCT00415532|7217809|FG001|Received Treatment|Treatment Period||154
6313478|NCT00415532|7217808|FG000|Switched to Romiplostim Group|Treatment Period||2
6313479|NCT00415532|7217809|FG001|Switched to Romiplostim Group|Treatment Period||0
6313480|NCT00415532|7217808|FG000|COMPLETED|Treatment Period||60
6313481|NCT00415532|7217809|FG001|COMPLETED|Treatment Period||142
6313482|NCT00415532|7217808|FG000|NOT COMPLETED|Treatment Period||17
6313483|NCT00415532|7217809|FG001|NOT COMPLETED|Treatment Period||15
6313484|NCT00415532|7217808|FG000|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
6313485|NCT00415532|7217809|FG001|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
6313486|NCT00415532|7217808|FG000|COMPLETED|Safety Follow Up Period||34
6313487|NCT00415532|7217809|FG001|COMPLETED|Safety Follow Up Period||18
6313488|NCT00415532|7217808|FG000|NOT COMPLETED|Safety Follow Up Period||9
6313489|NCT00415532|7217809|FG001|NOT COMPLETED|Safety Follow Up Period||12
6313490|NCT00415597|7217815|FG000|STARTED|Enrollment||467
6313491|NCT00415597|7217815|FG000|COMPLETED|Enrollment||465
6313492|NCT00415597|7217815|FG000|NOT COMPLETED|Enrollment||2
6313493|NCT00415597|7217815|FG000|STARTED|Treatment||465
6313494|NCT00415597|7217815|FG000|COMPLETED|Treatment||160
6313495|NCT00415597|7217815|FG000|NOT COMPLETED|Treatment||305
6313496|NCT00415610|7217822|FG000|STARTED|Overall Study||18
6313497|NCT00415610|7217823|FG001|STARTED|Overall Study||20
6313498|NCT00415610|7217824|FG002|STARTED|Overall Study||22
6313499|NCT00415610|7217822|FG000|COMPLETED|Overall Study||15
6313500|NCT00415610|7217823|FG001|COMPLETED|Overall Study||18
6313501|NCT00415610|7217824|FG002|COMPLETED|Overall Study||17
6774272|NCT03928327|7702094|FG001|COMPLETED|Period 1||12
6774273|NCT03928327|7702093|FG000|NOT COMPLETED|Period 1||0
6774274|NCT03928327|7702094|FG001|NOT COMPLETED|Period 1||0
6774275|NCT03928327|7702093|FG000|STARTED|Washout Period||12
6774276|NCT03928327|7702094|FG001|STARTED|Washout Period||12
6774277|NCT03928327|7702093|FG000|COMPLETED|Washout Period||12
6774278|NCT03928327|7702094|FG001|COMPLETED|Washout Period||12
6774279|NCT03928327|7702093|FG000|NOT COMPLETED|Washout Period||0
6774280|NCT03928327|7702094|FG001|NOT COMPLETED|Washout Period||0
6774281|NCT03928327|7702093|FG000|STARTED|Period 2||12
6774282|NCT03928327|7702094|FG001|STARTED|Period 2||12
6774283|NCT03928327|7702093|FG000|COMPLETED|Period 2||12
6774284|NCT03928327|7702094|FG001|COMPLETED|Period 2||12
6774285|NCT03928327|7702093|FG000|NOT COMPLETED|Period 2||0
6774286|NCT03928327|7702094|FG001|NOT COMPLETED|Period 2||0
6774287|NCT03933462|7702106|FG000|STARTED|Overall Study||10
6774288|NCT03933462|7702107|FG001|STARTED|Overall Study||10
6774289|NCT03933462|7702106|FG000|Crossover|Overall Study||8
6774290|NCT03933462|7702107|FG001|Crossover|Overall Study||10
6774291|NCT03933462|7702106|FG000|COMPLETED|Overall Study||8
6774292|NCT03933462|7702107|FG001|COMPLETED|Overall Study||10
6774293|NCT03933462|7702106|FG000|NOT COMPLETED|Overall Study||2
6774294|NCT03933462|7702107|FG001|NOT COMPLETED|Overall Study||0
6774295|NCT03933774|7702115|FG000|STARTED|Overall Study||12
6774296|NCT03933774|7702116|FG001|STARTED|Overall Study||13
6774297|NCT03933774|7702115|FG000|COMPLETED|Overall Study||10
6774298|NCT03933774|7702116|FG001|COMPLETED|Overall Study||11
6774299|NCT03933774|7702115|FG000|NOT COMPLETED|Overall Study||2
6774300|NCT03933774|7702116|FG001|NOT COMPLETED|Overall Study||2
6774301|NCT03931330|7702122|FG000|STARTED|Overall Study||8
6774302|NCT03931330|7702122|FG000|4 Weeks of Neuromodulation|Overall Study|at 4 weeks of neuromodulation|7
6774303|NCT03931330|7702122|FG000|COMPLETED|Overall Study||7
6774304|NCT03931330|7702122|FG000|NOT COMPLETED|Overall Study||1
6774305|NCT03918811|7702129|FG000|STARTED|Overall Study||367
6774306|NCT03918811|7702130|FG001|STARTED|Overall Study||358
6774307|NCT03918811|7702129|FG000|COMPLETED|Overall Study||363
6774308|NCT03918811|7702130|FG001|COMPLETED|Overall Study||345
6774309|NCT03918811|7702129|FG000|NOT COMPLETED|Overall Study||4
6774310|NCT03918811|7702130|FG001|NOT COMPLETED|Overall Study||13
6774311|NCT03933618|7702142|FG000|STARTED|Baseline||4
6774312|NCT03933618|7702143|FG001|STARTED|Baseline||4
6774313|NCT03933618|7702144|FG002|STARTED|Baseline||4
6774314|NCT03933618|7702145|FG003|STARTED|Baseline||4
6774315|NCT03933618|7702146|FG004|STARTED|Baseline||4
6313502|NCT00415610|7217822|FG000|NOT COMPLETED|Overall Study||3
6313503|NCT00415610|7217823|FG001|NOT COMPLETED|Overall Study||2
6313504|NCT00415610|7217824|FG002|NOT COMPLETED|Overall Study||5
6313505|NCT00415636|7217838|FG000|STARTED|Overall Study||3
6774316|NCT03933618|7702147|FG005|STARTED|Baseline||4
6774317|NCT03933618|7702142|FG000|COMPLETED|Baseline||4
6774318|NCT03933618|7702143|FG001|COMPLETED|Baseline||4
6774319|NCT03933618|7702144|FG002|COMPLETED|Baseline||4
6774320|NCT03933618|7702145|FG003|COMPLETED|Baseline||4
6774321|NCT03933618|7702146|FG004|COMPLETED|Baseline||4
6774322|NCT03933618|7702147|FG005|COMPLETED|Baseline||4
6313506|NCT00415636|7217839|FG001|STARTED|Overall Study||3
6313507|NCT00415636|7217840|FG002|STARTED|Overall Study||3
6774323|NCT03933618|7702142|FG000|NOT COMPLETED|Baseline||0
6313508|NCT00415636|7217841|FG003|STARTED|Overall Study||13
6313509|NCT00415636|7217842|FG004|STARTED|Overall Study||6
6313510|NCT00415636|7217843|FG005|STARTED|Overall Study||3
6313511|NCT00415636|7217838|FG000|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
6313512|NCT00415636|7217839|FG001|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|3
6313513|NCT00415636|7217840|FG002|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|2
6313514|NCT00415636|7217841|FG003|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|7
6313515|NCT00415636|7217842|FG004|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|4
6313516|NCT00415636|7217843|FG005|COMPLETED|Overall Study|Completed = Participant received 2 cycles of treatment|1
6313517|NCT00415636|7217838|FG000|NOT COMPLETED|Overall Study||1
6313518|NCT00415636|7217839|FG001|NOT COMPLETED|Overall Study||0
6313519|NCT00415636|7217840|FG002|NOT COMPLETED|Overall Study||1
6313520|NCT00415636|7217841|FG003|NOT COMPLETED|Overall Study||6
6313521|NCT00415636|7217842|FG004|NOT COMPLETED|Overall Study||2
6313522|NCT00415636|7217843|FG005|NOT COMPLETED|Overall Study||2
6313523|NCT00415857|7217867|FG000|STARTED|Overall Study||2
6313524|NCT00415857|7217868|FG001|STARTED|Overall Study||3
6313525|NCT00415857|7217867|FG000|COMPLETED|Overall Study||2
6313526|NCT00415857|7217868|FG001|COMPLETED|Overall Study||3
6313527|NCT00415857|7217867|FG000|NOT COMPLETED|Overall Study||0
6313528|NCT00415857|7217868|FG001|NOT COMPLETED|Overall Study||0
6774324|NCT03933618|7702143|FG001|NOT COMPLETED|Baseline||0
6774325|NCT03933618|7702144|FG002|NOT COMPLETED|Baseline||0
6774326|NCT03933618|7702145|FG003|NOT COMPLETED|Baseline||0
6774327|NCT03933618|7702146|FG004|NOT COMPLETED|Baseline||0
6774328|NCT03933618|7702147|FG005|NOT COMPLETED|Baseline||0
6774329|NCT03933618|7702142|FG000|STARTED|Baseline to Week 8||4
6774330|NCT03933618|7702143|FG001|STARTED|Baseline to Week 8||4
6774331|NCT03933618|7702144|FG002|STARTED|Baseline to Week 8||4
6774332|NCT03933618|7702145|FG003|STARTED|Baseline to Week 8||4
6774333|NCT03933618|7702146|FG004|STARTED|Baseline to Week 8||4
6774334|NCT03933618|7702147|FG005|STARTED|Baseline to Week 8||4
6774335|NCT03933618|7702142|FG000|COMPLETED|Baseline to Week 8||4
6774336|NCT03933618|7702143|FG001|COMPLETED|Baseline to Week 8||4
6774337|NCT03933618|7702144|FG002|COMPLETED|Baseline to Week 8||4
6774338|NCT03933618|7702145|FG003|COMPLETED|Baseline to Week 8||4
6774339|NCT03933618|7702146|FG004|COMPLETED|Baseline to Week 8||4
6774340|NCT03933618|7702147|FG005|COMPLETED|Baseline to Week 8||4
6774341|NCT03933618|7702142|FG000|NOT COMPLETED|Baseline to Week 8||0
6774342|NCT03933618|7702143|FG001|NOT COMPLETED|Baseline to Week 8||0
6774343|NCT03933618|7702144|FG002|NOT COMPLETED|Baseline to Week 8||0
6774344|NCT03933618|7702145|FG003|NOT COMPLETED|Baseline to Week 8||0
6774345|NCT03933618|7702146|FG004|NOT COMPLETED|Baseline to Week 8||0
6774346|NCT03933618|7702147|FG005|NOT COMPLETED|Baseline to Week 8||0
6774347|NCT03933618|7702142|FG000|STARTED|Week 8 to Week 16||4
6774348|NCT03933618|7702143|FG001|STARTED|Week 8 to Week 16||4
6774349|NCT03933618|7702144|FG002|STARTED|Week 8 to Week 16||4
6774350|NCT03933618|7702145|FG003|STARTED|Week 8 to Week 16||4
6774351|NCT03933618|7702146|FG004|STARTED|Week 8 to Week 16||4
6774352|NCT03933618|7702147|FG005|STARTED|Week 8 to Week 16||4
6774353|NCT03933618|7702142|FG000|COMPLETED|Week 8 to Week 16||4
6774354|NCT03933618|7702143|FG001|COMPLETED|Week 8 to Week 16||4
6774355|NCT03933618|7702144|FG002|COMPLETED|Week 8 to Week 16||4
6774356|NCT03933618|7702145|FG003|COMPLETED|Week 8 to Week 16||4
6774357|NCT03933618|7702146|FG004|COMPLETED|Week 8 to Week 16||4
6774358|NCT03933618|7702147|FG005|COMPLETED|Week 8 to Week 16||4
6774359|NCT03933618|7702142|FG000|NOT COMPLETED|Week 8 to Week 16||0
6774360|NCT03933618|7702143|FG001|NOT COMPLETED|Week 8 to Week 16||0
6774361|NCT03933618|7702144|FG002|NOT COMPLETED|Week 8 to Week 16||0
6774362|NCT03933618|7702145|FG003|NOT COMPLETED|Week 8 to Week 16||0
6774363|NCT03933618|7702146|FG004|NOT COMPLETED|Week 8 to Week 16||0
6774364|NCT03933618|7702147|FG005|NOT COMPLETED|Week 8 to Week 16||0
6774365|NCT03933618|7702142|FG000|STARTED|Week 16 to Week 24||4
6774366|NCT03933618|7702143|FG001|STARTED|Week 16 to Week 24||4
6774367|NCT03933618|7702144|FG002|STARTED|Week 16 to Week 24||4
6774368|NCT03933618|7702145|FG003|STARTED|Week 16 to Week 24||4
6774369|NCT03933618|7702146|FG004|STARTED|Week 16 to Week 24||4
6774370|NCT03933618|7702147|FG005|STARTED|Week 16 to Week 24||4
6774371|NCT03933618|7702142|FG000|COMPLETED|Week 16 to Week 24||4
6774372|NCT03933618|7702143|FG001|COMPLETED|Week 16 to Week 24||4
6774373|NCT03933618|7702144|FG002|COMPLETED|Week 16 to Week 24||4
6774374|NCT03933618|7702145|FG003|COMPLETED|Week 16 to Week 24||4
6774375|NCT03933618|7702146|FG004|COMPLETED|Week 16 to Week 24||4
6774376|NCT03933618|7702147|FG005|COMPLETED|Week 16 to Week 24||4
6774377|NCT03933618|7702142|FG000|NOT COMPLETED|Week 16 to Week 24||0
6774378|NCT03933618|7702143|FG001|NOT COMPLETED|Week 16 to Week 24||0
6774379|NCT03933618|7702144|FG002|NOT COMPLETED|Week 16 to Week 24||0
6774380|NCT03933618|7702145|FG003|NOT COMPLETED|Week 16 to Week 24||0
6774381|NCT03933618|7702146|FG004|NOT COMPLETED|Week 16 to Week 24||0
6774382|NCT03933618|7702147|FG005|NOT COMPLETED|Week 16 to Week 24||0
6774383|NCT03931785|7702165|FG000|STARTED|Overall Study||97
6774384|NCT03931785|7702166|FG001|STARTED|Overall Study||97
6774385|NCT03931785|7702167|FG002|STARTED|Overall Study||97
6774386|NCT03931785|7702168|FG003|STARTED|Overall Study||97
6774387|NCT03931785|7702165|FG000|COMPLETED|Overall Study||92
6774388|NCT03931785|7702166|FG001|COMPLETED|Overall Study||90
6774389|NCT03931785|7702167|FG002|COMPLETED|Overall Study||84
6313529|NCT00415870|7217876|FG000|STARTED|Overall Study||32
6313530|NCT00415870|7217877|FG001|STARTED|Overall Study||33
6313531|NCT00415870|7217876|FG000|COMPLETED|Overall Study||26
6313532|NCT00415870|7217877|FG001|COMPLETED|Overall Study||26
6313533|NCT00415870|7217876|FG000|NOT COMPLETED|Overall Study||6
6313534|NCT00415870|7217877|FG001|NOT COMPLETED|Overall Study||7
6313535|NCT00415909|7217883|FG000|STARTED|Overall Study||3
6313536|NCT00415909|7217883|FG000|COMPLETED|Overall Study||0
6313537|NCT00415909|7217883|FG000|NOT COMPLETED|Overall Study||3
6313538|NCT00416078|7217889|FG000|STARTED|Overall Study||29
6313539|NCT00416078|7217890|FG001|STARTED|Overall Study||24
6313540|NCT00416078|7217889|FG000|COMPLETED|Overall Study||18
6774390|NCT03931785|7702168|FG003|COMPLETED|Overall Study||86
6774391|NCT03931785|7702165|FG000|NOT COMPLETED|Overall Study||5
6774392|NCT03931785|7702166|FG001|NOT COMPLETED|Overall Study||7
6774393|NCT03931785|7702167|FG002|NOT COMPLETED|Overall Study||13
6774394|NCT03931785|7702168|FG003|NOT COMPLETED|Overall Study||11
6774395|NCT03930641|7702178|FG000|STARTED|Overall Study||34
6774396|NCT03930641|7702178|FG000|COMPLETED|Overall Study||34
6774397|NCT03930641|7702178|FG000|NOT COMPLETED|Overall Study||0
6774398|NCT03927846|7702184|FG000|STARTED|Overall Study||30
6774399|NCT03927846|7702185|FG001|STARTED|Overall Study||30
6774400|NCT03927846|7702184|FG000|COMPLETED|Overall Study||20
6774401|NCT03927846|7702185|FG001|COMPLETED|Overall Study||19
6774402|NCT03927846|7702184|FG000|NOT COMPLETED|Overall Study||10
6774403|NCT03927846|7702185|FG001|NOT COMPLETED|Overall Study||11
6774404|NCT03927105|7702191|FG000|STARTED|Overall Study||4
6774405|NCT03927105|7702191|FG000|Began Treatment|Overall Study||3
6774406|NCT03927105|7702191|FG000|Follow-up|Overall Study||3
6774407|NCT03927105|7702191|FG000|COMPLETED|Overall Study||0
6774408|NCT03927105|7702191|FG000|NOT COMPLETED|Overall Study||4
6774409|NCT03923933|7702197|FG000|STARTED|Overall Study||17
6774410|NCT03923933|7702198|FG001|STARTED|Overall Study||17
6774411|NCT03923933|7702197|FG000|COMPLETED|Overall Study||16
6774412|NCT03923933|7702198|FG001|COMPLETED|Overall Study||16
6774413|NCT03923933|7702197|FG000|NOT COMPLETED|Overall Study||1
6774414|NCT03923933|7702198|FG001|NOT COMPLETED|Overall Study||1
6774415|NCT03909295|7702204|FG000|STARTED|Overall Study||52
6774416|NCT03909295|7702204|FG000|Safety Set (SAF)|Overall Study||52
6774417|NCT03909295|7702204|FG000|COMPLETED|Overall Study||0
6774418|NCT03909295|7702204|FG000|NOT COMPLETED|Overall Study||52
6774419|NCT03908970|7702210|FG000|STARTED|Overall Study||182
6774420|NCT03908970|7702211|FG001|STARTED|Overall Study||182
6774421|NCT03908970|7702210|FG000|COMPLETED|Overall Study||165
6774422|NCT03908970|7702211|FG001|COMPLETED|Overall Study||135
6774423|NCT03908970|7702210|FG000|NOT COMPLETED|Overall Study||17
6774424|NCT03908970|7702211|FG001|NOT COMPLETED|Overall Study||47
6774425|NCT03897179|7702217|FG000|STARTED|Overall Study||27
6774426|NCT03897179|7702217|FG000|COMPLETED|Overall Study||26
6774427|NCT03897179|7702217|FG000|NOT COMPLETED|Overall Study||1
6774428|NCT03930264|7702223|FG000|STARTED|Overall Study||15
6774429|NCT03930264|7702224|FG001|STARTED|Overall Study||15
6774430|NCT03930264|7702223|FG000|COMPLETED|Overall Study||15
6774431|NCT03930264|7702224|FG001|COMPLETED|Overall Study||14
6774432|NCT03930264|7702223|FG000|NOT COMPLETED|Overall Study||0
6774433|NCT03930264|7702224|FG001|NOT COMPLETED|Overall Study||1
6774434|NCT03929367|7702230|FG000|STARTED|Overall Study||11
6774435|NCT03929367|7702230|FG000|COMPLETED|Overall Study||11
6774436|NCT03929367|7702230|FG000|NOT COMPLETED|Overall Study||0
6774437|NCT03928522|7702239|FG000|STARTED|Overall Study||12
6774438|NCT03928522|7702240|FG001|STARTED|Overall Study||12
6774439|NCT03928522|7702241|FG002|STARTED|Overall Study||12
6774440|NCT03928522|7702242|FG003|STARTED|Overall Study||12
6774441|NCT03928522|7702243|FG004|STARTED|Overall Study||12
6774442|NCT03928522|7702239|FG000|COMPLETED|Overall Study||12
6774443|NCT03928522|7702240|FG001|COMPLETED|Overall Study||12
6774444|NCT03928522|7702241|FG002|COMPLETED|Overall Study||12
6774445|NCT03928522|7702242|FG003|COMPLETED|Overall Study||12
6774446|NCT03928522|7702243|FG004|COMPLETED|Overall Study||12
6774447|NCT03928522|7702239|FG000|NOT COMPLETED|Overall Study||0
6774448|NCT03928522|7702240|FG001|NOT COMPLETED|Overall Study||0
6774449|NCT03928522|7702241|FG002|NOT COMPLETED|Overall Study||0
6774450|NCT03928522|7702242|FG003|NOT COMPLETED|Overall Study||0
6774451|NCT03928522|7702243|FG004|NOT COMPLETED|Overall Study||0
6774452|NCT03910439|7702255|FG000|STARTED|Overall Study||4
6774453|NCT03910439|7702255|FG000|COMPLETED|Overall Study||4
6774454|NCT03910439|7702255|FG000|NOT COMPLETED|Overall Study||0
6774455|NCT03907241|7702266|FG000|STARTED|Overall Study||27
6774456|NCT03907241|7702266|FG000|COMPLETED|Overall Study||23
6774457|NCT03907241|7702266|FG000|NOT COMPLETED|Overall Study||4
6774458|NCT03927950|7702281|FG000|STARTED|Overall Study||135
6774459|NCT03927950|7702281|FG000|COMPLETED|Overall Study||126
6774460|NCT03927950|7702281|FG000|NOT COMPLETED|Overall Study||9
6774461|NCT03927781|7702286|FG000|STARTED|Overall Study||10
6774462|NCT03927781|7702286|FG000|COMPLETED|Overall Study||10
6774463|NCT03927781|7702286|FG000|NOT COMPLETED|Overall Study||0
6774464|NCT03927209|7702292|FG000|STARTED|Overall Study||5
6774465|NCT03927209|7702293|FG001|STARTED|Overall Study||5
6774466|NCT03927209|7702292|FG000|COMPLETED|Overall Study||5
6774467|NCT03927209|7702293|FG001|COMPLETED|Overall Study||5
6313541|NCT00416078|7217890|FG001|COMPLETED|Overall Study||16
6774468|NCT03927209|7702292|FG000|NOT COMPLETED|Overall Study||0
6774469|NCT03927209|7702293|FG001|NOT COMPLETED|Overall Study||0
6313542|NCT00416078|7217889|FG000|NOT COMPLETED|Overall Study||11
6313543|NCT00416078|7217890|FG001|NOT COMPLETED|Overall Study||8
6313544|NCT00416182|7217898|FG000|STARTED|Overall Study||8
6313545|NCT00416182|7217899|FG001|STARTED|Overall Study||8
6313546|NCT00416182|7217898|FG000|COMPLETED|Overall Study||5
6313547|NCT00416182|7217899|FG001|COMPLETED|Overall Study||6
6313548|NCT00416182|7217898|FG000|NOT COMPLETED|Overall Study||3
6313549|NCT00416182|7217899|FG001|NOT COMPLETED|Overall Study||2
6313550|NCT00416195|7217913|FG000|STARTED|Overall Study||10
6313551|NCT00416195|7217914|FG001|STARTED|Overall Study||38
6313552|NCT00416195|7217913|FG000|COMPLETED|Overall Study||8
6313553|NCT00416195|7217914|FG001|COMPLETED|Overall Study||34
6313554|NCT00416195|7217913|FG000|NOT COMPLETED|Overall Study||2
6313555|NCT00416195|7217914|FG001|NOT COMPLETED|Overall Study||4
6313556|NCT00416312|7217920|FG000|STARTED|Overall Study||9
6313557|NCT00416312|7217920|FG000|Conventional Dosimetry|Overall Study||9
6313558|NCT00416312|7217920|FG000|Patient-specific Dosimetry|Overall Study||9
6313559|NCT00416312|7217920|FG000|COMPLETED|Overall Study||7
6313560|NCT00416312|7217920|FG000|NOT COMPLETED|Overall Study||2
6313561|NCT00416455|7217926|FG000|STARTED|Overall Study|This is a diagnostic imaging study.|169
6377842|NCT00765388|7288507|FG000|STARTED|Period 1|A cross-over study|16
6774470|NCT03920670|7702303|FG000|STARTED|Overall Study||60
6774471|NCT03920670|7702304|FG001|STARTED|Overall Study||60
6774472|NCT03920670|7702303|FG000|COMPLETED|Overall Study||57
6774473|NCT03920670|7702304|FG001|COMPLETED|Overall Study||58
6774474|NCT03920670|7702303|FG000|NOT COMPLETED|Overall Study||3
6774475|NCT03920670|7702304|FG001|NOT COMPLETED|Overall Study||2
6774476|NCT03919422|7702312|FG000|STARTED|Overall Study||40
6774477|NCT03919422|7702313|FG001|STARTED|Overall Study||40
6774478|NCT03919422|7702312|FG000|COMPLETED|Overall Study||40
6774479|NCT03919422|7702313|FG001|COMPLETED|Overall Study||40
6774480|NCT03919422|7702312|FG000|NOT COMPLETED|Overall Study||0
6774481|NCT03919422|7702313|FG001|NOT COMPLETED|Overall Study||0
6774482|NCT03907579|7702319|FG000|STARTED|Overall Study||100
6774483|NCT03907579|7702319|FG000|COMPLETED|Overall Study||100
6774484|NCT03907579|7702319|FG000|NOT COMPLETED|Overall Study||0
6774485|NCT03905811|7702325|FG000|STARTED|Overall Study||8
6774486|NCT03905811|7702326|FG001|STARTED|Overall Study||5
6774487|NCT03905811|7702325|FG000|COMPLETED|Overall Study||6
6774488|NCT03905811|7702326|FG001|COMPLETED|Overall Study||5
6774489|NCT03905811|7702325|FG000|NOT COMPLETED|Overall Study||2
6774490|NCT03905811|7702326|FG001|NOT COMPLETED|Overall Study||0
6774491|NCT03898063|7702334|FG000|STARTED|Overall Study||74
6774492|NCT03898063|7702335|FG001|STARTED|Overall Study||74
6774493|NCT03898063|7702334|FG000|COMPLETED|Overall Study||64
6774494|NCT03898063|7702335|FG001|COMPLETED|Overall Study||66
6774495|NCT03898063|7702334|FG000|NOT COMPLETED|Overall Study||10
6774496|NCT03898063|7702335|FG001|NOT COMPLETED|Overall Study||8
6774497|NCT03895307|7702345|FG000|STARTED|Overall Study||21
6774498|NCT03895307|7702346|FG001|STARTED|Overall Study||20
6774499|NCT03895307|7702347|FG002|STARTED|Overall Study||22
6774500|NCT03895307|7702348|FG003|STARTED|Overall Study||21
6774501|NCT03895307|7702345|FG000|COMPLETED|Overall Study||19
6774502|NCT03895307|7702346|FG001|COMPLETED|Overall Study||20
6774503|NCT03895307|7702347|FG002|COMPLETED|Overall Study||20
6774504|NCT03895307|7702348|FG003|COMPLETED|Overall Study||21
6774505|NCT03895307|7702345|FG000|NOT COMPLETED|Overall Study||2
6774506|NCT03895307|7702346|FG001|NOT COMPLETED|Overall Study||0
6774507|NCT03895307|7702347|FG002|NOT COMPLETED|Overall Study||2
6774508|NCT03895307|7702348|FG003|NOT COMPLETED|Overall Study||0
6774509|NCT03926208|7702360|FG000|STARTED|Overall Study||119
6774510|NCT03926208|7702361|FG001|STARTED|Overall Study||123
6774511|NCT03926208|7702360|FG000|COMPLETED|Overall Study||119
6774512|NCT03926208|7702361|FG001|COMPLETED|Overall Study||123
6774513|NCT03926208|7702360|FG000|NOT COMPLETED|Overall Study||0
6774514|NCT03926208|7702361|FG001|NOT COMPLETED|Overall Study||0
6774515|NCT03926065|7702367|FG000|STARTED|Study Week 1||11
6774516|NCT03926065|7702368|FG001|STARTED|Study Week 1||9
6774517|NCT03926065|7702369|FG002|STARTED|Study Week 1||14
6774518|NCT03926065|7702370|FG003|STARTED|Study Week 1||18
6774519|NCT03926065|7702371|FG004|STARTED|Study Week 1||15
6774520|NCT03926065|7702367|FG000|COMPLETED|Study Week 1||11
6774521|NCT03926065|7702368|FG001|COMPLETED|Study Week 1||9
6774522|NCT03926065|7702369|FG002|COMPLETED|Study Week 1||14
6774523|NCT03926065|7702370|FG003|COMPLETED|Study Week 1||18
6774524|NCT03926065|7702371|FG004|COMPLETED|Study Week 1||15
6774525|NCT03926065|7702367|FG000|NOT COMPLETED|Study Week 1||0
6774526|NCT03926065|7702368|FG001|NOT COMPLETED|Study Week 1||0
6774527|NCT03926065|7702369|FG002|NOT COMPLETED|Study Week 1||0
6774528|NCT03926065|7702370|FG003|NOT COMPLETED|Study Week 1||0
6774529|NCT03926065|7702371|FG004|NOT COMPLETED|Study Week 1||0
6774530|NCT03926065|7702367|FG000|STARTED|Study Week 2||11
6774531|NCT03926065|7702368|FG001|STARTED|Study Week 2||9
6774532|NCT03926065|7702369|FG002|STARTED|Study Week 2||14
6774533|NCT03926065|7702370|FG003|STARTED|Study Week 2||18
6774534|NCT03926065|7702371|FG004|STARTED|Study Week 2||15
6774535|NCT03926065|7702367|FG000|COMPLETED|Study Week 2||11
6774536|NCT03926065|7702368|FG001|COMPLETED|Study Week 2||9
6774537|NCT03926065|7702369|FG002|COMPLETED|Study Week 2||14
6774538|NCT03926065|7702370|FG003|COMPLETED|Study Week 2||18
6774539|NCT03926065|7702371|FG004|COMPLETED|Study Week 2||15
6774540|NCT03926065|7702367|FG000|NOT COMPLETED|Study Week 2||0
6774541|NCT03926065|7702368|FG001|NOT COMPLETED|Study Week 2||0
6313562|NCT00416455|7217927|FG001|STARTED|Overall Study|This is a diagnostic imaging study.|215
6313563|NCT00416455|7217926|FG000|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
6313564|NCT00416455|7217927|FG001|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
6774542|NCT03926065|7702369|FG002|NOT COMPLETED|Study Week 2||0
6774543|NCT03926065|7702370|FG003|NOT COMPLETED|Study Week 2||0
6774544|NCT03926065|7702371|FG004|NOT COMPLETED|Study Week 2||0
6774545|NCT03926065|7702367|FG000|STARTED|Study Week 3||11
6774546|NCT03926065|7702368|FG001|STARTED|Study Week 3||9
6774547|NCT03926065|7702369|FG002|STARTED|Study Week 3||14
6774548|NCT03926065|7702370|FG003|STARTED|Study Week 3||18
6774549|NCT03926065|7702371|FG004|STARTED|Study Week 3||15
6774550|NCT03926065|7702367|FG000|COMPLETED|Study Week 3||11
6774551|NCT03926065|7702368|FG001|COMPLETED|Study Week 3||9
6774552|NCT03926065|7702369|FG002|COMPLETED|Study Week 3||14
6774553|NCT03926065|7702370|FG003|COMPLETED|Study Week 3||18
6774554|NCT03926065|7702371|FG004|COMPLETED|Study Week 3||15
6774555|NCT03926065|7702367|FG000|NOT COMPLETED|Study Week 3||0
6774556|NCT03926065|7702368|FG001|NOT COMPLETED|Study Week 3||0
6774557|NCT03926065|7702369|FG002|NOT COMPLETED|Study Week 3||0
6774558|NCT03926065|7702370|FG003|NOT COMPLETED|Study Week 3||0
6774559|NCT03926065|7702371|FG004|NOT COMPLETED|Study Week 3||0
6774560|NCT03926065|7702367|FG000|STARTED|Study Week 4||11
6774561|NCT03926065|7702368|FG001|STARTED|Study Week 4||9
6774562|NCT03926065|7702369|FG002|STARTED|Study Week 4||14
6774563|NCT03926065|7702370|FG003|STARTED|Study Week 4||18
6774564|NCT03926065|7702371|FG004|STARTED|Study Week 4||15
6774565|NCT03926065|7702367|FG000|COMPLETED|Study Week 4||11
6774566|NCT03926065|7702368|FG001|COMPLETED|Study Week 4||9
6774567|NCT03926065|7702369|FG002|COMPLETED|Study Week 4||14
6774568|NCT03926065|7702370|FG003|COMPLETED|Study Week 4||18
6774569|NCT03926065|7702371|FG004|COMPLETED|Study Week 4||15
6774570|NCT03926065|7702367|FG000|NOT COMPLETED|Study Week 4||0
6774571|NCT03926065|7702368|FG001|NOT COMPLETED|Study Week 4||0
6774572|NCT03926065|7702369|FG002|NOT COMPLETED|Study Week 4||0
6774573|NCT03926065|7702370|FG003|NOT COMPLETED|Study Week 4||0
6774574|NCT03926065|7702371|FG004|NOT COMPLETED|Study Week 4||0
6774575|NCT03909100|7702381|FG000|STARTED|Overall Study||120
6774576|NCT03909100|7702381|FG000|Safety Population|Overall Study||112
6774577|NCT03909100|7702381|FG000|Received Treatment in Session 2|Overall Study||107
6774578|NCT03909100|7702381|FG000|Evaluable Population|Overall Study||106
6774579|NCT03909100|7702381|FG000|COMPLETED|Overall Study||105
6774580|NCT03909100|7702381|FG000|NOT COMPLETED|Overall Study||15
6774581|NCT03905642|7702388|FG000|STARTED|Overall Study||49
6774582|NCT03905642|7702388|FG000|COMPLETED|Overall Study||41
6774583|NCT03905642|7702388|FG000|NOT COMPLETED|Overall Study||8
6774584|NCT03892889|7702392|FG000|STARTED|Overall Study||277
6774585|NCT03892889|7702392|FG000|COMPLETED|Overall Study||73
6774586|NCT03892889|7702392|FG000|NOT COMPLETED|Overall Study||204
6774587|NCT03921723|7702396|FG000|STARTED|Period 1 (4 Days)||22
6774588|NCT03921723|7702396|FG000|COMPLETED|Period 1 (4 Days)||22
6774589|NCT03921723|7702396|FG000|NOT COMPLETED|Period 1 (4 Days)||0
6774590|NCT03921723|7702396|FG000|STARTED|Period 2 (4 Days)||22
6774591|NCT03921723|7702396|FG000|COMPLETED|Period 2 (4 Days)||19
6774592|NCT03921723|7702396|FG000|NOT COMPLETED|Period 2 (4 Days)||3
6774593|NCT03921723|7702396|FG000|STARTED|Period 3 (4 Days)||19
6774594|NCT03921723|7702396|FG000|COMPLETED|Period 3 (4 Days)||18
6774595|NCT03921723|7702396|FG000|NOT COMPLETED|Period 3 (4 Days)||1
6774596|NCT03921190|7702406|FG000|STARTED|Overall Study||56
6774597|NCT03921190|7702407|FG001|STARTED|Overall Study||64
6774598|NCT03921190|7702406|FG000|COMPLETED|Overall Study||56
6774599|NCT03921190|7702407|FG001|COMPLETED|Overall Study||64
6774600|NCT03921190|7702406|FG000|NOT COMPLETED|Overall Study||0
6774601|NCT03921190|7702407|FG001|NOT COMPLETED|Overall Study||0
6774602|NCT03920865|7702418|FG000|STARTED|Overall Study||8
6774603|NCT03920865|7702419|FG001|STARTED|Overall Study||8
6774604|NCT03920865|7702420|FG002|STARTED|Overall Study||10
6774605|NCT03920865|7702418|FG000|COMPLETED|Overall Study||8
6774606|NCT03920865|7702419|FG001|COMPLETED|Overall Study||8
6774607|NCT03920865|7702420|FG002|COMPLETED|Overall Study||10
6774608|NCT03920865|7702418|FG000|NOT COMPLETED|Overall Study||0
6774609|NCT03920865|7702419|FG001|NOT COMPLETED|Overall Study||0
6774610|NCT03920865|7702420|FG002|NOT COMPLETED|Overall Study||0
6774611|NCT03918239|7702440|FG000|STARTED|Overall Study||94
6774612|NCT03918239|7702441|FG001|STARTED|Overall Study||96
6774613|NCT03918239|7702440|FG000|COMPLETED|Overall Study||84
6774614|NCT03918239|7702441|FG001|COMPLETED|Overall Study||89
6774615|NCT03918239|7702440|FG000|NOT COMPLETED|Overall Study||10
6774616|NCT03918239|7702441|FG001|NOT COMPLETED|Overall Study||7
6774617|NCT03917823|7702449|FG000|STARTED|Overall Study||2
6774618|NCT03917823|7702450|FG001|STARTED|Overall Study||2
6774619|NCT03917823|7702449|FG000|COMPLETED|Overall Study||1
6774620|NCT03917823|7702450|FG001|COMPLETED|Overall Study||0
6774621|NCT03917823|7702449|FG000|NOT COMPLETED|Overall Study||1
6774622|NCT03917823|7702450|FG001|NOT COMPLETED|Overall Study||2
6774623|NCT03911752|7702459|FG000|STARTED|Overall Study||8
6774624|NCT03911752|7702460|FG001|STARTED|Overall Study||2
6774625|NCT03911752|7702461|FG002|STARTED|Overall Study||2
6774626|NCT03911752|7702459|FG000|COMPLETED|Overall Study||8
6774627|NCT03911752|7702460|FG001|COMPLETED|Overall Study||2
6774628|NCT03911752|7702461|FG002|COMPLETED|Overall Study||2
6774629|NCT03911752|7702459|FG000|NOT COMPLETED|Overall Study||0
6313565|NCT00416455|7217926|FG000|NOT COMPLETED|Overall Study||16
6313566|NCT00416455|7217927|FG001|NOT COMPLETED|Overall Study||8
6313567|NCT00416494|7217946|FG000|STARTED|Overall Study||19
6313568|NCT00416494|7217947|FG001|STARTED|Overall Study||31
6313569|NCT00416494|7217946|FG000|COMPLETED|Overall Study||19
6313570|NCT00416494|7217947|FG001|COMPLETED|Overall Study||31
6313571|NCT00416494|7217946|FG000|NOT COMPLETED|Overall Study||0
6313572|NCT00416494|7217947|FG001|NOT COMPLETED|Overall Study||0
6313573|NCT00416520|7217955|FG000|STARTED|Open-label Period||165
6313574|NCT00416520|7217956|FG001|STARTED|Open-label Period||171
6313575|NCT00416520|7217957|FG002|STARTED|Open-label Period||0
6313576|NCT00416520|7217958|FG003|STARTED|Open-label Period||0
6313577|NCT00416520|7217955|FG000|COMPLETED|Open-label Period||105
6313578|NCT00416520|7217956|FG001|COMPLETED|Open-label Period||139
6313579|NCT00416520|7217957|FG002|COMPLETED|Open-label Period||0
6313580|NCT00416520|7217958|FG003|COMPLETED|Open-label Period||0
6313581|NCT00416520|7217955|FG000|NOT COMPLETED|Open-label Period||60
6313582|NCT00416520|7217956|FG001|NOT COMPLETED|Open-label Period||32
6774630|NCT03911752|7702460|FG001|NOT COMPLETED|Overall Study||0
6774631|NCT03911752|7702461|FG002|NOT COMPLETED|Overall Study||0
6774632|NCT03902613|7702471|FG000|STARTED|Overall Study||1
6774633|NCT03902613|7702471|FG000|COMPLETED|Overall Study||0
6774634|NCT03902613|7702471|FG000|NOT COMPLETED|Overall Study||1
6774635|NCT03902574|7702478|FG000|STARTED|Overall Study||7
6774636|NCT03902574|7702479|FG001|STARTED|Overall Study||7
6774637|NCT03902574|7702480|FG002|STARTED|Overall Study||7
6774638|NCT03902574|7702478|FG000|COMPLETED|Overall Study||7
6774639|NCT03902574|7702479|FG001|COMPLETED|Overall Study||7
6774640|NCT03902574|7702480|FG002|COMPLETED|Overall Study||6
6774641|NCT03902574|7702478|FG000|NOT COMPLETED|Overall Study||0
6774642|NCT03902574|7702479|FG001|NOT COMPLETED|Overall Study||0
6774643|NCT03902574|7702480|FG002|NOT COMPLETED|Overall Study||1
6774644|NCT03914950|7702488|FG000|STARTED|Overall Study||174
6774645|NCT03914950|7702488|FG000|COMPLETED|Overall Study||120
6774646|NCT03914950|7702488|FG000|NOT COMPLETED|Overall Study||54
6774647|NCT03911843|7702500|FG000|STARTED|Overall Study||26
6774648|NCT03911843|7702501|FG001|STARTED|Overall Study||38
6774649|NCT03911843|7702500|FG000|COMPLETED|Overall Study||22
6774650|NCT03911843|7702501|FG001|COMPLETED|Overall Study||37
6774651|NCT03911843|7702500|FG000|NOT COMPLETED|Overall Study||4
6774652|NCT03911843|7702501|FG001|NOT COMPLETED|Overall Study||1
6774653|NCT03896633|7702509|FG000|STARTED|Overall Study||321
6774654|NCT03896633|7702510|FG001|STARTED|Overall Study||316
6774655|NCT03896633|7702509|FG000|COMPLETED|Overall Study||312
6774656|NCT03896633|7702510|FG001|COMPLETED|Overall Study||306
6774657|NCT03896633|7702509|FG000|NOT COMPLETED|Overall Study||9
6774658|NCT03896633|7702510|FG001|NOT COMPLETED|Overall Study||10
6774659|NCT03894813|7702518|FG000|STARTED|Overall Study||63
6774660|NCT03894813|7702519|FG001|STARTED|Overall Study||63
6774661|NCT03894813|7702518|FG000|COMPLETED|Overall Study||52
6774662|NCT03894813|7702519|FG001|COMPLETED|Overall Study||47
6774663|NCT03894813|7702518|FG000|NOT COMPLETED|Overall Study||11
6774664|NCT03894813|7702519|FG001|NOT COMPLETED|Overall Study||16
6774665|NCT03911960|7702527|FG000|STARTED|Overall Study||9
6774666|NCT03911960|7702528|FG001|STARTED|Overall Study||5
6774667|NCT03911960|7702527|FG000|COMPLETED|Overall Study||4
6774668|NCT03911960|7702528|FG001|COMPLETED|Overall Study||2
6774669|NCT03911960|7702527|FG000|NOT COMPLETED|Overall Study||5
6774670|NCT03911960|7702528|FG001|NOT COMPLETED|Overall Study||3
6774671|NCT03907072|7702538|FG000|STARTED|Overall Study||2
6774672|NCT03907072|7702539|FG001|STARTED|Overall Study||2
6774673|NCT03907072|7702540|FG002|STARTED|Overall Study||2
6774674|NCT03907072|7702538|FG000|COMPLETED|Overall Study||0
6774675|NCT03907072|7702539|FG001|COMPLETED|Overall Study||0
6774676|NCT03907072|7702540|FG002|COMPLETED|Overall Study||0
6774677|NCT03907072|7702538|FG000|NOT COMPLETED|Overall Study||2
6774678|NCT03907072|7702539|FG001|NOT COMPLETED|Overall Study||2
6774679|NCT03907072|7702540|FG002|NOT COMPLETED|Overall Study||2
6774680|NCT03906448|7702550|FG000|STARTED|Overall Study||1
6774681|NCT03906448|7702551|FG001|STARTED|Overall Study||0
6774682|NCT03906448|7702550|FG000|COMPLETED|Overall Study||1
6774683|NCT03906448|7702551|FG001|COMPLETED|Overall Study||0
6774684|NCT03906448|7702550|FG000|NOT COMPLETED|Overall Study||0
6774685|NCT03906448|7702551|FG001|NOT COMPLETED|Overall Study||0
6774686|NCT03911401|7702560|FG000|STARTED|Overall Study||83
6774687|NCT03911401|7702561|FG001|STARTED|Overall Study||85
6774688|NCT03911401|7702562|FG002|STARTED|Overall Study||83
6774689|NCT03911401|7702560|FG000|COMPLETED|Overall Study||76
6774690|NCT03911401|7702561|FG001|COMPLETED|Overall Study||76
6774691|NCT03911401|7702562|FG002|COMPLETED|Overall Study||58
6774692|NCT03911401|7702560|FG000|NOT COMPLETED|Overall Study||7
6774693|NCT03911401|7702561|FG001|NOT COMPLETED|Overall Study||9
6774694|NCT03911401|7702562|FG002|NOT COMPLETED|Overall Study||25
6774695|NCT03909763|7702570|FG000|STARTED|Overall Study||55
6774696|NCT03909763|7702570|FG000|COMPLETED|Overall Study||45
6774697|NCT03909763|7702570|FG000|NOT COMPLETED|Overall Study||10
6313583|NCT00416520|7217957|FG002|NOT COMPLETED|Open-label Period||0
6313584|NCT00416520|7217958|FG003|NOT COMPLETED|Open-label Period||0
6774698|NCT03909009|7702576|FG000|STARTED|Overall Study||10
6774699|NCT03909009|7702577|FG001|STARTED|Overall Study||10
6774700|NCT03909009|7702576|FG000|COMPLETED|Overall Study||10
6774701|NCT03909009|7702577|FG001|COMPLETED|Overall Study||10
6774702|NCT03909009|7702576|FG000|NOT COMPLETED|Overall Study||0
6313585|NCT00416520|7217955|FG000|STARTED|Placebo-controlled Withdrawal Period||0
6313586|NCT00416520|7217956|FG001|STARTED|Placebo-controlled Withdrawal Period||0
6313587|NCT00416520|7217957|FG002|STARTED|Placebo-controlled Withdrawal Period||50
6313588|NCT00416520|7217958|FG003|STARTED|Placebo-controlled Withdrawal Period||54
6313589|NCT00416520|7217955|FG000|COMPLETED|Placebo-controlled Withdrawal Period||0
6313590|NCT00416520|7217956|FG001|COMPLETED|Placebo-controlled Withdrawal Period||0
6313591|NCT00416520|7217957|FG002|COMPLETED|Placebo-controlled Withdrawal Period||49
6313592|NCT00416520|7217958|FG003|COMPLETED|Placebo-controlled Withdrawal Period||49
6313593|NCT00416520|7217955|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
6313594|NCT00416520|7217956|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
6313595|NCT00416520|7217957|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
6313596|NCT00416520|7217958|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
6313597|NCT00416572|7217971|FG000|STARTED|Overall Study||83
6313598|NCT00416572|7217972|FG001|STARTED|Overall Study||85
6313599|NCT00416572|7217973|FG002|STARTED|Overall Study||84
6313600|NCT00416572|7217971|FG000|COMPLETED|Overall Study||70
6313601|NCT00416572|7217972|FG001|COMPLETED|Overall Study||78
6313602|NCT00416572|7217973|FG002|COMPLETED|Overall Study||76
6313603|NCT00416572|7217971|FG000|NOT COMPLETED|Overall Study||13
6313604|NCT00416572|7217972|FG001|NOT COMPLETED|Overall Study||7
6774703|NCT03909009|7702577|FG001|NOT COMPLETED|Overall Study||0
6774704|NCT03906968|7702583|FG000|STARTED|Overall Study||40
6774705|NCT03906968|7702583|FG000|COMPLETED|Overall Study||40
6774706|NCT03906968|7702583|FG000|NOT COMPLETED|Overall Study||0
6774707|NCT03904420|7702589|FG000|STARTED|Overall Study||2
6774708|NCT03904420|7702590|FG001|STARTED|Overall Study||2
6774709|NCT03904420|7702589|FG000|COMPLETED|Overall Study||0
6774710|NCT03904420|7702590|FG001|COMPLETED|Overall Study||0
6774711|NCT03904420|7702589|FG000|NOT COMPLETED|Overall Study||2
6774712|NCT03904420|7702590|FG001|NOT COMPLETED|Overall Study||2
6774713|NCT03903822|7702604|FG000|STARTED|Treatment Phase (6 Weeks)||37
6774714|NCT03903822|7702605|FG001|STARTED|Treatment Phase (6 Weeks)||37
6774715|NCT03903822|7702606|FG002|STARTED|Treatment Phase (6 Weeks)||36
6774716|NCT03903822|7702607|FG003|STARTED|Treatment Phase (6 Weeks)||37
6774717|NCT03903822|7702608|FG004|STARTED|Treatment Phase (6 Weeks)||36
6774718|NCT03903822|7702609|FG005|STARTED|Treatment Phase (6 Weeks)||36
6774719|NCT03903822|7702610|FG006|STARTED|Treatment Phase (6 Weeks)||36
6774720|NCT03903822|7702611|FG007|STARTED|Treatment Phase (6 Weeks)||37
6774721|NCT03903822|7702604|FG000|COMPLETED|Treatment Phase (6 Weeks)||28
6774722|NCT03903822|7702605|FG001|COMPLETED|Treatment Phase (6 Weeks)||27
6774723|NCT03903822|7702606|FG002|COMPLETED|Treatment Phase (6 Weeks)||33
6774724|NCT03903822|7702607|FG003|COMPLETED|Treatment Phase (6 Weeks)||32
6774725|NCT03903822|7702608|FG004|COMPLETED|Treatment Phase (6 Weeks)||31
6774726|NCT03903822|7702609|FG005|COMPLETED|Treatment Phase (6 Weeks)||25
6774727|NCT03903822|7702610|FG006|COMPLETED|Treatment Phase (6 Weeks)||31
6774728|NCT03903822|7702611|FG007|COMPLETED|Treatment Phase (6 Weeks)||33
6774729|NCT03903822|7702604|FG000|NOT COMPLETED|Treatment Phase (6 Weeks)||9
6774730|NCT03903822|7702605|FG001|NOT COMPLETED|Treatment Phase (6 Weeks)||10
6774731|NCT03903822|7702606|FG002|NOT COMPLETED|Treatment Phase (6 Weeks)||3
6774732|NCT03903822|7702607|FG003|NOT COMPLETED|Treatment Phase (6 Weeks)||5
6774733|NCT03903822|7702608|FG004|NOT COMPLETED|Treatment Phase (6 Weeks)||5
6774734|NCT03903822|7702609|FG005|NOT COMPLETED|Treatment Phase (6 Weeks)||11
6774735|NCT03903822|7702610|FG006|NOT COMPLETED|Treatment Phase (6 Weeks)||5
6774736|NCT03903822|7702611|FG007|NOT COMPLETED|Treatment Phase (6 Weeks)||4
6774737|NCT03903822|7702604|FG000|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
6774738|NCT03903822|7702605|FG001|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
6774739|NCT03903822|7702606|FG002|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
6774740|NCT03903822|7702607|FG003|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
6774741|NCT03903822|7702608|FG004|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
6774742|NCT03903822|7702609|FG005|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
6774743|NCT03903822|7702610|FG006|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|36
6774744|NCT03903822|7702611|FG007|STARTED|Follow up Phase (4 Weeks)|Participants not completing treatment phase could also start this phase.|37
6774745|NCT03903822|7702604|FG000|COMPLETED|Follow up Phase (4 Weeks)||29
6774746|NCT03903822|7702605|FG001|COMPLETED|Follow up Phase (4 Weeks)||29
6774747|NCT03903822|7702606|FG002|COMPLETED|Follow up Phase (4 Weeks)||32
6774748|NCT03903822|7702607|FG003|COMPLETED|Follow up Phase (4 Weeks)||33
6774749|NCT03903822|7702608|FG004|COMPLETED|Follow up Phase (4 Weeks)||32
6774750|NCT03903822|7702609|FG005|COMPLETED|Follow up Phase (4 Weeks)||28
6774751|NCT03903822|7702610|FG006|COMPLETED|Follow up Phase (4 Weeks)||31
6774752|NCT03903822|7702611|FG007|COMPLETED|Follow up Phase (4 Weeks)||31
6774753|NCT03903822|7702604|FG000|NOT COMPLETED|Follow up Phase (4 Weeks)||8
6774754|NCT03903822|7702605|FG001|NOT COMPLETED|Follow up Phase (4 Weeks)||8
6774755|NCT03903822|7702606|FG002|NOT COMPLETED|Follow up Phase (4 Weeks)||4
6774756|NCT03903822|7702607|FG003|NOT COMPLETED|Follow up Phase (4 Weeks)||4
6774757|NCT03903822|7702608|FG004|NOT COMPLETED|Follow up Phase (4 Weeks)||4
6774758|NCT03903822|7702609|FG005|NOT COMPLETED|Follow up Phase (4 Weeks)||8
6774759|NCT03903822|7702610|FG006|NOT COMPLETED|Follow up Phase (4 Weeks)||5
6313605|NCT00416572|7217973|FG002|NOT COMPLETED|Overall Study||8
6313606|NCT00416598|7217981|FG000|STARTED|Induction & Intensification||546
6313607|NCT00416598|7217981|FG000|COMPLETED|Induction & Intensification||134
6313608|NCT00416598|7217981|FG000|NOT COMPLETED|Induction & Intensification||412
6313609|NCT00416598|7217981|FG000|STARTED|Decitabine Maintenance||134
6313610|NCT00416598|7217981|FG000|COMPLETED|Decitabine Maintenance||62
6313611|NCT00416598|7217981|FG000|NOT COMPLETED|Decitabine Maintenance||72
6313612|NCT00416624|7217989|FG000|STARTED|Overall Study||61
6774760|NCT03903822|7702611|FG007|NOT COMPLETED|Follow up Phase (4 Weeks)||6
6774761|NCT03905096|7702631|FG000|STARTED|Period 1 for Trial Part 1 and 2||18
6774762|NCT03905096|7702632|FG001|STARTED|Period 1 for Trial Part 1 and 2||14
6774763|NCT03905096|7702631|FG000|COMPLETED|Period 1 for Trial Part 1 and 2||18
6774764|NCT03905096|7702632|FG001|COMPLETED|Period 1 for Trial Part 1 and 2||14
6774765|NCT03905096|7702631|FG000|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
6774766|NCT03905096|7702632|FG001|NOT COMPLETED|Period 1 for Trial Part 1 and 2||0
6774767|NCT03905096|7702631|FG000|STARTED|Period 2 for Trial Part 1 and 2||18
6774768|NCT03905096|7702632|FG001|STARTED|Period 2 for Trial Part 1 and 2||14
6774769|NCT03905096|7702631|FG000|COMPLETED|Period 2 for Trial Part 1 and 2||17
6774770|NCT03905096|7702632|FG001|COMPLETED|Period 2 for Trial Part 1 and 2||14
6774771|NCT03905096|7702631|FG000|NOT COMPLETED|Period 2 for Trial Part 1 and 2||1
6774772|NCT03905096|7702632|FG001|NOT COMPLETED|Period 2 for Trial Part 1 and 2||0
6774773|NCT03899064|7702645|FG000|STARTED|Overall Study||58
6774774|NCT03899064|7702645|FG000|MC2-01 Cream, Irradiation|Overall Study||58
6774775|NCT03899064|7702645|FG000|MC2-01 Cream, No Irradiation|Overall Study||58
6774776|NCT03899064|7702645|FG000|MC2-01 Vehicle, Irradiation|Overall Study||58
6774777|NCT03899064|7702645|FG000|MC2-01 Vehicle, no Irradiation|Overall Study||58
6774778|NCT03899064|7702645|FG000|Control, Irradiation|Overall Study||58
6774779|NCT03899064|7702645|FG000|COMPLETED|Overall Study||51
6774780|NCT03899064|7702645|FG000|NOT COMPLETED|Overall Study||7
6774781|NCT03894969|7702654|FG000|STARTED|Overall Study||134
6774782|NCT03894969|7702655|FG001|STARTED|Overall Study||134
6774783|NCT03894969|7702656|FG002|STARTED|Overall Study||122
6774784|NCT03894969|7702657|FG003|STARTED|Overall Study||135
6774785|NCT03894969|7702658|FG004|STARTED|Overall Study||16
6774786|NCT03894969|7702654|FG000|COMPLETED|Overall Study||132
6774787|NCT03894969|7702655|FG001|COMPLETED|Overall Study||131
6774788|NCT03894969|7702656|FG002|COMPLETED|Overall Study||120
6774789|NCT03894969|7702657|FG003|COMPLETED|Overall Study||129
6774790|NCT03894969|7702658|FG004|COMPLETED|Overall Study||2
6774791|NCT03894969|7702654|FG000|NOT COMPLETED|Overall Study||2
6774792|NCT03894969|7702655|FG001|NOT COMPLETED|Overall Study||3
6774793|NCT03894969|7702656|FG002|NOT COMPLETED|Overall Study||2
6774794|NCT03894969|7702657|FG003|NOT COMPLETED|Overall Study||6
6774795|NCT03894969|7702658|FG004|NOT COMPLETED|Overall Study||14
6774796|NCT03903159|7702671|FG000|STARTED|Overall Study||15
6774797|NCT03903159|7702671|FG000|COMPLETED|Overall Study||10
6774798|NCT03903159|7702671|FG000|NOT COMPLETED|Overall Study||5
6774799|NCT03902392|7702677|FG000|STARTED|Overall Study||25
6774800|NCT03902392|7702678|FG001|STARTED|Overall Study||25
6774801|NCT03902392|7702677|FG000|COMPLETED|Overall Study||18
6774802|NCT03902392|7702678|FG001|COMPLETED|Overall Study||18
6774803|NCT03902392|7702677|FG000|NOT COMPLETED|Overall Study||7
6774804|NCT03902392|7702678|FG001|NOT COMPLETED|Overall Study||7
6774805|NCT03901105|7702684|FG000|STARTED|Overall Study||205
6774806|NCT03901105|7702684|FG000|COMPLETED|Overall Study||205
6774807|NCT03901105|7702684|FG000|NOT COMPLETED|Overall Study||0
6774808|NCT03895853|7702696|FG000|STARTED|Overall Study||0
6774809|NCT03895853|7702697|FG001|STARTED|Overall Study||2
6774810|NCT03895853|7702696|FG000|COMPLETED|Overall Study||0
6774811|NCT03895853|7702697|FG001|COMPLETED|Overall Study||2
6774812|NCT03895853|7702696|FG000|NOT COMPLETED|Overall Study||0
6774813|NCT03895853|7702697|FG001|NOT COMPLETED|Overall Study||0
6774814|NCT03901313|7702703|FG000|STARTED|Overall Study||4
6774815|NCT03901313|7702704|FG001|STARTED|Overall Study||4
6774816|NCT03901313|7702705|FG002|STARTED|Overall Study||4
6774817|NCT03901313|7702706|FG003|STARTED|Overall Study||4
6774818|NCT03901313|7702707|FG004|STARTED|Overall Study||4
6774819|NCT03901313|7702708|FG005|STARTED|Overall Study||4
6774820|NCT03901313|7702703|FG000|COMPLETED|Overall Study||4
6774821|NCT03901313|7702704|FG001|COMPLETED|Overall Study||4
6774822|NCT03901313|7702705|FG002|COMPLETED|Overall Study||4
6774823|NCT03901313|7702706|FG003|COMPLETED|Overall Study||4
6774824|NCT03901313|7702707|FG004|COMPLETED|Overall Study||4
6774825|NCT03901313|7702708|FG005|COMPLETED|Overall Study||4
6774826|NCT03901313|7702703|FG000|NOT COMPLETED|Overall Study||0
6774827|NCT03901313|7702704|FG001|NOT COMPLETED|Overall Study||0
6774828|NCT03901313|7702705|FG002|NOT COMPLETED|Overall Study||0
6774829|NCT03901313|7702706|FG003|NOT COMPLETED|Overall Study||0
6774830|NCT03901313|7702707|FG004|NOT COMPLETED|Overall Study||0
6774831|NCT03901313|7702708|FG005|NOT COMPLETED|Overall Study||0
6774832|NCT03901092|7702716|FG000|STARTED|Overall Study||83
6774833|NCT03901092|7702717|FG001|STARTED|Overall Study||159
6774834|NCT03901092|7702716|FG000|COMPLETED|Overall Study||83
6774835|NCT03901092|7702717|FG001|COMPLETED|Overall Study||159
6774836|NCT03901092|7702716|FG000|NOT COMPLETED|Overall Study||0
6774837|NCT03901092|7702717|FG001|NOT COMPLETED|Overall Study||0
6774838|NCT03895034|7702731|FG000|STARTED|Overall Study||66
6774839|NCT03895034|7702731|FG000|COMPLETED|Overall Study||64
6774840|NCT03895034|7702731|FG000|NOT COMPLETED|Overall Study||2
6774841|NCT03900728|7702738|FG000|STARTED|Overall Study||40
6774842|NCT03900728|7702739|FG001|STARTED|Overall Study||57
6774843|NCT03900728|7702740|FG002|STARTED|Overall Study||39
6774844|NCT03900728|7702738|FG000|COMPLETED|Overall Study||40
6774845|NCT03900728|7702739|FG001|COMPLETED|Overall Study||57
6774846|NCT03900728|7702740|FG002|COMPLETED|Overall Study||35
6774847|NCT03900728|7702738|FG000|NOT COMPLETED|Overall Study||0
6774848|NCT03900728|7702739|FG001|NOT COMPLETED|Overall Study||0
6774849|NCT03900728|7702740|FG002|NOT COMPLETED|Overall Study||4
6774850|NCT03900299|7702750|FG000|STARTED|Overall Study||56
6774851|NCT03900299|7702751|FG001|STARTED|Overall Study||58
6774852|NCT03900299|7702750|FG000|COMPLETED|Overall Study||56
6774853|NCT03900299|7702751|FG001|COMPLETED|Overall Study||58
6774854|NCT03900299|7702750|FG000|NOT COMPLETED|Overall Study||0
6774855|NCT03900299|7702751|FG001|NOT COMPLETED|Overall Study||0
6774856|NCT03898349|7702760|FG000|STARTED|Overall Study||125
6774857|NCT03898349|7702761|FG001|STARTED|Overall Study||625
6774858|NCT03898349|7702760|FG000|COMPLETED|Overall Study||15
6774859|NCT03898349|7702761|FG001|COMPLETED|Overall Study||15
6774860|NCT03898349|7702760|FG000|NOT COMPLETED|Overall Study||110
6774861|NCT03898349|7702761|FG001|NOT COMPLETED|Overall Study||610
6774862|NCT03897634|7702767|FG000|STARTED|Overall Study||22
6774863|NCT03897634|7702767|FG000|COMPLETED|Overall Study||22
6774864|NCT03897634|7702767|FG000|NOT COMPLETED|Overall Study||0
6774865|NCT03895372|7702779|FG000|STARTED|Investigational Treatment Period||23
6774866|NCT03895372|7702780|FG001|STARTED|Investigational Treatment Period||22
6774867|NCT03895372|7702781|FG002|STARTED|Investigational Treatment Period||11
6774868|NCT03895372|7702782|FG003|STARTED|Investigational Treatment Period||11
6774869|NCT03895372|7702783|FG004|STARTED|Investigational Treatment Period||12
6774870|NCT03895372|7702784|FG005|STARTED|Investigational Treatment Period||11
6774871|NCT03895372|7702785|FG006|STARTED|Investigational Treatment Period||45
6774872|NCT03895372|7702786|FG007|STARTED|Investigational Treatment Period||43
6774873|NCT03895372|7702779|FG000|COMPLETED|Investigational Treatment Period||19
6313613|NCT00416624|7217990|FG001|STARTED|Overall Study||60
6313614|NCT00416624|7217991|FG002|STARTED|Overall Study||58
6313615|NCT00416624|7217992|FG003|STARTED|Overall Study||57
6774874|NCT03895372|7702780|FG001|COMPLETED|Investigational Treatment Period||19
6774875|NCT03895372|7702781|FG002|COMPLETED|Investigational Treatment Period||10
6774876|NCT03895372|7702782|FG003|COMPLETED|Investigational Treatment Period||9
6774877|NCT03895372|7702783|FG004|COMPLETED|Investigational Treatment Period||12
6774878|NCT03895372|7702784|FG005|COMPLETED|Investigational Treatment Period||9
6774879|NCT03895372|7702785|FG006|COMPLETED|Investigational Treatment Period||37
6774880|NCT03895372|7702786|FG007|COMPLETED|Investigational Treatment Period||38
6774881|NCT03895372|7702779|FG000|NOT COMPLETED|Investigational Treatment Period||4
6774882|NCT03895372|7702780|FG001|NOT COMPLETED|Investigational Treatment Period||3
6774883|NCT03895372|7702781|FG002|NOT COMPLETED|Investigational Treatment Period||1
6774884|NCT03895372|7702782|FG003|NOT COMPLETED|Investigational Treatment Period||2
6774885|NCT03895372|7702783|FG004|NOT COMPLETED|Investigational Treatment Period||0
6774886|NCT03895372|7702784|FG005|NOT COMPLETED|Investigational Treatment Period||2
6774887|NCT03895372|7702785|FG006|NOT COMPLETED|Investigational Treatment Period||8
6774888|NCT03895372|7702786|FG007|NOT COMPLETED|Investigational Treatment Period||5
6774889|NCT03895372|7702779|FG000|STARTED|Extension Treatment Period||19
6774890|NCT03895372|7702780|FG001|STARTED|Extension Treatment Period||19
6774891|NCT03895372|7702781|FG002|STARTED|Extension Treatment Period||10
6774892|NCT03895372|7702782|FG003|STARTED|Extension Treatment Period||9
6774893|NCT03895372|7702783|FG004|STARTED|Extension Treatment Period||12
6774894|NCT03895372|7702784|FG005|STARTED|Extension Treatment Period||9
6774895|NCT03895372|7702785|FG006|STARTED|Extension Treatment Period||37
6774896|NCT03895372|7702786|FG007|STARTED|Extension Treatment Period||38
6774897|NCT03895372|7702779|FG000|COMPLETED|Extension Treatment Period||16
6774898|NCT03895372|7702780|FG001|COMPLETED|Extension Treatment Period||14
6774899|NCT03895372|7702781|FG002|COMPLETED|Extension Treatment Period||10
6313616|NCT00416624|7217989|FG000|COMPLETED|Overall Study||39
6557675|NCT01769326|7480238|FG000|NOT COMPLETED|Overall Study||2
6557676|NCT01769326|7480239|FG001|NOT COMPLETED|Overall Study||4
6557677|NCT01769326|7480240|FG002|NOT COMPLETED|Overall Study||1
6557678|NCT01769326|7480241|FG003|NOT COMPLETED|Overall Study||0
6557679|NCT01769339|7480251|FG000|STARTED|Overall Study||115
6557680|NCT01769339|7480251|FG000|COMPLETED|Overall Study||72
6557681|NCT01769339|7480251|FG000|NOT COMPLETED|Overall Study||43
6557682|NCT01769352|7480259|FG000|STARTED|Overall Study||13
6557683|NCT01769352|7480260|FG001|STARTED|Overall Study||12
6557684|NCT01769352|7480261|FG002|STARTED|Overall Study||9
6557685|NCT01769352|7480262|FG003|STARTED|Overall Study||8
6557686|NCT01769352|7480259|FG000|COMPLETED|Overall Study||13
6557687|NCT01769352|7480260|FG001|COMPLETED|Overall Study||12
6774900|NCT03895372|7702782|FG003|COMPLETED|Extension Treatment Period||8
6774901|NCT03895372|7702783|FG004|COMPLETED|Extension Treatment Period||9
6774902|NCT03895372|7702784|FG005|COMPLETED|Extension Treatment Period||8
6774903|NCT03895372|7702785|FG006|COMPLETED|Extension Treatment Period||33
6774904|NCT03895372|7702786|FG007|COMPLETED|Extension Treatment Period||32
6557688|NCT01769352|7480261|FG002|COMPLETED|Overall Study||9
6557689|NCT01769352|7480262|FG003|COMPLETED|Overall Study||8
6557690|NCT01769352|7480259|FG000|NOT COMPLETED|Overall Study||0
6557691|NCT01769352|7480260|FG001|NOT COMPLETED|Overall Study||0
6557692|NCT01769352|7480261|FG002|NOT COMPLETED|Overall Study||0
6313617|NCT00416624|7217990|FG001|COMPLETED|Overall Study||33
6313618|NCT00416624|7217991|FG002|COMPLETED|Overall Study||40
6313619|NCT00416624|7217992|FG003|COMPLETED|Overall Study||40
6313620|NCT00416624|7217989|FG000|NOT COMPLETED|Overall Study||22
6313621|NCT00416624|7217990|FG001|NOT COMPLETED|Overall Study||27
6313622|NCT00416624|7217991|FG002|NOT COMPLETED|Overall Study||18
6313623|NCT00416624|7217992|FG003|NOT COMPLETED|Overall Study||17
6313624|NCT00416715|7218002|FG000|STARTED|Overall Study||100
6313625|NCT00416715|7218002|FG000|COMPLETED|Overall Study||85
6313626|NCT00416715|7218002|FG000|NOT COMPLETED|Overall Study||15
6313627|NCT00416793|7218009|FG000|STARTED|Overall Study||9
6313628|NCT00416793|7218009|FG000|COMPLETED|Overall Study||9
6313629|NCT00416793|7218009|FG000|NOT COMPLETED|Overall Study||0
6313630|NCT00416884|7218013|FG000|STARTED|Overall Study||1
6313631|NCT00416884|7218013|FG000|COMPLETED|Overall Study||0
6313632|NCT00416884|7218013|FG000|NOT COMPLETED|Overall Study||1
6313633|NCT00416949|7218017|FG000|STARTED|Overall Study||9
6313634|NCT00416949|7218017|FG000|COMPLETED|Overall Study||4
6313635|NCT00416949|7218017|FG000|NOT COMPLETED|Overall Study||5
6313636|NCT00417027|7218024|FG000|STARTED|Overall Study||66
6313637|NCT00417027|7218025|FG001|STARTED|Overall Study||65
6313638|NCT00417027|7218026|FG002|STARTED|Overall Study||59
6313639|NCT00417027|7218024|FG000|COMPLETED|Overall Study||66
6313640|NCT00417027|7218025|FG001|COMPLETED|Overall Study||60
6313641|NCT00417027|7218026|FG002|COMPLETED|Overall Study||54
6313642|NCT00417027|7218024|FG000|NOT COMPLETED|Overall Study||0
6313643|NCT00417027|7218025|FG001|NOT COMPLETED|Overall Study||5
6313644|NCT00417027|7218026|FG002|NOT COMPLETED|Overall Study||5
6313645|NCT00417079|7218036|FG000|STARTED|Overall Study|Randomized patients|377
6313646|NCT00417079|7218037|FG001|STARTED|Overall Study|Randomized patients|378
6774905|NCT03895372|7702779|FG000|NOT COMPLETED|Extension Treatment Period||3
6774906|NCT03895372|7702780|FG001|NOT COMPLETED|Extension Treatment Period||5
6774907|NCT03895372|7702781|FG002|NOT COMPLETED|Extension Treatment Period||0
6774908|NCT03895372|7702782|FG003|NOT COMPLETED|Extension Treatment Period||1
6774909|NCT03895372|7702783|FG004|NOT COMPLETED|Extension Treatment Period||3
6774910|NCT03895372|7702784|FG005|NOT COMPLETED|Extension Treatment Period||1
6774911|NCT03895372|7702785|FG006|NOT COMPLETED|Extension Treatment Period||4
6774912|NCT03895372|7702786|FG007|NOT COMPLETED|Extension Treatment Period||6
6780761|NCT02865122|7709310|FG000|STARTED|Overall Study||1
6780762|NCT02865122|7709311|FG001|STARTED|Overall Study||1
6780763|NCT02865122|7709312|FG002|STARTED|Overall Study||0
6780764|NCT02865122|7709310|FG000|COMPLETED|Overall Study||0
6780765|NCT02865122|7709311|FG001|COMPLETED|Overall Study||1
6780766|NCT02865122|7709312|FG002|COMPLETED|Overall Study||0
6780767|NCT02865122|7709310|FG000|NOT COMPLETED|Overall Study||1
6780768|NCT02865122|7709311|FG001|NOT COMPLETED|Overall Study||0
6780769|NCT02865122|7709312|FG002|NOT COMPLETED|Overall Study||0
6780770|NCT02865915|7709322|FG000|STARTED|Overall Study||25
6780771|NCT02865915|7709323|FG001|STARTED|Overall Study||30
6780772|NCT02865915|7709322|FG000|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
6780773|NCT02865915|7709323|FG001|COMPLETED|Overall Study|Study terminated prior to completion by any subject|0
6780774|NCT02865915|7709322|FG000|NOT COMPLETED|Overall Study||25
6780775|NCT02865915|7709323|FG001|NOT COMPLETED|Overall Study||30
6780776|NCT02855411|7709329|FG000|STARTED|Overall Study||35
6780777|NCT02855411|7709329|FG000|Assigned to Study Treatment|Overall Study||0
6780778|NCT02855411|7709329|FG000|COMPLETED|Overall Study||0
6780779|NCT02855411|7709329|FG000|NOT COMPLETED|Overall Study||35
6780780|NCT02828124|7709337|FG000|STARTED|Overall Study||1
6780781|NCT02828124|7709338|FG001|STARTED|Overall Study||2
6780782|NCT02828124|7709339|FG002|STARTED|Overall Study||1
6780783|NCT02828124|7709340|FG003|STARTED|Overall Study||6
6780784|NCT02828124|7709337|FG000|COMPLETED|Overall Study||0
6780785|NCT02828124|7709338|FG001|COMPLETED|Overall Study||0
6780786|NCT02828124|7709339|FG002|COMPLETED|Overall Study||0
6780787|NCT02828124|7709340|FG003|COMPLETED|Overall Study||0
6780788|NCT02828124|7709337|FG000|NOT COMPLETED|Overall Study||1
6780789|NCT02828124|7709338|FG001|NOT COMPLETED|Overall Study||2
6780790|NCT02828124|7709339|FG002|NOT COMPLETED|Overall Study||1
6780791|NCT02828124|7709340|FG003|NOT COMPLETED|Overall Study||6
6780792|NCT02826551|7709352|FG000|STARTED|Overall Study||11
6780793|NCT02826551|7709353|FG001|STARTED|Overall Study||12
6780794|NCT02826551|7709352|FG000|COMPLETED|Overall Study||11
6780795|NCT02826551|7709353|FG001|COMPLETED|Overall Study||12
6780796|NCT02826551|7709352|FG000|NOT COMPLETED|Overall Study||0
6780797|NCT02826551|7709353|FG001|NOT COMPLETED|Overall Study||0
6780798|NCT02825043|7709359|FG000|STARTED|Overall Study||6
6780799|NCT02825043|7709359|FG000|COMPLETED|Overall Study||2
6780800|NCT02825043|7709359|FG000|NOT COMPLETED|Overall Study||4
6313647|NCT00417079|7218036|FG000|COMPLETED|Overall Study|Randomized patients|46
6313648|NCT00417079|7218037|FG001|COMPLETED|Overall Study|Randomized patients|105
6780801|NCT02819804|7709363|FG000|STARTED|Complete Cycle 1 (28 Days)||1
6780802|NCT02819804|7709363|FG000|COMPLETED|Complete Cycle 1 (28 Days)||0
6780803|NCT02819804|7709363|FG000|NOT COMPLETED|Complete Cycle 1 (28 Days)||1
6780804|NCT02819804|7709363|FG000|STARTED|Start Cycle 2 and Beyond||0
6780805|NCT02819804|7709363|FG000|COMPLETED|Start Cycle 2 and Beyond||0
6780806|NCT02819804|7709363|FG000|NOT COMPLETED|Start Cycle 2 and Beyond||0
6780807|NCT02819804|7709363|FG000|STARTED|Follow-up for 1 Year||1
6780808|NCT02819804|7709363|FG000|COMPLETED|Follow-up for 1 Year||1
6780809|NCT02819804|7709363|FG000|NOT COMPLETED|Follow-up for 1 Year||0
6313649|NCT00417079|7218036|FG000|NOT COMPLETED|Overall Study||331
6313650|NCT00417079|7218037|FG001|NOT COMPLETED|Overall Study||273
6313651|NCT00417170|7218045|FG000|STARTED|Overall Study|"Started indicates Safety population."|23
6313652|NCT00417170|7218046|FG001|STARTED|Overall Study||25
6313653|NCT00417170|7218045|FG000|Pharmacodynamics Population|Overall Study||21
6313654|NCT00417170|7218046|FG001|Pharmacodynamics Population|Overall Study||23
6313655|NCT00417170|7218045|FG000|COMPLETED|Overall Study||21
6313656|NCT00417170|7218046|FG001|COMPLETED|Overall Study||22
6313657|NCT00417170|7218045|FG000|NOT COMPLETED|Overall Study||2
6313658|NCT00417170|7218046|FG001|NOT COMPLETED|Overall Study||3
6313659|NCT00417274|7218052|FG000|STARTED|Overall Study||31
6313660|NCT00417274|7218052|FG000|COMPLETED|Overall Study||31
6313661|NCT00417274|7218052|FG000|NOT COMPLETED|Overall Study||0
6313662|NCT00417417|7218058|FG000|STARTED|Overall Study||4
6313663|NCT00417417|7218059|FG001|STARTED|Overall Study||6
6313664|NCT00417417|7218058|FG000|COMPLETED|Overall Study||4
6313665|NCT00417417|7218059|FG001|COMPLETED|Overall Study||6
6313666|NCT00417417|7218058|FG000|NOT COMPLETED|Overall Study||0
6313667|NCT00417417|7218059|FG001|NOT COMPLETED|Overall Study||0
6313668|NCT00417482|7218070|FG000|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
6313669|NCT00417482|7218071|FG001|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
6313670|NCT00417482|7218072|FG002|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
6313671|NCT00417482|7218070|FG000|COMPLETED|Phase B 1st 16 Weeks||13
6313672|NCT00417482|7218071|FG001|COMPLETED|Phase B 1st 16 Weeks||27
6313673|NCT00417482|7218072|FG002|COMPLETED|Phase B 1st 16 Weeks||13
6313674|NCT00417482|7218070|FG000|NOT COMPLETED|Phase B 1st 16 Weeks||19
6313675|NCT00417482|7218071|FG001|NOT COMPLETED|Phase B 1st 16 Weeks||11
6313676|NCT00417482|7218072|FG002|NOT COMPLETED|Phase B 1st 16 Weeks||27
6313677|NCT00417482|7218070|FG000|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
6313678|NCT00417482|7218071|FG001|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
6313679|NCT00417482|7218072|FG002|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
6313680|NCT00417482|7218070|FG000|COMPLETED|Phase B 2nd 16 Weeks||10
6313681|NCT00417482|7218071|FG001|COMPLETED|Phase B 2nd 16 Weeks||14
6313682|NCT00417482|7218072|FG002|COMPLETED|Phase B 2nd 16 Weeks||10
6313683|NCT00417482|7218070|FG000|NOT COMPLETED|Phase B 2nd 16 Weeks||3
6313684|NCT00417482|7218071|FG001|NOT COMPLETED|Phase B 2nd 16 Weeks||13
6313685|NCT00417482|7218072|FG002|NOT COMPLETED|Phase B 2nd 16 Weeks||3
6313686|NCT00417612|7218088|FG000|STARTED|Overall Study||22
6313687|NCT00417612|7218089|FG001|STARTED|Overall Study||11
6313688|NCT00417612|7218088|FG000|COMPLETED|Overall Study||19
6313689|NCT00417612|7218089|FG001|COMPLETED|Overall Study||8
6313690|NCT00417612|7218088|FG000|NOT COMPLETED|Overall Study||3
6313691|NCT00417612|7218089|FG001|NOT COMPLETED|Overall Study||3
6313692|NCT00417859|7218099|FG000|STARTED|Overall Study||26
6313693|NCT00417859|7218100|FG001|STARTED|Overall Study||30
6313694|NCT00417859|7218099|FG000|COMPLETED|Overall Study||26
6313695|NCT00417859|7218100|FG001|COMPLETED|Overall Study||29
6313696|NCT00417859|7218099|FG000|NOT COMPLETED|Overall Study||0
6313697|NCT00417859|7218100|FG001|NOT COMPLETED|Overall Study||1
6557693|NCT01769352|7480262|FG003|NOT COMPLETED|Overall Study||0
6557694|NCT01769365|7480276|FG000|STARTED|Overall Study||102
6557695|NCT01769365|7480277|FG001|STARTED|Overall Study||102
6313698|NCT00417885|7218108|FG000|STARTED|Overall Study||6
6313699|NCT00417885|7218108|FG000|COMPLETED|Overall Study||0
6313700|NCT00417885|7218108|FG000|NOT COMPLETED|Overall Study||6
6313701|NCT00417963|7218112|FG000|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
6313702|NCT00417963|7218112|FG000|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
6313703|NCT00417963|7218112|FG000|NOT COMPLETED|Overall Study||41
6313704|NCT00417976|7218121|FG000|STARTED|Overall Study||42
6313705|NCT00417976|7218121|FG000|COMPLETED|Overall Study||39
6313706|NCT00417976|7218121|FG000|NOT COMPLETED|Overall Study||3
6313707|NCT00417989|7218128|FG000|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
6313708|NCT00417989|7218129|FG001|STARTED|Overall Study||241
6313709|NCT00417989|7218128|FG000|COMPLETED|Overall Study||224
6313710|NCT00417989|7218129|FG001|COMPLETED|Overall Study||219
6313711|NCT00417989|7218128|FG000|NOT COMPLETED|Overall Study||20
6313712|NCT00417989|7218129|FG001|NOT COMPLETED|Overall Study||22
6313713|NCT00418015|7218141|FG000|STARTED|Overall Study||144
6313714|NCT00418015|7218142|FG001|STARTED|Overall Study||46
6313715|NCT00418015|7218143|FG002|STARTED|Overall Study||78
6313716|NCT00418015|7218144|FG003|STARTED|Overall Study||25
6313717|NCT00418015|7218141|FG000|COMPLETED|Overall Study||144
6313718|NCT00418015|7218142|FG001|COMPLETED|Overall Study||46
6313719|NCT00418015|7218143|FG002|COMPLETED|Overall Study||78
6313720|NCT00418015|7218144|FG003|COMPLETED|Overall Study||25
6313721|NCT00418015|7218141|FG000|NOT COMPLETED|Overall Study||0
6313722|NCT00418015|7218142|FG001|NOT COMPLETED|Overall Study||0
6313723|NCT00418015|7218143|FG002|NOT COMPLETED|Overall Study||0
6313724|NCT00418015|7218144|FG003|NOT COMPLETED|Overall Study||0
6313725|NCT00418028|7218156|FG000|STARTED|Overall Study||97
6313726|NCT00418028|7218157|FG001|STARTED|Overall Study||98
6313727|NCT00418028|7218156|FG000|COMPLETED|Overall Study||95
6313728|NCT00418028|7218157|FG001|COMPLETED|Overall Study||97
6313729|NCT00418028|7218156|FG000|NOT COMPLETED|Overall Study||2
6557696|NCT01769365|7480278|FG002|STARTED|Overall Study||103
6557697|NCT01769365|7480276|FG000|COMPLETED|Overall Study||102
6313730|NCT00418028|7218157|FG001|NOT COMPLETED|Overall Study||1
6313731|NCT00418093|7218163|FG000|STARTED|Overall Study||19
6313732|NCT00418093|7218163|FG000|Completed Study|Overall Study||19
6313733|NCT00418093|7218163|FG000|COMPLETED|Overall Study||19
6313734|NCT00418093|7218163|FG000|NOT COMPLETED|Overall Study||0
6313735|NCT00418184|7218169|FG000|STARTED|Double-blind Phase||137
6557698|NCT01769365|7480277|FG001|COMPLETED|Overall Study||100
6774913|NCT03896022|7702812|FG000|STARTED|Overall Study||74
6774914|NCT03896022|7702813|FG001|STARTED|Overall Study||51
6774915|NCT03896022|7702814|FG002|STARTED|Overall Study||52
6774916|NCT03896022|7702812|FG000|COMPLETED|Overall Study||70
6774917|NCT03896022|7702813|FG001|COMPLETED|Overall Study||51
6774918|NCT03896022|7702814|FG002|COMPLETED|Overall Study||52
6774919|NCT03896022|7702812|FG000|NOT COMPLETED|Overall Study||4
6774920|NCT03896022|7702813|FG001|NOT COMPLETED|Overall Study||0
6774921|NCT03896022|7702814|FG002|NOT COMPLETED|Overall Study||0
6774922|NCT03891862|7702826|FG000|STARTED|Open-label Period||135
6774923|NCT03891862|7702827|FG001|STARTED|Open-label Period||0
6774924|NCT03891862|7702828|FG002|STARTED|Open-label Period||0
6774925|NCT03891862|7702826|FG000|Safety Analysis Set|Open-label Period||132
6774926|NCT03891862|7702827|FG001|Safety Analysis Set|Open-label Period||0
6774927|NCT03891862|7702828|FG002|Safety Analysis Set|Open-label Period||0
6774928|NCT03891862|7702826|FG000|COMPLETED|Open-label Period||119
6774929|NCT03891862|7702827|FG001|COMPLETED|Open-label Period||0
6774930|NCT03891862|7702828|FG002|COMPLETED|Open-label Period||0
6774931|NCT03891862|7702826|FG000|NOT COMPLETED|Open-label Period||16
6774932|NCT03891862|7702827|FG001|NOT COMPLETED|Open-label Period||0
6774933|NCT03891862|7702828|FG002|NOT COMPLETED|Open-label Period||0
6774934|NCT03891862|7702826|FG000|STARTED|Placebo-controlled Period and Follow-up||0
6774935|NCT03891862|7702827|FG001|STARTED|Placebo-controlled Period and Follow-up||59
6774936|NCT03891862|7702828|FG002|STARTED|Placebo-controlled Period and Follow-up||59
6774937|NCT03891862|7702826|FG000|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||0
6774938|NCT03891862|7702827|FG001|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||58
6774939|NCT03891862|7702828|FG002|Persistence of Effect Analysis Set|Placebo-controlled Period and Follow-up||59
6774940|NCT03891862|7702826|FG000|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||0
6774941|NCT03891862|7702827|FG001|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||53
6774942|NCT03891862|7702828|FG002|Completed Placebo-controlled Period|Placebo-controlled Period and Follow-up||56
6774943|NCT03891862|7702826|FG000|COMPLETED|Placebo-controlled Period and Follow-up||0
6774944|NCT03891862|7702827|FG001|COMPLETED|Placebo-controlled Period and Follow-up||53
6774945|NCT03891862|7702828|FG002|COMPLETED|Placebo-controlled Period and Follow-up||55
6774946|NCT03891862|7702826|FG000|NOT COMPLETED|Placebo-controlled Period and Follow-up||0
6774947|NCT03891862|7702827|FG001|NOT COMPLETED|Placebo-controlled Period and Follow-up||6
6774948|NCT03891862|7702828|FG002|NOT COMPLETED|Placebo-controlled Period and Follow-up||4
6774949|NCT03894449|7702840|FG000|STARTED|Overall Study||15
6774950|NCT03894449|7702841|FG001|STARTED|Overall Study||15
6774951|NCT03894449|7702842|FG002|STARTED|Overall Study||15
6774952|NCT03894449|7702843|FG003|STARTED|Overall Study||15
6774953|NCT03894449|7702844|FG004|STARTED|Overall Study||15
6774954|NCT03894449|7702840|FG000|COMPLETED|Overall Study||15
6774955|NCT03894449|7702841|FG001|COMPLETED|Overall Study||15
6774956|NCT03894449|7702842|FG002|COMPLETED|Overall Study||15
6774957|NCT03894449|7702843|FG003|COMPLETED|Overall Study||15
6774958|NCT03894449|7702844|FG004|COMPLETED|Overall Study||15
6774959|NCT03894449|7702840|FG000|NOT COMPLETED|Overall Study||0
6774960|NCT03894449|7702841|FG001|NOT COMPLETED|Overall Study||0
6774961|NCT03894449|7702842|FG002|NOT COMPLETED|Overall Study||0
6774962|NCT03894449|7702843|FG003|NOT COMPLETED|Overall Study||0
6774963|NCT03894449|7702844|FG004|NOT COMPLETED|Overall Study||0
6774964|NCT03892564|7702856|FG000|STARTED|Overall Study||35
6774965|NCT03892564|7702856|FG000|MC2-01 Cream + Irridiation|Overall Study||35
6774966|NCT03892564|7702856|FG000|MC2-01 Cream + Non-irridiation|Overall Study||35
6774967|NCT03892564|7702856|FG000|MC2-01 Vehicle + Irridiation|Overall Study||35
6774968|NCT03892564|7702856|FG000|MC2-01 Vehicle + Non-irridiation|Overall Study||35
6774969|NCT03892564|7702856|FG000|Control Site|Overall Study||35
6774970|NCT03892564|7702856|FG000|COMPLETED|Overall Study||33
6774971|NCT03892564|7702856|FG000|NOT COMPLETED|Overall Study||2
6774972|NCT03892707|7702863|FG000|STARTED|Overall Study||250
6774973|NCT03892707|7702864|FG001|STARTED|Overall Study||250
6774974|NCT03892707|7702863|FG000|Started Study Treatment at Baseline|Overall Study||244
6774975|NCT03892707|7702864|FG001|Started Study Treatment at Baseline|Overall Study||250
6774976|NCT03892707|7702863|FG000|COMPLETED|Overall Study||244
6774977|NCT03892707|7702864|FG001|COMPLETED|Overall Study||244
6774978|NCT03892707|7702863|FG000|NOT COMPLETED|Overall Study||6
6774979|NCT03892707|7702864|FG001|NOT COMPLETED|Overall Study||6
6774980|NCT03892460|7702873|FG000|STARTED|Overall Study||30
6774981|NCT03892460|7702874|FG001|STARTED|Overall Study||24
6774982|NCT03892460|7702873|FG000|Randomization|Overall Study||25
6774983|NCT03892460|7702874|FG001|Randomization|Overall Study||20
6774984|NCT03892460|7702873|FG000|COMPLETED|Overall Study||18
6774985|NCT03892460|7702874|FG001|COMPLETED|Overall Study||19
6774986|NCT03892460|7702873|FG000|NOT COMPLETED|Overall Study||12
6774987|NCT03892460|7702874|FG001|NOT COMPLETED|Overall Study||5
6313736|NCT00418184|7218170|FG001|STARTED|Double-blind Phase||63
6774988|NCT03891641|7702883|FG000|STARTED|Overall Study||10
6557699|NCT01769365|7480278|FG002|COMPLETED|Overall Study||101
6313737|NCT00418184|7218169|FG000|COMPLETED|Double-blind Phase||110
6313738|NCT00418184|7218170|FG001|COMPLETED|Double-blind Phase||52
6313739|NCT00418184|7218169|FG000|NOT COMPLETED|Double-blind Phase||27
6313740|NCT00418184|7218170|FG001|NOT COMPLETED|Double-blind Phase||11
6313741|NCT00418184|7218169|FG000|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
6774989|NCT03891641|7702884|FG001|STARTED|Overall Study||7
6774990|NCT03891641|7702883|FG000|COMPLETED|Overall Study||8
6774991|NCT03891641|7702884|FG001|COMPLETED|Overall Study||5
6774992|NCT03891641|7702883|FG000|NOT COMPLETED|Overall Study||2
6774993|NCT03891641|7702884|FG001|NOT COMPLETED|Overall Study||2
6774994|NCT03889704|7702890|FG000|STARTED|Overall Study||2
6774995|NCT03889704|7702890|FG000|COMPLETED|Overall Study||1
6774996|NCT03889704|7702890|FG000|NOT COMPLETED|Overall Study||1
6774997|NCT03889444|7702894|FG000|STARTED|Overall Study||141
6774998|NCT03889444|7702894|FG000|COMPLETED|Overall Study||141
6774999|NCT03889444|7702894|FG000|NOT COMPLETED|Overall Study||0
6775000|NCT03888755|7702898|FG000|STARTED|Overall Study||8
6775001|NCT03888755|7702898|FG000|COMPLETED|Overall Study||8
6775002|NCT03888755|7702898|FG000|NOT COMPLETED|Overall Study||0
6775003|NCT03888391|7702904|FG000|STARTED|Overall Study||18
6775004|NCT03888391|7702904|FG000|COMPLETED|Overall Study||3
6775005|NCT03888391|7702904|FG000|NOT COMPLETED|Overall Study||15
6775006|NCT03888482|7702910|FG000|STARTED|First Wear Period (8 -1/+2 Days)||76
6775007|NCT03888482|7702911|FG001|STARTED|First Wear Period (8 -1/+2 Days)||75
6775008|NCT03888482|7702910|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||76
6775009|NCT03888482|7702911|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||75
6775010|NCT03888482|7702910|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
6775011|NCT03888482|7702911|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
6775012|NCT03888482|7702910|FG000|STARTED|Second Wear (8 -1/+2 Days)|2 subjects were discontinued between Treatment 1 and Treatment 2.|74
6775013|NCT03888482|7702911|FG001|STARTED|Second Wear (8 -1/+2 Days)||75
6775014|NCT03888482|7702910|FG000|COMPLETED|Second Wear (8 -1/+2 Days)||73
6775015|NCT03888482|7702911|FG001|COMPLETED|Second Wear (8 -1/+2 Days)||74
6775016|NCT03888482|7702910|FG000|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
6775017|NCT03888482|7702911|FG001|NOT COMPLETED|Second Wear (8 -1/+2 Days)||1
6775018|NCT03888274|7702919|FG000|STARTED|Overall Study||30
6775019|NCT03888274|7702919|FG000|COMPLETED|Overall Study||30
6775020|NCT03888274|7702919|FG000|NOT COMPLETED|Overall Study||0
6775021|NCT03888365|7702925|FG000|STARTED|Cohort A Peak Level/Cohort B Period 1||20
6775022|NCT03888365|7702926|FG001|STARTED|Cohort A Peak Level/Cohort B Period 1||23
6775023|NCT03888365|7702925|FG000|Safety Population|Cohort A Peak Level/Cohort B Period 1||20
6775024|NCT03888365|7702926|FG001|Safety Population|Cohort A Peak Level/Cohort B Period 1||23
6775025|NCT03888365|7702925|FG000|COMPLETED|Cohort A Peak Level/Cohort B Period 1||20
6775026|NCT03888365|7702926|FG001|COMPLETED|Cohort A Peak Level/Cohort B Period 1||23
6775027|NCT03888365|7702925|FG000|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
6775028|NCT03888365|7702926|FG001|NOT COMPLETED|Cohort A Peak Level/Cohort B Period 1||0
6775029|NCT03888365|7702925|FG000|STARTED|Rest - At Least 1 h||20
6775030|NCT03888365|7702926|FG001|STARTED|Rest - At Least 1 h||23
6775031|NCT03888365|7702925|FG000|COMPLETED|Rest - At Least 1 h||20
6775032|NCT03888365|7702926|FG001|COMPLETED|Rest - At Least 1 h||23
6775033|NCT03888365|7702925|FG000|NOT COMPLETED|Rest - At Least 1 h||0
6775034|NCT03888365|7702926|FG001|NOT COMPLETED|Rest - At Least 1 h||0
6775035|NCT03888365|7702925|FG000|STARTED|Cohort A Trough Level/Cohort B Period 2||20
6775036|NCT03888365|7702926|FG001|STARTED|Cohort A Trough Level/Cohort B Period 2||23
6775037|NCT03888365|7702925|FG000|COMPLETED|Cohort A Trough Level/Cohort B Period 2||20
6775038|NCT03888365|7702926|FG001|COMPLETED|Cohort A Trough Level/Cohort B Period 2||23
6775039|NCT03888365|7702925|FG000|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
6775040|NCT03888365|7702926|FG001|NOT COMPLETED|Cohort A Trough Level/Cohort B Period 2||0
6775041|NCT03888469|7702935|FG000|STARTED|First Wear Period (8 -1/+2 Days)||46
6775042|NCT03888469|7702936|FG001|STARTED|First Wear Period (8 -1/+2 Days)||46
6775043|NCT03888469|7702935|FG000|COMPLETED|First Wear Period (8 -1/+2 Days)||46
6775044|NCT03888469|7702936|FG001|COMPLETED|First Wear Period (8 -1/+2 Days)||46
6775045|NCT03888469|7702935|FG000|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
6775046|NCT03888469|7702936|FG001|NOT COMPLETED|First Wear Period (8 -1/+2 Days)||0
6775047|NCT03888469|7702935|FG000|STARTED|Second Wear Period (8 -1/+2 Days)||46
6775048|NCT03888469|7702936|FG001|STARTED|Second Wear Period (8 -1/+2 Days)||46
6775049|NCT03888469|7702935|FG000|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
6775050|NCT03888469|7702936|FG001|COMPLETED|Second Wear Period (8 -1/+2 Days)||46
6775051|NCT03888469|7702935|FG000|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
6775052|NCT03888469|7702936|FG001|NOT COMPLETED|Second Wear Period (8 -1/+2 Days)||0
6775053|NCT03887442|7702946|FG000|STARTED|Overall Study||9
6775054|NCT03887442|7702947|FG001|STARTED|Overall Study||8
6775055|NCT03887442|7702946|FG000|COMPLETED|Overall Study||8
6775056|NCT03887442|7702947|FG001|COMPLETED|Overall Study||8
6377843|NCT00765388|7288508|FG001|STARTED|Period 1||11
6775057|NCT03887442|7702946|FG000|NOT COMPLETED|Overall Study||1
6775058|NCT03887442|7702947|FG001|NOT COMPLETED|Overall Study||0
6775059|NCT03887286|7702955|FG000|STARTED|Overall Study||47
6775060|NCT03887286|7702955|FG000|COMPLETED|Overall Study||47
6775061|NCT03887286|7702955|FG000|NOT COMPLETED|Overall Study||0
6775062|NCT03881007|7702962|FG000|STARTED|First 3 Months||172
6775063|NCT03881007|7702963|FG001|STARTED|First 3 Months||171
6775064|NCT03881007|7702962|FG000|COMPLETED|First 3 Months||121
6313742|NCT00418184|7218170|FG001|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
6313743|NCT00418184|7218169|FG000|COMPLETED|Open-label Phase|5 dropped out|97
6313744|NCT00418184|7218170|FG001|COMPLETED|Open-label Phase|5 dropped out|43
6313745|NCT00418184|7218169|FG000|NOT COMPLETED|Open-label Phase||5
6313746|NCT00418184|7218170|FG001|NOT COMPLETED|Open-label Phase||5
6557700|NCT01769365|7480276|FG000|NOT COMPLETED|Overall Study||0
6313747|NCT00418262|7218176|FG000|STARTED|Visits 1 (Baseline) Thru 5||27
6313748|NCT00418262|7218176|FG000|COMPLETED|Visits 1 (Baseline) Thru 5||25
6313749|NCT00418262|7218176|FG000|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
6313750|NCT00418262|7218176|FG000|STARTED|Visits 5 Thru 8||25
6313751|NCT00418262|7218176|FG000|COMPLETED|Visits 5 Thru 8||16
6313752|NCT00418262|7218176|FG000|NOT COMPLETED|Visits 5 Thru 8||9
6313753|NCT00418262|7218176|FG000|STARTED|Visits 8 Thru 10||16
6313754|NCT00418262|7218176|FG000|COMPLETED|Visits 8 Thru 10||11
6313755|NCT00418262|7218176|FG000|NOT COMPLETED|Visits 8 Thru 10||5
6313756|NCT00418314|7218186|FG000|STARTED|Overall Study||817
6313757|NCT00418314|7218187|FG001|STARTED|Overall Study||830
6313758|NCT00418314|7218186|FG000|COMPLETED|Overall Study||816
6313759|NCT00418314|7218187|FG001|COMPLETED|Overall Study||828
6313760|NCT00418314|7218186|FG000|NOT COMPLETED|Overall Study||1
6313761|NCT00418314|7218187|FG001|NOT COMPLETED|Overall Study||2
6313762|NCT00418379|7218196|FG000|STARTED|Year 1||207
6313763|NCT00418379|7218197|FG001|STARTED|Year 1||207
6313764|NCT00418379|7218198|FG002|STARTED|Year 1||219
6313765|NCT00418379|7218196|FG000|COMPLETED|Year 1||189
6313766|NCT00418379|7218197|FG001|COMPLETED|Year 1||179
6313767|NCT00418379|7218198|FG002|COMPLETED|Year 1||204
6313768|NCT00418379|7218196|FG000|NOT COMPLETED|Year 1||18
6313769|NCT00418379|7218197|FG001|NOT COMPLETED|Year 1||28
6313770|NCT00418379|7218198|FG002|NOT COMPLETED|Year 1||15
6313771|NCT00418379|7218196|FG000|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
6313772|NCT00418379|7218197|FG001|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
6313773|NCT00418379|7218198|FG002|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
6313774|NCT00418379|7218196|FG000|COMPLETED|Year 2||159
6313775|NCT00418379|7218197|FG001|COMPLETED|Year 2||155
6313776|NCT00418379|7218198|FG002|COMPLETED|Year 2||172
6313777|NCT00418379|7218196|FG000|NOT COMPLETED|Year 2||8
6313778|NCT00418379|7218197|FG001|NOT COMPLETED|Year 2||4
6313779|NCT00418379|7218198|FG002|NOT COMPLETED|Year 2||10
6313780|NCT00418379|7218196|FG000|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
6313781|NCT00418379|7218197|FG001|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
6313782|NCT00418379|7218198|FG002|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
6313783|NCT00418379|7218196|FG000|COMPLETED|Year 3||148
6313784|NCT00418379|7218197|FG001|COMPLETED|Year 3||146
6313785|NCT00418379|7218198|FG002|COMPLETED|Year 3||163
6313786|NCT00418379|7218196|FG000|NOT COMPLETED|Year 3||3
6313787|NCT00418379|7218197|FG001|NOT COMPLETED|Year 3||2
6313788|NCT00418379|7218198|FG002|NOT COMPLETED|Year 3||3
6313789|NCT00418379|7218196|FG000|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
6313790|NCT00418379|7218197|FG001|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
6313791|NCT00418379|7218198|FG002|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
6313792|NCT00418379|7218196|FG000|COMPLETED|Year 4||142
6313793|NCT00418379|7218197|FG001|COMPLETED|Year 4||136
6313794|NCT00418379|7218198|FG002|COMPLETED|Year 4||154
6313795|NCT00418379|7218196|FG000|NOT COMPLETED|Year 4||3
6313796|NCT00418379|7218197|FG001|NOT COMPLETED|Year 4||5
6313797|NCT00418379|7218198|FG002|NOT COMPLETED|Year 4||2
6313798|NCT00418379|7218196|FG000|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
6313799|NCT00418379|7218197|FG001|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
6313800|NCT00418379|7218198|FG002|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
6313801|NCT00418379|7218196|FG000|COMPLETED|Year 5||126
6313802|NCT00418379|7218197|FG001|COMPLETED|Year 5||115
6313803|NCT00418379|7218198|FG002|COMPLETED|Year 5||131
6313804|NCT00418379|7218196|FG000|NOT COMPLETED|Year 5||2
6313805|NCT00418379|7218197|FG001|NOT COMPLETED|Year 5||5
6313806|NCT00418379|7218198|FG002|NOT COMPLETED|Year 5||3
6313807|NCT00418457|7218208|FG000|STARTED|Overall Study||1065
6313808|NCT00418457|7218209|FG001|STARTED|Overall Study||1043
6313809|NCT00418457|7218208|FG000|COMPLETED|Overall Study||1065
6313810|NCT00418457|7218209|FG001|COMPLETED|Overall Study||1043
6313811|NCT00418457|7218208|FG000|NOT COMPLETED|Overall Study||0
6313812|NCT00418457|7218209|FG001|NOT COMPLETED|Overall Study||0
6313813|NCT00418522|7218217|FG000|STARTED|Overall Study||219
6313814|NCT00418522|7218218|FG001|STARTED|Overall Study||194
6313815|NCT00418522|7218217|FG000|Received Treatment|Overall Study||212
6313816|NCT00418522|7218218|FG001|Received Treatment|Overall Study||190
6313817|NCT00418522|7218217|FG000|COMPLETED|Overall Study||136
6313818|NCT00418522|7218218|FG001|COMPLETED|Overall Study||152
6313819|NCT00418522|7218217|FG000|NOT COMPLETED|Overall Study||83
6313820|NCT00418522|7218218|FG001|NOT COMPLETED|Overall Study||42
6313821|NCT00418561|7218227|FG000|STARTED|Overall Study||4
6313822|NCT00418561|7218228|FG001|STARTED|Overall Study||5
6313823|NCT00418561|7218229|FG002|STARTED|Overall Study||4
6313824|NCT00418561|7218227|FG000|COMPLETED|Overall Study||4
6313825|NCT00418561|7218228|FG001|COMPLETED|Overall Study||4
6313826|NCT00418561|7218229|FG002|COMPLETED|Overall Study||4
6313827|NCT00418561|7218227|FG000|NOT COMPLETED|Overall Study||0
6313828|NCT00418561|7218228|FG001|NOT COMPLETED|Overall Study||1
6313829|NCT00418561|7218229|FG002|NOT COMPLETED|Overall Study||0
6313830|NCT00418574|7218239|FG000|STARTED|Overall Study||593
6313831|NCT00418574|7218240|FG001|STARTED|Overall Study||295
6313832|NCT00418574|7218239|FG000|TREATED|Overall Study||592
6313833|NCT00418574|7218240|FG001|TREATED|Overall Study||294
6313834|NCT00418574|7218239|FG000|COMPLETED|Overall Study||545
6313835|NCT00418574|7218240|FG001|COMPLETED|Overall Study||272
6313836|NCT00418574|7218239|FG000|NOT COMPLETED|Overall Study||48
6313837|NCT00418574|7218240|FG001|NOT COMPLETED|Overall Study||23
6313838|NCT00418665|7218249|FG000|STARTED|Treatment Period||12
6313839|NCT00418665|7218250|FG001|STARTED|Treatment Period||14
6313840|NCT00418665|7218251|FG002|STARTED|Treatment Period||13
6313841|NCT00418665|7218249|FG000|Received Study Medication|Treatment Period||11
6313842|NCT00418665|7218250|FG001|Received Study Medication|Treatment Period||13
6313843|NCT00418665|7218251|FG002|Received Study Medication|Treatment Period||13
6313844|NCT00418665|7218249|FG000|COMPLETED|Treatment Period||7
6313845|NCT00418665|7218250|FG001|COMPLETED|Treatment Period||8
6313846|NCT00418665|7218251|FG002|COMPLETED|Treatment Period||9
6313847|NCT00418665|7218249|FG000|NOT COMPLETED|Treatment Period||5
6313848|NCT00418665|7218250|FG001|NOT COMPLETED|Treatment Period||6
6313849|NCT00418665|7218251|FG002|NOT COMPLETED|Treatment Period||4
6313850|NCT00418665|7218249|FG000|STARTED|Treatment Extension||7
6313851|NCT00418665|7218250|FG001|STARTED|Treatment Extension||8
6313852|NCT00418665|7218251|FG002|STARTED|Treatment Extension||9
6313853|NCT00418665|7218249|FG000|COMPLETED|Treatment Extension||1
6313854|NCT00418665|7218250|FG001|COMPLETED|Treatment Extension||4
6313855|NCT00418665|7218251|FG002|COMPLETED|Treatment Extension||7
6313856|NCT00418665|7218249|FG000|NOT COMPLETED|Treatment Extension||6
6313857|NCT00418665|7218250|FG001|NOT COMPLETED|Treatment Extension||4
6313858|NCT00418665|7218251|FG002|NOT COMPLETED|Treatment Extension||2
6313859|NCT00418691|7218262|FG000|STARTED|Overall Study||11
6313860|NCT00418691|7218263|FG001|STARTED|Overall Study||12
6313861|NCT00418691|7218264|FG002|STARTED|Overall Study||10
6313862|NCT00418691|7218262|FG000|COMPLETED|Overall Study||9
6313863|NCT00418691|7218263|FG001|COMPLETED|Overall Study||10
6313864|NCT00418691|7218264|FG002|COMPLETED|Overall Study||5
6313865|NCT00418691|7218262|FG000|NOT COMPLETED|Overall Study||2
6313866|NCT00418691|7218263|FG001|NOT COMPLETED|Overall Study||2
6313867|NCT00418691|7218264|FG002|NOT COMPLETED|Overall Study||5
6313868|NCT00418717|7218272|FG000|STARTED|Treatment Period A - Weeks 1-4||42
6313869|NCT00418717|7218272|FG000|COMPLETED|Treatment Period A - Weeks 1-4||41
6313870|NCT00418717|7218272|FG000|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
6313871|NCT00418717|7218272|FG000|STARTED|Treatment Period B - Weeks 5-12||41
6313872|NCT00418717|7218272|FG000|COMPLETED|Treatment Period B - Weeks 5-12||39
6313873|NCT00418717|7218272|FG000|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
6313874|NCT00418886|7218278|FG000|STARTED|Overall Study|randomised patients|256
6313875|NCT00418886|7218279|FG001|STARTED|Overall Study|randomised patients|278
6313876|NCT00418886|7218278|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
6313877|NCT00418886|7218279|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
6313878|NCT00418886|7218278|FG000|NOT COMPLETED|Overall Study||226
6313879|NCT00418886|7218279|FG001|NOT COMPLETED|Overall Study||255
6775065|NCT03881007|7702963|FG001|COMPLETED|First 3 Months||119
6775066|NCT03881007|7702962|FG000|NOT COMPLETED|First 3 Months||51
6775067|NCT03881007|7702963|FG001|NOT COMPLETED|First 3 Months||52
6313880|NCT00418938|7218287|FG000|STARTED|Overall Study||133
6313881|NCT00418938|7218288|FG001|STARTED|Overall Study||131
6313882|NCT00418938|7218287|FG000|COMPLETED|Overall Study||109
6313883|NCT00418938|7218288|FG001|COMPLETED|Overall Study||108
6313884|NCT00418938|7218287|FG000|NOT COMPLETED|Overall Study||24
6313885|NCT00418938|7218288|FG001|NOT COMPLETED|Overall Study||23
6775068|NCT03881007|7702962|FG000|STARTED|Last 3 Months||121
6775069|NCT03881007|7702963|FG001|STARTED|Last 3 Months||119
6775070|NCT03881007|7702962|FG000|COMPLETED|Last 3 Months||77
6775071|NCT03881007|7702963|FG001|COMPLETED|Last 3 Months||74
6775072|NCT03881007|7702962|FG000|NOT COMPLETED|Last 3 Months||44
6775073|NCT03881007|7702963|FG001|NOT COMPLETED|Last 3 Months||45
6775074|NCT03878602|7702971|FG000|STARTED|Overall Study||75
6775075|NCT03878602|7702972|FG001|STARTED|Overall Study||67
6775076|NCT03878602|7702971|FG000|COMPLETED|Overall Study||66
6313886|NCT00418951|7218297|FG000|STARTED|Overall Study||39
6313887|NCT00418951|7218298|FG001|STARTED|Overall Study||33
6313888|NCT00418951|7218299|FG002|STARTED|Overall Study||40
6313889|NCT00418951|7218297|FG000|COMPLETED|Overall Study||39
6313890|NCT00418951|7218298|FG001|COMPLETED|Overall Study||33
6313891|NCT00418951|7218299|FG002|COMPLETED|Overall Study||40
6313892|NCT00418951|7218297|FG000|NOT COMPLETED|Overall Study||0
6313893|NCT00418951|7218298|FG001|NOT COMPLETED|Overall Study||0
6313894|NCT00418951|7218299|FG002|NOT COMPLETED|Overall Study||0
6313895|NCT00418964|7218310|FG000|STARTED|Overall Study||22
6313896|NCT00418964|7218311|FG001|STARTED|Overall Study||20
6313897|NCT00418964|7218312|FG002|STARTED|Overall Study||20
6313898|NCT00418964|7218310|FG000|COMPLETED|Overall Study||21
6313899|NCT00418964|7218311|FG001|COMPLETED|Overall Study||17
6313900|NCT00418964|7218312|FG002|COMPLETED|Overall Study||14
6313901|NCT00418964|7218310|FG000|NOT COMPLETED|Overall Study||1
6775077|NCT03878602|7702972|FG001|COMPLETED|Overall Study||66
6775078|NCT03878602|7702971|FG000|NOT COMPLETED|Overall Study||9
6313902|NCT00418964|7218311|FG001|NOT COMPLETED|Overall Study||3
6313903|NCT00418964|7218312|FG002|NOT COMPLETED|Overall Study||6
6313904|NCT00418977|7218322|FG000|STARTED|Overall Study||43
6313905|NCT00418977|7218323|FG001|STARTED|Overall Study||16
6313906|NCT00418977|7218322|FG000|COMPLETED|Overall Study||40
6313907|NCT00418977|7218323|FG001|COMPLETED|Overall Study||13
6313908|NCT00418977|7218322|FG000|NOT COMPLETED|Overall Study||3
6313909|NCT00418977|7218323|FG001|NOT COMPLETED|Overall Study||3
6313910|NCT00419003|7218331|FG000|STARTED|Phase I, Ketamine Infusion||13
6313911|NCT00419003|7218332|FG001|STARTED|Phase I, Ketamine Infusion||13
6313912|NCT00419003|7218331|FG000|COMPLETED|Phase I, Ketamine Infusion||7
6313913|NCT00419003|7218332|FG001|COMPLETED|Phase I, Ketamine Infusion||7
6313914|NCT00419003|7218331|FG000|NOT COMPLETED|Phase I, Ketamine Infusion||6
6313915|NCT00419003|7218332|FG001|NOT COMPLETED|Phase I, Ketamine Infusion||6
6313916|NCT00419003|7218331|FG000|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|6
6313917|NCT00419003|7218332|FG001|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn't split up evenly (same way as phase I) in the riluzole/placebo phase.|8
6313918|NCT00419003|7218331|FG000|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
6313919|NCT00419003|7218332|FG001|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
6313920|NCT00419003|7218331|FG000|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
6313921|NCT00419003|7218332|FG001|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
6313922|NCT00419094|7218343|FG000|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
6313923|NCT00419094|7218344|FG001|STARTED|Overall Study||171
6313924|NCT00419094|7218343|FG000|COMPLETED|Overall Study||50
6313925|NCT00419094|7218344|FG001|COMPLETED|Overall Study||141
6313926|NCT00419094|7218343|FG000|NOT COMPLETED|Overall Study||7
6313927|NCT00419094|7218344|FG001|NOT COMPLETED|Overall Study||30
6313928|NCT00419120|7218350|FG000|STARTED|Primary Study Period||10
6313929|NCT00419120|7218350|FG000|COMPLETED|Primary Study Period||10
6313930|NCT00419120|7218350|FG000|NOT COMPLETED|Primary Study Period||0
6313931|NCT00419120|7218350|FG000|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
6313932|NCT00419120|7218350|FG000|COMPLETED|Long Term Follow up Period||0
6313933|NCT00419120|7218350|FG000|NOT COMPLETED|Long Term Follow up Period||10
6313934|NCT00419159|7218356|FG000|STARTED|Overall Study|Full Analysis Set|99
6313935|NCT00419159|7218357|FG001|STARTED|Overall Study||100
6313936|NCT00419159|7218356|FG000|COMPLETED|Overall Study||0
6313937|NCT00419159|7218357|FG001|COMPLETED|Overall Study||0
6313938|NCT00419159|7218356|FG000|NOT COMPLETED|Overall Study||99
6313939|NCT00419159|7218357|FG001|NOT COMPLETED|Overall Study||100
6313940|NCT00419263|7218374|FG000|STARTED|Overall Study||115
6313941|NCT00419263|7218375|FG001|STARTED|Overall Study||114
6313942|NCT00419263|7218376|FG002|STARTED|Overall Study||115
6313943|NCT00419263|7218374|FG000|COMPLETED|Overall Study||112
6313944|NCT00419263|7218375|FG001|COMPLETED|Overall Study||112
6313945|NCT00419263|7218376|FG002|COMPLETED|Overall Study||112
6313946|NCT00419263|7218374|FG000|NOT COMPLETED|Overall Study||3
6313947|NCT00419263|7218375|FG001|NOT COMPLETED|Overall Study||2
6313948|NCT00419263|7218376|FG002|NOT COMPLETED|Overall Study||3
6313949|NCT00419315|7218387|FG000|STARTED|Overall Study||85
6313950|NCT00419315|7218388|FG001|STARTED|Overall Study||78
6313951|NCT00419315|7218387|FG000|COMPLETED|Overall Study||85
6313952|NCT00419315|7218388|FG001|COMPLETED|Overall Study||78
6313953|NCT00419315|7218387|FG000|NOT COMPLETED|Overall Study||0
6313954|NCT00419315|7218388|FG001|NOT COMPLETED|Overall Study||0
6313955|NCT00419341|7218394|FG000|STARTED|Wash in/Wash Out Period||49
6313956|NCT00419341|7218394|FG000|COMPLETED|Wash in/Wash Out Period||38
6313957|NCT00419341|7218394|FG000|NOT COMPLETED|Wash in/Wash Out Period||11
6313958|NCT00419341|7218394|FG000|STARTED|Efficacy Period||38
6313959|NCT00419341|7218394|FG000|COMPLETED|Efficacy Period||28
6313960|NCT00419341|7218394|FG000|NOT COMPLETED|Efficacy Period||10
6313961|NCT00419380|7218402|FG000|STARTED|Overall Study||19
6313962|NCT00419380|7218403|FG001|STARTED|Overall Study||22
6313963|NCT00419380|7218402|FG000|COMPLETED|Overall Study||18
6313964|NCT00419380|7218403|FG001|COMPLETED|Overall Study||12
6313965|NCT00419380|7218402|FG000|NOT COMPLETED|Overall Study||1
6313966|NCT00419380|7218403|FG001|NOT COMPLETED|Overall Study||10
6313967|NCT00419393|7218409|FG000|STARTED|Overall Study|One subject did not receive medication|190
6313968|NCT00419393|7218409|FG000|COMPLETED|Overall Study||166
6313969|NCT00419393|7218409|FG000|NOT COMPLETED|Overall Study||24
6313970|NCT00419445|7218416|FG000|STARTED|Overall Study||8
6313971|NCT00419445|7218417|FG001|STARTED|Overall Study||16
6313972|NCT00419445|7218418|FG002|STARTED|Overall Study||8
6313973|NCT00419445|7218416|FG000|COMPLETED|Overall Study||7
6313974|NCT00419445|7218417|FG001|COMPLETED|Overall Study||14
6313975|NCT00419445|7218418|FG002|COMPLETED|Overall Study||7
6313976|NCT00419445|7218416|FG000|NOT COMPLETED|Overall Study||1
6313977|NCT00419445|7218417|FG001|NOT COMPLETED|Overall Study||2
6313978|NCT00419445|7218418|FG002|NOT COMPLETED|Overall Study||1
6313979|NCT00419562|7218428|FG000|STARTED|Overall Study||283
6313980|NCT00419562|7218429|FG001|STARTED|Overall Study||277
6313981|NCT00419562|7218428|FG000|COMPLETED|Overall Study||250
6313982|NCT00419562|7218429|FG001|COMPLETED|Overall Study||246
6313983|NCT00419562|7218428|FG000|NOT COMPLETED|Overall Study||33
6313984|NCT00419562|7218429|FG001|NOT COMPLETED|Overall Study||31
6313985|NCT00419666|7218435|FG000|STARTED|Overall Study||25
6313986|NCT00419666|7218435|FG000|COMPLETED|Overall Study||25
6313987|NCT00419666|7218435|FG000|NOT COMPLETED|Overall Study||0
6313988|NCT00419744|7218442|FG000|STARTED|Overall Study||407
6313989|NCT00419744|7218443|FG001|STARTED|Overall Study||408
6313990|NCT00419744|7218444|FG002|STARTED|Overall Study||404
6313991|NCT00419744|7218442|FG000|COMPLETED|Overall Study||290
6313992|NCT00419744|7218443|FG001|COMPLETED|Overall Study||290
6313993|NCT00419744|7218444|FG002|COMPLETED|Overall Study||271
6313994|NCT00419744|7218442|FG000|NOT COMPLETED|Overall Study||117
6313995|NCT00419744|7218443|FG001|NOT COMPLETED|Overall Study||118
6313996|NCT00419744|7218444|FG002|NOT COMPLETED|Overall Study||133
6313997|NCT00419757|7218454|FG000|STARTED|Overall Study|Randomized patients|127
6313998|NCT00419757|7218455|FG001|STARTED|Overall Study|Randomized patients|123
6313999|NCT00419757|7218454|FG000|COMPLETED|Overall Study|Randomized patients|109
6314000|NCT00419757|7218455|FG001|COMPLETED|Overall Study|Randomized patients|102
6314001|NCT00419757|7218454|FG000|NOT COMPLETED|Overall Study||18
6314002|NCT00419757|7218455|FG001|NOT COMPLETED|Overall Study||21
6314003|NCT00419770|7218465|FG000|STARTED|Overall Study||11
6314004|NCT00419770|7218466|FG001|STARTED|Overall Study||9
6314005|NCT00419770|7218465|FG000|COMPLETED|Overall Study||6
6314006|NCT00419770|7218466|FG001|COMPLETED|Overall Study||8
6314007|NCT00419770|7218465|FG000|NOT COMPLETED|Overall Study||5
6314008|NCT00419770|7218466|FG001|NOT COMPLETED|Overall Study||1
6314009|NCT00419926|7218474|FG000|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
6314010|NCT00419926|7218475|FG001|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
6314011|NCT00419926|7218474|FG000|COMPLETED|Overall Study||141
6314012|NCT00419926|7218475|FG001|COMPLETED|Overall Study||148
6314013|NCT00419926|7218474|FG000|NOT COMPLETED|Overall Study||14
6314014|NCT00419926|7218475|FG001|NOT COMPLETED|Overall Study||10
6314015|NCT00419952|7218483|FG000|STARTED|Overall Study||377
6314016|NCT00419952|7218484|FG001|STARTED|Overall Study||365
6314017|NCT00419952|7218483|FG000|COMPLETED|Overall Study||228
6314018|NCT00419952|7218484|FG001|COMPLETED|Overall Study||240
6314019|NCT00419952|7218483|FG000|NOT COMPLETED|Overall Study||149
6314020|NCT00419952|7218484|FG001|NOT COMPLETED|Overall Study||125
6314021|NCT00420004|7218493|FG000|STARTED|Overall Study||269
6314022|NCT00420004|7218494|FG001|STARTED|Overall Study||138
6314023|NCT00420004|7218495|FG002|STARTED|Overall Study||62
6314024|NCT00420004|7218493|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|249
6314025|NCT00420004|7218494|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|122
6314026|NCT00420004|7218495|FG002|Received at Least 1 Dose of Study Drug|Overall Study|Participants who received >=1 dose of study drug and had baseline and post-baseline data available|54
6314027|NCT00420004|7218493|FG000|COMPLETED|Overall Study||140
6314028|NCT00420004|7218494|FG001|COMPLETED|Overall Study||67
6314029|NCT00420004|7218495|FG002|COMPLETED|Overall Study||30
6314030|NCT00420004|7218493|FG000|NOT COMPLETED|Overall Study||129
6314031|NCT00420004|7218494|FG001|NOT COMPLETED|Overall Study||71
6314032|NCT00420004|7218495|FG002|NOT COMPLETED|Overall Study||32
6314033|NCT00420017|7218509|FG000|STARTED|Overall Study||40
6314034|NCT00420017|7218510|FG001|STARTED|Overall Study||40
6314035|NCT00420017|7218509|FG000|COMPLETED|Overall Study|40 completed analysis|38
6314036|NCT00420017|7218510|FG001|COMPLETED|Overall Study||40
6314037|NCT00420017|7218509|FG000|NOT COMPLETED|Overall Study||2
6314038|NCT00420017|7218510|FG001|NOT COMPLETED|Overall Study||0
6314039|NCT00420056|7218516|FG000|STARTED|Overall Study||17
6314040|NCT00420056|7218516|FG000|COMPLETED|Overall Study||0
6314041|NCT00420056|7218516|FG000|NOT COMPLETED|Overall Study||17
6314042|NCT00420095|7218522|FG000|STARTED|Overall Study||57
6314043|NCT00420095|7218523|FG001|STARTED|Overall Study||60
6314044|NCT00420095|7218522|FG000|COMPLETED|Overall Study||54
6314045|NCT00420095|7218523|FG001|COMPLETED|Overall Study||59
6314046|NCT00420095|7218522|FG000|NOT COMPLETED|Overall Study||3
6314047|NCT00420095|7218523|FG001|NOT COMPLETED|Overall Study||1
6314048|NCT00420147|7218531|FG000|STARTED|Overall Study||19
6314049|NCT00420147|7218532|FG001|STARTED|Overall Study||19
6314050|NCT00420147|7218531|FG000|COMPLETED|Overall Study||19
6314051|NCT00420147|7218532|FG001|COMPLETED|Overall Study||19
6314052|NCT00420147|7218531|FG000|NOT COMPLETED|Overall Study||0
6314053|NCT00420147|7218532|FG001|NOT COMPLETED|Overall Study||0
6314054|NCT00420199|7218540|FG000|STARTED|Overall Study||27
6314055|NCT00420199|7218541|FG001|STARTED|Overall Study||23
6314056|NCT00420199|7218540|FG000|COMPLETED|Overall Study||26
6314057|NCT00420199|7218541|FG001|COMPLETED|Overall Study||23
6314058|NCT00420199|7218540|FG000|NOT COMPLETED|Overall Study||1
6314059|NCT00420199|7218541|FG001|NOT COMPLETED|Overall Study||0
6314060|NCT00420212|7218555|FG000|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
6314061|NCT00420212|7218556|FG001|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
6314062|NCT00420212|7218557|FG002|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
6314063|NCT00420212|7218555|FG000|COMPLETED|Overall Study||317
6314064|NCT00420212|7218556|FG001|COMPLETED|Overall Study||315
6314065|NCT00420212|7218557|FG002|COMPLETED|Overall Study||320
6314066|NCT00420212|7218555|FG000|NOT COMPLETED|Overall Study||91
6314067|NCT00420212|7218556|FG001|NOT COMPLETED|Overall Study||95
6314068|NCT00420212|7218557|FG002|NOT COMPLETED|Overall Study||96
6314069|NCT00420238|7218570|FG000|STARTED|12 Week Double-Blind Treatment Period 1||39
6314070|NCT00420238|7218571|FG001|STARTED|12 Week Double-Blind Treatment Period 1||43
6314071|NCT00420238|7218570|FG000|COMPLETED|12 Week Double-Blind Treatment Period 1||38
6314072|NCT00420238|7218571|FG001|COMPLETED|12 Week Double-Blind Treatment Period 1||39
6314073|NCT00420238|7218570|FG000|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
6314074|NCT00420238|7218571|FG001|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
6314075|NCT00420238|7218570|FG000|STARTED|12 Week Open-Label Treatment Period 2||38
6314076|NCT00420238|7218571|FG001|STARTED|12 Week Open-Label Treatment Period 2||39
6314077|NCT00420238|7218570|FG000|COMPLETED|12 Week Open-Label Treatment Period 2||36
6314078|NCT00420238|7218571|FG001|COMPLETED|12 Week Open-Label Treatment Period 2||38
6314079|NCT00420238|7218570|FG000|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
6314080|NCT00420238|7218571|FG001|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
6314081|NCT00420290|7218585|FG000|STARTED|Overall Study||11
6314082|NCT00420290|7218586|FG001|STARTED|Overall Study||11
6314083|NCT00420290|7218585|FG000|COMPLETED|Overall Study||7
6314084|NCT00420290|7218586|FG001|COMPLETED|Overall Study||7
6314085|NCT00420290|7218585|FG000|NOT COMPLETED|Overall Study||4
6314086|NCT00420290|7218586|FG001|NOT COMPLETED|Overall Study||4
6314087|NCT00420303|7218594|FG000|STARTED|Overall Study||12
6314088|NCT00420303|7218595|FG001|STARTED|Overall Study||12
6314089|NCT00420303|7218594|FG000|COMPLETED|Overall Study||11
6314090|NCT00420303|7218595|FG001|COMPLETED|Overall Study||8
6314091|NCT00420303|7218594|FG000|NOT COMPLETED|Overall Study||1
6314092|NCT00420303|7218595|FG001|NOT COMPLETED|Overall Study||4
6314093|NCT00420316|7218603|FG000|STARTED|Overall Study||1082
6314094|NCT00420316|7218604|FG001|STARTED|Overall Study||531
6314095|NCT00420316|7218603|FG000|COMPLETED|Overall Study||1070
6314096|NCT00420316|7218604|FG001|COMPLETED|Overall Study||522
6314097|NCT00420316|7218603|FG000|NOT COMPLETED|Overall Study||12
6314098|NCT00420316|7218604|FG001|NOT COMPLETED|Overall Study||9
6314099|NCT00420342|7218613|FG000|STARTED|Overall Study||30
6314100|NCT00420342|7218614|FG001|STARTED|Overall Study||33
6314101|NCT00420342|7218615|FG002|STARTED|Overall Study||29
6314102|NCT00420342|7218613|FG000|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
6314103|NCT00420342|7218614|FG001|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
6314104|NCT00420342|7218615|FG002|Received Treatment|Overall Study||29
6314105|NCT00420342|7218613|FG000|COMPLETED|Overall Study||29
6314106|NCT00420342|7218614|FG001|COMPLETED|Overall Study||31
6314107|NCT00420342|7218615|FG002|COMPLETED|Overall Study||28
6314108|NCT00420342|7218613|FG000|NOT COMPLETED|Overall Study||1
6314109|NCT00420342|7218614|FG001|NOT COMPLETED|Overall Study||2
6314110|NCT00420342|7218615|FG002|NOT COMPLETED|Overall Study||1
6314111|NCT00420381|7218623|FG000|STARTED|Overall Study||28
6314112|NCT00420381|7218623|FG000|Received at Least One Dose of Study Drug|Overall Study||27
6314113|NCT00420381|7218623|FG000|COMPLETED|Overall Study||27
6314114|NCT00420381|7218623|FG000|NOT COMPLETED|Overall Study||1
6314115|NCT00420407|7218629|FG000|STARTED|Overall Study||41
6314116|NCT00420407|7218630|FG001|STARTED|Overall Study||40
6314117|NCT00420407|7218629|FG000|COMPLETED|Overall Study||37
6314118|NCT00420407|7218630|FG001|COMPLETED|Overall Study||34
6314119|NCT00420407|7218629|FG000|NOT COMPLETED|Overall Study||4
6314120|NCT00420407|7218630|FG001|NOT COMPLETED|Overall Study||6
6314121|NCT00420420|7218639|FG000|STARTED|Overall Study|Number of patients randomized.|73
6314122|NCT00420420|7218640|FG001|STARTED|Overall Study|Number of patients randomized.|71
6314123|NCT00420420|7218639|FG000|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
6314124|NCT00420420|7218640|FG001|COMPLETED|Overall Study||67
6314125|NCT00420420|7218639|FG000|NOT COMPLETED|Overall Study||8
6314126|NCT00420420|7218640|FG001|NOT COMPLETED|Overall Study||4
6314127|NCT00420459|7218646|FG000|STARTED|Overall Study||12
6314128|NCT00420459|7218646|FG000|COMPLETED|Overall Study||12
6314129|NCT00420459|7218646|FG000|NOT COMPLETED|Overall Study||0
6375227|NCT00754338|7285817|FG000|COMPLETED|Second Intervention for Phase1&Phase2||17
6375228|NCT00754338|7285818|FG001|COMPLETED|Second Intervention for Phase1&Phase2||17
6375229|NCT00754338|7285819|FG002|COMPLETED|Second Intervention for Phase1&Phase2||16
6375230|NCT00754338|7285820|FG003|COMPLETED|Second Intervention for Phase1&Phase2||18
6375231|NCT00754338|7285817|FG000|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
6375232|NCT00754338|7285818|FG001|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
6375233|NCT00754338|7285819|FG002|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
6375234|NCT00754338|7285820|FG003|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
6375235|NCT00754377|7285834|FG000|STARTED|Overall Study||50
6375236|NCT00754377|7285835|FG001|STARTED|Overall Study||42
6375237|NCT00754377|7285834|FG000|COMPLETED|Overall Study||50
6375238|NCT00754377|7285835|FG001|COMPLETED|Overall Study||42
6375239|NCT00754377|7285834|FG000|NOT COMPLETED|Overall Study||0
6375240|NCT00754377|7285835|FG001|NOT COMPLETED|Overall Study||0
6375241|NCT00754390|7285843|FG000|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
6375242|NCT00754390|7285843|FG000|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
6375243|NCT00754390|7285843|FG000|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
6375244|NCT00754390|7285843|FG000|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
6375245|NCT00754390|7285843|FG000|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
6375246|NCT00754390|7285843|FG000|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
6375247|NCT00754390|7285843|FG000|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
6375248|NCT00754390|7285843|FG000|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
6375249|NCT00754390|7285843|FG000|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
6314130|NCT00420511|7218654|FG000|STARTED|Overall Study||10
6314131|NCT00420511|7218655|FG001|STARTED|Overall Study||11
6314132|NCT00420511|7218654|FG000|COMPLETED|Overall Study||8
6314133|NCT00420511|7218655|FG001|COMPLETED|Overall Study||10
6314134|NCT00420511|7218654|FG000|NOT COMPLETED|Overall Study||2
6314135|NCT00420511|7218655|FG001|NOT COMPLETED|Overall Study||1
6314136|NCT00420628|7218665|FG000|STARTED|Overall Study||72
6314137|NCT00420628|7218666|FG001|STARTED|Overall Study||36
6314138|NCT00420628|7218665|FG000|COMPLETED|Overall Study||63
6314139|NCT00420628|7218666|FG001|COMPLETED|Overall Study||32
6314140|NCT00420628|7218665|FG000|NOT COMPLETED|Overall Study||9
6314141|NCT00420628|7218666|FG001|NOT COMPLETED|Overall Study||4
6314142|NCT00420641|7218675|FG000|STARTED|Overall Study||160
6314143|NCT00420641|7218676|FG001|STARTED|Overall Study||172
6314144|NCT00420641|7218677|FG002|STARTED|Overall Study||172
6314145|NCT00420641|7218675|FG000|COMPLETED|Overall Study||115
6314146|NCT00420641|7218676|FG001|COMPLETED|Overall Study||100
6314147|NCT00420641|7218677|FG002|COMPLETED|Overall Study||128
6314148|NCT00420641|7218675|FG000|NOT COMPLETED|Overall Study||45
6314149|NCT00420641|7218676|FG001|NOT COMPLETED|Overall Study||72
6314150|NCT00420641|7218677|FG002|NOT COMPLETED|Overall Study||44
6314151|NCT00420745|7218687|FG000|STARTED|Overall Study||670
6314152|NCT00420745|7218688|FG001|STARTED|Overall Study||339
6314153|NCT00420745|7218687|FG000|COMPLETED|Overall Study||655
6314154|NCT00420745|7218688|FG001|COMPLETED|Overall Study||333
6314155|NCT00420745|7218687|FG000|NOT COMPLETED|Overall Study||15
6314156|NCT00420745|7218688|FG001|NOT COMPLETED|Overall Study||6
6314157|NCT00420771|7218696|FG000|STARTED|Overall Study||8
6314158|NCT00420771|7218697|FG001|STARTED|Overall Study||11
6314159|NCT00420771|7218696|FG000|COMPLETED|Overall Study||5
6314160|NCT00420771|7218697|FG001|COMPLETED|Overall Study||7
6314161|NCT00420771|7218696|FG000|NOT COMPLETED|Overall Study||3
6314162|NCT00420771|7218697|FG001|NOT COMPLETED|Overall Study||4
6314163|NCT00420784|7218707|FG000|STARTED|Overall Study||115
6314164|NCT00420784|7218708|FG001|STARTED|Overall Study||113
6314165|NCT00420784|7218709|FG002|STARTED|Overall Study||111
6314166|NCT00420784|7218710|FG003|STARTED|Overall Study||114
6314167|NCT00420784|7218707|FG000|COMPLETED|Overall Study||86
6314168|NCT00420784|7218708|FG001|COMPLETED|Overall Study||55
6314169|NCT00420784|7218709|FG002|COMPLETED|Overall Study||58
6314170|NCT00420784|7218710|FG003|COMPLETED|Overall Study||36
6314171|NCT00420784|7218707|FG000|NOT COMPLETED|Overall Study||29
6314172|NCT00420784|7218708|FG001|NOT COMPLETED|Overall Study||58
6314173|NCT00420784|7218709|FG002|NOT COMPLETED|Overall Study||53
6314174|NCT00420784|7218710|FG003|NOT COMPLETED|Overall Study||78
6314175|NCT00420849|7218721|FG000|STARTED|Overall Study||587
6314176|NCT00420849|7218721|FG000|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
6314177|NCT00420849|7218721|FG000|NOT COMPLETED|Overall Study||331
6314178|NCT00420927|7218735|FG000|STARTED|Period 1||515
6314179|NCT00420927|7218736|FG001|STARTED|Period 1||517
6314180|NCT00420927|7218737|FG002|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6314181|NCT00420927|7218738|FG003|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6314182|NCT00420927|7218739|FG004|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6314183|NCT00420927|7218740|FG005|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6314184|NCT00420927|7218741|FG006|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
6314185|NCT00420927|7218735|FG000|COMPLETED|Period 1||466
6314186|NCT00420927|7218736|FG001|COMPLETED|Period 1||460
6314187|NCT00420927|7218737|FG002|COMPLETED|Period 1||0
6314188|NCT00420927|7218738|FG003|COMPLETED|Period 1||0
6314189|NCT00420927|7218739|FG004|COMPLETED|Period 1||0
6557701|NCT01769365|7480277|FG001|NOT COMPLETED|Overall Study||2
6314190|NCT00420927|7218740|FG005|COMPLETED|Period 1||0
6314191|NCT00420927|7218741|FG006|COMPLETED|Period 1||0
6314192|NCT00420927|7218735|FG000|NOT COMPLETED|Period 1||49
6314193|NCT00420927|7218736|FG001|NOT COMPLETED|Period 1||57
6314194|NCT00420927|7218737|FG002|NOT COMPLETED|Period 1||0
6314195|NCT00420927|7218738|FG003|NOT COMPLETED|Period 1||0
6314196|NCT00420927|7218739|FG004|NOT COMPLETED|Period 1||0
6314197|NCT00420927|7218740|FG005|NOT COMPLETED|Period 1||0
6314198|NCT00420927|7218741|FG006|NOT COMPLETED|Period 1||0
6314199|NCT00420927|7218735|FG000|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
6314200|NCT00420927|7218736|FG001|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
6314201|NCT00420927|7218737|FG002|STARTED|Period 2||102
6314202|NCT00420927|7218738|FG003|STARTED|Period 2||105
6314203|NCT00420927|7218739|FG004|STARTED|Period 2||259
6314204|NCT00420927|7218740|FG005|STARTED|Period 2||112
6314205|NCT00420927|7218741|FG006|STARTED|Period 2||348
6314206|NCT00420927|7218735|FG000|COMPLETED|Period 2||0
6314207|NCT00420927|7218736|FG001|COMPLETED|Period 2||0
6314208|NCT00420927|7218737|FG002|COMPLETED|Period 2||89
6314209|NCT00420927|7218738|FG003|COMPLETED|Period 2||95
6314210|NCT00420927|7218739|FG004|COMPLETED|Period 2||216
6314211|NCT00420927|7218740|FG005|COMPLETED|Period 2||97
6314212|NCT00420927|7218741|FG006|COMPLETED|Period 2||295
6314213|NCT00420927|7218735|FG000|NOT COMPLETED|Period 2||0
6314214|NCT00420927|7218736|FG001|NOT COMPLETED|Period 2||0
6314215|NCT00420927|7218737|FG002|NOT COMPLETED|Period 2||13
6314216|NCT00420927|7218738|FG003|NOT COMPLETED|Period 2||10
6314217|NCT00420927|7218739|FG004|NOT COMPLETED|Period 2||43
6314218|NCT00420927|7218740|FG005|NOT COMPLETED|Period 2||15
6314219|NCT00420927|7218741|FG006|NOT COMPLETED|Period 2||53
6314220|NCT00420992|7218757|FG000|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
6314221|NCT00420992|7218758|FG001|STARTED|Titration Phase||0
6314222|NCT00420992|7218757|FG000|COMPLETED|Titration Phase||344
6314223|NCT00420992|7218758|FG001|COMPLETED|Titration Phase||0
6314224|NCT00420992|7218757|FG000|NOT COMPLETED|Titration Phase||203
6314225|NCT00420992|7218758|FG001|NOT COMPLETED|Titration Phase||0
6314226|NCT00420992|7218757|FG000|STARTED|Maintenance Phase||171
6314227|NCT00420992|7218758|FG001|STARTED|Maintenance Phase||173
6314228|NCT00420992|7218757|FG000|COMPLETED|Maintenance Phase||110
6314229|NCT00420992|7218758|FG001|COMPLETED|Maintenance Phase||98
6314230|NCT00420992|7218757|FG000|NOT COMPLETED|Maintenance Phase||61
6314231|NCT00420992|7218758|FG001|NOT COMPLETED|Maintenance Phase||75
6314232|NCT00421148|7218785|FG000|STARTED|Overall Study||2
6314233|NCT00421148|7218786|FG001|STARTED|Overall Study||2
6314234|NCT00421148|7218787|FG002|STARTED|Overall Study||2
6314235|NCT00421148|7218788|FG003|STARTED|Overall Study||1
6314236|NCT00421148|7218789|FG004|STARTED|Overall Study||1
6314237|NCT00421148|7218790|FG005|STARTED|Overall Study||5
6314238|NCT00421148|7218791|FG006|STARTED|Overall Study||6
6314239|NCT00421148|7218792|FG007|STARTED|Overall Study||5
6314240|NCT00421148|7218793|FG008|STARTED|Overall Study||5
6314241|NCT00421148|7218794|FG009|STARTED|Overall Study||5
6314242|NCT00421148|7218795|FG010|STARTED|Overall Study||6
6314243|NCT00421148|7218796|FG011|STARTED|Overall Study||6
6557702|NCT01769365|7480278|FG002|NOT COMPLETED|Overall Study||2
6557703|NCT01769378|7480288|FG000|STARTED|Overall Study||240
6557704|NCT01769378|7480289|FG001|STARTED|Overall Study||60
6557705|NCT01769378|7480288|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
6314244|NCT00421148|7218797|FG012|STARTED|Overall Study||6
6314245|NCT00421148|7218798|FG013|STARTED|Overall Study||6
6314246|NCT00421148|7218799|FG014|STARTED|Overall Study||6
6314247|NCT00421148|7218800|FG015|STARTED|Overall Study||6
6314248|NCT00421148|7218801|FG016|STARTED|Overall Study||6
6314249|NCT00421148|7218802|FG017|STARTED|Overall Study||6
6314250|NCT00421148|7218803|FG018|STARTED|Overall Study||6
6314251|NCT00421148|7218804|FG019|STARTED|Overall Study||6
6314252|NCT00421148|7218785|FG000|Treated|Overall Study||2
6314253|NCT00421148|7218786|FG001|Treated|Overall Study||2
6314254|NCT00421148|7218787|FG002|Treated|Overall Study||2
6314255|NCT00421148|7218788|FG003|Treated|Overall Study||1
6314256|NCT00421148|7218789|FG004|Treated|Overall Study||1
6314257|NCT00421148|7218790|FG005|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|4
6314258|NCT00421148|7218791|FG006|Treated|Overall Study||6
6314259|NCT00421148|7218792|FG007|Treated|Overall Study||5
6314260|NCT00421148|7218793|FG008|Treated|Overall Study||5
6314261|NCT00421148|7218794|FG009|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but was an adolescent|5
6314262|NCT00421148|7218795|FG010|Treated|Overall Study||6
6314263|NCT00421148|7218796|FG011|Treated|Overall Study|Includes 1 participant who was inadvertently randomized to group but received 5 mg/kg sugammadex|6
6314264|NCT00421148|7218797|FG012|Treated|Overall Study||6
6314265|NCT00421148|7218798|FG013|Treated|Overall Study||6
6314266|NCT00421148|7218799|FG014|Treated|Overall Study||6
6314267|NCT00421148|7218800|FG015|Treated|Overall Study||6
6314268|NCT00421148|7218801|FG016|Treated|Overall Study||6
6314269|NCT00421148|7218802|FG017|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
6314270|NCT00421148|7218803|FG018|Treated|Overall Study|1 additional participant discontinued prior to receiving study treatment|5
6314271|NCT00421148|7218804|FG019|Treated|Overall Study||6
6314272|NCT00421148|7218785|FG000|COMPLETED|Overall Study||2
6314273|NCT00421148|7218786|FG001|COMPLETED|Overall Study||2
6314274|NCT00421148|7218787|FG002|COMPLETED|Overall Study||2
6314275|NCT00421148|7218788|FG003|COMPLETED|Overall Study||1
6314276|NCT00421148|7218789|FG004|COMPLETED|Overall Study||1
6314277|NCT00421148|7218790|FG005|COMPLETED|Overall Study||4
6314278|NCT00421148|7218791|FG006|COMPLETED|Overall Study||6
6314279|NCT00421148|7218792|FG007|COMPLETED|Overall Study||5
6314280|NCT00421148|7218793|FG008|COMPLETED|Overall Study||5
6314281|NCT00421148|7218794|FG009|COMPLETED|Overall Study||5
6314282|NCT00421148|7218795|FG010|COMPLETED|Overall Study||6
6314283|NCT00421148|7218796|FG011|COMPLETED|Overall Study||6
6314284|NCT00421148|7218797|FG012|COMPLETED|Overall Study||6
6314285|NCT00421148|7218798|FG013|COMPLETED|Overall Study||6
6314286|NCT00421148|7218799|FG014|COMPLETED|Overall Study||6
6314287|NCT00421148|7218800|FG015|COMPLETED|Overall Study||6
6314288|NCT00421148|7218801|FG016|COMPLETED|Overall Study||6
6314289|NCT00421148|7218802|FG017|COMPLETED|Overall Study||4
6314290|NCT00421148|7218803|FG018|COMPLETED|Overall Study||5
6314291|NCT00421148|7218804|FG019|COMPLETED|Overall Study||6
6314292|NCT00421148|7218785|FG000|NOT COMPLETED|Overall Study||0
6314293|NCT00421148|7218786|FG001|NOT COMPLETED|Overall Study||0
6314294|NCT00421148|7218787|FG002|NOT COMPLETED|Overall Study||0
6314295|NCT00421148|7218788|FG003|NOT COMPLETED|Overall Study||0
6314296|NCT00421148|7218789|FG004|NOT COMPLETED|Overall Study||0
6314297|NCT00421148|7218790|FG005|NOT COMPLETED|Overall Study||1
6314298|NCT00421148|7218791|FG006|NOT COMPLETED|Overall Study||0
6314299|NCT00421148|7218792|FG007|NOT COMPLETED|Overall Study||0
6557706|NCT01769378|7480289|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
6314300|NCT00421148|7218793|FG008|NOT COMPLETED|Overall Study||0
6314301|NCT00421148|7218794|FG009|NOT COMPLETED|Overall Study||0
6314302|NCT00421148|7218795|FG010|NOT COMPLETED|Overall Study||0
6314303|NCT00421148|7218796|FG011|NOT COMPLETED|Overall Study||0
6314304|NCT00421148|7218797|FG012|NOT COMPLETED|Overall Study||0
6314305|NCT00421148|7218798|FG013|NOT COMPLETED|Overall Study||0
6314306|NCT00421148|7218799|FG014|NOT COMPLETED|Overall Study||0
6314307|NCT00421148|7218800|FG015|NOT COMPLETED|Overall Study||0
6314308|NCT00421148|7218801|FG016|NOT COMPLETED|Overall Study||0
6314309|NCT00421148|7218802|FG017|NOT COMPLETED|Overall Study||2
6314310|NCT00421148|7218803|FG018|NOT COMPLETED|Overall Study||1
6314311|NCT00421148|7218804|FG019|NOT COMPLETED|Overall Study||0
6314312|NCT00421174|7218848|FG000|STARTED|Overall Study||18
6314313|NCT00421174|7218849|FG001|STARTED|Overall Study||19
6314314|NCT00421174|7218848|FG000|COMPLETED|Overall Study||16
6314315|NCT00421174|7218849|FG001|COMPLETED|Overall Study||18
6314316|NCT00421174|7218848|FG000|NOT COMPLETED|Overall Study||2
6314317|NCT00421174|7218849|FG001|NOT COMPLETED|Overall Study||1
6314318|NCT00421304|7218858|FG000|STARTED|Overall Study||40
6314319|NCT00421304|7218859|FG001|STARTED|Overall Study||39
6314320|NCT00421304|7218860|FG002|STARTED|Overall Study||39
6314321|NCT00421304|7218858|FG000|COMPLETED|Overall Study||32
6314322|NCT00421304|7218859|FG001|COMPLETED|Overall Study||35
6314323|NCT00421304|7218860|FG002|COMPLETED|Overall Study||31
6314324|NCT00421304|7218858|FG000|NOT COMPLETED|Overall Study||8
6314325|NCT00421304|7218859|FG001|NOT COMPLETED|Overall Study||4
6314326|NCT00421304|7218860|FG002|NOT COMPLETED|Overall Study||8
6314327|NCT00421343|7218870|FG000|STARTED|Overall Study||29
6314328|NCT00421343|7218870|FG000|COMPLETED|Overall Study||23
6314329|NCT00421343|7218870|FG000|NOT COMPLETED|Overall Study||6
6314330|NCT00421408|7218876|FG000|STARTED|Overall Study||102
6314331|NCT00421408|7218877|FG001|STARTED|Overall Study||106
6314332|NCT00421408|7218876|FG000|COMPLETED|Overall Study||60
6314333|NCT00421408|7218877|FG001|COMPLETED|Overall Study||61
6314334|NCT00421408|7218876|FG000|NOT COMPLETED|Overall Study||42
6314335|NCT00421408|7218877|FG001|NOT COMPLETED|Overall Study||45
6314336|NCT00421603|7218885|FG000|STARTED|Overall Study||39
6314337|NCT00421603|7218886|FG001|STARTED|Overall Study||42
6314338|NCT00421603|7218885|FG000|COMPLETED|Overall Study|Completed all 14 week sof trial|28
6314339|NCT00421603|7218886|FG001|COMPLETED|Overall Study|Completed all 14 week sof trial|30
6314340|NCT00421603|7218885|FG000|NOT COMPLETED|Overall Study||11
6314341|NCT00421603|7218886|FG001|NOT COMPLETED|Overall Study||12
6314342|NCT00421707|7218894|FG000|STARTED|Period 1: Treatment Period 1||67
6314343|NCT00421707|7218895|FG001|STARTED|Period 1: Treatment Period 1||65
6314344|NCT00421707|7218894|FG000|COMPLETED|Period 1: Treatment Period 1||56
6314345|NCT00421707|7218895|FG001|COMPLETED|Period 1: Treatment Period 1||56
6314346|NCT00421707|7218894|FG000|NOT COMPLETED|Period 1: Treatment Period 1||11
6314347|NCT00421707|7218895|FG001|NOT COMPLETED|Period 1: Treatment Period 1||9
6314348|NCT00421707|7218894|FG000|STARTED|Period 2: Washout||56
6314349|NCT00421707|7218895|FG001|STARTED|Period 2: Washout||56
6314350|NCT00421707|7218894|FG000|COMPLETED|Period 2: Washout||55
6314351|NCT00421707|7218895|FG001|COMPLETED|Period 2: Washout||52
6314352|NCT00421707|7218894|FG000|NOT COMPLETED|Period 2: Washout||1
6314353|NCT00421707|7218895|FG001|NOT COMPLETED|Period 2: Washout||4
6314354|NCT00421707|7218894|FG000|STARTED|Period 3:Treatment Period 2||55
6314355|NCT00421707|7218895|FG001|STARTED|Period 3:Treatment Period 2||52
6314356|NCT00421707|7218894|FG000|COMPLETED|Period 3:Treatment Period 2||53
6314357|NCT00421707|7218895|FG001|COMPLETED|Period 3:Treatment Period 2||49
6314358|NCT00421707|7218894|FG000|NOT COMPLETED|Period 3:Treatment Period 2||2
6314359|NCT00421707|7218895|FG001|NOT COMPLETED|Period 3:Treatment Period 2||3
6314360|NCT00421733|7218907|FG000|STARTED|Overall Study||93
6314361|NCT00421733|7218908|FG001|STARTED|Overall Study||95
6314362|NCT00421733|7218909|FG002|STARTED|Overall Study||93
6314363|NCT00421733|7218907|FG000|COMPLETED|Overall Study||78
6314364|NCT00421733|7218908|FG001|COMPLETED|Overall Study||69
6314365|NCT00421733|7218909|FG002|COMPLETED|Overall Study||73
6314366|NCT00421733|7218907|FG000|NOT COMPLETED|Overall Study||15
6314367|NCT00421733|7218908|FG001|NOT COMPLETED|Overall Study||26
6314368|NCT00421733|7218909|FG002|NOT COMPLETED|Overall Study||20
6314369|NCT00421889|7218930|FG000|STARTED|Overall Study||5
6314370|NCT00421889|7218931|FG001|STARTED|Overall Study||5
6314371|NCT00421889|7218932|FG002|STARTED|Overall Study||3
6314372|NCT00421889|7218933|FG003|STARTED|Overall Study||4
6314373|NCT00421889|7218934|FG004|STARTED|Overall Study||6
6314374|NCT00421889|7218935|FG005|STARTED|Overall Study||35
6314375|NCT00421889|7218936|FG006|STARTED|Overall Study||4
6314376|NCT00421889|7218937|FG007|STARTED|Overall Study||3
6314377|NCT00421889|7218938|FG008|STARTED|Overall Study||15
6314378|NCT00421889|7218930|FG000|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
6314379|NCT00421889|7218931|FG001|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
6314380|NCT00421889|7218932|FG002|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
6314381|NCT00421889|7218933|FG003|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
6314382|NCT00421889|7218934|FG004|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
6314383|NCT00421889|7218935|FG005|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
6314384|NCT00421889|7218936|FG006|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
6314385|NCT00421889|7218937|FG007|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
6314386|NCT00421889|7218938|FG008|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
6314387|NCT00421889|7218930|FG000|NOT COMPLETED|Overall Study||5
6314388|NCT00421889|7218931|FG001|NOT COMPLETED|Overall Study||5
6314389|NCT00421889|7218932|FG002|NOT COMPLETED|Overall Study||3
6314390|NCT00421889|7218933|FG003|NOT COMPLETED|Overall Study||4
6314391|NCT00421889|7218934|FG004|NOT COMPLETED|Overall Study||6
6314392|NCT00421889|7218935|FG005|NOT COMPLETED|Overall Study||35
6314393|NCT00421889|7218936|FG006|NOT COMPLETED|Overall Study||4
6314394|NCT00421889|7218937|FG007|NOT COMPLETED|Overall Study||2
6314395|NCT00421889|7218938|FG008|NOT COMPLETED|Overall Study||11
6314396|NCT00421928|7218965|FG000|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
6314397|NCT00421928|7218966|FG001|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
6314398|NCT00421928|7218967|FG002|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
6314399|NCT00421928|7218965|FG000|COMPLETED|Overall Study||181
6314400|NCT00421928|7218966|FG001|COMPLETED|Overall Study||118
6314401|NCT00421928|7218967|FG002|COMPLETED|Overall Study||203
6314402|NCT00421928|7218965|FG000|NOT COMPLETED|Overall Study||163
6314403|NCT00421928|7218966|FG001|NOT COMPLETED|Overall Study||224
6314404|NCT00421928|7218967|FG002|NOT COMPLETED|Overall Study||134
6314405|NCT00421993|7218979|FG000|STARTED|Overall Study||419
6314406|NCT00421993|7218980|FG001|STARTED|Overall Study||418
6314407|NCT00421993|7218981|FG002|STARTED|Overall Study||415
6314408|NCT00421993|7218982|FG003|STARTED|Overall Study||418
6314409|NCT00421993|7218979|FG000|COMPLETED|Overall Study||366
6314410|NCT00421993|7218980|FG001|COMPLETED|Overall Study||369
6314411|NCT00421993|7218981|FG002|COMPLETED|Overall Study||363
6314412|NCT00421993|7218982|FG003|COMPLETED|Overall Study||361
6314413|NCT00421993|7218979|FG000|NOT COMPLETED|Overall Study||53
6314414|NCT00421993|7218980|FG001|NOT COMPLETED|Overall Study||49
6314415|NCT00421993|7218981|FG002|NOT COMPLETED|Overall Study||52
6314416|NCT00421993|7218982|FG003|NOT COMPLETED|Overall Study||57
6314417|NCT00422032|7218994|FG000|STARTED|Overall Study||37
6314418|NCT00422032|7218995|FG001|STARTED|Overall Study||21
6314419|NCT00422032|7218994|FG000|COMPLETED|Overall Study||37
6314420|NCT00422032|7218995|FG001|COMPLETED|Overall Study||21
6314421|NCT00422032|7218994|FG000|NOT COMPLETED|Overall Study||0
6314422|NCT00422032|7218995|FG001|NOT COMPLETED|Overall Study||0
6314423|NCT00422058|7219007|FG000|STARTED|Double-Blind, Week 0-20||98
6314424|NCT00422058|7219008|FG001|STARTED|Double-Blind, Week 0-20||95
6314425|NCT00422058|7219009|FG002|STARTED|Double-Blind, Week 0-20||90
6314426|NCT00422058|7219010|FG003|STARTED|Double-Blind, Week 0-20||93
6314427|NCT00422058|7219011|FG004|STARTED|Double-Blind, Week 0-20||93
6314428|NCT00422058|7219012|FG005|STARTED|Double-Blind, Week 0-20||95
6314429|NCT00422058|7219007|FG000|COMPLETED|Double-Blind, Week 0-20||79
6314430|NCT00422058|7219008|FG001|COMPLETED|Double-Blind, Week 0-20||85
6314431|NCT00422058|7219009|FG002|COMPLETED|Double-Blind, Week 0-20||74
6314432|NCT00422058|7219010|FG003|COMPLETED|Double-Blind, Week 0-20||73
6314433|NCT00422058|7219011|FG004|COMPLETED|Double-Blind, Week 0-20||82
6314434|NCT00422058|7219012|FG005|COMPLETED|Double-Blind, Week 0-20||79
6314435|NCT00422058|7219007|FG000|NOT COMPLETED|Double-Blind, Week 0-20||19
6314436|NCT00422058|7219008|FG001|NOT COMPLETED|Double-Blind, Week 0-20||10
6314437|NCT00422058|7219009|FG002|NOT COMPLETED|Double-Blind, Week 0-20||16
6314438|NCT00422058|7219010|FG003|NOT COMPLETED|Double-Blind, Week 0-20||20
6314439|NCT00422058|7219011|FG004|NOT COMPLETED|Double-Blind, Week 0-20||11
6314440|NCT00422058|7219012|FG005|NOT COMPLETED|Double-Blind, Week 0-20||16
6314441|NCT00422058|7219007|FG000|STARTED|Open-Label Extension, Week 20-104||79
6314442|NCT00422058|7219008|FG001|STARTED|Open-Label Extension, Week 20-104||85
6314443|NCT00422058|7219009|FG002|STARTED|Open-Label Extension, Week 20-104||74
6314444|NCT00422058|7219010|FG003|STARTED|Open-Label Extension, Week 20-104||73
6314445|NCT00422058|7219011|FG004|STARTED|Open-Label Extension, Week 20-104||82
6314446|NCT00422058|7219012|FG005|STARTED|Open-Label Extension, Week 20-104||79
6314447|NCT00422058|7219007|FG000|Enrolled in Extension|Open-Label Extension, Week 20-104||67
6314448|NCT00422058|7219008|FG001|Enrolled in Extension|Open-Label Extension, Week 20-104||68
6314449|NCT00422058|7219009|FG002|Enrolled in Extension|Open-Label Extension, Week 20-104||59
6557707|NCT01769378|7480288|FG000|COMPLETED|Overall Study|Completed the study on study treatment|215
6557708|NCT01769378|7480289|FG001|COMPLETED|Overall Study|Completed the study on study treatment|56
6775079|NCT03878602|7702972|FG001|NOT COMPLETED|Overall Study||1
6314450|NCT00422058|7219010|FG003|Enrolled in Extension|Open-Label Extension, Week 20-104||65
6314451|NCT00422058|7219011|FG004|Enrolled in Extension|Open-Label Extension, Week 20-104||72
6314452|NCT00422058|7219012|FG005|Enrolled in Extension|Open-Label Extension, Week 20-104||67
6775080|NCT03875118|7702982|FG000|STARTED|Overall Study||34
6775081|NCT03875118|7702983|FG001|STARTED|Overall Study||34
6775082|NCT03875118|7702982|FG000|COMPLETED|Overall Study||30
6775083|NCT03875118|7702983|FG001|COMPLETED|Overall Study||30
6775084|NCT03875118|7702982|FG000|NOT COMPLETED|Overall Study||4
6314453|NCT00422058|7219007|FG000|COMPLETED|Open-Label Extension, Week 20-104||47
6314454|NCT00422058|7219008|FG001|COMPLETED|Open-Label Extension, Week 20-104||46
6314455|NCT00422058|7219009|FG002|COMPLETED|Open-Label Extension, Week 20-104||38
6557709|NCT01769378|7480288|FG000|NOT COMPLETED|Overall Study||25
6775085|NCT03875118|7702983|FG001|NOT COMPLETED|Overall Study||4
6775086|NCT03873987|7702991|FG000|STARTED|Overall Study||52
6314456|NCT00422058|7219010|FG003|COMPLETED|Open-Label Extension, Week 20-104||45
6314457|NCT00422058|7219011|FG004|COMPLETED|Open-Label Extension, Week 20-104||47
6314458|NCT00422058|7219012|FG005|COMPLETED|Open-Label Extension, Week 20-104||45
6314459|NCT00422058|7219007|FG000|NOT COMPLETED|Open-Label Extension, Week 20-104||32
6775087|NCT03873987|7702992|FG001|STARTED|Overall Study||50
6775088|NCT03873987|7702991|FG000|COMPLETED|Overall Study||50
6775089|NCT03873987|7702992|FG001|COMPLETED|Overall Study||49
6775090|NCT03873987|7702991|FG000|NOT COMPLETED|Overall Study||2
6775091|NCT03873987|7702992|FG001|NOT COMPLETED|Overall Study||1
6775092|NCT03870893|7703001|FG000|STARTED|Overall Study||23
6775093|NCT03870893|7703002|FG001|STARTED|Overall Study||24
6775094|NCT03870893|7703001|FG000|COMPLETED|Overall Study||23
6775095|NCT03870893|7703002|FG001|COMPLETED|Overall Study||23
6775096|NCT03870893|7703001|FG000|NOT COMPLETED|Overall Study||0
6775097|NCT03870893|7703002|FG001|NOT COMPLETED|Overall Study||1
6775098|NCT03887299|7703011|FG000|STARTED|Overall Study||77
6775099|NCT03887299|7703012|FG001|STARTED|Overall Study||77
6775100|NCT03887299|7703011|FG000|COMPLETED|Overall Study||77
6775101|NCT03887299|7703012|FG001|COMPLETED|Overall Study||77
6314460|NCT00422058|7219008|FG001|NOT COMPLETED|Open-Label Extension, Week 20-104||39
6314461|NCT00422058|7219009|FG002|NOT COMPLETED|Open-Label Extension, Week 20-104||36
6314462|NCT00422058|7219010|FG003|NOT COMPLETED|Open-Label Extension, Week 20-104||28
6314463|NCT00422058|7219011|FG004|NOT COMPLETED|Open-Label Extension, Week 20-104||35
6314464|NCT00422058|7219012|FG005|NOT COMPLETED|Open-Label Extension, Week 20-104||34
6314465|NCT00422084|7219028|FG000|STARTED|Overall Study||849
6314466|NCT00422084|7219029|FG001|STARTED|Overall Study||423
6314467|NCT00422084|7219028|FG000|COMPLETED|Overall Study||751
6314468|NCT00422084|7219029|FG001|COMPLETED|Overall Study||347
6314469|NCT00422084|7219028|FG000|NOT COMPLETED|Overall Study||98
6314470|NCT00422084|7219029|FG001|NOT COMPLETED|Overall Study||76
6314471|NCT00422097|7219041|FG000|STARTED|Dose Level 1||3
6314472|NCT00422097|7219042|FG001|STARTED|Dose Level 1||0
6557710|NCT01769378|7480289|FG001|NOT COMPLETED|Overall Study||4
6557711|NCT01769391|7480297|FG000|STARTED|Overall Study||110
6314473|NCT00422097|7219043|FG002|STARTED|Dose Level 1||0
6314474|NCT00422097|7219044|FG003|STARTED|Dose Level 1||0
6314475|NCT00422097|7219045|FG004|STARTED|Dose Level 1||0
6314476|NCT00422097|7219046|FG005|STARTED|Dose Level 1||0
6314477|NCT00422097|7219047|FG006|STARTED|Dose Level 1||0
6314478|NCT00422097|7219048|FG007|STARTED|Dose Level 1||0
6314479|NCT00422097|7219041|FG000|COMPLETED|Dose Level 1||3
6314480|NCT00422097|7219042|FG001|COMPLETED|Dose Level 1||0
6314481|NCT00422097|7219043|FG002|COMPLETED|Dose Level 1||0
6314482|NCT00422097|7219044|FG003|COMPLETED|Dose Level 1||0
6314483|NCT00422097|7219045|FG004|COMPLETED|Dose Level 1||0
6314484|NCT00422097|7219046|FG005|COMPLETED|Dose Level 1||0
6314485|NCT00422097|7219047|FG006|COMPLETED|Dose Level 1||0
6314486|NCT00422097|7219048|FG007|COMPLETED|Dose Level 1||0
6314487|NCT00422097|7219041|FG000|NOT COMPLETED|Dose Level 1||0
6314488|NCT00422097|7219042|FG001|NOT COMPLETED|Dose Level 1||0
6314489|NCT00422097|7219043|FG002|NOT COMPLETED|Dose Level 1||0
6314490|NCT00422097|7219044|FG003|NOT COMPLETED|Dose Level 1||0
6314491|NCT00422097|7219045|FG004|NOT COMPLETED|Dose Level 1||0
6314492|NCT00422097|7219046|FG005|NOT COMPLETED|Dose Level 1||0
6314493|NCT00422097|7219047|FG006|NOT COMPLETED|Dose Level 1||0
6314494|NCT00422097|7219048|FG007|NOT COMPLETED|Dose Level 1||0
6314495|NCT00422097|7219041|FG000|STARTED|Dose Level 2||0
6314496|NCT00422097|7219042|FG001|STARTED|Dose Level 2||6
6314497|NCT00422097|7219043|FG002|STARTED|Dose Level 2||0
6314498|NCT00422097|7219044|FG003|STARTED|Dose Level 2||0
6314499|NCT00422097|7219045|FG004|STARTED|Dose Level 2||0
6314500|NCT00422097|7219046|FG005|STARTED|Dose Level 2||0
6314501|NCT00422097|7219047|FG006|STARTED|Dose Level 2||0
6314502|NCT00422097|7219048|FG007|STARTED|Dose Level 2||0
6314503|NCT00422097|7219041|FG000|COMPLETED|Dose Level 2||0
6314504|NCT00422097|7219042|FG001|COMPLETED|Dose Level 2||5
6314505|NCT00422097|7219043|FG002|COMPLETED|Dose Level 2||0
6314506|NCT00422097|7219044|FG003|COMPLETED|Dose Level 2||0
6314507|NCT00422097|7219045|FG004|COMPLETED|Dose Level 2||0
6314508|NCT00422097|7219046|FG005|COMPLETED|Dose Level 2||0
6314509|NCT00422097|7219047|FG006|COMPLETED|Dose Level 2||0
6314510|NCT00422097|7219048|FG007|COMPLETED|Dose Level 2||0
6314511|NCT00422097|7219041|FG000|NOT COMPLETED|Dose Level 2||0
6314512|NCT00422097|7219042|FG001|NOT COMPLETED|Dose Level 2||1
6314513|NCT00422097|7219043|FG002|NOT COMPLETED|Dose Level 2||0
6314514|NCT00422097|7219044|FG003|NOT COMPLETED|Dose Level 2||0
6314515|NCT00422097|7219045|FG004|NOT COMPLETED|Dose Level 2||0
6314516|NCT00422097|7219046|FG005|NOT COMPLETED|Dose Level 2||0
6314517|NCT00422097|7219047|FG006|NOT COMPLETED|Dose Level 2||0
6314518|NCT00422097|7219048|FG007|NOT COMPLETED|Dose Level 2||0
6314519|NCT00422097|7219041|FG000|STARTED|Dose Level 3||0
6557712|NCT01769391|7480298|FG001|STARTED|Overall Study||57
6557713|NCT01769391|7480297|FG000|Received at Least One Dose of Study Drug|Overall Study||106
6314520|NCT00422097|7219042|FG001|STARTED|Dose Level 3||0
6314521|NCT00422097|7219043|FG002|STARTED|Dose Level 3||3
6314522|NCT00422097|7219044|FG003|STARTED|Dose Level 3||0
6314523|NCT00422097|7219045|FG004|STARTED|Dose Level 3||0
6314524|NCT00422097|7219046|FG005|STARTED|Dose Level 3||0
6314525|NCT00422097|7219047|FG006|STARTED|Dose Level 3||0
6314526|NCT00422097|7219048|FG007|STARTED|Dose Level 3||0
6314527|NCT00422097|7219041|FG000|COMPLETED|Dose Level 3||0
6314528|NCT00422097|7219042|FG001|COMPLETED|Dose Level 3||0
6314529|NCT00422097|7219043|FG002|COMPLETED|Dose Level 3||3
6775102|NCT03887299|7703011|FG000|NOT COMPLETED|Overall Study||0
6314530|NCT00422097|7219044|FG003|COMPLETED|Dose Level 3||0
6314531|NCT00422097|7219045|FG004|COMPLETED|Dose Level 3||0
6314532|NCT00422097|7219046|FG005|COMPLETED|Dose Level 3||0
6314533|NCT00422097|7219047|FG006|COMPLETED|Dose Level 3||0
6314534|NCT00422097|7219048|FG007|COMPLETED|Dose Level 3||0
6314535|NCT00422097|7219041|FG000|NOT COMPLETED|Dose Level 3||0
6314536|NCT00422097|7219042|FG001|NOT COMPLETED|Dose Level 3||0
6314537|NCT00422097|7219043|FG002|NOT COMPLETED|Dose Level 3||0
6314538|NCT00422097|7219044|FG003|NOT COMPLETED|Dose Level 3||0
6314539|NCT00422097|7219045|FG004|NOT COMPLETED|Dose Level 3||0
6314540|NCT00422097|7219046|FG005|NOT COMPLETED|Dose Level 3||0
6314541|NCT00422097|7219047|FG006|NOT COMPLETED|Dose Level 3||0
6314542|NCT00422097|7219048|FG007|NOT COMPLETED|Dose Level 3||0
6314543|NCT00422097|7219041|FG000|STARTED|Dose Level 4||0
6314544|NCT00422097|7219042|FG001|STARTED|Dose Level 4||0
6314545|NCT00422097|7219043|FG002|STARTED|Dose Level 4||0
6314546|NCT00422097|7219044|FG003|STARTED|Dose Level 4||3
6314547|NCT00422097|7219045|FG004|STARTED|Dose Level 4||0
6314548|NCT00422097|7219046|FG005|STARTED|Dose Level 4||0
6314549|NCT00422097|7219047|FG006|STARTED|Dose Level 4||0
6314550|NCT00422097|7219048|FG007|STARTED|Dose Level 4||0
6314551|NCT00422097|7219041|FG000|COMPLETED|Dose Level 4||0
6314552|NCT00422097|7219042|FG001|COMPLETED|Dose Level 4||0
6314553|NCT00422097|7219043|FG002|COMPLETED|Dose Level 4||0
6314554|NCT00422097|7219044|FG003|COMPLETED|Dose Level 4||3
6314555|NCT00422097|7219045|FG004|COMPLETED|Dose Level 4||0
6314556|NCT00422097|7219046|FG005|COMPLETED|Dose Level 4||0
6314557|NCT00422097|7219047|FG006|COMPLETED|Dose Level 4||0
6314558|NCT00422097|7219048|FG007|COMPLETED|Dose Level 4||0
6314559|NCT00422097|7219041|FG000|NOT COMPLETED|Dose Level 4||0
6314560|NCT00422097|7219042|FG001|NOT COMPLETED|Dose Level 4||0
6314561|NCT00422097|7219043|FG002|NOT COMPLETED|Dose Level 4||0
6314562|NCT00422097|7219044|FG003|NOT COMPLETED|Dose Level 4||0
6314563|NCT00422097|7219045|FG004|NOT COMPLETED|Dose Level 4||0
6314564|NCT00422097|7219046|FG005|NOT COMPLETED|Dose Level 4||0
6314565|NCT00422097|7219047|FG006|NOT COMPLETED|Dose Level 4||0
6314566|NCT00422097|7219048|FG007|NOT COMPLETED|Dose Level 4||0
6314567|NCT00422097|7219041|FG000|STARTED|Dose Level 5||0
6314568|NCT00422097|7219042|FG001|STARTED|Dose Level 5||0
6314569|NCT00422097|7219043|FG002|STARTED|Dose Level 5||0
6314570|NCT00422097|7219044|FG003|STARTED|Dose Level 5||0
6314571|NCT00422097|7219045|FG004|STARTED|Dose Level 5||23
6314572|NCT00422097|7219046|FG005|STARTED|Dose Level 5||0
6314573|NCT00422097|7219047|FG006|STARTED|Dose Level 5||0
6314574|NCT00422097|7219048|FG007|STARTED|Dose Level 5||0
6314575|NCT00422097|7219041|FG000|COMPLETED|Dose Level 5||0
6314576|NCT00422097|7219042|FG001|COMPLETED|Dose Level 5||0
6314577|NCT00422097|7219043|FG002|COMPLETED|Dose Level 5||0
6314578|NCT00422097|7219044|FG003|COMPLETED|Dose Level 5||0
6314579|NCT00422097|7219045|FG004|COMPLETED|Dose Level 5||23
6314580|NCT00422097|7219046|FG005|COMPLETED|Dose Level 5||0
6314581|NCT00422097|7219047|FG006|COMPLETED|Dose Level 5||0
6314582|NCT00422097|7219048|FG007|COMPLETED|Dose Level 5||0
6314583|NCT00422097|7219041|FG000|NOT COMPLETED|Dose Level 5||0
6314584|NCT00422097|7219042|FG001|NOT COMPLETED|Dose Level 5||0
6314585|NCT00422097|7219043|FG002|NOT COMPLETED|Dose Level 5||0
6314586|NCT00422097|7219044|FG003|NOT COMPLETED|Dose Level 5||0
6314587|NCT00422097|7219045|FG004|NOT COMPLETED|Dose Level 5||0
6314588|NCT00422097|7219046|FG005|NOT COMPLETED|Dose Level 5||0
6314589|NCT00422097|7219047|FG006|NOT COMPLETED|Dose Level 5||0
6314590|NCT00422097|7219048|FG007|NOT COMPLETED|Dose Level 5||0
6314591|NCT00422097|7219041|FG000|STARTED|Dose Level 6||0
6314592|NCT00422097|7219042|FG001|STARTED|Dose Level 6||0
6314593|NCT00422097|7219043|FG002|STARTED|Dose Level 6||0
6314594|NCT00422097|7219044|FG003|STARTED|Dose Level 6||0
6314595|NCT00422097|7219045|FG004|STARTED|Dose Level 6||0
6314596|NCT00422097|7219046|FG005|STARTED|Dose Level 6||6
6314597|NCT00422097|7219047|FG006|STARTED|Dose Level 6||0
6314598|NCT00422097|7219048|FG007|STARTED|Dose Level 6||0
6314599|NCT00422097|7219041|FG000|COMPLETED|Dose Level 6||0
6314600|NCT00422097|7219042|FG001|COMPLETED|Dose Level 6||0
6314601|NCT00422097|7219043|FG002|COMPLETED|Dose Level 6||0
6314602|NCT00422097|7219044|FG003|COMPLETED|Dose Level 6||0
6314603|NCT00422097|7219045|FG004|COMPLETED|Dose Level 6||0
6314604|NCT00422097|7219046|FG005|COMPLETED|Dose Level 6||6
6314605|NCT00422097|7219047|FG006|COMPLETED|Dose Level 6||0
6314606|NCT00422097|7219048|FG007|COMPLETED|Dose Level 6||0
6314607|NCT00422097|7219041|FG000|NOT COMPLETED|Dose Level 6||0
6314608|NCT00422097|7219042|FG001|NOT COMPLETED|Dose Level 6||0
6314609|NCT00422097|7219043|FG002|NOT COMPLETED|Dose Level 6||0
6314610|NCT00422097|7219044|FG003|NOT COMPLETED|Dose Level 6||0
6314611|NCT00422097|7219045|FG004|NOT COMPLETED|Dose Level 6||0
6314612|NCT00422097|7219046|FG005|NOT COMPLETED|Dose Level 6||0
6314613|NCT00422097|7219047|FG006|NOT COMPLETED|Dose Level 6||0
6314614|NCT00422097|7219048|FG007|NOT COMPLETED|Dose Level 6||0
6314615|NCT00422097|7219041|FG000|STARTED|Ixabepilone With Famotidine or Food||0
6314616|NCT00422097|7219042|FG001|STARTED|Ixabepilone With Famotidine or Food||0
6314617|NCT00422097|7219043|FG002|STARTED|Ixabepilone With Famotidine or Food||0
6314618|NCT00422097|7219044|FG003|STARTED|Ixabepilone With Famotidine or Food||0
6314619|NCT00422097|7219045|FG004|STARTED|Ixabepilone With Famotidine or Food||0
6314620|NCT00422097|7219046|FG005|STARTED|Ixabepilone With Famotidine or Food||0
6314621|NCT00422097|7219047|FG006|STARTED|Ixabepilone With Famotidine or Food||8
6314622|NCT00422097|7219048|FG007|STARTED|Ixabepilone With Famotidine or Food||7
6314623|NCT00422097|7219041|FG000|COMPLETED|Ixabepilone With Famotidine or Food||0
6314624|NCT00422097|7219042|FG001|COMPLETED|Ixabepilone With Famotidine or Food||0
6314625|NCT00422097|7219043|FG002|COMPLETED|Ixabepilone With Famotidine or Food||0
6314626|NCT00422097|7219044|FG003|COMPLETED|Ixabepilone With Famotidine or Food||0
6314627|NCT00422097|7219045|FG004|COMPLETED|Ixabepilone With Famotidine or Food||0
6314628|NCT00422097|7219046|FG005|COMPLETED|Ixabepilone With Famotidine or Food||0
6314629|NCT00422097|7219047|FG006|COMPLETED|Ixabepilone With Famotidine or Food||8
6314630|NCT00422097|7219048|FG007|COMPLETED|Ixabepilone With Famotidine or Food||7
6314631|NCT00422097|7219041|FG000|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6314632|NCT00422097|7219042|FG001|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6314633|NCT00422097|7219043|FG002|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6314634|NCT00422097|7219044|FG003|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6314635|NCT00422097|7219045|FG004|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6314636|NCT00422097|7219046|FG005|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6314637|NCT00422097|7219047|FG006|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6314638|NCT00422097|7219048|FG007|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
6314639|NCT00422162|7219074|FG000|STARTED|Overall Study||167
6314640|NCT00422162|7219075|FG001|STARTED|Overall Study||172
6314641|NCT00422162|7219074|FG000|Received Treatment|Overall Study||167
6314642|NCT00422162|7219075|FG001|Received Treatment|Overall Study||171
6314643|NCT00422162|7219074|FG000|COMPLETED|Overall Study||143
6314644|NCT00422162|7219075|FG001|COMPLETED|Overall Study||142
6314645|NCT00422162|7219074|FG000|NOT COMPLETED|Overall Study||24
6314646|NCT00422162|7219075|FG001|NOT COMPLETED|Overall Study||30
6314647|NCT00422201|7219091|FG000|STARTED|Overall Study||18
6314648|NCT00422201|7219091|FG000|COMPLETED|Overall Study||7
6314649|NCT00422201|7219091|FG000|NOT COMPLETED|Overall Study||11
6314650|NCT00422227|7219098|FG000|STARTED|Overall Study||197
6314651|NCT00422227|7219099|FG001|STARTED|Overall Study||103
6314652|NCT00422227|7219098|FG000|COMPLETED|Overall Study||193
6314653|NCT00422227|7219099|FG001|COMPLETED|Overall Study||88
6314654|NCT00422227|7219098|FG000|NOT COMPLETED|Overall Study||4
6314655|NCT00422227|7219099|FG001|NOT COMPLETED|Overall Study||15
6314656|NCT00422279|7219107|FG000|STARTED|Overall Study||2
6314657|NCT00422279|7219108|FG001|STARTED|Overall Study||2
6314658|NCT00422279|7219107|FG000|24 Month After Loading Period|Overall Study||2
6314659|NCT00422279|7219108|FG001|24 Month After Loading Period|Overall Study||2
6314660|NCT00422279|7219107|FG000|COMPLETED|Overall Study||2
6314661|NCT00422279|7219108|FG001|COMPLETED|Overall Study||2
6314662|NCT00422279|7219107|FG000|NOT COMPLETED|Overall Study||0
6314663|NCT00422279|7219108|FG001|NOT COMPLETED|Overall Study||0
6314664|NCT00422292|7219120|FG000|STARTED|Overall Study||257
6314665|NCT00422292|7219121|FG001|STARTED|Overall Study||664
6314666|NCT00422292|7219122|FG002|STARTED|Overall Study||246
6314667|NCT00422292|7219123|FG003|STARTED|Overall Study||476
6314668|NCT00422292|7219120|FG000|COMPLETED|Overall Study||239
6314669|NCT00422292|7219121|FG001|COMPLETED|Overall Study||598
6314670|NCT00422292|7219122|FG002|COMPLETED|Overall Study||224
6314671|NCT00422292|7219123|FG003|COMPLETED|Overall Study||452
6314672|NCT00422292|7219120|FG000|NOT COMPLETED|Overall Study||18
6314673|NCT00422292|7219121|FG001|NOT COMPLETED|Overall Study||66
6314674|NCT00422292|7219122|FG002|NOT COMPLETED|Overall Study||22
6314675|NCT00422292|7219123|FG003|NOT COMPLETED|Overall Study||24
6314676|NCT00422383|7219138|FG000|STARTED|Overall Study||134
6314677|NCT00422383|7219139|FG001|STARTED|Overall Study||120
6314678|NCT00422383|7219140|FG002|STARTED|Overall Study||93
6314679|NCT00422383|7219141|FG003|STARTED|Overall Study||6
6314680|NCT00422383|7219142|FG004|STARTED|Overall Study||25
6314681|NCT00422383|7219138|FG000|COMPLETED|Overall Study||119
6314682|NCT00422383|7219139|FG001|COMPLETED|Overall Study||106
6314683|NCT00422383|7219140|FG002|COMPLETED|Overall Study||89
6314684|NCT00422383|7219141|FG003|COMPLETED|Overall Study||4
6314685|NCT00422383|7219142|FG004|COMPLETED|Overall Study||22
6314686|NCT00422383|7219138|FG000|NOT COMPLETED|Overall Study||15
6314687|NCT00422383|7219139|FG001|NOT COMPLETED|Overall Study||14
6314688|NCT00422383|7219140|FG002|NOT COMPLETED|Overall Study||4
6314689|NCT00422383|7219141|FG003|NOT COMPLETED|Overall Study||2
6314690|NCT00422383|7219142|FG004|NOT COMPLETED|Overall Study||3
6314691|NCT00422422|7219160|FG000|STARTED|Overall Study||100
6314692|NCT00422422|7219160|FG000|COMPLETED|Overall Study||90
6314693|NCT00422422|7219160|FG000|NOT COMPLETED|Overall Study||10
6314694|NCT00422448|7219166|FG000|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
6314695|NCT00422448|7219166|FG000|COMPLETED|Overall Study||43
6314696|NCT00422448|7219166|FG000|NOT COMPLETED|Overall Study||0
6314697|NCT00422461|7219174|FG000|STARTED|Overall Study||35
6314698|NCT00422461|7219175|FG001|STARTED|Overall Study||35
6314699|NCT00422461|7219176|FG002|STARTED|Overall Study||32
6314700|NCT00422461|7219177|FG003|STARTED|Overall Study||33
6314701|NCT00422461|7219174|FG000|Treated|Overall Study||34
6314702|NCT00422461|7219175|FG001|Treated|Overall Study||34
6314703|NCT00422461|7219176|FG002|Treated|Overall Study||32
6314704|NCT00422461|7219177|FG003|Treated|Overall Study||33
6314705|NCT00422461|7219174|FG000|Full Analysis Set|Overall Study||34
6314706|NCT00422461|7219175|FG001|Full Analysis Set|Overall Study||34
6314707|NCT00422461|7219176|FG002|Full Analysis Set|Overall Study||31
6314708|NCT00422461|7219177|FG003|Full Analysis Set|Overall Study||33
6314709|NCT00422461|7219174|FG000|COMPLETED|Overall Study||32
6314710|NCT00422461|7219175|FG001|COMPLETED|Overall Study||32
6314711|NCT00422461|7219176|FG002|COMPLETED|Overall Study||31
6314712|NCT00422461|7219177|FG003|COMPLETED|Overall Study||30
6314713|NCT00422461|7219174|FG000|NOT COMPLETED|Overall Study||3
6314714|NCT00422461|7219175|FG001|NOT COMPLETED|Overall Study||3
6314715|NCT00422461|7219176|FG002|NOT COMPLETED|Overall Study||1
6314716|NCT00422461|7219177|FG003|NOT COMPLETED|Overall Study||3
6314717|NCT00422513|7219189|FG000|STARTED|Overall Study||130
6314718|NCT00422513|7219190|FG001|STARTED|Overall Study||130
6314719|NCT00422513|7219189|FG000|COMPLETED|Overall Study||23
6314720|NCT00422513|7219190|FG001|COMPLETED|Overall Study||24
6314721|NCT00422513|7219189|FG000|NOT COMPLETED|Overall Study||107
6314722|NCT00422513|7219190|FG001|NOT COMPLETED|Overall Study||106
6314723|NCT00422591|7219196|FG000|STARTED|Overall Study||175
6314724|NCT00422591|7219196|FG000|COMPLETED|Overall Study||169
6314725|NCT00422591|7219196|FG000|NOT COMPLETED|Overall Study||6
6314726|NCT00422656|7219200|FG000|STARTED|Overall Study||37
6314727|NCT00422656|7219200|FG000|COMPLETED|Overall Study||37
6314728|NCT00422656|7219200|FG000|NOT COMPLETED|Overall Study||0
6314729|NCT00422695|7219206|FG000|STARTED|Overall Study||105
6314730|NCT00422695|7219207|FG001|STARTED|Overall Study||38
6314731|NCT00422695|7219206|FG000|COMPLETED|Overall Study||105
6314732|NCT00422695|7219207|FG001|COMPLETED|Overall Study||38
6314733|NCT00422695|7219206|FG000|NOT COMPLETED|Overall Study||0
6314734|NCT00422695|7219207|FG001|NOT COMPLETED|Overall Study||0
6314735|NCT00422734|7219215|FG000|STARTED|Overall Study||78
6314736|NCT00422734|7219216|FG001|STARTED|Overall Study||264
6314737|NCT00422734|7219215|FG000|COMPLETED|Overall Study||64
6314738|NCT00422734|7219216|FG001|COMPLETED|Overall Study||243
6314739|NCT00422734|7219215|FG000|NOT COMPLETED|Overall Study||14
6314740|NCT00422734|7219216|FG001|NOT COMPLETED|Overall Study||21
6314741|NCT00422799|7219222|FG000|STARTED|Overall Study||63
6314742|NCT00422799|7219222|FG000|COMPLETED|Overall Study||50
6314743|NCT00422799|7219222|FG000|NOT COMPLETED|Overall Study||13
6314744|NCT00422812|7219230|FG000|STARTED|Overall Study||98
6314745|NCT00422812|7219231|FG001|STARTED|Overall Study||104
6314746|NCT00422812|7219232|FG002|STARTED|Overall Study||93
6314747|NCT00422812|7219233|FG003|STARTED|Overall Study||105
6314748|NCT00422812|7219230|FG000|COMPLETED|Overall Study||98
6314749|NCT00422812|7219231|FG001|COMPLETED|Overall Study||103
6314750|NCT00422812|7219232|FG002|COMPLETED|Overall Study||91
6314751|NCT00422812|7219233|FG003|COMPLETED|Overall Study||103
6314752|NCT00422812|7219230|FG000|NOT COMPLETED|Overall Study||0
6314753|NCT00422812|7219231|FG001|NOT COMPLETED|Overall Study||1
6314754|NCT00422812|7219232|FG002|NOT COMPLETED|Overall Study||2
6314755|NCT00422812|7219233|FG003|NOT COMPLETED|Overall Study||2
6314756|NCT00422903|7219245|FG000|STARTED|Overall Study||49
6314757|NCT00422903|7219246|FG001|STARTED|Overall Study||43
6314758|NCT00422903|7219245|FG000|COMPLETED|Overall Study||45
6314759|NCT00422903|7219246|FG001|COMPLETED|Overall Study||38
6314760|NCT00422903|7219245|FG000|NOT COMPLETED|Overall Study||4
6314761|NCT00422903|7219246|FG001|NOT COMPLETED|Overall Study||5
6314762|NCT00423046|7219254|FG000|STARTED|Overall Study||553
6314763|NCT00423046|7219255|FG001|STARTED|Overall Study||553
6314764|NCT00423046|7219254|FG000|COMPLETED|Overall Study|Completed until Month 60|213
6314765|NCT00423046|7219255|FG001|COMPLETED|Overall Study|Completed until Month 60|208
6314766|NCT00423046|7219254|FG000|NOT COMPLETED|Overall Study||340
6314767|NCT00423046|7219255|FG001|NOT COMPLETED|Overall Study||345
6314768|NCT00423085|7219266|FG000|STARTED|24-Week Double-Blind Treatment Phase||288
6314769|NCT00423085|7219267|FG001|STARTED|24-Week Double-Blind Treatment Phase||284
6314770|NCT00423085|7219268|FG002|STARTED|24-Week Double-Blind Treatment Phase||287
6314771|NCT00423085|7219269|FG003|STARTED|24-Week Double-Blind Treatment Phase||0
6314772|NCT00423085|7219266|FG000|COMPLETED|24-Week Double-Blind Treatment Phase||242
6314773|NCT00423085|7219267|FG001|COMPLETED|24-Week Double-Blind Treatment Phase||220
6314774|NCT00423085|7219268|FG002|COMPLETED|24-Week Double-Blind Treatment Phase||228
6314775|NCT00423085|7219269|FG003|COMPLETED|24-Week Double-Blind Treatment Phase||0
6314776|NCT00423085|7219266|FG000|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
6314777|NCT00423085|7219267|FG001|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
6314778|NCT00423085|7219268|FG002|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
6314779|NCT00423085|7219269|FG003|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
6314780|NCT00423085|7219266|FG000|STARTED|52-Week Open-Label Extension Phase||0
6314781|NCT00423085|7219267|FG001|STARTED|52-Week Open-Label Extension Phase||0
6314782|NCT00423085|7219268|FG002|STARTED|52-Week Open-Label Extension Phase||0
6314783|NCT00423085|7219269|FG003|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
6314784|NCT00423085|7219266|FG000|COMPLETED|52-Week Open-Label Extension Phase||0
6314785|NCT00423085|7219267|FG001|COMPLETED|52-Week Open-Label Extension Phase||0
6314786|NCT00423085|7219268|FG002|COMPLETED|52-Week Open-Label Extension Phase||0
6314787|NCT00423085|7219269|FG003|COMPLETED|52-Week Open-Label Extension Phase||474
6314788|NCT00423085|7219266|FG000|NOT COMPLETED|52-Week Open-Label Extension Phase||0
6314789|NCT00423085|7219267|FG001|NOT COMPLETED|52-Week Open-Label Extension Phase||0
6314790|NCT00423085|7219268|FG002|NOT COMPLETED|52-Week Open-Label Extension Phase||0
6314791|NCT00423085|7219269|FG003|NOT COMPLETED|52-Week Open-Label Extension Phase||163
6314792|NCT00423098|7219281|FG000|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
6314793|NCT00423098|7219282|FG001|STARTED|Overall Study||39
6314794|NCT00423098|7219281|FG000|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
6314795|NCT00423098|7219282|FG001|COMPLETED|Overall Study||35
6314796|NCT00423098|7219281|FG000|NOT COMPLETED|Overall Study||3
6314797|NCT00423098|7219282|FG001|NOT COMPLETED|Overall Study||4
6314798|NCT00423137|7219292|FG000|STARTED|Overall Study||11
6314799|NCT00423137|7219293|FG001|STARTED|Overall Study||12
6314800|NCT00423137|7219294|FG002|STARTED|Overall Study||13
6314801|NCT00423137|7219295|FG003|STARTED|Overall Study||12
6314802|NCT00423137|7219292|FG000|COMPLETED|Overall Study||10
6314803|NCT00423137|7219293|FG001|COMPLETED|Overall Study||12
6314804|NCT00423137|7219294|FG002|COMPLETED|Overall Study||7
6314805|NCT00423137|7219295|FG003|COMPLETED|Overall Study||10
6314806|NCT00423137|7219292|FG000|NOT COMPLETED|Overall Study||1
6314807|NCT00423137|7219293|FG001|NOT COMPLETED|Overall Study||0
6314808|NCT00423137|7219294|FG002|NOT COMPLETED|Overall Study||6
6314809|NCT00423137|7219295|FG003|NOT COMPLETED|Overall Study||2
6314810|NCT00423150|7219308|FG000|STARTED|Overall Study||86
6314811|NCT00423150|7219308|FG000|COMPLETED|Overall Study||0
6314812|NCT00423150|7219308|FG000|NOT COMPLETED|Overall Study||86
6314813|NCT00423189|7219315|FG000|STARTED|Overall Study||2
6314814|NCT00423189|7219316|FG001|STARTED|Overall Study||3
6314815|NCT00423189|7219317|FG002|STARTED|Overall Study||2
6314816|NCT00423189|7219315|FG000|COMPLETED|Overall Study||2
6314817|NCT00423189|7219316|FG001|COMPLETED|Overall Study||2
6314818|NCT00423189|7219317|FG002|COMPLETED|Overall Study||2
6314819|NCT00423189|7219315|FG000|NOT COMPLETED|Overall Study||0
6314820|NCT00423189|7219316|FG001|NOT COMPLETED|Overall Study||1
6314821|NCT00423189|7219317|FG002|NOT COMPLETED|Overall Study||0
6314822|NCT00423267|7219332|FG000|STARTED|Period A||9
6314823|NCT00423267|7219333|FG001|STARTED|Period A||7
6314824|NCT00423267|7219332|FG000|COMPLETED|Period A||7
6314825|NCT00423267|7219333|FG001|COMPLETED|Period A||6
6314826|NCT00423267|7219332|FG000|NOT COMPLETED|Period A||2
6314827|NCT00423267|7219333|FG001|NOT COMPLETED|Period A||1
6314828|NCT00423267|7219332|FG000|STARTED|Period B||12
6314829|NCT00423267|7219333|FG001|STARTED|Period B||0
6314830|NCT00423267|7219332|FG000|COMPLETED|Period B||12
6314831|NCT00423267|7219333|FG001|COMPLETED|Period B||0
6314832|NCT00423267|7219332|FG000|NOT COMPLETED|Period B||0
6314833|NCT00423267|7219333|FG001|NOT COMPLETED|Period B||0
6314834|NCT00423293|7219341|FG000|STARTED|Overall Study||63
6314835|NCT00423293|7219341|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
6314836|NCT00423293|7219341|FG000|NOT COMPLETED|Overall Study||11
6314837|NCT00423319|7219347|FG000|STARTED|Overall Study|Randomized|2708
6314838|NCT00423319|7219348|FG001|STARTED|Overall Study|Randomized|2699
6314839|NCT00423319|7219347|FG000|Participants Who Received Treatment|Overall Study||2673
6314840|NCT00423319|7219348|FG001|Participants Who Received Treatment|Overall Study||2659
6314841|NCT00423319|7219347|FG000|COMPLETED|Overall Study||2484
6314842|NCT00423319|7219348|FG001|COMPLETED|Overall Study||2447
6314843|NCT00423319|7219347|FG000|NOT COMPLETED|Overall Study||224
6314844|NCT00423319|7219348|FG001|NOT COMPLETED|Overall Study||252
6314845|NCT00423332|7219357|FG000|STARTED|Overall Study|Randomised|53
6314846|NCT00423332|7219358|FG001|STARTED|Overall Study|Number randomised|18
6314847|NCT00423332|7219357|FG000|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
6314848|NCT00423332|7219358|FG001|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
6314849|NCT00423332|7219357|FG000|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
6314850|NCT00423332|7219358|FG001|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
6314851|NCT00423332|7219357|FG000|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
6314852|NCT00423332|7219358|FG001|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
6314853|NCT00423332|7219357|FG000|NOT COMPLETED|Overall Study||9
6314854|NCT00423332|7219358|FG001|NOT COMPLETED|Overall Study||7
6314855|NCT00423358|7219367|FG000|STARTED|Overall Study||11
6314856|NCT00423358|7219368|FG001|STARTED|Overall Study||11
6314857|NCT00423358|7219367|FG000|COMPLETED|Overall Study||11
6314858|NCT00423358|7219368|FG001|COMPLETED|Overall Study||11
6314859|NCT00423358|7219367|FG000|NOT COMPLETED|Overall Study||0
6314860|NCT00423358|7219368|FG001|NOT COMPLETED|Overall Study||0
6314861|NCT00423436|7219376|FG000|STARTED|Overall Study||35
6314862|NCT00423436|7219377|FG001|STARTED|Overall Study||33
6314863|NCT00423436|7219376|FG000|COMPLETED|Overall Study||35
6314864|NCT00423436|7219377|FG001|COMPLETED|Overall Study||33
6314865|NCT00423436|7219376|FG000|NOT COMPLETED|Overall Study||0
6314866|NCT00423436|7219377|FG001|NOT COMPLETED|Overall Study||0
6314867|NCT00423449|7219383|FG000|STARTED|Overall Study||4
6314868|NCT00423449|7219384|FG001|STARTED|Overall Study||6
6314869|NCT00423449|7219385|FG002|STARTED|Overall Study||17
6314870|NCT00423449|7219386|FG003|STARTED|Overall Study||27
6314871|NCT00423449|7219387|FG004|STARTED|Overall Study||7
6314872|NCT00423449|7219383|FG000|COMPLETED|Overall Study||1
6314873|NCT00423449|7219384|FG001|COMPLETED|Overall Study||2
6314874|NCT00423449|7219385|FG002|COMPLETED|Overall Study||2
6314875|NCT00423449|7219386|FG003|COMPLETED|Overall Study||5
6314876|NCT00423449|7219387|FG004|COMPLETED|Overall Study||0
6314877|NCT00423449|7219383|FG000|NOT COMPLETED|Overall Study||3
6314878|NCT00423449|7219384|FG001|NOT COMPLETED|Overall Study||4
6314879|NCT00423449|7219385|FG002|NOT COMPLETED|Overall Study||15
6314880|NCT00423449|7219386|FG003|NOT COMPLETED|Overall Study||22
6314881|NCT00423449|7219387|FG004|NOT COMPLETED|Overall Study||7
6314882|NCT00423592|7219400|FG000|STARTED|Overall Study|Enrolled|36
6314883|NCT00423592|7219400|FG000|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
6314884|NCT00423592|7219400|FG000|COMPLETED|Overall Study|Completed study|29
6314885|NCT00423592|7219400|FG000|NOT COMPLETED|Overall Study||7
6314886|NCT00423605|7219404|FG000|STARTED|Overall Study||560
6314887|NCT00423605|7219404|FG000|COMPLETED|Overall Study||319
6314888|NCT00423605|7219404|FG000|NOT COMPLETED|Overall Study||241
6314889|NCT00423657|7219410|FG000|STARTED|Overall Study||342
6314890|NCT00423657|7219411|FG001|STARTED|Overall Study||338
6314891|NCT00423657|7219410|FG000|COMPLETED|Overall Study||316
6314892|NCT00423657|7219411|FG001|COMPLETED|Overall Study||313
6314893|NCT00423657|7219410|FG000|NOT COMPLETED|Overall Study||26
6314894|NCT00423657|7219411|FG001|NOT COMPLETED|Overall Study||25
6314895|NCT00423670|7219424|FG000|STARTED|Treatment Period||104
6314896|NCT00423670|7219425|FG001|STARTED|Treatment Period||107
6314897|NCT00423670|7219426|FG002|STARTED|Treatment Period||103
6314898|NCT00423670|7219427|FG003|STARTED|Treatment Period||103
6314899|NCT00423670|7219428|FG004|STARTED|Treatment Period||103
6314900|NCT00423670|7219429|FG005|STARTED|Treatment Period||16
6314901|NCT00423670|7219430|FG006|STARTED|Treatment Period||59
6314902|NCT00423670|7219431|FG007|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
6314903|NCT00423670|7219424|FG000|COMPLETED|Treatment Period||52
6314904|NCT00423670|7219425|FG001|COMPLETED|Treatment Period||77
6314905|NCT00423670|7219426|FG002|COMPLETED|Treatment Period||76
6314906|NCT00423670|7219427|FG003|COMPLETED|Treatment Period||63
6314907|NCT00423670|7219428|FG004|COMPLETED|Treatment Period||76
6314908|NCT00423670|7219429|FG005|COMPLETED|Treatment Period||8
6314909|NCT00423670|7219430|FG006|COMPLETED|Treatment Period||28
6314910|NCT00423670|7219431|FG007|COMPLETED|Treatment Period||15
6314911|NCT00423670|7219424|FG000|NOT COMPLETED|Treatment Period||52
6314912|NCT00423670|7219425|FG001|NOT COMPLETED|Treatment Period||30
6314913|NCT00423670|7219426|FG002|NOT COMPLETED|Treatment Period||27
6314914|NCT00423670|7219427|FG003|NOT COMPLETED|Treatment Period||40
6314915|NCT00423670|7219428|FG004|NOT COMPLETED|Treatment Period||27
6314916|NCT00423670|7219429|FG005|NOT COMPLETED|Treatment Period||8
6314917|NCT00423670|7219430|FG006|NOT COMPLETED|Treatment Period||31
6314918|NCT00423670|7219431|FG007|NOT COMPLETED|Treatment Period||21
6314919|NCT00423670|7219424|FG000|STARTED|Follow-up Period||97
6314920|NCT00423670|7219425|FG001|STARTED|Follow-up Period||100
6314921|NCT00423670|7219426|FG002|STARTED|Follow-up Period||96
6314922|NCT00423670|7219427|FG003|STARTED|Follow-up Period||96
6314923|NCT00423670|7219428|FG004|STARTED|Follow-up Period||91
6314924|NCT00423670|7219429|FG005|STARTED|Follow-up Period||14
6314925|NCT00423670|7219430|FG006|STARTED|Follow-up Period||50
6314926|NCT00423670|7219431|FG007|STARTED|Follow-up Period||35
6314927|NCT00423670|7219424|FG000|COMPLETED|Follow-up Period||94
6314928|NCT00423670|7219425|FG001|COMPLETED|Follow-up Period||84
6314929|NCT00423670|7219426|FG002|COMPLETED|Follow-up Period||85
6314930|NCT00423670|7219427|FG003|COMPLETED|Follow-up Period||91
6314931|NCT00423670|7219428|FG004|COMPLETED|Follow-up Period||89
6314932|NCT00423670|7219429|FG005|COMPLETED|Follow-up Period||14
6314933|NCT00423670|7219430|FG006|COMPLETED|Follow-up Period||41
6314934|NCT00423670|7219431|FG007|COMPLETED|Follow-up Period||32
6314935|NCT00423670|7219424|FG000|NOT COMPLETED|Follow-up Period||3
6314936|NCT00423670|7219425|FG001|NOT COMPLETED|Follow-up Period||16
6314937|NCT00423670|7219426|FG002|NOT COMPLETED|Follow-up Period||11
6314938|NCT00423670|7219427|FG003|NOT COMPLETED|Follow-up Period||5
6314939|NCT00423670|7219428|FG004|NOT COMPLETED|Follow-up Period||2
6314940|NCT00423670|7219429|FG005|NOT COMPLETED|Follow-up Period||0
6314941|NCT00423670|7219430|FG006|NOT COMPLETED|Follow-up Period||9
6314942|NCT00423670|7219431|FG007|NOT COMPLETED|Follow-up Period||3
6314943|NCT00423683|7219454|FG000|STARTED|Overall Study||31
6314944|NCT00423683|7219455|FG001|STARTED|Overall Study||33
6314945|NCT00423683|7219454|FG000|COMPLETED|Overall Study||30
6314946|NCT00423683|7219455|FG001|COMPLETED|Overall Study||33
6314947|NCT00423683|7219454|FG000|NOT COMPLETED|Overall Study||1
6314948|NCT00423683|7219455|FG001|NOT COMPLETED|Overall Study||0
6314949|NCT00423722|7219465|FG000|STARTED|Overall Study||63
6314950|NCT00423722|7219466|FG001|STARTED|Overall Study||66
6314951|NCT00423722|7219465|FG000|COMPLETED|Overall Study||49
6314952|NCT00423722|7219466|FG001|COMPLETED|Overall Study||53
6314953|NCT00423722|7219465|FG000|NOT COMPLETED|Overall Study||14
6314954|NCT00423722|7219466|FG001|NOT COMPLETED|Overall Study||13
6314955|NCT00423735|7219481|FG000|STARTED|Overall Study||29
6314956|NCT00423735|7219482|FG001|STARTED|Overall Study||35
6314957|NCT00423735|7219483|FG002|STARTED|Overall Study||0
6314958|NCT00423735|7219481|FG000|COMPLETED|Overall Study||21
6314959|NCT00423735|7219482|FG001|COMPLETED|Overall Study||29
6314960|NCT00423735|7219483|FG002|COMPLETED|Overall Study||0
6314961|NCT00423735|7219481|FG000|NOT COMPLETED|Overall Study||8
6314962|NCT00423735|7219482|FG001|NOT COMPLETED|Overall Study||6
6314963|NCT00423735|7219483|FG002|NOT COMPLETED|Overall Study||0
6314964|NCT00423800|7219495|FG000|STARTED|Overall Study||3
6314965|NCT00423800|7219496|FG001|STARTED|Overall Study||2
6314966|NCT00423800|7219495|FG000|COMPLETED|Overall Study||3
6314967|NCT00423800|7219496|FG001|COMPLETED|Overall Study||1
6314968|NCT00423800|7219495|FG000|NOT COMPLETED|Overall Study||0
6314969|NCT00423800|7219496|FG001|NOT COMPLETED|Overall Study||1
6314970|NCT00423813|7219506|FG000|STARTED|Overall Study||188
6314971|NCT00423813|7219507|FG001|STARTED|Overall Study||195
6314972|NCT00423813|7219508|FG002|STARTED|Overall Study||190
6314973|NCT00423813|7219506|FG000|Treated|Overall Study||188
6314974|NCT00423813|7219507|FG001|Treated|Overall Study||194
6314975|NCT00423813|7219508|FG002|Treated|Overall Study||189
6314976|NCT00423813|7219506|FG000|COMPLETED|Overall Study||131
6314977|NCT00423813|7219507|FG001|COMPLETED|Overall Study||129
6314978|NCT00423813|7219508|FG002|COMPLETED|Overall Study||116
6314979|NCT00423813|7219506|FG000|NOT COMPLETED|Overall Study||57
6314980|NCT00423813|7219507|FG001|NOT COMPLETED|Overall Study||66
6314981|NCT00423813|7219508|FG002|NOT COMPLETED|Overall Study||74
6314982|NCT00423852|7219516|FG000|STARTED|Overall Study||26
6314983|NCT00423852|7219516|FG000|COMPLETED|Overall Study||23
6314984|NCT00423852|7219516|FG000|NOT COMPLETED|Overall Study||3
6314985|NCT00423878|7219522|FG000|STARTED|Overall Study||109
6314986|NCT00423878|7219523|FG001|STARTED|Overall Study||106
6314987|NCT00423878|7219522|FG000|COMPLETED|Overall Study||89
6314988|NCT00423878|7219523|FG001|COMPLETED|Overall Study||98
6314989|NCT00423878|7219522|FG000|NOT COMPLETED|Overall Study||20
6314990|NCT00423878|7219523|FG001|NOT COMPLETED|Overall Study||8
6314991|NCT00423891|7219532|FG000|STARTED|Enrolled||35
6314992|NCT00423891|7219533|FG001|STARTED|Enrolled||21
6314993|NCT00423891|7219534|FG002|STARTED|Enrolled||8
6314994|NCT00423891|7219532|FG000|COMPLETED|Enrolled||24
6314995|NCT00423891|7219533|FG001|COMPLETED|Enrolled||19
6314996|NCT00423891|7219534|FG002|COMPLETED|Enrolled||5
6314997|NCT00423891|7219532|FG000|NOT COMPLETED|Enrolled||11
6314998|NCT00423891|7219533|FG001|NOT COMPLETED|Enrolled||2
6314999|NCT00423891|7219534|FG002|NOT COMPLETED|Enrolled||3
6315000|NCT00423891|7219532|FG000|STARTED|Treatment||24
6315001|NCT00423891|7219533|FG001|STARTED|Treatment||19
6315002|NCT00423891|7219534|FG002|STARTED|Treatment||5
6315003|NCT00423891|7219532|FG000|COMPLETED|Treatment||22
6315004|NCT00423891|7219533|FG001|COMPLETED|Treatment||19
6315005|NCT00423891|7219534|FG002|COMPLETED|Treatment||5
6315006|NCT00423891|7219532|FG000|NOT COMPLETED|Treatment||2
6315007|NCT00423891|7219533|FG001|NOT COMPLETED|Treatment||0
6315008|NCT00423891|7219534|FG002|NOT COMPLETED|Treatment||0
6315009|NCT00423891|7219532|FG000|STARTED|Post-Dosing Follow Up||22
6315010|NCT00423891|7219533|FG001|STARTED|Post-Dosing Follow Up||18
6315011|NCT00423891|7219534|FG002|STARTED|Post-Dosing Follow Up||5
6315012|NCT00423891|7219532|FG000|COMPLETED|Post-Dosing Follow Up||20
6315013|NCT00423891|7219533|FG001|COMPLETED|Post-Dosing Follow Up||15
6315014|NCT00423891|7219534|FG002|COMPLETED|Post-Dosing Follow Up||3
6315015|NCT00423891|7219532|FG000|NOT COMPLETED|Post-Dosing Follow Up||2
6315016|NCT00423891|7219533|FG001|NOT COMPLETED|Post-Dosing Follow Up||3
6315017|NCT00423891|7219534|FG002|NOT COMPLETED|Post-Dosing Follow Up||2
6315018|NCT00423917|7219544|FG000|STARTED|Overall Study||36
6315019|NCT00423917|7219544|FG000|COMPLETED|Overall Study||33
6315020|NCT00423917|7219544|FG000|NOT COMPLETED|Overall Study||3
6315021|NCT00423930|7219548|FG000|STARTED|Overall Study||44
6315022|NCT00423930|7219548|FG000|COMPLETED|Overall Study||42
6315023|NCT00423930|7219548|FG000|NOT COMPLETED|Overall Study||2
6315024|NCT00423943|7219554|FG000|STARTED|Overall Study||19
6315025|NCT00423943|7219555|FG001|STARTED|Overall Study||14
6315026|NCT00423943|7219554|FG000|COMPLETED|Overall Study||16
6315027|NCT00423943|7219555|FG001|COMPLETED|Overall Study||13
6315028|NCT00423943|7219554|FG000|NOT COMPLETED|Overall Study||3
6315029|NCT00423943|7219555|FG001|NOT COMPLETED|Overall Study||1
6315030|NCT00424021|7219565|FG000|STARTED|NCT00046319 Study Period||16
6315031|NCT00424021|7219566|FG001|STARTED|NCT00046319 Study Period||19
6315032|NCT00424021|7219567|FG002|STARTED|NCT00046319 Study Period||16
6315033|NCT00424021|7219568|FG003|STARTED|NCT00046319 Study Period||13
6315034|NCT00424021|7219565|FG000|COMPLETED|NCT00046319 Study Period||15
6315035|NCT00424021|7219566|FG001|COMPLETED|NCT00046319 Study Period||16
6315036|NCT00424021|7219567|FG002|COMPLETED|NCT00046319 Study Period||15
6315037|NCT00424021|7219568|FG003|COMPLETED|NCT00046319 Study Period||12
6315038|NCT00424021|7219565|FG000|NOT COMPLETED|NCT00046319 Study Period||1
6315039|NCT00424021|7219566|FG001|NOT COMPLETED|NCT00046319 Study Period||3
6315040|NCT00424021|7219567|FG002|NOT COMPLETED|NCT00046319 Study Period||1
6315041|NCT00424021|7219568|FG003|NOT COMPLETED|NCT00046319 Study Period||1
6315042|NCT00424021|7219565|FG000|STARTED|AMB-220-E Study Period||2
6315043|NCT00424021|7219566|FG001|STARTED|AMB-220-E Study Period||7
6315044|NCT00424021|7219567|FG002|STARTED|AMB-220-E Study Period||19
6315045|NCT00424021|7219568|FG003|STARTED|AMB-220-E Study Period||26
6315046|NCT00424021|7219565|FG000|COMPLETED|AMB-220-E Study Period||1
6315047|NCT00424021|7219566|FG001|COMPLETED|AMB-220-E Study Period||5
6315048|NCT00424021|7219567|FG002|COMPLETED|AMB-220-E Study Period||14
6315049|NCT00424021|7219568|FG003|COMPLETED|AMB-220-E Study Period||16
6315050|NCT00424021|7219565|FG000|NOT COMPLETED|AMB-220-E Study Period||1
6315051|NCT00424021|7219566|FG001|NOT COMPLETED|AMB-220-E Study Period||2
6315052|NCT00424021|7219567|FG002|NOT COMPLETED|AMB-220-E Study Period||5
6315053|NCT00424021|7219568|FG003|NOT COMPLETED|AMB-220-E Study Period||10
6315054|NCT00424047|7219587|FG000|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
6315055|NCT00424047|7219588|FG001|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
6315056|NCT00424047|7219587|FG000|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
6315057|NCT00424047|7219588|FG001|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
6315058|NCT00424047|7219587|FG000|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
6315059|NCT00424047|7219588|FG001|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
6315060|NCT00424047|7219587|FG000|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
6315061|NCT00424047|7219588|FG001|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
6315062|NCT00424047|7219587|FG000|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
6315063|NCT00424047|7219588|FG001|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
6315064|NCT00424047|7219587|FG000|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
6315065|NCT00424047|7219588|FG001|STARTED|On Study at Time of Unblinding||175
6315066|NCT00424047|7219587|FG000|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
6315067|NCT00424047|7219588|FG001|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
6315068|NCT00424047|7219587|FG000|NOT COMPLETED|On Study at Time of Unblinding||155
6315069|NCT00424047|7219588|FG001|NOT COMPLETED|On Study at Time of Unblinding||167
6315070|NCT00424047|7219587|FG000|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
6315071|NCT00424047|7219588|FG001|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
6315072|NCT00424047|7219587|FG000|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
6315073|NCT00424047|7219588|FG001|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
6315074|NCT00424047|7219587|FG000|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
6315075|NCT00424047|7219588|FG001|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
6315076|NCT00424177|7219599|FG000|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
6315077|NCT00424177|7219599|FG000|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
6315078|NCT00424177|7219599|FG000|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
6315079|NCT00424177|7219599|FG000|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
6315080|NCT00424177|7219599|FG000|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
6315081|NCT00424177|7219599|FG000|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
6315082|NCT00424177|7219599|FG000|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
6315083|NCT00424177|7219599|FG000|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
6315084|NCT00424177|7219599|FG000|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
6315085|NCT00424190|7219613|FG000|STARTED|Overall Study||351
6315086|NCT00424190|7219614|FG001|STARTED|Overall Study||347
6315087|NCT00424190|7219613|FG000|COMPLETED|Overall Study||329
6315088|NCT00424190|7219614|FG001|COMPLETED|Overall Study||317
6315089|NCT00424190|7219613|FG000|NOT COMPLETED|Overall Study||22
6315090|NCT00424190|7219614|FG001|NOT COMPLETED|Overall Study||30
6315091|NCT00424255|7219622|FG000|STARTED|Overall Study||342
6315092|NCT00424255|7219623|FG001|STARTED|Overall Study||346
6315093|NCT00424255|7219622|FG000|COMPLETED|Overall Study||0
6315094|NCT00424255|7219623|FG001|COMPLETED|Overall Study||0
6315095|NCT00424255|7219622|FG000|NOT COMPLETED|Overall Study||342
6315096|NCT00424255|7219623|FG001|NOT COMPLETED|Overall Study||346
6315097|NCT00424268|7219631|FG000|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
6315098|NCT00424268|7219632|FG001|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
6315099|NCT00424268|7219631|FG000|COMPLETED|Overall Study||309
6315100|NCT00424268|7219632|FG001|COMPLETED|Overall Study||333
6315101|NCT00424268|7219631|FG000|NOT COMPLETED|Overall Study||62
6315102|NCT00424268|7219632|FG001|NOT COMPLETED|Overall Study||39
6315103|NCT00424294|7219640|FG000|STARTED|Overall Study||36
6315104|NCT00424294|7219641|FG001|STARTED|Overall Study||34
6315105|NCT00424294|7219640|FG000|Treated|Overall Study||35
6315106|NCT00424294|7219641|FG001|Treated|Overall Study||34
6315107|NCT00424294|7219640|FG000|COMPLETED|Overall Study||28
6315108|NCT00424294|7219641|FG001|COMPLETED|Overall Study||19
6315109|NCT00424294|7219640|FG000|NOT COMPLETED|Overall Study||8
6315110|NCT00424294|7219641|FG001|NOT COMPLETED|Overall Study||15
6315111|NCT00424346|7219651|FG000|STARTED|Core Study||71
6315112|NCT00424346|7219652|FG001|STARTED|Core Study||64
6315113|NCT00424346|7219653|FG002|STARTED|Core Study||69
6315114|NCT00424346|7219654|FG003|STARTED|Core Study||70
6315115|NCT00424346|7219651|FG000|COMPLETED|Core Study||62
6315116|NCT00424346|7219652|FG001|COMPLETED|Core Study||56
6315117|NCT00424346|7219653|FG002|COMPLETED|Core Study||65
6315118|NCT00424346|7219654|FG003|COMPLETED|Core Study||63
6315119|NCT00424346|7219651|FG000|NOT COMPLETED|Core Study||9
6315120|NCT00424346|7219652|FG001|NOT COMPLETED|Core Study||8
6315121|NCT00424346|7219653|FG002|NOT COMPLETED|Core Study||4
6315122|NCT00424346|7219654|FG003|NOT COMPLETED|Core Study||7
6315123|NCT00424346|7219651|FG000|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
6315124|NCT00424346|7219652|FG001|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
6315125|NCT00424346|7219653|FG002|STARTED|Extension Phase||59
6315126|NCT00424346|7219654|FG003|STARTED|Extension Phase||58
6315127|NCT00424346|7219651|FG000|COMPLETED|Extension Phase||0
6315128|NCT00424346|7219652|FG001|COMPLETED|Extension Phase||8
6315129|NCT00424346|7219653|FG002|COMPLETED|Extension Phase||4
6315130|NCT00424346|7219654|FG003|COMPLETED|Extension Phase||3
6315131|NCT00424346|7219651|FG000|NOT COMPLETED|Extension Phase||0
6315132|NCT00424346|7219652|FG001|NOT COMPLETED|Extension Phase||102
6315133|NCT00424346|7219653|FG002|NOT COMPLETED|Extension Phase||55
6315134|NCT00424346|7219654|FG003|NOT COMPLETED|Extension Phase||55
6315135|NCT00424372|7219667|FG000|STARTED|Overall Study||126
6315136|NCT00424372|7219667|FG000|COMPLETED|Overall Study||95
6315137|NCT00424372|7219667|FG000|NOT COMPLETED|Overall Study||31
6315138|NCT00424385|7219671|FG000|STARTED|Cohort 0||12
6315139|NCT00424385|7219671|FG000|COMPLETED|Cohort 0||6
6315140|NCT00424385|7219671|FG000|NOT COMPLETED|Cohort 0||6
6315141|NCT00424385|7219671|FG000|STARTED|Cohort 1||5
6315142|NCT00424385|7219671|FG000|COMPLETED|Cohort 1||4
6315143|NCT00424385|7219671|FG000|NOT COMPLETED|Cohort 1||1
6315144|NCT00424398|7219680|FG000|STARTED|Overall Study||35
6315145|NCT00424398|7219681|FG001|STARTED|Overall Study||36
6315146|NCT00424398|7219682|FG002|STARTED|Overall Study||36
6315147|NCT00424398|7219680|FG000|COMPLETED|Overall Study||32
6315148|NCT00424398|7219681|FG001|COMPLETED|Overall Study||35
6315149|NCT00424398|7219682|FG002|COMPLETED|Overall Study||36
6315150|NCT00424398|7219680|FG000|NOT COMPLETED|Overall Study||3
6315151|NCT00424398|7219681|FG001|NOT COMPLETED|Overall Study||1
6315152|NCT00424398|7219682|FG002|NOT COMPLETED|Overall Study||0
6315153|NCT00424463|7219693|FG000|STARTED|Overall Study||45
6315154|NCT00424463|7219694|FG001|STARTED|Overall Study||48
6315155|NCT00424463|7219695|FG002|STARTED|Overall Study||88
6315156|NCT00424463|7219693|FG000|COMPLETED|Overall Study||38
6315157|NCT00424463|7219694|FG001|COMPLETED|Overall Study||34
6315158|NCT00424463|7219695|FG002|COMPLETED|Overall Study||72
6315159|NCT00424463|7219693|FG000|NOT COMPLETED|Overall Study||7
6315160|NCT00424463|7219694|FG001|NOT COMPLETED|Overall Study||14
6315161|NCT00424463|7219695|FG002|NOT COMPLETED|Overall Study||16
6315162|NCT00424476|7219706|FG000|STARTED|Overall Study||287
6315163|NCT00424476|7219707|FG001|STARTED|Overall Study||288
6315164|NCT00424476|7219708|FG002|STARTED|Overall Study||290
6315165|NCT00424476|7219706|FG000|COMPLETED|Overall Study||226
6315166|NCT00424476|7219707|FG001|COMPLETED|Overall Study||240
6315167|NCT00424476|7219708|FG002|COMPLETED|Overall Study||241
6315168|NCT00424476|7219706|FG000|NOT COMPLETED|Overall Study||61
6315169|NCT00424476|7219707|FG001|NOT COMPLETED|Overall Study||48
6315170|NCT00424476|7219708|FG002|NOT COMPLETED|Overall Study||49
6315171|NCT00424489|7219716|FG000|STARTED|Overall Study||9
6315172|NCT00424489|7219716|FG000|COMPLETED|Overall Study||6
6315173|NCT00424489|7219716|FG000|NOT COMPLETED|Overall Study||3
6315174|NCT00424502|7219720|FG000|STARTED|Overall Study||20
6315175|NCT00424502|7219720|FG000|COMPLETED|Overall Study||20
6315176|NCT00424502|7219720|FG000|NOT COMPLETED|Overall Study||0
6315177|NCT00424515|7219726|FG000|STARTED|Overall Study||11
6315178|NCT00424515|7219727|FG001|STARTED|Overall Study||13
6315179|NCT00424515|7219726|FG000|COMPLETED|Overall Study||0
6315180|NCT00424515|7219727|FG001|COMPLETED|Overall Study||0
6315181|NCT00424515|7219726|FG000|NOT COMPLETED|Overall Study||11
6315182|NCT00424515|7219727|FG001|NOT COMPLETED|Overall Study||13
6315183|NCT00424528|7219736|FG000|STARTED|Overall Study||76
6315184|NCT00424528|7219737|FG001|STARTED|Overall Study||80
6315185|NCT00424528|7219738|FG002|STARTED|Overall Study||78
6315186|NCT00424528|7219736|FG000|COMPLETED|Overall Study||71
6315187|NCT00424528|7219737|FG001|COMPLETED|Overall Study||76
6557714|NCT01769391|7480298|FG001|Received at Least One Dose of Study Drug|Overall Study||55
6557715|NCT01769391|7480297|FG000|COMPLETED|Overall Study||93
6315188|NCT00424528|7219738|FG002|COMPLETED|Overall Study||74
6315189|NCT00424528|7219736|FG000|NOT COMPLETED|Overall Study||5
6315190|NCT00424528|7219737|FG001|NOT COMPLETED|Overall Study||4
6315191|NCT00424528|7219738|FG002|NOT COMPLETED|Overall Study||4
6315192|NCT00424554|7219748|FG000|STARTED|Overall Study||34
6315193|NCT00424554|7219749|FG001|STARTED|Overall Study||6
6315194|NCT00424554|7219748|FG000|COMPLETED|Overall Study||34
6315195|NCT00424554|7219749|FG001|COMPLETED|Overall Study||6
6315196|NCT00424554|7219748|FG000|NOT COMPLETED|Overall Study||0
6315197|NCT00424554|7219749|FG001|NOT COMPLETED|Overall Study||0
6315198|NCT00424593|7219757|FG000|STARTED|Acute Double-Blind Period||115
6315199|NCT00424593|7219758|FG001|STARTED|Acute Double-Blind Period||121
6315200|NCT00424593|7219757|FG000|COMPLETED|Acute Double-Blind Period||84
6315201|NCT00424593|7219758|FG001|COMPLETED|Acute Double-Blind Period||98
6315202|NCT00424593|7219757|FG000|NOT COMPLETED|Acute Double-Blind Period||31
6315203|NCT00424593|7219758|FG001|NOT COMPLETED|Acute Double-Blind Period||23
6315204|NCT00424593|7219757|FG000|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
6315205|NCT00424593|7219758|FG001|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
6315206|NCT00424593|7219757|FG000|COMPLETED|Dose-Blind Extension Period||117
6315207|NCT00424593|7219758|FG001|COMPLETED|Dose-Blind Extension Period||0
6315208|NCT00424593|7219757|FG000|NOT COMPLETED|Dose-Blind Extension Period||64
6315209|NCT00424593|7219758|FG001|NOT COMPLETED|Dose-Blind Extension Period||0
6315210|NCT00424619|7219767|FG000|STARTED|Baseline||22
6315211|NCT00424619|7219768|FG001|STARTED|Baseline||22
6315212|NCT00424619|7219769|FG002|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
6315213|NCT00424619|7219767|FG000|COMPLETED|Baseline||22
6315214|NCT00424619|7219768|FG001|COMPLETED|Baseline||22
6315215|NCT00424619|7219769|FG002|COMPLETED|Baseline||20
6315216|NCT00424619|7219767|FG000|NOT COMPLETED|Baseline||0
6315217|NCT00424619|7219768|FG001|NOT COMPLETED|Baseline||0
6315218|NCT00424619|7219769|FG002|NOT COMPLETED|Baseline||1
6315219|NCT00424619|7219767|FG000|STARTED|4 Week||18
6315220|NCT00424619|7219768|FG001|STARTED|4 Week||17
6315221|NCT00424619|7219769|FG002|STARTED|4 Week||17
6315222|NCT00424619|7219767|FG000|COMPLETED|4 Week||18
6315223|NCT00424619|7219768|FG001|COMPLETED|4 Week||17
6557716|NCT01769391|7480298|FG001|COMPLETED|Overall Study||48
6557717|NCT01769391|7480297|FG000|NOT COMPLETED|Overall Study||17
6557718|NCT01769391|7480298|FG001|NOT COMPLETED|Overall Study||9
6557719|NCT01769404|7480310|FG000|STARTED|Treatment Period 1||12
6557720|NCT01769404|7480311|FG001|STARTED|Treatment Period 1||13
6557721|NCT01769404|7480310|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
6315224|NCT00424619|7219769|FG002|COMPLETED|4 Week||17
6315225|NCT00424619|7219767|FG000|NOT COMPLETED|4 Week||0
6315226|NCT00424619|7219768|FG001|NOT COMPLETED|4 Week||0
6315227|NCT00424619|7219769|FG002|NOT COMPLETED|4 Week||0
6315228|NCT00424619|7219767|FG000|STARTED|3 Month||12
6315229|NCT00424619|7219768|FG001|STARTED|3 Month||18
6315230|NCT00424619|7219769|FG002|STARTED|3 Month||17
6315231|NCT00424619|7219767|FG000|COMPLETED|3 Month||12
6315232|NCT00424619|7219768|FG001|COMPLETED|3 Month||18
6315233|NCT00424619|7219769|FG002|COMPLETED|3 Month||17
6315234|NCT00424619|7219767|FG000|NOT COMPLETED|3 Month||0
6315235|NCT00424619|7219768|FG001|NOT COMPLETED|3 Month||0
6315236|NCT00424619|7219769|FG002|NOT COMPLETED|3 Month||0
6315237|NCT00424632|7219779|FG000|STARTED|Overall Study||1
6315238|NCT00424632|7219780|FG001|STARTED|Overall Study||1
6315239|NCT00424632|7219781|FG002|STARTED|Overall Study||1
6315240|NCT00424632|7219782|FG003|STARTED|Overall Study||4
6315241|NCT00424632|7219783|FG004|STARTED|Overall Study||3
6315242|NCT00424632|7219784|FG005|STARTED|Overall Study||15
6315243|NCT00424632|7219785|FG006|STARTED|Overall Study||7
6315244|NCT00424632|7219786|FG007|STARTED|Overall Study||3
6315245|NCT00424632|7219787|FG008|STARTED|Overall Study||16
6315246|NCT00424632|7219788|FG009|STARTED|Overall Study||6
6315247|NCT00424632|7219779|FG000|COMPLETED|Overall Study||0
6315248|NCT00424632|7219780|FG001|COMPLETED|Overall Study||0
6315249|NCT00424632|7219781|FG002|COMPLETED|Overall Study||0
6315250|NCT00424632|7219782|FG003|COMPLETED|Overall Study||0
6315251|NCT00424632|7219783|FG004|COMPLETED|Overall Study||0
6315252|NCT00424632|7219784|FG005|COMPLETED|Overall Study||0
6315253|NCT00424632|7219785|FG006|COMPLETED|Overall Study||0
6315254|NCT00424632|7219786|FG007|COMPLETED|Overall Study||0
6315255|NCT00424632|7219787|FG008|COMPLETED|Overall Study||0
6315256|NCT00424632|7219788|FG009|COMPLETED|Overall Study||0
6315257|NCT00424632|7219779|FG000|NOT COMPLETED|Overall Study||1
6315258|NCT00424632|7219780|FG001|NOT COMPLETED|Overall Study||1
6315259|NCT00424632|7219781|FG002|NOT COMPLETED|Overall Study||1
6315260|NCT00424632|7219782|FG003|NOT COMPLETED|Overall Study||4
6315261|NCT00424632|7219783|FG004|NOT COMPLETED|Overall Study||3
6315262|NCT00424632|7219784|FG005|NOT COMPLETED|Overall Study||15
6315263|NCT00424632|7219785|FG006|NOT COMPLETED|Overall Study||7
6315264|NCT00424632|7219786|FG007|NOT COMPLETED|Overall Study||3
6315265|NCT00424632|7219787|FG008|NOT COMPLETED|Overall Study||16
6315266|NCT00424632|7219788|FG009|NOT COMPLETED|Overall Study||6
6315267|NCT00424749|7219819|FG000|STARTED|Overall Study||4
6315268|NCT00424749|7219819|FG000|COMPLETED|Overall Study||3
6315269|NCT00424749|7219819|FG000|NOT COMPLETED|Overall Study||1
6315270|NCT00424762|7219825|FG000|STARTED|Overall Study||74
6315271|NCT00424762|7219826|FG001|STARTED|Overall Study||76
6315272|NCT00424762|7219825|FG000|COMPLETED|Overall Study||54
6315273|NCT00424762|7219826|FG001|COMPLETED|Overall Study||54
6315274|NCT00424762|7219825|FG000|NOT COMPLETED|Overall Study||20
6315275|NCT00424762|7219826|FG001|NOT COMPLETED|Overall Study||22
6315276|NCT00424775|7219832|FG000|STARTED|Overall Study||3
6315277|NCT00424775|7219833|FG001|STARTED|Overall Study||0
6315278|NCT00424775|7219832|FG000|COMPLETED|Overall Study||0
6315279|NCT00424775|7219833|FG001|COMPLETED|Overall Study||0
6315280|NCT00424775|7219832|FG000|NOT COMPLETED|Overall Study||3
6315281|NCT00424775|7219833|FG001|NOT COMPLETED|Overall Study||0
6315282|NCT00424827|7219837|FG000|STARTED|Overall Study||11
6315283|NCT00424827|7219837|FG000|COMPLETED|Overall Study||10
6315284|NCT00424827|7219837|FG000|NOT COMPLETED|Overall Study||1
6315285|NCT00424840|7219842|FG000|STARTED|Overall Study||3
6315286|NCT00424840|7219843|FG001|STARTED|Overall Study||4
6315287|NCT00424840|7219844|FG002|STARTED|Overall Study||5
6315288|NCT00424840|7219842|FG000|COMPLETED|Overall Study||3
6315289|NCT00424840|7219843|FG001|COMPLETED|Overall Study||4
6315290|NCT00424840|7219844|FG002|COMPLETED|Overall Study||5
6315291|NCT00424840|7219842|FG000|NOT COMPLETED|Overall Study||0
6315292|NCT00424840|7219843|FG001|NOT COMPLETED|Overall Study||0
6315293|NCT00424840|7219844|FG002|NOT COMPLETED|Overall Study||0
6315294|NCT00425061|7219857|FG000|STARTED|Overall Study||16
6315295|NCT00425061|7219858|FG001|STARTED|Overall Study||17
6315296|NCT00425061|7219859|FG002|STARTED|Overall Study||16
6315297|NCT00425061|7219860|FG003|STARTED|Overall Study||16
6315298|NCT00425061|7219861|FG004|STARTED|Overall Study||45
6315299|NCT00425061|7219862|FG005|STARTED|Overall Study||4
6315300|NCT00425061|7219863|FG006|STARTED|Overall Study||45
6315301|NCT00425061|7219857|FG000|COMPLETED|Overall Study||14
6315302|NCT00425061|7219858|FG001|COMPLETED|Overall Study||15
6315303|NCT00425061|7219859|FG002|COMPLETED|Overall Study||16
6315304|NCT00425061|7219860|FG003|COMPLETED|Overall Study||14
6315305|NCT00425061|7219861|FG004|COMPLETED|Overall Study||19
6315306|NCT00425061|7219862|FG005|COMPLETED|Overall Study||0
6315307|NCT00425061|7219863|FG006|COMPLETED|Overall Study||26
6557722|NCT01769404|7480311|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||13
6557723|NCT01769404|7480310|FG000|COMPLETED|Treatment Period 1||7
6315308|NCT00425061|7219857|FG000|NOT COMPLETED|Overall Study||2
6315309|NCT00425061|7219858|FG001|NOT COMPLETED|Overall Study||2
6315310|NCT00425061|7219859|FG002|NOT COMPLETED|Overall Study||0
6315311|NCT00425061|7219860|FG003|NOT COMPLETED|Overall Study||2
6315312|NCT00425061|7219861|FG004|NOT COMPLETED|Overall Study||26
6315313|NCT00425061|7219862|FG005|NOT COMPLETED|Overall Study||4
6315314|NCT00425061|7219863|FG006|NOT COMPLETED|Overall Study||19
6315315|NCT00425113|7219883|FG000|STARTED|Overall Study||17
6315316|NCT00425113|7219884|FG001|STARTED|Overall Study||18
6315317|NCT00425113|7219883|FG000|Exposed to Study Drug|Overall Study||16
6315318|NCT00425113|7219884|FG001|Exposed to Study Drug|Overall Study||17
6315319|NCT00425113|7219883|FG000|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
6315320|NCT00425113|7219884|FG001|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
6315321|NCT00425113|7219883|FG000|NOT COMPLETED|Overall Study||2
6315322|NCT00425113|7219884|FG001|NOT COMPLETED|Overall Study||2
6315323|NCT00425269|7219893|FG000|STARTED|Overall Study||101
6315324|NCT00425269|7219894|FG001|STARTED|Overall Study||97
6315325|NCT00425269|7219893|FG000|COMPLETED|Overall Study||82
6315326|NCT00425269|7219894|FG001|COMPLETED|Overall Study||77
6315327|NCT00425269|7219893|FG000|NOT COMPLETED|Overall Study||19
6315328|NCT00425269|7219894|FG001|NOT COMPLETED|Overall Study||20
6315329|NCT00425308|7219902|FG000|STARTED|Overall Study||15
6315330|NCT00425308|7219903|FG001|STARTED|Overall Study||15
6315331|NCT00425308|7219902|FG000|COMPLETED|Overall Study||11
6315332|NCT00425308|7219903|FG001|COMPLETED|Overall Study||14
6315333|NCT00425308|7219902|FG000|NOT COMPLETED|Overall Study||4
6315334|NCT00425308|7219903|FG001|NOT COMPLETED|Overall Study||1
6315335|NCT00425373|7219918|FG000|STARTED|Overall Study||159
6315336|NCT00425373|7219919|FG001|STARTED|Overall Study||167
6315337|NCT00425373|7219920|FG002|STARTED|Overall Study||160
6315338|NCT00425373|7219921|FG003|STARTED|Overall Study||162
6315339|NCT00425373|7219922|FG004|STARTED|Overall Study||169
6315340|NCT00425373|7219923|FG005|STARTED|Overall Study||163
6315341|NCT00425373|7219924|FG006|STARTED|Overall Study||161
6315342|NCT00425373|7219925|FG007|STARTED|Overall Study||161
6315343|NCT00425373|7219926|FG008|STARTED|Overall Study||166
6315344|NCT00425373|7219918|FG000|COMPLETED|Overall Study||154
6315345|NCT00425373|7219919|FG001|COMPLETED|Overall Study||164
6315346|NCT00425373|7219920|FG002|COMPLETED|Overall Study||157
6315347|NCT00425373|7219921|FG003|COMPLETED|Overall Study||160
6315348|NCT00425373|7219922|FG004|COMPLETED|Overall Study||159
6315349|NCT00425373|7219923|FG005|COMPLETED|Overall Study||154
6315350|NCT00425373|7219924|FG006|COMPLETED|Overall Study||154
6315351|NCT00425373|7219925|FG007|COMPLETED|Overall Study||151
6315352|NCT00425373|7219926|FG008|COMPLETED|Overall Study||148
6315353|NCT00425373|7219918|FG000|NOT COMPLETED|Overall Study||5
6557724|NCT01769404|7480311|FG001|COMPLETED|Treatment Period 1||13
6557725|NCT01769404|7480310|FG000|NOT COMPLETED|Treatment Period 1||5
6315354|NCT00425373|7219919|FG001|NOT COMPLETED|Overall Study||3
6315355|NCT00425373|7219920|FG002|NOT COMPLETED|Overall Study||3
6315356|NCT00425373|7219921|FG003|NOT COMPLETED|Overall Study||2
6315357|NCT00425373|7219922|FG004|NOT COMPLETED|Overall Study||10
6315358|NCT00425373|7219923|FG005|NOT COMPLETED|Overall Study||9
6315359|NCT00425373|7219924|FG006|NOT COMPLETED|Overall Study||7
6315360|NCT00425373|7219925|FG007|NOT COMPLETED|Overall Study||10
6315361|NCT00425373|7219926|FG008|NOT COMPLETED|Overall Study||18
6375250|NCT00754390|7285843|FG000|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
6375251|NCT00754390|7285843|FG000|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
6375252|NCT00754390|7285843|FG000|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
6375253|NCT00754442|7285852|FG000|STARTED|Overall Study|controls 11|11
6375254|NCT00754442|7285853|FG001|STARTED|Overall Study|patients 9|9
6375255|NCT00754442|7285852|FG000|COMPLETED|Overall Study||6
6375256|NCT00754442|7285853|FG001|COMPLETED|Overall Study||6
6375257|NCT00754442|7285852|FG000|NOT COMPLETED|Overall Study||5
6375258|NCT00754442|7285853|FG001|NOT COMPLETED|Overall Study||3
6375259|NCT00754468|7285862|FG000|STARTED|Overall Study||4
6375260|NCT00754468|7285863|FG001|STARTED|Overall Study||3
6375261|NCT00754468|7285862|FG000|COMPLETED|Overall Study||4
6375262|NCT00754468|7285863|FG001|COMPLETED|Overall Study||3
6375263|NCT00754468|7285862|FG000|NOT COMPLETED|Overall Study||0
6375264|NCT00754468|7285863|FG001|NOT COMPLETED|Overall Study||0
6375265|NCT00754494|7285874|FG000|STARTED|Overall Study||15
6498328|NCT01408901|7416891|FG003|NOT COMPLETED|6-Week Follow-Up||4
6498329|NCT01408901|7416888|FG000|STARTED|12-Week Follow-Up (Primary Endpoint)||50
6498330|NCT01408901|7416889|FG001|STARTED|12-Week Follow-Up (Primary Endpoint)||52
6498331|NCT01408901|7416890|FG002|STARTED|12-Week Follow-Up (Primary Endpoint)||50
6498332|NCT01408901|7416891|FG003|STARTED|12-Week Follow-Up (Primary Endpoint)||49
6498333|NCT01408901|7416888|FG000|COMPLETED|12-Week Follow-Up (Primary Endpoint)||49
6498334|NCT01408901|7416889|FG001|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
6498335|NCT01408901|7416890|FG002|COMPLETED|12-Week Follow-Up (Primary Endpoint)||50
6498336|NCT01408901|7416891|FG003|COMPLETED|12-Week Follow-Up (Primary Endpoint)||46
6498337|NCT01408901|7416888|FG000|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||1
6498338|NCT01408901|7416889|FG001|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||2
6375266|NCT00754494|7285875|FG001|STARTED|Overall Study||15
6375267|NCT00754494|7285876|FG002|STARTED|Overall Study||15
6375268|NCT00754494|7285874|FG000|COMPLETED|Overall Study||13
6375269|NCT00754494|7285875|FG001|COMPLETED|Overall Study||15
6375270|NCT00754494|7285876|FG002|COMPLETED|Overall Study||14
6315362|NCT00425386|7219946|FG000|STARTED|Overall Study||46
6315363|NCT00425386|7219946|FG000|COMPLETED|Overall Study||43
6315364|NCT00425386|7219946|FG000|NOT COMPLETED|Overall Study||3
6315365|NCT00425477|7219950|FG000|STARTED|Overall Study||26
6315366|NCT00425477|7219950|FG000|COMPLETED|Overall Study||13
6315367|NCT00425477|7219950|FG000|NOT COMPLETED|Overall Study||13
6315368|NCT00425503|7219954|FG000|STARTED|Overall Study||40
6315369|NCT00425503|7219954|FG000|COMPLETED|Overall Study||37
6315370|NCT00425503|7219954|FG000|NOT COMPLETED|Overall Study||3
6315371|NCT00425555|7219960|FG000|STARTED|Overall Study||79
6315372|NCT00425555|7219961|FG001|STARTED|Overall Study||60
6315373|NCT00425555|7219960|FG000|COMPLETED|Overall Study||0
6315374|NCT00425555|7219961|FG001|COMPLETED|Overall Study||0
6315375|NCT00425555|7219960|FG000|NOT COMPLETED|Overall Study||79
6315376|NCT00425555|7219961|FG001|NOT COMPLETED|Overall Study||60
6315377|NCT00425607|7219970|FG000|STARTED|Overall Study||29
6315378|NCT00425607|7219970|FG000|Received Treatment|Overall Study||28
6315379|NCT00425607|7219970|FG000|COMPLETED|Overall Study||27
6315380|NCT00425607|7219970|FG000|NOT COMPLETED|Overall Study||2
6315381|NCT00425672|7219974|FG000|STARTED|Overall Study||15
6315382|NCT00425672|7219974|FG000|COMPLETED|Overall Study||14
6315383|NCT00425672|7219974|FG000|NOT COMPLETED|Overall Study||1
6315384|NCT00425698|7219980|FG000|STARTED|Overall Study||44
6315385|NCT00425698|7219981|FG001|STARTED|Overall Study||44
6315386|NCT00425698|7219980|FG000|COMPLETED|Overall Study||41
6315387|NCT00425698|7219981|FG001|COMPLETED|Overall Study||42
6315388|NCT00425698|7219980|FG000|NOT COMPLETED|Overall Study||3
6315389|NCT00425698|7219981|FG001|NOT COMPLETED|Overall Study||2
6315390|NCT00425750|7219987|FG000|STARTED|Overall Study||25
6315391|NCT00425750|7219987|FG000|COMPLETED|Overall Study||0
6315392|NCT00425750|7219987|FG000|NOT COMPLETED|Overall Study||25
6315393|NCT00425802|7219991|FG000|STARTED|Overall Study||61
6315394|NCT00425802|7219991|FG000|COMPLETED|Overall Study||61
6315395|NCT00425802|7219991|FG000|NOT COMPLETED|Overall Study||0
6315396|NCT00425854|7219997|FG000|STARTED|Overall Study|Treated|29
6315397|NCT00425854|7219998|FG001|STARTED|Overall Study|Treated|21
6315398|NCT00425854|7219997|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
6315399|NCT00425854|7219998|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
6315400|NCT00425854|7219997|FG000|NOT COMPLETED|Overall Study||29
6315401|NCT00425854|7219998|FG001|NOT COMPLETED|Overall Study||21
6315402|NCT00425945|7220007|FG000|STARTED|Overall Study||64
6315403|NCT00425945|7220008|FG001|STARTED|Overall Study||66
6315404|NCT00425945|7220007|FG000|COMPLETED|Overall Study||60
6315405|NCT00425945|7220008|FG001|COMPLETED|Overall Study||61
6315406|NCT00425945|7220007|FG000|NOT COMPLETED|Overall Study||4
6315407|NCT00425945|7220008|FG001|NOT COMPLETED|Overall Study||5
6315408|NCT00426127|7220016|FG000|STARTED|Overall Study||2
6315409|NCT00426127|7220016|FG000|COMPLETED|Overall Study||0
6315410|NCT00426127|7220016|FG000|NOT COMPLETED|Overall Study||2
6315411|NCT00426153|7220022|FG000|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
6315412|NCT00426153|7220023|FG001|STARTED|Overall Study||14
6315413|NCT00426153|7220022|FG000|COMPLETED|Overall Study||28
6315414|NCT00426153|7220023|FG001|COMPLETED|Overall Study||14
6315415|NCT00426153|7220022|FG000|NOT COMPLETED|Overall Study||0
6315416|NCT00426153|7220023|FG001|NOT COMPLETED|Overall Study||0
6315417|NCT00426231|7220031|FG000|STARTED|Overall Study||36
6315418|NCT00426231|7220032|FG001|STARTED|Overall Study||37
6315419|NCT00426231|7220031|FG000|COMPLETED|Overall Study|For the 6 month endpoint|27
6315420|NCT00426231|7220032|FG001|COMPLETED|Overall Study|For the 6-month endpoint|25
6315421|NCT00426231|7220031|FG000|NOT COMPLETED|Overall Study||9
6315422|NCT00426231|7220032|FG001|NOT COMPLETED|Overall Study||12
6315423|NCT00426270|7220038|FG000|STARTED|Overall Study||116
6315424|NCT00426270|7220038|FG000|COMPLETED|Overall Study||110
6315425|NCT00426270|7220038|FG000|NOT COMPLETED|Overall Study||6
6315426|NCT00426283|7220044|FG000|STARTED|Overall Study||28
6315427|NCT00426283|7220045|FG001|STARTED|Overall Study||14
6315428|NCT00426283|7220044|FG000|COMPLETED|Overall Study||23
6315429|NCT00426283|7220045|FG001|COMPLETED|Overall Study||13
6315430|NCT00426283|7220044|FG000|NOT COMPLETED|Overall Study||5
6315431|NCT00426283|7220045|FG001|NOT COMPLETED|Overall Study||1
6315432|NCT00426361|7220058|FG000|STARTED|Overall Study||248
6315433|NCT00426361|7220059|FG001|STARTED|Overall Study||255
6315434|NCT00426361|7220060|FG002|STARTED|Overall Study||248
6315435|NCT00426361|7220058|FG000|COMPLETED|Overall Study||244
6315436|NCT00426361|7220059|FG001|COMPLETED|Overall Study||250
6315437|NCT00426361|7220060|FG002|COMPLETED|Overall Study||243
6315438|NCT00426361|7220058|FG000|NOT COMPLETED|Overall Study||4
6315439|NCT00426361|7220059|FG001|NOT COMPLETED|Overall Study||5
6315440|NCT00426361|7220060|FG002|NOT COMPLETED|Overall Study||5
6315441|NCT00426517|7220072|FG000|STARTED|Overall Study||7
6315442|NCT00426517|7220073|FG001|STARTED|Overall Study||36
6315443|NCT00426517|7220074|FG002|STARTED|Overall Study||3
6315444|NCT00426517|7220075|FG003|STARTED|Overall Study||2
6315445|NCT00426517|7220072|FG000|COMPLETED|Overall Study||7
6315446|NCT00426517|7220073|FG001|COMPLETED|Overall Study||36
6315447|NCT00426517|7220074|FG002|COMPLETED|Overall Study||3
6315448|NCT00426517|7220075|FG003|COMPLETED|Overall Study||2
6315449|NCT00426517|7220072|FG000|NOT COMPLETED|Overall Study||0
6315450|NCT00426517|7220073|FG001|NOT COMPLETED|Overall Study||0
6315451|NCT00426517|7220074|FG002|NOT COMPLETED|Overall Study||0
6315452|NCT00426517|7220075|FG003|NOT COMPLETED|Overall Study||0
6315453|NCT00426556|7220089|FG000|STARTED|Phase I - Core Phase||6
6315454|NCT00426556|7220090|FG001|STARTED|Phase I - Core Phase||17
6315455|NCT00426556|7220091|FG002|STARTED|Phase I - Core Phase||10
6315456|NCT00426556|7220092|FG003|STARTED|Phase I - Core Phase||0
6315457|NCT00426556|7220089|FG000|COMPLETED|Phase I - Core Phase||5
6315458|NCT00426556|7220090|FG001|COMPLETED|Phase I - Core Phase||7
6315459|NCT00426556|7220091|FG002|COMPLETED|Phase I - Core Phase||7
6315460|NCT00426556|7220092|FG003|COMPLETED|Phase I - Core Phase||0
6315461|NCT00426556|7220089|FG000|NOT COMPLETED|Phase I - Core Phase||1
6315462|NCT00426556|7220090|FG001|NOT COMPLETED|Phase I - Core Phase||10
6315463|NCT00426556|7220091|FG002|NOT COMPLETED|Phase I - Core Phase||3
6315464|NCT00426556|7220092|FG003|NOT COMPLETED|Phase I - Core Phase||0
6315465|NCT00426556|7220089|FG000|STARTED|Phase I - Extension Phase||5
6315466|NCT00426556|7220090|FG001|STARTED|Phase I - Extension Phase||7
6315467|NCT00426556|7220091|FG002|STARTED|Phase I - Extension Phase||7
6315468|NCT00426556|7220092|FG003|STARTED|Phase I - Extension Phase||0
6315469|NCT00426556|7220089|FG000|COMPLETED|Phase I - Extension Phase||0
6315470|NCT00426556|7220090|FG001|COMPLETED|Phase I - Extension Phase||1
6315471|NCT00426556|7220091|FG002|COMPLETED|Phase I - Extension Phase||0
6315472|NCT00426556|7220092|FG003|COMPLETED|Phase I - Extension Phase||0
6315473|NCT00426556|7220089|FG000|NOT COMPLETED|Phase I - Extension Phase||5
6315474|NCT00426556|7220090|FG001|NOT COMPLETED|Phase I - Extension Phase||6
6315475|NCT00426556|7220091|FG002|NOT COMPLETED|Phase I - Extension Phase||7
6315476|NCT00426556|7220092|FG003|NOT COMPLETED|Phase I - Extension Phase||0
6315477|NCT00426556|7220089|FG000|STARTED|Phase II - Core Phase||0
6315478|NCT00426556|7220090|FG001|STARTED|Phase II - Core Phase||0
6315479|NCT00426556|7220091|FG002|STARTED|Phase II - Core Phase||0
6315480|NCT00426556|7220092|FG003|STARTED|Phase II - Core Phase||55
6315481|NCT00426556|7220089|FG000|COMPLETED|Phase II - Core Phase||0
6315482|NCT00426556|7220090|FG001|COMPLETED|Phase II - Core Phase||0
6315483|NCT00426556|7220091|FG002|COMPLETED|Phase II - Core Phase||0
6315484|NCT00426556|7220092|FG003|COMPLETED|Phase II - Core Phase||28
6315485|NCT00426556|7220089|FG000|NOT COMPLETED|Phase II - Core Phase||0
6315486|NCT00426556|7220090|FG001|NOT COMPLETED|Phase II - Core Phase||0
6315487|NCT00426556|7220091|FG002|NOT COMPLETED|Phase II - Core Phase||0
6315488|NCT00426556|7220092|FG003|NOT COMPLETED|Phase II - Core Phase||27
6315489|NCT00426556|7220089|FG000|STARTED|Phase II - Extension Phase||0
6315490|NCT00426556|7220090|FG001|STARTED|Phase II - Extension Phase||0
6315491|NCT00426556|7220091|FG002|STARTED|Phase II - Extension Phase||0
6315492|NCT00426556|7220092|FG003|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
6315493|NCT00426556|7220089|FG000|COMPLETED|Phase II - Extension Phase||0
6315494|NCT00426556|7220090|FG001|COMPLETED|Phase II - Extension Phase||0
6315495|NCT00426556|7220091|FG002|COMPLETED|Phase II - Extension Phase||0
6315496|NCT00426556|7220092|FG003|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
6315497|NCT00426556|7220089|FG000|NOT COMPLETED|Phase II - Extension Phase||0
6315498|NCT00426556|7220090|FG001|NOT COMPLETED|Phase II - Extension Phase||0
6315499|NCT00426556|7220091|FG002|NOT COMPLETED|Phase II - Extension Phase||0
6315500|NCT00426556|7220092|FG003|NOT COMPLETED|Phase II - Extension Phase||23
6315501|NCT00426660|7220102|FG000|STARTED|Overall Study||1047
6315502|NCT00426660|7220102|FG000|Treated|Overall Study||1032
6315503|NCT00426660|7220102|FG000|Safety Analysis Set|Overall Study||1032
6315504|NCT00426660|7220102|FG000|COMPLETED|Overall Study||916
6315505|NCT00426660|7220102|FG000|NOT COMPLETED|Overall Study||131
6315506|NCT00426751|7220108|FG000|STARTED|Overall Study||226
6315507|NCT00426751|7220109|FG001|STARTED|Overall Study||203
6315508|NCT00426751|7220108|FG000|COMPLETED|Overall Study||204
6315509|NCT00426751|7220109|FG001|COMPLETED|Overall Study||183
6315510|NCT00426751|7220108|FG000|NOT COMPLETED|Overall Study||22
6315511|NCT00426751|7220109|FG001|NOT COMPLETED|Overall Study||20
6315512|NCT00426764|7220115|FG000|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
6315513|NCT00426764|7220115|FG000|Discontinued Prior to or During Cycle 6|Overall Study||98
6315514|NCT00426764|7220115|FG000|Discontinued at End of or After Cycle 6|Overall Study||33
6315515|NCT00426764|7220115|FG000|COMPLETED|Overall Study||0
6315516|NCT00426764|7220115|FG000|NOT COMPLETED|Overall Study||131
6315517|NCT00426842|7220125|FG000|STARTED|Overall Study||11
6315518|NCT00426842|7220125|FG000|COMPLETED|Overall Study||10
6315519|NCT00426842|7220125|FG000|NOT COMPLETED|Overall Study||1
6315520|NCT00426855|7220131|FG000|STARTED|Overall Study||12
6315521|NCT00426855|7220131|FG000|COMPLETED|Overall Study||12
6315522|NCT00426855|7220131|FG000|NOT COMPLETED|Overall Study||0
6315523|NCT00427011|7220135|FG000|STARTED|Overall Study||25
6315524|NCT00427011|7220135|FG000|COMPLETED|Overall Study||0
6315525|NCT00427011|7220135|FG000|NOT COMPLETED|Overall Study||25
6315526|NCT00427037|7220142|FG000|STARTED|Overall Study||17
6315527|NCT00427037|7220143|FG001|STARTED|Overall Study||17
6315528|NCT00427037|7220142|FG000|COMPLETED|Overall Study||10
6315529|NCT00427037|7220143|FG001|COMPLETED|Overall Study||10
6315530|NCT00427037|7220142|FG000|NOT COMPLETED|Overall Study||7
6315531|NCT00427037|7220143|FG001|NOT COMPLETED|Overall Study||7
6315532|NCT00427297|7220153|FG000|STARTED|Overall Study||17
6315533|NCT00427297|7220154|FG001|STARTED|Overall Study||17
6315534|NCT00427297|7220153|FG000|COMPLETED|Overall Study||17
6315535|NCT00427297|7220154|FG001|COMPLETED|Overall Study||17
6315536|NCT00427297|7220153|FG000|NOT COMPLETED|Overall Study||0
6315537|NCT00427297|7220154|FG001|NOT COMPLETED|Overall Study||0
6315538|NCT00427336|7220160|FG000|STARTED|Overall Study||9
6315539|NCT00427336|7220160|FG000|COMPLETED|Overall Study||9
6315540|NCT00427336|7220160|FG000|NOT COMPLETED|Overall Study||0
6315541|NCT00427349|7220164|FG000|STARTED|Overall Study||46
6775103|NCT03887299|7703012|FG001|NOT COMPLETED|Overall Study||0
6775104|NCT03878758|7703018|FG000|STARTED|Overall Study||158
6775105|NCT03878758|7703018|FG000|COMPLETED|Overall Study||154
6775106|NCT03878758|7703018|FG000|NOT COMPLETED|Overall Study||4
6775107|NCT03849300|7703035|FG000|STARTED|Overall Study||42
6775108|NCT03849300|7703036|FG001|STARTED|Overall Study||42
6775109|NCT03849300|7703037|FG002|STARTED|Overall Study||32
6775110|NCT03849300|7703038|FG003|STARTED|Overall Study||31
6775111|NCT03849300|7703035|FG000|COMPLETED|Overall Study||37
6775112|NCT03849300|7703036|FG001|COMPLETED|Overall Study||35
6775113|NCT03849300|7703037|FG002|COMPLETED|Overall Study||28
6775114|NCT03849300|7703038|FG003|COMPLETED|Overall Study||25
6315542|NCT00427349|7220164|FG000|Eligible|Overall Study||45
6315543|NCT00427349|7220164|FG000|Treated|Overall Study||45
6315544|NCT00427349|7220164|FG000|Eligible and Treated|Overall Study||44
6315545|NCT00427349|7220164|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
6315546|NCT00427349|7220164|FG000|NOT COMPLETED|Overall Study||46
6315547|NCT00427557|7220168|FG000|STARTED|Overall Study||30
6315548|NCT00427557|7220168|FG000|COMPLETED|Overall Study||30
6315549|NCT00427557|7220168|FG000|NOT COMPLETED|Overall Study||0
6315550|NCT00427635|7220174|FG000|STARTED|Treatment Phase|Randomised|26
6315551|NCT00427635|7220175|FG001|STARTED|Treatment Phase|Randomised|26
6315552|NCT00427635|7220174|FG000|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
6315553|NCT00427635|7220175|FG001|COMPLETED|Treatment Phase|ITT population|26
6315554|NCT00427635|7220174|FG000|NOT COMPLETED|Treatment Phase||1
6315555|NCT00427635|7220175|FG001|NOT COMPLETED|Treatment Phase||0
6315556|NCT00427635|7220174|FG000|STARTED|Study Completion to Safety Follow-up||25
6315557|NCT00427635|7220175|FG001|STARTED|Study Completion to Safety Follow-up||26
6315558|NCT00427635|7220174|FG000|COMPLETED|Study Completion to Safety Follow-up||25
6315559|NCT00427635|7220175|FG001|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
6315560|NCT00427635|7220174|FG000|NOT COMPLETED|Study Completion to Safety Follow-up||0
6315561|NCT00427635|7220175|FG001|NOT COMPLETED|Study Completion to Safety Follow-up||1
6315562|NCT00427648|7220183|FG000|STARTED|Overall Study||12
6315563|NCT00427648|7220184|FG001|STARTED|Overall Study||10
6315564|NCT00427648|7220183|FG000|COMPLETED|Overall Study||11
6315565|NCT00427648|7220184|FG001|COMPLETED|Overall Study||7
6315566|NCT00427648|7220183|FG000|NOT COMPLETED|Overall Study||1
6315567|NCT00427648|7220184|FG001|NOT COMPLETED|Overall Study||3
6315568|NCT00427661|7220192|FG000|STARTED|Overall Study||8
6315569|NCT00427661|7220192|FG000|COMPLETED|Overall Study||8
6315570|NCT00427661|7220192|FG000|NOT COMPLETED|Overall Study||0
6315571|NCT00427700|7220199|FG000|STARTED|Overall Study||40
6315572|NCT00427700|7220200|FG001|STARTED|Overall Study||42
6315573|NCT00427700|7220199|FG000|COMPLETED|Overall Study||37
6315574|NCT00427700|7220200|FG001|COMPLETED|Overall Study||31
6315575|NCT00427700|7220199|FG000|NOT COMPLETED|Overall Study||3
6315576|NCT00427700|7220200|FG001|NOT COMPLETED|Overall Study||11
6315577|NCT00427765|7220207|FG000|STARTED|Overall Study||164
6315578|NCT00427765|7220207|FG000|COMPLETED|Overall Study||164
6315579|NCT00427765|7220207|FG000|NOT COMPLETED|Overall Study||0
6315580|NCT00427778|7220211|FG000|STARTED|First Intervention (4 Weeks)||14
6315581|NCT00427778|7220212|FG001|STARTED|First Intervention (4 Weeks)||15
6315582|NCT00427778|7220211|FG000|COMPLETED|First Intervention (4 Weeks)||10
6315583|NCT00427778|7220212|FG001|COMPLETED|First Intervention (4 Weeks)||14
6315584|NCT00427778|7220211|FG000|NOT COMPLETED|First Intervention (4 Weeks)||4
6315585|NCT00427778|7220212|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
6315586|NCT00427778|7220211|FG000|STARTED|Wash Out (2 Weeks)||10
6315587|NCT00427778|7220212|FG001|STARTED|Wash Out (2 Weeks)||14
6315588|NCT00427778|7220211|FG000|COMPLETED|Wash Out (2 Weeks)||10
6315589|NCT00427778|7220212|FG001|COMPLETED|Wash Out (2 Weeks)||14
6315590|NCT00427778|7220211|FG000|NOT COMPLETED|Wash Out (2 Weeks)||0
6315591|NCT00427778|7220212|FG001|NOT COMPLETED|Wash Out (2 Weeks)||0
6315592|NCT00427778|7220211|FG000|STARTED|Second Intervention (4 Weeks)||10
6315593|NCT00427778|7220212|FG001|STARTED|Second Intervention (4 Weeks)||14
6315594|NCT00427778|7220211|FG000|COMPLETED|Second Intervention (4 Weeks)||10
6315595|NCT00427778|7220212|FG001|COMPLETED|Second Intervention (4 Weeks)||14
6315596|NCT00427778|7220211|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6315597|NCT00427778|7220212|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
6315598|NCT00427791|7220233|FG000|STARTED|Overall Study||10
6315599|NCT00427791|7220234|FG001|STARTED|Overall Study||13
6315600|NCT00427791|7220233|FG000|COMPLETED|Overall Study||10
6315601|NCT00427791|7220234|FG001|COMPLETED|Overall Study||13
6315602|NCT00427791|7220233|FG000|NOT COMPLETED|Overall Study||0
6315603|NCT00427791|7220234|FG001|NOT COMPLETED|Overall Study||0
6315604|NCT00427804|7220242|FG000|STARTED|Overall Study||4
6315605|NCT00427804|7220243|FG001|STARTED|Overall Study||5
6315606|NCT00427804|7220242|FG000|COMPLETED|Overall Study||4
6315607|NCT00427804|7220243|FG001|COMPLETED|Overall Study||5
6315608|NCT00427804|7220242|FG000|NOT COMPLETED|Overall Study||0
6315609|NCT00427804|7220243|FG001|NOT COMPLETED|Overall Study||0
6315610|NCT00427895|7220253|FG000|STARTED|Between 6-Month Follow-up - Year 1||411
6775115|NCT03849300|7703035|FG000|NOT COMPLETED|Overall Study||5
6775116|NCT03849300|7703036|FG001|NOT COMPLETED|Overall Study||7
6315611|NCT00427895|7220254|FG001|STARTED|Between 6-Month Follow-up - Year 1||411
6315612|NCT00427895|7220255|FG002|STARTED|Between 6-Month Follow-up - Year 1||392
6315613|NCT00427895|7220256|FG003|STARTED|Between 6-Month Follow-up - Year 1||854
6315614|NCT00427895|7220257|FG004|STARTED|Between 6-Month Follow-up - Year 1||0
6315615|NCT00427895|7220258|FG005|STARTED|Between 6-Month Follow-up - Year 1||0
6315616|NCT00427895|7220259|FG006|STARTED|Between 6-Month Follow-up - Year 1||0
6315617|NCT00427895|7220260|FG007|STARTED|Between 6-Month Follow-up - Year 1||0
6315618|NCT00427895|7220253|FG000|COMPLETED|Between 6-Month Follow-up - Year 1||411
6315619|NCT00427895|7220254|FG001|COMPLETED|Between 6-Month Follow-up - Year 1||411
6315620|NCT00427895|7220255|FG002|COMPLETED|Between 6-Month Follow-up - Year 1||392
6315621|NCT00427895|7220256|FG003|COMPLETED|Between 6-Month Follow-up - Year 1||502
6315622|NCT00427895|7220257|FG004|COMPLETED|Between 6-Month Follow-up - Year 1||0
6315623|NCT00427895|7220258|FG005|COMPLETED|Between 6-Month Follow-up - Year 1||0
6315624|NCT00427895|7220259|FG006|COMPLETED|Between 6-Month Follow-up - Year 1||0
6315625|NCT00427895|7220260|FG007|COMPLETED|Between 6-Month Follow-up - Year 1||0
6315626|NCT00427895|7220253|FG000|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6315627|NCT00427895|7220254|FG001|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6315628|NCT00427895|7220255|FG002|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6315629|NCT00427895|7220256|FG003|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
6315630|NCT00427895|7220257|FG004|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6315631|NCT00427895|7220258|FG005|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6315632|NCT00427895|7220259|FG006|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6315633|NCT00427895|7220260|FG007|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
6315634|NCT00427895|7220253|FG000|STARTED|Vax 2/Year 3 to 4||0
6315635|NCT00427895|7220254|FG001|STARTED|Vax 2/Year 3 to 4||0
6315636|NCT00427895|7220255|FG002|STARTED|Vax 2/Year 3 to 4||0
6315637|NCT00427895|7220256|FG003|STARTED|Vax 2/Year 3 to 4||0
6315638|NCT00427895|7220257|FG004|STARTED|Vax 2/Year 3 to 4||108
6315639|NCT00427895|7220258|FG005|STARTED|Vax 2/Year 3 to 4||108
6315640|NCT00427895|7220259|FG006|STARTED|Vax 2/Year 3 to 4||189
6315641|NCT00427895|7220260|FG007|STARTED|Vax 2/Year 3 to 4||214
6315642|NCT00427895|7220253|FG000|COMPLETED|Vax 2/Year 3 to 4||0
6315643|NCT00427895|7220254|FG001|COMPLETED|Vax 2/Year 3 to 4||0
6315644|NCT00427895|7220255|FG002|COMPLETED|Vax 2/Year 3 to 4||0
6315645|NCT00427895|7220256|FG003|COMPLETED|Vax 2/Year 3 to 4||0
6315646|NCT00427895|7220257|FG004|COMPLETED|Vax 2/Year 3 to 4||107
6315647|NCT00427895|7220258|FG005|COMPLETED|Vax 2/Year 3 to 4||108
6315648|NCT00427895|7220259|FG006|COMPLETED|Vax 2/Year 3 to 4||189
6315649|NCT00427895|7220260|FG007|COMPLETED|Vax 2/Year 3 to 4||212
6315650|NCT00427895|7220253|FG000|NOT COMPLETED|Vax 2/Year 3 to 4||0
6315651|NCT00427895|7220254|FG001|NOT COMPLETED|Vax 2/Year 3 to 4||0
6315652|NCT00427895|7220255|FG002|NOT COMPLETED|Vax 2/Year 3 to 4||0
6315653|NCT00427895|7220256|FG003|NOT COMPLETED|Vax 2/Year 3 to 4||0
6315654|NCT00427895|7220257|FG004|NOT COMPLETED|Vax 2/Year 3 to 4||1
6315655|NCT00427895|7220258|FG005|NOT COMPLETED|Vax 2/Year 3 to 4||0
6315656|NCT00427895|7220259|FG006|NOT COMPLETED|Vax 2/Year 3 to 4||0
6315657|NCT00427895|7220260|FG007|NOT COMPLETED|Vax 2/Year 3 to 4||2
6315658|NCT00427895|7220253|FG000|STARTED|Vax 1 Baseline/6-Month Follow-up||418
6315659|NCT00427895|7220254|FG001|STARTED|Vax 1 Baseline/6-Month Follow-up||417
6315660|NCT00427895|7220255|FG002|STARTED|Vax 1 Baseline/6-Month Follow-up||406
6315661|NCT00427895|7220256|FG003|STARTED|Vax 1 Baseline/6-Month Follow-up||900
6315662|NCT00427895|7220257|FG004|STARTED|Vax 1 Baseline/6-Month Follow-up||0
6315663|NCT00427895|7220258|FG005|STARTED|Vax 1 Baseline/6-Month Follow-up||0
6315664|NCT00427895|7220259|FG006|STARTED|Vax 1 Baseline/6-Month Follow-up||0
6315665|NCT00427895|7220260|FG007|STARTED|Vax 1 Baseline/6-Month Follow-up||0
6315666|NCT00427895|7220253|FG000|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
6315667|NCT00427895|7220254|FG001|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
6315668|NCT00427895|7220255|FG002|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
6315669|NCT00427895|7220256|FG003|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
6315670|NCT00427895|7220257|FG004|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
6315671|NCT00427895|7220258|FG005|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
6315672|NCT00427895|7220259|FG006|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
6315673|NCT00427895|7220260|FG007|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
6315674|NCT00427895|7220253|FG000|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
6315675|NCT00427895|7220254|FG001|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
6315676|NCT00427895|7220255|FG002|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
6315677|NCT00427895|7220256|FG003|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
6315678|NCT00427895|7220257|FG004|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6315679|NCT00427895|7220258|FG005|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6315680|NCT00427895|7220259|FG006|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6315681|NCT00427895|7220260|FG007|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6557726|NCT01769404|7480311|FG001|NOT COMPLETED|Treatment Period 1||0
6557727|NCT01769404|7480310|FG000|STARTED|Treatment Period 2||7
6557728|NCT01769404|7480311|FG001|STARTED|Treatment Period 2||13
6557729|NCT01769404|7480310|FG000|COMPLETED|Treatment Period 2||0
6315682|NCT00427895|7220253|FG000|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
6315683|NCT00427895|7220254|FG001|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
6315684|NCT00427895|7220255|FG002|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
6557730|NCT01769404|7480311|FG001|COMPLETED|Treatment Period 2||13
6557731|NCT01769404|7480310|FG000|NOT COMPLETED|Treatment Period 2||7
6315685|NCT00427895|7220256|FG003|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
6315686|NCT00427895|7220257|FG004|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6315687|NCT00427895|7220258|FG005|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6315688|NCT00427895|7220259|FG006|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6315689|NCT00427895|7220260|FG007|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
6315690|NCT00427895|7220253|FG000|STARTED|Vax 1/Year 1 Follow-up||411
6315691|NCT00427895|7220254|FG001|STARTED|Vax 1/Year 1 Follow-up||411
6315692|NCT00427895|7220255|FG002|STARTED|Vax 1/Year 1 Follow-up||392
6315693|NCT00427895|7220256|FG003|STARTED|Vax 1/Year 1 Follow-up||502
6315694|NCT00427895|7220257|FG004|STARTED|Vax 1/Year 1 Follow-up||0
6315695|NCT00427895|7220258|FG005|STARTED|Vax 1/Year 1 Follow-up||0
6315696|NCT00427895|7220259|FG006|STARTED|Vax 1/Year 1 Follow-up||0
6315697|NCT00427895|7220260|FG007|STARTED|Vax 1/Year 1 Follow-up||0
6315698|NCT00427895|7220253|FG000|COMPLETED|Vax 1/Year 1 Follow-up||404
6315699|NCT00427895|7220254|FG001|COMPLETED|Vax 1/Year 1 Follow-up||396
6315700|NCT00427895|7220255|FG002|COMPLETED|Vax 1/Year 1 Follow-up||373
6315701|NCT00427895|7220256|FG003|COMPLETED|Vax 1/Year 1 Follow-up||469
6315702|NCT00427895|7220257|FG004|COMPLETED|Vax 1/Year 1 Follow-up||0
6315703|NCT00427895|7220258|FG005|COMPLETED|Vax 1/Year 1 Follow-up||0
6315704|NCT00427895|7220259|FG006|COMPLETED|Vax 1/Year 1 Follow-up||0
6315705|NCT00427895|7220260|FG007|COMPLETED|Vax 1/Year 1 Follow-up||0
6315706|NCT00427895|7220253|FG000|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
6315707|NCT00427895|7220254|FG001|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
6315708|NCT00427895|7220255|FG002|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
6315709|NCT00427895|7220256|FG003|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
6315710|NCT00427895|7220257|FG004|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
6315711|NCT00427895|7220258|FG005|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
6315712|NCT00427895|7220259|FG006|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
6315713|NCT00427895|7220260|FG007|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
6315714|NCT00427895|7220253|FG000|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
6315715|NCT00427895|7220254|FG001|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
6315716|NCT00427895|7220255|FG002|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
6315717|NCT00427895|7220256|FG003|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
6315718|NCT00427895|7220257|FG004|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
6315719|NCT00427895|7220258|FG005|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
6315720|NCT00427895|7220259|FG006|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
6315721|NCT00427895|7220260|FG007|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
6315722|NCT00427895|7220253|FG000|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
6315723|NCT00427895|7220254|FG001|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
6315724|NCT00427895|7220255|FG002|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
6315725|NCT00427895|7220256|FG003|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315726|NCT00427895|7220257|FG004|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315727|NCT00427895|7220258|FG005|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315728|NCT00427895|7220259|FG006|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315729|NCT00427895|7220260|FG007|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315730|NCT00427895|7220253|FG000|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
6315731|NCT00427895|7220254|FG001|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
6315732|NCT00427895|7220255|FG002|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
6315733|NCT00427895|7220256|FG003|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
6315734|NCT00427895|7220257|FG004|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315735|NCT00427895|7220258|FG005|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315736|NCT00427895|7220259|FG006|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315737|NCT00427895|7220260|FG007|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
6315738|NCT00427908|7220303|FG000|STARTED|Primary Phase||229
6315739|NCT00427908|7220304|FG001|STARTED|Primary Phase||231
6315740|NCT00427908|7220305|FG002|STARTED|Primary Phase||75
6315741|NCT00427908|7220306|FG003|STARTED|Primary Phase||78
6315742|NCT00427908|7220303|FG000|COMPLETED|Primary Phase||224
6315743|NCT00427908|7220304|FG001|COMPLETED|Primary Phase||228
6315744|NCT00427908|7220305|FG002|COMPLETED|Primary Phase||72
6315745|NCT00427908|7220306|FG003|COMPLETED|Primary Phase||78
6315746|NCT00427908|7220303|FG000|NOT COMPLETED|Primary Phase||5
6315747|NCT00427908|7220304|FG001|NOT COMPLETED|Primary Phase||3
6557732|NCT01769404|7480311|FG001|NOT COMPLETED|Treatment Period 2||0
6557733|NCT01769456|7480319|FG000|STARTED|Overall Study|1 subject inadvertently enrolled, discontin'd after baseline, re-enrolled later and completed study|78
6557734|NCT01769456|7480319|FG000|COMPLETED|Overall Study||41
6557735|NCT01769456|7480319|FG000|NOT COMPLETED|Overall Study||37
6557736|NCT01769469|7480324|FG000|STARTED|Overall Study||101
6557737|NCT01769469|7480324|FG000|COMPLETED|Overall Study||66
6315748|NCT00427908|7220305|FG002|NOT COMPLETED|Primary Phase||3
6315749|NCT00427908|7220306|FG003|NOT COMPLETED|Primary Phase||0
6315750|NCT00427908|7220303|FG000|STARTED|Persistence Phase Year 1||222
6315751|NCT00427908|7220304|FG001|STARTED|Persistence Phase Year 1||221
6315752|NCT00427908|7220305|FG002|STARTED|Persistence Phase Year 1||71
6315753|NCT00427908|7220306|FG003|STARTED|Persistence Phase Year 1||78
6315754|NCT00427908|7220303|FG000|COMPLETED|Persistence Phase Year 1||222
6315755|NCT00427908|7220304|FG001|COMPLETED|Persistence Phase Year 1||221
6315756|NCT00427908|7220305|FG002|COMPLETED|Persistence Phase Year 1||71
6315757|NCT00427908|7220306|FG003|COMPLETED|Persistence Phase Year 1||78
6315758|NCT00427908|7220303|FG000|NOT COMPLETED|Persistence Phase Year 1||0
6315759|NCT00427908|7220304|FG001|NOT COMPLETED|Persistence Phase Year 1||0
6315760|NCT00427908|7220305|FG002|NOT COMPLETED|Persistence Phase Year 1||0
6315761|NCT00427908|7220306|FG003|NOT COMPLETED|Persistence Phase Year 1||0
6315762|NCT00427908|7220303|FG000|STARTED|Persistence Phase Year 2||208
6315763|NCT00427908|7220304|FG001|STARTED|Persistence Phase Year 2||215
6315764|NCT00427908|7220305|FG002|STARTED|Persistence Phase Year 2||53
6315765|NCT00427908|7220306|FG003|STARTED|Persistence Phase Year 2||61
6315766|NCT00427908|7220303|FG000|COMPLETED|Persistence Phase Year 2||208
6315767|NCT00427908|7220304|FG001|COMPLETED|Persistence Phase Year 2||215
6315768|NCT00427908|7220305|FG002|COMPLETED|Persistence Phase Year 2||53
6315769|NCT00427908|7220306|FG003|COMPLETED|Persistence Phase Year 2||61
6315770|NCT00427908|7220303|FG000|NOT COMPLETED|Persistence Phase Year 2||0
6315771|NCT00427908|7220304|FG001|NOT COMPLETED|Persistence Phase Year 2||0
6315772|NCT00427908|7220305|FG002|NOT COMPLETED|Persistence Phase Year 2||0
6315773|NCT00427908|7220306|FG003|NOT COMPLETED|Persistence Phase Year 2||0
6315774|NCT00427908|7220303|FG000|STARTED|Persistence Phase Year 3||185
6315775|NCT00427908|7220304|FG001|STARTED|Persistence Phase Year 3||201
6315776|NCT00427908|7220305|FG002|STARTED|Persistence Phase Year 3||38
6315777|NCT00427908|7220306|FG003|STARTED|Persistence Phase Year 3||38
6315778|NCT00427908|7220303|FG000|COMPLETED|Persistence Phase Year 3||185
6315779|NCT00427908|7220304|FG001|COMPLETED|Persistence Phase Year 3||201
6315780|NCT00427908|7220305|FG002|COMPLETED|Persistence Phase Year 3||38
6315781|NCT00427908|7220306|FG003|COMPLETED|Persistence Phase Year 3||38
6315782|NCT00427908|7220303|FG000|NOT COMPLETED|Persistence Phase Year 3||0
6315783|NCT00427908|7220304|FG001|NOT COMPLETED|Persistence Phase Year 3||0
6315784|NCT00427908|7220305|FG002|NOT COMPLETED|Persistence Phase Year 3||0
6315785|NCT00427908|7220306|FG003|NOT COMPLETED|Persistence Phase Year 3||0
6315786|NCT00427908|7220303|FG000|STARTED|Persistence Phase Year 4||165
6315787|NCT00427908|7220304|FG001|STARTED|Persistence Phase Year 4||192
6315788|NCT00427908|7220305|FG002|STARTED|Persistence Phase Year 4||34
6315789|NCT00427908|7220306|FG003|STARTED|Persistence Phase Year 4||32
6315790|NCT00427908|7220303|FG000|COMPLETED|Persistence Phase Year 4||165
6315791|NCT00427908|7220304|FG001|COMPLETED|Persistence Phase Year 4||192
6315792|NCT00427908|7220305|FG002|COMPLETED|Persistence Phase Year 4||34
6315793|NCT00427908|7220306|FG003|COMPLETED|Persistence Phase Year 4||32
6315794|NCT00427908|7220303|FG000|NOT COMPLETED|Persistence Phase Year 4||0
6315795|NCT00427908|7220304|FG001|NOT COMPLETED|Persistence Phase Year 4||0
6557738|NCT01769469|7480324|FG000|NOT COMPLETED|Overall Study||35
6557739|NCT01769508|7480330|FG000|STARTED|Overall Study||12
6557740|NCT01769508|7480330|FG000|COMPLETED|Overall Study||6
6557741|NCT01769508|7480330|FG000|NOT COMPLETED|Overall Study||6
6557742|NCT01769573|7480339|FG000|STARTED|Overall Study||10
6557743|NCT01769573|7480340|FG001|STARTED|Overall Study||6
6557744|NCT01769573|7480341|FG002|STARTED|Overall Study||10
6557745|NCT01769573|7480342|FG003|STARTED|Overall Study||0
6557746|NCT01769573|7480343|FG004|STARTED|Overall Study||10
6557747|NCT01769573|7480339|FG000|COMPLETED|Overall Study||10
6557748|NCT01769573|7480340|FG001|COMPLETED|Overall Study||6
6557749|NCT01769573|7480341|FG002|COMPLETED|Overall Study||10
6557750|NCT01769573|7480342|FG003|COMPLETED|Overall Study||0
6557751|NCT01769573|7480343|FG004|COMPLETED|Overall Study||10
6557752|NCT01769573|7480339|FG000|NOT COMPLETED|Overall Study||0
6315796|NCT00427908|7220305|FG002|NOT COMPLETED|Persistence Phase Year 4||0
6315797|NCT00427908|7220306|FG003|NOT COMPLETED|Persistence Phase Year 4||0
6315798|NCT00427908|7220303|FG000|STARTED|Persistence Phase Year 5||52
6315799|NCT00427908|7220304|FG001|STARTED|Persistence Phase Year 5||99
6315800|NCT00427908|7220305|FG002|STARTED|Persistence Phase Year 5||12
6315801|NCT00427908|7220306|FG003|STARTED|Persistence Phase Year 5||13
6315802|NCT00427908|7220303|FG000|COMPLETED|Persistence Phase Year 5||52
6315803|NCT00427908|7220304|FG001|COMPLETED|Persistence Phase Year 5||99
6315804|NCT00427908|7220305|FG002|COMPLETED|Persistence Phase Year 5||12
6315805|NCT00427908|7220306|FG003|COMPLETED|Persistence Phase Year 5||13
6315806|NCT00427908|7220303|FG000|NOT COMPLETED|Persistence Phase Year 5||0
6315807|NCT00427908|7220304|FG001|NOT COMPLETED|Persistence Phase Year 5||0
6315808|NCT00427908|7220305|FG002|NOT COMPLETED|Persistence Phase Year 5||0
6315809|NCT00427908|7220306|FG003|NOT COMPLETED|Persistence Phase Year 5||0
6315810|NCT00427921|7220341|FG000|STARTED|Overall Study||304
6315811|NCT00427921|7220341|FG000|COMPLETED|Overall Study||254
6315812|NCT00427921|7220341|FG000|NOT COMPLETED|Overall Study||50
6315813|NCT00427934|7220349|FG000|STARTED|Overall Study||8
6315814|NCT00427934|7220350|FG001|STARTED|Overall Study||8
6315815|NCT00427934|7220351|FG002|STARTED|Overall Study||78
6315816|NCT00427934|7220352|FG003|STARTED|Overall Study||34
6315817|NCT00427934|7220349|FG000|Treated|Overall Study||8
6315818|NCT00427934|7220350|FG001|Treated|Overall Study||8
6315819|NCT00427934|7220351|FG002|Treated|Overall Study||77
6315820|NCT00427934|7220352|FG003|Treated|Overall Study||33
6315821|NCT00427934|7220349|FG000|COMPLETED|Overall Study||7
6315822|NCT00427934|7220350|FG001|COMPLETED|Overall Study||8
6315823|NCT00427934|7220351|FG002|COMPLETED|Overall Study||55
6315824|NCT00427934|7220352|FG003|COMPLETED|Overall Study||19
6315825|NCT00427934|7220349|FG000|NOT COMPLETED|Overall Study||1
6315826|NCT00427934|7220350|FG001|NOT COMPLETED|Overall Study||0
6315827|NCT00427934|7220351|FG002|NOT COMPLETED|Overall Study||23
6315828|NCT00427934|7220352|FG003|NOT COMPLETED|Overall Study||15
6315829|NCT00427960|7220366|FG000|STARTED|Overall Study||30
6315830|NCT00427960|7220367|FG001|STARTED|Overall Study||25
6557753|NCT01769573|7480340|FG001|NOT COMPLETED|Overall Study||0
6315831|NCT00427960|7220366|FG000|COMPLETED|Overall Study||28
6315832|NCT00427960|7220367|FG001|COMPLETED|Overall Study||21
6315833|NCT00427960|7220366|FG000|NOT COMPLETED|Overall Study||2
6315834|NCT00427960|7220367|FG001|NOT COMPLETED|Overall Study||4
6315835|NCT00427973|7220373|FG000|STARTED|Overall Study||17
6315836|NCT00427973|7220373|FG000|COMPLETED|Overall Study||17
6315837|NCT00427973|7220373|FG000|NOT COMPLETED|Overall Study||0
6315838|NCT00427999|7220377|FG000|STARTED|Overall Study||65
6315839|NCT00427999|7220377|FG000|Intent to Treat (ITT)|Overall Study||61
6315840|NCT00427999|7220377|FG000|Extension Follow-up|Overall Study||19
6315841|NCT00427999|7220377|FG000|COMPLETED|Overall Study||33
6315842|NCT00427999|7220377|FG000|NOT COMPLETED|Overall Study||32
6315843|NCT00428077|7220382|FG000|STARTED|Overall Study||4
6315844|NCT00428077|7220382|FG000|COMPLETED|Overall Study||4
6315845|NCT00428077|7220382|FG000|NOT COMPLETED|Overall Study||0
6315846|NCT00428090|7220390|FG000|STARTED|Overall Study||165
6315847|NCT00428090|7220391|FG001|STARTED|Overall Study||166
6315848|NCT00428090|7220392|FG002|STARTED|Overall Study||165
6315849|NCT00428090|7220393|FG003|STARTED|Overall Study||83
6315850|NCT00428090|7220390|FG000|COMPLETED|Overall Study||131
6315851|NCT00428090|7220391|FG001|COMPLETED|Overall Study||135
6315852|NCT00428090|7220392|FG002|COMPLETED|Overall Study||127
6315853|NCT00428090|7220393|FG003|COMPLETED|Overall Study||55
6315854|NCT00428090|7220390|FG000|NOT COMPLETED|Overall Study||34
6315855|NCT00428090|7220391|FG001|NOT COMPLETED|Overall Study||31
6315856|NCT00428090|7220392|FG002|NOT COMPLETED|Overall Study||38
6315857|NCT00428090|7220393|FG003|NOT COMPLETED|Overall Study||28
6315858|NCT00428116|7220413|FG000|STARTED|Overall Study||21
6315859|NCT00428116|7220414|FG001|STARTED|Overall Study||21
6315860|NCT00428116|7220413|FG000|COMPLETED|Overall Study||18
6315861|NCT00428116|7220414|FG001|COMPLETED|Overall Study||21
6315862|NCT00428116|7220413|FG000|NOT COMPLETED|Overall Study||3
6557754|NCT01769573|7480341|FG002|NOT COMPLETED|Overall Study||0
6557755|NCT01769573|7480342|FG003|NOT COMPLETED|Overall Study||0
6557756|NCT01769573|7480343|FG004|NOT COMPLETED|Overall Study||0
6557757|NCT01769586|7480357|FG000|STARTED|Overall Study||100
6557758|NCT01769586|7480358|FG001|STARTED|Overall Study||100
6315863|NCT00428116|7220414|FG001|NOT COMPLETED|Overall Study||0
6315864|NCT00428220|7220421|FG000|STARTED|Overall Study||223
6315865|NCT00428220|7220421|FG000|COMPLETED|Overall Study||0
6315866|NCT00428220|7220421|FG000|NOT COMPLETED|Overall Study||223
6315867|NCT00428246|7220439|FG000|STARTED|Overall Study||8
6315868|NCT00428246|7220440|FG001|STARTED|Overall Study||8
6315869|NCT00428246|7220441|FG002|STARTED|Overall Study||8
6315870|NCT00428246|7220439|FG000|COMPLETED|Overall Study||7
6315871|NCT00428246|7220440|FG001|COMPLETED|Overall Study||8
6315872|NCT00428246|7220441|FG002|COMPLETED|Overall Study||7
6315873|NCT00428246|7220439|FG000|NOT COMPLETED|Overall Study||1
6315874|NCT00428246|7220440|FG001|NOT COMPLETED|Overall Study||0
6315875|NCT00428246|7220441|FG002|NOT COMPLETED|Overall Study||1
6315876|NCT00428298|7220451|FG000|STARTED|Overall Study||30
6315877|NCT00428298|7220452|FG001|STARTED|Overall Study||30
6315878|NCT00428298|7220451|FG000|Second RBANS at Study Exit|Overall Study||3
6315879|NCT00428298|7220452|FG001|Second RBANS at Study Exit|Overall Study||3
6315880|NCT00428298|7220451|FG000|COMPLETED|Overall Study||16
6315881|NCT00428298|7220452|FG001|COMPLETED|Overall Study||19
6315882|NCT00428298|7220451|FG000|NOT COMPLETED|Overall Study||14
6315883|NCT00428298|7220452|FG001|NOT COMPLETED|Overall Study||11
6315884|NCT00428389|7220462|FG000|STARTED|Core Phase||131
6315885|NCT00428389|7220463|FG001|STARTED|Core Phase||131
6315886|NCT00428389|7220462|FG000|Intent-to-treat Population|Core Phase||131
6315887|NCT00428389|7220463|FG001|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
6315888|NCT00428389|7220462|FG000|COMPLETED|Core Phase||120
6315889|NCT00428389|7220463|FG001|COMPLETED|Core Phase||120
6315890|NCT00428389|7220462|FG000|NOT COMPLETED|Core Phase||11
6315891|NCT00428389|7220463|FG001|NOT COMPLETED|Core Phase||11
6315892|NCT00428389|7220462|FG000|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
6315893|NCT00428389|7220463|FG001|STARTED|Extension Phase||117
6315894|NCT00428389|7220462|FG000|COMPLETED|Extension Phase||85
6315895|NCT00428389|7220463|FG001|COMPLETED|Extension Phase||91
6315896|NCT00428389|7220462|FG000|NOT COMPLETED|Extension Phase||32
6315897|NCT00428389|7220463|FG001|NOT COMPLETED|Extension Phase||26
6315898|NCT00428441|7220469|FG000|STARTED|Overall Study||75
6315899|NCT00428441|7220469|FG000|COMPLETED|Overall Study||74
6315900|NCT00428441|7220469|FG000|NOT COMPLETED|Overall Study||1
6315901|NCT00428584|7220475|FG000|STARTED|Comparative Phase||65
6315902|NCT00428584|7220476|FG001|STARTED|Comparative Phase||64
6315903|NCT00428584|7220475|FG000|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
6315904|NCT00428584|7220476|FG001|COMPLETED|Comparative Phase||63
6315905|NCT00428584|7220475|FG000|NOT COMPLETED|Comparative Phase||9
6315906|NCT00428584|7220476|FG001|NOT COMPLETED|Comparative Phase||1
6315907|NCT00428584|7220475|FG000|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
6315908|NCT00428584|7220476|FG001|STARTED|Extension Phase||63
6315909|NCT00428584|7220475|FG000|COMPLETED|Extension Phase||35
6315910|NCT00428584|7220476|FG001|COMPLETED|Extension Phase||34
6557759|NCT01769586|7480357|FG000|COMPLETED|Overall Study||100
6557760|NCT01769586|7480358|FG001|COMPLETED|Overall Study||100
6315911|NCT00428584|7220475|FG000|NOT COMPLETED|Extension Phase||21
6315912|NCT00428584|7220476|FG001|NOT COMPLETED|Extension Phase||29
6315913|NCT00428597|7220488|FG000|STARTED|Overall Study||86
6315914|NCT00428597|7220489|FG001|STARTED|Overall Study||85
6315915|NCT00428597|7220488|FG000|Received Treatment|Overall Study||83
6315916|NCT00428597|7220489|FG001|Received Treatment|Overall Study||82
6315917|NCT00428597|7220488|FG000|COMPLETED|Overall Study||0
6315918|NCT00428597|7220489|FG001|COMPLETED|Overall Study||0
6315919|NCT00428597|7220488|FG000|NOT COMPLETED|Overall Study||86
6315920|NCT00428597|7220489|FG001|NOT COMPLETED|Overall Study||85
6315921|NCT00428610|7220498|FG000|STARTED|Overall Study||53
6315922|NCT00428610|7220499|FG001|STARTED|Overall Study||18
6315923|NCT00428610|7220500|FG002|STARTED|Overall Study||32
6315924|NCT00428610|7220498|FG000|Received at Least One Dose of Study Drug|Overall Study||53
6315925|NCT00428610|7220499|FG001|Received at Least One Dose of Study Drug|Overall Study||18
6315926|NCT00428610|7220500|FG002|Received at Least One Dose of Study Drug|Overall Study||32
6315927|NCT00428610|7220498|FG000|COMPLETED|Overall Study||0
6315928|NCT00428610|7220499|FG001|COMPLETED|Overall Study||0
6315929|NCT00428610|7220500|FG002|COMPLETED|Overall Study||0
6315930|NCT00428610|7220498|FG000|NOT COMPLETED|Overall Study||53
6315931|NCT00428610|7220499|FG001|NOT COMPLETED|Overall Study||18
6315932|NCT00428610|7220500|FG002|NOT COMPLETED|Overall Study||32
6315933|NCT00428714|7220510|FG000|STARTED|Overall Study||31
6315934|NCT00428714|7220511|FG001|STARTED|Overall Study||42
6315935|NCT00428714|7220510|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
6315936|NCT00428714|7220511|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
6315937|NCT00428714|7220510|FG000|COMPLETED|Overall Study||0
6315938|NCT00428714|7220511|FG001|COMPLETED|Overall Study||0
6315939|NCT00428714|7220510|FG000|NOT COMPLETED|Overall Study||31
6315940|NCT00428714|7220511|FG001|NOT COMPLETED|Overall Study||42
6315941|NCT00428792|7220520|FG000|STARTED|Overall Study||80
6315942|NCT00428792|7220521|FG001|STARTED|Overall Study||70
6315943|NCT00428792|7220520|FG000|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
6315944|NCT00428792|7220521|FG001|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
6315945|NCT00428792|7220520|FG000|NOT COMPLETED|Overall Study||1
6315946|NCT00428792|7220521|FG001|NOT COMPLETED|Overall Study||4
6315947|NCT00428844|7220530|FG000|STARTED|Completed Study Drug Treatment||25
6315948|NCT00428844|7220531|FG001|STARTED|Completed Study Drug Treatment||24
6315949|NCT00428844|7220532|FG002|STARTED|Completed Study Drug Treatment||26
6315950|NCT00428844|7220530|FG000|Received First Dose|Completed Study Drug Treatment||25
6315951|NCT00428844|7220531|FG001|Received First Dose|Completed Study Drug Treatment||24
6315952|NCT00428844|7220532|FG002|Received First Dose|Completed Study Drug Treatment||25
6315953|NCT00428844|7220530|FG000|COMPLETED|Completed Study Drug Treatment||23
6315954|NCT00428844|7220531|FG001|COMPLETED|Completed Study Drug Treatment||18
6315955|NCT00428844|7220532|FG002|COMPLETED|Completed Study Drug Treatment||19
6315956|NCT00428844|7220530|FG000|NOT COMPLETED|Completed Study Drug Treatment||2
6315957|NCT00428844|7220531|FG001|NOT COMPLETED|Completed Study Drug Treatment||6
6315958|NCT00428844|7220532|FG002|NOT COMPLETED|Completed Study Drug Treatment||7
6315959|NCT00428844|7220530|FG000|STARTED|Completed Test of Cure (TOC) Visit||23
6315960|NCT00428844|7220531|FG001|STARTED|Completed Test of Cure (TOC) Visit||18
6315961|NCT00428844|7220532|FG002|STARTED|Completed Test of Cure (TOC) Visit||19
6315962|NCT00428844|7220530|FG000|COMPLETED|Completed Test of Cure (TOC) Visit||20
6315963|NCT00428844|7220531|FG001|COMPLETED|Completed Test of Cure (TOC) Visit||16
6315964|NCT00428844|7220532|FG002|COMPLETED|Completed Test of Cure (TOC) Visit||17
6315965|NCT00428844|7220530|FG000|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
6315966|NCT00428844|7220531|FG001|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
6315967|NCT00428844|7220532|FG002|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
6315968|NCT00428922|7220540|FG000|STARTED|Overall Study||26
6315969|NCT00428922|7220540|FG000|COMPLETED|Overall Study||26
6315970|NCT00428922|7220540|FG000|NOT COMPLETED|Overall Study||0
6315971|NCT00428948|7220546|FG000|STARTED|Overall Study||961
6315972|NCT00428948|7220547|FG001|STARTED|Overall Study||484
6315973|NCT00428948|7220546|FG000|Received Treatment|Overall Study||961
6315974|NCT00428948|7220547|FG001|Received Treatment|Overall Study||483
6315975|NCT00428948|7220546|FG000|COMPLETED|Overall Study||740
6315976|NCT00428948|7220547|FG001|COMPLETED|Overall Study||417
6315977|NCT00428948|7220546|FG000|NOT COMPLETED|Overall Study||221
6315978|NCT00428948|7220547|FG001|NOT COMPLETED|Overall Study||67
6315979|NCT00428974|7220557|FG000|STARTED|Overall Study|one patient was randomized but never received study treatment|25
6315980|NCT00428974|7220558|FG001|STARTED|Overall Study||17
6315981|NCT00428974|7220559|FG002|STARTED|Overall Study||15
6315982|NCT00428974|7220560|FG003|STARTED|Overall Study||19
6315983|NCT00428974|7220557|FG000|COMPLETED|Overall Study||17
6315984|NCT00428974|7220558|FG001|COMPLETED|Overall Study||17
6315985|NCT00428974|7220559|FG002|COMPLETED|Overall Study||14
6315986|NCT00428974|7220560|FG003|COMPLETED|Overall Study||16
6315987|NCT00428974|7220557|FG000|NOT COMPLETED|Overall Study||8
6315988|NCT00428974|7220558|FG001|NOT COMPLETED|Overall Study||0
6315989|NCT00428974|7220559|FG002|NOT COMPLETED|Overall Study||1
6315990|NCT00428974|7220560|FG003|NOT COMPLETED|Overall Study||3
6315991|NCT00429104|7220571|FG000|STARTED|Overall Study||18
6315992|NCT00429104|7220571|FG000|COMPLETED|Overall Study||17
6315993|NCT00429104|7220571|FG000|NOT COMPLETED|Overall Study||1
6315994|NCT00429143|7220575|FG000|STARTED|Overall Study||27
6315995|NCT00429143|7220575|FG000|COMPLETED|Overall Study||27
6315996|NCT00429143|7220575|FG000|NOT COMPLETED|Overall Study||0
6315997|NCT00429169|7220581|FG000|STARTED|Overall Study||38
6315998|NCT00429169|7220582|FG001|STARTED|Overall Study||40
6315999|NCT00429169|7220581|FG000|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
6316000|NCT00429169|7220582|FG001|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
6316001|NCT00429169|7220581|FG000|NOT COMPLETED|Overall Study||2
6316002|NCT00429169|7220582|FG001|NOT COMPLETED|Overall Study||2
6316003|NCT00429182|7220590|FG000|STARTED|Overall Study||32
6316004|NCT00429182|7220590|FG000|COMPLETED|Overall Study||25
6316005|NCT00429182|7220590|FG000|NOT COMPLETED|Overall Study||7
6316006|NCT00429273|7220597|FG000|STARTED|Overall Study||68
6316007|NCT00429273|7220598|FG001|STARTED|Overall Study||69
6316008|NCT00429273|7220599|FG002|STARTED|Overall Study||70
6316009|NCT00429273|7220597|FG000|COMPLETED|Overall Study||60
6316010|NCT00429273|7220598|FG001|COMPLETED|Overall Study||61
6316011|NCT00429273|7220599|FG002|COMPLETED|Overall Study||61
6316012|NCT00429273|7220597|FG000|NOT COMPLETED|Overall Study||8
6316013|NCT00429273|7220598|FG001|NOT COMPLETED|Overall Study||8
6316014|NCT00429273|7220599|FG002|NOT COMPLETED|Overall Study||9
6316015|NCT00429299|7220610|FG000|STARTED|Overall Study||36
6316016|NCT00429299|7220611|FG001|STARTED|Overall Study||39
6316017|NCT00429299|7220612|FG002|STARTED|Overall Study||46
6316018|NCT00429299|7220610|FG000|COMPLETED|Overall Study||32
6316019|NCT00429299|7220611|FG001|COMPLETED|Overall Study||32
6316020|NCT00429299|7220612|FG002|COMPLETED|Overall Study||42
6316021|NCT00429299|7220610|FG000|NOT COMPLETED|Overall Study||4
6316022|NCT00429299|7220611|FG001|NOT COMPLETED|Overall Study||7
6316023|NCT00429299|7220612|FG002|NOT COMPLETED|Overall Study||4
6316024|NCT00429364|7220622|FG000|STARTED|Overall Study||303
6316025|NCT00429364|7220623|FG001|STARTED|Overall Study||305
6316026|NCT00429364|7220622|FG000|COMPLETED|Overall Study||271
6316027|NCT00429364|7220623|FG001|COMPLETED|Overall Study||272
6316028|NCT00429364|7220622|FG000|NOT COMPLETED|Overall Study||32
6316029|NCT00429364|7220623|FG001|NOT COMPLETED|Overall Study||33
6316030|NCT00429403|7220631|FG000|STARTED|Overall Study||1
6557761|NCT01769586|7480357|FG000|NOT COMPLETED|Overall Study||0
6557762|NCT01769586|7480358|FG001|NOT COMPLETED|Overall Study||0
6557763|NCT01769612|7480364|FG000|STARTED|Overall Study||168
6557764|NCT01769612|7480364|FG000|COMPLETED|Overall Study||168
6557765|NCT01769612|7480364|FG000|NOT COMPLETED|Overall Study||0
6557766|NCT01770145|7480370|FG000|STARTED|Baseline||127
6316031|NCT00429403|7220632|FG001|STARTED|Overall Study||0
6316032|NCT00429403|7220631|FG000|COMPLETED|Overall Study||1
6316033|NCT00429403|7220632|FG001|COMPLETED|Overall Study||0
6316034|NCT00429403|7220631|FG000|NOT COMPLETED|Overall Study||0
6316035|NCT00429403|7220632|FG001|NOT COMPLETED|Overall Study||0
6316036|NCT00429416|7220638|FG000|STARTED|Overall Study||14
6316037|NCT00429416|7220638|FG000|COMPLETED|Overall Study||13
6316038|NCT00429416|7220638|FG000|NOT COMPLETED|Overall Study||1
6316039|NCT00429494|7220642|FG000|STARTED|Overall Study||59
6316040|NCT00429494|7220642|FG000|COMPLETED|Overall Study||44
6316041|NCT00429494|7220642|FG000|NOT COMPLETED|Overall Study||15
6316042|NCT00429507|7220646|FG000|STARTED|Overall Study||12
6316043|NCT00429507|7220646|FG000|COMPLETED|Overall Study||12
6316044|NCT00429507|7220646|FG000|NOT COMPLETED|Overall Study||0
6316045|NCT00429572|7220650|FG000|STARTED|Overall Study||19
6316046|NCT00429572|7220650|FG000|COMPLETED|Overall Study||18
6316047|NCT00429572|7220650|FG000|NOT COMPLETED|Overall Study||1
6316048|NCT00429585|7220656|FG000|STARTED|Overall Study||52
6316049|NCT00429585|7220657|FG001|STARTED|Overall Study||47
6316050|NCT00429585|7220656|FG000|COMPLETED|Overall Study||22
6316051|NCT00429585|7220657|FG001|COMPLETED|Overall Study||27
6316052|NCT00429585|7220656|FG000|NOT COMPLETED|Overall Study||30
6316053|NCT00429585|7220657|FG001|NOT COMPLETED|Overall Study||20
6316054|NCT00429663|7220665|FG000|STARTED|Overall Study||76
6316055|NCT00429663|7220666|FG001|STARTED|Overall Study||80
6316056|NCT00429663|7220665|FG000|COMPLETED|Overall Study||40
6316057|NCT00429663|7220666|FG001|COMPLETED|Overall Study||41
6316058|NCT00429663|7220665|FG000|NOT COMPLETED|Overall Study||36
6316059|NCT00429663|7220666|FG001|NOT COMPLETED|Overall Study||39
6316060|NCT00429702|7220674|FG000|STARTED|Overall Study||3
6316061|NCT00429702|7220675|FG001|STARTED|Overall Study||4
6316062|NCT00429702|7220674|FG000|COMPLETED|Overall Study||3
6316063|NCT00429702|7220675|FG001|COMPLETED|Overall Study||4
6316064|NCT00429702|7220674|FG000|NOT COMPLETED|Overall Study||0
6316065|NCT00429702|7220675|FG001|NOT COMPLETED|Overall Study||0
6316066|NCT00429793|7220681|FG000|STARTED|Overall Study||60
6316067|NCT00429793|7220681|FG000|COMPLETED|Overall Study||54
6316068|NCT00429793|7220681|FG000|NOT COMPLETED|Overall Study||6
6316069|NCT00429949|7220690|FG000|STARTED|Overall Study||21
6316070|NCT00429949|7220690|FG000|COMPLETED|Overall Study||21
6316071|NCT00429949|7220690|FG000|NOT COMPLETED|Overall Study||0
6316072|NCT00430183|7220698|FG000|STARTED|Overall Study||391
6316073|NCT00430183|7220699|FG001|STARTED|Overall Study||397
6316074|NCT00430183|7220698|FG000|COMPLETED|Overall Study||391
6316075|NCT00430183|7220699|FG001|COMPLETED|Overall Study||397
6316076|NCT00430183|7220698|FG000|NOT COMPLETED|Overall Study||0
6316077|NCT00430183|7220699|FG001|NOT COMPLETED|Overall Study||0
6316078|NCT00430248|7220708|FG000|STARTED|Overall Study||757
6316079|NCT00430248|7220709|FG001|STARTED|Overall Study||756
6316080|NCT00430248|7220710|FG002|STARTED|Overall Study||756
6316081|NCT00430248|7220708|FG000|COMPLETED|Overall Study||632
6316082|NCT00430248|7220709|FG001|COMPLETED|Overall Study||598
6316083|NCT00430248|7220710|FG002|COMPLETED|Overall Study||621
6316084|NCT00430248|7220708|FG000|NOT COMPLETED|Overall Study||125
6316085|NCT00430248|7220709|FG001|NOT COMPLETED|Overall Study||158
6316086|NCT00430248|7220710|FG002|NOT COMPLETED|Overall Study||135
6316087|NCT00430300|7220722|FG000|STARTED|Overall Study||17
6316088|NCT00430300|7220723|FG001|STARTED|Overall Study||18
6316089|NCT00430300|7220724|FG002|STARTED|Overall Study||35
6316090|NCT00430300|7220725|FG003|STARTED|Overall Study||17
6316091|NCT00430300|7220722|FG000|COMPLETED|Overall Study||15
6316092|NCT00430300|7220723|FG001|COMPLETED|Overall Study||16
6316093|NCT00430300|7220724|FG002|COMPLETED|Overall Study||29
6316094|NCT00430300|7220725|FG003|COMPLETED|Overall Study||15
6316095|NCT00430300|7220722|FG000|NOT COMPLETED|Overall Study||2
6316096|NCT00430300|7220723|FG001|NOT COMPLETED|Overall Study||2
6316097|NCT00430300|7220724|FG002|NOT COMPLETED|Overall Study||6
6316098|NCT00430300|7220725|FG003|NOT COMPLETED|Overall Study||2
6316099|NCT00430352|7220735|FG000|STARTED|Overall Study||545
6316100|NCT00430352|7220735|FG000|COMPLETED|Overall Study||407
6316101|NCT00430352|7220735|FG000|NOT COMPLETED|Overall Study||138
6316102|NCT00430482|7220741|FG000|STARTED|Completed Treatment||41
6316103|NCT00430482|7220742|FG001|STARTED|Completed Treatment||37
6316104|NCT00430482|7220741|FG000|Completed ASI at Midpoint|Completed Treatment||35
6316105|NCT00430482|7220742|FG001|Completed ASI at Midpoint|Completed Treatment||29
6316106|NCT00430482|7220741|FG000|COMPLETED|Completed Treatment||34
6316107|NCT00430482|7220742|FG001|COMPLETED|Completed Treatment||26
6316108|NCT00430482|7220741|FG000|NOT COMPLETED|Completed Treatment||7
6316109|NCT00430482|7220742|FG001|NOT COMPLETED|Completed Treatment||11
6316110|NCT00430482|7220741|FG000|STARTED|Completed 2 Follow-Up Visits||34
6316111|NCT00430482|7220742|FG001|STARTED|Completed 2 Follow-Up Visits||26
6316112|NCT00430482|7220741|FG000|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||27
6316113|NCT00430482|7220742|FG001|Completed ASI at Follow-Up #1|Completed 2 Follow-Up Visits||20
6316114|NCT00430482|7220741|FG000|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||29
6316115|NCT00430482|7220742|FG001|Completed ASI at Follow-Up #2|Completed 2 Follow-Up Visits||20
6316116|NCT00430482|7220741|FG000|COMPLETED|Completed 2 Follow-Up Visits||29
6316117|NCT00430482|7220742|FG001|COMPLETED|Completed 2 Follow-Up Visits||20
6316118|NCT00430482|7220741|FG000|NOT COMPLETED|Completed 2 Follow-Up Visits||5
6316119|NCT00430482|7220742|FG001|NOT COMPLETED|Completed 2 Follow-Up Visits||6
6316120|NCT00430495|7220752|FG000|STARTED|Overall Study||64
6316121|NCT00430495|7220753|FG001|STARTED|Overall Study||66
6316122|NCT00430495|7220754|FG002|STARTED|Overall Study||62
6316123|NCT00430495|7220755|FG003|STARTED|Overall Study||64
6316124|NCT00430495|7220752|FG000|Treated|Overall Study||62
6316125|NCT00430495|7220753|FG001|Treated|Overall Study||66
6316126|NCT00430495|7220754|FG002|Treated|Overall Study||62
6316127|NCT00430495|7220755|FG003|Treated|Overall Study||64
6316128|NCT00430495|7220752|FG000|COMPLETED|Overall Study||50
6316129|NCT00430495|7220753|FG001|COMPLETED|Overall Study||59
6316130|NCT00430495|7220754|FG002|COMPLETED|Overall Study||49
6316131|NCT00430495|7220755|FG003|COMPLETED|Overall Study||60
6316132|NCT00430495|7220752|FG000|NOT COMPLETED|Overall Study||14
6316133|NCT00430495|7220753|FG001|NOT COMPLETED|Overall Study||7
6316134|NCT00430495|7220754|FG002|NOT COMPLETED|Overall Study||13
6316135|NCT00430495|7220755|FG003|NOT COMPLETED|Overall Study||4
6316136|NCT00430521|7220773|FG000|STARTED|Overall Study||63
6316137|NCT00430521|7220774|FG001|STARTED|Overall Study||66
6316138|NCT00430521|7220775|FG002|STARTED|Overall Study||64
6316139|NCT00430521|7220776|FG003|STARTED|Overall Study||63
6316140|NCT00430521|7220777|FG004|STARTED|Overall Study||64
6316141|NCT00430521|7220778|FG005|STARTED|Overall Study||64
6316142|NCT00430521|7220779|FG006|STARTED|Overall Study||65
6316143|NCT00430521|7220780|FG007|STARTED|Overall Study||63
6316144|NCT00430521|7220773|FG000|COMPLETED|Overall Study||52
6316145|NCT00430521|7220774|FG001|COMPLETED|Overall Study||57
6316146|NCT00430521|7220775|FG002|COMPLETED|Overall Study||61
6316147|NCT00430521|7220776|FG003|COMPLETED|Overall Study||55
6316148|NCT00430521|7220777|FG004|COMPLETED|Overall Study||59
6316149|NCT00430521|7220778|FG005|COMPLETED|Overall Study||59
6316150|NCT00430521|7220779|FG006|COMPLETED|Overall Study||55
6316151|NCT00430521|7220780|FG007|COMPLETED|Overall Study||51
6316152|NCT00430521|7220773|FG000|NOT COMPLETED|Overall Study||11
6316153|NCT00430521|7220774|FG001|NOT COMPLETED|Overall Study||9
6316154|NCT00430521|7220775|FG002|NOT COMPLETED|Overall Study||3
6316155|NCT00430521|7220776|FG003|NOT COMPLETED|Overall Study||8
6316156|NCT00430521|7220777|FG004|NOT COMPLETED|Overall Study||5
6316157|NCT00430521|7220778|FG005|NOT COMPLETED|Overall Study||5
6316158|NCT00430521|7220779|FG006|NOT COMPLETED|Overall Study||10
6316159|NCT00430521|7220780|FG007|NOT COMPLETED|Overall Study||12
6316160|NCT00430573|7220811|FG000|STARTED|Overall Study||10
6316161|NCT00430573|7220811|FG000|COMPLETED|Overall Study|Only 5 took study drug on at least one occasion and 8 completed the baseline ASI.|5
6316162|NCT00430573|7220811|FG000|NOT COMPLETED|Overall Study||5
6316163|NCT00430625|7220818|FG000|STARTED|Overall Study||13
6316164|NCT00430625|7220819|FG001|STARTED|Overall Study||12
6316165|NCT00430625|7220818|FG000|COMPLETED|Overall Study||13
6316166|NCT00430625|7220819|FG001|COMPLETED|Overall Study||12
6316167|NCT00430625|7220818|FG000|NOT COMPLETED|Overall Study||0
6316168|NCT00430625|7220819|FG001|NOT COMPLETED|Overall Study||0
6316169|NCT00430638|7220828|FG000|STARTED|Overall Study||138
6316170|NCT00430638|7220829|FG001|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
6316171|NCT00430638|7220828|FG000|COMPLETED|Overall Study||60
6316172|NCT00430638|7220829|FG001|COMPLETED|Overall Study||92
6316173|NCT00430638|7220828|FG000|NOT COMPLETED|Overall Study||78
6316174|NCT00430638|7220829|FG001|NOT COMPLETED|Overall Study||48
6316175|NCT00430677|7220842|FG000|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
6316176|NCT00430677|7220843|FG001|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
6316177|NCT00430677|7220844|FG002|STARTED|Short-term Period||100
6316178|NCT00430677|7220842|FG000|COMPLETED|Short-term Period|Completed the short-term period|76
6316179|NCT00430677|7220843|FG001|COMPLETED|Short-term Period|Completed the short-term period|74
6316180|NCT00430677|7220844|FG002|COMPLETED|Short-term Period|Completed the short-term period|78
6316181|NCT00430677|7220842|FG000|NOT COMPLETED|Short-term Period||23
6316182|NCT00430677|7220843|FG001|NOT COMPLETED|Short-term Period||25
6316183|NCT00430677|7220844|FG002|NOT COMPLETED|Short-term Period||22
6316184|NCT00430677|7220842|FG000|STARTED|Long-term Extension Period||70
6316185|NCT00430677|7220843|FG001|STARTED|Long-term Extension Period||67
6316186|NCT00430677|7220844|FG002|STARTED|Long-term Extension Period||74
6316187|NCT00430677|7220842|FG000|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
6316188|NCT00430677|7220843|FG001|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
6316189|NCT00430677|7220844|FG002|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
6316190|NCT00430677|7220842|FG000|NOT COMPLETED|Long-term Extension Period||60
6316191|NCT00430677|7220843|FG001|NOT COMPLETED|Long-term Extension Period||58
6316192|NCT00430677|7220844|FG002|NOT COMPLETED|Long-term Extension Period||63
6316193|NCT00430716|7220873|FG000|STARTED|Double Blind Phase||42
6316194|NCT00430716|7220874|FG001|STARTED|Double Blind Phase||43
6316195|NCT00430716|7220875|FG002|STARTED|Double Blind Phase||45
6316196|NCT00430716|7220873|FG000|Treated|Double Blind Phase||41
6316197|NCT00430716|7220874|FG001|Treated|Double Blind Phase||43
6316198|NCT00430716|7220875|FG002|Treated|Double Blind Phase||45
6316199|NCT00430716|7220873|FG000|COMPLETED|Double Blind Phase||36
6316200|NCT00430716|7220874|FG001|COMPLETED|Double Blind Phase||38
6316201|NCT00430716|7220875|FG002|COMPLETED|Double Blind Phase||39
6316202|NCT00430716|7220873|FG000|NOT COMPLETED|Double Blind Phase||6
6316203|NCT00430716|7220874|FG001|NOT COMPLETED|Double Blind Phase||5
6316204|NCT00430716|7220875|FG002|NOT COMPLETED|Double Blind Phase||6
6316205|NCT00430716|7220873|FG000|STARTED|Open Label Phase||36
6316206|NCT00430716|7220874|FG001|STARTED|Open Label Phase||38
6316207|NCT00430716|7220875|FG002|STARTED|Open Label Phase||39
6316208|NCT00430716|7220873|FG000|COMPLETED|Open Label Phase||27
6316209|NCT00430716|7220874|FG001|COMPLETED|Open Label Phase||31
6316210|NCT00430716|7220875|FG002|COMPLETED|Open Label Phase||32
6316211|NCT00430716|7220873|FG000|NOT COMPLETED|Open Label Phase||9
6316212|NCT00430716|7220874|FG001|NOT COMPLETED|Open Label Phase||7
6316213|NCT00430716|7220875|FG002|NOT COMPLETED|Open Label Phase||7
6316214|NCT00430755|7220883|FG000|STARTED|Overall Study||98
6316215|NCT00430755|7220883|FG000|COMPLETED|Overall Study||45
6316216|NCT00430755|7220883|FG000|NOT COMPLETED|Overall Study||53
6316217|NCT00430768|7220890|FG000|STARTED|Overall Study||3
6316218|NCT00430768|7220891|FG001|STARTED|Overall Study||3
6316219|NCT00430768|7220892|FG002|STARTED|Overall Study||3
6316220|NCT00430768|7220890|FG000|COMPLETED|Overall Study||3
6557767|NCT01770145|7480370|FG000|COMPLETED|Baseline||101
6557768|NCT01770145|7480370|FG000|NOT COMPLETED|Baseline||26
6316221|NCT00430768|7220891|FG001|COMPLETED|Overall Study||3
6316222|NCT00430768|7220892|FG002|COMPLETED|Overall Study||3
6316223|NCT00430768|7220890|FG000|NOT COMPLETED|Overall Study||0
6316224|NCT00430768|7220891|FG001|NOT COMPLETED|Overall Study||0
6316225|NCT00430768|7220892|FG002|NOT COMPLETED|Overall Study||0
6316226|NCT00430781|7220909|FG000|STARTED|Interim Analysis; 11 February 2008||59
6316227|NCT00430781|7220910|FG001|STARTED|Interim Analysis; 11 February 2008||58
6316228|NCT00430781|7220911|FG002|STARTED|Interim Analysis; 11 February 2008||60
6316229|NCT00430781|7220909|FG000|Ongoing|Interim Analysis; 11 February 2008||23
6316230|NCT00430781|7220910|FG001|Ongoing|Interim Analysis; 11 February 2008||20
6316231|NCT00430781|7220911|FG002|Ongoing|Interim Analysis; 11 February 2008||25
6316232|NCT00430781|7220909|FG000|COMPLETED|Interim Analysis; 11 February 2008||0
6316233|NCT00430781|7220910|FG001|COMPLETED|Interim Analysis; 11 February 2008||0
6316234|NCT00430781|7220911|FG002|COMPLETED|Interim Analysis; 11 February 2008||0
6316235|NCT00430781|7220909|FG000|NOT COMPLETED|Interim Analysis; 11 February 2008||59
6316236|NCT00430781|7220910|FG001|NOT COMPLETED|Interim Analysis; 11 February 2008||58
6316237|NCT00430781|7220911|FG002|NOT COMPLETED|Interim Analysis; 11 February 2008||60
6316238|NCT00430781|7220909|FG000|STARTED|Final Analysis; 31 July 2008||0
6316239|NCT00430781|7220910|FG001|STARTED|Final Analysis; 31 July 2008||78
6316240|NCT00430781|7220911|FG002|STARTED|Final Analysis; 31 July 2008||74
6316241|NCT00430781|7220909|FG000|Ongoing|Final Analysis; 31 July 2008||0
6316242|NCT00430781|7220910|FG001|Ongoing|Final Analysis; 31 July 2008||29
6316243|NCT00430781|7220911|FG002|Ongoing|Final Analysis; 31 July 2008||32
6316244|NCT00430781|7220909|FG000|COMPLETED|Final Analysis; 31 July 2008||0
6316245|NCT00430781|7220910|FG001|COMPLETED|Final Analysis; 31 July 2008||39
6557769|NCT01770145|7480370|FG000|STARTED|Treatment||101
6316246|NCT00430781|7220911|FG002|COMPLETED|Final Analysis; 31 July 2008||26
6316247|NCT00430781|7220909|FG000|NOT COMPLETED|Final Analysis; 31 July 2008||0
6557770|NCT01770145|7480370|FG000|COMPLETED|Treatment||97
6557771|NCT01770145|7480370|FG000|NOT COMPLETED|Treatment||4
6316248|NCT00430781|7220910|FG001|NOT COMPLETED|Final Analysis; 31 July 2008||39
6316249|NCT00430781|7220911|FG002|NOT COMPLETED|Final Analysis; 31 July 2008||48
6316250|NCT00430781|7220909|FG000|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
6316251|NCT00430781|7220910|FG001|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
6316252|NCT00430781|7220911|FG002|STARTED|End-of-Study Analysis; 28 July 2011||74
6316253|NCT00430781|7220909|FG000|COMPLETED|End-of-Study Analysis; 28 July 2011||53
6316254|NCT00430781|7220910|FG001|COMPLETED|End-of-Study Analysis; 28 July 2011||59
6316255|NCT00430781|7220911|FG002|COMPLETED|End-of-Study Analysis; 28 July 2011||54
6316256|NCT00430781|7220909|FG000|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
6316257|NCT00430781|7220910|FG001|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
6316258|NCT00430781|7220911|FG002|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
6316259|NCT00430937|7220924|FG000|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
6316260|NCT00430937|7220925|FG001|STARTED|Overall Study||92
6316261|NCT00430937|7220924|FG000|COMPLETED|Overall Study||70
6316262|NCT00430937|7220925|FG001|COMPLETED|Overall Study||64
6316263|NCT00430937|7220924|FG000|NOT COMPLETED|Overall Study||27
6316264|NCT00430937|7220925|FG001|NOT COMPLETED|Overall Study||28
6316265|NCT00430989|7220933|FG000|STARTED|Overall Study||3543
6316266|NCT00430989|7220934|FG001|STARTED|Overall Study||3569
6316267|NCT00430989|7220933|FG000|COMPLETED|Overall Study||3483
6316268|NCT00430989|7220934|FG001|COMPLETED|Overall Study||3509
6316269|NCT00430989|7220933|FG000|NOT COMPLETED|Overall Study||60
6316270|NCT00430989|7220934|FG001|NOT COMPLETED|Overall Study||60
6316271|NCT00431041|7220944|FG000|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
6316272|NCT00431041|7220945|FG001|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
6316273|NCT00431041|7220944|FG000|COMPLETED|Overall Study||52
6316274|NCT00431041|7220945|FG001|COMPLETED|Overall Study||40
6316275|NCT00431041|7220944|FG000|NOT COMPLETED|Overall Study||16
6316276|NCT00431041|7220945|FG001|NOT COMPLETED|Overall Study||24
6316277|NCT00431067|7220951|FG000|STARTED|Overall Study|52 patients screened, 41 treated|41
6316278|NCT00431067|7220951|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
6316279|NCT00431067|7220951|FG000|NOT COMPLETED|Overall Study||41
6316280|NCT00431132|7220955|FG000|STARTED|Overall Study||336
6316281|NCT00431132|7220955|FG000|COMPLETED|Overall Study||292
6316282|NCT00431132|7220955|FG000|NOT COMPLETED|Overall Study||44
6316283|NCT00431184|7220961|FG000|STARTED|1st Intervention (Day 1)||10
6316284|NCT00431184|7220962|FG001|STARTED|1st Intervention (Day 1)||9
6316285|NCT00431184|7220961|FG000|COMPLETED|1st Intervention (Day 1)||10
6316286|NCT00431184|7220962|FG001|COMPLETED|1st Intervention (Day 1)||9
6316287|NCT00431184|7220961|FG000|NOT COMPLETED|1st Intervention (Day 1)||0
6316288|NCT00431184|7220962|FG001|NOT COMPLETED|1st Intervention (Day 1)||0
6316289|NCT00431184|7220961|FG000|STARTED|Second Intervention (Day 2)||10
6316290|NCT00431184|7220962|FG001|STARTED|Second Intervention (Day 2)||9
6316291|NCT00431184|7220961|FG000|COMPLETED|Second Intervention (Day 2)||10
6316292|NCT00431184|7220962|FG001|COMPLETED|Second Intervention (Day 2)||9
6316293|NCT00431184|7220961|FG000|NOT COMPLETED|Second Intervention (Day 2)||0
6316294|NCT00431184|7220962|FG001|NOT COMPLETED|Second Intervention (Day 2)||0
6375271|NCT00754494|7285874|FG000|NOT COMPLETED|Overall Study||2
6375272|NCT00754494|7285875|FG001|NOT COMPLETED|Overall Study||0
6375273|NCT00754494|7285876|FG002|NOT COMPLETED|Overall Study||1
6375274|NCT00754546|7285884|FG000|STARTED|Overall Study||20
6375275|NCT00754546|7285884|FG000|COMPLETED|Overall Study||20
6375276|NCT00754546|7285884|FG000|NOT COMPLETED|Overall Study||0
6375277|NCT00754559|7285894|FG000|STARTED|Overall Study||286
6375278|NCT00754559|7285894|FG000|COMPLETED|Overall Study||239
6375279|NCT00754559|7285894|FG000|NOT COMPLETED|Overall Study||47
6375280|NCT00754572|7285901|FG000|STARTED|Overall Study||418
6375281|NCT00754572|7285901|FG000|COMPLETED|Overall Study||347
6375282|NCT00754572|7285901|FG000|NOT COMPLETED|Overall Study||71
6375283|NCT00754624|7285905|FG000|STARTED|Overall Study||229
6375284|NCT00754624|7285905|FG000|COMPLETED|Overall Study||160
6375285|NCT00754624|7285905|FG000|NOT COMPLETED|Overall Study||69
6375286|NCT00754650|7285909|FG000|STARTED|Overall Study||2
6375287|NCT00754650|7285909|FG000|COMPLETED|Overall Study||0
6375288|NCT00754650|7285909|FG000|NOT COMPLETED|Overall Study||2
6375289|NCT00754741|7285916|FG000|STARTED|Overall Study||567
6375290|NCT00754741|7285917|FG001|STARTED|Overall Study||569
6375291|NCT00754741|7285918|FG002|STARTED|Overall Study||556
6375292|NCT00754741|7285916|FG000|COMPLETED|Overall Study||510
6375293|NCT00754741|7285917|FG001|COMPLETED|Overall Study||500
6375294|NCT00754741|7285918|FG002|COMPLETED|Overall Study||502
6375295|NCT00754741|7285916|FG000|NOT COMPLETED|Overall Study||57
6375296|NCT00754741|7285917|FG001|NOT COMPLETED|Overall Study||69
6375297|NCT00754741|7285918|FG002|NOT COMPLETED|Overall Study||54
6375298|NCT00754832|7285926|FG000|STARTED|First 6 Weeks Intervention||26
6375299|NCT00754832|7285927|FG001|STARTED|First 6 Weeks Intervention||30
6375300|NCT00754832|7285926|FG000|COMPLETED|First 6 Weeks Intervention||18
6375301|NCT00754832|7285927|FG001|COMPLETED|First 6 Weeks Intervention||28
6375302|NCT00754832|7285926|FG000|NOT COMPLETED|First 6 Weeks Intervention||8
6375303|NCT00754832|7285927|FG001|NOT COMPLETED|First 6 Weeks Intervention||2
6375304|NCT00754832|7285926|FG000|STARTED|2 Weeks Washout||18
6375305|NCT00754832|7285927|FG001|STARTED|2 Weeks Washout||28
6316295|NCT00431444|7220972|FG000|STARTED|Overall Study||56
6316296|NCT00431444|7220973|FG001|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
6316297|NCT00431444|7220972|FG000|COMPLETED|Overall Study||51
6316298|NCT00431444|7220973|FG001|COMPLETED|Overall Study||46
6316299|NCT00431444|7220972|FG000|NOT COMPLETED|Overall Study||5
6316300|NCT00431444|7220973|FG001|NOT COMPLETED|Overall Study||7
6316301|NCT00431496|7220979|FG000|STARTED|Overall Study||71
6316302|NCT00431496|7220979|FG000|COMPLETED|Overall Study||60
6316303|NCT00431496|7220979|FG000|NOT COMPLETED|Overall Study||11
6316304|NCT00431626|7220985|FG000|STARTED|Overall Study||4
6316305|NCT00431626|7220986|FG001|STARTED|Overall Study||0
6316306|NCT00431626|7220985|FG000|COMPLETED|Overall Study||4
6316307|NCT00431626|7220986|FG001|COMPLETED|Overall Study||0
6316308|NCT00431626|7220985|FG000|NOT COMPLETED|Overall Study||0
6316309|NCT00431626|7220986|FG001|NOT COMPLETED|Overall Study||0
6316310|NCT00431834|7220992|FG000|STARTED|Overall Study||75
6316311|NCT00431834|7220992|FG000|COMPLETED|Overall Study||62
6316312|NCT00431834|7220992|FG000|NOT COMPLETED|Overall Study||13
6316313|NCT00431847|7221003|FG000|STARTED|Overall Study||132
6316314|NCT00431847|7221004|FG001|STARTED|Overall Study||45
6316315|NCT00431847|7221005|FG002|STARTED|Overall Study||24
6316316|NCT00431847|7221006|FG003|STARTED|Overall Study||184
6316317|NCT00431847|7221007|FG004|STARTED|Overall Study||1
6316318|NCT00431847|7221003|FG000|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
6316319|NCT00431847|7221004|FG001|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
6316320|NCT00431847|7221005|FG002|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
6316321|NCT00431847|7221006|FG003|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
6316322|NCT00431847|7221007|FG004|COMPLETED|Overall Study||0
6316323|NCT00431847|7221003|FG000|NOT COMPLETED|Overall Study||6
6316324|NCT00431847|7221004|FG001|NOT COMPLETED|Overall Study||3
6316325|NCT00431847|7221005|FG002|NOT COMPLETED|Overall Study||4
6316326|NCT00431847|7221006|FG003|NOT COMPLETED|Overall Study||14
6316327|NCT00431847|7221007|FG004|NOT COMPLETED|Overall Study||1
6316328|NCT00431951|7221021|FG000|STARTED|Overall Study||8
6316329|NCT00431951|7221022|FG001|STARTED|Overall Study||8
6316330|NCT00431951|7221023|FG002|STARTED|Overall Study||8
6316331|NCT00431951|7221024|FG003|STARTED|Overall Study||6
6316332|NCT00431951|7221021|FG000|COMPLETED|Overall Study||7
6316333|NCT00431951|7221022|FG001|COMPLETED|Overall Study||6
6316334|NCT00431951|7221023|FG002|COMPLETED|Overall Study||6
6316335|NCT00431951|7221024|FG003|COMPLETED|Overall Study||4
6316336|NCT00431951|7221021|FG000|NOT COMPLETED|Overall Study||1
6316337|NCT00431951|7221022|FG001|NOT COMPLETED|Overall Study||2
6316338|NCT00431951|7221023|FG002|NOT COMPLETED|Overall Study||2
6316339|NCT00431951|7221024|FG003|NOT COMPLETED|Overall Study||2
6316340|NCT00431964|7221040|FG000|STARTED|Overall Study||131
6316341|NCT00431964|7221041|FG001|STARTED|Overall Study||132
6316342|NCT00431964|7221040|FG000|Randomized/Received Drug|Overall Study||131
6316343|NCT00431964|7221041|FG001|Randomized/Received Drug|Overall Study||129
6316344|NCT00431964|7221040|FG000|Did Not Receive Drug|Overall Study||0
6316345|NCT00431964|7221041|FG001|Did Not Receive Drug|Overall Study||3
6316346|NCT00431964|7221040|FG000|Withdrew From Study|Overall Study||6
6316347|NCT00431964|7221041|FG001|Withdrew From Study|Overall Study||5
6316348|NCT00431964|7221040|FG000|COMPLETED|Overall Study||125
6316349|NCT00431964|7221041|FG001|COMPLETED|Overall Study||124
6316350|NCT00431964|7221040|FG000|NOT COMPLETED|Overall Study||6
6316351|NCT00431964|7221041|FG001|NOT COMPLETED|Overall Study||8
6316352|NCT00432042|7221050|FG000|STARTED|Overall Study|Number randomized.|479
6316353|NCT00432042|7221051|FG001|STARTED|Overall Study|Number randomized.|235
6316354|NCT00432042|7221052|FG002|STARTED|Overall Study|Number randomized.|241
6316355|NCT00432042|7221050|FG000|Vaccinated|Overall Study||477
6557772|NCT01770314|7480376|FG000|STARTED|Overall Study||86
6557773|NCT01770314|7480377|FG001|STARTED|Overall Study||90
6557774|NCT01770314|7480376|FG000|Contributed Data to Baseline|Overall Study||68
6316356|NCT00432042|7221051|FG001|Vaccinated|Overall Study||235
6316357|NCT00432042|7221052|FG002|Vaccinated|Overall Study||240
6316358|NCT00432042|7221050|FG000|COMPLETED|Overall Study||472
6316359|NCT00432042|7221051|FG001|COMPLETED|Overall Study||234
6316360|NCT00432042|7221052|FG002|COMPLETED|Overall Study||239
6316361|NCT00432042|7221050|FG000|NOT COMPLETED|Overall Study||7
6316362|NCT00432042|7221051|FG001|NOT COMPLETED|Overall Study||1
6316363|NCT00432042|7221052|FG002|NOT COMPLETED|Overall Study||2
6316364|NCT00432159|7221065|FG000|STARTED|Overall Study||185
6316365|NCT00432159|7221066|FG001|STARTED|Overall Study||167
6316366|NCT00432159|7221067|FG002|STARTED|Overall Study||39
6557775|NCT01770314|7480377|FG001|Contributed Data to Baseline|Overall Study||72
6557776|NCT01770314|7480376|FG000|Contributed Data to Post-test|Overall Study||65
6557777|NCT01770314|7480377|FG001|Contributed Data to Post-test|Overall Study||67
6557778|NCT01770314|7480376|FG000|Contributed Data to One-month Follow-up|Overall Study||61
6557779|NCT01770314|7480377|FG001|Contributed Data to One-month Follow-up|Overall Study||66
6557780|NCT01770314|7480376|FG000|COMPLETED|Overall Study||86
6557781|NCT01770314|7480377|FG001|COMPLETED|Overall Study||90
6557782|NCT01770314|7480376|FG000|NOT COMPLETED|Overall Study||0
6316367|NCT00432159|7221068|FG003|STARTED|Overall Study||20
6316368|NCT00432159|7221069|FG004|STARTED|Overall Study||89
6316369|NCT00432159|7221065|FG000|COMPLETED|Overall Study|Actual (Complete efficacy)|163
6557783|NCT01770314|7480377|FG001|NOT COMPLETED|Overall Study||0
6557784|NCT01770353|7480385|FG000|STARTED|Overall Study||15
6557785|NCT01770353|7480386|FG001|STARTED|Overall Study||30
6557786|NCT01770353|7480385|FG000|Received FMX|Overall Study|2 subjects excluded from MM-398 safety population.|15
6557787|NCT01770353|7480386|FG001|Received FMX|Overall Study|1 subject excluded from MM-398 safety population.|30
6557788|NCT01770353|7480385|FG000|Received FMX and MM-398|Overall Study||13
6557789|NCT01770353|7480386|FG001|Received FMX and MM-398|Overall Study||29
6557790|NCT01770353|7480385|FG000|COMPLETED|Overall Study||9
6557791|NCT01770353|7480386|FG001|COMPLETED|Overall Study||18
6557792|NCT01770353|7480385|FG000|NOT COMPLETED|Overall Study||6
6557793|NCT01770353|7480386|FG001|NOT COMPLETED|Overall Study||12
6557794|NCT01770366|7480402|FG000|STARTED|Overall Study||4
6557795|NCT01770366|7480403|FG001|STARTED|Overall Study||6
6557796|NCT01770366|7480402|FG000|COMPLETED|Overall Study||2
6557797|NCT01770366|7480403|FG001|COMPLETED|Overall Study||4
6557798|NCT01770366|7480402|FG000|NOT COMPLETED|Overall Study||2
6557799|NCT01770366|7480403|FG001|NOT COMPLETED|Overall Study||2
6316370|NCT00432159|7221066|FG001|COMPLETED|Overall Study|Actual (Complete efficacy)|137
6316371|NCT00432159|7221067|FG002|COMPLETED|Overall Study|Actual (Complete efficacy)|35
6316372|NCT00432159|7221068|FG003|COMPLETED|Overall Study|Actual (Complete efficacy)|15
6316373|NCT00432159|7221069|FG004|COMPLETED|Overall Study|Actual (Complete efficacy)|79
6316374|NCT00432159|7221065|FG000|NOT COMPLETED|Overall Study||22
6316375|NCT00432159|7221066|FG001|NOT COMPLETED|Overall Study||30
6316376|NCT00432159|7221067|FG002|NOT COMPLETED|Overall Study||4
6316377|NCT00432159|7221068|FG003|NOT COMPLETED|Overall Study||5
6316378|NCT00432159|7221069|FG004|NOT COMPLETED|Overall Study||10
6316379|NCT00432172|7221085|FG000|STARTED|Overall Study||47
6316380|NCT00432172|7221086|FG001|STARTED|Overall Study||48
6316381|NCT00432172|7221087|FG002|STARTED|Overall Study||46
6316382|NCT00432172|7221088|FG003|STARTED|Overall Study||48
6316383|NCT00432172|7221085|FG000|COMPLETED|Overall Study||41
6316384|NCT00432172|7221086|FG001|COMPLETED|Overall Study||41
6316385|NCT00432172|7221087|FG002|COMPLETED|Overall Study||35
6316386|NCT00432172|7221088|FG003|COMPLETED|Overall Study||41
6316387|NCT00432172|7221085|FG000|NOT COMPLETED|Overall Study||6
6316388|NCT00432172|7221086|FG001|NOT COMPLETED|Overall Study||7
6316389|NCT00432172|7221087|FG002|NOT COMPLETED|Overall Study||11
6316390|NCT00432172|7221088|FG003|NOT COMPLETED|Overall Study||7
6316391|NCT00432237|7221104|FG000|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
6316392|NCT00432237|7221105|FG001|STARTED|Overall Study||485
6316393|NCT00432237|7221106|FG002|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
6316394|NCT00432237|7221107|FG003|STARTED|Overall Study||490
6316395|NCT00432237|7221104|FG000|Completed--With Data|Overall Study||176
6316396|NCT00432237|7221105|FG001|Completed--With Data|Overall Study||381
6316397|NCT00432237|7221106|FG002|Completed--With Data|Overall Study||370
6316398|NCT00432237|7221107|FG003|Completed--With Data|Overall Study||365
6316399|NCT00432237|7221104|FG000|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
6316400|NCT00432237|7221105|FG001|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
6316401|NCT00432237|7221106|FG002|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
6316402|NCT00432237|7221107|FG003|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
6316403|NCT00432237|7221104|FG000|COMPLETED|Overall Study||177
6316404|NCT00432237|7221105|FG001|COMPLETED|Overall Study||384
6316405|NCT00432237|7221106|FG002|COMPLETED|Overall Study||375
6316406|NCT00432237|7221107|FG003|COMPLETED|Overall Study||366
6316407|NCT00432237|7221104|FG000|NOT COMPLETED|Overall Study||67
6316408|NCT00432237|7221105|FG001|NOT COMPLETED|Overall Study||101
6316409|NCT00432237|7221106|FG002|NOT COMPLETED|Overall Study||109
6316410|NCT00432237|7221107|FG003|NOT COMPLETED|Overall Study||124
6316411|NCT00432276|7221119|FG000|STARTED|Overall Study||404
6316412|NCT00432276|7221120|FG001|STARTED|Overall Study||399
6316413|NCT00432276|7221119|FG000|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
6316414|NCT00432276|7221120|FG001|Per Protocol Set|Overall Study||306
6316415|NCT00432276|7221119|FG000|COMPLETED|Overall Study||283
6316416|NCT00432276|7221120|FG001|COMPLETED|Overall Study||243
6316417|NCT00432276|7221119|FG000|NOT COMPLETED|Overall Study||121
6316418|NCT00432276|7221120|FG001|NOT COMPLETED|Overall Study||156
6316419|NCT00432341|7221128|FG000|STARTED|Overall Study||24
6316420|NCT00432341|7221129|FG001|STARTED|Overall Study||30
6316421|NCT00432341|7221128|FG000|COMPLETED|Overall Study||24
6316422|NCT00432341|7221129|FG001|COMPLETED|Overall Study||30
6316423|NCT00432341|7221128|FG000|NOT COMPLETED|Overall Study||0
6316424|NCT00432341|7221129|FG001|NOT COMPLETED|Overall Study||0
6316425|NCT00432380|7221138|FG000|STARTED|Overall Study||150
6316426|NCT00432380|7221139|FG001|STARTED|Overall Study||150
6316427|NCT00432380|7221140|FG002|STARTED|Overall Study||75
6316428|NCT00432380|7221138|FG000|COMPLETED|Overall Study||146
6316429|NCT00432380|7221139|FG001|COMPLETED|Overall Study||146
6316430|NCT00432380|7221140|FG002|COMPLETED|Overall Study||74
6316431|NCT00432380|7221138|FG000|NOT COMPLETED|Overall Study||4
6316432|NCT00432380|7221139|FG001|NOT COMPLETED|Overall Study||4
6316433|NCT00432380|7221140|FG002|NOT COMPLETED|Overall Study||1
6557800|NCT01770379|7480412|FG000|STARTED|Overall Study||80
6316434|NCT00432458|7221151|FG000|STARTED|Overall Study||35
6316435|NCT00432458|7221152|FG001|STARTED|Overall Study||33
6316436|NCT00432458|7221151|FG000|COMPLETED|Overall Study||30
6316437|NCT00432458|7221152|FG001|COMPLETED|Overall Study||32
6316438|NCT00432458|7221151|FG000|NOT COMPLETED|Overall Study||5
6316439|NCT00432458|7221152|FG001|NOT COMPLETED|Overall Study||1
6316440|NCT00432562|7221160|FG000|STARTED|Overall Study||16
6316441|NCT00432562|7221161|FG001|STARTED|Overall Study||15
6316442|NCT00432562|7221160|FG000|COMPLETED|Overall Study||13
6316443|NCT00432562|7221161|FG001|COMPLETED|Overall Study||15
6316444|NCT00432562|7221160|FG000|NOT COMPLETED|Overall Study||3
6316445|NCT00432562|7221161|FG001|NOT COMPLETED|Overall Study||0
6316446|NCT00432601|7221169|FG000|STARTED|Time 1 to Time 2||510
6316447|NCT00432601|7221170|FG001|STARTED|Time 1 to Time 2||512
6316448|NCT00432601|7221169|FG000|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
6316449|NCT00432601|7221170|FG001|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
6316450|NCT00432601|7221169|FG000|NOT COMPLETED|Time 1 to Time 2||369
6316451|NCT00432601|7221170|FG001|NOT COMPLETED|Time 1 to Time 2||368
6316452|NCT00432601|7221169|FG000|STARTED|Time 2 to Time 3||141
6316453|NCT00432601|7221170|FG001|STARTED|Time 2 to Time 3||144
6316454|NCT00432601|7221169|FG000|COMPLETED|Time 2 to Time 3||122
6557801|NCT01770379|7480413|FG001|STARTED|Overall Study||81
6557802|NCT01770379|7480414|FG002|STARTED|Overall Study||81
6557803|NCT01770379|7480412|FG000|COMPLETED|Overall Study||41
6557804|NCT01770379|7480413|FG001|COMPLETED|Overall Study||37
6557805|NCT01770379|7480414|FG002|COMPLETED|Overall Study||39
6557806|NCT01770379|7480412|FG000|NOT COMPLETED|Overall Study||39
6316455|NCT00432601|7221170|FG001|COMPLETED|Time 2 to Time 3||122
6316456|NCT00432601|7221169|FG000|NOT COMPLETED|Time 2 to Time 3||19
6316457|NCT00432601|7221170|FG001|NOT COMPLETED|Time 2 to Time 3||22
6316458|NCT00432666|7221178|FG000|STARTED|Main Period||73
6316459|NCT00432666|7221179|FG001|STARTED|Main Period||75
6316460|NCT00432666|7221178|FG000|COMPLETED|Main Period||71
6316461|NCT00432666|7221179|FG001|COMPLETED|Main Period||74
6316462|NCT00432666|7221178|FG000|NOT COMPLETED|Main Period||2
6316463|NCT00432666|7221179|FG001|NOT COMPLETED|Main Period||1
6316464|NCT00432666|7221178|FG000|STARTED|Open-Label Extension Period||145
6316465|NCT00432666|7221179|FG001|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
6316466|NCT00432666|7221178|FG000|COMPLETED|Open-Label Extension Period||120
6316467|NCT00432666|7221179|FG001|COMPLETED|Open-Label Extension Period||0
6316468|NCT00432666|7221178|FG000|NOT COMPLETED|Open-Label Extension Period||25
6316469|NCT00432666|7221179|FG001|NOT COMPLETED|Open-Label Extension Period||0
6316470|NCT00432679|7221187|FG000|STARTED|Overall Study||74
6316471|NCT00432679|7221188|FG001|STARTED|Overall Study||75
6316472|NCT00432679|7221187|FG000|COMPLETED|Overall Study||69
6316473|NCT00432679|7221188|FG001|COMPLETED|Overall Study||72
6316474|NCT00432679|7221187|FG000|NOT COMPLETED|Overall Study||5
6316475|NCT00432679|7221188|FG001|NOT COMPLETED|Overall Study||3
6316476|NCT00432744|7221196|FG000|STARTED|Months 0-6||12
6316477|NCT00432744|7221197|FG001|STARTED|Months 0-6||12
6316478|NCT00432744|7221196|FG000|COMPLETED|Months 0-6||7
6316479|NCT00432744|7221197|FG001|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
6316480|NCT00432744|7221196|FG000|NOT COMPLETED|Months 0-6||5
6316481|NCT00432744|7221197|FG001|NOT COMPLETED|Months 0-6||4
6316482|NCT00432744|7221196|FG000|STARTED|Months 7 - 12||7
6316483|NCT00432744|7221197|FG001|STARTED|Months 7 - 12||8
6316484|NCT00432744|7221196|FG000|COMPLETED|Months 7 - 12||6
6316485|NCT00432744|7221197|FG001|COMPLETED|Months 7 - 12||7
6316486|NCT00432744|7221196|FG000|NOT COMPLETED|Months 7 - 12||1
6316487|NCT00432744|7221197|FG001|NOT COMPLETED|Months 7 - 12||1
6316488|NCT00432809|7221206|FG000|STARTED|1 Year Follow-up||50
6316489|NCT00432809|7221207|FG001|STARTED|1 Year Follow-up||50
6316490|NCT00432809|7221208|FG002|STARTED|1 Year Follow-up||50
6316491|NCT00432809|7221206|FG000|COMPLETED|1 Year Follow-up||41
6316492|NCT00432809|7221207|FG001|COMPLETED|1 Year Follow-up||50
6316493|NCT00432809|7221208|FG002|COMPLETED|1 Year Follow-up||49
6316494|NCT00432809|7221206|FG000|NOT COMPLETED|1 Year Follow-up||9
6316495|NCT00432809|7221207|FG001|NOT COMPLETED|1 Year Follow-up||0
6316496|NCT00432809|7221208|FG002|NOT COMPLETED|1 Year Follow-up||1
6316497|NCT00432809|7221206|FG000|STARTED|2 Year Sub-study||20
6316498|NCT00432809|7221207|FG001|STARTED|2 Year Sub-study||20
6316499|NCT00432809|7221208|FG002|STARTED|2 Year Sub-study||20
6316500|NCT00432809|7221206|FG000|COMPLETED|2 Year Sub-study||17
6316501|NCT00432809|7221207|FG001|COMPLETED|2 Year Sub-study||18
6316502|NCT00432809|7221208|FG002|COMPLETED|2 Year Sub-study||19
6316503|NCT00432809|7221206|FG000|NOT COMPLETED|2 Year Sub-study||3
6316504|NCT00432809|7221207|FG001|NOT COMPLETED|2 Year Sub-study||2
6316505|NCT00432809|7221208|FG002|NOT COMPLETED|2 Year Sub-study||1
6316506|NCT00432835|7221218|FG000|STARTED|Overall Study||28
6316507|NCT00432835|7221219|FG001|STARTED|Overall Study||30
6316508|NCT00432835|7221218|FG000|Completed 1st Intervention|Overall Study||22
6316509|NCT00432835|7221219|FG001|Completed 1st Intervention|Overall Study||23
6316510|NCT00432835|7221218|FG000|Completed 2nd Intervention|Overall Study||22
6316511|NCT00432835|7221219|FG001|Completed 2nd Intervention|Overall Study||23
6316512|NCT00432835|7221218|FG000|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
6375306|NCT00754832|7285926|FG000|COMPLETED|2 Weeks Washout||17
6557807|NCT01770379|7480413|FG001|NOT COMPLETED|Overall Study||44
6316513|NCT00432835|7221219|FG001|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
6316514|NCT00432835|7221218|FG000|NOT COMPLETED|Overall Study||6
6316515|NCT00432835|7221219|FG001|NOT COMPLETED|Overall Study||7
6316516|NCT00432965|7221227|FG000|STARTED|Overall Study||169
6316517|NCT00432965|7221228|FG001|STARTED|Overall Study||166
6316518|NCT00432965|7221227|FG000|COMPLETED|Overall Study||75
6316519|NCT00432965|7221228|FG001|COMPLETED|Overall Study||80
6316520|NCT00432965|7221227|FG000|NOT COMPLETED|Overall Study||94
6316521|NCT00432965|7221228|FG001|NOT COMPLETED|Overall Study||86
6316522|NCT00432991|7221236|FG000|STARTED|Overall Study||22
6316523|NCT00432991|7221237|FG001|STARTED|Overall Study||31
6316524|NCT00432991|7221236|FG000|COMPLETED|Overall Study||15
6316525|NCT00432991|7221237|FG001|COMPLETED|Overall Study||19
6316526|NCT00432991|7221236|FG000|NOT COMPLETED|Overall Study||7
6316527|NCT00432991|7221237|FG001|NOT COMPLETED|Overall Study||12
6316528|NCT00433004|7221245|FG000|STARTED|Overall Study||27
6316529|NCT00433004|7221246|FG001|STARTED|Overall Study||23
6316530|NCT00433004|7221245|FG000|COMPLETED|Overall Study||22
6316531|NCT00433004|7221246|FG001|COMPLETED|Overall Study||16
6316532|NCT00433004|7221245|FG000|NOT COMPLETED|Overall Study||5
6316533|NCT00433004|7221246|FG001|NOT COMPLETED|Overall Study||7
6316534|NCT00433017|7221254|FG000|STARTED|Overall Study||122
6316535|NCT00433017|7221255|FG001|STARTED|Overall Study||133
6316536|NCT00433017|7221254|FG000|Completed 12 Month Phase|Overall Study||114
6316537|NCT00433017|7221255|FG001|Completed 12 Month Phase|Overall Study||126
6316538|NCT00433017|7221254|FG000|COMPLETED|Overall Study||26
6316539|NCT00433017|7221255|FG001|COMPLETED|Overall Study||32
6316540|NCT00433017|7221254|FG000|NOT COMPLETED|Overall Study||96
6316541|NCT00433017|7221255|FG001|NOT COMPLETED|Overall Study||101
6316542|NCT00433147|7221265|FG000|STARTED|Overall Study||7
6316543|NCT00433147|7221266|FG001|STARTED|Overall Study||7
6316544|NCT00433147|7221267|FG002|STARTED|Overall Study||9
6316545|NCT00433147|7221268|FG003|STARTED|Overall Study||7
6316546|NCT00433147|7221265|FG000|Safety Population|Overall Study||7
6316547|NCT00433147|7221266|FG001|Safety Population|Overall Study||7
6316548|NCT00433147|7221267|FG002|Safety Population|Overall Study||9
6316549|NCT00433147|7221268|FG003|Safety Population|Overall Study||7
6316550|NCT00433147|7221265|FG000|PD Population|Overall Study||7
6316551|NCT00433147|7221266|FG001|PD Population|Overall Study||6
6316552|NCT00433147|7221267|FG002|PD Population|Overall Study||9
6316553|NCT00433147|7221268|FG003|PD Population|Overall Study||7
6316554|NCT00433147|7221265|FG000|Received at Least One Dose of Study Drug|Overall Study||7
6316555|NCT00433147|7221266|FG001|Received at Least One Dose of Study Drug|Overall Study||7
6316556|NCT00433147|7221267|FG002|Received at Least One Dose of Study Drug|Overall Study||9
6316557|NCT00433147|7221268|FG003|Received at Least One Dose of Study Drug|Overall Study||7
6316558|NCT00433147|7221265|FG000|COMPLETED|Overall Study||7
6316559|NCT00433147|7221266|FG001|COMPLETED|Overall Study||6
6316560|NCT00433147|7221267|FG002|COMPLETED|Overall Study||9
6316561|NCT00433147|7221268|FG003|COMPLETED|Overall Study||7
6316562|NCT00433147|7221265|FG000|NOT COMPLETED|Overall Study||0
6316563|NCT00433147|7221266|FG001|NOT COMPLETED|Overall Study||1
6316564|NCT00433147|7221267|FG002|NOT COMPLETED|Overall Study||0
6316565|NCT00433147|7221268|FG003|NOT COMPLETED|Overall Study||0
6316566|NCT00433160|7221280|FG000|STARTED|52-Week Double-Blind (DB) Period||137
6316567|NCT00433160|7221281|FG001|STARTED|52-Week Double-Blind (DB) Period||70
6316568|NCT00433160|7221280|FG000|Received Treatment|52-Week Double-Blind (DB) Period||136
6316569|NCT00433160|7221281|FG001|Received Treatment|52-Week Double-Blind (DB) Period||68
6316570|NCT00433160|7221280|FG000|COMPLETED|52-Week Double-Blind (DB) Period||120
6316571|NCT00433160|7221281|FG001|COMPLETED|52-Week Double-Blind (DB) Period||60
6316572|NCT00433160|7221280|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
6316573|NCT00433160|7221281|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
6316574|NCT00433160|7221280|FG000|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
6316575|NCT00433160|7221281|FG001|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
6316576|NCT00433160|7221280|FG000|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
6316577|NCT00433160|7221281|FG001|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
6316578|NCT00433160|7221280|FG000|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
6316579|NCT00433160|7221281|FG001|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
6316580|NCT00433160|7221280|FG000|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
6316581|NCT00433160|7221281|FG001|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
6316582|NCT00433160|7221280|FG000|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
6316583|NCT00433160|7221281|FG001|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
6316584|NCT00433160|7221280|FG000|Received Treatment|104 Weeks, 28-Week OL Period||102
6316585|NCT00433160|7221281|FG001|Received Treatment|104 Weeks, 28-Week OL Period||50
6316586|NCT00433160|7221280|FG000|COMPLETED|104 Weeks, 28-Week OL Period||92
6316587|NCT00433160|7221281|FG001|COMPLETED|104 Weeks, 28-Week OL Period||47
6316588|NCT00433160|7221280|FG000|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
6316589|NCT00433160|7221281|FG001|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
6316590|NCT00433199|7221293|FG000|STARTED|Double-Blind Period||40
6316591|NCT00433199|7221294|FG001|STARTED|Double-Blind Period||234
6316592|NCT00433199|7221293|FG000|COMPLETED|Double-Blind Period||28
6316593|NCT00433199|7221294|FG001|COMPLETED|Double-Blind Period||168
6316594|NCT00433199|7221293|FG000|NOT COMPLETED|Double-Blind Period||12
6316595|NCT00433199|7221294|FG001|NOT COMPLETED|Double-Blind Period||66
6316596|NCT00433199|7221293|FG000|STARTED|Open-Label Period||0
6316597|NCT00433199|7221294|FG001|STARTED|Open-Label Period||219
6316598|NCT00433199|7221293|FG000|COMPLETED|Open-Label Period||0
6316599|NCT00433199|7221294|FG001|COMPLETED|Open-Label Period||185
6316600|NCT00433199|7221293|FG000|NOT COMPLETED|Open-Label Period||0
6316601|NCT00433199|7221294|FG001|NOT COMPLETED|Open-Label Period||34
6316602|NCT00433290|7221307|FG000|STARTED|Overall Study||128
6316603|NCT00433290|7221308|FG001|STARTED|Overall Study||128
6557808|NCT01770379|7480414|FG002|NOT COMPLETED|Overall Study||42
6557809|NCT01770392|7480424|FG000|STARTED|Nintedanib||26
6557810|NCT01770392|7480424|FG000|COMPLETED|Nintedanib||26
6316604|NCT00433290|7221307|FG000|COMPLETED|Overall Study||93
6316605|NCT00433290|7221308|FG001|COMPLETED|Overall Study||111
6316606|NCT00433290|7221307|FG000|NOT COMPLETED|Overall Study||35
6316607|NCT00433290|7221308|FG001|NOT COMPLETED|Overall Study||17
6316608|NCT00433329|7221314|FG000|STARTED|Overall Study||100
6316609|NCT00433329|7221314|FG000|COMPLETED|Overall Study||79
6316610|NCT00433329|7221314|FG000|NOT COMPLETED|Overall Study||21
6316611|NCT00433381|7221320|FG000|STARTED|Overall Study||63
6316612|NCT00433381|7221321|FG001|STARTED|Overall Study||60
6316613|NCT00433381|7221320|FG000|COMPLETED|Overall Study|Subjects contributing data to [the primary] analysis are considered to have completed the study.|60
6316614|NCT00433381|7221321|FG001|COMPLETED|Overall Study||57
6316615|NCT00433381|7221320|FG000|NOT COMPLETED|Overall Study||3
6316616|NCT00433381|7221321|FG001|NOT COMPLETED|Overall Study||3
6316617|NCT00433446|7221335|FG000|STARTED|Overall Study||62
6316618|NCT00433446|7221335|FG000|Eligible|Overall Study||53
6316619|NCT00433446|7221335|FG000|Eligible and Began Protocol Therapy|Overall Study||53
6316620|NCT00433446|7221335|FG000|COMPLETED|Overall Study||1
6316621|NCT00433446|7221335|FG000|NOT COMPLETED|Overall Study||61
6316622|NCT00433537|7221339|FG000|STARTED|Step 1 - VcR-CVAD Induction||45
6316623|NCT00433537|7221340|FG001|STARTED|Step 1 - VcR-CVAD Induction||22
6316624|NCT00433537|7221341|FG002|STARTED|Step 1 - VcR-CVAD Induction||10
6316625|NCT00433537|7221339|FG000|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
6316626|NCT00433537|7221340|FG001|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
6316627|NCT00433537|7221341|FG002|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
6316628|NCT00433537|7221339|FG000|COMPLETED|Step 1 - VcR-CVAD Induction||44
6316629|NCT00433537|7221340|FG001|COMPLETED|Step 1 - VcR-CVAD Induction||22
6316630|NCT00433537|7221341|FG002|COMPLETED|Step 1 - VcR-CVAD Induction||1
6316631|NCT00433537|7221339|FG000|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
6316632|NCT00433537|7221340|FG001|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
6316633|NCT00433537|7221341|FG002|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
6316634|NCT00433537|7221339|FG000|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
6316635|NCT00433537|7221340|FG001|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
6316636|NCT00433537|7221341|FG002|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
6316637|NCT00433537|7221339|FG000|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
6316638|NCT00433537|7221340|FG001|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
6316639|NCT00433537|7221341|FG002|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
6316640|NCT00433537|7221339|FG000|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
6316641|NCT00433537|7221340|FG001|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
6316642|NCT00433537|7221341|FG002|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
6316643|NCT00433537|7221339|FG000|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
6316644|NCT00433537|7221340|FG001|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
6316645|NCT00433537|7221341|FG002|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
6316646|NCT00433550|7221351|FG000|STARTED|Overall Study||17
6316647|NCT00433550|7221352|FG001|STARTED|Overall Study||10
6316648|NCT00433550|7221353|FG002|STARTED|Overall Study||6
6316649|NCT00433550|7221351|FG000|COMPLETED|Overall Study||17
6316650|NCT00433550|7221352|FG001|COMPLETED|Overall Study||10
6316651|NCT00433550|7221353|FG002|COMPLETED|Overall Study||6
6557811|NCT01770392|7480424|FG000|NOT COMPLETED|Nintedanib||0
6316652|NCT00433550|7221351|FG000|NOT COMPLETED|Overall Study||0
6316653|NCT00433550|7221352|FG001|NOT COMPLETED|Overall Study||0
6316654|NCT00433550|7221353|FG002|NOT COMPLETED|Overall Study||0
6316655|NCT00433654|7221363|FG000|STARTED|Overall Study||258
6316656|NCT00433654|7221364|FG001|STARTED|Overall Study||206
6316657|NCT00433654|7221363|FG000|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
6316658|NCT00433654|7221364|FG001|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
6316659|NCT00433654|7221363|FG000|NOT COMPLETED|Overall Study||15
6316660|NCT00433654|7221364|FG001|NOT COMPLETED|Overall Study||5
6316661|NCT00433745|7221376|FG000|STARTED|Overall Study||4
6316662|NCT00433745|7221376|FG000|COMPLETED|Overall Study||4
6316663|NCT00433745|7221376|FG000|NOT COMPLETED|Overall Study||0
6316664|NCT00433771|7221381|FG000|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
6316665|NCT00433771|7221381|FG000|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
6316666|NCT00433771|7221381|FG000|NOT COMPLETED|Overall Study||19
6557812|NCT01770392|7480424|FG000|STARTED|Washout Period of at Least 14 Days||26
6316667|NCT00433836|7221387|FG000|STARTED|Overall Study||151
6316668|NCT00433836|7221388|FG001|STARTED|Overall Study||149
6316669|NCT00433836|7221387|FG000|COMPLETED|Overall Study||138
6316670|NCT00433836|7221388|FG001|COMPLETED|Overall Study||143
6316671|NCT00433836|7221387|FG000|NOT COMPLETED|Overall Study||13
6316672|NCT00433836|7221388|FG001|NOT COMPLETED|Overall Study||6
6316673|NCT00433914|7221396|FG000|STARTED|Overall Study||30
6316674|NCT00433914|7221397|FG001|STARTED|Overall Study||30
6316675|NCT00433914|7221396|FG000|COMPLETED|Overall Study||30
6316676|NCT00433914|7221397|FG001|COMPLETED|Overall Study||27
6316677|NCT00433914|7221396|FG000|NOT COMPLETED|Overall Study||0
6316678|NCT00433914|7221397|FG001|NOT COMPLETED|Overall Study||3
6316679|NCT00433966|7221405|FG000|STARTED|Pharmacology Intervention/Randomization||1800
6316680|NCT00433966|7221406|FG001|STARTED|Pharmacology Intervention/Randomization||1802
6316681|NCT00433966|7221407|FG002|STARTED|Pharmacology Intervention/Randomization||0
6316682|NCT00433966|7221408|FG003|STARTED|Pharmacology Intervention/Randomization||0
6316683|NCT00433966|7221405|FG000|30-Day Follow-up|Pharmacology Intervention/Randomization||1787
6316684|NCT00433966|7221406|FG001|30-Day Follow-up|Pharmacology Intervention/Randomization||1791
6316685|NCT00433966|7221407|FG002|30-Day Follow-up|Pharmacology Intervention/Randomization||0
6316686|NCT00433966|7221408|FG003|30-Day Follow-up|Pharmacology Intervention/Randomization||0
6316687|NCT00433966|7221405|FG000|1-Year Follow-up|Pharmacology Intervention/Randomization||1696
6316688|NCT00433966|7221406|FG001|1-Year Follow-up|Pharmacology Intervention/Randomization||1702
6316689|NCT00433966|7221407|FG002|1-Year Follow-up|Pharmacology Intervention/Randomization||0
6316690|NCT00433966|7221408|FG003|1-Year Follow-up|Pharmacology Intervention/Randomization||0
6316691|NCT00433966|7221405|FG000|3-Year Follow-up|Pharmacology Intervention/Randomization||1634
6316692|NCT00433966|7221406|FG001|3-Year Follow-up|Pharmacology Intervention/Randomization||1628
6316693|NCT00433966|7221407|FG002|3-Year Follow-up|Pharmacology Intervention/Randomization||0
6316694|NCT00433966|7221408|FG003|3-Year Follow-up|Pharmacology Intervention/Randomization||0
6316695|NCT00433966|7221405|FG000|COMPLETED|Pharmacology Intervention/Randomization||1634
6316696|NCT00433966|7221406|FG001|COMPLETED|Pharmacology Intervention/Randomization||1628
6316697|NCT00433966|7221407|FG002|COMPLETED|Pharmacology Intervention/Randomization||0
6316698|NCT00433966|7221408|FG003|COMPLETED|Pharmacology Intervention/Randomization||0
6316699|NCT00433966|7221405|FG000|NOT COMPLETED|Pharmacology Intervention/Randomization||166
6316700|NCT00433966|7221406|FG001|NOT COMPLETED|Pharmacology Intervention/Randomization||174
6316701|NCT00433966|7221407|FG002|NOT COMPLETED|Pharmacology Intervention/Randomization||0
6316702|NCT00433966|7221408|FG003|NOT COMPLETED|Pharmacology Intervention/Randomization||0
6316703|NCT00433966|7221405|FG000|STARTED|Stent Intervention/Randomization||0
6316704|NCT00433966|7221406|FG001|STARTED|Stent Intervention/Randomization||0
6316705|NCT00433966|7221407|FG002|STARTED|Stent Intervention/Randomization||2257
6316706|NCT00433966|7221408|FG003|STARTED|Stent Intervention/Randomization||749
6316707|NCT00433966|7221405|FG000|1-Year Follow-up|Stent Intervention/Randomization||0
6316708|NCT00433966|7221406|FG001|1-Year Follow-up|Stent Intervention/Randomization||0
6316709|NCT00433966|7221407|FG002|1-Year Follow-up|Stent Intervention/Randomization||2186
6316710|NCT00433966|7221408|FG003|1-Year Follow-up|Stent Intervention/Randomization||715
6316711|NCT00433966|7221405|FG000|3-Year Follow-up|Stent Intervention/Randomization||0
6316712|NCT00433966|7221406|FG001|3-Year Follow-up|Stent Intervention/Randomization||0
6316713|NCT00433966|7221407|FG002|3-Year Follow-up|Stent Intervention/Randomization||2103
6316714|NCT00433966|7221408|FG003|3-Year Follow-up|Stent Intervention/Randomization||687
6316715|NCT00433966|7221405|FG000|COMPLETED|Stent Intervention/Randomization||0
6316716|NCT00433966|7221406|FG001|COMPLETED|Stent Intervention/Randomization||0
6316717|NCT00433966|7221407|FG002|COMPLETED|Stent Intervention/Randomization||2103
6316718|NCT00433966|7221408|FG003|COMPLETED|Stent Intervention/Randomization||687
6316719|NCT00433966|7221405|FG000|NOT COMPLETED|Stent Intervention/Randomization||0
6316720|NCT00433966|7221406|FG001|NOT COMPLETED|Stent Intervention/Randomization||0
6316721|NCT00433966|7221407|FG002|NOT COMPLETED|Stent Intervention/Randomization||154
6316722|NCT00433966|7221408|FG003|NOT COMPLETED|Stent Intervention/Randomization||62
6316723|NCT00433992|7221420|FG000|STARTED|Overall Study||28
6316724|NCT00433992|7221421|FG001|STARTED|Overall Study||28
6316725|NCT00433992|7221420|FG000|COMPLETED|Overall Study||19
6316726|NCT00433992|7221421|FG001|COMPLETED|Overall Study||20
6316727|NCT00433992|7221420|FG000|NOT COMPLETED|Overall Study||9
6316728|NCT00433992|7221421|FG001|NOT COMPLETED|Overall Study||8
6316729|NCT00434018|7221433|FG000|STARTED|Overall Study||69
6316730|NCT00434018|7221434|FG001|STARTED|Overall Study||69
6316731|NCT00434018|7221433|FG000|COMPLETED|Overall Study||52
6316732|NCT00434018|7221434|FG001|COMPLETED|Overall Study||57
6316733|NCT00434018|7221433|FG000|NOT COMPLETED|Overall Study||17
6316734|NCT00434018|7221434|FG001|NOT COMPLETED|Overall Study||12
6316735|NCT00434057|7221441|FG000|STARTED|Overall Study||1383
6316736|NCT00434057|7221441|FG000|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
6316737|NCT00434057|7221441|FG000|NOT COMPLETED|Overall Study||1
6316738|NCT00434109|7221445|FG000|STARTED|Overall Study||39
6316739|NCT00434109|7221445|FG000|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
6316740|NCT00434109|7221445|FG000|NOT COMPLETED|Overall Study||18
6316741|NCT00434122|7221451|FG000|STARTED|Overall Study|Randomised|42
6316742|NCT00434122|7221452|FG001|STARTED|Overall Study|Randomised|43
6316743|NCT00434122|7221451|FG000|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
6375307|NCT00754832|7285927|FG001|COMPLETED|2 Weeks Washout||26
6316744|NCT00434122|7221452|FG001|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
6316745|NCT00434122|7221451|FG000|COMPLETED|Overall Study||36
6316746|NCT00434122|7221452|FG001|COMPLETED|Overall Study||36
6316747|NCT00434122|7221451|FG000|NOT COMPLETED|Overall Study||6
6316748|NCT00434122|7221452|FG001|NOT COMPLETED|Overall Study||7
6316749|NCT00434148|7221462|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
6316750|NCT00434148|7221463|FG001|STARTED|Overall Study||80
6316751|NCT00434148|7221462|FG000|Completed Month 12|Overall Study||39
6316752|NCT00434148|7221463|FG001|Completed Month 12|Overall Study||39
6316753|NCT00434148|7221462|FG000|Completed m. 12; Did Not Enter Extension|Overall Study||13
6316754|NCT00434148|7221463|FG001|Completed m. 12; Did Not Enter Extension|Overall Study||7
6316755|NCT00434148|7221462|FG000|Completed Month 12; Entered Extension|Overall Study||26
6316756|NCT00434148|7221463|FG001|Completed Month 12; Entered Extension|Overall Study||32
6316757|NCT00434148|7221462|FG000|COMPLETED|Overall Study||13
6316758|NCT00434148|7221463|FG001|COMPLETED|Overall Study||7
6316759|NCT00434148|7221462|FG000|NOT COMPLETED|Overall Study||69
6316760|NCT00434148|7221463|FG001|NOT COMPLETED|Overall Study||73
6316761|NCT00434161|7221472|FG000|STARTED|Overall Study||109
6316762|NCT00434161|7221473|FG001|STARTED|Overall Study||57
6316763|NCT00434161|7221474|FG002|STARTED|Overall Study||115
6316764|NCT00434161|7221472|FG000|COMPLETED|Overall Study||99
6316765|NCT00434161|7221473|FG001|COMPLETED|Overall Study||54
6316766|NCT00434161|7221474|FG002|COMPLETED|Overall Study||104
6316767|NCT00434161|7221472|FG000|NOT COMPLETED|Overall Study||10
6316768|NCT00434161|7221473|FG001|NOT COMPLETED|Overall Study||3
6316769|NCT00434161|7221474|FG002|NOT COMPLETED|Overall Study||11
6316770|NCT00434213|7221489|FG000|STARTED|Overall Study||309
6316771|NCT00434213|7221489|FG000|COMPLETED|Overall Study||260
6316772|NCT00434213|7221489|FG000|NOT COMPLETED|Overall Study||49
6316773|NCT00434252|7221495|FG000|STARTED|Overall Study||71
6316774|NCT00434252|7221496|FG001|STARTED|Overall Study||143
6316775|NCT00434252|7221495|FG000|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
6316776|NCT00434252|7221496|FG001|Treated|Overall Study||143
6316777|NCT00434252|7221495|FG000|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
6316778|NCT00434252|7221496|FG001|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
6316779|NCT00434252|7221495|FG000|NOT COMPLETED|Overall Study||64
6316780|NCT00434252|7221496|FG001|NOT COMPLETED|Overall Study||131
6316781|NCT00434278|7221504|FG000|STARTED|Overall Study||14
6316782|NCT00434278|7221505|FG001|STARTED|Overall Study||13
6316783|NCT00434278|7221504|FG000|COMPLETED|Overall Study||12
6316784|NCT00434278|7221505|FG001|COMPLETED|Overall Study||13
6316785|NCT00434278|7221504|FG000|NOT COMPLETED|Overall Study||2
6316786|NCT00434278|7221505|FG001|NOT COMPLETED|Overall Study||0
6316787|NCT00434304|7221511|FG000|STARTED|Overall Study||62
6316788|NCT00434304|7221511|FG000|COMPLETED|Overall Study||42
6316789|NCT00434304|7221511|FG000|NOT COMPLETED|Overall Study||20
6316790|NCT00434330|7221522|FG000|STARTED|Overall Study||15
6316791|NCT00434330|7221523|FG001|STARTED|Overall Study||15
6316792|NCT00434330|7221524|FG002|STARTED|Overall Study||16
6316793|NCT00434330|7221525|FG003|STARTED|Overall Study||15
6316794|NCT00434330|7221526|FG004|STARTED|Overall Study||15
6316795|NCT00434330|7221527|FG005|STARTED|Overall Study||15
6316796|NCT00434330|7221522|FG000|COMPLETED|Overall Study||14
6316797|NCT00434330|7221523|FG001|COMPLETED|Overall Study||15
6316798|NCT00434330|7221524|FG002|COMPLETED|Overall Study||13
6316799|NCT00434330|7221525|FG003|COMPLETED|Overall Study||13
6316800|NCT00434330|7221526|FG004|COMPLETED|Overall Study||14
6316801|NCT00434330|7221527|FG005|COMPLETED|Overall Study||14
6316802|NCT00434330|7221522|FG000|NOT COMPLETED|Overall Study||1
6316803|NCT00434330|7221523|FG001|NOT COMPLETED|Overall Study||0
6316804|NCT00434330|7221524|FG002|NOT COMPLETED|Overall Study||3
6316805|NCT00434330|7221525|FG003|NOT COMPLETED|Overall Study||2
6316806|NCT00434330|7221526|FG004|NOT COMPLETED|Overall Study||1
6316807|NCT00434330|7221527|FG005|NOT COMPLETED|Overall Study||1
6316808|NCT00434356|7221543|FG000|STARTED|Overall Study||23
6316809|NCT00434356|7221544|FG001|STARTED|Overall Study||23
6316810|NCT00434356|7221543|FG000|COMPLETED|Overall Study||0
6316811|NCT00434356|7221544|FG001|COMPLETED|Overall Study||0
6316812|NCT00434356|7221543|FG000|NOT COMPLETED|Overall Study||23
6316813|NCT00434356|7221544|FG001|NOT COMPLETED|Overall Study||23
6316814|NCT00434421|7221550|FG000|STARTED|Overall Study||28
6316815|NCT00434421|7221550|FG000|COMPLETED|Overall Study||26
6316816|NCT00434421|7221550|FG000|NOT COMPLETED|Overall Study||2
6316817|NCT00434434|7221557|FG000|STARTED|Overall Study||23
6316818|NCT00434434|7221558|FG001|STARTED|Overall Study||24
6316819|NCT00434434|7221559|FG002|STARTED|Overall Study||14
6316820|NCT00434434|7221557|FG000|COMPLETED|Overall Study||21
6316821|NCT00434434|7221558|FG001|COMPLETED|Overall Study||24
6316822|NCT00434434|7221559|FG002|COMPLETED|Overall Study||13
6316823|NCT00434434|7221557|FG000|NOT COMPLETED|Overall Study||2
6316824|NCT00434434|7221558|FG001|NOT COMPLETED|Overall Study||0
6316825|NCT00434434|7221559|FG002|NOT COMPLETED|Overall Study||1
6316826|NCT00434512|7221573|FG000|STARTED|Overall Study||10
6316827|NCT00434512|7221574|FG001|STARTED|Overall Study||10
6316828|NCT00434512|7221575|FG002|STARTED|Overall Study||10
6316829|NCT00434512|7221576|FG003|STARTED|Overall Study||50
6316830|NCT00434512|7221577|FG004|STARTED|Overall Study||50
6316831|NCT00434512|7221578|FG005|STARTED|Overall Study||50
6316832|NCT00434512|7221573|FG000|COMPLETED|Overall Study||10
6316833|NCT00434512|7221574|FG001|COMPLETED|Overall Study||9
6316834|NCT00434512|7221575|FG002|COMPLETED|Overall Study||10
6316835|NCT00434512|7221576|FG003|COMPLETED|Overall Study||49
6316836|NCT00434512|7221577|FG004|COMPLETED|Overall Study||49
6316837|NCT00434512|7221578|FG005|COMPLETED|Overall Study||49
6316838|NCT00434512|7221573|FG000|NOT COMPLETED|Overall Study||0
6316839|NCT00434512|7221574|FG001|NOT COMPLETED|Overall Study||1
6316840|NCT00434512|7221575|FG002|NOT COMPLETED|Overall Study||0
6316841|NCT00434512|7221576|FG003|NOT COMPLETED|Overall Study||1
6316842|NCT00434512|7221577|FG004|NOT COMPLETED|Overall Study||1
6316843|NCT00434512|7221578|FG005|NOT COMPLETED|Overall Study||1
6316844|NCT00434577|7221601|FG000|STARTED|Months 0-3||164
6316845|NCT00434577|7221602|FG001|STARTED|Months 0-3||166
6316846|NCT00434577|7221603|FG002|STARTED|Months 0-3||165
6316847|NCT00434577|7221604|FG003|STARTED|Months 0-3||165
6316848|NCT00434577|7221605|FG004|STARTED|Months 0-3||54
6316849|NCT00434577|7221601|FG000|COMPLETED|Months 0-3||161
6316850|NCT00434577|7221602|FG001|COMPLETED|Months 0-3||164
6316851|NCT00434577|7221603|FG002|COMPLETED|Months 0-3||161
6316852|NCT00434577|7221604|FG003|COMPLETED|Months 0-3||164
6316853|NCT00434577|7221605|FG004|COMPLETED|Months 0-3||51
6316854|NCT00434577|7221601|FG000|NOT COMPLETED|Months 0-3||3
6316855|NCT00434577|7221602|FG001|NOT COMPLETED|Months 0-3||2
6316856|NCT00434577|7221603|FG002|NOT COMPLETED|Months 0-3||4
6316857|NCT00434577|7221604|FG003|NOT COMPLETED|Months 0-3||1
6557813|NCT01770392|7480424|FG000|COMPLETED|Washout Period of at Least 14 Days||25
6557814|NCT01770392|7480424|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||1
6557815|NCT01770392|7480424|FG000|STARTED|Nintedanib+ Rifampicin||25
6557816|NCT01770392|7480424|FG000|COMPLETED|Nintedanib+ Rifampicin||25
6557817|NCT01770392|7480424|FG000|NOT COMPLETED|Nintedanib+ Rifampicin||0
6557818|NCT01770431|7480436|FG000|STARTED|Overall Study||696
6557819|NCT01770431|7480437|FG001|STARTED|Overall Study||348
6557820|NCT01770431|7480436|FG000|COMPLETED|Overall Study||686
6557821|NCT01770431|7480437|FG001|COMPLETED|Overall Study||316
6557822|NCT01770431|7480436|FG000|NOT COMPLETED|Overall Study||10
6557823|NCT01770431|7480437|FG001|NOT COMPLETED|Overall Study||32
6557824|NCT01770483|7480446|FG000|STARTED|Overall Study||33
6557825|NCT01770483|7480447|FG001|STARTED|Overall Study||33
6316858|NCT00434577|7221605|FG004|NOT COMPLETED|Months 0-3||3
6316859|NCT00434577|7221601|FG000|STARTED|Month 12||156
6316860|NCT00434577|7221602|FG001|STARTED|Month 12||159
6316861|NCT00434577|7221603|FG002|STARTED|Month 12||159
6316862|NCT00434577|7221604|FG003|STARTED|Month 12||161
6316863|NCT00434577|7221605|FG004|STARTED|Month 12||50
6316864|NCT00434577|7221601|FG000|COMPLETED|Month 12||156
6316865|NCT00434577|7221602|FG001|COMPLETED|Month 12||159
6316866|NCT00434577|7221603|FG002|COMPLETED|Month 12||159
6316867|NCT00434577|7221604|FG003|COMPLETED|Month 12||161
6316868|NCT00434577|7221605|FG004|COMPLETED|Month 12||50
6316869|NCT00434577|7221601|FG000|NOT COMPLETED|Month 12||0
6316870|NCT00434577|7221602|FG001|NOT COMPLETED|Month 12||0
6316871|NCT00434577|7221603|FG002|NOT COMPLETED|Month 12||0
6316872|NCT00434577|7221604|FG003|NOT COMPLETED|Month 12||0
6316873|NCT00434577|7221605|FG004|NOT COMPLETED|Month 12||0
6316874|NCT00434577|7221601|FG000|STARTED|Month 24||150
6316875|NCT00434577|7221602|FG001|STARTED|Month 24||155
6316876|NCT00434577|7221603|FG002|STARTED|Month 24||154
6316877|NCT00434577|7221604|FG003|STARTED|Month 24||157
6316878|NCT00434577|7221605|FG004|STARTED|Month 24||49
6316879|NCT00434577|7221601|FG000|COMPLETED|Month 24||150
6316880|NCT00434577|7221602|FG001|COMPLETED|Month 24||155
6316881|NCT00434577|7221603|FG002|COMPLETED|Month 24||154
6316882|NCT00434577|7221604|FG003|COMPLETED|Month 24||157
6316883|NCT00434577|7221605|FG004|COMPLETED|Month 24||49
6316884|NCT00434577|7221601|FG000|NOT COMPLETED|Month 24||0
6316885|NCT00434577|7221602|FG001|NOT COMPLETED|Month 24||0
6316886|NCT00434577|7221603|FG002|NOT COMPLETED|Month 24||0
6316887|NCT00434577|7221604|FG003|NOT COMPLETED|Month 24||0
6316888|NCT00434577|7221605|FG004|NOT COMPLETED|Month 24||0
6316889|NCT00434577|7221601|FG000|STARTED|Month 36||147
6316890|NCT00434577|7221602|FG001|STARTED|Month 36||147
6316891|NCT00434577|7221603|FG002|STARTED|Month 36||150
6316892|NCT00434577|7221604|FG003|STARTED|Month 36||155
6316893|NCT00434577|7221605|FG004|STARTED|Month 36||47
6316894|NCT00434577|7221601|FG000|COMPLETED|Month 36||147
6316895|NCT00434577|7221602|FG001|COMPLETED|Month 36||147
6316896|NCT00434577|7221603|FG002|COMPLETED|Month 36||150
6316897|NCT00434577|7221604|FG003|COMPLETED|Month 36||155
6316898|NCT00434577|7221605|FG004|COMPLETED|Month 36||47
6316899|NCT00434577|7221601|FG000|NOT COMPLETED|Month 36||0
6316900|NCT00434577|7221602|FG001|NOT COMPLETED|Month 36||0
6316901|NCT00434577|7221603|FG002|NOT COMPLETED|Month 36||0
6316902|NCT00434577|7221604|FG003|NOT COMPLETED|Month 36||0
6316903|NCT00434577|7221605|FG004|NOT COMPLETED|Month 36||0
6316904|NCT00434642|7221619|FG000|STARTED|Blinded Treatment Phase||242
6316905|NCT00434642|7221620|FG001|STARTED|Blinded Treatment Phase||242
6316906|NCT00434642|7221619|FG000|COMPLETED|Blinded Treatment Phase||0
6316907|NCT00434642|7221620|FG001|COMPLETED|Blinded Treatment Phase||13
6316908|NCT00434642|7221619|FG000|NOT COMPLETED|Blinded Treatment Phase||242
6316909|NCT00434642|7221620|FG001|NOT COMPLETED|Blinded Treatment Phase||229
6316910|NCT00434642|7221619|FG000|STARTED|Open-label Treatment Phase||0
6316911|NCT00434642|7221620|FG001|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
6316912|NCT00434642|7221619|FG000|COMPLETED|Open-label Treatment Phase||0
6316913|NCT00434642|7221620|FG001|COMPLETED|Open-label Treatment Phase||1
6316914|NCT00434642|7221619|FG000|NOT COMPLETED|Open-label Treatment Phase||0
6316915|NCT00434642|7221620|FG001|NOT COMPLETED|Open-label Treatment Phase||11
6316916|NCT00434759|7221628|FG000|STARTED|Overall Study||46
6316917|NCT00434759|7221629|FG001|STARTED|Overall Study||43
6316918|NCT00434759|7221628|FG000|COMPLETED|Overall Study||22
6316919|NCT00434759|7221629|FG001|COMPLETED|Overall Study||38
6316920|NCT00434759|7221628|FG000|NOT COMPLETED|Overall Study||24
6316921|NCT00434759|7221629|FG001|NOT COMPLETED|Overall Study||5
6316922|NCT00434876|7221639|FG000|STARTED|Overall Study||11
6316923|NCT00434876|7221640|FG001|STARTED|Overall Study||11
6316924|NCT00434876|7221639|FG000|COMPLETED|Overall Study||10
6316925|NCT00434876|7221640|FG001|COMPLETED|Overall Study||10
6316926|NCT00434876|7221639|FG000|NOT COMPLETED|Overall Study||1
6316927|NCT00434876|7221640|FG001|NOT COMPLETED|Overall Study||1
6316928|NCT00434954|7221648|FG000|STARTED|Overall Study||248
6316929|NCT00434954|7221649|FG001|STARTED|Overall Study||246
6316930|NCT00434954|7221648|FG000|Started - Previous Treatment MET Only|Overall Study||182
6316931|NCT00434954|7221649|FG001|Started - Previous Treatment MET Only|Overall Study||181
6316932|NCT00434954|7221648|FG000|Started - Previous Treatment MET + SU|Overall Study||66
6316933|NCT00434954|7221649|FG001|Started - Previous Treatment MET + SU|Overall Study||65
6316934|NCT00434954|7221648|FG000|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
6316935|NCT00434954|7221649|FG001|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
6316936|NCT00434954|7221648|FG000|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
6316937|NCT00434954|7221649|FG001|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
6316938|NCT00434954|7221648|FG000|FAS - Previous Treatment MET + SU|Overall Study||66
6316939|NCT00434954|7221649|FG001|FAS - Previous Treatment MET + SU|Overall Study||60
6316940|NCT00434954|7221648|FG000|Completed - Previous Treatment MET Only|Overall Study||135
6316941|NCT00434954|7221649|FG001|Completed - Previous Treatment MET Only|Overall Study||137
6316942|NCT00434954|7221648|FG000|Completed - Previous Treatment MET + SU|Overall Study||31
6316943|NCT00434954|7221649|FG001|Completed - Previous Treatment MET + SU|Overall Study||38
6316944|NCT00434954|7221648|FG000|COMPLETED|Overall Study||166
6316945|NCT00434954|7221649|FG001|COMPLETED|Overall Study||175
6316946|NCT00434954|7221648|FG000|NOT COMPLETED|Overall Study||82
6316947|NCT00434954|7221649|FG001|NOT COMPLETED|Overall Study||71
6316948|NCT00434967|7221659|FG000|STARTED|Overall Study||97
6316949|NCT00434967|7221660|FG001|STARTED|Overall Study||465
6316950|NCT00434967|7221661|FG002|STARTED|Overall Study||470
6316951|NCT00434967|7221662|FG003|STARTED|Overall Study||492
6316952|NCT00434967|7221659|FG000|COMPLETED|Overall Study||90
6316953|NCT00434967|7221660|FG001|COMPLETED|Overall Study||457
6316954|NCT00434967|7221661|FG002|COMPLETED|Overall Study||461
6316955|NCT00434967|7221662|FG003|COMPLETED|Overall Study||478
6316956|NCT00434967|7221659|FG000|NOT COMPLETED|Overall Study||7
6316957|NCT00434967|7221660|FG001|NOT COMPLETED|Overall Study||8
6316958|NCT00434967|7221661|FG002|NOT COMPLETED|Overall Study||9
6316959|NCT00434967|7221662|FG003|NOT COMPLETED|Overall Study||14
6316960|NCT00434993|7221674|FG000|STARTED|Overall Study||152
6316961|NCT00434993|7221675|FG001|STARTED|Overall Study||130
6316962|NCT00434993|7221674|FG000|COMPLETED|Overall Study||152
6316963|NCT00434993|7221675|FG001|COMPLETED|Overall Study||130
6316964|NCT00434993|7221674|FG000|NOT COMPLETED|Overall Study||0
6316965|NCT00434993|7221675|FG001|NOT COMPLETED|Overall Study||0
6316966|NCT00435019|7221683|FG000|STARTED|Overall Study|Randomised|177
6316967|NCT00435019|7221684|FG001|STARTED|Overall Study|Randomised|171
6316968|NCT00435019|7221683|FG000|Exposed to Study Drug|Overall Study||177
6316969|NCT00435019|7221684|FG001|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
6316970|NCT00435019|7221683|FG000|COMPLETED|Overall Study||164
6316971|NCT00435019|7221684|FG001|COMPLETED|Overall Study||161
6316972|NCT00435019|7221683|FG000|NOT COMPLETED|Overall Study||13
6316973|NCT00435019|7221684|FG001|NOT COMPLETED|Overall Study||10
6316974|NCT00435045|7221692|FG000|STARTED|Weeks 1-8 / 10 mg Dose Level||123
6316975|NCT00435045|7221693|FG001|STARTED|Weeks 1-8 / 10 mg Dose Level||122
6316976|NCT00435045|7221692|FG000|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
6316977|NCT00435045|7221693|FG001|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
6316978|NCT00435045|7221692|FG000|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
6316979|NCT00435045|7221693|FG001|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
6316980|NCT00435045|7221692|FG000|STARTED|Weeks 9-12 / 20mg Dose Level||118
6316981|NCT00435045|7221693|FG001|STARTED|Weeks 9-12 / 20mg Dose Level||118
6316982|NCT00435045|7221692|FG000|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
6316983|NCT00435045|7221693|FG001|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
6316984|NCT00435045|7221692|FG000|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
6316985|NCT00435045|7221693|FG001|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
6316986|NCT00435045|7221692|FG000|STARTED|Weeks 13-16 / 40mg Dose Level||113
6316987|NCT00435045|7221693|FG001|STARTED|Weeks 13-16 / 40mg Dose Level||113
6316988|NCT00435045|7221692|FG000|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
6316989|NCT00435045|7221693|FG001|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
6316990|NCT00435045|7221692|FG000|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
6316991|NCT00435045|7221693|FG001|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
6316992|NCT00435162|7221702|FG000|STARTED|Period 1 (6 Weeks)||15
6316993|NCT00435162|7221703|FG001|STARTED|Period 1 (6 Weeks)||15
6316994|NCT00435162|7221704|FG002|STARTED|Period 1 (6 Weeks)||6
6316995|NCT00435162|7221705|FG003|STARTED|Period 1 (6 Weeks)||8
6316996|NCT00435162|7221706|FG004|STARTED|Period 1 (6 Weeks)||15
6316997|NCT00435162|7221707|FG005|STARTED|Period 1 (6 Weeks)||15
6316998|NCT00435162|7221702|FG000|COMPLETED|Period 1 (6 Weeks)||15
6316999|NCT00435162|7221703|FG001|COMPLETED|Period 1 (6 Weeks)||15
6317000|NCT00435162|7221704|FG002|COMPLETED|Period 1 (6 Weeks)||6
6317001|NCT00435162|7221705|FG003|COMPLETED|Period 1 (6 Weeks)||8
6317002|NCT00435162|7221706|FG004|COMPLETED|Period 1 (6 Weeks)||15
6317003|NCT00435162|7221707|FG005|COMPLETED|Period 1 (6 Weeks)||15
6317004|NCT00435162|7221702|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
6317005|NCT00435162|7221703|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
6317006|NCT00435162|7221704|FG002|NOT COMPLETED|Period 1 (6 Weeks)||0
6317007|NCT00435162|7221705|FG003|NOT COMPLETED|Period 1 (6 Weeks)||0
6317008|NCT00435162|7221706|FG004|NOT COMPLETED|Period 1 (6 Weeks)||0
6317009|NCT00435162|7221707|FG005|NOT COMPLETED|Period 1 (6 Weeks)||0
6317010|NCT00435162|7221702|FG000|STARTED|Period 2 (2 Weeks)||15
6317011|NCT00435162|7221703|FG001|STARTED|Period 2 (2 Weeks)||15
6317012|NCT00435162|7221704|FG002|STARTED|Period 2 (2 Weeks)||6
6317013|NCT00435162|7221705|FG003|STARTED|Period 2 (2 Weeks)||8
6317014|NCT00435162|7221706|FG004|STARTED|Period 2 (2 Weeks)||15
6317015|NCT00435162|7221707|FG005|STARTED|Period 2 (2 Weeks)||15
6317016|NCT00435162|7221702|FG000|COMPLETED|Period 2 (2 Weeks)||15
6317017|NCT00435162|7221703|FG001|COMPLETED|Period 2 (2 Weeks)||14
6317018|NCT00435162|7221704|FG002|COMPLETED|Period 2 (2 Weeks)||6
6317019|NCT00435162|7221705|FG003|COMPLETED|Period 2 (2 Weeks)||8
6317020|NCT00435162|7221706|FG004|COMPLETED|Period 2 (2 Weeks)||15
6317021|NCT00435162|7221707|FG005|COMPLETED|Period 2 (2 Weeks)||15
6317022|NCT00435162|7221702|FG000|NOT COMPLETED|Period 2 (2 Weeks)||0
6317023|NCT00435162|7221703|FG001|NOT COMPLETED|Period 2 (2 Weeks)||1
6317024|NCT00435162|7221704|FG002|NOT COMPLETED|Period 2 (2 Weeks)||0
6317025|NCT00435162|7221705|FG003|NOT COMPLETED|Period 2 (2 Weeks)||0
6317026|NCT00435162|7221706|FG004|NOT COMPLETED|Period 2 (2 Weeks)||0
6317027|NCT00435162|7221707|FG005|NOT COMPLETED|Period 2 (2 Weeks)||0
6317028|NCT00435188|7221722|FG000|STARTED|Overall Study||199
6317029|NCT00435188|7221723|FG001|STARTED|Overall Study||199
6317030|NCT00435188|7221722|FG000|COMPLETED|Overall Study||177
6317031|NCT00435188|7221723|FG001|COMPLETED|Overall Study||176
6317032|NCT00435188|7221722|FG000|NOT COMPLETED|Overall Study||22
6317033|NCT00435188|7221723|FG001|NOT COMPLETED|Overall Study||23
6317034|NCT00435370|7221733|FG000|STARTED|Overall Study||90
6317035|NCT00435370|7221734|FG001|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
6317036|NCT00435370|7221733|FG000|COMPLETED|Overall Study||68
6317037|NCT00435370|7221734|FG001|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
6317038|NCT00435370|7221733|FG000|NOT COMPLETED|Overall Study||22
6317039|NCT00435370|7221734|FG001|NOT COMPLETED|Overall Study||20
6317040|NCT00435409|7221742|FG000|STARTED|Overall Study||221
6317041|NCT00435409|7221743|FG001|STARTED|Overall Study||143
6317042|NCT00435409|7221744|FG002|STARTED|Overall Study||78
6317043|NCT00435409|7221742|FG000|Treated|Overall Study||217
6317044|NCT00435409|7221743|FG001|Treated|Overall Study||139
6317045|NCT00435409|7221744|FG002|Treated|Overall Study||78
6317046|NCT00435409|7221742|FG000|COMPLETED|Overall Study||0
6317047|NCT00435409|7221743|FG001|COMPLETED|Overall Study||0
6317048|NCT00435409|7221744|FG002|COMPLETED|Overall Study||0
6317049|NCT00435409|7221742|FG000|NOT COMPLETED|Overall Study||221
6317050|NCT00435409|7221743|FG001|NOT COMPLETED|Overall Study||143
6317051|NCT00435409|7221744|FG002|NOT COMPLETED|Overall Study||78
6317052|NCT00435461|7221753|FG000|STARTED|Overall Study||313
6317053|NCT00435461|7221754|FG001|STARTED|Overall Study||312
6317054|NCT00435461|7221755|FG002|STARTED|Overall Study||311
6317055|NCT00435461|7221753|FG000|COMPLETED|Overall Study||290
6557826|NCT01770483|7480446|FG000|COMPLETED|Overall Study||33
6557827|NCT01770483|7480447|FG001|COMPLETED|Overall Study||33
6557828|NCT01770483|7480446|FG000|NOT COMPLETED|Overall Study||0
6557829|NCT01770483|7480447|FG001|NOT COMPLETED|Overall Study||0
6557830|NCT01770509|7480455|FG000|STARTED|Overall Study||12
6557831|NCT01770509|7480456|FG001|STARTED|Overall Study||17
6317056|NCT00435461|7221754|FG001|COMPLETED|Overall Study||298
6317057|NCT00435461|7221755|FG002|COMPLETED|Overall Study||287
6317058|NCT00435461|7221753|FG000|NOT COMPLETED|Overall Study||23
6317059|NCT00435461|7221754|FG001|NOT COMPLETED|Overall Study||14
6317060|NCT00435461|7221755|FG002|NOT COMPLETED|Overall Study||24
6317061|NCT00435487|7221765|FG000|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
6317062|NCT00435487|7221766|FG001|STARTED|Overall Study||86
6317063|NCT00435487|7221765|FG000|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
6317064|NCT00435487|7221766|FG001|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
6317065|NCT00435487|7221765|FG000|COMPLETED|Overall Study||76
6317066|NCT00435487|7221766|FG001|COMPLETED|Overall Study||71
6317067|NCT00435487|7221765|FG000|NOT COMPLETED|Overall Study||12
6317068|NCT00435487|7221766|FG001|NOT COMPLETED|Overall Study||15
6317069|NCT00435539|7221777|FG000|STARTED|Overall Study||12
6317070|NCT00435539|7221778|FG001|STARTED|Overall Study||13
6317071|NCT00435539|7221779|FG002|STARTED|Overall Study||11
6557832|NCT01770509|7480455|FG000|COMPLETED|Overall Study||11
6557833|NCT01770509|7480456|FG001|COMPLETED|Overall Study||14
6317072|NCT00435539|7221780|FG003|STARTED|Overall Study||12
6317073|NCT00435539|7221781|FG004|STARTED|Overall Study||12
6317074|NCT00435539|7221777|FG000|COMPLETED|Overall Study||12
6317075|NCT00435539|7221778|FG001|COMPLETED|Overall Study||13
6317076|NCT00435539|7221779|FG002|COMPLETED|Overall Study||11
6317077|NCT00435539|7221780|FG003|COMPLETED|Overall Study||12
6317078|NCT00435539|7221781|FG004|COMPLETED|Overall Study||12
6317079|NCT00435539|7221777|FG000|NOT COMPLETED|Overall Study||0
6317080|NCT00435539|7221778|FG001|NOT COMPLETED|Overall Study||0
6317081|NCT00435539|7221779|FG002|NOT COMPLETED|Overall Study||0
6317082|NCT00435539|7221780|FG003|NOT COMPLETED|Overall Study||0
6317083|NCT00435539|7221781|FG004|NOT COMPLETED|Overall Study||0
6317084|NCT00435591|7221796|FG000|STARTED|Overall Study||30
6317085|NCT00435591|7221797|FG001|STARTED|Overall Study||31
6557834|NCT01770509|7480455|FG000|NOT COMPLETED|Overall Study||1
6557835|NCT01770509|7480456|FG001|NOT COMPLETED|Overall Study||3
6557836|NCT01770652|7480466|FG000|STARTED|Overall Study||8
6557837|NCT01770652|7480467|FG001|STARTED|Overall Study||8
6557838|NCT01770652|7480468|FG002|STARTED|Overall Study||8
6557839|NCT01770652|7480469|FG003|STARTED|Overall Study||8
6317086|NCT00435591|7221798|FG002|STARTED|Overall Study||30
6317087|NCT00435591|7221799|FG003|STARTED|Overall Study||30
6317088|NCT00435591|7221796|FG000|Safety Analysis Set|Overall Study||28
6317089|NCT00435591|7221797|FG001|Safety Analysis Set|Overall Study||30
6317090|NCT00435591|7221798|FG002|Safety Analysis Set|Overall Study||30
6317091|NCT00435591|7221799|FG003|Safety Analysis Set|Overall Study||29
6557840|NCT01770652|7480466|FG000|COMPLETED|Overall Study||8
6557841|NCT01770652|7480467|FG001|COMPLETED|Overall Study||8
6557842|NCT01770652|7480468|FG002|COMPLETED|Overall Study||8
6557843|NCT01770652|7480469|FG003|COMPLETED|Overall Study||8
6557844|NCT01770652|7480466|FG000|NOT COMPLETED|Overall Study||0
6557845|NCT01770652|7480467|FG001|NOT COMPLETED|Overall Study||0
6557846|NCT01770652|7480468|FG002|NOT COMPLETED|Overall Study||0
6557847|NCT01770652|7480469|FG003|NOT COMPLETED|Overall Study||0
6317092|NCT00435591|7221796|FG000|Full Analysis Set|Overall Study||28
6317093|NCT00435591|7221797|FG001|Full Analysis Set|Overall Study||29
6317094|NCT00435591|7221798|FG002|Full Analysis Set|Overall Study||30
6317095|NCT00435591|7221799|FG003|Full Analysis Set|Overall Study||29
6317096|NCT00435591|7221796|FG000|End of Treatment|Overall Study||25
6317097|NCT00435591|7221797|FG001|End of Treatment|Overall Study||27
6317098|NCT00435591|7221798|FG002|End of Treatment|Overall Study||27
6317099|NCT00435591|7221799|FG003|End of Treatment|Overall Study||23
6317100|NCT00435591|7221796|FG000|COMPLETED|Overall Study||23
6317101|NCT00435591|7221797|FG001|COMPLETED|Overall Study||27
6317102|NCT00435591|7221798|FG002|COMPLETED|Overall Study||25
6317103|NCT00435591|7221799|FG003|COMPLETED|Overall Study||19
6317104|NCT00435591|7221796|FG000|NOT COMPLETED|Overall Study||7
6317105|NCT00435591|7221797|FG001|NOT COMPLETED|Overall Study||4
6317106|NCT00435591|7221798|FG002|NOT COMPLETED|Overall Study||5
6317107|NCT00435591|7221799|FG003|NOT COMPLETED|Overall Study||11
6317108|NCT00435812|7221814|FG000|STARTED|Overall Study||1820
6317109|NCT00435812|7221815|FG001|STARTED|Overall Study||608
6317110|NCT00435812|7221814|FG000|COMPLETED|Overall Study||1757
6317111|NCT00435812|7221815|FG001|COMPLETED|Overall Study||590
6317112|NCT00435812|7221814|FG000|NOT COMPLETED|Overall Study||63
6317113|NCT00435812|7221815|FG001|NOT COMPLETED|Overall Study||18
6317114|NCT00435825|7221825|FG000|STARTED|Overall Study||141
6317115|NCT00435825|7221826|FG001|STARTED|Overall Study||136
6317116|NCT00435825|7221827|FG002|STARTED|Overall Study||138
6317117|NCT00435825|7221828|FG003|STARTED|Overall Study||136
6317118|NCT00435825|7221825|FG000|Received Study Drug|Overall Study||140
6317119|NCT00435825|7221826|FG001|Received Study Drug|Overall Study||136
6317120|NCT00435825|7221827|FG002|Received Study Drug|Overall Study||136
6317121|NCT00435825|7221828|FG003|Received Study Drug|Overall Study||136
6317122|NCT00435825|7221825|FG000|Entered Follow-up|Overall Study||140
6317123|NCT00435825|7221826|FG001|Entered Follow-up|Overall Study||132
6317124|NCT00435825|7221827|FG002|Entered Follow-up|Overall Study||135
6317125|NCT00435825|7221828|FG003|Entered Follow-up|Overall Study||133
6317126|NCT00435825|7221825|FG000|Completed 24 Weeks Treatment|Overall Study||128
6317127|NCT00435825|7221826|FG001|Completed 24 Weeks Treatment|Overall Study||126
6317128|NCT00435825|7221827|FG002|Completed 24 Weeks Treatment|Overall Study||134
6317129|NCT00435825|7221828|FG003|Completed 24 Weeks Treatment|Overall Study||131
6317130|NCT00435825|7221825|FG000|Completed 48 Weeks Treatment|Overall Study||0
6317131|NCT00435825|7221826|FG001|Completed 48 Weeks Treatment|Overall Study||0
6317132|NCT00435825|7221827|FG002|Completed 48 Weeks Treatment|Overall Study||124
6317133|NCT00435825|7221828|FG003|Completed 48 Weeks Treatment|Overall Study||117
6317134|NCT00435825|7221825|FG000|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
6317135|NCT00435825|7221826|FG001|COMPLETED|Overall Study||124
6317136|NCT00435825|7221827|FG002|COMPLETED|Overall Study||127
6317137|NCT00435825|7221828|FG003|COMPLETED|Overall Study||120
6317138|NCT00435825|7221825|FG000|NOT COMPLETED|Overall Study||18
6317139|NCT00435825|7221826|FG001|NOT COMPLETED|Overall Study||12
6317140|NCT00435825|7221827|FG002|NOT COMPLETED|Overall Study||11
6317141|NCT00435825|7221828|FG003|NOT COMPLETED|Overall Study||16
6557848|NCT01770691|7480483|FG000|STARTED|Overall Study||7
6557849|NCT01770691|7480483|FG000|COMPLETED|Overall Study||7
6557850|NCT01770691|7480483|FG000|NOT COMPLETED|Overall Study||0
6557851|NCT01770743|7480495|FG000|STARTED|Overall Study||44
6557852|NCT01770743|7480496|FG001|STARTED|Overall Study||34
6317142|NCT00435929|7221840|FG000|STARTED|Overall Study||7
6317143|NCT00435929|7221841|FG001|STARTED|Overall Study||9
6317144|NCT00435929|7221840|FG000|COMPLETED|Overall Study||7
6317145|NCT00435929|7221841|FG001|COMPLETED|Overall Study||9
6317146|NCT00435929|7221840|FG000|NOT COMPLETED|Overall Study||0
6557853|NCT01770743|7480497|FG002|STARTED|Overall Study||23
6557854|NCT01770743|7480498|FG003|STARTED|Overall Study||44
6557855|NCT01770743|7480499|FG004|STARTED|Overall Study||23
6557856|NCT01770743|7480495|FG000|Treated|Overall Study||44
6557857|NCT01770743|7480496|FG001|Treated|Overall Study||34
6557858|NCT01770743|7480497|FG002|Treated|Overall Study||23
6317147|NCT00435929|7221841|FG001|NOT COMPLETED|Overall Study||0
6317148|NCT00435942|7221849|FG000|STARTED|Overall Study||120
6317149|NCT00435942|7221850|FG001|STARTED|Overall Study||60
6317150|NCT00435942|7221849|FG000|COMPLETED|Overall Study||97
6317151|NCT00435942|7221850|FG001|COMPLETED|Overall Study||33
6317152|NCT00435942|7221849|FG000|NOT COMPLETED|Overall Study||23
6317153|NCT00435942|7221850|FG001|NOT COMPLETED|Overall Study||27
6317154|NCT00435994|7221859|FG000|STARTED|Overall Study||22
6317155|NCT00435994|7221860|FG001|STARTED|Overall Study||25
6317156|NCT00435994|7221861|FG002|STARTED|Overall Study||12
6317157|NCT00435994|7221859|FG000|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
6317158|NCT00435994|7221860|FG001|COMPLETED|Overall Study||25
6557859|NCT01770743|7480498|FG003|Treated|Overall Study||44
6557860|NCT01770743|7480499|FG004|Treated|Overall Study||23
6557861|NCT01770743|7480495|FG000|COMPLETED|Overall Study||42
6557862|NCT01770743|7480496|FG001|COMPLETED|Overall Study||31
6317159|NCT00435994|7221861|FG002|COMPLETED|Overall Study||12
6317160|NCT00435994|7221859|FG000|NOT COMPLETED|Overall Study||7
6317161|NCT00435994|7221860|FG001|NOT COMPLETED|Overall Study||0
6317162|NCT00435994|7221861|FG002|NOT COMPLETED|Overall Study||0
6317163|NCT00436007|7221873|FG000|STARTED|Overall Study||170
6317164|NCT00436007|7221874|FG001|STARTED|Overall Study||170
6317165|NCT00436007|7221875|FG002|STARTED|Overall Study||171
6317166|NCT00436007|7221873|FG000|COMPLETED|Overall Study||151
6317167|NCT00436007|7221874|FG001|COMPLETED|Overall Study||156
6317168|NCT00436007|7221875|FG002|COMPLETED|Overall Study||148
6317169|NCT00436007|7221873|FG000|NOT COMPLETED|Overall Study||19
6317170|NCT00436007|7221874|FG001|NOT COMPLETED|Overall Study||14
6317171|NCT00436007|7221875|FG002|NOT COMPLETED|Overall Study||23
6317172|NCT00436046|7221891|FG000|STARTED|Overall Study||32
6317173|NCT00436046|7221892|FG001|STARTED|Overall Study||32
6317174|NCT00436046|7221893|FG002|STARTED|Overall Study||31
6317175|NCT00436046|7221891|FG000|COMPLETED|Overall Study||32
6317176|NCT00436046|7221892|FG001|COMPLETED|Overall Study||32
6317177|NCT00436046|7221893|FG002|COMPLETED|Overall Study||31
6317178|NCT00436046|7221891|FG000|NOT COMPLETED|Overall Study||0
6317179|NCT00436046|7221892|FG001|NOT COMPLETED|Overall Study||0
6317180|NCT00436046|7221893|FG002|NOT COMPLETED|Overall Study||0
6317181|NCT00436163|7221901|FG000|STARTED|Overall Study||39
6317182|NCT00436163|7221901|FG000|COMPLETED|Overall Study||36
6317183|NCT00436163|7221901|FG000|NOT COMPLETED|Overall Study||3
6317184|NCT00436215|7221906|FG000|STARTED|Overall Study||55
6317185|NCT00436215|7221906|FG000|COMPLETED|Overall Study||51
6317186|NCT00436215|7221906|FG000|NOT COMPLETED|Overall Study||4
6317187|NCT00436280|7221910|FG000|STARTED|Period 1: Induction||68
6317188|NCT00436280|7221910|FG000|Received at Least 1 Dose of Study Drug|Period 1: Induction||68
6317189|NCT00436280|7221910|FG000|COMPLETED|Period 1: Induction||40
6317190|NCT00436280|7221910|FG000|NOT COMPLETED|Period 1: Induction||28
6317191|NCT00436280|7221910|FG000|STARTED|Period 2: Consolidation||40
6317192|NCT00436280|7221910|FG000|COMPLETED|Period 2: Consolidation||23
6317193|NCT00436280|7221910|FG000|NOT COMPLETED|Period 2: Consolidation||17
6317194|NCT00436280|7221910|FG000|STARTED|Period 3: Maintenance||23
6317195|NCT00436280|7221910|FG000|COMPLETED|Period 3: Maintenance||5
6317196|NCT00436280|7221910|FG000|NOT COMPLETED|Period 3: Maintenance||18
6317197|NCT00436332|7221914|FG000|STARTED|Overall Study||84
6317198|NCT00436332|7221914|FG000|Eligible|Overall Study||82
6317199|NCT00436332|7221914|FG000|Eligible and Began Protocol Therapy|Overall Study||79
6317200|NCT00436332|7221914|FG000|COMPLETED|Overall Study||1
6317201|NCT00436332|7221914|FG000|NOT COMPLETED|Overall Study||83
6317202|NCT00436345|7221920|FG000|STARTED|Overall Study||21
6317203|NCT00436345|7221921|FG001|STARTED|Overall Study||18
6317204|NCT00436345|7221920|FG000|COMPLETED|Overall Study||18
6317205|NCT00436345|7221921|FG001|COMPLETED|Overall Study||18
6317206|NCT00436345|7221920|FG000|NOT COMPLETED|Overall Study||3
6317207|NCT00436345|7221921|FG001|NOT COMPLETED|Overall Study||0
6317208|NCT00436436|7221928|FG000|STARTED|Overall Study||12
6317209|NCT00436436|7221928|FG000|COMPLETED|Overall Study||0
6317210|NCT00436436|7221928|FG000|NOT COMPLETED|Overall Study||12
6317211|NCT00436475|7221936|FG000|STARTED|Overall Study||23
6317212|NCT00436475|7221937|FG001|STARTED|Overall Study||23
6317213|NCT00436475|7221938|FG002|STARTED|Overall Study||22
6317214|NCT00436475|7221939|FG003|STARTED|Overall Study||24
6317215|NCT00436475|7221936|FG000|COMPLETED|Overall Study||23
6317216|NCT00436475|7221937|FG001|COMPLETED|Overall Study||22
6317217|NCT00436475|7221938|FG002|COMPLETED|Overall Study||21
6317218|NCT00436475|7221939|FG003|COMPLETED|Overall Study||22
6317219|NCT00436475|7221936|FG000|NOT COMPLETED|Overall Study||0
6317220|NCT00436475|7221937|FG001|NOT COMPLETED|Overall Study||1
6557863|NCT01770743|7480497|FG002|COMPLETED|Overall Study||22
6557864|NCT01770743|7480498|FG003|COMPLETED|Overall Study||42
6557865|NCT01770743|7480499|FG004|COMPLETED|Overall Study||21
6317221|NCT00436475|7221938|FG002|NOT COMPLETED|Overall Study||1
6317222|NCT00436475|7221939|FG003|NOT COMPLETED|Overall Study||2
6317223|NCT00436501|7221951|FG000|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
6317224|NCT00436501|7221952|FG001|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
6317225|NCT00436501|7221951|FG000|COMPLETED|Complete Study Participation||9
6317226|NCT00436501|7221952|FG001|COMPLETED|Complete Study Participation||49
6317227|NCT00436501|7221951|FG000|NOT COMPLETED|Complete Study Participation||0
6317228|NCT00436501|7221952|FG001|NOT COMPLETED|Complete Study Participation||0
6317229|NCT00436501|7221951|FG000|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
6317230|NCT00436501|7221952|FG001|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
6317231|NCT00436501|7221951|FG000|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
6317232|NCT00436501|7221952|FG001|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
6317233|NCT00436501|7221951|FG000|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
6317234|NCT00436501|7221952|FG001|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
6317235|NCT00436501|7221951|FG000|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
6317236|NCT00436501|7221952|FG001|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
6317237|NCT00436501|7221951|FG000|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
6317238|NCT00436501|7221952|FG001|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
6317239|NCT00436501|7221951|FG000|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
6317240|NCT00436501|7221952|FG001|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
6317241|NCT00436553|7221962|FG000|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
6317242|NCT00436553|7221963|FG001|STARTED|Overall Study||105
6317243|NCT00436553|7221964|FG002|STARTED|Overall Study||112
6317244|NCT00436553|7221962|FG000|COMPLETED|Overall Study|Completed the 12 month study phase.|91
6317245|NCT00436553|7221963|FG001|COMPLETED|Overall Study||93
6317246|NCT00436553|7221964|FG002|COMPLETED|Overall Study||102
6317247|NCT00436553|7221962|FG000|NOT COMPLETED|Overall Study||13
6317248|NCT00436553|7221963|FG001|NOT COMPLETED|Overall Study||12
6317249|NCT00436553|7221964|FG002|NOT COMPLETED|Overall Study||10
6317250|NCT00436566|7221972|FG000|STARTED|Overall Study||112
6317251|NCT00436566|7221972|FG000|COMPLETED|Overall Study||109
6317252|NCT00436566|7221972|FG000|NOT COMPLETED|Overall Study||3
6317253|NCT00436605|7221976|FG000|STARTED|Overall Study||39
6317254|NCT00436605|7221976|FG000|COMPLETED|Overall Study||36
6317255|NCT00436605|7221976|FG000|NOT COMPLETED|Overall Study||3
6317256|NCT00436618|7221983|FG000|STARTED|Overall Study||114
6317257|NCT00436618|7221984|FG001|STARTED|Overall Study||55
6317258|NCT00436618|7221985|FG002|STARTED|Overall Study||107
6317259|NCT00436618|7221983|FG000|COMPLETED|Overall Study||84
6317260|NCT00436618|7221984|FG001|COMPLETED|Overall Study||28
6317261|NCT00436618|7221985|FG002|COMPLETED|Overall Study||46
6317262|NCT00436618|7221983|FG000|NOT COMPLETED|Overall Study||30
6317263|NCT00436618|7221984|FG001|NOT COMPLETED|Overall Study||27
6317264|NCT00436618|7221985|FG002|NOT COMPLETED|Overall Study||61
6317265|NCT00436644|7221993|FG000|STARTED|Overall Study||18
6317266|NCT00436644|7221993|FG000|COMPLETED|Overall Study||15
6317267|NCT00436644|7221993|FG000|NOT COMPLETED|Overall Study||3
6317268|NCT00436748|7221999|FG000|STARTED|Overall Study||59
6317269|NCT00436748|7222000|FG001|STARTED|Overall Study||57
6317270|NCT00436748|7221999|FG000|Received Treatment|Overall Study||58
6317271|NCT00436748|7222000|FG001|Received Treatment|Overall Study||56
6317272|NCT00436748|7221999|FG000|COMPLETED|Overall Study||48
6317273|NCT00436748|7222000|FG001|COMPLETED|Overall Study||45
6317274|NCT00436748|7221999|FG000|NOT COMPLETED|Overall Study||11
6317275|NCT00436748|7222000|FG001|NOT COMPLETED|Overall Study||12
6317276|NCT00436852|7222008|FG000|STARTED|Overall Study||45
6317277|NCT00436852|7222009|FG001|STARTED|Overall Study||47
6317278|NCT00436852|7222008|FG000|COMPLETED|Overall Study||10
6317279|NCT00436852|7222009|FG001|COMPLETED|Overall Study||2
6317280|NCT00436852|7222008|FG000|NOT COMPLETED|Overall Study||35
6317281|NCT00436852|7222009|FG001|NOT COMPLETED|Overall Study||45
6317282|NCT00436904|7222018|FG000|STARTED|Overall Study||30
6317283|NCT00436904|7222018|FG000|COMPLETED|Overall Study||30
6317284|NCT00436904|7222018|FG000|NOT COMPLETED|Overall Study||0
6317285|NCT00436917|7222022|FG000|STARTED|Overall Study|7 participants (1 cancellation, 1 major violation, 5 ineligibles) were excluded from all analysis.|53
6317286|NCT00436917|7222022|FG000|COMPLETED|Overall Study||32
6317287|NCT00436917|7222022|FG000|NOT COMPLETED|Overall Study||21
6317288|NCT00436956|7222026|FG000|STARTED|Overall Study||36
6317289|NCT00436956|7222027|FG001|STARTED|Overall Study||23
6317290|NCT00436956|7222026|FG000|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
6317291|NCT00436956|7222027|FG001|COMPLETED|Overall Study||23
6317292|NCT00436956|7222026|FG000|NOT COMPLETED|Overall Study||1
6317293|NCT00436956|7222027|FG001|NOT COMPLETED|Overall Study||0
6317294|NCT00436969|7222036|FG000|STARTED|Overall Study||88
6317295|NCT00436969|7222037|FG001|STARTED|Overall Study||186
6317296|NCT00436969|7222036|FG000|Randomized But Not Treated|Overall Study||1
6317297|NCT00436969|7222037|FG001|Randomized But Not Treated|Overall Study||3
6317298|NCT00436969|7222036|FG000|COMPLETED|Overall Study||66
6317299|NCT00436969|7222037|FG001|COMPLETED|Overall Study||134
6317300|NCT00436969|7222036|FG000|NOT COMPLETED|Overall Study||22
6317301|NCT00436969|7222037|FG001|NOT COMPLETED|Overall Study||52
6375308|NCT00754832|7285926|FG000|NOT COMPLETED|2 Weeks Washout||1
6375309|NCT00754832|7285927|FG001|NOT COMPLETED|2 Weeks Washout||2
6375310|NCT00754832|7285926|FG000|STARTED|Second 6 Weeks Intervention||17
6375311|NCT00754832|7285927|FG001|STARTED|Second 6 Weeks Intervention||26
6375312|NCT00754832|7285926|FG000|COMPLETED|Second 6 Weeks Intervention||17
6375313|NCT00754832|7285927|FG001|COMPLETED|Second 6 Weeks Intervention||24
6375314|NCT00754832|7285926|FG000|NOT COMPLETED|Second 6 Weeks Intervention||0
6375315|NCT00754832|7285927|FG001|NOT COMPLETED|Second 6 Weeks Intervention||2
6375316|NCT00754845|7285935|FG000|STARTED|Overall Study||959
6375317|NCT00754845|7285936|FG001|STARTED|Overall Study||959
6375318|NCT00754845|7285935|FG000|COMPLETED|Overall Study||959
6375319|NCT00754845|7285936|FG001|COMPLETED|Overall Study||959
6375320|NCT00754845|7285935|FG000|NOT COMPLETED|Overall Study||0
6375321|NCT00754845|7285936|FG001|NOT COMPLETED|Overall Study||0
6375322|NCT00754923|7285944|FG000|STARTED|Overall Study||11
6375323|NCT00754923|7285944|FG000|COMPLETED|Overall Study||11
6375324|NCT00754923|7285944|FG000|NOT COMPLETED|Overall Study||0
6375325|NCT00754936|7285948|FG000|STARTED|Overall Study||71
6375326|NCT00754936|7285948|FG000|COMPLETED|Overall Study||59
6375327|NCT00754936|7285948|FG000|NOT COMPLETED|Overall Study||12
6375328|NCT00755040|7285954|FG000|STARTED|Overall Study||83
6375329|NCT00755040|7285955|FG001|STARTED|Overall Study||81
6375330|NCT00755040|7285954|FG000|COMPLETED|Overall Study||40
6375331|NCT00755040|7285955|FG001|COMPLETED|Overall Study||47
6375332|NCT00755040|7285954|FG000|NOT COMPLETED|Overall Study||43
6375333|NCT00755040|7285955|FG001|NOT COMPLETED|Overall Study||34
6375334|NCT00755079|7285963|FG000|STARTED|Overall Study||18
6375335|NCT00755079|7285964|FG001|STARTED|Overall Study||22
6375336|NCT00755079|7285963|FG000|COMPLETED|Overall Study||17
6375337|NCT00755079|7285964|FG001|COMPLETED|Overall Study||16
6375338|NCT00755079|7285963|FG000|NOT COMPLETED|Overall Study||1
6375339|NCT00755079|7285964|FG001|NOT COMPLETED|Overall Study||6
6375340|NCT00755105|7285973|FG000|STARTED|Overall Study||38
6375341|NCT00755105|7285974|FG001|STARTED|Overall Study||30
6375342|NCT00755105|7285975|FG002|STARTED|Overall Study||9
6375343|NCT00755105|7285973|FG000|COMPLETED|Overall Study||29
6375344|NCT00755105|7285974|FG001|COMPLETED|Overall Study||19
6375345|NCT00755105|7285975|FG002|COMPLETED|Overall Study||5
6375346|NCT00755105|7285973|FG000|NOT COMPLETED|Overall Study||9
6375347|NCT00755105|7285974|FG001|NOT COMPLETED|Overall Study||11
6375348|NCT00755105|7285975|FG002|NOT COMPLETED|Overall Study||4
6375349|NCT00755131|7285985|FG000|STARTED|Overall Study||37
6375350|NCT00755131|7285986|FG001|STARTED|Overall Study||38
6375351|NCT00755131|7285985|FG000|COMPLETED|Overall Study||37
6375352|NCT00755131|7285986|FG001|COMPLETED|Overall Study||38
6375353|NCT00755131|7285985|FG000|NOT COMPLETED|Overall Study||0
6375354|NCT00755131|7285986|FG001|NOT COMPLETED|Overall Study||0
6375355|NCT00755183|7285994|FG000|STARTED|Overall Study||30
6375356|NCT00755183|7285995|FG001|STARTED|Overall Study||30
6375357|NCT00755183|7285994|FG000|COMPLETED|Overall Study||23
6375358|NCT00755183|7285995|FG001|COMPLETED|Overall Study||24
6375359|NCT00755183|7285994|FG000|NOT COMPLETED|Overall Study||7
6375360|NCT00755183|7285995|FG001|NOT COMPLETED|Overall Study||6
6375361|NCT00755196|7286003|FG000|STARTED|Overall Study||30
6375362|NCT00755196|7286003|FG000|COMPLETED|Overall Study||28
6375363|NCT00755196|7286003|FG000|NOT COMPLETED|Overall Study||2
6375364|NCT00755222|7286010|FG000|STARTED|Overall Study||111
6375365|NCT00755222|7286011|FG001|STARTED|Overall Study||36
6375366|NCT00755222|7286010|FG000|COMPLETED|Overall Study||103
6375367|NCT00755222|7286011|FG001|COMPLETED|Overall Study||34
6375368|NCT00755222|7286010|FG000|NOT COMPLETED|Overall Study||8
6375369|NCT00755222|7286011|FG001|NOT COMPLETED|Overall Study||2
6375370|NCT00755235|7286019|FG000|STARTED|Overall Study||106
6375371|NCT00755235|7286020|FG001|STARTED|Overall Study||102
6375372|NCT00755235|7286019|FG000|COMPLETED|Overall Study||104
6375373|NCT00755235|7286020|FG001|COMPLETED|Overall Study||93
6375374|NCT00755235|7286019|FG000|NOT COMPLETED|Overall Study||2
6375375|NCT00755235|7286020|FG001|NOT COMPLETED|Overall Study||9
6375376|NCT00755274|7286028|FG000|STARTED|Overall Study||24
6375377|NCT00755274|7286029|FG001|STARTED|Overall Study||8
6375378|NCT00755274|7286028|FG000|COMPLETED|Overall Study||24
6375379|NCT00755274|7286029|FG001|COMPLETED|Overall Study||8
6375380|NCT00755274|7286028|FG000|NOT COMPLETED|Overall Study||0
6375381|NCT00755274|7286029|FG001|NOT COMPLETED|Overall Study||0
6375382|NCT00755326|7286037|FG000|STARTED|Overall Study||47
6375383|NCT00755326|7286038|FG001|STARTED|Overall Study||45
6375384|NCT00755326|7286037|FG000|COMPLETED|Overall Study||45
6375385|NCT00755326|7286038|FG001|COMPLETED|Overall Study||42
6375386|NCT00755326|7286037|FG000|NOT COMPLETED|Overall Study||2
6375387|NCT00755326|7286038|FG001|NOT COMPLETED|Overall Study||3
6375388|NCT00755417|7286048|FG000|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
6375389|NCT00755417|7286049|FG001|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
6375390|NCT00755417|7286050|FG002|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
6375391|NCT00755417|7286048|FG000|COMPLETED|Overall Study||112
6375392|NCT00755417|7286049|FG001|COMPLETED|Overall Study||126
6375393|NCT00755417|7286050|FG002|COMPLETED|Overall Study||135
6375394|NCT00755417|7286048|FG000|NOT COMPLETED|Overall Study||62
6375395|NCT00755417|7286049|FG001|NOT COMPLETED|Overall Study||55
6375396|NCT00755417|7286050|FG002|NOT COMPLETED|Overall Study||42
6317302|NCT00436982|7222045|FG000|STARTED|Overall Study||30
6317303|NCT00436982|7222046|FG001|STARTED|Overall Study||30
6317304|NCT00436982|7222045|FG000|COMPLETED|Overall Study||26
6317305|NCT00436982|7222046|FG001|COMPLETED|Overall Study||26
6317306|NCT00436982|7222045|FG000|NOT COMPLETED|Overall Study||4
6317307|NCT00436982|7222046|FG001|NOT COMPLETED|Overall Study||4
6317308|NCT00437034|7222056|FG000|STARTED|Overall Study||6
6317309|NCT00437034|7222056|FG000|COMPLETED|Overall Study||0
6317310|NCT00437034|7222056|FG000|NOT COMPLETED|Overall Study||6
6317311|NCT00437073|7222062|FG000|STARTED|Overall Study||13
6317312|NCT00437073|7222063|FG001|STARTED|Overall Study||9
6317313|NCT00437073|7222062|FG000|COMPLETED|Overall Study||12
6317314|NCT00437073|7222063|FG001|COMPLETED|Overall Study||8
6317315|NCT00437073|7222062|FG000|NOT COMPLETED|Overall Study||1
6317316|NCT00437073|7222063|FG001|NOT COMPLETED|Overall Study||1
6317317|NCT00437125|7222069|FG000|STARTED|Overall Study||151
6317318|NCT00437125|7222069|FG000|COMPLETED|Overall Study||119
6317319|NCT00437125|7222069|FG000|NOT COMPLETED|Overall Study||32
6317320|NCT00437203|7222083|FG000|STARTED|Overall Study||6
6317321|NCT00437203|7222084|FG001|STARTED|Overall Study||8
6317322|NCT00437203|7222085|FG002|STARTED|Overall Study||3
6317323|NCT00437203|7222086|FG003|STARTED|Overall Study||3
6317324|NCT00437203|7222087|FG004|STARTED|Overall Study||3
6317325|NCT00437203|7222088|FG005|STARTED|Overall Study||3
6317326|NCT00437203|7222089|FG006|STARTED|Overall Study||7
6317327|NCT00437203|7222090|FG007|STARTED|Overall Study||3
6317328|NCT00437203|7222091|FG008|STARTED|Overall Study||3
6317329|NCT00437203|7222092|FG009|STARTED|Overall Study||4
6317330|NCT00437203|7222083|FG000|COMPLETED|Overall Study||0
6317331|NCT00437203|7222084|FG001|COMPLETED|Overall Study||0
6317332|NCT00437203|7222085|FG002|COMPLETED|Overall Study||0
6317333|NCT00437203|7222086|FG003|COMPLETED|Overall Study||0
6317334|NCT00437203|7222087|FG004|COMPLETED|Overall Study||0
6317335|NCT00437203|7222088|FG005|COMPLETED|Overall Study||0
6317336|NCT00437203|7222089|FG006|COMPLETED|Overall Study||0
6317337|NCT00437203|7222090|FG007|COMPLETED|Overall Study||0
6317338|NCT00437203|7222091|FG008|COMPLETED|Overall Study||0
6317339|NCT00437203|7222092|FG009|COMPLETED|Overall Study||0
6317340|NCT00437203|7222083|FG000|NOT COMPLETED|Overall Study||6
6317341|NCT00437203|7222084|FG001|NOT COMPLETED|Overall Study||8
6317342|NCT00437203|7222085|FG002|NOT COMPLETED|Overall Study||3
6317343|NCT00437203|7222086|FG003|NOT COMPLETED|Overall Study||3
6317344|NCT00437203|7222087|FG004|NOT COMPLETED|Overall Study||3
6317345|NCT00437203|7222088|FG005|NOT COMPLETED|Overall Study||3
6317346|NCT00437203|7222089|FG006|NOT COMPLETED|Overall Study||7
6317347|NCT00437203|7222090|FG007|NOT COMPLETED|Overall Study||3
6317348|NCT00437203|7222091|FG008|NOT COMPLETED|Overall Study||3
6317349|NCT00437203|7222092|FG009|NOT COMPLETED|Overall Study||4
6317350|NCT00437268|7222125|FG000|STARTED|Overall Study||13
6317351|NCT00437268|7222126|FG001|STARTED|Overall Study||13
6317352|NCT00437268|7222125|FG000|Received at Least 1 Dose of Study Drug|Overall Study||13
6317353|NCT00437268|7222126|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
6317354|NCT00437268|7222125|FG000|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|13
6317355|NCT00437268|7222126|FG001|Protocol Qualified (PQ) Participant|Overall Study|PQ population: randomized participants without an immune reaction to cetuximab after the first dose|12
6317356|NCT00437268|7222125|FG000|COMPLETED|Overall Study||0
6317357|NCT00437268|7222126|FG001|COMPLETED|Overall Study||0
6317358|NCT00437268|7222125|FG000|NOT COMPLETED|Overall Study||13
6317359|NCT00437268|7222126|FG001|NOT COMPLETED|Overall Study||13
6317360|NCT00437281|7222154|FG000|STARTED|Overall Study||3
6317361|NCT00437281|7222155|FG001|STARTED|Overall Study||3
6317362|NCT00437281|7222156|FG002|STARTED|Overall Study||3
6317363|NCT00437281|7222157|FG003|STARTED|Overall Study||3
6317364|NCT00437281|7222158|FG004|STARTED|Overall Study||4
6317365|NCT00437281|7222159|FG005|STARTED|Overall Study||4
6317366|NCT00437281|7222160|FG006|STARTED|Overall Study||3
6317367|NCT00437281|7222161|FG007|STARTED|Overall Study||3
6317368|NCT00437281|7222162|FG008|STARTED|Overall Study||3
6317369|NCT00437281|7222163|FG009|STARTED|Overall Study||5
6317370|NCT00437281|7222164|FG010|STARTED|Overall Study||3
6317371|NCT00437281|7222165|FG011|STARTED|Overall Study||3
6317372|NCT00437281|7222166|FG012|STARTED|Overall Study||2
6317373|NCT00437281|7222167|FG013|STARTED|Overall Study||3
6317374|NCT00437281|7222168|FG014|STARTED|Overall Study||5
6317375|NCT00437281|7222169|FG015|STARTED|Overall Study||3
6317376|NCT00437281|7222170|FG016|STARTED|Overall Study||3
6317377|NCT00437281|7222171|FG017|STARTED|Overall Study||4
6317378|NCT00437281|7222172|FG018|STARTED|Overall Study||2
6317379|NCT00437281|7222173|FG019|STARTED|Overall Study||3
6317380|NCT00437281|7222154|FG000|COMPLETED|Overall Study||3
6317381|NCT00437281|7222155|FG001|COMPLETED|Overall Study||3
6317382|NCT00437281|7222156|FG002|COMPLETED|Overall Study||3
6317383|NCT00437281|7222157|FG003|COMPLETED|Overall Study||2
6317384|NCT00437281|7222158|FG004|COMPLETED|Overall Study||4
6317385|NCT00437281|7222159|FG005|COMPLETED|Overall Study||3
6317386|NCT00437281|7222160|FG006|COMPLETED|Overall Study||3
6317387|NCT00437281|7222161|FG007|COMPLETED|Overall Study||3
6317388|NCT00437281|7222162|FG008|COMPLETED|Overall Study||3
6317389|NCT00437281|7222163|FG009|COMPLETED|Overall Study||4
6317390|NCT00437281|7222164|FG010|COMPLETED|Overall Study||3
6317391|NCT00437281|7222165|FG011|COMPLETED|Overall Study||3
6317392|NCT00437281|7222166|FG012|COMPLETED|Overall Study||2
6317393|NCT00437281|7222167|FG013|COMPLETED|Overall Study||2
6317394|NCT00437281|7222168|FG014|COMPLETED|Overall Study||4
6317395|NCT00437281|7222169|FG015|COMPLETED|Overall Study||3
6317396|NCT00437281|7222170|FG016|COMPLETED|Overall Study||3
6317397|NCT00437281|7222171|FG017|COMPLETED|Overall Study||4
6317398|NCT00437281|7222172|FG018|COMPLETED|Overall Study||1
6317399|NCT00437281|7222173|FG019|COMPLETED|Overall Study||2
6317400|NCT00437281|7222154|FG000|NOT COMPLETED|Overall Study||0
6317401|NCT00437281|7222155|FG001|NOT COMPLETED|Overall Study||0
6317402|NCT00437281|7222156|FG002|NOT COMPLETED|Overall Study||0
6317403|NCT00437281|7222157|FG003|NOT COMPLETED|Overall Study||1
6317404|NCT00437281|7222158|FG004|NOT COMPLETED|Overall Study||0
6317405|NCT00437281|7222159|FG005|NOT COMPLETED|Overall Study||1
6317406|NCT00437281|7222160|FG006|NOT COMPLETED|Overall Study||0
6317407|NCT00437281|7222161|FG007|NOT COMPLETED|Overall Study||0
6317408|NCT00437281|7222162|FG008|NOT COMPLETED|Overall Study||0
6317409|NCT00437281|7222163|FG009|NOT COMPLETED|Overall Study||1
6317410|NCT00437281|7222164|FG010|NOT COMPLETED|Overall Study||0
6317411|NCT00437281|7222165|FG011|NOT COMPLETED|Overall Study||0
6317412|NCT00437281|7222166|FG012|NOT COMPLETED|Overall Study||0
6317413|NCT00437281|7222167|FG013|NOT COMPLETED|Overall Study||1
6317414|NCT00437281|7222168|FG014|NOT COMPLETED|Overall Study||1
6317415|NCT00437281|7222169|FG015|NOT COMPLETED|Overall Study||0
6317416|NCT00437281|7222170|FG016|NOT COMPLETED|Overall Study||0
6317417|NCT00437281|7222171|FG017|NOT COMPLETED|Overall Study||0
6317418|NCT00437281|7222172|FG018|NOT COMPLETED|Overall Study||1
6317419|NCT00437281|7222173|FG019|NOT COMPLETED|Overall Study||1
6317420|NCT00437294|7222247|FG000|STARTED|Overall Study||43
6317421|NCT00437294|7222248|FG001|STARTED|Overall Study||43
6317422|NCT00437294|7222247|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
6317423|NCT00437294|7222248|FG001|Received at Least 1 Dose of Study Drug|Overall Study||43
6317424|NCT00437294|7222247|FG000|COMPLETED|Overall Study||0
6317425|NCT00437294|7222248|FG001|COMPLETED|Overall Study||0
6317426|NCT00437294|7222247|FG000|NOT COMPLETED|Overall Study||43
6317427|NCT00437294|7222248|FG001|NOT COMPLETED|Overall Study||43
6317428|NCT00437489|7222262|FG000|STARTED|Overall Study||25
6317429|NCT00437489|7222263|FG001|STARTED|Overall Study||24
6317430|NCT00437489|7222262|FG000|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
6317431|NCT00437489|7222263|FG001|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
6317432|NCT00437489|7222262|FG000|NOT COMPLETED|Overall Study||23
6317433|NCT00437489|7222263|FG001|NOT COMPLETED|Overall Study||22
6317434|NCT00437645|7222271|FG000|STARTED|Overall Study||592
6317435|NCT00437645|7222272|FG001|STARTED|Overall Study||591
6317436|NCT00437645|7222271|FG000|COMPLETED|Overall Study||557
6317437|NCT00437645|7222272|FG001|COMPLETED|Overall Study||476
6317438|NCT00437645|7222271|FG000|NOT COMPLETED|Overall Study||35
6317439|NCT00437645|7222272|FG001|NOT COMPLETED|Overall Study||115
6317440|NCT00437658|7222281|FG000|STARTED|Treatment Period (24 Weeks)||84
6317441|NCT00437658|7222282|FG001|STARTED|Treatment Period (24 Weeks)||84
6317442|NCT00437658|7222283|FG002|STARTED|Treatment Period (24 Weeks)||84
6317443|NCT00437658|7222281|FG000|Received Study Drug|Treatment Period (24 Weeks)||84
6317444|NCT00437658|7222282|FG001|Received Study Drug|Treatment Period (24 Weeks)||84
6317445|NCT00437658|7222283|FG002|Received Study Drug|Treatment Period (24 Weeks)||84
6317446|NCT00437658|7222281|FG000|COMPLETED|Treatment Period (24 Weeks)||56
6317447|NCT00437658|7222282|FG001|COMPLETED|Treatment Period (24 Weeks)||62
6317448|NCT00437658|7222283|FG002|COMPLETED|Treatment Period (24 Weeks)||51
6317449|NCT00437658|7222281|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||28
6317450|NCT00437658|7222282|FG001|NOT COMPLETED|Treatment Period (24 Weeks)||22
6317451|NCT00437658|7222283|FG002|NOT COMPLETED|Treatment Period (24 Weeks)||33
6317452|NCT00437658|7222281|FG000|STARTED|Post-treatment Period (24 Weeks)||56
6317453|NCT00437658|7222282|FG001|STARTED|Post-treatment Period (24 Weeks)||62
6317454|NCT00437658|7222283|FG002|STARTED|Post-treatment Period (24 Weeks)||51
6317455|NCT00437658|7222281|FG000|COMPLETED|Post-treatment Period (24 Weeks)||32
6317456|NCT00437658|7222282|FG001|COMPLETED|Post-treatment Period (24 Weeks)||54
6317457|NCT00437658|7222283|FG002|COMPLETED|Post-treatment Period (24 Weeks)||37
6317458|NCT00437658|7222281|FG000|NOT COMPLETED|Post-treatment Period (24 Weeks)||24
6317459|NCT00437658|7222282|FG001|NOT COMPLETED|Post-treatment Period (24 Weeks)||8
6317460|NCT00437658|7222283|FG002|NOT COMPLETED|Post-treatment Period (24 Weeks)||14
6317461|NCT00437983|7222293|FG000|STARTED|Overall Study||79
6317462|NCT00437983|7222294|FG001|STARTED|Overall Study||78
6317463|NCT00437983|7222293|FG000|COMPLETED|Overall Study||66
6317464|NCT00437983|7222294|FG001|COMPLETED|Overall Study||65
6317465|NCT00437983|7222293|FG000|NOT COMPLETED|Overall Study||13
6317466|NCT00437983|7222294|FG001|NOT COMPLETED|Overall Study||13
6317467|NCT00438100|7222302|FG000|STARTED|Overall Study||73
6557866|NCT01770743|7480495|FG000|NOT COMPLETED|Overall Study||2
6557867|NCT01770743|7480496|FG001|NOT COMPLETED|Overall Study||3
6557868|NCT01770743|7480497|FG002|NOT COMPLETED|Overall Study||1
6557869|NCT01770743|7480498|FG003|NOT COMPLETED|Overall Study||2
6317468|NCT00438100|7222303|FG001|STARTED|Overall Study||69
6317469|NCT00438100|7222302|FG000|COMPLETED|Overall Study||71
6317470|NCT00438100|7222303|FG001|COMPLETED|Overall Study||65
6317471|NCT00438100|7222302|FG000|NOT COMPLETED|Overall Study||2
6317472|NCT00438100|7222303|FG001|NOT COMPLETED|Overall Study||4
6557870|NCT01770743|7480499|FG004|NOT COMPLETED|Overall Study||2
6562858|NCT01803204|7485753|FG000|COMPLETED|Overall Study||20
6317473|NCT00438191|7222311|FG000|STARTED|Overall Study||43
6317474|NCT00438191|7222312|FG001|STARTED|Overall Study||40
6317475|NCT00438191|7222311|FG000|COMPLETED|Overall Study||32
6317476|NCT00438191|7222312|FG001|COMPLETED|Overall Study||26
6317477|NCT00438191|7222311|FG000|NOT COMPLETED|Overall Study||11
6317478|NCT00438191|7222312|FG001|NOT COMPLETED|Overall Study||14
6317479|NCT00438204|7222318|FG000|STARTED|Overall Study||39
6317480|NCT00438204|7222318|FG000|COMPLETED|Overall Study||39
6317481|NCT00438204|7222318|FG000|NOT COMPLETED|Overall Study||0
6317482|NCT00438256|7222323|FG000|STARTED|Overall Study||3
6317483|NCT00438256|7222324|FG001|STARTED|Overall Study||3
6317484|NCT00438256|7222325|FG002|STARTED|Overall Study||3
6317485|NCT00438256|7222326|FG003|STARTED|Overall Study||41
6317486|NCT00438256|7222323|FG000|Surgical Resection|Overall Study||1
6317487|NCT00438256|7222324|FG001|Surgical Resection|Overall Study||2
6317488|NCT00438256|7222325|FG002|Surgical Resection|Overall Study||2
6317489|NCT00438256|7222326|FG003|Surgical Resection|Overall Study||34
6317490|NCT00438256|7222323|FG000|COMPLETED|Overall Study||1
6317491|NCT00438256|7222324|FG001|COMPLETED|Overall Study||2
6317492|NCT00438256|7222325|FG002|COMPLETED|Overall Study||2
6317493|NCT00438256|7222326|FG003|COMPLETED|Overall Study||32
6317494|NCT00438256|7222323|FG000|NOT COMPLETED|Overall Study||2
6317495|NCT00438256|7222324|FG001|NOT COMPLETED|Overall Study||1
6317496|NCT00438256|7222325|FG002|NOT COMPLETED|Overall Study||1
6317497|NCT00438256|7222326|FG003|NOT COMPLETED|Overall Study||9
6317498|NCT00438360|7222341|FG000|STARTED|Overall Study|"Started indicates randomized patients."|162
6317499|NCT00438360|7222342|FG001|STARTED|Overall Study||81
6317500|NCT00438360|7222341|FG000|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
6317501|NCT00438360|7222342|FG001|Intention to Treat (ITT) Population|Overall Study||79
6317502|NCT00438360|7222341|FG000|COMPLETED|Overall Study||90
6317503|NCT00438360|7222342|FG001|COMPLETED|Overall Study||38
6317504|NCT00438360|7222341|FG000|NOT COMPLETED|Overall Study||72
6317505|NCT00438360|7222342|FG001|NOT COMPLETED|Overall Study||43
6317506|NCT00438399|7222351|FG000|STARTED|Overall Study||38
6317507|NCT00438399|7222352|FG001|STARTED|Overall Study||40
6317508|NCT00438399|7222353|FG002|STARTED|Overall Study||35
6317509|NCT00438399|7222354|FG003|STARTED|Overall Study||36
6317510|NCT00438399|7222355|FG004|STARTED|Overall Study||33
6317511|NCT00438399|7222356|FG005|STARTED|Overall Study||37
6317512|NCT00438399|7222351|FG000|TREATED & ANALYZED|Overall Study||30
6317513|NCT00438399|7222352|FG001|TREATED & ANALYZED|Overall Study||32
6317514|NCT00438399|7222353|FG002|TREATED & ANALYZED|Overall Study||28
6317515|NCT00438399|7222354|FG003|TREATED & ANALYZED|Overall Study||32
6317516|NCT00438399|7222355|FG004|TREATED & ANALYZED|Overall Study||30
6317517|NCT00438399|7222356|FG005|TREATED & ANALYZED|Overall Study||31
6317518|NCT00438399|7222351|FG000|COMPLETED|Overall Study||30
6317519|NCT00438399|7222352|FG001|COMPLETED|Overall Study||32
6317520|NCT00438399|7222353|FG002|COMPLETED|Overall Study||28
6317521|NCT00438399|7222354|FG003|COMPLETED|Overall Study||32
6317522|NCT00438399|7222355|FG004|COMPLETED|Overall Study||30
6317523|NCT00438399|7222356|FG005|COMPLETED|Overall Study||31
6317524|NCT00438399|7222351|FG000|NOT COMPLETED|Overall Study||8
6317525|NCT00438399|7222352|FG001|NOT COMPLETED|Overall Study||8
6317526|NCT00438399|7222353|FG002|NOT COMPLETED|Overall Study||7
6317527|NCT00438399|7222354|FG003|NOT COMPLETED|Overall Study||4
6317528|NCT00438399|7222355|FG004|NOT COMPLETED|Overall Study||3
6317529|NCT00438399|7222356|FG005|NOT COMPLETED|Overall Study||6
6317530|NCT00438451|7222368|FG000|STARTED|Overall Study||122
6317531|NCT00438451|7222369|FG001|STARTED|Overall Study||121
6317532|NCT00438451|7222370|FG002|STARTED|Overall Study||118
6317533|NCT00438451|7222368|FG000|Safety Population|Overall Study||122
6317534|NCT00438451|7222369|FG001|Safety Population|Overall Study||121
6317535|NCT00438451|7222370|FG002|Safety Population|Overall Study||117
6317536|NCT00438451|7222368|FG000|ITT Population|Overall Study||122
6317537|NCT00438451|7222369|FG001|ITT Population|Overall Study||120
6317538|NCT00438451|7222370|FG002|ITT Population|Overall Study||117
6317539|NCT00438451|7222368|FG000|Maintenance Phase (Week 7-58)|Overall Study||93
6317540|NCT00438451|7222369|FG001|Maintenance Phase (Week 7-58)|Overall Study||89
6317541|NCT00438451|7222370|FG002|Maintenance Phase (Week 7-58)|Overall Study||93
6317542|NCT00438451|7222368|FG000|COMPLETED|Overall Study||75
6317543|NCT00438451|7222369|FG001|COMPLETED|Overall Study||55
6317544|NCT00438451|7222370|FG002|COMPLETED|Overall Study||65
6317545|NCT00438451|7222368|FG000|NOT COMPLETED|Overall Study||47
6317546|NCT00438451|7222369|FG001|NOT COMPLETED|Overall Study||66
6317547|NCT00438451|7222370|FG002|NOT COMPLETED|Overall Study||53
6317548|NCT00438464|7222380|FG000|STARTED|Overall Study||103
6317549|NCT00438464|7222381|FG001|STARTED|Overall Study||101
6317550|NCT00438464|7222380|FG000|Received Assigned Intervention|Overall Study||89
6317551|NCT00438464|7222381|FG001|Received Assigned Intervention|Overall Study||94
6317552|NCT00438464|7222380|FG000|COMPLETED|Overall Study||89
6317553|NCT00438464|7222381|FG001|COMPLETED|Overall Study||94
6317554|NCT00438464|7222380|FG000|NOT COMPLETED|Overall Study||14
6317555|NCT00438464|7222381|FG001|NOT COMPLETED|Overall Study||7
6317556|NCT00438490|7222401|FG000|STARTED|Overall Study||12
6317557|NCT00438490|7222402|FG001|STARTED|Overall Study||9
6317558|NCT00438490|7222401|FG000|COMPLETED|Overall Study||12
6317559|NCT00438490|7222402|FG001|COMPLETED|Overall Study||9
6317560|NCT00438490|7222401|FG000|NOT COMPLETED|Overall Study||0
6317561|NCT00438490|7222402|FG001|NOT COMPLETED|Overall Study||0
6317562|NCT00438633|7222414|FG000|STARTED|Overall Study||32
6317563|NCT00438633|7222415|FG001|STARTED|Overall Study||31
6317564|NCT00438633|7222414|FG000|3-month Follow-up|Overall Study||26
6317565|NCT00438633|7222415|FG001|3-month Follow-up|Overall Study||24
6317566|NCT00438633|7222414|FG000|COMPLETED|Overall Study||16
6317567|NCT00438633|7222415|FG001|COMPLETED|Overall Study||14
6317568|NCT00438633|7222414|FG000|NOT COMPLETED|Overall Study||16
6317569|NCT00438633|7222415|FG001|NOT COMPLETED|Overall Study||17
6317570|NCT00438659|7222423|FG000|STARTED|Overall Study||90
6317571|NCT00438659|7222424|FG001|STARTED|Overall Study||86
6317572|NCT00438659|7222423|FG000|COMPLETED|Overall Study||84
6317573|NCT00438659|7222424|FG001|COMPLETED|Overall Study||82
6317574|NCT00438659|7222423|FG000|NOT COMPLETED|Overall Study||6
6317575|NCT00438659|7222424|FG001|NOT COMPLETED|Overall Study||4
6317576|NCT00438672|7222433|FG000|STARTED|Overall Study||31
6317577|NCT00438672|7222434|FG001|STARTED|Overall Study||33
6317578|NCT00438672|7222433|FG000|COMPLETED|Overall Study||24
6317579|NCT00438672|7222434|FG001|COMPLETED|Overall Study||24
6317580|NCT00438672|7222433|FG000|NOT COMPLETED|Overall Study||7
6317581|NCT00438672|7222434|FG001|NOT COMPLETED|Overall Study||9
6317582|NCT00438750|7222442|FG000|STARTED|Overall Study||48
6317583|NCT00438750|7222443|FG001|STARTED|Overall Study||46
6317584|NCT00438750|7222442|FG000|COMPLETED|Overall Study||39
6317585|NCT00438750|7222443|FG001|COMPLETED|Overall Study||37
6317586|NCT00438750|7222442|FG000|NOT COMPLETED|Overall Study||9
6317587|NCT00438750|7222443|FG001|NOT COMPLETED|Overall Study||9
6317588|NCT00438802|7222452|FG000|STARTED|Overall Study||6
6317589|NCT00438802|7222453|FG001|STARTED|Overall Study||8
6317590|NCT00438802|7222454|FG002|STARTED|Overall Study||9
6317591|NCT00438802|7222452|FG000|COMPLETED|Overall Study||6
6317592|NCT00438802|7222453|FG001|COMPLETED|Overall Study||8
6317593|NCT00438802|7222454|FG002|COMPLETED|Overall Study||9
6317594|NCT00438802|7222452|FG000|NOT COMPLETED|Overall Study||0
6317595|NCT00438802|7222453|FG001|NOT COMPLETED|Overall Study||0
6317596|NCT00438802|7222454|FG002|NOT COMPLETED|Overall Study||0
6317597|NCT00438815|7222464|FG000|STARTED|Overall Study||113
6317598|NCT00438815|7222464|FG000|COMPLETED|Overall Study||43
6317599|NCT00438815|7222464|FG000|NOT COMPLETED|Overall Study||70
6317600|NCT00438854|7222468|FG000|STARTED|Overall Study||15
6317601|NCT00438854|7222468|FG000|COMPLETED|Overall Study||15
6317602|NCT00438854|7222468|FG000|NOT COMPLETED|Overall Study||0
6317603|NCT00438880|7222474|FG000|STARTED|Overall Study||30
6317604|NCT00438880|7222475|FG001|STARTED|Overall Study||8
6317605|NCT00438880|7222474|FG000|COMPLETED|Overall Study||30
6317606|NCT00438880|7222475|FG001|COMPLETED|Overall Study||8
6317607|NCT00438880|7222474|FG000|NOT COMPLETED|Overall Study||0
6317608|NCT00438880|7222475|FG001|NOT COMPLETED|Overall Study||0
6317609|NCT00438932|7222485|FG000|STARTED|Overall Study||4
6317610|NCT00438932|7222486|FG001|STARTED|Overall Study||4
6317611|NCT00438932|7222487|FG002|STARTED|Overall Study||4
6317612|NCT00438932|7222488|FG003|STARTED|Overall Study||4
6317613|NCT00438932|7222485|FG000|COMPLETED|Overall Study||4
6317614|NCT00438932|7222486|FG001|COMPLETED|Overall Study||4
6317615|NCT00438932|7222487|FG002|COMPLETED|Overall Study||4
6317616|NCT00438932|7222488|FG003|COMPLETED|Overall Study||4
6317617|NCT00438932|7222485|FG000|NOT COMPLETED|Overall Study||0
6317618|NCT00438932|7222486|FG001|NOT COMPLETED|Overall Study||0
6317619|NCT00438932|7222487|FG002|NOT COMPLETED|Overall Study||0
6317620|NCT00438932|7222488|FG003|NOT COMPLETED|Overall Study||0
6317621|NCT00438971|7222498|FG000|STARTED|Overall Study||17
6317622|NCT00438971|7222498|FG000|COMPLETED|Overall Study||15
6317623|NCT00438971|7222498|FG000|NOT COMPLETED|Overall Study||2
6317624|NCT00439140|7222506|FG000|STARTED|Treatment Cycle 1||15
6317625|NCT00439140|7222507|FG001|STARTED|Treatment Cycle 1||14
6317626|NCT00439140|7222508|FG002|STARTED|Treatment Cycle 1||12
6317627|NCT00439140|7222506|FG000|COMPLETED|Treatment Cycle 1||14
6317628|NCT00439140|7222507|FG001|COMPLETED|Treatment Cycle 1||10
6317629|NCT00439140|7222508|FG002|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
6317630|NCT00439140|7222506|FG000|NOT COMPLETED|Treatment Cycle 1||1
6317631|NCT00439140|7222507|FG001|NOT COMPLETED|Treatment Cycle 1||4
6317632|NCT00439140|7222508|FG002|NOT COMPLETED|Treatment Cycle 1||1
6317633|NCT00439140|7222506|FG000|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
6317634|NCT00439140|7222507|FG001|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
6317635|NCT00439140|7222508|FG002|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
6317636|NCT00439140|7222506|FG000|COMPLETED|Treatment Cycle 2||11
6317637|NCT00439140|7222507|FG001|COMPLETED|Treatment Cycle 2||6
6317638|NCT00439140|7222508|FG002|COMPLETED|Treatment Cycle 2||0
6317639|NCT00439140|7222506|FG000|NOT COMPLETED|Treatment Cycle 2||2
6317640|NCT00439140|7222507|FG001|NOT COMPLETED|Treatment Cycle 2||1
6317641|NCT00439140|7222508|FG002|NOT COMPLETED|Treatment Cycle 2||0
6317642|NCT00439179|7222520|FG000|STARTED|Overall Study|1 with biliary|3
6317643|NCT00439179|7222521|FG001|STARTED|Overall Study|2 with biliary|13
6317644|NCT00439179|7222522|FG002|STARTED|Overall Study|2 with biliary|6
6317645|NCT00439179|7222523|FG003|STARTED|Overall Study|2 with biliry|5
6317646|NCT00439179|7222520|FG000|COMPLETED|Overall Study||3
6317647|NCT00439179|7222521|FG001|COMPLETED|Overall Study||11
6317648|NCT00439179|7222522|FG002|COMPLETED|Overall Study||6
6317649|NCT00439179|7222523|FG003|COMPLETED|Overall Study||5
6317650|NCT00439179|7222520|FG000|NOT COMPLETED|Overall Study||0
6317651|NCT00439179|7222521|FG001|NOT COMPLETED|Overall Study||2
6317652|NCT00439179|7222522|FG002|NOT COMPLETED|Overall Study||0
6317653|NCT00439179|7222523|FG003|NOT COMPLETED|Overall Study||0
6317654|NCT00439218|7222536|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||4
6317655|NCT00439218|7222536|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
6317656|NCT00439218|7222536|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
6317657|NCT00439218|7222536|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
6317658|NCT00439218|7222536|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
6317659|NCT00439218|7222536|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
6317660|NCT00439231|7222540|FG000|STARTED|Overall Study||33
6317661|NCT00439231|7222540|FG000|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
6317662|NCT00439231|7222540|FG000|NOT COMPLETED|Overall Study||28
6317663|NCT00439244|7222547|FG000|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
6317664|NCT00439244|7222548|FG001|STARTED|Overall Study||137
6317665|NCT00439244|7222549|FG002|STARTED|Overall Study||138
6317666|NCT00439244|7222547|FG000|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
6317667|NCT00439244|7222548|FG001|Safety Population|Overall Study||137
6317668|NCT00439244|7222549|FG002|Safety Population|Overall Study||137
6317669|NCT00439244|7222547|FG000|COMPLETED|Overall Study||126
6317670|NCT00439244|7222548|FG001|COMPLETED|Overall Study||131
6317671|NCT00439244|7222549|FG002|COMPLETED|Overall Study||131
6317672|NCT00439244|7222547|FG000|NOT COMPLETED|Overall Study||11
6317673|NCT00439244|7222548|FG001|NOT COMPLETED|Overall Study||6
6317674|NCT00439244|7222549|FG002|NOT COMPLETED|Overall Study||7
6317675|NCT00439270|7222562|FG000|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
6317676|NCT00439270|7222563|FG001|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
6317677|NCT00439270|7222564|FG002|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
6317678|NCT00439270|7222565|FG003|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
6317679|NCT00439270|7222566|FG004|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
6317680|NCT00439270|7222562|FG000|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
6317681|NCT00439270|7222563|FG001|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
6317682|NCT00439270|7222564|FG002|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
6317683|NCT00439270|7222565|FG003|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
6317684|NCT00439270|7222566|FG004|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
6317685|NCT00439270|7222562|FG000|NOT COMPLETED|Phase 1 (18.1 Months)||3
6317686|NCT00439270|7222563|FG001|NOT COMPLETED|Phase 1 (18.1 Months)||3
6317687|NCT00439270|7222564|FG002|NOT COMPLETED|Phase 1 (18.1 Months)||3
6317688|NCT00439270|7222565|FG003|NOT COMPLETED|Phase 1 (18.1 Months)||0
6317689|NCT00439270|7222566|FG004|NOT COMPLETED|Phase 1 (18.1 Months)||3
6317690|NCT00439270|7222562|FG000|STARTED|Phase 2 (51.6 Months)||0
6317691|NCT00439270|7222563|FG001|STARTED|Phase 2 (51.6 Months)||0
6317692|NCT00439270|7222564|FG002|STARTED|Phase 2 (51.6 Months)||0
6317693|NCT00439270|7222565|FG003|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
6317694|NCT00439270|7222566|FG004|STARTED|Phase 2 (51.6 Months)||0
6317695|NCT00439270|7222562|FG000|COMPLETED|Phase 2 (51.6 Months)||0
6317696|NCT00439270|7222563|FG001|COMPLETED|Phase 2 (51.6 Months)||0
6317697|NCT00439270|7222564|FG002|COMPLETED|Phase 2 (51.6 Months)||0
6317698|NCT00439270|7222565|FG003|COMPLETED|Phase 2 (51.6 Months)||0
6317699|NCT00439270|7222566|FG004|COMPLETED|Phase 2 (51.6 Months)||0
6317700|NCT00439270|7222562|FG000|NOT COMPLETED|Phase 2 (51.6 Months)||0
6317701|NCT00439270|7222563|FG001|NOT COMPLETED|Phase 2 (51.6 Months)||0
6317702|NCT00439270|7222564|FG002|NOT COMPLETED|Phase 2 (51.6 Months)||0
6317703|NCT00439270|7222565|FG003|NOT COMPLETED|Phase 2 (51.6 Months)||34
6317704|NCT00439270|7222566|FG004|NOT COMPLETED|Phase 2 (51.6 Months)||0
6317705|NCT00439296|7222587|FG000|STARTED|Overall Study||5
6317706|NCT00439296|7222588|FG001|STARTED|Overall Study||4
6317707|NCT00439296|7222587|FG000|Treatment Course 1|Overall Study||5
6317708|NCT00439296|7222588|FG001|Treatment Course 1|Overall Study||3
6317709|NCT00439296|7222587|FG000|Treatment Course 2|Overall Study||1
6317710|NCT00439296|7222588|FG001|Treatment Course 2|Overall Study||1
6317711|NCT00439296|7222587|FG000|COMPLETED|Overall Study||5
6317712|NCT00439296|7222588|FG001|COMPLETED|Overall Study||4
6317713|NCT00439296|7222587|FG000|NOT COMPLETED|Overall Study||0
6317714|NCT00439296|7222588|FG001|NOT COMPLETED|Overall Study||0
6317715|NCT00439309|7222596|FG000|STARTED|Treatment||54
6317716|NCT00439309|7222597|FG001|STARTED|Treatment||15
6317717|NCT00439309|7222596|FG000|COMPLETED|Treatment||54
6317718|NCT00439309|7222597|FG001|COMPLETED|Treatment||15
6317719|NCT00439309|7222596|FG000|NOT COMPLETED|Treatment||0
6317720|NCT00439309|7222597|FG001|NOT COMPLETED|Treatment||0
6317721|NCT00439309|7222596|FG000|STARTED|Follow-Up||54
6317722|NCT00439309|7222597|FG001|STARTED|Follow-Up||15
6317723|NCT00439309|7222596|FG000|COMPLETED|Follow-Up||51
6317724|NCT00439309|7222597|FG001|COMPLETED|Follow-Up||13
6317725|NCT00439309|7222596|FG000|NOT COMPLETED|Follow-Up||3
6317726|NCT00439309|7222597|FG001|NOT COMPLETED|Follow-Up||2
6317727|NCT00439335|7222605|FG000|STARTED|Overall Study||113
6317728|NCT00439335|7222606|FG001|STARTED|Overall Study||114
6317729|NCT00439335|7222605|FG000|COMPLETED|Overall Study||111
6317730|NCT00439335|7222606|FG001|COMPLETED|Overall Study||114
6317731|NCT00439335|7222605|FG000|NOT COMPLETED|Overall Study||2
6317732|NCT00439335|7222606|FG001|NOT COMPLETED|Overall Study||0
6317733|NCT00439374|7222614|FG000|STARTED|Overall Study||327
6317734|NCT00439374|7222615|FG001|STARTED|Overall Study||330
6317735|NCT00439374|7222614|FG000|COMPLETED|Overall Study||327
6317736|NCT00439374|7222615|FG001|COMPLETED|Overall Study||330
6317737|NCT00439374|7222614|FG000|NOT COMPLETED|Overall Study||0
6317738|NCT00439374|7222615|FG001|NOT COMPLETED|Overall Study||0
6317739|NCT00439413|7222623|FG000|STARTED|Overall Study||121
6317740|NCT00439413|7222624|FG001|STARTED|Overall Study||125
6317741|NCT00439413|7222623|FG000|COMPLETED|Overall Study||90
6317742|NCT00439413|7222624|FG001|COMPLETED|Overall Study||88
6317743|NCT00439413|7222623|FG000|NOT COMPLETED|Overall Study||31
6317744|NCT00439413|7222624|FG001|NOT COMPLETED|Overall Study||37
6317745|NCT00439465|7222632|FG000|STARTED|Overall Study||23
6317746|NCT00439465|7222632|FG000|COMPLETED|Overall Study||19
6317747|NCT00439465|7222632|FG000|NOT COMPLETED|Overall Study||4
6317748|NCT00439517|7222641|FG000|STARTED|Overall Study||152
6317749|NCT00439517|7222642|FG001|STARTED|Overall Study||150
6317750|NCT00439517|7222641|FG000|COMPLETED|Overall Study||150
6317751|NCT00439517|7222642|FG001|COMPLETED|Overall Study||150
6317752|NCT00439517|7222641|FG000|NOT COMPLETED|Overall Study||2
6317753|NCT00439517|7222642|FG001|NOT COMPLETED|Overall Study||0
6317754|NCT00439556|7222651|FG000|STARTED|Overall Study||36
6317755|NCT00439556|7222652|FG001|STARTED|Overall Study||4
6317756|NCT00439556|7222653|FG002|STARTED|Overall Study||0
6317757|NCT00439556|7222651|FG000|COMPLETED|Overall Study||36
6317758|NCT00439556|7222652|FG001|COMPLETED|Overall Study||3
6317759|NCT00439556|7222653|FG002|COMPLETED|Overall Study||0
6317760|NCT00439556|7222651|FG000|NOT COMPLETED|Overall Study||0
6317761|NCT00439556|7222652|FG001|NOT COMPLETED|Overall Study||1
6317762|NCT00439556|7222653|FG002|NOT COMPLETED|Overall Study||0
6317763|NCT00439608|7222662|FG000|STARTED|Overall Study||60
6317764|NCT00439608|7222662|FG000|COMPLETED|Overall Study||60
6317765|NCT00439608|7222662|FG000|NOT COMPLETED|Overall Study||0
6317766|NCT00439647|7222668|FG000|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
6775117|NCT03849300|7703037|FG002|NOT COMPLETED|Overall Study||4
6775118|NCT03849300|7703038|FG003|NOT COMPLETED|Overall Study||6
6775119|NCT03887429|7703054|FG000|STARTED|Overall Study||8
6775120|NCT03887429|7703055|FG001|STARTED|Overall Study||9
6775121|NCT03887429|7703056|FG002|STARTED|Overall Study||9
6775122|NCT03887429|7703057|FG003|STARTED|Overall Study||8
6775123|NCT03887429|7703054|FG000|Completed First Intervention (5 Days)|Overall Study||7
6775124|NCT03887429|7703055|FG001|Completed First Intervention (5 Days)|Overall Study||8
6557871|NCT01770860|7480511|FG000|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
6557872|NCT01770860|7480511|FG000|Randomization|Overall Study|One participant withdrew before randomization|45
6557873|NCT01770860|7480511|FG000|COMPLETED|Overall Study||40
6557874|NCT01770860|7480511|FG000|NOT COMPLETED|Overall Study||6
6557875|NCT01770912|7480521|FG000|STARTED|Overall Study||12
6557876|NCT01770912|7480522|FG001|STARTED|Overall Study||12
6775125|NCT03887429|7703056|FG002|Completed First Intervention (5 Days)|Overall Study||7
6775126|NCT03887429|7703057|FG003|Completed First Intervention (5 Days)|Overall Study||7
6775127|NCT03887429|7703054|FG000|Completed Washout (9 Days)|Overall Study||7
6775128|NCT03887429|7703055|FG001|Completed Washout (9 Days)|Overall Study||8
6775129|NCT03887429|7703056|FG002|Completed Washout (9 Days)|Overall Study||7
6775130|NCT03887429|7703057|FG003|Completed Washout (9 Days)|Overall Study||7
6775131|NCT03887429|7703054|FG000|Completed Second Intervention (5 Days)|Overall Study||7
6317767|NCT00439647|7222669|FG001|STARTED|Overall Study||611
6317768|NCT00439647|7222668|FG000|Modified Intent to Treat (mITT)|Overall Study||553
6317769|NCT00439647|7222669|FG001|Modified Intent to Treat (mITT)|Overall Study||574
6317770|NCT00439647|7222668|FG000|COMPLETED|Overall Study||530
6317771|NCT00439647|7222669|FG001|COMPLETED|Overall Study||540
6317772|NCT00439647|7222668|FG000|NOT COMPLETED|Overall Study||58
6557877|NCT01770912|7480521|FG000|COMPLETED|Overall Study||10
6557878|NCT01770912|7480522|FG001|COMPLETED|Overall Study||12
6557879|NCT01770912|7480521|FG000|NOT COMPLETED|Overall Study||2
6557880|NCT01770912|7480522|FG001|NOT COMPLETED|Overall Study||0
6557881|NCT01771055|7480530|FG000|STARTED|Overall Study||4
6775132|NCT03887429|7703055|FG001|Completed Second Intervention (5 Days)|Overall Study||8
6775133|NCT03887429|7703056|FG002|Completed Second Intervention (5 Days)|Overall Study||7
6317773|NCT00439647|7222669|FG001|NOT COMPLETED|Overall Study||71
6317774|NCT00439673|7222675|FG000|STARTED|Overall Study||62
6317775|NCT00439673|7222675|FG000|COMPLETED|Overall Study||26
6317776|NCT00439673|7222675|FG000|NOT COMPLETED|Overall Study||36
6317777|NCT00439725|7222681|FG000|STARTED|Treatment Period||602
6317778|NCT00439725|7222682|FG001|STARTED|Treatment Period||595
6317779|NCT00439725|7222681|FG000|Participants Received Treatment|Treatment Period|Safety population|598
6317780|NCT00439725|7222682|FG001|Participants Received Treatment|Treatment Period|Safety population|590
6317781|NCT00439725|7222681|FG000|COMPLETED|Treatment Period||366
6317782|NCT00439725|7222682|FG001|COMPLETED|Treatment Period||349
6317783|NCT00439725|7222681|FG000|NOT COMPLETED|Treatment Period||236
6317784|NCT00439725|7222682|FG001|NOT COMPLETED|Treatment Period||246
6317785|NCT00439725|7222681|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
6317786|NCT00439725|7222682|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
6317787|NCT00439725|7222681|FG000|COMPLETED|Observational Period||569
6317788|NCT00439725|7222682|FG001|COMPLETED|Observational Period||553
6317789|NCT00439725|7222681|FG000|NOT COMPLETED|Observational Period||8
6317790|NCT00439725|7222682|FG001|NOT COMPLETED|Observational Period||7
6317791|NCT00439777|7222690|FG000|STARTED|Treatment Period||2420
6317792|NCT00439777|7222691|FG001|STARTED|Treatment Period||2413
6317793|NCT00439777|7222690|FG000|Participants Received Treatment|Treatment Period||2412
6317794|NCT00439777|7222691|FG001|Participants Received Treatment|Treatment Period||2405
6317795|NCT00439777|7222690|FG000|COMPLETED|Treatment Period||2001
6317796|NCT00439777|7222691|FG001|COMPLETED|Treatment Period||1954
6317797|NCT00439777|7222690|FG000|NOT COMPLETED|Treatment Period||419
6317798|NCT00439777|7222691|FG001|NOT COMPLETED|Treatment Period||459
6317799|NCT00439777|7222690|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
6317800|NCT00439777|7222691|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
6317801|NCT00439777|7222690|FG000|COMPLETED|Observational Period||2165
6317802|NCT00439777|7222691|FG001|COMPLETED|Observational Period||2156
6317803|NCT00439777|7222690|FG000|NOT COMPLETED|Observational Period||41
6317804|NCT00439777|7222691|FG001|NOT COMPLETED|Observational Period||41
6317805|NCT00439946|7222697|FG000|STARTED|Overall Study||8
6317806|NCT00439946|7222697|FG000|COMPLETED|Overall Study||8
6317807|NCT00439946|7222697|FG000|NOT COMPLETED|Overall Study||0
6317808|NCT00440011|7222703|FG000|STARTED|Overall Study||131
6317809|NCT00440011|7222704|FG001|STARTED|Overall Study||135
6317810|NCT00440011|7222703|FG000|COMPLETED|Overall Study||127
6317811|NCT00440011|7222704|FG001|COMPLETED|Overall Study||132
6317812|NCT00440011|7222703|FG000|NOT COMPLETED|Overall Study||4
6317813|NCT00440011|7222704|FG001|NOT COMPLETED|Overall Study||3
6317814|NCT00440037|7222710|FG000|STARTED|Overall Study||44
6317815|NCT00440037|7222710|FG000|COMPLETED|Overall Study||35
6317816|NCT00440037|7222710|FG000|NOT COMPLETED|Overall Study||9
6317817|NCT00440050|7222716|FG000|STARTED|Overall Study||164
6317818|NCT00440050|7222717|FG001|STARTED|Overall Study||238
6317819|NCT00440050|7222716|FG000|COMPLETED|Overall Study||124
6317820|NCT00440050|7222717|FG001|COMPLETED|Overall Study||171
6317821|NCT00440050|7222716|FG000|NOT COMPLETED|Overall Study||40
6317822|NCT00440050|7222717|FG001|NOT COMPLETED|Overall Study||67
6317823|NCT00440115|7222726|FG000|STARTED|Overall Study||251
6317824|NCT00440115|7222727|FG001|STARTED|Overall Study||249
6317825|NCT00440115|7222728|FG002|STARTED|Overall Study||250
6317826|NCT00440115|7222726|FG000|COMPLETED|Overall Study||244
6317827|NCT00440115|7222727|FG001|COMPLETED|Overall Study||238
6317828|NCT00440115|7222728|FG002|COMPLETED|Overall Study||244
6317829|NCT00440115|7222726|FG000|NOT COMPLETED|Overall Study||7
6317830|NCT00440115|7222727|FG001|NOT COMPLETED|Overall Study||11
6317831|NCT00440115|7222728|FG002|NOT COMPLETED|Overall Study||6
6317832|NCT00440180|7222738|FG000|STARTED|Overall Study||10
6317833|NCT00440180|7222739|FG001|STARTED|Overall Study||10
6317834|NCT00440180|7222738|FG000|COMPLETED|Overall Study||10
6317835|NCT00440180|7222739|FG001|COMPLETED|Overall Study||10
6317836|NCT00440180|7222738|FG000|NOT COMPLETED|Overall Study||0
6317837|NCT00440180|7222739|FG001|NOT COMPLETED|Overall Study||0
6317838|NCT00440193|7222747|FG000|STARTED|Treatment Period||1731
6317839|NCT00440193|7222748|FG001|STARTED|Treatment Period||1718
6317840|NCT00440193|7222747|FG000|Participants Received Treatment|Treatment Period||1718
6317841|NCT00440193|7222748|FG001|Participants Received Treatment|Treatment Period||1711
6317842|NCT00440193|7222747|FG000|COMPLETED|Treatment Period||1426
6317843|NCT00440193|7222748|FG001|COMPLETED|Treatment Period||1367
6317844|NCT00440193|7222747|FG000|NOT COMPLETED|Treatment Period||305
6317845|NCT00440193|7222748|FG001|NOT COMPLETED|Treatment Period||351
6317846|NCT00440193|7222747|FG000|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
6317847|NCT00440193|7222748|FG001|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
6317848|NCT00440193|7222747|FG000|COMPLETED|Observational Period||1380
6317849|NCT00440193|7222748|FG001|COMPLETED|Observational Period||1369
6317850|NCT00440193|7222747|FG000|NOT COMPLETED|Observational Period||45
6317851|NCT00440193|7222748|FG001|NOT COMPLETED|Observational Period||38
6317852|NCT00440232|7222756|FG000|STARTED|Overall Study||36
6317853|NCT00440232|7222757|FG001|STARTED|Overall Study||38
6317854|NCT00440232|7222756|FG000|COMPLETED|Overall Study||33
6317855|NCT00440232|7222757|FG001|COMPLETED|Overall Study||34
6317856|NCT00440232|7222756|FG000|NOT COMPLETED|Overall Study||3
6775134|NCT03887429|7703057|FG003|Completed Second Intervention (5 Days)|Overall Study||7
6775135|NCT03887429|7703054|FG000|COMPLETED|Overall Study||7
6775136|NCT03887429|7703055|FG001|COMPLETED|Overall Study||8
6775137|NCT03887429|7703056|FG002|COMPLETED|Overall Study||7
6775138|NCT03887429|7703057|FG003|COMPLETED|Overall Study||7
6775139|NCT03887429|7703054|FG000|NOT COMPLETED|Overall Study||1
6775140|NCT03887429|7703055|FG001|NOT COMPLETED|Overall Study||1
6317857|NCT00440232|7222757|FG001|NOT COMPLETED|Overall Study||4
6317858|NCT00440297|7222765|FG000|STARTED|Overall Study||139
6317859|NCT00440297|7222766|FG001|STARTED|Overall Study||138
6317860|NCT00440297|7222765|FG000|Vaccination Visit 1|Overall Study||138
6317861|NCT00440297|7222766|FG001|Vaccination Visit 1|Overall Study||138
6317862|NCT00440297|7222765|FG000|Vaccination Visit 2|Overall Study||136
6317863|NCT00440297|7222766|FG001|Vaccination Visit 2|Overall Study||134
6317864|NCT00440297|7222765|FG000|Vaccination Visit 3|Overall Study||124
6317865|NCT00440297|7222766|FG001|Vaccination Visit 3|Overall Study||125
6317866|NCT00440297|7222765|FG000|Vaccination Visit 4|Overall Study||116
6317867|NCT00440297|7222766|FG001|Vaccination Visit 4|Overall Study||122
6317868|NCT00440297|7222765|FG000|COMPLETED|Overall Study||116
6317869|NCT00440297|7222766|FG001|COMPLETED|Overall Study||120
6317870|NCT00440297|7222765|FG000|NOT COMPLETED|Overall Study||23
6317871|NCT00440297|7222766|FG001|NOT COMPLETED|Overall Study||18
6317872|NCT00440310|7222774|FG000|STARTED|Overall Study||244
6317873|NCT00440310|7222775|FG001|STARTED|Overall Study||239
6317874|NCT00440310|7222774|FG000|Treated|Overall Study||222
6317875|NCT00440310|7222775|FG001|Treated|Overall Study||232
6317876|NCT00440310|7222774|FG000|COMPLETED|Overall Study||216
6317877|NCT00440310|7222775|FG001|COMPLETED|Overall Study||209
6317878|NCT00440310|7222774|FG000|NOT COMPLETED|Overall Study||28
6317879|NCT00440310|7222775|FG001|NOT COMPLETED|Overall Study||30
6317880|NCT00440401|7222783|FG000|STARTED|Overall Study||59
6317881|NCT00440401|7222784|FG001|STARTED|Overall Study||60
6317882|NCT00440401|7222783|FG000|COMPLETED|Overall Study||55
6317883|NCT00440401|7222784|FG001|COMPLETED|Overall Study||54
6317884|NCT00440401|7222783|FG000|NOT COMPLETED|Overall Study||4
6317885|NCT00440401|7222784|FG001|NOT COMPLETED|Overall Study||6
6317886|NCT00440466|7222793|FG000|STARTED|Overall Study||108
6317887|NCT00440466|7222794|FG001|STARTED|Overall Study||107
6317888|NCT00440466|7222795|FG002|STARTED|Overall Study||215
6317889|NCT00440466|7222793|FG000|COMPLETED|Overall Study||95
6317890|NCT00440466|7222794|FG001|COMPLETED|Overall Study||92
6317891|NCT00440466|7222795|FG002|COMPLETED|Overall Study||174
6317892|NCT00440466|7222793|FG000|NOT COMPLETED|Overall Study||13
6317893|NCT00440466|7222794|FG001|NOT COMPLETED|Overall Study||15
6317894|NCT00440466|7222795|FG002|NOT COMPLETED|Overall Study||41
6317895|NCT00440505|7222803|FG000|STARTED|First Intervention||5
6317896|NCT00440505|7222804|FG001|STARTED|First Intervention||2
6317897|NCT00440505|7222805|FG002|STARTED|First Intervention||1
6317898|NCT00440505|7222806|FG003|STARTED|First Intervention||2
6317899|NCT00440505|7222807|FG004|STARTED|First Intervention||5
6317900|NCT00440505|7222808|FG005|STARTED|First Intervention||5
6317901|NCT00440505|7222803|FG000|COMPLETED|First Intervention||5
6317902|NCT00440505|7222804|FG001|COMPLETED|First Intervention||2
6317903|NCT00440505|7222805|FG002|COMPLETED|First Intervention||1
6317904|NCT00440505|7222806|FG003|COMPLETED|First Intervention||2
6317905|NCT00440505|7222807|FG004|COMPLETED|First Intervention||5
6317906|NCT00440505|7222808|FG005|COMPLETED|First Intervention||5
6317907|NCT00440505|7222803|FG000|NOT COMPLETED|First Intervention||0
6317908|NCT00440505|7222804|FG001|NOT COMPLETED|First Intervention||0
6317909|NCT00440505|7222805|FG002|NOT COMPLETED|First Intervention||0
6317910|NCT00440505|7222806|FG003|NOT COMPLETED|First Intervention||0
6317911|NCT00440505|7222807|FG004|NOT COMPLETED|First Intervention||0
6317912|NCT00440505|7222808|FG005|NOT COMPLETED|First Intervention||0
6317913|NCT00440505|7222803|FG000|STARTED|Second Intervention||5
6317914|NCT00440505|7222804|FG001|STARTED|Second Intervention||2
6317915|NCT00440505|7222805|FG002|STARTED|Second Intervention||1
6317916|NCT00440505|7222806|FG003|STARTED|Second Intervention||2
6317917|NCT00440505|7222807|FG004|STARTED|Second Intervention||5
6317918|NCT00440505|7222808|FG005|STARTED|Second Intervention||5
6317919|NCT00440505|7222803|FG000|COMPLETED|Second Intervention||5
6317920|NCT00440505|7222804|FG001|COMPLETED|Second Intervention||2
6317921|NCT00440505|7222805|FG002|COMPLETED|Second Intervention||1
6317922|NCT00440505|7222806|FG003|COMPLETED|Second Intervention||2
6317923|NCT00440505|7222807|FG004|COMPLETED|Second Intervention||5
6317924|NCT00440505|7222808|FG005|COMPLETED|Second Intervention||5
6317925|NCT00440505|7222803|FG000|NOT COMPLETED|Second Intervention||0
6317926|NCT00440505|7222804|FG001|NOT COMPLETED|Second Intervention||0
6317927|NCT00440505|7222805|FG002|NOT COMPLETED|Second Intervention||0
6317928|NCT00440505|7222806|FG003|NOT COMPLETED|Second Intervention||0
6317929|NCT00440505|7222807|FG004|NOT COMPLETED|Second Intervention||0
6317930|NCT00440505|7222808|FG005|NOT COMPLETED|Second Intervention||0
6317931|NCT00440505|7222803|FG000|STARTED|Third Intervention||5
6317932|NCT00440505|7222804|FG001|STARTED|Third Intervention||2
6317933|NCT00440505|7222805|FG002|STARTED|Third Intervention||1
6317934|NCT00440505|7222806|FG003|STARTED|Third Intervention||2
6317935|NCT00440505|7222807|FG004|STARTED|Third Intervention||5
6317936|NCT00440505|7222808|FG005|STARTED|Third Intervention||5
6317937|NCT00440505|7222803|FG000|COMPLETED|Third Intervention||5
6317938|NCT00440505|7222804|FG001|COMPLETED|Third Intervention||2
6557882|NCT01771055|7480531|FG001|STARTED|Overall Study||3
6557883|NCT01771055|7480530|FG000|COMPLETED|Overall Study||4
6557884|NCT01771055|7480531|FG001|COMPLETED|Overall Study||3
6557885|NCT01771055|7480530|FG000|NOT COMPLETED|Overall Study||0
6557886|NCT01771055|7480531|FG001|NOT COMPLETED|Overall Study||0
6317939|NCT00440505|7222805|FG002|COMPLETED|Third Intervention||1
6317940|NCT00440505|7222806|FG003|COMPLETED|Third Intervention||1
6317941|NCT00440505|7222807|FG004|COMPLETED|Third Intervention||5
6317942|NCT00440505|7222808|FG005|COMPLETED|Third Intervention||5
6317943|NCT00440505|7222803|FG000|NOT COMPLETED|Third Intervention||0
6317944|NCT00440505|7222804|FG001|NOT COMPLETED|Third Intervention||0
6317945|NCT00440505|7222805|FG002|NOT COMPLETED|Third Intervention||0
6317946|NCT00440505|7222806|FG003|NOT COMPLETED|Third Intervention||1
6317947|NCT00440505|7222807|FG004|NOT COMPLETED|Third Intervention||0
6317948|NCT00440505|7222808|FG005|NOT COMPLETED|Third Intervention||0
6317949|NCT00440518|7222819|FG000|STARTED|Randomized /Titration Period||72
6557887|NCT01771172|7480537|FG000|STARTED|Overall Study||48
6557888|NCT01771172|7480537|FG000|COMPLETED|Overall Study||46
6317950|NCT00440518|7222820|FG001|STARTED|Randomized /Titration Period||72
6317951|NCT00440518|7222821|FG002|STARTED|Randomized /Titration Period||74
6317952|NCT00440518|7222819|FG000|COMPLETED|Randomized /Titration Period||59
6317953|NCT00440518|7222820|FG001|COMPLETED|Randomized /Titration Period||63
6317954|NCT00440518|7222821|FG002|COMPLETED|Randomized /Titration Period||70
6317955|NCT00440518|7222819|FG000|NOT COMPLETED|Randomized /Titration Period||13
6317956|NCT00440518|7222820|FG001|NOT COMPLETED|Randomized /Titration Period||9
6317957|NCT00440518|7222821|FG002|NOT COMPLETED|Randomized /Titration Period||4
6317958|NCT00440518|7222819|FG000|STARTED|Maintenance and Safety Follow-up Periods||59
6317959|NCT00440518|7222820|FG001|STARTED|Maintenance and Safety Follow-up Periods||63
6317960|NCT00440518|7222821|FG002|STARTED|Maintenance and Safety Follow-up Periods||70
6317961|NCT00440518|7222819|FG000|COMPLETED|Maintenance and Safety Follow-up Periods||52
6317962|NCT00440518|7222820|FG001|COMPLETED|Maintenance and Safety Follow-up Periods||51
6317963|NCT00440518|7222821|FG002|COMPLETED|Maintenance and Safety Follow-up Periods||55
6317964|NCT00440518|7222819|FG000|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
6317965|NCT00440518|7222820|FG001|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
6317966|NCT00440518|7222821|FG002|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
6317967|NCT00440557|7222832|FG000|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
6317968|NCT00440557|7222833|FG001|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
6317969|NCT00440557|7222834|FG002|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
6317970|NCT00440557|7222832|FG000|COMPLETED|Overall Study||98
6317971|NCT00440557|7222833|FG001|COMPLETED|Overall Study||96
6317972|NCT00440557|7222834|FG002|COMPLETED|Overall Study||90
6317973|NCT00440557|7222832|FG000|NOT COMPLETED|Overall Study||25
6317974|NCT00440557|7222833|FG001|NOT COMPLETED|Overall Study||29
6317975|NCT00440557|7222834|FG002|NOT COMPLETED|Overall Study||35
6317976|NCT00440596|7222844|FG000|STARTED|Overall Study||28
6317977|NCT00440596|7222845|FG001|STARTED|Overall Study||28
6317978|NCT00440596|7222844|FG000|COMPLETED|Overall Study||21
6317979|NCT00440596|7222845|FG001|COMPLETED|Overall Study||17
6317980|NCT00440596|7222844|FG000|NOT COMPLETED|Overall Study||7
6317981|NCT00440596|7222845|FG001|NOT COMPLETED|Overall Study||11
6317982|NCT00440700|7222856|FG000|STARTED|Overall Study||122
6317983|NCT00440700|7222857|FG001|STARTED|Overall Study||118
6317984|NCT00440700|7222858|FG002|STARTED|Overall Study||124
6317985|NCT00440700|7222856|FG000|COMPLETED|Overall Study||114
6317986|NCT00440700|7222857|FG001|COMPLETED|Overall Study||110
6317987|NCT00440700|7222858|FG002|COMPLETED|Overall Study||120
6317988|NCT00440700|7222856|FG000|NOT COMPLETED|Overall Study||8
6317989|NCT00440700|7222857|FG001|NOT COMPLETED|Overall Study||8
6317990|NCT00440700|7222858|FG002|NOT COMPLETED|Overall Study||4
6317991|NCT00440726|7222869|FG000|STARTED|Phase 1||4
6317992|NCT00440726|7222870|FG001|STARTED|Phase 1||6
6317993|NCT00440726|7222871|FG002|STARTED|Phase 1||0
6317994|NCT00440726|7222869|FG000|COMPLETED|Phase 1||3
6317995|NCT00440726|7222870|FG001|COMPLETED|Phase 1||5
6317996|NCT00440726|7222871|FG002|COMPLETED|Phase 1||0
6317997|NCT00440726|7222869|FG000|NOT COMPLETED|Phase 1||1
6317998|NCT00440726|7222870|FG001|NOT COMPLETED|Phase 1||1
6317999|NCT00440726|7222871|FG002|NOT COMPLETED|Phase 1||0
6318000|NCT00440726|7222869|FG000|STARTED|Phase 2||0
6318001|NCT00440726|7222870|FG001|STARTED|Phase 2||0
6318002|NCT00440726|7222871|FG002|STARTED|Phase 2||22
6318003|NCT00440726|7222869|FG000|COMPLETED|Phase 2||0
6318004|NCT00440726|7222870|FG001|COMPLETED|Phase 2||0
6318005|NCT00440726|7222871|FG002|COMPLETED|Phase 2||20
6318006|NCT00440726|7222869|FG000|NOT COMPLETED|Phase 2||0
6318007|NCT00440726|7222870|FG001|NOT COMPLETED|Phase 2||0
6318008|NCT00440726|7222871|FG002|NOT COMPLETED|Phase 2||2
6318009|NCT00440830|7222886|FG000|STARTED|Overall Study||20
6318010|NCT00440830|7222887|FG001|STARTED|Overall Study||8
6318011|NCT00440830|7222888|FG002|STARTED|Overall Study||30
6318012|NCT00440830|7222889|FG003|STARTED|Overall Study||10
6318013|NCT00440830|7222886|FG000|COMPLETED|Overall Study||20
6318014|NCT00440830|7222887|FG001|COMPLETED|Overall Study||8
6318015|NCT00440830|7222888|FG002|COMPLETED|Overall Study||30
6318016|NCT00440830|7222889|FG003|COMPLETED|Overall Study||10
6318017|NCT00440830|7222886|FG000|NOT COMPLETED|Overall Study||0
6318018|NCT00440830|7222887|FG001|NOT COMPLETED|Overall Study||0
6318019|NCT00440830|7222888|FG002|NOT COMPLETED|Overall Study||0
6318020|NCT00440830|7222889|FG003|NOT COMPLETED|Overall Study||0
6318021|NCT00440947|7222903|FG000|STARTED|36-Week Induction Phase||515
6318022|NCT00440947|7222904|FG001|STARTED|36-Week Induction Phase||0
6318023|NCT00440947|7222905|FG002|STARTED|36-Week Induction Phase||0
6318024|NCT00440947|7222906|FG003|STARTED|36-Week Induction Phase||0
6318025|NCT00440947|7222907|FG004|STARTED|36-Week Induction Phase||0
6318026|NCT00440947|7222903|FG000|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn't be randomized but weren't withdrawn.|442
6318027|NCT00440947|7222904|FG001|COMPLETED|36-Week Induction Phase||0
6318028|NCT00440947|7222905|FG002|COMPLETED|36-Week Induction Phase||0
6318029|NCT00440947|7222906|FG003|COMPLETED|36-Week Induction Phase||0
6318030|NCT00440947|7222907|FG004|COMPLETED|36-Week Induction Phase||0
6318031|NCT00440947|7222903|FG000|NOT COMPLETED|36-Week Induction Phase||73
6318032|NCT00440947|7222904|FG001|NOT COMPLETED|36-Week Induction Phase||0
6318033|NCT00440947|7222905|FG002|NOT COMPLETED|36-Week Induction Phase||0
6318034|NCT00440947|7222906|FG003|NOT COMPLETED|36-Week Induction Phase||0
6318035|NCT00440947|7222907|FG004|NOT COMPLETED|36-Week Induction Phase||0
6318036|NCT00440947|7222903|FG000|STARTED|48-Week Randomization Phase||0
6318037|NCT00440947|7222904|FG001|STARTED|48-Week Randomization Phase||210
6318038|NCT00440947|7222905|FG002|STARTED|48-Week Randomization Phase||209
6318039|NCT00440947|7222906|FG003|STARTED|48-Week Randomization Phase||0
6318040|NCT00440947|7222907|FG004|STARTED|48-Week Randomization Phase||0
6318041|NCT00440947|7222903|FG000|COMPLETED|48-Week Randomization Phase||0
6318042|NCT00440947|7222904|FG001|COMPLETED|48-Week Randomization Phase||194
6318043|NCT00440947|7222905|FG002|COMPLETED|48-Week Randomization Phase||185
6318044|NCT00440947|7222906|FG003|COMPLETED|48-Week Randomization Phase||0
6318045|NCT00440947|7222907|FG004|COMPLETED|48-Week Randomization Phase||0
6318046|NCT00440947|7222903|FG000|NOT COMPLETED|48-Week Randomization Phase||0
6318047|NCT00440947|7222904|FG001|NOT COMPLETED|48-Week Randomization Phase||16
6318048|NCT00440947|7222905|FG002|NOT COMPLETED|48-Week Randomization Phase||24
6318049|NCT00440947|7222906|FG003|NOT COMPLETED|48-Week Randomization Phase||0
6318050|NCT00440947|7222907|FG004|NOT COMPLETED|48-Week Randomization Phase||0
6318051|NCT00440947|7222903|FG000|STARTED|Optional 60-Week Extension Phase||0
6318052|NCT00440947|7222904|FG001|STARTED|Optional 60-Week Extension Phase||0
6318053|NCT00440947|7222905|FG002|STARTED|Optional 60-Week Extension Phase||0
6318054|NCT00440947|7222906|FG003|STARTED|Optional 60-Week Extension Phase||189
6318055|NCT00440947|7222907|FG004|STARTED|Optional 60-Week Extension Phase||180
6318056|NCT00440947|7222903|FG000|COMPLETED|Optional 60-Week Extension Phase||0
6318057|NCT00440947|7222904|FG001|COMPLETED|Optional 60-Week Extension Phase||0
6318058|NCT00440947|7222905|FG002|COMPLETED|Optional 60-Week Extension Phase||0
6318059|NCT00440947|7222906|FG003|COMPLETED|Optional 60-Week Extension Phase||160
6318060|NCT00440947|7222907|FG004|COMPLETED|Optional 60-Week Extension Phase||154
6318061|NCT00440947|7222903|FG000|NOT COMPLETED|Optional 60-Week Extension Phase||0
6318062|NCT00440947|7222904|FG001|NOT COMPLETED|Optional 60-Week Extension Phase||0
6318063|NCT00440947|7222905|FG002|NOT COMPLETED|Optional 60-Week Extension Phase||0
6318064|NCT00440947|7222906|FG003|NOT COMPLETED|Optional 60-Week Extension Phase||29
6318065|NCT00440947|7222907|FG004|NOT COMPLETED|Optional 60-Week Extension Phase||26
6318066|NCT00440999|7222921|FG000|STARTED|Overall Study||228
6318067|NCT00440999|7222922|FG001|STARTED|Overall Study||228
6318068|NCT00440999|7222921|FG000|COMPLETED|Overall Study||193
6318069|NCT00440999|7222922|FG001|COMPLETED|Overall Study||187
6318070|NCT00440999|7222921|FG000|NOT COMPLETED|Overall Study||35
6318071|NCT00440999|7222922|FG001|NOT COMPLETED|Overall Study||41
6318072|NCT00441012|7222932|FG000|STARTED|Overall Study||270
6318073|NCT00441012|7222933|FG001|STARTED|Overall Study||276
6318074|NCT00441012|7222932|FG000|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
6318075|NCT00441012|7222933|FG001|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
6318076|NCT00441012|7222932|FG000|Vaccination Visit 2|Overall Study||267
6318077|NCT00441012|7222933|FG001|Vaccination Visit 2|Overall Study||272
6318078|NCT00441012|7222932|FG000|Vaccination Visit 3|Overall Study||265
6318079|NCT00441012|7222933|FG001|Vaccination Visit 3|Overall Study||269
6318080|NCT00441012|7222932|FG000|COMPLETED|Overall Study||252
6318081|NCT00441012|7222933|FG001|COMPLETED|Overall Study||263
6318082|NCT00441012|7222932|FG000|NOT COMPLETED|Overall Study||18
6318083|NCT00441012|7222933|FG001|NOT COMPLETED|Overall Study||13
6318084|NCT00441064|7222941|FG000|STARTED|Overall Study||69
6318085|NCT00441064|7222942|FG001|STARTED|Overall Study||63
6318086|NCT00441064|7222941|FG000|Safety Population (SP)|Overall Study||69
6318087|NCT00441064|7222942|FG001|Safety Population (SP)|Overall Study||63
6318088|NCT00441064|7222941|FG000|Intent-to-treat (ITT) Population|Overall Study||61
6318089|NCT00441064|7222942|FG001|Intent-to-treat (ITT) Population|Overall Study||57
6318090|NCT00441064|7222941|FG000|COMPLETED|Overall Study||59
6318091|NCT00441064|7222942|FG001|COMPLETED|Overall Study||56
6318092|NCT00441064|7222941|FG000|NOT COMPLETED|Overall Study||10
6318093|NCT00441064|7222942|FG001|NOT COMPLETED|Overall Study||7
6318094|NCT00441090|7222953|FG000|STARTED|Overall Study||15
6318095|NCT00441090|7222954|FG001|STARTED|Overall Study||15
6318096|NCT00441090|7222955|FG002|STARTED|Overall Study||14
6318097|NCT00441090|7222956|FG003|STARTED|Overall Study||15
6318098|NCT00441090|7222957|FG004|STARTED|Overall Study||5
6318099|NCT00441090|7222953|FG000|COMPLETED|Overall Study||13
6318100|NCT00441090|7222954|FG001|COMPLETED|Overall Study||14
6318101|NCT00441090|7222955|FG002|COMPLETED|Overall Study||12
6318102|NCT00441090|7222956|FG003|COMPLETED|Overall Study||13
6318103|NCT00441090|7222957|FG004|COMPLETED|Overall Study||5
6318104|NCT00441090|7222953|FG000|NOT COMPLETED|Overall Study||2
6318105|NCT00441090|7222954|FG001|NOT COMPLETED|Overall Study||1
6318106|NCT00441090|7222955|FG002|NOT COMPLETED|Overall Study||2
6318107|NCT00441090|7222956|FG003|NOT COMPLETED|Overall Study||2
6318108|NCT00441090|7222957|FG004|NOT COMPLETED|Overall Study||0
6318109|NCT00441103|7222971|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
6318110|NCT00441103|7222972|FG001|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
6318111|NCT00441103|7222971|FG000|COMPLETED|Overall Study||109
6318112|NCT00441103|7222972|FG001|COMPLETED|Overall Study||56
6318113|NCT00441103|7222971|FG000|NOT COMPLETED|Overall Study||11
6318114|NCT00441103|7222972|FG001|NOT COMPLETED|Overall Study||4
6318115|NCT00441116|7222981|FG000|STARTED|Overall Study||76
6318116|NCT00441116|7222982|FG001|STARTED|Overall Study||77
6318117|NCT00441116|7222981|FG000|COMPLETED|Overall Study||73
6318118|NCT00441116|7222982|FG001|COMPLETED|Overall Study||75
6318119|NCT00441116|7222981|FG000|NOT COMPLETED|Overall Study||3
6318120|NCT00441116|7222982|FG001|NOT COMPLETED|Overall Study||2
6318121|NCT00441129|7222990|FG000|STARTED|Overall Study||60
6318122|NCT00441129|7222991|FG001|STARTED|Overall Study||55
6318123|NCT00441129|7222990|FG000|COMPLETED|Overall Study||54
6318124|NCT00441129|7222991|FG001|COMPLETED|Overall Study||41
6318125|NCT00441129|7222990|FG000|NOT COMPLETED|Overall Study||6
6318126|NCT00441129|7222991|FG001|NOT COMPLETED|Overall Study||14
6318127|NCT00441142|7223001|FG000|STARTED|Overall Study||6
6318128|NCT00441142|7223002|FG001|STARTED|Overall Study||7
6318129|NCT00441142|7223003|FG002|STARTED|Overall Study||29
6318130|NCT00441142|7223004|FG003|STARTED|Overall Study||69
6318131|NCT00441142|7223001|FG000|COMPLETED|Overall Study||0
6318132|NCT00441142|7223002|FG001|COMPLETED|Overall Study||0
6318133|NCT00441142|7223003|FG002|COMPLETED|Overall Study||7
6318134|NCT00441142|7223004|FG003|COMPLETED|Overall Study||1
6318135|NCT00441142|7223001|FG000|NOT COMPLETED|Overall Study||6
6318136|NCT00441142|7223002|FG001|NOT COMPLETED|Overall Study||7
6318137|NCT00441142|7223003|FG002|NOT COMPLETED|Overall Study||22
6318138|NCT00441142|7223004|FG003|NOT COMPLETED|Overall Study||68
6318139|NCT00441168|7223018|FG000|STARTED|Treatment Period||17
6318140|NCT00441168|7223019|FG001|STARTED|Treatment Period||13
6318141|NCT00441168|7223018|FG000|TREATED|Treatment Period||16
6318142|NCT00441168|7223019|FG001|TREATED|Treatment Period||13
6318143|NCT00441168|7223018|FG000|COMPLETED|Treatment Period||6
6318144|NCT00441168|7223019|FG001|COMPLETED|Treatment Period||7
6318145|NCT00441168|7223018|FG000|NOT COMPLETED|Treatment Period||11
6318146|NCT00441168|7223019|FG001|NOT COMPLETED|Treatment Period||6
6318147|NCT00441168|7223018|FG000|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
6318148|NCT00441168|7223019|FG001|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
6318149|NCT00441168|7223018|FG000|COMPLETED|Follow-up Period||5
6318150|NCT00441168|7223019|FG001|COMPLETED|Follow-up Period||4
6318151|NCT00441168|7223018|FG000|NOT COMPLETED|Follow-up Period||12
6318152|NCT00441168|7223019|FG001|NOT COMPLETED|Follow-up Period||9
6318153|NCT00441259|7223027|FG000|STARTED|Overall Study||48
6318154|NCT00441259|7223028|FG001|STARTED|Overall Study||48
6318155|NCT00441259|7223027|FG000|COMPLETED|Overall Study||48
6318156|NCT00441259|7223028|FG001|COMPLETED|Overall Study||48
6318157|NCT00441259|7223027|FG000|NOT COMPLETED|Overall Study||0
6318158|NCT00441259|7223028|FG001|NOT COMPLETED|Overall Study||0
6318159|NCT00441285|7223039|FG000|STARTED|Overall Study||16
6318160|NCT00441285|7223040|FG001|STARTED|Overall Study||16
6318161|NCT00441285|7223041|FG002|STARTED|Overall Study||41
6318162|NCT00441285|7223042|FG003|STARTED|Overall Study||40
6318163|NCT00441285|7223043|FG004|STARTED|Overall Study||43
6318164|NCT00441285|7223039|FG000|COMPLETED|Overall Study||16
6318165|NCT00441285|7223040|FG001|COMPLETED|Overall Study||16
6318166|NCT00441285|7223041|FG002|COMPLETED|Overall Study||41
6318167|NCT00441285|7223042|FG003|COMPLETED|Overall Study||40
6318168|NCT00441285|7223043|FG004|COMPLETED|Overall Study||43
6318169|NCT00441285|7223039|FG000|NOT COMPLETED|Overall Study||0
6318170|NCT00441285|7223040|FG001|NOT COMPLETED|Overall Study||0
6318171|NCT00441285|7223041|FG002|NOT COMPLETED|Overall Study||0
6318172|NCT00441285|7223042|FG003|NOT COMPLETED|Overall Study||0
6318173|NCT00441285|7223043|FG004|NOT COMPLETED|Overall Study||0
6318174|NCT00441337|7223059|FG000|STARTED|Overall Study||6
6318175|NCT00441337|7223060|FG001|STARTED|Overall Study||6
6318176|NCT00441337|7223061|FG002|STARTED|Overall Study||6
6318177|NCT00441337|7223062|FG003|STARTED|Overall Study||21
6318178|NCT00441337|7223059|FG000|COMPLETED|Overall Study||0
6318179|NCT00441337|7223060|FG001|COMPLETED|Overall Study||0
6318180|NCT00441337|7223061|FG002|COMPLETED|Overall Study||0
6318181|NCT00441337|7223062|FG003|COMPLETED|Overall Study||0
6318182|NCT00441337|7223059|FG000|NOT COMPLETED|Overall Study||6
6318183|NCT00441337|7223060|FG001|NOT COMPLETED|Overall Study||6
6318184|NCT00441337|7223061|FG002|NOT COMPLETED|Overall Study||6
6318185|NCT00441337|7223062|FG003|NOT COMPLETED|Overall Study||21
6318186|NCT00441350|7223082|FG000|STARTED|Phase A: Randomization to Week 8||285
6318187|NCT00441350|7223083|FG001|STARTED|Phase A: Randomization to Week 8||561
6318188|NCT00441350|7223084|FG002|STARTED|Phase A: Randomization to Week 8||0
6318189|NCT00441350|7223085|FG003|STARTED|Phase A: Randomization to Week 8||0
6318190|NCT00441350|7223086|FG004|STARTED|Phase A: Randomization to Week 8||0
6318191|NCT00441350|7223087|FG005|STARTED|Phase A: Randomization to Week 8||0
6318192|NCT00441350|7223082|FG000|COMPLETED|Phase A: Randomization to Week 8||268
6318193|NCT00441350|7223083|FG001|COMPLETED|Phase A: Randomization to Week 8||524
6318194|NCT00441350|7223084|FG002|COMPLETED|Phase A: Randomization to Week 8||0
6318195|NCT00441350|7223085|FG003|COMPLETED|Phase A: Randomization to Week 8||0
6318196|NCT00441350|7223086|FG004|COMPLETED|Phase A: Randomization to Week 8||0
6318197|NCT00441350|7223087|FG005|COMPLETED|Phase A: Randomization to Week 8||0
6318198|NCT00441350|7223082|FG000|NOT COMPLETED|Phase A: Randomization to Week 8||17
6318199|NCT00441350|7223083|FG001|NOT COMPLETED|Phase A: Randomization to Week 8||37
6318200|NCT00441350|7223084|FG002|NOT COMPLETED|Phase A: Randomization to Week 8||0
6318201|NCT00441350|7223085|FG003|NOT COMPLETED|Phase A: Randomization to Week 8||0
6318202|NCT00441350|7223086|FG004|NOT COMPLETED|Phase A: Randomization to Week 8||0
6318203|NCT00441350|7223087|FG005|NOT COMPLETED|Phase A: Randomization to Week 8||0
6318204|NCT00441350|7223082|FG000|STARTED|Phase B: Week 8 to Week 16||0
6318205|NCT00441350|7223083|FG001|STARTED|Phase B: Week 8 to Week 16||0
6318206|NCT00441350|7223084|FG002|STARTED|Phase B: Week 8 to Week 16||129
6318207|NCT00441350|7223085|FG003|STARTED|Phase B: Week 8 to Week 16||139
6318208|NCT00441350|7223086|FG004|STARTED|Phase B: Week 8 to Week 16||336
6318209|NCT00441350|7223087|FG005|STARTED|Phase B: Week 8 to Week 16||188
6318210|NCT00441350|7223082|FG000|COMPLETED|Phase B: Week 8 to Week 16||0
6318211|NCT00441350|7223083|FG001|COMPLETED|Phase B: Week 8 to Week 16||0
6318212|NCT00441350|7223084|FG002|COMPLETED|Phase B: Week 8 to Week 16||128
6318213|NCT00441350|7223085|FG003|COMPLETED|Phase B: Week 8 to Week 16||137
6318214|NCT00441350|7223086|FG004|COMPLETED|Phase B: Week 8 to Week 16||333
6318215|NCT00441350|7223087|FG005|COMPLETED|Phase B: Week 8 to Week 16||186
6318216|NCT00441350|7223082|FG000|NOT COMPLETED|Phase B: Week 8 to Week 16||0
6318217|NCT00441350|7223083|FG001|NOT COMPLETED|Phase B: Week 8 to Week 16||0
6318218|NCT00441350|7223084|FG002|NOT COMPLETED|Phase B: Week 8 to Week 16||1
6318219|NCT00441350|7223085|FG003|NOT COMPLETED|Phase B: Week 8 to Week 16||2
6318220|NCT00441350|7223086|FG004|NOT COMPLETED|Phase B: Week 8 to Week 16||3
6318221|NCT00441350|7223087|FG005|NOT COMPLETED|Phase B: Week 8 to Week 16||2
6318222|NCT00441363|7223103|FG000|STARTED|Overall Study||32
6318223|NCT00441363|7223104|FG001|STARTED|Overall Study||34
6318224|NCT00441363|7223103|FG000|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
6318225|NCT00441363|7223104|FG001|COMPLETED|Overall Study||19
6318226|NCT00441363|7223103|FG000|NOT COMPLETED|Overall Study||17
6318227|NCT00441363|7223104|FG001|NOT COMPLETED|Overall Study||15
6318228|NCT00441441|7223112|FG000|STARTED|Overall Study||173
6318229|NCT00441441|7223113|FG001|STARTED|Overall Study||177
6318230|NCT00441441|7223112|FG000|COMPLETED|Overall Study||162
6318231|NCT00441441|7223113|FG001|COMPLETED|Overall Study||163
6318232|NCT00441441|7223112|FG000|NOT COMPLETED|Overall Study||11
6318233|NCT00441441|7223113|FG001|NOT COMPLETED|Overall Study||14
6318234|NCT00441467|7223133|FG000|STARTED|Overall Study||22
6318235|NCT00441467|7223133|FG000|2 Cycles|Overall Study||17
6318236|NCT00441467|7223133|FG000|4 Cycles|Overall Study||7
6318237|NCT00441467|7223133|FG000|COMPLETED|Overall Study||4
6318238|NCT00441467|7223133|FG000|NOT COMPLETED|Overall Study||18
6318239|NCT00441480|7223139|FG000|STARTED|Overall Study||46
6318240|NCT00441480|7223140|FG001|STARTED|Overall Study||45
6318241|NCT00441480|7223139|FG000|COMPLETED|Overall Study||43
6318242|NCT00441480|7223140|FG001|COMPLETED|Overall Study||41
6318243|NCT00441480|7223139|FG000|NOT COMPLETED|Overall Study||3
6318244|NCT00441480|7223140|FG001|NOT COMPLETED|Overall Study||4
6318245|NCT00441545|7223146|FG000|STARTED|First Intervention||95
6318246|NCT00441545|7223147|FG001|STARTED|First Intervention||87
6318247|NCT00441545|7223146|FG000|COMPLETED|First Intervention||77
6318248|NCT00441545|7223147|FG001|COMPLETED|First Intervention||75
6318249|NCT00441545|7223146|FG000|NOT COMPLETED|First Intervention||18
6318250|NCT00441545|7223147|FG001|NOT COMPLETED|First Intervention||12
6318251|NCT00441545|7223146|FG000|STARTED|Washout||77
6318252|NCT00441545|7223147|FG001|STARTED|Washout||75
6318253|NCT00441545|7223146|FG000|COMPLETED|Washout||77
6318254|NCT00441545|7223147|FG001|COMPLETED|Washout||75
6318255|NCT00441545|7223146|FG000|NOT COMPLETED|Washout||0
6318256|NCT00441545|7223147|FG001|NOT COMPLETED|Washout||0
6318257|NCT00441545|7223146|FG000|STARTED|Second Intervention||77
6318258|NCT00441545|7223147|FG001|STARTED|Second Intervention||75
6318259|NCT00441545|7223146|FG000|COMPLETED|Second Intervention||65
6318260|NCT00441545|7223147|FG001|COMPLETED|Second Intervention||68
6318261|NCT00441545|7223146|FG000|NOT COMPLETED|Second Intervention||12
6318262|NCT00441545|7223147|FG001|NOT COMPLETED|Second Intervention||7
6318263|NCT00441558|7223153|FG000|STARTED|Overall Study||1723
6318264|NCT00441558|7223153|FG000|COMPLETED|Overall Study||667
6318265|NCT00441558|7223153|FG000|NOT COMPLETED|Overall Study||1056
6318266|NCT00441584|7223157|FG000|STARTED|Overall Study||117
6318267|NCT00441584|7223157|FG000|COMPLETED|Overall Study||12
6318268|NCT00441584|7223157|FG000|NOT COMPLETED|Overall Study||105
6318269|NCT00441701|7223171|FG000|STARTED|Overall Study||22
6318270|NCT00441701|7223172|FG001|STARTED|Overall Study||11
6318271|NCT00441701|7223173|FG002|STARTED|Overall Study||22
6318272|NCT00441701|7223174|FG003|STARTED|Overall Study||11
6318273|NCT00441701|7223175|FG004|STARTED|Overall Study||22
6318274|NCT00441701|7223176|FG005|STARTED|Overall Study||11
6318275|NCT00441701|7223177|FG006|STARTED|Overall Study||0
6318276|NCT00441701|7223178|FG007|STARTED|Overall Study||0
6318277|NCT00441701|7223179|FG008|STARTED|Overall Study||0
6318278|NCT00441701|7223180|FG009|STARTED|Overall Study||0
6318279|NCT00441701|7223171|FG000|COMPLETED|Overall Study||17
6318280|NCT00441701|7223172|FG001|COMPLETED|Overall Study||7
6318281|NCT00441701|7223173|FG002|COMPLETED|Overall Study||18
6318282|NCT00441701|7223174|FG003|COMPLETED|Overall Study||8
6318283|NCT00441701|7223175|FG004|COMPLETED|Overall Study||20
6318284|NCT00441701|7223176|FG005|COMPLETED|Overall Study||8
6318285|NCT00441701|7223177|FG006|COMPLETED|Overall Study||0
6318286|NCT00441701|7223178|FG007|COMPLETED|Overall Study||0
6318287|NCT00441701|7223179|FG008|COMPLETED|Overall Study||0
6318288|NCT00441701|7223180|FG009|COMPLETED|Overall Study||0
6318289|NCT00441701|7223171|FG000|NOT COMPLETED|Overall Study||5
6318290|NCT00441701|7223172|FG001|NOT COMPLETED|Overall Study||4
6318291|NCT00441701|7223173|FG002|NOT COMPLETED|Overall Study||4
6318292|NCT00441701|7223174|FG003|NOT COMPLETED|Overall Study||3
6318293|NCT00441701|7223175|FG004|NOT COMPLETED|Overall Study||2
6318294|NCT00441701|7223176|FG005|NOT COMPLETED|Overall Study||3
6318295|NCT00441701|7223177|FG006|NOT COMPLETED|Overall Study||0
6318296|NCT00441701|7223178|FG007|NOT COMPLETED|Overall Study||0
6318297|NCT00441701|7223179|FG008|NOT COMPLETED|Overall Study||0
6318298|NCT00441701|7223180|FG009|NOT COMPLETED|Overall Study||0
6318299|NCT00441727|7223201|FG000|STARTED|Overall Study|ITT/randomised|817
6318300|NCT00441727|7223202|FG001|STARTED|Overall Study|ITT/randomised|804
6318301|NCT00441727|7223203|FG002|STARTED|Overall Study|ITT/randomised|805
6318302|NCT00441727|7223201|FG000|COMPLETED|Overall Study|ITT/randomised|711
6318303|NCT00441727|7223202|FG001|COMPLETED|Overall Study|ITT/randomised|686
6318304|NCT00441727|7223203|FG002|COMPLETED|Overall Study|ITT/randomised|637
6318305|NCT00441727|7223201|FG000|NOT COMPLETED|Overall Study||106
6318306|NCT00441727|7223202|FG001|NOT COMPLETED|Overall Study||118
6318307|NCT00441727|7223203|FG002|NOT COMPLETED|Overall Study||168
6318308|NCT00441766|7223220|FG000|STARTED|Overall Study||53
6318309|NCT00441766|7223221|FG001|STARTED|Overall Study||53
6318310|NCT00441766|7223222|FG002|STARTED|Overall Study||53
6318311|NCT00441766|7223223|FG003|STARTED|Overall Study||54
6318312|NCT00441766|7223220|FG000|COMPLETED|Overall Study||39
6318313|NCT00441766|7223221|FG001|COMPLETED|Overall Study||46
6318314|NCT00441766|7223222|FG002|COMPLETED|Overall Study||44
6318315|NCT00441766|7223223|FG003|COMPLETED|Overall Study||48
6318316|NCT00441766|7223220|FG000|NOT COMPLETED|Overall Study||14
6318317|NCT00441766|7223221|FG001|NOT COMPLETED|Overall Study||7
6318318|NCT00441766|7223222|FG002|NOT COMPLETED|Overall Study||9
6318319|NCT00441766|7223223|FG003|NOT COMPLETED|Overall Study||6
6318320|NCT00441792|7223235|FG000|STARTED|Overall Study||59
6318321|NCT00441792|7223236|FG001|STARTED|Overall Study||63
6318322|NCT00441792|7223235|FG000|COMPLETED|Overall Study||59
6318323|NCT00441792|7223236|FG001|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
6318324|NCT00441792|7223235|FG000|NOT COMPLETED|Overall Study||0
6318325|NCT00441792|7223236|FG001|NOT COMPLETED|Overall Study||2
6318326|NCT00441883|7223247|FG000|STARTED|Overall Study||43
6318327|NCT00441883|7223248|FG001|STARTED|Overall Study||32
6318328|NCT00441883|7223249|FG002|STARTED|Overall Study||28
6318329|NCT00441883|7223250|FG003|STARTED|Overall Study||28
6318330|NCT00441883|7223251|FG004|STARTED|Overall Study||45
6318331|NCT00441883|7223247|FG000|ITT Population|Overall Study||43
6318332|NCT00441883|7223248|FG001|ITT Population|Overall Study||30
6318333|NCT00441883|7223249|FG002|ITT Population|Overall Study||30
6318334|NCT00441883|7223250|FG003|ITT Population|Overall Study||30
6318335|NCT00441883|7223251|FG004|ITT Population|Overall Study||43
6318336|NCT00441883|7223247|FG000|Per Protocol Population|Overall Study||38
6318337|NCT00441883|7223248|FG001|Per Protocol Population|Overall Study||29
6318338|NCT00441883|7223249|FG002|Per Protocol Population|Overall Study||25
6318339|NCT00441883|7223250|FG003|Per Protocol Population|Overall Study||24
6318340|NCT00441883|7223251|FG004|Per Protocol Population|Overall Study||38
6318341|NCT00441883|7223247|FG000|Safety Population|Overall Study||43
6318342|NCT00441883|7223248|FG001|Safety Population|Overall Study||32
6318343|NCT00441883|7223249|FG002|Safety Population|Overall Study||28
6318344|NCT00441883|7223250|FG003|Safety Population|Overall Study||28
6318345|NCT00441883|7223251|FG004|Safety Population|Overall Study||45
6318346|NCT00441883|7223247|FG000|COMPLETED|Overall Study||42
6318347|NCT00441883|7223248|FG001|COMPLETED|Overall Study||32
6318348|NCT00441883|7223249|FG002|COMPLETED|Overall Study||28
6318349|NCT00441883|7223250|FG003|COMPLETED|Overall Study||28
6318350|NCT00441883|7223251|FG004|COMPLETED|Overall Study||43
6318351|NCT00441883|7223247|FG000|NOT COMPLETED|Overall Study||1
6318352|NCT00441883|7223248|FG001|NOT COMPLETED|Overall Study||0
6318353|NCT00441883|7223249|FG002|NOT COMPLETED|Overall Study||0
6318354|NCT00441883|7223250|FG003|NOT COMPLETED|Overall Study||0
6318355|NCT00441883|7223251|FG004|NOT COMPLETED|Overall Study||2
6318356|NCT00441974|7223263|FG000|STARTED|Overall Study||1470
6318357|NCT00441974|7223263|FG000|COMPLETED|Overall Study||1342
6318358|NCT00441974|7223263|FG000|NOT COMPLETED|Overall Study||128
6318359|NCT00442013|7223272|FG000|STARTED|Overall Study||157
6318360|NCT00442013|7223273|FG001|STARTED|Overall Study||149
6318361|NCT00442013|7223272|FG000|COMPLETED|Overall Study||131
6318362|NCT00442013|7223273|FG001|COMPLETED|Overall Study||132
6318363|NCT00442013|7223272|FG000|NOT COMPLETED|Overall Study||26
6318364|NCT00442013|7223273|FG001|NOT COMPLETED|Overall Study||17
6318365|NCT00442169|7223286|FG000|STARTED|Part 1||17
6318366|NCT00442169|7223287|FG001|STARTED|Part 1||24
6318367|NCT00442169|7223288|FG002|STARTED|Part 1||40
6318368|NCT00442169|7223289|FG003|STARTED|Part 1||31
6318369|NCT00442169|7223290|FG004|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
6318370|NCT00442169|7223291|FG005|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
6318371|NCT00442169|7223286|FG000|COMPLETED|Part 1||17
6318372|NCT00442169|7223287|FG001|COMPLETED|Part 1||24
6318373|NCT00442169|7223288|FG002|COMPLETED|Part 1||40
6318374|NCT00442169|7223289|FG003|COMPLETED|Part 1||31
6318375|NCT00442169|7223290|FG004|COMPLETED|Part 1||0
6318376|NCT00442169|7223291|FG005|COMPLETED|Part 1||0
6318377|NCT00442169|7223286|FG000|NOT COMPLETED|Part 1||0
6318378|NCT00442169|7223287|FG001|NOT COMPLETED|Part 1||0
6318379|NCT00442169|7223288|FG002|NOT COMPLETED|Part 1||0
6318380|NCT00442169|7223289|FG003|NOT COMPLETED|Part 1||0
6318381|NCT00442169|7223290|FG004|NOT COMPLETED|Part 1||0
6318382|NCT00442169|7223291|FG005|NOT COMPLETED|Part 1||0
6375397|NCT00755716|7286061|FG000|STARTED|Overall Study||19
6318383|NCT00442169|7223286|FG000|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
6318384|NCT00442169|7223287|FG001|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
6318385|NCT00442169|7223288|FG002|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
6318386|NCT00442169|7223289|FG003|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
6318387|NCT00442169|7223290|FG004|STARTED|Part 2||25
6318388|NCT00442169|7223291|FG005|STARTED|Part 2||57
6318389|NCT00442169|7223286|FG000|COMPLETED|Part 2||0
6318390|NCT00442169|7223287|FG001|COMPLETED|Part 2||0
6318391|NCT00442169|7223288|FG002|COMPLETED|Part 2||0
6318392|NCT00442169|7223289|FG003|COMPLETED|Part 2||0
6318393|NCT00442169|7223290|FG004|COMPLETED|Part 2||25
6318394|NCT00442169|7223291|FG005|COMPLETED|Part 2||57
6318395|NCT00442169|7223286|FG000|NOT COMPLETED|Part 2||0
6318396|NCT00442169|7223287|FG001|NOT COMPLETED|Part 2||0
6318397|NCT00442169|7223288|FG002|NOT COMPLETED|Part 2||0
6318398|NCT00442169|7223289|FG003|NOT COMPLETED|Part 2||0
6318399|NCT00442169|7223290|FG004|NOT COMPLETED|Part 2||0
6318400|NCT00442169|7223291|FG005|NOT COMPLETED|Part 2||0
6318401|NCT00442286|7223308|FG000|STARTED|Overall Study||181
6318402|NCT00442286|7223309|FG001|STARTED|Overall Study||84
6318403|NCT00442286|7223308|FG000|6 Months|Overall Study||177
6318404|NCT00442286|7223309|FG001|6 Months|Overall Study||83
6318405|NCT00442286|7223308|FG000|12 Months|Overall Study||174
6318406|NCT00442286|7223309|FG001|12 Months|Overall Study||82
6318407|NCT00442286|7223308|FG000|COMPLETED|Overall Study||174
6318408|NCT00442286|7223309|FG001|COMPLETED|Overall Study||82
6318409|NCT00442286|7223308|FG000|NOT COMPLETED|Overall Study||7
6318410|NCT00442286|7223309|FG001|NOT COMPLETED|Overall Study||2
6318411|NCT00442364|7223317|FG000|STARTED|Overall Study||60
6318412|NCT00442364|7223317|FG000|COMPLETED|Overall Study||60
6318413|NCT00442364|7223317|FG000|NOT COMPLETED|Overall Study||0
6375398|NCT00755716|7286062|FG001|STARTED|Overall Study||19
6375399|NCT00755716|7286063|FG002|STARTED|Overall Study||19
6375400|NCT00755716|7286061|FG000|COMPLETED|Overall Study||11
6375401|NCT00755716|7286062|FG001|COMPLETED|Overall Study||11
6375402|NCT00755716|7286063|FG002|COMPLETED|Overall Study||16
6375403|NCT00755716|7286061|FG000|NOT COMPLETED|Overall Study||8
6375404|NCT00755716|7286062|FG001|NOT COMPLETED|Overall Study||8
6375405|NCT00755716|7286063|FG002|NOT COMPLETED|Overall Study||3
6375406|NCT00755755|7286074|FG000|STARTED|Overall Study|Safety population|95
6375407|NCT00755755|7286075|FG001|STARTED|Overall Study|Safety population|98
6375408|NCT00755755|7286076|FG002|STARTED|Overall Study|Safety population|48
6375409|NCT00755755|7286074|FG000|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
6375410|NCT00755755|7286075|FG001|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
6375411|NCT00755755|7286076|FG002|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
6375412|NCT00755755|7286074|FG000|NOT COMPLETED|Overall Study||6
6375413|NCT00755755|7286075|FG001|NOT COMPLETED|Overall Study||8
6375414|NCT00755755|7286076|FG002|NOT COMPLETED|Overall Study||3
6375415|NCT00755807|7286086|FG000|STARTED|Acute Phase||118
6375416|NCT00755807|7286087|FG001|STARTED|Acute Phase||121
6375417|NCT00755807|7286086|FG000|COMPLETED|Acute Phase||100
6375418|NCT00755807|7286087|FG001|COMPLETED|Acute Phase||109
6375419|NCT00755807|7286086|FG000|NOT COMPLETED|Acute Phase||18
6375420|NCT00755807|7286087|FG001|NOT COMPLETED|Acute Phase||12
6375421|NCT00755807|7286086|FG000|STARTED|Open-label Extension Phase||100
6375422|NCT00755807|7286087|FG001|STARTED|Open-label Extension Phase||109
6375423|NCT00755807|7286086|FG000|COMPLETED|Open-label Extension Phase||82
6375424|NCT00755807|7286087|FG001|COMPLETED|Open-label Extension Phase||93
6375425|NCT00755807|7286086|FG000|NOT COMPLETED|Open-label Extension Phase||18
6375426|NCT00755807|7286087|FG001|NOT COMPLETED|Open-label Extension Phase||16
6375427|NCT00755846|7286103|FG000|STARTED|Overall Study||43
6375428|NCT00755846|7286104|FG001|STARTED|Overall Study||44
6375429|NCT00755846|7286105|FG002|STARTED|Overall Study||44
6375430|NCT00755846|7286106|FG003|STARTED|Overall Study||45
6375431|NCT00755846|7286107|FG004|STARTED|Overall Study||44
6375432|NCT00755846|7286108|FG005|STARTED|Overall Study||45
6375433|NCT00755846|7286103|FG000|COMPLETED|Overall Study||18
6375434|NCT00755846|7286104|FG001|COMPLETED|Overall Study||27
6375435|NCT00755846|7286105|FG002|COMPLETED|Overall Study||32
6375436|NCT00755846|7286106|FG003|COMPLETED|Overall Study||32
6375437|NCT00755846|7286107|FG004|COMPLETED|Overall Study||27
6375438|NCT00755846|7286108|FG005|COMPLETED|Overall Study||31
6375439|NCT00755846|7286103|FG000|NOT COMPLETED|Overall Study||25
6375440|NCT00755846|7286104|FG001|NOT COMPLETED|Overall Study||17
6375441|NCT00755846|7286105|FG002|NOT COMPLETED|Overall Study||12
6375442|NCT00755846|7286106|FG003|NOT COMPLETED|Overall Study||13
6375443|NCT00755846|7286107|FG004|NOT COMPLETED|Overall Study||17
6375444|NCT00755846|7286108|FG005|NOT COMPLETED|Overall Study||14
6375445|NCT00755911|7286124|FG000|STARTED|Overall Study||12
6375446|NCT00755911|7286125|FG001|STARTED|Overall Study||12
6375447|NCT00755911|7286124|FG000|COMPLETED|Overall Study||12
6375448|NCT00755911|7286125|FG001|COMPLETED|Overall Study||12
6375449|NCT00755911|7286124|FG000|NOT COMPLETED|Overall Study||0
6375450|NCT00755911|7286125|FG001|NOT COMPLETED|Overall Study||0
6375451|NCT00755937|7286131|FG000|STARTED|Recruitment|Subjects registered in the program|556
6375452|NCT00755937|7286131|FG000|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
6375453|NCT00755937|7286131|FG000|NOT COMPLETED|Recruitment||164
6318414|NCT00442416|7223323|FG000|STARTED|Overall Study||39
6318415|NCT00442416|7223324|FG001|STARTED|Overall Study||41
6318416|NCT00442416|7223323|FG000|COMPLETED|Overall Study||2
6318417|NCT00442416|7223324|FG001|COMPLETED|Overall Study||2
6318418|NCT00442416|7223323|FG000|NOT COMPLETED|Overall Study||37
6318419|NCT00442416|7223324|FG001|NOT COMPLETED|Overall Study||39
6318420|NCT00442468|7223330|FG000|STARTED|Overall Study||1283
6318421|NCT00442468|7223330|FG000|COMPLETED|Overall Study||1100
6318422|NCT00442468|7223330|FG000|NOT COMPLETED|Overall Study||183
6318423|NCT00442507|7223334|FG000|STARTED|Overall Study||6
6318424|NCT00442507|7223334|FG000|COMPLETED|Overall Study||6
6318425|NCT00442507|7223334|FG000|NOT COMPLETED|Overall Study||0
6318426|NCT00442572|7223340|FG000|STARTED|Overall Study||17
6318427|NCT00442572|7223341|FG001|STARTED|Overall Study||4
6318428|NCT00442572|7223340|FG000|COMPLETED|Overall Study||9
6318429|NCT00442572|7223341|FG001|COMPLETED|Overall Study||1
6318430|NCT00442572|7223340|FG000|NOT COMPLETED|Overall Study||8
6318431|NCT00442572|7223341|FG001|NOT COMPLETED|Overall Study||3
6318432|NCT00442598|7223351|FG000|STARTED|Overall Study||7
6318433|NCT00442598|7223352|FG001|STARTED|Overall Study||10
6318434|NCT00442598|7223353|FG002|STARTED|Overall Study||0
6318435|NCT00442598|7223351|FG000|Two Cycles|Overall Study||5
6318436|NCT00442598|7223352|FG001|Two Cycles|Overall Study||6
6318437|NCT00442598|7223353|FG002|Two Cycles|Overall Study||0
6318438|NCT00442598|7223351|FG000|COMPLETED|Overall Study||1
6318439|NCT00442598|7223352|FG001|COMPLETED|Overall Study||2
6318440|NCT00442598|7223353|FG002|COMPLETED|Overall Study||0
6318441|NCT00442598|7223351|FG000|NOT COMPLETED|Overall Study||6
6318442|NCT00442598|7223352|FG001|NOT COMPLETED|Overall Study||8
6318443|NCT00442598|7223353|FG002|NOT COMPLETED|Overall Study||0
6318444|NCT00442611|7223362|FG000|STARTED|Overall Study||7
6318445|NCT00442611|7223363|FG001|STARTED|Overall Study||3
6318446|NCT00442611|7223362|FG000|COMPLETED|Overall Study||6
6318447|NCT00442611|7223363|FG001|COMPLETED|Overall Study||3
6318448|NCT00442611|7223362|FG000|NOT COMPLETED|Overall Study||1
6318449|NCT00442611|7223363|FG001|NOT COMPLETED|Overall Study||0
6318450|NCT00442689|7223372|FG000|STARTED|Overall Study||21
6318451|NCT00442689|7223373|FG001|STARTED|Overall Study||24
6318452|NCT00442689|7223374|FG002|STARTED|Overall Study||22
6318453|NCT00442689|7223372|FG000|COMPLETED|Overall Study||11
6318454|NCT00442689|7223373|FG001|COMPLETED|Overall Study||13
6318455|NCT00442689|7223374|FG002|COMPLETED|Overall Study||13
6318456|NCT00442689|7223372|FG000|NOT COMPLETED|Overall Study||10
6318457|NCT00442689|7223373|FG001|NOT COMPLETED|Overall Study||11
6318458|NCT00442689|7223374|FG002|NOT COMPLETED|Overall Study||9
6318459|NCT00442702|7223384|FG000|STARTED|Titration Period||114
6318460|NCT00442702|7223385|FG001|STARTED|Titration Period||114
6318461|NCT00442702|7223384|FG000|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
6318462|NCT00442702|7223385|FG001|Safety Population|Titration Period||113
6318463|NCT00442702|7223384|FG000|COMPLETED|Titration Period||102
6318464|NCT00442702|7223385|FG001|COMPLETED|Titration Period||111
6318465|NCT00442702|7223384|FG000|NOT COMPLETED|Titration Period||12
6318466|NCT00442702|7223385|FG001|NOT COMPLETED|Titration Period||3
6318467|NCT00442702|7223384|FG000|STARTED|Evaluation Period||102
6318468|NCT00442702|7223385|FG001|STARTED|Evaluation Period||111
6318469|NCT00442702|7223384|FG000|COMPLETED|Evaluation Period||97
6318470|NCT00442702|7223385|FG001|COMPLETED|Evaluation Period||107
6318471|NCT00442702|7223384|FG000|NOT COMPLETED|Evaluation Period||5
6318472|NCT00442702|7223385|FG001|NOT COMPLETED|Evaluation Period||4
6318473|NCT00442767|7223391|FG000|STARTED|Overall Study||8
6318474|NCT00442767|7223391|FG000|COMPLETED|Overall Study||8
6318475|NCT00442767|7223391|FG000|NOT COMPLETED|Overall Study||0
6318476|NCT00442936|7223401|FG000|STARTED|Overall Study||333
6318477|NCT00442936|7223402|FG001|STARTED|Overall Study||354
6318478|NCT00442936|7223403|FG002|STARTED|Overall Study||345
6318479|NCT00442936|7223404|FG003|STARTED|Overall Study||348
6318480|NCT00442936|7223401|FG000|COMPLETED|Overall Study||332
6318481|NCT00442936|7223402|FG001|COMPLETED|Overall Study||354
6318482|NCT00442936|7223403|FG002|COMPLETED|Overall Study||344
6318483|NCT00442936|7223404|FG003|COMPLETED|Overall Study||347
6318484|NCT00442936|7223401|FG000|NOT COMPLETED|Overall Study||1
6318485|NCT00442936|7223402|FG001|NOT COMPLETED|Overall Study||0
6318486|NCT00442936|7223403|FG002|NOT COMPLETED|Overall Study||1
6318487|NCT00442936|7223404|FG003|NOT COMPLETED|Overall Study||1
6318488|NCT00442962|7223414|FG000|STARTED|Overall Study||54
6318489|NCT00442962|7223414|FG000|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
6318490|NCT00442962|7223414|FG000|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
6318491|NCT00442962|7223414|FG000|NOT COMPLETED|Overall Study||8
6318492|NCT00443053|7223420|FG000|STARTED|Overall Study||1502
6318493|NCT00443053|7223421|FG001|STARTED|Overall Study||1500
6318494|NCT00443053|7223420|FG000|COMPLETED|Overall Study||1481
6318495|NCT00443053|7223421|FG001|COMPLETED|Overall Study||1467
6318496|NCT00443053|7223420|FG000|NOT COMPLETED|Overall Study||21
6318497|NCT00443053|7223421|FG001|NOT COMPLETED|Overall Study||33
6318498|NCT00443079|7223429|FG000|STARTED|Overall Study||3
6318499|NCT00443079|7223430|FG001|STARTED|Overall Study||3
6318500|NCT00443079|7223429|FG000|COMPLETED|Overall Study||3
6318501|NCT00443079|7223430|FG001|COMPLETED|Overall Study||2
6318502|NCT00443079|7223429|FG000|NOT COMPLETED|Overall Study||0
6318503|NCT00443079|7223430|FG001|NOT COMPLETED|Overall Study||1
6318504|NCT00443118|7223441|FG000|STARTED|Overall Study||515
6318505|NCT00443118|7223442|FG001|STARTED|Overall Study||291
6318506|NCT00443118|7223443|FG002|STARTED|Overall Study||226
6318507|NCT00443118|7223441|FG000|COMPLETED|Overall Study||511
6318508|NCT00443118|7223442|FG001|COMPLETED|Overall Study||290
6318509|NCT00443118|7223443|FG002|COMPLETED|Overall Study||226
6318510|NCT00443118|7223441|FG000|NOT COMPLETED|Overall Study||4
6318511|NCT00443118|7223442|FG001|NOT COMPLETED|Overall Study||1
6318512|NCT00443118|7223443|FG002|NOT COMPLETED|Overall Study||0
6318513|NCT00443209|7223471|FG000|STARTED|Months 1 to 12 Treatment Period||712
6318514|NCT00443209|7223472|FG001|STARTED|Months 1 to 12 Treatment Period||356
6318515|NCT00443209|7223471|FG000|Treated|Months 1 to 12 Treatment Period||641
6318516|NCT00443209|7223472|FG001|Treated|Months 1 to 12 Treatment Period||313
6318517|NCT00443209|7223471|FG000|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
6318518|NCT00443209|7223472|FG001|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
6318519|NCT00443209|7223471|FG000|NOT COMPLETED|Months 1 to 12 Treatment Period||345
6318520|NCT00443209|7223472|FG001|NOT COMPLETED|Months 1 to 12 Treatment Period||154
6318521|NCT00443209|7223471|FG000|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
6318522|NCT00443209|7223472|FG001|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
6318523|NCT00443209|7223471|FG000|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
6318524|NCT00443209|7223472|FG001|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
6318525|NCT00443209|7223471|FG000|NOT COMPLETED|Months 13 to 18 Treatment Period||99
6318526|NCT00443209|7223472|FG001|NOT COMPLETED|Months 13 to 18 Treatment Period||47
6318527|NCT00443261|7223478|FG000|STARTED|Overall Study||1
6318528|NCT00443261|7223478|FG000|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
6318529|NCT00443261|7223478|FG000|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
6318530|NCT00443261|7223478|FG000|NOT COMPLETED|Overall Study||1
6318531|NCT00443352|7223482|FG000|STARTED|Overall Study||27
6318532|NCT00443352|7223482|FG000|COMPLETED|Overall Study||22
6318533|NCT00443352|7223482|FG000|NOT COMPLETED|Overall Study||5
6318534|NCT00443430|7223488|FG000|STARTED|Overall Study||43
6318535|NCT00443430|7223489|FG001|STARTED|Overall Study||42
6318536|NCT00443430|7223488|FG000|COMPLETED|Overall Study||39
6318537|NCT00443430|7223489|FG001|COMPLETED|Overall Study||38
6318538|NCT00443430|7223488|FG000|NOT COMPLETED|Overall Study||4
6318539|NCT00443430|7223489|FG001|NOT COMPLETED|Overall Study||4
6318540|NCT00443456|7223495|FG000|STARTED|Overall Study||134
6318541|NCT00443456|7223495|FG000|COMPLETED|Overall Study||116
6318542|NCT00443456|7223495|FG000|NOT COMPLETED|Overall Study||18
6318543|NCT00443534|7223503|FG000|STARTED|Overall Study||123
6318544|NCT00443534|7223503|FG000|Treated|Overall Study||122
6318545|NCT00443534|7223503|FG000|COMPLETED|Overall Study||0
6318546|NCT00443534|7223503|FG000|NOT COMPLETED|Overall Study||123
6318547|NCT00443547|7223511|FG000|STARTED|Overall Study|Enrolled and Treated Per Protocol|89
6318548|NCT00443547|7223512|FG001|STARTED|Overall Study|Enrolled and Treated Per Protocol|88
6318549|NCT00443547|7223513|FG002|STARTED|Overall Study|Enrolled and Treated Per Protocol|48
6318550|NCT00443547|7223514|FG003|STARTED|Overall Study|Enrolled and Treated Per Protocol|6
6318551|NCT00443547|7223511|FG000|Evaluated at 12 Months|Overall Study||58
6318552|NCT00443547|7223512|FG001|Evaluated at 12 Months|Overall Study||55
6318553|NCT00443547|7223513|FG002|Evaluated at 12 Months|Overall Study||37
6318554|NCT00443547|7223514|FG003|Evaluated at 12 Months|Overall Study||5
6318555|NCT00443547|7223511|FG000|COMPLETED|Overall Study||44
6318556|NCT00443547|7223512|FG001|COMPLETED|Overall Study||46
6318557|NCT00443547|7223513|FG002|COMPLETED|Overall Study||27
6318558|NCT00443547|7223514|FG003|COMPLETED|Overall Study||4
6318559|NCT00443547|7223511|FG000|NOT COMPLETED|Overall Study||45
6318560|NCT00443547|7223512|FG001|NOT COMPLETED|Overall Study||42
6318561|NCT00443547|7223513|FG002|NOT COMPLETED|Overall Study||21
6318562|NCT00443547|7223514|FG003|NOT COMPLETED|Overall Study||2
6318563|NCT00443560|7223526|FG000|STARTED|Overall Study||1081
6557889|NCT01771172|7480537|FG000|NOT COMPLETED|Overall Study||2
6557890|NCT01771250|7480541|FG000|STARTED|Period 1||8
6318564|NCT00443560|7223527|FG001|STARTED|Overall Study||1081
6318565|NCT00443560|7223526|FG000|COMPLETED|Overall Study||1021
6318566|NCT00443560|7223527|FG001|COMPLETED|Overall Study||1051
6318567|NCT00443560|7223526|FG000|NOT COMPLETED|Overall Study||60
6318568|NCT00443560|7223527|FG001|NOT COMPLETED|Overall Study||30
6318569|NCT00443599|7223535|FG000|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
6318570|NCT00443599|7223536|FG001|STARTED|Overall Study|Randomly Assigned to Standard Care|493
6318571|NCT00443599|7223535|FG000|COMPLETED|Overall Study|Included in per-protocol analysis|490
6318572|NCT00443599|7223536|FG001|COMPLETED|Overall Study|Included in per-protocol analysis|490
6318573|NCT00443599|7223535|FG000|NOT COMPLETED|Overall Study||6
6318574|NCT00443599|7223536|FG001|NOT COMPLETED|Overall Study||3
6318575|NCT00443651|7223544|FG000|STARTED|Overall Study||401
6318576|NCT00443651|7223545|FG001|STARTED|Overall Study||176
6318577|NCT00443651|7223544|FG000|Week 24|Overall Study||376
6318578|NCT00443651|7223545|FG001|Week 24|Overall Study||160
6318579|NCT00443651|7223544|FG000|Week 48|Overall Study||338
6557891|NCT01771250|7480542|FG001|STARTED|Period 1||7
6318580|NCT00443651|7223545|FG001|Week 48|Overall Study||134
6318581|NCT00443651|7223544|FG000|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
6318582|NCT00443651|7223545|FG001|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
6318583|NCT00443651|7223544|FG000|NOT COMPLETED|Overall Study||95
6318584|NCT00443651|7223545|FG001|NOT COMPLETED|Overall Study||58
6318585|NCT00443703|7223553|FG000|STARTED|Overall Study||177
6318586|NCT00443703|7223554|FG001|STARTED|Overall Study||175
6318587|NCT00443703|7223553|FG000|Treated|Overall Study||174
6318588|NCT00443703|7223554|FG001|Treated|Overall Study||174
6318589|NCT00443703|7223553|FG000|COMPLETED|Overall Study||149
6318590|NCT00443703|7223554|FG001|COMPLETED|Overall Study||157
6318591|NCT00443703|7223553|FG000|NOT COMPLETED|Overall Study||28
6318592|NCT00443703|7223554|FG001|NOT COMPLETED|Overall Study||18
6318593|NCT00443729|7223562|FG000|STARTED|Overall Study||176
6318594|NCT00443729|7223563|FG001|STARTED|Overall Study||179
6318595|NCT00443729|7223562|FG000|Treated|Overall Study||176
6318596|NCT00443729|7223563|FG001|Treated|Overall Study||178
6318597|NCT00443729|7223562|FG000|COMPLETED|Overall Study||166
6318598|NCT00443729|7223563|FG001|COMPLETED|Overall Study||172
6318599|NCT00443729|7223562|FG000|NOT COMPLETED|Overall Study||10
6318600|NCT00443729|7223563|FG001|NOT COMPLETED|Overall Study||7
6318601|NCT00443755|7223571|FG000|STARTED|Overall Study||14
6318602|NCT00443755|7223572|FG001|STARTED|Overall Study||14
6318603|NCT00443755|7223571|FG000|COMPLETED|Overall Study||12
6318604|NCT00443755|7223572|FG001|COMPLETED|Overall Study||13
6318605|NCT00443755|7223571|FG000|NOT COMPLETED|Overall Study||2
6318606|NCT00443755|7223572|FG001|NOT COMPLETED|Overall Study||1
6318607|NCT00443781|7223578|FG000|STARTED|Overall Study||62
6318608|NCT00443781|7223578|FG000|COMPLETED|Overall Study||37
6318609|NCT00443781|7223578|FG000|NOT COMPLETED|Overall Study||25
6318610|NCT00443820|7223586|FG000|STARTED|Overall Study||133
6318611|NCT00443820|7223587|FG001|STARTED|Overall Study||130
6318612|NCT00443820|7223588|FG002|STARTED|Overall Study||135
6318613|NCT00443820|7223589|FG003|STARTED|Overall Study||128
6318614|NCT00443820|7223586|FG000|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
6318615|NCT00443820|7223587|FG001|Safety Population|Overall Study||129
6318616|NCT00443820|7223588|FG002|Safety Population|Overall Study||134
6318617|NCT00443820|7223589|FG003|Safety Population|Overall Study||126
6318618|NCT00443820|7223586|FG000|COMPLETED|Overall Study||112
6318619|NCT00443820|7223587|FG001|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
6318620|NCT00443820|7223588|FG002|COMPLETED|Overall Study||117
6318621|NCT00443820|7223589|FG003|COMPLETED|Overall Study||111
6318622|NCT00443820|7223586|FG000|NOT COMPLETED|Overall Study||21
6318623|NCT00443820|7223587|FG001|NOT COMPLETED|Overall Study||19
6318624|NCT00443820|7223588|FG002|NOT COMPLETED|Overall Study||18
6318625|NCT00443820|7223589|FG003|NOT COMPLETED|Overall Study||17
6318626|NCT00443846|7223601|FG000|STARTED|Overall Study||124
6318627|NCT00443846|7223602|FG001|STARTED|Overall Study||123
6318628|NCT00443846|7223601|FG000|Vaccinated|Overall Study||116
6318629|NCT00443846|7223602|FG001|Vaccinated|Overall Study||123
6318630|NCT00443846|7223601|FG000|COMPLETED|Overall Study||113
6318631|NCT00443846|7223602|FG001|COMPLETED|Overall Study||117
6318632|NCT00443846|7223601|FG000|NOT COMPLETED|Overall Study||11
6318633|NCT00443846|7223602|FG001|NOT COMPLETED|Overall Study||6
6318634|NCT00443872|7223608|FG000|STARTED|Overall Study||77
6318635|NCT00443872|7223608|FG000|COMPLETED|Overall Study||60
6318636|NCT00443872|7223608|FG000|NOT COMPLETED|Overall Study||17
6318637|NCT00443898|7223625|FG000|STARTED|Overall Study||126
6318638|NCT00443898|7223626|FG001|STARTED|Overall Study||128
6318639|NCT00443898|7223627|FG002|STARTED|Overall Study||136
6318640|NCT00443898|7223628|FG003|STARTED|Overall Study||128
6318641|NCT00443898|7223625|FG000|COMPLETED|Overall Study||102
6318642|NCT00443898|7223626|FG001|COMPLETED|Overall Study||103
6318643|NCT00443898|7223627|FG002|COMPLETED|Overall Study||107
6318644|NCT00443898|7223628|FG003|COMPLETED|Overall Study||110
6318645|NCT00443898|7223625|FG000|NOT COMPLETED|Overall Study||24
6318646|NCT00443898|7223626|FG001|NOT COMPLETED|Overall Study||25
6318647|NCT00443898|7223627|FG002|NOT COMPLETED|Overall Study||29
6318648|NCT00443898|7223628|FG003|NOT COMPLETED|Overall Study||18
6318649|NCT00444028|7223644|FG000|STARTED|Overall Study||14
6318650|NCT00444028|7223645|FG001|STARTED|Overall Study||7
6318651|NCT00444028|7223646|FG002|STARTED|Overall Study||8
6318652|NCT00444028|7223647|FG003|STARTED|Overall Study||6
6318653|NCT00444028|7223648|FG004|STARTED|Overall Study||7
6318654|NCT00444028|7223649|FG005|STARTED|Overall Study||8
6318655|NCT00444028|7223644|FG000|COMPLETED|Overall Study||14
6318656|NCT00444028|7223645|FG001|COMPLETED|Overall Study||7
6318657|NCT00444028|7223646|FG002|COMPLETED|Overall Study||8
6318658|NCT00444028|7223647|FG003|COMPLETED|Overall Study||6
6318659|NCT00444028|7223648|FG004|COMPLETED|Overall Study||7
6318660|NCT00444028|7223649|FG005|COMPLETED|Overall Study||8
6318661|NCT00444028|7223644|FG000|NOT COMPLETED|Overall Study||0
6318662|NCT00444028|7223645|FG001|NOT COMPLETED|Overall Study||0
6318663|NCT00444028|7223646|FG002|NOT COMPLETED|Overall Study||0
6318664|NCT00444028|7223647|FG003|NOT COMPLETED|Overall Study||0
6318665|NCT00444028|7223648|FG004|NOT COMPLETED|Overall Study||0
6318666|NCT00444028|7223649|FG005|NOT COMPLETED|Overall Study||0
6318667|NCT00444067|7223664|FG000|STARTED|Overall Study||74
6318668|NCT00444067|7223665|FG001|STARTED|Overall Study||24
6318669|NCT00444067|7223664|FG000|COMPLETED|Overall Study||74
6318670|NCT00444067|7223665|FG001|COMPLETED|Overall Study||23
6318671|NCT00444067|7223664|FG000|NOT COMPLETED|Overall Study||0
6318672|NCT00444067|7223665|FG001|NOT COMPLETED|Overall Study||1
6318673|NCT00444080|7223673|FG000|STARTED|Overall Study||61
6318674|NCT00444080|7223674|FG001|STARTED|Overall Study||59
6318675|NCT00444080|7223673|FG000|COMPLETED|Overall Study||61
6318676|NCT00444080|7223674|FG001|COMPLETED|Overall Study||59
6318677|NCT00444080|7223673|FG000|NOT COMPLETED|Overall Study||0
6318678|NCT00444080|7223674|FG001|NOT COMPLETED|Overall Study||0
6318679|NCT00444106|7223686|FG000|STARTED|Overall Study||159
6318680|NCT00444106|7223687|FG001|STARTED|Overall Study||53
6318681|NCT00444106|7223688|FG002|STARTED|Overall Study||53
6318682|NCT00444106|7223686|FG000|Completed Treatment Period|Overall Study||159
6318683|NCT00444106|7223687|FG001|Completed Treatment Period|Overall Study||53
6318684|NCT00444106|7223688|FG002|Completed Treatment Period|Overall Study||53
6318685|NCT00444106|7223686|FG000|COMPLETED|Overall Study||157
6318686|NCT00444106|7223687|FG001|COMPLETED|Overall Study||52
6318687|NCT00444106|7223688|FG002|COMPLETED|Overall Study||52
6318688|NCT00444106|7223686|FG000|NOT COMPLETED|Overall Study||2
6318689|NCT00444106|7223687|FG001|NOT COMPLETED|Overall Study||1
6318690|NCT00444106|7223688|FG002|NOT COMPLETED|Overall Study||1
6318691|NCT00444145|7223699|FG000|STARTED|Overall Study||38
6318692|NCT00444145|7223699|FG000|COMPLETED|Overall Study||19
6318693|NCT00444145|7223699|FG000|NOT COMPLETED|Overall Study||19
6318694|NCT00444275|7223706|FG000|STARTED|Initial Treatment Phase||2156
6318695|NCT00444275|7223707|FG001|STARTED|Initial Treatment Phase||873
6318696|NCT00444275|7223708|FG002|STARTED|Initial Treatment Phase||0
6318697|NCT00444275|7223709|FG003|STARTED|Initial Treatment Phase||0
6318698|NCT00444275|7223710|FG004|STARTED|Initial Treatment Phase||0
6318699|NCT00444275|7223706|FG000|COMPLETED|Initial Treatment Phase||1908
6318700|NCT00444275|7223707|FG001|COMPLETED|Initial Treatment Phase||777
6318701|NCT00444275|7223708|FG002|COMPLETED|Initial Treatment Phase||0
6318702|NCT00444275|7223709|FG003|COMPLETED|Initial Treatment Phase||0
6318703|NCT00444275|7223710|FG004|COMPLETED|Initial Treatment Phase||0
6318704|NCT00444275|7223706|FG000|NOT COMPLETED|Initial Treatment Phase||248
6318705|NCT00444275|7223707|FG001|NOT COMPLETED|Initial Treatment Phase||96
6318706|NCT00444275|7223708|FG002|NOT COMPLETED|Initial Treatment Phase||0
6318707|NCT00444275|7223709|FG003|NOT COMPLETED|Initial Treatment Phase||0
6318708|NCT00444275|7223710|FG004|NOT COMPLETED|Initial Treatment Phase||0
6318709|NCT00444275|7223706|FG000|STARTED|Maintenance Treatment Phase||0
6318710|NCT00444275|7223707|FG001|STARTED|Maintenance Treatment Phase||0
6318711|NCT00444275|7223708|FG002|STARTED|Maintenance Treatment Phase||908
6318712|NCT00444275|7223709|FG003|STARTED|Maintenance Treatment Phase||897
6318713|NCT00444275|7223710|FG004|STARTED|Maintenance Treatment Phase||880
6318714|NCT00444275|7223706|FG000|COMPLETED|Maintenance Treatment Phase||0
6318715|NCT00444275|7223707|FG001|COMPLETED|Maintenance Treatment Phase||0
6318716|NCT00444275|7223708|FG002|COMPLETED|Maintenance Treatment Phase||747
6318717|NCT00444275|7223709|FG003|COMPLETED|Maintenance Treatment Phase||764
6318718|NCT00444275|7223710|FG004|COMPLETED|Maintenance Treatment Phase||701
6318719|NCT00444275|7223706|FG000|NOT COMPLETED|Maintenance Treatment Phase||0
6318720|NCT00444275|7223707|FG001|NOT COMPLETED|Maintenance Treatment Phase||0
6318721|NCT00444275|7223708|FG002|NOT COMPLETED|Maintenance Treatment Phase||161
6318722|NCT00444275|7223709|FG003|NOT COMPLETED|Maintenance Treatment Phase||133
6318723|NCT00444275|7223710|FG004|NOT COMPLETED|Maintenance Treatment Phase||179
6318724|NCT00444457|7223729|FG000|STARTED|Infant Series||489
6318725|NCT00444457|7223730|FG001|STARTED|Infant Series||488
6318726|NCT00444457|7223731|FG002|STARTED|Infant Series||489
6318727|NCT00444457|7223732|FG003|STARTED|Infant Series||246
6318728|NCT00444457|7223729|FG000|Vaccinated Dose 1|Infant Series||486
6318729|NCT00444457|7223730|FG001|Vaccinated Dose 1|Infant Series||484
6318730|NCT00444457|7223731|FG002|Vaccinated Dose 1|Infant Series||485
6318731|NCT00444457|7223732|FG003|Vaccinated Dose 1|Infant Series||244
6318732|NCT00444457|7223729|FG000|Vaccinated Dose 2|Infant Series||455
6318733|NCT00444457|7223730|FG001|Vaccinated Dose 2|Infant Series||447
6318734|NCT00444457|7223731|FG002|Vaccinated Dose 2|Infant Series||455
6318735|NCT00444457|7223732|FG003|Vaccinated Dose 2|Infant Series||228
6318736|NCT00444457|7223729|FG000|Vaccinated Dose 3|Infant Series||442
6318737|NCT00444457|7223730|FG001|Vaccinated Dose 3|Infant Series||435
6318738|NCT00444457|7223731|FG002|Vaccinated Dose 3|Infant Series||438
6318739|NCT00444457|7223732|FG003|Vaccinated Dose 3|Infant Series||225
6318740|NCT00444457|7223729|FG000|COMPLETED|Infant Series||435
6318741|NCT00444457|7223730|FG001|COMPLETED|Infant Series||427
6318742|NCT00444457|7223731|FG002|COMPLETED|Infant Series||428
6318743|NCT00444457|7223732|FG003|COMPLETED|Infant Series||218
6318744|NCT00444457|7223729|FG000|NOT COMPLETED|Infant Series||54
6318745|NCT00444457|7223730|FG001|NOT COMPLETED|Infant Series||61
6318746|NCT00444457|7223731|FG002|NOT COMPLETED|Infant Series||61
6318747|NCT00444457|7223732|FG003|NOT COMPLETED|Infant Series||28
6318748|NCT00444457|7223729|FG000|STARTED|After Infant Series||435
6318749|NCT00444457|7223730|FG001|STARTED|After Infant Series||427
6318750|NCT00444457|7223731|FG002|STARTED|After Infant Series||427
6318751|NCT00444457|7223732|FG003|STARTED|After Infant Series||218
6318752|NCT00444457|7223729|FG000|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
6318753|NCT00444457|7223730|FG001|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
6318754|NCT00444457|7223731|FG002|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
6318755|NCT00444457|7223732|FG003|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
6318756|NCT00444457|7223729|FG000|NOT COMPLETED|After Infant Series||20
6318757|NCT00444457|7223730|FG001|NOT COMPLETED|After Infant Series||30
6318758|NCT00444457|7223731|FG002|NOT COMPLETED|After Infant Series||19
6318759|NCT00444457|7223732|FG003|NOT COMPLETED|After Infant Series||10
6318760|NCT00444457|7223729|FG000|STARTED|Toddler Dose|Vaccinated toddler dose|415
6318761|NCT00444457|7223730|FG001|STARTED|Toddler Dose|Vaccinated toddler dose|397
6318762|NCT00444457|7223731|FG002|STARTED|Toddler Dose|Vaccinated toddler dose|408
6318763|NCT00444457|7223732|FG003|STARTED|Toddler Dose|Vaccinated toddler dose|208
6318764|NCT00444457|7223729|FG000|COMPLETED|Toddler Dose||408
6318765|NCT00444457|7223730|FG001|COMPLETED|Toddler Dose||391
6318766|NCT00444457|7223731|FG002|COMPLETED|Toddler Dose||404
6318767|NCT00444457|7223732|FG003|COMPLETED|Toddler Dose||200
6318768|NCT00444457|7223729|FG000|NOT COMPLETED|Toddler Dose||7
6318769|NCT00444457|7223730|FG001|NOT COMPLETED|Toddler Dose||6
6318770|NCT00444457|7223731|FG002|NOT COMPLETED|Toddler Dose||4
6318771|NCT00444457|7223732|FG003|NOT COMPLETED|Toddler Dose||8
6318772|NCT00444535|7223753|FG000|STARTED|Overall Study||52
6318773|NCT00444535|7223753|FG000|COMPLETED|Overall Study||39
6318774|NCT00444535|7223753|FG000|NOT COMPLETED|Overall Study||13
6318775|NCT00444587|7223759|FG000|STARTED|Overall Study||93
6318776|NCT00444587|7223760|FG001|STARTED|Overall Study||16
6318777|NCT00444587|7223759|FG000|COMPLETED|Overall Study||10
6318778|NCT00444587|7223760|FG001|COMPLETED|Overall Study||1
6318779|NCT00444587|7223759|FG000|NOT COMPLETED|Overall Study||83
6318780|NCT00444587|7223760|FG001|NOT COMPLETED|Overall Study||15
6318781|NCT00444600|7223772|FG000|STARTED|Overall Study|Number of eyes|293
6318782|NCT00444600|7223773|FG001|STARTED|Overall Study|Number of eyes|187
6318783|NCT00444600|7223774|FG002|STARTED|Overall Study|Number of eyes|188
6318784|NCT00444600|7223775|FG003|STARTED|Overall Study|Number of eyes|186
6318785|NCT00444600|7223772|FG000|COMPLETED|Overall Study|Number of eyes|274
6318786|NCT00444600|7223773|FG001|COMPLETED|Overall Study|Number of eyes|171
6318787|NCT00444600|7223774|FG002|COMPLETED|Overall Study|Number of eyes|178
6318788|NCT00444600|7223775|FG003|COMPLETED|Overall Study|Number of eyes|176
6318789|NCT00444600|7223772|FG000|NOT COMPLETED|Overall Study||19
6318790|NCT00444600|7223773|FG001|NOT COMPLETED|Overall Study||16
6318791|NCT00444600|7223774|FG002|NOT COMPLETED|Overall Study||10
6318792|NCT00444600|7223775|FG003|NOT COMPLETED|Overall Study||10
6318793|NCT00444626|7223791|FG000|STARTED|Initial Treatment Period||140
6318794|NCT00444626|7223791|FG000|COMPLETED|Initial Treatment Period||128
6318795|NCT00444626|7223791|FG000|NOT COMPLETED|Initial Treatment Period||12
6318796|NCT00444626|7223791|FG000|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
6318797|NCT00444626|7223791|FG000|COMPLETED|Repeat Treatment Period||105
6318798|NCT00444626|7223791|FG000|NOT COMPLETED|Repeat Treatment Period||0
6318799|NCT00444678|7223804|FG000|STARTED|Overall Study||36
6318800|NCT00444678|7223804|FG000|COMPLETED|Overall Study||5
6318801|NCT00444678|7223804|FG000|NOT COMPLETED|Overall Study||31
6318802|NCT00444795|7223808|FG000|STARTED|Overall Study||620
6318803|NCT00444795|7223808|FG000|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
6318804|NCT00444795|7223808|FG000|NOT COMPLETED|Overall Study||3
6318805|NCT00444821|7223814|FG000|STARTED|Overall Study||362
6318806|NCT00444821|7223815|FG001|STARTED|Overall Study||366
6318807|NCT00444821|7223814|FG000|Received AAA Repair|Overall Study|Crossed over to AAA repair|122
6318808|NCT00444821|7223815|FG001|Received AAA Repair|Overall Study|Underwent AAA repair per protocol|326
6318809|NCT00444821|7223814|FG000|COMPLETED|Overall Study||0
6318810|NCT00444821|7223815|FG001|COMPLETED|Overall Study||0
6318811|NCT00444821|7223814|FG000|NOT COMPLETED|Overall Study||362
6318812|NCT00444821|7223815|FG001|NOT COMPLETED|Overall Study||366
6318813|NCT00444912|7223823|FG000|STARTED|Overall Study||15
6318814|NCT00444912|7223824|FG001|STARTED|Overall Study||15
6318815|NCT00444912|7223823|FG000|Received Plerixafor|Overall Study||15
6318816|NCT00444912|7223824|FG001|Received Plerixafor|Overall Study||15
6318817|NCT00444912|7223823|FG000|Received Transplant|Overall Study||14
6318818|NCT00444912|7223824|FG001|Received Transplant|Overall Study||14
6318819|NCT00444912|7223823|FG000|COMPLETED|Overall Study||12
6318820|NCT00444912|7223824|FG001|COMPLETED|Overall Study||13
6318821|NCT00444912|7223823|FG000|NOT COMPLETED|Overall Study||3
6318822|NCT00444912|7223824|FG001|NOT COMPLETED|Overall Study||2
6318823|NCT00444925|7223833|FG000|STARTED|Single-blind Placebo Run-In Period||2446
6318824|NCT00444925|7223834|FG001|STARTED|Single-blind Placebo Run-In Period||0
6318825|NCT00444925|7223835|FG002|STARTED|Single-blind Placebo Run-In Period||0
6318826|NCT00444925|7223833|FG000|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
6318827|NCT00444925|7223834|FG001|COMPLETED|Single-blind Placebo Run-In Period||0
6318828|NCT00444925|7223835|FG002|COMPLETED|Single-blind Placebo Run-In Period||0
6318829|NCT00444925|7223833|FG000|NOT COMPLETED|Single-blind Placebo Run-In Period||734
6318830|NCT00444925|7223834|FG001|NOT COMPLETED|Single-blind Placebo Run-In Period||0
6318831|NCT00444925|7223835|FG002|NOT COMPLETED|Single-blind Placebo Run-In Period||0
6318832|NCT00444925|7223833|FG000|STARTED|Randomized to Double-blind Treatment||337
6318833|NCT00444925|7223834|FG001|STARTED|Randomized to Double-blind Treatment||690
6318834|NCT00444925|7223835|FG002|STARTED|Randomized to Double-blind Treatment||685
6318835|NCT00444925|7223833|FG000|COMPLETED|Randomized to Double-blind Treatment||334
6318836|NCT00444925|7223834|FG001|COMPLETED|Randomized to Double-blind Treatment||684
6318837|NCT00444925|7223835|FG002|COMPLETED|Randomized to Double-blind Treatment||679
6375454|NCT00755937|7286131|FG000|STARTED|Observational Follow-up||392
6318838|NCT00444925|7223833|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||3
6318839|NCT00444925|7223834|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||6
6318840|NCT00444925|7223835|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||6
6318841|NCT00444925|7223833|FG000|STARTED|Double-blind Treatment Period||334
6318842|NCT00444925|7223834|FG001|STARTED|Double-blind Treatment Period||684
6318843|NCT00444925|7223835|FG002|STARTED|Double-blind Treatment Period||679
6318844|NCT00444925|7223833|FG000|COMPLETED|Double-blind Treatment Period||304
6318845|NCT00444925|7223834|FG001|COMPLETED|Double-blind Treatment Period||628
6318846|NCT00444925|7223835|FG002|COMPLETED|Double-blind Treatment Period||598
6318847|NCT00444925|7223833|FG000|NOT COMPLETED|Double-blind Treatment Period||30
6318848|NCT00444925|7223834|FG001|NOT COMPLETED|Double-blind Treatment Period||56
6318849|NCT00444925|7223835|FG002|NOT COMPLETED|Double-blind Treatment Period||81
6318850|NCT00444951|7223846|FG000|STARTED|Overall Study||145
6318851|NCT00444951|7223847|FG001|STARTED|Overall Study||142
6318852|NCT00444951|7223848|FG002|STARTED|Overall Study||163
6318853|NCT00444951|7223846|FG000|COMPLETED|Overall Study||140
6318854|NCT00444951|7223847|FG001|COMPLETED|Overall Study||136
6318855|NCT00444951|7223848|FG002|COMPLETED|Overall Study||160
6318856|NCT00444951|7223846|FG000|NOT COMPLETED|Overall Study||5
6318857|NCT00444951|7223847|FG001|NOT COMPLETED|Overall Study||6
6318858|NCT00444951|7223848|FG002|NOT COMPLETED|Overall Study||3
6318859|NCT00444964|7223856|FG000|STARTED|Overall Study||11
6318860|NCT00444964|7223856|FG000|COMPLETED|Overall Study||11
6318861|NCT00444964|7223856|FG000|NOT COMPLETED|Overall Study||0
6318862|NCT00445003|7223863|FG000|STARTED|Overall Study||123
6318863|NCT00445003|7223864|FG001|STARTED|Overall Study||113
6318864|NCT00445003|7223865|FG002|STARTED|Overall Study||109
6318865|NCT00445003|7223863|FG000|COMPLETED|Overall Study||118
6318866|NCT00445003|7223864|FG001|COMPLETED|Overall Study||103
6318867|NCT00445003|7223865|FG002|COMPLETED|Overall Study||105
6318868|NCT00445003|7223863|FG000|NOT COMPLETED|Overall Study||5
6318869|NCT00445003|7223864|FG001|NOT COMPLETED|Overall Study||10
6318870|NCT00445003|7223865|FG002|NOT COMPLETED|Overall Study||4
6318871|NCT00445068|7223873|FG000|STARTED|Overall Study||38
6318872|NCT00445068|7223873|FG000|COMPLETED|Overall Study||2
6318873|NCT00445068|7223873|FG000|NOT COMPLETED|Overall Study||36
6318874|NCT00445146|7223877|FG000|STARTED|Overall Study||192
6318875|NCT00445146|7223877|FG000|COMPLETED|Overall Study||73
6318876|NCT00445146|7223877|FG000|NOT COMPLETED|Overall Study||119
6318877|NCT00445211|7223883|FG000|STARTED|Overall Study||23
6318878|NCT00445211|7223884|FG001|STARTED|Overall Study||23
6318879|NCT00445211|7223883|FG000|COMPLETED|Overall Study||23
6318880|NCT00445211|7223884|FG001|COMPLETED|Overall Study||23
6318881|NCT00445211|7223883|FG000|NOT COMPLETED|Overall Study||0
6318882|NCT00445211|7223884|FG001|NOT COMPLETED|Overall Study||0
6557892|NCT01771250|7480541|FG000|Received at Least One Dose of Study Drug|Period 1||7
6557893|NCT01771250|7480542|FG001|Received at Least One Dose of Study Drug|Period 1||7
6318883|NCT00445224|7223892|FG000|STARTED|Specific Exercises||17
6318884|NCT00445224|7223893|FG001|STARTED|Specific Exercises||16
6318885|NCT00445224|7223892|FG000|Baseline|Specific Exercises||17
6318886|NCT00445224|7223893|FG001|Baseline|Specific Exercises||16
6318887|NCT00445224|7223892|FG000|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
6318888|NCT00445224|7223893|FG001|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
6318889|NCT00445224|7223892|FG000|COMPLETED|Specific Exercises|No adverse event occurred|13
6318890|NCT00445224|7223893|FG001|COMPLETED|Specific Exercises|No adverse event occurred|13
6318891|NCT00445224|7223892|FG000|NOT COMPLETED|Specific Exercises||4
6318892|NCT00445224|7223893|FG001|NOT COMPLETED|Specific Exercises||3
6318893|NCT00445224|7223892|FG000|STARTED|Combined Exercises||13
6318894|NCT00445224|7223893|FG001|STARTED|Combined Exercises||13
6318895|NCT00445224|7223892|FG000|COMPLETED|Combined Exercises||13
6318896|NCT00445224|7223893|FG001|COMPLETED|Combined Exercises||13
6318897|NCT00445224|7223892|FG000|NOT COMPLETED|Combined Exercises||0
6318898|NCT00445224|7223893|FG001|NOT COMPLETED|Combined Exercises||0
6318899|NCT00445263|7223901|FG000|STARTED|Overall Study||83
6318900|NCT00445263|7223902|FG001|STARTED|Overall Study||87
6318901|NCT00445263|7223901|FG000|COMPLETED|Overall Study||83
6318902|NCT00445263|7223902|FG001|COMPLETED|Overall Study||86
6318903|NCT00445263|7223901|FG000|NOT COMPLETED|Overall Study||0
6557894|NCT01771250|7480541|FG000|COMPLETED|Period 1||7
6318904|NCT00445263|7223902|FG001|NOT COMPLETED|Overall Study||1
6318905|NCT00445302|7223912|FG000|STARTED|Overall Study||6
6318906|NCT00445302|7223913|FG001|STARTED|Overall Study||5
6318907|NCT00445302|7223914|FG002|STARTED|Overall Study||6
6318908|NCT00445302|7223915|FG003|STARTED|Overall Study||6
6318909|NCT00445302|7223912|FG000|COMPLETED|Overall Study||6
6318910|NCT00445302|7223913|FG001|COMPLETED|Overall Study||5
6318911|NCT00445302|7223914|FG002|COMPLETED|Overall Study||6
6318912|NCT00445302|7223915|FG003|COMPLETED|Overall Study||6
6318913|NCT00445302|7223912|FG000|NOT COMPLETED|Overall Study||0
6318914|NCT00445302|7223913|FG001|NOT COMPLETED|Overall Study||0
6318915|NCT00445302|7223914|FG002|NOT COMPLETED|Overall Study||0
6318916|NCT00445302|7223915|FG003|NOT COMPLETED|Overall Study||0
6318917|NCT00445315|7223930|FG000|STARTED|Overall Study||6
6318918|NCT00445315|7223931|FG001|STARTED|Overall Study||6
6318919|NCT00445315|7223932|FG002|STARTED|Overall Study||6
6318920|NCT00445315|7223933|FG003|STARTED|Overall Study||6
6318921|NCT00445315|7223934|FG004|STARTED|Overall Study||8
6318922|NCT00445315|7223930|FG000|COMPLETED|Overall Study||6
6318923|NCT00445315|7223931|FG001|COMPLETED|Overall Study||6
6318924|NCT00445315|7223932|FG002|COMPLETED|Overall Study||6
6318925|NCT00445315|7223933|FG003|COMPLETED|Overall Study||6
6318926|NCT00445315|7223934|FG004|COMPLETED|Overall Study||8
6318927|NCT00445315|7223930|FG000|NOT COMPLETED|Overall Study||0
6318928|NCT00445315|7223931|FG001|NOT COMPLETED|Overall Study||0
6318929|NCT00445315|7223932|FG002|NOT COMPLETED|Overall Study||0
6318930|NCT00445315|7223933|FG003|NOT COMPLETED|Overall Study||0
6318931|NCT00445315|7223934|FG004|NOT COMPLETED|Overall Study||0
6318932|NCT00445328|7223949|FG000|STARTED|Overall Study||42
6318933|NCT00445328|7223950|FG001|STARTED|Overall Study||42
6318934|NCT00445328|7223949|FG000|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
6318935|NCT00445328|7223950|FG001|Received Treatment|Overall Study||42
6318936|NCT00445328|7223949|FG000|COMPLETED|Overall Study||39
6318937|NCT00445328|7223950|FG001|COMPLETED|Overall Study||36
6318938|NCT00445328|7223949|FG000|NOT COMPLETED|Overall Study||3
6318939|NCT00445328|7223950|FG001|NOT COMPLETED|Overall Study||6
6318940|NCT00445341|7223956|FG000|STARTED|Overall Study||28
6318941|NCT00445341|7223956|FG000|COMPLETED|Overall Study||26
6318942|NCT00445341|7223956|FG000|NOT COMPLETED|Overall Study||2
6318943|NCT00445432|7223963|FG000|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
6318944|NCT00445432|7223964|FG001|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
6318945|NCT00445432|7223965|FG002|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
6318946|NCT00445432|7223966|FG003|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
6318947|NCT00445432|7223963|FG000|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
6318948|NCT00445432|7223964|FG001|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
6318949|NCT00445432|7223965|FG002|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
6318950|NCT00445432|7223966|FG003|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
6318951|NCT00445432|7223963|FG000|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
6318952|NCT00445432|7223964|FG001|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
6318953|NCT00445432|7223965|FG002|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
6318954|NCT00445432|7223966|FG003|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
6318955|NCT00445432|7223963|FG000|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
6318956|NCT00445432|7223964|FG001|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
6318957|NCT00445432|7223965|FG002|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
6318958|NCT00445432|7223966|FG003|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
6318959|NCT00445432|7223963|FG000|COMPLETED|148 Weeks of Adalimumab Treatment||0
6318960|NCT00445432|7223964|FG001|COMPLETED|148 Weeks of Adalimumab Treatment||0
6318961|NCT00445432|7223965|FG002|COMPLETED|148 Weeks of Adalimumab Treatment||0
6318962|NCT00445432|7223966|FG003|COMPLETED|148 Weeks of Adalimumab Treatment||35
6318963|NCT00445432|7223963|FG000|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
6318964|NCT00445432|7223964|FG001|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
6318965|NCT00445432|7223965|FG002|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
6318966|NCT00445432|7223966|FG003|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
6318967|NCT00445458|7223981|FG000|STARTED|Overall Study||3
6318968|NCT00445458|7223982|FG001|STARTED|Overall Study||5
6318969|NCT00445458|7223983|FG002|STARTED|Overall Study||71
6318970|NCT00445458|7223984|FG003|STARTED|Overall Study||31
6318971|NCT00445458|7223981|FG000|COMPLETED|Overall Study||0
6318972|NCT00445458|7223982|FG001|COMPLETED|Overall Study||0
6318973|NCT00445458|7223983|FG002|COMPLETED|Overall Study||3
6318974|NCT00445458|7223984|FG003|COMPLETED|Overall Study||3
6318975|NCT00445458|7223981|FG000|NOT COMPLETED|Overall Study||3
6318976|NCT00445458|7223982|FG001|NOT COMPLETED|Overall Study||5
6318977|NCT00445458|7223983|FG002|NOT COMPLETED|Overall Study||68
6318978|NCT00445458|7223984|FG003|NOT COMPLETED|Overall Study||28
6318979|NCT00445484|7223999|FG000|STARTED|Overall Study||11
6318980|NCT00445484|7224000|FG001|STARTED|Overall Study||11
6318981|NCT00445484|7223999|FG000|COMPLETED|Overall Study||7
6318982|NCT00445484|7224000|FG001|COMPLETED|Overall Study||10
6318983|NCT00445484|7223999|FG000|NOT COMPLETED|Overall Study||4
6318984|NCT00445484|7224000|FG001|NOT COMPLETED|Overall Study||1
6318985|NCT00445549|7224006|FG000|STARTED|Overall Study||12
6318986|NCT00445549|7224006|FG000|COMPLETED|Overall Study||0
6318987|NCT00445549|7224006|FG000|NOT COMPLETED|Overall Study||12
6318988|NCT00445588|7224010|FG000|STARTED|Overall Study||56
6318989|NCT00445588|7224010|FG000|COMPLETED|Overall Study||56
6318990|NCT00445588|7224010|FG000|NOT COMPLETED|Overall Study||0
6318991|NCT00445601|7224017|FG000|STARTED|Overall Study||201
6318992|NCT00445601|7224018|FG001|STARTED|Overall Study||205
6318993|NCT00445601|7224017|FG000|Received TURBT|Overall Study||190
6318994|NCT00445601|7224018|FG001|Received TURBT|Overall Study||193
6318995|NCT00445601|7224017|FG000|COMPLETED|Overall Study||168
6318996|NCT00445601|7224018|FG001|COMPLETED|Overall Study||177
6318997|NCT00445601|7224017|FG000|NOT COMPLETED|Overall Study||33
6318998|NCT00445601|7224018|FG001|NOT COMPLETED|Overall Study||28
6318999|NCT00445679|7224032|FG000|STARTED|Overall Study||203
6319000|NCT00445679|7224033|FG001|STARTED|Overall Study||203
6319001|NCT00445679|7224034|FG002|STARTED|Overall Study||205
6319002|NCT00445679|7224035|FG003|STARTED|Overall Study||196
6319003|NCT00445679|7224032|FG000|COMPLETED|Overall Study||155
6319004|NCT00445679|7224033|FG001|COMPLETED|Overall Study||157
6775141|NCT03887429|7703056|FG002|NOT COMPLETED|Overall Study||2
6775142|NCT03887429|7703057|FG003|NOT COMPLETED|Overall Study||1
6775143|NCT03886701|7703072|FG000|STARTED|Period 1: Study Days 1-4||11
6775144|NCT03886701|7703072|FG000|COMPLETED|Period 1: Study Days 1-4||11
6775145|NCT03886701|7703072|FG000|NOT COMPLETED|Period 1: Study Days 1-4||0
6319005|NCT00445679|7224034|FG002|COMPLETED|Overall Study||139
6319006|NCT00445679|7224035|FG003|COMPLETED|Overall Study||149
6319007|NCT00445679|7224032|FG000|NOT COMPLETED|Overall Study||48
6319008|NCT00445679|7224033|FG001|NOT COMPLETED|Overall Study||46
6319009|NCT00445679|7224034|FG002|NOT COMPLETED|Overall Study||66
6319010|NCT00445679|7224035|FG003|NOT COMPLETED|Overall Study||47
6319011|NCT00445692|7224045|FG000|STARTED|Overall Study||31
6319012|NCT00445692|7224045|FG000|COMPLETED|Overall Study||15
6319013|NCT00445692|7224045|FG000|NOT COMPLETED|Overall Study||16
6319014|NCT00445705|7224055|FG000|STARTED|Overall Study||53
6319015|NCT00445705|7224056|FG001|STARTED|Overall Study||53
6319016|NCT00445705|7224057|FG002|STARTED|Overall Study||52
6319017|NCT00445705|7224058|FG003|STARTED|Overall Study||53
6319018|NCT00445705|7224055|FG000|COMPLETED|Overall Study||44
6319019|NCT00445705|7224056|FG001|COMPLETED|Overall Study||42
6319020|NCT00445705|7224057|FG002|COMPLETED|Overall Study||41
6319021|NCT00445705|7224058|FG003|COMPLETED|Overall Study||39
6319022|NCT00445705|7224055|FG000|NOT COMPLETED|Overall Study||9
6319023|NCT00445705|7224056|FG001|NOT COMPLETED|Overall Study||11
6319024|NCT00445705|7224057|FG002|NOT COMPLETED|Overall Study||11
6319025|NCT00445705|7224058|FG003|NOT COMPLETED|Overall Study||14
6319026|NCT00445744|7224068|FG000|STARTED|Overall Study||52
6319027|NCT00445744|7224068|FG000|COMPLETED|Overall Study||51
6319028|NCT00445744|7224068|FG000|NOT COMPLETED|Overall Study||1
6319029|NCT00445770|7224075|FG000|STARTED|Overall Study||176
6319030|NCT00445770|7224076|FG001|STARTED|Overall Study||192
6319031|NCT00445770|7224077|FG002|STARTED|Overall Study||182
6319032|NCT00445770|7224075|FG000|COMPLETED|Overall Study||123
6319033|NCT00445770|7224076|FG001|COMPLETED|Overall Study||157
6319034|NCT00445770|7224077|FG002|COMPLETED|Overall Study||151
6319035|NCT00445770|7224075|FG000|NOT COMPLETED|Overall Study||53
6319036|NCT00445770|7224076|FG001|NOT COMPLETED|Overall Study||35
6319037|NCT00445770|7224077|FG002|NOT COMPLETED|Overall Study||31
6319038|NCT00445848|7224087|FG000|STARTED|Overall Study||85
6319039|NCT00445848|7224087|FG000|COMPLETED|Overall Study||0
6319040|NCT00445848|7224087|FG000|NOT COMPLETED|Overall Study||85
6319041|NCT00445887|7224093|FG000|STARTED|Overall Study||33
6319042|NCT00445887|7224094|FG001|STARTED|Overall Study||31
6319043|NCT00445887|7224093|FG000|COMPLETED|Overall Study||33
6319044|NCT00445887|7224094|FG001|COMPLETED|Overall Study||31
6319045|NCT00445887|7224093|FG000|NOT COMPLETED|Overall Study||0
6319046|NCT00445887|7224094|FG001|NOT COMPLETED|Overall Study||0
6319047|NCT00445939|7224113|FG000|STARTED|Period A - Week 0 - Week 4||33
6319048|NCT00445939|7224114|FG001|STARTED|Period A - Week 0 - Week 4||34
6319049|NCT00445939|7224115|FG002|STARTED|Period A - Week 0 - Week 4||23
6319050|NCT00445939|7224116|FG003|STARTED|Period A - Week 0 - Week 4||0
6319051|NCT00445939|7224113|FG000|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
6319052|NCT00445939|7224114|FG001|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
6319053|NCT00445939|7224115|FG002|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
6319054|NCT00445939|7224116|FG003|COMPLETED|Period A - Week 0 - Week 4||0
6319055|NCT00445939|7224113|FG000|NOT COMPLETED|Period A - Week 0 - Week 4||1
6319056|NCT00445939|7224114|FG001|NOT COMPLETED|Period A - Week 0 - Week 4||2
6319057|NCT00445939|7224115|FG002|NOT COMPLETED|Period A - Week 0 - Week 4||0
6319058|NCT00445939|7224116|FG003|NOT COMPLETED|Period A - Week 0 - Week 4||0
6319059|NCT00445939|7224113|FG000|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
6319060|NCT00445939|7224114|FG001|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
6319061|NCT00445939|7224115|FG002|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
6319062|NCT00445939|7224116|FG003|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
6319063|NCT00445939|7224113|FG000|COMPLETED|Period B - Week 4 - Week 8||14
6319064|NCT00445939|7224114|FG001|COMPLETED|Period B - Week 4 - Week 8||0
6319065|NCT00445939|7224115|FG002|COMPLETED|Period B - Week 4 - Week 8||0
6319066|NCT00445939|7224116|FG003|COMPLETED|Period B - Week 4 - Week 8||20
6319067|NCT00445939|7224113|FG000|NOT COMPLETED|Period B - Week 4 - Week 8||2
6319068|NCT00445939|7224114|FG001|NOT COMPLETED|Period B - Week 4 - Week 8||0
6319069|NCT00445939|7224115|FG002|NOT COMPLETED|Period B - Week 4 - Week 8||0
6319070|NCT00445939|7224116|FG003|NOT COMPLETED|Period B - Week 4 - Week 8||1
6319071|NCT00445978|7224136|FG000|STARTED|Week 0 - Week 4 (2.5 mg/kg/Day)||32
6319072|NCT00445978|7224136|FG000|COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||29
6319073|NCT00445978|7224136|FG000|NOT COMPLETED|Week 0 - Week 4 (2.5 mg/kg/Day)||3
6319074|NCT00445978|7224136|FG000|STARTED|Week 4 - Week 8 (5 mg/kg/Day)||29
6319075|NCT00445978|7224136|FG000|Received Escalated Dose|Week 4 - Week 8 (5 mg/kg/Day)||29
6319076|NCT00445978|7224136|FG000|COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||25
6319077|NCT00445978|7224136|FG000|NOT COMPLETED|Week 4 - Week 8 (5 mg/kg/Day)||4
6319078|NCT00445978|7224136|FG000|STARTED|Week 8 - Week 12 (10 mg/kg/Day)||25
6775146|NCT03886701|7703072|FG000|STARTED|Period 2: Study Days 7-21||11
6319079|NCT00445978|7224136|FG000|Received Escalated Dose|Week 8 - Week 12 (10 mg/kg/Day)||25
6319080|NCT00445978|7224136|FG000|COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||24
6319081|NCT00445978|7224136|FG000|NOT COMPLETED|Week 8 - Week 12 (10 mg/kg/Day)||1
6319082|NCT00445978|7224136|FG000|STARTED|Week 12 - Week 16 (20 mg/kg/Day)||24
6319083|NCT00445978|7224136|FG000|Received Escalated Dose|Week 12 - Week 16 (20 mg/kg/Day)||21
6319084|NCT00445978|7224136|FG000|COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||23
6319085|NCT00445978|7224136|FG000|NOT COMPLETED|Week 12 - Week 16 (20 mg/kg/Day)||1
6319086|NCT00446030|7224149|FG000|STARTED|TREATMENT (up to 52 Weeks)||93
6319087|NCT00446030|7224150|FG001|STARTED|TREATMENT (up to 52 Weeks)||34
6319088|NCT00446030|7224149|FG000|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
6319089|NCT00446030|7224150|FG001|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
6319090|NCT00446030|7224149|FG000|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
6319091|NCT00446030|7224150|FG001|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
6319092|NCT00446030|7224149|FG000|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
6319093|NCT00446030|7224150|FG001|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
6319094|NCT00446030|7224149|FG000|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
6319095|NCT00446030|7224150|FG001|STARTED|FOLLOW-UP (up to 2-years)||34
6319096|NCT00446030|7224149|FG000|COMPLETED|FOLLOW-UP (up to 2-years)||63
6319097|NCT00446030|7224150|FG001|COMPLETED|FOLLOW-UP (up to 2-years)||25
6319098|NCT00446030|7224149|FG000|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
6319099|NCT00446030|7224150|FG001|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
6319100|NCT00446095|7224161|FG000|STARTED|Phase II (8 Weeks)||23
6319101|NCT00446095|7224162|FG001|STARTED|Phase II (8 Weeks)||21
6319102|NCT00446095|7224163|FG002|STARTED|Phase II (8 Weeks)||24
6319103|NCT00446095|7224164|FG003|STARTED|Phase II (8 Weeks)||0
6319104|NCT00446095|7224165|FG004|STARTED|Phase II (8 Weeks)||0
6319105|NCT00446095|7224161|FG000|COMPLETED|Phase II (8 Weeks)||11
6319106|NCT00446095|7224162|FG001|COMPLETED|Phase II (8 Weeks)||18
6319107|NCT00446095|7224163|FG002|COMPLETED|Phase II (8 Weeks)||21
6319108|NCT00446095|7224164|FG003|COMPLETED|Phase II (8 Weeks)||0
6319109|NCT00446095|7224165|FG004|COMPLETED|Phase II (8 Weeks)||0
6319110|NCT00446095|7224161|FG000|NOT COMPLETED|Phase II (8 Weeks)||12
6319111|NCT00446095|7224162|FG001|NOT COMPLETED|Phase II (8 Weeks)||3
6319112|NCT00446095|7224163|FG002|NOT COMPLETED|Phase II (8 Weeks)||3
6319113|NCT00446095|7224164|FG003|NOT COMPLETED|Phase II (8 Weeks)||0
6319114|NCT00446095|7224165|FG004|NOT COMPLETED|Phase II (8 Weeks)||0
6319115|NCT00446095|7224161|FG000|STARTED|Phase I (28 Days)||0
6319116|NCT00446095|7224162|FG001|STARTED|Phase I (28 Days)||0
6319117|NCT00446095|7224163|FG002|STARTED|Phase I (28 Days)||0
6319118|NCT00446095|7224164|FG003|STARTED|Phase I (28 Days)||6
6319119|NCT00446095|7224165|FG004|STARTED|Phase I (28 Days)||7
6319120|NCT00446095|7224161|FG000|COMPLETED|Phase I (28 Days)||0
6319121|NCT00446095|7224162|FG001|COMPLETED|Phase I (28 Days)||0
6319122|NCT00446095|7224163|FG002|COMPLETED|Phase I (28 Days)||0
6319123|NCT00446095|7224164|FG003|COMPLETED|Phase I (28 Days)||5
6319124|NCT00446095|7224165|FG004|COMPLETED|Phase I (28 Days)||4
6319125|NCT00446095|7224161|FG000|NOT COMPLETED|Phase I (28 Days)||0
6319126|NCT00446095|7224162|FG001|NOT COMPLETED|Phase I (28 Days)||0
6319127|NCT00446095|7224163|FG002|NOT COMPLETED|Phase I (28 Days)||0
6319128|NCT00446095|7224164|FG003|NOT COMPLETED|Phase I (28 Days)||1
6319129|NCT00446095|7224165|FG004|NOT COMPLETED|Phase I (28 Days)||3
6319130|NCT00446134|7224180|FG000|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
6319131|NCT00446134|7224181|FG001|STARTED|Overall Study||70
6319132|NCT00446134|7224182|FG002|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
6319133|NCT00446134|7224183|FG003|STARTED|Overall Study||70
6319134|NCT00446134|7224180|FG000|COMPLETED|Overall Study||35
6319135|NCT00446134|7224181|FG001|COMPLETED|Overall Study||25
6319136|NCT00446134|7224182|FG002|COMPLETED|Overall Study||26
6319137|NCT00446134|7224183|FG003|COMPLETED|Overall Study||25
6319138|NCT00446134|7224180|FG000|NOT COMPLETED|Overall Study||34
6319139|NCT00446134|7224181|FG001|NOT COMPLETED|Overall Study||45
6319140|NCT00446134|7224182|FG002|NOT COMPLETED|Overall Study||43
6319141|NCT00446134|7224183|FG003|NOT COMPLETED|Overall Study||45
6319142|NCT00446147|7224195|FG000|STARTED|Overall Study||195
6319143|NCT00446147|7224196|FG001|STARTED|Overall Study||194
6319144|NCT00446147|7224195|FG000|COMPLETED|Overall Study||180
6319145|NCT00446147|7224196|FG001|COMPLETED|Overall Study||180
6319146|NCT00446147|7224195|FG000|NOT COMPLETED|Overall Study||15
6319147|NCT00446147|7224196|FG001|NOT COMPLETED|Overall Study||14
6319148|NCT00446199|7224206|FG000|STARTED|Overall Study||183
6319149|NCT00446199|7224207|FG001|STARTED|Overall Study||184
6319150|NCT00446199|7224208|FG002|STARTED|Overall Study||185
6319151|NCT00446199|7224209|FG003|STARTED|Overall Study||183
6319152|NCT00446199|7224206|FG000|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
6319153|NCT00446199|7224207|FG001|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
6319154|NCT00446199|7224208|FG002|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
6319155|NCT00446199|7224209|FG003|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
6557895|NCT01771250|7480542|FG001|COMPLETED|Period 1||7
6557896|NCT01771250|7480541|FG000|NOT COMPLETED|Period 1||1
6319156|NCT00446199|7224206|FG000|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
6319157|NCT00446199|7224207|FG001|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
6319158|NCT00446199|7224208|FG002|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
6319159|NCT00446199|7224209|FG003|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
6319160|NCT00446199|7224206|FG000|COMPLETED|Overall Study||160
6319161|NCT00446199|7224207|FG001|COMPLETED|Overall Study||164
6319162|NCT00446199|7224208|FG002|COMPLETED|Overall Study||158
6319163|NCT00446199|7224209|FG003|COMPLETED|Overall Study||153
6319164|NCT00446199|7224206|FG000|NOT COMPLETED|Overall Study||23
6319165|NCT00446199|7224207|FG001|NOT COMPLETED|Overall Study||20
6319166|NCT00446199|7224208|FG002|NOT COMPLETED|Overall Study||27
6319167|NCT00446199|7224209|FG003|NOT COMPLETED|Overall Study||30
6319168|NCT00446251|7224219|FG000|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
6319169|NCT00446251|7224219|FG000|COMPLETED|Overall Study||9
6319170|NCT00446251|7224219|FG000|NOT COMPLETED|Overall Study||5
6319171|NCT00446264|7224223|FG000|STARTED|Overall Study||14
6319172|NCT00446264|7224223|FG000|COMPLETED|Overall Study||14
6319173|NCT00446264|7224223|FG000|NOT COMPLETED|Overall Study||0
6319174|NCT00446290|7224227|FG000|STARTED|Overall Study||22
6319175|NCT00446290|7224227|FG000|COMPLETED|Overall Study||22
6319176|NCT00446290|7224227|FG000|NOT COMPLETED|Overall Study||0
6319177|NCT00446446|7224231|FG000|STARTED|Overall Study||52
6319178|NCT00446446|7224231|FG000|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
6319179|NCT00446446|7224231|FG000|NOT COMPLETED|Overall Study||24
6319180|NCT00446459|7224235|FG000|STARTED|8 Months|34 subjects received any amount of MMF.|34
6319181|NCT00446459|7224235|FG000|COMPLETED|8 Months|22 subjects were on study at month 8.|22
6319182|NCT00446459|7224235|FG000|NOT COMPLETED|8 Months||12
6319183|NCT00446459|7224235|FG000|STARTED|12 Months|22 subjects remained on-study at month 8|22
6319184|NCT00446459|7224235|FG000|COMPLETED|12 Months|4 subjects remained at month 12|4
6319185|NCT00446459|7224235|FG000|NOT COMPLETED|12 Months||18
6319186|NCT00446511|7224243|FG000|STARTED|Overall Study||21
6319187|NCT00446511|7224244|FG001|STARTED|Overall Study||17
6319188|NCT00446511|7224245|FG002|STARTED|Overall Study||103
6319189|NCT00446511|7224246|FG003|STARTED|Overall Study||109
6319190|NCT00446511|7224243|FG000|COMPLETED|Overall Study||11
6319191|NCT00446511|7224244|FG001|COMPLETED|Overall Study||15
6319192|NCT00446511|7224245|FG002|COMPLETED|Overall Study||96
6319193|NCT00446511|7224246|FG003|COMPLETED|Overall Study||103
6319194|NCT00446511|7224243|FG000|NOT COMPLETED|Overall Study||10
6319195|NCT00446511|7224244|FG001|NOT COMPLETED|Overall Study||2
6319196|NCT00446511|7224245|FG002|NOT COMPLETED|Overall Study||7
6319197|NCT00446511|7224246|FG003|NOT COMPLETED|Overall Study||6
6319198|NCT00446550|7224260|FG000|STARTED|Overall Study||11
6319199|NCT00446550|7224261|FG001|STARTED|Overall Study||8
6319200|NCT00446550|7224260|FG000|Safety Population|Overall Study||11
6319201|NCT00446550|7224261|FG001|Safety Population|Overall Study||8
6319202|NCT00446550|7224260|FG000|PD Population|Overall Study||11
6319203|NCT00446550|7224261|FG001|PD Population|Overall Study||8
6319204|NCT00446550|7224260|FG000|COMPLETED|Overall Study||10
6319205|NCT00446550|7224261|FG001|COMPLETED|Overall Study||8
6319206|NCT00446550|7224260|FG000|NOT COMPLETED|Overall Study||1
6319207|NCT00446550|7224261|FG001|NOT COMPLETED|Overall Study||0
6319208|NCT00446563|7224270|FG000|STARTED|Overall Study||43
6319209|NCT00446563|7224271|FG001|STARTED|Overall Study||47
6319210|NCT00446563|7224270|FG000|COMPLETED|Overall Study||36
6319211|NCT00446563|7224271|FG001|COMPLETED|Overall Study||38
6319212|NCT00446563|7224270|FG000|NOT COMPLETED|Overall Study||7
6319213|NCT00446563|7224271|FG001|NOT COMPLETED|Overall Study||9
6319214|NCT00446641|7224279|FG000|STARTED|Overall Study||125
6319215|NCT00446641|7224280|FG001|STARTED|Overall Study||119
6319216|NCT00446641|7224279|FG000|COMPLETED|Overall Study||108
6319217|NCT00446641|7224280|FG001|COMPLETED|Overall Study||109
6319218|NCT00446641|7224279|FG000|NOT COMPLETED|Overall Study||17
6319219|NCT00446641|7224280|FG001|NOT COMPLETED|Overall Study||10
6319220|NCT00446654|7224288|FG000|STARTED|Overall Study||21
6319221|NCT00446654|7224289|FG001|STARTED|Overall Study||22
6319222|NCT00446654|7224288|FG000|COMPLETED|Overall Study||19
6319223|NCT00446654|7224289|FG001|COMPLETED|Overall Study||22
6319224|NCT00446654|7224288|FG000|NOT COMPLETED|Overall Study||2
6319225|NCT00446654|7224289|FG001|NOT COMPLETED|Overall Study||0
6319226|NCT00446797|7224297|FG000|STARTED|Overall Study||141
6319227|NCT00446797|7224298|FG001|STARTED|Overall Study||137
6319228|NCT00446797|7224297|FG000|COMPLETED|Overall Study||133
6319229|NCT00446797|7224298|FG001|COMPLETED|Overall Study||125
6319230|NCT00446797|7224297|FG000|NOT COMPLETED|Overall Study||8
6319231|NCT00446797|7224298|FG001|NOT COMPLETED|Overall Study||12
6319232|NCT00446849|7224304|FG000|STARTED|Acute Phase||138
6319233|NCT00446849|7224304|FG000|COMPLETED|Acute Phase||56
6319234|NCT00446849|7224304|FG000|NOT COMPLETED|Acute Phase||82
6319235|NCT00446849|7224304|FG000|STARTED|Maintenance Phase||208
6319236|NCT00446849|7224304|FG000|COMPLETED|Maintenance Phase||138
6319237|NCT00446849|7224304|FG000|NOT COMPLETED|Maintenance Phase||70
6319238|NCT00446966|7224311|FG000|STARTED|Overall Study||130
6319239|NCT00446966|7224312|FG001|STARTED|Overall Study||130
6319240|NCT00446966|7224311|FG000|COMPLETED|Overall Study||120
6319241|NCT00446966|7224312|FG001|COMPLETED|Overall Study||123
6319242|NCT00446966|7224311|FG000|NOT COMPLETED|Overall Study||10
6319243|NCT00446966|7224312|FG001|NOT COMPLETED|Overall Study||7
6319244|NCT00446992|7224318|FG000|STARTED|Overall Study|Beginning of Intervention|30
6319245|NCT00446992|7224318|FG000|COMPLETED|Overall Study|Intervention Completion|14
6319246|NCT00446992|7224318|FG000|NOT COMPLETED|Overall Study||16
6319247|NCT00447005|7224322|FG000|STARTED|Overall Study||12
6319248|NCT00447005|7224322|FG000|COMPLETED|Overall Study||0
6319249|NCT00447005|7224322|FG000|NOT COMPLETED|Overall Study||12
6319250|NCT00447057|7224330|FG000|STARTED|Overall Study||83
6319251|NCT00447057|7224331|FG001|STARTED|Overall Study||76
6319252|NCT00447057|7224332|FG002|STARTED|Overall Study||19
6319253|NCT00447057|7224333|FG003|STARTED|Overall Study||26
6319254|NCT00447057|7224330|FG000|COMPLETED|Overall Study||0
6557897|NCT01771250|7480542|FG001|NOT COMPLETED|Period 1||0
6557898|NCT01771250|7480541|FG000|STARTED|Period 2||7
6557899|NCT01771250|7480542|FG001|STARTED|Period 2||7
6557900|NCT01771250|7480541|FG000|COMPLETED|Period 2||7
6557901|NCT01771250|7480542|FG001|COMPLETED|Period 2||7
6557902|NCT01771250|7480541|FG000|NOT COMPLETED|Period 2||0
6557903|NCT01771250|7480542|FG001|NOT COMPLETED|Period 2||0
6557904|NCT01771627|7480550|FG000|STARTED|Overall Study||200
6557905|NCT01771627|7480551|FG001|STARTED|Overall Study||100
6557906|NCT01771627|7480550|FG000|COMPLETED|Overall Study||92
6557907|NCT01771627|7480551|FG001|COMPLETED|Overall Study||50
6557908|NCT01771627|7480550|FG000|NOT COMPLETED|Overall Study||108
6557909|NCT01771627|7480551|FG001|NOT COMPLETED|Overall Study||50
6557910|NCT01771666|7480557|FG000|STARTED|Overall Study||23
6557911|NCT01771666|7480557|FG000|COMPLETED|Overall Study||23
6557912|NCT01771666|7480557|FG000|NOT COMPLETED|Overall Study||0
6557913|NCT01771731|7480563|FG000|STARTED|Overall Study||13
6557914|NCT01771731|7480564|FG001|STARTED|Overall Study||14
6557915|NCT01771731|7480563|FG000|COMPLETED|Overall Study||11
6557916|NCT01771731|7480564|FG001|COMPLETED|Overall Study||12
6557917|NCT01771731|7480563|FG000|NOT COMPLETED|Overall Study||2
6557918|NCT01771731|7480564|FG001|NOT COMPLETED|Overall Study||2
6557919|NCT01771809|7480572|FG000|STARTED|Overall Study||164
6557920|NCT01771809|7480573|FG001|STARTED|Overall Study||166
6557921|NCT01771809|7480572|FG000|COMPLETED|Overall Study||93
6319255|NCT00447057|7224331|FG001|COMPLETED|Overall Study||3
6319256|NCT00447057|7224332|FG002|COMPLETED|Overall Study||0
6319257|NCT00447057|7224333|FG003|COMPLETED|Overall Study||0
6319258|NCT00447057|7224330|FG000|NOT COMPLETED|Overall Study||83
6319259|NCT00447057|7224331|FG001|NOT COMPLETED|Overall Study||73
6319260|NCT00447057|7224332|FG002|NOT COMPLETED|Overall Study||19
6319261|NCT00447057|7224333|FG003|NOT COMPLETED|Overall Study||26
6319262|NCT00447083|7224343|FG000|STARTED|Phase I||10
6319263|NCT00447083|7224344|FG001|STARTED|Phase I||9
6319264|NCT00447083|7224345|FG002|STARTED|Phase I||0
6319265|NCT00447083|7224346|FG003|STARTED|Phase I||0
6319266|NCT00447083|7224343|FG000|COMPLETED|Phase I|2 participants did not acclimate to phase II|10
6319267|NCT00447083|7224344|FG001|COMPLETED|Phase I|1 participant did not acclimate to phase II|9
6319268|NCT00447083|7224345|FG002|COMPLETED|Phase I||0
6319269|NCT00447083|7224346|FG003|COMPLETED|Phase I||0
6319270|NCT00447083|7224343|FG000|NOT COMPLETED|Phase I||0
6319271|NCT00447083|7224344|FG001|NOT COMPLETED|Phase I||0
6319272|NCT00447083|7224345|FG002|NOT COMPLETED|Phase I||0
6319273|NCT00447083|7224346|FG003|NOT COMPLETED|Phase I||0
6319274|NCT00447083|7224343|FG000|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
6319275|NCT00447083|7224344|FG001|STARTED|Phase II|Participants in this group will then be randomized to a phase 2 group in phase2|0
6319276|NCT00447083|7224345|FG002|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
6319277|NCT00447083|7224346|FG003|STARTED|Phase II|Only 8 participants qualified from the end of phase 1|8
6319278|NCT00447083|7224343|FG000|COMPLETED|Phase II||0
6319279|NCT00447083|7224344|FG001|COMPLETED|Phase II||0
6319280|NCT00447083|7224345|FG002|COMPLETED|Phase II||7
6319281|NCT00447083|7224346|FG003|COMPLETED|Phase II||7
6319282|NCT00447083|7224343|FG000|NOT COMPLETED|Phase II||0
6319283|NCT00447083|7224344|FG001|NOT COMPLETED|Phase II||0
6319284|NCT00447083|7224345|FG002|NOT COMPLETED|Phase II||1
6319285|NCT00447083|7224346|FG003|NOT COMPLETED|Phase II||1
6319286|NCT00447226|7224354|FG000|STARTED|12-Week Open-label Phase||0
6557922|NCT01771809|7480573|FG001|COMPLETED|Overall Study||83
6319287|NCT00447226|7224355|FG001|STARTED|12-Week Open-label Phase||32
6319288|NCT00447226|7224354|FG000|COMPLETED|12-Week Open-label Phase||0
6319289|NCT00447226|7224355|FG001|COMPLETED|12-Week Open-label Phase||7
6319290|NCT00447226|7224354|FG000|NOT COMPLETED|12-Week Open-label Phase||0
6319291|NCT00447226|7224355|FG001|NOT COMPLETED|12-Week Open-label Phase||25
6319292|NCT00447226|7224354|FG000|STARTED|Double-blind Phase||4
6319293|NCT00447226|7224355|FG001|STARTED|Double-blind Phase||3
6319294|NCT00447226|7224354|FG000|COMPLETED|Double-blind Phase||0
6319295|NCT00447226|7224355|FG001|COMPLETED|Double-blind Phase||0
6319296|NCT00447226|7224354|FG000|NOT COMPLETED|Double-blind Phase||4
6319297|NCT00447226|7224355|FG001|NOT COMPLETED|Double-blind Phase||3
6319298|NCT00447265|7224370|FG000|STARTED|Overall Study||1
6319299|NCT00447265|7224371|FG001|STARTED|Overall Study||0
6319300|NCT00447265|7224370|FG000|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
6319301|NCT00447265|7224371|FG001|COMPLETED|Overall Study||0
6557923|NCT01771809|7480572|FG000|NOT COMPLETED|Overall Study||71
6557924|NCT01771809|7480573|FG001|NOT COMPLETED|Overall Study||83
6319302|NCT00447265|7224370|FG000|NOT COMPLETED|Overall Study||1
6319303|NCT00447265|7224371|FG001|NOT COMPLETED|Overall Study||0
6319304|NCT00447278|7224377|FG000|STARTED|Period II (6 Month Open-Label)||199
6319305|NCT00447278|7224378|FG001|STARTED|Period II (6 Month Open-Label)||200
6319306|NCT00447278|7224377|FG000|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
6319307|NCT00447278|7224378|FG001|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
6319308|NCT00447278|7224377|FG000|COMPLETED|Period II (6 Month Open-Label)||157
6319309|NCT00447278|7224378|FG001|COMPLETED|Period II (6 Month Open-Label)||171
6319310|NCT00447278|7224377|FG000|NOT COMPLETED|Period II (6 Month Open-Label)||42
6319311|NCT00447278|7224378|FG001|NOT COMPLETED|Period II (6 Month Open-Label)||29
6319312|NCT00447278|7224377|FG000|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
6319313|NCT00447278|7224378|FG001|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
6319314|NCT00447278|7224377|FG000|COMPLETED|Period III (Optional 6 Month Extension)||109
6319315|NCT00447278|7224378|FG001|COMPLETED|Period III (Optional 6 Month Extension)||140
6319316|NCT00447278|7224377|FG000|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
6319317|NCT00447278|7224378|FG001|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
6375455|NCT00755937|7286131|FG000|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
6375456|NCT00755937|7286131|FG000|NOT COMPLETED|Observational Follow-up||148
6375457|NCT00756002|7286137|FG000|STARTED|Placebo Run-in||488
6375458|NCT00756002|7286138|FG001|STARTED|Placebo Run-in||0
6375459|NCT00756002|7286137|FG000|COMPLETED|Placebo Run-in||259
6375460|NCT00756002|7286138|FG001|COMPLETED|Placebo Run-in||0
6375461|NCT00756002|7286137|FG000|NOT COMPLETED|Placebo Run-in||229
6375462|NCT00756002|7286138|FG001|NOT COMPLETED|Placebo Run-in||0
6375463|NCT00756002|7286137|FG000|STARTED|Double-Blind Treatment Period||129
6375464|NCT00756002|7286138|FG001|STARTED|Double-Blind Treatment Period||130
6375465|NCT00756002|7286137|FG000|COMPLETED|Double-Blind Treatment Period||114
6375466|NCT00756002|7286138|FG001|COMPLETED|Double-Blind Treatment Period||115
6375467|NCT00756002|7286137|FG000|NOT COMPLETED|Double-Blind Treatment Period||15
6375468|NCT00756002|7286138|FG001|NOT COMPLETED|Double-Blind Treatment Period||15
6557925|NCT01771913|7480581|FG000|STARTED|Overall Study||9
6557926|NCT01771913|7480582|FG001|STARTED|Overall Study||11
6557927|NCT01771913|7480581|FG000|COMPLETED|Overall Study||8
6557928|NCT01771913|7480582|FG001|COMPLETED|Overall Study||11
6557929|NCT01771913|7480581|FG000|NOT COMPLETED|Overall Study||1
6557930|NCT01771913|7480582|FG001|NOT COMPLETED|Overall Study||0
6557931|NCT01771952|7480590|FG000|STARTED|Overall Study||45
6375469|NCT00756002|7286137|FG000|STARTED|Placebo Run-out||114
6375470|NCT00756002|7286138|FG001|STARTED|Placebo Run-out||0
6375471|NCT00756002|7286137|FG000|COMPLETED|Placebo Run-out||114
6375472|NCT00756002|7286138|FG001|COMPLETED|Placebo Run-out||0
6375473|NCT00756002|7286137|FG000|NOT COMPLETED|Placebo Run-out||0
6375474|NCT00756002|7286138|FG001|NOT COMPLETED|Placebo Run-out||0
6375475|NCT00756093|7286144|FG000|STARTED|First Intervention||5
6375476|NCT00756093|7286145|FG001|STARTED|First Intervention||5
6375477|NCT00756093|7286146|FG002|STARTED|First Intervention||5
6375478|NCT00756093|7286147|FG003|STARTED|First Intervention||5
6375479|NCT00756093|7286144|FG000|COMPLETED|First Intervention||5
6375480|NCT00756093|7286145|FG001|COMPLETED|First Intervention||5
6375481|NCT00756093|7286146|FG002|COMPLETED|First Intervention||5
6375482|NCT00756093|7286147|FG003|COMPLETED|First Intervention||5
6375483|NCT00756093|7286144|FG000|NOT COMPLETED|First Intervention||0
6375484|NCT00756093|7286145|FG001|NOT COMPLETED|First Intervention||0
6375485|NCT00756093|7286146|FG002|NOT COMPLETED|First Intervention||0
6375486|NCT00756093|7286147|FG003|NOT COMPLETED|First Intervention||0
6375487|NCT00756093|7286144|FG000|STARTED|Second Intervention||5
6375488|NCT00756093|7286145|FG001|STARTED|Second Intervention||5
6375489|NCT00756093|7286146|FG002|STARTED|Second Intervention||5
6375490|NCT00756093|7286147|FG003|STARTED|Second Intervention||5
6375491|NCT00756093|7286144|FG000|COMPLETED|Second Intervention||5
6375492|NCT00756093|7286145|FG001|COMPLETED|Second Intervention||5
6375493|NCT00756093|7286146|FG002|COMPLETED|Second Intervention||5
6375494|NCT00756093|7286147|FG003|COMPLETED|Second Intervention||5
6375495|NCT00756093|7286144|FG000|NOT COMPLETED|Second Intervention||0
6375496|NCT00756093|7286145|FG001|NOT COMPLETED|Second Intervention||0
6375497|NCT00756093|7286146|FG002|NOT COMPLETED|Second Intervention||0
6375498|NCT00756093|7286147|FG003|NOT COMPLETED|Second Intervention||0
6375499|NCT00756093|7286144|FG000|STARTED|Third Intervention||5
6375500|NCT00756093|7286145|FG001|STARTED|Third Intervention||5
6375501|NCT00756093|7286146|FG002|STARTED|Third Intervention||5
6375502|NCT00756093|7286147|FG003|STARTED|Third Intervention||5
6375503|NCT00756093|7286144|FG000|COMPLETED|Third Intervention||5
6375504|NCT00756093|7286145|FG001|COMPLETED|Third Intervention||5
6375505|NCT00756093|7286146|FG002|COMPLETED|Third Intervention||5
6375506|NCT00756093|7286147|FG003|COMPLETED|Third Intervention||5
6557932|NCT01771952|7480591|FG001|STARTED|Overall Study||41
6557933|NCT01771952|7480590|FG000|COMPLETED|Overall Study||42
6375507|NCT00756093|7286144|FG000|NOT COMPLETED|Third Intervention||0
6375508|NCT00756093|7286145|FG001|NOT COMPLETED|Third Intervention||0
6375509|NCT00756093|7286146|FG002|NOT COMPLETED|Third Intervention||0
6375510|NCT00756093|7286147|FG003|NOT COMPLETED|Third Intervention||0
6375511|NCT00756093|7286144|FG000|STARTED|Fourth Intervention||5
6319318|NCT00447330|7224385|FG000|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
6319319|NCT00447330|7224385|FG000|COMPLETED|Overall Study||58
6319320|NCT00447330|7224385|FG000|NOT COMPLETED|Overall Study||2
6319321|NCT00447382|7224392|FG000|STARTED|Overall Study||164
6319322|NCT00447382|7224393|FG001|STARTED|Overall Study||166
6319323|NCT00447382|7224392|FG000|COMPLETED|Overall Study||158
6319324|NCT00447382|7224393|FG001|COMPLETED|Overall Study||160
6319325|NCT00447382|7224392|FG000|NOT COMPLETED|Overall Study||6
6319326|NCT00447382|7224393|FG001|NOT COMPLETED|Overall Study||6
6319327|NCT00447499|7224399|FG000|STARTED|Overall Study||59
6319328|NCT00447499|7224399|FG000|COMPLETED|Overall Study||52
6319329|NCT00447499|7224399|FG000|NOT COMPLETED|Overall Study||7
6319330|NCT00447590|7224405|FG000|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
6319331|NCT00447590|7224405|FG000|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
6319332|NCT00447590|7224405|FG000|NOT COMPLETED|Overall Study||60
6319333|NCT00447694|7224409|FG000|STARTED|Overall Study||28
6319334|NCT00447694|7224409|FG000|COMPLETED|Overall Study||22
6319335|NCT00447694|7224409|FG000|NOT COMPLETED|Overall Study||6
6319336|NCT00447772|7224413|FG000|STARTED|Overall Study||516
6319337|NCT00447772|7224413|FG000|COMPLETED|Overall Study||489
6319338|NCT00447772|7224413|FG000|NOT COMPLETED|Overall Study||27
6319339|NCT00447876|7224422|FG000|STARTED|Overall Study||20
6319340|NCT00447876|7224423|FG001|STARTED|Overall Study||20
6319341|NCT00447876|7224422|FG000|COMPLETED|Overall Study||17
6319342|NCT00447876|7224423|FG001|COMPLETED|Overall Study||16
6319343|NCT00447876|7224422|FG000|NOT COMPLETED|Overall Study||3
6319344|NCT00447876|7224423|FG001|NOT COMPLETED|Overall Study||4
6319345|NCT00447902|7224431|FG000|STARTED|Overall Study||5
6319346|NCT00447902|7224432|FG001|STARTED|Overall Study||6
6319347|NCT00447902|7224431|FG000|COMPLETED|Overall Study||1
6319348|NCT00447902|7224432|FG001|COMPLETED|Overall Study||0
6319349|NCT00447902|7224431|FG000|NOT COMPLETED|Overall Study||4
6319350|NCT00447902|7224432|FG001|NOT COMPLETED|Overall Study||6
6557934|NCT01771952|7480591|FG001|COMPLETED|Overall Study||38
6557935|NCT01771952|7480590|FG000|NOT COMPLETED|Overall Study||3
6319351|NCT00448019|7224438|FG000|STARTED|Overall Study||64
6319352|NCT00448019|7224438|FG000|COMPLETED|Overall Study||57
6319353|NCT00448019|7224438|FG000|NOT COMPLETED|Overall Study||7
6319354|NCT00448123|7224444|FG000|STARTED|Overall Study||62
6319355|NCT00448123|7224445|FG001|STARTED|Overall Study||65
6319356|NCT00448123|7224444|FG000|COMPLETED|Overall Study||47
6319357|NCT00448123|7224445|FG001|COMPLETED|Overall Study||53
6319358|NCT00448123|7224444|FG000|NOT COMPLETED|Overall Study||15
6319359|NCT00448123|7224445|FG001|NOT COMPLETED|Overall Study||12
6319360|NCT00448136|7224456|FG000|STARTED|Overall Study||34
6319361|NCT00448136|7224457|FG001|STARTED|Overall Study||49
6319362|NCT00448136|7224456|FG000|COMPLETED|Overall Study||30
6319363|NCT00448136|7224457|FG001|COMPLETED|Overall Study||41
6319364|NCT00448136|7224456|FG000|NOT COMPLETED|Overall Study||4
6319365|NCT00448136|7224457|FG001|NOT COMPLETED|Overall Study||8
6319366|NCT00448175|7224465|FG000|STARTED|12 Weeks PTNS vs. Drug||50
6319367|NCT00448175|7224466|FG001|STARTED|12 Weeks PTNS vs. Drug||50
6319368|NCT00448175|7224465|FG000|COMPLETED|12 Weeks PTNS vs. Drug||41
6319369|NCT00448175|7224466|FG001|COMPLETED|12 Weeks PTNS vs. Drug||43
6319370|NCT00448175|7224465|FG000|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
6319371|NCT00448175|7224466|FG001|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
6319372|NCT00448175|7224465|FG000|STARTED|Continued PTNS Through 12 Months||35
6319373|NCT00448175|7224466|FG001|STARTED|Continued PTNS Through 12 Months||0
6319374|NCT00448175|7224465|FG000|COMPLETED|Continued PTNS Through 12 Months||25
6319375|NCT00448175|7224466|FG001|COMPLETED|Continued PTNS Through 12 Months||0
6319376|NCT00448175|7224465|FG000|NOT COMPLETED|Continued PTNS Through 12 Months||10
6319377|NCT00448175|7224466|FG001|NOT COMPLETED|Continued PTNS Through 12 Months||0
6319378|NCT00448201|7224472|FG000|STARTED|Overall Study||71
6319379|NCT00448201|7224472|FG000|COMPLETED|Overall Study||71
6319380|NCT00448201|7224472|FG000|NOT COMPLETED|Overall Study||0
6319381|NCT00448227|7224478|FG000|STARTED|Overall Study||18
6319382|NCT00448227|7224478|FG000|COMPLETED|Overall Study||18
6319383|NCT00448227|7224478|FG000|NOT COMPLETED|Overall Study||0
6319384|NCT00448279|7224487|FG000|STARTED|Overall Study||29
6319385|NCT00448279|7224488|FG001|STARTED|Overall Study||29
6319386|NCT00448279|7224487|FG000|COMPLETED|Overall Study||0
6319387|NCT00448279|7224488|FG001|COMPLETED|Overall Study||0
6319388|NCT00448279|7224487|FG000|NOT COMPLETED|Overall Study||29
6319389|NCT00448279|7224488|FG001|NOT COMPLETED|Overall Study||29
6319390|NCT00448344|7224496|FG000|STARTED|Overall Study||235
6319391|NCT00448344|7224497|FG001|STARTED|Overall Study||236
6319392|NCT00448344|7224496|FG000|COMPLETED|Overall Study||205
6557936|NCT01771952|7480591|FG001|NOT COMPLETED|Overall Study||3
6557937|NCT01771965|7480599|FG000|STARTED|Overall Study||10
6319393|NCT00448344|7224497|FG001|COMPLETED|Overall Study||200
6319394|NCT00448344|7224496|FG000|NOT COMPLETED|Overall Study||30
6319395|NCT00448344|7224497|FG001|NOT COMPLETED|Overall Study||36
6319396|NCT00448357|7224503|FG000|STARTED|Overall Study||54
6319397|NCT00448357|7224503|FG000|COMPLETED|Overall Study||54
6319398|NCT00448357|7224503|FG000|NOT COMPLETED|Overall Study||0
6319399|NCT00448435|7224519|FG000|STARTED|Treatment Period I - 4 Weeks||26
6319400|NCT00448435|7224520|FG001|STARTED|Treatment Period I - 4 Weeks||25
6319401|NCT00448435|7224519|FG000|COMPLETED|Treatment Period I - 4 Weeks||26
6319402|NCT00448435|7224520|FG001|COMPLETED|Treatment Period I - 4 Weeks||25
6319403|NCT00448435|7224519|FG000|NOT COMPLETED|Treatment Period I - 4 Weeks||0
6319404|NCT00448435|7224520|FG001|NOT COMPLETED|Treatment Period I - 4 Weeks||0
6319405|NCT00448435|7224519|FG000|STARTED|Washout Period - 2 Weeks||26
6319406|NCT00448435|7224520|FG001|STARTED|Washout Period - 2 Weeks||25
6319407|NCT00448435|7224519|FG000|COMPLETED|Washout Period - 2 Weeks||25
6319408|NCT00448435|7224520|FG001|COMPLETED|Washout Period - 2 Weeks||25
6319409|NCT00448435|7224519|FG000|NOT COMPLETED|Washout Period - 2 Weeks||1
6319410|NCT00448435|7224520|FG001|NOT COMPLETED|Washout Period - 2 Weeks||0
6319411|NCT00448435|7224519|FG000|STARTED|Treatment Period II - 4 Weeks||25
6319412|NCT00448435|7224520|FG001|STARTED|Treatment Period II - 4 Weeks||25
6319413|NCT00448435|7224519|FG000|COMPLETED|Treatment Period II - 4 Weeks||25
6319414|NCT00448435|7224520|FG001|COMPLETED|Treatment Period II - 4 Weeks||25
6319415|NCT00448435|7224519|FG000|NOT COMPLETED|Treatment Period II - 4 Weeks||0
6319416|NCT00448435|7224520|FG001|NOT COMPLETED|Treatment Period II - 4 Weeks||0
6319417|NCT00448435|7224519|FG000|STARTED|Extension Period - 20 Weeks||50
6319418|NCT00448435|7224520|FG001|STARTED|Extension Period - 20 Weeks||0
6319419|NCT00448435|7224519|FG000|COMPLETED|Extension Period - 20 Weeks||50
6319420|NCT00448435|7224520|FG001|COMPLETED|Extension Period - 20 Weeks||0
6319421|NCT00448435|7224519|FG000|NOT COMPLETED|Extension Period - 20 Weeks||0
6319422|NCT00448435|7224520|FG001|NOT COMPLETED|Extension Period - 20 Weeks||0
6319423|NCT00448448|7224531|FG000|STARTED|Overall Study||246
6319424|NCT00448448|7224532|FG001|STARTED|Overall Study||137
6319425|NCT00448448|7224531|FG000|COMPLETED|Overall Study||146
6319426|NCT00448448|7224532|FG001|COMPLETED|Overall Study||96
6319427|NCT00448448|7224531|FG000|NOT COMPLETED|Overall Study||100
6319428|NCT00448448|7224532|FG001|NOT COMPLETED|Overall Study||41
6319429|NCT00448539|7224540|FG000|STARTED|Overall Study||134
6319430|NCT00448539|7224541|FG001|STARTED|Overall Study||152
6319431|NCT00448539|7224540|FG000|COMPLETED|Overall Study||0
6319432|NCT00448539|7224541|FG001|COMPLETED|Overall Study||0
6319433|NCT00448539|7224540|FG000|NOT COMPLETED|Overall Study||134
6319434|NCT00448539|7224541|FG001|NOT COMPLETED|Overall Study||152
6319435|NCT00448591|7224547|FG000|STARTED|Overall Study||2296
6319436|NCT00448591|7224547|FG000|COMPLETED|Overall Study||0
6319437|NCT00448591|7224547|FG000|NOT COMPLETED|Overall Study||2296
6319438|NCT00448630|7224553|FG000|STARTED|Overall Study||328
6319439|NCT00448630|7224553|FG000|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
6319440|NCT00448630|7224553|FG000|NOT COMPLETED|Overall Study||27
6319441|NCT00448669|7224572|FG000|STARTED|Overall Study||611
6319442|NCT00448669|7224573|FG001|STARTED|Overall Study||608
6319443|NCT00448669|7224572|FG000|COMPLETED|Overall Study||393
6319444|NCT00448669|7224573|FG001|COMPLETED|Overall Study||410
6319445|NCT00448669|7224572|FG000|NOT COMPLETED|Overall Study||218
6319446|NCT00448669|7224573|FG001|NOT COMPLETED|Overall Study||198
6319447|NCT00448708|7224583|FG000|STARTED|Overall Study||112
6319448|NCT00448708|7224584|FG001|STARTED|Overall Study||110
6319449|NCT00448708|7224583|FG000|COMPLETED|Overall Study||77
6319450|NCT00448708|7224584|FG001|COMPLETED|Overall Study||79
6319451|NCT00448708|7224583|FG000|NOT COMPLETED|Overall Study||35
6319452|NCT00448708|7224584|FG001|NOT COMPLETED|Overall Study||31
6319453|NCT00448747|7224592|FG000|STARTED|Overall Study||53
6319454|NCT00448747|7224593|FG001|STARTED|Overall Study||48
6319455|NCT00448747|7224592|FG000|Received First Drug Administration|Overall Study||53
6319456|NCT00448747|7224593|FG001|Received First Drug Administration|Overall Study||48
6319457|NCT00448747|7224592|FG000|Received Second Drug Administration|Overall Study||42
6319458|NCT00448747|7224593|FG001|Received Second Drug Administration|Overall Study||10
6319459|NCT00448747|7224592|FG000|Received AEZS-130|Overall Study||52
6319460|NCT00448747|7224593|FG001|Received AEZS-130|Overall Study||48
6319461|NCT00448747|7224592|FG000|Received L-ARG-GHRH|Overall Study||43
6319462|NCT00448747|7224593|FG001|Received L-ARG-GHRH|Overall Study||10
6319463|NCT00448747|7224592|FG000|Received L-ARG-GHRH and AEZS-130|Overall Study||42
6319464|NCT00448747|7224593|FG001|Received L-ARG-GHRH and AEZS-130|Overall Study||10
6319465|NCT00448747|7224592|FG000|Per Protocol Population (PPS)|Overall Study||50
6319466|NCT00448747|7224593|FG001|Per Protocol Population (PPS)|Overall Study||48
6319467|NCT00448747|7224592|FG000|COMPLETED|Overall Study||52
6319468|NCT00448747|7224593|FG001|COMPLETED|Overall Study||48
6319469|NCT00448747|7224592|FG000|NOT COMPLETED|Overall Study||1
6319470|NCT00448747|7224593|FG001|NOT COMPLETED|Overall Study||0
6319471|NCT00448760|7224609|FG000|STARTED|Overall Study||29
6319472|NCT00448760|7224609|FG000|COMPLETED|Overall Study||26
6319473|NCT00448760|7224609|FG000|NOT COMPLETED|Overall Study||3
6319474|NCT00448812|7224615|FG000|STARTED|Year 1||45
6319475|NCT00448812|7224616|FG001|STARTED|Year 1||24
6319476|NCT00448812|7224615|FG000|COMPLETED|Year 1||45
6319477|NCT00448812|7224616|FG001|COMPLETED|Year 1||24
6319478|NCT00448812|7224615|FG000|NOT COMPLETED|Year 1||0
6319479|NCT00448812|7224616|FG001|NOT COMPLETED|Year 1||0
6319480|NCT00448812|7224615|FG000|STARTED|Year 2||45
6319481|NCT00448812|7224616|FG001|STARTED|Year 2||24
6319482|NCT00448812|7224615|FG000|COMPLETED|Year 2||41
6319483|NCT00448812|7224616|FG001|COMPLETED|Year 2||23
6319484|NCT00448812|7224615|FG000|NOT COMPLETED|Year 2||4
6319485|NCT00448812|7224616|FG001|NOT COMPLETED|Year 2||1
6319486|NCT00448812|7224615|FG000|STARTED|Year 3||45
6319487|NCT00448812|7224616|FG001|STARTED|Year 3||24
6319488|NCT00448812|7224615|FG000|COMPLETED|Year 3||41
6319489|NCT00448812|7224616|FG001|COMPLETED|Year 3||21
6319490|NCT00448812|7224615|FG000|NOT COMPLETED|Year 3||4
6319491|NCT00448812|7224616|FG001|NOT COMPLETED|Year 3||3
6319492|NCT00448812|7224615|FG000|STARTED|Year 4||43
6319493|NCT00448812|7224616|FG001|STARTED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
6319494|NCT00448812|7224615|FG000|COMPLETED|Year 4||43
6319495|NCT00448812|7224616|FG001|COMPLETED|Year 4|Control group subjects exited from study after completing Year 3 evaluation.|0
6319496|NCT00448812|7224615|FG000|NOT COMPLETED|Year 4||0
6319497|NCT00448812|7224616|FG001|NOT COMPLETED|Year 4||0
6319498|NCT00448812|7224615|FG000|STARTED|Year 5||43
6319499|NCT00448812|7224616|FG001|STARTED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
6319500|NCT00448812|7224615|FG000|COMPLETED|Year 5||42
6319501|NCT00448812|7224616|FG001|COMPLETED|Year 5|Control group subjects exited from study after completing Year 3 evaluation.|0
6319502|NCT00448812|7224615|FG000|NOT COMPLETED|Year 5||1
6319503|NCT00448812|7224616|FG001|NOT COMPLETED|Year 5||0
6319504|NCT00448864|7224637|FG000|STARTED|Overall Study||27
6319505|NCT00448864|7224638|FG001|STARTED|Overall Study||29
6319506|NCT00448864|7224639|FG002|STARTED|Overall Study||19
6319507|NCT00448864|7224637|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
6319508|NCT00448864|7224638|FG001|Received at Least 1 Dose of Study Drug|Overall Study||25
6319509|NCT00448864|7224639|FG002|Received at Least 1 Dose of Study Drug|Overall Study||18
6319510|NCT00448864|7224637|FG000|Started Post-operative Period|Overall Study||26
6319511|NCT00448864|7224638|FG001|Started Post-operative Period|Overall Study||25
6319512|NCT00448864|7224639|FG002|Started Post-operative Period|Overall Study||18
6319513|NCT00448864|7224637|FG000|Completed Post-operative Period|Overall Study||26
6319514|NCT00448864|7224638|FG001|Completed Post-operative Period|Overall Study||25
6319515|NCT00448864|7224639|FG002|Completed Post-operative Period|Overall Study||18
6319516|NCT00448864|7224637|FG000|COMPLETED|Overall Study||22
6319517|NCT00448864|7224638|FG001|COMPLETED|Overall Study||24
6319518|NCT00448864|7224639|FG002|COMPLETED|Overall Study||18
6319519|NCT00448864|7224637|FG000|NOT COMPLETED|Overall Study||5
6557938|NCT01771965|7480600|FG001|STARTED|Overall Study||9
6557939|NCT01771965|7480599|FG000|COMPLETED|Overall Study||7
6557940|NCT01771965|7480600|FG001|COMPLETED|Overall Study||4
6557941|NCT01771965|7480599|FG000|NOT COMPLETED|Overall Study||3
6557942|NCT01771965|7480600|FG001|NOT COMPLETED|Overall Study||5
6319520|NCT00448864|7224638|FG001|NOT COMPLETED|Overall Study||5
6319521|NCT00448864|7224639|FG002|NOT COMPLETED|Overall Study||1
6319522|NCT00448916|7224653|FG000|STARTED|Overall Study||16
6319523|NCT00448916|7224654|FG001|STARTED|Overall Study||15
6319524|NCT00448916|7224655|FG002|STARTED|Overall Study||12
6319525|NCT00448916|7224656|FG003|STARTED|Overall Study||11
6319526|NCT00448916|7224653|FG000|COMPLETED|Overall Study||9
6319527|NCT00448916|7224654|FG001|COMPLETED|Overall Study||9
6319528|NCT00448916|7224655|FG002|COMPLETED|Overall Study||6
6319529|NCT00448916|7224656|FG003|COMPLETED|Overall Study||5
6319530|NCT00448916|7224653|FG000|NOT COMPLETED|Overall Study||7
6319531|NCT00448916|7224654|FG001|NOT COMPLETED|Overall Study||6
6319532|NCT00448916|7224655|FG002|NOT COMPLETED|Overall Study||6
6319533|NCT00448916|7224656|FG003|NOT COMPLETED|Overall Study||6
6319534|NCT00449007|7224670|FG000|STARTED|Overall Study||2
6319535|NCT00449007|7224671|FG001|STARTED|Overall Study||3
6319536|NCT00449007|7224670|FG000|COMPLETED|Overall Study||2
6319537|NCT00449007|7224671|FG001|COMPLETED|Overall Study||3
6319538|NCT00449007|7224670|FG000|NOT COMPLETED|Overall Study||0
6319539|NCT00449007|7224671|FG001|NOT COMPLETED|Overall Study||0
6319540|NCT00449033|7224681|FG000|STARTED|Treatment Period||452
6319541|NCT00449033|7224682|FG001|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
6319542|NCT00449033|7224681|FG000|Received Treatment|Treatment Period||452
6319543|NCT00449033|7224682|FG001|Received Treatment|Treatment Period||449
6319544|NCT00449033|7224681|FG000|COMPLETED|Treatment Period||0
6319545|NCT00449033|7224682|FG001|COMPLETED|Treatment Period||0
6319546|NCT00449033|7224681|FG000|NOT COMPLETED|Treatment Period||452
6319547|NCT00449033|7224682|FG001|NOT COMPLETED|Treatment Period||452
6319548|NCT00449033|7224681|FG000|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
6319549|NCT00449033|7224682|FG001|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
6319550|NCT00449033|7224681|FG000|COMPLETED|Follow-up Period||0
6319551|NCT00449033|7224682|FG001|COMPLETED|Follow-up Period||0
6319552|NCT00449033|7224681|FG000|NOT COMPLETED|Follow-up Period||425
6319553|NCT00449033|7224682|FG001|NOT COMPLETED|Follow-up Period||434
6319554|NCT00449046|7224688|FG000|STARTED|Overall Study||40
6319555|NCT00449046|7224688|FG000|COMPLETED|Overall Study||40
6319556|NCT00449046|7224688|FG000|NOT COMPLETED|Overall Study||0
6319557|NCT00449072|7224694|FG000|STARTED|Overall Study||148
6319558|NCT00449072|7224695|FG001|STARTED|Overall Study||151
6319559|NCT00449072|7224694|FG000|COMPLETED|Overall Study||107
6319560|NCT00449072|7224695|FG001|COMPLETED|Overall Study||109
6319561|NCT00449072|7224694|FG000|NOT COMPLETED|Overall Study||41
6319562|NCT00449072|7224695|FG001|NOT COMPLETED|Overall Study||42
6319563|NCT00449150|7224704|FG000|STARTED|Overall Study||219
6319564|NCT00449150|7224705|FG001|STARTED|Overall Study||230
6319565|NCT00449150|7224706|FG002|STARTED|Overall Study||218
6319566|NCT00449150|7224704|FG000|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
6319567|NCT00449150|7224705|FG001|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
6557943|NCT01771991|7480608|FG000|STARTED|Overall Study||38
6319568|NCT00449150|7224706|FG002|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
6319569|NCT00449150|7224704|FG000|NOT COMPLETED|Overall Study||46
6319570|NCT00449150|7224705|FG001|NOT COMPLETED|Overall Study||53
6319571|NCT00449150|7224706|FG002|NOT COMPLETED|Overall Study||47
6319572|NCT00449163|7224717|FG000|STARTED|Overall Study||25
6319573|NCT00449163|7224717|FG000|COMPLETED|Overall Study||22
6319574|NCT00449163|7224717|FG000|NOT COMPLETED|Overall Study||3
6319575|NCT00449176|7224724|FG000|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
6319576|NCT00449176|7224725|FG001|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
6319577|NCT00449176|7224726|FG002|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
6319578|NCT00449176|7224724|FG000|COMPLETED|Overall Study||166
6319579|NCT00449176|7224725|FG001|COMPLETED|Overall Study||133
6319580|NCT00449176|7224726|FG002|COMPLETED|Overall Study||152
6319581|NCT00449176|7224724|FG000|NOT COMPLETED|Overall Study||152
6319582|NCT00449176|7224725|FG001|NOT COMPLETED|Overall Study||195
6319583|NCT00449176|7224726|FG002|NOT COMPLETED|Overall Study||167
6319584|NCT00449540|7224736|FG000|STARTED|Pretreatment Phase||267
6319585|NCT00449540|7224737|FG001|STARTED|Pretreatment Phase||0
6319586|NCT00449540|7224738|FG002|STARTED|Pretreatment Phase||0
6319587|NCT00449540|7224736|FG000|COMPLETED|Pretreatment Phase||201
6319588|NCT00449540|7224737|FG001|COMPLETED|Pretreatment Phase||0
6319589|NCT00449540|7224738|FG002|COMPLETED|Pretreatment Phase||0
6319590|NCT00449540|7224736|FG000|NOT COMPLETED|Pretreatment Phase||66
6319591|NCT00449540|7224737|FG001|NOT COMPLETED|Pretreatment Phase||0
6319592|NCT00449540|7224738|FG002|NOT COMPLETED|Pretreatment Phase||0
6319593|NCT00449540|7224736|FG000|STARTED|Treatment Phase||0
6319594|NCT00449540|7224737|FG001|STARTED|Treatment Phase||102
6319595|NCT00449540|7224738|FG002|STARTED|Treatment Phase||99
6319596|NCT00449540|7224736|FG000|COMPLETED|Treatment Phase||0
6319597|NCT00449540|7224737|FG001|COMPLETED|Treatment Phase||82
6319598|NCT00449540|7224738|FG002|COMPLETED|Treatment Phase||82
6319599|NCT00449540|7224736|FG000|NOT COMPLETED|Treatment Phase||0
6319600|NCT00449540|7224737|FG001|NOT COMPLETED|Treatment Phase||20
6319601|NCT00449540|7224738|FG002|NOT COMPLETED|Treatment Phase||17
6319602|NCT00449644|7224750|FG000|STARTED|Overall Study||23
6319603|NCT00449644|7224751|FG001|STARTED|Overall Study||24
6319604|NCT00449644|7224752|FG002|STARTED|Overall Study||79
6319605|NCT00449644|7224753|FG003|STARTED|Overall Study||81
6319606|NCT00449644|7224750|FG000|Rollover|Overall Study||0
6319607|NCT00449644|7224751|FG001|Rollover|Overall Study||0
6319608|NCT00449644|7224752|FG002|Rollover|Overall Study||0
6319609|NCT00449644|7224753|FG003|Rollover|Overall Study||1
6319610|NCT00449644|7224750|FG000|COMPLETED|Overall Study||13
6319611|NCT00449644|7224751|FG001|COMPLETED|Overall Study||11
6319612|NCT00449644|7224752|FG002|COMPLETED|Overall Study||50
6319613|NCT00449644|7224753|FG003|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
6319614|NCT00449644|7224750|FG000|NOT COMPLETED|Overall Study||10
6319615|NCT00449644|7224751|FG001|NOT COMPLETED|Overall Study||13
6319616|NCT00449644|7224752|FG002|NOT COMPLETED|Overall Study||29
6319617|NCT00449644|7224753|FG003|NOT COMPLETED|Overall Study||32
6319618|NCT00449670|7224768|FG000|STARTED|Primary Phase (Study no.109630)||961
6319619|NCT00449670|7224769|FG001|STARTED|Primary Phase (Study no.109630)||245
6319620|NCT00449670|7224768|FG000|COMPLETED|Primary Phase (Study no.109630)||947
6319621|NCT00449670|7224769|FG001|COMPLETED|Primary Phase (Study no.109630)||243
6319622|NCT00449670|7224768|FG000|NOT COMPLETED|Primary Phase (Study no.109630)||14
6319623|NCT00449670|7224769|FG001|NOT COMPLETED|Primary Phase (Study no.109630)||2
6319624|NCT00449670|7224768|FG000|STARTED|Booster Phase (Study no.109873)||265
6319625|NCT00449670|7224769|FG001|STARTED|Booster Phase (Study no.109873)||236
6319626|NCT00449670|7224768|FG000|COMPLETED|Booster Phase (Study no.109873)||265
6319627|NCT00449670|7224769|FG001|COMPLETED|Booster Phase (Study no.109873)||233
6319628|NCT00449670|7224768|FG000|NOT COMPLETED|Booster Phase (Study no.109873)||0
6319629|NCT00449670|7224769|FG001|NOT COMPLETED|Booster Phase (Study no.109873)||3
6319630|NCT00449696|7224784|FG000|STARTED|Overall Study||251
6319631|NCT00449696|7224785|FG001|STARTED|Overall Study||128
6319632|NCT00449696|7224784|FG000|Received Injection|Overall Study||249
6319633|NCT00449696|7224785|FG001|Received Injection|Overall Study||128
6319634|NCT00449696|7224784|FG000|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
6319635|NCT00449696|7224785|FG001|Analyzed Participants|Overall Study||128
6319636|NCT00449696|7224784|FG000|COMPLETED|Overall Study||231
6319637|NCT00449696|7224785|FG001|COMPLETED|Overall Study||119
6319638|NCT00449696|7224784|FG000|NOT COMPLETED|Overall Study||20
6319639|NCT00449696|7224785|FG001|NOT COMPLETED|Overall Study||9
6319640|NCT00449748|7224791|FG000|STARTED|Overall Study||10
6319641|NCT00449748|7224791|FG000|COMPLETED|Overall Study||10
6319642|NCT00449748|7224791|FG000|NOT COMPLETED|Overall Study||0
6319643|NCT00449761|7224795|FG000|STARTED|Overall Study||27
6319644|NCT00449761|7224795|FG000|COMPLETED|Overall Study||9
6319645|NCT00449761|7224795|FG000|NOT COMPLETED|Overall Study||18
6319646|NCT00449787|7224802|FG000|STARTED|Overall Study||203
6319647|NCT00449787|7224803|FG001|STARTED|Overall Study||198
6319648|NCT00449787|7224802|FG000|COMPLETED|Overall Study||98
6319649|NCT00449787|7224803|FG001|COMPLETED|Overall Study||98
6319650|NCT00449787|7224802|FG000|NOT COMPLETED|Overall Study||105
6319651|NCT00449787|7224803|FG001|NOT COMPLETED|Overall Study||100
6319652|NCT00449865|7224813|FG000|STARTED|Overall Study||867
6319653|NCT00449865|7224814|FG001|STARTED|Overall Study||874
6319654|NCT00449865|7224813|FG000|Completed Year 1|Overall Study|867 Expected at Year 1|802
6319655|NCT00449865|7224814|FG001|Completed Year 1|Overall Study|874 Expected at Year 1|822
6319656|NCT00449865|7224813|FG000|Completed Year 2|Overall Study|867 Expected at Year 2|768
6319657|NCT00449865|7224814|FG001|Completed Year 2|Overall Study|874 Expected at Year 2|766
6319658|NCT00449865|7224813|FG000|Completed Year 3|Overall Study|867 Expected at Year 3|719
6319659|NCT00449865|7224814|FG001|Completed Year 3|Overall Study|874 Expected at Year 3|715
6319660|NCT00449865|7224813|FG000|Completed Year 4|Overall Study|679 Expected at Year 4|521
6319661|NCT00449865|7224814|FG001|Completed Year 4|Overall Study|686 Expected at Year 4|523
6319662|NCT00449865|7224813|FG000|COMPLETED|Overall Study|478 Expected at Year 5|345
6319663|NCT00449865|7224814|FG001|COMPLETED|Overall Study|477 Expected at Year 5|340
6319664|NCT00449865|7224813|FG000|NOT COMPLETED|Overall Study||522
6319665|NCT00449865|7224814|FG001|NOT COMPLETED|Overall Study||534
6319666|NCT00449930|7224822|FG000|STARTED|Overall Study||528
6319667|NCT00449930|7224823|FG001|STARTED|Overall Study||522
6319668|NCT00449930|7224822|FG000|COMPLETED|Overall Study||467
6319669|NCT00449930|7224823|FG001|COMPLETED|Overall Study||447
6319670|NCT00449930|7224822|FG000|NOT COMPLETED|Overall Study||61
6319671|NCT00449930|7224823|FG001|NOT COMPLETED|Overall Study||75
6319672|NCT00449956|7224832|FG000|STARTED|Overall Study||189
6319673|NCT00449956|7224833|FG001|STARTED|Overall Study||92
6319674|NCT00449956|7224834|FG002|STARTED|Overall Study||193
6319675|NCT00449956|7224832|FG000|COMPLETED|Overall Study||179
6319676|NCT00449956|7224833|FG001|COMPLETED|Overall Study||88
6319677|NCT00449956|7224834|FG002|COMPLETED|Overall Study||184
6319678|NCT00449956|7224832|FG000|NOT COMPLETED|Overall Study||10
6319679|NCT00449956|7224833|FG001|NOT COMPLETED|Overall Study||4
6319680|NCT00449956|7224834|FG002|NOT COMPLETED|Overall Study||9
6319681|NCT00450073|7224845|FG000|STARTED|Overall Study||10
6319682|NCT00450073|7224846|FG001|STARTED|Overall Study||10
6319683|NCT00450073|7224847|FG002|STARTED|Overall Study||10
6319684|NCT00450073|7224845|FG000|COMPLETED|Overall Study||9
6319685|NCT00450073|7224846|FG001|COMPLETED|Overall Study||10
6319686|NCT00450073|7224847|FG002|COMPLETED|Overall Study||9
6319687|NCT00450073|7224845|FG000|NOT COMPLETED|Overall Study||1
6319688|NCT00450073|7224846|FG001|NOT COMPLETED|Overall Study||0
6319689|NCT00450073|7224847|FG002|NOT COMPLETED|Overall Study||1
6319690|NCT00450112|7224857|FG000|STARTED|Overall Study||125
6319691|NCT00450112|7224858|FG001|STARTED|Overall Study||77
6319692|NCT00450112|7224857|FG000|Received Injection|Overall Study||125
6319693|NCT00450112|7224858|FG001|Received Injection|Overall Study||74
6319694|NCT00450112|7224857|FG000|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
6319695|NCT00450112|7224858|FG001|Analyzed Participants|Overall Study||74
6319696|NCT00450112|7224857|FG000|COMPLETED|Overall Study||112
6319697|NCT00450112|7224858|FG001|COMPLETED|Overall Study||71
6319698|NCT00450112|7224857|FG000|NOT COMPLETED|Overall Study||13
6319699|NCT00450112|7224858|FG001|NOT COMPLETED|Overall Study||6
6319700|NCT00450177|7224866|FG000|STARTED|Overall Study||97
6319701|NCT00450177|7224867|FG001|STARTED|Overall Study||103
6557944|NCT01771991|7480609|FG001|STARTED|Overall Study||36
6557945|NCT01771991|7480608|FG000|Started Treatment|Overall Study||37
6557946|NCT01771991|7480609|FG001|Started Treatment|Overall Study||34
6319702|NCT00450177|7224866|FG000|COMPLETED|Overall Study||88
6319703|NCT00450177|7224867|FG001|COMPLETED|Overall Study||92
6319704|NCT00450177|7224866|FG000|NOT COMPLETED|Overall Study||9
6319705|NCT00450177|7224867|FG001|NOT COMPLETED|Overall Study||11
6319706|NCT00450190|7224873|FG000|STARTED|Overall Study||20
6319707|NCT00450190|7224873|FG000|COMPLETED|Overall Study||18
6557947|NCT01771991|7480608|FG000|COMPLETED|Overall Study||30
6557948|NCT01771991|7480609|FG001|COMPLETED|Overall Study||30
6557949|NCT01771991|7480608|FG000|NOT COMPLETED|Overall Study||8
6557950|NCT01771991|7480609|FG001|NOT COMPLETED|Overall Study||6
6557951|NCT01772134|7480619|FG000|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
6557952|NCT01772134|7480620|FG001|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
6557953|NCT01772134|7480621|FG002|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
6557954|NCT01772134|7480619|FG000|Received Randomized Study Medication|Overall Study||205
6319708|NCT00450190|7224873|FG000|NOT COMPLETED|Overall Study||2
6319709|NCT00450216|7224879|FG000|STARTED|Overall Study||607
6319710|NCT00450216|7224880|FG001|STARTED|Overall Study||299
6319711|NCT00450216|7224879|FG000|COMPLETED|Overall Study||433
6319712|NCT00450216|7224880|FG001|COMPLETED|Overall Study||170
6319713|NCT00450216|7224879|FG000|NOT COMPLETED|Overall Study||174
6557955|NCT01772134|7480620|FG001|Received Randomized Study Medication|Overall Study||204
6557956|NCT01772134|7480621|FG002|Received Randomized Study Medication|Overall Study||205
6557957|NCT01772134|7480619|FG000|COMPLETED|Overall Study||178
6319714|NCT00450216|7224880|FG001|NOT COMPLETED|Overall Study||129
6319715|NCT00450242|7224888|FG000|STARTED|Overall Study||7
6319716|NCT00450242|7224889|FG001|STARTED|Overall Study||7
6319717|NCT00450242|7224888|FG000|COMPLETED|Overall Study||4
6319718|NCT00450242|7224889|FG001|COMPLETED|Overall Study||6
6319719|NCT00450242|7224888|FG000|NOT COMPLETED|Overall Study||3
6319720|NCT00450242|7224889|FG001|NOT COMPLETED|Overall Study||1
6319721|NCT00450255|7224897|FG000|STARTED|Overall Study||41
6775147|NCT03886701|7703072|FG000|COMPLETED|Period 2: Study Days 7-21||11
6775148|NCT03886701|7703072|FG000|NOT COMPLETED|Period 2: Study Days 7-21||0
6319722|NCT00450255|7224897|FG000|COMPLETED|Overall Study||40
6557958|NCT01772134|7480620|FG001|COMPLETED|Overall Study||190
6557959|NCT01772134|7480621|FG002|COMPLETED|Overall Study||184
6557960|NCT01772134|7480619|FG000|NOT COMPLETED|Overall Study||29
6557961|NCT01772134|7480620|FG001|NOT COMPLETED|Overall Study||14
6557962|NCT01772134|7480621|FG002|NOT COMPLETED|Overall Study||22
6557963|NCT01772147|7480632|FG000|STARTED|Overall Study||201
6319723|NCT00450255|7224897|FG000|NOT COMPLETED|Overall Study||1
6319724|NCT00450294|7224902|FG000|STARTED|Overall Study||10
6319725|NCT00450294|7224902|FG000|COMPLETED|Overall Study||10
6319726|NCT00450294|7224902|FG000|NOT COMPLETED|Overall Study||0
6319727|NCT00450372|7224907|FG000|STARTED|Overall Study||38
6319728|NCT00450372|7224907|FG000|COMPLETED|Overall Study||37
6319729|NCT00450372|7224907|FG000|NOT COMPLETED|Overall Study||1
6319730|NCT00450385|7224914|FG000|STARTED|Overall Study||57
6319731|NCT00450385|7224914|FG000|COMPLETED|Overall Study||44
6319732|NCT00450385|7224914|FG000|NOT COMPLETED|Overall Study||13
6319733|NCT00450411|7224919|FG000|STARTED|Overall Study||100
6319734|NCT00450411|7224919|FG000|Eligible and Started Protocol Treatment|Overall Study||92
6319735|NCT00450411|7224919|FG000|COMPLETED|Overall Study||92
6319736|NCT00450411|7224919|FG000|NOT COMPLETED|Overall Study||8
6319737|NCT00450424|7224925|FG000|STARTED|Overall Study||122
6319738|NCT00450424|7224926|FG001|STARTED|Overall Study||117
6319739|NCT00450424|7224925|FG000|COMPLETED|Overall Study||102
6319740|NCT00450424|7224926|FG001|COMPLETED|Overall Study||106
6319741|NCT00450424|7224925|FG000|NOT COMPLETED|Overall Study||20
6319742|NCT00450424|7224926|FG001|NOT COMPLETED|Overall Study||11
6319743|NCT00450437|7224934|FG000|STARTED|Overall Study||1640
6319744|NCT00450437|7224935|FG001|STARTED|Overall Study||540
6319745|NCT00450437|7224936|FG002|STARTED|Overall Study||1023
6319746|NCT00450437|7224937|FG003|STARTED|Overall Study||336
6319747|NCT00450437|7224934|FG000|COMPLETED|Overall Study||1594
6319748|NCT00450437|7224935|FG001|COMPLETED|Overall Study||524
6319749|NCT00450437|7224936|FG002|COMPLETED|Overall Study||999
6319750|NCT00450437|7224937|FG003|COMPLETED|Overall Study||325
6319751|NCT00450437|7224934|FG000|NOT COMPLETED|Overall Study||46
6319752|NCT00450437|7224935|FG001|NOT COMPLETED|Overall Study||16
6319753|NCT00450437|7224936|FG002|NOT COMPLETED|Overall Study||24
6319754|NCT00450437|7224937|FG003|NOT COMPLETED|Overall Study||11
6319761|NCT00450463|7224962|FG000|STARTED|Initial Drug Administration||33
6319762|NCT00450463|7224963|FG001|STARTED|Initial Drug Administration||31
6319763|NCT00450463|7224962|FG000|COMPLETED|Initial Drug Administration||33
6319764|NCT00450463|7224963|FG001|COMPLETED|Initial Drug Administration||31
6319765|NCT00450463|7224962|FG000|NOT COMPLETED|Initial Drug Administration||0
6319766|NCT00450463|7224963|FG001|NOT COMPLETED|Initial Drug Administration||0
6319767|NCT00450463|7224962|FG000|STARTED|Progressed to Receive Vaccine Alone||11
6319768|NCT00450463|7224963|FG001|STARTED|Progressed to Receive Vaccine Alone||0
6319769|NCT00450463|7224962|FG000|COMPLETED|Progressed to Receive Vaccine Alone||11
6319770|NCT00450463|7224963|FG001|COMPLETED|Progressed to Receive Vaccine Alone||0
6319771|NCT00450463|7224962|FG000|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
6319772|NCT00450463|7224963|FG001|NOT COMPLETED|Progressed to Receive Vaccine Alone||0
6319773|NCT00450580|7224974|FG000|STARTED|Overall Study||106
6319774|NCT00450580|7224975|FG001|STARTED|Overall Study||106
6319775|NCT00450580|7224974|FG000|COMPLETED|Overall Study||90
6319776|NCT00450580|7224975|FG001|COMPLETED|Overall Study||90
6319777|NCT00450580|7224974|FG000|NOT COMPLETED|Overall Study||16
6319778|NCT00450580|7224975|FG001|NOT COMPLETED|Overall Study||16
6498339|NCT01408901|7416890|FG002|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||0
6498340|NCT01408901|7416891|FG003|NOT COMPLETED|12-Week Follow-Up (Primary Endpoint)||3
6498341|NCT01408901|7416888|FG000|STARTED|26-Week Follow-Up||49
6498342|NCT01408901|7416889|FG001|STARTED|26-Week Follow-Up||52
6498343|NCT01408901|7416890|FG002|STARTED|26-Week Follow-Up||50
6498344|NCT01408901|7416891|FG003|STARTED|26-Week Follow-Up||47
6498345|NCT01408901|7416888|FG000|COMPLETED|26-Week Follow-Up||48
6498346|NCT01408901|7416889|FG001|COMPLETED|26-Week Follow-Up||50
6557964|NCT01772147|7480633|FG001|STARTED|Overall Study||203
6319779|NCT00450619|7224983|FG000|STARTED|Overall Study||22
6319780|NCT00450619|7224984|FG001|STARTED|Overall Study||22
6319781|NCT00450619|7224983|FG000|COMPLETED|Overall Study||18
6319782|NCT00450619|7224984|FG001|COMPLETED|Overall Study||21
6319783|NCT00450619|7224983|FG000|NOT COMPLETED|Overall Study||4
6319784|NCT00450619|7224984|FG001|NOT COMPLETED|Overall Study||1
6319785|NCT00450658|7224993|FG000|STARTED|Overall Study||415
6319786|NCT00450658|7224994|FG001|STARTED|Overall Study||212
6319787|NCT00450658|7224993|FG000|COMPLETED|Overall Study||272
6319788|NCT00450658|7224994|FG001|COMPLETED|Overall Study||122
6319789|NCT00450658|7224993|FG000|NOT COMPLETED|Overall Study||143
6557965|NCT01772147|7480634|FG002|STARTED|Overall Study||202
6557966|NCT01772147|7480632|FG000|COMPLETED|Overall Study||170
6775149|NCT03883113|7703080|FG000|STARTED|Overall Study||87
6775150|NCT03883113|7703081|FG001|STARTED|Overall Study||58
6319790|NCT00450658|7224994|FG001|NOT COMPLETED|Overall Study||90
6319791|NCT00450723|7225000|FG000|STARTED|Overall Study||39
6319792|NCT00450723|7225000|FG000|COMPLETED|Overall Study||34
6319793|NCT00450723|7225000|FG000|NOT COMPLETED|Overall Study||5
6319794|NCT00450749|7225008|FG000|STARTED|Overall Study||3
6319795|NCT00450749|7225009|FG001|STARTED|Overall Study||3
6319796|NCT00450749|7225010|FG002|STARTED|Overall Study||4
6319797|NCT00450749|7225008|FG000|COMPLETED|Overall Study||3
6319798|NCT00450749|7225009|FG001|COMPLETED|Overall Study||2
6319799|NCT00450749|7225010|FG002|COMPLETED|Overall Study||2
6319800|NCT00450749|7225008|FG000|NOT COMPLETED|Overall Study||0
6319801|NCT00450749|7225009|FG001|NOT COMPLETED|Overall Study||1
6319802|NCT00450749|7225010|FG002|NOT COMPLETED|Overall Study||2
6557967|NCT01772147|7480633|FG001|COMPLETED|Overall Study||178
6557968|NCT01772147|7480634|FG002|COMPLETED|Overall Study||184
6557969|NCT01772147|7480632|FG000|NOT COMPLETED|Overall Study||31
6557970|NCT01772147|7480633|FG001|NOT COMPLETED|Overall Study||25
6557971|NCT01772147|7480634|FG002|NOT COMPLETED|Overall Study||18
6557972|NCT01772160|7480642|FG000|STARTED|Overall Study||394
6557973|NCT01772160|7480642|FG000|COMPLETED|Overall Study||346
6557974|NCT01772160|7480642|FG000|NOT COMPLETED|Overall Study||48
6557975|NCT01772316|7480646|FG000|STARTED|Overall Study||47
6557976|NCT01772316|7480646|FG000|COMPLETED|Overall Study||40
6319803|NCT00450801|7225018|FG000|STARTED|Overall Study||22
6319804|NCT00450801|7225018|FG000|COMPLETED|Overall Study||21
6319805|NCT00450801|7225018|FG000|NOT COMPLETED|Overall Study||1
6319806|NCT00450814|7225037|FG000|STARTED|Overall Study||3
6319807|NCT00450814|7225038|FG001|STARTED|Overall Study||3
6319808|NCT00450814|7225039|FG002|STARTED|Overall Study||3
6319809|NCT00450814|7225040|FG003|STARTED|Overall Study||4
6319810|NCT00450814|7225041|FG004|STARTED|Overall Study||4
6319811|NCT00450814|7225042|FG005|STARTED|Overall Study||7
6319812|NCT00450814|7225043|FG006|STARTED|Overall Study||3
6319813|NCT00450814|7225044|FG007|STARTED|Overall Study||3
6319814|NCT00450814|7225045|FG008|STARTED|Overall Study||2
6319815|NCT00450814|7225046|FG009|STARTED|Overall Study||12
6319816|NCT00450814|7225047|FG010|STARTED|Overall Study||4
6319817|NCT00450814|7225037|FG000|COMPLETED|Overall Study||3
6319818|NCT00450814|7225038|FG001|COMPLETED|Overall Study||3
6319819|NCT00450814|7225039|FG002|COMPLETED|Overall Study||3
6319820|NCT00450814|7225040|FG003|COMPLETED|Overall Study||3
6319821|NCT00450814|7225041|FG004|COMPLETED|Overall Study||3
6319822|NCT00450814|7225042|FG005|COMPLETED|Overall Study||6
6319823|NCT00450814|7225043|FG006|COMPLETED|Overall Study||3
6319824|NCT00450814|7225044|FG007|COMPLETED|Overall Study||3
6319825|NCT00450814|7225045|FG008|COMPLETED|Overall Study||2
6319826|NCT00450814|7225046|FG009|COMPLETED|Overall Study||11
6319827|NCT00450814|7225047|FG010|COMPLETED|Overall Study||4
6319828|NCT00450814|7225037|FG000|NOT COMPLETED|Overall Study||0
6319829|NCT00450814|7225038|FG001|NOT COMPLETED|Overall Study||0
6319830|NCT00450814|7225039|FG002|NOT COMPLETED|Overall Study||0
6319831|NCT00450814|7225040|FG003|NOT COMPLETED|Overall Study||1
6319832|NCT00450814|7225041|FG004|NOT COMPLETED|Overall Study||1
6319833|NCT00450814|7225042|FG005|NOT COMPLETED|Overall Study||1
6319834|NCT00450814|7225043|FG006|NOT COMPLETED|Overall Study||0
6319835|NCT00450814|7225044|FG007|NOT COMPLETED|Overall Study||0
6319836|NCT00450814|7225045|FG008|NOT COMPLETED|Overall Study||0
6319837|NCT00450814|7225046|FG009|NOT COMPLETED|Overall Study||1
6319838|NCT00450814|7225047|FG010|NOT COMPLETED|Overall Study||0
6319839|NCT00450866|7225072|FG000|STARTED|Overall Study||45
6319840|NCT00450866|7225073|FG001|STARTED|Overall Study||10
6319841|NCT00450866|7225072|FG000|COMPLETED|Overall Study||38
6319842|NCT00450866|7225073|FG001|COMPLETED|Overall Study||7
6319843|NCT00450866|7225072|FG000|NOT COMPLETED|Overall Study||7
6319844|NCT00450866|7225073|FG001|NOT COMPLETED|Overall Study||3
6319845|NCT00450983|7225079|FG000|STARTED|Overall Study||1
6319846|NCT00450983|7225079|FG000|COMPLETED|Overall Study||1
6319847|NCT00450983|7225079|FG000|NOT COMPLETED|Overall Study||0
6319848|NCT00451035|7225083|FG000|STARTED|Overall Study||29
6319849|NCT00451035|7225083|FG000|COMPLETED|Overall Study||12
6319850|NCT00451035|7225083|FG000|NOT COMPLETED|Overall Study||17
6319851|NCT00451048|7225088|FG000|STARTED|Overall Study||10
6319852|NCT00451048|7225088|FG000|COMPLETED|Overall Study||10
6319853|NCT00451048|7225088|FG000|NOT COMPLETED|Overall Study||0
6319854|NCT00451178|7225094|FG000|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||58
6319855|NCT00451178|7225095|FG001|STARTED|Chemotherapy (Up To Six 21-Day Cycles)||43
6319856|NCT00451178|7225094|FG000|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||57
6319857|NCT00451178|7225095|FG001|Received At Least 1 Dose Study Treatment|Chemotherapy (Up To Six 21-Day Cycles)||43
6319858|NCT00451178|7225094|FG000|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||40
6319859|NCT00451178|7225095|FG001|COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||26
6319860|NCT00451178|7225094|FG000|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||18
6319861|NCT00451178|7225095|FG001|NOT COMPLETED|Chemotherapy (Up To Six 21-Day Cycles)||17
6319862|NCT00451178|7225094|FG000|STARTED|Prior to Maintenance Therapy||40
6319863|NCT00451178|7225095|FG001|STARTED|Prior to Maintenance Therapy|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
6319864|NCT00451178|7225094|FG000|COMPLETED|Prior to Maintenance Therapy||36
6319865|NCT00451178|7225095|FG001|COMPLETED|Prior to Maintenance Therapy||0
6319866|NCT00451178|7225094|FG000|NOT COMPLETED|Prior to Maintenance Therapy||4
6557977|NCT01772316|7480646|FG000|NOT COMPLETED|Overall Study||7
6557978|NCT01772368|7480650|FG000|STARTED|Overall Study||72
6319867|NCT00451178|7225095|FG001|NOT COMPLETED|Prior to Maintenance Therapy||0
6319868|NCT00451178|7225094|FG000|STARTED|Maintenance Therapy (up to 3 Years)||36
6319869|NCT00451178|7225095|FG001|STARTED|Maintenance Therapy (up to 3 Years)|R-CHOP participants were excluded from maintenance therapy and went directly to long-term follow-up.|0
6319870|NCT00451178|7225094|FG000|COMPLETED|Maintenance Therapy (up to 3 Years)||6
6319871|NCT00451178|7225095|FG001|COMPLETED|Maintenance Therapy (up to 3 Years)||0
6319872|NCT00451178|7225094|FG000|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||30
6319873|NCT00451178|7225095|FG001|NOT COMPLETED|Maintenance Therapy (up to 3 Years)||0
6319874|NCT00451178|7225094|FG000|STARTED|Long-Term Follow-Up (Up to 2 Years)||6
6319875|NCT00451178|7225095|FG001|STARTED|Long-Term Follow-Up (Up to 2 Years)||26
6319876|NCT00451178|7225094|FG000|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
6319877|NCT00451178|7225095|FG001|COMPLETED|Long-Term Follow-Up (Up to 2 Years)||0
6319878|NCT00451178|7225094|FG000|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||6
6319879|NCT00451178|7225095|FG001|NOT COMPLETED|Long-Term Follow-Up (Up to 2 Years)||26
6319880|NCT00451191|7225107|FG000|STARTED|Overall Study||68
6319881|NCT00451191|7225108|FG001|STARTED|Overall Study||66
6319882|NCT00451191|7225107|FG000|COMPLETED|Overall Study||53
6319883|NCT00451191|7225108|FG001|COMPLETED|Overall Study||55
6319884|NCT00451191|7225107|FG000|NOT COMPLETED|Overall Study||15
6319885|NCT00451191|7225108|FG001|NOT COMPLETED|Overall Study||11
6319886|NCT00451204|7225116|FG000|STARTED|Overall Study||82
6319887|NCT00451204|7225117|FG001|STARTED|Overall Study||76
6319888|NCT00451204|7225116|FG000|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
6319889|NCT00451204|7225117|FG001|COMPLETED|Overall Study||56
6319890|NCT00451204|7225116|FG000|NOT COMPLETED|Overall Study||22
6319891|NCT00451204|7225117|FG001|NOT COMPLETED|Overall Study||20
6319892|NCT00451217|7225130|FG000|STARTED|Overall Study||49
6319893|NCT00451217|7225131|FG001|STARTED|Overall Study||49
6319894|NCT00451217|7225132|FG002|STARTED|Overall Study||51
6319895|NCT00451217|7225133|FG003|STARTED|Overall Study||49
6319896|NCT00451217|7225130|FG000|Treated|Overall Study||48
6319897|NCT00451217|7225131|FG001|Treated|Overall Study||48
6319898|NCT00451217|7225132|FG002|Treated|Overall Study||48
6319899|NCT00451217|7225133|FG003|Treated|Overall Study||45
6319900|NCT00451217|7225130|FG000|COMPLETED|Overall Study||47
6319901|NCT00451217|7225131|FG001|COMPLETED|Overall Study||47
6319902|NCT00451217|7225132|FG002|COMPLETED|Overall Study||47
6319903|NCT00451217|7225133|FG003|COMPLETED|Overall Study||44
6319904|NCT00451217|7225130|FG000|NOT COMPLETED|Overall Study||2
6319905|NCT00451217|7225131|FG001|NOT COMPLETED|Overall Study||2
6319906|NCT00451217|7225132|FG002|NOT COMPLETED|Overall Study||4
6319907|NCT00451217|7225133|FG003|NOT COMPLETED|Overall Study||5
6557979|NCT01772368|7480650|FG000|Received Fp MDPI 100 mcg|Overall Study||67
6557980|NCT01772368|7480650|FG000|Received FS MDPI 100/6.25 mcg|Overall Study||68
6557981|NCT01772368|7480650|FG000|Received FS MDPI 100/12.5mcg|Overall Study||69
6557982|NCT01772368|7480650|FG000|Received FS MDPI 100/25 mcg|Overall Study||67
6319908|NCT00451282|7225145|FG000|STARTED|Overall Study||46
6319909|NCT00451282|7225146|FG001|STARTED|Overall Study||39
6319910|NCT00451282|7225145|FG000|COMPLETED|Overall Study||40
6319911|NCT00451282|7225146|FG001|COMPLETED|Overall Study||34
6319912|NCT00451282|7225145|FG000|NOT COMPLETED|Overall Study||6
6319913|NCT00451282|7225146|FG001|NOT COMPLETED|Overall Study||5
6319914|NCT00451321|7225160|FG000|STARTED|Overall Study||8
6319915|NCT00451321|7225161|FG001|STARTED|Overall Study||15
6319916|NCT00451321|7225162|FG002|STARTED|Overall Study||18
6319917|NCT00451321|7225163|FG003|STARTED|Overall Study||19
6319918|NCT00451321|7225164|FG004|STARTED|Overall Study||7
6319919|NCT00451321|7225165|FG005|STARTED|Overall Study||9
6319920|NCT00451321|7225166|FG006|STARTED|Overall Study||6
6319921|NCT00451321|7225167|FG007|STARTED|Overall Study||6
6319922|NCT00451321|7225160|FG000|COMPLETED|Overall Study||1
6319923|NCT00451321|7225161|FG001|COMPLETED|Overall Study||10
6319924|NCT00451321|7225162|FG002|COMPLETED|Overall Study||0
6319925|NCT00451321|7225163|FG003|COMPLETED|Overall Study||7
6319926|NCT00451321|7225164|FG004|COMPLETED|Overall Study||0
6319927|NCT00451321|7225165|FG005|COMPLETED|Overall Study||0
6319928|NCT00451321|7225166|FG006|COMPLETED|Overall Study||0
6319929|NCT00451321|7225167|FG007|COMPLETED|Overall Study||0
6319930|NCT00451321|7225160|FG000|NOT COMPLETED|Overall Study||7
6319931|NCT00451321|7225161|FG001|NOT COMPLETED|Overall Study||5
6319932|NCT00451321|7225162|FG002|NOT COMPLETED|Overall Study||18
6319933|NCT00451321|7225163|FG003|NOT COMPLETED|Overall Study||12
6319934|NCT00451321|7225164|FG004|NOT COMPLETED|Overall Study||7
6319935|NCT00451321|7225165|FG005|NOT COMPLETED|Overall Study||9
6319936|NCT00451321|7225166|FG006|NOT COMPLETED|Overall Study||6
6319937|NCT00451321|7225167|FG007|NOT COMPLETED|Overall Study||6
6319938|NCT00451451|7225189|FG000|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
6319939|NCT00451451|7225190|FG001|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
6319940|NCT00451451|7225191|FG002|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
6319941|NCT00451451|7225192|FG003|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
6319942|NCT00451451|7225189|FG000|COMPLETED|Overall Study||278
6319943|NCT00451451|7225190|FG001|COMPLETED|Overall Study||284
6319944|NCT00451451|7225191|FG002|COMPLETED|Overall Study||273
6319945|NCT00451451|7225192|FG003|COMPLETED|Overall Study||292
6319946|NCT00451451|7225189|FG000|NOT COMPLETED|Overall Study||85
6557983|NCT01772368|7480650|FG000|Received FS MDPI 100/50 mcg|Overall Study||68
6319947|NCT00451451|7225190|FG001|NOT COMPLETED|Overall Study||75
6319948|NCT00451451|7225191|FG002|NOT COMPLETED|Overall Study||72
6319949|NCT00451451|7225192|FG003|NOT COMPLETED|Overall Study||58
6319950|NCT00451555|7225207|FG000|STARTED|Overall Study||96
6319951|NCT00451555|7225208|FG001|STARTED|Overall Study||60
6319952|NCT00451555|7225207|FG000|Received at Least One Dose of Study Drug|Overall Study||94
6319953|NCT00451555|7225208|FG001|Received at Least One Dose of Study Drug|Overall Study||58
6319954|NCT00451555|7225207|FG000|Enzastaurin Twice Daily Dosing (BID)|Overall Study||39
6319955|NCT00451555|7225208|FG001|Enzastaurin Twice Daily Dosing (BID)|Overall Study||0
6319956|NCT00451555|7225207|FG000|Enzastaurin Once Daily Dosing (QD)|Overall Study||55
6319957|NCT00451555|7225208|FG001|Enzastaurin Once Daily Dosing (QD)|Overall Study||0
6319958|NCT00451555|7225207|FG000|Progressive Disease|Overall Study||75
6319959|NCT00451555|7225208|FG001|Progressive Disease|Overall Study||54
6319960|NCT00451555|7225207|FG000|Death|Overall Study||2
6319961|NCT00451555|7225208|FG001|Death|Overall Study||0
6319962|NCT00451555|7225207|FG000|COMPLETED|Overall Study||83
6319963|NCT00451555|7225208|FG001|COMPLETED|Overall Study||56
6319964|NCT00451555|7225207|FG000|NOT COMPLETED|Overall Study||13
6319965|NCT00451555|7225208|FG001|NOT COMPLETED|Overall Study||4
6319966|NCT00451698|7225225|FG000|STARTED|Overall Study||3
6319967|NCT00451698|7225226|FG001|STARTED|Overall Study||6
6319968|NCT00451698|7225225|FG000|COMPLETED|Overall Study||3
6319969|NCT00451698|7225226|FG001|COMPLETED|Overall Study||6
6319970|NCT00451698|7225225|FG000|NOT COMPLETED|Overall Study||0
6319971|NCT00451698|7225226|FG001|NOT COMPLETED|Overall Study||0
6319972|NCT00451906|7225234|FG000|STARTED|Overall Study||2252
6319973|NCT00451906|7225234|FG000|COMPLETED|Overall Study||13
6319974|NCT00451906|7225234|FG000|NOT COMPLETED|Overall Study||2239
6319975|NCT00451958|7225242|FG000|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
6319976|NCT00451958|7225243|FG001|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
6319977|NCT00451958|7225244|FG002|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
6319978|NCT00451958|7225245|FG003|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
6319979|NCT00451958|7225246|FG004|STARTED|CS21 (NCT00295750)||204
6319980|NCT00451958|7225242|FG000|COMPLETED|CS21 (NCT00295750)||169
6319981|NCT00451958|7225243|FG001|COMPLETED|CS21 (NCT00295750)||163
6319982|NCT00451958|7225244|FG002|COMPLETED|CS21 (NCT00295750)||0
6319983|NCT00451958|7225245|FG003|COMPLETED|CS21 (NCT00295750)||0
6319984|NCT00451958|7225246|FG004|COMPLETED|CS21 (NCT00295750)||172
6319985|NCT00451958|7225242|FG000|NOT COMPLETED|CS21 (NCT00295750)||41
6319986|NCT00451958|7225243|FG001|NOT COMPLETED|CS21 (NCT00295750)||43
6319987|NCT00451958|7225244|FG002|NOT COMPLETED|CS21 (NCT00295750)||0
6319988|NCT00451958|7225245|FG003|NOT COMPLETED|CS21 (NCT00295750)||0
6319989|NCT00451958|7225246|FG004|NOT COMPLETED|CS21 (NCT00295750)||32
6319990|NCT00451958|7225242|FG000|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
6319991|NCT00451958|7225243|FG001|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
6319992|NCT00451958|7225244|FG002|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
6319993|NCT00451958|7225245|FG003|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
6319994|NCT00451958|7225246|FG004|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
6319995|NCT00451958|7225242|FG000|COMPLETED|CS21A (NCT00451958)||60
6319996|NCT00451958|7225243|FG001|COMPLETED|CS21A (NCT00451958)||49
6319997|NCT00451958|7225244|FG002|COMPLETED|CS21A (NCT00451958)||27
6319998|NCT00451958|7225245|FG003|COMPLETED|CS21A (NCT00451958)||27
6319999|NCT00451958|7225246|FG004|COMPLETED|CS21A (NCT00451958)||0
6320000|NCT00451958|7225242|FG000|NOT COMPLETED|CS21A (NCT00451958)||65
6320001|NCT00451958|7225243|FG001|NOT COMPLETED|CS21A (NCT00451958)||77
6320002|NCT00451958|7225244|FG002|NOT COMPLETED|CS21A (NCT00451958)||42
6320003|NCT00451958|7225245|FG003|NOT COMPLETED|CS21A (NCT00451958)||39
6320004|NCT00451958|7225246|FG004|NOT COMPLETED|CS21A (NCT00451958)||0
6320005|NCT00452114|7225262|FG000|STARTED|Overall Study||15
6320006|NCT00452114|7225263|FG001|STARTED|Overall Study||13
6320007|NCT00452114|7225262|FG000|COMPLETED|Overall Study||12
6320008|NCT00452114|7225263|FG001|COMPLETED|Overall Study||10
6320009|NCT00452114|7225262|FG000|NOT COMPLETED|Overall Study||3
6320010|NCT00452114|7225263|FG001|NOT COMPLETED|Overall Study||3
6320011|NCT00452335|7225272|FG000|STARTED|Overall Study||27
6320012|NCT00452335|7225273|FG001|STARTED|Overall Study||65
6320013|NCT00452335|7225274|FG002|STARTED|Overall Study||32
6320014|NCT00452335|7225272|FG000|COMPLETED|Overall Study||25
6320015|NCT00452335|7225273|FG001|COMPLETED|Overall Study||61
6320016|NCT00452335|7225274|FG002|COMPLETED|Overall Study||23
6320017|NCT00452335|7225272|FG000|NOT COMPLETED|Overall Study||2
6320018|NCT00452335|7225273|FG001|NOT COMPLETED|Overall Study||4
6320019|NCT00452335|7225274|FG002|NOT COMPLETED|Overall Study||9
6320020|NCT00452348|7225287|FG000|STARTED|Overall Study||310
6320021|NCT00452348|7225288|FG001|STARTED|Overall Study||318
6320022|NCT00452348|7225287|FG000|COMPLETED|Overall Study||231
6320023|NCT00452348|7225288|FG001|COMPLETED|Overall Study||234
6320024|NCT00452348|7225287|FG000|NOT COMPLETED|Overall Study||79
6320025|NCT00452348|7225288|FG001|NOT COMPLETED|Overall Study||84
6320026|NCT00452374|7225294|FG000|STARTED|Overall Study||48
6320027|NCT00452374|7225294|FG000|COMPLETED|Overall Study||48
6320028|NCT00452374|7225294|FG000|NOT COMPLETED|Overall Study||0
6320029|NCT00452387|7225298|FG000|STARTED|Overall Study||22
6320030|NCT00452387|7225298|FG000|COMPLETED|Overall Study||22
6320031|NCT00452387|7225298|FG000|NOT COMPLETED|Overall Study||0
6320032|NCT00452400|7225309|FG000|STARTED|Overall Study||79
6320033|NCT00452400|7225310|FG001|STARTED|Overall Study||81
6320034|NCT00452400|7225311|FG002|STARTED|Overall Study||80
6320035|NCT00452400|7225312|FG003|STARTED|Overall Study||86
6320036|NCT00452400|7225313|FG004|STARTED|Overall Study||79
6320037|NCT00452400|7225309|FG000|COMPLETED|Overall Study||74
6320038|NCT00452400|7225310|FG001|COMPLETED|Overall Study||80
6320039|NCT00452400|7225311|FG002|COMPLETED|Overall Study||73
6320040|NCT00452400|7225312|FG003|COMPLETED|Overall Study||85
6320041|NCT00452400|7225313|FG004|COMPLETED|Overall Study||76
6320042|NCT00452400|7225309|FG000|NOT COMPLETED|Overall Study||5
6320043|NCT00452400|7225310|FG001|NOT COMPLETED|Overall Study||1
6320044|NCT00452400|7225311|FG002|NOT COMPLETED|Overall Study||7
6320045|NCT00452400|7225312|FG003|NOT COMPLETED|Overall Study||1
6320046|NCT00452400|7225313|FG004|NOT COMPLETED|Overall Study||3
6320047|NCT00452413|7225328|FG000|STARTED|Overall Study||4
6320048|NCT00452413|7225329|FG001|STARTED|Overall Study||12
6320049|NCT00452413|7225330|FG002|STARTED|Overall Study||49
6320050|NCT00452413|7225328|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
6320051|NCT00452413|7225329|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
6320052|NCT00452413|7225330|FG002|Received at Least 1 Dose of Study Drug|Overall Study||49
6320053|NCT00452413|7225328|FG000|COMPLETED|Overall Study||0
6320054|NCT00452413|7225329|FG001|COMPLETED|Overall Study||0
6320055|NCT00452413|7225330|FG002|COMPLETED|Overall Study||0
6320056|NCT00452413|7225328|FG000|NOT COMPLETED|Overall Study||4
6320057|NCT00452413|7225329|FG001|NOT COMPLETED|Overall Study||12
6320058|NCT00452413|7225330|FG002|NOT COMPLETED|Overall Study||49
6320059|NCT00452426|7225341|FG000|STARTED|Overall Study||496
6320060|NCT00452426|7225342|FG001|STARTED|Overall Study||504
6320061|NCT00452426|7225341|FG000|COMPLETED|Overall Study||489
6320062|NCT00452426|7225342|FG001|COMPLETED|Overall Study||493
6320063|NCT00452426|7225341|FG000|NOT COMPLETED|Overall Study||7
6320064|NCT00452426|7225342|FG001|NOT COMPLETED|Overall Study||11
6320065|NCT00452439|7225350|FG000|STARTED|Overall Study||36
6320066|NCT00452439|7225351|FG001|STARTED|Overall Study||36
6320067|NCT00452439|7225350|FG000|COMPLETED|Overall Study||22
6320068|NCT00452439|7225351|FG001|COMPLETED|Overall Study||29
6320069|NCT00452439|7225350|FG000|NOT COMPLETED|Overall Study||14
6320070|NCT00452439|7225351|FG001|NOT COMPLETED|Overall Study||7
6320071|NCT00452452|7225360|FG000|STARTED|Overall Study||90
6320072|NCT00452452|7225361|FG001|STARTED|Overall Study||112
6320073|NCT00452452|7225362|FG002|STARTED|Overall Study||153
6320074|NCT00452452|7225360|FG000|Vaccinated Dose 1|Overall Study||90
6320075|NCT00452452|7225361|FG001|Vaccinated Dose 1|Overall Study||112
6775151|NCT03883113|7703080|FG000|COMPLETED|Overall Study||71
6775152|NCT03883113|7703081|FG001|COMPLETED|Overall Study||46
6320076|NCT00452452|7225362|FG002|Vaccinated Dose 1|Overall Study||152
6320077|NCT00452452|7225360|FG000|Vaccinated Dose 2|Overall Study||90
6320078|NCT00452452|7225361|FG001|Vaccinated Dose 2|Overall Study||112
6320079|NCT00452452|7225362|FG002|Vaccinated Dose 2|Overall Study||0
6320080|NCT00452452|7225360|FG000|Vaccinated Dose 3|Overall Study||89
6320081|NCT00452452|7225361|FG001|Vaccinated Dose 3|Overall Study||0
6320082|NCT00452452|7225362|FG002|Vaccinated Dose 3|Overall Study||0
6320083|NCT00452452|7225360|FG000|COMPLETED|Overall Study||88
6320084|NCT00452452|7225361|FG001|COMPLETED|Overall Study||112
6320085|NCT00452452|7225362|FG002|COMPLETED|Overall Study||152
6320086|NCT00452452|7225360|FG000|NOT COMPLETED|Overall Study||2
6320087|NCT00452452|7225361|FG001|NOT COMPLETED|Overall Study||0
6320088|NCT00452452|7225362|FG002|NOT COMPLETED|Overall Study||1
6320089|NCT00452530|7225378|FG000|STARTED|Overall Study|Randomized|1528
6320090|NCT00452530|7225379|FG001|STARTED|Overall Study|Randomized|1529
6320091|NCT00452530|7225378|FG000|Received Treatment|Overall Study||1501
6320092|NCT00452530|7225379|FG001|Received Treatment|Overall Study||1508
6320093|NCT00452530|7225378|FG000|Evaluable Participants|Overall Study||907
6320094|NCT00452530|7225379|FG001|Evaluable Participants|Overall Study||921
6320095|NCT00452530|7225378|FG000|Primary Participants|Overall Study||976
6775153|NCT03883113|7703080|FG000|NOT COMPLETED|Overall Study||16
6775154|NCT03883113|7703081|FG001|NOT COMPLETED|Overall Study||12
6320096|NCT00452530|7225379|FG001|Primary Participants|Overall Study||997
6320097|NCT00452530|7225378|FG000|COMPLETED|Overall Study||1392
6320098|NCT00452530|7225379|FG001|COMPLETED|Overall Study||1393
6320099|NCT00452530|7225378|FG000|NOT COMPLETED|Overall Study||136
6320100|NCT00452530|7225379|FG001|NOT COMPLETED|Overall Study||136
6320101|NCT00452543|7225391|FG000|STARTED|Overall Study||12
6320102|NCT00452543|7225392|FG001|STARTED|Overall Study||11
6320103|NCT00452543|7225391|FG000|COMPLETED|Overall Study||7
6320104|NCT00452543|7225392|FG001|COMPLETED|Overall Study||5
6320105|NCT00452543|7225391|FG000|NOT COMPLETED|Overall Study||5
6320106|NCT00452543|7225392|FG001|NOT COMPLETED|Overall Study||6
6320107|NCT00452673|7225402|FG000|STARTED|Dose Escalation Period||7
6320108|NCT00452673|7225403|FG001|STARTED|Dose Escalation Period||9
6320109|NCT00452673|7225404|FG002|STARTED|Dose Escalation Period||6
6320110|NCT00452673|7225405|FG003|STARTED|Dose Escalation Period||9
6320111|NCT00452673|7225406|FG004|STARTED|Dose Escalation Period||0
6320112|NCT00452673|7225402|FG000|COMPLETED|Dose Escalation Period||0
6320113|NCT00452673|7225403|FG001|COMPLETED|Dose Escalation Period||0
6320114|NCT00452673|7225404|FG002|COMPLETED|Dose Escalation Period||0
6320115|NCT00452673|7225405|FG003|COMPLETED|Dose Escalation Period||0
6320116|NCT00452673|7225406|FG004|COMPLETED|Dose Escalation Period||0
6320117|NCT00452673|7225402|FG000|NOT COMPLETED|Dose Escalation Period||7
6320118|NCT00452673|7225403|FG001|NOT COMPLETED|Dose Escalation Period||9
6320119|NCT00452673|7225404|FG002|NOT COMPLETED|Dose Escalation Period||6
6320120|NCT00452673|7225405|FG003|NOT COMPLETED|Dose Escalation Period||9
6320121|NCT00452673|7225406|FG004|NOT COMPLETED|Dose Escalation Period||0
6320122|NCT00452673|7225402|FG000|STARTED|Dose Expansion Period||0
6320123|NCT00452673|7225403|FG001|STARTED|Dose Expansion Period||0
6320124|NCT00452673|7225404|FG002|STARTED|Dose Expansion Period||0
6320125|NCT00452673|7225405|FG003|STARTED|Dose Expansion Period||0
6320126|NCT00452673|7225406|FG004|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
6320127|NCT00452673|7225402|FG000|COMPLETED|Dose Expansion Period||0
6320128|NCT00452673|7225403|FG001|COMPLETED|Dose Expansion Period||0
6320129|NCT00452673|7225404|FG002|COMPLETED|Dose Expansion Period||0
6320130|NCT00452673|7225405|FG003|COMPLETED|Dose Expansion Period||0
6320131|NCT00452673|7225406|FG004|COMPLETED|Dose Expansion Period||0
6320132|NCT00452673|7225402|FG000|NOT COMPLETED|Dose Expansion Period||0
6320133|NCT00452673|7225403|FG001|NOT COMPLETED|Dose Expansion Period||0
6320134|NCT00452673|7225404|FG002|NOT COMPLETED|Dose Expansion Period||0
6320135|NCT00452673|7225405|FG003|NOT COMPLETED|Dose Expansion Period||0
6320136|NCT00452673|7225406|FG004|NOT COMPLETED|Dose Expansion Period||21
6320137|NCT00452699|7225419|FG000|STARTED|Overall Study||306
6320138|NCT00452699|7225420|FG001|STARTED|Overall Study||315
6320139|NCT00452699|7225419|FG000|COMPLETED|Overall Study||225
6320140|NCT00452699|7225420|FG001|COMPLETED|Overall Study||242
6320141|NCT00452699|7225419|FG000|NOT COMPLETED|Overall Study||81
6320142|NCT00452699|7225420|FG001|NOT COMPLETED|Overall Study||73
6320143|NCT00452790|7225428|FG000|STARTED|Infant Series||354
6320144|NCT00452790|7225429|FG001|STARTED|Infant Series||355
6320145|NCT00452790|7225428|FG000|Vaccinated Dose 1|Infant Series||353
6320146|NCT00452790|7225429|FG001|Vaccinated Dose 1|Infant Series||353
6320147|NCT00452790|7225428|FG000|Vaccinated Dose 2|Infant Series||300
6320148|NCT00452790|7225429|FG001|Vaccinated Dose 2|Infant Series||300
6320149|NCT00452790|7225428|FG000|Vaccinated Dose 3|Infant Series||221
6320150|NCT00452790|7225429|FG001|Vaccinated Dose 3|Infant Series||218
6320151|NCT00452790|7225428|FG000|COMPLETED|Infant Series||219
6320152|NCT00452790|7225429|FG001|COMPLETED|Infant Series||214
6320153|NCT00452790|7225428|FG000|NOT COMPLETED|Infant Series||135
6320154|NCT00452790|7225429|FG001|NOT COMPLETED|Infant Series||141
6320155|NCT00452790|7225428|FG000|STARTED|After Infant Series||219
6320156|NCT00452790|7225429|FG001|STARTED|After Infant Series||214
6320157|NCT00452790|7225428|FG000|COMPLETED|After Infant Series||198
6320158|NCT00452790|7225429|FG001|COMPLETED|After Infant Series||200
6320159|NCT00452790|7225428|FG000|NOT COMPLETED|After Infant Series||21
6320160|NCT00452790|7225429|FG001|NOT COMPLETED|After Infant Series||14
6320161|NCT00452790|7225428|FG000|STARTED|Toddler Dose||198
6320162|NCT00452790|7225429|FG001|STARTED|Toddler Dose||200
6320163|NCT00452790|7225428|FG000|COMPLETED|Toddler Dose||198
6320164|NCT00452790|7225429|FG001|COMPLETED|Toddler Dose||198
6320165|NCT00452790|7225428|FG000|NOT COMPLETED|Toddler Dose||0
6320166|NCT00452790|7225429|FG001|NOT COMPLETED|Toddler Dose||2
6320167|NCT00452868|7225439|FG000|STARTED|Overall Study||13
6320168|NCT00452868|7225439|FG000|COMPLETED|Overall Study||11
6320169|NCT00452868|7225439|FG000|NOT COMPLETED|Overall Study||2
6320170|NCT00453102|7225443|FG000|STARTED|Overall Study||18
6320171|NCT00453102|7225443|FG000|COMPLETED|Overall Study||16
6320172|NCT00453102|7225443|FG000|NOT COMPLETED|Overall Study||2
6375512|NCT00756093|7286145|FG001|STARTED|Fourth Intervention||5
6375513|NCT00756093|7286146|FG002|STARTED|Fourth Intervention||5
6375514|NCT00756093|7286147|FG003|STARTED|Fourth Intervention||5
6375515|NCT00756093|7286144|FG000|COMPLETED|Fourth Intervention||5
6375516|NCT00756093|7286145|FG001|COMPLETED|Fourth Intervention||5
6375517|NCT00756093|7286146|FG002|COMPLETED|Fourth Intervention||5
6375518|NCT00756093|7286147|FG003|COMPLETED|Fourth Intervention||5
6375519|NCT00756093|7286144|FG000|NOT COMPLETED|Fourth Intervention||0
6375520|NCT00756093|7286145|FG001|NOT COMPLETED|Fourth Intervention||0
6375521|NCT00756093|7286146|FG002|NOT COMPLETED|Fourth Intervention||0
6375522|NCT00756093|7286147|FG003|NOT COMPLETED|Fourth Intervention||0
6375523|NCT00756106|7286157|FG000|STARTED|Overall Study||15
6375524|NCT00756106|7286157|FG000|COMPLETED|Overall Study||3
6375525|NCT00756106|7286157|FG000|NOT COMPLETED|Overall Study||12
6375526|NCT00756236|7286164|FG000|STARTED|Overall Study||20
6375527|NCT00756236|7286165|FG001|STARTED|Overall Study||20
6375528|NCT00756236|7286166|FG002|STARTED|Overall Study||20
6375529|NCT00756236|7286164|FG000|COMPLETED|Overall Study||20
6375530|NCT00756236|7286165|FG001|COMPLETED|Overall Study||20
6375531|NCT00756236|7286166|FG002|COMPLETED|Overall Study||20
6375532|NCT00756236|7286164|FG000|NOT COMPLETED|Overall Study||0
6375533|NCT00756236|7286165|FG001|NOT COMPLETED|Overall Study||0
6375534|NCT00756236|7286166|FG002|NOT COMPLETED|Overall Study||0
6375535|NCT00756275|7286176|FG000|STARTED|Overall Study||60
6375536|NCT00756275|7286177|FG001|STARTED|Overall Study||77
6375537|NCT00756275|7286176|FG000|COMPLETED|Overall Study||31
6375538|NCT00756275|7286177|FG001|COMPLETED|Overall Study||49
6375539|NCT00756275|7286176|FG000|NOT COMPLETED|Overall Study||29
6375540|NCT00756275|7286177|FG001|NOT COMPLETED|Overall Study||28
6375541|NCT00756314|7286185|FG000|STARTED|Overall Study||123
6375542|NCT00756314|7286186|FG001|STARTED|Overall Study||123
6375543|NCT00756314|7286185|FG000|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
6320173|NCT00453154|7225450|FG000|STARTED|Combination Chemotherapy||12
6320174|NCT00453154|7225451|FG001|STARTED|Combination Chemotherapy||144
6320175|NCT00453154|7225452|FG002|STARTED|Combination Chemotherapy||0
6320176|NCT00453154|7225453|FG003|STARTED|Combination Chemotherapy||0
6320177|NCT00453154|7225450|FG000|COMPLETED|Combination Chemotherapy||12
6320178|NCT00453154|7225451|FG001|COMPLETED|Combination Chemotherapy||95
6320179|NCT00453154|7225452|FG002|COMPLETED|Combination Chemotherapy||0
6320180|NCT00453154|7225453|FG003|COMPLETED|Combination Chemotherapy||0
6320181|NCT00453154|7225450|FG000|NOT COMPLETED|Combination Chemotherapy||0
6320182|NCT00453154|7225451|FG001|NOT COMPLETED|Combination Chemotherapy||49
6320183|NCT00453154|7225452|FG002|NOT COMPLETED|Combination Chemotherapy||0
6320184|NCT00453154|7225453|FG003|NOT COMPLETED|Combination Chemotherapy||0
6320185|NCT00453154|7225450|FG000|STARTED|Double BIind Maintenance||0
6320186|NCT00453154|7225451|FG001|STARTED|Double BIind Maintenance||0
6320187|NCT00453154|7225452|FG002|STARTED|Double BIind Maintenance||46
6320188|NCT00453154|7225453|FG003|STARTED|Double BIind Maintenance||49
6320189|NCT00453154|7225450|FG000|COMPLETED|Double BIind Maintenance||0
6320190|NCT00453154|7225451|FG001|COMPLETED|Double BIind Maintenance||0
6320191|NCT00453154|7225452|FG002|COMPLETED|Double BIind Maintenance||0
6320192|NCT00453154|7225453|FG003|COMPLETED|Double BIind Maintenance||0
6320193|NCT00453154|7225450|FG000|NOT COMPLETED|Double BIind Maintenance||0
6320194|NCT00453154|7225451|FG001|NOT COMPLETED|Double BIind Maintenance||0
6320195|NCT00453154|7225452|FG002|NOT COMPLETED|Double BIind Maintenance||46
6320196|NCT00453154|7225453|FG003|NOT COMPLETED|Double BIind Maintenance||49
6320197|NCT00453154|7225450|FG000|STARTED|Open Label Sunitinib Crossover||0
6320198|NCT00453154|7225451|FG001|STARTED|Open Label Sunitinib Crossover||0
6320199|NCT00453154|7225452|FG002|STARTED|Open Label Sunitinib Crossover||18
6320200|NCT00453154|7225453|FG003|STARTED|Open Label Sunitinib Crossover||0
6320201|NCT00453154|7225450|FG000|COMPLETED|Open Label Sunitinib Crossover||0
6320202|NCT00453154|7225451|FG001|COMPLETED|Open Label Sunitinib Crossover||0
6320203|NCT00453154|7225452|FG002|COMPLETED|Open Label Sunitinib Crossover||18
6320204|NCT00453154|7225453|FG003|COMPLETED|Open Label Sunitinib Crossover||0
6320205|NCT00453154|7225450|FG000|NOT COMPLETED|Open Label Sunitinib Crossover||0
6320206|NCT00453154|7225451|FG001|NOT COMPLETED|Open Label Sunitinib Crossover||0
6320207|NCT00453154|7225452|FG002|NOT COMPLETED|Open Label Sunitinib Crossover||0
6320208|NCT00453154|7225453|FG003|NOT COMPLETED|Open Label Sunitinib Crossover||0
6320209|NCT00453180|7225464|FG000|STARTED|Overall Study||16
6320210|NCT00453180|7225465|FG001|STARTED|Overall Study||15
6320211|NCT00453180|7225464|FG000|COMPLETED|Overall Study||13
6320212|NCT00453180|7225465|FG001|COMPLETED|Overall Study||12
6320213|NCT00453180|7225464|FG000|NOT COMPLETED|Overall Study||3
6320214|NCT00453180|7225465|FG001|NOT COMPLETED|Overall Study||3
6320215|NCT00453193|7225471|FG000|STARTED|Overall Study||24
6320216|NCT00453193|7225471|FG000|COMPLETED|Overall Study||24
6320217|NCT00453193|7225471|FG000|NOT COMPLETED|Overall Study||0
6320218|NCT00453206|7225475|FG000|STARTED|Overall Study||66
6320219|NCT00453206|7225475|FG000|COMPLETED|Overall Study||65
6320220|NCT00453206|7225475|FG000|NOT COMPLETED|Overall Study||1
6320221|NCT00453310|7225479|FG000|STARTED|Overall Study||10
6320222|NCT00453310|7225479|FG000|COMPLETED|Overall Study||0
6320223|NCT00453310|7225479|FG000|NOT COMPLETED|Overall Study||10
6320224|NCT00453336|7225483|FG000|STARTED|Overall Study||45
6320225|NCT00453336|7225483|FG000|COMPLETED|Overall Study||45
6320226|NCT00453336|7225483|FG000|NOT COMPLETED|Overall Study||0
6320227|NCT00453349|7225489|FG000|STARTED|Randomized||228
6320228|NCT00453349|7225490|FG001|STARTED|Randomized||232
6320229|NCT00453349|7225489|FG000|COMPLETED|Randomized||203
6320230|NCT00453349|7225490|FG001|COMPLETED|Randomized||209
6320231|NCT00453349|7225489|FG000|NOT COMPLETED|Randomized||25
6320232|NCT00453349|7225490|FG001|NOT COMPLETED|Randomized||23
6320233|NCT00453349|7225489|FG000|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
6320234|NCT00453349|7225490|FG001|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
6320235|NCT00453349|7225489|FG000|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
6320236|NCT00453349|7225490|FG001|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
6320237|NCT00453349|7225489|FG000|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
6320238|NCT00453349|7225490|FG001|COMPLETED|Reaching of Primary Endpoint (TOC)||219
6320239|NCT00453349|7225489|FG000|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
6320240|NCT00453349|7225490|FG001|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
6320241|NCT00453349|7225489|FG000|STARTED|Completed Study||228
6320242|NCT00453349|7225490|FG001|STARTED|Completed Study||232
6320243|NCT00453349|7225489|FG000|Completed Study Treatment|Completed Study|25 terminated prematurely|203
6320244|NCT00453349|7225490|FG001|Completed Study Treatment|Completed Study|23 terminated prematurely|209
6320245|NCT00453349|7225489|FG000|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
6320246|NCT00453349|7225490|FG001|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
6320247|NCT00453349|7225489|FG000|NOT COMPLETED|Completed Study||27
6320248|NCT00453349|7225490|FG001|NOT COMPLETED|Completed Study||34
6320249|NCT00453362|7225496|FG000|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
6320250|NCT00453362|7225496|FG000|Treated With Erlotinib|Overall Study||74
6320251|NCT00453362|7225496|FG000|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
6320252|NCT00453362|7225496|FG000|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
6320253|NCT00453362|7225496|FG000|COMPLETED|Overall Study||1
6320254|NCT00453362|7225496|FG000|NOT COMPLETED|Overall Study||87
6320255|NCT00453388|7225516|FG000|STARTED|Overall Study||0
6320256|NCT00453388|7225517|FG001|STARTED|Overall Study||5
6320257|NCT00453388|7225518|FG002|STARTED|Overall Study||1
6320258|NCT00453388|7225519|FG003|STARTED|Overall Study||0
6320259|NCT00453388|7225516|FG000|COMPLETED|Overall Study||0
6320260|NCT00453388|7225517|FG001|COMPLETED|Overall Study||5
6320261|NCT00453388|7225518|FG002|COMPLETED|Overall Study||1
6320262|NCT00453388|7225519|FG003|COMPLETED|Overall Study||0
6320263|NCT00453388|7225516|FG000|NOT COMPLETED|Overall Study||0
6320264|NCT00453388|7225517|FG001|NOT COMPLETED|Overall Study||0
6320265|NCT00453388|7225518|FG002|NOT COMPLETED|Overall Study||0
6320266|NCT00453388|7225519|FG003|NOT COMPLETED|Overall Study||0
6320267|NCT00453479|7225532|FG000|STARTED|Overall Study||6
6320268|NCT00453479|7225533|FG001|STARTED|Overall Study||9
6320269|NCT00453479|7225534|FG002|STARTED|Overall Study||8
6320270|NCT00453479|7225532|FG000|COMPLETED|Overall Study||6
6320271|NCT00453479|7225533|FG001|COMPLETED|Overall Study||9
6320272|NCT00453479|7225534|FG002|COMPLETED|Overall Study||8
6320273|NCT00453479|7225532|FG000|NOT COMPLETED|Overall Study||0
6320274|NCT00453479|7225533|FG001|NOT COMPLETED|Overall Study||0
6320275|NCT00453479|7225534|FG002|NOT COMPLETED|Overall Study||0
6320276|NCT00453895|7225544|FG000|STARTED|Overall Study||39
6320277|NCT00453895|7225544|FG000|COMPLETED|Overall Study||39
6320278|NCT00453895|7225544|FG000|NOT COMPLETED|Overall Study||0
6320279|NCT00453921|7225552|FG000|STARTED|Overall Study||19
6320280|NCT00453921|7225553|FG001|STARTED|Overall Study||18
6320281|NCT00453921|7225554|FG002|STARTED|Overall Study||20
6320282|NCT00453921|7225555|FG003|STARTED|Overall Study||19
6320283|NCT00453921|7225552|FG000|COMPLETED|Overall Study||18
6320284|NCT00453921|7225553|FG001|COMPLETED|Overall Study||17
6320285|NCT00453921|7225554|FG002|COMPLETED|Overall Study||18
6320286|NCT00453921|7225555|FG003|COMPLETED|Overall Study||18
6320287|NCT00453921|7225552|FG000|NOT COMPLETED|Overall Study||1
6320288|NCT00453921|7225553|FG001|NOT COMPLETED|Overall Study||1
6320289|NCT00453921|7225554|FG002|NOT COMPLETED|Overall Study||2
6320290|NCT00453921|7225555|FG003|NOT COMPLETED|Overall Study||1
6320291|NCT00453973|7225571|FG000|STARTED|Overall Study||51
6320292|NCT00453973|7225572|FG001|STARTED|Overall Study||63
6320293|NCT00453973|7225571|FG000|COMPLETED|Overall Study||0
6320294|NCT00453973|7225572|FG001|COMPLETED|Overall Study||15
6320295|NCT00453973|7225571|FG000|NOT COMPLETED|Overall Study||51
6320296|NCT00453973|7225572|FG001|NOT COMPLETED|Overall Study||48
6320297|NCT00453986|7225583|FG000|STARTED|Overall Study||311
6320298|NCT00453986|7225584|FG001|STARTED|Overall Study||311
6320299|NCT00453986|7225585|FG002|STARTED|Overall Study||313
6320300|NCT00453986|7225586|FG003|STARTED|Overall Study||312
6320301|NCT00453986|7225587|FG004|STARTED|Overall Study||105
6320302|NCT00453986|7225583|FG000|COMPLETED|Overall Study||305
6320303|NCT00453986|7225584|FG001|COMPLETED|Overall Study||306
6320304|NCT00453986|7225585|FG002|COMPLETED|Overall Study||307
6320305|NCT00453986|7225586|FG003|COMPLETED|Overall Study||310
6320306|NCT00453986|7225587|FG004|COMPLETED|Overall Study||105
6320307|NCT00453986|7225583|FG000|NOT COMPLETED|Overall Study||6
6320308|NCT00453986|7225584|FG001|NOT COMPLETED|Overall Study||5
6320309|NCT00453986|7225585|FG002|NOT COMPLETED|Overall Study||6
6320310|NCT00453986|7225586|FG003|NOT COMPLETED|Overall Study||2
6320311|NCT00453986|7225587|FG004|NOT COMPLETED|Overall Study||0
6320312|NCT00453999|7225606|FG000|STARTED|Overall Study||45
6320313|NCT00453999|7225607|FG001|STARTED|Overall Study||46
6320314|NCT00453999|7225608|FG002|STARTED|Overall Study||46
6320315|NCT00453999|7225606|FG000|COMPLETED|Overall Study||40
6320316|NCT00453999|7225607|FG001|COMPLETED|Overall Study||41
6320317|NCT00453999|7225608|FG002|COMPLETED|Overall Study||43
6320318|NCT00453999|7225606|FG000|NOT COMPLETED|Overall Study||5
6320319|NCT00453999|7225607|FG001|NOT COMPLETED|Overall Study||5
6320320|NCT00453999|7225608|FG002|NOT COMPLETED|Overall Study||3
6557984|NCT01772368|7480650|FG000|Received Advair Diskus 100/50 mcg|Overall Study||66
6557985|NCT01772368|7480650|FG000|COMPLETED|Overall Study||65
6557986|NCT01772368|7480650|FG000|NOT COMPLETED|Overall Study||7
6320321|NCT00454051|7225619|FG000|STARTED|Overall Study||20
6320322|NCT00454051|7225620|FG001|STARTED|Overall Study||11
6320323|NCT00454051|7225619|FG000|COMPLETED|Overall Study||17
6320324|NCT00454051|7225620|FG001|COMPLETED|Overall Study||8
6320325|NCT00454051|7225619|FG000|NOT COMPLETED|Overall Study||3
6320326|NCT00454051|7225620|FG001|NOT COMPLETED|Overall Study||3
6320327|NCT00454116|7225629|FG000|STARTED|Overall Study|randomised patients|35
6320328|NCT00454116|7225630|FG001|STARTED|Overall Study|randomised patients|36
6320329|NCT00454116|7225631|FG002|STARTED|Overall Study|randomised patients|35
6320330|NCT00454116|7225629|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
6320331|NCT00454116|7225630|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
6320332|NCT00454116|7225631|FG002|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
6320333|NCT00454116|7225629|FG000|NOT COMPLETED|Overall Study||27
6320334|NCT00454116|7225630|FG001|NOT COMPLETED|Overall Study||29
6320335|NCT00454116|7225631|FG002|NOT COMPLETED|Overall Study||28
6320336|NCT00454142|7225639|FG000|STARTED|Overall Study||33
6320337|NCT00454142|7225639|FG000|COMPLETED|Overall Study||32
6557987|NCT01772537|7480669|FG000|STARTED|Overall Study||5
6557988|NCT01772537|7480670|FG001|STARTED|Overall Study||3
6320338|NCT00454142|7225639|FG000|NOT COMPLETED|Overall Study||1
6320339|NCT00454181|7225647|FG000|STARTED|Overall Study||45
6320340|NCT00454181|7225648|FG001|STARTED|Overall Study||14
6320341|NCT00454181|7225647|FG000|COMPLETED|Overall Study||30
6320342|NCT00454181|7225648|FG001|COMPLETED|Overall Study||11
6320343|NCT00454181|7225647|FG000|NOT COMPLETED|Overall Study||15
6320344|NCT00454181|7225648|FG001|NOT COMPLETED|Overall Study||3
6320345|NCT00454194|7225656|FG000|STARTED|Overall Study||47
6320346|NCT00454194|7225657|FG001|STARTED|Overall Study||51
6320347|NCT00454194|7225656|FG000|COMPLETED|Overall Study||25
6320348|NCT00454194|7225657|FG001|COMPLETED|Overall Study||37
6320349|NCT00454194|7225656|FG000|NOT COMPLETED|Overall Study||22
6320350|NCT00454194|7225657|FG001|NOT COMPLETED|Overall Study||14
6320351|NCT00454207|7225665|FG000|STARTED|Overall Study||21
6320352|NCT00454207|7225666|FG001|STARTED|Overall Study||23
6320353|NCT00454207|7225665|FG000|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
6320354|NCT00454207|7225666|FG001|COMPLETED|Overall Study||21
6320355|NCT00454207|7225665|FG000|NOT COMPLETED|Overall Study||4
6320356|NCT00454207|7225666|FG001|NOT COMPLETED|Overall Study||2
6320357|NCT00454246|7225687|FG000|STARTED|Overall Study||73
6320358|NCT00454246|7225688|FG001|STARTED|Overall Study||29
6320359|NCT00454246|7225689|FG002|STARTED|Overall Study||9
6320360|NCT00454246|7225687|FG000|COMPLETED|Overall Study||0
6320361|NCT00454246|7225688|FG001|COMPLETED|Overall Study||0
6320362|NCT00454246|7225689|FG002|COMPLETED|Overall Study||0
6320363|NCT00454246|7225687|FG000|NOT COMPLETED|Overall Study||73
6320364|NCT00454246|7225688|FG001|NOT COMPLETED|Overall Study||29
6320365|NCT00454246|7225689|FG002|NOT COMPLETED|Overall Study||9
6320366|NCT00454324|7225699|FG000|STARTED|Overall Study||14
6320367|NCT00454324|7225700|FG001|STARTED|Overall Study||13
6320368|NCT00454324|7225699|FG000|COMPLETED|Overall Study||14
6320369|NCT00454324|7225700|FG001|COMPLETED|Overall Study||13
6320370|NCT00454324|7225699|FG000|NOT COMPLETED|Overall Study||0
6320371|NCT00454324|7225700|FG001|NOT COMPLETED|Overall Study||0
6320372|NCT00454363|7225708|FG000|STARTED|Overall Study||20
6320373|NCT00454363|7225709|FG001|STARTED|Overall Study||31
6320374|NCT00454363|7225708|FG000|COMPLETED|Overall Study||15
6320375|NCT00454363|7225709|FG001|COMPLETED|Overall Study||29
6320376|NCT00454363|7225708|FG000|NOT COMPLETED|Overall Study||5
6320377|NCT00454363|7225709|FG001|NOT COMPLETED|Overall Study||2
6320378|NCT00454532|7225718|FG000|STARTED|Overall Study||11
6320379|NCT00454532|7225719|FG001|STARTED|Overall Study||6
6320380|NCT00454532|7225720|FG002|STARTED|Overall Study||3
6320381|NCT00454532|7225721|FG003|STARTED|Overall Study||7
6320382|NCT00454532|7225718|FG000|COMPLETED|Overall Study||11
6320383|NCT00454532|7225719|FG001|COMPLETED|Overall Study||6
6320384|NCT00454532|7225720|FG002|COMPLETED|Overall Study||3
6320385|NCT00454532|7225721|FG003|COMPLETED|Overall Study||7
6320386|NCT00454532|7225718|FG000|NOT COMPLETED|Overall Study||0
6320387|NCT00454532|7225719|FG001|NOT COMPLETED|Overall Study||0
6320388|NCT00454532|7225720|FG002|NOT COMPLETED|Overall Study||0
6320389|NCT00454532|7225721|FG003|NOT COMPLETED|Overall Study||0
6320390|NCT00454584|7225734|FG000|STARTED|Controlled Period||347
6320391|NCT00454584|7225735|FG001|STARTED|Controlled Period||209
6320392|NCT00454584|7225736|FG002|STARTED|Controlled Period||347
6320393|NCT00454584|7225737|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6320394|NCT00454584|7225738|FG004|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6320395|NCT00454584|7225739|FG005|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
6320396|NCT00454584|7225734|FG000|COMPLETED|Controlled Period||336
6320397|NCT00454584|7225735|FG001|COMPLETED|Controlled Period||201
6320398|NCT00454584|7225736|FG002|COMPLETED|Controlled Period||342
6320399|NCT00454584|7225737|FG003|COMPLETED|Controlled Period||0
6320400|NCT00454584|7225738|FG004|COMPLETED|Controlled Period||0
6320401|NCT00454584|7225739|FG005|COMPLETED|Controlled Period||0
6320402|NCT00454584|7225734|FG000|NOT COMPLETED|Controlled Period||11
6320403|NCT00454584|7225735|FG001|NOT COMPLETED|Controlled Period||8
6320404|NCT00454584|7225736|FG002|NOT COMPLETED|Controlled Period||5
6320405|NCT00454584|7225737|FG003|NOT COMPLETED|Controlled Period||0
6320406|NCT00454584|7225738|FG004|NOT COMPLETED|Controlled Period||0
6320407|NCT00454584|7225739|FG005|NOT COMPLETED|Controlled Period||0
6320408|NCT00454584|7225734|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6320409|NCT00454584|7225735|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6320410|NCT00454584|7225736|FG002|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
6320411|NCT00454584|7225737|FG003|STARTED|After Controlled Period||336
6320412|NCT00454584|7225738|FG004|STARTED|After Controlled Period||201
6320413|NCT00454584|7225739|FG005|STARTED|After Controlled Period||342
6320414|NCT00454584|7225734|FG000|COMPLETED|After Controlled Period||0
6320415|NCT00454584|7225735|FG001|COMPLETED|After Controlled Period||0
6320416|NCT00454584|7225736|FG002|COMPLETED|After Controlled Period||0
6320417|NCT00454584|7225737|FG003|COMPLETED|After Controlled Period||310
6320418|NCT00454584|7225738|FG004|COMPLETED|After Controlled Period||189
6320419|NCT00454584|7225739|FG005|COMPLETED|After Controlled Period||310
6320420|NCT00454584|7225734|FG000|NOT COMPLETED|After Controlled Period||0
6320421|NCT00454584|7225735|FG001|NOT COMPLETED|After Controlled Period||0
6320422|NCT00454584|7225736|FG002|NOT COMPLETED|After Controlled Period||0
6320423|NCT00454584|7225737|FG003|NOT COMPLETED|After Controlled Period||26
6320424|NCT00454584|7225738|FG004|NOT COMPLETED|After Controlled Period||12
6320425|NCT00454584|7225739|FG005|NOT COMPLETED|After Controlled Period||32
6320426|NCT00454636|7225757|FG000|STARTED|Overall Study||41
6320427|NCT00454636|7225758|FG001|STARTED|Overall Study||32
6320428|NCT00454636|7225759|FG002|STARTED|Overall Study||27
6320429|NCT00454636|7225760|FG003|STARTED|Overall Study||58
6320430|NCT00454636|7225757|FG000|COMPLETED|Overall Study||10
6320431|NCT00454636|7225758|FG001|COMPLETED|Overall Study||9
6320432|NCT00454636|7225759|FG002|COMPLETED|Overall Study||7
6320433|NCT00454636|7225760|FG003|COMPLETED|Overall Study||26
6320434|NCT00454636|7225757|FG000|NOT COMPLETED|Overall Study||31
6320435|NCT00454636|7225758|FG001|NOT COMPLETED|Overall Study||23
6320436|NCT00454636|7225759|FG002|NOT COMPLETED|Overall Study||20
6320437|NCT00454636|7225760|FG003|NOT COMPLETED|Overall Study||32
6320438|NCT00454649|7225780|FG000|STARTED|Overall Study||3
6320439|NCT00454649|7225781|FG001|STARTED|Overall Study||5
6320440|NCT00454649|7225782|FG002|STARTED|Overall Study||20
6320441|NCT00454649|7225783|FG003|STARTED|Overall Study||7
6320442|NCT00454649|7225784|FG004|STARTED|Overall Study||1
6320443|NCT00454649|7225785|FG005|STARTED|Overall Study||7
6320444|NCT00454649|7225786|FG006|STARTED|Overall Study||9
6320445|NCT00454649|7225787|FG007|STARTED|Overall Study||19
6320446|NCT00454649|7225788|FG008|STARTED|Overall Study||21
6320447|NCT00454649|7225789|FG009|STARTED|Overall Study||6
6320448|NCT00454649|7225780|FG000|COMPLETED|Overall Study||0
6320449|NCT00454649|7225781|FG001|COMPLETED|Overall Study||1
6320450|NCT00454649|7225782|FG002|COMPLETED|Overall Study||1
6320451|NCT00454649|7225783|FG003|COMPLETED|Overall Study||1
6320452|NCT00454649|7225784|FG004|COMPLETED|Overall Study||0
6320453|NCT00454649|7225785|FG005|COMPLETED|Overall Study||0
6320454|NCT00454649|7225786|FG006|COMPLETED|Overall Study||0
6320455|NCT00454649|7225787|FG007|COMPLETED|Overall Study||0
6320456|NCT00454649|7225788|FG008|COMPLETED|Overall Study||1
6320457|NCT00454649|7225789|FG009|COMPLETED|Overall Study||1
6320458|NCT00454649|7225780|FG000|NOT COMPLETED|Overall Study||3
6320459|NCT00454649|7225781|FG001|NOT COMPLETED|Overall Study||4
6320460|NCT00454649|7225782|FG002|NOT COMPLETED|Overall Study||19
6320461|NCT00454649|7225783|FG003|NOT COMPLETED|Overall Study||6
6320462|NCT00454649|7225784|FG004|NOT COMPLETED|Overall Study||1
6320463|NCT00454649|7225785|FG005|NOT COMPLETED|Overall Study||7
6320464|NCT00454649|7225786|FG006|NOT COMPLETED|Overall Study||9
6320465|NCT00454649|7225787|FG007|NOT COMPLETED|Overall Study||19
6320466|NCT00454649|7225788|FG008|NOT COMPLETED|Overall Study||20
6320467|NCT00454649|7225789|FG009|NOT COMPLETED|Overall Study||5
6320468|NCT00454779|7225832|FG000|STARTED|First-line Treatment Phase||56
6320469|NCT00454779|7225833|FG001|STARTED|First-line Treatment Phase||57
6320470|NCT00454779|7225832|FG000|Received Study Medication|First-line Treatment Phase||56
6320471|NCT00454779|7225833|FG001|Received Study Medication|First-line Treatment Phase||55
6320472|NCT00454779|7225832|FG000|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
6320473|NCT00454779|7225833|FG001|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
6320474|NCT00454779|7225832|FG000|NOT COMPLETED|First-line Treatment Phase||5
6320475|NCT00454779|7225833|FG001|NOT COMPLETED|First-line Treatment Phase||8
6320476|NCT00454779|7225832|FG000|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
6320477|NCT00454779|7225833|FG001|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
6320478|NCT00454779|7225832|FG000|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
6320479|NCT00454779|7225833|FG001|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
6320480|NCT00454779|7225832|FG000|NOT COMPLETED|Second-line Treatment Phase||0
6320481|NCT00454779|7225833|FG001|NOT COMPLETED|Second-line Treatment Phase||3
6320482|NCT00454805|7225841|FG000|STARTED|Overall Study|Randomised|31
6320483|NCT00454805|7225842|FG001|STARTED|Overall Study|Randomised|31
6320484|NCT00454805|7225841|FG000|COMPLETED|Overall Study|Ongoing at data cut-off|5
6320485|NCT00454805|7225842|FG001|COMPLETED|Overall Study|Ongoing at data cut-off|8
6320486|NCT00454805|7225841|FG000|NOT COMPLETED|Overall Study||26
6320487|NCT00454805|7225842|FG001|NOT COMPLETED|Overall Study||23
6320488|NCT00454818|7225856|FG000|STARTED|Phase I: Open-label Dose-escalation||3
6320489|NCT00454818|7225857|FG001|STARTED|Phase I: Open-label Dose-escalation||3
6320490|NCT00454818|7225858|FG002|STARTED|Phase I: Open-label Dose-escalation||3
6320491|NCT00454818|7225859|FG003|STARTED|Phase I: Open-label Dose-escalation||3
6320492|NCT00454818|7225860|FG004|STARTED|Phase I: Open-label Dose-escalation||0
6320493|NCT00454818|7225856|FG000|COMPLETED|Phase I: Open-label Dose-escalation||2
6320494|NCT00454818|7225857|FG001|COMPLETED|Phase I: Open-label Dose-escalation||2
6320495|NCT00454818|7225858|FG002|COMPLETED|Phase I: Open-label Dose-escalation||2
6320496|NCT00454818|7225859|FG003|COMPLETED|Phase I: Open-label Dose-escalation||2
6320497|NCT00454818|7225860|FG004|COMPLETED|Phase I: Open-label Dose-escalation||0
6320498|NCT00454818|7225856|FG000|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
6320499|NCT00454818|7225857|FG001|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
6320500|NCT00454818|7225858|FG002|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
6320501|NCT00454818|7225859|FG003|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
6320502|NCT00454818|7225860|FG004|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
6320503|NCT00454818|7225856|FG000|STARTED|Phase 2: Randomized Double-blind||0
6320504|NCT00454818|7225857|FG001|STARTED|Phase 2: Randomized Double-blind||8
6320505|NCT00454818|7225858|FG002|STARTED|Phase 2: Randomized Double-blind||8
6320506|NCT00454818|7225859|FG003|STARTED|Phase 2: Randomized Double-blind||9
6320507|NCT00454818|7225860|FG004|STARTED|Phase 2: Randomized Double-blind||14
6320508|NCT00454818|7225856|FG000|COMPLETED|Phase 2: Randomized Double-blind||0
6320509|NCT00454818|7225857|FG001|COMPLETED|Phase 2: Randomized Double-blind||6
6320510|NCT00454818|7225858|FG002|COMPLETED|Phase 2: Randomized Double-blind||5
6320511|NCT00454818|7225859|FG003|COMPLETED|Phase 2: Randomized Double-blind||8
6320512|NCT00454818|7225860|FG004|COMPLETED|Phase 2: Randomized Double-blind||10
6320513|NCT00454818|7225856|FG000|NOT COMPLETED|Phase 2: Randomized Double-blind||0
6320514|NCT00454818|7225857|FG001|NOT COMPLETED|Phase 2: Randomized Double-blind||2
6320515|NCT00454818|7225858|FG002|NOT COMPLETED|Phase 2: Randomized Double-blind||3
6320516|NCT00454818|7225859|FG003|NOT COMPLETED|Phase 2: Randomized Double-blind||1
6320517|NCT00454818|7225860|FG004|NOT COMPLETED|Phase 2: Randomized Double-blind||4
6320518|NCT00454857|7225877|FG000|STARTED|Overall Study||326
6320519|NCT00454857|7225877|FG000|Completed Retrospective Chart Review|Overall Study||324
6320520|NCT00454857|7225877|FG000|Completed ≥1 Observational Study Visit|Overall Study||319
6320521|NCT00454857|7225877|FG000|COMPLETED|Overall Study||272
6320522|NCT00454857|7225877|FG000|NOT COMPLETED|Overall Study||54
6320523|NCT00454909|7225884|FG000|STARTED|Overall Study||587
6320524|NCT00454909|7225885|FG001|STARTED|Overall Study||197
6320525|NCT00454909|7225886|FG002|STARTED|Overall Study||88
6320526|NCT00454909|7225884|FG000|COMPLETED|Overall Study||580
6320527|NCT00454909|7225885|FG001|COMPLETED|Overall Study||194
6320528|NCT00454909|7225886|FG002|COMPLETED|Overall Study||86
6320529|NCT00454909|7225884|FG000|NOT COMPLETED|Overall Study||7
6320530|NCT00454909|7225885|FG001|NOT COMPLETED|Overall Study||3
6320531|NCT00454909|7225886|FG002|NOT COMPLETED|Overall Study||2
6320532|NCT00454987|7225898|FG000|STARTED|Booster Period (NCT00258700)||359
6557989|NCT01772537|7480671|FG002|STARTED|Overall Study||6
6557990|NCT01772537|7480669|FG000|COMPLETED|Overall Study||4
6557991|NCT01772537|7480670|FG001|COMPLETED|Overall Study||3
6320533|NCT00454987|7225899|FG001|STARTED|Booster Period (NCT00258700)||117
6320534|NCT00454987|7225900|FG002|STARTED|Booster Period (NCT00258700)||0
6320535|NCT00454987|7225898|FG000|COMPLETED|Booster Period (NCT00258700)||357
6320536|NCT00454987|7225899|FG001|COMPLETED|Booster Period (NCT00258700)||116
6320537|NCT00454987|7225900|FG002|COMPLETED|Booster Period (NCT00258700)||0
6320538|NCT00454987|7225898|FG000|NOT COMPLETED|Booster Period (NCT00258700)||2
6320539|NCT00454987|7225899|FG001|NOT COMPLETED|Booster Period (NCT00258700)||1
6320540|NCT00454987|7225900|FG002|NOT COMPLETED|Booster Period (NCT00258700)||0
6320541|NCT00454987|7225898|FG000|STARTED|Year 1 (NCT00454987)||221
6320542|NCT00454987|7225899|FG001|STARTED|Year 1 (NCT00454987)||67
6320543|NCT00454987|7225900|FG002|STARTED|Year 1 (NCT00454987)||0
6320544|NCT00454987|7225898|FG000|COMPLETED|Year 1 (NCT00454987)||221
6320545|NCT00454987|7225899|FG001|COMPLETED|Year 1 (NCT00454987)||67
6320546|NCT00454987|7225900|FG002|COMPLETED|Year 1 (NCT00454987)||0
6320547|NCT00454987|7225898|FG000|NOT COMPLETED|Year 1 (NCT00454987)||0
6320548|NCT00454987|7225899|FG001|NOT COMPLETED|Year 1 (NCT00454987)||0
6320549|NCT00454987|7225900|FG002|NOT COMPLETED|Year 1 (NCT00454987)||0
6320550|NCT00454987|7225898|FG000|STARTED|Year 2 (NCT00454987)||235
6320551|NCT00454987|7225899|FG001|STARTED|Year 2 (NCT00454987)||77
6320552|NCT00454987|7225900|FG002|STARTED|Year 2 (NCT00454987)||74
6320553|NCT00454987|7225898|FG000|COMPLETED|Year 2 (NCT00454987)||235
6320554|NCT00454987|7225899|FG001|COMPLETED|Year 2 (NCT00454987)||77
6320555|NCT00454987|7225900|FG002|COMPLETED|Year 2 (NCT00454987)||74
6320556|NCT00454987|7225898|FG000|NOT COMPLETED|Year 2 (NCT00454987)||0
6320557|NCT00454987|7225899|FG001|NOT COMPLETED|Year 2 (NCT00454987)||0
6320558|NCT00454987|7225900|FG002|NOT COMPLETED|Year 2 (NCT00454987)||0
6320559|NCT00454987|7225898|FG000|STARTED|Year 4 (NCT00454987)||206
6320560|NCT00454987|7225899|FG001|STARTED|Year 4 (NCT00454987)||62
6320561|NCT00454987|7225900|FG002|STARTED|Year 4 (NCT00454987)||0
6320562|NCT00454987|7225898|FG000|COMPLETED|Year 4 (NCT00454987)||206
6320563|NCT00454987|7225899|FG001|COMPLETED|Year 4 (NCT00454987)||62
6320564|NCT00454987|7225900|FG002|COMPLETED|Year 4 (NCT00454987)||0
6320565|NCT00454987|7225898|FG000|NOT COMPLETED|Year 4 (NCT00454987)||0
6320566|NCT00454987|7225899|FG001|NOT COMPLETED|Year 4 (NCT00454987)||0
6320567|NCT00454987|7225900|FG002|NOT COMPLETED|Year 4 (NCT00454987)||0
6320568|NCT00455013|7225912|FG000|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
6320569|NCT00455013|7225913|FG001|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
6320570|NCT00455013|7225914|FG002|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
6320571|NCT00455013|7225912|FG000|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
6320572|NCT00455013|7225913|FG001|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
6320573|NCT00455013|7225914|FG002|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
6320574|NCT00455013|7225912|FG000|NOT COMPLETED|Short Term Period||6
6320575|NCT00455013|7225913|FG001|NOT COMPLETED|Short Term Period||5
6320576|NCT00455013|7225914|FG002|NOT COMPLETED|Short Term Period||2
6320577|NCT00455013|7225912|FG000|STARTED|Long Term Extension (LTE)||27
6377844|NCT00765388|7288507|FG000|COMPLETED|Period 1||15
6557992|NCT01772537|7480671|FG002|COMPLETED|Overall Study||6
6557993|NCT01772537|7480669|FG000|NOT COMPLETED|Overall Study||1
6320578|NCT00455013|7225913|FG001|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
6320579|NCT00455013|7225914|FG002|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
6320580|NCT00455013|7225912|FG000|COMPLETED|Long Term Extension (LTE)||25
6320581|NCT00455013|7225913|FG001|COMPLETED|Long Term Extension (LTE)||16
6320582|NCT00455013|7225914|FG002|COMPLETED|Long Term Extension (LTE)||20
6320583|NCT00455013|7225912|FG000|NOT COMPLETED|Long Term Extension (LTE)||2
6320584|NCT00455013|7225913|FG001|NOT COMPLETED|Long Term Extension (LTE)||3
6320585|NCT00455013|7225914|FG002|NOT COMPLETED|Long Term Extension (LTE)||7
6320586|NCT00455195|7225924|FG000|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
6320587|NCT00455195|7225925|FG001|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
6320588|NCT00455195|7225924|FG000|COMPLETED|Double-blind Study AGLU02704||55
6320589|NCT00455195|7225925|FG001|COMPLETED|Double-blind Study AGLU02704||26
6320590|NCT00455195|7225924|FG000|NOT COMPLETED|Double-blind Study AGLU02704||5
6320591|NCT00455195|7225925|FG001|NOT COMPLETED|Double-blind Study AGLU02704||4
6320592|NCT00455195|7225924|FG000|STARTED|Extension Study AGLU03206||55
6320593|NCT00455195|7225925|FG001|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
6320594|NCT00455195|7225924|FG000|COMPLETED|Extension Study AGLU03206||55
6320595|NCT00455195|7225925|FG001|COMPLETED|Extension Study AGLU03206||26
6320596|NCT00455195|7225924|FG000|NOT COMPLETED|Extension Study AGLU03206||0
6320597|NCT00455195|7225925|FG001|NOT COMPLETED|Extension Study AGLU03206||0
6320598|NCT00455312|7225933|FG000|STARTED|Overall Study||15
6320599|NCT00455312|7225934|FG001|STARTED|Overall Study||21
6320600|NCT00455312|7225933|FG000|COMPLETED|Overall Study||15
6320601|NCT00455312|7225934|FG001|COMPLETED|Overall Study||20
6320602|NCT00455312|7225933|FG000|NOT COMPLETED|Overall Study||0
6320603|NCT00455312|7225934|FG001|NOT COMPLETED|Overall Study||1
6320604|NCT00455429|7225944|FG000|STARTED|Overall Study||18
6320605|NCT00455429|7225945|FG001|STARTED|Overall Study||15
6320606|NCT00455429|7225946|FG002|STARTED|Overall Study||17
6320607|NCT00455429|7225947|FG003|STARTED|Overall Study||34
6320608|NCT00455429|7225944|FG000|Treated|Overall Study||18
6320609|NCT00455429|7225945|FG001|Treated|Overall Study||15
6320610|NCT00455429|7225946|FG002|Treated|Overall Study||17
6320611|NCT00455429|7225947|FG003|Treated|Overall Study||32
6320612|NCT00455429|7225944|FG000|COMPLETED|Overall Study||16
6320613|NCT00455429|7225945|FG001|COMPLETED|Overall Study||10
6320614|NCT00455429|7225946|FG002|COMPLETED|Overall Study||16
6320615|NCT00455429|7225947|FG003|COMPLETED|Overall Study||20
6320616|NCT00455429|7225944|FG000|NOT COMPLETED|Overall Study||2
6320617|NCT00455429|7225945|FG001|NOT COMPLETED|Overall Study||5
6320618|NCT00455429|7225946|FG002|NOT COMPLETED|Overall Study||1
6320619|NCT00455429|7225947|FG003|NOT COMPLETED|Overall Study||14
6320620|NCT00455455|7225960|FG000|STARTED|Washout||25
6320621|NCT00455455|7225961|FG001|STARTED|Washout||25
6320622|NCT00455455|7225960|FG000|COMPLETED|Washout||25
6320623|NCT00455455|7225961|FG001|COMPLETED|Washout||24
6320624|NCT00455455|7225960|FG000|NOT COMPLETED|Washout||0
6320625|NCT00455455|7225961|FG001|NOT COMPLETED|Washout||1
6320626|NCT00455455|7225960|FG000|STARTED|First Intervention||25
6320627|NCT00455455|7225961|FG001|STARTED|First Intervention||24
6320628|NCT00455455|7225960|FG000|COMPLETED|First Intervention||25
6320629|NCT00455455|7225961|FG001|COMPLETED|First Intervention||24
6320630|NCT00455455|7225960|FG000|NOT COMPLETED|First Intervention||0
6320631|NCT00455455|7225961|FG001|NOT COMPLETED|First Intervention||0
6320632|NCT00455455|7225960|FG000|STARTED|Washout||25
6320633|NCT00455455|7225961|FG001|STARTED|Washout||24
6320634|NCT00455455|7225960|FG000|COMPLETED|Washout||24
6320635|NCT00455455|7225961|FG001|COMPLETED|Washout||24
6320636|NCT00455455|7225960|FG000|NOT COMPLETED|Washout||1
6320637|NCT00455455|7225961|FG001|NOT COMPLETED|Washout||0
6320638|NCT00455455|7225960|FG000|STARTED|Second Intervention||24
6320639|NCT00455455|7225961|FG001|STARTED|Second Intervention||24
6320640|NCT00455455|7225960|FG000|COMPLETED|Second Intervention||24
6320641|NCT00455455|7225961|FG001|COMPLETED|Second Intervention||24
6320642|NCT00455455|7225960|FG000|NOT COMPLETED|Second Intervention||0
6320643|NCT00455455|7225961|FG001|NOT COMPLETED|Second Intervention||0
6320644|NCT00455520|7225972|FG000|STARTED|Open Label Tapentadol Extended Release||591
6320645|NCT00455520|7225973|FG001|STARTED|Open Label Tapentadol Extended Release||0
6320646|NCT00455520|7225972|FG000|COMPLETED|Open Label Tapentadol Extended Release||395
6320647|NCT00455520|7225973|FG001|COMPLETED|Open Label Tapentadol Extended Release||0
6320648|NCT00455520|7225972|FG000|NOT COMPLETED|Open Label Tapentadol Extended Release||196
6320649|NCT00455520|7225973|FG001|NOT COMPLETED|Open Label Tapentadol Extended Release||0
6320650|NCT00455520|7225972|FG000|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
6320651|NCT00455520|7225973|FG001|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
6320652|NCT00455520|7225972|FG000|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
6320653|NCT00455520|7225973|FG001|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
6320654|NCT00455520|7225972|FG000|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
6320655|NCT00455520|7225973|FG001|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
6320656|NCT00455533|7225981|FG000|STARTED|Period One: Initial Chemotherapy||313
6320657|NCT00455533|7225982|FG001|STARTED|Period One: Initial Chemotherapy||0
6320658|NCT00455533|7225983|FG002|STARTED|Period One: Initial Chemotherapy||0
6320659|NCT00455533|7225981|FG000|COMPLETED|Period One: Initial Chemotherapy||295
6320660|NCT00455533|7225982|FG001|COMPLETED|Period One: Initial Chemotherapy||0
6320661|NCT00455533|7225983|FG002|COMPLETED|Period One: Initial Chemotherapy||0
6320662|NCT00455533|7225981|FG000|NOT COMPLETED|Period One: Initial Chemotherapy||18
6320663|NCT00455533|7225982|FG001|NOT COMPLETED|Period One: Initial Chemotherapy||0
6557994|NCT01772537|7480670|FG001|NOT COMPLETED|Overall Study||0
6557995|NCT01772537|7480671|FG002|NOT COMPLETED|Overall Study||0
6557996|NCT01772550|7480684|FG000|STARTED|Overall Study||102
6557997|NCT01772550|7480685|FG001|STARTED|Overall Study||103
6557998|NCT01772550|7480686|FG002|STARTED|Overall Study||33
6557999|NCT01772550|7480684|FG000|CT Pancreas|Overall Study||40
6320664|NCT00455533|7225983|FG002|NOT COMPLETED|Period One: Initial Chemotherapy||0
6320665|NCT00455533|7225981|FG000|STARTED|Period Two: Randomized Period||0
6320666|NCT00455533|7225982|FG001|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
6320667|NCT00455533|7225983|FG002|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
6320668|NCT00455533|7225981|FG000|COMPLETED|Period Two: Randomized Period||0
6320669|NCT00455533|7225982|FG001|COMPLETED|Period Two: Randomized Period||139
6320670|NCT00455533|7225983|FG002|COMPLETED|Period Two: Randomized Period||138
6320671|NCT00455533|7225981|FG000|NOT COMPLETED|Period Two: Randomized Period||0
6320672|NCT00455533|7225982|FG001|NOT COMPLETED|Period Two: Randomized Period||6
6320673|NCT00455533|7225983|FG002|NOT COMPLETED|Period Two: Randomized Period||6
6320674|NCT00455650|7225993|FG000|STARTED|Week 1||10
6320675|NCT00455650|7225994|FG001|STARTED|Week 1||10
6320676|NCT00455650|7225995|FG002|STARTED|Week 1||10
6320677|NCT00455650|7225996|FG003|STARTED|Week 1||14
6320678|NCT00455650|7225997|FG004|STARTED|Week 1||14
6320679|NCT00455650|7225998|FG005|STARTED|Week 1||13
6320680|NCT00455650|7225993|FG000|COMPLETED|Week 1||10
6320681|NCT00455650|7225994|FG001|COMPLETED|Week 1||10
6320682|NCT00455650|7225995|FG002|COMPLETED|Week 1||10
6320683|NCT00455650|7225996|FG003|COMPLETED|Week 1||14
6320684|NCT00455650|7225997|FG004|COMPLETED|Week 1||14
6320685|NCT00455650|7225998|FG005|COMPLETED|Week 1||13
6320686|NCT00455650|7225993|FG000|NOT COMPLETED|Week 1||0
6320687|NCT00455650|7225994|FG001|NOT COMPLETED|Week 1||0
6320688|NCT00455650|7225995|FG002|NOT COMPLETED|Week 1||0
6320689|NCT00455650|7225996|FG003|NOT COMPLETED|Week 1||0
6320690|NCT00455650|7225997|FG004|NOT COMPLETED|Week 1||0
6320691|NCT00455650|7225998|FG005|NOT COMPLETED|Week 1||0
6320692|NCT00455650|7225993|FG000|STARTED|Week 2||10
6320693|NCT00455650|7225994|FG001|STARTED|Week 2||10
6320694|NCT00455650|7225995|FG002|STARTED|Week 2||10
6320695|NCT00455650|7225996|FG003|STARTED|Week 2||14
6320696|NCT00455650|7225997|FG004|STARTED|Week 2||14
6320697|NCT00455650|7225998|FG005|STARTED|Week 2||13
6320698|NCT00455650|7225993|FG000|COMPLETED|Week 2||10
6320699|NCT00455650|7225994|FG001|COMPLETED|Week 2||10
6320700|NCT00455650|7225995|FG002|COMPLETED|Week 2||10
6320701|NCT00455650|7225996|FG003|COMPLETED|Week 2||14
6320702|NCT00455650|7225997|FG004|COMPLETED|Week 2||14
6320703|NCT00455650|7225998|FG005|COMPLETED|Week 2||13
6320704|NCT00455650|7225993|FG000|NOT COMPLETED|Week 2||0
6320705|NCT00455650|7225994|FG001|NOT COMPLETED|Week 2||0
6320706|NCT00455650|7225995|FG002|NOT COMPLETED|Week 2||0
6320707|NCT00455650|7225996|FG003|NOT COMPLETED|Week 2||0
6320708|NCT00455650|7225997|FG004|NOT COMPLETED|Week 2||0
6320709|NCT00455650|7225998|FG005|NOT COMPLETED|Week 2||0
6320710|NCT00455650|7225993|FG000|STARTED|Week 3||10
6320711|NCT00455650|7225994|FG001|STARTED|Week 3||10
6320712|NCT00455650|7225995|FG002|STARTED|Week 3||10
6320713|NCT00455650|7225996|FG003|STARTED|Week 3||14
6320714|NCT00455650|7225997|FG004|STARTED|Week 3||14
6320715|NCT00455650|7225998|FG005|STARTED|Week 3||13
6320716|NCT00455650|7225993|FG000|COMPLETED|Week 3||10
6320717|NCT00455650|7225994|FG001|COMPLETED|Week 3||10
6320718|NCT00455650|7225995|FG002|COMPLETED|Week 3||10
6320719|NCT00455650|7225996|FG003|COMPLETED|Week 3||14
6320720|NCT00455650|7225997|FG004|COMPLETED|Week 3||14
6320721|NCT00455650|7225998|FG005|COMPLETED|Week 3||13
6320722|NCT00455650|7225993|FG000|NOT COMPLETED|Week 3||0
6320723|NCT00455650|7225994|FG001|NOT COMPLETED|Week 3||0
6320724|NCT00455650|7225995|FG002|NOT COMPLETED|Week 3||0
6320725|NCT00455650|7225996|FG003|NOT COMPLETED|Week 3||0
6320726|NCT00455650|7225997|FG004|NOT COMPLETED|Week 3||0
6320727|NCT00455650|7225998|FG005|NOT COMPLETED|Week 3||0
6320728|NCT00455663|7226011|FG000|STARTED|Overall Study||37
6320729|NCT00455663|7226012|FG001|STARTED|Overall Study||36
6320730|NCT00455663|7226013|FG002|STARTED|Overall Study||32
6320731|NCT00455663|7226011|FG000|COMPLETED|Overall Study||34
6320732|NCT00455663|7226012|FG001|COMPLETED|Overall Study||32
6320733|NCT00455663|7226013|FG002|COMPLETED|Overall Study||29
6320734|NCT00455663|7226011|FG000|NOT COMPLETED|Overall Study||3
6320735|NCT00455663|7226012|FG001|NOT COMPLETED|Overall Study||4
6320736|NCT00455663|7226013|FG002|NOT COMPLETED|Overall Study||3
6320737|NCT00455689|7226027|FG000|STARTED|Overall Study||14
6320738|NCT00455689|7226028|FG001|STARTED|Overall Study||6
6320739|NCT00455689|7226027|FG000|COMPLETED|Overall Study||14
6320740|NCT00455689|7226028|FG001|COMPLETED|Overall Study||6
6320741|NCT00455689|7226027|FG000|NOT COMPLETED|Overall Study||0
6320742|NCT00455689|7226028|FG001|NOT COMPLETED|Overall Study||0
6320743|NCT00455702|7226035|FG000|STARTED|Overall Study||19
6320744|NCT00455702|7226036|FG001|STARTED|Overall Study||19
6558000|NCT01772550|7480685|FG001|CT Pancreas|Overall Study||36
6558001|NCT01772550|7480686|FG002|CT Pancreas|Overall Study||8
6320745|NCT00455702|7226035|FG000|COMPLETED|Overall Study||16
6320746|NCT00455702|7226036|FG001|COMPLETED|Overall Study||16
6320747|NCT00455702|7226035|FG000|NOT COMPLETED|Overall Study||3
6320748|NCT00455702|7226036|FG001|NOT COMPLETED|Overall Study||3
6320749|NCT00455741|7226046|FG000|STARTED|Overall Study||13
6320750|NCT00455741|7226047|FG001|STARTED|Overall Study||12
6320751|NCT00455741|7226046|FG000|COMPLETED|Overall Study||13
6320752|NCT00455741|7226047|FG001|COMPLETED|Overall Study||11
6320753|NCT00455741|7226046|FG000|NOT COMPLETED|Overall Study||0
6320754|NCT00455741|7226047|FG001|NOT COMPLETED|Overall Study||1
6320755|NCT00455858|7226063|FG000|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
6320756|NCT00455858|7226063|FG000|COMPLETED|Overall Study||81
6320757|NCT00455858|7226063|FG000|NOT COMPLETED|Overall Study||6
6320758|NCT00455923|7226069|FG000|STARTED|Overall Study||50
6320759|NCT00455923|7226070|FG001|STARTED|Overall Study||50
6320760|NCT00455923|7226069|FG000|COMPLETED|Overall Study||47
6320761|NCT00455923|7226070|FG001|COMPLETED|Overall Study||47
6320762|NCT00455923|7226069|FG000|NOT COMPLETED|Overall Study||3
6320763|NCT00455923|7226070|FG001|NOT COMPLETED|Overall Study||3
6320764|NCT00455962|7226078|FG000|STARTED|Overall Study||10
6320765|NCT00455962|7226079|FG001|STARTED|Overall Study||13
6320766|NCT00455962|7226078|FG000|COMPLETED|Overall Study||10
6320767|NCT00455962|7226079|FG001|COMPLETED|Overall Study||13
6320768|NCT00455962|7226078|FG000|NOT COMPLETED|Overall Study||0
6320769|NCT00455962|7226079|FG001|NOT COMPLETED|Overall Study||0
6320770|NCT00455975|7226087|FG000|STARTED|Overall Study||58
6320771|NCT00455975|7226088|FG001|STARTED|Overall Study||61
6320772|NCT00455975|7226087|FG000|COMPLETED|Overall Study||40
6320773|NCT00455975|7226088|FG001|COMPLETED|Overall Study||40
6320774|NCT00455975|7226087|FG000|NOT COMPLETED|Overall Study||18
6320775|NCT00455975|7226088|FG001|NOT COMPLETED|Overall Study||21
6320776|NCT00456014|7226094|FG000|STARTED|SSRI Phase||37
6320777|NCT00456014|7226094|FG000|COMPLETED|SSRI Phase||28
6320778|NCT00456014|7226094|FG000|NOT COMPLETED|SSRI Phase||9
6320779|NCT00456014|7226094|FG000|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
6320780|NCT00456014|7226094|FG000|COMPLETED|Tricyclic Phase||1
6320781|NCT00456014|7226094|FG000|NOT COMPLETED|Tricyclic Phase||3
6320782|NCT00456092|7226103|FG000|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|46
6320783|NCT00456092|7226104|FG001|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|40
6320784|NCT00456092|7226105|FG002|STARTED|Extension Phase||0
6320785|NCT00456092|7226106|FG003|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
6320786|NCT00456092|7226107|FG004|STARTED|Extension Phase|The Extension Phase was only open to participants enrolled after amendment 1 was in effect.|20
6320787|NCT00456092|7226103|FG000|COMPLETED|Extension Phase||35
6320788|NCT00456092|7226104|FG001|COMPLETED|Extension Phase||36
6320789|NCT00456092|7226105|FG002|COMPLETED|Extension Phase||0
6320790|NCT00456092|7226106|FG003|COMPLETED|Extension Phase||19
6320791|NCT00456092|7226107|FG004|COMPLETED|Extension Phase||13
6320792|NCT00456092|7226103|FG000|NOT COMPLETED|Extension Phase||11
6320793|NCT00456092|7226104|FG001|NOT COMPLETED|Extension Phase||4
6320794|NCT00456092|7226105|FG002|NOT COMPLETED|Extension Phase||0
6320795|NCT00456092|7226106|FG003|NOT COMPLETED|Extension Phase||1
6320796|NCT00456092|7226107|FG004|NOT COMPLETED|Extension Phase||7
6320797|NCT00456092|7226103|FG000|STARTED|Treatment Phase (12 Weeks)||67
6320798|NCT00456092|7226104|FG001|STARTED|Treatment Phase (12 Weeks)||69
6320799|NCT00456092|7226105|FG002|STARTED|Treatment Phase (12 Weeks)||68
6320800|NCT00456092|7226106|FG003|STARTED|Treatment Phase (12 Weeks)||0
6320801|NCT00456092|7226107|FG004|STARTED|Treatment Phase (12 Weeks)||0
6320802|NCT00456092|7226103|FG000|COMPLETED|Treatment Phase (12 Weeks)||60
6320803|NCT00456092|7226104|FG001|COMPLETED|Treatment Phase (12 Weeks)||55
6320804|NCT00456092|7226105|FG002|COMPLETED|Treatment Phase (12 Weeks)||50
6320805|NCT00456092|7226106|FG003|COMPLETED|Treatment Phase (12 Weeks)||0
6320806|NCT00456092|7226107|FG004|COMPLETED|Treatment Phase (12 Weeks)||0
6320807|NCT00456092|7226103|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||7
6320808|NCT00456092|7226104|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||14
6320809|NCT00456092|7226105|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||18
6320810|NCT00456092|7226106|FG003|NOT COMPLETED|Treatment Phase (12 Weeks)||0
6320811|NCT00456092|7226107|FG004|NOT COMPLETED|Treatment Phase (12 Weeks)||0
6320812|NCT00456261|7226123|FG000|STARTED|Combination Therapy||55
6320813|NCT00456261|7226124|FG001|STARTED|Combination Therapy||55
6320814|NCT00456261|7226123|FG000|COMPLETED|Combination Therapy||3
6320815|NCT00456261|7226124|FG001|COMPLETED|Combination Therapy||29
6320816|NCT00456261|7226123|FG000|NOT COMPLETED|Combination Therapy||52
6320817|NCT00456261|7226124|FG001|NOT COMPLETED|Combination Therapy||26
6320818|NCT00456261|7226123|FG000|STARTED|Maintenance Therapy||3
6320819|NCT00456261|7226124|FG001|STARTED|Maintenance Therapy||29
6320820|NCT00456261|7226123|FG000|COMPLETED|Maintenance Therapy||3
6320821|NCT00456261|7226124|FG001|COMPLETED|Maintenance Therapy||29
6320822|NCT00456261|7226123|FG000|NOT COMPLETED|Maintenance Therapy||0
6320823|NCT00456261|7226124|FG001|NOT COMPLETED|Maintenance Therapy||0
6320824|NCT00456300|7226130|FG000|STARTED|Overall Study||5
6320825|NCT00456300|7226131|FG001|STARTED|Overall Study||4
6320826|NCT00456300|7226130|FG000|COMPLETED|Overall Study||4
6320827|NCT00456300|7226131|FG001|COMPLETED|Overall Study||4
6320828|NCT00456300|7226130|FG000|NOT COMPLETED|Overall Study||1
6320829|NCT00456300|7226131|FG001|NOT COMPLETED|Overall Study||0
6320830|NCT00456365|7226141|FG000|STARTED|Overall Study||56
6320831|NCT00456365|7226142|FG001|STARTED|Overall Study||54
6320832|NCT00456365|7226141|FG000|COMPLETED|Overall Study||49
6320833|NCT00456365|7226142|FG001|COMPLETED|Overall Study||42
6320834|NCT00456365|7226141|FG000|NOT COMPLETED|Overall Study||7
6320835|NCT00456365|7226142|FG001|NOT COMPLETED|Overall Study||12
6320836|NCT00456495|7226150|FG000|STARTED|Overall Study||5
6320837|NCT00456495|7226150|FG000|COMPLETED|Overall Study||3
6320838|NCT00456495|7226150|FG000|NOT COMPLETED|Overall Study||2
6320839|NCT00456508|7226155|FG000|STARTED|Overall Study||147
6320840|NCT00456508|7226155|FG000|COMPLETED|Overall Study||147
6320841|NCT00456508|7226155|FG000|NOT COMPLETED|Overall Study||0
6320842|NCT00456521|7226161|FG000|STARTED|Overall Study||591
6320843|NCT00456521|7226162|FG001|STARTED|Overall Study||202
6320844|NCT00456521|7226161|FG000|COMPLETED|Overall Study||342
6320845|NCT00456521|7226162|FG001|COMPLETED|Overall Study||118
6320846|NCT00456521|7226161|FG000|NOT COMPLETED|Overall Study||249
6320847|NCT00456521|7226162|FG001|NOT COMPLETED|Overall Study||84
6320848|NCT00456547|7226171|FG000|STARTED|Overall Study||12
6320849|NCT00456547|7226172|FG001|STARTED|Overall Study||12
6320850|NCT00456547|7226171|FG000|COMPLETED|Overall Study||12
6320851|NCT00456547|7226172|FG001|COMPLETED|Overall Study||12
6320852|NCT00456547|7226171|FG000|NOT COMPLETED|Overall Study||0
6320853|NCT00456547|7226172|FG001|NOT COMPLETED|Overall Study||0
6320854|NCT00456599|7226178|FG000|STARTED|Overall Study||71
6320855|NCT00456599|7226178|FG000|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
6320856|NCT00456599|7226178|FG000|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
6320857|NCT00456599|7226178|FG000|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
6320858|NCT00456599|7226178|FG000|Completed Resection|Overall Study|43 patients underwent resection.|43
6320859|NCT00456599|7226178|FG000|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
6320860|NCT00456599|7226178|FG000|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
6320861|NCT00456599|7226178|FG000|COMPLETED|Overall Study||68
6320862|NCT00456599|7226178|FG000|NOT COMPLETED|Overall Study||3
6320863|NCT00456625|7226182|FG000|STARTED|Overall Study||76
6320864|NCT00456625|7226182|FG000|COMPLETED|Overall Study||76
6320865|NCT00456625|7226182|FG000|NOT COMPLETED|Overall Study||0
6320866|NCT00456755|7226188|FG000|STARTED|Overall Study||63
6320867|NCT00456755|7226189|FG001|STARTED|Overall Study||63
6320868|NCT00456755|7226188|FG000|COMPLETED|Overall Study||61
6320869|NCT00456755|7226189|FG001|COMPLETED|Overall Study||62
6320870|NCT00456755|7226188|FG000|NOT COMPLETED|Overall Study||2
6320871|NCT00456755|7226189|FG001|NOT COMPLETED|Overall Study||1
6320872|NCT00456807|7226197|FG000|STARTED|Overall Study||53
6320873|NCT00456807|7226198|FG001|STARTED|Overall Study||47
6320874|NCT00456807|7226197|FG000|COMPLETED|Overall Study||52
6320875|NCT00456807|7226198|FG001|COMPLETED|Overall Study||47
6320876|NCT00456807|7226197|FG000|NOT COMPLETED|Overall Study||1
6320877|NCT00456807|7226198|FG001|NOT COMPLETED|Overall Study||0
6320878|NCT00456846|7226206|FG000|STARTED|Overall Study||47
6320879|NCT00456846|7226207|FG001|STARTED|Overall Study||76
6320880|NCT00456846|7226206|FG000|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
6320881|NCT00456846|7226207|FG001|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
6320882|NCT00456846|7226206|FG000|NOT COMPLETED|Overall Study||16
6320883|NCT00456846|7226207|FG001|NOT COMPLETED|Overall Study||28
6320884|NCT00456885|7226213|FG000|STARTED|First Treatment Period, 16 Weeks||24
6320885|NCT00456885|7226214|FG001|STARTED|First Treatment Period, 16 Weeks||17
6320886|NCT00456885|7226213|FG000|COMPLETED|First Treatment Period, 16 Weeks||24
6320887|NCT00456885|7226214|FG001|COMPLETED|First Treatment Period, 16 Weeks||17
6320888|NCT00456885|7226213|FG000|NOT COMPLETED|First Treatment Period, 16 Weeks||0
6320889|NCT00456885|7226214|FG001|NOT COMPLETED|First Treatment Period, 16 Weeks||0
6320890|NCT00456885|7226213|FG000|STARTED|Washout, 3 Weeks||24
6320891|NCT00456885|7226214|FG001|STARTED|Washout, 3 Weeks||17
6320892|NCT00456885|7226213|FG000|COMPLETED|Washout, 3 Weeks||24
6320893|NCT00456885|7226214|FG001|COMPLETED|Washout, 3 Weeks||17
6320894|NCT00456885|7226213|FG000|NOT COMPLETED|Washout, 3 Weeks||0
6320895|NCT00456885|7226214|FG001|NOT COMPLETED|Washout, 3 Weeks||0
6320896|NCT00456885|7226213|FG000|STARTED|Second Treatment Period, 16 Weeks||24
6320897|NCT00456885|7226214|FG001|STARTED|Second Treatment Period, 16 Weeks||17
6320898|NCT00456885|7226213|FG000|COMPLETED|Second Treatment Period, 16 Weeks||23
6320899|NCT00456885|7226214|FG001|COMPLETED|Second Treatment Period, 16 Weeks||17
6320900|NCT00456885|7226213|FG000|NOT COMPLETED|Second Treatment Period, 16 Weeks||1
6320901|NCT00456885|7226214|FG001|NOT COMPLETED|Second Treatment Period, 16 Weeks||0
6320902|NCT00457002|7226221|FG000|STARTED|Overall Study||3255
6320903|NCT00457002|7226222|FG001|STARTED|Overall Study||3273
6320904|NCT00457002|7226221|FG000|COMPLETED|Overall Study||2442
6320905|NCT00457002|7226222|FG001|COMPLETED|Overall Study||2516
6320906|NCT00457002|7226221|FG000|NOT COMPLETED|Overall Study||813
6320907|NCT00457002|7226222|FG001|NOT COMPLETED|Overall Study||757
6320908|NCT00457015|7226230|FG000|STARTED|Overall Study||48
6320909|NCT00457015|7226231|FG001|STARTED|Overall Study||48
6320910|NCT00457015|7226230|FG000|COMPLETED|Overall Study||48
6320911|NCT00457015|7226231|FG001|COMPLETED|Overall Study||47
6320912|NCT00457015|7226230|FG000|NOT COMPLETED|Overall Study||0
6320913|NCT00457015|7226231|FG001|NOT COMPLETED|Overall Study||1
6320914|NCT00457197|7226239|FG000|STARTED|Overall Study||45
6320915|NCT00457197|7226240|FG001|STARTED|Overall Study||45
6320916|NCT00457197|7226239|FG000|COMPLETED|Overall Study||44
6320917|NCT00457197|7226240|FG001|COMPLETED|Overall Study||44
6558002|NCT01772550|7480684|FG000|CT Angiogram|Overall Study||24
6558003|NCT01772550|7480685|FG001|CT Angiogram|Overall Study||25
6558004|NCT01772550|7480686|FG002|CT Angiogram|Overall Study||4
6558005|NCT01772550|7480684|FG000|CT Liver|Overall Study||18
6558006|NCT01772550|7480685|FG001|CT Liver|Overall Study||14
6558007|NCT01772550|7480686|FG002|CT Liver|Overall Study||8
6558008|NCT01772550|7480684|FG000|CT Kidney|Overall Study||12
6558009|NCT01772550|7480685|FG001|CT Kidney|Overall Study||19
6558010|NCT01772550|7480686|FG002|CT Kidney|Overall Study||6
6558011|NCT01772550|7480684|FG000|CT Cardiac|Overall Study||7
6558012|NCT01772550|7480685|FG001|CT Cardiac|Overall Study||7
6558013|NCT01772550|7480686|FG002|CT Cardiac|Overall Study||1
6558014|NCT01772550|7480684|FG000|COMPLETED|Overall Study||101
6558015|NCT01772550|7480685|FG001|COMPLETED|Overall Study||102
6558016|NCT01772550|7480686|FG002|COMPLETED|Overall Study||27
6558017|NCT01772550|7480684|FG000|NOT COMPLETED|Overall Study||1
6558018|NCT01772550|7480685|FG001|NOT COMPLETED|Overall Study||1
6558019|NCT01772550|7480686|FG002|NOT COMPLETED|Overall Study||6
6558020|NCT01772576|7480694|FG000|STARTED|Overall Study||167
6558021|NCT01772576|7480694|FG000|COMPLETED|Overall Study||133
6558022|NCT01772576|7480694|FG000|NOT COMPLETED|Overall Study||34
6558023|NCT01772654|7480700|FG000|STARTED|Overall Study||2
6558024|NCT01772654|7480701|FG001|STARTED|Overall Study||15
6558025|NCT01772654|7480700|FG000|COMPLETED|Overall Study||2
6558026|NCT01772654|7480701|FG001|COMPLETED|Overall Study||15
6558027|NCT01772654|7480700|FG000|NOT COMPLETED|Overall Study||0
6558028|NCT01772654|7480701|FG001|NOT COMPLETED|Overall Study||0
6558029|NCT01772693|7480709|FG000|STARTED|Overall Study||20
6558030|NCT01772693|7480710|FG001|STARTED|Overall Study||7
6558031|NCT01772693|7480709|FG000|COMPLETED|Overall Study||14
6558032|NCT01772693|7480710|FG001|COMPLETED|Overall Study||6
6558033|NCT01772693|7480709|FG000|NOT COMPLETED|Overall Study||6
6558034|NCT01772693|7480710|FG001|NOT COMPLETED|Overall Study||1
6558035|NCT01772758|7480720|FG000|STARTED|Overall Study||18
6558036|NCT01772758|7480721|FG001|STARTED|Overall Study||17
6558037|NCT01772758|7480722|FG002|STARTED|Overall Study||12
6558038|NCT01772758|7480723|FG003|STARTED|Overall Study||17
6558039|NCT01772758|7480720|FG000|COMPLETED|Overall Study||18
6558040|NCT01772758|7480721|FG001|COMPLETED|Overall Study||17
6558041|NCT01772758|7480722|FG002|COMPLETED|Overall Study||12
6558042|NCT01772758|7480723|FG003|COMPLETED|Overall Study||17
6558043|NCT01772758|7480720|FG000|NOT COMPLETED|Overall Study||0
6558044|NCT01772758|7480721|FG001|NOT COMPLETED|Overall Study||0
6558045|NCT01772758|7480722|FG002|NOT COMPLETED|Overall Study||0
6558046|NCT01772758|7480723|FG003|NOT COMPLETED|Overall Study||0
6558047|NCT01772823|7480735|FG000|STARTED|Behavioral Intervention (BL -3MV or PCC)||128
6558048|NCT01772823|7480736|FG001|STARTED|Behavioral Intervention (BL -3MV or PCC)||72
6558049|NCT01772823|7480735|FG000|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||116
6558050|NCT01772823|7480736|FG001|COMPLETED|Behavioral Intervention (BL -3MV or PCC)||70
6558051|NCT01772823|7480735|FG000|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||12
6558052|NCT01772823|7480736|FG001|NOT COMPLETED|Behavioral Intervention (BL -3MV or PCC)||2
6558053|NCT01772823|7480735|FG000|STARTED|Treatment Phase (Week 0- Week 48)||116
6558054|NCT01772823|7480736|FG001|STARTED|Treatment Phase (Week 0- Week 48)||70
6558055|NCT01772823|7480735|FG000|COMPLETED|Treatment Phase (Week 0- Week 48)||88
6558056|NCT01772823|7480736|FG001|COMPLETED|Treatment Phase (Week 0- Week 48)||52
6558057|NCT01772823|7480735|FG000|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||28
6558058|NCT01772823|7480736|FG001|NOT COMPLETED|Treatment Phase (Week 0- Week 48)||18
6558059|NCT01772823|7480735|FG000|STARTED|Extension Phase (Visits 24,48wks Post tx|25 of the 88 subjects that completed the Treatment Phase were not eligible for the Extension Phase|63
6558060|NCT01772823|7480736|FG001|STARTED|Extension Phase (Visits 24,48wks Post tx|10 of the 52 subjects that completed the Treatment Phase were not eligible for the Extension Phase|42
6558061|NCT01772823|7480735|FG000|COMPLETED|Extension Phase (Visits 24,48wks Post tx||53
6320918|NCT00457197|7226239|FG000|NOT COMPLETED|Overall Study||1
6320919|NCT00457197|7226240|FG001|NOT COMPLETED|Overall Study||1
6320920|NCT00457249|7226248|FG000|STARTED|Overall Study||1170
6320921|NCT00457249|7226249|FG001|STARTED|Overall Study||391
6320922|NCT00457249|7226248|FG000|COMPLETED|Overall Study||1158
6320923|NCT00457249|7226249|FG001|COMPLETED|Overall Study||389
6320924|NCT00457249|7226248|FG000|NOT COMPLETED|Overall Study||12
6320925|NCT00457249|7226249|FG001|NOT COMPLETED|Overall Study||2
6320926|NCT00457301|7226259|FG000|STARTED|Overall Study||105
6320927|NCT00457301|7226260|FG001|STARTED|Overall Study||108
6558062|NCT01772823|7480736|FG001|COMPLETED|Extension Phase (Visits 24,48wks Post tx||33
6320928|NCT00457301|7226259|FG000|COMPLETED|Overall Study||82
6558063|NCT01772823|7480735|FG000|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||10
6558064|NCT01772823|7480736|FG001|NOT COMPLETED|Extension Phase (Visits 24,48wks Post tx||9
6558065|NCT01773070|7480747|FG000|STARTED|Overall Study||478
6558066|NCT01773070|7480747|FG000|COMPLETED|Overall Study||397
6320929|NCT00457301|7226260|FG001|COMPLETED|Overall Study||84
6558067|NCT01773070|7480747|FG000|NOT COMPLETED|Overall Study||81
6558068|NCT01773109|7480751|FG000|STARTED|Overall Study||40
6558069|NCT01773109|7480751|FG000|COMPLETED|Overall Study||37
6558070|NCT01773109|7480751|FG000|NOT COMPLETED|Overall Study||3
6320930|NCT00457301|7226259|FG000|NOT COMPLETED|Overall Study||23
6320931|NCT00457301|7226260|FG001|NOT COMPLETED|Overall Study||24
6320932|NCT00457366|7226268|FG000|STARTED|Overall Study||40
6320933|NCT00457366|7226269|FG001|STARTED|Overall Study||32
6320934|NCT00457366|7226268|FG000|COMPLETED|Overall Study||40
6320935|NCT00457366|7226269|FG001|COMPLETED|Overall Study||32
6320936|NCT00457366|7226268|FG000|NOT COMPLETED|Overall Study||0
6320937|NCT00457366|7226269|FG001|NOT COMPLETED|Overall Study||0
6320938|NCT00457392|7226277|FG000|STARTED|Overall Study||480
6320939|NCT00457392|7226278|FG001|STARTED|Overall Study||480
6320940|NCT00457392|7226277|FG000|Treated|Overall Study||473
6320941|NCT00457392|7226278|FG001|Treated|Overall Study||477
6320942|NCT00457392|7226277|FG000|COMPLETED|Overall Study||0
6320943|NCT00457392|7226278|FG001|COMPLETED|Overall Study||0
6320944|NCT00457392|7226277|FG000|NOT COMPLETED|Overall Study||480
6320945|NCT00457392|7226278|FG001|NOT COMPLETED|Overall Study||480
6320946|NCT00457418|7226284|FG000|STARTED|Pharmacokinetic (PK) Sampling Phase||32
6320947|NCT00457418|7226284|FG000|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
6320948|NCT00457418|7226284|FG000|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
6320949|NCT00457418|7226284|FG000|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
6320950|NCT00457418|7226284|FG000|COMPLETED|Post PK Maintenance||3
6320951|NCT00457418|7226284|FG000|NOT COMPLETED|Post PK Maintenance||28
6320952|NCT00457626|7226288|FG000|STARTED|Overall Study||66
6320953|NCT00457626|7226288|FG000|COMPLETED|Overall Study||60
6320954|NCT00457626|7226288|FG000|NOT COMPLETED|Overall Study||6
6320955|NCT00457639|7226292|FG000|STARTED|Intervention 1 (6 Months)|6 months on Cholic Acid and crossover to Placebo for 6 months|9
6320956|NCT00457639|7226293|FG001|STARTED|Intervention 1 (6 Months)|6 months on Placebo and crossover to cholic acid for 6 months|9
6320957|NCT00457639|7226292|FG000|COMPLETED|Intervention 1 (6 Months)|Number of Patients completing Cholic Acid Phase|6
6320958|NCT00457639|7226293|FG001|COMPLETED|Intervention 1 (6 Months)|Number of patients completing Placebo Phase|7
6320959|NCT00457639|7226292|FG000|NOT COMPLETED|Intervention 1 (6 Months)||3
6320960|NCT00457639|7226293|FG001|NOT COMPLETED|Intervention 1 (6 Months)||2
6320961|NCT00457639|7226292|FG000|STARTED|Intervention 2 (6 Months)||6
6320962|NCT00457639|7226293|FG001|STARTED|Intervention 2 (6 Months)||7
6320963|NCT00457639|7226292|FG000|COMPLETED|Intervention 2 (6 Months)||6
6320964|NCT00457639|7226293|FG001|COMPLETED|Intervention 2 (6 Months)||6
6320965|NCT00457639|7226292|FG000|NOT COMPLETED|Intervention 2 (6 Months)||0
6320966|NCT00457639|7226293|FG001|NOT COMPLETED|Intervention 2 (6 Months)||1
6320967|NCT00457665|7226301|FG000|STARTED|12 Months||28
6320968|NCT00457665|7226302|FG001|STARTED|12 Months||28
6320969|NCT00457665|7226301|FG000|COMPLETED|12 Months||20
6320970|NCT00457665|7226302|FG001|COMPLETED|12 Months||19
6320971|NCT00457665|7226301|FG000|NOT COMPLETED|12 Months||8
6320972|NCT00457665|7226302|FG001|NOT COMPLETED|12 Months||9
6320973|NCT00457665|7226301|FG000|STARTED|24 Months||20
6320974|NCT00457665|7226302|FG001|STARTED|24 Months||19
6320975|NCT00457665|7226301|FG000|COMPLETED|24 Months||15
6320976|NCT00457665|7226302|FG001|COMPLETED|24 Months||11
6320977|NCT00457665|7226301|FG000|NOT COMPLETED|24 Months||5
6320978|NCT00457665|7226302|FG001|NOT COMPLETED|24 Months||8
6320979|NCT00457691|7226310|FG000|STARTED|Overall Study||386
6320980|NCT00457691|7226311|FG001|STARTED|Overall Study||382
6320981|NCT00457691|7226310|FG000|COMPLETED|Overall Study||0
6320982|NCT00457691|7226311|FG001|COMPLETED|Overall Study||0
6320983|NCT00457691|7226310|FG000|NOT COMPLETED|Overall Study||386
6320984|NCT00457691|7226311|FG001|NOT COMPLETED|Overall Study||382
6320985|NCT00457730|7226319|FG000|STARTED|Overall Study||18
6320986|NCT00457730|7226320|FG001|STARTED|Overall Study||20
6320987|NCT00457730|7226319|FG000|COMPLETED|Overall Study||14
6320988|NCT00457730|7226320|FG001|COMPLETED|Overall Study||19
6320989|NCT00457730|7226319|FG000|NOT COMPLETED|Overall Study||4
6320990|NCT00457730|7226320|FG001|NOT COMPLETED|Overall Study||1
6320991|NCT00457743|7226333|FG000|STARTED|Overall Study|Overall study|3
6320992|NCT00457743|7226334|FG001|STARTED|Overall Study|Overall study|30
6320993|NCT00457743|7226335|FG002|STARTED|Overall Study|Overall study|3
6320994|NCT00457743|7226333|FG000|Enrolled in Phase 1|Overall Study||3
6320995|NCT00457743|7226334|FG001|Enrolled in Phase 1|Overall Study||6
6320996|NCT00457743|7226335|FG002|Enrolled in Phase 1|Overall Study||3
6320997|NCT00457743|7226333|FG000|Completed Phase 1|Overall Study||3
6320998|NCT00457743|7226334|FG001|Completed Phase 1|Overall Study||6
6320999|NCT00457743|7226335|FG002|Completed Phase 1|Overall Study||3
6321000|NCT00457743|7226333|FG000|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
6321001|NCT00457743|7226334|FG001|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
6321002|NCT00457743|7226335|FG002|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
6321003|NCT00457743|7226333|FG000|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
6321004|NCT00457743|7226334|FG001|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
6321005|NCT00457743|7226335|FG002|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
6321006|NCT00457743|7226333|FG000|NOT COMPLETED|Overall Study||3
6321007|NCT00457743|7226334|FG001|NOT COMPLETED|Overall Study||27
6321008|NCT00457743|7226335|FG002|NOT COMPLETED|Overall Study||3
6321009|NCT00457795|7226344|FG000|STARTED|Overall Study||15
6321010|NCT00457795|7226344|FG000|COMPLETED|Overall Study||15
6321011|NCT00457795|7226344|FG000|NOT COMPLETED|Overall Study||0
6321012|NCT00457821|7226356|FG000|STARTED|Part 1|Number of subjects randomized|4
6321013|NCT00457821|7226357|FG001|STARTED|Part 1|Number of subjects randomized|4
6321014|NCT00457821|7226358|FG002|STARTED|Part 1|Number of subjects randomized|5
6321015|NCT00457821|7226359|FG003|STARTED|Part 1|Number of subjects randomized|4
6321016|NCT00457821|7226360|FG004|STARTED|Part 1|Number of subjects randomized|4
6321017|NCT00457821|7226361|FG005|STARTED|Part 1|Arm in Part 2 only|0
6321018|NCT00457821|7226362|FG006|STARTED|Part 1|Arm in Part 2 only|0
6321019|NCT00457821|7226363|FG007|STARTED|Part 1|Arm in Part 2 only|0
6321020|NCT00457821|7226356|FG000|COMPLETED|Part 1||4
6321021|NCT00457821|7226357|FG001|COMPLETED|Part 1||4
6321022|NCT00457821|7226358|FG002|COMPLETED|Part 1||4
6321023|NCT00457821|7226359|FG003|COMPLETED|Part 1||4
6321024|NCT00457821|7226360|FG004|COMPLETED|Part 1||4
6321025|NCT00457821|7226361|FG005|COMPLETED|Part 1||0
6321026|NCT00457821|7226362|FG006|COMPLETED|Part 1||0
6321027|NCT00457821|7226363|FG007|COMPLETED|Part 1||0
6321028|NCT00457821|7226356|FG000|NOT COMPLETED|Part 1||0
6321029|NCT00457821|7226357|FG001|NOT COMPLETED|Part 1||0
6321030|NCT00457821|7226358|FG002|NOT COMPLETED|Part 1||1
6321031|NCT00457821|7226359|FG003|NOT COMPLETED|Part 1||0
6321032|NCT00457821|7226360|FG004|NOT COMPLETED|Part 1||0
6321033|NCT00457821|7226361|FG005|NOT COMPLETED|Part 1||0
6321034|NCT00457821|7226362|FG006|NOT COMPLETED|Part 1||0
6321035|NCT00457821|7226363|FG007|NOT COMPLETED|Part 1||0
6321036|NCT00457821|7226356|FG000|STARTED|Part 2|Arm in Part 1 only|0
6321037|NCT00457821|7226357|FG001|STARTED|Part 2|Arm in Part 1 only|0
6321038|NCT00457821|7226358|FG002|STARTED|Part 2|Arm in Part 1 only|0
6321039|NCT00457821|7226359|FG003|STARTED|Part 2|Arm in Part 1 only|0
6321040|NCT00457821|7226360|FG004|STARTED|Part 2|Arm in Part 1 only|0
6321041|NCT00457821|7226361|FG005|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
6321042|NCT00457821|7226362|FG006|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
6321043|NCT00457821|7226363|FG007|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
6321044|NCT00457821|7226356|FG000|Completed Study Drug Treatment|Part 2||0
6321045|NCT00457821|7226357|FG001|Completed Study Drug Treatment|Part 2||0
6321046|NCT00457821|7226358|FG002|Completed Study Drug Treatment|Part 2||0
6321047|NCT00457821|7226359|FG003|Completed Study Drug Treatment|Part 2||0
6321048|NCT00457821|7226360|FG004|Completed Study Drug Treatment|Part 2||0
6321049|NCT00457821|7226361|FG005|Completed Study Drug Treatment|Part 2||8
6321050|NCT00457821|7226362|FG006|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
6321051|NCT00457821|7226363|FG007|Completed Study Drug Treatment|Part 2||4
6321052|NCT00457821|7226356|FG000|COMPLETED|Part 2||0
6321053|NCT00457821|7226357|FG001|COMPLETED|Part 2||0
6321054|NCT00457821|7226358|FG002|COMPLETED|Part 2||0
6558071|NCT01773122|7480759|FG000|STARTED|Overall Study||20
6558072|NCT01773122|7480760|FG001|STARTED|Overall Study||19
6558073|NCT01773122|7480761|FG002|STARTED|Overall Study||19
6558074|NCT01773122|7480762|FG003|STARTED|Overall Study||19
6558075|NCT01773122|7480759|FG000|COMPLETED|Overall Study||17
6321055|NCT00457821|7226359|FG003|COMPLETED|Part 2||0
6321056|NCT00457821|7226360|FG004|COMPLETED|Part 2||0
6321057|NCT00457821|7226361|FG005|COMPLETED|Part 2||8
6321058|NCT00457821|7226362|FG006|COMPLETED|Part 2||7
6321059|NCT00457821|7226363|FG007|COMPLETED|Part 2||4
6321060|NCT00457821|7226356|FG000|NOT COMPLETED|Part 2||0
6321061|NCT00457821|7226357|FG001|NOT COMPLETED|Part 2||0
6321062|NCT00457821|7226358|FG002|NOT COMPLETED|Part 2||0
6321063|NCT00457821|7226359|FG003|NOT COMPLETED|Part 2||0
6321064|NCT00457821|7226360|FG004|NOT COMPLETED|Part 2||0
6321065|NCT00457821|7226361|FG005|NOT COMPLETED|Part 2||0
6321066|NCT00457821|7226362|FG006|NOT COMPLETED|Part 2||0
6321067|NCT00457821|7226363|FG007|NOT COMPLETED|Part 2||1
6321068|NCT00457977|7226382|FG000|STARTED|Overall Study||90
6321069|NCT00457977|7226383|FG001|STARTED|Overall Study||91
6321070|NCT00457977|7226382|FG000|1-Month|Overall Study||88
6321071|NCT00457977|7226383|FG001|1-Month|Overall Study||87
6321072|NCT00457977|7226382|FG000|1-Year|Overall Study||69
6321073|NCT00457977|7226383|FG001|1-Year|Overall Study||76
6321074|NCT00457977|7226382|FG000|2-Year|Overall Study||62
6321075|NCT00457977|7226383|FG001|2-Year|Overall Study||66
6321076|NCT00457977|7226382|FG000|COMPLETED|Overall Study||62
6558076|NCT01773122|7480760|FG001|COMPLETED|Overall Study||18
6321077|NCT00457977|7226383|FG001|COMPLETED|Overall Study||66
6321078|NCT00457977|7226382|FG000|NOT COMPLETED|Overall Study||28
6321079|NCT00457977|7226383|FG001|NOT COMPLETED|Overall Study||25
6321080|NCT00458211|7226389|FG000|STARTED|Overall Study||40
6321081|NCT00458211|7226389|FG000|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
6321082|NCT00458211|7226389|FG000|NOT COMPLETED|Overall Study||16
6321083|NCT00458237|7226400|FG000|STARTED|Overall Study||3
6321084|NCT00458237|7226401|FG001|STARTED|Overall Study||3
6321085|NCT00458237|7226402|FG002|STARTED|Overall Study||5
6321086|NCT00458237|7226400|FG000|COMPLETED|Overall Study||3
6321087|NCT00458237|7226401|FG001|COMPLETED|Overall Study||3
6321088|NCT00458237|7226402|FG002|COMPLETED|Overall Study||5
6321089|NCT00458237|7226400|FG000|NOT COMPLETED|Overall Study||0
6321090|NCT00458237|7226401|FG001|NOT COMPLETED|Overall Study||0
6321091|NCT00458237|7226402|FG002|NOT COMPLETED|Overall Study||0
6321092|NCT00458302|7226413|FG000|STARTED|Overall Study||129
6321093|NCT00458302|7226414|FG001|STARTED|Overall Study||127
6558077|NCT01773122|7480761|FG002|COMPLETED|Overall Study||19
6321094|NCT00458302|7226413|FG000|COMPLETED|Overall Study||109
6321095|NCT00458302|7226414|FG001|COMPLETED|Overall Study||103
6321096|NCT00458302|7226413|FG000|NOT COMPLETED|Overall Study||20
6321097|NCT00458302|7226414|FG001|NOT COMPLETED|Overall Study||24
6321098|NCT00458341|7226423|FG000|STARTED|Cycle 1||15
6321099|NCT00458341|7226424|FG001|STARTED|Cycle 1||15
6321100|NCT00458341|7226423|FG000|Received at Least 1 Dose of Study Drug|Cycle 1||15
6321101|NCT00458341|7226424|FG001|Received at Least 1 Dose of Study Drug|Cycle 1||15
6321102|NCT00458341|7226423|FG000|COMPLETED|Cycle 1|1 participant did not complete Cycle 1 since all procedures were not performed due to adverse event.|14
6321103|NCT00458341|7226424|FG001|COMPLETED|Cycle 1||15
6321104|NCT00458341|7226423|FG000|NOT COMPLETED|Cycle 1||1
6321105|NCT00458341|7226424|FG001|NOT COMPLETED|Cycle 1||0
6321106|NCT00458341|7226423|FG000|STARTED|Cycle 2|The participant who did not complete Cycle 1 was eligible for Cycle 2 and completed Cycle 2.|15
6321107|NCT00458341|7226424|FG001|STARTED|Cycle 2||15
6321108|NCT00458341|7226423|FG000|Received at Least 1 Dose of Study Drug|Cycle 2||15
6321109|NCT00458341|7226424|FG001|Received at Least 1 Dose of Study Drug|Cycle 2||15
6321110|NCT00458341|7226423|FG000|COMPLETED|Cycle 2||15
6321111|NCT00458341|7226424|FG001|COMPLETED|Cycle 2||15
6321112|NCT00458341|7226423|FG000|NOT COMPLETED|Cycle 2||0
6321113|NCT00458341|7226424|FG001|NOT COMPLETED|Cycle 2||0
6321114|NCT00458393|7226432|FG000|STARTED|Overall Study||1251
6321115|NCT00458393|7226433|FG001|STARTED|Overall Study||1248
6321116|NCT00458393|7226432|FG000|COMPLETED|Overall Study||942
6321117|NCT00458393|7226433|FG001|COMPLETED|Overall Study||953
6321118|NCT00458393|7226432|FG000|NOT COMPLETED|Overall Study||309
6321119|NCT00458393|7226433|FG001|NOT COMPLETED|Overall Study||295
6321120|NCT00458406|7226443|FG000|STARTED|Month 1||43
6321121|NCT00458406|7226444|FG001|STARTED|Month 1||13
6321122|NCT00458406|7226443|FG000|COMPLETED|Month 1||43
6321123|NCT00458406|7226444|FG001|COMPLETED|Month 1||13
6321124|NCT00458406|7226443|FG000|NOT COMPLETED|Month 1||0
6321125|NCT00458406|7226444|FG001|NOT COMPLETED|Month 1||0
6321126|NCT00458406|7226443|FG000|STARTED|Month 3||43
6321127|NCT00458406|7226444|FG001|STARTED|Month 3||13
6321128|NCT00458406|7226443|FG000|COMPLETED|Month 3||43
6321129|NCT00458406|7226444|FG001|COMPLETED|Month 3||13
6321130|NCT00458406|7226443|FG000|NOT COMPLETED|Month 3||0
6321131|NCT00458406|7226444|FG001|NOT COMPLETED|Month 3||0
6321132|NCT00458484|7226464|FG000|STARTED|Overall Study||4
6321133|NCT00458484|7226465|FG001|STARTED|Overall Study||6
6321134|NCT00458484|7226466|FG002|STARTED|Overall Study||3
6321135|NCT00458484|7226467|FG003|STARTED|Overall Study||6
6321136|NCT00458484|7226468|FG004|STARTED|Overall Study||4
6321137|NCT00458484|7226469|FG005|STARTED|Overall Study||5
6321138|NCT00458484|7226470|FG006|STARTED|Overall Study||3
6321139|NCT00458484|7226464|FG000|COMPLETED|Overall Study||4
6321140|NCT00458484|7226465|FG001|COMPLETED|Overall Study||6
6321141|NCT00458484|7226466|FG002|COMPLETED|Overall Study||3
6321142|NCT00458484|7226467|FG003|COMPLETED|Overall Study||6
6321143|NCT00458484|7226468|FG004|COMPLETED|Overall Study||4
6321144|NCT00458484|7226469|FG005|COMPLETED|Overall Study||4
6321145|NCT00458484|7226470|FG006|COMPLETED|Overall Study||3
6321146|NCT00458484|7226464|FG000|NOT COMPLETED|Overall Study||0
6321147|NCT00458484|7226465|FG001|NOT COMPLETED|Overall Study||0
6558078|NCT01773122|7480762|FG003|COMPLETED|Overall Study||18
6558079|NCT01773122|7480759|FG000|NOT COMPLETED|Overall Study||3
6558080|NCT01773122|7480760|FG001|NOT COMPLETED|Overall Study||1
6558081|NCT01773122|7480761|FG002|NOT COMPLETED|Overall Study||0
6321148|NCT00458484|7226466|FG002|NOT COMPLETED|Overall Study||0
6321149|NCT00458484|7226467|FG003|NOT COMPLETED|Overall Study||0
6321150|NCT00458484|7226468|FG004|NOT COMPLETED|Overall Study||0
6321151|NCT00458484|7226469|FG005|NOT COMPLETED|Overall Study||1
6321152|NCT00458484|7226470|FG006|NOT COMPLETED|Overall Study||0
6321153|NCT00458705|7226495|FG000|STARTED|Overall Study||45
6321154|NCT00458705|7226495|FG000|COMPLETED|Overall Study||40
6321155|NCT00458705|7226495|FG000|NOT COMPLETED|Overall Study||5
6321156|NCT00458783|7226501|FG000|STARTED|Overall Study||1914
6321157|NCT00458783|7226502|FG001|STARTED|Overall Study||1921
6321158|NCT00458783|7226501|FG000|COMPLETED|Overall Study||686
6321159|NCT00458783|7226502|FG001|COMPLETED|Overall Study||701
6321160|NCT00458783|7226501|FG000|NOT COMPLETED|Overall Study||1228
6321161|NCT00458783|7226502|FG001|NOT COMPLETED|Overall Study||1220
6321162|NCT00458822|7226508|FG000|STARTED|Overall Study||40
6321163|NCT00458822|7226508|FG000|COMPLETED|Overall Study||40
6321164|NCT00458822|7226508|FG000|NOT COMPLETED|Overall Study||0
6321165|NCT00458848|7226512|FG000|STARTED|Overall Study||51
6321166|NCT00458848|7226512|FG000|COMPLETED|Overall Study||51
6321167|NCT00458848|7226512|FG000|NOT COMPLETED|Overall Study||0
6321168|NCT00458952|7226518|FG000|STARTED|Overall Study||7
6321169|NCT00458952|7226519|FG001|STARTED|Overall Study||14
6321170|NCT00458952|7226518|FG000|COMPLETED|Overall Study||5
6321171|NCT00458952|7226519|FG001|COMPLETED|Overall Study||9
6321172|NCT00458952|7226518|FG000|NOT COMPLETED|Overall Study||2
6321173|NCT00458952|7226519|FG001|NOT COMPLETED|Overall Study||5
6321174|NCT00459043|7226525|FG000|STARTED|Overall Study||15
6321175|NCT00459043|7226526|FG001|STARTED|Overall Study||15
6321176|NCT00459043|7226525|FG000|COMPLETED|Overall Study||14
6321177|NCT00459043|7226526|FG001|COMPLETED|Overall Study||15
6321178|NCT00459043|7226525|FG000|NOT COMPLETED|Overall Study||1
6321179|NCT00459043|7226526|FG001|NOT COMPLETED|Overall Study||0
6321180|NCT00459056|7226534|FG000|STARTED|First Intervention (First Three Months)||10
6558082|NCT01773122|7480762|FG003|NOT COMPLETED|Overall Study||1
6321181|NCT00459056|7226535|FG001|STARTED|First Intervention (First Three Months)||15
6321182|NCT00459056|7226534|FG000|COMPLETED|First Intervention (First Three Months)||9
6321183|NCT00459056|7226535|FG001|COMPLETED|First Intervention (First Three Months)||14
6321184|NCT00459056|7226534|FG000|NOT COMPLETED|First Intervention (First Three Months)||1
6321185|NCT00459056|7226535|FG001|NOT COMPLETED|First Intervention (First Three Months)||1
6321186|NCT00459056|7226534|FG000|STARTED|Washout (1 Month)||9
6321187|NCT00459056|7226535|FG001|STARTED|Washout (1 Month)||14
6321188|NCT00459056|7226534|FG000|COMPLETED|Washout (1 Month)||9
6321189|NCT00459056|7226535|FG001|COMPLETED|Washout (1 Month)||14
6321190|NCT00459056|7226534|FG000|NOT COMPLETED|Washout (1 Month)||0
6321191|NCT00459056|7226535|FG001|NOT COMPLETED|Washout (1 Month)||0
6321192|NCT00459056|7226534|FG000|STARTED|Second Intervention (Final Three Months)||9
6321193|NCT00459056|7226535|FG001|STARTED|Second Intervention (Final Three Months)||14
6321194|NCT00459056|7226534|FG000|COMPLETED|Second Intervention (Final Three Months)||9
6321195|NCT00459056|7226535|FG001|COMPLETED|Second Intervention (Final Three Months)||14
6321196|NCT00459056|7226534|FG000|NOT COMPLETED|Second Intervention (Final Three Months)||0
6775155|NCT03880227|7703103|FG000|STARTED|First Visit||20
6775156|NCT03880227|7703104|FG001|STARTED|First Visit||21
6775157|NCT03880227|7703105|FG002|STARTED|First Visit||22
6775158|NCT03880227|7703106|FG003|STARTED|First Visit||18
6775159|NCT03880227|7703103|FG000|COMPLETED|First Visit||19
6775160|NCT03880227|7703104|FG001|COMPLETED|First Visit||21
6775161|NCT03880227|7703105|FG002|COMPLETED|First Visit||22
6775162|NCT03880227|7703106|FG003|COMPLETED|First Visit||18
6321197|NCT00459056|7226535|FG001|NOT COMPLETED|Second Intervention (Final Three Months)||0
6321198|NCT00459108|7226541|FG000|STARTED|Overall Study||25
6321199|NCT00459108|7226541|FG000|COMPLETED|Overall Study||14
6321200|NCT00459108|7226541|FG000|NOT COMPLETED|Overall Study||11
6321201|NCT00459134|7226548|FG000|STARTED|Overall Study||94
6321202|NCT00459134|7226549|FG001|STARTED|Overall Study||92
6321203|NCT00459134|7226548|FG000|COMPLETED|Overall Study||71
6321204|NCT00459134|7226549|FG001|COMPLETED|Overall Study||67
6321205|NCT00459134|7226548|FG000|NOT COMPLETED|Overall Study||23
6321206|NCT00459134|7226549|FG001|NOT COMPLETED|Overall Study||25
6321207|NCT00459186|7226555|FG000|STARTED|Single Agent RAD001||19
6321208|NCT00459186|7226555|FG000|COMPLETED|Single Agent RAD001||18
6321209|NCT00459186|7226555|FG000|NOT COMPLETED|Single Agent RAD001||1
6321210|NCT00459186|7226555|FG000|STARTED|PET Imaging and Assessment||18
6321211|NCT00459186|7226555|FG000|COMPLETED|PET Imaging and Assessment||15
6321212|NCT00459186|7226555|FG000|NOT COMPLETED|PET Imaging and Assessment||3
6321213|NCT00459186|7226555|FG000|STARTED|Combination RAD001 + Docetaxel||15
6321214|NCT00459186|7226555|FG000|COMPLETED|Combination RAD001 + Docetaxel||15
6321215|NCT00459186|7226555|FG000|NOT COMPLETED|Combination RAD001 + Docetaxel||0
6321216|NCT00459290|7226559|FG000|STARTED|Overall Study||24
6321217|NCT00459290|7226559|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
6321218|NCT00459290|7226559|FG000|NOT COMPLETED|Overall Study||5
6375544|NCT00756314|7286186|FG001|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
6375545|NCT00756314|7286185|FG000|NOT COMPLETED|Overall Study||2
6375546|NCT00756314|7286186|FG001|NOT COMPLETED|Overall Study||59
6375547|NCT00756444|7286194|FG000|STARTED|Overall Study||33
6375548|NCT00756444|7286195|FG001|STARTED|Overall Study||34
6375549|NCT00756444|7286194|FG000|COMPLETED|Overall Study||18
6375550|NCT00756444|7286195|FG001|COMPLETED|Overall Study||13
6375551|NCT00756444|7286194|FG000|NOT COMPLETED|Overall Study||15
6375552|NCT00756444|7286195|FG001|NOT COMPLETED|Overall Study||21
6375553|NCT00756457|7286204|FG000|STARTED|Overall Study||20
6375554|NCT00756457|7286205|FG001|STARTED|Overall Study||19
6375555|NCT00756457|7286204|FG000|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
6375556|NCT00756457|7286205|FG001|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
6375557|NCT00756457|7286204|FG000|NOT COMPLETED|Overall Study||1
6375558|NCT00756457|7286205|FG001|NOT COMPLETED|Overall Study||2
6375559|NCT00756470|7286227|FG000|STARTED|Overall Study||15
6375560|NCT00756470|7286227|FG000|COMPLETED|Overall Study||10
6375561|NCT00756470|7286227|FG000|NOT COMPLETED|Overall Study||5
6375562|NCT00756496|7286231|FG000|STARTED|Overall Study||442
6375563|NCT00756496|7286231|FG000|COMPLETED|Overall Study||442
6375564|NCT00756496|7286231|FG000|NOT COMPLETED|Overall Study||0
6375565|NCT00756548|7286238|FG000|STARTED|Overall Study||186
6375566|NCT00756548|7286239|FG001|STARTED|Overall Study||185
6375567|NCT00756548|7286238|FG000|COMPLETED|Overall Study||184
6375568|NCT00756548|7286239|FG001|COMPLETED|Overall Study||185
6375569|NCT00756548|7286238|FG000|NOT COMPLETED|Overall Study||2
6375570|NCT00756548|7286239|FG001|NOT COMPLETED|Overall Study||0
6775163|NCT03880227|7703103|FG000|NOT COMPLETED|First Visit||1
6775164|NCT03880227|7703104|FG001|NOT COMPLETED|First Visit||0
6775165|NCT03880227|7703105|FG002|NOT COMPLETED|First Visit||0
6375571|NCT00756561|7286247|FG000|STARTED|Overall Study||10
6375572|NCT00756561|7286247|FG000|COMPLETED|Overall Study||10
6375573|NCT00756561|7286247|FG000|NOT COMPLETED|Overall Study||0
6375574|NCT00756600|7286254|FG000|STARTED|Overall Study||287
6375575|NCT00756600|7286255|FG001|STARTED|Overall Study||356
6375576|NCT00756600|7286254|FG000|COMPLETED|Overall Study||287
6375577|NCT00756600|7286255|FG001|COMPLETED|Overall Study||356
6775166|NCT03880227|7703106|FG003|NOT COMPLETED|First Visit||0
6558083|NCT01773135|7480774|FG000|STARTED|Overall Study||262
6558084|NCT01773135|7480774|FG000|COMPLETED|Overall Study||262
6558085|NCT01773135|7480774|FG000|NOT COMPLETED|Overall Study||0
6558086|NCT01773187|7480781|FG000|STARTED|Overall Study||220
6321219|NCT00459303|7226570|FG000|STARTED|Overall Study||20
6321220|NCT00459303|7226570|FG000|COMPLETED|Overall Study||20
6321221|NCT00459303|7226570|FG000|NOT COMPLETED|Overall Study||0
6321222|NCT00459316|7226582|FG000|STARTED|Steps 1 & 2||280
6321223|NCT00459316|7226583|FG001|STARTED|Steps 1 & 2||39
6321224|NCT00459316|7226584|FG002|STARTED|Steps 1 & 2||59
6321225|NCT00459316|7226582|FG000|COMPLETED|Steps 1 & 2||259
6321226|NCT00459316|7226583|FG001|COMPLETED|Steps 1 & 2||32
6321227|NCT00459316|7226584|FG002|COMPLETED|Steps 1 & 2||57
6321228|NCT00459316|7226582|FG000|NOT COMPLETED|Steps 1 & 2||21
6321229|NCT00459316|7226583|FG001|NOT COMPLETED|Steps 1 & 2||7
6321230|NCT00459316|7226584|FG002|NOT COMPLETED|Steps 1 & 2||2
6321231|NCT00459316|7226582|FG000|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
6321232|NCT00459316|7226583|FG001|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
6321233|NCT00459316|7226584|FG002|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
6321234|NCT00459316|7226582|FG000|COMPLETED|Step 3||149
6321235|NCT00459316|7226583|FG001|COMPLETED|Step 3||0
6321236|NCT00459316|7226584|FG002|COMPLETED|Step 3||39
6321237|NCT00459316|7226582|FG000|NOT COMPLETED|Step 3||3
6321238|NCT00459316|7226583|FG001|NOT COMPLETED|Step 3||0
6321239|NCT00459316|7226584|FG002|NOT COMPLETED|Step 3||1
6321240|NCT00459342|7226607|FG000|STARTED|Overall Study||35
6321241|NCT00459342|7226607|FG000|COMPLETED|Overall Study||34
6321242|NCT00459342|7226607|FG000|NOT COMPLETED|Overall Study||1
6321243|NCT00459355|7226613|FG000|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
6321244|NCT00459355|7226614|FG001|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
6321245|NCT00459355|7226613|FG000|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
6321246|NCT00459355|7226614|FG001|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
6321247|NCT00459355|7226613|FG000|NOT COMPLETED|Overall Study||20
6321248|NCT00459355|7226614|FG001|NOT COMPLETED|Overall Study||18
6321249|NCT00459368|7226626|FG000|STARTED|Overall Study||1335
6321250|NCT00459368|7226627|FG001|STARTED|Overall Study||1363
6321251|NCT00459368|7226626|FG000|COMPLETED|Overall Study||1040
6321252|NCT00459368|7226627|FG001|COMPLETED|Overall Study||1034
6321253|NCT00459368|7226626|FG000|NOT COMPLETED|Overall Study||295
6321254|NCT00459368|7226627|FG001|NOT COMPLETED|Overall Study||329
6321255|NCT00459381|7226633|FG000|STARTED|Overall Study||35
6321256|NCT00459381|7226633|FG000|COMPLETED|Overall Study||35
6321257|NCT00459381|7226633|FG000|NOT COMPLETED|Overall Study||0
6321258|NCT00459537|7226639|FG000|STARTED|Overall Study||507
6321259|NCT00459537|7226640|FG001|STARTED|Overall Study||522
6321260|NCT00459537|7226639|FG000|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
6321261|NCT00459537|7226640|FG001|Safety Population|Overall Study||512
6321262|NCT00459537|7226639|FG000|COMPLETED|Overall Study||441
6321263|NCT00459537|7226640|FG001|COMPLETED|Overall Study||446
6321264|NCT00459537|7226639|FG000|NOT COMPLETED|Overall Study||66
6321265|NCT00459537|7226640|FG001|NOT COMPLETED|Overall Study||76
6321266|NCT00459667|7226649|FG000|STARTED|Overall Study||592
6321267|NCT00459667|7226650|FG001|STARTED|Overall Study||647
6321268|NCT00459667|7226651|FG002|STARTED|Overall Study||181
6321269|NCT00459667|7226649|FG000|Study Medication Dispensed|Overall Study||586
6321270|NCT00459667|7226650|FG001|Study Medication Dispensed|Overall Study||645
6321271|NCT00459667|7226651|FG002|Study Medication Dispensed|Overall Study||180
6321272|NCT00459667|7226649|FG000|Started Treatment|Overall Study||586
6321273|NCT00459667|7226650|FG001|Started Treatment|Overall Study||644
6321274|NCT00459667|7226651|FG002|Started Treatment|Overall Study||180
6321275|NCT00459667|7226649|FG000|COMPLETED|Overall Study||554
6321276|NCT00459667|7226650|FG001|COMPLETED|Overall Study||600
6321277|NCT00459667|7226651|FG002|COMPLETED|Overall Study||161
6321278|NCT00459667|7226649|FG000|NOT COMPLETED|Overall Study||38
6321279|NCT00459667|7226650|FG001|NOT COMPLETED|Overall Study||47
6321280|NCT00459667|7226651|FG002|NOT COMPLETED|Overall Study||20
6321281|NCT00459706|7226661|FG000|STARTED|Overall Study||325
6321282|NCT00459706|7226662|FG001|STARTED|Overall Study||315
6321283|NCT00459706|7226661|FG000|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
6321284|NCT00459706|7226662|FG001|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
6321285|NCT00459706|7226661|FG000|COMPLETED|Overall Study||299
6321286|NCT00459706|7226662|FG001|COMPLETED|Overall Study||294
6321287|NCT00459706|7226661|FG000|NOT COMPLETED|Overall Study||26
6321288|NCT00459706|7226662|FG001|NOT COMPLETED|Overall Study||21
6321289|NCT00459732|7226670|FG000|STARTED|Overall Study||23
6321290|NCT00459732|7226671|FG001|STARTED|Overall Study||17
6321291|NCT00459732|7226670|FG000|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
6321292|NCT00459732|7226671|FG001|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
6321293|NCT00459732|7226670|FG000|NOT COMPLETED|Overall Study||4
6321294|NCT00459732|7226671|FG001|NOT COMPLETED|Overall Study||3
6321295|NCT00459810|7226677|FG000|STARTED|Overall Study||21
6321296|NCT00459810|7226677|FG000|COMPLETED|Overall Study||21
6558087|NCT01773187|7480782|FG001|STARTED|Overall Study||107
6558088|NCT01773187|7480781|FG000|COMPLETED|Overall Study||167
6321297|NCT00459810|7226677|FG000|NOT COMPLETED|Overall Study||0
6321298|NCT00459862|7226681|FG000|STARTED|Overall Study||34
6321299|NCT00459862|7226681|FG000|COMPLETED|Overall Study||34
6321300|NCT00459862|7226681|FG000|NOT COMPLETED|Overall Study||0
6321301|NCT00459875|7226685|FG000|STARTED|Overall Study||24
6321302|NCT00459875|7226685|FG000|COMPLETED|Overall Study||21
6321303|NCT00459875|7226685|FG000|NOT COMPLETED|Overall Study||3
6321304|NCT00459953|7226691|FG000|STARTED|Overall Study||72
6321305|NCT00459953|7226692|FG001|STARTED|Overall Study||71
6321306|NCT00459953|7226691|FG000|COMPLETED|Overall Study||71
6321307|NCT00459953|7226692|FG001|COMPLETED|Overall Study||70
6321308|NCT00459953|7226691|FG000|NOT COMPLETED|Overall Study||1
6321309|NCT00459953|7226692|FG001|NOT COMPLETED|Overall Study||1
6321310|NCT00459979|7226698|FG000|STARTED|Overall Study||30
6321311|NCT00459979|7226698|FG000|COMPLETED|Overall Study||28
6321312|NCT00459979|7226698|FG000|NOT COMPLETED|Overall Study||2
6321313|NCT00460031|7226702|FG000|STARTED|Overall Study||34
6321314|NCT00460031|7226702|FG000|COMPLETED|Overall Study||23
6558089|NCT01773187|7480782|FG001|COMPLETED|Overall Study||75
6558090|NCT01773187|7480781|FG000|NOT COMPLETED|Overall Study||53
6558091|NCT01773187|7480782|FG001|NOT COMPLETED|Overall Study||32
6558092|NCT01773226|7480788|FG000|STARTED|Overall Study||11
6321315|NCT00460031|7226702|FG000|NOT COMPLETED|Overall Study||11
6321316|NCT00460109|7226706|FG000|STARTED|Overall Study||24
6321317|NCT00460109|7226706|FG000|COMPLETED|Overall Study||23
6321318|NCT00460109|7226706|FG000|NOT COMPLETED|Overall Study||1
6321319|NCT00460239|7226710|FG000|STARTED|Overall Study||0
6321320|NCT00460239|7226711|FG001|STARTED|Overall Study||3
6321321|NCT00460239|7226712|FG002|STARTED|Overall Study||1
6321322|NCT00460239|7226713|FG003|STARTED|Overall Study||0
6321323|NCT00460239|7226714|FG004|STARTED|Overall Study||1
6321324|NCT00460239|7226715|FG005|STARTED|Overall Study||4
6321325|NCT00460239|7226716|FG006|STARTED|Overall Study||1
6321326|NCT00460239|7226717|FG007|STARTED|Overall Study||1
6321327|NCT00460239|7226718|FG008|STARTED|Overall Study||1
6321328|NCT00460239|7226710|FG000|COMPLETED|Overall Study||0
6321329|NCT00460239|7226711|FG001|COMPLETED|Overall Study||2
6321330|NCT00460239|7226712|FG002|COMPLETED|Overall Study||1
6321331|NCT00460239|7226713|FG003|COMPLETED|Overall Study||0
6321332|NCT00460239|7226714|FG004|COMPLETED|Overall Study||1
6321333|NCT00460239|7226715|FG005|COMPLETED|Overall Study||1
6321334|NCT00460239|7226716|FG006|COMPLETED|Overall Study||1
6321335|NCT00460239|7226717|FG007|COMPLETED|Overall Study||1
6321336|NCT00460239|7226718|FG008|COMPLETED|Overall Study||1
6321337|NCT00460239|7226710|FG000|NOT COMPLETED|Overall Study||0
6321338|NCT00460239|7226711|FG001|NOT COMPLETED|Overall Study||1
6321339|NCT00460239|7226712|FG002|NOT COMPLETED|Overall Study||0
6321340|NCT00460239|7226713|FG003|NOT COMPLETED|Overall Study||0
6321341|NCT00460239|7226714|FG004|NOT COMPLETED|Overall Study||0
6321342|NCT00460239|7226715|FG005|NOT COMPLETED|Overall Study||3
6321343|NCT00460239|7226716|FG006|NOT COMPLETED|Overall Study||0
6321344|NCT00460239|7226717|FG007|NOT COMPLETED|Overall Study||0
6321345|NCT00460239|7226718|FG008|NOT COMPLETED|Overall Study||0
6321346|NCT00460265|7226733|FG000|STARTED|Overall Study||328
6321347|NCT00460265|7226734|FG001|STARTED|Overall Study||330
6321348|NCT00460265|7226733|FG000|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
6321349|NCT00460265|7226734|FG001|Randomized While Alive|Overall Study||330
6321350|NCT00460265|7226733|FG000|Received Study Medication|Overall Study||325
6321351|NCT00460265|7226734|FG001|Received Study Medication|Overall Study||325
6321352|NCT00460265|7226733|FG000|COMPLETED|Overall Study|Completed study=death|243
6321353|NCT00460265|7226734|FG001|COMPLETED|Overall Study|Completed study=death|241
6321354|NCT00460265|7226733|FG000|NOT COMPLETED|Overall Study||85
6321355|NCT00460265|7226734|FG001|NOT COMPLETED|Overall Study||89
6321356|NCT00460408|7226744|FG000|STARTED|Overall Study||403
6321357|NCT00460408|7226745|FG001|STARTED|Overall Study||16
6321358|NCT00460408|7226746|FG002|STARTED|Overall Study||75
6321359|NCT00460408|7226747|FG003|STARTED|Overall Study||7
6321360|NCT00460408|7226744|FG000|COMPLETED|Overall Study||336
6321361|NCT00460408|7226745|FG001|COMPLETED|Overall Study||13
6321362|NCT00460408|7226746|FG002|COMPLETED|Overall Study||69
6321363|NCT00460408|7226747|FG003|COMPLETED|Overall Study||7
6321364|NCT00460408|7226744|FG000|NOT COMPLETED|Overall Study||67
6321365|NCT00460408|7226745|FG001|NOT COMPLETED|Overall Study||3
6321366|NCT00460408|7226746|FG002|NOT COMPLETED|Overall Study||6
6321367|NCT00460408|7226747|FG003|NOT COMPLETED|Overall Study||0
6321368|NCT00460421|7226760|FG000|STARTED|Overall Study||9
6321369|NCT00460421|7226761|FG001|STARTED|Overall Study||9
6321370|NCT00460421|7226762|FG002|STARTED|Overall Study||9
6321371|NCT00460421|7226760|FG000|COMPLETED|Overall Study||9
6321372|NCT00460421|7226761|FG001|COMPLETED|Overall Study||9
6321373|NCT00460421|7226762|FG002|COMPLETED|Overall Study||9
6321374|NCT00460421|7226760|FG000|NOT COMPLETED|Overall Study||0
6321375|NCT00460421|7226761|FG001|NOT COMPLETED|Overall Study||0
6321376|NCT00460421|7226762|FG002|NOT COMPLETED|Overall Study||0
6321377|NCT00460434|7226771|FG000|STARTED|Overall Study||165
6321378|NCT00460434|7226772|FG001|STARTED|Overall Study||172
6321379|NCT00460434|7226771|FG000|3 Months|Overall Study||163
6321380|NCT00460434|7226772|FG001|3 Months|Overall Study||171
6321381|NCT00460434|7226771|FG000|12 Months|Overall Study||162
6321382|NCT00460434|7226772|FG001|12 Months|Overall Study||165
6321383|NCT00460434|7226771|FG000|COMPLETED|Overall Study||162
6562859|NCT01803204|7485754|FG001|COMPLETED|Overall Study||20
6321384|NCT00460434|7226772|FG001|COMPLETED|Overall Study||165
6321385|NCT00460434|7226771|FG000|NOT COMPLETED|Overall Study||3
6321386|NCT00460434|7226772|FG001|NOT COMPLETED|Overall Study||7
6321387|NCT00460525|7226780|FG000|STARTED|Overall Study||201
6321388|NCT00460525|7226781|FG001|STARTED|Overall Study||199
6321389|NCT00460525|7226780|FG000|COMPLETED|Overall Study||190
6321390|NCT00460525|7226781|FG001|COMPLETED|Overall Study||194
6321391|NCT00460525|7226780|FG000|NOT COMPLETED|Overall Study||11
6321392|NCT00460525|7226781|FG001|NOT COMPLETED|Overall Study||5
6321393|NCT00460551|7226787|FG000|STARTED|Overall Study||13
6321394|NCT00460551|7226787|FG000|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
6321395|NCT00460551|7226787|FG000|NOT COMPLETED|Overall Study||0
6321396|NCT00460564|7226795|FG000|STARTED|Double-Blind Phase (12 Weeks)||51
6321397|NCT00460564|7226796|FG001|STARTED|Double-Blind Phase (12 Weeks)||26
6321398|NCT00460564|7226797|FG002|STARTED|Double-Blind Phase (12 Weeks)||21
6321399|NCT00460564|7226798|FG003|STARTED|Double-Blind Phase (12 Weeks)||11
6321400|NCT00460564|7226799|FG004|STARTED|Double-Blind Phase (12 Weeks)||0
6321401|NCT00460564|7226800|FG005|STARTED|Double-Blind Phase (12 Weeks)||0
6321402|NCT00460564|7226801|FG006|STARTED|Double-Blind Phase (12 Weeks)||0
6321403|NCT00460564|7226802|FG007|STARTED|Double-Blind Phase (12 Weeks)||0
6321404|NCT00460564|7226795|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||47
6321405|NCT00460564|7226796|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||25
6321406|NCT00460564|7226797|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||21
6321407|NCT00460564|7226798|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||11
6321408|NCT00460564|7226799|FG004|COMPLETED|Double-Blind Phase (12 Weeks)||0
6321409|NCT00460564|7226800|FG005|COMPLETED|Double-Blind Phase (12 Weeks)||0
6321410|NCT00460564|7226801|FG006|COMPLETED|Double-Blind Phase (12 Weeks)||0
6321411|NCT00460564|7226802|FG007|COMPLETED|Double-Blind Phase (12 Weeks)||0
6321412|NCT00460564|7226795|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
6321413|NCT00460564|7226796|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
6321414|NCT00460564|7226797|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6321415|NCT00460564|7226798|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6321416|NCT00460564|7226799|FG004|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6321417|NCT00460564|7226800|FG005|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6321418|NCT00460564|7226801|FG006|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6321419|NCT00460564|7226802|FG007|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6321420|NCT00460564|7226795|FG000|STARTED|Open-Label Phase (36 Weeks)||0
6321421|NCT00460564|7226796|FG001|STARTED|Open-Label Phase (36 Weeks)||0
6321422|NCT00460564|7226797|FG002|STARTED|Open-Label Phase (36 Weeks)||0
6321423|NCT00460564|7226798|FG003|STARTED|Open-Label Phase (36 Weeks)||0
6321424|NCT00460564|7226799|FG004|STARTED|Open-Label Phase (36 Weeks)||47
6321425|NCT00460564|7226800|FG005|STARTED|Open-Label Phase (36 Weeks)||25
6321426|NCT00460564|7226801|FG006|STARTED|Open-Label Phase (36 Weeks)||21
6321427|NCT00460564|7226802|FG007|STARTED|Open-Label Phase (36 Weeks)||11
6321428|NCT00460564|7226795|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
6321429|NCT00460564|7226796|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
6321430|NCT00460564|7226797|FG002|COMPLETED|Open-Label Phase (36 Weeks)||0
6321431|NCT00460564|7226798|FG003|COMPLETED|Open-Label Phase (36 Weeks)||0
6321432|NCT00460564|7226799|FG004|COMPLETED|Open-Label Phase (36 Weeks)||38
6321433|NCT00460564|7226800|FG005|COMPLETED|Open-Label Phase (36 Weeks)||19
6321434|NCT00460564|7226801|FG006|COMPLETED|Open-Label Phase (36 Weeks)||19
6321435|NCT00460564|7226802|FG007|COMPLETED|Open-Label Phase (36 Weeks)||11
6321436|NCT00460564|7226795|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6321437|NCT00460564|7226796|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6321438|NCT00460564|7226797|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6321439|NCT00460564|7226798|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6321440|NCT00460564|7226799|FG004|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
6321441|NCT00460564|7226800|FG005|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
6321442|NCT00460564|7226801|FG006|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
6321443|NCT00460564|7226802|FG007|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6321444|NCT00460577|7226824|FG000|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
6321445|NCT00460577|7226825|FG001|STARTED|Overall Study||30
6321446|NCT00460577|7226824|FG000|COMPLETED|Overall Study||28
6321447|NCT00460577|7226825|FG001|COMPLETED|Overall Study||24
6321448|NCT00460577|7226824|FG000|NOT COMPLETED|Overall Study||2
6321449|NCT00460577|7226825|FG001|NOT COMPLETED|Overall Study||6
6321450|NCT00460603|7226843|FG000|STARTED|Phase 1||6
6321451|NCT00460603|7226844|FG001|STARTED|Phase 1||6
6321452|NCT00460603|7226845|FG002|STARTED|Phase 1||4
6321453|NCT00460603|7226846|FG003|STARTED|Phase 1||8
6321454|NCT00460603|7226847|FG004|STARTED|Phase 1||6
6321455|NCT00460603|7226848|FG005|STARTED|Phase 1||4
6321456|NCT00460603|7226849|FG006|STARTED|Phase 1||6
6321457|NCT00460603|7226850|FG007|STARTED|Phase 1||3
6321458|NCT00460603|7226851|FG008|STARTED|Phase 1||18
6321459|NCT00460603|7226852|FG009|STARTED|Phase 1||0
6321460|NCT00460603|7226853|FG010|STARTED|Phase 1||0
6321461|NCT00460603|7226854|FG011|STARTED|Phase 1||0
6321462|NCT00460603|7226843|FG000|COMPLETED|Phase 1||0
6321463|NCT00460603|7226844|FG001|COMPLETED|Phase 1||0
6321464|NCT00460603|7226845|FG002|COMPLETED|Phase 1||0
6321465|NCT00460603|7226846|FG003|COMPLETED|Phase 1||0
6321466|NCT00460603|7226847|FG004|COMPLETED|Phase 1||0
6321467|NCT00460603|7226848|FG005|COMPLETED|Phase 1||0
6321468|NCT00460603|7226849|FG006|COMPLETED|Phase 1||0
6321469|NCT00460603|7226850|FG007|COMPLETED|Phase 1||0
6321470|NCT00460603|7226851|FG008|COMPLETED|Phase 1||0
6321471|NCT00460603|7226852|FG009|COMPLETED|Phase 1||0
6321472|NCT00460603|7226853|FG010|COMPLETED|Phase 1||0
6321473|NCT00460603|7226854|FG011|COMPLETED|Phase 1||0
6321474|NCT00460603|7226843|FG000|NOT COMPLETED|Phase 1||6
6321475|NCT00460603|7226844|FG001|NOT COMPLETED|Phase 1||6
6321476|NCT00460603|7226845|FG002|NOT COMPLETED|Phase 1||4
6321477|NCT00460603|7226846|FG003|NOT COMPLETED|Phase 1||8
6321478|NCT00460603|7226847|FG004|NOT COMPLETED|Phase 1||6
6321479|NCT00460603|7226848|FG005|NOT COMPLETED|Phase 1||4
6321480|NCT00460603|7226849|FG006|NOT COMPLETED|Phase 1||6
6321481|NCT00460603|7226850|FG007|NOT COMPLETED|Phase 1||3
6321482|NCT00460603|7226851|FG008|NOT COMPLETED|Phase 1||18
6321483|NCT00460603|7226852|FG009|NOT COMPLETED|Phase 1||0
6321484|NCT00460603|7226853|FG010|NOT COMPLETED|Phase 1||0
6321485|NCT00460603|7226854|FG011|NOT COMPLETED|Phase 1||0
6321486|NCT00460603|7226843|FG000|STARTED|Phase 2||0
6321487|NCT00460603|7226844|FG001|STARTED|Phase 2||0
6321488|NCT00460603|7226845|FG002|STARTED|Phase 2||0
6321489|NCT00460603|7226846|FG003|STARTED|Phase 2||0
6321490|NCT00460603|7226847|FG004|STARTED|Phase 2||0
6321491|NCT00460603|7226848|FG005|STARTED|Phase 2||0
6321492|NCT00460603|7226849|FG006|STARTED|Phase 2||0
6321493|NCT00460603|7226850|FG007|STARTED|Phase 2||0
6321494|NCT00460603|7226851|FG008|STARTED|Phase 2||0
6321495|NCT00460603|7226852|FG009|STARTED|Phase 2||42
6321496|NCT00460603|7226853|FG010|STARTED|Phase 2||43
6321497|NCT00460603|7226854|FG011|STARTED|Phase 2||41
6321498|NCT00460603|7226843|FG000|Treated|Phase 2||0
6321499|NCT00460603|7226844|FG001|Treated|Phase 2||0
6321500|NCT00460603|7226845|FG002|Treated|Phase 2||0
6321501|NCT00460603|7226846|FG003|Treated|Phase 2||0
6321502|NCT00460603|7226847|FG004|Treated|Phase 2||0
6321503|NCT00460603|7226848|FG005|Treated|Phase 2||0
6321504|NCT00460603|7226849|FG006|Treated|Phase 2||0
6321505|NCT00460603|7226850|FG007|Treated|Phase 2||0
6321506|NCT00460603|7226851|FG008|Treated|Phase 2||0
6558093|NCT01773226|7480788|FG000|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
6558094|NCT01773226|7480788|FG000|NOT COMPLETED|Overall Study||1
6558095|NCT01773291|7480795|FG000|STARTED|Overall Study||8
6558096|NCT01773291|7480796|FG001|STARTED|Overall Study||9
6558097|NCT01773291|7480797|FG002|STARTED|Overall Study||7
6558098|NCT01773291|7480795|FG000|COMPLETED|Overall Study||7
6558099|NCT01773291|7480796|FG001|COMPLETED|Overall Study||9
6558100|NCT01773291|7480797|FG002|COMPLETED|Overall Study||6
6558101|NCT01773291|7480795|FG000|NOT COMPLETED|Overall Study||1
6558102|NCT01773291|7480796|FG001|NOT COMPLETED|Overall Study||0
6558103|NCT01773291|7480797|FG002|NOT COMPLETED|Overall Study||1
6558104|NCT01773421|7480810|FG000|STARTED|Treatment Phase||7
6321507|NCT00460603|7226852|FG009|Treated|Phase 2||39
6321508|NCT00460603|7226853|FG010|Treated|Phase 2||43
6321509|NCT00460603|7226854|FG011|Treated|Phase 2||41
6321510|NCT00460603|7226843|FG000|COMPLETED|Phase 2||0
6321511|NCT00460603|7226844|FG001|COMPLETED|Phase 2||0
6321512|NCT00460603|7226845|FG002|COMPLETED|Phase 2||0
6321513|NCT00460603|7226846|FG003|COMPLETED|Phase 2||0
6321514|NCT00460603|7226847|FG004|COMPLETED|Phase 2||0
6321515|NCT00460603|7226848|FG005|COMPLETED|Phase 2||0
6321516|NCT00460603|7226849|FG006|COMPLETED|Phase 2||0
6321517|NCT00460603|7226850|FG007|COMPLETED|Phase 2||0
6321518|NCT00460603|7226851|FG008|COMPLETED|Phase 2||0
6321519|NCT00460603|7226852|FG009|COMPLETED|Phase 2||0
6321520|NCT00460603|7226853|FG010|COMPLETED|Phase 2||0
6321521|NCT00460603|7226854|FG011|COMPLETED|Phase 2||0
6321522|NCT00460603|7226843|FG000|NOT COMPLETED|Phase 2||0
6321523|NCT00460603|7226844|FG001|NOT COMPLETED|Phase 2||0
6321524|NCT00460603|7226845|FG002|NOT COMPLETED|Phase 2||0
6321525|NCT00460603|7226846|FG003|NOT COMPLETED|Phase 2||0
6321526|NCT00460603|7226847|FG004|NOT COMPLETED|Phase 2||0
6321527|NCT00460603|7226848|FG005|NOT COMPLETED|Phase 2||0
6321528|NCT00460603|7226849|FG006|NOT COMPLETED|Phase 2||0
6321529|NCT00460603|7226850|FG007|NOT COMPLETED|Phase 2||0
6321530|NCT00460603|7226851|FG008|NOT COMPLETED|Phase 2||0
6321531|NCT00460603|7226852|FG009|NOT COMPLETED|Phase 2||42
6321532|NCT00460603|7226853|FG010|NOT COMPLETED|Phase 2||43
6321533|NCT00460603|7226854|FG011|NOT COMPLETED|Phase 2||41
6321534|NCT00460655|7226882|FG000|STARTED|Double-Blind Phase (12 Weeks)||58
6321535|NCT00460655|7226883|FG001|STARTED|Double-Blind Phase (12 Weeks)||62
6321536|NCT00460655|7226884|FG002|STARTED|Double-Blind Phase (12 Weeks)||0
6321537|NCT00460655|7226885|FG003|STARTED|Double-Blind Phase (12 Weeks)||0
6321538|NCT00460655|7226882|FG000|COMPLETED|Double-Blind Phase (12 Weeks)||52
6321539|NCT00460655|7226883|FG001|COMPLETED|Double-Blind Phase (12 Weeks)||61
6321540|NCT00460655|7226884|FG002|COMPLETED|Double-Blind Phase (12 Weeks)||0
6321541|NCT00460655|7226885|FG003|COMPLETED|Double-Blind Phase (12 Weeks)||0
6321542|NCT00460655|7226882|FG000|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
6321543|NCT00460655|7226883|FG001|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
6321544|NCT00460655|7226884|FG002|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6321545|NCT00460655|7226885|FG003|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
6321546|NCT00460655|7226882|FG000|STARTED|Open-Label Phase (36 Weeks)||0
6321547|NCT00460655|7226883|FG001|STARTED|Open-Label Phase (36 Weeks)||0
6321548|NCT00460655|7226884|FG002|STARTED|Open-Label Phase (36 Weeks)||52
6321549|NCT00460655|7226885|FG003|STARTED|Open-Label Phase (36 Weeks)||61
6321550|NCT00460655|7226882|FG000|COMPLETED|Open-Label Phase (36 Weeks)||0
6558105|NCT01773421|7480811|FG001|STARTED|Treatment Phase||8
6558106|NCT01773421|7480812|FG002|STARTED|Treatment Phase||19
6558107|NCT01773421|7480813|FG003|STARTED|Treatment Phase||7
6321551|NCT00460655|7226883|FG001|COMPLETED|Open-Label Phase (36 Weeks)||0
6321552|NCT00460655|7226884|FG002|COMPLETED|Open-Label Phase (36 Weeks)||45
6321553|NCT00460655|7226885|FG003|COMPLETED|Open-Label Phase (36 Weeks)||52
6321554|NCT00460655|7226882|FG000|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6321555|NCT00460655|7226883|FG001|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
6321556|NCT00460655|7226884|FG002|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
6775167|NCT03880227|7703103|FG000|STARTED|1 Week Washout/ Delay||19
6775168|NCT03880227|7703104|FG001|STARTED|1 Week Washout/ Delay||21
6775169|NCT03880227|7703105|FG002|STARTED|1 Week Washout/ Delay||22
6321557|NCT00460655|7226885|FG003|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
6321558|NCT00460746|7226895|FG000|STARTED|Overall Study||10
6321559|NCT00460746|7226895|FG000|COMPLETED|Overall Study||8
6321560|NCT00460746|7226895|FG000|NOT COMPLETED|Overall Study||2
6321561|NCT00460798|7226899|FG000|STARTED|Overall Study||448
6321562|NCT00460798|7226899|FG000|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
6321563|NCT00460798|7226899|FG000|COMPLETED|Overall Study||108
6321564|NCT00460798|7226899|FG000|NOT COMPLETED|Overall Study||340
6321565|NCT00460811|7226908|FG000|STARTED|Overall Study||79
6321566|NCT00460811|7226909|FG001|STARTED|Overall Study||82
6321567|NCT00460811|7226910|FG002|STARTED|Overall Study||85
6321568|NCT00460811|7226911|FG003|STARTED|Overall Study||89
6321569|NCT00460811|7226912|FG004|STARTED|Overall Study||85
6321570|NCT00460811|7226908|FG000|COMPLETED|Overall Study||63
6321571|NCT00460811|7226909|FG001|COMPLETED|Overall Study||67
6321572|NCT00460811|7226910|FG002|COMPLETED|Overall Study||71
6321573|NCT00460811|7226911|FG003|COMPLETED|Overall Study||71
6321574|NCT00460811|7226912|FG004|COMPLETED|Overall Study||65
6321575|NCT00460811|7226908|FG000|NOT COMPLETED|Overall Study||16
6321576|NCT00460811|7226909|FG001|NOT COMPLETED|Overall Study||15
6321577|NCT00460811|7226910|FG002|NOT COMPLETED|Overall Study||14
6321578|NCT00460811|7226911|FG003|NOT COMPLETED|Overall Study||18
6321579|NCT00460811|7226912|FG004|NOT COMPLETED|Overall Study||20
6321580|NCT00460993|7226931|FG000|STARTED|Phase 1 (6 Days)||14
6321581|NCT00460993|7226932|FG001|STARTED|Phase 1 (6 Days)||17
6321582|NCT00460993|7226931|FG000|COMPLETED|Phase 1 (6 Days)||14
6321583|NCT00460993|7226932|FG001|COMPLETED|Phase 1 (6 Days)||17
6321584|NCT00460993|7226931|FG000|NOT COMPLETED|Phase 1 (6 Days)||0
6321585|NCT00460993|7226932|FG001|NOT COMPLETED|Phase 1 (6 Days)||0
6321586|NCT00460993|7226931|FG000|STARTED|Phase 2 (6 Days)||14
6321587|NCT00460993|7226932|FG001|STARTED|Phase 2 (6 Days)||17
6321588|NCT00460993|7226931|FG000|COMPLETED|Phase 2 (6 Days)||14
6321589|NCT00460993|7226932|FG001|COMPLETED|Phase 2 (6 Days)||17
6321590|NCT00460993|7226931|FG000|NOT COMPLETED|Phase 2 (6 Days)||0
6321591|NCT00460993|7226932|FG001|NOT COMPLETED|Phase 2 (6 Days)||0
6321592|NCT00461045|7226938|FG000|STARTED|Overall Study||15
6321593|NCT00461045|7226938|FG000|COMPLETED|Overall Study||15
6321594|NCT00461045|7226938|FG000|NOT COMPLETED|Overall Study||0
6321595|NCT00461097|7226944|FG000|STARTED|Overall Study||40
6321596|NCT00461097|7226945|FG001|STARTED|Overall Study||15
6321597|NCT00461097|7226944|FG000|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
6321598|NCT00461097|7226945|FG001|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
6321599|NCT00461097|7226944|FG000|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
6321600|NCT00461097|7226945|FG001|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
6321601|NCT00461097|7226944|FG000|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
6321602|NCT00461097|7226945|FG001|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
6321603|NCT00461097|7226944|FG000|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
6321604|NCT00461097|7226945|FG001|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
6321605|NCT00461097|7226944|FG000|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
6321606|NCT00461097|7226945|FG001|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
6321607|NCT00461097|7226944|FG000|NOT COMPLETED|Overall Study||0
6321608|NCT00461097|7226945|FG001|NOT COMPLETED|Overall Study||0
6321609|NCT00461123|7226954|FG000|STARTED|Overall Study||25
6321610|NCT00461123|7226955|FG001|STARTED|Overall Study||25
6321611|NCT00461123|7226954|FG000|COMPLETED|Overall Study||19
6321612|NCT00461123|7226955|FG001|COMPLETED|Overall Study||19
6321613|NCT00461123|7226954|FG000|NOT COMPLETED|Overall Study||6
6321614|NCT00461123|7226955|FG001|NOT COMPLETED|Overall Study||6
6321615|NCT00461175|7226963|FG000|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
6321616|NCT00461175|7226964|FG001|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
6321617|NCT00461175|7226963|FG000|COMPLETED|Overall Study||43078
6321618|NCT00461175|7226964|FG001|COMPLETED|Overall Study||18370
6321619|NCT00461175|7226963|FG000|NOT COMPLETED|Overall Study||522
6321620|NCT00461175|7226964|FG001|NOT COMPLETED|Overall Study||365
6321621|NCT00461253|7226972|FG000|STARTED|Overall Study|Identified cases|10093
6321622|NCT00461253|7226973|FG001|STARTED|Overall Study|Identified controls|40250
6321623|NCT00461253|7226972|FG000|COMPLETED|Overall Study|Analyzed cases|5113
6321624|NCT00461253|7226973|FG001|COMPLETED|Overall Study|Analyzed controls|20452
6321625|NCT00461253|7226972|FG000|NOT COMPLETED|Overall Study||4980
6321626|NCT00461253|7226973|FG001|NOT COMPLETED|Overall Study||19798
6321627|NCT00461292|7226982|FG000|STARTED|Treatment Cycle 1||91
6321628|NCT00461292|7226983|FG001|STARTED|Treatment Cycle 1||92
6321629|NCT00461292|7226984|FG002|STARTED|Treatment Cycle 1||92
6321630|NCT00461292|7226982|FG000|COMPLETED|Treatment Cycle 1||76
6775170|NCT03880227|7703106|FG003|STARTED|1 Week Washout/ Delay||18
6775171|NCT03880227|7703103|FG000|COMPLETED|1 Week Washout/ Delay||19
6321631|NCT00461292|7226983|FG001|COMPLETED|Treatment Cycle 1||80
6321632|NCT00461292|7226984|FG002|COMPLETED|Treatment Cycle 1||81
6321633|NCT00461292|7226982|FG000|NOT COMPLETED|Treatment Cycle 1||15
6321634|NCT00461292|7226983|FG001|NOT COMPLETED|Treatment Cycle 1||12
6321635|NCT00461292|7226984|FG002|NOT COMPLETED|Treatment Cycle 1||11
6321636|NCT00461292|7226982|FG000|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
6321637|NCT00461292|7226983|FG001|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
6321638|NCT00461292|7226984|FG002|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
6321639|NCT00461292|7226982|FG000|COMPLETED|Treatment Cycle 2||58
6321640|NCT00461292|7226983|FG001|COMPLETED|Treatment Cycle 2||72
6321641|NCT00461292|7226984|FG002|COMPLETED|Treatment Cycle 2||0
6321642|NCT00461292|7226982|FG000|NOT COMPLETED|Treatment Cycle 2||5
6321643|NCT00461292|7226983|FG001|NOT COMPLETED|Treatment Cycle 2||2
6321644|NCT00461292|7226984|FG002|NOT COMPLETED|Treatment Cycle 2||0
6321645|NCT00461305|7226994|FG000|STARTED|Treatment|Enrolled|355
6321646|NCT00461305|7226995|FG001|STARTED|Treatment|Enrolled|65
6321647|NCT00461305|7226994|FG000|Subjects Dispensed Drugs|Treatment||350
6321648|NCT00461305|7226995|FG001|Subjects Dispensed Drugs|Treatment||65
6321649|NCT00461305|7226994|FG000|Subjects Received Treatment|Treatment|FAS, safety population|349
6321650|NCT00461305|7226995|FG001|Subjects Received Treatment|Treatment|FAS, safety population|65
6321651|NCT00461305|7226994|FG000|COMPLETED|Treatment||254
6321652|NCT00461305|7226995|FG001|COMPLETED|Treatment||56
6321653|NCT00461305|7226994|FG000|NOT COMPLETED|Treatment||101
6321654|NCT00461305|7226995|FG001|NOT COMPLETED|Treatment||9
6321655|NCT00461305|7226994|FG000|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
6321656|NCT00461305|7226995|FG001|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
6321657|NCT00461305|7226994|FG000|COMPLETED|Continued Treatment||254
6321658|NCT00461305|7226995|FG001|COMPLETED|Continued Treatment||0
6321659|NCT00461305|7226994|FG000|NOT COMPLETED|Continued Treatment||95
6321660|NCT00461305|7226995|FG001|NOT COMPLETED|Continued Treatment||0
6321661|NCT00461331|7227002|FG000|STARTED|Intervention 1||10
6321662|NCT00461331|7227003|FG001|STARTED|Intervention 1||10
6321663|NCT00461331|7227002|FG000|COMPLETED|Intervention 1||10
6321664|NCT00461331|7227003|FG001|COMPLETED|Intervention 1||10
6321665|NCT00461331|7227002|FG000|NOT COMPLETED|Intervention 1||0
6321666|NCT00461331|7227003|FG001|NOT COMPLETED|Intervention 1||0
6321667|NCT00461331|7227002|FG000|STARTED|Washout||10
6321668|NCT00461331|7227003|FG001|STARTED|Washout||10
6321669|NCT00461331|7227002|FG000|COMPLETED|Washout||10
6321670|NCT00461331|7227003|FG001|COMPLETED|Washout||10
6321671|NCT00461331|7227002|FG000|NOT COMPLETED|Washout||0
6321672|NCT00461331|7227003|FG001|NOT COMPLETED|Washout||0
6321673|NCT00461331|7227002|FG000|STARTED|Intervention 2||10
6321674|NCT00461331|7227003|FG001|STARTED|Intervention 2||10
6321675|NCT00461331|7227002|FG000|COMPLETED|Intervention 2||10
6321676|NCT00461331|7227003|FG001|COMPLETED|Intervention 2||10
6321677|NCT00461331|7227002|FG000|NOT COMPLETED|Intervention 2||0
6321678|NCT00461331|7227003|FG001|NOT COMPLETED|Intervention 2||0
6321679|NCT00461500|7227012|FG000|STARTED|Overall Study||37
6321680|NCT00461500|7227013|FG001|STARTED|Overall Study||44
6321681|NCT00461500|7227012|FG000|COMPLETED|Overall Study||30
6321682|NCT00461500|7227013|FG001|COMPLETED|Overall Study||38
6321683|NCT00461500|7227012|FG000|NOT COMPLETED|Overall Study||7
6321684|NCT00461500|7227013|FG001|NOT COMPLETED|Overall Study||6
6321685|NCT00461513|7227021|FG000|STARTED|Overall Study|6 patients dropped at time of randomization|187
6321686|NCT00461513|7227022|FG001|STARTED|Overall Study|2 patients dropped at time of randomization|197
6321687|NCT00461513|7227021|FG000|COMPLETED|Overall Study||165
6321688|NCT00461513|7227022|FG001|COMPLETED|Overall Study||172
6321689|NCT00461513|7227021|FG000|NOT COMPLETED|Overall Study||22
6321690|NCT00461513|7227022|FG001|NOT COMPLETED|Overall Study||25
6321691|NCT00461552|7227034|FG000|STARTED|Overall Study||7
6321692|NCT00461552|7227035|FG001|STARTED|Overall Study||7
6321693|NCT00461552|7227034|FG000|COMPLETED|Overall Study||7
6321694|NCT00461552|7227035|FG001|COMPLETED|Overall Study||5
6321695|NCT00461552|7227034|FG000|NOT COMPLETED|Overall Study||0
6321696|NCT00461552|7227035|FG001|NOT COMPLETED|Overall Study||2
6321697|NCT00461591|7227043|FG000|STARTED|Overall Study||406
6321698|NCT00461591|7227044|FG001|STARTED|Overall Study||396
6321699|NCT00461591|7227043|FG000|COMPLETED|Overall Study||317
6321700|NCT00461591|7227044|FG001|COMPLETED|Overall Study||311
6321701|NCT00461591|7227043|FG000|NOT COMPLETED|Overall Study||89
6321702|NCT00461591|7227044|FG001|NOT COMPLETED|Overall Study||85
6321703|NCT00461630|7227052|FG000|STARTED|Overall Study||12838
6321704|NCT00461630|7227053|FG001|STARTED|Overall Study||12835
6321705|NCT00461630|7227052|FG000|COMPLETED|Overall Study||11932
6321706|NCT00461630|7227053|FG001|COMPLETED|Overall Study||12008
6321707|NCT00461630|7227052|FG000|NOT COMPLETED|Overall Study||906
6775172|NCT03880227|7703104|FG001|COMPLETED|1 Week Washout/ Delay||20
6321708|NCT00461630|7227053|FG001|NOT COMPLETED|Overall Study||827
6321709|NCT00461708|7227061|FG000|STARTED|Overall Study||115
6321710|NCT00461708|7227062|FG001|STARTED|Overall Study||38
6321711|NCT00461708|7227061|FG000|COMPLETED|Overall Study||0
6321712|NCT00461708|7227062|FG001|COMPLETED|Overall Study||0
6321713|NCT00461708|7227061|FG000|NOT COMPLETED|Overall Study||115
6321714|NCT00461708|7227062|FG001|NOT COMPLETED|Overall Study||38
6321715|NCT00461734|7227073|FG000|STARTED|Overall Study||120
6321716|NCT00461734|7227074|FG001|STARTED|Overall Study||120
6321717|NCT00461734|7227073|FG000|COMPLETED|Overall Study||62
6321718|NCT00461734|7227074|FG001|COMPLETED|Overall Study||60
6321719|NCT00461734|7227073|FG000|NOT COMPLETED|Overall Study||58
6321720|NCT00461734|7227074|FG001|NOT COMPLETED|Overall Study||60
6321721|NCT00461773|7227087|FG000|STARTED|Overall Study||3
6321722|NCT00461773|7227088|FG001|STARTED|Overall Study||2
6321723|NCT00461773|7227087|FG000|COMPLETED|Overall Study||3
6321724|NCT00461773|7227088|FG001|COMPLETED|Overall Study||2
6321725|NCT00461773|7227087|FG000|NOT COMPLETED|Overall Study||0
6321726|NCT00461773|7227088|FG001|NOT COMPLETED|Overall Study||0
6321727|NCT00461786|7227094|FG000|STARTED|Overall Study||51
6321728|NCT00461786|7227094|FG000|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
6321729|NCT00461786|7227094|FG000|NOT COMPLETED|Overall Study||3
6321730|NCT00461851|7227098|FG000|STARTED|Overall Study||17
6321731|NCT00461851|7227098|FG000|COMPLETED|Overall Study||17
6321732|NCT00461851|7227098|FG000|NOT COMPLETED|Overall Study||0
6321733|NCT00461981|7227104|FG000|STARTED|Overall Study||50
6321734|NCT00461981|7227105|FG001|STARTED|Overall Study||51
6321735|NCT00461981|7227104|FG000|COMPLETED|Overall Study||39
6321736|NCT00461981|7227105|FG001|COMPLETED|Overall Study||42
6321737|NCT00461981|7227104|FG000|NOT COMPLETED|Overall Study||11
6321738|NCT00461981|7227105|FG001|NOT COMPLETED|Overall Study||9
6321739|NCT00462020|7227113|FG000|STARTED|Overall Study||52
6321740|NCT00462020|7227114|FG001|STARTED|Overall Study||50
6321741|NCT00462020|7227113|FG000|COMPLETED|Overall Study||52
6321742|NCT00462020|7227114|FG001|COMPLETED|Overall Study||50
6321743|NCT00462020|7227113|FG000|NOT COMPLETED|Overall Study||0
6321744|NCT00462020|7227114|FG001|NOT COMPLETED|Overall Study||0
6321745|NCT00462072|7227123|FG000|STARTED|Baseline (Week 0)||10
6321746|NCT00462072|7227124|FG001|STARTED|Baseline (Week 0)||12
6321747|NCT00462072|7227125|FG002|STARTED|Baseline (Week 0)||9
6321748|NCT00462072|7227123|FG000|COMPLETED|Baseline (Week 0)||10
6321749|NCT00462072|7227124|FG001|COMPLETED|Baseline (Week 0)||12
6321750|NCT00462072|7227125|FG002|COMPLETED|Baseline (Week 0)||9
6321751|NCT00462072|7227123|FG000|NOT COMPLETED|Baseline (Week 0)||0
6321752|NCT00462072|7227124|FG001|NOT COMPLETED|Baseline (Week 0)||0
6321753|NCT00462072|7227125|FG002|NOT COMPLETED|Baseline (Week 0)||0
6321754|NCT00462072|7227123|FG000|STARTED|Week 10||10
6321755|NCT00462072|7227124|FG001|STARTED|Week 10||12
6321756|NCT00462072|7227125|FG002|STARTED|Week 10||9
6321757|NCT00462072|7227123|FG000|COMPLETED|Week 10||10
6321758|NCT00462072|7227124|FG001|COMPLETED|Week 10||12
6321759|NCT00462072|7227125|FG002|COMPLETED|Week 10||9
6321760|NCT00462072|7227123|FG000|NOT COMPLETED|Week 10||0
6321761|NCT00462072|7227124|FG001|NOT COMPLETED|Week 10||0
6321762|NCT00462072|7227125|FG002|NOT COMPLETED|Week 10||0
6321763|NCT00462124|7227137|FG000|STARTED|Overall Study||7
6321764|NCT00462124|7227137|FG000|COMPLETED|Overall Study|One implant was misplaced and was disacitivated by puncture.|6
6321765|NCT00462124|7227137|FG000|NOT COMPLETED|Overall Study||1
6321766|NCT00462228|7227142|FG000|STARTED|Memantine or Placebo 12 Weeks||11
6321767|NCT00462228|7227142|FG000|COMPLETED|Memantine or Placebo 12 Weeks||11
6321768|NCT00462228|7227142|FG000|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
6321769|NCT00462228|7227142|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
6321770|NCT00462228|7227142|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
6321771|NCT00462228|7227142|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
6321772|NCT00462228|7227142|FG000|STARTED|Placebo or Memantine 12 Weeks||11
6321773|NCT00462228|7227142|FG000|COMPLETED|Placebo or Memantine 12 Weeks||11
6321774|NCT00462228|7227142|FG000|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
6321775|NCT00462228|7227142|FG000|STARTED|No Treatment (Washout) 4 Weeks||11
6321776|NCT00462228|7227142|FG000|COMPLETED|No Treatment (Washout) 4 Weeks||11
6321777|NCT00462228|7227142|FG000|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
6321778|NCT00462280|7227153|FG000|STARTED|Overall Study||34
6321779|NCT00462280|7227154|FG001|STARTED|Overall Study||32
6321780|NCT00462280|7227155|FG002|STARTED|Overall Study||7
6321781|NCT00462280|7227156|FG003|STARTED|Overall Study||7
6321782|NCT00462280|7227153|FG000|COMPLETED|Overall Study||24
6558108|NCT01773421|7480814|FG004|STARTED|Treatment Phase||0
6321783|NCT00462280|7227154|FG001|COMPLETED|Overall Study||25
6321784|NCT00462280|7227155|FG002|COMPLETED|Overall Study||7
6321785|NCT00462280|7227156|FG003|COMPLETED|Overall Study||4
6321786|NCT00462280|7227153|FG000|NOT COMPLETED|Overall Study||10
6321787|NCT00462280|7227154|FG001|NOT COMPLETED|Overall Study||7
6321788|NCT00462280|7227155|FG002|NOT COMPLETED|Overall Study||0
6321789|NCT00462280|7227156|FG003|NOT COMPLETED|Overall Study||3
6321790|NCT00462306|7227170|FG000|STARTED|Overall Study||4074
6321791|NCT00462306|7227171|FG001|STARTED|Overall Study||503
6321792|NCT00462306|7227170|FG000|COMPLETED|Overall Study||4074
6321793|NCT00462306|7227171|FG001|COMPLETED|Overall Study||490
6321794|NCT00462306|7227170|FG000|NOT COMPLETED|Overall Study||0
6321795|NCT00462306|7227171|FG001|NOT COMPLETED|Overall Study||13
6321796|NCT00462332|7227181|FG000|STARTED|Overall Study||45
6321797|NCT00462332|7227182|FG001|STARTED|Overall Study||41
6321798|NCT00462332|7227181|FG000|COMPLETED|Overall Study||45
6321799|NCT00462332|7227182|FG001|COMPLETED|Overall Study||41
6321800|NCT00462332|7227181|FG000|NOT COMPLETED|Overall Study||0
6321801|NCT00462332|7227182|FG001|NOT COMPLETED|Overall Study||0
6321802|NCT00462345|7227190|FG000|STARTED|Overall Study||40
6321803|NCT00462345|7227190|FG000|Completed First Course|Overall Study||38
6321804|NCT00462345|7227190|FG000|COMPLETED|Overall Study||37
6321805|NCT00462345|7227190|FG000|NOT COMPLETED|Overall Study||3
6321806|NCT00462384|7227194|FG000|STARTED|Overall Study||39
6321807|NCT00462384|7227194|FG000|COMPLETED|Overall Study||30
6321808|NCT00462384|7227194|FG000|NOT COMPLETED|Overall Study||9
6321809|NCT00462423|7227198|FG000|STARTED|Overall Study||50
6321810|NCT00462423|7227198|FG000|COMPLETED|Overall Study||50
6321811|NCT00462423|7227198|FG000|NOT COMPLETED|Overall Study||0
6321812|NCT00462449|7227205|FG000|STARTED|Overall Study||13
6321813|NCT00462449|7227206|FG001|STARTED|Overall Study||10
6321814|NCT00462449|7227205|FG000|COMPLETED|Overall Study||13
6321815|NCT00462449|7227206|FG001|COMPLETED|Overall Study||10
6321816|NCT00462449|7227205|FG000|NOT COMPLETED|Overall Study||0
6321817|NCT00462449|7227206|FG001|NOT COMPLETED|Overall Study||0
6321818|NCT00462462|7227214|FG000|STARTED|Overall Study||17
6321819|NCT00462462|7227215|FG001|STARTED|Overall Study||14
6321820|NCT00462462|7227214|FG000|COMPLETED|Overall Study||17
6321821|NCT00462462|7227215|FG001|COMPLETED|Overall Study||13
6321822|NCT00462462|7227214|FG000|NOT COMPLETED|Overall Study||0
6321823|NCT00462462|7227215|FG001|NOT COMPLETED|Overall Study||1
6321824|NCT00462488|7227225|FG000|STARTED|Overall Study||23
6321825|NCT00462488|7227226|FG001|STARTED|Overall Study||23
6321826|NCT00462488|7227225|FG000|Completed Induction Phase|Overall Study||22
6321827|NCT00462488|7227226|FG001|Completed Induction Phase|Overall Study||23
6321828|NCT00462488|7227225|FG000|Completed Induction 2/Maintenance 1|Overall Study||18
6321829|NCT00462488|7227226|FG001|Completed Induction 2/Maintenance 1|Overall Study||9
6321830|NCT00462488|7227225|FG000|Completed Maintenance 2|Overall Study||7
6321831|NCT00462488|7227226|FG001|Completed Maintenance 2|Overall Study||6
6321832|NCT00462488|7227225|FG000|COMPLETED|Overall Study||3
6321833|NCT00462488|7227226|FG001|COMPLETED|Overall Study||6
6321834|NCT00462488|7227225|FG000|NOT COMPLETED|Overall Study||20
6321835|NCT00462488|7227226|FG001|NOT COMPLETED|Overall Study||17
6321836|NCT00462501|7227232|FG000|STARTED|Overall Study||35
6321837|NCT00462501|7227232|FG000|COMPLETED|Overall Study||30
6321838|NCT00462501|7227232|FG000|NOT COMPLETED|Overall Study||5
6321839|NCT00462605|7227236|FG000|STARTED|Overall Study||24
6321840|NCT00462605|7227236|FG000|COMPLETED|Overall Study||10
6321841|NCT00462605|7227236|FG000|NOT COMPLETED|Overall Study||14
6321842|NCT00462644|7227242|FG000|STARTED|Overall Study||18
6321843|NCT00462644|7227243|FG001|STARTED|Overall Study||12
6321844|NCT00462644|7227242|FG000|COMPLETED|Overall Study||18
6321845|NCT00462644|7227243|FG001|COMPLETED|Overall Study||12
6321846|NCT00462644|7227242|FG000|NOT COMPLETED|Overall Study||0
6321847|NCT00462644|7227243|FG001|NOT COMPLETED|Overall Study||0
6321848|NCT00462670|7227251|FG000|STARTED|Overall Study||57
6321849|NCT00462670|7227252|FG001|STARTED|Overall Study||53
6321850|NCT00462670|7227251|FG000|COMPLETED|Overall Study||52
6321851|NCT00462670|7227252|FG001|COMPLETED|Overall Study||46
6321852|NCT00462670|7227251|FG000|NOT COMPLETED|Overall Study||5
6321853|NCT00462670|7227252|FG001|NOT COMPLETED|Overall Study||7
6321854|NCT00462709|7227258|FG000|STARTED|Overall Study||146
6321855|NCT00462709|7227258|FG000|COMPLETED|Overall Study||79
6321856|NCT00462709|7227258|FG000|NOT COMPLETED|Overall Study||67
6321857|NCT00462722|7227265|FG000|STARTED|Overall Study||50
6321858|NCT00462722|7227266|FG001|STARTED|Overall Study||55
6321859|NCT00462722|7227267|FG002|STARTED|Overall Study||54
6321860|NCT00462722|7227265|FG000|COMPLETED|Overall Study||37
6321861|NCT00462722|7227266|FG001|COMPLETED|Overall Study||51
6321862|NCT00462722|7227267|FG002|COMPLETED|Overall Study||42
6321863|NCT00462722|7227265|FG000|NOT COMPLETED|Overall Study||13
6321864|NCT00462722|7227266|FG001|NOT COMPLETED|Overall Study||4
6321865|NCT00462722|7227267|FG002|NOT COMPLETED|Overall Study||12
6321866|NCT00462735|7227275|FG000|STARTED|Overall Study||33
6321867|NCT00462735|7227275|FG000|COMPLETED|Overall Study||33
6321868|NCT00462735|7227275|FG000|NOT COMPLETED|Overall Study||0
6321869|NCT00462761|7227280|FG000|STARTED|Overall Study||76
6321870|NCT00462761|7227280|FG000|COMPLETED|Overall Study||0
6321871|NCT00462761|7227280|FG000|NOT COMPLETED|Overall Study||76
6321872|NCT00462826|7227312|FG000|STARTED|Overall Study||49
6321873|NCT00462826|7227312|FG000|COMPLETED|Overall Study||44
6321874|NCT00462826|7227312|FG000|NOT COMPLETED|Overall Study||5
6321875|NCT00462839|7227324|FG000|STARTED|Viewed First||53
6321876|NCT00462839|7227325|FG001|STARTED|Viewed First||53
6321877|NCT00462839|7227324|FG000|COMPLETED|Viewed First||53
6321878|NCT00462839|7227325|FG001|COMPLETED|Viewed First||53
6321879|NCT00462839|7227324|FG000|NOT COMPLETED|Viewed First||0
6321880|NCT00462839|7227325|FG001|NOT COMPLETED|Viewed First||0
6321881|NCT00462839|7227324|FG000|STARTED|Viewed Second||53
6321882|NCT00462839|7227325|FG001|STARTED|Viewed Second||53
6321883|NCT00462839|7227324|FG000|COMPLETED|Viewed Second||53
6321884|NCT00462839|7227325|FG001|COMPLETED|Viewed Second||53
6321885|NCT00462839|7227324|FG000|NOT COMPLETED|Viewed Second||0
6321886|NCT00462839|7227325|FG001|NOT COMPLETED|Viewed Second||0
6321887|NCT00462865|7227331|FG000|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
6321888|NCT00462865|7227331|FG000|COMPLETED|Overall Study||17
6321889|NCT00462865|7227331|FG000|NOT COMPLETED|Overall Study||1
6321890|NCT00462917|7227339|FG000|STARTED|Overall Study||72
6321891|NCT00462917|7227340|FG001|STARTED|Overall Study||75
6321892|NCT00462917|7227341|FG002|STARTED|Overall Study||66
6321893|NCT00462917|7227342|FG003|STARTED|Overall Study||77
6321894|NCT00462917|7227339|FG000|Met With Genetic Counselor|Overall Study||66
6321895|NCT00462917|7227340|FG001|Met With Genetic Counselor|Overall Study||71
6321896|NCT00462917|7227341|FG002|Met With Genetic Counselor|Overall Study||56
6321897|NCT00462917|7227342|FG003|Met With Genetic Counselor|Overall Study||71
6321898|NCT00462917|7227339|FG000|Received Risk Information|Overall Study||64
6321899|NCT00462917|7227340|FG001|Received Risk Information|Overall Study||70
6321900|NCT00462917|7227341|FG002|Received Risk Information|Overall Study||55
6321901|NCT00462917|7227342|FG003|Received Risk Information|Overall Study||68
6321902|NCT00462917|7227339|FG000|Completed 6 Week Follow-up|Overall Study||63
6321903|NCT00462917|7227340|FG001|Completed 6 Week Follow-up|Overall Study||70
6321904|NCT00462917|7227341|FG002|Completed 6 Week Follow-up|Overall Study||55
6321905|NCT00462917|7227342|FG003|Completed 6 Week Follow-up|Overall Study||68
6321906|NCT00462917|7227339|FG000|Completed 6 Month Follow-up|Overall Study||63
6321907|NCT00462917|7227340|FG001|Completed 6 Month Follow-up|Overall Study||68
6321908|NCT00462917|7227341|FG002|Completed 6 Month Follow-up|Overall Study||55
6321909|NCT00462917|7227342|FG003|Completed 6 Month Follow-up|Overall Study||66
6321910|NCT00462917|7227339|FG000|COMPLETED|Overall Study||62
6321911|NCT00462917|7227340|FG001|COMPLETED|Overall Study||65
6321912|NCT00462917|7227341|FG002|COMPLETED|Overall Study||54
6321913|NCT00462917|7227342|FG003|COMPLETED|Overall Study||66
6321914|NCT00462917|7227339|FG000|NOT COMPLETED|Overall Study||10
6321915|NCT00462917|7227340|FG001|NOT COMPLETED|Overall Study||10
6321916|NCT00462917|7227341|FG002|NOT COMPLETED|Overall Study||12
6321917|NCT00462917|7227342|FG003|NOT COMPLETED|Overall Study||11
6321918|NCT00462982|7227352|FG000|STARTED|Overall Study||8
6321919|NCT00462982|7227352|FG000|COMPLETED|Overall Study||5
6321920|NCT00462982|7227352|FG000|NOT COMPLETED|Overall Study||3
6321921|NCT00463047|7227356|FG000|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
6321922|NCT00463047|7227357|FG001|STARTED|Titration Period 1||160
6321923|NCT00463047|7227356|FG000|COMPLETED|Titration Period 1||123
6321924|NCT00463047|7227357|FG001|COMPLETED|Titration Period 1||121
6321925|NCT00463047|7227356|FG000|NOT COMPLETED|Titration Period 1||37
6321926|NCT00463047|7227357|FG001|NOT COMPLETED|Titration Period 1||39
6321927|NCT00463047|7227356|FG000|STARTED|Titration Period 2||123
6321928|NCT00463047|7227357|FG001|STARTED|Titration Period 2||121
6321929|NCT00463047|7227356|FG000|COMPLETED|Titration Period 2||93
6321930|NCT00463047|7227357|FG001|COMPLETED|Titration Period 2||98
6321931|NCT00463047|7227356|FG000|NOT COMPLETED|Titration Period 2||30
6321932|NCT00463047|7227357|FG001|NOT COMPLETED|Titration Period 2||23
6321933|NCT00463047|7227356|FG000|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
6321934|NCT00463047|7227357|FG001|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
6321935|NCT00463047|7227356|FG000|COMPLETED|Double-Blind Treatment Period 1||93
6321936|NCT00463047|7227357|FG001|COMPLETED|Double-Blind Treatment Period 1||90
6321937|NCT00463047|7227356|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||3
6321938|NCT00463047|7227357|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||4
6321939|NCT00463047|7227356|FG000|STARTED|Double-Blind Treatment Period 2||93
6321940|NCT00463047|7227357|FG001|STARTED|Double-Blind Treatment Period 2||90
6321941|NCT00463047|7227356|FG000|COMPLETED|Double-Blind Treatment Period 2||92
6321942|NCT00463047|7227357|FG001|COMPLETED|Double-Blind Treatment Period 2||88
6321943|NCT00463047|7227356|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
6321944|NCT00463047|7227357|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||2
6321945|NCT00463060|7227366|FG000|STARTED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
6321946|NCT00463060|7227366|FG000|COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||3
6321947|NCT00463060|7227366|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy + Sunitinib 25mg||0
6321948|NCT00463060|7227366|FG000|STARTED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
6321949|NCT00463060|7227366|FG000|COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||3
6321950|NCT00463060|7227366|FG000|NOT COMPLETED|Phase 1-Radiation 40 Gy+Sunitinib 37.5mg||0
6321951|NCT00463060|7227366|FG000|STARTED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
6321952|NCT00463060|7227366|FG000|COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||10
6321953|NCT00463060|7227366|FG000|NOT COMPLETED|Phase 1-Radiation 50 Gy+Sunitinib 37.5mg||0
6321954|NCT00463060|7227366|FG000|STARTED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
6321955|NCT00463060|7227366|FG000|COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||0
6321956|NCT00463060|7227366|FG000|NOT COMPLETED|Phase 1-Radiation 50Gy +Sunitinib 50mg||5
6321957|NCT00463060|7227366|FG000|STARTED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg|Not all patients participated in both Phase 1 and Phase II|26
6321958|NCT00463060|7227366|FG000|COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||25
6321959|NCT00463060|7227366|FG000|NOT COMPLETED|Phase 2-Radiation 50Gy +Sunitinib 37.5mg||1
6321960|NCT00463151|7227379|FG000|STARTED|Overall Study||35
6321961|NCT00463151|7227380|FG001|STARTED|Overall Study||29
6321962|NCT00463151|7227381|FG002|STARTED|Overall Study||29
6321963|NCT00463151|7227382|FG003|STARTED|Overall Study||31
6321964|NCT00463151|7227379|FG000|COMPLETED|Overall Study||33
6321965|NCT00463151|7227380|FG001|COMPLETED|Overall Study||24
6321966|NCT00463151|7227381|FG002|COMPLETED|Overall Study||26
6321967|NCT00463151|7227382|FG003|COMPLETED|Overall Study||24
6321968|NCT00463151|7227379|FG000|NOT COMPLETED|Overall Study||2
6321969|NCT00463151|7227380|FG001|NOT COMPLETED|Overall Study||5
6321970|NCT00463151|7227381|FG002|NOT COMPLETED|Overall Study||3
6321971|NCT00463151|7227382|FG003|NOT COMPLETED|Overall Study||7
6321972|NCT00463229|7227394|FG000|STARTED|Overall Study||52
6321973|NCT00463229|7227395|FG001|STARTED|Overall Study||49
6321974|NCT00463229|7227394|FG000|COMPLETED|Overall Study||43
6321975|NCT00463229|7227395|FG001|COMPLETED|Overall Study||39
6321976|NCT00463229|7227394|FG000|NOT COMPLETED|Overall Study||9
6321977|NCT00463229|7227395|FG001|NOT COMPLETED|Overall Study||10
6321978|NCT00463346|7227404|FG000|STARTED|Overall Study||12
6321979|NCT00463346|7227405|FG001|STARTED|Overall Study||11
6321980|NCT00463346|7227404|FG000|COMPLETED|Overall Study||9
6321981|NCT00463346|7227405|FG001|COMPLETED|Overall Study||8
6321982|NCT00463346|7227404|FG000|NOT COMPLETED|Overall Study||3
6321983|NCT00463346|7227405|FG001|NOT COMPLETED|Overall Study||3
6321984|NCT00463385|7227417|FG000|STARTED|Overall Study||22
6321985|NCT00463385|7227418|FG001|STARTED|Overall Study||22
6321986|NCT00463385|7227419|FG002|STARTED|Overall Study||22
6321987|NCT00463385|7227420|FG003|STARTED|Overall Study||22
6321988|NCT00463385|7227417|FG000|Treated|Overall Study||22
6321989|NCT00463385|7227418|FG001|Treated|Overall Study||22
6321990|NCT00463385|7227419|FG002|Treated|Overall Study||19
6321991|NCT00463385|7227420|FG003|Treated|Overall Study||22
6321992|NCT00463385|7227417|FG000|COMPLETED|Overall Study||0
6321993|NCT00463385|7227418|FG001|COMPLETED|Overall Study||0
6321994|NCT00463385|7227419|FG002|COMPLETED|Overall Study||0
6321995|NCT00463385|7227420|FG003|COMPLETED|Overall Study||0
6321996|NCT00463385|7227417|FG000|NOT COMPLETED|Overall Study||22
6321997|NCT00463385|7227418|FG001|NOT COMPLETED|Overall Study||22
6321998|NCT00463385|7227419|FG002|NOT COMPLETED|Overall Study||22
6321999|NCT00463385|7227420|FG003|NOT COMPLETED|Overall Study||22
6322000|NCT00463437|7227442|FG000|STARTED|Overall Study||359
6322001|NCT00463437|7227443|FG001|STARTED|Overall Study||363
6322002|NCT00463437|7227444|FG002|STARTED|Overall Study||358
6322003|NCT00463437|7227445|FG003|STARTED|Overall Study||357
6322004|NCT00463437|7227442|FG000|COMPLETED|Overall Study||355
6322005|NCT00463437|7227443|FG001|COMPLETED|Overall Study||352
6322006|NCT00463437|7227444|FG002|COMPLETED|Overall Study||352
6322007|NCT00463437|7227445|FG003|COMPLETED|Overall Study||350
6322008|NCT00463437|7227442|FG000|NOT COMPLETED|Overall Study||4
6322009|NCT00463437|7227443|FG001|NOT COMPLETED|Overall Study||11
6322010|NCT00463437|7227444|FG002|NOT COMPLETED|Overall Study||6
6322011|NCT00463437|7227445|FG003|NOT COMPLETED|Overall Study||7
6322012|NCT00463476|7227457|FG000|STARTED|Overall Study||151
6322013|NCT00463476|7227458|FG001|STARTED|Overall Study||154
6322014|NCT00463476|7227457|FG000|COMPLETED|Overall Study||149
6322015|NCT00463476|7227458|FG001|COMPLETED|Overall Study||151
6322016|NCT00463476|7227457|FG000|NOT COMPLETED|Overall Study||2
6322017|NCT00463476|7227458|FG001|NOT COMPLETED|Overall Study||3
6322018|NCT00463567|7227471|FG000|STARTED|Overall Study|Randomized Participants|420
6322019|NCT00463567|7227472|FG001|STARTED|Overall Study||418
6322020|NCT00463567|7227473|FG002|STARTED|Overall Study||420
6322021|NCT00463567|7227474|FG003|STARTED|Overall Study||425
6322022|NCT00463567|7227475|FG004|STARTED|Overall Study||130
6322023|NCT00463567|7227476|FG005|STARTED|Overall Study||123
6322024|NCT00463567|7227477|FG006|STARTED|Overall Study||123
6322025|NCT00463567|7227471|FG000|Safety Population: Received Study Drug|Overall Study||416
6322026|NCT00463567|7227472|FG001|Safety Population: Received Study Drug|Overall Study||416
6322027|NCT00463567|7227473|FG002|Safety Population: Received Study Drug|Overall Study||415
6322028|NCT00463567|7227474|FG003|Safety Population: Received Study Drug|Overall Study||418
6322029|NCT00463567|7227475|FG004|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
6322030|NCT00463567|7227476|FG005|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
6322031|NCT00463567|7227477|FG006|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
6322032|NCT00463567|7227471|FG000|COMPLETED|Overall Study||325
6322033|NCT00463567|7227472|FG001|COMPLETED|Overall Study||341
6322034|NCT00463567|7227473|FG002|COMPLETED|Overall Study||331
6322035|NCT00463567|7227474|FG003|COMPLETED|Overall Study||294
6322036|NCT00463567|7227475|FG004|COMPLETED|Overall Study||107
6322037|NCT00463567|7227476|FG005|COMPLETED|Overall Study||102
6322038|NCT00463567|7227477|FG006|COMPLETED|Overall Study||112
6322039|NCT00463567|7227471|FG000|NOT COMPLETED|Overall Study||95
6322040|NCT00463567|7227472|FG001|NOT COMPLETED|Overall Study||77
6322041|NCT00463567|7227473|FG002|NOT COMPLETED|Overall Study||89
6322042|NCT00463567|7227474|FG003|NOT COMPLETED|Overall Study||131
6322043|NCT00463567|7227475|FG004|NOT COMPLETED|Overall Study||23
6322044|NCT00463567|7227476|FG005|NOT COMPLETED|Overall Study||21
6322045|NCT00463567|7227477|FG006|NOT COMPLETED|Overall Study||11
6322046|NCT00463580|7227501|FG000|STARTED|Overall Study||30
6322047|NCT00463580|7227502|FG001|STARTED|Overall Study||30
6322048|NCT00463580|7227501|FG000|COMPLETED|Overall Study||27
6322049|NCT00463580|7227502|FG001|COMPLETED|Overall Study||28
6322050|NCT00463580|7227501|FG000|NOT COMPLETED|Overall Study||3
6322051|NCT00463580|7227502|FG001|NOT COMPLETED|Overall Study||2
6322052|NCT00463606|7227517|FG000|STARTED|Overall Study||253
6322053|NCT00463606|7227518|FG001|STARTED|Overall Study||254
6322054|NCT00463606|7227519|FG002|STARTED|Overall Study||251
6322055|NCT00463606|7227517|FG000|COMPLETED|Overall Study||212
6322056|NCT00463606|7227518|FG001|COMPLETED|Overall Study||220
6322057|NCT00463606|7227519|FG002|COMPLETED|Overall Study||231
6322058|NCT00463606|7227517|FG000|NOT COMPLETED|Overall Study||41
6322059|NCT00463606|7227518|FG001|NOT COMPLETED|Overall Study||34
6322060|NCT00463606|7227519|FG002|NOT COMPLETED|Overall Study||20
6322061|NCT00463684|7227527|FG000|STARTED|Overall Study||278
6322062|NCT00463684|7227527|FG000|COMPLETED|Overall Study||274
6322063|NCT00463684|7227527|FG000|NOT COMPLETED|Overall Study||4
6322064|NCT00463788|7227533|FG000|STARTED|Overall Study||115
6322065|NCT00463788|7227534|FG001|STARTED|Overall Study||58
6322066|NCT00463788|7227533|FG000|Treated|Overall Study||114
6322067|NCT00463788|7227534|FG001|Treated|Overall Study||57
6322068|NCT00463788|7227533|FG000|COMPLETED|Overall Study||6
6322069|NCT00463788|7227534|FG001|COMPLETED|Overall Study||4
6322070|NCT00463788|7227533|FG000|NOT COMPLETED|Overall Study||109
6322071|NCT00463788|7227534|FG001|NOT COMPLETED|Overall Study||54
6322072|NCT00463801|7227541|FG000|STARTED|Overall Study||52
6322073|NCT00463801|7227541|FG000|COMPLETED|Overall Study||39
6322074|NCT00463801|7227541|FG000|NOT COMPLETED|Overall Study||13
6322075|NCT00463840|7227545|FG000|STARTED|Overall Study||24
6322076|NCT00463840|7227545|FG000|COMPLETED|Overall Study||12
6322077|NCT00463840|7227545|FG000|NOT COMPLETED|Overall Study||12
6322078|NCT00463866|7227551|FG000|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
6322079|NCT00463866|7227552|FG001|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
6322080|NCT00463866|7227551|FG000|COMPLETED|Overall Study||3699
6322081|NCT00463866|7227552|FG001|COMPLETED|Overall Study||3705
6322082|NCT00463866|7227551|FG000|NOT COMPLETED|Overall Study||309
6322083|NCT00463866|7227552|FG001|NOT COMPLETED|Overall Study||340
6322084|NCT00464087|7227561|FG000|STARTED|Overall Study||49
6322085|NCT00464087|7227562|FG001|STARTED|Overall Study||51
6322086|NCT00464087|7227563|FG002|STARTED|Overall Study||29
6322087|NCT00464087|7227561|FG000|COMPLETED|Overall Study||49
6322088|NCT00464087|7227562|FG001|COMPLETED|Overall Study||51
6322089|NCT00464087|7227563|FG002|COMPLETED|Overall Study||0
6322090|NCT00464087|7227561|FG000|NOT COMPLETED|Overall Study||0
6322091|NCT00464087|7227562|FG001|NOT COMPLETED|Overall Study||0
6322092|NCT00464087|7227563|FG002|NOT COMPLETED|Overall Study||29
6322093|NCT00464204|7227573|FG000|STARTED|Overall Study||100
6322094|NCT00464204|7227574|FG001|STARTED|Overall Study||96
6322095|NCT00464204|7227573|FG000|Completed Treatment|Overall Study||81
6322096|NCT00464204|7227574|FG001|Completed Treatment|Overall Study||83
6322097|NCT00464204|7227573|FG000|Day 30 Follow-up Performed|Overall Study||89
6322098|NCT00464204|7227574|FG001|Day 30 Follow-up Performed|Overall Study||83
6322099|NCT00464204|7227573|FG000|Day 90 Follow-up Performed|Overall Study||69
6322100|NCT00464204|7227574|FG001|Day 90 Follow-up Performed|Overall Study||74
6322101|NCT00464204|7227573|FG000|Withdrawal Due to Discharge From ICU|Overall Study||18
6322102|NCT00464204|7227574|FG001|Withdrawal Due to Discharge From ICU|Overall Study||11
6322103|NCT00464204|7227573|FG000|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
6322104|NCT00464204|7227574|FG001|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
6322105|NCT00464204|7227573|FG000|NOT COMPLETED|Overall Study||49
6322106|NCT00464204|7227574|FG001|NOT COMPLETED|Overall Study||32
6322107|NCT00464269|7227586|FG000|STARTED|Overall Study||99
6322108|NCT00464269|7227587|FG001|STARTED|Overall Study||99
6322109|NCT00464269|7227588|FG002|STARTED|Overall Study||100
6322110|NCT00464269|7227589|FG003|STARTED|Overall Study||102
6322111|NCT00464269|7227586|FG000|COMPLETED|Overall Study||93
6322112|NCT00464269|7227587|FG001|COMPLETED|Overall Study||82
6322113|NCT00464269|7227588|FG002|COMPLETED|Overall Study||93
6322114|NCT00464269|7227589|FG003|COMPLETED|Overall Study||93
6322115|NCT00464269|7227586|FG000|NOT COMPLETED|Overall Study||6
6322116|NCT00464269|7227587|FG001|NOT COMPLETED|Overall Study||17
6322117|NCT00464269|7227588|FG002|NOT COMPLETED|Overall Study||7
6322118|NCT00464269|7227589|FG003|NOT COMPLETED|Overall Study||9
6322119|NCT00464308|7227604|FG000|STARTED|Overall Study||464
6322120|NCT00464308|7227605|FG001|STARTED|Overall Study||469
6322121|NCT00464308|7227606|FG002|STARTED|Overall Study||459
6322122|NCT00464308|7227604|FG000|COMPLETED|Overall Study||395
6322123|NCT00464308|7227605|FG001|COMPLETED|Overall Study||406
6322124|NCT00464308|7227606|FG002|COMPLETED|Overall Study||400
6322125|NCT00464308|7227604|FG000|NOT COMPLETED|Overall Study||69
6322126|NCT00464308|7227605|FG001|NOT COMPLETED|Overall Study||63
6322127|NCT00464308|7227606|FG002|NOT COMPLETED|Overall Study||59
6322128|NCT00464334|7227625|FG000|STARTED|Overall Study||5
6322129|NCT00464334|7227626|FG001|STARTED|Overall Study||13
6322130|NCT00464334|7227627|FG002|STARTED|Overall Study||8
6322131|NCT00464334|7227628|FG003|STARTED|Overall Study||8
6322132|NCT00464334|7227629|FG004|STARTED|Overall Study||7
6322133|NCT00464334|7227630|FG005|STARTED|Overall Study||7
6322134|NCT00464334|7227631|FG006|STARTED|Overall Study||9
6322135|NCT00464334|7227632|FG007|STARTED|Overall Study||8
6322136|NCT00464334|7227633|FG008|STARTED|Overall Study||8
6322137|NCT00464334|7227634|FG009|STARTED|Overall Study||5
6322138|NCT00464334|7227635|FG010|STARTED|Overall Study||8
6322139|NCT00464334|7227625|FG000|COMPLETED|Overall Study||4
6322140|NCT00464334|7227626|FG001|COMPLETED|Overall Study||5
6322141|NCT00464334|7227627|FG002|COMPLETED|Overall Study||3
6322142|NCT00464334|7227628|FG003|COMPLETED|Overall Study||4
6322143|NCT00464334|7227629|FG004|COMPLETED|Overall Study||3
6322144|NCT00464334|7227630|FG005|COMPLETED|Overall Study||3
6322145|NCT00464334|7227631|FG006|COMPLETED|Overall Study||6
6322146|NCT00464334|7227632|FG007|COMPLETED|Overall Study||7
6322147|NCT00464334|7227633|FG008|COMPLETED|Overall Study||2
6322148|NCT00464334|7227634|FG009|COMPLETED|Overall Study||4
6322149|NCT00464334|7227635|FG010|COMPLETED|Overall Study||4
6322150|NCT00464334|7227625|FG000|NOT COMPLETED|Overall Study||1
6322151|NCT00464334|7227626|FG001|NOT COMPLETED|Overall Study||8
6322152|NCT00464334|7227627|FG002|NOT COMPLETED|Overall Study||5
6322153|NCT00464334|7227628|FG003|NOT COMPLETED|Overall Study||4
6322154|NCT00464334|7227629|FG004|NOT COMPLETED|Overall Study||4
6322155|NCT00464334|7227630|FG005|NOT COMPLETED|Overall Study||4
6322156|NCT00464334|7227631|FG006|NOT COMPLETED|Overall Study||3
6322157|NCT00464334|7227632|FG007|NOT COMPLETED|Overall Study||1
6322158|NCT00464334|7227633|FG008|NOT COMPLETED|Overall Study||6
6322159|NCT00464334|7227634|FG009|NOT COMPLETED|Overall Study||1
6322160|NCT00464334|7227635|FG010|NOT COMPLETED|Overall Study||4
6322161|NCT00464438|7227672|FG000|STARTED|Overall Study||85
6322162|NCT00464438|7227673|FG001|STARTED|Overall Study||86
6322163|NCT00464438|7227672|FG000|COMPLETED|Overall Study||83
6322164|NCT00464438|7227673|FG001|COMPLETED|Overall Study||80
6322165|NCT00464438|7227672|FG000|NOT COMPLETED|Overall Study||2
6322166|NCT00464438|7227673|FG001|NOT COMPLETED|Overall Study||6
6322167|NCT00464464|7227681|FG000|STARTED|Overall Study||41
6322168|NCT00464464|7227682|FG001|STARTED|Overall Study||39
6322169|NCT00464464|7227681|FG000|COMPLETED|Overall Study||36
6322170|NCT00464464|7227682|FG001|COMPLETED|Overall Study||36
6322171|NCT00464464|7227681|FG000|NOT COMPLETED|Overall Study||5
6322172|NCT00464464|7227682|FG001|NOT COMPLETED|Overall Study||3
6375578|NCT00756600|7286254|FG000|NOT COMPLETED|Overall Study||0
6375579|NCT00756600|7286255|FG001|NOT COMPLETED|Overall Study||0
6375580|NCT00756613|7286264|FG000|STARTED|Overall Study||512
6375581|NCT00756613|7286265|FG001|STARTED|Overall Study||532
6375582|NCT00756613|7286264|FG000|COMPLETED|Overall Study||426
6375583|NCT00756613|7286265|FG001|COMPLETED|Overall Study||462
6375584|NCT00756613|7286264|FG000|NOT COMPLETED|Overall Study||86
6375585|NCT00756613|7286265|FG001|NOT COMPLETED|Overall Study||70
6375586|NCT00756652|7286274|FG000|STARTED|Original Phase||41452
6375587|NCT00756652|7286275|FG001|STARTED|Original Phase||1039
6375588|NCT00756652|7286274|FG000|COMPLETED|Original Phase|At Year 7|6063
6375589|NCT00756652|7286275|FG001|COMPLETED|Original Phase||118
6375590|NCT00756652|7286274|FG000|NOT COMPLETED|Original Phase||35389
6375591|NCT00756652|7286275|FG001|NOT COMPLETED|Original Phase||921
6375592|NCT00756652|7286274|FG000|STARTED|Re-Op Phase||11101
6375593|NCT00756652|7286275|FG001|STARTED|Re-Op Phase|NA - The Re-Op Phase was limited in scope to data collection for only MemoryGel participants.|0
6375594|NCT00756652|7286274|FG000|COMPLETED|Re-Op Phase||8225
6375595|NCT00756652|7286275|FG001|COMPLETED|Re-Op Phase||0
6375596|NCT00756652|7286274|FG000|NOT COMPLETED|Re-Op Phase||2876
6375597|NCT00756652|7286275|FG001|NOT COMPLETED|Re-Op Phase||0
6377845|NCT00765388|7288508|FG001|COMPLETED|Period 1||6
6377846|NCT00765388|7288507|FG000|NOT COMPLETED|Period 1||1
6377847|NCT00765388|7288508|FG001|NOT COMPLETED|Period 1||5
6377848|NCT00765388|7288507|FG000|STARTED|Period 2||15
6377849|NCT00765388|7288508|FG001|STARTED|Period 2||6
6377850|NCT00765388|7288507|FG000|COMPLETED|Period 2||15
6377851|NCT00765388|7288508|FG001|COMPLETED|Period 2||6
6377852|NCT00765388|7288507|FG000|NOT COMPLETED|Period 2||0
6377853|NCT00765388|7288508|FG001|NOT COMPLETED|Period 2||0
6377854|NCT00765570|7288516|FG000|STARTED|Overall Study||9
6377855|NCT00765570|7288517|FG001|STARTED|Overall Study||3
6377856|NCT00765570|7288516|FG000|COMPLETED|Overall Study||7
6377857|NCT00765570|7288517|FG001|COMPLETED|Overall Study||3
6377858|NCT00765570|7288516|FG000|NOT COMPLETED|Overall Study||2
6377859|NCT00765570|7288517|FG001|NOT COMPLETED|Overall Study||0
6377860|NCT00765648|7288525|FG000|STARTED|Overall Study||110
6377861|NCT00765648|7288526|FG001|STARTED|Overall Study||116
6377862|NCT00765648|7288525|FG000|COMPLETED|Overall Study||109
6377863|NCT00765648|7288526|FG001|COMPLETED|Overall Study||114
6377864|NCT00765648|7288525|FG000|NOT COMPLETED|Overall Study||1
6377865|NCT00765648|7288526|FG001|NOT COMPLETED|Overall Study||2
6377866|NCT00765661|7288534|FG000|STARTED|Overall Study||32
6377867|NCT00765661|7288535|FG001|STARTED|Overall Study||31
6377868|NCT00765661|7288534|FG000|COMPLETED|Overall Study||32
6377869|NCT00765661|7288535|FG001|COMPLETED|Overall Study||31
6377870|NCT00765661|7288534|FG000|NOT COMPLETED|Overall Study||0
6377871|NCT00765661|7288535|FG001|NOT COMPLETED|Overall Study||0
6377872|NCT00765674|7288545|FG000|STARTED|Overall Study||287
6377873|NCT00765674|7288546|FG001|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
6377874|NCT00765674|7288547|FG002|STARTED|Overall Study||296
6377875|NCT00765674|7288548|FG003|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
6377876|NCT00765674|7288545|FG000|COMPLETED|Overall Study||266
6377877|NCT00765674|7288546|FG001|COMPLETED|Overall Study||276
6377878|NCT00765674|7288547|FG002|COMPLETED|Overall Study||279
6377879|NCT00765674|7288548|FG003|COMPLETED|Overall Study||285
6377880|NCT00765674|7288545|FG000|NOT COMPLETED|Overall Study||21
6377881|NCT00765674|7288546|FG001|NOT COMPLETED|Overall Study||22
6377882|NCT00765674|7288547|FG002|NOT COMPLETED|Overall Study||17
6377883|NCT00765674|7288548|FG003|NOT COMPLETED|Overall Study||25
6377884|NCT00765726|7288558|FG000|STARTED|Overall Study||12
6377885|NCT00765726|7288558|FG000|COMPLETED|Overall Study||3
6377886|NCT00765726|7288558|FG000|NOT COMPLETED|Overall Study||9
6377887|NCT00765817|7288564|FG000|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
6377888|NCT00765817|7288565|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
6377889|NCT00765817|7288564|FG000|COMPLETED|Overall Study||112
6377890|NCT00765817|7288565|FG001|COMPLETED|Overall Study||101
6377891|NCT00765817|7288564|FG000|NOT COMPLETED|Overall Study||26
6322173|NCT00464490|7227690|FG000|STARTED|Overall Study||21
6322174|NCT00464490|7227691|FG001|STARTED|Overall Study||21
6322175|NCT00464490|7227690|FG000|COMPLETED|Overall Study||10
6322176|NCT00464490|7227691|FG001|COMPLETED|Overall Study||10
6322177|NCT00464490|7227690|FG000|NOT COMPLETED|Overall Study||11
6322178|NCT00464490|7227691|FG001|NOT COMPLETED|Overall Study||11
6322179|NCT00464542|7227697|FG000|STARTED|Pre-treatment||12
6322180|NCT00464542|7227697|FG000|COMPLETED|Pre-treatment||10
6322181|NCT00464542|7227697|FG000|NOT COMPLETED|Pre-treatment||2
6322182|NCT00464542|7227697|FG000|STARTED|Post-treatment||10
6322183|NCT00464542|7227697|FG000|COMPLETED|Post-treatment||10
6322184|NCT00464542|7227697|FG000|NOT COMPLETED|Post-treatment||0
6322185|NCT00464568|7227701|FG000|STARTED|Overall Study||32
6322186|NCT00464568|7227701|FG000|COMPLETED|Overall Study||30
6322187|NCT00464568|7227701|FG000|NOT COMPLETED|Overall Study||2
6322188|NCT00464620|7227718|FG000|STARTED|Overall Study||50
6322189|NCT00464620|7227719|FG001|STARTED|Overall Study||200
6322190|NCT00464620|7227720|FG002|STARTED|Overall Study||116
6322191|NCT00464620|7227718|FG000|COMPLETED|Overall Study|48 patients were evaluable.|48
6322192|NCT00464620|7227719|FG001|COMPLETED|Overall Study||198
6322193|NCT00464620|7227720|FG002|COMPLETED|Overall Study||109
6322194|NCT00464620|7227718|FG000|NOT COMPLETED|Overall Study||2
6322195|NCT00464620|7227719|FG001|NOT COMPLETED|Overall Study||2
6322196|NCT00464620|7227720|FG002|NOT COMPLETED|Overall Study||7
6322197|NCT00464646|7227735|FG000|STARTED|Overall Study||76
6322198|NCT00464646|7227736|FG001|STARTED|Overall Study||29
6322199|NCT00464646|7227735|FG000|COMPLETED|Overall Study||76
6322200|NCT00464646|7227736|FG001|COMPLETED|Overall Study||29
6322201|NCT00464646|7227735|FG000|NOT COMPLETED|Overall Study||0
6322202|NCT00464646|7227736|FG001|NOT COMPLETED|Overall Study||0
6322203|NCT00464672|7227745|FG000|STARTED|Overall Study||460
6322204|NCT00464672|7227746|FG001|STARTED|Overall Study||232
6322205|NCT00464672|7227747|FG002|STARTED|Overall Study||400
6322206|NCT00464672|7227748|FG003|STARTED|Overall Study||200
6322207|NCT00464672|7227749|FG004|STARTED|Overall Study||402
6322208|NCT00464672|7227750|FG005|STARTED|Overall Study||199
6322209|NCT00464672|7227745|FG000|COMPLETED|Overall Study||435
6322210|NCT00464672|7227746|FG001|COMPLETED|Overall Study||222
6322211|NCT00464672|7227747|FG002|COMPLETED|Overall Study||400
6322212|NCT00464672|7227748|FG003|COMPLETED|Overall Study||199
6322213|NCT00464672|7227749|FG004|COMPLETED|Overall Study||392
6322214|NCT00464672|7227750|FG005|COMPLETED|Overall Study||195
6322215|NCT00464672|7227745|FG000|NOT COMPLETED|Overall Study||25
6322216|NCT00464672|7227746|FG001|NOT COMPLETED|Overall Study||10
6322217|NCT00464672|7227747|FG002|NOT COMPLETED|Overall Study||0
6322218|NCT00464672|7227748|FG003|NOT COMPLETED|Overall Study||1
6322219|NCT00464672|7227749|FG004|NOT COMPLETED|Overall Study||10
6322220|NCT00464672|7227750|FG005|NOT COMPLETED|Overall Study||4
6322221|NCT00464685|7227780|FG000|STARTED|Overall Study||126
6322222|NCT00464685|7227781|FG001|STARTED|Overall Study||127
6322223|NCT00464685|7227780|FG000|COMPLETED|Overall Study||103
6322224|NCT00464685|7227781|FG001|COMPLETED|Overall Study||94
6322225|NCT00464685|7227780|FG000|NOT COMPLETED|Overall Study||23
6322226|NCT00464685|7227781|FG001|NOT COMPLETED|Overall Study||33
6322227|NCT00464698|7227787|FG000|STARTED|Period 1: 30 mg||20
6322228|NCT00464698|7227787|FG000|COMPLETED|Period 1: 30 mg||17
6322229|NCT00464698|7227787|FG000|NOT COMPLETED|Period 1: 30 mg||3
6322230|NCT00464698|7227787|FG000|STARTED|Period 2: 60 mg||17
6322231|NCT00464698|7227787|FG000|COMPLETED|Period 2: 60 mg||17
6322232|NCT00464698|7227787|FG000|NOT COMPLETED|Period 2: 60 mg||0
6322233|NCT00464698|7227787|FG000|STARTED|Period 3: 120mg||14
6322234|NCT00464698|7227787|FG000|COMPLETED|Period 3: 120mg||12
6322235|NCT00464698|7227787|FG000|NOT COMPLETED|Period 3: 120mg||2
6322236|NCT00464711|7227793|FG000|STARTED|Overall Study||40
6322237|NCT00464711|7227793|FG000|COMPLETED|Overall Study||25
6322238|NCT00464711|7227793|FG000|NOT COMPLETED|Overall Study||15
6322239|NCT00464737|7227800|FG000|STARTED|Overall Study||82
6322240|NCT00464737|7227801|FG001|STARTED|Overall Study||74
6322241|NCT00464737|7227802|FG002|STARTED|Overall Study||74
6322242|NCT00464737|7227800|FG000|COMPLETED|Overall Study||50
6322243|NCT00464737|7227801|FG001|COMPLETED|Overall Study||42
6322244|NCT00464737|7227802|FG002|COMPLETED|Overall Study||19
6322245|NCT00464737|7227800|FG000|NOT COMPLETED|Overall Study||32
6322246|NCT00464737|7227801|FG001|NOT COMPLETED|Overall Study||32
6322247|NCT00464737|7227802|FG002|NOT COMPLETED|Overall Study||55
6322248|NCT00464815|7227812|FG000|STARTED|Overall Study||768
6322249|NCT00464815|7227813|FG001|STARTED|Overall Study||257
6322250|NCT00464815|7227812|FG000|COMPLETED|Overall Study||762
6322251|NCT00464815|7227813|FG001|COMPLETED|Overall Study||254
6322252|NCT00464815|7227812|FG000|NOT COMPLETED|Overall Study||6
6322253|NCT00464815|7227813|FG001|NOT COMPLETED|Overall Study||3
6322254|NCT00464945|7227821|FG000|STARTED|Infant Series||135
6322255|NCT00464945|7227822|FG001|STARTED|Infant Series||134
6322256|NCT00464945|7227821|FG000|Vaccinated Dose 1|Infant Series||134
6322257|NCT00464945|7227822|FG001|Vaccinated Dose 1|Infant Series||134
6322258|NCT00464945|7227821|FG000|Vaccinated Dose 2|Infant Series||132
6322259|NCT00464945|7227822|FG001|Vaccinated Dose 2|Infant Series||133
6322260|NCT00464945|7227821|FG000|Vaccinated Dose 3|Infant Series||132
6322261|NCT00464945|7227822|FG001|Vaccinated Dose 3|Infant Series||133
6322262|NCT00464945|7227821|FG000|COMPLETED|Infant Series||131
6322263|NCT00464945|7227822|FG001|COMPLETED|Infant Series||133
6322264|NCT00464945|7227821|FG000|NOT COMPLETED|Infant Series||4
6322265|NCT00464945|7227822|FG001|NOT COMPLETED|Infant Series||1
6322266|NCT00464945|7227821|FG000|STARTED|After Infant Series||131
6322267|NCT00464945|7227822|FG001|STARTED|After Infant Series||133
6322268|NCT00464945|7227821|FG000|COMPLETED|After Infant Series||131
6322269|NCT00464945|7227822|FG001|COMPLETED|After Infant Series||131
6322270|NCT00464945|7227821|FG000|NOT COMPLETED|After Infant Series||0
6322271|NCT00464945|7227822|FG001|NOT COMPLETED|After Infant Series||2
6322272|NCT00464945|7227821|FG000|STARTED|Toddler Dose||131
6322273|NCT00464945|7227822|FG001|STARTED|Toddler Dose||131
6322274|NCT00464945|7227821|FG000|COMPLETED|Toddler Dose||131
6322275|NCT00464945|7227822|FG001|COMPLETED|Toddler Dose||130
6322276|NCT00464945|7227821|FG000|NOT COMPLETED|Toddler Dose||0
6322277|NCT00464945|7227822|FG001|NOT COMPLETED|Toddler Dose||1
6322278|NCT00465088|7227846|FG000|STARTED|Overall Study|For both arms, started means treated.|114
6322279|NCT00465088|7227847|FG001|STARTED|Overall Study||79
6322280|NCT00465088|7227846|FG000|COMPLETED|Overall Study||82
6322281|NCT00465088|7227847|FG001|COMPLETED|Overall Study||70
6322282|NCT00465088|7227846|FG000|NOT COMPLETED|Overall Study||32
6322283|NCT00465088|7227847|FG001|NOT COMPLETED|Overall Study||9
6322284|NCT00465101|7227853|FG000|STARTED|Overall Study||150
6322285|NCT00465101|7227853|FG000|COMPLETED|Overall Study||91
6322286|NCT00465101|7227853|FG000|NOT COMPLETED|Overall Study||59
6322287|NCT00465179|7227879|FG000|STARTED|Overall Study||57
6322288|NCT00465179|7227879|FG000|COMPLETED|Overall Study||4
6322289|NCT00465179|7227879|FG000|NOT COMPLETED|Overall Study||53
6322290|NCT00465270|7227885|FG000|STARTED|Overall Study||499
6322291|NCT00465270|7227886|FG001|STARTED|Overall Study||481
6322292|NCT00465270|7227885|FG000|COMPLETED|Overall Study||395
6322293|NCT00465270|7227886|FG001|COMPLETED|Overall Study||321
6322294|NCT00465270|7227885|FG000|NOT COMPLETED|Overall Study||104
6322295|NCT00465270|7227886|FG001|NOT COMPLETED|Overall Study||160
6322296|NCT00465361|7227892|FG000|STARTED|Baseline Assessment||7
6322297|NCT00465361|7227892|FG000|COMPLETED|Baseline Assessment||3
6322298|NCT00465361|7227892|FG000|NOT COMPLETED|Baseline Assessment||4
6322299|NCT00465361|7227892|FG000|STARTED|Post-Intervention Assessment||3
6322300|NCT00465361|7227892|FG000|COMPLETED|Post-Intervention Assessment||3
6322301|NCT00465361|7227892|FG000|NOT COMPLETED|Post-Intervention Assessment||0
6322302|NCT00465530|7227898|FG000|STARTED|Overall Study||21
6322303|NCT00465530|7227899|FG001|STARTED|Overall Study||19
6322304|NCT00465530|7227898|FG000|COMPLETED|Overall Study||19
6322305|NCT00465530|7227899|FG001|COMPLETED|Overall Study||15
6322306|NCT00465530|7227898|FG000|NOT COMPLETED|Overall Study||2
6322307|NCT00465530|7227899|FG001|NOT COMPLETED|Overall Study||4
6322308|NCT00465569|7227907|FG000|STARTED|Overall Study||13
6322309|NCT00465569|7227908|FG001|STARTED|Overall Study||7
6322310|NCT00465569|7227907|FG000|COMPLETED|Overall Study||12
6322311|NCT00465569|7227908|FG001|COMPLETED|Overall Study||7
6322312|NCT00465569|7227907|FG000|NOT COMPLETED|Overall Study||1
6322313|NCT00465569|7227908|FG001|NOT COMPLETED|Overall Study||0
6322314|NCT00465595|7227916|FG000|STARTED|Overall Study||27
6322315|NCT00465595|7227917|FG001|STARTED|Overall Study||29
6322316|NCT00465595|7227916|FG000|COMPLETED|Overall Study||22
6322317|NCT00465595|7227917|FG001|COMPLETED|Overall Study||24
6322318|NCT00465595|7227916|FG000|NOT COMPLETED|Overall Study||5
6322319|NCT00465595|7227917|FG001|NOT COMPLETED|Overall Study||5
6322320|NCT00465647|7227933|FG000|STARTED|Overall Study||39
6322321|NCT00465647|7227934|FG001|STARTED|Overall Study||23
6322322|NCT00465647|7227935|FG002|STARTED|Overall Study||29
6322323|NCT00465647|7227936|FG003|STARTED|Overall Study||25
6322324|NCT00465647|7227933|FG000|COMPLETED|Overall Study||26
6322325|NCT00465647|7227934|FG001|COMPLETED|Overall Study||15
6322326|NCT00465647|7227935|FG002|COMPLETED|Overall Study||18
6322327|NCT00465647|7227936|FG003|COMPLETED|Overall Study||12
6322328|NCT00465647|7227933|FG000|NOT COMPLETED|Overall Study||13
6322329|NCT00465647|7227934|FG001|NOT COMPLETED|Overall Study||8
6322330|NCT00465647|7227935|FG002|NOT COMPLETED|Overall Study||11
6322331|NCT00465647|7227936|FG003|NOT COMPLETED|Overall Study||13
6322332|NCT00465738|7227958|FG000|STARTED|Overall Study||97
6322333|NCT00465738|7227959|FG001|STARTED|Overall Study||95
6322334|NCT00465738|7227958|FG000|COMPLETED|Overall Study||91
6322335|NCT00465738|7227959|FG001|COMPLETED|Overall Study||89
6322336|NCT00465738|7227958|FG000|NOT COMPLETED|Overall Study||6
6322337|NCT00465738|7227959|FG001|NOT COMPLETED|Overall Study||6
6322338|NCT00465816|7227968|FG000|STARTED|Overall Study||367
6322339|NCT00465816|7227969|FG001|STARTED|Overall Study||122
6322340|NCT00465816|7227970|FG002|STARTED|Overall Study||122
6322341|NCT00465816|7227968|FG000|COMPLETED|Overall Study||367
6322342|NCT00465816|7227969|FG001|COMPLETED|Overall Study||122
6322343|NCT00465816|7227970|FG002|COMPLETED|Overall Study||120
6322344|NCT00465816|7227968|FG000|NOT COMPLETED|Overall Study||0
6322345|NCT00465816|7227969|FG001|NOT COMPLETED|Overall Study||0
6322346|NCT00465816|7227970|FG002|NOT COMPLETED|Overall Study||2
6322347|NCT00465894|7227981|FG000|STARTED|Treatment For 12 Weeks||30
6322348|NCT00465894|7227982|FG001|STARTED|Treatment For 12 Weeks||28
6322349|NCT00465894|7227981|FG000|COMPLETED|Treatment For 12 Weeks||25
6322350|NCT00465894|7227982|FG001|COMPLETED|Treatment For 12 Weeks||25
6322351|NCT00465894|7227981|FG000|NOT COMPLETED|Treatment For 12 Weeks||5
6322352|NCT00465894|7227982|FG001|NOT COMPLETED|Treatment For 12 Weeks||3
6322353|NCT00465894|7227981|FG000|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
6322354|NCT00465894|7227982|FG001|STARTED|Treatment From 12 Weeks To 24 Weeks|We included data only from participants that had complete data sets.|14
6322355|NCT00465894|7227981|FG000|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
6322356|NCT00465894|7227982|FG001|COMPLETED|Treatment From 12 Weeks To 24 Weeks||14
6322357|NCT00465894|7227981|FG000|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
6322358|NCT00465894|7227982|FG001|NOT COMPLETED|Treatment From 12 Weeks To 24 Weeks||0
6322359|NCT00465894|7227981|FG000|STARTED|Treatment From 24 Weeks to 52 Weeks|We included data only from participants that had complete data sets.|11
6322360|NCT00465894|7227982|FG001|STARTED|Treatment From 24 Weeks to 52 Weeks||14
6322361|NCT00465894|7227981|FG000|COMPLETED|Treatment From 24 Weeks to 52 Weeks||11
6322362|NCT00465894|7227982|FG001|COMPLETED|Treatment From 24 Weeks to 52 Weeks||14
6322363|NCT00465894|7227981|FG000|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
6322364|NCT00465894|7227982|FG001|NOT COMPLETED|Treatment From 24 Weeks to 52 Weeks||0
6322365|NCT00465972|7228006|FG000|STARTED|Overall Study||20
6322366|NCT00465972|7228007|FG001|STARTED|Overall Study||24
6322367|NCT00465972|7228006|FG000|COMPLETED|Overall Study||18
6322368|NCT00465972|7228007|FG001|COMPLETED|Overall Study||23
6322369|NCT00465972|7228006|FG000|NOT COMPLETED|Overall Study||2
6322370|NCT00465972|7228007|FG001|NOT COMPLETED|Overall Study||1
6322371|NCT00465985|7228015|FG000|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
6322372|NCT00465985|7228016|FG001|STARTED|Part I - Open-label Treatment Period||0
6322373|NCT00465985|7228015|FG000|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
6322374|NCT00465985|7228016|FG001|COMPLETED|Part I - Open-label Treatment Period||0
6322375|NCT00465985|7228015|FG000|NOT COMPLETED|Part I - Open-label Treatment Period||4
6322376|NCT00465985|7228016|FG001|NOT COMPLETED|Part I - Open-label Treatment Period||0
6322377|NCT00465985|7228015|FG000|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
6322378|NCT00465985|7228016|FG001|STARTED|Part II - 1:1 ACZ885:Placebo||16
6322379|NCT00465985|7228015|FG000|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
6322380|NCT00465985|7228016|FG001|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
6322381|NCT00465985|7228015|FG000|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
6322382|NCT00465985|7228016|FG001|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
6322383|NCT00465985|7228015|FG000|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
6322384|NCT00465985|7228016|FG001|STARTED|Part III - Open-label Treatment Period||0
6322385|NCT00465985|7228015|FG000|COMPLETED|Part III - Open-label Treatment Period||29
6322386|NCT00465985|7228016|FG001|COMPLETED|Part III - Open-label Treatment Period||0
6322387|NCT00465985|7228015|FG000|NOT COMPLETED|Part III - Open-label Treatment Period||2
6322388|NCT00465985|7228016|FG001|NOT COMPLETED|Part III - Open-label Treatment Period||0
6322389|NCT00465998|7228025|FG000|STARTED|Overall Study||275
6322390|NCT00465998|7228025|FG000|COMPLETED|Overall Study||275
6322391|NCT00465998|7228025|FG000|NOT COMPLETED|Overall Study||0
6322392|NCT00466167|7228033|FG000|STARTED|Overall Study||165
6322393|NCT00466167|7228034|FG001|STARTED|Overall Study||175
6322394|NCT00466167|7228035|FG002|STARTED|Overall Study||178
6322395|NCT00466167|7228033|FG000|COMPLETED|Overall Study||145
6322396|NCT00466167|7228034|FG001|COMPLETED|Overall Study||163
6322397|NCT00466167|7228035|FG002|COMPLETED|Overall Study||157
6322398|NCT00466167|7228033|FG000|NOT COMPLETED|Overall Study||20
6322399|NCT00466167|7228034|FG001|NOT COMPLETED|Overall Study||12
6322400|NCT00466167|7228035|FG002|NOT COMPLETED|Overall Study||21
6322401|NCT00466193|7228045|FG000|STARTED|Overall Study||150
6322402|NCT00466193|7228046|FG001|STARTED|Overall Study||145
6322403|NCT00466193|7228045|FG000|COMPLETED|Overall Study||138
6558109|NCT01773421|7480815|FG005|STARTED|Treatment Phase||0
6558110|NCT01773421|7480816|FG006|STARTED|Treatment Phase||0
6558111|NCT01773421|7480810|FG000|COMPLETED|Treatment Phase||7
6322404|NCT00466193|7228046|FG001|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
6322405|NCT00466193|7228045|FG000|NOT COMPLETED|Overall Study||12
6322406|NCT00466193|7228046|FG001|NOT COMPLETED|Overall Study||8
6322407|NCT00466206|7228052|FG000|STARTED|Overall Study||10
6322408|NCT00466206|7228052|FG000|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
6322409|NCT00466206|7228052|FG000|NOT COMPLETED|Overall Study||0
6322410|NCT00466310|7228062|FG000|STARTED|Overall Study||20
6322411|NCT00466310|7228063|FG001|STARTED|Overall Study||20
6322412|NCT00466310|7228064|FG002|STARTED|Overall Study||31
6322413|NCT00466310|7228062|FG000|COMPLETED|Overall Study||20
6322414|NCT00466310|7228063|FG001|COMPLETED|Overall Study||20
6322415|NCT00466310|7228064|FG002|COMPLETED|Overall Study||31
6322416|NCT00466310|7228062|FG000|NOT COMPLETED|Overall Study||0
6322417|NCT00466310|7228063|FG001|NOT COMPLETED|Overall Study||0
6322418|NCT00466310|7228064|FG002|NOT COMPLETED|Overall Study||0
6322419|NCT00466323|7228074|FG000|STARTED|Overall Study||117
6322420|NCT00466323|7228075|FG001|STARTED|Overall Study||115
6322421|NCT00466323|7228074|FG000|COMPLETED|Overall Study||89
6322422|NCT00466323|7228075|FG001|COMPLETED|Overall Study||92
6322423|NCT00466323|7228074|FG000|NOT COMPLETED|Overall Study||28
6322424|NCT00466323|7228075|FG001|NOT COMPLETED|Overall Study||23
6322425|NCT00466440|7228084|FG000|STARTED|Overall Study||14
6322426|NCT00466440|7228085|FG001|STARTED|Overall Study||48
6322427|NCT00466440|7228086|FG002|STARTED|Overall Study||46
6322428|NCT00466440|7228084|FG000|Received at Least One Dose of Study Drug|Overall Study||14
6322429|NCT00466440|7228085|FG001|Received at Least One Dose of Study Drug|Overall Study||47
6558112|NCT01773421|7480811|FG001|COMPLETED|Treatment Phase||8
6322430|NCT00466440|7228086|FG002|Received at Least One Dose of Study Drug|Overall Study||41
6322431|NCT00466440|7228084|FG000|COMPLETED|Overall Study||0
6322432|NCT00466440|7228085|FG001|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|36
6322433|NCT00466440|7228086|FG002|COMPLETED|Overall Study|Completed = completed 4 cycles of treatment|34
6322434|NCT00466440|7228084|FG000|NOT COMPLETED|Overall Study||14
6322435|NCT00466440|7228085|FG001|NOT COMPLETED|Overall Study||12
6322436|NCT00466440|7228086|FG002|NOT COMPLETED|Overall Study||12
6322437|NCT00466505|7228103|FG000|STARTED|Overall Study||17
6322438|NCT00466505|7228103|FG000|COMPLETED|Overall Study||0
6322439|NCT00466505|7228103|FG000|NOT COMPLETED|Overall Study||17
6322440|NCT00466661|7228109|FG000|STARTED|Overall Study||16
6322441|NCT00466661|7228110|FG001|STARTED|Overall Study||17
6322442|NCT00466661|7228109|FG000|At Least 1 Postrandomization Visit|Overall Study||14
6322443|NCT00466661|7228110|FG001|At Least 1 Postrandomization Visit|Overall Study||16
6322444|NCT00466661|7228109|FG000|COMPLETED|Overall Study||12
6322445|NCT00466661|7228110|FG001|COMPLETED|Overall Study||11
6322446|NCT00466661|7228109|FG000|NOT COMPLETED|Overall Study||4
6322447|NCT00466661|7228110|FG001|NOT COMPLETED|Overall Study||6
6322448|NCT00466687|7228116|FG000|STARTED|Overall Study||34
6322449|NCT00466687|7228116|FG000|COMPLETED|Overall Study||0
6322450|NCT00466687|7228116|FG000|NOT COMPLETED|Overall Study||34
6322451|NCT00466726|7228122|FG000|STARTED|Overall Study||57
6322452|NCT00466726|7228122|FG000|COMPLETED|Overall Study||43
6322453|NCT00466726|7228122|FG000|NOT COMPLETED|Overall Study||14
6322454|NCT00466752|7228128|FG000|STARTED|Overall Study||5
6322455|NCT00466752|7228129|FG001|STARTED|Overall Study||0
6322456|NCT00466752|7228128|FG000|COMPLETED|Overall Study||5
6322457|NCT00466752|7228129|FG001|COMPLETED|Overall Study||0
6322458|NCT00466752|7228128|FG000|NOT COMPLETED|Overall Study||0
6322459|NCT00466752|7228129|FG001|NOT COMPLETED|Overall Study||0
6322460|NCT00466817|7228137|FG000|STARTED|Overall Study||49
6322461|NCT00466817|7228138|FG001|STARTED|Overall Study||47
6322462|NCT00466817|7228137|FG000|COMPLETED|Overall Study||44
6322463|NCT00466817|7228138|FG001|COMPLETED|Overall Study||43
6322464|NCT00466817|7228137|FG000|NOT COMPLETED|Overall Study||5
6322465|NCT00466817|7228138|FG001|NOT COMPLETED|Overall Study||4
6322466|NCT00466921|7228153|FG000|STARTED|First 3 Cycles of Treatment|One patient completed only a few days of treatment|33
6322467|NCT00466921|7228153|FG000|Completed 1 Cycle|First 3 Cycles of Treatment||32
6322468|NCT00466921|7228153|FG000|Started Cycle 2|First 3 Cycles of Treatment||31
6322469|NCT00466921|7228153|FG000|Completed 3 Cycles|First 3 Cycles of Treatment||26
6322470|NCT00466921|7228153|FG000|COMPLETED|First 3 Cycles of Treatment||26
6322471|NCT00466921|7228153|FG000|NOT COMPLETED|First 3 Cycles of Treatment||7
6322472|NCT00466921|7228153|FG000|STARTED|Completed 4 Cycles/Reached 1st Response||26
6322473|NCT00466921|7228153|FG000|Completed 4 Cycles/1st Response|Completed 4 Cycles/Reached 1st Response||21
6322474|NCT00466921|7228153|FG000|COMPLETED|Completed 4 Cycles/Reached 1st Response||21
6322475|NCT00466921|7228153|FG000|NOT COMPLETED|Completed 4 Cycles/Reached 1st Response||5
6322476|NCT00466921|7228153|FG000|STARTED|Continued Treatment||21
6322477|NCT00466921|7228153|FG000|COMPLETED|Continued Treatment||21
6322478|NCT00466921|7228153|FG000|NOT COMPLETED|Continued Treatment||0
6322479|NCT00466921|7228153|FG000|STARTED|Follow up for a Minimum of 1 Year||33
6322480|NCT00466921|7228153|FG000|COMPLETED|Follow up for a Minimum of 1 Year||27
6322481|NCT00466921|7228153|FG000|NOT COMPLETED|Follow up for a Minimum of 1 Year||6
6322482|NCT00466947|7228159|FG000|STARTED|Primary Outcome Analysis Period||11875
6322483|NCT00466947|7228160|FG001|STARTED|Primary Outcome Analysis Period||11863
6322484|NCT00466947|7228159|FG000|Ongoing|Primary Outcome Analysis Period||11875
6322485|NCT00466947|7228160|FG001|Ongoing|Primary Outcome Analysis Period||11863
6322486|NCT00466947|7228159|FG000|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
6322487|NCT00466947|7228160|FG001|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
6322488|NCT00466947|7228159|FG000|NOT COMPLETED|Primary Outcome Analysis Period||11875
6558113|NCT01773421|7480812|FG002|COMPLETED|Treatment Phase||13
6558114|NCT01773421|7480813|FG003|COMPLETED|Treatment Phase||5
6558115|NCT01773421|7480814|FG004|COMPLETED|Treatment Phase||0
6558116|NCT01773421|7480815|FG005|COMPLETED|Treatment Phase||0
6558117|NCT01773421|7480816|FG006|COMPLETED|Treatment Phase||0
6558118|NCT01773421|7480810|FG000|NOT COMPLETED|Treatment Phase||0
6558119|NCT01773421|7480811|FG001|NOT COMPLETED|Treatment Phase||0
6558120|NCT01773421|7480812|FG002|NOT COMPLETED|Treatment Phase||6
6558121|NCT01773421|7480813|FG003|NOT COMPLETED|Treatment Phase||2
6322489|NCT00466947|7228160|FG001|NOT COMPLETED|Primary Outcome Analysis Period||11863
6322490|NCT00466947|7228159|FG000|STARTED|Study End Analysis Period||11798
6322491|NCT00466947|7228160|FG001|STARTED|Study End Analysis Period||11799
6322492|NCT00466947|7228159|FG000|COMPLETED|Study End Analysis Period||9302
6322493|NCT00466947|7228160|FG001|COMPLETED|Study End Analysis Period||9265
6558122|NCT01773421|7480814|FG004|NOT COMPLETED|Treatment Phase||0
6322494|NCT00466947|7228159|FG000|NOT COMPLETED|Study End Analysis Period||2496
6322495|NCT00466947|7228160|FG001|NOT COMPLETED|Study End Analysis Period||2534
6322496|NCT00466960|7228167|FG000|STARTED|Overall Study||21
6322497|NCT00466960|7228167|FG000|COMPLETED|Overall Study||21
6322498|NCT00466960|7228167|FG000|NOT COMPLETED|Overall Study||0
6322499|NCT00467038|7228173|FG000|STARTED|Overall Study||11
6558123|NCT01773421|7480815|FG005|NOT COMPLETED|Treatment Phase||0
6558124|NCT01773421|7480816|FG006|NOT COMPLETED|Treatment Phase||0
6558125|NCT01773421|7480810|FG000|STARTED|Extension Phase||0
6322500|NCT00467038|7228174|FG001|STARTED|Overall Study||11
6322501|NCT00467038|7228173|FG000|COMPLETED|Overall Study||11
6322502|NCT00467038|7228174|FG001|COMPLETED|Overall Study||11
6322503|NCT00467038|7228173|FG000|NOT COMPLETED|Overall Study||0
6322504|NCT00467038|7228174|FG001|NOT COMPLETED|Overall Study||0
6322505|NCT00467051|7228181|FG000|STARTED|Overall Study||20
6322506|NCT00467051|7228181|FG000|COMPLETED|Overall Study||18
6322507|NCT00467051|7228181|FG000|NOT COMPLETED|Overall Study||2
6322508|NCT00467077|7228186|FG000|STARTED|Overall Study||21
6322509|NCT00467077|7228186|FG000|COMPLETED|Overall Study||21
6322510|NCT00467077|7228186|FG000|NOT COMPLETED|Overall Study||0
6322511|NCT00467259|7228192|FG000|STARTED|Overall Study||251
6322512|NCT00467259|7228193|FG001|STARTED|Overall Study||1020
6322513|NCT00467259|7228192|FG000|ITT Population|Overall Study||251
6322514|NCT00467259|7228193|FG001|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
6322515|NCT00467259|7228192|FG000|COMPLETED|Overall Study||176
6322516|NCT00467259|7228193|FG001|COMPLETED|Overall Study||778
6322517|NCT00467259|7228192|FG000|NOT COMPLETED|Overall Study||75
6322518|NCT00467259|7228193|FG001|NOT COMPLETED|Overall Study||242
6322519|NCT00467272|7228199|FG000|STARTED|Overall Study||41
6322520|NCT00467272|7228199|FG000|COMPLETED|Overall Study||38
6322521|NCT00467272|7228199|FG000|NOT COMPLETED|Overall Study||3
6322522|NCT00467285|7228205|FG000|STARTED|Overall Study||32
6322523|NCT00467285|7228206|FG001|STARTED|Overall Study||64
6322524|NCT00467285|7228205|FG000|COMPLETED|Overall Study||28
6322525|NCT00467285|7228206|FG001|COMPLETED|Overall Study||60
6322526|NCT00467285|7228205|FG000|NOT COMPLETED|Overall Study||4
6322527|NCT00467285|7228206|FG001|NOT COMPLETED|Overall Study||4
6322528|NCT00467298|7228216|FG000|STARTED|Overall Study||46
6322529|NCT00467298|7228217|FG001|STARTED|Overall Study||44
6322530|NCT00467298|7228216|FG000|COMPLETED|Overall Study||42
6322531|NCT00467298|7228217|FG001|COMPLETED|Overall Study||38
6322532|NCT00467298|7228216|FG000|NOT COMPLETED|Overall Study||4
6322533|NCT00467298|7228217|FG001|NOT COMPLETED|Overall Study||6
6322534|NCT00467350|7228225|FG000|STARTED|Overall Study||41
6322535|NCT00467350|7228226|FG001|STARTED|Overall Study||39
6322536|NCT00467350|7228225|FG000|COMPLETED|Overall Study||40
6322537|NCT00467350|7228226|FG001|COMPLETED|Overall Study||39
6322538|NCT00467350|7228225|FG000|NOT COMPLETED|Overall Study||1
6322539|NCT00467350|7228226|FG001|NOT COMPLETED|Overall Study||0
6322540|NCT00467363|7228234|FG000|STARTED|Overall Study||615
6322541|NCT00467363|7228235|FG001|STARTED|Overall Study||613
6322542|NCT00467363|7228234|FG000|COMPLETED|Overall Study||535
6322543|NCT00467363|7228235|FG001|COMPLETED|Overall Study||543
6322544|NCT00467363|7228234|FG000|NOT COMPLETED|Overall Study||80
6322545|NCT00467363|7228235|FG001|NOT COMPLETED|Overall Study||70
6322546|NCT00467389|7228241|FG000|STARTED|Overall Study||6
6322547|NCT00467389|7228242|FG001|STARTED|Overall Study||6
6322548|NCT00467389|7228241|FG000|COMPLETED|Overall Study||6
6322549|NCT00467389|7228242|FG001|COMPLETED|Overall Study||6
6322550|NCT00467389|7228241|FG000|NOT COMPLETED|Overall Study||0
6322551|NCT00467389|7228242|FG001|NOT COMPLETED|Overall Study||0
6322552|NCT00467519|7228250|FG000|STARTED|Overall Study||531
6322553|NCT00467519|7228251|FG001|STARTED|Overall Study||511
6322554|NCT00467519|7228250|FG000|COMPLETED|Overall Study||517
6322555|NCT00467519|7228251|FG001|COMPLETED|Overall Study||488
6322556|NCT00467519|7228250|FG000|NOT COMPLETED|Overall Study||14
6322557|NCT00467519|7228251|FG001|NOT COMPLETED|Overall Study||23
6322558|NCT00467558|7228259|FG000|STARTED|Overall Study||4
6322559|NCT00467558|7228260|FG001|STARTED|Overall Study||3
6322560|NCT00467558|7228259|FG000|COMPLETED|Overall Study||2
6322561|NCT00467558|7228260|FG001|COMPLETED|Overall Study||3
6322562|NCT00467558|7228259|FG000|NOT COMPLETED|Overall Study||2
6322563|NCT00467558|7228260|FG001|NOT COMPLETED|Overall Study||0
6322564|NCT00467584|7228269|FG000|STARTED|Overall Study||21
6322565|NCT00467584|7228270|FG001|STARTED|Overall Study||20
6322566|NCT00467584|7228271|FG002|STARTED|Overall Study||21
6322567|NCT00467584|7228269|FG000|COMPLETED|Overall Study||17
6322568|NCT00467584|7228270|FG001|COMPLETED|Overall Study||15
6322569|NCT00467584|7228271|FG002|COMPLETED|Overall Study||20
6322570|NCT00467584|7228269|FG000|NOT COMPLETED|Overall Study||4
6322571|NCT00467584|7228270|FG001|NOT COMPLETED|Overall Study||5
6322572|NCT00467584|7228271|FG002|NOT COMPLETED|Overall Study||1
6322573|NCT00467597|7228283|FG000|STARTED|Overall Study||26
6322574|NCT00467597|7228284|FG001|STARTED|Overall Study||6
6322575|NCT00467597|7228283|FG000|COMPLETED|Overall Study||24
6322576|NCT00467597|7228284|FG001|COMPLETED|Overall Study||6
6322577|NCT00467597|7228283|FG000|NOT COMPLETED|Overall Study||2
6558126|NCT01773421|7480811|FG001|STARTED|Extension Phase||0
6558127|NCT01773421|7480812|FG002|STARTED|Extension Phase||0
6558128|NCT01773421|7480813|FG003|STARTED|Extension Phase||0
6558129|NCT01773421|7480814|FG004|STARTED|Extension Phase||15
6322578|NCT00467597|7228284|FG001|NOT COMPLETED|Overall Study||0
6322579|NCT00467610|7228294|FG000|STARTED|Overall Study||6
6558130|NCT01773421|7480815|FG005|STARTED|Extension Phase||3
6322580|NCT00467610|7228294|FG000|COMPLETED|Overall Study||5
6322581|NCT00467610|7228294|FG000|NOT COMPLETED|Overall Study||1
6322582|NCT00467649|7228300|FG000|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
6322583|NCT00467649|7228301|FG001|STARTED|Phase 1 (Randomized Population)||56
6322584|NCT00467649|7228302|FG002|STARTED|Phase 1 (Randomized Population)||0
6558131|NCT01773421|7480816|FG006|STARTED|Extension Phase||0
6322585|NCT00467649|7228303|FG003|STARTED|Phase 1 (Randomized Population)||0
6322586|NCT00467649|7228304|FG004|STARTED|Phase 1 (Randomized Population)||0
6322587|NCT00467649|7228305|FG005|STARTED|Phase 1 (Randomized Population)||0
6322588|NCT00467649|7228300|FG000|Intent to Treat|Phase 1 (Randomized Population)||56
6322589|NCT00467649|7228301|FG001|Intent to Treat|Phase 1 (Randomized Population)||56
6322590|NCT00467649|7228302|FG002|Intent to Treat|Phase 1 (Randomized Population)||0
6322591|NCT00467649|7228303|FG003|Intent to Treat|Phase 1 (Randomized Population)||0
6322592|NCT00467649|7228304|FG004|Intent to Treat|Phase 1 (Randomized Population)||0
6322593|NCT00467649|7228305|FG005|Intent to Treat|Phase 1 (Randomized Population)||0
6322594|NCT00467649|7228300|FG000|COMPLETED|Phase 1 (Randomized Population)||48
6322595|NCT00467649|7228301|FG001|COMPLETED|Phase 1 (Randomized Population)||50
6322596|NCT00467649|7228302|FG002|COMPLETED|Phase 1 (Randomized Population)||0
6322597|NCT00467649|7228303|FG003|COMPLETED|Phase 1 (Randomized Population)||0
6322598|NCT00467649|7228304|FG004|COMPLETED|Phase 1 (Randomized Population)||0
6322599|NCT00467649|7228305|FG005|COMPLETED|Phase 1 (Randomized Population)||0
6322600|NCT00467649|7228300|FG000|NOT COMPLETED|Phase 1 (Randomized Population)||9
6322601|NCT00467649|7228301|FG001|NOT COMPLETED|Phase 1 (Randomized Population)||6
6322602|NCT00467649|7228302|FG002|NOT COMPLETED|Phase 1 (Randomized Population)||0
6322603|NCT00467649|7228303|FG003|NOT COMPLETED|Phase 1 (Randomized Population)||0
6322604|NCT00467649|7228304|FG004|NOT COMPLETED|Phase 1 (Randomized Population)||0
6322605|NCT00467649|7228305|FG005|NOT COMPLETED|Phase 1 (Randomized Population)||0
6322606|NCT00467649|7228300|FG000|STARTED|Phase 2 (Intent-to-Treat Population)||0
6322607|NCT00467649|7228301|FG001|STARTED|Phase 2 (Intent-to-Treat Population)||0
6322608|NCT00467649|7228302|FG002|STARTED|Phase 2 (Intent-to-Treat Population)||17
6322609|NCT00467649|7228303|FG003|STARTED|Phase 2 (Intent-to-Treat Population)||31
6322610|NCT00467649|7228304|FG004|STARTED|Phase 2 (Intent-to-Treat Population)||14
6322611|NCT00467649|7228305|FG005|STARTED|Phase 2 (Intent-to-Treat Population)||36
6322612|NCT00467649|7228300|FG000|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6322613|NCT00467649|7228301|FG001|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6322614|NCT00467649|7228302|FG002|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
6322615|NCT00467649|7228303|FG003|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
6322616|NCT00467649|7228304|FG004|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
6322617|NCT00467649|7228305|FG005|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
6322618|NCT00467649|7228300|FG000|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6322619|NCT00467649|7228301|FG001|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6322620|NCT00467649|7228302|FG002|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6322621|NCT00467649|7228303|FG003|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
6322622|NCT00467649|7228304|FG004|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
6322623|NCT00467649|7228305|FG005|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
6322624|NCT00467740|7228328|FG000|STARTED|Overall Study||54
6322625|NCT00467740|7228329|FG001|STARTED|Overall Study||61
6322626|NCT00467740|7228330|FG002|STARTED|Overall Study||60
6322627|NCT00467740|7228331|FG003|STARTED|Overall Study||60
6322628|NCT00467740|7228332|FG004|STARTED|Overall Study||61
6322629|NCT00467740|7228328|FG000|COMPLETED|Overall Study||53
6322630|NCT00467740|7228329|FG001|COMPLETED|Overall Study||58
6322631|NCT00467740|7228330|FG002|COMPLETED|Overall Study||58
6322632|NCT00467740|7228331|FG003|COMPLETED|Overall Study||59
6322633|NCT00467740|7228332|FG004|COMPLETED|Overall Study||61
6322634|NCT00467740|7228328|FG000|NOT COMPLETED|Overall Study||1
6322635|NCT00467740|7228329|FG001|NOT COMPLETED|Overall Study||3
6322636|NCT00467740|7228330|FG002|NOT COMPLETED|Overall Study||2
6322637|NCT00467740|7228331|FG003|NOT COMPLETED|Overall Study||1
6322638|NCT00467740|7228332|FG004|NOT COMPLETED|Overall Study||0
6322639|NCT00467779|7228359|FG000|STARTED|Stage 1||4
6322640|NCT00467779|7228360|FG001|STARTED|Stage 1||3
6322641|NCT00467779|7228361|FG002|STARTED|Stage 1||3
6322642|NCT00467779|7228362|FG003|STARTED|Stage 1||3
6322643|NCT00467779|7228363|FG004|STARTED|Stage 1||3
6322644|NCT00467779|7228364|FG005|STARTED|Stage 1||6
6322645|NCT00467779|7228365|FG006|STARTED|Stage 1||7
6322646|NCT00467779|7228366|FG007|STARTED|Stage 1||7
6322647|NCT00467779|7228367|FG008|STARTED|Stage 1||0
6322648|NCT00467779|7228368|FG009|STARTED|Stage 1||0
6322649|NCT00467779|7228369|FG010|STARTED|Stage 1||0
6322650|NCT00467779|7228370|FG011|STARTED|Stage 1||0
6322651|NCT00467779|7228371|FG012|STARTED|Stage 1||0
6322652|NCT00467779|7228372|FG013|STARTED|Stage 1||0
6322653|NCT00467779|7228373|FG014|STARTED|Stage 1||0
6322654|NCT00467779|7228359|FG000|COMPLETED|Stage 1||0
6322655|NCT00467779|7228360|FG001|COMPLETED|Stage 1||0
6322656|NCT00467779|7228361|FG002|COMPLETED|Stage 1||0
6322657|NCT00467779|7228362|FG003|COMPLETED|Stage 1||0
6322658|NCT00467779|7228363|FG004|COMPLETED|Stage 1||0
6322659|NCT00467779|7228364|FG005|COMPLETED|Stage 1||1
6322660|NCT00467779|7228365|FG006|COMPLETED|Stage 1||0
6322661|NCT00467779|7228366|FG007|COMPLETED|Stage 1||0
6322662|NCT00467779|7228367|FG008|COMPLETED|Stage 1||0
6322663|NCT00467779|7228368|FG009|COMPLETED|Stage 1||0
6322664|NCT00467779|7228369|FG010|COMPLETED|Stage 1||0
6322665|NCT00467779|7228370|FG011|COMPLETED|Stage 1||0
6322666|NCT00467779|7228371|FG012|COMPLETED|Stage 1||0
6322667|NCT00467779|7228372|FG013|COMPLETED|Stage 1||0
6322668|NCT00467779|7228373|FG014|COMPLETED|Stage 1||0
6322669|NCT00467779|7228359|FG000|NOT COMPLETED|Stage 1||4
6322670|NCT00467779|7228360|FG001|NOT COMPLETED|Stage 1||3
6322671|NCT00467779|7228361|FG002|NOT COMPLETED|Stage 1||3
6322672|NCT00467779|7228362|FG003|NOT COMPLETED|Stage 1||3
6322673|NCT00467779|7228363|FG004|NOT COMPLETED|Stage 1||3
6322674|NCT00467779|7228364|FG005|NOT COMPLETED|Stage 1||5
6322675|NCT00467779|7228365|FG006|NOT COMPLETED|Stage 1||7
6322676|NCT00467779|7228366|FG007|NOT COMPLETED|Stage 1||7
6322677|NCT00467779|7228367|FG008|NOT COMPLETED|Stage 1||0
6322678|NCT00467779|7228368|FG009|NOT COMPLETED|Stage 1||0
6322679|NCT00467779|7228369|FG010|NOT COMPLETED|Stage 1||0
6322680|NCT00467779|7228370|FG011|NOT COMPLETED|Stage 1||0
6322681|NCT00467779|7228371|FG012|NOT COMPLETED|Stage 1||0
6322682|NCT00467779|7228372|FG013|NOT COMPLETED|Stage 1||0
6322683|NCT00467779|7228373|FG014|NOT COMPLETED|Stage 1||0
6322684|NCT00467779|7228359|FG000|STARTED|Stage 1A||0
6322685|NCT00467779|7228360|FG001|STARTED|Stage 1A||0
6322686|NCT00467779|7228361|FG002|STARTED|Stage 1A||0
6322687|NCT00467779|7228362|FG003|STARTED|Stage 1A||0
6322688|NCT00467779|7228363|FG004|STARTED|Stage 1A||0
6322689|NCT00467779|7228364|FG005|STARTED|Stage 1A||0
6322690|NCT00467779|7228365|FG006|STARTED|Stage 1A||0
6322691|NCT00467779|7228366|FG007|STARTED|Stage 1A||0
6322692|NCT00467779|7228367|FG008|STARTED|Stage 1A||0
6322693|NCT00467779|7228368|FG009|STARTED|Stage 1A||3
6322694|NCT00467779|7228369|FG010|STARTED|Stage 1A||3
6322695|NCT00467779|7228370|FG011|STARTED|Stage 1A||8
6322696|NCT00467779|7228371|FG012|STARTED|Stage 1A||6
6322697|NCT00467779|7228372|FG013|STARTED|Stage 1A||0
6558132|NCT01773421|7480810|FG000|COMPLETED|Extension Phase||0
6558133|NCT01773421|7480811|FG001|COMPLETED|Extension Phase||0
6558134|NCT01773421|7480812|FG002|COMPLETED|Extension Phase||0
6558135|NCT01773421|7480813|FG003|COMPLETED|Extension Phase||0
6775173|NCT03880227|7703105|FG002|COMPLETED|1 Week Washout/ Delay||19
6322698|NCT00467779|7228373|FG014|STARTED|Stage 1A||0
6322699|NCT00467779|7228359|FG000|COMPLETED|Stage 1A||0
6322700|NCT00467779|7228360|FG001|COMPLETED|Stage 1A||0
6322701|NCT00467779|7228361|FG002|COMPLETED|Stage 1A||0
6322702|NCT00467779|7228362|FG003|COMPLETED|Stage 1A||0
6322703|NCT00467779|7228363|FG004|COMPLETED|Stage 1A||0
6322704|NCT00467779|7228364|FG005|COMPLETED|Stage 1A||0
6322705|NCT00467779|7228365|FG006|COMPLETED|Stage 1A||0
6322706|NCT00467779|7228366|FG007|COMPLETED|Stage 1A||0
6322707|NCT00467779|7228367|FG008|COMPLETED|Stage 1A||0
6322708|NCT00467779|7228368|FG009|COMPLETED|Stage 1A||0
6322709|NCT00467779|7228369|FG010|COMPLETED|Stage 1A||0
6322710|NCT00467779|7228370|FG011|COMPLETED|Stage 1A||0
6322711|NCT00467779|7228371|FG012|COMPLETED|Stage 1A||0
6322712|NCT00467779|7228372|FG013|COMPLETED|Stage 1A||0
6322713|NCT00467779|7228373|FG014|COMPLETED|Stage 1A||0
6322714|NCT00467779|7228359|FG000|NOT COMPLETED|Stage 1A||0
6322715|NCT00467779|7228360|FG001|NOT COMPLETED|Stage 1A||0
6322716|NCT00467779|7228361|FG002|NOT COMPLETED|Stage 1A||0
6322717|NCT00467779|7228362|FG003|NOT COMPLETED|Stage 1A||0
6322718|NCT00467779|7228363|FG004|NOT COMPLETED|Stage 1A||0
6322719|NCT00467779|7228364|FG005|NOT COMPLETED|Stage 1A||0
6322720|NCT00467779|7228365|FG006|NOT COMPLETED|Stage 1A||0
6322721|NCT00467779|7228366|FG007|NOT COMPLETED|Stage 1A||0
6322722|NCT00467779|7228367|FG008|NOT COMPLETED|Stage 1A||0
6322723|NCT00467779|7228368|FG009|NOT COMPLETED|Stage 1A||3
6322724|NCT00467779|7228369|FG010|NOT COMPLETED|Stage 1A||3
6322725|NCT00467779|7228370|FG011|NOT COMPLETED|Stage 1A||8
6322726|NCT00467779|7228371|FG012|NOT COMPLETED|Stage 1A||6
6322727|NCT00467779|7228372|FG013|NOT COMPLETED|Stage 1A||0
6322728|NCT00467779|7228373|FG014|NOT COMPLETED|Stage 1A||0
6322729|NCT00467779|7228359|FG000|STARTED|Stage 2||0
6322730|NCT00467779|7228360|FG001|STARTED|Stage 2||0
6322731|NCT00467779|7228361|FG002|STARTED|Stage 2||0
6322732|NCT00467779|7228362|FG003|STARTED|Stage 2||0
6322733|NCT00467779|7228363|FG004|STARTED|Stage 2||0
6322734|NCT00467779|7228364|FG005|STARTED|Stage 2||0
6322735|NCT00467779|7228365|FG006|STARTED|Stage 2||0
6322736|NCT00467779|7228366|FG007|STARTED|Stage 2||0
6322737|NCT00467779|7228367|FG008|STARTED|Stage 2||21
6322738|NCT00467779|7228368|FG009|STARTED|Stage 2||0
6322739|NCT00467779|7228369|FG010|STARTED|Stage 2||0
6322740|NCT00467779|7228370|FG011|STARTED|Stage 2||0
6558136|NCT01773421|7480814|FG004|COMPLETED|Extension Phase||12
6775174|NCT03880227|7703106|FG003|COMPLETED|1 Week Washout/ Delay||18
6322741|NCT00467779|7228371|FG012|STARTED|Stage 2||0
6322742|NCT00467779|7228372|FG013|STARTED|Stage 2||0
6322743|NCT00467779|7228373|FG014|STARTED|Stage 2||0
6322744|NCT00467779|7228359|FG000|COMPLETED|Stage 2||0
6322745|NCT00467779|7228360|FG001|COMPLETED|Stage 2||0
6322746|NCT00467779|7228361|FG002|COMPLETED|Stage 2||0
6322747|NCT00467779|7228362|FG003|COMPLETED|Stage 2||0
6322748|NCT00467779|7228363|FG004|COMPLETED|Stage 2||0
6322749|NCT00467779|7228364|FG005|COMPLETED|Stage 2||0
6322750|NCT00467779|7228365|FG006|COMPLETED|Stage 2||0
6322751|NCT00467779|7228366|FG007|COMPLETED|Stage 2||0
6322752|NCT00467779|7228367|FG008|COMPLETED|Stage 2||0
6322753|NCT00467779|7228368|FG009|COMPLETED|Stage 2||0
6558137|NCT01773421|7480815|FG005|COMPLETED|Extension Phase||1
6558138|NCT01773421|7480816|FG006|COMPLETED|Extension Phase||0
6322754|NCT00467779|7228369|FG010|COMPLETED|Stage 2||0
6558139|NCT01773421|7480810|FG000|NOT COMPLETED|Extension Phase||0
6322755|NCT00467779|7228370|FG011|COMPLETED|Stage 2||0
6322756|NCT00467779|7228371|FG012|COMPLETED|Stage 2||0
6322757|NCT00467779|7228372|FG013|COMPLETED|Stage 2||0
6322758|NCT00467779|7228373|FG014|COMPLETED|Stage 2||0
6322759|NCT00467779|7228359|FG000|NOT COMPLETED|Stage 2||0
6322760|NCT00467779|7228360|FG001|NOT COMPLETED|Stage 2||0
6322761|NCT00467779|7228361|FG002|NOT COMPLETED|Stage 2||0
6322762|NCT00467779|7228362|FG003|NOT COMPLETED|Stage 2||0
6322763|NCT00467779|7228363|FG004|NOT COMPLETED|Stage 2||0
6322764|NCT00467779|7228364|FG005|NOT COMPLETED|Stage 2||0
6322765|NCT00467779|7228365|FG006|NOT COMPLETED|Stage 2||0
6322766|NCT00467779|7228366|FG007|NOT COMPLETED|Stage 2||0
6322767|NCT00467779|7228367|FG008|NOT COMPLETED|Stage 2||21
6322768|NCT00467779|7228368|FG009|NOT COMPLETED|Stage 2||0
6322769|NCT00467779|7228369|FG010|NOT COMPLETED|Stage 2||0
6322770|NCT00467779|7228370|FG011|NOT COMPLETED|Stage 2||0
6322771|NCT00467779|7228371|FG012|NOT COMPLETED|Stage 2||0
6322772|NCT00467779|7228372|FG013|NOT COMPLETED|Stage 2||0
6322773|NCT00467779|7228373|FG014|NOT COMPLETED|Stage 2||0
6322774|NCT00467779|7228359|FG000|STARTED|Stage 2A||0
6322775|NCT00467779|7228360|FG001|STARTED|Stage 2A||0
6322776|NCT00467779|7228361|FG002|STARTED|Stage 2A||0
6322777|NCT00467779|7228362|FG003|STARTED|Stage 2A||0
6322778|NCT00467779|7228363|FG004|STARTED|Stage 2A||0
6322779|NCT00467779|7228364|FG005|STARTED|Stage 2A||0
6322780|NCT00467779|7228365|FG006|STARTED|Stage 2A||0
6322781|NCT00467779|7228366|FG007|STARTED|Stage 2A||0
6322782|NCT00467779|7228367|FG008|STARTED|Stage 2A||0
6322783|NCT00467779|7228368|FG009|STARTED|Stage 2A||0
6322784|NCT00467779|7228369|FG010|STARTED|Stage 2A||0
6322785|NCT00467779|7228370|FG011|STARTED|Stage 2A||0
6322786|NCT00467779|7228371|FG012|STARTED|Stage 2A||0
6322787|NCT00467779|7228372|FG013|STARTED|Stage 2A||22
6322788|NCT00467779|7228373|FG014|STARTED|Stage 2A||0
6322789|NCT00467779|7228359|FG000|COMPLETED|Stage 2A||0
6322790|NCT00467779|7228360|FG001|COMPLETED|Stage 2A||0
6322791|NCT00467779|7228361|FG002|COMPLETED|Stage 2A||0
6322792|NCT00467779|7228362|FG003|COMPLETED|Stage 2A||0
6322793|NCT00467779|7228363|FG004|COMPLETED|Stage 2A||0
6322794|NCT00467779|7228364|FG005|COMPLETED|Stage 2A||0
6322795|NCT00467779|7228365|FG006|COMPLETED|Stage 2A||0
6322796|NCT00467779|7228366|FG007|COMPLETED|Stage 2A||0
6322797|NCT00467779|7228367|FG008|COMPLETED|Stage 2A||0
6322798|NCT00467779|7228368|FG009|COMPLETED|Stage 2A||0
6322799|NCT00467779|7228369|FG010|COMPLETED|Stage 2A||0
6322800|NCT00467779|7228370|FG011|COMPLETED|Stage 2A||0
6322801|NCT00467779|7228371|FG012|COMPLETED|Stage 2A||0
6322802|NCT00467779|7228372|FG013|COMPLETED|Stage 2A||1
6322803|NCT00467779|7228373|FG014|COMPLETED|Stage 2A||0
6322804|NCT00467779|7228359|FG000|NOT COMPLETED|Stage 2A||0
6322805|NCT00467779|7228360|FG001|NOT COMPLETED|Stage 2A||0
6322806|NCT00467779|7228361|FG002|NOT COMPLETED|Stage 2A||0
6322807|NCT00467779|7228362|FG003|NOT COMPLETED|Stage 2A||0
6322808|NCT00467779|7228363|FG004|NOT COMPLETED|Stage 2A||0
6322809|NCT00467779|7228364|FG005|NOT COMPLETED|Stage 2A||0
6322810|NCT00467779|7228365|FG006|NOT COMPLETED|Stage 2A||0
6322811|NCT00467779|7228366|FG007|NOT COMPLETED|Stage 2A||0
6322812|NCT00467779|7228367|FG008|NOT COMPLETED|Stage 2A||0
6322813|NCT00467779|7228368|FG009|NOT COMPLETED|Stage 2A||0
6322814|NCT00467779|7228369|FG010|NOT COMPLETED|Stage 2A||0
6322815|NCT00467779|7228370|FG011|NOT COMPLETED|Stage 2A||0
6322816|NCT00467779|7228371|FG012|NOT COMPLETED|Stage 2A||0
6322817|NCT00467779|7228372|FG013|NOT COMPLETED|Stage 2A||21
6322818|NCT00467779|7228373|FG014|NOT COMPLETED|Stage 2A||0
6322819|NCT00467779|7228359|FG000|STARTED|Stage 3||0
6322820|NCT00467779|7228360|FG001|STARTED|Stage 3||0
6322821|NCT00467779|7228361|FG002|STARTED|Stage 3||0
6322822|NCT00467779|7228362|FG003|STARTED|Stage 3||0
6322823|NCT00467779|7228363|FG004|STARTED|Stage 3||0
6322824|NCT00467779|7228364|FG005|STARTED|Stage 3||0
6322825|NCT00467779|7228365|FG006|STARTED|Stage 3||0
6322826|NCT00467779|7228366|FG007|STARTED|Stage 3||0
6322827|NCT00467779|7228367|FG008|STARTED|Stage 3||0
6322828|NCT00467779|7228368|FG009|STARTED|Stage 3||0
6322829|NCT00467779|7228369|FG010|STARTED|Stage 3||0
6322830|NCT00467779|7228370|FG011|STARTED|Stage 3||0
6322831|NCT00467779|7228371|FG012|STARTED|Stage 3||0
6322832|NCT00467779|7228372|FG013|STARTED|Stage 3||0
6322833|NCT00467779|7228373|FG014|STARTED|Stage 3||20
6322834|NCT00467779|7228359|FG000|COMPLETED|Stage 3||0
6322835|NCT00467779|7228360|FG001|COMPLETED|Stage 3||0
6322836|NCT00467779|7228361|FG002|COMPLETED|Stage 3||0
6322837|NCT00467779|7228362|FG003|COMPLETED|Stage 3||0
6322838|NCT00467779|7228363|FG004|COMPLETED|Stage 3||0
6322839|NCT00467779|7228364|FG005|COMPLETED|Stage 3||0
6322840|NCT00467779|7228365|FG006|COMPLETED|Stage 3||0
6322841|NCT00467779|7228366|FG007|COMPLETED|Stage 3||0
6322842|NCT00467779|7228367|FG008|COMPLETED|Stage 3||0
6322843|NCT00467779|7228368|FG009|COMPLETED|Stage 3||0
6322844|NCT00467779|7228369|FG010|COMPLETED|Stage 3||0
6322845|NCT00467779|7228370|FG011|COMPLETED|Stage 3||0
6322846|NCT00467779|7228371|FG012|COMPLETED|Stage 3||0
6322847|NCT00467779|7228372|FG013|COMPLETED|Stage 3||0
6322848|NCT00467779|7228373|FG014|COMPLETED|Stage 3||3
6322849|NCT00467779|7228359|FG000|NOT COMPLETED|Stage 3||0
6322850|NCT00467779|7228360|FG001|NOT COMPLETED|Stage 3||0
6322851|NCT00467779|7228361|FG002|NOT COMPLETED|Stage 3||0
6322852|NCT00467779|7228362|FG003|NOT COMPLETED|Stage 3||0
6322853|NCT00467779|7228363|FG004|NOT COMPLETED|Stage 3||0
6322854|NCT00467779|7228364|FG005|NOT COMPLETED|Stage 3||0
6322855|NCT00467779|7228365|FG006|NOT COMPLETED|Stage 3||0
6322856|NCT00467779|7228366|FG007|NOT COMPLETED|Stage 3||0
6322857|NCT00467779|7228367|FG008|NOT COMPLETED|Stage 3||0
6322858|NCT00467779|7228368|FG009|NOT COMPLETED|Stage 3||0
6322859|NCT00467779|7228369|FG010|NOT COMPLETED|Stage 3||0
6322860|NCT00467779|7228370|FG011|NOT COMPLETED|Stage 3||0
6322861|NCT00467779|7228371|FG012|NOT COMPLETED|Stage 3||0
6322862|NCT00467779|7228372|FG013|NOT COMPLETED|Stage 3||0
6322863|NCT00467779|7228373|FG014|NOT COMPLETED|Stage 3||17
6322864|NCT00467818|7228413|FG000|STARTED|Overall Study||9
6322865|NCT00467818|7228414|FG001|STARTED|Overall Study||8
6322866|NCT00467818|7228413|FG000|COMPLETED|Overall Study||6
6322867|NCT00467818|7228414|FG001|COMPLETED|Overall Study||6
6322868|NCT00467818|7228413|FG000|NOT COMPLETED|Overall Study||3
6322869|NCT00467818|7228414|FG001|NOT COMPLETED|Overall Study||2
6322870|NCT00467831|7228422|FG000|STARTED|Overall Study||3
6322871|NCT00467831|7228422|FG000|COMPLETED|Overall Study||0
6322872|NCT00467831|7228422|FG000|NOT COMPLETED|Overall Study||3
6322873|NCT00467844|7228429|FG000|STARTED|Overall Study||53
6322874|NCT00467844|7228430|FG001|STARTED|Overall Study||54
6322875|NCT00467844|7228431|FG002|STARTED|Overall Study||52
6322876|NCT00467844|7228429|FG000|COMPLETED|Overall Study||34
6322877|NCT00467844|7228430|FG001|COMPLETED|Overall Study||34
6322878|NCT00467844|7228431|FG002|COMPLETED|Overall Study||38
6322879|NCT00467844|7228429|FG000|NOT COMPLETED|Overall Study||19
6322880|NCT00467844|7228430|FG001|NOT COMPLETED|Overall Study||20
6322881|NCT00467844|7228431|FG002|NOT COMPLETED|Overall Study||14
6322882|NCT00467857|7228444|FG000|STARTED|Overall Study||146
6322883|NCT00467857|7228445|FG001|STARTED|Overall Study||147
6322884|NCT00467857|7228444|FG000|COMPLETED|Overall Study||143
6322885|NCT00467857|7228445|FG001|COMPLETED|Overall Study||139
6322886|NCT00467857|7228444|FG000|NOT COMPLETED|Overall Study||3
6322887|NCT00467857|7228445|FG001|NOT COMPLETED|Overall Study||8
6322888|NCT00467870|7228457|FG000|STARTED|Overall Study||120
6322889|NCT00467870|7228458|FG001|STARTED|Overall Study||117
6322890|NCT00467870|7228459|FG002|STARTED|Overall Study||22
6322891|NCT00467870|7228460|FG003|STARTED|Overall Study||112
6322892|NCT00467870|7228461|FG004|STARTED|Overall Study||130
6322893|NCT00467870|7228462|FG005|STARTED|Overall Study||23
6322894|NCT00467870|7228457|FG000|COMPLETED|Overall Study||75
6322895|NCT00467870|7228458|FG001|COMPLETED|Overall Study||74
6322896|NCT00467870|7228459|FG002|COMPLETED|Overall Study||18
6322897|NCT00467870|7228460|FG003|COMPLETED|Overall Study||79
6322898|NCT00467870|7228461|FG004|COMPLETED|Overall Study||93
6322899|NCT00467870|7228462|FG005|COMPLETED|Overall Study||21
6322900|NCT00467870|7228457|FG000|NOT COMPLETED|Overall Study||45
6322901|NCT00467870|7228458|FG001|NOT COMPLETED|Overall Study||43
6322902|NCT00467870|7228459|FG002|NOT COMPLETED|Overall Study||4
6322903|NCT00467870|7228460|FG003|NOT COMPLETED|Overall Study||33
6322904|NCT00467870|7228461|FG004|NOT COMPLETED|Overall Study||37
6322905|NCT00467870|7228462|FG005|NOT COMPLETED|Overall Study||2
6322906|NCT00467896|7228472|FG000|STARTED|Overall Study||62
6322907|NCT00467896|7228472|FG000|COMPLETED|Overall Study||11
6322908|NCT00467896|7228472|FG000|NOT COMPLETED|Overall Study||51
6322909|NCT00467961|7228478|FG000|STARTED|Overall Study||31
6322910|NCT00467961|7228478|FG000|COMPLETED|Overall Study||24
6322911|NCT00467961|7228478|FG000|NOT COMPLETED|Overall Study||7
6322912|NCT00468052|7228484|FG000|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
6322913|NCT00468052|7228485|FG001|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
6322914|NCT00468052|7228484|FG000|Target Enrollment|Overall Study||70
6322915|NCT00468052|7228485|FG001|Target Enrollment|Overall Study||70
6322916|NCT00468052|7228484|FG000|COMPLETED|Overall Study||61
6322917|NCT00468052|7228485|FG001|COMPLETED|Overall Study||61
6322918|NCT00468052|7228484|FG000|NOT COMPLETED|Overall Study||7
6322919|NCT00468052|7228485|FG001|NOT COMPLETED|Overall Study||8
6322920|NCT00468104|7228493|FG000|STARTED|First Intervention||54
6322921|NCT00468104|7228494|FG001|STARTED|First Intervention||46
6322922|NCT00468104|7228493|FG000|COMPLETED|First Intervention||45
6322923|NCT00468104|7228494|FG001|COMPLETED|First Intervention||45
6322924|NCT00468104|7228493|FG000|NOT COMPLETED|First Intervention||9
6322925|NCT00468104|7228494|FG001|NOT COMPLETED|First Intervention||1
6322926|NCT00468104|7228493|FG000|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
6322927|NCT00468104|7228494|FG001|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
6322928|NCT00468104|7228493|FG000|COMPLETED|Second Intervention||3
6322929|NCT00468104|7228494|FG001|COMPLETED|Second Intervention||37
6322930|NCT00468104|7228493|FG000|NOT COMPLETED|Second Intervention||5
6322931|NCT00468104|7228494|FG001|NOT COMPLETED|Second Intervention||4
6322932|NCT00468143|7228503|FG000|STARTED|First Intervention (3 Weeks)||31
6322933|NCT00468143|7228504|FG001|STARTED|First Intervention (3 Weeks)||31
6322934|NCT00468143|7228503|FG000|COMPLETED|First Intervention (3 Weeks)||28
6322935|NCT00468143|7228504|FG001|COMPLETED|First Intervention (3 Weeks)||27
6322936|NCT00468143|7228503|FG000|NOT COMPLETED|First Intervention (3 Weeks)||3
6322937|NCT00468143|7228504|FG001|NOT COMPLETED|First Intervention (3 Weeks)||4
6322938|NCT00468143|7228503|FG000|STARTED|Second Intervention (3 Weeks)||28
6322939|NCT00468143|7228504|FG001|STARTED|Second Intervention (3 Weeks)||27
6322940|NCT00468143|7228503|FG000|COMPLETED|Second Intervention (3 Weeks)||25
6322941|NCT00468143|7228504|FG001|COMPLETED|Second Intervention (3 Weeks)||24
6322942|NCT00468143|7228503|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||3
6322943|NCT00468143|7228504|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||3
6322944|NCT00468169|7228512|FG000|STARTED|Overall Study||57
6322945|NCT00468169|7228513|FG001|STARTED|Overall Study||53
6322946|NCT00468169|7228512|FG000|COMPLETED|Overall Study||56
6322947|NCT00468169|7228513|FG001|COMPLETED|Overall Study||53
6322948|NCT00468169|7228512|FG000|NOT COMPLETED|Overall Study||1
6322949|NCT00468169|7228513|FG001|NOT COMPLETED|Overall Study||0
6322950|NCT00468208|7228521|FG000|STARTED|Overall Study||20
6322951|NCT00468208|7228521|FG000|COMPLETED|Overall Study|All patients reached common closing or early termination|20
6322952|NCT00468208|7228521|FG000|NOT COMPLETED|Overall Study||0
6322953|NCT00468286|7228527|FG000|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
6322954|NCT00468286|7228528|FG001|STARTED|Overall Study||66
6322955|NCT00468286|7228527|FG000|COMPLETED|Overall Study||60
6322956|NCT00468286|7228528|FG001|COMPLETED|Overall Study||54
6322957|NCT00468286|7228527|FG000|NOT COMPLETED|Overall Study||7
6322958|NCT00468286|7228528|FG001|NOT COMPLETED|Overall Study||12
6322959|NCT00468299|7228536|FG000|STARTED|Overall Study||9
6322960|NCT00468299|7228537|FG001|STARTED|Overall Study||8
6322961|NCT00468299|7228536|FG000|COMPLETED|Overall Study||9
6322962|NCT00468299|7228537|FG001|COMPLETED|Overall Study||7
6322963|NCT00468299|7228536|FG000|NOT COMPLETED|Overall Study||0
6322964|NCT00468299|7228537|FG001|NOT COMPLETED|Overall Study||1
6322965|NCT00468481|7228547|FG000|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
6322966|NCT00468481|7228548|FG001|STARTED|Overall Study||94
6322967|NCT00468481|7228547|FG000|Subjects Treated|Overall Study||285
6322968|NCT00468481|7228548|FG001|Subjects Treated|Overall Study||94
6322969|NCT00468481|7228547|FG000|COMPLETED|Overall Study||203
6322970|NCT00468481|7228548|FG001|COMPLETED|Overall Study||70
6322971|NCT00468481|7228547|FG000|NOT COMPLETED|Overall Study||88
6322972|NCT00468481|7228548|FG001|NOT COMPLETED|Overall Study||24
6322973|NCT00468546|7228556|FG000|STARTED|Week 24 Analysis||208
6322974|NCT00468546|7228557|FG001|STARTED|Week 24 Analysis||308
6322975|NCT00468546|7228556|FG000|COMPLETED|Week 24 Analysis||111
6322976|NCT00468546|7228557|FG001|COMPLETED|Week 24 Analysis||253
6322977|NCT00468546|7228556|FG000|NOT COMPLETED|Week 24 Analysis||97
6322978|NCT00468546|7228557|FG001|NOT COMPLETED|Week 24 Analysis||55
6322979|NCT00468546|7228556|FG000|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
6322980|NCT00468546|7228557|FG001|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
6322981|NCT00468546|7228556|FG000|COMPLETED|Week 24 to Week 104 Analysis||103
6322982|NCT00468546|7228557|FG001|COMPLETED|Week 24 to Week 104 Analysis||83
6322983|NCT00468546|7228556|FG000|NOT COMPLETED|Week 24 to Week 104 Analysis||105
6322984|NCT00468546|7228557|FG001|NOT COMPLETED|Week 24 to Week 104 Analysis||225
6322985|NCT00468559|7228565|FG000|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
6322986|NCT00468559|7228566|FG001|STARTED|Open-label Treatment Phase||0
6322987|NCT00468559|7228567|FG002|STARTED|Open-label Treatment Phase||0
6322988|NCT00468559|7228565|FG000|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
6322989|NCT00468559|7228566|FG001|COMPLETED|Open-label Treatment Phase||0
6322990|NCT00468559|7228567|FG002|COMPLETED|Open-label Treatment Phase||0
6322991|NCT00468559|7228565|FG000|NOT COMPLETED|Open-label Treatment Phase||18
6322992|NCT00468559|7228566|FG001|NOT COMPLETED|Open-label Treatment Phase||0
6322993|NCT00468559|7228567|FG002|NOT COMPLETED|Open-label Treatment Phase||0
6322994|NCT00468559|7228565|FG000|STARTED|Double-blind, Treatment-withdrawal Phase||0
6322995|NCT00468559|7228566|FG001|STARTED|Double-blind, Treatment-withdrawal Phase||39
6322996|NCT00468559|7228567|FG002|STARTED|Double-blind, Treatment-withdrawal Phase||41
6322997|NCT00468559|7228565|FG000|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
6322998|NCT00468559|7228566|FG001|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
6322999|NCT00468559|7228567|FG002|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
6323000|NCT00468559|7228565|FG000|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
6323001|NCT00468559|7228566|FG001|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
6323002|NCT00468559|7228567|FG002|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
6323003|NCT00468585|7228579|FG000|STARTED|Overall Study||4
6323004|NCT00468585|7228580|FG001|STARTED|Overall Study||3
6323005|NCT00468585|7228581|FG002|STARTED|Overall Study||50
6323006|NCT00468585|7228582|FG003|STARTED|Overall Study||6
6323007|NCT00468585|7228579|FG000|COMPLETED|Overall Study||3
6323008|NCT00468585|7228580|FG001|COMPLETED|Overall Study||3
6323009|NCT00468585|7228581|FG002|COMPLETED|Overall Study||45
6323010|NCT00468585|7228582|FG003|COMPLETED|Overall Study||5
6323011|NCT00468585|7228579|FG000|NOT COMPLETED|Overall Study||1
6558140|NCT01773421|7480811|FG001|NOT COMPLETED|Extension Phase||0
6558141|NCT01773421|7480812|FG002|NOT COMPLETED|Extension Phase||0
6323012|NCT00468585|7228580|FG001|NOT COMPLETED|Overall Study||0
6323013|NCT00468585|7228581|FG002|NOT COMPLETED|Overall Study||5
6323014|NCT00468585|7228582|FG003|NOT COMPLETED|Overall Study||1
6323015|NCT00468650|7228592|FG000|STARTED|Overall Study||117
6323016|NCT00468650|7228592|FG000|COMPLETED|Overall Study||110
6323017|NCT00468650|7228592|FG000|NOT COMPLETED|Overall Study||7
6323018|NCT00468676|7228599|FG000|STARTED|Overall Study||108
6323019|NCT00468676|7228600|FG001|STARTED|Overall Study||106
6323020|NCT00468676|7228599|FG000|COMPLETED|Overall Study||92
6323021|NCT00468676|7228600|FG001|COMPLETED|Overall Study||94
6323022|NCT00468676|7228599|FG000|NOT COMPLETED|Overall Study||16
6323023|NCT00468676|7228600|FG001|NOT COMPLETED|Overall Study||12
6323024|NCT00468728|7228610|FG000|STARTED|Enrollment||264
6323025|NCT00468728|7228611|FG001|STARTED|Enrollment||271
6323026|NCT00468728|7228610|FG000|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
6323027|NCT00468728|7228611|FG001|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
6323028|NCT00468728|7228610|FG000|NOT COMPLETED|Enrollment||4
6323029|NCT00468728|7228611|FG001|NOT COMPLETED|Enrollment||7
6323030|NCT00468728|7228610|FG000|STARTED|Treatment||260
6323031|NCT00468728|7228611|FG001|STARTED|Treatment||264
6323032|NCT00468728|7228610|FG000|COMPLETED|Treatment||256
6323033|NCT00468728|7228611|FG001|COMPLETED|Treatment||253
6323034|NCT00468728|7228610|FG000|NOT COMPLETED|Treatment||4
6323035|NCT00468728|7228611|FG001|NOT COMPLETED|Treatment||11
6323036|NCT00468728|7228610|FG000|STARTED|Follow-up||256
6323037|NCT00468728|7228611|FG001|STARTED|Follow-up||253
6323038|NCT00468728|7228610|FG000|COMPLETED|Follow-up||222
6323039|NCT00468728|7228611|FG001|COMPLETED|Follow-up||222
6323040|NCT00468728|7228610|FG000|NOT COMPLETED|Follow-up||34
6323041|NCT00468728|7228611|FG001|NOT COMPLETED|Follow-up||31
6323042|NCT00468819|7228622|FG000|STARTED|Overall Study|Enrolled participants|48
6323043|NCT00468819|7228623|FG001|STARTED|Overall Study|Enrolled participants|44
6323044|NCT00468819|7228624|FG002|STARTED|Overall Study|Enrolled participants|48
6323045|NCT00468819|7228622|FG000|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
6323046|NCT00468819|7228623|FG001|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
6323047|NCT00468819|7228624|FG002|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
6323048|NCT00468819|7228622|FG000|COMPLETED|Overall Study||42
6323049|NCT00468819|7228623|FG001|COMPLETED|Overall Study||44
6323050|NCT00468819|7228624|FG002|COMPLETED|Overall Study||46
6323051|NCT00468819|7228622|FG000|NOT COMPLETED|Overall Study||6
6323052|NCT00468819|7228623|FG001|NOT COMPLETED|Overall Study||0
6323053|NCT00468819|7228624|FG002|NOT COMPLETED|Overall Study||2
6323054|NCT00468845|7228637|FG000|STARTED|Overall Study||162
6323055|NCT00468845|7228638|FG001|STARTED|Overall Study||170
6323056|NCT00468845|7228639|FG002|STARTED|Overall Study||169
6323057|NCT00468845|7228637|FG000|Received Treatment|Overall Study||161
6323058|NCT00468845|7228638|FG001|Received Treatment|Overall Study||166
6323059|NCT00468845|7228639|FG002|Received Treatment|Overall Study||167
6323060|NCT00468845|7228637|FG000|COMPLETED|Overall Study||141
6323061|NCT00468845|7228638|FG001|COMPLETED|Overall Study||136
6323062|NCT00468845|7228639|FG002|COMPLETED|Overall Study||139
6323063|NCT00468845|7228637|FG000|NOT COMPLETED|Overall Study||21
6323064|NCT00468845|7228638|FG001|NOT COMPLETED|Overall Study||34
6323065|NCT00468845|7228639|FG002|NOT COMPLETED|Overall Study||30
6323066|NCT00468858|7228650|FG000|STARTED|Overall Study||211
6323067|NCT00468858|7228651|FG001|STARTED|Overall Study||212
6323068|NCT00468858|7228652|FG002|STARTED|Overall Study||213
6323069|NCT00468858|7228650|FG000|COMPLETED|Overall Study||202
6323070|NCT00468858|7228651|FG001|COMPLETED|Overall Study||202
6323071|NCT00468858|7228652|FG002|COMPLETED|Overall Study||199
6323072|NCT00468858|7228650|FG000|NOT COMPLETED|Overall Study||9
6323073|NCT00468858|7228651|FG001|NOT COMPLETED|Overall Study||10
6323074|NCT00468858|7228652|FG002|NOT COMPLETED|Overall Study||14
6323075|NCT00468910|7228716|FG000|STARTED|Overall Study||40
6323076|NCT00468910|7228717|FG001|STARTED|Overall Study||39
6323077|NCT00468910|7228716|FG000|Randomization|Overall Study||40
6323078|NCT00468910|7228717|FG001|Randomization|Overall Study||39
6323079|NCT00468910|7228716|FG000|Treatment|Overall Study||36
6323080|NCT00468910|7228717|FG001|Treatment|Overall Study||36
6323081|NCT00468910|7228716|FG000|Post-Treatment Biopsy|Overall Study||36
6323082|NCT00468910|7228717|FG001|Post-Treatment Biopsy|Overall Study||36
6558142|NCT01773421|7480813|FG003|NOT COMPLETED|Extension Phase||0
6558143|NCT01773421|7480814|FG004|NOT COMPLETED|Extension Phase||3
6558144|NCT01773421|7480815|FG005|NOT COMPLETED|Extension Phase||2
6558145|NCT01773421|7480816|FG006|NOT COMPLETED|Extension Phase||0
6558146|NCT01773473|7480834|FG000|STARTED|Overall Study||207
6558147|NCT01773473|7480835|FG001|STARTED|Overall Study||196
6323083|NCT00468910|7228716|FG000|Follow-up|Overall Study||36
6323084|NCT00468910|7228717|FG001|Follow-up|Overall Study||36
6323085|NCT00468910|7228716|FG000|COMPLETED|Overall Study||36
6558148|NCT01773473|7480834|FG000|Received at Least 1 Dose of Study Drug|Overall Study||207
6558149|NCT01773473|7480835|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
6323086|NCT00468910|7228717|FG001|COMPLETED|Overall Study||36
6323087|NCT00468910|7228716|FG000|NOT COMPLETED|Overall Study||4
6323088|NCT00468910|7228717|FG001|NOT COMPLETED|Overall Study||3
6323089|NCT00469014|7228728|FG000|STARTED|Initial Phase Randomization||5
6323090|NCT00469014|7228729|FG001|STARTED|Initial Phase Randomization||4
6323091|NCT00469014|7228730|FG002|STARTED|Initial Phase Randomization||5
6323092|NCT00469014|7228731|FG003|STARTED|Initial Phase Randomization||6
6323093|NCT00469014|7228728|FG000|COMPLETED|Initial Phase Randomization||4
6323094|NCT00469014|7228729|FG001|COMPLETED|Initial Phase Randomization||3
6323095|NCT00469014|7228730|FG002|COMPLETED|Initial Phase Randomization||4
6323096|NCT00469014|7228731|FG003|COMPLETED|Initial Phase Randomization||5
6323097|NCT00469014|7228728|FG000|NOT COMPLETED|Initial Phase Randomization||1
6323098|NCT00469014|7228729|FG001|NOT COMPLETED|Initial Phase Randomization||1
6323099|NCT00469014|7228730|FG002|NOT COMPLETED|Initial Phase Randomization||1
6323100|NCT00469014|7228731|FG003|NOT COMPLETED|Initial Phase Randomization||1
6323101|NCT00469014|7228728|FG000|STARTED|Adaptive Randomization||13
6323102|NCT00469014|7228729|FG001|STARTED|Adaptive Randomization||3
6323103|NCT00469014|7228730|FG002|STARTED|Adaptive Randomization||24
6323104|NCT00469014|7228731|FG003|STARTED|Adaptive Randomization||11
6323105|NCT00469014|7228728|FG000|COMPLETED|Adaptive Randomization||12
6323106|NCT00469014|7228729|FG001|COMPLETED|Adaptive Randomization||2
6323107|NCT00469014|7228730|FG002|COMPLETED|Adaptive Randomization||23
6558150|NCT01773473|7480834|FG000|COMPLETED|Overall Study||191
6323108|NCT00469014|7228731|FG003|COMPLETED|Adaptive Randomization||10
6323109|NCT00469014|7228728|FG000|NOT COMPLETED|Adaptive Randomization||1
6323110|NCT00469014|7228729|FG001|NOT COMPLETED|Adaptive Randomization||1
6323111|NCT00469014|7228730|FG002|NOT COMPLETED|Adaptive Randomization||1
6323112|NCT00469014|7228731|FG003|NOT COMPLETED|Adaptive Randomization||1
6323113|NCT00469079|7228744|FG000|STARTED|Overall Study||27
6323114|NCT00469079|7228745|FG001|STARTED|Overall Study||52
6323115|NCT00469079|7228746|FG002|STARTED|Overall Study||51
6323116|NCT00469079|7228744|FG000|COMPLETED|Overall Study||18
6323117|NCT00469079|7228745|FG001|COMPLETED|Overall Study||30
6323118|NCT00469079|7228746|FG002|COMPLETED|Overall Study||32
6323119|NCT00469079|7228744|FG000|NOT COMPLETED|Overall Study||9
6323120|NCT00469079|7228745|FG001|NOT COMPLETED|Overall Study||22
6323121|NCT00469079|7228746|FG002|NOT COMPLETED|Overall Study||19
6323122|NCT00469092|7228762|FG000|STARTED|Overall Study||239
6323123|NCT00469092|7228763|FG001|STARTED|Overall Study||241
6323124|NCT00469092|7228762|FG000|Exposed to Study Drug|Overall Study||231
6323125|NCT00469092|7228763|FG001|Exposed to Study Drug|Overall Study||238
6323126|NCT00469092|7228762|FG000|COMPLETED|Overall Study||213
6323127|NCT00469092|7228763|FG001|COMPLETED|Overall Study||220
6323128|NCT00469092|7228762|FG000|NOT COMPLETED|Overall Study||26
6323129|NCT00469092|7228763|FG001|NOT COMPLETED|Overall Study||21
6323130|NCT00469144|7228771|FG000|STARTED|Overall Study|Eight assigned to Fixed Dose without randomization.|114
6323131|NCT00469144|7228772|FG001|STARTED|Overall Study||111
6323132|NCT00469144|7228771|FG000|COMPLETED|Overall Study||108
6323133|NCT00469144|7228772|FG001|COMPLETED|Overall Study||105
6323134|NCT00469144|7228771|FG000|NOT COMPLETED|Overall Study||6
6323135|NCT00469144|7228772|FG001|NOT COMPLETED|Overall Study||6
6323136|NCT00469209|7228785|FG000|STARTED|Overall Study||20
6323137|NCT00469209|7228786|FG001|STARTED|Overall Study||20
6323138|NCT00469209|7228787|FG002|STARTED|Overall Study||20
6323139|NCT00469209|7228785|FG000|COMPLETED|Overall Study||19
6323140|NCT00469209|7228786|FG001|COMPLETED|Overall Study||20
6323141|NCT00469209|7228787|FG002|COMPLETED|Overall Study||19
6323142|NCT00469209|7228785|FG000|NOT COMPLETED|Overall Study||1
6323143|NCT00469209|7228786|FG001|NOT COMPLETED|Overall Study||0
6323144|NCT00469209|7228787|FG002|NOT COMPLETED|Overall Study||1
6323145|NCT00469274|7228797|FG000|STARTED|Overall Study||44
6323146|NCT00469274|7228798|FG001|STARTED|Overall Study||42
6323147|NCT00469274|7228797|FG000|COMPLETED|Overall Study||44
6323148|NCT00469274|7228798|FG001|COMPLETED|Overall Study||42
6323149|NCT00469274|7228797|FG000|NOT COMPLETED|Overall Study||0
6323150|NCT00469274|7228798|FG001|NOT COMPLETED|Overall Study||0
6323151|NCT00469391|7228806|FG000|STARTED|Overall Study||27
6323152|NCT00469391|7228807|FG001|STARTED|Overall Study||29
6323153|NCT00469391|7228806|FG000|Discontinued Prior to Procedure|Overall Study||2
6323154|NCT00469391|7228807|FG001|Discontinued Prior to Procedure|Overall Study||3
6323155|NCT00469391|7228806|FG000|Unsuccessful Implant Procedure|Overall Study||4
6323156|NCT00469391|7228807|FG001|Unsuccessful Implant Procedure|Overall Study||0
6323157|NCT00469391|7228806|FG000|Adverse Event|Overall Study||8
6323158|NCT00469391|7228807|FG001|Adverse Event|Overall Study||0
6323159|NCT00469391|7228806|FG000|Lost to Follow up|Overall Study||0
6323160|NCT00469391|7228807|FG001|Lost to Follow up|Overall Study||1
6323161|NCT00469391|7228806|FG000|Patient Preference|Overall Study||0
6323162|NCT00469391|7228807|FG001|Patient Preference|Overall Study||1
6323163|NCT00469391|7228806|FG000|COMPLETED|Overall Study||13
6323164|NCT00469391|7228807|FG001|COMPLETED|Overall Study||24
6323165|NCT00469391|7228806|FG000|NOT COMPLETED|Overall Study||14
6323166|NCT00469391|7228807|FG001|NOT COMPLETED|Overall Study||5
6323167|NCT00469456|7228815|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
6323168|NCT00469456|7228816|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
6323169|NCT00469456|7228815|FG000|COMPLETED|Overall Study||120
6323170|NCT00469456|7228816|FG001|COMPLETED|Overall Study||131
6323171|NCT00469456|7228815|FG000|NOT COMPLETED|Overall Study||9
6323172|NCT00469456|7228816|FG001|NOT COMPLETED|Overall Study||4
6323173|NCT00469508|7228824|FG000|STARTED|Overall Study||34
6323174|NCT00469508|7228825|FG001|STARTED|Overall Study||37
6323175|NCT00469508|7228824|FG000|COMPLETED|Overall Study||14
6323176|NCT00469508|7228825|FG001|COMPLETED|Overall Study||13
6323177|NCT00469508|7228824|FG000|NOT COMPLETED|Overall Study||20
6323178|NCT00469508|7228825|FG001|NOT COMPLETED|Overall Study||24
6323179|NCT00469833|7228831|FG000|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
6558151|NCT01773473|7480835|FG001|COMPLETED|Overall Study||177
6323180|NCT00469833|7228831|FG000|COMPLETED|Overall Study||15
6323181|NCT00469833|7228831|FG000|NOT COMPLETED|Overall Study||2
6323182|NCT00469859|7228843|FG000|STARTED|Overall Study||6
6323183|NCT00469859|7228844|FG001|STARTED|Overall Study||8
6323184|NCT00469859|7228843|FG000|COMPLETED|Overall Study||6
6323185|NCT00469859|7228844|FG001|COMPLETED|Overall Study||6
6558152|NCT01773473|7480834|FG000|NOT COMPLETED|Overall Study||16
6323186|NCT00469859|7228843|FG000|NOT COMPLETED|Overall Study||0
6323187|NCT00469859|7228844|FG001|NOT COMPLETED|Overall Study||2
6323188|NCT00469898|7228850|FG000|STARTED|Overall Study||50
6323189|NCT00469898|7228850|FG000|COMPLETED|Overall Study||25
6323190|NCT00469898|7228850|FG000|NOT COMPLETED|Overall Study||25
6323191|NCT00469911|7228856|FG000|STARTED|Overall Study||8
6323192|NCT00469911|7228857|FG001|STARTED|Overall Study||10
6323193|NCT00469911|7228856|FG000|COMPLETED|Overall Study||8
6323194|NCT00469911|7228857|FG001|COMPLETED|Overall Study||10
6323195|NCT00469911|7228856|FG000|NOT COMPLETED|Overall Study||0
6323196|NCT00469911|7228857|FG001|NOT COMPLETED|Overall Study||0
6323197|NCT00470054|7228862|FG000|STARTED|Overall Study||44
6323198|NCT00470054|7228862|FG000|COMPLETED|Overall Study||43
6323199|NCT00470054|7228862|FG000|NOT COMPLETED|Overall Study||1
6323200|NCT00470093|7228866|FG000|STARTED|Overall Study||2
6323201|NCT00470093|7228866|FG000|COMPLETED|Overall Study||0
6323202|NCT00470093|7228866|FG000|NOT COMPLETED|Overall Study||2
6375598|NCT00756678|7286279|FG000|STARTED|Overall Study||51
6375599|NCT00756678|7286279|FG000|COMPLETED|Overall Study||50
6375600|NCT00756678|7286279|FG000|NOT COMPLETED|Overall Study||1
6375601|NCT00756717|7286284|FG000|STARTED|Overall Study||22
6375602|NCT00756717|7286284|FG000|COMPLETED|Overall Study||20
6375603|NCT00756717|7286284|FG000|NOT COMPLETED|Overall Study||2
6375604|NCT00756730|7286290|FG000|STARTED|Overall Study||25
6375605|NCT00756730|7286291|FG001|STARTED|Overall Study||24
6375606|NCT00756730|7286290|FG000|COMPLETED|Overall Study||25
6375607|NCT00756730|7286291|FG001|COMPLETED|Overall Study||22
6375608|NCT00756730|7286290|FG000|NOT COMPLETED|Overall Study||0
6375609|NCT00756730|7286291|FG001|NOT COMPLETED|Overall Study||2
6375610|NCT00756886|7286299|FG000|STARTED|Overall Study||41
6375611|NCT00756886|7286300|FG001|STARTED|Overall Study||32
6375612|NCT00756886|7286299|FG000|COMPLETED|Overall Study||30
6375613|NCT00756886|7286300|FG001|COMPLETED|Overall Study||25
6375614|NCT00756886|7286299|FG000|NOT COMPLETED|Overall Study||11
6375615|NCT00756886|7286300|FG001|NOT COMPLETED|Overall Study||7
6375616|NCT00756964|7286308|FG000|STARTED|Overall Study||13
6375617|NCT00756964|7286309|FG001|STARTED|Overall Study||13
6375618|NCT00756964|7286308|FG000|COMPLETED|Overall Study||13
6375619|NCT00756964|7286309|FG001|COMPLETED|Overall Study||13
6375620|NCT00756964|7286308|FG000|NOT COMPLETED|Overall Study||0
6375621|NCT00756964|7286309|FG001|NOT COMPLETED|Overall Study||0
6375622|NCT00756977|7286317|FG000|STARTED|Overall Study||196
6375623|NCT00756977|7286318|FG001|STARTED|Overall Study||198
6375624|NCT00756977|7286317|FG000|COMPLETED|Overall Study||175
6375625|NCT00756977|7286318|FG001|COMPLETED|Overall Study||187
6375626|NCT00756977|7286317|FG000|NOT COMPLETED|Overall Study||21
6375627|NCT00756977|7286318|FG001|NOT COMPLETED|Overall Study||11
6375628|NCT00757003|7286324|FG000|STARTED|Overall Study||100
6375629|NCT00757003|7286324|FG000|COMPLETED|Overall Study||51
6375630|NCT00757003|7286324|FG000|NOT COMPLETED|Overall Study||49
6375631|NCT00757172|7286329|FG000|STARTED|Overall Study||65
6375632|NCT00757172|7286329|FG000|COMPLETED|Overall Study|Participants underwent surgery.|54
6375633|NCT00757172|7286329|FG000|NOT COMPLETED|Overall Study||11
6375634|NCT00757237|7286335|FG000|STARTED|Overall Study||137
6375635|NCT00757237|7286336|FG001|STARTED|Overall Study||136
6375636|NCT00757237|7286335|FG000|Treated|Overall Study||136
6375637|NCT00757237|7286336|FG001|Treated|Overall Study||132
6375638|NCT00757237|7286335|FG000|COMPLETED|Overall Study||124
6375639|NCT00757237|7286336|FG001|COMPLETED|Overall Study||111
6375640|NCT00757237|7286335|FG000|NOT COMPLETED|Overall Study||13
6375641|NCT00757237|7286336|FG001|NOT COMPLETED|Overall Study||25
6375642|NCT00757484|7286342|FG000|STARTED|Overall Study||491
6375643|NCT00757484|7286342|FG000|COMPLETED|Overall Study||491
6375644|NCT00757484|7286342|FG000|NOT COMPLETED|Overall Study||0
6375645|NCT00757588|7286350|FG000|STARTED|Period 1: Short-term (24-week) Phase||304
6375646|NCT00757588|7286351|FG001|STARTED|Period 1: Short-term (24-week) Phase||151
6375647|NCT00757588|7286350|FG000|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
6375648|NCT00757588|7286351|FG001|COMPLETED|Period 1: Short-term (24-week) Phase||134
6375649|NCT00757588|7286350|FG000|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
6375650|NCT00757588|7286351|FG001|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
6375651|NCT00757588|7286350|FG000|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
6375652|NCT00757588|7286351|FG001|STARTED|Period 2: Long-term (52-week) Phase||134
6375653|NCT00757588|7286350|FG000|COMPLETED|Period 2: Long-term (52-week) Phase||246
6375654|NCT00757588|7286351|FG001|COMPLETED|Period 2: Long-term (52-week) Phase||125
6375655|NCT00757588|7286350|FG000|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
6375656|NCT00757588|7286351|FG001|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
6375657|NCT00757601|7286357|FG000|STARTED|Period 1||2
6375658|NCT00757601|7286358|FG001|STARTED|Period 1||2
6375659|NCT00757601|7286359|FG002|STARTED|Period 1||2
6375660|NCT00757601|7286360|FG003|STARTED|Period 1||2
6375661|NCT00757601|7286361|FG004|STARTED|Period 1||2
6375662|NCT00757601|7286362|FG005|STARTED|Period 1||2
6375663|NCT00757601|7286363|FG006|STARTED|Period 1||2
6375664|NCT00757601|7286364|FG007|STARTED|Period 1||2
6375665|NCT00757601|7286365|FG008|STARTED|Period 1||2
6375666|NCT00757601|7286366|FG009|STARTED|Period 1||2
6375667|NCT00757601|7286367|FG010|STARTED|Period 1||2
6375668|NCT00757601|7286368|FG011|STARTED|Period 1||3
6375669|NCT00757601|7286357|FG000|COMPLETED|Period 1||2
6375670|NCT00757601|7286358|FG001|COMPLETED|Period 1||2
6375671|NCT00757601|7286359|FG002|COMPLETED|Period 1||2
6375672|NCT00757601|7286360|FG003|COMPLETED|Period 1||2
6375673|NCT00757601|7286361|FG004|COMPLETED|Period 1||2
6375674|NCT00757601|7286362|FG005|COMPLETED|Period 1||2
6375675|NCT00757601|7286363|FG006|COMPLETED|Period 1||2
6375676|NCT00757601|7286364|FG007|COMPLETED|Period 1||2
6375677|NCT00757601|7286365|FG008|COMPLETED|Period 1||2
6375678|NCT00757601|7286366|FG009|COMPLETED|Period 1||2
6323203|NCT00470106|7228874|FG000|STARTED|Overall Study||19
6323204|NCT00470106|7228875|FG001|STARTED|Overall Study||24
6323205|NCT00470106|7228876|FG002|STARTED|Overall Study||21
6323206|NCT00470106|7228877|FG003|STARTED|Overall Study||21
6323207|NCT00470106|7228874|FG000|COMPLETED|Overall Study||16
6323208|NCT00470106|7228875|FG001|COMPLETED|Overall Study||19
6323209|NCT00470106|7228876|FG002|COMPLETED|Overall Study||14
6323210|NCT00470106|7228877|FG003|COMPLETED|Overall Study||19
6323211|NCT00470106|7228874|FG000|NOT COMPLETED|Overall Study||3
6323212|NCT00470106|7228875|FG001|NOT COMPLETED|Overall Study||5
6323213|NCT00470106|7228876|FG002|NOT COMPLETED|Overall Study||7
6323214|NCT00470106|7228877|FG003|NOT COMPLETED|Overall Study||2
6323215|NCT00470158|7228896|FG000|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
6323216|NCT00470158|7228897|FG001|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
6323217|NCT00470158|7228898|FG002|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
6323218|NCT00470158|7228899|FG003|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
6323219|NCT00470158|7228900|FG004|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
6323220|NCT00470158|7228896|FG000|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
6323221|NCT00470158|7228897|FG001|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
6323222|NCT00470158|7228898|FG002|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
6323223|NCT00470158|7228899|FG003|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
6323224|NCT00470158|7228900|FG004|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
6323225|NCT00470158|7228896|FG000|NOT COMPLETED|Overall Study||8
6323226|NCT00470158|7228897|FG001|NOT COMPLETED|Overall Study||8
6323227|NCT00470158|7228898|FG002|NOT COMPLETED|Overall Study||8
6323228|NCT00470158|7228899|FG003|NOT COMPLETED|Overall Study||5
6323229|NCT00470158|7228900|FG004|NOT COMPLETED|Overall Study||6
6323230|NCT00470184|7228912|FG000|STARTED|Overall Study||41
6323231|NCT00470184|7228912|FG000|Treated With Study Therapy|Overall Study||36
6323232|NCT00470184|7228912|FG000|COMPLETED|Overall Study||19
6323233|NCT00470184|7228912|FG000|NOT COMPLETED|Overall Study||22
6323234|NCT00470262|7228919|FG000|STARTED|Overall Study||15
6323235|NCT00470262|7228920|FG001|STARTED|Overall Study||12
6323236|NCT00470262|7228919|FG000|COMPLETED|Overall Study||13
6323237|NCT00470262|7228920|FG001|COMPLETED|Overall Study||12
6323238|NCT00470262|7228919|FG000|NOT COMPLETED|Overall Study||2
6323239|NCT00470262|7228920|FG001|NOT COMPLETED|Overall Study||0
6323240|NCT00470275|7228927|FG000|STARTED|Overall Study||10
6323241|NCT00470275|7228927|FG000|COMPLETED|Overall Study||0
6323242|NCT00470275|7228927|FG000|NOT COMPLETED|Overall Study||10
6323243|NCT00470301|7228931|FG000|STARTED|Overall Study||60
6323244|NCT00470301|7228931|FG000|COMPLETED|Overall Study||55
6323245|NCT00470301|7228931|FG000|NOT COMPLETED|Overall Study||5
6323246|NCT00470366|7228936|FG000|STARTED|Overall Study||60
6323247|NCT00470366|7228936|FG000|COMPLETED|Overall Study||56
6323248|NCT00470366|7228936|FG000|NOT COMPLETED|Overall Study||4
6323249|NCT00470392|7228942|FG000|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
6323250|NCT00470392|7228943|FG001|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
6323251|NCT00470392|7228942|FG000|COMPLETED|Overall Study||7
6323252|NCT00470392|7228943|FG001|COMPLETED|Overall Study||2
6323253|NCT00470392|7228942|FG000|NOT COMPLETED|Overall Study||0
6323254|NCT00470392|7228943|FG001|NOT COMPLETED|Overall Study||0
6323255|NCT00470418|7228952|FG000|STARTED|Overall Study||7
6323256|NCT00470418|7228953|FG001|STARTED|Overall Study||3
6323257|NCT00470418|7228952|FG000|COMPLETED|Overall Study||6
6323258|NCT00470418|7228953|FG001|COMPLETED|Overall Study||3
6323259|NCT00470418|7228952|FG000|NOT COMPLETED|Overall Study||1
6323260|NCT00470418|7228953|FG001|NOT COMPLETED|Overall Study||0
6323261|NCT00470470|7228959|FG000|STARTED|Overall Study||30
6323262|NCT00470470|7228959|FG000|COMPLETED|Overall Study||25
6323263|NCT00470470|7228959|FG000|NOT COMPLETED|Overall Study||5
6323264|NCT00470535|7228963|FG000|STARTED|Overall Study||18
6323265|NCT00470535|7228963|FG000|COMPLETED|Overall Study||0
6323266|NCT00470535|7228963|FG000|NOT COMPLETED|Overall Study||18
6323267|NCT00470548|7228969|FG000|STARTED|Overall Study||3
6323268|NCT00470548|7228970|FG001|STARTED|Overall Study||3
6323269|NCT00470548|7228971|FG002|STARTED|Overall Study||6
6323270|NCT00470548|7228972|FG003|STARTED|Overall Study||37
6323271|NCT00470548|7228969|FG000|COMPLETED|Overall Study||3
6323272|NCT00470548|7228970|FG001|COMPLETED|Overall Study||3
6323273|NCT00470548|7228971|FG002|COMPLETED|Overall Study||6
6323274|NCT00470548|7228972|FG003|COMPLETED|Overall Study||37
6323275|NCT00470548|7228969|FG000|NOT COMPLETED|Overall Study||0
6323276|NCT00470548|7228970|FG001|NOT COMPLETED|Overall Study||0
6323277|NCT00470548|7228971|FG002|NOT COMPLETED|Overall Study||0
6323278|NCT00470548|7228972|FG003|NOT COMPLETED|Overall Study||0
6323279|NCT00470600|7228984|FG000|STARTED|Overall Study||86
6323280|NCT00470600|7228985|FG001|STARTED|Overall Study||99
6323281|NCT00470600|7228984|FG000|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
6323282|NCT00470600|7228985|FG001|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
6323283|NCT00470600|7228984|FG000|NOT COMPLETED|Overall Study||0
6323284|NCT00470600|7228985|FG001|NOT COMPLETED|Overall Study||0
6323285|NCT00470626|7228991|FG000|STARTED|Overall Study||129
6323286|NCT00470626|7228991|FG000|COMPLETED|Overall Study||112
6323287|NCT00470626|7228991|FG000|NOT COMPLETED|Overall Study||17
6323288|NCT00470717|7228995|FG000|STARTED|Overall Study|Each participant could be called up to 4 times weekly for 13 weeks (38x4x13)|38
6323289|NCT00470717|7228995|FG000|COMPLETED|Overall Study||38
6323290|NCT00470717|7228995|FG000|NOT COMPLETED|Overall Study||0
6323291|NCT00470834|7229001|FG000|STARTED|Treatment Period (18 Months)||65
6323292|NCT00470834|7229002|FG001|STARTED|Treatment Period (18 Months)||62
6323293|NCT00470834|7229001|FG000|COMPLETED|Treatment Period (18 Months)||27
6323294|NCT00470834|7229002|FG001|COMPLETED|Treatment Period (18 Months)||31
6323295|NCT00470834|7229001|FG000|NOT COMPLETED|Treatment Period (18 Months)||38
6323296|NCT00470834|7229002|FG001|NOT COMPLETED|Treatment Period (18 Months)||31
6323297|NCT00470834|7229001|FG000|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
6323298|NCT00470834|7229002|FG001|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
6323299|NCT00470834|7229001|FG000|COMPLETED|Extension Period (24 Months)||11
6323300|NCT00470834|7229002|FG001|COMPLETED|Extension Period (24 Months)||7
6323301|NCT00470834|7229001|FG000|NOT COMPLETED|Extension Period (24 Months)||15
6323302|NCT00470834|7229002|FG001|NOT COMPLETED|Extension Period (24 Months)||23
6323303|NCT00470847|7229008|FG000|STARTED|Overall Study||35
6323304|NCT00470847|7229008|FG000|COMPLETED|Overall Study||34
6323305|NCT00470847|7229008|FG000|NOT COMPLETED|Overall Study||1
6323306|NCT00471068|7229016|FG000|STARTED|Overall Study||21
6323307|NCT00471068|7229017|FG001|STARTED|Overall Study||25
6323308|NCT00471068|7229016|FG000|COMPLETED|Overall Study||20
6323309|NCT00471068|7229017|FG001|COMPLETED|Overall Study||24
6323310|NCT00471068|7229016|FG000|NOT COMPLETED|Overall Study||1
6323311|NCT00471068|7229017|FG001|NOT COMPLETED|Overall Study||1
6323312|NCT00471081|7229025|FG000|STARTED|Active Phase||160
6323313|NCT00471081|7229026|FG001|STARTED|Active Phase||189
6323314|NCT00471081|7229025|FG000|COMPLETED|Active Phase||158
6323315|NCT00471081|7229026|FG001|COMPLETED|Active Phase||176
6323316|NCT00471081|7229025|FG000|NOT COMPLETED|Active Phase||2
6323317|NCT00471081|7229026|FG001|NOT COMPLETED|Active Phase||13
6323318|NCT00471081|7229025|FG000|STARTED|Extended Safety Follow-Up||160
6323319|NCT00471081|7229026|FG001|STARTED|Extended Safety Follow-Up||189
6323320|NCT00471081|7229025|FG000|COMPLETED|Extended Safety Follow-Up||158
6323321|NCT00471081|7229026|FG001|COMPLETED|Extended Safety Follow-Up||176
6323322|NCT00471081|7229025|FG000|NOT COMPLETED|Extended Safety Follow-Up||2
6323323|NCT00471081|7229026|FG001|NOT COMPLETED|Extended Safety Follow-Up||13
6323324|NCT00471107|7229036|FG000|STARTED|Overall Study||15
6323325|NCT00471107|7229037|FG001|STARTED|Overall Study||15
6323326|NCT00471107|7229038|FG002|STARTED|Overall Study||15
6323327|NCT00471107|7229036|FG000|COMPLETED|Overall Study||12
6323328|NCT00471107|7229037|FG001|COMPLETED|Overall Study||14
6323329|NCT00471107|7229038|FG002|COMPLETED|Overall Study||12
6323330|NCT00471107|7229036|FG000|NOT COMPLETED|Overall Study||3
6323331|NCT00471107|7229037|FG001|NOT COMPLETED|Overall Study||1
6323332|NCT00471107|7229038|FG002|NOT COMPLETED|Overall Study||3
6323333|NCT00471146|7229048|FG000|STARTED|Overall Study||314
6323334|NCT00471146|7229049|FG001|STARTED|Overall Study||316
6323335|NCT00471146|7229048|FG000|Treated|Overall Study||305
6323336|NCT00471146|7229049|FG001|Treated|Overall Study||308
6323337|NCT00471146|7229048|FG000|COMPLETED|Overall Study||142
6323338|NCT00471146|7229049|FG001|COMPLETED|Overall Study||142
6323339|NCT00471146|7229048|FG000|NOT COMPLETED|Overall Study||172
6323340|NCT00471146|7229049|FG001|NOT COMPLETED|Overall Study||174
6323341|NCT00471237|7229062|FG000|STARTED|Overall Study||90
6323342|NCT00471237|7229063|FG001|STARTED|Overall Study||87
6323343|NCT00471237|7229064|FG002|STARTED|Overall Study||82
6323344|NCT00471237|7229065|FG003|STARTED|Overall Study||88
6323345|NCT00471237|7229066|FG004|STARTED|Overall Study||87
6323346|NCT00471237|7229067|FG005|STARTED|Overall Study||89
6323347|NCT00471237|7229068|FG006|STARTED|Overall Study||41
6323348|NCT00471237|7229062|FG000|COMPLETED|Overall Study||49
6323349|NCT00471237|7229063|FG001|COMPLETED|Overall Study||45
6323350|NCT00471237|7229064|FG002|COMPLETED|Overall Study||48
6323351|NCT00471237|7229065|FG003|COMPLETED|Overall Study||43
6323352|NCT00471237|7229066|FG004|COMPLETED|Overall Study||46
6323353|NCT00471237|7229067|FG005|COMPLETED|Overall Study||50
6323354|NCT00471237|7229068|FG006|COMPLETED|Overall Study||38
6323355|NCT00471237|7229062|FG000|NOT COMPLETED|Overall Study||41
6323356|NCT00471237|7229063|FG001|NOT COMPLETED|Overall Study||42
6323357|NCT00471237|7229064|FG002|NOT COMPLETED|Overall Study||34
6323358|NCT00471237|7229065|FG003|NOT COMPLETED|Overall Study||45
6323359|NCT00471237|7229066|FG004|NOT COMPLETED|Overall Study||41
6323360|NCT00471237|7229067|FG005|NOT COMPLETED|Overall Study||39
6323361|NCT00471237|7229068|FG006|NOT COMPLETED|Overall Study||3
6323362|NCT00471276|7229088|FG000|STARTED|Overall Study||83
6323363|NCT00471276|7229088|FG000|COMPLETED|Overall Study||0
6323364|NCT00471276|7229088|FG000|NOT COMPLETED|Overall Study||83
6323365|NCT00471315|7229092|FG000|STARTED|Overall Study||18
6323366|NCT00471315|7229092|FG000|COMPLETED|Overall Study||10
6323367|NCT00471315|7229092|FG000|NOT COMPLETED|Overall Study||8
6323368|NCT00471328|7229098|FG000|STARTED|Core Phase||165
6323369|NCT00471328|7229099|FG001|STARTED|Core Phase||83
6323370|NCT00471328|7229098|FG000|Crossover to Nilotinib:Started Extension|Core Phase||0
6323371|NCT00471328|7229099|FG001|Crossover to Nilotinib:Started Extension|Core Phase||53
6323372|NCT00471328|7229098|FG000|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
6323373|NCT00471328|7229099|FG001|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
6323374|NCT00471328|7229098|FG000|NOT COMPLETED|Core Phase||107
6323375|NCT00471328|7229099|FG001|NOT COMPLETED|Core Phase||67
6323376|NCT00471328|7229098|FG000|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
6323377|NCT00471328|7229099|FG001|STARTED|Extension Phase||67
6323378|NCT00471328|7229098|FG000|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
6323379|NCT00471328|7229099|FG001|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
6323380|NCT00471328|7229098|FG000|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
6323381|NCT00471328|7229099|FG001|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
6323382|NCT00471328|7229098|FG000|Started:CrossOver During Extension|Extension Phase||0
6323383|NCT00471328|7229099|FG001|Started:CrossOver During Extension|Extension Phase||10
6323384|NCT00471328|7229098|FG000|COMPLETED|Extension Phase||0
6323385|NCT00471328|7229099|FG001|COMPLETED|Extension Phase||0
6323386|NCT00471328|7229098|FG000|NOT COMPLETED|Extension Phase||41
6323387|NCT00471328|7229099|FG001|NOT COMPLETED|Extension Phase||67
6323388|NCT00471354|7229107|FG000|STARTED|Overall Study||228
6323389|NCT00471354|7229107|FG000|COMPLETED|Overall Study||176
6323390|NCT00471354|7229107|FG000|NOT COMPLETED|Overall Study||52
6323391|NCT00471380|7229111|FG000|STARTED|First Intervention||22
6323392|NCT00471380|7229112|FG001|STARTED|First Intervention||24
6323393|NCT00471380|7229111|FG000|COMPLETED|First Intervention||18
6323394|NCT00471380|7229112|FG001|COMPLETED|First Intervention||20
6323395|NCT00471380|7229111|FG000|NOT COMPLETED|First Intervention||4
6323396|NCT00471380|7229112|FG001|NOT COMPLETED|First Intervention||4
6323397|NCT00471380|7229111|FG000|STARTED|Second Intervention||18
6323398|NCT00471380|7229112|FG001|STARTED|Second Intervention||20
6323399|NCT00471380|7229111|FG000|COMPLETED|Second Intervention||18
6323400|NCT00471380|7229112|FG001|COMPLETED|Second Intervention||16
6323401|NCT00471380|7229111|FG000|NOT COMPLETED|Second Intervention||0
6323402|NCT00471380|7229112|FG001|NOT COMPLETED|Second Intervention||4
6323403|NCT00471380|7229111|FG000|STARTED|Third Intervention||18
6323404|NCT00471380|7229112|FG001|STARTED|Third Intervention||16
6323405|NCT00471380|7229111|FG000|COMPLETED|Third Intervention||17
6323406|NCT00471380|7229112|FG001|COMPLETED|Third Intervention||14
6323407|NCT00471380|7229111|FG000|NOT COMPLETED|Third Intervention||1
6323408|NCT00471380|7229112|FG001|NOT COMPLETED|Third Intervention||2
6323409|NCT00471445|7229120|FG000|STARTED|Overall Study||229
6323410|NCT00471445|7229121|FG001|STARTED|Overall Study||233
6323411|NCT00471445|7229120|FG000|COMPLETED|Overall Study||227
6323412|NCT00471445|7229121|FG001|COMPLETED|Overall Study||231
6323413|NCT00471445|7229120|FG000|NOT COMPLETED|Overall Study||2
6323414|NCT00471445|7229121|FG001|NOT COMPLETED|Overall Study||2
6323415|NCT00471497|7229130|FG000|STARTED|Core Treatment Phase||283
6323416|NCT00471497|7229131|FG001|STARTED|Core Treatment Phase||282
6323417|NCT00471497|7229132|FG002|STARTED|Core Treatment Phase||281
6323418|NCT00471497|7229130|FG000|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|280
6323419|NCT00471497|7229131|FG001|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|279
6323420|NCT00471497|7229132|FG002|Safety Analysis Set|Core Treatment Phase|Safety set contained patients who received at least one dose of study medication.|277
6323421|NCT00471497|7229130|FG000|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||235
6323422|NCT00471497|7229131|FG001|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||256
6323423|NCT00471497|7229132|FG002|Discon. Core/Did Not Enter Ext.|Core Treatment Phase||278
6323424|NCT00471497|7229130|FG000|Discontinued Core/Entered Ext.|Core Treatment Phase||48
6323425|NCT00471497|7229131|FG001|Discontinued Core/Entered Ext.|Core Treatment Phase||26
6323426|NCT00471497|7229132|FG002|Discontinued Core/Entered Ext.|Core Treatment Phase||3
6323427|NCT00471497|7229130|FG000|COMPLETED|Core Treatment Phase||99
6323428|NCT00471497|7229131|FG001|COMPLETED|Core Treatment Phase||107
6323429|NCT00471497|7229132|FG002|COMPLETED|Core Treatment Phase||99
6323430|NCT00471497|7229130|FG000|NOT COMPLETED|Core Treatment Phase||184
6323431|NCT00471497|7229131|FG001|NOT COMPLETED|Core Treatment Phase||175
6323432|NCT00471497|7229132|FG002|NOT COMPLETED|Core Treatment Phase||182
6323433|NCT00471497|7229130|FG000|STARTED|Extension Phase||48
6323434|NCT00471497|7229131|FG001|STARTED|Extension Phase||26
6323435|NCT00471497|7229132|FG002|STARTED|Extension Phase||3
6323436|NCT00471497|7229130|FG000|COMPLETED|Extension Phase||21
6323437|NCT00471497|7229131|FG001|COMPLETED|Extension Phase||12
6323438|NCT00471497|7229132|FG002|COMPLETED|Extension Phase||2
6323439|NCT00471497|7229130|FG000|NOT COMPLETED|Extension Phase||27
6323440|NCT00471497|7229131|FG001|NOT COMPLETED|Extension Phase||14
6323441|NCT00471497|7229132|FG002|NOT COMPLETED|Extension Phase||1
6323442|NCT00471536|7229143|FG000|STARTED|Overall Study||19
6323443|NCT00471536|7229143|FG000|COMPLETED|Overall Study||18
6323444|NCT00471536|7229143|FG000|NOT COMPLETED|Overall Study||1
6323445|NCT00471705|7229150|FG000|STARTED|Overall Study||145
6323446|NCT00471705|7229151|FG001|STARTED|Overall Study||143
6323447|NCT00471705|7229152|FG002|STARTED|Overall Study||149
6323448|NCT00471705|7229150|FG000|COMPLETED|Overall Study||121
6323449|NCT00471705|7229151|FG001|COMPLETED|Overall Study||121
6323450|NCT00471705|7229152|FG002|COMPLETED|Overall Study||134
6323451|NCT00471705|7229150|FG000|NOT COMPLETED|Overall Study||24
6323452|NCT00471705|7229151|FG001|NOT COMPLETED|Overall Study||22
6323453|NCT00471705|7229152|FG002|NOT COMPLETED|Overall Study||15
6323454|NCT00471718|7229160|FG000|STARTED|Overall Study||27
6323455|NCT00471718|7229160|FG000|COMPLETED|Overall Study||0
6323456|NCT00471718|7229160|FG000|NOT COMPLETED|Overall Study||27
6323457|NCT00471822|7229168|FG000|STARTED|Overall Study||9707
6323458|NCT00471822|7229168|FG000|Treated|Overall Study||9705
6323459|NCT00471822|7229168|FG000|COMPLETED|Overall Study||9705
6323460|NCT00471822|7229168|FG000|NOT COMPLETED|Overall Study||2
6323461|NCT00471848|7229172|FG000|STARTED|Overall Study||35
6323462|NCT00471848|7229172|FG000|COMPLETED|Overall Study|35 registered patients received the full 5-day Rabbit Antithymocyte Globuline (RATG) treatment|35
6775175|NCT03880227|7703103|FG000|NOT COMPLETED|1 Week Washout/ Delay||0
6775176|NCT03880227|7703104|FG001|NOT COMPLETED|1 Week Washout/ Delay||1
6775177|NCT03880227|7703105|FG002|NOT COMPLETED|1 Week Washout/ Delay||3
6775178|NCT03880227|7703106|FG003|NOT COMPLETED|1 Week Washout/ Delay||0
6323463|NCT00471848|7229172|FG000|NOT COMPLETED|Overall Study||0
6323464|NCT00471887|7229176|FG000|STARTED|Overall Study||32
6323465|NCT00471887|7229176|FG000|COMPLETED|Overall Study||23
6323466|NCT00471887|7229176|FG000|NOT COMPLETED|Overall Study||9
6323467|NCT00472030|7229182|FG000|STARTED|Overall Study||2
6323468|NCT00472030|7229183|FG001|STARTED|Overall Study||0
6323469|NCT00472030|7229182|FG000|COMPLETED|Overall Study||1
6323470|NCT00472030|7229183|FG001|COMPLETED|Overall Study||0
6323471|NCT00472030|7229182|FG000|NOT COMPLETED|Overall Study||1
6323472|NCT00472030|7229183|FG001|NOT COMPLETED|Overall Study||0
6323473|NCT00472056|7229197|FG000|STARTED|Overall Study||25
6323474|NCT00472056|7229198|FG001|STARTED|Overall Study||19
6323475|NCT00472056|7229199|FG002|STARTED|Overall Study||32
6323476|NCT00472056|7229200|FG003|STARTED|Overall Study||17
6323477|NCT00472056|7229197|FG000|COMPLETED|Overall Study||25
6323478|NCT00472056|7229198|FG001|COMPLETED|Overall Study||19
6323479|NCT00472056|7229199|FG002|COMPLETED|Overall Study||32
6323480|NCT00472056|7229200|FG003|COMPLETED|Overall Study||17
6323481|NCT00472056|7229197|FG000|NOT COMPLETED|Overall Study||0
6323482|NCT00472056|7229198|FG001|NOT COMPLETED|Overall Study||0
6323483|NCT00472056|7229199|FG002|NOT COMPLETED|Overall Study||0
6323484|NCT00472056|7229200|FG003|NOT COMPLETED|Overall Study||0
6323485|NCT00472199|7229210|FG000|STARTED|Overall Study||166
6323486|NCT00472199|7229211|FG001|STARTED|Overall Study||163
6323487|NCT00472199|7229210|FG000|COMPLETED|Overall Study||131
6323488|NCT00472199|7229211|FG001|COMPLETED|Overall Study||103
6323489|NCT00472199|7229210|FG000|NOT COMPLETED|Overall Study||35
6323490|NCT00472199|7229211|FG001|NOT COMPLETED|Overall Study||60
6323491|NCT00472290|7229217|FG000|STARTED|Overall Study||72
6323492|NCT00472290|7229217|FG000|COMPLETED|Overall Study||0
6323493|NCT00472290|7229217|FG000|NOT COMPLETED|Overall Study||72
6323494|NCT00472303|7229223|FG000|STARTED|Titration Phase||338
6323495|NCT00472303|7229224|FG001|STARTED|Titration Phase||158
6323496|NCT00472303|7229225|FG002|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
6323497|NCT00472303|7229223|FG000|COMPLETED|Titration Phase||279
6323498|NCT00472303|7229224|FG001|COMPLETED|Titration Phase||129
6323499|NCT00472303|7229225|FG002|COMPLETED|Titration Phase||0
6323500|NCT00472303|7229223|FG000|NOT COMPLETED|Titration Phase||59
6323501|NCT00472303|7229224|FG001|NOT COMPLETED|Titration Phase||29
6323502|NCT00472303|7229225|FG002|NOT COMPLETED|Titration Phase||0
6323503|NCT00472303|7229223|FG000|STARTED|Discontinuations After Titration Phase||279
6323504|NCT00472303|7229224|FG001|STARTED|Discontinuations After Titration Phase||129
6323505|NCT00472303|7229225|FG002|STARTED|Discontinuations After Titration Phase||0
6323506|NCT00472303|7229223|FG000|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
6323507|NCT00472303|7229224|FG001|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
6323508|NCT00472303|7229225|FG002|COMPLETED|Discontinuations After Titration Phase||0
6323509|NCT00472303|7229223|FG000|NOT COMPLETED|Discontinuations After Titration Phase||61
6558153|NCT01773473|7480835|FG001|NOT COMPLETED|Overall Study||19
6558154|NCT01773889|7480841|FG000|STARTED|Overall Study||2
6558155|NCT01773889|7480841|FG000|COMPLETED|Overall Study||0
6323510|NCT00472303|7229224|FG001|NOT COMPLETED|Discontinuations After Titration Phase||20
6323511|NCT00472303|7229225|FG002|NOT COMPLETED|Discontinuations After Titration Phase||0
6323512|NCT00472303|7229223|FG000|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
6323513|NCT00472303|7229224|FG001|STARTED|Maintenance Phase||109
6323514|NCT00472303|7229225|FG002|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
6323515|NCT00472303|7229223|FG000|COMPLETED|Maintenance Phase||89
6323516|NCT00472303|7229224|FG001|COMPLETED|Maintenance Phase||93
6323517|NCT00472303|7229225|FG002|COMPLETED|Maintenance Phase||95
6323518|NCT00472303|7229223|FG000|NOT COMPLETED|Maintenance Phase||17
6323519|NCT00472303|7229224|FG001|NOT COMPLETED|Maintenance Phase||16
6323520|NCT00472303|7229225|FG002|NOT COMPLETED|Maintenance Phase||17
6323521|NCT00472420|7229253|FG000|STARTED|Induction Treatment Period||48
6323522|NCT00472420|7229253|FG000|COMPLETED|Induction Treatment Period||32
6323523|NCT00472420|7229253|FG000|NOT COMPLETED|Induction Treatment Period||16
6323524|NCT00472420|7229253|FG000|STARTED|Follow-up Period||32
6323525|NCT00472420|7229253|FG000|COMPLETED|Follow-up Period||15
6558156|NCT01773889|7480841|FG000|NOT COMPLETED|Overall Study||2
6323526|NCT00472420|7229253|FG000|NOT COMPLETED|Follow-up Period||17
6323527|NCT00472446|7229261|FG000|STARTED|Overall Study||46
6323528|NCT00472446|7229262|FG001|STARTED|Overall Study||47
6323529|NCT00472446|7229263|FG002|STARTED|Overall Study||45
6323530|NCT00472446|7229264|FG003|STARTED|Overall Study||45
6323531|NCT00472446|7229261|FG000|COMPLETED|Overall Study||41
6323532|NCT00472446|7229262|FG001|COMPLETED|Overall Study||41
6323533|NCT00472446|7229263|FG002|COMPLETED|Overall Study||38
6323534|NCT00472446|7229264|FG003|COMPLETED|Overall Study||39
6323535|NCT00472446|7229261|FG000|NOT COMPLETED|Overall Study||5
6323536|NCT00472446|7229262|FG001|NOT COMPLETED|Overall Study||6
6323537|NCT00472446|7229263|FG002|NOT COMPLETED|Overall Study||7
6323538|NCT00472446|7229264|FG003|NOT COMPLETED|Overall Study||6
6323539|NCT00472576|7229276|FG000|STARTED|First Intervention||2
6323540|NCT00472576|7229277|FG001|STARTED|First Intervention||3
6323541|NCT00472576|7229276|FG000|COMPLETED|First Intervention||2
6323542|NCT00472576|7229277|FG001|COMPLETED|First Intervention||3
6323543|NCT00472576|7229276|FG000|NOT COMPLETED|First Intervention||0
6323544|NCT00472576|7229277|FG001|NOT COMPLETED|First Intervention||0
6323545|NCT00472576|7229276|FG000|STARTED|Second Intervention||2
6323546|NCT00472576|7229277|FG001|STARTED|Second Intervention||3
6323547|NCT00472576|7229276|FG000|COMPLETED|Second Intervention||2
6323548|NCT00472576|7229277|FG001|COMPLETED|Second Intervention||3
6323549|NCT00472576|7229276|FG000|NOT COMPLETED|Second Intervention||0
6323550|NCT00472576|7229277|FG001|NOT COMPLETED|Second Intervention||0
6323551|NCT00472641|7229283|FG000|STARTED|Overall Study||25
6323552|NCT00472641|7229283|FG000|COMPLETED|Overall Study||18
6323553|NCT00472641|7229283|FG000|NOT COMPLETED|Overall Study||7
6558157|NCT01773954|7480845|FG000|STARTED|Overall Study||40
6558158|NCT01773954|7480845|FG000|COMPLETED|Overall Study||31
6558159|NCT01773954|7480845|FG000|NOT COMPLETED|Overall Study||9
6323554|NCT00472732|7229289|FG000|STARTED|Overall Study||24
6323555|NCT00472732|7229290|FG001|STARTED|Overall Study||22
6323556|NCT00472732|7229289|FG000|COMPLETED|Overall Study||24
6323557|NCT00472732|7229290|FG001|COMPLETED|Overall Study||22
6323558|NCT00472732|7229289|FG000|NOT COMPLETED|Overall Study||0
6323559|NCT00472732|7229290|FG001|NOT COMPLETED|Overall Study||0
6323560|NCT00472797|7229298|FG000|STARTED|Overall Study||119
6323561|NCT00472797|7229299|FG001|STARTED|Overall Study||113
6323562|NCT00472797|7229298|FG000|COMPLETED|Overall Study||115
6323563|NCT00472797|7229299|FG001|COMPLETED|Overall Study||112
6323564|NCT00472797|7229298|FG000|NOT COMPLETED|Overall Study||4
6323565|NCT00472797|7229299|FG001|NOT COMPLETED|Overall Study||1
6323566|NCT00472849|7229310|FG000|STARTED|Overall Study||12
6323567|NCT00472849|7229311|FG001|STARTED|Overall Study||78
6323568|NCT00472849|7229310|FG000|COMPLETED|Overall Study||12
6323569|NCT00472849|7229311|FG001|COMPLETED|Overall Study||78
6323570|NCT00472849|7229310|FG000|NOT COMPLETED|Overall Study||0
6323571|NCT00472849|7229311|FG001|NOT COMPLETED|Overall Study||0
6558160|NCT01773967|7480851|FG000|STARTED|Overall Study||483
6558161|NCT01773967|7480852|FG001|STARTED|Overall Study||488
6558162|NCT01773967|7480851|FG000|COMPLETED|Overall Study||468
6558163|NCT01773967|7480852|FG001|COMPLETED|Overall Study||475
6558164|NCT01773967|7480851|FG000|NOT COMPLETED|Overall Study||15
6558165|NCT01773967|7480852|FG001|NOT COMPLETED|Overall Study||13
6558166|NCT01773993|7480858|FG000|STARTED|Overall Study||534
6558167|NCT01773993|7480858|FG000|COMPLETED|Overall Study|Number of participants whose survey form were collected and included in analyses is shown.|499
6558168|NCT01773993|7480858|FG000|NOT COMPLETED|Overall Study||35
6558169|NCT01774045|7480864|FG000|STARTED|Overall Study||23
6558170|NCT01774045|7480865|FG001|STARTED|Overall Study||7
6558171|NCT01774045|7480864|FG000|COMPLETED|Overall Study||23
6558172|NCT01774045|7480865|FG001|COMPLETED|Overall Study||7
6558173|NCT01774045|7480864|FG000|NOT COMPLETED|Overall Study||0
6558174|NCT01774045|7480865|FG001|NOT COMPLETED|Overall Study||0
6558175|NCT01774084|7480874|FG000|STARTED|Overall Study||11
6558176|NCT01774084|7480875|FG001|STARTED|Overall Study||12
6323572|NCT00473083|7229320|FG000|STARTED|Overall Study||50
6323573|NCT00473083|7229321|FG001|STARTED|Overall Study||50
6323574|NCT00473083|7229322|FG002|STARTED|Overall Study||50
6323575|NCT00473083|7229320|FG000|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
6323576|NCT00473083|7229321|FG001|COMPLETED|Overall Study||50
6323577|NCT00473083|7229322|FG002|COMPLETED|Overall Study||50
6323578|NCT00473083|7229320|FG000|NOT COMPLETED|Overall Study||1
6323579|NCT00473083|7229321|FG001|NOT COMPLETED|Overall Study||0
6323580|NCT00473083|7229322|FG002|NOT COMPLETED|Overall Study||0
6323581|NCT00473265|7229333|FG000|STARTED|Overall Study||68
6323582|NCT00473265|7229333|FG000|COMPLETED|Overall Study||48
6323583|NCT00473265|7229333|FG000|NOT COMPLETED|Overall Study||20
6323584|NCT00473330|7229340|FG000|STARTED|Core Study||125
6558177|NCT01774084|7480874|FG000|COMPLETED|Overall Study||10
6558178|NCT01774084|7480875|FG001|COMPLETED|Overall Study||12
6558179|NCT01774084|7480874|FG000|NOT COMPLETED|Overall Study||1
6558180|NCT01774084|7480875|FG001|NOT COMPLETED|Overall Study||0
6323585|NCT00473330|7229341|FG001|STARTED|Core Study||125
6323586|NCT00473330|7229342|FG002|STARTED|Core Study||127
6323587|NCT00473330|7229340|FG000|COMPLETED|Core Study||98
6323588|NCT00473330|7229341|FG001|COMPLETED|Core Study||100
6323589|NCT00473330|7229342|FG002|COMPLETED|Core Study||86
6323590|NCT00473330|7229340|FG000|NOT COMPLETED|Core Study||27
6558181|NCT01774097|7480883|FG000|STARTED|Overall Study||40
6558182|NCT01774097|7480884|FG001|STARTED|Overall Study||42
6323591|NCT00473330|7229341|FG001|NOT COMPLETED|Core Study||25
6323592|NCT00473330|7229342|FG002|NOT COMPLETED|Core Study||41
6323593|NCT00473330|7229340|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
6323594|NCT00473330|7229341|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
6323595|NCT00473330|7229342|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
6323596|NCT00473330|7229340|FG000|COMPLETED|Open-label Extension Through Month 48||63
6323597|NCT00473330|7229341|FG001|COMPLETED|Open-label Extension Through Month 48||59
6323598|NCT00473330|7229342|FG002|COMPLETED|Open-label Extension Through Month 48||50
6323599|NCT00473330|7229340|FG000|NOT COMPLETED|Open-label Extension Through Month 48||26
6323600|NCT00473330|7229341|FG001|NOT COMPLETED|Open-label Extension Through Month 48||20
6323601|NCT00473330|7229342|FG002|NOT COMPLETED|Open-label Extension Through Month 48||27
6323602|NCT00473330|7229340|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
6323603|NCT00473330|7229341|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
6323604|NCT00473330|7229342|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
6323605|NCT00473330|7229340|FG000|COMPLETED|Open-label Extension Through Month 60||1
6323606|NCT00473330|7229341|FG001|COMPLETED|Open-label Extension Through Month 60||1
6323607|NCT00473330|7229342|FG002|COMPLETED|Open-label Extension Through Month 60||0
6323608|NCT00473330|7229340|FG000|NOT COMPLETED|Open-label Extension Through Month 60||88
6323609|NCT00473330|7229341|FG001|NOT COMPLETED|Open-label Extension Through Month 60||78
6323610|NCT00473330|7229342|FG002|NOT COMPLETED|Open-label Extension Through Month 60||77
6323611|NCT00473382|7229373|FG000|STARTED|Core Study||130
6323612|NCT00473382|7229374|FG001|STARTED|Core Study||125
6323613|NCT00473382|7229375|FG002|STARTED|Core Study||127
6323614|NCT00473382|7229373|FG000|COMPLETED|Core Study||102
6323615|NCT00473382|7229374|FG001|COMPLETED|Core Study||98
6323616|NCT00473382|7229375|FG002|COMPLETED|Core Study||98
6323617|NCT00473382|7229373|FG000|NOT COMPLETED|Core Study||28
6323618|NCT00473382|7229374|FG001|NOT COMPLETED|Core Study||27
6323619|NCT00473382|7229375|FG002|NOT COMPLETED|Core Study||29
6323620|NCT00473382|7229373|FG000|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
6323621|NCT00473382|7229374|FG001|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
6323622|NCT00473382|7229375|FG002|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
6323623|NCT00473382|7229373|FG000|COMPLETED|Open-label Extension Through Month 48||38
6323624|NCT00473382|7229374|FG001|COMPLETED|Open-label Extension Through Month 48||42
6323625|NCT00473382|7229375|FG002|COMPLETED|Open-label Extension Through Month 48||37
6323626|NCT00473382|7229373|FG000|NOT COMPLETED|Open-label Extension Through Month 48||50
6323627|NCT00473382|7229374|FG001|NOT COMPLETED|Open-label Extension Through Month 48||41
6323628|NCT00473382|7229375|FG002|NOT COMPLETED|Open-label Extension Through Month 48||47
6323629|NCT00473382|7229373|FG000|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
6323630|NCT00473382|7229374|FG001|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
6323631|NCT00473382|7229375|FG002|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
6323632|NCT00473382|7229373|FG000|COMPLETED|Open-label Extension Through Month 60||2
6323633|NCT00473382|7229374|FG001|COMPLETED|Open-label Extension Through Month 60||1
6323634|NCT00473382|7229375|FG002|COMPLETED|Open-label Extension Through Month 60||2
6323635|NCT00473382|7229373|FG000|NOT COMPLETED|Open-label Extension Through Month 60||86
6323636|NCT00473382|7229374|FG001|NOT COMPLETED|Open-label Extension Through Month 60||82
6323637|NCT00473382|7229375|FG002|NOT COMPLETED|Open-label Extension Through Month 60||82
6323638|NCT00473434|7229401|FG000|STARTED|Overall Study||64
6323639|NCT00473434|7229401|FG000|COMPLETED|Overall Study||32
6323640|NCT00473434|7229401|FG000|NOT COMPLETED|Overall Study||32
6323641|NCT00473512|7229423|FG000|STARTED|Period 1 (Phase 1)||3
6323642|NCT00473512|7229424|FG001|STARTED|Period 1 (Phase 1)||3
6323643|NCT00473512|7229425|FG002|STARTED|Period 1 (Phase 1)||3
6323644|NCT00473512|7229426|FG003|STARTED|Period 1 (Phase 1)||42
6323645|NCT00473512|7229427|FG004|STARTED|Period 1 (Phase 1)||3
6323646|NCT00473512|7229423|FG000|COMPLETED|Period 1 (Phase 1)||2
6323647|NCT00473512|7229424|FG001|COMPLETED|Period 1 (Phase 1)||2
6323648|NCT00473512|7229425|FG002|COMPLETED|Period 1 (Phase 1)||3
6323649|NCT00473512|7229426|FG003|COMPLETED|Period 1 (Phase 1)||25
6323650|NCT00473512|7229427|FG004|COMPLETED|Period 1 (Phase 1)||2
6323651|NCT00473512|7229423|FG000|NOT COMPLETED|Period 1 (Phase 1)||1
6323652|NCT00473512|7229424|FG001|NOT COMPLETED|Period 1 (Phase 1)||1
6323653|NCT00473512|7229425|FG002|NOT COMPLETED|Period 1 (Phase 1)||0
6323654|NCT00473512|7229426|FG003|NOT COMPLETED|Period 1 (Phase 1)||17
6323655|NCT00473512|7229427|FG004|NOT COMPLETED|Period 1 (Phase 1)||1
6323656|NCT00473512|7229423|FG000|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
6323657|NCT00473512|7229424|FG001|STARTED|Period 2 (Phase 2)||2
6375679|NCT00757601|7286367|FG010|COMPLETED|Period 1||2
6323658|NCT00473512|7229425|FG002|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
6323659|NCT00473512|7229426|FG003|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
6323660|NCT00473512|7229427|FG004|STARTED|Period 2 (Phase 2)||2
6323661|NCT00473512|7229423|FG000|COMPLETED|Period 2 (Phase 2)||0
6323662|NCT00473512|7229424|FG001|COMPLETED|Period 2 (Phase 2)||0
6323663|NCT00473512|7229425|FG002|COMPLETED|Period 2 (Phase 2)||0
6323664|NCT00473512|7229426|FG003|COMPLETED|Period 2 (Phase 2)||0
6323665|NCT00473512|7229427|FG004|COMPLETED|Period 2 (Phase 2)||0
6323666|NCT00473512|7229423|FG000|NOT COMPLETED|Period 2 (Phase 2)||1
6323667|NCT00473512|7229424|FG001|NOT COMPLETED|Period 2 (Phase 2)||2
6323668|NCT00473512|7229425|FG002|NOT COMPLETED|Period 2 (Phase 2)||2
6323669|NCT00473512|7229426|FG003|NOT COMPLETED|Period 2 (Phase 2)||23
6323670|NCT00473512|7229427|FG004|NOT COMPLETED|Period 2 (Phase 2)||2
6323671|NCT00473564|7229447|FG000|STARTED|Overall Study||170
6323672|NCT00473564|7229447|FG000|COMPLETED|Overall Study||147
6323673|NCT00473564|7229447|FG000|NOT COMPLETED|Overall Study||23
6323674|NCT00473590|7229453|FG000|STARTED|Overall Study||53
6323675|NCT00473590|7229454|FG001|STARTED|Overall Study||49
6323676|NCT00473590|7229453|FG000|Treated|Overall Study||52
6323677|NCT00473590|7229454|FG001|Treated|Overall Study||48
6323678|NCT00473590|7229453|FG000|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
6323679|NCT00473590|7229454|FG001|Safety Population|Overall Study||50
6323680|NCT00473590|7229453|FG000|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
6323681|NCT00473590|7229454|FG001|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
6323682|NCT00473590|7229453|FG000|NOT COMPLETED|Overall Study||45
6323683|NCT00473590|7229454|FG001|NOT COMPLETED|Overall Study||38
6323684|NCT00473642|7229463|FG000|STARTED|Overall Study||10
6323685|NCT00473642|7229464|FG001|STARTED|Overall Study||11
6323686|NCT00473642|7229465|FG002|STARTED|Overall Study||10
6323687|NCT00473642|7229463|FG000|COMPLETED|Overall Study||8
6323688|NCT00473642|7229464|FG001|COMPLETED|Overall Study||10
6323689|NCT00473642|7229465|FG002|COMPLETED|Overall Study||8
6323690|NCT00473642|7229463|FG000|NOT COMPLETED|Overall Study||2
6323691|NCT00473642|7229464|FG001|NOT COMPLETED|Overall Study||1
6558183|NCT01774097|7480883|FG000|COMPLETED|Overall Study||38
6558184|NCT01774097|7480884|FG001|COMPLETED|Overall Study||40
6558185|NCT01774097|7480883|FG000|NOT COMPLETED|Overall Study||2
6558186|NCT01774097|7480884|FG001|NOT COMPLETED|Overall Study||2
6558187|NCT01774110|7480892|FG000|STARTED|Overall Study||12
6558188|NCT01774110|7480892|FG000|COMPLETED|Overall Study||5
6558189|NCT01774110|7480892|FG000|NOT COMPLETED|Overall Study||7
6558190|NCT01774149|7480899|FG000|STARTED|Overall Study||15
6558191|NCT01774149|7480900|FG001|STARTED|Overall Study||15
6558192|NCT01774149|7480899|FG000|COMPLETED|Overall Study||14
6558193|NCT01774149|7480900|FG001|COMPLETED|Overall Study||12
6558194|NCT01774149|7480899|FG000|NOT COMPLETED|Overall Study||1
6323692|NCT00473642|7229465|FG002|NOT COMPLETED|Overall Study||2
6323693|NCT00473655|7229479|FG000|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
6323694|NCT00473655|7229480|FG001|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
6323695|NCT00473655|7229481|FG002|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
6323696|NCT00473655|7229479|FG000|COMPLETED|Overall Study|9 participants were lost of follow up|102
6323697|NCT00473655|7229480|FG001|COMPLETED|Overall Study|5 participants were lost of follow up|107
6323698|NCT00473655|7229481|FG002|COMPLETED|Overall Study|8 participants were lost of follow up|103
6323699|NCT00473655|7229479|FG000|NOT COMPLETED|Overall Study||9
6323700|NCT00473655|7229480|FG001|NOT COMPLETED|Overall Study||5
6323701|NCT00473655|7229481|FG002|NOT COMPLETED|Overall Study||8
6323702|NCT00473668|7229492|FG000|STARTED|Overall Study||100
6323703|NCT00473668|7229493|FG001|STARTED|Overall Study||100
6323704|NCT00473668|7229494|FG002|STARTED|Overall Study||99
6323705|NCT00473668|7229492|FG000|COMPLETED|Overall Study||95
6323706|NCT00473668|7229493|FG001|COMPLETED|Overall Study||89
6323707|NCT00473668|7229494|FG002|COMPLETED|Overall Study||89
6323708|NCT00473668|7229492|FG000|NOT COMPLETED|Overall Study||5
6323709|NCT00473668|7229493|FG001|NOT COMPLETED|Overall Study||11
6323710|NCT00473668|7229494|FG002|NOT COMPLETED|Overall Study||10
6323711|NCT00473694|7229506|FG000|STARTED|Overall Study||48
6323712|NCT00473694|7229507|FG001|STARTED|Overall Study|Includes 1 participant randomized to vecuronium+sugammadex but treated with rocuronium+neostigmine|41
6323713|NCT00473694|7229508|FG002|STARTED|Overall Study||51
6323714|NCT00473694|7229509|FG003|STARTED|Overall Study||42
6323715|NCT00473694|7229506|FG000|Treated|Overall Study|Number of participants treated was based on actual treatment received.|37
6323716|NCT00473694|7229507|FG001|Treated|Overall Study|Number of participants treated was based on actual treatment received.|38
6323717|NCT00473694|7229508|FG002|Treated|Overall Study|Number of participants treated was based on actual treatment received.|46
6323718|NCT00473694|7229509|FG003|Treated|Overall Study|Number of participants treated was based on actual treatment received.|36
6323719|NCT00473694|7229506|FG000|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
6323720|NCT00473694|7229507|FG001|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|37
6323721|NCT00473694|7229508|FG002|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|46
6558195|NCT01774149|7480900|FG001|NOT COMPLETED|Overall Study||3
6558196|NCT01774305|7480908|FG000|STARTED|Overall Study||71
6323722|NCT00473694|7229509|FG003|COMPLETED|Overall Study|Number of participants completed was based on actual treatment received.|35
6323723|NCT00473694|7229506|FG000|NOT COMPLETED|Overall Study||11
6323724|NCT00473694|7229507|FG001|NOT COMPLETED|Overall Study||4
6323725|NCT00473694|7229508|FG002|NOT COMPLETED|Overall Study||5
6323726|NCT00473694|7229509|FG003|NOT COMPLETED|Overall Study||7
6323727|NCT00473746|7229527|FG000|STARTED|Period 1 (Phase 1)||6
6323728|NCT00473746|7229528|FG001|STARTED|Period 1 (Phase 1)||9
6323729|NCT00473746|7229529|FG002|STARTED|Period 1 (Phase 1)||6
6323730|NCT00473746|7229530|FG003|STARTED|Period 1 (Phase 1)||12
6323731|NCT00473746|7229531|FG004|STARTED|Period 1 (Phase 1)||0
6323732|NCT00473746|7229527|FG000|COMPLETED|Period 1 (Phase 1)||0
6323733|NCT00473746|7229528|FG001|COMPLETED|Period 1 (Phase 1)||0
6323734|NCT00473746|7229529|FG002|COMPLETED|Period 1 (Phase 1)||0
6323735|NCT00473746|7229530|FG003|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
6323736|NCT00473746|7229531|FG004|COMPLETED|Period 1 (Phase 1)||0
6323737|NCT00473746|7229527|FG000|NOT COMPLETED|Period 1 (Phase 1)||6
6323738|NCT00473746|7229528|FG001|NOT COMPLETED|Period 1 (Phase 1)||9
6323739|NCT00473746|7229529|FG002|NOT COMPLETED|Period 1 (Phase 1)||6
6323740|NCT00473746|7229530|FG003|NOT COMPLETED|Period 1 (Phase 1)||10
6323741|NCT00473746|7229531|FG004|NOT COMPLETED|Period 1 (Phase 1)||0
6323742|NCT00473746|7229527|FG000|STARTED|Period 2 (Phase 2)||0
6323743|NCT00473746|7229528|FG001|STARTED|Period 2 (Phase 2)||0
6323744|NCT00473746|7229529|FG002|STARTED|Period 2 (Phase 2)||0
6323745|NCT00473746|7229530|FG003|STARTED|Period 2 (Phase 2)||0
6323746|NCT00473746|7229531|FG004|STARTED|Period 2 (Phase 2)||33
6323747|NCT00473746|7229527|FG000|COMPLETED|Period 2 (Phase 2)||0
6323748|NCT00473746|7229528|FG001|COMPLETED|Period 2 (Phase 2)||0
6323749|NCT00473746|7229529|FG002|COMPLETED|Period 2 (Phase 2)||0
6323750|NCT00473746|7229530|FG003|COMPLETED|Period 2 (Phase 2)||0
6323751|NCT00473746|7229531|FG004|COMPLETED|Period 2 (Phase 2)||6
6323752|NCT00473746|7229527|FG000|NOT COMPLETED|Period 2 (Phase 2)||0
6323753|NCT00473746|7229528|FG001|NOT COMPLETED|Period 2 (Phase 2)||0
6323754|NCT00473746|7229529|FG002|NOT COMPLETED|Period 2 (Phase 2)||0
6323755|NCT00473746|7229530|FG003|NOT COMPLETED|Period 2 (Phase 2)||0
6323756|NCT00473746|7229531|FG004|NOT COMPLETED|Period 2 (Phase 2)||27
6323757|NCT00473824|7229547|FG000|STARTED|Overall Study||5
6323758|NCT00473824|7229548|FG001|STARTED|Overall Study||2
6323759|NCT00473824|7229547|FG000|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
6323760|NCT00473824|7229548|FG001|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
6323761|NCT00473824|7229547|FG000|NOT COMPLETED|Overall Study||5
6323762|NCT00473824|7229548|FG001|NOT COMPLETED|Overall Study||0
6323763|NCT00473837|7229556|FG000|STARTED|Overall Study||50
6323764|NCT00473837|7229557|FG001|STARTED|Overall Study||46
6323765|NCT00473837|7229556|FG000|COMPLETED|Overall Study||49
6323766|NCT00473837|7229557|FG001|COMPLETED|Overall Study||43
6323767|NCT00473837|7229556|FG000|NOT COMPLETED|Overall Study||1
6323768|NCT00473837|7229557|FG001|NOT COMPLETED|Overall Study||3
6323769|NCT00473876|7229565|FG000|STARTED|Overall Study||39
6323770|NCT00473876|7229566|FG001|STARTED|Overall Study||23
6323771|NCT00473876|7229565|FG000|COMPLETED|Overall Study||36
6323772|NCT00473876|7229566|FG001|COMPLETED|Overall Study||22
6323773|NCT00473876|7229565|FG000|NOT COMPLETED|Overall Study||3
6323774|NCT00473876|7229566|FG001|NOT COMPLETED|Overall Study||1
6323775|NCT00473889|7229576|FG000|STARTED|Overall Study||126
6323776|NCT00473889|7229577|FG001|STARTED|Overall Study||127
6323777|NCT00473889|7229576|FG000|COMPLETED|Overall Study||43
6323778|NCT00473889|7229577|FG001|COMPLETED|Overall Study||63
6323779|NCT00473889|7229576|FG000|NOT COMPLETED|Overall Study||83
6323780|NCT00473889|7229577|FG001|NOT COMPLETED|Overall Study||64
6323781|NCT00474045|7229585|FG000|STARTED|Overall Study||233
6323782|NCT00474045|7229586|FG001|STARTED|Overall Study||237
6323783|NCT00474045|7229585|FG000|Exposed-All Subjects|Overall Study||233
6323784|NCT00474045|7229586|FG001|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
6323785|NCT00474045|7229585|FG000|Exposed-Pregnant Subjects|Overall Study||152
6323786|NCT00474045|7229586|FG001|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
6323787|NCT00474045|7229585|FG000|Pregnancies (for Exposed-pregnant)|Overall Study||152
6323788|NCT00474045|7229586|FG001|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
6323789|NCT00474045|7229585|FG000|COMPLETED|Overall Study||127
6323790|NCT00474045|7229586|FG001|COMPLETED|Overall Study||136
6323791|NCT00474045|7229585|FG000|NOT COMPLETED|Overall Study||106
6323792|NCT00474045|7229586|FG001|NOT COMPLETED|Overall Study||101
6323793|NCT00474058|7229594|FG000|STARTED|Overall Study||190
6323794|NCT00474058|7229595|FG001|STARTED|Overall Study||97
6323795|NCT00474058|7229594|FG000|COMPLETED|Overall Study||166
6323796|NCT00474058|7229595|FG001|COMPLETED|Overall Study||80
6323797|NCT00474058|7229594|FG000|NOT COMPLETED|Overall Study||24
6323798|NCT00474058|7229595|FG001|NOT COMPLETED|Overall Study||17
6323799|NCT00474123|7229603|FG000|STARTED|Overall Study||38
6323800|NCT00474123|7229604|FG001|STARTED|Overall Study||40
6323801|NCT00474123|7229603|FG000|COMPLETED|Overall Study||38
6323802|NCT00474123|7229604|FG001|COMPLETED|Overall Study||40
6323803|NCT00474123|7229603|FG000|NOT COMPLETED|Overall Study||0
6323804|NCT00474123|7229604|FG001|NOT COMPLETED|Overall Study||0
6323805|NCT00474175|7229613|FG000|STARTED|Overall Study||115
6323806|NCT00474175|7229614|FG001|STARTED|Overall Study||233
6323807|NCT00474175|7229615|FG002|STARTED|Overall Study||229
6323808|NCT00474175|7229613|FG000|Treated|Overall Study||115
6323809|NCT00474175|7229614|FG001|Treated|Overall Study||233
6323810|NCT00474175|7229615|FG002|Treated|Overall Study||228
6323811|NCT00474175|7229613|FG000|COMPLETED|Overall Study||114
6323812|NCT00474175|7229614|FG001|COMPLETED|Overall Study||226
6323813|NCT00474175|7229615|FG002|COMPLETED|Overall Study||225
6323814|NCT00474175|7229613|FG000|NOT COMPLETED|Overall Study||1
6323815|NCT00474175|7229614|FG001|NOT COMPLETED|Overall Study||7
6323816|NCT00474175|7229615|FG002|NOT COMPLETED|Overall Study||4
6323817|NCT00474201|7229623|FG000|STARTED|Overall Study||15
6323818|NCT00474201|7229623|FG000|COMPLETED|Overall Study||15
6323819|NCT00474201|7229623|FG000|NOT COMPLETED|Overall Study||0
6323820|NCT00474240|7229634|FG000|STARTED|Overall Study||27
6323821|NCT00474240|7229635|FG001|STARTED|Overall Study||26
6323822|NCT00474240|7229636|FG002|STARTED|Overall Study||26
6323823|NCT00474240|7229637|FG003|STARTED|Overall Study||26
6323824|NCT00474240|7229638|FG004|STARTED|Overall Study||26
6323825|NCT00474240|7229639|FG005|STARTED|Overall Study||26
6323826|NCT00474240|7229634|FG000|COMPLETED|Overall Study||26
6323827|NCT00474240|7229635|FG001|COMPLETED|Overall Study||25
6323828|NCT00474240|7229636|FG002|COMPLETED|Overall Study||17
6323829|NCT00474240|7229637|FG003|COMPLETED|Overall Study||10
6323830|NCT00474240|7229638|FG004|COMPLETED|Overall Study||18
6323831|NCT00474240|7229639|FG005|COMPLETED|Overall Study||8
6323832|NCT00474240|7229634|FG000|NOT COMPLETED|Overall Study||1
6323833|NCT00474240|7229635|FG001|NOT COMPLETED|Overall Study||1
6323834|NCT00474240|7229636|FG002|NOT COMPLETED|Overall Study||9
6323835|NCT00474240|7229637|FG003|NOT COMPLETED|Overall Study||16
6323836|NCT00474240|7229638|FG004|NOT COMPLETED|Overall Study||8
6323837|NCT00474240|7229639|FG005|NOT COMPLETED|Overall Study||18
6323838|NCT00474253|7229655|FG000|STARTED|Overall Study|Includes 2 participants randomized to succinylcholine group who received rocuronium + sugammadex.|58
6323839|NCT00474253|7229656|FG001|STARTED|Overall Study|Includes 1 participant randomized to rocuronium + sugammadex group who received succinylcholine.|57
6323840|NCT00474253|7229655|FG000|Treated|Overall Study|Based on actual treatment received.|56
6323841|NCT00474253|7229656|FG001|Treated|Overall Study|Based on actual treatment received.|54
6323842|NCT00474253|7229655|FG000|COMPLETED|Overall Study|Based on actual treatment received.|55
6323843|NCT00474253|7229656|FG001|COMPLETED|Overall Study|Based on actual treatment received.|53
6323844|NCT00474253|7229655|FG000|NOT COMPLETED|Overall Study||3
6323845|NCT00474253|7229656|FG001|NOT COMPLETED|Overall Study||4
6323846|NCT00474266|7229666|FG000|STARTED|Overall Study||375
6323847|NCT00474266|7229667|FG001|STARTED|Overall Study||374
6323848|NCT00474266|7229668|FG002|STARTED|Overall Study||126
6323849|NCT00474266|7229669|FG003|STARTED|Overall Study||125
6323850|NCT00474266|7229666|FG000|COMPLETED|Overall Study||368
6323851|NCT00474266|7229667|FG001|COMPLETED|Overall Study||354
6323852|NCT00474266|7229668|FG002|COMPLETED|Overall Study||122
6323853|NCT00474266|7229669|FG003|COMPLETED|Overall Study||118
6323854|NCT00474266|7229666|FG000|NOT COMPLETED|Overall Study||7
6323855|NCT00474266|7229667|FG001|NOT COMPLETED|Overall Study||20
6323856|NCT00474266|7229668|FG002|NOT COMPLETED|Overall Study||4
6323857|NCT00474266|7229669|FG003|NOT COMPLETED|Overall Study||7
6323858|NCT00474383|7229682|FG000|STARTED|Main Study||47
6323859|NCT00474383|7229683|FG001|STARTED|Main Study||0
6323860|NCT00474383|7229682|FG000|COMPLETED|Main Study||11
6323861|NCT00474383|7229683|FG001|COMPLETED|Main Study||0
6323862|NCT00474383|7229682|FG000|NOT COMPLETED|Main Study||36
6323863|NCT00474383|7229683|FG001|NOT COMPLETED|Main Study||0
6323864|NCT00474383|7229682|FG000|STARTED|Between Main Study and Extension||11
6323865|NCT00474383|7229683|FG001|STARTED|Between Main Study and Extension||0
6558197|NCT01774305|7480909|FG001|STARTED|Overall Study||71
6558198|NCT01774305|7480908|FG000|COMPLETED|Overall Study||70
6558199|NCT01774305|7480909|FG001|COMPLETED|Overall Study||71
6558200|NCT01774305|7480908|FG000|NOT COMPLETED|Overall Study||1
6323866|NCT00474383|7229682|FG000|COMPLETED|Between Main Study and Extension||5
6323867|NCT00474383|7229683|FG001|COMPLETED|Between Main Study and Extension||0
6323868|NCT00474383|7229682|FG000|NOT COMPLETED|Between Main Study and Extension||6
6323869|NCT00474383|7229683|FG001|NOT COMPLETED|Between Main Study and Extension||0
6323870|NCT00474383|7229682|FG000|STARTED|Extension||0
6323871|NCT00474383|7229683|FG001|STARTED|Extension||5
6323872|NCT00474383|7229682|FG000|COMPLETED|Extension||0
6323873|NCT00474383|7229683|FG001|COMPLETED|Extension||0
6323874|NCT00474383|7229682|FG000|NOT COMPLETED|Extension||0
6323875|NCT00474383|7229683|FG001|NOT COMPLETED|Extension||5
6323876|NCT00474487|7229691|FG000|STARTED|Overall Study||1606
6323877|NCT00474487|7229692|FG001|STARTED|Overall Study||217
6323878|NCT00474487|7229693|FG002|STARTED|Overall Study||899
6323879|NCT00474487|7229694|FG003|STARTED|Overall Study||109
6323880|NCT00474487|7229691|FG000|COMPLETED|Overall Study||1576
6323881|NCT00474487|7229692|FG001|COMPLETED|Overall Study||215
6323882|NCT00474487|7229693|FG002|COMPLETED|Overall Study||885
6323883|NCT00474487|7229694|FG003|COMPLETED|Overall Study||109
6323884|NCT00474487|7229691|FG000|NOT COMPLETED|Overall Study||30
6558201|NCT01774305|7480909|FG001|NOT COMPLETED|Overall Study||0
6558202|NCT01774344|7480917|FG000|STARTED|Overall Study||194
6323885|NCT00474487|7229692|FG001|NOT COMPLETED|Overall Study||2
6323886|NCT00474487|7229693|FG002|NOT COMPLETED|Overall Study||14
6323887|NCT00474487|7229694|FG003|NOT COMPLETED|Overall Study||0
6323888|NCT00474526|7229721|FG000|STARTED|Overall Study||154
6323889|NCT00474526|7229722|FG001|STARTED|Overall Study||166
6323890|NCT00474526|7229723|FG002|STARTED|Overall Study||159
6323891|NCT00474526|7229724|FG003|STARTED|Overall Study||680
6323892|NCT00474526|7229725|FG004|STARTED|Overall Study||76
6323893|NCT00474526|7229726|FG005|STARTED|Overall Study||70
6323894|NCT00474526|7229727|FG006|STARTED|Overall Study||203
6323895|NCT00474526|7229728|FG007|STARTED|Overall Study||151
6323896|NCT00474526|7229729|FG008|STARTED|Overall Study||150
6558203|NCT01774344|7480918|FG001|STARTED|Overall Study||379
6558204|NCT01774344|7480917|FG000|Treated|Overall Study||193
6558205|NCT01774344|7480918|FG001|Treated|Overall Study||374
6558206|NCT01774344|7480917|FG000|Entered Survival FU|Overall Study||145
6558207|NCT01774344|7480918|FG001|Entered Survival FU|Overall Study||291
6558208|NCT01774344|7480917|FG000|COMPLETED|Overall Study||132
6558209|NCT01774344|7480918|FG001|COMPLETED|Overall Study||258
6558210|NCT01774344|7480917|FG000|NOT COMPLETED|Overall Study||62
6323897|NCT00474526|7229730|FG009|STARTED|Overall Study||148
6323898|NCT00474526|7229731|FG010|STARTED|Overall Study||151
6323899|NCT00474526|7229732|FG011|STARTED|Overall Study||150
6323900|NCT00474526|7229733|FG012|STARTED|Overall Study||150
6323901|NCT00474526|7229734|FG013|STARTED|Overall Study||1426
6323902|NCT00474526|7229735|FG014|STARTED|Overall Study||358
6323903|NCT00474526|7229736|FG015|STARTED|Overall Study||170
6323904|NCT00474526|7229737|FG016|STARTED|Overall Study||183
6323905|NCT00474526|7229721|FG000|COMPLETED|Overall Study||121
6323906|NCT00474526|7229722|FG001|COMPLETED|Overall Study||120
6323907|NCT00474526|7229723|FG002|COMPLETED|Overall Study||110
6323908|NCT00474526|7229724|FG003|COMPLETED|Overall Study||561
6323909|NCT00474526|7229725|FG004|COMPLETED|Overall Study||8
6323910|NCT00474526|7229726|FG005|COMPLETED|Overall Study||54
6323911|NCT00474526|7229727|FG006|COMPLETED|Overall Study||178
6323912|NCT00474526|7229728|FG007|COMPLETED|Overall Study||145
6323913|NCT00474526|7229729|FG008|COMPLETED|Overall Study||144
6323914|NCT00474526|7229730|FG009|COMPLETED|Overall Study||121
6323915|NCT00474526|7229731|FG010|COMPLETED|Overall Study||141
6323916|NCT00474526|7229732|FG011|COMPLETED|Overall Study||139
6323917|NCT00474526|7229733|FG012|COMPLETED|Overall Study||135
6323918|NCT00474526|7229734|FG013|COMPLETED|Overall Study||1270
6323919|NCT00474526|7229735|FG014|COMPLETED|Overall Study||281
6323920|NCT00474526|7229736|FG015|COMPLETED|Overall Study||152
6323921|NCT00474526|7229737|FG016|COMPLETED|Overall Study||174
6323922|NCT00474526|7229721|FG000|NOT COMPLETED|Overall Study||33
6323923|NCT00474526|7229722|FG001|NOT COMPLETED|Overall Study||46
6323924|NCT00474526|7229723|FG002|NOT COMPLETED|Overall Study||49
6323925|NCT00474526|7229724|FG003|NOT COMPLETED|Overall Study||119
6323926|NCT00474526|7229725|FG004|NOT COMPLETED|Overall Study||68
6323927|NCT00474526|7229726|FG005|NOT COMPLETED|Overall Study||16
6323928|NCT00474526|7229727|FG006|NOT COMPLETED|Overall Study||25
6323929|NCT00474526|7229728|FG007|NOT COMPLETED|Overall Study||6
6323930|NCT00474526|7229729|FG008|NOT COMPLETED|Overall Study||6
6323931|NCT00474526|7229730|FG009|NOT COMPLETED|Overall Study||27
6323932|NCT00474526|7229731|FG010|NOT COMPLETED|Overall Study||10
6323933|NCT00474526|7229732|FG011|NOT COMPLETED|Overall Study||11
6323934|NCT00474526|7229733|FG012|NOT COMPLETED|Overall Study||15
6323935|NCT00474526|7229734|FG013|NOT COMPLETED|Overall Study||156
6323936|NCT00474526|7229735|FG014|NOT COMPLETED|Overall Study||77
6323937|NCT00474526|7229736|FG015|NOT COMPLETED|Overall Study||18
6323938|NCT00474526|7229737|FG016|NOT COMPLETED|Overall Study||9
6323939|NCT00474539|7229825|FG000|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
6323940|NCT00474539|7229826|FG001|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
6323941|NCT00474539|7229825|FG000|Vaccinated Dose 1|Infant Series||218
6323942|NCT00474539|7229826|FG001|Vaccinated Dose 1|Infant Series||226
6323943|NCT00474539|7229825|FG000|Vaccinated Dose 2|Infant Series||217
6323944|NCT00474539|7229826|FG001|Vaccinated Dose 2|Infant Series||222
6323945|NCT00474539|7229825|FG000|Vaccinated Dose 3|Infant Series||214
6323946|NCT00474539|7229826|FG001|Vaccinated Dose 3|Infant Series||221
6323947|NCT00474539|7229825|FG000|COMPLETED|Infant Series||213
6323948|NCT00474539|7229826|FG001|COMPLETED|Infant Series||220
6323949|NCT00474539|7229825|FG000|NOT COMPLETED|Infant Series||10
6323950|NCT00474539|7229826|FG001|NOT COMPLETED|Infant Series||6
6323951|NCT00474539|7229825|FG000|STARTED|After Infant Series||213
6323952|NCT00474539|7229826|FG001|STARTED|After Infant Series||220
6323953|NCT00474539|7229825|FG000|COMPLETED|After Infant Series||209
6323954|NCT00474539|7229826|FG001|COMPLETED|After Infant Series||220
6323955|NCT00474539|7229825|FG000|NOT COMPLETED|After Infant Series||4
6323956|NCT00474539|7229826|FG001|NOT COMPLETED|After Infant Series||0
6323957|NCT00474539|7229825|FG000|STARTED|Toddler Dose||209
6323958|NCT00474539|7229826|FG001|STARTED|Toddler Dose||220
6323959|NCT00474539|7229825|FG000|COMPLETED|Toddler Dose||208
6323960|NCT00474539|7229826|FG001|COMPLETED|Toddler Dose||220
6323961|NCT00474539|7229825|FG000|NOT COMPLETED|Toddler Dose||1
6323962|NCT00474539|7229826|FG001|NOT COMPLETED|Toddler Dose||0
6323963|NCT00474617|7229860|FG000|STARTED|Overall Study||56
6323964|NCT00474617|7229861|FG001|STARTED|Overall Study||64
6323965|NCT00474617|7229862|FG002|STARTED|Overall Study||42
6323966|NCT00474617|7229860|FG000|Treated|Overall Study||48
6323967|NCT00474617|7229861|FG001|Treated|Overall Study||62
6323968|NCT00474617|7229862|FG002|Treated|Overall Study||40
6323969|NCT00474617|7229860|FG000|COMPLETED|Overall Study||48
6323970|NCT00474617|7229861|FG001|COMPLETED|Overall Study||61
6323971|NCT00474617|7229862|FG002|COMPLETED|Overall Study||40
6323972|NCT00474617|7229860|FG000|NOT COMPLETED|Overall Study||8
6558211|NCT01774344|7480918|FG001|NOT COMPLETED|Overall Study||121
6558212|NCT01774591|7480926|FG000|STARTED|Overall Study||10
6323973|NCT00474617|7229861|FG001|NOT COMPLETED|Overall Study||3
6323974|NCT00474617|7229862|FG002|NOT COMPLETED|Overall Study||2
6323975|NCT00474630|7229872|FG000|STARTED|Overall Study||335
6323976|NCT00474630|7229873|FG001|STARTED|Overall Study||170
6323977|NCT00474630|7229872|FG000|COMPLETED|Overall Study||175
6323978|NCT00474630|7229873|FG001|COMPLETED|Overall Study||100
6323979|NCT00474630|7229872|FG000|NOT COMPLETED|Overall Study||160
6323980|NCT00474630|7229873|FG001|NOT COMPLETED|Overall Study||70
6323981|NCT00474708|7229882|FG000|STARTED|Overall Study||791
6323982|NCT00474708|7229883|FG001|STARTED|Overall Study||367
6323983|NCT00474708|7229882|FG000|COMPLETED|Overall Study||734
6323984|NCT00474708|7229883|FG001|COMPLETED|Overall Study||342
6323985|NCT00474708|7229882|FG000|NOT COMPLETED|Overall Study||57
6323986|NCT00474708|7229883|FG001|NOT COMPLETED|Overall Study||25
6323987|NCT00474760|7229896|FG000|STARTED|Overall Study||3
6323988|NCT00474760|7229897|FG001|STARTED|Overall Study||3
6323989|NCT00474760|7229898|FG002|STARTED|Overall Study||3
6323990|NCT00474760|7229899|FG003|STARTED|Overall Study||3
6323991|NCT00474760|7229900|FG004|STARTED|Overall Study||13
6323992|NCT00474760|7229901|FG005|STARTED|Overall Study||29
6323993|NCT00474760|7229902|FG006|STARTED|Overall Study||11
6323994|NCT00474760|7229896|FG000|COMPLETED|Overall Study||0
6323995|NCT00474760|7229897|FG001|COMPLETED|Overall Study||0
6323996|NCT00474760|7229898|FG002|COMPLETED|Overall Study||0
6323997|NCT00474760|7229899|FG003|COMPLETED|Overall Study||0
6323998|NCT00474760|7229900|FG004|COMPLETED|Overall Study||1
6323999|NCT00474760|7229901|FG005|COMPLETED|Overall Study||0
6324000|NCT00474760|7229902|FG006|COMPLETED|Overall Study||1
6324001|NCT00474760|7229896|FG000|NOT COMPLETED|Overall Study||3
6324002|NCT00474760|7229897|FG001|NOT COMPLETED|Overall Study||3
6324003|NCT00474760|7229898|FG002|NOT COMPLETED|Overall Study||3
6324004|NCT00474760|7229899|FG003|NOT COMPLETED|Overall Study||3
6324005|NCT00474760|7229900|FG004|NOT COMPLETED|Overall Study||12
6324006|NCT00474760|7229901|FG005|NOT COMPLETED|Overall Study||29
6324007|NCT00474760|7229902|FG006|NOT COMPLETED|Overall Study||10
6324008|NCT00474786|7229927|FG000|STARTED|Overall Study||259
6324009|NCT00474786|7229928|FG001|STARTED|Overall Study||253
6324010|NCT00474786|7229927|FG000|COMPLETED|Overall Study||0
6324011|NCT00474786|7229928|FG001|COMPLETED|Overall Study||0
6324012|NCT00474786|7229927|FG000|NOT COMPLETED|Overall Study||259
6324013|NCT00474786|7229928|FG001|NOT COMPLETED|Overall Study||253
6324014|NCT00474812|7229934|FG000|STARTED|Overall Study||51
6324015|NCT00474812|7229934|FG000|COMPLETED|Overall Study||44
6324016|NCT00474812|7229934|FG000|NOT COMPLETED|Overall Study||7
6324017|NCT00474851|7229940|FG000|STARTED|Overall Study||26
6324018|NCT00474851|7229941|FG001|STARTED|Overall Study||27
6558213|NCT01774591|7480927|FG001|STARTED|Overall Study||11
6775179|NCT03880227|7703103|FG000|STARTED|Second Visit||19
6775180|NCT03880227|7703104|FG001|STARTED|Second Visit||20
6324019|NCT00474851|7229940|FG000|Completed Baseline|Overall Study||25
6324020|NCT00474851|7229941|FG001|Completed Baseline|Overall Study||26
6324021|NCT00474851|7229940|FG000|COMPLETED|Overall Study||18
6324022|NCT00474851|7229941|FG001|COMPLETED|Overall Study||16
6324023|NCT00474851|7229940|FG000|NOT COMPLETED|Overall Study||8
6324024|NCT00474851|7229941|FG001|NOT COMPLETED|Overall Study||11
6324025|NCT00474903|7229951|FG000|STARTED|Overall Study||30
6324026|NCT00474903|7229952|FG001|STARTED|Overall Study||47
6324027|NCT00474903|7229953|FG002|STARTED|Overall Study||45
6324028|NCT00474903|7229951|FG000|COMPLETED|Overall Study||29
6324029|NCT00474903|7229952|FG001|COMPLETED|Overall Study||42
6324030|NCT00474903|7229953|FG002|COMPLETED|Overall Study||43
6324031|NCT00474903|7229951|FG000|NOT COMPLETED|Overall Study||1
6324032|NCT00474903|7229952|FG001|NOT COMPLETED|Overall Study||5
6324033|NCT00474903|7229953|FG002|NOT COMPLETED|Overall Study||2
6324034|NCT00474929|7229966|FG000|STARTED|Overall Study||6
6324035|NCT00474929|7229967|FG001|STARTED|Overall Study||6
6324036|NCT00474929|7229968|FG002|STARTED|Overall Study||7
6324037|NCT00474929|7229969|FG003|STARTED|Overall Study||7
6324038|NCT00474929|7229970|FG004|STARTED|Overall Study||77
6324039|NCT00474929|7229966|FG000|COMPLETED|Overall Study||6
6324040|NCT00474929|7229967|FG001|COMPLETED|Overall Study||5
6324041|NCT00474929|7229968|FG002|COMPLETED|Overall Study||5
6324042|NCT00474929|7229969|FG003|COMPLETED|Overall Study||5
6775181|NCT03880227|7703105|FG002|STARTED|Second Visit||19
6324043|NCT00474929|7229970|FG004|COMPLETED|Overall Study||77
6324044|NCT00474929|7229966|FG000|NOT COMPLETED|Overall Study||0
6324045|NCT00474929|7229967|FG001|NOT COMPLETED|Overall Study||1
6324046|NCT00474929|7229968|FG002|NOT COMPLETED|Overall Study||2
6324047|NCT00474929|7229969|FG003|NOT COMPLETED|Overall Study||2
6324048|NCT00474929|7229970|FG004|NOT COMPLETED|Overall Study||0
6324049|NCT00474955|7229983|FG000|STARTED|Overall Study||27
6324050|NCT00474955|7229983|FG000|COMPLETED|Overall Study||19
6324051|NCT00474955|7229983|FG000|NOT COMPLETED|Overall Study||8
6324052|NCT00474968|7229989|FG000|STARTED|Overall Study||366
6324053|NCT00474968|7229990|FG001|STARTED|Overall Study||371
6324054|NCT00474968|7229989|FG000|COMPLETED|Overall Study||348
6324055|NCT00474968|7229990|FG001|COMPLETED|Overall Study||355
6324056|NCT00474968|7229989|FG000|NOT COMPLETED|Overall Study||18
6558214|NCT01774591|7480926|FG000|COMPLETED|Overall Study||9
6324057|NCT00474968|7229990|FG001|NOT COMPLETED|Overall Study||16
6324058|NCT00474994|7229996|FG000|STARTED|Overall Study||53
6324059|NCT00474994|7229996|FG000|COMPLETED|Overall Study||48
6324060|NCT00474994|7229996|FG000|NOT COMPLETED|Overall Study||5
6324061|NCT00475020|7230000|FG000|STARTED|Overall Study||63
6324062|NCT00475020|7230000|FG000|COMPLETED|Overall Study||58
6324063|NCT00475020|7230000|FG000|NOT COMPLETED|Overall Study||5
6324064|NCT00475033|7230006|FG000|STARTED|Infant Series||300
6324065|NCT00475033|7230007|FG001|STARTED|Infant Series||303
6324066|NCT00475033|7230006|FG000|Vaccinated Dose 1|Infant Series||300
6324067|NCT00475033|7230007|FG001|Vaccinated Dose 1|Infant Series||303
6324068|NCT00475033|7230006|FG000|Vaccinated Dose 2|Infant Series||297
6324069|NCT00475033|7230007|FG001|Vaccinated Dose 2|Infant Series||296
6324070|NCT00475033|7230006|FG000|Vaccinated Dose 3|Infant Series||293
6324071|NCT00475033|7230007|FG001|Vaccinated Dose 3|Infant Series||294
6324072|NCT00475033|7230006|FG000|COMPLETED|Infant Series||293
6324073|NCT00475033|7230007|FG001|COMPLETED|Infant Series||290
6324074|NCT00475033|7230006|FG000|NOT COMPLETED|Infant Series||7
6324075|NCT00475033|7230007|FG001|NOT COMPLETED|Infant Series||13
6324076|NCT00475033|7230006|FG000|STARTED|After the Infant Series||293
6324077|NCT00475033|7230007|FG001|STARTED|After the Infant Series||290
6324078|NCT00475033|7230006|FG000|Withdrawn After Infant Series|After the Infant Series||6
6324079|NCT00475033|7230007|FG001|Withdrawn After Infant Series|After the Infant Series||8
6324080|NCT00475033|7230006|FG000|COMPLETED|After the Infant Series||287
6324081|NCT00475033|7230007|FG001|COMPLETED|After the Infant Series||282
6324082|NCT00475033|7230006|FG000|NOT COMPLETED|After the Infant Series||6
6324083|NCT00475033|7230007|FG001|NOT COMPLETED|After the Infant Series||8
6324084|NCT00475033|7230006|FG000|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
6324085|NCT00475033|7230007|FG001|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
6324086|NCT00475033|7230006|FG000|COMPLETED|Toddler Dose||283
6324087|NCT00475033|7230007|FG001|COMPLETED|Toddler Dose||282
6324088|NCT00475033|7230006|FG000|NOT COMPLETED|Toddler Dose||4
6324089|NCT00475033|7230007|FG001|NOT COMPLETED|Toddler Dose||0
6324090|NCT00475085|7230024|FG000|STARTED|Overall Study||253
6324091|NCT00475085|7230025|FG001|STARTED|Overall Study||254
6324092|NCT00475085|7230026|FG002|STARTED|Overall Study||260
6324093|NCT00475085|7230027|FG003|STARTED|Overall Study||254
6324094|NCT00475085|7230024|FG000|COMPLETED|Overall Study||235
6324095|NCT00475085|7230025|FG001|COMPLETED|Overall Study||234
6324096|NCT00475085|7230026|FG002|COMPLETED|Overall Study||241
6324097|NCT00475085|7230027|FG003|COMPLETED|Overall Study||234
6324098|NCT00475085|7230024|FG000|NOT COMPLETED|Overall Study||18
6324099|NCT00475085|7230025|FG001|NOT COMPLETED|Overall Study||20
6324100|NCT00475085|7230026|FG002|NOT COMPLETED|Overall Study||19
6324101|NCT00475085|7230027|FG003|NOT COMPLETED|Overall Study||20
6324102|NCT00475150|7230039|FG000|STARTED|Overall Study||23
6324103|NCT00475150|7230040|FG001|STARTED|Overall Study||16
6324104|NCT00475150|7230039|FG000|COMPLETED|Overall Study||23
6324105|NCT00475150|7230040|FG001|COMPLETED|Overall Study||16
6324106|NCT00475150|7230039|FG000|NOT COMPLETED|Overall Study||0
6324107|NCT00475150|7230040|FG001|NOT COMPLETED|Overall Study||0
6324108|NCT00475176|7230045|FG000|STARTED|Overall Study||24
6324109|NCT00475176|7230045|FG000|COMPLETED|Overall Study||20
6324110|NCT00475176|7230045|FG000|NOT COMPLETED|Overall Study||4
6324111|NCT00475215|7230051|FG000|STARTED|Overall Study||44
6324112|NCT00475215|7230052|FG001|STARTED|Overall Study||42
6324113|NCT00475215|7230051|FG000|Treated|Overall Study||39
6324114|NCT00475215|7230052|FG001|Treated|Overall Study||38
6324115|NCT00475215|7230051|FG000|COMPLETED|Overall Study||39
6324116|NCT00475215|7230052|FG001|COMPLETED|Overall Study||38
6324117|NCT00475215|7230051|FG000|NOT COMPLETED|Overall Study||5
6324118|NCT00475215|7230052|FG001|NOT COMPLETED|Overall Study||4
6324119|NCT00475228|7230060|FG000|STARTED|Overall Study||44
6324120|NCT00475228|7230061|FG001|STARTED|Overall Study||44
6324121|NCT00475228|7230060|FG000|COMPLETED|Overall Study||27
6324122|NCT00475228|7230061|FG001|COMPLETED|Overall Study||27
6324123|NCT00475228|7230060|FG000|NOT COMPLETED|Overall Study||17
6324124|NCT00475228|7230061|FG001|NOT COMPLETED|Overall Study||17
6324125|NCT00475241|7230073|FG000|STARTED|Overall Study||18
6324126|NCT00475241|7230074|FG001|STARTED|Overall Study||18
6324127|NCT00475241|7230073|FG000|COMPLETED|Overall Study||11
6324128|NCT00475241|7230074|FG001|COMPLETED|Overall Study||15
6324129|NCT00475241|7230073|FG000|NOT COMPLETED|Overall Study||7
6324130|NCT00475241|7230074|FG001|NOT COMPLETED|Overall Study||3
6324131|NCT00475306|7230085|FG000|STARTED|Overall Study||73
6324132|NCT00475306|7230086|FG001|STARTED|Overall Study||72
6324133|NCT00475306|7230087|FG002|STARTED|Overall Study||72
6324134|NCT00475306|7230088|FG003|STARTED|Overall Study||72
6324135|NCT00475306|7230085|FG000|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
6324136|NCT00475306|7230086|FG001|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
6324137|NCT00475306|7230087|FG002|COMPLETED|Overall Study||72
6324138|NCT00475306|7230088|FG003|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
6324139|NCT00475306|7230085|FG000|NOT COMPLETED|Overall Study||1
6324140|NCT00475306|7230086|FG001|NOT COMPLETED|Overall Study||1
6324141|NCT00475306|7230087|FG002|NOT COMPLETED|Overall Study||0
6324142|NCT00475306|7230088|FG003|NOT COMPLETED|Overall Study||1
6324143|NCT00475319|7230101|FG000|STARTED|Overall Study||103
6324144|NCT00475319|7230102|FG001|STARTED|Overall Study||102
6324145|NCT00475319|7230103|FG002|STARTED|Overall Study||103
6324146|NCT00475319|7230101|FG000|COMPLETED|Overall Study||101
6324147|NCT00475319|7230102|FG001|COMPLETED|Overall Study||101
6324148|NCT00475319|7230103|FG002|COMPLETED|Overall Study||99
6324149|NCT00475319|7230101|FG000|NOT COMPLETED|Overall Study||2
6324150|NCT00475319|7230102|FG001|NOT COMPLETED|Overall Study||1
6324151|NCT00475319|7230103|FG002|NOT COMPLETED|Overall Study||4
6324152|NCT00475423|7230114|FG000|STARTED|Overall Study||122
6324153|NCT00475423|7230114|FG000|COMPLETED|Overall Study||90
6324154|NCT00475423|7230114|FG000|NOT COMPLETED|Overall Study||32
6324155|NCT00475501|7230122|FG000|STARTED|Overall Study||14
6324156|NCT00475501|7230123|FG001|STARTED|Overall Study||13
6324157|NCT00475501|7230124|FG002|STARTED|Overall Study||17
6324158|NCT00475501|7230125|FG003|STARTED|Overall Study||16
6324159|NCT00475501|7230122|FG000|COMPLETED|Overall Study||7
6324160|NCT00475501|7230123|FG001|COMPLETED|Overall Study||8
6324161|NCT00475501|7230124|FG002|COMPLETED|Overall Study||13
6324162|NCT00475501|7230125|FG003|COMPLETED|Overall Study||12
6324163|NCT00475501|7230122|FG000|NOT COMPLETED|Overall Study||7
6324164|NCT00475501|7230123|FG001|NOT COMPLETED|Overall Study||5
6324165|NCT00475501|7230124|FG002|NOT COMPLETED|Overall Study||4
6324166|NCT00475501|7230125|FG003|NOT COMPLETED|Overall Study||4
6375680|NCT00757601|7286368|FG011|COMPLETED|Period 1||3
6375681|NCT00757601|7286357|FG000|NOT COMPLETED|Period 1||0
6375682|NCT00757601|7286358|FG001|NOT COMPLETED|Period 1||0
6375683|NCT00757601|7286359|FG002|NOT COMPLETED|Period 1||0
6375684|NCT00757601|7286360|FG003|NOT COMPLETED|Period 1||0
6375685|NCT00757601|7286361|FG004|NOT COMPLETED|Period 1||0
6375686|NCT00757601|7286362|FG005|NOT COMPLETED|Period 1||0
6375687|NCT00757601|7286363|FG006|NOT COMPLETED|Period 1||0
6375688|NCT00757601|7286364|FG007|NOT COMPLETED|Period 1||0
6375689|NCT00757601|7286365|FG008|NOT COMPLETED|Period 1||0
6375690|NCT00757601|7286366|FG009|NOT COMPLETED|Period 1||0
6375691|NCT00757601|7286367|FG010|NOT COMPLETED|Period 1||0
6375692|NCT00757601|7286368|FG011|NOT COMPLETED|Period 1||0
6375693|NCT00757601|7286357|FG000|STARTED|Period 2||2
6375694|NCT00757601|7286358|FG001|STARTED|Period 2||2
6375695|NCT00757601|7286359|FG002|STARTED|Period 2||2
6375696|NCT00757601|7286360|FG003|STARTED|Period 2||2
6375697|NCT00757601|7286361|FG004|STARTED|Period 2||2
6375698|NCT00757601|7286362|FG005|STARTED|Period 2||2
6375699|NCT00757601|7286363|FG006|STARTED|Period 2||2
6375700|NCT00757601|7286364|FG007|STARTED|Period 2||2
6375701|NCT00757601|7286365|FG008|STARTED|Period 2||2
6375702|NCT00757601|7286366|FG009|STARTED|Period 2||2
6375703|NCT00757601|7286367|FG010|STARTED|Period 2||2
6375704|NCT00757601|7286368|FG011|STARTED|Period 2||3
6375705|NCT00757601|7286357|FG000|COMPLETED|Period 2||2
6375706|NCT00757601|7286358|FG001|COMPLETED|Period 2||2
6375707|NCT00757601|7286359|FG002|COMPLETED|Period 2||2
6375708|NCT00757601|7286360|FG003|COMPLETED|Period 2||2
6375709|NCT00757601|7286361|FG004|COMPLETED|Period 2||2
6375710|NCT00757601|7286362|FG005|COMPLETED|Period 2||2
6375711|NCT00757601|7286363|FG006|COMPLETED|Period 2||2
6375712|NCT00757601|7286364|FG007|COMPLETED|Period 2||2
6375713|NCT00757601|7286365|FG008|COMPLETED|Period 2||2
6375714|NCT00757601|7286366|FG009|COMPLETED|Period 2||2
6375715|NCT00757601|7286367|FG010|COMPLETED|Period 2||2
6375716|NCT00757601|7286368|FG011|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
6375717|NCT00757601|7286357|FG000|NOT COMPLETED|Period 2||0
6375718|NCT00757601|7286358|FG001|NOT COMPLETED|Period 2||0
6375719|NCT00757601|7286359|FG002|NOT COMPLETED|Period 2||0
6375720|NCT00757601|7286360|FG003|NOT COMPLETED|Period 2||0
6375721|NCT00757601|7286361|FG004|NOT COMPLETED|Period 2||0
6375722|NCT00757601|7286362|FG005|NOT COMPLETED|Period 2||0
6375723|NCT00757601|7286363|FG006|NOT COMPLETED|Period 2||0
6375724|NCT00757601|7286364|FG007|NOT COMPLETED|Period 2||0
6375725|NCT00757601|7286365|FG008|NOT COMPLETED|Period 2||0
6375726|NCT00757601|7286366|FG009|NOT COMPLETED|Period 2||0
6375727|NCT00757601|7286367|FG010|NOT COMPLETED|Period 2||0
6375728|NCT00757601|7286368|FG011|NOT COMPLETED|Period 2||1
6375729|NCT00757601|7286357|FG000|STARTED|Period 3||2
6375730|NCT00757601|7286358|FG001|STARTED|Period 3||2
6375731|NCT00757601|7286359|FG002|STARTED|Period 3||2
6375732|NCT00757601|7286360|FG003|STARTED|Period 3||2
6375733|NCT00757601|7286361|FG004|STARTED|Period 3||2
6375734|NCT00757601|7286362|FG005|STARTED|Period 3||2
6375735|NCT00757601|7286363|FG006|STARTED|Period 3||2
6375736|NCT00757601|7286364|FG007|STARTED|Period 3||2
6375737|NCT00757601|7286365|FG008|STARTED|Period 3||2
6375738|NCT00757601|7286366|FG009|STARTED|Period 3||2
6375739|NCT00757601|7286367|FG010|STARTED|Period 3||2
6375740|NCT00757601|7286368|FG011|STARTED|Period 3||2
6375741|NCT00757601|7286357|FG000|COMPLETED|Period 3||2
6375742|NCT00757601|7286358|FG001|COMPLETED|Period 3||2
6375743|NCT00757601|7286359|FG002|COMPLETED|Period 3||2
6375744|NCT00757601|7286360|FG003|COMPLETED|Period 3||2
6375745|NCT00757601|7286361|FG004|COMPLETED|Period 3||2
6375746|NCT00757601|7286362|FG005|COMPLETED|Period 3||2
6375747|NCT00757601|7286363|FG006|COMPLETED|Period 3||2
6375748|NCT00757601|7286364|FG007|COMPLETED|Period 3||2
6375749|NCT00757601|7286365|FG008|COMPLETED|Period 3||2
6375750|NCT00757601|7286366|FG009|COMPLETED|Period 3||2
6375751|NCT00757601|7286367|FG010|COMPLETED|Period 3||2
6375752|NCT00757601|7286368|FG011|COMPLETED|Period 3||2
6375753|NCT00757601|7286357|FG000|NOT COMPLETED|Period 3||0
6375754|NCT00757601|7286358|FG001|NOT COMPLETED|Period 3||0
6375755|NCT00757601|7286359|FG002|NOT COMPLETED|Period 3||0
6375756|NCT00757601|7286360|FG003|NOT COMPLETED|Period 3||0
6375757|NCT00757601|7286361|FG004|NOT COMPLETED|Period 3||0
6375758|NCT00757601|7286362|FG005|NOT COMPLETED|Period 3||0
6375759|NCT00757601|7286363|FG006|NOT COMPLETED|Period 3||0
6375760|NCT00757601|7286364|FG007|NOT COMPLETED|Period 3||0
6324167|NCT00475644|7230167|FG000|STARTED|Overall Study||66
6324168|NCT00475644|7230167|FG000|Received at Least One Dose of Study Drug|Overall Study||66
6324169|NCT00475644|7230167|FG000|COMPLETED|Overall Study||53
6324170|NCT00475644|7230167|FG000|NOT COMPLETED|Overall Study||13
6324171|NCT00475670|7230173|FG000|STARTED|Overall Study||3
6324172|NCT00475670|7230174|FG001|STARTED|Overall Study||41
6324173|NCT00475670|7230173|FG000|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
6324174|NCT00475670|7230174|FG001|COMPLETED|Overall Study||0
6324175|NCT00475670|7230173|FG000|NOT COMPLETED|Overall Study||3
6324176|NCT00475670|7230174|FG001|NOT COMPLETED|Overall Study||41
6324177|NCT00475709|7230180|FG000|STARTED|Overall Study||1022
6324178|NCT00475709|7230180|FG000|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
6324179|NCT00475709|7230180|FG000|COMPLETED|Overall Study||946
6324180|NCT00475709|7230180|FG000|NOT COMPLETED|Overall Study||76
6324181|NCT00475722|7230186|FG000|STARTED|Overall Study||61
6324182|NCT00475722|7230187|FG001|STARTED|Overall Study||59
6324183|NCT00475722|7230186|FG000|COMPLETED|Overall Study||46
6324184|NCT00475722|7230187|FG001|COMPLETED|Overall Study||47
6324185|NCT00475722|7230186|FG000|NOT COMPLETED|Overall Study||15
6324186|NCT00475722|7230187|FG001|NOT COMPLETED|Overall Study||12
6324187|NCT00475735|7230199|FG000|STARTED|Treatment Period 1||14
6324188|NCT00475735|7230200|FG001|STARTED|Treatment Period 1||13
6324189|NCT00475735|7230201|FG002|STARTED|Treatment Period 1||7
6324190|NCT00475735|7230202|FG003|STARTED|Treatment Period 1||7
6324191|NCT00475735|7230203|FG004|STARTED|Treatment Period 1||16
6324192|NCT00475735|7230204|FG005|STARTED|Treatment Period 1||15
6324193|NCT00475735|7230199|FG000|COMPLETED|Treatment Period 1||10
6324194|NCT00475735|7230200|FG001|COMPLETED|Treatment Period 1||11
6324195|NCT00475735|7230201|FG002|COMPLETED|Treatment Period 1||7
6324196|NCT00475735|7230202|FG003|COMPLETED|Treatment Period 1||5
6324197|NCT00475735|7230203|FG004|COMPLETED|Treatment Period 1||14
6324198|NCT00475735|7230204|FG005|COMPLETED|Treatment Period 1||12
6324199|NCT00475735|7230199|FG000|NOT COMPLETED|Treatment Period 1||4
6324200|NCT00475735|7230200|FG001|NOT COMPLETED|Treatment Period 1||2
6324201|NCT00475735|7230201|FG002|NOT COMPLETED|Treatment Period 1||0
6324202|NCT00475735|7230202|FG003|NOT COMPLETED|Treatment Period 1||2
6324203|NCT00475735|7230203|FG004|NOT COMPLETED|Treatment Period 1||2
6324204|NCT00475735|7230204|FG005|NOT COMPLETED|Treatment Period 1||3
6324205|NCT00475735|7230199|FG000|STARTED|Treatment Washout||10
6324206|NCT00475735|7230200|FG001|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
6324207|NCT00475735|7230201|FG002|STARTED|Treatment Washout||7
6324208|NCT00475735|7230202|FG003|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
6324209|NCT00475735|7230203|FG004|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
6324210|NCT00475735|7230204|FG005|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
6324211|NCT00475735|7230199|FG000|COMPLETED|Treatment Washout||10
6324212|NCT00475735|7230200|FG001|COMPLETED|Treatment Washout||10
6324213|NCT00475735|7230201|FG002|COMPLETED|Treatment Washout||7
6324214|NCT00475735|7230202|FG003|COMPLETED|Treatment Washout||6
6324215|NCT00475735|7230203|FG004|COMPLETED|Treatment Washout||16
6324216|NCT00475735|7230204|FG005|COMPLETED|Treatment Washout||14
6324217|NCT00475735|7230199|FG000|NOT COMPLETED|Treatment Washout||0
6324218|NCT00475735|7230200|FG001|NOT COMPLETED|Treatment Washout||2
6324219|NCT00475735|7230201|FG002|NOT COMPLETED|Treatment Washout||0
6324220|NCT00475735|7230202|FG003|NOT COMPLETED|Treatment Washout||0
6324221|NCT00475735|7230203|FG004|NOT COMPLETED|Treatment Washout||0
6324222|NCT00475735|7230204|FG005|NOT COMPLETED|Treatment Washout||0
6324223|NCT00475735|7230199|FG000|STARTED|Treatment Period 2||10
6324224|NCT00475735|7230200|FG001|STARTED|Treatment Period 2||10
6324225|NCT00475735|7230201|FG002|STARTED|Treatment Period 2||7
6324226|NCT00475735|7230202|FG003|STARTED|Treatment Period 2||6
6324227|NCT00475735|7230203|FG004|STARTED|Treatment Period 2||16
6324228|NCT00475735|7230204|FG005|STARTED|Treatment Period 2||14
6324229|NCT00475735|7230199|FG000|COMPLETED|Treatment Period 2||10
6324230|NCT00475735|7230200|FG001|COMPLETED|Treatment Period 2||9
6324231|NCT00475735|7230201|FG002|COMPLETED|Treatment Period 2||7
6324232|NCT00475735|7230202|FG003|COMPLETED|Treatment Period 2||4
6324233|NCT00475735|7230203|FG004|COMPLETED|Treatment Period 2||15
6324234|NCT00475735|7230204|FG005|COMPLETED|Treatment Period 2||13
6324235|NCT00475735|7230199|FG000|NOT COMPLETED|Treatment Period 2||0
6324236|NCT00475735|7230200|FG001|NOT COMPLETED|Treatment Period 2||1
6324237|NCT00475735|7230201|FG002|NOT COMPLETED|Treatment Period 2||0
6324238|NCT00475735|7230202|FG003|NOT COMPLETED|Treatment Period 2||2
6324239|NCT00475735|7230203|FG004|NOT COMPLETED|Treatment Period 2||1
6324240|NCT00475735|7230204|FG005|NOT COMPLETED|Treatment Period 2||1
6324241|NCT00475787|7230214|FG000|STARTED|Overall Study||69
6324242|NCT00475787|7230215|FG001|STARTED|Overall Study||67
6324243|NCT00475787|7230214|FG000|COMPLETED|Overall Study||61
6324244|NCT00475787|7230215|FG001|COMPLETED|Overall Study||60
6324245|NCT00475787|7230214|FG000|NOT COMPLETED|Overall Study||8
6324246|NCT00475787|7230215|FG001|NOT COMPLETED|Overall Study||7
6324247|NCT00475852|7230225|FG000|STARTED|Overall Study||3564
6324248|NCT00475852|7230226|FG001|STARTED|Overall Study||3577
6324249|NCT00475852|7230225|FG000|COMPLETED|Overall Study||3047
6324250|NCT00475852|7230226|FG001|COMPLETED|Overall Study||3029
6324251|NCT00475852|7230225|FG000|NOT COMPLETED|Overall Study||517
6324252|NCT00475852|7230226|FG001|NOT COMPLETED|Overall Study||548
6324253|NCT00475865|7230235|FG000|STARTED|Overall Study|randomized|41
6324254|NCT00475865|7230236|FG001|STARTED|Overall Study|randomized|42
6324255|NCT00475865|7230237|FG002|STARTED|Overall Study|randomized|40
6324256|NCT00475865|7230235|FG000|Treated|Overall Study|completed treatment period|41
6324257|NCT00475865|7230236|FG001|Treated|Overall Study||42
6324258|NCT00475865|7230237|FG002|Treated|Overall Study||40
6324259|NCT00475865|7230235|FG000|COMPLETED|Overall Study||39
6324260|NCT00475865|7230236|FG001|COMPLETED|Overall Study|completed treatment period|37
6324261|NCT00475865|7230237|FG002|COMPLETED|Overall Study|completed treatment period|34
6324262|NCT00475865|7230235|FG000|NOT COMPLETED|Overall Study||2
6324263|NCT00475865|7230236|FG001|NOT COMPLETED|Overall Study||5
6324264|NCT00475865|7230237|FG002|NOT COMPLETED|Overall Study||6
6324265|NCT00475878|7230249|FG000|STARTED|Overall Study||75
6324266|NCT00475878|7230250|FG001|STARTED|Overall Study||72
6324267|NCT00475878|7230249|FG000|COMPLETED|Overall Study||75
6324268|NCT00475878|7230250|FG001|COMPLETED|Overall Study||72
6324269|NCT00475878|7230249|FG000|NOT COMPLETED|Overall Study||0
6324270|NCT00475878|7230250|FG001|NOT COMPLETED|Overall Study||0
6324271|NCT00475904|7230261|FG000|STARTED|Overall Study||140
6324272|NCT00475904|7230262|FG001|STARTED|Overall Study||144
6324273|NCT00475904|7230263|FG002|STARTED|Overall Study||76
6324274|NCT00475904|7230261|FG000|COMPLETED|Overall Study||125
6324275|NCT00475904|7230262|FG001|COMPLETED|Overall Study||131
6324276|NCT00475904|7230263|FG002|COMPLETED|Overall Study||72
6324277|NCT00475904|7230261|FG000|NOT COMPLETED|Overall Study||15
6324278|NCT00475904|7230262|FG001|NOT COMPLETED|Overall Study||13
6324279|NCT00475904|7230263|FG002|NOT COMPLETED|Overall Study||4
6324280|NCT00475982|7230273|FG000|STARTED|Overall Study||23
6324281|NCT00475982|7230274|FG001|STARTED|Overall Study||21
6324282|NCT00475982|7230273|FG000|COMPLETED|Overall Study||16
6324283|NCT00475982|7230274|FG001|COMPLETED|Overall Study||18
6324284|NCT00475982|7230273|FG000|NOT COMPLETED|Overall Study||7
6324285|NCT00475982|7230274|FG001|NOT COMPLETED|Overall Study||3
6324286|NCT00476008|7230282|FG000|STARTED|Overall Study||22
6324287|NCT00476008|7230283|FG001|STARTED|Overall Study||21
6324288|NCT00476008|7230282|FG000|6 Month Testing|Overall Study||15
6324289|NCT00476008|7230283|FG001|6 Month Testing|Overall Study||14
6324290|NCT00476008|7230282|FG000|COMPLETED|Overall Study||13
6324291|NCT00476008|7230283|FG001|COMPLETED|Overall Study||13
6324292|NCT00476008|7230282|FG000|NOT COMPLETED|Overall Study||9
6324293|NCT00476008|7230283|FG001|NOT COMPLETED|Overall Study||8
6324294|NCT00476021|7230295|FG000|STARTED|Overall Study||51
6324295|NCT00476021|7230296|FG001|STARTED|Overall Study||51
6324296|NCT00476021|7230295|FG000|COMPLETED|Overall Study||51
6324297|NCT00476021|7230296|FG001|COMPLETED|Overall Study||51
6324298|NCT00476021|7230295|FG000|NOT COMPLETED|Overall Study||0
6324299|NCT00476021|7230296|FG001|NOT COMPLETED|Overall Study||0
6324300|NCT00476047|7230308|FG000|STARTED|Overall Study||16
6324301|NCT00476047|7230308|FG000|Completed Treatment|Overall Study||16
6324302|NCT00476047|7230308|FG000|COMPLETED|Overall Study||15
6324303|NCT00476047|7230308|FG000|NOT COMPLETED|Overall Study||1
6324304|NCT00476086|7230314|FG000|STARTED|Overall Study||20
6324305|NCT00476086|7230314|FG000|Received Chemotherapy|Overall Study||19
6324306|NCT00476086|7230314|FG000|Received Radiation|Overall Study||15
6324307|NCT00476086|7230314|FG000|COMPLETED|Overall Study||15
6324308|NCT00476086|7230314|FG000|NOT COMPLETED|Overall Study||5
6324309|NCT00476151|7230322|FG000|STARTED|Overall Study||112
6324310|NCT00476151|7230323|FG001|STARTED|Overall Study||114
6324311|NCT00476151|7230322|FG000|COMPLETED|Overall Study||109
6324312|NCT00476151|7230323|FG001|COMPLETED|Overall Study||107
6324313|NCT00476151|7230322|FG000|NOT COMPLETED|Overall Study||3
6324314|NCT00476151|7230323|FG001|NOT COMPLETED|Overall Study||7
6324315|NCT00476229|7230329|FG000|STARTED|Overall Study||20
6324316|NCT00476229|7230329|FG000|COMPLETED|Overall Study||19
6324317|NCT00476229|7230329|FG000|NOT COMPLETED|Overall Study||1
6324318|NCT00476242|7230335|FG000|STARTED|Overall Study||27
6324319|NCT00476242|7230336|FG001|STARTED|Overall Study||28
6558215|NCT01774591|7480927|FG001|COMPLETED|Overall Study||7
6324320|NCT00476242|7230335|FG000|COMPLETED|Overall Study||19
6324321|NCT00476242|7230336|FG001|COMPLETED|Overall Study||12
6324322|NCT00476242|7230335|FG000|NOT COMPLETED|Overall Study||8
6324323|NCT00476242|7230336|FG001|NOT COMPLETED|Overall Study||16
6324324|NCT00476476|7230346|FG000|STARTED|Overall Study||17
6324325|NCT00476476|7230347|FG001|STARTED|Overall Study||24
6324326|NCT00476476|7230346|FG000|Response Evaluable|Overall Study||17
6324327|NCT00476476|7230347|FG001|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
6324328|NCT00476476|7230346|FG000|COMPLETED|Overall Study||15
6324329|NCT00476476|7230347|FG001|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
6324330|NCT00476476|7230346|FG000|NOT COMPLETED|Overall Study||2
6324331|NCT00476476|7230347|FG001|NOT COMPLETED|Overall Study||24
6324332|NCT00476593|7230356|FG000|STARTED|Overall Study||32
6558216|NCT01774591|7480926|FG000|NOT COMPLETED|Overall Study||1
6324333|NCT00476593|7230357|FG001|STARTED|Overall Study||19
6324334|NCT00476593|7230358|FG002|STARTED|Overall Study||38
6324335|NCT00476593|7230359|FG003|STARTED|Overall Study||129
6375761|NCT00757601|7286365|FG008|NOT COMPLETED|Period 3||0
6558217|NCT01774591|7480927|FG001|NOT COMPLETED|Overall Study||4
6324336|NCT00476593|7230356|FG000|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
6324337|NCT00476593|7230357|FG001|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
6324338|NCT00476593|7230358|FG002|COMPLETED|Overall Study||30
6324339|NCT00476593|7230359|FG003|COMPLETED|Overall Study||107
6324340|NCT00476593|7230356|FG000|NOT COMPLETED|Overall Study||10
6324341|NCT00476593|7230357|FG001|NOT COMPLETED|Overall Study||2
6324342|NCT00476593|7230358|FG002|NOT COMPLETED|Overall Study||8
6324343|NCT00476593|7230359|FG003|NOT COMPLETED|Overall Study||22
6324344|NCT00476645|7230369|FG000|STARTED|Overall Study||10
6324345|NCT00476645|7230369|FG000|COMPLETED|Overall Study||10
6324346|NCT00476645|7230369|FG000|NOT COMPLETED|Overall Study||0
6324347|NCT00476788|7230373|FG000|STARTED|Overall Study||14
6324348|NCT00476788|7230373|FG000|COMPLETED|Overall Study||11
6324349|NCT00476788|7230373|FG000|NOT COMPLETED|Overall Study||3
6324350|NCT00476957|7230379|FG000|STARTED|Overall Study||4357
6324351|NCT00476957|7230380|FG001|STARTED|Overall Study||4352
6324352|NCT00476957|7230379|FG000|COMPLETED|Overall Study||4181
6324353|NCT00476957|7230380|FG001|COMPLETED|Overall Study||4159
6324354|NCT00476957|7230379|FG000|NOT COMPLETED|Overall Study||176
6324355|NCT00476957|7230380|FG001|NOT COMPLETED|Overall Study||193
6324356|NCT00476996|7230389|FG000|STARTED|Blinded Treatment Phase (up to Week 48)||277
6324357|NCT00476996|7230390|FG001|STARTED|Blinded Treatment Phase (up to Week 48)||277
6324358|NCT00476996|7230391|FG002|STARTED|Blinded Treatment Phase (up to Week 48)||282
6324359|NCT00476996|7230392|FG003|STARTED|Blinded Treatment Phase (up to Week 48)||0
6324360|NCT00476996|7230389|FG000|COMPLETED|Blinded Treatment Phase (up to Week 48)||205
6324361|NCT00476996|7230390|FG001|COMPLETED|Blinded Treatment Phase (up to Week 48)||222
6324362|NCT00476996|7230391|FG002|COMPLETED|Blinded Treatment Phase (up to Week 48)||237
6324363|NCT00476996|7230392|FG003|COMPLETED|Blinded Treatment Phase (up to Week 48)||0
6324364|NCT00476996|7230389|FG000|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||72
6324365|NCT00476996|7230390|FG001|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||55
6324366|NCT00476996|7230391|FG002|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||45
6324367|NCT00476996|7230392|FG003|NOT COMPLETED|Blinded Treatment Phase (up to Week 48)||0
6324368|NCT00476996|7230389|FG000|STARTED|OLE Phase (From Week 48)||0
6324369|NCT00476996|7230390|FG001|STARTED|OLE Phase (From Week 48)||0
6324370|NCT00476996|7230391|FG002|STARTED|OLE Phase (From Week 48)||0
6324371|NCT00476996|7230392|FG003|STARTED|OLE Phase (From Week 48)||664
6324372|NCT00476996|7230389|FG000|COMPLETED|OLE Phase (From Week 48)||0
6324373|NCT00476996|7230390|FG001|COMPLETED|OLE Phase (From Week 48)||0
6324374|NCT00476996|7230391|FG002|COMPLETED|OLE Phase (From Week 48)||0
6324375|NCT00476996|7230392|FG003|COMPLETED|OLE Phase (From Week 48)||0
6324376|NCT00476996|7230389|FG000|NOT COMPLETED|OLE Phase (From Week 48)||0
6324377|NCT00476996|7230390|FG001|NOT COMPLETED|OLE Phase (From Week 48)||0
6324378|NCT00476996|7230391|FG002|NOT COMPLETED|OLE Phase (From Week 48)||0
6324379|NCT00476996|7230392|FG003|NOT COMPLETED|OLE Phase (From Week 48)||664
6324380|NCT00477087|7230401|FG000|STARTED|Overall Study||10
6324381|NCT00477087|7230401|FG000|COMPLETED|Overall Study||10
6324382|NCT00477087|7230401|FG000|NOT COMPLETED|Overall Study||0
6324383|NCT00477152|7230405|FG000|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
6324384|NCT00477152|7230405|FG000|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
6324385|NCT00477152|7230405|FG000|NOT COMPLETED|Overall Study||3
6324386|NCT00477165|7230411|FG000|STARTED|Overall Study||27
6324387|NCT00477165|7230412|FG001|STARTED|Overall Study||27
6324388|NCT00477165|7230411|FG000|COMPLETED|Overall Study||20
6324389|NCT00477165|7230412|FG001|COMPLETED|Overall Study||25
6324390|NCT00477165|7230411|FG000|NOT COMPLETED|Overall Study||7
6324391|NCT00477165|7230412|FG001|NOT COMPLETED|Overall Study||2
6324392|NCT00477191|7230418|FG000|STARTED|Overall Study||18
6324393|NCT00477191|7230418|FG000|COMPLETED|Overall Study||13
6324394|NCT00477191|7230418|FG000|NOT COMPLETED|Overall Study||5
6324395|NCT00477204|7230424|FG000|STARTED|Overall Study||4
6324396|NCT00477204|7230425|FG001|STARTED|Overall Study||5
6324397|NCT00477204|7230424|FG000|COMPLETED|Overall Study||4
6324398|NCT00477204|7230425|FG001|COMPLETED|Overall Study||5
6324399|NCT00477204|7230424|FG000|NOT COMPLETED|Overall Study||0
6324400|NCT00477204|7230425|FG001|NOT COMPLETED|Overall Study||0
6324401|NCT00477269|7230433|FG000|STARTED|Core Study||28
6324402|NCT00477269|7230434|FG001|STARTED|Core Study||31
6324403|NCT00477269|7230435|FG002|STARTED|Core Study||0
6324404|NCT00477269|7230433|FG000|COMPLETED|Core Study||19
6324405|NCT00477269|7230434|FG001|COMPLETED|Core Study||23
6324406|NCT00477269|7230435|FG002|COMPLETED|Core Study||0
6324407|NCT00477269|7230433|FG000|NOT COMPLETED|Core Study||9
6324408|NCT00477269|7230434|FG001|NOT COMPLETED|Core Study||8
6324409|NCT00477269|7230435|FG002|NOT COMPLETED|Core Study||0
6324410|NCT00477269|7230433|FG000|STARTED|Open Label Extension|Arm in the Core study not extension|0
6324411|NCT00477269|7230434|FG001|STARTED|Open Label Extension|Arm in the Core study not extension|0
6324412|NCT00477269|7230435|FG002|STARTED|Open Label Extension||22
6324413|NCT00477269|7230433|FG000|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
6324414|NCT00477269|7230434|FG001|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
6324415|NCT00477269|7230435|FG002|COMPLETED|Open Label Extension||9
6324416|NCT00477269|7230433|FG000|NOT COMPLETED|Open Label Extension||0
6324417|NCT00477269|7230434|FG001|NOT COMPLETED|Open Label Extension||0
6324418|NCT00477269|7230435|FG002|NOT COMPLETED|Open Label Extension||13
6324419|NCT00477295|7230445|FG000|STARTED|Overall Study||282
6324420|NCT00477295|7230446|FG001|STARTED|Overall Study||301
6324421|NCT00477295|7230445|FG000|COMPLETED|Overall Study||161
6324422|NCT00477295|7230446|FG001|COMPLETED|Overall Study||192
6324423|NCT00477295|7230445|FG000|NOT COMPLETED|Overall Study||121
6324424|NCT00477295|7230446|FG001|NOT COMPLETED|Overall Study||109
6324425|NCT00477334|7230456|FG000|STARTED|Overall Study||312
6324426|NCT00477334|7230457|FG001|STARTED|Overall Study||151
6324427|NCT00477334|7230456|FG000|Randomized and Took Study Drug|Overall Study||206
6324428|NCT00477334|7230457|FG001|Randomized and Took Study Drug|Overall Study||98
6324429|NCT00477334|7230456|FG000|Intent to Treat Population|Overall Study||201
6324430|NCT00477334|7230457|FG001|Intent to Treat Population|Overall Study||98
6324431|NCT00477334|7230456|FG000|Participants Completing First Recurrence|Overall Study||187
6324432|NCT00477334|7230457|FG001|Participants Completing First Recurrence|Overall Study||92
6324433|NCT00477334|7230456|FG000|Modified Intent to Treat Population|Overall Study||152
6324434|NCT00477334|7230457|FG001|Modified Intent to Treat Population|Overall Study||78
6324435|NCT00477334|7230456|FG000|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
6324436|NCT00477334|7230457|FG001|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
6324437|NCT00477334|7230456|FG000|NOT COMPLETED|Overall Study||170
6324438|NCT00477334|7230457|FG001|NOT COMPLETED|Overall Study||76
6324439|NCT00477386|7230469|FG000|STARTED|Overall Study||11
6324440|NCT00477386|7230470|FG001|STARTED|Overall Study||17
6324441|NCT00477386|7230469|FG000|COMPLETED|Overall Study||0
6324442|NCT00477386|7230470|FG001|COMPLETED|Overall Study||0
6324443|NCT00477386|7230469|FG000|NOT COMPLETED|Overall Study||11
6324444|NCT00477386|7230470|FG001|NOT COMPLETED|Overall Study||17
6324445|NCT00477451|7230480|FG000|STARTED|Overall Study||20
6324446|NCT00477451|7230481|FG001|STARTED|Overall Study||20
6324447|NCT00477451|7230482|FG002|STARTED|Overall Study||7
6324448|NCT00477451|7230483|FG003|STARTED|Overall Study||2
6324449|NCT00477451|7230480|FG000|COMPLETED|Overall Study||20
6324450|NCT00477451|7230481|FG001|COMPLETED|Overall Study||20
6324451|NCT00477451|7230482|FG002|COMPLETED|Overall Study||7
6324452|NCT00477451|7230483|FG003|COMPLETED|Overall Study||2
6324453|NCT00477451|7230480|FG000|NOT COMPLETED|Overall Study||0
6324454|NCT00477451|7230481|FG001|NOT COMPLETED|Overall Study||0
6324455|NCT00477451|7230482|FG002|NOT COMPLETED|Overall Study||0
6324456|NCT00477451|7230483|FG003|NOT COMPLETED|Overall Study||0
6324457|NCT00477464|7230491|FG000|STARTED|Overall Study||51
6324458|NCT00477464|7230491|FG000|COMPLETED|Overall Study||0
6324459|NCT00477464|7230491|FG000|NOT COMPLETED|Overall Study||51
6324460|NCT00477490|7230502|FG000|STARTED|Part I: 4 Week Efficacy||160
6324461|NCT00477490|7230503|FG001|STARTED|Part I: 4 Week Efficacy||163
6324462|NCT00477490|7230504|FG002|STARTED|Part I: 4 Week Efficacy||158
6324463|NCT00477490|7230505|FG003|STARTED|Part I: 4 Week Efficacy||158
6324464|NCT00477490|7230506|FG004|STARTED|Part I: 4 Week Efficacy||160
6324465|NCT00477490|7230507|FG005|STARTED|Part I: 4 Week Efficacy||0
6324466|NCT00477490|7230508|FG006|STARTED|Part I: 4 Week Efficacy||0
6324467|NCT00477490|7230509|FG007|STARTED|Part I: 4 Week Efficacy||0
6324468|NCT00477490|7230510|FG008|STARTED|Part I: 4 Week Efficacy||0
6324469|NCT00477490|7230502|FG000|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
6324470|NCT00477490|7230503|FG001|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
6324471|NCT00477490|7230504|FG002|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
6324472|NCT00477490|7230505|FG003|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
6324473|NCT00477490|7230506|FG004|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
6324474|NCT00477490|7230507|FG005|ITT Population|Part I: 4 Week Efficacy||0
6324475|NCT00477490|7230508|FG006|ITT Population|Part I: 4 Week Efficacy||0
6324476|NCT00477490|7230509|FG007|ITT Population|Part I: 4 Week Efficacy||0
6324477|NCT00477490|7230510|FG008|ITT Population|Part I: 4 Week Efficacy||0
6324478|NCT00477490|7230502|FG000|COMPLETED|Part I: 4 Week Efficacy||145
6324479|NCT00477490|7230503|FG001|COMPLETED|Part I: 4 Week Efficacy||144
6324480|NCT00477490|7230504|FG002|COMPLETED|Part I: 4 Week Efficacy||148
6324481|NCT00477490|7230505|FG003|COMPLETED|Part I: 4 Week Efficacy||138
6324482|NCT00477490|7230506|FG004|COMPLETED|Part I: 4 Week Efficacy||135
6324483|NCT00477490|7230507|FG005|COMPLETED|Part I: 4 Week Efficacy||0
6324484|NCT00477490|7230508|FG006|COMPLETED|Part I: 4 Week Efficacy||0
6324485|NCT00477490|7230509|FG007|COMPLETED|Part I: 4 Week Efficacy||0
6324486|NCT00477490|7230510|FG008|COMPLETED|Part I: 4 Week Efficacy||0
6324487|NCT00477490|7230502|FG000|NOT COMPLETED|Part I: 4 Week Efficacy||15
6324488|NCT00477490|7230503|FG001|NOT COMPLETED|Part I: 4 Week Efficacy||19
6324489|NCT00477490|7230504|FG002|NOT COMPLETED|Part I: 4 Week Efficacy||10
6324490|NCT00477490|7230505|FG003|NOT COMPLETED|Part I: 4 Week Efficacy||20
6324491|NCT00477490|7230506|FG004|NOT COMPLETED|Part I: 4 Week Efficacy||25
6324492|NCT00477490|7230507|FG005|NOT COMPLETED|Part I: 4 Week Efficacy||0
6324493|NCT00477490|7230508|FG006|NOT COMPLETED|Part I: 4 Week Efficacy||0
6324494|NCT00477490|7230509|FG007|NOT COMPLETED|Part I: 4 Week Efficacy||0
6324495|NCT00477490|7230510|FG008|NOT COMPLETED|Part I: 4 Week Efficacy||0
6375762|NCT00757601|7286366|FG009|NOT COMPLETED|Period 3||0
6324496|NCT00477490|7230502|FG000|STARTED|Part II: Extension Week 5 up to Day 169||0
6324497|NCT00477490|7230503|FG001|STARTED|Part II: Extension Week 5 up to Day 169||135
6324498|NCT00477490|7230504|FG002|STARTED|Part II: Extension Week 5 up to Day 169||135
6324499|NCT00477490|7230505|FG003|STARTED|Part II: Extension Week 5 up to Day 169||132
6324500|NCT00477490|7230506|FG004|STARTED|Part II: Extension Week 5 up to Day 169||127
6324501|NCT00477490|7230507|FG005|STARTED|Part II: Extension Week 5 up to Day 169||31
6324502|NCT00477490|7230508|FG006|STARTED|Part II: Extension Week 5 up to Day 169||37
6324503|NCT00477490|7230509|FG007|STARTED|Part II: Extension Week 5 up to Day 169||34
6324504|NCT00477490|7230510|FG008|STARTED|Part II: Extension Week 5 up to Day 169||34
6324505|NCT00477490|7230502|FG000|COMPLETED|Part II: Extension Week 5 up to Day 169||0
6324506|NCT00477490|7230503|FG001|COMPLETED|Part II: Extension Week 5 up to Day 169||107
6324507|NCT00477490|7230504|FG002|COMPLETED|Part II: Extension Week 5 up to Day 169||120
6324508|NCT00477490|7230505|FG003|COMPLETED|Part II: Extension Week 5 up to Day 169||120
6324509|NCT00477490|7230506|FG004|COMPLETED|Part II: Extension Week 5 up to Day 169||107
6324510|NCT00477490|7230507|FG005|COMPLETED|Part II: Extension Week 5 up to Day 169||25
6324511|NCT00477490|7230508|FG006|COMPLETED|Part II: Extension Week 5 up to Day 169||32
6324512|NCT00477490|7230509|FG007|COMPLETED|Part II: Extension Week 5 up to Day 169||29
6324513|NCT00477490|7230510|FG008|COMPLETED|Part II: Extension Week 5 up to Day 169||26
6324514|NCT00477490|7230502|FG000|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
6324515|NCT00477490|7230503|FG001|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
6324516|NCT00477490|7230504|FG002|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
6324517|NCT00477490|7230505|FG003|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
6324518|NCT00477490|7230506|FG004|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
6324519|NCT00477490|7230507|FG005|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
6324520|NCT00477490|7230508|FG006|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
6324521|NCT00477490|7230509|FG007|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
6324522|NCT00477490|7230510|FG008|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
6324523|NCT00477594|7230540|FG000|STARTED|Year 1 and Year 2||16
6324524|NCT00477594|7230541|FG001|STARTED|Year 1 and Year 2||5
6324525|NCT00477594|7230540|FG000|COMPLETED|Year 1 and Year 2||7
6324526|NCT00477594|7230541|FG001|COMPLETED|Year 1 and Year 2||1
6324527|NCT00477594|7230540|FG000|NOT COMPLETED|Year 1 and Year 2||9
6324528|NCT00477594|7230541|FG001|NOT COMPLETED|Year 1 and Year 2||4
6324529|NCT00477594|7230540|FG000|STARTED|Year 3||4
6324530|NCT00477594|7230541|FG001|STARTED|Year 3||0
6324531|NCT00477594|7230540|FG000|COMPLETED|Year 3||2
6324532|NCT00477594|7230541|FG001|COMPLETED|Year 3||0
6324533|NCT00477594|7230540|FG000|NOT COMPLETED|Year 3||2
6324534|NCT00477594|7230541|FG001|NOT COMPLETED|Year 3||0
6324535|NCT00477594|7230540|FG000|STARTED|Follow-up Period||16
6324536|NCT00477594|7230541|FG001|STARTED|Follow-up Period||5
6324537|NCT00477594|7230540|FG000|COMPLETED|Follow-up Period||13
6324538|NCT00477594|7230541|FG001|COMPLETED|Follow-up Period||4
6324539|NCT00477594|7230540|FG000|NOT COMPLETED|Follow-up Period||3
6324540|NCT00477594|7230541|FG001|NOT COMPLETED|Follow-up Period||1
6324541|NCT00477607|7230549|FG000|STARTED|Overall Study||19
6324542|NCT00477607|7230550|FG001|STARTED|Overall Study||20
6324543|NCT00477607|7230549|FG000|COMPLETED|Overall Study||12
6324544|NCT00477607|7230550|FG001|COMPLETED|Overall Study||13
6324545|NCT00477607|7230549|FG000|NOT COMPLETED|Overall Study||7
6324546|NCT00477607|7230550|FG001|NOT COMPLETED|Overall Study||7
6324547|NCT00477633|7230556|FG000|STARTED|Overall Study||1700
6324548|NCT00477633|7230556|FG000|COMPLETED|Overall Study||991
6324549|NCT00477633|7230556|FG000|NOT COMPLETED|Overall Study||709
6324550|NCT00477659|7230560|FG000|STARTED|Overall Study||14
6324551|NCT00477659|7230560|FG000|COMPLETED|Overall Study||14
6324552|NCT00477659|7230560|FG000|NOT COMPLETED|Overall Study||0
6324553|NCT00477672|7230567|FG000|STARTED|Overall Study||98
6324554|NCT00477672|7230568|FG001|STARTED|Overall Study||101
6324555|NCT00477672|7230569|FG002|STARTED|Overall Study||99
6324556|NCT00477672|7230567|FG000|COMPLETED|Overall Study||91
6324557|NCT00477672|7230568|FG001|COMPLETED|Overall Study||85
6324558|NCT00477672|7230569|FG002|COMPLETED|Overall Study||83
6324559|NCT00477672|7230567|FG000|NOT COMPLETED|Overall Study||7
6324560|NCT00477672|7230568|FG001|NOT COMPLETED|Overall Study||16
6324561|NCT00477672|7230569|FG002|NOT COMPLETED|Overall Study||16
6324562|NCT00477685|7230577|FG000|STARTED|Overall Study||10
6324563|NCT00477685|7230577|FG000|COMPLETED|Overall Study||10
6324564|NCT00477685|7230577|FG000|NOT COMPLETED|Overall Study||0
6324565|NCT00477750|7230581|FG000|STARTED|Overall Study||26
6324566|NCT00477750|7230581|FG000|COMPLETED|Overall Study||15
6324567|NCT00477750|7230581|FG000|NOT COMPLETED|Overall Study||11
6324568|NCT00477971|7230589|FG000|STARTED|Overall Study||34
6324569|NCT00477971|7230590|FG001|STARTED|Overall Study||55
6324570|NCT00477971|7230589|FG000|COMPLETED|Overall Study||17
6324571|NCT00477971|7230590|FG001|COMPLETED|Overall Study||49
6324572|NCT00477971|7230589|FG000|NOT COMPLETED|Overall Study||17
6324573|NCT00477971|7230590|FG001|NOT COMPLETED|Overall Study||6
6324574|NCT00478023|7230601|FG000|STARTED|Overall Study||170
6324575|NCT00478023|7230602|FG001|STARTED|Overall Study||168
6324576|NCT00478023|7230603|FG002|STARTED|Overall Study||171
6324577|NCT00478023|7230604|FG003|STARTED|Overall Study||176
6324578|NCT00478023|7230605|FG004|STARTED|Overall Study||169
6324579|NCT00478023|7230601|FG000|COMPLETED|Overall Study||135
6324580|NCT00478023|7230602|FG001|COMPLETED|Overall Study||144
6324581|NCT00478023|7230603|FG002|COMPLETED|Overall Study||151
6324582|NCT00478023|7230604|FG003|COMPLETED|Overall Study||146
6324583|NCT00478023|7230605|FG004|COMPLETED|Overall Study||114
6324584|NCT00478023|7230601|FG000|NOT COMPLETED|Overall Study||35
6324585|NCT00478023|7230602|FG001|NOT COMPLETED|Overall Study||24
6324586|NCT00478023|7230603|FG002|NOT COMPLETED|Overall Study||20
6324587|NCT00478023|7230604|FG003|NOT COMPLETED|Overall Study||30
6324588|NCT00478023|7230605|FG004|NOT COMPLETED|Overall Study||55
6324589|NCT00478036|7230620|FG000|STARTED|Overall Study||10
6324590|NCT00478036|7230621|FG001|STARTED|Overall Study||7
6324591|NCT00478036|7230622|FG002|STARTED|Overall Study||14
6324592|NCT00478036|7230620|FG000|COMPLETED|Overall Study||10
6324593|NCT00478036|7230621|FG001|COMPLETED|Overall Study||7
6324594|NCT00478036|7230622|FG002|COMPLETED|Overall Study||14
6324595|NCT00478036|7230620|FG000|NOT COMPLETED|Overall Study||0
6324596|NCT00478036|7230621|FG001|NOT COMPLETED|Overall Study||0
6324597|NCT00478036|7230622|FG002|NOT COMPLETED|Overall Study||0
6324598|NCT00478140|7230630|FG000|STARTED|Overall Study||4
6324599|NCT00478140|7230630|FG000|COMPLETED|Overall Study||3
6324600|NCT00478140|7230630|FG000|NOT COMPLETED|Overall Study||1
6324601|NCT00478192|7230637|FG000|STARTED|Overall Study||20
6324602|NCT00478192|7230638|FG001|STARTED|Overall Study||20
6324603|NCT00478192|7230639|FG002|STARTED|Overall Study||10
6324604|NCT00478192|7230637|FG000|Full Analysis Set / Safety Analysis Set|Overall Study||20
6324605|NCT00478192|7230638|FG001|Full Analysis Set / Safety Analysis Set|Overall Study||20
6324606|NCT00478192|7230639|FG002|Full Analysis Set / Safety Analysis Set|Overall Study||9
6324607|NCT00478192|7230637|FG000|End of Treatment|Overall Study||18
6324608|NCT00478192|7230638|FG001|End of Treatment|Overall Study||16
6324609|NCT00478192|7230639|FG002|End of Treatment|Overall Study||8
6324610|NCT00478192|7230637|FG000|COMPLETED|Overall Study||16
6324611|NCT00478192|7230638|FG001|COMPLETED|Overall Study||15
6324612|NCT00478192|7230639|FG002|COMPLETED|Overall Study||8
6324613|NCT00478192|7230637|FG000|NOT COMPLETED|Overall Study||4
6324614|NCT00478192|7230638|FG001|NOT COMPLETED|Overall Study||5
6324615|NCT00478192|7230639|FG002|NOT COMPLETED|Overall Study||2
6324616|NCT00478205|7230650|FG000|STARTED|Overall Study||981
6324617|NCT00478205|7230651|FG001|STARTED|Overall Study||486
6324618|NCT00478205|7230650|FG000|COMPLETED|Overall Study||685
6324619|NCT00478205|7230651|FG001|COMPLETED|Overall Study||399
6324620|NCT00478205|7230650|FG000|NOT COMPLETED|Overall Study||296
6324621|NCT00478205|7230651|FG001|NOT COMPLETED|Overall Study||87
6324622|NCT00478218|7230659|FG000|STARTED|Overall Study||34
6324623|NCT00478218|7230660|FG001|STARTED|Overall Study||19
6324624|NCT00478218|7230659|FG000|COMPLETED|Overall Study||34
6324625|NCT00478218|7230660|FG001|COMPLETED|Overall Study||19
6324626|NCT00478218|7230659|FG000|NOT COMPLETED|Overall Study||0
6324627|NCT00478218|7230660|FG001|NOT COMPLETED|Overall Study||0
6324628|NCT00478231|7230666|FG000|STARTED|Overall Study||209
6324629|NCT00478231|7230666|FG000|Treated|Overall Study||206
6324630|NCT00478231|7230666|FG000|COMPLETED|Overall Study||125
6324631|NCT00478231|7230666|FG000|NOT COMPLETED|Overall Study||84
6324632|NCT00478244|7230670|FG000|STARTED|Overall Study||7
6324633|NCT00478244|7230670|FG000|COMPLETED|Overall Study||6
6324634|NCT00478244|7230670|FG000|NOT COMPLETED|Overall Study||1
6324635|NCT00478257|7230676|FG000|STARTED|Overall Study||23
6324636|NCT00478257|7230677|FG001|STARTED|Overall Study||16
6324637|NCT00478257|7230676|FG000|COMPLETED|Overall Study||15
6324638|NCT00478257|7230677|FG001|COMPLETED|Overall Study||13
6324639|NCT00478257|7230676|FG000|NOT COMPLETED|Overall Study||8
6324640|NCT00478257|7230677|FG001|NOT COMPLETED|Overall Study||3
6324641|NCT00478335|7230685|FG000|STARTED|Period 1 (4 Days)||2
6324642|NCT00478335|7230686|FG001|STARTED|Period 1 (4 Days)||2
6324643|NCT00478335|7230685|FG000|COMPLETED|Period 1 (4 Days)||2
6324644|NCT00478335|7230686|FG001|COMPLETED|Period 1 (4 Days)||2
6324645|NCT00478335|7230685|FG000|NOT COMPLETED|Period 1 (4 Days)||0
6324646|NCT00478335|7230686|FG001|NOT COMPLETED|Period 1 (4 Days)||0
6324647|NCT00478335|7230685|FG000|STARTED|Period 2 (4 Days)||2
6324648|NCT00478335|7230686|FG001|STARTED|Period 2 (4 Days)||2
6324649|NCT00478335|7230685|FG000|COMPLETED|Period 2 (4 Days)||2
6324650|NCT00478335|7230686|FG001|COMPLETED|Period 2 (4 Days)||2
6324651|NCT00478335|7230685|FG000|NOT COMPLETED|Period 2 (4 Days)||0
6324652|NCT00478335|7230686|FG001|NOT COMPLETED|Period 2 (4 Days)||0
6324653|NCT00478361|7230692|FG000|STARTED|Overall Study||39
6324654|NCT00478361|7230692|FG000|COMPLETED|Overall Study||39
6324655|NCT00478361|7230692|FG000|NOT COMPLETED|Overall Study||0
6324656|NCT00478426|7230696|FG000|STARTED|Overall Study||34
6324657|NCT00478426|7230696|FG000|COMPLETED|Overall Study||33
6324658|NCT00478426|7230696|FG000|NOT COMPLETED|Overall Study||1
6324659|NCT00478556|7230702|FG000|STARTED|Overall Study||151
6324660|NCT00478556|7230703|FG001|STARTED|Overall Study||149
6324661|NCT00478556|7230702|FG000|COMPLETED|Overall Study||151
6324662|NCT00478556|7230703|FG001|COMPLETED|Overall Study||149
6324663|NCT00478556|7230702|FG000|NOT COMPLETED|Overall Study||0
6324664|NCT00478556|7230703|FG001|NOT COMPLETED|Overall Study||0
6324665|NCT00478569|7230709|FG000|STARTED|Overall Study||1170
6324666|NCT00478569|7230709|FG000|COMPLETED|Overall Study||761
6324667|NCT00478569|7230709|FG000|NOT COMPLETED|Overall Study||409
6324668|NCT00478608|7230721|FG000|STARTED|Overall Study||79
6324669|NCT00478608|7230721|FG000|COMPLETED|Overall Study||59
6324670|NCT00478608|7230721|FG000|NOT COMPLETED|Overall Study||20
6324671|NCT00478647|7230725|FG000|STARTED|Overall Study||40
6324672|NCT00478647|7230725|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
6324673|NCT00478647|7230725|FG000|NOT COMPLETED|Overall Study||2
6324674|NCT00478673|7230729|FG000|STARTED|30-Days Post-Procedure||298
6324675|NCT00478673|7230729|FG000|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
6324676|NCT00478673|7230729|FG000|NOT COMPLETED|30-Days Post-Procedure||10
6324677|NCT00478673|7230729|FG000|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
6324678|NCT00478673|7230729|FG000|COMPLETED|12-Months Post-Procedure||231
6324679|NCT00478673|7230729|FG000|NOT COMPLETED|12-Months Post-Procedure||64
6324680|NCT00478777|7230733|FG000|STARTED|Overall Study||150
6324681|NCT00478777|7230733|FG000|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
6324682|NCT00478777|7230733|FG000|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
6324683|NCT00478777|7230733|FG000|NOT COMPLETED|Overall Study||77
6324684|NCT00478881|7230739|FG000|STARTED|Overall Study||199
6324685|NCT00478881|7230740|FG001|STARTED|Overall Study||198
6324686|NCT00478881|7230739|FG000|Received Medication|Overall Study||198
6324687|NCT00478881|7230740|FG001|Received Medication|Overall Study||198
6324688|NCT00478881|7230739|FG000|COMPLETED|Overall Study||160
6324689|NCT00478881|7230740|FG001|COMPLETED|Overall Study||176
6324690|NCT00478881|7230739|FG000|NOT COMPLETED|Overall Study||39
6324691|NCT00478881|7230740|FG001|NOT COMPLETED|Overall Study||22
6324692|NCT00478933|7230746|FG000|STARTED|Overall Study||1223
6324693|NCT00478933|7230746|FG000|COMPLETED|Overall Study||1145
6324694|NCT00478933|7230746|FG000|NOT COMPLETED|Overall Study||78
6324695|NCT00479037|7230772|FG000|STARTED|Overall Study||41
6324696|NCT00479037|7230773|FG001|STARTED|Overall Study||40
6324697|NCT00479037|7230772|FG000|COMPLETED|Overall Study||38
6324698|NCT00479037|7230773|FG001|COMPLETED|Overall Study||34
6324699|NCT00479037|7230772|FG000|NOT COMPLETED|Overall Study||3
6324700|NCT00479037|7230773|FG001|NOT COMPLETED|Overall Study||6
6324701|NCT00479089|7230781|FG000|STARTED|Overall Study||25
6324702|NCT00479089|7230782|FG001|STARTED|Overall Study||25
6324703|NCT00479089|7230781|FG000|COMPLETED|Overall Study||25
6324704|NCT00479089|7230782|FG001|COMPLETED|Overall Study||25
6324705|NCT00479089|7230781|FG000|NOT COMPLETED|Overall Study||0
6324706|NCT00479089|7230782|FG001|NOT COMPLETED|Overall Study||0
6324707|NCT00479115|7230788|FG000|STARTED|Overall Study||1
6324708|NCT00479115|7230788|FG000|COMPLETED|Overall Study||1
6324709|NCT00479115|7230788|FG000|NOT COMPLETED|Overall Study||0
6324710|NCT00479154|7230794|FG000|STARTED|Overall Study||3
6324711|NCT00479154|7230795|FG001|STARTED|Overall Study||3
6324712|NCT00479154|7230794|FG000|COMPLETED|Overall Study||3
6324713|NCT00479154|7230795|FG001|COMPLETED|Overall Study||3
6324714|NCT00479154|7230794|FG000|NOT COMPLETED|Overall Study||0
6324715|NCT00479154|7230795|FG001|NOT COMPLETED|Overall Study||0
6324716|NCT00479232|7230803|FG000|STARTED|Overall Study||3
6324717|NCT00479232|7230804|FG001|STARTED|Overall Study||3
6324718|NCT00479232|7230805|FG002|STARTED|Overall Study||28
6324719|NCT00479232|7230806|FG003|STARTED|Overall Study||3
6324720|NCT00479232|7230807|FG004|STARTED|Overall Study||4
6324721|NCT00479232|7230808|FG005|STARTED|Overall Study||30
6324722|NCT00479232|7230803|FG000|COMPLETED|Overall Study||0
6324723|NCT00479232|7230804|FG001|COMPLETED|Overall Study||0
6324724|NCT00479232|7230805|FG002|COMPLETED|Overall Study||0
6324725|NCT00479232|7230806|FG003|COMPLETED|Overall Study||0
6324726|NCT00479232|7230807|FG004|COMPLETED|Overall Study||0
6775182|NCT03880227|7703106|FG003|STARTED|Second Visit||18
6775183|NCT03880227|7703103|FG000|COMPLETED|Second Visit||19
6558218|NCT01774604|7480935|FG000|STARTED|Overall Study||223
6775184|NCT03880227|7703104|FG001|COMPLETED|Second Visit||20
6775185|NCT03880227|7703105|FG002|COMPLETED|Second Visit||19
6775186|NCT03880227|7703106|FG003|COMPLETED|Second Visit||18
6775187|NCT03880227|7703103|FG000|NOT COMPLETED|Second Visit||0
6775188|NCT03880227|7703104|FG001|NOT COMPLETED|Second Visit||0
6775189|NCT03880227|7703105|FG002|NOT COMPLETED|Second Visit||0
6775190|NCT03880227|7703106|FG003|NOT COMPLETED|Second Visit||0
6775191|NCT03876743|7703120|FG000|STARTED|Overall Study||54
6775192|NCT03876743|7703121|FG001|STARTED|Overall Study||51
6775193|NCT03876743|7703122|FG002|STARTED|Overall Study||46
6775194|NCT03876743|7703123|FG003|STARTED|Overall Study||50
6775195|NCT03876743|7703120|FG000|COMPLETED|Overall Study||48
6324727|NCT00479232|7230808|FG005|COMPLETED|Overall Study||0
6324728|NCT00479232|7230803|FG000|NOT COMPLETED|Overall Study||3
6324729|NCT00479232|7230804|FG001|NOT COMPLETED|Overall Study||3
6324730|NCT00479232|7230805|FG002|NOT COMPLETED|Overall Study||28
6324731|NCT00479232|7230806|FG003|NOT COMPLETED|Overall Study||3
6324732|NCT00479232|7230807|FG004|NOT COMPLETED|Overall Study||4
6324733|NCT00479232|7230808|FG005|NOT COMPLETED|Overall Study||30
6775196|NCT03876743|7703121|FG001|COMPLETED|Overall Study||47
6775197|NCT03876743|7703122|FG002|COMPLETED|Overall Study||42
6775198|NCT03876743|7703123|FG003|COMPLETED|Overall Study||43
6324734|NCT00479336|7230830|FG000|STARTED|Overall Study||27
6324735|NCT00479336|7230831|FG001|STARTED|Overall Study||26
6324736|NCT00479336|7230832|FG002|STARTED|Overall Study||25
6324737|NCT00479336|7230833|FG003|STARTED|Overall Study||26
6324738|NCT00479336|7230830|FG000|COMPLETED|Overall Study||23
6324739|NCT00479336|7230831|FG001|COMPLETED|Overall Study||20
6324740|NCT00479336|7230832|FG002|COMPLETED|Overall Study||24
6775199|NCT03876743|7703120|FG000|NOT COMPLETED|Overall Study||6
6775200|NCT03876743|7703121|FG001|NOT COMPLETED|Overall Study||4
6324741|NCT00479336|7230833|FG003|COMPLETED|Overall Study||21
6324742|NCT00479336|7230830|FG000|NOT COMPLETED|Overall Study||4
6324743|NCT00479336|7230831|FG001|NOT COMPLETED|Overall Study||6
6324744|NCT00479336|7230832|FG002|NOT COMPLETED|Overall Study||1
6324745|NCT00479336|7230833|FG003|NOT COMPLETED|Overall Study||5
6324746|NCT00479388|7230845|FG000|STARTED|Overall Study||606
6324747|NCT00479388|7230846|FG001|STARTED|Overall Study||610
6324748|NCT00479388|7230845|FG000|COMPLETED|Overall Study||474
6324749|NCT00479388|7230846|FG001|COMPLETED|Overall Study||537
6324750|NCT00479388|7230845|FG000|NOT COMPLETED|Overall Study||132
6324751|NCT00479388|7230846|FG001|NOT COMPLETED|Overall Study||73
6324752|NCT00479401|7230855|FG000|STARTED|Overall Study||223
6324753|NCT00479401|7230856|FG001|STARTED|Overall Study||213
6324754|NCT00479401|7230857|FG002|STARTED|Overall Study||103
6324755|NCT00479401|7230855|FG000|COMPLETED|Overall Study||174
6324756|NCT00479401|7230856|FG001|COMPLETED|Overall Study||176
6324757|NCT00479401|7230857|FG002|COMPLETED|Overall Study||91
6324758|NCT00479401|7230855|FG000|NOT COMPLETED|Overall Study||49
6324759|NCT00479401|7230856|FG001|NOT COMPLETED|Overall Study||37
6324760|NCT00479401|7230857|FG002|NOT COMPLETED|Overall Study||12
6324761|NCT00479466|7230871|FG000|STARTED|Overall Study||57
6324762|NCT00479466|7230872|FG001|STARTED|Overall Study||57
6324763|NCT00479466|7230873|FG002|STARTED|Overall Study||57
6324764|NCT00479466|7230874|FG003|STARTED|Overall Study||58
6324765|NCT00479466|7230875|FG004|STARTED|Overall Study||56
6324766|NCT00479466|7230876|FG005|STARTED|Overall Study||57
6324767|NCT00479466|7230871|FG000|COMPLETED|Overall Study||44
6324768|NCT00479466|7230872|FG001|COMPLETED|Overall Study||49
6324769|NCT00479466|7230873|FG002|COMPLETED|Overall Study||54
6558219|NCT01774604|7480936|FG001|STARTED|Overall Study||226
6558220|NCT01774604|7480935|FG000|COMPLETED|Overall Study||223
6558221|NCT01774604|7480936|FG001|COMPLETED|Overall Study||226
6558222|NCT01774604|7480935|FG000|NOT COMPLETED|Overall Study||0
6324770|NCT00479466|7230874|FG003|COMPLETED|Overall Study||55
6324771|NCT00479466|7230875|FG004|COMPLETED|Overall Study||48
6324772|NCT00479466|7230876|FG005|COMPLETED|Overall Study||53
6324773|NCT00479466|7230871|FG000|NOT COMPLETED|Overall Study||13
6324774|NCT00479466|7230872|FG001|NOT COMPLETED|Overall Study||8
6324775|NCT00479466|7230873|FG002|NOT COMPLETED|Overall Study||3
6324776|NCT00479466|7230874|FG003|NOT COMPLETED|Overall Study||3
6324777|NCT00479466|7230875|FG004|NOT COMPLETED|Overall Study||8
6324778|NCT00479466|7230876|FG005|NOT COMPLETED|Overall Study||4
6324779|NCT00479557|7230897|FG000|STARTED|Overall Study||36
6324780|NCT00479557|7230898|FG001|STARTED|Overall Study||61
6324781|NCT00479557|7230899|FG002|STARTED|Overall Study||40
6324782|NCT00479557|7230900|FG003|STARTED|Overall Study||35
6324783|NCT00479557|7230901|FG004|STARTED|Overall Study||12
6324784|NCT00479557|7230902|FG005|STARTED|Overall Study||44
6324785|NCT00479557|7230903|FG006|STARTED|Overall Study||17
6324786|NCT00479557|7230897|FG000|Treated|Overall Study||36
6324787|NCT00479557|7230898|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
6324788|NCT00479557|7230899|FG002|Treated|Overall Study||40
6324789|NCT00479557|7230900|FG003|Treated|Overall Study||35
6324790|NCT00479557|7230901|FG004|Treated|Overall Study||12
6324791|NCT00479557|7230902|FG005|Treated|Overall Study||44
6324792|NCT00479557|7230903|FG006|Treated|Overall Study||17
6324793|NCT00479557|7230897|FG000|COMPLETED|Overall Study||26
6324794|NCT00479557|7230898|FG001|COMPLETED|Overall Study||51
6324795|NCT00479557|7230899|FG002|COMPLETED|Overall Study||32
6324796|NCT00479557|7230900|FG003|COMPLETED|Overall Study||30
6324797|NCT00479557|7230901|FG004|COMPLETED|Overall Study||8
6324798|NCT00479557|7230902|FG005|COMPLETED|Overall Study||31
6324799|NCT00479557|7230903|FG006|COMPLETED|Overall Study||15
6324800|NCT00479557|7230897|FG000|NOT COMPLETED|Overall Study||10
6324801|NCT00479557|7230898|FG001|NOT COMPLETED|Overall Study||10
6324802|NCT00479557|7230899|FG002|NOT COMPLETED|Overall Study||8
6324803|NCT00479557|7230900|FG003|NOT COMPLETED|Overall Study||5
6324804|NCT00479557|7230901|FG004|NOT COMPLETED|Overall Study||4
6324805|NCT00479557|7230902|FG005|NOT COMPLETED|Overall Study||13
6324806|NCT00479557|7230903|FG006|NOT COMPLETED|Overall Study||2
6324807|NCT00479674|7230925|FG000|STARTED|Overall Study||41
6324808|NCT00479674|7230925|FG000|COMPLETED|Overall Study||0
6324809|NCT00479674|7230925|FG000|NOT COMPLETED|Overall Study||41
6324810|NCT00479687|7230931|FG000|STARTED|Ph 1: Blinded, Randomized, Controlled||150
6324811|NCT00479687|7230932|FG001|STARTED|Ph 1: Blinded, Randomized, Controlled||150
6324812|NCT00479687|7230933|FG002|STARTED|Ph 1: Blinded, Randomized, Controlled||0
6324813|NCT00479687|7230931|FG000|COMPLETED|Ph 1: Blinded, Randomized, Controlled||125
6324814|NCT00479687|7230932|FG001|COMPLETED|Ph 1: Blinded, Randomized, Controlled||131
6324815|NCT00479687|7230933|FG002|COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
6324816|NCT00479687|7230931|FG000|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||25
6324817|NCT00479687|7230932|FG001|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||19
6558223|NCT01774604|7480936|FG001|NOT COMPLETED|Overall Study||0
6324818|NCT00479687|7230933|FG002|NOT COMPLETED|Ph 1: Blinded, Randomized, Controlled||0
6324819|NCT00479687|7230931|FG000|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
6324820|NCT00479687|7230932|FG001|STARTED|Ph 2: Open Label, Single (Supartz) Arm||0
6324821|NCT00479687|7230933|FG002|STARTED|Ph 2: Open Label, Single (Supartz) Arm|Four did not continue to Ph2; 224 received at least 1 inj. and 28 received no trt. (only follow-up)|224
6375763|NCT00757601|7286367|FG010|NOT COMPLETED|Period 3||0
6558224|NCT01774760|7480942|FG000|STARTED|Overall Study||10
6324822|NCT00479687|7230931|FG000|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
6324823|NCT00479687|7230932|FG001|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
6324824|NCT00479687|7230933|FG002|COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||215
6324825|NCT00479687|7230931|FG000|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
6324826|NCT00479687|7230932|FG001|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||0
6324827|NCT00479687|7230933|FG002|NOT COMPLETED|Ph 2: Open Label, Single (Supartz) Arm||9
6324828|NCT00479765|7230940|FG000|STARTED|Overall Study||4
6324829|NCT00479765|7230940|FG000|COMPLETED|Overall Study||0
6324830|NCT00479765|7230940|FG000|NOT COMPLETED|Overall Study||4
6324831|NCT00479856|7230944|FG000|STARTED|Overall Study||9
6324832|NCT00479856|7230944|FG000|COMPLETED|Overall Study||6
6324833|NCT00479856|7230944|FG000|NOT COMPLETED|Overall Study||3
6324834|NCT00479882|7230952|FG000|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
6324835|NCT00479882|7230953|FG001|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
6324836|NCT00479882|7230954|FG002|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
6324837|NCT00479882|7230955|FG003|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
6324838|NCT00479882|7230952|FG000|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
6324839|NCT00479882|7230953|FG001|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
6324840|NCT00479882|7230954|FG002|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
6324841|NCT00479882|7230955|FG003|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
6324842|NCT00479882|7230952|FG000|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
6324843|NCT00479882|7230953|FG001|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
6324844|NCT00479882|7230954|FG002|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
6324845|NCT00479882|7230955|FG003|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
6324846|NCT00479882|7230952|FG000|STARTED|Crossover: Period III (Weeks 13-20)||472
6324847|NCT00479882|7230953|FG001|STARTED|Crossover: Period III (Weeks 13-20)||440
6324848|NCT00479882|7230954|FG002|STARTED|Crossover: Period III (Weeks 13-20)||440
6324849|NCT00479882|7230955|FG003|STARTED|Crossover: Period III (Weeks 13-20)||465
6324850|NCT00479882|7230952|FG000|COMPLETED|Crossover: Period III (Weeks 13-20)||447
6324851|NCT00479882|7230953|FG001|COMPLETED|Crossover: Period III (Weeks 13-20)||419
6324852|NCT00479882|7230954|FG002|COMPLETED|Crossover: Period III (Weeks 13-20)||420
6324853|NCT00479882|7230955|FG003|COMPLETED|Crossover: Period III (Weeks 13-20)||447
6324854|NCT00479882|7230952|FG000|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
6324855|NCT00479882|7230953|FG001|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
6324856|NCT00479882|7230954|FG002|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
6324857|NCT00479882|7230955|FG003|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
6324858|NCT00480025|7230983|FG000|STARTED|Overall Study||1515
6324859|NCT00480025|7230984|FG001|STARTED|Overall Study||757
6324860|NCT00480025|7230983|FG000|COMPLETED|Overall Study||763
6324861|NCT00480025|7230984|FG001|COMPLETED|Overall Study||388
6324862|NCT00480025|7230983|FG000|NOT COMPLETED|Overall Study||752
6324863|NCT00480025|7230984|FG001|NOT COMPLETED|Overall Study||369
6324864|NCT00480077|7230998|FG000|STARTED|Overall Study||168
6324865|NCT00480077|7230999|FG001|STARTED|Overall Study||167
6324866|NCT00480077|7230998|FG000|COMPLETED|Overall Study||137
6324867|NCT00480077|7230999|FG001|COMPLETED|Overall Study||141
6324868|NCT00480077|7230998|FG000|NOT COMPLETED|Overall Study||31
6324869|NCT00480077|7230999|FG001|NOT COMPLETED|Overall Study||26
6324870|NCT00480324|7231007|FG000|STARTED|Overall Study||508
6324871|NCT00480324|7231008|FG001|STARTED|Overall Study||257
6324872|NCT00480324|7231007|FG000|COMPLETED|Overall Study||476
6324873|NCT00480324|7231008|FG001|COMPLETED|Overall Study||241
6324874|NCT00480324|7231007|FG000|NOT COMPLETED|Overall Study||32
6324875|NCT00480324|7231008|FG001|NOT COMPLETED|Overall Study||16
6324876|NCT00480441|7231016|FG000|STARTED|Screening||61
6324877|NCT00480441|7231017|FG001|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
6324878|NCT00480441|7231018|FG002|STARTED|Screening|"Participants did not enter this arm until period 3 randomization"|0
6324879|NCT00480441|7231016|FG000|COMPLETED|Screening||24
6324880|NCT00480441|7231017|FG001|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
6324881|NCT00480441|7231018|FG002|COMPLETED|Screening|"Participants did not enter this arm until period 3 randomization"|0
6324882|NCT00480441|7231016|FG000|NOT COMPLETED|Screening||37
6324883|NCT00480441|7231017|FG001|NOT COMPLETED|Screening||0
6324884|NCT00480441|7231018|FG002|NOT COMPLETED|Screening||0
6324885|NCT00480441|7231016|FG000|STARTED|Baseline Functional MRI|All non-randomized participants who also met specific eligibility for baseline functional MRI|24
6324886|NCT00480441|7231017|FG001|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
6324887|NCT00480441|7231018|FG002|STARTED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
6324888|NCT00480441|7231016|FG000|COMPLETED|Baseline Functional MRI||12
6324889|NCT00480441|7231017|FG001|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
6324890|NCT00480441|7231018|FG002|COMPLETED|Baseline Functional MRI|"Participants did not enter this arm until period 3 randomization"|0
6324891|NCT00480441|7231016|FG000|NOT COMPLETED|Baseline Functional MRI||12
6324892|NCT00480441|7231017|FG001|NOT COMPLETED|Baseline Functional MRI||0
6324893|NCT00480441|7231018|FG002|NOT COMPLETED|Baseline Functional MRI||0
6324894|NCT00480441|7231016|FG000|STARTED|Randomization||0
6324895|NCT00480441|7231017|FG001|STARTED|Randomization||13
6324896|NCT00480441|7231018|FG002|STARTED|Randomization||11
6324897|NCT00480441|7231016|FG000|COMPLETED|Randomization||0
6324898|NCT00480441|7231017|FG001|COMPLETED|Randomization||6
6324899|NCT00480441|7231018|FG002|COMPLETED|Randomization||9
6324900|NCT00480441|7231016|FG000|NOT COMPLETED|Randomization||0
6324901|NCT00480441|7231017|FG001|NOT COMPLETED|Randomization||7
6324902|NCT00480441|7231018|FG002|NOT COMPLETED|Randomization||2
6324903|NCT00480493|7231027|FG000|STARTED|Overall Study||32
6324904|NCT00480493|7231028|FG001|STARTED|Overall Study||28
6324905|NCT00480493|7231027|FG000|Randomized|Overall Study||32
6324906|NCT00480493|7231028|FG001|Randomized|Overall Study||28
6324907|NCT00480493|7231027|FG000|COMPLETED|Overall Study||30
6324908|NCT00480493|7231028|FG001|COMPLETED|Overall Study||21
6324909|NCT00480493|7231027|FG000|NOT COMPLETED|Overall Study||2
6324910|NCT00480493|7231028|FG001|NOT COMPLETED|Overall Study||7
6324911|NCT00480532|7231040|FG000|STARTED|Overall Study||33
6324912|NCT00480532|7231041|FG001|STARTED|Overall Study||33
6324913|NCT00480532|7231042|FG002|STARTED|Overall Study||33
6324914|NCT00480532|7231043|FG003|STARTED|Overall Study||32
6324915|NCT00480532|7231040|FG000|COMPLETED|Overall Study||31
6324916|NCT00480532|7231041|FG001|COMPLETED|Overall Study||29
6324917|NCT00480532|7231042|FG002|COMPLETED|Overall Study||29
6324918|NCT00480532|7231043|FG003|COMPLETED|Overall Study||31
6324919|NCT00480532|7231040|FG000|NOT COMPLETED|Overall Study||2
6324920|NCT00480532|7231041|FG001|NOT COMPLETED|Overall Study||4
6324921|NCT00480532|7231042|FG002|NOT COMPLETED|Overall Study||4
6324922|NCT00480532|7231043|FG003|NOT COMPLETED|Overall Study||1
6324923|NCT00480636|7231053|FG000|STARTED|Overall Study||102
6324924|NCT00480636|7231053|FG000|COMPLETED|Overall Study||83
6324925|NCT00480636|7231053|FG000|NOT COMPLETED|Overall Study||19
6324926|NCT00480740|7231060|FG000|STARTED|Overall Study||26
6324927|NCT00480740|7231061|FG001|STARTED|Overall Study||9
6324928|NCT00480740|7231062|FG002|STARTED|Overall Study||6
6324929|NCT00480740|7231060|FG000|COMPLETED|Overall Study||26
6324930|NCT00480740|7231061|FG001|COMPLETED|Overall Study||9
6324931|NCT00480740|7231062|FG002|COMPLETED|Overall Study||6
6324932|NCT00480740|7231060|FG000|NOT COMPLETED|Overall Study||0
6324933|NCT00480740|7231061|FG001|NOT COMPLETED|Overall Study||0
6324934|NCT00480740|7231062|FG002|NOT COMPLETED|Overall Study||0
6324935|NCT00480779|7231072|FG000|STARTED|Overall Study||26
6324936|NCT00480779|7231073|FG001|STARTED|Overall Study||22
6324937|NCT00480779|7231072|FG000|COMPLETED|Overall Study||24
6324938|NCT00480779|7231073|FG001|COMPLETED|Overall Study||19
6324939|NCT00480779|7231072|FG000|NOT COMPLETED|Overall Study||2
6324940|NCT00480779|7231073|FG001|NOT COMPLETED|Overall Study||3
6324941|NCT00480857|7231079|FG000|STARTED|Overall Study||19
6324942|NCT00480857|7231079|FG000|COMPLETED|Overall Study||17
6324943|NCT00480857|7231079|FG000|NOT COMPLETED|Overall Study||2
6324944|NCT00480987|7231083|FG000|STARTED|Overall Study||27
6324945|NCT00480987|7231083|FG000|COMPLETED|Overall Study||27
6324946|NCT00480987|7231083|FG000|NOT COMPLETED|Overall Study||0
6324947|NCT00481065|7231095|FG000|STARTED|Overall Study||51
6324948|NCT00481065|7231096|FG001|STARTED|Overall Study||50
6324949|NCT00481065|7231097|FG002|STARTED|Overall Study||51
6324950|NCT00481065|7231098|FG003|STARTED|Overall Study||52
6324951|NCT00481065|7231099|FG004|STARTED|Overall Study||51
6324952|NCT00481065|7231100|FG005|STARTED|Overall Study||51
6324953|NCT00481065|7231101|FG006|STARTED|Overall Study||50
6324954|NCT00481065|7231102|FG007|STARTED|Overall Study||49
6324955|NCT00481065|7231095|FG000|COMPLETED|Overall Study||29
6324956|NCT00481065|7231096|FG001|COMPLETED|Overall Study||33
6324957|NCT00481065|7231097|FG002|COMPLETED|Overall Study||32
6324958|NCT00481065|7231098|FG003|COMPLETED|Overall Study||37
6324959|NCT00481065|7231099|FG004|COMPLETED|Overall Study||28
6324960|NCT00481065|7231100|FG005|COMPLETED|Overall Study||27
6558225|NCT01774760|7480942|FG000|COMPLETED|Overall Study||10
6558226|NCT01774760|7480942|FG000|NOT COMPLETED|Overall Study||0
6324961|NCT00481065|7231101|FG006|COMPLETED|Overall Study||34
6324962|NCT00481065|7231102|FG007|COMPLETED|Overall Study||30
6324963|NCT00481065|7231095|FG000|NOT COMPLETED|Overall Study||22
6324964|NCT00481065|7231096|FG001|NOT COMPLETED|Overall Study||17
6324965|NCT00481065|7231097|FG002|NOT COMPLETED|Overall Study||19
6324966|NCT00481065|7231098|FG003|NOT COMPLETED|Overall Study||15
6324967|NCT00481065|7231099|FG004|NOT COMPLETED|Overall Study||23
6324968|NCT00481065|7231100|FG005|NOT COMPLETED|Overall Study||24
6324969|NCT00481065|7231101|FG006|NOT COMPLETED|Overall Study||16
6324970|NCT00481065|7231102|FG007|NOT COMPLETED|Overall Study||19
6324971|NCT00481078|7231124|FG000|STARTED|Overall Study||62
6324972|NCT00481078|7231125|FG001|STARTED|Overall Study||32
6324973|NCT00481078|7231124|FG000|COMPLETED|Overall Study||20
6324974|NCT00481078|7231125|FG001|COMPLETED|Overall Study||12
6324975|NCT00481078|7231124|FG000|NOT COMPLETED|Overall Study||42
6324976|NCT00481078|7231125|FG001|NOT COMPLETED|Overall Study||20
6324977|NCT00481195|7231133|FG000|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
6324978|NCT00481195|7231134|FG001|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
6324979|NCT00481195|7231133|FG000|COMPLETED|Overall Study||89
6324980|NCT00481195|7231134|FG001|COMPLETED|Overall Study||90
6324981|NCT00481195|7231133|FG000|NOT COMPLETED|Overall Study||39
6324982|NCT00481195|7231134|FG001|NOT COMPLETED|Overall Study||39
6324983|NCT00481247|7231142|FG000|STARTED|Overall Study|Randomized|259
6324984|NCT00481247|7231143|FG001|STARTED|Overall Study|Randomized|260
6324985|NCT00481247|7231142|FG000|Received Treatment|Overall Study||258
6324986|NCT00481247|7231143|FG001|Received Treatment|Overall Study||258
6324987|NCT00481247|7231142|FG000|COMPLETED|Overall Study||0
6324988|NCT00481247|7231143|FG001|COMPLETED|Overall Study||0
6324989|NCT00481247|7231142|FG000|NOT COMPLETED|Overall Study||259
6324990|NCT00481247|7231143|FG001|NOT COMPLETED|Overall Study||260
6324991|NCT00481351|7231151|FG000|STARTED|Overall Study||13
6324992|NCT00481351|7231152|FG001|STARTED|Overall Study||12
6324993|NCT00481351|7231151|FG000|COMPLETED|Overall Study||13
6324994|NCT00481351|7231152|FG001|COMPLETED|Overall Study||12
6324995|NCT00481351|7231151|FG000|NOT COMPLETED|Overall Study||0
6324996|NCT00481351|7231152|FG001|NOT COMPLETED|Overall Study||0
6324997|NCT00481507|7231160|FG000|STARTED|Overall Study||64
6324998|NCT00481507|7231161|FG001|STARTED|Overall Study||61
6324999|NCT00481507|7231160|FG000|COMPLETED|Overall Study||64
6325000|NCT00481507|7231161|FG001|COMPLETED|Overall Study||61
6325001|NCT00481507|7231160|FG000|NOT COMPLETED|Overall Study||0
6325002|NCT00481507|7231161|FG001|NOT COMPLETED|Overall Study||0
6325003|NCT00481676|7231169|FG000|STARTED|Overall Study||27
6325004|NCT00481676|7231170|FG001|STARTED|Overall Study||22
6325005|NCT00481676|7231169|FG000|COMPLETED|Overall Study||25
6325006|NCT00481676|7231170|FG001|COMPLETED|Overall Study||17
6325007|NCT00481676|7231169|FG000|NOT COMPLETED|Overall Study||2
6325008|NCT00481676|7231170|FG001|NOT COMPLETED|Overall Study||5
6325009|NCT00481767|7231178|FG000|STARTED|Overall Study||450
6325010|NCT00481767|7231179|FG001|STARTED|Overall Study||226
6325011|NCT00481767|7231178|FG000|COMPLETED|Overall Study||418
6325012|NCT00481767|7231179|FG001|COMPLETED|Overall Study||205
6325013|NCT00481767|7231178|FG000|NOT COMPLETED|Overall Study||32
6325014|NCT00481767|7231179|FG001|NOT COMPLETED|Overall Study||21
6325015|NCT00481832|7231185|FG000|STARTED|Enrollment||50
6325016|NCT00481832|7231185|FG000|COMPLETED|Enrollment||40
6325017|NCT00481832|7231185|FG000|NOT COMPLETED|Enrollment||10
6325018|NCT00481832|7231185|FG000|STARTED|Autologous Hematopoietic Cell Transplant||40
6325019|NCT00481832|7231185|FG000|COMPLETED|Autologous Hematopoietic Cell Transplant||40
6325020|NCT00481832|7231185|FG000|NOT COMPLETED|Autologous Hematopoietic Cell Transplant||0
6325021|NCT00481832|7231185|FG000|STARTED|Inter-transplant Period||40
6325022|NCT00481832|7231185|FG000|COMPLETED|Inter-transplant Period||13
6325023|NCT00481832|7231185|FG000|NOT COMPLETED|Inter-transplant Period||27
6325024|NCT00481832|7231185|FG000|STARTED|Allogenic Hematopoietic Cell Transplant||13
6325025|NCT00481832|7231185|FG000|COMPLETED|Allogenic Hematopoietic Cell Transplant||13
6325026|NCT00481832|7231185|FG000|NOT COMPLETED|Allogenic Hematopoietic Cell Transplant||0
6325027|NCT00481845|7231191|FG000|STARTED|Overall Study||1
6325028|NCT00481845|7231192|FG001|STARTED|Overall Study||0
6325029|NCT00481845|7231191|FG000|COMPLETED|Overall Study||1
6325030|NCT00481845|7231192|FG001|COMPLETED|Overall Study||0
6325031|NCT00481845|7231191|FG000|NOT COMPLETED|Overall Study||0
6325032|NCT00481845|7231192|FG001|NOT COMPLETED|Overall Study||0
6375764|NCT00757601|7286368|FG011|NOT COMPLETED|Period 3||0
6375765|NCT00757601|7286357|FG000|STARTED|Period 4||2
6375766|NCT00757601|7286358|FG001|STARTED|Period 4||2
6375767|NCT00757601|7286359|FG002|STARTED|Period 4||2
6375768|NCT00757601|7286360|FG003|STARTED|Period 4||2
6375769|NCT00757601|7286361|FG004|STARTED|Period 4||2
6375770|NCT00757601|7286362|FG005|STARTED|Period 4||2
6375771|NCT00757601|7286363|FG006|STARTED|Period 4||2
6375772|NCT00757601|7286364|FG007|STARTED|Period 4||2
6375773|NCT00757601|7286365|FG008|STARTED|Period 4||2
6375774|NCT00757601|7286366|FG009|STARTED|Period 4||2
6375775|NCT00757601|7286367|FG010|STARTED|Period 4||2
6375776|NCT00757601|7286368|FG011|STARTED|Period 4||2
6375777|NCT00757601|7286357|FG000|COMPLETED|Period 4||2
6375778|NCT00757601|7286358|FG001|COMPLETED|Period 4||2
6375779|NCT00757601|7286359|FG002|COMPLETED|Period 4||2
6375780|NCT00757601|7286360|FG003|COMPLETED|Period 4||2
6375781|NCT00757601|7286361|FG004|COMPLETED|Period 4||2
6375782|NCT00757601|7286362|FG005|COMPLETED|Period 4||2
6375783|NCT00757601|7286363|FG006|COMPLETED|Period 4||2
6375784|NCT00757601|7286364|FG007|COMPLETED|Period 4||2
6375785|NCT00757601|7286365|FG008|COMPLETED|Period 4||2
6375786|NCT00757601|7286366|FG009|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
6375787|NCT00757601|7286367|FG010|COMPLETED|Period 4||2
6375788|NCT00757601|7286368|FG011|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
6375789|NCT00757601|7286357|FG000|NOT COMPLETED|Period 4||0
6375790|NCT00757601|7286358|FG001|NOT COMPLETED|Period 4||0
6375791|NCT00757601|7286359|FG002|NOT COMPLETED|Period 4||0
6375792|NCT00757601|7286360|FG003|NOT COMPLETED|Period 4||0
6375793|NCT00757601|7286361|FG004|NOT COMPLETED|Period 4||0
6375794|NCT00757601|7286362|FG005|NOT COMPLETED|Period 4||0
6375795|NCT00757601|7286363|FG006|NOT COMPLETED|Period 4||0
6375796|NCT00757601|7286364|FG007|NOT COMPLETED|Period 4||0
6375797|NCT00757601|7286365|FG008|NOT COMPLETED|Period 4||0
6375798|NCT00757601|7286366|FG009|NOT COMPLETED|Period 4||1
6375799|NCT00757601|7286367|FG010|NOT COMPLETED|Period 4||0
6375800|NCT00757601|7286368|FG011|NOT COMPLETED|Period 4||1
6375801|NCT00757601|7286357|FG000|STARTED|Period 5||2
6375802|NCT00757601|7286358|FG001|STARTED|Period 5||2
6375803|NCT00757601|7286359|FG002|STARTED|Period 5||2
6375804|NCT00757601|7286360|FG003|STARTED|Period 5||2
6375805|NCT00757601|7286361|FG004|STARTED|Period 5||2
6375806|NCT00757601|7286362|FG005|STARTED|Period 5||2
6375807|NCT00757601|7286363|FG006|STARTED|Period 5||2
6375808|NCT00757601|7286364|FG007|STARTED|Period 5||2
6375809|NCT00757601|7286365|FG008|STARTED|Period 5||2
6375810|NCT00757601|7286366|FG009|STARTED|Period 5||1
6375811|NCT00757601|7286367|FG010|STARTED|Period 5||2
6325033|NCT00481871|7231203|FG000|STARTED|Overall Study||7
6325034|NCT00481871|7231204|FG001|STARTED|Overall Study||10
6325035|NCT00481871|7231205|FG002|STARTED|Overall Study||18
6325036|NCT00481871|7231206|FG003|STARTED|Overall Study||38
6325037|NCT00481871|7231207|FG004|STARTED|Overall Study||34
6558227|NCT01774786|7480948|FG000|STARTED|Overall Study||388
6558228|NCT01774786|7480949|FG001|STARTED|Overall Study||392
6558229|NCT01774786|7480948|FG000|Did Not Receive Any Study Treatment|Overall Study|2 patients found ineligible after enrollment and 2 patients died before treatment.|4
6558230|NCT01774786|7480949|FG001|Did Not Receive Any Study Treatment|Overall Study|All 3 patients found ineligible for the study after enrollment and before treatment.|3
6558231|NCT01774786|7480948|FG000|Received at Least One Dose of Pertuzumab|Overall Study||384
6558232|NCT01774786|7480949|FG001|Received at Least One Dose of Pertuzumab|Overall Study|One participant randomized to placebo arm received 1 dose of pertuzumab by error.|1
6558233|NCT01774786|7480948|FG000|Received Placebo (No Pertuzumab)|Overall Study||0
6558234|NCT01774786|7480949|FG001|Received Placebo (No Pertuzumab)|Overall Study||388
6558235|NCT01774786|7480948|FG000|COMPLETED|Overall Study||60
6325038|NCT00481871|7231203|FG000|COMPLETED|Overall Study||7
6325039|NCT00481871|7231204|FG001|COMPLETED|Overall Study||10
6325040|NCT00481871|7231205|FG002|COMPLETED|Overall Study||17
6325041|NCT00481871|7231206|FG003|COMPLETED|Overall Study||38
6325042|NCT00481871|7231207|FG004|COMPLETED|Overall Study||34
6325043|NCT00481871|7231203|FG000|NOT COMPLETED|Overall Study||0
6325044|NCT00481871|7231204|FG001|NOT COMPLETED|Overall Study||0
6325045|NCT00481871|7231205|FG002|NOT COMPLETED|Overall Study||1
6325046|NCT00481871|7231206|FG003|NOT COMPLETED|Overall Study||0
6325047|NCT00481871|7231207|FG004|NOT COMPLETED|Overall Study||0
6325048|NCT00481988|7231217|FG000|STARTED|Overall Study||12
6325049|NCT00481988|7231218|FG001|STARTED|Overall Study|one patient was dropped from the study before randomization|9
6325050|NCT00481988|7231217|FG000|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
6325051|NCT00481988|7231218|FG001|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
6325052|NCT00481988|7231217|FG000|COMPLETED|Overall Study||11
6558236|NCT01774786|7480949|FG001|COMPLETED|Overall Study||46
6558237|NCT01774786|7480948|FG000|NOT COMPLETED|Overall Study||328
6325053|NCT00481988|7231218|FG001|COMPLETED|Overall Study||8
6325054|NCT00481988|7231217|FG000|NOT COMPLETED|Overall Study||1
6325055|NCT00481988|7231218|FG001|NOT COMPLETED|Overall Study||1
6325056|NCT00482001|7231226|FG000|STARTED|Overall Study||11
6325057|NCT00482001|7231227|FG001|STARTED|Overall Study||11
6325058|NCT00482001|7231226|FG000|COMPLETED|Overall Study||10
6325059|NCT00482001|7231227|FG001|COMPLETED|Overall Study||10
6325060|NCT00482001|7231226|FG000|NOT COMPLETED|Overall Study||1
6325061|NCT00482001|7231227|FG001|NOT COMPLETED|Overall Study||1
6325062|NCT00482014|7231239|FG000|STARTED|Overall Study||9
6325063|NCT00482014|7231240|FG001|STARTED|Overall Study||13
6325064|NCT00482014|7231241|FG002|STARTED|Overall Study||46
6325065|NCT00482014|7231242|FG003|STARTED|Overall Study||52
6325066|NCT00482014|7231239|FG000|COMPLETED|Overall Study||2
6325067|NCT00482014|7231240|FG001|COMPLETED|Overall Study||7
6325068|NCT00482014|7231241|FG002|COMPLETED|Overall Study||35
6325069|NCT00482014|7231242|FG003|COMPLETED|Overall Study||29
6325070|NCT00482014|7231239|FG000|NOT COMPLETED|Overall Study||7
6325071|NCT00482014|7231240|FG001|NOT COMPLETED|Overall Study||6
6325072|NCT00482014|7231241|FG002|NOT COMPLETED|Overall Study||11
6325073|NCT00482014|7231242|FG003|NOT COMPLETED|Overall Study||23
6325074|NCT00482053|7231254|FG000|STARTED|Autologous Peripheral Stem Cells||3
6325075|NCT00482053|7231254|FG000|COMPLETED|Autologous Peripheral Stem Cells||3
6325076|NCT00482053|7231254|FG000|NOT COMPLETED|Autologous Peripheral Stem Cells||0
6325077|NCT00482053|7231254|FG000|STARTED|Inter-treatment Period||3
6325078|NCT00482053|7231254|FG000|COMPLETED|Inter-treatment Period||2
6325079|NCT00482053|7231254|FG000|NOT COMPLETED|Inter-treatment Period||1
6325080|NCT00482053|7231254|FG000|STARTED|Allogeneic Peripheral Stem Cells||2
6325081|NCT00482053|7231254|FG000|COMPLETED|Allogeneic Peripheral Stem Cells||2
6325082|NCT00482053|7231254|FG000|NOT COMPLETED|Allogeneic Peripheral Stem Cells||0
6325083|NCT00482170|7231260|FG000|STARTED|Overall Study||207
6325084|NCT00482170|7231261|FG001|STARTED|Overall Study||214
6325085|NCT00482170|7231260|FG000|Treated|Overall Study||207
6325086|NCT00482170|7231261|FG001|Treated|Overall Study||211
6325087|NCT00482170|7231260|FG000|COMPLETED|Overall Study||192
6325088|NCT00482170|7231261|FG001|COMPLETED|Overall Study||194
6325089|NCT00482170|7231260|FG000|NOT COMPLETED|Overall Study||15
6325090|NCT00482170|7231261|FG001|NOT COMPLETED|Overall Study||20
6325091|NCT00482274|7231267|FG000|STARTED|Overall Study||3
6325092|NCT00482274|7231267|FG000|COMPLETED|Overall Study||2
6325093|NCT00482274|7231267|FG000|NOT COMPLETED|Overall Study||1
6325094|NCT00482391|7231271|FG000|STARTED|Overall Study||95
6325095|NCT00482391|7231271|FG000|COMPLETED|Overall Study||92
6325096|NCT00482391|7231271|FG000|NOT COMPLETED|Overall Study||3
6325097|NCT00482547|7231278|FG000|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
6325098|NCT00482547|7231279|FG001|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
6325099|NCT00482547|7231278|FG000|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
6325100|NCT00482547|7231279|FG001|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
6375812|NCT00757601|7286368|FG011|STARTED|Period 5||1
6375813|NCT00757601|7286357|FG000|COMPLETED|Period 5||2
6325101|NCT00482547|7231278|FG000|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
6325102|NCT00482547|7231279|FG001|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
6325103|NCT00482547|7231278|FG000|COMPLETED|Overall Study||426
6325104|NCT00482547|7231279|FG001|COMPLETED|Overall Study||428
6325105|NCT00482547|7231278|FG000|NOT COMPLETED|Overall Study||173
6325106|NCT00482547|7231279|FG001|NOT COMPLETED|Overall Study||161
6325107|NCT00482612|7231289|FG000|STARTED|In-treatment Period||137
6325108|NCT00482612|7231290|FG001|STARTED|In-treatment Period||125
6325109|NCT00482612|7231291|FG002|STARTED|In-treatment Period||129
6325110|NCT00482612|7231292|FG003|STARTED|In-treatment Period||135
6325111|NCT00482612|7231289|FG000|Treated|In-treatment Period||137
6325112|NCT00482612|7231290|FG001|Treated|In-treatment Period||125
6325113|NCT00482612|7231291|FG002|Treated|In-treatment Period||128
6325114|NCT00482612|7231292|FG003|Treated|In-treatment Period||135
6325115|NCT00482612|7231289|FG000|COMPLETED|In-treatment Period||137
6325116|NCT00482612|7231290|FG001|COMPLETED|In-treatment Period||125
6325117|NCT00482612|7231291|FG002|COMPLETED|In-treatment Period||128
6325118|NCT00482612|7231292|FG003|COMPLETED|In-treatment Period||135
6325119|NCT00482612|7231289|FG000|NOT COMPLETED|In-treatment Period||0
6325120|NCT00482612|7231290|FG001|NOT COMPLETED|In-treatment Period||0
6325121|NCT00482612|7231291|FG002|NOT COMPLETED|In-treatment Period||1
6325122|NCT00482612|7231292|FG003|NOT COMPLETED|In-treatment Period||0
6325123|NCT00482612|7231289|FG000|STARTED|Follow-up Period||137
6325124|NCT00482612|7231290|FG001|STARTED|Follow-up Period||125
6325125|NCT00482612|7231291|FG002|STARTED|Follow-up Period||128
6325126|NCT00482612|7231292|FG003|STARTED|Follow-up Period||135
6325127|NCT00482612|7231289|FG000|COMPLETED|Follow-up Period||123
6325128|NCT00482612|7231290|FG001|COMPLETED|Follow-up Period||107
6325129|NCT00482612|7231291|FG002|COMPLETED|Follow-up Period||106
6325130|NCT00482612|7231292|FG003|COMPLETED|Follow-up Period||127
6325131|NCT00482612|7231289|FG000|NOT COMPLETED|Follow-up Period||14
6325132|NCT00482612|7231290|FG001|NOT COMPLETED|Follow-up Period||18
6325133|NCT00482612|7231291|FG002|NOT COMPLETED|Follow-up Period||22
6325134|NCT00482612|7231292|FG003|NOT COMPLETED|Follow-up Period||8
6325135|NCT00482625|7231306|FG000|STARTED|Overall Study||6
6325136|NCT00482625|7231306|FG000|COMPLETED|Overall Study||6
6325137|NCT00482625|7231306|FG000|NOT COMPLETED|Overall Study||0
6325138|NCT00482677|7231312|FG000|STARTED|Overall Study||281
6325139|NCT00482677|7231313|FG001|STARTED|Overall Study||281
6325140|NCT00482677|7231312|FG000|COMPLETED|Overall Study||281
6325141|NCT00482677|7231313|FG001|COMPLETED|Overall Study||281
6325142|NCT00482677|7231312|FG000|NOT COMPLETED|Overall Study||0
6325143|NCT00482677|7231313|FG001|NOT COMPLETED|Overall Study||0
6325144|NCT00482703|7231321|FG000|STARTED|Overall Study|number enrolled, randomized and treated|11
6325145|NCT00482703|7231322|FG001|STARTED|Overall Study|number enrolled, randomized and treated|12
6325146|NCT00482703|7231321|FG000|COMPLETED|Overall Study||10
6325147|NCT00482703|7231322|FG001|COMPLETED|Overall Study||12
6325148|NCT00482703|7231321|FG000|NOT COMPLETED|Overall Study||1
6325149|NCT00482703|7231322|FG001|NOT COMPLETED|Overall Study||0
6325150|NCT00482729|7231337|FG000|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
6325151|NCT00482729|7231338|FG001|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
6325152|NCT00482729|7231337|FG000|Completed Phase A|Overall Study||484
6325153|NCT00482729|7231338|FG001|Completed Phase A|Overall Study||482
6325154|NCT00482729|7231337|FG000|Completed Phase B|Overall Study||409
6325155|NCT00482729|7231338|FG001|Completed Phase B|Overall Study||406
6325156|NCT00482729|7231337|FG000|COMPLETED|Overall Study||409
6325157|NCT00482729|7231338|FG001|COMPLETED|Overall Study||406
6325158|NCT00482729|7231337|FG000|NOT COMPLETED|Overall Study||217
6325159|NCT00482729|7231338|FG001|NOT COMPLETED|Overall Study||218
6325160|NCT00482911|7231346|FG000|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
6325161|NCT00482911|7231347|FG001|STARTED|Dosing Schedule 1: Len & Cyc||0
6325162|NCT00482911|7231346|FG000|COMPLETED|Dosing Schedule 1: Len & Cyc||3
6325163|NCT00482911|7231347|FG001|COMPLETED|Dosing Schedule 1: Len & Cyc||0
6325164|NCT00482911|7231346|FG000|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
6325165|NCT00482911|7231347|FG001|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
6325166|NCT00482911|7231346|FG000|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
6325167|NCT00482911|7231347|FG001|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
6558238|NCT01774786|7480949|FG001|NOT COMPLETED|Overall Study||346
6558239|NCT01774799|7480959|FG000|STARTED|Overall Study||212
6325168|NCT00482911|7231346|FG000|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
6325169|NCT00482911|7231347|FG001|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
6325170|NCT00482911|7231346|FG000|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
6325171|NCT00482911|7231347|FG001|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
6325172|NCT00482911|7231346|FG000|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
6325173|NCT00482911|7231347|FG001|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
6325174|NCT00482911|7231346|FG000|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
6325175|NCT00482911|7231347|FG001|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
6325176|NCT00482911|7231346|FG000|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
6325177|NCT00482911|7231347|FG001|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
6325178|NCT00483002|7231353|FG000|STARTED|Overall Study||3719
6325179|NCT00483002|7231353|FG000|COMPLETED|Overall Study||1165
6325180|NCT00483002|7231353|FG000|NOT COMPLETED|Overall Study||2554
6325181|NCT00483041|7231359|FG000|STARTED|Overall Study||5
6325182|NCT00483041|7231360|FG001|STARTED|Overall Study||6
6325183|NCT00483041|7231359|FG000|COMPLETED|Overall Study||5
6325184|NCT00483041|7231360|FG001|COMPLETED|Overall Study||5
6325185|NCT00483041|7231359|FG000|NOT COMPLETED|Overall Study||0
6325186|NCT00483041|7231360|FG001|NOT COMPLETED|Overall Study||1
6325187|NCT00483184|7231369|FG000|STARTED|Overall Study||27
6325188|NCT00483184|7231370|FG001|STARTED|Overall Study||31
6325189|NCT00483184|7231371|FG002|STARTED|Overall Study||26
6325190|NCT00483184|7231369|FG000|COMPLETED|Overall Study||22
6325191|NCT00483184|7231370|FG001|COMPLETED|Overall Study||27
6325192|NCT00483184|7231371|FG002|COMPLETED|Overall Study||23
6325193|NCT00483184|7231369|FG000|NOT COMPLETED|Overall Study||5
6325194|NCT00483184|7231370|FG001|NOT COMPLETED|Overall Study||4
6325195|NCT00483184|7231371|FG002|NOT COMPLETED|Overall Study||3
6325196|NCT00483223|7231379|FG000|STARTED|Overall Study||86
6325197|NCT00483223|7231379|FG000|COMPLETED|Overall Study||86
6325198|NCT00483223|7231379|FG000|NOT COMPLETED|Overall Study||0
6325199|NCT00483262|7231385|FG000|STARTED|Overall Study||20
6325200|NCT00483262|7231386|FG001|STARTED|Overall Study||43
6325201|NCT00483262|7231385|FG000|COMPLETED|Overall Study||20
6325202|NCT00483262|7231386|FG001|COMPLETED|Overall Study||43
6325203|NCT00483262|7231385|FG000|NOT COMPLETED|Overall Study||0
6325204|NCT00483262|7231386|FG001|NOT COMPLETED|Overall Study||0
6325205|NCT00483327|7231396|FG000|STARTED|Overall Study||30
6325206|NCT00483327|7231396|FG000|COMPLETED|Overall Study||20
6325207|NCT00483327|7231396|FG000|NOT COMPLETED|Overall Study||10
6325208|NCT00483379|7231404|FG000|STARTED|Treatment Period||6
6325209|NCT00483379|7231405|FG001|STARTED|Treatment Period||7
6325210|NCT00483379|7231404|FG000|COMPLETED|Treatment Period||4
6325211|NCT00483379|7231405|FG001|COMPLETED|Treatment Period||7
6325212|NCT00483379|7231404|FG000|NOT COMPLETED|Treatment Period||2
6325213|NCT00483379|7231405|FG001|NOT COMPLETED|Treatment Period||0
6325214|NCT00483379|7231404|FG000|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
6325215|NCT00483379|7231405|FG001|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
6325216|NCT00483379|7231404|FG000|COMPLETED|Extension Period||1
6325217|NCT00483379|7231405|FG001|COMPLETED|Extension Period||2
6325218|NCT00483379|7231404|FG000|NOT COMPLETED|Extension Period||0
6325219|NCT00483379|7231405|FG001|NOT COMPLETED|Extension Period||0
6325220|NCT00483405|7231413|FG000|STARTED|Overall Study||28
6325221|NCT00483405|7231413|FG000|COMPLETED|Overall Study||0
6325222|NCT00483405|7231413|FG000|NOT COMPLETED|Overall Study||28
6325223|NCT00483496|7231417|FG000|STARTED|Overall Study||16
6325224|NCT00483496|7231417|FG000|COMPLETED|Overall Study||15
6325225|NCT00483496|7231417|FG000|NOT COMPLETED|Overall Study||1
6325226|NCT00483509|7231429|FG000|STARTED|Overall Study||28
6325227|NCT00483509|7231429|FG000|COMPLETED|Overall Study||28
6325228|NCT00483509|7231429|FG000|NOT COMPLETED|Overall Study||0
6325229|NCT00483548|7231435|FG000|STARTED|Overall Study||148
6325230|NCT00483548|7231436|FG001|STARTED|Overall Study||150
6325231|NCT00483548|7231435|FG000|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
6325232|NCT00483548|7231436|FG001|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
6325233|NCT00483548|7231435|FG000|COMPLETED|Overall Study||88
6325234|NCT00483548|7231436|FG001|COMPLETED|Overall Study||104
6325235|NCT00483548|7231435|FG000|NOT COMPLETED|Overall Study||60
6325236|NCT00483548|7231436|FG001|NOT COMPLETED|Overall Study||46
6325237|NCT00483561|7231442|FG000|STARTED|Overall Study||26
6325238|NCT00483561|7231442|FG000|COMPLETED|Overall Study||15
6325239|NCT00483561|7231442|FG000|NOT COMPLETED|Overall Study||11
6325240|NCT00483574|7231448|FG000|STARTED|Overall Study||1053
6325241|NCT00483574|7231449|FG001|STARTED|Overall Study||321
6325242|NCT00483574|7231448|FG000|COMPLETED|Overall Study||951
6325243|NCT00483574|7231449|FG001|COMPLETED|Overall Study||308
6325244|NCT00483574|7231448|FG000|NOT COMPLETED|Overall Study||102
6325245|NCT00483574|7231449|FG001|NOT COMPLETED|Overall Study||13
6325246|NCT00483652|7231459|FG000|STARTED|Double-blind Treatment Period||120
6325247|NCT00483652|7231460|FG001|STARTED|Double-blind Treatment Period||119
6325248|NCT00483652|7231459|FG000|COMPLETED|Double-blind Treatment Period||113
6325249|NCT00483652|7231460|FG001|COMPLETED|Double-blind Treatment Period||114
6325250|NCT00483652|7231459|FG000|NOT COMPLETED|Double-blind Treatment Period||7
6325251|NCT00483652|7231460|FG001|NOT COMPLETED|Double-blind Treatment Period||5
6325252|NCT00483652|7231459|FG000|STARTED|Post-study Follow-up||113
6325253|NCT00483652|7231460|FG001|STARTED|Post-study Follow-up||114
6325254|NCT00483652|7231459|FG000|COMPLETED|Post-study Follow-up||113
6325255|NCT00483652|7231460|FG001|COMPLETED|Post-study Follow-up||114
6325256|NCT00483652|7231459|FG000|NOT COMPLETED|Post-study Follow-up||0
6325257|NCT00483652|7231460|FG001|NOT COMPLETED|Post-study Follow-up||0
6325258|NCT00483704|7231469|FG000|STARTED|Randomization||644
6325259|NCT00483704|7231470|FG001|STARTED|Randomization||645
6325260|NCT00483704|7231471|FG002|STARTED|Randomization||646
6325261|NCT00483704|7231469|FG000|COMPLETED|Randomization||573
6325262|NCT00483704|7231470|FG001|COMPLETED|Randomization||549
6325263|NCT00483704|7231471|FG002|COMPLETED|Randomization||555
6325264|NCT00483704|7231469|FG000|NOT COMPLETED|Randomization||71
6325265|NCT00483704|7231470|FG001|NOT COMPLETED|Randomization||96
6325266|NCT00483704|7231471|FG002|NOT COMPLETED|Randomization||91
6325267|NCT00483704|7231469|FG000|STARTED|Treatment||573
6325268|NCT00483704|7231470|FG001|STARTED|Treatment||549
6325269|NCT00483704|7231471|FG002|STARTED|Treatment||555
6325270|NCT00483704|7231469|FG000|COMPLETED|Treatment||444
6325271|NCT00483704|7231470|FG001|COMPLETED|Treatment||420
6325272|NCT00483704|7231471|FG002|COMPLETED|Treatment||399
6325273|NCT00483704|7231469|FG000|NOT COMPLETED|Treatment||129
6325274|NCT00483704|7231470|FG001|NOT COMPLETED|Treatment||129
6325275|NCT00483704|7231471|FG002|NOT COMPLETED|Treatment||156
6325276|NCT00483717|7231484|FG000|STARTED|Overall Study||87
6325277|NCT00483717|7231485|FG001|STARTED|Overall Study||86
6325278|NCT00483717|7231484|FG000|COMPLETED|Overall Study||63
6325279|NCT00483717|7231485|FG001|COMPLETED|Overall Study||65
6325280|NCT00483717|7231484|FG000|NOT COMPLETED|Overall Study||24
6325281|NCT00483717|7231485|FG001|NOT COMPLETED|Overall Study||21
6325282|NCT00483756|7231494|FG000|STARTED|Overall Study||110
6325283|NCT00483756|7231495|FG001|STARTED|Overall Study||110
6325284|NCT00483756|7231496|FG002|STARTED|Overall Study||111
6325285|NCT00483756|7231494|FG000|Treated|Overall Study||109
6325286|NCT00483756|7231495|FG001|Treated|Overall Study||106
6325287|NCT00483756|7231496|FG002|Treated|Overall Study||107
6325288|NCT00483756|7231494|FG000|COMPLETED|Overall Study||77
6325289|NCT00483756|7231495|FG001|COMPLETED|Overall Study||60
6325290|NCT00483756|7231496|FG002|COMPLETED|Overall Study||59
6325291|NCT00483756|7231494|FG000|NOT COMPLETED|Overall Study||33
6325292|NCT00483756|7231495|FG001|NOT COMPLETED|Overall Study||50
6325293|NCT00483756|7231496|FG002|NOT COMPLETED|Overall Study||52
6325294|NCT00483938|7231511|FG000|STARTED|Overall Study||41
6325295|NCT00483938|7231512|FG001|STARTED|Overall Study||43
6325296|NCT00483938|7231513|FG002|STARTED|Overall Study||30
6325297|NCT00483938|7231514|FG003|STARTED|Overall Study||31
6325298|NCT00483938|7231515|FG004|STARTED|Overall Study||25
6325299|NCT00483938|7231516|FG005|STARTED|Overall Study||26
6325300|NCT00483938|7231517|FG006|STARTED|Overall Study||40
6325301|NCT00483938|7231511|FG000|COMPLETED|Overall Study||36
6325302|NCT00483938|7231512|FG001|COMPLETED|Overall Study||24
6325303|NCT00483938|7231513|FG002|COMPLETED|Overall Study||30
6325304|NCT00483938|7231514|FG003|COMPLETED|Overall Study||25
6325305|NCT00483938|7231515|FG004|COMPLETED|Overall Study||23
6325306|NCT00483938|7231516|FG005|COMPLETED|Overall Study||18
6325307|NCT00483938|7231517|FG006|COMPLETED|Overall Study||0
6325308|NCT00483938|7231511|FG000|NOT COMPLETED|Overall Study||5
6325309|NCT00483938|7231512|FG001|NOT COMPLETED|Overall Study||19
6325310|NCT00483938|7231513|FG002|NOT COMPLETED|Overall Study||0
6325311|NCT00483938|7231514|FG003|NOT COMPLETED|Overall Study||6
6325312|NCT00483938|7231515|FG004|NOT COMPLETED|Overall Study||2
6325313|NCT00483938|7231516|FG005|NOT COMPLETED|Overall Study||8
6325314|NCT00483938|7231517|FG006|NOT COMPLETED|Overall Study||40
6325315|NCT00484094|7231536|FG000|STARTED|Overall Study||209
6325316|NCT00484094|7231536|FG000|COMPLETED|Overall Study||167
6325317|NCT00484094|7231536|FG000|NOT COMPLETED|Overall Study||42
6325318|NCT00484159|7231543|FG000|STARTED|Overall Study||50
6325319|NCT00484159|7231544|FG001|STARTED|Overall Study||50
6325320|NCT00484159|7231545|FG002|STARTED|Overall Study||51
6325321|NCT00484159|7231543|FG000|COMPLETED|Overall Study||49
6325322|NCT00484159|7231544|FG001|COMPLETED|Overall Study||49
6325323|NCT00484159|7231545|FG002|COMPLETED|Overall Study||51
6325324|NCT00484159|7231543|FG000|NOT COMPLETED|Overall Study||1
6325325|NCT00484159|7231544|FG001|NOT COMPLETED|Overall Study||1
6325326|NCT00484159|7231545|FG002|NOT COMPLETED|Overall Study||0
6325327|NCT00484185|7231553|FG000|STARTED|Overall Study||183
6325328|NCT00484185|7231553|FG000|Treated|Overall Study||178
6325329|NCT00484185|7231553|FG000|COMPLETED|Overall Study||112
6325330|NCT00484185|7231553|FG000|NOT COMPLETED|Overall Study||71
6325331|NCT00484198|7231561|FG000|STARTED|Overall Study||137
6325332|NCT00484198|7231562|FG001|STARTED|Overall Study||274
6325333|NCT00484198|7231563|FG002|STARTED|Overall Study||750
6325334|NCT00484198|7231564|FG003|STARTED|Overall Study||751
6325335|NCT00484198|7231561|FG000|COMPLETED|Overall Study||96
6325336|NCT00484198|7231562|FG001|COMPLETED|Overall Study||208
6325337|NCT00484198|7231563|FG002|COMPLETED|Overall Study||599
6325338|NCT00484198|7231564|FG003|COMPLETED|Overall Study||579
6325339|NCT00484198|7231561|FG000|NOT COMPLETED|Overall Study||41
6325340|NCT00484198|7231562|FG001|NOT COMPLETED|Overall Study||66
6325341|NCT00484198|7231563|FG002|NOT COMPLETED|Overall Study||151
6325342|NCT00484198|7231564|FG003|NOT COMPLETED|Overall Study||172
6325343|NCT00484289|7231582|FG000|STARTED|Long Term Phase||13
6325344|NCT00484289|7231583|FG001|STARTED|Long Term Phase||178
6325345|NCT00484289|7231584|FG002|STARTED|Long Term Phase||26
6325346|NCT00484289|7231582|FG000|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
6325347|NCT00484289|7231583|FG001|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
6325348|NCT00484289|7231584|FG002|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
6325349|NCT00484289|7231582|FG000|NOT COMPLETED|Long Term Phase||3
6325350|NCT00484289|7231583|FG001|NOT COMPLETED|Long Term Phase||36
6325351|NCT00484289|7231584|FG002|NOT COMPLETED|Long Term Phase||16
6325352|NCT00484289|7231582|FG000|STARTED|Post Marketing Phase||10
6325353|NCT00484289|7231583|FG001|STARTED|Post Marketing Phase||142
6325354|NCT00484289|7231584|FG002|STARTED|Post Marketing Phase||10
6325355|NCT00484289|7231582|FG000|COMPLETED|Post Marketing Phase||10
6325356|NCT00484289|7231583|FG001|COMPLETED|Post Marketing Phase||141
6325357|NCT00484289|7231584|FG002|COMPLETED|Post Marketing Phase||10
6325358|NCT00484289|7231582|FG000|NOT COMPLETED|Post Marketing Phase||0
6325359|NCT00484289|7231583|FG001|NOT COMPLETED|Post Marketing Phase||1
6325360|NCT00484289|7231584|FG002|NOT COMPLETED|Post Marketing Phase||0
6325361|NCT00484315|7231595|FG000|STARTED|12-Month Clinical Follow-up||942
6325362|NCT00484315|7231596|FG001|STARTED|12-Month Clinical Follow-up||320
6325363|NCT00484315|7231595|FG000|COMPLETED|12-Month Clinical Follow-up||914
6325364|NCT00484315|7231596|FG001|COMPLETED|12-Month Clinical Follow-up||311
6325365|NCT00484315|7231595|FG000|NOT COMPLETED|12-Month Clinical Follow-up||28
6325366|NCT00484315|7231596|FG001|NOT COMPLETED|12-Month Clinical Follow-up||9
6325367|NCT00484315|7231595|FG000|STARTED|9-Month Angiographic Follow-up||256
6325368|NCT00484315|7231596|FG001|STARTED|9-Month Angiographic Follow-up||74
6325369|NCT00484315|7231595|FG000|COMPLETED|9-Month Angiographic Follow-up||228
6558240|NCT01774799|7480960|FG001|STARTED|Overall Study||190
6558241|NCT01774799|7480961|FG002|STARTED|Overall Study||212
6558242|NCT01774799|7480962|FG003|STARTED|Overall Study||190
6558243|NCT01774799|7480959|FG000|COMPLETED|Overall Study||211
6558244|NCT01774799|7480960|FG001|COMPLETED|Overall Study||189
6558245|NCT01774799|7480961|FG002|COMPLETED|Overall Study||212
6558246|NCT01774799|7480962|FG003|COMPLETED|Overall Study||190
6558247|NCT01774799|7480959|FG000|NOT COMPLETED|Overall Study||1
6558248|NCT01774799|7480960|FG001|NOT COMPLETED|Overall Study||1
6558249|NCT01774799|7480961|FG002|NOT COMPLETED|Overall Study||0
6558250|NCT01774799|7480962|FG003|NOT COMPLETED|Overall Study||0
6558251|NCT01774851|7480970|FG000|STARTED|Overall Study||42
6558252|NCT01774851|7480971|FG001|STARTED|Overall Study||42
6558253|NCT01774851|7480970|FG000|COMPLETED|Overall Study||42
6558254|NCT01774851|7480971|FG001|COMPLETED|Overall Study||42
6558255|NCT01774851|7480970|FG000|NOT COMPLETED|Overall Study||0
6558256|NCT01774851|7480971|FG001|NOT COMPLETED|Overall Study||0
6558257|NCT01774903|7480977|FG000|STARTED|Overall Study||45
6558258|NCT01774903|7480977|FG000|COMPLETED|Overall Study||34
6558259|NCT01774903|7480977|FG000|NOT COMPLETED|Overall Study||11
6558260|NCT01774929|7480982|FG000|STARTED|Overall Study||35
6558261|NCT01774929|7480982|FG000|COMPLETED|Overall Study||32
6558262|NCT01774929|7480982|FG000|NOT COMPLETED|Overall Study||3
6558263|NCT01774968|7480988|FG000|STARTED|Overall Study||162
6558264|NCT01774968|7480989|FG001|STARTED|Overall Study||163
6558265|NCT01774968|7480988|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
6558266|NCT01774968|7480989|FG001|Received at Least 1 Dose of Study Drug|Overall Study||161
6558267|NCT01774968|7480988|FG000|COMPLETED|Overall Study||132
6558268|NCT01774968|7480989|FG001|COMPLETED|Overall Study||128
6558269|NCT01774968|7480988|FG000|NOT COMPLETED|Overall Study||30
6558270|NCT01774968|7480989|FG001|NOT COMPLETED|Overall Study||35
6558271|NCT01774981|7481003|FG000|STARTED|Overall Study||3
6558272|NCT01774981|7481004|FG001|STARTED|Overall Study||4
6325370|NCT00484315|7231596|FG001|COMPLETED|9-Month Angiographic Follow-up||61
6325371|NCT00484315|7231595|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||28
6325372|NCT00484315|7231596|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||13
6325373|NCT00484354|7231604|FG000|STARTED|Overall Study||64
6325374|NCT00484354|7231605|FG001|STARTED|Overall Study||59
6325375|NCT00484354|7231604|FG000|COMPLETED|Overall Study||63
6325376|NCT00484354|7231605|FG001|COMPLETED|Overall Study||57
6325377|NCT00484354|7231604|FG000|NOT COMPLETED|Overall Study||1
6325378|NCT00484354|7231605|FG001|NOT COMPLETED|Overall Study||2
6325379|NCT00484393|7231613|FG000|STARTED|Overall Study||4
6325380|NCT00484393|7231614|FG001|STARTED|Overall Study||3
6325381|NCT00484393|7231613|FG000|COMPLETED|Overall Study||4
6325382|NCT00484393|7231614|FG001|COMPLETED|Overall Study||3
6325383|NCT00484393|7231613|FG000|NOT COMPLETED|Overall Study||0
6325384|NCT00484393|7231614|FG001|NOT COMPLETED|Overall Study||0
6325385|NCT00484679|7231620|FG000|STARTED|Overall Study||18
6325386|NCT00484679|7231620|FG000|COMPLETED|Overall Study||15
6325387|NCT00484679|7231620|FG000|NOT COMPLETED|Overall Study||3
6325388|NCT00484874|7231624|FG000|STARTED|Overall Study||12
6325389|NCT00484874|7231624|FG000|COMPLETED|Overall Study||12
6325390|NCT00484874|7231624|FG000|NOT COMPLETED|Overall Study||0
6325391|NCT00484939|7231633|FG000|STARTED|Overall Study||140
6325392|NCT00484939|7231634|FG001|STARTED|Overall Study||140
6325393|NCT00484939|7231633|FG000|COMPLETED|Overall Study||0
6325394|NCT00484939|7231634|FG001|COMPLETED|Overall Study||0
6325395|NCT00484939|7231633|FG000|NOT COMPLETED|Overall Study||140
6325396|NCT00484939|7231634|FG001|NOT COMPLETED|Overall Study||140
6325397|NCT00485069|7231642|FG000|STARTED|Overall Study||65
6325398|NCT00485069|7231643|FG001|STARTED|Overall Study||58
6558273|NCT01774981|7481005|FG002|STARTED|Overall Study||4
6558274|NCT01774981|7481006|FG003|STARTED|Overall Study||4
6558275|NCT01774981|7481007|FG004|STARTED|Overall Study||6
6558276|NCT01774981|7481008|FG005|STARTED|Overall Study||14
6558277|NCT01774981|7481009|FG006|STARTED|Overall Study||13
6558278|NCT01774981|7481010|FG007|STARTED|Overall Study||12
6558279|NCT01774981|7481003|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6558280|NCT01774981|7481004|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
6558281|NCT01774981|7481005|FG002|Received at Least 1 Dose of Study Drug|Overall Study||4
6558282|NCT01774981|7481006|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
6558283|NCT01774981|7481007|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
6558284|NCT01774981|7481008|FG005|Received at Least 1 Dose of Study Drug|Overall Study||14
6558285|NCT01774981|7481009|FG006|Received at Least 1 Dose of Study Drug|Overall Study||13
6325399|NCT00485069|7231642|FG000|COMPLETED|Overall Study||47
6325400|NCT00485069|7231643|FG001|COMPLETED|Overall Study||46
6325401|NCT00485069|7231642|FG000|NOT COMPLETED|Overall Study||18
6325402|NCT00485069|7231643|FG001|NOT COMPLETED|Overall Study||12
6325403|NCT00485134|7231664|FG000|STARTED|Overall Study||12
6325404|NCT00485134|7231665|FG001|STARTED|Overall Study||12
6325405|NCT00485134|7231666|FG002|STARTED|Overall Study||12
6325406|NCT00485134|7231667|FG003|STARTED|Overall Study||8
6325407|NCT00485134|7231668|FG004|STARTED|Overall Study||10
6558286|NCT01774981|7481010|FG007|Received at Least 1 Dose of Study Drug|Overall Study||12
6558287|NCT01774981|7481003|FG000|COMPLETED|Overall Study||3
6558288|NCT01774981|7481004|FG001|COMPLETED|Overall Study||4
6558289|NCT01774981|7481005|FG002|COMPLETED|Overall Study||4
6558290|NCT01774981|7481006|FG003|COMPLETED|Overall Study||4
6558291|NCT01774981|7481007|FG004|COMPLETED|Overall Study||5
6558292|NCT01774981|7481008|FG005|COMPLETED|Overall Study||13
6558293|NCT01774981|7481009|FG006|COMPLETED|Overall Study||13
6558294|NCT01774981|7481010|FG007|COMPLETED|Overall Study||11
6558295|NCT01774981|7481003|FG000|NOT COMPLETED|Overall Study||0
6558296|NCT01774981|7481004|FG001|NOT COMPLETED|Overall Study||0
6558297|NCT01774981|7481005|FG002|NOT COMPLETED|Overall Study||0
6325408|NCT00485134|7231669|FG005|STARTED|Overall Study||7
6325409|NCT00485134|7231670|FG006|STARTED|Overall Study||31
6325410|NCT00485134|7231671|FG007|STARTED|Overall Study||21
6325411|NCT00485134|7231664|FG000|COMPLETED|Overall Study||11
6325412|NCT00485134|7231665|FG001|COMPLETED|Overall Study||10
6325413|NCT00485134|7231666|FG002|COMPLETED|Overall Study||9
6325414|NCT00485134|7231667|FG003|COMPLETED|Overall Study||7
6325415|NCT00485134|7231668|FG004|COMPLETED|Overall Study||7
6325416|NCT00485134|7231669|FG005|COMPLETED|Overall Study||3
6325417|NCT00485134|7231670|FG006|COMPLETED|Overall Study||28
6325418|NCT00485134|7231671|FG007|COMPLETED|Overall Study||20
6325419|NCT00485134|7231664|FG000|NOT COMPLETED|Overall Study||1
6325420|NCT00485134|7231665|FG001|NOT COMPLETED|Overall Study||2
6325421|NCT00485134|7231666|FG002|NOT COMPLETED|Overall Study||3
6325422|NCT00485134|7231667|FG003|NOT COMPLETED|Overall Study||1
6325423|NCT00485134|7231668|FG004|NOT COMPLETED|Overall Study||3
6325424|NCT00485134|7231669|FG005|NOT COMPLETED|Overall Study||4
6325425|NCT00485134|7231670|FG006|NOT COMPLETED|Overall Study||3
6325426|NCT00485134|7231671|FG007|NOT COMPLETED|Overall Study||1
6325427|NCT00485173|7231685|FG000|STARTED|Overall Study||224
6325428|NCT00485173|7231686|FG001|STARTED|Overall Study||486
6325429|NCT00485173|7231685|FG000|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
6325430|NCT00485173|7231686|FG001|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
6325431|NCT00485173|7231685|FG000|NOT COMPLETED|Overall Study||36
6325432|NCT00485173|7231686|FG001|NOT COMPLETED|Overall Study||64
6325433|NCT00485264|7231698|FG000|STARTED|Overall Study||71
6325434|NCT00485264|7231699|FG001|STARTED|Overall Study||16
6325435|NCT00485264|7231700|FG002|STARTED|Overall Study||18
6325436|NCT00485264|7231701|FG003|STARTED|Overall Study||21
6325437|NCT00485264|7231702|FG004|STARTED|Overall Study||15
6325438|NCT00485264|7231703|FG005|STARTED|Overall Study||12
6325439|NCT00485264|7231698|FG000|Completed Week 24|Overall Study||67
6325440|NCT00485264|7231699|FG001|Completed Week 24|Overall Study||16
6325441|NCT00485264|7231700|FG002|Completed Week 24|Overall Study||18
6325442|NCT00485264|7231701|FG003|Completed Week 24|Overall Study||21
6325443|NCT00485264|7231702|FG004|Completed Week 24|Overall Study||14
6325444|NCT00485264|7231703|FG005|Completed Week 24|Overall Study||11
6325445|NCT00485264|7231698|FG000|COMPLETED|Overall Study||35
6325446|NCT00485264|7231699|FG001|COMPLETED|Overall Study||9
6325447|NCT00485264|7231700|FG002|COMPLETED|Overall Study||12
6325448|NCT00485264|7231701|FG003|COMPLETED|Overall Study||17
6325449|NCT00485264|7231702|FG004|COMPLETED|Overall Study||9
6325450|NCT00485264|7231703|FG005|COMPLETED|Overall Study||5
6325451|NCT00485264|7231698|FG000|NOT COMPLETED|Overall Study||36
6325452|NCT00485264|7231699|FG001|NOT COMPLETED|Overall Study||7
6325453|NCT00485264|7231700|FG002|NOT COMPLETED|Overall Study||6
6325454|NCT00485264|7231701|FG003|NOT COMPLETED|Overall Study||4
6325455|NCT00485264|7231702|FG004|NOT COMPLETED|Overall Study||6
6325456|NCT00485264|7231703|FG005|NOT COMPLETED|Overall Study||7
6325457|NCT00485303|7231722|FG000|STARTED|Overall Study||58
6325458|NCT00485303|7231722|FG000|COMPLETED|Overall Study||2
6325459|NCT00485303|7231722|FG000|NOT COMPLETED|Overall Study||56
6325460|NCT00485433|7231730|FG000|STARTED|Overall Study||24
6325461|NCT00485433|7231731|FG001|STARTED|Overall Study||25
6325462|NCT00485433|7231732|FG002|STARTED|Overall Study||24
6325463|NCT00485433|7231733|FG003|STARTED|Overall Study||25
6325464|NCT00485433|7231730|FG000|COMPLETED|Overall Study||24
6325465|NCT00485433|7231731|FG001|COMPLETED|Overall Study||25
6325466|NCT00485433|7231732|FG002|COMPLETED|Overall Study||24
6325467|NCT00485433|7231733|FG003|COMPLETED|Overall Study||25
6325468|NCT00485433|7231730|FG000|NOT COMPLETED|Overall Study||0
6325469|NCT00485433|7231731|FG001|NOT COMPLETED|Overall Study||0
6558298|NCT01774981|7481006|FG003|NOT COMPLETED|Overall Study||0
6558299|NCT01774981|7481007|FG004|NOT COMPLETED|Overall Study||1
6558300|NCT01774981|7481008|FG005|NOT COMPLETED|Overall Study||1
6325470|NCT00485433|7231732|FG002|NOT COMPLETED|Overall Study||0
6325471|NCT00485433|7231733|FG003|NOT COMPLETED|Overall Study||0
6325472|NCT00485472|7231743|FG000|STARTED|Overall Study||73
6325473|NCT00485472|7231744|FG001|STARTED|Overall Study||76
6325474|NCT00485472|7231743|FG000|Entered Maintenance Phase|Overall Study||65
6325475|NCT00485472|7231744|FG001|Entered Maintenance Phase|Overall Study||67
6325476|NCT00485472|7231743|FG000|COMPLETED|Overall Study||57
6325477|NCT00485472|7231744|FG001|COMPLETED|Overall Study||64
6325478|NCT00485472|7231743|FG000|NOT COMPLETED|Overall Study||16
6325479|NCT00485472|7231744|FG001|NOT COMPLETED|Overall Study||12
6325480|NCT00485485|7231750|FG000|STARTED|Overall Study||7
6325481|NCT00485485|7231750|FG000|COMPLETED|Overall Study||7
6325482|NCT00485485|7231750|FG000|NOT COMPLETED|Overall Study||0
6325483|NCT00485589|7231757|FG000|STARTED|Overall Study||210
6325484|NCT00485589|7231758|FG001|STARTED|Overall Study||200
6325485|NCT00485589|7231759|FG002|STARTED|Overall Study||203
6325486|NCT00485589|7231757|FG000|COMPLETED|Overall Study||183
6325487|NCT00485589|7231758|FG001|COMPLETED|Overall Study||180
6325488|NCT00485589|7231759|FG002|COMPLETED|Overall Study||185
6325489|NCT00485589|7231757|FG000|NOT COMPLETED|Overall Study||27
6325490|NCT00485589|7231758|FG001|NOT COMPLETED|Overall Study||20
6325491|NCT00485589|7231759|FG002|NOT COMPLETED|Overall Study||18
6325492|NCT00485693|7231778|FG000|STARTED|Overall Study||34
6325493|NCT00485693|7231779|FG001|STARTED|Overall Study||104
6325494|NCT00485693|7231778|FG000|COMPLETED|Overall Study||34
6325495|NCT00485693|7231779|FG001|COMPLETED|Overall Study||104
6325496|NCT00485693|7231778|FG000|NOT COMPLETED|Overall Study||0
6325497|NCT00485693|7231779|FG001|NOT COMPLETED|Overall Study||0
6325498|NCT00485732|7231790|FG000|STARTED|Overall Study||149
6325499|NCT00485732|7231791|FG001|STARTED|Overall Study||76
6325500|NCT00485732|7231790|FG000|COMPLETED|Overall Study||141
6325501|NCT00485732|7231791|FG001|COMPLETED|Overall Study||67
6325502|NCT00485732|7231790|FG000|NOT COMPLETED|Overall Study||8
6325503|NCT00485732|7231791|FG001|NOT COMPLETED|Overall Study||9
6325504|NCT00485758|7231799|FG000|STARTED|Overall Study||454
6325505|NCT00485758|7231800|FG001|STARTED|Overall Study||342
6325506|NCT00485758|7231799|FG000|COMPLETED|Overall Study||298
6325507|NCT00485758|7231800|FG001|COMPLETED|Overall Study||277
6325508|NCT00485758|7231799|FG000|NOT COMPLETED|Overall Study||156
6325509|NCT00485758|7231800|FG001|NOT COMPLETED|Overall Study||65
6325510|NCT00485836|7231809|FG000|STARTED|Overall Study||130
6325511|NCT00485836|7231810|FG001|STARTED|Overall Study||132
6325512|NCT00485836|7231811|FG002|STARTED|Overall Study||130
6325513|NCT00485836|7231809|FG000|Received Study Drug (Safety Population)|Overall Study||129
6325514|NCT00485836|7231810|FG001|Received Study Drug (Safety Population)|Overall Study||132
6325515|NCT00485836|7231811|FG002|Received Study Drug (Safety Population)|Overall Study||129
6325516|NCT00485836|7231809|FG000|COMPLETED|Overall Study||115
6325517|NCT00485836|7231810|FG001|COMPLETED|Overall Study||129
6325518|NCT00485836|7231811|FG002|COMPLETED|Overall Study||119
6325519|NCT00485836|7231809|FG000|NOT COMPLETED|Overall Study||15
6325520|NCT00485836|7231810|FG001|NOT COMPLETED|Overall Study||3
6325521|NCT00485836|7231811|FG002|NOT COMPLETED|Overall Study||11
6325522|NCT00485953|7231821|FG000|STARTED|Overall Study||55
6325523|NCT00485953|7231822|FG001|STARTED|Overall Study||54
6325524|NCT00485953|7231821|FG000|COMPLETED|Overall Study||48
6325525|NCT00485953|7231822|FG001|COMPLETED|Overall Study||47
6325526|NCT00485953|7231821|FG000|NOT COMPLETED|Overall Study||7
6325527|NCT00485953|7231822|FG001|NOT COMPLETED|Overall Study||7
6325528|NCT00486018|7231833|FG000|STARTED|Overall Study||132
6325529|NCT00486018|7231834|FG001|STARTED|Overall Study||134
6325530|NCT00486018|7231835|FG002|STARTED|Overall Study||131
6325531|NCT00486018|7231833|FG000|Received Drug (Safety Population)|Overall Study||131
6325532|NCT00486018|7231834|FG001|Received Drug (Safety Population)|Overall Study||134
6325533|NCT00486018|7231835|FG002|Received Drug (Safety Population)|Overall Study||130
6325534|NCT00486018|7231833|FG000|COMPLETED|Overall Study||123
6325535|NCT00486018|7231834|FG001|COMPLETED|Overall Study||128
6325536|NCT00486018|7231835|FG002|COMPLETED|Overall Study||125
6325537|NCT00486018|7231833|FG000|NOT COMPLETED|Overall Study||9
6325538|NCT00486018|7231834|FG001|NOT COMPLETED|Overall Study||6
6325539|NCT00486018|7231835|FG002|NOT COMPLETED|Overall Study||6
6325540|NCT00486031|7231843|FG000|STARTED|Overall Study||443
6325541|NCT00486031|7231843|FG000|COMPLETED|Overall Study||440
6325542|NCT00486031|7231843|FG000|NOT COMPLETED|Overall Study||3
6325543|NCT00486044|7231850|FG000|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
6325544|NCT00486044|7231851|FG001|STARTED|Overall Study|23 in MRI sub-study|49
6325545|NCT00486044|7231850|FG000|COMPLETED|Overall Study|27 completed MRI sub-study|49
6325546|NCT00486044|7231851|FG001|COMPLETED|Overall Study|21 completed MRI sub-study|46
6325547|NCT00486044|7231850|FG000|NOT COMPLETED|Overall Study||2
6325548|NCT00486044|7231851|FG001|NOT COMPLETED|Overall Study||3
6325549|NCT00486226|7231857|FG000|STARTED|Overall Study||105
6325550|NCT00486226|7231857|FG000|COMPLETED|Overall Study||92
6325551|NCT00486226|7231857|FG000|NOT COMPLETED|Overall Study||13
6325552|NCT00486252|7231864|FG000|STARTED|Overall Study||996
6325553|NCT00486252|7231864|FG000|COMPLETED|Overall Study||938
6325554|NCT00486252|7231864|FG000|NOT COMPLETED|Overall Study||58
6325555|NCT00486265|7231870|FG000|STARTED|Overall Study|Partipants dosed on day 1.|9
6325556|NCT00486265|7231870|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
6325557|NCT00486265|7231870|FG000|NOT COMPLETED|Overall Study||9
6325558|NCT00486278|7231874|FG000|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
6325559|NCT00486278|7231874|FG000|COMPLETED|Overall Study||42
6325560|NCT00486278|7231874|FG000|NOT COMPLETED|Overall Study||9
6325561|NCT00486291|7231890|FG000|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
6325562|NCT00486291|7231891|FG001|STARTED|Overall Study|1 subject discontinued prior to first dose|105
6325563|NCT00486291|7231890|FG000|COMPLETED|Overall Study||89
6325564|NCT00486291|7231891|FG001|COMPLETED|Overall Study||76
6325565|NCT00486291|7231890|FG000|NOT COMPLETED|Overall Study||16
6325566|NCT00486291|7231891|FG001|NOT COMPLETED|Overall Study||29
6325567|NCT00486330|7231897|FG000|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
6325568|NCT00486330|7231897|FG000|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
6775201|NCT03876743|7703122|FG002|NOT COMPLETED|Overall Study||4
6775202|NCT03876743|7703123|FG003|NOT COMPLETED|Overall Study||7
6775203|NCT03885934|7703143|FG000|STARTED|Overall Study||64
6775204|NCT03885934|7703144|FG001|STARTED|Overall Study||64
6325569|NCT00486330|7231897|FG000|NOT COMPLETED|Overall Study||2
6325570|NCT00486434|7231903|FG000|STARTED|Overall Study||588
6325571|NCT00486434|7231904|FG001|STARTED|Overall Study||588
6325572|NCT00486434|7231903|FG000|COMPLETED|Overall Study||394
6325573|NCT00486434|7231904|FG001|COMPLETED|Overall Study||454
6325574|NCT00486434|7231903|FG000|NOT COMPLETED|Overall Study||194
6325575|NCT00486434|7231904|FG001|NOT COMPLETED|Overall Study||134
6325576|NCT00486447|7231911|FG000|STARTED|Overall Study||249
6325577|NCT00486447|7231911|FG000|COMPLETED|Overall Study||249
6325578|NCT00486447|7231911|FG000|NOT COMPLETED|Overall Study||0
6558301|NCT01774981|7481009|FG006|NOT COMPLETED|Overall Study||0
6558302|NCT01774981|7481010|FG007|NOT COMPLETED|Overall Study||1
6558303|NCT01775124|7481035|FG000|STARTED|Core Period||168
6775205|NCT03885934|7703145|FG002|STARTED|Overall Study||62
6775206|NCT03885934|7703146|FG003|STARTED|Overall Study||64
6325579|NCT00486525|7231918|FG000|STARTED|Overall Study||100
6325580|NCT00486525|7231919|FG001|STARTED|Overall Study||100
6325581|NCT00486525|7231918|FG000|COMPLETED|Overall Study||94
6325582|NCT00486525|7231919|FG001|COMPLETED|Overall Study||87
6325583|NCT00486525|7231918|FG000|NOT COMPLETED|Overall Study||6
6325584|NCT00486525|7231919|FG001|NOT COMPLETED|Overall Study||13
6325585|NCT00486603|7231927|FG000|STARTED|Overall Study||3
6325586|NCT00486603|7231928|FG001|STARTED|Overall Study||7
6325587|NCT00486603|7231929|FG002|STARTED|Overall Study||3
6325588|NCT00486603|7231930|FG003|STARTED|Overall Study||3
6325589|NCT00486603|7231931|FG004|STARTED|Overall Study||76
6325590|NCT00486603|7231927|FG000|COMPLETED|Overall Study||2
6325591|NCT00486603|7231928|FG001|COMPLETED|Overall Study||6
6325592|NCT00486603|7231929|FG002|COMPLETED|Overall Study||3
6325593|NCT00486603|7231930|FG003|COMPLETED|Overall Study||3
6325594|NCT00486603|7231931|FG004|COMPLETED|Overall Study||76
6325595|NCT00486603|7231927|FG000|NOT COMPLETED|Overall Study||1
6325596|NCT00486603|7231928|FG001|NOT COMPLETED|Overall Study||1
6325597|NCT00486603|7231929|FG002|NOT COMPLETED|Overall Study||0
6325598|NCT00486603|7231930|FG003|NOT COMPLETED|Overall Study||0
6325599|NCT00486603|7231931|FG004|NOT COMPLETED|Overall Study||0
6325600|NCT00486642|7231948|FG000|STARTED|Overall Study||10
6325601|NCT00486642|7231949|FG001|STARTED|Overall Study||13
6325602|NCT00486642|7231948|FG000|COMPLETED|Overall Study||10
6325603|NCT00486642|7231949|FG001|COMPLETED|Overall Study||13
6325604|NCT00486642|7231948|FG000|NOT COMPLETED|Overall Study||0
6325605|NCT00486642|7231949|FG001|NOT COMPLETED|Overall Study||0
6325606|NCT00486720|7231959|FG000|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
6325607|NCT00486720|7231960|FG001|STARTED|Overall Study||12
6325608|NCT00486720|7231959|FG000|COMPLETED|Overall Study||0
6325609|NCT00486720|7231960|FG001|COMPLETED|Overall Study||0
6325610|NCT00486720|7231959|FG000|NOT COMPLETED|Overall Study||10
6325611|NCT00486720|7231960|FG001|NOT COMPLETED|Overall Study||12
6325612|NCT00486759|7231968|FG000|STARTED|Treatment||390
6325613|NCT00486759|7231969|FG001|STARTED|Treatment||397
6325614|NCT00486759|7231968|FG000|COMPLETED|Treatment||203
6325615|NCT00486759|7231969|FG001|COMPLETED|Treatment||260
6325616|NCT00486759|7231968|FG000|NOT COMPLETED|Treatment||187
6325617|NCT00486759|7231969|FG001|NOT COMPLETED|Treatment||137
6325618|NCT00486759|7231968|FG000|STARTED|Safety Follow-up||203
6325619|NCT00486759|7231969|FG001|STARTED|Safety Follow-up||260
6325620|NCT00486759|7231968|FG000|COMPLETED|Safety Follow-up||64
6325621|NCT00486759|7231969|FG001|COMPLETED|Safety Follow-up||142
6325622|NCT00486759|7231968|FG000|NOT COMPLETED|Safety Follow-up||139
6325623|NCT00486759|7231969|FG001|NOT COMPLETED|Safety Follow-up||118
6325624|NCT00486811|7231978|FG000|STARTED|Overall Study||337
6325625|NCT00486811|7231979|FG001|STARTED|Overall Study|One participant was not eligible to be dosed.|320
6325626|NCT00486811|7231980|FG002|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
6325627|NCT00486811|7231978|FG000|COMPLETED|Overall Study||215
6325628|NCT00486811|7231979|FG001|COMPLETED|Overall Study||179
6775207|NCT03885934|7703147|FG004|STARTED|Overall Study||177
6325629|NCT00486811|7231980|FG002|COMPLETED|Overall Study||119
6325630|NCT00486811|7231978|FG000|NOT COMPLETED|Overall Study||122
6325631|NCT00486811|7231979|FG001|NOT COMPLETED|Overall Study||141
6325632|NCT00486811|7231980|FG002|NOT COMPLETED|Overall Study||214
6325633|NCT00486824|7231990|FG000|STARTED|Overall Study||5
6325634|NCT00486824|7231991|FG001|STARTED|Overall Study||5
6325635|NCT00486824|7231990|FG000|COMPLETED|Overall Study||3
6325636|NCT00486824|7231991|FG001|COMPLETED|Overall Study||3
6325637|NCT00486824|7231990|FG000|NOT COMPLETED|Overall Study||2
6558304|NCT01775124|7481036|FG001|STARTED|Core Period||166
6558305|NCT01775124|7481035|FG000|Full Analysis Set|Core Period||167
6325638|NCT00486824|7231991|FG001|NOT COMPLETED|Overall Study||2
6325639|NCT00486837|7231999|FG000|STARTED|Overall Study||37
6325640|NCT00486837|7232000|FG001|STARTED|Overall Study||35
6325641|NCT00486837|7231999|FG000|COMPLETED|Overall Study||28
6325642|NCT00486837|7232000|FG001|COMPLETED|Overall Study||28
6325643|NCT00486837|7231999|FG000|NOT COMPLETED|Overall Study||9
6325644|NCT00486837|7232000|FG001|NOT COMPLETED|Overall Study||7
6325645|NCT00486863|7232010|FG000|STARTED|Overall Study||184
6325646|NCT00486863|7232011|FG001|STARTED|Overall Study||186
6325647|NCT00486863|7232010|FG000|COMPLETED|Overall Study||183
6325648|NCT00486863|7232011|FG001|COMPLETED|Overall Study||183
6325649|NCT00486863|7232010|FG000|NOT COMPLETED|Overall Study||1
6325650|NCT00486863|7232011|FG001|NOT COMPLETED|Overall Study||3
6325651|NCT00486902|7232020|FG000|STARTED|Overall Study||94
6325652|NCT00486902|7232021|FG001|STARTED|Overall Study||94
6325653|NCT00486902|7232020|FG000|COMPLETED|Overall Study||85
6325654|NCT00486902|7232021|FG001|COMPLETED|Overall Study||89
6325655|NCT00486902|7232020|FG000|NOT COMPLETED|Overall Study||9
6325656|NCT00486902|7232021|FG001|NOT COMPLETED|Overall Study||5
6325657|NCT00486954|7232031|FG000|STARTED|Pilot Part||6
6325658|NCT00486954|7232032|FG001|STARTED|Pilot Part||0
6325659|NCT00486954|7232033|FG002|STARTED|Pilot Part||6
6325660|NCT00486954|7232034|FG003|STARTED|Pilot Part||0
6325661|NCT00486954|7232035|FG004|STARTED|Pilot Part||0
6325662|NCT00486954|7232031|FG000|COMPLETED|Pilot Part||0
6325663|NCT00486954|7232032|FG001|COMPLETED|Pilot Part||0
6325664|NCT00486954|7232033|FG002|COMPLETED|Pilot Part||0
6325665|NCT00486954|7232034|FG003|COMPLETED|Pilot Part||0
6325666|NCT00486954|7232035|FG004|COMPLETED|Pilot Part||0
6325667|NCT00486954|7232031|FG000|NOT COMPLETED|Pilot Part||6
6325668|NCT00486954|7232032|FG001|NOT COMPLETED|Pilot Part||0
6325669|NCT00486954|7232033|FG002|NOT COMPLETED|Pilot Part||6
6325670|NCT00486954|7232034|FG003|NOT COMPLETED|Pilot Part||0
6325671|NCT00486954|7232035|FG004|NOT COMPLETED|Pilot Part||0
6325672|NCT00486954|7232031|FG000|STARTED|Randomized Part||0
6325673|NCT00486954|7232032|FG001|STARTED|Randomized Part||0
6325674|NCT00486954|7232033|FG002|STARTED|Randomized Part||0
6325675|NCT00486954|7232034|FG003|STARTED|Randomized Part||132
6325676|NCT00486954|7232035|FG004|STARTED|Randomized Part||129
6325677|NCT00486954|7232031|FG000|COMPLETED|Randomized Part||0
6325678|NCT00486954|7232032|FG001|COMPLETED|Randomized Part||0
6325679|NCT00486954|7232033|FG002|COMPLETED|Randomized Part||0
6325680|NCT00486954|7232034|FG003|COMPLETED|Randomized Part||112
6325681|NCT00486954|7232035|FG004|COMPLETED|Randomized Part||115
6325682|NCT00486954|7232031|FG000|NOT COMPLETED|Randomized Part||0
6325683|NCT00486954|7232032|FG001|NOT COMPLETED|Randomized Part||0
6325684|NCT00486954|7232033|FG002|NOT COMPLETED|Randomized Part||0
6325685|NCT00486954|7232034|FG003|NOT COMPLETED|Randomized Part||20
6325686|NCT00486954|7232035|FG004|NOT COMPLETED|Randomized Part||14
6325687|NCT00487084|7232048|FG000|STARTED|Overall Study||33
6325688|NCT00487084|7232049|FG001|STARTED|Overall Study||33
6325689|NCT00487084|7232050|FG002|STARTED|Overall Study||33
6325690|NCT00487084|7232048|FG000|COMPLETED|Overall Study||29
6325691|NCT00487084|7232049|FG001|COMPLETED|Overall Study||30
6325692|NCT00487084|7232050|FG002|COMPLETED|Overall Study||28
6325693|NCT00487084|7232048|FG000|NOT COMPLETED|Overall Study||4
6325694|NCT00487084|7232049|FG001|NOT COMPLETED|Overall Study||3
6325695|NCT00487084|7232050|FG002|NOT COMPLETED|Overall Study||5
6325696|NCT00487188|7232060|FG000|STARTED|Induction Phase||31
6325697|NCT00487188|7232061|FG001|STARTED|Induction Phase||16
6325698|NCT00487188|7232062|FG002|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
6325699|NCT00487188|7232060|FG000|Safety Population|Induction Phase||29
6325700|NCT00487188|7232061|FG001|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
6325701|NCT00487188|7232062|FG002|Safety Population|Induction Phase||0
6325702|NCT00487188|7232060|FG000|COMPLETED|Induction Phase||22
6325703|NCT00487188|7232061|FG001|COMPLETED|Induction Phase||9
6325704|NCT00487188|7232062|FG002|COMPLETED|Induction Phase||0
6325705|NCT00487188|7232060|FG000|NOT COMPLETED|Induction Phase||9
6325706|NCT00487188|7232061|FG001|NOT COMPLETED|Induction Phase||7
6325707|NCT00487188|7232062|FG002|NOT COMPLETED|Induction Phase||0
6325708|NCT00487188|7232060|FG000|STARTED|Maintenance Phase||10
6325709|NCT00487188|7232061|FG001|STARTED|Maintenance Phase||8
6325710|NCT00487188|7232062|FG002|STARTED|Maintenance Phase||9
6325711|NCT00487188|7232060|FG000|COMPLETED|Maintenance Phase||7
6325712|NCT00487188|7232061|FG001|COMPLETED|Maintenance Phase||8
6325713|NCT00487188|7232062|FG002|COMPLETED|Maintenance Phase||8
6325714|NCT00487188|7232060|FG000|NOT COMPLETED|Maintenance Phase||3
6325715|NCT00487188|7232061|FG001|NOT COMPLETED|Maintenance Phase||0
6325716|NCT00487188|7232062|FG002|NOT COMPLETED|Maintenance Phase||1
6325717|NCT00487240|7232080|FG000|STARTED|Overall Study||195
6325718|NCT00487240|7232081|FG001|STARTED|Overall Study||192
6325719|NCT00487240|7232080|FG000|Full Analysis Set (ITT Population)|Overall Study||192
6325720|NCT00487240|7232081|FG001|Full Analysis Set (ITT Population)|Overall Study||189
6325721|NCT00487240|7232080|FG000|COMPLETED|Overall Study||164
6325722|NCT00487240|7232081|FG001|COMPLETED|Overall Study||166
6325723|NCT00487240|7232080|FG000|NOT COMPLETED|Overall Study||31
6325724|NCT00487240|7232081|FG001|NOT COMPLETED|Overall Study||26
6325725|NCT00487279|7232089|FG000|STARTED|Overall Study||44
6325726|NCT00487279|7232090|FG001|STARTED|Overall Study||37
6325727|NCT00487279|7232089|FG000|COMPLETED|Overall Study||43
6325728|NCT00487279|7232090|FG001|COMPLETED|Overall Study||35
6558306|NCT01775124|7481036|FG001|Full Analysis Set|Core Period||166
6558307|NCT01775124|7481035|FG000|Per Protocol Set|Core Period||157
6325729|NCT00487279|7232089|FG000|NOT COMPLETED|Overall Study||1
6325730|NCT00487279|7232090|FG001|NOT COMPLETED|Overall Study||2
6325731|NCT00487396|7232096|FG000|STARTED|Overall Study||98
6325732|NCT00487396|7232096|FG000|COMPLETED|Overall Study||95
6325733|NCT00487396|7232096|FG000|NOT COMPLETED|Overall Study||3
6325734|NCT00487435|7232105|FG000|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
6325735|NCT00487435|7232105|FG000|COMPLETED|Overall Study||669
6325736|NCT00487435|7232105|FG000|NOT COMPLETED|Overall Study||485
6325737|NCT00487539|7232113|FG000|STARTED|Overall Study||331
6325738|NCT00487539|7232114|FG001|STARTED|Overall Study||72
6325739|NCT00487539|7232115|FG002|STARTED|Overall Study||331
6325740|NCT00487539|7232116|FG003|STARTED|Overall Study||331
6325741|NCT00487539|7232113|FG000|COMPLETED|Overall Study||324
6325742|NCT00487539|7232114|FG001|COMPLETED|Overall Study||69
6325743|NCT00487539|7232115|FG002|COMPLETED|Overall Study||328
6325744|NCT00487539|7232116|FG003|COMPLETED|Overall Study||327
6325745|NCT00487539|7232113|FG000|NOT COMPLETED|Overall Study||7
6325746|NCT00487539|7232114|FG001|NOT COMPLETED|Overall Study||3
6325747|NCT00487539|7232115|FG002|NOT COMPLETED|Overall Study||3
6325748|NCT00487539|7232116|FG003|NOT COMPLETED|Overall Study||4
6325749|NCT00487552|7232125|FG000|STARTED|Overall Study||18
6325750|NCT00487552|7232125|FG000|COMPLETED|Overall Study||12
6325751|NCT00487552|7232125|FG000|NOT COMPLETED|Overall Study||6
6325752|NCT00487565|7232130|FG000|STARTED|Overall Study||210
6325753|NCT00487565|7232130|FG000|COMPLETED|Overall Study||182
6325754|NCT00487565|7232130|FG000|NOT COMPLETED|Overall Study||28
6325755|NCT00487669|7232134|FG000|STARTED|Overall Study||12
6325756|NCT00487669|7232134|FG000|COMPLETED|Overall Study||12
6325757|NCT00487669|7232134|FG000|NOT COMPLETED|Overall Study||0
6325758|NCT00487695|7232140|FG000|STARTED|First Procedure||23
6325759|NCT00487695|7232141|FG001|STARTED|First Procedure||23
6325760|NCT00487695|7232140|FG000|COMPLETED|First Procedure||20
6325761|NCT00487695|7232141|FG001|COMPLETED|First Procedure||23
6325762|NCT00487695|7232140|FG000|NOT COMPLETED|First Procedure||3
6325763|NCT00487695|7232141|FG001|NOT COMPLETED|First Procedure||0
6325764|NCT00487695|7232140|FG000|STARTED|Second Procedure||20
6325765|NCT00487695|7232141|FG001|STARTED|Second Procedure||23
6325766|NCT00487695|7232140|FG000|COMPLETED|Second Procedure||19
6325767|NCT00487695|7232141|FG001|COMPLETED|Second Procedure||20
6325768|NCT00487695|7232140|FG000|NOT COMPLETED|Second Procedure||1
6325769|NCT00487695|7232141|FG001|NOT COMPLETED|Second Procedure||3
6325770|NCT00487721|7232149|FG000|STARTED|Overall Study||6
6325771|NCT00487721|7232150|FG001|STARTED|Overall Study||6
6325772|NCT00487721|7232149|FG000|COMPLETED|Overall Study||6
6325773|NCT00487721|7232150|FG001|COMPLETED|Overall Study||6
6325774|NCT00487721|7232149|FG000|NOT COMPLETED|Overall Study||0
6325775|NCT00487721|7232150|FG001|NOT COMPLETED|Overall Study||0
6325776|NCT00487747|7232155|FG000|STARTED|Overall Study||18
6325777|NCT00487747|7232155|FG000|COMPLETED|Overall Study||7
6325778|NCT00487747|7232155|FG000|NOT COMPLETED|Overall Study||11
6325779|NCT00487825|7232161|FG000|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
6325780|NCT00487825|7232162|FG001|STARTED|Overall Study||26
6325781|NCT00487825|7232161|FG000|COMPLETED|Overall Study||46
6325782|NCT00487825|7232162|FG001|COMPLETED|Overall Study||21
6325783|NCT00487825|7232161|FG000|NOT COMPLETED|Overall Study||6
6325784|NCT00487825|7232162|FG001|NOT COMPLETED|Overall Study||5
6325785|NCT00487942|7232172|FG000|STARTED|Overall Study||15
6325786|NCT00487942|7232173|FG001|STARTED|Overall Study||15
6325787|NCT00487942|7232174|FG002|STARTED|Overall Study||15
6325788|NCT00487942|7232175|FG003|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
6325789|NCT00487942|7232172|FG000|COMPLETED|Overall Study||12
6325790|NCT00487942|7232173|FG001|COMPLETED|Overall Study||12
6325791|NCT00487942|7232174|FG002|COMPLETED|Overall Study||12
6325792|NCT00487942|7232175|FG003|COMPLETED|Overall Study||13
6325793|NCT00487942|7232172|FG000|NOT COMPLETED|Overall Study||3
6325794|NCT00487942|7232173|FG001|NOT COMPLETED|Overall Study||3
6325795|NCT00487942|7232174|FG002|NOT COMPLETED|Overall Study||3
6325796|NCT00487942|7232175|FG003|NOT COMPLETED|Overall Study||2
6325797|NCT00488033|7232187|FG000|STARTED|Overall Study||448
6325798|NCT00488033|7232188|FG001|STARTED|Overall Study||452
6325799|NCT00488033|7232187|FG000|COMPLETED|Overall Study||447
6325800|NCT00488033|7232188|FG001|COMPLETED|Overall Study||452
6325801|NCT00488033|7232187|FG000|NOT COMPLETED|Overall Study||1
6325802|NCT00488033|7232188|FG001|NOT COMPLETED|Overall Study||0
6325803|NCT00488059|7232194|FG000|STARTED|Phase I: ENF 90mg SC BID||29
6325804|NCT00488059|7232195|FG001|STARTED|Phase I: ENF 90mg SC BID||0
6325805|NCT00488059|7232196|FG002|STARTED|Phase I: ENF 90mg SC BID||0
6325806|NCT00488059|7232194|FG000|COMPLETED|Phase I: ENF 90mg SC BID||14
6325807|NCT00488059|7232195|FG001|COMPLETED|Phase I: ENF 90mg SC BID||0
6325808|NCT00488059|7232196|FG002|COMPLETED|Phase I: ENF 90mg SC BID||0
6325809|NCT00488059|7232194|FG000|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
6325810|NCT00488059|7232195|FG001|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
6325811|NCT00488059|7232196|FG002|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
6325812|NCT00488059|7232194|FG000|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6325813|NCT00488059|7232195|FG001|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
6325814|NCT00488059|7232196|FG002|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6325815|NCT00488059|7232194|FG000|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6325816|NCT00488059|7232195|FG001|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
6325817|NCT00488059|7232196|FG002|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6325818|NCT00488059|7232194|FG000|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6325819|NCT00488059|7232195|FG001|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
6325820|NCT00488059|7232196|FG002|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
6325821|NCT00488059|7232194|FG000|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6325822|NCT00488059|7232195|FG001|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6325823|NCT00488059|7232196|FG002|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
6325824|NCT00488059|7232194|FG000|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6325825|NCT00488059|7232195|FG001|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6325826|NCT00488059|7232196|FG002|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
6325827|NCT00488059|7232194|FG000|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6325828|NCT00488059|7232195|FG001|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
6325829|NCT00488059|7232196|FG002|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
6325830|NCT00488293|7232211|FG000|STARTED|Overall Study||196
6325831|NCT00488293|7232212|FG001|STARTED|Overall Study||196
6325832|NCT00488293|7232211|FG000|COMPLETED|Overall Study||160
6325833|NCT00488293|7232212|FG001|COMPLETED|Overall Study||166
6325834|NCT00488293|7232211|FG000|NOT COMPLETED|Overall Study||36
6325835|NCT00488293|7232212|FG001|NOT COMPLETED|Overall Study||30
6325836|NCT00488319|7232221|FG000|STARTED|Overall Study||39
6325837|NCT00488319|7232222|FG001|STARTED|Overall Study||118
6325838|NCT00488319|7232223|FG002|STARTED|Overall Study||243
6325839|NCT00488319|7232221|FG000|COMPLETED|Overall Study||24
6325840|NCT00488319|7232222|FG001|COMPLETED|Overall Study||75
6325841|NCT00488319|7232223|FG002|COMPLETED|Overall Study||121
6325842|NCT00488319|7232221|FG000|NOT COMPLETED|Overall Study||15
6325843|NCT00488319|7232222|FG001|NOT COMPLETED|Overall Study||43
6325844|NCT00488319|7232223|FG002|NOT COMPLETED|Overall Study||122
6325845|NCT00488345|7232235|FG000|STARTED|Overall Study||17
6325846|NCT00488345|7232236|FG001|STARTED|Overall Study||21
6325847|NCT00488345|7232237|FG002|STARTED|Overall Study||20
6325848|NCT00488345|7232235|FG000|COMPLETED|Overall Study||17
6325849|NCT00488345|7232236|FG001|COMPLETED|Overall Study||17
6325850|NCT00488345|7232237|FG002|COMPLETED|Overall Study||17
6325851|NCT00488345|7232235|FG000|NOT COMPLETED|Overall Study||0
6325852|NCT00488345|7232236|FG001|NOT COMPLETED|Overall Study||4
6325853|NCT00488345|7232237|FG002|NOT COMPLETED|Overall Study||3
6375814|NCT00757601|7286358|FG001|COMPLETED|Period 5||2
6375815|NCT00757601|7286359|FG002|COMPLETED|Period 5||2
6375816|NCT00757601|7286360|FG003|COMPLETED|Period 5||2
6375817|NCT00757601|7286361|FG004|COMPLETED|Period 5||2
6375818|NCT00757601|7286362|FG005|COMPLETED|Period 5||2
6375819|NCT00757601|7286363|FG006|COMPLETED|Period 5||2
6375820|NCT00757601|7286364|FG007|COMPLETED|Period 5||2
6375821|NCT00757601|7286365|FG008|COMPLETED|Period 5||2
6375822|NCT00757601|7286366|FG009|COMPLETED|Period 5||1
6375823|NCT00757601|7286367|FG010|COMPLETED|Period 5||2
6375824|NCT00757601|7286368|FG011|COMPLETED|Period 5||1
6375825|NCT00757601|7286357|FG000|NOT COMPLETED|Period 5||0
6375826|NCT00757601|7286358|FG001|NOT COMPLETED|Period 5||0
6375827|NCT00757601|7286359|FG002|NOT COMPLETED|Period 5||0
6375828|NCT00757601|7286360|FG003|NOT COMPLETED|Period 5||0
6375829|NCT00757601|7286361|FG004|NOT COMPLETED|Period 5||0
6375830|NCT00757601|7286362|FG005|NOT COMPLETED|Period 5||0
6375831|NCT00757601|7286363|FG006|NOT COMPLETED|Period 5||0
6375832|NCT00757601|7286364|FG007|NOT COMPLETED|Period 5||0
6375833|NCT00757601|7286365|FG008|NOT COMPLETED|Period 5||0
6375834|NCT00757601|7286366|FG009|NOT COMPLETED|Period 5||0
6375835|NCT00757601|7286367|FG010|NOT COMPLETED|Period 5||0
6375836|NCT00757601|7286368|FG011|NOT COMPLETED|Period 5||0
6375837|NCT00757666|7286400|FG000|STARTED|Overall Study||34
6375838|NCT00757666|7286401|FG001|STARTED|Overall Study||34
6375839|NCT00757666|7286400|FG000|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
6375840|NCT00757666|7286401|FG001|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
6375841|NCT00757666|7286400|FG000|NOT COMPLETED|Overall Study||22
6375842|NCT00757666|7286401|FG001|NOT COMPLETED|Overall Study||23
6375843|NCT00757705|7286411|FG000|STARTED|Overall Study||299
6375844|NCT00757705|7286411|FG000|COMPLETED|Overall Study||178
6375845|NCT00757705|7286411|FG000|NOT COMPLETED|Overall Study||121
6375846|NCT00757783|7286417|FG000|STARTED|Overall Study||34
6375847|NCT00757783|7286418|FG001|STARTED|Overall Study||31
6375848|NCT00757783|7286417|FG000|COMPLETED|Overall Study||29
6375849|NCT00757783|7286418|FG001|COMPLETED|Overall Study||25
6375850|NCT00757783|7286417|FG000|NOT COMPLETED|Overall Study||5
6375851|NCT00757783|7286418|FG001|NOT COMPLETED|Overall Study||6
6375852|NCT00757822|7286426|FG000|STARTED|Overall Study||92
6375853|NCT00757822|7286427|FG001|STARTED|Overall Study||88
6375854|NCT00757822|7286426|FG000|Day of Surgery (DOS) Assessment|Overall Study||92
6375855|NCT00757822|7286427|FG001|Day of Surgery (DOS) Assessment|Overall Study||88
6375856|NCT00757822|7286426|FG000|Withdrawal by Subject-no Intervention|Overall Study||1
6375857|NCT00757822|7286427|FG001|Withdrawal by Subject-no Intervention|Overall Study||3
6375858|NCT00757822|7286426|FG000|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
6377892|NCT00765817|7288565|FG001|NOT COMPLETED|Overall Study||22
6325854|NCT00488475|7232246|FG000|STARTED|Overall Study||4945
6325855|NCT00488475|7232246|FG000|COMPLETED|Overall Study||3191
6325856|NCT00488475|7232246|FG000|NOT COMPLETED|Overall Study||1754
6325857|NCT00488488|7232250|FG000|STARTED|Overall Study||1028
6325858|NCT00488488|7232250|FG000|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
6325859|NCT00488488|7232250|FG000|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
6325860|NCT00488488|7232250|FG000|NOT COMPLETED|Overall Study||268
6325861|NCT00488514|7232254|FG000|STARTED|Overall Study||656
6325862|NCT00488514|7232254|FG000|COMPLETED|Overall Study||363
6325863|NCT00488514|7232254|FG000|NOT COMPLETED|Overall Study||293
6325864|NCT00488592|7232275|FG000|STARTED|Overall Study|10 subjects were accrued|10
6325865|NCT00488592|7232275|FG000|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
6325866|NCT00488592|7232275|FG000|NOT COMPLETED|Overall Study||3
6325867|NCT00488618|7232281|FG000|STARTED|Overall Study||120
6325868|NCT00488618|7232282|FG001|STARTED|Overall Study||118
6325869|NCT00488618|7232281|FG000|Safety Population: Received Study Drug|Overall Study||118
6325870|NCT00488618|7232282|FG001|Safety Population: Received Study Drug|Overall Study||118
6325871|NCT00488618|7232281|FG000|COMPLETED|Overall Study||73
6325872|NCT00488618|7232282|FG001|COMPLETED|Overall Study||75
6325873|NCT00488618|7232281|FG000|NOT COMPLETED|Overall Study||47
6325874|NCT00488618|7232282|FG001|NOT COMPLETED|Overall Study||43
6325875|NCT00488631|7232294|FG000|STARTED|Double Blind Period (Week 0-54)||156
6325876|NCT00488631|7232295|FG001|STARTED|Double Blind Period (Week 0-54)||154
6325877|NCT00488631|7232296|FG002|STARTED|Double Blind Period (Week 0-54)||154
6325878|NCT00488631|7232297|FG003|STARTED|Double Blind Period (Week 0-54)||129
6325879|NCT00488631|7232298|FG004|STARTED|Double Blind Period (Week 0-54)||230
6325880|NCT00488631|7232299|FG005|STARTED|Double Blind Period (Week 0-54)||405
6325881|NCT00488631|7232300|FG006|STARTED|Double Blind Period (Week 0-54)||0
6325882|NCT00488631|7232301|FG007|STARTED|Double Blind Period (Week 0-54)||0
6325883|NCT00488631|7232302|FG008|STARTED|Double Blind Period (Week 0-54)||0
6325884|NCT00488631|7232303|FG009|STARTED|Double Blind Period (Week 0-54)||0
6325885|NCT00488631|7232294|FG000|COMPLETED|Double Blind Period (Week 0-54)||113
6325886|NCT00488631|7232295|FG001|COMPLETED|Double Blind Period (Week 0-54)||111
6325887|NCT00488631|7232296|FG002|COMPLETED|Double Blind Period (Week 0-54)||109
6325888|NCT00488631|7232297|FG003|COMPLETED|Double Blind Period (Week 0-54)||88
6325889|NCT00488631|7232298|FG004|COMPLETED|Double Blind Period (Week 0-54)||127
6325890|NCT00488631|7232299|FG005|COMPLETED|Double Blind Period (Week 0-54)||189
6325891|NCT00488631|7232300|FG006|COMPLETED|Double Blind Period (Week 0-54)||0
6325892|NCT00488631|7232301|FG007|COMPLETED|Double Blind Period (Week 0-54)||0
6325893|NCT00488631|7232302|FG008|COMPLETED|Double Blind Period (Week 0-54)||0
6325894|NCT00488631|7232303|FG009|COMPLETED|Double Blind Period (Week 0-54)||0
6325895|NCT00488631|7232294|FG000|NOT COMPLETED|Double Blind Period (Week 0-54)||43
6325896|NCT00488631|7232295|FG001|NOT COMPLETED|Double Blind Period (Week 0-54)||43
6325897|NCT00488631|7232296|FG002|NOT COMPLETED|Double Blind Period (Week 0-54)||45
6325898|NCT00488631|7232297|FG003|NOT COMPLETED|Double Blind Period (Week 0-54)||41
6325899|NCT00488631|7232298|FG004|NOT COMPLETED|Double Blind Period (Week 0-54)||103
6325900|NCT00488631|7232299|FG005|NOT COMPLETED|Double Blind Period (Week 0-54)||216
6325901|NCT00488631|7232300|FG006|NOT COMPLETED|Double Blind Period (Week 0-54)||0
6325902|NCT00488631|7232301|FG007|NOT COMPLETED|Double Blind Period (Week 0-54)||0
6325903|NCT00488631|7232302|FG008|NOT COMPLETED|Double Blind Period (Week 0-54)||0
6325904|NCT00488631|7232303|FG009|NOT COMPLETED|Double Blind Period (Week 0-54)||0
6325905|NCT00488631|7232294|FG000|STARTED|Open Label Study Extension (Week 54-228)||0
6325906|NCT00488631|7232295|FG001|STARTED|Open Label Study Extension (Week 54-228)||0
6325907|NCT00488631|7232296|FG002|STARTED|Open Label Study Extension (Week 54-228)||0
6325908|NCT00488631|7232297|FG003|STARTED|Open Label Study Extension (Week 54-228)||0
6325909|NCT00488631|7232298|FG004|STARTED|Open Label Study Extension (Week 54-228)||0
6325910|NCT00488631|7232299|FG005|STARTED|Open Label Study Extension (Week 54-228)||0
6325911|NCT00488631|7232300|FG006|STARTED|Open Label Study Extension (Week 54-228)||96
6325912|NCT00488631|7232301|FG007|STARTED|Open Label Study Extension (Week 54-228)||93
6325913|NCT00488631|7232302|FG008|STARTED|Open Label Study Extension (Week 54-228)||470
6325914|NCT00488631|7232303|FG009|STARTED|Open Label Study Extension (Week 54-228)||7
6325915|NCT00488631|7232294|FG000|COMPLETED|Open Label Study Extension (Week 54-228)||0
6325916|NCT00488631|7232295|FG001|COMPLETED|Open Label Study Extension (Week 54-228)||0
6325917|NCT00488631|7232296|FG002|COMPLETED|Open Label Study Extension (Week 54-228)||0
6325918|NCT00488631|7232297|FG003|COMPLETED|Open Label Study Extension (Week 54-228)||0
6325919|NCT00488631|7232298|FG004|COMPLETED|Open Label Study Extension (Week 54-228)||0
6558308|NCT01775124|7481036|FG001|Per Protocol Set|Core Period||155
6558309|NCT01775124|7481035|FG000|Safety Set|Core Period|1 patient was mis-randomized & 1 patient discontinued due to AE. No treatment given|166
6558310|NCT01775124|7481036|FG001|Safety Set|Core Period||166
6558311|NCT01775124|7481035|FG000|COMPLETED|Core Period||157
6325920|NCT00488631|7232299|FG005|COMPLETED|Open Label Study Extension (Week 54-228)||0
6325921|NCT00488631|7232300|FG006|COMPLETED|Open Label Study Extension (Week 54-228)||16
6325922|NCT00488631|7232301|FG007|COMPLETED|Open Label Study Extension (Week 54-228)||66
6325923|NCT00488631|7232302|FG008|COMPLETED|Open Label Study Extension (Week 54-228)||288
6325924|NCT00488631|7232303|FG009|COMPLETED|Open Label Study Extension (Week 54-228)||4
6325925|NCT00488631|7232294|FG000|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6558312|NCT01775124|7481036|FG001|COMPLETED|Core Period||156
6558313|NCT01775124|7481035|FG000|NOT COMPLETED|Core Period||11
6325926|NCT00488631|7232295|FG001|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6325927|NCT00488631|7232296|FG002|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6325928|NCT00488631|7232297|FG003|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6325929|NCT00488631|7232298|FG004|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6325930|NCT00488631|7232299|FG005|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
6325931|NCT00488631|7232300|FG006|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
6325932|NCT00488631|7232301|FG007|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
6325933|NCT00488631|7232302|FG008|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
6325934|NCT00488631|7232303|FG009|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
6325935|NCT00488644|7232326|FG000|STARTED|Overall Study||12
6325936|NCT00488644|7232326|FG000|COMPLETED|Overall Study||10
6325937|NCT00488644|7232326|FG000|NOT COMPLETED|Overall Study||2
6325938|NCT00488683|7232333|FG000|STARTED|Overall Study||108
6325939|NCT00488683|7232334|FG001|STARTED|Overall Study||54
6325940|NCT00488683|7232335|FG002|STARTED|Overall Study||54
6325941|NCT00488683|7232333|FG000|COMPLETED|Overall Study||96
6325942|NCT00488683|7232334|FG001|COMPLETED|Overall Study||48
6325943|NCT00488683|7232335|FG002|COMPLETED|Overall Study||52
6558314|NCT01775124|7481036|FG001|NOT COMPLETED|Core Period||10
6558315|NCT01775124|7481035|FG000|STARTED|Extension Period||157
6558316|NCT01775124|7481036|FG001|STARTED|Extension Period||156
6558317|NCT01775124|7481035|FG000|COMPLETED|Extension Period||145
6558318|NCT01775124|7481036|FG001|COMPLETED|Extension Period||138
6558319|NCT01775124|7481035|FG000|NOT COMPLETED|Extension Period||12
6325944|NCT00488683|7232333|FG000|NOT COMPLETED|Overall Study||12
6325945|NCT00488683|7232334|FG001|NOT COMPLETED|Overall Study||6
6325946|NCT00488683|7232335|FG002|NOT COMPLETED|Overall Study||2
6325947|NCT00488774|7232351|FG000|STARTED|Overall Study||77
6325948|NCT00488774|7232352|FG001|STARTED|Overall Study||62
6325949|NCT00488774|7232353|FG002|STARTED|Overall Study||75
6325950|NCT00488774|7232354|FG003|STARTED|Overall Study||77
6325951|NCT00488774|7232351|FG000|COMPLETED|Overall Study||69
6325952|NCT00488774|7232352|FG001|COMPLETED|Overall Study||57
6325953|NCT00488774|7232353|FG002|COMPLETED|Overall Study||70
6325954|NCT00488774|7232354|FG003|COMPLETED|Overall Study||74
6325955|NCT00488774|7232351|FG000|NOT COMPLETED|Overall Study||8
6325956|NCT00488774|7232352|FG001|NOT COMPLETED|Overall Study||5
6325957|NCT00488774|7232353|FG002|NOT COMPLETED|Overall Study||5
6325958|NCT00488774|7232354|FG003|NOT COMPLETED|Overall Study||3
6325959|NCT00488826|7232368|FG000|STARTED|Overall Study||300
6325960|NCT00488826|7232369|FG001|STARTED|Overall Study||296
6325961|NCT00488826|7232370|FG002|STARTED|Overall Study||204
6325962|NCT00488826|7232368|FG000|COMPLETED|Overall Study||244
6325963|NCT00488826|7232369|FG001|COMPLETED|Overall Study||244
6325964|NCT00488826|7232370|FG002|COMPLETED|Overall Study||178
6325965|NCT00488826|7232368|FG000|NOT COMPLETED|Overall Study||56
6325966|NCT00488826|7232369|FG001|NOT COMPLETED|Overall Study||52
6325967|NCT00488826|7232370|FG002|NOT COMPLETED|Overall Study||26
6325968|NCT00488865|7232378|FG000|STARTED|Overall Study||100
6325969|NCT00488865|7232378|FG000|COMPLETED|Overall Study||100
6325970|NCT00488865|7232378|FG000|NOT COMPLETED|Overall Study||0
6325971|NCT00488982|7232382|FG000|STARTED|Induction Chemotherapy||125
6325972|NCT00488982|7232383|FG001|STARTED|Induction Chemotherapy||0
6325973|NCT00488982|7232384|FG002|STARTED|Induction Chemotherapy||0
6325974|NCT00488982|7232382|FG000|6 Cycles Completed|Induction Chemotherapy||94
6325975|NCT00488982|7232383|FG001|6 Cycles Completed|Induction Chemotherapy||0
6325976|NCT00488982|7232384|FG002|6 Cycles Completed|Induction Chemotherapy||0
6325977|NCT00488982|7232382|FG000|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||52
6325978|NCT00488982|7232383|FG001|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
6325979|NCT00488982|7232384|FG002|≥ 50% Prostate-specific Antigen Decline|Induction Chemotherapy||0
6325980|NCT00488982|7232382|FG000|COMPLETED|Induction Chemotherapy||52
6325981|NCT00488982|7232383|FG001|COMPLETED|Induction Chemotherapy||0
6325982|NCT00488982|7232384|FG002|COMPLETED|Induction Chemotherapy||0
6325983|NCT00488982|7232382|FG000|NOT COMPLETED|Induction Chemotherapy||73
6325984|NCT00488982|7232383|FG001|NOT COMPLETED|Induction Chemotherapy||0
6325985|NCT00488982|7232384|FG002|NOT COMPLETED|Induction Chemotherapy||0
6325986|NCT00488982|7232382|FG000|STARTED|Course 1||0
6325987|NCT00488982|7232383|FG001|STARTED|Course 1||25
6325988|NCT00488982|7232384|FG002|STARTED|Course 1||27
6325989|NCT00488982|7232382|FG000|COMPLETED|Course 1||0
6325990|NCT00488982|7232383|FG001|COMPLETED|Course 1||13
6325991|NCT00488982|7232384|FG002|COMPLETED|Course 1||13
6325992|NCT00488982|7232382|FG000|NOT COMPLETED|Course 1||0
6325993|NCT00488982|7232383|FG001|NOT COMPLETED|Course 1||12
6325994|NCT00488982|7232384|FG002|NOT COMPLETED|Course 1||14
6325995|NCT00488982|7232382|FG000|STARTED|Course 2||0
6325996|NCT00488982|7232383|FG001|STARTED|Course 2||13
6325997|NCT00488982|7232384|FG002|STARTED|Course 2||13
6325998|NCT00488982|7232382|FG000|COMPLETED|Course 2||0
6325999|NCT00488982|7232383|FG001|COMPLETED|Course 2||4
6558320|NCT01775124|7481036|FG001|NOT COMPLETED|Extension Period||18
6558321|NCT01775137|7481043|FG000|STARTED|Overall Study||45
6558322|NCT01775137|7481043|FG000|COMPLETED|Overall Study||34
6326000|NCT00488982|7232384|FG002|COMPLETED|Course 2||8
6326001|NCT00488982|7232382|FG000|NOT COMPLETED|Course 2||0
6326002|NCT00488982|7232383|FG001|NOT COMPLETED|Course 2||9
6326003|NCT00488982|7232384|FG002|NOT COMPLETED|Course 2||5
6326004|NCT00488982|7232382|FG000|STARTED|Course 3||0
6326005|NCT00488982|7232383|FG001|STARTED|Course 3||4
6326006|NCT00488982|7232384|FG002|STARTED|Course 3||8
6326007|NCT00488982|7232382|FG000|COMPLETED|Course 3||0
6326008|NCT00488982|7232383|FG001|COMPLETED|Course 3||2
6326009|NCT00488982|7232384|FG002|COMPLETED|Course 3||3
6326010|NCT00488982|7232382|FG000|NOT COMPLETED|Course 3||0
6326011|NCT00488982|7232383|FG001|NOT COMPLETED|Course 3||2
6326012|NCT00488982|7232384|FG002|NOT COMPLETED|Course 3||5
6326013|NCT00488982|7232382|FG000|STARTED|Response to Course 3||0
6326014|NCT00488982|7232383|FG001|STARTED|Response to Course 3||2
6326015|NCT00488982|7232384|FG002|STARTED|Response to Course 3||3
6326016|NCT00488982|7232382|FG000|COMPLETED|Response to Course 3||0
6326017|NCT00488982|7232383|FG001|COMPLETED|Response to Course 3||1
6326018|NCT00488982|7232384|FG002|COMPLETED|Response to Course 3||0
6326019|NCT00488982|7232382|FG000|NOT COMPLETED|Response to Course 3||0
6326020|NCT00488982|7232383|FG001|NOT COMPLETED|Response to Course 3||1
6326021|NCT00488982|7232384|FG002|NOT COMPLETED|Response to Course 3||3
6326022|NCT00489086|7232398|FG000|STARTED|Overall Study||36
6326023|NCT00489086|7232398|FG000|Completed 18 Months|Overall Study||23
6326024|NCT00489086|7232398|FG000|COMPLETED|Overall Study||13
6326025|NCT00489086|7232398|FG000|NOT COMPLETED|Overall Study||23
6326026|NCT00489216|7232402|FG000|STARTED|Overall Study||2
6326027|NCT00489216|7232402|FG000|COMPLETED|Overall Study||1
6326028|NCT00489216|7232402|FG000|NOT COMPLETED|Overall Study||1
6326029|NCT00489255|7232408|FG000|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
6326030|NCT00489255|7232409|FG001|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
6326031|NCT00489255|7232408|FG000|COMPLETED|Screening and Initial Randomization||136
6326032|NCT00489255|7232409|FG001|COMPLETED|Screening and Initial Randomization||46
6326033|NCT00489255|7232408|FG000|NOT COMPLETED|Screening and Initial Randomization||9
6326034|NCT00489255|7232409|FG001|NOT COMPLETED|Screening and Initial Randomization||3
6326035|NCT00489255|7232408|FG000|STARTED|Period 1: Days 1 to 28||136
6326036|NCT00489255|7232409|FG001|STARTED|Period 1: Days 1 to 28||46
6326037|NCT00489255|7232408|FG000|Completed and Follow Period 2|Period 1: Days 1 to 28||94
6326038|NCT00489255|7232409|FG001|Completed and Follow Period 2|Period 1: Days 1 to 28||29
6326039|NCT00489255|7232408|FG000|Completed But Discontinued Study|Period 1: Days 1 to 28||13
6326040|NCT00489255|7232409|FG001|Completed But Discontinued Study|Period 1: Days 1 to 28||5
6326041|NCT00489255|7232408|FG000|COMPLETED|Period 1: Days 1 to 28||107
6326042|NCT00489255|7232409|FG001|COMPLETED|Period 1: Days 1 to 28||34
6326043|NCT00489255|7232408|FG000|NOT COMPLETED|Period 1: Days 1 to 28||29
6326044|NCT00489255|7232409|FG001|NOT COMPLETED|Period 1: Days 1 to 28||12
6326045|NCT00489255|7232408|FG000|STARTED|Period 2: Days 29 to 56||64
6326046|NCT00489255|7232409|FG001|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
6326047|NCT00489255|7232408|FG000|Completed and Follow Period 3|Period 2: Days 29 to 56||58
6326048|NCT00489255|7232409|FG001|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
6326049|NCT00489255|7232408|FG000|Completed But Discontinued Study|Period 2: Days 29 to 56||3
6326050|NCT00489255|7232409|FG001|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
6326051|NCT00489255|7232408|FG000|COMPLETED|Period 2: Days 29 to 56||61
6326052|NCT00489255|7232409|FG001|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
6326053|NCT00489255|7232408|FG000|NOT COMPLETED|Period 2: Days 29 to 56||3
6326054|NCT00489255|7232409|FG001|NOT COMPLETED|Period 2: Days 29 to 56||4
6326055|NCT00489255|7232408|FG000|STARTED|Period 3: Days 57 to 84||28
6326056|NCT00489255|7232409|FG001|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
6326057|NCT00489255|7232408|FG000|COMPLETED|Period 3: Days 57 to 84||24
6326058|NCT00489255|7232409|FG001|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
6326059|NCT00489255|7232408|FG000|NOT COMPLETED|Period 3: Days 57 to 84||4
6326060|NCT00489255|7232409|FG001|NOT COMPLETED|Period 3: Days 57 to 84||4
6558323|NCT01775137|7481043|FG000|NOT COMPLETED|Overall Study||11
6558324|NCT01775189|7481050|FG000|STARTED|Naloxone Challenge Phase||45
6558325|NCT01775189|7481051|FG001|STARTED|Naloxone Challenge Phase||0
6558326|NCT01775189|7481052|FG002|STARTED|Naloxone Challenge Phase||0
6326061|NCT00489268|7232420|FG000|STARTED|Overall Study||1
6326062|NCT00489268|7232421|FG001|STARTED|Overall Study||10
6326063|NCT00489268|7232422|FG002|STARTED|Overall Study||10
6326064|NCT00489268|7232423|FG003|STARTED|Overall Study||11
6326065|NCT00489268|7232424|FG004|STARTED|Overall Study||70
6326066|NCT00489268|7232420|FG000|COMPLETED|Overall Study||1
6326067|NCT00489268|7232421|FG001|COMPLETED|Overall Study||10
6326068|NCT00489268|7232422|FG002|COMPLETED|Overall Study||9
6326069|NCT00489268|7232423|FG003|COMPLETED|Overall Study||11
6326070|NCT00489268|7232424|FG004|COMPLETED|Overall Study||50
6326071|NCT00489268|7232420|FG000|NOT COMPLETED|Overall Study||0
6326072|NCT00489268|7232421|FG001|NOT COMPLETED|Overall Study||0
6326073|NCT00489268|7232422|FG002|NOT COMPLETED|Overall Study||1
6326074|NCT00489268|7232423|FG003|NOT COMPLETED|Overall Study||0
6326075|NCT00489268|7232424|FG004|NOT COMPLETED|Overall Study||20
6326076|NCT00489281|7232438|FG000|STARTED|Overall Study||29
6326077|NCT00489281|7232439|FG001|STARTED|Overall Study||13
6558327|NCT01775189|7481053|FG003|STARTED|Naloxone Challenge Phase||0
6558328|NCT01775189|7481054|FG004|STARTED|Naloxone Challenge Phase||0
6326078|NCT00489281|7232438|FG000|COMPLETED|Overall Study||29
6326079|NCT00489281|7232439|FG001|COMPLETED|Overall Study||13
6326080|NCT00489281|7232438|FG000|NOT COMPLETED|Overall Study||0
6326081|NCT00489281|7232439|FG001|NOT COMPLETED|Overall Study||0
6326082|NCT00489359|7232447|FG000|STARTED|Overall Study||20
6326083|NCT00489359|7232448|FG001|STARTED|Overall Study||66
6326084|NCT00489359|7232447|FG000|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
6326085|NCT00489359|7232448|FG001|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
6326086|NCT00489359|7232447|FG000|NOT COMPLETED|Overall Study||7
6326087|NCT00489359|7232448|FG001|NOT COMPLETED|Overall Study||29
6326088|NCT00489411|7232461|FG000|STARTED|Initial Treatment Period (Weeks 1-5)||115
6326089|NCT00489411|7232462|FG001|STARTED|Initial Treatment Period (Weeks 1-5)||116
6326090|NCT00489411|7232461|FG000|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
6326091|NCT00489411|7232462|FG001|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
6326092|NCT00489411|7232461|FG000|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
6326093|NCT00489411|7232462|FG001|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
6326094|NCT00489411|7232461|FG000|STARTED|Washout Period (Weeks 6-7)||87
6558329|NCT01775189|7481055|FG005|STARTED|Naloxone Challenge Phase||0
6558330|NCT01775189|7481056|FG006|STARTED|Naloxone Challenge Phase||0
6558331|NCT01775189|7481050|FG000|COMPLETED|Naloxone Challenge Phase||45
6558332|NCT01775189|7481051|FG001|COMPLETED|Naloxone Challenge Phase||0
6558333|NCT01775189|7481052|FG002|COMPLETED|Naloxone Challenge Phase||0
6558334|NCT01775189|7481053|FG003|COMPLETED|Naloxone Challenge Phase||0
6558335|NCT01775189|7481054|FG004|COMPLETED|Naloxone Challenge Phase||0
6558336|NCT01775189|7481055|FG005|COMPLETED|Naloxone Challenge Phase||0
6558337|NCT01775189|7481056|FG006|COMPLETED|Naloxone Challenge Phase||0
6558338|NCT01775189|7481050|FG000|NOT COMPLETED|Naloxone Challenge Phase||0
6558339|NCT01775189|7481051|FG001|NOT COMPLETED|Naloxone Challenge Phase||0
6558340|NCT01775189|7481052|FG002|NOT COMPLETED|Naloxone Challenge Phase||0
6558341|NCT01775189|7481053|FG003|NOT COMPLETED|Naloxone Challenge Phase||0
6558342|NCT01775189|7481054|FG004|NOT COMPLETED|Naloxone Challenge Phase||0
6558343|NCT01775189|7481055|FG005|NOT COMPLETED|Naloxone Challenge Phase||0
6558344|NCT01775189|7481056|FG006|NOT COMPLETED|Naloxone Challenge Phase||0
6558345|NCT01775189|7481050|FG000|STARTED|Drug Discrimination Phase: Day 1||0
6558346|NCT01775189|7481051|FG001|STARTED|Drug Discrimination Phase: Day 1||22
6558347|NCT01775189|7481052|FG002|STARTED|Drug Discrimination Phase: Day 1||23
6558348|NCT01775189|7481053|FG003|STARTED|Drug Discrimination Phase: Day 1||0
6558349|NCT01775189|7481054|FG004|STARTED|Drug Discrimination Phase: Day 1||0
6558350|NCT01775189|7481055|FG005|STARTED|Drug Discrimination Phase: Day 1||0
6558351|NCT01775189|7481056|FG006|STARTED|Drug Discrimination Phase: Day 1||0
6558352|NCT01775189|7481050|FG000|COMPLETED|Drug Discrimination Phase: Day 1||0
6558353|NCT01775189|7481051|FG001|COMPLETED|Drug Discrimination Phase: Day 1||19
6558354|NCT01775189|7481052|FG002|COMPLETED|Drug Discrimination Phase: Day 1||23
6558355|NCT01775189|7481053|FG003|COMPLETED|Drug Discrimination Phase: Day 1||0
6558356|NCT01775189|7481054|FG004|COMPLETED|Drug Discrimination Phase: Day 1||0
6558357|NCT01775189|7481055|FG005|COMPLETED|Drug Discrimination Phase: Day 1||0
6326095|NCT00489411|7232462|FG001|STARTED|Washout Period (Weeks 6-7)||94
6326096|NCT00489411|7232461|FG000|COMPLETED|Washout Period (Weeks 6-7)||85
6326097|NCT00489411|7232462|FG001|COMPLETED|Washout Period (Weeks 6-7)||93
6326098|NCT00489411|7232461|FG000|NOT COMPLETED|Washout Period (Weeks 6-7)||2
6326099|NCT00489411|7232462|FG001|NOT COMPLETED|Washout Period (Weeks 6-7)||1
6326100|NCT00489411|7232461|FG000|STARTED|Crossover Treatment Period (Weeks 8-12)||85
6326101|NCT00489411|7232462|FG001|STARTED|Crossover Treatment Period (Weeks 8-12)||93
6326102|NCT00489411|7232461|FG000|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
6326103|NCT00489411|7232462|FG001|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
6326104|NCT00489411|7232461|FG000|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
6326105|NCT00489411|7232462|FG001|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
6326106|NCT00489424|7232471|FG000|STARTED|Overall Study||267
6326107|NCT00489424|7232472|FG001|STARTED|Overall Study||264
6326108|NCT00489424|7232473|FG002|STARTED|Overall Study||262
6326109|NCT00489424|7232471|FG000|COMPLETED|Overall Study||263
6326110|NCT00489424|7232472|FG001|COMPLETED|Overall Study||259
6326111|NCT00489424|7232473|FG002|COMPLETED|Overall Study||257
6326112|NCT00489424|7232471|FG000|NOT COMPLETED|Overall Study||4
6326113|NCT00489424|7232472|FG001|NOT COMPLETED|Overall Study||5
6326114|NCT00489424|7232473|FG002|NOT COMPLETED|Overall Study||5
6326115|NCT00489476|7232485|FG000|STARTED|Overall Study||39
6326116|NCT00489476|7232486|FG001|STARTED|Overall Study||43
6326117|NCT00489476|7232487|FG002|STARTED|Overall Study||43
6326118|NCT00489476|7232488|FG003|STARTED|Overall Study||43
6326119|NCT00489476|7232485|FG000|COMPLETED|Overall Study||39
6326120|NCT00489476|7232486|FG001|COMPLETED|Overall Study||42
6326121|NCT00489476|7232487|FG002|COMPLETED|Overall Study||43
6326122|NCT00489476|7232488|FG003|COMPLETED|Overall Study||43
6326123|NCT00489476|7232485|FG000|NOT COMPLETED|Overall Study||0
6326124|NCT00489476|7232486|FG001|NOT COMPLETED|Overall Study||1
6326125|NCT00489476|7232487|FG002|NOT COMPLETED|Overall Study||0
6326126|NCT00489476|7232488|FG003|NOT COMPLETED|Overall Study||0
6326127|NCT00489489|7232501|FG000|STARTED|Overall Study|randomized|41
6558358|NCT01775189|7481056|FG006|COMPLETED|Drug Discrimination Phase: Day 1||0
6558359|NCT01775189|7481050|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6326128|NCT00489489|7232502|FG001|STARTED|Overall Study|randomized|37
6326129|NCT00489489|7232503|FG002|STARTED|Overall Study|randomized|40
6326130|NCT00489489|7232501|FG000|Treated|Overall Study||41
6326131|NCT00489489|7232502|FG001|Treated|Overall Study||36
6326132|NCT00489489|7232503|FG002|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
6326133|NCT00489489|7232501|FG000|COMPLETED|Overall Study|completed treatment period|38
6326134|NCT00489489|7232502|FG001|COMPLETED|Overall Study|completed treatment period|32
6326135|NCT00489489|7232503|FG002|COMPLETED|Overall Study|completed treatment period|37
6326136|NCT00489489|7232501|FG000|NOT COMPLETED|Overall Study||3
6326137|NCT00489489|7232502|FG001|NOT COMPLETED|Overall Study||5
6326138|NCT00489489|7232503|FG002|NOT COMPLETED|Overall Study||3
6326139|NCT00489541|7232515|FG000|STARTED|12-Month Clinical Follow-up||224
6326140|NCT00489541|7232516|FG001|STARTED|12-Month Clinical Follow-up||125
6326141|NCT00489541|7232515|FG000|COMPLETED|12-Month Clinical Follow-up||215
6326142|NCT00489541|7232516|FG001|COMPLETED|12-Month Clinical Follow-up||120
6326143|NCT00489541|7232515|FG000|NOT COMPLETED|12-Month Clinical Follow-up||9
6326144|NCT00489541|7232516|FG001|NOT COMPLETED|12-Month Clinical Follow-up||5
6326145|NCT00489541|7232515|FG000|STARTED|9-Month Angiographic Follow-up||224
6326146|NCT00489541|7232516|FG001|STARTED|9-Month Angiographic Follow-up||125
6326147|NCT00489541|7232515|FG000|COMPLETED|9-Month Angiographic Follow-up||197
6326148|NCT00489541|7232516|FG001|COMPLETED|9-Month Angiographic Follow-up||108
6326149|NCT00489541|7232515|FG000|NOT COMPLETED|9-Month Angiographic Follow-up||27
6326150|NCT00489541|7232516|FG001|NOT COMPLETED|9-Month Angiographic Follow-up||17
6326151|NCT00489554|7232522|FG000|STARTED|Overall Study||230
6326152|NCT00489554|7232522|FG000|COMPLETED|Overall Study||226
6326153|NCT00489554|7232522|FG000|NOT COMPLETED|Overall Study||4
6326154|NCT00489736|7232528|FG000|STARTED|Overall Study|Randomized and treated patients|249
6326155|NCT00489736|7232529|FG001|STARTED|Overall Study|Randomized and treated patients|255
6326156|NCT00489736|7232528|FG000|COMPLETED|Overall Study|completed study drug period|153
6326157|NCT00489736|7232529|FG001|COMPLETED|Overall Study|completed study drug period|186
6326158|NCT00489736|7232528|FG000|NOT COMPLETED|Overall Study||96
6326159|NCT00489736|7232529|FG001|NOT COMPLETED|Overall Study||69
6326160|NCT00489827|7232537|FG000|STARTED|Overall Study||430
6326161|NCT00489827|7232538|FG001|STARTED|Overall Study||435
6326162|NCT00489827|7232537|FG000|COMPLETED|Overall Study||428
6326163|NCT00489827|7232538|FG001|COMPLETED|Overall Study||433
6326164|NCT00489827|7232537|FG000|NOT COMPLETED|Overall Study||2
6326165|NCT00489827|7232538|FG001|NOT COMPLETED|Overall Study||2
6326166|NCT00489853|7232544|FG000|STARTED|Treatment Period 1||36
6326167|NCT00489853|7232545|FG001|STARTED|Treatment Period 1||37
6326168|NCT00489853|7232546|FG002|STARTED|Treatment Period 1||38
6326169|NCT00489853|7232544|FG000|COMPLETED|Treatment Period 1||36
6326170|NCT00489853|7232545|FG001|COMPLETED|Treatment Period 1||37
6326171|NCT00489853|7232546|FG002|COMPLETED|Treatment Period 1||38
6326172|NCT00489853|7232544|FG000|NOT COMPLETED|Treatment Period 1||0
6326173|NCT00489853|7232545|FG001|NOT COMPLETED|Treatment Period 1||0
6326174|NCT00489853|7232546|FG002|NOT COMPLETED|Treatment Period 1||0
6326175|NCT00489853|7232544|FG000|STARTED|Wash-out Period 1||36
6326176|NCT00489853|7232545|FG001|STARTED|Wash-out Period 1||37
6326177|NCT00489853|7232546|FG002|STARTED|Wash-out Period 1||38
6326178|NCT00489853|7232544|FG000|COMPLETED|Wash-out Period 1||35
6326179|NCT00489853|7232545|FG001|COMPLETED|Wash-out Period 1||34
6326180|NCT00489853|7232546|FG002|COMPLETED|Wash-out Period 1||32
6326181|NCT00489853|7232544|FG000|NOT COMPLETED|Wash-out Period 1||1
6326182|NCT00489853|7232545|FG001|NOT COMPLETED|Wash-out Period 1||3
6326183|NCT00489853|7232546|FG002|NOT COMPLETED|Wash-out Period 1||6
6326184|NCT00489853|7232544|FG000|STARTED|Treatment Period 2||33
6326185|NCT00489853|7232545|FG001|STARTED|Treatment Period 2||35
6326186|NCT00489853|7232546|FG002|STARTED|Treatment Period 2||33
6326187|NCT00489853|7232544|FG000|COMPLETED|Treatment Period 2||33
6326188|NCT00489853|7232545|FG001|COMPLETED|Treatment Period 2||35
6326189|NCT00489853|7232546|FG002|COMPLETED|Treatment Period 2||33
6326190|NCT00489853|7232544|FG000|NOT COMPLETED|Treatment Period 2||0
6326191|NCT00489853|7232545|FG001|NOT COMPLETED|Treatment Period 2||0
6326192|NCT00489853|7232546|FG002|NOT COMPLETED|Treatment Period 2||0
6326193|NCT00489853|7232544|FG000|STARTED|Wash-out Period 2||33
6326194|NCT00489853|7232545|FG001|STARTED|Wash-out Period 2||35
6326195|NCT00489853|7232546|FG002|STARTED|Wash-out Period 2||33
6326196|NCT00489853|7232544|FG000|COMPLETED|Wash-out Period 2||29
6326197|NCT00489853|7232545|FG001|COMPLETED|Wash-out Period 2||32
6326198|NCT00489853|7232546|FG002|COMPLETED|Wash-out Period 2||31
6326199|NCT00489853|7232544|FG000|NOT COMPLETED|Wash-out Period 2||4
6326200|NCT00489853|7232545|FG001|NOT COMPLETED|Wash-out Period 2||3
6326201|NCT00489853|7232546|FG002|NOT COMPLETED|Wash-out Period 2||2
6326202|NCT00489853|7232544|FG000|STARTED|Treatment Period 3||29
6326203|NCT00489853|7232545|FG001|STARTED|Treatment Period 3||30
6326204|NCT00489853|7232546|FG002|STARTED|Treatment Period 3||33
6326205|NCT00489853|7232544|FG000|COMPLETED|Treatment Period 3||29
6326206|NCT00489853|7232545|FG001|COMPLETED|Treatment Period 3||29
6326207|NCT00489853|7232546|FG002|COMPLETED|Treatment Period 3||33
6326208|NCT00489853|7232544|FG000|NOT COMPLETED|Treatment Period 3||0
6326209|NCT00489853|7232545|FG001|NOT COMPLETED|Treatment Period 3||1
6326210|NCT00489853|7232546|FG002|NOT COMPLETED|Treatment Period 3||0
6326211|NCT00489853|7232544|FG000|STARTED|Follow-up Period||29
6326212|NCT00489853|7232545|FG001|STARTED|Follow-up Period||29
6326213|NCT00489853|7232546|FG002|STARTED|Follow-up Period||33
6326214|NCT00489853|7232544|FG000|COMPLETED|Follow-up Period||29
6326215|NCT00489853|7232545|FG001|COMPLETED|Follow-up Period||29
6326216|NCT00489853|7232546|FG002|COMPLETED|Follow-up Period||33
6326217|NCT00489853|7232544|FG000|NOT COMPLETED|Follow-up Period||0
6326218|NCT00489853|7232545|FG001|NOT COMPLETED|Follow-up Period||0
6326219|NCT00489853|7232546|FG002|NOT COMPLETED|Follow-up Period||0
6326220|NCT00489866|7232556|FG000|STARTED|Overall Study||7
6326221|NCT00489866|7232557|FG001|STARTED|Overall Study||7
6326222|NCT00489866|7232556|FG000|COMPLETED|Overall Study||5
6326223|NCT00489866|7232557|FG001|COMPLETED|Overall Study||7
6326224|NCT00489866|7232556|FG000|NOT COMPLETED|Overall Study||2
6326225|NCT00489866|7232557|FG001|NOT COMPLETED|Overall Study||0
6326226|NCT00489918|7232576|FG000|STARTED|Overall Study||33
6326227|NCT00489918|7232577|FG001|STARTED|Overall Study||34
6326228|NCT00489918|7232578|FG002|STARTED|Overall Study||32
6326229|NCT00489918|7232579|FG003|STARTED|Overall Study||33
6326230|NCT00489918|7232580|FG004|STARTED|Overall Study||33
6326231|NCT00489918|7232576|FG000|COMPLETED|Overall Study||31
6326232|NCT00489918|7232577|FG001|COMPLETED|Overall Study||32
6326233|NCT00489918|7232578|FG002|COMPLETED|Overall Study||28
6326234|NCT00489918|7232579|FG003|COMPLETED|Overall Study||32
6326235|NCT00489918|7232580|FG004|COMPLETED|Overall Study||32
6326236|NCT00489918|7232576|FG000|NOT COMPLETED|Overall Study||2
6326237|NCT00489918|7232577|FG001|NOT COMPLETED|Overall Study||2
6326238|NCT00489918|7232578|FG002|NOT COMPLETED|Overall Study||4
6326239|NCT00489918|7232579|FG003|NOT COMPLETED|Overall Study||1
6326240|NCT00489918|7232580|FG004|NOT COMPLETED|Overall Study||1
6326241|NCT00489970|7232595|FG000|STARTED|Persistence Year 1||1069
6326242|NCT00489970|7232596|FG001|STARTED|Persistence Year 1||523
6326243|NCT00489970|7232597|FG002|STARTED|Persistence Year 1||0
6326244|NCT00489970|7232595|FG000|COMPLETED|Persistence Year 1||1069
6326245|NCT00489970|7232596|FG001|COMPLETED|Persistence Year 1||523
6326246|NCT00489970|7232597|FG002|COMPLETED|Persistence Year 1||0
6326247|NCT00489970|7232595|FG000|NOT COMPLETED|Persistence Year 1||0
6326248|NCT00489970|7232596|FG001|NOT COMPLETED|Persistence Year 1||0
6326249|NCT00489970|7232597|FG002|NOT COMPLETED|Persistence Year 1||0
6326250|NCT00489970|7232595|FG000|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
6326251|NCT00489970|7232596|FG001|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
6326252|NCT00489970|7232597|FG002|STARTED|Persistence Year 3||0
6326253|NCT00489970|7232595|FG000|COMPLETED|Persistence Year 3||1019
6326254|NCT00489970|7232596|FG001|COMPLETED|Persistence Year 3||486
6326255|NCT00489970|7232597|FG002|COMPLETED|Persistence Year 3||0
6326256|NCT00489970|7232595|FG000|NOT COMPLETED|Persistence Year 3||0
6326257|NCT00489970|7232596|FG001|NOT COMPLETED|Persistence Year 3||0
6326258|NCT00489970|7232597|FG002|NOT COMPLETED|Persistence Year 3||0
6326259|NCT00489970|7232595|FG000|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
6326260|NCT00489970|7232596|FG001|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
6326261|NCT00489970|7232597|FG002|STARTED|Persistence Year 5||0
6326262|NCT00489970|7232595|FG000|COMPLETED|Persistence Year 5||856
6326263|NCT00489970|7232596|FG001|COMPLETED|Persistence Year 5||401
6326264|NCT00489970|7232597|FG002|COMPLETED|Persistence Year 5||0
6326265|NCT00489970|7232595|FG000|NOT COMPLETED|Persistence Year 5||0
6326266|NCT00489970|7232596|FG001|NOT COMPLETED|Persistence Year 5||0
6326267|NCT00489970|7232597|FG002|NOT COMPLETED|Persistence Year 5||0
6326268|NCT00489970|7232595|FG000|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|309
6326269|NCT00489970|7232596|FG001|STARTED|Persistence Year 9|Number of subjects who returned at Year 9.|138
6326270|NCT00489970|7232597|FG002|STARTED|Persistence Year 9|Number of subjects who received the first dose at Year 9.|362
6326271|NCT00489970|7232595|FG000|COMPLETED|Persistence Year 9||306
6326272|NCT00489970|7232596|FG001|COMPLETED|Persistence Year 9||136
6326273|NCT00489970|7232597|FG002|COMPLETED|Persistence Year 9||357
6326274|NCT00489970|7232595|FG000|NOT COMPLETED|Persistence Year 9||3
6326275|NCT00489970|7232596|FG001|NOT COMPLETED|Persistence Year 9||2
6326276|NCT00489970|7232597|FG002|NOT COMPLETED|Persistence Year 9||5
6326277|NCT00490009|7232608|FG000|STARTED|Overall Study||9
6326278|NCT00490009|7232608|FG000|COMPLETED|Overall Study||9
6326279|NCT00490009|7232608|FG000|NOT COMPLETED|Overall Study||0
6326280|NCT00490022|7232615|FG000|STARTED|Overall Study||16
6326281|NCT00490022|7232616|FG001|STARTED|Overall Study||15
6326282|NCT00490022|7232615|FG000|COMPLETED|Overall Study||15
6326283|NCT00490022|7232616|FG001|COMPLETED|Overall Study||12
6326284|NCT00490022|7232615|FG000|NOT COMPLETED|Overall Study||1
6558360|NCT01775189|7481051|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
6558361|NCT01775189|7481052|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6558362|NCT01775189|7481053|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6558363|NCT01775189|7481054|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6558364|NCT01775189|7481055|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6326285|NCT00490022|7232616|FG001|NOT COMPLETED|Overall Study||3
6326286|NCT00490035|7232626|FG000|STARTED|Overall Study||100
6326287|NCT00490035|7232627|FG001|STARTED|Overall Study||99
6326288|NCT00490035|7232628|FG002|STARTED|Overall Study||100
6326289|NCT00490035|7232629|FG003|STARTED|Overall Study||100
6326290|NCT00490035|7232626|FG000|COMPLETED|Overall Study||92
6326291|NCT00490035|7232627|FG001|COMPLETED|Overall Study||93
6326292|NCT00490035|7232628|FG002|COMPLETED|Overall Study||88
6558365|NCT01775189|7481056|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
6558366|NCT01775189|7481050|FG000|STARTED|Drug Discrimination Phase: Day 2||0
6326293|NCT00490035|7232629|FG003|COMPLETED|Overall Study||94
6326294|NCT00490035|7232626|FG000|NOT COMPLETED|Overall Study||8
6326295|NCT00490035|7232627|FG001|NOT COMPLETED|Overall Study||6
6326296|NCT00490035|7232628|FG002|NOT COMPLETED|Overall Study||12
6326297|NCT00490035|7232629|FG003|NOT COMPLETED|Overall Study||6
6326298|NCT00490061|7232639|FG000|STARTED|Overall Study||17
6326299|NCT00490061|7232639|FG000|COMPLETED|Overall Study||16
6326300|NCT00490061|7232639|FG000|NOT COMPLETED|Overall Study||1
6326301|NCT00490100|7232643|FG000|STARTED|Overall Study||6
6326302|NCT00490100|7232643|FG000|COMPLETED|Overall Study||3
6326303|NCT00490100|7232643|FG000|NOT COMPLETED|Overall Study||3
6326304|NCT00490139|7232652|FG000|STARTED|Overall Study||2093
6326305|NCT00490139|7232653|FG001|STARTED|Overall Study||2091
6326306|NCT00490139|7232654|FG002|STARTED|Overall Study||2100
6326307|NCT00490139|7232655|FG003|STARTED|Overall Study||2097
6326308|NCT00490139|7232652|FG000|COMPLETED|Overall Study||1785
6326309|NCT00490139|7232653|FG001|COMPLETED|Overall Study||1816
6326310|NCT00490139|7232654|FG002|COMPLETED|Overall Study||1666
6326311|NCT00490139|7232655|FG003|COMPLETED|Overall Study||1790
6326312|NCT00490139|7232652|FG000|NOT COMPLETED|Overall Study||308
6326313|NCT00490139|7232653|FG001|NOT COMPLETED|Overall Study||275
6326314|NCT00490139|7232654|FG002|NOT COMPLETED|Overall Study||434
6326315|NCT00490139|7232655|FG003|NOT COMPLETED|Overall Study||307
6326316|NCT00490256|7232669|FG000|STARTED|Overall Study||7
6326317|NCT00490256|7232670|FG001|STARTED|Overall Study||7
6326318|NCT00490256|7232669|FG000|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
6326319|NCT00490256|7232670|FG001|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
6326320|NCT00490256|7232669|FG000|COMPLETED|Overall Study||7
6326321|NCT00490256|7232670|FG001|COMPLETED|Overall Study||7
6326322|NCT00490256|7232669|FG000|NOT COMPLETED|Overall Study||0
6326323|NCT00490256|7232670|FG001|NOT COMPLETED|Overall Study||0
6326324|NCT00490269|7232678|FG000|STARTED|Dronabinol Then Placebo||6
6326325|NCT00490269|7232679|FG001|STARTED|Dronabinol Then Placebo||6
6326326|NCT00490269|7232678|FG000|COMPLETED|Dronabinol Then Placebo||6
6326327|NCT00490269|7232679|FG001|COMPLETED|Dronabinol Then Placebo||6
6326328|NCT00490269|7232678|FG000|NOT COMPLETED|Dronabinol Then Placebo||0
6326329|NCT00490269|7232679|FG001|NOT COMPLETED|Dronabinol Then Placebo||0
6326330|NCT00490269|7232678|FG000|STARTED|Placebo Then Dronabinol||6
6326331|NCT00490269|7232679|FG001|STARTED|Placebo Then Dronabinol||6
6326332|NCT00490269|7232678|FG000|COMPLETED|Placebo Then Dronabinol||6
6326333|NCT00490269|7232679|FG001|COMPLETED|Placebo Then Dronabinol||6
6326334|NCT00490269|7232678|FG000|NOT COMPLETED|Placebo Then Dronabinol||0
6326335|NCT00490269|7232679|FG001|NOT COMPLETED|Placebo Then Dronabinol||0
6326336|NCT00490282|7232685|FG000|STARTED|Overall Study||25
6326337|NCT00490282|7232685|FG000|COMPLETED|Overall Study||22
6326338|NCT00490282|7232685|FG000|NOT COMPLETED|Overall Study||3
6326339|NCT00490451|7232692|FG000|STARTED|Overall Study||63
6326340|NCT00490451|7232693|FG001|STARTED|Overall Study||38
6326341|NCT00490451|7232692|FG000|COMPLETED|Overall Study||0
6326342|NCT00490451|7232693|FG001|COMPLETED|Overall Study||0
6326343|NCT00490451|7232692|FG000|NOT COMPLETED|Overall Study||63
6326344|NCT00490451|7232693|FG001|NOT COMPLETED|Overall Study||38
6326345|NCT00490477|7232701|FG000|STARTED|Overall Study||8
6326346|NCT00490477|7232702|FG001|STARTED|Overall Study||8
6326347|NCT00490477|7232701|FG000|COMPLETED|Overall Study||8
6326348|NCT00490477|7232702|FG001|COMPLETED|Overall Study||8
6326349|NCT00490477|7232701|FG000|NOT COMPLETED|Overall Study||0
6326350|NCT00490477|7232702|FG001|NOT COMPLETED|Overall Study||0
6326351|NCT00490490|7232708|FG000|STARTED|Completed Assessment for CR||8
6326352|NCT00490490|7232708|FG000|COMPLETED|Completed Assessment for CR||8
6326353|NCT00490490|7232708|FG000|NOT COMPLETED|Completed Assessment for CR||0
6326354|NCT00490490|7232708|FG000|STARTED|Completed Assessment for TTP||8
6326355|NCT00490490|7232708|FG000|COMPLETED|Completed Assessment for TTP||5
6326356|NCT00490490|7232708|FG000|NOT COMPLETED|Completed Assessment for TTP||3
6326357|NCT00490529|7232712|FG000|STARTED|Completed Pre-CpG-MCL Vaccine Procedures||59
6326358|NCT00490529|7232712|FG000|COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||48
6326359|NCT00490529|7232712|FG000|NOT COMPLETED|Completed Pre-CpG-MCL Vaccine Procedures||11
6326360|NCT00490529|7232712|FG000|STARTED|Treatment With CpG-MCL Vaccine||48
6326361|NCT00490529|7232712|FG000|COMPLETED|Treatment With CpG-MCL Vaccine||47
6326362|NCT00490529|7232712|FG000|NOT COMPLETED|Treatment With CpG-MCL Vaccine||1
6326363|NCT00490542|7232718|FG000|STARTED|Overall Study||38
6326364|NCT00490542|7232719|FG001|STARTED|Overall Study||35
6326365|NCT00490542|7232718|FG000|COMPLETED|Overall Study||31
6326366|NCT00490542|7232719|FG001|COMPLETED|Overall Study||31
6326367|NCT00490542|7232718|FG000|NOT COMPLETED|Overall Study||7
6326368|NCT00490542|7232719|FG001|NOT COMPLETED|Overall Study||4
6326369|NCT00490555|7232729|FG000|STARTED|Overall Study||8
6326370|NCT00490555|7232730|FG001|STARTED|Overall Study||8
6326371|NCT00490555|7232731|FG002|STARTED|Overall Study||9
6326372|NCT00490555|7232732|FG003|STARTED|Overall Study||7
6326373|NCT00490555|7232729|FG000|COMPLETED|Overall Study||8
6326374|NCT00490555|7232730|FG001|COMPLETED|Overall Study||8
6326375|NCT00490555|7232731|FG002|COMPLETED|Overall Study||7
6326376|NCT00490555|7232732|FG003|COMPLETED|Overall Study||7
6326377|NCT00490555|7232729|FG000|NOT COMPLETED|Overall Study||0
6326378|NCT00490555|7232730|FG001|NOT COMPLETED|Overall Study||0
6326379|NCT00490555|7232731|FG002|NOT COMPLETED|Overall Study||2
6326380|NCT00490555|7232732|FG003|NOT COMPLETED|Overall Study||0
6326381|NCT00490568|7232742|FG000|STARTED|Overall Study||1461
6326382|NCT00490568|7232742|FG000|COMPLETED|Overall Study||97
6326383|NCT00490568|7232742|FG000|NOT COMPLETED|Overall Study||1364
6326384|NCT00490646|7232749|FG000|STARTED|Overall Study||25
6326385|NCT00490646|7232750|FG001|STARTED|Overall Study||25
6326386|NCT00490646|7232749|FG000|Treated|Overall Study||24
6326387|NCT00490646|7232750|FG001|Treated|Overall Study||24
6326388|NCT00490646|7232749|FG000|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
6326389|NCT00490646|7232750|FG001|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
6326390|NCT00490646|7232749|FG000|NOT COMPLETED|Overall Study||2
6326391|NCT00490646|7232750|FG001|NOT COMPLETED|Overall Study||2
6326392|NCT00490698|7232756|FG000|STARTED|Overall Study||11
6326393|NCT00490698|7232756|FG000|COMPLETED|Overall Study||1
6326394|NCT00490698|7232756|FG000|NOT COMPLETED|Overall Study||10
6326395|NCT00490724|7232763|FG000|STARTED|Period I||21
6326396|NCT00490724|7232764|FG001|STARTED|Period I||20
6326397|NCT00490724|7232765|FG002|STARTED|Period I||20
6326398|NCT00490724|7232763|FG000|COMPLETED|Period I||21
6326399|NCT00490724|7232764|FG001|COMPLETED|Period I||20
6326400|NCT00490724|7232765|FG002|COMPLETED|Period I||19
6326401|NCT00490724|7232763|FG000|NOT COMPLETED|Period I||0
6326402|NCT00490724|7232764|FG001|NOT COMPLETED|Period I||0
6326403|NCT00490724|7232765|FG002|NOT COMPLETED|Period I||1
6326404|NCT00490724|7232763|FG000|STARTED|Period II||21
6326405|NCT00490724|7232764|FG001|STARTED|Period II||20
6326406|NCT00490724|7232765|FG002|STARTED|Period II||19
6326407|NCT00490724|7232763|FG000|COMPLETED|Period II||18
6326408|NCT00490724|7232764|FG001|COMPLETED|Period II||19
6326409|NCT00490724|7232765|FG002|COMPLETED|Period II||16
6326410|NCT00490724|7232763|FG000|NOT COMPLETED|Period II||3
6326411|NCT00490724|7232764|FG001|NOT COMPLETED|Period II||1
6326412|NCT00490724|7232765|FG002|NOT COMPLETED|Period II||3
6326413|NCT00490802|7232775|FG000|STARTED|Overall Study||10
6326414|NCT00490802|7232776|FG001|STARTED|Overall Study||9
6326415|NCT00490802|7232775|FG000|COMPLETED|Overall Study||9
6326416|NCT00490802|7232776|FG001|COMPLETED|Overall Study||7
6326417|NCT00490802|7232775|FG000|NOT COMPLETED|Overall Study||1
6326418|NCT00490802|7232776|FG001|NOT COMPLETED|Overall Study||2
6326419|NCT00490815|7232785|FG000|STARTED|Overall Study||20
6326420|NCT00490815|7232786|FG001|STARTED|Overall Study||17
6326421|NCT00490815|7232785|FG000|COMPLETED|Overall Study||12
6326422|NCT00490815|7232786|FG001|COMPLETED|Overall Study||8
6326423|NCT00490815|7232785|FG000|NOT COMPLETED|Overall Study||8
6326424|NCT00490815|7232786|FG001|NOT COMPLETED|Overall Study||9
6326425|NCT00490841|7232792|FG000|STARTED|Overall Study||202
6326426|NCT00490841|7232792|FG000|COMPLETED|Overall Study||189
6326427|NCT00490841|7232792|FG000|NOT COMPLETED|Overall Study||13
6326428|NCT00490919|7232799|FG000|STARTED|Open-label Run-in Period||1024
6326429|NCT00490919|7232800|FG001|STARTED|Open-label Run-in Period||0
6326430|NCT00490919|7232801|FG002|STARTED|Open-label Run-in Period||0
6326431|NCT00490919|7232799|FG000|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
6326432|NCT00490919|7232800|FG001|COMPLETED|Open-label Run-in Period||0
6326433|NCT00490919|7232801|FG002|COMPLETED|Open-label Run-in Period||0
6326434|NCT00490919|7232799|FG000|NOT COMPLETED|Open-label Run-in Period||483
6326435|NCT00490919|7232800|FG001|NOT COMPLETED|Open-label Run-in Period||0
6326436|NCT00490919|7232801|FG002|NOT COMPLETED|Open-label Run-in Period||0
6326437|NCT00490919|7232799|FG000|STARTED|Double-blind Phase||0
6326438|NCT00490919|7232800|FG001|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
6326439|NCT00490919|7232801|FG002|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
6326440|NCT00490919|7232799|FG000|COMPLETED|Double-blind Phase||0
6326441|NCT00490919|7232800|FG001|COMPLETED|Double-blind Phase||170
6326442|NCT00490919|7232801|FG002|COMPLETED|Double-blind Phase||199
6326443|NCT00490919|7232799|FG000|NOT COMPLETED|Double-blind Phase||0
6326444|NCT00490919|7232800|FG001|NOT COMPLETED|Double-blind Phase||86
6326445|NCT00490919|7232801|FG002|NOT COMPLETED|Double-blind Phase||84
6326446|NCT00490945|7232813|FG000|STARTED|Overall Study||8
6326447|NCT00490945|7232814|FG001|STARTED|Overall Study||9
6326448|NCT00490945|7232815|FG002|STARTED|Overall Study||8
6326449|NCT00490945|7232816|FG003|STARTED|Overall Study||7
6326450|NCT00490945|7232817|FG004|STARTED|Overall Study||7
6326451|NCT00490945|7232813|FG000|COMPLETED|Overall Study||8
6326452|NCT00490945|7232814|FG001|COMPLETED|Overall Study||8
6326453|NCT00490945|7232815|FG002|COMPLETED|Overall Study||8
6326454|NCT00490945|7232816|FG003|COMPLETED|Overall Study||7
6326455|NCT00490945|7232817|FG004|COMPLETED|Overall Study||7
6326456|NCT00490945|7232813|FG000|NOT COMPLETED|Overall Study||0
6326457|NCT00490945|7232814|FG001|NOT COMPLETED|Overall Study||1
6326458|NCT00490945|7232815|FG002|NOT COMPLETED|Overall Study||0
6326459|NCT00490945|7232816|FG003|NOT COMPLETED|Overall Study||0
6326460|NCT00490945|7232817|FG004|NOT COMPLETED|Overall Study||0
6326461|NCT00490971|7232837|FG000|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
6326462|NCT00490971|7232838|FG001|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
6326463|NCT00490971|7232839|FG002|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6326464|NCT00490971|7232840|FG003|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6326465|NCT00490971|7232841|FG004|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6326466|NCT00490971|7232837|FG000|COMPLETED|Acute/Continuation||308
6326467|NCT00490971|7232838|FG001|COMPLETED|Acute/Continuation||86
6326468|NCT00490971|7232839|FG002|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6326469|NCT00490971|7232840|FG003|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6326470|NCT00490971|7232841|FG004|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
6326471|NCT00490971|7232837|FG000|NOT COMPLETED|Acute/Continuation||306
6326472|NCT00490971|7232838|FG001|NOT COMPLETED|Acute/Continuation||62
6326473|NCT00490971|7232839|FG002|NOT COMPLETED|Acute/Continuation||0
6326474|NCT00490971|7232840|FG003|NOT COMPLETED|Acute/Continuation||0
6326475|NCT00490971|7232841|FG004|NOT COMPLETED|Acute/Continuation||0
6326476|NCT00490971|7232837|FG000|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
6326477|NCT00490971|7232838|FG001|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
6326478|NCT00490971|7232839|FG002|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
6326479|NCT00490971|7232840|FG003|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
6326480|NCT00490971|7232841|FG004|STARTED|Maintenance||83
6326481|NCT00490971|7232837|FG000|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
6326482|NCT00490971|7232838|FG001|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
6326483|NCT00490971|7232839|FG002|COMPLETED|Maintenance||96
6326484|NCT00490971|7232840|FG003|COMPLETED|Maintenance||96
6558367|NCT01775189|7481051|FG001|STARTED|Drug Discrimination Phase: Day 2||19
6558368|NCT01775189|7481052|FG002|STARTED|Drug Discrimination Phase: Day 2||23
6558369|NCT01775189|7481053|FG003|STARTED|Drug Discrimination Phase: Day 2||0
6558370|NCT01775189|7481054|FG004|STARTED|Drug Discrimination Phase: Day 2||0
6558371|NCT01775189|7481055|FG005|STARTED|Drug Discrimination Phase: Day 2||0
6326485|NCT00490971|7232841|FG004|COMPLETED|Maintenance||44
6326486|NCT00490971|7232837|FG000|NOT COMPLETED|Maintenance||0
6326487|NCT00490971|7232838|FG001|NOT COMPLETED|Maintenance||0
6326488|NCT00490971|7232839|FG002|NOT COMPLETED|Maintenance||51
6326489|NCT00490971|7232840|FG003|NOT COMPLETED|Maintenance||53
6326490|NCT00490971|7232841|FG004|NOT COMPLETED|Maintenance||39
6326491|NCT00491075|7232853|FG000|STARTED|Overall Study||16
6326492|NCT00491075|7232853|FG000|COMPLETED|Overall Study||14
6326493|NCT00491075|7232853|FG000|NOT COMPLETED|Overall Study||2
6326494|NCT00491179|7232859|FG000|STARTED|Overall Study||25
6326495|NCT00491179|7232860|FG001|STARTED|Overall Study||10
6326496|NCT00491179|7232859|FG000|COMPLETED|Overall Study||18
6326497|NCT00491179|7232860|FG001|COMPLETED|Overall Study||8
6326498|NCT00491179|7232859|FG000|NOT COMPLETED|Overall Study||7
6326499|NCT00491179|7232860|FG001|NOT COMPLETED|Overall Study||2
6326500|NCT00491244|7232868|FG000|STARTED|Overall Study||189
6326501|NCT00491244|7232869|FG001|STARTED|Overall Study||188
6326502|NCT00491244|7232868|FG000|COMPLETED|Overall Study||162
6326503|NCT00491244|7232869|FG001|COMPLETED|Overall Study||168
6326504|NCT00491244|7232868|FG000|NOT COMPLETED|Overall Study||27
6326505|NCT00491244|7232869|FG001|NOT COMPLETED|Overall Study||20
6326506|NCT00491322|7232877|FG000|STARTED|Overall Study||41
6326507|NCT00491322|7232878|FG001|STARTED|Overall Study||51
6326508|NCT00491322|7232877|FG000|COMPLETED|Overall Study||40
6326509|NCT00491322|7232878|FG001|COMPLETED|Overall Study||50
6326510|NCT00491322|7232877|FG000|NOT COMPLETED|Overall Study||1
6326511|NCT00491322|7232878|FG001|NOT COMPLETED|Overall Study||1
6326512|NCT00491374|7232886|FG000|STARTED|Overall Study||0
6326513|NCT00491374|7232887|FG001|STARTED|Overall Study||0
6326514|NCT00491374|7232886|FG000|COMPLETED|Overall Study||0
6326515|NCT00491374|7232887|FG001|COMPLETED|Overall Study||0
6326516|NCT00491374|7232886|FG000|NOT COMPLETED|Overall Study||0
6326517|NCT00491374|7232887|FG001|NOT COMPLETED|Overall Study||0
6326518|NCT00491491|7232895|FG000|STARTED|Overall Study||22
6326519|NCT00491491|7232896|FG001|STARTED|Overall Study||21
6326520|NCT00491491|7232895|FG000|COMPLETED|Overall Study||22
6326521|NCT00491491|7232896|FG001|COMPLETED|Overall Study||21
6326522|NCT00491491|7232895|FG000|NOT COMPLETED|Overall Study||0
6326523|NCT00491491|7232896|FG001|NOT COMPLETED|Overall Study||0
6326524|NCT00491530|7232905|FG000|STARTED|Overall Study||174
6326525|NCT00491530|7232906|FG001|STARTED|Overall Study||50
6326526|NCT00491530|7232907|FG002|STARTED|Overall Study||86
6326527|NCT00491530|7232905|FG000|COMPLETED|Overall Study||162
6326528|NCT00491530|7232906|FG001|COMPLETED|Overall Study||44
6326529|NCT00491530|7232907|FG002|COMPLETED|Overall Study||81
6326530|NCT00491530|7232905|FG000|NOT COMPLETED|Overall Study||12
6326531|NCT00491530|7232906|FG001|NOT COMPLETED|Overall Study||6
6326532|NCT00491530|7232907|FG002|NOT COMPLETED|Overall Study||5
6326533|NCT00491556|7232917|FG000|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
6326534|NCT00491556|7232918|FG001|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
6326535|NCT00491556|7232917|FG000|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
6326536|NCT00491556|7232918|FG001|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
6326537|NCT00491556|7232917|FG000|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
6326538|NCT00491556|7232918|FG001|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
6326539|NCT00491556|7232917|FG000|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
6326540|NCT00491556|7232918|FG001|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
6326541|NCT00491556|7232917|FG000|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
6326542|NCT00491556|7232918|FG001|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
6326543|NCT00491556|7232917|FG000|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
6326544|NCT00491556|7232918|FG001|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
6326545|NCT00491556|7232917|FG000|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
6326546|NCT00491556|7232918|FG001|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
6326547|NCT00491608|7232924|FG000|STARTED|Overall Study|Participants who received treatment|209
6326548|NCT00491608|7232924|FG000|COMPLETED|Overall Study||206
6326549|NCT00491608|7232924|FG000|NOT COMPLETED|Overall Study||3
6326550|NCT00491751|7232931|FG000|STARTED|Overall Study||22
6326551|NCT00491751|7232932|FG001|STARTED|Overall Study||44
6326552|NCT00491751|7232933|FG002|STARTED|Overall Study||42
6326553|NCT00491751|7232931|FG000|COMPLETED|Overall Study||22
6326554|NCT00491751|7232932|FG001|COMPLETED|Overall Study||44
6326555|NCT00491751|7232933|FG002|COMPLETED|Overall Study||42
6326556|NCT00491751|7232931|FG000|NOT COMPLETED|Overall Study||0
6326557|NCT00491751|7232932|FG001|NOT COMPLETED|Overall Study||0
6558372|NCT01775189|7481056|FG006|STARTED|Drug Discrimination Phase: Day 2||0
6558373|NCT01775189|7481050|FG000|COMPLETED|Drug Discrimination Phase: Day 2||0
6558374|NCT01775189|7481051|FG001|COMPLETED|Drug Discrimination Phase: Day 2||16
6558375|NCT01775189|7481052|FG002|COMPLETED|Drug Discrimination Phase: Day 2||16
6558376|NCT01775189|7481053|FG003|COMPLETED|Drug Discrimination Phase: Day 2||0
6558377|NCT01775189|7481054|FG004|COMPLETED|Drug Discrimination Phase: Day 2||0
6558378|NCT01775189|7481055|FG005|COMPLETED|Drug Discrimination Phase: Day 2||0
6558379|NCT01775189|7481056|FG006|COMPLETED|Drug Discrimination Phase: Day 2||0
6558380|NCT01775189|7481050|FG000|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6558381|NCT01775189|7481051|FG001|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
6558382|NCT01775189|7481052|FG002|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
6558383|NCT01775189|7481053|FG003|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6558384|NCT01775189|7481054|FG004|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6558385|NCT01775189|7481055|FG005|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6558386|NCT01775189|7481056|FG006|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
6326558|NCT00491751|7232933|FG002|NOT COMPLETED|Overall Study||0
6326559|NCT00491764|7232949|FG000|STARTED|Overall Study||37
6326560|NCT00491764|7232950|FG001|STARTED|Overall Study||37
6326561|NCT00491764|7232951|FG002|STARTED|Overall Study||36
6326562|NCT00491764|7232952|FG003|STARTED|Overall Study||36
6326563|NCT00491764|7232953|FG004|STARTED|Overall Study||36
6326564|NCT00491764|7232954|FG005|STARTED|Overall Study||36
6326565|NCT00491764|7232949|FG000|COMPLETED|Overall Study||32
6326566|NCT00491764|7232950|FG001|COMPLETED|Overall Study||30
6326567|NCT00491764|7232951|FG002|COMPLETED|Overall Study||28
6326568|NCT00491764|7232952|FG003|COMPLETED|Overall Study||28
6326569|NCT00491764|7232953|FG004|COMPLETED|Overall Study||33
6326570|NCT00491764|7232954|FG005|COMPLETED|Overall Study||27
6326571|NCT00491764|7232949|FG000|NOT COMPLETED|Overall Study||5
6326572|NCT00491764|7232950|FG001|NOT COMPLETED|Overall Study||7
6326573|NCT00491764|7232951|FG002|NOT COMPLETED|Overall Study||8
6326574|NCT00491764|7232952|FG003|NOT COMPLETED|Overall Study||8
6326575|NCT00491764|7232953|FG004|NOT COMPLETED|Overall Study||3
6326576|NCT00491764|7232954|FG005|NOT COMPLETED|Overall Study||9
6326577|NCT00491829|7232971|FG000|STARTED|Overall Study||311
6326578|NCT00491829|7232972|FG001|STARTED|Overall Study||316
6326579|NCT00491829|7232973|FG002|STARTED|Overall Study||318
6326580|NCT00491829|7232971|FG000|COMPLETED|Overall Study||216
6326581|NCT00491829|7232972|FG001|COMPLETED|Overall Study||202
6326582|NCT00491829|7232973|FG002|COMPLETED|Overall Study||243
6326583|NCT00491829|7232971|FG000|NOT COMPLETED|Overall Study||95
6326584|NCT00491829|7232972|FG001|NOT COMPLETED|Overall Study||114
6326585|NCT00491829|7232973|FG002|NOT COMPLETED|Overall Study||75
6326586|NCT00491894|7232981|FG000|STARTED|Overall Study||137
6326587|NCT00491894|7232981|FG000|COMPLETED|Overall Study||103
6326588|NCT00491894|7232981|FG000|NOT COMPLETED|Overall Study||34
6326589|NCT00492024|7232987|FG000|STARTED|Treatment||251
6326590|NCT00492024|7232988|FG001|STARTED|Treatment||123
6326591|NCT00492024|7232987|FG000|COMPLETED|Treatment||222
6326592|NCT00492024|7232988|FG001|COMPLETED|Treatment||101
6326593|NCT00492024|7232987|FG000|NOT COMPLETED|Treatment||29
6326594|NCT00492024|7232988|FG001|NOT COMPLETED|Treatment||22
6326595|NCT00492024|7232987|FG000|STARTED|Follow up||222
6326596|NCT00492024|7232988|FG001|STARTED|Follow up||101
6326597|NCT00492024|7232987|FG000|COMPLETED|Follow up||221
6326598|NCT00492024|7232988|FG001|COMPLETED|Follow up||99
6326599|NCT00492024|7232987|FG000|NOT COMPLETED|Follow up||1
6326600|NCT00492024|7232988|FG001|NOT COMPLETED|Follow up||2
6326601|NCT00492063|7232998|FG000|STARTED|Overall Study||652
6326602|NCT00492063|7232999|FG001|STARTED|Overall Study||648
6326603|NCT00492063|7233000|FG002|STARTED|Overall Study||678
6326604|NCT00492063|7233001|FG003|STARTED|Overall Study||676
6326605|NCT00492063|7232998|FG000|COMPLETED|Overall Study||642
6326606|NCT00492063|7232999|FG001|COMPLETED|Overall Study||634
6326607|NCT00492063|7233000|FG002|COMPLETED|Overall Study||667
6326608|NCT00492063|7233001|FG003|COMPLETED|Overall Study||666
6326609|NCT00492063|7232998|FG000|NOT COMPLETED|Overall Study||10
6326610|NCT00492063|7232999|FG001|NOT COMPLETED|Overall Study||14
6326611|NCT00492063|7233000|FG002|NOT COMPLETED|Overall Study||11
6326612|NCT00492063|7233001|FG003|NOT COMPLETED|Overall Study||10
6326613|NCT00492089|7233013|FG000|STARTED|First Intervention (6 Weeks)||5
6326614|NCT00492089|7233014|FG001|STARTED|First Intervention (6 Weeks)||6
6326615|NCT00492089|7233013|FG000|COMPLETED|First Intervention (6 Weeks)||5
6326616|NCT00492089|7233014|FG001|COMPLETED|First Intervention (6 Weeks)||6
6326617|NCT00492089|7233013|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
6326618|NCT00492089|7233014|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
6326619|NCT00492089|7233013|FG000|STARTED|Second Intervention (6 Weeks)||5
6326620|NCT00492089|7233014|FG001|STARTED|Second Intervention (6 Weeks)||6
6326621|NCT00492089|7233013|FG000|COMPLETED|Second Intervention (6 Weeks)||5
6326622|NCT00492089|7233014|FG001|COMPLETED|Second Intervention (6 Weeks)||6
6326623|NCT00492089|7233013|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6326624|NCT00492089|7233014|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6326625|NCT00492115|7233022|FG000|STARTED|Overall Study||19
6326626|NCT00492115|7233023|FG001|STARTED|Overall Study||19
6326627|NCT00492115|7233022|FG000|COMPLETED|Overall Study|3 dropped due to anxiety or not being able to tolerate CPAP|16
6326628|NCT00492115|7233023|FG001|COMPLETED|Overall Study|4 dropped due to not being able to tolerate CPAP|15
6326629|NCT00492115|7233022|FG000|NOT COMPLETED|Overall Study||3
6326630|NCT00492115|7233023|FG001|NOT COMPLETED|Overall Study||4
6326631|NCT00492206|7233029|FG000|STARTED|Overall Study||40
6326632|NCT00492206|7233029|FG000|COMPLETED|Overall Study||40
6326633|NCT00492206|7233029|FG000|NOT COMPLETED|Overall Study||0
6326634|NCT00492232|7233037|FG000|STARTED|Placebo Run-in||0
6326635|NCT00492232|7233038|FG001|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
6326636|NCT00492232|7233037|FG000|COMPLETED|Placebo Run-in||0
6326637|NCT00492232|7233038|FG001|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
6326638|NCT00492232|7233037|FG000|NOT COMPLETED|Placebo Run-in||0
6326639|NCT00492232|7233038|FG001|NOT COMPLETED|Placebo Run-in||70
6326640|NCT00492232|7233037|FG000|STARTED|Double-Blind Treatment||65
6326641|NCT00492232|7233038|FG001|STARTED|Double-Blind Treatment||70
6326642|NCT00492232|7233037|FG000|COMPLETED|Double-Blind Treatment||47
6326643|NCT00492232|7233038|FG001|COMPLETED|Double-Blind Treatment||45
6326644|NCT00492232|7233037|FG000|NOT COMPLETED|Double-Blind Treatment||18
6326645|NCT00492232|7233038|FG001|NOT COMPLETED|Double-Blind Treatment||25
6326646|NCT00492232|7233037|FG000|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
6326647|NCT00492232|7233038|FG001|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
6326648|NCT00492232|7233037|FG000|COMPLETED|Open-Label Treatment||88
6326649|NCT00492232|7233038|FG001|COMPLETED|Open-Label Treatment||0
6326650|NCT00492232|7233037|FG000|NOT COMPLETED|Open-Label Treatment||1
6326651|NCT00492232|7233038|FG001|NOT COMPLETED|Open-Label Treatment||0
6326652|NCT00492284|7233048|FG000|STARTED|Overall Study||39
6326653|NCT00492284|7233049|FG001|STARTED|Overall Study||39
6326654|NCT00492284|7233050|FG002|STARTED|Overall Study||43
6326655|NCT00492284|7233051|FG003|STARTED|Overall Study||41
6326656|NCT00492284|7233048|FG000|COMPLETED|Overall Study||38
6326657|NCT00492284|7233049|FG001|COMPLETED|Overall Study||35
6326658|NCT00492284|7233050|FG002|COMPLETED|Overall Study||37
6326659|NCT00492284|7233051|FG003|COMPLETED|Overall Study||31
6326660|NCT00492284|7233048|FG000|NOT COMPLETED|Overall Study||1
6326661|NCT00492284|7233049|FG001|NOT COMPLETED|Overall Study||4
6326662|NCT00492284|7233050|FG002|NOT COMPLETED|Overall Study||6
6326663|NCT00492284|7233051|FG003|NOT COMPLETED|Overall Study||10
6326664|NCT00492297|7233061|FG000|STARTED|Treatment||83
6326665|NCT00492297|7233061|FG000|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
6326666|NCT00492297|7233061|FG000|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
6326667|NCT00492297|7233061|FG000|COMPLETED|Treatment||78
6326668|NCT00492297|7233061|FG000|NOT COMPLETED|Treatment||5
6326669|NCT00492297|7233061|FG000|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
6326670|NCT00492297|7233061|FG000|COMPLETED|Active Follow-up 30(+4) Days Duration||59
6326671|NCT00492297|7233061|FG000|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
6326672|NCT00492297|7233061|FG000|STARTED|Survival Only Follow-up||59
6326673|NCT00492297|7233061|FG000|COMPLETED|Survival Only Follow-up||0
6326674|NCT00492297|7233061|FG000|NOT COMPLETED|Survival Only Follow-up||59
6326675|NCT00492336|7233067|FG000|STARTED|Overall Study||28
6326676|NCT00492336|7233068|FG001|STARTED|Overall Study||29
6326677|NCT00492336|7233067|FG000|COMPLETED|Overall Study||26
6326678|NCT00492336|7233068|FG001|COMPLETED|Overall Study||23
6326679|NCT00492336|7233067|FG000|NOT COMPLETED|Overall Study||2
6326680|NCT00492336|7233068|FG001|NOT COMPLETED|Overall Study||6
6326681|NCT00492401|7233074|FG000|STARTED|Overall Study||55
6326682|NCT00492401|7233074|FG000|COMPLETED|Overall Study||55
6326683|NCT00492401|7233074|FG000|NOT COMPLETED|Overall Study||0
6775208|NCT03885934|7703148|FG005|STARTED|Overall Study||175
6775209|NCT03885934|7703143|FG000|PCV Dose 1|Overall Study||64
6775210|NCT03885934|7703144|FG001|PCV Dose 1|Overall Study||64
6775211|NCT03885934|7703145|FG002|PCV Dose 1|Overall Study||62
6775212|NCT03885934|7703146|FG003|PCV Dose 1|Overall Study||64
6775213|NCT03885934|7703147|FG004|PCV Dose 1|Overall Study||177
6775214|NCT03885934|7703148|FG005|PCV Dose 1|Overall Study||175
6326684|NCT00492531|7233082|FG000|STARTED|Overall Study||37
6326685|NCT00492531|7233083|FG001|STARTED|Overall Study||37
6377893|NCT00765843|7288574|FG000|STARTED|Overall Study||26
6775215|NCT03885934|7703143|FG000|PCV Dose 2|Overall Study||63
6326686|NCT00492531|7233082|FG000|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
6326687|NCT00492531|7233083|FG001|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
6326688|NCT00492531|7233082|FG000|NOT COMPLETED|Overall Study||22
6326689|NCT00492531|7233083|FG001|NOT COMPLETED|Overall Study||23
6326690|NCT00492544|7233089|FG000|STARTED|Overall Study||100
6326691|NCT00492544|7233089|FG000|COMPLETED|Overall Study||100
6326692|NCT00492544|7233089|FG000|NOT COMPLETED|Overall Study||0
6326693|NCT00492557|7233095|FG000|STARTED|Overall Study||580
6326694|NCT00492557|7233096|FG001|STARTED|Overall Study||580
6326695|NCT00492557|7233095|FG000|Vaccinated Dose 1|Overall Study||577
6326696|NCT00492557|7233096|FG001|Vaccinated Dose 1|Overall Study||575
6326697|NCT00492557|7233095|FG000|Vaccinated Dose 2|Overall Study||560
6326698|NCT00492557|7233096|FG001|Vaccinated Dose 2|Overall Study||558
6326699|NCT00492557|7233095|FG000|COMPLETED|Overall Study||556
6326700|NCT00492557|7233096|FG001|COMPLETED|Overall Study||557
6326701|NCT00492557|7233095|FG000|NOT COMPLETED|Overall Study||24
6326702|NCT00492557|7233096|FG001|NOT COMPLETED|Overall Study||23
6326703|NCT00492583|7233107|FG000|STARTED|Overall Study||95
6326704|NCT00492583|7233108|FG001|STARTED|Overall Study||87
6326705|NCT00492583|7233107|FG000|COMPLETED|Overall Study||95
6326706|NCT00492583|7233108|FG001|COMPLETED|Overall Study||87
6326707|NCT00492583|7233107|FG000|NOT COMPLETED|Overall Study||0
6326708|NCT00492583|7233108|FG001|NOT COMPLETED|Overall Study||0
6326709|NCT00492622|7233114|FG000|STARTED|Overall Study|all subjects received the immediate release formulation|12
6326710|NCT00492622|7233114|FG000|COMPLETED|Overall Study||12
6326711|NCT00492622|7233114|FG000|NOT COMPLETED|Overall Study||0
6326712|NCT00492648|7233124|FG000|STARTED|Month 30 (109671 Study)||4
6326713|NCT00492648|7233125|FG001|STARTED|Month 30 (109671 Study)||30
6326714|NCT00492648|7233124|FG000|COMPLETED|Month 30 (109671 Study)||4
6326715|NCT00492648|7233125|FG001|COMPLETED|Month 30 (109671 Study)||29
6326716|NCT00492648|7233124|FG000|NOT COMPLETED|Month 30 (109671 Study)||0
6326717|NCT00492648|7233125|FG001|NOT COMPLETED|Month 30 (109671 Study)||1
6326718|NCT00492648|7233124|FG000|STARTED|Month 42 (109674 Study)||3
6326719|NCT00492648|7233125|FG001|STARTED|Month 42 (109674 Study)||20
6326720|NCT00492648|7233124|FG000|COMPLETED|Month 42 (109674 Study)||3
6326721|NCT00492648|7233125|FG001|COMPLETED|Month 42 (109674 Study)||20
6326722|NCT00492648|7233124|FG000|NOT COMPLETED|Month 42 (109674 Study)||0
6326723|NCT00492648|7233125|FG001|NOT COMPLETED|Month 42 (109674 Study)||0
6326724|NCT00492726|7233133|FG000|STARTED|Overall Study||410
6326725|NCT00492726|7233134|FG001|STARTED|Overall Study||394
6326726|NCT00492726|7233133|FG000|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
6326727|NCT00492726|7233134|FG001|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
6326728|NCT00492726|7233133|FG000|End of Study|Overall Study||360
6326729|NCT00492726|7233134|FG001|End of Study|Overall Study||358
6326730|NCT00492726|7233133|FG000|COMPLETED|Overall Study||360
6326731|NCT00492726|7233134|FG001|COMPLETED|Overall Study||358
6326732|NCT00492726|7233133|FG000|NOT COMPLETED|Overall Study||50
6326733|NCT00492726|7233134|FG001|NOT COMPLETED|Overall Study||36
6326734|NCT00492752|7233142|FG000|STARTED|Double Blind Treatment||134
6326735|NCT00492752|7233143|FG001|STARTED|Double Blind Treatment||16
6326736|NCT00492752|7233144|FG002|STARTED|Double Blind Treatment||70
6326737|NCT00492752|7233145|FG003|STARTED|Double Blind Treatment||6
6326738|NCT00492752|7233142|FG000|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
6326739|NCT00492752|7233143|FG001|Received Treatment|Double Blind Treatment|Safety Population|16
6326740|NCT00492752|7233144|FG002|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
6326741|NCT00492752|7233145|FG003|Received Treatment|Double Blind Treatment|Safety Population|6
6326742|NCT00492752|7233142|FG000|COMPLETED|Double Blind Treatment||120
6326743|NCT00492752|7233143|FG001|COMPLETED|Double Blind Treatment||16
6326744|NCT00492752|7233144|FG002|COMPLETED|Double Blind Treatment||67
6326745|NCT00492752|7233145|FG003|COMPLETED|Double Blind Treatment||6
6326746|NCT00492752|7233142|FG000|NOT COMPLETED|Double Blind Treatment||14
6326747|NCT00492752|7233143|FG001|NOT COMPLETED|Double Blind Treatment||0
6326748|NCT00492752|7233144|FG002|NOT COMPLETED|Double Blind Treatment||3
6326749|NCT00492752|7233145|FG003|NOT COMPLETED|Double Blind Treatment||0
6326750|NCT00492752|7233142|FG000|STARTED|Follow-up and/or Open Label Sorafenib||120
6326751|NCT00492752|7233143|FG001|STARTED|Follow-up and/or Open Label Sorafenib||16
6326752|NCT00492752|7233144|FG002|STARTED|Follow-up and/or Open Label Sorafenib||67
6326753|NCT00492752|7233145|FG003|STARTED|Follow-up and/or Open Label Sorafenib||6
6326754|NCT00492752|7233142|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
6326755|NCT00492752|7233143|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
6326756|NCT00492752|7233144|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
6326757|NCT00492752|7233145|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
6326758|NCT00492752|7233142|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
6326759|NCT00492752|7233143|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
6326760|NCT00492752|7233144|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
6326761|NCT00492752|7233145|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
6326762|NCT00492752|7233142|FG000|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
6326763|NCT00492752|7233143|FG001|COMPLETED|Follow-up and/or Open Label Sorafenib||0
6326764|NCT00492752|7233144|FG002|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
6326765|NCT00492752|7233145|FG003|COMPLETED|Follow-up and/or Open Label Sorafenib||0
6326766|NCT00492752|7233142|FG000|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
6326767|NCT00492752|7233143|FG001|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
6326768|NCT00492752|7233144|FG002|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
6326769|NCT00492752|7233145|FG003|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
6326770|NCT00492856|7233152|FG000|STARTED|Induction||105
6326771|NCT00492856|7233153|FG001|STARTED|Induction||0
6326772|NCT00492856|7233154|FG002|STARTED|Induction||0
6326773|NCT00492856|7233155|FG003|STARTED|Induction||0
6326774|NCT00492856|7233152|FG000|COMPLETED|Induction||99
6326775|NCT00492856|7233153|FG001|COMPLETED|Induction||0
6326776|NCT00492856|7233154|FG002|COMPLETED|Induction||0
6326777|NCT00492856|7233155|FG003|COMPLETED|Induction||0
6326778|NCT00492856|7233152|FG000|NOT COMPLETED|Induction||6
6326779|NCT00492856|7233153|FG001|NOT COMPLETED|Induction||0
6326780|NCT00492856|7233154|FG002|NOT COMPLETED|Induction||0
6326781|NCT00492856|7233155|FG003|NOT COMPLETED|Induction||0
6326782|NCT00492856|7233152|FG000|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
6326783|NCT00492856|7233153|FG001|STARTED|Consolidation||0
6326784|NCT00492856|7233154|FG002|STARTED|Consolidation||0
6326785|NCT00492856|7233155|FG003|STARTED|Consolidation||0
6326786|NCT00492856|7233152|FG000|COMPLETED|Consolidation||83
6326787|NCT00492856|7233153|FG001|COMPLETED|Consolidation||0
6326788|NCT00492856|7233154|FG002|COMPLETED|Consolidation||0
6326789|NCT00492856|7233155|FG003|COMPLETED|Consolidation||0
6326790|NCT00492856|7233152|FG000|NOT COMPLETED|Consolidation||9
6326791|NCT00492856|7233153|FG001|NOT COMPLETED|Consolidation||0
6326792|NCT00492856|7233154|FG002|NOT COMPLETED|Consolidation||0
6326793|NCT00492856|7233155|FG003|NOT COMPLETED|Consolidation||0
6326794|NCT00492856|7233152|FG000|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
6326795|NCT00492856|7233153|FG001|STARTED|Post-consolidation||41
6326796|NCT00492856|7233154|FG002|STARTED|Post-consolidation||27
6326797|NCT00492856|7233155|FG003|STARTED|Post-consolidation||1
6326798|NCT00492856|7233152|FG000|COMPLETED|Post-consolidation||0
6326799|NCT00492856|7233153|FG001|COMPLETED|Post-consolidation||29
6326800|NCT00492856|7233154|FG002|COMPLETED|Post-consolidation||0
6326801|NCT00492856|7233155|FG003|COMPLETED|Post-consolidation||0
6326802|NCT00492856|7233152|FG000|NOT COMPLETED|Post-consolidation||0
6326803|NCT00492856|7233153|FG001|NOT COMPLETED|Post-consolidation||12
6326804|NCT00492856|7233154|FG002|NOT COMPLETED|Post-consolidation||27
6326805|NCT00492856|7233155|FG003|NOT COMPLETED|Post-consolidation||1
6558387|NCT01775189|7481050|FG000|STARTED|Treatment Phase: First Intervention||0
6558388|NCT01775189|7481051|FG001|STARTED|Treatment Phase: First Intervention||0
6558389|NCT01775189|7481052|FG002|STARTED|Treatment Phase: First Intervention||0
6558390|NCT01775189|7481053|FG003|STARTED|Treatment Phase: First Intervention||8
6326806|NCT00492921|7233167|FG000|STARTED|Overall Study||5
6326807|NCT00492921|7233168|FG001|STARTED|Overall Study||4
6326808|NCT00492921|7233169|FG002|STARTED|Overall Study||3
6326809|NCT00492921|7233167|FG000|COMPLETED|Overall Study||4
6326810|NCT00492921|7233168|FG001|COMPLETED|Overall Study||4
6326811|NCT00492921|7233169|FG002|COMPLETED|Overall Study||2
6326812|NCT00492921|7233167|FG000|NOT COMPLETED|Overall Study||1
6326813|NCT00492921|7233168|FG001|NOT COMPLETED|Overall Study||0
6326814|NCT00492921|7233169|FG002|NOT COMPLETED|Overall Study||1
6326815|NCT00492973|7233179|FG000|STARTED|Overall Study||37
6326816|NCT00492973|7233180|FG001|STARTED|Overall Study||39
6326817|NCT00492973|7233179|FG000|COMPLETED|Overall Study||37
6326818|NCT00492973|7233180|FG001|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
6326819|NCT00492973|7233179|FG000|NOT COMPLETED|Overall Study||0
6326820|NCT00492973|7233180|FG001|NOT COMPLETED|Overall Study||1
6326821|NCT00493012|7233188|FG000|STARTED|Overall Study||100
6326822|NCT00493012|7233189|FG001|STARTED|Overall Study||100
6326823|NCT00493012|7233188|FG000|COMPLETED|Overall Study||82
6326824|NCT00493012|7233189|FG001|COMPLETED|Overall Study||83
6326825|NCT00493012|7233188|FG000|NOT COMPLETED|Overall Study||18
6326826|NCT00493012|7233189|FG001|NOT COMPLETED|Overall Study||17
6326827|NCT00493038|7233197|FG000|STARTED|Treatment||147
6326828|NCT00493038|7233198|FG001|STARTED|Treatment||146
6326829|NCT00493038|7233197|FG000|Randomization|Treatment||147
6326830|NCT00493038|7233198|FG001|Randomization|Treatment||146
6326831|NCT00493038|7233197|FG000|Treated With Study Medication|Treatment||145
6326832|NCT00493038|7233198|FG001|Treated With Study Medication|Treatment||142
6326833|NCT00493038|7233197|FG000|Test-of-Cure Visit|Treatment||123
6326834|NCT00493038|7233198|FG001|Test-of-Cure Visit|Treatment||126
6326835|NCT00493038|7233197|FG000|COMPLETED|Treatment||123
6326836|NCT00493038|7233198|FG001|COMPLETED|Treatment||126
6326837|NCT00493038|7233197|FG000|NOT COMPLETED|Treatment||24
6326838|NCT00493038|7233198|FG001|NOT COMPLETED|Treatment||20
6326839|NCT00493038|7233197|FG000|STARTED|Follow-up||123
6326840|NCT00493038|7233198|FG001|STARTED|Follow-up||126
6326841|NCT00493038|7233197|FG000|COMPLETED|Follow-up||122
6326842|NCT00493038|7233198|FG001|COMPLETED|Follow-up||126
6326843|NCT00493038|7233197|FG000|NOT COMPLETED|Follow-up||1
6326844|NCT00493038|7233198|FG001|NOT COMPLETED|Follow-up||0
6326845|NCT00493064|7233204|FG000|STARTED|Overall Study||63
6326846|NCT00493064|7233204|FG000|COMPLETED|Overall Study||52
6326847|NCT00493064|7233204|FG000|NOT COMPLETED|Overall Study||11
6326848|NCT00493181|7233208|FG000|STARTED|Overall Study||8
6326849|NCT00493181|7233208|FG000|COMPLETED|Overall Study||8
6326850|NCT00493181|7233208|FG000|NOT COMPLETED|Overall Study||0
6326851|NCT00493220|7233218|FG000|STARTED|First Intervention||5
6326852|NCT00493220|7233219|FG001|STARTED|First Intervention||5
6326853|NCT00493220|7233220|FG002|STARTED|First Intervention||5
6326854|NCT00493220|7233221|FG003|STARTED|First Intervention||5
6326855|NCT00493220|7233222|FG004|STARTED|First Intervention||5
6326856|NCT00493220|7233223|FG005|STARTED|First Intervention||5
6326857|NCT00493220|7233218|FG000|COMPLETED|First Intervention||5
6326858|NCT00493220|7233219|FG001|COMPLETED|First Intervention||5
6326859|NCT00493220|7233220|FG002|COMPLETED|First Intervention||5
6326860|NCT00493220|7233221|FG003|COMPLETED|First Intervention||5
6326861|NCT00493220|7233222|FG004|COMPLETED|First Intervention||5
6326862|NCT00493220|7233223|FG005|COMPLETED|First Intervention||5
6326863|NCT00493220|7233218|FG000|NOT COMPLETED|First Intervention||0
6326864|NCT00493220|7233219|FG001|NOT COMPLETED|First Intervention||0
6326865|NCT00493220|7233220|FG002|NOT COMPLETED|First Intervention||0
6326866|NCT00493220|7233221|FG003|NOT COMPLETED|First Intervention||0
6326867|NCT00493220|7233222|FG004|NOT COMPLETED|First Intervention||0
6326868|NCT00493220|7233223|FG005|NOT COMPLETED|First Intervention||0
6326869|NCT00493220|7233218|FG000|STARTED|First 7-Day Washout & Safety Follow-up||5
6326870|NCT00493220|7233219|FG001|STARTED|First 7-Day Washout & Safety Follow-up||5
6326871|NCT00493220|7233220|FG002|STARTED|First 7-Day Washout & Safety Follow-up||5
6326872|NCT00493220|7233221|FG003|STARTED|First 7-Day Washout & Safety Follow-up||5
6326873|NCT00493220|7233222|FG004|STARTED|First 7-Day Washout & Safety Follow-up||5
6326874|NCT00493220|7233223|FG005|STARTED|First 7-Day Washout & Safety Follow-up||5
6326875|NCT00493220|7233218|FG000|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6326876|NCT00493220|7233219|FG001|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6326877|NCT00493220|7233220|FG002|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6326878|NCT00493220|7233221|FG003|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6326879|NCT00493220|7233222|FG004|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6326880|NCT00493220|7233223|FG005|COMPLETED|First 7-Day Washout & Safety Follow-up||5
6326881|NCT00493220|7233218|FG000|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6326882|NCT00493220|7233219|FG001|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6326883|NCT00493220|7233220|FG002|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6326884|NCT00493220|7233221|FG003|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6326885|NCT00493220|7233222|FG004|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6326886|NCT00493220|7233223|FG005|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
6326887|NCT00493220|7233218|FG000|STARTED|Second Intervention||5
6326888|NCT00493220|7233219|FG001|STARTED|Second Intervention||5
6326889|NCT00493220|7233220|FG002|STARTED|Second Intervention||5
6326890|NCT00493220|7233221|FG003|STARTED|Second Intervention||5
6326891|NCT00493220|7233222|FG004|STARTED|Second Intervention||5
6326892|NCT00493220|7233223|FG005|STARTED|Second Intervention||5
6326893|NCT00493220|7233218|FG000|COMPLETED|Second Intervention||5
6326894|NCT00493220|7233219|FG001|COMPLETED|Second Intervention||5
6326895|NCT00493220|7233220|FG002|COMPLETED|Second Intervention||5
6326896|NCT00493220|7233221|FG003|COMPLETED|Second Intervention||5
6326897|NCT00493220|7233222|FG004|COMPLETED|Second Intervention||5
6326898|NCT00493220|7233223|FG005|COMPLETED|Second Intervention||5
6326899|NCT00493220|7233218|FG000|NOT COMPLETED|Second Intervention||0
6326900|NCT00493220|7233219|FG001|NOT COMPLETED|Second Intervention||0
6326901|NCT00493220|7233220|FG002|NOT COMPLETED|Second Intervention||0
6326902|NCT00493220|7233221|FG003|NOT COMPLETED|Second Intervention||0
6326903|NCT00493220|7233222|FG004|NOT COMPLETED|Second Intervention||0
6326904|NCT00493220|7233223|FG005|NOT COMPLETED|Second Intervention||0
6326905|NCT00493220|7233218|FG000|STARTED|Second 7-Day Washout & Safety Follow-up||5
6326906|NCT00493220|7233219|FG001|STARTED|Second 7-Day Washout & Safety Follow-up||5
6326907|NCT00493220|7233220|FG002|STARTED|Second 7-Day Washout & Safety Follow-up||5
6326908|NCT00493220|7233221|FG003|STARTED|Second 7-Day Washout & Safety Follow-up||5
6326909|NCT00493220|7233222|FG004|STARTED|Second 7-Day Washout & Safety Follow-up||5
6326910|NCT00493220|7233223|FG005|STARTED|Second 7-Day Washout & Safety Follow-up||5
6326911|NCT00493220|7233218|FG000|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6326912|NCT00493220|7233219|FG001|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6326913|NCT00493220|7233220|FG002|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6326914|NCT00493220|7233221|FG003|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6326915|NCT00493220|7233222|FG004|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6326916|NCT00493220|7233223|FG005|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
6326917|NCT00493220|7233218|FG000|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6326918|NCT00493220|7233219|FG001|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6326919|NCT00493220|7233220|FG002|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6326920|NCT00493220|7233221|FG003|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6326921|NCT00493220|7233222|FG004|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6326922|NCT00493220|7233223|FG005|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
6326923|NCT00493220|7233218|FG000|STARTED|Third Intervention||5
6326924|NCT00493220|7233219|FG001|STARTED|Third Intervention||5
6562860|NCT01803204|7485753|FG000|NOT COMPLETED|Overall Study||0
6326925|NCT00493220|7233220|FG002|STARTED|Third Intervention||5
6326926|NCT00493220|7233221|FG003|STARTED|Third Intervention||5
6326927|NCT00493220|7233222|FG004|STARTED|Third Intervention||5
6326928|NCT00493220|7233223|FG005|STARTED|Third Intervention||5
6326929|NCT00493220|7233218|FG000|COMPLETED|Third Intervention||4
6326930|NCT00493220|7233219|FG001|COMPLETED|Third Intervention||5
6326931|NCT00493220|7233220|FG002|COMPLETED|Third Intervention||5
6326932|NCT00493220|7233221|FG003|COMPLETED|Third Intervention||5
6326933|NCT00493220|7233222|FG004|COMPLETED|Third Intervention||5
6326934|NCT00493220|7233223|FG005|COMPLETED|Third Intervention||5
6326935|NCT00493220|7233218|FG000|NOT COMPLETED|Third Intervention||1
6326936|NCT00493220|7233219|FG001|NOT COMPLETED|Third Intervention||0
6326937|NCT00493220|7233220|FG002|NOT COMPLETED|Third Intervention||0
6326938|NCT00493220|7233221|FG003|NOT COMPLETED|Third Intervention||0
6326939|NCT00493220|7233222|FG004|NOT COMPLETED|Third Intervention||0
6326940|NCT00493220|7233223|FG005|NOT COMPLETED|Third Intervention||0
6326941|NCT00493220|7233218|FG000|STARTED|Final 7-Day Safety Follow-up||4
6326942|NCT00493220|7233219|FG001|STARTED|Final 7-Day Safety Follow-up||5
6326943|NCT00493220|7233220|FG002|STARTED|Final 7-Day Safety Follow-up||5
6326944|NCT00493220|7233221|FG003|STARTED|Final 7-Day Safety Follow-up||5
6326945|NCT00493220|7233222|FG004|STARTED|Final 7-Day Safety Follow-up||5
6326946|NCT00493220|7233223|FG005|STARTED|Final 7-Day Safety Follow-up||5
6326947|NCT00493220|7233218|FG000|COMPLETED|Final 7-Day Safety Follow-up||4
6326948|NCT00493220|7233219|FG001|COMPLETED|Final 7-Day Safety Follow-up||5
6326949|NCT00493220|7233220|FG002|COMPLETED|Final 7-Day Safety Follow-up||5
6326950|NCT00493220|7233221|FG003|COMPLETED|Final 7-Day Safety Follow-up||5
6326951|NCT00493220|7233222|FG004|COMPLETED|Final 7-Day Safety Follow-up||5
6326952|NCT00493220|7233223|FG005|COMPLETED|Final 7-Day Safety Follow-up||5
6326953|NCT00493220|7233218|FG000|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6326954|NCT00493220|7233219|FG001|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6326955|NCT00493220|7233220|FG002|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6326956|NCT00493220|7233221|FG003|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6326957|NCT00493220|7233222|FG004|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6326958|NCT00493220|7233223|FG005|NOT COMPLETED|Final 7-Day Safety Follow-up||0
6326959|NCT00493246|7233241|FG000|STARTED|Overall Study||2
6326960|NCT00493246|7233242|FG001|STARTED|Overall Study||1
6326961|NCT00493246|7233243|FG002|STARTED|Overall Study||12
6326962|NCT00493246|7233244|FG003|STARTED|Overall Study||13
6326963|NCT00493246|7233245|FG004|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
6326964|NCT00493246|7233246|FG005|STARTED|Overall Study|All subjects who were randomized.|16
6326965|NCT00493246|7233247|FG006|STARTED|Overall Study|All subjects who were randomized.|12
6326966|NCT00493246|7233248|FG007|STARTED|Overall Study|All subjects who were randomized.|10
6326967|NCT00493246|7233241|FG000|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
6326968|NCT00493246|7233242|FG001|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
6326969|NCT00493246|7233243|FG002|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
6326970|NCT00493246|7233244|FG003|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
6326971|NCT00493246|7233245|FG004|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
6558391|NCT01775189|7481054|FG004|STARTED|Treatment Phase: First Intervention||8
6558392|NCT01775189|7481055|FG005|STARTED|Treatment Phase: First Intervention||8
6558393|NCT01775189|7481056|FG006|STARTED|Treatment Phase: First Intervention||8
6558394|NCT01775189|7481050|FG000|COMPLETED|Treatment Phase: First Intervention||0
6558395|NCT01775189|7481051|FG001|COMPLETED|Treatment Phase: First Intervention||0
6558396|NCT01775189|7481052|FG002|COMPLETED|Treatment Phase: First Intervention||0
6558397|NCT01775189|7481053|FG003|COMPLETED|Treatment Phase: First Intervention||8
6558398|NCT01775189|7481054|FG004|COMPLETED|Treatment Phase: First Intervention||8
6326972|NCT00493246|7233246|FG005|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
6326973|NCT00493246|7233247|FG006|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
6326974|NCT00493246|7233248|FG007|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
6326975|NCT00493246|7233241|FG000|NOT COMPLETED|Overall Study||0
6326976|NCT00493246|7233242|FG001|NOT COMPLETED|Overall Study||0
6326977|NCT00493246|7233243|FG002|NOT COMPLETED|Overall Study||0
6326978|NCT00493246|7233244|FG003|NOT COMPLETED|Overall Study||0
6326979|NCT00493246|7233245|FG004|NOT COMPLETED|Overall Study||1
6326980|NCT00493246|7233246|FG005|NOT COMPLETED|Overall Study||1
6326981|NCT00493246|7233247|FG006|NOT COMPLETED|Overall Study||1
6326982|NCT00493246|7233248|FG007|NOT COMPLETED|Overall Study||0
6326983|NCT00493285|7233272|FG000|STARTED|Overall Study||13
6326984|NCT00493285|7233273|FG001|STARTED|Overall Study||6
6326985|NCT00493285|7233274|FG002|STARTED|Overall Study||9
6326986|NCT00493285|7233275|FG003|STARTED|Overall Study||6
6326987|NCT00493285|7233276|FG004|STARTED|Overall Study||10
6326988|NCT00493285|7233277|FG005|STARTED|Overall Study||5
6326989|NCT00493285|7233272|FG000|COMPLETED|Overall Study||13
6326990|NCT00493285|7233273|FG001|COMPLETED|Overall Study||6
6326991|NCT00493285|7233274|FG002|COMPLETED|Overall Study||9
6326992|NCT00493285|7233275|FG003|COMPLETED|Overall Study||6
6326993|NCT00493285|7233276|FG004|COMPLETED|Overall Study||9
6558399|NCT01775189|7481055|FG005|COMPLETED|Treatment Phase: First Intervention||8
6558400|NCT01775189|7481056|FG006|COMPLETED|Treatment Phase: First Intervention||8
6558401|NCT01775189|7481050|FG000|NOT COMPLETED|Treatment Phase: First Intervention||0
6558402|NCT01775189|7481051|FG001|NOT COMPLETED|Treatment Phase: First Intervention||0
6326994|NCT00493285|7233277|FG005|COMPLETED|Overall Study||5
6326995|NCT00493285|7233272|FG000|NOT COMPLETED|Overall Study||0
6326996|NCT00493285|7233273|FG001|NOT COMPLETED|Overall Study||0
6326997|NCT00493285|7233274|FG002|NOT COMPLETED|Overall Study||0
6326998|NCT00493285|7233275|FG003|NOT COMPLETED|Overall Study||0
6326999|NCT00493285|7233276|FG004|NOT COMPLETED|Overall Study||1
6327000|NCT00493285|7233277|FG005|NOT COMPLETED|Overall Study||0
6327001|NCT00493311|7233293|FG000|STARTED|Overall Study||29
6327002|NCT00493311|7233294|FG001|STARTED|Overall Study||31
6327003|NCT00493311|7233293|FG000|COMPLETED|Overall Study||27
6327004|NCT00493311|7233294|FG001|COMPLETED|Overall Study||29
6327005|NCT00493311|7233293|FG000|NOT COMPLETED|Overall Study||2
6327006|NCT00493311|7233294|FG001|NOT COMPLETED|Overall Study||2
6327007|NCT00493454|7233300|FG000|STARTED|Overall Study||6
6327008|NCT00493454|7233300|FG000|COMPLETED|Overall Study||5
6327009|NCT00493454|7233300|FG000|NOT COMPLETED|Overall Study||1
6327010|NCT00493467|7233304|FG000|STARTED|Overall Study||31
6327011|NCT00493467|7233304|FG000|COMPLETED|Overall Study||30
6327012|NCT00493467|7233304|FG000|NOT COMPLETED|Overall Study||1
6327013|NCT00493636|7233310|FG000|STARTED|Overall Study||81
6327014|NCT00493636|7233311|FG001|STARTED|Overall Study||79
6327015|NCT00493636|7233310|FG000|COMPLETED|Overall Study||79
6327016|NCT00493636|7233311|FG001|COMPLETED|Overall Study||77
6327017|NCT00493636|7233310|FG000|NOT COMPLETED|Overall Study||2
6327018|NCT00493636|7233311|FG001|NOT COMPLETED|Overall Study||2
6375859|NCT00757822|7286427|FG001|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
6375860|NCT00757822|7286426|FG000|Received Study Intervention|Overall Study||85
6375861|NCT00757822|7286427|FG001|Received Study Intervention|Overall Study||74
6375862|NCT00757822|7286426|FG000|DOS: Post-operative Assessments|Overall Study||85
6375863|NCT00757822|7286427|FG001|DOS: Post-operative Assessments|Overall Study||74
6375864|NCT00757822|7286426|FG000|24-48 hr Telephone Assessment|Overall Study||85
6375865|NCT00757822|7286427|FG001|24-48 hr Telephone Assessment|Overall Study||74
6375866|NCT00757822|7286426|FG000|2-6 wk Post-op Assessment|Overall Study||85
6375867|NCT00757822|7286427|FG001|2-6 wk Post-op Assessment|Overall Study||74
6375868|NCT00757822|7286426|FG000|Data Entry, QC Assessment|Overall Study||85
6375869|NCT00757822|7286427|FG001|Data Entry, QC Assessment|Overall Study||74
6375870|NCT00757822|7286426|FG000|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
6375871|NCT00757822|7286427|FG001|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
6375872|NCT00757822|7286426|FG000|Withdrawn-protocol Deviation|Overall Study||9
6375873|NCT00757822|7286427|FG001|Withdrawn-protocol Deviation|Overall Study||8
6375874|NCT00757822|7286426|FG000|Data Lock, Unblinding Analysis|Overall Study||64
6375875|NCT00757822|7286427|FG001|Data Lock, Unblinding Analysis|Overall Study||57
6375876|NCT00757822|7286426|FG000|COMPLETED|Overall Study||64
6375877|NCT00757822|7286427|FG001|COMPLETED|Overall Study||57
6375878|NCT00757822|7286426|FG000|NOT COMPLETED|Overall Study||28
6375879|NCT00757822|7286427|FG001|NOT COMPLETED|Overall Study||31
6375880|NCT00757848|7286438|FG000|STARTED|Overall Study||27
6375881|NCT00757848|7286439|FG001|STARTED|Overall Study||29
6375882|NCT00757848|7286438|FG000|COMPLETED|Overall Study||24
6375883|NCT00757848|7286439|FG001|COMPLETED|Overall Study||27
6375884|NCT00757848|7286438|FG000|NOT COMPLETED|Overall Study||3
6375885|NCT00757848|7286439|FG001|NOT COMPLETED|Overall Study||2
6375886|NCT00758043|7286449|FG000|STARTED|Overall Study||162
6375887|NCT00758043|7286450|FG001|STARTED|Overall Study||160
6375888|NCT00758043|7286451|FG002|STARTED|Overall Study||118
6375889|NCT00758043|7286452|FG003|STARTED|Overall Study||100
6375890|NCT00758043|7286449|FG000|COMPLETED|Overall Study||161
6375891|NCT00758043|7286450|FG001|COMPLETED|Overall Study||119
6375892|NCT00758043|7286451|FG002|COMPLETED|Overall Study||79
6375893|NCT00758043|7286452|FG003|COMPLETED|Overall Study||0
6375894|NCT00758043|7286449|FG000|NOT COMPLETED|Overall Study||1
6375895|NCT00758043|7286450|FG001|NOT COMPLETED|Overall Study||41
6375896|NCT00758043|7286451|FG002|NOT COMPLETED|Overall Study||39
6375897|NCT00758043|7286452|FG003|NOT COMPLETED|Overall Study||100
6375898|NCT00758069|7286471|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
6375899|NCT00758069|7286472|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
6375900|NCT00758069|7286473|FG002|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
6375901|NCT00758069|7286471|FG000|COMPLETED|Overall Study||26
6375902|NCT00758069|7286472|FG001|COMPLETED|Overall Study||25
6375903|NCT00758069|7286473|FG002|COMPLETED|Overall Study||27
6375904|NCT00758069|7286471|FG000|NOT COMPLETED|Overall Study||1
6375905|NCT00758069|7286472|FG001|NOT COMPLETED|Overall Study||0
6375906|NCT00758069|7286473|FG002|NOT COMPLETED|Overall Study||1
6375907|NCT00758160|7286481|FG000|STARTED|Overall Study||296
6375908|NCT00758160|7286481|FG000|COMPLETED|Overall Study||230
6375909|NCT00758160|7286481|FG000|NOT COMPLETED|Overall Study||66
6375910|NCT00758264|7286492|FG000|STARTED|Active Phase||182
6375911|NCT00758264|7286493|FG001|STARTED|Active Phase||91
6375912|NCT00758264|7286494|FG002|STARTED|Active Phase||90
6375913|NCT00758264|7286492|FG000|COMPLETED|Active Phase||181
6375914|NCT00758264|7286493|FG001|COMPLETED|Active Phase||91
6375915|NCT00758264|7286494|FG002|COMPLETED|Active Phase||85
6375916|NCT00758264|7286492|FG000|NOT COMPLETED|Active Phase||1
6375917|NCT00758264|7286493|FG001|NOT COMPLETED|Active Phase||0
6375918|NCT00758264|7286494|FG002|NOT COMPLETED|Active Phase||5
6375919|NCT00758264|7286492|FG000|STARTED|Extended Safety Follow Up (ESFU) Phase||181
6327019|NCT00493649|7233317|FG000|STARTED|Overall Study||493
6327020|NCT00493649|7233317|FG000|COMPLETED|Overall Study||411
6327021|NCT00493649|7233317|FG000|NOT COMPLETED|Overall Study||82
6558403|NCT01775189|7481052|FG002|NOT COMPLETED|Treatment Phase: First Intervention||0
6558404|NCT01775189|7481053|FG003|NOT COMPLETED|Treatment Phase: First Intervention||0
6558405|NCT01775189|7481054|FG004|NOT COMPLETED|Treatment Phase: First Intervention||0
6327022|NCT00493779|7233324|FG000|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
6327023|NCT00493779|7233324|FG000|COMPLETED|Overall Study|Completed follow-up phase|97
6327024|NCT00493779|7233324|FG000|NOT COMPLETED|Overall Study||1
6327025|NCT00493805|7233329|FG000|STARTED|Overall Study||17
6327026|NCT00493805|7233330|FG001|STARTED|Overall Study||42
6327027|NCT00493805|7233329|FG000|COMPLETED|Overall Study||17
6327028|NCT00493805|7233330|FG001|COMPLETED|Overall Study||42
6327029|NCT00493805|7233329|FG000|NOT COMPLETED|Overall Study||0
6327030|NCT00493805|7233330|FG001|NOT COMPLETED|Overall Study||0
6327031|NCT00493974|7233338|FG000|STARTED|Overall Study||60
6327032|NCT00493974|7233339|FG001|STARTED|Overall Study||59
6327033|NCT00493974|7233338|FG000|COMPLETED|Overall Study||47
6327034|NCT00493974|7233339|FG001|COMPLETED|Overall Study||45
6327035|NCT00493974|7233338|FG000|NOT COMPLETED|Overall Study||13
6327036|NCT00493974|7233339|FG001|NOT COMPLETED|Overall Study||14
6327037|NCT00494013|7233347|FG000|STARTED|Overall Study||223
6327038|NCT00494013|7233348|FG001|STARTED|Overall Study||219
6327039|NCT00494013|7233347|FG000|Full Analysis Set (Intent to Treat)|Overall Study||219
6327040|NCT00494013|7233348|FG001|Full Analysis Set (Intent to Treat)|Overall Study||210
6327041|NCT00494013|7233347|FG000|COMPLETED|Overall Study||193
6327042|NCT00494013|7233348|FG001|COMPLETED|Overall Study||183
6327043|NCT00494013|7233347|FG000|NOT COMPLETED|Overall Study||30
6327044|NCT00494013|7233348|FG001|NOT COMPLETED|Overall Study||36
6327045|NCT00494026|7233354|FG000|STARTED|Overall Study||4
6327046|NCT00494026|7233354|FG000|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
6327047|NCT00494026|7233354|FG000|NOT COMPLETED|Overall Study||4
6327048|NCT00494091|7233360|FG000|STARTED|Overall Study||6
6327049|NCT00494091|7233361|FG001|STARTED|Overall Study||76
6327050|NCT00494091|7233360|FG000|COMPLETED|Overall Study||0
6327051|NCT00494091|7233361|FG001|COMPLETED|Overall Study||0
6327052|NCT00494091|7233360|FG000|NOT COMPLETED|Overall Study||6
6327053|NCT00494091|7233361|FG001|NOT COMPLETED|Overall Study||76
6327054|NCT00494143|7233368|FG000|STARTED|Overall Study||1
6327055|NCT00494143|7233369|FG001|STARTED|Overall Study||2
6327056|NCT00494143|7233370|FG002|STARTED|Overall Study||3
6327057|NCT00494143|7233371|FG003|STARTED|Overall Study||0
6327058|NCT00494143|7233372|FG004|STARTED|Overall Study||1
6327059|NCT00494143|7233373|FG005|STARTED|Overall Study||0
6327060|NCT00494143|7233368|FG000|COMPLETED|Overall Study||1
6327061|NCT00494143|7233369|FG001|COMPLETED|Overall Study||2
6327062|NCT00494143|7233370|FG002|COMPLETED|Overall Study||3
6327063|NCT00494143|7233371|FG003|COMPLETED|Overall Study||0
6327064|NCT00494143|7233372|FG004|COMPLETED|Overall Study||1
6327065|NCT00494143|7233373|FG005|COMPLETED|Overall Study||0
6327066|NCT00494143|7233368|FG000|NOT COMPLETED|Overall Study||0
6327067|NCT00494143|7233369|FG001|NOT COMPLETED|Overall Study||0
6327068|NCT00494143|7233370|FG002|NOT COMPLETED|Overall Study||0
6327069|NCT00494143|7233371|FG003|NOT COMPLETED|Overall Study||0
6327070|NCT00494143|7233372|FG004|NOT COMPLETED|Overall Study||0
6327071|NCT00494143|7233373|FG005|NOT COMPLETED|Overall Study||0
6327072|NCT00494221|7233388|FG000|STARTED|Overall Study||58
6327073|NCT00494221|7233389|FG001|STARTED|Overall Study||56
6327074|NCT00494221|7233390|FG002|STARTED|Overall Study||58
6327075|NCT00494221|7233388|FG000|COMPLETED|Overall Study||42
6327076|NCT00494221|7233389|FG001|COMPLETED|Overall Study||45
6327077|NCT00494221|7233390|FG002|COMPLETED|Overall Study||44
6327078|NCT00494221|7233388|FG000|NOT COMPLETED|Overall Study||16
6327079|NCT00494221|7233389|FG001|NOT COMPLETED|Overall Study||11
6327080|NCT00494221|7233390|FG002|NOT COMPLETED|Overall Study||14
6327081|NCT00494299|7233400|FG000|STARTED|Overall Study||229
6327082|NCT00494299|7233401|FG001|STARTED|Overall Study||229
6327083|NCT00494299|7233400|FG000|Received Treatment|Overall Study||229
6327084|NCT00494299|7233401|FG001|Received Treatment|Overall Study||227
6327085|NCT00494299|7233400|FG000|COMPLETED|Overall Study||0
6327086|NCT00494299|7233401|FG001|COMPLETED|Overall Study||0
6327087|NCT00494299|7233400|FG000|NOT COMPLETED|Overall Study||229
6327088|NCT00494299|7233401|FG001|NOT COMPLETED|Overall Study||229
6327089|NCT00494442|7233409|FG000|STARTED|Overall Study|Patients received treatment|24
6327090|NCT00494442|7233410|FG001|STARTED|Overall Study|Patients received treatment|33
6327091|NCT00494442|7233409|FG000|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
6327092|NCT00494442|7233410|FG001|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
6327093|NCT00494442|7233409|FG000|NOT COMPLETED|Overall Study||17
6327094|NCT00494442|7233410|FG001|NOT COMPLETED|Overall Study||16
6327095|NCT00494481|7233418|FG000|STARTED|Overall Study|randomised patients|35
6327096|NCT00494481|7233419|FG001|STARTED|Overall Study|randomised patients|29
6327097|NCT00494481|7233418|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
6327098|NCT00494481|7233419|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
6327099|NCT00494481|7233418|FG000|NOT COMPLETED|Overall Study||29
6327100|NCT00494481|7233419|FG001|NOT COMPLETED|Overall Study||24
6327101|NCT00494494|7233427|FG000|STARTED|Overall Study||40
6327102|NCT00494494|7233428|FG001|STARTED|Overall Study||39
6327103|NCT00494494|7233427|FG000|COMPLETED|Overall Study||40
6327104|NCT00494494|7233428|FG001|COMPLETED|Overall Study||39
6327105|NCT00494494|7233427|FG000|NOT COMPLETED|Overall Study||0
6327106|NCT00494494|7233428|FG001|NOT COMPLETED|Overall Study||0
6327107|NCT00494507|7233438|FG000|STARTED|Double-Blind Phase||12
6327108|NCT00494507|7233439|FG001|STARTED|Double-Blind Phase||9
6327109|NCT00494507|7233440|FG002|STARTED|Double-Blind Phase||24
6327110|NCT00494507|7233441|FG003|STARTED|Double-Blind Phase||20
6327111|NCT00494507|7233438|FG000|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
6327112|NCT00494507|7233439|FG001|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
6327113|NCT00494507|7233440|FG002|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
6327114|NCT00494507|7233441|FG003|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
6327115|NCT00494507|7233438|FG000|COMPLETED|Double-Blind Phase||9
6327116|NCT00494507|7233439|FG001|COMPLETED|Double-Blind Phase||9
6327117|NCT00494507|7233440|FG002|COMPLETED|Double-Blind Phase||22
6327118|NCT00494507|7233441|FG003|COMPLETED|Double-Blind Phase||19
6327119|NCT00494507|7233438|FG000|NOT COMPLETED|Double-Blind Phase||3
6327120|NCT00494507|7233439|FG001|NOT COMPLETED|Double-Blind Phase||0
6327121|NCT00494507|7233440|FG002|NOT COMPLETED|Double-Blind Phase||2
6327122|NCT00494507|7233441|FG003|NOT COMPLETED|Double-Blind Phase||1
6327123|NCT00494507|7233438|FG000|STARTED|Open-Label Phase||9
6327124|NCT00494507|7233439|FG001|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
6327125|NCT00494507|7233440|FG002|STARTED|Open-Label Phase||22
6327126|NCT00494507|7233441|FG003|STARTED|Open-Label Phase||19
6327127|NCT00494507|7233438|FG000|COMPLETED|Open-Label Phase||9
6327128|NCT00494507|7233439|FG001|COMPLETED|Open-Label Phase||7
6327129|NCT00494507|7233440|FG002|COMPLETED|Open-Label Phase||17
6327130|NCT00494507|7233441|FG003|COMPLETED|Open-Label Phase||14
6327131|NCT00494507|7233438|FG000|NOT COMPLETED|Open-Label Phase||0
6327132|NCT00494507|7233439|FG001|NOT COMPLETED|Open-Label Phase||1
6327133|NCT00494507|7233440|FG002|NOT COMPLETED|Open-Label Phase||5
6327134|NCT00494507|7233441|FG003|NOT COMPLETED|Open-Label Phase||5
6327135|NCT00494585|7233461|FG000|STARTED|Overall Study||22
6327136|NCT00494585|7233461|FG000|COMPLETED|Overall Study||22
6327137|NCT00494585|7233461|FG000|NOT COMPLETED|Overall Study||0
6327138|NCT00494676|7233465|FG000|STARTED|Allocation||37
6327139|NCT00494676|7233466|FG001|STARTED|Allocation||36
6327140|NCT00494676|7233465|FG000|COMPLETED|Allocation||35
6327141|NCT00494676|7233466|FG001|COMPLETED|Allocation||32
6327142|NCT00494676|7233465|FG000|NOT COMPLETED|Allocation||2
6327143|NCT00494676|7233466|FG001|NOT COMPLETED|Allocation||4
6327144|NCT00494676|7233465|FG000|STARTED|First Intervention||35
6327145|NCT00494676|7233466|FG001|STARTED|First Intervention||32
6327146|NCT00494676|7233465|FG000|COMPLETED|First Intervention||34
6327147|NCT00494676|7233466|FG001|COMPLETED|First Intervention||29
6327148|NCT00494676|7233465|FG000|NOT COMPLETED|First Intervention||1
6327149|NCT00494676|7233466|FG001|NOT COMPLETED|First Intervention||3
6327150|NCT00494676|7233465|FG000|STARTED|Second Intervention||34
6327151|NCT00494676|7233466|FG001|STARTED|Second Intervention||29
6327152|NCT00494676|7233465|FG000|COMPLETED|Second Intervention||33
6327153|NCT00494676|7233466|FG001|COMPLETED|Second Intervention||28
6327154|NCT00494676|7233465|FG000|NOT COMPLETED|Second Intervention||1
6327155|NCT00494676|7233466|FG001|NOT COMPLETED|Second Intervention||1
6327156|NCT00494780|7233474|FG000|STARTED|Overall Study||29
6327157|NCT00494780|7233475|FG001|STARTED|Overall Study||30
6327158|NCT00494780|7233474|FG000|COMPLETED|Overall Study||18
6327159|NCT00494780|7233475|FG001|COMPLETED|Overall Study||17
6327160|NCT00494780|7233474|FG000|NOT COMPLETED|Overall Study||11
6327161|NCT00494780|7233475|FG001|NOT COMPLETED|Overall Study||13
6327162|NCT00494806|7233485|FG000|STARTED|Overall Study||34
6327163|NCT00494806|7233486|FG001|STARTED|Overall Study||32
6327164|NCT00494806|7233485|FG000|COMPLETED|Overall Study||34
6327165|NCT00494806|7233486|FG001|COMPLETED|Overall Study||32
6327166|NCT00494806|7233485|FG000|NOT COMPLETED|Overall Study||0
6327167|NCT00494806|7233486|FG001|NOT COMPLETED|Overall Study||0
6327168|NCT00494871|7233494|FG000|STARTED|Double-blind (DB) Treatment Period||640
6327169|NCT00494871|7233495|FG001|STARTED|Double-blind (DB) Treatment Period||640
6327170|NCT00494871|7233494|FG000|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
6327171|NCT00494871|7233495|FG001|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
6327172|NCT00494871|7233494|FG000|COMPLETED|Double-blind (DB) Treatment Period||480
6327173|NCT00494871|7233495|FG001|COMPLETED|Double-blind (DB) Treatment Period||468
6327174|NCT00494871|7233494|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||160
6327175|NCT00494871|7233495|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||172
6327176|NCT00494871|7233494|FG000|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
6327177|NCT00494871|7233495|FG001|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
6327178|NCT00494871|7233494|FG000|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
6327179|NCT00494871|7233495|FG001|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
6327180|NCT00494871|7233494|FG000|COMPLETED|Follow-up (FU) Period||610
6327181|NCT00494871|7233495|FG001|COMPLETED|Follow-up (FU) Period||616
6327182|NCT00494871|7233494|FG000|NOT COMPLETED|Follow-up (FU) Period||29
6327183|NCT00494871|7233495|FG001|NOT COMPLETED|Follow-up (FU) Period||23
6327184|NCT00494975|7233505|FG000|STARTED|Overall Study||10
6327185|NCT00494975|7233506|FG001|STARTED|Overall Study||11
6327186|NCT00494975|7233505|FG000|COMPLETED|Overall Study||8
6327187|NCT00494975|7233506|FG001|COMPLETED|Overall Study||10
6327188|NCT00494975|7233505|FG000|NOT COMPLETED|Overall Study||2
6327189|NCT00494975|7233506|FG001|NOT COMPLETED|Overall Study||1
6327190|NCT00495040|7233512|FG000|STARTED|Overall Study||38
6327191|NCT00495040|7233512|FG000|COMPLETED|Overall Study||35
6327192|NCT00495040|7233512|FG000|NOT COMPLETED|Overall Study||3
6327193|NCT00495079|7233516|FG000|STARTED|Overall Study||65
6327194|NCT00495079|7233516|FG000|COMPLETED|Overall Study||65
6327195|NCT00495079|7233516|FG000|NOT COMPLETED|Overall Study||0
6327196|NCT00495157|7233526|FG000|STARTED|Overall Study||113
6327197|NCT00495157|7233527|FG001|STARTED|Overall Study||115
6327198|NCT00495157|7233528|FG002|STARTED|Overall Study||114
6327199|NCT00495157|7233526|FG000|COMPLETED|Overall Study||97
6327200|NCT00495157|7233527|FG001|COMPLETED|Overall Study||92
6327201|NCT00495157|7233528|FG002|COMPLETED|Overall Study||101
6327202|NCT00495157|7233526|FG000|NOT COMPLETED|Overall Study||16
6327203|NCT00495157|7233527|FG001|NOT COMPLETED|Overall Study||23
6327204|NCT00495157|7233528|FG002|NOT COMPLETED|Overall Study||13
6327205|NCT00495170|7233536|FG000|STARTED|Overall Study||84
6327206|NCT00495170|7233536|FG000|COMPLETED|Overall Study||64
6327207|NCT00495170|7233536|FG000|NOT COMPLETED|Overall Study||20
6327208|NCT00495391|7233542|FG000|STARTED|Overall Study||42
6327209|NCT00495391|7233543|FG001|STARTED|Overall Study||22
6327210|NCT00495391|7233542|FG000|From Baseline to Week 8|Overall Study||31
6327211|NCT00495391|7233543|FG001|From Baseline to Week 8|Overall Study||20
6327212|NCT00495391|7233542|FG000|From Baseline to Week 16|Overall Study||24
6327213|NCT00495391|7233543|FG001|From Baseline to Week 16|Overall Study||11
6327214|NCT00495391|7233542|FG000|From Baseline to End of Treatment|Overall Study||6
6327215|NCT00495391|7233543|FG001|From Baseline to End of Treatment|Overall Study||1
6327216|NCT00495391|7233542|FG000|From Baseline to End of Follow up|Overall Study||6
6327217|NCT00495391|7233543|FG001|From Baseline to End of Follow up|Overall Study||1
6327218|NCT00495391|7233542|FG000|COMPLETED|Overall Study||6
6327219|NCT00495391|7233543|FG001|COMPLETED|Overall Study||1
6327220|NCT00495391|7233542|FG000|NOT COMPLETED|Overall Study||36
6327221|NCT00495391|7233543|FG001|NOT COMPLETED|Overall Study||21
6327222|NCT00495469|7233556|FG000|STARTED|Overall Study||36
6327223|NCT00495469|7233557|FG001|STARTED|Overall Study||37
6327224|NCT00495469|7233558|FG002|STARTED|Overall Study||34
6327225|NCT00495469|7233559|FG003|STARTED|Overall Study||36
6327226|NCT00495469|7233560|FG004|STARTED|Overall Study||36
6327227|NCT00495469|7233561|FG005|STARTED|Overall Study||36
6327228|NCT00495469|7233562|FG006|STARTED|Overall Study||35
6327229|NCT00495469|7233556|FG000|COMPLETED|Overall Study||30
6327230|NCT00495469|7233557|FG001|COMPLETED|Overall Study||30
6327231|NCT00495469|7233558|FG002|COMPLETED|Overall Study||27
6327232|NCT00495469|7233559|FG003|COMPLETED|Overall Study||32
6327233|NCT00495469|7233560|FG004|COMPLETED|Overall Study||31
6327234|NCT00495469|7233561|FG005|COMPLETED|Overall Study||31
6327235|NCT00495469|7233562|FG006|COMPLETED|Overall Study||30
6327236|NCT00495469|7233556|FG000|NOT COMPLETED|Overall Study||6
6327237|NCT00495469|7233557|FG001|NOT COMPLETED|Overall Study||7
6327238|NCT00495469|7233558|FG002|NOT COMPLETED|Overall Study||7
6327239|NCT00495469|7233559|FG003|NOT COMPLETED|Overall Study||4
6327240|NCT00495469|7233560|FG004|NOT COMPLETED|Overall Study||5
6327241|NCT00495469|7233561|FG005|NOT COMPLETED|Overall Study||5
6327242|NCT00495469|7233562|FG006|NOT COMPLETED|Overall Study||5
6327243|NCT00495495|7233585|FG000|STARTED|Overall Study||394
6327244|NCT00495495|7233585|FG000|COMPLETED|Overall Study||295
6327245|NCT00495495|7233585|FG000|NOT COMPLETED|Overall Study||99
6327246|NCT00495521|7233592|FG000|STARTED|Overall Study||1
6327247|NCT00495521|7233593|FG001|STARTED|Overall Study||1
6327248|NCT00495521|7233592|FG000|COMPLETED|Overall Study||1
6327249|NCT00495521|7233593|FG001|COMPLETED|Overall Study||0
6327250|NCT00495521|7233592|FG000|NOT COMPLETED|Overall Study||0
6327251|NCT00495521|7233593|FG001|NOT COMPLETED|Overall Study||1
6327252|NCT00495586|7233601|FG000|STARTED|Overall Study||156
6327253|NCT00495586|7233602|FG001|STARTED|Overall Study||162
6327254|NCT00495586|7233601|FG000|COMPLETED|Overall Study||152
6327255|NCT00495586|7233602|FG001|COMPLETED|Overall Study||158
6327256|NCT00495586|7233601|FG000|NOT COMPLETED|Overall Study||4
6327257|NCT00495586|7233602|FG001|NOT COMPLETED|Overall Study||4
6327258|NCT00495612|7233612|FG000|STARTED|Overall Study||36
6327259|NCT00495612|7233613|FG001|STARTED|Overall Study||33
6327260|NCT00495612|7233612|FG000|COMPLETED|Overall Study||32
6327261|NCT00495612|7233613|FG001|COMPLETED|Overall Study||33
6327262|NCT00495612|7233612|FG000|NOT COMPLETED|Overall Study||4
6327263|NCT00495612|7233613|FG001|NOT COMPLETED|Overall Study||0
6327264|NCT00495625|7233619|FG000|STARTED|Overall Study||33
6327265|NCT00495625|7233619|FG000|COMPLETED|Overall Study||23
6327266|NCT00495625|7233619|FG000|NOT COMPLETED|Overall Study||10
6327267|NCT00495677|7233630|FG000|STARTED|Stage 1 (25 Days)||2
6327268|NCT00495677|7233631|FG001|STARTED|Stage 1 (25 Days)||6
6327269|NCT00495677|7233632|FG002|STARTED|Stage 1 (25 Days)||6
6327270|NCT00495677|7233633|FG003|STARTED|Stage 1 (25 Days)||6
6327271|NCT00495677|7233634|FG004|STARTED|Stage 1 (25 Days)||0
6327272|NCT00495677|7233635|FG005|STARTED|Stage 1 (25 Days)||0
6327273|NCT00495677|7233636|FG006|STARTED|Stage 1 (25 Days)||0
6327274|NCT00495677|7233630|FG000|COMPLETED|Stage 1 (25 Days)||2
6327275|NCT00495677|7233631|FG001|COMPLETED|Stage 1 (25 Days)||6
6327276|NCT00495677|7233632|FG002|COMPLETED|Stage 1 (25 Days)||5
6327277|NCT00495677|7233633|FG003|COMPLETED|Stage 1 (25 Days)||6
6327278|NCT00495677|7233634|FG004|COMPLETED|Stage 1 (25 Days)||0
6327279|NCT00495677|7233635|FG005|COMPLETED|Stage 1 (25 Days)||0
6327280|NCT00495677|7233636|FG006|COMPLETED|Stage 1 (25 Days)||0
6327281|NCT00495677|7233630|FG000|NOT COMPLETED|Stage 1 (25 Days)||0
6327282|NCT00495677|7233631|FG001|NOT COMPLETED|Stage 1 (25 Days)||0
6327283|NCT00495677|7233632|FG002|NOT COMPLETED|Stage 1 (25 Days)||1
6327284|NCT00495677|7233633|FG003|NOT COMPLETED|Stage 1 (25 Days)||0
6327285|NCT00495677|7233634|FG004|NOT COMPLETED|Stage 1 (25 Days)||0
6327286|NCT00495677|7233635|FG005|NOT COMPLETED|Stage 1 (25 Days)||0
6327287|NCT00495677|7233636|FG006|NOT COMPLETED|Stage 1 (25 Days)||0
6327288|NCT00495677|7233630|FG000|STARTED|Stage 2 (25 Days)||0
6327289|NCT00495677|7233631|FG001|STARTED|Stage 2 (25 Days)||0
6327290|NCT00495677|7233632|FG002|STARTED|Stage 2 (25 Days)||0
6327291|NCT00495677|7233633|FG003|STARTED|Stage 2 (25 Days)||0
6327292|NCT00495677|7233634|FG004|STARTED|Stage 2 (25 Days)||8
6327293|NCT00495677|7233635|FG005|STARTED|Stage 2 (25 Days)||8
6327294|NCT00495677|7233636|FG006|STARTED|Stage 2 (25 Days)||7
6327295|NCT00495677|7233630|FG000|COMPLETED|Stage 2 (25 Days)||0
6327296|NCT00495677|7233631|FG001|COMPLETED|Stage 2 (25 Days)||0
6327297|NCT00495677|7233632|FG002|COMPLETED|Stage 2 (25 Days)||0
6327298|NCT00495677|7233633|FG003|COMPLETED|Stage 2 (25 Days)||0
6327299|NCT00495677|7233634|FG004|COMPLETED|Stage 2 (25 Days)||8
6327300|NCT00495677|7233635|FG005|COMPLETED|Stage 2 (25 Days)||8
6327301|NCT00495677|7233636|FG006|COMPLETED|Stage 2 (25 Days)||7
6327302|NCT00495677|7233630|FG000|NOT COMPLETED|Stage 2 (25 Days)||0
6327303|NCT00495677|7233631|FG001|NOT COMPLETED|Stage 2 (25 Days)||0
6558406|NCT01775189|7481055|FG005|NOT COMPLETED|Treatment Phase: First Intervention||0
6558407|NCT01775189|7481056|FG006|NOT COMPLETED|Treatment Phase: First Intervention||0
6558408|NCT01775189|7481050|FG000|STARTED|Treatment Phase: Washout Period 1||0
6558409|NCT01775189|7481051|FG001|STARTED|Treatment Phase: Washout Period 1||0
6558410|NCT01775189|7481052|FG002|STARTED|Treatment Phase: Washout Period 1||0
6558411|NCT01775189|7481053|FG003|STARTED|Treatment Phase: Washout Period 1||8
6558412|NCT01775189|7481054|FG004|STARTED|Treatment Phase: Washout Period 1||8
6558413|NCT01775189|7481055|FG005|STARTED|Treatment Phase: Washout Period 1||8
6558414|NCT01775189|7481056|FG006|STARTED|Treatment Phase: Washout Period 1||8
6327304|NCT00495677|7233632|FG002|NOT COMPLETED|Stage 2 (25 Days)||0
6327305|NCT00495677|7233633|FG003|NOT COMPLETED|Stage 2 (25 Days)||0
6327306|NCT00495677|7233634|FG004|NOT COMPLETED|Stage 2 (25 Days)||0
6327307|NCT00495677|7233635|FG005|NOT COMPLETED|Stage 2 (25 Days)||0
6327308|NCT00495677|7233636|FG006|NOT COMPLETED|Stage 2 (25 Days)||0
6327309|NCT00495755|7233652|FG000|STARTED|Overall Study||13
6327310|NCT00495755|7233652|FG000|COMPLETED|Overall Study||10
6327311|NCT00495755|7233652|FG000|NOT COMPLETED|Overall Study||3
6327312|NCT00495794|7233659|FG000|STARTED|Overall Study||2319
6327313|NCT00495794|7233660|FG001|STARTED|Overall Study||2303
6327314|NCT00495794|7233659|FG000|COMPLETED|Overall Study||1797
6327315|NCT00495794|7233660|FG001|COMPLETED|Overall Study||2303
6327316|NCT00495794|7233659|FG000|NOT COMPLETED|Overall Study||522
6327317|NCT00495794|7233660|FG001|NOT COMPLETED|Overall Study||0
6327318|NCT00495820|7233668|FG000|STARTED|Overall Study||30
6327319|NCT00495820|7233669|FG001|STARTED|Overall Study||30
6327320|NCT00495820|7233668|FG000|COMPLETED|Overall Study||29
6327321|NCT00495820|7233669|FG001|COMPLETED|Overall Study||29
6327322|NCT00495820|7233668|FG000|NOT COMPLETED|Overall Study||1
6327323|NCT00495820|7233669|FG001|NOT COMPLETED|Overall Study||1
6327324|NCT00496015|7233680|FG000|STARTED|Overall Study||178
6327325|NCT00496015|7233681|FG001|STARTED|Overall Study||27
6327326|NCT00496015|7233682|FG002|STARTED|Overall Study||172
6327327|NCT00496015|7233683|FG003|STARTED|Overall Study||37
6327328|NCT00496015|7233684|FG004|STARTED|Overall Study||336
6327329|NCT00496015|7233680|FG000|COMPLETED|Overall Study||177
6327330|NCT00496015|7233681|FG001|COMPLETED|Overall Study||27
6327331|NCT00496015|7233682|FG002|COMPLETED|Overall Study||172
6327332|NCT00496015|7233683|FG003|COMPLETED|Overall Study||36
6327333|NCT00496015|7233684|FG004|COMPLETED|Overall Study||336
6327334|NCT00496015|7233680|FG000|NOT COMPLETED|Overall Study||1
6327335|NCT00496015|7233681|FG001|NOT COMPLETED|Overall Study||0
6327336|NCT00496015|7233682|FG002|NOT COMPLETED|Overall Study||0
6327337|NCT00496015|7233683|FG003|NOT COMPLETED|Overall Study||1
6327338|NCT00496015|7233684|FG004|NOT COMPLETED|Overall Study||0
6327339|NCT00496054|7233704|FG000|STARTED|Overall Study||110
6327340|NCT00496054|7233704|FG000|COMPLETED|Overall Study||102
6327341|NCT00496054|7233704|FG000|NOT COMPLETED|Overall Study||8
6327342|NCT00496080|7233708|FG000|STARTED|Overall Study||87
6327343|NCT00496080|7233708|FG000|COMPLETED|Overall Study||60
6327344|NCT00496080|7233708|FG000|NOT COMPLETED|Overall Study||27
6327345|NCT00496197|7233713|FG000|STARTED|Overall Study||282
6327346|NCT00496197|7233713|FG000|COMPLETED|Overall Study||160
6327347|NCT00496197|7233713|FG000|NOT COMPLETED|Overall Study||122
6558415|NCT01775189|7481050|FG000|COMPLETED|Treatment Phase: Washout Period 1||0
6558416|NCT01775189|7481051|FG001|COMPLETED|Treatment Phase: Washout Period 1||0
6558417|NCT01775189|7481052|FG002|COMPLETED|Treatment Phase: Washout Period 1||0
6327348|NCT00496262|7233717|FG000|STARTED|Overall Study||15
6327349|NCT00496262|7233717|FG000|COMPLETED|Overall Study||15
6327350|NCT00496262|7233717|FG000|NOT COMPLETED|Overall Study||0
6327351|NCT00496340|7233723|FG000|STARTED|Overall Study||42
6327352|NCT00496340|7233723|FG000|COMPLETED|Overall Study||42
6327353|NCT00496340|7233723|FG000|NOT COMPLETED|Overall Study||0
6327354|NCT00496366|7233727|FG000|STARTED|Overall Study||11
6558418|NCT01775189|7481053|FG003|COMPLETED|Treatment Phase: Washout Period 1||8
6558419|NCT01775189|7481054|FG004|COMPLETED|Treatment Phase: Washout Period 1||8
6558420|NCT01775189|7481055|FG005|COMPLETED|Treatment Phase: Washout Period 1||7
6558421|NCT01775189|7481056|FG006|COMPLETED|Treatment Phase: Washout Period 1||8
6558422|NCT01775189|7481050|FG000|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6558423|NCT01775189|7481051|FG001|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6558424|NCT01775189|7481052|FG002|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6558425|NCT01775189|7481053|FG003|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6558426|NCT01775189|7481054|FG004|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6558427|NCT01775189|7481055|FG005|NOT COMPLETED|Treatment Phase: Washout Period 1||1
6558428|NCT01775189|7481056|FG006|NOT COMPLETED|Treatment Phase: Washout Period 1||0
6558429|NCT01775189|7481050|FG000|STARTED|Treatment Phase: Second Intervention||0
6558430|NCT01775189|7481051|FG001|STARTED|Treatment Phase: Second Intervention||0
6558431|NCT01775189|7481052|FG002|STARTED|Treatment Phase: Second Intervention||0
6558432|NCT01775189|7481053|FG003|STARTED|Treatment Phase: Second Intervention||8
6558433|NCT01775189|7481054|FG004|STARTED|Treatment Phase: Second Intervention||8
6558434|NCT01775189|7481055|FG005|STARTED|Treatment Phase: Second Intervention||7
6558435|NCT01775189|7481056|FG006|STARTED|Treatment Phase: Second Intervention||8
6558436|NCT01775189|7481050|FG000|COMPLETED|Treatment Phase: Second Intervention||0
6558437|NCT01775189|7481051|FG001|COMPLETED|Treatment Phase: Second Intervention||0
6558438|NCT01775189|7481052|FG002|COMPLETED|Treatment Phase: Second Intervention||0
6558439|NCT01775189|7481053|FG003|COMPLETED|Treatment Phase: Second Intervention||8
6558440|NCT01775189|7481054|FG004|COMPLETED|Treatment Phase: Second Intervention||8
6558441|NCT01775189|7481055|FG005|COMPLETED|Treatment Phase: Second Intervention||7
6558442|NCT01775189|7481056|FG006|COMPLETED|Treatment Phase: Second Intervention||8
6558443|NCT01775189|7481050|FG000|NOT COMPLETED|Treatment Phase: Second Intervention||0
6558444|NCT01775189|7481051|FG001|NOT COMPLETED|Treatment Phase: Second Intervention||0
6558445|NCT01775189|7481052|FG002|NOT COMPLETED|Treatment Phase: Second Intervention||0
6327355|NCT00496366|7233727|FG000|COMPLETED|Overall Study||10
6327356|NCT00496366|7233727|FG000|NOT COMPLETED|Overall Study||1
6327357|NCT00496379|7233731|FG000|STARTED|Overall Study||15
6327358|NCT00496379|7233731|FG000|COMPLETED|Overall Study||15
6327359|NCT00496379|7233731|FG000|NOT COMPLETED|Overall Study||0
6327360|NCT00496470|7233737|FG000|STARTED|Overall Study||329
6327361|NCT00496470|7233738|FG001|STARTED|Overall Study||331
6327362|NCT00496470|7233737|FG000|Received Study Medication|Overall Study||329
6327363|NCT00496470|7233738|FG001|Received Study Medication|Overall Study||330
6327364|NCT00496470|7233737|FG000|COMPLETED|Overall Study||303
6327365|NCT00496470|7233738|FG001|COMPLETED|Overall Study||302
6327366|NCT00496470|7233737|FG000|NOT COMPLETED|Overall Study||26
6327367|NCT00496470|7233738|FG001|NOT COMPLETED|Overall Study||29
6327368|NCT00496483|7233744|FG000|STARTED|Overall Study||60
6327369|NCT00496483|7233744|FG000|Dosed|Overall Study||51
6327370|NCT00496483|7233744|FG000|COMPLETED|Overall Study||48
6327371|NCT00496483|7233744|FG000|NOT COMPLETED|Overall Study||12
6327372|NCT00496587|7233751|FG000|STARTED|Overall Study||34
6327373|NCT00496587|7233751|FG000|COMPLETED|Overall Study||3
6327374|NCT00496587|7233751|FG000|NOT COMPLETED|Overall Study||31
6327375|NCT00496626|7233757|FG000|STARTED|Overall Study||302
6327376|NCT00496626|7233758|FG001|STARTED|Overall Study||298
6327377|NCT00496626|7233757|FG000|COMPLETED|Overall Study||296
6327378|NCT00496626|7233758|FG001|COMPLETED|Overall Study||292
6327379|NCT00496626|7233757|FG000|NOT COMPLETED|Overall Study||6
6327380|NCT00496626|7233758|FG001|NOT COMPLETED|Overall Study||6
6327381|NCT00496769|7233770|FG000|STARTED|Double Blind|Randomized|2807
6327382|NCT00496769|7233771|FG001|STARTED|Double Blind|Randomized|2791
6558446|NCT01775189|7481053|FG003|NOT COMPLETED|Treatment Phase: Second Intervention||0
6558447|NCT01775189|7481054|FG004|NOT COMPLETED|Treatment Phase: Second Intervention||0
6558448|NCT01775189|7481055|FG005|NOT COMPLETED|Treatment Phase: Second Intervention||0
6558449|NCT01775189|7481056|FG006|NOT COMPLETED|Treatment Phase: Second Intervention||0
6558450|NCT01775189|7481050|FG000|STARTED|Treatment Phase: Washout Period 2||0
6558451|NCT01775189|7481051|FG001|STARTED|Treatment Phase: Washout Period 2||0
6558452|NCT01775189|7481052|FG002|STARTED|Treatment Phase: Washout Period 2||0
6558453|NCT01775189|7481053|FG003|STARTED|Treatment Phase: Washout Period 2||8
6558454|NCT01775189|7481054|FG004|STARTED|Treatment Phase: Washout Period 2||8
6327383|NCT00496769|7233772|FG002|STARTED|Double Blind||0
6327384|NCT00496769|7233770|FG000|Received Treatment|Double Blind||2798
6327385|NCT00496769|7233771|FG001|Received Treatment|Double Blind||2708
6327386|NCT00496769|7233772|FG002|Received Treatment|Double Blind||0
6327387|NCT00496769|7233770|FG000|COMPLETED|Double Blind||2249
6327388|NCT00496769|7233771|FG001|COMPLETED|Double Blind||2142
6327389|NCT00496769|7233772|FG002|COMPLETED|Double Blind||0
6327390|NCT00496769|7233770|FG000|NOT COMPLETED|Double Blind||558
6327391|NCT00496769|7233771|FG001|NOT COMPLETED|Double Blind||649
6327392|NCT00496769|7233772|FG002|NOT COMPLETED|Double Blind||0
6327393|NCT00496769|7233770|FG000|STARTED|Open Label||0
6558455|NCT01775189|7481055|FG005|STARTED|Treatment Phase: Washout Period 2||7
6558456|NCT01775189|7481056|FG006|STARTED|Treatment Phase: Washout Period 2||8
6558457|NCT01775189|7481050|FG000|COMPLETED|Treatment Phase: Washout Period 2||0
6327394|NCT00496769|7233771|FG001|STARTED|Open Label||0
6327395|NCT00496769|7233772|FG002|STARTED|Open Label||3275
6327396|NCT00496769|7233770|FG000|COMPLETED|Open Label||0
6327397|NCT00496769|7233771|FG001|COMPLETED|Open Label||0
6327398|NCT00496769|7233772|FG002|COMPLETED|Open Label||2264
6327399|NCT00496769|7233770|FG000|NOT COMPLETED|Open Label||0
6327400|NCT00496769|7233771|FG001|NOT COMPLETED|Open Label||0
6327401|NCT00496769|7233772|FG002|NOT COMPLETED|Open Label||1011
6327402|NCT00496808|7233781|FG000|STARTED|Overall Study||69
6327403|NCT00496808|7233781|FG000|COMPLETED|Overall Study||69
6327404|NCT00496808|7233781|FG000|NOT COMPLETED|Overall Study||0
6327405|NCT00496860|7233788|FG000|STARTED|Overall Study||4
6327406|NCT00496860|7233789|FG001|STARTED|Overall Study||16
6327407|NCT00496860|7233790|FG002|STARTED|Overall Study||6
6327408|NCT00496860|7233788|FG000|COMPLETED|Overall Study||3
6327409|NCT00496860|7233789|FG001|COMPLETED|Overall Study||15
6327410|NCT00496860|7233790|FG002|COMPLETED|Overall Study||6
6327411|NCT00496860|7233788|FG000|NOT COMPLETED|Overall Study||1
6327412|NCT00496860|7233789|FG001|NOT COMPLETED|Overall Study||1
6327413|NCT00496860|7233790|FG002|NOT COMPLETED|Overall Study||0
6327414|NCT00496873|7233798|FG000|STARTED|Overall Study||85
6327415|NCT00496873|7233798|FG000|COMPLETED|Overall Study||78
6327416|NCT00496873|7233798|FG000|NOT COMPLETED|Overall Study||7
6327417|NCT00496964|7233804|FG000|STARTED|Overall Study||1
6327418|NCT00496964|7233805|FG001|STARTED|Overall Study||4
6327419|NCT00496964|7233804|FG000|COMPLETED|Overall Study||1
6327420|NCT00496964|7233805|FG001|COMPLETED|Overall Study||3
6327421|NCT00496964|7233804|FG000|NOT COMPLETED|Overall Study||0
6327422|NCT00496964|7233805|FG001|NOT COMPLETED|Overall Study||1
6327423|NCT00497055|7233815|FG000|STARTED|Overall Study||45
6327424|NCT00497055|7233816|FG001|STARTED|Overall Study||45
6327425|NCT00497055|7233815|FG000|COMPLETED|Overall Study||35
6327426|NCT00497055|7233816|FG001|COMPLETED|Overall Study||40
6327427|NCT00497055|7233815|FG000|NOT COMPLETED|Overall Study||10
6327428|NCT00497055|7233816|FG001|NOT COMPLETED|Overall Study||5
6327429|NCT00497081|7233824|FG000|STARTED|Overall Study||30
6327430|NCT00497081|7233825|FG001|STARTED|Overall Study||30
6327431|NCT00497081|7233824|FG000|COMPLETED|Overall Study||28
6327432|NCT00497081|7233825|FG001|COMPLETED|Overall Study||28
6327433|NCT00497081|7233824|FG000|NOT COMPLETED|Overall Study||2
6327434|NCT00497081|7233825|FG001|NOT COMPLETED|Overall Study||2
6327435|NCT00497146|7233833|FG000|STARTED|Treatment Period||115
6327436|NCT00497146|7233834|FG001|STARTED|Treatment Period||112
6327437|NCT00497146|7233833|FG000|COMPLETED|Treatment Period||88
6327438|NCT00497146|7233834|FG001|COMPLETED|Treatment Period||91
6327439|NCT00497146|7233833|FG000|NOT COMPLETED|Treatment Period||27
6327440|NCT00497146|7233834|FG001|NOT COMPLETED|Treatment Period||21
6327441|NCT00497146|7233833|FG000|STARTED|Long-term Follow-up Period||65
6327442|NCT00497146|7233834|FG001|STARTED|Long-term Follow-up Period||72
6327443|NCT00497146|7233833|FG000|COMPLETED|Long-term Follow-up Period||50
6327444|NCT00497146|7233834|FG001|COMPLETED|Long-term Follow-up Period||66
6327445|NCT00497146|7233833|FG000|NOT COMPLETED|Long-term Follow-up Period||15
6327446|NCT00497146|7233834|FG001|NOT COMPLETED|Long-term Follow-up Period||6
6327447|NCT00497198|7233844|FG000|STARTED|Overall Study||92
6327448|NCT00497198|7233845|FG001|STARTED|Overall Study||91
6327449|NCT00497198|7233844|FG000|COMPLETED|Overall Study||87
6327450|NCT00497198|7233845|FG001|COMPLETED|Overall Study||86
6327451|NCT00497198|7233844|FG000|NOT COMPLETED|Overall Study||5
6327452|NCT00497198|7233845|FG001|NOT COMPLETED|Overall Study||5
6327453|NCT00497289|7233853|FG000|STARTED|Overall Study||24
6327454|NCT00497289|7233854|FG001|STARTED|Overall Study||24
6327455|NCT00497289|7233853|FG000|COMPLETED|Overall Study||19
6327456|NCT00497289|7233854|FG001|COMPLETED|Overall Study||18
6327457|NCT00497289|7233853|FG000|NOT COMPLETED|Overall Study||5
6327458|NCT00497289|7233854|FG001|NOT COMPLETED|Overall Study||6
6327459|NCT00497770|7233866|FG000|STARTED|Overall Study||304
6327460|NCT00497770|7233867|FG001|STARTED|Overall Study||65
6327461|NCT00497770|7233868|FG002|STARTED|Overall Study||37
6327462|NCT00497770|7233869|FG003|STARTED|Overall Study||28
6327463|NCT00497770|7233866|FG000|COMPLETED|Overall Study||304
6327464|NCT00497770|7233867|FG001|COMPLETED|Overall Study||65
6327465|NCT00497770|7233868|FG002|COMPLETED|Overall Study||37
6327466|NCT00497770|7233869|FG003|COMPLETED|Overall Study||28
6327467|NCT00497770|7233866|FG000|NOT COMPLETED|Overall Study||0
6327468|NCT00497770|7233867|FG001|NOT COMPLETED|Overall Study||0
6327469|NCT00497770|7233868|FG002|NOT COMPLETED|Overall Study||0
6327470|NCT00497770|7233869|FG003|NOT COMPLETED|Overall Study||0
6327471|NCT00497796|7233882|FG000|STARTED|Overall Study||147
6327472|NCT00497796|7233883|FG001|STARTED|Overall Study||160
6327473|NCT00497796|7233882|FG000|COMPLETED|Overall Study||62
6327474|NCT00497796|7233883|FG001|COMPLETED|Overall Study||101
6327475|NCT00497796|7233882|FG000|NOT COMPLETED|Overall Study||85
6327476|NCT00497796|7233883|FG001|NOT COMPLETED|Overall Study||59
6327477|NCT00497874|7233891|FG000|STARTED|Overall Study||443
6327478|NCT00497874|7233892|FG001|STARTED|Overall Study||459
6327479|NCT00497874|7233891|FG000|COMPLETED|Overall Study||296
6327480|NCT00497874|7233892|FG001|COMPLETED|Overall Study||343
6327481|NCT00497874|7233891|FG000|NOT COMPLETED|Overall Study||147
6327482|NCT00497874|7233892|FG001|NOT COMPLETED|Overall Study||116
6327483|NCT00498173|7233902|FG000|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
6327484|NCT00498173|7233903|FG001|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
6327485|NCT00498173|7233904|FG002|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
6327486|NCT00498173|7233902|FG000|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
6327487|NCT00498173|7233903|FG001|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
6327488|NCT00498173|7233904|FG002|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
6775216|NCT03885934|7703144|FG001|PCV Dose 2|Overall Study||64
6775217|NCT03885934|7703145|FG002|PCV Dose 2|Overall Study||62
6775218|NCT03885934|7703146|FG003|PCV Dose 2|Overall Study||64
6775219|NCT03885934|7703147|FG004|PCV Dose 2|Overall Study||0
6327489|NCT00498173|7233902|FG000|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
6327490|NCT00498173|7233903|FG001|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
6327491|NCT00498173|7233904|FG002|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
6327492|NCT00498173|7233902|FG000|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6327493|NCT00498173|7233903|FG001|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6327494|NCT00498173|7233904|FG002|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
6327495|NCT00498173|7233902|FG000|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6327496|NCT00498173|7233903|FG001|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6327497|NCT00498173|7233904|FG002|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
6327498|NCT00498173|7233902|FG000|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6327499|NCT00498173|7233903|FG001|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6327500|NCT00498173|7233904|FG002|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
6327501|NCT00498186|7233912|FG000|STARTED|Overall Study||295
6327502|NCT00498186|7233912|FG000|COMPLETED|Overall Study||122
6327503|NCT00498186|7233912|FG000|NOT COMPLETED|Overall Study||173
6327504|NCT00498355|7233916|FG000|STARTED|Overall Study||7
6327505|NCT00498355|7233916|FG000|COMPLETED|Overall Study||6
6327506|NCT00498355|7233916|FG000|NOT COMPLETED|Overall Study||1
6327507|NCT00498368|7233923|FG000|STARTED|Overall Study||17
6327508|NCT00498368|7233924|FG001|STARTED|Overall Study||17
6327509|NCT00498368|7233923|FG000|COMPLETED|Overall Study||14
6327510|NCT00498368|7233924|FG001|COMPLETED|Overall Study||15
6327511|NCT00498368|7233923|FG000|NOT COMPLETED|Overall Study||3
6327512|NCT00498368|7233924|FG001|NOT COMPLETED|Overall Study||2
6327513|NCT00498433|7233933|FG000|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
6327514|NCT00498433|7233934|FG001|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6327515|NCT00498433|7233935|FG002|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6327516|NCT00498433|7233933|FG000|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
6327517|NCT00498433|7233934|FG001|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6327518|NCT00498433|7233935|FG002|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6327519|NCT00498433|7233933|FG000|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6327520|NCT00498433|7233934|FG001|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6327521|NCT00498433|7233935|FG002|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
6558458|NCT01775189|7481051|FG001|COMPLETED|Treatment Phase: Washout Period 2||0
6558459|NCT01775189|7481052|FG002|COMPLETED|Treatment Phase: Washout Period 2||0
6558460|NCT01775189|7481053|FG003|COMPLETED|Treatment Phase: Washout Period 2||7
6558461|NCT01775189|7481054|FG004|COMPLETED|Treatment Phase: Washout Period 2||8
6558462|NCT01775189|7481055|FG005|COMPLETED|Treatment Phase: Washout Period 2||7
6558463|NCT01775189|7481056|FG006|COMPLETED|Treatment Phase: Washout Period 2||8
6558464|NCT01775189|7481050|FG000|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6558465|NCT01775189|7481051|FG001|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6558466|NCT01775189|7481052|FG002|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6558467|NCT01775189|7481053|FG003|NOT COMPLETED|Treatment Phase: Washout Period 2||1
6558468|NCT01775189|7481054|FG004|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6558469|NCT01775189|7481055|FG005|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6558470|NCT01775189|7481056|FG006|NOT COMPLETED|Treatment Phase: Washout Period 2||0
6558471|NCT01775189|7481050|FG000|STARTED|Treatment Phase: Third Intervention||0
6327522|NCT00498433|7233933|FG000|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6327523|NCT00498433|7233934|FG001|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
6327524|NCT00498433|7233935|FG002|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6327525|NCT00498433|7233933|FG000|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6327526|NCT00498433|7233934|FG001|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
6327527|NCT00498433|7233935|FG002|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6327528|NCT00498433|7233933|FG000|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6327529|NCT00498433|7233934|FG001|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6327530|NCT00498433|7233935|FG002|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
6327531|NCT00498433|7233933|FG000|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6327532|NCT00498433|7233934|FG001|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6327533|NCT00498433|7233935|FG002|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
6327534|NCT00498433|7233933|FG000|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6327535|NCT00498433|7233934|FG001|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6327536|NCT00498433|7233935|FG002|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
6327537|NCT00498433|7233933|FG000|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6327538|NCT00498433|7233934|FG001|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6327539|NCT00498433|7233935|FG002|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
6327540|NCT00498433|7233933|FG000|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
6327541|NCT00498433|7233934|FG001|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
6327542|NCT00498433|7233935|FG002|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
6558472|NCT01775189|7481051|FG001|STARTED|Treatment Phase: Third Intervention||0
6558473|NCT01775189|7481052|FG002|STARTED|Treatment Phase: Third Intervention||0
6775220|NCT03885934|7703148|FG005|PCV Dose 2|Overall Study||0
6558474|NCT01775189|7481053|FG003|STARTED|Treatment Phase: Third Intervention||7
6558475|NCT01775189|7481054|FG004|STARTED|Treatment Phase: Third Intervention||8
6327543|NCT00498433|7233933|FG000|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
6327544|NCT00498433|7233934|FG001|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
6327545|NCT00498433|7233935|FG002|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
6327546|NCT00498433|7233933|FG000|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
6327547|NCT00498433|7233934|FG001|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
6327548|NCT00498433|7233935|FG002|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
6327549|NCT00498433|7233933|FG000|STARTED|Part 2: Double Blind (12 Weeks)||0
6327550|NCT00498433|7233934|FG001|STARTED|Part 2: Double Blind (12 Weeks)||8
6327551|NCT00498433|7233935|FG002|STARTED|Part 2: Double Blind (12 Weeks)||8
6327552|NCT00498433|7233933|FG000|COMPLETED|Part 2: Double Blind (12 Weeks)||0
6327553|NCT00498433|7233934|FG001|COMPLETED|Part 2: Double Blind (12 Weeks)||8
6327554|NCT00498433|7233935|FG002|COMPLETED|Part 2: Double Blind (12 Weeks)||8
6327555|NCT00498433|7233933|FG000|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
6327556|NCT00498433|7233934|FG001|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
6327557|NCT00498433|7233935|FG002|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
6327558|NCT00498485|7233954|FG000|STARTED|Overall Study||7
6327559|NCT00498485|7233955|FG001|STARTED|Overall Study||10
6327560|NCT00498485|7233954|FG000|COMPLETED|Overall Study||6
6327561|NCT00498485|7233955|FG001|COMPLETED|Overall Study||5
6327562|NCT00498485|7233954|FG000|NOT COMPLETED|Overall Study||1
6327563|NCT00498485|7233955|FG001|NOT COMPLETED|Overall Study||5
6327564|NCT00498550|7233965|FG000|STARTED|Overall Study||15
6327565|NCT00498550|7233966|FG001|STARTED|Overall Study||16
6327566|NCT00498550|7233965|FG000|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
6327567|NCT00498550|7233966|FG001|COMPLETED|Overall Study||15
6327568|NCT00498550|7233965|FG000|NOT COMPLETED|Overall Study||0
6327569|NCT00498550|7233966|FG001|NOT COMPLETED|Overall Study||1
6327570|NCT00498602|7233979|FG000|STARTED|Overall Study||36
6327571|NCT00498602|7233980|FG001|STARTED|Overall Study||61
6327572|NCT00498602|7233981|FG002|STARTED|Overall Study||40
6327573|NCT00498602|7233982|FG003|STARTED|Overall Study||35
6327574|NCT00498602|7233983|FG004|STARTED|Overall Study||12
6327575|NCT00498602|7233984|FG005|STARTED|Overall Study||44
6327576|NCT00498602|7233985|FG006|STARTED|Overall Study||17
6327577|NCT00498602|7233979|FG000|Treated|Overall Study||36
6327578|NCT00498602|7233980|FG001|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
6327579|NCT00498602|7233981|FG002|Treated|Overall Study||40
6327580|NCT00498602|7233982|FG003|Treated|Overall Study||35
6327581|NCT00498602|7233983|FG004|Treated|Overall Study||12
6327582|NCT00498602|7233984|FG005|Treated|Overall Study||44
6327583|NCT00498602|7233985|FG006|Treated|Overall Study||17
6327584|NCT00498602|7233979|FG000|COMPLETED|Overall Study||26
6775221|NCT03885934|7703143|FG000|PCV Dose 3|Overall Study||63
6775222|NCT03885934|7703144|FG001|PCV Dose 3|Overall Study||64
6775223|NCT03885934|7703145|FG002|PCV Dose 3|Overall Study||0
6775224|NCT03885934|7703146|FG003|PCV Dose 3|Overall Study||0
6775225|NCT03885934|7703147|FG004|PCV Dose 3|Overall Study||0
6775226|NCT03885934|7703148|FG005|PCV Dose 3|Overall Study||0
6775227|NCT03885934|7703143|FG000|COMPLETED|Overall Study||63
6327585|NCT00498602|7233980|FG001|COMPLETED|Overall Study||51
6327586|NCT00498602|7233981|FG002|COMPLETED|Overall Study||32
6327587|NCT00498602|7233982|FG003|COMPLETED|Overall Study||30
6327588|NCT00498602|7233983|FG004|COMPLETED|Overall Study||8
6327589|NCT00498602|7233984|FG005|COMPLETED|Overall Study||31
6558476|NCT01775189|7481055|FG005|STARTED|Treatment Phase: Third Intervention||7
6558477|NCT01775189|7481056|FG006|STARTED|Treatment Phase: Third Intervention||8
6558478|NCT01775189|7481050|FG000|COMPLETED|Treatment Phase: Third Intervention||0
6558479|NCT01775189|7481051|FG001|COMPLETED|Treatment Phase: Third Intervention||0
6327590|NCT00498602|7233985|FG006|COMPLETED|Overall Study||15
6327591|NCT00498602|7233979|FG000|NOT COMPLETED|Overall Study||10
6327592|NCT00498602|7233980|FG001|NOT COMPLETED|Overall Study||10
6327593|NCT00498602|7233981|FG002|NOT COMPLETED|Overall Study||8
6327594|NCT00498602|7233982|FG003|NOT COMPLETED|Overall Study||5
6327595|NCT00498602|7233983|FG004|NOT COMPLETED|Overall Study||4
6327596|NCT00498602|7233984|FG005|NOT COMPLETED|Overall Study||13
6327597|NCT00498602|7233985|FG006|NOT COMPLETED|Overall Study||2
6327598|NCT00498615|7234001|FG000|STARTED|Fasudil 80mg||2
6327599|NCT00498615|7234002|FG001|STARTED|Fasudil 80mg||4
6327600|NCT00498615|7234003|FG002|STARTED|Fasudil 80mg||3
6327601|NCT00498615|7234004|FG003|STARTED|Fasudil 80mg||2
6327602|NCT00498615|7234005|FG004|STARTED|Fasudil 80mg||3
6327603|NCT00498615|7234006|FG005|STARTED|Fasudil 80mg||3
6327604|NCT00498615|7234001|FG000|COMPLETED|Fasudil 80mg||2
6327605|NCT00498615|7234002|FG001|COMPLETED|Fasudil 80mg||4
6327606|NCT00498615|7234003|FG002|COMPLETED|Fasudil 80mg||3
6327607|NCT00498615|7234004|FG003|COMPLETED|Fasudil 80mg||2
6327608|NCT00498615|7234005|FG004|COMPLETED|Fasudil 80mg||3
6327609|NCT00498615|7234006|FG005|COMPLETED|Fasudil 80mg||3
6327610|NCT00498615|7234001|FG000|NOT COMPLETED|Fasudil 80mg||0
6327611|NCT00498615|7234002|FG001|NOT COMPLETED|Fasudil 80mg||0
6327612|NCT00498615|7234003|FG002|NOT COMPLETED|Fasudil 80mg||0
6327613|NCT00498615|7234004|FG003|NOT COMPLETED|Fasudil 80mg||0
6775228|NCT03885934|7703144|FG001|COMPLETED|Overall Study||64
6775229|NCT03885934|7703145|FG002|COMPLETED|Overall Study||62
6775230|NCT03885934|7703146|FG003|COMPLETED|Overall Study||64
6327614|NCT00498615|7234005|FG004|NOT COMPLETED|Fasudil 80mg||0
6327615|NCT00498615|7234006|FG005|NOT COMPLETED|Fasudil 80mg||0
6327616|NCT00498615|7234001|FG000|STARTED|Fasudil 40mg||2
6327617|NCT00498615|7234002|FG001|STARTED|Fasudil 40mg||4
6327618|NCT00498615|7234003|FG002|STARTED|Fasudil 40mg||3
6327619|NCT00498615|7234004|FG003|STARTED|Fasudil 40mg||2
6327620|NCT00498615|7234005|FG004|STARTED|Fasudil 40mg||3
6327621|NCT00498615|7234006|FG005|STARTED|Fasudil 40mg||3
6327622|NCT00498615|7234001|FG000|COMPLETED|Fasudil 40mg||2
6327623|NCT00498615|7234002|FG001|COMPLETED|Fasudil 40mg||4
6327624|NCT00498615|7234003|FG002|COMPLETED|Fasudil 40mg||3
6327625|NCT00498615|7234004|FG003|COMPLETED|Fasudil 40mg||2
6327626|NCT00498615|7234005|FG004|COMPLETED|Fasudil 40mg||3
6327627|NCT00498615|7234006|FG005|COMPLETED|Fasudil 40mg||3
6775231|NCT03885934|7703147|FG004|COMPLETED|Overall Study||177
6775232|NCT03885934|7703148|FG005|COMPLETED|Overall Study||175
6775233|NCT03885934|7703143|FG000|NOT COMPLETED|Overall Study||1
6775234|NCT03885934|7703144|FG001|NOT COMPLETED|Overall Study||0
6775235|NCT03885934|7703145|FG002|NOT COMPLETED|Overall Study||0
6775236|NCT03885934|7703146|FG003|NOT COMPLETED|Overall Study||0
6775237|NCT03885934|7703147|FG004|NOT COMPLETED|Overall Study||0
6327628|NCT00498615|7234001|FG000|NOT COMPLETED|Fasudil 40mg||0
6327629|NCT00498615|7234002|FG001|NOT COMPLETED|Fasudil 40mg||0
6327630|NCT00498615|7234003|FG002|NOT COMPLETED|Fasudil 40mg||0
6327631|NCT00498615|7234004|FG003|NOT COMPLETED|Fasudil 40mg||0
6327632|NCT00498615|7234005|FG004|NOT COMPLETED|Fasudil 40mg||0
6327633|NCT00498615|7234006|FG005|NOT COMPLETED|Fasudil 40mg||0
6327634|NCT00498615|7234001|FG000|STARTED|Placebo||2
6327635|NCT00498615|7234002|FG001|STARTED|Placebo||4
6327636|NCT00498615|7234003|FG002|STARTED|Placebo||3
6327637|NCT00498615|7234004|FG003|STARTED|Placebo||2
6327638|NCT00498615|7234005|FG004|STARTED|Placebo||3
6327639|NCT00498615|7234006|FG005|STARTED|Placebo||3
6327640|NCT00498615|7234001|FG000|COMPLETED|Placebo||2
6327641|NCT00498615|7234002|FG001|COMPLETED|Placebo||4
6327642|NCT00498615|7234003|FG002|COMPLETED|Placebo||3
6327643|NCT00498615|7234004|FG003|COMPLETED|Placebo||2
6327644|NCT00498615|7234005|FG004|COMPLETED|Placebo||3
6327645|NCT00498615|7234006|FG005|COMPLETED|Placebo||3
6327646|NCT00498615|7234001|FG000|NOT COMPLETED|Placebo||0
6327647|NCT00498615|7234002|FG001|NOT COMPLETED|Placebo||0
6327648|NCT00498615|7234003|FG002|NOT COMPLETED|Placebo||0
6327649|NCT00498615|7234004|FG003|NOT COMPLETED|Placebo||0
6327650|NCT00498615|7234005|FG004|NOT COMPLETED|Placebo||0
6327651|NCT00498615|7234006|FG005|NOT COMPLETED|Placebo||0
6327652|NCT00498628|7234022|FG000|STARTED|Overall Study||105
6327653|NCT00498628|7234023|FG001|STARTED|Overall Study||113
6327654|NCT00498628|7234022|FG000|COMPLETED|Overall Study||90
6327655|NCT00498628|7234023|FG001|COMPLETED|Overall Study||92
6327656|NCT00498628|7234022|FG000|NOT COMPLETED|Overall Study||15
6327657|NCT00498628|7234023|FG001|NOT COMPLETED|Overall Study||21
6327658|NCT00498706|7234033|FG000|STARTED|Overall Study||163
6327659|NCT00498706|7234034|FG001|STARTED|Overall Study||162
6327660|NCT00498706|7234033|FG000|Post Treatment Week 18|Overall Study||163
6327661|NCT00498706|7234034|FG001|Post Treatment Week 18|Overall Study||162
6327662|NCT00498706|7234033|FG000|COMPLETED|Overall Study||163
6327663|NCT00498706|7234034|FG001|COMPLETED|Overall Study||162
6327664|NCT00498706|7234033|FG000|NOT COMPLETED|Overall Study||0
6327665|NCT00498706|7234034|FG001|NOT COMPLETED|Overall Study||0
6327666|NCT00498797|7234044|FG000|STARTED|Overall Study|randomised patients|43
6327667|NCT00498797|7234045|FG001|STARTED|Overall Study|randomised patients|43
6327668|NCT00498797|7234044|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
6327669|NCT00498797|7234045|FG001|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
6327670|NCT00498797|7234044|FG000|NOT COMPLETED|Overall Study||38
6327671|NCT00498797|7234045|FG001|NOT COMPLETED|Overall Study||29
6327672|NCT00498927|7234051|FG000|STARTED|Overall Study||47
6327673|NCT00498927|7234051|FG000|COMPLETED|Overall Study||47
6327674|NCT00498927|7234051|FG000|NOT COMPLETED|Overall Study||0
6327675|NCT00498940|7234057|FG000|STARTED|Overall Study||30
6327676|NCT00498940|7234058|FG001|STARTED|Overall Study||31
6327677|NCT00498940|7234057|FG000|COMPLETED|Overall Study||30
6327678|NCT00498940|7234058|FG001|COMPLETED|Overall Study||31
6327679|NCT00498940|7234057|FG000|NOT COMPLETED|Overall Study||0
6327680|NCT00498940|7234058|FG001|NOT COMPLETED|Overall Study||0
6327681|NCT00499031|7234064|FG000|STARTED|Overall Study|Total number participants enrolled on study|38
6327682|NCT00499031|7234064|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
6558480|NCT01775189|7481052|FG002|COMPLETED|Treatment Phase: Third Intervention||0
6558481|NCT01775189|7481053|FG003|COMPLETED|Treatment Phase: Third Intervention||7
6558482|NCT01775189|7481054|FG004|COMPLETED|Treatment Phase: Third Intervention||8
6558483|NCT01775189|7481055|FG005|COMPLETED|Treatment Phase: Third Intervention||7
6558484|NCT01775189|7481056|FG006|COMPLETED|Treatment Phase: Third Intervention||8
6558485|NCT01775189|7481050|FG000|NOT COMPLETED|Treatment Phase: Third Intervention||0
6558486|NCT01775189|7481051|FG001|NOT COMPLETED|Treatment Phase: Third Intervention||0
6558487|NCT01775189|7481052|FG002|NOT COMPLETED|Treatment Phase: Third Intervention||0
6562861|NCT01803204|7485754|FG001|NOT COMPLETED|Overall Study||0
6775238|NCT03885934|7703148|FG005|NOT COMPLETED|Overall Study||0
6327683|NCT00499031|7234064|FG000|NOT COMPLETED|Overall Study||3
6327684|NCT00499083|7234068|FG000|STARTED|Overall Study||17
6327685|NCT00499083|7234068|FG000|Participants at UNMC|Overall Study||3
6377894|NCT00765843|7288575|FG001|STARTED|Overall Study||25
6558488|NCT01775189|7481053|FG003|NOT COMPLETED|Treatment Phase: Third Intervention||0
6327686|NCT00499083|7234068|FG000|Participants at Moffitt Cancer Center|Overall Study||14
6327687|NCT00499083|7234068|FG000|COMPLETED|Overall Study||14
6558489|NCT01775189|7481054|FG004|NOT COMPLETED|Treatment Phase: Third Intervention||0
6558490|NCT01775189|7481055|FG005|NOT COMPLETED|Treatment Phase: Third Intervention||0
6558491|NCT01775189|7481056|FG006|NOT COMPLETED|Treatment Phase: Third Intervention||0
6327688|NCT00499083|7234068|FG000|NOT COMPLETED|Overall Study||3
6327689|NCT00499096|7234074|FG000|STARTED|Overall Study||58
6327690|NCT00499096|7234075|FG001|STARTED|Overall Study||60
6327691|NCT00499096|7234074|FG000|COMPLETED|Overall Study||35
6327692|NCT00499096|7234075|FG001|COMPLETED|Overall Study||40
6327693|NCT00499096|7234074|FG000|NOT COMPLETED|Overall Study||23
6327694|NCT00499096|7234075|FG001|NOT COMPLETED|Overall Study||20
6327695|NCT00499109|7234085|FG000|STARTED|Overall Study||183
6327696|NCT00499109|7234086|FG001|STARTED|Overall Study||92
6327697|NCT00499109|7234085|FG000|COMPLETED|Overall Study||165
6327698|NCT00499109|7234086|FG001|COMPLETED|Overall Study||85
6327699|NCT00499109|7234085|FG000|NOT COMPLETED|Overall Study||18
6327700|NCT00499109|7234086|FG001|NOT COMPLETED|Overall Study||7
6327701|NCT00499122|7234095|FG000|STARTED|Overall Study||41
6327702|NCT00499122|7234095|FG000|COMPLETED|Overall Study||39
6327703|NCT00499122|7234095|FG000|NOT COMPLETED|Overall Study||2
6327704|NCT00499174|7234102|FG000|STARTED|Overall Study||78
6327705|NCT00499174|7234103|FG001|STARTED|Overall Study||102
6327706|NCT00499174|7234102|FG000|COMPLETED|Overall Study||0
6327707|NCT00499174|7234103|FG001|COMPLETED|Overall Study||93
6327708|NCT00499174|7234102|FG000|NOT COMPLETED|Overall Study||78
6327709|NCT00499174|7234103|FG001|NOT COMPLETED|Overall Study||9
6327710|NCT00499252|7234111|FG000|STARTED|Overall Study||51
6327711|NCT00499252|7234111|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
6327712|NCT00499252|7234111|FG000|NOT COMPLETED|Overall Study||12
6327713|NCT00499343|7234121|FG000|STARTED|Overall Study||41
6327714|NCT00499343|7234122|FG001|STARTED|Overall Study||43
6327715|NCT00499343|7234121|FG000|COMPLETED|Overall Study||41
6327716|NCT00499343|7234122|FG001|COMPLETED|Overall Study||43
6327717|NCT00499343|7234121|FG000|NOT COMPLETED|Overall Study||0
6327718|NCT00499343|7234122|FG001|NOT COMPLETED|Overall Study||0
6327719|NCT00499369|7234133|FG000|STARTED|Overall Study||16
6327720|NCT00499369|7234134|FG001|STARTED|Overall Study||18
6327721|NCT00499369|7234135|FG002|STARTED|Overall Study||17
6327722|NCT00499369|7234136|FG003|STARTED|Overall Study||9
6327723|NCT00499369|7234137|FG004|STARTED|Overall Study||12
6327724|NCT00499369|7234133|FG000|Eligible|Overall Study||14
6327725|NCT00499369|7234134|FG001|Eligible|Overall Study||16
6327726|NCT00499369|7234135|FG002|Eligible|Overall Study||16
6327727|NCT00499369|7234136|FG003|Eligible|Overall Study||8
6327728|NCT00499369|7234137|FG004|Eligible|Overall Study||12
6327729|NCT00499369|7234133|FG000|COMPLETED|Overall Study||0
6327730|NCT00499369|7234134|FG001|COMPLETED|Overall Study||0
6327731|NCT00499369|7234135|FG002|COMPLETED|Overall Study||0
6327732|NCT00499369|7234136|FG003|COMPLETED|Overall Study||0
6327733|NCT00499369|7234137|FG004|COMPLETED|Overall Study||0
6327734|NCT00499369|7234133|FG000|NOT COMPLETED|Overall Study||16
6327735|NCT00499369|7234134|FG001|NOT COMPLETED|Overall Study||18
6327736|NCT00499369|7234135|FG002|NOT COMPLETED|Overall Study||17
6327737|NCT00499369|7234136|FG003|NOT COMPLETED|Overall Study||9
6327738|NCT00499369|7234137|FG004|NOT COMPLETED|Overall Study||12
6327739|NCT00499408|7234149|FG000|STARTED|Overall Study||26
6327740|NCT00499408|7234149|FG000|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
6327741|NCT00499408|7234149|FG000|NOT COMPLETED|Overall Study||0
6327742|NCT00499447|7234153|FG000|STARTED|Overall Study||13
6327743|NCT00499447|7234153|FG000|COMPLETED|Overall Study||13
6327744|NCT00499447|7234153|FG000|NOT COMPLETED|Overall Study||0
6327745|NCT00499460|7234159|FG000|STARTED|Intervention 1 (30 Days)||8
6327746|NCT00499460|7234160|FG001|STARTED|Intervention 1 (30 Days)||7
6327747|NCT00499460|7234159|FG000|COMPLETED|Intervention 1 (30 Days)||6
6327748|NCT00499460|7234160|FG001|COMPLETED|Intervention 1 (30 Days)||7
6327749|NCT00499460|7234159|FG000|NOT COMPLETED|Intervention 1 (30 Days)||2
6327750|NCT00499460|7234160|FG001|NOT COMPLETED|Intervention 1 (30 Days)||0
6327751|NCT00499460|7234159|FG000|STARTED|Intervention 2 (30 Days)||6
6327752|NCT00499460|7234160|FG001|STARTED|Intervention 2 (30 Days)||7
6327753|NCT00499460|7234159|FG000|COMPLETED|Intervention 2 (30 Days)||6
6327754|NCT00499460|7234160|FG001|COMPLETED|Intervention 2 (30 Days)||6
6327755|NCT00499460|7234159|FG000|NOT COMPLETED|Intervention 2 (30 Days)||0
6327756|NCT00499460|7234160|FG001|NOT COMPLETED|Intervention 2 (30 Days)||1
6327757|NCT00499473|7234178|FG000|STARTED|Overall Study||27
6327758|NCT00499473|7234179|FG001|STARTED|Overall Study||4
6327759|NCT00499473|7234178|FG000|COMPLETED|Overall Study|Patients evaluable|21
6327760|NCT00499473|7234179|FG001|COMPLETED|Overall Study||4
6327761|NCT00499473|7234178|FG000|NOT COMPLETED|Overall Study||6
6327762|NCT00499473|7234179|FG001|NOT COMPLETED|Overall Study||0
6327763|NCT00499486|7234185|FG000|STARTED|Overall Study||47
6327764|NCT00499486|7234185|FG000|COMPLETED|Overall Study||31
6327765|NCT00499486|7234185|FG000|NOT COMPLETED|Overall Study||16
6327766|NCT00499603|7234191|FG000|STARTED|Overall Study||27
6327767|NCT00499603|7234192|FG001|STARTED|Overall Study||23
6327768|NCT00499603|7234191|FG000|COMPLETED|Overall Study||27
6327769|NCT00499603|7234192|FG001|COMPLETED|Overall Study||22
6327770|NCT00499603|7234191|FG000|NOT COMPLETED|Overall Study||0
6327771|NCT00499603|7234192|FG001|NOT COMPLETED|Overall Study||1
6327772|NCT00499616|7234204|FG000|STARTED|Overall Study||176
6558492|NCT01775189|7481050|FG000|STARTED|Treatment Phase: Washout Period 3||0
6558493|NCT01775189|7481051|FG001|STARTED|Treatment Phase: Washout Period 3||0
6558494|NCT01775189|7481052|FG002|STARTED|Treatment Phase: Washout Period 3||0
6558495|NCT01775189|7481053|FG003|STARTED|Treatment Phase: Washout Period 3||7
6558496|NCT01775189|7481054|FG004|STARTED|Treatment Phase: Washout Period 3||8
6558497|NCT01775189|7481055|FG005|STARTED|Treatment Phase: Washout Period 3||7
6558498|NCT01775189|7481056|FG006|STARTED|Treatment Phase: Washout Period 3||8
6558499|NCT01775189|7481050|FG000|COMPLETED|Treatment Phase: Washout Period 3||0
6327773|NCT00499616|7234205|FG001|STARTED|Overall Study||142
6327774|NCT00499616|7234206|FG002|STARTED|Overall Study||89
6327775|NCT00499616|7234207|FG003|STARTED|Overall Study||57
6327776|NCT00499616|7234204|FG000|COMPLETED|Overall Study||161
6327777|NCT00499616|7234205|FG001|COMPLETED|Overall Study||114
6327778|NCT00499616|7234206|FG002|COMPLETED|Overall Study||53
6558500|NCT01775189|7481051|FG001|COMPLETED|Treatment Phase: Washout Period 3||0
6558501|NCT01775189|7481052|FG002|COMPLETED|Treatment Phase: Washout Period 3||0
6558502|NCT01775189|7481053|FG003|COMPLETED|Treatment Phase: Washout Period 3||6
6558503|NCT01775189|7481054|FG004|COMPLETED|Treatment Phase: Washout Period 3||8
6558504|NCT01775189|7481055|FG005|COMPLETED|Treatment Phase: Washout Period 3||7
6327779|NCT00499616|7234207|FG003|COMPLETED|Overall Study||0
6327780|NCT00499616|7234204|FG000|NOT COMPLETED|Overall Study||15
6327781|NCT00499616|7234205|FG001|NOT COMPLETED|Overall Study||28
6327782|NCT00499616|7234206|FG002|NOT COMPLETED|Overall Study||36
6327783|NCT00499616|7234207|FG003|NOT COMPLETED|Overall Study||57
6327784|NCT00499655|7234222|FG000|STARTED|Overall Study||53
6327785|NCT00499655|7234223|FG001|STARTED|Overall Study||54
6327786|NCT00499655|7234222|FG000|COMPLETED|Overall Study||53
6327787|NCT00499655|7234223|FG001|COMPLETED|Overall Study||54
6327788|NCT00499655|7234222|FG000|NOT COMPLETED|Overall Study||0
6327789|NCT00499655|7234223|FG001|NOT COMPLETED|Overall Study||0
6327790|NCT00499681|7234232|FG000|STARTED|Overall Study||4
6327791|NCT00499681|7234233|FG001|STARTED|Overall Study||2
6327792|NCT00499681|7234232|FG000|COMPLETED|Overall Study||4
6327793|NCT00499681|7234233|FG001|COMPLETED|Overall Study||0
6327794|NCT00499681|7234232|FG000|NOT COMPLETED|Overall Study||0
6327795|NCT00499681|7234233|FG001|NOT COMPLETED|Overall Study||2
6327796|NCT00499694|7234239|FG000|STARTED|Overall Study||31
6327797|NCT00499694|7234239|FG000|COMPLETED|Overall Study||30
6327798|NCT00499694|7234239|FG000|NOT COMPLETED|Overall Study||1
6327799|NCT00499746|7234244|FG000|STARTED|Phase 1(6-9 One Day Sessions)||20
6327800|NCT00499746|7234244|FG000|COMPLETED|Phase 1(6-9 One Day Sessions)||8
6327801|NCT00499746|7234244|FG000|NOT COMPLETED|Phase 1(6-9 One Day Sessions)||12
6327802|NCT00499746|7234244|FG000|STARTED|Phase 2 (6-9 One Day Sessions)||8
6327803|NCT00499746|7234244|FG000|COMPLETED|Phase 2 (6-9 One Day Sessions)||8
6327804|NCT00499746|7234244|FG000|NOT COMPLETED|Phase 2 (6-9 One Day Sessions)||0
6327805|NCT00499746|7234244|FG000|STARTED|Phase 3 (9-14 One Day Sessions)||8
6327806|NCT00499746|7234244|FG000|COMPLETED|Phase 3 (9-14 One Day Sessions)||8
6327807|NCT00499746|7234244|FG000|NOT COMPLETED|Phase 3 (9-14 One Day Sessions)||0
6327808|NCT00499863|7234260|FG000|STARTED|Overall Study||145
6327809|NCT00499863|7234261|FG001|STARTED|Overall Study||72
6327810|NCT00499863|7234260|FG000|COMPLETED|Overall Study||95
6327811|NCT00499863|7234261|FG001|COMPLETED|Overall Study||29
6327812|NCT00499863|7234260|FG000|NOT COMPLETED|Overall Study||50
6327813|NCT00499863|7234261|FG001|NOT COMPLETED|Overall Study||43
6327814|NCT00499889|7234267|FG000|STARTED|Overall Study||42
6327815|NCT00499889|7234267|FG000|COMPLETED|Overall Study||41
6327816|NCT00499889|7234267|FG000|NOT COMPLETED|Overall Study||1
6327817|NCT00499915|7234273|FG000|STARTED|Overall Study||83
6327818|NCT00499915|7234274|FG001|STARTED|Overall Study||82
6327819|NCT00499915|7234273|FG000|COMPLETED|Overall Study||68
6327820|NCT00499915|7234274|FG001|COMPLETED|Overall Study||76
6327821|NCT00499915|7234273|FG000|NOT COMPLETED|Overall Study||15
6327822|NCT00499915|7234274|FG001|NOT COMPLETED|Overall Study||6
6327823|NCT00500110|7234280|FG000|STARTED|Overall Study||39
6327824|NCT00500110|7234280|FG000|COMPLETED|Overall Study||36
6327825|NCT00500110|7234280|FG000|NOT COMPLETED|Overall Study||3
6327826|NCT00500149|7234284|FG000|STARTED|Enrolled (Dose-optimization Phase)||129
6327827|NCT00500149|7234285|FG001|STARTED|Enrolled (Dose-optimization Phase)||0
6327828|NCT00500149|7234284|FG000|COMPLETED|Enrolled (Dose-optimization Phase)||117
6327829|NCT00500149|7234285|FG001|COMPLETED|Enrolled (Dose-optimization Phase)||0
6327830|NCT00500149|7234284|FG000|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
6327831|NCT00500149|7234285|FG001|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
6327832|NCT00500149|7234284|FG000|STARTED|First Intervention (Cross-over Phase)||58
6327833|NCT00500149|7234285|FG001|STARTED|First Intervention (Cross-over Phase)||59
6327834|NCT00500149|7234284|FG000|COMPLETED|First Intervention (Cross-over Phase)||56
6327835|NCT00500149|7234285|FG001|COMPLETED|First Intervention (Cross-over Phase)||57
6327836|NCT00500149|7234284|FG000|NOT COMPLETED|First Intervention (Cross-over Phase)||2
6558505|NCT01775189|7481056|FG006|COMPLETED|Treatment Phase: Washout Period 3||7
6327837|NCT00500149|7234285|FG001|NOT COMPLETED|First Intervention (Cross-over Phase)||2
6327838|NCT00500149|7234284|FG000|STARTED|Second Intervention (Cross-over Phase)||56
6327839|NCT00500149|7234285|FG001|STARTED|Second Intervention (Cross-over Phase)||57
6327840|NCT00500149|7234284|FG000|COMPLETED|Second Intervention (Cross-over Phase)||54
6327841|NCT00500149|7234285|FG001|COMPLETED|Second Intervention (Cross-over Phase)||57
6327842|NCT00500149|7234284|FG000|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
6327843|NCT00500149|7234285|FG001|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
6327844|NCT00500240|7234293|FG000|STARTED|Overall Study||25
6327845|NCT00500240|7234294|FG001|STARTED|Overall Study||26
6327846|NCT00500240|7234293|FG000|COMPLETED|Overall Study||25
6327847|NCT00500240|7234294|FG001|COMPLETED|Overall Study||26
6327848|NCT00500240|7234293|FG000|NOT COMPLETED|Overall Study||0
6327849|NCT00500240|7234294|FG001|NOT COMPLETED|Overall Study||0
6375920|NCT00758264|7286493|FG001|STARTED|Extended Safety Follow Up (ESFU) Phase||90
6375921|NCT00758264|7286494|FG002|STARTED|Extended Safety Follow Up (ESFU) Phase||89
6375922|NCT00758264|7286492|FG000|COMPLETED|Extended Safety Follow Up (ESFU) Phase||181
6375923|NCT00758264|7286493|FG001|COMPLETED|Extended Safety Follow Up (ESFU) Phase||90
6375924|NCT00758264|7286494|FG002|COMPLETED|Extended Safety Follow Up (ESFU) Phase||89
6375925|NCT00758264|7286492|FG000|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
6375926|NCT00758264|7286493|FG001|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
6375927|NCT00758264|7286494|FG002|NOT COMPLETED|Extended Safety Follow Up (ESFU) Phase||0
6375928|NCT00758342|7286504|FG000|STARTED|Overall Study||19
6375929|NCT00758342|7286505|FG001|STARTED|Overall Study||18
6375930|NCT00758342|7286504|FG000|COMPLETED|Overall Study||15
6375931|NCT00758342|7286505|FG001|COMPLETED|Overall Study||17
6375932|NCT00758342|7286504|FG000|NOT COMPLETED|Overall Study||4
6375933|NCT00758342|7286505|FG001|NOT COMPLETED|Overall Study||1
6375934|NCT00758394|7286515|FG000|STARTED|1st Intervention||8
6375935|NCT00758394|7286516|FG001|STARTED|1st Intervention||7
6375936|NCT00758394|7286517|FG002|STARTED|1st Intervention||6
6375937|NCT00758394|7286518|FG003|STARTED|1st Intervention||8
6375938|NCT00758394|7286515|FG000|COMPLETED|1st Intervention||8
6375939|NCT00758394|7286516|FG001|COMPLETED|1st Intervention||7
6375940|NCT00758394|7286517|FG002|COMPLETED|1st Intervention||6
6375941|NCT00758394|7286518|FG003|COMPLETED|1st Intervention||8
6375942|NCT00758394|7286515|FG000|NOT COMPLETED|1st Intervention||0
6375943|NCT00758394|7286516|FG001|NOT COMPLETED|1st Intervention||0
6375944|NCT00758394|7286517|FG002|NOT COMPLETED|1st Intervention||0
6375945|NCT00758394|7286518|FG003|NOT COMPLETED|1st Intervention||0
6558506|NCT01775189|7481050|FG000|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6558507|NCT01775189|7481051|FG001|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6558508|NCT01775189|7481052|FG002|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6558509|NCT01775189|7481053|FG003|NOT COMPLETED|Treatment Phase: Washout Period 3||1
6558510|NCT01775189|7481054|FG004|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6558511|NCT01775189|7481055|FG005|NOT COMPLETED|Treatment Phase: Washout Period 3||0
6375946|NCT00758394|7286515|FG000|STARTED|Washout After 1st Intervention||8
6375947|NCT00758394|7286516|FG001|STARTED|Washout After 1st Intervention||7
6375948|NCT00758394|7286517|FG002|STARTED|Washout After 1st Intervention||6
6375949|NCT00758394|7286518|FG003|STARTED|Washout After 1st Intervention||8
6375950|NCT00758394|7286515|FG000|COMPLETED|Washout After 1st Intervention||8
6375951|NCT00758394|7286516|FG001|COMPLETED|Washout After 1st Intervention||7
6375952|NCT00758394|7286517|FG002|COMPLETED|Washout After 1st Intervention||6
6375953|NCT00758394|7286518|FG003|COMPLETED|Washout After 1st Intervention||8
6375954|NCT00758394|7286515|FG000|NOT COMPLETED|Washout After 1st Intervention||0
6558512|NCT01775189|7481056|FG006|NOT COMPLETED|Treatment Phase: Washout Period 3||1
6558513|NCT01775189|7481050|FG000|STARTED|Treatment Phase: Fourth Intervention||0
6558514|NCT01775189|7481051|FG001|STARTED|Treatment Phase: Fourth Intervention||0
6558515|NCT01775189|7481052|FG002|STARTED|Treatment Phase: Fourth Intervention||0
6558516|NCT01775189|7481053|FG003|STARTED|Treatment Phase: Fourth Intervention||6
6558517|NCT01775189|7481054|FG004|STARTED|Treatment Phase: Fourth Intervention||8
6558518|NCT01775189|7481055|FG005|STARTED|Treatment Phase: Fourth Intervention||7
6558519|NCT01775189|7481056|FG006|STARTED|Treatment Phase: Fourth Intervention||7
6558520|NCT01775189|7481050|FG000|COMPLETED|Treatment Phase: Fourth Intervention||0
6558521|NCT01775189|7481051|FG001|COMPLETED|Treatment Phase: Fourth Intervention||0
6375955|NCT00758394|7286516|FG001|NOT COMPLETED|Washout After 1st Intervention||0
6375956|NCT00758394|7286517|FG002|NOT COMPLETED|Washout After 1st Intervention||0
6375957|NCT00758394|7286518|FG003|NOT COMPLETED|Washout After 1st Intervention||0
6375958|NCT00758394|7286515|FG000|STARTED|2nd Intervention Order||8
6375959|NCT00758394|7286516|FG001|STARTED|2nd Intervention Order||7
6375960|NCT00758394|7286517|FG002|STARTED|2nd Intervention Order||6
6375961|NCT00758394|7286518|FG003|STARTED|2nd Intervention Order||8
6375962|NCT00758394|7286515|FG000|COMPLETED|2nd Intervention Order||8
6375963|NCT00758394|7286516|FG001|COMPLETED|2nd Intervention Order||6
6375964|NCT00758394|7286517|FG002|COMPLETED|2nd Intervention Order||6
6375965|NCT00758394|7286518|FG003|COMPLETED|2nd Intervention Order||8
6375966|NCT00758394|7286515|FG000|NOT COMPLETED|2nd Intervention Order||0
6375967|NCT00758394|7286516|FG001|NOT COMPLETED|2nd Intervention Order||1
6375968|NCT00758394|7286517|FG002|NOT COMPLETED|2nd Intervention Order||0
6375969|NCT00758394|7286518|FG003|NOT COMPLETED|2nd Intervention Order||0
6375970|NCT00758394|7286515|FG000|STARTED|Washout After 2nd Intervention||8
6375971|NCT00758394|7286516|FG001|STARTED|Washout After 2nd Intervention||6
6375972|NCT00758394|7286517|FG002|STARTED|Washout After 2nd Intervention||6
6375973|NCT00758394|7286518|FG003|STARTED|Washout After 2nd Intervention||8
6375974|NCT00758394|7286515|FG000|COMPLETED|Washout After 2nd Intervention||8
6375975|NCT00758394|7286516|FG001|COMPLETED|Washout After 2nd Intervention||6
6327850|NCT00500266|7234302|FG000|STARTED|Overall Study||1053
6327851|NCT00500266|7234302|FG000|Treated|Overall Study||1049
6327852|NCT00500266|7234302|FG000|COMPLETED|Overall Study||1040
6327853|NCT00500266|7234302|FG000|NOT COMPLETED|Overall Study||13
6327854|NCT00500292|7234310|FG000|STARTED|Overall Study|randomised patients|32
6327855|NCT00500292|7234311|FG001|STARTED|Overall Study|randomised patients|35
6327856|NCT00500292|7234312|FG002|STARTED|Overall Study|randomised patients|37
6327857|NCT00500292|7234310|FG000|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|7
6327858|NCT00500292|7234311|FG001|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|4
6327859|NCT00500292|7234312|FG002|COMPLETED|Overall Study|Ongoing study treatment at data cut-off date 8 March 2008.|10
6327860|NCT00500292|7234310|FG000|NOT COMPLETED|Overall Study||25
6327861|NCT00500292|7234311|FG001|NOT COMPLETED|Overall Study||31
6327862|NCT00500292|7234312|FG002|NOT COMPLETED|Overall Study||27
6327863|NCT00500318|7234322|FG000|STARTED|Overall Study||86
6327864|NCT00500318|7234323|FG001|STARTED|Overall Study||95
6327865|NCT00500318|7234322|FG000|COMPLETED|Overall Study||81
6327866|NCT00500318|7234323|FG001|COMPLETED|Overall Study||78
6327867|NCT00500318|7234322|FG000|NOT COMPLETED|Overall Study||5
6327868|NCT00500318|7234323|FG001|NOT COMPLETED|Overall Study||17
6327869|NCT00500331|7234336|FG000|STARTED|Overall Study||48
6327870|NCT00500331|7234337|FG001|STARTED|Overall Study||47
6327871|NCT00500331|7234338|FG002|STARTED|Overall Study||48
6327872|NCT00500331|7234339|FG003|STARTED|Overall Study||48
6327873|NCT00500331|7234340|FG004|STARTED|Overall Study||48
6327874|NCT00500331|7234341|FG005|STARTED|Overall Study||47
6327875|NCT00500331|7234342|FG006|STARTED|Overall Study||48
6327876|NCT00500331|7234336|FG000|COMPLETED|Overall Study||33
6327877|NCT00500331|7234337|FG001|COMPLETED|Overall Study||42
6327878|NCT00500331|7234338|FG002|COMPLETED|Overall Study||43
6327879|NCT00500331|7234339|FG003|COMPLETED|Overall Study||38
6327880|NCT00500331|7234340|FG004|COMPLETED|Overall Study||44
6327881|NCT00500331|7234341|FG005|COMPLETED|Overall Study||42
6327882|NCT00500331|7234342|FG006|COMPLETED|Overall Study||46
6327883|NCT00500331|7234336|FG000|NOT COMPLETED|Overall Study||15
6327884|NCT00500331|7234337|FG001|NOT COMPLETED|Overall Study||5
6327885|NCT00500331|7234338|FG002|NOT COMPLETED|Overall Study||5
6327886|NCT00500331|7234339|FG003|NOT COMPLETED|Overall Study||10
6327887|NCT00500331|7234340|FG004|NOT COMPLETED|Overall Study||4
6327888|NCT00500331|7234341|FG005|NOT COMPLETED|Overall Study||5
6327889|NCT00500331|7234342|FG006|NOT COMPLETED|Overall Study||2
6327890|NCT00500357|7234359|FG000|STARTED|Overall Study||105
6327891|NCT00500357|7234359|FG000|Received 13vPnC (Vax 3)|Overall Study||105
6327892|NCT00500357|7234359|FG000|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
6327893|NCT00500357|7234359|FG000|COMPLETED|Overall Study||104
6327894|NCT00500357|7234359|FG000|NOT COMPLETED|Overall Study||1
6327895|NCT00500370|7234376|FG000|STARTED|Overall Study||80
6327896|NCT00500370|7234377|FG001|STARTED|Overall Study||83
6327897|NCT00500370|7234376|FG000|Treatment Start-Baseline (Week 0)|Overall Study||73
6327898|NCT00500370|7234377|FG001|Treatment Start-Baseline (Week 0)|Overall Study||79
6327899|NCT00500370|7234376|FG000|Treatment Complete (Week 24)|Overall Study||48
6327900|NCT00500370|7234377|FG001|Treatment Complete (Week 24)|Overall Study||54
6327901|NCT00500370|7234376|FG000|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
6327902|NCT00500370|7234377|FG001|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
6327903|NCT00500370|7234376|FG000|NOT COMPLETED|Overall Study||33
6327904|NCT00500370|7234377|FG001|NOT COMPLETED|Overall Study||34
6327905|NCT00500448|7234385|FG000|STARTED|Overall Study||14
6327906|NCT00500448|7234386|FG001|STARTED|Overall Study||16
6327907|NCT00500448|7234385|FG000|COMPLETED|Overall Study||14
6327908|NCT00500448|7234386|FG001|COMPLETED|Overall Study||16
6327909|NCT00500448|7234385|FG000|NOT COMPLETED|Overall Study||0
6327910|NCT00500448|7234386|FG001|NOT COMPLETED|Overall Study||0
6327911|NCT00500539|7234392|FG000|STARTED|Treatment Period (24 Weeks)||155
6327912|NCT00500539|7234392|FG000|COMPLETED|Treatment Period (24 Weeks)||140
6327913|NCT00500539|7234392|FG000|NOT COMPLETED|Treatment Period (24 Weeks)||15
6327914|NCT00500539|7234392|FG000|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
6327915|NCT00500539|7234392|FG000|COMPLETED|Follow-up Period (16 Weeks)||136
6327916|NCT00500539|7234392|FG000|NOT COMPLETED|Follow-up Period (16 Weeks)||12
6327917|NCT00500578|7234401|FG000|STARTED|Overall Study||18
6327918|NCT00500578|7234402|FG001|STARTED|Overall Study||32
6327919|NCT00500578|7234401|FG000|COMPLETED|Overall Study|All completed|18
6327920|NCT00500578|7234402|FG001|COMPLETED|Overall Study|All completed|32
6327921|NCT00500578|7234401|FG000|NOT COMPLETED|Overall Study||0
6327922|NCT00500578|7234402|FG001|NOT COMPLETED|Overall Study||0
6327923|NCT00500656|7234412|FG000|STARTED|Controlled Phase||36
6327924|NCT00500656|7234413|FG001|STARTED|Controlled Phase||38
6327925|NCT00500656|7234414|FG002|STARTED|Controlled Phase||3
6327926|NCT00500656|7234415|FG003|STARTED|Controlled Phase||8
6327927|NCT00500656|7234412|FG000|COMPLETED|Controlled Phase||26
6327928|NCT00500656|7234413|FG001|COMPLETED|Controlled Phase||28
6327929|NCT00500656|7234414|FG002|COMPLETED|Controlled Phase||2
6327930|NCT00500656|7234415|FG003|COMPLETED|Controlled Phase||0
6327931|NCT00500656|7234412|FG000|NOT COMPLETED|Controlled Phase||10
6327932|NCT00500656|7234413|FG001|NOT COMPLETED|Controlled Phase||10
6327933|NCT00500656|7234414|FG002|NOT COMPLETED|Controlled Phase||1
6327934|NCT00500656|7234415|FG003|NOT COMPLETED|Controlled Phase||8
6327935|NCT00500656|7234412|FG000|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
6327936|NCT00500656|7234413|FG001|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
6327937|NCT00500656|7234414|FG002|STARTED|Open Label Extension (OLE) Phase||2
6327938|NCT00500656|7234415|FG003|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
6327939|NCT00500656|7234412|FG000|COMPLETED|Open Label Extension (OLE) Phase||16
6327940|NCT00500656|7234413|FG001|COMPLETED|Open Label Extension (OLE) Phase||9
6327941|NCT00500656|7234414|FG002|COMPLETED|Open Label Extension (OLE) Phase||1
6327942|NCT00500656|7234415|FG003|COMPLETED|Open Label Extension (OLE) Phase||6
6327943|NCT00500656|7234412|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||7
6327944|NCT00500656|7234413|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||12
6327945|NCT00500656|7234414|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||1
6327946|NCT00500656|7234415|FG003|NOT COMPLETED|Open Label Extension (OLE) Phase||2
6327947|NCT00500682|7234427|FG000|STARTED|Overall Study||510
6327948|NCT00500682|7234428|FG001|STARTED|Overall Study||510
6327949|NCT00500682|7234427|FG000|COMPLETED|Overall Study||204
6327950|NCT00500682|7234428|FG001|COMPLETED|Overall Study||223
6327951|NCT00500682|7234427|FG000|NOT COMPLETED|Overall Study||306
6327952|NCT00500682|7234428|FG001|NOT COMPLETED|Overall Study||287
6327953|NCT00500760|7234436|FG000|STARTED|Overall Study||89
6327954|NCT00500760|7234437|FG001|STARTED|Overall Study||64
6327955|NCT00500760|7234436|FG000|Received Treatment|Overall Study||87
6327956|NCT00500760|7234437|FG001|Received Treatment|Overall Study||63
6327957|NCT00500760|7234436|FG000|COMPLETED|Overall Study||46
6327958|NCT00500760|7234437|FG001|COMPLETED|Overall Study||40
6327959|NCT00500760|7234436|FG000|NOT COMPLETED|Overall Study||43
6327960|NCT00500760|7234437|FG001|NOT COMPLETED|Overall Study||24
6327961|NCT00500903|7234446|FG000|STARTED|Overall Study||65
6327962|NCT00500903|7234447|FG001|STARTED|Overall Study||2
6327963|NCT00500903|7234448|FG002|STARTED|Overall Study||20
6327964|NCT00500903|7234446|FG000|COMPLETED|Overall Study||0
6327965|NCT00500903|7234447|FG001|COMPLETED|Overall Study||0
6327966|NCT00500903|7234448|FG002|COMPLETED|Overall Study||0
6327967|NCT00500903|7234446|FG000|NOT COMPLETED|Overall Study||65
6327968|NCT00500903|7234447|FG001|NOT COMPLETED|Overall Study||2
6327969|NCT00500903|7234448|FG002|NOT COMPLETED|Overall Study||20
6327970|NCT00501007|7234486|FG000|STARTED|Overall Study||100
6327971|NCT00501007|7234487|FG001|STARTED|Overall Study||103
6327972|NCT00501007|7234486|FG000|COMPLETED|Overall Study||71
6327973|NCT00501007|7234487|FG001|COMPLETED|Overall Study||78
6327974|NCT00501007|7234486|FG000|NOT COMPLETED|Overall Study||29
6327975|NCT00501007|7234487|FG001|NOT COMPLETED|Overall Study||25
6327976|NCT00501046|7234495|FG000|STARTED|Overall Study||508
6327977|NCT00501046|7234496|FG001|STARTED|Overall Study||507
6327978|NCT00501046|7234495|FG000|COMPLETED|Overall Study||238
6327979|NCT00501046|7234496|FG001|COMPLETED|Overall Study||213
6327980|NCT00501046|7234495|FG000|NOT COMPLETED|Overall Study||270
6327981|NCT00501046|7234496|FG001|NOT COMPLETED|Overall Study||294
6327982|NCT00501059|7234504|FG000|STARTED|Overall Study||6270
6327983|NCT00501059|7234505|FG001|STARTED|Overall Study||6276
6327984|NCT00501059|7234504|FG000|COMPLETED|Overall Study||4402
6327985|NCT00501059|7234505|FG001|COMPLETED|Overall Study||4384
6327986|NCT00501059|7234504|FG000|NOT COMPLETED|Overall Study||1868
6327987|NCT00501059|7234505|FG001|NOT COMPLETED|Overall Study||1892
6327988|NCT00501085|7234513|FG000|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
6327989|NCT00501085|7234513|FG000|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
6327990|NCT00501085|7234513|FG000|NOT COMPLETED|Overall Study||432
6327991|NCT00501293|7234519|FG000|STARTED|Optimization Period||110
6327992|NCT00501293|7234520|FG001|STARTED|Optimization Period||53
6327993|NCT00501293|7234519|FG000|COMPLETED|Optimization Period||109
6327994|NCT00501293|7234520|FG001|COMPLETED|Optimization Period||53
6327995|NCT00501293|7234519|FG000|NOT COMPLETED|Optimization Period||1
6327996|NCT00501293|7234520|FG001|NOT COMPLETED|Optimization Period||0
6327997|NCT00501293|7234519|FG000|STARTED|Maintenance Period||109
6327998|NCT00501293|7234520|FG001|STARTED|Maintenance Period||53
6327999|NCT00501293|7234519|FG000|COMPLETED|Maintenance Period||63
6328000|NCT00501293|7234520|FG001|COMPLETED|Maintenance Period||25
6328001|NCT00501293|7234519|FG000|NOT COMPLETED|Maintenance Period||46
6328002|NCT00501293|7234520|FG001|NOT COMPLETED|Maintenance Period||28
6328003|NCT00501540|7234527|FG000|STARTED|Overall Study||15
6328004|NCT00501540|7234527|FG000|COMPLETED|Overall Study||10
6328005|NCT00501540|7234527|FG000|NOT COMPLETED|Overall Study||5
6328006|NCT00501592|7234534|FG000|STARTED|Overall Study||20
6328007|NCT00501592|7234535|FG001|STARTED|Overall Study||21
6328008|NCT00501592|7234536|FG002|STARTED|Overall Study||23
6328009|NCT00501592|7234534|FG000|COMPLETED|Overall Study||20
6328010|NCT00501592|7234535|FG001|COMPLETED|Overall Study||16
6328011|NCT00501592|7234536|FG002|COMPLETED|Overall Study||20
6328012|NCT00501592|7234534|FG000|NOT COMPLETED|Overall Study||0
6328013|NCT00501592|7234535|FG001|NOT COMPLETED|Overall Study||5
6328014|NCT00501592|7234536|FG002|NOT COMPLETED|Overall Study||3
6328015|NCT00501631|7234546|FG000|STARTED|Part A (Double-blind Period)||152
6328016|NCT00501631|7234547|FG001|STARTED|Part A (Double-blind Period)||148
6328017|NCT00501631|7234546|FG000|COMPLETED|Part A (Double-blind Period)||90
6328018|NCT00501631|7234547|FG001|COMPLETED|Part A (Double-blind Period)||99
6328019|NCT00501631|7234546|FG000|NOT COMPLETED|Part A (Double-blind Period)||62
6328020|NCT00501631|7234547|FG001|NOT COMPLETED|Part A (Double-blind Period)||49
6328021|NCT00501631|7234546|FG000|STARTED|Part B (Open-label Period)||90
6328022|NCT00501631|7234547|FG001|STARTED|Part B (Open-label Period)||99
6328023|NCT00501631|7234546|FG000|COMPLETED|Part B (Open-label Period)||37
6328024|NCT00501631|7234547|FG001|COMPLETED|Part B (Open-label Period)||48
6328025|NCT00501631|7234546|FG000|NOT COMPLETED|Part B (Open-label Period)||53
6328026|NCT00501631|7234547|FG001|NOT COMPLETED|Part B (Open-label Period)||51
6328027|NCT00501644|7234553|FG000|STARTED|Overall Study||59
6328028|NCT00501644|7234553|FG000|COMPLETED|Overall Study||54
6328029|NCT00501644|7234553|FG000|NOT COMPLETED|Overall Study||5
6328030|NCT00501852|7234557|FG000|STARTED|Overall Study||83
6328031|NCT00501852|7234557|FG000|NVA237 12.5µg|Overall Study||55
6328032|NCT00501852|7234557|FG000|NVA237 25µg|Overall Study||51
6328033|NCT00501852|7234557|FG000|NVA237 50µg|Overall Study||53
6328034|NCT00501852|7234557|FG000|NVA237 100µg|Overall Study||54
6328035|NCT00501852|7234557|FG000|Placebo|Overall Study||55
6328036|NCT00501852|7234557|FG000|Tiotropium|Overall Study||55
6328037|NCT00501852|7234557|FG000|COMPLETED|Overall Study||78
6328038|NCT00501852|7234557|FG000|NOT COMPLETED|Overall Study||5
6328039|NCT00501891|7234571|FG000|STARTED|Overall Study||32
6328040|NCT00501891|7234571|FG000|COMPLETED|Overall Study||32
6328041|NCT00501891|7234571|FG000|NOT COMPLETED|Overall Study||0
6328042|NCT00501943|7234578|FG000|STARTED|Overall Study||22
6328043|NCT00501943|7234579|FG001|STARTED|Overall Study||21
6328044|NCT00501943|7234578|FG000|COMPLETED|Overall Study||20
6328045|NCT00501943|7234579|FG001|COMPLETED|Overall Study||18
6328046|NCT00501943|7234578|FG000|NOT COMPLETED|Overall Study||2
6328047|NCT00501943|7234579|FG001|NOT COMPLETED|Overall Study||3
6328048|NCT00501969|7234587|FG000|STARTED|Overall Study||395
6328049|NCT00501969|7234587|FG000|COMPLETED|Overall Study||189
6328050|NCT00501969|7234587|FG000|NOT COMPLETED|Overall Study||206
6328051|NCT00501995|7234591|FG000|STARTED|Overall Study||6
6328052|NCT00501995|7234591|FG000|COMPLETED|Overall Study||5
6328053|NCT00501995|7234591|FG000|NOT COMPLETED|Overall Study||1
6328054|NCT00502203|7234595|FG000|STARTED|Overall Study||23
6328055|NCT00502203|7234595|FG000|COMPLETED|Overall Study||22
6328056|NCT00502203|7234595|FG000|NOT COMPLETED|Overall Study||1
6328057|NCT00502216|7234601|FG000|STARTED|Overall Study||21
6328058|NCT00502216|7234602|FG001|STARTED|Overall Study||19
6328059|NCT00502216|7234601|FG000|COMPLETED|Overall Study||21
6328060|NCT00502216|7234602|FG001|COMPLETED|Overall Study||19
6328061|NCT00502216|7234601|FG000|NOT COMPLETED|Overall Study||0
6328062|NCT00502216|7234602|FG001|NOT COMPLETED|Overall Study||0
6328063|NCT00502242|7234610|FG000|STARTED|Overall Study||155
6328064|NCT00502242|7234611|FG001|STARTED|Overall Study||140
6328065|NCT00502242|7234610|FG000|COMPLETED|Overall Study||104
6328066|NCT00502242|7234611|FG001|COMPLETED|Overall Study||84
6328067|NCT00502242|7234610|FG000|NOT COMPLETED|Overall Study||51
6328068|NCT00502242|7234611|FG001|NOT COMPLETED|Overall Study||56
6328069|NCT00502307|7234617|FG000|STARTED|Open Label Period (16 Weeks)||272
6328070|NCT00502307|7234618|FG001|STARTED|Open Label Period (16 Weeks)||0
6328071|NCT00502307|7234619|FG002|STARTED|Open Label Period (16 Weeks)||0
6328072|NCT00502307|7234617|FG000|COMPLETED|Open Label Period (16 Weeks)||196
6328073|NCT00502307|7234618|FG001|COMPLETED|Open Label Period (16 Weeks)||0
6328074|NCT00502307|7234619|FG002|COMPLETED|Open Label Period (16 Weeks)||0
6328075|NCT00502307|7234617|FG000|NOT COMPLETED|Open Label Period (16 Weeks)||76
6328076|NCT00502307|7234618|FG001|NOT COMPLETED|Open Label Period (16 Weeks)||0
6328077|NCT00502307|7234619|FG002|NOT COMPLETED|Open Label Period (16 Weeks)||0
6328078|NCT00502307|7234617|FG000|STARTED|Double-Blind Period (12 Weeks)||0
6328079|NCT00502307|7234618|FG001|STARTED|Double-Blind Period (12 Weeks)||61
6328080|NCT00502307|7234619|FG002|STARTED|Double-Blind Period (12 Weeks)||57
6328081|NCT00502307|7234617|FG000|COMPLETED|Double-Blind Period (12 Weeks)||0
6328082|NCT00502307|7234618|FG001|COMPLETED|Double-Blind Period (12 Weeks)||35
6328083|NCT00502307|7234619|FG002|COMPLETED|Double-Blind Period (12 Weeks)||48
6328084|NCT00502307|7234617|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
6328085|NCT00502307|7234618|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||26
6328086|NCT00502307|7234619|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||9
6328087|NCT00502307|7234617|FG000|STARTED|Maintenance Period||148
6328088|NCT00502307|7234618|FG001|STARTED|Maintenance Period||0
6328089|NCT00502307|7234619|FG002|STARTED|Maintenance Period||0
6328090|NCT00502307|7234617|FG000|COMPLETED|Maintenance Period||0
6328091|NCT00502307|7234618|FG001|COMPLETED|Maintenance Period||0
6328092|NCT00502307|7234619|FG002|COMPLETED|Maintenance Period||0
6328093|NCT00502307|7234617|FG000|NOT COMPLETED|Maintenance Period||148
6328094|NCT00502307|7234618|FG001|NOT COMPLETED|Maintenance Period||0
6328095|NCT00502307|7234619|FG002|NOT COMPLETED|Maintenance Period||0
6328096|NCT00502320|7234638|FG000|STARTED|Overall Study||25
6328097|NCT00502320|7234639|FG001|STARTED|Overall Study||25
6328098|NCT00502320|7234638|FG000|Screening Visit|Overall Study||25
6328099|NCT00502320|7234639|FG001|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
6328100|NCT00502320|7234638|FG000|COMPLETED|Overall Study||19
6328101|NCT00502320|7234639|FG001|COMPLETED|Overall Study||18
6328102|NCT00502320|7234638|FG000|NOT COMPLETED|Overall Study||6
6328103|NCT00502320|7234639|FG001|NOT COMPLETED|Overall Study||7
6328104|NCT00502593|7234657|FG000|STARTED|Overall Study||51
6328105|NCT00502593|7234658|FG001|STARTED|Overall Study||18
6328106|NCT00502593|7234659|FG002|STARTED|Overall Study||51
6328107|NCT00502593|7234660|FG003|STARTED|Overall Study||18
6328108|NCT00502593|7234661|FG004|STARTED|Overall Study||51
6328109|NCT00502593|7234662|FG005|STARTED|Overall Study||17
6328110|NCT00502593|7234663|FG006|STARTED|Overall Study||49
6328111|NCT00502593|7234664|FG007|STARTED|Overall Study||17
6328112|NCT00502593|7234665|FG008|STARTED|Overall Study||49
6328113|NCT00502593|7234666|FG009|STARTED|Overall Study||17
6328114|NCT00502593|7234667|FG010|STARTED|Overall Study||49
6328115|NCT00502593|7234668|FG011|STARTED|Overall Study||18
6328116|NCT00502593|7234657|FG000|COMPLETED|Overall Study||48
6328117|NCT00502593|7234658|FG001|COMPLETED|Overall Study||16
6328118|NCT00502593|7234659|FG002|COMPLETED|Overall Study||41
6328119|NCT00502593|7234660|FG003|COMPLETED|Overall Study||14
6328120|NCT00502593|7234661|FG004|COMPLETED|Overall Study||47
6328121|NCT00502593|7234662|FG005|COMPLETED|Overall Study||17
6328122|NCT00502593|7234663|FG006|COMPLETED|Overall Study||44
6328123|NCT00502593|7234664|FG007|COMPLETED|Overall Study||17
6328124|NCT00502593|7234665|FG008|COMPLETED|Overall Study||43
6328125|NCT00502593|7234666|FG009|COMPLETED|Overall Study||17
6328126|NCT00502593|7234667|FG010|COMPLETED|Overall Study||47
6328127|NCT00502593|7234668|FG011|COMPLETED|Overall Study||18
6328128|NCT00502593|7234657|FG000|NOT COMPLETED|Overall Study||3
6328129|NCT00502593|7234658|FG001|NOT COMPLETED|Overall Study||2
6328130|NCT00502593|7234659|FG002|NOT COMPLETED|Overall Study||10
6328131|NCT00502593|7234660|FG003|NOT COMPLETED|Overall Study||4
6328132|NCT00502593|7234661|FG004|NOT COMPLETED|Overall Study||4
6328133|NCT00502593|7234662|FG005|NOT COMPLETED|Overall Study||0
6328134|NCT00502593|7234663|FG006|NOT COMPLETED|Overall Study||5
6328135|NCT00502593|7234664|FG007|NOT COMPLETED|Overall Study||0
6328136|NCT00502593|7234665|FG008|NOT COMPLETED|Overall Study||6
6328137|NCT00502593|7234666|FG009|NOT COMPLETED|Overall Study||0
6328138|NCT00502593|7234667|FG010|NOT COMPLETED|Overall Study||2
6328139|NCT00502593|7234668|FG011|NOT COMPLETED|Overall Study||0
6328140|NCT00502671|7234717|FG000|STARTED|Overall Study||228
6328141|NCT00502671|7234717|FG000|COMPLETED|Overall Study||151
6328142|NCT00502671|7234717|FG000|NOT COMPLETED|Overall Study||77
6328143|NCT00502697|7234723|FG000|STARTED|Overall Study||122
6328144|NCT00502697|7234724|FG001|STARTED|Overall Study||114
6328145|NCT00502697|7234723|FG000|COMPLETED|Overall Study||109
6328146|NCT00502697|7234724|FG001|COMPLETED|Overall Study||102
6328147|NCT00502697|7234723|FG000|NOT COMPLETED|Overall Study||13
6328148|NCT00502697|7234724|FG001|NOT COMPLETED|Overall Study||12
6328149|NCT00502775|7234733|FG000|STARTED|Overall Study||229
6328150|NCT00502775|7234734|FG001|STARTED|Overall Study||224
6328151|NCT00502775|7234735|FG002|STARTED|Overall Study||227
6328152|NCT00502775|7234733|FG000|COMPLETED|Overall Study||219
6328153|NCT00502775|7234734|FG001|COMPLETED|Overall Study||209
6328154|NCT00502775|7234735|FG002|COMPLETED|Overall Study||214
6328155|NCT00502775|7234733|FG000|NOT COMPLETED|Overall Study||10
6328156|NCT00502775|7234734|FG001|NOT COMPLETED|Overall Study||15
6328157|NCT00502775|7234735|FG002|NOT COMPLETED|Overall Study||13
6328158|NCT00502801|7234743|FG000|STARTED|Treatment Period||183
6328159|NCT00502801|7234743|FG000|COMPLETED|Treatment Period||129
6328160|NCT00502801|7234743|FG000|NOT COMPLETED|Treatment Period||54
6328161|NCT00502801|7234743|FG000|STARTED|End of Therapy to Test of Cure||129
6328162|NCT00502801|7234743|FG000|COMPLETED|End of Therapy to Test of Cure||121
6328163|NCT00502801|7234743|FG000|NOT COMPLETED|End of Therapy to Test of Cure||8
6328164|NCT00502840|7234747|FG000|STARTED|Overall Study||193
6328165|NCT00502840|7234747|FG000|COMPLETED|Overall Study||93
6328166|NCT00502840|7234747|FG000|NOT COMPLETED|Overall Study||100
6328167|NCT00502853|7234752|FG000|STARTED|Overall Study||10
6328168|NCT00502853|7234752|FG000|COMPLETED|Overall Study||10
6328169|NCT00502853|7234752|FG000|NOT COMPLETED|Overall Study||0
6328170|NCT00502905|7234757|FG000|STARTED|Overall Study||196
6328171|NCT00502905|7234757|FG000|COMPLETED|Overall Study||196
6328172|NCT00502905|7234757|FG000|NOT COMPLETED|Overall Study||0
6328173|NCT00502944|7234763|FG000|STARTED|Overall Study||2446
6328174|NCT00502944|7234764|FG001|STARTED|Overall Study||2409
6328175|NCT00502944|7234763|FG000|COMPLETED|Overall Study||1382
6328176|NCT00502944|7234764|FG001|COMPLETED|Overall Study||643
6328177|NCT00502944|7234763|FG000|NOT COMPLETED|Overall Study||1064
6328178|NCT00502944|7234764|FG001|NOT COMPLETED|Overall Study||1766
6328179|NCT00502996|7234770|FG000|STARTED|Overall Study||232
6328180|NCT00502996|7234770|FG000|COMPLETED|Overall Study||188
6328181|NCT00502996|7234770|FG000|NOT COMPLETED|Overall Study||44
6328182|NCT00503113|7234777|FG000|STARTED|Overall Study||268
6328183|NCT00503113|7234778|FG001|STARTED|Overall Study||264
6328184|NCT00503113|7234779|FG002|STARTED|Overall Study||269
6328185|NCT00503113|7234777|FG000|Intent to Treat Population (ITT)|Overall Study||262
6328186|NCT00503113|7234778|FG001|Intent to Treat Population (ITT)|Overall Study||261
6328187|NCT00503113|7234779|FG002|Intent to Treat Population (ITT)|Overall Study||268
6328188|NCT00503113|7234777|FG000|Per Protocol Population (PP)|Overall Study||246
6328189|NCT00503113|7234778|FG001|Per Protocol Population (PP)|Overall Study||243
6328190|NCT00503113|7234779|FG002|Per Protocol Population (PP)|Overall Study||241
6328191|NCT00503113|7234777|FG000|Safety Population|Overall Study||263
6328192|NCT00503113|7234778|FG001|Safety Population|Overall Study||263
6328193|NCT00503113|7234779|FG002|Safety Population|Overall Study||267
6558522|NCT01775189|7481052|FG002|COMPLETED|Treatment Phase: Fourth Intervention||0
6558523|NCT01775189|7481053|FG003|COMPLETED|Treatment Phase: Fourth Intervention||6
6328194|NCT00503113|7234777|FG000|COMPLETED|Overall Study||235
6328195|NCT00503113|7234778|FG001|COMPLETED|Overall Study||236
6328196|NCT00503113|7234779|FG002|COMPLETED|Overall Study||241
6328197|NCT00503113|7234777|FG000|NOT COMPLETED|Overall Study||33
6328198|NCT00503113|7234778|FG001|NOT COMPLETED|Overall Study||28
6328199|NCT00503113|7234779|FG002|NOT COMPLETED|Overall Study||28
6328200|NCT00503139|7234787|FG000|STARTED|Overall Study||684
6328201|NCT00503139|7234787|FG000|COMPLETED|Overall Study||676
6328202|NCT00503139|7234787|FG000|NOT COMPLETED|Overall Study||8
6328203|NCT00503308|7234793|FG000|STARTED|Overall Study||146
6328204|NCT00503308|7234794|FG001|STARTED|Overall Study||135
6328205|NCT00503308|7234793|FG000|COMPLETED|Overall Study||144
6328206|NCT00503308|7234794|FG001|COMPLETED|Overall Study||134
6328207|NCT00503308|7234793|FG000|NOT COMPLETED|Overall Study||2
6328208|NCT00503308|7234794|FG001|NOT COMPLETED|Overall Study||1
6328209|NCT00503399|7234802|FG000|STARTED|Overall Study||45
6328210|NCT00503399|7234803|FG001|STARTED|Overall Study||47
6328211|NCT00503399|7234802|FG000|COMPLETED|Overall Study||38
6328212|NCT00503399|7234803|FG001|COMPLETED|Overall Study||39
6328213|NCT00503399|7234802|FG000|NOT COMPLETED|Overall Study||7
6328214|NCT00503399|7234803|FG001|NOT COMPLETED|Overall Study||8
6328215|NCT00503425|7234809|FG000|STARTED|Overall Study||215
6328216|NCT00503425|7234809|FG000|COMPLETED|Overall Study||161
6328217|NCT00503425|7234809|FG000|NOT COMPLETED|Overall Study||54
6328218|NCT00503685|7234817|FG000|STARTED|Overall Study||23
6328219|NCT00503685|7234818|FG001|STARTED|Overall Study||22
6328220|NCT00503685|7234819|FG002|STARTED|Overall Study||20
6328221|NCT00503685|7234817|FG000|Received at Least 1 Dose of Study Drug|Overall Study||23
6328222|NCT00503685|7234818|FG001|Received at Least 1 Dose of Study Drug|Overall Study||21
6328223|NCT00503685|7234819|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
6328224|NCT00503685|7234817|FG000|COMPLETED|Overall Study||23
6328225|NCT00503685|7234818|FG001|COMPLETED|Overall Study||19
6328226|NCT00503685|7234819|FG002|COMPLETED|Overall Study||18
6328227|NCT00503685|7234817|FG000|NOT COMPLETED|Overall Study||0
6328228|NCT00503685|7234818|FG001|NOT COMPLETED|Overall Study||3
6328229|NCT00503685|7234819|FG002|NOT COMPLETED|Overall Study||2
6328230|NCT00503698|7234830|FG000|STARTED|Overall Study|Randomised|357
6328231|NCT00503698|7234831|FG001|STARTED|Overall Study|Randomised|355
6328232|NCT00503698|7234830|FG000|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
6328233|NCT00503698|7234831|FG001|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
6328234|NCT00503698|7234830|FG000|COMPLETED|Overall Study|Trial prematurely terminated|0
6328235|NCT00503698|7234831|FG001|COMPLETED|Overall Study|Trial prematurely terminated|0
6328236|NCT00503698|7234830|FG000|NOT COMPLETED|Overall Study||357
6328237|NCT00503698|7234831|FG001|NOT COMPLETED|Overall Study||355
6328238|NCT00503750|7234837|FG000|STARTED|Overall Study||27
6328239|NCT00503750|7234837|FG000|COMPLETED|Overall Study||27
6328240|NCT00503750|7234837|FG000|NOT COMPLETED|Overall Study||0
6654950|NCT02448914|7584961|FG000|COMPLETED|First Intervention (1 Day)||6
6328241|NCT00503776|7234845|FG000|STARTED|Overall Study||8
6328242|NCT00503776|7234846|FG001|STARTED|Overall Study||12
6328243|NCT00503776|7234847|FG002|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
6328244|NCT00503776|7234848|FG003|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
6328245|NCT00503776|7234845|FG000|COMPLETED|Overall Study||7
6328246|NCT00503776|7234846|FG001|COMPLETED|Overall Study||12
6328247|NCT00503776|7234847|FG002|COMPLETED|Overall Study||10
6328248|NCT00503776|7234848|FG003|COMPLETED|Overall Study||8
6328249|NCT00503776|7234845|FG000|NOT COMPLETED|Overall Study||1
6328250|NCT00503776|7234846|FG001|NOT COMPLETED|Overall Study||0
6328251|NCT00503776|7234847|FG002|NOT COMPLETED|Overall Study||2
6328252|NCT00503776|7234848|FG003|NOT COMPLETED|Overall Study||2
6328253|NCT00503867|7234863|FG000|STARTED|Overall Study||10
6328254|NCT00503867|7234863|FG000|COMPLETED|Overall Study||8
6328255|NCT00503867|7234863|FG000|NOT COMPLETED|Overall Study||2
6328256|NCT00503906|7234867|FG000|STARTED|Overall Study||30
6328257|NCT00503906|7234867|FG000|COMPLETED|Overall Study||29
6328258|NCT00503906|7234867|FG000|NOT COMPLETED|Overall Study||1
6328259|NCT00503984|7234874|FG000|STARTED|Overall Study||3
6328260|NCT00503984|7234875|FG001|STARTED|Overall Study||3
6328261|NCT00503984|7234876|FG002|STARTED|Overall Study||3
6328262|NCT00503984|7234877|FG003|STARTED|Overall Study||6
6328263|NCT00503984|7234878|FG004|STARTED|Overall Study||6
6558524|NCT01775189|7481054|FG004|COMPLETED|Treatment Phase: Fourth Intervention||8
6558525|NCT01775189|7481055|FG005|COMPLETED|Treatment Phase: Fourth Intervention||7
6558526|NCT01775189|7481056|FG006|COMPLETED|Treatment Phase: Fourth Intervention||7
6558527|NCT01775189|7481050|FG000|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6558528|NCT01775189|7481051|FG001|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6558529|NCT01775189|7481052|FG002|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6558530|NCT01775189|7481053|FG003|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6558531|NCT01775189|7481054|FG004|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6558532|NCT01775189|7481055|FG005|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6558533|NCT01775189|7481056|FG006|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
6558534|NCT01775371|7481086|FG000|STARTED|Overall Study||306
6328264|NCT00503984|7234879|FG005|STARTED|Overall Study||1
6328265|NCT00503984|7234874|FG000|COMPLETED|Overall Study||3
6328266|NCT00503984|7234875|FG001|COMPLETED|Overall Study||1
6328267|NCT00503984|7234876|FG002|COMPLETED|Overall Study||3
6328268|NCT00503984|7234877|FG003|COMPLETED|Overall Study||6
6328269|NCT00503984|7234878|FG004|COMPLETED|Overall Study||5
6328270|NCT00503984|7234879|FG005|COMPLETED|Overall Study||1
6328271|NCT00503984|7234874|FG000|NOT COMPLETED|Overall Study||0
6328272|NCT00503984|7234875|FG001|NOT COMPLETED|Overall Study||2
6328273|NCT00503984|7234876|FG002|NOT COMPLETED|Overall Study||0
6328274|NCT00503984|7234877|FG003|NOT COMPLETED|Overall Study||0
6328275|NCT00503984|7234878|FG004|NOT COMPLETED|Overall Study||1
6328276|NCT00503984|7234879|FG005|NOT COMPLETED|Overall Study||0
6328277|NCT00503997|7234903|FG000|STARTED|Overall Study||42
6328278|NCT00503997|7234903|FG000|COMPLETED|Overall Study||34
6328279|NCT00503997|7234903|FG000|NOT COMPLETED|Overall Study||8
6328280|NCT00504023|7234907|FG000|STARTED|Overall Study||8
6328281|NCT00504023|7234907|FG000|COMPLETED|Overall Study||8
6328282|NCT00504023|7234907|FG000|NOT COMPLETED|Overall Study||0
6328283|NCT00504075|7234911|FG000|STARTED|Overall Study||35
6328284|NCT00504075|7234911|FG000|COMPLETED|Overall Study||27
6328285|NCT00504075|7234911|FG000|NOT COMPLETED|Overall Study||8
6328286|NCT00504153|7234916|FG000|STARTED|Overall Study||19
6328287|NCT00504153|7234916|FG000|COMPLETED|Overall Study||13
6328288|NCT00504153|7234916|FG000|NOT COMPLETED|Overall Study||6
6328289|NCT00504166|7234922|FG000|STARTED|Overall Study||26
6328290|NCT00504166|7234923|FG001|STARTED|Overall Study||27
6328291|NCT00504166|7234922|FG000|COMPLETED|Overall Study||20
6328292|NCT00504166|7234923|FG001|COMPLETED|Overall Study||13
6328293|NCT00504166|7234922|FG000|NOT COMPLETED|Overall Study||6
6328294|NCT00504166|7234923|FG001|NOT COMPLETED|Overall Study||14
6328295|NCT00504231|7234933|FG000|STARTED|Overall Study||65
6328296|NCT00504231|7234934|FG001|STARTED|Overall Study||64
6328297|NCT00504231|7234935|FG002|STARTED|Overall Study||64
6328298|NCT00504231|7234936|FG003|STARTED|Overall Study||65
6328299|NCT00504231|7234933|FG000|COMPLETED|Overall Study||65
6328300|NCT00504231|7234934|FG001|COMPLETED|Overall Study||64
6328301|NCT00504231|7234935|FG002|COMPLETED|Overall Study||63
6328302|NCT00504231|7234936|FG003|COMPLETED|Overall Study||65
6328303|NCT00504231|7234933|FG000|NOT COMPLETED|Overall Study||0
6328304|NCT00504231|7234934|FG001|NOT COMPLETED|Overall Study||0
6328305|NCT00504231|7234935|FG002|NOT COMPLETED|Overall Study||1
6328306|NCT00504231|7234936|FG003|NOT COMPLETED|Overall Study||0
6328307|NCT00504257|7234950|FG000|STARTED|Overall Study||45
6328308|NCT00504257|7234950|FG000|COMPLETED|Overall Study||41
6328309|NCT00504257|7234950|FG000|NOT COMPLETED|Overall Study||4
6328310|NCT00504309|7234960|FG000|STARTED|Overall Study||7
6328311|NCT00504309|7234961|FG001|STARTED|Overall Study||5
6328312|NCT00504309|7234962|FG002|STARTED|Overall Study||2
6328313|NCT00504309|7234963|FG003|STARTED|Overall Study||3
6328314|NCT00504309|7234964|FG004|STARTED|Overall Study||8
6328315|NCT00504309|7234965|FG005|STARTED|Overall Study||3
6328316|NCT00504309|7234960|FG000|COMPLETED|Overall Study||7
6328317|NCT00504309|7234961|FG001|COMPLETED|Overall Study||5
6775239|NCT03885726|7703162|FG000|STARTED|Overall Study||32
6775240|NCT03885726|7703162|FG000|COMPLETED|Overall Study||28
6775241|NCT03885726|7703162|FG000|NOT COMPLETED|Overall Study||4
6775242|NCT03885154|7703174|FG000|STARTED|Overall Study||12
6775243|NCT03885154|7703175|FG001|STARTED|Overall Study||10
6775244|NCT03885154|7703176|FG002|STARTED|Overall Study||0
6775245|NCT03885154|7703177|FG003|STARTED|Overall Study||2
6328318|NCT00504309|7234962|FG002|COMPLETED|Overall Study|Participant dropped out during second period|1
6328319|NCT00504309|7234963|FG003|COMPLETED|Overall Study||3
6328320|NCT00504309|7234964|FG004|COMPLETED|Overall Study|Participant died during washout after 2nd period|7
6328321|NCT00504309|7234965|FG005|COMPLETED|Overall Study||3
6328322|NCT00504309|7234960|FG000|NOT COMPLETED|Overall Study||0
6328323|NCT00504309|7234961|FG001|NOT COMPLETED|Overall Study||0
6328324|NCT00504309|7234962|FG002|NOT COMPLETED|Overall Study||1
6328325|NCT00504309|7234963|FG003|NOT COMPLETED|Overall Study||0
6328326|NCT00504309|7234964|FG004|NOT COMPLETED|Overall Study||1
6328327|NCT00504309|7234965|FG005|NOT COMPLETED|Overall Study||0
6328328|NCT00504348|7234977|FG000|STARTED|Overall Study||25
6328329|NCT00504348|7234977|FG000|COMPLETED|Overall Study||17
6328330|NCT00504348|7234977|FG000|NOT COMPLETED|Overall Study||8
6328331|NCT00504426|7234985|FG000|STARTED|Overall Study||32
6328332|NCT00504426|7234986|FG001|STARTED|Overall Study||23
6328333|NCT00504426|7234987|FG002|STARTED|Overall Study||22
6328334|NCT00504426|7234988|FG003|STARTED|Overall Study||24
6328335|NCT00504426|7234985|FG000|COMPLETED|Overall Study||29
6328336|NCT00504426|7234986|FG001|COMPLETED|Overall Study||22
6328337|NCT00504426|7234987|FG002|COMPLETED|Overall Study||18
6328338|NCT00504426|7234988|FG003|COMPLETED|Overall Study||24
6328339|NCT00504426|7234985|FG000|NOT COMPLETED|Overall Study||3
6328340|NCT00504426|7234986|FG001|NOT COMPLETED|Overall Study||1
6328341|NCT00504426|7234987|FG002|NOT COMPLETED|Overall Study||4
6328342|NCT00504426|7234988|FG003|NOT COMPLETED|Overall Study||0
6328343|NCT00504504|7235001|FG000|STARTED|Overall Study||82
6328344|NCT00504504|7235001|FG000|COMPLETED|Overall Study||82
6328345|NCT00504504|7235001|FG000|NOT COMPLETED|Overall Study||0
6328346|NCT00504556|7235010|FG000|STARTED|Overall Study||235
6328347|NCT00504556|7235011|FG001|STARTED|Overall Study||245
6328348|NCT00504556|7235012|FG002|STARTED|Overall Study||235
6775246|NCT03885154|7703174|FG000|COMPLETED|Overall Study||12
6328349|NCT00504556|7235013|FG003|STARTED|Overall Study||180
6328350|NCT00504556|7235014|FG004|STARTED|Overall Study||251
6328351|NCT00504556|7235010|FG000|Safety Analysis Set|Overall Study||235
6328352|NCT00504556|7235011|FG001|Safety Analysis Set|Overall Study||244
6328353|NCT00504556|7235012|FG002|Safety Analysis Set|Overall Study||234
6328354|NCT00504556|7235013|FG003|Safety Analysis Set|Overall Study||180
6328355|NCT00504556|7235014|FG004|Safety Analysis Set|Overall Study||250
6328356|NCT00504556|7235010|FG000|Per Protocol Analysis Set|Overall Study||235
6328357|NCT00504556|7235011|FG001|Per Protocol Analysis Set|Overall Study||243
6328358|NCT00504556|7235012|FG002|Per Protocol Analysis Set|Overall Study||234
6328359|NCT00504556|7235013|FG003|Per Protocol Analysis Set|Overall Study||180
6328360|NCT00504556|7235014|FG004|Per Protocol Analysis Set|Overall Study||250
6328361|NCT00504556|7235010|FG000|Pharmacodynamic Analysis Set|Overall Study||230
6328362|NCT00504556|7235011|FG001|Pharmacodynamic Analysis Set|Overall Study||236
6328363|NCT00504556|7235012|FG002|Pharmacodynamic Analysis Set|Overall Study||228
6328364|NCT00504556|7235013|FG003|Pharmacodynamic Analysis Set|Overall Study||170
6328365|NCT00504556|7235014|FG004|Pharmacodynamic Analysis Set|Overall Study||244
6328366|NCT00504556|7235010|FG000|COMPLETED|Overall Study||200
6328367|NCT00504556|7235011|FG001|COMPLETED|Overall Study||207
6328368|NCT00504556|7235012|FG002|COMPLETED|Overall Study||204
6328369|NCT00504556|7235013|FG003|COMPLETED|Overall Study||52
6328370|NCT00504556|7235014|FG004|COMPLETED|Overall Study||226
6328371|NCT00504556|7235010|FG000|NOT COMPLETED|Overall Study||35
6328372|NCT00504556|7235011|FG001|NOT COMPLETED|Overall Study||38
6328373|NCT00504556|7235012|FG002|NOT COMPLETED|Overall Study||31
6328374|NCT00504556|7235013|FG003|NOT COMPLETED|Overall Study||128
6328375|NCT00504556|7235014|FG004|NOT COMPLETED|Overall Study||25
6328385|NCT00504595|7235043|FG000|STARTED|Overall Study||50
6328386|NCT00504595|7235044|FG001|STARTED|Overall Study||10
6328387|NCT00504595|7235045|FG002|STARTED|Overall Study||10
6328388|NCT00504595|7235046|FG003|STARTED|Overall Study||10
6328389|NCT00504595|7235043|FG000|COMPLETED|Overall Study||49
6328390|NCT00504595|7235044|FG001|COMPLETED|Overall Study||10
6328391|NCT00504595|7235045|FG002|COMPLETED|Overall Study||8
6328392|NCT00504595|7235046|FG003|COMPLETED|Overall Study||10
6328393|NCT00504595|7235043|FG000|NOT COMPLETED|Overall Study||1
6328394|NCT00504595|7235044|FG001|NOT COMPLETED|Overall Study||0
6328395|NCT00504595|7235045|FG002|NOT COMPLETED|Overall Study||2
6328396|NCT00504595|7235046|FG003|NOT COMPLETED|Overall Study||0
6328397|NCT00504660|7235058|FG000|STARTED|Overall Study||31
6328398|NCT00504660|7235059|FG001|STARTED|Overall Study||43
6328399|NCT00504660|7235058|FG000|COMPLETED|Overall Study||31
6328400|NCT00504660|7235059|FG001|COMPLETED|Overall Study||43
6328401|NCT00504660|7235058|FG000|NOT COMPLETED|Overall Study||0
6328402|NCT00504660|7235059|FG001|NOT COMPLETED|Overall Study||0
6328403|NCT00504725|7235067|FG000|STARTED|Overall Study||21
6328404|NCT00504725|7235068|FG001|STARTED|Overall Study||20
6328405|NCT00504725|7235067|FG000|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
6328406|NCT00504725|7235068|FG001|COMPLETED|Overall Study||20
6328407|NCT00504725|7235067|FG000|NOT COMPLETED|Overall Study||1
6328408|NCT00504725|7235068|FG001|NOT COMPLETED|Overall Study||0
6328409|NCT00504751|7235074|FG000|STARTED|Overall Study||15
6328410|NCT00504751|7235074|FG000|COMPLETED|Overall Study||15
6328411|NCT00504751|7235074|FG000|NOT COMPLETED|Overall Study||0
6328412|NCT00504777|7235078|FG000|STARTED|Overall Study||36
6328413|NCT00504777|7235078|FG000|COMPLETED|Overall Study||35
6328414|NCT00504777|7235078|FG000|NOT COMPLETED|Overall Study||1
6328415|NCT00504829|7235085|FG000|STARTED|Overall Study||73
6328416|NCT00504829|7235086|FG001|STARTED|Overall Study||74
6328417|NCT00504829|7235087|FG002|STARTED|Overall Study||73
6328418|NCT00504829|7235085|FG000|COMPLETED|Overall Study||67
6328419|NCT00504829|7235086|FG001|COMPLETED|Overall Study||70
6328420|NCT00504829|7235087|FG002|COMPLETED|Overall Study||63
6328421|NCT00504829|7235085|FG000|NOT COMPLETED|Overall Study||6
6328422|NCT00504829|7235086|FG001|NOT COMPLETED|Overall Study||4
6328423|NCT00504829|7235087|FG002|NOT COMPLETED|Overall Study||10
6328424|NCT00504881|7235097|FG000|STARTED|Overall Study||121
6328425|NCT00504881|7235098|FG001|STARTED|Overall Study||359
6328426|NCT00504881|7235097|FG000|COMPLETED|Overall Study||111
6328427|NCT00504881|7235098|FG001|COMPLETED|Overall Study||323
6328428|NCT00504881|7235097|FG000|NOT COMPLETED|Overall Study||10
6328429|NCT00504881|7235098|FG001|NOT COMPLETED|Overall Study||36
6328430|NCT00504894|7235109|FG000|STARTED|Overall Study||20
6328431|NCT00504894|7235110|FG001|STARTED|Overall Study||21
6328432|NCT00504894|7235111|FG002|STARTED|Overall Study||19
6328433|NCT00504894|7235109|FG000|COMPLETED|Overall Study||17
6328434|NCT00504894|7235110|FG001|COMPLETED|Overall Study||18
6328435|NCT00504894|7235111|FG002|COMPLETED|Overall Study||19
6328436|NCT00504894|7235109|FG000|NOT COMPLETED|Overall Study||3
6328437|NCT00504894|7235110|FG001|NOT COMPLETED|Overall Study||3
6328438|NCT00504894|7235111|FG002|NOT COMPLETED|Overall Study||0
6328439|NCT00505076|7235122|FG000|STARTED|Overall Study||22
6328440|NCT00505076|7235123|FG001|STARTED|Overall Study||19
6328441|NCT00505076|7235124|FG002|STARTED|Overall Study||22
6558535|NCT01775371|7481087|FG001|STARTED|Overall Study||330
6558536|NCT01775371|7481086|FG000|COMPLETED|Overall Study||306
6558537|NCT01775371|7481087|FG001|COMPLETED|Overall Study||330
6328442|NCT00505076|7235122|FG000|COMPLETED|Overall Study||19
6328443|NCT00505076|7235123|FG001|COMPLETED|Overall Study||17
6328444|NCT00505076|7235124|FG002|COMPLETED|Overall Study||17
6328445|NCT00505076|7235122|FG000|NOT COMPLETED|Overall Study||3
6328446|NCT00505076|7235123|FG001|NOT COMPLETED|Overall Study||2
6328447|NCT00505076|7235124|FG002|NOT COMPLETED|Overall Study||5
6328448|NCT00505284|7235137|FG000|STARTED|Overall Study||73
6328449|NCT00505284|7235138|FG001|STARTED|Overall Study||72
6328450|NCT00505284|7235139|FG002|STARTED|Overall Study||69
6328451|NCT00505284|7235140|FG003|STARTED|Overall Study||68
6328452|NCT00505284|7235141|FG004|STARTED|Overall Study||70
6328453|NCT00505284|7235137|FG000|COMPLETED|Overall Study||63
6328454|NCT00505284|7235138|FG001|COMPLETED|Overall Study||56
6328455|NCT00505284|7235139|FG002|COMPLETED|Overall Study||57
6328456|NCT00505284|7235140|FG003|COMPLETED|Overall Study||49
6328457|NCT00505284|7235141|FG004|COMPLETED|Overall Study||37
6328458|NCT00505284|7235137|FG000|NOT COMPLETED|Overall Study||10
6328459|NCT00505284|7235138|FG001|NOT COMPLETED|Overall Study||16
6328460|NCT00505284|7235139|FG002|NOT COMPLETED|Overall Study||12
6328461|NCT00505284|7235140|FG003|NOT COMPLETED|Overall Study||19
6328462|NCT00505284|7235141|FG004|NOT COMPLETED|Overall Study||33
6328463|NCT00505362|7235155|FG000|STARTED|Overall Study||35
6328464|NCT00505362|7235156|FG001|STARTED|Overall Study||28
6328465|NCT00505362|7235155|FG000|COMPLETED|Overall Study||35
6328466|NCT00505362|7235156|FG001|COMPLETED|Overall Study||28
6328467|NCT00505362|7235155|FG000|NOT COMPLETED|Overall Study||0
6328468|NCT00505362|7235156|FG001|NOT COMPLETED|Overall Study||0
6328469|NCT00505375|7235164|FG000|STARTED|Overall Study||77
6328470|NCT00505375|7235165|FG001|STARTED|Overall Study||35
6328471|NCT00505375|7235164|FG000|COMPLETED|Overall Study||73
6328472|NCT00505375|7235165|FG001|COMPLETED|Overall Study||30
6328473|NCT00505375|7235164|FG000|NOT COMPLETED|Overall Study||4
6328474|NCT00505375|7235165|FG001|NOT COMPLETED|Overall Study||5
6328475|NCT00505414|7235173|FG000|STARTED|Titration Phase||0
6328476|NCT00505414|7235174|FG001|STARTED|Titration Phase||0
6328477|NCT00505414|7235175|FG002|STARTED|Titration Phase||0
6328478|NCT00505414|7235176|FG003|STARTED|Titration Phase||62
6328479|NCT00505414|7235177|FG004|STARTED|Titration Phase||31
6328480|NCT00505414|7235173|FG000|COMPLETED|Titration Phase||0
6328481|NCT00505414|7235174|FG001|COMPLETED|Titration Phase||0
6328482|NCT00505414|7235175|FG002|COMPLETED|Titration Phase||0
6328483|NCT00505414|7235176|FG003|COMPLETED|Titration Phase||32
6328484|NCT00505414|7235177|FG004|COMPLETED|Titration Phase||19
6328485|NCT00505414|7235173|FG000|NOT COMPLETED|Titration Phase||0
6328486|NCT00505414|7235174|FG001|NOT COMPLETED|Titration Phase||0
6328487|NCT00505414|7235175|FG002|NOT COMPLETED|Titration Phase||0
6328488|NCT00505414|7235176|FG003|NOT COMPLETED|Titration Phase||30
6328489|NCT00505414|7235177|FG004|NOT COMPLETED|Titration Phase||12
6328490|NCT00505414|7235173|FG000|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
6328491|NCT00505414|7235174|FG001|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
6328492|NCT00505414|7235175|FG002|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
6328493|NCT00505414|7235176|FG003|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
6328494|NCT00505414|7235177|FG004|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
6328495|NCT00505414|7235173|FG000|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
6328496|NCT00505414|7235174|FG001|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
6328497|NCT00505414|7235175|FG002|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
6328498|NCT00505414|7235176|FG003|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
6328499|NCT00505414|7235177|FG004|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
6328500|NCT00505414|7235173|FG000|COMPLETED|Maintenance Phase||12
6328501|NCT00505414|7235174|FG001|COMPLETED|Maintenance Phase||10
6328502|NCT00505414|7235175|FG002|COMPLETED|Maintenance Phase||6
6328503|NCT00505414|7235176|FG003|COMPLETED|Maintenance Phase||0
6328504|NCT00505414|7235177|FG004|COMPLETED|Maintenance Phase||0
6328505|NCT00505414|7235173|FG000|NOT COMPLETED|Maintenance Phase||6
6328506|NCT00505414|7235174|FG001|NOT COMPLETED|Maintenance Phase||5
6328507|NCT00505414|7235175|FG002|NOT COMPLETED|Maintenance Phase||8
6328508|NCT00505414|7235176|FG003|NOT COMPLETED|Maintenance Phase||0
6328509|NCT00505414|7235177|FG004|NOT COMPLETED|Maintenance Phase||0
6328510|NCT00505518|7235189|FG000|STARTED|Overall Study||9
6328511|NCT00505518|7235189|FG000|COMPLETED|Overall Study||9
6328512|NCT00505518|7235189|FG000|NOT COMPLETED|Overall Study||0
6328513|NCT00505622|7235196|FG000|STARTED|Overall Study||121
6328514|NCT00505622|7235197|FG001|STARTED|Overall Study||108
6328515|NCT00505622|7235198|FG002|STARTED|Overall Study||96
6328516|NCT00505622|7235196|FG000|COMPLETED|Overall Study||0
6328517|NCT00505622|7235197|FG001|COMPLETED|Overall Study||0
6328518|NCT00505622|7235198|FG002|COMPLETED|Overall Study||0
6328519|NCT00505622|7235196|FG000|NOT COMPLETED|Overall Study||121
6558538|NCT01775371|7481086|FG000|NOT COMPLETED|Overall Study||0
6558539|NCT01775371|7481087|FG001|NOT COMPLETED|Overall Study||0
6328520|NCT00505622|7235197|FG001|NOT COMPLETED|Overall Study||108
6328521|NCT00505622|7235198|FG002|NOT COMPLETED|Overall Study||96
6328522|NCT00505635|7235206|FG000|STARTED|Overall Study||5
6328523|NCT00505635|7235206|FG000|COMPLETED|Overall Study||5
6328524|NCT00505635|7235206|FG000|NOT COMPLETED|Overall Study||0
6328525|NCT00505661|7235210|FG000|STARTED|Overall Study||16
6328526|NCT00505661|7235210|FG000|COMPLETED|Overall Study||12
6328527|NCT00505661|7235210|FG000|NOT COMPLETED|Overall Study||4
6328528|NCT00505687|7235214|FG000|STARTED|Overall Study||186
6328529|NCT00505687|7235214|FG000|COMPLETED|Overall Study||91
6328530|NCT00505687|7235214|FG000|NOT COMPLETED|Overall Study||95
6328531|NCT00505752|7235222|FG000|STARTED|Overall Study||132
6328532|NCT00505752|7235223|FG001|STARTED|Overall Study||128
6328533|NCT00505752|7235224|FG002|STARTED|Overall Study||128
6328534|NCT00505752|7235225|FG003|STARTED|Overall Study||132
6328535|NCT00505752|7235222|FG000|COMPLETED|Overall Study||126
6328536|NCT00505752|7235223|FG001|COMPLETED|Overall Study||119
6328537|NCT00505752|7235224|FG002|COMPLETED|Overall Study||120
6328538|NCT00505752|7235225|FG003|COMPLETED|Overall Study||126
6328539|NCT00505752|7235222|FG000|NOT COMPLETED|Overall Study||6
6328540|NCT00505752|7235223|FG001|NOT COMPLETED|Overall Study||9
6328541|NCT00505752|7235224|FG002|NOT COMPLETED|Overall Study||8
6328542|NCT00505752|7235225|FG003|NOT COMPLETED|Overall Study||6
6328543|NCT00505765|7235238|FG000|STARTED|Overall Study||21
6328544|NCT00505765|7235239|FG001|STARTED|Overall Study||20
6328545|NCT00505765|7235240|FG002|STARTED|Overall Study||22
6328546|NCT00505765|7235238|FG000|Mid-Point Assessment|Overall Study||20
6328547|NCT00505765|7235239|FG001|Mid-Point Assessment|Overall Study||19
6328548|NCT00505765|7235240|FG002|Mid-Point Assessment|Overall Study||21
6328549|NCT00505765|7235238|FG000|COMPLETED|Overall Study||19
6328550|NCT00505765|7235239|FG001|COMPLETED|Overall Study||17
6328551|NCT00505765|7235240|FG002|COMPLETED|Overall Study||19
6328552|NCT00505765|7235238|FG000|NOT COMPLETED|Overall Study||2
6328553|NCT00505765|7235239|FG001|NOT COMPLETED|Overall Study||3
6328554|NCT00505765|7235240|FG002|NOT COMPLETED|Overall Study||3
6328555|NCT00505778|7235250|FG000|STARTED|Overall Study||514
6328556|NCT00505778|7235251|FG001|STARTED|Overall Study||513
6328557|NCT00505778|7235250|FG000|Intent to Treat (ITT) Population|Overall Study||512
6328558|NCT00505778|7235251|FG001|Intent to Treat (ITT) Population|Overall Study||511
6328559|NCT00505778|7235250|FG000|COMPLETED|Overall Study||380
6328560|NCT00505778|7235251|FG001|COMPLETED|Overall Study||378
6328561|NCT00505778|7235250|FG000|NOT COMPLETED|Overall Study||134
6328562|NCT00505778|7235251|FG001|NOT COMPLETED|Overall Study||135
6328563|NCT00505895|7235259|FG000|STARTED|Overall Study||27
6328564|NCT00505895|7235260|FG001|STARTED|Overall Study||23
6328565|NCT00505895|7235259|FG000|COMPLETED|Overall Study||27
6328566|NCT00505895|7235260|FG001|COMPLETED|Overall Study||23
6328567|NCT00505895|7235259|FG000|NOT COMPLETED|Overall Study||0
6328568|NCT00505895|7235260|FG001|NOT COMPLETED|Overall Study||0
6328569|NCT00505921|7235266|FG000|STARTED|Overall Study||27
6328570|NCT00505921|7235266|FG000|COMPLETED|Overall Study||18
6328571|NCT00505921|7235266|FG000|NOT COMPLETED|Overall Study||9
6328572|NCT00505934|7235270|FG000|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
6328573|NCT00505934|7235270|FG000|COMPLETED|Overall Study||16
6328574|NCT00505934|7235270|FG000|NOT COMPLETED|Overall Study||3
6328575|NCT00506025|7235277|FG000|STARTED|Overall Study||10
6328576|NCT00506025|7235278|FG001|STARTED|Overall Study||9
6328577|NCT00506025|7235279|FG002|STARTED|Overall Study||8
6328578|NCT00506025|7235277|FG000|COMPLETED|Overall Study||10
6328579|NCT00506025|7235278|FG001|COMPLETED|Overall Study||9
6328580|NCT00506025|7235279|FG002|COMPLETED|Overall Study||8
6328581|NCT00506025|7235277|FG000|NOT COMPLETED|Overall Study||0
6328582|NCT00506025|7235278|FG001|NOT COMPLETED|Overall Study||0
6328583|NCT00506025|7235279|FG002|NOT COMPLETED|Overall Study||0
6328584|NCT00506077|7235289|FG000|STARTED|Treatment Period 1||28
6328585|NCT00506077|7235290|FG001|STARTED|Treatment Period 1||27
6328586|NCT00506077|7235289|FG000|COMPLETED|Treatment Period 1||24
6328587|NCT00506077|7235290|FG001|COMPLETED|Treatment Period 1||24
6328588|NCT00506077|7235289|FG000|NOT COMPLETED|Treatment Period 1||4
6328589|NCT00506077|7235290|FG001|NOT COMPLETED|Treatment Period 1||3
6328590|NCT00506077|7235289|FG000|STARTED|Washout||24
6328591|NCT00506077|7235290|FG001|STARTED|Washout||24
6328592|NCT00506077|7235289|FG000|COMPLETED|Washout||24
6328593|NCT00506077|7235290|FG001|COMPLETED|Washout||24
6328594|NCT00506077|7235289|FG000|NOT COMPLETED|Washout||0
6328595|NCT00506077|7235290|FG001|NOT COMPLETED|Washout||0
6328596|NCT00506077|7235289|FG000|STARTED|Treatment Period 2||24
6328597|NCT00506077|7235290|FG001|STARTED|Treatment Period 2||24
6328598|NCT00506077|7235289|FG000|COMPLETED|Treatment Period 2||23
6328599|NCT00506077|7235290|FG001|COMPLETED|Treatment Period 2||23
6328600|NCT00506077|7235289|FG000|NOT COMPLETED|Treatment Period 2||1
6328601|NCT00506077|7235290|FG001|NOT COMPLETED|Treatment Period 2||1
6328602|NCT00506129|7235296|FG000|STARTED|Overall Study||33
6328603|NCT00506129|7235296|FG000|COMPLETED|Overall Study||11
6328604|NCT00506129|7235296|FG000|NOT COMPLETED|Overall Study||22
6328605|NCT00506142|7235302|FG000|STARTED|Overall Study||35
6328606|NCT00506142|7235303|FG001|STARTED|Overall Study||19
6328607|NCT00506142|7235302|FG000|COMPLETED|Overall Study||0
6328608|NCT00506142|7235303|FG001|COMPLETED|Overall Study||0
6328609|NCT00506142|7235302|FG000|NOT COMPLETED|Overall Study||35
6328610|NCT00506142|7235303|FG001|NOT COMPLETED|Overall Study||19
6328611|NCT00506155|7235309|FG000|STARTED|Overall Study||60
6328612|NCT00506155|7235309|FG000|COMPLETED|Overall Study||60
6328613|NCT00506155|7235309|FG000|NOT COMPLETED|Overall Study||0
6328614|NCT00506285|7235315|FG000|STARTED|3 Week Screening Phase||46
6328615|NCT00506285|7235316|FG001|STARTED|3 Week Screening Phase||46
6328616|NCT00506285|7235315|FG000|COMPLETED|3 Week Screening Phase||29
6328617|NCT00506285|7235316|FG001|COMPLETED|3 Week Screening Phase||36
6328618|NCT00506285|7235315|FG000|NOT COMPLETED|3 Week Screening Phase||17
6328619|NCT00506285|7235316|FG001|NOT COMPLETED|3 Week Screening Phase||10
6328620|NCT00506285|7235315|FG000|STARTED|Double Blind Cross-Over Phase||29
6328621|NCT00506285|7235316|FG001|STARTED|Double Blind Cross-Over Phase||36
6328622|NCT00506285|7235315|FG000|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
6328623|NCT00506285|7235316|FG001|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
6328624|NCT00506285|7235315|FG000|COMPLETED|Double Blind Cross-Over Phase||20
6328625|NCT00506285|7235316|FG001|COMPLETED|Double Blind Cross-Over Phase||31
6328626|NCT00506285|7235315|FG000|NOT COMPLETED|Double Blind Cross-Over Phase||9
6328627|NCT00506285|7235316|FG001|NOT COMPLETED|Double Blind Cross-Over Phase||5
6328628|NCT00506285|7235315|FG000|STARTED|6-month Open Label Phase||20
6328629|NCT00506285|7235316|FG001|STARTED|6-month Open Label Phase||31
6328630|NCT00506285|7235315|FG000|COMPLETED|6-month Open Label Phase||10
6328631|NCT00506285|7235316|FG001|COMPLETED|6-month Open Label Phase||19
6328632|NCT00506285|7235315|FG000|NOT COMPLETED|6-month Open Label Phase||10
6328633|NCT00506285|7235316|FG001|NOT COMPLETED|6-month Open Label Phase||12
6328634|NCT00506350|7235333|FG000|STARTED|Overall Study||36
6328635|NCT00506350|7235334|FG001|STARTED|Overall Study||40
6328636|NCT00506350|7235335|FG002|STARTED|Overall Study||37
6328637|NCT00506350|7235336|FG003|STARTED|Overall Study||36
6328638|NCT00506350|7235337|FG004|STARTED|Overall Study||50
6328639|NCT00506350|7235338|FG005|STARTED|Overall Study||40
6328640|NCT00506350|7235339|FG006|STARTED|Overall Study||35
6328641|NCT00506350|7235340|FG007|STARTED|Overall Study||41
6328642|NCT00506350|7235341|FG008|STARTED|Overall Study||35
6328643|NCT00506350|7235333|FG000|COMPLETED|Overall Study||33
6328644|NCT00506350|7235334|FG001|COMPLETED|Overall Study||37
6328645|NCT00506350|7235335|FG002|COMPLETED|Overall Study||31
6328646|NCT00506350|7235336|FG003|COMPLETED|Overall Study||34
6328647|NCT00506350|7235337|FG004|COMPLETED|Overall Study||40
6328648|NCT00506350|7235338|FG005|COMPLETED|Overall Study||38
6328649|NCT00506350|7235339|FG006|COMPLETED|Overall Study||33
6328650|NCT00506350|7235340|FG007|COMPLETED|Overall Study||36
6328651|NCT00506350|7235341|FG008|COMPLETED|Overall Study||30
6328652|NCT00506350|7235333|FG000|NOT COMPLETED|Overall Study||3
6328653|NCT00506350|7235334|FG001|NOT COMPLETED|Overall Study||3
6328654|NCT00506350|7235335|FG002|NOT COMPLETED|Overall Study||6
6328655|NCT00506350|7235336|FG003|NOT COMPLETED|Overall Study||2
6328656|NCT00506350|7235337|FG004|NOT COMPLETED|Overall Study||10
6328657|NCT00506350|7235338|FG005|NOT COMPLETED|Overall Study||2
6328658|NCT00506350|7235339|FG006|NOT COMPLETED|Overall Study||2
6328659|NCT00506350|7235340|FG007|NOT COMPLETED|Overall Study||5
6328660|NCT00506350|7235341|FG008|NOT COMPLETED|Overall Study||5
6328661|NCT00506389|7235371|FG000|STARTED|In-treatment Period||143
6328662|NCT00506389|7235372|FG001|STARTED|In-treatment Period||139
6328663|NCT00506389|7235373|FG002|STARTED|In-treatment Period||137
6328664|NCT00506389|7235371|FG000|All Participants Treated|In-treatment Period||139
6328665|NCT00506389|7235372|FG001|All Participants Treated|In-treatment Period||138
6328666|NCT00506389|7235373|FG002|All Participants Treated|In-treatment Period||136
6328667|NCT00506389|7235371|FG000|COMPLETED|In-treatment Period||117
6328668|NCT00506389|7235372|FG001|COMPLETED|In-treatment Period||124
6328669|NCT00506389|7235373|FG002|COMPLETED|In-treatment Period||125
6328670|NCT00506389|7235371|FG000|NOT COMPLETED|In-treatment Period||26
6328671|NCT00506389|7235372|FG001|NOT COMPLETED|In-treatment Period||15
6328672|NCT00506389|7235373|FG002|NOT COMPLETED|In-treatment Period||12
6328673|NCT00506389|7235371|FG000|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
6328674|NCT00506389|7235372|FG001|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
6328675|NCT00506389|7235373|FG002|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
6328676|NCT00506389|7235371|FG000|COMPLETED|Follow-up Period||139
6328677|NCT00506389|7235372|FG001|COMPLETED|Follow-up Period||138
6328678|NCT00506389|7235373|FG002|COMPLETED|Follow-up Period||136
6328679|NCT00506389|7235371|FG000|NOT COMPLETED|Follow-up Period||0
6328680|NCT00506389|7235372|FG001|NOT COMPLETED|Follow-up Period||0
6328681|NCT00506389|7235373|FG002|NOT COMPLETED|Follow-up Period||0
6328682|NCT00506415|7235384|FG000|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
6328683|NCT00506415|7235385|FG001|STARTED|Initial Open Label (Maximum 48 Weeks)||0
6328684|NCT00506415|7235386|FG002|STARTED|Initial Open Label (Maximum 48 Weeks)||0
6328685|NCT00506415|7235387|FG003|STARTED|Initial Open Label (Maximum 48 Weeks)||0
6328686|NCT00506415|7235384|FG000|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
6328687|NCT00506415|7235385|FG001|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
6328688|NCT00506415|7235386|FG002|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
6328689|NCT00506415|7235387|FG003|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
6328690|NCT00506415|7235384|FG000|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
6328691|NCT00506415|7235385|FG001|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6328692|NCT00506415|7235386|FG002|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6328693|NCT00506415|7235387|FG003|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6328694|NCT00506415|7235384|FG000|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
6328695|NCT00506415|7235385|FG001|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6328696|NCT00506415|7235386|FG002|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6328697|NCT00506415|7235387|FG003|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
6328698|NCT00506415|7235384|FG000|STARTED|Double Blind (Maximum 48 Weeks )||0
6328699|NCT00506415|7235385|FG001|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
6328700|NCT00506415|7235386|FG002|STARTED|Double Blind (Maximum 48 Weeks )||280
6328701|NCT00506415|7235387|FG003|STARTED|Double Blind (Maximum 48 Weeks )||0
6328702|NCT00506415|7235384|FG000|COMPLETED|Double Blind (Maximum 48 Weeks )||0
6328703|NCT00506415|7235385|FG001|COMPLETED|Double Blind (Maximum 48 Weeks )||203
6328704|NCT00506415|7235386|FG002|COMPLETED|Double Blind (Maximum 48 Weeks )||207
6328705|NCT00506415|7235387|FG003|COMPLETED|Double Blind (Maximum 48 Weeks )||0
6328706|NCT00506415|7235384|FG000|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
6328707|NCT00506415|7235385|FG001|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
6328708|NCT00506415|7235386|FG002|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
6328709|NCT00506415|7235387|FG003|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
6328710|NCT00506415|7235384|FG000|STARTED|Extended Open Label (Maximum 48 Weeks)||0
6328711|NCT00506415|7235385|FG001|STARTED|Extended Open Label (Maximum 48 Weeks)||0
6328712|NCT00506415|7235386|FG002|STARTED|Extended Open Label (Maximum 48 Weeks)||0
6328713|NCT00506415|7235387|FG003|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
6328714|NCT00506415|7235384|FG000|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6328715|NCT00506415|7235385|FG001|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6328716|NCT00506415|7235386|FG002|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6328717|NCT00506415|7235387|FG003|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
6328718|NCT00506415|7235384|FG000|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6328719|NCT00506415|7235385|FG001|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6328720|NCT00506415|7235386|FG002|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
6328721|NCT00506415|7235387|FG003|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
6375976|NCT00758394|7286517|FG002|COMPLETED|Washout After 2nd Intervention||6
6375977|NCT00758394|7286518|FG003|COMPLETED|Washout After 2nd Intervention||8
6375978|NCT00758394|7286515|FG000|NOT COMPLETED|Washout After 2nd Intervention||0
6375979|NCT00758394|7286516|FG001|NOT COMPLETED|Washout After 2nd Intervention||0
6375980|NCT00758394|7286517|FG002|NOT COMPLETED|Washout After 2nd Intervention||0
6375981|NCT00758394|7286518|FG003|NOT COMPLETED|Washout After 2nd Intervention||0
6375982|NCT00758394|7286515|FG000|STARTED|3rd Intervention||8
6375983|NCT00758394|7286516|FG001|STARTED|3rd Intervention||6
6375984|NCT00758394|7286517|FG002|STARTED|3rd Intervention||6
6375985|NCT00758394|7286518|FG003|STARTED|3rd Intervention||8
6375986|NCT00758394|7286515|FG000|COMPLETED|3rd Intervention||7
6375987|NCT00758394|7286516|FG001|COMPLETED|3rd Intervention||6
6375988|NCT00758394|7286517|FG002|COMPLETED|3rd Intervention||6
6375989|NCT00758394|7286518|FG003|COMPLETED|3rd Intervention||7
6375990|NCT00758394|7286515|FG000|NOT COMPLETED|3rd Intervention||1
6375991|NCT00758394|7286516|FG001|NOT COMPLETED|3rd Intervention||0
6375992|NCT00758394|7286517|FG002|NOT COMPLETED|3rd Intervention||0
6375993|NCT00758394|7286518|FG003|NOT COMPLETED|3rd Intervention||1
6375994|NCT00758394|7286515|FG000|STARTED|Washout After 3rd Intervention||7
6375995|NCT00758394|7286516|FG001|STARTED|Washout After 3rd Intervention||6
6375996|NCT00758394|7286517|FG002|STARTED|Washout After 3rd Intervention||6
6375997|NCT00758394|7286518|FG003|STARTED|Washout After 3rd Intervention||7
6375998|NCT00758394|7286515|FG000|COMPLETED|Washout After 3rd Intervention||7
6375999|NCT00758394|7286516|FG001|COMPLETED|Washout After 3rd Intervention||6
6376000|NCT00758394|7286517|FG002|COMPLETED|Washout After 3rd Intervention||6
6376001|NCT00758394|7286518|FG003|COMPLETED|Washout After 3rd Intervention||7
6376002|NCT00758394|7286515|FG000|NOT COMPLETED|Washout After 3rd Intervention||0
6376003|NCT00758394|7286516|FG001|NOT COMPLETED|Washout After 3rd Intervention||0
6376004|NCT00758394|7286517|FG002|NOT COMPLETED|Washout After 3rd Intervention||0
6376005|NCT00758394|7286518|FG003|NOT COMPLETED|Washout After 3rd Intervention||0
6376006|NCT00758394|7286515|FG000|STARTED|4th Intervention||7
6376007|NCT00758394|7286516|FG001|STARTED|4th Intervention||6
6376008|NCT00758394|7286517|FG002|STARTED|4th Intervention||6
6376009|NCT00758394|7286518|FG003|STARTED|4th Intervention||7
6376010|NCT00758394|7286515|FG000|COMPLETED|4th Intervention||7
6376011|NCT00758394|7286516|FG001|COMPLETED|4th Intervention||6
6376012|NCT00758394|7286517|FG002|COMPLETED|4th Intervention||6
6376013|NCT00758394|7286518|FG003|COMPLETED|4th Intervention||7
6376014|NCT00758394|7286515|FG000|NOT COMPLETED|4th Intervention||0
6376015|NCT00758394|7286516|FG001|NOT COMPLETED|4th Intervention||0
6376016|NCT00758394|7286517|FG002|NOT COMPLETED|4th Intervention||0
6376017|NCT00758394|7286518|FG003|NOT COMPLETED|4th Intervention||0
6376018|NCT00758420|7286530|FG000|STARTED|Overall Study||39
6376019|NCT00758420|7286531|FG001|STARTED|Overall Study||38
6376020|NCT00758420|7286530|FG000|COMPLETED|Overall Study||39
6376021|NCT00758420|7286531|FG001|COMPLETED|Overall Study||38
6376022|NCT00758420|7286530|FG000|NOT COMPLETED|Overall Study||0
6376023|NCT00758420|7286531|FG001|NOT COMPLETED|Overall Study||0
6376024|NCT00758459|7286539|FG000|STARTED|Overall Study||35
6376025|NCT00758459|7286540|FG001|STARTED|Overall Study||39
6328722|NCT00506441|7235400|FG000|STARTED|Period 1; Open-label Period||245
6328723|NCT00506441|7235401|FG001|STARTED|Period 1; Open-label Period||0
6328724|NCT00506441|7235400|FG000|COMPLETED|Period 1; Open-label Period||169
6328725|NCT00506441|7235401|FG001|COMPLETED|Period 1; Open-label Period||0
6328726|NCT00506441|7235400|FG000|NOT COMPLETED|Period 1; Open-label Period||76
6328727|NCT00506441|7235401|FG001|NOT COMPLETED|Period 1; Open-label Period||0
6328728|NCT00506441|7235400|FG000|STARTED|Period 2; Double-blind Period||85
6328729|NCT00506441|7235401|FG001|STARTED|Period 2; Double-blind Period||84
6328730|NCT00506441|7235400|FG000|COMPLETED|Period 2; Double-blind Period||82
6328731|NCT00506441|7235401|FG001|COMPLETED|Period 2; Double-blind Period||79
6328732|NCT00506441|7235400|FG000|NOT COMPLETED|Period 2; Double-blind Period||3
6328733|NCT00506441|7235401|FG001|NOT COMPLETED|Period 2; Double-blind Period||5
6328734|NCT00506454|7235411|FG000|STARTED|Overall Study||11
6328735|NCT00506454|7235412|FG001|STARTED|Overall Study||11
6328736|NCT00506454|7235411|FG000|COMPLETED|Overall Study||10
6328737|NCT00506454|7235412|FG001|COMPLETED|Overall Study||10
6328738|NCT00506454|7235411|FG000|NOT COMPLETED|Overall Study||1
6328739|NCT00506454|7235412|FG001|NOT COMPLETED|Overall Study||1
6328740|NCT00506493|7235418|FG000|STARTED|Overall Study||75
6328741|NCT00506493|7235418|FG000|COMPLETED|Overall Study||64
6328742|NCT00506493|7235418|FG000|NOT COMPLETED|Overall Study||11
6328743|NCT00506519|7235427|FG000|STARTED|Overall Study||10
6328744|NCT00506519|7235428|FG001|STARTED|Overall Study||10
6328745|NCT00506519|7235429|FG002|STARTED|Overall Study||5
6328746|NCT00506519|7235427|FG000|Completed Treatment (Day 5)|Overall Study||8
6328747|NCT00506519|7235428|FG001|Completed Treatment (Day 5)|Overall Study||7
6328748|NCT00506519|7235429|FG002|Completed Treatment (Day 5)|Overall Study||5
6328749|NCT00506519|7235427|FG000|Day 28 Follow up|Overall Study||8
6328750|NCT00506519|7235428|FG001|Day 28 Follow up|Overall Study||6
6328751|NCT00506519|7235429|FG002|Day 28 Follow up|Overall Study||5
6328752|NCT00506519|7235427|FG000|COMPLETED|Overall Study||5
6328753|NCT00506519|7235428|FG001|COMPLETED|Overall Study||4
6328754|NCT00506519|7235429|FG002|COMPLETED|Overall Study||5
6328755|NCT00506519|7235427|FG000|NOT COMPLETED|Overall Study||5
6328756|NCT00506519|7235428|FG001|NOT COMPLETED|Overall Study||6
6328757|NCT00506519|7235429|FG002|NOT COMPLETED|Overall Study||0
6328758|NCT00506597|7235440|FG000|STARTED|Overall Study||33
6328759|NCT00506597|7235440|FG000|COMPLETED|Overall Study||33
6328760|NCT00506597|7235440|FG000|NOT COMPLETED|Overall Study||0
6328761|NCT00506662|7235446|FG000|STARTED|Overall Study||38
6328762|NCT00506662|7235447|FG001|STARTED|Overall Study||48
6328763|NCT00506662|7235446|FG000|COMPLETED|Overall Study||21
6328764|NCT00506662|7235447|FG001|COMPLETED|Overall Study||20
6328765|NCT00506662|7235446|FG000|NOT COMPLETED|Overall Study||17
6328766|NCT00506662|7235447|FG001|NOT COMPLETED|Overall Study||28
6328767|NCT00506675|7235455|FG000|STARTED|Overall Study||27
6328768|NCT00506675|7235456|FG001|STARTED|Overall Study||28
6328769|NCT00506675|7235455|FG000|COMPLETED|Overall Study||27
6328770|NCT00506675|7235456|FG001|COMPLETED|Overall Study||28
6328771|NCT00506675|7235455|FG000|NOT COMPLETED|Overall Study||0
6328772|NCT00506675|7235456|FG001|NOT COMPLETED|Overall Study||0
6328773|NCT00506714|7235464|FG000|STARTED|Overall Study||13
6328774|NCT00506714|7235465|FG001|STARTED|Overall Study||13
6328775|NCT00506714|7235464|FG000|COMPLETED|Overall Study||13
6328776|NCT00506714|7235465|FG001|COMPLETED|Overall Study||13
6328777|NCT00506714|7235464|FG000|NOT COMPLETED|Overall Study||0
6328778|NCT00506714|7235465|FG001|NOT COMPLETED|Overall Study||0
6328779|NCT00506753|7235475|FG000|STARTED|Overall Study||100
6328780|NCT00506753|7235476|FG001|STARTED|Overall Study||99
6328781|NCT00506753|7235475|FG000|COMPLETED|Overall Study||79
6328782|NCT00506753|7235476|FG001|COMPLETED|Overall Study||84
6328783|NCT00506753|7235475|FG000|NOT COMPLETED|Overall Study||21
6328784|NCT00506753|7235476|FG001|NOT COMPLETED|Overall Study||15
6328785|NCT00506779|7235484|FG000|STARTED|Overall Study||4
6328786|NCT00506779|7235485|FG001|STARTED|Overall Study||6
6328787|NCT00506779|7235486|FG002|STARTED|Overall Study||2
6328788|NCT00506779|7235487|FG003|STARTED|Overall Study||5
6328789|NCT00506779|7235484|FG000|COMPLETED|Overall Study||3
6328790|NCT00506779|7235485|FG001|COMPLETED|Overall Study||5
6328791|NCT00506779|7235486|FG002|COMPLETED|Overall Study||0
6328792|NCT00506779|7235487|FG003|COMPLETED|Overall Study||4
6328793|NCT00506779|7235484|FG000|NOT COMPLETED|Overall Study||1
6328794|NCT00506779|7235485|FG001|NOT COMPLETED|Overall Study||1
6328795|NCT00506779|7235486|FG002|NOT COMPLETED|Overall Study||2
6328796|NCT00506779|7235487|FG003|NOT COMPLETED|Overall Study||1
6328797|NCT00506831|7235498|FG000|STARTED|Overall Study||9
6328798|NCT00506831|7235498|FG000|COMPLETED|Overall Study||7
6328799|NCT00506831|7235498|FG000|NOT COMPLETED|Overall Study||2
6328800|NCT00506857|7235502|FG000|STARTED|Overall Study||80
6328801|NCT00506857|7235502|FG000|COMPLETED|Overall Study||80
6328802|NCT00506857|7235502|FG000|NOT COMPLETED|Overall Study||0
6328803|NCT00506883|7235510|FG000|STARTED|Overall Study||52
6328804|NCT00506883|7235511|FG001|STARTED|Overall Study||74
6328805|NCT00506883|7235512|FG002|STARTED|Overall Study||59
6328806|NCT00506883|7235510|FG000|COMPLETED|Overall Study||45
6328807|NCT00506883|7235511|FG001|COMPLETED|Overall Study||71
6328808|NCT00506883|7235512|FG002|COMPLETED|Overall Study||55
6328809|NCT00506883|7235510|FG000|NOT COMPLETED|Overall Study||7
6328810|NCT00506883|7235511|FG001|NOT COMPLETED|Overall Study||3
6328811|NCT00506883|7235512|FG002|NOT COMPLETED|Overall Study||4
6328812|NCT00506922|7235525|FG000|STARTED|Overall Study||37
6328813|NCT00506922|7235526|FG001|STARTED|Overall Study||10
6328814|NCT00506922|7235527|FG002|STARTED|Overall Study||29
6328815|NCT00506922|7235528|FG003|STARTED|Overall Study||63
6328816|NCT00506922|7235529|FG004|STARTED|Overall Study||11
6328817|NCT00506922|7235525|FG000|COMPLETED|Overall Study||37
6328818|NCT00506922|7235526|FG001|COMPLETED|Overall Study||10
6328819|NCT00506922|7235527|FG002|COMPLETED|Overall Study||29
6328820|NCT00506922|7235528|FG003|COMPLETED|Overall Study||61
6328821|NCT00506922|7235529|FG004|COMPLETED|Overall Study||10
6328822|NCT00506922|7235525|FG000|NOT COMPLETED|Overall Study||0
6328823|NCT00506922|7235526|FG001|NOT COMPLETED|Overall Study||0
6328824|NCT00506922|7235527|FG002|NOT COMPLETED|Overall Study||0
6328825|NCT00506922|7235528|FG003|NOT COMPLETED|Overall Study||2
6328826|NCT00506922|7235529|FG004|NOT COMPLETED|Overall Study||1
6328827|NCT00506948|7235537|FG000|STARTED|Overall Study||10
6328828|NCT00506948|7235537|FG000|COMPLETED|Overall Study||0
6328829|NCT00506948|7235537|FG000|NOT COMPLETED|Overall Study||10
6328830|NCT00507026|7235544|FG000|STARTED|Overall Study||145
6328831|NCT00507026|7235545|FG001|STARTED|Overall Study||60
6328832|NCT00507026|7235546|FG002|STARTED|Overall Study||72
6328833|NCT00507026|7235544|FG000|COMPLETED|Overall Study||132
6328834|NCT00507026|7235545|FG001|COMPLETED|Overall Study||56
6328835|NCT00507026|7235546|FG002|COMPLETED|Overall Study||51
6328836|NCT00507026|7235544|FG000|NOT COMPLETED|Overall Study||13
6328837|NCT00507026|7235545|FG001|NOT COMPLETED|Overall Study||4
6328838|NCT00507026|7235546|FG002|NOT COMPLETED|Overall Study||21
6328839|NCT00507130|7235558|FG000|STARTED|Overall Study||9
6328840|NCT00507130|7235559|FG001|STARTED|Overall Study||9
6328841|NCT00507130|7235560|FG002|STARTED|Overall Study||9
6328842|NCT00507130|7235561|FG003|STARTED|Overall Study||9
6328843|NCT00507130|7235558|FG000|COMPLETED|Overall Study||8
6328844|NCT00507130|7235559|FG001|COMPLETED|Overall Study||9
6328845|NCT00507130|7235560|FG002|COMPLETED|Overall Study||8
6328846|NCT00507130|7235561|FG003|COMPLETED|Overall Study||8
6328847|NCT00507130|7235558|FG000|NOT COMPLETED|Overall Study||1
6328848|NCT00507130|7235559|FG001|NOT COMPLETED|Overall Study||0
6328849|NCT00507130|7235560|FG002|NOT COMPLETED|Overall Study||1
6328850|NCT00507130|7235561|FG003|NOT COMPLETED|Overall Study||1
6328851|NCT00507208|7235573|FG000|STARTED|Overall Study||27
6328852|NCT00507208|7235574|FG001|STARTED|Overall Study||26
6328853|NCT00507208|7235573|FG000|Received Dynasplint in Crossover|Overall Study||0
6328854|NCT00507208|7235574|FG001|Received Dynasplint in Crossover|Overall Study||3
6328855|NCT00507208|7235573|FG000|COMPLETED|Overall Study||27
6328856|NCT00507208|7235574|FG001|COMPLETED|Overall Study||26
6328857|NCT00507208|7235573|FG000|NOT COMPLETED|Overall Study||0
6328858|NCT00507208|7235574|FG001|NOT COMPLETED|Overall Study||0
6328859|NCT00507416|7235583|FG000|STARTED|Overall Study||168
6328860|NCT00507416|7235584|FG001|STARTED|Overall Study||167
6328861|NCT00507416|7235585|FG002|STARTED|Overall Study||167
6328862|NCT00507416|7235583|FG000|Treated (Safety Population)|Overall Study||165
6328863|NCT00507416|7235584|FG001|Treated (Safety Population)|Overall Study||158
6328864|NCT00507416|7235585|FG002|Treated (Safety Population)|Overall Study||163
6328865|NCT00507416|7235583|FG000|Completed 8 Treatment Cycles|Overall Study||82
6328866|NCT00507416|7235584|FG001|Completed 8 Treatment Cycles|Overall Study||60
6328867|NCT00507416|7235585|FG002|Completed 8 Treatment Cycles|Overall Study||69
6328868|NCT00507416|7235583|FG000|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
6328869|NCT00507416|7235584|FG001|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
6328870|NCT00507416|7235585|FG002|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
6328871|NCT00507416|7235583|FG000|NOT COMPLETED|Overall Study||118
6328872|NCT00507416|7235584|FG001|NOT COMPLETED|Overall Study||125
6328873|NCT00507416|7235585|FG002|NOT COMPLETED|Overall Study||114
6328874|NCT00507429|7235595|FG000|STARTED|Treatment Phase|Randomized|55
6328875|NCT00507429|7235596|FG001|STARTED|Treatment Phase|Randomized|25
6328876|NCT00507429|7235595|FG000|COMPLETED|Treatment Phase||18
6328877|NCT00507429|7235596|FG001|COMPLETED|Treatment Phase||7
6328878|NCT00507429|7235595|FG000|NOT COMPLETED|Treatment Phase||37
6328879|NCT00507429|7235596|FG001|NOT COMPLETED|Treatment Phase||18
6328880|NCT00507429|7235595|FG000|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
6328881|NCT00507429|7235596|FG001|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
6328882|NCT00507429|7235595|FG000|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
6328883|NCT00507429|7235596|FG001|COMPLETED|Maintenance Phase||0
6328884|NCT00507429|7235595|FG000|NOT COMPLETED|Maintenance Phase||14
6328885|NCT00507429|7235596|FG001|NOT COMPLETED|Maintenance Phase||0
6328886|NCT00507442|7235608|FG000|STARTED|Overall Study||42
6328887|NCT00507442|7235609|FG001|STARTED|Overall Study||66
6328888|NCT00507442|7235610|FG002|STARTED|Overall Study||33
6328889|NCT00507442|7235611|FG003|STARTED|Overall Study||17
6328890|NCT00507442|7235608|FG000|COMPLETED|Overall Study||26
6328891|NCT00507442|7235609|FG001|COMPLETED|Overall Study||39
6328892|NCT00507442|7235610|FG002|COMPLETED|Overall Study||18
6328893|NCT00507442|7235611|FG003|COMPLETED|Overall Study||12
6328894|NCT00507442|7235608|FG000|NOT COMPLETED|Overall Study||16
6328895|NCT00507442|7235609|FG001|NOT COMPLETED|Overall Study||27
6328896|NCT00507442|7235610|FG002|NOT COMPLETED|Overall Study||15
6328897|NCT00507442|7235611|FG003|NOT COMPLETED|Overall Study||5
6328898|NCT00507455|7235628|FG000|STARTED|Overall Study||74
6328899|NCT00507455|7235629|FG001|STARTED|Overall Study||74
6328900|NCT00507455|7235630|FG002|STARTED|Overall Study||74
6328901|NCT00507455|7235628|FG000|COMPLETED|Overall Study||62
6328902|NCT00507455|7235629|FG001|COMPLETED|Overall Study||68
6328903|NCT00507455|7235630|FG002|COMPLETED|Overall Study||62
6328904|NCT00507455|7235628|FG000|NOT COMPLETED|Overall Study||12
6328905|NCT00507455|7235629|FG001|NOT COMPLETED|Overall Study||6
6328906|NCT00507455|7235630|FG002|NOT COMPLETED|Overall Study||12
6328907|NCT00507507|7235640|FG000|STARTED|Treatment Period||64
6328908|NCT00507507|7235641|FG001|STARTED|Treatment Period||62
6328909|NCT00507507|7235640|FG000|Completed 192 Weeks of Treatment|Treatment Period||52
6328910|NCT00507507|7235641|FG001|Completed 192 Weeks of Treatment|Treatment Period||52
6328911|NCT00507507|7235640|FG000|COMPLETED|Treatment Period||12
6328912|NCT00507507|7235641|FG001|COMPLETED|Treatment Period||9
6328913|NCT00507507|7235640|FG000|NOT COMPLETED|Treatment Period||52
6328914|NCT00507507|7235641|FG001|NOT COMPLETED|Treatment Period||53
6328915|NCT00507507|7235640|FG000|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
6328916|NCT00507507|7235641|FG001|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
6328917|NCT00507507|7235640|FG000|COMPLETED|24-week Treatment-free Follow-up Period||16
6328918|NCT00507507|7235641|FG001|COMPLETED|24-week Treatment-free Follow-up Period||12
6328919|NCT00507507|7235640|FG000|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
6328920|NCT00507507|7235641|FG001|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
6328921|NCT00507546|7235651|FG000|STARTED|Overall Study||4
6328922|NCT00507546|7235652|FG001|STARTED|Overall Study||4
6328923|NCT00507546|7235651|FG000|COMPLETED|Overall Study||2
6328924|NCT00507546|7235652|FG001|COMPLETED|Overall Study||3
6328925|NCT00507546|7235651|FG000|NOT COMPLETED|Overall Study||2
6328926|NCT00507546|7235652|FG001|NOT COMPLETED|Overall Study||1
6328927|NCT00507559|7235660|FG000|STARTED|Overall Study||155
6328928|NCT00507559|7235660|FG000|COMPLETED|Overall Study||84
6328929|NCT00507559|7235660|FG000|NOT COMPLETED|Overall Study||71
6328930|NCT00507689|7235667|FG000|STARTED|Pre-Randomization Period||40
6328931|NCT00507689|7235668|FG001|STARTED|Pre-Randomization Period||0
6328932|NCT00507689|7235667|FG000|COMPLETED|Pre-Randomization Period||37
6328933|NCT00507689|7235668|FG001|COMPLETED|Pre-Randomization Period||0
6328934|NCT00507689|7235667|FG000|NOT COMPLETED|Pre-Randomization Period||3
6328935|NCT00507689|7235668|FG001|NOT COMPLETED|Pre-Randomization Period||0
6328936|NCT00507689|7235667|FG000|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
6328937|NCT00507689|7235668|FG001|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
6328938|NCT00507689|7235667|FG000|COMPLETED|Randomized Period||18
6328939|NCT00507689|7235668|FG001|COMPLETED|Randomized Period||16
6328940|NCT00507689|7235667|FG000|NOT COMPLETED|Randomized Period||1
6328941|NCT00507689|7235668|FG001|NOT COMPLETED|Randomized Period||2
6328942|NCT00507728|7235678|FG000|STARTED|Randomization to Month 3||75
6328943|NCT00507728|7235679|FG001|STARTED|Randomization to Month 3||89
6328944|NCT00507728|7235680|FG002|STARTED|Randomization to Month 3||90
6328945|NCT00507728|7235678|FG000|COMPLETED|Randomization to Month 3||60
6328946|NCT00507728|7235679|FG001|COMPLETED|Randomization to Month 3||75
6328947|NCT00507728|7235680|FG002|COMPLETED|Randomization to Month 3||70
6328948|NCT00507728|7235678|FG000|NOT COMPLETED|Randomization to Month 3||15
6328949|NCT00507728|7235679|FG001|NOT COMPLETED|Randomization to Month 3||14
6328950|NCT00507728|7235680|FG002|NOT COMPLETED|Randomization to Month 3||20
6328951|NCT00507728|7235678|FG000|STARTED|From 3 Months to 6 Months||60
6328952|NCT00507728|7235679|FG001|STARTED|From 3 Months to 6 Months||75
6328953|NCT00507728|7235680|FG002|STARTED|From 3 Months to 6 Months||70
6328954|NCT00507728|7235678|FG000|COMPLETED|From 3 Months to 6 Months||54
6328955|NCT00507728|7235679|FG001|COMPLETED|From 3 Months to 6 Months||65
6328956|NCT00507728|7235680|FG002|COMPLETED|From 3 Months to 6 Months||61
6328957|NCT00507728|7235678|FG000|NOT COMPLETED|From 3 Months to 6 Months||6
6328958|NCT00507728|7235679|FG001|NOT COMPLETED|From 3 Months to 6 Months||10
6328959|NCT00507728|7235680|FG002|NOT COMPLETED|From 3 Months to 6 Months||9
6328960|NCT00507767|7235694|FG000|STARTED|Overall Study||15
6328961|NCT00507767|7235694|FG000|COMPLETED|Overall Study||15
6328962|NCT00507767|7235694|FG000|NOT COMPLETED|Overall Study||0
6328963|NCT00507819|7235698|FG000|STARTED|First Intervention (6 Weeks)||14
6328964|NCT00507819|7235699|FG001|STARTED|First Intervention (6 Weeks)||14
6328965|NCT00507819|7235698|FG000|COMPLETED|First Intervention (6 Weeks)||14
6328966|NCT00507819|7235699|FG001|COMPLETED|First Intervention (6 Weeks)||14
6328967|NCT00507819|7235698|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
6328968|NCT00507819|7235699|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
6328969|NCT00507819|7235698|FG000|STARTED|Washout (6 Weeks)||14
6328970|NCT00507819|7235699|FG001|STARTED|Washout (6 Weeks)||14
6328971|NCT00507819|7235698|FG000|COMPLETED|Washout (6 Weeks)||13
6328972|NCT00507819|7235699|FG001|COMPLETED|Washout (6 Weeks)||14
6328973|NCT00507819|7235698|FG000|NOT COMPLETED|Washout (6 Weeks)||1
6328974|NCT00507819|7235699|FG001|NOT COMPLETED|Washout (6 Weeks)||0
6328975|NCT00507819|7235698|FG000|STARTED|Second Intervention (6 Weeks)||13
6328976|NCT00507819|7235699|FG001|STARTED|Second Intervention (6 Weeks)||14
6328977|NCT00507819|7235698|FG000|COMPLETED|Second Intervention (6 Weeks)||13
6328978|NCT00507819|7235699|FG001|COMPLETED|Second Intervention (6 Weeks)||14
6328979|NCT00507819|7235698|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6328980|NCT00507819|7235699|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6328981|NCT00508001|7235708|FG000|STARTED|Overall Study||19
6328982|NCT00508001|7235709|FG001|STARTED|Overall Study||25
6328983|NCT00508001|7235710|FG002|STARTED|Overall Study||23
6328984|NCT00508001|7235708|FG000|Secondary Treatment Phase|Overall Study||0
6328985|NCT00508001|7235709|FG001|Secondary Treatment Phase|Overall Study||13
6328986|NCT00508001|7235710|FG002|Secondary Treatment Phase|Overall Study||16
6328987|NCT00508001|7235708|FG000|COMPLETED|Overall Study||0
6328988|NCT00508001|7235709|FG001|COMPLETED|Overall Study||13
6328989|NCT00508001|7235710|FG002|COMPLETED|Overall Study||16
6328990|NCT00508001|7235708|FG000|NOT COMPLETED|Overall Study||19
6328991|NCT00508001|7235709|FG001|NOT COMPLETED|Overall Study||12
6328992|NCT00508001|7235710|FG002|NOT COMPLETED|Overall Study||7
6328993|NCT00508027|7235718|FG000|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
6328994|NCT00508027|7235718|FG000|COMPLETED|Dose Level 1||12
6328995|NCT00508027|7235718|FG000|NOT COMPLETED|Dose Level 1||8
6328996|NCT00508027|7235718|FG000|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
6328997|NCT00508027|7235718|FG000|COMPLETED|Dose Level 2||16
6328998|NCT00508027|7235718|FG000|NOT COMPLETED|Dose Level 2||4
6328999|NCT00508027|7235718|FG000|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
6329000|NCT00508027|7235718|FG000|COMPLETED|Dose Level 3||2
6329001|NCT00508027|7235718|FG000|NOT COMPLETED|Dose Level 3||0
6329002|NCT00508105|7235733|FG000|STARTED|Overall Study||44
6329003|NCT00508105|7235734|FG001|STARTED|Overall Study||43
6329004|NCT00508105|7235733|FG000|COMPLETED|Overall Study||40
6329005|NCT00508105|7235734|FG001|COMPLETED|Overall Study||37
6329006|NCT00508105|7235733|FG000|NOT COMPLETED|Overall Study||4
6329007|NCT00508105|7235734|FG001|NOT COMPLETED|Overall Study||6
6329008|NCT00508118|7235743|FG000|STARTED|Overall Study||3
6329009|NCT00508118|7235744|FG001|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
6329010|NCT00508118|7235743|FG000|COMPLETED|Overall Study||3
6329011|NCT00508118|7235744|FG001|COMPLETED|Overall Study||4
6329012|NCT00508118|7235743|FG000|NOT COMPLETED|Overall Study||0
6329013|NCT00508118|7235744|FG001|NOT COMPLETED|Overall Study||0
6329014|NCT00508144|7235751|FG000|STARTED|Overall Study||64
6329015|NCT00508144|7235751|FG000|COMPLETED|Overall Study||53
6329016|NCT00508144|7235751|FG000|NOT COMPLETED|Overall Study||11
6329017|NCT00508157|7235757|FG000|STARTED|Overall Study||26
6329018|NCT00508157|7235758|FG001|STARTED|Overall Study||26
6329019|NCT00508157|7235757|FG000|Randomized Sample|Overall Study||26
6329020|NCT00508157|7235758|FG001|Randomized Sample|Overall Study||26
6329021|NCT00508157|7235757|FG000|Safety Sample|Overall Study||26
6329022|NCT00508157|7235758|FG001|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
6329023|NCT00508157|7235757|FG000|COMPLETED|Overall Study||24
6329024|NCT00508157|7235758|FG001|COMPLETED|Overall Study||23
6329025|NCT00508157|7235757|FG000|NOT COMPLETED|Overall Study||2
6329026|NCT00508157|7235758|FG001|NOT COMPLETED|Overall Study||3
6329027|NCT00508183|7235766|FG000|STARTED|Overall Study||48
6329028|NCT00508183|7235767|FG001|STARTED|Overall Study||42
6329029|NCT00508183|7235766|FG000|COMPLETED|Overall Study||39
6329030|NCT00508183|7235767|FG001|COMPLETED|Overall Study||34
6329031|NCT00508183|7235766|FG000|NOT COMPLETED|Overall Study||9
6329032|NCT00508183|7235767|FG001|NOT COMPLETED|Overall Study||8
6329033|NCT00508196|7235773|FG000|STARTED|Overall Study||11
6329034|NCT00508196|7235774|FG001|STARTED|Overall Study||11
6329035|NCT00508196|7235773|FG000|COMPLETED|Overall Study||11
6329036|NCT00508196|7235774|FG001|COMPLETED|Overall Study||11
6329037|NCT00508196|7235773|FG000|NOT COMPLETED|Overall Study||0
6329038|NCT00508196|7235774|FG001|NOT COMPLETED|Overall Study||0
6329039|NCT00508261|7235784|FG000|STARTED|Overall Study||222
6329040|NCT00508261|7235785|FG001|STARTED|Overall Study||220
6329041|NCT00508261|7235786|FG002|STARTED|Overall Study||224
6329042|NCT00508261|7235787|FG003|STARTED|Overall Study||127
6329043|NCT00508261|7235784|FG000|COMPLETED|Overall Study||219
6329044|NCT00508261|7235785|FG001|COMPLETED|Overall Study||212
6329045|NCT00508261|7235786|FG002|COMPLETED|Overall Study||218
6329046|NCT00508261|7235787|FG003|COMPLETED|Overall Study||126
6329047|NCT00508261|7235784|FG000|NOT COMPLETED|Overall Study||3
6329048|NCT00508261|7235785|FG001|NOT COMPLETED|Overall Study||8
6329049|NCT00508261|7235786|FG002|NOT COMPLETED|Overall Study||6
6329050|NCT00508261|7235787|FG003|NOT COMPLETED|Overall Study||1
6329051|NCT00508274|7235801|FG000|STARTED|Overall Study||52
6329052|NCT00508274|7235801|FG000|COMPLETED|Overall Study||2
6329053|NCT00508274|7235801|FG000|NOT COMPLETED|Overall Study||50
6329054|NCT00508300|7235807|FG000|STARTED|Overall Study||67
6329055|NCT00508300|7235808|FG001|STARTED|Overall Study||61
6329056|NCT00508300|7235807|FG000|COMPLETED|Overall Study||65
6329057|NCT00508300|7235808|FG001|COMPLETED|Overall Study||57
6329058|NCT00508300|7235807|FG000|NOT COMPLETED|Overall Study||2
6329059|NCT00508300|7235808|FG001|NOT COMPLETED|Overall Study||4
6329060|NCT00508391|7235816|FG000|STARTED|First Treatment||60
6329061|NCT00508391|7235817|FG001|STARTED|First Treatment||62
6329062|NCT00508391|7235816|FG000|COMPLETED|First Treatment||54
6329063|NCT00508391|7235817|FG001|COMPLETED|First Treatment||59
6329064|NCT00508391|7235816|FG000|NOT COMPLETED|First Treatment||6
6329065|NCT00508391|7235817|FG001|NOT COMPLETED|First Treatment||3
6329066|NCT00508391|7235816|FG000|STARTED|Second Treatment||54
6329067|NCT00508391|7235817|FG001|STARTED|Second Treatment||59
6329068|NCT00508391|7235816|FG000|COMPLETED|Second Treatment||52
6329069|NCT00508391|7235817|FG001|COMPLETED|Second Treatment||59
6329070|NCT00508391|7235816|FG000|NOT COMPLETED|Second Treatment||2
6329071|NCT00508391|7235817|FG001|NOT COMPLETED|Second Treatment||0
6329072|NCT00508404|7235825|FG000|STARTED|Overall Study||154
6329073|NCT00508404|7235825|FG000|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
6329074|NCT00508404|7235825|FG000|NOT COMPLETED|Overall Study||42
6329075|NCT00508469|7235832|FG000|STARTED|Overall Study||52
6329076|NCT00508469|7235833|FG001|STARTED|Overall Study||50
6329077|NCT00508469|7235832|FG000|COMPLETED|Overall Study||35
6329078|NCT00508469|7235833|FG001|COMPLETED|Overall Study||40
6329079|NCT00508469|7235832|FG000|NOT COMPLETED|Overall Study||17
6329080|NCT00508469|7235833|FG001|NOT COMPLETED|Overall Study||10
6329081|NCT00508482|7235842|FG000|STARTED|Over 4 Weeks of Treatment||237
6329082|NCT00508482|7235843|FG001|STARTED|Over 4 Weeks of Treatment||119
6329083|NCT00508482|7235844|FG002|STARTED|Over 4 Weeks of Treatment||119
6329084|NCT00508482|7235842|FG000|COMPLETED|Over 4 Weeks of Treatment||216
6329085|NCT00508482|7235843|FG001|COMPLETED|Over 4 Weeks of Treatment||102
6329086|NCT00508482|7235844|FG002|COMPLETED|Over 4 Weeks of Treatment||99
6329087|NCT00508482|7235842|FG000|NOT COMPLETED|Over 4 Weeks of Treatment||21
6329088|NCT00508482|7235843|FG001|NOT COMPLETED|Over 4 Weeks of Treatment||17
6329089|NCT00508482|7235844|FG002|NOT COMPLETED|Over 4 Weeks of Treatment||20
6329090|NCT00508482|7235842|FG000|STARTED|at the 4th Week of Follow-up||216
6329091|NCT00508482|7235843|FG001|STARTED|at the 4th Week of Follow-up||102
6329092|NCT00508482|7235844|FG002|STARTED|at the 4th Week of Follow-up||99
6329093|NCT00508482|7235842|FG000|COMPLETED|at the 4th Week of Follow-up||196
6329094|NCT00508482|7235843|FG001|COMPLETED|at the 4th Week of Follow-up||96
6329095|NCT00508482|7235844|FG002|COMPLETED|at the 4th Week of Follow-up||98
6329096|NCT00508482|7235842|FG000|NOT COMPLETED|at the 4th Week of Follow-up||20
6329097|NCT00508482|7235843|FG001|NOT COMPLETED|at the 4th Week of Follow-up||6
6329098|NCT00508482|7235844|FG002|NOT COMPLETED|at the 4th Week of Follow-up||1
6329099|NCT00508482|7235842|FG000|STARTED|at the 12th Week of Follow-up||196
6329100|NCT00508482|7235843|FG001|STARTED|at the 12th Week of Follow-up||96
6329101|NCT00508482|7235844|FG002|STARTED|at the 12th Week of Follow-up||98
6329102|NCT00508482|7235842|FG000|COMPLETED|at the 12th Week of Follow-up||196
6329103|NCT00508482|7235843|FG001|COMPLETED|at the 12th Week of Follow-up||96
6329104|NCT00508482|7235844|FG002|COMPLETED|at the 12th Week of Follow-up||98
6329105|NCT00508482|7235842|FG000|NOT COMPLETED|at the 12th Week of Follow-up||0
6329106|NCT00508482|7235843|FG001|NOT COMPLETED|at the 12th Week of Follow-up||0
6329107|NCT00508482|7235844|FG002|NOT COMPLETED|at the 12th Week of Follow-up||0
6329108|NCT00508521|7235853|FG000|STARTED|Overall Study||4
6329109|NCT00508521|7235853|FG000|COMPLETED|Overall Study||4
6329110|NCT00508521|7235853|FG000|NOT COMPLETED|Overall Study||0
6329111|NCT00508651|7235859|FG000|STARTED|Overall Study||20
6329112|NCT00508651|7235860|FG001|STARTED|Overall Study||10
6329113|NCT00508651|7235859|FG000|COMPLETED|Overall Study||16
6329114|NCT00508651|7235860|FG001|COMPLETED|Overall Study||8
6329115|NCT00508651|7235859|FG000|NOT COMPLETED|Overall Study||4
6329116|NCT00508651|7235860|FG001|NOT COMPLETED|Overall Study||2
6329117|NCT00508716|7235868|FG000|STARTED|Overall Study||61
6329118|NCT00508716|7235869|FG001|STARTED|Overall Study||63
6329119|NCT00508716|7235868|FG000|COMPLETED|Overall Study||61
6329120|NCT00508716|7235869|FG001|COMPLETED|Overall Study||63
6329121|NCT00508716|7235868|FG000|NOT COMPLETED|Overall Study||0
6329122|NCT00508716|7235869|FG001|NOT COMPLETED|Overall Study||0
6329123|NCT00508742|7235877|FG000|STARTED|Period 1: Infant Series||932
6329124|NCT00508742|7235878|FG001|STARTED|Period 1: Infant Series||934
6329125|NCT00508742|7235877|FG000|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
6329126|NCT00508742|7235878|FG001|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
6329127|NCT00508742|7235877|FG000|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
6329128|NCT00508742|7235878|FG001|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
6329129|NCT00508742|7235877|FG000|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
6329130|NCT00508742|7235878|FG001|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
6329131|NCT00508742|7235877|FG000|COMPLETED|Period 1: Infant Series||890
6329132|NCT00508742|7235878|FG001|COMPLETED|Period 1: Infant Series||889
6329133|NCT00508742|7235877|FG000|NOT COMPLETED|Period 1: Infant Series||42
6329134|NCT00508742|7235878|FG001|NOT COMPLETED|Period 1: Infant Series||45
6329135|NCT00508742|7235877|FG000|STARTED|Period 2: After Infant Series||890
6329136|NCT00508742|7235878|FG001|STARTED|Period 2: After Infant Series||889
6329137|NCT00508742|7235877|FG000|COMPLETED|Period 2: After Infant Series||883
6329138|NCT00508742|7235878|FG001|COMPLETED|Period 2: After Infant Series||878
6329139|NCT00508742|7235877|FG000|NOT COMPLETED|Period 2: After Infant Series||7
6329140|NCT00508742|7235878|FG001|NOT COMPLETED|Period 2: After Infant Series||11
6329141|NCT00508742|7235877|FG000|STARTED|Period 3: Toddler Dose||883
6329142|NCT00508742|7235878|FG001|STARTED|Period 3: Toddler Dose||878
6329143|NCT00508742|7235877|FG000|COMPLETED|Period 3: Toddler Dose||858
6329144|NCT00508742|7235878|FG001|COMPLETED|Period 3: Toddler Dose||863
6329145|NCT00508742|7235877|FG000|NOT COMPLETED|Period 3: Toddler Dose||25
6329146|NCT00508742|7235878|FG001|NOT COMPLETED|Period 3: Toddler Dose||15
6329147|NCT00508755|7235890|FG000|STARTED|Overall Study||6
6329148|NCT00508755|7235890|FG000|COMPLETED|Overall Study||5
6329149|NCT00508755|7235890|FG000|NOT COMPLETED|Overall Study||1
6329150|NCT00508820|7235898|FG000|STARTED|Overall Study||168
6329151|NCT00508820|7235899|FG001|STARTED|Overall Study||239
6329152|NCT00508820|7235898|FG000|COMPLETED|Overall Study||113
6329153|NCT00508820|7235899|FG001|COMPLETED|Overall Study||175
6329154|NCT00508820|7235898|FG000|NOT COMPLETED|Overall Study||55
6329155|NCT00508820|7235899|FG001|NOT COMPLETED|Overall Study||64
6329156|NCT00508924|7235909|FG000|STARTED|Overall Study||36
6329157|NCT00508924|7235910|FG001|STARTED|Overall Study||38
6329158|NCT00508924|7235911|FG002|STARTED|Overall Study||32
6329159|NCT00508924|7235912|FG003|STARTED|Overall Study||34
6329160|NCT00508924|7235909|FG000|COMPLETED|Overall Study||36
6329161|NCT00508924|7235910|FG001|COMPLETED|Overall Study||38
6329162|NCT00508924|7235911|FG002|COMPLETED|Overall Study||31
6329163|NCT00508924|7235912|FG003|COMPLETED|Overall Study||33
6329164|NCT00508924|7235909|FG000|NOT COMPLETED|Overall Study||0
6329165|NCT00508924|7235910|FG001|NOT COMPLETED|Overall Study||0
6329166|NCT00508924|7235911|FG002|NOT COMPLETED|Overall Study||1
6329167|NCT00508924|7235912|FG003|NOT COMPLETED|Overall Study||1
6329168|NCT00509002|7235922|FG000|STARTED|Overall Study||37
6329169|NCT00509002|7235922|FG000|COMPLETED|Overall Study||37
6329170|NCT00509002|7235922|FG000|NOT COMPLETED|Overall Study||0
6329171|NCT00509028|7235928|FG000|STARTED|Overall Study||121
6329172|NCT00509028|7235929|FG001|STARTED|Overall Study||120
6329173|NCT00509028|7235928|FG000|COMPLETED|Overall Study||109
6329174|NCT00509028|7235929|FG001|COMPLETED|Overall Study||113
6329175|NCT00509028|7235928|FG000|NOT COMPLETED|Overall Study||12
6329176|NCT00509028|7235929|FG001|NOT COMPLETED|Overall Study||7
6329177|NCT00509041|7235935|FG000|STARTED|Overall Study||43
6329178|NCT00509041|7235935|FG000|COMPLETED|Overall Study||43
6329179|NCT00509041|7235935|FG000|NOT COMPLETED|Overall Study||0
6329180|NCT00509067|7235941|FG000|STARTED|Overall Study||19
6329181|NCT00509067|7235942|FG001|STARTED|Overall Study||24
6329182|NCT00509067|7235941|FG000|COMPLETED|Overall Study||15
6329183|NCT00509067|7235942|FG001|COMPLETED|Overall Study||19
6329184|NCT00509067|7235941|FG000|NOT COMPLETED|Overall Study||4
6329185|NCT00509067|7235942|FG001|NOT COMPLETED|Overall Study||5
6329186|NCT00509093|7235952|FG000|STARTED|Overall Study||32
6329187|NCT00509093|7235952|FG000|COMPLETED|Overall Study||8
6329188|NCT00509093|7235952|FG000|NOT COMPLETED|Overall Study||24
6329189|NCT00509106|7235958|FG000|STARTED|Overall Study||315
6329190|NCT00509106|7235959|FG001|STARTED|Overall Study||307
6329191|NCT00509106|7235958|FG000|COMPLETED|Overall Study||284
6329192|NCT00509106|7235959|FG001|COMPLETED|Overall Study||278
6329193|NCT00509106|7235958|FG000|NOT COMPLETED|Overall Study||31
6329194|NCT00509106|7235959|FG001|NOT COMPLETED|Overall Study||29
6329195|NCT00509145|7235967|FG000|STARTED|Overall Study||550
6329196|NCT00509145|7235968|FG001|STARTED|Overall Study||556
6329197|NCT00509145|7235967|FG000|COMPLETED|Overall Study||437
6329198|NCT00509145|7235968|FG001|COMPLETED|Overall Study||427
6329199|NCT00509145|7235967|FG000|NOT COMPLETED|Overall Study||113
6329200|NCT00509145|7235968|FG001|NOT COMPLETED|Overall Study||129
6329201|NCT00509171|7235976|FG000|STARTED|Overall Study||11
6329202|NCT00509171|7235977|FG001|STARTED|Overall Study||11
6329203|NCT00509171|7235976|FG000|COMPLETED|Overall Study||11
6329204|NCT00509171|7235977|FG001|COMPLETED|Overall Study||11
6329205|NCT00509171|7235976|FG000|NOT COMPLETED|Overall Study||0
6329206|NCT00509171|7235977|FG001|NOT COMPLETED|Overall Study||0
6329207|NCT00509197|7235985|FG000|STARTED|Overall Study||6
6329208|NCT00509197|7235986|FG001|STARTED|Overall Study||6
6329209|NCT00509197|7235985|FG000|COMPLETED|Overall Study||6
6329210|NCT00509197|7235986|FG001|COMPLETED|Overall Study||6
6329211|NCT00509197|7235985|FG000|NOT COMPLETED|Overall Study||0
6329212|NCT00509197|7235986|FG001|NOT COMPLETED|Overall Study||0
6329213|NCT00509223|7235996|FG000|STARTED|Overall Study||207
6329214|NCT00509223|7235997|FG001|STARTED|Overall Study||209
6329215|NCT00509223|7235996|FG000|COMPLETED|Overall Study||119
6329216|NCT00509223|7235997|FG001|COMPLETED|Overall Study||137
6329217|NCT00509223|7235996|FG000|NOT COMPLETED|Overall Study||88
6558540|NCT01775410|7481095|FG000|STARTED|Overall Study||4
6558541|NCT01775410|7481095|FG000|COMPLETED|Overall Study||4
6558542|NCT01775410|7481095|FG000|NOT COMPLETED|Overall Study||0
6558543|NCT01775501|7481099|FG000|STARTED|Overall Study||40
6329218|NCT00509223|7235997|FG001|NOT COMPLETED|Overall Study||72
6329219|NCT00509236|7236005|FG000|STARTED|Overall Study||64
6329220|NCT00509236|7236006|FG001|STARTED|Overall Study||65
6329221|NCT00509236|7236005|FG000|COMPLETED|Overall Study||47
6329222|NCT00509236|7236006|FG001|COMPLETED|Overall Study||45
6329223|NCT00509236|7236005|FG000|NOT COMPLETED|Overall Study||17
6329224|NCT00509236|7236006|FG001|NOT COMPLETED|Overall Study||20
6329225|NCT00509249|7236012|FG000|STARTED|Overall Study||18
6329226|NCT00509249|7236012|FG000|COMPLETED|Overall Study||18
6329227|NCT00509249|7236012|FG000|NOT COMPLETED|Overall Study||0
6329228|NCT00509262|7236018|FG000|STARTED|Overall Study||211
6329229|NCT00509262|7236019|FG001|STARTED|Overall Study||212
6329230|NCT00509262|7236018|FG000|COMPLETED|Overall Study||164
6329231|NCT00509262|7236019|FG001|COMPLETED|Overall Study||170
6329232|NCT00509262|7236018|FG000|NOT COMPLETED|Overall Study||47
6329233|NCT00509262|7236019|FG001|NOT COMPLETED|Overall Study||42
6558544|NCT01775501|7481099|FG000|COMPLETED|Overall Study||39
6558545|NCT01775501|7481099|FG000|NOT COMPLETED|Overall Study||1
6558546|NCT01775553|7481103|FG000|STARTED|Overall Study||13
6558547|NCT01775553|7481103|FG000|COMPLETED|Overall Study||0
6329234|NCT00509288|7236027|FG000|STARTED|Overall Study||21
6329235|NCT00509288|7236028|FG001|STARTED|Overall Study||3
6329236|NCT00509288|7236027|FG000|COMPLETED|Overall Study||21
6329237|NCT00509288|7236028|FG001|COMPLETED|Overall Study||3
6329238|NCT00509288|7236027|FG000|NOT COMPLETED|Overall Study||0
6329239|NCT00509288|7236028|FG001|NOT COMPLETED|Overall Study||0
6329240|NCT00509366|7236039|FG000|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
6329241|NCT00509366|7236040|FG001|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
6329242|NCT00509366|7236041|FG002|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
6329243|NCT00509366|7236042|FG003|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
6329244|NCT00509366|7236043|FG004|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
6329245|NCT00509366|7236039|FG000|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
6329246|NCT00509366|7236040|FG001|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
6329247|NCT00509366|7236041|FG002|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
6329248|NCT00509366|7236042|FG003|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
6329249|NCT00509366|7236043|FG004|Assigned Treatment|Overall Study||0
6329250|NCT00509366|7236039|FG000|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
6329251|NCT00509366|7236040|FG001|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
6329252|NCT00509366|7236041|FG002|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
6329253|NCT00509366|7236042|FG003|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
6329254|NCT00509366|7236043|FG004|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
6329255|NCT00509366|7236039|FG000|NOT COMPLETED|Overall Study||1
6329256|NCT00509366|7236040|FG001|NOT COMPLETED|Overall Study||1
6329257|NCT00509366|7236041|FG002|NOT COMPLETED|Overall Study||1
6329258|NCT00509366|7236042|FG003|NOT COMPLETED|Overall Study||0
6329259|NCT00509366|7236043|FG004|NOT COMPLETED|Overall Study||0
6329260|NCT00509392|7236055|FG000|STARTED|Overall Study||32
6329261|NCT00509392|7236056|FG001|STARTED|Overall Study||33
6329262|NCT00509392|7236057|FG002|STARTED|Overall Study||4
6329263|NCT00509392|7236055|FG000|COMPLETED|Overall Study||32
6329264|NCT00509392|7236056|FG001|COMPLETED|Overall Study||33
6329265|NCT00509392|7236057|FG002|COMPLETED|Overall Study||4
6329266|NCT00509392|7236055|FG000|NOT COMPLETED|Overall Study||0
6329267|NCT00509392|7236056|FG001|NOT COMPLETED|Overall Study||0
6329268|NCT00509392|7236057|FG002|NOT COMPLETED|Overall Study||0
6329269|NCT00509496|7236065|FG000|STARTED|Overall Study||19
6329270|NCT00509496|7236066|FG001|STARTED|Overall Study||2
6329271|NCT00509496|7236065|FG000|COMPLETED|Overall Study||19
6329272|NCT00509496|7236066|FG001|COMPLETED|Overall Study||2
6329273|NCT00509496|7236065|FG000|NOT COMPLETED|Overall Study||0
6329274|NCT00509496|7236066|FG001|NOT COMPLETED|Overall Study||0
6329275|NCT00509587|7236072|FG000|STARTED|Overall Study||21
6329276|NCT00509587|7236072|FG000|COMPLETED|Overall Study||21
6329277|NCT00509587|7236072|FG000|NOT COMPLETED|Overall Study||0
6329278|NCT00509665|7236076|FG000|STARTED|Overall Study||18
6329279|NCT00509665|7236076|FG000|COMPLETED|Overall Study||18
6329280|NCT00509665|7236076|FG000|NOT COMPLETED|Overall Study||0
6329281|NCT00509769|7236080|FG000|STARTED|Overall Study||112
6329282|NCT00509769|7236080|FG000|COMPLETED|Overall Study||21
6329283|NCT00509769|7236080|FG000|NOT COMPLETED|Overall Study||91
6329284|NCT00509795|7236088|FG000|STARTED|Overall Study||306
6329285|NCT00509795|7236089|FG001|STARTED|Overall Study||304
6329286|NCT00509795|7236090|FG002|STARTED|Overall Study||304
6329287|NCT00509795|7236091|FG003|STARTED|Overall Study||303
6329288|NCT00509795|7236088|FG000|Patients Received Treatment (SAF)|Overall Study||304
6558548|NCT01775553|7481103|FG000|NOT COMPLETED|Overall Study||13
6558549|NCT01775670|7481109|FG000|STARTED|Overall Study||1
6329289|NCT00509795|7236089|FG001|Patients Received Treatment (SAF)|Overall Study||304
6329290|NCT00509795|7236090|FG002|Patients Received Treatment (SAF)|Overall Study||304
6329291|NCT00509795|7236091|FG003|Patients Received Treatment (SAF)|Overall Study||303
6329292|NCT00509795|7236088|FG000|Full Analysis Set (FAS) Population|Overall Study||304
6329293|NCT00509795|7236089|FG001|Full Analysis Set (FAS) Population|Overall Study||304
6329294|NCT00509795|7236090|FG002|Full Analysis Set (FAS) Population|Overall Study||301
6329295|NCT00509795|7236091|FG003|Full Analysis Set (FAS) Population|Overall Study||301
6329296|NCT00509795|7236088|FG000|Per Protocol Set (PPS) Population|Overall Study||269
6329297|NCT00509795|7236089|FG001|Per Protocol Set (PPS) Population|Overall Study||285
6329298|NCT00509795|7236090|FG002|Per Protocol Set (PPS) Population|Overall Study||270
6329299|NCT00509795|7236091|FG003|Per Protocol Set (PPS) Population|Overall Study||265
6329300|NCT00509795|7236088|FG000|COMPLETED|Overall Study||284
6329301|NCT00509795|7236089|FG001|COMPLETED|Overall Study||293
6329302|NCT00509795|7236090|FG002|COMPLETED|Overall Study||277
6329303|NCT00509795|7236091|FG003|COMPLETED|Overall Study||276
6329304|NCT00509795|7236088|FG000|NOT COMPLETED|Overall Study||22
6329305|NCT00509795|7236089|FG001|NOT COMPLETED|Overall Study||11
6329306|NCT00509795|7236090|FG002|NOT COMPLETED|Overall Study||27
6329307|NCT00509795|7236091|FG003|NOT COMPLETED|Overall Study||27
6329308|NCT00509821|7236104|FG000|STARTED|Study Period 1 (Induction)||3
6558550|NCT01775670|7481110|FG001|STARTED|Overall Study||3
6329309|NCT00509821|7236105|FG001|STARTED|Study Period 1 (Induction)||57
6329310|NCT00509821|7236104|FG000|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||3
6329311|NCT00509821|7236105|FG001|Received at Least 1 Dose of Study Drug|Study Period 1 (Induction)||57
6329312|NCT00509821|7236104|FG000|COMPLETED|Study Period 1 (Induction)||3
6329313|NCT00509821|7236105|FG001|COMPLETED|Study Period 1 (Induction)||53
6329314|NCT00509821|7236104|FG000|NOT COMPLETED|Study Period 1 (Induction)||0
6329315|NCT00509821|7236105|FG001|NOT COMPLETED|Study Period 1 (Induction)||4
6329316|NCT00509821|7236104|FG000|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|3
6329317|NCT00509821|7236105|FG001|STARTED|Study Period 2 (Radiation)|Participants moved to Radiation Phase.|53
6329318|NCT00509821|7236104|FG000|COMPLETED|Study Period 2 (Radiation)||3
6329319|NCT00509821|7236105|FG001|COMPLETED|Study Period 2 (Radiation)||0
6329320|NCT00509821|7236104|FG000|NOT COMPLETED|Study Period 2 (Radiation)||0
6329321|NCT00509821|7236105|FG001|NOT COMPLETED|Study Period 2 (Radiation)||53
6329322|NCT00509821|7236104|FG000|STARTED|Study Period 3 (Maintenance)||3
6329323|NCT00509821|7236105|FG001|STARTED|Study Period 3 (Maintenance)|4 participants completed Radiation Phase but did not enter Maintenance Phase.|49
6329324|NCT00509821|7236104|FG000|COMPLETED|Study Period 3 (Maintenance)||3
6329325|NCT00509821|7236105|FG001|COMPLETED|Study Period 3 (Maintenance)||0
6329326|NCT00509821|7236104|FG000|NOT COMPLETED|Study Period 3 (Maintenance)||0
6329327|NCT00509821|7236105|FG001|NOT COMPLETED|Study Period 3 (Maintenance)||49
6329328|NCT00509821|7236104|FG000|STARTED|Study Period 4 (Follow Up)|1 Participant completed Maintenance Phase but did not enter Follow-Up.|2
6329329|NCT00509821|7236105|FG001|STARTED|Study Period 4 (Follow Up)|1 Participant completed Radiation Phase, did not enter Maintenance Phase but entered Follow Up.|50
6329330|NCT00509821|7236104|FG000|COMPLETED|Study Period 4 (Follow Up)||2
6329331|NCT00509821|7236105|FG001|COMPLETED|Study Period 4 (Follow Up)||50
6329332|NCT00509821|7236104|FG000|NOT COMPLETED|Study Period 4 (Follow Up)||0
6329333|NCT00509821|7236105|FG001|NOT COMPLETED|Study Period 4 (Follow Up)||0
6329334|NCT00509873|7236118|FG000|STARTED|Overall Study||287
6329335|NCT00509873|7236119|FG001|STARTED|Overall Study||291
6329336|NCT00509873|7236118|FG000|COMPLETED|Overall Study||276
6329337|NCT00509873|7236119|FG001|COMPLETED|Overall Study||276
6329338|NCT00509873|7236118|FG000|NOT COMPLETED|Overall Study||11
6329339|NCT00509873|7236119|FG001|NOT COMPLETED|Overall Study||15
6329340|NCT00509899|7236133|FG000|STARTED|Overall Study||30
6329341|NCT00509899|7236134|FG001|STARTED|Overall Study||35
6329342|NCT00509899|7236135|FG002|STARTED|Overall Study||47
6329343|NCT00509899|7236136|FG003|STARTED|Overall Study||5
6329344|NCT00509899|7236137|FG004|STARTED|Overall Study||6
6329345|NCT00509899|7236138|FG005|STARTED|Overall Study||22
6329346|NCT00509899|7236139|FG006|STARTED|Overall Study||6
6329347|NCT00509899|7236140|FG007|STARTED|Overall Study||3
6329348|NCT00509899|7236133|FG000|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
6329349|NCT00509899|7236134|FG001|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
6329350|NCT00509899|7236135|FG002|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
6329351|NCT00509899|7236136|FG003|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
6329352|NCT00509899|7236137|FG004|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
6329353|NCT00509899|7236138|FG005|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
6329354|NCT00509899|7236139|FG006|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
6329355|NCT00509899|7236140|FG007|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
6329356|NCT00509899|7236133|FG000|NOT COMPLETED|Overall Study||16
6329357|NCT00509899|7236134|FG001|NOT COMPLETED|Overall Study||9
6329358|NCT00509899|7236135|FG002|NOT COMPLETED|Overall Study||20
6329359|NCT00509899|7236136|FG003|NOT COMPLETED|Overall Study||4
6329360|NCT00509899|7236137|FG004|NOT COMPLETED|Overall Study||5
6329361|NCT00509899|7236138|FG005|NOT COMPLETED|Overall Study||10
6329362|NCT00509899|7236139|FG006|NOT COMPLETED|Overall Study||1
6329363|NCT00509899|7236140|FG007|NOT COMPLETED|Overall Study||1
6329364|NCT00509925|7236154|FG000|STARTED|Overall Study||12
6329365|NCT00509925|7236155|FG001|STARTED|Overall Study||11
6329366|NCT00509925|7236154|FG000|COMPLETED|Overall Study||12
6329367|NCT00509925|7236155|FG001|COMPLETED|Overall Study||10
6329368|NCT00509925|7236154|FG000|NOT COMPLETED|Overall Study||0
6329369|NCT00509925|7236155|FG001|NOT COMPLETED|Overall Study||1
6329370|NCT00510068|7236165|FG000|STARTED|Double-blind Period||207
6329371|NCT00510068|7236166|FG001|STARTED|Double-blind Period||203
6329372|NCT00510068|7236165|FG000|Safety Population|Double-blind Period||204
6329373|NCT00510068|7236166|FG001|Safety Population|Double-blind Period||203
6329374|NCT00510068|7236165|FG000|COMPLETED|Double-blind Period||0
6329375|NCT00510068|7236166|FG001|COMPLETED|Double-blind Period||0
6329376|NCT00510068|7236165|FG000|NOT COMPLETED|Double-blind Period||207
6329377|NCT00510068|7236166|FG001|NOT COMPLETED|Double-blind Period||203
6376026|NCT00758459|7286539|FG000|COMPLETED|Overall Study||32
6558551|NCT01775670|7481109|FG000|COMPLETED|Overall Study||0
6558552|NCT01775670|7481110|FG001|COMPLETED|Overall Study||2
6558553|NCT01775670|7481109|FG000|NOT COMPLETED|Overall Study||1
6558554|NCT01775670|7481110|FG001|NOT COMPLETED|Overall Study||1
6558555|NCT01775722|7481116|FG000|STARTED|Overall Study||22
6558556|NCT01775722|7481116|FG000|COMPLETED|Overall Study||20
6558557|NCT01775722|7481116|FG000|NOT COMPLETED|Overall Study||2
6558558|NCT01775735|7481124|FG000|STARTED|Intervention (6 Months)||8
6558559|NCT01775735|7481125|FG001|STARTED|Intervention (6 Months)||7
6558560|NCT01775735|7481124|FG000|COMPLETED|Intervention (6 Months)||8
6558561|NCT01775735|7481125|FG001|COMPLETED|Intervention (6 Months)||7
6558562|NCT01775735|7481124|FG000|NOT COMPLETED|Intervention (6 Months)||0
6558563|NCT01775735|7481125|FG001|NOT COMPLETED|Intervention (6 Months)||0
6558564|NCT01775735|7481124|FG000|STARTED|Open Label (24 Months)||8
6558565|NCT01775735|7481125|FG001|STARTED|Open Label (24 Months)||7
6558566|NCT01775735|7481124|FG000|COMPLETED|Open Label (24 Months)||7
6558567|NCT01775735|7481125|FG001|COMPLETED|Open Label (24 Months)||3
6558568|NCT01775735|7481124|FG000|NOT COMPLETED|Open Label (24 Months)||1
6558569|NCT01775735|7481125|FG001|NOT COMPLETED|Open Label (24 Months)||4
6558570|NCT01775774|7481134|FG000|STARTED|Overall Study||3
6558571|NCT01775774|7481135|FG001|STARTED|Overall Study||3
6558572|NCT01775774|7481136|FG002|STARTED|Overall Study||3
6558573|NCT01775774|7481134|FG000|COMPLETED|Overall Study||3
6558574|NCT01775774|7481135|FG001|COMPLETED|Overall Study||3
6558575|NCT01775774|7481136|FG002|COMPLETED|Overall Study||3
6558576|NCT01775774|7481134|FG000|NOT COMPLETED|Overall Study||0
6558577|NCT01775774|7481135|FG001|NOT COMPLETED|Overall Study||0
6558578|NCT01775774|7481136|FG002|NOT COMPLETED|Overall Study||0
6558579|NCT01775787|7481144|FG000|STARTED|First 7-10 Days||13
6558580|NCT01775787|7481145|FG001|STARTED|First 7-10 Days||14
6329378|NCT00510068|7236165|FG000|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
6329379|NCT00510068|7236166|FG001|STARTED|Open-label Period||0
6329380|NCT00510068|7236165|FG000|COMPLETED|Open-label Period||0
6558581|NCT01775787|7481144|FG000|COMPLETED|First 7-10 Days||12
6558582|NCT01775787|7481145|FG001|COMPLETED|First 7-10 Days||8
6558583|NCT01775787|7481144|FG000|NOT COMPLETED|First 7-10 Days||1
6558584|NCT01775787|7481145|FG001|NOT COMPLETED|First 7-10 Days||6
6558585|NCT01775787|7481144|FG000|STARTED|Second 7-10 Days||12
6558586|NCT01775787|7481145|FG001|STARTED|Second 7-10 Days||8
6558587|NCT01775787|7481144|FG000|COMPLETED|Second 7-10 Days||12
6558588|NCT01775787|7481145|FG001|COMPLETED|Second 7-10 Days||6
6558589|NCT01775787|7481144|FG000|NOT COMPLETED|Second 7-10 Days||0
6329381|NCT00510068|7236166|FG001|COMPLETED|Open-label Period||0
6329382|NCT00510068|7236165|FG000|NOT COMPLETED|Open-label Period||225
6329383|NCT00510068|7236166|FG001|NOT COMPLETED|Open-label Period||0
6329384|NCT00510146|7236176|FG000|STARTED|Double-Blind Treatment||343
6329385|NCT00510146|7236177|FG001|STARTED|Double-Blind Treatment||171
6329386|NCT00510146|7236176|FG000|COMPLETED|Double-Blind Treatment||267
6329387|NCT00510146|7236177|FG001|COMPLETED|Double-Blind Treatment||122
6329388|NCT00510146|7236176|FG000|NOT COMPLETED|Double-Blind Treatment||76
6329389|NCT00510146|7236177|FG001|NOT COMPLETED|Double-Blind Treatment||49
6329390|NCT00510146|7236176|FG000|STARTED|Open-Label Treatment||267
6329391|NCT00510146|7236177|FG001|STARTED|Open-Label Treatment||122
6329392|NCT00510146|7236176|FG000|COMPLETED|Open-Label Treatment||196
6329393|NCT00510146|7236177|FG001|COMPLETED|Open-Label Treatment||96
6329394|NCT00510146|7236176|FG000|NOT COMPLETED|Open-Label Treatment||71
6329395|NCT00510146|7236177|FG001|NOT COMPLETED|Open-Label Treatment||26
6329396|NCT00510198|7236187|FG000|STARTED|Overall Study||59
6329397|NCT00510198|7236188|FG001|STARTED|Overall Study||58
6329398|NCT00510198|7236187|FG000|COMPLETED|Overall Study||54
6329399|NCT00510198|7236188|FG001|COMPLETED|Overall Study||54
6329400|NCT00510198|7236187|FG000|NOT COMPLETED|Overall Study||5
6329401|NCT00510198|7236188|FG001|NOT COMPLETED|Overall Study||4
6329402|NCT00510224|7236196|FG000|STARTED|Overall Study||13
6329403|NCT00510224|7236196|FG000|COMPLETED|Overall Study||10
6329404|NCT00510224|7236196|FG000|NOT COMPLETED|Overall Study||3
6329405|NCT00510276|7236202|FG000|STARTED|Acute Double-Blind Phase||220
6329406|NCT00510276|7236203|FG001|STARTED|Acute Double-Blind Phase||225
6329407|NCT00510276|7236202|FG000|COMPLETED|Acute Double-Blind Phase||115
6329408|NCT00510276|7236203|FG001|COMPLETED|Acute Double-Blind Phase||130
6329409|NCT00510276|7236202|FG000|NOT COMPLETED|Acute Double-Blind Phase||105
6329410|NCT00510276|7236203|FG001|NOT COMPLETED|Acute Double-Blind Phase||95
6329411|NCT00510276|7236202|FG000|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
6329412|NCT00510276|7236203|FG001|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
6329413|NCT00510276|7236202|FG000|COMPLETED|Extension Open-Label Phase||78
6329414|NCT00510276|7236203|FG001|COMPLETED|Extension Open-Label Phase||81
6329415|NCT00510276|7236202|FG000|NOT COMPLETED|Extension Open-Label Phase||33
6329416|NCT00510276|7236203|FG001|NOT COMPLETED|Extension Open-Label Phase||48
6329417|NCT00510289|7236216|FG000|STARTED|Overall Study|All patients who consented|19
6329418|NCT00510289|7236216|FG000|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
6376027|NCT00758459|7286540|FG001|COMPLETED|Overall Study||35
6558590|NCT01775787|7481145|FG001|NOT COMPLETED|Second 7-10 Days||2
6558591|NCT01775800|7481155|FG000|STARTED|Overall Study||8
6558592|NCT01775800|7481156|FG001|STARTED|Overall Study||8
6558593|NCT01775800|7481155|FG000|COMPLETED|Overall Study||8
6558594|NCT01775800|7481156|FG001|COMPLETED|Overall Study||8
6558595|NCT01775800|7481155|FG000|NOT COMPLETED|Overall Study||0
6558596|NCT01775800|7481156|FG001|NOT COMPLETED|Overall Study||0
6562862|NCT01803269|7485763|FG000|STARTED|Overall Study||7
6329419|NCT00510289|7236216|FG000|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
6329420|NCT00510289|7236216|FG000|NOT COMPLETED|Overall Study||12
6329421|NCT00510458|7236221|FG000|STARTED|Overall Study||74
6329422|NCT00510458|7236221|FG000|COMPLETED|Overall Study||27
6329423|NCT00510458|7236221|FG000|NOT COMPLETED|Overall Study||47
6329424|NCT00510484|7236228|FG000|STARTED|Period 1||16
6329425|NCT00510484|7236229|FG001|STARTED|Period 1||16
6329426|NCT00510484|7236228|FG000|COMPLETED|Period 1||16
6329427|NCT00510484|7236229|FG001|COMPLETED|Period 1||16
6329428|NCT00510484|7236228|FG000|NOT COMPLETED|Period 1||0
6329429|NCT00510484|7236229|FG001|NOT COMPLETED|Period 1||0
6329430|NCT00510484|7236228|FG000|STARTED|Wash-out Period||16
6329431|NCT00510484|7236229|FG001|STARTED|Wash-out Period||16
6329432|NCT00510484|7236228|FG000|COMPLETED|Wash-out Period||16
6329433|NCT00510484|7236229|FG001|COMPLETED|Wash-out Period||15
6329434|NCT00510484|7236228|FG000|NOT COMPLETED|Wash-out Period||0
6329435|NCT00510484|7236229|FG001|NOT COMPLETED|Wash-out Period||1
6329436|NCT00510484|7236228|FG000|STARTED|Period 2||16
6329437|NCT00510484|7236229|FG001|STARTED|Period 2||15
6329438|NCT00510484|7236228|FG000|COMPLETED|Period 2||16
6329439|NCT00510484|7236229|FG001|COMPLETED|Period 2||15
6329440|NCT00510484|7236228|FG000|NOT COMPLETED|Period 2||0
6329441|NCT00510484|7236229|FG001|NOT COMPLETED|Period 2||0
6329442|NCT00510497|7236235|FG000|STARTED|Overall Study||11
6329443|NCT00510497|7236235|FG000|COMPLETED|Overall Study||8
6329444|NCT00510497|7236235|FG000|NOT COMPLETED|Overall Study||3
6329445|NCT00510510|7236242|FG000|STARTED|Overall Study||92
6329446|NCT00510510|7236243|FG001|STARTED|Overall Study||98
6329447|NCT00510510|7236244|FG002|STARTED|Overall Study||91
6329448|NCT00510510|7236242|FG000|COMPLETED|Overall Study||87
6329449|NCT00510510|7236243|FG001|COMPLETED|Overall Study||89
6329450|NCT00510510|7236244|FG002|COMPLETED|Overall Study||74
6329451|NCT00510510|7236242|FG000|NOT COMPLETED|Overall Study||5
6329452|NCT00510510|7236243|FG001|NOT COMPLETED|Overall Study||9
6329453|NCT00510510|7236244|FG002|NOT COMPLETED|Overall Study||17
6329454|NCT00510653|7236252|FG000|STARTED|Overall Study||24
6329455|NCT00510653|7236252|FG000|COMPLETED|Overall Study||13
6329456|NCT00510653|7236252|FG000|NOT COMPLETED|Overall Study||11
6329457|NCT00510692|7236258|FG000|STARTED|Overall Study||29
6329458|NCT00510692|7236259|FG001|STARTED|Overall Study||29
6329459|NCT00510692|7236258|FG000|COMPLETED|Overall Study||27
6329460|NCT00510692|7236259|FG001|COMPLETED|Overall Study||26
6329461|NCT00510692|7236258|FG000|NOT COMPLETED|Overall Study||2
6329462|NCT00510692|7236259|FG001|NOT COMPLETED|Overall Study||3
6329463|NCT00510718|7236274|FG000|STARTED|Single Dose Period: 1 Week||15
6329464|NCT00510718|7236275|FG001|STARTED|Single Dose Period: 1 Week||12
6329465|NCT00510718|7236274|FG000|30 mg/Day|Single Dose Period: 1 Week||3
6329466|NCT00510718|7236275|FG001|30 mg/Day|Single Dose Period: 1 Week||0
6329467|NCT00510718|7236274|FG000|60 mg/Day|Single Dose Period: 1 Week||3
6329468|NCT00510718|7236275|FG001|60 mg/Day|Single Dose Period: 1 Week||0
6329469|NCT00510718|7236274|FG000|150/160 mg/Day|Single Dose Period: 1 Week||2
6329470|NCT00510718|7236275|FG001|150/160 mg/Day|Single Dose Period: 1 Week||1
6329471|NCT00510718|7236274|FG000|240 mg/Day|Single Dose Period: 1 Week||3
6329472|NCT00510718|7236275|FG001|240 mg/Day|Single Dose Period: 1 Week||0
6329473|NCT00510718|7236274|FG000|360 mg/Day|Single Dose Period: 1 Week||4
6329474|NCT00510718|7236275|FG001|360 mg/Day|Single Dose Period: 1 Week||2
6329475|NCT00510718|7236274|FG000|480 mg/Day|Single Dose Period: 1 Week||0
6329476|NCT00510718|7236275|FG001|480 mg/Day|Single Dose Period: 1 Week||6
6329477|NCT00510718|7236274|FG000|600 mg/Day|Single Dose Period: 1 Week||0
6329478|NCT00510718|7236275|FG001|600 mg/Day|Single Dose Period: 1 Week||3
6329479|NCT00510718|7236274|FG000|COMPLETED|Single Dose Period: 1 Week||15
6329480|NCT00510718|7236275|FG001|COMPLETED|Single Dose Period: 1 Week||12
6329481|NCT00510718|7236274|FG000|NOT COMPLETED|Single Dose Period: 1 Week||0
6329482|NCT00510718|7236275|FG001|NOT COMPLETED|Single Dose Period: 1 Week||0
6329483|NCT00510718|7236274|FG000|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|65
6329484|NCT00510718|7236275|FG001|STARTED|Multiple Dose Period: 12 Weeks|Participants who completed single dose period + new participants enrolled in multiple dose period.|75
6329485|NCT00510718|7236274|FG000|30 mg/Day|Multiple Dose Period: 12 Weeks||3
6329486|NCT00510718|7236275|FG001|30 mg/Day|Multiple Dose Period: 12 Weeks||0
6329487|NCT00510718|7236274|FG000|60 mg/Day|Multiple Dose Period: 12 Weeks||15
6329488|NCT00510718|7236275|FG001|60 mg/Day|Multiple Dose Period: 12 Weeks||12
6329489|NCT00510718|7236274|FG000|150/160 mg/Day|Multiple Dose Period: 12 Weeks||15
6329490|NCT00510718|7236275|FG001|150/160 mg/Day|Multiple Dose Period: 12 Weeks||13
6329491|NCT00510718|7236274|FG000|240 mg/Day|Multiple Dose Period: 12 Weeks||17
6329492|NCT00510718|7236275|FG001|240 mg/Day|Multiple Dose Period: 12 Weeks||12
6329493|NCT00510718|7236274|FG000|360 mg/Day|Multiple Dose Period: 12 Weeks||15
6329494|NCT00510718|7236275|FG001|360 mg/Day|Multiple Dose Period: 12 Weeks||13
6329495|NCT00510718|7236274|FG000|480 mg/Day|Multiple Dose Period: 12 Weeks||0
6329496|NCT00510718|7236275|FG001|480 mg/Day|Multiple Dose Period: 12 Weeks||22
6329497|NCT00510718|7236274|FG000|600 mg/Day|Multiple Dose Period: 12 Weeks||0
6329498|NCT00510718|7236275|FG001|600 mg/Day|Multiple Dose Period: 12 Weeks||3
6329499|NCT00510718|7236274|FG000|COMPLETED|Multiple Dose Period: 12 Weeks||50
6329500|NCT00510718|7236275|FG001|COMPLETED|Multiple Dose Period: 12 Weeks||43
6329501|NCT00510718|7236274|FG000|NOT COMPLETED|Multiple Dose Period: 12 Weeks||15
6329502|NCT00510718|7236275|FG001|NOT COMPLETED|Multiple Dose Period: 12 Weeks||32
6329503|NCT00510744|7236294|FG000|STARTED|Overall Study||5
6329504|NCT00510744|7236294|FG000|COMPLETED|Overall Study||5
6329505|NCT00510744|7236294|FG000|NOT COMPLETED|Overall Study||0
6329506|NCT00510783|7236300|FG000|STARTED|Overall Study||82
6329507|NCT00510783|7236301|FG001|STARTED|Overall Study||76
6329508|NCT00510783|7236300|FG000|COMPLETED|Overall Study||51
6329509|NCT00510783|7236301|FG001|COMPLETED|Overall Study||47
6329510|NCT00510783|7236300|FG000|NOT COMPLETED|Overall Study||31
6329511|NCT00510783|7236301|FG001|NOT COMPLETED|Overall Study||29
6329512|NCT00510809|7236310|FG000|STARTED|Overall Study||18
6329513|NCT00510809|7236311|FG001|STARTED|Overall Study||18
6329514|NCT00510809|7236312|FG002|STARTED|Overall Study||18
6329515|NCT00510809|7236310|FG000|COMPLETED|Overall Study||18
6329516|NCT00510809|7236311|FG001|COMPLETED|Overall Study||18
6329517|NCT00510809|7236312|FG002|COMPLETED|Overall Study||18
6329518|NCT00510809|7236310|FG000|NOT COMPLETED|Overall Study||0
6329519|NCT00510809|7236311|FG001|NOT COMPLETED|Overall Study||0
6329520|NCT00510809|7236312|FG002|NOT COMPLETED|Overall Study||0
6329521|NCT00510835|7236323|FG000|STARTED|Overall Study||445
6329522|NCT00510835|7236324|FG001|STARTED|Overall Study||448
6329523|NCT00510835|7236325|FG002|STARTED|Overall Study||458
6329524|NCT00510835|7236323|FG000|COMPLETED|Overall Study||439
6329525|NCT00510835|7236324|FG001|COMPLETED|Overall Study||446
6329526|NCT00510835|7236325|FG002|COMPLETED|Overall Study||456
6329527|NCT00510835|7236323|FG000|NOT COMPLETED|Overall Study||6
6329528|NCT00510835|7236324|FG001|NOT COMPLETED|Overall Study||2
6329529|NCT00510835|7236325|FG002|NOT COMPLETED|Overall Study||2
6329530|NCT00510874|7236340|FG000|STARTED|Overall Study||78
6329531|NCT00510874|7236341|FG001|STARTED|Overall Study||152
6329532|NCT00510874|7236342|FG002|STARTED|Overall Study||151
6329533|NCT00510874|7236343|FG003|STARTED|Overall Study||151
6329534|NCT00510874|7236344|FG004|STARTED|Overall Study||148
6329535|NCT00510874|7236345|FG005|STARTED|Overall Study||50
6329536|NCT00510874|7236346|FG006|STARTED|Overall Study||50
6329537|NCT00510874|7236340|FG000|COMPLETED|Overall Study|Upto Day 182|75
6329538|NCT00510874|7236341|FG001|COMPLETED|Overall Study|Upto Day 182|148
6329539|NCT00510874|7236342|FG002|COMPLETED|Overall Study|Upto Day 182|150
6329540|NCT00510874|7236343|FG003|COMPLETED|Overall Study|Upto Day 182|148
6329541|NCT00510874|7236344|FG004|COMPLETED|Overall Study|Upto Day 182|141
6329542|NCT00510874|7236345|FG005|COMPLETED|Overall Study|Upto Day 182|50
6329543|NCT00510874|7236346|FG006|COMPLETED|Overall Study|Upto Day 182|49
6329544|NCT00510874|7236340|FG000|NOT COMPLETED|Overall Study||3
6329545|NCT00510874|7236341|FG001|NOT COMPLETED|Overall Study||4
6329546|NCT00510874|7236342|FG002|NOT COMPLETED|Overall Study||1
6329547|NCT00510874|7236343|FG003|NOT COMPLETED|Overall Study||3
6329548|NCT00510874|7236344|FG004|NOT COMPLETED|Overall Study||7
6329549|NCT00510874|7236345|FG005|NOT COMPLETED|Overall Study||0
6329550|NCT00510874|7236346|FG006|NOT COMPLETED|Overall Study||1
6329551|NCT00510887|7236363|FG000|STARTED|Overall Study||12
6329552|NCT00510887|7236363|FG000|COMPLETED|Overall Study||11
6329553|NCT00510887|7236363|FG000|NOT COMPLETED|Overall Study||1
6329554|NCT00510952|7236369|FG000|STARTED|Overall Study||235
6329555|NCT00510952|7236370|FG001|STARTED|Overall Study||236
6329556|NCT00510952|7236369|FG000|Full Analysis Set (Intent to Treat)|Overall Study||229
6329557|NCT00510952|7236370|FG001|Full Analysis Set (Intent to Treat)|Overall Study||229
6329558|NCT00510952|7236369|FG000|COMPLETED|Overall Study||209
6329559|NCT00510952|7236370|FG001|COMPLETED|Overall Study||220
6329560|NCT00510952|7236369|FG000|NOT COMPLETED|Overall Study||26
6329561|NCT00510952|7236370|FG001|NOT COMPLETED|Overall Study||16
6329562|NCT00511004|7236379|FG000|STARTED|Overall Study||13
6329563|NCT00511004|7236380|FG001|STARTED|Overall Study||13
6329564|NCT00511004|7236381|FG002|STARTED|Overall Study||14
6329565|NCT00511004|7236379|FG000|COMPLETED|Overall Study||13
6329566|NCT00511004|7236380|FG001|COMPLETED|Overall Study||13
6329567|NCT00511004|7236381|FG002|COMPLETED|Overall Study||10
6329568|NCT00511004|7236379|FG000|NOT COMPLETED|Overall Study||0
6329569|NCT00511004|7236380|FG001|NOT COMPLETED|Overall Study||0
6329570|NCT00511004|7236381|FG002|NOT COMPLETED|Overall Study||4
6329571|NCT00511095|7236392|FG000|STARTED|Overall Study||207
6329572|NCT00511095|7236392|FG000|COMPLETED|Overall Study||196
6329573|NCT00511095|7236392|FG000|NOT COMPLETED|Overall Study||11
6329574|NCT00511108|7236406|FG000|STARTED|Overall Study||52
6329575|NCT00511108|7236407|FG001|STARTED|Overall Study||54
6329576|NCT00511108|7236408|FG002|STARTED|Overall Study||52
6329577|NCT00511108|7236409|FG003|STARTED|Overall Study||53
6329578|NCT00511108|7236406|FG000|COMPLETED|Overall Study||46
6329579|NCT00511108|7236407|FG001|COMPLETED|Overall Study||52
6329580|NCT00511108|7236408|FG002|COMPLETED|Overall Study||47
6329581|NCT00511108|7236409|FG003|COMPLETED|Overall Study||48
6329582|NCT00511108|7236406|FG000|NOT COMPLETED|Overall Study||6
6329583|NCT00511108|7236407|FG001|NOT COMPLETED|Overall Study||2
6329584|NCT00511108|7236408|FG002|NOT COMPLETED|Overall Study||5
6329585|NCT00511108|7236409|FG003|NOT COMPLETED|Overall Study||5
6329586|NCT00511134|7236421|FG000|STARTED|Overall Study||1
6329587|NCT00511134|7236422|FG001|STARTED|Overall Study||3
6329588|NCT00511134|7236421|FG000|COMPLETED|Overall Study||1
6329589|NCT00511134|7236422|FG001|COMPLETED|Overall Study||1
6329590|NCT00511134|7236421|FG000|NOT COMPLETED|Overall Study||0
6329591|NCT00511134|7236422|FG001|NOT COMPLETED|Overall Study||2
6376028|NCT00758459|7286539|FG000|NOT COMPLETED|Overall Study||3
6376029|NCT00758459|7286540|FG001|NOT COMPLETED|Overall Study||4
6376030|NCT00758485|7286548|FG000|STARTED|Overall Study||70
6329592|NCT00511147|7236428|FG000|STARTED|Overall Study||64
6329593|NCT00511147|7236428|FG000|COMPLETED|Overall Study||57
6329594|NCT00511147|7236428|FG000|NOT COMPLETED|Overall Study||7
6329595|NCT00511173|7236432|FG000|STARTED|Overall Study||102
6329596|NCT00511173|7236432|FG000|COMPLETED|Overall Study||102
6329597|NCT00511173|7236432|FG000|NOT COMPLETED|Overall Study||0
6329598|NCT00511238|7236439|FG000|STARTED|Overall Study||46
6329599|NCT00511238|7236440|FG001|STARTED|Overall Study||266
6329600|NCT00511238|7236439|FG000|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
6329601|NCT00511238|7236440|FG001|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
6329602|NCT00511238|7236439|FG000|NOT COMPLETED|Overall Study||42
6329603|NCT00511238|7236440|FG001|NOT COMPLETED|Overall Study||226
6329604|NCT00511472|7236458|FG000|STARTED|Overall Study||47
6329605|NCT00511472|7236459|FG001|STARTED|Overall Study||23
6329606|NCT00511472|7236458|FG000|COMPLETED|Overall Study||44
6329607|NCT00511472|7236459|FG001|COMPLETED|Overall Study||17
6329608|NCT00511472|7236458|FG000|NOT COMPLETED|Overall Study||3
6329609|NCT00511472|7236459|FG001|NOT COMPLETED|Overall Study||6
6329610|NCT00511667|7236476|FG000|STARTED|Overall Study||52
6329611|NCT00511667|7236477|FG001|STARTED|Overall Study||18
6329612|NCT00511667|7236476|FG000|COMPLETED|Overall Study||40
6329613|NCT00511667|7236477|FG001|COMPLETED|Overall Study||15
6329614|NCT00511667|7236476|FG000|NOT COMPLETED|Overall Study||12
6329615|NCT00511667|7236477|FG001|NOT COMPLETED|Overall Study||3
6329616|NCT00511706|7236491|FG000|STARTED|Overall Study||123
6329617|NCT00511706|7236492|FG001|STARTED|Overall Study||120
6329618|NCT00511706|7236491|FG000|COMPLETED|Overall Study||115
6329619|NCT00511706|7236492|FG001|COMPLETED|Overall Study||115
6329620|NCT00511706|7236491|FG000|NOT COMPLETED|Overall Study||8
6329621|NCT00511706|7236492|FG001|NOT COMPLETED|Overall Study||5
6329622|NCT00511797|7236502|FG000|STARTED|Overall Study||62
6329623|NCT00511797|7236503|FG001|STARTED|Overall Study||63
6329624|NCT00511797|7236504|FG002|STARTED|Overall Study||62
6329625|NCT00511797|7236505|FG003|STARTED|Overall Study||62
6329626|NCT00511797|7236502|FG000|Subjects Dispensed Drugs|Overall Study||61
6329627|NCT00511797|7236503|FG001|Subjects Dispensed Drugs|Overall Study||63
6329628|NCT00511797|7236504|FG002|Subjects Dispensed Drugs|Overall Study||61
6329629|NCT00511797|7236505|FG003|Subjects Dispensed Drugs|Overall Study||59
6329630|NCT00511797|7236502|FG000|Subjects Received Treatment|Overall Study|FAS|61
6329631|NCT00511797|7236503|FG001|Subjects Received Treatment|Overall Study|FAS|62
6329632|NCT00511797|7236504|FG002|Subjects Received Treatment|Overall Study|FAS|61
6329633|NCT00511797|7236505|FG003|Subjects Received Treatment|Overall Study|FAS|58
6329634|NCT00511797|7236502|FG000|COMPLETED|Overall Study||55
6329635|NCT00511797|7236503|FG001|COMPLETED|Overall Study||55
6329636|NCT00511797|7236504|FG002|COMPLETED|Overall Study||51
6329637|NCT00511797|7236505|FG003|COMPLETED|Overall Study||47
6329638|NCT00511797|7236502|FG000|NOT COMPLETED|Overall Study||7
6329639|NCT00511797|7236503|FG001|NOT COMPLETED|Overall Study||8
6329640|NCT00511797|7236504|FG002|NOT COMPLETED|Overall Study||11
6329641|NCT00511797|7236505|FG003|NOT COMPLETED|Overall Study||15
6329642|NCT00511810|7236517|FG000|STARTED|Overall Study||8
6329643|NCT00511810|7236518|FG001|STARTED|Overall Study||12
6329644|NCT00511810|7236517|FG000|COMPLETED|Overall Study||7
6329645|NCT00511810|7236518|FG001|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
6329646|NCT00511810|7236517|FG000|NOT COMPLETED|Overall Study||1
6329647|NCT00511810|7236518|FG001|NOT COMPLETED|Overall Study||5
6329648|NCT00511836|7236526|FG000|STARTED|Double-blind Period||16
6329649|NCT00511836|7236527|FG001|STARTED|Double-blind Period||15
6329650|NCT00511836|7236526|FG000|COMPLETED|Double-blind Period||15
6329651|NCT00511836|7236527|FG001|COMPLETED|Double-blind Period||15
6329652|NCT00511836|7236526|FG000|NOT COMPLETED|Double-blind Period||1
6329653|NCT00511836|7236527|FG001|NOT COMPLETED|Double-blind Period||0
6329654|NCT00511836|7236526|FG000|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
6329655|NCT00511836|7236527|FG001|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
6329656|NCT00511836|7236526|FG000|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
6329657|NCT00511836|7236527|FG001|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
6329658|NCT00511836|7236526|FG000|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
6329659|NCT00511836|7236527|FG001|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
6329660|NCT00511862|7236537|FG000|STARTED|Overall Study||61
6329661|NCT00511862|7236538|FG001|STARTED|Overall Study||43
6329662|NCT00511862|7236539|FG002|STARTED|Overall Study||47
6329663|NCT00511862|7236537|FG000|COMPLETED|Overall Study||61
6329664|NCT00511862|7236538|FG001|COMPLETED|Overall Study||43
6329665|NCT00511862|7236539|FG002|COMPLETED|Overall Study||47
6329666|NCT00511862|7236537|FG000|NOT COMPLETED|Overall Study||0
6329667|NCT00511862|7236538|FG001|NOT COMPLETED|Overall Study||0
6329668|NCT00511862|7236539|FG002|NOT COMPLETED|Overall Study||0
6329669|NCT00511875|7236551|FG000|STARTED|Overall Study||15
6329670|NCT00511875|7236552|FG001|STARTED|Overall Study||15
6329671|NCT00511875|7236551|FG000|COMPLETED|Overall Study||10
6329672|NCT00511875|7236552|FG001|COMPLETED|Overall Study||15
6329673|NCT00511875|7236551|FG000|NOT COMPLETED|Overall Study||5
6329674|NCT00511875|7236552|FG001|NOT COMPLETED|Overall Study||0
6329675|NCT00511901|7236560|FG000|STARTED|Overall Study||11
6329676|NCT00511901|7236561|FG001|STARTED|Overall Study||11
6329677|NCT00511901|7236560|FG000|COMPLETED|Overall Study||10
6329678|NCT00511901|7236561|FG001|COMPLETED|Overall Study||8
6329679|NCT00511901|7236560|FG000|NOT COMPLETED|Overall Study||1
6329680|NCT00511901|7236561|FG001|NOT COMPLETED|Overall Study||3
6329681|NCT00511914|7236569|FG000|STARTED|Overall Study||68
6329682|NCT00511914|7236570|FG001|STARTED|Overall Study||67
6329683|NCT00511914|7236569|FG000|COMPLETED|Overall Study||68
6329684|NCT00511914|7236570|FG001|COMPLETED|Overall Study||67
6329685|NCT00511914|7236569|FG000|NOT COMPLETED|Overall Study||0
6329686|NCT00511914|7236570|FG001|NOT COMPLETED|Overall Study||0
6329687|NCT00511992|7236576|FG000|STARTED|Overall Study||20
6329688|NCT00511992|7236576|FG000|COMPLETED|Overall Study||13
6329689|NCT00511992|7236576|FG000|NOT COMPLETED|Overall Study||7
6329690|NCT00512096|7236580|FG000|STARTED|Overall Study||30
6329691|NCT00512096|7236580|FG000|COMPLETED|Overall Study||23
6329692|NCT00512096|7236580|FG000|NOT COMPLETED|Overall Study||7
6329693|NCT00512135|7236584|FG000|STARTED|Overall Study||801
6329694|NCT00512135|7236584|FG000|Treated|Overall Study||796
6329695|NCT00512135|7236584|FG000|COMPLETED|Overall Study||717
6329696|NCT00512135|7236584|FG000|NOT COMPLETED|Overall Study||84
6329697|NCT00512148|7236589|FG000|STARTED|Primay Study Period||7
6329698|NCT00512148|7236589|FG000|COMPLETED|Primay Study Period||6
6329699|NCT00512148|7236589|FG000|NOT COMPLETED|Primay Study Period||1
6329700|NCT00512148|7236589|FG000|STARTED|Long Term Follow Up Period||6
6329701|NCT00512148|7236589|FG000|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
6329702|NCT00512148|7236589|FG000|NOT COMPLETED|Long Term Follow Up Period||6
6329703|NCT00512252|7236598|FG000|STARTED|Overall Study||3
6329704|NCT00512252|7236599|FG001|STARTED|Overall Study||3
6329705|NCT00512252|7236600|FG002|STARTED|Overall Study||46
6329706|NCT00512252|7236598|FG000|COMPLETED|Overall Study||3
6329707|NCT00512252|7236599|FG001|COMPLETED|Overall Study||3
6329708|NCT00512252|7236600|FG002|COMPLETED|Overall Study||43
6329709|NCT00512252|7236598|FG000|NOT COMPLETED|Overall Study||0
6329710|NCT00512252|7236599|FG001|NOT COMPLETED|Overall Study||0
6329711|NCT00512252|7236600|FG002|NOT COMPLETED|Overall Study||3
6329712|NCT00512278|7236617|FG000|STARTED|Overall Study||73
6329713|NCT00512278|7236618|FG001|STARTED|Overall Study||73
6329714|NCT00512278|7236617|FG000|COMPLETED|Overall Study||45
6329715|NCT00512278|7236618|FG001|COMPLETED|Overall Study||56
6329716|NCT00512278|7236617|FG000|NOT COMPLETED|Overall Study||28
6329717|NCT00512278|7236618|FG001|NOT COMPLETED|Overall Study||17
6329718|NCT00512707|7236628|FG000|STARTED|Overall Study||70
6329719|NCT00512707|7236629|FG001|STARTED|Overall Study||70
6329720|NCT00512707|7236628|FG000|COMPLETED|Overall Study||60
6329721|NCT00512707|7236629|FG001|COMPLETED|Overall Study||58
6329722|NCT00512707|7236628|FG000|NOT COMPLETED|Overall Study||10
6329723|NCT00512707|7236629|FG001|NOT COMPLETED|Overall Study||12
6329724|NCT00512798|7236637|FG000|STARTED|Overall Study||19
6329725|NCT00512798|7236638|FG001|STARTED|Overall Study||28
6329726|NCT00512798|7236637|FG000|COMPLETED|Overall Study||0
6329727|NCT00512798|7236638|FG001|COMPLETED|Overall Study||1
6329728|NCT00512798|7236637|FG000|NOT COMPLETED|Overall Study||19
6329729|NCT00512798|7236638|FG001|NOT COMPLETED|Overall Study||27
6329730|NCT00512876|7236645|FG000|STARTED|Overall Study||24
6329731|NCT00512876|7236645|FG000|COMPLETED|Overall Study||20
6329732|NCT00512876|7236645|FG000|NOT COMPLETED|Overall Study||4
6329733|NCT00512902|7236649|FG000|STARTED|Overall Study||20
6329734|NCT00512902|7236649|FG000|COMPLETED|Overall Study||12
6329735|NCT00512902|7236649|FG000|NOT COMPLETED|Overall Study||8
6329736|NCT00513019|7236655|FG000|STARTED|Overall Study||17
6329737|NCT00513019|7236656|FG001|STARTED|Overall Study||18
6329738|NCT00513019|7236655|FG000|COMPLETED|Overall Study||12
6329739|NCT00513019|7236656|FG001|COMPLETED|Overall Study||13
6329740|NCT00513019|7236655|FG000|NOT COMPLETED|Overall Study||5
6329741|NCT00513019|7236656|FG001|NOT COMPLETED|Overall Study||5
6329742|NCT00513071|7236662|FG000|STARTED|Overall Study||28
6329743|NCT00513071|7236662|FG000|COMPLETED|Overall Study||23
6329744|NCT00513071|7236662|FG000|NOT COMPLETED|Overall Study||5
6329745|NCT00513240|7236668|FG000|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
6329746|NCT00513240|7236669|FG001|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
6329747|NCT00513240|7236668|FG000|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
6329748|NCT00513240|7236669|FG001|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
6329749|NCT00513240|7236668|FG000|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
6329750|NCT00513240|7236669|FG001|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
6329751|NCT00513240|7236668|FG000|NOT COMPLETED|Overall Study||13
6329752|NCT00513240|7236669|FG001|NOT COMPLETED|Overall Study||7
6329753|NCT00513292|7236680|FG000|STARTED|Overall Study||138
6329754|NCT00513292|7236681|FG001|STARTED|Overall Study||142
6329755|NCT00513292|7236680|FG000|COMPLETED|Overall Study||138
6329756|NCT00513292|7236681|FG001|COMPLETED|Overall Study||142
6329757|NCT00513292|7236680|FG000|NOT COMPLETED|Overall Study||0
6329758|NCT00513292|7236681|FG001|NOT COMPLETED|Overall Study||0
6329759|NCT00513305|7236689|FG000|STARTED|Overall Study||33
6329760|NCT00513305|7236690|FG001|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
6329761|NCT00513305|7236689|FG000|COMPLETED|Overall Study||5
6329762|NCT00513305|7236690|FG001|COMPLETED|Overall Study||7
6329763|NCT00513305|7236689|FG000|NOT COMPLETED|Overall Study||28
6558597|NCT01775852|7481165|FG000|STARTED|Overall Study||31
6558598|NCT01775852|7481166|FG001|STARTED|Overall Study||14
6558599|NCT01775852|7481165|FG000|COMPLETED|Overall Study||31
6558600|NCT01775852|7481166|FG001|COMPLETED|Overall Study||13
6329764|NCT00513305|7236690|FG001|NOT COMPLETED|Overall Study||27
6329765|NCT00513344|7236696|FG000|STARTED|Diet Restriction (3 Days)||5
6329766|NCT00513344|7236696|FG000|COMPLETED|Diet Restriction (3 Days)||5
6329767|NCT00513344|7236696|FG000|NOT COMPLETED|Diet Restriction (3 Days)||0
6329768|NCT00513344|7236696|FG000|STARTED|1st Intervention 1 Day||5
6329769|NCT00513344|7236696|FG000|COMPLETED|1st Intervention 1 Day||5
6329770|NCT00513344|7236696|FG000|NOT COMPLETED|1st Intervention 1 Day||0
6329771|NCT00513344|7236696|FG000|STARTED|Washout Period 3 Days||5
6329772|NCT00513344|7236696|FG000|COMPLETED|Washout Period 3 Days||5
6329773|NCT00513344|7236696|FG000|NOT COMPLETED|Washout Period 3 Days||0
6329774|NCT00513344|7236696|FG000|STARTED|2nd Intervention 1 Day||5
6329775|NCT00513344|7236696|FG000|COMPLETED|2nd Intervention 1 Day||5
6329776|NCT00513344|7236696|FG000|NOT COMPLETED|2nd Intervention 1 Day||0
6329777|NCT00513344|7236696|FG000|STARTED|Washout Period 3 Days||5
6329778|NCT00513344|7236696|FG000|COMPLETED|Washout Period 3 Days||5
6329779|NCT00513344|7236696|FG000|NOT COMPLETED|Washout Period 3 Days||0
6329780|NCT00513344|7236696|FG000|STARTED|3rd Intervention 1 Day||5
6329781|NCT00513344|7236696|FG000|COMPLETED|3rd Intervention 1 Day||5
6329782|NCT00513344|7236696|FG000|NOT COMPLETED|3rd Intervention 1 Day||0
6329783|NCT00513357|7236706|FG000|STARTED|Overall Study||38
6329784|NCT00513357|7236707|FG001|STARTED|Overall Study||35
6329785|NCT00513357|7236706|FG000|COMPLETED|Overall Study||23
6329786|NCT00513357|7236707|FG001|COMPLETED|Overall Study||25
6329787|NCT00513357|7236706|FG000|NOT COMPLETED|Overall Study||15
6329788|NCT00513357|7236707|FG001|NOT COMPLETED|Overall Study||10
6329789|NCT00513370|7236713|FG000|STARTED|Overall Study||203
6329790|NCT00513370|7236713|FG000|COMPLETED|Overall Study||179
6329791|NCT00513370|7236713|FG000|NOT COMPLETED|Overall Study||24
6329792|NCT00513409|7236721|FG000|STARTED|Overall Study||84
6329793|NCT00513409|7236722|FG001|STARTED|Overall Study||79
6329794|NCT00513409|7236721|FG000|COMPLETED|Overall Study||82
6329795|NCT00513409|7236722|FG001|COMPLETED|Overall Study||73
6329796|NCT00513409|7236721|FG000|NOT COMPLETED|Overall Study||2
6329797|NCT00513409|7236722|FG001|NOT COMPLETED|Overall Study||6
6329798|NCT00513435|7236728|FG000|STARTED|Overall Study||9
6329799|NCT00513435|7236728|FG000|COMPLETED|Overall Study||9
6329800|NCT00513435|7236728|FG000|NOT COMPLETED|Overall Study||0
6329801|NCT00513461|7236734|FG000|STARTED|Overall Study||57
6329802|NCT00513461|7236735|FG001|STARTED|Overall Study||53
6329803|NCT00513461|7236734|FG000|COMPLETED|Overall Study||44
6329804|NCT00513461|7236735|FG001|COMPLETED|Overall Study||43
6329805|NCT00513461|7236734|FG000|NOT COMPLETED|Overall Study||13
6329806|NCT00513461|7236735|FG001|NOT COMPLETED|Overall Study||10
6329807|NCT00513474|7236743|FG000|STARTED|Overall Study||25
6329808|NCT00513474|7236744|FG001|STARTED|Overall Study||21
6329809|NCT00513474|7236743|FG000|Received Rasburicase Per Protocol|Overall Study||24
6329810|NCT00513474|7236744|FG001|Received Rasburicase Per Protocol|Overall Study||0
6329811|NCT00513474|7236743|FG000|COMPLETED|Overall Study||18
6329812|NCT00513474|7236744|FG001|COMPLETED|Overall Study||12
6329813|NCT00513474|7236743|FG000|NOT COMPLETED|Overall Study||7
6329814|NCT00513474|7236744|FG001|NOT COMPLETED|Overall Study||9
6329815|NCT00513500|7236752|FG000|STARTED|Overall Study||1017
6329816|NCT00513500|7236753|FG001|STARTED|Overall Study||2108
6329817|NCT00513500|7236752|FG000|COMPLETED|Overall Study||976
6329818|NCT00513500|7236753|FG001|COMPLETED|Overall Study||2054
6329819|NCT00513500|7236752|FG000|NOT COMPLETED|Overall Study||41
6329820|NCT00513500|7236753|FG001|NOT COMPLETED|Overall Study||54
6329821|NCT00513526|7236759|FG000|STARTED|Overall Study||109
6329822|NCT00513526|7236759|FG000|COMPLETED|Overall Study||92
6329823|NCT00513526|7236759|FG000|NOT COMPLETED|Overall Study||17
6329824|NCT00513604|7236770|FG000|STARTED|Overall Study|Cohort 1 = unselected TIL|26
6329825|NCT00513604|7236771|FG001|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
6329826|NCT00513604|7236772|FG002|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
6329827|NCT00513604|7236773|FG003|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
6329828|NCT00513604|7236774|FG004|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
6558601|NCT01775852|7481165|FG000|NOT COMPLETED|Overall Study||0
6329829|NCT00513604|7236770|FG000|COMPLETED|Overall Study||24
6329830|NCT00513604|7236771|FG001|COMPLETED|Overall Study||36
6329831|NCT00513604|7236772|FG002|COMPLETED|Overall Study||21
6329832|NCT00513604|7236773|FG003|COMPLETED|Overall Study||34
6329833|NCT00513604|7236774|FG004|COMPLETED|Overall Study||35
6329834|NCT00513604|7236770|FG000|NOT COMPLETED|Overall Study||2
6329835|NCT00513604|7236771|FG001|NOT COMPLETED|Overall Study||3
6329836|NCT00513604|7236772|FG002|NOT COMPLETED|Overall Study||3
6329837|NCT00513604|7236773|FG003|NOT COMPLETED|Overall Study||0
6329838|NCT00513604|7236774|FG004|NOT COMPLETED|Overall Study||0
6329839|NCT00513682|7236786|FG000|STARTED|Screening Phase||9
6329840|NCT00513682|7236786|FG000|COMPLETED|Screening Phase||9
6329841|NCT00513682|7236786|FG000|NOT COMPLETED|Screening Phase||0
6329842|NCT00513682|7236786|FG000|STARTED|Washout Phase||9
6329843|NCT00513682|7236786|FG000|COMPLETED|Washout Phase||7
6329844|NCT00513682|7236786|FG000|NOT COMPLETED|Washout Phase||2
6558602|NCT01775852|7481166|FG001|NOT COMPLETED|Overall Study||1
6329845|NCT00513682|7236786|FG000|STARTED|Treatment Phase||7
6329846|NCT00513682|7236786|FG000|COMPLETED|Treatment Phase||7
6329847|NCT00513682|7236786|FG000|NOT COMPLETED|Treatment Phase||0
6329848|NCT00513695|7236793|FG000|STARTED|Overall Study||68
6329849|NCT00513695|7236793|FG000|COMPLETED|Overall Study||63
6329850|NCT00513695|7236793|FG000|NOT COMPLETED|Overall Study||5
6329851|NCT00513708|7236800|FG000|STARTED|Overall Study||50
6329852|NCT00513708|7236801|FG001|STARTED|Overall Study||50
6329853|NCT00513708|7236802|FG002|STARTED|Overall Study||50
6329854|NCT00513708|7236800|FG000|COMPLETED|Overall Study||46
6329855|NCT00513708|7236801|FG001|COMPLETED|Overall Study||46
6329856|NCT00513708|7236802|FG002|COMPLETED|Overall Study||46
6329857|NCT00513708|7236800|FG000|NOT COMPLETED|Overall Study||4
6329858|NCT00513708|7236801|FG001|NOT COMPLETED|Overall Study||4
6329859|NCT00513708|7236802|FG002|NOT COMPLETED|Overall Study||4
6329860|NCT00513747|7236813|FG000|STARTED|Overall Study||17
6329861|NCT00513747|7236814|FG001|STARTED|Overall Study||11
6329862|NCT00513747|7236815|FG002|STARTED|Overall Study||55
6329863|NCT00513747|7236813|FG000|Received at Least One Dose of Treatment|Overall Study||9
6329864|NCT00513747|7236814|FG001|Received at Least One Dose of Treatment|Overall Study||11
6329865|NCT00513747|7236815|FG002|Received at Least One Dose of Treatment|Overall Study||40
6329866|NCT00513747|7236813|FG000|COMPLETED|Overall Study||17
6329867|NCT00513747|7236814|FG001|COMPLETED|Overall Study||11
6329868|NCT00513747|7236815|FG002|COMPLETED|Overall Study||55
6329869|NCT00513747|7236813|FG000|NOT COMPLETED|Overall Study||0
6329870|NCT00513747|7236814|FG001|NOT COMPLETED|Overall Study||0
6329871|NCT00513747|7236815|FG002|NOT COMPLETED|Overall Study||0
6329872|NCT00513799|7236829|FG000|STARTED|One-Month Follow-Up||75
6329873|NCT00513799|7236830|FG001|STARTED|One-Month Follow-Up||75
6329874|NCT00513799|7236831|FG002|STARTED|One-Month Follow-Up||75
6329875|NCT00513799|7236832|FG003|STARTED|One-Month Follow-Up||75
6329876|NCT00513799|7236829|FG000|COMPLETED|One-Month Follow-Up||64
6329877|NCT00513799|7236830|FG001|COMPLETED|One-Month Follow-Up||62
6775247|NCT03885154|7703175|FG001|COMPLETED|Overall Study||10
6775248|NCT03885154|7703176|FG002|COMPLETED|Overall Study||0
6775249|NCT03885154|7703177|FG003|COMPLETED|Overall Study||2
6775250|NCT03885154|7703174|FG000|NOT COMPLETED|Overall Study||0
6329878|NCT00513799|7236831|FG002|COMPLETED|One-Month Follow-Up||64
6329879|NCT00513799|7236832|FG003|COMPLETED|One-Month Follow-Up||54
6329880|NCT00513799|7236829|FG000|NOT COMPLETED|One-Month Follow-Up||11
6329881|NCT00513799|7236830|FG001|NOT COMPLETED|One-Month Follow-Up||13
6329882|NCT00513799|7236831|FG002|NOT COMPLETED|One-Month Follow-Up||11
6329883|NCT00513799|7236832|FG003|NOT COMPLETED|One-Month Follow-Up||21
6329884|NCT00513799|7236829|FG000|STARTED|Four-Month Follow-Up||64
6329885|NCT00513799|7236830|FG001|STARTED|Four-Month Follow-Up||62
6329886|NCT00513799|7236831|FG002|STARTED|Four-Month Follow-Up||64
6329887|NCT00513799|7236832|FG003|STARTED|Four-Month Follow-Up||54
6329888|NCT00513799|7236829|FG000|COMPLETED|Four-Month Follow-Up||64
6329889|NCT00513799|7236830|FG001|COMPLETED|Four-Month Follow-Up||57
6329890|NCT00513799|7236831|FG002|COMPLETED|Four-Month Follow-Up||57
6329891|NCT00513799|7236832|FG003|COMPLETED|Four-Month Follow-Up||51
6329892|NCT00513799|7236829|FG000|NOT COMPLETED|Four-Month Follow-Up||0
6329893|NCT00513799|7236830|FG001|NOT COMPLETED|Four-Month Follow-Up||5
6329894|NCT00513799|7236831|FG002|NOT COMPLETED|Four-Month Follow-Up||7
6329895|NCT00513799|7236832|FG003|NOT COMPLETED|Four-Month Follow-Up||3
6558603|NCT01775865|7481175|FG000|STARTED|Overall Study||14
6558604|NCT01775865|7481176|FG001|STARTED|Overall Study||14
6558605|NCT01775865|7481177|FG002|STARTED|Overall Study||17
6558606|NCT01775865|7481175|FG000|COMPLETED|Overall Study||11
6558607|NCT01775865|7481176|FG001|COMPLETED|Overall Study||13
6329896|NCT00514020|7236846|FG000|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
6329897|NCT00514020|7236846|FG000|COMPLETED|Overall Study||5
6329898|NCT00514020|7236846|FG000|NOT COMPLETED|Overall Study||28
6329899|NCT00514046|7236859|FG000|STARTED|Overall Study||5
6329900|NCT00514046|7236860|FG001|STARTED|Overall Study||1
6329901|NCT00514046|7236861|FG002|STARTED|Overall Study||5
6329902|NCT00514046|7236862|FG003|STARTED|Overall Study||1
6329903|NCT00514046|7236863|FG004|STARTED|Overall Study||1
6329904|NCT00514046|7236864|FG005|STARTED|Overall Study||1
6329905|NCT00514046|7236865|FG006|STARTED|Overall Study||1
6329906|NCT00514046|7236866|FG007|STARTED|Overall Study||1
6329907|NCT00514046|7236867|FG008|STARTED|Overall Study||1
6329908|NCT00514046|7236859|FG000|COMPLETED|Overall Study||2
6329909|NCT00514046|7236860|FG001|COMPLETED|Overall Study||0
6329910|NCT00514046|7236861|FG002|COMPLETED|Overall Study||0
6329911|NCT00514046|7236862|FG003|COMPLETED|Overall Study||1
6329912|NCT00514046|7236863|FG004|COMPLETED|Overall Study||0
6329913|NCT00514046|7236864|FG005|COMPLETED|Overall Study||0
6775251|NCT03885154|7703175|FG001|NOT COMPLETED|Overall Study||0
6329914|NCT00514046|7236865|FG006|COMPLETED|Overall Study||1
6329915|NCT00514046|7236866|FG007|COMPLETED|Overall Study||0
6329916|NCT00514046|7236867|FG008|COMPLETED|Overall Study||0
6329917|NCT00514046|7236859|FG000|NOT COMPLETED|Overall Study||3
6329918|NCT00514046|7236860|FG001|NOT COMPLETED|Overall Study||1
6329919|NCT00514046|7236861|FG002|NOT COMPLETED|Overall Study||5
6329920|NCT00514046|7236862|FG003|NOT COMPLETED|Overall Study||0
6329921|NCT00514046|7236863|FG004|NOT COMPLETED|Overall Study||1
6329922|NCT00514046|7236864|FG005|NOT COMPLETED|Overall Study||1
6329923|NCT00514046|7236865|FG006|NOT COMPLETED|Overall Study||0
6329924|NCT00514046|7236866|FG007|NOT COMPLETED|Overall Study||1
6329925|NCT00514046|7236867|FG008|NOT COMPLETED|Overall Study||1
6329926|NCT00514137|7236889|FG000|STARTED|Overall Study||13
6329927|NCT00514137|7236889|FG000|COMPLETED|Overall Study||13
6329928|NCT00514137|7236889|FG000|NOT COMPLETED|Overall Study||0
6329929|NCT00514215|7236893|FG000|STARTED|Overall Study||8
6329930|NCT00514215|7236893|FG000|COMPLETED|Overall Study||8
6329931|NCT00514215|7236893|FG000|NOT COMPLETED|Overall Study||0
6329932|NCT00514449|7236899|FG000|STARTED|Overall Study||12
6329933|NCT00514449|7236900|FG001|STARTED|Overall Study||12
6329934|NCT00514449|7236899|FG000|COMPLETED|Overall Study||9
6329935|NCT00514449|7236900|FG001|COMPLETED|Overall Study||8
6329936|NCT00514449|7236899|FG000|NOT COMPLETED|Overall Study||3
6329937|NCT00514449|7236900|FG001|NOT COMPLETED|Overall Study||4
6329938|NCT00514501|7236909|FG000|STARTED|Overall Study||510
6329939|NCT00514501|7236909|FG000|COMPLETED|Overall Study||507
6329940|NCT00514501|7236909|FG000|NOT COMPLETED|Overall Study||3
6329941|NCT00514514|7236916|FG000|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
6329942|NCT00514514|7236917|FG001|STARTED|Pre-phase||0
6329943|NCT00514514|7236918|FG002|STARTED|Pre-phase||0
6329944|NCT00514514|7236916|FG000|COMPLETED|Pre-phase||499
6329945|NCT00514514|7236917|FG001|COMPLETED|Pre-phase||0
6329946|NCT00514514|7236918|FG002|COMPLETED|Pre-phase||0
6329947|NCT00514514|7236916|FG000|NOT COMPLETED|Pre-phase||303
6329948|NCT00514514|7236917|FG001|NOT COMPLETED|Pre-phase||0
6329949|NCT00514514|7236918|FG002|NOT COMPLETED|Pre-phase||0
6329950|NCT00514514|7236916|FG000|STARTED|Randomized - 9 Month||166
6329951|NCT00514514|7236917|FG001|STARTED|Randomized - 9 Month||171
6329952|NCT00514514|7236918|FG002|STARTED|Randomized - 9 Month||162
6329953|NCT00514514|7236916|FG000|Randomized - Received Treatment|Randomized - 9 Month||165
6329954|NCT00514514|7236917|FG001|Randomized - Received Treatment|Randomized - 9 Month||171
6329955|NCT00514514|7236918|FG002|Randomized - Received Treatment|Randomized - 9 Month||161
6329956|NCT00514514|7236916|FG000|COMPLETED|Randomized - 9 Month||127
6329957|NCT00514514|7236917|FG001|COMPLETED|Randomized - 9 Month||110
6329958|NCT00514514|7236918|FG002|COMPLETED|Randomized - 9 Month||124
6329959|NCT00514514|7236916|FG000|NOT COMPLETED|Randomized - 9 Month||39
6558608|NCT01775865|7481177|FG002|COMPLETED|Overall Study||17
6558609|NCT01775865|7481175|FG000|NOT COMPLETED|Overall Study||3
6558610|NCT01775865|7481176|FG001|NOT COMPLETED|Overall Study||1
6558611|NCT01775865|7481177|FG002|NOT COMPLETED|Overall Study||0
6558612|NCT01775904|7481190|FG000|STARTED|LY2886721 ODT (no Water, Fasting)||26
6558613|NCT01775904|7481190|FG000|Received at Least One Dose of Drug|LY2886721 ODT (no Water, Fasting)||26
6558614|NCT01775904|7481190|FG000|COMPLETED|LY2886721 ODT (no Water, Fasting)||26
6558615|NCT01775904|7481190|FG000|NOT COMPLETED|LY2886721 ODT (no Water, Fasting)||0
6329960|NCT00514514|7236917|FG001|NOT COMPLETED|Randomized - 9 Month||61
6329961|NCT00514514|7236918|FG002|NOT COMPLETED|Randomized - 9 Month||38
6329962|NCT00514514|7236916|FG000|STARTED|Extension - 4 Years||145
6329963|NCT00514514|7236917|FG001|STARTED|Extension - 4 Years||139
6329964|NCT00514514|7236918|FG002|STARTED|Extension - 4 Years||134
6329965|NCT00514514|7236916|FG000|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
6329966|NCT00514514|7236917|FG001|Non-randomized (Followed)|Extension - 4 Years||0
6329967|NCT00514514|7236918|FG002|Non-randomized (Followed)|Extension - 4 Years||0
6329968|NCT00514514|7236916|FG000|COMPLETED|Extension - 4 Years||108
6329969|NCT00514514|7236917|FG001|COMPLETED|Extension - 4 Years||117
6329970|NCT00514514|7236918|FG002|COMPLETED|Extension - 4 Years||113
6329971|NCT00514514|7236916|FG000|NOT COMPLETED|Extension - 4 Years||37
6329972|NCT00514514|7236917|FG001|NOT COMPLETED|Extension - 4 Years||22
6329973|NCT00514514|7236918|FG002|NOT COMPLETED|Extension - 4 Years||21
6329974|NCT00514540|7236926|FG000|STARTED|First-Line Chemo||113
6558616|NCT01775904|7481190|FG000|STARTED|First Washout (7 Days)||26
6558617|NCT01775904|7481190|FG000|COMPLETED|First Washout (7 Days)||26
6558618|NCT01775904|7481190|FG000|NOT COMPLETED|First Washout (7 Days)||0
6558619|NCT01775904|7481190|FG000|STARTED|LY2886721 Capsule (Water, Fasting)||26
6558620|NCT01775904|7481190|FG000|Received at Least One Dose of Drug|LY2886721 Capsule (Water, Fasting)||26
6558621|NCT01775904|7481190|FG000|COMPLETED|LY2886721 Capsule (Water, Fasting)||25
6558622|NCT01775904|7481190|FG000|NOT COMPLETED|LY2886721 Capsule (Water, Fasting)||1
6558623|NCT01775904|7481190|FG000|STARTED|Second Washout (7 Days)||25
6558624|NCT01775904|7481190|FG000|COMPLETED|Second Washout (7 Days)||25
6329975|NCT00514540|7236926|FG000|COMPLETED|First-Line Chemo||105
6329976|NCT00514540|7236926|FG000|NOT COMPLETED|First-Line Chemo||8
6329977|NCT00514540|7236926|FG000|STARTED|Second-Line||105
6329978|NCT00514540|7236926|FG000|COMPLETED|Second-Line||74
6329979|NCT00514540|7236926|FG000|NOT COMPLETED|Second-Line||31
6329980|NCT00514592|7236934|FG000|STARTED|Overall Study||230
6329981|NCT00514592|7236934|FG000|COMPLETED|Overall Study||230
6329982|NCT00514592|7236934|FG000|NOT COMPLETED|Overall Study||0
6329983|NCT00514683|7236943|FG000|STARTED|Overall Study|Randomised|87
6329984|NCT00514683|7236944|FG001|STARTED|Overall Study|Randomised|87
6329985|NCT00514683|7236945|FG002|STARTED|Overall Study|Randomised|86
6329986|NCT00514683|7236946|FG003|STARTED|Overall Study|Randomised|86
6329987|NCT00514683|7236947|FG004|STARTED|Overall Study|Randomised|86
6329988|NCT00514683|7236943|FG000|COMPLETED|Overall Study||61
6329989|NCT00514683|7236944|FG001|COMPLETED|Overall Study||62
6558625|NCT01775904|7481190|FG000|NOT COMPLETED|Second Washout (7 Days)||0
6329990|NCT00514683|7236945|FG002|COMPLETED|Overall Study||68
6329991|NCT00514683|7236946|FG003|COMPLETED|Overall Study||72
6329992|NCT00514683|7236947|FG004|COMPLETED|Overall Study||53
6329993|NCT00514683|7236943|FG000|NOT COMPLETED|Overall Study||26
6329994|NCT00514683|7236944|FG001|NOT COMPLETED|Overall Study||25
6329995|NCT00514683|7236945|FG002|NOT COMPLETED|Overall Study||18
6329996|NCT00514683|7236946|FG003|NOT COMPLETED|Overall Study||14
6329997|NCT00514683|7236947|FG004|NOT COMPLETED|Overall Study||33
6329998|NCT00514709|7236965|FG000|STARTED|Overall Study||1230
6329999|NCT00514709|7236966|FG001|STARTED|Overall Study||613
6330000|NCT00514709|7236965|FG000|COMPLETED|Overall Study||1230
6330001|NCT00514709|7236966|FG001|COMPLETED|Overall Study||613
6330002|NCT00514709|7236965|FG000|NOT COMPLETED|Overall Study||0
6330003|NCT00514709|7236966|FG001|NOT COMPLETED|Overall Study||0
6330004|NCT00514735|7236976|FG000|STARTED|Overall Study||138
6330005|NCT00514735|7236977|FG001|STARTED|Overall Study||72
6330006|NCT00514735|7236976|FG000|COMPLETED|Overall Study||124
6330007|NCT00514735|7236977|FG001|COMPLETED|Overall Study||66
6330008|NCT00514735|7236976|FG000|NOT COMPLETED|Overall Study||14
6330009|NCT00514735|7236977|FG001|NOT COMPLETED|Overall Study||6
6330010|NCT00514852|7236987|FG000|STARTED|Overall Study||157
6330011|NCT00514852|7236988|FG001|STARTED|Overall Study||159
6330012|NCT00514852|7236987|FG000|COMPLETED|Overall Study||152
6330013|NCT00514852|7236988|FG001|COMPLETED|Overall Study||154
6330014|NCT00514852|7236987|FG000|NOT COMPLETED|Overall Study||5
6330015|NCT00514852|7236988|FG001|NOT COMPLETED|Overall Study||5
6330016|NCT00514904|7236996|FG000|STARTED|Overall Study||1125
6330017|NCT00514904|7236997|FG001|STARTED|Overall Study||376
6330018|NCT00514904|7236996|FG000|COMPLETED|Overall Study||1101
6330019|NCT00514904|7236997|FG001|COMPLETED|Overall Study||371
6330020|NCT00514904|7236996|FG000|NOT COMPLETED|Overall Study||24
6330021|NCT00514904|7236997|FG001|NOT COMPLETED|Overall Study||5
6330022|NCT00514917|7237005|FG000|STARTED|Overall Study||207
6330023|NCT00514917|7237006|FG001|STARTED|Overall Study||206
6330024|NCT00514917|7237005|FG000|Treated|Overall Study||196
6330025|NCT00514917|7237006|FG001|Treated|Overall Study||204
6330026|NCT00514917|7237005|FG000|Completed Study Treatment|Overall Study||170
6330027|NCT00514917|7237006|FG001|Completed Study Treatment|Overall Study||182
6330028|NCT00514917|7237005|FG000|Testosterone-Specific Evaluable|Overall Study||122
6330029|NCT00514917|7237006|FG001|Testosterone-Specific Evaluable|Overall Study||124
6330030|NCT00514917|7237005|FG000|COMPLETED|Overall Study||81
6330031|NCT00514917|7237006|FG001|COMPLETED|Overall Study||91
6330032|NCT00514917|7237005|FG000|NOT COMPLETED|Overall Study||126
6330033|NCT00514917|7237006|FG001|NOT COMPLETED|Overall Study||115
6330034|NCT00514943|7237016|FG000|STARTED|Stage 1|1 randomized patient was not treated|62
6330035|NCT00514943|7237017|FG001|STARTED|Stage 1|2 randomized patients were not treated|62
6330036|NCT00514943|7237016|FG000|COMPLETED|Stage 1||32
6330037|NCT00514943|7237017|FG001|COMPLETED|Stage 1||36
6330038|NCT00514943|7237016|FG000|NOT COMPLETED|Stage 1||30
6330039|NCT00514943|7237017|FG001|NOT COMPLETED|Stage 1||26
6330040|NCT00514943|7237016|FG000|STARTED|Stage 2||32
6330041|NCT00514943|7237017|FG001|STARTED|Stage 2||36
6330042|NCT00514943|7237016|FG000|COMPLETED|Stage 2||0
6330043|NCT00514943|7237017|FG001|COMPLETED|Stage 2||0
6330044|NCT00514943|7237016|FG000|NOT COMPLETED|Stage 2||32
6330045|NCT00514943|7237017|FG001|NOT COMPLETED|Stage 2||36
6330046|NCT00515008|7237040|FG000|STARTED|Overall Study||33
6330047|NCT00515008|7237041|FG001|STARTED|Overall Study||33
6330048|NCT00515008|7237040|FG000|Completed 12 Week Evaluation|Overall Study||32
6330049|NCT00515008|7237041|FG001|Completed 12 Week Evaluation|Overall Study||29
6330050|NCT00515008|7237040|FG000|COMPLETED|Overall Study||30
6330051|NCT00515008|7237041|FG001|COMPLETED|Overall Study||29
6330052|NCT00515008|7237040|FG000|NOT COMPLETED|Overall Study||3
6330053|NCT00515008|7237041|FG001|NOT COMPLETED|Overall Study||4
6330054|NCT00515021|7237052|FG000|STARTED|Overall Study||9
6330055|NCT00515021|7237053|FG001|STARTED|Overall Study||11
6330056|NCT00515021|7237052|FG000|COMPLETED|Overall Study||9
6330057|NCT00515021|7237053|FG001|COMPLETED|Overall Study||11
6330058|NCT00515021|7237052|FG000|NOT COMPLETED|Overall Study||0
6330059|NCT00515021|7237053|FG001|NOT COMPLETED|Overall Study||0
6330060|NCT00515034|7237065|FG000|STARTED|Overall Study||49
6330061|NCT00515034|7237066|FG001|STARTED|Overall Study||15
6330062|NCT00515034|7237067|FG002|STARTED|Overall Study||62
6330063|NCT00515034|7237068|FG003|STARTED|Overall Study||20
6330064|NCT00515034|7237065|FG000|TREATED|Overall Study||48
6330065|NCT00515034|7237066|FG001|TREATED|Overall Study||15
6330066|NCT00515034|7237067|FG002|TREATED|Overall Study||61
6330067|NCT00515034|7237068|FG003|TREATED|Overall Study||19
6330068|NCT00515034|7237065|FG000|COMPLETED|Overall Study||41
6330069|NCT00515034|7237066|FG001|COMPLETED|Overall Study||13
6330070|NCT00515034|7237067|FG002|COMPLETED|Overall Study||54
6330071|NCT00515034|7237068|FG003|COMPLETED|Overall Study||15
6330072|NCT00515034|7237065|FG000|NOT COMPLETED|Overall Study||8
6330073|NCT00515034|7237066|FG001|NOT COMPLETED|Overall Study||2
6330074|NCT00515034|7237067|FG002|NOT COMPLETED|Overall Study||8
6330075|NCT00515034|7237068|FG003|NOT COMPLETED|Overall Study||5
6330076|NCT00515073|7237078|FG000|STARTED|Overall Study||30
6330077|NCT00515073|7237078|FG000|COMPLETED|Overall Study||28
6330078|NCT00515073|7237078|FG000|NOT COMPLETED|Overall Study||2
6330079|NCT00515086|7237086|FG000|STARTED|Overall Study||24
6330080|NCT00515086|7237087|FG001|STARTED|Overall Study||6
6330081|NCT00515086|7237088|FG002|STARTED|Overall Study||5
6330082|NCT00515086|7237089|FG003|STARTED|Overall Study||6
6330083|NCT00515086|7237086|FG000|COMPLETED|Overall Study||0
6330084|NCT00515086|7237087|FG001|COMPLETED|Overall Study||0
6330085|NCT00515086|7237088|FG002|COMPLETED|Overall Study||0
6330086|NCT00515086|7237089|FG003|COMPLETED|Overall Study||0
6330087|NCT00515086|7237086|FG000|NOT COMPLETED|Overall Study||24
6330088|NCT00515086|7237087|FG001|NOT COMPLETED|Overall Study||6
6330089|NCT00515086|7237088|FG002|NOT COMPLETED|Overall Study||5
6330090|NCT00515086|7237089|FG003|NOT COMPLETED|Overall Study||6
6330091|NCT00515099|7237107|FG000|STARTED|Overall Study||38
6330092|NCT00515099|7237108|FG001|STARTED|Overall Study||20
6330093|NCT00515099|7237107|FG000|COMPLETED|Overall Study||35
6330094|NCT00515099|7237108|FG001|COMPLETED|Overall Study||16
6330095|NCT00515099|7237107|FG000|NOT COMPLETED|Overall Study||3
6330096|NCT00515099|7237108|FG001|NOT COMPLETED|Overall Study||4
6330097|NCT00515177|7237116|FG000|STARTED|Overall Study||20
6330098|NCT00515177|7237117|FG001|STARTED|Overall Study||10
6330099|NCT00515177|7237116|FG000|COMPLETED|Overall Study||18
6330100|NCT00515177|7237117|FG001|COMPLETED|Overall Study||9
6330101|NCT00515177|7237116|FG000|NOT COMPLETED|Overall Study||2
6330102|NCT00515177|7237117|FG001|NOT COMPLETED|Overall Study||1
6330103|NCT00515203|7237126|FG000|STARTED|Overall Study||17
6330104|NCT00515203|7237127|FG001|STARTED|Overall Study||5
6330105|NCT00515203|7237126|FG000|COMPLETED|Overall Study||17
6330106|NCT00515203|7237127|FG001|COMPLETED|Overall Study||5
6330107|NCT00515203|7237126|FG000|NOT COMPLETED|Overall Study||0
6330108|NCT00515203|7237127|FG001|NOT COMPLETED|Overall Study||0
6330109|NCT00515216|7237133|FG000|STARTED|Overall Study||26
6330110|NCT00515216|7237133|FG000|COMPLETED|Overall Study||25
6330111|NCT00515216|7237133|FG000|NOT COMPLETED|Overall Study||1
6330112|NCT00515294|7237142|FG000|STARTED|Overall Study||38
6330113|NCT00515294|7237143|FG001|STARTED|Overall Study||39
6330114|NCT00515294|7237144|FG002|STARTED|Overall Study||38
6330115|NCT00515294|7237145|FG003|STARTED|Overall Study||39
6330116|NCT00515294|7237142|FG000|COMPLETED|Overall Study||29
6330117|NCT00515294|7237143|FG001|COMPLETED|Overall Study||36
6330118|NCT00515294|7237144|FG002|COMPLETED|Overall Study||27
6330119|NCT00515294|7237145|FG003|COMPLETED|Overall Study||35
6330120|NCT00515294|7237142|FG000|NOT COMPLETED|Overall Study||9
6330121|NCT00515294|7237143|FG001|NOT COMPLETED|Overall Study||3
6330122|NCT00515294|7237144|FG002|NOT COMPLETED|Overall Study||11
6330123|NCT00515294|7237145|FG003|NOT COMPLETED|Overall Study||4
6330124|NCT00515411|7237158|FG000|STARTED|Overall Study||54
6330125|NCT00515411|7237159|FG001|STARTED|Overall Study||31
6330126|NCT00515411|7237160|FG002|STARTED|Overall Study||26
6330127|NCT00515411|7237158|FG000|COMPLETED|Overall Study||54
6330128|NCT00515411|7237159|FG001|COMPLETED|Overall Study||31
6330129|NCT00515411|7237160|FG002|COMPLETED|Overall Study||26
6330130|NCT00515411|7237158|FG000|NOT COMPLETED|Overall Study||0
6330131|NCT00515411|7237159|FG001|NOT COMPLETED|Overall Study||0
6330132|NCT00515411|7237160|FG002|NOT COMPLETED|Overall Study||0
6330133|NCT00515437|7237172|FG000|STARTED|Overall Study||14
6330134|NCT00515437|7237173|FG001|STARTED|Overall Study||12
6330135|NCT00515437|7237174|FG002|STARTED|Overall Study||13
6330136|NCT00515437|7237175|FG003|STARTED|Overall Study||15
6330137|NCT00515437|7237172|FG000|COMPLETED|Overall Study||14
6330138|NCT00515437|7237173|FG001|COMPLETED|Overall Study||12
6330139|NCT00515437|7237174|FG002|COMPLETED|Overall Study||13
6330140|NCT00515437|7237175|FG003|COMPLETED|Overall Study||14
6330141|NCT00515437|7237172|FG000|NOT COMPLETED|Overall Study||0
6330142|NCT00515437|7237173|FG001|NOT COMPLETED|Overall Study||0
6330143|NCT00515437|7237174|FG002|NOT COMPLETED|Overall Study||0
6330144|NCT00515437|7237175|FG003|NOT COMPLETED|Overall Study||1
6330145|NCT00515463|7237187|FG000|STARTED|Overall Study||155
6330146|NCT00515463|7237188|FG001|STARTED|Overall Study||156
6330147|NCT00515463|7237187|FG000|Received Study Medication|Overall Study||154
6330148|NCT00515463|7237188|FG001|Received Study Medication|Overall Study||156
6330149|NCT00515463|7237187|FG000|COMPLETED|Overall Study||141
6330150|NCT00515463|7237188|FG001|COMPLETED|Overall Study||142
6330151|NCT00515463|7237187|FG000|NOT COMPLETED|Overall Study||14
6330152|NCT00515463|7237188|FG001|NOT COMPLETED|Overall Study||14
6330153|NCT00515502|7237195|FG000|STARTED|Treatment Period 1||1
6330154|NCT00515502|7237196|FG001|STARTED|Treatment Period 1||4
6330155|NCT00515502|7237197|FG002|STARTED|Treatment Period 1||4
6330156|NCT00515502|7237198|FG003|STARTED|Treatment Period 1||3
6330157|NCT00515502|7237199|FG004|STARTED|Treatment Period 1||3
6330158|NCT00515502|7237200|FG005|STARTED|Treatment Period 1||1
6330159|NCT00515502|7237201|FG006|STARTED|Treatment Period 1||2
6330160|NCT00515502|7237202|FG007|STARTED|Treatment Period 1||1
6330161|NCT00515502|7237203|FG008|STARTED|Treatment Period 1||1
6330162|NCT00515502|7237204|FG009|STARTED|Treatment Period 1||2
6330163|NCT00515502|7237205|FG010|STARTED|Treatment Period 1||1
6330164|NCT00515502|7237206|FG011|STARTED|Treatment Period 1||1
6330165|NCT00515502|7237195|FG000|COMPLETED|Treatment Period 1||1
6330166|NCT00515502|7237196|FG001|COMPLETED|Treatment Period 1||4
6330167|NCT00515502|7237197|FG002|COMPLETED|Treatment Period 1||4
6330168|NCT00515502|7237198|FG003|COMPLETED|Treatment Period 1||3
6330169|NCT00515502|7237199|FG004|COMPLETED|Treatment Period 1||3
6330170|NCT00515502|7237200|FG005|COMPLETED|Treatment Period 1||1
6330171|NCT00515502|7237201|FG006|COMPLETED|Treatment Period 1||1
6330172|NCT00515502|7237202|FG007|COMPLETED|Treatment Period 1||1
6330173|NCT00515502|7237203|FG008|COMPLETED|Treatment Period 1||0
6330174|NCT00515502|7237204|FG009|COMPLETED|Treatment Period 1||2
6330175|NCT00515502|7237205|FG010|COMPLETED|Treatment Period 1||1
6330176|NCT00515502|7237206|FG011|COMPLETED|Treatment Period 1||0
6330177|NCT00515502|7237195|FG000|NOT COMPLETED|Treatment Period 1||0
6330178|NCT00515502|7237196|FG001|NOT COMPLETED|Treatment Period 1||0
6330179|NCT00515502|7237197|FG002|NOT COMPLETED|Treatment Period 1||0
6330180|NCT00515502|7237198|FG003|NOT COMPLETED|Treatment Period 1||0
6330181|NCT00515502|7237199|FG004|NOT COMPLETED|Treatment Period 1||0
6330182|NCT00515502|7237200|FG005|NOT COMPLETED|Treatment Period 1||0
6330183|NCT00515502|7237201|FG006|NOT COMPLETED|Treatment Period 1||1
6330184|NCT00515502|7237202|FG007|NOT COMPLETED|Treatment Period 1||0
6330185|NCT00515502|7237203|FG008|NOT COMPLETED|Treatment Period 1||1
6330186|NCT00515502|7237204|FG009|NOT COMPLETED|Treatment Period 1||0
6330187|NCT00515502|7237205|FG010|NOT COMPLETED|Treatment Period 1||0
6330188|NCT00515502|7237206|FG011|NOT COMPLETED|Treatment Period 1||1
6330189|NCT00515502|7237195|FG000|STARTED|Washout Period 1||1
6330190|NCT00515502|7237196|FG001|STARTED|Washout Period 1||4
6330191|NCT00515502|7237197|FG002|STARTED|Washout Period 1||4
6330192|NCT00515502|7237198|FG003|STARTED|Washout Period 1||3
6330193|NCT00515502|7237199|FG004|STARTED|Washout Period 1||3
6330194|NCT00515502|7237200|FG005|STARTED|Washout Period 1||1
6330195|NCT00515502|7237201|FG006|STARTED|Washout Period 1||1
6330196|NCT00515502|7237202|FG007|STARTED|Washout Period 1||1
6330197|NCT00515502|7237203|FG008|STARTED|Washout Period 1||0
6330198|NCT00515502|7237204|FG009|STARTED|Washout Period 1||2
6330199|NCT00515502|7237205|FG010|STARTED|Washout Period 1||1
6330200|NCT00515502|7237206|FG011|STARTED|Washout Period 1||0
6330201|NCT00515502|7237195|FG000|COMPLETED|Washout Period 1||1
6330202|NCT00515502|7237196|FG001|COMPLETED|Washout Period 1||4
6330203|NCT00515502|7237197|FG002|COMPLETED|Washout Period 1||4
6330204|NCT00515502|7237198|FG003|COMPLETED|Washout Period 1||3
6330205|NCT00515502|7237199|FG004|COMPLETED|Washout Period 1||3
6330206|NCT00515502|7237200|FG005|COMPLETED|Washout Period 1||1
6330207|NCT00515502|7237201|FG006|COMPLETED|Washout Period 1||1
6330208|NCT00515502|7237202|FG007|COMPLETED|Washout Period 1||1
6330209|NCT00515502|7237203|FG008|COMPLETED|Washout Period 1||0
6330210|NCT00515502|7237204|FG009|COMPLETED|Washout Period 1||2
6330211|NCT00515502|7237205|FG010|COMPLETED|Washout Period 1||1
6330212|NCT00515502|7237206|FG011|COMPLETED|Washout Period 1||0
6330213|NCT00515502|7237195|FG000|NOT COMPLETED|Washout Period 1||0
6330214|NCT00515502|7237196|FG001|NOT COMPLETED|Washout Period 1||0
6330215|NCT00515502|7237197|FG002|NOT COMPLETED|Washout Period 1||0
6330216|NCT00515502|7237198|FG003|NOT COMPLETED|Washout Period 1||0
6330217|NCT00515502|7237199|FG004|NOT COMPLETED|Washout Period 1||0
6330218|NCT00515502|7237200|FG005|NOT COMPLETED|Washout Period 1||0
6330219|NCT00515502|7237201|FG006|NOT COMPLETED|Washout Period 1||0
6330220|NCT00515502|7237202|FG007|NOT COMPLETED|Washout Period 1||0
6330221|NCT00515502|7237203|FG008|NOT COMPLETED|Washout Period 1||0
6330222|NCT00515502|7237204|FG009|NOT COMPLETED|Washout Period 1||0
6330223|NCT00515502|7237205|FG010|NOT COMPLETED|Washout Period 1||0
6330224|NCT00515502|7237206|FG011|NOT COMPLETED|Washout Period 1||0
6330225|NCT00515502|7237195|FG000|STARTED|Treatment Period 2||1
6330226|NCT00515502|7237196|FG001|STARTED|Treatment Period 2||4
6330227|NCT00515502|7237197|FG002|STARTED|Treatment Period 2||4
6330228|NCT00515502|7237198|FG003|STARTED|Treatment Period 2||3
6330229|NCT00515502|7237199|FG004|STARTED|Treatment Period 2||3
6330230|NCT00515502|7237200|FG005|STARTED|Treatment Period 2||1
6330231|NCT00515502|7237201|FG006|STARTED|Treatment Period 2||1
6330232|NCT00515502|7237202|FG007|STARTED|Treatment Period 2||1
6330233|NCT00515502|7237203|FG008|STARTED|Treatment Period 2||0
6330234|NCT00515502|7237204|FG009|STARTED|Treatment Period 2||2
6330235|NCT00515502|7237205|FG010|STARTED|Treatment Period 2||1
6330236|NCT00515502|7237206|FG011|STARTED|Treatment Period 2||0
6330237|NCT00515502|7237195|FG000|COMPLETED|Treatment Period 2||1
6330238|NCT00515502|7237196|FG001|COMPLETED|Treatment Period 2||3
6330239|NCT00515502|7237197|FG002|COMPLETED|Treatment Period 2||4
6330240|NCT00515502|7237198|FG003|COMPLETED|Treatment Period 2||3
6330241|NCT00515502|7237199|FG004|COMPLETED|Treatment Period 2||3
6330242|NCT00515502|7237200|FG005|COMPLETED|Treatment Period 2||1
6330243|NCT00515502|7237201|FG006|COMPLETED|Treatment Period 2||1
6330244|NCT00515502|7237202|FG007|COMPLETED|Treatment Period 2||1
6330245|NCT00515502|7237203|FG008|COMPLETED|Treatment Period 2||0
6330246|NCT00515502|7237204|FG009|COMPLETED|Treatment Period 2||2
6330247|NCT00515502|7237205|FG010|COMPLETED|Treatment Period 2||1
6330248|NCT00515502|7237206|FG011|COMPLETED|Treatment Period 2||0
6330249|NCT00515502|7237195|FG000|NOT COMPLETED|Treatment Period 2||0
6330250|NCT00515502|7237196|FG001|NOT COMPLETED|Treatment Period 2||1
6330251|NCT00515502|7237197|FG002|NOT COMPLETED|Treatment Period 2||0
6330252|NCT00515502|7237198|FG003|NOT COMPLETED|Treatment Period 2||0
6330253|NCT00515502|7237199|FG004|NOT COMPLETED|Treatment Period 2||0
6330254|NCT00515502|7237200|FG005|NOT COMPLETED|Treatment Period 2||0
6330255|NCT00515502|7237201|FG006|NOT COMPLETED|Treatment Period 2||0
6330256|NCT00515502|7237202|FG007|NOT COMPLETED|Treatment Period 2||0
6330257|NCT00515502|7237203|FG008|NOT COMPLETED|Treatment Period 2||0
6330258|NCT00515502|7237204|FG009|NOT COMPLETED|Treatment Period 2||0
6330259|NCT00515502|7237205|FG010|NOT COMPLETED|Treatment Period 2||0
6330260|NCT00515502|7237206|FG011|NOT COMPLETED|Treatment Period 2||0
6330261|NCT00515502|7237195|FG000|STARTED|Washout Period 2||1
6330262|NCT00515502|7237196|FG001|STARTED|Washout Period 2||3
6330263|NCT00515502|7237197|FG002|STARTED|Washout Period 2||4
6330264|NCT00515502|7237198|FG003|STARTED|Washout Period 2||3
6330265|NCT00515502|7237199|FG004|STARTED|Washout Period 2||3
6330266|NCT00515502|7237200|FG005|STARTED|Washout Period 2||1
6330267|NCT00515502|7237201|FG006|STARTED|Washout Period 2||1
6330268|NCT00515502|7237202|FG007|STARTED|Washout Period 2||1
6330269|NCT00515502|7237203|FG008|STARTED|Washout Period 2||0
6330270|NCT00515502|7237204|FG009|STARTED|Washout Period 2||2
6330271|NCT00515502|7237205|FG010|STARTED|Washout Period 2||1
6330272|NCT00515502|7237206|FG011|STARTED|Washout Period 2||0
6330273|NCT00515502|7237195|FG000|COMPLETED|Washout Period 2||1
6330274|NCT00515502|7237196|FG001|COMPLETED|Washout Period 2||3
6330275|NCT00515502|7237197|FG002|COMPLETED|Washout Period 2||4
6330276|NCT00515502|7237198|FG003|COMPLETED|Washout Period 2||3
6330277|NCT00515502|7237199|FG004|COMPLETED|Washout Period 2||3
6330278|NCT00515502|7237200|FG005|COMPLETED|Washout Period 2||1
6330279|NCT00515502|7237201|FG006|COMPLETED|Washout Period 2||1
6330280|NCT00515502|7237202|FG007|COMPLETED|Washout Period 2||1
6330281|NCT00515502|7237203|FG008|COMPLETED|Washout Period 2||0
6330282|NCT00515502|7237204|FG009|COMPLETED|Washout Period 2||2
6330283|NCT00515502|7237205|FG010|COMPLETED|Washout Period 2||1
6330284|NCT00515502|7237206|FG011|COMPLETED|Washout Period 2||0
6330285|NCT00515502|7237195|FG000|NOT COMPLETED|Washout Period 2||0
6330286|NCT00515502|7237196|FG001|NOT COMPLETED|Washout Period 2||0
6330287|NCT00515502|7237197|FG002|NOT COMPLETED|Washout Period 2||0
6330288|NCT00515502|7237198|FG003|NOT COMPLETED|Washout Period 2||0
6330289|NCT00515502|7237199|FG004|NOT COMPLETED|Washout Period 2||0
6330290|NCT00515502|7237200|FG005|NOT COMPLETED|Washout Period 2||0
6330291|NCT00515502|7237201|FG006|NOT COMPLETED|Washout Period 2||0
6330292|NCT00515502|7237202|FG007|NOT COMPLETED|Washout Period 2||0
6330293|NCT00515502|7237203|FG008|NOT COMPLETED|Washout Period 2||0
6330294|NCT00515502|7237204|FG009|NOT COMPLETED|Washout Period 2||0
6330295|NCT00515502|7237205|FG010|NOT COMPLETED|Washout Period 2||0
6330296|NCT00515502|7237206|FG011|NOT COMPLETED|Washout Period 2||0
6330297|NCT00515502|7237195|FG000|STARTED|Treatment Period 3||1
6330298|NCT00515502|7237196|FG001|STARTED|Treatment Period 3||3
6330299|NCT00515502|7237197|FG002|STARTED|Treatment Period 3||4
6330300|NCT00515502|7237198|FG003|STARTED|Treatment Period 3||3
6330301|NCT00515502|7237199|FG004|STARTED|Treatment Period 3||3
6330302|NCT00515502|7237200|FG005|STARTED|Treatment Period 3||1
6330303|NCT00515502|7237201|FG006|STARTED|Treatment Period 3||1
6330304|NCT00515502|7237202|FG007|STARTED|Treatment Period 3||1
6330305|NCT00515502|7237203|FG008|STARTED|Treatment Period 3||0
6330306|NCT00515502|7237204|FG009|STARTED|Treatment Period 3||2
6330307|NCT00515502|7237205|FG010|STARTED|Treatment Period 3||1
6330308|NCT00515502|7237206|FG011|STARTED|Treatment Period 3||0
6330309|NCT00515502|7237195|FG000|COMPLETED|Treatment Period 3||1
6330310|NCT00515502|7237196|FG001|COMPLETED|Treatment Period 3||3
6330311|NCT00515502|7237197|FG002|COMPLETED|Treatment Period 3||4
6330312|NCT00515502|7237198|FG003|COMPLETED|Treatment Period 3||3
6330313|NCT00515502|7237199|FG004|COMPLETED|Treatment Period 3||3
6330314|NCT00515502|7237200|FG005|COMPLETED|Treatment Period 3||1
6330315|NCT00515502|7237201|FG006|COMPLETED|Treatment Period 3||1
6330316|NCT00515502|7237202|FG007|COMPLETED|Treatment Period 3||1
6558626|NCT01775904|7481190|FG000|STARTED|LY2886721 ODT (Water, Fed)||25
6558627|NCT01775904|7481190|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fed)||25
6558628|NCT01775904|7481190|FG000|COMPLETED|LY2886721 ODT (Water, Fed)||25
6330317|NCT00515502|7237203|FG008|COMPLETED|Treatment Period 3||0
6330318|NCT00515502|7237204|FG009|COMPLETED|Treatment Period 3||2
6330319|NCT00515502|7237205|FG010|COMPLETED|Treatment Period 3||1
6330320|NCT00515502|7237206|FG011|COMPLETED|Treatment Period 3||0
6330321|NCT00515502|7237195|FG000|NOT COMPLETED|Treatment Period 3||0
6330322|NCT00515502|7237196|FG001|NOT COMPLETED|Treatment Period 3||0
6330323|NCT00515502|7237197|FG002|NOT COMPLETED|Treatment Period 3||0
6330324|NCT00515502|7237198|FG003|NOT COMPLETED|Treatment Period 3||0
6330325|NCT00515502|7237199|FG004|NOT COMPLETED|Treatment Period 3||0
6330326|NCT00515502|7237200|FG005|NOT COMPLETED|Treatment Period 3||0
6330327|NCT00515502|7237201|FG006|NOT COMPLETED|Treatment Period 3||0
6330328|NCT00515502|7237202|FG007|NOT COMPLETED|Treatment Period 3||0
6330329|NCT00515502|7237203|FG008|NOT COMPLETED|Treatment Period 3||0
6330330|NCT00515502|7237204|FG009|NOT COMPLETED|Treatment Period 3||0
6330331|NCT00515502|7237205|FG010|NOT COMPLETED|Treatment Period 3||0
6330332|NCT00515502|7237206|FG011|NOT COMPLETED|Treatment Period 3||0
6330333|NCT00515502|7237195|FG000|STARTED|Washout Period 3||1
6330334|NCT00515502|7237196|FG001|STARTED|Washout Period 3||3
6330335|NCT00515502|7237197|FG002|STARTED|Washout Period 3||4
6330336|NCT00515502|7237198|FG003|STARTED|Washout Period 3||3
6330337|NCT00515502|7237199|FG004|STARTED|Washout Period 3||3
6330338|NCT00515502|7237200|FG005|STARTED|Washout Period 3||1
6330339|NCT00515502|7237201|FG006|STARTED|Washout Period 3||1
6558629|NCT01775904|7481190|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fed)||0
6558630|NCT01775904|7481190|FG000|STARTED|Third Washout (7 Days)||25
6558631|NCT01775904|7481190|FG000|COMPLETED|Third Washout (7 Days)||25
6558632|NCT01775904|7481190|FG000|NOT COMPLETED|Third Washout (7 Days)||0
6558633|NCT01775904|7481190|FG000|STARTED|LY2886721 ODT (Water, Fasting)||25
6330340|NCT00515502|7237202|FG007|STARTED|Washout Period 3||1
6330341|NCT00515502|7237203|FG008|STARTED|Washout Period 3||0
6330342|NCT00515502|7237204|FG009|STARTED|Washout Period 3||2
6562863|NCT01803269|7485764|FG001|STARTED|Overall Study||8
6330343|NCT00515502|7237205|FG010|STARTED|Washout Period 3||1
6330344|NCT00515502|7237206|FG011|STARTED|Washout Period 3||0
6330345|NCT00515502|7237195|FG000|COMPLETED|Washout Period 3||1
6330346|NCT00515502|7237196|FG001|COMPLETED|Washout Period 3||3
6330347|NCT00515502|7237197|FG002|COMPLETED|Washout Period 3||4
6330348|NCT00515502|7237198|FG003|COMPLETED|Washout Period 3||3
6330349|NCT00515502|7237199|FG004|COMPLETED|Washout Period 3||3
6330350|NCT00515502|7237200|FG005|COMPLETED|Washout Period 3||1
6330351|NCT00515502|7237201|FG006|COMPLETED|Washout Period 3||1
6562864|NCT01803269|7485765|FG002|STARTED|Overall Study||14
6562865|NCT01803269|7485763|FG000|COMPLETED|Overall Study||4
6330352|NCT00515502|7237202|FG007|COMPLETED|Washout Period 3||1
6330353|NCT00515502|7237203|FG008|COMPLETED|Washout Period 3||0
6330354|NCT00515502|7237204|FG009|COMPLETED|Washout Period 3||2
6330355|NCT00515502|7237205|FG010|COMPLETED|Washout Period 3||1
6330356|NCT00515502|7237206|FG011|COMPLETED|Washout Period 3||0
6330357|NCT00515502|7237195|FG000|NOT COMPLETED|Washout Period 3||0
6330358|NCT00515502|7237196|FG001|NOT COMPLETED|Washout Period 3||0
6330359|NCT00515502|7237197|FG002|NOT COMPLETED|Washout Period 3||0
6330360|NCT00515502|7237198|FG003|NOT COMPLETED|Washout Period 3||0
6330361|NCT00515502|7237199|FG004|NOT COMPLETED|Washout Period 3||0
6330362|NCT00515502|7237200|FG005|NOT COMPLETED|Washout Period 3||0
6330363|NCT00515502|7237201|FG006|NOT COMPLETED|Washout Period 3||0
6330364|NCT00515502|7237202|FG007|NOT COMPLETED|Washout Period 3||0
6330365|NCT00515502|7237203|FG008|NOT COMPLETED|Washout Period 3||0
6330366|NCT00515502|7237204|FG009|NOT COMPLETED|Washout Period 3||0
6330367|NCT00515502|7237205|FG010|NOT COMPLETED|Washout Period 3||0
6330368|NCT00515502|7237206|FG011|NOT COMPLETED|Washout Period 3||0
6330369|NCT00515502|7237195|FG000|STARTED|Treatment Period 4||1
6330370|NCT00515502|7237196|FG001|STARTED|Treatment Period 4||3
6330371|NCT00515502|7237197|FG002|STARTED|Treatment Period 4||4
6330372|NCT00515502|7237198|FG003|STARTED|Treatment Period 4||3
6330373|NCT00515502|7237199|FG004|STARTED|Treatment Period 4||3
6330374|NCT00515502|7237200|FG005|STARTED|Treatment Period 4||1
6330375|NCT00515502|7237201|FG006|STARTED|Treatment Period 4||1
6330376|NCT00515502|7237202|FG007|STARTED|Treatment Period 4||1
6330377|NCT00515502|7237203|FG008|STARTED|Treatment Period 4||0
6330378|NCT00515502|7237204|FG009|STARTED|Treatment Period 4||2
6330379|NCT00515502|7237205|FG010|STARTED|Treatment Period 4||1
6330380|NCT00515502|7237206|FG011|STARTED|Treatment Period 4||0
6330381|NCT00515502|7237195|FG000|COMPLETED|Treatment Period 4||1
6330382|NCT00515502|7237196|FG001|COMPLETED|Treatment Period 4||3
6330383|NCT00515502|7237197|FG002|COMPLETED|Treatment Period 4||4
6330384|NCT00515502|7237198|FG003|COMPLETED|Treatment Period 4||3
6330385|NCT00515502|7237199|FG004|COMPLETED|Treatment Period 4||3
6330386|NCT00515502|7237200|FG005|COMPLETED|Treatment Period 4||1
6330387|NCT00515502|7237201|FG006|COMPLETED|Treatment Period 4||1
6330388|NCT00515502|7237202|FG007|COMPLETED|Treatment Period 4||1
6330389|NCT00515502|7237203|FG008|COMPLETED|Treatment Period 4||0
6330390|NCT00515502|7237204|FG009|COMPLETED|Treatment Period 4||2
6330391|NCT00515502|7237205|FG010|COMPLETED|Treatment Period 4||1
6330392|NCT00515502|7237206|FG011|COMPLETED|Treatment Period 4||0
6330393|NCT00515502|7237195|FG000|NOT COMPLETED|Treatment Period 4||0
6330394|NCT00515502|7237196|FG001|NOT COMPLETED|Treatment Period 4||0
6330395|NCT00515502|7237197|FG002|NOT COMPLETED|Treatment Period 4||0
6330396|NCT00515502|7237198|FG003|NOT COMPLETED|Treatment Period 4||0
6330397|NCT00515502|7237199|FG004|NOT COMPLETED|Treatment Period 4||0
6330398|NCT00515502|7237200|FG005|NOT COMPLETED|Treatment Period 4||0
6330399|NCT00515502|7237201|FG006|NOT COMPLETED|Treatment Period 4||0
6330400|NCT00515502|7237202|FG007|NOT COMPLETED|Treatment Period 4||0
6330401|NCT00515502|7237203|FG008|NOT COMPLETED|Treatment Period 4||0
6330402|NCT00515502|7237204|FG009|NOT COMPLETED|Treatment Period 4||0
6330403|NCT00515502|7237205|FG010|NOT COMPLETED|Treatment Period 4||0
6330404|NCT00515502|7237206|FG011|NOT COMPLETED|Treatment Period 4||0
6330405|NCT00515528|7237225|FG000|STARTED|Overall Study||10
6330406|NCT00515528|7237226|FG001|STARTED|Overall Study||7
6330407|NCT00515528|7237225|FG000|COMPLETED|Overall Study||10
6330408|NCT00515528|7237226|FG001|COMPLETED|Overall Study||7
6330409|NCT00515528|7237225|FG000|NOT COMPLETED|Overall Study||0
6330410|NCT00515528|7237226|FG001|NOT COMPLETED|Overall Study||0
6330411|NCT00515541|7237236|FG000|STARTED|Overall Study||10
6330412|NCT00515541|7237237|FG001|STARTED|Overall Study||12
6330413|NCT00515541|7237238|FG002|STARTED|Overall Study||10
6330414|NCT00515541|7237239|FG003|STARTED|Overall Study||11
6330415|NCT00515541|7237236|FG000|6 Weeks (1 gm Lovaza)|Overall Study||10
6330416|NCT00515541|7237237|FG001|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
6330417|NCT00515541|7237238|FG002|6 Weeks (1 gm Lovaza)|Overall Study||10
6330418|NCT00515541|7237239|FG003|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
6330419|NCT00515541|7237236|FG000|12 Weeks (2 gm Lovaza)|Overall Study||10
6330420|NCT00515541|7237237|FG001|12 Weeks (2 gm Lovaza)|Overall Study||10
6330421|NCT00515541|7237238|FG002|12 Weeks (2 gm Lovaza)|Overall Study||10
6330422|NCT00515541|7237239|FG003|12 Weeks (2 gm Lovaza)|Overall Study||10
6330423|NCT00515541|7237236|FG000|18 Weeks (4 gm Lovaza)|Overall Study||10
6330424|NCT00515541|7237237|FG001|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
6330425|NCT00515541|7237238|FG002|18 Weeks (4 gm Lovaza)|Overall Study||10
6330426|NCT00515541|7237239|FG003|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
6330427|NCT00515541|7237236|FG000|24 Weeks (8 gm Lovaza)|Overall Study||10
6376031|NCT00758485|7286549|FG001|STARTED|Overall Study||70
6376032|NCT00758485|7286548|FG000|TREATED|Overall Study||69
6330428|NCT00515541|7237237|FG001|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
6330429|NCT00515541|7237238|FG002|24 Weeks (8 gm Lovaza)|Overall Study||10
6330430|NCT00515541|7237239|FG003|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
6330431|NCT00515541|7237236|FG000|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
6330432|NCT00515541|7237237|FG001|COMPLETED|Overall Study||7
6330433|NCT00515541|7237238|FG002|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
6330434|NCT00515541|7237239|FG003|COMPLETED|Overall Study||6
6330435|NCT00515541|7237236|FG000|NOT COMPLETED|Overall Study||0
6330436|NCT00515541|7237237|FG001|NOT COMPLETED|Overall Study||5
6330437|NCT00515541|7237238|FG002|NOT COMPLETED|Overall Study||0
6330438|NCT00515541|7237239|FG003|NOT COMPLETED|Overall Study||5
6330439|NCT00515619|7237249|FG000|STARTED|Overall Study||376
6558634|NCT01775904|7481190|FG000|Received at Least One Dose of Drug|LY2886721 ODT (Water, Fasting)|One participant was not dosed in this period due to an adverse event (AE).|24
6558635|NCT01775904|7481190|FG000|COMPLETED|LY2886721 ODT (Water, Fasting)||24
6558636|NCT01775904|7481190|FG000|NOT COMPLETED|LY2886721 ODT (Water, Fasting)||1
6558637|NCT01775930|7481200|FG000|STARTED|Overall Study||10
6330440|NCT00515619|7237249|FG000|Safety Set|Overall Study||376
6330441|NCT00515619|7237249|FG000|COMPLETED|Overall Study||160
6330442|NCT00515619|7237249|FG000|NOT COMPLETED|Overall Study||216
6330443|NCT00515697|7237253|FG000|STARTED|Overall Study||39
6330444|NCT00515697|7237253|FG000|Received at Least 1 Dose of Study Drug|Overall Study||39
6330445|NCT00515697|7237253|FG000|COMPLETED|Overall Study||39
6330446|NCT00515697|7237253|FG000|NOT COMPLETED|Overall Study||0
6330447|NCT00515723|7237261|FG000|STARTED|Overall Study||25
6330448|NCT00515723|7237262|FG001|STARTED|Overall Study||22
6330449|NCT00515723|7237263|FG002|STARTED|Overall Study||22
6330450|NCT00515723|7237264|FG003|STARTED|Overall Study||27
6330451|NCT00515723|7237261|FG000|COMPLETED|Overall Study||20
6330452|NCT00515723|7237262|FG001|COMPLETED|Overall Study||21
6330453|NCT00515723|7237263|FG002|COMPLETED|Overall Study||21
6330454|NCT00515723|7237264|FG003|COMPLETED|Overall Study||21
6330455|NCT00515723|7237261|FG000|NOT COMPLETED|Overall Study||5
6330456|NCT00515723|7237262|FG001|NOT COMPLETED|Overall Study||1
6330457|NCT00515723|7237263|FG002|NOT COMPLETED|Overall Study||1
6330458|NCT00515723|7237264|FG003|NOT COMPLETED|Overall Study||6
6330459|NCT00515827|7237277|FG000|STARTED|First Intervention (12 Weeks)||27
6330460|NCT00515827|7237278|FG001|STARTED|First Intervention (12 Weeks)||26
6330461|NCT00515827|7237277|FG000|COMPLETED|First Intervention (12 Weeks)||26
6330462|NCT00515827|7237278|FG001|COMPLETED|First Intervention (12 Weeks)||25
6330463|NCT00515827|7237277|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
6330464|NCT00515827|7237278|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
6330465|NCT00515827|7237277|FG000|STARTED|Second Intervention (12 Weeks)||26
6330466|NCT00515827|7237278|FG001|STARTED|Second Intervention (12 Weeks)||25
6330467|NCT00515827|7237277|FG000|COMPLETED|Second Intervention (12 Weeks)||25
6330468|NCT00515827|7237278|FG001|COMPLETED|Second Intervention (12 Weeks)||25
6330469|NCT00515827|7237277|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||1
6330470|NCT00515827|7237278|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||0
6330471|NCT00515879|7237288|FG000|STARTED|Overall Study||87
6330472|NCT00515879|7237289|FG001|STARTED|Overall Study||82
6330473|NCT00515879|7237288|FG000|COMPLETED|Overall Study||62
6330474|NCT00515879|7237289|FG001|COMPLETED|Overall Study||62
6330475|NCT00515879|7237288|FG000|NOT COMPLETED|Overall Study||25
6330476|NCT00515879|7237289|FG001|NOT COMPLETED|Overall Study||20
6330477|NCT00516048|7237299|FG000|STARTED|Overall Study||15
6330478|NCT00516048|7237300|FG001|STARTED|Overall Study||42
6330479|NCT00516048|7237301|FG002|STARTED|Overall Study||1
6330480|NCT00516048|7237299|FG000|COMPLETED|Overall Study||15
6330481|NCT00516048|7237300|FG001|COMPLETED|Overall Study||40
6330482|NCT00516048|7237301|FG002|COMPLETED|Overall Study||0
6330483|NCT00516048|7237299|FG000|NOT COMPLETED|Overall Study||0
6330484|NCT00516048|7237300|FG001|NOT COMPLETED|Overall Study||2
6330485|NCT00516048|7237301|FG002|NOT COMPLETED|Overall Study||1
6330486|NCT00516074|7237311|FG000|STARTED|Overall Study||28
6330487|NCT00516074|7237312|FG001|STARTED|Overall Study||26
6330488|NCT00516074|7237311|FG000|COMPLETED|Overall Study||22
6330489|NCT00516074|7237312|FG001|COMPLETED|Overall Study||23
6330490|NCT00516074|7237311|FG000|NOT COMPLETED|Overall Study||6
6330491|NCT00516074|7237312|FG001|NOT COMPLETED|Overall Study||3
6330492|NCT00516139|7237318|FG000|STARTED|Overall Study||122
6330493|NCT00516139|7237318|FG000|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
6330494|NCT00516139|7237318|FG000|NOT COMPLETED|Overall Study||38
6330495|NCT00516165|7237326|FG000|STARTED|Overall Study||28
6330496|NCT00516165|7237326|FG000|COMPLETED|Overall Study||28
6330497|NCT00516165|7237326|FG000|NOT COMPLETED|Overall Study||0
6330498|NCT00516217|7237330|FG000|STARTED|Overall Study||29
6330499|NCT00516217|7237330|FG000|COMPLETED|Overall Study||29
6330500|NCT00516217|7237330|FG000|NOT COMPLETED|Overall Study||0
6330501|NCT00516269|7237336|FG000|STARTED|Overall Study||19
6330502|NCT00516269|7237337|FG001|STARTED|Overall Study||19
6330503|NCT00516269|7237336|FG000|COMPLETED|Overall Study|2 patients had an early termination|17
6330504|NCT00516269|7237337|FG001|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
6330505|NCT00516269|7237336|FG000|NOT COMPLETED|Overall Study||2
6330506|NCT00516269|7237337|FG001|NOT COMPLETED|Overall Study||3
6330507|NCT00516295|7237346|FG000|STARTED|Overall Study||7
6330508|NCT00516295|7237347|FG001|STARTED|Overall Study||0
6330509|NCT00516295|7237348|FG002|STARTED|Overall Study||0
6330510|NCT00516295|7237346|FG000|COMPLETED|Overall Study||4
6330511|NCT00516295|7237347|FG001|COMPLETED|Overall Study||0
6330512|NCT00516295|7237348|FG002|COMPLETED|Overall Study||0
6330513|NCT00516295|7237346|FG000|NOT COMPLETED|Overall Study||3
6330514|NCT00516295|7237347|FG001|NOT COMPLETED|Overall Study||0
6330515|NCT00516295|7237348|FG002|NOT COMPLETED|Overall Study||0
6558638|NCT01775930|7481200|FG000|COMPLETED|Overall Study||9
6558639|NCT01775930|7481200|FG000|NOT COMPLETED|Overall Study||1
6558640|NCT01775995|7481206|FG000|STARTED|Overall Study||21
6330516|NCT00516321|7237358|FG000|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
6330517|NCT00516321|7237359|FG001|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
6330518|NCT00516321|7237360|FG002|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
6330519|NCT00516321|7237358|FG000|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
6330520|NCT00516321|7237359|FG001|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
6330521|NCT00516321|7237360|FG002|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
6330522|NCT00516321|7237358|FG000|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
6330523|NCT00516321|7237359|FG001|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
6330524|NCT00516321|7237360|FG002|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
6330525|NCT00516321|7237358|FG000|STARTED|Double-blind (DB) Antiviral Treatment||0
6330526|NCT00516321|7237359|FG001|STARTED|Double-blind (DB) Antiviral Treatment||232
6330527|NCT00516321|7237360|FG002|STARTED|Double-blind (DB) Antiviral Treatment||450
6330528|NCT00516321|7237358|FG000|COMPLETED|Double-blind (DB) Antiviral Treatment||0
6330529|NCT00516321|7237359|FG001|COMPLETED|Double-blind (DB) Antiviral Treatment||197
6330530|NCT00516321|7237360|FG002|COMPLETED|Double-blind (DB) Antiviral Treatment||396
6330531|NCT00516321|7237358|FG000|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
6330532|NCT00516321|7237359|FG001|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
6330533|NCT00516321|7237360|FG002|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
6330534|NCT00516386|7237368|FG000|STARTED|Overall Study||16
6330535|NCT00516386|7237368|FG000|COMPLETED|Overall Study||10
6330536|NCT00516386|7237368|FG000|NOT COMPLETED|Overall Study||6
6330537|NCT00516503|7237374|FG000|STARTED|Overall Study||101
6330538|NCT00516503|7237375|FG001|STARTED|Overall Study||102
6330539|NCT00516503|7237374|FG000|COMPLETED|Overall Study||101
6330540|NCT00516503|7237375|FG001|COMPLETED|Overall Study||102
6330541|NCT00516503|7237374|FG000|NOT COMPLETED|Overall Study||0
6330542|NCT00516503|7237375|FG001|NOT COMPLETED|Overall Study||0
6330543|NCT00516893|7237381|FG000|STARTED|Overall Study||113
6330544|NCT00516893|7237381|FG000|Received Study Treatment|Overall Study||112
6330545|NCT00516893|7237381|FG000|COMPLETED|Overall Study||92
6330546|NCT00516893|7237381|FG000|NOT COMPLETED|Overall Study||21
6330547|NCT00516906|7237387|FG000|STARTED|Overall Study||36
6330548|NCT00516906|7237388|FG001|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
6330549|NCT00516906|7237387|FG000|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
6330550|NCT00516906|7237388|FG001|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
6330551|NCT00516906|7237387|FG000|NOT COMPLETED|Overall Study||6
6330552|NCT00516906|7237388|FG001|NOT COMPLETED|Overall Study||2
6330553|NCT00516919|7237394|FG000|STARTED|Overall Study||40
6330554|NCT00516919|7237395|FG001|STARTED|Overall Study||39
6330555|NCT00516919|7237394|FG000|COMPLETED|Overall Study||30
6330556|NCT00516919|7237395|FG001|COMPLETED|Overall Study||32
6330557|NCT00516919|7237394|FG000|NOT COMPLETED|Overall Study||10
6330558|NCT00516919|7237395|FG001|NOT COMPLETED|Overall Study||7
6330559|NCT00517010|7237401|FG000|STARTED|Overall Study||6
6330560|NCT00517010|7237401|FG000|COMPLETED|Overall Study||5
6330561|NCT00517010|7237401|FG000|NOT COMPLETED|Overall Study||1
6330562|NCT00517296|7237407|FG000|STARTED|Overall Study||10
6330563|NCT00517296|7237408|FG001|STARTED|Overall Study||11
6330564|NCT00517296|7237407|FG000|COMPLETED|Overall Study||9
6330565|NCT00517296|7237408|FG001|COMPLETED|Overall Study||11
6330566|NCT00517296|7237407|FG000|NOT COMPLETED|Overall Study||1
6330567|NCT00517296|7237408|FG001|NOT COMPLETED|Overall Study||0
6330568|NCT00517413|7237414|FG000|STARTED|Overall Study||163
6330569|NCT00517413|7237414|FG000|COMPLETED|Overall Study||102
6330570|NCT00517413|7237414|FG000|NOT COMPLETED|Overall Study||61
6330571|NCT00517530|7237425|FG000|STARTED|Overall Study||21
6330572|NCT00517530|7237426|FG001|STARTED|Overall Study||13
6330573|NCT00517530|7237427|FG002|STARTED|Overall Study||18
6330574|NCT00517530|7237428|FG003|STARTED|Overall Study||22
6330575|NCT00517530|7237429|FG004|STARTED|Overall Study||21
6330576|NCT00517530|7237430|FG005|STARTED|Overall Study||19
6330577|NCT00517530|7237431|FG006|STARTED|Overall Study||20
6330578|NCT00517530|7237425|FG000|Completed Treatment|Overall Study||11
6330579|NCT00517530|7237426|FG001|Completed Treatment|Overall Study||13
6330580|NCT00517530|7237427|FG002|Completed Treatment|Overall Study||13
6330581|NCT00517530|7237428|FG003|Completed Treatment|Overall Study||18
6330582|NCT00517530|7237429|FG004|Completed Treatment|Overall Study||9
6330583|NCT00517530|7237430|FG005|Completed Treatment|Overall Study||9
6330584|NCT00517530|7237431|FG006|Completed Treatment|Overall Study||13
6330585|NCT00517530|7237425|FG000|Started Follow-up|Overall Study||20
6330586|NCT00517530|7237426|FG001|Started Follow-up|Overall Study||13
6558641|NCT01775995|7481207|FG001|STARTED|Overall Study||14
6562866|NCT01803269|7485764|FG001|COMPLETED|Overall Study||8
6330587|NCT00517530|7237427|FG002|Started Follow-up|Overall Study||17
6330588|NCT00517530|7237428|FG003|Started Follow-up|Overall Study||21
6330589|NCT00517530|7237429|FG004|Started Follow-up|Overall Study||17
6330590|NCT00517530|7237430|FG005|Started Follow-up|Overall Study||16
6330591|NCT00517530|7237431|FG006|Started Follow-up|Overall Study||19
6330592|NCT00517530|7237425|FG000|Completed Follow-up|Overall Study||2
6330593|NCT00517530|7237426|FG001|Completed Follow-up|Overall Study||0
6330594|NCT00517530|7237427|FG002|Completed Follow-up|Overall Study||0
6330595|NCT00517530|7237428|FG003|Completed Follow-up|Overall Study||1
6330596|NCT00517530|7237429|FG004|Completed Follow-up|Overall Study||0
6330597|NCT00517530|7237430|FG005|Completed Follow-up|Overall Study||0
6330598|NCT00517530|7237431|FG006|Completed Follow-up|Overall Study||1
6330599|NCT00517530|7237425|FG000|Retreated Population|Overall Study||2
6330600|NCT00517530|7237426|FG001|Retreated Population|Overall Study||2
6330601|NCT00517530|7237427|FG002|Retreated Population|Overall Study||1
6330602|NCT00517530|7237428|FG003|Retreated Population|Overall Study||4
6330603|NCT00517530|7237429|FG004|Retreated Population|Overall Study||2
6330604|NCT00517530|7237430|FG005|Retreated Population|Overall Study||2
6330605|NCT00517530|7237431|FG006|Retreated Population|Overall Study||0
6330606|NCT00517530|7237425|FG000|COMPLETED|Overall Study||2
6330607|NCT00517530|7237426|FG001|COMPLETED|Overall Study||0
6330608|NCT00517530|7237427|FG002|COMPLETED|Overall Study||0
6330609|NCT00517530|7237428|FG003|COMPLETED|Overall Study||1
6330610|NCT00517530|7237429|FG004|COMPLETED|Overall Study||1
6330611|NCT00517530|7237430|FG005|COMPLETED|Overall Study||0
6330612|NCT00517530|7237431|FG006|COMPLETED|Overall Study||1
6330613|NCT00517530|7237425|FG000|NOT COMPLETED|Overall Study||19
6330614|NCT00517530|7237426|FG001|NOT COMPLETED|Overall Study||13
6330615|NCT00517530|7237427|FG002|NOT COMPLETED|Overall Study||18
6330616|NCT00517530|7237428|FG003|NOT COMPLETED|Overall Study||21
6330617|NCT00517530|7237429|FG004|NOT COMPLETED|Overall Study||20
6330618|NCT00517530|7237430|FG005|NOT COMPLETED|Overall Study||19
6330619|NCT00517530|7237431|FG006|NOT COMPLETED|Overall Study||19
6330620|NCT00517556|7237464|FG000|STARTED|Overall Study||19
6330621|NCT00517556|7237465|FG001|STARTED|Overall Study||19
6330622|NCT00517556|7237464|FG000|COMPLETED|Overall Study||15
6330623|NCT00517556|7237465|FG001|COMPLETED|Overall Study||14
6330624|NCT00517556|7237464|FG000|NOT COMPLETED|Overall Study||4
6330625|NCT00517556|7237465|FG001|NOT COMPLETED|Overall Study||5
6330626|NCT00517595|7237471|FG000|STARTED|Overall Study||48
6330627|NCT00517595|7237471|FG000|COMPLETED|Overall Study||48
6330628|NCT00517595|7237471|FG000|NOT COMPLETED|Overall Study||0
6330629|NCT00517634|7237475|FG000|STARTED|First Treatment Period||4
6330630|NCT00517634|7237476|FG001|STARTED|First Treatment Period||4
6330631|NCT00517634|7237477|FG002|STARTED|First Treatment Period||4
6330632|NCT00517634|7237478|FG003|STARTED|First Treatment Period||3
6330633|NCT00517634|7237479|FG004|STARTED|First Treatment Period||4
6330634|NCT00517634|7237480|FG005|STARTED|First Treatment Period||4
6330635|NCT00517634|7237475|FG000|COMPLETED|First Treatment Period||4
6330636|NCT00517634|7237476|FG001|COMPLETED|First Treatment Period||4
6330637|NCT00517634|7237477|FG002|COMPLETED|First Treatment Period||4
6330638|NCT00517634|7237478|FG003|COMPLETED|First Treatment Period||3
6330639|NCT00517634|7237479|FG004|COMPLETED|First Treatment Period||4
6330640|NCT00517634|7237480|FG005|COMPLETED|First Treatment Period||4
6330641|NCT00517634|7237475|FG000|NOT COMPLETED|First Treatment Period||0
6330642|NCT00517634|7237476|FG001|NOT COMPLETED|First Treatment Period||0
6330643|NCT00517634|7237477|FG002|NOT COMPLETED|First Treatment Period||0
6330644|NCT00517634|7237478|FG003|NOT COMPLETED|First Treatment Period||0
6330645|NCT00517634|7237479|FG004|NOT COMPLETED|First Treatment Period||0
6330646|NCT00517634|7237480|FG005|NOT COMPLETED|First Treatment Period||0
6330647|NCT00517634|7237475|FG000|STARTED|Second Treatment Period||4
6330648|NCT00517634|7237476|FG001|STARTED|Second Treatment Period||4
6330649|NCT00517634|7237477|FG002|STARTED|Second Treatment Period||4
6330650|NCT00517634|7237478|FG003|STARTED|Second Treatment Period||3
6330651|NCT00517634|7237479|FG004|STARTED|Second Treatment Period||4
6330652|NCT00517634|7237480|FG005|STARTED|Second Treatment Period||4
6330653|NCT00517634|7237475|FG000|COMPLETED|Second Treatment Period||4
6330654|NCT00517634|7237476|FG001|COMPLETED|Second Treatment Period||4
6330655|NCT00517634|7237477|FG002|COMPLETED|Second Treatment Period||4
6330656|NCT00517634|7237478|FG003|COMPLETED|Second Treatment Period||3
6330657|NCT00517634|7237479|FG004|COMPLETED|Second Treatment Period||3
6330658|NCT00517634|7237480|FG005|COMPLETED|Second Treatment Period||4
6330659|NCT00517634|7237475|FG000|NOT COMPLETED|Second Treatment Period||0
6330660|NCT00517634|7237476|FG001|NOT COMPLETED|Second Treatment Period||0
6330661|NCT00517634|7237477|FG002|NOT COMPLETED|Second Treatment Period||0
6330662|NCT00517634|7237478|FG003|NOT COMPLETED|Second Treatment Period||0
6330663|NCT00517634|7237479|FG004|NOT COMPLETED|Second Treatment Period||1
6330664|NCT00517634|7237480|FG005|NOT COMPLETED|Second Treatment Period||0
6330665|NCT00517634|7237475|FG000|STARTED|Third Treatment Period||4
6330666|NCT00517634|7237476|FG001|STARTED|Third Treatment Period||4
6330667|NCT00517634|7237477|FG002|STARTED|Third Treatment Period||4
6330668|NCT00517634|7237478|FG003|STARTED|Third Treatment Period||3
6330669|NCT00517634|7237479|FG004|STARTED|Third Treatment Period||3
6330670|NCT00517634|7237480|FG005|STARTED|Third Treatment Period||4
6330671|NCT00517634|7237475|FG000|COMPLETED|Third Treatment Period||4
6330672|NCT00517634|7237476|FG001|COMPLETED|Third Treatment Period||4
6330673|NCT00517634|7237477|FG002|COMPLETED|Third Treatment Period||4
6330674|NCT00517634|7237478|FG003|COMPLETED|Third Treatment Period||3
6330675|NCT00517634|7237479|FG004|COMPLETED|Third Treatment Period||3
6330676|NCT00517634|7237480|FG005|COMPLETED|Third Treatment Period||4
6330677|NCT00517634|7237475|FG000|NOT COMPLETED|Third Treatment Period||0
6330678|NCT00517634|7237476|FG001|NOT COMPLETED|Third Treatment Period||0
6330679|NCT00517634|7237477|FG002|NOT COMPLETED|Third Treatment Period||0
6330680|NCT00517634|7237478|FG003|NOT COMPLETED|Third Treatment Period||0
6330681|NCT00517634|7237479|FG004|NOT COMPLETED|Third Treatment Period||0
6330682|NCT00517634|7237480|FG005|NOT COMPLETED|Third Treatment Period||0
6376033|NCT00758485|7286549|FG001|TREATED|Overall Study||68
6376034|NCT00758485|7286548|FG000|COMPLETED|Overall Study||69
6376035|NCT00758485|7286549|FG001|COMPLETED|Overall Study||67
6376036|NCT00758485|7286548|FG000|NOT COMPLETED|Overall Study||1
6376037|NCT00758485|7286549|FG001|NOT COMPLETED|Overall Study||3
6376038|NCT00758498|7286559|FG000|STARTED|Overall Study||142
6376039|NCT00758498|7286560|FG001|STARTED|Overall Study||143
6376040|NCT00758498|7286561|FG002|STARTED|Overall Study||142
6376041|NCT00758498|7286559|FG000|COMPLETED|Overall Study||139
6558642|NCT01775995|7481206|FG000|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
6775252|NCT03885154|7703176|FG002|NOT COMPLETED|Overall Study||0
6775253|NCT03885154|7703177|FG003|NOT COMPLETED|Overall Study||0
6376042|NCT00758498|7286560|FG001|COMPLETED|Overall Study||141
6376043|NCT00758498|7286561|FG002|COMPLETED|Overall Study||137
6376044|NCT00758498|7286559|FG000|NOT COMPLETED|Overall Study||3
6376045|NCT00758498|7286560|FG001|NOT COMPLETED|Overall Study||2
6376046|NCT00758498|7286561|FG002|NOT COMPLETED|Overall Study||5
6376047|NCT00758524|7286575|FG000|STARTED|Core Period (Week 0 to Week 8)||92
6376048|NCT00758524|7286576|FG001|STARTED|Core Period (Week 0 to Week 8)||88
6376049|NCT00758524|7286577|FG002|STARTED|Core Period (Week 0 to Week 8)||86
6376050|NCT00758524|7286578|FG003|STARTED|Core Period (Week 0 to Week 8)|One participant in this arm group was randomized twice and was excluded from Full Analysis Set.|97
6376051|NCT00758524|7286579|FG004|STARTED|Core Period (Week 0 to Week 8)||84
6376052|NCT00758524|7286580|FG005|STARTED|Core Period (Week 0 to Week 8)||77
6376053|NCT00758524|7286581|FG006|STARTED|Core Period (Week 0 to Week 8)||0
6376054|NCT00758524|7286582|FG007|STARTED|Core Period (Week 0 to Week 8)||0
6376055|NCT00758524|7286583|FG008|STARTED|Core Period (Week 0 to Week 8)||0
6376056|NCT00758524|7286584|FG009|STARTED|Core Period (Week 0 to Week 8)||0
6376057|NCT00758524|7286585|FG010|STARTED|Core Period (Week 0 to Week 8)||0
6376058|NCT00758524|7286586|FG011|STARTED|Core Period (Week 0 to Week 8)||0
6775254|NCT03883386|7703187|FG000|STARTED|First Assignment||2
6775255|NCT03883386|7703188|FG001|STARTED|First Assignment||1
6775256|NCT03883386|7703187|FG000|Surveys Begun|First Assignment||1
6775257|NCT03883386|7703188|FG001|Surveys Begun|First Assignment||1
6775258|NCT03883386|7703187|FG000|COMPLETED|First Assignment||0
6775259|NCT03883386|7703188|FG001|COMPLETED|First Assignment||0
6775260|NCT03883386|7703187|FG000|NOT COMPLETED|First Assignment||2
6775261|NCT03883386|7703188|FG001|NOT COMPLETED|First Assignment||1
6775262|NCT03883386|7703187|FG000|STARTED|Washout and Second Assignment||0
6775263|NCT03883386|7703188|FG001|STARTED|Washout and Second Assignment||0
6775264|NCT03883386|7703187|FG000|COMPLETED|Washout and Second Assignment||0
6775265|NCT03883386|7703188|FG001|COMPLETED|Washout and Second Assignment||0
6775266|NCT03883386|7703187|FG000|NOT COMPLETED|Washout and Second Assignment||0
6775267|NCT03883386|7703188|FG001|NOT COMPLETED|Washout and Second Assignment||0
6775268|NCT03882528|7703194|FG000|STARTED|Overall Study||12
6775269|NCT03882528|7703194|FG000|COMPLETED|Overall Study||12
6775270|NCT03882528|7703194|FG000|NOT COMPLETED|Overall Study||0
6775271|NCT03882801|7703200|FG000|STARTED|Period 1||12
6775272|NCT03882801|7703201|FG001|STARTED|Period 1||12
6775273|NCT03882801|7703200|FG000|Treated|Period 1|1 participant did not receive any dose of study drug|11
6775274|NCT03882801|7703201|FG001|Treated|Period 1||12
6376059|NCT00758524|7286587|FG012|STARTED|Core Period (Week 0 to Week 8)||0
6376060|NCT00758524|7286588|FG013|STARTED|Core Period (Week 0 to Week 8)||0
6376061|NCT00758524|7286589|FG014|STARTED|Core Period (Week 0 to Week 8)||0
6376062|NCT00758524|7286590|FG015|STARTED|Core Period (Week 0 to Week 8)||0
6376063|NCT00758524|7286591|FG016|STARTED|Core Period (Week 0 to Week 8)||0
6376064|NCT00758524|7286575|FG000|Treated|Core Period (Week 0 to Week 8)||92
6376065|NCT00758524|7286576|FG001|Treated|Core Period (Week 0 to Week 8)||87
6376066|NCT00758524|7286577|FG002|Treated|Core Period (Week 0 to Week 8)|One participant from LCI699 0.5 mg QD was randomized to LCI699 1.0 mg QD and received LCI699 1.0 mg QD, thus was included in this arm in the Safety Set.|87
6376067|NCT00758524|7286578|FG003|Treated|Core Period (Week 0 to Week 8)||97
6376068|NCT00758524|7286579|FG004|Treated|Core Period (Week 0 to Week 8)||84
6376069|NCT00758524|7286580|FG005|Treated|Core Period (Week 0 to Week 8)||76
6376070|NCT00758524|7286581|FG006|Treated|Core Period (Week 0 to Week 8)||0
6376071|NCT00758524|7286582|FG007|Treated|Core Period (Week 0 to Week 8)||0
6376072|NCT00758524|7286583|FG008|Treated|Core Period (Week 0 to Week 8)||0
6376073|NCT00758524|7286584|FG009|Treated|Core Period (Week 0 to Week 8)||0
6376074|NCT00758524|7286585|FG010|Treated|Core Period (Week 0 to Week 8)||0
6376075|NCT00758524|7286586|FG011|Treated|Core Period (Week 0 to Week 8)||0
6376076|NCT00758524|7286587|FG012|Treated|Core Period (Week 0 to Week 8)||0
6376077|NCT00758524|7286588|FG013|Treated|Core Period (Week 0 to Week 8)||0
6775275|NCT03882801|7703200|FG000|COMPLETED|Period 1||10
6775276|NCT03882801|7703201|FG001|COMPLETED|Period 1||10
6775277|NCT03882801|7703200|FG000|NOT COMPLETED|Period 1||2
6775278|NCT03882801|7703201|FG001|NOT COMPLETED|Period 1||2
6330683|NCT00517751|7237488|FG000|STARTED|Overall Study||162
6330684|NCT00517751|7237488|FG000|COMPLETED|Overall Study||33
6330685|NCT00517751|7237488|FG000|NOT COMPLETED|Overall Study||129
6330686|NCT00517829|7237494|FG000|STARTED|Overall Study||75
6330687|NCT00517829|7237495|FG001|STARTED|Overall Study||75
6330688|NCT00517829|7237494|FG000|COMPLETED|Overall Study||0
6330689|NCT00517829|7237495|FG001|COMPLETED|Overall Study||0
6330690|NCT00517829|7237494|FG000|NOT COMPLETED|Overall Study||75
6330691|NCT00517829|7237495|FG001|NOT COMPLETED|Overall Study||75
6330692|NCT00517881|7237501|FG000|STARTED|Overall Study||29
6330693|NCT00517881|7237501|FG000|COMPLETED|Overall Study||24
6330694|NCT00517881|7237501|FG000|NOT COMPLETED|Overall Study||5
6330695|NCT00517933|7237507|FG000|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
6330696|NCT00517933|7237508|FG001|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
6330697|NCT00517933|7237507|FG000|COMPLETED|Period 1||81
6330698|NCT00517933|7237508|FG001|COMPLETED|Period 1||85
6330699|NCT00517933|7237507|FG000|NOT COMPLETED|Period 1||8
6330700|NCT00517933|7237508|FG001|NOT COMPLETED|Period 1||6
6330701|NCT00517933|7237507|FG000|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
6330702|NCT00517933|7237508|FG001|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
6330703|NCT00517933|7237507|FG000|COMPLETED|Period 2||73
6330704|NCT00517933|7237508|FG001|COMPLETED|Period 2||70
6330705|NCT00517933|7237507|FG000|NOT COMPLETED|Period 2||6
6330706|NCT00517933|7237508|FG001|NOT COMPLETED|Period 2||13
6330707|NCT00518011|7237519|FG000|STARTED|Overall Study||9
6330708|NCT00518011|7237520|FG001|STARTED|Overall Study||8
6330709|NCT00518011|7237519|FG000|COMPLETED|Overall Study||0
6330710|NCT00518011|7237520|FG001|COMPLETED|Overall Study||0
6330711|NCT00518011|7237519|FG000|NOT COMPLETED|Overall Study||9
6330712|NCT00518011|7237520|FG001|NOT COMPLETED|Overall Study||8
6330713|NCT00518089|7237529|FG000|STARTED|Overall Study||430
6330714|NCT00518089|7237530|FG001|STARTED|Overall Study||429
6330715|NCT00518089|7237529|FG000|COMPLETED|Overall Study||402
6330716|NCT00518089|7237530|FG001|COMPLETED|Overall Study||398
6330717|NCT00518089|7237529|FG000|NOT COMPLETED|Overall Study||28
6330718|NCT00518089|7237530|FG001|NOT COMPLETED|Overall Study||31
6330719|NCT00518115|7237546|FG000|STARTED|Overall Study||52
6330720|NCT00518115|7237547|FG001|STARTED|Overall Study||35
6330721|NCT00518115|7237548|FG002|STARTED|Overall Study||36
6330722|NCT00518115|7237549|FG003|STARTED|Overall Study||35
6330723|NCT00518115|7237550|FG004|STARTED|Overall Study||31
6330724|NCT00518115|7237551|FG005|STARTED|Overall Study||34
6330725|NCT00518115|7237552|FG006|STARTED|Overall Study||33
6330726|NCT00518115|7237553|FG007|STARTED|Overall Study||35
6330727|NCT00518115|7237554|FG008|STARTED|Overall Study||35
6330728|NCT00518115|7237555|FG009|STARTED|Overall Study||35
6330729|NCT00518115|7237546|FG000|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
6330730|NCT00518115|7237547|FG001|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6330731|NCT00518115|7237548|FG002|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6330732|NCT00518115|7237549|FG003|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6330733|NCT00518115|7237550|FG004|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
6330734|NCT00518115|7237551|FG005|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
6330735|NCT00518115|7237552|FG006|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
6330736|NCT00518115|7237553|FG007|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6330737|NCT00518115|7237554|FG008|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
6330738|NCT00518115|7237555|FG009|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
6330739|NCT00518115|7237546|FG000|COMPLETED|Overall Study||40
6330740|NCT00518115|7237547|FG001|COMPLETED|Overall Study||29
6330741|NCT00518115|7237548|FG002|COMPLETED|Overall Study||19
6330742|NCT00518115|7237549|FG003|COMPLETED|Overall Study||24
6330743|NCT00518115|7237550|FG004|COMPLETED|Overall Study||21
6330744|NCT00518115|7237551|FG005|COMPLETED|Overall Study||19
6330745|NCT00518115|7237552|FG006|COMPLETED|Overall Study||25
6330746|NCT00518115|7237553|FG007|COMPLETED|Overall Study||20
6330747|NCT00518115|7237554|FG008|COMPLETED|Overall Study||30
6330748|NCT00518115|7237555|FG009|COMPLETED|Overall Study||20
6330749|NCT00518115|7237546|FG000|NOT COMPLETED|Overall Study||12
6330750|NCT00518115|7237547|FG001|NOT COMPLETED|Overall Study||6
6330751|NCT00518115|7237548|FG002|NOT COMPLETED|Overall Study||17
6330752|NCT00518115|7237549|FG003|NOT COMPLETED|Overall Study||11
6330753|NCT00518115|7237550|FG004|NOT COMPLETED|Overall Study||10
6330754|NCT00518115|7237551|FG005|NOT COMPLETED|Overall Study||15
6330755|NCT00518115|7237552|FG006|NOT COMPLETED|Overall Study||8
6330756|NCT00518115|7237553|FG007|NOT COMPLETED|Overall Study||15
6330757|NCT00518115|7237554|FG008|NOT COMPLETED|Overall Study||5
6330758|NCT00518115|7237555|FG009|NOT COMPLETED|Overall Study||15
6330759|NCT00518154|7237578|FG000|STARTED|Overall Study||7
6330760|NCT00518154|7237578|FG000|COMPLETED|Overall Study||7
6330761|NCT00518154|7237578|FG000|NOT COMPLETED|Overall Study||0
6330762|NCT00518180|7237585|FG000|STARTED|Overall Study||540
6330763|NCT00518180|7237586|FG001|STARTED|Overall Study||541
6330764|NCT00518180|7237587|FG002|STARTED|Overall Study||539
6330765|NCT00518180|7237585|FG000|COMPLETED|Overall Study||475
6330766|NCT00518180|7237586|FG001|COMPLETED|Overall Study||472
6330767|NCT00518180|7237587|FG002|COMPLETED|Overall Study||457
6330768|NCT00518180|7237585|FG000|NOT COMPLETED|Overall Study||65
6330769|NCT00518180|7237586|FG001|NOT COMPLETED|Overall Study||69
6330770|NCT00518180|7237587|FG002|NOT COMPLETED|Overall Study||82
6330771|NCT00518206|7237606|FG000|STARTED|Overall Study||27
6330772|NCT00518206|7237607|FG001|STARTED|Overall Study||19
6330773|NCT00518206|7237606|FG000|COMPLETED|Overall Study||16
6330774|NCT00518206|7237607|FG001|COMPLETED|Overall Study||13
6330775|NCT00518206|7237606|FG000|NOT COMPLETED|Overall Study||11
6330776|NCT00518206|7237607|FG001|NOT COMPLETED|Overall Study||6
6330777|NCT00518284|7237617|FG000|STARTED|Overall Study||0
6558643|NCT01775995|7481207|FG001|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
6558644|NCT01775995|7481206|FG000|NOT COMPLETED|Overall Study||1
6558645|NCT01775995|7481207|FG001|NOT COMPLETED|Overall Study||1
6558646|NCT01776008|7481213|FG000|STARTED|Overall Study||16
6558647|NCT01776008|7481213|FG000|COMPLETED|Overall Study||14
6558648|NCT01776008|7481213|FG000|NOT COMPLETED|Overall Study||2
6558649|NCT01776268|7481219|FG000|STARTED|Overall Study||48
6558650|NCT01776268|7481220|FG001|STARTED|Overall Study||51
6558651|NCT01776268|7481219|FG000|COMPLETED|Overall Study||48
6558652|NCT01776268|7481220|FG001|COMPLETED|Overall Study||51
6330778|NCT00518284|7237618|FG001|STARTED|Overall Study||3
6330779|NCT00518284|7237619|FG002|STARTED|Overall Study||1
6330780|NCT00518284|7237620|FG003|STARTED|Overall Study||2
6330781|NCT00518284|7237617|FG000|COMPLETED|Overall Study||0
6330782|NCT00518284|7237618|FG001|COMPLETED|Overall Study||0
6330783|NCT00518284|7237619|FG002|COMPLETED|Overall Study||0
6330784|NCT00518284|7237620|FG003|COMPLETED|Overall Study||0
6330785|NCT00518284|7237617|FG000|NOT COMPLETED|Overall Study||0
6330786|NCT00518284|7237618|FG001|NOT COMPLETED|Overall Study||3
6330787|NCT00518284|7237619|FG002|NOT COMPLETED|Overall Study||1
6330788|NCT00518284|7237620|FG003|NOT COMPLETED|Overall Study||2
6330789|NCT00518323|7237634|FG000|STARTED|Overall Study||54
6330790|NCT00518323|7237635|FG001|STARTED|Overall Study||48
6330791|NCT00518323|7237636|FG002|STARTED|Overall Study||48
6330792|NCT00518323|7237637|FG003|STARTED|Overall Study||51
6330793|NCT00518323|7237634|FG000|COMPLETED|Overall Study||35
6330794|NCT00518323|7237635|FG001|COMPLETED|Overall Study||40
6330795|NCT00518323|7237636|FG002|COMPLETED|Overall Study||37
6330796|NCT00518323|7237637|FG003|COMPLETED|Overall Study||26
6330797|NCT00518323|7237634|FG000|NOT COMPLETED|Overall Study||19
6330798|NCT00518323|7237635|FG001|NOT COMPLETED|Overall Study||8
6330799|NCT00518323|7237636|FG002|NOT COMPLETED|Overall Study||11
6330800|NCT00518323|7237637|FG003|NOT COMPLETED|Overall Study||25
6330801|NCT00518336|7237649|FG000|STARTED|Year 7||222
6330802|NCT00518336|7237650|FG001|STARTED|Year 7||211
6330803|NCT00518336|7237649|FG000|COMPLETED|Year 7||220
6330804|NCT00518336|7237650|FG001|COMPLETED|Year 7||208
6330805|NCT00518336|7237649|FG000|NOT COMPLETED|Year 7||2
6330806|NCT00518336|7237650|FG001|NOT COMPLETED|Year 7||3
6330807|NCT00518336|7237649|FG000|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
6330808|NCT00518336|7237650|FG001|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
6330809|NCT00518336|7237649|FG000|COMPLETED|Year 8||222
6330810|NCT00518336|7237650|FG001|COMPLETED|Year 8||211
6330811|NCT00518336|7237649|FG000|NOT COMPLETED|Year 8||1
6330812|NCT00518336|7237650|FG001|NOT COMPLETED|Year 8||2
6330813|NCT00518336|7237649|FG000|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
6330814|NCT00518336|7237650|FG001|STARTED|Year 9||213
6330815|NCT00518336|7237649|FG000|COMPLETED|Year 9||219
6330816|NCT00518336|7237650|FG001|COMPLETED|Year 9||212
6330817|NCT00518336|7237649|FG000|NOT COMPLETED|Year 9||5
6330818|NCT00518336|7237650|FG001|NOT COMPLETED|Year 9||1
6330819|NCT00518349|7237658|FG000|STARTED|Overall Study||60
6330820|NCT00518349|7237659|FG001|STARTED|Overall Study||60
6330821|NCT00518349|7237658|FG000|COMPLETED|Overall Study||60
6330822|NCT00518349|7237659|FG001|COMPLETED|Overall Study||60
6330823|NCT00518349|7237658|FG000|NOT COMPLETED|Overall Study||0
6330824|NCT00518349|7237659|FG001|NOT COMPLETED|Overall Study||0
6330825|NCT00518531|7237667|FG000|STARTED|Treatment Period 1||124
6330826|NCT00518531|7237668|FG001|STARTED|Treatment Period 1||126
6330827|NCT00518531|7237667|FG000|Received Treatment|Treatment Period 1||119
6330828|NCT00518531|7237668|FG001|Received Treatment|Treatment Period 1||124
6330829|NCT00518531|7237667|FG000|COMPLETED|Treatment Period 1||106
6330830|NCT00518531|7237668|FG001|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
6330831|NCT00518531|7237667|FG000|NOT COMPLETED|Treatment Period 1||18
6330832|NCT00518531|7237668|FG001|NOT COMPLETED|Treatment Period 1||12
6330833|NCT00518531|7237667|FG000|STARTED|Treatment Period 2||106
6330834|NCT00518531|7237668|FG001|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
6330835|NCT00518531|7237667|FG000|Received Treatment|Treatment Period 2||106
6330836|NCT00518531|7237668|FG001|Received Treatment|Treatment Period 2||110
6330837|NCT00518531|7237667|FG000|COMPLETED|Treatment Period 2||103
6558653|NCT01776268|7481219|FG000|NOT COMPLETED|Overall Study||0
6558654|NCT01776268|7481220|FG001|NOT COMPLETED|Overall Study||0
6558655|NCT01776424|7481230|FG000|STARTED|Overall Study||9152
6558656|NCT01776424|7481231|FG001|STARTED|Overall Study||9117
6558657|NCT01776424|7481232|FG002|STARTED|Overall Study||9126
6330838|NCT00518531|7237668|FG001|COMPLETED|Treatment Period 2||95
6330839|NCT00518531|7237667|FG000|NOT COMPLETED|Treatment Period 2||3
6330840|NCT00518531|7237668|FG001|NOT COMPLETED|Treatment Period 2||20
6330841|NCT00518622|7237684|FG000|STARTED|Overall Study||3
6330842|NCT00518622|7237685|FG001|STARTED|Overall Study||6
6330843|NCT00518622|7237686|FG002|STARTED|Overall Study||6
6330844|NCT00518622|7237687|FG003|STARTED|Overall Study||5
6330845|NCT00518622|7237688|FG004|STARTED|Overall Study||6
6330846|NCT00518622|7237689|FG005|STARTED|Overall Study||5
6330847|NCT00518622|7237690|FG006|STARTED|Overall Study||4
6330848|NCT00518622|7237691|FG007|STARTED|Overall Study||5
6330849|NCT00518622|7237684|FG000|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
6330850|NCT00518622|7237685|FG001|Completed Therapy|Overall Study||5
6330851|NCT00518622|7237686|FG002|Completed Therapy|Overall Study||6
6330852|NCT00518622|7237687|FG003|Completed Therapy|Overall Study||5
6330853|NCT00518622|7237688|FG004|Completed Therapy|Overall Study||6
6330854|NCT00518622|7237689|FG005|Completed Therapy|Overall Study||5
6330855|NCT00518622|7237690|FG006|Completed Therapy|Overall Study||4
6330856|NCT00518622|7237691|FG007|Completed Therapy|Overall Study||5
6330857|NCT00518622|7237684|FG000|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
6330858|NCT00518622|7237685|FG001|Discontinued Therapy|Overall Study||1
6330859|NCT00518622|7237686|FG002|Discontinued Therapy|Overall Study||0
6330860|NCT00518622|7237687|FG003|Discontinued Therapy|Overall Study||0
6330861|NCT00518622|7237688|FG004|Discontinued Therapy|Overall Study||0
6330862|NCT00518622|7237689|FG005|Discontinued Therapy|Overall Study||0
6330863|NCT00518622|7237690|FG006|Discontinued Therapy|Overall Study||0
6330864|NCT00518622|7237691|FG007|Discontinued Therapy|Overall Study||0
6330865|NCT00518622|7237684|FG000|COMPLETED|Overall Study||3
6330866|NCT00518622|7237685|FG001|COMPLETED|Overall Study||5
6330867|NCT00518622|7237686|FG002|COMPLETED|Overall Study||5
6330868|NCT00518622|7237687|FG003|COMPLETED|Overall Study||5
6330869|NCT00518622|7237688|FG004|COMPLETED|Overall Study||6
6330870|NCT00518622|7237689|FG005|COMPLETED|Overall Study||5
6330871|NCT00518622|7237690|FG006|COMPLETED|Overall Study||4
6330872|NCT00518622|7237691|FG007|COMPLETED|Overall Study||5
6330873|NCT00518622|7237684|FG000|NOT COMPLETED|Overall Study||0
6330874|NCT00518622|7237685|FG001|NOT COMPLETED|Overall Study||1
6330875|NCT00518622|7237686|FG002|NOT COMPLETED|Overall Study||1
6330876|NCT00518622|7237687|FG003|NOT COMPLETED|Overall Study||0
6330877|NCT00518622|7237688|FG004|NOT COMPLETED|Overall Study||0
6558658|NCT01776424|7481230|FG000|Treated|Overall Study||9134
6330878|NCT00518622|7237689|FG005|NOT COMPLETED|Overall Study||0
6330879|NCT00518622|7237690|FG006|NOT COMPLETED|Overall Study||0
6330880|NCT00518622|7237691|FG007|NOT COMPLETED|Overall Study||0
6330881|NCT00518687|7237711|FG000|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
6330882|NCT00518687|7237712|FG001|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
6330883|NCT00518687|7237711|FG000|Vaccinated|Overall Study||3981
6330884|NCT00518687|7237712|FG001|Vaccinated|Overall Study||3982
6330885|NCT00518687|7237711|FG000|COMPLETED|Overall Study||2568
6330886|NCT00518687|7237712|FG001|COMPLETED|Overall Study||2585
6330887|NCT00518687|7237711|FG000|NOT COMPLETED|Overall Study||1437
6330888|NCT00518687|7237712|FG001|NOT COMPLETED|Overall Study||1420
6330889|NCT00518713|7237722|FG000|STARTED|Overall Study||58
6330890|NCT00518713|7237723|FG001|STARTED|Overall Study||62
6330891|NCT00518713|7237724|FG002|STARTED|Overall Study||59
6330892|NCT00518713|7237725|FG003|STARTED|Overall Study||59
6330893|NCT00518713|7237722|FG000|Modified Intent-to-Treat Population|Overall Study||53
6330894|NCT00518713|7237723|FG001|Modified Intent-to-Treat Population|Overall Study||58
6330895|NCT00518713|7237724|FG002|Modified Intent-to-Treat Population|Overall Study||49
6330896|NCT00518713|7237725|FG003|Modified Intent-to-Treat Population|Overall Study||57
6330897|NCT00518713|7237722|FG000|COMPLETED|Overall Study||50
6330898|NCT00518713|7237723|FG001|COMPLETED|Overall Study||45
6330899|NCT00518713|7237724|FG002|COMPLETED|Overall Study||41
6330900|NCT00518713|7237725|FG003|COMPLETED|Overall Study||41
6330901|NCT00518713|7237722|FG000|NOT COMPLETED|Overall Study||8
6330902|NCT00518713|7237723|FG001|NOT COMPLETED|Overall Study||17
6330903|NCT00518713|7237724|FG002|NOT COMPLETED|Overall Study||18
6330904|NCT00518713|7237725|FG003|NOT COMPLETED|Overall Study||18
6330905|NCT00518882|7237737|FG000|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
6330906|NCT00518882|7237738|FG001|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
6330907|NCT00518882|7237737|FG000|Randomised|Double-Blind, Week 0-26||233
6330908|NCT00518882|7237738|FG001|Randomised|Double-Blind, Week 0-26||231
6330909|NCT00518882|7237737|FG000|COMPLETED|Double-Blind, Week 0-26||202
6330910|NCT00518882|7237738|FG001|COMPLETED|Double-Blind, Week 0-26||187
6330911|NCT00518882|7237737|FG000|NOT COMPLETED|Double-Blind, Week 0-26||33
6330912|NCT00518882|7237738|FG001|NOT COMPLETED|Double-Blind, Week 0-26||45
6330913|NCT00518882|7237737|FG000|STARTED|Open-Label Extension, Week 26-78||202
6330914|NCT00518882|7237738|FG001|STARTED|Open-Label Extension, Week 26-78||187
6330915|NCT00518882|7237737|FG000|COMPLETED|Open-Label Extension, Week 26-78||161
6330916|NCT00518882|7237738|FG001|COMPLETED|Open-Label Extension, Week 26-78||138
6330917|NCT00518882|7237737|FG000|NOT COMPLETED|Open-Label Extension, Week 26-78||41
6330918|NCT00518882|7237738|FG001|NOT COMPLETED|Open-Label Extension, Week 26-78||49
6330919|NCT00518973|7237746|FG000|STARTED|Overall Study||9
6330920|NCT00518973|7237747|FG001|STARTED|Overall Study||6
6330921|NCT00518973|7237746|FG000|COMPLETED|Overall Study||6
6330922|NCT00518973|7237747|FG001|COMPLETED|Overall Study||4
6330923|NCT00518973|7237746|FG000|NOT COMPLETED|Overall Study||3
6330924|NCT00518973|7237747|FG001|NOT COMPLETED|Overall Study||2
6330925|NCT00518986|7237755|FG000|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
6330926|NCT00518986|7237756|FG001|STARTED|Overall Study||124
6330927|NCT00518986|7237755|FG000|COMPLETED|Overall Study||99
6330928|NCT00518986|7237756|FG001|COMPLETED|Overall Study||98
6330929|NCT00518986|7237755|FG000|NOT COMPLETED|Overall Study||26
6330930|NCT00518986|7237756|FG001|NOT COMPLETED|Overall Study||26
6330931|NCT00519077|7237762|FG000|STARTED|Overall Study||44
6330932|NCT00519077|7237762|FG000|COMPLETED|Overall Study||36
6330933|NCT00519077|7237762|FG000|NOT COMPLETED|Overall Study||8
6330934|NCT00519194|7237766|FG000|STARTED|Overall Study||112
6330935|NCT00519194|7237766|FG000|COMPLETED|Overall Study||91
6330936|NCT00519194|7237766|FG000|NOT COMPLETED|Overall Study||21
6330937|NCT00519285|7237772|FG000|STARTED|Overall Study|Randomized|612
6330938|NCT00519285|7237773|FG001|STARTED|Overall Study|Randomized|612
6330939|NCT00519285|7237772|FG000|TREATED|Overall Study|Received at least part of one dose of placebo|604
6330940|NCT00519285|7237773|FG001|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
6330941|NCT00519285|7237772|FG000|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
6330942|NCT00519285|7237773|FG001|Still Treated at Cut-off Date|Overall Study||2
6330943|NCT00519285|7237772|FG000|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
6330944|NCT00519285|7237773|FG001|COMPLETED|Overall Study||0
6330945|NCT00519285|7237772|FG000|NOT COMPLETED|Overall Study||612
6330946|NCT00519285|7237773|FG001|NOT COMPLETED|Overall Study||612
6330947|NCT00519376|7237779|FG000|STARTED|Treatment Period 1||2
6330948|NCT00519376|7237780|FG001|STARTED|Treatment Period 1||2
6330949|NCT00519376|7237781|FG002|STARTED|Treatment Period 1||2
6330950|NCT00519376|7237782|FG003|STARTED|Treatment Period 1||2
6330951|NCT00519376|7237783|FG004|STARTED|Treatment Period 1||1
6330952|NCT00519376|7237784|FG005|STARTED|Treatment Period 1||1
6330953|NCT00519376|7237785|FG006|STARTED|Treatment Period 1||1
6330954|NCT00519376|7237786|FG007|STARTED|Treatment Period 1||1
6330955|NCT00519376|7237787|FG008|STARTED|Treatment Period 1||1
6330956|NCT00519376|7237788|FG009|STARTED|Treatment Period 1||1
6330957|NCT00519376|7237789|FG010|STARTED|Treatment Period 1||1
6330958|NCT00519376|7237790|FG011|STARTED|Treatment Period 1||1
6330959|NCT00519376|7237791|FG012|STARTED|Treatment Period 1||1
6330960|NCT00519376|7237792|FG013|STARTED|Treatment Period 1||1
6330961|NCT00519376|7237793|FG014|STARTED|Treatment Period 1||1
6330962|NCT00519376|7237794|FG015|STARTED|Treatment Period 1||1
6330963|NCT00519376|7237779|FG000|COMPLETED|Treatment Period 1||2
6330964|NCT00519376|7237780|FG001|COMPLETED|Treatment Period 1||2
6330965|NCT00519376|7237781|FG002|COMPLETED|Treatment Period 1||2
6330966|NCT00519376|7237782|FG003|COMPLETED|Treatment Period 1||2
6330967|NCT00519376|7237783|FG004|COMPLETED|Treatment Period 1||1
6330968|NCT00519376|7237784|FG005|COMPLETED|Treatment Period 1||1
6330969|NCT00519376|7237785|FG006|COMPLETED|Treatment Period 1||1
6330970|NCT00519376|7237786|FG007|COMPLETED|Treatment Period 1||1
6330971|NCT00519376|7237787|FG008|COMPLETED|Treatment Period 1||1
6330972|NCT00519376|7237788|FG009|COMPLETED|Treatment Period 1||1
6330973|NCT00519376|7237789|FG010|COMPLETED|Treatment Period 1||1
6330974|NCT00519376|7237790|FG011|COMPLETED|Treatment Period 1||1
6330975|NCT00519376|7237791|FG012|COMPLETED|Treatment Period 1||1
6330976|NCT00519376|7237792|FG013|COMPLETED|Treatment Period 1||1
6330977|NCT00519376|7237793|FG014|COMPLETED|Treatment Period 1||1
6330978|NCT00519376|7237794|FG015|COMPLETED|Treatment Period 1||1
6330979|NCT00519376|7237779|FG000|NOT COMPLETED|Treatment Period 1||0
6330980|NCT00519376|7237780|FG001|NOT COMPLETED|Treatment Period 1||0
6330981|NCT00519376|7237781|FG002|NOT COMPLETED|Treatment Period 1||0
6330982|NCT00519376|7237782|FG003|NOT COMPLETED|Treatment Period 1||0
6330983|NCT00519376|7237783|FG004|NOT COMPLETED|Treatment Period 1||0
6330984|NCT00519376|7237784|FG005|NOT COMPLETED|Treatment Period 1||0
6330985|NCT00519376|7237785|FG006|NOT COMPLETED|Treatment Period 1||0
6330986|NCT00519376|7237786|FG007|NOT COMPLETED|Treatment Period 1||0
6330987|NCT00519376|7237787|FG008|NOT COMPLETED|Treatment Period 1||0
6330988|NCT00519376|7237788|FG009|NOT COMPLETED|Treatment Period 1||0
6330989|NCT00519376|7237789|FG010|NOT COMPLETED|Treatment Period 1||0
6330990|NCT00519376|7237790|FG011|NOT COMPLETED|Treatment Period 1||0
6330991|NCT00519376|7237791|FG012|NOT COMPLETED|Treatment Period 1||0
6330992|NCT00519376|7237792|FG013|NOT COMPLETED|Treatment Period 1||0
6330993|NCT00519376|7237793|FG014|NOT COMPLETED|Treatment Period 1||0
6330994|NCT00519376|7237794|FG015|NOT COMPLETED|Treatment Period 1||0
6330995|NCT00519376|7237779|FG000|STARTED|Washout Period 1||2
6330996|NCT00519376|7237780|FG001|STARTED|Washout Period 1||2
6330997|NCT00519376|7237781|FG002|STARTED|Washout Period 1||2
6330998|NCT00519376|7237782|FG003|STARTED|Washout Period 1||2
6330999|NCT00519376|7237783|FG004|STARTED|Washout Period 1||1
6331000|NCT00519376|7237784|FG005|STARTED|Washout Period 1||1
6331001|NCT00519376|7237785|FG006|STARTED|Washout Period 1||1
6331002|NCT00519376|7237786|FG007|STARTED|Washout Period 1||1
6331003|NCT00519376|7237787|FG008|STARTED|Washout Period 1||1
6331004|NCT00519376|7237788|FG009|STARTED|Washout Period 1||1
6331005|NCT00519376|7237789|FG010|STARTED|Washout Period 1||1
6331006|NCT00519376|7237790|FG011|STARTED|Washout Period 1||1
6331007|NCT00519376|7237791|FG012|STARTED|Washout Period 1||1
6331008|NCT00519376|7237792|FG013|STARTED|Washout Period 1||1
6331009|NCT00519376|7237793|FG014|STARTED|Washout Period 1||1
6331010|NCT00519376|7237794|FG015|STARTED|Washout Period 1||1
6331011|NCT00519376|7237779|FG000|COMPLETED|Washout Period 1||2
6331012|NCT00519376|7237780|FG001|COMPLETED|Washout Period 1||2
6331013|NCT00519376|7237781|FG002|COMPLETED|Washout Period 1||2
6331014|NCT00519376|7237782|FG003|COMPLETED|Washout Period 1||2
6331015|NCT00519376|7237783|FG004|COMPLETED|Washout Period 1||1
6331016|NCT00519376|7237784|FG005|COMPLETED|Washout Period 1||1
6331017|NCT00519376|7237785|FG006|COMPLETED|Washout Period 1||1
6331018|NCT00519376|7237786|FG007|COMPLETED|Washout Period 1||1
6331019|NCT00519376|7237787|FG008|COMPLETED|Washout Period 1||1
6331020|NCT00519376|7237788|FG009|COMPLETED|Washout Period 1||1
6331021|NCT00519376|7237789|FG010|COMPLETED|Washout Period 1||1
6331022|NCT00519376|7237790|FG011|COMPLETED|Washout Period 1||1
6331023|NCT00519376|7237791|FG012|COMPLETED|Washout Period 1||1
6331024|NCT00519376|7237792|FG013|COMPLETED|Washout Period 1||1
6331025|NCT00519376|7237793|FG014|COMPLETED|Washout Period 1||1
6331026|NCT00519376|7237794|FG015|COMPLETED|Washout Period 1||1
6331027|NCT00519376|7237779|FG000|NOT COMPLETED|Washout Period 1||0
6331028|NCT00519376|7237780|FG001|NOT COMPLETED|Washout Period 1||0
6331029|NCT00519376|7237781|FG002|NOT COMPLETED|Washout Period 1||0
6331030|NCT00519376|7237782|FG003|NOT COMPLETED|Washout Period 1||0
6331031|NCT00519376|7237783|FG004|NOT COMPLETED|Washout Period 1||0
6331032|NCT00519376|7237784|FG005|NOT COMPLETED|Washout Period 1||0
6331033|NCT00519376|7237785|FG006|NOT COMPLETED|Washout Period 1||0
6331034|NCT00519376|7237786|FG007|NOT COMPLETED|Washout Period 1||0
6331035|NCT00519376|7237787|FG008|NOT COMPLETED|Washout Period 1||0
6331036|NCT00519376|7237788|FG009|NOT COMPLETED|Washout Period 1||0
6331037|NCT00519376|7237789|FG010|NOT COMPLETED|Washout Period 1||0
6331038|NCT00519376|7237790|FG011|NOT COMPLETED|Washout Period 1||0
6331039|NCT00519376|7237791|FG012|NOT COMPLETED|Washout Period 1||0
6331040|NCT00519376|7237792|FG013|NOT COMPLETED|Washout Period 1||0
6775279|NCT03882801|7703200|FG000|STARTED|Washout Period||10
6775280|NCT03882801|7703201|FG001|STARTED|Washout Period||10
6775281|NCT03882801|7703200|FG000|COMPLETED|Washout Period||10
6775282|NCT03882801|7703201|FG001|COMPLETED|Washout Period||9
6775283|NCT03882801|7703200|FG000|NOT COMPLETED|Washout Period||0
6331041|NCT00519376|7237793|FG014|NOT COMPLETED|Washout Period 1||0
6331042|NCT00519376|7237794|FG015|NOT COMPLETED|Washout Period 1||0
6331043|NCT00519376|7237779|FG000|STARTED|Treatment Period 2||2
6331044|NCT00519376|7237780|FG001|STARTED|Treatment Period 2||2
6331045|NCT00519376|7237781|FG002|STARTED|Treatment Period 2||2
6331046|NCT00519376|7237782|FG003|STARTED|Treatment Period 2||2
6331047|NCT00519376|7237783|FG004|STARTED|Treatment Period 2||1
6331048|NCT00519376|7237784|FG005|STARTED|Treatment Period 2||1
6331049|NCT00519376|7237785|FG006|STARTED|Treatment Period 2||1
6331050|NCT00519376|7237786|FG007|STARTED|Treatment Period 2||1
6331051|NCT00519376|7237787|FG008|STARTED|Treatment Period 2||1
6331052|NCT00519376|7237788|FG009|STARTED|Treatment Period 2||1
6331053|NCT00519376|7237789|FG010|STARTED|Treatment Period 2||1
6331054|NCT00519376|7237790|FG011|STARTED|Treatment Period 2||1
6331055|NCT00519376|7237791|FG012|STARTED|Treatment Period 2||1
6331056|NCT00519376|7237792|FG013|STARTED|Treatment Period 2||1
6331057|NCT00519376|7237793|FG014|STARTED|Treatment Period 2||1
6331058|NCT00519376|7237794|FG015|STARTED|Treatment Period 2||1
6331059|NCT00519376|7237779|FG000|COMPLETED|Treatment Period 2||2
6331060|NCT00519376|7237780|FG001|COMPLETED|Treatment Period 2||2
6331061|NCT00519376|7237781|FG002|COMPLETED|Treatment Period 2||2
6331062|NCT00519376|7237782|FG003|COMPLETED|Treatment Period 2||2
6331063|NCT00519376|7237783|FG004|COMPLETED|Treatment Period 2||1
6331064|NCT00519376|7237784|FG005|COMPLETED|Treatment Period 2||1
6331065|NCT00519376|7237785|FG006|COMPLETED|Treatment Period 2||1
6331066|NCT00519376|7237786|FG007|COMPLETED|Treatment Period 2||1
6331067|NCT00519376|7237787|FG008|COMPLETED|Treatment Period 2||1
6331068|NCT00519376|7237788|FG009|COMPLETED|Treatment Period 2||1
6331069|NCT00519376|7237789|FG010|COMPLETED|Treatment Period 2||1
6331070|NCT00519376|7237790|FG011|COMPLETED|Treatment Period 2||1
6331071|NCT00519376|7237791|FG012|COMPLETED|Treatment Period 2||0
6331072|NCT00519376|7237792|FG013|COMPLETED|Treatment Period 2||1
6331073|NCT00519376|7237793|FG014|COMPLETED|Treatment Period 2||1
6331074|NCT00519376|7237794|FG015|COMPLETED|Treatment Period 2||1
6331075|NCT00519376|7237779|FG000|NOT COMPLETED|Treatment Period 2||0
6331076|NCT00519376|7237780|FG001|NOT COMPLETED|Treatment Period 2||0
6331077|NCT00519376|7237781|FG002|NOT COMPLETED|Treatment Period 2||0
6775284|NCT03882801|7703201|FG001|NOT COMPLETED|Washout Period||1
6331078|NCT00519376|7237782|FG003|NOT COMPLETED|Treatment Period 2||0
6331079|NCT00519376|7237783|FG004|NOT COMPLETED|Treatment Period 2||0
6331080|NCT00519376|7237784|FG005|NOT COMPLETED|Treatment Period 2||0
6331081|NCT00519376|7237785|FG006|NOT COMPLETED|Treatment Period 2||0
6331082|NCT00519376|7237786|FG007|NOT COMPLETED|Treatment Period 2||0
6331083|NCT00519376|7237787|FG008|NOT COMPLETED|Treatment Period 2||0
6331084|NCT00519376|7237788|FG009|NOT COMPLETED|Treatment Period 2||0
6331085|NCT00519376|7237789|FG010|NOT COMPLETED|Treatment Period 2||0
6331086|NCT00519376|7237790|FG011|NOT COMPLETED|Treatment Period 2||0
6331087|NCT00519376|7237791|FG012|NOT COMPLETED|Treatment Period 2||1
6331088|NCT00519376|7237792|FG013|NOT COMPLETED|Treatment Period 2||0
6331089|NCT00519376|7237793|FG014|NOT COMPLETED|Treatment Period 2||0
6331090|NCT00519376|7237794|FG015|NOT COMPLETED|Treatment Period 2||0
6331091|NCT00519376|7237779|FG000|STARTED|Washout Period 2||2
6331092|NCT00519376|7237780|FG001|STARTED|Washout Period 2||2
6331093|NCT00519376|7237781|FG002|STARTED|Washout Period 2||2
6331094|NCT00519376|7237782|FG003|STARTED|Washout Period 2||2
6331095|NCT00519376|7237783|FG004|STARTED|Washout Period 2||1
6331096|NCT00519376|7237784|FG005|STARTED|Washout Period 2||1
6331097|NCT00519376|7237785|FG006|STARTED|Washout Period 2||1
6331098|NCT00519376|7237786|FG007|STARTED|Washout Period 2||1
6331099|NCT00519376|7237787|FG008|STARTED|Washout Period 2||1
6331100|NCT00519376|7237788|FG009|STARTED|Washout Period 2||1
6331101|NCT00519376|7237789|FG010|STARTED|Washout Period 2||1
6331102|NCT00519376|7237790|FG011|STARTED|Washout Period 2||1
6331103|NCT00519376|7237791|FG012|STARTED|Washout Period 2||0
6331104|NCT00519376|7237792|FG013|STARTED|Washout Period 2||1
6331105|NCT00519376|7237793|FG014|STARTED|Washout Period 2||1
6331106|NCT00519376|7237794|FG015|STARTED|Washout Period 2||1
6331107|NCT00519376|7237779|FG000|COMPLETED|Washout Period 2||2
6331108|NCT00519376|7237780|FG001|COMPLETED|Washout Period 2||2
6331109|NCT00519376|7237781|FG002|COMPLETED|Washout Period 2||2
6331110|NCT00519376|7237782|FG003|COMPLETED|Washout Period 2||2
6331111|NCT00519376|7237783|FG004|COMPLETED|Washout Period 2||1
6331112|NCT00519376|7237784|FG005|COMPLETED|Washout Period 2||1
6331113|NCT00519376|7237785|FG006|COMPLETED|Washout Period 2||1
6331114|NCT00519376|7237786|FG007|COMPLETED|Washout Period 2||1
6331115|NCT00519376|7237787|FG008|COMPLETED|Washout Period 2||1
6331116|NCT00519376|7237788|FG009|COMPLETED|Washout Period 2||1
6331117|NCT00519376|7237789|FG010|COMPLETED|Washout Period 2||1
6331118|NCT00519376|7237790|FG011|COMPLETED|Washout Period 2||1
6331119|NCT00519376|7237791|FG012|COMPLETED|Washout Period 2||0
6331120|NCT00519376|7237792|FG013|COMPLETED|Washout Period 2||1
6331121|NCT00519376|7237793|FG014|COMPLETED|Washout Period 2||1
6331122|NCT00519376|7237794|FG015|COMPLETED|Washout Period 2||1
6331123|NCT00519376|7237779|FG000|NOT COMPLETED|Washout Period 2||0
6331124|NCT00519376|7237780|FG001|NOT COMPLETED|Washout Period 2||0
6331125|NCT00519376|7237781|FG002|NOT COMPLETED|Washout Period 2||0
6331126|NCT00519376|7237782|FG003|NOT COMPLETED|Washout Period 2||0
6331127|NCT00519376|7237783|FG004|NOT COMPLETED|Washout Period 2||0
6331128|NCT00519376|7237784|FG005|NOT COMPLETED|Washout Period 2||0
6331129|NCT00519376|7237785|FG006|NOT COMPLETED|Washout Period 2||0
6331130|NCT00519376|7237786|FG007|NOT COMPLETED|Washout Period 2||0
6331131|NCT00519376|7237787|FG008|NOT COMPLETED|Washout Period 2||0
6331132|NCT00519376|7237788|FG009|NOT COMPLETED|Washout Period 2||0
6331133|NCT00519376|7237789|FG010|NOT COMPLETED|Washout Period 2||0
6331134|NCT00519376|7237790|FG011|NOT COMPLETED|Washout Period 2||0
6331135|NCT00519376|7237791|FG012|NOT COMPLETED|Washout Period 2||0
6775285|NCT03882801|7703200|FG000|STARTED|Period 2||10
6775286|NCT03882801|7703201|FG001|STARTED|Period 2||9
6775287|NCT03882801|7703200|FG000|COMPLETED|Period 2||10
6775288|NCT03882801|7703201|FG001|COMPLETED|Period 2||8
6775289|NCT03882801|7703200|FG000|NOT COMPLETED|Period 2||0
6775290|NCT03882801|7703201|FG001|NOT COMPLETED|Period 2||1
6775291|NCT03882424|7703212|FG000|STARTED|Overall Study||38
6775292|NCT03882424|7703213|FG001|STARTED|Overall Study||38
6775293|NCT03882424|7703214|FG002|STARTED|Overall Study||38
6775294|NCT03882424|7703212|FG000|COMPLETED|Overall Study||34
6331136|NCT00519376|7237792|FG013|NOT COMPLETED|Washout Period 2||0
6331137|NCT00519376|7237793|FG014|NOT COMPLETED|Washout Period 2||0
6331138|NCT00519376|7237794|FG015|NOT COMPLETED|Washout Period 2||0
6331139|NCT00519376|7237779|FG000|STARTED|Treatment Period 3||2
6331140|NCT00519376|7237780|FG001|STARTED|Treatment Period 3||2
6331141|NCT00519376|7237781|FG002|STARTED|Treatment Period 3||2
6331142|NCT00519376|7237782|FG003|STARTED|Treatment Period 3||2
6331143|NCT00519376|7237783|FG004|STARTED|Treatment Period 3||1
6331144|NCT00519376|7237784|FG005|STARTED|Treatment Period 3||1
6331145|NCT00519376|7237785|FG006|STARTED|Treatment Period 3||1
6331146|NCT00519376|7237786|FG007|STARTED|Treatment Period 3||1
6331147|NCT00519376|7237787|FG008|STARTED|Treatment Period 3||1
6331148|NCT00519376|7237788|FG009|STARTED|Treatment Period 3||1
6331149|NCT00519376|7237789|FG010|STARTED|Treatment Period 3||1
6331150|NCT00519376|7237790|FG011|STARTED|Treatment Period 3||1
6331151|NCT00519376|7237791|FG012|STARTED|Treatment Period 3||0
6331152|NCT00519376|7237792|FG013|STARTED|Treatment Period 3||1
6331153|NCT00519376|7237793|FG014|STARTED|Treatment Period 3||1
6331154|NCT00519376|7237794|FG015|STARTED|Treatment Period 3||1
6775295|NCT03882424|7703213|FG001|COMPLETED|Overall Study||38
6775296|NCT03882424|7703214|FG002|COMPLETED|Overall Study||38
6331155|NCT00519376|7237779|FG000|COMPLETED|Treatment Period 3||2
6331156|NCT00519376|7237780|FG001|COMPLETED|Treatment Period 3||2
6331157|NCT00519376|7237781|FG002|COMPLETED|Treatment Period 3||2
6331158|NCT00519376|7237782|FG003|COMPLETED|Treatment Period 3||2
6331159|NCT00519376|7237783|FG004|COMPLETED|Treatment Period 3||1
6331160|NCT00519376|7237784|FG005|COMPLETED|Treatment Period 3||1
6331161|NCT00519376|7237785|FG006|COMPLETED|Treatment Period 3||1
6775297|NCT03882424|7703212|FG000|NOT COMPLETED|Overall Study||4
6775298|NCT03882424|7703213|FG001|NOT COMPLETED|Overall Study||0
6775299|NCT03882424|7703214|FG002|NOT COMPLETED|Overall Study||0
6331162|NCT00519376|7237786|FG007|COMPLETED|Treatment Period 3||1
6331163|NCT00519376|7237787|FG008|COMPLETED|Treatment Period 3||1
6331164|NCT00519376|7237788|FG009|COMPLETED|Treatment Period 3||1
6331165|NCT00519376|7237789|FG010|COMPLETED|Treatment Period 3||1
6331166|NCT00519376|7237790|FG011|COMPLETED|Treatment Period 3||1
6331167|NCT00519376|7237791|FG012|COMPLETED|Treatment Period 3||0
6331168|NCT00519376|7237792|FG013|COMPLETED|Treatment Period 3||1
6331169|NCT00519376|7237793|FG014|COMPLETED|Treatment Period 3||1
6331170|NCT00519376|7237794|FG015|COMPLETED|Treatment Period 3||1
6331171|NCT00519376|7237779|FG000|NOT COMPLETED|Treatment Period 3||0
6331172|NCT00519376|7237780|FG001|NOT COMPLETED|Treatment Period 3||0
6331173|NCT00519376|7237781|FG002|NOT COMPLETED|Treatment Period 3||0
6331174|NCT00519376|7237782|FG003|NOT COMPLETED|Treatment Period 3||0
6331175|NCT00519376|7237783|FG004|NOT COMPLETED|Treatment Period 3||0
6331176|NCT00519376|7237784|FG005|NOT COMPLETED|Treatment Period 3||0
6331177|NCT00519376|7237785|FG006|NOT COMPLETED|Treatment Period 3||0
6331178|NCT00519376|7237786|FG007|NOT COMPLETED|Treatment Period 3||0
6331179|NCT00519376|7237787|FG008|NOT COMPLETED|Treatment Period 3||0
6331180|NCT00519376|7237788|FG009|NOT COMPLETED|Treatment Period 3||0
6331181|NCT00519376|7237789|FG010|NOT COMPLETED|Treatment Period 3||0
6331182|NCT00519376|7237790|FG011|NOT COMPLETED|Treatment Period 3||0
6331183|NCT00519376|7237791|FG012|NOT COMPLETED|Treatment Period 3||0
6331184|NCT00519376|7237792|FG013|NOT COMPLETED|Treatment Period 3||0
6331185|NCT00519376|7237793|FG014|NOT COMPLETED|Treatment Period 3||0
6331186|NCT00519376|7237794|FG015|NOT COMPLETED|Treatment Period 3||0
6331187|NCT00519376|7237779|FG000|STARTED|Washout Period 3||2
6775300|NCT03881163|7703222|FG000|STARTED|Overall Study||24
6775301|NCT03881163|7703222|FG000|COMPLETED|Overall Study||24
6775302|NCT03881163|7703222|FG000|NOT COMPLETED|Overall Study||0
6775303|NCT03881670|7703230|FG000|STARTED|Overall Study||12
6775304|NCT03881670|7703231|FG001|STARTED|Overall Study||12
6775305|NCT03881670|7703230|FG000|Completed First Intervention|Overall Study||12
6775306|NCT03881670|7703231|FG001|Completed First Intervention|Overall Study||12
6775307|NCT03881670|7703230|FG000|Completed Second Intervetion|Overall Study||12
6775308|NCT03881670|7703231|FG001|Completed Second Intervetion|Overall Study||12
6331188|NCT00519376|7237780|FG001|STARTED|Washout Period 3||2
6331189|NCT00519376|7237781|FG002|STARTED|Washout Period 3||2
6331190|NCT00519376|7237782|FG003|STARTED|Washout Period 3||2
6331191|NCT00519376|7237783|FG004|STARTED|Washout Period 3||1
6331192|NCT00519376|7237784|FG005|STARTED|Washout Period 3||1
6331193|NCT00519376|7237785|FG006|STARTED|Washout Period 3||1
6331194|NCT00519376|7237786|FG007|STARTED|Washout Period 3||1
6331195|NCT00519376|7237787|FG008|STARTED|Washout Period 3||1
6331196|NCT00519376|7237788|FG009|STARTED|Washout Period 3||1
6331197|NCT00519376|7237789|FG010|STARTED|Washout Period 3||1
6331198|NCT00519376|7237790|FG011|STARTED|Washout Period 3||1
6331199|NCT00519376|7237791|FG012|STARTED|Washout Period 3||0
6331200|NCT00519376|7237792|FG013|STARTED|Washout Period 3||1
6331201|NCT00519376|7237793|FG014|STARTED|Washout Period 3||1
6331202|NCT00519376|7237794|FG015|STARTED|Washout Period 3||1
6331203|NCT00519376|7237779|FG000|COMPLETED|Washout Period 3||2
6331204|NCT00519376|7237780|FG001|COMPLETED|Washout Period 3||2
6331205|NCT00519376|7237781|FG002|COMPLETED|Washout Period 3||2
6331206|NCT00519376|7237782|FG003|COMPLETED|Washout Period 3||2
6331207|NCT00519376|7237783|FG004|COMPLETED|Washout Period 3||1
6331208|NCT00519376|7237784|FG005|COMPLETED|Washout Period 3||1
6331209|NCT00519376|7237785|FG006|COMPLETED|Washout Period 3||1
6331210|NCT00519376|7237786|FG007|COMPLETED|Washout Period 3||1
6331211|NCT00519376|7237787|FG008|COMPLETED|Washout Period 3||1
6331212|NCT00519376|7237788|FG009|COMPLETED|Washout Period 3||1
6331213|NCT00519376|7237789|FG010|COMPLETED|Washout Period 3||1
6331214|NCT00519376|7237790|FG011|COMPLETED|Washout Period 3||1
6331215|NCT00519376|7237791|FG012|COMPLETED|Washout Period 3||0
6331216|NCT00519376|7237792|FG013|COMPLETED|Washout Period 3||1
6331217|NCT00519376|7237793|FG014|COMPLETED|Washout Period 3||1
6331218|NCT00519376|7237794|FG015|COMPLETED|Washout Period 3||1
6331219|NCT00519376|7237779|FG000|NOT COMPLETED|Washout Period 3||0
6331220|NCT00519376|7237780|FG001|NOT COMPLETED|Washout Period 3||0
6331221|NCT00519376|7237781|FG002|NOT COMPLETED|Washout Period 3||0
6331222|NCT00519376|7237782|FG003|NOT COMPLETED|Washout Period 3||0
6331223|NCT00519376|7237783|FG004|NOT COMPLETED|Washout Period 3||0
6331224|NCT00519376|7237784|FG005|NOT COMPLETED|Washout Period 3||0
6331225|NCT00519376|7237785|FG006|NOT COMPLETED|Washout Period 3||0
6331226|NCT00519376|7237786|FG007|NOT COMPLETED|Washout Period 3||0
6331227|NCT00519376|7237787|FG008|NOT COMPLETED|Washout Period 3||0
6331228|NCT00519376|7237788|FG009|NOT COMPLETED|Washout Period 3||0
6331229|NCT00519376|7237789|FG010|NOT COMPLETED|Washout Period 3||0
6331230|NCT00519376|7237790|FG011|NOT COMPLETED|Washout Period 3||0
6331231|NCT00519376|7237791|FG012|NOT COMPLETED|Washout Period 3||0
6331232|NCT00519376|7237792|FG013|NOT COMPLETED|Washout Period 3||0
6331233|NCT00519376|7237793|FG014|NOT COMPLETED|Washout Period 3||0
6331234|NCT00519376|7237794|FG015|NOT COMPLETED|Washout Period 3||0
6331235|NCT00519376|7237779|FG000|STARTED|Treatment Period 4||2
6331236|NCT00519376|7237780|FG001|STARTED|Treatment Period 4||2
6331237|NCT00519376|7237781|FG002|STARTED|Treatment Period 4||2
6331238|NCT00519376|7237782|FG003|STARTED|Treatment Period 4||2
6775309|NCT03881670|7703230|FG000|COMPLETED|Overall Study||12
6331239|NCT00519376|7237783|FG004|STARTED|Treatment Period 4||1
6331240|NCT00519376|7237784|FG005|STARTED|Treatment Period 4||1
6331241|NCT00519376|7237785|FG006|STARTED|Treatment Period 4||1
6331242|NCT00519376|7237786|FG007|STARTED|Treatment Period 4||1
6331243|NCT00519376|7237787|FG008|STARTED|Treatment Period 4||1
6331244|NCT00519376|7237788|FG009|STARTED|Treatment Period 4||1
6331245|NCT00519376|7237789|FG010|STARTED|Treatment Period 4||1
6331246|NCT00519376|7237790|FG011|STARTED|Treatment Period 4||1
6331247|NCT00519376|7237791|FG012|STARTED|Treatment Period 4||0
6331248|NCT00519376|7237792|FG013|STARTED|Treatment Period 4||1
6331249|NCT00519376|7237793|FG014|STARTED|Treatment Period 4||1
6331250|NCT00519376|7237794|FG015|STARTED|Treatment Period 4||1
6331251|NCT00519376|7237779|FG000|COMPLETED|Treatment Period 4||2
6331252|NCT00519376|7237780|FG001|COMPLETED|Treatment Period 4||2
6331253|NCT00519376|7237781|FG002|COMPLETED|Treatment Period 4||1
6331254|NCT00519376|7237782|FG003|COMPLETED|Treatment Period 4||2
6331255|NCT00519376|7237783|FG004|COMPLETED|Treatment Period 4||1
6331256|NCT00519376|7237784|FG005|COMPLETED|Treatment Period 4||1
6331257|NCT00519376|7237785|FG006|COMPLETED|Treatment Period 4||1
6331258|NCT00519376|7237786|FG007|COMPLETED|Treatment Period 4||1
6331259|NCT00519376|7237787|FG008|COMPLETED|Treatment Period 4||1
6331260|NCT00519376|7237788|FG009|COMPLETED|Treatment Period 4||1
6331261|NCT00519376|7237789|FG010|COMPLETED|Treatment Period 4||1
6331262|NCT00519376|7237790|FG011|COMPLETED|Treatment Period 4||1
6331263|NCT00519376|7237791|FG012|COMPLETED|Treatment Period 4||0
6331264|NCT00519376|7237792|FG013|COMPLETED|Treatment Period 4||1
6331265|NCT00519376|7237793|FG014|COMPLETED|Treatment Period 4||1
6331266|NCT00519376|7237794|FG015|COMPLETED|Treatment Period 4||1
6331267|NCT00519376|7237779|FG000|NOT COMPLETED|Treatment Period 4||0
6331268|NCT00519376|7237780|FG001|NOT COMPLETED|Treatment Period 4||0
6331269|NCT00519376|7237781|FG002|NOT COMPLETED|Treatment Period 4||1
6331270|NCT00519376|7237782|FG003|NOT COMPLETED|Treatment Period 4||0
6331271|NCT00519376|7237783|FG004|NOT COMPLETED|Treatment Period 4||0
6331272|NCT00519376|7237784|FG005|NOT COMPLETED|Treatment Period 4||0
6331273|NCT00519376|7237785|FG006|NOT COMPLETED|Treatment Period 4||0
6331274|NCT00519376|7237786|FG007|NOT COMPLETED|Treatment Period 4||0
6331275|NCT00519376|7237787|FG008|NOT COMPLETED|Treatment Period 4||0
6331276|NCT00519376|7237788|FG009|NOT COMPLETED|Treatment Period 4||0
6331277|NCT00519376|7237789|FG010|NOT COMPLETED|Treatment Period 4||0
6331278|NCT00519376|7237790|FG011|NOT COMPLETED|Treatment Period 4||0
6331279|NCT00519376|7237791|FG012|NOT COMPLETED|Treatment Period 4||0
6331280|NCT00519376|7237792|FG013|NOT COMPLETED|Treatment Period 4||0
6331281|NCT00519376|7237793|FG014|NOT COMPLETED|Treatment Period 4||0
6331282|NCT00519376|7237794|FG015|NOT COMPLETED|Treatment Period 4||0
6331283|NCT00519428|7237809|FG000|STARTED|Overall Study||78
6331284|NCT00519428|7237810|FG001|STARTED|Overall Study||84
6331285|NCT00519428|7237811|FG002|STARTED|Overall Study||83
6331286|NCT00519428|7237809|FG000|COMPLETED|Overall Study||57
6331287|NCT00519428|7237810|FG001|COMPLETED|Overall Study||69
6331288|NCT00519428|7237811|FG002|COMPLETED|Overall Study||58
6331289|NCT00519428|7237809|FG000|NOT COMPLETED|Overall Study||21
6331290|NCT00519428|7237810|FG001|NOT COMPLETED|Overall Study||15
6331291|NCT00519428|7237811|FG002|NOT COMPLETED|Overall Study||25
6331292|NCT00519532|7237822|FG000|STARTED|Overall Study||84
6331293|NCT00519532|7237822|FG000|COMPLETED|Overall Study||66
6331294|NCT00519532|7237822|FG000|NOT COMPLETED|Overall Study||18
6331295|NCT00519584|7237830|FG000|STARTED|Overall Study||54
6331296|NCT00519584|7237831|FG001|STARTED|Overall Study||54
6558659|NCT01776424|7481231|FG001|Treated|Overall Study||9110
6558660|NCT01776424|7481232|FG002|Treated|Overall Study||9107
6558661|NCT01776424|7481230|FG000|COMPLETED|Overall Study||9132
6331297|NCT00519584|7237832|FG002|STARTED|Overall Study||54
6331298|NCT00519584|7237833|FG003|STARTED|Overall Study||56
6331299|NCT00519584|7237830|FG000|COMPLETED|Overall Study||54
6331300|NCT00519584|7237831|FG001|COMPLETED|Overall Study||54
6331301|NCT00519584|7237832|FG002|COMPLETED|Overall Study||54
6331302|NCT00519584|7237833|FG003|COMPLETED|Overall Study||56
6558662|NCT01776424|7481231|FG001|COMPLETED|Overall Study||9098
6558663|NCT01776424|7481232|FG002|COMPLETED|Overall Study||9102
6558664|NCT01776424|7481230|FG000|NOT COMPLETED|Overall Study||20
6558665|NCT01776424|7481231|FG001|NOT COMPLETED|Overall Study||19
6331303|NCT00519584|7237830|FG000|NOT COMPLETED|Overall Study||0
6331304|NCT00519584|7237831|FG001|NOT COMPLETED|Overall Study||0
6331305|NCT00519584|7237832|FG002|NOT COMPLETED|Overall Study||0
6331306|NCT00519584|7237833|FG003|NOT COMPLETED|Overall Study||0
6331307|NCT00519623|7237843|FG000|STARTED|Overall Study||9
6331308|NCT00519623|7237843|FG000|COMPLETED|Overall Study||8
6331309|NCT00519623|7237843|FG000|NOT COMPLETED|Overall Study||1
6331310|NCT00519636|7237851|FG000|STARTED|Treatment Period 1||91
6331311|NCT00519636|7237852|FG001|STARTED|Treatment Period 1||86
6331312|NCT00519636|7237853|FG002|STARTED|Treatment Period 1||90
6331313|NCT00519636|7237854|FG003|STARTED|Treatment Period 1||93
6331314|NCT00519636|7237851|FG000|COMPLETED|Treatment Period 1||89
6331315|NCT00519636|7237852|FG001|COMPLETED|Treatment Period 1||86
6331316|NCT00519636|7237853|FG002|COMPLETED|Treatment Period 1||89
6331317|NCT00519636|7237854|FG003|COMPLETED|Treatment Period 1||93
6331318|NCT00519636|7237851|FG000|NOT COMPLETED|Treatment Period 1||2
6331319|NCT00519636|7237852|FG001|NOT COMPLETED|Treatment Period 1||0
6331320|NCT00519636|7237853|FG002|NOT COMPLETED|Treatment Period 1||1
6558666|NCT01776424|7481232|FG002|NOT COMPLETED|Overall Study||24
6558667|NCT01776541|7481242|FG000|STARTED|Overall Study||488
6558668|NCT01776541|7481243|FG001|STARTED|Overall Study||491
6331321|NCT00519636|7237854|FG003|NOT COMPLETED|Treatment Period 1||0
6331322|NCT00519636|7237851|FG000|STARTED|Washout Period||89
6331323|NCT00519636|7237852|FG001|STARTED|Washout Period||86
6331324|NCT00519636|7237853|FG002|STARTED|Washout Period||89
6331325|NCT00519636|7237854|FG003|STARTED|Washout Period||93
6331326|NCT00519636|7237851|FG000|COMPLETED|Washout Period||69
6331327|NCT00519636|7237852|FG001|COMPLETED|Washout Period||72
6331328|NCT00519636|7237853|FG002|COMPLETED|Washout Period||75
6331329|NCT00519636|7237854|FG003|COMPLETED|Washout Period||88
6331330|NCT00519636|7237851|FG000|NOT COMPLETED|Washout Period||20
6331331|NCT00519636|7237852|FG001|NOT COMPLETED|Washout Period||14
6331332|NCT00519636|7237853|FG002|NOT COMPLETED|Washout Period||14
6331333|NCT00519636|7237854|FG003|NOT COMPLETED|Washout Period||5
6331334|NCT00519636|7237851|FG000|STARTED|Treatment Period 2||69
6331335|NCT00519636|7237852|FG001|STARTED|Treatment Period 2||72
6331336|NCT00519636|7237853|FG002|STARTED|Treatment Period 2||75
6331337|NCT00519636|7237854|FG003|STARTED|Treatment Period 2||88
6331338|NCT00519636|7237851|FG000|COMPLETED|Treatment Period 2||69
6331339|NCT00519636|7237852|FG001|COMPLETED|Treatment Period 2||71
6331340|NCT00519636|7237853|FG002|COMPLETED|Treatment Period 2||74
6331341|NCT00519636|7237854|FG003|COMPLETED|Treatment Period 2||86
6331342|NCT00519636|7237851|FG000|NOT COMPLETED|Treatment Period 2||0
6331343|NCT00519636|7237852|FG001|NOT COMPLETED|Treatment Period 2||1
6331344|NCT00519636|7237853|FG002|NOT COMPLETED|Treatment Period 2||1
6331345|NCT00519636|7237854|FG003|NOT COMPLETED|Treatment Period 2||2
6331346|NCT00519636|7237851|FG000|STARTED|Post Study Period||69
6331347|NCT00519636|7237852|FG001|STARTED|Post Study Period||71
6331348|NCT00519636|7237853|FG002|STARTED|Post Study Period||74
6331349|NCT00519636|7237854|FG003|STARTED|Post Study Period||86
6331350|NCT00519636|7237851|FG000|COMPLETED|Post Study Period||69
6331351|NCT00519636|7237852|FG001|COMPLETED|Post Study Period||71
6331352|NCT00519636|7237853|FG002|COMPLETED|Post Study Period||74
6331353|NCT00519636|7237854|FG003|COMPLETED|Post Study Period||85
6331354|NCT00519636|7237851|FG000|NOT COMPLETED|Post Study Period||0
6331355|NCT00519636|7237852|FG001|NOT COMPLETED|Post Study Period||0
6331356|NCT00519636|7237853|FG002|NOT COMPLETED|Post Study Period||0
6331357|NCT00519636|7237854|FG003|NOT COMPLETED|Post Study Period||1
6331358|NCT00519649|7237868|FG000|STARTED|Overall Study||300
6331359|NCT00519649|7237868|FG000|COMPLETED|Overall Study||299
6331360|NCT00519649|7237868|FG000|NOT COMPLETED|Overall Study||1
6331361|NCT00519779|7237874|FG000|STARTED|Overall Study||34
6331362|NCT00519779|7237875|FG001|STARTED|Overall Study||34
6331363|NCT00519779|7237874|FG000|COMPLETED|Overall Study||34
6331364|NCT00519779|7237875|FG001|COMPLETED|Overall Study||33
6331365|NCT00519779|7237874|FG000|NOT COMPLETED|Overall Study||0
6331366|NCT00519779|7237875|FG001|NOT COMPLETED|Overall Study||1
6331367|NCT00519831|7237881|FG000|STARTED|Overall Study||16
6331368|NCT00519831|7237881|FG000|COMPLETED|Overall Study||13
6331369|NCT00519831|7237881|FG000|NOT COMPLETED|Overall Study||3
6331370|NCT00519896|7237885|FG000|STARTED|Overall Study||35
6331371|NCT00519896|7237885|FG000|COMPLETED|Overall Study||33
6331372|NCT00519896|7237885|FG000|NOT COMPLETED|Overall Study||2
6331373|NCT00520013|7237892|FG000|STARTED|Overall Study||23
6331374|NCT00520013|7237893|FG001|STARTED|Overall Study||25
6331375|NCT00520013|7237894|FG002|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
6331376|NCT00520013|7237892|FG000|Treated|Overall Study||23
6331377|NCT00520013|7237893|FG001|Treated|Overall Study||25
6331378|NCT00520013|7237894|FG002|Treated|Overall Study||11
6331379|NCT00520013|7237892|FG000|COMPLETED|Overall Study||11
6331380|NCT00520013|7237893|FG001|COMPLETED|Overall Study||10
6331381|NCT00520013|7237894|FG002|COMPLETED|Overall Study||0
6331382|NCT00520013|7237892|FG000|NOT COMPLETED|Overall Study||12
6331383|NCT00520013|7237893|FG001|NOT COMPLETED|Overall Study||15
6331384|NCT00520013|7237894|FG002|NOT COMPLETED|Overall Study||11
6331385|NCT00520039|7237902|FG000|STARTED|Overall Study||28
6331386|NCT00520039|7237903|FG001|STARTED|Overall Study||24
6331387|NCT00520039|7237902|FG000|COMPLETED|Overall Study||21
6331388|NCT00520039|7237903|FG001|COMPLETED|Overall Study||19
6331389|NCT00520039|7237902|FG000|NOT COMPLETED|Overall Study||7
6331390|NCT00520039|7237903|FG001|NOT COMPLETED|Overall Study||5
6558669|NCT01776541|7481242|FG000|COMPLETED|Overall Study||432
6331391|NCT00520130|7237913|FG000|STARTED|Overall Study||44
6331392|NCT00520130|7237914|FG001|STARTED|Overall Study||45
6331393|NCT00520130|7237913|FG000|COMPLETED|Overall Study||39
6331394|NCT00520130|7237914|FG001|COMPLETED|Overall Study||44
6331395|NCT00520130|7237913|FG000|NOT COMPLETED|Overall Study||5
6331396|NCT00520130|7237914|FG001|NOT COMPLETED|Overall Study||1
6331397|NCT00520234|7237926|FG000|STARTED|Overall Study||118
6331398|NCT00520234|7237927|FG001|STARTED|Overall Study||104
6331399|NCT00520234|7237926|FG000|COMPLETED|Overall Study||117
6331400|NCT00520234|7237927|FG001|COMPLETED|Overall Study||102
6331401|NCT00520234|7237926|FG000|NOT COMPLETED|Overall Study||1
6331402|NCT00520234|7237927|FG001|NOT COMPLETED|Overall Study||2
6331403|NCT00520286|7237936|FG000|STARTED|Overall Study||142
6331404|NCT00520286|7237937|FG001|STARTED|Overall Study||68
6331405|NCT00520286|7237936|FG000|COMPLETED|Overall Study||76
6331406|NCT00520286|7237937|FG001|COMPLETED|Overall Study||36
6331407|NCT00520286|7237936|FG000|NOT COMPLETED|Overall Study||66
6331408|NCT00520286|7237937|FG001|NOT COMPLETED|Overall Study||32
6558670|NCT01776541|7481243|FG001|COMPLETED|Overall Study||416
6331409|NCT00520299|7237946|FG000|STARTED|Overall Study||6
6558671|NCT01776541|7481242|FG000|NOT COMPLETED|Overall Study||56
6331410|NCT00520299|7237947|FG001|STARTED|Overall Study||6
6331411|NCT00520299|7237948|FG002|STARTED|Overall Study||19
6331412|NCT00520299|7237946|FG000|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
6331413|NCT00520299|7237947|FG001|COMPLETED|Overall Study||3
6331414|NCT00520299|7237948|FG002|COMPLETED|Overall Study||13
6331415|NCT00520299|7237946|FG000|NOT COMPLETED|Overall Study||0
6331416|NCT00520299|7237947|FG001|NOT COMPLETED|Overall Study||3
6331417|NCT00520299|7237948|FG002|NOT COMPLETED|Overall Study||6
6331418|NCT00520351|7237958|FG000|STARTED|First Intervention|Start date is Sep.06, 2007|15
6775310|NCT03881670|7703231|FG001|COMPLETED|Overall Study||12
6775311|NCT03881670|7703230|FG000|NOT COMPLETED|Overall Study||0
6775312|NCT03881670|7703231|FG001|NOT COMPLETED|Overall Study||0
6775313|NCT03880266|7703247|FG000|STARTED|Overall Study||12
6775314|NCT03880266|7703248|FG001|STARTED|Overall Study||6
6775315|NCT03880266|7703249|FG002|STARTED|Overall Study||12
6331419|NCT00520351|7237959|FG001|STARTED|First Intervention|Start date is Sep.06, 2007|15
6331420|NCT00520351|7237958|FG000|COMPLETED|First Intervention|End date is Feb.25, 2008|14
6331421|NCT00520351|7237959|FG001|COMPLETED|First Intervention|End date is Feb.25, 2008|14
6331422|NCT00520351|7237958|FG000|NOT COMPLETED|First Intervention||1
6331423|NCT00520351|7237959|FG001|NOT COMPLETED|First Intervention||1
6331424|NCT00520351|7237958|FG000|STARTED|Second Intervention||14
6331425|NCT00520351|7237959|FG001|STARTED|Second Intervention||14
6331426|NCT00520351|7237958|FG000|COMPLETED|Second Intervention||14
6331427|NCT00520351|7237959|FG001|COMPLETED|Second Intervention||14
6331428|NCT00520351|7237958|FG000|NOT COMPLETED|Second Intervention||0
6331429|NCT00520351|7237959|FG001|NOT COMPLETED|Second Intervention||0
6331430|NCT00520403|7237965|FG000|STARTED|Bevacizumab + IFN/Vinblastine||25
6331431|NCT00520403|7237965|FG000|COMPLETED|Bevacizumab + IFN/Vinblastine||7
6331432|NCT00520403|7237965|FG000|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
6331433|NCT00520403|7237965|FG000|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
6331434|NCT00520403|7237965|FG000|COMPLETED|Bevacizumab Monotherapy||0
6331435|NCT00520403|7237965|FG000|NOT COMPLETED|Bevacizumab Monotherapy||2
6331436|NCT00520468|7237969|FG000|STARTED|Overall Study||14
6331437|NCT00520468|7237969|FG000|COMPLETED|Overall Study||14
6331438|NCT00520468|7237969|FG000|NOT COMPLETED|Overall Study||0
6331439|NCT00520481|7237975|FG000|STARTED|Overall Study||31
6331440|NCT00520481|7237976|FG001|STARTED|Overall Study||10
6331441|NCT00520481|7237975|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
6558672|NCT01776541|7481243|FG001|NOT COMPLETED|Overall Study||75
6558673|NCT01776554|7481252|FG000|STARTED|Overall Study||332
6558674|NCT01776554|7481253|FG001|STARTED|Overall Study||330
6558675|NCT01776554|7481252|FG000|COMPLETED|Overall Study||315
6558676|NCT01776554|7481253|FG001|COMPLETED|Overall Study||307
6558677|NCT01776554|7481252|FG000|NOT COMPLETED|Overall Study||17
6558678|NCT01776554|7481253|FG001|NOT COMPLETED|Overall Study||23
6558679|NCT01776632|7481262|FG000|STARTED|Overall Study||217
6558680|NCT01776632|7481263|FG001|STARTED|Overall Study||219
6558681|NCT01776632|7481262|FG000|COMPLETED|Overall Study||190
6558682|NCT01776632|7481263|FG001|COMPLETED|Overall Study||190
6558683|NCT01776632|7481262|FG000|NOT COMPLETED|Overall Study||27
6558684|NCT01776632|7481263|FG001|NOT COMPLETED|Overall Study||29
6558685|NCT01776645|7481271|FG000|STARTED|Overall Study||28
6558686|NCT01776645|7481272|FG001|STARTED|Overall Study||28
6558687|NCT01776645|7481271|FG000|COMPLETED|Overall Study||14
6558688|NCT01776645|7481272|FG001|COMPLETED|Overall Study||14
6558689|NCT01776645|7481271|FG000|NOT COMPLETED|Overall Study||14
6558690|NCT01776645|7481272|FG001|NOT COMPLETED|Overall Study||14
6558691|NCT01777126|7481279|FG000|STARTED|Overall Study||48
6558692|NCT01777126|7481280|FG001|STARTED|Overall Study||46
6558693|NCT01777126|7481279|FG000|COMPLETED|Overall Study||48
6558694|NCT01777126|7481280|FG001|COMPLETED|Overall Study||46
6558695|NCT01777126|7481279|FG000|NOT COMPLETED|Overall Study||0
6331442|NCT00520481|7237976|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
6331443|NCT00520481|7237975|FG000|COMPLETED|Overall Study||24
6331444|NCT00520481|7237976|FG001|COMPLETED|Overall Study||9
6331445|NCT00520481|7237975|FG000|NOT COMPLETED|Overall Study||7
6558696|NCT01777126|7481280|FG001|NOT COMPLETED|Overall Study||0
6558697|NCT01777139|7481288|FG000|STARTED|Primary Reporting Phase (Up to 4 Years)||30
6558698|NCT01777139|7481289|FG001|STARTED|Primary Reporting Phase (Up to 4 Years)||0
6558699|NCT01777139|7481288|FG000|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
6775316|NCT03880266|7703250|FG003|STARTED|Overall Study||4
6775317|NCT03880266|7703251|FG004|STARTED|Overall Study||12
6775318|NCT03880266|7703252|FG005|STARTED|Overall Study||6
6331446|NCT00520481|7237976|FG001|NOT COMPLETED|Overall Study||1
6331447|NCT00520494|7237984|FG000|STARTED|Overall Study||18
6331448|NCT00520494|7237984|FG000|COMPLETED|Overall Study||17
6331449|NCT00520494|7237984|FG000|NOT COMPLETED|Overall Study||1
6331450|NCT00520533|7237988|FG000|STARTED|Overall Study||8
6331451|NCT00520533|7237988|FG000|COMPLETED|Overall Study||4
6331452|NCT00520533|7237988|FG000|NOT COMPLETED|Overall Study||4
6331453|NCT00520546|7237993|FG000|STARTED|Overall Study||44
6331454|NCT00520546|7237993|FG000|COMPLETED|Overall Study||38
6331455|NCT00520546|7237993|FG000|NOT COMPLETED|Overall Study||6
6376078|NCT00758524|7286589|FG014|Treated|Core Period (Week 0 to Week 8)||0
6558700|NCT01777139|7481289|FG001|COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
6558701|NCT01777139|7481288|FG000|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||30
6562867|NCT01803269|7485765|FG002|COMPLETED|Overall Study||14
6331456|NCT00520572|7238008|FG000|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
6331457|NCT00520572|7238009|FG001|STARTED|Overall Study|Participants randomised.|64
6331458|NCT00520572|7238010|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
6331459|NCT00520572|7238011|FG003|STARTED|Overall Study|Participants randomised.|64
6331460|NCT00520572|7238012|FG004|STARTED|Overall Study|Participants randomised.|65
6331461|NCT00520572|7238013|FG005|STARTED|Overall Study|Participants randomised.|64
6331462|NCT00520572|7238008|FG000|COMPLETED|Overall Study|Participants completed the study.|52
6331463|NCT00520572|7238009|FG001|COMPLETED|Overall Study|Participants completed the study.|50
6331464|NCT00520572|7238010|FG002|COMPLETED|Overall Study|Participants completed the study.|49
6331465|NCT00520572|7238011|FG003|COMPLETED|Overall Study|Participants completed the study.|50
6331466|NCT00520572|7238012|FG004|COMPLETED|Overall Study|Participants completed the study.|53
6331467|NCT00520572|7238013|FG005|COMPLETED|Overall Study|Participants completed the study.|62
6331468|NCT00520572|7238008|FG000|NOT COMPLETED|Overall Study||12
6331469|NCT00520572|7238009|FG001|NOT COMPLETED|Overall Study||14
6331470|NCT00520572|7238010|FG002|NOT COMPLETED|Overall Study||15
6331471|NCT00520572|7238011|FG003|NOT COMPLETED|Overall Study||14
6331472|NCT00520572|7238012|FG004|NOT COMPLETED|Overall Study||12
6331473|NCT00520572|7238013|FG005|NOT COMPLETED|Overall Study||2
6331474|NCT00520676|7238029|FG000|STARTED|Overall Study||128
6331475|NCT00520676|7238030|FG001|STARTED|Overall Study||132
6331476|NCT00520676|7238029|FG000|Received at Least 1 Dose of Study Drug|Overall Study||118
6331477|NCT00520676|7238030|FG001|Received at Least 1 Dose of Study Drug|Overall Study||127
6331478|NCT00520676|7238029|FG000|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
6331479|NCT00520676|7238030|FG001|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
6331480|NCT00520676|7238029|FG000|COMPLETED|Overall Study||27
6331481|NCT00520676|7238030|FG001|COMPLETED|Overall Study||29
6331482|NCT00520676|7238029|FG000|NOT COMPLETED|Overall Study||101
6331483|NCT00520676|7238030|FG001|NOT COMPLETED|Overall Study||103
6331484|NCT00520741|7238038|FG000|STARTED|Overall Study||106
6331485|NCT00520741|7238039|FG001|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
6331486|NCT00520741|7238038|FG000|COMPLETED|Overall Study||69
6331487|NCT00520741|7238039|FG001|COMPLETED|Overall Study||194
6331488|NCT00520741|7238038|FG000|NOT COMPLETED|Overall Study||37
6331489|NCT00520741|7238039|FG001|NOT COMPLETED|Overall Study||125
6331490|NCT00520767|7238047|FG000|STARTED|Overall Study||35
6331491|NCT00520767|7238047|FG000|COMPLETED|Overall Study||33
6331492|NCT00520767|7238047|FG000|NOT COMPLETED|Overall Study||2
6331493|NCT00520845|7238051|FG000|STARTED|Overall Study||23
6331494|NCT00520845|7238051|FG000|COMPLETED|Overall Study||1
6331495|NCT00520845|7238051|FG000|NOT COMPLETED|Overall Study||22
6331496|NCT00520884|7238057|FG000|STARTED|Overall Study||3
6331497|NCT00520884|7238058|FG001|STARTED|Overall Study||2
6331498|NCT00520884|7238059|FG002|STARTED|Overall Study||2
6331499|NCT00520884|7238060|FG003|STARTED|Overall Study||3
6331500|NCT00520884|7238057|FG000|COMPLETED|Overall Study||3
6331501|NCT00520884|7238058|FG001|COMPLETED|Overall Study||2
6331502|NCT00520884|7238059|FG002|COMPLETED|Overall Study||2
6331503|NCT00520884|7238060|FG003|COMPLETED|Overall Study||3
6331504|NCT00520884|7238057|FG000|NOT COMPLETED|Overall Study||0
6331505|NCT00520884|7238058|FG001|NOT COMPLETED|Overall Study||0
6331506|NCT00520884|7238059|FG002|NOT COMPLETED|Overall Study||0
6331507|NCT00520884|7238060|FG003|NOT COMPLETED|Overall Study||0
6331508|NCT00520910|7238069|FG000|STARTED|Overall Study||5
6331509|NCT00520910|7238070|FG001|STARTED|Overall Study||5
6331510|NCT00520910|7238069|FG000|COMPLETED|Overall Study||5
6331511|NCT00520910|7238070|FG001|COMPLETED|Overall Study||5
6331512|NCT00520910|7238069|FG000|NOT COMPLETED|Overall Study||0
6331513|NCT00520910|7238070|FG001|NOT COMPLETED|Overall Study||0
6331514|NCT00520936|7238084|FG000|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
6331515|NCT00520936|7238085|FG001|STARTED|Overall Study||11
6331516|NCT00520936|7238086|FG002|STARTED|Overall Study||9
6331517|NCT00520936|7238087|FG003|STARTED|Overall Study||5
6331518|NCT00520936|7238088|FG004|STARTED|Overall Study||6
6331519|NCT00520936|7238089|FG005|STARTED|Overall Study||10
6331520|NCT00520936|7238090|FG006|STARTED|Overall Study||11
6331521|NCT00520936|7238091|FG007|STARTED|Overall Study||10
6331522|NCT00520936|7238084|FG000|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
6331523|NCT00520936|7238085|FG001|COMPLETED|Overall Study||7
6331524|NCT00520936|7238086|FG002|COMPLETED|Overall Study||7
6331525|NCT00520936|7238087|FG003|COMPLETED|Overall Study||5
6331526|NCT00520936|7238088|FG004|COMPLETED|Overall Study||5
6331527|NCT00520936|7238089|FG005|COMPLETED|Overall Study||10
6331528|NCT00520936|7238090|FG006|COMPLETED|Overall Study||7
6331529|NCT00520936|7238091|FG007|COMPLETED|Overall Study||9
6331530|NCT00520936|7238084|FG000|NOT COMPLETED|Overall Study||0
6331531|NCT00520936|7238085|FG001|NOT COMPLETED|Overall Study||4
6331532|NCT00520936|7238086|FG002|NOT COMPLETED|Overall Study||2
6331533|NCT00520936|7238087|FG003|NOT COMPLETED|Overall Study||0
6331534|NCT00520936|7238088|FG004|NOT COMPLETED|Overall Study||1
6331535|NCT00520936|7238089|FG005|NOT COMPLETED|Overall Study||0
6331536|NCT00520936|7238090|FG006|NOT COMPLETED|Overall Study||4
6331537|NCT00520936|7238091|FG007|NOT COMPLETED|Overall Study||1
6331538|NCT00520975|7238104|FG000|STARTED|Overall Study||48
6331539|NCT00520975|7238105|FG001|STARTED|Overall Study||48
6331540|NCT00520975|7238104|FG000|Treated and Reported Adverse Events Data|Overall Study||47
6331541|NCT00520975|7238105|FG001|Treated and Reported Adverse Events Data|Overall Study||45
6331542|NCT00520975|7238104|FG000|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
6331543|NCT00520975|7238105|FG001|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
6331544|NCT00520975|7238104|FG000|NOT COMPLETED|Overall Study||48
6331545|NCT00520975|7238105|FG001|NOT COMPLETED|Overall Study||48
6331546|NCT00521001|7238111|FG000|STARTED|Overall Study||49
6331547|NCT00521001|7238111|FG000|COMPLETED|Overall Study||48
6331548|NCT00521001|7238111|FG000|NOT COMPLETED|Overall Study||1
6331549|NCT00521014|7238115|FG000|STARTED|Overall Study||14
6331550|NCT00521014|7238115|FG000|COMPLETED|Overall Study||13
6331551|NCT00521014|7238115|FG000|NOT COMPLETED|Overall Study||1
6331552|NCT00521053|7238119|FG000|STARTED|Treatment Phase||80
6775319|NCT03880266|7703253|FG006|STARTED|Overall Study||13
6331553|NCT00521053|7238119|FG000|Received 1 Cycle of PV-10|Treatment Phase||35
6331554|NCT00521053|7238119|FG000|Received 2 Cycles of PV-10|Treatment Phase||26
6331555|NCT00521053|7238119|FG000|Received 3 Cycles of PV-10|Treatment Phase||16
6331556|NCT00521053|7238119|FG000|Received 4 Cycles of PV-10|Treatment Phase||3
6331557|NCT00521053|7238119|FG000|COMPLETED|Treatment Phase||80
6331558|NCT00521053|7238119|FG000|NOT COMPLETED|Treatment Phase||0
6331559|NCT00521053|7238119|FG000|STARTED|Observation Phase||80
6331560|NCT00521053|7238119|FG000|COMPLETED|Observation Phase||12
6331561|NCT00521053|7238119|FG000|NOT COMPLETED|Observation Phase||68
6331562|NCT00521079|7238128|FG000|STARTED|Overall Study||192
6331563|NCT00521079|7238129|FG001|STARTED|Overall Study||102
6331564|NCT00521079|7238128|FG000|Surgical Roll-In|Overall Study||9
6331565|NCT00521079|7238129|FG001|Surgical Roll-In|Overall Study||5
6331566|NCT00521079|7238128|FG000|COMPLETED|Overall Study||178
6558702|NCT01777139|7481289|FG001|NOT COMPLETED|Primary Reporting Phase (Up to 4 Years)||0
6558703|NCT01777139|7481288|FG000|STARTED|SFUCP (Up to 1.4 Years)||0
6558704|NCT01777139|7481289|FG001|STARTED|SFUCP (Up to 1.4 Years)||4
6558705|NCT01777139|7481288|FG000|COMPLETED|SFUCP (Up to 1.4 Years)||0
6558706|NCT01777139|7481289|FG001|COMPLETED|SFUCP (Up to 1.4 Years)||0
6558707|NCT01777139|7481288|FG000|NOT COMPLETED|SFUCP (Up to 1.4 Years)||0
6558708|NCT01777139|7481289|FG001|NOT COMPLETED|SFUCP (Up to 1.4 Years)||4
6558709|NCT01777152|7481298|FG000|STARTED|Overall Study||226
6558710|NCT01777152|7481299|FG001|STARTED|Overall Study||226
6558711|NCT01777152|7481298|FG000|COMPLETED|Overall Study||131
6558712|NCT01777152|7481299|FG001|COMPLETED|Overall Study||116
6558713|NCT01777152|7481298|FG000|NOT COMPLETED|Overall Study||95
6558714|NCT01777152|7481299|FG001|NOT COMPLETED|Overall Study||110
6331567|NCT00521079|7238129|FG001|COMPLETED|Overall Study||97
6331568|NCT00521079|7238128|FG000|NOT COMPLETED|Overall Study||14
6331569|NCT00521079|7238129|FG001|NOT COMPLETED|Overall Study||5
6331570|NCT00521144|7238140|FG000|STARTED|Overall Study||6
6331571|NCT00521144|7238141|FG001|STARTED|Overall Study||5
6331572|NCT00521144|7238142|FG002|STARTED|Overall Study||3
6331573|NCT00521144|7238143|FG003|STARTED|Overall Study||1
6331574|NCT00521144|7238144|FG004|STARTED|Overall Study||7
6331575|NCT00521144|7238140|FG000|COMPLETED|Overall Study||2
6331576|NCT00521144|7238141|FG001|COMPLETED|Overall Study||2
6331577|NCT00521144|7238142|FG002|COMPLETED|Overall Study||1
6331578|NCT00521144|7238143|FG003|COMPLETED|Overall Study||0
6331579|NCT00521144|7238144|FG004|COMPLETED|Overall Study||0
6331580|NCT00521144|7238140|FG000|NOT COMPLETED|Overall Study||4
6331581|NCT00521144|7238141|FG001|NOT COMPLETED|Overall Study||3
6331582|NCT00521144|7238142|FG002|NOT COMPLETED|Overall Study||2
6331583|NCT00521144|7238143|FG003|NOT COMPLETED|Overall Study||1
6331584|NCT00521144|7238144|FG004|NOT COMPLETED|Overall Study||7
6331585|NCT00521339|7238156|FG000|STARTED|Treatment Phase||31
6331586|NCT00521339|7238157|FG001|STARTED|Treatment Phase||0
6331587|NCT00521339|7238158|FG002|STARTED|Treatment Phase||0
6331588|NCT00521339|7238156|FG000|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
6331589|NCT00521339|7238157|FG001|Received Apremilast|Treatment Phase||0
6331590|NCT00521339|7238158|FG002|Received Apremilast|Treatment Phase||0
6331591|NCT00521339|7238156|FG000|COMPLETED|Treatment Phase||19
6331592|NCT00521339|7238157|FG001|COMPLETED|Treatment Phase||0
6331593|NCT00521339|7238158|FG002|COMPLETED|Treatment Phase||0
6331594|NCT00521339|7238156|FG000|NOT COMPLETED|Treatment Phase||12
6331595|NCT00521339|7238157|FG001|NOT COMPLETED|Treatment Phase||0
6331596|NCT00521339|7238158|FG002|NOT COMPLETED|Treatment Phase||0
6558715|NCT01777191|7481308|FG000|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
6558716|NCT01777191|7481309|FG001|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
6558717|NCT01777191|7481308|FG000|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
6558718|NCT01777191|7481309|FG001|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
6558719|NCT01777191|7481308|FG000|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
6558720|NCT01777191|7481309|FG001|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
6558721|NCT01777191|7481308|FG000|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
6558722|NCT01777191|7481309|FG001|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
6558723|NCT01777191|7481308|FG000|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
6775320|NCT03880266|7703254|FG007|STARTED|Overall Study||7
6331597|NCT00521339|7238156|FG000|STARTED|Treatment Extension Phase||0
6331598|NCT00521339|7238157|FG001|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
6331599|NCT00521339|7238158|FG002|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
6331600|NCT00521339|7238156|FG000|COMPLETED|Treatment Extension Phase||0
6331601|NCT00521339|7238157|FG001|COMPLETED|Treatment Extension Phase||4
6331602|NCT00521339|7238158|FG002|COMPLETED|Treatment Extension Phase||4
6331603|NCT00521339|7238156|FG000|NOT COMPLETED|Treatment Extension Phase||0
6331604|NCT00521339|7238157|FG001|NOT COMPLETED|Treatment Extension Phase||0
6331605|NCT00521339|7238158|FG002|NOT COMPLETED|Treatment Extension Phase||3
6331606|NCT00521339|7238156|FG000|STARTED|Observational Follow Up Phase||14
6331607|NCT00521339|7238157|FG001|STARTED|Observational Follow Up Phase||4
6331608|NCT00521339|7238158|FG002|STARTED|Observational Follow Up Phase||4
6331609|NCT00521339|7238156|FG000|COMPLETED|Observational Follow Up Phase||14
6331610|NCT00521339|7238157|FG001|COMPLETED|Observational Follow Up Phase||4
6331611|NCT00521339|7238158|FG002|COMPLETED|Observational Follow Up Phase||4
6331612|NCT00521339|7238156|FG000|NOT COMPLETED|Observational Follow Up Phase||0
6331613|NCT00521339|7238157|FG001|NOT COMPLETED|Observational Follow Up Phase||0
6331614|NCT00521339|7238158|FG002|NOT COMPLETED|Observational Follow Up Phase||0
6331615|NCT00521352|7238181|FG000|STARTED|Overall Study||12
6331616|NCT00521352|7238182|FG001|STARTED|Overall Study||13
6331617|NCT00521352|7238181|FG000|COMPLETED|Overall Study||11
6331618|NCT00521352|7238182|FG001|COMPLETED|Overall Study||10
6331619|NCT00521352|7238181|FG000|NOT COMPLETED|Overall Study||1
6331620|NCT00521352|7238182|FG001|NOT COMPLETED|Overall Study||3
6331621|NCT00521365|7238188|FG000|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
6331622|NCT00521365|7238188|FG000|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
6331623|NCT00521365|7238188|FG000|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
6331624|NCT00521365|7238188|FG000|Safety Analysis Set|Overall Study|All participants who received study treatment|88
6331625|NCT00521365|7238188|FG000|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
6331626|NCT00521365|7238188|FG000|NOT COMPLETED|Overall Study||20
6331627|NCT00521404|7238192|FG000|STARTED|Overall Study||62
6331628|NCT00521404|7238192|FG000|COMPLETED|Overall Study||0
6331629|NCT00521404|7238192|FG000|NOT COMPLETED|Overall Study||62
6331630|NCT00521456|7238198|FG000|STARTED|Overall Study||176
6331631|NCT00521456|7238199|FG001|STARTED|Overall Study||87
6331632|NCT00521456|7238198|FG000|COMPLETED|Overall Study||163
6331633|NCT00521456|7238199|FG001|COMPLETED|Overall Study||59
6331634|NCT00521456|7238198|FG000|NOT COMPLETED|Overall Study||13
6331635|NCT00521456|7238199|FG001|NOT COMPLETED|Overall Study||28
6331636|NCT00521586|7238207|FG000|STARTED|Initial Vaccination (Year 0)||554
6331637|NCT00521586|7238208|FG001|STARTED|Initial Vaccination (Year 0)||562
6331638|NCT00521586|7238207|FG000|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
6331639|NCT00521586|7238208|FG001|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
6331640|NCT00521586|7238207|FG000|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
6331641|NCT00521586|7238208|FG001|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
6331642|NCT00521586|7238207|FG000|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
6331643|NCT00521586|7238208|FG001|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
6331644|NCT00521586|7238207|FG000|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
6331645|NCT00521586|7238208|FG001|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
6331646|NCT00521586|7238207|FG000|NOT COMPLETED|Initial Vaccination (Year 0)||21
6331647|NCT00521586|7238208|FG001|NOT COMPLETED|Initial Vaccination (Year 0)||29
6331648|NCT00521586|7238207|FG000|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
6331649|NCT00521586|7238208|FG001|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
6331650|NCT00521586|7238207|FG000|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
6331651|NCT00521586|7238208|FG001|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
6331652|NCT00521586|7238207|FG000|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
6331653|NCT00521586|7238208|FG001|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
6331654|NCT00521586|7238207|FG000|STARTED|Revaccination With 13vPnC (Year 5)||364
6331655|NCT00521586|7238208|FG001|STARTED|Revaccination With 13vPnC (Year 5)||363
6331656|NCT00521586|7238207|FG000|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
6331657|NCT00521586|7238208|FG001|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
6331658|NCT00521586|7238207|FG000|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
6331659|NCT00521586|7238208|FG001|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
6331660|NCT00521586|7238207|FG000|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
6331661|NCT00521586|7238208|FG001|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
6331662|NCT00521586|7238207|FG000|COMPLETED|Revaccination With 13vPnC (Year 5)||361
6331663|NCT00521586|7238208|FG001|COMPLETED|Revaccination With 13vPnC (Year 5)||351
6331664|NCT00521586|7238207|FG000|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
6331665|NCT00521586|7238208|FG001|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
6331666|NCT00521976|7238226|FG000|STARTED|Overall Study||871
6331667|NCT00521976|7238226|FG000|COMPLETED|Overall Study||871
6331668|NCT00521976|7238226|FG000|NOT COMPLETED|Overall Study||0
6331669|NCT00521989|7238235|FG000|STARTED|Overall Study||56
6331670|NCT00521989|7238236|FG001|STARTED|Overall Study||54
6331671|NCT00521989|7238237|FG002|STARTED|Overall Study||57
6331672|NCT00521989|7238238|FG003|STARTED|Overall Study||54
6331673|NCT00521989|7238239|FG004|STARTED|Overall Study||58
6331674|NCT00521989|7238235|FG000|COMPLETED|Overall Study||36
6331675|NCT00521989|7238236|FG001|COMPLETED|Overall Study||37
6331676|NCT00521989|7238237|FG002|COMPLETED|Overall Study||41
6331677|NCT00521989|7238238|FG003|COMPLETED|Overall Study||42
6331678|NCT00521989|7238239|FG004|COMPLETED|Overall Study||35
6331679|NCT00521989|7238235|FG000|NOT COMPLETED|Overall Study||20
6331680|NCT00521989|7238236|FG001|NOT COMPLETED|Overall Study||17
6331681|NCT00521989|7238237|FG002|NOT COMPLETED|Overall Study||16
6331682|NCT00521989|7238238|FG003|NOT COMPLETED|Overall Study||12
6331683|NCT00521989|7238239|FG004|NOT COMPLETED|Overall Study||23
6331684|NCT00522041|7238253|FG000|STARTED|Overall Study||123
6331685|NCT00522041|7238254|FG001|STARTED|Overall Study||125
6331686|NCT00522041|7238253|FG000|Received Treatment|Overall Study||123
6331687|NCT00522041|7238254|FG001|Received Treatment|Overall Study||124
6331688|NCT00522041|7238253|FG000|COMPLETED|Overall Study||106
6331689|NCT00522041|7238254|FG001|COMPLETED|Overall Study||113
6331690|NCT00522041|7238253|FG000|NOT COMPLETED|Overall Study||17
6331691|NCT00522041|7238254|FG001|NOT COMPLETED|Overall Study||12
6331692|NCT00522171|7238263|FG000|STARTED|Overall Study||15
6331693|NCT00522171|7238264|FG001|STARTED|Overall Study||15
6331694|NCT00522171|7238263|FG000|COMPLETED|Overall Study||15
6331695|NCT00522171|7238264|FG001|COMPLETED|Overall Study||15
6331696|NCT00522171|7238263|FG000|NOT COMPLETED|Overall Study||0
6331697|NCT00522171|7238264|FG001|NOT COMPLETED|Overall Study||0
6331698|NCT00522275|7238270|FG000|STARTED|Overall Study||308
6331699|NCT00522275|7238270|FG000|COMPLETED|Overall Study||138
6331700|NCT00522275|7238270|FG000|NOT COMPLETED|Overall Study||170
6331701|NCT00522379|7238279|FG000|STARTED|Overall Study||101
6331702|NCT00522379|7238280|FG001|STARTED|Overall Study||107
6331703|NCT00522379|7238281|FG002|STARTED|Overall Study||104
6331704|NCT00522379|7238282|FG003|STARTED|Overall Study||94
6331705|NCT00522379|7238283|FG004|STARTED|Overall Study||108
6331706|NCT00522379|7238279|FG000|COMPLETED|Overall Study||79
6331707|NCT00522379|7238280|FG001|COMPLETED|Overall Study||84
6331708|NCT00522379|7238281|FG002|COMPLETED|Overall Study||82
6331709|NCT00522379|7238282|FG003|COMPLETED|Overall Study||80
6331710|NCT00522379|7238283|FG004|COMPLETED|Overall Study||81
6331711|NCT00522379|7238279|FG000|NOT COMPLETED|Overall Study||22
6331712|NCT00522379|7238280|FG001|NOT COMPLETED|Overall Study||23
6331713|NCT00522379|7238281|FG002|NOT COMPLETED|Overall Study||22
6331714|NCT00522379|7238282|FG003|NOT COMPLETED|Overall Study||14
6331715|NCT00522379|7238283|FG004|NOT COMPLETED|Overall Study||27
6331716|NCT00522392|7238297|FG000|STARTED|Overall Study||23
6331717|NCT00522392|7238298|FG001|STARTED|Overall Study||25
6331718|NCT00522392|7238297|FG000|Pts w/ Measurable Disease at Baseline|Overall Study||16
6331719|NCT00522392|7238298|FG001|Pts w/ Measurable Disease at Baseline|Overall Study||16
6331720|NCT00522392|7238297|FG000|Pts w/ QOL Assessments Complete|Overall Study||12
6331721|NCT00522392|7238298|FG001|Pts w/ QOL Assessments Complete|Overall Study||8
6331722|NCT00522392|7238297|FG000|COMPLETED|Overall Study||15
6331723|NCT00522392|7238298|FG001|COMPLETED|Overall Study||12
6331724|NCT00522392|7238297|FG000|NOT COMPLETED|Overall Study||8
6331725|NCT00522392|7238298|FG001|NOT COMPLETED|Overall Study||13
6331726|NCT00522418|7238306|FG000|STARTED|Overall Study||59
6331727|NCT00522418|7238307|FG001|STARTED|Overall Study||63
6331728|NCT00522418|7238306|FG000|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|54
6331729|NCT00522418|7238307|FG001|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site's local ethics committee.|58
6331730|NCT00522418|7238306|FG000|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
6331731|NCT00522418|7238307|FG001|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
6331732|NCT00522418|7238306|FG000|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
6331733|NCT00522418|7238307|FG001|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
6331734|NCT00522418|7238306|FG000|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
6331735|NCT00522418|7238307|FG001|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
6331736|NCT00522418|7238306|FG000|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
6331737|NCT00522418|7238307|FG001|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
6331738|NCT00522418|7238306|FG000|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
6331739|NCT00522418|7238307|FG001|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
6331740|NCT00522418|7238306|FG000|COMPLETED|Overall Study|Completed 2-year follow-up|2
6331741|NCT00522418|7238307|FG001|COMPLETED|Overall Study|Completed 2-year follow-up|5
6331742|NCT00522418|7238306|FG000|NOT COMPLETED|Overall Study||57
6331743|NCT00522418|7238307|FG001|NOT COMPLETED|Overall Study||58
6331744|NCT00522431|7238315|FG000|STARTED|Overall Study||149
6331745|NCT00522431|7238315|FG000|COMPLETED|Overall Study||138
6331746|NCT00522431|7238315|FG000|NOT COMPLETED|Overall Study||11
6331747|NCT00522548|7238321|FG000|STARTED|Overall Study||18
6331748|NCT00522548|7238322|FG001|STARTED|Overall Study||19
6331749|NCT00522548|7238321|FG000|Consented to Pharmacokinetic Study|Overall Study||11
6331750|NCT00522548|7238322|FG001|Consented to Pharmacokinetic Study|Overall Study||10
6331751|NCT00522548|7238321|FG000|Completed 0/2 PK Visits|Overall Study||3
6331752|NCT00522548|7238322|FG001|Completed 0/2 PK Visits|Overall Study||4
6331753|NCT00522548|7238321|FG000|Completed 1/2 PK Visits|Overall Study||1
6331754|NCT00522548|7238322|FG001|Completed 1/2 PK Visits|Overall Study||1
6331755|NCT00522548|7238321|FG000|Completed 2/2 PK Visits|Overall Study||7
6331756|NCT00522548|7238322|FG001|Completed 2/2 PK Visits|Overall Study||5
6331757|NCT00522548|7238321|FG000|COMPLETED|Overall Study||16
6331758|NCT00522548|7238322|FG001|COMPLETED|Overall Study||15
6331759|NCT00522548|7238321|FG000|NOT COMPLETED|Overall Study||2
6331760|NCT00522548|7238322|FG001|NOT COMPLETED|Overall Study||4
6331761|NCT00522626|7238328|FG000|STARTED|Overall Study||19
6331762|NCT00522626|7238328|FG000|COMPLETED|Overall Study||12
6331763|NCT00522626|7238328|FG000|NOT COMPLETED|Overall Study||7
6331764|NCT00522795|7238332|FG000|STARTED|Overall Study||40
6331765|NCT00522795|7238332|FG000|COMPLETED|Overall Study||40
6331766|NCT00522795|7238332|FG000|NOT COMPLETED|Overall Study||0
6331767|NCT00522873|7238338|FG000|STARTED|Overall Study||490
6331768|NCT00522873|7238339|FG001|STARTED|Overall Study||172
6331769|NCT00522873|7238338|FG000|Received Treatment|Overall Study||489
6331770|NCT00522873|7238339|FG001|Received Treatment|Overall Study||172
6331771|NCT00522873|7238338|FG000|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
6331772|NCT00522873|7238339|FG001|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
6331773|NCT00522873|7238338|FG000|NOT COMPLETED|Overall Study||96
6331774|NCT00522873|7238339|FG001|NOT COMPLETED|Overall Study||44
6331775|NCT00522925|7238348|FG000|STARTED|Overall Study||36
6331776|NCT00522925|7238349|FG001|STARTED|Overall Study||39
6331777|NCT00522925|7238350|FG002|STARTED|Overall Study||38
6331778|NCT00522925|7238348|FG000|COMPLETED|Overall Study||28
6331779|NCT00522925|7238349|FG001|COMPLETED|Overall Study||38
6331780|NCT00522925|7238350|FG002|COMPLETED|Overall Study||36
6331781|NCT00522925|7238348|FG000|NOT COMPLETED|Overall Study||8
6331782|NCT00522925|7238349|FG001|NOT COMPLETED|Overall Study||1
6331783|NCT00522925|7238350|FG002|NOT COMPLETED|Overall Study||2
6331784|NCT00522951|7238358|FG000|STARTED|Period 1||86
6331785|NCT00522951|7238359|FG001|STARTED|Period 1||79
6331786|NCT00522951|7238358|FG000|Received Treatment|Period 1||86
6331787|NCT00522951|7238359|FG001|Received Treatment|Period 1||78
6331788|NCT00522951|7238358|FG000|COMPLETED|Period 1||86
6331789|NCT00522951|7238359|FG001|COMPLETED|Period 1||78
6331790|NCT00522951|7238358|FG000|NOT COMPLETED|Period 1||0
6331791|NCT00522951|7238359|FG001|NOT COMPLETED|Period 1||1
6331792|NCT00522951|7238358|FG000|STARTED|Washout Period||86
6331793|NCT00522951|7238359|FG001|STARTED|Washout Period||78
6331794|NCT00522951|7238358|FG000|COMPLETED|Washout Period||86
6331795|NCT00522951|7238359|FG001|COMPLETED|Washout Period||76
6331796|NCT00522951|7238358|FG000|NOT COMPLETED|Washout Period||0
6331797|NCT00522951|7238359|FG001|NOT COMPLETED|Washout Period||2
6331798|NCT00522951|7238358|FG000|STARTED|Period 2||86
6331799|NCT00522951|7238359|FG001|STARTED|Period 2||76
6331800|NCT00522951|7238358|FG000|Subjects Received Treatment|Period 2||84
6331801|NCT00522951|7238359|FG001|Subjects Received Treatment|Period 2||75
6331802|NCT00522951|7238358|FG000|COMPLETED|Period 2||84
6331803|NCT00522951|7238359|FG001|COMPLETED|Period 2||75
6331804|NCT00522951|7238358|FG000|NOT COMPLETED|Period 2||2
6331805|NCT00522951|7238359|FG001|NOT COMPLETED|Period 2||1
6331806|NCT00523237|7238369|FG000|STARTED|Overall Study||14
6331807|NCT00523237|7238369|FG000|COMPLETED|Overall Study||14
6331808|NCT00523237|7238369|FG000|NOT COMPLETED|Overall Study||0
6331809|NCT00523302|7238375|FG000|STARTED|Overall Study||10
6331810|NCT00523302|7238376|FG001|STARTED|Overall Study||10
6331811|NCT00523302|7238375|FG000|COMPLETED|Overall Study||10
6331812|NCT00523302|7238376|FG001|COMPLETED|Overall Study||10
6331813|NCT00523302|7238375|FG000|NOT COMPLETED|Overall Study||0
6331814|NCT00523302|7238376|FG001|NOT COMPLETED|Overall Study||0
6331815|NCT00523341|7238384|FG000|STARTED|Overall Study||2207
6331816|NCT00523341|7238385|FG001|STARTED|Overall Study||2343
6331817|NCT00523341|7238384|FG000|Received Treatment|Overall Study||2206
6331818|NCT00523341|7238385|FG001|Received Treatment|Overall Study||2343
6331819|NCT00523341|7238384|FG000|COMPLETED|Overall Study||1283
6331820|NCT00523341|7238385|FG001|COMPLETED|Overall Study||1343
6331821|NCT00523341|7238384|FG000|NOT COMPLETED|Overall Study||924
6331822|NCT00523341|7238385|FG001|NOT COMPLETED|Overall Study||1000
6331823|NCT00523367|7238391|FG000|STARTED|Overall Study||25
6331824|NCT00523367|7238391|FG000|COMPLETED|Overall Study||2
6331825|NCT00523367|7238391|FG000|NOT COMPLETED|Overall Study||23
6331826|NCT00523419|7238395|FG000|STARTED|Overall Study||32
6331827|NCT00523419|7238395|FG000|COMPLETED|Overall Study||0
6331828|NCT00523419|7238395|FG000|NOT COMPLETED|Overall Study||32
6331829|NCT00523549|7238401|FG000|STARTED|Overall Study||114
6331830|NCT00523549|7238402|FG001|STARTED|Overall Study||115
6331831|NCT00523549|7238401|FG000|COMPLETED|Overall Study||95
6331832|NCT00523549|7238402|FG001|COMPLETED|Overall Study||99
6331833|NCT00523549|7238401|FG000|NOT COMPLETED|Overall Study||19
6331834|NCT00523549|7238402|FG001|NOT COMPLETED|Overall Study||16
6331835|NCT00523614|7238410|FG000|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
6331836|NCT00523614|7238411|FG001|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
6331837|NCT00523614|7238410|FG000|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
6376079|NCT00758524|7286590|FG015|Treated|Core Period (Week 0 to Week 8)||0
6331838|NCT00523614|7238411|FG001|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
6331839|NCT00523614|7238410|FG000|NOT COMPLETED|Overall Study||0
6331840|NCT00523614|7238411|FG001|NOT COMPLETED|Overall Study||0
6331841|NCT00523640|7238417|FG000|STARTED|Overall Study||30
6331842|NCT00523640|7238417|FG000|COMPLETED|Overall Study|1 patient died before starting treatment|29
6331843|NCT00523640|7238417|FG000|NOT COMPLETED|Overall Study||1
6331844|NCT00523705|7238423|FG000|STARTED|Overall Study||7
6331845|NCT00523705|7238424|FG001|STARTED|Overall Study||4
6331846|NCT00523705|7238423|FG000|COMPLETED|Overall Study||7
6331847|NCT00523705|7238424|FG001|COMPLETED|Overall Study|1 withdrew due to no time|3
6331848|NCT00523705|7238423|FG000|NOT COMPLETED|Overall Study||0
6331849|NCT00523705|7238424|FG001|NOT COMPLETED|Overall Study||1
6331850|NCT00523718|7238432|FG000|STARTED|Overall Study||20
6331851|NCT00523718|7238433|FG001|STARTED|Overall Study||18
6331852|NCT00523718|7238432|FG000|COMPLETED|Overall Study||17
6331853|NCT00523718|7238433|FG001|COMPLETED|Overall Study||18
6331854|NCT00523718|7238432|FG000|NOT COMPLETED|Overall Study||3
6331855|NCT00523718|7238433|FG001|NOT COMPLETED|Overall Study||0
6331856|NCT00523744|7238439|FG000|STARTED|Phase 1 - Amlodipine+Olmesartan||257
6331857|NCT00523744|7238439|FG000|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
6775321|NCT03880266|7703247|FG000|COMPLETED|Overall Study||12
6775322|NCT03880266|7703248|FG001|COMPLETED|Overall Study||5
6331858|NCT00523744|7238439|FG000|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
6331859|NCT00523744|7238439|FG000|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
6331860|NCT00523744|7238439|FG000|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
6331861|NCT00523744|7238439|FG000|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
6331862|NCT00523744|7238439|FG000|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
6331863|NCT00523744|7238439|FG000|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
6331864|NCT00523744|7238439|FG000|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
6331865|NCT00523848|7238446|FG000|STARTED|Overall Study||46
6331866|NCT00523848|7238446|FG000|Treated With Study Therapy|Overall Study||44
6331867|NCT00523848|7238446|FG000|COMPLETED|Overall Study||22
6331868|NCT00523848|7238446|FG000|NOT COMPLETED|Overall Study||24
6331869|NCT00523978|7238452|FG000|STARTED|Overall Study||171
6331870|NCT00523978|7238453|FG001|STARTED|Overall Study||87
6331871|NCT00523978|7238452|FG000|COMPLETED|Overall Study||162
6331872|NCT00523978|7238453|FG001|COMPLETED|Overall Study||79
6331873|NCT00523978|7238452|FG000|NOT COMPLETED|Overall Study||9
6331874|NCT00523978|7238453|FG001|NOT COMPLETED|Overall Study||8
6331875|NCT00523991|7238462|FG000|STARTED|Overall Study||219
6331876|NCT00523991|7238463|FG001|STARTED|Overall Study||238
6331877|NCT00523991|7238462|FG000|COMPLETED|Overall Study||198
6331878|NCT00523991|7238463|FG001|COMPLETED|Overall Study||211
6331879|NCT00523991|7238462|FG000|NOT COMPLETED|Overall Study||21
6331880|NCT00523991|7238463|FG001|NOT COMPLETED|Overall Study||27
6331881|NCT00524017|7238471|FG000|STARTED|Overall Study||13
6331882|NCT00524017|7238472|FG001|STARTED|Overall Study||6
6331883|NCT00524017|7238471|FG000|COMPLETED|Overall Study||13
6331884|NCT00524017|7238472|FG001|COMPLETED|Overall Study||5
6331885|NCT00524017|7238471|FG000|NOT COMPLETED|Overall Study||0
6331886|NCT00524017|7238472|FG001|NOT COMPLETED|Overall Study||1
6331887|NCT00524030|7238480|FG000|STARTED|Overall Study||32
6331888|NCT00524030|7238481|FG001|STARTED|Overall Study||129
6331889|NCT00524030|7238480|FG000|Completed Double-Blind Treatment Phase|Overall Study||15
6331890|NCT00524030|7238481|FG001|Completed Double-Blind Treatment Phase|Overall Study||70
6331891|NCT00524030|7238480|FG000|Completed Taper/Titration Phase|Overall Study||15
6331892|NCT00524030|7238481|FG001|Completed Taper/Titration Phase|Overall Study||70
6331893|NCT00524030|7238480|FG000|COMPLETED|Overall Study||15
6331894|NCT00524030|7238481|FG001|COMPLETED|Overall Study||70
6331895|NCT00524030|7238480|FG000|NOT COMPLETED|Overall Study||17
6331896|NCT00524030|7238481|FG001|NOT COMPLETED|Overall Study||59
6331897|NCT00524043|7238491|FG000|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
6331898|NCT00524043|7238492|FG001|STARTED|Overall Study||70
6331899|NCT00524043|7238493|FG002|STARTED|Overall Study||66
6331900|NCT00524043|7238491|FG000|COMPLETED|Overall Study||34
6331901|NCT00524043|7238492|FG001|COMPLETED|Overall Study||42
6331902|NCT00524043|7238493|FG002|COMPLETED|Overall Study||35
6331903|NCT00524043|7238491|FG000|NOT COMPLETED|Overall Study||30
6331904|NCT00524043|7238492|FG001|NOT COMPLETED|Overall Study||28
6331905|NCT00524043|7238493|FG002|NOT COMPLETED|Overall Study||31
6775323|NCT03880266|7703249|FG002|COMPLETED|Overall Study||11
6331906|NCT00524121|7238501|FG000|STARTED|Overall Study||22
6331907|NCT00524121|7238501|FG000|COMPLETED|Overall Study||3
6331908|NCT00524121|7238501|FG000|NOT COMPLETED|Overall Study||19
6376080|NCT00758524|7286591|FG016|Treated|Core Period (Week 0 to Week 8)||0
6376081|NCT00758524|7286575|FG000|COMPLETED|Core Period (Week 0 to Week 8)||84
6376082|NCT00758524|7286576|FG001|COMPLETED|Core Period (Week 0 to Week 8)||81
6376083|NCT00758524|7286577|FG002|COMPLETED|Core Period (Week 0 to Week 8)||77
6376084|NCT00758524|7286578|FG003|COMPLETED|Core Period (Week 0 to Week 8)||90
6376085|NCT00758524|7286579|FG004|COMPLETED|Core Period (Week 0 to Week 8)||75
6376086|NCT00758524|7286580|FG005|COMPLETED|Core Period (Week 0 to Week 8)||67
6376087|NCT00758524|7286581|FG006|COMPLETED|Core Period (Week 0 to Week 8)||0
6376088|NCT00758524|7286582|FG007|COMPLETED|Core Period (Week 0 to Week 8)||0
6775324|NCT03880266|7703250|FG003|COMPLETED|Overall Study||4
6331909|NCT00524173|7238518|FG000|STARTED|Overall Study||17
6331910|NCT00524173|7238519|FG001|STARTED|Overall Study||15
6331911|NCT00524173|7238518|FG000|COMPLETED|Overall Study||12
6331912|NCT00524173|7238519|FG001|COMPLETED|Overall Study||13
6331913|NCT00524173|7238518|FG000|NOT COMPLETED|Overall Study||5
6331914|NCT00524173|7238519|FG001|NOT COMPLETED|Overall Study||2
6331915|NCT00524225|7238525|FG000|STARTED|Overall Study||3
6331916|NCT00524225|7238525|FG000|COMPLETED|Overall Study||3
6331917|NCT00524225|7238525|FG000|NOT COMPLETED|Overall Study||0
6331918|NCT00524264|7238532|FG000|STARTED|Overall Study||164
6331919|NCT00524264|7238533|FG001|STARTED|Overall Study||84
6331920|NCT00524264|7238532|FG000|COMPLETED|Overall Study||144
6331921|NCT00524264|7238533|FG001|COMPLETED|Overall Study||57
6331922|NCT00524264|7238532|FG000|NOT COMPLETED|Overall Study||20
6331923|NCT00524264|7238533|FG001|NOT COMPLETED|Overall Study||27
6331924|NCT00524303|7238542|FG000|STARTED|Overall Study||33
6331925|NCT00524303|7238543|FG001|STARTED|Overall Study||34
6331926|NCT00524303|7238544|FG002|STARTED|Overall Study||33
6331927|NCT00524303|7238542|FG000|COMPLETED|Overall Study||21
6331928|NCT00524303|7238543|FG001|COMPLETED|Overall Study||24
6331929|NCT00524303|7238544|FG002|COMPLETED|Overall Study||15
6331930|NCT00524303|7238542|FG000|NOT COMPLETED|Overall Study||12
6331931|NCT00524303|7238543|FG001|NOT COMPLETED|Overall Study||10
6331932|NCT00524303|7238544|FG002|NOT COMPLETED|Overall Study||18
6331933|NCT00524316|7238555|FG000|STARTED|Overall Study||16
6331934|NCT00524316|7238555|FG000|COMPLETED|Overall Study||0
6331935|NCT00524316|7238555|FG000|NOT COMPLETED|Overall Study||16
6331936|NCT00524342|7238559|FG000|STARTED|Overall Study||7
6331937|NCT00524342|7238559|FG000|COMPLETED|Overall Study||7
6331938|NCT00524342|7238559|FG000|NOT COMPLETED|Overall Study||0
6331939|NCT00524368|7238565|FG000|STARTED|Overall Study||294
6331940|NCT00524368|7238566|FG001|STARTED|Overall Study||296
6331941|NCT00524368|7238565|FG000|COMPLETED|Overall Study||253
6331942|NCT00524368|7238566|FG001|COMPLETED|Overall Study||248
6331943|NCT00524368|7238565|FG000|NOT COMPLETED|Overall Study||41
6331944|NCT00524368|7238566|FG001|NOT COMPLETED|Overall Study||48
6331945|NCT00524420|7238574|FG000|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
6331946|NCT00524420|7238575|FG001|STARTED|Overall Study||11
6331947|NCT00524420|7238574|FG000|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
6331948|NCT00524420|7238575|FG001|COMPLETED|Overall Study||11
6331949|NCT00524420|7238574|FG000|NOT COMPLETED|Overall Study||1
6331950|NCT00524420|7238575|FG001|NOT COMPLETED|Overall Study||0
6331951|NCT00524472|7238585|FG000|STARTED|Overall Study||709
6331952|NCT00524472|7238586|FG001|STARTED|Overall Study||730
6331953|NCT00524472|7238585|FG000|COMPLETED|Overall Study||709
6331954|NCT00524472|7238586|FG001|COMPLETED|Overall Study||730
6331955|NCT00524472|7238585|FG000|NOT COMPLETED|Overall Study||0
6331956|NCT00524472|7238586|FG001|NOT COMPLETED|Overall Study||0
6331957|NCT00524537|7238592|FG000|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
6331958|NCT00524537|7238592|FG000|Discontinued|Overall Study|Discontinued from study|2811
6331959|NCT00524537|7238592|FG000|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
6331960|NCT00524537|7238592|FG000|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
6331961|NCT00524537|7238592|FG000|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
6331962|NCT00524537|7238592|FG000|NOT COMPLETED|Overall Study||2574
6331963|NCT00524576|7238598|FG000|STARTED|Overall Study||97
6331964|NCT00524576|7238599|FG001|STARTED|Overall Study||47
6331965|NCT00524576|7238598|FG000|COMPLETED|Overall Study||97
6331966|NCT00524576|7238599|FG001|COMPLETED|Overall Study||47
6558724|NCT01777191|7481309|FG001|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
6558725|NCT01777191|7481308|FG000|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
6558726|NCT01777191|7481309|FG001|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
6558727|NCT01777217|7481320|FG000|STARTED|Overall Study||4
6558728|NCT01777217|7481321|FG001|STARTED|Overall Study||4
6558729|NCT01777217|7481320|FG000|COMPLETED|Overall Study||4
6558730|NCT01777217|7481321|FG001|COMPLETED|Overall Study||4
6558731|NCT01777217|7481320|FG000|NOT COMPLETED|Overall Study||0
6558732|NCT01777217|7481321|FG001|NOT COMPLETED|Overall Study||0
6558733|NCT01777269|7481329|FG000|STARTED|Overall Study||246
6558734|NCT01777269|7481330|FG001|STARTED|Overall Study||243
6558735|NCT01777269|7481329|FG000|COMPLETED|Overall Study||191
6558736|NCT01777269|7481330|FG001|COMPLETED|Overall Study||184
6558737|NCT01777269|7481329|FG000|NOT COMPLETED|Overall Study||55
6558738|NCT01777269|7481330|FG001|NOT COMPLETED|Overall Study||59
6558739|NCT01777282|7481341|FG000|STARTED|Overall Study||120
6558740|NCT01777282|7481342|FG001|STARTED|Overall Study||67
6558741|NCT01777282|7481343|FG002|STARTED|Overall Study||65
6558742|NCT01777282|7481344|FG003|STARTED|Overall Study||61
6331967|NCT00524576|7238598|FG000|NOT COMPLETED|Overall Study||0
6331968|NCT00524576|7238599|FG001|NOT COMPLETED|Overall Study||0
6331969|NCT00524589|7238605|FG000|STARTED|Overall Study||18
6331970|NCT00524589|7238605|FG000|COMPLETED|Overall Study||0
6331971|NCT00524589|7238605|FG000|NOT COMPLETED|Overall Study||18
6331972|NCT00524680|7238613|FG000|STARTED|Overall Study||37
6331973|NCT00524680|7238614|FG001|STARTED|Overall Study||35
6558743|NCT01777282|7481345|FG004|STARTED|Overall Study||61
6558744|NCT01777282|7481341|FG000|Completing Treatment Period|Overall Study||109
6558745|NCT01777282|7481342|FG001|Completing Treatment Period|Overall Study||63
6558746|NCT01777282|7481343|FG002|Completing Treatment Period|Overall Study||59
6558747|NCT01777282|7481344|FG003|Completing Treatment Period|Overall Study||59
6558748|NCT01777282|7481345|FG004|Completing Treatment Period|Overall Study||54
6558749|NCT01777282|7481341|FG000|Completing Follow-up Period|Overall Study||109
6558750|NCT01777282|7481342|FG001|Completing Follow-up Period|Overall Study||63
6558751|NCT01777282|7481343|FG002|Completing Follow-up Period|Overall Study||59
6331974|NCT00524680|7238615|FG002|STARTED|Overall Study||36
6331975|NCT00524680|7238616|FG003|STARTED|Overall Study||40
6331976|NCT00524680|7238613|FG000|COMPLETED|Overall Study||34
6331977|NCT00524680|7238614|FG001|COMPLETED|Overall Study||34
6331978|NCT00524680|7238615|FG002|COMPLETED|Overall Study||33
6331979|NCT00524680|7238616|FG003|COMPLETED|Overall Study||34
6331980|NCT00524680|7238613|FG000|NOT COMPLETED|Overall Study||3
6331981|NCT00524680|7238614|FG001|NOT COMPLETED|Overall Study||1
6331982|NCT00524680|7238615|FG002|NOT COMPLETED|Overall Study||3
6331983|NCT00524680|7238616|FG003|NOT COMPLETED|Overall Study||6
6331984|NCT00524745|7238630|FG000|STARTED|Overall Study||229
6331985|NCT00524745|7238631|FG001|STARTED|Overall Study||206
6558752|NCT01777282|7481344|FG003|Completing Follow-up Period|Overall Study||59
6558753|NCT01777282|7481345|FG004|Completing Follow-up Period|Overall Study||54
6558754|NCT01777282|7481341|FG000|COMPLETED|Overall Study||109
6331986|NCT00524745|7238632|FG002|STARTED|Overall Study||241
6331987|NCT00524745|7238633|FG003|STARTED|Overall Study||227
6331988|NCT00524745|7238630|FG000|COMPLETED|Overall Study||195
6331989|NCT00524745|7238631|FG001|COMPLETED|Overall Study||193
6331990|NCT00524745|7238632|FG002|COMPLETED|Overall Study||212
6331991|NCT00524745|7238633|FG003|COMPLETED|Overall Study||205
6331992|NCT00524745|7238630|FG000|NOT COMPLETED|Overall Study||34
6331993|NCT00524745|7238631|FG001|NOT COMPLETED|Overall Study||13
6331994|NCT00524745|7238632|FG002|NOT COMPLETED|Overall Study||29
6331995|NCT00524745|7238633|FG003|NOT COMPLETED|Overall Study||22
6331996|NCT00524771|7238645|FG000|STARTED|Overall Study||17084
6331997|NCT00524771|7238646|FG001|STARTED|Overall Study||17016
6331998|NCT00524771|7238645|FG000|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
6331999|NCT00524771|7238646|FG001|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
6332000|NCT00524771|7238645|FG000|NOT COMPLETED|Overall Study||220
6332001|NCT00524771|7238646|FG001|NOT COMPLETED|Overall Study||585
6332002|NCT00524940|7238653|FG000|STARTED|Overall Study||124
6332003|NCT00524940|7238653|FG000|COMPLETED|Overall Study||124
6332004|NCT00524940|7238653|FG000|NOT COMPLETED|Overall Study||0
6332005|NCT00525031|7238659|FG000|STARTED|Overall Study||27
6332006|NCT00525031|7238660|FG001|STARTED|Overall Study||25
6332007|NCT00525031|7238659|FG000|COMPLETED|Overall Study||26
6332008|NCT00525031|7238660|FG001|COMPLETED|Overall Study||24
6332009|NCT00525031|7238659|FG000|NOT COMPLETED|Overall Study||1
6332010|NCT00525031|7238660|FG001|NOT COMPLETED|Overall Study||1
6332011|NCT00525044|7238669|FG000|STARTED|Overall Study||124
6332012|NCT00525044|7238670|FG001|STARTED|Overall Study||125
6332013|NCT00525044|7238669|FG000|COMPLETED|Overall Study||124
6332014|NCT00525044|7238670|FG001|COMPLETED|Overall Study||124
6332015|NCT00525044|7238669|FG000|NOT COMPLETED|Overall Study||0
6332016|NCT00525044|7238670|FG001|NOT COMPLETED|Overall Study||1
6332017|NCT00525057|7238678|FG000|STARTED|Overall Study||25
6332018|NCT00525057|7238679|FG001|STARTED|Overall Study||25
6332019|NCT00525057|7238678|FG000|COMPLETED|Overall Study||25
6332020|NCT00525057|7238679|FG001|COMPLETED|Overall Study||25
6332021|NCT00525057|7238678|FG000|NOT COMPLETED|Overall Study||0
6332022|NCT00525057|7238679|FG001|NOT COMPLETED|Overall Study||0
6332023|NCT00525135|7238685|FG000|STARTED|Overall Study||5
6332024|NCT00525135|7238685|FG000|COMPLETED|Overall Study||5
6332025|NCT00525135|7238685|FG000|NOT COMPLETED|Overall Study||0
6332026|NCT00525148|7238693|FG000|STARTED|Overall Study|entered and treated|23
6332027|NCT00525148|7238694|FG001|STARTED|Overall Study|entered and treated|38
6332028|NCT00525148|7238695|FG002|STARTED|Overall Study|entered and treated|7
6332029|NCT00525148|7238696|FG003|STARTED|Overall Study|entered and treated|61
6332030|NCT00525148|7238693|FG000|COMPLETED|Overall Study||0
6332031|NCT00525148|7238694|FG001|COMPLETED|Overall Study||0
6332032|NCT00525148|7238695|FG002|COMPLETED|Overall Study||0
6332033|NCT00525148|7238696|FG003|COMPLETED|Overall Study||0
6332034|NCT00525148|7238693|FG000|NOT COMPLETED|Overall Study||23
6332035|NCT00525148|7238694|FG001|NOT COMPLETED|Overall Study||38
6332036|NCT00525148|7238695|FG002|NOT COMPLETED|Overall Study||7
6332037|NCT00525148|7238696|FG003|NOT COMPLETED|Overall Study||61
6332038|NCT00525161|7238706|FG000|STARTED|Overall Study||11
6332039|NCT00525161|7238706|FG000|COMPLETED|Overall Study||10
6332040|NCT00525161|7238706|FG000|NOT COMPLETED|Overall Study||1
6332041|NCT00525174|7238712|FG000|STARTED|Overall Study||97
6332042|NCT00525174|7238713|FG001|STARTED|Overall Study||89
6332043|NCT00525174|7238712|FG000|COMPLETED|Overall Study||88
6332044|NCT00525174|7238713|FG001|COMPLETED|Overall Study||81
6332045|NCT00525174|7238712|FG000|NOT COMPLETED|Overall Study||9
6332046|NCT00525174|7238713|FG001|NOT COMPLETED|Overall Study||8
6332047|NCT00525265|7238721|FG000|STARTED|Overall Study||10
6332048|NCT00525265|7238722|FG001|STARTED|Overall Study||10
6332049|NCT00525265|7238721|FG000|COMPLETED|Overall Study||9
6558755|NCT01777282|7481342|FG001|COMPLETED|Overall Study||63
6558756|NCT01777282|7481343|FG002|COMPLETED|Overall Study||59
6558757|NCT01777282|7481344|FG003|COMPLETED|Overall Study||59
6332050|NCT00525265|7238722|FG001|COMPLETED|Overall Study||10
6332051|NCT00525265|7238721|FG000|NOT COMPLETED|Overall Study||1
6332052|NCT00525265|7238722|FG001|NOT COMPLETED|Overall Study||0
6332053|NCT00525421|7238730|FG000|STARTED|Overall Study|Enrollment started october 2007|10
6332054|NCT00525421|7238731|FG001|STARTED|Overall Study||10
6332055|NCT00525421|7238730|FG000|COMPLETED|Overall Study||10
6332056|NCT00525421|7238731|FG001|COMPLETED|Overall Study||10
6332057|NCT00525421|7238730|FG000|NOT COMPLETED|Overall Study||0
6332058|NCT00525421|7238731|FG001|NOT COMPLETED|Overall Study||0
6332059|NCT00525499|7238741|FG000|STARTED|Overall Study||47
6332060|NCT00525499|7238742|FG001|STARTED|Overall Study||46
6332061|NCT00525499|7238743|FG002|STARTED|Overall Study||47
6332062|NCT00525499|7238744|FG003|STARTED|Overall Study||46
6332063|NCT00525499|7238741|FG000|COMPLETED|Overall Study||40
6332064|NCT00525499|7238742|FG001|COMPLETED|Overall Study||39
6332065|NCT00525499|7238743|FG002|COMPLETED|Overall Study||40
6332066|NCT00525499|7238744|FG003|COMPLETED|Overall Study||39
6332067|NCT00525499|7238741|FG000|NOT COMPLETED|Overall Study||7
6332068|NCT00525499|7238742|FG001|NOT COMPLETED|Overall Study||7
6332069|NCT00525499|7238743|FG002|NOT COMPLETED|Overall Study||7
6332070|NCT00525499|7238744|FG003|NOT COMPLETED|Overall Study||7
6332071|NCT00525512|7238756|FG000|STARTED|Double-Blind Phase||259
6332072|NCT00525512|7238757|FG001|STARTED|Double-Blind Phase||260
6332073|NCT00525512|7238758|FG002|STARTED|Double-Blind Phase||0
6332074|NCT00525512|7238759|FG003|STARTED|Double-Blind Phase||0
6332075|NCT00525512|7238756|FG000|COMPLETED|Double-Blind Phase||163
6332076|NCT00525512|7238757|FG001|COMPLETED|Double-Blind Phase||194
6332077|NCT00525512|7238758|FG002|COMPLETED|Double-Blind Phase||0
6332078|NCT00525512|7238759|FG003|COMPLETED|Double-Blind Phase||0
6332079|NCT00525512|7238756|FG000|NOT COMPLETED|Double-Blind Phase||96
6332080|NCT00525512|7238757|FG001|NOT COMPLETED|Double-Blind Phase||66
6332081|NCT00525512|7238758|FG002|NOT COMPLETED|Double-Blind Phase||0
6332082|NCT00525512|7238759|FG003|NOT COMPLETED|Double-Blind Phase||0
6332083|NCT00525512|7238756|FG000|STARTED|Open-Label Phase||0
6332084|NCT00525512|7238757|FG001|STARTED|Open-Label Phase||0
6332085|NCT00525512|7238758|FG002|STARTED|Open-Label Phase||164
6332086|NCT00525512|7238759|FG003|STARTED|Open-Label Phase||194
6332087|NCT00525512|7238756|FG000|COMPLETED|Open-Label Phase||0
6332088|NCT00525512|7238757|FG001|COMPLETED|Open-Label Phase||0
6332089|NCT00525512|7238758|FG002|COMPLETED|Open-Label Phase||158
6332090|NCT00525512|7238759|FG003|COMPLETED|Open-Label Phase||189
6332091|NCT00525512|7238756|FG000|NOT COMPLETED|Open-Label Phase||0
6332092|NCT00525512|7238757|FG001|NOT COMPLETED|Open-Label Phase||0
6332093|NCT00525512|7238758|FG002|NOT COMPLETED|Open-Label Phase||6
6332094|NCT00525512|7238759|FG003|NOT COMPLETED|Open-Label Phase||5
6332095|NCT00525525|7238773|FG000|STARTED|Overall Study||59
6332096|NCT00525525|7238774|FG001|STARTED|Overall Study||15
6332097|NCT00525525|7238773|FG000|COMPLETED|Overall Study||59
6332098|NCT00525525|7238774|FG001|COMPLETED|Overall Study||15
6332099|NCT00525525|7238773|FG000|NOT COMPLETED|Overall Study||0
6332100|NCT00525525|7238774|FG001|NOT COMPLETED|Overall Study||0
6332101|NCT00525590|7238780|FG000|STARTED|Overall Study||59
6332102|NCT00525590|7238780|FG000|COMPLETED|Overall Study||14
6332103|NCT00525590|7238780|FG000|NOT COMPLETED|Overall Study||45
6332104|NCT00525603|7238784|FG000|STARTED|Overall Study||60
6332105|NCT00525603|7238784|FG000|COMPLETED|Overall Study||60
6332106|NCT00525603|7238784|FG000|NOT COMPLETED|Overall Study||0
6332107|NCT00525629|7238788|FG000|STARTED|First Intervention||20
6332108|NCT00525629|7238789|FG001|STARTED|First Intervention||20
6332109|NCT00525629|7238788|FG000|COMPLETED|First Intervention||15
6332110|NCT00525629|7238789|FG001|COMPLETED|First Intervention||15
6332111|NCT00525629|7238788|FG000|NOT COMPLETED|First Intervention||5
6332112|NCT00525629|7238789|FG001|NOT COMPLETED|First Intervention||5
6332113|NCT00525629|7238788|FG000|STARTED|Washout||15
6332114|NCT00525629|7238789|FG001|STARTED|Washout||15
6332115|NCT00525629|7238788|FG000|COMPLETED|Washout||15
6332116|NCT00525629|7238789|FG001|COMPLETED|Washout||15
6332117|NCT00525629|7238788|FG000|NOT COMPLETED|Washout||0
6332118|NCT00525629|7238789|FG001|NOT COMPLETED|Washout||0
6332119|NCT00525629|7238788|FG000|STARTED|Second Intervention||15
6332120|NCT00525629|7238789|FG001|STARTED|Second Intervention||15
6332121|NCT00525629|7238788|FG000|COMPLETED|Second Intervention||0
6332122|NCT00525629|7238789|FG001|COMPLETED|Second Intervention||0
6332123|NCT00525629|7238788|FG000|NOT COMPLETED|Second Intervention||15
6332124|NCT00525629|7238789|FG001|NOT COMPLETED|Second Intervention||15
6332125|NCT00525733|7238797|FG000|STARTED|Overall Study||14
6332126|NCT00525733|7238798|FG001|STARTED|Overall Study||26
6332127|NCT00525733|7238797|FG000|COMPLETED|Overall Study||11
6332128|NCT00525733|7238798|FG001|COMPLETED|Overall Study||23
6332129|NCT00525733|7238797|FG000|NOT COMPLETED|Overall Study||3
6332130|NCT00525733|7238798|FG001|NOT COMPLETED|Overall Study||3
6332131|NCT00525785|7238804|FG000|STARTED|Overall Study||58
6332132|NCT00525785|7238804|FG000|COMPLETED|Overall Study||55
6332133|NCT00525785|7238804|FG000|NOT COMPLETED|Overall Study||3
6332134|NCT00525798|7238810|FG000|STARTED|Overall Study||2334
6332135|NCT00525798|7238811|FG001|STARTED|Overall Study||2331
6332136|NCT00525798|7238810|FG000|COMPLETED|Overall Study||1578
6332137|NCT00525798|7238811|FG001|COMPLETED|Overall Study||1732
6332138|NCT00525798|7238810|FG000|NOT COMPLETED|Overall Study||756
6332139|NCT00525798|7238811|FG001|NOT COMPLETED|Overall Study||599
6332140|NCT00525824|7238821|FG000|STARTED|Overall Study|Randomized population|214
6332141|NCT00525824|7238822|FG001|STARTED|Overall Study|Randomized population|214
6332142|NCT00525824|7238823|FG002|STARTED|Overall Study|Randomized population|202
6332143|NCT00525824|7238824|FG003|STARTED|Overall Study|Randomized population|203
6332144|NCT00525824|7238821|FG000|COMPLETED|Overall Study||195
6332145|NCT00525824|7238822|FG001|COMPLETED|Overall Study||186
6332146|NCT00525824|7238823|FG002|COMPLETED|Overall Study||183
6332147|NCT00525824|7238824|FG003|COMPLETED|Overall Study||188
6332148|NCT00525824|7238821|FG000|NOT COMPLETED|Overall Study||19
6332149|NCT00525824|7238822|FG001|NOT COMPLETED|Overall Study||28
6332150|NCT00525824|7238823|FG002|NOT COMPLETED|Overall Study||19
6332151|NCT00525824|7238824|FG003|NOT COMPLETED|Overall Study||15
6332152|NCT00525837|7238838|FG000|STARTED|Overall Study||18
6332153|NCT00525837|7238838|FG000|COMPLETED|Overall Study||14
6332154|NCT00525837|7238838|FG000|NOT COMPLETED|Overall Study||4
6332155|NCT00525876|7238845|FG000|STARTED|Overall Study||16
6332156|NCT00525876|7238846|FG001|STARTED|Overall Study||20
6332157|NCT00525876|7238845|FG000|COMPLETED|Overall Study||16
6332158|NCT00525876|7238846|FG001|COMPLETED|Overall Study||20
6332159|NCT00525876|7238845|FG000|NOT COMPLETED|Overall Study||0
6332160|NCT00525876|7238846|FG001|NOT COMPLETED|Overall Study||0
6332161|NCT00525902|7238852|FG000|STARTED|Overall Study||31
6332162|NCT00525902|7238852|FG000|10 Weeks|Overall Study||30
6332163|NCT00525902|7238852|FG000|50 Weeks|Overall Study||12
6332164|NCT00525902|7238852|FG000|COMPLETED|Overall Study||30
6332165|NCT00525902|7238852|FG000|NOT COMPLETED|Overall Study||1
6332166|NCT00525915|7238858|FG000|STARTED|Overall Study||63
6332167|NCT00525915|7238859|FG001|STARTED|Overall Study||63
6332168|NCT00525915|7238858|FG000|COMPLETED|Overall Study|Participants who underwent surgery.|55
6332169|NCT00525915|7238859|FG001|COMPLETED|Overall Study||54
6332170|NCT00525915|7238858|FG000|NOT COMPLETED|Overall Study||8
6332171|NCT00525915|7238859|FG001|NOT COMPLETED|Overall Study||9
6332172|NCT00526058|7238867|FG000|STARTED|Period: First Intervention||9
6332173|NCT00526058|7238868|FG001|STARTED|Period: First Intervention||9
6332174|NCT00526058|7238867|FG000|COMPLETED|Period: First Intervention||9
6332175|NCT00526058|7238868|FG001|COMPLETED|Period: First Intervention||9
6332176|NCT00526058|7238867|FG000|NOT COMPLETED|Period: First Intervention||0
6332177|NCT00526058|7238868|FG001|NOT COMPLETED|Period: First Intervention||0
6332178|NCT00526058|7238867|FG000|STARTED|Period: Second Intervention||9
6332179|NCT00526058|7238868|FG001|STARTED|Period: Second Intervention||9
6332180|NCT00526058|7238867|FG000|COMPLETED|Period: Second Intervention||9
6332181|NCT00526058|7238868|FG001|COMPLETED|Period: Second Intervention||9
6332182|NCT00526058|7238867|FG000|NOT COMPLETED|Period: Second Intervention||0
6332183|NCT00526058|7238868|FG001|NOT COMPLETED|Period: Second Intervention||0
6332184|NCT00526071|7238874|FG000|STARTED|Overall Study||23
6332185|NCT00526071|7238874|FG000|Safety Population|Overall Study||23
6332186|NCT00526071|7238874|FG000|Pharmacodynamic (PD) Population|Overall Study||23
6332187|NCT00526071|7238874|FG000|Amenable Population; Men|Overall Study||11
6332188|NCT00526071|7238874|FG000|Amenable Population; Women|Overall Study||5
6332189|NCT00526071|7238874|FG000|Non-amenable Population; Men|Overall Study||3
6332190|NCT00526071|7238874|FG000|Non-amenable Population; Women|Overall Study||4
6332191|NCT00526071|7238874|FG000|COMPLETED|Overall Study||17
6332192|NCT00526071|7238874|FG000|NOT COMPLETED|Overall Study||6
6332193|NCT00526097|7238884|FG000|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
6332194|NCT00526097|7238885|FG001|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
6332195|NCT00526097|7238884|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
6332196|NCT00526097|7238885|FG001|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
6332197|NCT00526097|7238884|FG000|NOT COMPLETED|Overall Study||15
6332198|NCT00526097|7238885|FG001|NOT COMPLETED|Overall Study||56
6332199|NCT00526110|7238893|FG000|STARTED|Overall Study||53
6332200|NCT00526110|7238894|FG001|STARTED|Overall Study||45
6332201|NCT00526110|7238893|FG000|COMPLETED|Overall Study||51
6332202|NCT00526110|7238894|FG001|COMPLETED|Overall Study||4
6332203|NCT00526110|7238893|FG000|NOT COMPLETED|Overall Study||2
6332204|NCT00526110|7238894|FG001|NOT COMPLETED|Overall Study||41
6332205|NCT00526123|7238902|FG000|STARTED|Overall Study|Intent-to-Treat population|303
6332206|NCT00526123|7238903|FG001|STARTED|Overall Study|Intent-to-Treat population|296
6332207|NCT00526123|7238902|FG000|COMPLETED|Overall Study||39
6332208|NCT00526123|7238903|FG001|COMPLETED|Overall Study||50
6332209|NCT00526123|7238902|FG000|NOT COMPLETED|Overall Study||264
6332210|NCT00526123|7238903|FG001|NOT COMPLETED|Overall Study||246
6332211|NCT00526162|7238909|FG000|STARTED|Overall Study||83
6332212|NCT00526162|7238909|FG000|COMPLETED|Overall Study||80
6332213|NCT00526162|7238909|FG000|NOT COMPLETED|Overall Study||3
6332214|NCT00526188|7238917|FG000|STARTED|Overall Study||234
6332215|NCT00526188|7238917|FG000|COMPLETED|Overall Study||234
6332216|NCT00526188|7238917|FG000|NOT COMPLETED|Overall Study||0
6332217|NCT00526292|7238921|FG000|STARTED|Overall Study||6
6332218|NCT00526292|7238921|FG000|COMPLETED|Overall Study||6
6332219|NCT00526292|7238921|FG000|NOT COMPLETED|Overall Study||0
6332220|NCT00526474|7238927|FG000|STARTED|Overall Study||13224
6332221|NCT00526474|7238928|FG001|STARTED|Overall Study||13225
6332222|NCT00526474|7238927|FG000|Received Study Drug|Overall Study||13166
6332223|NCT00526474|7238928|FG001|Received Study Drug|Overall Study||13186
6332224|NCT00526474|7238927|FG000|COMPLETED|Overall Study||12932
6332225|NCT00526474|7238928|FG001|COMPLETED|Overall Study||12953
6332226|NCT00526474|7238927|FG000|NOT COMPLETED|Overall Study||292
6332227|NCT00526474|7238928|FG001|NOT COMPLETED|Overall Study||272
6332228|NCT00526591|7238936|FG000|STARTED|Overall Study||8
6332229|NCT00526591|7238937|FG001|STARTED|Overall Study||9
6332230|NCT00526591|7238936|FG000|COMPLETED|Overall Study||8
6332231|NCT00526591|7238937|FG001|COMPLETED|Overall Study||9
6332232|NCT00526591|7238936|FG000|NOT COMPLETED|Overall Study||0
6332233|NCT00526591|7238937|FG001|NOT COMPLETED|Overall Study||0
6332234|NCT00526630|7238945|FG000|STARTED|First Intervention Period - 12 Weeks||12
6332235|NCT00526630|7238946|FG001|STARTED|First Intervention Period - 12 Weeks||11
6332236|NCT00526630|7238945|FG000|COMPLETED|First Intervention Period - 12 Weeks||12
6332237|NCT00526630|7238946|FG001|COMPLETED|First Intervention Period - 12 Weeks||8
6332238|NCT00526630|7238945|FG000|NOT COMPLETED|First Intervention Period - 12 Weeks||0
6332239|NCT00526630|7238946|FG001|NOT COMPLETED|First Intervention Period - 12 Weeks||3
6332240|NCT00526630|7238945|FG000|STARTED|Second Intervention Period - 12 Weeks||12
6332241|NCT00526630|7238946|FG001|STARTED|Second Intervention Period - 12 Weeks||8
6332242|NCT00526630|7238945|FG000|COMPLETED|Second Intervention Period - 12 Weeks||10
6332243|NCT00526630|7238946|FG001|COMPLETED|Second Intervention Period - 12 Weeks||7
6332244|NCT00526630|7238945|FG000|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
6332245|NCT00526630|7238946|FG001|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
6332246|NCT00526656|7238954|FG000|STARTED|Overall Study||9
6332247|NCT00526656|7238954|FG000|COMPLETED|Overall Study||7
6332248|NCT00526656|7238954|FG000|NOT COMPLETED|Overall Study||2
6332249|NCT00526669|7238959|FG000|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
6332250|NCT00526669|7238960|FG001|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
6332251|NCT00526669|7238959|FG000|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
6332252|NCT00526669|7238960|FG001|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
6332253|NCT00526669|7238959|FG000|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
6332254|NCT00526669|7238960|FG001|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
6332255|NCT00526669|7238959|FG000|STARTED|Combined Treatment Phase||0
6332256|NCT00526669|7238960|FG001|STARTED|Combined Treatment Phase||67
6332257|NCT00526669|7238959|FG000|COMPLETED|Combined Treatment Phase||0
6332258|NCT00526669|7238960|FG001|COMPLETED|Combined Treatment Phase||59
6332259|NCT00526669|7238959|FG000|NOT COMPLETED|Combined Treatment Phase||0
6332260|NCT00526669|7238960|FG001|NOT COMPLETED|Combined Treatment Phase||8
6332261|NCT00526799|7238968|FG000|STARTED|Overall Study||16
6332262|NCT00526799|7238969|FG001|STARTED|Overall Study||14
6332263|NCT00526799|7238968|FG000|COMPLETED|Overall Study||15
6332264|NCT00526799|7238969|FG001|COMPLETED|Overall Study||13
6332265|NCT00526799|7238968|FG000|NOT COMPLETED|Overall Study||1
6332266|NCT00526799|7238969|FG001|NOT COMPLETED|Overall Study||1
6332267|NCT00526890|7238975|FG000|STARTED|Overall Study||16
6332268|NCT00526890|7238975|FG000|COMPLETED|Overall Study||14
6332269|NCT00526890|7238975|FG000|NOT COMPLETED|Overall Study||2
6332270|NCT00526994|7238982|FG000|STARTED|Overall Study||909
6332271|NCT00526994|7238983|FG001|STARTED|Overall Study||893
6332272|NCT00526994|7238984|FG002|STARTED|Overall Study||898
6332273|NCT00526994|7238982|FG000|COMPLETED|Overall Study||801
6332274|NCT00526994|7238983|FG001|COMPLETED|Overall Study||772
6332275|NCT00526994|7238984|FG002|COMPLETED|Overall Study||791
6332276|NCT00526994|7238982|FG000|NOT COMPLETED|Overall Study||108
6332277|NCT00526994|7238983|FG001|NOT COMPLETED|Overall Study||121
6332278|NCT00526994|7238984|FG002|NOT COMPLETED|Overall Study||107
6332279|NCT00527072|7238992|FG000|STARTED|Overall Study||215
6332280|NCT00527072|7238992|FG000|COMPLETED|Overall Study||179
6332281|NCT00527072|7238992|FG000|NOT COMPLETED|Overall Study||36
6332282|NCT00527098|7238999|FG000|STARTED|Overall Study||36
6332283|NCT00527098|7239000|FG001|STARTED|Overall Study||83
6332284|NCT00527098|7238999|FG000|COMPLETED|Overall Study||36
6332285|NCT00527098|7239000|FG001|COMPLETED|Overall Study||83
6332286|NCT00527098|7238999|FG000|NOT COMPLETED|Overall Study||0
6332287|NCT00527098|7239000|FG001|NOT COMPLETED|Overall Study||0
6332288|NCT00527111|7239007|FG000|STARTED|Overall Study||70
6332289|NCT00527111|7239008|FG001|STARTED|Overall Study||69
6332290|NCT00527111|7239007|FG000|COMPLETED|Overall Study||50
6332291|NCT00527111|7239008|FG001|COMPLETED|Overall Study||47
6332292|NCT00527111|7239007|FG000|NOT COMPLETED|Overall Study||20
6332293|NCT00527111|7239008|FG001|NOT COMPLETED|Overall Study||22
6332294|NCT00527124|7239016|FG000|STARTED|Overall Study||29
6332295|NCT00527124|7239017|FG001|STARTED|Overall Study||28
6332296|NCT00527124|7239016|FG000|COMPLETED|Overall Study||29
6332297|NCT00527124|7239017|FG001|COMPLETED|Overall Study||28
6332298|NCT00527124|7239016|FG000|NOT COMPLETED|Overall Study||0
6332299|NCT00527124|7239017|FG001|NOT COMPLETED|Overall Study||0
6332300|NCT00527319|7239026|FG000|STARTED|Overall Study||12
6332301|NCT00527319|7239027|FG001|STARTED|Overall Study||12
6332302|NCT00527319|7239028|FG002|STARTED|Overall Study||13
6332303|NCT00527319|7239026|FG000|COMPLETED|Overall Study||6
6332304|NCT00527319|7239027|FG001|COMPLETED|Overall Study||8
6332305|NCT00527319|7239028|FG002|COMPLETED|Overall Study||7
6332306|NCT00527319|7239026|FG000|NOT COMPLETED|Overall Study||6
6332307|NCT00527319|7239027|FG001|NOT COMPLETED|Overall Study||4
6332308|NCT00527319|7239028|FG002|NOT COMPLETED|Overall Study||6
6332309|NCT00527332|7239038|FG000|STARTED|Overall Study||91
6332310|NCT00527332|7239039|FG001|STARTED|Overall Study||89
6332311|NCT00527332|7239038|FG000|COMPLETED|Overall Study||82
6332312|NCT00527332|7239039|FG001|COMPLETED|Overall Study||80
6332313|NCT00527332|7239038|FG000|NOT COMPLETED|Overall Study||9
6332314|NCT00527332|7239039|FG001|NOT COMPLETED|Overall Study||9
6332315|NCT00527397|7239045|FG000|STARTED|Overall Study||24
6332316|NCT00527397|7239045|FG000|COMPLETED|Overall Study||0
6332317|NCT00527397|7239045|FG000|NOT COMPLETED|Overall Study||24
6332318|NCT00527423|7239052|FG000|STARTED|Overall Study||157
6332319|NCT00527423|7239052|FG000|COMPLETED|Overall Study||120
6332320|NCT00527423|7239052|FG000|NOT COMPLETED|Overall Study||37
6332321|NCT00527475|7239060|FG000|STARTED|Overall Study||30
6332322|NCT00527475|7239061|FG001|STARTED|Overall Study||30
6332323|NCT00527475|7239060|FG000|COMPLETED|Overall Study||27
6332324|NCT00527475|7239061|FG001|COMPLETED|Overall Study||29
6332325|NCT00527475|7239060|FG000|NOT COMPLETED|Overall Study||3
6332326|NCT00527475|7239061|FG001|NOT COMPLETED|Overall Study||1
6332327|NCT00527488|7239071|FG000|STARTED|Overall Study||13
6332328|NCT00527488|7239072|FG001|STARTED|Overall Study||13
6332329|NCT00527488|7239073|FG002|STARTED|Overall Study||13
6332330|NCT00527488|7239074|FG003|STARTED|Overall Study||13
6332331|NCT00527488|7239071|FG000|COMPLETED|Overall Study||13
6332332|NCT00527488|7239072|FG001|COMPLETED|Overall Study||12
6332333|NCT00527488|7239073|FG002|COMPLETED|Overall Study||12
6332334|NCT00527488|7239074|FG003|COMPLETED|Overall Study||13
6332335|NCT00527488|7239071|FG000|NOT COMPLETED|Overall Study||0
6332336|NCT00527488|7239072|FG001|NOT COMPLETED|Overall Study||1
6332337|NCT00527488|7239073|FG002|NOT COMPLETED|Overall Study||1
6332338|NCT00527488|7239074|FG003|NOT COMPLETED|Overall Study||0
6332339|NCT00527514|7239084|FG000|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
6332340|NCT00527514|7239084|FG000|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
6332341|NCT00527514|7239084|FG000|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
6332342|NCT00527514|7239084|FG000|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
6332343|NCT00527514|7239084|FG000|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
6332344|NCT00527514|7239084|FG000|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
6332345|NCT00527514|7239084|FG000|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
6332346|NCT00527514|7239084|FG000|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
6332347|NCT00527514|7239084|FG000|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
6332348|NCT00527514|7239084|FG000|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
6332349|NCT00527514|7239084|FG000|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
6332350|NCT00527514|7239084|FG000|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
6332351|NCT00527566|7239095|FG000|STARTED|Overall Study||10
6332352|NCT00527566|7239095|FG000|COMPLETED|Overall Study||10
6332353|NCT00527566|7239095|FG000|NOT COMPLETED|Overall Study||0
6332354|NCT00527592|7239101|FG000|STARTED|Overall Study||54
6332355|NCT00527592|7239101|FG000|COMPLETED|Overall Study||54
6332356|NCT00527592|7239101|FG000|NOT COMPLETED|Overall Study||0
6332357|NCT00527605|7239109|FG000|STARTED|Overall Study||126
6332358|NCT00527605|7239110|FG001|STARTED|Overall Study||127
6332359|NCT00527605|7239109|FG000|COMPLETED|Overall Study||113
6332360|NCT00527605|7239110|FG001|COMPLETED|Overall Study||116
6332361|NCT00527605|7239109|FG000|NOT COMPLETED|Overall Study||13
6332362|NCT00527605|7239110|FG001|NOT COMPLETED|Overall Study||11
6332363|NCT00527618|7239116|FG000|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
6332364|NCT00527618|7239117|FG001|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
6332365|NCT00527618|7239116|FG000|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
6332366|NCT00527618|7239117|FG001|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
6332367|NCT00527618|7239116|FG000|NOT COMPLETED|Week 1-12 (First Intervention)||3
6332368|NCT00527618|7239117|FG001|NOT COMPLETED|Week 1-12 (First Intervention)||2
6332369|NCT00527618|7239116|FG000|STARTED|Week 13-14 (Washout)||13
6332370|NCT00527618|7239117|FG001|STARTED|Week 13-14 (Washout)||16
6332371|NCT00527618|7239116|FG000|COMPLETED|Week 13-14 (Washout)||12
6332372|NCT00527618|7239117|FG001|COMPLETED|Week 13-14 (Washout)||16
6332373|NCT00527618|7239116|FG000|NOT COMPLETED|Week 13-14 (Washout)||1
6332374|NCT00527618|7239117|FG001|NOT COMPLETED|Week 13-14 (Washout)||0
6332375|NCT00527618|7239116|FG000|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
6332376|NCT00527618|7239117|FG001|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
6332377|NCT00527618|7239116|FG000|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
6332378|NCT00527618|7239117|FG001|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
6332379|NCT00527618|7239116|FG000|NOT COMPLETED|Week 15-18 (Second Intervention)||0
6332380|NCT00527618|7239117|FG001|NOT COMPLETED|Week 15-18 (Second Intervention)||3
6332381|NCT00527644|7239124|FG000|STARTED|Overall Study||14
6332382|NCT00527644|7239124|FG000|COMPLETED|Overall Study||14
6332383|NCT00527644|7239124|FG000|NOT COMPLETED|Overall Study||0
6332384|NCT00527722|7239130|FG000|STARTED|Overall Study||22
6332385|NCT00527722|7239131|FG001|STARTED|Overall Study||25
6332386|NCT00527722|7239130|FG000|COMPLETED|Overall Study||22
6332387|NCT00527722|7239131|FG001|COMPLETED|Overall Study||25
6332388|NCT00527722|7239130|FG000|NOT COMPLETED|Overall Study||0
6332389|NCT00527722|7239131|FG001|NOT COMPLETED|Overall Study||0
6332390|NCT00527735|7239140|FG000|STARTED|Overall Study|Treated|113
6332391|NCT00527735|7239141|FG001|STARTED|Overall Study|Treated|109
6332392|NCT00527735|7239142|FG002|STARTED|Overall Study|Treated|109
6332393|NCT00527735|7239140|FG000|COMPLETED|Overall Study|Still on treatment|5
6332394|NCT00527735|7239141|FG001|COMPLETED|Overall Study|Still on treatment|2
6332395|NCT00527735|7239142|FG002|COMPLETED|Overall Study|Still on treatment|2
6332396|NCT00527735|7239140|FG000|NOT COMPLETED|Overall Study||108
6332397|NCT00527735|7239141|FG001|NOT COMPLETED|Overall Study||107
6332398|NCT00527735|7239142|FG002|NOT COMPLETED|Overall Study||107
6332399|NCT00527787|7239164|FG000|STARTED|Overall Study||218
6332400|NCT00527787|7239165|FG001|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
6332401|NCT00527787|7239164|FG000|COMPLETED|Overall Study||180
6332402|NCT00527787|7239165|FG001|COMPLETED|Overall Study||153
6332403|NCT00527787|7239164|FG000|NOT COMPLETED|Overall Study||38
6332404|NCT00527787|7239165|FG001|NOT COMPLETED|Overall Study||63
6332405|NCT00527826|7239173|FG000|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
6332406|NCT00527826|7239174|FG001|STARTED|Overall Study||106
6332407|NCT00527826|7239173|FG000|COMPLETED|Overall Study||87
6332408|NCT00527826|7239174|FG001|COMPLETED|Overall Study||80
6332409|NCT00527826|7239173|FG000|NOT COMPLETED|Overall Study||21
6332410|NCT00527826|7239174|FG001|NOT COMPLETED|Overall Study||26
6332411|NCT00527878|7239183|FG000|STARTED|Intervention 1||7
6332412|NCT00527878|7239184|FG001|STARTED|Intervention 1||7
6332413|NCT00527878|7239183|FG000|COMPLETED|Intervention 1||5
6332414|NCT00527878|7239184|FG001|COMPLETED|Intervention 1||4
6332415|NCT00527878|7239183|FG000|NOT COMPLETED|Intervention 1||2
6332416|NCT00527878|7239184|FG001|NOT COMPLETED|Intervention 1||3
6332417|NCT00527878|7239183|FG000|STARTED|Intervention 2||5
6332418|NCT00527878|7239184|FG001|STARTED|Intervention 2||4
6332419|NCT00527878|7239183|FG000|COMPLETED|Intervention 2||5
6332420|NCT00527878|7239184|FG001|COMPLETED|Intervention 2||4
6332421|NCT00527878|7239183|FG000|NOT COMPLETED|Intervention 2||0
6332422|NCT00527878|7239184|FG001|NOT COMPLETED|Intervention 2||0
6332423|NCT00527904|7239190|FG000|STARTED|Overall Study||239
6332424|NCT00527904|7239190|FG000|COMPLETED|Overall Study||143
6332425|NCT00527904|7239190|FG000|NOT COMPLETED|Overall Study||96
6332426|NCT00527943|7239196|FG000|STARTED|Overall Study||6471
6332427|NCT00527943|7239197|FG001|STARTED|Overall Study||6473
6332428|NCT00527943|7239196|FG000|Received Treatment|Overall Study||6441
6332429|NCT00527943|7239197|FG001|Received Treatment|Overall Study||6446
6332430|NCT00527943|7239196|FG000|COMPLETED|Overall Study||6311
6332431|NCT00527943|7239197|FG001|COMPLETED|Overall Study||6327
6332432|NCT00527943|7239196|FG000|NOT COMPLETED|Overall Study||160
6332433|NCT00527943|7239197|FG001|NOT COMPLETED|Overall Study||146
6332434|NCT00528021|7239207|FG000|STARTED|Overall Study||59
6332435|NCT00528021|7239208|FG001|STARTED|Overall Study||59
6332436|NCT00528021|7239209|FG002|STARTED|Overall Study||56
6332437|NCT00528021|7239210|FG003|STARTED|Overall Study||56
6332438|NCT00528021|7239207|FG000|COMPLETED|Overall Study||42
6332439|NCT00528021|7239208|FG001|COMPLETED|Overall Study||46
6332440|NCT00528021|7239209|FG002|COMPLETED|Overall Study||49
6332441|NCT00528021|7239210|FG003|COMPLETED|Overall Study||47
6332442|NCT00528021|7239207|FG000|NOT COMPLETED|Overall Study||17
6332443|NCT00528021|7239208|FG001|NOT COMPLETED|Overall Study||13
6332444|NCT00528021|7239209|FG002|NOT COMPLETED|Overall Study||7
6332445|NCT00528021|7239210|FG003|NOT COMPLETED|Overall Study||9
6332446|NCT00528112|7239222|FG000|STARTED|Treatment up to 3 Years||1432
6332447|NCT00528112|7239223|FG001|STARTED|Treatment up to 3 Years||1453
6332448|NCT00528112|7239222|FG000|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
6332449|NCT00528112|7239223|FG001|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
6332450|NCT00528112|7239222|FG000|COMPLETED|Treatment up to 3 Years||819
6332451|NCT00528112|7239223|FG001|COMPLETED|Treatment up to 3 Years||870
6332452|NCT00528112|7239222|FG000|NOT COMPLETED|Treatment up to 3 Years||613
6332453|NCT00528112|7239223|FG001|NOT COMPLETED|Treatment up to 3 Years||583
6332454|NCT00528112|7239222|FG000|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
6332455|NCT00528112|7239223|FG001|STARTED|Extension Phase||707
6332456|NCT00528112|7239222|FG000|COMPLETED|Extension Phase||0
6332457|NCT00528112|7239223|FG001|COMPLETED|Extension Phase||550
6332458|NCT00528112|7239222|FG000|NOT COMPLETED|Extension Phase||0
6332459|NCT00528112|7239223|FG001|NOT COMPLETED|Extension Phase||157
6332460|NCT00528190|7239233|FG000|STARTED|Overall Study||18
6332461|NCT00528190|7239234|FG001|STARTED|Overall Study||17
6332462|NCT00528190|7239233|FG000|COMPLETED|Overall Study||18
6332463|NCT00528190|7239234|FG001|COMPLETED|Overall Study||16
6332464|NCT00528190|7239233|FG000|NOT COMPLETED|Overall Study||0
6332465|NCT00528190|7239234|FG001|NOT COMPLETED|Overall Study||1
6332466|NCT00528268|7239242|FG000|STARTED|Overall Study||6
6332467|NCT00528268|7239243|FG001|STARTED|Overall Study||8
6332468|NCT00528268|7239242|FG000|COMPLETED|Overall Study||5
6332469|NCT00528268|7239243|FG001|COMPLETED|Overall Study||7
6332470|NCT00528268|7239242|FG000|NOT COMPLETED|Overall Study||1
6332471|NCT00528268|7239243|FG001|NOT COMPLETED|Overall Study||1
6332472|NCT00528372|7239258|FG000|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
6332473|NCT00528372|7239259|FG001|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
6332474|NCT00528372|7239260|FG002|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
6332475|NCT00528372|7239261|FG003|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
6332476|NCT00528372|7239262|FG004|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
6332477|NCT00528372|7239263|FG005|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
6332478|NCT00528372|7239264|FG006|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
6332479|NCT00528372|7239265|FG007|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
6332480|NCT00528372|7239266|FG008|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
6332481|NCT00528372|7239258|FG000|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
6332482|NCT00528372|7239259|FG001|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
6332483|NCT00528372|7239260|FG002|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
6332484|NCT00528372|7239261|FG003|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
6332485|NCT00528372|7239262|FG004|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
6332486|NCT00528372|7239263|FG005|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
6332487|NCT00528372|7239264|FG006|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
6332488|NCT00528372|7239265|FG007|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
6332489|NCT00528372|7239266|FG008|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
6332490|NCT00528372|7239258|FG000|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
6332491|NCT00528372|7239259|FG001|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
6332492|NCT00528372|7239260|FG002|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
6332493|NCT00528372|7239261|FG003|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
6332494|NCT00528372|7239262|FG004|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
6332495|NCT00528372|7239263|FG005|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
6332496|NCT00528372|7239264|FG006|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
6332497|NCT00528372|7239265|FG007|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
6332498|NCT00528372|7239266|FG008|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
6332499|NCT00528372|7239258|FG000|STARTED|Long-term (LT) Period (Weeks 24-102)||62
6332500|NCT00528372|7239259|FG001|STARTED|Long-term (LT) Period (Weeks 24-102)||59
6332501|NCT00528372|7239260|FG002|STARTED|Long-term (LT) Period (Weeks 24-102)||51
6332502|NCT00528372|7239261|FG003|STARTED|Long-term (LT) Period (Weeks 24-102)||56
6332503|NCT00528372|7239262|FG004|STARTED|Long-term (LT) Period (Weeks 24-102)||58
6332504|NCT00528372|7239263|FG005|STARTED|Long-term (LT) Period (Weeks 24-102)||57
6332505|NCT00528372|7239264|FG006|STARTED|Long-term (LT) Period (Weeks 24-102)||65
6332506|NCT00528372|7239265|FG007|STARTED|Long-term (LT) Period (Weeks 24-102)||28
6332507|NCT00528372|7239266|FG008|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
6332508|NCT00528372|7239258|FG000|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
6332509|NCT00528372|7239259|FG001|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
6332510|NCT00528372|7239260|FG002|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
6332511|NCT00528372|7239261|FG003|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
6332512|NCT00528372|7239262|FG004|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
6332513|NCT00528372|7239263|FG005|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
6332514|NCT00528372|7239264|FG006|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
6332515|NCT00528372|7239265|FG007|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
6332516|NCT00528372|7239266|FG008|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
6332517|NCT00528372|7239258|FG000|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
6332518|NCT00528372|7239259|FG001|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
6332519|NCT00528372|7239260|FG002|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
6332520|NCT00528372|7239261|FG003|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
6332521|NCT00528372|7239262|FG004|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
6332522|NCT00528372|7239263|FG005|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
6332523|NCT00528372|7239264|FG006|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
6332524|NCT00528372|7239265|FG007|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
6332525|NCT00528372|7239266|FG008|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
6332526|NCT00528398|7239312|FG000|STARTED|Overall Study||111
6332527|NCT00528398|7239312|FG000|COMPLETED|Overall Study||111
6332528|NCT00528398|7239312|FG000|NOT COMPLETED|Overall Study||0
6332529|NCT00528411|7239319|FG000|STARTED|Overall Study||57
6332530|NCT00528411|7239320|FG001|STARTED|Overall Study||54
6332531|NCT00528411|7239321|FG002|STARTED|Overall Study||12
6332532|NCT00528411|7239319|FG000|COMPLETED|Overall Study||52
6332533|NCT00528411|7239320|FG001|COMPLETED|Overall Study||51
6332534|NCT00528411|7239321|FG002|COMPLETED|Overall Study||11
6332535|NCT00528411|7239319|FG000|NOT COMPLETED|Overall Study||5
6332536|NCT00528411|7239320|FG001|NOT COMPLETED|Overall Study||3
6332537|NCT00528411|7239321|FG002|NOT COMPLETED|Overall Study||1
6332538|NCT00528424|7239329|FG000|STARTED|Overall Study||286
6332539|NCT00528424|7239329|FG000|COMPLETED|Overall Study||257
6332540|NCT00528424|7239329|FG000|NOT COMPLETED|Overall Study||29
6332541|NCT00528450|7239333|FG000|STARTED|Overall Study||1
6332542|NCT00528450|7239333|FG000|COMPLETED|Overall Study||1
6332543|NCT00528450|7239333|FG000|NOT COMPLETED|Overall Study||0
6332544|NCT00528528|7239341|FG000|STARTED|Overall Study||40
6332545|NCT00528528|7239342|FG001|STARTED|Overall Study||42
6332546|NCT00528528|7239343|FG002|STARTED|Overall Study||40
6332547|NCT00528528|7239344|FG003|STARTED|Overall Study||39
6332548|NCT00528528|7239341|FG000|Ongoing at Time of Cut-off|Overall Study||0
6332549|NCT00528528|7239342|FG001|Ongoing at Time of Cut-off|Overall Study||0
6332550|NCT00528528|7239343|FG002|Ongoing at Time of Cut-off|Overall Study||1
6332551|NCT00528528|7239344|FG003|Ongoing at Time of Cut-off|Overall Study||0
6332552|NCT00528528|7239341|FG000|COMPLETED|Overall Study||37
6332553|NCT00528528|7239342|FG001|COMPLETED|Overall Study||39
6332554|NCT00528528|7239343|FG002|COMPLETED|Overall Study||37
6332555|NCT00528528|7239344|FG003|COMPLETED|Overall Study||36
6332556|NCT00528528|7239341|FG000|NOT COMPLETED|Overall Study||3
6332557|NCT00528528|7239342|FG001|NOT COMPLETED|Overall Study||3
6332558|NCT00528528|7239343|FG002|NOT COMPLETED|Overall Study||3
6332559|NCT00528528|7239344|FG003|NOT COMPLETED|Overall Study||3
6332560|NCT00528541|7239358|FG000|STARTED|Overall Study||75
6332561|NCT00528541|7239359|FG001|STARTED|Overall Study||70
6332562|NCT00528541|7239358|FG000|COMPLETED|Overall Study||73
6332563|NCT00528541|7239359|FG001|COMPLETED|Overall Study||69
6332564|NCT00528541|7239358|FG000|NOT COMPLETED|Overall Study||2
6332565|NCT00528541|7239359|FG001|NOT COMPLETED|Overall Study||1
6332566|NCT00528567|7239367|FG000|STARTED|Overall Study||1301
6332567|NCT00528567|7239368|FG001|STARTED|Overall Study||1290
6332568|NCT00528567|7239367|FG000|Intention to Treat|Overall Study||1301
6332569|NCT00528567|7239368|FG001|Intention to Treat|Overall Study||1290
6332570|NCT00528567|7239367|FG000|Safety Population|Overall Study||1288
6332571|NCT00528567|7239368|FG001|Safety Population|Overall Study||1271
6332572|NCT00528567|7239367|FG000|COMPLETED|Overall Study||870
6332573|NCT00528567|7239368|FG001|COMPLETED|Overall Study||982
6332574|NCT00528567|7239367|FG000|NOT COMPLETED|Overall Study||431
6332575|NCT00528567|7239368|FG001|NOT COMPLETED|Overall Study||308
6332576|NCT00528580|7239383|FG000|STARTED|Overall Study||34
6332577|NCT00528580|7239384|FG001|STARTED|Overall Study||34
6332578|NCT00528580|7239383|FG000|COMPLETED|Overall Study||34
6332579|NCT00528580|7239384|FG001|COMPLETED|Overall Study||34
6332580|NCT00528580|7239383|FG000|NOT COMPLETED|Overall Study||0
6332581|NCT00528580|7239384|FG001|NOT COMPLETED|Overall Study||0
6332582|NCT00528606|7239392|FG000|STARTED|Overall Study||204
6332583|NCT00528606|7239393|FG001|STARTED|Overall Study||104
6332584|NCT00528606|7239392|FG000|COMPLETED|Overall Study||191
6332585|NCT00528606|7239393|FG001|COMPLETED|Overall Study||100
6332586|NCT00528606|7239392|FG000|NOT COMPLETED|Overall Study||13
6332587|NCT00528606|7239393|FG001|NOT COMPLETED|Overall Study||4
6332588|NCT00528645|7239399|FG000|STARTED|Overall Study||23
6332589|NCT00528645|7239399|FG000|COMPLETED|Overall Study||20
6332590|NCT00528645|7239399|FG000|NOT COMPLETED|Overall Study||3
6332591|NCT00528788|7239404|FG000|STARTED|Overall Study||24
6332592|NCT00528788|7239404|FG000|COMPLETED|Overall Study||20
6332593|NCT00528788|7239404|FG000|NOT COMPLETED|Overall Study||4
6332594|NCT00528801|7239410|FG000|STARTED|Overall Study||160
6332595|NCT00528801|7239411|FG001|STARTED|Overall Study||52
6332596|NCT00528801|7239410|FG000|COMPLETED|Overall Study||133
6332597|NCT00528801|7239411|FG001|COMPLETED|Overall Study||41
6332598|NCT00528801|7239410|FG000|NOT COMPLETED|Overall Study||27
6332599|NCT00528801|7239411|FG001|NOT COMPLETED|Overall Study||11
6332600|NCT00528840|7239417|FG000|STARTED|Overall Study||201
6332601|NCT00528840|7239417|FG000|COMPLETED|Overall Study||168
6332602|NCT00528840|7239417|FG000|NOT COMPLETED|Overall Study||33
6332603|NCT00528866|7239421|FG000|STARTED|Overall Study||80
6332604|NCT00528866|7239421|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
6332605|NCT00528866|7239421|FG000|NOT COMPLETED|Overall Study||6
6332606|NCT00528879|7239430|FG000|STARTED|Short-term Period (Day 1 to Week 24)||137
6332607|NCT00528879|7239431|FG001|STARTED|Short-term Period (Day 1 to Week 24)||137
6332608|NCT00528879|7239432|FG002|STARTED|Short-term Period (Day 1 to Week 24)||137
6332609|NCT00528879|7239433|FG003|STARTED|Short-term Period (Day 1 to Week 24)||135
6332610|NCT00528879|7239430|FG000|Completed the Period|Short-term Period (Day 1 to Week 24)||119
6332611|NCT00528879|7239431|FG001|Completed the Period|Short-term Period (Day 1 to Week 24)||121
6332612|NCT00528879|7239432|FG002|Completed the Period|Short-term Period (Day 1 to Week 24)||122
6332613|NCT00528879|7239433|FG003|Completed the Period|Short-term Period (Day 1 to Week 24)||121
6332614|NCT00528879|7239430|FG000|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
6332615|NCT00528879|7239431|FG001|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
6775325|NCT03880266|7703251|FG004|COMPLETED|Overall Study||12
6775326|NCT03880266|7703252|FG005|COMPLETED|Overall Study||6
6775327|NCT03880266|7703253|FG006|COMPLETED|Overall Study||13
6775328|NCT03880266|7703254|FG007|COMPLETED|Overall Study||7
6775329|NCT03880266|7703247|FG000|NOT COMPLETED|Overall Study||0
6775330|NCT03880266|7703248|FG001|NOT COMPLETED|Overall Study||1
6775331|NCT03880266|7703249|FG002|NOT COMPLETED|Overall Study||1
6775332|NCT03880266|7703250|FG003|NOT COMPLETED|Overall Study||0
6775333|NCT03880266|7703251|FG004|NOT COMPLETED|Overall Study||0
6775334|NCT03880266|7703252|FG005|NOT COMPLETED|Overall Study||0
6775335|NCT03880266|7703253|FG006|NOT COMPLETED|Overall Study||0
6775336|NCT03880266|7703254|FG007|NOT COMPLETED|Overall Study||0
6775337|NCT03856320|7703274|FG000|STARTED|Overall Study||20
6775338|NCT03856320|7703275|FG001|STARTED|Overall Study||22
6775339|NCT03856320|7703274|FG000|COMPLETED|Overall Study||20
6775340|NCT03856320|7703275|FG001|COMPLETED|Overall Study||20
6775341|NCT03856320|7703274|FG000|NOT COMPLETED|Overall Study||0
6775342|NCT03856320|7703275|FG001|NOT COMPLETED|Overall Study||2
6775343|NCT03848871|7703281|FG000|STARTED|Overall Study||20
6775344|NCT03848871|7703281|FG000|COMPLETED|Overall Study||20
6332616|NCT00528879|7239432|FG002|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
6332617|NCT00528879|7239433|FG003|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
6332618|NCT00528879|7239430|FG000|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
6332619|NCT00528879|7239431|FG001|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
6332620|NCT00528879|7239432|FG002|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
6332621|NCT00528879|7239433|FG003|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
6775345|NCT03848871|7703281|FG000|NOT COMPLETED|Overall Study||0
6332622|NCT00528879|7239430|FG000|STARTED|Long-term Period (Weeks 24 to 102)||115
6332623|NCT00528879|7239431|FG001|STARTED|Long-term Period (Weeks 24 to 102)||120
6332624|NCT00528879|7239432|FG002|STARTED|Long-term Period (Weeks 24 to 102)||122
6332625|NCT00528879|7239433|FG003|STARTED|Long-term Period (Weeks 24 to 102)||119
6332626|NCT00528879|7239430|FG000|COMPLETED|Long-term Period (Weeks 24 to 102)||73
6332627|NCT00528879|7239431|FG001|COMPLETED|Long-term Period (Weeks 24 to 102)||82
6332628|NCT00528879|7239432|FG002|COMPLETED|Long-term Period (Weeks 24 to 102)||89
6332629|NCT00528879|7239433|FG003|COMPLETED|Long-term Period (Weeks 24 to 102)||95
6332630|NCT00528879|7239430|FG000|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
6332631|NCT00528879|7239431|FG001|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
6332632|NCT00528879|7239432|FG002|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
6775346|NCT03880474|7703287|FG000|STARTED|Overall Study||1077
6775347|NCT03880474|7703288|FG001|STARTED|Overall Study||1075
6775348|NCT03880474|7703287|FG000|COMPLETED|Overall Study||1054
6775349|NCT03880474|7703288|FG001|COMPLETED|Overall Study||1055
6775350|NCT03880474|7703287|FG000|NOT COMPLETED|Overall Study||23
6775351|NCT03880474|7703288|FG001|NOT COMPLETED|Overall Study||20
6332633|NCT00528879|7239433|FG003|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
6332634|NCT00528931|7239443|FG000|STARTED|Overall Study||16
6332635|NCT00528931|7239443|FG000|COMPLETED|Overall Study||15
6332636|NCT00528931|7239443|FG000|NOT COMPLETED|Overall Study||1
6332637|NCT00528957|7239450|FG000|STARTED|Randomized Phase (Baseline to Week 48)||48
6332638|NCT00528957|7239451|FG001|STARTED|Randomized Phase (Baseline to Week 48)||49
6332639|NCT00528957|7239450|FG000|COMPLETED|Randomized Phase (Baseline to Week 48)||44
6332640|NCT00528957|7239451|FG001|COMPLETED|Randomized Phase (Baseline to Week 48)||48
6332641|NCT00528957|7239450|FG000|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
6332642|NCT00528957|7239451|FG001|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
6332643|NCT00528957|7239450|FG000|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
6332644|NCT00528957|7239451|FG001|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
6332645|NCT00528957|7239450|FG000|COMPLETED|First Extension (Week 48 to Week 144)||35
6332646|NCT00528957|7239451|FG001|COMPLETED|First Extension (Week 48 to Week 144)||40
6332647|NCT00528957|7239450|FG000|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
6332648|NCT00528957|7239451|FG001|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
6332649|NCT00528957|7239450|FG000|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
6332650|NCT00528957|7239451|FG001|STARTED|Second Extension (Week 144 to Week 240)||40
6332651|NCT00528957|7239450|FG000|COMPLETED|Second Extension (Week 144 to Week 240)||27
6332652|NCT00528957|7239451|FG001|COMPLETED|Second Extension (Week 144 to Week 240)||37
6332653|NCT00528957|7239450|FG000|NOT COMPLETED|Second Extension (Week 144 to Week 240)||7
6332654|NCT00528957|7239451|FG001|NOT COMPLETED|Second Extension (Week 144 to Week 240)||3
6332655|NCT00528957|7239450|FG000|STARTED|Third Extension (Week 240 to Week 336)||27
6332656|NCT00528957|7239451|FG001|STARTED|Third Extension (Week 240 to Week 336)||37
6332657|NCT00528957|7239450|FG000|COMPLETED|Third Extension (Week 240 to Week 336)||21
6332658|NCT00528957|7239451|FG001|COMPLETED|Third Extension (Week 240 to Week 336)||27
6332659|NCT00528957|7239450|FG000|NOT COMPLETED|Third Extension (Week 240 to Week 336)||6
6332660|NCT00528957|7239451|FG001|NOT COMPLETED|Third Extension (Week 240 to Week 336)||10
6332661|NCT00528957|7239450|FG000|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|19
6332662|NCT00528957|7239451|FG001|STARTED|Long-Term Extension (Week 336 and On)|Two participants completed the third extension and did not enroll in the long-term extension.|25
6332663|NCT00528957|7239450|FG000|COMPLETED|Long-Term Extension (Week 336 and On)||9
6332664|NCT00528957|7239451|FG001|COMPLETED|Long-Term Extension (Week 336 and On)||8
6332665|NCT00528957|7239450|FG000|NOT COMPLETED|Long-Term Extension (Week 336 and On)||10
6332666|NCT00528957|7239451|FG001|NOT COMPLETED|Long-Term Extension (Week 336 and On)||17
6376089|NCT00758524|7286583|FG008|COMPLETED|Core Period (Week 0 to Week 8)||0
6376090|NCT00758524|7286584|FG009|COMPLETED|Core Period (Week 0 to Week 8)||0
6376091|NCT00758524|7286585|FG010|COMPLETED|Core Period (Week 0 to Week 8)||0
6376092|NCT00758524|7286586|FG011|COMPLETED|Core Period (Week 0 to Week 8)||0
6376093|NCT00758524|7286587|FG012|COMPLETED|Core Period (Week 0 to Week 8)||0
6376094|NCT00758524|7286588|FG013|COMPLETED|Core Period (Week 0 to Week 8)||0
6376095|NCT00758524|7286589|FG014|COMPLETED|Core Period (Week 0 to Week 8)||0
6376096|NCT00758524|7286590|FG015|COMPLETED|Core Period (Week 0 to Week 8)||0
6376097|NCT00758524|7286591|FG016|COMPLETED|Core Period (Week 0 to Week 8)||0
6376098|NCT00758524|7286575|FG000|NOT COMPLETED|Core Period (Week 0 to Week 8)||8
6775352|NCT03878160|7703297|FG000|STARTED|Overall Study||7
6775353|NCT03878160|7703298|FG001|STARTED|Overall Study||9
6775354|NCT03878160|7703299|FG002|STARTED|Overall Study||11
6775355|NCT03878160|7703297|FG000|COMPLETED|Overall Study||5
6775356|NCT03878160|7703298|FG001|COMPLETED|Overall Study||8
6775357|NCT03878160|7703299|FG002|COMPLETED|Overall Study||10
6775358|NCT03878160|7703297|FG000|NOT COMPLETED|Overall Study||2
6775359|NCT03878160|7703298|FG001|NOT COMPLETED|Overall Study||1
6775360|NCT03878160|7703299|FG002|NOT COMPLETED|Overall Study||1
6775361|NCT03864627|7703309|FG000|STARTED|Overall Study||11
6775362|NCT03864627|7703310|FG001|STARTED|Overall Study||22
6775363|NCT03864627|7703309|FG000|COMPLETED|Overall Study||7
6775364|NCT03864627|7703310|FG001|COMPLETED|Overall Study||10
6332667|NCT00528970|7239470|FG000|STARTED|Overall Study||124
6332668|NCT00528970|7239471|FG001|STARTED|Overall Study||125
6332669|NCT00528970|7239472|FG002|STARTED|Overall Study||125
6332670|NCT00528970|7239470|FG000|Received at Least 1 Dose of Study Drug|Overall Study||124
6332671|NCT00528970|7239471|FG001|Received at Least 1 Dose of Study Drug|Overall Study||125
6332672|NCT00528970|7239472|FG002|Received at Least 1 Dose of Study Drug|Overall Study||124
6332673|NCT00528970|7239470|FG000|COMPLETED|Overall Study||110
6332674|NCT00528970|7239471|FG001|COMPLETED|Overall Study||110
6332675|NCT00528970|7239472|FG002|COMPLETED|Overall Study||105
6332676|NCT00528970|7239470|FG000|NOT COMPLETED|Overall Study||14
6332677|NCT00528970|7239471|FG001|NOT COMPLETED|Overall Study||15
6332678|NCT00528970|7239472|FG002|NOT COMPLETED|Overall Study||20
6332679|NCT00528996|7239485|FG000|STARTED|Overall Study||429
6332680|NCT00528996|7239486|FG001|STARTED|Overall Study||419
6332681|NCT00528996|7239487|FG002|STARTED|Overall Study||415
6332682|NCT00528996|7239488|FG003|STARTED|Overall Study||390
6332683|NCT00528996|7239489|FG004|STARTED|Overall Study||427
6332684|NCT00528996|7239485|FG000|COMPLETED|Overall Study||365
6332685|NCT00528996|7239486|FG001|COMPLETED|Overall Study||395
6332686|NCT00528996|7239487|FG002|COMPLETED|Overall Study||372
6332687|NCT00528996|7239488|FG003|COMPLETED|Overall Study||340
6332688|NCT00528996|7239489|FG004|COMPLETED|Overall Study||390
6332689|NCT00528996|7239485|FG000|NOT COMPLETED|Overall Study||64
6332690|NCT00528996|7239486|FG001|NOT COMPLETED|Overall Study||24
6332691|NCT00528996|7239487|FG002|NOT COMPLETED|Overall Study||43
6332692|NCT00528996|7239488|FG003|NOT COMPLETED|Overall Study||50
6332693|NCT00528996|7239489|FG004|NOT COMPLETED|Overall Study||37
6332694|NCT00529035|7239504|FG000|STARTED|Overall Study|29 enrolled|29
6332695|NCT00529035|7239504|FG000|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
6332696|NCT00529035|7239504|FG000|NOT COMPLETED|Overall Study||1
6332697|NCT00529087|7239518|FG000|STARTED|Overall Study||150
6332698|NCT00529087|7239519|FG001|STARTED|Overall Study||148
6332699|NCT00529087|7239520|FG002|STARTED|Overall Study||162
6332700|NCT00529087|7239518|FG000|COMPLETED|Overall Study||122
6332701|NCT00529087|7239519|FG001|COMPLETED|Overall Study||120
6332702|NCT00529087|7239520|FG002|COMPLETED|Overall Study||146
6332703|NCT00529087|7239518|FG000|NOT COMPLETED|Overall Study||28
6332704|NCT00529087|7239519|FG001|NOT COMPLETED|Overall Study||28
6332705|NCT00529087|7239520|FG002|NOT COMPLETED|Overall Study||16
6332706|NCT00529100|7239541|FG000|STARTED|Overall Study||16
6332707|NCT00529100|7239542|FG001|STARTED|Overall Study||33
6332708|NCT00529100|7239541|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
6332709|NCT00529100|7239542|FG001|Received at Least 1 Dose of Study Drug|Overall Study||33
6332710|NCT00529100|7239541|FG000|COMPLETED|Overall Study||16
6332711|NCT00529100|7239542|FG001|COMPLETED|Overall Study||24
6332712|NCT00529100|7239541|FG000|NOT COMPLETED|Overall Study||0
6332713|NCT00529100|7239542|FG001|NOT COMPLETED|Overall Study||9
6332714|NCT00529126|7239556|FG000|STARTED|Overall Study||25
6332715|NCT00529126|7239557|FG001|STARTED|Overall Study||25
6332716|NCT00529126|7239558|FG002|STARTED|Overall Study||24
6332717|NCT00529126|7239559|FG003|STARTED|Overall Study||26
6332718|NCT00529126|7239556|FG000|COMPLETED|Overall Study||25
6332719|NCT00529126|7239557|FG001|COMPLETED|Overall Study||25
6332720|NCT00529126|7239558|FG002|COMPLETED|Overall Study||24
6332721|NCT00529126|7239559|FG003|COMPLETED|Overall Study||26
6332722|NCT00529126|7239556|FG000|NOT COMPLETED|Overall Study||0
6332723|NCT00529126|7239557|FG001|NOT COMPLETED|Overall Study||0
6332724|NCT00529126|7239558|FG002|NOT COMPLETED|Overall Study||0
6332725|NCT00529126|7239559|FG003|NOT COMPLETED|Overall Study||0
6332726|NCT00529191|7239571|FG000|STARTED|Overall Study||27
6332727|NCT00529191|7239572|FG001|STARTED|Overall Study||13
6332728|NCT00529191|7239571|FG000|COMPLETED|Overall Study||24
6332729|NCT00529191|7239572|FG001|COMPLETED|Overall Study||13
6332730|NCT00529191|7239571|FG000|NOT COMPLETED|Overall Study||3
6332731|NCT00529191|7239572|FG001|NOT COMPLETED|Overall Study||0
6332732|NCT00529204|7239587|FG000|STARTED|Overall Study||1
6332733|NCT00529204|7239587|FG000|COMPLETED|Overall Study||1
6332734|NCT00529204|7239587|FG000|NOT COMPLETED|Overall Study||0
6332735|NCT00529217|7239591|FG000|STARTED|Overall Study||12
6332736|NCT00529217|7239591|FG000|COMPLETED|Overall Study||8
6332737|NCT00529217|7239591|FG000|NOT COMPLETED|Overall Study||4
6332738|NCT00529243|7239596|FG000|STARTED|Overall Study||52
6332739|NCT00529243|7239596|FG000|COMPLETED|Overall Study||49
6498347|NCT01408901|7416890|FG002|COMPLETED|26-Week Follow-Up||50
6332740|NCT00529243|7239596|FG000|NOT COMPLETED|Overall Study||3
6332741|NCT00529308|7239602|FG000|STARTED|Overall Study||9
6332742|NCT00529308|7239603|FG001|STARTED|Overall Study||11
6332743|NCT00529308|7239602|FG000|COMPLETED|Overall Study||8
6332744|NCT00529308|7239603|FG001|COMPLETED|Overall Study||10
6332745|NCT00529308|7239602|FG000|NOT COMPLETED|Overall Study||1
6332746|NCT00529308|7239603|FG001|NOT COMPLETED|Overall Study||1
6332747|NCT00529373|7239611|FG000|STARTED|Base Study||8043
6332748|NCT00529373|7239612|FG001|STARTED|Base Study||8028
6332749|NCT00529373|7239611|FG000|COMPLETED|Base Study||4297
6332750|NCT00529373|7239612|FG001|COMPLETED|Base Study||3960
6332751|NCT00529373|7239611|FG000|NOT COMPLETED|Base Study||3746
6332752|NCT00529373|7239612|FG001|NOT COMPLETED|Base Study||4068
6332753|NCT00529373|7239611|FG000|STARTED|First Extension Study||4297
6332754|NCT00529373|7239612|FG001|STARTED|First Extension Study||3960
6332755|NCT00529373|7239611|FG000|COMPLETED|First Extension Study||3144
6332756|NCT00529373|7239612|FG001|COMPLETED|First Extension Study||2309
6332757|NCT00529373|7239611|FG000|NOT COMPLETED|First Extension Study||1153
6332758|NCT00529373|7239612|FG001|NOT COMPLETED|First Extension Study||1651
6332759|NCT00529373|7239611|FG000|STARTED|Second Extension Study||3144
6332760|NCT00529373|7239612|FG001|STARTED|Second Extension Study||2309
6332761|NCT00529373|7239611|FG000|COMPLETED|Second Extension Study||2844
6332762|NCT00529373|7239612|FG001|COMPLETED|Second Extension Study||2112
6332763|NCT00529373|7239611|FG000|NOT COMPLETED|Second Extension Study||300
6332764|NCT00529373|7239612|FG001|NOT COMPLETED|Second Extension Study||197
6332765|NCT00529386|7239626|FG000|STARTED|Overall Study|Study has been discontinued|7
6332766|NCT00529386|7239626|FG000|COMPLETED|Overall Study|Study discontinued after 7 patients enrolled and analyzed|6
6332767|NCT00529386|7239626|FG000|NOT COMPLETED|Overall Study||1
6332768|NCT00529399|7239633|FG000|STARTED|Overall Study||48
6332769|NCT00529399|7239634|FG001|STARTED|Overall Study||49
6332770|NCT00529399|7239635|FG002|STARTED|Overall Study||48
6332771|NCT00529399|7239633|FG000|COMPLETED|Overall Study||46
6332772|NCT00529399|7239634|FG001|COMPLETED|Overall Study||48
6332773|NCT00529399|7239635|FG002|COMPLETED|Overall Study||46
6332774|NCT00529399|7239633|FG000|NOT COMPLETED|Overall Study||2
6332775|NCT00529399|7239634|FG001|NOT COMPLETED|Overall Study||1
6332776|NCT00529399|7239635|FG002|NOT COMPLETED|Overall Study||2
6332777|NCT00529451|7239647|FG000|STARTED|Overall Study||331
6332778|NCT00529451|7239648|FG001|STARTED|Overall Study||323
6332779|NCT00529451|7239649|FG002|STARTED|Overall Study||332
6332780|NCT00529451|7239650|FG003|STARTED|Overall Study||330
6332781|NCT00529451|7239647|FG000|COMPLETED|Overall Study||294
6332782|NCT00529451|7239648|FG001|COMPLETED|Overall Study||275
6332783|NCT00529451|7239649|FG002|COMPLETED|Overall Study||292
6332784|NCT00529451|7239650|FG003|COMPLETED|Overall Study||299
6332785|NCT00529451|7239647|FG000|NOT COMPLETED|Overall Study||37
6332786|NCT00529451|7239648|FG001|NOT COMPLETED|Overall Study||48
6332787|NCT00529451|7239649|FG002|NOT COMPLETED|Overall Study||40
6332788|NCT00529451|7239650|FG003|NOT COMPLETED|Overall Study||31
6332789|NCT00529516|7239666|FG000|STARTED|Overall Study||475
6332790|NCT00529516|7239667|FG001|STARTED|Overall Study||488
6332791|NCT00529516|7239668|FG002|STARTED|Overall Study||289
6332792|NCT00529516|7239666|FG000|COMPLETED|Overall Study||472
6332793|NCT00529516|7239667|FG001|COMPLETED|Overall Study||486
6332794|NCT00529516|7239668|FG002|COMPLETED|Overall Study||288
6332795|NCT00529516|7239666|FG000|NOT COMPLETED|Overall Study||3
6332796|NCT00529516|7239667|FG001|NOT COMPLETED|Overall Study||2
6332797|NCT00529516|7239668|FG002|NOT COMPLETED|Overall Study||1
6332798|NCT00529529|7239679|FG000|STARTED|Overall Study||268
6332799|NCT00529529|7239680|FG001|STARTED|Overall Study||268
6332800|NCT00529529|7239681|FG002|STARTED|Overall Study||269
6332801|NCT00529529|7239679|FG000|COMPLETED|Overall Study||225
6332802|NCT00529529|7239680|FG001|COMPLETED|Overall Study||225
6332803|NCT00529529|7239681|FG002|COMPLETED|Overall Study||238
6332804|NCT00529529|7239679|FG000|NOT COMPLETED|Overall Study||43
6332805|NCT00529529|7239680|FG001|NOT COMPLETED|Overall Study||43
6332806|NCT00529529|7239681|FG002|NOT COMPLETED|Overall Study||31
6332807|NCT00529542|7239691|FG000|STARTED|Overall Study||9
6332808|NCT00529542|7239692|FG001|STARTED|Overall Study||11
6332809|NCT00529542|7239691|FG000|COMPLETED|Overall Study||8
6332810|NCT00529542|7239692|FG001|COMPLETED|Overall Study||10
6332811|NCT00529542|7239691|FG000|NOT COMPLETED|Overall Study||1
6332812|NCT00529542|7239692|FG001|NOT COMPLETED|Overall Study||1
6332813|NCT00529555|7239701|FG000|STARTED|Overall Study||200
6332814|NCT00529555|7239702|FG001|STARTED|Overall Study||202
6332815|NCT00529555|7239703|FG002|STARTED|Overall Study||200
6332816|NCT00529555|7239701|FG000|COMPLETED|Overall Study||171
6332817|NCT00529555|7239702|FG001|COMPLETED|Overall Study||172
6332818|NCT00529555|7239703|FG002|COMPLETED|Overall Study||174
6332819|NCT00529555|7239701|FG000|NOT COMPLETED|Overall Study||29
6332820|NCT00529555|7239702|FG001|NOT COMPLETED|Overall Study||30
6332821|NCT00529555|7239703|FG002|NOT COMPLETED|Overall Study||26
6332822|NCT00529568|7239713|FG000|STARTED|Open-label Pre-Antiviral Treatment Phase||805
6332823|NCT00529568|7239714|FG001|STARTED|Open-label Pre-Antiviral Treatment Phase||0
6332824|NCT00529568|7239715|FG002|STARTED|Open-label Pre-Antiviral Treatment Phase||0
6332825|NCT00529568|7239713|FG000|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
6332826|NCT00529568|7239714|FG001|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
6332827|NCT00529568|7239715|FG002|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
6332828|NCT00529568|7239713|FG000|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
6332829|NCT00529568|7239714|FG001|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
6332830|NCT00529568|7239715|FG002|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
6332831|NCT00529568|7239713|FG000|STARTED|Double-bilnd Antiviral Treatment Phase||0
6332832|NCT00529568|7239714|FG001|STARTED|Double-bilnd Antiviral Treatment Phase||253
6332833|NCT00529568|7239715|FG002|STARTED|Double-bilnd Antiviral Treatment Phase||506
6332834|NCT00529568|7239713|FG000|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
6332835|NCT00529568|7239714|FG001|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
6332836|NCT00529568|7239715|FG002|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
6332837|NCT00529568|7239713|FG000|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
6332838|NCT00529568|7239714|FG001|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
6332839|NCT00529568|7239715|FG002|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
6332840|NCT00529633|7239726|FG000|STARTED|Overall Study||2
6332841|NCT00529633|7239727|FG001|STARTED|Overall Study||2
6332842|NCT00529633|7239726|FG000|COMPLETED|Overall Study||1
6332843|NCT00529633|7239727|FG001|COMPLETED|Overall Study||1
6332844|NCT00529633|7239726|FG000|NOT COMPLETED|Overall Study||1
6332845|NCT00529633|7239727|FG001|NOT COMPLETED|Overall Study||1
6332846|NCT00529659|7239735|FG000|STARTED|Overall Study||81
6332847|NCT00529659|7239736|FG001|STARTED|Overall Study||89
6332848|NCT00529659|7239735|FG000|COMPLETED|Overall Study||70
6332849|NCT00529659|7239736|FG001|COMPLETED|Overall Study||66
6332850|NCT00529659|7239735|FG000|NOT COMPLETED|Overall Study||11
6332851|NCT00529659|7239736|FG001|NOT COMPLETED|Overall Study||23
6332852|NCT00529789|7239742|FG000|STARTED|Study Period II/III||72
6332853|NCT00529789|7239742|FG000|COMPLETED|Study Period II/III||48
6332854|NCT00529789|7239742|FG000|NOT COMPLETED|Study Period II/III||24
6332855|NCT00529789|7239742|FG000|STARTED|Study Period IV||48
6332856|NCT00529789|7239742|FG000|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
6332857|NCT00529789|7239742|FG000|NOT COMPLETED|Study Period IV||6
6332858|NCT00529802|7239752|FG000|STARTED|Evaluable for Primary Endpoint|60 patients started trial|60
6332859|NCT00529802|7239752|FG000|COMPLETED|Evaluable for Primary Endpoint|Evaluable for primary endpoint|50
6332860|NCT00529802|7239752|FG000|NOT COMPLETED|Evaluable for Primary Endpoint||10
6332861|NCT00529802|7239752|FG000|STARTED|Evaluable for Secondary Endpoint||50
6332862|NCT00529802|7239752|FG000|COMPLETED|Evaluable for Secondary Endpoint||48
6332863|NCT00529802|7239752|FG000|NOT COMPLETED|Evaluable for Secondary Endpoint||2
6332864|NCT00529958|7239761|FG000|STARTED|2-Year Follow-up||110
6332865|NCT00529958|7239762|FG001|STARTED|2-Year Follow-up|110 randomized to HT, but there was (n=1) cross-over from the DB group|110
6332866|NCT00529958|7239763|FG002|STARTED|2-Year Follow-up|110 randomized to DB, but there was (n=1) cross-over to the HT group|110
6332867|NCT00529958|7239761|FG000|COMPLETED|2-Year Follow-up||106
6332868|NCT00529958|7239762|FG001|COMPLETED|2-Year Follow-up|108 HT patients analyzed excludes n=1 cross-over patient (analyzed on intention-to-treat basis).|108
6332869|NCT00529958|7239763|FG002|COMPLETED|2-Year Follow-up|108 DB patients analyzed include 1 cross-over with HT graft (analyzed on intention-to-treat basis).|108
6332870|NCT00529958|7239761|FG000|NOT COMPLETED|2-Year Follow-up||4
6332871|NCT00529958|7239762|FG001|NOT COMPLETED|2-Year Follow-up||2
6332872|NCT00529958|7239763|FG002|NOT COMPLETED|2-Year Follow-up||2
6332873|NCT00529958|7239761|FG000|STARTED|5-Year Follow-up||106
6332874|NCT00529958|7239762|FG001|STARTED|5-Year Follow-up|108 HT patients available for 5-year follow-up excludes n=1 cross-over patient from the DB group|108
6332875|NCT00529958|7239763|FG002|STARTED|5-Year Follow-up|108 DB patients available for 5-year follow-up includes n=1 cross-over with a single-bundle HT graft|108
6332876|NCT00529958|7239761|FG000|COMPLETED|5-Year Follow-up||103
6332877|NCT00529958|7239762|FG001|COMPLETED|5-Year Follow-up||105
6332878|NCT00529958|7239763|FG002|COMPLETED|5-Year Follow-up||107
6332879|NCT00529958|7239761|FG000|NOT COMPLETED|5-Year Follow-up||3
6332880|NCT00529958|7239762|FG001|NOT COMPLETED|5-Year Follow-up||3
6332881|NCT00529958|7239763|FG002|NOT COMPLETED|5-Year Follow-up||1
6332882|NCT00530023|7239773|FG000|STARTED|Overall Study||14
6332883|NCT00530023|7239774|FG001|STARTED|Overall Study||15
6332884|NCT00530023|7239773|FG000|COMPLETED|Overall Study||14
6332885|NCT00530023|7239774|FG001|COMPLETED|Overall Study||14
6332886|NCT00530023|7239773|FG000|NOT COMPLETED|Overall Study||0
6332887|NCT00530023|7239774|FG001|NOT COMPLETED|Overall Study||1
6332888|NCT00530075|7239780|FG000|STARTED|Overall Study||45
6332889|NCT00530075|7239780|FG000|COMPLETED|Overall Study||38
6332890|NCT00530075|7239780|FG000|NOT COMPLETED|Overall Study||7
6332891|NCT00530088|7239784|FG000|STARTED|Overall Study||30
6332892|NCT00530088|7239784|FG000|COMPLETED|Overall Study||20
6332893|NCT00530088|7239784|FG000|NOT COMPLETED|Overall Study||10
6332894|NCT00530218|7239788|FG000|STARTED|Overall Study||61
6332895|NCT00530218|7239788|FG000|COMPLETED|Overall Study|CMV Reactivation Was Detected|36
6332896|NCT00530218|7239788|FG000|NOT COMPLETED|Overall Study||25
6332897|NCT00530257|7239795|FG000|STARTED|Overall Study||31
6332898|NCT00530257|7239795|FG000|COMPLETED|Overall Study||30
6332899|NCT00530257|7239795|FG000|NOT COMPLETED|Overall Study||1
6332900|NCT00530270|7239804|FG000|STARTED|Overall Study||6
6332901|NCT00530270|7239805|FG001|STARTED|Overall Study||6
6332902|NCT00530270|7239804|FG000|COMPLETED|Overall Study||5
6332903|NCT00530270|7239805|FG001|COMPLETED|Overall Study||6
6332904|NCT00530270|7239804|FG000|NOT COMPLETED|Overall Study||1
6332905|NCT00530270|7239805|FG001|NOT COMPLETED|Overall Study||0
6332906|NCT00530335|7239811|FG000|STARTED|Overall Study||45
6332907|NCT00530335|7239811|FG000|COMPLETED|Overall Study||39
6332908|NCT00530335|7239811|FG000|NOT COMPLETED|Overall Study||6
6332909|NCT00530348|7239817|FG000|STARTED|Overall Study|Randomized.|195
6332910|NCT00530348|7239818|FG001|STARTED|Overall Study|Randomized.|386
6332911|NCT00530348|7239817|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
6332912|NCT00530348|7239818|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
6332913|NCT00530348|7239817|FG000|COMPLETED|Overall Study||173
6332914|NCT00530348|7239818|FG001|COMPLETED|Overall Study||367
6332915|NCT00530348|7239817|FG000|NOT COMPLETED|Overall Study||22
6332916|NCT00530348|7239818|FG001|NOT COMPLETED|Overall Study||19
6498348|NCT01408901|7416891|FG003|COMPLETED|26-Week Follow-Up||46
6498349|NCT01408901|7416888|FG000|NOT COMPLETED|26-Week Follow-Up||1
6498350|NCT01408901|7416889|FG001|NOT COMPLETED|26-Week Follow-Up||2
6498351|NCT01408901|7416890|FG002|NOT COMPLETED|26-Week Follow-Up||0
6498352|NCT01408901|7416891|FG003|NOT COMPLETED|26-Week Follow-Up||1
6498353|NCT01408914|7416906|FG000|STARTED|Overall Study||60
6498354|NCT01408914|7416907|FG001|STARTED|Overall Study||60
6332917|NCT00530439|7239826|FG000|STARTED|Overall Study||180
6332918|NCT00530439|7239827|FG001|STARTED|Overall Study||180
6332919|NCT00530439|7239826|FG000|COMPLETED|Overall Study||150
6332920|NCT00530439|7239827|FG001|COMPLETED|Overall Study||154
6332921|NCT00530439|7239826|FG000|NOT COMPLETED|Overall Study||30
6332922|NCT00530439|7239827|FG001|NOT COMPLETED|Overall Study||26
6332923|NCT00530504|7239833|FG000|STARTED|Overall Study||1500
6332924|NCT00530504|7239833|FG000|COMPLETED|Overall Study||1348
6332925|NCT00530504|7239833|FG000|NOT COMPLETED|Overall Study||152
6332926|NCT00530621|7239839|FG000|STARTED|Overall Study||80
6332927|NCT00530621|7239840|FG001|STARTED|Overall Study||80
6332928|NCT00530621|7239839|FG000|Received at Least 1 Dose of Study Drug|Overall Study||79
6332929|NCT00530621|7239840|FG001|Received at Least 1 Dose of Study Drug|Overall Study||80
6332930|NCT00530621|7239839|FG000|COMPLETED|Overall Study||0
6332931|NCT00530621|7239840|FG001|COMPLETED|Overall Study||0
6332932|NCT00530621|7239839|FG000|NOT COMPLETED|Overall Study||80
6332933|NCT00530621|7239840|FG001|NOT COMPLETED|Overall Study||80
6332934|NCT00530634|7239850|FG000|STARTED|Overall Study||3
6332935|NCT00530634|7239850|FG000|COMPLETED|Overall Study||3
6332936|NCT00530634|7239850|FG000|NOT COMPLETED|Overall Study||0
6332937|NCT00530712|7239854|FG000|STARTED|Enrollment|Total Enrolled Subjects|287
6332938|NCT00530712|7239854|FG000|COMPLETED|Enrollment|Subjects Available at Discharge|287
6332939|NCT00530712|7239854|FG000|NOT COMPLETED|Enrollment||0
6332940|NCT00530712|7239854|FG000|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
6332941|NCT00530712|7239854|FG000|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
6332942|NCT00530712|7239854|FG000|NOT COMPLETED|30 Day Follow-up Visit||7
6332943|NCT00530712|7239854|FG000|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
6332944|NCT00530712|7239854|FG000|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
6332945|NCT00530712|7239854|FG000|NOT COMPLETED|6 Month Follow-up Visit||12
6332946|NCT00530712|7239854|FG000|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
6332947|NCT00530712|7239854|FG000|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
6332948|NCT00530712|7239854|FG000|NOT COMPLETED|12 Month Follow-up Visit||24
6332949|NCT00530764|7239863|FG000|STARTED|Overall Study||90
6332950|NCT00530764|7239864|FG001|STARTED|Overall Study||88
6332951|NCT00530764|7239865|FG002|STARTED|Overall Study||91
6332952|NCT00530764|7239866|FG003|STARTED|Overall Study||91
6332953|NCT00530764|7239863|FG000|COMPLETED|Overall Study||59
6332954|NCT00530764|7239864|FG001|COMPLETED|Overall Study||67
6332955|NCT00530764|7239865|FG002|COMPLETED|Overall Study||71
6332956|NCT00530764|7239866|FG003|COMPLETED|Overall Study||66
6332957|NCT00530764|7239863|FG000|NOT COMPLETED|Overall Study||31
6332958|NCT00530764|7239864|FG001|NOT COMPLETED|Overall Study||21
6332959|NCT00530764|7239865|FG002|NOT COMPLETED|Overall Study||20
6332960|NCT00530764|7239866|FG003|NOT COMPLETED|Overall Study||25
6332961|NCT00530777|7239881|FG000|STARTED|Overall Study||74
6332962|NCT00530777|7239882|FG001|STARTED|Overall Study||74
6332963|NCT00530777|7239881|FG000|COMPLETED|Overall Study||67
6332964|NCT00530777|7239882|FG001|COMPLETED|Overall Study||69
6332965|NCT00530777|7239881|FG000|NOT COMPLETED|Overall Study||7
6332966|NCT00530777|7239882|FG001|NOT COMPLETED|Overall Study||5
6332967|NCT00530790|7239888|FG000|STARTED|Overall Study||35
6332968|NCT00530790|7239888|FG000|COMPLETED|Overall Study||30
6332969|NCT00530790|7239888|FG000|NOT COMPLETED|Overall Study||5
6332970|NCT00530803|7239894|FG000|STARTED|Overall Study||50
6332971|NCT00530803|7239895|FG001|STARTED|Overall Study||50
6332972|NCT00530803|7239894|FG000|COMPLETED|Overall Study||50
6332973|NCT00530803|7239895|FG001|COMPLETED|Overall Study||50
6332974|NCT00530803|7239894|FG000|NOT COMPLETED|Overall Study||0
6332975|NCT00530803|7239895|FG001|NOT COMPLETED|Overall Study||0
6332976|NCT00530816|7239904|FG000|STARTED|Overall Study||35
6332977|NCT00530816|7239905|FG001|STARTED|Overall Study||59
6332978|NCT00530816|7239906|FG002|STARTED|Overall Study||70
6332979|NCT00530816|7239904|FG000|COMPLETED|Overall Study||9
6332980|NCT00530816|7239905|FG001|COMPLETED|Overall Study||17
6332981|NCT00530816|7239906|FG002|COMPLETED|Overall Study||29
6332982|NCT00530816|7239904|FG000|NOT COMPLETED|Overall Study||26
6332983|NCT00530816|7239905|FG001|NOT COMPLETED|Overall Study||42
6332984|NCT00530816|7239906|FG002|NOT COMPLETED|Overall Study||41
6332985|NCT00530842|7239916|FG000|STARTED|Overall Study||172
6332986|NCT00530842|7239917|FG001|STARTED|Overall Study||172
6332987|NCT00530842|7239916|FG000|COMPLETED|Overall Study||149
6332988|NCT00530842|7239917|FG001|COMPLETED|Overall Study||151
6558758|NCT01777282|7481345|FG004|COMPLETED|Overall Study||54
6558759|NCT01777282|7481341|FG000|NOT COMPLETED|Overall Study||11
6558760|NCT01777282|7481342|FG001|NOT COMPLETED|Overall Study||4
6332989|NCT00530842|7239916|FG000|NOT COMPLETED|Overall Study||23
6332990|NCT00530842|7239917|FG001|NOT COMPLETED|Overall Study||21
6332991|NCT00530842|7239916|FG000|STARTED|Period 1||172
6332992|NCT00530842|7239917|FG001|STARTED|Period 1||172
6332993|NCT00530842|7239916|FG000|COMPLETED|Period 1||158
6332994|NCT00530842|7239917|FG001|COMPLETED|Period 1||161
6332995|NCT00530842|7239916|FG000|NOT COMPLETED|Period 1||14
6332996|NCT00530842|7239917|FG001|NOT COMPLETED|Period 1||11
6332997|NCT00530842|7239916|FG000|STARTED|Period 2||157
6332998|NCT00530842|7239917|FG001|STARTED|Period 2||160
6332999|NCT00530842|7239916|FG000|COMPLETED|Period 2||149
6558761|NCT01777282|7481343|FG002|NOT COMPLETED|Overall Study||6
6333000|NCT00530842|7239917|FG001|COMPLETED|Period 2||151
6333001|NCT00530842|7239916|FG000|NOT COMPLETED|Period 2||8
6558762|NCT01777282|7481344|FG003|NOT COMPLETED|Overall Study||2
6558763|NCT01777282|7481345|FG004|NOT COMPLETED|Overall Study||7
6558764|NCT01777308|7481359|FG000|STARTED|Overall Study||119
6558765|NCT01777308|7481360|FG001|STARTED|Overall Study||37
6333002|NCT00530842|7239917|FG001|NOT COMPLETED|Period 2||9
6333003|NCT00530855|7239925|FG000|STARTED|Overall Study||322
6333004|NCT00530855|7239925|FG000|COMPLETED|Overall Study||210
6333005|NCT00530855|7239925|FG000|NOT COMPLETED|Overall Study||112
6333006|NCT00530894|7239933|FG000|STARTED|Overall Study||348
6333007|NCT00530894|7239934|FG001|STARTED|Overall Study||351
6333008|NCT00530894|7239935|FG002|STARTED|Overall Study||179
6333009|NCT00530894|7239936|FG003|STARTED|Overall Study||179
6333010|NCT00530894|7239933|FG000|COMPLETED|Overall Study||260
6333011|NCT00530894|7239934|FG001|COMPLETED|Overall Study||236
6333012|NCT00530894|7239935|FG002|COMPLETED|Overall Study||124
6333013|NCT00530894|7239936|FG003|COMPLETED|Overall Study||85
6333014|NCT00530894|7239933|FG000|NOT COMPLETED|Overall Study||88
6333015|NCT00530894|7239934|FG001|NOT COMPLETED|Overall Study||115
6333016|NCT00530894|7239935|FG002|NOT COMPLETED|Overall Study||55
6333017|NCT00530894|7239936|FG003|NOT COMPLETED|Overall Study||94
6333018|NCT00530920|7239951|FG000|STARTED|Overall Study||30
6333019|NCT00530920|7239952|FG001|STARTED|Overall Study||27
6333020|NCT00530920|7239953|FG002|STARTED|Overall Study||28
6333021|NCT00530920|7239951|FG000|COMPLETED|Overall Study||30
6333022|NCT00530920|7239952|FG001|COMPLETED|Overall Study||25
6333023|NCT00530920|7239953|FG002|COMPLETED|Overall Study||24
6333024|NCT00530920|7239951|FG000|NOT COMPLETED|Overall Study||0
6333025|NCT00530920|7239952|FG001|NOT COMPLETED|Overall Study||2
6333026|NCT00530920|7239953|FG002|NOT COMPLETED|Overall Study||4
6333027|NCT00530946|7239966|FG000|STARTED|Overall Study||43
6333028|NCT00530946|7239967|FG001|STARTED|Overall Study||41
6333029|NCT00530946|7239968|FG002|STARTED|Overall Study||41
6333030|NCT00530946|7239969|FG003|STARTED|Overall Study||40
6333031|NCT00530946|7239966|FG000|COMPLETED|Overall Study||41
6333032|NCT00530946|7239967|FG001|COMPLETED|Overall Study||39
6333033|NCT00530946|7239968|FG002|COMPLETED|Overall Study||40
6333034|NCT00530946|7239969|FG003|COMPLETED|Overall Study||38
6333035|NCT00530946|7239966|FG000|NOT COMPLETED|Overall Study||2
6333036|NCT00530946|7239967|FG001|NOT COMPLETED|Overall Study||2
6333037|NCT00530946|7239968|FG002|NOT COMPLETED|Overall Study||1
6333038|NCT00530946|7239969|FG003|NOT COMPLETED|Overall Study||2
6333039|NCT00531011|7239981|FG000|STARTED|Overall Study||103
6333040|NCT00531011|7239982|FG001|STARTED|Overall Study||97
6333041|NCT00531011|7239981|FG000|COMPLETED|Overall Study||99
6333042|NCT00531011|7239982|FG001|COMPLETED|Overall Study||90
6333043|NCT00531011|7239981|FG000|NOT COMPLETED|Overall Study||4
6333044|NCT00531011|7239982|FG001|NOT COMPLETED|Overall Study||7
6333045|NCT00531050|7239994|FG000|STARTED|Part 1: Period 1||4
6333046|NCT00531050|7239995|FG001|STARTED|Part 1: Period 1||5
6333047|NCT00531050|7239996|FG002|STARTED|Part 1: Period 1||4
6333048|NCT00531050|7239997|FG003|STARTED|Part 1: Period 1||5
6333049|NCT00531050|7239998|FG004|STARTED|Part 1: Period 1||4
6333050|NCT00531050|7239999|FG005|STARTED|Part 1: Period 1||5
6333051|NCT00531050|7239994|FG000|COMPLETED|Part 1: Period 1||4
6333052|NCT00531050|7239995|FG001|COMPLETED|Part 1: Period 1||4
6333053|NCT00531050|7239996|FG002|COMPLETED|Part 1: Period 1||4
6333054|NCT00531050|7239997|FG003|COMPLETED|Part 1: Period 1||4
6333055|NCT00531050|7239998|FG004|COMPLETED|Part 1: Period 1||4
6333056|NCT00531050|7239999|FG005|COMPLETED|Part 1: Period 1||5
6333057|NCT00531050|7239994|FG000|NOT COMPLETED|Part 1: Period 1||0
6333058|NCT00531050|7239995|FG001|NOT COMPLETED|Part 1: Period 1||1
6333059|NCT00531050|7239996|FG002|NOT COMPLETED|Part 1: Period 1||0
6333060|NCT00531050|7239997|FG003|NOT COMPLETED|Part 1: Period 1||1
6333061|NCT00531050|7239998|FG004|NOT COMPLETED|Part 1: Period 1||0
6333062|NCT00531050|7239999|FG005|NOT COMPLETED|Part 1: Period 1||0
6333063|NCT00531050|7239994|FG000|STARTED|Part 1: Period 2||4
6333064|NCT00531050|7239995|FG001|STARTED|Part 1: Period 2||4
6333065|NCT00531050|7239996|FG002|STARTED|Part 1: Period 2||4
6333066|NCT00531050|7239997|FG003|STARTED|Part 1: Period 2||4
6333067|NCT00531050|7239998|FG004|STARTED|Part 1: Period 2||4
6333068|NCT00531050|7239999|FG005|STARTED|Part 1: Period 2||5
6333069|NCT00531050|7239994|FG000|COMPLETED|Part 1: Period 2||4
6333070|NCT00531050|7239995|FG001|COMPLETED|Part 1: Period 2||4
6333071|NCT00531050|7239996|FG002|COMPLETED|Part 1: Period 2||4
6333072|NCT00531050|7239997|FG003|COMPLETED|Part 1: Period 2||4
6333073|NCT00531050|7239998|FG004|COMPLETED|Part 1: Period 2||4
6333074|NCT00531050|7239999|FG005|COMPLETED|Part 1: Period 2||5
6333075|NCT00531050|7239994|FG000|NOT COMPLETED|Part 1: Period 2||0
6333076|NCT00531050|7239995|FG001|NOT COMPLETED|Part 1: Period 2||0
6333077|NCT00531050|7239996|FG002|NOT COMPLETED|Part 1: Period 2||0
6333078|NCT00531050|7239997|FG003|NOT COMPLETED|Part 1: Period 2||0
6333079|NCT00531050|7239998|FG004|NOT COMPLETED|Part 1: Period 2||0
6333080|NCT00531050|7239999|FG005|NOT COMPLETED|Part 1: Period 2||0
6333081|NCT00531050|7239994|FG000|STARTED|Part 1: Period 3||4
6333082|NCT00531050|7239995|FG001|STARTED|Part 1: Period 3||4
6333083|NCT00531050|7239996|FG002|STARTED|Part 1: Period 3||4
6333084|NCT00531050|7239997|FG003|STARTED|Part 1: Period 3||4
6333085|NCT00531050|7239998|FG004|STARTED|Part 1: Period 3||4
6333086|NCT00531050|7239999|FG005|STARTED|Part 1: Period 3||5
6558766|NCT01777308|7481359|FG000|Completed up to Month 73|Overall Study||118
6558767|NCT01777308|7481360|FG001|Completed up to Month 73|Overall Study||37
6558768|NCT01777308|7481359|FG000|COMPLETED|Overall Study||105
6558769|NCT01777308|7481360|FG001|COMPLETED|Overall Study||34
6333087|NCT00531050|7239994|FG000|COMPLETED|Part 1: Period 3||3
6333088|NCT00531050|7239995|FG001|COMPLETED|Part 1: Period 3||4
6333089|NCT00531050|7239996|FG002|COMPLETED|Part 1: Period 3||4
6333090|NCT00531050|7239997|FG003|COMPLETED|Part 1: Period 3||4
6333091|NCT00531050|7239998|FG004|COMPLETED|Part 1: Period 3||4
6333092|NCT00531050|7239999|FG005|COMPLETED|Part 1: Period 3||5
6333093|NCT00531050|7239994|FG000|NOT COMPLETED|Part 1: Period 3||1
6333094|NCT00531050|7239995|FG001|NOT COMPLETED|Part 1: Period 3||0
6333095|NCT00531050|7239996|FG002|NOT COMPLETED|Part 1: Period 3||0
6333096|NCT00531050|7239997|FG003|NOT COMPLETED|Part 1: Period 3||0
6333097|NCT00531050|7239998|FG004|NOT COMPLETED|Part 1: Period 3||0
6333098|NCT00531050|7239999|FG005|NOT COMPLETED|Part 1: Period 3||0
6333099|NCT00531050|7239994|FG000|STARTED|Part 2: Period 1||3
6333100|NCT00531050|7239995|FG001|STARTED|Part 2: Period 1||4
6333101|NCT00531050|7239996|FG002|STARTED|Part 2: Period 1||4
6333102|NCT00531050|7239997|FG003|STARTED|Part 2: Period 1||4
6333103|NCT00531050|7239998|FG004|STARTED|Part 2: Period 1||4
6333104|NCT00531050|7239999|FG005|STARTED|Part 2: Period 1||5
6333105|NCT00531050|7239994|FG000|COMPLETED|Part 2: Period 1||3
6333106|NCT00531050|7239995|FG001|COMPLETED|Part 2: Period 1||4
6333107|NCT00531050|7239996|FG002|COMPLETED|Part 2: Period 1||4
6333108|NCT00531050|7239997|FG003|COMPLETED|Part 2: Period 1||4
6333109|NCT00531050|7239998|FG004|COMPLETED|Part 2: Period 1||4
6333110|NCT00531050|7239999|FG005|COMPLETED|Part 2: Period 1||4
6333111|NCT00531050|7239994|FG000|NOT COMPLETED|Part 2: Period 1||0
6333112|NCT00531050|7239995|FG001|NOT COMPLETED|Part 2: Period 1||0
6333113|NCT00531050|7239996|FG002|NOT COMPLETED|Part 2: Period 1||0
6333114|NCT00531050|7239997|FG003|NOT COMPLETED|Part 2: Period 1||0
6333115|NCT00531050|7239998|FG004|NOT COMPLETED|Part 2: Period 1||0
6333116|NCT00531050|7239999|FG005|NOT COMPLETED|Part 2: Period 1||1
6333117|NCT00531050|7239994|FG000|STARTED|Part 2: Period 2||3
6333118|NCT00531050|7239995|FG001|STARTED|Part 2: Period 2||4
6333119|NCT00531050|7239996|FG002|STARTED|Part 2: Period 2||4
6333120|NCT00531050|7239997|FG003|STARTED|Part 2: Period 2||4
6333121|NCT00531050|7239998|FG004|STARTED|Part 2: Period 2||4
6333122|NCT00531050|7239999|FG005|STARTED|Part 2: Period 2||4
6333123|NCT00531050|7239994|FG000|COMPLETED|Part 2: Period 2||3
6333124|NCT00531050|7239995|FG001|COMPLETED|Part 2: Period 2||4
6333125|NCT00531050|7239996|FG002|COMPLETED|Part 2: Period 2||4
6333126|NCT00531050|7239997|FG003|COMPLETED|Part 2: Period 2||4
6333127|NCT00531050|7239998|FG004|COMPLETED|Part 2: Period 2||4
6333128|NCT00531050|7239999|FG005|COMPLETED|Part 2: Period 2||4
6333129|NCT00531050|7239994|FG000|NOT COMPLETED|Part 2: Period 2||0
6333130|NCT00531050|7239995|FG001|NOT COMPLETED|Part 2: Period 2||0
6333131|NCT00531050|7239996|FG002|NOT COMPLETED|Part 2: Period 2||0
6333132|NCT00531050|7239997|FG003|NOT COMPLETED|Part 2: Period 2||0
6333133|NCT00531050|7239998|FG004|NOT COMPLETED|Part 2: Period 2||0
6333134|NCT00531050|7239999|FG005|NOT COMPLETED|Part 2: Period 2||0
6333135|NCT00531050|7239994|FG000|STARTED|Part 2: Period 3||3
6333136|NCT00531050|7239995|FG001|STARTED|Part 2: Period 3||4
6333137|NCT00531050|7239996|FG002|STARTED|Part 2: Period 3||4
6333138|NCT00531050|7239997|FG003|STARTED|Part 2: Period 3||4
6333139|NCT00531050|7239998|FG004|STARTED|Part 2: Period 3||4
6333140|NCT00531050|7239999|FG005|STARTED|Part 2: Period 3||4
6333141|NCT00531050|7239994|FG000|COMPLETED|Part 2: Period 3||2
6333142|NCT00531050|7239995|FG001|COMPLETED|Part 2: Period 3||4
6333143|NCT00531050|7239996|FG002|COMPLETED|Part 2: Period 3||4
6333144|NCT00531050|7239997|FG003|COMPLETED|Part 2: Period 3||4
6333145|NCT00531050|7239998|FG004|COMPLETED|Part 2: Period 3||4
6333146|NCT00531050|7239999|FG005|COMPLETED|Part 2: Period 3||3
6333147|NCT00531050|7239994|FG000|NOT COMPLETED|Part 2: Period 3||1
6333148|NCT00531050|7239995|FG001|NOT COMPLETED|Part 2: Period 3||0
6333149|NCT00531050|7239996|FG002|NOT COMPLETED|Part 2: Period 3||0
6333150|NCT00531050|7239997|FG003|NOT COMPLETED|Part 2: Period 3||0
6333151|NCT00531050|7239998|FG004|NOT COMPLETED|Part 2: Period 3||0
6333152|NCT00531050|7239999|FG005|NOT COMPLETED|Part 2: Period 3||1
6333153|NCT00531206|7240016|FG000|STARTED|Overall Study||65
6333154|NCT00531206|7240016|FG000|COMPLETED|Overall Study||45
6333155|NCT00531206|7240016|FG000|NOT COMPLETED|Overall Study||20
6333156|NCT00531284|7240037|FG000|STARTED|Overall Study||3
6333157|NCT00531284|7240038|FG001|STARTED|Overall Study||4
6333158|NCT00531284|7240039|FG002|STARTED|Overall Study||7
6333159|NCT00531284|7240040|FG003|STARTED|Overall Study||65
6333160|NCT00531284|7240041|FG004|STARTED|Overall Study||6
6333161|NCT00531284|7240042|FG005|STARTED|Overall Study||7
6333162|NCT00531284|7240043|FG006|STARTED|Overall Study||6
6333163|NCT00531284|7240044|FG007|STARTED|Overall Study||10
6558770|NCT01777308|7481359|FG000|NOT COMPLETED|Overall Study||14
6333164|NCT00531284|7240045|FG008|STARTED|Overall Study||11
6333165|NCT00531284|7240046|FG009|STARTED|Overall Study||4
6333166|NCT00531284|7240047|FG010|STARTED|Overall Study||3
6333167|NCT00531284|7240048|FG011|STARTED|Overall Study||24
6333168|NCT00531284|7240049|FG012|STARTED|Overall Study||2
6333169|NCT00531284|7240050|FG013|STARTED|Overall Study||3
6333170|NCT00531284|7240051|FG014|STARTED|Overall Study||7
6333171|NCT00531284|7240052|FG015|STARTED|Overall Study||14
6333172|NCT00531284|7240053|FG016|STARTED|Overall Study||8
6333173|NCT00531284|7240037|FG000|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
6333174|NCT00531284|7240038|FG001|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
6377895|NCT00765843|7288576|FG002|STARTED|Overall Study||26
6558771|NCT01777308|7481360|FG001|NOT COMPLETED|Overall Study||3
6558772|NCT01777321|7481369|FG000|STARTED|Overall Study||30
6558773|NCT01777321|7481370|FG001|STARTED|Overall Study||30
6558774|NCT01777321|7481369|FG000|COMPLETED|Overall Study||30
6558775|NCT01777321|7481370|FG001|COMPLETED|Overall Study||29
6333175|NCT00531284|7240039|FG002|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
6333176|NCT00531284|7240040|FG003|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
6333177|NCT00531284|7240041|FG004|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333178|NCT00531284|7240042|FG005|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333179|NCT00531284|7240043|FG006|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333180|NCT00531284|7240044|FG007|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333181|NCT00531284|7240045|FG008|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333182|NCT00531284|7240046|FG009|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333183|NCT00531284|7240047|FG010|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333184|NCT00531284|7240048|FG011|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6775365|NCT03864627|7703309|FG000|NOT COMPLETED|Overall Study||4
6775366|NCT03864627|7703310|FG001|NOT COMPLETED|Overall Study||12
6775367|NCT03861000|7703319|FG000|STARTED|Overall Study||2
6775368|NCT03861000|7703320|FG001|STARTED|Overall Study||1
6775369|NCT03861000|7703319|FG000|COMPLETED|Overall Study||2
6775370|NCT03861000|7703320|FG001|COMPLETED|Overall Study||1
6333185|NCT00531284|7240049|FG012|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333186|NCT00531284|7240050|FG013|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333187|NCT00531284|7240051|FG014|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
6333188|NCT00531284|7240052|FG015|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
6333189|NCT00531284|7240053|FG016|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
6333190|NCT00531284|7240037|FG000|NOT COMPLETED|Overall Study||3
6333191|NCT00531284|7240038|FG001|NOT COMPLETED|Overall Study||4
6333192|NCT00531284|7240039|FG002|NOT COMPLETED|Overall Study||6
6333193|NCT00531284|7240040|FG003|NOT COMPLETED|Overall Study||63
6333194|NCT00531284|7240041|FG004|NOT COMPLETED|Overall Study||6
6333195|NCT00531284|7240042|FG005|NOT COMPLETED|Overall Study||7
6333196|NCT00531284|7240043|FG006|NOT COMPLETED|Overall Study||6
6333197|NCT00531284|7240044|FG007|NOT COMPLETED|Overall Study||10
6333198|NCT00531284|7240045|FG008|NOT COMPLETED|Overall Study||11
6333199|NCT00531284|7240046|FG009|NOT COMPLETED|Overall Study||4
6333200|NCT00531284|7240047|FG010|NOT COMPLETED|Overall Study||3
6333201|NCT00531284|7240048|FG011|NOT COMPLETED|Overall Study||24
6333202|NCT00531284|7240049|FG012|NOT COMPLETED|Overall Study||2
6333203|NCT00531284|7240050|FG013|NOT COMPLETED|Overall Study||3
6333204|NCT00531284|7240051|FG014|NOT COMPLETED|Overall Study||4
6333205|NCT00531284|7240052|FG015|NOT COMPLETED|Overall Study||12
6558776|NCT01777321|7481369|FG000|NOT COMPLETED|Overall Study||0
6558777|NCT01777321|7481370|FG001|NOT COMPLETED|Overall Study||1
6558778|NCT01777334|7481378|FG000|STARTED|Overall Study||454
6558779|NCT01777334|7481379|FG001|STARTED|Overall Study||451
6775371|NCT03861000|7703319|FG000|NOT COMPLETED|Overall Study||0
6775372|NCT03861000|7703320|FG001|NOT COMPLETED|Overall Study||0
6333206|NCT00531284|7240053|FG016|NOT COMPLETED|Overall Study||8
6333207|NCT00531427|7240111|FG000|STARTED|Overall Study||282
6333208|NCT00531427|7240112|FG001|STARTED|Overall Study||285
6333209|NCT00531427|7240111|FG000|COMPLETED|Overall Study||209
6333210|NCT00531427|7240112|FG001|COMPLETED|Overall Study||191
6333211|NCT00531427|7240111|FG000|NOT COMPLETED|Overall Study||73
6775373|NCT03848403|7703325|FG000|STARTED|Period 1 (Day 1)||24
6775374|NCT03848403|7703326|FG001|STARTED|Period 1 (Day 1)||24
6775375|NCT03848403|7703327|FG002|STARTED|Period 1 (Day 1)||22
6775376|NCT03848403|7703325|FG000|Received Intervention|Period 1 (Day 1)||24
6775377|NCT03848403|7703326|FG001|Received Intervention|Period 1 (Day 1)||24
6775378|NCT03848403|7703327|FG002|Received Intervention|Period 1 (Day 1)||22
6775379|NCT03848403|7703325|FG000|COMPLETED|Period 1 (Day 1)||24
6775380|NCT03848403|7703326|FG001|COMPLETED|Period 1 (Day 1)||24
6775381|NCT03848403|7703327|FG002|COMPLETED|Period 1 (Day 1)||22
6775382|NCT03848403|7703325|FG000|NOT COMPLETED|Period 1 (Day 1)||0
6775383|NCT03848403|7703326|FG001|NOT COMPLETED|Period 1 (Day 1)||0
6775384|NCT03848403|7703327|FG002|NOT COMPLETED|Period 1 (Day 1)||0
6333212|NCT00531427|7240112|FG001|NOT COMPLETED|Overall Study||94
6333213|NCT00531453|7240121|FG000|STARTED|Overall Study|02 October 2007|49
6333214|NCT00531453|7240122|FG001|STARTED|Overall Study|02 October 2007|49
6333215|NCT00531453|7240121|FG000|COMPLETED|Overall Study|10 April 2009|49
6333216|NCT00531453|7240122|FG001|COMPLETED|Overall Study|10 April 2009|49
6333217|NCT00531453|7240121|FG000|NOT COMPLETED|Overall Study||0
6558780|NCT01777334|7481378|FG000|COMPLETED|Overall Study||401
6558781|NCT01777334|7481379|FG001|COMPLETED|Overall Study||388
6775385|NCT03848403|7703325|FG000|STARTED|Period 2 (Day 8)||24
6775386|NCT03848403|7703326|FG001|STARTED|Period 2 (Day 8)||24
6333218|NCT00531453|7240122|FG001|NOT COMPLETED|Overall Study||0
6333219|NCT00531479|7240130|FG000|STARTED|Overall Study||230
6333220|NCT00531479|7240131|FG001|STARTED|Overall Study||229
6333221|NCT00531479|7240130|FG000|Treated|Overall Study||228
6333222|NCT00531479|7240131|FG001|Treated|Overall Study||226
6333223|NCT00531479|7240130|FG000|COMPLETED|Overall Study||154
6333224|NCT00531479|7240131|FG001|COMPLETED|Overall Study||146
6333225|NCT00531479|7240130|FG000|NOT COMPLETED|Overall Study||76
6333226|NCT00531479|7240131|FG001|NOT COMPLETED|Overall Study||83
6333227|NCT00531518|7240139|FG000|STARTED|Overall Study||87
6333228|NCT00531518|7240140|FG001|STARTED|Overall Study||205
6333229|NCT00531518|7240139|FG000|COMPLETED|Overall Study||55
6333230|NCT00531518|7240140|FG001|COMPLETED|Overall Study||134
6333231|NCT00531518|7240139|FG000|NOT COMPLETED|Overall Study||32
6333232|NCT00531518|7240140|FG001|NOT COMPLETED|Overall Study||71
6333233|NCT00531661|7240148|FG000|STARTED|6 Months||270
6333234|NCT00531661|7240149|FG001|STARTED|6 Months||280
6333235|NCT00531661|7240148|FG000|COMPLETED|6 Months||244
6333236|NCT00531661|7240149|FG001|COMPLETED|6 Months||254
6333237|NCT00531661|7240148|FG000|NOT COMPLETED|6 Months||26
6333238|NCT00531661|7240149|FG001|NOT COMPLETED|6 Months||26
6333239|NCT00531661|7240148|FG000|STARTED|Study Duration: 15 Months Avg. Follow-up||244
6333240|NCT00531661|7240149|FG001|STARTED|Study Duration: 15 Months Avg. Follow-up||254
6333241|NCT00531661|7240148|FG000|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
6333242|NCT00531661|7240149|FG001|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
6333243|NCT00531661|7240148|FG000|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
6333244|NCT00531661|7240149|FG001|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
6333245|NCT00531752|7240162|FG000|STARTED|First Double-blind Intervention Period||17
6333246|NCT00531752|7240163|FG001|STARTED|First Double-blind Intervention Period||17
6333247|NCT00531752|7240164|FG002|STARTED|First Double-blind Intervention Period||16
6333248|NCT00531752|7240165|FG003|STARTED|First Double-blind Intervention Period||16
6333249|NCT00531752|7240162|FG000|Treated|First Double-blind Intervention Period||16
6333250|NCT00531752|7240163|FG001|Treated|First Double-blind Intervention Period||17
6333251|NCT00531752|7240164|FG002|Treated|First Double-blind Intervention Period||16
6333252|NCT00531752|7240165|FG003|Treated|First Double-blind Intervention Period||16
6333253|NCT00531752|7240162|FG000|COMPLETED|First Double-blind Intervention Period||11
6333254|NCT00531752|7240163|FG001|COMPLETED|First Double-blind Intervention Period||13
6333255|NCT00531752|7240164|FG002|COMPLETED|First Double-blind Intervention Period||9
6333256|NCT00531752|7240165|FG003|COMPLETED|First Double-blind Intervention Period||13
6333257|NCT00531752|7240162|FG000|NOT COMPLETED|First Double-blind Intervention Period||6
6333258|NCT00531752|7240163|FG001|NOT COMPLETED|First Double-blind Intervention Period||4
6333259|NCT00531752|7240164|FG002|NOT COMPLETED|First Double-blind Intervention Period||7
6333260|NCT00531752|7240165|FG003|NOT COMPLETED|First Double-blind Intervention Period||3
6333261|NCT00531752|7240162|FG000|STARTED|Wash-out Period (at Least 7 Days)||11
6333262|NCT00531752|7240163|FG001|STARTED|Wash-out Period (at Least 7 Days)||13
6333263|NCT00531752|7240164|FG002|STARTED|Wash-out Period (at Least 7 Days)||9
6333264|NCT00531752|7240165|FG003|STARTED|Wash-out Period (at Least 7 Days)||13
6333265|NCT00531752|7240162|FG000|COMPLETED|Wash-out Period (at Least 7 Days)||11
6333266|NCT00531752|7240163|FG001|COMPLETED|Wash-out Period (at Least 7 Days)||13
6333267|NCT00531752|7240164|FG002|COMPLETED|Wash-out Period (at Least 7 Days)||9
6333268|NCT00531752|7240165|FG003|COMPLETED|Wash-out Period (at Least 7 Days)||13
6333269|NCT00531752|7240162|FG000|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6333270|NCT00531752|7240163|FG001|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6333271|NCT00531752|7240164|FG002|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6333272|NCT00531752|7240165|FG003|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
6333273|NCT00531752|7240162|FG000|STARTED|Second Double-blind Intervention Period||11
6333274|NCT00531752|7240163|FG001|STARTED|Second Double-blind Intervention Period||13
6333275|NCT00531752|7240164|FG002|STARTED|Second Double-blind Intervention Period||9
6333276|NCT00531752|7240165|FG003|STARTED|Second Double-blind Intervention Period||13
6333277|NCT00531752|7240162|FG000|COMPLETED|Second Double-blind Intervention Period||9
6333278|NCT00531752|7240163|FG001|COMPLETED|Second Double-blind Intervention Period||11
6333279|NCT00531752|7240164|FG002|COMPLETED|Second Double-blind Intervention Period||9
6333280|NCT00531752|7240165|FG003|COMPLETED|Second Double-blind Intervention Period||11
6333281|NCT00531752|7240162|FG000|NOT COMPLETED|Second Double-blind Intervention Period||2
6333282|NCT00531752|7240163|FG001|NOT COMPLETED|Second Double-blind Intervention Period||2
6333283|NCT00531752|7240164|FG002|NOT COMPLETED|Second Double-blind Intervention Period||0
6333284|NCT00531752|7240165|FG003|NOT COMPLETED|Second Double-blind Intervention Period||2
6333285|NCT00531817|7240175|FG000|STARTED|Randomized||412
6333286|NCT00531817|7240176|FG001|STARTED|Randomized||207
6333287|NCT00531817|7240175|FG000|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
6333288|NCT00531817|7240176|FG001|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
6333289|NCT00531817|7240175|FG000|COMPLETED|Randomized||353
6333290|NCT00531817|7240176|FG001|COMPLETED|Randomized||173
6333291|NCT00531817|7240175|FG000|NOT COMPLETED|Randomized||59
6333292|NCT00531817|7240176|FG001|NOT COMPLETED|Randomized||34
6333293|NCT00531817|7240175|FG000|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|343
6376099|NCT00758524|7286576|FG001|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
6333294|NCT00531817|7240176|FG001|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator's discretion.|170
6333295|NCT00531817|7240175|FG000|COMPLETED|Entered Extended Treatment Period||206
6333296|NCT00531817|7240176|FG001|COMPLETED|Entered Extended Treatment Period||113
6333297|NCT00531817|7240175|FG000|NOT COMPLETED|Entered Extended Treatment Period||137
6333298|NCT00531817|7240176|FG001|NOT COMPLETED|Entered Extended Treatment Period||57
6333299|NCT00531843|7240185|FG000|STARTED|Overall Study||81
6333300|NCT00531843|7240186|FG001|STARTED|Overall Study||6
6333301|NCT00531843|7240185|FG000|COMPLETED|Overall Study||81
6333302|NCT00531843|7240186|FG001|COMPLETED|Overall Study||6
6333303|NCT00531843|7240185|FG000|NOT COMPLETED|Overall Study||0
6333304|NCT00531843|7240186|FG001|NOT COMPLETED|Overall Study||0
6333305|NCT00531882|7240195|FG000|STARTED|Overall Study||10
6333306|NCT00531882|7240196|FG001|STARTED|Overall Study||10
6333307|NCT00531882|7240197|FG002|STARTED|Overall Study||5
6333308|NCT00531882|7240195|FG000|COMPLETED|Overall Study||10
6333309|NCT00531882|7240196|FG001|COMPLETED|Overall Study||10
6333310|NCT00531882|7240197|FG002|COMPLETED|Overall Study||5
6333311|NCT00531882|7240195|FG000|NOT COMPLETED|Overall Study||0
6333312|NCT00531882|7240196|FG001|NOT COMPLETED|Overall Study||0
6333313|NCT00531882|7240197|FG002|NOT COMPLETED|Overall Study||0
6333314|NCT00531934|7240207|FG000|STARTED|Overall Study||73
6333315|NCT00531934|7240208|FG001|STARTED|Overall Study||74
6333316|NCT00531934|7240207|FG000|COMPLETED|Overall Study||7
6333317|NCT00531934|7240208|FG001|COMPLETED|Overall Study||11
6333318|NCT00531934|7240207|FG000|NOT COMPLETED|Overall Study||66
6333319|NCT00531934|7240208|FG001|NOT COMPLETED|Overall Study||63
6333320|NCT00531947|7240216|FG000|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
6333321|NCT00531947|7240217|FG001|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
6333322|NCT00531947|7240216|FG000|COMPLETED|Overall Study||114
6333323|NCT00531947|7240217|FG001|COMPLETED|Overall Study||101
6333324|NCT00531947|7240216|FG000|NOT COMPLETED|Overall Study||42
6333325|NCT00531947|7240217|FG001|NOT COMPLETED|Overall Study||51
6333326|NCT00531960|7240225|FG000|STARTED|Overall Study||61
6333327|NCT00531960|7240226|FG001|STARTED|Overall Study||63
6333328|NCT00531960|7240225|FG000|COMPLETED|Overall Study||0
6333329|NCT00531960|7240226|FG001|COMPLETED|Overall Study||0
6333330|NCT00531960|7240225|FG000|NOT COMPLETED|Overall Study||61
6333331|NCT00531960|7240226|FG001|NOT COMPLETED|Overall Study||63
6333332|NCT00532129|7240232|FG000|STARTED|Treatment Period||100
6333333|NCT00532129|7240232|FG000|COMPLETED|Treatment Period||51
6333334|NCT00532129|7240232|FG000|NOT COMPLETED|Treatment Period||49
6333335|NCT00532129|7240232|FG000|STARTED|Follow-up Period||98
6333336|NCT00532129|7240232|FG000|COMPLETED|Follow-up Period||33
6333337|NCT00532129|7240232|FG000|NOT COMPLETED|Follow-up Period||65
6333338|NCT00532155|7240238|FG000|STARTED|Overall Study||457
6333339|NCT00532155|7240239|FG001|STARTED|Overall Study||456
6333340|NCT00532155|7240238|FG000|SAFETY POPULATION|Overall Study||455
6333341|NCT00532155|7240239|FG001|SAFETY POPULATION|Overall Study||450
6333342|NCT00532155|7240238|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
6333343|NCT00532155|7240239|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
6333344|NCT00532155|7240238|FG000|NOT COMPLETED|Overall Study||457
6333345|NCT00532155|7240239|FG001|NOT COMPLETED|Overall Study||456
6333346|NCT00532259|7240245|FG000|STARTED|Overall Study||72
6333347|NCT00532259|7240245|FG000|COMPLETED|Overall Study||40
6333348|NCT00532259|7240245|FG000|NOT COMPLETED|Overall Study||32
6333349|NCT00532298|7240256|FG000|STARTED|Overall Study||269
6333350|NCT00532298|7240257|FG001|STARTED|Overall Study||266
6333351|NCT00532298|7240258|FG002|STARTED|Overall Study||264
6333352|NCT00532298|7240259|FG003|STARTED|Overall Study||264
6333353|NCT00532298|7240260|FG004|STARTED|Overall Study||268
6333354|NCT00532298|7240261|FG005|STARTED|Overall Study||263
6333355|NCT00532298|7240256|FG000|COMPLETED|Overall Study||267
6333356|NCT00532298|7240257|FG001|COMPLETED|Overall Study||265
6333357|NCT00532298|7240258|FG002|COMPLETED|Overall Study||263
6775387|NCT03848403|7703327|FG002|STARTED|Period 2 (Day 8)||22
6775388|NCT03848403|7703325|FG000|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
6333358|NCT00532298|7240259|FG003|COMPLETED|Overall Study||264
6333359|NCT00532298|7240260|FG004|COMPLETED|Overall Study||267
6333360|NCT00532298|7240261|FG005|COMPLETED|Overall Study||261
6333361|NCT00532298|7240256|FG000|NOT COMPLETED|Overall Study||2
6333362|NCT00532298|7240257|FG001|NOT COMPLETED|Overall Study||1
6333363|NCT00532298|7240258|FG002|NOT COMPLETED|Overall Study||1
6333364|NCT00532298|7240259|FG003|NOT COMPLETED|Overall Study||0
6333365|NCT00532298|7240260|FG004|NOT COMPLETED|Overall Study||1
6333366|NCT00532298|7240261|FG005|NOT COMPLETED|Overall Study||2
6333367|NCT00532441|7240275|FG000|STARTED|Overall Study||14
6333368|NCT00532441|7240276|FG001|STARTED|Overall Study||11
6333369|NCT00532441|7240275|FG000|COMPLETED|Overall Study||13
6333370|NCT00532441|7240276|FG001|COMPLETED|Overall Study||11
6333371|NCT00532441|7240275|FG000|NOT COMPLETED|Overall Study||1
6333372|NCT00532441|7240276|FG001|NOT COMPLETED|Overall Study||0
6333373|NCT00532480|7240285|FG000|STARTED|Overall Study||10
6333374|NCT00532480|7240285|FG000|COMPLETED|Overall Study||7
6333375|NCT00532480|7240285|FG000|NOT COMPLETED|Overall Study||3
6333376|NCT00532493|7240291|FG000|STARTED|Overall Study||152
6333377|NCT00532493|7240292|FG001|STARTED|Overall Study||152
6333378|NCT00532493|7240291|FG000|COMPLETED|Overall Study||122
6333379|NCT00532493|7240292|FG001|COMPLETED|Overall Study||123
6333380|NCT00532493|7240291|FG000|NOT COMPLETED|Overall Study||30
6333381|NCT00532493|7240292|FG001|NOT COMPLETED|Overall Study||29
6333382|NCT00532779|7240303|FG000|STARTED|Overall Study||578
6333383|NCT00532779|7240304|FG001|STARTED|Overall Study||583
6333384|NCT00532779|7240305|FG002|STARTED|Overall Study||581
6333385|NCT00532779|7240303|FG000|COMPLETED|Overall Study||284
6333386|NCT00532779|7240304|FG001|COMPLETED|Overall Study||296
6333387|NCT00532779|7240305|FG002|COMPLETED|Overall Study||290
6333388|NCT00532779|7240303|FG000|NOT COMPLETED|Overall Study||294
6333389|NCT00532779|7240304|FG001|NOT COMPLETED|Overall Study||287
6333390|NCT00532779|7240305|FG002|NOT COMPLETED|Overall Study||291
6333391|NCT00532844|7240315|FG000|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
6558782|NCT01777334|7481378|FG000|NOT COMPLETED|Overall Study||53
6558783|NCT01777334|7481379|FG001|NOT COMPLETED|Overall Study||63
6558784|NCT01777412|7481385|FG000|STARTED|Overall Study||10
6558785|NCT01777412|7481385|FG000|COMPLETED|Overall Study||10
6558786|NCT01777412|7481385|FG000|NOT COMPLETED|Overall Study||0
6558787|NCT01777425|7481389|FG000|STARTED|Overall Study||389
6558788|NCT01777425|7481389|FG000|COMPLETED|Overall Study||389
6333392|NCT00532844|7240316|FG001|STARTED|Treatment Period - Day 1 to Day 14|Only the 48 subjects enrolled in the final protocol are included in the participant flow.|24
6333393|NCT00532844|7240315|FG000|COMPLETED|Treatment Period - Day 1 to Day 14||24
6333394|NCT00532844|7240316|FG001|COMPLETED|Treatment Period - Day 1 to Day 14||23
6333395|NCT00532844|7240315|FG000|NOT COMPLETED|Treatment Period - Day 1 to Day 14||0
6333396|NCT00532844|7240316|FG001|NOT COMPLETED|Treatment Period - Day 1 to Day 14||1
6333397|NCT00532844|7240315|FG000|STARTED|Washout (1 Day)||24
6333398|NCT00532844|7240316|FG001|STARTED|Washout (1 Day)||23
6333399|NCT00532844|7240315|FG000|COMPLETED|Washout (1 Day)||24
6333400|NCT00532844|7240316|FG001|COMPLETED|Washout (1 Day)||23
6333401|NCT00532844|7240315|FG000|NOT COMPLETED|Washout (1 Day)||0
6333402|NCT00532844|7240316|FG001|NOT COMPLETED|Washout (1 Day)||0
6333403|NCT00532844|7240315|FG000|STARTED|Treatment Period - Day 15 to Day 28||24
6333404|NCT00532844|7240316|FG001|STARTED|Treatment Period - Day 15 to Day 28||23
6333405|NCT00532844|7240315|FG000|COMPLETED|Treatment Period - Day 15 to Day 28||20
6333406|NCT00532844|7240316|FG001|COMPLETED|Treatment Period - Day 15 to Day 28||23
6333407|NCT00532844|7240315|FG000|NOT COMPLETED|Treatment Period - Day 15 to Day 28||4
6333408|NCT00532844|7240316|FG001|NOT COMPLETED|Treatment Period - Day 15 to Day 28||0
6333409|NCT00532883|7240339|FG000|STARTED|Overall Study||11
6333410|NCT00532883|7240340|FG001|STARTED|Overall Study||12
6333411|NCT00532883|7240341|FG002|STARTED|Overall Study||10
6333412|NCT00532883|7240342|FG003|STARTED|Overall Study||11
6333413|NCT00532883|7240339|FG000|COMPLETED|Overall Study|Study terminated early.|5
6333414|NCT00532883|7240340|FG001|COMPLETED|Overall Study|Study terminated early.|5
6333415|NCT00532883|7240341|FG002|COMPLETED|Overall Study|Study terminated early.|6
6333416|NCT00532883|7240342|FG003|COMPLETED|Overall Study|Study terminated early.|6
6333417|NCT00532883|7240339|FG000|NOT COMPLETED|Overall Study||6
6333418|NCT00532883|7240340|FG001|NOT COMPLETED|Overall Study||7
6333419|NCT00532883|7240341|FG002|NOT COMPLETED|Overall Study||4
6333420|NCT00532883|7240342|FG003|NOT COMPLETED|Overall Study||5
6333421|NCT00532935|7240354|FG000|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
6333422|NCT00532935|7240355|FG001|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
6333423|NCT00532935|7240354|FG000|COMPLETED|Overall Study||210
6333424|NCT00532935|7240355|FG001|COMPLETED|Overall Study||204
6333425|NCT00532935|7240354|FG000|NOT COMPLETED|Overall Study||51
6333426|NCT00532935|7240355|FG001|NOT COMPLETED|Overall Study||52
6333427|NCT00532948|7240364|FG000|STARTED|Overall Study||4
6333428|NCT00532948|7240365|FG001|STARTED|Overall Study||14
6333429|NCT00532948|7240366|FG002|STARTED|Overall Study||6
6333430|NCT00532948|7240364|FG000|COMPLETED|Overall Study||0
6333431|NCT00532948|7240365|FG001|COMPLETED|Overall Study||9
6333432|NCT00532948|7240366|FG002|COMPLETED|Overall Study||2
6333433|NCT00532948|7240364|FG000|NOT COMPLETED|Overall Study||4
6333434|NCT00532948|7240365|FG001|NOT COMPLETED|Overall Study||5
6333435|NCT00532948|7240366|FG002|NOT COMPLETED|Overall Study||4
6333436|NCT00533117|7240382|FG000|STARTED|Overall Study||18
6333437|NCT00533117|7240383|FG001|STARTED|Overall Study||19
6333438|NCT00533117|7240384|FG002|STARTED|Overall Study||20
6333439|NCT00533117|7240385|FG003|STARTED|Overall Study||18
6333440|NCT00533117|7240382|FG000|COMPLETED|Overall Study||14
6333441|NCT00533117|7240383|FG001|COMPLETED|Overall Study||14
6558789|NCT01777425|7481389|FG000|NOT COMPLETED|Overall Study||0
6333442|NCT00533117|7240384|FG002|COMPLETED|Overall Study||14
6333443|NCT00533117|7240385|FG003|COMPLETED|Overall Study||13
6333444|NCT00533117|7240382|FG000|NOT COMPLETED|Overall Study||4
6333445|NCT00533117|7240383|FG001|NOT COMPLETED|Overall Study||5
6333446|NCT00533117|7240384|FG002|NOT COMPLETED|Overall Study||6
6333447|NCT00533117|7240385|FG003|NOT COMPLETED|Overall Study||5
6333448|NCT00533273|7240397|FG000|STARTED|Double-blind||45
6333449|NCT00533273|7240398|FG001|STARTED|Double-blind||21
6333450|NCT00533273|7240397|FG000|COMPLETED|Double-blind||45
6333451|NCT00533273|7240398|FG001|COMPLETED|Double-blind||19
6333452|NCT00533273|7240397|FG000|NOT COMPLETED|Double-blind||0
6333453|NCT00533273|7240398|FG001|NOT COMPLETED|Double-blind||2
6558790|NCT01777438|7481396|FG000|STARTED|Overall Study||352
6558791|NCT01777438|7481397|FG001|STARTED|Overall Study||82
6333454|NCT00533273|7240397|FG000|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
6333455|NCT00533273|7240398|FG001|STARTED|Open-label|no placebo - this phase was open label|0
6333456|NCT00533273|7240397|FG000|COMPLETED|Open-label||58
6333457|NCT00533273|7240398|FG001|COMPLETED|Open-label||0
6333458|NCT00533273|7240397|FG000|NOT COMPLETED|Open-label||6
6333459|NCT00533273|7240398|FG001|NOT COMPLETED|Open-label||0
6333460|NCT00533429|7240406|FG000|STARTED|Overall Study||20
6333461|NCT00533429|7240407|FG001|STARTED|Overall Study||20
6333462|NCT00533429|7240406|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
6333463|NCT00533429|7240407|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
6333464|NCT00533429|7240406|FG000|Entered Maintenance|Overall Study||8
6333465|NCT00533429|7240407|FG001|Entered Maintenance|Overall Study||10
6333466|NCT00533429|7240406|FG000|COMPLETED|Overall Study||1
6333467|NCT00533429|7240407|FG001|COMPLETED|Overall Study||4
6333468|NCT00533429|7240406|FG000|NOT COMPLETED|Overall Study||19
6333469|NCT00533429|7240407|FG001|NOT COMPLETED|Overall Study||16
6333470|NCT00533442|7240417|FG000|STARTED|Allocation and Intent to Treat Analysis||86
6333471|NCT00533442|7240418|FG001|STARTED|Allocation and Intent to Treat Analysis||84
6333472|NCT00533442|7240417|FG000|COMPLETED|Allocation and Intent to Treat Analysis||86
6333473|NCT00533442|7240418|FG001|COMPLETED|Allocation and Intent to Treat Analysis||84
6333474|NCT00533442|7240417|FG000|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
6333475|NCT00533442|7240418|FG001|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
6333476|NCT00533442|7240417|FG000|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
6333477|NCT00533442|7240418|FG001|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
6333478|NCT00533442|7240417|FG000|COMPLETED|Follow-up||77
6333479|NCT00533442|7240418|FG001|COMPLETED|Follow-up||74
6333480|NCT00533442|7240417|FG000|NOT COMPLETED|Follow-up||9
6333481|NCT00533442|7240418|FG001|NOT COMPLETED|Follow-up||10
6333482|NCT00533507|7240426|FG000|STARTED|Overall Study||230
6333483|NCT00533507|7240426|FG000|COMPLETED|Overall Study||229
6333484|NCT00533507|7240426|FG000|NOT COMPLETED|Overall Study||1
6333485|NCT00533546|7240430|FG000|STARTED|Overall Study||12
6333486|NCT00533546|7240430|FG000|COMPLETED|Overall Study||12
6333487|NCT00533546|7240430|FG000|NOT COMPLETED|Overall Study||0
6333488|NCT00533702|7240437|FG000|STARTED|Overall Study||54
6333489|NCT00533702|7240438|FG001|STARTED|Overall Study||52
6333490|NCT00533702|7240437|FG000|Received Any Quantity of Study Drug|Overall Study||52
6333491|NCT00533702|7240438|FG001|Received Any Quantity of Study Drug|Overall Study||50
6333492|NCT00533702|7240437|FG000|COMPLETED|Overall Study||49
6333493|NCT00533702|7240438|FG001|COMPLETED|Overall Study||50
6333494|NCT00533702|7240437|FG000|NOT COMPLETED|Overall Study||5
6333495|NCT00533702|7240438|FG001|NOT COMPLETED|Overall Study||2
6333496|NCT00533845|7240446|FG000|STARTED|Overall Study||15
6333497|NCT00533845|7240447|FG001|STARTED|Overall Study||15
6333498|NCT00533845|7240446|FG000|COMPLETED|Overall Study||14
6333499|NCT00533845|7240447|FG001|COMPLETED|Overall Study||15
6333500|NCT00533845|7240446|FG000|NOT COMPLETED|Overall Study||1
6333501|NCT00533845|7240447|FG001|NOT COMPLETED|Overall Study||0
6333502|NCT00533897|7240456|FG000|STARTED|Lead-in (LI) Period 1||167
6333503|NCT00533897|7240457|FG001|STARTED|Lead-in (LI) Period 1||0
6333504|NCT00533897|7240458|FG002|STARTED|Lead-in (LI) Period 1||0
6333505|NCT00533897|7240459|FG003|STARTED|Lead-in (LI) Period 1||0
6333506|NCT00533897|7240460|FG004|STARTED|Lead-in (LI) Period 1||0
6333507|NCT00533897|7240461|FG005|STARTED|Lead-in (LI) Period 1||0
6333508|NCT00533897|7240462|FG006|STARTED|Lead-in (LI) Period 1||0
6333509|NCT00533897|7240463|FG007|STARTED|Lead-in (LI) Period 1||0
6333510|NCT00533897|7240456|FG000|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
6333511|NCT00533897|7240457|FG001|COMPLETED|Lead-in (LI) Period 1||0
6333512|NCT00533897|7240458|FG002|COMPLETED|Lead-in (LI) Period 1||0
6333513|NCT00533897|7240459|FG003|COMPLETED|Lead-in (LI) Period 1||0
6333514|NCT00533897|7240460|FG004|COMPLETED|Lead-in (LI) Period 1||0
6333515|NCT00533897|7240461|FG005|COMPLETED|Lead-in (LI) Period 1||0
6333516|NCT00533897|7240462|FG006|COMPLETED|Lead-in (LI) Period 1||0
6333517|NCT00533897|7240463|FG007|COMPLETED|Lead-in (LI) Period 1||0
6333518|NCT00533897|7240456|FG000|NOT COMPLETED|Lead-in (LI) Period 1||10
6333519|NCT00533897|7240457|FG001|NOT COMPLETED|Lead-in (LI) Period 1||0
6333520|NCT00533897|7240458|FG002|NOT COMPLETED|Lead-in (LI) Period 1||0
6333521|NCT00533897|7240459|FG003|NOT COMPLETED|Lead-in (LI) Period 1||0
6333522|NCT00533897|7240460|FG004|NOT COMPLETED|Lead-in (LI) Period 1||0
6333523|NCT00533897|7240461|FG005|NOT COMPLETED|Lead-in (LI) Period 1||0
6333524|NCT00533897|7240462|FG006|NOT COMPLETED|Lead-in (LI) Period 1||0
6333525|NCT00533897|7240463|FG007|NOT COMPLETED|Lead-in (LI) Period 1||0
6333526|NCT00533897|7240456|FG000|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6333527|NCT00533897|7240457|FG001|STARTED|Double-blind Withdrawal (DBW) Period 2||40
6333528|NCT00533897|7240458|FG002|STARTED|Double-blind Withdrawal (DBW) Period 2||80
6333529|NCT00533897|7240459|FG003|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6333530|NCT00533897|7240460|FG004|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6333531|NCT00533897|7240461|FG005|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6333532|NCT00533897|7240462|FG006|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6333533|NCT00533897|7240463|FG007|STARTED|Double-blind Withdrawal (DBW) Period 2||0
6333534|NCT00533897|7240456|FG000|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6377896|NCT00765843|7288574|FG000|COMPLETED|Overall Study||25
6333535|NCT00533897|7240457|FG001|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
6333536|NCT00533897|7240458|FG002|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
6333537|NCT00533897|7240459|FG003|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333538|NCT00533897|7240460|FG004|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333539|NCT00533897|7240461|FG005|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333540|NCT00533897|7240462|FG006|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333541|NCT00533897|7240463|FG007|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333542|NCT00533897|7240456|FG000|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333543|NCT00533897|7240457|FG001|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
6333544|NCT00533897|7240458|FG002|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
6333545|NCT00533897|7240459|FG003|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333546|NCT00533897|7240460|FG004|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333547|NCT00533897|7240461|FG005|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333548|NCT00533897|7240462|FG006|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333549|NCT00533897|7240463|FG007|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
6333550|NCT00533897|7240456|FG000|STARTED|Re-introduction (RI) Period 3||0
6333551|NCT00533897|7240457|FG001|STARTED|Re-introduction (RI) Period 3||0
6333552|NCT00533897|7240458|FG002|STARTED|Re-introduction (RI) Period 3||0
6333553|NCT00533897|7240459|FG003|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
6333554|NCT00533897|7240460|FG004|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
6333555|NCT00533897|7240461|FG005|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
6333556|NCT00533897|7240462|FG006|STARTED|Re-introduction (RI) Period 3||0
6333557|NCT00533897|7240463|FG007|STARTED|Re-introduction (RI) Period 3||0
6333558|NCT00533897|7240456|FG000|COMPLETED|Re-introduction (RI) Period 3||0
6333559|NCT00533897|7240457|FG001|COMPLETED|Re-introduction (RI) Period 3||0
6333560|NCT00533897|7240458|FG002|COMPLETED|Re-introduction (RI) Period 3||0
6333561|NCT00533897|7240459|FG003|COMPLETED|Re-introduction (RI) Period 3||40
6333562|NCT00533897|7240460|FG004|COMPLETED|Re-introduction (RI) Period 3||35
6333563|NCT00533897|7240461|FG005|COMPLETED|Re-introduction (RI) Period 3||42
6333564|NCT00533897|7240462|FG006|COMPLETED|Re-introduction (RI) Period 3||0
6333565|NCT00533897|7240463|FG007|COMPLETED|Re-introduction (RI) Period 3||0
6333566|NCT00533897|7240456|FG000|NOT COMPLETED|Re-introduction (RI) Period 3||0
6333567|NCT00533897|7240457|FG001|NOT COMPLETED|Re-introduction (RI) Period 3||0
6333568|NCT00533897|7240458|FG002|NOT COMPLETED|Re-introduction (RI) Period 3||0
6333569|NCT00533897|7240459|FG003|NOT COMPLETED|Re-introduction (RI) Period 3||0
6333570|NCT00533897|7240460|FG004|NOT COMPLETED|Re-introduction (RI) Period 3||0
6333571|NCT00533897|7240461|FG005|NOT COMPLETED|Re-introduction (RI) Period 3||2
6333572|NCT00533897|7240462|FG006|NOT COMPLETED|Re-introduction (RI) Period 3||0
6333573|NCT00533897|7240463|FG007|NOT COMPLETED|Re-introduction (RI) Period 3||0
6333574|NCT00533897|7240456|FG000|STARTED|Long Term Extension (LTE)||0
6333575|NCT00533897|7240457|FG001|STARTED|Long Term Extension (LTE)||0
6333576|NCT00533897|7240458|FG002|STARTED|Long Term Extension (LTE)||0
6333577|NCT00533897|7240459|FG003|STARTED|Long Term Extension (LTE)||0
6333578|NCT00533897|7240460|FG004|STARTED|Long Term Extension (LTE)||0
6333579|NCT00533897|7240461|FG005|STARTED|Long Term Extension (LTE)||0
6333580|NCT00533897|7240462|FG006|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
6333581|NCT00533897|7240463|FG007|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
6333582|NCT00533897|7240456|FG000|COMPLETED|Long Term Extension (LTE)||0
6333583|NCT00533897|7240457|FG001|COMPLETED|Long Term Extension (LTE)||0
6333584|NCT00533897|7240458|FG002|COMPLETED|Long Term Extension (LTE)||0
6333585|NCT00533897|7240459|FG003|COMPLETED|Long Term Extension (LTE)||0
6333586|NCT00533897|7240460|FG004|COMPLETED|Long Term Extension (LTE)||0
6333587|NCT00533897|7240461|FG005|COMPLETED|Long Term Extension (LTE)||0
6333588|NCT00533897|7240462|FG006|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
6333589|NCT00533897|7240463|FG007|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
6333590|NCT00533897|7240456|FG000|NOT COMPLETED|Long Term Extension (LTE)||0
6333591|NCT00533897|7240457|FG001|NOT COMPLETED|Long Term Extension (LTE)||0
6558792|NCT01777438|7481396|FG000|COMPLETED|Overall Study||352
6558793|NCT01777438|7481397|FG001|COMPLETED|Overall Study||82
6558794|NCT01777438|7481396|FG000|NOT COMPLETED|Overall Study||0
6333592|NCT00533897|7240458|FG002|NOT COMPLETED|Long Term Extension (LTE)||0
6558795|NCT01777438|7481397|FG001|NOT COMPLETED|Overall Study||0
6558796|NCT01777490|7481407|FG000|STARTED|Overall Study||123
6558797|NCT01777490|7481408|FG001|STARTED|Overall Study||123
6558798|NCT01777490|7481409|FG002|STARTED|Overall Study||119
6558799|NCT01777490|7481410|FG003|STARTED|Overall Study||119
6558800|NCT01777490|7481407|FG000|COMPLETED|Overall Study||123
6558801|NCT01777490|7481408|FG001|COMPLETED|Overall Study||123
6558802|NCT01777490|7481409|FG002|COMPLETED|Overall Study||118
6558803|NCT01777490|7481410|FG003|COMPLETED|Overall Study||118
6558804|NCT01777490|7481407|FG000|NOT COMPLETED|Overall Study||0
6558805|NCT01777490|7481408|FG001|NOT COMPLETED|Overall Study||0
6558806|NCT01777490|7481409|FG002|NOT COMPLETED|Overall Study||1
6558807|NCT01777490|7481410|FG003|NOT COMPLETED|Overall Study||1
6558808|NCT01777542|7481422|FG000|STARTED|First Intervention (20 Weeks)||15
6558809|NCT01777542|7481423|FG001|STARTED|First Intervention (20 Weeks)||15
6558810|NCT01777542|7481422|FG000|COMPLETED|First Intervention (20 Weeks)||15
6558811|NCT01777542|7481423|FG001|COMPLETED|First Intervention (20 Weeks)||15
6558812|NCT01777542|7481422|FG000|NOT COMPLETED|First Intervention (20 Weeks)||0
6333593|NCT00533897|7240459|FG003|NOT COMPLETED|Long Term Extension (LTE)||0
6333594|NCT00533897|7240460|FG004|NOT COMPLETED|Long Term Extension (LTE)||0
6333595|NCT00533897|7240461|FG005|NOT COMPLETED|Long Term Extension (LTE)||0
6333596|NCT00533897|7240462|FG006|NOT COMPLETED|Long Term Extension (LTE)||13
6333597|NCT00533897|7240463|FG007|NOT COMPLETED|Long Term Extension (LTE)||25
6333598|NCT00533910|7240496|FG000|STARTED|Overall Study||21
6333599|NCT00533910|7240497|FG001|STARTED|Overall Study||21
6333600|NCT00533910|7240496|FG000|COMPLETED|Overall Study||21
6333601|NCT00533910|7240497|FG001|COMPLETED|Overall Study||21
6333602|NCT00533910|7240496|FG000|NOT COMPLETED|Overall Study||0
6333603|NCT00533910|7240497|FG001|NOT COMPLETED|Overall Study||0
6333604|NCT00533949|7240507|FG000|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
6333605|NCT00533949|7240508|FG001|STARTED|Overall Study||121
6333606|NCT00533949|7240509|FG002|STARTED|Overall Study||147
6333607|NCT00533949|7240510|FG003|STARTED|Overall Study||110
6333608|NCT00533949|7240507|FG000|COMPLETED|Overall Study||151
6333609|NCT00533949|7240508|FG001|COMPLETED|Overall Study||107
6333610|NCT00533949|7240509|FG002|COMPLETED|Overall Study||137
6333611|NCT00533949|7240510|FG003|COMPLETED|Overall Study||100
6333612|NCT00533949|7240507|FG000|NOT COMPLETED|Overall Study||15
6333613|NCT00533949|7240508|FG001|NOT COMPLETED|Overall Study||14
6333614|NCT00533949|7240509|FG002|NOT COMPLETED|Overall Study||10
6333615|NCT00533949|7240510|FG003|NOT COMPLETED|Overall Study||10
6333616|NCT00534001|7240530|FG000|STARTED|Overall Study||48
6333617|NCT00534001|7240531|FG001|STARTED|Overall Study||47
6333618|NCT00534001|7240530|FG000|COMPLETED|Overall Study||43
6333619|NCT00534001|7240531|FG001|COMPLETED|Overall Study||43
6333620|NCT00534001|7240530|FG000|NOT COMPLETED|Overall Study||5
6333621|NCT00534001|7240531|FG001|NOT COMPLETED|Overall Study||4
6333622|NCT00534092|7240539|FG000|STARTED|Overall Study||55
6333623|NCT00534092|7240540|FG001|STARTED|Overall Study||14
6333624|NCT00534092|7240539|FG000|COMPLETED|Overall Study||53
6333625|NCT00534092|7240540|FG001|COMPLETED|Overall Study||14
6333626|NCT00534092|7240539|FG000|NOT COMPLETED|Overall Study||2
6333627|NCT00534092|7240540|FG001|NOT COMPLETED|Overall Study||0
6333628|NCT00534105|7240550|FG000|STARTED|Overall Study||47
6333629|NCT00534105|7240551|FG001|STARTED|Overall Study||59
6333630|NCT00534105|7240550|FG000|COMPLETED|Overall Study||24
6333631|NCT00534105|7240551|FG001|COMPLETED|Overall Study||20
6333632|NCT00534105|7240550|FG000|NOT COMPLETED|Overall Study||23
6333633|NCT00534105|7240551|FG001|NOT COMPLETED|Overall Study||39
6333634|NCT00534118|7240559|FG000|STARTED|Overall Study||17
6333635|NCT00534118|7240560|FG001|STARTED|Overall Study||22
6333636|NCT00534118|7240559|FG000|COMPLETED|Overall Study||17
6333637|NCT00534118|7240560|FG001|COMPLETED|Overall Study||22
6333638|NCT00534118|7240559|FG000|NOT COMPLETED|Overall Study||0
6333639|NCT00534118|7240560|FG001|NOT COMPLETED|Overall Study||0
6333640|NCT00534209|7240568|FG000|STARTED|Overall Study||1
6333641|NCT00534209|7240568|FG000|COMPLETED|Overall Study||1
6333642|NCT00534209|7240568|FG000|NOT COMPLETED|Overall Study||0
6333643|NCT00534235|7240576|FG000|STARTED|Overall Study||107
6333644|NCT00534235|7240577|FG001|STARTED|Overall Study||215
6333645|NCT00534235|7240576|FG000|COMPLETED|Overall Study||91
6333646|NCT00534235|7240577|FG001|COMPLETED|Overall Study||192
6333647|NCT00534235|7240576|FG000|NOT COMPLETED|Overall Study||16
6333648|NCT00534235|7240577|FG001|NOT COMPLETED|Overall Study||23
6333649|NCT00534248|7240586|FG000|STARTED|Overall Study||11211
6333650|NCT00534248|7240587|FG001|STARTED|Overall Study||11228
6333651|NCT00534248|7240586|FG000|VACCINATED|Overall Study||11186
6333652|NCT00534248|7240587|FG001|VACCINATED|Overall Study||11210
6333653|NCT00534248|7240586|FG000|COMPLETED|Overall Study||10550
6333654|NCT00534248|7240587|FG001|COMPLETED|Overall Study||10555
6333655|NCT00534248|7240586|FG000|NOT COMPLETED|Overall Study||661
6333656|NCT00534248|7240587|FG001|NOT COMPLETED|Overall Study||673
6333657|NCT00534313|7240597|FG000|STARTED|Short-term Period||43
6333658|NCT00534313|7240598|FG001|STARTED|Short-term Period||40
6333659|NCT00534313|7240599|FG002|STARTED|Short-term Period||45
6333660|NCT00534313|7240600|FG003|STARTED|Short-term Period||42
6333661|NCT00534313|7240597|FG000|COMPLETED|Short-term Period|Completed the short-term study|37
6333662|NCT00534313|7240598|FG001|COMPLETED|Short-term Period|Completed the short-term study|34
6333663|NCT00534313|7240599|FG002|COMPLETED|Short-term Period|Completed the short-term study|43
6333664|NCT00534313|7240600|FG003|COMPLETED|Short-term Period|Completed the short-term study|33
6333665|NCT00534313|7240597|FG000|NOT COMPLETED|Short-term Period||6
6333666|NCT00534313|7240598|FG001|NOT COMPLETED|Short-term Period||6
6333667|NCT00534313|7240599|FG002|NOT COMPLETED|Short-term Period||2
6333668|NCT00534313|7240600|FG003|NOT COMPLETED|Short-term Period||9
6333669|NCT00534313|7240597|FG000|STARTED|Long-term Period||37
6333670|NCT00534313|7240598|FG001|STARTED|Long-term Period||34
6333671|NCT00534313|7240599|FG002|STARTED|Long-term Period||43
6333672|NCT00534313|7240600|FG003|STARTED|Long-term Period||33
6558813|NCT01777542|7481423|FG001|NOT COMPLETED|First Intervention (20 Weeks)||0
6333673|NCT00534313|7240597|FG000|COMPLETED|Long-term Period||0
6333674|NCT00534313|7240598|FG001|COMPLETED|Long-term Period||0
6333675|NCT00534313|7240599|FG002|COMPLETED|Long-term Period||0
6333676|NCT00534313|7240600|FG003|COMPLETED|Long-term Period||0
6333677|NCT00534313|7240597|FG000|NOT COMPLETED|Long-term Period||37
6333678|NCT00534313|7240598|FG001|NOT COMPLETED|Long-term Period||34
6333679|NCT00534313|7240599|FG002|NOT COMPLETED|Long-term Period||43
6333680|NCT00534313|7240600|FG003|NOT COMPLETED|Long-term Period||33
6333681|NCT00534352|7240645|FG000|STARTED|Treatment A: TMC125 + TDF/FTC||23
6333682|NCT00534352|7240645|FG000|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
6333683|NCT00534352|7240645|FG000|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
6333684|NCT00534352|7240645|FG000|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
6333685|NCT00534352|7240645|FG000|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
6333686|NCT00534352|7240645|FG000|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
6333687|NCT00534352|7240645|FG000|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
6333688|NCT00534352|7240645|FG000|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
6333689|NCT00534352|7240645|FG000|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
6333690|NCT00534352|7240645|FG000|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
6333691|NCT00534352|7240645|FG000|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
6333692|NCT00534352|7240645|FG000|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
6333693|NCT00534365|7240660|FG000|STARTED|Overall Study||127
6333694|NCT00534365|7240661|FG001|STARTED|Overall Study||136
6333695|NCT00534365|7240660|FG000|Received Procedure|Overall Study||127
6333696|NCT00534365|7240661|FG001|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
6333697|NCT00534365|7240660|FG000|Any Follow up|Overall Study||126
6333698|NCT00534365|7240661|FG001|Any Follow up|Overall Study||135
6333699|NCT00534365|7240660|FG000|Follow up at 12 Months or More|Overall Study||119
6333700|NCT00534365|7240661|FG001|Follow up at 12 Months or More|Overall Study||128
6333701|NCT00534365|7240660|FG000|Included in Intent to Treat Analysis|Overall Study||127
6333702|NCT00534365|7240661|FG001|Included in Intent to Treat Analysis|Overall Study||136
6333703|NCT00534365|7240660|FG000|COMPLETED|Overall Study||127
6333704|NCT00534365|7240661|FG001|COMPLETED|Overall Study||129
6333705|NCT00534365|7240660|FG000|NOT COMPLETED|Overall Study||0
6333706|NCT00534365|7240661|FG001|NOT COMPLETED|Overall Study||7
6333707|NCT00534404|7240672|FG000|STARTED|Overall Study||827
6333708|NCT00534404|7240673|FG001|STARTED|Overall Study||830
6333709|NCT00534404|7240674|FG002|STARTED|Overall Study||828
6333710|NCT00534404|7240672|FG000|Completed at Least 1 Online Session|Overall Study||781
6333711|NCT00534404|7240673|FG001|Completed at Least 1 Online Session|Overall Study||813
6333712|NCT00534404|7240674|FG002|Completed at Least 1 Online Session|Overall Study||658
6333713|NCT00534404|7240672|FG000|Completed First NRT Order|Overall Study||765
6333714|NCT00534404|7240673|FG001|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
6333715|NCT00534404|7240674|FG002|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
6333716|NCT00534404|7240672|FG000|Completed Second NRT Order|Overall Study||640
6333717|NCT00534404|7240673|FG001|Completed Second NRT Order|Overall Study||789
6333718|NCT00534404|7240674|FG002|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
6333719|NCT00534404|7240672|FG000|Completed at Least 1 Counseling Call|Overall Study||813
6333720|NCT00534404|7240673|FG001|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
6333721|NCT00534404|7240674|FG002|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
6333722|NCT00534404|7240672|FG000|1-month Follow up Completed|Overall Study||742
6333723|NCT00534404|7240673|FG001|1-month Follow up Completed|Overall Study||781
6333724|NCT00534404|7240674|FG002|1-month Follow up Completed|Overall Study||626
6333725|NCT00534404|7240672|FG000|3-month Follow up Completed|Overall Study||682
6333726|NCT00534404|7240673|FG001|3-month Follow up Completed|Overall Study||731
6333727|NCT00534404|7240674|FG002|3-month Follow up Completed|Overall Study||593
6333728|NCT00534404|7240672|FG000|COMPLETED|Overall Study||647
6333729|NCT00534404|7240673|FG001|COMPLETED|Overall Study||687
6333730|NCT00534404|7240674|FG002|COMPLETED|Overall Study||586
6333731|NCT00534404|7240672|FG000|NOT COMPLETED|Overall Study||180
6333732|NCT00534404|7240673|FG001|NOT COMPLETED|Overall Study||143
6333733|NCT00534404|7240674|FG002|NOT COMPLETED|Overall Study||242
6333734|NCT00534417|7240682|FG000|STARTED|Overall Study||41
6333735|NCT00534417|7240682|FG000|COMPLETED|Overall Study||41
6333736|NCT00534417|7240682|FG000|NOT COMPLETED|Overall Study||0
6333737|NCT00534495|7240688|FG000|STARTED|Double Blind Placebo Phase Week 0-4||36
6333738|NCT00534495|7240689|FG001|STARTED|Double Blind Placebo Phase Week 0-4||35
6333739|NCT00534495|7240690|FG002|STARTED|Double Blind Placebo Phase Week 0-4||0
6333740|NCT00534495|7240688|FG000|COMPLETED|Double Blind Placebo Phase Week 0-4||36
6333741|NCT00534495|7240689|FG001|COMPLETED|Double Blind Placebo Phase Week 0-4||34
6333742|NCT00534495|7240690|FG002|COMPLETED|Double Blind Placebo Phase Week 0-4||0
6333743|NCT00534495|7240688|FG000|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
6333744|NCT00534495|7240689|FG001|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
6333745|NCT00534495|7240690|FG002|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
6333746|NCT00534495|7240688|FG000|STARTED|All Active Treatment Phase Week 4-24||36
6333747|NCT00534495|7240689|FG001|STARTED|All Active Treatment Phase Week 4-24||34
6333748|NCT00534495|7240690|FG002|STARTED|All Active Treatment Phase Week 4-24||0
6333749|NCT00534495|7240688|FG000|COMPLETED|All Active Treatment Phase Week 4-24||32
6333750|NCT00534495|7240689|FG001|COMPLETED|All Active Treatment Phase Week 4-24||25
6333751|NCT00534495|7240690|FG002|COMPLETED|All Active Treatment Phase Week 4-24||0
6333752|NCT00534495|7240688|FG000|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
6333753|NCT00534495|7240689|FG001|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
6333754|NCT00534495|7240690|FG002|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
6333755|NCT00534495|7240688|FG000|STARTED|Long Term Ext. Phase Week 24-month 21||0
6333756|NCT00534495|7240689|FG001|STARTED|Long Term Ext. Phase Week 24-month 21||0
6333757|NCT00534495|7240690|FG002|STARTED|Long Term Ext. Phase Week 24-month 21||40
6333758|NCT00534495|7240688|FG000|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
6333759|NCT00534495|7240689|FG001|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
6333760|NCT00534495|7240690|FG002|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
6333761|NCT00534495|7240688|FG000|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
6333762|NCT00534495|7240689|FG001|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
6333763|NCT00534495|7240690|FG002|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
6376100|NCT00758524|7286577|FG002|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
6376101|NCT00758524|7286578|FG003|NOT COMPLETED|Core Period (Week 0 to Week 8)||7
6376102|NCT00758524|7286579|FG004|NOT COMPLETED|Core Period (Week 0 to Week 8)||9
6376103|NCT00758524|7286580|FG005|NOT COMPLETED|Core Period (Week 0 to Week 8)||10
6376104|NCT00758524|7286581|FG006|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376105|NCT00758524|7286582|FG007|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376106|NCT00758524|7286583|FG008|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376107|NCT00758524|7286584|FG009|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376108|NCT00758524|7286585|FG010|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376109|NCT00758524|7286586|FG011|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376110|NCT00758524|7286587|FG012|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376111|NCT00758524|7286588|FG013|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376112|NCT00758524|7286589|FG014|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376113|NCT00758524|7286590|FG015|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376114|NCT00758524|7286591|FG016|NOT COMPLETED|Core Period (Week 0 to Week 8)||0
6376115|NCT00758524|7286575|FG000|STARTED|Withdrawal Period (Week 8 to Week 9)||0
6376116|NCT00758524|7286576|FG001|STARTED|Withdrawal Period (Week 8 to Week 9)||0
6376117|NCT00758524|7286577|FG002|STARTED|Withdrawal Period (Week 8 to Week 9)||0
6376118|NCT00758524|7286578|FG003|STARTED|Withdrawal Period (Week 8 to Week 9)||0
6376119|NCT00758524|7286579|FG004|STARTED|Withdrawal Period (Week 8 to Week 9)||0
6376120|NCT00758524|7286580|FG005|STARTED|Withdrawal Period (Week 8 to Week 9)||0
6376121|NCT00758524|7286581|FG006|STARTED|Withdrawal Period (Week 8 to Week 9)||46
6376122|NCT00758524|7286582|FG007|STARTED|Withdrawal Period (Week 8 to Week 9)||38
6376123|NCT00758524|7286583|FG008|STARTED|Withdrawal Period (Week 8 to Week 9)||44
6376124|NCT00758524|7286584|FG009|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set.|37
6376125|NCT00758524|7286585|FG010|STARTED|Withdrawal Period (Week 8 to Week 9)||41
6376126|NCT00758524|7286586|FG011|STARTED|Withdrawal Period (Week 8 to Week 9)|One participant randomized to LCI699 0.5 mg BID in the core period received LCI699 1.0 mg QD and was considered in the LCI699 1.0 mg QD arm in Randomized Withdrawal Safety Set.|37
6376127|NCT00758524|7286587|FG012|STARTED|Withdrawal Period (Week 8 to Week 9)||45
6376128|NCT00758524|7286588|FG013|STARTED|Withdrawal Period (Week 8 to Week 9)||45
6376129|NCT00758524|7286589|FG014|STARTED|Withdrawal Period (Week 8 to Week 9)||39
6376130|NCT00758524|7286590|FG015|STARTED|Withdrawal Period (Week 8 to Week 9)||36
6376131|NCT00758524|7286591|FG016|STARTED|Withdrawal Period (Week 8 to Week 9)||66
6376132|NCT00758524|7286575|FG000|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
6376133|NCT00758524|7286576|FG001|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
6376134|NCT00758524|7286577|FG002|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
6376135|NCT00758524|7286578|FG003|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
6376136|NCT00758524|7286579|FG004|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
6376137|NCT00758524|7286580|FG005|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||0
6376138|NCT00758524|7286581|FG006|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
6376139|NCT00758524|7286582|FG007|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||38
6376140|NCT00758524|7286583|FG008|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||43
6376141|NCT00758524|7286584|FG009|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||37
6376142|NCT00758524|7286585|FG010|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||41
6376143|NCT00758524|7286586|FG011|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
6376144|NCT00758524|7286587|FG012|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||45
6376145|NCT00758524|7286588|FG013|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||44
6376146|NCT00758524|7286589|FG014|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||39
6558814|NCT01777542|7481422|FG000|STARTED|Washout Period (28 +/- 2 Weeks)||15
6558815|NCT01777542|7481423|FG001|STARTED|Washout Period (28 +/- 2 Weeks)||15
6558816|NCT01777542|7481422|FG000|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
6558817|NCT01777542|7481423|FG001|COMPLETED|Washout Period (28 +/- 2 Weeks)||15
6558818|NCT01777542|7481422|FG000|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
6558819|NCT01777542|7481423|FG001|NOT COMPLETED|Washout Period (28 +/- 2 Weeks)||0
6558820|NCT01777542|7481422|FG000|STARTED|Second Intervention (20 Weeks)||15
6376147|NCT00758524|7286590|FG015|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)||36
6377897|NCT00765843|7288575|FG001|COMPLETED|Overall Study||21
6333764|NCT00534599|7240703|FG000|STARTED|Overall Study|Randomized|209
6333765|NCT00534599|7240704|FG001|STARTED|Overall Study|Randomized|200
6333766|NCT00534599|7240703|FG000|COMPLETED|Overall Study||152
6333767|NCT00534599|7240704|FG001|COMPLETED|Overall Study||168
6333768|NCT00534599|7240703|FG000|NOT COMPLETED|Overall Study||57
6333769|NCT00534599|7240704|FG001|NOT COMPLETED|Overall Study||32
6333770|NCT00534638|7240712|FG000|STARTED|Overall Study||14837
6333771|NCT00534638|7240713|FG001|STARTED|Overall Study||17338
6333772|NCT00534638|7240712|FG000|COMPLETED|Overall Study||8346
6333773|NCT00534638|7240713|FG001|COMPLETED|Overall Study||5547
6333774|NCT00534638|7240712|FG000|NOT COMPLETED|Overall Study||6491
6333775|NCT00534638|7240713|FG001|NOT COMPLETED|Overall Study||11791
6333776|NCT00534703|7240726|FG000|STARTED|Overall Study||4
6333777|NCT00534703|7240727|FG001|STARTED|Overall Study||1
6333778|NCT00534703|7240726|FG000|COMPLETED|Overall Study||4
6333779|NCT00534703|7240727|FG001|COMPLETED|Overall Study||1
6333780|NCT00534703|7240726|FG000|NOT COMPLETED|Overall Study||0
6333781|NCT00534703|7240727|FG001|NOT COMPLETED|Overall Study||0
6333782|NCT00534794|7240737|FG000|STARTED|Overall Study||40
6333783|NCT00534794|7240738|FG001|STARTED|Overall Study||39
6333784|NCT00534794|7240737|FG000|COMPLETED|Overall Study||40
6333785|NCT00534794|7240738|FG001|COMPLETED|Overall Study||39
6333786|NCT00534794|7240737|FG000|NOT COMPLETED|Overall Study||0
6333787|NCT00534794|7240738|FG001|NOT COMPLETED|Overall Study||0
6333788|NCT00534833|7240746|FG000|STARTED|Overall Study||182
6333789|NCT00534833|7240747|FG001|STARTED|Overall Study||180
6333790|NCT00534833|7240746|FG000|COMPLETED|Overall Study||182
6333791|NCT00534833|7240747|FG001|COMPLETED|Overall Study||180
6333792|NCT00534833|7240746|FG000|NOT COMPLETED|Overall Study||0
6333793|NCT00534833|7240747|FG001|NOT COMPLETED|Overall Study||0
6333794|NCT00534937|7240757|FG000|STARTED|Overall Study||42
6333795|NCT00534937|7240758|FG001|STARTED|Overall Study||47
6333796|NCT00534937|7240757|FG000|COMPLETED|Overall Study||34
6333797|NCT00534937|7240758|FG001|COMPLETED|Overall Study||35
6333798|NCT00534937|7240757|FG000|NOT COMPLETED|Overall Study||8
6333799|NCT00534937|7240758|FG001|NOT COMPLETED|Overall Study||12
6333800|NCT00535002|7240774|FG000|STARTED|Overall Study||19
6333801|NCT00535002|7240775|FG001|STARTED|Overall Study||12
6333802|NCT00535002|7240776|FG002|STARTED|Overall Study||13
6333803|NCT00535002|7240777|FG003|STARTED|Overall Study||14
6333804|NCT00535002|7240778|FG004|STARTED|Overall Study||9
6333805|NCT00535002|7240779|FG005|STARTED|Overall Study||17
6333806|NCT00535002|7240780|FG006|STARTED|Overall Study||12
6333807|NCT00535002|7240781|FG007|STARTED|Overall Study||16
6333808|NCT00535002|7240774|FG000|COMPLETED|Overall Study||19
6333809|NCT00535002|7240775|FG001|COMPLETED|Overall Study||12
6333810|NCT00535002|7240776|FG002|COMPLETED|Overall Study||13
6333811|NCT00535002|7240777|FG003|COMPLETED|Overall Study||14
6333812|NCT00535002|7240778|FG004|COMPLETED|Overall Study||9
6333813|NCT00535002|7240779|FG005|COMPLETED|Overall Study||17
6333814|NCT00535002|7240780|FG006|COMPLETED|Overall Study||12
6333815|NCT00535002|7240781|FG007|COMPLETED|Overall Study||16
6333816|NCT00535002|7240774|FG000|NOT COMPLETED|Overall Study||0
6333817|NCT00535002|7240775|FG001|NOT COMPLETED|Overall Study||0
6333818|NCT00535002|7240776|FG002|NOT COMPLETED|Overall Study||0
6333819|NCT00535002|7240777|FG003|NOT COMPLETED|Overall Study||0
6333820|NCT00535002|7240778|FG004|NOT COMPLETED|Overall Study||0
6333821|NCT00535002|7240779|FG005|NOT COMPLETED|Overall Study||0
6333822|NCT00535002|7240780|FG006|NOT COMPLETED|Overall Study||0
6333823|NCT00535002|7240781|FG007|NOT COMPLETED|Overall Study||0
6333824|NCT00535132|7240797|FG000|STARTED|Randomized Population|Number of Subjects Randomized|100
6333825|NCT00535132|7240798|FG001|STARTED|Randomized Population|Number of Subjects Randomized|101
6333826|NCT00535132|7240797|FG000|COMPLETED|Randomized Population||100
6333827|NCT00535132|7240798|FG001|COMPLETED|Randomized Population||101
6333828|NCT00535132|7240797|FG000|NOT COMPLETED|Randomized Population||0
6333829|NCT00535132|7240798|FG001|NOT COMPLETED|Randomized Population||0
6333830|NCT00535132|7240797|FG000|STARTED|Safety Analysis Set||100
6333831|NCT00535132|7240798|FG001|STARTED|Safety Analysis Set||101
6333832|NCT00535132|7240797|FG000|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
6333833|NCT00535132|7240798|FG001|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
6333834|NCT00535132|7240797|FG000|NOT COMPLETED|Safety Analysis Set||2
6333835|NCT00535132|7240798|FG001|NOT COMPLETED|Safety Analysis Set||2
6333836|NCT00535132|7240797|FG000|STARTED|Intent-to-Treat (ITT) Analysis Set||98
6333837|NCT00535132|7240798|FG001|STARTED|Intent-to-Treat (ITT) Analysis Set||99
6333838|NCT00535132|7240797|FG000|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
6333839|NCT00535132|7240798|FG001|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
6333840|NCT00535132|7240797|FG000|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
6333841|NCT00535132|7240798|FG001|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
6333842|NCT00535145|7240806|FG000|STARTED|Phase I||114
6333843|NCT00535145|7240806|FG000|COMPLETED|Phase I||85
6333844|NCT00535145|7240806|FG000|NOT COMPLETED|Phase I||29
6333845|NCT00535145|7240806|FG000|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
6333846|NCT00535145|7240806|FG000|COMPLETED|Phase II||69
6333847|NCT00535145|7240806|FG000|NOT COMPLETED|Phase II||15
6333848|NCT00535223|7240816|FG000|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
6377898|NCT00765843|7288576|FG002|COMPLETED|Overall Study||23
6333849|NCT00535223|7240817|FG001|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
6333850|NCT00535223|7240816|FG000|COMPLETED|Overall Study||37
6333851|NCT00535223|7240817|FG001|COMPLETED|Overall Study||39
6333852|NCT00535223|7240816|FG000|NOT COMPLETED|Overall Study||4
6333853|NCT00535223|7240817|FG001|NOT COMPLETED|Overall Study||1
6333854|NCT00535236|7240833|FG000|STARTED|Overall Study||40
6333855|NCT00535236|7240834|FG001|STARTED|Overall Study||10
6333856|NCT00535236|7240835|FG002|STARTED|Overall Study||41
6333857|NCT00535236|7240836|FG003|STARTED|Overall Study||10
6333858|NCT00535236|7240837|FG004|STARTED|Overall Study||59
6333859|NCT00535236|7240838|FG005|STARTED|Overall Study||20
6333860|NCT00535236|7240839|FG006|STARTED|Overall Study||62
6558821|NCT01777542|7481423|FG001|STARTED|Second Intervention (20 Weeks)||15
6558822|NCT01777542|7481422|FG000|COMPLETED|Second Intervention (20 Weeks)||15
6558823|NCT01777542|7481423|FG001|COMPLETED|Second Intervention (20 Weeks)||14
6558824|NCT01777542|7481422|FG000|NOT COMPLETED|Second Intervention (20 Weeks)||0
6558825|NCT01777542|7481423|FG001|NOT COMPLETED|Second Intervention (20 Weeks)||1
6558826|NCT01777568|7481432|FG000|STARTED|Overall Study||2853
6558827|NCT01777568|7481433|FG001|STARTED|Overall Study||2896
6558828|NCT01777568|7481432|FG000|COMPLETED|Overall Study||2853
6558829|NCT01777568|7481433|FG001|COMPLETED|Overall Study||2896
6558830|NCT01777568|7481432|FG000|NOT COMPLETED|Overall Study||0
6558831|NCT01777568|7481433|FG001|NOT COMPLETED|Overall Study||0
6558832|NCT01777581|7481441|FG000|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
6558833|NCT01777581|7481442|FG001|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
6558834|NCT01777581|7481441|FG000|COMPLETED|Overall Study||5
6558835|NCT01777581|7481442|FG001|COMPLETED|Overall Study||3
6775389|NCT03848403|7703326|FG001|Received at Least One Dose of Study Drug|Period 2 (Day 8)||24
6775390|NCT03848403|7703327|FG002|Received at Least One Dose of Study Drug|Period 2 (Day 8)||22
6775391|NCT03848403|7703325|FG000|COMPLETED|Period 2 (Day 8)||15
6333861|NCT00535236|7240840|FG007|STARTED|Overall Study||19
6333862|NCT00535236|7240841|FG008|STARTED|Overall Study||60
6333863|NCT00535236|7240842|FG009|STARTED|Overall Study||20
6333864|NCT00535236|7240833|FG000|Vaccination 1|Overall Study||40
6333865|NCT00535236|7240834|FG001|Vaccination 1|Overall Study||10
6333866|NCT00535236|7240835|FG002|Vaccination 1|Overall Study||40
6333867|NCT00535236|7240836|FG003|Vaccination 1|Overall Study||10
6333868|NCT00535236|7240837|FG004|Vaccination 1|Overall Study||58
6333869|NCT00535236|7240838|FG005|Vaccination 1|Overall Study||19
6333870|NCT00535236|7240839|FG006|Vaccination 1|Overall Study||61
6333871|NCT00535236|7240840|FG007|Vaccination 1|Overall Study||19
6333872|NCT00535236|7240841|FG008|Vaccination 1|Overall Study||60
6333873|NCT00535236|7240842|FG009|Vaccination 1|Overall Study||20
6333874|NCT00535236|7240833|FG000|Vaccination 2|Overall Study||35
6333875|NCT00535236|7240834|FG001|Vaccination 2|Overall Study||10
6333876|NCT00535236|7240835|FG002|Vaccination 2|Overall Study||37
6333877|NCT00535236|7240836|FG003|Vaccination 2|Overall Study||8
6333878|NCT00535236|7240837|FG004|Vaccination 2|Overall Study||52
6333879|NCT00535236|7240838|FG005|Vaccination 2|Overall Study||19
6333880|NCT00535236|7240839|FG006|Vaccination 2|Overall Study||58
6333881|NCT00535236|7240840|FG007|Vaccination 2|Overall Study||19
6333882|NCT00535236|7240841|FG008|Vaccination 2|Overall Study||57
6333883|NCT00535236|7240842|FG009|Vaccination 2|Overall Study||19
6333884|NCT00535236|7240833|FG000|Vaccination 3|Overall Study||34
6333885|NCT00535236|7240834|FG001|Vaccination 3|Overall Study||10
6333886|NCT00535236|7240835|FG002|Vaccination 3|Overall Study||35
6333887|NCT00535236|7240836|FG003|Vaccination 3|Overall Study||8
6333888|NCT00535236|7240837|FG004|Vaccination 3|Overall Study||48
6333889|NCT00535236|7240838|FG005|Vaccination 3|Overall Study||19
6333890|NCT00535236|7240839|FG006|Vaccination 3|Overall Study||51
6333891|NCT00535236|7240840|FG007|Vaccination 3|Overall Study||18
6333892|NCT00535236|7240841|FG008|Vaccination 3|Overall Study||53
6333893|NCT00535236|7240842|FG009|Vaccination 3|Overall Study||18
6333894|NCT00535236|7240833|FG000|Vaccination 4|Overall Study||34
6333895|NCT00535236|7240834|FG001|Vaccination 4|Overall Study||10
6333896|NCT00535236|7240835|FG002|Vaccination 4|Overall Study||32
6333897|NCT00535236|7240836|FG003|Vaccination 4|Overall Study||6
6333898|NCT00535236|7240837|FG004|Vaccination 4|Overall Study||47
6333899|NCT00535236|7240838|FG005|Vaccination 4|Overall Study||19
6333900|NCT00535236|7240839|FG006|Vaccination 4|Overall Study||51
6333901|NCT00535236|7240840|FG007|Vaccination 4|Overall Study||18
6333902|NCT00535236|7240841|FG008|Vaccination 4|Overall Study||50
6333903|NCT00535236|7240842|FG009|Vaccination 4|Overall Study||17
6333904|NCT00535236|7240833|FG000|COMPLETED|Overall Study||33
6333905|NCT00535236|7240834|FG001|COMPLETED|Overall Study||8
6333906|NCT00535236|7240835|FG002|COMPLETED|Overall Study||29
6333907|NCT00535236|7240836|FG003|COMPLETED|Overall Study||6
6333908|NCT00535236|7240837|FG004|COMPLETED|Overall Study||47
6333909|NCT00535236|7240838|FG005|COMPLETED|Overall Study||19
6333910|NCT00535236|7240839|FG006|COMPLETED|Overall Study||51
6333911|NCT00535236|7240840|FG007|COMPLETED|Overall Study||18
6333912|NCT00535236|7240841|FG008|COMPLETED|Overall Study||47
6333913|NCT00535236|7240842|FG009|COMPLETED|Overall Study||16
6333914|NCT00535236|7240833|FG000|NOT COMPLETED|Overall Study||7
6333915|NCT00535236|7240834|FG001|NOT COMPLETED|Overall Study||2
6558836|NCT01777581|7481441|FG000|NOT COMPLETED|Overall Study||3
6558837|NCT01777581|7481442|FG001|NOT COMPLETED|Overall Study||2
6558838|NCT01777620|7481450|FG000|STARTED|Overall Study||63
6333916|NCT00535236|7240835|FG002|NOT COMPLETED|Overall Study||12
6333917|NCT00535236|7240836|FG003|NOT COMPLETED|Overall Study||4
6333918|NCT00535236|7240837|FG004|NOT COMPLETED|Overall Study||12
6333919|NCT00535236|7240838|FG005|NOT COMPLETED|Overall Study||1
6333920|NCT00535236|7240839|FG006|NOT COMPLETED|Overall Study||11
6333921|NCT00535236|7240840|FG007|NOT COMPLETED|Overall Study||1
6333922|NCT00535236|7240841|FG008|NOT COMPLETED|Overall Study||13
6333923|NCT00535236|7240842|FG009|NOT COMPLETED|Overall Study||4
6333924|NCT00535288|7240872|FG000|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
6333925|NCT00535288|7240873|FG001|STARTED|Overall Study||162
6333926|NCT00535288|7240874|FG002|STARTED|Overall Study||160
6333927|NCT00535288|7240875|FG003|STARTED|Overall Study||151
6333928|NCT00535288|7240876|FG004|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
6333929|NCT00535288|7240872|FG000|COMPLETED|Overall Study||260
6333930|NCT00535288|7240873|FG001|COMPLETED|Overall Study||130
6333931|NCT00535288|7240874|FG002|COMPLETED|Overall Study||127
6333932|NCT00535288|7240875|FG003|COMPLETED|Overall Study||122
6333933|NCT00535288|7240876|FG004|COMPLETED|Overall Study||116
6333934|NCT00535288|7240872|FG000|NOT COMPLETED|Overall Study||54
6333935|NCT00535288|7240873|FG001|NOT COMPLETED|Overall Study||32
6333936|NCT00535288|7240874|FG002|NOT COMPLETED|Overall Study||33
6333937|NCT00535288|7240875|FG003|NOT COMPLETED|Overall Study||29
6333938|NCT00535288|7240876|FG004|NOT COMPLETED|Overall Study||42
6333939|NCT00535301|7240895|FG000|STARTED|Overall Study||38
6333940|NCT00535301|7240896|FG001|STARTED|Overall Study||38
6333941|NCT00535301|7240895|FG000|COMPLETED|Overall Study||33
6333942|NCT00535301|7240896|FG001|COMPLETED|Overall Study||33
6333943|NCT00535301|7240895|FG000|NOT COMPLETED|Overall Study||5
6333944|NCT00535301|7240896|FG001|NOT COMPLETED|Overall Study||5
6333945|NCT00535392|7240904|FG000|STARTED|Overall Study||33
6333946|NCT00535392|7240904|FG000|COMPLETED|Overall Study||33
6333947|NCT00535392|7240904|FG000|NOT COMPLETED|Overall Study||0
6333948|NCT00535496|7240910|FG000|STARTED|Overall Study||15
6333949|NCT00535496|7240911|FG001|STARTED|Overall Study||15
6333950|NCT00535496|7240912|FG002|STARTED|Overall Study||30
6333951|NCT00535496|7240913|FG003|STARTED|Overall Study||31
6333952|NCT00535496|7240910|FG000|All-Subjects-Treated (AST) Group|Overall Study||15
6333953|NCT00535496|7240911|FG001|All-Subjects-Treated (AST) Group|Overall Study||14
6333954|NCT00535496|7240912|FG002|All-Subjects-Treated (AST) Group|Overall Study||30
6333955|NCT00535496|7240913|FG003|All-Subjects-Treated (AST) Group|Overall Study||31
6333956|NCT00535496|7240910|FG000|COMPLETED|Overall Study||15
6333957|NCT00535496|7240911|FG001|COMPLETED|Overall Study||13
6333958|NCT00535496|7240912|FG002|COMPLETED|Overall Study||30
6333959|NCT00535496|7240913|FG003|COMPLETED|Overall Study||31
6333960|NCT00535496|7240910|FG000|NOT COMPLETED|Overall Study||0
6333961|NCT00535496|7240911|FG001|NOT COMPLETED|Overall Study||2
6333962|NCT00535496|7240912|FG002|NOT COMPLETED|Overall Study||0
6333963|NCT00535496|7240913|FG003|NOT COMPLETED|Overall Study||0
6333964|NCT00535587|7240924|FG000|STARTED|Overall Study||53
6333965|NCT00535587|7240925|FG001|STARTED|Overall Study||53
6333966|NCT00535587|7240926|FG002|STARTED|Overall Study||47
6333967|NCT00535587|7240927|FG003|STARTED|Overall Study||54
6333968|NCT00535587|7240924|FG000|COMPLETED|Overall Study||43
6333969|NCT00535587|7240925|FG001|COMPLETED|Overall Study||42
6333970|NCT00535587|7240926|FG002|COMPLETED|Overall Study||39
6333971|NCT00535587|7240927|FG003|COMPLETED|Overall Study||41
6333972|NCT00535587|7240924|FG000|NOT COMPLETED|Overall Study||10
6333973|NCT00535587|7240925|FG001|NOT COMPLETED|Overall Study||11
6333974|NCT00535587|7240926|FG002|NOT COMPLETED|Overall Study||8
6333975|NCT00535587|7240927|FG003|NOT COMPLETED|Overall Study||13
6333976|NCT00535613|7240937|FG000|STARTED|Overall Study||49
6333977|NCT00535613|7240938|FG001|STARTED|Overall Study||50
6333978|NCT00535613|7240937|FG000|COMPLETED|Overall Study||49
6333979|NCT00535613|7240938|FG001|COMPLETED|Overall Study||50
6333980|NCT00535613|7240937|FG000|NOT COMPLETED|Overall Study||0
6333981|NCT00535613|7240938|FG001|NOT COMPLETED|Overall Study||0
6333982|NCT00535626|7240944|FG000|STARTED|Overall Study||190
6775392|NCT03848403|7703326|FG001|COMPLETED|Period 2 (Day 8)||15
6775393|NCT03848403|7703327|FG002|COMPLETED|Period 2 (Day 8)||15
6775394|NCT03848403|7703325|FG000|NOT COMPLETED|Period 2 (Day 8)||9
6333983|NCT00535626|7240944|FG000|COMPLETED|Overall Study||85
6333984|NCT00535626|7240944|FG000|NOT COMPLETED|Overall Study||105
6333985|NCT00535652|7240949|FG000|STARTED|Overall Study||23
6333986|NCT00535652|7240949|FG000|COMPLETED|Overall Study||20
6333987|NCT00535652|7240949|FG000|NOT COMPLETED|Overall Study||3
6333988|NCT00535730|7240955|FG000|STARTED|Overall Study||236
6333989|NCT00535730|7240956|FG001|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
6333990|NCT00535730|7240955|FG000|COMPLETED|Overall Study||234
6333991|NCT00535730|7240956|FG001|COMPLETED|Overall Study||230
6333992|NCT00535730|7240955|FG000|NOT COMPLETED|Overall Study||2
6333993|NCT00535730|7240956|FG001|NOT COMPLETED|Overall Study||7
6333994|NCT00535743|7240987|FG000|STARTED|Overall Study||5
6333995|NCT00535743|7240988|FG001|STARTED|Overall Study||11
6333996|NCT00535743|7240989|FG002|STARTED|Overall Study||11
6333997|NCT00535743|7240990|FG003|STARTED|Overall Study||11
6333998|NCT00535743|7240991|FG004|STARTED|Overall Study||11
6333999|NCT00535743|7240992|FG005|STARTED|Overall Study||10
6334000|NCT00535743|7240993|FG006|STARTED|Overall Study||3
6334001|NCT00535743|7240994|FG007|STARTED|Overall Study||5
6334002|NCT00535743|7240995|FG008|STARTED|Overall Study||5
6334003|NCT00535743|7240996|FG009|STARTED|Overall Study||5
6334004|NCT00535743|7240997|FG010|STARTED|Overall Study||5
6334005|NCT00535743|7240998|FG011|STARTED|Overall Study||5
6334006|NCT00535743|7240999|FG012|STARTED|Overall Study||5
6334007|NCT00535743|7241000|FG013|STARTED|Overall Study||10
6334008|NCT00535743|7241001|FG014|STARTED|Overall Study||9
6334009|NCT00535743|7241002|FG015|STARTED|Overall Study|N=11 randomized to Arm P. An additional N=2 (randomized to Arm O) are counted as Started in Arm P|13
6334010|NCT00535743|7241003|FG016|STARTED|Overall Study||10
6334011|NCT00535743|7241004|FG017|STARTED|Overall Study||11
6334012|NCT00535743|7241005|FG018|STARTED|Overall Study||3
6334013|NCT00535743|7241006|FG019|STARTED|Overall Study||5
6334014|NCT00535743|7241007|FG020|STARTED|Overall Study||5
6334015|NCT00535743|7241008|FG021|STARTED|Overall Study||5
6334016|NCT00535743|7241009|FG022|STARTED|Overall Study|N=5 randomized to Arm W. An additional N=1 (randomized to Arm Q) is counted as Started in Arm W|6
6334017|NCT00535743|7241010|FG023|STARTED|Overall Study||5
6334018|NCT00535743|7240987|FG000|Treated|Overall Study||5
6334019|NCT00535743|7240988|FG001|Treated|Overall Study||11
6334020|NCT00535743|7240989|FG002|Treated|Overall Study||11
6334021|NCT00535743|7240990|FG003|Treated|Overall Study||11
6334022|NCT00535743|7240991|FG004|Treated|Overall Study||11
6334023|NCT00535743|7240992|FG005|Treated|Overall Study||10
6334024|NCT00535743|7240993|FG006|Treated|Overall Study||3
6334025|NCT00535743|7240994|FG007|Treated|Overall Study||5
6334026|NCT00535743|7240995|FG008|Treated|Overall Study||4
6334027|NCT00535743|7240996|FG009|Treated|Overall Study||5
6334028|NCT00535743|7240997|FG010|Treated|Overall Study||5
6334029|NCT00535743|7240998|FG011|Treated|Overall Study||5
6334030|NCT00535743|7240999|FG012|Treated|Overall Study||5
6334031|NCT00535743|7241000|FG013|Treated|Overall Study||10
6334032|NCT00535743|7241001|FG014|Treated|Overall Study||9
6334033|NCT00535743|7241002|FG015|Treated|Overall Study|N=2 (randomized to Arm O) rec'd 8 mg/kg Sugammadex, 3 min after 1.2 mg/kg Esmeron®|13
6334034|NCT00535743|7241003|FG016|Treated|Overall Study||10
6334035|NCT00535743|7241004|FG017|Treated|Overall Study||11
6334036|NCT00535743|7241005|FG018|Treated|Overall Study||3
6334037|NCT00535743|7241006|FG019|Treated|Overall Study||5
6334038|NCT00535743|7241007|FG020|Treated|Overall Study||5
6334039|NCT00535743|7241008|FG021|Treated|Overall Study||5
6334040|NCT00535743|7241009|FG022|Treated|Overall Study|N=1 (randomized to Arm Q) rec'd 12 mg/kg Sugammadex, 29 min after 1.2 mg/kg Esmeron®|6
6334041|NCT00535743|7241010|FG023|Treated|Overall Study||5
6334042|NCT00535743|7240987|FG000|COMPLETED|Overall Study||5
6334043|NCT00535743|7240988|FG001|COMPLETED|Overall Study||11
6334044|NCT00535743|7240989|FG002|COMPLETED|Overall Study||11
6334045|NCT00535743|7240990|FG003|COMPLETED|Overall Study||11
6334046|NCT00535743|7240991|FG004|COMPLETED|Overall Study||11
6334047|NCT00535743|7240992|FG005|COMPLETED|Overall Study||10
6334048|NCT00535743|7240993|FG006|COMPLETED|Overall Study||3
6334049|NCT00535743|7240994|FG007|COMPLETED|Overall Study||5
6775395|NCT03848403|7703326|FG001|NOT COMPLETED|Period 2 (Day 8)||9
6775396|NCT03848403|7703327|FG002|NOT COMPLETED|Period 2 (Day 8)||7
6775397|NCT03848403|7703325|FG000|STARTED|Period 3 (Day 15)||15
6775398|NCT03848403|7703326|FG001|STARTED|Period 3 (Day 15)||15
6775399|NCT03848403|7703327|FG002|STARTED|Period 3 (Day 15)||15
6775400|NCT03848403|7703325|FG000|COMPLETED|Period 3 (Day 15)||15
6775401|NCT03848403|7703326|FG001|COMPLETED|Period 3 (Day 15)||15
6775402|NCT03848403|7703327|FG002|COMPLETED|Period 3 (Day 15)||15
6775403|NCT03848403|7703325|FG000|NOT COMPLETED|Period 3 (Day 15)||0
6775404|NCT03848403|7703326|FG001|NOT COMPLETED|Period 3 (Day 15)||0
6775405|NCT03848403|7703327|FG002|NOT COMPLETED|Period 3 (Day 15)||0
6775406|NCT03847233|7703335|FG000|STARTED|Index Procedure||31
6775407|NCT03847233|7703335|FG000|COMPLETED|Index Procedure||31
6775408|NCT03847233|7703335|FG000|NOT COMPLETED|Index Procedure||0
6775409|NCT03847233|7703335|FG000|STARTED|6 Month After Index Procedure||31
6775410|NCT03847233|7703335|FG000|COMPLETED|6 Month After Index Procedure||30
6775411|NCT03847233|7703335|FG000|NOT COMPLETED|6 Month After Index Procedure||1
6775412|NCT03879603|7703346|FG000|STARTED|Overall Study||5
6775413|NCT03879603|7703347|FG001|STARTED|Overall Study||5
6775414|NCT03879603|7703348|FG002|STARTED|Overall Study||5
6775415|NCT03879603|7703349|FG003|STARTED|Overall Study||5
6334050|NCT00535743|7240995|FG008|COMPLETED|Overall Study||4
6334051|NCT00535743|7240996|FG009|COMPLETED|Overall Study||4
6334052|NCT00535743|7240997|FG010|COMPLETED|Overall Study||5
6334053|NCT00535743|7240998|FG011|COMPLETED|Overall Study||5
6775416|NCT03879603|7703350|FG004|STARTED|Overall Study||5
6775417|NCT03879603|7703351|FG005|STARTED|Overall Study||5
6775418|NCT03879603|7703346|FG000|Received First Product Administration|Overall Study||5
6775419|NCT03879603|7703347|FG001|Received First Product Administration|Overall Study||5
6775420|NCT03879603|7703348|FG002|Received First Product Administration|Overall Study||5
6775421|NCT03879603|7703349|FG003|Received First Product Administration|Overall Study||5
6775422|NCT03879603|7703350|FG004|Received First Product Administration|Overall Study||5
6775423|NCT03879603|7703351|FG005|Received First Product Administration|Overall Study||5
6775424|NCT03879603|7703346|FG000|Received All Product Administrations|Overall Study|Second administration not completed due to a grade 3 neutropenia not related to study product.|4
6334054|NCT00535743|7240999|FG012|COMPLETED|Overall Study||5
6334055|NCT00535743|7241000|FG013|COMPLETED|Overall Study||10
6334056|NCT00535743|7241001|FG014|COMPLETED|Overall Study||9
6334057|NCT00535743|7241002|FG015|COMPLETED|Overall Study||13
6334058|NCT00535743|7241003|FG016|COMPLETED|Overall Study||10
6334059|NCT00535743|7241004|FG017|COMPLETED|Overall Study||11
6334060|NCT00535743|7241005|FG018|COMPLETED|Overall Study||3
6334061|NCT00535743|7241006|FG019|COMPLETED|Overall Study||5
6334062|NCT00535743|7241007|FG020|COMPLETED|Overall Study||5
6334063|NCT00535743|7241008|FG021|COMPLETED|Overall Study||4
6334064|NCT00535743|7241009|FG022|COMPLETED|Overall Study||6
6334065|NCT00535743|7241010|FG023|COMPLETED|Overall Study||5
6334066|NCT00535743|7240987|FG000|NOT COMPLETED|Overall Study||0
6334067|NCT00535743|7240988|FG001|NOT COMPLETED|Overall Study||0
6334068|NCT00535743|7240989|FG002|NOT COMPLETED|Overall Study||0
6334069|NCT00535743|7240990|FG003|NOT COMPLETED|Overall Study||0
6334070|NCT00535743|7240991|FG004|NOT COMPLETED|Overall Study||0
6334071|NCT00535743|7240992|FG005|NOT COMPLETED|Overall Study||0
6334072|NCT00535743|7240993|FG006|NOT COMPLETED|Overall Study||0
6334073|NCT00535743|7240994|FG007|NOT COMPLETED|Overall Study||0
6334074|NCT00535743|7240995|FG008|NOT COMPLETED|Overall Study||1
6334075|NCT00535743|7240996|FG009|NOT COMPLETED|Overall Study||1
6334076|NCT00535743|7240997|FG010|NOT COMPLETED|Overall Study||0
6334077|NCT00535743|7240998|FG011|NOT COMPLETED|Overall Study||0
6334078|NCT00535743|7240999|FG012|NOT COMPLETED|Overall Study||0
6334079|NCT00535743|7241000|FG013|NOT COMPLETED|Overall Study||0
6334080|NCT00535743|7241001|FG014|NOT COMPLETED|Overall Study||0
6334081|NCT00535743|7241002|FG015|NOT COMPLETED|Overall Study||0
6334082|NCT00535743|7241003|FG016|NOT COMPLETED|Overall Study||0
6334083|NCT00535743|7241004|FG017|NOT COMPLETED|Overall Study||0
6334084|NCT00535743|7241005|FG018|NOT COMPLETED|Overall Study||0
6334085|NCT00535743|7241006|FG019|NOT COMPLETED|Overall Study||0
6334086|NCT00535743|7241007|FG020|NOT COMPLETED|Overall Study||0
6334087|NCT00535743|7241008|FG021|NOT COMPLETED|Overall Study||1
6334088|NCT00535743|7241009|FG022|NOT COMPLETED|Overall Study||0
6334089|NCT00535743|7241010|FG023|NOT COMPLETED|Overall Study||0
6334090|NCT00535769|7241062|FG000|STARTED|Overall Study||35
6334091|NCT00535769|7241063|FG001|STARTED|Overall Study||35
6334092|NCT00535769|7241062|FG000|COMPLETED|Overall Study||35
6334093|NCT00535769|7241063|FG001|COMPLETED|Overall Study||35
6334094|NCT00535769|7241062|FG000|NOT COMPLETED|Overall Study||0
6334095|NCT00535769|7241063|FG001|NOT COMPLETED|Overall Study||0
6334096|NCT00535782|7241072|FG000|STARTED|Part 1: 24-Week Double-blind Period||69
6334097|NCT00535782|7241073|FG001|STARTED|Part 1: 24-Week Double-blind Period||63
6334098|NCT00535782|7241074|FG002|STARTED|Part 1: 24-Week Double-blind Period||0
6334099|NCT00535782|7241072|FG000|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
6334100|NCT00535782|7241073|FG001|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
6334101|NCT00535782|7241074|FG002|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
6334102|NCT00535782|7241072|FG000|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
6334103|NCT00535782|7241073|FG001|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
6334104|NCT00535782|7241074|FG002|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
6334105|NCT00535782|7241072|FG000|COMPLETED|Part 1: 24-Week Double-blind Period||65
6334106|NCT00535782|7241073|FG001|COMPLETED|Part 1: 24-Week Double-blind Period||59
6334107|NCT00535782|7241074|FG002|COMPLETED|Part 1: 24-Week Double-blind Period||0
6334108|NCT00535782|7241072|FG000|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
6334109|NCT00535782|7241073|FG001|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
6334110|NCT00535782|7241074|FG002|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
6334111|NCT00535782|7241072|FG000|STARTED|Part 2: 80-Week Open-label Period||0
6334112|NCT00535782|7241073|FG001|STARTED|Part 2: 80-Week Open-label Period||0
6334113|NCT00535782|7241074|FG002|STARTED|Part 2: 80-Week Open-label Period||124
6334114|NCT00535782|7241072|FG000|COMPLETED|Part 2: 80-Week Open-label Period||0
6334115|NCT00535782|7241073|FG001|COMPLETED|Part 2: 80-Week Open-label Period||0
6334116|NCT00535782|7241074|FG002|COMPLETED|Part 2: 80-Week Open-label Period||98
6334117|NCT00535782|7241072|FG000|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
6334118|NCT00535782|7241073|FG001|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
6334119|NCT00535782|7241074|FG002|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
6334120|NCT00535821|7241083|FG000|STARTED|Overall Study||2
6334121|NCT00535821|7241084|FG001|STARTED|Overall Study||3
6334122|NCT00535821|7241083|FG000|COMPLETED|Overall Study||2
6334123|NCT00535821|7241084|FG001|COMPLETED|Overall Study||3
6334124|NCT00535821|7241083|FG000|NOT COMPLETED|Overall Study||0
6334125|NCT00535821|7241084|FG001|NOT COMPLETED|Overall Study||0
6334126|NCT00535847|7241093|FG000|STARTED|Overall Study||81
6334127|NCT00535847|7241094|FG001|STARTED|Overall Study||34
6334128|NCT00535847|7241095|FG002|STARTED|Overall Study||2
6334129|NCT00535847|7241093|FG000|COMPLETED|Overall Study||59
6334130|NCT00535847|7241094|FG001|COMPLETED|Overall Study||20
6334131|NCT00535847|7241095|FG002|COMPLETED|Overall Study||0
6334132|NCT00535847|7241093|FG000|NOT COMPLETED|Overall Study||22
6334133|NCT00535847|7241094|FG001|NOT COMPLETED|Overall Study||14
6334134|NCT00535847|7241095|FG002|NOT COMPLETED|Overall Study||2
6334135|NCT00535873|7241107|FG000|STARTED|Overall Study||60
6334136|NCT00535873|7241107|FG000|COMPLETED|Overall Study||60
6334137|NCT00535873|7241107|FG000|NOT COMPLETED|Overall Study||0
6334138|NCT00535925|7241113|FG000|STARTED|Overall Study||188
6334139|NCT00535925|7241114|FG001|STARTED|Overall Study||207
6334140|NCT00535925|7241113|FG000|COMPLETED|Overall Study||169
6334141|NCT00535925|7241114|FG001|COMPLETED|Overall Study||199
6334142|NCT00535925|7241113|FG000|NOT COMPLETED|Overall Study||19
6334143|NCT00535925|7241114|FG001|NOT COMPLETED|Overall Study||8
6334144|NCT00535938|7241124|FG000|STARTED|Overall Study||506
6334145|NCT00535938|7241125|FG001|STARTED|Overall Study||866
6334146|NCT00535938|7241124|FG000|COMPLETED|Overall Study||115
6334147|NCT00535938|7241125|FG001|COMPLETED|Overall Study||404
6334148|NCT00535938|7241124|FG000|NOT COMPLETED|Overall Study||391
6334149|NCT00535938|7241125|FG001|NOT COMPLETED|Overall Study||462
6334150|NCT00536107|7241133|FG000|STARTED|Overall Study||8
6334151|NCT00536107|7241134|FG001|STARTED|Overall Study||6
6334152|NCT00536107|7241133|FG000|COMPLETED|Overall Study||0
6334153|NCT00536107|7241134|FG001|COMPLETED|Overall Study||0
6334154|NCT00536107|7241133|FG000|NOT COMPLETED|Overall Study||8
6334155|NCT00536107|7241134|FG001|NOT COMPLETED|Overall Study||6
6334156|NCT00536120|7241142|FG000|STARTED|Overall Study||30
6334157|NCT00536120|7241143|FG001|STARTED|Overall Study||30
6334158|NCT00536120|7241142|FG000|COMPLETED|Overall Study||24
6334159|NCT00536120|7241143|FG001|COMPLETED|Overall Study||27
6334160|NCT00536120|7241142|FG000|NOT COMPLETED|Overall Study||6
6334161|NCT00536120|7241143|FG001|NOT COMPLETED|Overall Study||3
6334162|NCT00536172|7241151|FG000|STARTED|Overall Study||74
6334163|NCT00536172|7241152|FG001|STARTED|Overall Study||74
6334164|NCT00536172|7241151|FG000|COMPLETED|Overall Study||60
6334165|NCT00536172|7241152|FG001|COMPLETED|Overall Study||65
6334166|NCT00536172|7241151|FG000|NOT COMPLETED|Overall Study||14
6334167|NCT00536172|7241152|FG001|NOT COMPLETED|Overall Study||9
6334168|NCT00536198|7241160|FG000|STARTED|Overall Study||125
6334169|NCT00536198|7241161|FG001|STARTED|Overall Study||127
6334170|NCT00536198|7241160|FG000|Cycle 1|Overall Study||110
6334171|NCT00536198|7241161|FG001|Cycle 1|Overall Study||123
6334172|NCT00536198|7241160|FG000|Cycle 2|Overall Study||104
6334173|NCT00536198|7241161|FG001|Cycle 2|Overall Study||112
6334174|NCT00536198|7241160|FG000|Cycle 3|Overall Study||100
6334175|NCT00536198|7241161|FG001|Cycle 3|Overall Study||101
6334176|NCT00536198|7241160|FG000|Cycle 4|Overall Study||95
6334177|NCT00536198|7241161|FG001|Cycle 4|Overall Study||98
6334178|NCT00536198|7241160|FG000|Cycle 5|Overall Study||88
6334179|NCT00536198|7241161|FG001|Cycle 5|Overall Study||85
6334180|NCT00536198|7241160|FG000|Cycle 6|Overall Study||88
6334181|NCT00536198|7241161|FG001|Cycle 6|Overall Study||88
6334182|NCT00536198|7241160|FG000|COMPLETED|Overall Study||88
6334183|NCT00536198|7241161|FG001|COMPLETED|Overall Study||88
6334184|NCT00536198|7241160|FG000|NOT COMPLETED|Overall Study||37
6334185|NCT00536198|7241161|FG001|NOT COMPLETED|Overall Study||39
6334186|NCT00536263|7241172|FG000|STARTED|Overall Study||225
6334187|NCT00536263|7241173|FG001|STARTED|Overall Study||221
6334188|NCT00536263|7241174|FG002|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
6498355|NCT01408914|7416908|FG002|STARTED|Overall Study||60
6498356|NCT01408914|7416906|FG000|COMPLETED|Overall Study||48
6498357|NCT01408914|7416907|FG001|COMPLETED|Overall Study||48
6498358|NCT01408914|7416908|FG002|COMPLETED|Overall Study||47
6498359|NCT01408914|7416906|FG000|NOT COMPLETED|Overall Study||12
6498360|NCT01408914|7416907|FG001|NOT COMPLETED|Overall Study||12
6334189|NCT00536263|7241172|FG000|COMPLETED|Overall Study||214
6334190|NCT00536263|7241173|FG001|COMPLETED|Overall Study||207
6334191|NCT00536263|7241174|FG002|COMPLETED|Overall Study||204
6334192|NCT00536263|7241172|FG000|NOT COMPLETED|Overall Study||11
6558839|NCT01777620|7481451|FG001|STARTED|Overall Study||62
6558840|NCT01777620|7481450|FG000|COMPLETED|Overall Study||62
6558841|NCT01777620|7481451|FG001|COMPLETED|Overall Study||62
6558842|NCT01777620|7481450|FG000|NOT COMPLETED|Overall Study||1
6558843|NCT01777620|7481451|FG001|NOT COMPLETED|Overall Study||0
6558844|NCT01777763|7481459|FG000|STARTED|Overall Study||20
6558845|NCT01777763|7481460|FG001|STARTED|Overall Study||210
6334193|NCT00536263|7241173|FG001|NOT COMPLETED|Overall Study||14
6334194|NCT00536263|7241174|FG002|NOT COMPLETED|Overall Study||21
6334195|NCT00536341|7241184|FG000|STARTED|Overall Study||10
6334196|NCT00536341|7241185|FG001|STARTED|Overall Study||54
6334197|NCT00536341|7241184|FG000|COMPLETED|Overall Study||5
6334198|NCT00536341|7241185|FG001|COMPLETED|Overall Study||43
6334199|NCT00536341|7241184|FG000|NOT COMPLETED|Overall Study||5
6334200|NCT00536341|7241185|FG001|NOT COMPLETED|Overall Study||11
6334201|NCT00536471|7241196|FG000|STARTED|Overall Study||257
6334202|NCT00536471|7241197|FG001|STARTED|Overall Study||127
6334203|NCT00536471|7241198|FG002|STARTED|Overall Study||261
6334204|NCT00536471|7241199|FG003|STARTED|Overall Study||131
6334205|NCT00536471|7241196|FG000|COMPLETED|Overall Study||101
6334206|NCT00536471|7241197|FG001|COMPLETED|Overall Study||43
6334207|NCT00536471|7241198|FG002|COMPLETED|Overall Study||122
6334208|NCT00536471|7241199|FG003|COMPLETED|Overall Study||57
6334209|NCT00536471|7241196|FG000|NOT COMPLETED|Overall Study||156
6498361|NCT01408914|7416908|FG002|NOT COMPLETED|Overall Study||13
6498362|NCT01408992|7416916|FG000|STARTED|Overall Study||558
6498363|NCT01408992|7416916|FG000|COMPLETED|Overall Study||558
6498364|NCT01408992|7416916|FG000|NOT COMPLETED|Overall Study||0
6498365|NCT01409096|7416930|FG000|STARTED|Overall Study||40
6498366|NCT01409096|7416931|FG001|STARTED|Overall Study||40
6498367|NCT01409096|7416930|FG000|COMPLETED|Overall Study||38
6498368|NCT01409096|7416931|FG001|COMPLETED|Overall Study||35
6498369|NCT01409096|7416930|FG000|NOT COMPLETED|Overall Study||2
6558846|NCT01777763|7481459|FG000|COMPLETED|Overall Study||16
6558847|NCT01777763|7481460|FG001|COMPLETED|Overall Study||163
6558848|NCT01777763|7481459|FG000|NOT COMPLETED|Overall Study||4
6558849|NCT01777763|7481460|FG001|NOT COMPLETED|Overall Study||47
6334210|NCT00536471|7241197|FG001|NOT COMPLETED|Overall Study||84
6334211|NCT00536471|7241198|FG002|NOT COMPLETED|Overall Study||139
6334212|NCT00536471|7241199|FG003|NOT COMPLETED|Overall Study||74
6334213|NCT00536484|7241218|FG000|STARTED|Overall Study|448 participants randomised; 3 not treated|445
6334214|NCT00536484|7241219|FG001|STARTED|Overall Study|448 participants randomised; 10 not treated|438
6334215|NCT00536484|7241218|FG000|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
6334216|NCT00536484|7241219|FG001|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
6334217|NCT00536484|7241218|FG000|NOT COMPLETED|Overall Study||60
6334218|NCT00536484|7241219|FG001|NOT COMPLETED|Overall Study||56
6334219|NCT00536510|7241227|FG000|STARTED|Overall Study||322
6334220|NCT00536510|7241228|FG001|STARTED|Overall Study||324
6334221|NCT00536510|7241227|FG000|COMPLETED|Overall Study||240
6334222|NCT00536510|7241228|FG001|COMPLETED|Overall Study||295
6334223|NCT00536510|7241227|FG000|NOT COMPLETED|Overall Study||82
6334224|NCT00536510|7241228|FG001|NOT COMPLETED|Overall Study||29
6334225|NCT00536575|7241234|FG000|STARTED|Overall Study||13
6334226|NCT00536575|7241234|FG000|COMPLETED|Overall Study||11
6334227|NCT00536575|7241234|FG000|NOT COMPLETED|Overall Study||2
6334228|NCT00536601|7241243|FG000|STARTED|Overall Study||6
6334229|NCT00536601|7241244|FG001|STARTED|Overall Study||21
6334230|NCT00536601|7241245|FG002|STARTED|Overall Study||71
6334231|NCT00536601|7241246|FG003|STARTED|Overall Study||65
6334232|NCT00536601|7241247|FG004|STARTED|Overall Study||11
6334233|NCT00536601|7241243|FG000|COMPLETED|Overall Study||6
6334234|NCT00536601|7241244|FG001|COMPLETED|Overall Study||21
6334235|NCT00536601|7241245|FG002|COMPLETED|Overall Study||71
6334236|NCT00536601|7241246|FG003|COMPLETED|Overall Study||65
6334237|NCT00536601|7241247|FG004|COMPLETED|Overall Study||11
6334238|NCT00536601|7241243|FG000|NOT COMPLETED|Overall Study||0
6334239|NCT00536601|7241244|FG001|NOT COMPLETED|Overall Study||0
6334240|NCT00536601|7241245|FG002|NOT COMPLETED|Overall Study||0
6334241|NCT00536601|7241246|FG003|NOT COMPLETED|Overall Study||0
6334242|NCT00536601|7241247|FG004|NOT COMPLETED|Overall Study||0
6334243|NCT00536731|7241262|FG000|STARTED|Overall Study||253
6334244|NCT00536731|7241263|FG001|STARTED|Overall Study||246
6334245|NCT00536731|7241264|FG002|STARTED|Overall Study||243
6334246|NCT00536731|7241262|FG000|COMPLETED|Overall Study||249
6334247|NCT00536731|7241263|FG001|COMPLETED|Overall Study||241
6334248|NCT00536731|7241264|FG002|COMPLETED|Overall Study||238
6334249|NCT00536731|7241262|FG000|NOT COMPLETED|Overall Study||4
6334250|NCT00536731|7241263|FG001|NOT COMPLETED|Overall Study||5
6334251|NCT00536731|7241264|FG002|NOT COMPLETED|Overall Study||5
6334252|NCT00536744|7241274|FG000|STARTED|Overall Study||107
6334253|NCT00536744|7241275|FG001|STARTED|Overall Study||99
6334254|NCT00536744|7241274|FG000|COMPLETED|Overall Study||78
6334255|NCT00536744|7241275|FG001|COMPLETED|Overall Study||71
6334256|NCT00536744|7241274|FG000|NOT COMPLETED|Overall Study||29
6334257|NCT00536744|7241275|FG001|NOT COMPLETED|Overall Study||28
6334258|NCT00536809|7241281|FG000|STARTED|Phase I (Dose-finding Phase)||10
6334259|NCT00536809|7241281|FG000|COMPLETED|Phase I (Dose-finding Phase)||10
6334260|NCT00536809|7241281|FG000|NOT COMPLETED|Phase I (Dose-finding Phase)||0
6334261|NCT00536809|7241281|FG000|STARTED|Phase II||2
6334262|NCT00536809|7241281|FG000|COMPLETED|Phase II||0
6334263|NCT00536809|7241281|FG000|NOT COMPLETED|Phase II||2
6334264|NCT00536874|7241285|FG000|STARTED|Overall Study||39
6334265|NCT00536874|7241285|FG000|COMPLETED|Overall Study||35
6334266|NCT00536874|7241285|FG000|NOT COMPLETED|Overall Study||4
6334267|NCT00536913|7241291|FG000|STARTED|Overall Study||55
6334268|NCT00536913|7241292|FG001|STARTED|Overall Study||52
6334269|NCT00536913|7241291|FG000|COMPLETED|Overall Study||55
6334270|NCT00536913|7241292|FG001|COMPLETED|Overall Study||52
6334271|NCT00536913|7241291|FG000|NOT COMPLETED|Overall Study||0
6334272|NCT00536913|7241292|FG001|NOT COMPLETED|Overall Study||0
6334273|NCT00536939|7241298|FG000|STARTED|Overall Study||2
6334274|NCT00536939|7241299|FG001|STARTED|Overall Study||0
6334275|NCT00536939|7241298|FG000|Entered Safety lead-in|Overall Study||2
6334276|NCT00536939|7241299|FG001|Entered Safety lead-in|Overall Study||0
6334277|NCT00536939|7241298|FG000|Randomized|Overall Study||0
6334278|NCT00536939|7241299|FG001|Randomized|Overall Study||0
6334279|NCT00536939|7241298|FG000|COMPLETED|Overall Study||0
6334280|NCT00536939|7241299|FG001|COMPLETED|Overall Study||0
6334281|NCT00536939|7241298|FG000|NOT COMPLETED|Overall Study||2
6334282|NCT00536939|7241299|FG001|NOT COMPLETED|Overall Study||0
6334283|NCT00536991|7241304|FG000|STARTED|Overall Study||51
6334284|NCT00536991|7241304|FG000|COMPLETED|Overall Study||38
6334285|NCT00536991|7241304|FG000|NOT COMPLETED|Overall Study||13
6334286|NCT00537017|7241309|FG000|STARTED|Treatment Phase||140
6498370|NCT01409096|7416931|FG001|NOT COMPLETED|Overall Study||5
6498371|NCT01409213|7416937|FG000|STARTED|Overall Study||1523
6498372|NCT01409213|7416937|FG000|COMPLETED|Overall Study||1523
6498373|NCT01409213|7416937|FG000|NOT COMPLETED|Overall Study||0
6334287|NCT00537017|7241309|FG000|COMPLETED|Treatment Phase||106
6334288|NCT00537017|7241309|FG000|NOT COMPLETED|Treatment Phase||34
6334289|NCT00537017|7241309|FG000|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
6334290|NCT00537017|7241309|FG000|COMPLETED|Follow-up Phase||126
6334291|NCT00537017|7241309|FG000|NOT COMPLETED|Follow-up Phase||9
6334292|NCT00537030|7241313|FG000|STARTED|Overall Study||59
6334293|NCT00537030|7241313|FG000|COMPLETED|Overall Study||43
6334294|NCT00537030|7241313|FG000|NOT COMPLETED|Overall Study||16
6498374|NCT01409239|7416943|FG000|STARTED|Overall Study||16
6498375|NCT01409239|7416944|FG001|STARTED|Overall Study||17
6558850|NCT01777776|7481470|FG000|STARTED|Overall Study||6
6558851|NCT01777776|7481471|FG001|STARTED|Overall Study||12
6558852|NCT01777776|7481472|FG002|STARTED|Overall Study||6
6498376|NCT01409239|7416943|FG000|COMPLETED|Overall Study||16
6498377|NCT01409239|7416944|FG001|COMPLETED|Overall Study||17
6498378|NCT01409239|7416943|FG000|NOT COMPLETED|Overall Study||0
6498379|NCT01409239|7416944|FG001|NOT COMPLETED|Overall Study||0
6498380|NCT01409291|7416952|FG000|STARTED|Overall Study||36
6498381|NCT01409291|7416953|FG001|STARTED|Overall Study||28
6498382|NCT01409291|7416952|FG000|COMPLETED|Overall Study||29
6498383|NCT01409291|7416953|FG001|COMPLETED|Overall Study||19
6498384|NCT01409291|7416952|FG000|NOT COMPLETED|Overall Study||7
6498385|NCT01409291|7416953|FG001|NOT COMPLETED|Overall Study||9
6498386|NCT01409382|7416961|FG000|STARTED|Overall Study||240
6498387|NCT01409382|7416962|FG001|STARTED|Overall Study||240
6334295|NCT00537056|7241317|FG000|STARTED|Baseline PET/CT||17
6334296|NCT00537056|7241317|FG000|COMPLETED|Baseline PET/CT||17
6334297|NCT00537056|7241317|FG000|NOT COMPLETED|Baseline PET/CT||0
6334298|NCT00537056|7241317|FG000|STARTED|Interim PET/CT||17
6334299|NCT00537056|7241317|FG000|COMPLETED|Interim PET/CT||12
6334300|NCT00537056|7241317|FG000|NOT COMPLETED|Interim PET/CT||5
6334301|NCT00537056|7241317|FG000|STARTED|12-month Follow-up||17
6334302|NCT00537056|7241317|FG000|COMPLETED|12-month Follow-up||17
6334303|NCT00537056|7241317|FG000|NOT COMPLETED|12-month Follow-up||0
6334304|NCT00537082|7241326|FG000|STARTED|Overall Study||57
6334305|NCT00537082|7241327|FG001|STARTED|Overall Study||57
6334306|NCT00537082|7241328|FG002|STARTED|Overall Study||57
6334307|NCT00537082|7241326|FG000|COMPLETED|Overall Study||48
6334308|NCT00537082|7241327|FG001|COMPLETED|Overall Study||48
6334309|NCT00537082|7241328|FG002|COMPLETED|Overall Study||51
6334310|NCT00537082|7241326|FG000|NOT COMPLETED|Overall Study||9
6334311|NCT00537082|7241327|FG001|NOT COMPLETED|Overall Study||9
6334312|NCT00537082|7241328|FG002|NOT COMPLETED|Overall Study||6
6558853|NCT01777776|7481473|FG003|STARTED|Overall Study||4
6558854|NCT01777776|7481470|FG000|COMPLETED|Overall Study||0
6558855|NCT01777776|7481471|FG001|COMPLETED|Overall Study||0
6558856|NCT01777776|7481472|FG002|COMPLETED|Overall Study||0
6558857|NCT01777776|7481473|FG003|COMPLETED|Overall Study||0
6558858|NCT01777776|7481470|FG000|NOT COMPLETED|Overall Study||6
6558859|NCT01777776|7481471|FG001|NOT COMPLETED|Overall Study||12
6558860|NCT01777776|7481472|FG002|NOT COMPLETED|Overall Study||6
6558861|NCT01777776|7481473|FG003|NOT COMPLETED|Overall Study||4
6558862|NCT01777932|7481492|FG000|STARTED|Overall Study||220
6558863|NCT01777932|7481492|FG000|COMPLETED|Overall Study||15
6558864|NCT01777932|7481492|FG000|NOT COMPLETED|Overall Study||205
6654951|NCT02448914|7584962|FG001|COMPLETED|First Intervention (1 Day)||5
6654952|NCT02448914|7584961|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6775425|NCT03879603|7703347|FG001|Received All Product Administrations|Overall Study||5
6775426|NCT03879603|7703348|FG002|Received All Product Administrations|Overall Study||5
6775427|NCT03879603|7703349|FG003|Received All Product Administrations|Overall Study||5
6775428|NCT03879603|7703350|FG004|Received All Product Administrations|Overall Study||5
6334313|NCT00537095|7241338|FG000|STARTED|Overall Study||72
6334314|NCT00537095|7241339|FG001|STARTED|Overall Study||73
6334315|NCT00537095|7241338|FG000|COMPLETED|Overall Study||21
6334316|NCT00537095|7241339|FG001|COMPLETED|Overall Study||16
6775429|NCT03879603|7703351|FG005|Received All Product Administrations|Overall Study||5
6775430|NCT03879603|7703346|FG000|COMPLETED|Overall Study||5
6775431|NCT03879603|7703347|FG001|COMPLETED|Overall Study||5
6775432|NCT03879603|7703348|FG002|COMPLETED|Overall Study||5
6775433|NCT03879603|7703349|FG003|COMPLETED|Overall Study||5
6775434|NCT03879603|7703350|FG004|COMPLETED|Overall Study||5
6775435|NCT03879603|7703351|FG005|COMPLETED|Overall Study||5
6775436|NCT03879603|7703346|FG000|NOT COMPLETED|Overall Study||0
6775437|NCT03879603|7703347|FG001|NOT COMPLETED|Overall Study||0
6775438|NCT03879603|7703348|FG002|NOT COMPLETED|Overall Study||0
6775439|NCT03879603|7703349|FG003|NOT COMPLETED|Overall Study||0
6654953|NCT02448914|7584962|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6654954|NCT02448914|7584961|FG000|STARTED|Second Intervention (1 Day)||6
6775440|NCT03879603|7703350|FG004|NOT COMPLETED|Overall Study||0
6775441|NCT03879603|7703351|FG005|NOT COMPLETED|Overall Study||0
6775442|NCT03878745|7703367|FG000|STARTED|Overall Study||55
6334317|NCT00537095|7241338|FG000|NOT COMPLETED|Overall Study||51
6334318|NCT00537095|7241339|FG001|NOT COMPLETED|Overall Study||57
6334319|NCT00537238|7241347|FG000|STARTED|Overall Study||254
6334320|NCT00537238|7241348|FG001|STARTED|Overall Study||255
6334321|NCT00537238|7241347|FG000|Completed Titration Phase|Overall Study||226
6334322|NCT00537238|7241348|FG001|Completed Titration Phase|Overall Study||236
6498388|NCT01409382|7416961|FG000|COMPLETED|Overall Study||159
6498389|NCT01409382|7416962|FG001|COMPLETED|Overall Study||160
6775443|NCT03878745|7703367|FG000|COMPLETED|Overall Study||55
6775444|NCT03878745|7703367|FG000|NOT COMPLETED|Overall Study||0
6498390|NCT01409382|7416961|FG000|NOT COMPLETED|Overall Study||81
6558865|NCT01777945|7481496|FG000|STARTED|Overall Study||46
6558866|NCT01777945|7481496|FG000|Evaluable Participants|Overall Study||45
6558867|NCT01777945|7481496|FG000|COMPLETED|Overall Study||46
6558868|NCT01777945|7481496|FG000|NOT COMPLETED|Overall Study||0
6558869|NCT01777997|7481500|FG000|STARTED|12 Week lead-in of no ART||38
6654955|NCT02448914|7584962|FG001|STARTED|Second Intervention (1 Day)||5
6334323|NCT00537238|7241347|FG000|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
6334324|NCT00537238|7241348|FG001|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
6334325|NCT00537238|7241347|FG000|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
6334326|NCT00537238|7241348|FG001|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
6334327|NCT00537238|7241347|FG000|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
6334328|NCT00537238|7241348|FG001|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
6558870|NCT01777997|7481500|FG000|COMPLETED|12 Week lead-in of no ART||36
6334329|NCT00537238|7241347|FG000|NOT COMPLETED|Overall Study||174
6334330|NCT00537238|7241348|FG001|NOT COMPLETED|Overall Study||173
6334331|NCT00537277|7241354|FG000|STARTED|Overall Study||161
6498391|NCT01409382|7416962|FG001|NOT COMPLETED|Overall Study||80
6498392|NCT01409434|7416972|FG000|STARTED|Overall Study||44
6498393|NCT01409434|7416972|FG000|COMPLETED|Overall Study||40
6498394|NCT01409434|7416972|FG000|NOT COMPLETED|Overall Study||4
6498395|NCT01409564|7416978|FG000|STARTED|Overall Study||23
6498396|NCT01409564|7416979|FG001|STARTED|Overall Study||23
6498397|NCT01409564|7416978|FG000|COMPLETED|Overall Study||18
6498398|NCT01409564|7416979|FG001|COMPLETED|Overall Study||18
6498399|NCT01409564|7416978|FG000|NOT COMPLETED|Overall Study||5
6498400|NCT01409564|7416979|FG001|NOT COMPLETED|Overall Study||5
6498401|NCT01409707|7416992|FG000|STARTED|Overall Study||41
6498402|NCT01409707|7416993|FG001|STARTED|Overall Study||45
6498403|NCT01409707|7416994|FG002|STARTED|Overall Study||40
6498404|NCT01409707|7416992|FG000|COMPLETED|Overall Study||36
6498405|NCT01409707|7416993|FG001|COMPLETED|Overall Study||28
6498406|NCT01409707|7416994|FG002|COMPLETED|Overall Study||24
6498407|NCT01409707|7416992|FG000|NOT COMPLETED|Overall Study||5
6498408|NCT01409707|7416993|FG001|NOT COMPLETED|Overall Study||17
6498409|NCT01409707|7416994|FG002|NOT COMPLETED|Overall Study||16
6498410|NCT01409811|7417001|FG000|STARTED|Overall Study||9
6498411|NCT01409811|7417001|FG000|COMPLETED|Overall Study||8
6498412|NCT01409811|7417001|FG000|NOT COMPLETED|Overall Study||1
6498413|NCT01409837|7417007|FG000|STARTED|Overall Study||17
6498414|NCT01409837|7417008|FG001|STARTED|Overall Study||16
6498415|NCT01409837|7417007|FG000|6th Week|Overall Study||17
6498416|NCT01409837|7417008|FG001|6th Week|Overall Study||16
6498417|NCT01409837|7417007|FG000|12th Week|Overall Study|Moved away to another location|16
6498418|NCT01409837|7417008|FG001|12th Week|Overall Study||16
6334332|NCT00537277|7241354|FG000|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
6334333|NCT00537277|7241354|FG000|COMPLETED|Overall Study||112
6334334|NCT00537277|7241354|FG000|NOT COMPLETED|Overall Study||49
6334335|NCT00537290|7241358|FG000|STARTED|Overall Study||19
6334336|NCT00537290|7241358|FG000|COMPLETED|Overall Study||19
6334337|NCT00537290|7241358|FG000|NOT COMPLETED|Overall Study||0
6334338|NCT00537303|7241364|FG000|STARTED|Overall Study||146
6334339|NCT00537303|7241365|FG001|STARTED|Overall Study||150
6334340|NCT00537303|7241364|FG000|COMPLETED|Overall Study||120
6334341|NCT00537303|7241365|FG001|COMPLETED|Overall Study||125
6334342|NCT00537303|7241364|FG000|NOT COMPLETED|Overall Study||26
6334343|NCT00537303|7241365|FG001|NOT COMPLETED|Overall Study||25
6334344|NCT00537316|7241377|FG000|STARTED|Part 1||79
6334345|NCT00537316|7241378|FG001|STARTED|Part 1||80
6334346|NCT00537316|7241379|FG002|STARTED|Part 1||80
6334347|NCT00537316|7241380|FG003|STARTED|Part 1||0
6334348|NCT00537316|7241381|FG004|STARTED|Part 1||0
6334349|NCT00537316|7241382|FG005|STARTED|Part 1||0
6334350|NCT00537316|7241383|FG006|STARTED|Part 1||0
6334351|NCT00537316|7241377|FG000|COMPLETED|Part 1||65
6334352|NCT00537316|7241378|FG001|COMPLETED|Part 1||53
6334353|NCT00537316|7241379|FG002|COMPLETED|Part 1||63
6334354|NCT00537316|7241380|FG003|COMPLETED|Part 1||0
6334355|NCT00537316|7241381|FG004|COMPLETED|Part 1||0
6334356|NCT00537316|7241382|FG005|COMPLETED|Part 1||0
6334357|NCT00537316|7241383|FG006|COMPLETED|Part 1||0
6334358|NCT00537316|7241377|FG000|NOT COMPLETED|Part 1||14
6334359|NCT00537316|7241378|FG001|NOT COMPLETED|Part 1||27
6334360|NCT00537316|7241379|FG002|NOT COMPLETED|Part 1||17
6334361|NCT00537316|7241380|FG003|NOT COMPLETED|Part 1||0
6334362|NCT00537316|7241381|FG004|NOT COMPLETED|Part 1||0
6334363|NCT00537316|7241382|FG005|NOT COMPLETED|Part 1||0
6334364|NCT00537316|7241383|FG006|NOT COMPLETED|Part 1||0
6334365|NCT00537316|7241377|FG000|STARTED|Part 2||37
6334366|NCT00537316|7241378|FG001|STARTED|Part 2||10
6334367|NCT00537316|7241379|FG002|STARTED|Part 2||48
6498419|NCT01409837|7417007|FG000|24th Week|Overall Study||16
6498420|NCT01409837|7417008|FG001|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
6498421|NCT01409837|7417007|FG000|48th Week|Overall Study|Lost to follow-up|15
6498422|NCT01409837|7417008|FG001|48th Week|Overall Study||15
6498423|NCT01409837|7417007|FG000|96th Week|Overall Study||15
6498424|NCT01409837|7417008|FG001|96th Week|Overall Study||15
6498425|NCT01409837|7417007|FG000|102nd Week|Overall Study||15
6334368|NCT00537316|7241380|FG003|STARTED|Part 2||5
6334369|NCT00537316|7241381|FG004|STARTED|Part 2||2
6334370|NCT00537316|7241382|FG005|STARTED|Part 2||4
6498426|NCT01409837|7417008|FG001|102nd Week|Overall Study|Married another wife|14
6498427|NCT01409837|7417007|FG000|114th Week|Overall Study||15
6498428|NCT01409837|7417008|FG001|114th Week|Overall Study||14
6334371|NCT00537316|7241383|FG006|STARTED|Part 2||2
6334372|NCT00537316|7241377|FG000|COMPLETED|Part 2||11
6334373|NCT00537316|7241378|FG001|COMPLETED|Part 2||1
6334374|NCT00537316|7241379|FG002|COMPLETED|Part 2||16
6334375|NCT00537316|7241380|FG003|COMPLETED|Part 2||2
6334376|NCT00537316|7241381|FG004|COMPLETED|Part 2||1
6334377|NCT00537316|7241382|FG005|COMPLETED|Part 2||0
6334378|NCT00537316|7241383|FG006|COMPLETED|Part 2||0
6334379|NCT00537316|7241377|FG000|NOT COMPLETED|Part 2||26
6334380|NCT00537316|7241378|FG001|NOT COMPLETED|Part 2||9
6334381|NCT00537316|7241379|FG002|NOT COMPLETED|Part 2||32
6334382|NCT00537316|7241380|FG003|NOT COMPLETED|Part 2||3
6334383|NCT00537316|7241381|FG004|NOT COMPLETED|Part 2||1
6334384|NCT00537316|7241382|FG005|NOT COMPLETED|Part 2||4
6334385|NCT00537316|7241383|FG006|NOT COMPLETED|Part 2||2
6334386|NCT00537329|7241402|FG000|STARTED|Overall Study||43
6334387|NCT00537329|7241402|FG000|COMPLETED|Overall Study||17
6334388|NCT00537329|7241402|FG000|NOT COMPLETED|Overall Study||26
6334389|NCT00537381|7241408|FG000|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
6334390|NCT00537381|7241409|FG001|STARTED|Overall Study||66
6334391|NCT00537381|7241408|FG000|COMPLETED|Overall Study||9
6334392|NCT00537381|7241409|FG001|COMPLETED|Overall Study||4
6334393|NCT00537381|7241408|FG000|NOT COMPLETED|Overall Study||56
6334394|NCT00537381|7241409|FG001|NOT COMPLETED|Overall Study||62
6334395|NCT00537394|7241420|FG000|STARTED|First Year of Follow-up||181
6334396|NCT00537394|7241421|FG001|STARTED|First Year of Follow-up||179
6334397|NCT00537394|7241422|FG002|STARTED|First Year of Follow-up||53
6334398|NCT00537394|7241420|FG000|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
6334399|NCT00537394|7241421|FG001|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
6334400|NCT00537394|7241422|FG002|COMPLETED|First Year of Follow-up||50
6334401|NCT00537394|7241420|FG000|NOT COMPLETED|First Year of Follow-up||12
6334402|NCT00537394|7241421|FG001|NOT COMPLETED|First Year of Follow-up||11
6334403|NCT00537394|7241422|FG002|NOT COMPLETED|First Year of Follow-up||3
6334404|NCT00537394|7241420|FG000|STARTED|2nd Year of Follow-up||169
6334405|NCT00537394|7241421|FG001|STARTED|2nd Year of Follow-up||168
6334406|NCT00537394|7241422|FG002|STARTED|2nd Year of Follow-up||50
6334407|NCT00537394|7241420|FG000|COMPLETED|2nd Year of Follow-up||158
6334408|NCT00537394|7241421|FG001|COMPLETED|2nd Year of Follow-up||159
6334409|NCT00537394|7241422|FG002|COMPLETED|2nd Year of Follow-up||44
6334410|NCT00537394|7241420|FG000|NOT COMPLETED|2nd Year of Follow-up||11
6334411|NCT00537394|7241421|FG001|NOT COMPLETED|2nd Year of Follow-up||9
6334412|NCT00537394|7241422|FG002|NOT COMPLETED|2nd Year of Follow-up||6
6334413|NCT00537407|7241433|FG000|STARTED|Part 1 Weeks 1-4||10
6334414|NCT00537407|7241434|FG001|STARTED|Part 1 Weeks 1-4||9
6334415|NCT00537407|7241435|FG002|STARTED|Part 1 Weeks 1-4||11
6334416|NCT00537407|7241436|FG003|STARTED|Part 1 Weeks 1-4||10
6558871|NCT01777997|7481500|FG000|NOT COMPLETED|12 Week lead-in of no ART||2
6558872|NCT01777997|7481500|FG000|STARTED|Weeks 0 to 24/48 on ART||36
6558873|NCT01777997|7481500|FG000|COMPLETED|Weeks 0 to 24/48 on ART|7 of these participants opted not to continue ART into next period|35
6558874|NCT01777997|7481500|FG000|NOT COMPLETED|Weeks 0 to 24/48 on ART||1
6558875|NCT01777997|7481500|FG000|STARTED|Weeks 48 to 72/96 on ART||28
6558876|NCT01777997|7481500|FG000|COMPLETED|Weeks 48 to 72/96 on ART||26
6558877|NCT01777997|7481500|FG000|NOT COMPLETED|Weeks 48 to 72/96 on ART||2
6558878|NCT01778010|7481504|FG000|STARTED|Overall Study||13
6558879|NCT01778010|7481504|FG000|COMPLETED|Overall Study||8
6558880|NCT01778010|7481504|FG000|NOT COMPLETED|Overall Study||5
6558881|NCT01778023|7481523|FG000|STARTED|Overall Study||36
6558882|NCT01778023|7481524|FG001|STARTED|Overall Study||18
6558883|NCT01778023|7481523|FG000|Exposed|Overall Study||36
6558884|NCT01778023|7481524|FG001|Exposed|Overall Study||15
6558885|NCT01778023|7481523|FG000|COMPLETED|Overall Study||36
6558886|NCT01778023|7481524|FG001|COMPLETED|Overall Study||15
6558887|NCT01778023|7481523|FG000|NOT COMPLETED|Overall Study||0
6558888|NCT01778023|7481524|FG001|NOT COMPLETED|Overall Study||3
6558889|NCT01778049|7481532|FG000|STARTED|Open Label Treatment Period||354
6558890|NCT01778049|7481533|FG001|STARTED|Open Label Treatment Period||355
6558891|NCT01778049|7481534|FG002|STARTED|Open Label Treatment Period||0
6654956|NCT02448914|7584961|FG000|COMPLETED|Second Intervention (1 Day)||6
6654957|NCT02448914|7584962|FG001|COMPLETED|Second Intervention (1 Day)||5
6654958|NCT02448914|7584961|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6775445|NCT03848221|7703382|FG000|STARTED|Overall Study||25
6775446|NCT03848221|7703383|FG001|STARTED|Overall Study||24
6775447|NCT03848221|7703384|FG002|STARTED|Overall Study||24
6775448|NCT03848221|7703382|FG000|COMPLETED|Overall Study||25
6775449|NCT03848221|7703383|FG001|COMPLETED|Overall Study||24
6775450|NCT03848221|7703384|FG002|COMPLETED|Overall Study||24
6775451|NCT03848221|7703382|FG000|NOT COMPLETED|Overall Study||0
6775452|NCT03848221|7703383|FG001|NOT COMPLETED|Overall Study||0
6775453|NCT03848221|7703384|FG002|NOT COMPLETED|Overall Study||0
6558892|NCT01778049|7481535|FG003|STARTED|Open Label Treatment Period||0
6558893|NCT01778049|7481536|FG004|STARTED|Open Label Treatment Period||0
6654959|NCT02448914|7584962|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6775454|NCT03878108|7703394|FG000|STARTED|Overall Study||11
6775455|NCT03878108|7703395|FG001|STARTED|Overall Study||10
6334417|NCT00537407|7241437|FG004|STARTED|Part 1 Weeks 1-4||10
6334418|NCT00537407|7241433|FG000|COMPLETED|Part 1 Weeks 1-4||10
6334419|NCT00537407|7241434|FG001|COMPLETED|Part 1 Weeks 1-4||9
6334420|NCT00537407|7241435|FG002|COMPLETED|Part 1 Weeks 1-4||11
6334421|NCT00537407|7241436|FG003|COMPLETED|Part 1 Weeks 1-4||10
6334422|NCT00537407|7241437|FG004|COMPLETED|Part 1 Weeks 1-4||10
6334423|NCT00537407|7241433|FG000|NOT COMPLETED|Part 1 Weeks 1-4||0
6334424|NCT00537407|7241434|FG001|NOT COMPLETED|Part 1 Weeks 1-4||0
6334425|NCT00537407|7241435|FG002|NOT COMPLETED|Part 1 Weeks 1-4||0
6334426|NCT00537407|7241436|FG003|NOT COMPLETED|Part 1 Weeks 1-4||0
6334427|NCT00537407|7241437|FG004|NOT COMPLETED|Part 1 Weeks 1-4||0
6334428|NCT00537407|7241433|FG000|STARTED|Part 2 Weeks 5-48 or 72||10
6334429|NCT00537407|7241434|FG001|STARTED|Part 2 Weeks 5-48 or 72||9
6334430|NCT00537407|7241435|FG002|STARTED|Part 2 Weeks 5-48 or 72||11
6334431|NCT00537407|7241436|FG003|STARTED|Part 2 Weeks 5-48 or 72||10
6334432|NCT00537407|7241437|FG004|STARTED|Part 2 Weeks 5-48 or 72||10
6334433|NCT00537407|7241433|FG000|COMPLETED|Part 2 Weeks 5-48 or 72||2
6334434|NCT00537407|7241434|FG001|COMPLETED|Part 2 Weeks 5-48 or 72||1
6334435|NCT00537407|7241435|FG002|COMPLETED|Part 2 Weeks 5-48 or 72||2
6334436|NCT00537407|7241436|FG003|COMPLETED|Part 2 Weeks 5-48 or 72||4
6334437|NCT00537407|7241437|FG004|COMPLETED|Part 2 Weeks 5-48 or 72||3
6334438|NCT00537407|7241433|FG000|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
6334439|NCT00537407|7241434|FG001|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
6334440|NCT00537407|7241435|FG002|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
6334441|NCT00537407|7241436|FG003|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
6334442|NCT00537407|7241437|FG004|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
6334443|NCT00537485|7241455|FG000|STARTED|Overall Study||90
6334444|NCT00537485|7241456|FG001|STARTED|Overall Study||90
6334445|NCT00537485|7241455|FG000|COMPLETED|Overall Study||75
6334446|NCT00537485|7241456|FG001|COMPLETED|Overall Study||80
6334447|NCT00537485|7241455|FG000|NOT COMPLETED|Overall Study||15
6334448|NCT00537485|7241456|FG001|NOT COMPLETED|Overall Study||10
6334449|NCT00537511|7241462|FG000|STARTED|Treatment Period (Combination)||22
6334450|NCT00537511|7241462|FG000|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
6334451|NCT00537511|7241462|FG000|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
6334452|NCT00537511|7241462|FG000|COMPLETED|Treatment Period (Combination)||17
6334453|NCT00537511|7241462|FG000|NOT COMPLETED|Treatment Period (Combination)||5
6334454|NCT00537511|7241462|FG000|STARTED|Extension Period (Combination)||17
6334455|NCT00537511|7241462|FG000|COMPLETED|Extension Period (Combination)||11
6334456|NCT00537511|7241462|FG000|NOT COMPLETED|Extension Period (Combination)||6
6334457|NCT00537511|7241462|FG000|STARTED|Recovery Period (Monotherapy)||11
6334458|NCT00537511|7241462|FG000|COMPLETED|Recovery Period (Monotherapy)||3
6334459|NCT00537511|7241462|FG000|NOT COMPLETED|Recovery Period (Monotherapy)||8
6334460|NCT00537511|7241462|FG000|STARTED|Maintenance Phase (Monotherapy)||8
6334461|NCT00537511|7241462|FG000|COMPLETED|Maintenance Phase (Monotherapy)||0
6334462|NCT00537511|7241462|FG000|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
6334463|NCT00537576|7241485|FG000|STARTED|Overall Study||3
6334464|NCT00537576|7241486|FG001|STARTED|Overall Study||3
6334465|NCT00537576|7241487|FG002|STARTED|Overall Study||3
6334466|NCT00537576|7241488|FG003|STARTED|Overall Study||1
6334467|NCT00537576|7241489|FG004|STARTED|Overall Study||1
6334468|NCT00537576|7241490|FG005|STARTED|Overall Study||1
6334469|NCT00537576|7241485|FG000|COMPLETED|Overall Study||3
6334470|NCT00537576|7241486|FG001|COMPLETED|Overall Study||3
6334471|NCT00537576|7241487|FG002|COMPLETED|Overall Study||3
6334472|NCT00537576|7241488|FG003|COMPLETED|Overall Study||1
6334473|NCT00537576|7241489|FG004|COMPLETED|Overall Study||1
6334474|NCT00537576|7241490|FG005|COMPLETED|Overall Study||1
6334475|NCT00537576|7241485|FG000|NOT COMPLETED|Overall Study||0
6334476|NCT00537576|7241486|FG001|NOT COMPLETED|Overall Study||0
6334477|NCT00537576|7241487|FG002|NOT COMPLETED|Overall Study||0
6334478|NCT00537576|7241488|FG003|NOT COMPLETED|Overall Study||0
6334479|NCT00537576|7241489|FG004|NOT COMPLETED|Overall Study||0
6334480|NCT00537576|7241490|FG005|NOT COMPLETED|Overall Study||0
6334481|NCT00537680|7241507|FG000|STARTED|Overall Study||22
6334482|NCT00537680|7241508|FG001|STARTED|Overall Study||24
6334483|NCT00537680|7241509|FG002|STARTED|Overall Study||24
6334484|NCT00537680|7241507|FG000|COMPLETED|Overall Study||22
6334485|NCT00537680|7241508|FG001|COMPLETED|Overall Study||22
6334486|NCT00537680|7241509|FG002|COMPLETED|Overall Study||24
6334487|NCT00537680|7241507|FG000|NOT COMPLETED|Overall Study||0
6334488|NCT00537680|7241508|FG001|NOT COMPLETED|Overall Study||2
6334489|NCT00537680|7241509|FG002|NOT COMPLETED|Overall Study||0
6376148|NCT00758524|7286591|FG016|Randomized Withdrawal Set|Withdrawal Period (Week 8 to Week 9)|One participant randomized to Placebo arm in Withdrawal Period received LCI699 0.5 mg QD and was counted in LCI699 0.5 mg QD arm in the Randomized Withdrawal Safety Set. However, this participant was counted in the Placebo arm (N=67) in the Randomized Withdrawal Set.|67
6376149|NCT00758524|7286575|FG000|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376150|NCT00758524|7286576|FG001|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376151|NCT00758524|7286577|FG002|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376152|NCT00758524|7286578|FG003|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376153|NCT00758524|7286579|FG004|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376154|NCT00758524|7286580|FG005|COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376155|NCT00758524|7286581|FG006|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
6376156|NCT00758524|7286582|FG007|COMPLETED|Withdrawal Period (Week 8 to Week 9)||38
6376157|NCT00758524|7286583|FG008|COMPLETED|Withdrawal Period (Week 8 to Week 9)||42
6376158|NCT00758524|7286584|FG009|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
6334490|NCT00537745|7241517|FG000|STARTED|Overall Study|There were three screen fails and two early terminations.|14
6334491|NCT00537745|7241517|FG000|Began Intervention|Overall Study||11
6334492|NCT00537745|7241517|FG000|COMPLETED|Overall Study||9
6334493|NCT00537745|7241517|FG000|NOT COMPLETED|Overall Study||5
6334494|NCT00537771|7241524|FG000|STARTED|Overall Study||178
6334495|NCT00537771|7241525|FG001|STARTED|Overall Study||175
6334496|NCT00537771|7241524|FG000|COMPLETED|Overall Study||149
6334497|NCT00537771|7241525|FG001|COMPLETED|Overall Study||114
6334498|NCT00537771|7241524|FG000|NOT COMPLETED|Overall Study||29
6334499|NCT00537771|7241525|FG001|NOT COMPLETED|Overall Study||61
6334500|NCT00537810|7241535|FG000|STARTED|Overall Study||26
6334501|NCT00537810|7241536|FG001|STARTED|Overall Study||27
6334502|NCT00537810|7241537|FG002|STARTED|Overall Study||25
6334503|NCT00537810|7241538|FG003|STARTED|Overall Study||26
6334504|NCT00537810|7241535|FG000|COMPLETED|Overall Study||20
6334505|NCT00537810|7241536|FG001|COMPLETED|Overall Study||14
6334506|NCT00537810|7241537|FG002|COMPLETED|Overall Study||21
6334507|NCT00537810|7241538|FG003|COMPLETED|Overall Study||22
6334508|NCT00537810|7241535|FG000|NOT COMPLETED|Overall Study||6
6334509|NCT00537810|7241536|FG001|NOT COMPLETED|Overall Study||13
6334510|NCT00537810|7241537|FG002|NOT COMPLETED|Overall Study||4
6334511|NCT00537810|7241538|FG003|NOT COMPLETED|Overall Study||4
6334512|NCT00537823|7241550|FG000|STARTED|Overall Study||7
6334513|NCT00537823|7241551|FG001|STARTED|Overall Study||2
6334514|NCT00537823|7241550|FG000|COMPLETED|Overall Study||5
6334515|NCT00537823|7241551|FG001|COMPLETED|Overall Study||2
6334516|NCT00537823|7241550|FG000|NOT COMPLETED|Overall Study||2
6334517|NCT00537823|7241551|FG001|NOT COMPLETED|Overall Study||0
6334518|NCT00537940|7241560|FG000|STARTED|Overall Study||241
6334519|NCT00537940|7241561|FG001|STARTED|Overall Study||241
6334520|NCT00537940|7241560|FG000|Completed Titration Phase|Overall Study||213
6334521|NCT00537940|7241561|FG001|Completed Titration Phase|Overall Study||210
6334522|NCT00537940|7241560|FG000|Completed Maintenance Phase|Overall Study||187
6334523|NCT00537940|7241561|FG001|Completed Maintenance Phase|Overall Study||172
6334524|NCT00537940|7241560|FG000|Entered Opt Blinded Continuation Phase|Overall Study||140
6334525|NCT00537940|7241561|FG001|Entered Opt Blinded Continuation Phase|Overall Study||139
6334526|NCT00537940|7241560|FG000|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
6334527|NCT00537940|7241561|FG001|COMPLETED|Overall Study||62
6334528|NCT00537940|7241560|FG000|NOT COMPLETED|Overall Study||183
6334529|NCT00537940|7241561|FG001|NOT COMPLETED|Overall Study||179
6334530|NCT00537979|7241569|FG000|STARTED|Overall Study||38
6334531|NCT00537979|7241570|FG001|STARTED|Overall Study||109
6334532|NCT00537979|7241569|FG000|COMPLETED|Overall Study||32
6334533|NCT00537979|7241570|FG001|COMPLETED|Overall Study||89
6334534|NCT00537979|7241569|FG000|NOT COMPLETED|Overall Study||6
6334535|NCT00537979|7241570|FG001|NOT COMPLETED|Overall Study||20
6334536|NCT00538213|7241580|FG000|STARTED|Overall Study||55
6334537|NCT00538213|7241581|FG001|STARTED|Overall Study||40
6334538|NCT00538213|7241582|FG002|STARTED|Overall Study||38
6334539|NCT00538213|7241580|FG000|COMPLETED|Overall Study||55
6334540|NCT00538213|7241581|FG001|COMPLETED|Overall Study||40
6334541|NCT00538213|7241582|FG002|COMPLETED|Overall Study||38
6334542|NCT00538213|7241580|FG000|NOT COMPLETED|Overall Study||0
6334543|NCT00538213|7241581|FG001|NOT COMPLETED|Overall Study||0
6334544|NCT00538213|7241582|FG002|NOT COMPLETED|Overall Study||0
6334545|NCT00538291|7241591|FG000|STARTED|Overall Study||13
6334546|NCT00538291|7241591|FG000|COMPLETED|Overall Study||10
6334547|NCT00538291|7241591|FG000|NOT COMPLETED|Overall Study||3
6334548|NCT00538304|7241597|FG000|STARTED|Overall Study||151
6334549|NCT00538304|7241598|FG001|STARTED|Overall Study||71
6334550|NCT00538304|7241597|FG000|COMPLETED|Overall Study||144
6334551|NCT00538304|7241598|FG001|COMPLETED|Overall Study||66
6334552|NCT00538304|7241597|FG000|NOT COMPLETED|Overall Study||7
6334553|NCT00538304|7241598|FG001|NOT COMPLETED|Overall Study||5
6334554|NCT00538434|7241608|FG000|STARTED|Overall Study||56
6334555|NCT00538434|7241609|FG001|STARTED|Overall Study||57
6334556|NCT00538434|7241610|FG002|STARTED|Overall Study||57
6334557|NCT00538434|7241611|FG003|STARTED|Overall Study||57
6334558|NCT00538434|7241608|FG000|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
6334559|NCT00538434|7241609|FG001|Intent-to-treat (ITT) Population|Overall Study||57
6334560|NCT00538434|7241610|FG002|Intent-to-treat (ITT) Population|Overall Study||57
6334561|NCT00538434|7241611|FG003|Intent-to-treat (ITT) Population|Overall Study||57
6334562|NCT00538434|7241608|FG000|COMPLETED|Overall Study|Completed all scheduled study visits|47
6334563|NCT00538434|7241609|FG001|COMPLETED|Overall Study|Completed all scheduled study visits|46
6334564|NCT00538434|7241610|FG002|COMPLETED|Overall Study|Completed all scheduled study visits|50
6334565|NCT00538434|7241611|FG003|COMPLETED|Overall Study|Completed all scheduled study visits|51
6334566|NCT00538434|7241608|FG000|NOT COMPLETED|Overall Study||9
6334567|NCT00538434|7241609|FG001|NOT COMPLETED|Overall Study||11
6334568|NCT00538434|7241610|FG002|NOT COMPLETED|Overall Study||7
6334569|NCT00538434|7241611|FG003|NOT COMPLETED|Overall Study||6
6334570|NCT00538473|7241624|FG000|STARTED|Overall Study||33
6334571|NCT00538473|7241625|FG001|STARTED|Overall Study||35
6334572|NCT00538473|7241624|FG000|COMPLETED|Overall Study||32
6334573|NCT00538473|7241625|FG001|COMPLETED|Overall Study||35
6334574|NCT00538473|7241624|FG000|NOT COMPLETED|Overall Study||1
6334575|NCT00538473|7241625|FG001|NOT COMPLETED|Overall Study||0
6334576|NCT00538512|7241634|FG000|STARTED|Overall Study||814
6334577|NCT00538512|7241635|FG001|STARTED|Overall Study||813
6334578|NCT00538512|7241636|FG002|STARTED|Overall Study||325
6334579|NCT00538512|7241634|FG000|COMPLETED|Overall Study||787
6334580|NCT00538512|7241635|FG001|COMPLETED|Overall Study||783
6334581|NCT00538512|7241636|FG002|COMPLETED|Overall Study||312
6334582|NCT00538512|7241634|FG000|NOT COMPLETED|Overall Study||27
6334583|NCT00538512|7241635|FG001|NOT COMPLETED|Overall Study||30
6334584|NCT00538512|7241636|FG002|NOT COMPLETED|Overall Study||13
6334585|NCT00538590|7241646|FG000|STARTED|Overall Study||10
6334586|NCT00538590|7241647|FG001|STARTED|Overall Study||10
6334587|NCT00538590|7241646|FG000|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
6334588|NCT00538590|7241647|FG001|COMPLETED|Overall Study||10
6334589|NCT00538590|7241646|FG000|NOT COMPLETED|Overall Study||1
6334590|NCT00538590|7241647|FG001|NOT COMPLETED|Overall Study||0
6334591|NCT00538616|7241655|FG000|STARTED|Overall Study||5
6334592|NCT00538616|7241656|FG001|STARTED|Overall Study||3
6334593|NCT00538616|7241655|FG000|COMPLETED|Overall Study||5
6334594|NCT00538616|7241656|FG001|COMPLETED|Overall Study||3
6334595|NCT00538616|7241655|FG000|NOT COMPLETED|Overall Study||0
6334596|NCT00538616|7241656|FG001|NOT COMPLETED|Overall Study||0
6334597|NCT00538629|7241662|FG000|STARTED|Overall Study||471
6334598|NCT00538629|7241662|FG000|COMPLETED|Overall Study||449
6334599|NCT00538629|7241662|FG000|NOT COMPLETED|Overall Study||22
6334600|NCT00538642|7241668|FG000|STARTED|Overall Study||10
6334601|NCT00538642|7241669|FG001|STARTED|Overall Study||14
6334602|NCT00538642|7241668|FG000|COMPLETED|Overall Study||9
6334603|NCT00538642|7241669|FG001|COMPLETED|Overall Study||9
6334604|NCT00538642|7241668|FG000|NOT COMPLETED|Overall Study||1
6334605|NCT00538642|7241669|FG001|NOT COMPLETED|Overall Study||5
6334606|NCT00538681|7241680|FG000|STARTED|Overall Study||9
6334607|NCT00538681|7241681|FG001|STARTED|Overall Study||4
6334608|NCT00538681|7241682|FG002|STARTED|Overall Study||11
6334609|NCT00538681|7241683|FG003|STARTED|Overall Study|One (1) participant received pemetrexed and cisplatin only before the study was closed.|11
6334610|NCT00538681|7241680|FG000|Received ≥1 Dose of Any Study Drug|Overall Study||9
6334611|NCT00538681|7241681|FG001|Received ≥1 Dose of Any Study Drug|Overall Study||4
6334612|NCT00538681|7241682|FG002|Received ≥1 Dose of Any Study Drug|Overall Study||11
6334613|NCT00538681|7241683|FG003|Received ≥1 Dose of Any Study Drug|Overall Study||11
6334614|NCT00538681|7241680|FG000|COMPLETED|Overall Study||0
6334615|NCT00538681|7241681|FG001|COMPLETED|Overall Study||0
6334616|NCT00538681|7241682|FG002|COMPLETED|Overall Study||0
6334617|NCT00538681|7241683|FG003|COMPLETED|Overall Study||0
6334618|NCT00538681|7241680|FG000|NOT COMPLETED|Overall Study||9
6334619|NCT00538681|7241681|FG001|NOT COMPLETED|Overall Study||4
6334620|NCT00538681|7241682|FG002|NOT COMPLETED|Overall Study||11
6334621|NCT00538681|7241683|FG003|NOT COMPLETED|Overall Study||11
6334622|NCT00538733|7241694|FG000|STARTED|Overall Study||26
6334623|NCT00538733|7241694|FG000|Removed Due to Progression of Disease|Overall Study||1
6334624|NCT00538733|7241694|FG000|Removed to Pursue a Stem Cell Transplant|Overall Study||11
6334625|NCT00538733|7241694|FG000|Removed to Pursue Alternative Theray|Overall Study||2
6334626|NCT00538733|7241694|FG000|COMPLETED|Overall Study||14
6558894|NCT01778049|7481537|FG005|STARTED|Open Label Treatment Period||0
6558895|NCT01778049|7481532|FG000|COMPLETED|Open Label Treatment Period||256
6558896|NCT01778049|7481533|FG001|COMPLETED|Open Label Treatment Period||226
6558897|NCT01778049|7481534|FG002|COMPLETED|Open Label Treatment Period||0
6558898|NCT01778049|7481535|FG003|COMPLETED|Open Label Treatment Period||0
6558899|NCT01778049|7481536|FG004|COMPLETED|Open Label Treatment Period||0
6558900|NCT01778049|7481537|FG005|COMPLETED|Open Label Treatment Period||0
6558901|NCT01778049|7481532|FG000|NOT COMPLETED|Open Label Treatment Period||98
6558902|NCT01778049|7481533|FG001|NOT COMPLETED|Open Label Treatment Period||129
6558903|NCT01778049|7481534|FG002|NOT COMPLETED|Open Label Treatment Period||0
6775456|NCT03878108|7703394|FG000|Completed First Phase|Overall Study||10
6775457|NCT03878108|7703395|FG001|Completed First Phase|Overall Study||10
6775458|NCT03878108|7703394|FG000|COMPLETED|Overall Study||10
6775459|NCT03878108|7703395|FG001|COMPLETED|Overall Study||10
6775460|NCT03878108|7703394|FG000|NOT COMPLETED|Overall Study||1
6775461|NCT03878108|7703395|FG001|NOT COMPLETED|Overall Study||0
6775462|NCT03877432|7703401|FG000|STARTED|Overall Study||10
6775463|NCT03877432|7703401|FG000|COMPLETED|Overall Study||10
6775464|NCT03877432|7703401|FG000|NOT COMPLETED|Overall Study||0
6775465|NCT03877237|7703411|FG000|STARTED|Overall Study||156
6775466|NCT03877237|7703412|FG001|STARTED|Overall Study||157
6775467|NCT03877237|7703411|FG000|Treated|Overall Study||156
6775468|NCT03877237|7703412|FG001|Treated|Overall Study||157
6775469|NCT03877237|7703411|FG000|COMPLETED|Overall Study||151
6775470|NCT03877237|7703412|FG001|COMPLETED|Overall Study||151
6334627|NCT00538733|7241694|FG000|NOT COMPLETED|Overall Study||12
6775471|NCT03877237|7703411|FG000|NOT COMPLETED|Overall Study||5
6775472|NCT03877237|7703412|FG001|NOT COMPLETED|Overall Study||6
6334628|NCT00538759|7241703|FG000|STARTED|Overall Study||13
6334629|NCT00538759|7241704|FG001|STARTED|Overall Study||8
6334630|NCT00538759|7241703|FG000|COMPLETED|Overall Study||13
6334631|NCT00538759|7241704|FG001|COMPLETED|Overall Study||8
6334632|NCT00538759|7241703|FG000|NOT COMPLETED|Overall Study||0
6334633|NCT00538759|7241704|FG001|NOT COMPLETED|Overall Study||0
6377899|NCT00765843|7288574|FG000|NOT COMPLETED|Overall Study||1
6558904|NCT01778049|7481535|FG003|NOT COMPLETED|Open Label Treatment Period||0
6775473|NCT03866434|7703418|FG000|STARTED|Overall Study||20
6334634|NCT00538785|7241712|FG000|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
6334635|NCT00538785|7241713|FG001|STARTED|Overall Study||612
6334636|NCT00538785|7241712|FG000|COMPLETED|Overall Study||604
6334637|NCT00538785|7241713|FG001|COMPLETED|Overall Study||595
6334638|NCT00538785|7241712|FG000|NOT COMPLETED|Overall Study||19
6334639|NCT00538785|7241713|FG001|NOT COMPLETED|Overall Study||17
6334640|NCT00538824|7241719|FG000|STARTED|Overall Study||5
6334641|NCT00538824|7241719|FG000|Progression of Disease|Overall Study||2
6334642|NCT00538824|7241719|FG000|COMPLETED|Overall Study||5
6334643|NCT00538824|7241719|FG000|NOT COMPLETED|Overall Study||0
6334644|NCT00538850|7241723|FG000|STARTED|Titration Period||130
6334645|NCT00538850|7241724|FG001|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
6334646|NCT00538850|7241725|FG002|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
6334647|NCT00538850|7241723|FG000|COMPLETED|Titration Period||98
6334648|NCT00538850|7241724|FG001|COMPLETED|Titration Period||0
6334649|NCT00538850|7241725|FG002|COMPLETED|Titration Period||0
6334650|NCT00538850|7241723|FG000|NOT COMPLETED|Titration Period||32
6334651|NCT00538850|7241724|FG001|NOT COMPLETED|Titration Period||0
6334652|NCT00538850|7241725|FG002|NOT COMPLETED|Titration Period||0
6334653|NCT00538850|7241723|FG000|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
6334654|NCT00538850|7241724|FG001|STARTED|Fentanyl Sublingual Spray - Double-blind||98
6334655|NCT00538850|7241725|FG002|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
6334656|NCT00538850|7241723|FG000|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
6334657|NCT00538850|7241724|FG001|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
6334658|NCT00538850|7241725|FG002|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
6334659|NCT00538850|7241723|FG000|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
6334660|NCT00538850|7241724|FG001|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
6334661|NCT00538850|7241725|FG002|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
6334662|NCT00538850|7241723|FG000|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
6334663|NCT00538850|7241724|FG001|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
6334664|NCT00538850|7241725|FG002|STARTED|Placebo - Double-blind||98
6334665|NCT00538850|7241723|FG000|COMPLETED|Placebo - Double-blind||0
6334666|NCT00538850|7241724|FG001|COMPLETED|Placebo - Double-blind||0
6334667|NCT00538850|7241725|FG002|COMPLETED|Placebo - Double-blind||95
6334668|NCT00538850|7241723|FG000|NOT COMPLETED|Placebo - Double-blind||0
6334669|NCT00538850|7241724|FG001|NOT COMPLETED|Placebo - Double-blind||0
6334670|NCT00538850|7241725|FG002|NOT COMPLETED|Placebo - Double-blind||3
6334671|NCT00538863|7241731|FG000|STARTED|Open-label Titration||229
6334672|NCT00538863|7241731|FG000|COMPLETED|Open-label Titration||184
6334673|NCT00538863|7241731|FG000|NOT COMPLETED|Open-label Titration||45
6334674|NCT00538863|7241731|FG000|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
6334675|NCT00538863|7241731|FG000|COMPLETED|Open-label Maintenance||163
6334676|NCT00538863|7241731|FG000|NOT COMPLETED|Open-label Maintenance||106
6334677|NCT00538902|7241740|FG000|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
6334678|NCT00538902|7241741|FG001|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
6334679|NCT00538902|7241742|FG002|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
6334680|NCT00538902|7241740|FG000|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
6377900|NCT00765843|7288575|FG001|NOT COMPLETED|Overall Study||4
6775474|NCT03866434|7703418|FG000|COMPLETED|Overall Study||20
6775475|NCT03866434|7703418|FG000|NOT COMPLETED|Overall Study||0
6775476|NCT03863210|7703424|FG000|STARTED|Overall Study|March 1st, 2014.|104
6775477|NCT03863210|7703424|FG000|COMPLETED|Overall Study|September 1st, 2014.|102
6775478|NCT03863210|7703424|FG000|NOT COMPLETED|Overall Study||2
6775479|NCT03859323|7703441|FG000|STARTED|Overall Study||5
6775480|NCT03859323|7703442|FG001|STARTED|Overall Study||5
6775481|NCT03859323|7703443|FG002|STARTED|Overall Study||5
6775482|NCT03859323|7703444|FG003|STARTED|Overall Study||5
6775483|NCT03859323|7703445|FG004|STARTED|Overall Study||5
6775484|NCT03859323|7703446|FG005|STARTED|Overall Study||5
6775485|NCT03859323|7703447|FG006|STARTED|Overall Study||12
6775486|NCT03859323|7703448|FG007|STARTED|Overall Study||10
6775487|NCT03859323|7703449|FG008|STARTED|Overall Study||10
6775488|NCT03859323|7703450|FG009|STARTED|Overall Study||10
6775489|NCT03859323|7703451|FG010|STARTED|Overall Study||10
6775490|NCT03859323|7703452|FG011|STARTED|Overall Study||12
6775491|NCT03859323|7703453|FG012|STARTED|Overall Study||10
6775492|NCT03859323|7703441|FG000|COMPLETED|Overall Study||5
6775493|NCT03859323|7703442|FG001|COMPLETED|Overall Study||5
6775494|NCT03859323|7703443|FG002|COMPLETED|Overall Study||4
6775495|NCT03859323|7703444|FG003|COMPLETED|Overall Study||5
6775496|NCT03859323|7703445|FG004|COMPLETED|Overall Study||5
6775497|NCT03859323|7703446|FG005|COMPLETED|Overall Study||4
6775498|NCT03859323|7703447|FG006|COMPLETED|Overall Study||11
6775499|NCT03859323|7703448|FG007|COMPLETED|Overall Study||10
6775500|NCT03859323|7703449|FG008|COMPLETED|Overall Study||10
6775501|NCT03859323|7703450|FG009|COMPLETED|Overall Study||8
6775502|NCT03859323|7703451|FG010|COMPLETED|Overall Study||9
6775503|NCT03859323|7703452|FG011|COMPLETED|Overall Study||10
6775504|NCT03859323|7703453|FG012|COMPLETED|Overall Study||9
6775505|NCT03859323|7703441|FG000|NOT COMPLETED|Overall Study||0
6334681|NCT00538902|7241741|FG001|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
6334682|NCT00538902|7241742|FG002|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
6334683|NCT00538902|7241740|FG000|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
6334684|NCT00538902|7241741|FG001|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
6334685|NCT00538902|7241742|FG002|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
6334686|NCT00538902|7241740|FG000|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
6334687|NCT00538902|7241741|FG001|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
6334688|NCT00538902|7241742|FG002|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
6334689|NCT00538902|7241740|FG000|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
6334690|NCT00538902|7241741|FG001|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
6334691|NCT00538902|7241742|FG002|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
6334692|NCT00538902|7241740|FG000|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
6334693|NCT00538902|7241741|FG001|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
6334694|NCT00538902|7241742|FG002|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
6334695|NCT00538915|7241752|FG000|STARTED|Overall Study||63
6334696|NCT00538915|7241752|FG000|COMPLETED|Overall Study||52
6334697|NCT00538915|7241752|FG000|NOT COMPLETED|Overall Study||11
6334698|NCT00539006|7241760|FG000|STARTED|Pre-treatment||96
6334699|NCT00539006|7241761|FG001|STARTED|Pre-treatment||95
6334700|NCT00539006|7241762|FG002|STARTED|Pre-treatment||95
6334701|NCT00539006|7241763|FG003|STARTED|Pre-treatment||91
6334702|NCT00539006|7241760|FG000|COMPLETED|Pre-treatment||96
6334703|NCT00539006|7241761|FG001|COMPLETED|Pre-treatment||94
6334704|NCT00539006|7241762|FG002|COMPLETED|Pre-treatment||95
6334705|NCT00539006|7241763|FG003|COMPLETED|Pre-treatment||91
6334706|NCT00539006|7241760|FG000|NOT COMPLETED|Pre-treatment||0
6334707|NCT00539006|7241761|FG001|NOT COMPLETED|Pre-treatment||1
6334708|NCT00539006|7241762|FG002|NOT COMPLETED|Pre-treatment||0
6334709|NCT00539006|7241763|FG003|NOT COMPLETED|Pre-treatment||0
6334710|NCT00539006|7241760|FG000|STARTED|Treatment Period 1||96
6334711|NCT00539006|7241761|FG001|STARTED|Treatment Period 1||94
6334712|NCT00539006|7241762|FG002|STARTED|Treatment Period 1||95
6334713|NCT00539006|7241763|FG003|STARTED|Treatment Period 1||91
6334714|NCT00539006|7241760|FG000|COMPLETED|Treatment Period 1||96
6334715|NCT00539006|7241761|FG001|COMPLETED|Treatment Period 1||94
6334716|NCT00539006|7241762|FG002|COMPLETED|Treatment Period 1||93
6334717|NCT00539006|7241763|FG003|COMPLETED|Treatment Period 1||90
6334718|NCT00539006|7241760|FG000|NOT COMPLETED|Treatment Period 1||0
6334719|NCT00539006|7241761|FG001|NOT COMPLETED|Treatment Period 1||0
6334720|NCT00539006|7241762|FG002|NOT COMPLETED|Treatment Period 1||2
6334721|NCT00539006|7241763|FG003|NOT COMPLETED|Treatment Period 1||1
6334722|NCT00539006|7241760|FG000|STARTED|Washout||96
6334723|NCT00539006|7241761|FG001|STARTED|Washout||94
6334724|NCT00539006|7241762|FG002|STARTED|Washout||93
6334725|NCT00539006|7241763|FG003|STARTED|Washout||90
6334726|NCT00539006|7241760|FG000|COMPLETED|Washout||76
6334727|NCT00539006|7241761|FG001|COMPLETED|Washout||84
6334728|NCT00539006|7241762|FG002|COMPLETED|Washout||77
6334729|NCT00539006|7241763|FG003|COMPLETED|Washout||81
6334730|NCT00539006|7241760|FG000|NOT COMPLETED|Washout||20
6334731|NCT00539006|7241761|FG001|NOT COMPLETED|Washout||10
6334732|NCT00539006|7241762|FG002|NOT COMPLETED|Washout||16
6334733|NCT00539006|7241763|FG003|NOT COMPLETED|Washout||9
6334734|NCT00539006|7241760|FG000|STARTED|Treatment Period 2||76
6334735|NCT00539006|7241761|FG001|STARTED|Treatment Period 2||84
6334736|NCT00539006|7241762|FG002|STARTED|Treatment Period 2||77
6334737|NCT00539006|7241763|FG003|STARTED|Treatment Period 2||81
6334738|NCT00539006|7241760|FG000|COMPLETED|Treatment Period 2||75
6334739|NCT00539006|7241761|FG001|COMPLETED|Treatment Period 2||83
6334740|NCT00539006|7241762|FG002|COMPLETED|Treatment Period 2||77
6334741|NCT00539006|7241763|FG003|COMPLETED|Treatment Period 2||81
6334742|NCT00539006|7241760|FG000|NOT COMPLETED|Treatment Period 2||1
6334743|NCT00539006|7241761|FG001|NOT COMPLETED|Treatment Period 2||1
6334744|NCT00539006|7241762|FG002|NOT COMPLETED|Treatment Period 2||0
6334745|NCT00539006|7241763|FG003|NOT COMPLETED|Treatment Period 2||0
6334746|NCT00539006|7241760|FG000|STARTED|Post-Study||75
6334747|NCT00539006|7241761|FG001|STARTED|Post-Study||83
6334748|NCT00539006|7241762|FG002|STARTED|Post-Study||77
6334749|NCT00539006|7241763|FG003|STARTED|Post-Study||81
6334750|NCT00539006|7241760|FG000|COMPLETED|Post-Study||75
6334751|NCT00539006|7241761|FG001|COMPLETED|Post-Study||83
6334752|NCT00539006|7241762|FG002|COMPLETED|Post-Study||77
6334753|NCT00539006|7241763|FG003|COMPLETED|Post-Study||81
6334754|NCT00539006|7241760|FG000|NOT COMPLETED|Post-Study||0
6334755|NCT00539006|7241761|FG001|NOT COMPLETED|Post-Study||0
6775506|NCT03859323|7703442|FG001|NOT COMPLETED|Overall Study||0
6775507|NCT03859323|7703443|FG002|NOT COMPLETED|Overall Study||1
6775508|NCT03859323|7703444|FG003|NOT COMPLETED|Overall Study||0
6775509|NCT03859323|7703445|FG004|NOT COMPLETED|Overall Study||0
6775510|NCT03859323|7703446|FG005|NOT COMPLETED|Overall Study||1
6775511|NCT03859323|7703447|FG006|NOT COMPLETED|Overall Study||1
6334756|NCT00539006|7241762|FG002|NOT COMPLETED|Post-Study||0
6334757|NCT00539006|7241763|FG003|NOT COMPLETED|Post-Study||0
6334758|NCT00539032|7241781|FG000|STARTED|Overall Study||153
6334759|NCT00539032|7241782|FG001|STARTED|Overall Study||85
6334760|NCT00539032|7241781|FG000|COMPLETED|Overall Study||151
6334761|NCT00539032|7241782|FG001|COMPLETED|Overall Study||84
6334762|NCT00539032|7241781|FG000|NOT COMPLETED|Overall Study||2
6334763|NCT00539032|7241782|FG001|NOT COMPLETED|Overall Study||1
6334764|NCT00539110|7241790|FG000|STARTED|Overall Study||5
6334765|NCT00539110|7241791|FG001|STARTED|Overall Study||5
6334766|NCT00539110|7241790|FG000|COMPLETED|Overall Study||5
6334767|NCT00539110|7241791|FG001|COMPLETED|Overall Study||5
6334768|NCT00539110|7241790|FG000|NOT COMPLETED|Overall Study||0
6334769|NCT00539110|7241791|FG001|NOT COMPLETED|Overall Study||0
6334770|NCT00539188|7241799|FG000|STARTED|Overall Study||4
6334771|NCT00539188|7241800|FG001|STARTED|Overall Study||2
6334772|NCT00539188|7241799|FG000|Received Allocated Intervention|Overall Study||3
6334773|NCT00539188|7241800|FG001|Received Allocated Intervention|Overall Study||2
6334774|NCT00539188|7241799|FG000|COMPLETED|Overall Study||1
6334775|NCT00539188|7241800|FG001|COMPLETED|Overall Study||1
6334776|NCT00539188|7241799|FG000|NOT COMPLETED|Overall Study||3
6334777|NCT00539188|7241800|FG001|NOT COMPLETED|Overall Study||1
6334778|NCT00539240|7241809|FG000|STARTED|Overall Study||59
6334779|NCT00539240|7241810|FG001|STARTED|Overall Study||55
6334780|NCT00539240|7241811|FG002|STARTED|Overall Study||54
6334781|NCT00539240|7241809|FG000|COMPLETED|Overall Study||53
6334782|NCT00539240|7241810|FG001|COMPLETED|Overall Study||48
6334783|NCT00539240|7241811|FG002|COMPLETED|Overall Study||39
6334784|NCT00539240|7241809|FG000|NOT COMPLETED|Overall Study||6
6334785|NCT00539240|7241810|FG001|NOT COMPLETED|Overall Study||7
6334786|NCT00539240|7241811|FG002|NOT COMPLETED|Overall Study||15
6334787|NCT00539253|7241819|FG000|STARTED|Overall Study||45
6334788|NCT00539253|7241819|FG000|COMPLETED|Overall Study||19
6334789|NCT00539253|7241819|FG000|NOT COMPLETED|Overall Study||26
6334790|NCT00539279|7241825|FG000|STARTED|Treatment||41
6334791|NCT00539279|7241826|FG001|STARTED|Treatment||46
6334792|NCT00539279|7241825|FG000|COMPLETED|Treatment||30
6334793|NCT00539279|7241826|FG001|COMPLETED|Treatment||38
6334794|NCT00539279|7241825|FG000|NOT COMPLETED|Treatment||11
6334795|NCT00539279|7241826|FG001|NOT COMPLETED|Treatment||8
6334796|NCT00539279|7241825|FG000|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
6334797|NCT00539279|7241826|FG001|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
6334798|NCT00539279|7241825|FG000|COMPLETED|Post-Treatment Assessment||18
6334799|NCT00539279|7241826|FG001|COMPLETED|Post-Treatment Assessment||29
6334800|NCT00539279|7241825|FG000|NOT COMPLETED|Post-Treatment Assessment||12
6334801|NCT00539279|7241826|FG001|NOT COMPLETED|Post-Treatment Assessment||9
6334802|NCT00539279|7241825|FG000|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
6334803|NCT00539279|7241826|FG001|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
6334804|NCT00539279|7241825|FG000|COMPLETED|6-Month Follow-Up Assessment||17
6334805|NCT00539279|7241826|FG001|COMPLETED|6-Month Follow-Up Assessment||22
6334806|NCT00539279|7241825|FG000|NOT COMPLETED|6-Month Follow-Up Assessment||1
6334807|NCT00539279|7241826|FG001|NOT COMPLETED|6-Month Follow-Up Assessment||7
6334808|NCT00539305|7241834|FG000|STARTED|Overall Study||10
6334809|NCT00539305|7241835|FG001|STARTED|Overall Study||12
6334810|NCT00539305|7241834|FG000|COMPLETED|Overall Study||9
6334811|NCT00539305|7241835|FG001|COMPLETED|Overall Study||10
6334812|NCT00539305|7241834|FG000|NOT COMPLETED|Overall Study||1
6334813|NCT00539305|7241835|FG001|NOT COMPLETED|Overall Study||2
6334814|NCT00539500|7241841|FG000|STARTED|Overall Study||3
6334815|NCT00539500|7241841|FG000|COMPLETED|Overall Study||0
6334816|NCT00539500|7241841|FG000|NOT COMPLETED|Overall Study||3
6334817|NCT00539513|7241847|FG000|STARTED|Overall Study||5
6334818|NCT00539513|7241848|FG001|STARTED|Overall Study||5
6334819|NCT00539513|7241847|FG000|Received Allocated Intervention|Overall Study||3
6334820|NCT00539513|7241848|FG001|Received Allocated Intervention|Overall Study||4
6334821|NCT00539513|7241847|FG000|COMPLETED|Overall Study||3
6334822|NCT00539513|7241848|FG001|COMPLETED|Overall Study||3
6334823|NCT00539513|7241847|FG000|NOT COMPLETED|Overall Study||2
6334824|NCT00539513|7241848|FG001|NOT COMPLETED|Overall Study||2
6334825|NCT00539526|7241857|FG000|STARTED|Overall Study||35
6334826|NCT00539526|7241858|FG001|STARTED|Overall Study||33
6334827|NCT00539526|7241859|FG002|STARTED|Overall Study||38
6334828|NCT00539526|7241857|FG000|COMPLETED|Overall Study||32
6334829|NCT00539526|7241858|FG001|COMPLETED|Overall Study||31
6334830|NCT00539526|7241859|FG002|COMPLETED|Overall Study||36
6334831|NCT00539526|7241857|FG000|NOT COMPLETED|Overall Study||3
6334832|NCT00539526|7241858|FG001|NOT COMPLETED|Overall Study||2
6334833|NCT00539526|7241859|FG002|NOT COMPLETED|Overall Study||2
6376159|NCT00758524|7286585|FG010|COMPLETED|Withdrawal Period (Week 8 to Week 9)||41
6376160|NCT00758524|7286586|FG011|COMPLETED|Withdrawal Period (Week 8 to Week 9)||37
6376161|NCT00758524|7286587|FG012|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
6376162|NCT00758524|7286588|FG013|COMPLETED|Withdrawal Period (Week 8 to Week 9)||45
6376163|NCT00758524|7286589|FG014|COMPLETED|Withdrawal Period (Week 8 to Week 9)||39
6376164|NCT00758524|7286590|FG015|COMPLETED|Withdrawal Period (Week 8 to Week 9)||36
6376165|NCT00758524|7286591|FG016|COMPLETED|Withdrawal Period (Week 8 to Week 9)||66
6376166|NCT00758524|7286575|FG000|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376167|NCT00758524|7286576|FG001|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376168|NCT00758524|7286577|FG002|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376169|NCT00758524|7286578|FG003|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376170|NCT00758524|7286579|FG004|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376171|NCT00758524|7286580|FG005|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6334834|NCT00539539|7241869|FG000|STARTED|Overall Study||815
6334835|NCT00539539|7241870|FG001|STARTED|Overall Study||771
6334836|NCT00539539|7241869|FG000|COMPLETED|Overall Study||815
6334837|NCT00539539|7241870|FG001|COMPLETED|Overall Study||771
6334838|NCT00539539|7241869|FG000|NOT COMPLETED|Overall Study||0
6334839|NCT00539539|7241870|FG001|NOT COMPLETED|Overall Study||0
6334840|NCT00539656|7241876|FG000|STARTED|Overall Study||3
6334841|NCT00539656|7241876|FG000|COMPLETED|Overall Study||3
6334842|NCT00539656|7241876|FG000|NOT COMPLETED|Overall Study||0
6334843|NCT00539695|7241880|FG000|STARTED|Overall Study||25
6334844|NCT00539695|7241880|FG000|Evaluable Patients|Overall Study|Patients who received IL-2.|22
6334845|NCT00539695|7241880|FG000|COMPLETED|Overall Study||12
6334846|NCT00539695|7241880|FG000|NOT COMPLETED|Overall Study||13
6334847|NCT00539734|7241884|FG000|STARTED|Overall Study||26
6334848|NCT00539734|7241884|FG000|COMPLETED|Overall Study||25
6334849|NCT00539734|7241884|FG000|NOT COMPLETED|Overall Study||1
6334850|NCT00539864|7241890|FG000|STARTED|Overall Study||300
6334851|NCT00539864|7241891|FG001|STARTED|Overall Study||302
6334852|NCT00539864|7241890|FG000|COMPLETED|Overall Study||299
6334853|NCT00539864|7241891|FG001|COMPLETED|Overall Study||300
6334854|NCT00539864|7241890|FG000|NOT COMPLETED|Overall Study||1
6334855|NCT00539864|7241891|FG001|NOT COMPLETED|Overall Study||2
6334856|NCT00539942|7241899|FG000|STARTED|Overall Study||4
6334857|NCT00539942|7241900|FG001|STARTED|Overall Study||3
6334858|NCT00539942|7241899|FG000|COMPLETED|Overall Study||4
6334859|NCT00539942|7241900|FG001|COMPLETED|Overall Study||3
6334860|NCT00539942|7241899|FG000|NOT COMPLETED|Overall Study||0
6334861|NCT00539942|7241900|FG001|NOT COMPLETED|Overall Study||0
6334862|NCT00539994|7241909|FG000|STARTED|Overall Study||23
6334863|NCT00539994|7241910|FG001|STARTED|Overall Study||19
6334864|NCT00539994|7241911|FG002|STARTED|Overall Study||15
6334865|NCT00539994|7241909|FG000|COMPLETED|Overall Study||20
6334866|NCT00539994|7241910|FG001|COMPLETED|Overall Study||18
6334867|NCT00539994|7241911|FG002|COMPLETED|Overall Study||13
6334868|NCT00539994|7241909|FG000|NOT COMPLETED|Overall Study||3
6334869|NCT00539994|7241910|FG001|NOT COMPLETED|Overall Study||1
6334870|NCT00539994|7241911|FG002|NOT COMPLETED|Overall Study||2
6334871|NCT00540007|7241928|FG000|STARTED|Overall Study||38
6334872|NCT00540007|7241929|FG001|STARTED|Overall Study||42
6334873|NCT00540007|7241928|FG000|COMPLETED|Overall Study||38
6334874|NCT00540007|7241929|FG001|COMPLETED|Overall Study||42
6334875|NCT00540007|7241928|FG000|NOT COMPLETED|Overall Study||0
6334876|NCT00540007|7241929|FG001|NOT COMPLETED|Overall Study||0
6334877|NCT00540046|7241938|FG000|STARTED|Overall Study||104
6334878|NCT00540046|7241939|FG001|STARTED|Overall Study||111
6334879|NCT00540046|7241938|FG000|COMPLETED|Overall Study||71
6334880|NCT00540046|7241939|FG001|COMPLETED|Overall Study||88
6334881|NCT00540046|7241938|FG000|NOT COMPLETED|Overall Study||33
6334882|NCT00540046|7241939|FG001|NOT COMPLETED|Overall Study||23
6334883|NCT00540124|7241950|FG000|STARTED|Overall Study||51
6775512|NCT03859323|7703448|FG007|NOT COMPLETED|Overall Study||0
6775513|NCT03859323|7703449|FG008|NOT COMPLETED|Overall Study||0
6775514|NCT03859323|7703450|FG009|NOT COMPLETED|Overall Study||2
6775515|NCT03859323|7703451|FG010|NOT COMPLETED|Overall Study||1
6775516|NCT03859323|7703452|FG011|NOT COMPLETED|Overall Study||2
6775517|NCT03859323|7703453|FG012|NOT COMPLETED|Overall Study||1
6775518|NCT03867838|7703492|FG000|STARTED|Overall Study||6
6775519|NCT03867838|7703492|FG000|COMPLETED|Overall Study||6
6775520|NCT03867838|7703492|FG000|NOT COMPLETED|Overall Study||0
6775521|NCT03855059|7703498|FG000|STARTED|Overall Study||25
6775522|NCT03855059|7703499|FG001|STARTED|Overall Study||25
6775523|NCT03855059|7703498|FG000|COMPLETED|Overall Study||23
6775524|NCT03855059|7703499|FG001|COMPLETED|Overall Study||25
6775525|NCT03855059|7703498|FG000|NOT COMPLETED|Overall Study||2
6775526|NCT03855059|7703499|FG001|NOT COMPLETED|Overall Study||0
6775527|NCT03852537|7703507|FG000|STARTED|Overall Study||23
6775528|NCT03852537|7703508|FG001|STARTED|Overall Study||21
6775529|NCT03852537|7703507|FG000|COMPLETED|Overall Study||23
6775530|NCT03852537|7703508|FG001|COMPLETED|Overall Study||21
6775531|NCT03852537|7703507|FG000|NOT COMPLETED|Overall Study||0
6775532|NCT03852537|7703508|FG001|NOT COMPLETED|Overall Study||0
6775533|NCT03875859|7703514|FG000|STARTED|Overall Study||4
6775534|NCT03875859|7703514|FG000|COMPLETED|Overall Study||4
6775535|NCT03875859|7703514|FG000|NOT COMPLETED|Overall Study||0
6775536|NCT03875508|7703518|FG000|STARTED|Overall Study||108
6775537|NCT03875508|7703518|FG000|COMPLETED|Overall Study||96
6775538|NCT03875508|7703518|FG000|NOT COMPLETED|Overall Study||12
6775539|NCT03869333|7703526|FG000|STARTED|Overall Study||14
6775540|NCT03869333|7703527|FG001|STARTED|Overall Study||16
6775541|NCT03869333|7703528|FG002|STARTED|Overall Study||16
6334884|NCT00540124|7241951|FG001|STARTED|Overall Study||51
6334885|NCT00540124|7241952|FG002|STARTED|Overall Study||49
6775542|NCT03869333|7703529|FG003|STARTED|Overall Study||12
6775543|NCT03869333|7703526|FG000|Received First Dose|Overall Study||14
6775544|NCT03869333|7703527|FG001|Received First Dose|Overall Study||16
6775545|NCT03869333|7703528|FG002|Received First Dose|Overall Study||16
6334886|NCT00540124|7241950|FG000|COMPLETED|Overall Study||47
6334887|NCT00540124|7241951|FG001|COMPLETED|Overall Study||48
6775546|NCT03869333|7703529|FG003|Received First Dose|Overall Study||12
6775547|NCT03869333|7703526|FG000|Received Second Dose|Overall Study||13
6775548|NCT03869333|7703527|FG001|Received Second Dose|Overall Study||15
6775549|NCT03869333|7703528|FG002|Received Second Dose|Overall Study||16
6334888|NCT00540124|7241952|FG002|COMPLETED|Overall Study||48
6334889|NCT00540124|7241950|FG000|NOT COMPLETED|Overall Study||4
6334890|NCT00540124|7241951|FG001|NOT COMPLETED|Overall Study||3
6334891|NCT00540124|7241952|FG002|NOT COMPLETED|Overall Study||1
6334892|NCT00540228|7241965|FG000|STARTED|Overall Study||200
6334893|NCT00540228|7241966|FG001|STARTED|Overall Study||198
6334894|NCT00540228|7241967|FG002|STARTED|Overall Study||204
6334895|NCT00540228|7241968|FG003|STARTED|Overall Study||202
6334896|NCT00540228|7241969|FG004|STARTED|Overall Study||202
6334897|NCT00540228|7241965|FG000|COMPLETED|Overall Study||197
6334898|NCT00540228|7241966|FG001|COMPLETED|Overall Study||197
6334899|NCT00540228|7241967|FG002|COMPLETED|Overall Study||204
6334900|NCT00540228|7241968|FG003|COMPLETED|Overall Study||202
6334901|NCT00540228|7241969|FG004|COMPLETED|Overall Study||202
6334902|NCT00540228|7241965|FG000|NOT COMPLETED|Overall Study||3
6334903|NCT00540228|7241966|FG001|NOT COMPLETED|Overall Study||1
6334904|NCT00540228|7241967|FG002|NOT COMPLETED|Overall Study||0
6334905|NCT00540228|7241968|FG003|NOT COMPLETED|Overall Study||0
6334906|NCT00540228|7241969|FG004|NOT COMPLETED|Overall Study||0
6334907|NCT00540293|7241981|FG000|STARTED|Overall Study||425
6334908|NCT00540293|7241981|FG000|COMPLETED|Overall Study||390
6334909|NCT00540293|7241981|FG000|NOT COMPLETED|Overall Study||35
6334910|NCT00540423|7241993|FG000|STARTED|Double-Blind Treatment Period||8
6334911|NCT00540423|7241994|FG001|STARTED|Double-Blind Treatment Period||15
6334912|NCT00540423|7241995|FG002|STARTED|Double-Blind Treatment Period||0
6558905|NCT01778049|7481536|FG004|NOT COMPLETED|Open Label Treatment Period||0
6558906|NCT01778049|7481537|FG005|NOT COMPLETED|Open Label Treatment Period||0
6558907|NCT01778049|7481532|FG000|STARTED|Double Blind Treatment Period||0
6558908|NCT01778049|7481533|FG001|STARTED|Double Blind Treatment Period||0
6558909|NCT01778049|7481534|FG002|STARTED|Double Blind Treatment Period||126
6558910|NCT01778049|7481535|FG003|STARTED|Double Blind Treatment Period||130
6334913|NCT00540423|7241993|FG000|COMPLETED|Double-Blind Treatment Period||8
6334914|NCT00540423|7241994|FG001|COMPLETED|Double-Blind Treatment Period||14
6334915|NCT00540423|7241995|FG002|COMPLETED|Double-Blind Treatment Period||0
6334916|NCT00540423|7241993|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6334917|NCT00540423|7241994|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
6334918|NCT00540423|7241995|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
6334919|NCT00540423|7241993|FG000|STARTED|Open-Label Treatment Period||0
6334920|NCT00540423|7241994|FG001|STARTED|Open-Label Treatment Period||0
6334921|NCT00540423|7241995|FG002|STARTED|Open-Label Treatment Period||22
6334922|NCT00540423|7241993|FG000|COMPLETED|Open-Label Treatment Period||0
6334923|NCT00540423|7241994|FG001|COMPLETED|Open-Label Treatment Period||0
6334924|NCT00540423|7241995|FG002|COMPLETED|Open-Label Treatment Period||20
6334925|NCT00540423|7241993|FG000|NOT COMPLETED|Open-Label Treatment Period||0
6334926|NCT00540423|7241994|FG001|NOT COMPLETED|Open-Label Treatment Period||0
6334927|NCT00540423|7241995|FG002|NOT COMPLETED|Open-Label Treatment Period||2
6334928|NCT00540436|7242013|FG000|STARTED|First 12-Week Treatment Period||25
6334929|NCT00540436|7242013|FG000|COMPLETED|First 12-Week Treatment Period||22
6334930|NCT00540436|7242013|FG000|NOT COMPLETED|First 12-Week Treatment Period||3
6334931|NCT00540436|7242013|FG000|STARTED|Second 12-Week Treatment Period||22
6334932|NCT00540436|7242013|FG000|COMPLETED|Second 12-Week Treatment Period||21
6334933|NCT00540436|7242013|FG000|NOT COMPLETED|Second 12-Week Treatment Period||1
6334934|NCT00540449|7242019|FG000|STARTED|Overall Study||346
6334935|NCT00540449|7242020|FG001|STARTED|Overall Study||344
6334936|NCT00540449|7242019|FG000|COMPLETED|Overall Study||262
6334937|NCT00540449|7242020|FG001|COMPLETED|Overall Study||266
6334938|NCT00540449|7242019|FG000|NOT COMPLETED|Overall Study||84
6334939|NCT00540449|7242020|FG001|NOT COMPLETED|Overall Study||78
6334940|NCT00540514|7242028|FG000|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
6334941|NCT00540514|7242029|FG001|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
6334942|NCT00540514|7242028|FG000|Treated|Overall Study||514
6334943|NCT00540514|7242029|FG001|Treated|Overall Study||524
6334944|NCT00540514|7242028|FG000|Biomarker Population|Overall Study||35
6558911|NCT01778049|7481536|FG004|STARTED|Double Blind Treatment Period||114
6775550|NCT03869333|7703529|FG003|Received Second Dose|Overall Study||12
6558912|NCT01778049|7481537|FG005|STARTED|Double Blind Treatment Period||112
6558913|NCT01778049|7481532|FG000|COMPLETED|Double Blind Treatment Period||0
6558914|NCT01778049|7481533|FG001|COMPLETED|Double Blind Treatment Period||0
6558915|NCT01778049|7481534|FG002|COMPLETED|Double Blind Treatment Period||111
6558916|NCT01778049|7481535|FG003|COMPLETED|Double Blind Treatment Period||118
6558917|NCT01778049|7481536|FG004|COMPLETED|Double Blind Treatment Period||102
6654960|NCT02449018|7584971|FG000|STARTED|Overall Study||64
6654961|NCT02449018|7584972|FG001|STARTED|Overall Study||28
6654962|NCT02449018|7584971|FG000|COMPLETED|Overall Study||52
6654963|NCT02449018|7584972|FG001|COMPLETED|Overall Study||26
6654964|NCT02449018|7584971|FG000|NOT COMPLETED|Overall Study||12
6654965|NCT02449018|7584972|FG001|NOT COMPLETED|Overall Study||2
6654966|NCT02449044|7584978|FG000|STARTED|Overall Study||111
6654967|NCT02449044|7584978|FG000|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
6654968|NCT02449044|7584978|FG000|NOT COMPLETED|Overall Study||64
6654969|NCT02449174|7584984|FG000|STARTED|Overall Study||36
6654970|NCT02449174|7584985|FG001|STARTED|Overall Study||32
6654971|NCT02449174|7584984|FG000|COMPLETED|Overall Study||36
6654972|NCT02449174|7584985|FG001|COMPLETED|Overall Study||32
6654973|NCT02449174|7584984|FG000|NOT COMPLETED|Overall Study||0
6654974|NCT02449174|7584985|FG001|NOT COMPLETED|Overall Study||0
6654975|NCT02449291|7584994|FG000|STARTED|Overall Study||191
6654976|NCT02449291|7584995|FG001|STARTED|Overall Study||188
6775551|NCT03869333|7703526|FG000|Received Third Dose|Overall Study||13
6775552|NCT03869333|7703527|FG001|Received Third Dose|Overall Study||15
6775553|NCT03869333|7703528|FG002|Received Third Dose|Overall Study||16
6775554|NCT03869333|7703529|FG003|Received Third Dose|Overall Study||11
6775555|NCT03869333|7703526|FG000|COMPLETED|Overall Study||12
6775556|NCT03869333|7703527|FG001|COMPLETED|Overall Study||15
6775557|NCT03869333|7703528|FG002|COMPLETED|Overall Study||16
6775558|NCT03869333|7703529|FG003|COMPLETED|Overall Study||12
6775559|NCT03869333|7703526|FG000|NOT COMPLETED|Overall Study||2
6775560|NCT03869333|7703527|FG001|NOT COMPLETED|Overall Study||1
6775561|NCT03869333|7703528|FG002|NOT COMPLETED|Overall Study||0
6775562|NCT03869333|7703529|FG003|NOT COMPLETED|Overall Study||0
6775563|NCT03864900|7703541|FG000|STARTED|Overall Study||36
6775564|NCT03864900|7703542|FG001|STARTED|Overall Study||36
6775565|NCT03864900|7703541|FG000|COMPLETED|Overall Study||33
6775566|NCT03864900|7703542|FG001|COMPLETED|Overall Study||30
6334945|NCT00540514|7242029|FG001|Biomarker Population|Overall Study||36
6334946|NCT00540514|7242028|FG000|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
6334947|NCT00540514|7242029|FG001|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
6334948|NCT00540514|7242028|FG000|NOT COMPLETED|Overall Study||246
6334949|NCT00540514|7242029|FG001|NOT COMPLETED|Overall Study||266
6334950|NCT00540579|7242036|FG000|STARTED|Overall Study||23
6334951|NCT00540579|7242036|FG000|COMPLETED|Overall Study||23
6334952|NCT00540579|7242036|FG000|NOT COMPLETED|Overall Study||0
6334953|NCT00540592|7242050|FG000|STARTED|Overall Study||204
6334954|NCT00540592|7242051|FG001|STARTED|Overall Study||202
6334955|NCT00540592|7242052|FG002|STARTED|Overall Study||202
6334956|NCT00540592|7242053|FG003|STARTED|Overall Study||202
6334957|NCT00540592|7242054|FG004|STARTED|Overall Study||199
6334958|NCT00540592|7242055|FG005|STARTED|Overall Study||198
6334959|NCT00540592|7242056|FG006|STARTED|Overall Study||198
6334960|NCT00540592|7242057|FG007|STARTED|Overall Study||199
6334961|NCT00540592|7242058|FG008|STARTED|Overall Study||200
6334962|NCT00540592|7242059|FG009|STARTED|Overall Study||203
6334963|NCT00540592|7242050|FG000|Completed at Day 180|Overall Study||200
6334964|NCT00540592|7242051|FG001|Completed at Day 180|Overall Study||201
6334965|NCT00540592|7242052|FG002|Completed at Day 180|Overall Study||197
6334966|NCT00540592|7242053|FG003|Completed at Day 180|Overall Study||197
6334967|NCT00540592|7242054|FG004|Completed at Day 180|Overall Study||195
6334968|NCT00540592|7242055|FG005|Completed at Day 180|Overall Study||198
6334969|NCT00540592|7242056|FG006|Completed at Day 180|Overall Study||196
6334970|NCT00540592|7242057|FG007|Completed at Day 180|Overall Study||193
6334971|NCT00540592|7242058|FG008|Completed at Day 180|Overall Study||198
6334972|NCT00540592|7242059|FG009|Completed at Day 180|Overall Study||189
6334973|NCT00540592|7242050|FG000|COMPLETED|Overall Study||202
6334974|NCT00540592|7242051|FG001|COMPLETED|Overall Study||201
6334975|NCT00540592|7242052|FG002|COMPLETED|Overall Study||201
6334976|NCT00540592|7242053|FG003|COMPLETED|Overall Study||201
6334977|NCT00540592|7242054|FG004|COMPLETED|Overall Study||198
6334978|NCT00540592|7242055|FG005|COMPLETED|Overall Study||198
6334979|NCT00540592|7242056|FG006|COMPLETED|Overall Study||198
6334980|NCT00540592|7242057|FG007|COMPLETED|Overall Study||198
6334981|NCT00540592|7242058|FG008|COMPLETED|Overall Study||199
6334982|NCT00540592|7242059|FG009|COMPLETED|Overall Study||201
6334983|NCT00540592|7242050|FG000|NOT COMPLETED|Overall Study||2
6334984|NCT00540592|7242051|FG001|NOT COMPLETED|Overall Study||1
6334985|NCT00540592|7242052|FG002|NOT COMPLETED|Overall Study||1
6334986|NCT00540592|7242053|FG003|NOT COMPLETED|Overall Study||1
6334987|NCT00540592|7242054|FG004|NOT COMPLETED|Overall Study||1
6334988|NCT00540592|7242055|FG005|NOT COMPLETED|Overall Study||0
6334989|NCT00540592|7242056|FG006|NOT COMPLETED|Overall Study||0
6334990|NCT00540592|7242057|FG007|NOT COMPLETED|Overall Study||1
6334991|NCT00540592|7242058|FG008|NOT COMPLETED|Overall Study||1
6334992|NCT00540592|7242059|FG009|NOT COMPLETED|Overall Study||2
6334993|NCT00540644|7242083|FG000|STARTED|Overall Study||48
6334994|NCT00540644|7242084|FG001|STARTED|Overall Study||22
6334995|NCT00540644|7242083|FG000|COMPLETED|Overall Study||39
6334996|NCT00540644|7242084|FG001|COMPLETED|Overall Study||13
6334997|NCT00540644|7242083|FG000|NOT COMPLETED|Overall Study||9
6334998|NCT00540644|7242084|FG001|NOT COMPLETED|Overall Study||9
6334999|NCT00540722|7242090|FG000|STARTED|Overall Study||56
6335000|NCT00540722|7242090|FG000|COMPLETED|Overall Study||56
6335001|NCT00540722|7242090|FG000|NOT COMPLETED|Overall Study||0
6335002|NCT00540982|7242095|FG000|STARTED|Overall Study||47
6335003|NCT00540982|7242095|FG000|Normal Liver Function|Overall Study||11
6335004|NCT00540982|7242095|FG000|Mild Liver Dysfunction|Overall Study||6
6335005|NCT00540982|7242095|FG000|Moderate Liver Dysfunction|Overall Study||18
6335006|NCT00540982|7242095|FG000|Severe Liver Dysfunction|Overall Study||12
6654977|NCT02449291|7584996|FG002|STARTED|Overall Study||181
6654978|NCT02449291|7584994|FG000|COMPLETED|Overall Study||186
6775567|NCT03864900|7703541|FG000|NOT COMPLETED|Overall Study||3
6775568|NCT03864900|7703542|FG001|NOT COMPLETED|Overall Study||6
6775569|NCT03863795|7703552|FG000|STARTED|Overall Study||306
6775570|NCT03863795|7703553|FG001|STARTED|Overall Study||269
6775571|NCT03863795|7703554|FG002|STARTED|Overall Study||244
6775572|NCT03863795|7703555|FG003|STARTED|Overall Study||281
6335007|NCT00540982|7242095|FG000|COMPLETED|Overall Study||47
6335008|NCT00540982|7242095|FG000|NOT COMPLETED|Overall Study||0
6335009|NCT00541034|7242117|FG000|STARTED|Overall Study||49
6335010|NCT00541034|7242117|FG000|COMPLETED|Overall Study||46
6335011|NCT00541034|7242117|FG000|NOT COMPLETED|Overall Study||3
6335012|NCT00541099|7242121|FG000|STARTED|Overall Study||11
6335013|NCT00541099|7242121|FG000|COMPLETED|Overall Study||8
6335014|NCT00541099|7242121|FG000|NOT COMPLETED|Overall Study||3
6335015|NCT00541190|7242127|FG000|STARTED|Overall Study||10
6335016|NCT00541190|7242128|FG001|STARTED|Overall Study||11
6335017|NCT00541190|7242127|FG000|COMPLETED|Overall Study||10
6335018|NCT00541190|7242128|FG001|COMPLETED|Overall Study||11
6335019|NCT00541190|7242127|FG000|NOT COMPLETED|Overall Study||0
6335020|NCT00541190|7242128|FG001|NOT COMPLETED|Overall Study||0
6335021|NCT00541229|7242142|FG000|STARTED|Treatment Period I (Week 1)||17
6335022|NCT00541229|7242143|FG001|STARTED|Treatment Period I (Week 1)||16
6335023|NCT00541229|7242144|FG002|STARTED|Treatment Period I (Week 1)||20
6335024|NCT00541229|7242145|FG003|STARTED|Treatment Period I (Week 1)||18
6335025|NCT00541229|7242146|FG004|STARTED|Treatment Period I (Week 1)||14
6335026|NCT00541229|7242147|FG005|STARTED|Treatment Period I (Week 1)||18
6335027|NCT00541229|7242142|FG000|COMPLETED|Treatment Period I (Week 1)||17
6335028|NCT00541229|7242143|FG001|COMPLETED|Treatment Period I (Week 1)||15
6335029|NCT00541229|7242144|FG002|COMPLETED|Treatment Period I (Week 1)||17
6335030|NCT00541229|7242145|FG003|COMPLETED|Treatment Period I (Week 1)||17
6335031|NCT00541229|7242146|FG004|COMPLETED|Treatment Period I (Week 1)||14
6335032|NCT00541229|7242147|FG005|COMPLETED|Treatment Period I (Week 1)||16
6335033|NCT00541229|7242142|FG000|NOT COMPLETED|Treatment Period I (Week 1)||0
6335034|NCT00541229|7242143|FG001|NOT COMPLETED|Treatment Period I (Week 1)||1
6335035|NCT00541229|7242144|FG002|NOT COMPLETED|Treatment Period I (Week 1)||3
6335036|NCT00541229|7242145|FG003|NOT COMPLETED|Treatment Period I (Week 1)||1
6335037|NCT00541229|7242146|FG004|NOT COMPLETED|Treatment Period I (Week 1)||0
6335038|NCT00541229|7242147|FG005|NOT COMPLETED|Treatment Period I (Week 1)||2
6335039|NCT00541229|7242142|FG000|STARTED|Washout Period I (Week 2-5)||17
6335040|NCT00541229|7242143|FG001|STARTED|Washout Period I (Week 2-5)||15
6335041|NCT00541229|7242144|FG002|STARTED|Washout Period I (Week 2-5)||17
6335042|NCT00541229|7242145|FG003|STARTED|Washout Period I (Week 2-5)||17
6335043|NCT00541229|7242146|FG004|STARTED|Washout Period I (Week 2-5)||14
6335044|NCT00541229|7242147|FG005|STARTED|Washout Period I (Week 2-5)||16
6335045|NCT00541229|7242142|FG000|COMPLETED|Washout Period I (Week 2-5)||13
6335046|NCT00541229|7242143|FG001|COMPLETED|Washout Period I (Week 2-5)||13
6335047|NCT00541229|7242144|FG002|COMPLETED|Washout Period I (Week 2-5)||13
6335048|NCT00541229|7242145|FG003|COMPLETED|Washout Period I (Week 2-5)||13
6335049|NCT00541229|7242146|FG004|COMPLETED|Washout Period I (Week 2-5)||13
6335050|NCT00541229|7242147|FG005|COMPLETED|Washout Period I (Week 2-5)||11
6335051|NCT00541229|7242142|FG000|NOT COMPLETED|Washout Period I (Week 2-5)||4
6335052|NCT00541229|7242143|FG001|NOT COMPLETED|Washout Period I (Week 2-5)||2
6335053|NCT00541229|7242144|FG002|NOT COMPLETED|Washout Period I (Week 2-5)||4
6335054|NCT00541229|7242145|FG003|NOT COMPLETED|Washout Period I (Week 2-5)||4
6335055|NCT00541229|7242146|FG004|NOT COMPLETED|Washout Period I (Week 2-5)||1
6335056|NCT00541229|7242147|FG005|NOT COMPLETED|Washout Period I (Week 2-5)||5
6335057|NCT00541229|7242142|FG000|STARTED|Treatment Period II (Week 6)||13
6335058|NCT00541229|7242143|FG001|STARTED|Treatment Period II (Week 6)||13
6335059|NCT00541229|7242144|FG002|STARTED|Treatment Period II (Week 6)||13
6335060|NCT00541229|7242145|FG003|STARTED|Treatment Period II (Week 6)||13
6335061|NCT00541229|7242146|FG004|STARTED|Treatment Period II (Week 6)||13
6335062|NCT00541229|7242147|FG005|STARTED|Treatment Period II (Week 6)||11
6335063|NCT00541229|7242142|FG000|COMPLETED|Treatment Period II (Week 6)||11
6335064|NCT00541229|7242143|FG001|COMPLETED|Treatment Period II (Week 6)||12
6335065|NCT00541229|7242144|FG002|COMPLETED|Treatment Period II (Week 6)||12
6335066|NCT00541229|7242145|FG003|COMPLETED|Treatment Period II (Week 6)||12
6335067|NCT00541229|7242146|FG004|COMPLETED|Treatment Period II (Week 6)||11
6335068|NCT00541229|7242147|FG005|COMPLETED|Treatment Period II (Week 6)||8
6335069|NCT00541229|7242142|FG000|NOT COMPLETED|Treatment Period II (Week 6)||2
6335070|NCT00541229|7242143|FG001|NOT COMPLETED|Treatment Period II (Week 6)||1
6335071|NCT00541229|7242144|FG002|NOT COMPLETED|Treatment Period II (Week 6)||1
6335072|NCT00541229|7242145|FG003|NOT COMPLETED|Treatment Period II (Week 6)||1
6335073|NCT00541229|7242146|FG004|NOT COMPLETED|Treatment Period II (Week 6)||2
6335074|NCT00541229|7242147|FG005|NOT COMPLETED|Treatment Period II (Week 6)||3
6335075|NCT00541229|7242142|FG000|STARTED|Washout Period II (Week 7-10)||11
6335076|NCT00541229|7242143|FG001|STARTED|Washout Period II (Week 7-10)||12
6335077|NCT00541229|7242144|FG002|STARTED|Washout Period II (Week 7-10)||12
6335078|NCT00541229|7242145|FG003|STARTED|Washout Period II (Week 7-10)||12
6335079|NCT00541229|7242146|FG004|STARTED|Washout Period II (Week 7-10)||11
6335080|NCT00541229|7242147|FG005|STARTED|Washout Period II (Week 7-10)||8
6335081|NCT00541229|7242142|FG000|COMPLETED|Washout Period II (Week 7-10)||7
6335082|NCT00541229|7242143|FG001|COMPLETED|Washout Period II (Week 7-10)||8
6335083|NCT00541229|7242144|FG002|COMPLETED|Washout Period II (Week 7-10)||10
6335084|NCT00541229|7242145|FG003|COMPLETED|Washout Period II (Week 7-10)||8
6335085|NCT00541229|7242146|FG004|COMPLETED|Washout Period II (Week 7-10)||7
6335086|NCT00541229|7242147|FG005|COMPLETED|Washout Period II (Week 7-10)||5
6335087|NCT00541229|7242142|FG000|NOT COMPLETED|Washout Period II (Week 7-10)||4
6335088|NCT00541229|7242143|FG001|NOT COMPLETED|Washout Period II (Week 7-10)||4
6335089|NCT00541229|7242144|FG002|NOT COMPLETED|Washout Period II (Week 7-10)||2
6335090|NCT00541229|7242145|FG003|NOT COMPLETED|Washout Period II (Week 7-10)||4
6335091|NCT00541229|7242146|FG004|NOT COMPLETED|Washout Period II (Week 7-10)||4
6335092|NCT00541229|7242147|FG005|NOT COMPLETED|Washout Period II (Week 7-10)||3
6335093|NCT00541229|7242142|FG000|STARTED|Treatment Period III (Week 11)||7
6335094|NCT00541229|7242143|FG001|STARTED|Treatment Period III (Week 11)||8
6335095|NCT00541229|7242144|FG002|STARTED|Treatment Period III (Week 11)||10
6335096|NCT00541229|7242145|FG003|STARTED|Treatment Period III (Week 11)||8
6335097|NCT00541229|7242146|FG004|STARTED|Treatment Period III (Week 11)||7
6335098|NCT00541229|7242147|FG005|STARTED|Treatment Period III (Week 11)||5
6335099|NCT00541229|7242142|FG000|COMPLETED|Treatment Period III (Week 11)||7
6335100|NCT00541229|7242143|FG001|COMPLETED|Treatment Period III (Week 11)||8
6335101|NCT00541229|7242144|FG002|COMPLETED|Treatment Period III (Week 11)||9
6335102|NCT00541229|7242145|FG003|COMPLETED|Treatment Period III (Week 11)||8
6335103|NCT00541229|7242146|FG004|COMPLETED|Treatment Period III (Week 11)||6
6335104|NCT00541229|7242147|FG005|COMPLETED|Treatment Period III (Week 11)||4
6335105|NCT00541229|7242142|FG000|NOT COMPLETED|Treatment Period III (Week 11)||0
6335106|NCT00541229|7242143|FG001|NOT COMPLETED|Treatment Period III (Week 11)||0
6335107|NCT00541229|7242144|FG002|NOT COMPLETED|Treatment Period III (Week 11)||1
6335108|NCT00541229|7242145|FG003|NOT COMPLETED|Treatment Period III (Week 11)||0
6335109|NCT00541229|7242146|FG004|NOT COMPLETED|Treatment Period III (Week 11)||1
6335110|NCT00541229|7242147|FG005|NOT COMPLETED|Treatment Period III (Week 11)||1
6335111|NCT00541242|7242157|FG000|STARTED|Treatment Period 1||0
6335112|NCT00541242|7242158|FG001|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
6335113|NCT00541242|7242157|FG000|COMPLETED|Treatment Period 1||0
6335114|NCT00541242|7242158|FG001|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
6335115|NCT00541242|7242157|FG000|NOT COMPLETED|Treatment Period 1||0
6335116|NCT00541242|7242158|FG001|NOT COMPLETED|Treatment Period 1||0
6335117|NCT00541242|7242157|FG000|STARTED|Treatment Period 2||270
6335118|NCT00541242|7242158|FG001|STARTED|Treatment Period 2||273
6335119|NCT00541242|7242157|FG000|COMPLETED|Treatment Period 2||261
6335120|NCT00541242|7242158|FG001|COMPLETED|Treatment Period 2||266
6335121|NCT00541242|7242157|FG000|NOT COMPLETED|Treatment Period 2||9
6335122|NCT00541242|7242158|FG001|NOT COMPLETED|Treatment Period 2||7
6335123|NCT00541307|7242164|FG000|STARTED|Overall Study||119
6335124|NCT00541307|7242164|FG000|COMPLETED|Overall Study||95
6335125|NCT00541307|7242164|FG000|NOT COMPLETED|Overall Study||24
6335126|NCT00541346|7242168|FG000|STARTED|Baseline||16
6335127|NCT00541346|7242168|FG000|COMPLETED|Baseline||16
6335128|NCT00541346|7242168|FG000|NOT COMPLETED|Baseline||0
6335129|NCT00541346|7242168|FG000|STARTED|Follow-up||16
6335130|NCT00541346|7242168|FG000|COMPLETED|Follow-up||15
6335131|NCT00541346|7242168|FG000|NOT COMPLETED|Follow-up||1
6335132|NCT00541385|7242174|FG000|STARTED|Overall Study||355
6335133|NCT00541385|7242175|FG001|STARTED|Overall Study||180
6335134|NCT00541385|7242174|FG000|COMPLETED|Overall Study||274
6335135|NCT00541385|7242175|FG001|COMPLETED|Overall Study||142
6335136|NCT00541385|7242174|FG000|NOT COMPLETED|Overall Study||81
6335137|NCT00541385|7242175|FG001|NOT COMPLETED|Overall Study||38
6335138|NCT00541450|7242183|FG000|STARTED|Phase A||244
6335139|NCT00541450|7242184|FG001|STARTED|Phase A||248
6335140|NCT00541450|7242183|FG000|COMPLETED|Phase A||224
6335141|NCT00541450|7242184|FG001|COMPLETED|Phase A||231
6335142|NCT00541450|7242183|FG000|NOT COMPLETED|Phase A||20
6335143|NCT00541450|7242184|FG001|NOT COMPLETED|Phase A||17
6335144|NCT00541450|7242183|FG000|STARTED|Phase B||224
6335145|NCT00541450|7242184|FG001|STARTED|Phase B||231
6335146|NCT00541450|7242183|FG000|COMPLETED|Phase B||187
6335147|NCT00541450|7242184|FG001|COMPLETED|Phase B||200
6335148|NCT00541450|7242183|FG000|NOT COMPLETED|Phase B||37
6335149|NCT00541450|7242184|FG001|NOT COMPLETED|Phase B||31
6335150|NCT00541593|7242194|FG000|STARTED|Overall Study||5
6335151|NCT00541593|7242194|FG000|COMPLETED|Overall Study||5
6335152|NCT00541593|7242194|FG000|NOT COMPLETED|Overall Study||0
6335153|NCT00541658|7242201|FG000|STARTED|Overall Study||308
6335154|NCT00541658|7242202|FG001|STARTED|Overall Study||307
6335155|NCT00541658|7242203|FG002|STARTED|Overall Study||308
6335156|NCT00541658|7242201|FG000|ITT Population|Overall Study||307
6335157|NCT00541658|7242202|FG001|ITT Population|Overall Study||307
6335158|NCT00541658|7242203|FG002|ITT Population|Overall Study||308
6335159|NCT00541658|7242201|FG000|COMPLETED|Overall Study||248
6335160|NCT00541658|7242202|FG001|COMPLETED|Overall Study||234
6335161|NCT00541658|7242203|FG002|COMPLETED|Overall Study||240
6335162|NCT00541658|7242201|FG000|NOT COMPLETED|Overall Study||60
6335163|NCT00541658|7242202|FG001|NOT COMPLETED|Overall Study||73
6335164|NCT00541658|7242203|FG002|NOT COMPLETED|Overall Study||68
6335165|NCT00541671|7242215|FG000|STARTED|Overall Study||13
6335166|NCT00541671|7242216|FG001|STARTED|Overall Study||12
6335167|NCT00541671|7242215|FG000|COMPLETED|Overall Study||13
6335168|NCT00541671|7242216|FG001|COMPLETED|Overall Study||12
6335169|NCT00541671|7242215|FG000|NOT COMPLETED|Overall Study||0
6335170|NCT00541671|7242216|FG001|NOT COMPLETED|Overall Study||0
6335171|NCT00541775|7242225|FG000|STARTED|Overall Study||94
6335172|NCT00541775|7242226|FG001|STARTED|Overall Study||87
6335173|NCT00541775|7242227|FG002|STARTED|Overall Study||92
6335174|NCT00541775|7242225|FG000|COMPLETED|Overall Study||85
6335175|NCT00541775|7242226|FG001|COMPLETED|Overall Study||85
6335176|NCT00541775|7242227|FG002|COMPLETED|Overall Study||84
6335177|NCT00541775|7242225|FG000|NOT COMPLETED|Overall Study||9
6335178|NCT00541775|7242226|FG001|NOT COMPLETED|Overall Study||2
6335179|NCT00541775|7242227|FG002|NOT COMPLETED|Overall Study||8
6335180|NCT00541866|7242240|FG000|STARTED|Overall Study|41 started, but only 39 treated|41
6335181|NCT00541866|7242241|FG001|STARTED|Overall Study||18
6335182|NCT00541866|7242242|FG002|STARTED|Overall Study||17
6335183|NCT00541866|7242243|FG003|STARTED|Overall Study||16
6335184|NCT00541866|7242244|FG004|STARTED|Overall Study||18
6335185|NCT00541866|7242240|FG000|COMPLETED|Overall Study||7
6335186|NCT00541866|7242241|FG001|COMPLETED|Overall Study||0
6335187|NCT00541866|7242242|FG002|COMPLETED|Overall Study||2
6335188|NCT00541866|7242243|FG003|COMPLETED|Overall Study||0
6335189|NCT00541866|7242244|FG004|COMPLETED|Overall Study||3
6335190|NCT00541866|7242240|FG000|NOT COMPLETED|Overall Study||34
6335191|NCT00541866|7242241|FG001|NOT COMPLETED|Overall Study||18
6335192|NCT00541866|7242242|FG002|NOT COMPLETED|Overall Study||15
6335193|NCT00541866|7242243|FG003|NOT COMPLETED|Overall Study||16
6335194|NCT00541866|7242244|FG004|NOT COMPLETED|Overall Study||15
6335195|NCT00541931|7242274|FG000|STARTED|Overall Study||22
6335196|NCT00541931|7242275|FG001|STARTED|Overall Study||15
6335197|NCT00541931|7242274|FG000|COMPLETED|Overall Study||17
6335198|NCT00541931|7242275|FG001|COMPLETED|Overall Study||11
6335199|NCT00541931|7242274|FG000|NOT COMPLETED|Overall Study||5
6335200|NCT00541931|7242275|FG001|NOT COMPLETED|Overall Study||4
6335201|NCT00541970|7242287|FG000|STARTED|Month 7||240
6335202|NCT00541970|7242288|FG001|STARTED|Month 7||241
6335203|NCT00541970|7242289|FG002|STARTED|Month 7||240
6335204|NCT00541970|7242290|FG003|STARTED|Month 7||239
6335205|NCT00541970|7242287|FG000|COMPLETED|Month 7||231
6335206|NCT00541970|7242288|FG001|COMPLETED|Month 7||228
6335207|NCT00541970|7242289|FG002|COMPLETED|Month 7||229
6335208|NCT00541970|7242290|FG003|COMPLETED|Month 7||234
6335209|NCT00541970|7242287|FG000|NOT COMPLETED|Month 7||9
6335210|NCT00541970|7242288|FG001|NOT COMPLETED|Month 7||13
6335211|NCT00541970|7242289|FG002|NOT COMPLETED|Month 7||11
6335212|NCT00541970|7242290|FG003|NOT COMPLETED|Month 7||5
6335213|NCT00541970|7242287|FG000|STARTED|Month 12||240
6335214|NCT00541970|7242288|FG001|STARTED|Month 12||241
6335215|NCT00541970|7242289|FG002|STARTED|Month 12||240
6335216|NCT00541970|7242290|FG003|STARTED|Month 12||239
6335217|NCT00541970|7242287|FG000|COMPLETED|Month 12||228
6335218|NCT00541970|7242288|FG001|COMPLETED|Month 12||219
6335219|NCT00541970|7242289|FG002|COMPLETED|Month 12||219
6335220|NCT00541970|7242290|FG003|COMPLETED|Month 12||223
6335221|NCT00541970|7242287|FG000|NOT COMPLETED|Month 12||12
6335222|NCT00541970|7242288|FG001|NOT COMPLETED|Month 12||22
6335223|NCT00541970|7242289|FG002|NOT COMPLETED|Month 12||21
6335224|NCT00541970|7242290|FG003|NOT COMPLETED|Month 12||16
6335225|NCT00541970|7242287|FG000|STARTED|Month 18||240
6335226|NCT00541970|7242288|FG001|STARTED|Month 18||241
6335227|NCT00541970|7242289|FG002|STARTED|Month 18||240
6335228|NCT00541970|7242290|FG003|STARTED|Month 18||239
6335229|NCT00541970|7242287|FG000|COMPLETED|Month 18||226
6335230|NCT00541970|7242288|FG001|COMPLETED|Month 18||217
6335231|NCT00541970|7242289|FG002|COMPLETED|Month 18||215
6335232|NCT00541970|7242290|FG003|COMPLETED|Month 18||222
6335233|NCT00541970|7242287|FG000|NOT COMPLETED|Month 18||14
6775573|NCT03863795|7703552|FG000|COMPLETED|Overall Study||306
6775574|NCT03863795|7703553|FG001|COMPLETED|Overall Study||269
6775575|NCT03863795|7703554|FG002|COMPLETED|Overall Study||244
6775576|NCT03863795|7703555|FG003|COMPLETED|Overall Study||281
6775577|NCT03863795|7703552|FG000|NOT COMPLETED|Overall Study||0
6775578|NCT03863795|7703553|FG001|NOT COMPLETED|Overall Study||0
6775579|NCT03863795|7703554|FG002|NOT COMPLETED|Overall Study||0
6775580|NCT03863795|7703555|FG003|NOT COMPLETED|Overall Study||0
6775581|NCT03875482|7703567|FG000|STARTED|Overall Study||105
6775582|NCT03875482|7703568|FG001|STARTED|Overall Study||52
6775583|NCT03875482|7703567|FG000|COMPLETED|Overall Study||92
6775584|NCT03875482|7703568|FG001|COMPLETED|Overall Study||32
6775585|NCT03875482|7703567|FG000|NOT COMPLETED|Overall Study||13
6775586|NCT03875482|7703568|FG001|NOT COMPLETED|Overall Study||20
6775587|NCT03874377|7703574|FG000|STARTED|Overall Study||11
6775588|NCT03874377|7703574|FG000|COMPLETED|Overall Study||8
6775589|NCT03874377|7703574|FG000|NOT COMPLETED|Overall Study||3
6775590|NCT03863496|7703578|FG000|STARTED|Overall Study||71
6335234|NCT00541970|7242288|FG001|NOT COMPLETED|Month 18||24
6335235|NCT00541970|7242289|FG002|NOT COMPLETED|Month 18||25
6335236|NCT00541970|7242290|FG003|NOT COMPLETED|Month 18||17
6335237|NCT00541970|7242287|FG000|STARTED|Month 24||240
6335238|NCT00541970|7242288|FG001|STARTED|Month 24||241
6335239|NCT00541970|7242289|FG002|STARTED|Month 24||240
6335240|NCT00541970|7242290|FG003|STARTED|Month 24||239
6335241|NCT00541970|7242287|FG000|COMPLETED|Month 24||211
6775591|NCT03863496|7703578|FG000|COMPLETED|Overall Study||71
6775592|NCT03863496|7703578|FG000|NOT COMPLETED|Overall Study||0
6775593|NCT03874013|7703586|FG000|STARTED|Overall Study||22
6775594|NCT03874013|7703587|FG001|STARTED|Overall Study||22
6775595|NCT03874013|7703586|FG000|COMPLETED|Overall Study||22
6335242|NCT00541970|7242288|FG001|COMPLETED|Month 24||209
6335243|NCT00541970|7242289|FG002|COMPLETED|Month 24||208
6335244|NCT00541970|7242290|FG003|COMPLETED|Month 24||217
6335245|NCT00541970|7242287|FG000|NOT COMPLETED|Month 24||29
6335246|NCT00541970|7242288|FG001|NOT COMPLETED|Month 24||32
6335247|NCT00541970|7242289|FG002|NOT COMPLETED|Month 24||32
6335248|NCT00541970|7242290|FG003|NOT COMPLETED|Month 24||22
6335249|NCT00541970|7242287|FG000|STARTED|Month 36||240
6335250|NCT00541970|7242288|FG001|STARTED|Month 36||241
6335251|NCT00541970|7242289|FG002|STARTED|Month 36||240
6335252|NCT00541970|7242290|FG003|STARTED|Month 36||239
6335253|NCT00541970|7242287|FG000|COMPLETED|Month 36||179
6335254|NCT00541970|7242288|FG001|COMPLETED|Month 36||175
6335255|NCT00541970|7242289|FG002|COMPLETED|Month 36||174
6335256|NCT00541970|7242290|FG003|COMPLETED|Month 36||179
6335257|NCT00541970|7242287|FG000|NOT COMPLETED|Month 36||61
6335258|NCT00541970|7242288|FG001|NOT COMPLETED|Month 36||66
6335259|NCT00541970|7242289|FG002|NOT COMPLETED|Month 36||66
6335260|NCT00541970|7242290|FG003|NOT COMPLETED|Month 36||60
6335261|NCT00541970|7242287|FG000|STARTED|Month 48||240
6335262|NCT00541970|7242288|FG001|STARTED|Month 48||241
6335263|NCT00541970|7242289|FG002|STARTED|Month 48||240
6335264|NCT00541970|7242290|FG003|STARTED|Month 48||239
6335265|NCT00541970|7242287|FG000|COMPLETED|Month 48||169
6335266|NCT00541970|7242288|FG001|COMPLETED|Month 48||168
6335267|NCT00541970|7242289|FG002|COMPLETED|Month 48||167
6335268|NCT00541970|7242290|FG003|COMPLETED|Month 48||164
6335269|NCT00541970|7242287|FG000|NOT COMPLETED|Month 48||71
6335270|NCT00541970|7242288|FG001|NOT COMPLETED|Month 48||73
6335271|NCT00541970|7242289|FG002|NOT COMPLETED|Month 48||73
6335272|NCT00541970|7242290|FG003|NOT COMPLETED|Month 48||75
6335273|NCT00541970|7242287|FG000|STARTED|Month 60||240
6335274|NCT00541970|7242288|FG001|STARTED|Month 60||241
6335275|NCT00541970|7242289|FG002|STARTED|Month 60||240
6335276|NCT00541970|7242290|FG003|STARTED|Month 60||239
6335277|NCT00541970|7242287|FG000|COMPLETED|Month 60||162
6335278|NCT00541970|7242288|FG001|COMPLETED|Month 60||164
6335279|NCT00541970|7242289|FG002|COMPLETED|Month 60||158
6335280|NCT00541970|7242290|FG003|COMPLETED|Month 60||167
6335281|NCT00541970|7242287|FG000|NOT COMPLETED|Month 60||78
6335282|NCT00541970|7242288|FG001|NOT COMPLETED|Month 60||77
6335283|NCT00541970|7242289|FG002|NOT COMPLETED|Month 60||82
6335284|NCT00541970|7242290|FG003|NOT COMPLETED|Month 60||72
6335285|NCT00542178|7242306|FG000|STARTED|Overall Study||390
6335286|NCT00542178|7242307|FG001|STARTED|Overall Study||412
6335287|NCT00542178|7242308|FG002|STARTED|Overall Study||382
6335288|NCT00542178|7242309|FG003|STARTED|Overall Study||370
6335289|NCT00542178|7242310|FG004|STARTED|Overall Study||464
6335290|NCT00542178|7242311|FG005|STARTED|Overall Study||495
6335291|NCT00542178|7242312|FG006|STARTED|Overall Study||493
6335292|NCT00542178|7242313|FG007|STARTED|Overall Study||466
6335293|NCT00542178|7242306|FG000|COMPLETED|Overall Study||315
6335294|NCT00542178|7242307|FG001|COMPLETED|Overall Study||332
6335295|NCT00542178|7242308|FG002|COMPLETED|Overall Study||308
6335296|NCT00542178|7242309|FG003|COMPLETED|Overall Study||308
6335297|NCT00542178|7242310|FG004|COMPLETED|Overall Study||400
6335298|NCT00542178|7242311|FG005|COMPLETED|Overall Study||406
6335299|NCT00542178|7242312|FG006|COMPLETED|Overall Study||406
6335300|NCT00542178|7242313|FG007|COMPLETED|Overall Study||381
6335301|NCT00542178|7242306|FG000|NOT COMPLETED|Overall Study||75
6335302|NCT00542178|7242307|FG001|NOT COMPLETED|Overall Study||80
6335303|NCT00542178|7242308|FG002|NOT COMPLETED|Overall Study||74
6335304|NCT00542178|7242309|FG003|NOT COMPLETED|Overall Study||62
6335305|NCT00542178|7242310|FG004|NOT COMPLETED|Overall Study||64
6335306|NCT00542178|7242311|FG005|NOT COMPLETED|Overall Study||89
6335307|NCT00542178|7242312|FG006|NOT COMPLETED|Overall Study||87
6335308|NCT00542178|7242313|FG007|NOT COMPLETED|Overall Study||85
6335309|NCT00542191|7242327|FG000|STARTED|Overall Study||21
6335310|NCT00542191|7242327|FG000|COMPLETED|Overall Study||18
6335311|NCT00542191|7242327|FG000|NOT COMPLETED|Overall Study||3
6335312|NCT00542269|7242334|FG000|STARTED|Overall Study||61
6335313|NCT00542269|7242335|FG001|STARTED|Overall Study||60
6335314|NCT00542269|7242336|FG002|STARTED|Overall Study||57
6335315|NCT00542269|7242334|FG000|COMPLETED|Overall Study||48
6335316|NCT00542269|7242335|FG001|COMPLETED|Overall Study||54
6335317|NCT00542269|7242336|FG002|COMPLETED|Overall Study||51
6335318|NCT00542269|7242334|FG000|NOT COMPLETED|Overall Study||13
6335319|NCT00542269|7242335|FG001|NOT COMPLETED|Overall Study||6
6335320|NCT00542269|7242336|FG002|NOT COMPLETED|Overall Study||6
6335321|NCT00542308|7242346|FG000|STARTED|Overall Study||90
6335322|NCT00542308|7242346|FG000|COMPLETED|Overall Study||90
6335323|NCT00542308|7242346|FG000|NOT COMPLETED|Overall Study||0
6335324|NCT00542321|7242352|FG000|STARTED|Overall Study||8
6335325|NCT00542321|7242353|FG001|STARTED|Overall Study||8
6335326|NCT00542321|7242352|FG000|COMPLETED|Overall Study||8
6335327|NCT00542321|7242353|FG001|COMPLETED|Overall Study||7
6335328|NCT00542321|7242352|FG000|NOT COMPLETED|Overall Study||0
6335329|NCT00542321|7242353|FG001|NOT COMPLETED|Overall Study||1
6335330|NCT00542386|7242365|FG000|STARTED|Overall Study||104
6335331|NCT00542386|7242366|FG001|STARTED|Overall Study||102
6335332|NCT00542386|7242367|FG002|STARTED|Overall Study||99
6335333|NCT00542386|7242368|FG003|STARTED|Overall Study||103
6335334|NCT00542386|7242369|FG004|STARTED|Overall Study||102
6335335|NCT00542386|7242370|FG005|STARTED|Overall Study||132
6335336|NCT00542386|7242365|FG000|COMPLETED|Overall Study||61
6335337|NCT00542386|7242366|FG001|COMPLETED|Overall Study||74
6335338|NCT00542386|7242367|FG002|COMPLETED|Overall Study||66
6335339|NCT00542386|7242368|FG003|COMPLETED|Overall Study||65
6335340|NCT00542386|7242369|FG004|COMPLETED|Overall Study||62
6335341|NCT00542386|7242370|FG005|COMPLETED|Overall Study||82
6335342|NCT00542386|7242365|FG000|NOT COMPLETED|Overall Study||43
6335343|NCT00542386|7242366|FG001|NOT COMPLETED|Overall Study||28
6335344|NCT00542386|7242367|FG002|NOT COMPLETED|Overall Study||33
6335345|NCT00542386|7242368|FG003|NOT COMPLETED|Overall Study||38
6335346|NCT00542386|7242369|FG004|NOT COMPLETED|Overall Study||40
6335347|NCT00542386|7242370|FG005|NOT COMPLETED|Overall Study||50
6335348|NCT00542425|7242389|FG000|STARTED|Initial 24 Weeks||46
6335349|NCT00542425|7242390|FG001|STARTED|Initial 24 Weeks||43
6335350|NCT00542425|7242391|FG002|STARTED|Initial 24 Weeks||43
6335351|NCT00542425|7242392|FG003|STARTED|Initial 24 Weeks||45
6335352|NCT00542425|7242393|FG004|STARTED|Initial 24 Weeks||45
6335353|NCT00542425|7242389|FG000|COMPLETED|Initial 24 Weeks||42
6335354|NCT00542425|7242390|FG001|COMPLETED|Initial 24 Weeks||33
6335355|NCT00542425|7242391|FG002|COMPLETED|Initial 24 Weeks||36
6335356|NCT00542425|7242392|FG003|COMPLETED|Initial 24 Weeks||34
6335357|NCT00542425|7242393|FG004|COMPLETED|Initial 24 Weeks||39
6335358|NCT00542425|7242389|FG000|NOT COMPLETED|Initial 24 Weeks||4
6335359|NCT00542425|7242390|FG001|NOT COMPLETED|Initial 24 Weeks||10
6335360|NCT00542425|7242391|FG002|NOT COMPLETED|Initial 24 Weeks||7
6335361|NCT00542425|7242392|FG003|NOT COMPLETED|Initial 24 Weeks||11
6335362|NCT00542425|7242393|FG004|NOT COMPLETED|Initial 24 Weeks||6
6335363|NCT00542425|7242389|FG000|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
6335364|NCT00542425|7242390|FG001|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
6335365|NCT00542425|7242391|FG002|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
6335366|NCT00542425|7242392|FG003|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
6335367|NCT00542425|7242393|FG004|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
6335368|NCT00542425|7242389|FG000|COMPLETED|Extended 24 Weeks of Treatment||10
6335369|NCT00542425|7242390|FG001|COMPLETED|Extended 24 Weeks of Treatment||11
6335370|NCT00542425|7242391|FG002|COMPLETED|Extended 24 Weeks of Treatment||8
6335371|NCT00542425|7242392|FG003|COMPLETED|Extended 24 Weeks of Treatment||6
6335372|NCT00542425|7242393|FG004|COMPLETED|Extended 24 Weeks of Treatment||13
6335373|NCT00542425|7242389|FG000|NOT COMPLETED|Extended 24 Weeks of Treatment||1
6335374|NCT00542425|7242390|FG001|NOT COMPLETED|Extended 24 Weeks of Treatment||2
6335375|NCT00542425|7242391|FG002|NOT COMPLETED|Extended 24 Weeks of Treatment||2
6335376|NCT00542425|7242392|FG003|NOT COMPLETED|Extended 24 Weeks of Treatment||1
6335377|NCT00542425|7242393|FG004|NOT COMPLETED|Extended 24 Weeks of Treatment||1
6335378|NCT00542490|7242405|FG000|STARTED|Overall Study||23
6335379|NCT00542490|7242405|FG000|COMPLETED|Overall Study||21
6335380|NCT00542490|7242405|FG000|NOT COMPLETED|Overall Study||2
6335381|NCT00542620|7242411|FG000|STARTED|Overall Study||13
6335382|NCT00542620|7242412|FG001|STARTED|Overall Study||12
6335383|NCT00542620|7242411|FG000|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
6335384|NCT00542620|7242412|FG001|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
6335385|NCT00542620|7242411|FG000|COMPLETED|Overall Study||13
6335386|NCT00542620|7242412|FG001|COMPLETED|Overall Study||12
6335387|NCT00542620|7242411|FG000|NOT COMPLETED|Overall Study||0
6335388|NCT00542620|7242412|FG001|NOT COMPLETED|Overall Study||0
6335389|NCT00542750|7242418|FG000|STARTED|Overall Study||24
6335390|NCT00542750|7242418|FG000|COMPLETED|Overall Study||24
6335391|NCT00542750|7242418|FG000|NOT COMPLETED|Overall Study||0
6335392|NCT00542789|7242424|FG000|STARTED|Overall Study|Randomised|175
6335393|NCT00542789|7242425|FG001|STARTED|Overall Study|Randomised|168
6335394|NCT00542789|7242424|FG000|COMPLETED|Overall Study||134
6775596|NCT03874013|7703587|FG001|COMPLETED|Overall Study||21
6775597|NCT03874013|7703586|FG000|NOT COMPLETED|Overall Study||0
6775598|NCT03874013|7703587|FG001|NOT COMPLETED|Overall Study||1
6775599|NCT03873116|7703596|FG000|STARTED|Overall Study||6
6775600|NCT03873116|7703597|FG001|STARTED|Overall Study||7
6775601|NCT03873116|7703598|FG002|STARTED|Overall Study||6
6775602|NCT03873116|7703596|FG000|COMPLETED|Overall Study||6
6775603|NCT03873116|7703597|FG001|COMPLETED|Overall Study||7
6775604|NCT03873116|7703598|FG002|COMPLETED|Overall Study||5
6775605|NCT03873116|7703596|FG000|NOT COMPLETED|Overall Study||0
6775606|NCT03873116|7703597|FG001|NOT COMPLETED|Overall Study||0
6775607|NCT03873116|7703598|FG002|NOT COMPLETED|Overall Study||1
6775608|NCT03872843|7703608|FG000|STARTED|Overall Study||12
6775609|NCT03872843|7703609|FG001|STARTED|Overall Study||10
6775610|NCT03872843|7703608|FG000|COMPLETED|Overall Study||7
6775611|NCT03872843|7703609|FG001|COMPLETED|Overall Study||3
6775612|NCT03872843|7703608|FG000|NOT COMPLETED|Overall Study||5
6775613|NCT03872843|7703609|FG001|NOT COMPLETED|Overall Study||7
6775614|NCT03870997|7703621|FG000|STARTED|Overall Study||15702
6775615|NCT03870997|7703622|FG001|STARTED|Overall Study||15702
6775616|NCT03870997|7703623|FG002|STARTED|Overall Study||15756
6775617|NCT03870997|7703624|FG003|STARTED|Overall Study||15757
6775618|NCT03870997|7703625|FG004|STARTED|Overall Study||15702
6775619|NCT03870997|7703626|FG005|STARTED|Overall Study||15702
6775620|NCT03870997|7703621|FG000|COMPLETED|Overall Study||5158
6775621|NCT03870997|7703622|FG001|COMPLETED|Overall Study||5271
6775622|NCT03870997|7703623|FG002|COMPLETED|Overall Study||4778
6775623|NCT03870997|7703624|FG003|COMPLETED|Overall Study||4810
6775624|NCT03870997|7703625|FG004|COMPLETED|Overall Study||5114
6335395|NCT00542789|7242425|FG001|COMPLETED|Overall Study||90
6335396|NCT00542789|7242424|FG000|NOT COMPLETED|Overall Study||41
6335397|NCT00542789|7242425|FG001|NOT COMPLETED|Overall Study||78
6775625|NCT03870997|7703626|FG005|COMPLETED|Overall Study||5171
6775626|NCT03870997|7703621|FG000|NOT COMPLETED|Overall Study||10544
6335398|NCT00542815|7242434|FG000|STARTED|Overall Study||432
6335399|NCT00542815|7242435|FG001|STARTED|Overall Study||76
6335400|NCT00542815|7242436|FG002|STARTED|Overall Study||124
6335401|NCT00542815|7242434|FG000|COMPLETED|Overall Study||326
6335402|NCT00542815|7242435|FG001|COMPLETED|Overall Study||44
6335403|NCT00542815|7242436|FG002|COMPLETED|Overall Study||92
6335404|NCT00542815|7242434|FG000|NOT COMPLETED|Overall Study||106
6335405|NCT00542815|7242435|FG001|NOT COMPLETED|Overall Study||32
6335406|NCT00542815|7242436|FG002|NOT COMPLETED|Overall Study||32
6335407|NCT00542828|7242444|FG000|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
6335408|NCT00542828|7242444|FG000|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
6335409|NCT00542828|7242444|FG000|NOT COMPLETED|Overall Study||13
6335410|NCT00542880|7242450|FG000|STARTED|Period 1|This was a cross-over study|217
6335411|NCT00542880|7242451|FG001|STARTED|Period 1||225
6335412|NCT00542880|7242450|FG000|COMPLETED|Period 1||211
6335413|NCT00542880|7242451|FG001|COMPLETED|Period 1||213
6335414|NCT00542880|7242450|FG000|NOT COMPLETED|Period 1||6
6335415|NCT00542880|7242451|FG001|NOT COMPLETED|Period 1||12
6335416|NCT00542880|7242450|FG000|STARTED|Period 2||211
6335417|NCT00542880|7242451|FG001|STARTED|Period 2||213
6335418|NCT00542880|7242450|FG000|COMPLETED|Period 2||204
6335419|NCT00542880|7242451|FG001|COMPLETED|Period 2||203
6335420|NCT00542880|7242450|FG000|NOT COMPLETED|Period 2||7
6335421|NCT00542880|7242451|FG001|NOT COMPLETED|Period 2||10
6335422|NCT00542880|7242450|FG000|STARTED|Period 3||204
6335423|NCT00542880|7242451|FG001|STARTED|Period 3||203
6335424|NCT00542880|7242450|FG000|COMPLETED|Period 3||204
6335425|NCT00542880|7242451|FG001|COMPLETED|Period 3||201
6335426|NCT00542880|7242450|FG000|NOT COMPLETED|Period 3||0
6335427|NCT00542880|7242451|FG001|NOT COMPLETED|Period 3||2
6335428|NCT00542919|7242461|FG000|STARTED|Overall Study||23
6335429|NCT00542919|7242462|FG001|STARTED|Overall Study||19
6335430|NCT00542919|7242463|FG002|STARTED|Overall Study||15
6335431|NCT00542919|7242461|FG000|Received At Least One Dose of Study Drug|Overall Study||23
6335432|NCT00542919|7242462|FG001|Received At Least One Dose of Study Drug|Overall Study||19
6335433|NCT00542919|7242463|FG002|Received At Least One Dose of Study Drug|Overall Study||15
6335434|NCT00542919|7242461|FG000|Progressive Disease|Overall Study||15
6335435|NCT00542919|7242462|FG001|Progressive Disease|Overall Study||11
6335436|NCT00542919|7242463|FG002|Progressive Disease|Overall Study||7
6335437|NCT00542919|7242461|FG000|Death|Overall Study||1
6335438|NCT00542919|7242462|FG001|Death|Overall Study||1
6335439|NCT00542919|7242463|FG002|Death|Overall Study||2
6335440|NCT00542919|7242461|FG000|COMPLETED|Overall Study||16
6335441|NCT00542919|7242462|FG001|COMPLETED|Overall Study||12
6335442|NCT00542919|7242463|FG002|COMPLETED|Overall Study||9
6335443|NCT00542919|7242461|FG000|NOT COMPLETED|Overall Study||7
6335444|NCT00542919|7242462|FG001|NOT COMPLETED|Overall Study||7
6335445|NCT00542919|7242463|FG002|NOT COMPLETED|Overall Study||6
6335446|NCT00542971|7242486|FG000|STARTED|Overall Study||75
6335447|NCT00542971|7242486|FG000|COMPLETED|Overall Study||75
6335448|NCT00542971|7242486|FG000|NOT COMPLETED|Overall Study||0
6335449|NCT00542997|7242490|FG000|STARTED|Wash in / Wash Out Period||51
6335450|NCT00542997|7242490|FG000|COMPLETED|Wash in / Wash Out Period||46
6335451|NCT00542997|7242490|FG000|NOT COMPLETED|Wash in / Wash Out Period||5
6335452|NCT00542997|7242490|FG000|STARTED|Efficacy Period||46
6335453|NCT00542997|7242490|FG000|COMPLETED|Efficacy Period||43
6335454|NCT00542997|7242490|FG000|NOT COMPLETED|Efficacy Period||3
6335455|NCT00543062|7242497|FG000|STARTED|Overall Study||12
6335456|NCT00543062|7242498|FG001|STARTED|Overall Study||12
6335457|NCT00543062|7242499|FG002|STARTED|Overall Study||12
6335458|NCT00543062|7242500|FG003|STARTED|Overall Study||12
6558918|NCT01778049|7481537|FG005|COMPLETED|Double Blind Treatment Period||105
6558919|NCT01778049|7481532|FG000|NOT COMPLETED|Double Blind Treatment Period||0
6775627|NCT03870997|7703622|FG001|NOT COMPLETED|Overall Study||10431
6335459|NCT00543062|7242497|FG000|COMPLETED|Overall Study||10
6335460|NCT00543062|7242498|FG001|COMPLETED|Overall Study||11
6335461|NCT00543062|7242499|FG002|COMPLETED|Overall Study||9
6335462|NCT00543062|7242500|FG003|COMPLETED|Overall Study||11
6335463|NCT00543062|7242497|FG000|NOT COMPLETED|Overall Study||2
6335464|NCT00543062|7242498|FG001|NOT COMPLETED|Overall Study||1
6335465|NCT00543062|7242499|FG002|NOT COMPLETED|Overall Study||3
6335466|NCT00543062|7242500|FG003|NOT COMPLETED|Overall Study||1
6335467|NCT00543101|7242520|FG000|STARTED|Overall Study||12
6335468|NCT00543101|7242521|FG001|STARTED|Overall Study||12
6335469|NCT00543101|7242520|FG000|COMPLETED|Overall Study||12
6775628|NCT03870997|7703623|FG002|NOT COMPLETED|Overall Study||10978
6775629|NCT03870997|7703624|FG003|NOT COMPLETED|Overall Study||10947
6775630|NCT03870997|7703625|FG004|NOT COMPLETED|Overall Study||10588
6775631|NCT03870997|7703626|FG005|NOT COMPLETED|Overall Study||10531
6775632|NCT03869684|7703638|FG000|STARTED|Overall Study||3
6775633|NCT03869684|7703639|FG001|STARTED|Overall Study||5
6335470|NCT00543101|7242521|FG001|COMPLETED|Overall Study||12
6335471|NCT00543101|7242520|FG000|NOT COMPLETED|Overall Study||0
6335472|NCT00543101|7242521|FG001|NOT COMPLETED|Overall Study||0
6335473|NCT00543127|7242530|FG000|STARTED|Overall Study||433
6335474|NCT00543127|7242531|FG001|STARTED|Overall Study||437
6335475|NCT00543127|7242530|FG000|COMPLETED|Overall Study||303
6335476|NCT00543127|7242531|FG001|COMPLETED|Overall Study||350
6335477|NCT00543127|7242530|FG000|NOT COMPLETED|Overall Study||130
6335478|NCT00543127|7242531|FG001|NOT COMPLETED|Overall Study||87
6335479|NCT00543140|7242537|FG000|STARTED|Overall Study||303
6335480|NCT00543140|7242537|FG000|COMPLETED|Overall Study||231
6335481|NCT00543140|7242537|FG000|NOT COMPLETED|Overall Study||72
6335482|NCT00543296|7242541|FG000|STARTED|Overall Study||21
6335483|NCT00543296|7242541|FG000|COMPLETED|Overall Study||14
6335484|NCT00543296|7242541|FG000|NOT COMPLETED|Overall Study||7
6335485|NCT00543309|7242548|FG000|STARTED|Overall Study||35
6335486|NCT00543309|7242549|FG001|STARTED|Overall Study||36
6335487|NCT00543309|7242550|FG002|STARTED|Overall Study||35
6335488|NCT00543309|7242548|FG000|COMPLETED|Overall Study||35
6335489|NCT00543309|7242549|FG001|COMPLETED|Overall Study||35
6335490|NCT00543309|7242550|FG002|COMPLETED|Overall Study||35
6335491|NCT00543309|7242548|FG000|NOT COMPLETED|Overall Study||0
6335492|NCT00543309|7242549|FG001|NOT COMPLETED|Overall Study||1
6335493|NCT00543309|7242550|FG002|NOT COMPLETED|Overall Study||0
6335494|NCT00543387|7242568|FG000|STARTED|Panel 1 + Panel 2||3
6335495|NCT00543387|7242569|FG001|STARTED|Panel 1 + Panel 2||3
6335496|NCT00543387|7242570|FG002|STARTED|Panel 1 + Panel 2||3
6335497|NCT00543387|7242571|FG003|STARTED|Panel 1 + Panel 2||3
6335498|NCT00543387|7242572|FG004|STARTED|Panel 1 + Panel 2||3
6335499|NCT00543387|7242573|FG005|STARTED|Panel 1 + Panel 2||3
6335500|NCT00543387|7242574|FG006|STARTED|Panel 1 + Panel 2||6
6335501|NCT00543387|7242575|FG007|STARTED|Panel 1 + Panel 2||6
6335502|NCT00543387|7242576|FG008|STARTED|Panel 1 + Panel 2||5
6335503|NCT00543387|7242577|FG009|STARTED|Panel 1 + Panel 2||0
6335504|NCT00543387|7242578|FG010|STARTED|Panel 1 + Panel 2||0
6335505|NCT00543387|7242568|FG000|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6335506|NCT00543387|7242569|FG001|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
6335507|NCT00543387|7242570|FG002|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6335508|NCT00543387|7242571|FG003|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6335509|NCT00543387|7242572|FG004|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||2
6335510|NCT00543387|7242573|FG005|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||1
6335511|NCT00543387|7242574|FG006|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6335512|NCT00543387|7242575|FG007|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6335513|NCT00543387|7242576|FG008|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6335514|NCT00543387|7242577|FG009|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6335515|NCT00543387|7242578|FG010|Crossed Over to Panel 2 Due to PD|Panel 1 + Panel 2||0
6335516|NCT00543387|7242568|FG000|COMPLETED|Panel 1 + Panel 2||0
6335517|NCT00543387|7242569|FG001|COMPLETED|Panel 1 + Panel 2||0
6335518|NCT00543387|7242570|FG002|COMPLETED|Panel 1 + Panel 2||0
6335519|NCT00543387|7242571|FG003|COMPLETED|Panel 1 + Panel 2||0
6335520|NCT00543387|7242572|FG004|COMPLETED|Panel 1 + Panel 2||0
6335521|NCT00543387|7242573|FG005|COMPLETED|Panel 1 + Panel 2||0
6335522|NCT00543387|7242574|FG006|COMPLETED|Panel 1 + Panel 2||0
6775634|NCT03869684|7703640|FG002|STARTED|Overall Study||5
6775635|NCT03869684|7703638|FG000|COMPLETED|Overall Study||1
6775636|NCT03869684|7703639|FG001|COMPLETED|Overall Study||2
6335523|NCT00543387|7242575|FG007|COMPLETED|Panel 1 + Panel 2||0
6335524|NCT00543387|7242576|FG008|COMPLETED|Panel 1 + Panel 2||0
6335525|NCT00543387|7242577|FG009|COMPLETED|Panel 1 + Panel 2||0
6335526|NCT00543387|7242578|FG010|COMPLETED|Panel 1 + Panel 2||0
6335527|NCT00543387|7242568|FG000|NOT COMPLETED|Panel 1 + Panel 2||3
6335528|NCT00543387|7242569|FG001|NOT COMPLETED|Panel 1 + Panel 2||3
6335529|NCT00543387|7242570|FG002|NOT COMPLETED|Panel 1 + Panel 2||3
6335530|NCT00543387|7242571|FG003|NOT COMPLETED|Panel 1 + Panel 2||3
6335531|NCT00543387|7242572|FG004|NOT COMPLETED|Panel 1 + Panel 2||3
6335532|NCT00543387|7242573|FG005|NOT COMPLETED|Panel 1 + Panel 2||3
6335533|NCT00543387|7242574|FG006|NOT COMPLETED|Panel 1 + Panel 2||6
6335534|NCT00543387|7242575|FG007|NOT COMPLETED|Panel 1 + Panel 2||6
6335535|NCT00543387|7242576|FG008|NOT COMPLETED|Panel 1 + Panel 2||5
6335536|NCT00543387|7242577|FG009|NOT COMPLETED|Panel 1 + Panel 2||0
6335537|NCT00543387|7242578|FG010|NOT COMPLETED|Panel 1 + Panel 2||0
6335538|NCT00543387|7242568|FG000|STARTED|Crossover Participants||0
6335539|NCT00543387|7242569|FG001|STARTED|Crossover Participants||0
6335540|NCT00543387|7242570|FG002|STARTED|Crossover Participants||0
6335541|NCT00543387|7242571|FG003|STARTED|Crossover Participants||0
6335542|NCT00543387|7242572|FG004|STARTED|Crossover Participants||0
6335543|NCT00543387|7242573|FG005|STARTED|Crossover Participants||0
6335544|NCT00543387|7242574|FG006|STARTED|Crossover Participants||0
6335545|NCT00543387|7242575|FG007|STARTED|Crossover Participants||0
6335546|NCT00543387|7242576|FG008|STARTED|Crossover Participants||0
6335547|NCT00543387|7242577|FG009|STARTED|Crossover Participants|Participant originally treated in MK-5108 400 mg BID (Panel 1) in Period 1|1
6335548|NCT00543387|7242578|FG010|STARTED|Crossover Participants|3 participants originally treated with 1500 (2) and 1800 mg (1) MK-5108 in Panel 1 Period 1|3
6775637|NCT03869684|7703640|FG002|COMPLETED|Overall Study||2
6775638|NCT03869684|7703638|FG000|NOT COMPLETED|Overall Study||2
6775639|NCT03869684|7703639|FG001|NOT COMPLETED|Overall Study||3
6335549|NCT00543387|7242568|FG000|COMPLETED|Crossover Participants||0
6335550|NCT00543387|7242569|FG001|COMPLETED|Crossover Participants||0
6335551|NCT00543387|7242570|FG002|COMPLETED|Crossover Participants||0
6335552|NCT00543387|7242571|FG003|COMPLETED|Crossover Participants||0
6335553|NCT00543387|7242572|FG004|COMPLETED|Crossover Participants||0
6335554|NCT00543387|7242573|FG005|COMPLETED|Crossover Participants||0
6335555|NCT00543387|7242574|FG006|COMPLETED|Crossover Participants||0
6335556|NCT00543387|7242575|FG007|COMPLETED|Crossover Participants||0
6775640|NCT03869684|7703640|FG002|NOT COMPLETED|Overall Study||3
6775641|NCT03861338|7703648|FG000|STARTED|Overall Study||10
6335557|NCT00543387|7242576|FG008|COMPLETED|Crossover Participants||0
6335558|NCT00543387|7242577|FG009|COMPLETED|Crossover Participants||0
6335559|NCT00543387|7242578|FG010|COMPLETED|Crossover Participants||0
6335560|NCT00543387|7242568|FG000|NOT COMPLETED|Crossover Participants||0
6335561|NCT00543387|7242569|FG001|NOT COMPLETED|Crossover Participants||0
6335562|NCT00543387|7242570|FG002|NOT COMPLETED|Crossover Participants||0
6335563|NCT00543387|7242571|FG003|NOT COMPLETED|Crossover Participants||0
6335564|NCT00543387|7242572|FG004|NOT COMPLETED|Crossover Participants||0
6335565|NCT00543387|7242573|FG005|NOT COMPLETED|Crossover Participants||0
6335566|NCT00543387|7242574|FG006|NOT COMPLETED|Crossover Participants||0
6335567|NCT00543387|7242575|FG007|NOT COMPLETED|Crossover Participants||0
6335568|NCT00543387|7242576|FG008|NOT COMPLETED|Crossover Participants||0
6335569|NCT00543387|7242577|FG009|NOT COMPLETED|Crossover Participants||1
6335570|NCT00543387|7242578|FG010|NOT COMPLETED|Crossover Participants||3
6335571|NCT00543400|7242606|FG000|STARTED|Overall Study||151
6335572|NCT00543400|7242607|FG001|STARTED|Overall Study||44
6335573|NCT00543400|7242608|FG002|STARTED|Overall Study||152
6335574|NCT00543400|7242609|FG003|STARTED|Overall Study||156
6335575|NCT00543400|7242606|FG000|COMPLETED|Overall Study||146
6335576|NCT00543400|7242607|FG001|COMPLETED|Overall Study||43
6335577|NCT00543400|7242608|FG002|COMPLETED|Overall Study||148
6335578|NCT00543400|7242609|FG003|COMPLETED|Overall Study||151
6335579|NCT00543400|7242606|FG000|NOT COMPLETED|Overall Study||5
6335580|NCT00543400|7242607|FG001|NOT COMPLETED|Overall Study||1
6335581|NCT00543400|7242608|FG002|NOT COMPLETED|Overall Study||4
6335582|NCT00543400|7242609|FG003|NOT COMPLETED|Overall Study||5
6335583|NCT00543439|7242622|FG000|STARTED|Period 1||10
6335584|NCT00543439|7242623|FG001|STARTED|Period 1||29
6335585|NCT00543439|7242624|FG002|STARTED|Period 1||27
6335586|NCT00543439|7242622|FG000|Treated|Period 1||9
6335587|NCT00543439|7242623|FG001|Treated|Period 1||29
6335588|NCT00543439|7242624|FG002|Treated|Period 1||27
6335589|NCT00543439|7242622|FG000|COMPLETED|Period 1||9
6335590|NCT00543439|7242623|FG001|COMPLETED|Period 1||26
6335591|NCT00543439|7242624|FG002|COMPLETED|Period 1||25
6335592|NCT00543439|7242622|FG000|NOT COMPLETED|Period 1||1
6335593|NCT00543439|7242623|FG001|NOT COMPLETED|Period 1||3
6335594|NCT00543439|7242624|FG002|NOT COMPLETED|Period 1||2
6335595|NCT00543439|7242622|FG000|STARTED|Period 2||9
6335596|NCT00543439|7242623|FG001|STARTED|Period 2||26
6335597|NCT00543439|7242624|FG002|STARTED|Period 2||25
6335598|NCT00543439|7242622|FG000|COMPLETED|Period 2||8
6335599|NCT00543439|7242623|FG001|COMPLETED|Period 2||25
6335600|NCT00543439|7242624|FG002|COMPLETED|Period 2||23
6335601|NCT00543439|7242622|FG000|NOT COMPLETED|Period 2||1
6335602|NCT00543439|7242623|FG001|NOT COMPLETED|Period 2||1
6335603|NCT00543439|7242624|FG002|NOT COMPLETED|Period 2||2
6335604|NCT00543543|7242645|FG000|STARTED|Base Study||315
6335605|NCT00543543|7242646|FG001|STARTED|Base Study||7106
6335606|NCT00543543|7242647|FG002|STARTED|Base Study||310
6335607|NCT00543543|7242648|FG003|STARTED|Base Study||7109
6335608|NCT00543543|7242645|FG000|Completed 3 Vaccinations|Base Study||300
6335609|NCT00543543|7242646|FG001|Completed 3 Vaccinations|Base Study||6928
6335610|NCT00543543|7242647|FG002|Completed 3 Vaccinations|Base Study||297
6335611|NCT00543543|7242648|FG003|Completed 3 Vaccinations|Base Study||6934
6335612|NCT00543543|7242645|FG000|COMPLETED|Base Study|Follow-up was up to 7 months|295
6335613|NCT00543543|7242646|FG001|COMPLETED|Base Study|Follow-up was up to 54 months|5854
6335614|NCT00543543|7242647|FG002|COMPLETED|Base Study|Follow-up was up to 7 months|296
6335615|NCT00543543|7242648|FG003|COMPLETED|Base Study|Follow-up was up to 54 months|5887
6335616|NCT00543543|7242645|FG000|NOT COMPLETED|Base Study||20
6335617|NCT00543543|7242646|FG001|NOT COMPLETED|Base Study||1252
6335618|NCT00543543|7242647|FG002|NOT COMPLETED|Base Study||14
6335619|NCT00543543|7242648|FG003|NOT COMPLETED|Base Study||1222
6335620|NCT00543543|7242645|FG000|STARTED|Extension Study|This group did not participate in the Extension Study|0
6335621|NCT00543543|7242646|FG001|STARTED|Extension Study|Cohort 1|150
6335622|NCT00543543|7242647|FG002|STARTED|Extension Study|This group did not participate in the Extension Study|0
6335623|NCT00543543|7242648|FG003|STARTED|Extension Study|Cohort 2|3050
6335624|NCT00543543|7242645|FG000|COMPLETED|Extension Study||0
6335625|NCT00543543|7242646|FG001|COMPLETED|Extension Study||150
6335626|NCT00543543|7242647|FG002|COMPLETED|Extension Study||0
6335627|NCT00543543|7242648|FG003|COMPLETED|Extension Study||2824
6335628|NCT00543543|7242645|FG000|NOT COMPLETED|Extension Study||0
6335629|NCT00543543|7242646|FG001|NOT COMPLETED|Extension Study||0
6335630|NCT00543543|7242647|FG002|NOT COMPLETED|Extension Study||0
6335631|NCT00543543|7242648|FG003|NOT COMPLETED|Extension Study||226
6335632|NCT00543569|7242667|FG000|STARTED|Overall Study||82
6335633|NCT00543569|7242668|FG001|STARTED|Overall Study||80
6335634|NCT00543569|7242669|FG002|STARTED|Overall Study||80
6335635|NCT00543569|7242670|FG003|STARTED|Overall Study||81
6335636|NCT00543569|7242667|FG000|Received Treatment|Overall Study||79
6335637|NCT00543569|7242668|FG001|Received Treatment|Overall Study||77
6335638|NCT00543569|7242669|FG002|Received Treatment|Overall Study||75
6335639|NCT00543569|7242670|FG003|Received Treatment|Overall Study||78
6335640|NCT00543569|7242667|FG000|COMPLETED|Overall Study||70
6335641|NCT00543569|7242668|FG001|COMPLETED|Overall Study||72
6335642|NCT00543569|7242669|FG002|COMPLETED|Overall Study||60
6335643|NCT00543569|7242670|FG003|COMPLETED|Overall Study||72
6335644|NCT00543569|7242667|FG000|NOT COMPLETED|Overall Study||12
6335645|NCT00543569|7242668|FG001|NOT COMPLETED|Overall Study||8
6335646|NCT00543569|7242669|FG002|NOT COMPLETED|Overall Study||20
6335647|NCT00543569|7242670|FG003|NOT COMPLETED|Overall Study||9
6335648|NCT00543725|7242682|FG000|STARTED|Overall Study||340
6335649|NCT00543725|7242683|FG001|STARTED|Overall Study||338
6335650|NCT00543725|7242682|FG000|COMPLETED|Overall Study||272
6335651|NCT00543725|7242683|FG001|COMPLETED|Overall Study||264
6335652|NCT00543725|7242682|FG000|NOT COMPLETED|Overall Study||68
6335653|NCT00543725|7242683|FG001|NOT COMPLETED|Overall Study||74
6335654|NCT00543764|7242691|FG000|STARTED|Overall Study||100
6335655|NCT00543764|7242692|FG001|STARTED|Overall Study||50
6335656|NCT00543764|7242691|FG000|COMPLETED|Overall Study||100
6335657|NCT00543764|7242692|FG001|COMPLETED|Overall Study||50
6335658|NCT00543764|7242691|FG000|NOT COMPLETED|Overall Study||0
6335659|NCT00543764|7242692|FG001|NOT COMPLETED|Overall Study||0
6775642|NCT03861338|7703648|FG000|COMPLETED|Overall Study||8
6775643|NCT03861338|7703648|FG000|NOT COMPLETED|Overall Study||2
6775644|NCT03858335|7703654|FG000|STARTED|Overall Study||16
6775645|NCT03858335|7703655|FG001|STARTED|Overall Study||16
6775646|NCT03858335|7703654|FG000|COMPLETED|Overall Study||12
6775647|NCT03858335|7703655|FG001|COMPLETED|Overall Study||12
6335660|NCT00543777|7242698|FG000|STARTED|Overall Study||44
6335661|NCT00543777|7242698|FG000|COMPLETED|Overall Study||44
6335662|NCT00543777|7242698|FG000|NOT COMPLETED|Overall Study||0
6335663|NCT00543803|7242702|FG000|STARTED|Overall Study||334
6335664|NCT00543803|7242702|FG000|COMPLETED|Overall Study||192
6335665|NCT00543803|7242702|FG000|NOT COMPLETED|Overall Study||142
6335666|NCT00543855|7242712|FG000|STARTED|Overall Study||35
6335667|NCT00543855|7242713|FG001|STARTED|Overall Study||33
6335668|NCT00543855|7242714|FG002|STARTED|Overall Study||37
6335669|NCT00543855|7242715|FG003|STARTED|Overall Study||34
6335670|NCT00543855|7242712|FG000|COMPLETED|Overall Study||31
6335671|NCT00543855|7242713|FG001|COMPLETED|Overall Study||31
6335672|NCT00543855|7242714|FG002|COMPLETED|Overall Study||31
6558920|NCT01778049|7481533|FG001|NOT COMPLETED|Double Blind Treatment Period||0
6558921|NCT01778049|7481534|FG002|NOT COMPLETED|Double Blind Treatment Period||15
6775648|NCT03858335|7703654|FG000|NOT COMPLETED|Overall Study||4
6775649|NCT03858335|7703655|FG001|NOT COMPLETED|Overall Study||4
6775650|NCT03857243|7703663|FG000|STARTED|Overall Study||1
6775651|NCT03857243|7703664|FG001|STARTED|Overall Study||1
6775652|NCT03857243|7703663|FG000|COMPLETED|Overall Study||1
6775653|NCT03857243|7703664|FG001|COMPLETED|Overall Study||1
6775654|NCT03857243|7703663|FG000|NOT COMPLETED|Overall Study||0
6775655|NCT03857243|7703664|FG001|NOT COMPLETED|Overall Study||0
6775656|NCT03851744|7703672|FG000|STARTED|Overall Study||4
6775657|NCT03851744|7703673|FG001|STARTED|Overall Study||6
6775658|NCT03851744|7703672|FG000|COMPLETED|Overall Study||4
6775659|NCT03851744|7703673|FG001|COMPLETED|Overall Study||4
6775660|NCT03851744|7703672|FG000|NOT COMPLETED|Overall Study||0
6775661|NCT03851744|7703673|FG001|NOT COMPLETED|Overall Study||2
6775662|NCT03849937|7703679|FG000|STARTED|Overall Study||147
6775663|NCT03849937|7703680|FG001|STARTED|Overall Study||72
6775664|NCT03849937|7703679|FG000|COMPLETED|Overall Study||94
6775665|NCT03849937|7703680|FG001|COMPLETED|Overall Study||35
6775666|NCT03849937|7703679|FG000|NOT COMPLETED|Overall Study||53
6775667|NCT03849937|7703680|FG001|NOT COMPLETED|Overall Study||37
6775668|NCT03848416|7703694|FG000|STARTED|Overall Study||33
6775669|NCT03848416|7703695|FG001|STARTED|Overall Study||33
6775670|NCT03848416|7703696|FG002|STARTED|Overall Study||33
6775671|NCT03848416|7703694|FG000|Received at Least One Dose of Study Drug|Overall Study||33
6775672|NCT03848416|7703695|FG001|Received at Least One Dose of Study Drug|Overall Study||33
6775673|NCT03848416|7703696|FG002|Received at Least One Dose of Study Drug|Overall Study||33
6775674|NCT03848416|7703694|FG000|COMPLETED|Overall Study||32
6775675|NCT03848416|7703695|FG001|COMPLETED|Overall Study||33
6775676|NCT03848416|7703696|FG002|COMPLETED|Overall Study||32
6775677|NCT03848416|7703694|FG000|NOT COMPLETED|Overall Study||1
6775678|NCT03848416|7703695|FG001|NOT COMPLETED|Overall Study||0
6775679|NCT03848416|7703696|FG002|NOT COMPLETED|Overall Study||1
6775680|NCT03847987|7703706|FG000|STARTED|Overall Study||16
6775681|NCT03847987|7703707|FG001|STARTED|Overall Study||8
6775682|NCT03847987|7703706|FG000|COMPLETED|Overall Study||13
6775683|NCT03847987|7703707|FG001|COMPLETED|Overall Study||8
6775684|NCT03847987|7703706|FG000|NOT COMPLETED|Overall Study||3
6775685|NCT03847987|7703707|FG001|NOT COMPLETED|Overall Study||0
6775686|NCT03854253|7703726|FG000|STARTED|Overall Study||50
6775687|NCT03854253|7703727|FG001|STARTED|Overall Study||50
6775688|NCT03854253|7703726|FG000|COMPLETED|Overall Study||49
6335673|NCT00543855|7242715|FG003|COMPLETED|Overall Study||30
6775689|NCT03854253|7703727|FG001|COMPLETED|Overall Study||50
6775690|NCT03854253|7703726|FG000|NOT COMPLETED|Overall Study||1
6775691|NCT03854253|7703727|FG001|NOT COMPLETED|Overall Study||0
6775692|NCT03870737|7703733|FG000|STARTED|Overall Study||22
6775693|NCT03870737|7703733|FG000|COMPLETED|Overall Study||20
6775694|NCT03870737|7703733|FG000|NOT COMPLETED|Overall Study||2
6775695|NCT03860181|7703741|FG000|STARTED|Overall Study||21
6335674|NCT00543855|7242712|FG000|NOT COMPLETED|Overall Study||4
6335675|NCT00543855|7242713|FG001|NOT COMPLETED|Overall Study||2
6335676|NCT00543855|7242714|FG002|NOT COMPLETED|Overall Study||6
6775696|NCT03860181|7703742|FG001|STARTED|Overall Study||22
6775697|NCT03860181|7703743|FG002|STARTED|Overall Study||25
6775698|NCT03860181|7703744|FG003|STARTED|Overall Study||21
6775699|NCT03860181|7703741|FG000|COMPLETED|Overall Study||21
6775700|NCT03860181|7703742|FG001|COMPLETED|Overall Study||22
6775701|NCT03860181|7703743|FG002|COMPLETED|Overall Study||25
6335677|NCT00543855|7242715|FG003|NOT COMPLETED|Overall Study||4
6335678|NCT00543985|7242725|FG000|STARTED|Overall Study||36
6335679|NCT00543985|7242725|FG000|COMPLETED|Overall Study||32
6335680|NCT00543985|7242725|FG000|NOT COMPLETED|Overall Study||4
6335681|NCT00544076|7242735|FG000|STARTED|Overall Study||34
6335682|NCT00544076|7242736|FG001|STARTED|Overall Study||35
6335683|NCT00544076|7242737|FG002|STARTED|Overall Study||31
6335684|NCT00544076|7242735|FG000|COMPLETED|Overall Study||17
6335685|NCT00544076|7242736|FG001|COMPLETED|Overall Study||19
6335686|NCT00544076|7242737|FG002|COMPLETED|Overall Study||20
6335687|NCT00544076|7242735|FG000|NOT COMPLETED|Overall Study||17
6335688|NCT00544076|7242736|FG001|NOT COMPLETED|Overall Study||16
6335689|NCT00544076|7242737|FG002|NOT COMPLETED|Overall Study||11
6335690|NCT00544167|7242746|FG000|STARTED|Overall Study||45
6335691|NCT00544167|7242746|FG000|COMPLETED|Overall Study||16
6335692|NCT00544167|7242746|FG000|NOT COMPLETED|Overall Study||29
6335693|NCT00544440|7242750|FG000|STARTED|Overall Study||57
6335694|NCT00544440|7242750|FG000|COMPLETED|Overall Study||0
6335695|NCT00544440|7242750|FG000|NOT COMPLETED|Overall Study||57
6335696|NCT00544544|7242754|FG000|STARTED|Overall Study||14
6335697|NCT00544544|7242754|FG000|COMPLETED|Overall Study||11
6335698|NCT00544544|7242754|FG000|NOT COMPLETED|Overall Study||3
6335699|NCT00544557|7242758|FG000|STARTED|Overall Study||1685
6335700|NCT00544557|7242758|FG000|COMPLETED|Overall Study||1251
6335701|NCT00544557|7242758|FG000|NOT COMPLETED|Overall Study||434
6335702|NCT00544648|7242764|FG000|STARTED|Overall Study||11
6335703|NCT00544648|7242765|FG001|STARTED|Overall Study||2
6335704|NCT00544648|7242764|FG000|COMPLETED|Overall Study||8
6335705|NCT00544648|7242765|FG001|COMPLETED|Overall Study||1
6335706|NCT00544648|7242764|FG000|NOT COMPLETED|Overall Study||3
6335707|NCT00544648|7242765|FG001|NOT COMPLETED|Overall Study||1
6335708|NCT00544674|7242773|FG000|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
6335709|NCT00544674|7242773|FG000|COMPLETED|Overall Study||4
6335710|NCT00544674|7242773|FG000|NOT COMPLETED|Overall Study||1
6558922|NCT01778049|7481535|FG003|NOT COMPLETED|Double Blind Treatment Period||12
6558923|NCT01778049|7481536|FG004|NOT COMPLETED|Double Blind Treatment Period||12
6558924|NCT01778049|7481537|FG005|NOT COMPLETED|Double Blind Treatment Period||7
6558925|NCT01778062|7481551|FG000|STARTED|Overall Study||68
6558926|NCT01778062|7481552|FG001|STARTED|Overall Study||68
6335711|NCT00544713|7242779|FG000|STARTED|Overall Study||114
6335712|NCT00544713|7242780|FG001|STARTED|Overall Study||114
6335713|NCT00544713|7242779|FG000|COMPLETED|Overall Study||111
6335714|NCT00544713|7242780|FG001|COMPLETED|Overall Study||109
6335715|NCT00544713|7242779|FG000|NOT COMPLETED|Overall Study||3
6335716|NCT00544713|7242780|FG001|NOT COMPLETED|Overall Study||5
6335717|NCT00544778|7242786|FG000|STARTED|Overall Study||7
6335718|NCT00544778|7242786|FG000|COMPLETED|Overall Study||7
6335719|NCT00544778|7242786|FG000|NOT COMPLETED|Overall Study||0
6335720|NCT00544817|7242790|FG000|STARTED|Combined Modality||47
6335721|NCT00544817|7242790|FG000|COMPLETED|Combined Modality||40
6335722|NCT00544817|7242790|FG000|NOT COMPLETED|Combined Modality||7
6335723|NCT00544817|7242790|FG000|STARTED|No Treatment Interval||40
6335724|NCT00544817|7242790|FG000|COMPLETED|No Treatment Interval||28
6335725|NCT00544817|7242790|FG000|NOT COMPLETED|No Treatment Interval||12
6335726|NCT00544817|7242790|FG000|STARTED|Follow-up Systemic Therapy||28
6335727|NCT00544817|7242790|FG000|COMPLETED|Follow-up Systemic Therapy||9
6335728|NCT00544817|7242790|FG000|NOT COMPLETED|Follow-up Systemic Therapy||19
6335729|NCT00544869|7242797|FG000|STARTED|Overall Study||36
6335730|NCT00544869|7242798|FG001|STARTED|Overall Study||14
6335731|NCT00544869|7242799|FG002|STARTED|Overall Study||2
6335732|NCT00544869|7242797|FG000|COMPLETED|Overall Study||24
6335733|NCT00544869|7242798|FG001|COMPLETED|Overall Study||12
6335734|NCT00544869|7242799|FG002|COMPLETED|Overall Study||2
6335735|NCT00544869|7242797|FG000|NOT COMPLETED|Overall Study||12
6335736|NCT00544869|7242798|FG001|NOT COMPLETED|Overall Study||2
6335737|NCT00544869|7242799|FG002|NOT COMPLETED|Overall Study||0
6335738|NCT00544882|7242809|FG000|STARTED|Cycle 1: Run-in Cycle||61
6335739|NCT00544882|7242810|FG001|STARTED|Cycle 1: Run-in Cycle||0
6335740|NCT00544882|7242811|FG002|STARTED|Cycle 1: Run-in Cycle||0
6335741|NCT00544882|7242809|FG000|COMPLETED|Cycle 1: Run-in Cycle||58
6335742|NCT00544882|7242810|FG001|COMPLETED|Cycle 1: Run-in Cycle||0
6335743|NCT00544882|7242811|FG002|COMPLETED|Cycle 1: Run-in Cycle||0
6335744|NCT00544882|7242809|FG000|NOT COMPLETED|Cycle 1: Run-in Cycle||3
6335745|NCT00544882|7242810|FG001|NOT COMPLETED|Cycle 1: Run-in Cycle||0
6335746|NCT00544882|7242811|FG002|NOT COMPLETED|Cycle 1: Run-in Cycle||0
6335747|NCT00544882|7242809|FG000|STARTED|Cycle 2: Randomized Treatment Cycle||0
6335748|NCT00544882|7242810|FG001|STARTED|Cycle 2: Randomized Treatment Cycle||29
6335749|NCT00544882|7242811|FG002|STARTED|Cycle 2: Randomized Treatment Cycle||29
6335750|NCT00544882|7242809|FG000|Treated|Cycle 2: Randomized Treatment Cycle||0
6335751|NCT00544882|7242810|FG001|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
6558927|NCT01778062|7481551|FG000|Safety Set|Overall Study||68
6335752|NCT00544882|7242811|FG002|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
6335753|NCT00544882|7242809|FG000|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
6335754|NCT00544882|7242810|FG001|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
6335755|NCT00544882|7242811|FG002|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
6335756|NCT00544882|7242809|FG000|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
6558928|NCT01778062|7481552|FG001|Safety Set|Overall Study||68
6335757|NCT00544882|7242810|FG001|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
6335758|NCT00544882|7242811|FG002|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
6335759|NCT00544882|7242809|FG000|STARTED|Cycle 3: Follow-up||0
6335760|NCT00544882|7242810|FG001|STARTED|Cycle 3: Follow-up||28
6335761|NCT00544882|7242811|FG002|STARTED|Cycle 3: Follow-up||28
6335762|NCT00544882|7242809|FG000|COMPLETED|Cycle 3: Follow-up||0
6335763|NCT00544882|7242810|FG001|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
6335764|NCT00544882|7242811|FG002|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
6335765|NCT00544882|7242809|FG000|NOT COMPLETED|Cycle 3: Follow-up||0
6335766|NCT00544882|7242810|FG001|NOT COMPLETED|Cycle 3: Follow-up||2
6335767|NCT00544882|7242811|FG002|NOT COMPLETED|Cycle 3: Follow-up||0
6335768|NCT00544908|7242817|FG000|STARTED|Overall Study||7
6335769|NCT00544908|7242817|FG000|COMPLETED|Overall Study||7
6335770|NCT00544908|7242817|FG000|NOT COMPLETED|Overall Study||0
6335771|NCT00545025|7242823|FG000|STARTED|Overall Study||160
6335772|NCT00545025|7242824|FG001|STARTED|Overall Study||83
6335773|NCT00545025|7242823|FG000|COMPLETED|Overall Study||160
6335774|NCT00545025|7242824|FG001|COMPLETED|Overall Study||83
6335775|NCT00545025|7242823|FG000|NOT COMPLETED|Overall Study||0
6335776|NCT00545025|7242824|FG001|NOT COMPLETED|Overall Study||0
6335777|NCT00545051|7242832|FG000|STARTED|Overall Study||68
6335778|NCT00545051|7242833|FG001|STARTED|Overall Study||72
6335779|NCT00545051|7242832|FG000|COMPLETED|Overall Study||59
6335780|NCT00545051|7242833|FG001|COMPLETED|Overall Study||65
6335781|NCT00545051|7242832|FG000|NOT COMPLETED|Overall Study||9
6335782|NCT00545051|7242833|FG001|NOT COMPLETED|Overall Study||7
6335783|NCT00545064|7242839|FG000|STARTED|Overall Study||178
6335784|NCT00545064|7242839|FG000|Visit 1 (Baseline)|Overall Study||178
6335785|NCT00545064|7242839|FG000|Visit 2 (Week 4)|Overall Study||169
6335786|NCT00545064|7242839|FG000|Visit 3 (Week 8)|Overall Study|8 patients didn't complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
6335787|NCT00545064|7242839|FG000|COMPLETED|Overall Study||170
6335788|NCT00545064|7242839|FG000|NOT COMPLETED|Overall Study||8
6335789|NCT00545077|7242847|FG000|STARTED|Overall Study||189
6335790|NCT00545077|7242848|FG001|STARTED|Overall Study||191
6335791|NCT00545077|7242847|FG000|COMPLETED|Overall Study||41
6775702|NCT03860181|7703744|FG003|COMPLETED|Overall Study||21
6775703|NCT03860181|7703741|FG000|NOT COMPLETED|Overall Study||0
6775704|NCT03860181|7703742|FG001|NOT COMPLETED|Overall Study||0
6775705|NCT03860181|7703743|FG002|NOT COMPLETED|Overall Study||0
6775706|NCT03860181|7703744|FG003|NOT COMPLETED|Overall Study||0
6775707|NCT03856944|7703765|FG000|STARTED|Overall Study||29
6775708|NCT03856944|7703765|FG000|COMPLETED|Overall Study||29
6775709|NCT03856944|7703765|FG000|NOT COMPLETED|Overall Study||0
6775710|NCT03853551|7703769|FG000|STARTED|Overall Study||60
6775711|NCT03853551|7703769|FG000|COMPLETED|Overall Study||51
6775712|NCT03853551|7703769|FG000|NOT COMPLETED|Overall Study||9
6775713|NCT03870555|7703776|FG000|STARTED|Period 1 (2 Days)||2
6775714|NCT03870555|7703777|FG001|STARTED|Period 1 (2 Days)||2
6775715|NCT03870555|7703778|FG002|STARTED|Period 1 (2 Days)||2
6775716|NCT03870555|7703776|FG000|COMPLETED|Period 1 (2 Days)||2
6775717|NCT03870555|7703777|FG001|COMPLETED|Period 1 (2 Days)||2
6775718|NCT03870555|7703778|FG002|COMPLETED|Period 1 (2 Days)||2
6775719|NCT03870555|7703776|FG000|NOT COMPLETED|Period 1 (2 Days)||0
6775720|NCT03870555|7703777|FG001|NOT COMPLETED|Period 1 (2 Days)||0
6775721|NCT03870555|7703778|FG002|NOT COMPLETED|Period 1 (2 Days)||0
6775722|NCT03870555|7703776|FG000|STARTED|Washout Period (at Least 16 Days)||2
6775723|NCT03870555|7703777|FG001|STARTED|Washout Period (at Least 16 Days)||2
6775724|NCT03870555|7703778|FG002|STARTED|Washout Period (at Least 16 Days)||2
6775725|NCT03870555|7703776|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
6775726|NCT03870555|7703777|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
6775727|NCT03870555|7703778|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
6775728|NCT03870555|7703776|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6775729|NCT03870555|7703777|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6775730|NCT03870555|7703778|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6775731|NCT03870555|7703776|FG000|STARTED|Period 2 (2 Days)||2
6775732|NCT03870555|7703777|FG001|STARTED|Period 2 (2 Days)||2
6775733|NCT03870555|7703778|FG002|STARTED|Period 2 (2 Days)||2
6775734|NCT03870555|7703776|FG000|COMPLETED|Period 2 (2 Days)||2
6775735|NCT03870555|7703777|FG001|COMPLETED|Period 2 (2 Days)||2
6775736|NCT03870555|7703778|FG002|COMPLETED|Period 2 (2 Days)||2
6775737|NCT03870555|7703776|FG000|NOT COMPLETED|Period 2 (2 Days)||0
6775738|NCT03870555|7703777|FG001|NOT COMPLETED|Period 2 (2 Days)||0
6775739|NCT03870555|7703778|FG002|NOT COMPLETED|Period 2 (2 Days)||0
6775740|NCT03870555|7703776|FG000|STARTED|Washout Period (at Least 16 Days)||2
6775741|NCT03870555|7703777|FG001|STARTED|Washout Period (at Least 16 Days)||2
6775742|NCT03870555|7703778|FG002|STARTED|Washout Period (at Least 16 Days)||2
6775743|NCT03870555|7703776|FG000|COMPLETED|Washout Period (at Least 16 Days)||2
6335792|NCT00545077|7242848|FG001|COMPLETED|Overall Study||36
6335793|NCT00545077|7242847|FG000|NOT COMPLETED|Overall Study||148
6335794|NCT00545077|7242848|FG001|NOT COMPLETED|Overall Study||155
6335795|NCT00545103|7242858|FG000|STARTED|Overall Study||148
6335796|NCT00545103|7242859|FG001|STARTED|Overall Study||148
6335797|NCT00545103|7242860|FG002|STARTED|Overall Study||150
6335798|NCT00545103|7242861|FG003|STARTED|Overall Study||146
6335799|NCT00545103|7242858|FG000|COMPLETED|Overall Study||73
6335800|NCT00545103|7242859|FG001|COMPLETED|Overall Study||70
6775744|NCT03870555|7703777|FG001|COMPLETED|Washout Period (at Least 16 Days)||2
6335801|NCT00545103|7242860|FG002|COMPLETED|Overall Study||74
6335802|NCT00545103|7242861|FG003|COMPLETED|Overall Study||76
6335803|NCT00545103|7242858|FG000|NOT COMPLETED|Overall Study||75
6335804|NCT00545103|7242859|FG001|NOT COMPLETED|Overall Study||78
6335805|NCT00545103|7242860|FG002|NOT COMPLETED|Overall Study||76
6335806|NCT00545103|7242861|FG003|NOT COMPLETED|Overall Study||70
6335807|NCT00545155|7242871|FG000|STARTED|Overall Study||187
6335808|NCT00545155|7242871|FG000|COMPLETED|Overall Study||187
6335809|NCT00545155|7242871|FG000|NOT COMPLETED|Overall Study||0
6335810|NCT00545168|7242878|FG000|STARTED|Overall Study||203
6335811|NCT00545168|7242879|FG001|STARTED|Overall Study||63
6335812|NCT00545168|7242880|FG002|STARTED|Overall Study||214
6335813|NCT00545168|7242878|FG000|COMPLETED|Overall Study||187
6335814|NCT00545168|7242879|FG001|COMPLETED|Overall Study||58
6335815|NCT00545168|7242880|FG002|COMPLETED|Overall Study||193
6335816|NCT00545168|7242878|FG000|NOT COMPLETED|Overall Study||16
6335817|NCT00545168|7242879|FG001|NOT COMPLETED|Overall Study||5
6558929|NCT01778062|7481551|FG000|Intent to Treat (ITT)|Overall Study||68
6558930|NCT01778062|7481552|FG001|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
6558931|NCT01778062|7481551|FG000|COMPLETED|Overall Study||62
6558932|NCT01778062|7481552|FG001|COMPLETED|Overall Study||57
6775745|NCT03870555|7703778|FG002|COMPLETED|Washout Period (at Least 16 Days)||2
6775746|NCT03870555|7703776|FG000|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6335818|NCT00545168|7242880|FG002|NOT COMPLETED|Overall Study||21
6335819|NCT00545181|7242891|FG000|STARTED|Overall Study||29
6335820|NCT00545181|7242892|FG001|STARTED|Overall Study||25
6335821|NCT00545181|7242891|FG000|COMPLETED|Overall Study||29
6335822|NCT00545181|7242892|FG001|COMPLETED|Overall Study||25
6335823|NCT00545181|7242891|FG000|NOT COMPLETED|Overall Study||0
6335824|NCT00545181|7242892|FG001|NOT COMPLETED|Overall Study||0
6335825|NCT00545233|7242900|FG000|STARTED|Overall Study||79
6335826|NCT00545233|7242901|FG001|STARTED|Overall Study||76
6335827|NCT00545233|7242900|FG000|Safety Set|Overall Study||77
6335828|NCT00545233|7242901|FG001|Safety Set|Overall Study||75
6335829|NCT00545233|7242900|FG000|Intent-to-Treat (ITT)|Overall Study||77
6335830|NCT00545233|7242901|FG001|Intent-to-Treat (ITT)|Overall Study||73
6335831|NCT00545233|7242900|FG000|COMPLETED|Overall Study||33
6335832|NCT00545233|7242901|FG001|COMPLETED|Overall Study||41
6335833|NCT00545233|7242900|FG000|NOT COMPLETED|Overall Study||46
6335834|NCT00545233|7242901|FG001|NOT COMPLETED|Overall Study||35
6335835|NCT00545272|7242914|FG000|STARTED|Overall Study||61
6335836|NCT00545272|7242915|FG001|STARTED|Overall Study||68
6335837|NCT00545272|7242916|FG002|STARTED|Overall Study||65
6335838|NCT00545272|7242917|FG003|STARTED|Overall Study||72
6335839|NCT00545272|7242918|FG004|STARTED|Overall Study||64
6335840|NCT00545272|7242919|FG005|STARTED|Overall Study||62
6335841|NCT00545272|7242914|FG000|COMPLETED|Overall Study||61
6335842|NCT00545272|7242915|FG001|COMPLETED|Overall Study||67
6775747|NCT03870555|7703777|FG001|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6775748|NCT03870555|7703778|FG002|NOT COMPLETED|Washout Period (at Least 16 Days)||0
6775749|NCT03870555|7703776|FG000|STARTED|Period 3 (2 Days)||2
6775750|NCT03870555|7703777|FG001|STARTED|Period 3 (2 Days)||2
6775751|NCT03870555|7703778|FG002|STARTED|Period 3 (2 Days)||2
6775752|NCT03870555|7703776|FG000|COMPLETED|Period 3 (2 Days)||1
6775753|NCT03870555|7703777|FG001|COMPLETED|Period 3 (2 Days)||2
6775754|NCT03870555|7703778|FG002|COMPLETED|Period 3 (2 Days)||2
6775755|NCT03870555|7703776|FG000|NOT COMPLETED|Period 3 (2 Days)||1
6775756|NCT03870555|7703777|FG001|NOT COMPLETED|Period 3 (2 Days)||0
6775757|NCT03870555|7703778|FG002|NOT COMPLETED|Period 3 (2 Days)||0
6775758|NCT03861845|7703792|FG000|STARTED|Overall Study||6
6775759|NCT03861845|7703793|FG001|STARTED|Overall Study||5
6775760|NCT03861845|7703794|FG002|STARTED|Overall Study||4
6775761|NCT03861845|7703792|FG000|COMPLETED|Overall Study||6
6775762|NCT03861845|7703793|FG001|COMPLETED|Overall Study||5
6775763|NCT03861845|7703794|FG002|COMPLETED|Overall Study||4
6775764|NCT03861845|7703792|FG000|NOT COMPLETED|Overall Study||0
6775765|NCT03861845|7703793|FG001|NOT COMPLETED|Overall Study||0
6775766|NCT03861845|7703794|FG002|NOT COMPLETED|Overall Study||0
6775767|NCT03851094|7703804|FG000|STARTED|Overall Study||111
6775768|NCT03851094|7703805|FG001|STARTED|Overall Study||55
6775769|NCT03851094|7703804|FG000|COMPLETED|Overall Study||111
6775770|NCT03851094|7703805|FG001|COMPLETED|Overall Study||51
6775771|NCT03851094|7703804|FG000|NOT COMPLETED|Overall Study||0
6775772|NCT03851094|7703805|FG001|NOT COMPLETED|Overall Study||4
6775773|NCT03869450|7703816|FG000|STARTED|Overall Study||31
6775774|NCT03869450|7703817|FG001|STARTED|Overall Study||25
6775775|NCT03869450|7703818|FG002|STARTED|Overall Study||34
6775776|NCT03869450|7703816|FG000|COMPLETED|Overall Study||30
6775777|NCT03869450|7703817|FG001|COMPLETED|Overall Study||23
6775778|NCT03869450|7703818|FG002|COMPLETED|Overall Study||34
6775779|NCT03869450|7703816|FG000|NOT COMPLETED|Overall Study||1
6775780|NCT03869450|7703817|FG001|NOT COMPLETED|Overall Study||2
6335843|NCT00545272|7242916|FG002|COMPLETED|Overall Study||64
6335844|NCT00545272|7242917|FG003|COMPLETED|Overall Study||71
6335845|NCT00545272|7242918|FG004|COMPLETED|Overall Study||62
6335846|NCT00545272|7242919|FG005|COMPLETED|Overall Study||59
6335847|NCT00545272|7242914|FG000|NOT COMPLETED|Overall Study||0
6335848|NCT00545272|7242915|FG001|NOT COMPLETED|Overall Study||1
6775781|NCT03869450|7703818|FG002|NOT COMPLETED|Overall Study||0
6775782|NCT03868631|7703828|FG000|STARTED|Baseline to Week 6||30
6335849|NCT00545272|7242916|FG002|NOT COMPLETED|Overall Study||1
6335850|NCT00545272|7242917|FG003|NOT COMPLETED|Overall Study||1
6335851|NCT00545272|7242918|FG004|NOT COMPLETED|Overall Study||2
6335852|NCT00545272|7242919|FG005|NOT COMPLETED|Overall Study||3
6335853|NCT00545298|7242936|FG000|STARTED|Overall Study||2
6335854|NCT00545298|7242937|FG001|STARTED|Overall Study||1
6335855|NCT00545298|7242938|FG002|STARTED|Overall Study||1
6335856|NCT00545298|7242936|FG000|COMPLETED|Overall Study||0
6335857|NCT00545298|7242937|FG001|COMPLETED|Overall Study||1
6335858|NCT00545298|7242938|FG002|COMPLETED|Overall Study||0
6335859|NCT00545298|7242936|FG000|NOT COMPLETED|Overall Study||2
6335860|NCT00545298|7242937|FG001|NOT COMPLETED|Overall Study||0
6335861|NCT00545298|7242938|FG002|NOT COMPLETED|Overall Study||1
6335862|NCT00545363|7242951|FG000|STARTED|Overall Study||358
6335863|NCT00545363|7242952|FG001|STARTED|Overall Study||358
6335864|NCT00545363|7242951|FG000|Treated|Overall Study||354
6335865|NCT00545363|7242952|FG001|Treated|Overall Study||357
6335866|NCT00545363|7242951|FG000|COMPLETED|Overall Study||339
6335867|NCT00545363|7242952|FG001|COMPLETED|Overall Study||343
6335868|NCT00545363|7242951|FG000|NOT COMPLETED|Overall Study||19
6335869|NCT00545363|7242952|FG001|NOT COMPLETED|Overall Study||15
6335870|NCT00545402|7242960|FG000|STARTED|Overall Study||90
6335871|NCT00545402|7242961|FG001|STARTED|Overall Study||90
6335872|NCT00545402|7242960|FG000|COMPLETED|Overall Study||56
6335873|NCT00545402|7242961|FG001|COMPLETED|Overall Study||61
6335874|NCT00545402|7242960|FG000|NOT COMPLETED|Overall Study||34
6335875|NCT00545402|7242961|FG001|NOT COMPLETED|Overall Study||29
6335876|NCT00545441|7242969|FG000|STARTED|Overall Study||44
6335877|NCT00545441|7242970|FG001|STARTED|Overall Study||42
6335878|NCT00545441|7242969|FG000|COMPLETED|Overall Study||26
6335879|NCT00545441|7242970|FG001|COMPLETED|Overall Study||26
6335880|NCT00545441|7242969|FG000|NOT COMPLETED|Overall Study||18
6335881|NCT00545441|7242970|FG001|NOT COMPLETED|Overall Study||16
6335882|NCT00545532|7242978|FG000|STARTED|Overall Study||105
6335883|NCT00545532|7242979|FG001|STARTED|Overall Study||110
6335884|NCT00545532|7242978|FG000|COMPLETED|Overall Study||99
6335885|NCT00545532|7242979|FG001|COMPLETED|Overall Study||100
6335886|NCT00545532|7242978|FG000|NOT COMPLETED|Overall Study||6
6335887|NCT00545532|7242979|FG001|NOT COMPLETED|Overall Study||10
6335888|NCT00545571|7242987|FG000|STARTED|Overall Study||120
6335889|NCT00545571|7242987|FG000|COMPLETED|Overall Study||53
6335890|NCT00545571|7242987|FG000|NOT COMPLETED|Overall Study||67
6376172|NCT00758524|7286581|FG006|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||1
6376173|NCT00758524|7286582|FG007|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376174|NCT00758524|7286583|FG008|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||2
6376175|NCT00758524|7286584|FG009|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376176|NCT00758524|7286585|FG010|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376177|NCT00758524|7286586|FG011|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376178|NCT00758524|7286587|FG012|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376179|NCT00758524|7286588|FG013|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376180|NCT00758524|7286589|FG014|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376181|NCT00758524|7286590|FG015|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376182|NCT00758524|7286591|FG016|NOT COMPLETED|Withdrawal Period (Week 8 to Week 9)||0
6376183|NCT00758550|7286631|FG000|STARTED|Overall Study||30
6376184|NCT00758550|7286632|FG001|STARTED|Overall Study||30
6376185|NCT00758550|7286631|FG000|COMPLETED|Overall Study||30
6376186|NCT00758550|7286632|FG001|COMPLETED|Overall Study||30
6376187|NCT00758550|7286631|FG000|NOT COMPLETED|Overall Study||0
6376188|NCT00758550|7286632|FG001|NOT COMPLETED|Overall Study||0
6376189|NCT00758576|7286638|FG000|STARTED|Overall Study||64
6376190|NCT00758576|7286638|FG000|COMPLETED|Overall Study||63
6376191|NCT00758576|7286638|FG000|NOT COMPLETED|Overall Study||1
6376192|NCT00758589|7286646|FG000|STARTED|Overall Study||95
6376193|NCT00758589|7286647|FG001|STARTED|Overall Study||90
6376194|NCT00758589|7286648|FG002|STARTED|Overall Study||92
6775783|NCT03868631|7703829|FG001|STARTED|Baseline to Week 6||31
6775784|NCT03868631|7703828|FG000|COMPLETED|Baseline to Week 6||26
6775785|NCT03868631|7703829|FG001|COMPLETED|Baseline to Week 6||27
6775786|NCT03868631|7703828|FG000|NOT COMPLETED|Baseline to Week 6||4
6775787|NCT03868631|7703829|FG001|NOT COMPLETED|Baseline to Week 6||4
6775788|NCT03868631|7703828|FG000|STARTED|Week 6 to Week 12 (Study Completion)||26
6376195|NCT00758589|7286649|FG003|STARTED|Overall Study||91
6376196|NCT00758589|7286646|FG000|COMPLETED|Overall Study||92
6376197|NCT00758589|7286647|FG001|COMPLETED|Overall Study||87
6376198|NCT00758589|7286648|FG002|COMPLETED|Overall Study||86
6376199|NCT00758589|7286649|FG003|COMPLETED|Overall Study||85
6376200|NCT00758589|7286646|FG000|NOT COMPLETED|Overall Study||3
6376201|NCT00758589|7286647|FG001|NOT COMPLETED|Overall Study||3
6376202|NCT00758589|7286648|FG002|NOT COMPLETED|Overall Study||6
6376203|NCT00758589|7286649|FG003|NOT COMPLETED|Overall Study||6
6376204|NCT00758602|7286661|FG000|STARTED|Overall Study||104
6376205|NCT00758602|7286662|FG001|STARTED|Overall Study||106
6376206|NCT00758602|7286661|FG000|COMPLETED|Overall Study||85
6376207|NCT00758602|7286662|FG001|COMPLETED|Overall Study||84
6376208|NCT00758602|7286661|FG000|NOT COMPLETED|Overall Study||19
6775789|NCT03868631|7703829|FG001|STARTED|Week 6 to Week 12 (Study Completion)||27
6775790|NCT03868631|7703828|FG000|COMPLETED|Week 6 to Week 12 (Study Completion)||22
6376209|NCT00758602|7286662|FG001|NOT COMPLETED|Overall Study||22
6376210|NCT00758667|7286671|FG000|STARTED|Overall Study||9
6376211|NCT00758667|7286672|FG001|STARTED|Overall Study||11
6335891|NCT00545584|7242994|FG000|STARTED|Overall Study||412
6335892|NCT00545584|7242995|FG001|STARTED|Overall Study||414
6335893|NCT00545584|7242996|FG002|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
6335894|NCT00545584|7242994|FG000|COMPLETED|Overall Study||333
6335895|NCT00545584|7242995|FG001|COMPLETED|Overall Study||334
6335896|NCT00545584|7242996|FG002|COMPLETED|Overall Study||250
6335897|NCT00545584|7242994|FG000|NOT COMPLETED|Overall Study||79
6335898|NCT00545584|7242995|FG001|NOT COMPLETED|Overall Study||80
6335899|NCT00545584|7242996|FG002|NOT COMPLETED|Overall Study||56
6335900|NCT00545623|7243008|FG000|STARTED|Overall Study||32
6335901|NCT00545623|7243009|FG001|STARTED|Overall Study||31
6335902|NCT00545623|7243010|FG002|STARTED|Overall Study||33
6335903|NCT00545623|7243011|FG003|STARTED|Overall Study||34
6335904|NCT00545623|7243008|FG000|COMPLETED|Overall Study||25
6335905|NCT00545623|7243009|FG001|COMPLETED|Overall Study||21
6335906|NCT00545623|7243010|FG002|COMPLETED|Overall Study||20
6335907|NCT00545623|7243011|FG003|COMPLETED|Overall Study||23
6335908|NCT00545623|7243008|FG000|NOT COMPLETED|Overall Study||7
6335909|NCT00545623|7243009|FG001|NOT COMPLETED|Overall Study||10
6335910|NCT00545623|7243010|FG002|NOT COMPLETED|Overall Study||13
6335911|NCT00545623|7243011|FG003|NOT COMPLETED|Overall Study||11
6335912|NCT00545662|7243023|FG000|STARTED|Overall Study||606
6335913|NCT00545662|7243024|FG001|STARTED|Overall Study||607
6335914|NCT00545662|7243023|FG000|COMPLETED|Overall Study||521
6335915|NCT00545662|7243024|FG001|COMPLETED|Overall Study||528
6335916|NCT00545662|7243023|FG000|NOT COMPLETED|Overall Study||85
6335917|NCT00545662|7243024|FG001|NOT COMPLETED|Overall Study||79
6335918|NCT00545688|7243034|FG000|STARTED|Neo-Adjuvant Treatment Period||107
6335919|NCT00545688|7243035|FG001|STARTED|Neo-Adjuvant Treatment Period||107
6335920|NCT00545688|7243036|FG002|STARTED|Neo-Adjuvant Treatment Period||108
6335921|NCT00545688|7243037|FG003|STARTED|Neo-Adjuvant Treatment Period||94
6335922|NCT00545688|7243034|FG000|COMPLETED|Neo-Adjuvant Treatment Period||103
6335923|NCT00545688|7243035|FG001|COMPLETED|Neo-Adjuvant Treatment Period||102
6335924|NCT00545688|7243036|FG002|COMPLETED|Neo-Adjuvant Treatment Period||94
6335925|NCT00545688|7243037|FG003|COMPLETED|Neo-Adjuvant Treatment Period||88
6335926|NCT00545688|7243034|FG000|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
6335927|NCT00545688|7243035|FG001|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
6335928|NCT00545688|7243036|FG002|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
6335929|NCT00545688|7243037|FG003|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
6335930|NCT00545688|7243034|FG000|STARTED|Adjuvant Treatment Period||103
6335931|NCT00545688|7243035|FG001|STARTED|Adjuvant Treatment Period||102
6335932|NCT00545688|7243036|FG002|STARTED|Adjuvant Treatment Period||94
6335933|NCT00545688|7243037|FG003|STARTED|Adjuvant Treatment Period||88
6335934|NCT00545688|7243034|FG000|COMPLETED|Adjuvant Treatment Period||98
6335935|NCT00545688|7243035|FG001|COMPLETED|Adjuvant Treatment Period||94
6335936|NCT00545688|7243036|FG002|COMPLETED|Adjuvant Treatment Period||90
6335937|NCT00545688|7243037|FG003|COMPLETED|Adjuvant Treatment Period||74
6335938|NCT00545688|7243034|FG000|NOT COMPLETED|Adjuvant Treatment Period||5
6335939|NCT00545688|7243035|FG001|NOT COMPLETED|Adjuvant Treatment Period||8
6335940|NCT00545688|7243036|FG002|NOT COMPLETED|Adjuvant Treatment Period||4
6775791|NCT03868631|7703829|FG001|COMPLETED|Week 6 to Week 12 (Study Completion)||26
6775792|NCT03868631|7703828|FG000|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||4
6775793|NCT03868631|7703829|FG001|NOT COMPLETED|Week 6 to Week 12 (Study Completion)||1
6775794|NCT03865953|7703837|FG000|STARTED|First Intervention (4 Weeks)||25
6335941|NCT00545688|7243037|FG003|NOT COMPLETED|Adjuvant Treatment Period||14
6775795|NCT03865953|7703838|FG001|STARTED|First Intervention (4 Weeks)||28
6775796|NCT03865953|7703837|FG000|COMPLETED|First Intervention (4 Weeks)||23
6775797|NCT03865953|7703838|FG001|COMPLETED|First Intervention (4 Weeks)||27
6775798|NCT03865953|7703837|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
6775799|NCT03865953|7703838|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
6775800|NCT03865953|7703837|FG000|STARTED|Washout/Baseline Period (3 Weeks)||23
6775801|NCT03865953|7703838|FG001|STARTED|Washout/Baseline Period (3 Weeks)||27
6775802|NCT03865953|7703837|FG000|COMPLETED|Washout/Baseline Period (3 Weeks)||23
6775803|NCT03865953|7703838|FG001|COMPLETED|Washout/Baseline Period (3 Weeks)||27
6775804|NCT03865953|7703837|FG000|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
6775805|NCT03865953|7703838|FG001|NOT COMPLETED|Washout/Baseline Period (3 Weeks)||0
6775806|NCT03865953|7703837|FG000|STARTED|Second Intervention (4 Weeks)||23
6775807|NCT03865953|7703838|FG001|STARTED|Second Intervention (4 Weeks)||27
6775808|NCT03865953|7703837|FG000|COMPLETED|Second Intervention (4 Weeks)||23
6775809|NCT03865953|7703838|FG001|COMPLETED|Second Intervention (4 Weeks)||25
6775810|NCT03865953|7703837|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6775811|NCT03865953|7703838|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||2
6775812|NCT03865381|7703844|FG000|STARTED|Overall Study||60
6775813|NCT03865381|7703844|FG000|COMPLETED|Overall Study||55
6775814|NCT03865381|7703844|FG000|NOT COMPLETED|Overall Study||5
6775815|NCT03865446|7703850|FG000|STARTED|Overall Study||8
6775816|NCT03865446|7703851|FG001|STARTED|Overall Study||8
6775817|NCT03865446|7703850|FG000|COMPLETED|Overall Study||8
6775818|NCT03865446|7703851|FG001|COMPLETED|Overall Study||8
6335942|NCT00545688|7243034|FG000|STARTED|Follow-Up Period||98
6335943|NCT00545688|7243035|FG001|STARTED|Follow-Up Period||102
6775819|NCT03865446|7703850|FG000|NOT COMPLETED|Overall Study||0
6775820|NCT03865446|7703851|FG001|NOT COMPLETED|Overall Study||0
6335944|NCT00545688|7243036|FG002|STARTED|Follow-Up Period||98
6775821|NCT03862027|7703857|FG000|STARTED|Overall Study||1
6335945|NCT00545688|7243037|FG003|STARTED|Follow-Up Period||87
6335946|NCT00545688|7243034|FG000|COMPLETED|Follow-Up Period||77
6335947|NCT00545688|7243035|FG001|COMPLETED|Follow-Up Period||83
6335948|NCT00545688|7243036|FG002|COMPLETED|Follow-Up Period||78
6335949|NCT00545688|7243037|FG003|COMPLETED|Follow-Up Period||60
6335950|NCT00545688|7243034|FG000|NOT COMPLETED|Follow-Up Period||21
6335951|NCT00545688|7243035|FG001|NOT COMPLETED|Follow-Up Period||19
6335952|NCT00545688|7243036|FG002|NOT COMPLETED|Follow-Up Period||20
6335953|NCT00545688|7243037|FG003|NOT COMPLETED|Follow-Up Period||27
6335954|NCT00545714|7243050|FG000|STARTED|Induction Phase (6 Months)||86
6335955|NCT00545714|7243050|FG000|Safety Population|Induction Phase (6 Months)||86
6335956|NCT00545714|7243050|FG000|Intent-to-Treat (ITT) Population|Induction Phase (6 Months)||84
6335957|NCT00545714|7243050|FG000|COMPLETED|Induction Phase (6 Months)||74
6335958|NCT00545714|7243050|FG000|NOT COMPLETED|Induction Phase (6 Months)||12
6335959|NCT00545714|7243050|FG000|STARTED|Maintenance Phase (36 Months)||74
6335960|NCT00545714|7243050|FG000|COMPLETED|Maintenance Phase (36 Months)||42
6335961|NCT00545714|7243050|FG000|NOT COMPLETED|Maintenance Phase (36 Months)||32
6335962|NCT00545740|7243058|FG000|STARTED|Overall Study||145
6335963|NCT00545740|7243059|FG001|STARTED|Overall Study||145
6335964|NCT00545740|7243060|FG002|STARTED|Overall Study||151
6335965|NCT00545740|7243061|FG003|STARTED|Overall Study||149
6335966|NCT00545740|7243058|FG000|COMPLETED|Overall Study||70
6335967|NCT00545740|7243059|FG001|COMPLETED|Overall Study||62
6335968|NCT00545740|7243060|FG002|COMPLETED|Overall Study||55
6335969|NCT00545740|7243061|FG003|COMPLETED|Overall Study||78
6335970|NCT00545740|7243058|FG000|NOT COMPLETED|Overall Study||75
6335971|NCT00545740|7243059|FG001|NOT COMPLETED|Overall Study||83
6335972|NCT00545740|7243060|FG002|NOT COMPLETED|Overall Study||96
6335973|NCT00545740|7243061|FG003|NOT COMPLETED|Overall Study||71
6335974|NCT00545753|7243074|FG000|STARTED|Overall Study||243
6335975|NCT00545753|7243075|FG001|STARTED|Overall Study||59
6335976|NCT00545753|7243076|FG002|STARTED|Overall Study||256
6335977|NCT00545753|7243074|FG000|COMPLETED|Overall Study||227
6335978|NCT00545753|7243075|FG001|COMPLETED|Overall Study||54
6335979|NCT00545753|7243076|FG002|COMPLETED|Overall Study||230
6335980|NCT00545753|7243074|FG000|NOT COMPLETED|Overall Study||16
6335981|NCT00545753|7243075|FG001|NOT COMPLETED|Overall Study||5
6335982|NCT00545753|7243076|FG002|NOT COMPLETED|Overall Study||26
6335983|NCT00545779|7243085|FG000|STARTED|Overall Study||677
6335984|NCT00545779|7243085|FG000|COMPLETED|Overall Study||633
6335985|NCT00545779|7243085|FG000|NOT COMPLETED|Overall Study||44
6335986|NCT00545792|7243089|FG000|STARTED|Overall Study||21
6335987|NCT00545792|7243089|FG000|COMPLETED|Overall Study||20
6335988|NCT00545792|7243089|FG000|NOT COMPLETED|Overall Study||1
6335989|NCT00545818|7243095|FG000|STARTED|Overall Study||49
6335990|NCT00545818|7243096|FG001|STARTED|Overall Study||46
6335991|NCT00545818|7243095|FG000|COMPLETED|Overall Study||46
6335992|NCT00545818|7243096|FG001|COMPLETED|Overall Study||39
6335993|NCT00545818|7243095|FG000|NOT COMPLETED|Overall Study||3
6775822|NCT03862027|7703857|FG000|COMPLETED|Overall Study||1
6775823|NCT03862027|7703857|FG000|NOT COMPLETED|Overall Study||0
6775824|NCT03859960|7703863|FG000|STARTED|Overall Study||14
6775825|NCT03859960|7703864|FG001|STARTED|Overall Study||19
6775826|NCT03859960|7703863|FG000|COMPLETED|Overall Study||14
6775827|NCT03859960|7703864|FG001|COMPLETED|Overall Study||19
6775828|NCT03859960|7703863|FG000|NOT COMPLETED|Overall Study||0
6775829|NCT03859960|7703864|FG001|NOT COMPLETED|Overall Study||0
6775830|NCT03868059|7703872|FG000|STARTED|Overall Study||138
6775831|NCT03868059|7703872|FG000|COMPLETED|Overall Study||126
6775832|NCT03868059|7703872|FG000|NOT COMPLETED|Overall Study||12
6775833|NCT03868254|7703878|FG000|STARTED|Overall Study||98
6775834|NCT03868254|7703879|FG001|STARTED|Overall Study||76
6775835|NCT03868254|7703878|FG000|COMPLETED|Overall Study||98
6775836|NCT03868254|7703879|FG001|COMPLETED|Overall Study||76
6775837|NCT03868254|7703878|FG000|NOT COMPLETED|Overall Study||0
6775838|NCT03868254|7703879|FG001|NOT COMPLETED|Overall Study||0
6775839|NCT03865407|7703887|FG000|STARTED|Overall Study||10
6775840|NCT03865407|7703888|FG001|STARTED|Overall Study||7
6775841|NCT03865407|7703887|FG000|COMPLETED|Overall Study||7
6775842|NCT03865407|7703888|FG001|COMPLETED|Overall Study||7
6775843|NCT03865407|7703887|FG000|NOT COMPLETED|Overall Study||3
6775844|NCT03865407|7703888|FG001|NOT COMPLETED|Overall Study||0
6775845|NCT03857230|7703896|FG000|STARTED|Period 1 (Primapur-Gonal-F)||12
6775846|NCT03857230|7703897|FG001|STARTED|Period 1 (Primapur-Gonal-F)||12
6775847|NCT03857230|7703896|FG000|COMPLETED|Period 1 (Primapur-Gonal-F)||12
6775848|NCT03857230|7703897|FG001|COMPLETED|Period 1 (Primapur-Gonal-F)||12
6775849|NCT03857230|7703896|FG000|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
6775850|NCT03857230|7703897|FG001|NOT COMPLETED|Period 1 (Primapur-Gonal-F)||0
6335994|NCT00545818|7243096|FG001|NOT COMPLETED|Overall Study||7
6335995|NCT00545948|7243105|FG000|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
6335996|NCT00545948|7243106|FG001|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
6335997|NCT00545948|7243107|FG002|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
6335998|NCT00545948|7243105|FG000|Assigned Treatment|Overall Study||9
6335999|NCT00545948|7243106|FG001|Assigned Treatment|Overall Study||15
6775851|NCT03857230|7703896|FG000|STARTED|Period 2 (Gonal-F-Primapur)||12
6775852|NCT03857230|7703897|FG001|STARTED|Period 2 (Gonal-F-Primapur)||12
6775853|NCT03857230|7703896|FG000|COMPLETED|Period 2 (Gonal-F-Primapur)||12
6336000|NCT00545948|7243107|FG002|Assigned Treatment|Overall Study||0
6336001|NCT00545948|7243105|FG000|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
6558933|NCT01778062|7481551|FG000|NOT COMPLETED|Overall Study||6
6558934|NCT01778062|7481552|FG001|NOT COMPLETED|Overall Study||11
6336002|NCT00545948|7243106|FG001|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
6336003|NCT00545948|7243107|FG002|COMPLETED|Overall Study||0
6336004|NCT00545948|7243105|FG000|NOT COMPLETED|Overall Study||1
6336005|NCT00545948|7243106|FG001|NOT COMPLETED|Overall Study||1
6336006|NCT00545948|7243107|FG002|NOT COMPLETED|Overall Study||7
6336007|NCT00545974|7243118|FG000|STARTED|Overall Study|subjects randomized to memantine cohort|39
6336008|NCT00545974|7243119|FG001|STARTED|Overall Study|subjects randomized to placebo cohort|42
6336009|NCT00545974|7243118|FG000|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
6336010|NCT00545974|7243119|FG001|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
6336011|NCT00545974|7243118|FG000|NOT COMPLETED|Overall Study||2
6336012|NCT00545974|7243119|FG001|NOT COMPLETED|Overall Study||3
6336013|NCT00546000|7243125|FG000|STARTED|Overall Study||56
6336014|NCT00546000|7243125|FG000|COMPLETED|Overall Study||52
6336015|NCT00546000|7243125|FG000|NOT COMPLETED|Overall Study||4
6336016|NCT00546078|7243131|FG000|STARTED|Overall Study||65
6336017|NCT00546078|7243132|FG001|STARTED|Overall Study||50
6336018|NCT00546078|7243131|FG000|Month 18|Overall Study||61
6336019|NCT00546078|7243132|FG001|Month 18|Overall Study||45
6336020|NCT00546078|7243131|FG000|COMPLETED|Overall Study||61
6336021|NCT00546078|7243132|FG001|COMPLETED|Overall Study||43
6336022|NCT00546078|7243131|FG000|NOT COMPLETED|Overall Study||4
6336023|NCT00546078|7243132|FG001|NOT COMPLETED|Overall Study||7
6336024|NCT00546104|7243138|FG000|STARTED|Overall Study||31
6336025|NCT00546104|7243138|FG000|COMPLETED|Overall Study||31
6336026|NCT00546104|7243138|FG000|NOT COMPLETED|Overall Study||0
6336027|NCT00546117|7243144|FG000|STARTED|Overall Study||9
6336028|NCT00546117|7243145|FG001|STARTED|Overall Study||7
6336029|NCT00546117|7243144|FG000|COMPLETED|Overall Study||5
6336030|NCT00546117|7243145|FG001|COMPLETED|Overall Study||7
6336031|NCT00546117|7243144|FG000|NOT COMPLETED|Overall Study||4
6336032|NCT00546117|7243145|FG001|NOT COMPLETED|Overall Study||0
6336033|NCT00546156|7243155|FG000|STARTED|Overall Study||84
6336034|NCT00546156|7243156|FG001|STARTED|Overall Study||20
6336035|NCT00546156|7243155|FG000|COMPLETED|Overall Study||70
6336036|NCT00546156|7243156|FG001|COMPLETED|Overall Study||19
6336037|NCT00546156|7243155|FG000|NOT COMPLETED|Overall Study||14
6336038|NCT00546156|7243156|FG001|NOT COMPLETED|Overall Study||1
6336039|NCT00546260|7243163|FG000|STARTED|Overall Study||36
6336040|NCT00546260|7243164|FG001|STARTED|Overall Study||34
6336041|NCT00546260|7243163|FG000|COMPLETED|Overall Study||28
6336042|NCT00546260|7243164|FG001|COMPLETED|Overall Study||32
6336043|NCT00546260|7243163|FG000|NOT COMPLETED|Overall Study||8
6336044|NCT00546260|7243164|FG001|NOT COMPLETED|Overall Study||2
6336045|NCT00546351|7243170|FG000|STARTED|Overall Study||621
6336046|NCT00546351|7243170|FG000|COMPLETED|Overall Study||385
6336047|NCT00546351|7243170|FG000|NOT COMPLETED|Overall Study||236
6336048|NCT00546364|7243177|FG000|STARTED|Overall Study||20
6336049|NCT00546364|7243178|FG001|STARTED|Overall Study||22
6336050|NCT00546364|7243179|FG002|STARTED|Overall Study||20
6336051|NCT00546364|7243177|FG000|Never Treated|Overall Study||0
6336052|NCT00546364|7243178|FG001|Never Treated|Overall Study||0
6336053|NCT00546364|7243179|FG002|Never Treated|Overall Study||0
6336054|NCT00546364|7243177|FG000|COMPLETED|Overall Study|Still on treatment|3
6336055|NCT00546364|7243178|FG001|COMPLETED|Overall Study|Still on treatment|4
6336056|NCT00546364|7243179|FG002|COMPLETED|Overall Study|Still on treatment|3
6336057|NCT00546364|7243177|FG000|NOT COMPLETED|Overall Study||17
6336058|NCT00546364|7243178|FG001|NOT COMPLETED|Overall Study||18
6336059|NCT00546364|7243179|FG002|NOT COMPLETED|Overall Study||17
6336060|NCT00546377|7243187|FG000|STARTED|Overall Study||50
6336061|NCT00546377|7243187|FG000|COMPLETED|Overall Study||43
6336062|NCT00546377|7243187|FG000|NOT COMPLETED|Overall Study||7
6336063|NCT00546390|7243193|FG000|STARTED|Overall Study||27
6336064|NCT00546390|7243194|FG001|STARTED|Overall Study||28
6336065|NCT00546390|7243193|FG000|COMPLETED|Overall Study||27
6336066|NCT00546390|7243194|FG001|COMPLETED|Overall Study||28
6336067|NCT00546390|7243193|FG000|NOT COMPLETED|Overall Study||0
6336068|NCT00546390|7243194|FG001|NOT COMPLETED|Overall Study||0
6336069|NCT00546429|7243201|FG000|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
6336070|NCT00546429|7243201|FG000|COMPLETED|Overall Study||32
6336071|NCT00546429|7243201|FG000|NOT COMPLETED|Overall Study||30
6336072|NCT00546481|7243207|FG000|STARTED|Correction Phase (CERA or Epoetin Beta)||39
6336073|NCT00546481|7243208|FG001|STARTED|Correction Phase (CERA or Epoetin Beta)||41
6336074|NCT00546481|7243209|FG002|STARTED|Correction Phase (CERA or Epoetin Beta)||0
6336075|NCT00546481|7243207|FG000|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
6336076|NCT00546481|7243208|FG001|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
6336077|NCT00546481|7243209|FG002|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
6336078|NCT00546481|7243207|FG000|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
6336079|NCT00546481|7243208|FG001|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
6336080|NCT00546481|7243209|FG002|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
6336081|NCT00546481|7243207|FG000|STARTED|Maintenance Phase (CERA)||0
6558935|NCT01778127|7481561|FG000|STARTED|Overall Study||33
6336082|NCT00546481|7243208|FG001|STARTED|Maintenance Phase (CERA)||0
6336083|NCT00546481|7243209|FG002|STARTED|Maintenance Phase (CERA)||54
6336084|NCT00546481|7243207|FG000|COMPLETED|Maintenance Phase (CERA)||0
6336085|NCT00546481|7243208|FG001|COMPLETED|Maintenance Phase (CERA)||0
6336086|NCT00546481|7243209|FG002|COMPLETED|Maintenance Phase (CERA)||50
6336087|NCT00546481|7243207|FG000|NOT COMPLETED|Maintenance Phase (CERA)||0
6336088|NCT00546481|7243208|FG001|NOT COMPLETED|Maintenance Phase (CERA)||0
6336089|NCT00546481|7243209|FG002|NOT COMPLETED|Maintenance Phase (CERA)||4
6336090|NCT00546572|7243219|FG000|STARTED|Vax 1 / Year 0||464
6336091|NCT00546572|7243220|FG001|STARTED|Vax 1 / Year 0||474
6336092|NCT00546572|7243219|FG000|Received Vax 1|Vax 1 / Year 0||463
6336093|NCT00546572|7243220|FG001|Received Vax 1|Vax 1 / Year 0||473
6336094|NCT00546572|7243219|FG000|COMPLETED|Vax 1 / Year 0||391
6336095|NCT00546572|7243220|FG001|COMPLETED|Vax 1 / Year 0||404
6336096|NCT00546572|7243219|FG000|NOT COMPLETED|Vax 1 / Year 0||73
6336097|NCT00546572|7243220|FG001|NOT COMPLETED|Vax 1 / Year 0||70
6336098|NCT00546572|7243219|FG000|STARTED|Vax 2 / Year 1||391
6336099|NCT00546572|7243220|FG001|STARTED|Vax 2 / Year 1||404
6336100|NCT00546572|7243219|FG000|Received Vax 2|Vax 2 / Year 1||391
6336101|NCT00546572|7243220|FG001|Received Vax 2|Vax 2 / Year 1||404
6336102|NCT00546572|7243219|FG000|COMPLETED|Vax 2 / Year 1||387
6336103|NCT00546572|7243220|FG001|COMPLETED|Vax 2 / Year 1||402
6336104|NCT00546572|7243219|FG000|NOT COMPLETED|Vax 2 / Year 1||4
6336105|NCT00546572|7243220|FG001|NOT COMPLETED|Vax 2 / Year 1||2
6336106|NCT00546637|7243239|FG000|STARTED|Overall Study||474
6336107|NCT00546637|7243240|FG001|STARTED|Overall Study||473
6336108|NCT00546637|7243239|FG000|Received Treatment|Overall Study||471
6336109|NCT00546637|7243240|FG001|Received Treatment|Overall Study||472
6336110|NCT00546637|7243239|FG000|COMPLETED|Overall Study||401
6336111|NCT00546637|7243240|FG001|COMPLETED|Overall Study||424
6336112|NCT00546637|7243239|FG000|NOT COMPLETED|Overall Study||73
6336113|NCT00546637|7243240|FG001|NOT COMPLETED|Overall Study||49
6336114|NCT00546715|7243250|FG000|STARTED|Overall Study||6
6336115|NCT00546715|7243251|FG001|STARTED|Overall Study||5
6336116|NCT00546715|7243252|FG002|STARTED|Overall Study||5
6336117|NCT00546715|7243253|FG003|STARTED|Overall Study||2
6336118|NCT00546715|7243250|FG000|COMPLETED|Overall Study||6
6336119|NCT00546715|7243251|FG001|COMPLETED|Overall Study||4
6336120|NCT00546715|7243252|FG002|COMPLETED|Overall Study||5
6336121|NCT00546715|7243253|FG003|COMPLETED|Overall Study||2
6336122|NCT00546715|7243250|FG000|NOT COMPLETED|Overall Study||0
6775854|NCT03857230|7703897|FG001|COMPLETED|Period 2 (Gonal-F-Primapur)||12
6775855|NCT03857230|7703896|FG000|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
6775856|NCT03857230|7703897|FG001|NOT COMPLETED|Period 2 (Gonal-F-Primapur)||0
6775857|NCT03865329|7703903|FG000|STARTED|Overall Study||9
6775858|NCT03865329|7703903|FG000|COMPLETED|Overall Study||9
6775859|NCT03865329|7703903|FG000|NOT COMPLETED|Overall Study||0
6780810|NCT02809118|7709370|FG000|STARTED|Overall Study||18
6780811|NCT02809118|7709371|FG001|STARTED|Overall Study||19
6780812|NCT02809118|7709372|FG002|STARTED|Overall Study||19
6780813|NCT02809118|7709370|FG000|COMPLETED|Overall Study||18
6780814|NCT02809118|7709371|FG001|COMPLETED|Overall Study||18
6780815|NCT02809118|7709372|FG002|COMPLETED|Overall Study||18
6780816|NCT02809118|7709370|FG000|NOT COMPLETED|Overall Study||0
6780817|NCT02809118|7709371|FG001|NOT COMPLETED|Overall Study||1
6780818|NCT02809118|7709372|FG002|NOT COMPLETED|Overall Study||1
6780819|NCT02818946|7709380|FG000|STARTED|Overall Study||30
6780820|NCT02818946|7709380|FG000|COMPLETED|Overall Study||30
6780821|NCT02818946|7709380|FG000|NOT COMPLETED|Overall Study||0
6780822|NCT02819908|7709386|FG000|STARTED|Overall Study||12
6780823|NCT02819908|7709387|FG001|STARTED|Overall Study||13
6780824|NCT02819908|7709386|FG000|COMPLETED|Overall Study||12
6780825|NCT02819908|7709387|FG001|COMPLETED|Overall Study||13
6780826|NCT02819908|7709386|FG000|NOT COMPLETED|Overall Study||0
6780827|NCT02819908|7709387|FG001|NOT COMPLETED|Overall Study||0
6780828|NCT02808390|7709398|FG000|STARTED|Overall Study||4
6780829|NCT02808390|7709399|FG001|STARTED|Overall Study||8
6780830|NCT02808390|7709400|FG002|STARTED|Overall Study||7
6780831|NCT02808390|7709398|FG000|COMPLETED|Overall Study||2
6780832|NCT02808390|7709399|FG001|COMPLETED|Overall Study||2
6780833|NCT02808390|7709400|FG002|COMPLETED|Overall Study||4
6780834|NCT02808390|7709398|FG000|NOT COMPLETED|Overall Study||2
6780835|NCT02808390|7709399|FG001|NOT COMPLETED|Overall Study||6
6780836|NCT02808390|7709400|FG002|NOT COMPLETED|Overall Study||3
6780837|NCT02806960|7709408|FG000|STARTED|Period 1||3
6336123|NCT00546715|7243251|FG001|NOT COMPLETED|Overall Study||1
6336124|NCT00546715|7243252|FG002|NOT COMPLETED|Overall Study||0
6780838|NCT02806960|7709409|FG001|STARTED|Period 1||3
6780839|NCT02806960|7709410|FG002|STARTED|Period 1||3
6780840|NCT02806960|7709411|FG003|STARTED|Period 1||3
6780841|NCT02806960|7709408|FG000|COMPLETED|Period 1||0
6336125|NCT00546715|7243253|FG003|NOT COMPLETED|Overall Study||0
6336126|NCT00546728|7243265|FG000|STARTED|Overall Study||25
6336127|NCT00546728|7243266|FG001|STARTED|Overall Study||25
6336128|NCT00546728|7243265|FG000|COMPLETED|Overall Study||25
6336129|NCT00546728|7243266|FG001|COMPLETED|Overall Study||25
6780842|NCT02806960|7709409|FG001|COMPLETED|Period 1||0
6780843|NCT02806960|7709410|FG002|COMPLETED|Period 1||0
6780844|NCT02806960|7709411|FG003|COMPLETED|Period 1||0
6780845|NCT02806960|7709408|FG000|NOT COMPLETED|Period 1||3
6780846|NCT02806960|7709409|FG001|NOT COMPLETED|Period 1||3
6780847|NCT02806960|7709410|FG002|NOT COMPLETED|Period 1||3
6336130|NCT00546728|7243265|FG000|NOT COMPLETED|Overall Study||0
6336131|NCT00546728|7243266|FG001|NOT COMPLETED|Overall Study||0
6336132|NCT00546819|7243274|FG000|STARTED|Overall Study||207
6336133|NCT00546819|7243275|FG001|STARTED|Overall Study||102
6336134|NCT00546819|7243274|FG000|VACCINATED|Overall Study||206
6336135|NCT00546819|7243275|FG001|VACCINATED|Overall Study||100
6336136|NCT00546819|7243274|FG000|COMPLETED|Overall Study||199
6336137|NCT00546819|7243275|FG001|COMPLETED|Overall Study||96
6336138|NCT00546819|7243274|FG000|NOT COMPLETED|Overall Study||8
6336139|NCT00546819|7243275|FG001|NOT COMPLETED|Overall Study||6
6336140|NCT00546871|7243281|FG000|STARTED|Part 1 - IV Infusions of IGIV, PK||14
6336141|NCT00546871|7243282|FG001|STARTED|Part 1 - IV Infusions of IGIV, PK||35
6336142|NCT00546871|7243281|FG000|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
6336143|NCT00546871|7243282|FG001|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
6336144|NCT00546871|7243281|FG000|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
6336145|NCT00546871|7243282|FG001|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
6336146|NCT00546871|7243281|FG000|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
6336147|NCT00546871|7243282|FG001|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
6336148|NCT00546871|7243281|FG000|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
6336149|NCT00546871|7243282|FG001|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
6336150|NCT00546871|7243281|FG000|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
6336151|NCT00546871|7243282|FG001|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
6336152|NCT00546871|7243281|FG000|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
6775860|NCT03864653|7703907|FG000|STARTED|Overall Study||39
6775861|NCT03864653|7703907|FG000|COMPLETED|Overall Study||38
6775862|NCT03864653|7703907|FG000|NOT COMPLETED|Overall Study||1
6775863|NCT03862482|7703914|FG000|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 1 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
6775864|NCT03862482|7703915|FG001|STARTED|Overall Study|Eight participants (forty implant units) were randomly allocated to Configuration 2 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|8
6775865|NCT03862482|7703916|FG002|STARTED|Overall Study|Six participants (thirty implant units) were randomly allocated to Configuration 3 by study coordinator. Each participant was also randomly assigned one of the three implant units (B or SW or SC) on a rotating basis to one of five sites between mental foramen. As a result, an equal number of each implant unit type was placed at each the five sites|6
6775866|NCT03862482|7703914|FG000|COMPLETED|Overall Study|Sixteen B, 16 SW, and eight SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, one implant unit (SW) had fractured and was subsequently excluded from all future analyses|8
6775867|NCT03862482|7703915|FG001|COMPLETED|Overall Study|Eight B, 16 SW, and 16 SC implant units were placed on a rotating basis at the five sites for a total of 40 implant units. Of these, two implant units (one B, one SW) were removed from all future analyses due to technical issues with radiographs|8
6775868|NCT03862482|7703916|FG002|COMPLETED|Overall Study|Twelve B, six SW, and 12 SC implant units were placed on a rotating basis at the five sites for a total of 30 implant units|6
6775869|NCT03862482|7703914|FG000|NOT COMPLETED|Overall Study||0
6775870|NCT03862482|7703915|FG001|NOT COMPLETED|Overall Study||0
6775871|NCT03862482|7703916|FG002|NOT COMPLETED|Overall Study||0
6775872|NCT03853213|7703924|FG000|STARTED|Overall Study||11
6775873|NCT03853213|7703925|FG001|STARTED|Overall Study||9
6775874|NCT03853213|7703924|FG000|COMPLETED|Overall Study||10
6775875|NCT03853213|7703925|FG001|COMPLETED|Overall Study||7
6775876|NCT03853213|7703924|FG000|NOT COMPLETED|Overall Study||1
6775877|NCT03853213|7703925|FG001|NOT COMPLETED|Overall Study||2
6775878|NCT03847610|7703931|FG000|STARTED|Overall Study||11
6775879|NCT03847610|7703931|FG000|COMPLETED|Overall Study||10
6775880|NCT03847610|7703931|FG000|NOT COMPLETED|Overall Study||1
6775881|NCT03850093|7703938|FG000|STARTED|Overall Study||22
6775882|NCT03850093|7703939|FG001|STARTED|Overall Study||22
6775883|NCT03850093|7703940|FG002|STARTED|Overall Study||19
6775884|NCT03850093|7703938|FG000|COMPLETED|Overall Study||21
6775885|NCT03850093|7703939|FG001|COMPLETED|Overall Study||22
6775886|NCT03850093|7703940|FG002|COMPLETED|Overall Study||17
6775887|NCT03850093|7703938|FG000|NOT COMPLETED|Overall Study||1
6775888|NCT03850093|7703939|FG001|NOT COMPLETED|Overall Study||0
6775889|NCT03850093|7703940|FG002|NOT COMPLETED|Overall Study||2
6775890|NCT03848208|7703958|FG000|STARTED|Overall Study||18
6775891|NCT03848208|7703959|FG001|STARTED|Overall Study||6
6775892|NCT03848208|7703960|FG002|STARTED|Overall Study||6
6775893|NCT03848208|7703961|FG003|STARTED|Overall Study||6
6775894|NCT03848208|7703962|FG004|STARTED|Overall Study||6
6775895|NCT03848208|7703963|FG005|STARTED|Overall Study||6
6775896|NCT03848208|7703964|FG006|STARTED|Overall Study||6
6775897|NCT03848208|7703965|FG007|STARTED|Overall Study||6
6775898|NCT03848208|7703966|FG008|STARTED|Overall Study||6
6775899|NCT03848208|7703967|FG009|STARTED|Overall Study||6
6775900|NCT03848208|7703958|FG000|COMPLETED|Overall Study||18
6775901|NCT03848208|7703959|FG001|COMPLETED|Overall Study||6
6775902|NCT03848208|7703960|FG002|COMPLETED|Overall Study||6
6775903|NCT03848208|7703961|FG003|COMPLETED|Overall Study||6
6775904|NCT03848208|7703962|FG004|COMPLETED|Overall Study||6
6336153|NCT00546871|7243282|FG001|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
6336154|NCT00546871|7243281|FG000|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
6336155|NCT00546871|7243282|FG001|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
6336156|NCT00546871|7243281|FG000|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
6336157|NCT00546871|7243282|FG001|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
6336158|NCT00546871|7243281|FG000|STARTED|Part 3b - SC IGIV 12 Weeks||12
6336159|NCT00546871|7243282|FG001|STARTED|Part 3b - SC IGIV 12 Weeks||32
6336160|NCT00546871|7243281|FG000|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
6336161|NCT00546871|7243282|FG001|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
6336162|NCT00546871|7243281|FG000|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
6336163|NCT00546871|7243282|FG001|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
6336164|NCT00546871|7243281|FG000|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
6336165|NCT00546871|7243282|FG001|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
6336166|NCT00546871|7243281|FG000|COMPLETED|Study Extension Period||9
6336167|NCT00546871|7243282|FG001|COMPLETED|Study Extension Period||25
6336168|NCT00546871|7243281|FG000|NOT COMPLETED|Study Extension Period||1
6336169|NCT00546871|7243282|FG001|NOT COMPLETED|Study Extension Period||1
6336170|NCT00546884|7243313|FG000|STARTED|Overall Study||145
6336171|NCT00546884|7243314|FG001|STARTED|Overall Study||117
6336172|NCT00546884|7243313|FG000|COMPLETED|Overall Study||145
6336173|NCT00546884|7243314|FG001|COMPLETED|Overall Study||117
6336174|NCT00546884|7243313|FG000|NOT COMPLETED|Overall Study||0
6336175|NCT00546884|7243314|FG001|NOT COMPLETED|Overall Study||0
6775905|NCT03848208|7703963|FG005|COMPLETED|Overall Study||6
6775906|NCT03848208|7703964|FG006|COMPLETED|Overall Study||6
6775907|NCT03848208|7703965|FG007|COMPLETED|Overall Study||6
6775908|NCT03848208|7703966|FG008|COMPLETED|Overall Study||6
6775909|NCT03848208|7703967|FG009|COMPLETED|Overall Study||6
6775910|NCT03848208|7703958|FG000|NOT COMPLETED|Overall Study||0
6775911|NCT03848208|7703959|FG001|NOT COMPLETED|Overall Study||0
6775912|NCT03848208|7703960|FG002|NOT COMPLETED|Overall Study||0
6775913|NCT03848208|7703961|FG003|NOT COMPLETED|Overall Study||0
6775914|NCT03848208|7703962|FG004|NOT COMPLETED|Overall Study||0
6775915|NCT03848208|7703963|FG005|NOT COMPLETED|Overall Study||0
6775916|NCT03848208|7703964|FG006|NOT COMPLETED|Overall Study||0
6775917|NCT03848208|7703965|FG007|NOT COMPLETED|Overall Study||0
6775918|NCT03848208|7703966|FG008|NOT COMPLETED|Overall Study||0
6775919|NCT03848208|7703967|FG009|NOT COMPLETED|Overall Study||0
6775920|NCT03847389|7704001|FG000|STARTED|Overall Study||8
6775921|NCT03847389|7704002|FG001|STARTED|Overall Study|Start of Cohort 2 can only happen if less than or equal to 40% of subjects in Cohort 1 had HPA axis suppression.|0
6775922|NCT03847389|7704003|FG002|STARTED|Overall Study|Start of Cohort 3 can only happen if less than or equal to 40% of subjects in Cohort 2 had HPA axis suppression.|0
6775923|NCT03847389|7704001|FG000|COMPLETED|Overall Study||8
6775924|NCT03847389|7704002|FG001|COMPLETED|Overall Study||0
6775925|NCT03847389|7704003|FG002|COMPLETED|Overall Study||0
6775926|NCT03847389|7704001|FG000|NOT COMPLETED|Overall Study||0
6775927|NCT03847389|7704002|FG001|NOT COMPLETED|Overall Study||0
6775928|NCT03847389|7704003|FG002|NOT COMPLETED|Overall Study||0
6775929|NCT03862040|7704014|FG000|STARTED|Overall Study||7
6775930|NCT03862040|7704014|FG000|COMPLETED|Overall Study||7
6775931|NCT03862040|7704014|FG000|NOT COMPLETED|Overall Study||0
6775932|NCT03861936|7704021|FG000|STARTED|Overall Study||48
6775933|NCT03861936|7704022|FG001|STARTED|Overall Study||53
6775934|NCT03861936|7704023|FG002|STARTED|Overall Study||49
6775935|NCT03861936|7704021|FG000|COMPLETED|Overall Study||34
6775936|NCT03861936|7704022|FG001|COMPLETED|Overall Study||43
6775937|NCT03861936|7704023|FG002|COMPLETED|Overall Study||39
6775938|NCT03861936|7704021|FG000|NOT COMPLETED|Overall Study||14
6775939|NCT03861936|7704022|FG001|NOT COMPLETED|Overall Study||10
6775940|NCT03861936|7704023|FG002|NOT COMPLETED|Overall Study||10
6775941|NCT03859739|7704035|FG000|STARTED|Overall Study||5
6775942|NCT03859739|7704036|FG001|STARTED|Overall Study||6
6775943|NCT03859739|7704037|FG002|STARTED|Overall Study||6
6775944|NCT03859739|7704038|FG003|STARTED|Overall Study||4
6775945|NCT03859739|7704035|FG000|COMPLETED|Overall Study||5
6775946|NCT03859739|7704036|FG001|COMPLETED|Overall Study||6
6775947|NCT03859739|7704037|FG002|COMPLETED|Overall Study||6
6775948|NCT03859739|7704038|FG003|COMPLETED|Overall Study||4
6775949|NCT03859739|7704035|FG000|NOT COMPLETED|Overall Study||0
6775950|NCT03859739|7704036|FG001|NOT COMPLETED|Overall Study||0
6775951|NCT03859739|7704037|FG002|NOT COMPLETED|Overall Study||0
6775952|NCT03859739|7704038|FG003|NOT COMPLETED|Overall Study||0
6775953|NCT03857750|7704050|FG000|STARTED|Overall Study||16
6775954|NCT03857750|7704051|FG001|STARTED|Overall Study||16
6775955|NCT03857750|7704050|FG000|COMPLETED|Overall Study||16
6775956|NCT03857750|7704051|FG001|COMPLETED|Overall Study||16
6775957|NCT03857750|7704050|FG000|NOT COMPLETED|Overall Study||0
6775958|NCT03857750|7704051|FG001|NOT COMPLETED|Overall Study||0
6775959|NCT03856255|7704057|FG000|STARTED|Overall Study||23
6775960|NCT03856255|7704057|FG000|COMPLETED|Overall Study||23
6775961|NCT03856255|7704057|FG000|NOT COMPLETED|Overall Study||0
6336176|NCT00546897|7243322|FG000|STARTED|Overall Study||15
6775962|NCT03850509|7704063|FG000|STARTED|Overall Study||2
6775963|NCT03850509|7704064|FG001|STARTED|Overall Study||1
6775964|NCT03850509|7704063|FG000|COMPLETED|Overall Study||0
6775965|NCT03850509|7704064|FG001|COMPLETED|Overall Study||0
6775966|NCT03850509|7704063|FG000|NOT COMPLETED|Overall Study||2
6775967|NCT03850509|7704064|FG001|NOT COMPLETED|Overall Study||1
6775968|NCT03860753|7704072|FG000|STARTED|Overall Study||4
6775969|NCT03860753|7704073|FG001|STARTED|Overall Study||0
6336177|NCT00546897|7243323|FG001|STARTED|Overall Study||33
6336178|NCT00546897|7243322|FG000|COMPLETED|Overall Study||15
6336179|NCT00546897|7243323|FG001|COMPLETED|Overall Study||33
6336180|NCT00546897|7243322|FG000|NOT COMPLETED|Overall Study||0
6336181|NCT00546897|7243323|FG001|NOT COMPLETED|Overall Study||0
6336182|NCT00546910|7243331|FG000|STARTED|Overall Study||63
6336183|NCT00546910|7243332|FG001|STARTED|Overall Study||62
6336184|NCT00546910|7243331|FG000|COMPLETED|Overall Study||54
6336185|NCT00546910|7243332|FG001|COMPLETED|Overall Study||51
6336186|NCT00546910|7243331|FG000|NOT COMPLETED|Overall Study||9
6336187|NCT00546910|7243332|FG001|NOT COMPLETED|Overall Study||11
6336188|NCT00547105|7243338|FG000|STARTED|Overall Study||24
6336189|NCT00547105|7243338|FG000|COMPLETED|Overall Study||24
6336190|NCT00547105|7243338|FG000|NOT COMPLETED|Overall Study||0
6336191|NCT00547118|7243344|FG000|STARTED|Overall Study||8
6336192|NCT00547118|7243345|FG001|STARTED|Overall Study||9
6336193|NCT00547118|7243344|FG000|COMPLETED|Overall Study||0
6336194|NCT00547118|7243345|FG001|COMPLETED|Overall Study||0
6336195|NCT00547118|7243344|FG000|NOT COMPLETED|Overall Study||8
6336196|NCT00547118|7243345|FG001|NOT COMPLETED|Overall Study||9
6336197|NCT00547157|7243355|FG000|STARTED|Overall Study||90
6336198|NCT00547157|7243356|FG001|STARTED|Overall Study||62
6336199|NCT00547157|7243355|FG000|COMPLETED|Overall Study||41
6336200|NCT00547157|7243356|FG001|COMPLETED|Overall Study||39
6336201|NCT00547157|7243355|FG000|NOT COMPLETED|Overall Study||49
6336202|NCT00547157|7243356|FG001|NOT COMPLETED|Overall Study||23
6336203|NCT00547248|7243366|FG000|STARTED|Overall Study||280
6336204|NCT00547248|7243367|FG001|STARTED|Overall Study||93
6336205|NCT00547248|7243368|FG002|STARTED|Overall Study||285
6336206|NCT00547248|7243369|FG003|STARTED|Overall Study||98
6336207|NCT00547248|7243366|FG000|COMPLETED|Overall Study||280
6336208|NCT00547248|7243367|FG001|COMPLETED|Overall Study||93
6336209|NCT00547248|7243368|FG002|COMPLETED|Overall Study||275
6336210|NCT00547248|7243369|FG003|COMPLETED|Overall Study||96
6336211|NCT00547248|7243366|FG000|NOT COMPLETED|Overall Study||0
6336212|NCT00547248|7243367|FG001|NOT COMPLETED|Overall Study||0
6336213|NCT00547248|7243368|FG002|NOT COMPLETED|Overall Study||10
6336214|NCT00547248|7243369|FG003|NOT COMPLETED|Overall Study||2
6336215|NCT00547365|7243382|FG000|STARTED|Overall Study||10
6336216|NCT00547365|7243382|FG000|COMPLETED|Overall Study||2
6336217|NCT00547365|7243382|FG000|NOT COMPLETED|Overall Study||8
6336218|NCT00547378|7243390|FG000|STARTED|Randomized Cohort||70
6336219|NCT00547378|7243391|FG001|STARTED|Randomized Cohort||77
6336220|NCT00547378|7243392|FG002|STARTED|Randomized Cohort||0
6775970|NCT03860753|7704072|FG000|COMPLETED|Overall Study||4
6775971|NCT03860753|7704073|FG001|COMPLETED|Overall Study||0
6775972|NCT03860753|7704072|FG000|NOT COMPLETED|Overall Study||0
6775973|NCT03860753|7704073|FG001|NOT COMPLETED|Overall Study||0
6775974|NCT03848455|7704082|FG000|STARTED|Overall Study||90
6775975|NCT03848455|7704083|FG001|STARTED|Overall Study||125
6775976|NCT03848455|7704084|FG002|STARTED|Overall Study||23
6775977|NCT03848455|7704082|FG000|COMPLETED|Overall Study||90
6775978|NCT03848455|7704083|FG001|COMPLETED|Overall Study||125
6775979|NCT03848455|7704084|FG002|COMPLETED|Overall Study||23
6775980|NCT03848455|7704082|FG000|NOT COMPLETED|Overall Study||0
6775981|NCT03848455|7704083|FG001|NOT COMPLETED|Overall Study||0
6775982|NCT03848455|7704084|FG002|NOT COMPLETED|Overall Study||0
6775983|NCT03858894|7704095|FG000|STARTED|Overall Study||48
6775984|NCT03858894|7704096|FG001|STARTED|Overall Study||50
6775985|NCT03858894|7704095|FG000|COMPLETED|Overall Study||44
6775986|NCT03858894|7704096|FG001|COMPLETED|Overall Study||50
6775987|NCT03858894|7704095|FG000|NOT COMPLETED|Overall Study||4
6775988|NCT03858894|7704096|FG001|NOT COMPLETED|Overall Study||0
6775989|NCT03856164|7704104|FG000|STARTED|Overall Study||55
6775990|NCT03856164|7704105|FG001|STARTED|Overall Study||55
6775991|NCT03856164|7704104|FG000|COMPLETED|Overall Study||55
6775992|NCT03856164|7704105|FG001|COMPLETED|Overall Study||55
6775993|NCT03856164|7704104|FG000|NOT COMPLETED|Overall Study||0
6775994|NCT03856164|7704105|FG001|NOT COMPLETED|Overall Study||0
6775995|NCT03850275|7704119|FG000|STARTED|Overall Study||5
6775996|NCT03850275|7704120|FG001|STARTED|Overall Study||5
6775997|NCT03850275|7704121|FG002|STARTED|Overall Study||5
6775998|NCT03850275|7704122|FG003|STARTED|Overall Study||5
6775999|NCT03850275|7704123|FG004|STARTED|Overall Study||5
6776000|NCT03850275|7704124|FG005|STARTED|Overall Study||5
6336221|NCT00547378|7243390|FG000|Month 3|Randomized Cohort|This includes IST subjects reached Month 3 visit, regardless of implant or not.|62
6336222|NCT00547378|7243391|FG001|Month 3|Randomized Cohort|This included SMT subjects who reached SMT Month 3 visit.|72
6336223|NCT00547378|7243392|FG002|Month 3|Randomized Cohort||0
6336224|NCT00547378|7243390|FG000|Month 6|Randomized Cohort|This includes IST subjects reached Month 6 visit, regardless of implant or not.|59
6336225|NCT00547378|7243391|FG001|Month 6|Randomized Cohort|This included SMT subjects who reached SMT Month 6 visit.|71
6336226|NCT00547378|7243392|FG002|Month 6|Randomized Cohort||0
6776001|NCT03850275|7704119|FG000|COMPLETED|Overall Study||5
6776002|NCT03850275|7704120|FG001|COMPLETED|Overall Study||5
6776003|NCT03850275|7704121|FG002|COMPLETED|Overall Study||5
6776004|NCT03850275|7704122|FG003|COMPLETED|Overall Study||5
6776005|NCT03850275|7704123|FG004|COMPLETED|Overall Study||5
6776006|NCT03850275|7704124|FG005|COMPLETED|Overall Study||5
6776007|NCT03850275|7704119|FG000|NOT COMPLETED|Overall Study||0
6776008|NCT03850275|7704120|FG001|NOT COMPLETED|Overall Study||0
6776009|NCT03850275|7704121|FG002|NOT COMPLETED|Overall Study||0
6776010|NCT03850275|7704122|FG003|NOT COMPLETED|Overall Study||0
6336227|NCT00547378|7243390|FG000|COMPLETED|Randomized Cohort||59
6336228|NCT00547378|7243391|FG001|COMPLETED|Randomized Cohort||71
6336229|NCT00547378|7243392|FG002|COMPLETED|Randomized Cohort||0
6336230|NCT00547378|7243390|FG000|NOT COMPLETED|Randomized Cohort||11
6336231|NCT00547378|7243391|FG001|NOT COMPLETED|Randomized Cohort||6
6336232|NCT00547378|7243392|FG002|NOT COMPLETED|Randomized Cohort||0
6776011|NCT03850275|7704123|FG004|NOT COMPLETED|Overall Study||0
6776012|NCT03850275|7704124|FG005|NOT COMPLETED|Overall Study||0
6776013|NCT03851016|7704149|FG000|STARTED|First Intervention (3 Weeks)||12
6776014|NCT03851016|7704150|FG001|STARTED|First Intervention (3 Weeks)||12
6776015|NCT03851016|7704149|FG000|COMPLETED|First Intervention (3 Weeks)||11
6776016|NCT03851016|7704150|FG001|COMPLETED|First Intervention (3 Weeks)||10
6776017|NCT03851016|7704149|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
6776018|NCT03851016|7704150|FG001|NOT COMPLETED|First Intervention (3 Weeks)||2
6776019|NCT03851016|7704149|FG000|STARTED|Washout (1 Week)||11
6776020|NCT03851016|7704150|FG001|STARTED|Washout (1 Week)||10
6776021|NCT03851016|7704149|FG000|COMPLETED|Washout (1 Week)||11
6776022|NCT03851016|7704150|FG001|COMPLETED|Washout (1 Week)||10
6776023|NCT03851016|7704149|FG000|NOT COMPLETED|Washout (1 Week)||0
6776024|NCT03851016|7704150|FG001|NOT COMPLETED|Washout (1 Week)||0
6776025|NCT03851016|7704149|FG000|STARTED|Second Intervention (3 Weeks)||11
6776026|NCT03851016|7704150|FG001|STARTED|Second Intervention (3 Weeks)||10
6776027|NCT03851016|7704149|FG000|COMPLETED|Second Intervention (3 Weeks)||11
6776028|NCT03851016|7704150|FG001|COMPLETED|Second Intervention (3 Weeks)||10
6654979|NCT02449291|7584995|FG001|COMPLETED|Overall Study||186
6654980|NCT02449291|7584996|FG002|COMPLETED|Overall Study||180
6654981|NCT02449291|7584994|FG000|NOT COMPLETED|Overall Study||5
6654982|NCT02449291|7584995|FG001|NOT COMPLETED|Overall Study||2
6654983|NCT02449291|7584996|FG002|NOT COMPLETED|Overall Study||1
6654984|NCT02449356|7585009|FG000|STARTED|Overall Study||30
6654985|NCT02449356|7585010|FG001|STARTED|Overall Study||30
6654986|NCT02449356|7585009|FG000|COMPLETED|Overall Study||30
6654987|NCT02449356|7585010|FG001|COMPLETED|Overall Study||30
6654988|NCT02449356|7585009|FG000|NOT COMPLETED|Overall Study||0
6654989|NCT02449356|7585010|FG001|NOT COMPLETED|Overall Study||0
6654990|NCT02449434|7585020|FG000|STARTED|Overall Study||300
6654991|NCT02449434|7585021|FG001|STARTED|Overall Study||300
6654992|NCT02449434|7585020|FG000|COMPLETED|Overall Study||300
6776029|NCT03851016|7704149|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6776030|NCT03851016|7704150|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6776031|NCT03850496|7704159|FG000|STARTED|Overall Study||26
6776032|NCT03850496|7704160|FG001|STARTED|Overall Study||25
6776033|NCT03850496|7704161|FG002|STARTED|Overall Study||25
6776034|NCT03850496|7704159|FG000|COMPLETED|Overall Study||25
6776035|NCT03850496|7704160|FG001|COMPLETED|Overall Study||24
6776036|NCT03850496|7704161|FG002|COMPLETED|Overall Study||21
6776037|NCT03850496|7704159|FG000|NOT COMPLETED|Overall Study||1
6776038|NCT03850496|7704160|FG001|NOT COMPLETED|Overall Study||1
6776039|NCT03850496|7704161|FG002|NOT COMPLETED|Overall Study||4
6776040|NCT03848949|7704171|FG000|STARTED|Overall Study||54
6776041|NCT03848949|7704172|FG001|STARTED|Overall Study||53
6776042|NCT03848949|7704171|FG000|COMPLETED|Overall Study||49
6776043|NCT03848949|7704172|FG001|COMPLETED|Overall Study||46
6776044|NCT03848949|7704171|FG000|NOT COMPLETED|Overall Study||5
6776045|NCT03848949|7704172|FG001|NOT COMPLETED|Overall Study||7
6776046|NCT03849690|7704178|FG000|STARTED|Period 1 (3 Days)||12
6776047|NCT03849690|7704178|FG000|COMPLETED|Period 1 (3 Days)||12
6776048|NCT03849690|7704178|FG000|NOT COMPLETED|Period 1 (3 Days)||0
6776049|NCT03849690|7704178|FG000|STARTED|Washout Period (at Least 4 Days)||12
6776050|NCT03849690|7704178|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
6776051|NCT03849690|7704178|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
6776052|NCT03849690|7704178|FG000|STARTED|Period 2 (6 Days)||12
6776053|NCT03849690|7704178|FG000|COMPLETED|Period 2 (6 Days)||12
6776054|NCT03849690|7704178|FG000|NOT COMPLETED|Period 2 (6 Days)||0
6776055|NCT03845933|7704189|FG000|STARTED|Overall Study||131
6776056|NCT03845933|7704190|FG001|STARTED|Overall Study||131
6776057|NCT03845933|7704189|FG000|COMPLETED|Overall Study||131
6776058|NCT03845933|7704190|FG001|COMPLETED|Overall Study||131
6776059|NCT03845933|7704189|FG000|NOT COMPLETED|Overall Study||0
6776060|NCT03845933|7704190|FG001|NOT COMPLETED|Overall Study||0
6776061|NCT03844945|7704200|FG000|STARTED|Overall Study||55
6776062|NCT03844945|7704201|FG001|STARTED|Overall Study||54
6776063|NCT03844945|7704202|FG002|STARTED|Overall Study||51
6776064|NCT03844945|7704203|FG003|STARTED|Overall Study||55
6776065|NCT03844945|7704200|FG000|COMPLETED|Overall Study||54
6776066|NCT03844945|7704201|FG001|COMPLETED|Overall Study||53
6336233|NCT00547378|7243390|FG000|STARTED|All Implanted Cohort|This included subjects who received full system implant after randomized to IST.|51
6336234|NCT00547378|7243391|FG001|STARTED|All Implanted Cohort|This included SMT subjects who received full system implant after completing randomization period.|40
6654993|NCT02449434|7585021|FG001|COMPLETED|Overall Study||300
6776067|NCT03844945|7704202|FG002|COMPLETED|Overall Study||46
6776068|NCT03844945|7704203|FG003|COMPLETED|Overall Study||54
6776069|NCT03844945|7704200|FG000|NOT COMPLETED|Overall Study||1
6776070|NCT03844945|7704201|FG001|NOT COMPLETED|Overall Study||1
6776071|NCT03844945|7704202|FG002|NOT COMPLETED|Overall Study||5
6776072|NCT03844945|7704203|FG003|NOT COMPLETED|Overall Study||1
6776073|NCT03844321|7704215|FG000|STARTED|Overall Study||2220
6776074|NCT03844321|7704216|FG001|STARTED|Overall Study||2192
6776075|NCT03844321|7704215|FG000|COMPLETED|Overall Study||579
6336235|NCT00547378|7243392|FG002|STARTED|All Implanted Cohort|This included subjects who received full system implant from non-randomized subjects.|181
6336236|NCT00547378|7243390|FG000|Month 3|All Implanted Cohort||51
6336237|NCT00547378|7243391|FG001|Month 3|All Implanted Cohort||39
6336238|NCT00547378|7243392|FG002|Month 3|All Implanted Cohort||178
6336239|NCT00547378|7243390|FG000|Month 6|All Implanted Cohort||50
6336240|NCT00547378|7243391|FG001|Month 6|All Implanted Cohort||36
6776076|NCT03844321|7704216|FG001|COMPLETED|Overall Study||533
6776077|NCT03844321|7704215|FG000|NOT COMPLETED|Overall Study||1641
6776078|NCT03844321|7704216|FG001|NOT COMPLETED|Overall Study||1659
6776079|NCT03843632|7704226|FG000|STARTED|Overall Study||50
6776080|NCT03843632|7704227|FG001|STARTED|Overall Study||30
6776081|NCT03843632|7704228|FG002|STARTED|Overall Study||33
6776082|NCT03843632|7704229|FG003|STARTED|Overall Study||37
6776083|NCT03843632|7704226|FG000|Vaccination 1|Overall Study||50
6776084|NCT03843632|7704227|FG001|Vaccination 1|Overall Study||30
6776085|NCT03843632|7704228|FG002|Vaccination 1|Overall Study||33
6776086|NCT03843632|7704229|FG003|Vaccination 1|Overall Study||37
6776087|NCT03843632|7704226|FG000|Vaccination 2|Overall Study||49
6776088|NCT03843632|7704227|FG001|Vaccination 2|Overall Study||30
6776089|NCT03843632|7704228|FG002|Vaccination 2|Overall Study||0
6776090|NCT03843632|7704229|FG003|Vaccination 2|Overall Study||0
6776091|NCT03843632|7704226|FG000|COMPLETED|Overall Study||49
6776092|NCT03843632|7704227|FG001|COMPLETED|Overall Study||30
6776093|NCT03843632|7704228|FG002|COMPLETED|Overall Study||33
6776094|NCT03843632|7704229|FG003|COMPLETED|Overall Study||37
6776095|NCT03843632|7704226|FG000|NOT COMPLETED|Overall Study||1
6776096|NCT03843632|7704227|FG001|NOT COMPLETED|Overall Study||0
6776097|NCT03843632|7704228|FG002|NOT COMPLETED|Overall Study||0
6776098|NCT03843632|7704229|FG003|NOT COMPLETED|Overall Study||0
6776099|NCT03840811|7704242|FG000|STARTED|Overall Study||9
6776100|NCT03840811|7704243|FG001|STARTED|Overall Study||6
6776101|NCT03840811|7704244|FG002|STARTED|Overall Study||12
6776102|NCT03840811|7704242|FG000|COMPLETED|Overall Study||9
6776103|NCT03840811|7704243|FG001|COMPLETED|Overall Study||6
6776104|NCT03840811|7704244|FG002|COMPLETED|Overall Study||11
6776105|NCT03840811|7704242|FG000|NOT COMPLETED|Overall Study||0
6776106|NCT03840811|7704243|FG001|NOT COMPLETED|Overall Study||0
6776107|NCT03840811|7704244|FG002|NOT COMPLETED|Overall Study||1
6776108|NCT03837028|7704256|FG000|STARTED|Overall Study||35
6776109|NCT03837028|7704257|FG001|STARTED|Overall Study||34
6776110|NCT03837028|7704258|FG002|STARTED|Overall Study||33
6776111|NCT03837028|7704259|FG003|STARTED|Overall Study||25
6776112|NCT03837028|7704256|FG000|COMPLETED|Overall Study||19
6776113|NCT03837028|7704257|FG001|COMPLETED|Overall Study||23
6776114|NCT03837028|7704258|FG002|COMPLETED|Overall Study||20
6776115|NCT03837028|7704259|FG003|COMPLETED|Overall Study||18
6776116|NCT03837028|7704256|FG000|NOT COMPLETED|Overall Study||16
6776117|NCT03837028|7704257|FG001|NOT COMPLETED|Overall Study||11
6776118|NCT03837028|7704258|FG002|NOT COMPLETED|Overall Study||13
6776119|NCT03837028|7704259|FG003|NOT COMPLETED|Overall Study||7
6776120|NCT03825939|7704272|FG000|STARTED|Overall Study||18
6776121|NCT03825939|7704273|FG001|STARTED|Overall Study||20
6776122|NCT03825939|7704274|FG002|STARTED|Overall Study||14
6776123|NCT03825939|7704272|FG000|COMPLETED|Overall Study||18
6776124|NCT03825939|7704273|FG001|COMPLETED|Overall Study||20
6776125|NCT03825939|7704274|FG002|COMPLETED|Overall Study||14
6776126|NCT03825939|7704272|FG000|NOT COMPLETED|Overall Study||0
6776127|NCT03825939|7704273|FG001|NOT COMPLETED|Overall Study||0
6776128|NCT03825939|7704274|FG002|NOT COMPLETED|Overall Study||0
6776129|NCT03817775|7704284|FG000|STARTED|Overall Study||22
6776130|NCT03817775|7704285|FG001|STARTED|Overall Study||54
6776131|NCT03817775|7704284|FG000|COMPLETED|Overall Study||22
6776132|NCT03817775|7704285|FG001|COMPLETED|Overall Study||54
6776133|NCT03817775|7704284|FG000|NOT COMPLETED|Overall Study||0
6776134|NCT03817775|7704285|FG001|NOT COMPLETED|Overall Study||0
6776135|NCT03843372|7704293|FG000|STARTED|Overall Study||14
6776136|NCT03843372|7704294|FG001|STARTED|Overall Study||18
6776137|NCT03843372|7704293|FG000|COMPLETED|Overall Study||12
6776138|NCT03843372|7704294|FG001|COMPLETED|Overall Study||16
6776139|NCT03843372|7704293|FG000|NOT COMPLETED|Overall Study||2
6776140|NCT03843372|7704294|FG001|NOT COMPLETED|Overall Study||2
6776141|NCT03841331|7704302|FG000|STARTED|Overall Study||117
6776142|NCT03841331|7704303|FG001|STARTED|Overall Study||116
6776143|NCT03841331|7704302|FG000|COMPLETED|Overall Study||108
6776144|NCT03841331|7704303|FG001|COMPLETED|Overall Study||106
6776145|NCT03841331|7704302|FG000|NOT COMPLETED|Overall Study||9
6776146|NCT03841331|7704303|FG001|NOT COMPLETED|Overall Study||10
6776147|NCT03840278|7704309|FG000|STARTED|Overall Study||5
6776148|NCT03840278|7704310|FG001|STARTED|Overall Study||5
6776149|NCT03840278|7704309|FG000|COMPLETED|Overall Study||5
6776150|NCT03840278|7704310|FG001|COMPLETED|Overall Study||5
6776151|NCT03840278|7704309|FG000|NOT COMPLETED|Overall Study||0
6776152|NCT03840278|7704310|FG001|NOT COMPLETED|Overall Study||0
6776153|NCT03840135|7704318|FG000|STARTED|Overall Study||86
6776154|NCT03840135|7704319|FG001|STARTED|Overall Study||86
6776155|NCT03840135|7704318|FG000|COMPLETED|Overall Study||79
6776156|NCT03840135|7704319|FG001|COMPLETED|Overall Study||85
6776157|NCT03840135|7704318|FG000|NOT COMPLETED|Overall Study||7
6776158|NCT03840135|7704319|FG001|NOT COMPLETED|Overall Study||1
6776159|NCT03839641|7704331|FG000|STARTED|Overall Study||5
6776160|NCT03839641|7704332|FG001|STARTED|Overall Study||5
6776161|NCT03839641|7704331|FG000|COMPLETED|Overall Study||4
6336241|NCT00547378|7243392|FG002|Month 6|All Implanted Cohort||178
6336242|NCT00547378|7243390|FG000|Month 12|All Implanted Cohort||48
6336243|NCT00547378|7243391|FG001|Month 12|All Implanted Cohort||32
6336244|NCT00547378|7243392|FG002|Month 12|All Implanted Cohort||175
6336245|NCT00547378|7243390|FG000|Month 24|All Implanted Cohort||42
6336246|NCT00547378|7243391|FG001|Month 24|All Implanted Cohort||30
6336247|NCT00547378|7243392|FG002|Month 24|All Implanted Cohort||161
6336248|NCT00547378|7243390|FG000|Month 36|All Implanted Cohort||42
6336249|NCT00547378|7243391|FG001|Month 36|All Implanted Cohort||29
6336250|NCT00547378|7243392|FG002|Month 36|All Implanted Cohort||146
6336251|NCT00547378|7243390|FG000|Month 48|All Implanted Cohort||38
6336252|NCT00547378|7243391|FG001|Month 48|All Implanted Cohort||27
6336253|NCT00547378|7243392|FG002|Month 48|All Implanted Cohort||136
6336254|NCT00547378|7243390|FG000|Month 60|All Implanted Cohort||36
6336255|NCT00547378|7243391|FG001|Month 60|All Implanted Cohort||23
6336256|NCT00547378|7243392|FG002|Month 60|All Implanted Cohort||114
6776162|NCT03839641|7704332|FG001|COMPLETED|Overall Study||4
6776163|NCT03839641|7704331|FG000|NOT COMPLETED|Overall Study||1
6776164|NCT03839641|7704332|FG001|NOT COMPLETED|Overall Study||1
6776165|NCT03839212|7704340|FG000|STARTED|Overall Study||18
6776166|NCT03839212|7704340|FG000|COMPLETED|Overall Study||14
6776167|NCT03839212|7704340|FG000|NOT COMPLETED|Overall Study||4
6776168|NCT03839355|7704346|FG000|STARTED|Overall Study||18
6776169|NCT03839355|7704347|FG001|STARTED|Overall Study||16
6776170|NCT03839355|7704346|FG000|COMPLETED|Overall Study||17
6776171|NCT03839355|7704347|FG001|COMPLETED|Overall Study||16
6776172|NCT03839355|7704346|FG000|NOT COMPLETED|Overall Study||1
6776173|NCT03839355|7704347|FG001|NOT COMPLETED|Overall Study||0
6776174|NCT03838874|7704355|FG000|STARTED|Overall Study||80
6776175|NCT03838874|7704356|FG001|STARTED|Overall Study||74
6776176|NCT03838874|7704355|FG000|COMPLETED|Overall Study||80
6776177|NCT03838874|7704356|FG001|COMPLETED|Overall Study||74
6776178|NCT03838874|7704355|FG000|NOT COMPLETED|Overall Study||0
6776179|NCT03838874|7704356|FG001|NOT COMPLETED|Overall Study||0
6776180|NCT03838731|7704364|FG000|STARTED|Overall Study||27
6776181|NCT03838731|7704365|FG001|STARTED|Overall Study||29
6776182|NCT03838731|7704364|FG000|COMPLETED|Overall Study||26
6776183|NCT03838731|7704365|FG001|COMPLETED|Overall Study||28
6776184|NCT03838731|7704364|FG000|NOT COMPLETED|Overall Study||1
6776185|NCT03838731|7704365|FG001|NOT COMPLETED|Overall Study||1
6776186|NCT03838198|7704373|FG000|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
6776187|NCT03838198|7704374|FG001|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
6776188|NCT03838198|7704375|FG002|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts|Because it was a SMART trial, no participants were allocated to receive booster calls until Phase 2.|0
6776189|NCT03838198|7704376|FG003|STARTED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
6776190|NCT03838198|7704373|FG000|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
6776191|NCT03838198|7704374|FG001|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
6776192|NCT03838198|7704375|FG002|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
6776193|NCT03838198|7704376|FG003|COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||40
6776194|NCT03838198|7704373|FG000|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
6776195|NCT03838198|7704374|FG001|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
6776196|NCT03838198|7704375|FG002|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
6776197|NCT03838198|7704376|FG003|NOT COMPLETED|Phase 1: Safety Plan (SP) vs. SP w/Texts||0
6776198|NCT03838198|7704373|FG000|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with added booster call.|18
6776199|NCT03838198|7704374|FG001|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan and text) with no added booster call.|22
6776200|NCT03838198|7704375|FG002|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with added booster call.|18
6776201|NCT03838198|7704376|FG003|STARTED|Phase 2: Added Booster Call or Not|These participants continued with Phase 1 intervention (Safety plan only) with no added booster call in Phase 2|22
6776202|NCT03838198|7704373|FG000|COMPLETED|Phase 2: Added Booster Call or Not|All 18 completed the safety plan; but only 14 had both parent and adolescent completing the call; 1 had parent only; 1 had adolescent only; 2 were unable to be reached.|18
6776203|NCT03838198|7704374|FG001|COMPLETED|Phase 2: Added Booster Call or Not||0
6776204|NCT03838198|7704375|FG002|COMPLETED|Phase 2: Added Booster Call or Not|Of the 17 who completed the safety plan, only 15 had both parent and adolescent completing the call; 1 had parent only; 1 was unable to be reached.|17
6776205|NCT03838198|7704376|FG003|COMPLETED|Phase 2: Added Booster Call or Not||0
6776206|NCT03838198|7704373|FG000|NOT COMPLETED|Phase 2: Added Booster Call or Not||0
6776207|NCT03838198|7704374|FG001|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
6776208|NCT03838198|7704375|FG002|NOT COMPLETED|Phase 2: Added Booster Call or Not||1
6776209|NCT03838198|7704376|FG003|NOT COMPLETED|Phase 2: Added Booster Call or Not||22
6776210|NCT03838198|7704373|FG000|STARTED|1 Month Follow up Period||18
6776211|NCT03838198|7704374|FG001|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
6776212|NCT03838198|7704375|FG002|STARTED|1 Month Follow up Period||17
6776213|NCT03838198|7704376|FG003|STARTED|1 Month Follow up Period|All participants from Phase 1 and 2 were followed unless they withdrew.|22
6776214|NCT03838198|7704373|FG000|Adolescent Surveys Completed|1 Month Follow up Period||16
6336257|NCT00547378|7243390|FG000|COMPLETED|All Implanted Cohort||36
6336258|NCT00547378|7243391|FG001|COMPLETED|All Implanted Cohort||22
6336259|NCT00547378|7243392|FG002|COMPLETED|All Implanted Cohort||111
6336260|NCT00547378|7243390|FG000|NOT COMPLETED|All Implanted Cohort||15
6776215|NCT03838198|7704374|FG001|Adolescent Surveys Completed|1 Month Follow up Period||22
6776216|NCT03838198|7704375|FG002|Adolescent Surveys Completed|1 Month Follow up Period||16
6776217|NCT03838198|7704376|FG003|Adolescent Surveys Completed|1 Month Follow up Period||22
6776218|NCT03838198|7704373|FG000|COMPLETED|1 Month Follow up Period||16
6776219|NCT03838198|7704374|FG001|COMPLETED|1 Month Follow up Period||22
6776220|NCT03838198|7704375|FG002|COMPLETED|1 Month Follow up Period||16
6776221|NCT03838198|7704376|FG003|COMPLETED|1 Month Follow up Period||21
6776222|NCT03838198|7704373|FG000|NOT COMPLETED|1 Month Follow up Period||2
6776223|NCT03838198|7704374|FG001|NOT COMPLETED|1 Month Follow up Period||0
6776224|NCT03838198|7704375|FG002|NOT COMPLETED|1 Month Follow up Period||1
6776225|NCT03838198|7704376|FG003|NOT COMPLETED|1 Month Follow up Period||1
6776226|NCT03838198|7704373|FG000|STARTED|3 Month Follow up Period||18
6776227|NCT03838198|7704374|FG001|STARTED|3 Month Follow up Period||22
6776228|NCT03838198|7704375|FG002|STARTED|3 Month Follow up Period||17
6776229|NCT03838198|7704376|FG003|STARTED|3 Month Follow up Period||22
6776230|NCT03838198|7704373|FG000|Adolescent Survey Completed|3 Month Follow up Period||16
6776231|NCT03838198|7704374|FG001|Adolescent Survey Completed|3 Month Follow up Period||21
6776232|NCT03838198|7704375|FG002|Adolescent Survey Completed|3 Month Follow up Period||15
6776233|NCT03838198|7704376|FG003|Adolescent Survey Completed|3 Month Follow up Period||21
6776234|NCT03838198|7704373|FG000|COMPLETED|3 Month Follow up Period||15
6776235|NCT03838198|7704374|FG001|COMPLETED|3 Month Follow up Period||19
6776236|NCT03838198|7704375|FG002|COMPLETED|3 Month Follow up Period||14
6776237|NCT03838198|7704376|FG003|COMPLETED|3 Month Follow up Period||18
6776238|NCT03838198|7704373|FG000|NOT COMPLETED|3 Month Follow up Period||3
6776239|NCT03838198|7704374|FG001|NOT COMPLETED|3 Month Follow up Period||3
6776240|NCT03838198|7704375|FG002|NOT COMPLETED|3 Month Follow up Period||3
6776241|NCT03838198|7704376|FG003|NOT COMPLETED|3 Month Follow up Period||4
6776242|NCT03831451|7704389|FG000|STARTED|Overall Study||74
6776243|NCT03831451|7704390|FG001|STARTED|Overall Study||55
6776244|NCT03831451|7704389|FG000|COMPLETED|Overall Study||74
6776245|NCT03831451|7704390|FG001|COMPLETED|Overall Study||55
6776246|NCT03831451|7704389|FG000|NOT COMPLETED|Overall Study||0
6776247|NCT03831451|7704390|FG001|NOT COMPLETED|Overall Study||0
6776248|NCT03822078|7704402|FG000|STARTED|Overall Study||12
6776249|NCT03822078|7704403|FG001|STARTED|Overall Study||6
6776250|NCT03822078|7704404|FG002|STARTED|Overall Study||6
6776251|NCT03822078|7704405|FG003|STARTED|Overall Study||8
6776252|NCT03822078|7704406|FG004|STARTED|Overall Study||7
6776253|NCT03822078|7704407|FG005|STARTED|Overall Study||6
6776254|NCT03822078|7704402|FG000|Received Study Drug|Overall Study||10
6776255|NCT03822078|7704403|FG001|Received Study Drug|Overall Study||6
6776256|NCT03822078|7704404|FG002|Received Study Drug|Overall Study||6
6776257|NCT03822078|7704405|FG003|Received Study Drug|Overall Study||6
6776258|NCT03822078|7704406|FG004|Received Study Drug|Overall Study||6
6776259|NCT03822078|7704407|FG005|Received Study Drug|Overall Study||6
6776260|NCT03822078|7704402|FG000|COMPLETED|Overall Study||10
6776261|NCT03822078|7704403|FG001|COMPLETED|Overall Study||6
6776262|NCT03822078|7704404|FG002|COMPLETED|Overall Study||6
6776263|NCT03822078|7704405|FG003|COMPLETED|Overall Study||6
6776264|NCT03822078|7704406|FG004|COMPLETED|Overall Study||6
6776265|NCT03822078|7704407|FG005|COMPLETED|Overall Study||6
6776266|NCT03822078|7704402|FG000|NOT COMPLETED|Overall Study||2
6776267|NCT03822078|7704403|FG001|NOT COMPLETED|Overall Study||0
6776268|NCT03822078|7704404|FG002|NOT COMPLETED|Overall Study||0
6776269|NCT03822078|7704405|FG003|NOT COMPLETED|Overall Study||2
6776270|NCT03822078|7704406|FG004|NOT COMPLETED|Overall Study||1
6776271|NCT03822078|7704407|FG005|NOT COMPLETED|Overall Study||0
6776272|NCT03815240|7704427|FG000|STARTED|Intervention no Dressing||2
6776273|NCT03815240|7704428|FG001|STARTED|Intervention no Dressing||1
6776274|NCT03815240|7704429|FG002|STARTED|Intervention no Dressing||1
6776275|NCT03815240|7704430|FG003|STARTED|Intervention no Dressing||2
6776276|NCT03815240|7704431|FG004|STARTED|Intervention no Dressing||1
6776277|NCT03815240|7704432|FG005|STARTED|Intervention no Dressing||2
6776278|NCT03815240|7704433|FG006|STARTED|Intervention no Dressing||1
6776279|NCT03815240|7704434|FG007|STARTED|Intervention no Dressing||1
6776280|NCT03815240|7704435|FG008|STARTED|Intervention no Dressing||1
6776281|NCT03815240|7704427|FG000|COMPLETED|Intervention no Dressing||2
6776282|NCT03815240|7704428|FG001|COMPLETED|Intervention no Dressing||1
6776283|NCT03815240|7704429|FG002|COMPLETED|Intervention no Dressing||1
6776284|NCT03815240|7704430|FG003|COMPLETED|Intervention no Dressing||2
6776285|NCT03815240|7704431|FG004|COMPLETED|Intervention no Dressing||1
6776286|NCT03815240|7704432|FG005|COMPLETED|Intervention no Dressing||2
6776287|NCT03815240|7704433|FG006|COMPLETED|Intervention no Dressing||1
6776288|NCT03815240|7704434|FG007|COMPLETED|Intervention no Dressing||1
6776289|NCT03815240|7704435|FG008|COMPLETED|Intervention no Dressing||1
6776290|NCT03815240|7704427|FG000|NOT COMPLETED|Intervention no Dressing||0
6776291|NCT03815240|7704428|FG001|NOT COMPLETED|Intervention no Dressing||0
6776292|NCT03815240|7704429|FG002|NOT COMPLETED|Intervention no Dressing||0
6776293|NCT03815240|7704430|FG003|NOT COMPLETED|Intervention no Dressing||0
6776294|NCT03815240|7704431|FG004|NOT COMPLETED|Intervention no Dressing||0
6776295|NCT03815240|7704432|FG005|NOT COMPLETED|Intervention no Dressing||0
6776296|NCT03815240|7704433|FG006|NOT COMPLETED|Intervention no Dressing||0
6776297|NCT03815240|7704434|FG007|NOT COMPLETED|Intervention no Dressing||0
6336261|NCT00547378|7243391|FG001|NOT COMPLETED|All Implanted Cohort||18
6336262|NCT00547378|7243392|FG002|NOT COMPLETED|All Implanted Cohort||70
6336263|NCT00547521|7243402|FG000|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
6336264|NCT00547521|7243403|FG001|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
6336265|NCT00547521|7243402|FG000|COMPLETED|Short Term Study (4 Months)||50
6336266|NCT00547521|7243403|FG001|COMPLETED|Short Term Study (4 Months)||45
6336267|NCT00547521|7243402|FG000|NOT COMPLETED|Short Term Study (4 Months)||1
6336268|NCT00547521|7243403|FG001|NOT COMPLETED|Short Term Study (4 Months)||4
6336269|NCT00547521|7243402|FG000|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
6336270|NCT00547521|7243403|FG001|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
6336271|NCT00547521|7243402|FG000|COMPLETED|Long Term Extension (LTE) Study||0
6336272|NCT00547521|7243403|FG001|COMPLETED|Long Term Extension (LTE) Study||59
6336273|NCT00547521|7243402|FG000|NOT COMPLETED|Long Term Extension (LTE) Study||0
6336274|NCT00547521|7243403|FG001|NOT COMPLETED|Long Term Extension (LTE) Study||31
6336275|NCT00547534|7243416|FG000|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
6336276|NCT00547534|7243416|FG000|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
6336277|NCT00547534|7243416|FG000|NOT COMPLETED|Overall Study||11
6336278|NCT00547586|7243426|FG000|STARTED|Overall Study||33
6336279|NCT00547586|7243427|FG001|STARTED|Overall Study||7
6336280|NCT00547586|7243428|FG002|STARTED|Overall Study||14
6336281|NCT00547586|7243429|FG003|STARTED|Overall Study||33
6336282|NCT00547586|7243430|FG004|STARTED|Overall Study||35
6336283|NCT00547586|7243426|FG000|COMPLETED|Overall Study||28
6336284|NCT00547586|7243427|FG001|COMPLETED|Overall Study||6
6336285|NCT00547586|7243428|FG002|COMPLETED|Overall Study||13
6558936|NCT01778127|7481562|FG001|STARTED|Overall Study||33
6558937|NCT01778127|7481563|FG002|STARTED|Overall Study||32
6336286|NCT00547586|7243429|FG003|COMPLETED|Overall Study||27
6336287|NCT00547586|7243430|FG004|COMPLETED|Overall Study||32
6336288|NCT00547586|7243426|FG000|NOT COMPLETED|Overall Study||5
6336289|NCT00547586|7243427|FG001|NOT COMPLETED|Overall Study||1
6336290|NCT00547586|7243428|FG002|NOT COMPLETED|Overall Study||1
6336291|NCT00547586|7243429|FG003|NOT COMPLETED|Overall Study||6
6336292|NCT00547586|7243430|FG004|NOT COMPLETED|Overall Study||3
6336293|NCT00547638|7243444|FG000|STARTED|Overall Study||143
6336294|NCT00547638|7243445|FG001|STARTED|Overall Study||73
6336295|NCT00547638|7243444|FG000|COMPLETED|Overall Study||119
6336296|NCT00547638|7243445|FG001|COMPLETED|Overall Study||59
6336297|NCT00547638|7243444|FG000|NOT COMPLETED|Overall Study||24
6336298|NCT00547638|7243445|FG001|NOT COMPLETED|Overall Study||14
6336299|NCT00547703|7243453|FG000|STARTED|Overall Study||4
6336300|NCT00547703|7243454|FG001|STARTED|Overall Study||1
6336301|NCT00547703|7243453|FG000|COMPLETED|Overall Study||3
6336302|NCT00547703|7243454|FG001|COMPLETED|Overall Study||1
6336303|NCT00547703|7243453|FG000|NOT COMPLETED|Overall Study||1
6336304|NCT00547703|7243454|FG001|NOT COMPLETED|Overall Study||0
6336305|NCT00547729|7243460|FG000|STARTED|Overall Study||71
6336306|NCT00547729|7243460|FG000|COMPLETED|Overall Study||71
6336307|NCT00547729|7243460|FG000|NOT COMPLETED|Overall Study||0
6336308|NCT00547898|7243468|FG000|STARTED|Overall Study||138
6336309|NCT00547898|7243469|FG001|STARTED|Overall Study||136
6336310|NCT00547898|7243470|FG002|STARTED|Overall Study||54
6336311|NCT00547898|7243471|FG003|STARTED|Overall Study||46
6336312|NCT00547898|7243468|FG000|COMPLETED|Overall Study||129
6336313|NCT00547898|7243469|FG001|COMPLETED|Overall Study||126
6336314|NCT00547898|7243470|FG002|COMPLETED|Overall Study||54
6336315|NCT00547898|7243471|FG003|COMPLETED|Overall Study||40
6336316|NCT00547898|7243468|FG000|NOT COMPLETED|Overall Study||9
6336317|NCT00547898|7243469|FG001|NOT COMPLETED|Overall Study||10
6336318|NCT00547898|7243470|FG002|NOT COMPLETED|Overall Study||0
6336319|NCT00547898|7243471|FG003|NOT COMPLETED|Overall Study||6
6336320|NCT00547911|7243487|FG000|STARTED|Overall Study||2
6336321|NCT00547911|7243488|FG001|STARTED|Overall Study||2
6336322|NCT00547911|7243489|FG002|STARTED|Overall Study||2
6336323|NCT00547911|7243490|FG003|STARTED|Overall Study||2
6336324|NCT00547911|7243491|FG004|STARTED|Overall Study||3
6336325|NCT00547911|7243492|FG005|STARTED|Overall Study||3
6336326|NCT00547911|7243487|FG000|COMPLETED|Overall Study||2
6336327|NCT00547911|7243488|FG001|COMPLETED|Overall Study||2
6336328|NCT00547911|7243489|FG002|COMPLETED|Overall Study||2
6336329|NCT00547911|7243490|FG003|COMPLETED|Overall Study||1
6336330|NCT00547911|7243491|FG004|COMPLETED|Overall Study||3
6336331|NCT00547911|7243492|FG005|COMPLETED|Overall Study||3
6336332|NCT00547911|7243487|FG000|NOT COMPLETED|Overall Study||0
6336333|NCT00547911|7243488|FG001|NOT COMPLETED|Overall Study||0
6336334|NCT00547911|7243489|FG002|NOT COMPLETED|Overall Study||0
6336335|NCT00547911|7243490|FG003|NOT COMPLETED|Overall Study||1
6336336|NCT00547911|7243491|FG004|NOT COMPLETED|Overall Study||0
6336337|NCT00547911|7243492|FG005|NOT COMPLETED|Overall Study||0
6336338|NCT00548041|7243505|FG000|STARTED|Overall Study||100
6336339|NCT00548041|7243505|FG000|COMPLETED|Overall Study||100
6558938|NCT01778127|7481561|FG000|COMPLETED|Overall Study||25
6558939|NCT01778127|7481562|FG001|COMPLETED|Overall Study||31
6558940|NCT01778127|7481563|FG002|COMPLETED|Overall Study||26
6336340|NCT00548041|7243505|FG000|NOT COMPLETED|Overall Study||0
6336341|NCT00548132|7243511|FG000|STARTED|Overall Study||534
6336342|NCT00548132|7243512|FG001|STARTED|Overall Study||554
6336343|NCT00548132|7243511|FG000|Consented to Study|Overall Study||534
6336344|NCT00548132|7243512|FG001|Consented to Study|Overall Study||554
6336345|NCT00548132|7243511|FG000|COMPLETED|Overall Study||534
6336346|NCT00548132|7243512|FG001|COMPLETED|Overall Study||554
6336347|NCT00548132|7243511|FG000|NOT COMPLETED|Overall Study||0
6336348|NCT00548132|7243512|FG001|NOT COMPLETED|Overall Study||0
6336349|NCT00548145|7243522|FG000|STARTED|Overall Study||18
6336350|NCT00548145|7243523|FG001|STARTED|Overall Study||20
6336351|NCT00548145|7243522|FG000|COMPLETED|Overall Study||17
6336352|NCT00548145|7243523|FG001|COMPLETED|Overall Study||16
6336353|NCT00548145|7243522|FG000|NOT COMPLETED|Overall Study||1
6336354|NCT00548145|7243523|FG001|NOT COMPLETED|Overall Study||4
6336355|NCT00548171|7243531|FG000|STARTED|Overall Study||164
6336356|NCT00548171|7243532|FG001|STARTED|Overall Study||39
6336357|NCT00548171|7243531|FG000|COMPLETED|Overall Study||164
6336358|NCT00548171|7243532|FG001|COMPLETED|Overall Study||39
6336359|NCT00548171|7243531|FG000|NOT COMPLETED|Overall Study||0
6336360|NCT00548171|7243532|FG001|NOT COMPLETED|Overall Study||0
6336361|NCT00548184|7243538|FG000|STARTED|Overall Study||65
6336362|NCT00548184|7243538|FG000|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
6336363|NCT00548184|7243538|FG000|NOT COMPLETED|Overall Study||5
6336364|NCT00548197|7243544|FG000|STARTED|Overall Study||18
6336365|NCT00548197|7243545|FG001|STARTED|Overall Study||22
6336366|NCT00548197|7243544|FG000|COMPLETED|Overall Study||18
6336367|NCT00548197|7243545|FG001|COMPLETED|Overall Study||22
6336368|NCT00548197|7243544|FG000|NOT COMPLETED|Overall Study||0
6336369|NCT00548197|7243545|FG001|NOT COMPLETED|Overall Study||0
6336370|NCT00548249|7243558|FG000|STARTED|Overall Study||26
6336371|NCT00548249|7243559|FG001|STARTED|Overall Study||26
6336372|NCT00548249|7243560|FG002|STARTED|Overall Study||29
6336373|NCT00548249|7243561|FG003|STARTED|Overall Study||22
6336374|NCT00548249|7243562|FG004|STARTED|Overall Study||28
6336375|NCT00548249|7243558|FG000|COMPLETED|Overall Study||10
6336376|NCT00548249|7243559|FG001|COMPLETED|Overall Study||13
6336377|NCT00548249|7243560|FG002|COMPLETED|Overall Study||9
6336378|NCT00548249|7243561|FG003|COMPLETED|Overall Study||9
6336379|NCT00548249|7243562|FG004|COMPLETED|Overall Study||7
6336380|NCT00548249|7243558|FG000|NOT COMPLETED|Overall Study||16
6336381|NCT00548249|7243559|FG001|NOT COMPLETED|Overall Study||13
6776298|NCT03815240|7704435|FG008|NOT COMPLETED|Intervention no Dressing||0
6776299|NCT03815240|7704427|FG000|STARTED|Intervention Mepilex Dressing||2
6776300|NCT03815240|7704428|FG001|STARTED|Intervention Mepilex Dressing||1
6776301|NCT03815240|7704429|FG002|STARTED|Intervention Mepilex Dressing||1
6776302|NCT03815240|7704430|FG003|STARTED|Intervention Mepilex Dressing||2
6776303|NCT03815240|7704431|FG004|STARTED|Intervention Mepilex Dressing||1
6776304|NCT03815240|7704432|FG005|STARTED|Intervention Mepilex Dressing||2
6776305|NCT03815240|7704433|FG006|STARTED|Intervention Mepilex Dressing||1
6776306|NCT03815240|7704434|FG007|STARTED|Intervention Mepilex Dressing||1
6776307|NCT03815240|7704435|FG008|STARTED|Intervention Mepilex Dressing||1
6776308|NCT03815240|7704427|FG000|COMPLETED|Intervention Mepilex Dressing||2
6776309|NCT03815240|7704428|FG001|COMPLETED|Intervention Mepilex Dressing||1
6776310|NCT03815240|7704429|FG002|COMPLETED|Intervention Mepilex Dressing||1
6776311|NCT03815240|7704430|FG003|COMPLETED|Intervention Mepilex Dressing||2
6776312|NCT03815240|7704431|FG004|COMPLETED|Intervention Mepilex Dressing||1
6776313|NCT03815240|7704432|FG005|COMPLETED|Intervention Mepilex Dressing||2
6776314|NCT03815240|7704433|FG006|COMPLETED|Intervention Mepilex Dressing||1
6776315|NCT03815240|7704434|FG007|COMPLETED|Intervention Mepilex Dressing||1
6776316|NCT03815240|7704435|FG008|COMPLETED|Intervention Mepilex Dressing||1
6776317|NCT03815240|7704427|FG000|NOT COMPLETED|Intervention Mepilex Dressing||0
6776318|NCT03815240|7704428|FG001|NOT COMPLETED|Intervention Mepilex Dressing||0
6776319|NCT03815240|7704429|FG002|NOT COMPLETED|Intervention Mepilex Dressing||0
6776320|NCT03815240|7704430|FG003|NOT COMPLETED|Intervention Mepilex Dressing||0
6776321|NCT03815240|7704431|FG004|NOT COMPLETED|Intervention Mepilex Dressing||0
6776322|NCT03815240|7704432|FG005|NOT COMPLETED|Intervention Mepilex Dressing||0
6776323|NCT03815240|7704433|FG006|NOT COMPLETED|Intervention Mepilex Dressing||0
6776324|NCT03815240|7704434|FG007|NOT COMPLETED|Intervention Mepilex Dressing||0
6776325|NCT03815240|7704435|FG008|NOT COMPLETED|Intervention Mepilex Dressing||0
6776326|NCT03815240|7704427|FG000|STARTED|Intervention Allevyn Dressing||2
6776327|NCT03815240|7704428|FG001|STARTED|Intervention Allevyn Dressing||1
6776328|NCT03815240|7704429|FG002|STARTED|Intervention Allevyn Dressing||1
6776329|NCT03815240|7704430|FG003|STARTED|Intervention Allevyn Dressing||2
6776330|NCT03815240|7704431|FG004|STARTED|Intervention Allevyn Dressing||1
6776331|NCT03815240|7704432|FG005|STARTED|Intervention Allevyn Dressing||2
6336382|NCT00548249|7243560|FG002|NOT COMPLETED|Overall Study||20
6336383|NCT00548249|7243561|FG003|NOT COMPLETED|Overall Study||13
6336384|NCT00548249|7243562|FG004|NOT COMPLETED|Overall Study||21
6336385|NCT00548262|7243574|FG000|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
6336386|NCT00548262|7243574|FG000|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
6336387|NCT00548262|7243574|FG000|NOT COMPLETED|Overall Study||32
6336388|NCT00548340|7243581|FG000|STARTED|Overall Study||109
6336389|NCT00548340|7243582|FG001|STARTED|Overall Study||109
6776332|NCT03815240|7704433|FG006|STARTED|Intervention Allevyn Dressing||1
6336390|NCT00548340|7243583|FG002|STARTED|Overall Study||104
6336391|NCT00548340|7243581|FG000|COMPLETED|Overall Study||101
6336392|NCT00548340|7243582|FG001|COMPLETED|Overall Study||98
6336393|NCT00548340|7243583|FG002|COMPLETED|Overall Study||95
6336394|NCT00548340|7243581|FG000|NOT COMPLETED|Overall Study||8
6336395|NCT00548340|7243582|FG001|NOT COMPLETED|Overall Study||11
6336396|NCT00548340|7243583|FG002|NOT COMPLETED|Overall Study||9
6336397|NCT00548405|7243594|FG000|STARTED|Overall Study|Randomized.|231
6336398|NCT00548405|7243595|FG001|STARTED|Overall Study|Randomized.|436
6336399|NCT00548405|7243596|FG002|STARTED|Overall Study|Randomized.|173
6336400|NCT00548405|7243594|FG000|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
6336401|NCT00548405|7243595|FG001|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
6336402|NCT00548405|7243596|FG002|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
6336403|NCT00548405|7243594|FG000|COMPLETED|Overall Study||175
6336404|NCT00548405|7243595|FG001|COMPLETED|Overall Study||416
6336405|NCT00548405|7243596|FG002|COMPLETED|Overall Study||164
6336406|NCT00548405|7243594|FG000|NOT COMPLETED|Overall Study||56
6336407|NCT00548405|7243595|FG001|NOT COMPLETED|Overall Study||20
6336408|NCT00548405|7243596|FG002|NOT COMPLETED|Overall Study||9
6336409|NCT00548418|7243605|FG000|STARTED|Overall Study||27
6336410|NCT00548418|7243605|FG000|COMPLETED|Overall Study||27
6336411|NCT00548418|7243605|FG000|NOT COMPLETED|Overall Study||0
6336412|NCT00548431|7243609|FG000|STARTED|Overall Study||38
6336413|NCT00548431|7243609|FG000|COMPLETED|Overall Study||38
6336414|NCT00548431|7243609|FG000|NOT COMPLETED|Overall Study||0
6336415|NCT00548470|7243613|FG000|STARTED|Overall Study||14
6336416|NCT00548470|7243613|FG000|COMPLETED|Overall Study||12
6336417|NCT00548470|7243613|FG000|NOT COMPLETED|Overall Study||2
6336418|NCT00548548|7243619|FG000|STARTED|Overall Study||387
6336419|NCT00548548|7243620|FG001|STARTED|Overall Study||387
6336420|NCT00548548|7243619|FG000|Treated|Overall Study||383
6336421|NCT00548548|7243620|FG001|Treated|Overall Study||384
6336422|NCT00548548|7243619|FG000|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
6336423|NCT00548548|7243620|FG001|Safety Population|Overall Study||381
6336424|NCT00548548|7243619|FG000|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
6336425|NCT00548548|7243620|FG001|COMPLETED|Overall Study||21
6336426|NCT00548548|7243619|FG000|NOT COMPLETED|Overall Study||362
6336427|NCT00548548|7243620|FG001|NOT COMPLETED|Overall Study||366
6336428|NCT00548652|7243629|FG000|STARTED|Overall Study||18
6336429|NCT00548652|7243630|FG001|STARTED|Overall Study||38
6336430|NCT00548652|7243631|FG002|STARTED|Overall Study||45
6336431|NCT00548652|7243629|FG000|COMPLETED|Overall Study||16
6336432|NCT00548652|7243630|FG001|COMPLETED|Overall Study||29
6336433|NCT00548652|7243631|FG002|COMPLETED|Overall Study||34
6336434|NCT00548652|7243629|FG000|NOT COMPLETED|Overall Study||2
6336435|NCT00548652|7243630|FG001|NOT COMPLETED|Overall Study||9
6336436|NCT00548652|7243631|FG002|NOT COMPLETED|Overall Study||11
6336437|NCT00548691|7243641|FG000|STARTED|Overall Study||258
6336438|NCT00548691|7243642|FG001|STARTED|Overall Study||259
6336439|NCT00548691|7243641|FG000|COMPLETED|Overall Study||251
6336440|NCT00548691|7243642|FG001|COMPLETED|Overall Study||250
6336441|NCT00548691|7243641|FG000|NOT COMPLETED|Overall Study||7
6336442|NCT00548691|7243642|FG001|NOT COMPLETED|Overall Study||9
6336443|NCT00548717|7243650|FG000|STARTED|Overall Study||13
6336444|NCT00548717|7243651|FG001|STARTED|Overall Study||2
6336445|NCT00548717|7243650|FG000|COMPLETED|Overall Study||4
6336446|NCT00548717|7243651|FG001|COMPLETED|Overall Study||0
6336447|NCT00548717|7243650|FG000|NOT COMPLETED|Overall Study||9
6336448|NCT00548717|7243651|FG001|NOT COMPLETED|Overall Study||2
6336449|NCT00548808|7243662|FG000|STARTED|Overall Study||214
6336450|NCT00548808|7243663|FG001|STARTED|Overall Study||212
6336451|NCT00548808|7243662|FG000|Full Analysis Set|Overall Study||211
6336452|NCT00548808|7243663|FG001|Full Analysis Set|Overall Study||212
6336453|NCT00548808|7243662|FG000|Per-Protocol Set|Overall Study||177
6336454|NCT00548808|7243663|FG001|Per-Protocol Set|Overall Study||184
6336455|NCT00548808|7243662|FG000|COMPLETED|Overall Study||172
6336456|NCT00548808|7243663|FG001|COMPLETED|Overall Study||186
6336457|NCT00548808|7243662|FG000|NOT COMPLETED|Overall Study||42
6336458|NCT00548808|7243663|FG001|NOT COMPLETED|Overall Study||26
6336459|NCT00548847|7243669|FG000|STARTED|Overall Study||15
6336460|NCT00548847|7243669|FG000|COMPLETED|Overall Study||8
6336461|NCT00548847|7243669|FG000|NOT COMPLETED|Overall Study||7
6336462|NCT00548860|7243675|FG000|STARTED|Overall Study||996
6336463|NCT00548860|7243676|FG001|STARTED|Overall Study||1022
6336464|NCT00548860|7243675|FG000|COMPLETED|Overall Study||860
6336465|NCT00548860|7243676|FG001|COMPLETED|Overall Study||847
6336466|NCT00548860|7243675|FG000|NOT COMPLETED|Overall Study||136
6336467|NCT00548860|7243676|FG001|NOT COMPLETED|Overall Study||175
6336468|NCT00549042|7243684|FG000|STARTED|Conversion and Titration Phase||459
6336469|NCT00549042|7243685|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
6336470|NCT00549042|7243684|FG000|COMPLETED|Conversion and Titration Phase||268
6336471|NCT00549042|7243685|FG001|COMPLETED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
6336472|NCT00549042|7243684|FG000|NOT COMPLETED|Conversion and Titration Phase||191
6336473|NCT00549042|7243685|FG001|NOT COMPLETED|Conversion and Titration Phase||0
6336474|NCT00549042|7243684|FG000|STARTED|Double-blind Phase||134
6336475|NCT00549042|7243685|FG001|STARTED|Double-blind Phase||134
6336476|NCT00549042|7243684|FG000|COMPLETED|Double-blind Phase||66
6336477|NCT00549042|7243685|FG001|COMPLETED|Double-blind Phase||44
6336478|NCT00549042|7243684|FG000|NOT COMPLETED|Double-blind Phase||68
6336479|NCT00549042|7243685|FG001|NOT COMPLETED|Double-blind Phase||90
6336480|NCT00549055|7243692|FG000|STARTED|Overall Study||38
6336481|NCT00549055|7243692|FG000|COMPLETED|Overall Study||3
6336482|NCT00549055|7243692|FG000|NOT COMPLETED|Overall Study||35
6336483|NCT00549172|7243698|FG000|STARTED|Overall Study||70
6336484|NCT00549172|7243699|FG001|STARTED|Overall Study||76
6336485|NCT00549172|7243698|FG000|COMPLETED|Overall Study||70
6336486|NCT00549172|7243699|FG001|COMPLETED|Overall Study||76
6336487|NCT00549172|7243698|FG000|NOT COMPLETED|Overall Study||0
6336488|NCT00549172|7243699|FG001|NOT COMPLETED|Overall Study||0
6336489|NCT00549198|7243707|FG000|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
6336490|NCT00549198|7243708|FG001|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
6336491|NCT00549198|7243707|FG000|COMPLETED|Overall Study||115
6336492|NCT00549198|7243708|FG001|COMPLETED|Overall Study||134
6336493|NCT00549198|7243707|FG000|NOT COMPLETED|Overall Study||80
6336494|NCT00549198|7243708|FG001|NOT COMPLETED|Overall Study||63
6336495|NCT00549302|7243716|FG000|STARTED|Double-Blind||63
6336496|NCT00549302|7243717|FG001|STARTED|Double-Blind||294
6336497|NCT00549302|7243718|FG002|STARTED|Double-Blind||0
6336498|NCT00549302|7243716|FG000|Received at Least One Dose of Study Drug|Double-Blind||63
6336499|NCT00549302|7243717|FG001|Received at Least One Dose of Study Drug|Double-Blind||294
6336500|NCT00549302|7243718|FG002|Received at Least One Dose of Study Drug|Double-Blind||0
6336501|NCT00549302|7243716|FG000|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
6336502|NCT00549302|7243717|FG001|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
6336503|NCT00549302|7243718|FG002|COMPLETED|Double-Blind||0
6336504|NCT00549302|7243716|FG000|NOT COMPLETED|Double-Blind||11
6336505|NCT00549302|7243717|FG001|NOT COMPLETED|Double-Blind||53
6336506|NCT00549302|7243718|FG002|NOT COMPLETED|Double-Blind||0
6336507|NCT00549302|7243716|FG000|STARTED|Open-Label||0
6336508|NCT00549302|7243717|FG001|STARTED|Open-Label||0
6336509|NCT00549302|7243718|FG002|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
6336510|NCT00549302|7243716|FG000|COMPLETED|Open-Label||0
6336511|NCT00549302|7243717|FG001|COMPLETED|Open-Label||0
6336512|NCT00549302|7243718|FG002|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
6336513|NCT00549302|7243716|FG000|NOT COMPLETED|Open-Label||0
6336514|NCT00549302|7243717|FG001|NOT COMPLETED|Open-Label||0
6336515|NCT00549302|7243718|FG002|NOT COMPLETED|Open-Label||69
6336516|NCT00549393|7243728|FG000|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
6336517|NCT00549393|7243729|FG001|STARTED|Period 1 (6 Months)|ITT|1199
6336518|NCT00549393|7243728|FG000|Per Protocol|Period 1 (6 Months)||880
6336519|NCT00549393|7243729|FG001|Per Protocol|Period 1 (6 Months)||1199
6336520|NCT00549393|7243728|FG000|COMPLETED|Period 1 (6 Months)||1319
6336521|NCT00549393|7243729|FG001|COMPLETED|Period 1 (6 Months)||1199
6336522|NCT00549393|7243728|FG000|NOT COMPLETED|Period 1 (6 Months)||0
6336523|NCT00549393|7243729|FG001|NOT COMPLETED|Period 1 (6 Months)||0
6336524|NCT00549393|7243728|FG000|STARTED|Period 2 Washout (2 Weeks)||0
6336525|NCT00549393|7243729|FG001|STARTED|Period 2 Washout (2 Weeks)||0
6336526|NCT00549393|7243728|FG000|COMPLETED|Period 2 Washout (2 Weeks)||0
6336527|NCT00549393|7243729|FG001|COMPLETED|Period 2 Washout (2 Weeks)||0
6336528|NCT00549393|7243728|FG000|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
6336529|NCT00549393|7243729|FG001|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
6336530|NCT00549393|7243728|FG000|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
6336531|NCT00549393|7243729|FG001|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
6336532|NCT00549393|7243728|FG000|Per Protocol|Period 3 (6 Months)||667
6336533|NCT00549393|7243729|FG001|Per Protocol|Period 3 (6 Months)||1326
6336534|NCT00549393|7243728|FG000|COMPLETED|Period 3 (6 Months)||1103
6336535|NCT00549393|7243729|FG001|COMPLETED|Period 3 (6 Months)||1326
6336536|NCT00549393|7243728|FG000|NOT COMPLETED|Period 3 (6 Months)||0
6336537|NCT00549393|7243729|FG001|NOT COMPLETED|Period 3 (6 Months)||0
6336538|NCT00549445|7243739|FG000|STARTED|Overall Study||23
6336539|NCT00549445|7243740|FG001|STARTED|Overall Study||30
6336540|NCT00549445|7243739|FG000|COMPLETED|Overall Study||8
6336541|NCT00549445|7243740|FG001|COMPLETED|Overall Study||13
6336542|NCT00549445|7243739|FG000|NOT COMPLETED|Overall Study||15
6336543|NCT00549445|7243740|FG001|NOT COMPLETED|Overall Study||17
6336544|NCT00549549|7243750|FG000|STARTED|Overall Study||101
6336545|NCT00549549|7243751|FG001|STARTED|Overall Study||99
6336546|NCT00549549|7243752|FG002|STARTED|Overall Study||99
6336547|NCT00549549|7243753|FG003|STARTED|Overall Study||103
6336548|NCT00549549|7243750|FG000|Treated|Overall Study||101
6336549|NCT00549549|7243751|FG001|Treated|Overall Study||99
6336550|NCT00549549|7243752|FG002|Treated|Overall Study||98
6336551|NCT00549549|7243753|FG003|Treated|Overall Study||102
6336552|NCT00549549|7243750|FG000|COMPLETED|Overall Study||77
6336553|NCT00549549|7243751|FG001|COMPLETED|Overall Study||77
6336554|NCT00549549|7243752|FG002|COMPLETED|Overall Study||82
6336555|NCT00549549|7243753|FG003|COMPLETED|Overall Study||78
6336556|NCT00549549|7243750|FG000|NOT COMPLETED|Overall Study||24
6336557|NCT00549549|7243751|FG001|NOT COMPLETED|Overall Study||22
6336558|NCT00549549|7243752|FG002|NOT COMPLETED|Overall Study||17
6336559|NCT00549549|7243753|FG003|NOT COMPLETED|Overall Study||25
6336560|NCT00549562|7243763|FG000|STARTED|Overall Study||25
6336561|NCT00549562|7243763|FG000|COMPLETED|Overall Study||23
6336562|NCT00549562|7243763|FG000|NOT COMPLETED|Overall Study||2
6336563|NCT00549601|7243770|FG000|STARTED|Randomized||43
6336564|NCT00549601|7243771|FG001|STARTED|Randomized||48
6336565|NCT00549601|7243772|FG002|STARTED|Randomized||51
6336566|NCT00549601|7243770|FG000|COMPLETED|Randomized||43
6336567|NCT00549601|7243771|FG001|COMPLETED|Randomized||47
6336568|NCT00549601|7243772|FG002|COMPLETED|Randomized||49
6336569|NCT00549601|7243770|FG000|NOT COMPLETED|Randomized||0
6336570|NCT00549601|7243771|FG001|NOT COMPLETED|Randomized||1
6336571|NCT00549601|7243772|FG002|NOT COMPLETED|Randomized||2
6336572|NCT00549601|7243770|FG000|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
6336573|NCT00549601|7243771|FG001|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
6336574|NCT00549601|7243772|FG002|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
6336575|NCT00549601|7243770|FG000|COMPLETED|Received Study Drug||36
6336576|NCT00549601|7243771|FG001|COMPLETED|Received Study Drug||36
6336577|NCT00549601|7243772|FG002|COMPLETED|Received Study Drug||45
6336578|NCT00549601|7243770|FG000|NOT COMPLETED|Received Study Drug||7
6336579|NCT00549601|7243771|FG001|NOT COMPLETED|Received Study Drug||11
6336580|NCT00549601|7243772|FG002|NOT COMPLETED|Received Study Drug||4
6336581|NCT00549640|7243784|FG000|STARTED|Overall Study||40
6336582|NCT00549640|7243785|FG001|STARTED|Overall Study||40
6336583|NCT00549640|7243784|FG000|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
6336584|NCT00549640|7243785|FG001|COMPLETED|Overall Study||24
6336585|NCT00549640|7243784|FG000|NOT COMPLETED|Overall Study||18
6336586|NCT00549640|7243785|FG001|NOT COMPLETED|Overall Study||16
6336587|NCT00549718|7243795|FG000|STARTED|Overall Study||125
6336588|NCT00549718|7243796|FG001|STARTED|Overall Study||123
6336589|NCT00549718|7243797|FG002|STARTED|Overall Study||124
6336590|NCT00549718|7243798|FG003|STARTED|Overall Study||128
6336591|NCT00549718|7243795|FG000|COMPLETED|Overall Study||84
6336592|NCT00549718|7243796|FG001|COMPLETED|Overall Study||86
6336593|NCT00549718|7243797|FG002|COMPLETED|Overall Study||85
6336594|NCT00549718|7243798|FG003|COMPLETED|Overall Study||73
6336595|NCT00549718|7243795|FG000|NOT COMPLETED|Overall Study||41
6336596|NCT00549718|7243796|FG001|NOT COMPLETED|Overall Study||37
6336597|NCT00549718|7243797|FG002|NOT COMPLETED|Overall Study||39
6336598|NCT00549718|7243798|FG003|NOT COMPLETED|Overall Study||55
6336599|NCT00549757|7243810|FG000|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
6336600|NCT00549757|7243811|FG001|STARTED|Active Treatment Phase: Max. 50 Months||4310
6336601|NCT00549757|7243810|FG000|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
6336602|NCT00549757|7243811|FG001|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
6336603|NCT00549757|7243810|FG000|Safety Set|Active Treatment Phase: Max. 50 Months||4272
6336604|NCT00549757|7243811|FG001|Safety Set|Active Treatment Phase: Max. 50 Months||4285
6336605|NCT00549757|7243810|FG000|COMPLETED|Active Treatment Phase: Max. 50 Months||0
6336606|NCT00549757|7243811|FG001|COMPLETED|Active Treatment Phase: Max. 50 Months||0
6336607|NCT00549757|7243810|FG000|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
6336608|NCT00549757|7243811|FG001|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
6336609|NCT00549757|7243810|FG000|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
6336610|NCT00549757|7243811|FG001|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
6336611|NCT00549757|7243810|FG000|COMPLETED|Extension Period (in Average 9 Months)||3148
6336612|NCT00549757|7243811|FG001|COMPLETED|Extension Period (in Average 9 Months)||3182
6336613|NCT00549757|7243810|FG000|NOT COMPLETED|Extension Period (in Average 9 Months)||625
6336614|NCT00549757|7243811|FG001|NOT COMPLETED|Extension Period (in Average 9 Months)||635
6336615|NCT00549770|7243831|FG000|STARTED|Overall Study||156
6336616|NCT00549770|7243832|FG001|STARTED|Overall Study||169
6336617|NCT00549770|7243833|FG002|STARTED|Overall Study||172
6336618|NCT00549770|7243834|FG003|STARTED|Overall Study||163
6336619|NCT00549770|7243835|FG004|STARTED|Overall Study||166
6336620|NCT00549770|7243836|FG005|STARTED|Overall Study||164
6558941|NCT01778127|7481561|FG000|NOT COMPLETED|Overall Study||8
6558942|NCT01778127|7481562|FG001|NOT COMPLETED|Overall Study||2
6558943|NCT01778127|7481563|FG002|NOT COMPLETED|Overall Study||6
6558944|NCT01778179|7481573|FG000|STARTED|Overall Study||25
6558945|NCT01778179|7481574|FG001|STARTED|Overall Study||25
6558946|NCT01778179|7481573|FG000|COMPLETED|Overall Study||23
6558947|NCT01778179|7481574|FG001|COMPLETED|Overall Study||22
6558948|NCT01778179|7481573|FG000|NOT COMPLETED|Overall Study||2
6558949|NCT01778179|7481574|FG001|NOT COMPLETED|Overall Study||3
6558950|NCT01778296|7481580|FG000|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
6336621|NCT00549770|7243837|FG006|STARTED|Overall Study||165
6336622|NCT00549770|7243838|FG007|STARTED|Overall Study||173
6336623|NCT00549770|7243831|FG000|Intent-to-treat Population|Overall Study||154
6336624|NCT00549770|7243832|FG001|Intent-to-treat Population|Overall Study||168
6336625|NCT00549770|7243833|FG002|Intent-to-treat Population|Overall Study||170
6336626|NCT00549770|7243834|FG003|Intent-to-treat Population|Overall Study||163
6336627|NCT00549770|7243835|FG004|Intent-to-treat Population|Overall Study||163
6336628|NCT00549770|7243836|FG005|Intent-to-treat Population|Overall Study||163
6336629|NCT00549770|7243837|FG006|Intent-to-treat Population|Overall Study||164
6336630|NCT00549770|7243838|FG007|Intent-to-treat Population|Overall Study||172
6336631|NCT00549770|7243831|FG000|Ambulatory Blood Pressure Monitoring|Overall Study||48
6336632|NCT00549770|7243832|FG001|Ambulatory Blood Pressure Monitoring|Overall Study||61
6336633|NCT00549770|7243833|FG002|Ambulatory Blood Pressure Monitoring|Overall Study||53
6336634|NCT00549770|7243834|FG003|Ambulatory Blood Pressure Monitoring|Overall Study||55
6336635|NCT00549770|7243835|FG004|Ambulatory Blood Pressure Monitoring|Overall Study||49
6336636|NCT00549770|7243836|FG005|Ambulatory Blood Pressure Monitoring|Overall Study||54
6336637|NCT00549770|7243837|FG006|Ambulatory Blood Pressure Monitoring|Overall Study||50
6336638|NCT00549770|7243838|FG007|Ambulatory Blood Pressure Monitoring|Overall Study||57
6336639|NCT00549770|7243831|FG000|COMPLETED|Overall Study||149
6336640|NCT00549770|7243832|FG001|COMPLETED|Overall Study||158
6336641|NCT00549770|7243833|FG002|COMPLETED|Overall Study||162
6336642|NCT00549770|7243834|FG003|COMPLETED|Overall Study||147
6336643|NCT00549770|7243835|FG004|COMPLETED|Overall Study||149
6336644|NCT00549770|7243836|FG005|COMPLETED|Overall Study||151
6336645|NCT00549770|7243837|FG006|COMPLETED|Overall Study||151
6336646|NCT00549770|7243838|FG007|COMPLETED|Overall Study||148
6336647|NCT00549770|7243831|FG000|NOT COMPLETED|Overall Study||7
6336648|NCT00549770|7243832|FG001|NOT COMPLETED|Overall Study||11
6336649|NCT00549770|7243833|FG002|NOT COMPLETED|Overall Study||10
6336650|NCT00549770|7243834|FG003|NOT COMPLETED|Overall Study||16
6336651|NCT00549770|7243835|FG004|NOT COMPLETED|Overall Study||17
6336652|NCT00549770|7243836|FG005|NOT COMPLETED|Overall Study||13
6336653|NCT00549770|7243837|FG006|NOT COMPLETED|Overall Study||14
6336654|NCT00549770|7243838|FG007|NOT COMPLETED|Overall Study||25
6336655|NCT00549783|7243858|FG000|STARTED|Overall Study||139
6336656|NCT00549783|7243859|FG001|STARTED|Overall Study||135
6336657|NCT00549783|7243858|FG000|COMPLETED|Overall Study||131
6336658|NCT00549783|7243859|FG001|COMPLETED|Overall Study||122
6336659|NCT00549783|7243858|FG000|NOT COMPLETED|Overall Study||8
6336660|NCT00549783|7243859|FG001|NOT COMPLETED|Overall Study||13
6336661|NCT00549822|7243865|FG000|STARTED|Overall Study||3
6558951|NCT01778296|7481580|FG000|COMPLETED|Overall Study|No patient was lost to follow-up.|12
6558952|NCT01778296|7481580|FG000|NOT COMPLETED|Overall Study||0
6336662|NCT00549822|7243865|FG000|COMPLETED|Overall Study||3
6336663|NCT00549822|7243865|FG000|NOT COMPLETED|Overall Study||0
6336664|NCT00549900|7243869|FG000|STARTED|Overall Study||30
6336665|NCT00549900|7243869|FG000|COMPLETED|Overall Study||29
6336666|NCT00549900|7243869|FG000|NOT COMPLETED|Overall Study||1
6336667|NCT00549939|7243876|FG000|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
6336668|NCT00549939|7243877|FG001|STARTED|12-week Double Blind Treatment Period||57
6336669|NCT00549939|7243878|FG002|STARTED|12-week Double Blind Treatment Period||58
6336670|NCT00549939|7243876|FG000|COMPLETED|12-week Double Blind Treatment Period||56
6336671|NCT00549939|7243877|FG001|COMPLETED|12-week Double Blind Treatment Period||55
6336672|NCT00549939|7243878|FG002|COMPLETED|12-week Double Blind Treatment Period||56
6336673|NCT00549939|7243876|FG000|NOT COMPLETED|12-week Double Blind Treatment Period||1
6336674|NCT00549939|7243877|FG001|NOT COMPLETED|12-week Double Blind Treatment Period||2
6336675|NCT00549939|7243878|FG002|NOT COMPLETED|12-week Double Blind Treatment Period||2
6336676|NCT00549939|7243876|FG000|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
6336677|NCT00549939|7243877|FG001|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
6336678|NCT00549939|7243878|FG002|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
6336679|NCT00549939|7243876|FG000|COMPLETED|40-week Open Label Treatment Period||0
6336680|NCT00549939|7243877|FG001|COMPLETED|40-week Open Label Treatment Period||75
6336681|NCT00549939|7243878|FG002|COMPLETED|40-week Open Label Treatment Period||78
6336682|NCT00549939|7243876|FG000|NOT COMPLETED|40-week Open Label Treatment Period||0
6336683|NCT00549939|7243877|FG001|NOT COMPLETED|40-week Open Label Treatment Period||5
6336684|NCT00549939|7243878|FG002|NOT COMPLETED|40-week Open Label Treatment Period||5
6336685|NCT00550043|7243893|FG000|STARTED|Overall Study||9
6336686|NCT00550043|7243894|FG001|STARTED|Overall Study||12
6336687|NCT00550043|7243895|FG002|STARTED|Overall Study||9
6336688|NCT00550043|7243896|FG003|STARTED|Overall Study||10
6336689|NCT00550043|7243897|FG004|STARTED|Overall Study||10
6336690|NCT00550043|7243893|FG000|COMPLETED|Overall Study||9
6336691|NCT00550043|7243894|FG001|COMPLETED|Overall Study||9
6336692|NCT00550043|7243895|FG002|COMPLETED|Overall Study||8
6336693|NCT00550043|7243896|FG003|COMPLETED|Overall Study||8
6336694|NCT00550043|7243897|FG004|COMPLETED|Overall Study||9
6336695|NCT00550043|7243893|FG000|NOT COMPLETED|Overall Study||0
6336696|NCT00550043|7243894|FG001|NOT COMPLETED|Overall Study||3
6336697|NCT00550043|7243895|FG002|NOT COMPLETED|Overall Study||1
6336698|NCT00550043|7243896|FG003|NOT COMPLETED|Overall Study||2
6336699|NCT00550043|7243897|FG004|NOT COMPLETED|Overall Study||1
6336700|NCT00550147|7243909|FG000|STARTED|OROS Methylphenidate Monotherapy||30
6336701|NCT00550147|7243909|FG000|COMPLETED|OROS Methylphenidate Monotherapy||24
6336702|NCT00550147|7243909|FG000|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
6558953|NCT01778426|7481586|FG000|STARTED|Overall Study - Full Analysis Set (FAS)||264
6336703|NCT00550147|7243909|FG000|STARTED|Quetiapine Addition Treatment Period||24
6336704|NCT00550147|7243909|FG000|COMPLETED|Quetiapine Addition Treatment Period||18
6336705|NCT00550147|7243909|FG000|NOT COMPLETED|Quetiapine Addition Treatment Period||6
6336706|NCT00550173|7243925|FG000|STARTED|Overall Study||81
6336707|NCT00550173|7243926|FG001|STARTED|Overall Study||82
6558954|NCT01778426|7481587|FG001|STARTED|Overall Study - Full Analysis Set (FAS)||138
6558955|NCT01778426|7481586|FG000|COMPLETED|Overall Study - Full Analysis Set (FAS)||208
6558956|NCT01778426|7481587|FG001|COMPLETED|Overall Study - Full Analysis Set (FAS)||113
6558957|NCT01778426|7481586|FG000|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||56
6558958|NCT01778426|7481587|FG001|NOT COMPLETED|Overall Study - Full Analysis Set (FAS)||25
6558959|NCT01778426|7481586|FG000|STARTED|Intention-To-Treat (ITT) - Completer||198
6336708|NCT00550173|7243927|FG002|STARTED|Overall Study||84
6558960|NCT01778426|7481587|FG001|STARTED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
6558961|NCT01778426|7481586|FG000|COMPLETED|Intention-To-Treat (ITT) - Completer||198
6558962|NCT01778426|7481587|FG001|COMPLETED|Intention-To-Treat (ITT) - Completer|Not applicable: ITT-completer contains only primo-implant subjects.|0
6336709|NCT00550173|7243925|FG000|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
6336710|NCT00550173|7243926|FG001|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
6336711|NCT00550173|7243927|FG002|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
6336712|NCT00550173|7243925|FG000|Not Discontinued at 18 Months|Overall Study||9
6336713|NCT00550173|7243926|FG001|Not Discontinued at 18 Months|Overall Study||19
6336714|NCT00550173|7243927|FG002|Not Discontinued at 18 Months|Overall Study||11
6336715|NCT00550173|7243925|FG000|COMPLETED|Overall Study||9
6336716|NCT00550173|7243926|FG001|COMPLETED|Overall Study||19
6336717|NCT00550173|7243927|FG002|COMPLETED|Overall Study||11
6336718|NCT00550173|7243925|FG000|NOT COMPLETED|Overall Study||72
6336719|NCT00550173|7243926|FG001|NOT COMPLETED|Overall Study||63
6336720|NCT00550173|7243927|FG002|NOT COMPLETED|Overall Study||73
6336721|NCT00550238|7243936|FG000|STARTED|Overall Study||459
6336722|NCT00550238|7243936|FG000|COMPLETED|Overall Study||0
6336723|NCT00550238|7243936|FG000|NOT COMPLETED|Overall Study||459
6336724|NCT00550277|7243940|FG000|STARTED|Overall Study||20
6336725|NCT00550277|7243940|FG000|COMPLETED|Overall Study||11
6336726|NCT00550277|7243940|FG000|NOT COMPLETED|Overall Study||9
6336727|NCT00550290|7243946|FG000|STARTED|Overall Study||10
6336728|NCT00550290|7243947|FG001|STARTED|Overall Study||8
6336729|NCT00550290|7243946|FG000|COMPLETED|Overall Study||10
6336730|NCT00550290|7243947|FG001|COMPLETED|Overall Study||8
6336731|NCT00550290|7243946|FG000|NOT COMPLETED|Overall Study||0
6336732|NCT00550290|7243947|FG001|NOT COMPLETED|Overall Study||0
6336733|NCT00550368|7243955|FG000|STARTED|Overall Study||26
6336734|NCT00550368|7243956|FG001|STARTED|Overall Study||19
6336735|NCT00550368|7243955|FG000|COMPLETED|Overall Study||26
6336736|NCT00550368|7243956|FG001|COMPLETED|Overall Study||19
6336737|NCT00550368|7243955|FG000|NOT COMPLETED|Overall Study||0
6336738|NCT00550368|7243956|FG001|NOT COMPLETED|Overall Study||0
6336739|NCT00550394|7243964|FG000|STARTED|Overall Study||21
6336740|NCT00550394|7243965|FG001|STARTED|Overall Study||18
6336741|NCT00550394|7243964|FG000|COMPLETED|Overall Study||9
6336742|NCT00550394|7243965|FG001|COMPLETED|Overall Study||5
6336743|NCT00550394|7243964|FG000|NOT COMPLETED|Overall Study||12
6336744|NCT00550394|7243965|FG001|NOT COMPLETED|Overall Study||13
6336745|NCT00550407|7243975|FG000|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
6336746|NCT00550407|7243976|FG001|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
6336747|NCT00550407|7243977|FG002|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
6336748|NCT00550407|7243975|FG000|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
6336749|NCT00550407|7243976|FG001|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
6558963|NCT01778426|7481586|FG000|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
6558964|NCT01778426|7481587|FG001|NOT COMPLETED|Intention-To-Treat (ITT) - Completer||0
6558965|NCT01778465|7481596|FG000|STARTED|First Intervention (7 Days)||3
6558966|NCT01778465|7481597|FG001|STARTED|First Intervention (7 Days)||4
6558967|NCT01778465|7481596|FG000|COMPLETED|First Intervention (7 Days)||3
6558968|NCT01778465|7481597|FG001|COMPLETED|First Intervention (7 Days)||4
6336750|NCT00550407|7243977|FG002|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
6336751|NCT00550407|7243975|FG000|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
6336752|NCT00550407|7243976|FG001|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
6336753|NCT00550407|7243977|FG002|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
6336754|NCT00550407|7243975|FG000|STARTED|26-Week Randomized Phase||0
6336755|NCT00550407|7243976|FG001|STARTED|26-Week Randomized Phase||58
6336756|NCT00550407|7243977|FG002|STARTED|26-Week Randomized Phase||45
6336757|NCT00550407|7243975|FG000|COMPLETED|26-Week Randomized Phase||0
6336758|NCT00550407|7243976|FG001|COMPLETED|26-Week Randomized Phase||15
6336759|NCT00550407|7243977|FG002|COMPLETED|26-Week Randomized Phase||21
6336760|NCT00550407|7243975|FG000|NOT COMPLETED|26-Week Randomized Phase||0
6336761|NCT00550407|7243976|FG001|NOT COMPLETED|26-Week Randomized Phase||43
6336762|NCT00550407|7243977|FG002|NOT COMPLETED|26-Week Randomized Phase||24
6336763|NCT00550420|7243985|FG000|STARTED|Overall Study||331
6336764|NCT00550420|7243985|FG000|COMPLETED|Overall Study||26
6336765|NCT00550420|7243985|FG000|NOT COMPLETED|Overall Study||305
6336766|NCT00550446|7243998|FG000|STARTED|Up To Week 12||54
6336767|NCT00550446|7243999|FG001|STARTED|Up To Week 12||52
6336768|NCT00550446|7244000|FG002|STARTED|Up To Week 12||50
6336769|NCT00550446|7244001|FG003|STARTED|Up To Week 12||61
6336770|NCT00550446|7244002|FG004|STARTED|Up To Week 12||57
6336771|NCT00550446|7244003|FG005|STARTED|Up To Week 12||53
6336772|NCT00550446|7244004|FG006|STARTED|Up To Week 12||59
6336773|NCT00550446|7244005|FG007|STARTED|Up To Week 12||0
6336774|NCT00550446|7244006|FG008|STARTED|Up To Week 12||0
6336775|NCT00550446|7244007|FG009|STARTED|Up To Week 12||0
6336776|NCT00550446|7244008|FG010|STARTED|Up To Week 12||0
6336777|NCT00550446|7243998|FG000|Treated|Up To Week 12||54
6336778|NCT00550446|7243999|FG001|Treated|Up To Week 12||51
6336779|NCT00550446|7244000|FG002|Treated|Up To Week 12||49
6336780|NCT00550446|7244001|FG003|Treated|Up To Week 12||61
6336781|NCT00550446|7244002|FG004|Treated|Up To Week 12||57
6336782|NCT00550446|7244003|FG005|Treated|Up To Week 12||53
6336783|NCT00550446|7244004|FG006|Treated|Up To Week 12||59
6336784|NCT00550446|7244005|FG007|Treated|Up To Week 12||0
6336785|NCT00550446|7244006|FG008|Treated|Up To Week 12||0
6336786|NCT00550446|7244007|FG009|Treated|Up To Week 12||0
6336787|NCT00550446|7244008|FG010|Treated|Up To Week 12||0
6336788|NCT00550446|7243998|FG000|COMPLETED|Up To Week 12||44
6336789|NCT00550446|7243999|FG001|COMPLETED|Up To Week 12||47
6336790|NCT00550446|7244000|FG002|COMPLETED|Up To Week 12||46
6336791|NCT00550446|7244001|FG003|COMPLETED|Up To Week 12||58
6336792|NCT00550446|7244002|FG004|COMPLETED|Up To Week 12||54
6336793|NCT00550446|7244003|FG005|COMPLETED|Up To Week 12||45
6336794|NCT00550446|7244004|FG006|COMPLETED|Up To Week 12||46
6336795|NCT00550446|7244005|FG007|COMPLETED|Up To Week 12||0
6336796|NCT00550446|7244006|FG008|COMPLETED|Up To Week 12||0
6336797|NCT00550446|7244007|FG009|COMPLETED|Up To Week 12||0
6336798|NCT00550446|7244008|FG010|COMPLETED|Up To Week 12||0
6336799|NCT00550446|7243998|FG000|NOT COMPLETED|Up To Week 12||10
6336800|NCT00550446|7243999|FG001|NOT COMPLETED|Up To Week 12||5
6336801|NCT00550446|7244000|FG002|NOT COMPLETED|Up To Week 12||4
6336802|NCT00550446|7244001|FG003|NOT COMPLETED|Up To Week 12||3
6336803|NCT00550446|7244002|FG004|NOT COMPLETED|Up To Week 12||3
6336804|NCT00550446|7244003|FG005|NOT COMPLETED|Up To Week 12||8
6336805|NCT00550446|7244004|FG006|NOT COMPLETED|Up To Week 12||13
6336806|NCT00550446|7244005|FG007|NOT COMPLETED|Up To Week 12||0
6336807|NCT00550446|7244006|FG008|NOT COMPLETED|Up To Week 12||0
6336808|NCT00550446|7244007|FG009|NOT COMPLETED|Up To Week 12||0
6336809|NCT00550446|7244008|FG010|NOT COMPLETED|Up To Week 12||0
6336810|NCT00550446|7243998|FG000|STARTED|Post Week 12||27
6336811|NCT00550446|7243999|FG001|STARTED|Post Week 12||30
6336812|NCT00550446|7244000|FG002|STARTED|Post Week 12||46
6336813|NCT00550446|7244001|FG003|STARTED|Post Week 12||58
6336814|NCT00550446|7244002|FG004|STARTED|Post Week 12||54
6336815|NCT00550446|7244003|FG005|STARTED|Post Week 12||1
6336816|NCT00550446|7244004|FG006|STARTED|Post Week 12||21
6336817|NCT00550446|7244005|FG007|STARTED|Post Week 12||17
6336818|NCT00550446|7244006|FG008|STARTED|Post Week 12||17
6336819|NCT00550446|7244007|FG009|STARTED|Post Week 12||44
6336820|NCT00550446|7244008|FG010|STARTED|Post Week 12||25
6336821|NCT00550446|7243998|FG000|COMPLETED|Post Week 12||24
6336822|NCT00550446|7243999|FG001|COMPLETED|Post Week 12||28
6336823|NCT00550446|7244000|FG002|COMPLETED|Post Week 12||43
6336824|NCT00550446|7244001|FG003|COMPLETED|Post Week 12||55
6336825|NCT00550446|7244002|FG004|COMPLETED|Post Week 12||52
6336826|NCT00550446|7244003|FG005|COMPLETED|Post Week 12||0
6336827|NCT00550446|7244004|FG006|COMPLETED|Post Week 12||19
6336828|NCT00550446|7244005|FG007|COMPLETED|Post Week 12||16
6336829|NCT00550446|7244006|FG008|COMPLETED|Post Week 12||15
6336830|NCT00550446|7244007|FG009|COMPLETED|Post Week 12||37
6336831|NCT00550446|7244008|FG010|COMPLETED|Post Week 12||24
6336832|NCT00550446|7243998|FG000|NOT COMPLETED|Post Week 12||3
6336833|NCT00550446|7243999|FG001|NOT COMPLETED|Post Week 12||2
6336834|NCT00550446|7244000|FG002|NOT COMPLETED|Post Week 12||3
6336835|NCT00550446|7244001|FG003|NOT COMPLETED|Post Week 12||3
6336836|NCT00550446|7244002|FG004|NOT COMPLETED|Post Week 12||2
6336837|NCT00550446|7244003|FG005|NOT COMPLETED|Post Week 12||1
6336838|NCT00550446|7244004|FG006|NOT COMPLETED|Post Week 12||2
6336839|NCT00550446|7244005|FG007|NOT COMPLETED|Post Week 12||1
6336840|NCT00550446|7244006|FG008|NOT COMPLETED|Post Week 12||2
6336841|NCT00550446|7244007|FG009|NOT COMPLETED|Post Week 12||7
6336842|NCT00550446|7244008|FG010|NOT COMPLETED|Post Week 12||1
6336843|NCT00550459|7244048|FG000|STARTED|Overall Study||28
6336844|NCT00550459|7244049|FG001|STARTED|Overall Study||29
6336845|NCT00550459|7244048|FG000|COMPLETED|Overall Study||27
6336846|NCT00550459|7244049|FG001|COMPLETED|Overall Study||26
6336847|NCT00550459|7244048|FG000|NOT COMPLETED|Overall Study||1
6336848|NCT00550459|7244049|FG001|NOT COMPLETED|Overall Study||3
6336849|NCT00550537|7244055|FG000|STARTED|Overall Study||116
6336850|NCT00550537|7244055|FG000|COMPLETED|Overall Study||12
6336851|NCT00550537|7244055|FG000|NOT COMPLETED|Overall Study||104
6498429|NCT01409837|7417007|FG000|138th Week|Overall Study||15
6498430|NCT01409837|7417008|FG001|138th Week|Overall Study||14
6498431|NCT01409837|7417007|FG000|186th Week|Overall Study|Moved away to another location|14
6498432|NCT01409837|7417008|FG001|186th Week|Overall Study||14
6498433|NCT01409837|7417007|FG000|282nd Week|Overall Study||14
6498434|NCT01409837|7417008|FG001|282nd Week|Overall Study||14
6336852|NCT00550550|7244066|FG000|STARTED|Overall Study||176
6336853|NCT00550550|7244067|FG001|STARTED|Overall Study||169
6336854|NCT00550550|7244066|FG000|Number Treated|Overall Study||175
6336855|NCT00550550|7244067|FG001|Number Treated|Overall Study||169
6336856|NCT00550550|7244066|FG000|COMPLETED|Overall Study||142
6336857|NCT00550550|7244067|FG001|COMPLETED|Overall Study||140
6336858|NCT00550550|7244066|FG000|NOT COMPLETED|Overall Study||34
6336859|NCT00550550|7244067|FG001|NOT COMPLETED|Overall Study||29
6336860|NCT00550589|7244073|FG000|STARTED|Overall Study||33
6336861|NCT00550589|7244073|FG000|COMPLETED|Overall Study||33
6336862|NCT00550589|7244073|FG000|NOT COMPLETED|Overall Study||0
6376212|NCT00758667|7286671|FG000|COMPLETED|Overall Study||9
6376213|NCT00758667|7286672|FG001|COMPLETED|Overall Study||11
6376214|NCT00758667|7286671|FG000|NOT COMPLETED|Overall Study||0
6376215|NCT00758667|7286672|FG001|NOT COMPLETED|Overall Study||0
6376216|NCT00758680|7286679|FG000|STARTED|Overall Study||6
6376217|NCT00758680|7286680|FG001|STARTED|Overall Study||6
6376218|NCT00758680|7286681|FG002|STARTED|Overall Study||6
6376219|NCT00758680|7286682|FG003|STARTED|Overall Study||6
6376220|NCT00758680|7286683|FG004|STARTED|Overall Study||6
6376221|NCT00758680|7286684|FG005|STARTED|Overall Study||6
6376222|NCT00758680|7286685|FG006|STARTED|Overall Study||7
6376223|NCT00758680|7286686|FG007|STARTED|Overall Study||20
6376224|NCT00758680|7286687|FG008|STARTED|Overall Study||20
6376225|NCT00758680|7286688|FG009|STARTED|Overall Study||29
6376226|NCT00758680|7286679|FG000|COMPLETED|Overall Study||6
6376227|NCT00758680|7286680|FG001|COMPLETED|Overall Study||6
6376228|NCT00758680|7286681|FG002|COMPLETED|Overall Study||6
6376229|NCT00758680|7286682|FG003|COMPLETED|Overall Study||6
6376230|NCT00758680|7286683|FG004|COMPLETED|Overall Study||6
6376231|NCT00758680|7286684|FG005|COMPLETED|Overall Study||6
6376232|NCT00758680|7286685|FG006|COMPLETED|Overall Study||6
6376233|NCT00758680|7286686|FG007|COMPLETED|Overall Study||19
6376234|NCT00758680|7286687|FG008|COMPLETED|Overall Study||18
6376235|NCT00758680|7286688|FG009|COMPLETED|Overall Study||28
6376236|NCT00758680|7286679|FG000|NOT COMPLETED|Overall Study||0
6376237|NCT00758680|7286680|FG001|NOT COMPLETED|Overall Study||0
6376238|NCT00758680|7286681|FG002|NOT COMPLETED|Overall Study||0
6376239|NCT00758680|7286682|FG003|NOT COMPLETED|Overall Study||0
6376240|NCT00758680|7286683|FG004|NOT COMPLETED|Overall Study||0
6376241|NCT00758680|7286684|FG005|NOT COMPLETED|Overall Study||0
6376242|NCT00758680|7286685|FG006|NOT COMPLETED|Overall Study||1
6376243|NCT00758680|7286686|FG007|NOT COMPLETED|Overall Study||1
6376244|NCT00758680|7286687|FG008|NOT COMPLETED|Overall Study||2
6376245|NCT00758680|7286688|FG009|NOT COMPLETED|Overall Study||1
6376246|NCT00758706|7286713|FG000|STARTED|Overall Study||26
6376247|NCT00758706|7286714|FG001|STARTED|Overall Study||29
6376248|NCT00758706|7286713|FG000|COMPLETED|Overall Study||22
6376249|NCT00758706|7286714|FG001|COMPLETED|Overall Study||25
6376250|NCT00758706|7286713|FG000|NOT COMPLETED|Overall Study||4
6376251|NCT00758706|7286714|FG001|NOT COMPLETED|Overall Study||4
6376252|NCT00758745|7286722|FG000|STARTED|Overall Study||81
6376253|NCT00758745|7286723|FG001|STARTED|Overall Study||81
6376254|NCT00758745|7286722|FG000|COMPLETED|Overall Study||60
6376255|NCT00758745|7286723|FG001|COMPLETED|Overall Study||60
6376256|NCT00758745|7286722|FG000|NOT COMPLETED|Overall Study||21
6376257|NCT00758745|7286723|FG001|NOT COMPLETED|Overall Study||21
6376258|NCT00758758|7286737|FG000|STARTED|Overall Study||14
6376259|NCT00758758|7286738|FG001|STARTED|Overall Study||74
6376260|NCT00758758|7286739|FG002|STARTED|Overall Study||53
6376261|NCT00758758|7286740|FG003|STARTED|Overall Study||6
6376262|NCT00758758|7286741|FG004|STARTED|Overall Study||3
6376263|NCT00758758|7286742|FG005|STARTED|Overall Study||50
6376264|NCT00758758|7286743|FG006|STARTED|Overall Study||31
6376265|NCT00758758|7286744|FG007|STARTED|Overall Study||0
6376266|NCT00758758|7286737|FG000|COMPLETED|Overall Study||11
6376267|NCT00758758|7286738|FG001|COMPLETED|Overall Study||49
6376268|NCT00758758|7286739|FG002|COMPLETED|Overall Study||35
6376269|NCT00758758|7286740|FG003|COMPLETED|Overall Study||4
6376270|NCT00758758|7286741|FG004|COMPLETED|Overall Study||1
6376271|NCT00758758|7286742|FG005|COMPLETED|Overall Study||36
6376272|NCT00758758|7286743|FG006|COMPLETED|Overall Study||17
6376273|NCT00758758|7286744|FG007|COMPLETED|Overall Study||0
6376274|NCT00758758|7286737|FG000|NOT COMPLETED|Overall Study||3
6376275|NCT00758758|7286738|FG001|NOT COMPLETED|Overall Study||25
6376276|NCT00758758|7286739|FG002|NOT COMPLETED|Overall Study||18
6376277|NCT00758758|7286740|FG003|NOT COMPLETED|Overall Study||2
6376278|NCT00758758|7286741|FG004|NOT COMPLETED|Overall Study||2
6376279|NCT00758758|7286742|FG005|NOT COMPLETED|Overall Study||14
6376280|NCT00758758|7286743|FG006|NOT COMPLETED|Overall Study||14
6376281|NCT00758758|7286744|FG007|NOT COMPLETED|Overall Study||0
6376282|NCT00758771|7286772|FG000|STARTED|Overall Study||18
6376283|NCT00758771|7286773|FG001|STARTED|Overall Study||20
6376284|NCT00758771|7286772|FG000|COMPLETED|Overall Study||15
6376285|NCT00758771|7286773|FG001|COMPLETED|Overall Study||15
6376286|NCT00758771|7286772|FG000|NOT COMPLETED|Overall Study||3
6376287|NCT00758771|7286773|FG001|NOT COMPLETED|Overall Study||5
6376288|NCT00758784|7286779|FG000|STARTED|Overall Study||38
6376289|NCT00758784|7286779|FG000|COMPLETED|Overall Study||36
6376290|NCT00758784|7286779|FG000|NOT COMPLETED|Overall Study||2
6376291|NCT00758836|7286787|FG000|STARTED|Overall Study||171
6376292|NCT00758836|7286788|FG001|STARTED|Overall Study||171
6376293|NCT00758836|7286789|FG002|STARTED|Overall Study||171
6376294|NCT00758836|7286790|FG003|STARTED|Overall Study||170
6376295|NCT00758836|7286787|FG000|Treated|Overall Study||147
6376296|NCT00758836|7286788|FG001|Treated|Overall Study||145
6376297|NCT00758836|7286789|FG002|Treated|Overall Study||133
6376298|NCT00758836|7286790|FG003|Treated|Overall Study||138
6336863|NCT00550615|7244081|FG000|STARTED|Overall Study||3
6336864|NCT00550615|7244082|FG001|STARTED|Overall Study||3
6336865|NCT00550615|7244083|FG002|STARTED|Overall Study||10
6336866|NCT00550615|7244084|FG003|STARTED|Overall Study||22
6336867|NCT00550615|7244081|FG000|COMPLETED|Overall Study||3
6336868|NCT00550615|7244082|FG001|COMPLETED|Overall Study||3
6336869|NCT00550615|7244083|FG002|COMPLETED|Overall Study||6
6336870|NCT00550615|7244084|FG003|COMPLETED|Overall Study||12
6336871|NCT00550615|7244081|FG000|NOT COMPLETED|Overall Study||0
6336872|NCT00550615|7244082|FG001|NOT COMPLETED|Overall Study||0
6336873|NCT00550615|7244083|FG002|NOT COMPLETED|Overall Study||4
6336874|NCT00550615|7244084|FG003|NOT COMPLETED|Overall Study||10
6336875|NCT00550654|7244090|FG000|STARTED|Overall Study||1
6336876|NCT00550654|7244090|FG000|COMPLETED|Overall Study||1
6336877|NCT00550654|7244090|FG000|NOT COMPLETED|Overall Study||0
6336878|NCT00550680|7244094|FG000|STARTED|Overall Study||208
6336879|NCT00550680|7244094|FG000|COMPLETED|Overall Study||152
6336880|NCT00550680|7244094|FG000|NOT COMPLETED|Overall Study||56
6336881|NCT00550732|7244098|FG000|STARTED|Overall Study||40
6336882|NCT00550732|7244098|FG000|COMPLETED|Overall Study||29
6336883|NCT00550732|7244098|FG000|NOT COMPLETED|Overall Study||11
6336884|NCT00550745|7244105|FG000|STARTED|Overall Study||6000
6336885|NCT00550745|7244106|FG001|STARTED|Overall Study||5999
6336886|NCT00550745|7244105|FG000|COMPLETED|Overall Study||5913
6336887|NCT00550745|7244106|FG001|COMPLETED|Overall Study||5939
6336888|NCT00550745|7244105|FG000|NOT COMPLETED|Overall Study||87
6336889|NCT00550745|7244106|FG001|NOT COMPLETED|Overall Study||60
6336890|NCT00550771|7244114|FG000|STARTED|Overall Study||121
6336891|NCT00550771|7244115|FG001|STARTED|Overall Study||60
6336892|NCT00550771|7244114|FG000|COMPLETED|Overall Study||104
6336893|NCT00550771|7244115|FG001|COMPLETED|Overall Study||50
6336894|NCT00550771|7244114|FG000|NOT COMPLETED|Overall Study||17
6336895|NCT00550771|7244115|FG001|NOT COMPLETED|Overall Study||10
6336896|NCT00550836|7244123|FG000|STARTED|Overall Study||49
6336897|NCT00550836|7244124|FG001|STARTED|Overall Study||55
6336898|NCT00550836|7244123|FG000|COMPLETED|Overall Study||46
6336899|NCT00550836|7244124|FG001|COMPLETED|Overall Study||46
6336900|NCT00550836|7244123|FG000|NOT COMPLETED|Overall Study||3
6336901|NCT00550836|7244124|FG001|NOT COMPLETED|Overall Study||9
6336902|NCT00550862|7244134|FG000|STARTED|Overall Study||38
6336903|NCT00550862|7244135|FG001|STARTED|Overall Study||48
6336904|NCT00550862|7244136|FG002|STARTED|Overall Study||41
6336905|NCT00550862|7244137|FG003|STARTED|Overall Study||38
6336906|NCT00550862|7244134|FG000|COMPLETED|Overall Study||32
6336907|NCT00550862|7244135|FG001|COMPLETED|Overall Study||42
6336908|NCT00550862|7244136|FG002|COMPLETED|Overall Study||25
6336909|NCT00550862|7244137|FG003|COMPLETED|Overall Study||37
6336910|NCT00550862|7244134|FG000|NOT COMPLETED|Overall Study||6
6336911|NCT00550862|7244135|FG001|NOT COMPLETED|Overall Study||6
6336912|NCT00550862|7244136|FG002|NOT COMPLETED|Overall Study||16
6336913|NCT00550862|7244137|FG003|NOT COMPLETED|Overall Study||1
6336914|NCT00550953|7244149|FG000|STARTED|Overall Study||156
6336915|NCT00550953|7244150|FG001|STARTED|Overall Study||158
6336916|NCT00550953|7244149|FG000|COMPLETED|Overall Study||150
6336917|NCT00550953|7244150|FG001|COMPLETED|Overall Study||152
6336918|NCT00550953|7244149|FG000|NOT COMPLETED|Overall Study||6
6336919|NCT00550953|7244150|FG001|NOT COMPLETED|Overall Study||6
6336920|NCT00551031|7244161|FG000|STARTED|Overall Study||637
6336921|NCT00551031|7244162|FG001|STARTED|Overall Study||636
6336922|NCT00551031|7244163|FG002|STARTED|Overall Study||319
6336923|NCT00551031|7244164|FG003|STARTED|Overall Study||320
6336924|NCT00551031|7244165|FG004|STARTED|Overall Study||186
6336925|NCT00551031|7244161|FG000|COMPLETED|Overall Study||635
6336926|NCT00551031|7244162|FG001|COMPLETED|Overall Study||625
6336927|NCT00551031|7244163|FG002|COMPLETED|Overall Study||317
6336928|NCT00551031|7244164|FG003|COMPLETED|Overall Study||317
6336929|NCT00551031|7244165|FG004|COMPLETED|Overall Study||185
6336930|NCT00551031|7244161|FG000|NOT COMPLETED|Overall Study||2
6336931|NCT00551031|7244162|FG001|NOT COMPLETED|Overall Study||11
6336932|NCT00551031|7244163|FG002|NOT COMPLETED|Overall Study||2
6336933|NCT00551031|7244164|FG003|NOT COMPLETED|Overall Study||3
6336934|NCT00551031|7244165|FG004|NOT COMPLETED|Overall Study||1
6336935|NCT00551070|7244177|FG000|STARTED|Overall Study||52
6336936|NCT00551070|7244177|FG000|COMPLETED|Overall Study||52
6336937|NCT00551070|7244177|FG000|NOT COMPLETED|Overall Study||0
6336938|NCT00551135|7244185|FG000|STARTED|Overall Study||108
6336939|NCT00551135|7244186|FG001|STARTED|Overall Study||106
6336940|NCT00551135|7244187|FG002|STARTED|Overall Study||103
6336941|NCT00551135|7244188|FG003|STARTED|Overall Study||108
6336942|NCT00551135|7244185|FG000|COMPLETED|Overall Study||103
6336943|NCT00551135|7244186|FG001|COMPLETED|Overall Study||104
6336944|NCT00551135|7244187|FG002|COMPLETED|Overall Study||98
6336945|NCT00551135|7244188|FG003|COMPLETED|Overall Study||103
6336946|NCT00551135|7244185|FG000|NOT COMPLETED|Overall Study||5
6336947|NCT00551135|7244186|FG001|NOT COMPLETED|Overall Study||2
6336948|NCT00551135|7244187|FG002|NOT COMPLETED|Overall Study||5
6336949|NCT00551135|7244188|FG003|NOT COMPLETED|Overall Study||5
6336950|NCT00551161|7244198|FG000|STARTED|Overall Study||12
6336951|NCT00551161|7244198|FG000|COMPLETED|Overall Study||11
6336952|NCT00551161|7244198|FG000|NOT COMPLETED|Overall Study||1
6336953|NCT00551174|7244204|FG000|STARTED|Overall Study||381
6336954|NCT00551174|7244205|FG001|STARTED|Overall Study||400
6336955|NCT00551174|7244204|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
6336956|NCT00551174|7244205|FG001|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
6336957|NCT00551174|7244204|FG000|NOT COMPLETED|Overall Study||19
6336958|NCT00551174|7244205|FG001|NOT COMPLETED|Overall Study||6
6336959|NCT00551200|7244211|FG000|STARTED|Overall Study||14
6336960|NCT00551200|7244211|FG000|COMPLETED|Overall Study||10
6336961|NCT00551200|7244211|FG000|NOT COMPLETED|Overall Study||4
6336962|NCT00551213|7244223|FG000|STARTED|Overall Study||50
6336963|NCT00551213|7244224|FG001|STARTED|Overall Study||17
6336964|NCT00551213|7244223|FG000|Treated|Overall Study||49
6336965|NCT00551213|7244224|FG001|Treated|Overall Study||15
6336966|NCT00551213|7244223|FG000|COMPLETED|Overall Study||0
6336967|NCT00551213|7244224|FG001|COMPLETED|Overall Study||0
6336968|NCT00551213|7244223|FG000|NOT COMPLETED|Overall Study||50
6336969|NCT00551213|7244224|FG001|NOT COMPLETED|Overall Study||17
6336970|NCT00551291|7244230|FG000|STARTED|Overall Study||10
6336971|NCT00551291|7244230|FG000|COMPLETED|Overall Study||9
6336972|NCT00551291|7244230|FG000|NOT COMPLETED|Overall Study||1
6336973|NCT00551369|7244234|FG000|STARTED|Overall Study||33
6336974|NCT00551369|7244234|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
6336975|NCT00551369|7244234|FG000|NOT COMPLETED|Overall Study||7
6336976|NCT00551421|7244238|FG000|STARTED|Original Protocol, Dose Level 1||3
6336977|NCT00551421|7244238|FG000|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
6336978|NCT00551421|7244238|FG000|NOT COMPLETED|Original Protocol, Dose Level 1||0
6336979|NCT00551421|7244238|FG000|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
6336980|NCT00551421|7244238|FG000|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
6336981|NCT00551421|7244238|FG000|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
6336982|NCT00551460|7244243|FG000|STARTED|Overall Study||78
6336983|NCT00551460|7244243|FG000|COMPLETED|Overall Study||60
6336984|NCT00551460|7244243|FG000|NOT COMPLETED|Overall Study||18
6336985|NCT00551525|7244247|FG000|STARTED|Overall Study||67
6336986|NCT00551525|7244247|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
6336987|NCT00551525|7244247|FG000|NOT COMPLETED|Overall Study||5
6336988|NCT00551642|7244253|FG000|STARTED|Treatment Period||399
6336989|NCT00551642|7244254|FG001|STARTED|Treatment Period||401
6336990|NCT00551642|7244253|FG000|Safety Population|Treatment Period||395
6336991|NCT00551642|7244254|FG001|Safety Population|Treatment Period||397
6336992|NCT00551642|7244253|FG000|COMPLETED|Treatment Period||338
6336993|NCT00551642|7244254|FG001|COMPLETED|Treatment Period||338
6336994|NCT00551642|7244253|FG000|NOT COMPLETED|Treatment Period||61
6336995|NCT00551642|7244254|FG001|NOT COMPLETED|Treatment Period||63
6336996|NCT00551642|7244253|FG000|STARTED|7-Year Follow-up||152
6336997|NCT00551642|7244254|FG001|STARTED|7-Year Follow-up||153
6336998|NCT00551642|7244253|FG000|COMPLETED|7-Year Follow-up||152
6336999|NCT00551642|7244254|FG001|COMPLETED|7-Year Follow-up||153
6337000|NCT00551642|7244253|FG000|NOT COMPLETED|7-Year Follow-up||0
6337001|NCT00551642|7244254|FG001|NOT COMPLETED|7-Year Follow-up||0
6337002|NCT00551707|7244265|FG000|STARTED|Overall Study||4
6337003|NCT00551707|7244266|FG001|STARTED|Overall Study||22
6337004|NCT00551707|7244267|FG002|STARTED|Overall Study||13
6337005|NCT00551707|7244268|FG003|STARTED|Overall Study||8
6337006|NCT00551707|7244269|FG004|STARTED|Overall Study||4
6337007|NCT00551707|7244265|FG000|COMPLETED|Overall Study||4
6337008|NCT00551707|7244266|FG001|COMPLETED|Overall Study||16
6337009|NCT00551707|7244267|FG002|COMPLETED|Overall Study||10
6337010|NCT00551707|7244268|FG003|COMPLETED|Overall Study||4
6337011|NCT00551707|7244269|FG004|COMPLETED|Overall Study||3
6337012|NCT00551707|7244265|FG000|NOT COMPLETED|Overall Study||0
6337013|NCT00551707|7244266|FG001|NOT COMPLETED|Overall Study||6
6337014|NCT00551707|7244267|FG002|NOT COMPLETED|Overall Study||3
6337015|NCT00551707|7244268|FG003|NOT COMPLETED|Overall Study||4
6337016|NCT00551707|7244269|FG004|NOT COMPLETED|Overall Study||1
6337017|NCT00551746|7244285|FG000|STARTED|Overall Study||36
6337018|NCT00551746|7244286|FG001|STARTED|Overall Study||34
6337019|NCT00551746|7244285|FG000|COMPLETED|Overall Study||25
6337020|NCT00551746|7244286|FG001|COMPLETED|Overall Study||26
6337021|NCT00551746|7244285|FG000|NOT COMPLETED|Overall Study||11
6337022|NCT00551746|7244286|FG001|NOT COMPLETED|Overall Study||8
6337023|NCT00551759|7244292|FG000|STARTED|Overall Study||22
6337024|NCT00551759|7244292|FG000|Eligible and Began Treatment|Overall Study||21
6337025|NCT00551759|7244292|FG000|Underwent Surgery|Overall Study||17
6337026|NCT00551759|7244292|FG000|Received Adjuvant Therapy|Overall Study||12
6337027|NCT00551759|7244292|FG000|COMPLETED|Overall Study||9
6337028|NCT00551759|7244292|FG000|NOT COMPLETED|Overall Study||13
6337029|NCT00552058|7244298|FG000|STARTED|Overall Study||223
6337030|NCT00552058|7244299|FG001|STARTED|Overall Study||216
6337031|NCT00552058|7244298|FG000|COMPLETED|Overall Study||207
6337032|NCT00552058|7244299|FG001|COMPLETED|Overall Study||192
6337033|NCT00552058|7244298|FG000|NOT COMPLETED|Overall Study||16
6337034|NCT00552058|7244299|FG001|NOT COMPLETED|Overall Study||24
6337035|NCT00552071|7244307|FG000|STARTED|Overall Study||10
6337036|NCT00552071|7244308|FG001|STARTED|Overall Study||11
6337037|NCT00552071|7244307|FG000|COMPLETED|Overall Study||6
6337038|NCT00552071|7244308|FG001|COMPLETED|Overall Study||9
6337039|NCT00552071|7244307|FG000|NOT COMPLETED|Overall Study||4
6337040|NCT00552071|7244308|FG001|NOT COMPLETED|Overall Study||2
6337041|NCT00552084|7244318|FG000|STARTED|Overall Study||126
6337042|NCT00552084|7244319|FG001|STARTED|Overall Study||64
6337043|NCT00552084|7244318|FG000|COMPLETED|Overall Study||118
6337044|NCT00552084|7244319|FG001|COMPLETED|Overall Study||55
6337045|NCT00552084|7244318|FG000|NOT COMPLETED|Overall Study||8
6337046|NCT00552084|7244319|FG001|NOT COMPLETED|Overall Study||9
6337047|NCT00552110|7244330|FG000|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
6337048|NCT00552110|7244331|FG001|STARTED|Overall Study||139
6337049|NCT00552110|7244332|FG002|STARTED|Overall Study||139
6337050|NCT00552110|7244333|FG003|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
6337051|NCT00552110|7244334|FG004|STARTED|Overall Study||142
6337052|NCT00552110|7244330|FG000|COMPLETED|Overall Study||142
6337053|NCT00552110|7244331|FG001|COMPLETED|Overall Study||134
6337054|NCT00552110|7244332|FG002|COMPLETED|Overall Study||137
6337055|NCT00552110|7244333|FG003|COMPLETED|Overall Study||133
6337056|NCT00552110|7244334|FG004|COMPLETED|Overall Study||133
6337057|NCT00552110|7244330|FG000|NOT COMPLETED|Overall Study||4
6337058|NCT00552110|7244331|FG001|NOT COMPLETED|Overall Study||5
6337059|NCT00552110|7244332|FG002|NOT COMPLETED|Overall Study||2
6337060|NCT00552110|7244333|FG003|NOT COMPLETED|Overall Study||8
6337061|NCT00552110|7244334|FG004|NOT COMPLETED|Overall Study||9
6337062|NCT00552175|7244349|FG000|STARTED|Overall Study||167
6337063|NCT00552175|7244350|FG001|STARTED|Overall Study||86
6337064|NCT00552175|7244351|FG002|STARTED|Overall Study||86
6337065|NCT00552175|7244349|FG000|Full Analysis Set Population|Overall Study||167
6337066|NCT00552175|7244350|FG001|Full Analysis Set Population|Overall Study||85
6337067|NCT00552175|7244351|FG002|Full Analysis Set Population|Overall Study||86
6337068|NCT00552175|7244349|FG000|COMPLETED|Overall Study||150
6337069|NCT00552175|7244350|FG001|COMPLETED|Overall Study||73
6337070|NCT00552175|7244351|FG002|COMPLETED|Overall Study||72
6337071|NCT00552175|7244349|FG000|NOT COMPLETED|Overall Study||17
6337072|NCT00552175|7244350|FG001|NOT COMPLETED|Overall Study||13
6337073|NCT00552175|7244351|FG002|NOT COMPLETED|Overall Study||14
6337074|NCT00552188|7244362|FG000|STARTED|Overall Study||26
6337075|NCT00552188|7244363|FG001|STARTED|Overall Study||26
6337076|NCT00552188|7244362|FG000|COMPLETED|Overall Study||24
6337077|NCT00552188|7244363|FG001|COMPLETED|Overall Study||21
6337078|NCT00552188|7244362|FG000|NOT COMPLETED|Overall Study||2
6337079|NCT00552188|7244363|FG001|NOT COMPLETED|Overall Study||5
6337080|NCT00552240|7244371|FG000|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
6337081|NCT00552240|7244372|FG001|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
6337082|NCT00552240|7244371|FG000|COMPLETED|Overall Study||51
6337083|NCT00552240|7244372|FG001|COMPLETED|Overall Study||59
6337084|NCT00552240|7244371|FG000|NOT COMPLETED|Overall Study||24
6337085|NCT00552240|7244372|FG001|NOT COMPLETED|Overall Study||18
6337086|NCT00552279|7244380|FG000|STARTED|Overall Study||403
6337087|NCT00552279|7244381|FG001|STARTED|Overall Study||401
6337088|NCT00552279|7244380|FG000|COMPLETED|Overall Study||389
6337089|NCT00552279|7244381|FG001|COMPLETED|Overall Study||398
6337090|NCT00552279|7244380|FG000|NOT COMPLETED|Overall Study||14
6337091|NCT00552279|7244381|FG001|NOT COMPLETED|Overall Study||3
6337092|NCT00552305|7244387|FG000|STARTED|Overall Study||370
6337093|NCT00552305|7244387|FG000|COMPLETED|Overall Study||120
6337094|NCT00552305|7244387|FG000|NOT COMPLETED|Overall Study||250
6337095|NCT00552344|7244391|FG000|STARTED|Overall Study||402
6337096|NCT00552344|7244391|FG000|COMPLETED|Overall Study||87
6337097|NCT00552344|7244391|FG000|NOT COMPLETED|Overall Study||315
6337098|NCT00552396|7244403|FG000|STARTED|Overall Study||4
6337099|NCT00552396|7244404|FG001|STARTED|Overall Study||3
6337100|NCT00552396|7244405|FG002|STARTED|Overall Study||3
6337101|NCT00552396|7244406|FG003|STARTED|Overall Study||6
6337102|NCT00552396|7244407|FG004|STARTED|Overall Study||3
6337103|NCT00552396|7244408|FG005|STARTED|Overall Study||3
6337104|NCT00552396|7244409|FG006|STARTED|Overall Study||10
6337105|NCT00552396|7244403|FG000|COMPLETED|Overall Study||1
6337106|NCT00552396|7244404|FG001|COMPLETED|Overall Study||0
6337107|NCT00552396|7244405|FG002|COMPLETED|Overall Study||0
6337108|NCT00552396|7244406|FG003|COMPLETED|Overall Study||0
6337109|NCT00552396|7244407|FG004|COMPLETED|Overall Study||0
6337110|NCT00552396|7244408|FG005|COMPLETED|Overall Study||0
6337111|NCT00552396|7244409|FG006|COMPLETED|Overall Study||1
6337112|NCT00552396|7244403|FG000|NOT COMPLETED|Overall Study||3
6337113|NCT00552396|7244404|FG001|NOT COMPLETED|Overall Study||3
6337114|NCT00552396|7244405|FG002|NOT COMPLETED|Overall Study||3
6337115|NCT00552396|7244406|FG003|NOT COMPLETED|Overall Study||6
6337116|NCT00552396|7244407|FG004|NOT COMPLETED|Overall Study||3
6337117|NCT00552396|7244408|FG005|NOT COMPLETED|Overall Study||3
6337118|NCT00552396|7244409|FG006|NOT COMPLETED|Overall Study||9
6337119|NCT00552409|7244445|FG000|STARTED|Overall Study||11
6337120|NCT00552409|7244446|FG001|STARTED|Overall Study||11
6337121|NCT00552409|7244445|FG000|COMPLETED|Overall Study||10
6337122|NCT00552409|7244446|FG001|COMPLETED|Overall Study||9
6337123|NCT00552409|7244445|FG000|NOT COMPLETED|Overall Study||1
6337124|NCT00552409|7244446|FG001|NOT COMPLETED|Overall Study||2
6337125|NCT00552422|7244452|FG000|STARTED|Overall Study||6
6337126|NCT00552422|7244452|FG000|COMPLETED|Overall Study||6
6337127|NCT00552422|7244452|FG000|NOT COMPLETED|Overall Study||0
6337128|NCT00552448|7244458|FG000|STARTED|Overall Study||20
6337129|NCT00552448|7244459|FG001|STARTED|Overall Study||16
6337130|NCT00552448|7244458|FG000|COMPLETED|Overall Study||19
6337131|NCT00552448|7244459|FG001|COMPLETED|Overall Study||16
6337132|NCT00552448|7244458|FG000|NOT COMPLETED|Overall Study||1
6337133|NCT00552448|7244459|FG001|NOT COMPLETED|Overall Study||0
6337134|NCT00552578|7244467|FG000|STARTED|Overall Study||6
6337135|NCT00552578|7244468|FG001|STARTED|Overall Study||6
6337136|NCT00552578|7244467|FG000|COMPLETED|Overall Study||5
6337137|NCT00552578|7244468|FG001|COMPLETED|Overall Study||5
6337138|NCT00552578|7244467|FG000|NOT COMPLETED|Overall Study||1
6337139|NCT00552578|7244468|FG001|NOT COMPLETED|Overall Study||1
6337140|NCT00552617|7244484|FG000|STARTED|Overall Study||10
6337141|NCT00552617|7244485|FG001|STARTED|Overall Study||10
6337142|NCT00552617|7244486|FG002|STARTED|Overall Study||10
6337143|NCT00552617|7244487|FG003|STARTED|Overall Study||10
6337144|NCT00552617|7244488|FG004|STARTED|Overall Study||10
6337145|NCT00552617|7244489|FG005|STARTED|Overall Study||10
6337146|NCT00552617|7244490|FG006|STARTED|Overall Study||10
6337147|NCT00552617|7244491|FG007|STARTED|Overall Study||10
6337148|NCT00552617|7244492|FG008|STARTED|Overall Study||10
6337149|NCT00552617|7244493|FG009|STARTED|Overall Study||10
6337150|NCT00552617|7244484|FG000|Treated|Overall Study||10
6337151|NCT00552617|7244485|FG001|Treated|Overall Study||10
6337152|NCT00552617|7244486|FG002|Treated|Overall Study||9
6337153|NCT00552617|7244487|FG003|Treated|Overall Study||10
6337154|NCT00552617|7244488|FG004|Treated|Overall Study||10
6337155|NCT00552617|7244489|FG005|Treated|Overall Study||10
6337156|NCT00552617|7244490|FG006|Treated|Overall Study||10
6337157|NCT00552617|7244491|FG007|Treated|Overall Study||10
6337158|NCT00552617|7244492|FG008|Treated|Overall Study||10
6337159|NCT00552617|7244493|FG009|Treated|Overall Study||9
6337160|NCT00552617|7244484|FG000|COMPLETED|Overall Study||10
6337161|NCT00552617|7244485|FG001|COMPLETED|Overall Study||10
6337162|NCT00552617|7244486|FG002|COMPLETED|Overall Study||9
6337163|NCT00552617|7244487|FG003|COMPLETED|Overall Study||9
6337164|NCT00552617|7244488|FG004|COMPLETED|Overall Study||10
6337165|NCT00552617|7244489|FG005|COMPLETED|Overall Study||8
6337166|NCT00552617|7244490|FG006|COMPLETED|Overall Study||10
6337167|NCT00552617|7244491|FG007|COMPLETED|Overall Study||10
6337168|NCT00552617|7244492|FG008|COMPLETED|Overall Study||8
6337169|NCT00552617|7244493|FG009|COMPLETED|Overall Study||9
6337170|NCT00552617|7244484|FG000|NOT COMPLETED|Overall Study||0
6337171|NCT00552617|7244485|FG001|NOT COMPLETED|Overall Study||0
6337172|NCT00552617|7244486|FG002|NOT COMPLETED|Overall Study||1
6337173|NCT00552617|7244487|FG003|NOT COMPLETED|Overall Study||1
6337174|NCT00552617|7244488|FG004|NOT COMPLETED|Overall Study||0
6337175|NCT00552617|7244489|FG005|NOT COMPLETED|Overall Study||2
6337176|NCT00552617|7244490|FG006|NOT COMPLETED|Overall Study||0
6337177|NCT00552617|7244491|FG007|NOT COMPLETED|Overall Study||0
6337178|NCT00552617|7244492|FG008|NOT COMPLETED|Overall Study||2
6337179|NCT00552617|7244493|FG009|NOT COMPLETED|Overall Study||1
6558969|NCT01778465|7481596|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6558970|NCT01778465|7481597|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6558971|NCT01778465|7481596|FG000|STARTED|Second Intervention (7 Days)||3
6558972|NCT01778465|7481597|FG001|STARTED|Second Intervention (7 Days)||4
6558973|NCT01778465|7481596|FG000|COMPLETED|Second Intervention (7 Days)||3
6558974|NCT01778465|7481597|FG001|COMPLETED|Second Intervention (7 Days)||4
6558975|NCT01778465|7481596|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6558976|NCT01778465|7481597|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6558977|NCT01778530|7481606|FG000|STARTED|Overall Study||2
6558978|NCT01778530|7481606|FG000|COMPLETED|Overall Study||0
6337180|NCT00552669|7244517|FG000|STARTED|Overall Study|patients|100
6337181|NCT00552669|7244518|FG001|STARTED|Overall Study|patients|100
6337182|NCT00552669|7244517|FG000|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
6337183|NCT00552669|7244518|FG001|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
6337184|NCT00552669|7244517|FG000|NOT COMPLETED|Overall Study||3
6337185|NCT00552669|7244518|FG001|NOT COMPLETED|Overall Study||7
6337186|NCT00552695|7244526|FG000|STARTED|Overall Study|August 2007|22
6337187|NCT00552695|7244527|FG001|STARTED|Overall Study|August 2007|23
6337188|NCT00552695|7244526|FG000|COMPLETED|Overall Study|September 2007|22
6337189|NCT00552695|7244527|FG001|COMPLETED|Overall Study|September 2007|23
6337190|NCT00552695|7244526|FG000|NOT COMPLETED|Overall Study||0
6337191|NCT00552695|7244527|FG001|NOT COMPLETED|Overall Study||0
6337192|NCT00552760|7244535|FG000|STARTED|Overall Study||42
6337193|NCT00552760|7244536|FG001|STARTED|Overall Study||41
6337194|NCT00552760|7244535|FG000|COMPLETED|Overall Study||16
6337195|NCT00552760|7244536|FG001|COMPLETED|Overall Study||8
6337196|NCT00552760|7244535|FG000|NOT COMPLETED|Overall Study||26
6337197|NCT00552760|7244536|FG001|NOT COMPLETED|Overall Study||33
6337198|NCT00552786|7244544|FG000|STARTED|First Intervention||25
6337199|NCT00552786|7244545|FG001|STARTED|First Intervention||28
6337200|NCT00552786|7244544|FG000|Medication and Hearing Evaluation|First Intervention||25
6337201|NCT00552786|7244545|FG001|Medication and Hearing Evaluation|First Intervention||28
6337202|NCT00552786|7244544|FG000|COMPLETED|First Intervention||25
6337203|NCT00552786|7244545|FG001|COMPLETED|First Intervention||28
6337204|NCT00552786|7244544|FG000|NOT COMPLETED|First Intervention||0
6337205|NCT00552786|7244545|FG001|NOT COMPLETED|First Intervention||0
6337206|NCT00552786|7244544|FG000|STARTED|Washout Period of 2 Weeks||25
6558979|NCT01778530|7481606|FG000|NOT COMPLETED|Overall Study||2
6337207|NCT00552786|7244545|FG001|STARTED|Washout Period of 2 Weeks||28
6337208|NCT00552786|7244544|FG000|COMPLETED|Washout Period of 2 Weeks||25
6337209|NCT00552786|7244545|FG001|COMPLETED|Washout Period of 2 Weeks||28
6558980|NCT01778556|7481612|FG000|STARTED|Intervention 1 (5 Days)||15
6337210|NCT00552786|7244544|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6337211|NCT00552786|7244545|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6337212|NCT00552786|7244544|FG000|STARTED|Second Intervention||25
6337213|NCT00552786|7244545|FG001|STARTED|Second Intervention||28
6337214|NCT00552786|7244544|FG000|COMPLETED|Second Intervention||25
6337215|NCT00552786|7244545|FG001|COMPLETED|Second Intervention||28
6337216|NCT00552786|7244544|FG000|NOT COMPLETED|Second Intervention||0
6337217|NCT00552786|7244545|FG001|NOT COMPLETED|Second Intervention||0
6337218|NCT00552812|7244551|FG000|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
6337219|NCT00552812|7244551|FG000|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
6337220|NCT00552812|7244551|FG000|NOT COMPLETED|Overall Study||20
6337221|NCT00552929|7244565|FG000|STARTED|Overall Study||9
6337222|NCT00552929|7244566|FG001|STARTED|Overall Study||10
6337223|NCT00552929|7244567|FG002|STARTED|Overall Study||10
6337224|NCT00552929|7244568|FG003|STARTED|Overall Study||11
6337225|NCT00552929|7244569|FG004|STARTED|Overall Study||10
6337226|NCT00552929|7244570|FG005|STARTED|Overall Study||10
6337227|NCT00552929|7244571|FG006|STARTED|Overall Study||10
6337228|NCT00552929|7244572|FG007|STARTED|Overall Study||11
6337229|NCT00552929|7244573|FG008|STARTED|Overall Study||10
6337230|NCT00552929|7244574|FG009|STARTED|Overall Study||11
6337231|NCT00552929|7244565|FG000|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|9
6337232|NCT00552929|7244566|FG001|Participants as Treated|Overall Study||10
6337233|NCT00552929|7244567|FG002|Participants as Treated|Overall Study||10
6337234|NCT00552929|7244568|FG003|Participants as Treated|Overall Study|One participant randomized to sugammadex 0.5 mg/kg received sugammadex 3.7 mg/kg (4.0 mg\kg group)|11
6337235|NCT00552929|7244569|FG004|Participants as Treated|Overall Study||10
6337236|NCT00552929|7244570|FG005|Participants as Treated|Overall Study||9
6337237|NCT00552929|7244571|FG006|Participants as Treated|Overall Study||10
6337238|NCT00552929|7244572|FG007|Participants as Treated|Overall Study||11
6337239|NCT00552929|7244573|FG008|Participants as Treated|Overall Study||10
6337240|NCT00552929|7244574|FG009|Participants as Treated|Overall Study||11
6337241|NCT00552929|7244565|FG000|COMPLETED|Overall Study||9
6337242|NCT00552929|7244566|FG001|COMPLETED|Overall Study||10
6337243|NCT00552929|7244567|FG002|COMPLETED|Overall Study||10
6337244|NCT00552929|7244568|FG003|COMPLETED|Overall Study||11
6337245|NCT00552929|7244569|FG004|COMPLETED|Overall Study||10
6337246|NCT00552929|7244570|FG005|COMPLETED|Overall Study||9
6337247|NCT00552929|7244571|FG006|COMPLETED|Overall Study||10
6337248|NCT00552929|7244572|FG007|COMPLETED|Overall Study||11
6337249|NCT00552929|7244573|FG008|COMPLETED|Overall Study||9
6337250|NCT00552929|7244574|FG009|COMPLETED|Overall Study||11
6337251|NCT00552929|7244565|FG000|NOT COMPLETED|Overall Study||0
6337252|NCT00552929|7244566|FG001|NOT COMPLETED|Overall Study||0
6337253|NCT00552929|7244567|FG002|NOT COMPLETED|Overall Study||0
6337254|NCT00552929|7244568|FG003|NOT COMPLETED|Overall Study||0
6337255|NCT00552929|7244569|FG004|NOT COMPLETED|Overall Study||0
6337256|NCT00552929|7244570|FG005|NOT COMPLETED|Overall Study||1
6337257|NCT00552929|7244571|FG006|NOT COMPLETED|Overall Study||0
6337258|NCT00552929|7244572|FG007|NOT COMPLETED|Overall Study||0
6337259|NCT00552929|7244573|FG008|NOT COMPLETED|Overall Study||1
6337260|NCT00552929|7244574|FG009|NOT COMPLETED|Overall Study||0
6337261|NCT00553059|7244598|FG000|STARTED|Overall Study||31
6337262|NCT00553059|7244599|FG001|STARTED|Overall Study||31
6337263|NCT00553059|7244598|FG000|COMPLETED|Overall Study||30
6337264|NCT00553059|7244599|FG001|COMPLETED|Overall Study||29
6337265|NCT00553059|7244598|FG000|NOT COMPLETED|Overall Study||1
6337266|NCT00553059|7244599|FG001|NOT COMPLETED|Overall Study||2
6337267|NCT00553098|7244605|FG000|STARTED|Overall Study||29
6337268|NCT00553098|7244605|FG000|COMPLETED|Overall Study||28
6337269|NCT00553098|7244605|FG000|NOT COMPLETED|Overall Study||1
6337270|NCT00553150|7244615|FG000|STARTED|Overall Study||6
6337271|NCT00553150|7244616|FG001|STARTED|Overall Study||6
6337272|NCT00553150|7244617|FG002|STARTED|Overall Study||6
6337273|NCT00553150|7244618|FG003|STARTED|Overall Study||104
6337274|NCT00553150|7244615|FG000|COMPLETED|Overall Study||6
6337275|NCT00553150|7244616|FG001|COMPLETED|Overall Study||6
6337276|NCT00553150|7244617|FG002|COMPLETED|Overall Study||6
6337277|NCT00553150|7244618|FG003|COMPLETED|Overall Study||100
6337278|NCT00553150|7244615|FG000|NOT COMPLETED|Overall Study||0
6337279|NCT00553150|7244616|FG001|NOT COMPLETED|Overall Study||0
6337280|NCT00553150|7244617|FG002|NOT COMPLETED|Overall Study||0
6337281|NCT00553150|7244618|FG003|NOT COMPLETED|Overall Study||4
6558981|NCT01778556|7481613|FG001|STARTED|Intervention 1 (5 Days)||10
6337282|NCT00553163|7244628|FG000|STARTED|Overall Study||16
6337283|NCT00553163|7244629|FG001|STARTED|Overall Study||10
6337284|NCT00553163|7244628|FG000|COMPLETED|Overall Study||16
6337285|NCT00553163|7244629|FG001|COMPLETED|Overall Study||10
6337286|NCT00553163|7244628|FG000|NOT COMPLETED|Overall Study||0
6337287|NCT00553163|7244629|FG001|NOT COMPLETED|Overall Study||0
6337288|NCT00553202|7244640|FG000|STARTED|Overall Study||158
6337289|NCT00553202|7244640|FG000|COMPLETED|Overall Study||90
6337290|NCT00553202|7244640|FG000|NOT COMPLETED|Overall Study||68
6337291|NCT00553254|7244647|FG000|STARTED|Overall Study||6
6337292|NCT00553254|7244648|FG001|STARTED|Overall Study||6
6337293|NCT00553254|7244649|FG002|STARTED|Overall Study||43
6558982|NCT01778556|7481612|FG000|COMPLETED|Intervention 1 (5 Days)||15
6337294|NCT00553254|7244647|FG000|COMPLETED|Overall Study||0
6337295|NCT00553254|7244648|FG001|COMPLETED|Overall Study||0
6337296|NCT00553254|7244649|FG002|COMPLETED|Overall Study||0
6337297|NCT00553254|7244647|FG000|NOT COMPLETED|Overall Study||6
6337298|NCT00553254|7244648|FG001|NOT COMPLETED|Overall Study||6
6337299|NCT00553254|7244649|FG002|NOT COMPLETED|Overall Study||43
6337300|NCT00553267|7244664|FG000|STARTED|Overall Study||315
6337301|NCT00553267|7244665|FG001|STARTED|Overall Study||315
6337302|NCT00553267|7244666|FG002|STARTED|Overall Study||317
6337303|NCT00553267|7244664|FG000|COMPLETED|Overall Study||301
6337304|NCT00553267|7244665|FG001|COMPLETED|Overall Study||297
6337305|NCT00553267|7244666|FG002|COMPLETED|Overall Study||307
6337306|NCT00553267|7244664|FG000|NOT COMPLETED|Overall Study||14
6337307|NCT00553267|7244665|FG001|NOT COMPLETED|Overall Study||18
6337308|NCT00553267|7244666|FG002|NOT COMPLETED|Overall Study||10
6337309|NCT00553280|7244674|FG000|STARTED|Overall Study||123
6337310|NCT00553280|7244674|FG000|COMPLETED|Overall Study||97
6337311|NCT00553280|7244674|FG000|NOT COMPLETED|Overall Study||26
6337312|NCT00553319|7244681|FG000|STARTED|Overall Study||43
6337313|NCT00553319|7244682|FG001|STARTED|Overall Study||40
6337314|NCT00553319|7244683|FG002|STARTED|Overall Study||43
6337315|NCT00553319|7244681|FG000|COMPLETED|Overall Study||29
6337316|NCT00553319|7244682|FG001|COMPLETED|Overall Study||30
6337317|NCT00553319|7244683|FG002|COMPLETED|Overall Study||34
6337318|NCT00553319|7244681|FG000|NOT COMPLETED|Overall Study||14
6337319|NCT00553319|7244682|FG001|NOT COMPLETED|Overall Study||10
6337320|NCT00553319|7244683|FG002|NOT COMPLETED|Overall Study||9
6337321|NCT00553332|7244691|FG000|STARTED|Overall Study||29
6337322|NCT00553332|7244691|FG000|COMPLETED|Overall Study|evaluable for response|28
6337323|NCT00553332|7244691|FG000|NOT COMPLETED|Overall Study||1
6337324|NCT00553358|7244698|FG000|STARTED|Overall Study||152
6337325|NCT00553358|7244699|FG001|STARTED|Overall Study||154
6337326|NCT00553358|7244700|FG002|STARTED|Overall Study||149
6337327|NCT00553358|7244698|FG000|COMPLETED|Overall Study||73
6337328|NCT00553358|7244699|FG001|COMPLETED|Overall Study||58
6337329|NCT00553358|7244700|FG002|COMPLETED|Overall Study||61
6337330|NCT00553358|7244698|FG000|NOT COMPLETED|Overall Study||79
6337331|NCT00553358|7244699|FG001|NOT COMPLETED|Overall Study||96
6337332|NCT00553358|7244700|FG002|NOT COMPLETED|Overall Study||88
6558983|NCT01778556|7481613|FG001|COMPLETED|Intervention 1 (5 Days)||8
6558984|NCT01778556|7481612|FG000|NOT COMPLETED|Intervention 1 (5 Days)||0
6558985|NCT01778556|7481613|FG001|NOT COMPLETED|Intervention 1 (5 Days)||2
6558986|NCT01778556|7481612|FG000|STARTED|Intervention 2 (14 Days)||15
6558987|NCT01778556|7481613|FG001|STARTED|Intervention 2 (14 Days)||8
6558988|NCT01778556|7481612|FG000|COMPLETED|Intervention 2 (14 Days)||14
6558989|NCT01778556|7481613|FG001|COMPLETED|Intervention 2 (14 Days)||8
6558990|NCT01778556|7481612|FG000|NOT COMPLETED|Intervention 2 (14 Days)||1
6558991|NCT01778556|7481613|FG001|NOT COMPLETED|Intervention 2 (14 Days)||0
6558992|NCT01778556|7481612|FG000|STARTED|Long-term Follow-up||15
6558993|NCT01778556|7481613|FG001|STARTED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
6558994|NCT01778556|7481612|FG000|COMPLETED|Long-term Follow-up||14
6558995|NCT01778556|7481613|FG001|COMPLETED|Long-term Follow-up|no long-term follow-up period in on-leptin arm|0
6558996|NCT01778556|7481612|FG000|NOT COMPLETED|Long-term Follow-up||1
6558997|NCT01778556|7481613|FG001|NOT COMPLETED|Long-term Follow-up||0
6558998|NCT01778634|7481624|FG000|STARTED|Overall Study||61
6558999|NCT01778634|7481625|FG001|STARTED|Overall Study||60
6559000|NCT01778634|7481624|FG000|COMPLETED|Overall Study||61
6559001|NCT01778634|7481625|FG001|COMPLETED|Overall Study||60
6559002|NCT01778634|7481624|FG000|NOT COMPLETED|Overall Study||0
6559003|NCT01778634|7481625|FG001|NOT COMPLETED|Overall Study||0
6559004|NCT01778751|7481634|FG000|STARTED|Overall Study||25
6559005|NCT01778751|7481635|FG001|STARTED|Overall Study||25
6559006|NCT01778751|7481634|FG000|COMPLETED|Overall Study||23
6559007|NCT01778751|7481635|FG001|COMPLETED|Overall Study||23
6559008|NCT01778751|7481634|FG000|NOT COMPLETED|Overall Study||2
6559009|NCT01778751|7481635|FG001|NOT COMPLETED|Overall Study||2
6559010|NCT01778855|7481643|FG000|STARTED|Overall Study||2
6559011|NCT01778855|7481644|FG001|STARTED|Overall Study||4
6559012|NCT01778855|7481643|FG000|COMPLETED|Overall Study||2
6559013|NCT01778855|7481644|FG001|COMPLETED|Overall Study||3
6559014|NCT01778855|7481643|FG000|NOT COMPLETED|Overall Study||0
6559015|NCT01778855|7481644|FG001|NOT COMPLETED|Overall Study||1
6559016|NCT01778985|7481652|FG000|STARTED|Overall Study||15
6559017|NCT01778985|7481653|FG001|STARTED|Overall Study||15
6559018|NCT01778985|7481652|FG000|COMPLETED|Overall Study||8
6559019|NCT01778985|7481653|FG001|COMPLETED|Overall Study||12
6559020|NCT01778985|7481652|FG000|NOT COMPLETED|Overall Study||7
6559021|NCT01778985|7481653|FG001|NOT COMPLETED|Overall Study||3
6559022|NCT01779024|7481659|FG000|STARTED|1st Visit - Alcohol Self-Administration||8
6559023|NCT01779024|7481660|FG001|STARTED|1st Visit - Alcohol Self-Administration||9
6559024|NCT01779024|7481659|FG000|COMPLETED|1st Visit - Alcohol Self-Administration||8
6559025|NCT01779024|7481660|FG001|COMPLETED|1st Visit - Alcohol Self-Administration||9
6337333|NCT00553410|7244716|FG000|STARTED|Overall Study||2441
6337334|NCT00553410|7244717|FG001|STARTED|Overall Study||2443
6337335|NCT00553410|7244716|FG000|COMPLETED|Overall Study||2426
6337336|NCT00553410|7244717|FG001|COMPLETED|Overall Study||2425
6337337|NCT00553410|7244716|FG000|NOT COMPLETED|Overall Study||15
6337338|NCT00553410|7244717|FG001|NOT COMPLETED|Overall Study||18
6337339|NCT00553436|7244723|FG000|STARTED|Overall Study|20 August 2007|7
6337340|NCT00553436|7244723|FG000|COMPLETED|Overall Study|09 April 2009|6
6337341|NCT00553436|7244723|FG000|NOT COMPLETED|Overall Study||1
6337342|NCT00553462|7244727|FG000|STARTED|Overall Study||75
6337343|NCT00553462|7244727|FG000|COMPLETED|Overall Study||61
6337344|NCT00553462|7244727|FG000|NOT COMPLETED|Overall Study||14
6337345|NCT00553475|7244734|FG000|STARTED|Overall Study||135
6337346|NCT00553475|7244735|FG001|STARTED|Overall Study||134
6337347|NCT00553475|7244736|FG002|STARTED|Overall Study||45
6337348|NCT00553475|7244734|FG000|COMPLETED|Overall Study||119
6337349|NCT00553475|7244735|FG001|COMPLETED|Overall Study||114
6337350|NCT00553475|7244736|FG002|COMPLETED|Overall Study||32
6337351|NCT00553475|7244734|FG000|NOT COMPLETED|Overall Study||16
6337352|NCT00553475|7244735|FG001|NOT COMPLETED|Overall Study||20
6337353|NCT00553475|7244736|FG002|NOT COMPLETED|Overall Study||13
6337354|NCT00553501|7244746|FG000|STARTED|Overall Study||59
6337355|NCT00553501|7244746|FG000|COMPLETED|Overall Study||55
6337356|NCT00553501|7244746|FG000|NOT COMPLETED|Overall Study||4
6337357|NCT00553514|7244755|FG000|STARTED|Overall Study||14
6337358|NCT00553514|7244756|FG001|STARTED|Overall Study||14
6337359|NCT00553514|7244757|FG002|STARTED|Overall Study||15
6337360|NCT00553514|7244758|FG003|STARTED|Overall Study||13
6337361|NCT00553514|7244759|FG004|STARTED|Overall Study||15
6337362|NCT00553514|7244755|FG000|COMPLETED|Overall Study||6
6337363|NCT00553514|7244756|FG001|COMPLETED|Overall Study||6
6337364|NCT00553514|7244757|FG002|COMPLETED|Overall Study||9
6337365|NCT00553514|7244758|FG003|COMPLETED|Overall Study||6
6337366|NCT00553514|7244759|FG004|COMPLETED|Overall Study||8
6337367|NCT00553514|7244755|FG000|NOT COMPLETED|Overall Study||8
6337368|NCT00553514|7244756|FG001|NOT COMPLETED|Overall Study||8
6337369|NCT00553514|7244757|FG002|NOT COMPLETED|Overall Study||6
6337370|NCT00553514|7244758|FG003|NOT COMPLETED|Overall Study||7
6337371|NCT00553514|7244759|FG004|NOT COMPLETED|Overall Study||7
6337372|NCT00553540|7244773|FG000|STARTED|Overall Study||25
6337373|NCT00553540|7244774|FG001|STARTED|Overall Study||25
6337374|NCT00553540|7244773|FG000|COMPLETED|Overall Study||23
6337375|NCT00553540|7244774|FG001|COMPLETED|Overall Study||20
6337376|NCT00553540|7244773|FG000|NOT COMPLETED|Overall Study||2
6337377|NCT00553540|7244774|FG001|NOT COMPLETED|Overall Study||5
6337378|NCT00553605|7244782|FG000|STARTED|Overall Study||176
6337379|NCT00553605|7244783|FG001|STARTED|Overall Study||164
6337380|NCT00553605|7244782|FG000|Treated|Overall Study||174
6337381|NCT00553605|7244783|FG001|Treated|Overall Study||164
6337382|NCT00553605|7244782|FG000|COMPLETED|Overall Study||172
6337383|NCT00553605|7244783|FG001|COMPLETED|Overall Study||161
6337384|NCT00553605|7244782|FG000|NOT COMPLETED|Overall Study||4
6337385|NCT00553605|7244783|FG001|NOT COMPLETED|Overall Study||3
6337386|NCT00553631|7244791|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|17
6337387|NCT00553631|7244792|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|17
6337388|NCT00553631|7244791|FG000|COMPLETED|Overall Study||16
6337389|NCT00553631|7244792|FG001|COMPLETED|Overall Study||16
6337390|NCT00553631|7244791|FG000|NOT COMPLETED|Overall Study||1
6337391|NCT00553631|7244792|FG001|NOT COMPLETED|Overall Study||1
6337392|NCT00553644|7244798|FG000|STARTED|Overall Study||53
6337393|NCT00553644|7244798|FG000|COMPLETED|Overall Study||25
6337394|NCT00553644|7244798|FG000|NOT COMPLETED|Overall Study||28
6337395|NCT00553696|7244806|FG000|STARTED|Overall Study||4
6337396|NCT00553696|7244807|FG001|STARTED|Overall Study||16
6337397|NCT00553696|7244808|FG002|STARTED|Overall Study||6
6337398|NCT00553696|7244809|FG003|STARTED|Overall Study||1
6337399|NCT00553696|7244806|FG000|COMPLETED|Overall Study||0
6337400|NCT00553696|7244807|FG001|COMPLETED|Overall Study||0
6337401|NCT00553696|7244808|FG002|COMPLETED|Overall Study||0
6337402|NCT00553696|7244809|FG003|COMPLETED|Overall Study||0
6337403|NCT00553696|7244806|FG000|NOT COMPLETED|Overall Study||4
6337404|NCT00553696|7244807|FG001|NOT COMPLETED|Overall Study||16
6337405|NCT00553696|7244808|FG002|NOT COMPLETED|Overall Study||6
6337406|NCT00553696|7244809|FG003|NOT COMPLETED|Overall Study||1
6337407|NCT00553735|7244822|FG000|STARTED|Overall Study||8
6337408|NCT00553735|7244822|FG000|COMPLETED|Overall Study||1
6337409|NCT00553735|7244822|FG000|NOT COMPLETED|Overall Study||7
6337410|NCT00553787|7244832|FG000|STARTED|Overall Study||994
6337411|NCT00553787|7244833|FG001|STARTED|Overall Study||498
6337412|NCT00553787|7244834|FG002|STARTED|Overall Study||995
6337413|NCT00553787|7244832|FG000|COMPLETED|Overall Study||616
6337414|NCT00553787|7244833|FG001|COMPLETED|Overall Study||374
6337415|NCT00553787|7244834|FG002|COMPLETED|Overall Study||733
6337416|NCT00553787|7244832|FG000|NOT COMPLETED|Overall Study||378
6337417|NCT00553787|7244833|FG001|NOT COMPLETED|Overall Study||124
6337418|NCT00553787|7244834|FG002|NOT COMPLETED|Overall Study||262
6559026|NCT01779024|7481659|FG000|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
6559027|NCT01779024|7481660|FG001|NOT COMPLETED|1st Visit - Alcohol Self-Administration||0
6559028|NCT01779024|7481659|FG000|STARTED|2nd Visit - Alcohol Self-Administration||8
6559029|NCT01779024|7481660|FG001|STARTED|2nd Visit - Alcohol Self-Administration||9
6337419|NCT00553839|7244842|FG000|STARTED|Overall Study||21
6337420|NCT00553839|7244842|FG000|COMPLETED|Overall Study||21
6337421|NCT00553839|7244842|FG000|NOT COMPLETED|Overall Study||0
6337422|NCT00553969|7244850|FG000|STARTED|Overall Study||31
6337423|NCT00553969|7244851|FG001|STARTED|Overall Study||24
6337424|NCT00553969|7244852|FG002|STARTED|Overall Study||22
6337425|NCT00553969|7244853|FG003|STARTED|Overall Study||24
6337426|NCT00553969|7244850|FG000|COMPLETED|Overall Study||23
6559030|NCT01779024|7481659|FG000|COMPLETED|2nd Visit - Alcohol Self-Administration||6
6337427|NCT00553969|7244851|FG001|COMPLETED|Overall Study||24
6337428|NCT00553969|7244852|FG002|COMPLETED|Overall Study||21
6337429|NCT00553969|7244853|FG003|COMPLETED|Overall Study||23
6337430|NCT00553969|7244850|FG000|NOT COMPLETED|Overall Study||8
6337431|NCT00553969|7244851|FG001|NOT COMPLETED|Overall Study||0
6337432|NCT00553969|7244852|FG002|NOT COMPLETED|Overall Study||1
6337433|NCT00553969|7244853|FG003|NOT COMPLETED|Overall Study||1
6337434|NCT00554099|7244866|FG000|STARTED|Treatment Period (12 Weeks)||41
6337435|NCT00554099|7244867|FG001|STARTED|Treatment Period (12 Weeks)||40
6337436|NCT00554099|7244868|FG002|STARTED|Treatment Period (12 Weeks)||36
6337437|NCT00554099|7244866|FG000|COMPLETED|Treatment Period (12 Weeks)||29
6337438|NCT00554099|7244867|FG001|COMPLETED|Treatment Period (12 Weeks)||32
6337439|NCT00554099|7244868|FG002|COMPLETED|Treatment Period (12 Weeks)||27
6337440|NCT00554099|7244866|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||12
6337441|NCT00554099|7244867|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||8
6337442|NCT00554099|7244868|FG002|NOT COMPLETED|Treatment Period (12 Weeks)||9
6337443|NCT00554099|7244866|FG000|STARTED|Non-Treatment Phase (9 Months)||29
6337444|NCT00554099|7244867|FG001|STARTED|Non-Treatment Phase (9 Months)||32
6337445|NCT00554099|7244868|FG002|STARTED|Non-Treatment Phase (9 Months)||27
6337446|NCT00554099|7244866|FG000|COMPLETED|Non-Treatment Phase (9 Months)||22
6337447|NCT00554099|7244867|FG001|COMPLETED|Non-Treatment Phase (9 Months)||27
6337448|NCT00554099|7244868|FG002|COMPLETED|Non-Treatment Phase (9 Months)||24
6337449|NCT00554099|7244866|FG000|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
6337450|NCT00554099|7244867|FG001|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
6337451|NCT00554099|7244868|FG002|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
6337452|NCT00554216|7244879|FG000|STARTED|Overall Study||514
6337453|NCT00554216|7244880|FG001|STARTED|Overall Study||241
6337454|NCT00554216|7244881|FG002|STARTED|Overall Study||512
6337455|NCT00554216|7244879|FG000|COMPLETED|Overall Study||272
6337456|NCT00554216|7244880|FG001|COMPLETED|Overall Study||147
6337457|NCT00554216|7244881|FG002|COMPLETED|Overall Study||340
6337458|NCT00554216|7244879|FG000|NOT COMPLETED|Overall Study||242
6337459|NCT00554216|7244880|FG001|NOT COMPLETED|Overall Study||94
6337460|NCT00554216|7244881|FG002|NOT COMPLETED|Overall Study||172
6337461|NCT00554229|7244891|FG000|STARTED|Overall Study||299
6337462|NCT00554229|7244892|FG001|STARTED|Overall Study||295
6337463|NCT00554229|7244891|FG000|Patients Who Received Treatment|Overall Study||298
6337464|NCT00554229|7244892|FG001|Patients Who Received Treatment|Overall Study||295
6337465|NCT00554229|7244891|FG000|COMPLETED|Overall Study||73
6337466|NCT00554229|7244892|FG001|COMPLETED|Overall Study||70
6337467|NCT00554229|7244891|FG000|NOT COMPLETED|Overall Study||226
6337468|NCT00554229|7244892|FG001|NOT COMPLETED|Overall Study||225
6559031|NCT01779024|7481660|FG001|COMPLETED|2nd Visit - Alcohol Self-Administration||9
6559032|NCT01779024|7481659|FG000|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||2
6559033|NCT01779024|7481660|FG001|NOT COMPLETED|2nd Visit - Alcohol Self-Administration||0
6559034|NCT01779024|7481659|FG000|STARTED|1st Visit - Functional MRI||6
6559035|NCT01779024|7481660|FG001|STARTED|1st Visit - Functional MRI||7
6559036|NCT01779024|7481659|FG000|COMPLETED|1st Visit - Functional MRI||4
6559037|NCT01779024|7481660|FG001|COMPLETED|1st Visit - Functional MRI||5
6559038|NCT01779024|7481659|FG000|NOT COMPLETED|1st Visit - Functional MRI||2
6559039|NCT01779024|7481660|FG001|NOT COMPLETED|1st Visit - Functional MRI||2
6559040|NCT01779024|7481659|FG000|STARTED|2nd Visit - Functional MRI||5
6559041|NCT01779024|7481660|FG001|STARTED|2nd Visit - Functional MRI||6
6559042|NCT01779024|7481659|FG000|COMPLETED|2nd Visit - Functional MRI||5
6559043|NCT01779024|7481660|FG001|COMPLETED|2nd Visit - Functional MRI||6
6559044|NCT01779024|7481659|FG000|NOT COMPLETED|2nd Visit - Functional MRI||0
6559045|NCT01779024|7481660|FG001|NOT COMPLETED|2nd Visit - Functional MRI||0
6337469|NCT00554372|7244900|FG000|STARTED|Overall Study||14
6337470|NCT00554372|7244901|FG001|STARTED|Overall Study||16
6337471|NCT00554372|7244900|FG000|COMPLETED|Overall Study||14
6337472|NCT00554372|7244901|FG001|COMPLETED|Overall Study||16
6337473|NCT00554372|7244900|FG000|NOT COMPLETED|Overall Study||0
6337474|NCT00554372|7244901|FG001|NOT COMPLETED|Overall Study||0
6337475|NCT00554463|7244909|FG000|STARTED|Overall Study||5
6337476|NCT00554463|7244909|FG000|COMPLETED|Overall Study||5
6559046|NCT01779141|7481666|FG000|STARTED|Overall Study||481
6776333|NCT03815240|7704434|FG007|STARTED|Intervention Allevyn Dressing||1
6776334|NCT03815240|7704435|FG008|STARTED|Intervention Allevyn Dressing||1
6776335|NCT03815240|7704427|FG000|COMPLETED|Intervention Allevyn Dressing||2
6776336|NCT03815240|7704428|FG001|COMPLETED|Intervention Allevyn Dressing||1
6776337|NCT03815240|7704429|FG002|COMPLETED|Intervention Allevyn Dressing||1
6776338|NCT03815240|7704430|FG003|COMPLETED|Intervention Allevyn Dressing||2
6776339|NCT03815240|7704431|FG004|COMPLETED|Intervention Allevyn Dressing||1
6776340|NCT03815240|7704432|FG005|COMPLETED|Intervention Allevyn Dressing||2
6776341|NCT03815240|7704433|FG006|COMPLETED|Intervention Allevyn Dressing||1
6776342|NCT03815240|7704434|FG007|COMPLETED|Intervention Allevyn Dressing||1
6337477|NCT00554463|7244909|FG000|NOT COMPLETED|Overall Study||0
6337478|NCT00554515|7244913|FG000|STARTED|Overall Study||123
6337479|NCT00554515|7244913|FG000|Treated|Overall Study||120
6337480|NCT00554515|7244913|FG000|COMPLETED|Overall Study||5
6337481|NCT00554515|7244913|FG000|NOT COMPLETED|Overall Study||118
6337482|NCT00554619|7244938|FG000|STARTED|Overall Study||21
6337483|NCT00554619|7244938|FG000|COMPLETED|Overall Study||18
6337484|NCT00554619|7244938|FG000|NOT COMPLETED|Overall Study||3
6559047|NCT01779141|7481666|FG000|COMPLETED|Overall Study||300
6337485|NCT00554671|7244944|FG000|STARTED|Overall Study||117
6337486|NCT00554671|7244945|FG001|STARTED|Overall Study||133
6337487|NCT00554671|7244944|FG000|COMPLETED|Overall Study||97
6337488|NCT00554671|7244945|FG001|COMPLETED|Overall Study||117
6337489|NCT00554671|7244944|FG000|NOT COMPLETED|Overall Study||20
6337490|NCT00554671|7244945|FG001|NOT COMPLETED|Overall Study||16
6337491|NCT00554749|7244952|FG000|STARTED|Overall Study||7
6337492|NCT00554749|7244952|FG000|COMPLETED|Overall Study||7
6337493|NCT00554749|7244952|FG000|NOT COMPLETED|Overall Study||0
6337494|NCT00554788|7244959|FG000|STARTED|Overall Study||21
6337495|NCT00554788|7244960|FG001|STARTED|Overall Study||18
6337496|NCT00554788|7244961|FG002|STARTED|Overall Study||21
6337497|NCT00554788|7244959|FG000|COMPLETED|Overall Study||14
6337498|NCT00554788|7244960|FG001|COMPLETED|Overall Study||12
6337499|NCT00554788|7244961|FG002|COMPLETED|Overall Study||7
6337500|NCT00554788|7244959|FG000|NOT COMPLETED|Overall Study||7
6337501|NCT00554788|7244960|FG001|NOT COMPLETED|Overall Study||6
6337502|NCT00554788|7244961|FG002|NOT COMPLETED|Overall Study||14
6337503|NCT00554801|7244972|FG000|STARTED|Overall Study||55
6337504|NCT00554801|7244973|FG001|STARTED|Overall Study||29
6337505|NCT00554801|7244972|FG000|COMPLETED|Overall Study||36
6337506|NCT00554801|7244973|FG001|COMPLETED|Overall Study||29
6337507|NCT00554801|7244972|FG000|NOT COMPLETED|Overall Study||19
6337508|NCT00554801|7244973|FG001|NOT COMPLETED|Overall Study||0
6337509|NCT00554853|7244983|FG000|STARTED|First Arm of Study||72
6337510|NCT00554853|7244984|FG001|STARTED|First Arm of Study||71
6337511|NCT00554853|7244983|FG000|COMPLETED|First Arm of Study||56
6337512|NCT00554853|7244984|FG001|COMPLETED|First Arm of Study||64
6337513|NCT00554853|7244983|FG000|NOT COMPLETED|First Arm of Study||16
6337514|NCT00554853|7244984|FG001|NOT COMPLETED|First Arm of Study||7
6337515|NCT00554853|7244983|FG000|STARTED|Washout Period (2 Weeks)||56
6337516|NCT00554853|7244984|FG001|STARTED|Washout Period (2 Weeks)||64
6337517|NCT00554853|7244983|FG000|COMPLETED|Washout Period (2 Weeks)||56
6337518|NCT00554853|7244984|FG001|COMPLETED|Washout Period (2 Weeks)||57
6337519|NCT00554853|7244983|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
6337520|NCT00554853|7244984|FG001|NOT COMPLETED|Washout Period (2 Weeks)||7
6337521|NCT00554853|7244983|FG000|STARTED|Crossover Arm (3 Months)||56
6337522|NCT00554853|7244984|FG001|STARTED|Crossover Arm (3 Months)||57
6337523|NCT00554853|7244983|FG000|COMPLETED|Crossover Arm (3 Months)||53
6337524|NCT00554853|7244984|FG001|COMPLETED|Crossover Arm (3 Months)||55
6337525|NCT00554853|7244983|FG000|NOT COMPLETED|Crossover Arm (3 Months)||3
6337526|NCT00554853|7244984|FG001|NOT COMPLETED|Crossover Arm (3 Months)||2
6337527|NCT00554970|7245000|FG000|STARTED|Period 1||8
6337528|NCT00554970|7245001|FG001|STARTED|Period 1||8
6337529|NCT00554970|7245002|FG002|STARTED|Period 1||8
6337530|NCT00554970|7245003|FG003|STARTED|Period 1||8
6337531|NCT00554970|7245000|FG000|COMPLETED|Period 1||7
6337532|NCT00554970|7245001|FG001|COMPLETED|Period 1||8
6337533|NCT00554970|7245002|FG002|COMPLETED|Period 1||8
6337534|NCT00554970|7245003|FG003|COMPLETED|Period 1||8
6337535|NCT00554970|7245000|FG000|NOT COMPLETED|Period 1||1
6337536|NCT00554970|7245001|FG001|NOT COMPLETED|Period 1||0
6337537|NCT00554970|7245002|FG002|NOT COMPLETED|Period 1||0
6776343|NCT03815240|7704435|FG008|COMPLETED|Intervention Allevyn Dressing||1
6776344|NCT03815240|7704427|FG000|NOT COMPLETED|Intervention Allevyn Dressing||0
6776345|NCT03815240|7704428|FG001|NOT COMPLETED|Intervention Allevyn Dressing||0
6776346|NCT03815240|7704429|FG002|NOT COMPLETED|Intervention Allevyn Dressing||0
6559048|NCT01779141|7481666|FG000|NOT COMPLETED|Overall Study||181
6559049|NCT01779167|7481670|FG000|STARTED|Overall Study||4
6559050|NCT01779167|7481670|FG000|COMPLETED|Overall Study||3
6776347|NCT03815240|7704430|FG003|NOT COMPLETED|Intervention Allevyn Dressing||0
6776348|NCT03815240|7704431|FG004|NOT COMPLETED|Intervention Allevyn Dressing||0
6776349|NCT03815240|7704432|FG005|NOT COMPLETED|Intervention Allevyn Dressing||0
6776350|NCT03815240|7704433|FG006|NOT COMPLETED|Intervention Allevyn Dressing||0
6337538|NCT00554970|7245003|FG003|NOT COMPLETED|Period 1||0
6337539|NCT00554970|7245000|FG000|STARTED|Period 2||7
6337540|NCT00554970|7245001|FG001|STARTED|Period 2||8
6337541|NCT00554970|7245002|FG002|STARTED|Period 2||8
6337542|NCT00554970|7245003|FG003|STARTED|Period 2||8
6337543|NCT00554970|7245000|FG000|COMPLETED|Period 2||7
6337544|NCT00554970|7245001|FG001|COMPLETED|Period 2||8
6337545|NCT00554970|7245002|FG002|COMPLETED|Period 2||7
6337546|NCT00554970|7245003|FG003|COMPLETED|Period 2||8
6337547|NCT00554970|7245000|FG000|NOT COMPLETED|Period 2||0
6337548|NCT00554970|7245001|FG001|NOT COMPLETED|Period 2||0
6337549|NCT00554970|7245002|FG002|NOT COMPLETED|Period 2||1
6337550|NCT00554970|7245003|FG003|NOT COMPLETED|Period 2||0
6337551|NCT00554996|7245013|FG000|STARTED|Overall Study||10
6337552|NCT00554996|7245013|FG000|COMPLETED|Overall Study||10
6337553|NCT00554996|7245013|FG000|NOT COMPLETED|Overall Study||0
6337554|NCT00555048|7245017|FG000|STARTED|Overall Study||1
6337555|NCT00555048|7245017|FG000|COMPLETED|Overall Study||1
6337556|NCT00555048|7245017|FG000|NOT COMPLETED|Overall Study||0
6337557|NCT00555061|7245021|FG000|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
6337558|NCT00555061|7245021|FG000|COMPLETED|Overall Study||78
6337559|NCT00555061|7245021|FG000|NOT COMPLETED|Overall Study||9
6337560|NCT00555152|7245029|FG000|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
6337561|NCT00555152|7245030|FG001|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
6559051|NCT01779167|7481670|FG000|NOT COMPLETED|Overall Study||1
6337562|NCT00555152|7245031|FG002|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
6337563|NCT00555152|7245032|FG003|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
6337564|NCT00555152|7245029|FG000|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
6337565|NCT00555152|7245030|FG001|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6337566|NCT00555152|7245031|FG002|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6337567|NCT00555152|7245032|FG003|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
6337568|NCT00555152|7245029|FG000|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6337569|NCT00555152|7245030|FG001|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6337570|NCT00555152|7245031|FG002|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6337571|NCT00555152|7245032|FG003|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
6337572|NCT00555152|7245029|FG000|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
6337573|NCT00555152|7245030|FG001|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
6337574|NCT00555152|7245031|FG002|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6337575|NCT00555152|7245032|FG003|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
6337576|NCT00555152|7245029|FG000|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6337577|NCT00555152|7245030|FG001|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
6337578|NCT00555152|7245031|FG002|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6337579|NCT00555152|7245032|FG003|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
6337580|NCT00555152|7245029|FG000|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6337581|NCT00555152|7245030|FG001|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6337582|NCT00555152|7245031|FG002|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6337583|NCT00555152|7245032|FG003|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
6337584|NCT00555217|7245044|FG000|STARTED|Overall Study||724
6337585|NCT00555217|7245045|FG001|STARTED|Overall Study||724
6337586|NCT00555217|7245044|FG000|COMPLETED|Overall Study||649
6337587|NCT00555217|7245045|FG001|COMPLETED|Overall Study||656
6337588|NCT00555217|7245044|FG000|NOT COMPLETED|Overall Study||75
6337589|NCT00555217|7245045|FG001|NOT COMPLETED|Overall Study||68
6337590|NCT00555321|7245056|FG000|STARTED|Treatment Phase up to 12-months||52
6337591|NCT00555321|7245057|FG001|STARTED|Treatment Phase up to 12-months||51
6337592|NCT00555321|7245058|FG002|STARTED|Treatment Phase up to 12-months||50
6337593|NCT00555321|7245059|FG003|STARTED|Treatment Phase up to 12-months||53
6337594|NCT00555321|7245060|FG004|STARTED|Treatment Phase up to 12-months||54
6337595|NCT00555321|7245056|FG000|Received Transplant and Treated|Treatment Phase up to 12-months||50
6337596|NCT00555321|7245057|FG001|Received Transplant and Treated|Treatment Phase up to 12-months||48
6337597|NCT00555321|7245058|FG002|Received Transplant and Treated|Treatment Phase up to 12-months||49
6337598|NCT00555321|7245059|FG003|Received Transplant and Treated|Treatment Phase up to 12-months||53
6337599|NCT00555321|7245060|FG004|Received Transplant and Treated|Treatment Phase up to 12-months||50
6337600|NCT00555321|7245056|FG000|COMPLETED|Treatment Phase up to 12-months||31
6337601|NCT00555321|7245057|FG001|COMPLETED|Treatment Phase up to 12-months||29
6337602|NCT00555321|7245058|FG002|COMPLETED|Treatment Phase up to 12-months||26
6337603|NCT00555321|7245059|FG003|COMPLETED|Treatment Phase up to 12-months||46
6337604|NCT00555321|7245060|FG004|COMPLETED|Treatment Phase up to 12-months||32
6337605|NCT00555321|7245056|FG000|NOT COMPLETED|Treatment Phase up to 12-months||21
6337606|NCT00555321|7245057|FG001|NOT COMPLETED|Treatment Phase up to 12-months||22
6337607|NCT00555321|7245058|FG002|NOT COMPLETED|Treatment Phase up to 12-months||24
6337608|NCT00555321|7245059|FG003|NOT COMPLETED|Treatment Phase up to 12-months||7
6337609|NCT00555321|7245060|FG004|NOT COMPLETED|Treatment Phase up to 12-months||22
6337610|NCT00555321|7245056|FG000|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
6337611|NCT00555321|7245057|FG001|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
6337612|NCT00555321|7245058|FG002|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
6337613|NCT00555321|7245059|FG003|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
6337614|NCT00555321|7245060|FG004|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
6337615|NCT00555321|7245056|FG000|COMPLETED|Long-term Extension Phase||0
6337616|NCT00555321|7245057|FG001|COMPLETED|Long-term Extension Phase||0
6337617|NCT00555321|7245058|FG002|COMPLETED|Long-term Extension Phase||0
6337618|NCT00555321|7245059|FG003|COMPLETED|Long-term Extension Phase||0
6337619|NCT00555321|7245060|FG004|COMPLETED|Long-term Extension Phase||0
6337620|NCT00555321|7245056|FG000|NOT COMPLETED|Long-term Extension Phase||30
6337621|NCT00555321|7245057|FG001|NOT COMPLETED|Long-term Extension Phase||27
6337622|NCT00555321|7245058|FG002|NOT COMPLETED|Long-term Extension Phase||24
6337623|NCT00555321|7245059|FG003|NOT COMPLETED|Long-term Extension Phase||38
6337624|NCT00555321|7245060|FG004|NOT COMPLETED|Long-term Extension Phase||26
6337625|NCT00555360|7245079|FG000|STARTED|Overall Study||183
6337626|NCT00555360|7245080|FG001|STARTED|Overall Study||189
6337627|NCT00555360|7245079|FG000|COMPLETED|Overall Study||156
6337628|NCT00555360|7245080|FG001|COMPLETED|Overall Study||153
6337629|NCT00555360|7245079|FG000|NOT COMPLETED|Overall Study||27
6337630|NCT00555360|7245080|FG001|NOT COMPLETED|Overall Study||36
6337631|NCT00555425|7245089|FG000|STARTED|Overall Study||57
6337632|NCT00555425|7245090|FG001|STARTED|Overall Study||56
6337633|NCT00555425|7245089|FG000|COMPLETED|Overall Study||6
6337634|NCT00555425|7245090|FG001|COMPLETED|Overall Study||37
6337635|NCT00555425|7245089|FG000|NOT COMPLETED|Overall Study||51
6337636|NCT00555425|7245090|FG001|NOT COMPLETED|Overall Study||19
6337637|NCT00555438|7245096|FG000|STARTED|10 Days Post-operative||442
6337638|NCT00555438|7245096|FG000|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
6337639|NCT00555438|7245096|FG000|NOT COMPLETED|10 Days Post-operative||4
6337640|NCT00555438|7245096|FG000|STARTED|Between 10 Days and 30 Days Postoperativ||438
6337641|NCT00555438|7245096|FG000|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
6337642|NCT00555438|7245096|FG000|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
6337643|NCT00555464|7245102|FG000|STARTED|Overall Study||4
6559052|NCT01779219|7481676|FG000|STARTED|Overall Study|First interim analysis|21
6559053|NCT01779219|7481677|FG001|STARTED|Overall Study|First interim analysis|21
6559054|NCT01779219|7481676|FG000|COMPLETED|Overall Study|First interim analysis|21
6337644|NCT00555464|7245103|FG001|STARTED|Overall Study||4
6337645|NCT00555464|7245102|FG000|COMPLETED|Overall Study||4
6337646|NCT00555464|7245103|FG001|COMPLETED|Overall Study||1
6337647|NCT00555464|7245102|FG000|NOT COMPLETED|Overall Study||0
6337648|NCT00555464|7245103|FG001|NOT COMPLETED|Overall Study||3
6337649|NCT00555477|7245111|FG000|STARTED|Overall Study||14
6337650|NCT00555477|7245112|FG001|STARTED|Overall Study||45
6337651|NCT00555477|7245111|FG000|COMPLETED|Overall Study||12
6337652|NCT00555477|7245112|FG001|COMPLETED|Overall Study||32
6337653|NCT00555477|7245111|FG000|NOT COMPLETED|Overall Study||2
6337654|NCT00555477|7245112|FG001|NOT COMPLETED|Overall Study||13
6337655|NCT00555568|7245120|FG000|STARTED|Overall Study||100
6337656|NCT00555568|7245121|FG001|STARTED|Overall Study||98
6337657|NCT00555568|7245122|FG002|STARTED|Overall Study||100
6337658|NCT00555568|7245120|FG000|COMPLETED|Overall Study||74
6337659|NCT00555568|7245121|FG001|COMPLETED|Overall Study||82
6337660|NCT00555568|7245122|FG002|COMPLETED|Overall Study||84
6337661|NCT00555568|7245120|FG000|NOT COMPLETED|Overall Study||26
6337662|NCT00555568|7245121|FG001|NOT COMPLETED|Overall Study||16
6337663|NCT00555568|7245122|FG002|NOT COMPLETED|Overall Study||16
6337664|NCT00555581|7245130|FG000|STARTED|Overall Study||30
6337665|NCT00555581|7245130|FG000|COMPLETED|Overall Study||24
6337666|NCT00555581|7245130|FG000|NOT COMPLETED|Overall Study||6
6337667|NCT00555620|7245140|FG000|STARTED|Overall Study||6
6337668|NCT00555620|7245141|FG001|STARTED|Overall Study||7
6337669|NCT00555620|7245142|FG002|STARTED|Overall Study||15
6337670|NCT00555620|7245143|FG003|STARTED|Overall Study||23
6337671|NCT00555620|7245144|FG004|STARTED|Overall Study||3
6337672|NCT00555620|7245145|FG005|STARTED|Overall Study||22
6337673|NCT00555620|7245140|FG000|COMPLETED|Overall Study||0
6337674|NCT00555620|7245141|FG001|COMPLETED|Overall Study||0
6337675|NCT00555620|7245142|FG002|COMPLETED|Overall Study||0
6337676|NCT00555620|7245143|FG003|COMPLETED|Overall Study||0
6337677|NCT00555620|7245144|FG004|COMPLETED|Overall Study||0
6337678|NCT00555620|7245145|FG005|COMPLETED|Overall Study||0
6337679|NCT00555620|7245140|FG000|NOT COMPLETED|Overall Study||6
6337680|NCT00555620|7245141|FG001|NOT COMPLETED|Overall Study||7
6337681|NCT00555620|7245142|FG002|NOT COMPLETED|Overall Study||15
6337682|NCT00555620|7245143|FG003|NOT COMPLETED|Overall Study||23
6337683|NCT00555620|7245144|FG004|NOT COMPLETED|Overall Study||3
6337684|NCT00555620|7245145|FG005|NOT COMPLETED|Overall Study||22
6376299|NCT00758836|7286787|FG000|COMPLETED|Overall Study||147
6376300|NCT00758836|7286788|FG001|COMPLETED|Overall Study||145
6376301|NCT00758836|7286789|FG002|COMPLETED|Overall Study||133
6376302|NCT00758836|7286790|FG003|COMPLETED|Overall Study||138
6376303|NCT00758836|7286787|FG000|NOT COMPLETED|Overall Study||24
6376304|NCT00758836|7286788|FG001|NOT COMPLETED|Overall Study||26
6376305|NCT00758836|7286789|FG002|NOT COMPLETED|Overall Study||38
6376306|NCT00758836|7286790|FG003|NOT COMPLETED|Overall Study||32
6376307|NCT00758862|7286800|FG000|STARTED|Overall Study||20
6376308|NCT00758862|7286800|FG000|COMPLETED|Overall Study||19
6376309|NCT00758862|7286800|FG000|NOT COMPLETED|Overall Study||1
6376310|NCT00759031|7286806|FG000|STARTED|First Intervention (1 Day)||10
6376311|NCT00759031|7286807|FG001|STARTED|First Intervention (1 Day)||9
6376312|NCT00759031|7286806|FG000|COMPLETED|First Intervention (1 Day)||8
6376313|NCT00759031|7286807|FG001|COMPLETED|First Intervention (1 Day)||8
6376314|NCT00759031|7286806|FG000|NOT COMPLETED|First Intervention (1 Day)||2
6376315|NCT00759031|7286807|FG001|NOT COMPLETED|First Intervention (1 Day)||1
6376316|NCT00759031|7286806|FG000|STARTED|Washout After 1st Intervention (1 Week)||8
6376317|NCT00759031|7286807|FG001|STARTED|Washout After 1st Intervention (1 Week)||8
6376318|NCT00759031|7286806|FG000|COMPLETED|Washout After 1st Intervention (1 Week)||8
6376319|NCT00759031|7286807|FG001|COMPLETED|Washout After 1st Intervention (1 Week)||8
6376320|NCT00759031|7286806|FG000|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
6376321|NCT00759031|7286807|FG001|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
6376322|NCT00759031|7286806|FG000|STARTED|Second Intervention (1 Day)||8
6376323|NCT00759031|7286807|FG001|STARTED|Second Intervention (1 Day)||8
6376324|NCT00759031|7286806|FG000|COMPLETED|Second Intervention (1 Day)||8
6376325|NCT00759031|7286807|FG001|COMPLETED|Second Intervention (1 Day)||8
6376326|NCT00759031|7286806|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6376327|NCT00759031|7286807|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6376328|NCT00759096|7286813|FG000|STARTED|Overall Study||30
6376329|NCT00759096|7286813|FG000|COMPLETED|Overall Study||30
6376330|NCT00759096|7286813|FG000|NOT COMPLETED|Overall Study||0
6376331|NCT00759109|7286819|FG000|STARTED|Overall Study||74
6376332|NCT00759109|7286820|FG001|STARTED|Overall Study||76
6376333|NCT00759109|7286819|FG000|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
6337685|NCT00555672|7245165|FG000|STARTED|Overall Study||24
6337686|NCT00555672|7245166|FG001|STARTED|Overall Study||10
6337687|NCT00555672|7245165|FG000|COMPLETED|Overall Study||0
6337688|NCT00555672|7245166|FG001|COMPLETED|Overall Study||0
6337689|NCT00555672|7245165|FG000|NOT COMPLETED|Overall Study||24
6337690|NCT00555672|7245166|FG001|NOT COMPLETED|Overall Study||10
6337691|NCT00555750|7245174|FG000|STARTED|Overall Study||10
6337692|NCT00555750|7245175|FG001|STARTED|Overall Study||10
6337693|NCT00555750|7245174|FG000|COMPLETED|Overall Study||10
6337694|NCT00555750|7245175|FG001|COMPLETED|Overall Study||10
6337695|NCT00555750|7245174|FG000|NOT COMPLETED|Overall Study||0
6337696|NCT00555750|7245175|FG001|NOT COMPLETED|Overall Study||0
6337697|NCT00555880|7245183|FG000|STARTED|Treatment Period 1 (1 Day)||13
6337698|NCT00555880|7245184|FG001|STARTED|Treatment Period 1 (1 Day)||11
6337699|NCT00555880|7245183|FG000|COMPLETED|Treatment Period 1 (1 Day)||13
6337700|NCT00555880|7245184|FG001|COMPLETED|Treatment Period 1 (1 Day)||11
6337701|NCT00555880|7245183|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6337702|NCT00555880|7245184|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6337703|NCT00555880|7245183|FG000|STARTED|Washout (1 Day)||13
6337704|NCT00555880|7245184|FG001|STARTED|Washout (1 Day)||11
6337705|NCT00555880|7245183|FG000|COMPLETED|Washout (1 Day)||13
6337706|NCT00555880|7245184|FG001|COMPLETED|Washout (1 Day)||11
6337707|NCT00555880|7245183|FG000|NOT COMPLETED|Washout (1 Day)||0
6337708|NCT00555880|7245184|FG001|NOT COMPLETED|Washout (1 Day)||0
6337709|NCT00555880|7245183|FG000|STARTED|Treatment Period 2 (1 Day)||13
6337710|NCT00555880|7245184|FG001|STARTED|Treatment Period 2 (1 Day)||11
6337711|NCT00555880|7245183|FG000|COMPLETED|Treatment Period 2 (1 Day)||13
6337712|NCT00555880|7245184|FG001|COMPLETED|Treatment Period 2 (1 Day)||11
6337713|NCT00555880|7245183|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6337714|NCT00555880|7245184|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6337715|NCT00555893|7245193|FG000|STARTED|Overall Study||130
6337716|NCT00555893|7245194|FG001|STARTED|Overall Study||63
6337717|NCT00555893|7245193|FG000|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
6337718|NCT00555893|7245194|FG001|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
6337719|NCT00555893|7245193|FG000|COMPLETED|Overall Study||130
6337720|NCT00555893|7245194|FG001|COMPLETED|Overall Study||63
6337721|NCT00555893|7245193|FG000|NOT COMPLETED|Overall Study||0
6337722|NCT00555893|7245194|FG001|NOT COMPLETED|Overall Study||0
6337723|NCT00555906|7245203|FG000|STARTED|Phase 1||3
6337724|NCT00555906|7245204|FG001|STARTED|Phase 1||6
6337725|NCT00555906|7245205|FG002|STARTED|Phase 1||7
6337726|NCT00555906|7245206|FG003|STARTED|Phase 1||5
6337727|NCT00555906|7245207|FG004|STARTED|Phase 1||0
6337728|NCT00555906|7245203|FG000|COMPLETED|Phase 1||0
6337729|NCT00555906|7245204|FG001|COMPLETED|Phase 1||0
6337730|NCT00555906|7245205|FG002|COMPLETED|Phase 1||0
6337731|NCT00555906|7245206|FG003|COMPLETED|Phase 1||0
6337732|NCT00555906|7245207|FG004|COMPLETED|Phase 1||0
6337733|NCT00555906|7245203|FG000|NOT COMPLETED|Phase 1||3
6337734|NCT00555906|7245204|FG001|NOT COMPLETED|Phase 1||6
6337735|NCT00555906|7245205|FG002|NOT COMPLETED|Phase 1||7
6337736|NCT00555906|7245206|FG003|NOT COMPLETED|Phase 1||5
6337737|NCT00555906|7245207|FG004|NOT COMPLETED|Phase 1||0
6337738|NCT00555906|7245203|FG000|STARTED|Phase 2||0
6337739|NCT00555906|7245204|FG001|STARTED|Phase 2||0
6337740|NCT00555906|7245205|FG002|STARTED|Phase 2||0
6337741|NCT00555906|7245206|FG003|STARTED|Phase 2||0
6337742|NCT00555906|7245207|FG004|STARTED|Phase 2||32
6337743|NCT00555906|7245203|FG000|Treated|Phase 2||0
6337744|NCT00555906|7245204|FG001|Treated|Phase 2||0
6337745|NCT00555906|7245205|FG002|Treated|Phase 2||0
6337746|NCT00555906|7245206|FG003|Treated|Phase 2||0
6337747|NCT00555906|7245207|FG004|Treated|Phase 2||30
6337748|NCT00555906|7245203|FG000|COMPLETED|Phase 2||0
6337749|NCT00555906|7245204|FG001|COMPLETED|Phase 2||0
6337750|NCT00555906|7245205|FG002|COMPLETED|Phase 2||0
6337751|NCT00555906|7245206|FG003|COMPLETED|Phase 2||0
6337752|NCT00555906|7245207|FG004|COMPLETED|Phase 2||0
6337753|NCT00555906|7245203|FG000|NOT COMPLETED|Phase 2||0
6337754|NCT00555906|7245204|FG001|NOT COMPLETED|Phase 2||0
6337755|NCT00555906|7245205|FG002|NOT COMPLETED|Phase 2||0
6337756|NCT00555906|7245206|FG003|NOT COMPLETED|Phase 2||0
6337757|NCT00555906|7245207|FG004|NOT COMPLETED|Phase 2||32
6337758|NCT00555971|7245224|FG000|STARTED|Overall Study||5
6337759|NCT00555971|7245225|FG001|STARTED|Overall Study||8
6337760|NCT00555971|7245224|FG000|COMPLETED|Overall Study||4
6337761|NCT00555971|7245225|FG001|COMPLETED|Overall Study||7
6337762|NCT00555971|7245224|FG000|NOT COMPLETED|Overall Study||1
6337763|NCT00555971|7245225|FG001|NOT COMPLETED|Overall Study||1
6337764|NCT00555997|7245234|FG000|STARTED|Phase 1 SPCD||29
6337765|NCT00555997|7245235|FG001|STARTED|Phase 1 SPCD||91
6337766|NCT00555997|7245236|FG002|STARTED|Phase 1 SPCD||0
6337767|NCT00555997|7245237|FG003|STARTED|Phase 1 SPCD||0
6337768|NCT00555997|7245234|FG000|COMPLETED|Phase 1 SPCD||17
6337769|NCT00555997|7245235|FG001|COMPLETED|Phase 1 SPCD||76
6337770|NCT00555997|7245236|FG002|COMPLETED|Phase 1 SPCD||0
6337771|NCT00555997|7245237|FG003|COMPLETED|Phase 1 SPCD||0
6337772|NCT00555997|7245234|FG000|NOT COMPLETED|Phase 1 SPCD||12
6337773|NCT00555997|7245235|FG001|NOT COMPLETED|Phase 1 SPCD||15
6337774|NCT00555997|7245236|FG002|NOT COMPLETED|Phase 1 SPCD||0
6337775|NCT00555997|7245237|FG003|NOT COMPLETED|Phase 1 SPCD||0
6337776|NCT00555997|7245234|FG000|STARTED|Phase 2 SPCD||0
6337777|NCT00555997|7245235|FG001|STARTED|Phase 2 SPCD||0
6337778|NCT00555997|7245236|FG002|STARTED|Phase 2 SPCD||38
6337779|NCT00555997|7245237|FG003|STARTED|Phase 2 SPCD||25
6337780|NCT00555997|7245234|FG000|COMPLETED|Phase 2 SPCD||0
6337781|NCT00555997|7245235|FG001|COMPLETED|Phase 2 SPCD||0
6337782|NCT00555997|7245236|FG002|COMPLETED|Phase 2 SPCD||31
6337783|NCT00555997|7245237|FG003|COMPLETED|Phase 2 SPCD||22
6337784|NCT00555997|7245234|FG000|NOT COMPLETED|Phase 2 SPCD||0
6337785|NCT00555997|7245235|FG001|NOT COMPLETED|Phase 2 SPCD||0
6337786|NCT00555997|7245236|FG002|NOT COMPLETED|Phase 2 SPCD||7
6337787|NCT00555997|7245237|FG003|NOT COMPLETED|Phase 2 SPCD||3
6337788|NCT00556049|7245249|FG000|STARTED|Overall Study||72
6337789|NCT00556049|7245249|FG000|COMPLETED|Overall Study||72
6337790|NCT00556049|7245249|FG000|NOT COMPLETED|Overall Study||0
6337791|NCT00556140|7245253|FG000|STARTED|Overall Study||16
6337792|NCT00556140|7245253|FG000|COMPLETED|Overall Study||13
6337793|NCT00556140|7245253|FG000|NOT COMPLETED|Overall Study||3
6337794|NCT00556322|7245259|FG000|STARTED|Overall Study||221
6337795|NCT00556322|7245260|FG001|STARTED|Overall Study||203
6337796|NCT00556322|7245259|FG000|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
6337797|NCT00556322|7245260|FG001|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
6337798|NCT00556322|7245259|FG000|NOT COMPLETED|Overall Study||221
6337799|NCT00556322|7245260|FG001|NOT COMPLETED|Overall Study||203
6337800|NCT00556374|7245271|FG000|STARTED|Overall Study||1709
6337801|NCT00556374|7245272|FG001|STARTED|Overall Study||1711
6337802|NCT00556374|7245271|FG000|Received Study Drug|Overall Study||1699
6337803|NCT00556374|7245272|FG001|Received Study Drug|Overall Study||1700
6337804|NCT00556374|7245271|FG000|COMPLETED|Overall Study|Indicates participants continuing study|1462
6337805|NCT00556374|7245272|FG001|COMPLETED|Overall Study|Indicates participants continuing study|1491
6337806|NCT00556374|7245271|FG000|NOT COMPLETED|Overall Study||247
6337807|NCT00556374|7245272|FG001|NOT COMPLETED|Overall Study||220
6337808|NCT00556426|7245278|FG000|STARTED|Overall Study||100
6337809|NCT00556426|7245278|FG000|COMPLETED|Overall Study||91
6337810|NCT00556426|7245278|FG000|NOT COMPLETED|Overall Study||9
6337811|NCT00556439|7245287|FG000|STARTED|Study Entry to Week 12|58 signed informed consent with 9 not being eligible. The remaining 49 received study drug.|49
6337812|NCT00556439|7245288|FG001|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
6337813|NCT00556439|7245289|FG002|STARTED|Study Entry to Week 12|39 signed informed consent with 5 not being eligible. The remaining 34 received study drug.|34
6337814|NCT00556439|7245290|FG003|STARTED|Study Entry to Week 12|No participants received placebo until the Week 12 Randomization|0
6337815|NCT00556439|7245287|FG000|COMPLETED|Study Entry to Week 12||41
6337816|NCT00556439|7245288|FG001|COMPLETED|Study Entry to Week 12||0
6337817|NCT00556439|7245289|FG002|COMPLETED|Study Entry to Week 12||26
6337818|NCT00556439|7245290|FG003|COMPLETED|Study Entry to Week 12||0
6337819|NCT00556439|7245287|FG000|NOT COMPLETED|Study Entry to Week 12||8
6337820|NCT00556439|7245288|FG001|NOT COMPLETED|Study Entry to Week 12||0
6337821|NCT00556439|7245289|FG002|NOT COMPLETED|Study Entry to Week 12||8
6337822|NCT00556439|7245290|FG003|NOT COMPLETED|Study Entry to Week 12||0
6337823|NCT00556439|7245287|FG000|STARTED|After Week 12 (Randomized Study Period)||20
6337824|NCT00556439|7245288|FG001|STARTED|After Week 12 (Randomized Study Period)||21
6337825|NCT00556439|7245289|FG002|STARTED|After Week 12 (Randomized Study Period)||11
6337826|NCT00556439|7245290|FG003|STARTED|After Week 12 (Randomized Study Period)||15
6337827|NCT00556439|7245287|FG000|COMPLETED|After Week 12 (Randomized Study Period)||17
6337828|NCT00556439|7245288|FG001|COMPLETED|After Week 12 (Randomized Study Period)||17
6337829|NCT00556439|7245289|FG002|COMPLETED|After Week 12 (Randomized Study Period)||11
6337830|NCT00556439|7245290|FG003|COMPLETED|After Week 12 (Randomized Study Period)||14
6559055|NCT01779219|7481677|FG001|COMPLETED|Overall Study|First interim analysis|21
6559056|NCT01779219|7481676|FG000|NOT COMPLETED|Overall Study||0
6559057|NCT01779219|7481677|FG001|NOT COMPLETED|Overall Study||0
6559058|NCT01779375|7481685|FG000|STARTED|Overall Study||47
6559059|NCT01779375|7481686|FG001|STARTED|Overall Study||44
6337831|NCT00556439|7245287|FG000|NOT COMPLETED|After Week 12 (Randomized Study Period)||3
6337832|NCT00556439|7245288|FG001|NOT COMPLETED|After Week 12 (Randomized Study Period)||4
6337833|NCT00556439|7245289|FG002|NOT COMPLETED|After Week 12 (Randomized Study Period)||0
6337834|NCT00556439|7245290|FG003|NOT COMPLETED|After Week 12 (Randomized Study Period)||1
6337835|NCT00556452|7245303|FG000|STARTED|Overall Study||6
6337836|NCT00556452|7245304|FG001|STARTED|Overall Study||21
6337837|NCT00556452|7245305|FG002|STARTED|Overall Study||19
6337838|NCT00556452|7245303|FG000|COMPLETED|Overall Study||6
6337839|NCT00556452|7245304|FG001|COMPLETED|Overall Study||21
6337840|NCT00556452|7245305|FG002|COMPLETED|Overall Study||19
6337841|NCT00556452|7245303|FG000|NOT COMPLETED|Overall Study||0
6337842|NCT00556452|7245304|FG001|NOT COMPLETED|Overall Study||0
6559060|NCT01779375|7481685|FG000|COMPLETED|Overall Study||45
6559061|NCT01779375|7481686|FG001|COMPLETED|Overall Study||41
6559062|NCT01779375|7481685|FG000|NOT COMPLETED|Overall Study||2
6559063|NCT01779375|7481686|FG001|NOT COMPLETED|Overall Study||3
6337843|NCT00556452|7245305|FG002|NOT COMPLETED|Overall Study||0
6337844|NCT00556478|7245312|FG000|STARTED|Double-blind Phase||171
6337845|NCT00556478|7245313|FG001|STARTED|Double-blind Phase||85
6337846|NCT00556478|7245312|FG000|ITT|Double-blind Phase||167
6337847|NCT00556478|7245313|FG001|ITT|Double-blind Phase||82
6337848|NCT00556478|7245312|FG000|COMPLETED|Double-blind Phase||150
6337849|NCT00556478|7245313|FG001|COMPLETED|Double-blind Phase||77
6337850|NCT00556478|7245312|FG000|NOT COMPLETED|Double-blind Phase||21
6337851|NCT00556478|7245313|FG001|NOT COMPLETED|Double-blind Phase||8
6337852|NCT00556478|7245312|FG000|STARTED|Open-Label Phase||146
6337853|NCT00556478|7245313|FG001|STARTED|Open-Label Phase||77
6337854|NCT00556478|7245312|FG000|Treated in Open-label|Open-Label Phase||142
6337855|NCT00556478|7245313|FG001|Treated in Open-label|Open-Label Phase||71
6337856|NCT00556478|7245312|FG000|COMPLETED|Open-Label Phase||132
6337857|NCT00556478|7245313|FG001|COMPLETED|Open-Label Phase||67
6337858|NCT00556478|7245312|FG000|NOT COMPLETED|Open-Label Phase||14
6337859|NCT00556478|7245313|FG001|NOT COMPLETED|Open-Label Phase||10
6337860|NCT00556491|7245324|FG000|STARTED|Overall Study|January 2008|20
6337861|NCT00556491|7245325|FG001|STARTED|Overall Study||20
6337862|NCT00556491|7245324|FG000|COMPLETED|Overall Study||19
6337863|NCT00556491|7245325|FG001|COMPLETED|Overall Study||19
6337864|NCT00556491|7245324|FG000|NOT COMPLETED|Overall Study||1
6337865|NCT00556491|7245325|FG001|NOT COMPLETED|Overall Study||1
6337866|NCT00556504|7245343|FG000|STARTED|Overall Study||42
6337867|NCT00556504|7245344|FG001|STARTED|Overall Study||42
6337868|NCT00556504|7245343|FG000|Intend-to Treat Population|Overall Study||42
6337869|NCT00556504|7245344|FG001|Intend-to Treat Population|Overall Study||42
6337870|NCT00556504|7245343|FG000|Safety Population|Overall Study||41
6337871|NCT00556504|7245344|FG001|Safety Population|Overall Study||42
6337872|NCT00556504|7245343|FG000|COMPLETED|Overall Study||34
6337873|NCT00556504|7245344|FG001|COMPLETED|Overall Study||33
6337874|NCT00556504|7245343|FG000|NOT COMPLETED|Overall Study||8
6337875|NCT00556504|7245344|FG001|NOT COMPLETED|Overall Study||9
6337876|NCT00556543|7245350|FG000|STARTED|Overall Study||10
6337877|NCT00556543|7245350|FG000|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
6337878|NCT00556543|7245350|FG000|NOT COMPLETED|Overall Study||0
6337879|NCT00556673|7245359|FG000|STARTED|Overall Study||16
6337880|NCT00556673|7245360|FG001|STARTED|Overall Study||15
6337881|NCT00556673|7245359|FG000|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
6337882|NCT00556673|7245360|FG001|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
6337883|NCT00556673|7245359|FG000|COMPLETED|Overall Study||13
6337884|NCT00556673|7245360|FG001|COMPLETED|Overall Study||13
6337885|NCT00556673|7245359|FG000|NOT COMPLETED|Overall Study||3
6337886|NCT00556673|7245360|FG001|NOT COMPLETED|Overall Study||2
6337887|NCT00556712|7245370|FG000|STARTED|Overall Study||451
6337888|NCT00556712|7245371|FG001|STARTED|Overall Study||438
6337889|NCT00556712|7245370|FG000|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
6337890|NCT00556712|7245371|FG001|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
6337891|NCT00556712|7245370|FG000|NOT COMPLETED|Overall Study||451
6337892|NCT00556712|7245371|FG001|NOT COMPLETED|Overall Study||438
6337893|NCT00556842|7245379|FG000|STARTED|Overall Study||749
6337894|NCT00556842|7245380|FG001|STARTED|Overall Study||746
6337895|NCT00556842|7245379|FG000|COMPLETED|Overall Study||718
6337896|NCT00556842|7245380|FG001|COMPLETED|Overall Study||723
6337897|NCT00556842|7245379|FG000|NOT COMPLETED|Overall Study||31
6337898|NCT00556842|7245380|FG001|NOT COMPLETED|Overall Study||23
6337899|NCT00556894|7245397|FG000|STARTED|Overall Study||82
6337900|NCT00556894|7245398|FG001|STARTED|Overall Study||87
6337901|NCT00556894|7245399|FG002|STARTED|Overall Study||84
6337902|NCT00556894|7245397|FG000|COMPLETED|Overall Study||66
6337903|NCT00556894|7245398|FG001|COMPLETED|Overall Study||68
6337904|NCT00556894|7245399|FG002|COMPLETED|Overall Study||65
6337905|NCT00556894|7245397|FG000|NOT COMPLETED|Overall Study||16
6337906|NCT00556894|7245398|FG001|NOT COMPLETED|Overall Study||19
6337907|NCT00556894|7245399|FG002|NOT COMPLETED|Overall Study||19
6337908|NCT00556933|7245411|FG000|STARTED|Single vs. Divided-dose rATG Induction||45
6337909|NCT00556933|7245412|FG001|STARTED|Single vs. Divided-dose rATG Induction||45
6337910|NCT00556933|7245413|FG002|STARTED|Single vs. Divided-dose rATG Induction||45
6337911|NCT00556933|7245414|FG003|STARTED|Single vs. Divided-dose rATG Induction||45
6337912|NCT00556933|7245411|FG000|COMPLETED|Single vs. Divided-dose rATG Induction||43
6337913|NCT00556933|7245412|FG001|COMPLETED|Single vs. Divided-dose rATG Induction||37
6337914|NCT00556933|7245413|FG002|COMPLETED|Single vs. Divided-dose rATG Induction||39
6337915|NCT00556933|7245414|FG003|COMPLETED|Single vs. Divided-dose rATG Induction||43
6337916|NCT00556933|7245411|FG000|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
6337917|NCT00556933|7245412|FG001|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
6337918|NCT00556933|7245413|FG002|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
6337919|NCT00556933|7245414|FG003|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
6337920|NCT00556933|7245411|FG000|STARTED|CNI Withdrawal vs. Minimization||43
6337921|NCT00556933|7245412|FG001|STARTED|CNI Withdrawal vs. Minimization||37
6337922|NCT00556933|7245413|FG002|STARTED|CNI Withdrawal vs. Minimization||39
6337923|NCT00556933|7245414|FG003|STARTED|CNI Withdrawal vs. Minimization||43
6337924|NCT00556933|7245411|FG000|COMPLETED|CNI Withdrawal vs. Minimization||42
6337925|NCT00556933|7245412|FG001|COMPLETED|CNI Withdrawal vs. Minimization||33
6337926|NCT00556933|7245413|FG002|COMPLETED|CNI Withdrawal vs. Minimization||36
6337927|NCT00556933|7245414|FG003|COMPLETED|CNI Withdrawal vs. Minimization||41
6337928|NCT00556933|7245411|FG000|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
6337929|NCT00556933|7245412|FG001|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
6337930|NCT00556933|7245413|FG002|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
6337931|NCT00556933|7245414|FG003|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
6337932|NCT00556946|7245433|FG000|STARTED|Overall Study||17
6337933|NCT00556946|7245433|FG000|COMPLETED|Overall Study||16
6337934|NCT00556946|7245433|FG000|NOT COMPLETED|Overall Study||1
6337935|NCT00556972|7245437|FG000|STARTED|Overall Study||4
6337936|NCT00556972|7245437|FG000|COMPLETED|Overall Study||4
6337937|NCT00556972|7245437|FG000|NOT COMPLETED|Overall Study||0
6337938|NCT00556998|7245441|FG000|STARTED|Voriconazole Intravenous (IV)||26
6337939|NCT00556998|7245441|FG000|Treated|Voriconazole Intravenous (IV)||26
6337940|NCT00556998|7245441|FG000|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
6337941|NCT00556998|7245441|FG000|NOT COMPLETED|Voriconazole Intravenous (IV)||5
6337942|NCT00556998|7245441|FG000|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
6337943|NCT00556998|7245441|FG000|COMPLETED|Voriconazole Oral||20
6337944|NCT00556998|7245441|FG000|NOT COMPLETED|Voriconazole Oral||2
6337945|NCT00557076|7245451|FG000|STARTED|Overall Study||8
6337946|NCT00557076|7245452|FG001|STARTED|Overall Study||8
6337947|NCT00557076|7245451|FG000|COMPLETED|Overall Study||8
6337948|NCT00557076|7245452|FG001|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
6337949|NCT00557076|7245451|FG000|NOT COMPLETED|Overall Study||0
6337950|NCT00557076|7245452|FG001|NOT COMPLETED|Overall Study||1
6337951|NCT00557245|7245461|FG000|STARTED|Overall Study||1589
6337952|NCT00557245|7245462|FG001|STARTED|Overall Study||1583
6337953|NCT00557245|7245463|FG002|STARTED|Overall Study||1586
6337954|NCT00557245|7245461|FG000|COMPLETED|Overall Study||1577
6337955|NCT00557245|7245462|FG001|COMPLETED|Overall Study||1571
6337956|NCT00557245|7245463|FG002|COMPLETED|Overall Study||1574
6337957|NCT00557245|7245461|FG000|NOT COMPLETED|Overall Study||12
6337958|NCT00557245|7245462|FG001|NOT COMPLETED|Overall Study||12
6337959|NCT00557245|7245463|FG002|NOT COMPLETED|Overall Study||12
6337960|NCT00557284|7245476|FG000|STARTED|Overall Study||9
6337961|NCT00557284|7245477|FG001|STARTED|Overall Study||11
6337962|NCT00557284|7245476|FG000|COMPLETED|Overall Study||9
6337963|NCT00557284|7245477|FG001|COMPLETED|Overall Study||11
6337964|NCT00557284|7245476|FG000|NOT COMPLETED|Overall Study||0
6337965|NCT00557284|7245477|FG001|NOT COMPLETED|Overall Study||0
6337966|NCT00557310|7245483|FG000|STARTED|Main Study (0 - 18 Months)||35
6337967|NCT00557310|7245483|FG000|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
6337968|NCT00557310|7245483|FG000|NOT COMPLETED|Main Study (0 - 18 Months)||5
6337969|NCT00557310|7245483|FG000|STARTED|Extension Phase (18 - 24 Months)||30
6337970|NCT00557310|7245483|FG000|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
6337971|NCT00557310|7245483|FG000|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
6337972|NCT00557323|7245487|FG000|STARTED|Overall Study||34
6337973|NCT00557323|7245487|FG000|COMPLETED|Overall Study||27
6337974|NCT00557323|7245487|FG000|NOT COMPLETED|Overall Study||7
6337975|NCT00557349|7245493|FG000|STARTED|Overall Study|omeprazole/bicarb|22
6337976|NCT00557349|7245494|FG001|STARTED|Overall Study||18
6337977|NCT00557349|7245493|FG000|COMPLETED|Overall Study||17
6337978|NCT00557349|7245494|FG001|COMPLETED|Overall Study||13
6337979|NCT00557349|7245493|FG000|NOT COMPLETED|Overall Study||5
6337980|NCT00557349|7245494|FG001|NOT COMPLETED|Overall Study||5
6337981|NCT00557362|7245504|FG000|STARTED|Overall Study||30
6337982|NCT00557362|7245505|FG001|STARTED|Overall Study||30
6337983|NCT00557362|7245506|FG002|STARTED|Overall Study||30
6337984|NCT00557362|7245507|FG003|STARTED|Overall Study||30
6337985|NCT00557362|7245504|FG000|COMPLETED|Overall Study||28
6337986|NCT00557362|7245505|FG001|COMPLETED|Overall Study||28
6337987|NCT00557362|7245506|FG002|COMPLETED|Overall Study||26
6337988|NCT00557362|7245507|FG003|COMPLETED|Overall Study||27
6337989|NCT00557362|7245504|FG000|NOT COMPLETED|Overall Study||2
6337990|NCT00557362|7245505|FG001|NOT COMPLETED|Overall Study||2
6337991|NCT00557362|7245506|FG002|NOT COMPLETED|Overall Study||4
6337992|NCT00557362|7245507|FG003|NOT COMPLETED|Overall Study||3
6337993|NCT00557440|7245523|FG000|STARTED|Treatment Period 1||12
6337994|NCT00557440|7245524|FG001|STARTED|Treatment Period 1||12
6337995|NCT00557440|7245525|FG002|STARTED|Treatment Period 1||13
6337996|NCT00557440|7245523|FG000|COMPLETED|Treatment Period 1||12
6337997|NCT00557440|7245524|FG001|COMPLETED|Treatment Period 1||12
6337998|NCT00557440|7245525|FG002|COMPLETED|Treatment Period 1||12
6337999|NCT00557440|7245523|FG000|NOT COMPLETED|Treatment Period 1||0
6338000|NCT00557440|7245524|FG001|NOT COMPLETED|Treatment Period 1||0
6338001|NCT00557440|7245525|FG002|NOT COMPLETED|Treatment Period 1||1
6338002|NCT00557440|7245523|FG000|STARTED|Treatment Period 2||12
6338003|NCT00557440|7245524|FG001|STARTED|Treatment Period 2||12
6338004|NCT00557440|7245525|FG002|STARTED|Treatment Period 2||12
6338005|NCT00557440|7245523|FG000|COMPLETED|Treatment Period 2||12
6338006|NCT00557440|7245524|FG001|COMPLETED|Treatment Period 2||12
6338007|NCT00557440|7245525|FG002|COMPLETED|Treatment Period 2||12
6338008|NCT00557440|7245523|FG000|NOT COMPLETED|Treatment Period 2||0
6338009|NCT00557440|7245524|FG001|NOT COMPLETED|Treatment Period 2||0
6338010|NCT00557440|7245525|FG002|NOT COMPLETED|Treatment Period 2||0
6338011|NCT00557440|7245523|FG000|STARTED|Treatment Period 3||12
6338012|NCT00557440|7245524|FG001|STARTED|Treatment Period 3||12
6338013|NCT00557440|7245525|FG002|STARTED|Treatment Period 3||12
6338014|NCT00557440|7245523|FG000|COMPLETED|Treatment Period 3||12
6338015|NCT00557440|7245524|FG001|COMPLETED|Treatment Period 3||12
6338016|NCT00557440|7245525|FG002|COMPLETED|Treatment Period 3||12
6338017|NCT00557440|7245523|FG000|NOT COMPLETED|Treatment Period 3||0
6338018|NCT00557440|7245524|FG001|NOT COMPLETED|Treatment Period 3||0
6338019|NCT00557440|7245525|FG002|NOT COMPLETED|Treatment Period 3||0
6338020|NCT00557466|7245539|FG000|STARTED|Overall Study||98
6338021|NCT00557466|7245540|FG001|STARTED|Overall Study||92
6338022|NCT00557466|7245541|FG002|STARTED|Overall Study||101
6338023|NCT00557466|7245542|FG003|STARTED|Overall Study||96
6338024|NCT00557466|7245543|FG004|STARTED|Overall Study||90
6338025|NCT00557466|7245544|FG005|STARTED|Overall Study||91
6338026|NCT00557466|7245539|FG000|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
6338027|NCT00557466|7245540|FG001|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
6338028|NCT00557466|7245541|FG002|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
6338029|NCT00557466|7245542|FG003|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
6338030|NCT00557466|7245543|FG004|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
6338031|NCT00557466|7245544|FG005|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
6338032|NCT00557466|7245539|FG000|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
6338033|NCT00557466|7245540|FG001|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
6338034|NCT00557466|7245541|FG002|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
6338035|NCT00557466|7245542|FG003|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
6338036|NCT00557466|7245543|FG004|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
6338037|NCT00557466|7245544|FG005|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
6338038|NCT00557466|7245539|FG000|COMPLETED|Overall Study||94
6338039|NCT00557466|7245540|FG001|COMPLETED|Overall Study||87
6338040|NCT00557466|7245541|FG002|COMPLETED|Overall Study||95
6338041|NCT00557466|7245542|FG003|COMPLETED|Overall Study||92
6338042|NCT00557466|7245543|FG004|COMPLETED|Overall Study||87
6338043|NCT00557466|7245544|FG005|COMPLETED|Overall Study||85
6338044|NCT00557466|7245539|FG000|NOT COMPLETED|Overall Study||4
6338045|NCT00557466|7245540|FG001|NOT COMPLETED|Overall Study||5
6338046|NCT00557466|7245541|FG002|NOT COMPLETED|Overall Study||6
6338047|NCT00557466|7245542|FG003|NOT COMPLETED|Overall Study||4
6338048|NCT00557466|7245543|FG004|NOT COMPLETED|Overall Study||3
6338049|NCT00557466|7245544|FG005|NOT COMPLETED|Overall Study||6
6338050|NCT00557492|7245558|FG000|STARTED|Overall Study||59
6338051|NCT00557492|7245558|FG000|COMPLETED|Overall Study|Evaluable for outcomes|58
6338052|NCT00557492|7245558|FG000|NOT COMPLETED|Overall Study||1
6338053|NCT00557505|7245571|FG000|STARTED|Overall Study||3
6338054|NCT00557505|7245572|FG001|STARTED|Overall Study||3
6338055|NCT00557505|7245573|FG002|STARTED|Overall Study||4
6338056|NCT00557505|7245574|FG003|STARTED|Overall Study||3
6338057|NCT00557505|7245575|FG004|STARTED|Overall Study||2
6338058|NCT00557505|7245576|FG005|STARTED|Overall Study||3
6338059|NCT00557505|7245577|FG006|STARTED|Overall Study||3
6338060|NCT00557505|7245578|FG007|STARTED|Overall Study||5
6338061|NCT00557505|7245579|FG008|STARTED|Overall Study||17
6338062|NCT00557505|7245571|FG000|COMPLETED|Overall Study||0
6338063|NCT00557505|7245572|FG001|COMPLETED|Overall Study||0
6338064|NCT00557505|7245573|FG002|COMPLETED|Overall Study||0
6338065|NCT00557505|7245574|FG003|COMPLETED|Overall Study||0
6338066|NCT00557505|7245575|FG004|COMPLETED|Overall Study||0
6338067|NCT00557505|7245576|FG005|COMPLETED|Overall Study||0
6338068|NCT00557505|7245577|FG006|COMPLETED|Overall Study||0
6338069|NCT00557505|7245578|FG007|COMPLETED|Overall Study||0
6338070|NCT00557505|7245579|FG008|COMPLETED|Overall Study||0
6338071|NCT00557505|7245571|FG000|NOT COMPLETED|Overall Study||3
6338072|NCT00557505|7245572|FG001|NOT COMPLETED|Overall Study||3
6338073|NCT00557505|7245573|FG002|NOT COMPLETED|Overall Study||4
6559064|NCT01779440|7481696|FG000|STARTED|Overall Study||30
6559065|NCT01779440|7481697|FG001|STARTED|Overall Study||28
6559066|NCT01779440|7481696|FG000|COMPLETED|Overall Study||27
6559067|NCT01779440|7481697|FG001|COMPLETED|Overall Study||23
6559068|NCT01779440|7481696|FG000|NOT COMPLETED|Overall Study||3
6559069|NCT01779440|7481697|FG001|NOT COMPLETED|Overall Study||5
6338074|NCT00557505|7245574|FG003|NOT COMPLETED|Overall Study||3
6338075|NCT00557505|7245575|FG004|NOT COMPLETED|Overall Study||2
6338076|NCT00557505|7245576|FG005|NOT COMPLETED|Overall Study||3
6338077|NCT00557505|7245577|FG006|NOT COMPLETED|Overall Study||3
6338078|NCT00557505|7245578|FG007|NOT COMPLETED|Overall Study||5
6338079|NCT00557505|7245579|FG008|NOT COMPLETED|Overall Study||17
6338080|NCT00557622|7245604|FG000|STARTED|4-Week Run-in Phase||5
6338081|NCT00557622|7245605|FG001|STARTED|4-Week Run-in Phase||0
6338082|NCT00557622|7245604|FG000|COMPLETED|4-Week Run-in Phase||3
6338083|NCT00557622|7245605|FG001|COMPLETED|4-Week Run-in Phase||0
6338084|NCT00557622|7245604|FG000|NOT COMPLETED|4-Week Run-in Phase||2
6338085|NCT00557622|7245605|FG001|NOT COMPLETED|4-Week Run-in Phase||0
6338086|NCT00557622|7245604|FG000|STARTED|12-Week Treatment Phase||1
6338087|NCT00557622|7245605|FG001|STARTED|12-Week Treatment Phase||2
6338088|NCT00557622|7245604|FG000|COMPLETED|12-Week Treatment Phase||1
6338089|NCT00557622|7245605|FG001|COMPLETED|12-Week Treatment Phase||1
6338090|NCT00557622|7245604|FG000|NOT COMPLETED|12-Week Treatment Phase||0
6338091|NCT00557622|7245605|FG001|NOT COMPLETED|12-Week Treatment Phase||1
6338092|NCT00557830|7245614|FG000|STARTED|Screening Treatment Phase||12
6338093|NCT00557830|7245615|FG001|STARTED|Screening Treatment Phase||0
6338094|NCT00557830|7245616|FG002|STARTED|Screening Treatment Phase||0
6338095|NCT00557830|7245614|FG000|COMPLETED|Screening Treatment Phase||6
6338096|NCT00557830|7245615|FG001|COMPLETED|Screening Treatment Phase||0
6338097|NCT00557830|7245616|FG002|COMPLETED|Screening Treatment Phase||0
6338098|NCT00557830|7245614|FG000|NOT COMPLETED|Screening Treatment Phase||6
6338099|NCT00557830|7245615|FG001|NOT COMPLETED|Screening Treatment Phase||0
6338100|NCT00557830|7245616|FG002|NOT COMPLETED|Screening Treatment Phase||0
6338101|NCT00557830|7245614|FG000|STARTED|Treatment Phase||0
6338102|NCT00557830|7245615|FG001|STARTED|Treatment Phase||4
6776351|NCT03815240|7704434|FG007|NOT COMPLETED|Intervention Allevyn Dressing||0
6776352|NCT03815240|7704435|FG008|NOT COMPLETED|Intervention Allevyn Dressing||0
6338103|NCT00557830|7245616|FG002|STARTED|Treatment Phase||2
6338104|NCT00557830|7245614|FG000|COMPLETED|Treatment Phase||0
6338105|NCT00557830|7245615|FG001|COMPLETED|Treatment Phase||4
6338106|NCT00557830|7245616|FG002|COMPLETED|Treatment Phase||2
6338107|NCT00557830|7245614|FG000|NOT COMPLETED|Treatment Phase||0
6338108|NCT00557830|7245615|FG001|NOT COMPLETED|Treatment Phase||0
6338109|NCT00557830|7245616|FG002|NOT COMPLETED|Treatment Phase||0
6338110|NCT00557856|7245624|FG000|STARTED|Part 1: Dose Escalation Phase||7
6338111|NCT00557856|7245625|FG001|STARTED|Part 1: Dose Escalation Phase||5
6338112|NCT00557856|7245626|FG002|STARTED|Part 1: Dose Escalation Phase||6
6338113|NCT00557856|7245627|FG003|STARTED|Part 1: Dose Escalation Phase||3
6338114|NCT00557856|7245628|FG004|STARTED|Part 1: Dose Escalation Phase||4
6338115|NCT00557856|7245629|FG005|STARTED|Part 1: Dose Escalation Phase||8
6338116|NCT00557856|7245630|FG006|STARTED|Part 1: Dose Escalation Phase||7
6338117|NCT00557856|7245631|FG007|STARTED|Part 1: Dose Escalation Phase||6
6338118|NCT00557856|7245632|FG008|STARTED|Part 1: Dose Escalation Phase||0
6338119|NCT00557856|7245624|FG000|Treated|Part 1: Dose Escalation Phase||5
6338120|NCT00557856|7245625|FG001|Treated|Part 1: Dose Escalation Phase||5
6338121|NCT00557856|7245626|FG002|Treated|Part 1: Dose Escalation Phase||6
6338122|NCT00557856|7245627|FG003|Treated|Part 1: Dose Escalation Phase||3
6338123|NCT00557856|7245628|FG004|Treated|Part 1: Dose Escalation Phase||4
6338124|NCT00557856|7245629|FG005|Treated|Part 1: Dose Escalation Phase||8
6338125|NCT00557856|7245630|FG006|Treated|Part 1: Dose Escalation Phase||7
6338126|NCT00557856|7245631|FG007|Treated|Part 1: Dose Escalation Phase||6
6338127|NCT00557856|7245632|FG008|Treated|Part 1: Dose Escalation Phase||0
6338128|NCT00557856|7245624|FG000|COMPLETED|Part 1: Dose Escalation Phase||0
6338129|NCT00557856|7245625|FG001|COMPLETED|Part 1: Dose Escalation Phase||0
6338130|NCT00557856|7245626|FG002|COMPLETED|Part 1: Dose Escalation Phase||0
6338131|NCT00557856|7245627|FG003|COMPLETED|Part 1: Dose Escalation Phase||0
6338132|NCT00557856|7245628|FG004|COMPLETED|Part 1: Dose Escalation Phase||0
6338133|NCT00557856|7245629|FG005|COMPLETED|Part 1: Dose Escalation Phase||0
6338134|NCT00557856|7245630|FG006|COMPLETED|Part 1: Dose Escalation Phase||0
6338135|NCT00557856|7245631|FG007|COMPLETED|Part 1: Dose Escalation Phase||0
6338136|NCT00557856|7245632|FG008|COMPLETED|Part 1: Dose Escalation Phase||0
6338137|NCT00557856|7245624|FG000|NOT COMPLETED|Part 1: Dose Escalation Phase||7
6338138|NCT00557856|7245625|FG001|NOT COMPLETED|Part 1: Dose Escalation Phase||5
6338139|NCT00557856|7245626|FG002|NOT COMPLETED|Part 1: Dose Escalation Phase||6
6338140|NCT00557856|7245627|FG003|NOT COMPLETED|Part 1: Dose Escalation Phase||3
6338141|NCT00557856|7245628|FG004|NOT COMPLETED|Part 1: Dose Escalation Phase||4
6338142|NCT00557856|7245629|FG005|NOT COMPLETED|Part 1: Dose Escalation Phase||8
6338143|NCT00557856|7245630|FG006|NOT COMPLETED|Part 1: Dose Escalation Phase||7
6338144|NCT00557856|7245631|FG007|NOT COMPLETED|Part 1: Dose Escalation Phase||6
6338145|NCT00557856|7245632|FG008|NOT COMPLETED|Part 1: Dose Escalation Phase||0
6338146|NCT00557856|7245624|FG000|STARTED|Part 2: Exploratory Phase||0
6338147|NCT00557856|7245625|FG001|STARTED|Part 2: Exploratory Phase||0
6338148|NCT00557856|7245626|FG002|STARTED|Part 2: Exploratory Phase||0
6338149|NCT00557856|7245627|FG003|STARTED|Part 2: Exploratory Phase||0
6338150|NCT00557856|7245628|FG004|STARTED|Part 2: Exploratory Phase||0
6338151|NCT00557856|7245629|FG005|STARTED|Part 2: Exploratory Phase||0
6338152|NCT00557856|7245630|FG006|STARTED|Part 2: Exploratory Phase||0
6338153|NCT00557856|7245631|FG007|STARTED|Part 2: Exploratory Phase||0
6338154|NCT00557856|7245632|FG008|STARTED|Part 2: Exploratory Phase||24
6338155|NCT00557856|7245624|FG000|COMPLETED|Part 2: Exploratory Phase||0
6338156|NCT00557856|7245625|FG001|COMPLETED|Part 2: Exploratory Phase||0
6338157|NCT00557856|7245626|FG002|COMPLETED|Part 2: Exploratory Phase||0
6338158|NCT00557856|7245627|FG003|COMPLETED|Part 2: Exploratory Phase||0
6338159|NCT00557856|7245628|FG004|COMPLETED|Part 2: Exploratory Phase||0
6338160|NCT00557856|7245629|FG005|COMPLETED|Part 2: Exploratory Phase||0
6338161|NCT00557856|7245630|FG006|COMPLETED|Part 2: Exploratory Phase||0
6338162|NCT00557856|7245631|FG007|COMPLETED|Part 2: Exploratory Phase||0
6338163|NCT00557856|7245632|FG008|COMPLETED|Part 2: Exploratory Phase||0
6338164|NCT00557856|7245624|FG000|NOT COMPLETED|Part 2: Exploratory Phase||0
6338165|NCT00557856|7245625|FG001|NOT COMPLETED|Part 2: Exploratory Phase||0
6338166|NCT00557856|7245626|FG002|NOT COMPLETED|Part 2: Exploratory Phase||0
6338167|NCT00557856|7245627|FG003|NOT COMPLETED|Part 2: Exploratory Phase||0
6338168|NCT00557856|7245628|FG004|NOT COMPLETED|Part 2: Exploratory Phase||0
6338169|NCT00557856|7245629|FG005|NOT COMPLETED|Part 2: Exploratory Phase||0
6338170|NCT00557856|7245630|FG006|NOT COMPLETED|Part 2: Exploratory Phase||0
6338171|NCT00557856|7245631|FG007|NOT COMPLETED|Part 2: Exploratory Phase||0
6338172|NCT00557856|7245632|FG008|NOT COMPLETED|Part 2: Exploratory Phase||24
6338173|NCT00557882|7245649|FG000|STARTED|Overall Study||32
6338174|NCT00557882|7245650|FG001|STARTED|Overall Study||33
6338175|NCT00557882|7245649|FG000|COMPLETED|Overall Study||27
6338176|NCT00557882|7245650|FG001|COMPLETED|Overall Study||33
6338177|NCT00557882|7245649|FG000|NOT COMPLETED|Overall Study||5
6338178|NCT00557882|7245650|FG001|NOT COMPLETED|Overall Study||0
6338179|NCT00557947|7245656|FG000|STARTED|Overall Study||83
6338180|NCT00557947|7245656|FG000|COMPLETED|Overall Study||83
6338181|NCT00557947|7245656|FG000|NOT COMPLETED|Overall Study||0
6338182|NCT00558012|7245666|FG000|STARTED|Overall Study||89
6338183|NCT00558012|7245667|FG001|STARTED|Overall Study||92
6338184|NCT00558012|7245666|FG000|COMPLETED|Overall Study||64
6338185|NCT00558012|7245667|FG001|COMPLETED|Overall Study||74
6338186|NCT00558012|7245666|FG000|NOT COMPLETED|Overall Study||25
6338187|NCT00558012|7245667|FG001|NOT COMPLETED|Overall Study||18
6338188|NCT00558025|7245675|FG000|STARTED|Overall Study||104
6338189|NCT00558025|7245676|FG001|STARTED|Overall Study||52
6338190|NCT00558025|7245675|FG000|COMPLETED|Overall Study||100
6338191|NCT00558025|7245676|FG001|COMPLETED|Overall Study||49
6338192|NCT00558025|7245675|FG000|NOT COMPLETED|Overall Study||4
6338193|NCT00558025|7245676|FG001|NOT COMPLETED|Overall Study||3
6338194|NCT00558064|7245684|FG000|STARTED|Overall Study||269
6338195|NCT00558064|7245685|FG001|STARTED|Overall Study||262
6338196|NCT00558064|7245684|FG000|COMPLETED|Overall Study||264
6338197|NCT00558064|7245685|FG001|COMPLETED|Overall Study||257
6338198|NCT00558064|7245684|FG000|NOT COMPLETED|Overall Study||5
6338199|NCT00558064|7245685|FG001|NOT COMPLETED|Overall Study||5
6338200|NCT00558103|7245696|FG000|STARTED|Randomized Treatment Phase||38
6338201|NCT00558103|7245697|FG001|STARTED|Randomized Treatment Phase||38
6338202|NCT00558103|7245698|FG002|STARTED|Randomized Treatment Phase||36
6338203|NCT00558103|7245699|FG003|STARTED|Randomized Treatment Phase||13
6338204|NCT00558103|7245700|FG004|STARTED|Randomized Treatment Phase||38
6338205|NCT00558103|7245701|FG005|STARTED|Randomized Treatment Phase||0
6338206|NCT00558103|7245696|FG000|COMPLETED|Randomized Treatment Phase||33
6338207|NCT00558103|7245697|FG001|COMPLETED|Randomized Treatment Phase||34
6338208|NCT00558103|7245698|FG002|COMPLETED|Randomized Treatment Phase||33
6338209|NCT00558103|7245699|FG003|COMPLETED|Randomized Treatment Phase||11
6338210|NCT00558103|7245700|FG004|COMPLETED|Randomized Treatment Phase||33
6338211|NCT00558103|7245701|FG005|COMPLETED|Randomized Treatment Phase||0
6338212|NCT00558103|7245696|FG000|NOT COMPLETED|Randomized Treatment Phase||5
6338213|NCT00558103|7245697|FG001|NOT COMPLETED|Randomized Treatment Phase||4
6338214|NCT00558103|7245698|FG002|NOT COMPLETED|Randomized Treatment Phase||3
6338215|NCT00558103|7245699|FG003|NOT COMPLETED|Randomized Treatment Phase||2
6338216|NCT00558103|7245700|FG004|NOT COMPLETED|Randomized Treatment Phase||5
6338217|NCT00558103|7245701|FG005|NOT COMPLETED|Randomized Treatment Phase||0
6338218|NCT00558103|7245696|FG000|STARTED|Monotherapy Extension Phase||0
6338219|NCT00558103|7245697|FG001|STARTED|Monotherapy Extension Phase||0
6338220|NCT00558103|7245698|FG002|STARTED|Monotherapy Extension Phase||0
6338221|NCT00558103|7245699|FG003|STARTED|Monotherapy Extension Phase||0
6338222|NCT00558103|7245700|FG004|STARTED|Monotherapy Extension Phase||0
6338223|NCT00558103|7245701|FG005|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
6338224|NCT00558103|7245696|FG000|COMPLETED|Monotherapy Extension Phase||0
6338225|NCT00558103|7245697|FG001|COMPLETED|Monotherapy Extension Phase||0
6338226|NCT00558103|7245698|FG002|COMPLETED|Monotherapy Extension Phase||0
6338227|NCT00558103|7245699|FG003|COMPLETED|Monotherapy Extension Phase||0
6338228|NCT00558103|7245700|FG004|COMPLETED|Monotherapy Extension Phase||0
6338229|NCT00558103|7245701|FG005|COMPLETED|Monotherapy Extension Phase||0
6338230|NCT00558103|7245696|FG000|NOT COMPLETED|Monotherapy Extension Phase||0
6338231|NCT00558103|7245697|FG001|NOT COMPLETED|Monotherapy Extension Phase||0
6338232|NCT00558103|7245698|FG002|NOT COMPLETED|Monotherapy Extension Phase||0
6338233|NCT00558103|7245699|FG003|NOT COMPLETED|Monotherapy Extension Phase||0
6338234|NCT00558103|7245700|FG004|NOT COMPLETED|Monotherapy Extension Phase||0
6338235|NCT00558103|7245701|FG005|NOT COMPLETED|Monotherapy Extension Phase||9
6338236|NCT00558246|7245714|FG000|STARTED|Overall Study||79
6338237|NCT00558246|7245714|FG000|COMPLETED|Overall Study||79
6338238|NCT00558246|7245714|FG000|NOT COMPLETED|Overall Study||0
6338239|NCT00558259|7245723|FG000|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
6338240|NCT00558259|7245724|FG001|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
6338241|NCT00558259|7245723|FG000|COMPLETED|Overall Study|Completed treatment.|610
6338242|NCT00558259|7245724|FG001|COMPLETED|Overall Study|Completed treatment.|563
6338243|NCT00558259|7245723|FG000|NOT COMPLETED|Overall Study||71
6338244|NCT00558259|7245724|FG001|NOT COMPLETED|Overall Study||99
6338245|NCT00558272|7245732|FG000|STARTED|Overall Study|Randomised|69
6338246|NCT00558272|7245733|FG001|STARTED|Overall Study|Randomised|70
6338247|NCT00558272|7245732|FG000|30 Days Follow-up|Overall Study|30 days after last dose|41
6338248|NCT00558272|7245733|FG001|30 Days Follow-up|Overall Study|30 days after last dose|67
6338249|NCT00558272|7245732|FG000|COMPLETED|Overall Study|4-week treatment period|56
6338250|NCT00558272|7245733|FG001|COMPLETED|Overall Study|4-week treatment period|68
6338251|NCT00558272|7245732|FG000|NOT COMPLETED|Overall Study||13
6338252|NCT00558272|7245733|FG001|NOT COMPLETED|Overall Study||2
6338253|NCT00558285|7245744|FG000|STARTED|Overall Study||50
6338254|NCT00558285|7245745|FG001|STARTED|Overall Study||51
6338255|NCT00558285|7245746|FG002|STARTED|Overall Study||51
6338256|NCT00558285|7245747|FG003|STARTED|Overall Study||52
6338257|NCT00558285|7245748|FG004|STARTED|Overall Study||53
6338258|NCT00558285|7245744|FG000|Safety: Received Study Drug|Overall Study||49
6338259|NCT00558285|7245745|FG001|Safety: Received Study Drug|Overall Study||51
6338260|NCT00558285|7245746|FG002|Safety: Received Study Drug|Overall Study||51
6338261|NCT00558285|7245747|FG003|Safety: Received Study Drug|Overall Study||51
6338262|NCT00558285|7245748|FG004|Safety: Received Study Drug|Overall Study||53
6338263|NCT00558285|7245744|FG000|COMPLETED|Overall Study||44
6338264|NCT00558285|7245745|FG001|COMPLETED|Overall Study||48
6338265|NCT00558285|7245746|FG002|COMPLETED|Overall Study||46
6338266|NCT00558285|7245747|FG003|COMPLETED|Overall Study||48
6338267|NCT00558285|7245748|FG004|COMPLETED|Overall Study||49
6338268|NCT00558285|7245744|FG000|NOT COMPLETED|Overall Study||6
6338269|NCT00558285|7245745|FG001|NOT COMPLETED|Overall Study||3
6338270|NCT00558285|7245746|FG002|NOT COMPLETED|Overall Study||5
6338271|NCT00558285|7245747|FG003|NOT COMPLETED|Overall Study||4
6338272|NCT00558285|7245748|FG004|NOT COMPLETED|Overall Study||4
6338273|NCT00558363|7245762|FG000|STARTED|Overall Study||147
6338274|NCT00558363|7245763|FG001|STARTED|Overall Study||147
6338275|NCT00558363|7245762|FG000|COMPLETED|Overall Study||76
6338276|NCT00558363|7245763|FG001|COMPLETED|Overall Study||111
6338277|NCT00558363|7245762|FG000|NOT COMPLETED|Overall Study||71
6338278|NCT00558363|7245763|FG001|NOT COMPLETED|Overall Study||36
6338279|NCT00558428|7245773|FG000|STARTED|Overall Study||267
6338280|NCT00558428|7245774|FG001|STARTED|Overall Study||276
6338281|NCT00558428|7245775|FG002|STARTED|Overall Study||277
6338282|NCT00558428|7245776|FG003|STARTED|Overall Study||277
6338283|NCT00558428|7245773|FG000|COMPLETED|Overall Study||255
6338284|NCT00558428|7245774|FG001|COMPLETED|Overall Study||252
6338285|NCT00558428|7245775|FG002|COMPLETED|Overall Study||273
6338286|NCT00558428|7245776|FG003|COMPLETED|Overall Study||266
6338287|NCT00558428|7245773|FG000|NOT COMPLETED|Overall Study||12
6338288|NCT00558428|7245774|FG001|NOT COMPLETED|Overall Study||24
6338289|NCT00558428|7245775|FG002|NOT COMPLETED|Overall Study||4
6338290|NCT00558428|7245776|FG003|NOT COMPLETED|Overall Study||11
6338291|NCT00558467|7245788|FG000|STARTED|Overall Study||20
6338292|NCT00558467|7245789|FG001|STARTED|Overall Study||43
6338293|NCT00558467|7245788|FG000|COMPLETED|Overall Study||19
6338294|NCT00558467|7245789|FG001|COMPLETED|Overall Study||39
6338295|NCT00558467|7245788|FG000|NOT COMPLETED|Overall Study||1
6338296|NCT00558467|7245789|FG001|NOT COMPLETED|Overall Study||4
6338297|NCT00558519|7245795|FG000|STARTED|Overall Study||318
6338298|NCT00558519|7245795|FG000|COMPLETED|Overall Study||295
6338299|NCT00558519|7245795|FG000|NOT COMPLETED|Overall Study||23
6338300|NCT00558571|7245803|FG000|STARTED|Overall Study||16
6338301|NCT00558571|7245804|FG001|STARTED|Overall Study||16
6338302|NCT00558571|7245805|FG002|STARTED|Overall Study||16
6338303|NCT00558571|7245806|FG003|STARTED|Overall Study||30
6338304|NCT00558571|7245803|FG000|COMPLETED|Overall Study||16
6338305|NCT00558571|7245804|FG001|COMPLETED|Overall Study||16
6338306|NCT00558571|7245805|FG002|COMPLETED|Overall Study||16
6338307|NCT00558571|7245806|FG003|COMPLETED|Overall Study||30
6338308|NCT00558571|7245803|FG000|NOT COMPLETED|Overall Study||0
6338309|NCT00558571|7245804|FG001|NOT COMPLETED|Overall Study||0
6338310|NCT00558571|7245805|FG002|NOT COMPLETED|Overall Study||0
6338311|NCT00558571|7245806|FG003|NOT COMPLETED|Overall Study||0
6338312|NCT00558636|7245829|FG000|STARTED|Treatment|up to 6 cycles of combination therapy|47
6338313|NCT00558636|7245830|FG001|STARTED|Treatment||44
6338314|NCT00558636|7245829|FG000|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
6338315|NCT00558636|7245830|FG001|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
6338316|NCT00558636|7245829|FG000|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
6338317|NCT00558636|7245830|FG001|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
6338318|NCT00558636|7245829|FG000|NOT COMPLETED|Treatment||47
6338319|NCT00558636|7245830|FG001|NOT COMPLETED|Treatment||44
6338320|NCT00558636|7245829|FG000|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
6338321|NCT00558636|7245830|FG001|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
6338322|NCT00558636|7245829|FG000|COMPLETED|Follow-up|Study was prematurely terminated|0
6338323|NCT00558636|7245830|FG001|COMPLETED|Follow-up|Study was prematurely terminated|0
6338324|NCT00558636|7245829|FG000|NOT COMPLETED|Follow-up||12
6338325|NCT00558636|7245830|FG001|NOT COMPLETED|Follow-up||7
6338326|NCT00558701|7245838|FG000|STARTED|Overall Study||15
6338327|NCT00558701|7245839|FG001|STARTED|Overall Study||15
6338328|NCT00558701|7245838|FG000|COMPLETED|Overall Study||14
6338329|NCT00558701|7245839|FG001|COMPLETED|Overall Study||11
6338330|NCT00558701|7245838|FG000|NOT COMPLETED|Overall Study||1
6338331|NCT00558701|7245839|FG001|NOT COMPLETED|Overall Study||4
6338332|NCT00558753|7245847|FG000|STARTED|Overall Study||120
6338333|NCT00558753|7245848|FG001|STARTED|Overall Study||120
6338334|NCT00558753|7245847|FG000|COMPLETED|Overall Study||115
6338335|NCT00558753|7245848|FG001|COMPLETED|Overall Study||113
6338336|NCT00558753|7245847|FG000|NOT COMPLETED|Overall Study||5
6338337|NCT00558753|7245848|FG001|NOT COMPLETED|Overall Study||7
6338338|NCT00558792|7245857|FG000|STARTED|Overall Study||68
6338339|NCT00558792|7245858|FG001|STARTED|Overall Study||63
6338340|NCT00558792|7245859|FG002|STARTED|Overall Study||60
6338341|NCT00558792|7245857|FG000|COMPLETED|Overall Study||68
6338342|NCT00558792|7245858|FG001|COMPLETED|Overall Study||63
6338343|NCT00558792|7245859|FG002|COMPLETED|Overall Study||60
6338344|NCT00558792|7245857|FG000|NOT COMPLETED|Overall Study||0
6338345|NCT00558792|7245858|FG001|NOT COMPLETED|Overall Study||0
6338346|NCT00558792|7245859|FG002|NOT COMPLETED|Overall Study||0
6338347|NCT00558831|7245870|FG000|STARTED|Overall Study||11
6338348|NCT00558831|7245870|FG000|COMPLETED|Overall Study||10
6338349|NCT00558831|7245870|FG000|NOT COMPLETED|Overall Study||1
6338350|NCT00558844|7245881|FG000|STARTED|Overall Study||15
6338351|NCT00558844|7245882|FG001|STARTED|Overall Study||7
6338352|NCT00558844|7245883|FG002|STARTED|Overall Study||7
6338353|NCT00558844|7245884|FG003|STARTED|Overall Study||5
6338354|NCT00558844|7245885|FG004|STARTED|Overall Study||7
6338355|NCT00558844|7245881|FG000|COMPLETED|Overall Study||12
6338356|NCT00558844|7245882|FG001|COMPLETED|Overall Study||7
6338357|NCT00558844|7245883|FG002|COMPLETED|Overall Study||6
6338358|NCT00558844|7245884|FG003|COMPLETED|Overall Study||5
6338359|NCT00558844|7245885|FG004|COMPLETED|Overall Study||6
6338360|NCT00558844|7245881|FG000|NOT COMPLETED|Overall Study||3
6338361|NCT00558844|7245882|FG001|NOT COMPLETED|Overall Study||0
6338362|NCT00558844|7245883|FG002|NOT COMPLETED|Overall Study||1
6338363|NCT00558844|7245884|FG003|NOT COMPLETED|Overall Study||0
6338364|NCT00558844|7245885|FG004|NOT COMPLETED|Overall Study||1
6338365|NCT00558896|7245905|FG000|STARTED|Overall Study||60
6338366|NCT00558896|7245906|FG001|STARTED|Overall Study||34
6338367|NCT00558896|7245907|FG002|STARTED|Overall Study||35
6559070|NCT01779648|7481705|FG000|STARTED|Overall Study||28
6559071|NCT01779648|7481706|FG001|STARTED|Overall Study||27
6559072|NCT01779648|7481705|FG000|COMPLETED|Overall Study||27
6559073|NCT01779648|7481706|FG001|COMPLETED|Overall Study||27
6559074|NCT01779648|7481705|FG000|NOT COMPLETED|Overall Study||1
6559075|NCT01779648|7481706|FG001|NOT COMPLETED|Overall Study||0
6559076|NCT01779700|7481714|FG000|STARTED|Overall Study||18
6559077|NCT01779700|7481715|FG001|STARTED|Overall Study||22
6338368|NCT00558896|7245908|FG003|STARTED|Overall Study||35
6338369|NCT00558896|7245909|FG004|STARTED|Overall Study||60
6338370|NCT00558896|7245910|FG005|STARTED|Overall Study||120
6338371|NCT00558896|7245911|FG006|STARTED|Overall Study||33
6338372|NCT00558896|7245905|FG000|COMPLETED|Overall Study||39
6338373|NCT00558896|7245906|FG001|COMPLETED|Overall Study||27
6338374|NCT00558896|7245907|FG002|COMPLETED|Overall Study||30
6338375|NCT00558896|7245908|FG003|COMPLETED|Overall Study||23
6338376|NCT00558896|7245909|FG004|COMPLETED|Overall Study||37
6338377|NCT00558896|7245910|FG005|COMPLETED|Overall Study||68
6338378|NCT00558896|7245911|FG006|COMPLETED|Overall Study||9
6338379|NCT00558896|7245905|FG000|NOT COMPLETED|Overall Study||21
6338380|NCT00558896|7245906|FG001|NOT COMPLETED|Overall Study||7
6338381|NCT00558896|7245907|FG002|NOT COMPLETED|Overall Study||5
6338382|NCT00558896|7245908|FG003|NOT COMPLETED|Overall Study||12
6338383|NCT00558896|7245909|FG004|NOT COMPLETED|Overall Study||23
6338384|NCT00558896|7245910|FG005|NOT COMPLETED|Overall Study||52
6338385|NCT00558896|7245911|FG006|NOT COMPLETED|Overall Study||24
6338386|NCT00559013|7245927|FG000|STARTED|Overall Study||38
6338387|NCT00559013|7245927|FG000|COMPLETED|Overall Study||38
6338388|NCT00559013|7245927|FG000|NOT COMPLETED|Overall Study||0
6338389|NCT00559104|7245933|FG000|STARTED|Overall Study||55
6338390|NCT00559104|7245934|FG001|STARTED|Overall Study||5
6338391|NCT00559104|7245933|FG000|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
6338392|NCT00559104|7245934|FG001|COMPLETED|Overall Study||5
6338393|NCT00559104|7245933|FG000|NOT COMPLETED|Overall Study||9
6338394|NCT00559104|7245934|FG001|NOT COMPLETED|Overall Study||0
6338395|NCT00559273|7245942|FG000|STARTED|Correction Period (20 Weeks)||153
6338396|NCT00559273|7245943|FG001|STARTED|Correction Period (20 Weeks)||154
6338397|NCT00559273|7245942|FG000|Treated|Correction Period (20 Weeks)||151
6338398|NCT00559273|7245943|FG001|Treated|Correction Period (20 Weeks)||154
6338399|NCT00559273|7245942|FG000|COMPLETED|Correction Period (20 Weeks)||144
6338400|NCT00559273|7245943|FG001|COMPLETED|Correction Period (20 Weeks)||142
6338401|NCT00559273|7245942|FG000|NOT COMPLETED|Correction Period (20 Weeks)||9
6338402|NCT00559273|7245943|FG001|NOT COMPLETED|Correction Period (20 Weeks)||12
6338403|NCT00559273|7245942|FG000|STARTED|Evaluation Period (8 Weeks)||144
6338404|NCT00559273|7245943|FG001|STARTED|Evaluation Period (8 Weeks)||142
6338405|NCT00559273|7245942|FG000|COMPLETED|Evaluation Period (8 Weeks)||141
6338406|NCT00559273|7245943|FG001|COMPLETED|Evaluation Period (8 Weeks)||137
6338407|NCT00559273|7245942|FG000|NOT COMPLETED|Evaluation Period (8 Weeks)||3
6338408|NCT00559273|7245943|FG001|NOT COMPLETED|Evaluation Period (8 Weeks)||5
6338409|NCT00559364|7245951|FG000|STARTED|Overall Study||30
6338410|NCT00559364|7245952|FG001|STARTED|Overall Study||20
6338411|NCT00559364|7245951|FG000|COMPLETED|Overall Study||29
6338412|NCT00559364|7245952|FG001|COMPLETED|Overall Study||20
6338413|NCT00559364|7245951|FG000|NOT COMPLETED|Overall Study||1
6338414|NCT00559364|7245952|FG001|NOT COMPLETED|Overall Study||0
6338415|NCT00559377|7245958|FG000|STARTED|Overall Study||16
6338416|NCT00559377|7245958|FG000|COMPLETED|Overall Study||7
6338417|NCT00559377|7245958|FG000|NOT COMPLETED|Overall Study||9
6338418|NCT00559468|7245967|FG000|STARTED|Overall Study||26
6338419|NCT00559468|7245968|FG001|STARTED|Overall Study||26
6338420|NCT00559468|7245967|FG000|Treated|Overall Study||26
6559078|NCT01779700|7481714|FG000|COMPLETED|Overall Study||14
6338421|NCT00559468|7245968|FG001|Treated|Overall Study||25
6338422|NCT00559468|7245967|FG000|COMPLETED|Overall Study||26
6338423|NCT00559468|7245968|FG001|COMPLETED|Overall Study||25
6338424|NCT00559468|7245967|FG000|NOT COMPLETED|Overall Study||0
6338425|NCT00559468|7245968|FG001|NOT COMPLETED|Overall Study||1
6338426|NCT00559507|7245974|FG000|STARTED|Overall Study||12
6338427|NCT00559507|7245974|FG000|COMPLETED|Overall Study||9
6338428|NCT00559507|7245974|FG000|NOT COMPLETED|Overall Study||3
6338429|NCT00559585|7245980|FG000|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
6338430|NCT00559585|7245981|FG001|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
6338431|NCT00559585|7245980|FG000|COMPLETED|Double Blind ST Period Main Study||693
6338432|NCT00559585|7245981|FG001|COMPLETED|Double Blind ST Period Main Study||676
6338433|NCT00559585|7245980|FG000|NOT COMPLETED|Double Blind ST Period Main Study||43
6338434|NCT00559585|7245981|FG001|NOT COMPLETED|Double Blind ST Period Main Study||45
6338435|NCT00559585|7245980|FG000|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
6338436|NCT00559585|7245981|FG001|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
6338437|NCT00559585|7245980|FG000|COMPLETED|Anti-TNF Sub-Study in ST Period||7
6338438|NCT00559585|7245981|FG001|COMPLETED|Anti-TNF Sub-Study in ST Period||9
6338439|NCT00559585|7245980|FG000|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
6338440|NCT00559585|7245981|FG001|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
6338441|NCT00559585|7245980|FG000|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
6338442|NCT00559585|7245981|FG001|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
6338443|NCT00559585|7245980|FG000|COMPLETED|Open Label LT Period Main + Sub-Study||945
6338444|NCT00559585|7245981|FG001|COMPLETED|Open Label LT Period Main + Sub-Study||0
6338445|NCT00559585|7245980|FG000|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
6338446|NCT00559585|7245981|FG001|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
6338447|NCT00559637|7245998|FG000|STARTED|Overall Study||184
6338448|NCT00559637|7245998|FG000|COMPLETED|Overall Study||130
6338449|NCT00559637|7245998|FG000|NOT COMPLETED|Overall Study||54
6338450|NCT00559754|7246002|FG000|STARTED|Overall Study||72
6338451|NCT00559754|7246002|FG000|COMPLETED|Overall Study||61
6338452|NCT00559754|7246002|FG000|NOT COMPLETED|Overall Study||11
6338453|NCT00559845|7246006|FG000|STARTED|Overall Study||56
6338454|NCT00559845|7246006|FG000|COMPLETED|Overall Study||49
6338455|NCT00559845|7246006|FG000|NOT COMPLETED|Overall Study||7
6338459|NCT00559949|7246014|FG000|STARTED|Overall Study||39
6338460|NCT00559949|7246014|FG000|COMPLETED|Overall Study||32
6338461|NCT00559949|7246014|FG000|NOT COMPLETED|Overall Study||7
6338462|NCT00559962|7246026|FG000|STARTED|Overall Study||33
6338463|NCT00559962|7246027|FG001|STARTED|Overall Study||34
6338464|NCT00559962|7246028|FG002|STARTED|Overall Study||34
6338465|NCT00559962|7246029|FG003|STARTED|Overall Study||34
6338466|NCT00559962|7246030|FG004|STARTED|Overall Study||35
6338467|NCT00559962|7246031|FG005|STARTED|Overall Study||28
6338468|NCT00559962|7246032|FG006|STARTED|Overall Study||33
6338469|NCT00559962|7246033|FG007|STARTED|Overall Study||29
6338470|NCT00559962|7246026|FG000|COMPLETED|Overall Study||31
6338471|NCT00559962|7246027|FG001|COMPLETED|Overall Study||25
6338472|NCT00559962|7246028|FG002|COMPLETED|Overall Study||24
6338473|NCT00559962|7246029|FG003|COMPLETED|Overall Study||29
6338474|NCT00559962|7246030|FG004|COMPLETED|Overall Study||21
6338475|NCT00559962|7246031|FG005|COMPLETED|Overall Study||23
6338476|NCT00559962|7246032|FG006|COMPLETED|Overall Study||28
6338477|NCT00559962|7246033|FG007|COMPLETED|Overall Study||25
6338478|NCT00559962|7246026|FG000|NOT COMPLETED|Overall Study||2
6338479|NCT00559962|7246027|FG001|NOT COMPLETED|Overall Study||9
6338480|NCT00559962|7246028|FG002|NOT COMPLETED|Overall Study||10
6338481|NCT00559962|7246029|FG003|NOT COMPLETED|Overall Study||5
6338482|NCT00559962|7246030|FG004|NOT COMPLETED|Overall Study||14
6338483|NCT00559962|7246031|FG005|NOT COMPLETED|Overall Study||5
6338484|NCT00559962|7246032|FG006|NOT COMPLETED|Overall Study||5
6338485|NCT00559962|7246033|FG007|NOT COMPLETED|Overall Study||4
6338486|NCT00559988|7246054|FG000|STARTED|Overall Study||1357
6338487|NCT00559988|7246055|FG001|STARTED|Overall Study||1361
6338488|NCT00559988|7246054|FG000|COMPLETED|Overall Study||1006
6338489|NCT00559988|7246055|FG001|COMPLETED|Overall Study||1009
6338490|NCT00559988|7246054|FG000|NOT COMPLETED|Overall Study||351
6338491|NCT00559988|7246055|FG001|NOT COMPLETED|Overall Study||352
6338492|NCT00560066|7246063|FG000|STARTED|Overall Study||396
6338493|NCT00560066|7246064|FG001|STARTED|Overall Study||1002
6338494|NCT00560066|7246063|FG000|COMPLETED|Overall Study||390
6338495|NCT00560066|7246064|FG001|COMPLETED|Overall Study||980
6338496|NCT00560066|7246063|FG000|NOT COMPLETED|Overall Study||6
6338497|NCT00560066|7246064|FG001|NOT COMPLETED|Overall Study||22
6338498|NCT00560105|7246077|FG000|STARTED|Overall Study||20
6338499|NCT00560105|7246078|FG001|STARTED|Overall Study||20
6559079|NCT01779700|7481715|FG001|COMPLETED|Overall Study||17
6559080|NCT01779700|7481714|FG000|NOT COMPLETED|Overall Study||4
6559081|NCT01779700|7481715|FG001|NOT COMPLETED|Overall Study||5
6559082|NCT01779856|7481721|FG000|STARTED|Overall Study||81
6338500|NCT00560105|7246077|FG000|COMPLETED|Overall Study||19
6338501|NCT00560105|7246078|FG001|COMPLETED|Overall Study||18
6338502|NCT00560105|7246077|FG000|NOT COMPLETED|Overall Study||1
6559083|NCT01779856|7481721|FG000|COMPLETED|Overall Study||57
6559084|NCT01779856|7481721|FG000|NOT COMPLETED|Overall Study||24
6338503|NCT00560105|7246078|FG001|NOT COMPLETED|Overall Study||2
6338504|NCT00560235|7246087|FG000|STARTED|Phase 1||10
6338505|NCT00560235|7246088|FG001|STARTED|Phase 1||0
6338506|NCT00560235|7246089|FG002|STARTED|Phase 1||0
6338507|NCT00560235|7246087|FG000|COMPLETED|Phase 1||2
6338508|NCT00560235|7246088|FG001|COMPLETED|Phase 1||0
6338509|NCT00560235|7246089|FG002|COMPLETED|Phase 1||0
6338510|NCT00560235|7246087|FG000|NOT COMPLETED|Phase 1||8
6338511|NCT00560235|7246088|FG001|NOT COMPLETED|Phase 1||0
6338512|NCT00560235|7246089|FG002|NOT COMPLETED|Phase 1||0
6338513|NCT00560235|7246087|FG000|STARTED|Phase 1B||0
6338514|NCT00560235|7246088|FG001|STARTED|Phase 1B||21
6338515|NCT00560235|7246089|FG002|STARTED|Phase 1B||0
6338516|NCT00560235|7246087|FG000|COMPLETED|Phase 1B||0
6338517|NCT00560235|7246088|FG001|COMPLETED|Phase 1B||2
6338518|NCT00560235|7246089|FG002|COMPLETED|Phase 1B||0
6338519|NCT00560235|7246087|FG000|NOT COMPLETED|Phase 1B||0
6338520|NCT00560235|7246088|FG001|NOT COMPLETED|Phase 1B||19
6338521|NCT00560235|7246089|FG002|NOT COMPLETED|Phase 1B||0
6338522|NCT00560235|7246087|FG000|STARTED|Phase 2||0
6338523|NCT00560235|7246088|FG001|STARTED|Phase 2||0
6338524|NCT00560235|7246089|FG002|STARTED|Phase 2||107
6338525|NCT00560235|7246087|FG000|COMPLETED|Phase 2||0
6338526|NCT00560235|7246088|FG001|COMPLETED|Phase 2||0
6338527|NCT00560235|7246089|FG002|COMPLETED|Phase 2||10
6338528|NCT00560235|7246087|FG000|NOT COMPLETED|Phase 2||0
6338529|NCT00560235|7246088|FG001|NOT COMPLETED|Phase 2||0
6338530|NCT00560235|7246089|FG002|NOT COMPLETED|Phase 2||97
6338531|NCT00560313|7246107|FG000|STARTED|Overall Study||54
6498435|NCT01409837|7417007|FG000|COMPLETED|Overall Study||14
6498436|NCT01409837|7417008|FG001|COMPLETED|Overall Study||14
6498437|NCT01409837|7417007|FG000|NOT COMPLETED|Overall Study||3
6498438|NCT01409837|7417008|FG001|NOT COMPLETED|Overall Study||2
6498439|NCT01409915|7417018|FG000|STARTED|Overall Study||21
6498440|NCT01409915|7417019|FG001|STARTED|Overall Study||23
6498441|NCT01409915|7417018|FG000|COMPLETED|Overall Study||20
6498442|NCT01409915|7417019|FG001|COMPLETED|Overall Study||20
6498443|NCT01409915|7417018|FG000|NOT COMPLETED|Overall Study||1
6498444|NCT01409915|7417019|FG001|NOT COMPLETED|Overall Study||3
6498445|NCT01409928|7417025|FG000|STARTED|Overall Study||16
6498446|NCT01409928|7417025|FG000|COMPLETED|Overall Study||4
6338532|NCT00560313|7246107|FG000|COMPLETED|Overall Study||48
6338533|NCT00560313|7246107|FG000|NOT COMPLETED|Overall Study||6
6338534|NCT00560352|7246129|FG000|STARTED|Overall Study||7
6338535|NCT00560352|7246130|FG001|STARTED|Overall Study||3
6338536|NCT00560352|7246131|FG002|STARTED|Overall Study||4
6338537|NCT00560352|7246129|FG000|COMPLETED|Overall Study||0
6338538|NCT00560352|7246130|FG001|COMPLETED|Overall Study||0
6338539|NCT00560352|7246131|FG002|COMPLETED|Overall Study||0
6338540|NCT00560352|7246129|FG000|NOT COMPLETED|Overall Study||7
6338541|NCT00560352|7246130|FG001|NOT COMPLETED|Overall Study||3
6338542|NCT00560352|7246131|FG002|NOT COMPLETED|Overall Study||4
6338543|NCT00560391|7246148|FG000|STARTED|Overall Study|Participants who received treatment|6
6338544|NCT00560391|7246149|FG001|STARTED|Overall Study|Participants who received treatment|3
6338545|NCT00560391|7246150|FG002|STARTED|Overall Study|Participants who received treatment|3
6338546|NCT00560391|7246151|FG003|STARTED|Overall Study|Participants who received treatment|6
6338547|NCT00560391|7246152|FG004|STARTED|Overall Study|Participants who received treatment|17
6338548|NCT00560391|7246148|FG000|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
6338549|NCT00560391|7246149|FG001|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
6338550|NCT00560391|7246150|FG002|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
6338551|NCT00560391|7246151|FG003|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
6338552|NCT00560391|7246152|FG004|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
6338553|NCT00560391|7246148|FG000|NOT COMPLETED|Overall Study||0
6338554|NCT00560391|7246149|FG001|NOT COMPLETED|Overall Study||0
6338555|NCT00560391|7246150|FG002|NOT COMPLETED|Overall Study||0
6338556|NCT00560391|7246151|FG003|NOT COMPLETED|Overall Study||1
6338557|NCT00560391|7246152|FG004|NOT COMPLETED|Overall Study||2
6338558|NCT00560404|7246167|FG000|STARTED|Overall Study||112
6338559|NCT00560404|7246168|FG001|STARTED|Overall Study||121
6338560|NCT00560404|7246167|FG000|COMPLETED|Overall Study||76
6338561|NCT00560404|7246168|FG001|COMPLETED|Overall Study||100
6338562|NCT00560404|7246167|FG000|NOT COMPLETED|Overall Study||36
6338563|NCT00560404|7246168|FG001|NOT COMPLETED|Overall Study||21
6338564|NCT00560417|7246176|FG000|STARTED|Overall Study||171
6338565|NCT00560417|7246177|FG001|STARTED|Overall Study||168
6338566|NCT00560417|7246176|FG000|Intention to Treat (ITT) Population|Overall Study||170
6338567|NCT00560417|7246177|FG001|Intention to Treat (ITT) Population|Overall Study||167
6338568|NCT00560417|7246176|FG000|COMPLETED|Overall Study||154
6338569|NCT00560417|7246177|FG001|COMPLETED|Overall Study||151
6338570|NCT00560417|7246176|FG000|NOT COMPLETED|Overall Study||17
6338571|NCT00560417|7246177|FG001|NOT COMPLETED|Overall Study||17
6338572|NCT00560508|7246185|FG000|STARTED|12 Week Double-blind Period||56
6338573|NCT00560508|7246186|FG001|STARTED|12 Week Double-blind Period||56
6338574|NCT00560508|7246185|FG000|COMPLETED|12 Week Double-blind Period||51
6338575|NCT00560508|7246186|FG001|COMPLETED|12 Week Double-blind Period||53
6338576|NCT00560508|7246185|FG000|NOT COMPLETED|12 Week Double-blind Period||5
6498447|NCT01409928|7417025|FG000|NOT COMPLETED|Overall Study||12
6338577|NCT00560508|7246186|FG001|NOT COMPLETED|12 Week Double-blind Period||3
6338578|NCT00560508|7246185|FG000|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
6338579|NCT00560508|7246186|FG001|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
6338580|NCT00560508|7246185|FG000|COMPLETED|52-week Open-label Period Pramipexole ER||43
6338581|NCT00560508|7246186|FG001|COMPLETED|52-week Open-label Period Pramipexole ER||42
6338582|NCT00560508|7246185|FG000|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
6338583|NCT00560508|7246186|FG001|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
6338584|NCT00560560|7246199|FG000|STARTED|Overall Study||85
6338585|NCT00560560|7246200|FG001|STARTED|Overall Study||83
6338586|NCT00560560|7246199|FG000|COMPLETED|Overall Study||0
6338587|NCT00560560|7246200|FG001|COMPLETED|Overall Study||0
6338588|NCT00560560|7246199|FG000|NOT COMPLETED|Overall Study||85
6338589|NCT00560560|7246200|FG001|NOT COMPLETED|Overall Study||83
6338590|NCT00560573|7246206|FG000|STARTED|Overall Study||6
6338591|NCT00560573|7246207|FG001|STARTED|Overall Study||3
6338592|NCT00560573|7246208|FG002|STARTED|Overall Study||6
6338593|NCT00560573|7246209|FG003|STARTED|Overall Study||10
6338594|NCT00560573|7246210|FG004|STARTED|Overall Study||8
6338595|NCT00560573|7246211|FG005|STARTED|Overall Study||13
6338596|NCT00560573|7246206|FG000|Treated|Overall Study||6
6338597|NCT00560573|7246207|FG001|Treated|Overall Study||3
6338598|NCT00560573|7246208|FG002|Treated|Overall Study||6
6338599|NCT00560573|7246209|FG003|Treated|Overall Study||10
6338600|NCT00560573|7246210|FG004|Treated|Overall Study||7
6338601|NCT00560573|7246211|FG005|Treated|Overall Study||13
6338602|NCT00560573|7246206|FG000|COMPLETED|Overall Study||0
6338603|NCT00560573|7246207|FG001|COMPLETED|Overall Study||0
6338604|NCT00560573|7246208|FG002|COMPLETED|Overall Study||0
6338605|NCT00560573|7246209|FG003|COMPLETED|Overall Study||0
6338606|NCT00560573|7246210|FG004|COMPLETED|Overall Study||1
6338607|NCT00560573|7246211|FG005|COMPLETED|Overall Study||0
6338608|NCT00560573|7246206|FG000|NOT COMPLETED|Overall Study||6
6338609|NCT00560573|7246207|FG001|NOT COMPLETED|Overall Study||3
6338610|NCT00560573|7246208|FG002|NOT COMPLETED|Overall Study||6
6338611|NCT00560573|7246209|FG003|NOT COMPLETED|Overall Study||10
6338612|NCT00560573|7246210|FG004|NOT COMPLETED|Overall Study||7
6338613|NCT00560573|7246211|FG005|NOT COMPLETED|Overall Study||13
6338614|NCT00560612|7246243|FG000|STARTED|Overall Study||5
6338615|NCT00560612|7246244|FG001|STARTED|Overall Study||7
6338616|NCT00560612|7246243|FG000|COMPLETED|Overall Study||5
6338617|NCT00560612|7246244|FG001|COMPLETED|Overall Study||7
6338618|NCT00560612|7246243|FG000|NOT COMPLETED|Overall Study||0
6338619|NCT00560612|7246244|FG001|NOT COMPLETED|Overall Study||0
6338620|NCT00560703|7246252|FG000|STARTED|Overall Study||46
6338621|NCT00560703|7246253|FG001|STARTED|Overall Study||24
6338622|NCT00560703|7246252|FG000|COMPLETED|Overall Study||46
6338623|NCT00560703|7246253|FG001|COMPLETED|Overall Study||18
6338624|NCT00560703|7246252|FG000|NOT COMPLETED|Overall Study||0
6338625|NCT00560703|7246253|FG001|NOT COMPLETED|Overall Study||6
6338626|NCT00560755|7246259|FG000|STARTED|Overall Study|Vaccinated (at least one ProQuad® dose)|3388
6338627|NCT00560755|7246259|FG000|ProQuad® Dose 1 and Dose 2|Overall Study||3346
6338628|NCT00560755|7246259|FG000|COMPLETED|Overall Study||3328
6338629|NCT00560755|7246259|FG000|NOT COMPLETED|Overall Study||60
6338630|NCT00560794|7246264|FG000|STARTED|Overall Study||21
6338631|NCT00560794|7246264|FG000|Completed 1 Treatment Cycle|Overall Study||20
6338632|NCT00560794|7246264|FG000|COMPLETED|Overall Study||10
6338633|NCT00560794|7246264|FG000|NOT COMPLETED|Overall Study||11
6338634|NCT00560833|7246275|FG000|STARTED|Overall Study||317
6338635|NCT00560833|7246276|FG001|STARTED|Overall Study||155
6338636|NCT00560833|7246277|FG002|STARTED|Overall Study||160
6338637|NCT00560833|7246278|FG003|STARTED|Overall Study||155
6338638|NCT00560833|7246279|FG004|STARTED|Overall Study||156
6338639|NCT00560833|7246275|FG000|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
6338640|NCT00560833|7246276|FG001|Treated|Overall Study|One participant was randomized but not treated|154
6338641|NCT00560833|7246277|FG002|Treated|Overall Study||160
6338642|NCT00560833|7246278|FG003|Treated|Overall Study||155
6338643|NCT00560833|7246279|FG004|Treated|Overall Study|One participant was randomized but not treated|155
6338644|NCT00560833|7246275|FG000|COMPLETED|Overall Study||273
6338645|NCT00560833|7246276|FG001|COMPLETED|Overall Study||129
6338646|NCT00560833|7246277|FG002|COMPLETED|Overall Study||121
6338647|NCT00560833|7246278|FG003|COMPLETED|Overall Study||124
6338648|NCT00560833|7246279|FG004|COMPLETED|Overall Study||114
6338649|NCT00560833|7246275|FG000|NOT COMPLETED|Overall Study||44
6338650|NCT00560833|7246276|FG001|NOT COMPLETED|Overall Study||26
6338651|NCT00560833|7246277|FG002|NOT COMPLETED|Overall Study||39
6338652|NCT00560833|7246278|FG003|NOT COMPLETED|Overall Study||31
6338653|NCT00560833|7246279|FG004|NOT COMPLETED|Overall Study||42
6338654|NCT00560859|7246293|FG000|STARTED|Overall Study||226
6338655|NCT00560859|7246294|FG001|STARTED|Overall Study||227
6338656|NCT00560859|7246293|FG000|COMPLETED|Overall Study||194
6338657|NCT00560859|7246294|FG001|COMPLETED|Overall Study||203
6338658|NCT00560859|7246293|FG000|NOT COMPLETED|Overall Study||32
6338659|NCT00560859|7246294|FG001|NOT COMPLETED|Overall Study||24
6338660|NCT00560885|7246301|FG000|STARTED|Overall Study||55
6338661|NCT00560885|7246301|FG000|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
6338662|NCT00560885|7246301|FG000|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
6338663|NCT00560885|7246301|FG000|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
6338664|NCT00560885|7246301|FG000|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
6338665|NCT00560885|7246301|FG000|2 Year Follow-up|Overall Study||47
6338666|NCT00560885|7246301|FG000|COMPLETED|Overall Study||47
6338667|NCT00560885|7246301|FG000|NOT COMPLETED|Overall Study||8
6338668|NCT00560937|7246307|FG000|STARTED|Overall Study||10
6338669|NCT00560937|7246308|FG001|STARTED|Overall Study||11
6338670|NCT00560937|7246307|FG000|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
6338671|NCT00560937|7246308|FG001|COMPLETED|Overall Study||9
6338672|NCT00560937|7246307|FG000|NOT COMPLETED|Overall Study||1
6338673|NCT00560937|7246308|FG001|NOT COMPLETED|Overall Study||2
6338674|NCT00560950|7246316|FG000|STARTED|Overall Study||72
6338675|NCT00560950|7246317|FG001|STARTED|Overall Study||71
6338676|NCT00560950|7246316|FG000|COMPLETED|Overall Study||71
6338677|NCT00560950|7246317|FG001|COMPLETED|Overall Study||71
6338678|NCT00560950|7246316|FG000|NOT COMPLETED|Overall Study||1
6338679|NCT00560950|7246317|FG001|NOT COMPLETED|Overall Study||0
6338680|NCT00561002|7246327|FG000|STARTED|Overall Study||23
6338681|NCT00561002|7246328|FG001|STARTED|Overall Study||9
6338682|NCT00561002|7246327|FG000|COMPLETED|Overall Study||23
6776353|NCT03815240|7704427|FG000|STARTED|Intervention Optifoam Dressing||2
6776354|NCT03815240|7704428|FG001|STARTED|Intervention Optifoam Dressing||1
6776355|NCT03815240|7704429|FG002|STARTED|Intervention Optifoam Dressing||1
6776356|NCT03815240|7704430|FG003|STARTED|Intervention Optifoam Dressing||2
6776357|NCT03815240|7704431|FG004|STARTED|Intervention Optifoam Dressing||1
6776358|NCT03815240|7704432|FG005|STARTED|Intervention Optifoam Dressing||2
6776359|NCT03815240|7704433|FG006|STARTED|Intervention Optifoam Dressing||1
6338683|NCT00561002|7246328|FG001|COMPLETED|Overall Study||9
6338684|NCT00561002|7246327|FG000|NOT COMPLETED|Overall Study||0
6338685|NCT00561002|7246328|FG001|NOT COMPLETED|Overall Study||0
6338686|NCT00561015|7246340|FG000|STARTED|Overall Study||9
6338687|NCT00561015|7246341|FG001|STARTED|Overall Study||5
6338688|NCT00561015|7246342|FG002|STARTED|Overall Study||9
6338689|NCT00561015|7246343|FG003|STARTED|Overall Study||8
6338690|NCT00561015|7246344|FG004|STARTED|Overall Study||9
6338691|NCT00561015|7246345|FG005|STARTED|Overall Study||9
6338692|NCT00561015|7246340|FG000|COMPLETED|Overall Study||5
6338693|NCT00561015|7246341|FG001|COMPLETED|Overall Study||5
6338694|NCT00561015|7246342|FG002|COMPLETED|Overall Study||9
6338695|NCT00561015|7246343|FG003|COMPLETED|Overall Study||7
6338696|NCT00561015|7246344|FG004|COMPLETED|Overall Study||8
6338697|NCT00561015|7246345|FG005|COMPLETED|Overall Study||6
6338698|NCT00561015|7246340|FG000|NOT COMPLETED|Overall Study||4
6338699|NCT00561015|7246341|FG001|NOT COMPLETED|Overall Study||0
6338700|NCT00561015|7246342|FG002|NOT COMPLETED|Overall Study||0
6338701|NCT00561015|7246343|FG003|NOT COMPLETED|Overall Study||1
6338702|NCT00561015|7246344|FG004|NOT COMPLETED|Overall Study||1
6338703|NCT00561015|7246345|FG005|NOT COMPLETED|Overall Study||3
6338704|NCT00561080|7246366|FG000|STARTED|Vaccination Period (up to Month 4)||253
6338705|NCT00561080|7246367|FG001|STARTED|Vaccination Period (up to Month 4)||255
6338706|NCT00561080|7246368|FG002|STARTED|Vaccination Period (up to Month 4)||251
6338707|NCT00561080|7246366|FG000|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||253
6338708|NCT00561080|7246367|FG001|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||254
6338709|NCT00561080|7246368|FG002|Received at Least 1 Vaccination|Vaccination Period (up to Month 4)||250
6338710|NCT00561080|7246366|FG000|COMPLETED|Vaccination Period (up to Month 4)||250
6338711|NCT00561080|7246367|FG001|COMPLETED|Vaccination Period (up to Month 4)||229
6338712|NCT00561080|7246368|FG002|COMPLETED|Vaccination Period (up to Month 4)||225
6338713|NCT00561080|7246366|FG000|NOT COMPLETED|Vaccination Period (up to Month 4)||3
6338714|NCT00561080|7246367|FG001|NOT COMPLETED|Vaccination Period (up to Month 4)||26
6338715|NCT00561080|7246368|FG002|NOT COMPLETED|Vaccination Period (up to Month 4)||26
6338716|NCT00561080|7246366|FG000|STARTED|12-month Post Last Dose Follow-up||250
6338717|NCT00561080|7246367|FG001|STARTED|12-month Post Last Dose Follow-up||229
6338718|NCT00561080|7246368|FG002|STARTED|12-month Post Last Dose Follow-up||225
6338719|NCT00561080|7246366|FG000|COMPLETED|12-month Post Last Dose Follow-up||243
6338720|NCT00561080|7246367|FG001|COMPLETED|12-month Post Last Dose Follow-up||220
6338721|NCT00561080|7246368|FG002|COMPLETED|12-month Post Last Dose Follow-up||215
6338722|NCT00561080|7246366|FG000|NOT COMPLETED|12-month Post Last Dose Follow-up||7
6338723|NCT00561080|7246367|FG001|NOT COMPLETED|12-month Post Last Dose Follow-up||9
6338724|NCT00561080|7246368|FG002|NOT COMPLETED|12-month Post Last Dose Follow-up||10
6338725|NCT00561080|7246366|FG000|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6338726|NCT00561080|7246367|FG001|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6338727|NCT00561080|7246368|FG002|STARTED|24-month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6338728|NCT00561080|7246366|FG000|COMPLETED|24-month Post Last Dose Follow-up||0
6338729|NCT00561080|7246367|FG001|COMPLETED|24-month Post Last Dose Follow-up||0
6338730|NCT00561080|7246368|FG002|COMPLETED|24-month Post Last Dose Follow-up||0
6338731|NCT00561080|7246366|FG000|NOT COMPLETED|24-month Post Last Dose Follow-up||0
6338732|NCT00561080|7246367|FG001|NOT COMPLETED|24-month Post Last Dose Follow-up||0
6338733|NCT00561080|7246368|FG002|NOT COMPLETED|24-month Post Last Dose Follow-up||0
6377901|NCT00765843|7288576|FG002|NOT COMPLETED|Overall Study||3
6776360|NCT03815240|7704434|FG007|STARTED|Intervention Optifoam Dressing||1
6338734|NCT00561080|7246366|FG000|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6338735|NCT00561080|7246367|FG001|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6338736|NCT00561080|7246368|FG002|STARTED|36 Month Post Last Dose Follow-up|Study stopped at 1 year post last dose|0
6338737|NCT00561080|7246366|FG000|COMPLETED|36 Month Post Last Dose Follow-up||0
6338738|NCT00561080|7246367|FG001|COMPLETED|36 Month Post Last Dose Follow-up||0
6338739|NCT00561080|7246368|FG002|COMPLETED|36 Month Post Last Dose Follow-up||0
6338740|NCT00561080|7246366|FG000|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
6338741|NCT00561080|7246367|FG001|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
6338742|NCT00561080|7246368|FG002|NOT COMPLETED|36 Month Post Last Dose Follow-up||0
6376334|NCT00759109|7286820|FG001|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
6376335|NCT00759109|7286819|FG000|NOT COMPLETED|Overall Study||39
6376336|NCT00759109|7286820|FG001|NOT COMPLETED|Overall Study||35
6376337|NCT00759148|7286828|FG000|STARTED|Overall Study||593
6376338|NCT00759148|7286829|FG001|STARTED|Overall Study||586
6376339|NCT00759148|7286828|FG000|COMPLETED|Overall Study||579
6376340|NCT00759148|7286829|FG001|COMPLETED|Overall Study||554
6376341|NCT00759148|7286828|FG000|NOT COMPLETED|Overall Study||14
6376342|NCT00759148|7286829|FG001|NOT COMPLETED|Overall Study||32
6376343|NCT00759161|7286835|FG000|STARTED|Overall Study||35
6376344|NCT00759161|7286835|FG000|COMPLETED|Overall Study||35
6376345|NCT00759161|7286835|FG000|NOT COMPLETED|Overall Study||0
6376346|NCT00759174|7286844|FG000|STARTED|Overall Study||76
6376347|NCT00759174|7286845|FG001|STARTED|Overall Study||597
6376348|NCT00759174|7286844|FG000|COMPLETED|Overall Study||76
6376349|NCT00759174|7286845|FG001|COMPLETED|Overall Study||595
6376350|NCT00759174|7286844|FG000|NOT COMPLETED|Overall Study||0
6376351|NCT00759174|7286845|FG001|NOT COMPLETED|Overall Study||2
6376352|NCT00759187|7286855|FG000|STARTED|Overall Study||8
6376353|NCT00759187|7286856|FG001|STARTED|Overall Study||8
6376354|NCT00759187|7286857|FG002|STARTED|Overall Study||9
6376355|NCT00759187|7286855|FG000|COMPLETED|Overall Study||8
6376356|NCT00759187|7286856|FG001|COMPLETED|Overall Study||8
6376357|NCT00759187|7286857|FG002|COMPLETED|Overall Study||9
6376358|NCT00759187|7286855|FG000|NOT COMPLETED|Overall Study||0
6376359|NCT00759187|7286856|FG001|NOT COMPLETED|Overall Study||0
6376360|NCT00759187|7286857|FG002|NOT COMPLETED|Overall Study||0
6376361|NCT00759330|7286869|FG000|STARTED|Overall Study||20
6376362|NCT00759330|7286870|FG001|STARTED|Overall Study||42
6376363|NCT00759330|7286871|FG002|STARTED|Overall Study||22
6376364|NCT00759330|7286872|FG003|STARTED|Overall Study||43
6376365|NCT00759330|7286869|FG000|COMPLETED|Overall Study||19
6376366|NCT00759330|7286870|FG001|COMPLETED|Overall Study||41
6376367|NCT00759330|7286871|FG002|COMPLETED|Overall Study||22
6376368|NCT00759330|7286872|FG003|COMPLETED|Overall Study||41
6376369|NCT00759330|7286869|FG000|NOT COMPLETED|Overall Study||1
6376370|NCT00759330|7286870|FG001|NOT COMPLETED|Overall Study||1
6376371|NCT00759330|7286871|FG002|NOT COMPLETED|Overall Study||0
6376372|NCT00759330|7286872|FG003|NOT COMPLETED|Overall Study||2
6376373|NCT00759356|7286885|FG000|STARTED|Overall Study||18
6376374|NCT00759356|7286886|FG001|STARTED|Overall Study||18
6376375|NCT00759356|7286885|FG000|COMPLETED|Overall Study||17
6376376|NCT00759356|7286886|FG001|COMPLETED|Overall Study||15
6376377|NCT00759356|7286885|FG000|NOT COMPLETED|Overall Study||1
6376378|NCT00759356|7286886|FG001|NOT COMPLETED|Overall Study||3
6376379|NCT00759395|7286894|FG000|STARTED|Overall Study||13
6376380|NCT00759395|7286895|FG001|STARTED|Overall Study||9
6376381|NCT00759395|7286894|FG000|COMPLETED|Overall Study||11
6376382|NCT00759395|7286895|FG001|COMPLETED|Overall Study||7
6376383|NCT00759395|7286894|FG000|NOT COMPLETED|Overall Study||2
6376384|NCT00759395|7286895|FG001|NOT COMPLETED|Overall Study||2
6376385|NCT00759408|7286901|FG000|STARTED|Overall Study||38
6376386|NCT00759408|7286901|FG000|COMPLETED|Overall Study||19
6376387|NCT00759408|7286901|FG000|NOT COMPLETED|Overall Study||19
6376388|NCT00759473|7286910|FG000|STARTED|Overall Study||10
6376389|NCT00759473|7286911|FG001|STARTED|Overall Study||10
6376390|NCT00759473|7286912|FG002|STARTED|Overall Study||12
6376391|NCT00759473|7286913|FG003|STARTED|Overall Study||23
6376392|NCT00759473|7286914|FG004|STARTED|Overall Study||24
6559085|NCT01779869|7481732|FG000|STARTED|Overall Study||16
6559086|NCT01779869|7481732|FG000|COMPLETED|Overall Study||14
6559087|NCT01779869|7481732|FG000|NOT COMPLETED|Overall Study||2
6559088|NCT01780324|7481738|FG000|STARTED|Overall Study||41
6559089|NCT01780324|7481739|FG001|STARTED|Overall Study||39
6376393|NCT00759473|7286910|FG000|COMPLETED|Overall Study||10
6376394|NCT00759473|7286911|FG001|COMPLETED|Overall Study||10
6376395|NCT00759473|7286912|FG002|COMPLETED|Overall Study||12
6376396|NCT00759473|7286913|FG003|COMPLETED|Overall Study||23
6376397|NCT00759473|7286914|FG004|COMPLETED|Overall Study||24
6376398|NCT00759473|7286910|FG000|NOT COMPLETED|Overall Study||0
6376399|NCT00759473|7286911|FG001|NOT COMPLETED|Overall Study||0
6376400|NCT00759473|7286912|FG002|NOT COMPLETED|Overall Study||0
6376401|NCT00759473|7286913|FG003|NOT COMPLETED|Overall Study||0
6559090|NCT01780324|7481738|FG000|COMPLETED|Overall Study||40
6376402|NCT00759473|7286914|FG004|NOT COMPLETED|Overall Study||0
6376403|NCT00759525|7286926|FG000|STARTED|First Intervention (14 Days)||7
6376404|NCT00759525|7286927|FG001|STARTED|First Intervention (14 Days)||8
6376405|NCT00759525|7286926|FG000|COMPLETED|First Intervention (14 Days)||7
6376406|NCT00759525|7286927|FG001|COMPLETED|First Intervention (14 Days)||8
6338743|NCT00561145|7246380|FG000|STARTED|Overall Study||15
6338744|NCT00561145|7246381|FG001|STARTED|Overall Study||17
6338745|NCT00561145|7246380|FG000|COMPLETED|Overall Study||15
6338746|NCT00561145|7246381|FG001|COMPLETED|Overall Study||17
6338747|NCT00561145|7246380|FG000|NOT COMPLETED|Overall Study||0
6338748|NCT00561145|7246381|FG001|NOT COMPLETED|Overall Study||0
6338749|NCT00561340|7246389|FG000|STARTED|Overall Study||13
6338750|NCT00561340|7246390|FG001|STARTED|Overall Study||16
6338751|NCT00561340|7246389|FG000|COMPLETED|Overall Study||7
6338752|NCT00561340|7246390|FG001|COMPLETED|Overall Study||16
6338753|NCT00561340|7246389|FG000|NOT COMPLETED|Overall Study||6
6338754|NCT00561340|7246390|FG001|NOT COMPLETED|Overall Study||0
6338755|NCT00561353|7246406|FG000|STARTED|Overall Study||18
6338756|NCT00561353|7246407|FG001|STARTED|Overall Study||19
6338757|NCT00561353|7246408|FG002|STARTED|Overall Study||13
6338758|NCT00561353|7246409|FG003|STARTED|Overall Study||18
6338759|NCT00561353|7246410|FG004|STARTED|Overall Study||6
6338760|NCT00561353|7246411|FG005|STARTED|Overall Study||9
6338761|NCT00561353|7246412|FG006|STARTED|Overall Study||9
6338762|NCT00561353|7246413|FG007|STARTED|Overall Study||10
6338763|NCT00561353|7246414|FG008|STARTED|Overall Study||9
6338764|NCT00561353|7246415|FG009|STARTED|Overall Study||5
6338765|NCT00561353|7246406|FG000|COMPLETED|Overall Study||13
6338766|NCT00561353|7246407|FG001|COMPLETED|Overall Study||16
6338767|NCT00561353|7246408|FG002|COMPLETED|Overall Study||10
6338768|NCT00561353|7246409|FG003|COMPLETED|Overall Study||12
6338769|NCT00561353|7246410|FG004|COMPLETED|Overall Study||5
6338770|NCT00561353|7246411|FG005|COMPLETED|Overall Study||3
6338771|NCT00561353|7246412|FG006|COMPLETED|Overall Study||3
6338772|NCT00561353|7246413|FG007|COMPLETED|Overall Study||6
6338773|NCT00561353|7246414|FG008|COMPLETED|Overall Study||2
6338774|NCT00561353|7246415|FG009|COMPLETED|Overall Study||3
6338775|NCT00561353|7246406|FG000|NOT COMPLETED|Overall Study||5
6338776|NCT00561353|7246407|FG001|NOT COMPLETED|Overall Study||3
6338777|NCT00561353|7246408|FG002|NOT COMPLETED|Overall Study||3
6338778|NCT00561353|7246409|FG003|NOT COMPLETED|Overall Study||6
6338779|NCT00561353|7246410|FG004|NOT COMPLETED|Overall Study||1
6338780|NCT00561353|7246411|FG005|NOT COMPLETED|Overall Study||6
6338781|NCT00561353|7246412|FG006|NOT COMPLETED|Overall Study||6
6338782|NCT00561353|7246413|FG007|NOT COMPLETED|Overall Study||4
6338783|NCT00561353|7246414|FG008|NOT COMPLETED|Overall Study||7
6338784|NCT00561353|7246415|FG009|NOT COMPLETED|Overall Study||2
6338785|NCT00561392|7246477|FG000|STARTED|Overall Study||208
6338786|NCT00561392|7246477|FG000|COMPLETED|Overall Study||155
6338787|NCT00561392|7246477|FG000|NOT COMPLETED|Overall Study||53
6338788|NCT00561418|7246481|FG000|STARTED|Overall Study||23
6338789|NCT00561418|7246481|FG000|COMPLETED|Overall Study||23
6338790|NCT00561418|7246481|FG000|NOT COMPLETED|Overall Study||0
6338791|NCT00561431|7246487|FG000|STARTED|Overall Study||100
6338792|NCT00561431|7246488|FG001|STARTED|Overall Study||100
6338793|NCT00561431|7246487|FG000|COMPLETED|Overall Study||100
6338794|NCT00561431|7246488|FG001|COMPLETED|Overall Study||100
6338795|NCT00561431|7246487|FG000|NOT COMPLETED|Overall Study||0
6338796|NCT00561431|7246488|FG001|NOT COMPLETED|Overall Study||0
6338797|NCT00561457|7246494|FG000|STARTED|Overall Study||134
6338798|NCT00561457|7246494|FG000|COMPLETED|Overall Study||110
6338799|NCT00561457|7246494|FG000|NOT COMPLETED|Overall Study||24
6338800|NCT00561470|7246500|FG000|STARTED|Overall Study||614
6338801|NCT00561470|7246501|FG001|STARTED|Overall Study||612
6338802|NCT00561470|7246500|FG000|TREATED|Overall Study||609
6338803|NCT00561470|7246501|FG001|TREATED|Overall Study||607
6338804|NCT00561470|7246500|FG000|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
6338805|NCT00561470|7246501|FG001|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
6338806|NCT00561470|7246500|FG000|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
6338807|NCT00561470|7246501|FG001|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
6338808|NCT00561470|7246500|FG000|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
6338809|NCT00561470|7246501|FG001|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
6338810|NCT00561470|7246500|FG000|NOT COMPLETED|Overall Study||614
6338811|NCT00561470|7246501|FG001|NOT COMPLETED|Overall Study||612
6338812|NCT00561574|7246511|FG000|STARTED|Overall Study||128
6338813|NCT00561574|7246512|FG001|STARTED|Overall Study||131
6338814|NCT00561574|7246511|FG000|COMPLETED|Overall Study||80
6338815|NCT00561574|7246512|FG001|COMPLETED|Overall Study||73
6338816|NCT00561574|7246511|FG000|NOT COMPLETED|Overall Study||48
6338817|NCT00561574|7246512|FG001|NOT COMPLETED|Overall Study||58
6338818|NCT00561600|7246520|FG000|STARTED|Overall Study||130
6338819|NCT00561600|7246521|FG001|STARTED|Overall Study||135
6338820|NCT00561600|7246520|FG000|COMPLETED|Overall Study||112
6338821|NCT00561600|7246521|FG001|COMPLETED|Overall Study||119
6338822|NCT00561600|7246520|FG000|NOT COMPLETED|Overall Study||18
6338823|NCT00561600|7246521|FG001|NOT COMPLETED|Overall Study||16
6338824|NCT00561652|7246531|FG000|STARTED|Overall Study||10
6338825|NCT00561652|7246532|FG001|STARTED|Overall Study||20
6338826|NCT00561652|7246531|FG000|COMPLETED|Overall Study||10
6338827|NCT00561652|7246532|FG001|COMPLETED|Overall Study||19
6338828|NCT00561652|7246531|FG000|NOT COMPLETED|Overall Study||0
6338829|NCT00561652|7246532|FG001|NOT COMPLETED|Overall Study||1
6338830|NCT00561678|7246540|FG000|STARTED|Overall Study||197
6338831|NCT00561678|7246541|FG001|STARTED|Overall Study||207
6338832|NCT00561678|7246540|FG000|COMPLETED|Overall Study||189
6338833|NCT00561678|7246541|FG001|COMPLETED|Overall Study||201
6338834|NCT00561678|7246540|FG000|NOT COMPLETED|Overall Study||8
6338835|NCT00561678|7246541|FG001|NOT COMPLETED|Overall Study||6
6338836|NCT00561730|7246547|FG000|STARTED|Overall Study||1995
6338837|NCT00561730|7246547|FG000|COMPLETED|Overall Study||1986
6338838|NCT00561730|7246547|FG000|NOT COMPLETED|Overall Study||9
6338839|NCT00561821|7246557|FG000|STARTED|Overall Study||132
6338840|NCT00561821|7246558|FG001|STARTED|Overall Study||136
6338841|NCT00561821|7246559|FG002|STARTED|Overall Study||134
6338842|NCT00561821|7246560|FG003|STARTED|Overall Study||136
6338843|NCT00561821|7246557|FG000|Treated|Overall Study||132
6338844|NCT00561821|7246558|FG001|Treated|Overall Study||136
6338845|NCT00561821|7246559|FG002|Treated|Overall Study||133
6338846|NCT00561821|7246560|FG003|Treated|Overall Study||136
6338847|NCT00561821|7246557|FG000|COMPLETED|Overall Study||127
6338848|NCT00561821|7246558|FG001|COMPLETED|Overall Study||130
6338849|NCT00561821|7246559|FG002|COMPLETED|Overall Study||132
6338850|NCT00561821|7246560|FG003|COMPLETED|Overall Study||133
6338851|NCT00561821|7246557|FG000|NOT COMPLETED|Overall Study||5
6338852|NCT00561821|7246558|FG001|NOT COMPLETED|Overall Study||6
6338853|NCT00561821|7246559|FG002|NOT COMPLETED|Overall Study||2
6338854|NCT00561821|7246560|FG003|NOT COMPLETED|Overall Study||3
6338855|NCT00561834|7246570|FG000|STARTED|Overall Study||2
6338856|NCT00561834|7246570|FG000|COMPLETED|Overall Study||2
6338857|NCT00561834|7246570|FG000|NOT COMPLETED|Overall Study||0
6338858|NCT00561925|7246577|FG000|STARTED|14 Day Lead-In Period||1068
6338859|NCT00561925|7246578|FG001|STARTED|14 Day Lead-In Period||0
6338860|NCT00561925|7246579|FG002|STARTED|14 Day Lead-In Period||0
6338861|NCT00561925|7246580|FG003|STARTED|14 Day Lead-In Period||0
6338862|NCT00561925|7246581|FG004|STARTED|14 Day Lead-In Period||0
6338863|NCT00561925|7246577|FG000|COMPLETED|14 Day Lead-In Period||1013
6338864|NCT00561925|7246578|FG001|COMPLETED|14 Day Lead-In Period||0
6338865|NCT00561925|7246579|FG002|COMPLETED|14 Day Lead-In Period||0
6338866|NCT00561925|7246580|FG003|COMPLETED|14 Day Lead-In Period||0
6338867|NCT00561925|7246581|FG004|COMPLETED|14 Day Lead-In Period||0
6338868|NCT00561925|7246577|FG000|NOT COMPLETED|14 Day Lead-In Period||55
6338869|NCT00561925|7246578|FG001|NOT COMPLETED|14 Day Lead-In Period||0
6338870|NCT00561925|7246579|FG002|NOT COMPLETED|14 Day Lead-In Period||0
6338871|NCT00561925|7246580|FG003|NOT COMPLETED|14 Day Lead-In Period||0
6338872|NCT00561925|7246581|FG004|NOT COMPLETED|14 Day Lead-In Period||0
6338873|NCT00561925|7246577|FG000|STARTED|144-week Double-blind, Double-dummy||0
6338874|NCT00561925|7246578|FG001|STARTED|144-week Double-blind, Double-dummy||508
6338875|NCT00561925|7246579|FG002|STARTED|144-week Double-blind, Double-dummy||505
6338876|NCT00561925|7246580|FG003|STARTED|144-week Double-blind, Double-dummy||0
6338877|NCT00561925|7246581|FG004|STARTED|144-week Double-blind, Double-dummy||0
6338878|NCT00561925|7246577|FG000|COMPLETED|144-week Double-blind, Double-dummy||0
6338879|NCT00561925|7246578|FG001|COMPLETED|144-week Double-blind, Double-dummy||358
6338880|NCT00561925|7246579|FG002|COMPLETED|144-week Double-blind, Double-dummy||378
6338881|NCT00561925|7246580|FG003|COMPLETED|144-week Double-blind, Double-dummy||0
6338882|NCT00561925|7246581|FG004|COMPLETED|144-week Double-blind, Double-dummy||0
6338883|NCT00561925|7246577|FG000|NOT COMPLETED|144-week Double-blind, Double-dummy||0
6776361|NCT03815240|7704435|FG008|STARTED|Intervention Optifoam Dressing||1
6776362|NCT03815240|7704427|FG000|COMPLETED|Intervention Optifoam Dressing||2
6776363|NCT03815240|7704428|FG001|COMPLETED|Intervention Optifoam Dressing||1
6776364|NCT03815240|7704429|FG002|COMPLETED|Intervention Optifoam Dressing||1
6776365|NCT03815240|7704430|FG003|COMPLETED|Intervention Optifoam Dressing||2
6338884|NCT00561925|7246578|FG001|NOT COMPLETED|144-week Double-blind, Double-dummy||150
6338885|NCT00561925|7246579|FG002|NOT COMPLETED|144-week Double-blind, Double-dummy||127
6338886|NCT00561925|7246580|FG003|NOT COMPLETED|144-week Double-blind, Double-dummy||0
6338887|NCT00561925|7246581|FG004|NOT COMPLETED|144-week Double-blind, Double-dummy||0
6338888|NCT00561925|7246577|FG000|STARTED|Open-Label Extension Period||0
6338889|NCT00561925|7246578|FG001|STARTED|Open-Label Extension Period||1
6338890|NCT00561925|7246579|FG002|STARTED|Open-Label Extension Period||0
6338891|NCT00561925|7246580|FG003|STARTED|Open-Label Extension Period||358
6338892|NCT00561925|7246581|FG004|STARTED|Open-Label Extension Period||378
6338893|NCT00561925|7246577|FG000|COMPLETED|Open-Label Extension Period||0
6338894|NCT00561925|7246578|FG001|COMPLETED|Open-Label Extension Period||1
6338895|NCT00561925|7246579|FG002|COMPLETED|Open-Label Extension Period||0
6338896|NCT00561925|7246580|FG003|COMPLETED|Open-Label Extension Period||315
6338897|NCT00561925|7246581|FG004|COMPLETED|Open-Label Extension Period||328
6338898|NCT00561925|7246577|FG000|NOT COMPLETED|Open-Label Extension Period||0
6338899|NCT00561925|7246578|FG001|NOT COMPLETED|Open-Label Extension Period||0
6338900|NCT00561925|7246579|FG002|NOT COMPLETED|Open-Label Extension Period||0
6338901|NCT00561925|7246580|FG003|NOT COMPLETED|Open-Label Extension Period||43
6338902|NCT00561925|7246581|FG004|NOT COMPLETED|Open-Label Extension Period||50
6498448|NCT01409993|7417031|FG000|STARTED|Overall Study||25
6338903|NCT00561951|7246602|FG000|STARTED|Overall Study||318
6338904|NCT00561951|7246603|FG001|STARTED|Overall Study||320
6338905|NCT00561951|7246604|FG002|STARTED|Overall Study||313
6338906|NCT00561951|7246602|FG000|COMPLETED|Overall Study||285
6498449|NCT01409993|7417032|FG001|STARTED|Overall Study||26
6776366|NCT03815240|7704431|FG004|COMPLETED|Intervention Optifoam Dressing||1
6338907|NCT00561951|7246603|FG001|COMPLETED|Overall Study||286
6338908|NCT00561951|7246604|FG002|COMPLETED|Overall Study||281
6338909|NCT00561951|7246602|FG000|NOT COMPLETED|Overall Study||33
6338910|NCT00561951|7246603|FG001|NOT COMPLETED|Overall Study||34
6338911|NCT00561951|7246604|FG002|NOT COMPLETED|Overall Study||32
6338912|NCT00561977|7246615|FG000|STARTED|Overall Study||12
6338913|NCT00561977|7246616|FG001|STARTED|Overall Study||12
6338914|NCT00561977|7246617|FG002|STARTED|Overall Study||12
6338915|NCT00561977|7246615|FG000|COMPLETED|Overall Study||12
6338916|NCT00561977|7246616|FG001|COMPLETED|Overall Study||9
6338917|NCT00561977|7246617|FG002|COMPLETED|Overall Study||10
6338918|NCT00561977|7246615|FG000|NOT COMPLETED|Overall Study||0
6338919|NCT00561977|7246616|FG001|NOT COMPLETED|Overall Study||3
6338920|NCT00561977|7246617|FG002|NOT COMPLETED|Overall Study||2
6338921|NCT00562094|7246625|FG000|STARTED|Overall Study||8616
6338922|NCT00562094|7246625|FG000|COMPLETED|Overall Study||8554
6338923|NCT00562094|7246625|FG000|NOT COMPLETED|Overall Study||62
6338924|NCT00562120|7246633|FG000|STARTED|First Intervention Period||6
6338925|NCT00562120|7246634|FG001|STARTED|First Intervention Period||5
6338926|NCT00562120|7246635|FG002|STARTED|First Intervention Period||5
6338927|NCT00562120|7246636|FG003|STARTED|First Intervention Period||5
6338928|NCT00562120|7246633|FG000|Treated|First Intervention Period||5
6338929|NCT00562120|7246634|FG001|Treated|First Intervention Period||5
6338930|NCT00562120|7246635|FG002|Treated|First Intervention Period||5
6338931|NCT00562120|7246636|FG003|Treated|First Intervention Period||5
6338932|NCT00562120|7246633|FG000|COMPLETED|First Intervention Period||4
6338933|NCT00562120|7246634|FG001|COMPLETED|First Intervention Period||5
6338934|NCT00562120|7246635|FG002|COMPLETED|First Intervention Period||5
6338935|NCT00562120|7246636|FG003|COMPLETED|First Intervention Period||5
6338936|NCT00562120|7246633|FG000|NOT COMPLETED|First Intervention Period||2
6338937|NCT00562120|7246634|FG001|NOT COMPLETED|First Intervention Period||0
6338938|NCT00562120|7246635|FG002|NOT COMPLETED|First Intervention Period||0
6338939|NCT00562120|7246636|FG003|NOT COMPLETED|First Intervention Period||0
6338940|NCT00562120|7246633|FG000|STARTED|Washout Period 1 (At Least 14 Days)||4
6338941|NCT00562120|7246634|FG001|STARTED|Washout Period 1 (At Least 14 Days)||5
6338942|NCT00562120|7246635|FG002|STARTED|Washout Period 1 (At Least 14 Days)||5
6338943|NCT00562120|7246636|FG003|STARTED|Washout Period 1 (At Least 14 Days)||5
6338944|NCT00562120|7246633|FG000|COMPLETED|Washout Period 1 (At Least 14 Days)||4
6338945|NCT00562120|7246634|FG001|COMPLETED|Washout Period 1 (At Least 14 Days)||5
6338946|NCT00562120|7246635|FG002|COMPLETED|Washout Period 1 (At Least 14 Days)||5
6338947|NCT00562120|7246636|FG003|COMPLETED|Washout Period 1 (At Least 14 Days)||5
6338948|NCT00562120|7246633|FG000|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
6338949|NCT00562120|7246634|FG001|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
6338950|NCT00562120|7246635|FG002|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
6338951|NCT00562120|7246636|FG003|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
6338952|NCT00562120|7246633|FG000|STARTED|Second Intervention Period||4
6338953|NCT00562120|7246634|FG001|STARTED|Second Intervention Period||5
6338954|NCT00562120|7246635|FG002|STARTED|Second Intervention Period||5
6338955|NCT00562120|7246636|FG003|STARTED|Second Intervention Period||5
6338956|NCT00562120|7246633|FG000|COMPLETED|Second Intervention Period||4
6338957|NCT00562120|7246634|FG001|COMPLETED|Second Intervention Period||5
6338958|NCT00562120|7246635|FG002|COMPLETED|Second Intervention Period||5
6338959|NCT00562120|7246636|FG003|COMPLETED|Second Intervention Period||5
6338960|NCT00562120|7246633|FG000|NOT COMPLETED|Second Intervention Period||0
6338961|NCT00562120|7246634|FG001|NOT COMPLETED|Second Intervention Period||0
6338962|NCT00562120|7246635|FG002|NOT COMPLETED|Second Intervention Period||0
6338963|NCT00562120|7246636|FG003|NOT COMPLETED|Second Intervention Period||0
6338964|NCT00562120|7246633|FG000|STARTED|Washout Period 2 (At Least 14 Days)||4
6338965|NCT00562120|7246634|FG001|STARTED|Washout Period 2 (At Least 14 Days)||5
6338966|NCT00562120|7246635|FG002|STARTED|Washout Period 2 (At Least 14 Days)||5
6338967|NCT00562120|7246636|FG003|STARTED|Washout Period 2 (At Least 14 Days)||5
6338968|NCT00562120|7246633|FG000|COMPLETED|Washout Period 2 (At Least 14 Days)||4
6338969|NCT00562120|7246634|FG001|COMPLETED|Washout Period 2 (At Least 14 Days)||5
6338970|NCT00562120|7246635|FG002|COMPLETED|Washout Period 2 (At Least 14 Days)||5
6338971|NCT00562120|7246636|FG003|COMPLETED|Washout Period 2 (At Least 14 Days)||5
6338972|NCT00562120|7246633|FG000|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
6338973|NCT00562120|7246634|FG001|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
6338974|NCT00562120|7246635|FG002|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
6338975|NCT00562120|7246636|FG003|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
6338976|NCT00562120|7246633|FG000|STARTED|Third Intervention Period||4
6338977|NCT00562120|7246634|FG001|STARTED|Third Intervention Period||5
6338978|NCT00562120|7246635|FG002|STARTED|Third Intervention Period||5
6338979|NCT00562120|7246636|FG003|STARTED|Third Intervention Period||5
6338980|NCT00562120|7246633|FG000|COMPLETED|Third Intervention Period||4
6338981|NCT00562120|7246634|FG001|COMPLETED|Third Intervention Period||5
6338982|NCT00562120|7246635|FG002|COMPLETED|Third Intervention Period||5
6338983|NCT00562120|7246636|FG003|COMPLETED|Third Intervention Period||5
6338984|NCT00562120|7246633|FG000|NOT COMPLETED|Third Intervention Period||0
6338985|NCT00562120|7246634|FG001|NOT COMPLETED|Third Intervention Period||0
6338986|NCT00562120|7246635|FG002|NOT COMPLETED|Third Intervention Period||0
6338987|NCT00562120|7246636|FG003|NOT COMPLETED|Third Intervention Period||0
6338988|NCT00562120|7246633|FG000|STARTED|Washout Period 3 (At Least 14 Days)||4
6338989|NCT00562120|7246634|FG001|STARTED|Washout Period 3 (At Least 14 Days)||5
6338990|NCT00562120|7246635|FG002|STARTED|Washout Period 3 (At Least 14 Days)||5
6338991|NCT00562120|7246636|FG003|STARTED|Washout Period 3 (At Least 14 Days)||5
6338992|NCT00562120|7246633|FG000|COMPLETED|Washout Period 3 (At Least 14 Days)||4
6338993|NCT00562120|7246634|FG001|COMPLETED|Washout Period 3 (At Least 14 Days)||5
6338994|NCT00562120|7246635|FG002|COMPLETED|Washout Period 3 (At Least 14 Days)||5
6338995|NCT00562120|7246636|FG003|COMPLETED|Washout Period 3 (At Least 14 Days)||5
6338996|NCT00562120|7246633|FG000|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
6338997|NCT00562120|7246634|FG001|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
6338998|NCT00562120|7246635|FG002|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
6338999|NCT00562120|7246636|FG003|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
6339000|NCT00562120|7246633|FG000|STARTED|Fourth Intervention Period||4
6339001|NCT00562120|7246634|FG001|STARTED|Fourth Intervention Period||5
6339002|NCT00562120|7246635|FG002|STARTED|Fourth Intervention Period||5
6339003|NCT00562120|7246636|FG003|STARTED|Fourth Intervention Period||5
6339004|NCT00562120|7246633|FG000|COMPLETED|Fourth Intervention Period||4
6339005|NCT00562120|7246634|FG001|COMPLETED|Fourth Intervention Period||5
6339006|NCT00562120|7246635|FG002|COMPLETED|Fourth Intervention Period||5
6339007|NCT00562120|7246636|FG003|COMPLETED|Fourth Intervention Period||5
6339008|NCT00562120|7246633|FG000|NOT COMPLETED|Fourth Intervention Period||0
6339009|NCT00562120|7246634|FG001|NOT COMPLETED|Fourth Intervention Period||0
6339010|NCT00562120|7246635|FG002|NOT COMPLETED|Fourth Intervention Period||0
6339011|NCT00562120|7246636|FG003|NOT COMPLETED|Fourth Intervention Period||0
6339012|NCT00562159|7246648|FG000|STARTED|Overall Study||213
6339013|NCT00562159|7246649|FG001|STARTED|Overall Study||225
6339014|NCT00562159|7246648|FG000|COMPLETED|Overall Study||175
6339015|NCT00562159|7246649|FG001|COMPLETED|Overall Study||192
6339016|NCT00562159|7246648|FG000|NOT COMPLETED|Overall Study||38
6339017|NCT00562159|7246649|FG001|NOT COMPLETED|Overall Study||33
6339018|NCT00562302|7246658|FG000|STARTED|Overall Study||170
6339019|NCT00562302|7246659|FG001|STARTED|Overall Study||169
6339020|NCT00562302|7246658|FG000|COMPLETED|Overall Study||150
6339021|NCT00562302|7246659|FG001|COMPLETED|Overall Study||137
6339022|NCT00562302|7246658|FG000|NOT COMPLETED|Overall Study||20
6339023|NCT00562302|7246659|FG001|NOT COMPLETED|Overall Study||32
6339024|NCT00562315|7246665|FG000|STARTED|Overall Study||93
6339025|NCT00562315|7246665|FG000|COMPLETED|Overall Study||93
6339026|NCT00562315|7246665|FG000|NOT COMPLETED|Overall Study||0
6339027|NCT00562328|7246671|FG000|STARTED|Overall Study||33
6339028|NCT00562328|7246671|FG000|COMPLETED|Overall Study||33
6339029|NCT00562328|7246671|FG000|NOT COMPLETED|Overall Study||0
6339030|NCT00562354|7246677|FG000|STARTED|Overall Study||134
6339031|NCT00562354|7246678|FG001|STARTED|Overall Study||137
6339032|NCT00562354|7246677|FG000|Received Study Treatment|Overall Study||134
6339033|NCT00562354|7246678|FG001|Received Study Treatment|Overall Study||136
6339034|NCT00562354|7246677|FG000|Evaluable Immunogenicity Population|Overall Study||134
6339035|NCT00562354|7246678|FG001|Evaluable Immunogenicity Population|Overall Study||134
6339036|NCT00562354|7246677|FG000|COMPLETED|Overall Study||134
6339037|NCT00562354|7246678|FG001|COMPLETED|Overall Study||135
6339038|NCT00562354|7246677|FG000|NOT COMPLETED|Overall Study||0
6339039|NCT00562354|7246678|FG001|NOT COMPLETED|Overall Study||2
6339040|NCT00562484|7246688|FG000|STARTED|Overall Study||10033
6339041|NCT00562484|7246689|FG001|STARTED|Overall Study||5011
6339042|NCT00562484|7246688|FG000|COMPLETED|Overall Study||9827
6339043|NCT00562484|7246689|FG001|COMPLETED|Overall Study||4907
6339044|NCT00562484|7246688|FG000|NOT COMPLETED|Overall Study||206
6339045|NCT00562484|7246689|FG001|NOT COMPLETED|Overall Study||104
6339046|NCT00562588|7246697|FG000|STARTED|Overall Study||260
6339047|NCT00562588|7246698|FG001|STARTED|Overall Study||283
6339048|NCT00562588|7246697|FG000|COMPLETED|Overall Study||168
6339049|NCT00562588|7246698|FG001|COMPLETED|Overall Study||184
6339050|NCT00562588|7246697|FG000|NOT COMPLETED|Overall Study||92
6339051|NCT00562588|7246698|FG001|NOT COMPLETED|Overall Study||99
6339052|NCT00562627|7246707|FG000|STARTED|Overall Study||34
6339053|NCT00562627|7246708|FG001|STARTED|Overall Study||34
6339054|NCT00562627|7246709|FG002|STARTED|Overall Study||34
6339055|NCT00562627|7246707|FG000|COMPLETED|Overall Study||33
6339056|NCT00562627|7246708|FG001|COMPLETED|Overall Study||33
6339057|NCT00562627|7246709|FG002|COMPLETED|Overall Study||33
6339058|NCT00562627|7246707|FG000|NOT COMPLETED|Overall Study||1
6339059|NCT00562627|7246708|FG001|NOT COMPLETED|Overall Study||1
6339060|NCT00562627|7246709|FG002|NOT COMPLETED|Overall Study||1
6339061|NCT00562718|7246717|FG000|STARTED|Overall Study||50
6339062|NCT00562718|7246717|FG000|COMPLETED|Overall Study||39
6339063|NCT00562718|7246717|FG000|NOT COMPLETED|Overall Study||11
6339064|NCT00562861|7246723|FG000|STARTED|Overall Study||60
6339065|NCT00562861|7246724|FG001|STARTED|Overall Study||59
6339066|NCT00562861|7246723|FG000|COMPLETED|Overall Study||40
6339067|NCT00562861|7246724|FG001|COMPLETED|Overall Study||48
6339068|NCT00562861|7246723|FG000|NOT COMPLETED|Overall Study||20
6339069|NCT00562861|7246724|FG001|NOT COMPLETED|Overall Study||11
6339070|NCT00562965|7246732|FG000|STARTED|Overall Study||15
6339071|NCT00562965|7246733|FG001|STARTED|Overall Study||14
6339072|NCT00562965|7246732|FG000|Treated|Overall Study||15
6339073|NCT00562965|7246733|FG001|Treated|Overall Study||13
6339074|NCT00562965|7246732|FG000|COMPLETED|Overall Study||12
6339075|NCT00562965|7246733|FG001|COMPLETED|Overall Study||8
6339076|NCT00562965|7246732|FG000|NOT COMPLETED|Overall Study||3
6339077|NCT00562965|7246733|FG001|NOT COMPLETED|Overall Study||6
6339078|NCT00562978|7246741|FG000|STARTED|Overall Study||6
6339079|NCT00562978|7246742|FG001|STARTED|Overall Study||48
6339080|NCT00562978|7246741|FG000|COMPLETED|Overall Study||5
6339081|NCT00562978|7246742|FG001|COMPLETED|Overall Study||37
6339082|NCT00562978|7246741|FG000|NOT COMPLETED|Overall Study||1
6339083|NCT00562978|7246742|FG001|NOT COMPLETED|Overall Study||11
6339084|NCT00563186|7246750|FG000|STARTED|Overall Study|Patients allocated to the Novel Hospital Ward|1008
6339085|NCT00563186|7246751|FG001|STARTED|Overall Study|Patients allocated to the Traditional Hospital Ward|679
6339086|NCT00563186|7246750|FG000|COMPLETED|Overall Study||910
6339087|NCT00563186|7246751|FG001|COMPLETED|Overall Study||604
6339088|NCT00563186|7246750|FG000|NOT COMPLETED|Overall Study||98
6339089|NCT00563186|7246751|FG001|NOT COMPLETED|Overall Study||75
6339090|NCT00563290|7246762|FG000|STARTED|Overall Study||3
6339091|NCT00563290|7246763|FG001|STARTED|Overall Study||4
6339092|NCT00563290|7246762|FG000|COMPLETED|Overall Study||3
6339093|NCT00563290|7246763|FG001|COMPLETED|Overall Study||4
6339094|NCT00563290|7246762|FG000|NOT COMPLETED|Overall Study||0
6339095|NCT00563290|7246763|FG001|NOT COMPLETED|Overall Study||0
6339096|NCT00563316|7246771|FG000|STARTED|Overall Study||28
6339097|NCT00563316|7246771|FG000|Received Investigational Product|Overall Study||27
6339098|NCT00563316|7246771|FG000|COMPLETED|Overall Study||16
6339099|NCT00563316|7246771|FG000|NOT COMPLETED|Overall Study||12
6339100|NCT00563368|7246786|FG000|STARTED|Overall Study||109
6339101|NCT00563368|7246787|FG001|STARTED|Overall Study||109
6339102|NCT00563368|7246788|FG002|STARTED|Overall Study||108
6339103|NCT00563368|7246789|FG003|STARTED|Overall Study||107
6339104|NCT00563368|7246790|FG004|STARTED|Overall Study||108
6339105|NCT00563368|7246791|FG005|STARTED|Overall Study||107
6339106|NCT00563368|7246792|FG006|STARTED|Overall Study||108
6339107|NCT00563368|7246786|FG000|COMPLETED|Overall Study||74
6339108|NCT00563368|7246787|FG001|COMPLETED|Overall Study||79
6339109|NCT00563368|7246788|FG002|COMPLETED|Overall Study||78
6339110|NCT00563368|7246789|FG003|COMPLETED|Overall Study||78
6339111|NCT00563368|7246790|FG004|COMPLETED|Overall Study||80
6339112|NCT00563368|7246791|FG005|COMPLETED|Overall Study||77
6339113|NCT00563368|7246792|FG006|COMPLETED|Overall Study||75
6339114|NCT00563368|7246786|FG000|NOT COMPLETED|Overall Study||35
6339115|NCT00563368|7246787|FG001|NOT COMPLETED|Overall Study||30
6339116|NCT00563368|7246788|FG002|NOT COMPLETED|Overall Study||30
6339117|NCT00563368|7246789|FG003|NOT COMPLETED|Overall Study||29
6339118|NCT00563368|7246790|FG004|NOT COMPLETED|Overall Study||28
6339119|NCT00563368|7246791|FG005|NOT COMPLETED|Overall Study||30
6339120|NCT00563368|7246792|FG006|NOT COMPLETED|Overall Study||33
6339121|NCT00563381|7246810|FG000|STARTED|Overall Study|Started treatment|3707
6339122|NCT00563381|7246811|FG001|STARTED|Overall Study|Started treatment|3669
6339123|NCT00563381|7246810|FG000|COMPLETED|Overall Study|Completed treatment|3122
6339124|NCT00563381|7246811|FG001|COMPLETED|Overall Study|Completed treatment|3021
6339125|NCT00563381|7246810|FG000|NOT COMPLETED|Overall Study||585
6339126|NCT00563381|7246811|FG001|NOT COMPLETED|Overall Study||648
6339127|NCT00563706|7246826|FG000|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
6339128|NCT00563706|7246827|FG001|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
6339129|NCT00563706|7246828|FG002|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
6339130|NCT00563706|7246829|FG003|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
6339131|NCT00563706|7246830|FG004|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
6339132|NCT00563706|7246831|FG005|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
6339133|NCT00563706|7246832|FG006|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
6339134|NCT00563706|7246833|FG007|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
6339135|NCT00563706|7246834|FG008|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
6339136|NCT00563706|7246826|FG000|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
6339137|NCT00563706|7246827|FG001|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
6339138|NCT00563706|7246828|FG002|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
6339139|NCT00563706|7246829|FG003|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
6339140|NCT00563706|7246830|FG004|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
6339141|NCT00563706|7246831|FG005|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
6339142|NCT00563706|7246832|FG006|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
6339143|NCT00563706|7246833|FG007|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
6339144|NCT00563706|7246834|FG008|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
6339145|NCT00563706|7246826|FG000|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
6339146|NCT00563706|7246827|FG001|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
6339147|NCT00563706|7246828|FG002|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
6339148|NCT00563706|7246829|FG003|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
6339149|NCT00563706|7246830|FG004|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
6339150|NCT00563706|7246831|FG005|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
6339151|NCT00563706|7246832|FG006|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
6339152|NCT00563706|7246833|FG007|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
6339153|NCT00563706|7246834|FG008|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
6339154|NCT00563706|7246826|FG000|STARTED|Taper Phase (Day 29 up to Day 35)||20
6339155|NCT00563706|7246827|FG001|STARTED|Taper Phase (Day 29 up to Day 35)||13
6339156|NCT00563706|7246828|FG002|STARTED|Taper Phase (Day 29 up to Day 35)||3
6339157|NCT00563706|7246829|FG003|STARTED|Taper Phase (Day 29 up to Day 35)||9
6339158|NCT00563706|7246830|FG004|STARTED|Taper Phase (Day 29 up to Day 35)||11
6339159|NCT00563706|7246831|FG005|STARTED|Taper Phase (Day 29 up to Day 35)||14
6339160|NCT00563706|7246832|FG006|STARTED|Taper Phase (Day 29 up to Day 35)||9
6339161|NCT00563706|7246833|FG007|STARTED|Taper Phase (Day 29 up to Day 35)||16
6339162|NCT00563706|7246834|FG008|STARTED|Taper Phase (Day 29 up to Day 35)||32
6339163|NCT00563706|7246826|FG000|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
6339164|NCT00563706|7246827|FG001|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
6339165|NCT00563706|7246828|FG002|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
6339166|NCT00563706|7246829|FG003|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
6339167|NCT00563706|7246830|FG004|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
6339168|NCT00563706|7246831|FG005|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
6339169|NCT00563706|7246832|FG006|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
6339170|NCT00563706|7246833|FG007|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
6339171|NCT00563706|7246834|FG008|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
6339172|NCT00563706|7246826|FG000|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339173|NCT00563706|7246827|FG001|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339174|NCT00563706|7246828|FG002|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339175|NCT00563706|7246829|FG003|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339176|NCT00563706|7246830|FG004|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339177|NCT00563706|7246831|FG005|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339178|NCT00563706|7246832|FG006|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339179|NCT00563706|7246833|FG007|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339180|NCT00563706|7246834|FG008|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
6339181|NCT00563784|7246854|FG000|STARTED|Overall Study||68
6339182|NCT00563784|7246854|FG000|COMPLETED|Overall Study||46
6339183|NCT00563784|7246854|FG000|NOT COMPLETED|Overall Study||22
6339184|NCT00563797|7246860|FG000|STARTED|Overall Study||11
6339185|NCT00563797|7246861|FG001|STARTED|Overall Study||10
6339186|NCT00563797|7246860|FG000|Received Allocated Intervention|Overall Study||11
6339187|NCT00563797|7246861|FG001|Received Allocated Intervention|Overall Study||10
6339188|NCT00563797|7246860|FG000|Follow-Up|Overall Study||11
6339189|NCT00563797|7246861|FG001|Follow-Up|Overall Study||10
6339190|NCT00563797|7246860|FG000|COMPLETED|Overall Study||4
6339191|NCT00563797|7246861|FG001|COMPLETED|Overall Study||8
6339192|NCT00563797|7246860|FG000|NOT COMPLETED|Overall Study||7
6339193|NCT00563797|7246861|FG001|NOT COMPLETED|Overall Study||2
6339194|NCT00564018|7246872|FG000|STARTED|Overall Study||11
6339195|NCT00564018|7246873|FG001|STARTED|Overall Study||10
6339196|NCT00564018|7246874|FG002|STARTED|Overall Study||12
6339197|NCT00564018|7246872|FG000|COMPLETED|Overall Study||9
6339198|NCT00564018|7246873|FG001|COMPLETED|Overall Study||7
6339199|NCT00564018|7246874|FG002|COMPLETED|Overall Study||11
6339200|NCT00564018|7246872|FG000|NOT COMPLETED|Overall Study||2
6339201|NCT00564018|7246873|FG001|NOT COMPLETED|Overall Study||3
6339202|NCT00564018|7246874|FG002|NOT COMPLETED|Overall Study||1
6339203|NCT00564070|7246884|FG000|STARTED|Overall Study||42
6339204|NCT00564070|7246885|FG001|STARTED|Overall Study||45
6339205|NCT00564070|7246884|FG000|COMPLETED|Overall Study||30
6339206|NCT00564070|7246885|FG001|COMPLETED|Overall Study||38
6339207|NCT00564070|7246884|FG000|NOT COMPLETED|Overall Study||12
6339208|NCT00564070|7246885|FG001|NOT COMPLETED|Overall Study||7
6339209|NCT00564265|7246891|FG000|STARTED|Overall Study||24
6339210|NCT00564265|7246891|FG000|COMPLETED|Overall Study||24
6339211|NCT00564265|7246891|FG000|NOT COMPLETED|Overall Study||0
6339212|NCT00564278|7246897|FG000|STARTED|Overall Study||97
6339213|NCT00564278|7246898|FG001|STARTED|Overall Study||98
6339214|NCT00564278|7246897|FG000|COMPLETED|Overall Study||50
6339215|NCT00564278|7246898|FG001|COMPLETED|Overall Study||56
6339216|NCT00564278|7246897|FG000|NOT COMPLETED|Overall Study||47
6339217|NCT00564278|7246898|FG001|NOT COMPLETED|Overall Study||42
6339218|NCT00564395|7246904|FG000|STARTED|First Intervention (10 Days)||9
6339219|NCT00564395|7246905|FG001|STARTED|First Intervention (10 Days)||9
6339220|NCT00564395|7246904|FG000|Received Intervention|First Intervention (10 Days)||7
6339221|NCT00564395|7246905|FG001|Received Intervention|First Intervention (10 Days)||7
6339222|NCT00564395|7246904|FG000|COMPLETED|First Intervention (10 Days)||7
6339223|NCT00564395|7246905|FG001|COMPLETED|First Intervention (10 Days)||7
6339224|NCT00564395|7246904|FG000|NOT COMPLETED|First Intervention (10 Days)||2
6339225|NCT00564395|7246905|FG001|NOT COMPLETED|First Intervention (10 Days)||2
6339226|NCT00564395|7246904|FG000|STARTED|Second Intervention (10 Days)||7
6339227|NCT00564395|7246905|FG001|STARTED|Second Intervention (10 Days)||7
6339228|NCT00564395|7246904|FG000|COMPLETED|Second Intervention (10 Days)||7
6339229|NCT00564395|7246905|FG001|COMPLETED|Second Intervention (10 Days)||7
6339230|NCT00564395|7246904|FG000|NOT COMPLETED|Second Intervention (10 Days)||0
6339231|NCT00564395|7246905|FG001|NOT COMPLETED|Second Intervention (10 Days)||0
6339232|NCT00564447|7246919|FG000|STARTED|Overall Study||6
6339233|NCT00564447|7246920|FG001|STARTED|Overall Study||6
6339234|NCT00564447|7246921|FG002|STARTED|Overall Study||6
6339235|NCT00564447|7246922|FG003|STARTED|Overall Study||6
6339236|NCT00564447|7246923|FG004|STARTED|Overall Study||6
6339237|NCT00564447|7246924|FG005|STARTED|Overall Study||6
6339238|NCT00564447|7246925|FG006|STARTED|Overall Study||6
6339239|NCT00564447|7246926|FG007|STARTED|Overall Study||6
6339240|NCT00564447|7246919|FG000|COMPLETED|Overall Study||6
6339241|NCT00564447|7246920|FG001|COMPLETED|Overall Study||6
6339242|NCT00564447|7246921|FG002|COMPLETED|Overall Study||6
6339243|NCT00564447|7246922|FG003|COMPLETED|Overall Study||6
6339244|NCT00564447|7246923|FG004|COMPLETED|Overall Study||6
6339245|NCT00564447|7246924|FG005|COMPLETED|Overall Study||6
6339246|NCT00564447|7246925|FG006|COMPLETED|Overall Study||6
6339247|NCT00564447|7246926|FG007|COMPLETED|Overall Study||6
6339248|NCT00564447|7246919|FG000|NOT COMPLETED|Overall Study||0
6339249|NCT00564447|7246920|FG001|NOT COMPLETED|Overall Study||0
6339250|NCT00564447|7246921|FG002|NOT COMPLETED|Overall Study||0
6339251|NCT00564447|7246922|FG003|NOT COMPLETED|Overall Study||0
6339252|NCT00564447|7246923|FG004|NOT COMPLETED|Overall Study||0
6339253|NCT00564447|7246924|FG005|NOT COMPLETED|Overall Study||0
6339254|NCT00564447|7246925|FG006|NOT COMPLETED|Overall Study||0
6339255|NCT00564447|7246926|FG007|NOT COMPLETED|Overall Study||0
6339256|NCT00564486|7246947|FG000|STARTED|Overall Study||43
6339257|NCT00564486|7246948|FG001|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
6339258|NCT00564486|7246949|FG002|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
6339259|NCT00564486|7246950|FG003|STARTED|Overall Study||67
6339260|NCT00564486|7246947|FG000|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
6339261|NCT00564486|7246948|FG001|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
6339262|NCT00564486|7246949|FG002|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
6339263|NCT00564486|7246950|FG003|COMPLETED|Overall Study||60
6339264|NCT00564486|7246947|FG000|NOT COMPLETED|Overall Study||7
6339265|NCT00564486|7246948|FG001|NOT COMPLETED|Overall Study||1
6339266|NCT00564486|7246949|FG002|NOT COMPLETED|Overall Study||3
6339267|NCT00564486|7246950|FG003|NOT COMPLETED|Overall Study||7
6339268|NCT00564629|7246966|FG000|STARTED|Overall Study||51
6339269|NCT00564629|7246967|FG001|STARTED|Overall Study||54
6339270|NCT00564629|7246966|FG000|COMPLETED|Overall Study||36
6339271|NCT00564629|7246967|FG001|COMPLETED|Overall Study||45
6339272|NCT00564629|7246966|FG000|NOT COMPLETED|Overall Study||15
6339273|NCT00564629|7246967|FG001|NOT COMPLETED|Overall Study||9
6339274|NCT00564681|7246977|FG000|STARTED|Overall Study||117
6339275|NCT00564681|7246978|FG001|STARTED|Overall Study||61
6339276|NCT00564681|7246979|FG002|STARTED|Overall Study||43
6339277|NCT00564681|7246980|FG003|STARTED|Overall Study||21
6339278|NCT00564681|7246977|FG000|COMPLETED|Overall Study||106
6339279|NCT00564681|7246978|FG001|COMPLETED|Overall Study||58
6339280|NCT00564681|7246979|FG002|COMPLETED|Overall Study||40
6339281|NCT00564681|7246980|FG003|COMPLETED|Overall Study||19
6339282|NCT00564681|7246977|FG000|NOT COMPLETED|Overall Study||11
6339283|NCT00564681|7246978|FG001|NOT COMPLETED|Overall Study||3
6339284|NCT00564681|7246979|FG002|NOT COMPLETED|Overall Study||3
6339285|NCT00564681|7246980|FG003|NOT COMPLETED|Overall Study||2
6339286|NCT00564733|7246989|FG000|STARTED|Overall Study||55
6339287|NCT00564733|7246989|FG000|COMPLETED|Overall Study||46
6339288|NCT00564733|7246989|FG000|NOT COMPLETED|Overall Study||9
6339289|NCT00564850|7246993|FG000|STARTED|Overall Study||37
6339290|NCT00564850|7246993|FG000|COMPLETED|Overall Study||35
6339291|NCT00564850|7246993|FG000|NOT COMPLETED|Overall Study||2
6339292|NCT00564889|7246997|FG000|STARTED|Overall Study||35
6339293|NCT00564889|7246997|FG000|COMPLETED|Overall Study||6
6339294|NCT00564889|7246997|FG000|NOT COMPLETED|Overall Study||29
6339295|NCT00564902|7247004|FG000|STARTED|Overall Study||10
6339296|NCT00564902|7247005|FG001|STARTED|Overall Study||25
6339297|NCT00564902|7247006|FG002|STARTED|Overall Study||25
6339298|NCT00564902|7247004|FG000|4 Months|Overall Study||9
6339299|NCT00564902|7247005|FG001|4 Months|Overall Study||24
6339300|NCT00564902|7247006|FG002|4 Months|Overall Study||23
6339301|NCT00564902|7247004|FG000|8 Months|Overall Study||9
6339302|NCT00564902|7247005|FG001|8 Months|Overall Study||22
6339303|NCT00564902|7247006|FG002|8 Months|Overall Study||21
6339304|NCT00564902|7247004|FG000|12 Months|Overall Study||9
6339305|NCT00564902|7247005|FG001|12 Months|Overall Study||21
6339306|NCT00564902|7247006|FG002|12 Months|Overall Study||21
6339307|NCT00564902|7247004|FG000|COMPLETED|Overall Study||9
6339308|NCT00564902|7247005|FG001|COMPLETED|Overall Study||21
6339309|NCT00564902|7247006|FG002|COMPLETED|Overall Study||21
6339310|NCT00564902|7247004|FG000|NOT COMPLETED|Overall Study||1
6339311|NCT00564902|7247005|FG001|NOT COMPLETED|Overall Study||4
6559091|NCT01780324|7481739|FG001|COMPLETED|Overall Study||33
6559092|NCT01780324|7481738|FG000|NOT COMPLETED|Overall Study||1
6559093|NCT01780324|7481739|FG001|NOT COMPLETED|Overall Study||6
6559094|NCT01780337|7481747|FG000|STARTED|Overall Study||6
6559095|NCT01780337|7481748|FG001|STARTED|Overall Study||6
6559096|NCT01780337|7481747|FG000|COMPLETED|Overall Study||6
6559097|NCT01780337|7481748|FG001|COMPLETED|Overall Study||6
6559098|NCT01780337|7481747|FG000|NOT COMPLETED|Overall Study||0
6559099|NCT01780337|7481748|FG001|NOT COMPLETED|Overall Study||0
6559100|NCT01780350|7481754|FG000|STARTED|Overall Study||200
6559101|NCT01780350|7481754|FG000|COMPLETED|Overall Study||200
6559102|NCT01780350|7481754|FG000|NOT COMPLETED|Overall Study||0
6339312|NCT00564902|7247006|FG002|NOT COMPLETED|Overall Study||4
6339313|NCT00564954|7247016|FG000|STARTED|Period 1- 1 Week||44
6559103|NCT01780389|7481758|FG000|STARTED|Overall Study||5
6339314|NCT00564954|7247017|FG001|STARTED|Period 1- 1 Week||42
6339315|NCT00564954|7247016|FG000|COMPLETED|Period 1- 1 Week||44
6339316|NCT00564954|7247017|FG001|COMPLETED|Period 1- 1 Week||42
6339317|NCT00564954|7247016|FG000|NOT COMPLETED|Period 1- 1 Week||0
6339318|NCT00564954|7247017|FG001|NOT COMPLETED|Period 1- 1 Week||0
6339319|NCT00564954|7247016|FG000|STARTED|Period 2- 1 Week||44
6339320|NCT00564954|7247017|FG001|STARTED|Period 2- 1 Week||42
6339321|NCT00564954|7247016|FG000|COMPLETED|Period 2- 1 Week||44
6339322|NCT00564954|7247017|FG001|COMPLETED|Period 2- 1 Week||42
6339323|NCT00564954|7247016|FG000|NOT COMPLETED|Period 2- 1 Week||0
6339324|NCT00564954|7247017|FG001|NOT COMPLETED|Period 2- 1 Week||0
6339325|NCT00565045|7247025|FG000|STARTED|Overall Study||10
6339326|NCT00565045|7247026|FG001|STARTED|Overall Study||11
6339327|NCT00565045|7247025|FG000|COMPLETED|Overall Study||9
6339328|NCT00565045|7247026|FG001|COMPLETED|Overall Study||8
6339329|NCT00565045|7247025|FG000|NOT COMPLETED|Overall Study||1
6339330|NCT00565045|7247026|FG001|NOT COMPLETED|Overall Study||3
6339331|NCT00565058|7247034|FG000|STARTED|Overall Study||10
6339332|NCT00565058|7247035|FG001|STARTED|Overall Study||15
6339333|NCT00565058|7247034|FG000|COMPLETED|Overall Study||9
6339334|NCT00565058|7247035|FG001|COMPLETED|Overall Study||15
6339335|NCT00565058|7247034|FG000|NOT COMPLETED|Overall Study||1
6339336|NCT00565058|7247035|FG001|NOT COMPLETED|Overall Study||0
6339337|NCT00565084|7247041|FG000|STARTED|First Treatment Period||11
6339338|NCT00565084|7247042|FG001|STARTED|First Treatment Period||11
6339339|NCT00565084|7247043|FG002|STARTED|First Treatment Period||11
6339340|NCT00565084|7247041|FG000|COMPLETED|First Treatment Period||11
6339341|NCT00565084|7247042|FG001|COMPLETED|First Treatment Period||11
6339342|NCT00565084|7247043|FG002|COMPLETED|First Treatment Period||11
6339343|NCT00565084|7247041|FG000|NOT COMPLETED|First Treatment Period||0
6339344|NCT00565084|7247042|FG001|NOT COMPLETED|First Treatment Period||0
6339345|NCT00565084|7247043|FG002|NOT COMPLETED|First Treatment Period||0
6339346|NCT00565084|7247041|FG000|STARTED|Second Treatment Period||11
6339347|NCT00565084|7247042|FG001|STARTED|Second Treatment Period||11
6339348|NCT00565084|7247043|FG002|STARTED|Second Treatment Period||11
6339349|NCT00565084|7247041|FG000|COMPLETED|Second Treatment Period||11
6339350|NCT00565084|7247042|FG001|COMPLETED|Second Treatment Period||11
6339351|NCT00565084|7247043|FG002|COMPLETED|Second Treatment Period||11
6559104|NCT01780389|7481758|FG000|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
6559105|NCT01780389|7481758|FG000|NOT COMPLETED|Overall Study||1
6559106|NCT01780454|7481763|FG000|STARTED|Overall Study||2
6559107|NCT01780454|7481763|FG000|COMPLETED|Overall Study||2
6559108|NCT01780454|7481763|FG000|NOT COMPLETED|Overall Study||0
6339352|NCT00565084|7247041|FG000|NOT COMPLETED|Second Treatment Period||0
6339353|NCT00565084|7247042|FG001|NOT COMPLETED|Second Treatment Period||0
6339354|NCT00565084|7247043|FG002|NOT COMPLETED|Second Treatment Period||0
6339355|NCT00565084|7247041|FG000|STARTED|Third Treatment Period||11
6339356|NCT00565084|7247042|FG001|STARTED|Third Treatment Period||11
6339357|NCT00565084|7247043|FG002|STARTED|Third Treatment Period||11
6339358|NCT00565084|7247041|FG000|COMPLETED|Third Treatment Period||11
6339359|NCT00565084|7247042|FG001|COMPLETED|Third Treatment Period||11
6339360|NCT00565084|7247043|FG002|COMPLETED|Third Treatment Period||11
6339361|NCT00565084|7247041|FG000|NOT COMPLETED|Third Treatment Period||0
6339362|NCT00565084|7247042|FG001|NOT COMPLETED|Third Treatment Period||0
6339363|NCT00565084|7247043|FG002|NOT COMPLETED|Third Treatment Period||0
6339364|NCT00565110|7247053|FG000|STARTED|Overall Study||230
6339365|NCT00565110|7247054|FG001|STARTED|Overall Study||242
6339366|NCT00565110|7247053|FG000|12-Month|Overall Study||114
6339367|NCT00565110|7247054|FG001|12-Month|Overall Study||144
6339368|NCT00565110|7247053|FG000|COMPLETED|Overall Study||99
6339369|NCT00565110|7247054|FG001|COMPLETED|Overall Study||111
6339370|NCT00565110|7247053|FG000|NOT COMPLETED|Overall Study||131
6339371|NCT00565110|7247054|FG001|NOT COMPLETED|Overall Study||131
6339372|NCT00565136|7247060|FG000|STARTED|Overall Study||29
6339373|NCT00565136|7247060|FG000|COMPLETED|Overall Study||26
6339374|NCT00565136|7247060|FG000|NOT COMPLETED|Overall Study||3
6339375|NCT00565266|7247064|FG000|STARTED|Overall Study||210
6339376|NCT00565266|7247064|FG000|COMPLETED|Overall Study||174
6339377|NCT00565266|7247064|FG000|NOT COMPLETED|Overall Study||36
6339378|NCT00565370|7247072|FG000|STARTED|Overall Study||21
6339379|NCT00565370|7247072|FG000|COMPLETED|Overall Study||21
6339380|NCT00565370|7247072|FG000|NOT COMPLETED|Overall Study||0
6339381|NCT00565409|7247076|FG000|STARTED|Period 1 Open Label||834
6339382|NCT00565409|7247077|FG001|STARTED|Period 1 Open Label||0
6339383|NCT00565409|7247078|FG002|STARTED|Period 1 Open Label||0
6339384|NCT00565409|7247079|FG003|STARTED|Period 1 Open Label||0
6339385|NCT00565409|7247076|FG000|COMPLETED|Period 1 Open Label||756
6339386|NCT00565409|7247077|FG001|COMPLETED|Period 1 Open Label||0
6339387|NCT00565409|7247078|FG002|COMPLETED|Period 1 Open Label||0
6339388|NCT00565409|7247079|FG003|COMPLETED|Period 1 Open Label||0
6339389|NCT00565409|7247076|FG000|NOT COMPLETED|Period 1 Open Label||78
6339390|NCT00565409|7247077|FG001|NOT COMPLETED|Period 1 Open Label||0
6339391|NCT00565409|7247078|FG002|NOT COMPLETED|Period 1 Open Label||0
6339392|NCT00565409|7247079|FG003|NOT COMPLETED|Period 1 Open Label||0
6339393|NCT00565409|7247076|FG000|STARTED|After Period 1, Prior to Period 2||756
6339394|NCT00565409|7247077|FG001|STARTED|After Period 1, Prior to Period 2||0
6339395|NCT00565409|7247078|FG002|STARTED|After Period 1, Prior to Period 2||0
6339396|NCT00565409|7247079|FG003|STARTED|After Period 1, Prior to Period 2||0
6339397|NCT00565409|7247076|FG000|COMPLETED|After Period 1, Prior to Period 2||604
6559109|NCT01780506|7481769|FG000|STARTED|Double-Blind Phase||438
6559110|NCT01780506|7481770|FG001|STARTED|Double-Blind Phase||434
6559111|NCT01780506|7481769|FG000|COMPLETED|Double-Blind Phase||368
6339398|NCT00565409|7247077|FG001|COMPLETED|After Period 1, Prior to Period 2||0
6339399|NCT00565409|7247078|FG002|COMPLETED|After Period 1, Prior to Period 2||0
6339400|NCT00565409|7247079|FG003|COMPLETED|After Period 1, Prior to Period 2||0
6339401|NCT00565409|7247076|FG000|NOT COMPLETED|After Period 1, Prior to Period 2||152
6339402|NCT00565409|7247077|FG001|NOT COMPLETED|After Period 1, Prior to Period 2||0
6339403|NCT00565409|7247078|FG002|NOT COMPLETED|After Period 1, Prior to Period 2||0
6339404|NCT00565409|7247079|FG003|NOT COMPLETED|After Period 1, Prior to Period 2||0
6339405|NCT00565409|7247076|FG000|STARTED|Period 2 Double-Blind||0
6339406|NCT00565409|7247077|FG001|STARTED|Period 2 Double-Blind||202
6339407|NCT00565409|7247078|FG002|STARTED|Period 2 Double-Blind||202
6339408|NCT00565409|7247079|FG003|STARTED|Period 2 Double-Blind||200
6339409|NCT00565409|7247076|FG000|COMPLETED|Period 2 Double-Blind||0
6339410|NCT00565409|7247077|FG001|COMPLETED|Period 2 Double-Blind||181
6339411|NCT00565409|7247078|FG002|COMPLETED|Period 2 Double-Blind||175
6339412|NCT00565409|7247079|FG003|COMPLETED|Period 2 Double-Blind||141
6339413|NCT00565409|7247076|FG000|NOT COMPLETED|Period 2 Double-Blind||0
6339414|NCT00565409|7247077|FG001|NOT COMPLETED|Period 2 Double-Blind||21
6339415|NCT00565409|7247078|FG002|NOT COMPLETED|Period 2 Double-Blind||27
6339416|NCT00565409|7247079|FG003|NOT COMPLETED|Period 2 Double-Blind||59
6339417|NCT00565448|7247091|FG000|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
6339418|NCT00565448|7247092|FG001|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
6339419|NCT00565448|7247091|FG000|COMPLETED|Overall Study|Completed induction period as per protocol.|47
6339420|NCT00565448|7247092|FG001|COMPLETED|Overall Study|Completed induction period as per protocol.|23
6339421|NCT00565448|7247091|FG000|NOT COMPLETED|Overall Study||3
6339422|NCT00565448|7247092|FG001|NOT COMPLETED|Overall Study||2
6339423|NCT00565604|7247101|FG000|STARTED|Overall Study||43
6339424|NCT00565604|7247101|FG000|7 Day|Overall Study||41
6339425|NCT00565604|7247101|FG000|2 Week|Overall Study||41
6339426|NCT00565604|7247101|FG000|6 Week|Overall Study||39
6339427|NCT00565604|7247101|FG000|6 Month|Overall Study||39
6339428|NCT00565604|7247101|FG000|COMPLETED|Overall Study||39
6339429|NCT00565604|7247101|FG000|NOT COMPLETED|Overall Study||4
6339430|NCT00565643|7247107|FG000|STARTED|Overall Study||380
6339431|NCT00565643|7247108|FG001|STARTED|Overall Study||373
6339432|NCT00565643|7247107|FG000|Safety Data|Overall Study||380
6339433|NCT00565643|7247108|FG001|Safety Data|Overall Study||373
6339434|NCT00565643|7247107|FG000|Primary Outcome (Subsequent Cesarean)|Overall Study||80
6339435|NCT00565643|7247108|FG001|Primary Outcome (Subsequent Cesarean)|Overall Study||92
6339436|NCT00565643|7247107|FG000|COMPLETED|Overall Study||380
6339437|NCT00565643|7247108|FG001|COMPLETED|Overall Study||373
6339438|NCT00565643|7247107|FG000|NOT COMPLETED|Overall Study||0
6339439|NCT00565643|7247108|FG001|NOT COMPLETED|Overall Study||0
6339440|NCT00565669|7247117|FG000|STARTED|Overall Study||11
6339441|NCT00565669|7247118|FG001|STARTED|Overall Study||9
6339442|NCT00565669|7247117|FG000|COMPLETED|Overall Study||11
6339443|NCT00565669|7247118|FG001|COMPLETED|Overall Study||9
6339444|NCT00565669|7247117|FG000|NOT COMPLETED|Overall Study||0
6339445|NCT00565669|7247118|FG001|NOT COMPLETED|Overall Study||0
6339446|NCT00565721|7247124|FG000|STARTED|Overall Study||33
6339447|NCT00565721|7247124|FG000|COMPLETED|Overall Study||16
6339448|NCT00565721|7247124|FG000|NOT COMPLETED|Overall Study||17
6339449|NCT00565747|7247145|FG000|STARTED|Overall Study||654
6339450|NCT00565747|7247146|FG001|STARTED|Overall Study||678
6339451|NCT00565747|7247145|FG000|COMPLETED|Overall Study|Completed with an embryo transfer|587
6339452|NCT00565747|7247146|FG001|COMPLETED|Overall Study|Completed with an embryo transfer|605
6339453|NCT00565747|7247145|FG000|NOT COMPLETED|Overall Study||67
6339454|NCT00565747|7247146|FG001|NOT COMPLETED|Overall Study||73
6339455|NCT00565773|7247152|FG000|STARTED|Overall Study||40
6339456|NCT00565773|7247152|FG000|COMPLETED|Overall Study||38
6339457|NCT00565773|7247152|FG000|NOT COMPLETED|Overall Study||2
6339458|NCT00565812|7247159|FG000|STARTED|Overall Study||485
6339459|NCT00565812|7247160|FG001|STARTED|Overall Study||486
6559112|NCT01780506|7481770|FG001|COMPLETED|Double-Blind Phase||356
6559113|NCT01780506|7481769|FG000|NOT COMPLETED|Double-Blind Phase||70
6559114|NCT01780506|7481770|FG001|NOT COMPLETED|Double-Blind Phase||78
6559115|NCT01780506|7481769|FG000|STARTED|Open-Label Extension Phase|278 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|90
6339460|NCT00565812|7247161|FG002|STARTED|Overall Study||486
6339461|NCT00565812|7247159|FG000|COMPLETED|Overall Study||341
6339462|NCT00565812|7247160|FG001|COMPLETED|Overall Study||351
6339463|NCT00565812|7247161|FG002|COMPLETED|Overall Study||356
6339464|NCT00565812|7247159|FG000|NOT COMPLETED|Overall Study||144
6339465|NCT00565812|7247160|FG001|NOT COMPLETED|Overall Study||135
6339466|NCT00565812|7247161|FG002|NOT COMPLETED|Overall Study||130
6339467|NCT00565864|7247172|FG000|STARTED|Overall Study||58
6339468|NCT00565864|7247173|FG001|STARTED|Overall Study||59
6339469|NCT00565864|7247174|FG002|STARTED|Overall Study||56
6339470|NCT00565864|7247172|FG000|COMPLETED|Overall Study||46
6339471|NCT00565864|7247173|FG001|COMPLETED|Overall Study||47
6339472|NCT00565864|7247174|FG002|COMPLETED|Overall Study||45
6339473|NCT00565864|7247172|FG000|NOT COMPLETED|Overall Study||12
6339474|NCT00565864|7247173|FG001|NOT COMPLETED|Overall Study||12
6339475|NCT00565864|7247174|FG002|NOT COMPLETED|Overall Study||11
6339476|NCT00565916|7247186|FG000|STARTED|Overall Study||11
6339477|NCT00565916|7247187|FG001|STARTED|Overall Study||11
6339478|NCT00565916|7247186|FG000|COMPLETED|Overall Study||11
6339479|NCT00565916|7247187|FG001|COMPLETED|Overall Study||11
6339480|NCT00565916|7247186|FG000|NOT COMPLETED|Overall Study||0
6339481|NCT00565916|7247187|FG001|NOT COMPLETED|Overall Study||0
6339482|NCT00566020|7247193|FG000|STARTED|6-week Dosage Adjustment Phase||92
6339483|NCT00566020|7247194|FG001|STARTED|6-week Dosage Adjustment Phase||0
6339484|NCT00566020|7247193|FG000|COMPLETED|6-week Dosage Adjustment Phase||85
6339485|NCT00566020|7247194|FG001|COMPLETED|6-week Dosage Adjustment Phase||0
6339486|NCT00566020|7247193|FG000|NOT COMPLETED|6-week Dosage Adjustment Phase||7
6339487|NCT00566020|7247194|FG001|NOT COMPLETED|6-week Dosage Adjustment Phase||0
6339488|NCT00566020|7247193|FG000|STARTED|46-week Long-term Administration Phase||0
6339489|NCT00566020|7247194|FG001|STARTED|46-week Long-term Administration Phase||85
6339490|NCT00566020|7247193|FG000|COMPLETED|46-week Long-term Administration Phase||0
6339491|NCT00566020|7247194|FG001|COMPLETED|46-week Long-term Administration Phase||68
6339492|NCT00566020|7247193|FG000|NOT COMPLETED|46-week Long-term Administration Phase||0
6339493|NCT00566020|7247194|FG001|NOT COMPLETED|46-week Long-term Administration Phase||17
6339494|NCT00566098|7247199|FG000|STARTED|Collection of MILs||25
6339495|NCT00566098|7247199|FG000|COMPLETED|Collection of MILs||23
6339496|NCT00566098|7247199|FG000|NOT COMPLETED|Collection of MILs||2
6339497|NCT00566098|7247199|FG000|STARTED|Generation of MILs Product||23
6339498|NCT00566098|7247199|FG000|COMPLETED|Generation of MILs Product||22
6339499|NCT00566098|7247199|FG000|NOT COMPLETED|Generation of MILs Product||1
6339500|NCT00566098|7247199|FG000|STARTED|Administration of ASCT+MILs||22
6339501|NCT00566098|7247199|FG000|COMPLETED|Administration of ASCT+MILs||4
6339502|NCT00566098|7247199|FG000|NOT COMPLETED|Administration of ASCT+MILs||18
6339503|NCT00566111|7247206|FG000|STARTED|Overall Study||2
6339504|NCT00566111|7247207|FG001|STARTED|Overall Study||3
6339505|NCT00566111|7247206|FG000|COMPLETED|Overall Study||2
6339506|NCT00566111|7247207|FG001|COMPLETED|Overall Study||1
6339507|NCT00566111|7247206|FG000|NOT COMPLETED|Overall Study||0
6339508|NCT00566111|7247207|FG001|NOT COMPLETED|Overall Study||2
6339509|NCT00566150|7247215|FG000|STARTED|Overall Study||19
6339510|NCT00566150|7247216|FG001|STARTED|Overall Study||16
6339511|NCT00566150|7247215|FG000|COMPLETED|Overall Study||10
6339512|NCT00566150|7247216|FG001|COMPLETED|Overall Study||11
6339513|NCT00566150|7247215|FG000|NOT COMPLETED|Overall Study||9
6339514|NCT00566150|7247216|FG001|NOT COMPLETED|Overall Study||5
6339515|NCT00566228|7247224|FG000|STARTED|Overall Study||62
6339516|NCT00566228|7247225|FG001|STARTED|Overall Study||60
6339517|NCT00566228|7247224|FG000|COMPLETED|Overall Study||56
6339518|NCT00566228|7247225|FG001|COMPLETED|Overall Study||55
6339519|NCT00566228|7247224|FG000|NOT COMPLETED|Overall Study||6
6339520|NCT00566228|7247225|FG001|NOT COMPLETED|Overall Study||5
6339521|NCT00566254|7247233|FG000|STARTED|Overall Study||100
6339522|NCT00566254|7247234|FG001|STARTED|Overall Study||107
6339523|NCT00566254|7247233|FG000|COMPLETED|Overall Study||90
6339524|NCT00566254|7247234|FG001|COMPLETED|Overall Study||93
6339525|NCT00566254|7247233|FG000|NOT COMPLETED|Overall Study||10
6339526|NCT00566254|7247234|FG001|NOT COMPLETED|Overall Study||14
6339527|NCT00566501|7247242|FG000|STARTED|Overall Study||570
6339528|NCT00566501|7247243|FG001|STARTED|Overall Study||332
6339529|NCT00566501|7247242|FG000|COMPLETED|Overall Study||423
6339530|NCT00566501|7247243|FG001|COMPLETED|Overall Study||210
6339531|NCT00566501|7247242|FG000|NOT COMPLETED|Overall Study||147
6339532|NCT00566501|7247243|FG001|NOT COMPLETED|Overall Study||122
6339533|NCT00566527|7247252|FG000|STARTED|Overall Study|Number randomized.|541
6339534|NCT00566527|7247253|FG001|STARTED|Overall Study|Number randomized.|540
6339535|NCT00566527|7247254|FG002|STARTED|Overall Study|Number randomized.|539
6339536|NCT00566527|7247252|FG000|Received ProQuad® Dose 1|Overall Study||529
6339537|NCT00566527|7247253|FG001|Received ProQuad® Dose 1|Overall Study||484
6339538|NCT00566527|7247254|FG002|Received ProQuad® Dose 1|Overall Study||470
6339539|NCT00566527|7247252|FG000|Received ProQuad® Dose 2|Overall Study||525
6339540|NCT00566527|7247253|FG001|Received ProQuad® Dose 2|Overall Study||478
6339541|NCT00566527|7247254|FG002|Received ProQuad® Dose 2|Overall Study||462
6339542|NCT00566527|7247252|FG000|COMPLETED|Overall Study||524
6339543|NCT00566527|7247253|FG001|COMPLETED|Overall Study||474
6339544|NCT00566527|7247254|FG002|COMPLETED|Overall Study||461
6339545|NCT00566527|7247252|FG000|NOT COMPLETED|Overall Study||17
6339546|NCT00566527|7247253|FG001|NOT COMPLETED|Overall Study||66
6339547|NCT00566527|7247254|FG002|NOT COMPLETED|Overall Study||78
6339548|NCT00566540|7247264|FG000|STARTED|Overall Study||11
6339549|NCT00566540|7247264|FG000|COMPLETED|Overall Study||11
6339550|NCT00566540|7247264|FG000|NOT COMPLETED|Overall Study||0
6339551|NCT00566579|7247270|FG000|STARTED|Overall Study||29
6339552|NCT00566579|7247271|FG001|STARTED|Overall Study||31
6339553|NCT00566579|7247270|FG000|COMPLETED|Overall Study||29
6339554|NCT00566579|7247271|FG001|COMPLETED|Overall Study||31
6339555|NCT00566579|7247270|FG000|NOT COMPLETED|Overall Study||0
6339556|NCT00566579|7247271|FG001|NOT COMPLETED|Overall Study||0
6339557|NCT00566631|7247277|FG000|STARTED|Part 1: Core Treatment Phase||294
6339558|NCT00566631|7247277|FG000|COMPLETED|Part 1: Core Treatment Phase||234
6339559|NCT00566631|7247277|FG000|NOT COMPLETED|Part 1: Core Treatment Phase||60
6339560|NCT00566631|7247277|FG000|STARTED|Between Treatment and Extension Phase||234
6339561|NCT00566631|7247277|FG000|COMPLETED|Between Treatment and Extension Phase||139
6339562|NCT00566631|7247277|FG000|NOT COMPLETED|Between Treatment and Extension Phase||95
6339563|NCT00566631|7247277|FG000|STARTED|Part 2: Extension Phase||139
6339564|NCT00566631|7247277|FG000|COMPLETED|Part 2: Extension Phase||57
6339565|NCT00566631|7247277|FG000|NOT COMPLETED|Part 2: Extension Phase||82
6339566|NCT00566696|7247281|FG000|STARTED|Overall Study||73
6339567|NCT00566696|7247281|FG000|COMPLETED|Overall Study||31
6339568|NCT00566696|7247281|FG000|NOT COMPLETED|Overall Study||42
6339569|NCT00566709|7247287|FG000|STARTED|Overall Study||51
6339570|NCT00566709|7247288|FG001|STARTED|Overall Study||51
6339571|NCT00566709|7247287|FG000|COMPLETED|Overall Study||46
6339572|NCT00566709|7247288|FG001|COMPLETED|Overall Study||51
6339573|NCT00566709|7247287|FG000|NOT COMPLETED|Overall Study||5
6339574|NCT00566709|7247288|FG001|NOT COMPLETED|Overall Study||0
6339575|NCT00566722|7247297|FG000|STARTED|Overall Study||41
6339576|NCT00566722|7247298|FG001|STARTED|Overall Study||29
6339577|NCT00566722|7247299|FG002|STARTED|Overall Study||82
6339578|NCT00566722|7247297|FG000|COMPLETED|Overall Study||39
6339579|NCT00566722|7247298|FG001|COMPLETED|Overall Study||24
6339580|NCT00566722|7247299|FG002|COMPLETED|Overall Study||73
6339581|NCT00566722|7247297|FG000|NOT COMPLETED|Overall Study||2
6339582|NCT00566722|7247298|FG001|NOT COMPLETED|Overall Study||5
6339583|NCT00566722|7247299|FG002|NOT COMPLETED|Overall Study||9
6339584|NCT00566735|7247312|FG000|STARTED|Overall Study||20
6339585|NCT00566735|7247313|FG001|STARTED|Overall Study||19
6339586|NCT00566735|7247312|FG000|Withdrew Before Baseline Measures|Overall Study||2
6339587|NCT00566735|7247313|FG001|Withdrew Before Baseline Measures|Overall Study||7
6339588|NCT00566735|7247312|FG000|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
6339589|NCT00566735|7247313|FG001|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
6339590|NCT00566735|7247312|FG000|NOT COMPLETED|Overall Study||2
6339591|NCT00566735|7247313|FG001|NOT COMPLETED|Overall Study||7
6339592|NCT00566813|7247321|FG000|STARTED|Overall Study||4
6339593|NCT00566813|7247322|FG001|STARTED|Overall Study||6
6339594|NCT00566813|7247321|FG000|COMPLETED|Overall Study||4
6339595|NCT00566813|7247322|FG001|COMPLETED|Overall Study||6
6339596|NCT00566813|7247321|FG000|NOT COMPLETED|Overall Study||0
6339597|NCT00566813|7247322|FG001|NOT COMPLETED|Overall Study||0
6339598|NCT00566852|7247330|FG000|STARTED|Overall Study||278
6339599|NCT00566852|7247331|FG001|STARTED|Overall Study||276
6339600|NCT00566852|7247330|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
6339601|NCT00566852|7247331|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
6339602|NCT00566852|7247330|FG000|NOT COMPLETED|Overall Study||207
6339603|NCT00566852|7247331|FG001|NOT COMPLETED|Overall Study||198
6339604|NCT00566930|7247340|FG000|STARTED|Overall Study||29
6339605|NCT00566930|7247341|FG001|STARTED|Overall Study||36
6339606|NCT00566930|7247342|FG002|STARTED|Overall Study||33
6339607|NCT00566930|7247340|FG000|COMPLETED|Overall Study||27
6339608|NCT00566930|7247341|FG001|COMPLETED|Overall Study||32
6339609|NCT00566930|7247342|FG002|COMPLETED|Overall Study||32
6339610|NCT00566930|7247340|FG000|NOT COMPLETED|Overall Study||2
6339611|NCT00566930|7247341|FG001|NOT COMPLETED|Overall Study||4
6339612|NCT00566930|7247342|FG002|NOT COMPLETED|Overall Study||1
6339613|NCT00566943|7247352|FG000|STARTED|Overall Study||52
6339614|NCT00566943|7247353|FG001|STARTED|Overall Study||49
6339615|NCT00566943|7247352|FG000|COMPLETED|Overall Study||52
6339616|NCT00566943|7247353|FG001|COMPLETED|Overall Study||49
6339617|NCT00566943|7247352|FG000|NOT COMPLETED|Overall Study||0
6339618|NCT00566943|7247353|FG001|NOT COMPLETED|Overall Study||0
6339619|NCT00566969|7247368|FG000|STARTED|Overall Study||34
6339620|NCT00566969|7247369|FG001|STARTED|Overall Study||37
6559116|NCT01780506|7481770|FG001|STARTED|Open-Label Extension Phase|261 participants completed the Double-Blind Phase but did not enter the Open-Label Extension Phase|95
6559117|NCT01780506|7481769|FG000|COMPLETED|Open-Label Extension Phase||90
6559118|NCT01780506|7481770|FG001|COMPLETED|Open-Label Extension Phase||94
6559119|NCT01780506|7481769|FG000|NOT COMPLETED|Open-Label Extension Phase||0
6339621|NCT00566969|7247370|FG002|STARTED|Overall Study||35
6339622|NCT00566969|7247368|FG000|COMPLETED|Overall Study||19
6339623|NCT00566969|7247369|FG001|COMPLETED|Overall Study||28
6339624|NCT00566969|7247370|FG002|COMPLETED|Overall Study||23
6339625|NCT00566969|7247368|FG000|NOT COMPLETED|Overall Study||15
6339626|NCT00566969|7247369|FG001|NOT COMPLETED|Overall Study||9
6339627|NCT00566969|7247370|FG002|NOT COMPLETED|Overall Study||12
6339628|NCT00566982|7247380|FG000|STARTED|Overall Study||63
6339629|NCT00566982|7247381|FG001|STARTED|Overall Study||363
6339630|NCT00566982|7247380|FG000|COMPLETED|Overall Study||55
6339631|NCT00566982|7247381|FG001|COMPLETED|Overall Study||294
6339632|NCT00566982|7247380|FG000|NOT COMPLETED|Overall Study||8
6339633|NCT00566982|7247381|FG001|NOT COMPLETED|Overall Study||69
6339634|NCT00567008|7247392|FG000|STARTED|Overall Study||18
6339635|NCT00567008|7247393|FG001|STARTED|Overall Study||19
6339636|NCT00567008|7247392|FG000|COMPLETED|Overall Study||17
6339637|NCT00567008|7247393|FG001|COMPLETED|Overall Study||18
6339638|NCT00567008|7247392|FG000|NOT COMPLETED|Overall Study||1
6339639|NCT00567008|7247393|FG001|NOT COMPLETED|Overall Study||1
6339640|NCT00567112|7247399|FG000|STARTED|Treatment Period 1 (3 Days)||7
6339641|NCT00567112|7247400|FG001|STARTED|Treatment Period 1 (3 Days)||8
6339642|NCT00567112|7247401|FG002|STARTED|Treatment Period 1 (3 Days)||0
6339643|NCT00567112|7247399|FG000|COMPLETED|Treatment Period 1 (3 Days)||7
6339644|NCT00567112|7247400|FG001|COMPLETED|Treatment Period 1 (3 Days)||8
6339645|NCT00567112|7247401|FG002|COMPLETED|Treatment Period 1 (3 Days)||0
6339646|NCT00567112|7247399|FG000|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6339647|NCT00567112|7247400|FG001|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6339648|NCT00567112|7247401|FG002|NOT COMPLETED|Treatment Period 1 (3 Days)||0
6339649|NCT00567112|7247399|FG000|STARTED|Washout Period 1 (3 Days)||7
6339650|NCT00567112|7247400|FG001|STARTED|Washout Period 1 (3 Days)||8
6339651|NCT00567112|7247401|FG002|STARTED|Washout Period 1 (3 Days)||0
6339652|NCT00567112|7247399|FG000|COMPLETED|Washout Period 1 (3 Days)||7
6339653|NCT00567112|7247400|FG001|COMPLETED|Washout Period 1 (3 Days)||8
6339654|NCT00567112|7247401|FG002|COMPLETED|Washout Period 1 (3 Days)||0
6339655|NCT00567112|7247399|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
6339656|NCT00567112|7247400|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
6559120|NCT01780506|7481770|FG001|NOT COMPLETED|Open-Label Extension Phase||1
6559121|NCT01780545|7481780|FG000|STARTED|Overall Study||99
6559122|NCT01780545|7481781|FG001|STARTED|Overall Study||101
6559123|NCT01780545|7481780|FG000|COMPLETED|Overall Study||95
6339657|NCT00567112|7247401|FG002|NOT COMPLETED|Washout Period 1 (3 Days)||0
6339658|NCT00567112|7247399|FG000|STARTED|Treatment Period 2 (3 Days)||7
6339659|NCT00567112|7247400|FG001|STARTED|Treatment Period 2 (3 Days)||8
6339660|NCT00567112|7247401|FG002|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
6339661|NCT00567112|7247399|FG000|COMPLETED|Treatment Period 2 (3 Days)||7
6339662|NCT00567112|7247400|FG001|COMPLETED|Treatment Period 2 (3 Days)||7
6339663|NCT00567112|7247401|FG002|COMPLETED|Treatment Period 2 (3 Days)||3
6339664|NCT00567112|7247399|FG000|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6339665|NCT00567112|7247400|FG001|NOT COMPLETED|Treatment Period 2 (3 Days)||1
6339666|NCT00567112|7247401|FG002|NOT COMPLETED|Treatment Period 2 (3 Days)||0
6339667|NCT00567112|7247399|FG000|STARTED|Washout Period 2 (3 Days)||7
6339668|NCT00567112|7247400|FG001|STARTED|Washout Period 2 (3 Days)||7
6339669|NCT00567112|7247401|FG002|STARTED|Washout Period 2 (3 Days)||3
6339670|NCT00567112|7247399|FG000|COMPLETED|Washout Period 2 (3 Days)||7
6339671|NCT00567112|7247400|FG001|COMPLETED|Washout Period 2 (3 Days)||7
6339672|NCT00567112|7247401|FG002|COMPLETED|Washout Period 2 (3 Days)||3
6339673|NCT00567112|7247399|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
6339674|NCT00567112|7247400|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
6339675|NCT00567112|7247401|FG002|NOT COMPLETED|Washout Period 2 (3 Days)||0
6339676|NCT00567112|7247399|FG000|STARTED|Treatment Period 3 (3 Days)||7
6339677|NCT00567112|7247400|FG001|STARTED|Treatment Period 3 (3 Days)||7
6339678|NCT00567112|7247401|FG002|STARTED|Treatment Period 3 (3 Days)||3
6339679|NCT00567112|7247399|FG000|COMPLETED|Treatment Period 3 (3 Days)||7
6339680|NCT00567112|7247400|FG001|COMPLETED|Treatment Period 3 (3 Days)||7
6339681|NCT00567112|7247401|FG002|COMPLETED|Treatment Period 3 (3 Days)||3
6339682|NCT00567112|7247399|FG000|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6339683|NCT00567112|7247400|FG001|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6339684|NCT00567112|7247401|FG002|NOT COMPLETED|Treatment Period 3 (3 Days)||0
6339685|NCT00567112|7247399|FG000|STARTED|Washout Period 3 (3 Days)||7
6339686|NCT00567112|7247400|FG001|STARTED|Washout Period 3 (3 Days)||7
6339687|NCT00567112|7247401|FG002|STARTED|Washout Period 3 (3 Days)||3
6339688|NCT00567112|7247399|FG000|COMPLETED|Washout Period 3 (3 Days)||4
6339689|NCT00567112|7247400|FG001|COMPLETED|Washout Period 3 (3 Days)||7
6339690|NCT00567112|7247401|FG002|COMPLETED|Washout Period 3 (3 Days)||3
6339691|NCT00567112|7247399|FG000|NOT COMPLETED|Washout Period 3 (3 Days)||3
6339692|NCT00567112|7247400|FG001|NOT COMPLETED|Washout Period 3 (3 Days)||0
6339693|NCT00567112|7247401|FG002|NOT COMPLETED|Washout Period 3 (3 Days)||0
6339694|NCT00567112|7247399|FG000|STARTED|Treatment Period 4 (3 Days)||4
6339695|NCT00567112|7247400|FG001|STARTED|Treatment Period 4 (3 Days)||7
6339696|NCT00567112|7247401|FG002|STARTED|Treatment Period 4 (3 Days)||3
6339697|NCT00567112|7247399|FG000|COMPLETED|Treatment Period 4 (3 Days)||4
6339698|NCT00567112|7247400|FG001|COMPLETED|Treatment Period 4 (3 Days)||7
6339699|NCT00567112|7247401|FG002|COMPLETED|Treatment Period 4 (3 Days)||3
6339700|NCT00567112|7247399|FG000|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6339701|NCT00567112|7247400|FG001|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6339702|NCT00567112|7247401|FG002|NOT COMPLETED|Treatment Period 4 (3 Days)||0
6339703|NCT00567164|7247413|FG000|STARTED|Overall Study||1421
6339704|NCT00567164|7247414|FG001|STARTED|Overall Study||234
6339705|NCT00567164|7247415|FG002|STARTED|Overall Study||232
6339706|NCT00567164|7247413|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
6339707|NCT00567164|7247414|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set|232
6339708|NCT00567164|7247415|FG002|Subjects Received Treatment|Overall Study|Full Analysis Set|226
6339709|NCT00567164|7247413|FG000|COMPLETED|Overall Study||875
6339710|NCT00567164|7247414|FG001|COMPLETED|Overall Study||161
6339711|NCT00567164|7247415|FG002|COMPLETED|Overall Study||160
6339712|NCT00567164|7247413|FG000|NOT COMPLETED|Overall Study||546
6339713|NCT00567164|7247414|FG001|NOT COMPLETED|Overall Study||73
6339714|NCT00567164|7247415|FG002|NOT COMPLETED|Overall Study||72
6339715|NCT00567190|7247429|FG000|STARTED|Overall Study||402
6339716|NCT00567190|7247430|FG001|STARTED|Overall Study||406
6339717|NCT00567190|7247429|FG000|Did Not Receive Any Study Treatment|Overall Study||2
6339718|NCT00567190|7247430|FG001|Did Not Receive Any Study Treatment|Overall Study||2
6339719|NCT00567190|7247429|FG000|Received at Least One Dose of Pertuzumab|Overall Study||399
6339720|NCT00567190|7247430|FG001|Received at Least One Dose of Pertuzumab|Overall Study|9 participants randomized to the Placebo arm actually received at least one dose of pertuzumab.|9
6339721|NCT00567190|7247429|FG000|Received at Least One Dose of Placebo|Overall Study|1 participant randomized to the Pertuzumab arm actually received placebo at every treatment cycle.|1
6559124|NCT01780545|7481781|FG001|COMPLETED|Overall Study||99
6339722|NCT00567190|7247430|FG001|Received at Least One Dose of Placebo|Overall Study||395
6339723|NCT00567190|7247429|FG000|Crossover From Placebo to Pertuzumab|Overall Study||0
6339724|NCT00567190|7247430|FG001|Crossover From Placebo to Pertuzumab|Overall Study|From July 2012, 50 participants randomized to Placebo arm crossed over to open-label pertuzumab.|50
6339725|NCT00567190|7247429|FG000|COMPLETED|Overall Study||119
6339726|NCT00567190|7247430|FG001|COMPLETED|Overall Study||73
6339727|NCT00567190|7247429|FG000|NOT COMPLETED|Overall Study||283
6339728|NCT00567190|7247430|FG001|NOT COMPLETED|Overall Study||333
6339729|NCT00567229|7247441|FG000|STARTED|Overall Study||3
6339730|NCT00567229|7247441|FG000|COMPLETED|Overall Study||3
6339731|NCT00567229|7247441|FG000|NOT COMPLETED|Overall Study||0
6339732|NCT00567242|7247447|FG000|STARTED|Overall Study||7
6339733|NCT00567242|7247448|FG001|STARTED|Overall Study||7
6339734|NCT00567242|7247447|FG000|COMPLETED|Overall Study||7
6339735|NCT00567242|7247448|FG001|COMPLETED|Overall Study||7
6339736|NCT00567242|7247447|FG000|NOT COMPLETED|Overall Study||0
6339737|NCT00567242|7247448|FG001|NOT COMPLETED|Overall Study||0
6339738|NCT00567255|7247456|FG000|STARTED|Overall Study||1001
6339739|NCT00567255|7247457|FG001|STARTED|Overall Study||495
6339740|NCT00567255|7247456|FG000|COMPLETED|Overall Study||538
6339741|NCT00567255|7247457|FG001|COMPLETED|Overall Study||267
6339742|NCT00567255|7247456|FG000|NOT COMPLETED|Overall Study||463
6339743|NCT00567255|7247457|FG001|NOT COMPLETED|Overall Study||228
6376407|NCT00759525|7286926|FG000|NOT COMPLETED|First Intervention (14 Days)||0
6376408|NCT00759525|7286927|FG001|NOT COMPLETED|First Intervention (14 Days)||0
6376409|NCT00759525|7286926|FG000|STARTED|Washout (14 Days)||7
6376410|NCT00759525|7286927|FG001|STARTED|Washout (14 Days)||8
6376411|NCT00759525|7286926|FG000|COMPLETED|Washout (14 Days)||7
6376412|NCT00759525|7286927|FG001|COMPLETED|Washout (14 Days)||8
6376413|NCT00759525|7286926|FG000|NOT COMPLETED|Washout (14 Days)||0
6376414|NCT00759525|7286927|FG001|NOT COMPLETED|Washout (14 Days)||0
6376415|NCT00759525|7286926|FG000|STARTED|Second Intervention (14 Days)||7
6376416|NCT00759525|7286927|FG001|STARTED|Second Intervention (14 Days)||8
6559125|NCT01780545|7481780|FG000|NOT COMPLETED|Overall Study||4
6559126|NCT01780545|7481781|FG001|NOT COMPLETED|Overall Study||2
6559127|NCT01780584|7481793|FG000|STARTED|Overall Study||15
6376417|NCT00759525|7286926|FG000|COMPLETED|Second Intervention (14 Days)||7
6376418|NCT00759525|7286927|FG001|COMPLETED|Second Intervention (14 Days)||8
6376419|NCT00759525|7286926|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
6376420|NCT00759525|7286927|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
6376421|NCT00759564|7286938|FG000|STARTED|First Intervention Period (4 Days)||8
6376422|NCT00759564|7286939|FG001|STARTED|First Intervention Period (4 Days)||8
6559128|NCT01780584|7481794|FG001|STARTED|Overall Study||15
6559129|NCT01780584|7481795|FG002|STARTED|Overall Study||15
6559130|NCT01780584|7481793|FG000|COMPLETED|Overall Study||14
6376423|NCT00759564|7286940|FG002|STARTED|First Intervention Period (4 Days)||8
6376424|NCT00759564|7286941|FG003|STARTED|First Intervention Period (4 Days)||1
6376425|NCT00759564|7286942|FG004|STARTED|First Intervention Period (4 Days)||4
6376426|NCT00759564|7286938|FG000|COMPLETED|First Intervention Period (4 Days)||8
6376427|NCT00759564|7286939|FG001|COMPLETED|First Intervention Period (4 Days)||8
6376428|NCT00759564|7286940|FG002|COMPLETED|First Intervention Period (4 Days)||8
6376429|NCT00759564|7286941|FG003|COMPLETED|First Intervention Period (4 Days)||1
6376430|NCT00759564|7286942|FG004|COMPLETED|First Intervention Period (4 Days)||4
6376431|NCT00759564|7286938|FG000|NOT COMPLETED|First Intervention Period (4 Days)||0
6376432|NCT00759564|7286939|FG001|NOT COMPLETED|First Intervention Period (4 Days)||0
6376433|NCT00759564|7286940|FG002|NOT COMPLETED|First Intervention Period (4 Days)||0
6376434|NCT00759564|7286941|FG003|NOT COMPLETED|First Intervention Period (4 Days)||0
6376435|NCT00759564|7286942|FG004|NOT COMPLETED|First Intervention Period (4 Days)||0
6376436|NCT00759564|7286938|FG000|STARTED|Washout Period (at Least 14 Days)||8
6559131|NCT01780584|7481794|FG001|COMPLETED|Overall Study||14
6559132|NCT01780584|7481795|FG002|COMPLETED|Overall Study||13
6559133|NCT01780584|7481793|FG000|NOT COMPLETED|Overall Study||1
6559134|NCT01780584|7481794|FG001|NOT COMPLETED|Overall Study||1
6376437|NCT00759564|7286939|FG001|STARTED|Washout Period (at Least 14 Days)||8
6376438|NCT00759564|7286940|FG002|STARTED|Washout Period (at Least 14 Days)||8
6376439|NCT00759564|7286941|FG003|STARTED|Washout Period (at Least 14 Days)||1
6376440|NCT00759564|7286942|FG004|STARTED|Washout Period (at Least 14 Days)||4
6376441|NCT00759564|7286938|FG000|COMPLETED|Washout Period (at Least 14 Days)||8
6376442|NCT00759564|7286939|FG001|COMPLETED|Washout Period (at Least 14 Days)||8
6376443|NCT00759564|7286940|FG002|COMPLETED|Washout Period (at Least 14 Days)||8
6376444|NCT00759564|7286941|FG003|COMPLETED|Washout Period (at Least 14 Days)||1
6376445|NCT00759564|7286942|FG004|COMPLETED|Washout Period (at Least 14 Days)||3
6376446|NCT00759564|7286938|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6376447|NCT00759564|7286939|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6376448|NCT00759564|7286940|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6376449|NCT00759564|7286941|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6376450|NCT00759564|7286942|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||1
6376451|NCT00759564|7286938|FG000|STARTED|Second Intervention Period (4 Days)||8
6559135|NCT01780584|7481795|FG002|NOT COMPLETED|Overall Study||2
6559136|NCT01780662|7481806|FG000|STARTED|Overall Study||3
6559137|NCT01780662|7481807|FG001|STARTED|Overall Study||13
6559138|NCT01780662|7481808|FG002|STARTED|Overall Study||30
6376452|NCT00759564|7286939|FG001|STARTED|Second Intervention Period (4 Days)||8
6339744|NCT00567268|7247463|FG000|STARTED|Overall Study||1194
6339745|NCT00567268|7247463|FG000|COMPLETED|Overall Study||1144
6339746|NCT00567268|7247463|FG000|NOT COMPLETED|Overall Study||50
6339747|NCT00567307|7247504|FG000|STARTED|Overall Study||111
6339748|NCT00567307|7247505|FG001|STARTED|Overall Study||105
6339749|NCT00567307|7247504|FG000|COMPLETED|Overall Study||99
6339750|NCT00567307|7247505|FG001|COMPLETED|Overall Study||104
6339751|NCT00567307|7247504|FG000|NOT COMPLETED|Overall Study||12
6339752|NCT00567307|7247505|FG001|NOT COMPLETED|Overall Study||1
6339753|NCT00567320|7247513|FG000|STARTED|Overall Study||13
6339754|NCT00567320|7247514|FG001|STARTED|Overall Study||18
6339755|NCT00567320|7247513|FG000|COMPLETED|Overall Study||13
6339756|NCT00567320|7247514|FG001|COMPLETED|Overall Study||18
6339757|NCT00567320|7247513|FG000|NOT COMPLETED|Overall Study||0
6339758|NCT00567320|7247514|FG001|NOT COMPLETED|Overall Study||0
6339759|NCT00567359|7247520|FG000|STARTED|Overall Study||100
6339760|NCT00567359|7247520|FG000|COMPLETED|Overall Study||99
6339761|NCT00567359|7247520|FG000|NOT COMPLETED|Overall Study||1
6339762|NCT00567398|7247526|FG000|STARTED|Overall Study||127
6339763|NCT00567398|7247527|FG001|STARTED|Overall Study||124
6339764|NCT00567398|7247526|FG000|COMPLETED|Overall Study||120
6339765|NCT00567398|7247527|FG001|COMPLETED|Overall Study||101
6339766|NCT00567398|7247526|FG000|NOT COMPLETED|Overall Study||7
6339767|NCT00567398|7247527|FG001|NOT COMPLETED|Overall Study||23
6339768|NCT00567476|7247535|FG000|STARTED|Overall Study||78
6339769|NCT00567476|7247536|FG001|STARTED|Overall Study||38
6339770|NCT00567476|7247535|FG000|COMPLETED|Overall Study||70
6339771|NCT00567476|7247536|FG001|COMPLETED|Overall Study||34
6339772|NCT00567476|7247535|FG000|NOT COMPLETED|Overall Study||8
6339773|NCT00567476|7247536|FG001|NOT COMPLETED|Overall Study||4
6339774|NCT00567489|7247544|FG000|STARTED|Overall Study||127
6339775|NCT00567489|7247545|FG001|STARTED|Overall Study||124
6339776|NCT00567489|7247544|FG000|COMPLETED|Overall Study||120
6339777|NCT00567489|7247545|FG001|COMPLETED|Overall Study||101
6339778|NCT00567489|7247544|FG000|NOT COMPLETED|Overall Study||7
6339779|NCT00567489|7247545|FG001|NOT COMPLETED|Overall Study||23
6339780|NCT00567502|7247555|FG000|STARTED|Overall Study||804
6339781|NCT00567502|7247556|FG001|STARTED|Overall Study||141
6339782|NCT00567502|7247557|FG002|STARTED|Overall Study||2666
6339783|NCT00567502|7247558|FG003|STARTED|Overall Study||110
6339784|NCT00567502|7247555|FG000|Initiated Treatment|Overall Study||804
6339785|NCT00567502|7247556|FG001|Initiated Treatment|Overall Study||141
6339786|NCT00567502|7247557|FG002|Initiated Treatment|Overall Study||2666
6339787|NCT00567502|7247558|FG003|Initiated Treatment|Overall Study||38
6339788|NCT00567502|7247555|FG000|COMPLETED|Overall Study||563
6339789|NCT00567502|7247556|FG001|COMPLETED|Overall Study||108
6339790|NCT00567502|7247557|FG002|COMPLETED|Overall Study||1758
6339791|NCT00567502|7247558|FG003|COMPLETED|Overall Study||23
6339792|NCT00567502|7247555|FG000|NOT COMPLETED|Overall Study||241
6339793|NCT00567502|7247556|FG001|NOT COMPLETED|Overall Study||33
6339794|NCT00567502|7247557|FG002|NOT COMPLETED|Overall Study||908
6339795|NCT00567502|7247558|FG003|NOT COMPLETED|Overall Study||87
6339796|NCT00567541|7247581|FG000|STARTED|Overall Study||7
6339797|NCT00567541|7247582|FG001|STARTED|Overall Study||9
6339798|NCT00567541|7247581|FG000|COMPLETED|Overall Study||7
6339799|NCT00567541|7247582|FG001|COMPLETED|Overall Study||8
6339800|NCT00567541|7247581|FG000|NOT COMPLETED|Overall Study||0
6339801|NCT00567541|7247582|FG001|NOT COMPLETED|Overall Study||1
6339802|NCT00567593|7247588|FG000|STARTED|Overall Study||12
6339803|NCT00567593|7247588|FG000|COMPLETED|Overall Study||10
6339804|NCT00567593|7247588|FG000|NOT COMPLETED|Overall Study||2
6339805|NCT00567840|7247597|FG000|STARTED|Overall Study||15
6339806|NCT00567840|7247598|FG001|STARTED|Overall Study||15
6339807|NCT00567840|7247599|FG002|STARTED|Overall Study||16
6339808|NCT00567840|7247600|FG003|STARTED|Overall Study||15
6339809|NCT00567840|7247601|FG004|STARTED|Overall Study||8
6339810|NCT00567840|7247597|FG000|COMPLETED|Overall Study||13
6339811|NCT00567840|7247598|FG001|COMPLETED|Overall Study||15
6339812|NCT00567840|7247599|FG002|COMPLETED|Overall Study||15
6339813|NCT00567840|7247600|FG003|COMPLETED|Overall Study||14
6339814|NCT00567840|7247601|FG004|COMPLETED|Overall Study||8
6339815|NCT00567840|7247597|FG000|NOT COMPLETED|Overall Study||2
6339816|NCT00567840|7247598|FG001|NOT COMPLETED|Overall Study||0
6339817|NCT00567840|7247599|FG002|NOT COMPLETED|Overall Study||1
6339818|NCT00567840|7247600|FG003|NOT COMPLETED|Overall Study||1
6339819|NCT00567840|7247601|FG004|NOT COMPLETED|Overall Study||0
6339820|NCT00567879|7247619|FG000|STARTED|Overall Study||7
6339821|NCT00567879|7247620|FG001|STARTED|Overall Study||7
6339822|NCT00567879|7247621|FG002|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
6339823|NCT00567879|7247622|FG003|STARTED|Overall Study||6
6339824|NCT00567879|7247623|FG004|STARTED|Overall Study||12
6339825|NCT00567879|7247624|FG005|STARTED|Overall Study||3
6339826|NCT00567879|7247619|FG000|Maximum Tolerated Dose Determining Set|Overall Study||5
6339827|NCT00567879|7247620|FG001|Maximum Tolerated Dose Determining Set|Overall Study||7
6339828|NCT00567879|7247621|FG002|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
6339829|NCT00567879|7247622|FG003|Maximum Tolerated Dose Determining Set|Overall Study||6
6339830|NCT00567879|7247623|FG004|Maximum Tolerated Dose Determining Set|Overall Study||12
6339831|NCT00567879|7247624|FG005|Maximum Tolerated Dose Determining Set|Overall Study||3
6339832|NCT00567879|7247619|FG000|COMPLETED|Overall Study||0
6339833|NCT00567879|7247620|FG001|COMPLETED|Overall Study||0
6339834|NCT00567879|7247621|FG002|COMPLETED|Overall Study||0
6339835|NCT00567879|7247622|FG003|COMPLETED|Overall Study||0
6339836|NCT00567879|7247623|FG004|COMPLETED|Overall Study||0
6339837|NCT00567879|7247624|FG005|COMPLETED|Overall Study||0
6339838|NCT00567879|7247619|FG000|NOT COMPLETED|Overall Study||7
6339839|NCT00567879|7247620|FG001|NOT COMPLETED|Overall Study||7
6339840|NCT00567879|7247621|FG002|NOT COMPLETED|Overall Study||21
6339841|NCT00567879|7247622|FG003|NOT COMPLETED|Overall Study||6
6339842|NCT00567879|7247623|FG004|NOT COMPLETED|Overall Study||12
6339843|NCT00567879|7247624|FG005|NOT COMPLETED|Overall Study||3
6339844|NCT00567892|7247644|FG000|STARTED|First Treatment (2 or 4 Weeks)||7
6339845|NCT00567892|7247645|FG001|STARTED|First Treatment (2 or 4 Weeks)||7
6339846|NCT00567892|7247646|FG002|STARTED|First Treatment (2 or 4 Weeks)||10
6339847|NCT00567892|7247647|FG003|STARTED|First Treatment (2 or 4 Weeks)||10
6339848|NCT00567892|7247644|FG000|COMPLETED|First Treatment (2 or 4 Weeks)||7
6339849|NCT00567892|7247645|FG001|COMPLETED|First Treatment (2 or 4 Weeks)||7
6339850|NCT00567892|7247646|FG002|COMPLETED|First Treatment (2 or 4 Weeks)||9
6339851|NCT00567892|7247647|FG003|COMPLETED|First Treatment (2 or 4 Weeks)||6
6339852|NCT00567892|7247644|FG000|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
6339853|NCT00567892|7247645|FG001|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
6339854|NCT00567892|7247646|FG002|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
6339855|NCT00567892|7247647|FG003|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
6339856|NCT00567892|7247644|FG000|STARTED|Washout (2 Weeks)||7
6339857|NCT00567892|7247645|FG001|STARTED|Washout (2 Weeks)||7
6339858|NCT00567892|7247646|FG002|STARTED|Washout (2 Weeks)||9
6339859|NCT00567892|7247647|FG003|STARTED|Washout (2 Weeks)||6
6339860|NCT00567892|7247644|FG000|COMPLETED|Washout (2 Weeks)||7
6339861|NCT00567892|7247645|FG001|COMPLETED|Washout (2 Weeks)||7
6339862|NCT00567892|7247646|FG002|COMPLETED|Washout (2 Weeks)||9
6339863|NCT00567892|7247647|FG003|COMPLETED|Washout (2 Weeks)||6
6339864|NCT00567892|7247644|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6339865|NCT00567892|7247645|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6339866|NCT00567892|7247646|FG002|NOT COMPLETED|Washout (2 Weeks)||0
6339867|NCT00567892|7247647|FG003|NOT COMPLETED|Washout (2 Weeks)||0
6339868|NCT00567892|7247644|FG000|STARTED|Second Treatment (2 or 4 Weeks)||7
6339869|NCT00567892|7247645|FG001|STARTED|Second Treatment (2 or 4 Weeks)||7
6339870|NCT00567892|7247646|FG002|STARTED|Second Treatment (2 or 4 Weeks)||9
6339871|NCT00567892|7247647|FG003|STARTED|Second Treatment (2 or 4 Weeks)||6
6339872|NCT00567892|7247644|FG000|COMPLETED|Second Treatment (2 or 4 Weeks)||7
6339873|NCT00567892|7247645|FG001|COMPLETED|Second Treatment (2 or 4 Weeks)||7
6339874|NCT00567892|7247646|FG002|COMPLETED|Second Treatment (2 or 4 Weeks)||9
6339875|NCT00567892|7247647|FG003|COMPLETED|Second Treatment (2 or 4 Weeks)||5
6339876|NCT00567892|7247644|FG000|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
6339877|NCT00567892|7247645|FG001|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
6339878|NCT00567892|7247646|FG002|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
6339879|NCT00567892|7247647|FG003|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
6339880|NCT00567996|7247662|FG000|STARTED|Overall Study|Randomized participants|333
6339881|NCT00567996|7247663|FG001|STARTED|Overall Study||334
6339882|NCT00567996|7247664|FG002|STARTED|Overall Study||335
6339883|NCT00567996|7247662|FG000|Intent-to-treat: Received Study Drug|Overall Study||330
6339884|NCT00567996|7247663|FG001|Intent-to-treat: Received Study Drug|Overall Study||333
6339885|NCT00567996|7247664|FG002|Intent-to-treat: Received Study Drug|Overall Study||335
6339886|NCT00567996|7247662|FG000|COMPLETED|Overall Study||289
6339887|NCT00567996|7247663|FG001|COMPLETED|Overall Study||284
6339888|NCT00567996|7247664|FG002|COMPLETED|Overall Study||265
6339889|NCT00567996|7247662|FG000|NOT COMPLETED|Overall Study||44
6339890|NCT00567996|7247663|FG001|NOT COMPLETED|Overall Study||50
6339891|NCT00567996|7247664|FG002|NOT COMPLETED|Overall Study||70
6339892|NCT00568022|7247675|FG000|STARTED|Overall Study||3
6339893|NCT00568022|7247676|FG001|STARTED|Overall Study||3
6339894|NCT00568022|7247677|FG002|STARTED|Overall Study||3
6339895|NCT00568022|7247675|FG000|COMPLETED|Overall Study||3
6339896|NCT00568022|7247676|FG001|COMPLETED|Overall Study||3
6339897|NCT00568022|7247677|FG002|COMPLETED|Overall Study||3
6339898|NCT00568022|7247675|FG000|NOT COMPLETED|Overall Study||0
6339899|NCT00568022|7247676|FG001|NOT COMPLETED|Overall Study||0
6339900|NCT00568022|7247677|FG002|NOT COMPLETED|Overall Study||0
6339901|NCT00568061|7247688|FG000|STARTED|Overall Study||13
6339902|NCT00568061|7247689|FG001|STARTED|Overall Study||16
6339903|NCT00568061|7247688|FG000|COMPLETED|Overall Study||8
6339904|NCT00568061|7247689|FG001|COMPLETED|Overall Study||14
6339905|NCT00568061|7247688|FG000|NOT COMPLETED|Overall Study||5
6339906|NCT00568061|7247689|FG001|NOT COMPLETED|Overall Study||2
6339907|NCT00568087|7247698|FG000|STARTED|Overall Study||22
6339908|NCT00568087|7247699|FG001|STARTED|Overall Study||24
6339909|NCT00568087|7247698|FG000|Received Intervention|Overall Study||21
6339910|NCT00568087|7247699|FG001|Received Intervention|Overall Study||23
6339911|NCT00568087|7247698|FG000|COMPLETED|Overall Study||15
6339912|NCT00568087|7247699|FG001|COMPLETED|Overall Study||17
6339913|NCT00568087|7247698|FG000|NOT COMPLETED|Overall Study||7
6339914|NCT00568087|7247699|FG001|NOT COMPLETED|Overall Study||7
6339915|NCT00568126|7247707|FG000|STARTED|Overall Study||24
6339916|NCT00568126|7247708|FG001|STARTED|Overall Study||21
6339917|NCT00568126|7247707|FG000|COMPLETED|Overall Study||13
6339918|NCT00568126|7247708|FG001|COMPLETED|Overall Study||12
6339919|NCT00568126|7247707|FG000|NOT COMPLETED|Overall Study||11
6339920|NCT00568126|7247708|FG001|NOT COMPLETED|Overall Study||9
6339921|NCT00568321|7247717|FG000|STARTED|Overall Study||33
6339922|NCT00568321|7247718|FG001|STARTED|Overall Study||33
6339923|NCT00568321|7247719|FG002|STARTED|Overall Study||33
6339924|NCT00568321|7247717|FG000|Treated|Overall Study||31
6339925|NCT00568321|7247718|FG001|Treated|Overall Study||33
6339926|NCT00568321|7247719|FG002|Treated|Overall Study||32
6339927|NCT00568321|7247717|FG000|COMPLETED|Overall Study||20
6339928|NCT00568321|7247718|FG001|COMPLETED|Overall Study||28
6339929|NCT00568321|7247719|FG002|COMPLETED|Overall Study||24
6339930|NCT00568321|7247717|FG000|NOT COMPLETED|Overall Study||13
6339931|NCT00568321|7247718|FG001|NOT COMPLETED|Overall Study||5
6339932|NCT00568321|7247719|FG002|NOT COMPLETED|Overall Study||9
6339933|NCT00568334|7247731|FG000|STARTED|Overall Study||122
6339934|NCT00568334|7247732|FG001|STARTED|Overall Study||122
6339935|NCT00568334|7247731|FG000|COMPLETED|Overall Study||121
6339936|NCT00568334|7247732|FG001|COMPLETED|Overall Study||121
6339937|NCT00568334|7247731|FG000|NOT COMPLETED|Overall Study||1
6339938|NCT00568334|7247732|FG001|NOT COMPLETED|Overall Study||1
6339939|NCT00568386|7247740|FG000|STARTED|Overall Study||20
6339940|NCT00568386|7247741|FG001|STARTED|Overall Study||20
6339941|NCT00568386|7247740|FG000|COMPLETED|Overall Study||20
6339942|NCT00568386|7247741|FG001|COMPLETED|Overall Study||20
6339943|NCT00568386|7247740|FG000|NOT COMPLETED|Overall Study||0
6339944|NCT00568386|7247741|FG001|NOT COMPLETED|Overall Study||0
6339945|NCT00568399|7247747|FG000|STARTED|Overall Study||37
6339946|NCT00568399|7247747|FG000|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
6339947|NCT00568399|7247747|FG000|NOT COMPLETED|Overall Study||15
6339948|NCT00568451|7247755|FG000|STARTED|Overall Study||0
6339949|NCT00568451|7247756|FG001|STARTED|Overall Study||0
6339950|NCT00568451|7247757|FG002|STARTED|Overall Study||2
6339951|NCT00568451|7247758|FG003|STARTED|Overall Study||9
6339952|NCT00568451|7247755|FG000|COMPLETED|Overall Study||0
6339953|NCT00568451|7247756|FG001|COMPLETED|Overall Study||0
6559139|NCT01780662|7481806|FG000|COMPLETED|Overall Study||2
6559140|NCT01780662|7481807|FG001|COMPLETED|Overall Study||7
6559141|NCT01780662|7481808|FG002|COMPLETED|Overall Study||20
6559142|NCT01780662|7481806|FG000|NOT COMPLETED|Overall Study||1
6339954|NCT00568451|7247757|FG002|COMPLETED|Overall Study||0
6339955|NCT00568451|7247758|FG003|COMPLETED|Overall Study||2
6339956|NCT00568451|7247755|FG000|NOT COMPLETED|Overall Study||0
6339957|NCT00568451|7247756|FG001|NOT COMPLETED|Overall Study||0
6339958|NCT00568451|7247757|FG002|NOT COMPLETED|Overall Study||2
6339959|NCT00568451|7247758|FG003|NOT COMPLETED|Overall Study||7
6339960|NCT00568555|7247771|FG000|STARTED|Overall Study||16
6339961|NCT00568555|7247772|FG001|STARTED|Overall Study||15
6339962|NCT00568555|7247771|FG000|COMPLETED|Overall Study||15
6339963|NCT00568555|7247772|FG001|COMPLETED|Overall Study||14
6339964|NCT00568555|7247771|FG000|NOT COMPLETED|Overall Study||1
6339965|NCT00568555|7247772|FG001|NOT COMPLETED|Overall Study||1
6339966|NCT00568633|7247782|FG000|STARTED|Overall Study||25
6339967|NCT00568633|7247783|FG001|STARTED|Overall Study||33
6339968|NCT00568633|7247782|FG000|COMPLETED|Overall Study||25
6339969|NCT00568633|7247783|FG001|COMPLETED|Overall Study||33
6339970|NCT00568633|7247782|FG000|NOT COMPLETED|Overall Study||0
6339971|NCT00568633|7247783|FG001|NOT COMPLETED|Overall Study||0
6339972|NCT00568685|7247792|FG000|STARTED|Overall Study||51
6339973|NCT00568685|7247793|FG001|STARTED|Overall Study||51
6339974|NCT00568685|7247794|FG002|STARTED|Overall Study||51
6339975|NCT00568685|7247792|FG000|COMPLETED|Overall Study||41
6339976|NCT00568685|7247793|FG001|COMPLETED|Overall Study||46
6339977|NCT00568685|7247794|FG002|COMPLETED|Overall Study||46
6339978|NCT00568685|7247792|FG000|NOT COMPLETED|Overall Study||10
6339979|NCT00568685|7247793|FG001|NOT COMPLETED|Overall Study||5
6339980|NCT00568685|7247794|FG002|NOT COMPLETED|Overall Study||5
6339981|NCT00568776|7247810|FG000|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
6339982|NCT00568776|7247811|FG001|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
6339983|NCT00568776|7247812|FG002|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
6339984|NCT00568776|7247813|FG003|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
6339985|NCT00568776|7247810|FG000|COMPLETED|Overall Study||53
6339986|NCT00568776|7247811|FG001|COMPLETED|Overall Study||52
6339987|NCT00568776|7247812|FG002|COMPLETED|Overall Study||15
6339988|NCT00568776|7247813|FG003|COMPLETED|Overall Study||19
6339989|NCT00568776|7247810|FG000|NOT COMPLETED|Overall Study||30
6339990|NCT00568776|7247811|FG001|NOT COMPLETED|Overall Study||36
6339991|NCT00568776|7247812|FG002|NOT COMPLETED|Overall Study||74
6559143|NCT01780662|7481807|FG001|NOT COMPLETED|Overall Study||6
6339992|NCT00568776|7247813|FG003|NOT COMPLETED|Overall Study||72
6339993|NCT00568854|7247825|FG000|STARTED|Overall Study||6
6339994|NCT00568854|7247826|FG001|STARTED|Overall Study||4
6339995|NCT00568854|7247825|FG000|COMPLETED|Overall Study||6
6339996|NCT00568854|7247826|FG001|COMPLETED|Overall Study||4
6339997|NCT00568854|7247825|FG000|NOT COMPLETED|Overall Study||0
6339998|NCT00568854|7247826|FG001|NOT COMPLETED|Overall Study||0
6339999|NCT00568958|7247834|FG000|STARTED|Allocation||70
6340000|NCT00568958|7247835|FG001|STARTED|Allocation||70
6340001|NCT00568958|7247834|FG000|COMPLETED|Allocation||61
6340002|NCT00568958|7247835|FG001|COMPLETED|Allocation||67
6340003|NCT00568958|7247834|FG000|NOT COMPLETED|Allocation||9
6340004|NCT00568958|7247835|FG001|NOT COMPLETED|Allocation||3
6340005|NCT00568958|7247834|FG000|STARTED|Follow-Up||61
6340006|NCT00568958|7247835|FG001|STARTED|Follow-Up||67
6340007|NCT00568958|7247834|FG000|COMPLETED|Follow-Up||52
6340008|NCT00568958|7247835|FG001|COMPLETED|Follow-Up||60
6340009|NCT00568958|7247834|FG000|NOT COMPLETED|Follow-Up||9
6340010|NCT00568958|7247835|FG001|NOT COMPLETED|Follow-Up||7
6340011|NCT00569010|7247845|FG000|STARTED|Overall Study||6
6340012|NCT00569010|7247846|FG001|STARTED|Overall Study||6
6340013|NCT00569010|7247847|FG002|STARTED|Overall Study||11
6340014|NCT00569010|7247848|FG003|STARTED|Overall Study||11
6340015|NCT00569010|7247845|FG000|COMPLETED|Overall Study||6
6340016|NCT00569010|7247846|FG001|COMPLETED|Overall Study||6
6340017|NCT00569010|7247847|FG002|COMPLETED|Overall Study||11
6340018|NCT00569010|7247848|FG003|COMPLETED|Overall Study||11
6340019|NCT00569010|7247845|FG000|NOT COMPLETED|Overall Study||0
6340020|NCT00569010|7247846|FG001|NOT COMPLETED|Overall Study||0
6340021|NCT00569010|7247847|FG002|NOT COMPLETED|Overall Study||0
6340022|NCT00569010|7247848|FG003|NOT COMPLETED|Overall Study||0
6340023|NCT00569166|7247861|FG000|STARTED|Overall Study||30
6340024|NCT00569166|7247862|FG001|STARTED|Overall Study||31
6340025|NCT00569166|7247863|FG002|STARTED|Overall Study||31
6340026|NCT00569166|7247861|FG000|COMPLETED|Overall Study||21
6340027|NCT00569166|7247862|FG001|COMPLETED|Overall Study||25
6340028|NCT00569166|7247863|FG002|COMPLETED|Overall Study||27
6340029|NCT00569166|7247861|FG000|NOT COMPLETED|Overall Study||9
6340030|NCT00569166|7247862|FG001|NOT COMPLETED|Overall Study||6
6340031|NCT00569166|7247863|FG002|NOT COMPLETED|Overall Study||4
6340032|NCT00569192|7247874|FG000|STARTED|Overall Study||111
6340033|NCT00569192|7247875|FG001|STARTED|Overall Study||125
6340034|NCT00569192|7247876|FG002|STARTED|Overall Study||124
6340035|NCT00569192|7247874|FG000|COMPLETED|Overall Study||88
6340036|NCT00569192|7247875|FG001|COMPLETED|Overall Study||105
6340037|NCT00569192|7247876|FG002|COMPLETED|Overall Study||99
6340038|NCT00569192|7247874|FG000|NOT COMPLETED|Overall Study||23
6340039|NCT00569192|7247875|FG001|NOT COMPLETED|Overall Study||20
6340040|NCT00569192|7247876|FG002|NOT COMPLETED|Overall Study||25
6340041|NCT00569231|7247884|FG000|STARTED|Overall Study||18
6340042|NCT00569231|7247884|FG000|COMPLETED|Overall Study||11
6340043|NCT00569231|7247884|FG000|NOT COMPLETED|Overall Study||7
6340044|NCT00569270|7247888|FG000|STARTED|Period: First Intervention|randomized cross over study|15
6340045|NCT00569270|7247889|FG001|STARTED|Period: First Intervention||15
6340046|NCT00569270|7247888|FG000|COMPLETED|Period: First Intervention||15
6340047|NCT00569270|7247889|FG001|COMPLETED|Period: First Intervention||14
6340048|NCT00569270|7247888|FG000|NOT COMPLETED|Period: First Intervention||0
6340049|NCT00569270|7247889|FG001|NOT COMPLETED|Period: First Intervention||1
6340050|NCT00569270|7247888|FG000|STARTED|Period: Second Intervention||15
6340051|NCT00569270|7247889|FG001|STARTED|Period: Second Intervention||14
6340052|NCT00569270|7247888|FG000|29 Days|Period: Second Intervention||15
6340053|NCT00569270|7247889|FG001|29 Days|Period: Second Intervention||14
6340054|NCT00569270|7247888|FG000|COMPLETED|Period: Second Intervention||15
6340055|NCT00569270|7247889|FG001|COMPLETED|Period: Second Intervention||14
6340056|NCT00569270|7247888|FG000|NOT COMPLETED|Period: Second Intervention||0
6340057|NCT00569270|7247889|FG001|NOT COMPLETED|Period: Second Intervention||0
6340058|NCT00569309|7247904|FG000|STARTED|Overall Study||30
6340059|NCT00569309|7247904|FG000|COMPLETED|Overall Study||30
6340060|NCT00569309|7247904|FG000|NOT COMPLETED|Overall Study||0
6340061|NCT00569374|7247908|FG000|STARTED|Overall Study||8
6340062|NCT00569374|7247908|FG000|COMPLETED|Overall Study||4
6340063|NCT00569374|7247908|FG000|NOT COMPLETED|Overall Study||4
6340064|NCT00569530|7247914|FG000|STARTED|Overall Study||43
6340065|NCT00569530|7247915|FG001|STARTED|Overall Study||42
6340066|NCT00569530|7247914|FG000|COMPLETED|Overall Study||43
6340067|NCT00569530|7247915|FG001|COMPLETED|Overall Study||42
6340068|NCT00569530|7247914|FG000|NOT COMPLETED|Overall Study||0
6340069|NCT00569530|7247915|FG001|NOT COMPLETED|Overall Study||0
6340070|NCT00569582|7247921|FG000|STARTED|Overall Study||50
6340071|NCT00569582|7247921|FG000|COMPLETED|Overall Study||34
6340072|NCT00569582|7247921|FG000|NOT COMPLETED|Overall Study||16
6340073|NCT00569660|7247925|FG000|STARTED|Overall Study||34
6340074|NCT00569660|7247925|FG000|COMPLETED|Overall Study||34
6340075|NCT00569660|7247925|FG000|NOT COMPLETED|Overall Study||0
6340076|NCT00569673|7247929|FG000|STARTED|Overall Study|Total number participants enrolled on study|71
6340077|NCT00569673|7247929|FG000|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
6340078|NCT00569673|7247929|FG000|NOT COMPLETED|Overall Study||0
6340079|NCT00569777|7247935|FG000|STARTED|Overall Study||206
6340080|NCT00569777|7247936|FG001|STARTED|Overall Study||104
6340081|NCT00569777|7247935|FG000|COMPLETED|Overall Study||196
6340082|NCT00569777|7247936|FG001|COMPLETED|Overall Study||101
6340083|NCT00569777|7247935|FG000|NOT COMPLETED|Overall Study||10
6340084|NCT00569777|7247936|FG001|NOT COMPLETED|Overall Study||3
6340085|NCT00569803|7247950|FG000|STARTED|Overall Study||5
6340086|NCT00569803|7247951|FG001|STARTED|Overall Study||5
6340087|NCT00569803|7247952|FG002|STARTED|Overall Study||5
6340088|NCT00569803|7247953|FG003|STARTED|Overall Study||6
6340089|NCT00569803|7247954|FG004|STARTED|Overall Study||5
6340090|NCT00569803|7247955|FG005|STARTED|Overall Study||5
6340091|NCT00569803|7247956|FG006|STARTED|Overall Study||10
6340092|NCT00569803|7247957|FG007|STARTED|Overall Study||6
6340093|NCT00569803|7247950|FG000|COMPLETED|Overall Study||4
6340094|NCT00569803|7247951|FG001|COMPLETED|Overall Study||5
6340095|NCT00569803|7247952|FG002|COMPLETED|Overall Study||5
6340096|NCT00569803|7247953|FG003|COMPLETED|Overall Study||5
6340097|NCT00569803|7247954|FG004|COMPLETED|Overall Study||5
6340098|NCT00569803|7247955|FG005|COMPLETED|Overall Study||5
6340099|NCT00569803|7247956|FG006|COMPLETED|Overall Study||10
6340100|NCT00569803|7247957|FG007|COMPLETED|Overall Study||5
6340101|NCT00569803|7247950|FG000|NOT COMPLETED|Overall Study||1
6340102|NCT00569803|7247951|FG001|NOT COMPLETED|Overall Study||0
6340103|NCT00569803|7247952|FG002|NOT COMPLETED|Overall Study||0
6340104|NCT00569803|7247953|FG003|NOT COMPLETED|Overall Study||1
6340105|NCT00569803|7247954|FG004|NOT COMPLETED|Overall Study||0
6340106|NCT00569803|7247955|FG005|NOT COMPLETED|Overall Study||0
6340107|NCT00569803|7247956|FG006|NOT COMPLETED|Overall Study||0
6340108|NCT00569803|7247957|FG007|NOT COMPLETED|Overall Study||1
6340109|NCT00569855|7247979|FG000|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
6340110|NCT00569855|7247979|FG000|COMPLETED|Overall Study|785 subjects treated with study drug|785
6340111|NCT00569855|7247979|FG000|NOT COMPLETED|Overall Study||0
6340112|NCT00569946|7247983|FG000|STARTED|Overall Study||64
6340113|NCT00569946|7247983|FG000|COMPLETED|Overall Study||5
6340114|NCT00569946|7247983|FG000|NOT COMPLETED|Overall Study||59
6340115|NCT00570037|7247989|FG000|STARTED|Overall Study||238
6340116|NCT00570037|7247990|FG001|STARTED|Overall Study||306
6340117|NCT00570037|7247989|FG000|COMPLETED|Overall Study||194
6340118|NCT00570037|7247990|FG001|COMPLETED|Overall Study||237
6340119|NCT00570037|7247989|FG000|NOT COMPLETED|Overall Study||44
6340120|NCT00570037|7247990|FG001|NOT COMPLETED|Overall Study||69
6340121|NCT00570063|7247998|FG000|STARTED|Overall Study||24
6340122|NCT00570063|7247999|FG001|STARTED|Overall Study||11
6340123|NCT00570063|7247998|FG000|COMPLETED|Overall Study||9
6340124|NCT00570063|7247999|FG001|COMPLETED|Overall Study||3
6340125|NCT00570063|7247998|FG000|NOT COMPLETED|Overall Study||15
6340126|NCT00570063|7247999|FG001|NOT COMPLETED|Overall Study||8
6340127|NCT00570089|7248005|FG000|STARTED|Period 1||10
6340128|NCT00570089|7248006|FG001|STARTED|Period 1||10
6340129|NCT00570089|7248005|FG000|COMPLETED|Period 1||10
6340130|NCT00570089|7248006|FG001|COMPLETED|Period 1||10
6340131|NCT00570089|7248005|FG000|NOT COMPLETED|Period 1||0
6340132|NCT00570089|7248006|FG001|NOT COMPLETED|Period 1||0
6340133|NCT00570089|7248005|FG000|STARTED|Perod 2||10
6340134|NCT00570089|7248006|FG001|STARTED|Perod 2||10
6340135|NCT00570089|7248005|FG000|COMPLETED|Perod 2||10
6340136|NCT00570089|7248006|FG001|COMPLETED|Perod 2||10
6340137|NCT00570089|7248005|FG000|NOT COMPLETED|Perod 2||0
6340138|NCT00570089|7248006|FG001|NOT COMPLETED|Perod 2||0
6340139|NCT00570128|7248016|FG000|STARTED|Overall Study||64
6340140|NCT00570128|7248017|FG001|STARTED|Overall Study||65
6340141|NCT00570128|7248016|FG000|Intent to Treat (ITT) Population|Overall Study||62
6340142|NCT00570128|7248017|FG001|Intent to Treat (ITT) Population|Overall Study||65
6340143|NCT00570128|7248016|FG000|COMPLETED|Overall Study||60
6340144|NCT00570128|7248017|FG001|COMPLETED|Overall Study||65
6340145|NCT00570128|7248016|FG000|NOT COMPLETED|Overall Study||4
6340146|NCT00570128|7248017|FG001|NOT COMPLETED|Overall Study||0
6340147|NCT00570141|7248023|FG000|STARTED|Overall Study||13
6340148|NCT00570141|7248023|FG000|COMPLETED|Overall Study||10
6340149|NCT00570141|7248023|FG000|NOT COMPLETED|Overall Study||3
6340150|NCT00570232|7248027|FG000|STARTED|Overall Study||31
6340151|NCT00570232|7248027|FG000|COMPLETED|Overall Study||8
6340152|NCT00570232|7248027|FG000|NOT COMPLETED|Overall Study||23
6340153|NCT00570310|7248033|FG000|STARTED|Overall Study||53
6340154|NCT00570310|7248034|FG001|STARTED|Overall Study||51
6340155|NCT00570310|7248033|FG000|COMPLETED|Overall Study||51
6340156|NCT00570310|7248034|FG001|COMPLETED|Overall Study||45
6340157|NCT00570310|7248033|FG000|NOT COMPLETED|Overall Study||2
6340158|NCT00570310|7248034|FG001|NOT COMPLETED|Overall Study||6
6340159|NCT00570323|7248042|FG000|STARTED|Started Treatment After Randomization||36
6340160|NCT00570323|7248043|FG001|STARTED|Started Treatment After Randomization||36
6340161|NCT00570323|7248042|FG000|COMPLETED|Started Treatment After Randomization||34
6340162|NCT00570323|7248043|FG001|COMPLETED|Started Treatment After Randomization||35
6340163|NCT00570323|7248042|FG000|NOT COMPLETED|Started Treatment After Randomization||2
6340164|NCT00570323|7248043|FG001|NOT COMPLETED|Started Treatment After Randomization||1
6340165|NCT00570323|7248042|FG000|STARTED|Complete Study After Start||34
6340166|NCT00570323|7248043|FG001|STARTED|Complete Study After Start||35
6340167|NCT00570323|7248042|FG000|COMPLETED|Complete Study After Start||31
6559144|NCT01780662|7481808|FG002|NOT COMPLETED|Overall Study||10
6559145|NCT01780831|7481821|FG000|STARTED|Overall Study||10
6559146|NCT01780831|7481822|FG001|STARTED|Overall Study||6
6559147|NCT01780831|7481823|FG002|STARTED|Overall Study||26
6340168|NCT00570323|7248043|FG001|COMPLETED|Complete Study After Start||34
6340169|NCT00570323|7248042|FG000|NOT COMPLETED|Complete Study After Start||3
6340170|NCT00570323|7248043|FG001|NOT COMPLETED|Complete Study After Start||1
6340171|NCT00570349|7248054|FG000|STARTED|Overall Study||6
6340172|NCT00570349|7248055|FG001|STARTED|Overall Study||6
6340173|NCT00570349|7248056|FG002|STARTED|Overall Study||6
6340174|NCT00570349|7248054|FG000|COMPLETED|Overall Study||6
6340175|NCT00570349|7248055|FG001|COMPLETED|Overall Study||6
6340176|NCT00570349|7248056|FG002|COMPLETED|Overall Study||6
6340177|NCT00570349|7248054|FG000|NOT COMPLETED|Overall Study||0
6340178|NCT00570349|7248055|FG001|NOT COMPLETED|Overall Study||0
6340179|NCT00570349|7248056|FG002|NOT COMPLETED|Overall Study||0
6559148|NCT01780831|7481824|FG003|STARTED|Overall Study||10
6559149|NCT01780831|7481821|FG000|COMPLETED|Overall Study||10
6559150|NCT01780831|7481822|FG001|COMPLETED|Overall Study||6
6559151|NCT01780831|7481823|FG002|COMPLETED|Overall Study||22
6340180|NCT00570362|7248066|FG000|STARTED|Overall Study||19
6340181|NCT00570362|7248067|FG001|STARTED|Overall Study||30
6340182|NCT00570362|7248066|FG000|COMPLETED|Overall Study||19
6340183|NCT00570362|7248067|FG001|COMPLETED|Overall Study||30
6340184|NCT00570362|7248066|FG000|NOT COMPLETED|Overall Study||0
6340185|NCT00570362|7248067|FG001|NOT COMPLETED|Overall Study||0
6340186|NCT00570401|7248073|FG000|STARTED|Overall Study||21
6340187|NCT00570401|7248073|FG000|COMPLETED|Overall Study||19
6340188|NCT00570401|7248073|FG000|NOT COMPLETED|Overall Study||2
6340189|NCT00570492|7248079|FG000|STARTED|16-week Single-blind Baseline Period||910
6340190|NCT00570492|7248080|FG001|STARTED|16-week Single-blind Baseline Period||0
6340191|NCT00570492|7248081|FG002|STARTED|16-week Single-blind Baseline Period||0
6340192|NCT00570492|7248079|FG000|COMPLETED|16-week Single-blind Baseline Period||474
6340193|NCT00570492|7248080|FG001|COMPLETED|16-week Single-blind Baseline Period||0
6340194|NCT00570492|7248081|FG002|COMPLETED|16-week Single-blind Baseline Period||0
6340195|NCT00570492|7248079|FG000|NOT COMPLETED|16-week Single-blind Baseline Period||436
6340196|NCT00570492|7248080|FG001|NOT COMPLETED|16-week Single-blind Baseline Period||0
6340197|NCT00570492|7248081|FG002|NOT COMPLETED|16-week Single-blind Baseline Period||0
6340198|NCT00570492|7248079|FG000|STARTED|52-week Double-blind Treatment Period||0
6340199|NCT00570492|7248080|FG001|STARTED|52-week Double-blind Treatment Period||237
6340200|NCT00570492|7248081|FG002|STARTED|52-week Double-blind Treatment Period||237
6340201|NCT00570492|7248079|FG000|COMPLETED|52-week Double-blind Treatment Period||0
6340202|NCT00570492|7248080|FG001|COMPLETED|52-week Double-blind Treatment Period||187
6340203|NCT00570492|7248081|FG002|COMPLETED|52-week Double-blind Treatment Period||186
6340204|NCT00570492|7248079|FG000|NOT COMPLETED|52-week Double-blind Treatment Period||0
6340205|NCT00570492|7248080|FG001|NOT COMPLETED|52-week Double-blind Treatment Period||50
6340206|NCT00570492|7248081|FG002|NOT COMPLETED|52-week Double-blind Treatment Period||51
6340207|NCT00570505|7248087|FG000|STARTED|Overall Study||149
6340208|NCT00570505|7248087|FG000|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
6340209|NCT00570505|7248087|FG000|NOT COMPLETED|Overall Study||41
6340210|NCT00570661|7248091|FG000|STARTED|Overall Study||17
6340211|NCT00570661|7248091|FG000|COMPLETED|Overall Study||10
6340212|NCT00570661|7248091|FG000|NOT COMPLETED|Overall Study||7
6340213|NCT00570674|7248096|FG000|STARTED|Overall Study||6
6340214|NCT00570674|7248097|FG001|STARTED|Overall Study||3
6340215|NCT00570674|7248098|FG002|STARTED|Overall Study||4
6340216|NCT00570674|7248099|FG003|STARTED|Overall Study||3
6340217|NCT00570674|7248100|FG004|STARTED|Overall Study||3
6340218|NCT00570674|7248101|FG005|STARTED|Overall Study||10
6340219|NCT00570674|7248102|FG006|STARTED|Overall Study|The study did not continue beyond phase I.|0
6340220|NCT00570674|7248096|FG000|Treated|Overall Study||6
6340221|NCT00570674|7248097|FG001|Treated|Overall Study||3
6340222|NCT00570674|7248098|FG002|Treated|Overall Study||3
6340223|NCT00570674|7248099|FG003|Treated|Overall Study||3
6340224|NCT00570674|7248100|FG004|Treated|Overall Study||3
6340225|NCT00570674|7248101|FG005|Treated|Overall Study||10
6340226|NCT00570674|7248102|FG006|Treated|Overall Study||0
6340227|NCT00570674|7248096|FG000|PEG Evaluable|Overall Study||6
6340228|NCT00570674|7248097|FG001|PEG Evaluable|Overall Study||3
6340229|NCT00570674|7248098|FG002|PEG Evaluable|Overall Study||3
6340230|NCT00570674|7248099|FG003|PEG Evaluable|Overall Study||3
6340231|NCT00570674|7248100|FG004|PEG Evaluable|Overall Study||2
6340232|NCT00570674|7248101|FG005|PEG Evaluable|Overall Study||10
6340233|NCT00570674|7248102|FG006|PEG Evaluable|Overall Study||0
6340234|NCT00570674|7248096|FG000|COMPLETED|Overall Study||6
6340235|NCT00570674|7248097|FG001|COMPLETED|Overall Study||3
6340236|NCT00570674|7248098|FG002|COMPLETED|Overall Study||3
6340237|NCT00570674|7248099|FG003|COMPLETED|Overall Study||3
6340238|NCT00570674|7248100|FG004|COMPLETED|Overall Study||3
6340239|NCT00570674|7248101|FG005|COMPLETED|Overall Study||10
6340240|NCT00570674|7248102|FG006|COMPLETED|Overall Study||0
6340241|NCT00570674|7248096|FG000|NOT COMPLETED|Overall Study||0
6340242|NCT00570674|7248097|FG001|NOT COMPLETED|Overall Study||0
6340243|NCT00570674|7248098|FG002|NOT COMPLETED|Overall Study||1
6340244|NCT00570674|7248099|FG003|NOT COMPLETED|Overall Study||0
6340245|NCT00570674|7248100|FG004|NOT COMPLETED|Overall Study||0
6340246|NCT00570674|7248101|FG005|NOT COMPLETED|Overall Study||0
6340247|NCT00570674|7248102|FG006|NOT COMPLETED|Overall Study||0
6340248|NCT00570687|7248115|FG000|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340249|NCT00570687|7248116|FG001|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340250|NCT00570687|7248117|FG002|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340251|NCT00570687|7248118|FG003|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340252|NCT00570687|7248119|FG004|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340253|NCT00570687|7248120|FG005|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340254|NCT00570687|7248121|FG006|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340255|NCT00570687|7248122|FG007|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340256|NCT00570687|7248123|FG008|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340257|NCT00570687|7248124|FG009|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340258|NCT00570687|7248115|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340259|NCT00570687|7248116|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6559152|NCT01780831|7481824|FG003|COMPLETED|Overall Study||9
6654994|NCT02449434|7585020|FG000|NOT COMPLETED|Overall Study||0
6654995|NCT02449434|7585021|FG001|NOT COMPLETED|Overall Study||0
6654996|NCT02449473|7585029|FG000|STARTED|Overall Study||39
6654997|NCT02449473|7585030|FG001|STARTED|Overall Study||40
6340260|NCT00570687|7248117|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340261|NCT00570687|7248118|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340262|NCT00570687|7248119|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340263|NCT00570687|7248120|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340264|NCT00570687|7248121|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340265|NCT00570687|7248122|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340266|NCT00570687|7248123|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340267|NCT00570687|7248124|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
6340268|NCT00570687|7248115|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340269|NCT00570687|7248116|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340270|NCT00570687|7248117|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340271|NCT00570687|7248118|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340272|NCT00570687|7248119|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340273|NCT00570687|7248120|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340274|NCT00570687|7248121|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340275|NCT00570687|7248122|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340276|NCT00570687|7248123|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340277|NCT00570687|7248124|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
6340278|NCT00570687|7248115|FG000|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
6340279|NCT00570687|7248116|FG001|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
6340280|NCT00570687|7248117|FG002|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
6340281|NCT00570687|7248118|FG003|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
6340282|NCT00570687|7248119|FG004|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6340283|NCT00570687|7248120|FG005|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6340284|NCT00570687|7248121|FG006|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6340285|NCT00570687|7248122|FG007|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6340286|NCT00570687|7248123|FG008|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6340287|NCT00570687|7248124|FG009|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
6340288|NCT00570687|7248115|FG000|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340289|NCT00570687|7248116|FG001|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340290|NCT00570687|7248117|FG002|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340291|NCT00570687|7248118|FG003|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340292|NCT00570687|7248119|FG004|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6340293|NCT00570687|7248120|FG005|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6340294|NCT00570687|7248121|FG006|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6340295|NCT00570687|7248122|FG007|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6340296|NCT00570687|7248123|FG008|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6340297|NCT00570687|7248124|FG009|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
6340298|NCT00570687|7248115|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340299|NCT00570687|7248116|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340300|NCT00570687|7248117|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340301|NCT00570687|7248118|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340302|NCT00570687|7248119|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340303|NCT00570687|7248120|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340304|NCT00570687|7248121|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340305|NCT00570687|7248122|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340306|NCT00570687|7248123|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6559153|NCT01780831|7481821|FG000|NOT COMPLETED|Overall Study||0
6559154|NCT01780831|7481822|FG001|NOT COMPLETED|Overall Study||0
6559155|NCT01780831|7481823|FG002|NOT COMPLETED|Overall Study||4
6340307|NCT00570687|7248124|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
6340308|NCT00570687|7248115|FG000|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340309|NCT00570687|7248116|FG001|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340310|NCT00570687|7248117|FG002|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340311|NCT00570687|7248118|FG003|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340312|NCT00570687|7248119|FG004|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340313|NCT00570687|7248120|FG005|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340314|NCT00570687|7248121|FG006|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340315|NCT00570687|7248122|FG007|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340316|NCT00570687|7248123|FG008|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340317|NCT00570687|7248124|FG009|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6559156|NCT01780831|7481824|FG003|NOT COMPLETED|Overall Study||1
6559157|NCT01780870|7481883|FG000|STARTED|Overall Study||0
6559158|NCT01780870|7481884|FG001|STARTED|Overall Study||5
6559159|NCT01780870|7481883|FG000|COMPLETED|Overall Study||0
6559160|NCT01780870|7481884|FG001|COMPLETED|Overall Study||5
6559161|NCT01780870|7481883|FG000|NOT COMPLETED|Overall Study||0
6559162|NCT01780870|7481884|FG001|NOT COMPLETED|Overall Study||0
6559163|NCT01780922|7481890|FG000|STARTED|First Intervention (1 Day)||2
6559164|NCT01780922|7481891|FG001|STARTED|First Intervention (1 Day)||2
6559165|NCT01780922|7481892|FG002|STARTED|First Intervention (1 Day)||2
6340318|NCT00570687|7248115|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340319|NCT00570687|7248116|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340320|NCT00570687|7248117|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340321|NCT00570687|7248118|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340322|NCT00570687|7248119|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340323|NCT00570687|7248120|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340324|NCT00570687|7248121|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340325|NCT00570687|7248122|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340326|NCT00570687|7248123|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340327|NCT00570687|7248124|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
6340328|NCT00570687|7248115|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340329|NCT00570687|7248116|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340330|NCT00570687|7248117|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340331|NCT00570687|7248118|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340332|NCT00570687|7248119|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340333|NCT00570687|7248120|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340334|NCT00570687|7248121|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340335|NCT00570687|7248122|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340336|NCT00570687|7248123|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340337|NCT00570687|7248124|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
6340338|NCT00570687|7248115|FG000|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
6340339|NCT00570687|7248116|FG001|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
6340340|NCT00570687|7248117|FG002|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
6340341|NCT00570687|7248118|FG003|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
6340342|NCT00570687|7248119|FG004|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6340343|NCT00570687|7248120|FG005|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6340344|NCT00570687|7248121|FG006|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6340345|NCT00570687|7248122|FG007|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6340346|NCT00570687|7248123|FG008|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6340347|NCT00570687|7248124|FG009|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
6340348|NCT00570687|7248115|FG000|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340349|NCT00570687|7248116|FG001|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340350|NCT00570687|7248117|FG002|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340351|NCT00570687|7248118|FG003|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340352|NCT00570687|7248119|FG004|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6340353|NCT00570687|7248120|FG005|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6340354|NCT00570687|7248121|FG006|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6340355|NCT00570687|7248122|FG007|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6340356|NCT00570687|7248123|FG008|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6340357|NCT00570687|7248124|FG009|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
6340358|NCT00570687|7248115|FG000|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340359|NCT00570687|7248116|FG001|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340360|NCT00570687|7248117|FG002|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340361|NCT00570687|7248118|FG003|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340362|NCT00570687|7248119|FG004|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340363|NCT00570687|7248120|FG005|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340364|NCT00570687|7248121|FG006|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340365|NCT00570687|7248122|FG007|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340366|NCT00570687|7248123|FG008|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340367|NCT00570687|7248124|FG009|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
6340368|NCT00570687|7248115|FG000|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340369|NCT00570687|7248116|FG001|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340370|NCT00570687|7248117|FG002|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340371|NCT00570687|7248118|FG003|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340372|NCT00570687|7248119|FG004|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340373|NCT00570687|7248120|FG005|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340374|NCT00570687|7248121|FG006|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340375|NCT00570687|7248122|FG007|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340376|NCT00570687|7248123|FG008|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340377|NCT00570687|7248124|FG009|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340378|NCT00570687|7248115|FG000|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340379|NCT00570687|7248116|FG001|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340380|NCT00570687|7248117|FG002|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340381|NCT00570687|7248118|FG003|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340382|NCT00570687|7248119|FG004|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340383|NCT00570687|7248120|FG005|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340384|NCT00570687|7248121|FG006|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340385|NCT00570687|7248122|FG007|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340386|NCT00570687|7248123|FG008|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340387|NCT00570687|7248124|FG009|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
6340388|NCT00570687|7248115|FG000|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340389|NCT00570687|7248116|FG001|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340390|NCT00570687|7248117|FG002|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340391|NCT00570687|7248118|FG003|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340392|NCT00570687|7248119|FG004|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340393|NCT00570687|7248120|FG005|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340394|NCT00570687|7248121|FG006|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340395|NCT00570687|7248122|FG007|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340396|NCT00570687|7248123|FG008|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340397|NCT00570687|7248124|FG009|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
6340398|NCT00570687|7248115|FG000|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
6340399|NCT00570687|7248116|FG001|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
6340400|NCT00570687|7248117|FG002|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
6340401|NCT00570687|7248118|FG003|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
6340402|NCT00570687|7248119|FG004|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6340403|NCT00570687|7248120|FG005|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6340404|NCT00570687|7248121|FG006|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6340405|NCT00570687|7248122|FG007|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6340406|NCT00570687|7248123|FG008|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6340407|NCT00570687|7248124|FG009|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
6340408|NCT00570687|7248115|FG000|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340409|NCT00570687|7248116|FG001|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340410|NCT00570687|7248117|FG002|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340411|NCT00570687|7248118|FG003|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340412|NCT00570687|7248119|FG004|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340413|NCT00570687|7248120|FG005|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340414|NCT00570687|7248121|FG006|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
6340415|NCT00570687|7248122|FG007|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340416|NCT00570687|7248123|FG008|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
6340417|NCT00570687|7248124|FG009|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340418|NCT00570687|7248115|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340419|NCT00570687|7248116|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340420|NCT00570687|7248117|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340421|NCT00570687|7248118|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
6340422|NCT00570687|7248119|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
6340423|NCT00570687|7248120|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
6340424|NCT00570687|7248121|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
6340425|NCT00570687|7248122|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
6340426|NCT00570687|7248123|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
6340427|NCT00570687|7248124|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
6340428|NCT00570687|7248115|FG000|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6340429|NCT00570687|7248116|FG001|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6340430|NCT00570687|7248117|FG002|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6340431|NCT00570687|7248118|FG003|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6340432|NCT00570687|7248119|FG004|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6340433|NCT00570687|7248120|FG005|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6340434|NCT00570687|7248121|FG006|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
6340435|NCT00570687|7248122|FG007|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6340436|NCT00570687|7248123|FG008|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
6340437|NCT00570687|7248124|FG009|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
6340438|NCT00570687|7248115|FG000|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340439|NCT00570687|7248116|FG001|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340440|NCT00570687|7248117|FG002|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340441|NCT00570687|7248118|FG003|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340442|NCT00570687|7248119|FG004|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340443|NCT00570687|7248120|FG005|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340444|NCT00570687|7248121|FG006|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
6340445|NCT00570687|7248122|FG007|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340446|NCT00570687|7248123|FG008|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
6340447|NCT00570687|7248124|FG009|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340448|NCT00570687|7248115|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340449|NCT00570687|7248116|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340450|NCT00570687|7248117|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340451|NCT00570687|7248118|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340452|NCT00570687|7248119|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340453|NCT00570687|7248120|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340454|NCT00570687|7248121|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340455|NCT00570687|7248122|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340456|NCT00570687|7248123|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340457|NCT00570687|7248124|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
6340458|NCT00570687|7248115|FG000|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6340459|NCT00570687|7248116|FG001|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6340460|NCT00570687|7248117|FG002|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6340461|NCT00570687|7248118|FG003|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6340462|NCT00570687|7248119|FG004|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6377902|NCT00765856|7288584|FG000|STARTED|Titration Period||27
6340463|NCT00570687|7248120|FG005|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6340464|NCT00570687|7248121|FG006|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
6340465|NCT00570687|7248122|FG007|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6340466|NCT00570687|7248123|FG008|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
6340467|NCT00570687|7248124|FG009|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
6340468|NCT00570687|7248115|FG000|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340469|NCT00570687|7248116|FG001|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340470|NCT00570687|7248117|FG002|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340471|NCT00570687|7248118|FG003|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340472|NCT00570687|7248119|FG004|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340473|NCT00570687|7248120|FG005|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340474|NCT00570687|7248121|FG006|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
6340475|NCT00570687|7248122|FG007|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340476|NCT00570687|7248123|FG008|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340477|NCT00570687|7248124|FG009|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340478|NCT00570687|7248115|FG000|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340479|NCT00570687|7248116|FG001|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340480|NCT00570687|7248117|FG002|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340481|NCT00570687|7248118|FG003|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340482|NCT00570687|7248119|FG004|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340483|NCT00570687|7248120|FG005|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340484|NCT00570687|7248121|FG006|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340485|NCT00570687|7248122|FG007|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340486|NCT00570687|7248123|FG008|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
6340487|NCT00570687|7248124|FG009|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
6340488|NCT00570687|7248115|FG000|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340489|NCT00570687|7248116|FG001|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340490|NCT00570687|7248117|FG002|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340491|NCT00570687|7248118|FG003|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340492|NCT00570687|7248119|FG004|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340493|NCT00570687|7248120|FG005|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340494|NCT00570687|7248121|FG006|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
6340495|NCT00570687|7248122|FG007|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340496|NCT00570687|7248123|FG008|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340497|NCT00570687|7248124|FG009|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
6340498|NCT00570687|7248115|FG000|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340499|NCT00570687|7248116|FG001|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340500|NCT00570687|7248117|FG002|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340501|NCT00570687|7248118|FG003|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340502|NCT00570687|7248119|FG004|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340503|NCT00570687|7248120|FG005|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340504|NCT00570687|7248121|FG006|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
6340505|NCT00570687|7248122|FG007|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340506|NCT00570687|7248123|FG008|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340507|NCT00570687|7248124|FG009|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340508|NCT00570687|7248115|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340509|NCT00570687|7248116|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340510|NCT00570687|7248117|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340511|NCT00570687|7248118|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340512|NCT00570687|7248119|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340513|NCT00570687|7248120|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340514|NCT00570687|7248121|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340515|NCT00570687|7248122|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340516|NCT00570687|7248123|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340517|NCT00570687|7248124|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
6340518|NCT00570687|7248115|FG000|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340519|NCT00570687|7248116|FG001|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340520|NCT00570687|7248117|FG002|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340521|NCT00570687|7248118|FG003|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340522|NCT00570687|7248119|FG004|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340523|NCT00570687|7248120|FG005|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340524|NCT00570687|7248121|FG006|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
6340525|NCT00570687|7248122|FG007|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340526|NCT00570687|7248123|FG008|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340527|NCT00570687|7248124|FG009|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
6340528|NCT00570687|7248115|FG000|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340529|NCT00570687|7248116|FG001|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340530|NCT00570687|7248117|FG002|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340531|NCT00570687|7248118|FG003|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340532|NCT00570687|7248119|FG004|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340533|NCT00570687|7248120|FG005|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340534|NCT00570687|7248121|FG006|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340535|NCT00570687|7248122|FG007|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340536|NCT00570687|7248123|FG008|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340537|NCT00570687|7248124|FG009|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340538|NCT00570687|7248115|FG000|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340539|NCT00570687|7248116|FG001|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340540|NCT00570687|7248117|FG002|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340541|NCT00570687|7248118|FG003|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340542|NCT00570687|7248119|FG004|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340543|NCT00570687|7248120|FG005|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340544|NCT00570687|7248121|FG006|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
6340545|NCT00570687|7248122|FG007|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340546|NCT00570687|7248123|FG008|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340547|NCT00570687|7248124|FG009|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
6340548|NCT00570687|7248115|FG000|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
6340549|NCT00570687|7248116|FG001|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
6340550|NCT00570687|7248117|FG002|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
6340551|NCT00570687|7248118|FG003|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
6340552|NCT00570687|7248119|FG004|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340553|NCT00570687|7248120|FG005|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340554|NCT00570687|7248121|FG006|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340555|NCT00570687|7248122|FG007|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340556|NCT00570687|7248123|FG008|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340557|NCT00570687|7248124|FG009|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340558|NCT00570687|7248115|FG000|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
6340559|NCT00570687|7248116|FG001|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
6340560|NCT00570687|7248117|FG002|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
6340561|NCT00570687|7248118|FG003|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
6340562|NCT00570687|7248119|FG004|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340563|NCT00570687|7248120|FG005|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340564|NCT00570687|7248121|FG006|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340565|NCT00570687|7248122|FG007|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340566|NCT00570687|7248123|FG008|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340567|NCT00570687|7248124|FG009|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340568|NCT00570687|7248115|FG000|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340569|NCT00570687|7248116|FG001|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340570|NCT00570687|7248117|FG002|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340571|NCT00570687|7248118|FG003|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340572|NCT00570687|7248119|FG004|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340573|NCT00570687|7248120|FG005|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340574|NCT00570687|7248121|FG006|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340575|NCT00570687|7248122|FG007|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340576|NCT00570687|7248123|FG008|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340577|NCT00570687|7248124|FG009|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
6340578|NCT00570687|7248115|FG000|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
6340579|NCT00570687|7248116|FG001|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
6340580|NCT00570687|7248117|FG002|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
6340581|NCT00570687|7248118|FG003|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
6340582|NCT00570687|7248119|FG004|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6340583|NCT00570687|7248120|FG005|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6340584|NCT00570687|7248121|FG006|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6340585|NCT00570687|7248122|FG007|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6340586|NCT00570687|7248123|FG008|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6340587|NCT00570687|7248124|FG009|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
6340588|NCT00570687|7248115|FG000|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
6340589|NCT00570687|7248116|FG001|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
6340590|NCT00570687|7248117|FG002|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
6340591|NCT00570687|7248118|FG003|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
6340592|NCT00570687|7248119|FG004|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340593|NCT00570687|7248120|FG005|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340594|NCT00570687|7248121|FG006|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340595|NCT00570687|7248122|FG007|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340596|NCT00570687|7248123|FG008|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340597|NCT00570687|7248124|FG009|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340598|NCT00570687|7248115|FG000|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340599|NCT00570687|7248116|FG001|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340600|NCT00570687|7248117|FG002|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340601|NCT00570687|7248118|FG003|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340602|NCT00570687|7248119|FG004|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340603|NCT00570687|7248120|FG005|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340604|NCT00570687|7248121|FG006|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340605|NCT00570687|7248122|FG007|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340606|NCT00570687|7248123|FG008|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340607|NCT00570687|7248124|FG009|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
6340608|NCT00570687|7248115|FG000|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
6340609|NCT00570687|7248116|FG001|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
6340610|NCT00570687|7248117|FG002|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
6340611|NCT00570687|7248118|FG003|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
6340612|NCT00570687|7248119|FG004|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340613|NCT00570687|7248120|FG005|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340614|NCT00570687|7248121|FG006|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340615|NCT00570687|7248122|FG007|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340616|NCT00570687|7248123|FG008|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340617|NCT00570687|7248124|FG009|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340618|NCT00570687|7248115|FG000|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
6340619|NCT00570687|7248116|FG001|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
6340620|NCT00570687|7248117|FG002|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
6340621|NCT00570687|7248118|FG003|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
6340622|NCT00570687|7248119|FG004|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340623|NCT00570687|7248120|FG005|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340624|NCT00570687|7248121|FG006|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340625|NCT00570687|7248122|FG007|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340626|NCT00570687|7248123|FG008|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340627|NCT00570687|7248124|FG009|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340628|NCT00570687|7248115|FG000|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340629|NCT00570687|7248116|FG001|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340630|NCT00570687|7248117|FG002|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340631|NCT00570687|7248118|FG003|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340632|NCT00570687|7248119|FG004|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340633|NCT00570687|7248120|FG005|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340634|NCT00570687|7248121|FG006|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340635|NCT00570687|7248122|FG007|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340636|NCT00570687|7248123|FG008|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340637|NCT00570687|7248124|FG009|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
6340638|NCT00570687|7248115|FG000|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
6340639|NCT00570687|7248116|FG001|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
6340640|NCT00570687|7248117|FG002|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
6340641|NCT00570687|7248118|FG003|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
6340642|NCT00570687|7248119|FG004|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6340643|NCT00570687|7248120|FG005|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6340644|NCT00570687|7248121|FG006|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6340645|NCT00570687|7248122|FG007|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6340646|NCT00570687|7248123|FG008|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6340647|NCT00570687|7248124|FG009|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
6340648|NCT00570687|7248115|FG000|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
6340649|NCT00570687|7248116|FG001|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
6340650|NCT00570687|7248117|FG002|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
6340651|NCT00570687|7248118|FG003|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
6340652|NCT00570687|7248119|FG004|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340653|NCT00570687|7248120|FG005|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340654|NCT00570687|7248121|FG006|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340655|NCT00570687|7248122|FG007|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340656|NCT00570687|7248123|FG008|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340657|NCT00570687|7248124|FG009|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340658|NCT00570687|7248115|FG000|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340659|NCT00570687|7248116|FG001|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340660|NCT00570687|7248117|FG002|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340661|NCT00570687|7248118|FG003|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340662|NCT00570687|7248119|FG004|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340663|NCT00570687|7248120|FG005|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340664|NCT00570687|7248121|FG006|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340665|NCT00570687|7248122|FG007|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340666|NCT00570687|7248123|FG008|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340667|NCT00570687|7248124|FG009|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
6340668|NCT00570687|7248115|FG000|STARTED|Clamp 1 (1 Day) - Amendment 1||4
6340669|NCT00570687|7248116|FG001|STARTED|Clamp 1 (1 Day) - Amendment 1||2
6340670|NCT00570687|7248117|FG002|STARTED|Clamp 1 (1 Day) - Amendment 1||2
6340671|NCT00570687|7248118|FG003|STARTED|Clamp 1 (1 Day) - Amendment 1||4
6340672|NCT00570687|7248119|FG004|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6340673|NCT00570687|7248120|FG005|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6340674|NCT00570687|7248121|FG006|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6340675|NCT00570687|7248122|FG007|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6340676|NCT00570687|7248123|FG008|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6340677|NCT00570687|7248124|FG009|STARTED|Clamp 1 (1 Day) - Amendment 1||0
6340678|NCT00570687|7248115|FG000|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
6340679|NCT00570687|7248116|FG001|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
6340680|NCT00570687|7248117|FG002|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
6340681|NCT00570687|7248118|FG003|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
6340682|NCT00570687|7248119|FG004|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340683|NCT00570687|7248120|FG005|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340684|NCT00570687|7248121|FG006|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340685|NCT00570687|7248122|FG007|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340686|NCT00570687|7248123|FG008|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340687|NCT00570687|7248124|FG009|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340688|NCT00570687|7248115|FG000|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340689|NCT00570687|7248116|FG001|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340690|NCT00570687|7248117|FG002|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340691|NCT00570687|7248118|FG003|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340692|NCT00570687|7248119|FG004|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340693|NCT00570687|7248120|FG005|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340694|NCT00570687|7248121|FG006|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340695|NCT00570687|7248122|FG007|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340696|NCT00570687|7248123|FG008|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340697|NCT00570687|7248124|FG009|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
6340698|NCT00570687|7248115|FG000|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
6340699|NCT00570687|7248116|FG001|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
6340700|NCT00570687|7248117|FG002|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
6340701|NCT00570687|7248118|FG003|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
6340702|NCT00570687|7248119|FG004|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6340703|NCT00570687|7248120|FG005|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6340704|NCT00570687|7248121|FG006|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6340705|NCT00570687|7248122|FG007|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6340706|NCT00570687|7248123|FG008|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6340707|NCT00570687|7248124|FG009|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
6340708|NCT00570687|7248115|FG000|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
6340709|NCT00570687|7248116|FG001|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
6340710|NCT00570687|7248117|FG002|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
6340711|NCT00570687|7248118|FG003|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
6340712|NCT00570687|7248119|FG004|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340713|NCT00570687|7248120|FG005|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340714|NCT00570687|7248121|FG006|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340715|NCT00570687|7248122|FG007|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340716|NCT00570687|7248123|FG008|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340717|NCT00570687|7248124|FG009|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340718|NCT00570687|7248115|FG000|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340719|NCT00570687|7248116|FG001|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340720|NCT00570687|7248117|FG002|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340721|NCT00570687|7248118|FG003|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340722|NCT00570687|7248119|FG004|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340723|NCT00570687|7248120|FG005|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340724|NCT00570687|7248121|FG006|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340725|NCT00570687|7248122|FG007|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340726|NCT00570687|7248123|FG008|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340727|NCT00570687|7248124|FG009|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
6340728|NCT00570687|7248115|FG000|STARTED|Clamp 2 (1 Day) - Amendment 1||4
6340729|NCT00570687|7248116|FG001|STARTED|Clamp 2 (1 Day) - Amendment 1||2
6340730|NCT00570687|7248117|FG002|STARTED|Clamp 2 (1 Day) - Amendment 1||2
6340731|NCT00570687|7248118|FG003|STARTED|Clamp 2 (1 Day) - Amendment 1||4
6340732|NCT00570687|7248119|FG004|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6340733|NCT00570687|7248120|FG005|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6340734|NCT00570687|7248121|FG006|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6340735|NCT00570687|7248122|FG007|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6340736|NCT00570687|7248123|FG008|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6340737|NCT00570687|7248124|FG009|STARTED|Clamp 2 (1 Day) - Amendment 1||0
6340738|NCT00570687|7248115|FG000|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
6340739|NCT00570687|7248116|FG001|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
6340740|NCT00570687|7248117|FG002|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
6340741|NCT00570687|7248118|FG003|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
6340742|NCT00570687|7248119|FG004|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340743|NCT00570687|7248120|FG005|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340744|NCT00570687|7248121|FG006|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340745|NCT00570687|7248122|FG007|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340746|NCT00570687|7248123|FG008|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340747|NCT00570687|7248124|FG009|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340748|NCT00570687|7248115|FG000|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340749|NCT00570687|7248116|FG001|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340750|NCT00570687|7248117|FG002|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340751|NCT00570687|7248118|FG003|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340752|NCT00570687|7248119|FG004|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340753|NCT00570687|7248120|FG005|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340754|NCT00570687|7248121|FG006|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340755|NCT00570687|7248122|FG007|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340756|NCT00570687|7248123|FG008|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340757|NCT00570687|7248124|FG009|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
6340758|NCT00570700|7248138|FG000|STARTED|Overall Study||38
6340759|NCT00570700|7248138|FG000|COMPLETED|Overall Study||27
6340760|NCT00570700|7248138|FG000|NOT COMPLETED|Overall Study||11
6340761|NCT00570713|7248144|FG000|STARTED|Overall Study||78
6340762|NCT00570713|7248145|FG001|STARTED|Overall Study||77
6340763|NCT00570713|7248144|FG000|COMPLETED|Overall Study||0
6340764|NCT00570713|7248145|FG001|COMPLETED|Overall Study||0
6340765|NCT00570713|7248144|FG000|NOT COMPLETED|Overall Study||78
6340766|NCT00570713|7248145|FG001|NOT COMPLETED|Overall Study||77
6340767|NCT00570739|7248155|FG000|STARTED|Overall Study||141
6340768|NCT00570739|7248156|FG001|STARTED|Overall Study||145
6340769|NCT00570739|7248157|FG002|STARTED|Overall Study||108
6340770|NCT00570739|7248158|FG003|STARTED|Overall Study||108
6340771|NCT00570739|7248155|FG000|COMPLETED|Overall Study||120
6340772|NCT00570739|7248156|FG001|COMPLETED|Overall Study||124
6340773|NCT00570739|7248157|FG002|COMPLETED|Overall Study||92
6340774|NCT00570739|7248158|FG003|COMPLETED|Overall Study||96
6340775|NCT00570739|7248155|FG000|NOT COMPLETED|Overall Study||21
6340776|NCT00570739|7248156|FG001|NOT COMPLETED|Overall Study||21
6340777|NCT00570739|7248157|FG002|NOT COMPLETED|Overall Study||16
6340778|NCT00570739|7248158|FG003|NOT COMPLETED|Overall Study||12
6340779|NCT00570765|7248191|FG000|STARTED|DB Phase||20
6340780|NCT00570765|7248192|FG001|STARTED|DB Phase||16
6340781|NCT00570765|7248193|FG002|STARTED|DB Phase||24
6340782|NCT00570765|7248194|FG003|STARTED|DB Phase||0
6340783|NCT00570765|7248191|FG000|Received at Least 1 Dose of Study Drug|DB Phase||20
6340784|NCT00570765|7248192|FG001|Received at Least 1 Dose of Study Drug|DB Phase||16
6340785|NCT00570765|7248193|FG002|Received at Least 1 Dose of Study Drug|DB Phase||23
6340786|NCT00570765|7248194|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
6340787|NCT00570765|7248191|FG000|Safety Population|DB Phase||20
6340788|NCT00570765|7248192|FG001|Safety Population|DB Phase||16
6340789|NCT00570765|7248193|FG002|Safety Population|DB Phase||23
6340790|NCT00570765|7248194|FG003|Safety Population|DB Phase||0
6340791|NCT00570765|7248191|FG000|COMPLETED|DB Phase||16
6340792|NCT00570765|7248192|FG001|COMPLETED|DB Phase||9
6340793|NCT00570765|7248193|FG002|COMPLETED|DB Phase||23
6340794|NCT00570765|7248194|FG003|COMPLETED|DB Phase||0
6340795|NCT00570765|7248191|FG000|NOT COMPLETED|DB Phase||4
6340796|NCT00570765|7248192|FG001|NOT COMPLETED|DB Phase||7
6340797|NCT00570765|7248193|FG002|NOT COMPLETED|DB Phase||1
6340798|NCT00570765|7248194|FG003|NOT COMPLETED|DB Phase||0
6340799|NCT00570765|7248191|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
6340800|NCT00570765|7248192|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
6340801|NCT00570765|7248193|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|0
6340802|NCT00570765|7248194|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase enrolled in the LTSE phase.|28
6340803|NCT00570765|7248191|FG000|Received at Least 1 Dose of Study Drug|LTSE Phase||0
6340804|NCT00570765|7248192|FG001|Received at Least 1 Dose of Study Drug|LTSE Phase||0
6340805|NCT00570765|7248193|FG002|Received at Least 1 Dose of Study Drug|LTSE Phase||0
6340806|NCT00570765|7248194|FG003|Received at Least 1 Dose of Study Drug|LTSE Phase||28
6340807|NCT00570765|7248191|FG000|Safety Population|LTSE Phase||0
6340808|NCT00570765|7248192|FG001|Safety Population|LTSE Phase||0
6340809|NCT00570765|7248193|FG002|Safety Population|LTSE Phase||0
6340810|NCT00570765|7248194|FG003|Safety Population|LTSE Phase||28
6340811|NCT00570765|7248191|FG000|COMPLETED|LTSE Phase||0
6340812|NCT00570765|7248192|FG001|COMPLETED|LTSE Phase||0
6340813|NCT00570765|7248193|FG002|COMPLETED|LTSE Phase||0
6340814|NCT00570765|7248194|FG003|COMPLETED|LTSE Phase||16
6340815|NCT00570765|7248191|FG000|NOT COMPLETED|LTSE Phase||0
6340816|NCT00570765|7248192|FG001|NOT COMPLETED|LTSE Phase||0
6340817|NCT00570765|7248193|FG002|NOT COMPLETED|LTSE Phase||0
6340818|NCT00570765|7248194|FG003|NOT COMPLETED|LTSE Phase||12
6340819|NCT00570778|7248205|FG000|STARTED|Overall Study||41
6340820|NCT00570778|7248206|FG001|STARTED|Overall Study||38
6340821|NCT00570778|7248207|FG002|STARTED|Overall Study||37
6340822|NCT00570778|7248208|FG003|STARTED|Overall Study||38
6340823|NCT00570778|7248205|FG000|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
6340824|NCT00570778|7248206|FG001|Safety Population: Received Study Drug|Overall Study||38
6340825|NCT00570778|7248207|FG002|Safety Population: Received Study Drug|Overall Study||36
6340826|NCT00570778|7248208|FG003|Safety Population: Received Study Drug|Overall Study||38
6340827|NCT00570778|7248205|FG000|Modified Intent-to-treat Population|Overall Study||40
6340828|NCT00570778|7248206|FG001|Modified Intent-to-treat Population|Overall Study||37
6340829|NCT00570778|7248207|FG002|Modified Intent-to-treat Population|Overall Study||35
6340830|NCT00570778|7248208|FG003|Modified Intent-to-treat Population|Overall Study||37
6340831|NCT00570778|7248205|FG000|COMPLETED|Overall Study||37
6340832|NCT00570778|7248206|FG001|COMPLETED|Overall Study||34
6340833|NCT00570778|7248207|FG002|COMPLETED|Overall Study||30
6340834|NCT00570778|7248208|FG003|COMPLETED|Overall Study||34
6340835|NCT00570778|7248205|FG000|NOT COMPLETED|Overall Study||4
6340836|NCT00570778|7248206|FG001|NOT COMPLETED|Overall Study||4
6340837|NCT00570778|7248207|FG002|NOT COMPLETED|Overall Study||7
6340838|NCT00570778|7248208|FG003|NOT COMPLETED|Overall Study||4
6340839|NCT00570908|7248218|FG000|STARTED|Overall Study||12
6340840|NCT00570908|7248218|FG000|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
6340841|NCT00570908|7248218|FG000|NOT COMPLETED|Overall Study||7
6340842|NCT00570921|7248222|FG000|STARTED|Overall Study||33
6340843|NCT00570921|7248222|FG000|COMPLETED|Overall Study||31
6340844|NCT00570921|7248222|FG000|NOT COMPLETED|Overall Study||2
6340845|NCT00570960|7248228|FG000|STARTED|Overall Study||4
6340846|NCT00570960|7248229|FG001|STARTED|Overall Study||4
6340847|NCT00570960|7248228|FG000|COMPLETED|Overall Study||4
6340848|NCT00570960|7248229|FG001|COMPLETED|Overall Study||4
6340849|NCT00570960|7248228|FG000|NOT COMPLETED|Overall Study||0
6340850|NCT00570960|7248229|FG001|NOT COMPLETED|Overall Study||0
6340851|NCT00571038|7248237|FG000|STARTED|Overall Study||219
6340852|NCT00571038|7248238|FG001|STARTED|Overall Study||185
6340853|NCT00571038|7248237|FG000|6 Month Follow up|Overall Study||208
6340854|NCT00571038|7248238|FG001|6 Month Follow up|Overall Study||176
6340855|NCT00571038|7248237|FG000|18 Month Survey Only|Overall Study||199
6340856|NCT00571038|7248238|FG001|18 Month Survey Only|Overall Study||163
6340857|NCT00571038|7248237|FG000|COMPLETED|Overall Study|"7 died 2 moved~1 asked to be withdrawn~1 unable to reach"|208
6340858|NCT00571038|7248238|FG001|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
6340859|NCT00571038|7248237|FG000|NOT COMPLETED|Overall Study||11
6340860|NCT00571038|7248238|FG001|NOT COMPLETED|Overall Study||14
6340861|NCT00571064|7248244|FG000|STARTED|Overall Study||97
6340862|NCT00571064|7248244|FG000|COMPLETED|Overall Study||76
6340863|NCT00571064|7248244|FG000|NOT COMPLETED|Overall Study||21
6340864|NCT00571103|7248249|FG000|STARTED|Overall Study||28
6340865|NCT00571103|7248249|FG000|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
6340866|NCT00571103|7248249|FG000|NOT COMPLETED|Overall Study||2
6340867|NCT00571259|7248255|FG000|STARTED|Overall Study||148
6340868|NCT00571259|7248256|FG001|STARTED|Overall Study||155
6340869|NCT00571259|7248255|FG000|COMPLETED|Overall Study||4
6340870|NCT00571259|7248256|FG001|COMPLETED|Overall Study||14
6340871|NCT00571259|7248255|FG000|NOT COMPLETED|Overall Study||144
6340872|NCT00571259|7248256|FG001|NOT COMPLETED|Overall Study||141
6340873|NCT00571324|7248264|FG000|STARTED|Intervention 1 (7 Hours)||5
6340874|NCT00571324|7248265|FG001|STARTED|Intervention 1 (7 Hours)||4
6340875|NCT00571324|7248264|FG000|COMPLETED|Intervention 1 (7 Hours)||5
6340876|NCT00571324|7248265|FG001|COMPLETED|Intervention 1 (7 Hours)||4
6340877|NCT00571324|7248264|FG000|NOT COMPLETED|Intervention 1 (7 Hours)||0
6340878|NCT00571324|7248265|FG001|NOT COMPLETED|Intervention 1 (7 Hours)||0
6340879|NCT00571324|7248264|FG000|STARTED|Intervention 2 (7 Hours)||5
6340880|NCT00571324|7248265|FG001|STARTED|Intervention 2 (7 Hours)||4
6340881|NCT00571324|7248264|FG000|COMPLETED|Intervention 2 (7 Hours)||5
6340882|NCT00571324|7248265|FG001|COMPLETED|Intervention 2 (7 Hours)||4
6340883|NCT00571324|7248264|FG000|NOT COMPLETED|Intervention 2 (7 Hours)||0
6340884|NCT00571324|7248265|FG001|NOT COMPLETED|Intervention 2 (7 Hours)||0
6340885|NCT00571428|7248273|FG000|STARTED|Overall Study||15
6340886|NCT00571428|7248274|FG001|STARTED|Overall Study||18
6340887|NCT00571428|7248273|FG000|COMPLETED|Overall Study||15
6340888|NCT00571428|7248274|FG001|COMPLETED|Overall Study||18
6340889|NCT00571428|7248273|FG000|NOT COMPLETED|Overall Study||0
6340890|NCT00571428|7248274|FG001|NOT COMPLETED|Overall Study||0
6340891|NCT00571493|7248280|FG000|STARTED|Overall Study||3
6340892|NCT00571493|7248281|FG001|STARTED|Overall Study||4
6340893|NCT00571493|7248282|FG002|STARTED|Overall Study||3
6340894|NCT00571493|7248283|FG003|STARTED|Overall Study||3
6340895|NCT00571493|7248284|FG004|STARTED|Overall Study||11
6340896|NCT00571493|7248285|FG005|STARTED|Overall Study||12
6340897|NCT00571493|7248286|FG006|STARTED|Overall Study||6
6340898|NCT00571493|7248280|FG000|COMPLETED|Overall Study||3
6340899|NCT00571493|7248281|FG001|COMPLETED|Overall Study||4
6340900|NCT00571493|7248282|FG002|COMPLETED|Overall Study||3
6340901|NCT00571493|7248283|FG003|COMPLETED|Overall Study||3
6340902|NCT00571493|7248284|FG004|COMPLETED|Overall Study||11
6340903|NCT00571493|7248285|FG005|COMPLETED|Overall Study||12
6340904|NCT00571493|7248286|FG006|COMPLETED|Overall Study||6
6340905|NCT00571493|7248280|FG000|NOT COMPLETED|Overall Study||0
6340906|NCT00571493|7248281|FG001|NOT COMPLETED|Overall Study||0
6340907|NCT00571493|7248282|FG002|NOT COMPLETED|Overall Study||0
6340908|NCT00571493|7248283|FG003|NOT COMPLETED|Overall Study||0
6340909|NCT00571493|7248284|FG004|NOT COMPLETED|Overall Study||0
6340910|NCT00571493|7248285|FG005|NOT COMPLETED|Overall Study||0
6340911|NCT00571493|7248286|FG006|NOT COMPLETED|Overall Study||0
6340912|NCT00571519|7248301|FG000|STARTED|Overall Study||3
6340913|NCT00571519|7248302|FG001|STARTED|Overall Study||9
6340914|NCT00571519|7248303|FG002|STARTED|Overall Study||12
6340915|NCT00571519|7248304|FG003|STARTED|Overall Study||27
6340916|NCT00571519|7248305|FG004|STARTED|Overall Study||9
6340917|NCT00571519|7248306|FG005|STARTED|Overall Study||10
6340918|NCT00571519|7248307|FG006|STARTED|Overall Study||24
6340919|NCT00571519|7248301|FG000|COMPLETED|Overall Study||0
6340920|NCT00571519|7248302|FG001|COMPLETED|Overall Study||0
6340921|NCT00571519|7248303|FG002|COMPLETED|Overall Study||0
6340922|NCT00571519|7248304|FG003|COMPLETED|Overall Study||0
6340923|NCT00571519|7248305|FG004|COMPLETED|Overall Study||0
6340924|NCT00571519|7248306|FG005|COMPLETED|Overall Study||0
6340925|NCT00571519|7248307|FG006|COMPLETED|Overall Study||0
6340926|NCT00571519|7248301|FG000|NOT COMPLETED|Overall Study||3
6340927|NCT00571519|7248302|FG001|NOT COMPLETED|Overall Study||9
6340928|NCT00571519|7248303|FG002|NOT COMPLETED|Overall Study||12
6340929|NCT00571519|7248304|FG003|NOT COMPLETED|Overall Study||27
6340930|NCT00571519|7248305|FG004|NOT COMPLETED|Overall Study||9
6340931|NCT00571519|7248306|FG005|NOT COMPLETED|Overall Study||10
6340932|NCT00571519|7248307|FG006|NOT COMPLETED|Overall Study||24
6340933|NCT00571649|7248325|FG000|STARTED|Treatment Period||4050
6340934|NCT00571649|7248326|FG001|STARTED|Treatment Period||4051
6340935|NCT00571649|7248325|FG000|Participants Received Treatment|Treatment Period||3997
6340936|NCT00571649|7248326|FG001|Participants Received Treatment|Treatment Period||4001
6340937|NCT00571649|7248325|FG000|Day 10|Treatment Period||3454
6340938|NCT00571649|7248326|FG001|Day 10|Treatment Period||3499
6340939|NCT00571649|7248325|FG000|Day 35|Treatment Period||3033
6340940|NCT00571649|7248326|FG001|Day 35|Treatment Period||3115
6340941|NCT00571649|7248325|FG000|COMPLETED|Treatment Period||2958
6340942|NCT00571649|7248326|FG001|COMPLETED|Treatment Period||3047
6340943|NCT00571649|7248325|FG000|NOT COMPLETED|Treatment Period||1092
6340944|NCT00571649|7248326|FG001|NOT COMPLETED|Treatment Period||1004
6498450|NCT01409993|7417033|FG002|STARTED|Overall Study||14
6498451|NCT01409993|7417034|FG003|STARTED|Overall Study||13
6498452|NCT01409993|7417031|FG000|COMPLETED|Overall Study||21
6498453|NCT01409993|7417032|FG001|COMPLETED|Overall Study||21
6498454|NCT01409993|7417033|FG002|COMPLETED|Overall Study||11
6498455|NCT01409993|7417034|FG003|COMPLETED|Overall Study||8
6498456|NCT01409993|7417031|FG000|NOT COMPLETED|Overall Study||4
6498457|NCT01409993|7417032|FG001|NOT COMPLETED|Overall Study||5
6498458|NCT01409993|7417033|FG002|NOT COMPLETED|Overall Study||3
6498459|NCT01409993|7417034|FG003|NOT COMPLETED|Overall Study||5
6498460|NCT01410058|7417050|FG000|STARTED|Washout Day 0||13
6498461|NCT01410058|7417051|FG001|STARTED|Washout Day 0||6
6340945|NCT00571649|7248325|FG000|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
6340946|NCT00571649|7248326|FG001|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
6340947|NCT00571649|7248325|FG000|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
6340948|NCT00571649|7248326|FG001|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
6340949|NCT00571649|7248325|FG000|NOT COMPLETED|Follow-up Period||545
6340950|NCT00571649|7248326|FG001|NOT COMPLETED|Follow-up Period||528
6340951|NCT00571662|7248332|FG000|STARTED|Overall Study||76
6340952|NCT00571662|7248332|FG000|COMPLETED|Overall Study||68
6340953|NCT00571662|7248332|FG000|NOT COMPLETED|Overall Study||8
6340954|NCT00571688|7248340|FG000|STARTED|Overall Study||25
6340955|NCT00571688|7248341|FG001|STARTED|Overall Study||25
6340956|NCT00571688|7248340|FG000|COMPLETED|Overall Study||20
6340957|NCT00571688|7248341|FG001|COMPLETED|Overall Study||19
6340958|NCT00571688|7248340|FG000|NOT COMPLETED|Overall Study||5
6340959|NCT00571688|7248341|FG001|NOT COMPLETED|Overall Study||6
6340960|NCT00571701|7248349|FG000|STARTED|First Intervention 12 Months||19
6340961|NCT00571701|7248350|FG001|STARTED|First Intervention 12 Months||22
6340962|NCT00571701|7248349|FG000|COMPLETED|First Intervention 12 Months||16
6340963|NCT00571701|7248350|FG001|COMPLETED|First Intervention 12 Months||21
6340964|NCT00571701|7248349|FG000|NOT COMPLETED|First Intervention 12 Months||3
6340965|NCT00571701|7248350|FG001|NOT COMPLETED|First Intervention 12 Months||1
6340966|NCT00571701|7248349|FG000|STARTED|Second Intervention 12 Months||16
6340967|NCT00571701|7248350|FG001|STARTED|Second Intervention 12 Months||21
6340968|NCT00571701|7248349|FG000|COMPLETED|Second Intervention 12 Months||13
6340969|NCT00571701|7248350|FG001|COMPLETED|Second Intervention 12 Months||20
6340970|NCT00571701|7248349|FG000|NOT COMPLETED|Second Intervention 12 Months||3
6340971|NCT00571701|7248350|FG001|NOT COMPLETED|Second Intervention 12 Months||1
6340972|NCT00571948|7248376|FG000|STARTED|Overall Study||66
6340973|NCT00571948|7248377|FG001|STARTED|Overall Study||66
6340974|NCT00571948|7248376|FG000|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
6340975|NCT00571948|7248377|FG001|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
6340976|NCT00571948|7248376|FG000|NOT COMPLETED|Overall Study||11
6340977|NCT00571948|7248377|FG001|NOT COMPLETED|Overall Study||14
6340978|NCT00571961|7248383|FG000|STARTED|Overall Study||12
6340979|NCT00571961|7248383|FG000|COMPLETED|Overall Study||12
6340980|NCT00571961|7248383|FG000|NOT COMPLETED|Overall Study||0
6340981|NCT00571974|7248389|FG000|STARTED|Phase I||9
6340982|NCT00571974|7248390|FG001|STARTED|Phase I||0
6340983|NCT00571974|7248389|FG000|COMPLETED|Phase I||9
6340984|NCT00571974|7248390|FG001|COMPLETED|Phase I||0
6340985|NCT00571974|7248389|FG000|NOT COMPLETED|Phase I||0
6340986|NCT00571974|7248390|FG001|NOT COMPLETED|Phase I||0
6340987|NCT00571974|7248389|FG000|STARTED|Phase II||0
6340988|NCT00571974|7248390|FG001|STARTED|Phase II|3 participants are from phase I|21
6340989|NCT00571974|7248389|FG000|COMPLETED|Phase II||0
6340990|NCT00571974|7248390|FG001|COMPLETED|Phase II||17
6340991|NCT00571974|7248389|FG000|NOT COMPLETED|Phase II||0
6340992|NCT00571974|7248390|FG001|NOT COMPLETED|Phase II||4
6340993|NCT00571987|7248396|FG000|STARTED|Overall Study||107
6340994|NCT00571987|7248396|FG000|COMPLETED|Overall Study||100
6340995|NCT00571987|7248396|FG000|NOT COMPLETED|Overall Study||7
6340996|NCT00572039|7248403|FG000|STARTED|Overall Study||121
6340997|NCT00572039|7248404|FG001|STARTED|Overall Study||120
6340998|NCT00572039|7248403|FG000|COMPLETED|Overall Study||105
6340999|NCT00572039|7248404|FG001|COMPLETED|Overall Study||110
6341000|NCT00572039|7248403|FG000|NOT COMPLETED|Overall Study||16
6341001|NCT00572039|7248404|FG001|NOT COMPLETED|Overall Study||10
6341002|NCT00572117|7248414|FG000|STARTED|Overall Study||5
6341003|NCT00572117|7248415|FG001|STARTED|Overall Study||7
6341004|NCT00572117|7248414|FG000|COMPLETED|Overall Study||3
6341005|NCT00572117|7248415|FG001|COMPLETED|Overall Study||5
6341006|NCT00572117|7248414|FG000|NOT COMPLETED|Overall Study||2
6341007|NCT00572117|7248415|FG001|NOT COMPLETED|Overall Study||2
6341008|NCT00572156|7248427|FG000|STARTED|Overall Study||26
6341009|NCT00572156|7248428|FG001|STARTED|Overall Study||27
6341010|NCT00572156|7248429|FG002|STARTED|Overall Study||27
6341011|NCT00572156|7248430|FG003|STARTED|Overall Study||26
6341012|NCT00572156|7248427|FG000|COMPLETED|Overall Study||0
6341013|NCT00572156|7248428|FG001|COMPLETED|Overall Study||1
6341014|NCT00572156|7248429|FG002|COMPLETED|Overall Study||0
6341015|NCT00572156|7248430|FG003|COMPLETED|Overall Study||1
6341016|NCT00572156|7248427|FG000|NOT COMPLETED|Overall Study||26
6341017|NCT00572156|7248428|FG001|NOT COMPLETED|Overall Study||26
6341018|NCT00572156|7248429|FG002|NOT COMPLETED|Overall Study||27
6341019|NCT00572156|7248430|FG003|NOT COMPLETED|Overall Study||25
6341020|NCT00572195|7248440|FG000|STARTED|Overall Study||230
6341021|NCT00572195|7248440|FG000|COMPLETED|Overall Study||162
6341022|NCT00572195|7248440|FG000|NOT COMPLETED|Overall Study||68
6341023|NCT00572234|7248446|FG000|STARTED|Overall Study||19
6341024|NCT00572234|7248447|FG001|STARTED|Overall Study||21
6341025|NCT00572234|7248446|FG000|COMPLETED|Overall Study||18
6341026|NCT00572234|7248447|FG001|COMPLETED|Overall Study||16
6341027|NCT00572234|7248446|FG000|NOT COMPLETED|Overall Study||1
6341028|NCT00572234|7248447|FG001|NOT COMPLETED|Overall Study||5
6341029|NCT00572455|7248467|FG000|STARTED|Stage I (14 Days)||9
6341030|NCT00572455|7248468|FG001|STARTED|Stage I (14 Days)||9
6341031|NCT00572455|7248469|FG002|STARTED|Stage I (14 Days)||9
6341032|NCT00572455|7248470|FG003|STARTED|Stage I (14 Days)||10
6341033|NCT00572455|7248471|FG004|STARTED|Stage I (14 Days)||9
6341034|NCT00572455|7248472|FG005|STARTED|Stage I (14 Days)||9
6341035|NCT00572455|7248473|FG006|STARTED|Stage I (14 Days)||12
6341036|NCT00572455|7248474|FG007|STARTED|Stage I (14 Days)||0
6341037|NCT00572455|7248475|FG008|STARTED|Stage I (14 Days)||0
6341038|NCT00572455|7248476|FG009|STARTED|Stage I (14 Days)||0
6341039|NCT00572455|7248477|FG010|STARTED|Stage I (14 Days)||0
6341040|NCT00572455|7248478|FG011|STARTED|Stage I (14 Days)||0
6341041|NCT00572455|7248479|FG012|STARTED|Stage I (14 Days)||0
6341042|NCT00572455|7248480|FG013|STARTED|Stage I (14 Days)||0
6341043|NCT00572455|7248467|FG000|COMPLETED|Stage I (14 Days)||9
6341044|NCT00572455|7248468|FG001|COMPLETED|Stage I (14 Days)||9
6341045|NCT00572455|7248469|FG002|COMPLETED|Stage I (14 Days)||9
6341046|NCT00572455|7248470|FG003|COMPLETED|Stage I (14 Days)||10
6341047|NCT00572455|7248471|FG004|COMPLETED|Stage I (14 Days)||8
6341048|NCT00572455|7248472|FG005|COMPLETED|Stage I (14 Days)||6
6341049|NCT00572455|7248473|FG006|COMPLETED|Stage I (14 Days)||12
6341050|NCT00572455|7248474|FG007|COMPLETED|Stage I (14 Days)||0
6341051|NCT00572455|7248475|FG008|COMPLETED|Stage I (14 Days)||0
6341052|NCT00572455|7248476|FG009|COMPLETED|Stage I (14 Days)||0
6341053|NCT00572455|7248477|FG010|COMPLETED|Stage I (14 Days)||0
6341054|NCT00572455|7248478|FG011|COMPLETED|Stage I (14 Days)||0
6341055|NCT00572455|7248479|FG012|COMPLETED|Stage I (14 Days)||0
6341056|NCT00572455|7248480|FG013|COMPLETED|Stage I (14 Days)||0
6341057|NCT00572455|7248467|FG000|NOT COMPLETED|Stage I (14 Days)||0
6341058|NCT00572455|7248468|FG001|NOT COMPLETED|Stage I (14 Days)||0
6341059|NCT00572455|7248469|FG002|NOT COMPLETED|Stage I (14 Days)||0
6341060|NCT00572455|7248470|FG003|NOT COMPLETED|Stage I (14 Days)||0
6341061|NCT00572455|7248471|FG004|NOT COMPLETED|Stage I (14 Days)||1
6341062|NCT00572455|7248472|FG005|NOT COMPLETED|Stage I (14 Days)||3
6341063|NCT00572455|7248473|FG006|NOT COMPLETED|Stage I (14 Days)||0
6341064|NCT00572455|7248474|FG007|NOT COMPLETED|Stage I (14 Days)||0
6341065|NCT00572455|7248475|FG008|NOT COMPLETED|Stage I (14 Days)||0
6341066|NCT00572455|7248476|FG009|NOT COMPLETED|Stage I (14 Days)||0
6341067|NCT00572455|7248477|FG010|NOT COMPLETED|Stage I (14 Days)||0
6341068|NCT00572455|7248478|FG011|NOT COMPLETED|Stage I (14 Days)||0
6341069|NCT00572455|7248479|FG012|NOT COMPLETED|Stage I (14 Days)||0
6341070|NCT00572455|7248480|FG013|NOT COMPLETED|Stage I (14 Days)||0
6341071|NCT00572455|7248467|FG000|STARTED|Stage II (28 Days)||0
6341072|NCT00572455|7248468|FG001|STARTED|Stage II (28 Days)||0
6341073|NCT00572455|7248469|FG002|STARTED|Stage II (28 Days)||0
6341074|NCT00572455|7248470|FG003|STARTED|Stage II (28 Days)||0
6341075|NCT00572455|7248471|FG004|STARTED|Stage II (28 Days)||0
6341076|NCT00572455|7248472|FG005|STARTED|Stage II (28 Days)||0
6341077|NCT00572455|7248473|FG006|STARTED|Stage II (28 Days)||0
6341078|NCT00572455|7248474|FG007|STARTED|Stage II (28 Days)||35
6341079|NCT00572455|7248475|FG008|STARTED|Stage II (28 Days)||36
6341080|NCT00572455|7248476|FG009|STARTED|Stage II (28 Days)||36
6341081|NCT00572455|7248477|FG010|STARTED|Stage II (28 Days)||36
6341082|NCT00572455|7248478|FG011|STARTED|Stage II (28 Days)||36
6341083|NCT00572455|7248479|FG012|STARTED|Stage II (28 Days)||36
6341084|NCT00572455|7248480|FG013|STARTED|Stage II (28 Days)||36
6341085|NCT00572455|7248467|FG000|Treated|Stage II (28 Days)||0
6341086|NCT00572455|7248468|FG001|Treated|Stage II (28 Days)||0
6341087|NCT00572455|7248469|FG002|Treated|Stage II (28 Days)||0
6341088|NCT00572455|7248470|FG003|Treated|Stage II (28 Days)||0
6341089|NCT00572455|7248471|FG004|Treated|Stage II (28 Days)||0
6341090|NCT00572455|7248472|FG005|Treated|Stage II (28 Days)||0
6341091|NCT00572455|7248473|FG006|Treated|Stage II (28 Days)||0
6341092|NCT00572455|7248474|FG007|Treated|Stage II (28 Days)||35
6341093|NCT00572455|7248475|FG008|Treated|Stage II (28 Days)||36
6341094|NCT00572455|7248476|FG009|Treated|Stage II (28 Days)||36
6341095|NCT00572455|7248477|FG010|Treated|Stage II (28 Days)||36
6341096|NCT00572455|7248478|FG011|Treated|Stage II (28 Days)||36
6341097|NCT00572455|7248479|FG012|Treated|Stage II (28 Days)||36
6341098|NCT00572455|7248480|FG013|Treated|Stage II (28 Days)||35
6341099|NCT00572455|7248467|FG000|COMPLETED|Stage II (28 Days)||0
6341100|NCT00572455|7248468|FG001|COMPLETED|Stage II (28 Days)||0
6341101|NCT00572455|7248469|FG002|COMPLETED|Stage II (28 Days)||0
6341102|NCT00572455|7248470|FG003|COMPLETED|Stage II (28 Days)||0
6341103|NCT00572455|7248471|FG004|COMPLETED|Stage II (28 Days)||0
6341104|NCT00572455|7248472|FG005|COMPLETED|Stage II (28 Days)||0
6341105|NCT00572455|7248473|FG006|COMPLETED|Stage II (28 Days)||0
6341106|NCT00572455|7248474|FG007|COMPLETED|Stage II (28 Days)||34
6341107|NCT00572455|7248475|FG008|COMPLETED|Stage II (28 Days)||33
6341108|NCT00572455|7248476|FG009|COMPLETED|Stage II (28 Days)||33
6341109|NCT00572455|7248477|FG010|COMPLETED|Stage II (28 Days)||31
6341110|NCT00572455|7248478|FG011|COMPLETED|Stage II (28 Days)||32
6341111|NCT00572455|7248479|FG012|COMPLETED|Stage II (28 Days)||31
6341112|NCT00572455|7248480|FG013|COMPLETED|Stage II (28 Days)||34
6341113|NCT00572455|7248467|FG000|NOT COMPLETED|Stage II (28 Days)||0
6341114|NCT00572455|7248468|FG001|NOT COMPLETED|Stage II (28 Days)||0
6341115|NCT00572455|7248469|FG002|NOT COMPLETED|Stage II (28 Days)||0
6341116|NCT00572455|7248470|FG003|NOT COMPLETED|Stage II (28 Days)||0
6341117|NCT00572455|7248471|FG004|NOT COMPLETED|Stage II (28 Days)||0
6341118|NCT00572455|7248472|FG005|NOT COMPLETED|Stage II (28 Days)||0
6341119|NCT00572455|7248473|FG006|NOT COMPLETED|Stage II (28 Days)||0
6341120|NCT00572455|7248474|FG007|NOT COMPLETED|Stage II (28 Days)||1
6341121|NCT00572455|7248475|FG008|NOT COMPLETED|Stage II (28 Days)||3
6341122|NCT00572455|7248476|FG009|NOT COMPLETED|Stage II (28 Days)||3
6341123|NCT00572455|7248477|FG010|NOT COMPLETED|Stage II (28 Days)||5
6341124|NCT00572455|7248478|FG011|NOT COMPLETED|Stage II (28 Days)||4
6341125|NCT00572455|7248479|FG012|NOT COMPLETED|Stage II (28 Days)||5
6341126|NCT00572455|7248480|FG013|NOT COMPLETED|Stage II (28 Days)||2
6341127|NCT00572468|7248512|FG000|STARTED|Overall Study||22
6341128|NCT00572468|7248513|FG001|STARTED|Overall Study||20
6341129|NCT00572468|7248512|FG000|COMPLETED|Overall Study||20
6341130|NCT00572468|7248513|FG001|COMPLETED|Overall Study||16
6341131|NCT00572468|7248512|FG000|NOT COMPLETED|Overall Study||2
6341132|NCT00572468|7248513|FG001|NOT COMPLETED|Overall Study||4
6341133|NCT00572533|7248521|FG000|STARTED|Overall Study||31
6341134|NCT00572533|7248522|FG001|STARTED|Overall Study||31
6341135|NCT00572533|7248521|FG000|COMPLETED|Overall Study||24
6341136|NCT00572533|7248522|FG001|COMPLETED|Overall Study||28
6341137|NCT00572533|7248521|FG000|NOT COMPLETED|Overall Study||7
6341138|NCT00572533|7248522|FG001|NOT COMPLETED|Overall Study||3
6341139|NCT00572572|7248530|FG000|STARTED|Overall Study||35
6341140|NCT00572572|7248531|FG001|STARTED|Overall Study||34
6341141|NCT00572572|7248530|FG000|COMPLETED|Overall Study||32
6341142|NCT00572572|7248531|FG001|COMPLETED|Overall Study||28
6341143|NCT00572572|7248530|FG000|NOT COMPLETED|Overall Study||3
6341144|NCT00572572|7248531|FG001|NOT COMPLETED|Overall Study||6
6341145|NCT00572624|7248539|FG000|STARTED|Overall Study||37
6341146|NCT00572624|7248540|FG001|STARTED|Overall Study||14
6341147|NCT00572624|7248539|FG000|COMPLETED|Overall Study||20
6341148|NCT00572624|7248540|FG001|COMPLETED|Overall Study||10
6341149|NCT00572624|7248539|FG000|NOT COMPLETED|Overall Study||17
6341150|NCT00572624|7248540|FG001|NOT COMPLETED|Overall Study||4
6341151|NCT00572728|7248546|FG000|STARTED|Overall Study|Registered|90
6341152|NCT00572728|7248546|FG000|Eligible|Overall Study||87
6341153|NCT00572728|7248546|FG000|Enrolled Under Amendment 5 or Later|Overall Study||82
6341154|NCT00572728|7248546|FG000|Did Not Withdraw|Overall Study||72
6341155|NCT00572728|7248546|FG000|On Study|Overall Study||71
6341156|NCT00572728|7248546|FG000|Completed FLT1 Scan|Overall Study||67
6341157|NCT00572728|7248546|FG000|First Therapy Initiated|Overall Study||65
6341158|NCT00572728|7248546|FG000|Completed FLT2 Scan|Overall Study||60
6341159|NCT00572728|7248546|FG000|Second Chemotherapy Initiated|Overall Study||59
6341160|NCT00572728|7248546|FG000|Second Chemotherapy Initiated After FLT2|Overall Study||52
6341161|NCT00572728|7248546|FG000|Pathology Complete|Overall Study||51
6341162|NCT00572728|7248546|FG000|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
6341163|NCT00572728|7248546|FG000|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
6341164|NCT00572728|7248546|FG000|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
6341165|NCT00572728|7248546|FG000|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
6341166|NCT00572728|7248546|FG000|NOT COMPLETED|Overall Study||39
6341167|NCT00572832|7248554|FG000|STARTED|Overall Study||100
6341168|NCT00572832|7248555|FG001|STARTED|Overall Study||100
6341169|NCT00572832|7248554|FG000|COMPLETED|Overall Study||100
6341170|NCT00572832|7248555|FG001|COMPLETED|Overall Study||88
6341171|NCT00572832|7248554|FG000|NOT COMPLETED|Overall Study||0
6341172|NCT00572832|7248555|FG001|NOT COMPLETED|Overall Study||12
6559166|NCT01780922|7481893|FG003|STARTED|First Intervention (1 Day)||2
6559167|NCT01780922|7481894|FG004|STARTED|First Intervention (1 Day)||2
6559168|NCT01780922|7481895|FG005|STARTED|First Intervention (1 Day)||2
6341173|NCT00572897|7248563|FG000|STARTED|Overall Study||32
6341174|NCT00572897|7248564|FG001|STARTED|Overall Study||34
6341175|NCT00572897|7248563|FG000|COMPLETED|Overall Study||32
6341176|NCT00572897|7248564|FG001|COMPLETED|Overall Study||34
6341177|NCT00572897|7248563|FG000|NOT COMPLETED|Overall Study||0
6341178|NCT00572897|7248564|FG001|NOT COMPLETED|Overall Study||0
6341179|NCT00572910|7248576|FG000|STARTED|Overall Study||19
6341180|NCT00572910|7248577|FG001|STARTED|Overall Study||18
6341181|NCT00572910|7248578|FG002|STARTED|Overall Study||19
6341182|NCT00572910|7248579|FG003|STARTED|Overall Study||18
6341183|NCT00572910|7248580|FG004|STARTED|Overall Study||19
6559169|NCT01780922|7481890|FG000|COMPLETED|First Intervention (1 Day)||2
6559170|NCT01780922|7481891|FG001|COMPLETED|First Intervention (1 Day)||2
6559171|NCT01780922|7481892|FG002|COMPLETED|First Intervention (1 Day)||2
6559172|NCT01780922|7481893|FG003|COMPLETED|First Intervention (1 Day)||2
6559173|NCT01780922|7481894|FG004|COMPLETED|First Intervention (1 Day)||2
6559174|NCT01780922|7481895|FG005|COMPLETED|First Intervention (1 Day)||2
6559175|NCT01780922|7481890|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6341184|NCT00572910|7248581|FG005|STARTED|Overall Study||19
6341185|NCT00572910|7248582|FG006|STARTED|Overall Study||19
6341186|NCT00572910|7248583|FG007|STARTED|Overall Study||19
6341187|NCT00572910|7248584|FG008|STARTED|Overall Study||19
6341188|NCT00572910|7248585|FG009|STARTED|Overall Study||19
6341189|NCT00572910|7248586|FG010|STARTED|Overall Study||18
6341190|NCT00572910|7248576|FG000|COMPLETED|Overall Study||15
6341191|NCT00572910|7248577|FG001|COMPLETED|Overall Study||15
6341192|NCT00572910|7248578|FG002|COMPLETED|Overall Study||17
6341193|NCT00572910|7248579|FG003|COMPLETED|Overall Study||14
6341194|NCT00572910|7248580|FG004|COMPLETED|Overall Study||17
6341195|NCT00572910|7248581|FG005|COMPLETED|Overall Study||16
6341196|NCT00572910|7248582|FG006|COMPLETED|Overall Study||15
6341197|NCT00572910|7248583|FG007|COMPLETED|Overall Study||15
6341198|NCT00572910|7248584|FG008|COMPLETED|Overall Study||16
6341199|NCT00572910|7248585|FG009|COMPLETED|Overall Study||13
6341200|NCT00572910|7248586|FG010|COMPLETED|Overall Study||15
6341201|NCT00572910|7248576|FG000|NOT COMPLETED|Overall Study||4
6341202|NCT00572910|7248577|FG001|NOT COMPLETED|Overall Study||3
6341203|NCT00572910|7248578|FG002|NOT COMPLETED|Overall Study||2
6341204|NCT00572910|7248579|FG003|NOT COMPLETED|Overall Study||4
6341205|NCT00572910|7248580|FG004|NOT COMPLETED|Overall Study||2
6341206|NCT00572910|7248581|FG005|NOT COMPLETED|Overall Study||3
6341207|NCT00572910|7248582|FG006|NOT COMPLETED|Overall Study||4
6341208|NCT00572910|7248583|FG007|NOT COMPLETED|Overall Study||4
6341209|NCT00572910|7248584|FG008|NOT COMPLETED|Overall Study||3
6341210|NCT00572910|7248585|FG009|NOT COMPLETED|Overall Study||6
6341211|NCT00572910|7248586|FG010|NOT COMPLETED|Overall Study||3
6341212|NCT00572936|7248621|FG000|STARTED|First Intervention||4
6341213|NCT00572936|7248622|FG001|STARTED|First Intervention||4
6341214|NCT00572936|7248623|FG002|STARTED|First Intervention||5
6341215|NCT00572936|7248624|FG003|STARTED|First Intervention||5
6341216|NCT00572936|7248625|FG004|STARTED|First Intervention||5
6341217|NCT00572936|7248626|FG005|STARTED|First Intervention||5
6341218|NCT00572936|7248621|FG000|COMPLETED|First Intervention||4
6341219|NCT00572936|7248622|FG001|COMPLETED|First Intervention||4
6341220|NCT00572936|7248623|FG002|COMPLETED|First Intervention||5
6341221|NCT00572936|7248624|FG003|COMPLETED|First Intervention||5
6341222|NCT00572936|7248625|FG004|COMPLETED|First Intervention||5
6341223|NCT00572936|7248626|FG005|COMPLETED|First Intervention||5
6341224|NCT00572936|7248621|FG000|NOT COMPLETED|First Intervention||0
6341225|NCT00572936|7248622|FG001|NOT COMPLETED|First Intervention||0
6341226|NCT00572936|7248623|FG002|NOT COMPLETED|First Intervention||0
6341227|NCT00572936|7248624|FG003|NOT COMPLETED|First Intervention||0
6341228|NCT00572936|7248625|FG004|NOT COMPLETED|First Intervention||0
6341229|NCT00572936|7248626|FG005|NOT COMPLETED|First Intervention||0
6341230|NCT00572936|7248621|FG000|STARTED|Second Intervention||4
6341231|NCT00572936|7248622|FG001|STARTED|Second Intervention|1 participant dropped out between the first and second intervention due to car accident|3
6341232|NCT00572936|7248623|FG002|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
6341233|NCT00572936|7248624|FG003|STARTED|Second Intervention||5
6341234|NCT00572936|7248625|FG004|STARTED|Second Intervention|1 participant dropped out between first intervention and second intervention due to increased IOP|4
6341235|NCT00572936|7248626|FG005|STARTED|Second Intervention||5
6341236|NCT00572936|7248621|FG000|COMPLETED|Second Intervention||4
6341237|NCT00572936|7248622|FG001|COMPLETED|Second Intervention||3
6341238|NCT00572936|7248623|FG002|COMPLETED|Second Intervention||4
6341239|NCT00572936|7248624|FG003|COMPLETED|Second Intervention||5
6341240|NCT00572936|7248625|FG004|COMPLETED|Second Intervention||4
6341241|NCT00572936|7248626|FG005|COMPLETED|Second Intervention||5
6341242|NCT00572936|7248621|FG000|NOT COMPLETED|Second Intervention||0
6559176|NCT01780922|7481891|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6559177|NCT01780922|7481892|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6559178|NCT01780922|7481893|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6559179|NCT01780922|7481894|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6559180|NCT01780922|7481895|FG005|NOT COMPLETED|First Intervention (1 Day)||0
6559181|NCT01780922|7481890|FG000|STARTED|Washout (7 Days)||2
6341243|NCT00572936|7248622|FG001|NOT COMPLETED|Second Intervention||0
6341244|NCT00572936|7248623|FG002|NOT COMPLETED|Second Intervention||0
6341245|NCT00572936|7248624|FG003|NOT COMPLETED|Second Intervention||0
6341246|NCT00572936|7248625|FG004|NOT COMPLETED|Second Intervention||0
6341247|NCT00572936|7248626|FG005|NOT COMPLETED|Second Intervention||0
6559182|NCT01780922|7481891|FG001|STARTED|Washout (7 Days)||2
6559183|NCT01780922|7481892|FG002|STARTED|Washout (7 Days)||2
6559184|NCT01780922|7481893|FG003|STARTED|Washout (7 Days)||2
6341248|NCT00572936|7248621|FG000|STARTED|Third Intervention||4
6341249|NCT00572936|7248622|FG001|STARTED|Third Intervention||3
6341250|NCT00572936|7248623|FG002|STARTED|Third Intervention||4
6341251|NCT00572936|7248624|FG003|STARTED|Third Intervention||5
6341252|NCT00572936|7248625|FG004|STARTED|Third Intervention|1 participant dropped out between second intervention and third intervention due to increased IOP|3
6341253|NCT00572936|7248626|FG005|STARTED|Third Intervention||5
6341254|NCT00572936|7248621|FG000|COMPLETED|Third Intervention||4
6341255|NCT00572936|7248622|FG001|COMPLETED|Third Intervention||3
6341256|NCT00572936|7248623|FG002|COMPLETED|Third Intervention||4
6341257|NCT00572936|7248624|FG003|COMPLETED|Third Intervention||5
6341258|NCT00572936|7248625|FG004|COMPLETED|Third Intervention||3
6341259|NCT00572936|7248626|FG005|COMPLETED|Third Intervention||5
6341260|NCT00572936|7248621|FG000|NOT COMPLETED|Third Intervention||0
6341261|NCT00572936|7248622|FG001|NOT COMPLETED|Third Intervention||0
6341262|NCT00572936|7248623|FG002|NOT COMPLETED|Third Intervention||0
6341263|NCT00572936|7248624|FG003|NOT COMPLETED|Third Intervention||0
6341264|NCT00572936|7248625|FG004|NOT COMPLETED|Third Intervention||0
6341265|NCT00572936|7248626|FG005|NOT COMPLETED|Third Intervention||0
6341266|NCT00573066|7248634|FG000|STARTED|Overall Study||56
6341267|NCT00573066|7248634|FG000|COMPLETED|Overall Study||36
6341268|NCT00573066|7248634|FG000|NOT COMPLETED|Overall Study||20
6376453|NCT00759564|7286940|FG002|STARTED|Second Intervention Period (4 Days)||8
6376454|NCT00759564|7286941|FG003|STARTED|Second Intervention Period (4 Days)||1
6376455|NCT00759564|7286942|FG004|STARTED|Second Intervention Period (4 Days)||3
6376456|NCT00759564|7286938|FG000|COMPLETED|Second Intervention Period (4 Days)||8
6376457|NCT00759564|7286939|FG001|COMPLETED|Second Intervention Period (4 Days)||8
6376458|NCT00759564|7286940|FG002|COMPLETED|Second Intervention Period (4 Days)||8
6376459|NCT00759564|7286941|FG003|COMPLETED|Second Intervention Period (4 Days)||1
6376460|NCT00759564|7286942|FG004|COMPLETED|Second Intervention Period (4 Days)||3
6376461|NCT00759564|7286938|FG000|NOT COMPLETED|Second Intervention Period (4 Days)||0
6376462|NCT00759564|7286939|FG001|NOT COMPLETED|Second Intervention Period (4 Days)||0
6376463|NCT00759564|7286940|FG002|NOT COMPLETED|Second Intervention Period (4 Days)||0
6376464|NCT00759564|7286941|FG003|NOT COMPLETED|Second Intervention Period (4 Days)||0
6376465|NCT00759564|7286942|FG004|NOT COMPLETED|Second Intervention Period (4 Days)||0
6376466|NCT00759603|7286974|FG000|STARTED|Overall Study||59
6376467|NCT00759603|7286974|FG000|COMPLETED|Overall Study||59
6376468|NCT00759603|7286974|FG000|NOT COMPLETED|Overall Study||0
6376469|NCT00759642|7286978|FG000|STARTED|Overall Study||33
6376470|NCT00759642|7286978|FG000|COMPLETED|Overall Study||33
6376471|NCT00759642|7286978|FG000|NOT COMPLETED|Overall Study||0
6376472|NCT00759655|7286982|FG000|STARTED|Overall Study||1
6376473|NCT00759655|7286982|FG000|COMPLETED|Overall Study||0
6376474|NCT00759655|7286982|FG000|NOT COMPLETED|Overall Study||1
6376475|NCT00759668|7286988|FG000|STARTED|Overall Study||17
6376476|NCT00759668|7286989|FG001|STARTED|Overall Study||18
6376477|NCT00759668|7286988|FG000|COMPLETED|Overall Study||16
6376478|NCT00759668|7286989|FG001|COMPLETED|Overall Study||15
6376479|NCT00759668|7286988|FG000|NOT COMPLETED|Overall Study||1
6376480|NCT00759668|7286989|FG001|NOT COMPLETED|Overall Study||3
6376481|NCT00759681|7286997|FG000|STARTED|Overall Study||107
6376482|NCT00759681|7286998|FG001|STARTED|Overall Study||110
6376483|NCT00759681|7286997|FG000|COMPLETED|Overall Study||97
6376484|NCT00759681|7286998|FG001|COMPLETED|Overall Study||100
6376485|NCT00759681|7286997|FG000|NOT COMPLETED|Overall Study||10
6376486|NCT00759681|7286998|FG001|NOT COMPLETED|Overall Study||10
6376487|NCT00759707|7287005|FG000|STARTED|Overall Study||19
6376488|NCT00759707|7287005|FG000|COMPLETED|Overall Study||19
6376489|NCT00759707|7287005|FG000|NOT COMPLETED|Overall Study||0
6376490|NCT00759759|7287011|FG000|STARTED|Overall Study||18
6376491|NCT00759759|7287012|FG001|STARTED|Overall Study||18
6376492|NCT00759759|7287011|FG000|COMPLETED|Overall Study||14
6376493|NCT00759759|7287012|FG001|COMPLETED|Overall Study||17
6376494|NCT00759759|7287011|FG000|NOT COMPLETED|Overall Study||4
6376495|NCT00759759|7287012|FG001|NOT COMPLETED|Overall Study||1
6376496|NCT00759772|7287020|FG000|STARTED|Overall Study||12
6376497|NCT00759772|7287021|FG001|STARTED|Overall Study||11
6376498|NCT00759772|7287020|FG000|COMPLETED|Overall Study||12
6376499|NCT00759772|7287021|FG001|COMPLETED|Overall Study||11
6376500|NCT00759772|7287020|FG000|NOT COMPLETED|Overall Study||0
6376501|NCT00759772|7287021|FG001|NOT COMPLETED|Overall Study||0
6376502|NCT00759785|7287029|FG000|STARTED|Overall Study||26
6376503|NCT00759785|7287030|FG001|STARTED|Overall Study||22
6376504|NCT00759785|7287029|FG000|Treated|Overall Study||25
6376505|NCT00759785|7287030|FG001|Treated|Overall Study||20
6376506|NCT00759785|7287029|FG000|COMPLETED|Overall Study||14
6376507|NCT00759785|7287030|FG001|COMPLETED|Overall Study||17
6376508|NCT00759785|7287029|FG000|NOT COMPLETED|Overall Study||12
6376509|NCT00759785|7287030|FG001|NOT COMPLETED|Overall Study||5
6376510|NCT00759798|7287036|FG000|STARTED|Overall Study||289
6376511|NCT00759798|7287036|FG000|COMPLETED|Overall Study||289
6376512|NCT00759798|7287036|FG000|NOT COMPLETED|Overall Study||0
6376513|NCT00759811|7287042|FG000|STARTED|Overall Study||25
6376514|NCT00759811|7287043|FG001|STARTED|Overall Study||25
6376515|NCT00759811|7287042|FG000|COMPLETED|Overall Study||23
6376516|NCT00759811|7287043|FG001|COMPLETED|Overall Study||24
6376517|NCT00759811|7287042|FG000|NOT COMPLETED|Overall Study||2
6376518|NCT00759811|7287043|FG001|NOT COMPLETED|Overall Study||1
6376519|NCT00759863|7287051|FG000|STARTED|Overall Study||144
6376520|NCT00759863|7287052|FG001|STARTED|Overall Study||98
6376521|NCT00759863|7287051|FG000|COMPLETED|Overall Study||124
6376522|NCT00759863|7287052|FG001|COMPLETED|Overall Study||80
6376523|NCT00759863|7287051|FG000|NOT COMPLETED|Overall Study||20
6376524|NCT00759863|7287052|FG001|NOT COMPLETED|Overall Study||18
6376525|NCT00759876|7287058|FG000|STARTED|Overall Study||36
6376526|NCT00759876|7287058|FG000|As-Treated Population|Overall Study||36
6376527|NCT00759876|7287058|FG000|Evaluable Population|Overall Study||35
6341269|NCT00573131|7248640|FG000|STARTED|Overall Study||72
6341270|NCT00573131|7248641|FG001|STARTED|Overall Study||65
6341271|NCT00573131|7248640|FG000|COMPLETED|Overall Study||62
6341272|NCT00573131|7248641|FG001|COMPLETED|Overall Study||57
6341273|NCT00573131|7248640|FG000|NOT COMPLETED|Overall Study||10
6341274|NCT00573131|7248641|FG001|NOT COMPLETED|Overall Study||8
6341275|NCT00573144|7248649|FG000|STARTED|Overall Study||30
6341276|NCT00573144|7248650|FG001|STARTED|Overall Study||28
6341277|NCT00573144|7248649|FG000|COMPLETED|Overall Study||28
6341278|NCT00573144|7248650|FG001|COMPLETED|Overall Study||25
6341279|NCT00573144|7248649|FG000|NOT COMPLETED|Overall Study||2
6341280|NCT00573144|7248650|FG001|NOT COMPLETED|Overall Study||3
6341281|NCT00573170|7248656|FG000|STARTED|First Treatment Period||64
6341282|NCT00573170|7248657|FG001|STARTED|First Treatment Period||60
6341283|NCT00573170|7248658|FG002|STARTED|First Treatment Period||60
6341284|NCT00573170|7248659|FG003|STARTED|First Treatment Period||66
6341285|NCT00573170|7248660|FG004|STARTED|First Treatment Period||63
6341286|NCT00573170|7248661|FG005|STARTED|First Treatment Period||62
6341287|NCT00573170|7248656|FG000|COMPLETED|First Treatment Period||64
6341288|NCT00573170|7248657|FG001|COMPLETED|First Treatment Period||60
6341289|NCT00573170|7248658|FG002|COMPLETED|First Treatment Period||60
6341290|NCT00573170|7248659|FG003|COMPLETED|First Treatment Period||66
6341291|NCT00573170|7248660|FG004|COMPLETED|First Treatment Period||62
6341292|NCT00573170|7248661|FG005|COMPLETED|First Treatment Period||62
6341293|NCT00573170|7248656|FG000|NOT COMPLETED|First Treatment Period||0
6341294|NCT00573170|7248657|FG001|NOT COMPLETED|First Treatment Period||0
6341295|NCT00573170|7248658|FG002|NOT COMPLETED|First Treatment Period||0
6341296|NCT00573170|7248659|FG003|NOT COMPLETED|First Treatment Period||0
6341297|NCT00573170|7248660|FG004|NOT COMPLETED|First Treatment Period||1
6341298|NCT00573170|7248661|FG005|NOT COMPLETED|First Treatment Period||0
6341299|NCT00573170|7248656|FG000|STARTED|First Washout Period||64
6341300|NCT00573170|7248657|FG001|STARTED|First Washout Period||60
6341301|NCT00573170|7248658|FG002|STARTED|First Washout Period||60
6341302|NCT00573170|7248659|FG003|STARTED|First Washout Period||66
6341303|NCT00573170|7248660|FG004|STARTED|First Washout Period||62
6341304|NCT00573170|7248661|FG005|STARTED|First Washout Period||62
6341305|NCT00573170|7248656|FG000|COMPLETED|First Washout Period||56
6341306|NCT00573170|7248657|FG001|COMPLETED|First Washout Period||58
6341307|NCT00573170|7248658|FG002|COMPLETED|First Washout Period||59
6341308|NCT00573170|7248659|FG003|COMPLETED|First Washout Period||61
6341309|NCT00573170|7248660|FG004|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
6341310|NCT00573170|7248661|FG005|COMPLETED|First Washout Period||55
6341311|NCT00573170|7248656|FG000|NOT COMPLETED|First Washout Period||8
6341312|NCT00573170|7248657|FG001|NOT COMPLETED|First Washout Period||2
6341313|NCT00573170|7248658|FG002|NOT COMPLETED|First Washout Period||1
6341314|NCT00573170|7248659|FG003|NOT COMPLETED|First Washout Period||5
6341315|NCT00573170|7248660|FG004|NOT COMPLETED|First Washout Period||3
6341316|NCT00573170|7248661|FG005|NOT COMPLETED|First Washout Period||7
6341317|NCT00573170|7248656|FG000|STARTED|Second Treatment Period||56
6341318|NCT00573170|7248657|FG001|STARTED|Second Treatment Period||58
6341319|NCT00573170|7248658|FG002|STARTED|Second Treatment Period||59
6341320|NCT00573170|7248659|FG003|STARTED|Second Treatment Period||61
6341321|NCT00573170|7248660|FG004|STARTED|Second Treatment Period||59
6341322|NCT00573170|7248661|FG005|STARTED|Second Treatment Period||55
6341323|NCT00573170|7248656|FG000|COMPLETED|Second Treatment Period||56
6341324|NCT00573170|7248657|FG001|COMPLETED|Second Treatment Period||58
6341325|NCT00573170|7248658|FG002|COMPLETED|Second Treatment Period||59
6341326|NCT00573170|7248659|FG003|COMPLETED|Second Treatment Period||61
6341327|NCT00573170|7248660|FG004|COMPLETED|Second Treatment Period||59
6341328|NCT00573170|7248661|FG005|COMPLETED|Second Treatment Period||55
6341329|NCT00573170|7248656|FG000|NOT COMPLETED|Second Treatment Period||0
6341330|NCT00573170|7248657|FG001|NOT COMPLETED|Second Treatment Period||0
6341331|NCT00573170|7248658|FG002|NOT COMPLETED|Second Treatment Period||0
6341332|NCT00573170|7248659|FG003|NOT COMPLETED|Second Treatment Period||0
6341333|NCT00573170|7248660|FG004|NOT COMPLETED|Second Treatment Period||0
6341334|NCT00573170|7248661|FG005|NOT COMPLETED|Second Treatment Period||0
6341335|NCT00573170|7248656|FG000|STARTED|Second Washout Period||56
6341336|NCT00573170|7248657|FG001|STARTED|Second Washout Period||58
6341337|NCT00573170|7248658|FG002|STARTED|Second Washout Period||59
6341338|NCT00573170|7248659|FG003|STARTED|Second Washout Period||61
6341339|NCT00573170|7248660|FG004|STARTED|Second Washout Period||59
6341340|NCT00573170|7248661|FG005|STARTED|Second Washout Period||55
6341341|NCT00573170|7248656|FG000|COMPLETED|Second Washout Period||51
6341342|NCT00573170|7248657|FG001|COMPLETED|Second Washout Period||54
6341343|NCT00573170|7248658|FG002|COMPLETED|Second Washout Period||55
6341344|NCT00573170|7248659|FG003|COMPLETED|Second Washout Period||56
6341345|NCT00573170|7248660|FG004|COMPLETED|Second Washout Period||51
6341346|NCT00573170|7248661|FG005|COMPLETED|Second Washout Period||53
6341347|NCT00573170|7248656|FG000|NOT COMPLETED|Second Washout Period||5
6341348|NCT00573170|7248657|FG001|NOT COMPLETED|Second Washout Period||4
6341349|NCT00573170|7248658|FG002|NOT COMPLETED|Second Washout Period||4
6341350|NCT00573170|7248659|FG003|NOT COMPLETED|Second Washout Period||5
6341351|NCT00573170|7248660|FG004|NOT COMPLETED|Second Washout Period||8
6341352|NCT00573170|7248661|FG005|NOT COMPLETED|Second Washout Period||2
6341353|NCT00573170|7248656|FG000|STARTED|Third Treatment Period||51
6341354|NCT00573170|7248657|FG001|STARTED|Third Treatment Period||54
6341355|NCT00573170|7248658|FG002|STARTED|Third Treatment Period||55
6341356|NCT00573170|7248659|FG003|STARTED|Third Treatment Period||56
6341357|NCT00573170|7248660|FG004|STARTED|Third Treatment Period||51
6341358|NCT00573170|7248661|FG005|STARTED|Third Treatment Period||53
6341359|NCT00573170|7248656|FG000|COMPLETED|Third Treatment Period||50
6341360|NCT00573170|7248657|FG001|COMPLETED|Third Treatment Period||54
6341361|NCT00573170|7248658|FG002|COMPLETED|Third Treatment Period||55
6341362|NCT00573170|7248659|FG003|COMPLETED|Third Treatment Period||56
6341363|NCT00573170|7248660|FG004|COMPLETED|Third Treatment Period||51
6341364|NCT00573170|7248661|FG005|COMPLETED|Third Treatment Period||51
6341365|NCT00573170|7248656|FG000|NOT COMPLETED|Third Treatment Period||1
6341366|NCT00573170|7248657|FG001|NOT COMPLETED|Third Treatment Period||0
6341367|NCT00573170|7248658|FG002|NOT COMPLETED|Third Treatment Period||0
6341368|NCT00573170|7248659|FG003|NOT COMPLETED|Third Treatment Period||0
6341369|NCT00573170|7248660|FG004|NOT COMPLETED|Third Treatment Period||0
6341370|NCT00573170|7248661|FG005|NOT COMPLETED|Third Treatment Period||2
6341371|NCT00573183|7248680|FG000|STARTED|Overall Study||234
6341372|NCT00573183|7248681|FG001|STARTED|Overall Study||237
6341373|NCT00573183|7248680|FG000|COMPLETED|Overall Study||162
6341374|NCT00573183|7248681|FG001|COMPLETED|Overall Study||174
6341375|NCT00573183|7248680|FG000|NOT COMPLETED|Overall Study||72
6341376|NCT00573183|7248681|FG001|NOT COMPLETED|Overall Study||63
6341377|NCT00573248|7248691|FG000|STARTED|Overall Study||40
6341378|NCT00573248|7248692|FG001|STARTED|Overall Study||38
6341379|NCT00573248|7248691|FG000|Nicotine Patches and Placebo Patches|Overall Study||25
6341380|NCT00573248|7248692|FG001|Nicotine Patches and Placebo Patches|Overall Study||27
6341381|NCT00573248|7248691|FG000|COMPLETED|Overall Study||25
6341382|NCT00573248|7248692|FG001|COMPLETED|Overall Study||27
6341383|NCT00573248|7248691|FG000|NOT COMPLETED|Overall Study||15
6341384|NCT00573248|7248692|FG001|NOT COMPLETED|Overall Study||11
6341385|NCT00573261|7248700|FG000|STARTED|Overall Study||20
6341386|NCT00573261|7248701|FG001|STARTED|Overall Study||20
6341387|NCT00573261|7248700|FG000|COMPLETED|Overall Study||14
6341388|NCT00573261|7248701|FG001|COMPLETED|Overall Study||15
6341389|NCT00573261|7248700|FG000|NOT COMPLETED|Overall Study||6
6341390|NCT00573261|7248701|FG001|NOT COMPLETED|Overall Study||5
6341391|NCT00573287|7248711|FG000|STARTED|Overall Study||7
6341392|NCT00573287|7248712|FG001|STARTED|Overall Study||7
6341393|NCT00573287|7248711|FG000|COMPLETED|Overall Study||3
6341394|NCT00573287|7248712|FG001|COMPLETED|Overall Study||4
6341395|NCT00573287|7248711|FG000|NOT COMPLETED|Overall Study||4
6341396|NCT00573287|7248712|FG001|NOT COMPLETED|Overall Study||3
6341397|NCT00573313|7248722|FG000|STARTED|Overall Study|Eighteen participants recruited to start.|18
6341398|NCT00573313|7248723|FG001|STARTED|Overall Study||28
6341399|NCT00573313|7248724|FG002|STARTED|Overall Study|Nineteen recruited to start.|19
6341400|NCT00573313|7248725|FG003|STARTED|Overall Study||26
6341401|NCT00573313|7248722|FG000|COMPLETED|Overall Study||13
6341402|NCT00573313|7248723|FG001|COMPLETED|Overall Study||28
6341403|NCT00573313|7248724|FG002|COMPLETED|Overall Study||13
6341404|NCT00573313|7248725|FG003|COMPLETED|Overall Study||26
6559185|NCT01780922|7481894|FG004|STARTED|Washout (7 Days)||2
6559186|NCT01780922|7481895|FG005|STARTED|Washout (7 Days)||2
6559187|NCT01780922|7481890|FG000|COMPLETED|Washout (7 Days)||2
6559188|NCT01780922|7481891|FG001|COMPLETED|Washout (7 Days)||2
6559189|NCT01780922|7481892|FG002|COMPLETED|Washout (7 Days)||2
6559190|NCT01780922|7481893|FG003|COMPLETED|Washout (7 Days)||2
6559191|NCT01780922|7481894|FG004|COMPLETED|Washout (7 Days)||2
6559192|NCT01780922|7481895|FG005|COMPLETED|Washout (7 Days)||2
6559193|NCT01780922|7481890|FG000|NOT COMPLETED|Washout (7 Days)||0
6559194|NCT01780922|7481891|FG001|NOT COMPLETED|Washout (7 Days)||0
6559195|NCT01780922|7481892|FG002|NOT COMPLETED|Washout (7 Days)||0
6559196|NCT01780922|7481893|FG003|NOT COMPLETED|Washout (7 Days)||0
6559197|NCT01780922|7481894|FG004|NOT COMPLETED|Washout (7 Days)||0
6559198|NCT01780922|7481895|FG005|NOT COMPLETED|Washout (7 Days)||0
6559199|NCT01780922|7481890|FG000|STARTED|Second Intervention (1 Day)||2
6559200|NCT01780922|7481891|FG001|STARTED|Second Intervention (1 Day)||2
6559201|NCT01780922|7481892|FG002|STARTED|Second Intervention (1 Day)||2
6559202|NCT01780922|7481893|FG003|STARTED|Second Intervention (1 Day)||2
6559203|NCT01780922|7481894|FG004|STARTED|Second Intervention (1 Day)||2
6559204|NCT01780922|7481895|FG005|STARTED|Second Intervention (1 Day)||2
6559205|NCT01780922|7481890|FG000|COMPLETED|Second Intervention (1 Day)||2
6559206|NCT01780922|7481891|FG001|COMPLETED|Second Intervention (1 Day)||2
6559207|NCT01780922|7481892|FG002|COMPLETED|Second Intervention (1 Day)||2
6559208|NCT01780922|7481893|FG003|COMPLETED|Second Intervention (1 Day)||2
6559209|NCT01780922|7481894|FG004|COMPLETED|Second Intervention (1 Day)||2
6341405|NCT00573313|7248722|FG000|NOT COMPLETED|Overall Study||5
6341406|NCT00573313|7248723|FG001|NOT COMPLETED|Overall Study||0
6341407|NCT00573313|7248724|FG002|NOT COMPLETED|Overall Study||6
6341408|NCT00573313|7248725|FG003|NOT COMPLETED|Overall Study||0
6341409|NCT00573430|7248735|FG000|STARTED|Overall Study|randomized|40
6559210|NCT01780922|7481895|FG005|COMPLETED|Second Intervention (1 Day)||2
6559211|NCT01780922|7481890|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6559212|NCT01780922|7481891|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6559213|NCT01780922|7481892|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6559214|NCT01780922|7481893|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6559215|NCT01780922|7481894|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6559216|NCT01780922|7481895|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
6559217|NCT01780922|7481890|FG000|STARTED|Washout (7 Days)||2
6559218|NCT01780922|7481891|FG001|STARTED|Washout (7 Days)||2
6559219|NCT01780922|7481892|FG002|STARTED|Washout (7 Days)||2
6559220|NCT01780922|7481893|FG003|STARTED|Washout (7 Days)||2
6559221|NCT01780922|7481894|FG004|STARTED|Washout (7 Days)||2
6341410|NCT00573430|7248736|FG001|STARTED|Overall Study|randomized|45
6341411|NCT00573430|7248737|FG002|STARTED|Overall Study|randomized|43
6341412|NCT00573430|7248735|FG000|COMPLETED|Overall Study||39
6341413|NCT00573430|7248736|FG001|COMPLETED|Overall Study||40
6341414|NCT00573430|7248737|FG002|COMPLETED|Overall Study||33
6341415|NCT00573430|7248735|FG000|NOT COMPLETED|Overall Study||1
6341416|NCT00573430|7248736|FG001|NOT COMPLETED|Overall Study||5
6341417|NCT00573430|7248737|FG002|NOT COMPLETED|Overall Study||10
6341418|NCT00573443|7248748|FG000|STARTED|Double-Blind Phase||110
6341419|NCT00573443|7248749|FG001|STARTED|Double-Blind Phase||107
6341420|NCT00573443|7248750|FG002|STARTED|Double-Blind Phase||109
6341421|NCT00573443|7248748|FG000|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
6341422|NCT00573443|7248749|FG001|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
6341423|NCT00573443|7248750|FG002|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
6341424|NCT00573443|7248748|FG000|Subjects With PBA Secondary to MS|Double-Blind Phase||45
6341425|NCT00573443|7248749|FG001|Subjects With PBA Secondary to MS|Double-Blind Phase||39
6341426|NCT00573443|7248750|FG002|Subjects With PBA Secondary to MS|Double-Blind Phase||45
6341427|NCT00573443|7248748|FG000|COMPLETED|Double-Blind Phase||101
6341428|NCT00573443|7248749|FG001|COMPLETED|Double-Blind Phase||88
6341429|NCT00573443|7248750|FG002|COMPLETED|Double-Blind Phase||94
6341430|NCT00573443|7248748|FG000|NOT COMPLETED|Double-Blind Phase||9
6341431|NCT00573443|7248749|FG001|NOT COMPLETED|Double-Blind Phase||19
6341432|NCT00573443|7248750|FG002|NOT COMPLETED|Double-Blind Phase||15
6341433|NCT00573443|7248748|FG000|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
6341434|NCT00573443|7248749|FG001|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6341435|NCT00573443|7248750|FG002|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6341436|NCT00573443|7248748|FG000|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
6341437|NCT00573443|7248749|FG001|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6341438|NCT00573443|7248750|FG002|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6341439|NCT00573443|7248748|FG000|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
6341440|NCT00573443|7248749|FG001|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6341441|NCT00573443|7248750|FG002|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6341442|NCT00573443|7248748|FG000|COMPLETED|Open-Label Extension Phase||235
6341443|NCT00573443|7248749|FG001|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6341444|NCT00573443|7248750|FG002|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
6341445|NCT00573443|7248748|FG000|NOT COMPLETED|Open-Label Extension Phase||18
6341446|NCT00573443|7248749|FG001|NOT COMPLETED|Open-Label Extension Phase||0
6341447|NCT00573443|7248750|FG002|NOT COMPLETED|Open-Label Extension Phase||0
6341448|NCT00573469|7248762|FG000|STARTED|Overall Study||26
6341449|NCT00573469|7248763|FG001|STARTED|Overall Study||25
6341450|NCT00573469|7248764|FG002|STARTED|Overall Study||26
6341451|NCT00573469|7248762|FG000|COMPLETED|Overall Study||20
6341452|NCT00573469|7248763|FG001|COMPLETED|Overall Study||21
6341453|NCT00573469|7248764|FG002|COMPLETED|Overall Study||22
6341454|NCT00573469|7248762|FG000|NOT COMPLETED|Overall Study||6
6341455|NCT00573469|7248763|FG001|NOT COMPLETED|Overall Study||4
6341456|NCT00573469|7248764|FG002|NOT COMPLETED|Overall Study||4
6341457|NCT00573508|7248774|FG000|STARTED|Overall Study||382
6341458|NCT00573508|7248775|FG001|STARTED|Overall Study||386
6341459|NCT00573508|7248774|FG000|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
6341460|NCT00573508|7248775|FG001|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
6341461|NCT00573508|7248774|FG000|COMPLETED|Overall Study||318
6341462|NCT00573508|7248775|FG001|COMPLETED|Overall Study||345
6341463|NCT00573508|7248774|FG000|NOT COMPLETED|Overall Study||64
6341464|NCT00573508|7248775|FG001|NOT COMPLETED|Overall Study||41
6341465|NCT00573534|7248781|FG000|STARTED|Overall Study||8
6341466|NCT00573534|7248781|FG000|COMPLETED|Overall Study||5
6341467|NCT00573534|7248781|FG000|NOT COMPLETED|Overall Study||3
6341468|NCT00573755|7248788|FG000|STARTED|Overall Study||2
6341469|NCT00573755|7248789|FG001|STARTED|Overall Study||2
6341470|NCT00573755|7248788|FG000|COMPLETED|Overall Study||1
6341471|NCT00573755|7248789|FG001|COMPLETED|Overall Study||2
6341472|NCT00573755|7248788|FG000|NOT COMPLETED|Overall Study||1
6341473|NCT00573755|7248789|FG001|NOT COMPLETED|Overall Study||0
6341474|NCT00573768|7248798|FG000|STARTED|Overall Study||89
6559222|NCT01780922|7481895|FG005|STARTED|Washout (7 Days)||2
6559223|NCT01780922|7481890|FG000|COMPLETED|Washout (7 Days)||2
6559224|NCT01780922|7481891|FG001|COMPLETED|Washout (7 Days)||2
6559225|NCT01780922|7481892|FG002|COMPLETED|Washout (7 Days)||2
6341475|NCT00573768|7248799|FG001|STARTED|Overall Study||91
6341476|NCT00573768|7248800|FG002|STARTED|Overall Study||91
6341477|NCT00573768|7248798|FG000|COMPLETED|Overall Study||87
6341478|NCT00573768|7248799|FG001|COMPLETED|Overall Study||89
6341479|NCT00573768|7248800|FG002|COMPLETED|Overall Study||87
6341480|NCT00573768|7248798|FG000|NOT COMPLETED|Overall Study||2
6341481|NCT00573768|7248799|FG001|NOT COMPLETED|Overall Study||2
6341482|NCT00573768|7248800|FG002|NOT COMPLETED|Overall Study||4
6341483|NCT00573794|7248808|FG000|STARTED|Overall Study||585
6341484|NCT00573794|7248808|FG000|COMPLETED|Overall Study||255
6341485|NCT00573794|7248808|FG000|NOT COMPLETED|Overall Study||330
6341486|NCT00573833|7248812|FG000|STARTED|Overall Study||23
6341487|NCT00573833|7248812|FG000|COMPLETED|Overall Study||21
6341488|NCT00573833|7248812|FG000|NOT COMPLETED|Overall Study||2
6341489|NCT00573859|7248816|FG000|STARTED|Medication Versus Placebo||27
6341490|NCT00573859|7248816|FG000|COMPLETED|Medication Versus Placebo||15
6341491|NCT00573859|7248816|FG000|NOT COMPLETED|Medication Versus Placebo||12
6341492|NCT00573859|7248816|FG000|STARTED|Smoking Versus Abstinence||27
6341493|NCT00573859|7248816|FG000|COMPLETED|Smoking Versus Abstinence||15
6341494|NCT00573859|7248816|FG000|NOT COMPLETED|Smoking Versus Abstinence||12
6341495|NCT00573872|7248820|FG000|STARTED|Overall Study|# of patients that signed consent|43
6341496|NCT00573872|7248820|FG000|COMPLETED|Overall Study|# of patients that completed treatment|32
6341497|NCT00573872|7248820|FG000|NOT COMPLETED|Overall Study||11
6341498|NCT00573989|7248824|FG000|STARTED|Erlotinib Phase I||4
6341499|NCT00573989|7248825|FG001|STARTED|Erlotinib Phase I||6
6341500|NCT00573989|7248826|FG002|STARTED|Erlotinib Phase I||5
6341501|NCT00573989|7248827|FG003|STARTED|Erlotinib Phase I||0
6341502|NCT00573989|7248824|FG000|COMPLETED|Erlotinib Phase I||4
6341503|NCT00573989|7248825|FG001|COMPLETED|Erlotinib Phase I||6
6341504|NCT00573989|7248826|FG002|COMPLETED|Erlotinib Phase I||5
6341505|NCT00573989|7248827|FG003|COMPLETED|Erlotinib Phase I||0
6341506|NCT00573989|7248824|FG000|NOT COMPLETED|Erlotinib Phase I||0
6341507|NCT00573989|7248825|FG001|NOT COMPLETED|Erlotinib Phase I||0
6341508|NCT00573989|7248826|FG002|NOT COMPLETED|Erlotinib Phase I||0
6341509|NCT00573989|7248827|FG003|NOT COMPLETED|Erlotinib Phase I||0
6341510|NCT00573989|7248824|FG000|STARTED|Erlotinib 125mg- Phase II||0
6341511|NCT00573989|7248825|FG001|STARTED|Erlotinib 125mg- Phase II||0
6341512|NCT00573989|7248826|FG002|STARTED|Erlotinib 125mg- Phase II||0
6341513|NCT00573989|7248827|FG003|STARTED|Erlotinib 125mg- Phase II||12
6341514|NCT00573989|7248824|FG000|COMPLETED|Erlotinib 125mg- Phase II||0
6341515|NCT00573989|7248825|FG001|COMPLETED|Erlotinib 125mg- Phase II||0
6341516|NCT00573989|7248826|FG002|COMPLETED|Erlotinib 125mg- Phase II||0
6341517|NCT00573989|7248827|FG003|COMPLETED|Erlotinib 125mg- Phase II||12
6341518|NCT00573989|7248824|FG000|NOT COMPLETED|Erlotinib 125mg- Phase II||0
6341519|NCT00573989|7248825|FG001|NOT COMPLETED|Erlotinib 125mg- Phase II||0
6341520|NCT00573989|7248826|FG002|NOT COMPLETED|Erlotinib 125mg- Phase II||0
6341521|NCT00573989|7248827|FG003|NOT COMPLETED|Erlotinib 125mg- Phase II||0
6341522|NCT00574067|7248838|FG000|STARTED|Overall Study||53
6341523|NCT00574067|7248839|FG001|STARTED|Overall Study||53
6341524|NCT00574067|7248840|FG002|STARTED|Overall Study||54
6341525|NCT00574067|7248841|FG003|STARTED|Overall Study||53
6341526|NCT00574067|7248838|FG000|COMPLETED|Overall Study||52
6341527|NCT00574067|7248839|FG001|COMPLETED|Overall Study||52
6341528|NCT00574067|7248840|FG002|COMPLETED|Overall Study||54
6341529|NCT00574067|7248841|FG003|COMPLETED|Overall Study||53
6341530|NCT00574067|7248838|FG000|NOT COMPLETED|Overall Study||1
6341531|NCT00574067|7248839|FG001|NOT COMPLETED|Overall Study||1
6341532|NCT00574067|7248840|FG002|NOT COMPLETED|Overall Study||0
6341533|NCT00574067|7248841|FG003|NOT COMPLETED|Overall Study||0
6341534|NCT00574119|7248855|FG000|STARTED|Overall Study||16
6341535|NCT00574119|7248855|FG000|COMPLETED|Overall Study||12
6341536|NCT00574119|7248855|FG000|NOT COMPLETED|Overall Study||4
6341537|NCT00574145|7248861|FG000|STARTED|Overall Study||22
6341538|NCT00574145|7248862|FG001|STARTED|Overall Study||22
6341539|NCT00574145|7248861|FG000|COMPLETED|Overall Study||20
6341540|NCT00574145|7248862|FG001|COMPLETED|Overall Study||21
6341541|NCT00574145|7248861|FG000|NOT COMPLETED|Overall Study||2
6341542|NCT00574145|7248862|FG001|NOT COMPLETED|Overall Study||1
6341543|NCT00574171|7248868|FG000|STARTED|Overall Study||29
6341544|NCT00574171|7248868|FG000|COMPLETED|Overall Study||29
6341545|NCT00574171|7248868|FG000|NOT COMPLETED|Overall Study||0
6341546|NCT00574197|7248872|FG000|STARTED|Overall Study||11
6341547|NCT00574197|7248872|FG000|COMPLETED|Overall Study||6
6341548|NCT00574197|7248872|FG000|NOT COMPLETED|Overall Study||5
6341549|NCT00574236|7248876|FG000|STARTED|Overall Study||4
6341550|NCT00574236|7248876|FG000|COMPLETED|Overall Study||4
6341551|NCT00574236|7248876|FG000|NOT COMPLETED|Overall Study||0
6341552|NCT00574249|7248882|FG000|STARTED|Overall Study||364
6341553|NCT00574249|7248883|FG001|STARTED|Overall Study||366
6341554|NCT00574249|7248882|FG000|COMPLETED|Overall Study||338
6341555|NCT00574249|7248883|FG001|COMPLETED|Overall Study||338
6341556|NCT00574249|7248882|FG000|NOT COMPLETED|Overall Study||26
6341557|NCT00574249|7248883|FG001|NOT COMPLETED|Overall Study||28
6341558|NCT00574275|7248891|FG000|STARTED|Overall Study||275
6341559|NCT00574275|7248892|FG001|STARTED|Overall Study||271
6341560|NCT00574275|7248891|FG000|TREATED|Overall Study||273
6341561|NCT00574275|7248892|FG001|TREATED|Overall Study||268
6341562|NCT00574275|7248891|FG000|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
6376528|NCT00759876|7287058|FG000|Ambulatory Evaluable Population|Overall Study||24
6341563|NCT00574275|7248892|FG001|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
6341564|NCT00574275|7248891|FG000|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
6341565|NCT00574275|7248892|FG001|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
6341566|NCT00574275|7248891|FG000|NOT COMPLETED|Overall Study||275
6341567|NCT00574275|7248892|FG001|NOT COMPLETED|Overall Study||271
6341568|NCT00574288|7248905|FG000|STARTED|Overall Study||20
6341569|NCT00574288|7248906|FG001|STARTED|Overall Study||3
6341570|NCT00574288|7248907|FG002|STARTED|Overall Study||3
6341571|NCT00574288|7248908|FG003|STARTED|Overall Study||3
6341572|NCT00574288|7248909|FG004|STARTED|Overall Study||3
6341573|NCT00574288|7248910|FG005|STARTED|Overall Study||30
6341574|NCT00574288|7248911|FG006|STARTED|Overall Study||42
6341575|NCT00574288|7248905|FG000|COMPLETED|Overall Study||0
6341576|NCT00574288|7248906|FG001|COMPLETED|Overall Study||0
6341577|NCT00574288|7248907|FG002|COMPLETED|Overall Study||0
6341578|NCT00574288|7248908|FG003|COMPLETED|Overall Study||1
6341579|NCT00574288|7248909|FG004|COMPLETED|Overall Study||1
6341580|NCT00574288|7248910|FG005|COMPLETED|Overall Study||4
6341581|NCT00574288|7248911|FG006|COMPLETED|Overall Study||14
6341582|NCT00574288|7248905|FG000|NOT COMPLETED|Overall Study||20
6341583|NCT00574288|7248906|FG001|NOT COMPLETED|Overall Study||3
6341584|NCT00574288|7248907|FG002|NOT COMPLETED|Overall Study||3
6341585|NCT00574288|7248908|FG003|NOT COMPLETED|Overall Study||2
6341586|NCT00574288|7248909|FG004|NOT COMPLETED|Overall Study||2
6341587|NCT00574288|7248910|FG005|NOT COMPLETED|Overall Study||26
6341588|NCT00574288|7248911|FG006|NOT COMPLETED|Overall Study||28
6341589|NCT00574340|7248937|FG000|STARTED|Study 1 (2 Days)||10
6559226|NCT01780922|7481893|FG003|COMPLETED|Washout (7 Days)||2
6559227|NCT01780922|7481894|FG004|COMPLETED|Washout (7 Days)||2
6559228|NCT01780922|7481895|FG005|COMPLETED|Washout (7 Days)||2
6559229|NCT01780922|7481890|FG000|NOT COMPLETED|Washout (7 Days)||0
6559230|NCT01780922|7481891|FG001|NOT COMPLETED|Washout (7 Days)||0
6559231|NCT01780922|7481892|FG002|NOT COMPLETED|Washout (7 Days)||0
6559232|NCT01780922|7481893|FG003|NOT COMPLETED|Washout (7 Days)||0
6559233|NCT01780922|7481894|FG004|NOT COMPLETED|Washout (7 Days)||0
6559234|NCT01780922|7481895|FG005|NOT COMPLETED|Washout (7 Days)||0
6559235|NCT01780922|7481890|FG000|STARTED|Third Intervention (1 Day)||2
6559236|NCT01780922|7481891|FG001|STARTED|Third Intervention (1 Day)||2
6559237|NCT01780922|7481892|FG002|STARTED|Third Intervention (1 Day)||2
6559238|NCT01780922|7481893|FG003|STARTED|Third Intervention (1 Day)||2
6559239|NCT01780922|7481894|FG004|STARTED|Third Intervention (1 Day)||2
6559240|NCT01780922|7481895|FG005|STARTED|Third Intervention (1 Day)||2
6559241|NCT01780922|7481890|FG000|COMPLETED|Third Intervention (1 Day)||2
6559242|NCT01780922|7481891|FG001|COMPLETED|Third Intervention (1 Day)||2
6559243|NCT01780922|7481892|FG002|COMPLETED|Third Intervention (1 Day)||2
6559244|NCT01780922|7481893|FG003|COMPLETED|Third Intervention (1 Day)||2
6559245|NCT01780922|7481894|FG004|COMPLETED|Third Intervention (1 Day)||2
6559246|NCT01780922|7481895|FG005|COMPLETED|Third Intervention (1 Day)||2
6341590|NCT00574340|7248938|FG001|STARTED|Study 1 (2 Days)||10
6341591|NCT00574340|7248937|FG000|COMPLETED|Study 1 (2 Days)||10
6341592|NCT00574340|7248938|FG001|COMPLETED|Study 1 (2 Days)||10
6341593|NCT00574340|7248937|FG000|NOT COMPLETED|Study 1 (2 Days)||0
6341594|NCT00574340|7248938|FG001|NOT COMPLETED|Study 1 (2 Days)||0
6341595|NCT00574340|7248937|FG000|STARTED|Study 2 (2 Days)||6
6341596|NCT00574340|7248938|FG001|STARTED|Study 2 (2 Days)||6
6341597|NCT00574340|7248937|FG000|COMPLETED|Study 2 (2 Days)||6
6341598|NCT00574340|7248938|FG001|COMPLETED|Study 2 (2 Days)||6
6341599|NCT00574340|7248937|FG000|NOT COMPLETED|Study 2 (2 Days)||0
6341600|NCT00574340|7248938|FG001|NOT COMPLETED|Study 2 (2 Days)||0
6341601|NCT00574405|7248946|FG000|STARTED|Overall Study||12
6341602|NCT00574405|7248947|FG001|STARTED|Overall Study||12
6341603|NCT00574405|7248946|FG000|COMPLETED|Overall Study||9
6341604|NCT00574405|7248947|FG001|COMPLETED|Overall Study||10
6341605|NCT00574405|7248946|FG000|NOT COMPLETED|Overall Study||3
6341606|NCT00574405|7248947|FG001|NOT COMPLETED|Overall Study||2
6341607|NCT00574548|7248955|FG000|STARTED|Overall Study||482
6341608|NCT00574548|7248956|FG001|STARTED|Overall Study||238
6341609|NCT00574548|7248955|FG000|Received Vaccination 1 (Vax 1)|Overall Study||478
6341610|NCT00574548|7248956|FG001|Received Vaccination 1 (Vax 1)|Overall Study||237
6341611|NCT00574548|7248955|FG000|Completed Vax 1 (6 Month Contact)|Overall Study||468
6341612|NCT00574548|7248956|FG001|Completed Vax 1 (6 Month Contact)|Overall Study||234
6341613|NCT00574548|7248955|FG000|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
6341614|NCT00574548|7248956|FG001|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
6341615|NCT00574548|7248955|FG000|Withdrawn Before Vax 2|Overall Study||41
6341616|NCT00574548|7248956|FG001|Withdrawn Before Vax 2|Overall Study||11
6341617|NCT00574548|7248955|FG000|Received Vax 2|Overall Study||427
6341618|NCT00574548|7248956|FG001|Received Vax 2|Overall Study||223
6341619|NCT00574548|7248955|FG000|Completed Vax 2 (6 Month Contact)|Overall Study||421
6341620|NCT00574548|7248956|FG001|Completed Vax 2 (6 Month Contact)|Overall Study||222
6341621|NCT00574548|7248955|FG000|COMPLETED|Overall Study||421
6341622|NCT00574548|7248956|FG001|COMPLETED|Overall Study||222
6341623|NCT00574548|7248955|FG000|NOT COMPLETED|Overall Study||61
6341624|NCT00574548|7248956|FG001|NOT COMPLETED|Overall Study||16
6341625|NCT00574587|7248984|FG000|STARTED|Overall Study||3
6341626|NCT00574587|7248985|FG001|STARTED|Overall Study||23
6341627|NCT00574587|7248986|FG002|STARTED|Overall Study||16
6341628|NCT00574587|7248987|FG003|STARTED|Overall Study||13
6341629|NCT00574587|7248984|FG000|COMPLETED|Overall Study||3
6341630|NCT00574587|7248985|FG001|COMPLETED|Overall Study||23
6341631|NCT00574587|7248986|FG002|COMPLETED|Overall Study||16
6341632|NCT00574587|7248987|FG003|COMPLETED|Overall Study||13
6341633|NCT00574587|7248984|FG000|NOT COMPLETED|Overall Study||0
6341634|NCT00574587|7248985|FG001|NOT COMPLETED|Overall Study||0
6341635|NCT00574587|7248986|FG002|NOT COMPLETED|Overall Study||0
6341636|NCT00574587|7248987|FG003|NOT COMPLETED|Overall Study||0
6341637|NCT00574704|7249002|FG000|STARTED|Overall Study||10
6341638|NCT00574704|7249003|FG001|STARTED|Overall Study||10
6341639|NCT00574704|7249004|FG002|STARTED|Overall Study||10
6341640|NCT00574704|7249005|FG003|STARTED|Overall Study||10
6341641|NCT00574704|7249002|FG000|COMPLETED|Overall Study||10
6341642|NCT00574704|7249003|FG001|COMPLETED|Overall Study||10
6341643|NCT00574704|7249004|FG002|COMPLETED|Overall Study||9
6341644|NCT00574704|7249005|FG003|COMPLETED|Overall Study||10
6341645|NCT00574704|7249002|FG000|NOT COMPLETED|Overall Study||0
6341646|NCT00574704|7249003|FG001|NOT COMPLETED|Overall Study||0
6341647|NCT00574704|7249004|FG002|NOT COMPLETED|Overall Study||1
6341648|NCT00574704|7249005|FG003|NOT COMPLETED|Overall Study||0
6341649|NCT00574795|7249015|FG000|STARTED|Infant Series||193
6341650|NCT00574795|7249015|FG000|Vaccinated Dose 1|Infant Series||193
6341651|NCT00574795|7249015|FG000|Vaccinated Dose 2|Infant Series||190
6341652|NCT00574795|7249015|FG000|Vaccinated Dose 3|Infant Series||190
6341653|NCT00574795|7249015|FG000|COMPLETED|Infant Series||188
6341654|NCT00574795|7249015|FG000|NOT COMPLETED|Infant Series||5
6341655|NCT00574795|7249015|FG000|STARTED|After Infant Series||188
6341656|NCT00574795|7249015|FG000|COMPLETED|After Infant Series||185
6341657|NCT00574795|7249015|FG000|NOT COMPLETED|After Infant Series||3
6341658|NCT00574795|7249015|FG000|STARTED|Toddler Dose||185
6341659|NCT00574795|7249015|FG000|COMPLETED|Toddler Dose||184
6341660|NCT00574795|7249015|FG000|NOT COMPLETED|Toddler Dose||1
6341661|NCT00574834|7249033|FG000|STARTED|Overall Study||9
6341662|NCT00574834|7249034|FG001|STARTED|Overall Study||4
6341663|NCT00574834|7249035|FG002|STARTED|Overall Study||4
6341664|NCT00574834|7249033|FG000|COMPLETED|Overall Study||9
6341665|NCT00574834|7249034|FG001|COMPLETED|Overall Study||4
6341666|NCT00574834|7249035|FG002|COMPLETED|Overall Study||4
6341667|NCT00574834|7249033|FG000|NOT COMPLETED|Overall Study||0
6341668|NCT00574834|7249034|FG001|NOT COMPLETED|Overall Study||0
6341669|NCT00574834|7249035|FG002|NOT COMPLETED|Overall Study||0
6341670|NCT00574847|7249045|FG000|STARTED|Overall Study||64
6341671|NCT00574847|7249046|FG001|STARTED|Overall Study||63
6341672|NCT00574847|7249045|FG000|COMPLETED|Overall Study||56
6341673|NCT00574847|7249046|FG001|COMPLETED|Overall Study||56
6341674|NCT00574847|7249045|FG000|NOT COMPLETED|Overall Study||8
6341675|NCT00574847|7249046|FG001|NOT COMPLETED|Overall Study||7
6341676|NCT00574873|7249054|FG000|STARTED|Overall Study||250
6341677|NCT00574873|7249055|FG001|STARTED|Overall Study||252
6341678|NCT00574873|7249054|FG000|Treated|Overall Study||248
6341679|NCT00574873|7249055|FG001|Treated|Overall Study||251
6341680|NCT00574873|7249054|FG000|COMPLETED|Overall Study||12
6341681|NCT00574873|7249055|FG001|COMPLETED|Overall Study||1
6341682|NCT00574873|7249054|FG000|NOT COMPLETED|Overall Study||238
6341683|NCT00574873|7249055|FG001|NOT COMPLETED|Overall Study||251
6341684|NCT00574912|7249061|FG000|STARTED|Overall Study||20
6341685|NCT00574912|7249061|FG000|Completed Placebo|Overall Study|12 original participants started the trial.|12
6341686|NCT00574912|7249061|FG000|Completed 0.5|Overall Study||12
6341687|NCT00574912|7249061|FG000|Completed 1.0|Overall Study||12
6341688|NCT00574912|7249061|FG000|Completed 1.5|Overall Study||12
6341689|NCT00574912|7249061|FG000|Completed 2.0|Overall Study||12
6341690|NCT00574912|7249061|FG000|COMPLETED|Overall Study||12
6341691|NCT00574912|7249061|FG000|NOT COMPLETED|Overall Study||8
6341692|NCT00574951|7249073|FG000|STARTED|Overall Study||23
6341693|NCT00574951|7249073|FG000|COMPLETED|Overall Study||22
6341694|NCT00574951|7249073|FG000|NOT COMPLETED|Overall Study||1
6341695|NCT00574990|7249080|FG000|STARTED|Overall Study||12
6341696|NCT00574990|7249081|FG001|STARTED|Overall Study||19
6341697|NCT00574990|7249082|FG002|STARTED|Overall Study||8
6341698|NCT00574990|7249080|FG000|COMPLETED|Overall Study||12
6341699|NCT00574990|7249081|FG001|COMPLETED|Overall Study||19
6341700|NCT00574990|7249082|FG002|COMPLETED|Overall Study||8
6341701|NCT00574990|7249080|FG000|NOT COMPLETED|Overall Study||0
6341702|NCT00574990|7249081|FG001|NOT COMPLETED|Overall Study||0
6341703|NCT00574990|7249082|FG002|NOT COMPLETED|Overall Study||0
6341704|NCT00575016|7249097|FG000|STARTED|Treatment Cycle 1||17
6341705|NCT00575016|7249098|FG001|STARTED|Treatment Cycle 1||21
6341706|NCT00575016|7249099|FG002|STARTED|Treatment Cycle 1||19
6341707|NCT00575016|7249100|FG003|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
6341708|NCT00575016|7249097|FG000|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
6341709|NCT00575016|7249098|FG001|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
6341710|NCT00575016|7249099|FG002|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
6341711|NCT00575016|7249100|FG003|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
6341712|NCT00575016|7249097|FG000|NOT COMPLETED|Treatment Cycle 1||9
6341713|NCT00575016|7249098|FG001|NOT COMPLETED|Treatment Cycle 1||5
6341714|NCT00575016|7249099|FG002|NOT COMPLETED|Treatment Cycle 1||4
6341715|NCT00575016|7249100|FG003|NOT COMPLETED|Treatment Cycle 1||5
6341716|NCT00575016|7249097|FG000|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
6341717|NCT00575016|7249098|FG001|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
6341718|NCT00575016|7249099|FG002|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
6341719|NCT00575016|7249100|FG003|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
6341720|NCT00575016|7249097|FG000|COMPLETED|Treatment Cycle 2||30
6341721|NCT00575016|7249098|FG001|COMPLETED|Treatment Cycle 2||0
6341722|NCT00575016|7249099|FG002|COMPLETED|Treatment Cycle 2||0
6341723|NCT00575016|7249100|FG003|COMPLETED|Treatment Cycle 2||0
6341724|NCT00575016|7249097|FG000|NOT COMPLETED|Treatment Cycle 2||1
6341725|NCT00575016|7249098|FG001|NOT COMPLETED|Treatment Cycle 2||0
6341726|NCT00575016|7249099|FG002|NOT COMPLETED|Treatment Cycle 2||0
6341727|NCT00575016|7249100|FG003|NOT COMPLETED|Treatment Cycle 2||0
6341728|NCT00575029|7249110|FG000|STARTED|Overall Study||7
6341729|NCT00575029|7249110|FG000|COMPLETED|Overall Study||7
6341730|NCT00575029|7249110|FG000|NOT COMPLETED|Overall Study||0
6341731|NCT00575042|7249114|FG000|STARTED|Overall Study||20
6341732|NCT00575042|7249114|FG000|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
6341733|NCT00575042|7249114|FG000|NOT COMPLETED|Overall Study||3
6341734|NCT00575094|7249119|FG000|STARTED|Overall Study||9
6341735|NCT00575094|7249119|FG000|COMPLETED|Overall Study||6
6341736|NCT00575094|7249119|FG000|NOT COMPLETED|Overall Study||3
6341737|NCT00575146|7249123|FG000|STARTED|Overall Study||20
6341738|NCT00575146|7249123|FG000|COMPLETED|Overall Study||17
6341739|NCT00575146|7249123|FG000|NOT COMPLETED|Overall Study||3
6341740|NCT00575159|7249127|FG000|STARTED|Overall Study||10
6341741|NCT00575159|7249127|FG000|COMPLETED|Overall Study||10
6341742|NCT00575159|7249127|FG000|NOT COMPLETED|Overall Study||0
6341743|NCT00575185|7249145|FG000|STARTED|Overall Study||12
6341744|NCT00575185|7249146|FG001|STARTED|Overall Study||11
6341745|NCT00575185|7249145|FG000|COMPLETED|Overall Study||12
6341746|NCT00575185|7249146|FG001|COMPLETED|Overall Study||11
6341747|NCT00575185|7249145|FG000|NOT COMPLETED|Overall Study||0
6341748|NCT00575185|7249146|FG001|NOT COMPLETED|Overall Study||0
6341749|NCT00575328|7249156|FG000|STARTED|Overall Study||4
6341750|NCT00575328|7249157|FG001|STARTED|Overall Study||4
6341751|NCT00575328|7249156|FG000|COMPLETED|Overall Study||1
6341752|NCT00575328|7249157|FG001|COMPLETED|Overall Study||2
6341753|NCT00575328|7249156|FG000|NOT COMPLETED|Overall Study||3
6341754|NCT00575328|7249157|FG001|NOT COMPLETED|Overall Study||2
6341755|NCT00575367|7249165|FG000|STARTED|Overall Study||19
6341756|NCT00575367|7249166|FG001|STARTED|Overall Study||18
6341757|NCT00575367|7249165|FG000|COMPLETED|Overall Study||19
6341758|NCT00575367|7249166|FG001|COMPLETED|Overall Study||18
6341759|NCT00575367|7249165|FG000|NOT COMPLETED|Overall Study||0
6341760|NCT00575367|7249166|FG001|NOT COMPLETED|Overall Study||0
6341761|NCT00575380|7249174|FG000|STARTED|Overall Study||58
6341762|NCT00575380|7249175|FG001|STARTED|Overall Study||58
6341763|NCT00575380|7249174|FG000|COMPLETED|Overall Study||57
6341764|NCT00575380|7249175|FG001|COMPLETED|Overall Study||55
6341765|NCT00575380|7249174|FG000|NOT COMPLETED|Overall Study||1
6341766|NCT00575380|7249175|FG001|NOT COMPLETED|Overall Study||3
6341767|NCT00575510|7249184|FG000|STARTED|Overall Study||114
6341768|NCT00575510|7249185|FG001|STARTED|Overall Study||114
6341769|NCT00575510|7249186|FG002|STARTED|Overall Study||113
6341770|NCT00575510|7249184|FG000|COMPLETED|Overall Study||102
6341771|NCT00575510|7249185|FG001|COMPLETED|Overall Study||101
6341772|NCT00575510|7249186|FG002|COMPLETED|Overall Study||96
6341773|NCT00575510|7249184|FG000|NOT COMPLETED|Overall Study||12
6341774|NCT00575510|7249185|FG001|NOT COMPLETED|Overall Study||13
6341775|NCT00575510|7249186|FG002|NOT COMPLETED|Overall Study||17
6341776|NCT00575588|7249197|FG000|STARTED|Overall Study|Randomized and treated|428
6341777|NCT00575588|7249198|FG001|STARTED|Overall Study|Randomized and treated|430
6341778|NCT00575588|7249197|FG000|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
6341779|NCT00575588|7249198|FG001|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
6341780|NCT00575588|7249197|FG000|NOT COMPLETED|Overall Study||263
6341781|NCT00575588|7249198|FG001|NOT COMPLETED|Overall Study||283
6341782|NCT00575666|7249206|FG000|STARTED|Overall Study||21
6341783|NCT00575666|7249207|FG001|STARTED|Overall Study||24
6341784|NCT00575666|7249206|FG000|COMPLETED|Overall Study||17
6341785|NCT00575666|7249207|FG001|COMPLETED|Overall Study||21
6341786|NCT00575666|7249206|FG000|NOT COMPLETED|Overall Study||4
6341787|NCT00575666|7249207|FG001|NOT COMPLETED|Overall Study||3
6341788|NCT00575887|7249213|FG000|STARTED|Overall Study||25
6341789|NCT00575887|7249213|FG000|COMPLETED|Overall Study||25
6341790|NCT00575887|7249213|FG000|NOT COMPLETED|Overall Study||0
6341791|NCT00575965|7249217|FG000|STARTED|Overall Study||18
6341792|NCT00575965|7249217|FG000|COMPLETED|Overall Study||18
6341793|NCT00575965|7249217|FG000|NOT COMPLETED|Overall Study||0
6341794|NCT00576056|7249221|FG000|STARTED|Overall Study||19
6341795|NCT00576056|7249221|FG000|COMPLETED|Overall Study||5
6341796|NCT00576056|7249221|FG000|NOT COMPLETED|Overall Study||14
6341797|NCT00576147|7249225|FG000|STARTED|Overall Study||431
6341798|NCT00576147|7249225|FG000|COMPLETED|Overall Study||431
6498462|NCT01410058|7417050|FG000|COMPLETED|Washout Day 0||13
6341799|NCT00576147|7249225|FG000|NOT COMPLETED|Overall Study||0
6341800|NCT00576199|7249229|FG000|STARTED|Overall Study||30
6341801|NCT00576199|7249229|FG000|COMPLETED|Overall Study||0
6341802|NCT00576199|7249229|FG000|NOT COMPLETED|Overall Study||30
6341803|NCT00576251|7249235|FG000|STARTED|Overall Study||109
6341804|NCT00576251|7249236|FG001|STARTED|Overall Study||112
6341805|NCT00576251|7249235|FG000|COMPLETED|Overall Study||108
6341806|NCT00576251|7249236|FG001|COMPLETED|Overall Study||111
6654998|NCT02449473|7585029|FG000|COMPLETED|Overall Study||39
6654999|NCT02449473|7585030|FG001|COMPLETED|Overall Study||40
6655000|NCT02449473|7585029|FG000|NOT COMPLETED|Overall Study||0
6655001|NCT02449473|7585030|FG001|NOT COMPLETED|Overall Study||0
6655002|NCT02449798|7585036|FG000|STARTED|Overall Study||120
6655003|NCT02449798|7585036|FG000|COMPLETED|Overall Study||120
6655004|NCT02449798|7585036|FG000|NOT COMPLETED|Overall Study||0
6655005|NCT02449889|7585043|FG000|STARTED|Overall Study||58
6655006|NCT02449889|7585044|FG001|STARTED|Overall Study||58
6655007|NCT02449889|7585045|FG002|STARTED|Overall Study||60
6655008|NCT02449889|7585043|FG000|COMPLETED|Overall Study||57
6655009|NCT02449889|7585044|FG001|COMPLETED|Overall Study||52
6655010|NCT02449889|7585045|FG002|COMPLETED|Overall Study||59
6655011|NCT02449889|7585043|FG000|NOT COMPLETED|Overall Study||1
6655012|NCT02449889|7585044|FG001|NOT COMPLETED|Overall Study||6
6655013|NCT02449889|7585045|FG002|NOT COMPLETED|Overall Study||1
6655014|NCT02449902|7585055|FG000|STARTED|Overall Study||24
6655015|NCT02449902|7585056|FG001|STARTED|Overall Study||26
6655016|NCT02449902|7585055|FG000|COMPLETED|Overall Study||24
6655017|NCT02449902|7585056|FG001|COMPLETED|Overall Study||24
6655018|NCT02449902|7585055|FG000|NOT COMPLETED|Overall Study||0
6655019|NCT02449902|7585056|FG001|NOT COMPLETED|Overall Study||2
6655020|NCT02449915|7585066|FG000|STARTED|Overall Study||35
6655021|NCT02449915|7585067|FG001|STARTED|Overall Study||35
6655022|NCT02449915|7585066|FG000|COMPLETED|Overall Study||33
6655023|NCT02449915|7585067|FG001|COMPLETED|Overall Study||31
6655024|NCT02449915|7585066|FG000|NOT COMPLETED|Overall Study||2
6341807|NCT00576251|7249235|FG000|NOT COMPLETED|Overall Study||1
6341808|NCT00576251|7249236|FG001|NOT COMPLETED|Overall Study||1
6341809|NCT00576303|7249242|FG000|STARTED|Dose Titration Period||200
6341810|NCT00576303|7249242|FG000|COMPLETED|Dose Titration Period||183
6341811|NCT00576303|7249242|FG000|NOT COMPLETED|Dose Titration Period||17
6341812|NCT00576303|7249242|FG000|STARTED|Efficacy Evaluation Period||183
6341813|NCT00576303|7249242|FG000|COMPLETED|Efficacy Evaluation Period||178
6341814|NCT00576303|7249242|FG000|NOT COMPLETED|Efficacy Evaluation Period||5
6341815|NCT00576303|7249242|FG000|STARTED|Long Term Safety Period||178
6341816|NCT00576303|7249242|FG000|COMPLETED|Long Term Safety Period||162
6341817|NCT00576303|7249242|FG000|NOT COMPLETED|Long Term Safety Period||16
6341818|NCT00576316|7249246|FG000|STARTED|Overall Study|Number of patients recruited|201
6341819|NCT00576316|7249246|FG000|COMPLETED|Overall Study|Number of patients who completed study|181
6341820|NCT00576316|7249246|FG000|NOT COMPLETED|Overall Study||20
6341821|NCT00576381|7249250|FG000|STARTED|Overall Study||30
6341822|NCT00576381|7249250|FG000|COMPLETED|Overall Study||23
6559247|NCT01780922|7481890|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6559248|NCT01780922|7481891|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6559249|NCT01780922|7481892|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6341823|NCT00576381|7249250|FG000|NOT COMPLETED|Overall Study||7
6341824|NCT00576420|7249257|FG000|STARTED|Overall Study||26
6341825|NCT00576420|7249258|FG001|STARTED|Overall Study||24
6341826|NCT00576420|7249259|FG002|STARTED|Overall Study||23
6341827|NCT00576420|7249257|FG000|COMPLETED|Overall Study||26
6341828|NCT00576420|7249258|FG001|COMPLETED|Overall Study||24
6341829|NCT00576420|7249259|FG002|COMPLETED|Overall Study||22
6341830|NCT00576420|7249257|FG000|NOT COMPLETED|Overall Study||0
6341831|NCT00576420|7249258|FG001|NOT COMPLETED|Overall Study||0
6341832|NCT00576420|7249259|FG002|NOT COMPLETED|Overall Study||1
6559250|NCT01780922|7481893|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6559251|NCT01780922|7481894|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
6559252|NCT01780922|7481895|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
6559253|NCT01780935|7481905|FG000|STARTED|Overall Study||335
6559254|NCT01780935|7481906|FG001|STARTED|Overall Study||336
6559255|NCT01780935|7481905|FG000|Safety Set|Overall Study||334
6559256|NCT01780935|7481906|FG001|Safety Set|Overall Study||336
6559257|NCT01780935|7481905|FG000|COMPLETED|Overall Study||0
6559258|NCT01780935|7481906|FG001|COMPLETED|Overall Study||0
6559259|NCT01780935|7481905|FG000|NOT COMPLETED|Overall Study||335
6559260|NCT01780935|7481906|FG001|NOT COMPLETED|Overall Study||336
6559261|NCT01780974|7481914|FG000|STARTED|Overall Study||21
6559262|NCT01780974|7481915|FG001|STARTED|Overall Study||21
6559263|NCT01780974|7481914|FG000|COMPLETED|Overall Study||19
6559264|NCT01780974|7481915|FG001|COMPLETED|Overall Study||18
6559265|NCT01780974|7481914|FG000|NOT COMPLETED|Overall Study||2
6559266|NCT01780974|7481915|FG001|NOT COMPLETED|Overall Study||3
6559267|NCT01780987|7481923|FG000|STARTED|Overall Study||40
6559268|NCT01780987|7481924|FG001|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
6655025|NCT02449915|7585067|FG001|NOT COMPLETED|Overall Study||4
6655026|NCT02450383|7585075|FG000|STARTED|Overall Study||10
6559269|NCT01780987|7481923|FG000|COMPLETED|Overall Study||37
6559270|NCT01780987|7481924|FG001|COMPLETED|Overall Study||34
6559271|NCT01780987|7481923|FG000|NOT COMPLETED|Overall Study||3
6655027|NCT02450383|7585076|FG001|STARTED|Overall Study||10
6655028|NCT02450383|7585075|FG000|COMPLETED|Overall Study||10
6655029|NCT02450383|7585076|FG001|COMPLETED|Overall Study||10
6655030|NCT02450383|7585075|FG000|NOT COMPLETED|Overall Study||0
6655031|NCT02450383|7585076|FG001|NOT COMPLETED|Overall Study||0
6655032|NCT02450487|7585082|FG000|STARTED|Overall Study||105
6341833|NCT00576472|7249323|FG000|STARTED|Initial Screening||230
6341834|NCT00576472|7249324|FG001|STARTED|Initial Screening||40
6341835|NCT00576472|7249325|FG002|STARTED|Initial Screening||199
6341836|NCT00576472|7249326|FG003|STARTED|Initial Screening||0
6341837|NCT00576472|7249327|FG004|STARTED|Initial Screening||0
6341838|NCT00576472|7249328|FG005|STARTED|Initial Screening||0
6341839|NCT00576472|7249329|FG006|STARTED|Initial Screening||0
6341840|NCT00576472|7249330|FG007|STARTED|Initial Screening||0
6341841|NCT00576472|7249331|FG008|STARTED|Initial Screening||0
6341842|NCT00576472|7249332|FG009|STARTED|Initial Screening||0
6341843|NCT00576472|7249333|FG010|STARTED|Initial Screening||0
6341844|NCT00576472|7249334|FG011|STARTED|Initial Screening||0
6341845|NCT00576472|7249335|FG012|STARTED|Initial Screening||0
6341846|NCT00576472|7249336|FG013|STARTED|Initial Screening||0
6341847|NCT00576472|7249337|FG014|STARTED|Initial Screening||0
6341848|NCT00576472|7249323|FG000|COMPLETED|Initial Screening||230
6341849|NCT00576472|7249324|FG001|COMPLETED|Initial Screening||40
6341850|NCT00576472|7249325|FG002|COMPLETED|Initial Screening||199
6341851|NCT00576472|7249326|FG003|COMPLETED|Initial Screening||0
6341852|NCT00576472|7249327|FG004|COMPLETED|Initial Screening||0
6559272|NCT01780987|7481924|FG001|NOT COMPLETED|Overall Study||6
6559273|NCT01781078|7481932|FG000|STARTED|Overall Study|Randomized post implantation|229
6559274|NCT01781078|7481933|FG001|STARTED|Overall Study|Randomized post implantation|118
6559275|NCT01781078|7481934|FG002|STARTED|Overall Study||16
6559276|NCT01781078|7481932|FG000|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
6559277|NCT01781078|7481933|FG001|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
6559278|NCT01781078|7481934|FG002|COMPLETED|Overall Study||0
6559279|NCT01781078|7481932|FG000|NOT COMPLETED|Overall Study||12
6559280|NCT01781078|7481933|FG001|NOT COMPLETED|Overall Study||5
6559281|NCT01781078|7481934|FG002|NOT COMPLETED|Overall Study||16
6559282|NCT01781169|7481945|FG000|STARTED|Overall Study||22
6559283|NCT01781169|7481946|FG001|STARTED|Overall Study||21
6559284|NCT01781169|7481945|FG000|COMPLETED|Overall Study||21
6559285|NCT01781169|7481946|FG001|COMPLETED|Overall Study||21
6559286|NCT01781169|7481945|FG000|NOT COMPLETED|Overall Study||1
6559287|NCT01781169|7481946|FG001|NOT COMPLETED|Overall Study||0
6559288|NCT01781208|7481952|FG000|STARTED|Overall Study||62
6559289|NCT01781208|7481952|FG000|Overall Study|Overall Study||62
6559290|NCT01781208|7481952|FG000|COMPLETED|Overall Study||62
6559291|NCT01781208|7481952|FG000|NOT COMPLETED|Overall Study||0
6559292|NCT01781234|7481959|FG000|STARTED|Overall Study||27
6559293|NCT01781234|7481960|FG001|STARTED|Overall Study||24
6559294|NCT01781234|7481959|FG000|COMPLETED|Overall Study||18
6559295|NCT01781234|7481960|FG001|COMPLETED|Overall Study||21
6559296|NCT01781234|7481959|FG000|NOT COMPLETED|Overall Study||9
6559297|NCT01781234|7481960|FG001|NOT COMPLETED|Overall Study||3
6341853|NCT00576472|7249328|FG005|COMPLETED|Initial Screening||0
6341854|NCT00576472|7249329|FG006|COMPLETED|Initial Screening||0
6341855|NCT00576472|7249330|FG007|COMPLETED|Initial Screening||0
6341856|NCT00576472|7249331|FG008|COMPLETED|Initial Screening||0
6341857|NCT00576472|7249332|FG009|COMPLETED|Initial Screening||0
6341858|NCT00576472|7249333|FG010|COMPLETED|Initial Screening||0
6341859|NCT00576472|7249334|FG011|COMPLETED|Initial Screening||0
6341860|NCT00576472|7249335|FG012|COMPLETED|Initial Screening||0
6341861|NCT00576472|7249336|FG013|COMPLETED|Initial Screening||0
6341862|NCT00576472|7249337|FG014|COMPLETED|Initial Screening||0
6341863|NCT00576472|7249323|FG000|NOT COMPLETED|Initial Screening||0
6341864|NCT00576472|7249324|FG001|NOT COMPLETED|Initial Screening||0
6341865|NCT00576472|7249325|FG002|NOT COMPLETED|Initial Screening||0
6341866|NCT00576472|7249326|FG003|NOT COMPLETED|Initial Screening||0
6341867|NCT00576472|7249327|FG004|NOT COMPLETED|Initial Screening||0
6341868|NCT00576472|7249328|FG005|NOT COMPLETED|Initial Screening||0
6341869|NCT00576472|7249329|FG006|NOT COMPLETED|Initial Screening||0
6341870|NCT00576472|7249330|FG007|NOT COMPLETED|Initial Screening||0
6341871|NCT00576472|7249331|FG008|NOT COMPLETED|Initial Screening||0
6341872|NCT00576472|7249332|FG009|NOT COMPLETED|Initial Screening||0
6341873|NCT00576472|7249333|FG010|NOT COMPLETED|Initial Screening||0
6341874|NCT00576472|7249334|FG011|NOT COMPLETED|Initial Screening||0
6341875|NCT00576472|7249335|FG012|NOT COMPLETED|Initial Screening||0
6341876|NCT00576472|7249336|FG013|NOT COMPLETED|Initial Screening||0
6341877|NCT00576472|7249337|FG014|NOT COMPLETED|Initial Screening||0
6341878|NCT00576472|7249323|FG000|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
6341879|NCT00576472|7249324|FG001|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
6341880|NCT00576472|7249325|FG002|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
6341881|NCT00576472|7249326|FG003|STARTED|MPH In-Lab Phase||335
6341882|NCT00576472|7249327|FG004|STARTED|MPH In-Lab Phase||67
6341883|NCT00576472|7249328|FG005|STARTED|MPH In-Lab Phase||67
6341884|NCT00576472|7249329|FG006|STARTED|MPH In-Lab Phase||0
6341885|NCT00576472|7249330|FG007|STARTED|MPH In-Lab Phase||0
6341886|NCT00576472|7249331|FG008|STARTED|MPH In-Lab Phase||0
6341887|NCT00576472|7249332|FG009|STARTED|MPH In-Lab Phase||0
6341888|NCT00576472|7249333|FG010|STARTED|MPH In-Lab Phase||0
6341889|NCT00576472|7249334|FG011|STARTED|MPH In-Lab Phase||0
6341890|NCT00576472|7249335|FG012|STARTED|MPH In-Lab Phase||0
6341891|NCT00576472|7249336|FG013|STARTED|MPH In-Lab Phase||0
6341892|NCT00576472|7249337|FG014|STARTED|MPH In-Lab Phase||0
6341893|NCT00576472|7249323|FG000|COMPLETED|MPH In-Lab Phase||0
6341894|NCT00576472|7249324|FG001|COMPLETED|MPH In-Lab Phase||0
6341895|NCT00576472|7249325|FG002|COMPLETED|MPH In-Lab Phase||0
6341896|NCT00576472|7249326|FG003|COMPLETED|MPH In-Lab Phase||0
6341897|NCT00576472|7249327|FG004|COMPLETED|MPH In-Lab Phase||67
6341898|NCT00576472|7249328|FG005|COMPLETED|MPH In-Lab Phase||67
6341899|NCT00576472|7249329|FG006|COMPLETED|MPH In-Lab Phase||0
6341900|NCT00576472|7249330|FG007|COMPLETED|MPH In-Lab Phase||0
6341901|NCT00576472|7249331|FG008|COMPLETED|MPH In-Lab Phase||0
6341902|NCT00576472|7249332|FG009|COMPLETED|MPH In-Lab Phase||0
6341903|NCT00576472|7249333|FG010|COMPLETED|MPH In-Lab Phase||0
6341904|NCT00576472|7249334|FG011|COMPLETED|MPH In-Lab Phase||0
6341905|NCT00576472|7249335|FG012|COMPLETED|MPH In-Lab Phase||0
6341906|NCT00576472|7249336|FG013|COMPLETED|MPH In-Lab Phase||0
6341907|NCT00576472|7249337|FG014|COMPLETED|MPH In-Lab Phase||0
6341908|NCT00576472|7249323|FG000|NOT COMPLETED|MPH In-Lab Phase||0
6341909|NCT00576472|7249324|FG001|NOT COMPLETED|MPH In-Lab Phase||0
6341910|NCT00576472|7249325|FG002|NOT COMPLETED|MPH In-Lab Phase||0
6341911|NCT00576472|7249326|FG003|NOT COMPLETED|MPH In-Lab Phase||335
6341912|NCT00576472|7249327|FG004|NOT COMPLETED|MPH In-Lab Phase||0
6341913|NCT00576472|7249328|FG005|NOT COMPLETED|MPH In-Lab Phase||0
6341914|NCT00576472|7249329|FG006|NOT COMPLETED|MPH In-Lab Phase||0
6341915|NCT00576472|7249330|FG007|NOT COMPLETED|MPH In-Lab Phase||0
6341916|NCT00576472|7249331|FG008|NOT COMPLETED|MPH In-Lab Phase||0
6341917|NCT00576472|7249332|FG009|NOT COMPLETED|MPH In-Lab Phase||0
6341918|NCT00576472|7249333|FG010|NOT COMPLETED|MPH In-Lab Phase||0
6341919|NCT00576472|7249334|FG011|NOT COMPLETED|MPH In-Lab Phase||0
6341920|NCT00576472|7249335|FG012|NOT COMPLETED|MPH In-Lab Phase||0
6341921|NCT00576472|7249336|FG013|NOT COMPLETED|MPH In-Lab Phase||0
6341922|NCT00576472|7249337|FG014|NOT COMPLETED|MPH In-Lab Phase||0
6341923|NCT00576472|7249323|FG000|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6341924|NCT00576472|7249324|FG001|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6341925|NCT00576472|7249325|FG002|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6341926|NCT00576472|7249326|FG003|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6341927|NCT00576472|7249327|FG004|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6341928|NCT00576472|7249328|FG005|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
6341929|NCT00576472|7249329|FG006|STARTED|MPH Cross Over Phase||12
6341930|NCT00576472|7249330|FG007|STARTED|MPH Cross Over Phase||20
6341931|NCT00576472|7249331|FG008|STARTED|MPH Cross Over Phase||18
6341932|NCT00576472|7249332|FG009|STARTED|MPH Cross Over Phase||22
6341933|NCT00576472|7249333|FG010|STARTED|MPH Cross Over Phase||23
6341934|NCT00576472|7249334|FG011|STARTED|MPH Cross Over Phase||18
6341935|NCT00576472|7249335|FG012|STARTED|MPH Cross Over Phase||21
6341936|NCT00576472|7249336|FG013|STARTED|MPH Cross Over Phase||0
6341937|NCT00576472|7249337|FG014|STARTED|MPH Cross Over Phase||0
6341938|NCT00576472|7249323|FG000|COMPLETED|MPH Cross Over Phase||0
6341939|NCT00576472|7249324|FG001|COMPLETED|MPH Cross Over Phase||0
6341940|NCT00576472|7249325|FG002|COMPLETED|MPH Cross Over Phase||0
6341941|NCT00576472|7249326|FG003|COMPLETED|MPH Cross Over Phase||0
6341942|NCT00576472|7249327|FG004|COMPLETED|MPH Cross Over Phase||0
6341943|NCT00576472|7249328|FG005|COMPLETED|MPH Cross Over Phase||0
6341944|NCT00576472|7249329|FG006|COMPLETED|MPH Cross Over Phase||0
6341945|NCT00576472|7249330|FG007|COMPLETED|MPH Cross Over Phase||20
6341946|NCT00576472|7249331|FG008|COMPLETED|MPH Cross Over Phase||16
6341947|NCT00576472|7249332|FG009|COMPLETED|MPH Cross Over Phase||22
6341948|NCT00576472|7249333|FG010|COMPLETED|MPH Cross Over Phase||22
6341949|NCT00576472|7249334|FG011|COMPLETED|MPH Cross Over Phase||17
6341950|NCT00576472|7249335|FG012|COMPLETED|MPH Cross Over Phase||21
6341951|NCT00576472|7249336|FG013|COMPLETED|MPH Cross Over Phase||0
6341952|NCT00576472|7249337|FG014|COMPLETED|MPH Cross Over Phase||0
6341953|NCT00576472|7249323|FG000|NOT COMPLETED|MPH Cross Over Phase||0
6341954|NCT00576472|7249324|FG001|NOT COMPLETED|MPH Cross Over Phase||0
6341955|NCT00576472|7249325|FG002|NOT COMPLETED|MPH Cross Over Phase||0
6341956|NCT00576472|7249326|FG003|NOT COMPLETED|MPH Cross Over Phase||0
6341957|NCT00576472|7249327|FG004|NOT COMPLETED|MPH Cross Over Phase||0
6341958|NCT00576472|7249328|FG005|NOT COMPLETED|MPH Cross Over Phase||0
6341959|NCT00576472|7249329|FG006|NOT COMPLETED|MPH Cross Over Phase||12
6341960|NCT00576472|7249330|FG007|NOT COMPLETED|MPH Cross Over Phase||0
6341961|NCT00576472|7249331|FG008|NOT COMPLETED|MPH Cross Over Phase||2
6341962|NCT00576472|7249332|FG009|NOT COMPLETED|MPH Cross Over Phase||0
6341963|NCT00576472|7249333|FG010|NOT COMPLETED|MPH Cross Over Phase||1
6341964|NCT00576472|7249334|FG011|NOT COMPLETED|MPH Cross Over Phase||1
6341965|NCT00576472|7249335|FG012|NOT COMPLETED|MPH Cross Over Phase||0
6341966|NCT00576472|7249336|FG013|NOT COMPLETED|MPH Cross Over Phase||0
6341967|NCT00576472|7249337|FG014|NOT COMPLETED|MPH Cross Over Phase||0
6341968|NCT00576472|7249323|FG000|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6376529|NCT00759876|7287058|FG000|COMPLETED|Overall Study||0
6559298|NCT01781286|7481968|FG000|STARTED|Overall Study||7
6559299|NCT01781286|7481969|FG001|STARTED|Overall Study||4
6559300|NCT01781286|7481970|FG002|STARTED|Overall Study||9
6559301|NCT01781286|7481971|FG003|STARTED|Overall Study||8
6559302|NCT01781286|7481972|FG004|STARTED|Overall Study||6
6559303|NCT01781286|7481973|FG005|STARTED|Overall Study||3
6559304|NCT01781286|7481968|FG000|Started 1st Intervention|Overall Study||6
6559305|NCT01781286|7481969|FG001|Started 1st Intervention|Overall Study||4
6341969|NCT00576472|7249324|FG001|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341970|NCT00576472|7249325|FG002|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341971|NCT00576472|7249326|FG003|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341972|NCT00576472|7249327|FG004|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341973|NCT00576472|7249328|FG005|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341974|NCT00576472|7249329|FG006|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341975|NCT00576472|7249330|FG007|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341976|NCT00576472|7249331|FG008|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341977|NCT00576472|7249332|FG009|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341978|NCT00576472|7249333|FG010|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341979|NCT00576472|7249334|FG011|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341980|NCT00576472|7249335|FG012|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
6341981|NCT00576472|7249336|FG013|STARTED|MPH Home Maintenance Phase||27
6341982|NCT00576472|7249337|FG014|STARTED|MPH Home Maintenance Phase||91
6341983|NCT00576472|7249323|FG000|COMPLETED|MPH Home Maintenance Phase||0
6341984|NCT00576472|7249324|FG001|COMPLETED|MPH Home Maintenance Phase||0
6559306|NCT01781286|7481970|FG002|Started 1st Intervention|Overall Study||9
6559307|NCT01781286|7481971|FG003|Started 1st Intervention|Overall Study||8
6559308|NCT01781286|7481972|FG004|Started 1st Intervention|Overall Study||6
6559309|NCT01781286|7481973|FG005|Started 1st Intervention|Overall Study||2
6559310|NCT01781286|7481968|FG000|Started 2nd Intervention|Overall Study||5
6559311|NCT01781286|7481969|FG001|Started 2nd Intervention|Overall Study||4
6341985|NCT00576472|7249325|FG002|COMPLETED|MPH Home Maintenance Phase||0
6341986|NCT00576472|7249326|FG003|COMPLETED|MPH Home Maintenance Phase||0
6341987|NCT00576472|7249327|FG004|COMPLETED|MPH Home Maintenance Phase||0
6341988|NCT00576472|7249328|FG005|COMPLETED|MPH Home Maintenance Phase||0
6341989|NCT00576472|7249329|FG006|COMPLETED|MPH Home Maintenance Phase||0
6341990|NCT00576472|7249330|FG007|COMPLETED|MPH Home Maintenance Phase||0
6341991|NCT00576472|7249331|FG008|COMPLETED|MPH Home Maintenance Phase||0
6341992|NCT00576472|7249332|FG009|COMPLETED|MPH Home Maintenance Phase||0
6341993|NCT00576472|7249333|FG010|COMPLETED|MPH Home Maintenance Phase||0
6341994|NCT00576472|7249334|FG011|COMPLETED|MPH Home Maintenance Phase||0
6341995|NCT00576472|7249335|FG012|COMPLETED|MPH Home Maintenance Phase||0
6341996|NCT00576472|7249336|FG013|COMPLETED|MPH Home Maintenance Phase||0
6341997|NCT00576472|7249337|FG014|COMPLETED|MPH Home Maintenance Phase||68
6341998|NCT00576472|7249323|FG000|NOT COMPLETED|MPH Home Maintenance Phase||0
6341999|NCT00576472|7249324|FG001|NOT COMPLETED|MPH Home Maintenance Phase||0
6342000|NCT00576472|7249325|FG002|NOT COMPLETED|MPH Home Maintenance Phase||0
6342001|NCT00576472|7249326|FG003|NOT COMPLETED|MPH Home Maintenance Phase||0
6342002|NCT00576472|7249327|FG004|NOT COMPLETED|MPH Home Maintenance Phase||0
6342003|NCT00576472|7249328|FG005|NOT COMPLETED|MPH Home Maintenance Phase||0
6342004|NCT00576472|7249329|FG006|NOT COMPLETED|MPH Home Maintenance Phase||0
6342005|NCT00576472|7249330|FG007|NOT COMPLETED|MPH Home Maintenance Phase||0
6342006|NCT00576472|7249331|FG008|NOT COMPLETED|MPH Home Maintenance Phase||0
6342007|NCT00576472|7249332|FG009|NOT COMPLETED|MPH Home Maintenance Phase||0
6342008|NCT00576472|7249333|FG010|NOT COMPLETED|MPH Home Maintenance Phase||0
6342009|NCT00576472|7249334|FG011|NOT COMPLETED|MPH Home Maintenance Phase||0
6342010|NCT00576472|7249335|FG012|NOT COMPLETED|MPH Home Maintenance Phase||0
6342011|NCT00576472|7249336|FG013|NOT COMPLETED|MPH Home Maintenance Phase||27
6342012|NCT00576472|7249337|FG014|NOT COMPLETED|MPH Home Maintenance Phase||23
6342013|NCT00576576|7249368|FG000|STARTED|Overall Study||27
6342014|NCT00576576|7249368|FG000|COMPLETED|Overall Study||20
6342015|NCT00576576|7249368|FG000|NOT COMPLETED|Overall Study||7
6342016|NCT00576628|7249372|FG000|STARTED|Overall Study||125
6342017|NCT00576628|7249372|FG000|COMPLETED|Overall Study||82
6342018|NCT00576628|7249372|FG000|NOT COMPLETED|Overall Study||43
6342019|NCT00576680|7249377|FG000|STARTED|Overall Study||43
6342020|NCT00576680|7249377|FG000|COMPLETED|Overall Study||43
6342021|NCT00576680|7249377|FG000|NOT COMPLETED|Overall Study||0
6342022|NCT00576693|7249383|FG000|STARTED|Overall Study||224
6342023|NCT00576693|7249384|FG001|STARTED|Overall Study||227
6342024|NCT00576693|7249383|FG000|COMPLETED|Overall Study||214
6342025|NCT00576693|7249384|FG001|COMPLETED|Overall Study||203
6342026|NCT00576693|7249383|FG000|NOT COMPLETED|Overall Study||10
6342027|NCT00576693|7249384|FG001|NOT COMPLETED|Overall Study||24
6342028|NCT00576732|7249393|FG000|STARTED|DOUBLE BLIND||35
6342029|NCT00576732|7249394|FG001|STARTED|DOUBLE BLIND||30
6342030|NCT00576732|7249395|FG002|STARTED|DOUBLE BLIND||31
6342031|NCT00576732|7249396|FG003|STARTED|DOUBLE BLIND||0
6342032|NCT00576732|7249397|FG004|STARTED|DOUBLE BLIND||0
6342033|NCT00576732|7249398|FG005|STARTED|DOUBLE BLIND||0
6342034|NCT00576732|7249393|FG000|COMPLETED|DOUBLE BLIND||27
6342035|NCT00576732|7249394|FG001|COMPLETED|DOUBLE BLIND||25
6342036|NCT00576732|7249395|FG002|COMPLETED|DOUBLE BLIND||25
6342037|NCT00576732|7249396|FG003|COMPLETED|DOUBLE BLIND||0
6342038|NCT00576732|7249397|FG004|COMPLETED|DOUBLE BLIND||0
6342039|NCT00576732|7249398|FG005|COMPLETED|DOUBLE BLIND||0
6342040|NCT00576732|7249393|FG000|NOT COMPLETED|DOUBLE BLIND||8
6342041|NCT00576732|7249394|FG001|NOT COMPLETED|DOUBLE BLIND||5
6342042|NCT00576732|7249395|FG002|NOT COMPLETED|DOUBLE BLIND||6
6342043|NCT00576732|7249396|FG003|NOT COMPLETED|DOUBLE BLIND||0
6342044|NCT00576732|7249397|FG004|NOT COMPLETED|DOUBLE BLIND||0
6342045|NCT00576732|7249398|FG005|NOT COMPLETED|DOUBLE BLIND||0
6342046|NCT00576732|7249393|FG000|STARTED|OPEN LABEL||0
6342047|NCT00576732|7249394|FG001|STARTED|OPEN LABEL||0
6342048|NCT00576732|7249395|FG002|STARTED|OPEN LABEL||0
6342049|NCT00576732|7249396|FG003|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
6342050|NCT00576732|7249397|FG004|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
6342051|NCT00576732|7249398|FG005|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
6342052|NCT00576732|7249393|FG000|COMPLETED|OPEN LABEL||0
6342053|NCT00576732|7249394|FG001|COMPLETED|OPEN LABEL||0
6342054|NCT00576732|7249395|FG002|COMPLETED|OPEN LABEL||0
6342055|NCT00576732|7249396|FG003|COMPLETED|OPEN LABEL||19
6342056|NCT00576732|7249397|FG004|COMPLETED|OPEN LABEL||20
6342057|NCT00576732|7249398|FG005|COMPLETED|OPEN LABEL||17
6342058|NCT00576732|7249393|FG000|NOT COMPLETED|OPEN LABEL||0
6342059|NCT00576732|7249394|FG001|NOT COMPLETED|OPEN LABEL||0
6342060|NCT00576732|7249395|FG002|NOT COMPLETED|OPEN LABEL||0
6342061|NCT00576732|7249396|FG003|NOT COMPLETED|OPEN LABEL||11
6342062|NCT00576732|7249397|FG004|NOT COMPLETED|OPEN LABEL||4
6342063|NCT00576732|7249398|FG005|NOT COMPLETED|OPEN LABEL||8
6342064|NCT00576758|7249412|FG000|STARTED|Induction Treatment Period||87
6342065|NCT00576758|7249413|FG001|STARTED|Induction Treatment Period||88
6342066|NCT00576758|7249412|FG000|Received Treatment|Induction Treatment Period||86
6342067|NCT00576758|7249413|FG001|Received Treatment|Induction Treatment Period||87
6342068|NCT00576758|7249412|FG000|COMPLETED|Induction Treatment Period||79
6342069|NCT00576758|7249413|FG001|COMPLETED|Induction Treatment Period||83
6342070|NCT00576758|7249412|FG000|NOT COMPLETED|Induction Treatment Period||8
6342071|NCT00576758|7249413|FG001|NOT COMPLETED|Induction Treatment Period||5
6342072|NCT00576758|7249412|FG000|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
6342073|NCT00576758|7249413|FG001|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
6342074|NCT00576758|7249412|FG000|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
6342075|NCT00576758|7249413|FG001|COMPLETED|Extension Treatment Period||30
6342076|NCT00576758|7249412|FG000|NOT COMPLETED|Extension Treatment Period||42
6342077|NCT00576758|7249413|FG001|NOT COMPLETED|Extension Treatment Period||43
6342078|NCT00576758|7249412|FG000|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
6342079|NCT00576758|7249413|FG001|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
6342080|NCT00576758|7249412|FG000|COMPLETED|Follow-up Period||28
6342081|NCT00576758|7249413|FG001|COMPLETED|Follow-up Period||34
6342082|NCT00576758|7249412|FG000|NOT COMPLETED|Follow-up Period||27
6342083|NCT00576758|7249413|FG001|NOT COMPLETED|Follow-up Period||17
6342084|NCT00576823|7249423|FG000|STARTED|12-week Efficacy Phase||12
6342085|NCT00576823|7249424|FG001|STARTED|12-week Efficacy Phase||6
6342086|NCT00576823|7249425|FG002|STARTED|12-week Efficacy Phase||7
6342087|NCT00576823|7249423|FG000|COMPLETED|12-week Efficacy Phase||11
6342088|NCT00576823|7249424|FG001|COMPLETED|12-week Efficacy Phase||6
6342089|NCT00576823|7249425|FG002|COMPLETED|12-week Efficacy Phase||7
6342090|NCT00576823|7249423|FG000|NOT COMPLETED|12-week Efficacy Phase||1
6342091|NCT00576823|7249424|FG001|NOT COMPLETED|12-week Efficacy Phase||0
6342092|NCT00576823|7249425|FG002|NOT COMPLETED|12-week Efficacy Phase||0
6342093|NCT00576823|7249423|FG000|STARTED|40-week Safety Extension Phase||11
6342094|NCT00576823|7249424|FG001|STARTED|40-week Safety Extension Phase||6
6342095|NCT00576823|7249425|FG002|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
6342096|NCT00576823|7249423|FG000|COMPLETED|40-week Safety Extension Phase||10
6342097|NCT00576823|7249424|FG001|COMPLETED|40-week Safety Extension Phase||6
6342098|NCT00576823|7249425|FG002|COMPLETED|40-week Safety Extension Phase||6
6342099|NCT00576823|7249423|FG000|NOT COMPLETED|40-week Safety Extension Phase||1
6342100|NCT00576823|7249424|FG001|NOT COMPLETED|40-week Safety Extension Phase||0
6342101|NCT00576823|7249425|FG002|NOT COMPLETED|40-week Safety Extension Phase||0
6342102|NCT00576901|7249436|FG000|STARTED|Overall Study||23
6342103|NCT00576901|7249436|FG000|COMPLETED|Overall Study||20
6342104|NCT00576901|7249436|FG000|NOT COMPLETED|Overall Study||3
6342105|NCT00576927|7249442|FG000|STARTED|Clinical Assessment||79
6342106|NCT00576927|7249442|FG000|COMPLETED|Clinical Assessment||43
6342107|NCT00576927|7249442|FG000|NOT COMPLETED|Clinical Assessment||36
6342108|NCT00576927|7249442|FG000|STARTED|Baseline||43
6342109|NCT00576927|7249442|FG000|COMPLETED|Baseline||30
6342110|NCT00576927|7249442|FG000|NOT COMPLETED|Baseline||13
6342111|NCT00576927|7249442|FG000|STARTED|Sleep Hygiene Behavioral Intervention||30
6342112|NCT00576927|7249442|FG000|COMPLETED|Sleep Hygiene Behavioral Intervention||23
6342113|NCT00576927|7249442|FG000|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
6342114|NCT00576927|7249442|FG000|STARTED|Sleep Hygiene With the Placebo||23
6342115|NCT00576927|7249442|FG000|COMPLETED|Sleep Hygiene With the Placebo||22
6342116|NCT00576927|7249442|FG000|NOT COMPLETED|Sleep Hygiene With the Placebo||1
6342117|NCT00576927|7249442|FG000|STARTED|Sleep Hygiene With Study Drug||22
6342118|NCT00576927|7249442|FG000|COMPLETED|Sleep Hygiene With Study Drug||22
6342119|NCT00576927|7249442|FG000|NOT COMPLETED|Sleep Hygiene With Study Drug||0
6342120|NCT00576927|7249442|FG000|STARTED|Randomization 1:1 Placebo or Active Drug||22
6342121|NCT00576927|7249442|FG000|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
6342122|NCT00576927|7249442|FG000|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
6342123|NCT00577005|7249450|FG000|STARTED|Overall Study||16
6342124|NCT00577005|7249451|FG001|STARTED|Overall Study||12
6342125|NCT00577005|7249450|FG000|COMPLETED|Overall Study||11
6342126|NCT00577005|7249451|FG001|COMPLETED|Overall Study||9
6342127|NCT00577005|7249450|FG000|NOT COMPLETED|Overall Study||5
6342128|NCT00577005|7249451|FG001|NOT COMPLETED|Overall Study||3
6342129|NCT00577031|7249460|FG000|STARTED|Overall Study||205
6342130|NCT00577031|7249460|FG000|COMPLETED|Overall Study||0
6342131|NCT00577031|7249460|FG000|NOT COMPLETED|Overall Study||205
6342132|NCT00577083|7249469|FG000|STARTED|First Intervention (14 Days)||48
6342133|NCT00577083|7249470|FG001|STARTED|First Intervention (14 Days)||52
6342134|NCT00577083|7249469|FG000|COMPLETED|First Intervention (14 Days)||48
6342135|NCT00577083|7249470|FG001|COMPLETED|First Intervention (14 Days)||52
6342136|NCT00577083|7249469|FG000|NOT COMPLETED|First Intervention (14 Days)||0
6342137|NCT00577083|7249470|FG001|NOT COMPLETED|First Intervention (14 Days)||0
6342138|NCT00577083|7249469|FG000|STARTED|Washout (14 Days)||48
6342139|NCT00577083|7249470|FG001|STARTED|Washout (14 Days)||52
6342140|NCT00577083|7249469|FG000|COMPLETED|Washout (14 Days)||48
6342141|NCT00577083|7249470|FG001|COMPLETED|Washout (14 Days)||52
6342142|NCT00577083|7249469|FG000|NOT COMPLETED|Washout (14 Days)||0
6342143|NCT00577083|7249470|FG001|NOT COMPLETED|Washout (14 Days)||0
6342144|NCT00577083|7249469|FG000|STARTED|Second Intervention (14days)||48
6342145|NCT00577083|7249470|FG001|STARTED|Second Intervention (14days)||52
6342146|NCT00577083|7249469|FG000|COMPLETED|Second Intervention (14days)||48
6342147|NCT00577083|7249470|FG001|COMPLETED|Second Intervention (14days)||52
6342148|NCT00577083|7249469|FG000|NOT COMPLETED|Second Intervention (14days)||0
6342149|NCT00577083|7249470|FG001|NOT COMPLETED|Second Intervention (14days)||0
6342150|NCT00577096|7249484|FG000|STARTED|Short Term Participation||69
6342151|NCT00577096|7249485|FG001|STARTED|Short Term Participation||66
6342152|NCT00577096|7249484|FG000|COMPLETED|Short Term Participation||62
6342153|NCT00577096|7249485|FG001|COMPLETED|Short Term Participation||58
6342154|NCT00577096|7249484|FG000|NOT COMPLETED|Short Term Participation||7
6342155|NCT00577096|7249485|FG001|NOT COMPLETED|Short Term Participation||8
6342156|NCT00577096|7249484|FG000|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
6342157|NCT00577096|7249485|FG001|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
6342158|NCT00577096|7249484|FG000|COMPLETED|Long Term Participation||34
6342159|NCT00577096|7249485|FG001|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
6342160|NCT00577096|7249484|FG000|NOT COMPLETED|Long Term Participation||0
6342161|NCT00577096|7249485|FG001|NOT COMPLETED|Long Term Participation||0
6342162|NCT00577122|7249493|FG000|STARTED|Overall Study||14
6342163|NCT00577122|7249494|FG001|STARTED|Overall Study||16
6342164|NCT00577122|7249493|FG000|COMPLETED|Overall Study||0
6342165|NCT00577122|7249494|FG001|COMPLETED|Overall Study||0
6342166|NCT00577122|7249493|FG000|NOT COMPLETED|Overall Study||14
6342167|NCT00577122|7249494|FG001|NOT COMPLETED|Overall Study||16
6342168|NCT00577135|7249505|FG000|STARTED|Overall Study||74
6342169|NCT00577135|7249506|FG001|STARTED|Overall Study||82
6342170|NCT00577135|7249507|FG002|STARTED|Overall Study||77
6559312|NCT01781286|7481970|FG002|Started 2nd Intervention|Overall Study||9
6559313|NCT01781286|7481971|FG003|Started 2nd Intervention|Overall Study||8
6559314|NCT01781286|7481972|FG004|Started 2nd Intervention|Overall Study||6
6342171|NCT00577135|7249508|FG003|STARTED|Overall Study||75
6342172|NCT00577135|7249505|FG000|COMPLETED|Overall Study||74
6342173|NCT00577135|7249506|FG001|COMPLETED|Overall Study||82
6342174|NCT00577135|7249507|FG002|COMPLETED|Overall Study||77
6559315|NCT01781286|7481973|FG005|Started 2nd Intervention|Overall Study||2
6559316|NCT01781286|7481968|FG000|Started 3rd Intervention|Overall Study||5
6559317|NCT01781286|7481969|FG001|Started 3rd Intervention|Overall Study||4
6559318|NCT01781286|7481970|FG002|Started 3rd Intervention|Overall Study||7
6559319|NCT01781286|7481971|FG003|Started 3rd Intervention|Overall Study||7
6559320|NCT01781286|7481972|FG004|Started 3rd Intervention|Overall Study||6
6342175|NCT00577135|7249508|FG003|COMPLETED|Overall Study||75
6342176|NCT00577135|7249505|FG000|NOT COMPLETED|Overall Study||0
6342177|NCT00577135|7249506|FG001|NOT COMPLETED|Overall Study||0
6342178|NCT00577135|7249507|FG002|NOT COMPLETED|Overall Study||0
6342179|NCT00577135|7249508|FG003|NOT COMPLETED|Overall Study||0
6342180|NCT00577382|7249520|FG000|STARTED|Overall Study||21
6342181|NCT00577382|7249521|FG001|STARTED|Overall Study||31
6342182|NCT00577382|7249520|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6342183|NCT00577382|7249521|FG001|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6342184|NCT00577382|7249520|FG000|NOT COMPLETED|Overall Study||21
6342185|NCT00577382|7249521|FG001|NOT COMPLETED|Overall Study||31
6342186|NCT00577408|7249529|FG000|STARTED|Overall Study||28
6342187|NCT00577408|7249530|FG001|STARTED|Overall Study||32
6342188|NCT00577408|7249529|FG000|COMPLETED|Overall Study||16
6342189|NCT00577408|7249530|FG001|COMPLETED|Overall Study||9
6342190|NCT00577408|7249529|FG000|NOT COMPLETED|Overall Study||12
6342191|NCT00577408|7249530|FG001|NOT COMPLETED|Overall Study||23
6342192|NCT00577460|7249539|FG000|STARTED|Overall Study||129
6342193|NCT00577460|7249540|FG001|STARTED|Overall Study||123
6342194|NCT00577460|7249541|FG002|STARTED|Overall Study||139
6342195|NCT00577460|7249539|FG000|COMPLETED|Overall Study||113
6342196|NCT00577460|7249540|FG001|COMPLETED|Overall Study||104
6342197|NCT00577460|7249541|FG002|COMPLETED|Overall Study||112
6342198|NCT00577460|7249539|FG000|NOT COMPLETED|Overall Study||16
6342199|NCT00577460|7249540|FG001|NOT COMPLETED|Overall Study||19
6342200|NCT00577460|7249541|FG002|NOT COMPLETED|Overall Study||27
6342201|NCT00577473|7249558|FG000|STARTED|Overall Study||154
6342202|NCT00577473|7249559|FG001|STARTED|Overall Study||147
6342203|NCT00577473|7249558|FG000|ITT Population|Overall Study||150
6342204|NCT00577473|7249559|FG001|ITT Population|Overall Study||136
6342205|NCT00577473|7249558|FG000|COMPLETED|Overall Study||133
6342206|NCT00577473|7249559|FG001|COMPLETED|Overall Study||123
6342207|NCT00577473|7249558|FG000|NOT COMPLETED|Overall Study||21
6342208|NCT00577473|7249559|FG001|NOT COMPLETED|Overall Study||24
6342209|NCT00577512|7249565|FG000|STARTED|Overall Study||4
6342210|NCT00577512|7249565|FG000|COMPLETED|Overall Study||0
6342211|NCT00577512|7249565|FG000|NOT COMPLETED|Overall Study||4
6342212|NCT00577590|7249572|FG000|STARTED|Overall Study||28
6342213|NCT00577590|7249573|FG001|STARTED|Overall Study||27
6342214|NCT00577590|7249574|FG002|STARTED|Overall Study||23
6342215|NCT00577590|7249572|FG000|COMPLETED|Overall Study||28
6342216|NCT00577590|7249573|FG001|COMPLETED|Overall Study||27
6342217|NCT00577590|7249574|FG002|COMPLETED|Overall Study||23
6342218|NCT00577590|7249572|FG000|NOT COMPLETED|Overall Study||0
6342219|NCT00577590|7249573|FG001|NOT COMPLETED|Overall Study||0
6342220|NCT00577590|7249574|FG002|NOT COMPLETED|Overall Study||0
6342221|NCT00577629|7249582|FG000|STARTED|Treatment Period||39
6342222|NCT00577629|7249582|FG000|COMPLETED|Treatment Period||38
6342223|NCT00577629|7249582|FG000|NOT COMPLETED|Treatment Period||1
6342224|NCT00577629|7249582|FG000|STARTED|Long Term Follow-Up||38
6342225|NCT00577629|7249582|FG000|COMPLETED|Long Term Follow-Up||13
6342226|NCT00577629|7249582|FG000|NOT COMPLETED|Long Term Follow-Up||25
6342227|NCT00577642|7249588|FG000|STARTED|Overall Study||29
6342228|NCT00577642|7249588|FG000|COMPLETED|Overall Study||28
6342229|NCT00577642|7249588|FG000|NOT COMPLETED|Overall Study||1
6342230|NCT00577655|7249594|FG000|STARTED|Overall Study|This number represents the number of participants randomized.|52
6342231|NCT00577655|7249595|FG001|STARTED|Overall Study|This number represents the number of participants randomized.|51
6342232|NCT00577655|7249594|FG000|COMPLETED|Overall Study||51
6342233|NCT00577655|7249595|FG001|COMPLETED|Overall Study||47
6342234|NCT00577655|7249594|FG000|NOT COMPLETED|Overall Study||1
6342235|NCT00577655|7249595|FG001|NOT COMPLETED|Overall Study||4
6342236|NCT00577707|7249602|FG000|STARTED|Overall Study||9
6342237|NCT00577707|7249602|FG000|COMPLETED|Overall Study||6
6342238|NCT00577707|7249602|FG000|NOT COMPLETED|Overall Study||3
6342239|NCT00577720|7249610|FG000|STARTED|Overall Study||37
6342240|NCT00577720|7249611|FG001|STARTED|Overall Study||36
6342241|NCT00577720|7249612|FG002|STARTED|Overall Study||36
6342242|NCT00577720|7249613|FG003|STARTED|Overall Study||72
6342243|NCT00577720|7249610|FG000|ITT (Intent to Treat) Population|Overall Study||34
6342244|NCT00577720|7249611|FG001|ITT (Intent to Treat) Population|Overall Study||35
6342245|NCT00577720|7249612|FG002|ITT (Intent to Treat) Population|Overall Study||35
6342246|NCT00577720|7249613|FG003|ITT (Intent to Treat) Population|Overall Study||65
6342247|NCT00577720|7249610|FG000|COMPLETED|Overall Study||33
6342248|NCT00577720|7249611|FG001|COMPLETED|Overall Study||35
6342249|NCT00577720|7249612|FG002|COMPLETED|Overall Study||35
6342250|NCT00577720|7249613|FG003|COMPLETED|Overall Study||65
6342251|NCT00577720|7249610|FG000|NOT COMPLETED|Overall Study||4
6342252|NCT00577720|7249611|FG001|NOT COMPLETED|Overall Study||1
6342253|NCT00577720|7249612|FG002|NOT COMPLETED|Overall Study||1
6342254|NCT00577720|7249613|FG003|NOT COMPLETED|Overall Study||7
6342255|NCT00577824|7249626|FG000|STARTED|Overall Study|Started=Randomized|72
6342256|NCT00577824|7249627|FG001|STARTED|Overall Study||73
6342257|NCT00577824|7249628|FG002|STARTED|Overall Study||36
6342258|NCT00577824|7249626|FG000|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
6342259|NCT00577824|7249627|FG001|Full Analysis Set|Overall Study||72
6342260|NCT00577824|7249628|FG002|Full Analysis Set|Overall Study||35
6342261|NCT00577824|7249626|FG000|COMPLETED|Overall Study||65
6342262|NCT00577824|7249627|FG001|COMPLETED|Overall Study||53
6342263|NCT00577824|7249628|FG002|COMPLETED|Overall Study||34
6342264|NCT00577824|7249626|FG000|NOT COMPLETED|Overall Study||7
6342265|NCT00577824|7249627|FG001|NOT COMPLETED|Overall Study||20
6342266|NCT00577824|7249628|FG002|NOT COMPLETED|Overall Study||2
6342267|NCT00577863|7249638|FG000|STARTED|Overall Study||92
6342268|NCT00577863|7249639|FG001|STARTED|Overall Study||108
6342269|NCT00577863|7249638|FG000|Received at Least One Injection|Overall Study||92
6342270|NCT00577863|7249639|FG001|Received at Least One Injection|Overall Study||107
6342271|NCT00577863|7249638|FG000|COMPLETED|Overall Study||82
6342272|NCT00577863|7249639|FG001|COMPLETED|Overall Study||94
6342273|NCT00577863|7249638|FG000|NOT COMPLETED|Overall Study||10
6342274|NCT00577863|7249639|FG001|NOT COMPLETED|Overall Study||14
6342275|NCT00577889|7249648|FG000|STARTED|Overall Study||9
6342276|NCT00577889|7249649|FG001|STARTED|Overall Study||6
6342277|NCT00577889|7249650|FG002|STARTED|Overall Study||6
6342278|NCT00577889|7249648|FG000|COMPLETED|Overall Study||8
6342279|NCT00577889|7249649|FG001|COMPLETED|Overall Study||6
6342280|NCT00577889|7249650|FG002|COMPLETED|Overall Study||6
6342281|NCT00577889|7249648|FG000|NOT COMPLETED|Overall Study||1
6342282|NCT00577889|7249649|FG001|NOT COMPLETED|Overall Study||0
6342283|NCT00577889|7249650|FG002|NOT COMPLETED|Overall Study||0
6342284|NCT00577993|7249661|FG000|STARTED|Overall Study||85
6342285|NCT00577993|7249662|FG001|STARTED|Overall Study||90
6342286|NCT00577993|7249663|FG002|STARTED|Overall Study||35
6342287|NCT00577993|7249661|FG000|COMPLETED|Overall Study||78
6342288|NCT00577993|7249662|FG001|COMPLETED|Overall Study||80
6342289|NCT00577993|7249663|FG002|COMPLETED|Overall Study||32
6342290|NCT00577993|7249661|FG000|NOT COMPLETED|Overall Study||7
6342291|NCT00577993|7249662|FG001|NOT COMPLETED|Overall Study||10
6342292|NCT00577993|7249663|FG002|NOT COMPLETED|Overall Study||3
6342293|NCT00578071|7249669|FG000|STARTED|Overall Study||29
6342294|NCT00578071|7249669|FG000|COMPLETED|Overall Study||29
6342295|NCT00578071|7249669|FG000|NOT COMPLETED|Overall Study||0
6342296|NCT00578136|7249676|FG000|STARTED|Overall Study||27
6342297|NCT00578136|7249677|FG001|STARTED|Overall Study||27
6342298|NCT00578136|7249676|FG000|COMPLETED|Overall Study||26
6342299|NCT00578136|7249677|FG001|COMPLETED|Overall Study||26
6342300|NCT00578136|7249676|FG000|NOT COMPLETED|Overall Study||1
6342301|NCT00578136|7249677|FG001|NOT COMPLETED|Overall Study||1
6342302|NCT00578175|7249686|FG000|STARTED|Overall Study||705
6342303|NCT00578175|7249687|FG001|STARTED|Overall Study||689
6342304|NCT00578175|7249688|FG002|STARTED|Overall Study||389
6342305|NCT00578175|7249686|FG000|COMPLETED|Overall Study||635
6342306|NCT00578175|7249687|FG001|COMPLETED|Overall Study||646
6342307|NCT00578175|7249688|FG002|COMPLETED|Overall Study||365
6342308|NCT00578175|7249686|FG000|NOT COMPLETED|Overall Study||70
6342309|NCT00578175|7249687|FG001|NOT COMPLETED|Overall Study||43
6342310|NCT00578175|7249688|FG002|NOT COMPLETED|Overall Study||24
6342311|NCT00578214|7249701|FG000|STARTED|Overall Study||22
6342312|NCT00578214|7249702|FG001|STARTED|Overall Study||22
6342313|NCT00578214|7249703|FG002|STARTED|Overall Study||31
6342314|NCT00578214|7249701|FG000|COMPLETED|Overall Study||22
6342315|NCT00578214|7249702|FG001|COMPLETED|Overall Study||22
6342316|NCT00578214|7249703|FG002|COMPLETED|Overall Study||31
6342317|NCT00578214|7249701|FG000|NOT COMPLETED|Overall Study||0
6342318|NCT00578214|7249702|FG001|NOT COMPLETED|Overall Study||0
6342319|NCT00578214|7249703|FG002|NOT COMPLETED|Overall Study||0
6342320|NCT00578227|7249714|FG000|STARTED|Overall Study||272
6342321|NCT00578227|7249715|FG001|STARTED|Overall Study||270
6342322|NCT00578227|7249716|FG002|STARTED|Overall Study||271
6342323|NCT00578227|7249714|FG000|COMPLETED|Overall Study||267
6342324|NCT00578227|7249715|FG001|COMPLETED|Overall Study||268
6342325|NCT00578227|7249716|FG002|COMPLETED|Overall Study||267
6342326|NCT00578227|7249714|FG000|NOT COMPLETED|Overall Study||5
6342327|NCT00578227|7249715|FG001|NOT COMPLETED|Overall Study||2
6342328|NCT00578227|7249716|FG002|NOT COMPLETED|Overall Study||4
6376530|NCT00759876|7287058|FG000|NOT COMPLETED|Overall Study||36
6376531|NCT00759902|7287064|FG000|STARTED|Overall Study||18
6376532|NCT00759902|7287065|FG001|STARTED|Overall Study||18
6376533|NCT00759902|7287064|FG000|COMPLETED|Overall Study||18
6376534|NCT00759902|7287065|FG001|COMPLETED|Overall Study||17
6376535|NCT00759902|7287064|FG000|NOT COMPLETED|Overall Study||0
6376536|NCT00759902|7287065|FG001|NOT COMPLETED|Overall Study||1
6376537|NCT00759915|7287073|FG000|STARTED|Overall Study||18
6376538|NCT00759915|7287074|FG001|STARTED|Overall Study||18
6376539|NCT00759915|7287073|FG000|COMPLETED|Overall Study||17
6376540|NCT00759915|7287074|FG001|COMPLETED|Overall Study||17
6376541|NCT00759915|7287073|FG000|NOT COMPLETED|Overall Study||1
6376542|NCT00759915|7287074|FG001|NOT COMPLETED|Overall Study||1
6376543|NCT00759941|7287082|FG000|STARTED|Overall Study||42
6376544|NCT00759941|7287083|FG001|STARTED|Overall Study||44
6376545|NCT00759941|7287082|FG000|COMPLETED|Overall Study||39
6376546|NCT00759941|7287083|FG001|COMPLETED|Overall Study||43
6376547|NCT00759941|7287082|FG000|NOT COMPLETED|Overall Study||3
6376548|NCT00759941|7287083|FG001|NOT COMPLETED|Overall Study||1
6376549|NCT00759954|7287091|FG000|STARTED|Overall Study|All assigned participants entered trial|18
6376550|NCT00759954|7287092|FG001|STARTED|Overall Study|All assigned participants entered trial|18
6376551|NCT00759954|7287091|FG000|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
6376552|NCT00759954|7287092|FG001|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
6376553|NCT00759954|7287091|FG000|NOT COMPLETED|Overall Study||2
6376554|NCT00759954|7287092|FG001|NOT COMPLETED|Overall Study||2
6376555|NCT00759967|7287098|FG000|STARTED|First Intervention||10
6376556|NCT00759967|7287099|FG001|STARTED|First Intervention||9
6376557|NCT00759967|7287098|FG000|COMPLETED|First Intervention||10
6376558|NCT00759967|7287099|FG001|COMPLETED|First Intervention||9
6376559|NCT00759967|7287098|FG000|NOT COMPLETED|First Intervention||0
6376560|NCT00759967|7287099|FG001|NOT COMPLETED|First Intervention||0
6376561|NCT00759967|7287098|FG000|STARTED|Second Intervention||10
6376562|NCT00759967|7287099|FG001|STARTED|Second Intervention||9
6376563|NCT00759967|7287098|FG000|COMPLETED|Second Intervention||8
6376564|NCT00759967|7287099|FG001|COMPLETED|Second Intervention||9
6376565|NCT00759967|7287098|FG000|NOT COMPLETED|Second Intervention||2
6376566|NCT00759967|7287099|FG001|NOT COMPLETED|Second Intervention||0
6376567|NCT00760006|7287111|FG000|STARTED|Overall Study||86
6376568|NCT00760006|7287112|FG001|STARTED|Overall Study||138
6376569|NCT00760006|7287111|FG000|COMPLETED|Overall Study||86
6376570|NCT00760006|7287112|FG001|COMPLETED|Overall Study||138
6342329|NCT00578279|7249728|FG000|STARTED|Overall Study||10
6342330|NCT00578279|7249729|FG001|STARTED|Overall Study||10
6342331|NCT00578279|7249728|FG000|COMPLETED|Overall Study||10
6342332|NCT00578279|7249729|FG001|COMPLETED|Overall Study||10
6342333|NCT00578279|7249728|FG000|NOT COMPLETED|Overall Study||0
6342334|NCT00578279|7249729|FG001|NOT COMPLETED|Overall Study||0
6342335|NCT00578292|7249735|FG000|STARTED|Overall Study||10
6342336|NCT00578292|7249735|FG000|COMPLETED|Overall Study||7
6342337|NCT00578292|7249735|FG000|NOT COMPLETED|Overall Study||3
6342338|NCT00578305|7249742|FG000|STARTED|Double-blind Treatment Phase||62
6342339|NCT00578305|7249743|FG001|STARTED|Double-blind Treatment Phase||60
6342340|NCT00578305|7249744|FG002|STARTED|Double-blind Treatment Phase||63
6342341|NCT00578305|7249742|FG000|Treated|Double-blind Treatment Phase||62
6342342|NCT00578305|7249743|FG001|Treated|Double-blind Treatment Phase||60
6342343|NCT00578305|7249744|FG002|Treated|Double-blind Treatment Phase||63
6342344|NCT00578305|7249742|FG000|COMPLETED|Double-blind Treatment Phase||59
6342345|NCT00578305|7249743|FG001|COMPLETED|Double-blind Treatment Phase||56
6342346|NCT00578305|7249744|FG002|COMPLETED|Double-blind Treatment Phase||49
6342347|NCT00578305|7249742|FG000|NOT COMPLETED|Double-blind Treatment Phase||3
6342348|NCT00578305|7249743|FG001|NOT COMPLETED|Double-blind Treatment Phase||4
6342349|NCT00578305|7249744|FG002|NOT COMPLETED|Double-blind Treatment Phase||14
6342350|NCT00578305|7249742|FG000|STARTED|Extension Phase||53
6342351|NCT00578305|7249743|FG001|STARTED|Extension Phase||50
6342352|NCT00578305|7249744|FG002|STARTED|Extension Phase||43
6342353|NCT00578305|7249742|FG000|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
6342354|NCT00578305|7249743|FG001|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
6559321|NCT01781286|7481973|FG005|Started 3rd Intervention|Overall Study||2
6559322|NCT01781286|7481968|FG000|COMPLETED|Overall Study||5
6559323|NCT01781286|7481969|FG001|COMPLETED|Overall Study||4
6559324|NCT01781286|7481970|FG002|COMPLETED|Overall Study||7
6342355|NCT00578305|7249744|FG002|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
6342356|NCT00578305|7249742|FG000|NOT COMPLETED|Extension Phase||4
6342357|NCT00578305|7249743|FG001|NOT COMPLETED|Extension Phase||1
6342358|NCT00578305|7249744|FG002|NOT COMPLETED|Extension Phase||3
6342359|NCT00578305|7249742|FG000|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
6342360|NCT00578305|7249743|FG001|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
6342361|NCT00578305|7249744|FG002|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
6342362|NCT00578305|7249742|FG000|COMPLETED|Safety Follow-up Phase||11
6342363|NCT00578305|7249743|FG001|COMPLETED|Safety Follow-up Phase||9
6342364|NCT00578305|7249744|FG002|COMPLETED|Safety Follow-up Phase||8
6342365|NCT00578305|7249742|FG000|NOT COMPLETED|Safety Follow-up Phase||46
6342366|NCT00578305|7249743|FG001|NOT COMPLETED|Safety Follow-up Phase||45
6776367|NCT03815240|7704432|FG005|COMPLETED|Intervention Optifoam Dressing||2
6776368|NCT03815240|7704433|FG006|COMPLETED|Intervention Optifoam Dressing||1
6776369|NCT03815240|7704434|FG007|COMPLETED|Intervention Optifoam Dressing||1
6776370|NCT03815240|7704435|FG008|COMPLETED|Intervention Optifoam Dressing||1
6776371|NCT03815240|7704427|FG000|NOT COMPLETED|Intervention Optifoam Dressing||0
6776372|NCT03815240|7704428|FG001|NOT COMPLETED|Intervention Optifoam Dressing||0
6776373|NCT03815240|7704429|FG002|NOT COMPLETED|Intervention Optifoam Dressing||0
6776374|NCT03815240|7704430|FG003|NOT COMPLETED|Intervention Optifoam Dressing||0
6776375|NCT03815240|7704431|FG004|NOT COMPLETED|Intervention Optifoam Dressing||0
6776376|NCT03815240|7704432|FG005|NOT COMPLETED|Intervention Optifoam Dressing||0
6776377|NCT03815240|7704433|FG006|NOT COMPLETED|Intervention Optifoam Dressing||0
6776378|NCT03815240|7704434|FG007|NOT COMPLETED|Intervention Optifoam Dressing||0
6776379|NCT03815240|7704435|FG008|NOT COMPLETED|Intervention Optifoam Dressing||0
6776380|NCT03836859|7704453|FG000|STARTED|Overall Study||20
6776381|NCT03836859|7704454|FG001|STARTED|Overall Study||10
6776382|NCT03836859|7704453|FG000|COMPLETED|Overall Study||20
6776383|NCT03836859|7704454|FG001|COMPLETED|Overall Study||10
6776384|NCT03836859|7704453|FG000|NOT COMPLETED|Overall Study||0
6776385|NCT03836859|7704454|FG001|NOT COMPLETED|Overall Study||0
6776386|NCT03835078|7704460|FG000|STARTED|Overall Study||39
6776387|NCT03835078|7704460|FG000|COMPLETED|Overall Study||39
6342367|NCT00578305|7249744|FG002|NOT COMPLETED|Safety Follow-up Phase||46
6342368|NCT00578318|7249760|FG000|STARTED|Overall Study||8
6342369|NCT00578318|7249761|FG001|STARTED|Overall Study||8
6342370|NCT00578318|7249760|FG000|COMPLETED|Overall Study||5
6342371|NCT00578318|7249761|FG001|COMPLETED|Overall Study||8
6559325|NCT01781286|7481971|FG003|COMPLETED|Overall Study||7
6776388|NCT03835078|7704460|FG000|NOT COMPLETED|Overall Study||0
6342372|NCT00578318|7249760|FG000|NOT COMPLETED|Overall Study||3
6342373|NCT00578318|7249761|FG001|NOT COMPLETED|Overall Study||0
6342374|NCT00578331|7249769|FG000|STARTED|Overall Study||445
6342375|NCT00578331|7249770|FG001|STARTED|Overall Study||445
6342376|NCT00578331|7249769|FG000|COMPLETED|Overall Study||329
6342377|NCT00578331|7249770|FG001|COMPLETED|Overall Study||320
6342378|NCT00578331|7249769|FG000|NOT COMPLETED|Overall Study||116
6342379|NCT00578331|7249770|FG001|NOT COMPLETED|Overall Study||125
6559326|NCT01781286|7481972|FG004|COMPLETED|Overall Study||6
6559327|NCT01781286|7481973|FG005|COMPLETED|Overall Study||2
6342380|NCT00578344|7249776|FG000|STARTED|Overall Study||8
6342381|NCT00578344|7249776|FG000|COMPLETED|Overall Study||6
6342382|NCT00578344|7249776|FG000|NOT COMPLETED|Overall Study||2
6342383|NCT00578383|7249784|FG000|STARTED|Overall Study||37
6342384|NCT00578383|7249785|FG001|STARTED|Overall Study||36
6342385|NCT00578383|7249786|FG002|STARTED|Overall Study||19
6342386|NCT00578383|7249787|FG003|STARTED|Overall Study||15
6342387|NCT00578383|7249784|FG000|COMPLETED|Overall Study||21
6342388|NCT00578383|7249785|FG001|COMPLETED|Overall Study||20
6342389|NCT00578383|7249786|FG002|COMPLETED|Overall Study||13
6342390|NCT00578383|7249787|FG003|COMPLETED|Overall Study||9
6342391|NCT00578383|7249784|FG000|NOT COMPLETED|Overall Study||16
6342392|NCT00578383|7249785|FG001|NOT COMPLETED|Overall Study||16
6342393|NCT00578383|7249786|FG002|NOT COMPLETED|Overall Study||6
6342394|NCT00578383|7249787|FG003|NOT COMPLETED|Overall Study||6
6342395|NCT00578448|7249801|FG000|STARTED|Day 1 up to 3 Years of Planned Study||12
6342396|NCT00578448|7249801|FG000|COMPLETED|Day 1 up to 3 Years of Planned Study||9
6342397|NCT00578448|7249801|FG000|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
6342398|NCT00578448|7249801|FG000|STARTED|1 Year Long Term Extension (LTE)||9
6342399|NCT00578448|7249801|FG000|COMPLETED|1 Year Long Term Extension (LTE)||8
6342400|NCT00578448|7249801|FG000|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
6342401|NCT00578461|7249807|FG000|STARTED|Overall Study||26
6342402|NCT00578461|7249807|FG000|COMPLETED|Overall Study||26
6342403|NCT00578461|7249807|FG000|NOT COMPLETED|Overall Study||0
6342404|NCT00578539|7249811|FG000|STARTED|Overall Study||24
6342405|NCT00578539|7249811|FG000|COMPLETED|Overall Study||24
6342406|NCT00578539|7249811|FG000|NOT COMPLETED|Overall Study||0
6342407|NCT00578552|7249818|FG000|STARTED|Overall Study||27
6342408|NCT00578552|7249819|FG001|STARTED|Overall Study||27
6342409|NCT00578552|7249820|FG002|STARTED|Overall Study||26
6342410|NCT00578552|7249818|FG000|COMPLETED|Overall Study||12
6342411|NCT00578552|7249819|FG001|COMPLETED|Overall Study||13
6342412|NCT00578552|7249820|FG002|COMPLETED|Overall Study||11
6342413|NCT00578552|7249818|FG000|NOT COMPLETED|Overall Study||15
6342414|NCT00578552|7249819|FG001|NOT COMPLETED|Overall Study||14
6342415|NCT00578552|7249820|FG002|NOT COMPLETED|Overall Study||15
6342416|NCT00578565|7249828|FG000|STARTED|Overall Study||10
6342417|NCT00578565|7249828|FG000|COMPLETED|Overall Study||7
6342418|NCT00578565|7249828|FG000|NOT COMPLETED|Overall Study||3
6342419|NCT00578617|7249835|FG000|STARTED|Overall Study||31
6342420|NCT00578617|7249836|FG001|STARTED|Overall Study||29
6342421|NCT00578617|7249835|FG000|COMPLETED|Overall Study||31
6342422|NCT00578617|7249836|FG001|COMPLETED|Overall Study||29
6342423|NCT00578617|7249835|FG000|NOT COMPLETED|Overall Study||0
6342424|NCT00578617|7249836|FG001|NOT COMPLETED|Overall Study||0
6342425|NCT00578643|7249842|FG000|STARTED|Overall Study||15
6342426|NCT00578643|7249842|FG000|COMPLETED|Overall Study||13
6342427|NCT00578643|7249842|FG000|NOT COMPLETED|Overall Study||2
6342428|NCT00578669|7249848|FG000|STARTED|Overall Study||107
6342429|NCT00578669|7249849|FG001|STARTED|Overall Study||99
6342430|NCT00578669|7249848|FG000|COMPLETED|Overall Study||107
6342431|NCT00578669|7249849|FG001|COMPLETED|Overall Study||99
6342432|NCT00578669|7249848|FG000|NOT COMPLETED|Overall Study||0
6342433|NCT00578669|7249849|FG001|NOT COMPLETED|Overall Study||0
6342434|NCT00578734|7249857|FG000|STARTED|Overall Study||84
6342435|NCT00578734|7249858|FG001|STARTED|Overall Study||81
6342436|NCT00578734|7249857|FG000|COMPLETED|Overall Study||84
6342437|NCT00578734|7249858|FG001|COMPLETED|Overall Study||81
6342438|NCT00578734|7249857|FG000|NOT COMPLETED|Overall Study||0
6342439|NCT00578734|7249858|FG001|NOT COMPLETED|Overall Study||0
6342440|NCT00578786|7249867|FG000|STARTED|Overall Study||96
6342441|NCT00578786|7249868|FG001|STARTED|Overall Study||190
6342442|NCT00578786|7249869|FG002|STARTED|Overall Study||97
6342443|NCT00578786|7249867|FG000|COMPLETED|Overall Study||57
6342444|NCT00578786|7249868|FG001|COMPLETED|Overall Study||124
6342445|NCT00578786|7249869|FG002|COMPLETED|Overall Study||67
6342446|NCT00578786|7249867|FG000|NOT COMPLETED|Overall Study||39
6342447|NCT00578786|7249868|FG001|NOT COMPLETED|Overall Study||66
6342448|NCT00578786|7249869|FG002|NOT COMPLETED|Overall Study||30
6342449|NCT00578812|7249889|FG000|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
6342450|NCT00578812|7249890|FG001|STARTED|Overall Study||192
6342451|NCT00578812|7249889|FG000|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
6342452|NCT00578812|7249890|FG001|COMPLETED|Overall Study||185
6342453|NCT00578812|7249889|FG000|NOT COMPLETED|Overall Study||6
6342454|NCT00578812|7249890|FG001|NOT COMPLETED|Overall Study||7
6342455|NCT00578864|7249899|FG000|STARTED|Overall Study||7
6342456|NCT00578864|7249900|FG001|STARTED|Overall Study||6
6342457|NCT00578864|7249899|FG000|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
6342458|NCT00578864|7249900|FG001|COMPLETED|Overall Study||6
6342459|NCT00578864|7249899|FG000|NOT COMPLETED|Overall Study||1
6342460|NCT00578864|7249900|FG001|NOT COMPLETED|Overall Study||0
6342461|NCT00578877|7249908|FG000|STARTED|Overall Study||150
6342462|NCT00578877|7249909|FG001|STARTED|Overall Study||300
6342463|NCT00578877|7249908|FG000|COMPLETED|Overall Study||69
6342464|NCT00578877|7249909|FG001|COMPLETED|Overall Study||172
6342465|NCT00578877|7249908|FG000|NOT COMPLETED|Overall Study||81
6342466|NCT00578877|7249909|FG001|NOT COMPLETED|Overall Study||128
6342467|NCT00578903|7249915|FG000|STARTED|Overall Study||22
6342468|NCT00578903|7249915|FG000|COMPLETED|Overall Study||22
6342469|NCT00578903|7249915|FG000|NOT COMPLETED|Overall Study||0
6342470|NCT00578929|7249923|FG000|STARTED|Vehicle Run-In Period||0
6342471|NCT00578929|7249924|FG001|STARTED|Vehicle Run-In Period||2388
6342472|NCT00578929|7249925|FG002|STARTED|Vehicle Run-In Period||0
6342473|NCT00578929|7249926|FG003|STARTED|Vehicle Run-In Period||0
6342474|NCT00578929|7249923|FG000|COMPLETED|Vehicle Run-In Period||0
6342475|NCT00578929|7249924|FG001|COMPLETED|Vehicle Run-In Period||2388
6342476|NCT00578929|7249925|FG002|COMPLETED|Vehicle Run-In Period||0
6342477|NCT00578929|7249926|FG003|COMPLETED|Vehicle Run-In Period||0
6342478|NCT00578929|7249923|FG000|NOT COMPLETED|Vehicle Run-In Period||0
6342479|NCT00578929|7249924|FG001|NOT COMPLETED|Vehicle Run-In Period||0
6342480|NCT00578929|7249925|FG002|NOT COMPLETED|Vehicle Run-In Period||0
6342481|NCT00578929|7249926|FG003|NOT COMPLETED|Vehicle Run-In Period||0
6342482|NCT00578929|7249923|FG000|STARTED|Randomized Period||298
6342483|NCT00578929|7249924|FG001|STARTED|Randomized Period||297
6342484|NCT00578929|7249925|FG002|STARTED|Randomized Period||296
6342485|NCT00578929|7249926|FG003|STARTED|Randomized Period||297
6342486|NCT00578929|7249923|FG000|COMPLETED|Randomized Period||281
6342487|NCT00578929|7249924|FG001|COMPLETED|Randomized Period||283
6342488|NCT00578929|7249925|FG002|COMPLETED|Randomized Period||288
6342489|NCT00578929|7249926|FG003|COMPLETED|Randomized Period||283
6342490|NCT00578929|7249923|FG000|NOT COMPLETED|Randomized Period||17
6342491|NCT00578929|7249924|FG001|NOT COMPLETED|Randomized Period||14
6342492|NCT00578929|7249925|FG002|NOT COMPLETED|Randomized Period||8
6342493|NCT00578929|7249926|FG003|NOT COMPLETED|Randomized Period||14
6342494|NCT00578942|7249937|FG000|STARTED|Overall Study||48
6342495|NCT00578942|7249937|FG000|COMPLETED|Overall Study||47
6342496|NCT00578942|7249937|FG000|NOT COMPLETED|Overall Study||1
6342497|NCT00578968|7249944|FG000|STARTED|Baseline (Prior to Intervention)||12
6342498|NCT00578968|7249945|FG001|STARTED|Baseline (Prior to Intervention)||12
6342499|NCT00578968|7249946|FG002|STARTED|Baseline (Prior to Intervention)||12
6342500|NCT00578968|7249944|FG000|COMPLETED|Baseline (Prior to Intervention)||12
6342501|NCT00578968|7249945|FG001|COMPLETED|Baseline (Prior to Intervention)||12
6342502|NCT00578968|7249946|FG002|COMPLETED|Baseline (Prior to Intervention)||12
6342503|NCT00578968|7249944|FG000|NOT COMPLETED|Baseline (Prior to Intervention)||0
6342504|NCT00578968|7249945|FG001|NOT COMPLETED|Baseline (Prior to Intervention)||0
6342505|NCT00578968|7249946|FG002|NOT COMPLETED|Baseline (Prior to Intervention)||0
6342506|NCT00578968|7249944|FG000|STARTED|Intervention||12
6342507|NCT00578968|7249945|FG001|STARTED|Intervention||12
6342508|NCT00578968|7249946|FG002|STARTED|Intervention||0
6342509|NCT00578968|7249944|FG000|COMPLETED|Intervention||12
6342510|NCT00578968|7249945|FG001|COMPLETED|Intervention||12
6342511|NCT00578968|7249946|FG002|COMPLETED|Intervention||0
6342512|NCT00578968|7249944|FG000|NOT COMPLETED|Intervention||0
6342513|NCT00578968|7249945|FG001|NOT COMPLETED|Intervention||0
6342514|NCT00578968|7249946|FG002|NOT COMPLETED|Intervention||0
6342515|NCT00579059|7249957|FG000|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
6342516|NCT00579059|7249958|FG001|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
6342517|NCT00579059|7249957|FG000|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
6342518|NCT00579059|7249958|FG001|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
6342519|NCT00579059|7249957|FG000|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
6342520|NCT00579059|7249958|FG001|6 Months|Overall Study|6 patients didn't return for follow-up.|4
6342521|NCT00579059|7249957|FG000|1 Year|Overall Study|13 patients didn't return for follow-up.|8
6342522|NCT00579059|7249958|FG001|1 Year|Overall Study|7 patients didn't return for follow-up.|3
6342523|NCT00579059|7249957|FG000|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
6342524|NCT00579059|7249958|FG001|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
6342525|NCT00579059|7249957|FG000|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
6342526|NCT00579059|7249958|FG001|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
6342527|NCT00579059|7249957|FG000|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
6342528|NCT00579059|7249958|FG001|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
6342529|NCT00579059|7249957|FG000|NOT COMPLETED|Overall Study||21
6342530|NCT00579059|7249958|FG001|NOT COMPLETED|Overall Study||10
6342531|NCT00579098|7249966|FG000|STARTED|Overall Study||62
6342532|NCT00579098|7249967|FG001|STARTED|Overall Study||63
6342533|NCT00579098|7249966|FG000|COMPLETED|Overall Study||53
6342534|NCT00579098|7249967|FG001|COMPLETED|Overall Study||55
6342535|NCT00579098|7249966|FG000|NOT COMPLETED|Overall Study||9
6342536|NCT00579098|7249967|FG001|NOT COMPLETED|Overall Study||8
6342537|NCT00579111|7249975|FG000|STARTED|Overall Study||3
6342538|NCT00579111|7249976|FG001|STARTED|Overall Study||1
6342539|NCT00579111|7249975|FG000|COMPLETED|Overall Study||1
6342540|NCT00579111|7249976|FG001|COMPLETED|Overall Study||0
6342541|NCT00579111|7249975|FG000|NOT COMPLETED|Overall Study||2
6342542|NCT00579111|7249976|FG001|NOT COMPLETED|Overall Study||1
6342543|NCT00579137|7249982|FG000|STARTED|Overall Study||3
6342544|NCT00579137|7249982|FG000|COMPLETED|Overall Study||3
6342545|NCT00579137|7249982|FG000|NOT COMPLETED|Overall Study||0
6342546|NCT00579280|7249989|FG000|STARTED|Overall Study||49
6342547|NCT00579280|7249990|FG001|STARTED|Overall Study||49
6342548|NCT00579280|7249991|FG002|STARTED|Overall Study||51
6342549|NCT00579280|7249989|FG000|COMPLETED|Overall Study|LOCF evaluable sample|47
6342550|NCT00579280|7249990|FG001|COMPLETED|Overall Study|LOCF evaluable sample|46
6342551|NCT00579280|7249991|FG002|COMPLETED|Overall Study|LOCF evaluable sample|51
6342552|NCT00579280|7249989|FG000|NOT COMPLETED|Overall Study||2
6342553|NCT00579280|7249990|FG001|NOT COMPLETED|Overall Study||3
6342554|NCT00579280|7249991|FG002|NOT COMPLETED|Overall Study||0
6342555|NCT00579345|7250007|FG000|STARTED|Overall Study||549
6342556|NCT00579345|7250008|FG001|STARTED|Overall Study||169
6342557|NCT00579345|7250009|FG002|STARTED|Overall Study||391
6342558|NCT00579345|7250010|FG003|STARTED|Overall Study||144
6342559|NCT00579345|7250011|FG004|STARTED|Overall Study||90
6342560|NCT00579345|7250012|FG005|STARTED|Overall Study||78
6342561|NCT00579345|7250013|FG006|STARTED|Overall Study||57
6342562|NCT00579345|7250014|FG007|STARTED|Overall Study||44
6342563|NCT00579345|7250007|FG000|COMPLETED|Overall Study||544
6342564|NCT00579345|7250008|FG001|COMPLETED|Overall Study||168
6342565|NCT00579345|7250009|FG002|COMPLETED|Overall Study||389
6342566|NCT00579345|7250010|FG003|COMPLETED|Overall Study||143
6342567|NCT00579345|7250011|FG004|COMPLETED|Overall Study||90
6342568|NCT00579345|7250012|FG005|COMPLETED|Overall Study||78
6342569|NCT00579345|7250013|FG006|COMPLETED|Overall Study||57
6342570|NCT00579345|7250014|FG007|COMPLETED|Overall Study||42
6342571|NCT00579345|7250007|FG000|NOT COMPLETED|Overall Study||5
6342572|NCT00579345|7250008|FG001|NOT COMPLETED|Overall Study||1
6342573|NCT00579345|7250009|FG002|NOT COMPLETED|Overall Study||2
6342574|NCT00579345|7250010|FG003|NOT COMPLETED|Overall Study||1
6342575|NCT00579345|7250011|FG004|NOT COMPLETED|Overall Study||0
6342576|NCT00579345|7250012|FG005|NOT COMPLETED|Overall Study||0
6342577|NCT00579345|7250013|FG006|NOT COMPLETED|Overall Study||0
6342578|NCT00579345|7250014|FG007|NOT COMPLETED|Overall Study||2
6342579|NCT00579436|7250044|FG000|STARTED|Overall Study||19
6342580|NCT00579436|7250045|FG001|STARTED|Overall Study||14
6342581|NCT00579436|7250044|FG000|COMPLETED|Overall Study||19
6342582|NCT00579436|7250045|FG001|COMPLETED|Overall Study||14
6342583|NCT00579436|7250044|FG000|NOT COMPLETED|Overall Study||0
6342584|NCT00579436|7250045|FG001|NOT COMPLETED|Overall Study||0
6342585|NCT00579501|7250051|FG000|STARTED|Overall Study||29
6342586|NCT00579501|7250051|FG000|COMPLETED|Overall Study||0
6342587|NCT00579501|7250051|FG000|NOT COMPLETED|Overall Study||29
6342588|NCT00579553|7250057|FG000|STARTED|Overall Study||82
6342589|NCT00579553|7250058|FG001|STARTED|Overall Study||92
6342590|NCT00579553|7250057|FG000|COMPLETED|Overall Study||66
6342591|NCT00579553|7250058|FG001|COMPLETED|Overall Study||79
6342592|NCT00579553|7250057|FG000|NOT COMPLETED|Overall Study||16
6342593|NCT00579553|7250058|FG001|NOT COMPLETED|Overall Study||13
6342594|NCT00579670|7250069|FG000|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
6342595|NCT00579670|7250070|FG001|STARTED|Overall Study||57
6342596|NCT00579670|7250071|FG002|STARTED|Overall Study||88
6342597|NCT00579670|7250072|FG003|STARTED|Overall Study||285
6342598|NCT00579670|7250073|FG004|STARTED|Overall Study||5
6342599|NCT00579670|7250069|FG000|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
6342600|NCT00579670|7250070|FG001|Population: Within SmPC (Started)|Overall Study||56
6342601|NCT00579670|7250071|FG002|Population: Within SmPC (Started)|Overall Study||83
6342602|NCT00579670|7250072|FG003|Population: Within SmPC (Started)|Overall Study||159
6342603|NCT00579670|7250073|FG004|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
6342604|NCT00579670|7250069|FG000|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
6342605|NCT00579670|7250070|FG001|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
6342606|NCT00579670|7250071|FG002|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
6342607|NCT00579670|7250072|FG003|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
6342608|NCT00579670|7250073|FG004|Population: Within SmPC (Completed)|Overall Study||0
6342609|NCT00579670|7250069|FG000|COMPLETED|Overall Study||13
6342610|NCT00579670|7250070|FG001|COMPLETED|Overall Study||56
6342611|NCT00579670|7250071|FG002|COMPLETED|Overall Study||84
6342612|NCT00579670|7250072|FG003|COMPLETED|Overall Study||263
6342613|NCT00579670|7250073|FG004|COMPLETED|Overall Study||5
6342614|NCT00579670|7250069|FG000|NOT COMPLETED|Overall Study||2
6342615|NCT00579670|7250070|FG001|NOT COMPLETED|Overall Study||1
6342616|NCT00579670|7250071|FG002|NOT COMPLETED|Overall Study||4
6342617|NCT00579670|7250072|FG003|NOT COMPLETED|Overall Study||22
6342618|NCT00579670|7250073|FG004|NOT COMPLETED|Overall Study||0
6342619|NCT00579813|7250099|FG000|STARTED|Overall Study||60
6342620|NCT00579813|7250100|FG001|STARTED|Overall Study||10
6342621|NCT00579813|7250099|FG000|COMPLETED|Overall Study||60
6342622|NCT00579813|7250100|FG001|COMPLETED|Overall Study||10
6342623|NCT00579813|7250099|FG000|NOT COMPLETED|Overall Study||0
6342624|NCT00579813|7250100|FG001|NOT COMPLETED|Overall Study||0
6342625|NCT00579878|7250110|FG000|STARTED|Overall Study||22
6342626|NCT00579878|7250111|FG001|STARTED|Overall Study||23
6342627|NCT00579878|7250112|FG002|STARTED|Overall Study||24
6342628|NCT00579878|7250110|FG000|COMPLETED|Overall Study||15
6342629|NCT00579878|7250111|FG001|COMPLETED|Overall Study||20
6342630|NCT00579878|7250112|FG002|COMPLETED|Overall Study||14
6342631|NCT00579878|7250110|FG000|NOT COMPLETED|Overall Study||7
6342632|NCT00579878|7250111|FG001|NOT COMPLETED|Overall Study||3
6342633|NCT00579878|7250112|FG002|NOT COMPLETED|Overall Study||10
6342634|NCT00579982|7250120|FG000|STARTED|Overall Study||97
6342635|NCT00579982|7250120|FG000|COMPLETED|Overall Study||89
6342636|NCT00579982|7250120|FG000|NOT COMPLETED|Overall Study||8
6342637|NCT00580034|7250124|FG000|STARTED|Overall Study||88
6342638|NCT00580034|7250125|FG001|STARTED|Overall Study||88
6342639|NCT00580034|7250124|FG000|COMPLETED|Overall Study||78
6342640|NCT00580034|7250125|FG001|COMPLETED|Overall Study||88
6342641|NCT00580034|7250124|FG000|NOT COMPLETED|Overall Study||10
6342642|NCT00580034|7250125|FG001|NOT COMPLETED|Overall Study||0
6342643|NCT00580047|7250132|FG000|STARTED|Overall Study||24
6342644|NCT00580047|7250133|FG001|STARTED|Overall Study||23
6342645|NCT00580047|7250134|FG002|STARTED|Overall Study||12
6342646|NCT00580047|7250132|FG000|COMPLETED|Overall Study||21
6342647|NCT00580047|7250133|FG001|COMPLETED|Overall Study||21
6342648|NCT00580047|7250134|FG002|COMPLETED|Overall Study||10
6342649|NCT00580047|7250132|FG000|NOT COMPLETED|Overall Study||3
6342650|NCT00580047|7250133|FG001|NOT COMPLETED|Overall Study||2
6342651|NCT00580047|7250134|FG002|NOT COMPLETED|Overall Study||2
6342652|NCT00580073|7250145|FG000|STARTED|Overall Study||6
6342653|NCT00580073|7250145|FG000|COMPLETED|Overall Study||6
6342654|NCT00580073|7250145|FG000|NOT COMPLETED|Overall Study||0
6342655|NCT00580138|7250149|FG000|STARTED|Overall Study||30
6342656|NCT00580138|7250149|FG000|COMPLETED|Overall Study||30
6342657|NCT00580138|7250149|FG000|NOT COMPLETED|Overall Study||0
6342658|NCT00580151|7250155|FG000|STARTED|Overall Study||9
6342659|NCT00580151|7250156|FG001|STARTED|Overall Study||0
6342660|NCT00580151|7250155|FG000|COMPLETED|Overall Study||9
6342661|NCT00580151|7250156|FG001|COMPLETED|Overall Study||0
6342662|NCT00580151|7250155|FG000|NOT COMPLETED|Overall Study||0
6342663|NCT00580151|7250156|FG001|NOT COMPLETED|Overall Study||0
6342664|NCT00580229|7250162|FG000|STARTED|Overall Study||50
6342665|NCT00580229|7250162|FG000|COMPLETED|Overall Study||50
6342666|NCT00580229|7250162|FG000|NOT COMPLETED|Overall Study||0
6342667|NCT00580294|7250166|FG000|STARTED|Overall Study||12
6342668|NCT00580294|7250166|FG000|COMPLETED|Overall Study||12
6342669|NCT00580294|7250166|FG000|NOT COMPLETED|Overall Study||0
6342670|NCT00580333|7250170|FG000|STARTED|Overall Study||51
6342671|NCT00580333|7250170|FG000|COMPLETED|Overall Study||51
6342672|NCT00580333|7250170|FG000|NOT COMPLETED|Overall Study||0
6342673|NCT00580372|7250175|FG000|STARTED|Overall Study||231
6342674|NCT00580372|7250175|FG000|COMPLETED|Overall Study||231
6342675|NCT00580372|7250175|FG000|NOT COMPLETED|Overall Study||0
6342676|NCT00580398|7250181|FG000|STARTED|Overall Study||17
6342677|NCT00580398|7250182|FG001|STARTED|Overall Study||32
6342678|NCT00580398|7250181|FG000|COMPLETED|Overall Study||17
6342679|NCT00580398|7250182|FG001|COMPLETED|Overall Study||32
6342680|NCT00580398|7250181|FG000|NOT COMPLETED|Overall Study||0
6342681|NCT00580398|7250182|FG001|NOT COMPLETED|Overall Study||0
6342682|NCT00580502|7250188|FG000|STARTED|Overall Study||50
6342683|NCT00580502|7250188|FG000|COMPLETED|Overall Study||50
6342684|NCT00580502|7250188|FG000|NOT COMPLETED|Overall Study||0
6342685|NCT00580606|7250194|FG000|STARTED|Double Blind (DB)||20
6342686|NCT00580606|7250195|FG001|STARTED|Double Blind (DB)||20
6342687|NCT00580606|7250194|FG000|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
6342688|NCT00580606|7250195|FG001|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
6342689|NCT00580606|7250194|FG000|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
6342690|NCT00580606|7250195|FG001|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
6342691|NCT00580606|7250194|FG000|NOT COMPLETED|Double Blind (DB)||0
6342692|NCT00580606|7250195|FG001|NOT COMPLETED|Double Blind (DB)||0
6342693|NCT00580606|7250194|FG000|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
6342694|NCT00580606|7250195|FG001|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
6342695|NCT00580606|7250194|FG000|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
6342696|NCT00580606|7250195|FG001|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
6342697|NCT00580606|7250194|FG000|Had Week 68 Oral Food Challenge|Open Label (OL)||15
6342698|NCT00580606|7250195|FG001|Had Week 68 Oral Food Challenge|Open Label (OL)||12
6342699|NCT00580606|7250194|FG000|Had Week 116 Oral Food Challenge|Open Label (OL)||13
6342700|NCT00580606|7250195|FG001|Had Week 116 Oral Food Challenge|Open Label (OL)||6
6342701|NCT00580606|7250194|FG000|Had Week 164 Oral Food Challenge|Open Label (OL)||9
6342702|NCT00580606|7250195|FG001|Had Week 164 Oral Food Challenge|Open Label (OL)||5
6342703|NCT00580606|7250194|FG000|Had Week 172 Oral Food Challenge|Open Label (OL)||2
6342704|NCT00580606|7250195|FG001|Had Week 172 Oral Food Challenge|Open Label (OL)||2
6342705|NCT00580606|7250194|FG000|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
6342706|NCT00580606|7250195|FG001|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
6342707|NCT00580606|7250194|FG000|NOT COMPLETED|Open Label (OL)||9
6342708|NCT00580606|7250195|FG001|NOT COMPLETED|Open Label (OL)||12
6342709|NCT00580645|7250212|FG000|STARTED|Overall Study||20
6342710|NCT00580645|7250213|FG001|STARTED|Overall Study||20
6342711|NCT00580645|7250214|FG002|STARTED|Overall Study||20
6342712|NCT00580645|7250212|FG000|COMPLETED|Overall Study||20
6342713|NCT00580645|7250213|FG001|COMPLETED|Overall Study||20
6342714|NCT00580645|7250214|FG002|COMPLETED|Overall Study||20
6342715|NCT00580645|7250212|FG000|NOT COMPLETED|Overall Study||0
6342716|NCT00580645|7250213|FG001|NOT COMPLETED|Overall Study||0
6342717|NCT00580645|7250214|FG002|NOT COMPLETED|Overall Study||0
6342718|NCT00580671|7250225|FG000|STARTED|Overall Study||51
6342719|NCT00580671|7250226|FG001|STARTED|Overall Study||51
6342720|NCT00580671|7250227|FG002|STARTED|Overall Study||51
6342721|NCT00580671|7250225|FG000|COMPLETED|Overall Study||35
6342722|NCT00580671|7250226|FG001|COMPLETED|Overall Study||35
6342723|NCT00580671|7250227|FG002|COMPLETED|Overall Study||34
6342724|NCT00580671|7250225|FG000|NOT COMPLETED|Overall Study||16
6342725|NCT00580671|7250226|FG001|NOT COMPLETED|Overall Study||16
6342726|NCT00580671|7250227|FG002|NOT COMPLETED|Overall Study||17
6342727|NCT00580723|7250235|FG000|STARTED|Overall Study||24
6342728|NCT00580723|7250235|FG000|COMPLETED|Overall Study||16
6342729|NCT00580723|7250235|FG000|NOT COMPLETED|Overall Study||8
6342730|NCT00580788|7250243|FG000|STARTED|Overall Study||3
6342731|NCT00580788|7250244|FG001|STARTED|Overall Study||6
6342732|NCT00580788|7250245|FG002|STARTED|Overall Study||3
6342733|NCT00580788|7250246|FG003|STARTED|Overall Study||2
6342734|NCT00580788|7250243|FG000|COMPLETED|Overall Study||3
6342735|NCT00580788|7250244|FG001|COMPLETED|Overall Study||6
6342736|NCT00580788|7250245|FG002|COMPLETED|Overall Study||3
6342737|NCT00580788|7250246|FG003|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
6342738|NCT00580788|7250243|FG000|NOT COMPLETED|Overall Study||0
6342739|NCT00580788|7250244|FG001|NOT COMPLETED|Overall Study||0
6342740|NCT00580788|7250245|FG002|NOT COMPLETED|Overall Study||0
6342741|NCT00580788|7250246|FG003|NOT COMPLETED|Overall Study||1
6342742|NCT00580801|7250266|FG000|STARTED|Overall Study||8
6342743|NCT00580801|7250267|FG001|STARTED|Overall Study||8
6342744|NCT00580801|7250268|FG002|STARTED|Overall Study||8
6342745|NCT00580801|7250266|FG000|COMPLETED|Overall Study||2
6342746|NCT00580801|7250267|FG001|COMPLETED|Overall Study||7
6342747|NCT00580801|7250268|FG002|COMPLETED|Overall Study||5
6342748|NCT00580801|7250266|FG000|NOT COMPLETED|Overall Study||6
6342749|NCT00580801|7250267|FG001|NOT COMPLETED|Overall Study||1
6342750|NCT00580801|7250268|FG002|NOT COMPLETED|Overall Study||3
6342751|NCT00580840|7250276|FG000|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
6342752|NCT00580840|7250277|FG001|STARTED|Run-in||0
6342753|NCT00580840|7250278|FG002|STARTED|Run-in||0
6342754|NCT00580840|7250279|FG003|STARTED|Run-in||0
6342755|NCT00580840|7250276|FG000|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
6342756|NCT00580840|7250277|FG001|COMPLETED|Run-in||0
6342757|NCT00580840|7250278|FG002|COMPLETED|Run-in||0
6342758|NCT00580840|7250279|FG003|COMPLETED|Run-in||0
6342759|NCT00580840|7250276|FG000|NOT COMPLETED|Run-in||124
6342760|NCT00580840|7250277|FG001|NOT COMPLETED|Run-in||0
6342761|NCT00580840|7250278|FG002|NOT COMPLETED|Run-in||0
6342762|NCT00580840|7250279|FG003|NOT COMPLETED|Run-in||0
6342763|NCT00580840|7250276|FG000|STARTED|Double-Blind||0
6342764|NCT00580840|7250277|FG001|STARTED|Double-Blind||70
6342765|NCT00580840|7250278|FG002|STARTED|Double-Blind||70
6342766|NCT00580840|7250279|FG003|STARTED|Double-Blind||69
6342767|NCT00580840|7250276|FG000|COMPLETED|Double-Blind||0
6342768|NCT00580840|7250277|FG001|COMPLETED|Double-Blind||63
6342769|NCT00580840|7250278|FG002|COMPLETED|Double-Blind||61
6342770|NCT00580840|7250279|FG003|COMPLETED|Double-Blind||54
6342771|NCT00580840|7250276|FG000|NOT COMPLETED|Double-Blind||0
6342772|NCT00580840|7250277|FG001|NOT COMPLETED|Double-Blind||7
6342773|NCT00580840|7250278|FG002|NOT COMPLETED|Double-Blind||9
6342774|NCT00580840|7250279|FG003|NOT COMPLETED|Double-Blind||15
6342775|NCT00580853|7250292|FG000|STARTED|Overall Study||20
6342776|NCT00580853|7250293|FG001|STARTED|Overall Study||21
6342777|NCT00580853|7250294|FG002|STARTED|Overall Study||21
6342778|NCT00580853|7250292|FG000|COMPLETED|Overall Study||20
6342779|NCT00580853|7250293|FG001|COMPLETED|Overall Study||21
6342780|NCT00580853|7250294|FG002|COMPLETED|Overall Study||21
6342781|NCT00580853|7250292|FG000|NOT COMPLETED|Overall Study||0
6342782|NCT00580853|7250293|FG001|NOT COMPLETED|Overall Study||0
6342783|NCT00580853|7250294|FG002|NOT COMPLETED|Overall Study||0
6342784|NCT00580866|7250304|FG000|STARTED|Overall Study||10
6342785|NCT00580866|7250305|FG001|STARTED|Overall Study||7
6342786|NCT00580866|7250304|FG000|COMPLETED|Overall Study||8
6342787|NCT00580866|7250305|FG001|COMPLETED|Overall Study||5
6342788|NCT00580866|7250304|FG000|NOT COMPLETED|Overall Study||2
6342789|NCT00580866|7250305|FG001|NOT COMPLETED|Overall Study||2
6342790|NCT00580957|7250313|FG000|STARTED|Overall Study||28
6342791|NCT00580957|7250314|FG001|STARTED|Overall Study||28
6342792|NCT00580957|7250313|FG000|COMPLETED|Overall Study||21
6342793|NCT00580957|7250314|FG001|COMPLETED|Overall Study||21
6342794|NCT00580957|7250313|FG000|NOT COMPLETED|Overall Study||7
6342795|NCT00580957|7250314|FG001|NOT COMPLETED|Overall Study||7
6342796|NCT00580970|7250322|FG000|STARTED|Pre-treatment||73
6342797|NCT00580970|7250322|FG000|COMPLETED|Pre-treatment||72
6342798|NCT00580970|7250322|FG000|NOT COMPLETED|Pre-treatment||1
6342799|NCT00580970|7250322|FG000|STARTED|Treatment (Lovastatin)||72
6342800|NCT00580970|7250322|FG000|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
6342801|NCT00580970|7250322|FG000|COMPLETED|Treatment (Lovastatin)||53
6342802|NCT00580970|7250322|FG000|NOT COMPLETED|Treatment (Lovastatin)||19
6342803|NCT00580983|7250326|FG000|STARTED|Overall Study||80
6342804|NCT00580983|7250326|FG000|COMPLETED|Overall Study||73
6342805|NCT00580983|7250326|FG000|NOT COMPLETED|Overall Study||7
6342806|NCT00581048|7250330|FG000|STARTED|Overall Study||33
6342807|NCT00581048|7250330|FG000|COMPLETED|Overall Study||33
6342808|NCT00581048|7250330|FG000|NOT COMPLETED|Overall Study||0
6342809|NCT00581061|7250335|FG000|STARTED|Overall Study||13
6342810|NCT00581061|7250335|FG000|COMPLETED|Overall Study||13
6342811|NCT00581061|7250335|FG000|NOT COMPLETED|Overall Study||0
6342812|NCT00581100|7250343|FG000|STARTED|Overall Study||38
6342813|NCT00581100|7250344|FG001|STARTED|Overall Study||34
6342814|NCT00581100|7250343|FG000|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
6342815|NCT00581100|7250344|FG001|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
6342816|NCT00581100|7250343|FG000|COMPLETED|Overall Study||31
6342817|NCT00581100|7250344|FG001|COMPLETED|Overall Study||29
6342818|NCT00581100|7250343|FG000|NOT COMPLETED|Overall Study||7
6342819|NCT00581100|7250344|FG001|NOT COMPLETED|Overall Study||5
6342820|NCT00581230|7250350|FG000|STARTED|Overall Study||51
6342821|NCT00581230|7250350|FG000|Laryngoscopy Without RAMP|Overall Study||51
6342822|NCT00581230|7250350|FG000|Laryngoscopy With RAMP|Overall Study||51
6342823|NCT00581230|7250350|FG000|COMPLETED|Overall Study||51
6342824|NCT00581230|7250350|FG000|NOT COMPLETED|Overall Study||0
6342825|NCT00581256|7250359|FG000|STARTED|Overall Study||28
6342826|NCT00581256|7250360|FG001|STARTED|Overall Study||26
6342827|NCT00581256|7250359|FG000|COMPLETED|Overall Study||28
6342828|NCT00581256|7250360|FG001|COMPLETED|Overall Study||26
6342829|NCT00581256|7250359|FG000|NOT COMPLETED|Overall Study||0
6342830|NCT00581256|7250360|FG001|NOT COMPLETED|Overall Study||0
6342831|NCT00581308|7250366|FG000|STARTED|Pre Discharge||215
6342832|NCT00581308|7250366|FG000|COMPLETED|Pre Discharge||213
6342833|NCT00581308|7250366|FG000|NOT COMPLETED|Pre Discharge||2
6342834|NCT00581308|7250366|FG000|STARTED|Month 1||213
6342835|NCT00581308|7250366|FG000|COMPLETED|Month 1||205
6342836|NCT00581308|7250366|FG000|NOT COMPLETED|Month 1||8
6342837|NCT00581308|7250366|FG000|STARTED|Month 6||205
6342838|NCT00581308|7250366|FG000|COMPLETED|Month 6||202
6342839|NCT00581308|7250366|FG000|NOT COMPLETED|Month 6||3
6342840|NCT00581308|7250366|FG000|STARTED|Month 12||202
6342841|NCT00581308|7250366|FG000|COMPLETED|Month 12||182
6342842|NCT00581308|7250366|FG000|NOT COMPLETED|Month 12||20
6342843|NCT00581308|7250366|FG000|STARTED|24 Months||182
6342844|NCT00581308|7250366|FG000|COMPLETED|24 Months||176
6342845|NCT00581308|7250366|FG000|NOT COMPLETED|24 Months||6
6342846|NCT00581308|7250366|FG000|STARTED|36 Months||176
6342847|NCT00581308|7250366|FG000|COMPLETED|36 Months||170
6342848|NCT00581308|7250366|FG000|NOT COMPLETED|36 Months||6
6342849|NCT00581308|7250366|FG000|STARTED|48 Months||170
6342850|NCT00581308|7250366|FG000|COMPLETED|48 Months||161
6342851|NCT00581308|7250366|FG000|NOT COMPLETED|48 Months||9
6342852|NCT00581308|7250366|FG000|STARTED|60 Months||161
6342853|NCT00581308|7250366|FG000|COMPLETED|60 Months||158
6342854|NCT00581308|7250366|FG000|NOT COMPLETED|60 Months||3
6342855|NCT00581347|7250375|FG000|STARTED|Overall Study||3839
6342856|NCT00581347|7250376|FG001|STARTED|Overall Study||3707
6342857|NCT00581347|7250375|FG000|COMPLETED|Overall Study||3839
6342858|NCT00581347|7250376|FG001|COMPLETED|Overall Study||3707
6342859|NCT00581347|7250375|FG000|NOT COMPLETED|Overall Study||0
6342860|NCT00581347|7250376|FG001|NOT COMPLETED|Overall Study||0
6342861|NCT00581360|7250382|FG000|STARTED|Overall Study||10
6342862|NCT00581360|7250382|FG000|COMPLETED|Overall Study||9
6776389|NCT03834025|7704473|FG000|STARTED|Sent Recruitment Letter (Phase 1)||4150
6342863|NCT00581360|7250382|FG000|NOT COMPLETED|Overall Study||1
6342864|NCT00581386|7250389|FG000|STARTED|Overall Study|05/30/2007|73
6342865|NCT00581386|7250390|FG001|STARTED|Overall Study|05/30/2007|73
6342866|NCT00581386|7250391|FG002|STARTED|Overall Study|05/30/2007|72
6342867|NCT00581386|7250389|FG000|COMPLETED|Overall Study|04/15/2009|73
6342868|NCT00581386|7250390|FG001|COMPLETED|Overall Study|04/15/2009|73
6342869|NCT00581386|7250391|FG002|COMPLETED|Overall Study|04/15/2009|72
6342870|NCT00581386|7250389|FG000|NOT COMPLETED|Overall Study||0
6342871|NCT00581386|7250390|FG001|NOT COMPLETED|Overall Study||0
6342872|NCT00581386|7250391|FG002|NOT COMPLETED|Overall Study||0
6342873|NCT00581399|7250401|FG000|STARTED|Overall Study||46
6342874|NCT00581399|7250402|FG001|STARTED|Overall Study||48
6342875|NCT00581399|7250401|FG000|COMPLETED|Overall Study||46
6342876|NCT00581399|7250402|FG001|COMPLETED|Overall Study||48
6342877|NCT00581399|7250401|FG000|NOT COMPLETED|Overall Study||0
6342878|NCT00581399|7250402|FG001|NOT COMPLETED|Overall Study||0
6655033|NCT02450487|7585082|FG000|COMPLETED|Overall Study||102
6655034|NCT02450487|7585082|FG000|NOT COMPLETED|Overall Study||3
6655035|NCT02450526|7585091|FG000|STARTED|DB Period (Cycle 1)||325
6655036|NCT02450526|7585092|FG001|STARTED|DB Period (Cycle 1)||66
6655037|NCT02450526|7585093|FG002|STARTED|DB Period (Cycle 1)||107
6655038|NCT02450526|7585094|FG003|STARTED|DB Period (Cycle 1)||22
6655039|NCT02450526|7585095|FG004|STARTED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
6776390|NCT03834025|7704474|FG001|STARTED|Sent Recruitment Letter (Phase 1)||3871
6655040|NCT02450526|7585091|FG000|Safety Population|DB Period (Cycle 1)||326
6655041|NCT02450526|7585092|FG001|Safety Population|DB Period (Cycle 1)||66
6342879|NCT00581529|7250408|FG000|STARTED|Overall Study||34
6342880|NCT00581529|7250408|FG000|COMPLETED|Overall Study||34
6342881|NCT00581529|7250408|FG000|NOT COMPLETED|Overall Study||0
6342882|NCT00581542|7250414|FG000|STARTED|Overall Study||62
6342883|NCT00581542|7250415|FG001|STARTED|Overall Study||62
6342884|NCT00581542|7250414|FG000|COMPLETED|Overall Study||51
6342885|NCT00581542|7250415|FG001|COMPLETED|Overall Study||39
6655042|NCT02450526|7585093|FG002|Safety Population|DB Period (Cycle 1)||107
6342886|NCT00581542|7250414|FG000|NOT COMPLETED|Overall Study||11
6342887|NCT00581542|7250415|FG001|NOT COMPLETED|Overall Study||23
6342888|NCT00581555|7250425|FG000|STARTED|Overall Study||62
6342889|NCT00581555|7250426|FG001|STARTED|Overall Study||58
6342890|NCT00581555|7250425|FG000|COMPLETED|Overall Study||19
6342891|NCT00581555|7250426|FG001|COMPLETED|Overall Study||38
6342892|NCT00581555|7250425|FG000|NOT COMPLETED|Overall Study||43
6342893|NCT00581555|7250426|FG001|NOT COMPLETED|Overall Study||20
6342894|NCT00581581|7250434|FG000|STARTED|Overall Study||32
6342895|NCT00581581|7250435|FG001|STARTED|Overall Study||30
6342896|NCT00581581|7250434|FG000|COMPLETED|Overall Study||32
6342897|NCT00581581|7250435|FG001|COMPLETED|Overall Study||30
6342898|NCT00581581|7250434|FG000|NOT COMPLETED|Overall Study||0
6342899|NCT00581581|7250435|FG001|NOT COMPLETED|Overall Study||0
6342900|NCT00581776|7250441|FG000|STARTED|Overall Study||30
6342901|NCT00581776|7250441|FG000|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
6342902|NCT00581776|7250441|FG000|NOT COMPLETED|Overall Study||3
6342903|NCT00581828|7250445|FG000|STARTED|Overall Study||19
6342904|NCT00581828|7250445|FG000|COMPLETED|Overall Study||18
6342905|NCT00581828|7250445|FG000|NOT COMPLETED|Overall Study||1
6342906|NCT00581854|7250449|FG000|STARTED|Overall Study||22
6342907|NCT00581854|7250449|FG000|COMPLETED|Overall Study||22
6342908|NCT00581854|7250449|FG000|NOT COMPLETED|Overall Study||0
6342909|NCT00581867|7250453|FG000|STARTED|First Intervention||16
6342910|NCT00581867|7250454|FG001|STARTED|First Intervention||15
6342911|NCT00581867|7250453|FG000|COMPLETED|First Intervention||16
6342912|NCT00581867|7250454|FG001|COMPLETED|First Intervention||15
6342913|NCT00581867|7250453|FG000|NOT COMPLETED|First Intervention||0
6342914|NCT00581867|7250454|FG001|NOT COMPLETED|First Intervention||0
6342915|NCT00581867|7250453|FG000|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
6342916|NCT00581867|7250454|FG001|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
6342917|NCT00581867|7250453|FG000|COMPLETED|Second Intervention||15
6342918|NCT00581867|7250454|FG001|COMPLETED|Second Intervention||14
6342919|NCT00581867|7250453|FG000|NOT COMPLETED|Second Intervention||0
6342920|NCT00581867|7250454|FG001|NOT COMPLETED|Second Intervention||0
6342921|NCT00581893|7250460|FG000|STARTED|First Intervention (1 Month)||10
6342922|NCT00581893|7250461|FG001|STARTED|First Intervention (1 Month)||10
6342923|NCT00581893|7250460|FG000|COMPLETED|First Intervention (1 Month)||10
6342924|NCT00581893|7250461|FG001|COMPLETED|First Intervention (1 Month)||10
6342925|NCT00581893|7250460|FG000|NOT COMPLETED|First Intervention (1 Month)||0
6342926|NCT00581893|7250461|FG001|NOT COMPLETED|First Intervention (1 Month)||0
6342927|NCT00581893|7250460|FG000|STARTED|Washout (14 Days)||10
6342928|NCT00581893|7250461|FG001|STARTED|Washout (14 Days)||10
6342929|NCT00581893|7250460|FG000|COMPLETED|Washout (14 Days)||10
6342930|NCT00581893|7250461|FG001|COMPLETED|Washout (14 Days)||10
6342931|NCT00581893|7250460|FG000|NOT COMPLETED|Washout (14 Days)||0
6342932|NCT00581893|7250461|FG001|NOT COMPLETED|Washout (14 Days)||0
6342933|NCT00581893|7250460|FG000|STARTED|Second Intervention (1 Month)||10
6342934|NCT00581893|7250461|FG001|STARTED|Second Intervention (1 Month)||10
6342935|NCT00581893|7250460|FG000|COMPLETED|Second Intervention (1 Month)||7
6342936|NCT00581893|7250461|FG001|COMPLETED|Second Intervention (1 Month)||8
6342937|NCT00581893|7250460|FG000|NOT COMPLETED|Second Intervention (1 Month)||3
6342938|NCT00581893|7250461|FG001|NOT COMPLETED|Second Intervention (1 Month)||2
6342939|NCT00581919|7250467|FG000|STARTED|Overall Study||32
6559328|NCT01781286|7481968|FG000|NOT COMPLETED|Overall Study||2
6559329|NCT01781286|7481969|FG001|NOT COMPLETED|Overall Study||0
6559330|NCT01781286|7481970|FG002|NOT COMPLETED|Overall Study||2
6559331|NCT01781286|7481971|FG003|NOT COMPLETED|Overall Study||1
6559332|NCT01781286|7481972|FG004|NOT COMPLETED|Overall Study||0
6342940|NCT00581919|7250467|FG000|COMPLETED|Overall Study||8
6342941|NCT00581919|7250467|FG000|NOT COMPLETED|Overall Study||24
6342942|NCT00581945|7250474|FG000|STARTED|Overall Study||74
6342943|NCT00581945|7250475|FG001|STARTED|Overall Study||73
6342944|NCT00581945|7250474|FG000|COMPLETED|Overall Study||65
6342945|NCT00581945|7250475|FG001|COMPLETED|Overall Study||63
6342946|NCT00581945|7250474|FG000|NOT COMPLETED|Overall Study||9
6342947|NCT00581945|7250475|FG001|NOT COMPLETED|Overall Study||10
6342948|NCT00581971|7250481|FG000|STARTED|Overall Study||30
6342949|NCT00581971|7250481|FG000|COMPLETED|Overall Study||30
6342950|NCT00581971|7250481|FG000|NOT COMPLETED|Overall Study||0
6342951|NCT00582010|7250488|FG000|STARTED|Overall Study||40
6342952|NCT00582010|7250489|FG001|STARTED|Overall Study||40
6342953|NCT00582010|7250488|FG000|COMPLETED|Overall Study||40
6342954|NCT00582010|7250489|FG001|COMPLETED|Overall Study||39
6342955|NCT00582010|7250488|FG000|NOT COMPLETED|Overall Study||0
6342956|NCT00582010|7250489|FG001|NOT COMPLETED|Overall Study||1
6342957|NCT00582075|7250495|FG000|STARTED|Overall Study||25
6342958|NCT00582075|7250495|FG000|COMPLETED|Overall Study||25
6342959|NCT00582075|7250495|FG000|NOT COMPLETED|Overall Study||0
6342960|NCT00582114|7250501|FG000|STARTED|Overall Study||100
6342961|NCT00582114|7250502|FG001|STARTED|Overall Study||100
6342962|NCT00582114|7250501|FG000|COMPLETED|Overall Study||58
6342963|NCT00582114|7250502|FG001|COMPLETED|Overall Study||46
6342964|NCT00582114|7250501|FG000|NOT COMPLETED|Overall Study||42
6559333|NCT01781286|7481973|FG005|NOT COMPLETED|Overall Study||1
6342965|NCT00582114|7250502|FG001|NOT COMPLETED|Overall Study||54
6342966|NCT00582166|7250508|FG000|STARTED|Overall Study||18
6342967|NCT00582166|7250508|FG000|COMPLETED|Overall Study||16
6342968|NCT00582166|7250508|FG000|NOT COMPLETED|Overall Study||2
6342969|NCT00582205|7250512|FG000|STARTED|Overall Study||21
6342970|NCT00582205|7250512|FG000|COMPLETED|Overall Study||11
6342971|NCT00582205|7250512|FG000|NOT COMPLETED|Overall Study||10
6342972|NCT00582309|7250519|FG000|STARTED|Overall Study||56
6342973|NCT00582309|7250520|FG001|STARTED|Overall Study||49
6342974|NCT00582309|7250521|FG002|STARTED|Overall Study||46
6342975|NCT00582309|7250519|FG000|COMPLETED|Overall Study||56
6342976|NCT00582309|7250520|FG001|COMPLETED|Overall Study||49
6342977|NCT00582309|7250521|FG002|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
6342978|NCT00582309|7250519|FG000|NOT COMPLETED|Overall Study||0
6342979|NCT00582309|7250520|FG001|NOT COMPLETED|Overall Study||0
6342980|NCT00582309|7250521|FG002|NOT COMPLETED|Overall Study||2
6342981|NCT00582361|7250531|FG000|STARTED|Overall Study||25
6342982|NCT00582361|7250532|FG001|STARTED|Overall Study||38
6342983|NCT00582361|7250531|FG000|COMPLETED|Overall Study||25
6342984|NCT00582361|7250532|FG001|COMPLETED|Overall Study||38
6342985|NCT00582361|7250531|FG000|NOT COMPLETED|Overall Study||0
6342986|NCT00582361|7250532|FG001|NOT COMPLETED|Overall Study||0
6342987|NCT00582400|7250538|FG000|STARTED|Overall Study||9
6342988|NCT00582400|7250538|FG000|COMPLETED|Overall Study||6
6342989|NCT00582400|7250538|FG000|NOT COMPLETED|Overall Study||3
6342990|NCT00582426|7250544|FG000|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
6342991|NCT00582426|7250545|FG001|STARTED|Overall Study||71
6342992|NCT00582426|7250544|FG000|COMPLETED|Overall Study||48
6342993|NCT00582426|7250545|FG001|COMPLETED|Overall Study||58
6342994|NCT00582426|7250544|FG000|NOT COMPLETED|Overall Study||20
6342995|NCT00582426|7250545|FG001|NOT COMPLETED|Overall Study||13
6342996|NCT00582491|7250553|FG000|STARTED|Overall Study||11
6342997|NCT00582491|7250554|FG001|STARTED|Overall Study||10
6342998|NCT00582491|7250553|FG000|COMPLETED|Overall Study||10
6342999|NCT00582491|7250554|FG001|COMPLETED|Overall Study||10
6343000|NCT00582491|7250553|FG000|NOT COMPLETED|Overall Study||1
6343001|NCT00582491|7250554|FG001|NOT COMPLETED|Overall Study||0
6343002|NCT00582517|7250562|FG000|STARTED|Overall Study||45
6343003|NCT00582517|7250563|FG001|STARTED|Overall Study||55
6343004|NCT00582517|7250562|FG000|COMPLETED|Overall Study||45
6343005|NCT00582517|7250563|FG001|COMPLETED|Overall Study||55
6343006|NCT00582517|7250562|FG000|NOT COMPLETED|Overall Study||0
6343007|NCT00582517|7250563|FG001|NOT COMPLETED|Overall Study||0
6343008|NCT00582556|7250572|FG000|STARTED|Overall Study||14
6343009|NCT00582556|7250573|FG001|STARTED|Overall Study||15
6343010|NCT00582556|7250574|FG002|STARTED|Overall Study||14
6343011|NCT00582556|7250572|FG000|COMPLETED|Overall Study||14
6343012|NCT00582556|7250573|FG001|COMPLETED|Overall Study||14
6343013|NCT00582556|7250574|FG002|COMPLETED|Overall Study||12
6343014|NCT00582556|7250572|FG000|NOT COMPLETED|Overall Study||0
6343015|NCT00582556|7250573|FG001|NOT COMPLETED|Overall Study||1
6343016|NCT00582556|7250574|FG002|NOT COMPLETED|Overall Study||2
6343017|NCT00582608|7250583|FG000|STARTED|Overall Study||12
6343018|NCT00582608|7250583|FG000|COMPLETED|Overall Study||0
6776391|NCT03834025|7704475|FG002|STARTED|Sent Recruitment Letter (Phase 1)||4121
6343019|NCT00582608|7250583|FG000|NOT COMPLETED|Overall Study||12
6343020|NCT00582660|7250589|FG000|STARTED|Overall Study||20
6343021|NCT00582660|7250590|FG001|STARTED|Overall Study||20
6343022|NCT00582660|7250589|FG000|COMPLETED|Overall Study||20
6343023|NCT00582660|7250590|FG001|COMPLETED|Overall Study||20
6343024|NCT00582660|7250589|FG000|NOT COMPLETED|Overall Study||0
6343025|NCT00582660|7250590|FG001|NOT COMPLETED|Overall Study||0
6343026|NCT00582738|7250598|FG000|STARTED|Overall Study||21
6343027|NCT00582738|7250599|FG001|STARTED|Overall Study||22
6343028|NCT00582738|7250598|FG000|COMPLETED|Overall Study||12
6343029|NCT00582738|7250599|FG001|COMPLETED|Overall Study||4
6343030|NCT00582738|7250598|FG000|NOT COMPLETED|Overall Study||9
6343031|NCT00582738|7250599|FG001|NOT COMPLETED|Overall Study||18
6343032|NCT00582790|7250611|FG000|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
6343033|NCT00582790|7250611|FG000|COMPLETED|Overall Study||11
6343034|NCT00582790|7250611|FG000|NOT COMPLETED|Overall Study||1
6343035|NCT00582816|7250616|FG000|STARTED|Overall Study||9
6343036|NCT00582816|7250616|FG000|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
6343037|NCT00582816|7250616|FG000|NOT COMPLETED|Overall Study||3
6343038|NCT00582894|7250620|FG000|STARTED|Overall Study||17
6343039|NCT00582894|7250620|FG000|Day 100 Post Transplant|Overall Study||17
6343040|NCT00582894|7250620|FG000|COMPLETED|Overall Study||17
6343041|NCT00582894|7250620|FG000|NOT COMPLETED|Overall Study||0
6376571|NCT00760006|7287111|FG000|NOT COMPLETED|Overall Study||0
6376572|NCT00760006|7287112|FG001|NOT COMPLETED|Overall Study||0
6376573|NCT00760019|7287120|FG000|STARTED|Overall Study||15
6376574|NCT00760019|7287121|FG001|STARTED|Overall Study||15
6376575|NCT00760019|7287122|FG002|STARTED|Overall Study||14
6376576|NCT00760019|7287123|FG003|STARTED|Overall Study||14
6376577|NCT00760019|7287120|FG000|COMPLETED|Overall Study||15
6376578|NCT00760019|7287121|FG001|COMPLETED|Overall Study||15
6776392|NCT03834025|7704476|FG003|STARTED|Sent Recruitment Letter (Phase 1)||3693
6376579|NCT00760019|7287122|FG002|COMPLETED|Overall Study||14
6376580|NCT00760019|7287123|FG003|COMPLETED|Overall Study||14
6376581|NCT00760019|7287120|FG000|NOT COMPLETED|Overall Study||0
6498463|NCT01410058|7417051|FG001|COMPLETED|Washout Day 0||6
6498464|NCT01410058|7417050|FG000|NOT COMPLETED|Washout Day 0||0
6498465|NCT01410058|7417051|FG001|NOT COMPLETED|Washout Day 0||0
6498466|NCT01410058|7417050|FG000|STARTED|Baseline Day 22||13
6498467|NCT01410058|7417051|FG001|STARTED|Baseline Day 22||6
6498468|NCT01410058|7417050|FG000|COMPLETED|Baseline Day 22||13
6343042|NCT00582907|7250624|FG000|STARTED|1st Course||4
6343043|NCT00582907|7250625|FG001|STARTED|1st Course||3
6343044|NCT00582907|7250626|FG002|STARTED|1st Course||3
6343045|NCT00582907|7250627|FG003|STARTED|1st Course||4
6343046|NCT00582907|7250624|FG000|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
6343047|NCT00582907|7250625|FG001|COMPLETED|1st Course||3
6343048|NCT00582907|7250626|FG002|COMPLETED|1st Course||3
6343049|NCT00582907|7250627|FG003|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
6343050|NCT00582907|7250624|FG000|NOT COMPLETED|1st Course||1
6343051|NCT00582907|7250625|FG001|NOT COMPLETED|1st Course||0
6343052|NCT00582907|7250626|FG002|NOT COMPLETED|1st Course||0
6343053|NCT00582907|7250627|FG003|NOT COMPLETED|1st Course||1
6343054|NCT00582907|7250624|FG000|STARTED|2nd Course||3
6343055|NCT00582907|7250625|FG001|STARTED|2nd Course||3
6343056|NCT00582907|7250626|FG002|STARTED|2nd Course||3
6343057|NCT00582907|7250627|FG003|STARTED|2nd Course||3
6343058|NCT00582907|7250624|FG000|COMPLETED|2nd Course||2
6343059|NCT00582907|7250625|FG001|COMPLETED|2nd Course||3
6343060|NCT00582907|7250626|FG002|COMPLETED|2nd Course||3
6343061|NCT00582907|7250627|FG003|COMPLETED|2nd Course||3
6343062|NCT00582907|7250624|FG000|NOT COMPLETED|2nd Course||1
6343063|NCT00582907|7250625|FG001|NOT COMPLETED|2nd Course||0
6343064|NCT00582907|7250626|FG002|NOT COMPLETED|2nd Course||0
6343065|NCT00582907|7250627|FG003|NOT COMPLETED|2nd Course||0
6343066|NCT00582907|7250624|FG000|STARTED|3rd Course||2
6343067|NCT00582907|7250625|FG001|STARTED|3rd Course||3
6343068|NCT00582907|7250626|FG002|STARTED|3rd Course||3
6343069|NCT00582907|7250627|FG003|STARTED|3rd Course||3
6343070|NCT00582907|7250624|FG000|COMPLETED|3rd Course||2
6343071|NCT00582907|7250625|FG001|COMPLETED|3rd Course||3
6343072|NCT00582907|7250626|FG002|COMPLETED|3rd Course||3
6343073|NCT00582907|7250627|FG003|COMPLETED|3rd Course||3
6343074|NCT00582907|7250624|FG000|NOT COMPLETED|3rd Course||0
6343075|NCT00582907|7250625|FG001|NOT COMPLETED|3rd Course||0
6343076|NCT00582907|7250626|FG002|NOT COMPLETED|3rd Course||0
6343077|NCT00582907|7250627|FG003|NOT COMPLETED|3rd Course||0
6343078|NCT00582907|7250624|FG000|STARTED|4th Course||2
6343079|NCT00582907|7250625|FG001|STARTED|4th Course||3
6559334|NCT01781299|7481985|FG000|STARTED|Overall Study||4
6343080|NCT00582907|7250626|FG002|STARTED|4th Course||3
6343081|NCT00582907|7250627|FG003|STARTED|4th Course||3
6343082|NCT00582907|7250624|FG000|COMPLETED|4th Course||2
6343083|NCT00582907|7250625|FG001|COMPLETED|4th Course||3
6343084|NCT00582907|7250626|FG002|COMPLETED|4th Course||3
6343085|NCT00582907|7250627|FG003|COMPLETED|4th Course||3
6343086|NCT00582907|7250624|FG000|NOT COMPLETED|4th Course||0
6343087|NCT00582907|7250625|FG001|NOT COMPLETED|4th Course||0
6343088|NCT00582907|7250626|FG002|NOT COMPLETED|4th Course||0
6343089|NCT00582907|7250627|FG003|NOT COMPLETED|4th Course||0
6343090|NCT00582933|7250633|FG000|STARTED|Overall Study||95
6343091|NCT00582933|7250633|FG000|COMPLETED|Overall Study||92
6343092|NCT00582933|7250633|FG000|NOT COMPLETED|Overall Study||3
6343093|NCT00582946|7250637|FG000|STARTED|Overall Study||16
6343094|NCT00582946|7250637|FG000|COMPLETED|Overall Study||16
6343095|NCT00582946|7250637|FG000|NOT COMPLETED|Overall Study||0
6343096|NCT00582972|7250641|FG000|STARTED|Overall Study||23
6343097|NCT00582972|7250641|FG000|COMPLETED|Overall Study||21
6343098|NCT00582972|7250641|FG000|NOT COMPLETED|Overall Study||2
6343099|NCT00582998|7250648|FG000|STARTED|Overall Study||119
6343100|NCT00582998|7250649|FG001|STARTED|Overall Study||130
6343101|NCT00582998|7250648|FG000|COMPLETED|Overall Study||119
6343102|NCT00582998|7250649|FG001|COMPLETED|Overall Study||130
6343103|NCT00582998|7250648|FG000|NOT COMPLETED|Overall Study||0
6343104|NCT00582998|7250649|FG001|NOT COMPLETED|Overall Study||0
6343105|NCT00583011|7250657|FG000|STARTED|Overall Study||36
6343106|NCT00583011|7250658|FG001|STARTED|Overall Study||40
6343107|NCT00583011|7250657|FG000|COMPLETED|Overall Study||36
6343108|NCT00583011|7250658|FG001|COMPLETED|Overall Study||40
6343109|NCT00583011|7250657|FG000|NOT COMPLETED|Overall Study||0
6343110|NCT00583011|7250658|FG001|NOT COMPLETED|Overall Study||0
6343111|NCT00583050|7250665|FG000|STARTED|Overall Study||1366
6343112|NCT00583050|7250665|FG000|COMPLETED|Overall Study||1366
6343113|NCT00583050|7250665|FG000|NOT COMPLETED|Overall Study||0
6343114|NCT00583102|7250669|FG000|STARTED|Overall Study||23
6343115|NCT00583102|7250669|FG000|COMPLETED|Overall Study||20
6343116|NCT00583102|7250669|FG000|NOT COMPLETED|Overall Study||3
6343117|NCT00583219|7250673|FG000|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
6343118|NCT00583219|7250673|FG000|COMPLETED|Phase 1||9
6343119|NCT00583219|7250673|FG000|NOT COMPLETED|Phase 1||0
6343120|NCT00583219|7250673|FG000|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
6343121|NCT00583219|7250673|FG000|COMPLETED|Phase 2||21
6343122|NCT00583219|7250673|FG000|NOT COMPLETED|Phase 2||1
6343123|NCT00583362|7250677|FG000|STARTED|Overall Study||298
6343124|NCT00583362|7250677|FG000|COMPLETED|Overall Study||96
6343125|NCT00583362|7250677|FG000|NOT COMPLETED|Overall Study||202
6559335|NCT01781299|7481986|FG001|STARTED|Overall Study||5
6559336|NCT01781299|7481985|FG000|COMPLETED|Overall Study||4
6343126|NCT00583375|7250683|FG000|STARTED|Overall Study||142
6343127|NCT00583375|7250684|FG001|STARTED|Overall Study||272
6343128|NCT00583375|7250683|FG000|COMPLETED|Overall Study||142
6343129|NCT00583375|7250684|FG001|COMPLETED|Overall Study||272
6343130|NCT00583375|7250683|FG000|NOT COMPLETED|Overall Study||0
6343131|NCT00583375|7250684|FG001|NOT COMPLETED|Overall Study||0
6343132|NCT00583414|7250690|FG000|STARTED|Overall Study||401
6343133|NCT00583414|7250690|FG000|COMPLETED|Overall Study||401
6343134|NCT00583414|7250690|FG000|NOT COMPLETED|Overall Study||0
6343135|NCT00583453|7250696|FG000|STARTED|Overall Study||9
6343136|NCT00583453|7250697|FG001|STARTED|Overall Study||8
6343137|NCT00583453|7250696|FG000|COMPLETED|Overall Study||9
6343138|NCT00583453|7250697|FG001|COMPLETED|Overall Study||6
6343139|NCT00583453|7250696|FG000|NOT COMPLETED|Overall Study||0
6343140|NCT00583453|7250697|FG001|NOT COMPLETED|Overall Study||2
6343141|NCT00583492|7250707|FG000|STARTED|Overall Study||21
6343142|NCT00583492|7250708|FG001|STARTED|Overall Study||23
6343143|NCT00583492|7250707|FG000|COMPLETED|Overall Study||21
6343144|NCT00583492|7250708|FG001|COMPLETED|Overall Study||23
6343145|NCT00583492|7250707|FG000|NOT COMPLETED|Overall Study||0
6343146|NCT00583492|7250708|FG001|NOT COMPLETED|Overall Study||0
6343147|NCT00583557|7250714|FG000|STARTED|Overall Study||155
6343148|NCT00583557|7250714|FG000|Received at Least 1 Dose Belimumab|Overall Study||153
6343149|NCT00583557|7250714|FG000|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
6343150|NCT00583557|7250714|FG000|NOT COMPLETED|Overall Study||70
6343151|NCT00583596|7250718|FG000|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
6343152|NCT00583596|7250718|FG000|COMPLETED|Overall Study||152
6343153|NCT00583596|7250718|FG000|NOT COMPLETED|Overall Study||284
6343154|NCT00583622|7250723|FG000|STARTED|Overall Study||12
6343155|NCT00583622|7250723|FG000|COMPLETED|Overall Study||12
6343156|NCT00583622|7250723|FG000|NOT COMPLETED|Overall Study||0
6343157|NCT00583661|7250727|FG000|STARTED|Overall Study||48
6343158|NCT00583661|7250727|FG000|COMPLETED|Overall Study||48
6343159|NCT00583661|7250727|FG000|NOT COMPLETED|Overall Study||0
6343160|NCT00583700|7250734|FG000|STARTED|Overall Study||27
6343161|NCT00583700|7250735|FG001|STARTED|Overall Study||27
6343162|NCT00583700|7250734|FG000|COMPLETED|Overall Study||24
6343163|NCT00583700|7250735|FG001|COMPLETED|Overall Study||23
6343164|NCT00583700|7250734|FG000|NOT COMPLETED|Overall Study||3
6343165|NCT00583700|7250735|FG001|NOT COMPLETED|Overall Study||4
6343166|NCT00583713|7250744|FG000|STARTED|Overall Study||6
6343167|NCT00583713|7250745|FG001|STARTED|Overall Study||6
6343168|NCT00583713|7250746|FG002|STARTED|Overall Study||6
6343169|NCT00583713|7250744|FG000|COMPLETED|Overall Study||6
6343170|NCT00583713|7250745|FG001|COMPLETED|Overall Study||6
6343171|NCT00583713|7250746|FG002|COMPLETED|Overall Study||6
6343172|NCT00583713|7250744|FG000|NOT COMPLETED|Overall Study||0
6343173|NCT00583713|7250745|FG001|NOT COMPLETED|Overall Study||0
6343174|NCT00583713|7250746|FG002|NOT COMPLETED|Overall Study||0
6343175|NCT00583791|7250754|FG000|STARTED|Overall Study||91
6343176|NCT00583791|7250754|FG000|COMPLETED|Overall Study||18
6343177|NCT00583791|7250754|FG000|NOT COMPLETED|Overall Study||73
6343178|NCT00583908|7250758|FG000|STARTED|Period 1 - First Intervention||1
6343179|NCT00583908|7250759|FG001|STARTED|Period 1 - First Intervention||2
6343180|NCT00583908|7250760|FG002|STARTED|Period 1 - First Intervention||1
6343181|NCT00583908|7250761|FG003|STARTED|Period 1 - First Intervention||1
6343182|NCT00583908|7250762|FG004|STARTED|Period 1 - First Intervention||2
6343183|NCT00583908|7250763|FG005|STARTED|Period 1 - First Intervention||1
6343184|NCT00583908|7250764|FG006|STARTED|Period 1 - First Intervention||1
6343185|NCT00583908|7250765|FG007|STARTED|Period 1 - First Intervention||1
6343186|NCT00583908|7250766|FG008|STARTED|Period 1 - First Intervention||1
6343187|NCT00583908|7250767|FG009|STARTED|Period 1 - First Intervention||1
6343188|NCT00583908|7250768|FG010|STARTED|Period 1 - First Intervention||1
6343189|NCT00583908|7250769|FG011|STARTED|Period 1 - First Intervention||1
6343190|NCT00583908|7250758|FG000|COMPLETED|Period 1 - First Intervention||1
6343191|NCT00583908|7250759|FG001|COMPLETED|Period 1 - First Intervention||2
6343192|NCT00583908|7250760|FG002|COMPLETED|Period 1 - First Intervention||1
6343193|NCT00583908|7250761|FG003|COMPLETED|Period 1 - First Intervention||1
6343194|NCT00583908|7250762|FG004|COMPLETED|Period 1 - First Intervention||2
6343195|NCT00583908|7250763|FG005|COMPLETED|Period 1 - First Intervention||1
6343196|NCT00583908|7250764|FG006|COMPLETED|Period 1 - First Intervention||1
6343197|NCT00583908|7250765|FG007|COMPLETED|Period 1 - First Intervention||1
6343198|NCT00583908|7250766|FG008|COMPLETED|Period 1 - First Intervention||1
6343199|NCT00583908|7250767|FG009|COMPLETED|Period 1 - First Intervention||1
6343200|NCT00583908|7250768|FG010|COMPLETED|Period 1 - First Intervention||1
6343201|NCT00583908|7250769|FG011|COMPLETED|Period 1 - First Intervention||1
6343202|NCT00583908|7250758|FG000|NOT COMPLETED|Period 1 - First Intervention||0
6343203|NCT00583908|7250759|FG001|NOT COMPLETED|Period 1 - First Intervention||0
6343204|NCT00583908|7250760|FG002|NOT COMPLETED|Period 1 - First Intervention||0
6343205|NCT00583908|7250761|FG003|NOT COMPLETED|Period 1 - First Intervention||0
6343206|NCT00583908|7250762|FG004|NOT COMPLETED|Period 1 - First Intervention||0
6343207|NCT00583908|7250763|FG005|NOT COMPLETED|Period 1 - First Intervention||0
6343208|NCT00583908|7250764|FG006|NOT COMPLETED|Period 1 - First Intervention||0
6343209|NCT00583908|7250765|FG007|NOT COMPLETED|Period 1 - First Intervention||0
6343210|NCT00583908|7250766|FG008|NOT COMPLETED|Period 1 - First Intervention||0
6343211|NCT00583908|7250767|FG009|NOT COMPLETED|Period 1 - First Intervention||0
6343212|NCT00583908|7250768|FG010|NOT COMPLETED|Period 1 - First Intervention||0
6343213|NCT00583908|7250769|FG011|NOT COMPLETED|Period 1 - First Intervention||0
6343214|NCT00583908|7250758|FG000|STARTED|Period 2 - Second Intervention||1
6343215|NCT00583908|7250759|FG001|STARTED|Period 2 - Second Intervention||2
6343216|NCT00583908|7250760|FG002|STARTED|Period 2 - Second Intervention||1
6343217|NCT00583908|7250761|FG003|STARTED|Period 2 - Second Intervention||1
6343218|NCT00583908|7250762|FG004|STARTED|Period 2 - Second Intervention||2
6343219|NCT00583908|7250763|FG005|STARTED|Period 2 - Second Intervention||1
6343220|NCT00583908|7250764|FG006|STARTED|Period 2 - Second Intervention||1
6343221|NCT00583908|7250765|FG007|STARTED|Period 2 - Second Intervention||1
6343222|NCT00583908|7250766|FG008|STARTED|Period 2 - Second Intervention||1
6343223|NCT00583908|7250767|FG009|STARTED|Period 2 - Second Intervention||1
6343224|NCT00583908|7250768|FG010|STARTED|Period 2 - Second Intervention||1
6343225|NCT00583908|7250769|FG011|STARTED|Period 2 - Second Intervention||1
6343226|NCT00583908|7250758|FG000|COMPLETED|Period 2 - Second Intervention||1
6343227|NCT00583908|7250759|FG001|COMPLETED|Period 2 - Second Intervention||2
6343228|NCT00583908|7250760|FG002|COMPLETED|Period 2 - Second Intervention||1
6343229|NCT00583908|7250761|FG003|COMPLETED|Period 2 - Second Intervention||1
6343230|NCT00583908|7250762|FG004|COMPLETED|Period 2 - Second Intervention||2
6343231|NCT00583908|7250763|FG005|COMPLETED|Period 2 - Second Intervention||1
6343232|NCT00583908|7250764|FG006|COMPLETED|Period 2 - Second Intervention||1
6343233|NCT00583908|7250765|FG007|COMPLETED|Period 2 - Second Intervention||1
6343234|NCT00583908|7250766|FG008|COMPLETED|Period 2 - Second Intervention||1
6343235|NCT00583908|7250767|FG009|COMPLETED|Period 2 - Second Intervention||1
6343236|NCT00583908|7250768|FG010|COMPLETED|Period 2 - Second Intervention||1
6343237|NCT00583908|7250769|FG011|COMPLETED|Period 2 - Second Intervention||1
6343238|NCT00583908|7250758|FG000|NOT COMPLETED|Period 2 - Second Intervention||0
6343239|NCT00583908|7250759|FG001|NOT COMPLETED|Period 2 - Second Intervention||0
6343240|NCT00583908|7250760|FG002|NOT COMPLETED|Period 2 - Second Intervention||0
6343241|NCT00583908|7250761|FG003|NOT COMPLETED|Period 2 - Second Intervention||0
6343242|NCT00583908|7250762|FG004|NOT COMPLETED|Period 2 - Second Intervention||0
6343243|NCT00583908|7250763|FG005|NOT COMPLETED|Period 2 - Second Intervention||0
6343244|NCT00583908|7250764|FG006|NOT COMPLETED|Period 2 - Second Intervention||0
6343245|NCT00583908|7250765|FG007|NOT COMPLETED|Period 2 - Second Intervention||0
6343246|NCT00583908|7250766|FG008|NOT COMPLETED|Period 2 - Second Intervention||0
6343247|NCT00583908|7250767|FG009|NOT COMPLETED|Period 2 - Second Intervention||0
6343248|NCT00583908|7250768|FG010|NOT COMPLETED|Period 2 - Second Intervention||0
6343249|NCT00583908|7250769|FG011|NOT COMPLETED|Period 2 - Second Intervention||0
6343250|NCT00583908|7250758|FG000|STARTED|Period 3 - Third Intervention||1
6343251|NCT00583908|7250759|FG001|STARTED|Period 3 - Third Intervention||2
6343252|NCT00583908|7250760|FG002|STARTED|Period 3 - Third Intervention||1
6343253|NCT00583908|7250761|FG003|STARTED|Period 3 - Third Intervention||1
6343254|NCT00583908|7250762|FG004|STARTED|Period 3 - Third Intervention||2
6343255|NCT00583908|7250763|FG005|STARTED|Period 3 - Third Intervention||1
6343256|NCT00583908|7250764|FG006|STARTED|Period 3 - Third Intervention||1
6343257|NCT00583908|7250765|FG007|STARTED|Period 3 - Third Intervention||1
6343258|NCT00583908|7250766|FG008|STARTED|Period 3 - Third Intervention||1
6343259|NCT00583908|7250767|FG009|STARTED|Period 3 - Third Intervention||1
6343260|NCT00583908|7250768|FG010|STARTED|Period 3 - Third Intervention||1
6343261|NCT00583908|7250769|FG011|STARTED|Period 3 - Third Intervention||1
6343262|NCT00583908|7250758|FG000|COMPLETED|Period 3 - Third Intervention||1
6343263|NCT00583908|7250759|FG001|COMPLETED|Period 3 - Third Intervention||2
6343264|NCT00583908|7250760|FG002|COMPLETED|Period 3 - Third Intervention||1
6343265|NCT00583908|7250761|FG003|COMPLETED|Period 3 - Third Intervention||1
6343266|NCT00583908|7250762|FG004|COMPLETED|Period 3 - Third Intervention||2
6343267|NCT00583908|7250763|FG005|COMPLETED|Period 3 - Third Intervention||1
6343268|NCT00583908|7250764|FG006|COMPLETED|Period 3 - Third Intervention||1
6343269|NCT00583908|7250765|FG007|COMPLETED|Period 3 - Third Intervention||1
6343270|NCT00583908|7250766|FG008|COMPLETED|Period 3 - Third Intervention||1
6343271|NCT00583908|7250767|FG009|COMPLETED|Period 3 - Third Intervention||1
6343272|NCT00583908|7250768|FG010|COMPLETED|Period 3 - Third Intervention||1
6343273|NCT00583908|7250769|FG011|COMPLETED|Period 3 - Third Intervention||1
6343274|NCT00583908|7250758|FG000|NOT COMPLETED|Period 3 - Third Intervention||0
6343275|NCT00583908|7250759|FG001|NOT COMPLETED|Period 3 - Third Intervention||0
6343276|NCT00583908|7250760|FG002|NOT COMPLETED|Period 3 - Third Intervention||0
6343277|NCT00583908|7250761|FG003|NOT COMPLETED|Period 3 - Third Intervention||0
6343278|NCT00583908|7250762|FG004|NOT COMPLETED|Period 3 - Third Intervention||0
6343279|NCT00583908|7250763|FG005|NOT COMPLETED|Period 3 - Third Intervention||0
6343280|NCT00583908|7250764|FG006|NOT COMPLETED|Period 3 - Third Intervention||0
6343281|NCT00583908|7250765|FG007|NOT COMPLETED|Period 3 - Third Intervention||0
6343282|NCT00583908|7250766|FG008|NOT COMPLETED|Period 3 - Third Intervention||0
6343283|NCT00583908|7250767|FG009|NOT COMPLETED|Period 3 - Third Intervention||0
6343284|NCT00583908|7250768|FG010|NOT COMPLETED|Period 3 - Third Intervention||0
6343285|NCT00583908|7250769|FG011|NOT COMPLETED|Period 3 - Third Intervention||0
6343286|NCT00583908|7250758|FG000|STARTED|Period 4 - Fourth Intervention||1
6343287|NCT00583908|7250759|FG001|STARTED|Period 4 - Fourth Intervention||2
6343288|NCT00583908|7250760|FG002|STARTED|Period 4 - Fourth Intervention||1
6343289|NCT00583908|7250761|FG003|STARTED|Period 4 - Fourth Intervention||1
6343290|NCT00583908|7250762|FG004|STARTED|Period 4 - Fourth Intervention||2
6343291|NCT00583908|7250763|FG005|STARTED|Period 4 - Fourth Intervention||1
6343292|NCT00583908|7250764|FG006|STARTED|Period 4 - Fourth Intervention||1
6343293|NCT00583908|7250765|FG007|STARTED|Period 4 - Fourth Intervention||1
6343294|NCT00583908|7250766|FG008|STARTED|Period 4 - Fourth Intervention||1
6343295|NCT00583908|7250767|FG009|STARTED|Period 4 - Fourth Intervention||1
6343296|NCT00583908|7250768|FG010|STARTED|Period 4 - Fourth Intervention||1
6343297|NCT00583908|7250769|FG011|STARTED|Period 4 - Fourth Intervention||1
6343298|NCT00583908|7250758|FG000|COMPLETED|Period 4 - Fourth Intervention||1
6343299|NCT00583908|7250759|FG001|COMPLETED|Period 4 - Fourth Intervention||2
6343300|NCT00583908|7250760|FG002|COMPLETED|Period 4 - Fourth Intervention||1
6343301|NCT00583908|7250761|FG003|COMPLETED|Period 4 - Fourth Intervention||1
6343302|NCT00583908|7250762|FG004|COMPLETED|Period 4 - Fourth Intervention||2
6343303|NCT00583908|7250763|FG005|COMPLETED|Period 4 - Fourth Intervention||1
6343304|NCT00583908|7250764|FG006|COMPLETED|Period 4 - Fourth Intervention||1
6343305|NCT00583908|7250765|FG007|COMPLETED|Period 4 - Fourth Intervention||1
6343306|NCT00583908|7250766|FG008|COMPLETED|Period 4 - Fourth Intervention||1
6343307|NCT00583908|7250767|FG009|COMPLETED|Period 4 - Fourth Intervention||1
6343308|NCT00583908|7250768|FG010|COMPLETED|Period 4 - Fourth Intervention||1
6343309|NCT00583908|7250769|FG011|COMPLETED|Period 4 - Fourth Intervention||1
6343310|NCT00583908|7250758|FG000|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343311|NCT00583908|7250759|FG001|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343312|NCT00583908|7250760|FG002|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343313|NCT00583908|7250761|FG003|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343314|NCT00583908|7250762|FG004|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343315|NCT00583908|7250763|FG005|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343316|NCT00583908|7250764|FG006|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343317|NCT00583908|7250765|FG007|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343318|NCT00583908|7250766|FG008|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343319|NCT00583908|7250767|FG009|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343320|NCT00583908|7250768|FG010|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343321|NCT00583908|7250769|FG011|NOT COMPLETED|Period 4 - Fourth Intervention||0
6343322|NCT00583947|7250789|FG000|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
6343323|NCT00583947|7250790|FG001|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
6343324|NCT00583947|7250789|FG000|COMPLETED|Cross-over Period||22
6343325|NCT00583947|7250790|FG001|COMPLETED|Cross-over Period||24
6343326|NCT00583947|7250789|FG000|NOT COMPLETED|Cross-over Period||5
6343327|NCT00583947|7250790|FG001|NOT COMPLETED|Cross-over Period||2
6343328|NCT00583947|7250789|FG000|STARTED|Washout||22
6343329|NCT00583947|7250790|FG001|STARTED|Washout||24
6343330|NCT00583947|7250789|FG000|COMPLETED|Washout||22
6343331|NCT00583947|7250790|FG001|COMPLETED|Washout||24
6343332|NCT00583947|7250789|FG000|NOT COMPLETED|Washout||0
6343333|NCT00583947|7250790|FG001|NOT COMPLETED|Washout||0
6343334|NCT00583947|7250789|FG000|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
6343335|NCT00583947|7250790|FG001|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
6343336|NCT00583947|7250789|FG000|COMPLETED|Open Label Period||22
6343337|NCT00583947|7250790|FG001|COMPLETED|Open Label Period||24
6343338|NCT00583947|7250789|FG000|NOT COMPLETED|Open Label Period||0
6343339|NCT00583947|7250790|FG001|NOT COMPLETED|Open Label Period||0
6343340|NCT00584077|7250798|FG000|STARTED|Overall Study||15
6343341|NCT00584077|7250798|FG000|COMPLETED|Overall Study||15
6343342|NCT00584077|7250798|FG000|NOT COMPLETED|Overall Study||0
6343343|NCT00584194|7250803|FG000|STARTED|Overall Study||278
6343344|NCT00584194|7250803|FG000|COMPLETED|Overall Study||143
6343345|NCT00584194|7250803|FG000|NOT COMPLETED|Overall Study||135
6343346|NCT00584220|7250807|FG000|STARTED|First Period||48
6343347|NCT00584220|7250808|FG001|STARTED|First Period||39
6343348|NCT00584220|7250807|FG000|COMPLETED|First Period||48
6343349|NCT00584220|7250808|FG001|COMPLETED|First Period||39
6343350|NCT00584220|7250807|FG000|NOT COMPLETED|First Period||0
6343351|NCT00584220|7250808|FG001|NOT COMPLETED|First Period||0
6343352|NCT00584220|7250807|FG000|STARTED|Second Period||48
6343353|NCT00584220|7250808|FG001|STARTED|Second Period||39
6343354|NCT00584220|7250807|FG000|COMPLETED|Second Period||48
6343355|NCT00584220|7250808|FG001|COMPLETED|Second Period||39
6343356|NCT00584220|7250807|FG000|NOT COMPLETED|Second Period||0
6343357|NCT00584220|7250808|FG001|NOT COMPLETED|Second Period||0
6343358|NCT00584285|7250814|FG000|STARTED|Overall Study||18
6343359|NCT00584285|7250814|FG000|COMPLETED|Overall Study||18
6343360|NCT00584285|7250814|FG000|NOT COMPLETED|Overall Study||0
6343361|NCT00584402|7250818|FG000|STARTED|Overall Study||8
6343362|NCT00584402|7250818|FG000|COMPLETED|Overall Study||8
6343363|NCT00584402|7250818|FG000|NOT COMPLETED|Overall Study||0
6343364|NCT00584415|7250822|FG000|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
6343365|NCT00584415|7250822|FG000|COMPLETED|Overall Study||112
6343366|NCT00584415|7250822|FG000|NOT COMPLETED|Overall Study||7
6343367|NCT00584454|7250827|FG000|STARTED|Overall Study||10
6343368|NCT00584454|7250827|FG000|COMPLETED|Overall Study||6
6343369|NCT00584454|7250827|FG000|NOT COMPLETED|Overall Study||4
6343370|NCT00584480|7250831|FG000|STARTED|First 8 Weeks (40 Treatments)||10
6343371|NCT00584480|7250831|FG000|COMPLETED|First 8 Weeks (40 Treatments)||10
6343372|NCT00584480|7250831|FG000|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
6343373|NCT00584480|7250831|FG000|STARTED|4-Week Break From Treatment||10
6343374|NCT00584480|7250831|FG000|COMPLETED|4-Week Break From Treatment||10
6343375|NCT00584480|7250831|FG000|NOT COMPLETED|4-Week Break From Treatment||0
6343376|NCT00584480|7250831|FG000|STARTED|Second 8 Weeks (40 Treatments)||10
6343377|NCT00584480|7250831|FG000|COMPLETED|Second 8 Weeks (40 Treatments)||10
6343378|NCT00584480|7250831|FG000|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
6343379|NCT00584558|7250835|FG000|STARTED|Overall Study||2420
6343380|NCT00584558|7250835|FG000|COMPLETED|Overall Study||2420
6343381|NCT00584558|7250835|FG000|NOT COMPLETED|Overall Study||0
6343382|NCT00584701|7250840|FG000|STARTED|Active Risperidone||49
6343383|NCT00584701|7250840|FG000|COMPLETED|Active Risperidone||46
6343384|NCT00584701|7250840|FG000|NOT COMPLETED|Active Risperidone||3
6343385|NCT00584701|7250840|FG000|STARTED|Follow-up||46
6343386|NCT00584701|7250840|FG000|COMPLETED|Follow-up||34
6343387|NCT00584701|7250840|FG000|NOT COMPLETED|Follow-up||12
6343388|NCT00584727|7250845|FG000|STARTED|First Intervention||17
6343389|NCT00584727|7250846|FG001|STARTED|First Intervention||17
6343390|NCT00584727|7250847|FG002|STARTED|First Intervention||16
6343391|NCT00584727|7250848|FG003|STARTED|First Intervention||14
6343392|NCT00584727|7250849|FG004|STARTED|First Intervention||16
6343393|NCT00584727|7250850|FG005|STARTED|First Intervention||16
6343394|NCT00584727|7250845|FG000|COMPLETED|First Intervention||17
6343395|NCT00584727|7250846|FG001|COMPLETED|First Intervention||17
6343396|NCT00584727|7250847|FG002|COMPLETED|First Intervention||15
6343397|NCT00584727|7250848|FG003|COMPLETED|First Intervention||14
6343398|NCT00584727|7250849|FG004|COMPLETED|First Intervention||16
6343399|NCT00584727|7250850|FG005|COMPLETED|First Intervention||16
6343400|NCT00584727|7250845|FG000|NOT COMPLETED|First Intervention||0
6343401|NCT00584727|7250846|FG001|NOT COMPLETED|First Intervention||0
6343402|NCT00584727|7250847|FG002|NOT COMPLETED|First Intervention||1
6343403|NCT00584727|7250848|FG003|NOT COMPLETED|First Intervention||0
6343404|NCT00584727|7250849|FG004|NOT COMPLETED|First Intervention||0
6343405|NCT00584727|7250850|FG005|NOT COMPLETED|First Intervention||0
6343406|NCT00584727|7250845|FG000|STARTED|Second Intervention||17
6343407|NCT00584727|7250846|FG001|STARTED|Second Intervention||17
6343408|NCT00584727|7250847|FG002|STARTED|Second Intervention||15
6343409|NCT00584727|7250848|FG003|STARTED|Second Intervention||14
6343410|NCT00584727|7250849|FG004|STARTED|Second Intervention||16
6343411|NCT00584727|7250850|FG005|STARTED|Second Intervention||16
6343412|NCT00584727|7250845|FG000|COMPLETED|Second Intervention||17
6343413|NCT00584727|7250846|FG001|COMPLETED|Second Intervention||17
6343414|NCT00584727|7250847|FG002|COMPLETED|Second Intervention||15
6343415|NCT00584727|7250848|FG003|COMPLETED|Second Intervention||14
6343416|NCT00584727|7250849|FG004|COMPLETED|Second Intervention||16
6343417|NCT00584727|7250850|FG005|COMPLETED|Second Intervention||16
6343418|NCT00584727|7250845|FG000|NOT COMPLETED|Second Intervention||0
6343419|NCT00584727|7250846|FG001|NOT COMPLETED|Second Intervention||0
6343420|NCT00584727|7250847|FG002|NOT COMPLETED|Second Intervention||0
6343421|NCT00584727|7250848|FG003|NOT COMPLETED|Second Intervention||0
6343422|NCT00584727|7250849|FG004|NOT COMPLETED|Second Intervention||0
6343423|NCT00584727|7250850|FG005|NOT COMPLETED|Second Intervention||0
6343424|NCT00584727|7250845|FG000|STARTED|Third Intervention||17
6343425|NCT00584727|7250846|FG001|STARTED|Third Intervention||17
6343426|NCT00584727|7250847|FG002|STARTED|Third Intervention||15
6343427|NCT00584727|7250848|FG003|STARTED|Third Intervention||14
6343428|NCT00584727|7250849|FG004|STARTED|Third Intervention||16
6343429|NCT00584727|7250850|FG005|STARTED|Third Intervention||16
6343430|NCT00584727|7250845|FG000|COMPLETED|Third Intervention||17
6343431|NCT00584727|7250846|FG001|COMPLETED|Third Intervention||17
6343432|NCT00584727|7250847|FG002|COMPLETED|Third Intervention||14
6343433|NCT00584727|7250848|FG003|COMPLETED|Third Intervention||14
6343434|NCT00584727|7250849|FG004|COMPLETED|Third Intervention||12
6343435|NCT00584727|7250850|FG005|COMPLETED|Third Intervention||14
6343436|NCT00584727|7250845|FG000|NOT COMPLETED|Third Intervention||0
6343437|NCT00584727|7250846|FG001|NOT COMPLETED|Third Intervention||0
6343438|NCT00584727|7250847|FG002|NOT COMPLETED|Third Intervention||1
6343439|NCT00584727|7250848|FG003|NOT COMPLETED|Third Intervention||0
6343440|NCT00584727|7250849|FG004|NOT COMPLETED|Third Intervention||4
6343441|NCT00584727|7250850|FG005|NOT COMPLETED|Third Intervention||2
6343442|NCT00584740|7250863|FG000|STARTED|Overall Study||39
6343443|NCT00584740|7250864|FG001|STARTED|Overall Study||20
6343444|NCT00584740|7250863|FG000|COMPLETED|Overall Study||27
6343445|NCT00584740|7250864|FG001|COMPLETED|Overall Study||14
6343446|NCT00584740|7250863|FG000|NOT COMPLETED|Overall Study||12
6343447|NCT00584740|7250864|FG001|NOT COMPLETED|Overall Study||6
6343448|NCT00584805|7250870|FG000|STARTED|Overall Study||138
6343449|NCT00584805|7250870|FG000|COMPLETED|Overall Study||39
6343450|NCT00584805|7250870|FG000|NOT COMPLETED|Overall Study||99
6343451|NCT00584831|7250876|FG000|STARTED|Intervention 1||1
6343452|NCT00584831|7250877|FG001|STARTED|Intervention 1||3
6343453|NCT00584831|7250878|FG002|STARTED|Intervention 1||2
6343454|NCT00584831|7250879|FG003|STARTED|Intervention 1||1
6343455|NCT00584831|7250880|FG004|STARTED|Intervention 1||2
6343456|NCT00584831|7250881|FG005|STARTED|Intervention 1||1
6343457|NCT00584831|7250882|FG006|STARTED|Intervention 1||6
6343458|NCT00584831|7250883|FG007|STARTED|Intervention 1||2
6343459|NCT00584831|7250884|FG008|STARTED|Intervention 1||4
6343460|NCT00584831|7250885|FG009|STARTED|Intervention 1||2
6343461|NCT00584831|7250886|FG010|STARTED|Intervention 1||2
6343462|NCT00584831|7250887|FG011|STARTED|Intervention 1||1
6343463|NCT00584831|7250888|FG012|STARTED|Intervention 1||2
6343464|NCT00584831|7250889|FG013|STARTED|Intervention 1||1
6343465|NCT00584831|7250890|FG014|STARTED|Intervention 1||3
6343466|NCT00584831|7250891|FG015|STARTED|Intervention 1||1
6343467|NCT00584831|7250892|FG016|STARTED|Intervention 1||4
6343468|NCT00584831|7250893|FG017|STARTED|Intervention 1||1
6343469|NCT00584831|7250894|FG018|STARTED|Intervention 1||1
6343470|NCT00584831|7250876|FG000|COMPLETED|Intervention 1||1
6343471|NCT00584831|7250877|FG001|COMPLETED|Intervention 1||3
6343472|NCT00584831|7250878|FG002|COMPLETED|Intervention 1||2
6343473|NCT00584831|7250879|FG003|COMPLETED|Intervention 1||1
6343474|NCT00584831|7250880|FG004|COMPLETED|Intervention 1||2
6343475|NCT00584831|7250881|FG005|COMPLETED|Intervention 1||1
6776393|NCT03834025|7704477|FG004|STARTED|Sent Recruitment Letter (Phase 1)||0
6776394|NCT03834025|7704478|FG005|STARTED|Sent Recruitment Letter (Phase 1)||0
6776395|NCT03834025|7704479|FG006|STARTED|Sent Recruitment Letter (Phase 1)||0
6776396|NCT03834025|7704473|FG000|Sent Letter|Sent Recruitment Letter (Phase 1)||4150
6343476|NCT00584831|7250882|FG006|COMPLETED|Intervention 1||6
6343477|NCT00584831|7250883|FG007|COMPLETED|Intervention 1||2
6343478|NCT00584831|7250884|FG008|COMPLETED|Intervention 1||4
6343479|NCT00584831|7250885|FG009|COMPLETED|Intervention 1||2
6343480|NCT00584831|7250886|FG010|COMPLETED|Intervention 1||2
6343481|NCT00584831|7250887|FG011|COMPLETED|Intervention 1||1
6343482|NCT00584831|7250888|FG012|COMPLETED|Intervention 1||2
6343483|NCT00584831|7250889|FG013|COMPLETED|Intervention 1||1
6343484|NCT00584831|7250890|FG014|COMPLETED|Intervention 1||3
6343485|NCT00584831|7250891|FG015|COMPLETED|Intervention 1||1
6343486|NCT00584831|7250892|FG016|COMPLETED|Intervention 1||4
6343487|NCT00584831|7250893|FG017|COMPLETED|Intervention 1||1
6343488|NCT00584831|7250894|FG018|COMPLETED|Intervention 1||1
6343489|NCT00584831|7250876|FG000|NOT COMPLETED|Intervention 1||0
6343490|NCT00584831|7250877|FG001|NOT COMPLETED|Intervention 1||0
6343491|NCT00584831|7250878|FG002|NOT COMPLETED|Intervention 1||0
6343492|NCT00584831|7250879|FG003|NOT COMPLETED|Intervention 1||0
6343493|NCT00584831|7250880|FG004|NOT COMPLETED|Intervention 1||0
6343494|NCT00584831|7250881|FG005|NOT COMPLETED|Intervention 1||0
6343495|NCT00584831|7250882|FG006|NOT COMPLETED|Intervention 1||0
6343496|NCT00584831|7250883|FG007|NOT COMPLETED|Intervention 1||0
6343497|NCT00584831|7250884|FG008|NOT COMPLETED|Intervention 1||0
6343498|NCT00584831|7250885|FG009|NOT COMPLETED|Intervention 1||0
6343499|NCT00584831|7250886|FG010|NOT COMPLETED|Intervention 1||0
6343500|NCT00584831|7250887|FG011|NOT COMPLETED|Intervention 1||0
6343501|NCT00584831|7250888|FG012|NOT COMPLETED|Intervention 1||0
6343502|NCT00584831|7250889|FG013|NOT COMPLETED|Intervention 1||0
6343503|NCT00584831|7250890|FG014|NOT COMPLETED|Intervention 1||0
6343504|NCT00584831|7250891|FG015|NOT COMPLETED|Intervention 1||0
6343505|NCT00584831|7250892|FG016|NOT COMPLETED|Intervention 1||0
6343506|NCT00584831|7250893|FG017|NOT COMPLETED|Intervention 1||0
6343507|NCT00584831|7250894|FG018|NOT COMPLETED|Intervention 1||0
6343508|NCT00584831|7250876|FG000|STARTED|Intervention 2||1
6343509|NCT00584831|7250877|FG001|STARTED|Intervention 2||3
6343510|NCT00584831|7250878|FG002|STARTED|Intervention 2||2
6343511|NCT00584831|7250879|FG003|STARTED|Intervention 2||1
6343512|NCT00584831|7250880|FG004|STARTED|Intervention 2||2
6343513|NCT00584831|7250881|FG005|STARTED|Intervention 2||1
6343514|NCT00584831|7250882|FG006|STARTED|Intervention 2||6
6343515|NCT00584831|7250883|FG007|STARTED|Intervention 2||2
6343516|NCT00584831|7250884|FG008|STARTED|Intervention 2||4
6343517|NCT00584831|7250885|FG009|STARTED|Intervention 2||2
6343518|NCT00584831|7250886|FG010|STARTED|Intervention 2||2
6343519|NCT00584831|7250887|FG011|STARTED|Intervention 2||1
6343520|NCT00584831|7250888|FG012|STARTED|Intervention 2||2
6343521|NCT00584831|7250889|FG013|STARTED|Intervention 2||1
6343522|NCT00584831|7250890|FG014|STARTED|Intervention 2||3
6343523|NCT00584831|7250891|FG015|STARTED|Intervention 2||1
6343524|NCT00584831|7250892|FG016|STARTED|Intervention 2||4
6776397|NCT03834025|7704474|FG001|Sent Letter|Sent Recruitment Letter (Phase 1)||3871
6343525|NCT00584831|7250893|FG017|STARTED|Intervention 2||1
6343526|NCT00584831|7250894|FG018|STARTED|Intervention 2||1
6343527|NCT00584831|7250876|FG000|COMPLETED|Intervention 2||1
6776398|NCT03834025|7704475|FG002|Sent Letter|Sent Recruitment Letter (Phase 1)||4121
6776399|NCT03834025|7704476|FG003|Sent Letter|Sent Recruitment Letter (Phase 1)||3693
6776400|NCT03834025|7704477|FG004|Sent Letter|Sent Recruitment Letter (Phase 1)||0
6343528|NCT00584831|7250877|FG001|COMPLETED|Intervention 2||3
6343529|NCT00584831|7250878|FG002|COMPLETED|Intervention 2||2
6343530|NCT00584831|7250879|FG003|COMPLETED|Intervention 2||1
6343531|NCT00584831|7250880|FG004|COMPLETED|Intervention 2||2
6343532|NCT00584831|7250881|FG005|COMPLETED|Intervention 2||1
6343533|NCT00584831|7250882|FG006|COMPLETED|Intervention 2||6
6343534|NCT00584831|7250883|FG007|COMPLETED|Intervention 2||2
6343535|NCT00584831|7250884|FG008|COMPLETED|Intervention 2||4
6343536|NCT00584831|7250885|FG009|COMPLETED|Intervention 2||2
6343537|NCT00584831|7250886|FG010|COMPLETED|Intervention 2||2
6343538|NCT00584831|7250887|FG011|COMPLETED|Intervention 2||1
6343539|NCT00584831|7250888|FG012|COMPLETED|Intervention 2||2
6343540|NCT00584831|7250889|FG013|COMPLETED|Intervention 2||1
6343541|NCT00584831|7250890|FG014|COMPLETED|Intervention 2||3
6343542|NCT00584831|7250891|FG015|COMPLETED|Intervention 2||1
6343543|NCT00584831|7250892|FG016|COMPLETED|Intervention 2||4
6343544|NCT00584831|7250893|FG017|COMPLETED|Intervention 2||1
6343545|NCT00584831|7250894|FG018|COMPLETED|Intervention 2||1
6343546|NCT00584831|7250876|FG000|NOT COMPLETED|Intervention 2||0
6343547|NCT00584831|7250877|FG001|NOT COMPLETED|Intervention 2||0
6343548|NCT00584831|7250878|FG002|NOT COMPLETED|Intervention 2||0
6343549|NCT00584831|7250879|FG003|NOT COMPLETED|Intervention 2||0
6343550|NCT00584831|7250880|FG004|NOT COMPLETED|Intervention 2||0
6343551|NCT00584831|7250881|FG005|NOT COMPLETED|Intervention 2||0
6343552|NCT00584831|7250882|FG006|NOT COMPLETED|Intervention 2||0
6343553|NCT00584831|7250883|FG007|NOT COMPLETED|Intervention 2||0
6343554|NCT00584831|7250884|FG008|NOT COMPLETED|Intervention 2||0
6343555|NCT00584831|7250885|FG009|NOT COMPLETED|Intervention 2||0
6343556|NCT00584831|7250886|FG010|NOT COMPLETED|Intervention 2||0
6343557|NCT00584831|7250887|FG011|NOT COMPLETED|Intervention 2||0
6343558|NCT00584831|7250888|FG012|NOT COMPLETED|Intervention 2||0
6343559|NCT00584831|7250889|FG013|NOT COMPLETED|Intervention 2||0
6343560|NCT00584831|7250890|FG014|NOT COMPLETED|Intervention 2||0
6343561|NCT00584831|7250891|FG015|NOT COMPLETED|Intervention 2||0
6343562|NCT00584831|7250892|FG016|NOT COMPLETED|Intervention 2||0
6343563|NCT00584831|7250893|FG017|NOT COMPLETED|Intervention 2||0
6343564|NCT00584831|7250894|FG018|NOT COMPLETED|Intervention 2||0
6343565|NCT00584831|7250876|FG000|STARTED|Intervention 3||1
6343566|NCT00584831|7250877|FG001|STARTED|Intervention 3||3
6343567|NCT00584831|7250878|FG002|STARTED|Intervention 3||2
6343568|NCT00584831|7250879|FG003|STARTED|Intervention 3||1
6343569|NCT00584831|7250880|FG004|STARTED|Intervention 3||2
6343570|NCT00584831|7250881|FG005|STARTED|Intervention 3||1
6343571|NCT00584831|7250882|FG006|STARTED|Intervention 3||6
6343572|NCT00584831|7250883|FG007|STARTED|Intervention 3||2
6343573|NCT00584831|7250884|FG008|STARTED|Intervention 3||4
6343574|NCT00584831|7250885|FG009|STARTED|Intervention 3||2
6343575|NCT00584831|7250886|FG010|STARTED|Intervention 3||2
6343576|NCT00584831|7250887|FG011|STARTED|Intervention 3||1
6343577|NCT00584831|7250888|FG012|STARTED|Intervention 3||2
6343578|NCT00584831|7250889|FG013|STARTED|Intervention 3||1
6343579|NCT00584831|7250890|FG014|STARTED|Intervention 3||3
6343580|NCT00584831|7250891|FG015|STARTED|Intervention 3||1
6343581|NCT00584831|7250892|FG016|STARTED|Intervention 3||4
6343582|NCT00584831|7250893|FG017|STARTED|Intervention 3||1
6343583|NCT00584831|7250894|FG018|STARTED|Intervention 3||1
6343584|NCT00584831|7250876|FG000|COMPLETED|Intervention 3||1
6343585|NCT00584831|7250877|FG001|COMPLETED|Intervention 3||3
6343586|NCT00584831|7250878|FG002|COMPLETED|Intervention 3||2
6343587|NCT00584831|7250879|FG003|COMPLETED|Intervention 3||1
6343588|NCT00584831|7250880|FG004|COMPLETED|Intervention 3||2
6343589|NCT00584831|7250881|FG005|COMPLETED|Intervention 3||1
6343590|NCT00584831|7250882|FG006|COMPLETED|Intervention 3||6
6343591|NCT00584831|7250883|FG007|COMPLETED|Intervention 3||2
6343592|NCT00584831|7250884|FG008|COMPLETED|Intervention 3||4
6343593|NCT00584831|7250885|FG009|COMPLETED|Intervention 3||2
6343594|NCT00584831|7250886|FG010|COMPLETED|Intervention 3||2
6343595|NCT00584831|7250887|FG011|COMPLETED|Intervention 3||1
6343596|NCT00584831|7250888|FG012|COMPLETED|Intervention 3||2
6343597|NCT00584831|7250889|FG013|COMPLETED|Intervention 3||1
6343598|NCT00584831|7250890|FG014|COMPLETED|Intervention 3||3
6343599|NCT00584831|7250891|FG015|COMPLETED|Intervention 3||1
6343600|NCT00584831|7250892|FG016|COMPLETED|Intervention 3||4
6343601|NCT00584831|7250893|FG017|COMPLETED|Intervention 3||1
6343602|NCT00584831|7250894|FG018|COMPLETED|Intervention 3||1
6343603|NCT00584831|7250876|FG000|NOT COMPLETED|Intervention 3||0
6343604|NCT00584831|7250877|FG001|NOT COMPLETED|Intervention 3||0
6343605|NCT00584831|7250878|FG002|NOT COMPLETED|Intervention 3||0
6343606|NCT00584831|7250879|FG003|NOT COMPLETED|Intervention 3||0
6343607|NCT00584831|7250880|FG004|NOT COMPLETED|Intervention 3||0
6343608|NCT00584831|7250881|FG005|NOT COMPLETED|Intervention 3||0
6343609|NCT00584831|7250882|FG006|NOT COMPLETED|Intervention 3||0
6343610|NCT00584831|7250883|FG007|NOT COMPLETED|Intervention 3||0
6343611|NCT00584831|7250884|FG008|NOT COMPLETED|Intervention 3||0
6343612|NCT00584831|7250885|FG009|NOT COMPLETED|Intervention 3||0
6343613|NCT00584831|7250886|FG010|NOT COMPLETED|Intervention 3||0
6343614|NCT00584831|7250887|FG011|NOT COMPLETED|Intervention 3||0
6343615|NCT00584831|7250888|FG012|NOT COMPLETED|Intervention 3||0
6343616|NCT00584831|7250889|FG013|NOT COMPLETED|Intervention 3||0
6343617|NCT00584831|7250890|FG014|NOT COMPLETED|Intervention 3||0
6343618|NCT00584831|7250891|FG015|NOT COMPLETED|Intervention 3||0
6498469|NCT01410058|7417051|FG001|COMPLETED|Baseline Day 22||6
6498470|NCT01410058|7417050|FG000|NOT COMPLETED|Baseline Day 22||0
6498471|NCT01410058|7417051|FG001|NOT COMPLETED|Baseline Day 22||0
6498472|NCT01410058|7417050|FG000|STARTED|Day 35||13
6498473|NCT01410058|7417051|FG001|STARTED|Day 35||6
6343619|NCT00584831|7250892|FG016|NOT COMPLETED|Intervention 3||0
6343620|NCT00584831|7250893|FG017|NOT COMPLETED|Intervention 3||0
6343621|NCT00584831|7250894|FG018|NOT COMPLETED|Intervention 3||0
6343622|NCT00584831|7250876|FG000|STARTED|Intervention 4||1
6343623|NCT00584831|7250877|FG001|STARTED|Intervention 4||3
6343624|NCT00584831|7250878|FG002|STARTED|Intervention 4||2
6343625|NCT00584831|7250879|FG003|STARTED|Intervention 4||1
6343626|NCT00584831|7250880|FG004|STARTED|Intervention 4||2
6343627|NCT00584831|7250881|FG005|STARTED|Intervention 4||1
6343628|NCT00584831|7250882|FG006|STARTED|Intervention 4||6
6343629|NCT00584831|7250883|FG007|STARTED|Intervention 4||2
6343630|NCT00584831|7250884|FG008|STARTED|Intervention 4||3
6343631|NCT00584831|7250885|FG009|STARTED|Intervention 4||2
6343632|NCT00584831|7250886|FG010|STARTED|Intervention 4||2
6343633|NCT00584831|7250887|FG011|STARTED|Intervention 4||1
6343634|NCT00584831|7250888|FG012|STARTED|Intervention 4||2
6343635|NCT00584831|7250889|FG013|STARTED|Intervention 4||1
6343636|NCT00584831|7250890|FG014|STARTED|Intervention 4||2
6343637|NCT00584831|7250891|FG015|STARTED|Intervention 4||1
6343638|NCT00584831|7250892|FG016|STARTED|Intervention 4||4
6343639|NCT00584831|7250893|FG017|STARTED|Intervention 4||1
6343640|NCT00584831|7250894|FG018|STARTED|Intervention 4||1
6343641|NCT00584831|7250876|FG000|COMPLETED|Intervention 4||1
6343642|NCT00584831|7250877|FG001|COMPLETED|Intervention 4||3
6343643|NCT00584831|7250878|FG002|COMPLETED|Intervention 4||2
6343644|NCT00584831|7250879|FG003|COMPLETED|Intervention 4||1
6343645|NCT00584831|7250880|FG004|COMPLETED|Intervention 4||2
6343646|NCT00584831|7250881|FG005|COMPLETED|Intervention 4||1
6343647|NCT00584831|7250882|FG006|COMPLETED|Intervention 4||6
6343648|NCT00584831|7250883|FG007|COMPLETED|Intervention 4||2
6343649|NCT00584831|7250884|FG008|COMPLETED|Intervention 4||3
6343650|NCT00584831|7250885|FG009|COMPLETED|Intervention 4||2
6343651|NCT00584831|7250886|FG010|COMPLETED|Intervention 4||2
6343652|NCT00584831|7250887|FG011|COMPLETED|Intervention 4||1
6343653|NCT00584831|7250888|FG012|COMPLETED|Intervention 4||2
6343654|NCT00584831|7250889|FG013|COMPLETED|Intervention 4||1
6343655|NCT00584831|7250890|FG014|COMPLETED|Intervention 4||2
6343656|NCT00584831|7250891|FG015|COMPLETED|Intervention 4||1
6343657|NCT00584831|7250892|FG016|COMPLETED|Intervention 4||4
6343658|NCT00584831|7250893|FG017|COMPLETED|Intervention 4||1
6343659|NCT00584831|7250894|FG018|COMPLETED|Intervention 4||1
6343660|NCT00584831|7250876|FG000|NOT COMPLETED|Intervention 4||0
6343661|NCT00584831|7250877|FG001|NOT COMPLETED|Intervention 4||0
6343662|NCT00584831|7250878|FG002|NOT COMPLETED|Intervention 4||0
6343663|NCT00584831|7250879|FG003|NOT COMPLETED|Intervention 4||0
6343664|NCT00584831|7250880|FG004|NOT COMPLETED|Intervention 4||0
6343665|NCT00584831|7250881|FG005|NOT COMPLETED|Intervention 4||0
6343666|NCT00584831|7250882|FG006|NOT COMPLETED|Intervention 4||0
6343667|NCT00584831|7250883|FG007|NOT COMPLETED|Intervention 4||0
6343668|NCT00584831|7250884|FG008|NOT COMPLETED|Intervention 4||0
6343669|NCT00584831|7250885|FG009|NOT COMPLETED|Intervention 4||0
6343670|NCT00584831|7250886|FG010|NOT COMPLETED|Intervention 4||0
6343671|NCT00584831|7250887|FG011|NOT COMPLETED|Intervention 4||0
6343672|NCT00584831|7250888|FG012|NOT COMPLETED|Intervention 4||0
6343673|NCT00584831|7250889|FG013|NOT COMPLETED|Intervention 4||0
6343674|NCT00584831|7250890|FG014|NOT COMPLETED|Intervention 4||0
6343675|NCT00584831|7250891|FG015|NOT COMPLETED|Intervention 4||0
6343676|NCT00584831|7250892|FG016|NOT COMPLETED|Intervention 4||0
6343677|NCT00584831|7250893|FG017|NOT COMPLETED|Intervention 4||0
6343678|NCT00584831|7250894|FG018|NOT COMPLETED|Intervention 4||0
6343679|NCT00584844|7250904|FG000|STARTED|Overall Study||484
6343680|NCT00584844|7250904|FG000|COMPLETED|Overall Study||405
6343681|NCT00584844|7250904|FG000|NOT COMPLETED|Overall Study||79
6343682|NCT00584857|7250912|FG000|STARTED|Overall Study||30
6343683|NCT00584857|7250912|FG000|COMPLETED|Overall Study||30
6343684|NCT00584857|7250912|FG000|NOT COMPLETED|Overall Study||0
6343685|NCT00584870|7250919|FG000|STARTED|Overall Study||88
6343686|NCT00584870|7250920|FG001|STARTED|Overall Study||89
6343687|NCT00584870|7250921|FG002|STARTED|Overall Study||43
6343688|NCT00584870|7250919|FG000|Treated|Overall Study||88
6343689|NCT00584870|7250920|FG001|Treated|Overall Study||88
6343690|NCT00584870|7250921|FG002|Treated|Overall Study||41
6343691|NCT00584870|7250919|FG000|COMPLETED|Overall Study||59
6343692|NCT00584870|7250920|FG001|COMPLETED|Overall Study||64
6343693|NCT00584870|7250921|FG002|COMPLETED|Overall Study||25
6343694|NCT00584870|7250919|FG000|NOT COMPLETED|Overall Study||29
6343695|NCT00584870|7250920|FG001|NOT COMPLETED|Overall Study||25
6343696|NCT00584870|7250921|FG002|NOT COMPLETED|Overall Study||18
6343697|NCT00584909|7250929|FG000|STARTED|Overall Study||13
6343698|NCT00584909|7250929|FG000|COMPLETED|Overall Study||9
6343699|NCT00584909|7250929|FG000|NOT COMPLETED|Overall Study||4
6343700|NCT00584922|7250933|FG000|STARTED|Overall Study||175
6343701|NCT00584922|7250933|FG000|COMPLETED|Overall Study||175
6343702|NCT00584922|7250933|FG000|NOT COMPLETED|Overall Study||0
6343703|NCT00584948|7250939|FG000|STARTED|Overall Study||47
6343704|NCT00584948|7250940|FG001|STARTED|Overall Study||47
6343705|NCT00584948|7250939|FG000|COMPLETED|Overall Study||34
6343706|NCT00584948|7250940|FG001|COMPLETED|Overall Study||36
6343707|NCT00584948|7250939|FG000|NOT COMPLETED|Overall Study||13
6343708|NCT00584948|7250940|FG001|NOT COMPLETED|Overall Study||11
6343709|NCT00584987|7250950|FG000|STARTED|Overall Study||15
6343710|NCT00584987|7250951|FG001|STARTED|Overall Study||16
6343711|NCT00584987|7250952|FG002|STARTED|Overall Study||17
6343712|NCT00584987|7250953|FG003|STARTED|Overall Study||16
6343713|NCT00584987|7250950|FG000|COMPLETED|Overall Study||14
6343714|NCT00584987|7250951|FG001|COMPLETED|Overall Study||15
6343715|NCT00584987|7250952|FG002|COMPLETED|Overall Study||16
6343716|NCT00584987|7250953|FG003|COMPLETED|Overall Study||15
6343717|NCT00584987|7250950|FG000|NOT COMPLETED|Overall Study||1
6343718|NCT00584987|7250951|FG001|NOT COMPLETED|Overall Study||1
6343719|NCT00584987|7250952|FG002|NOT COMPLETED|Overall Study||1
6343720|NCT00584987|7250953|FG003|NOT COMPLETED|Overall Study||1
6343721|NCT00585013|7250965|FG000|STARTED|Overall Study||8
6343722|NCT00585013|7250966|FG001|STARTED|Overall Study||8
6343723|NCT00585013|7250965|FG000|COMPLETED|Overall Study||8
6343724|NCT00585013|7250966|FG001|COMPLETED|Overall Study||8
6343725|NCT00585013|7250965|FG000|NOT COMPLETED|Overall Study||0
6343726|NCT00585013|7250966|FG001|NOT COMPLETED|Overall Study||0
6343727|NCT00585039|7250976|FG000|STARTED|Overall Study||57
6343728|NCT00585039|7250977|FG001|STARTED|Overall Study||44
6343729|NCT00585039|7250976|FG000|COMPLETED|Overall Study||55
6343730|NCT00585039|7250977|FG001|COMPLETED|Overall Study||44
6343731|NCT00585039|7250976|FG000|NOT COMPLETED|Overall Study||2
6343732|NCT00585039|7250977|FG001|NOT COMPLETED|Overall Study||0
6343733|NCT00585052|7250985|FG000|STARTED|Overall Study||11
6343734|NCT00585052|7250985|FG000|COMPLETED|Overall Study||10
6343735|NCT00585052|7250985|FG000|NOT COMPLETED|Overall Study||1
6343736|NCT00585078|7250989|FG000|STARTED|Overall Study||40
6343737|NCT00585078|7250989|FG000|Treated|Overall Study||37
6343738|NCT00585078|7250989|FG000|Toxicity Evaluable|Overall Study||36
6343739|NCT00585078|7250989|FG000|Response Evaluable|Overall Study||24
6343740|NCT00585078|7250989|FG000|COMPLETED|Overall Study||0
6343741|NCT00585078|7250989|FG000|NOT COMPLETED|Overall Study||40
6343742|NCT00585104|7250993|FG000|STARTED|Overall Study||10
6343743|NCT00585104|7250993|FG000|COMPLETED|Overall Study||6
6343744|NCT00585104|7250993|FG000|NOT COMPLETED|Overall Study||4
6343745|NCT00585169|7250997|FG000|STARTED|Overall Study||29
6343746|NCT00585169|7250997|FG000|COMPLETED|Overall Study||28
6343747|NCT00585169|7250997|FG000|NOT COMPLETED|Overall Study||1
6343748|NCT00585182|7251003|FG000|STARTED|Overall Study||28
6343749|NCT00585182|7251003|FG000|COMPLETED|Overall Study||28
6343750|NCT00585182|7251003|FG000|NOT COMPLETED|Overall Study||0
6343751|NCT00585247|7251009|FG000|STARTED|Overall Study||14
6343752|NCT00585247|7251010|FG001|STARTED|Overall Study||13
6343753|NCT00585247|7251009|FG000|COMPLETED|Overall Study||14
6343754|NCT00585247|7251010|FG001|COMPLETED|Overall Study||13
6343755|NCT00585247|7251009|FG000|NOT COMPLETED|Overall Study||0
6343756|NCT00585247|7251010|FG001|NOT COMPLETED|Overall Study||0
6343757|NCT00585286|7251016|FG000|STARTED|Overall Study||15
6343758|NCT00585286|7251016|FG000|COMPLETED|Overall Study||14
6343759|NCT00585286|7251016|FG000|NOT COMPLETED|Overall Study||1
6343760|NCT00585312|7251022|FG000|STARTED|Overall Study|STARTED=Randomized|55
6343761|NCT00585312|7251023|FG001|STARTED|Overall Study|STARTED=Randomized|51
6343762|NCT00585312|7251022|FG000|Treated|Overall Study||53
6343763|NCT00585312|7251023|FG001|Treated|Overall Study||48
6343764|NCT00585312|7251022|FG000|COMPLETED|Overall Study||4
6343765|NCT00585312|7251023|FG001|COMPLETED|Overall Study||7
6343766|NCT00585312|7251022|FG000|NOT COMPLETED|Overall Study||51
6343767|NCT00585312|7251023|FG001|NOT COMPLETED|Overall Study||44
6343768|NCT00585325|7251031|FG000|STARTED|Overall Study||10
6343769|NCT00585325|7251032|FG001|STARTED|Overall Study||13
6343770|NCT00585325|7251031|FG000|COMPLETED|Overall Study||9
6343771|NCT00585325|7251032|FG001|COMPLETED|Overall Study||12
6343772|NCT00585325|7251031|FG000|NOT COMPLETED|Overall Study||1
6343773|NCT00585325|7251032|FG001|NOT COMPLETED|Overall Study||1
6343774|NCT00585351|7251044|FG000|STARTED|Notification Period (Informed Consent)||50
6343775|NCT00585351|7251045|FG001|STARTED|Notification Period (Informed Consent)||50
6343776|NCT00585351|7251046|FG002|STARTED|Notification Period (Informed Consent)||0
6343777|NCT00585351|7251047|FG003|STARTED|Notification Period (Informed Consent)||0
6343778|NCT00585351|7251048|FG004|STARTED|Notification Period (Informed Consent)||0
6343779|NCT00585351|7251049|FG005|STARTED|Notification Period (Informed Consent)||0
6343780|NCT00585351|7251050|FG006|STARTED|Notification Period (Informed Consent)||0
6343781|NCT00585351|7251051|FG007|STARTED|Notification Period (Informed Consent)||0
6343782|NCT00585351|7251044|FG000|COMPLETED|Notification Period (Informed Consent)||27
6343783|NCT00585351|7251045|FG001|COMPLETED|Notification Period (Informed Consent)||25
6343784|NCT00585351|7251046|FG002|COMPLETED|Notification Period (Informed Consent)||0
6343785|NCT00585351|7251047|FG003|COMPLETED|Notification Period (Informed Consent)||0
6343786|NCT00585351|7251048|FG004|COMPLETED|Notification Period (Informed Consent)||0
6343787|NCT00585351|7251049|FG005|COMPLETED|Notification Period (Informed Consent)||0
6343788|NCT00585351|7251050|FG006|COMPLETED|Notification Period (Informed Consent)||0
6343789|NCT00585351|7251051|FG007|COMPLETED|Notification Period (Informed Consent)||0
6343790|NCT00585351|7251044|FG000|NOT COMPLETED|Notification Period (Informed Consent)||23
6343791|NCT00585351|7251045|FG001|NOT COMPLETED|Notification Period (Informed Consent)||25
6343792|NCT00585351|7251046|FG002|NOT COMPLETED|Notification Period (Informed Consent)||0
6343793|NCT00585351|7251047|FG003|NOT COMPLETED|Notification Period (Informed Consent)||0
6343794|NCT00585351|7251048|FG004|NOT COMPLETED|Notification Period (Informed Consent)||0
6343795|NCT00585351|7251049|FG005|NOT COMPLETED|Notification Period (Informed Consent)||0
6343796|NCT00585351|7251050|FG006|NOT COMPLETED|Notification Period (Informed Consent)||0
6343797|NCT00585351|7251051|FG007|NOT COMPLETED|Notification Period (Informed Consent)||0
6343798|NCT00585351|7251044|FG000|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
6343799|NCT00585351|7251045|FG001|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
6343800|NCT00585351|7251046|FG002|STARTED|Enrollment Period (Intervention)||15
6343801|NCT00585351|7251047|FG003|STARTED|Enrollment Period (Intervention)||15
6343802|NCT00585351|7251048|FG004|STARTED|Enrollment Period (Intervention)||5
6343803|NCT00585351|7251049|FG005|STARTED|Enrollment Period (Intervention)||7
6343804|NCT00585351|7251050|FG006|STARTED|Enrollment Period (Intervention)||7
6343805|NCT00585351|7251051|FG007|STARTED|Enrollment Period (Intervention)||3
6343806|NCT00585351|7251044|FG000|COMPLETED|Enrollment Period (Intervention)||0
6343807|NCT00585351|7251045|FG001|COMPLETED|Enrollment Period (Intervention)||0
6343808|NCT00585351|7251046|FG002|COMPLETED|Enrollment Period (Intervention)||15
6343809|NCT00585351|7251047|FG003|COMPLETED|Enrollment Period (Intervention)||15
6343810|NCT00585351|7251048|FG004|COMPLETED|Enrollment Period (Intervention)||3
6343811|NCT00585351|7251049|FG005|COMPLETED|Enrollment Period (Intervention)||5
6343812|NCT00585351|7251050|FG006|COMPLETED|Enrollment Period (Intervention)||5
6343813|NCT00585351|7251051|FG007|COMPLETED|Enrollment Period (Intervention)||2
6343814|NCT00585351|7251044|FG000|NOT COMPLETED|Enrollment Period (Intervention)||0
6343815|NCT00585351|7251045|FG001|NOT COMPLETED|Enrollment Period (Intervention)||0
6343816|NCT00585351|7251046|FG002|NOT COMPLETED|Enrollment Period (Intervention)||0
6343817|NCT00585351|7251047|FG003|NOT COMPLETED|Enrollment Period (Intervention)||0
6343818|NCT00585351|7251048|FG004|NOT COMPLETED|Enrollment Period (Intervention)||2
6343819|NCT00585351|7251049|FG005|NOT COMPLETED|Enrollment Period (Intervention)||2
6343820|NCT00585351|7251050|FG006|NOT COMPLETED|Enrollment Period (Intervention)||2
6343821|NCT00585351|7251051|FG007|NOT COMPLETED|Enrollment Period (Intervention)||1
6343822|NCT00585377|7251065|FG000|STARTED|Overall Study||50
6343823|NCT00585377|7251065|FG000|COMPLETED|Overall Study||50
6343824|NCT00585377|7251065|FG000|NOT COMPLETED|Overall Study||0
6343825|NCT00585468|7251069|FG000|STARTED|First Intervention||10
6343826|NCT00585468|7251070|FG001|STARTED|First Intervention||11
6343827|NCT00585468|7251069|FG000|COMPLETED|First Intervention||9
6343828|NCT00585468|7251070|FG001|COMPLETED|First Intervention||10
6343829|NCT00585468|7251069|FG000|NOT COMPLETED|First Intervention||1
6343830|NCT00585468|7251070|FG001|NOT COMPLETED|First Intervention||1
6343831|NCT00585468|7251069|FG000|STARTED|Second Intervention||9
6343832|NCT00585468|7251070|FG001|STARTED|Second Intervention||10
6343833|NCT00585468|7251069|FG000|COMPLETED|Second Intervention||9
6343834|NCT00585468|7251070|FG001|COMPLETED|Second Intervention||10
6343835|NCT00585468|7251069|FG000|NOT COMPLETED|Second Intervention||0
6343836|NCT00585468|7251070|FG001|NOT COMPLETED|Second Intervention||0
6343837|NCT00585494|7251078|FG000|STARTED|Overall Study||300
6343838|NCT00585494|7251078|FG000|COMPLETED|Overall Study||244
6343839|NCT00585494|7251078|FG000|NOT COMPLETED|Overall Study||56
6343840|NCT00585533|7251082|FG000|STARTED|Overall Study||40
6343841|NCT00585533|7251082|FG000|COMPLETED|Overall Study||31
6343842|NCT00585533|7251082|FG000|NOT COMPLETED|Overall Study||9
6343843|NCT00585546|7251086|FG000|STARTED|LVAD Implantation Required for 4 Months||18
6343844|NCT00585546|7251086|FG000|COMPLETED|LVAD Implantation Required for 4 Months||13
6343845|NCT00585546|7251086|FG000|NOT COMPLETED|LVAD Implantation Required for 4 Months||5
6343846|NCT00585546|7251086|FG000|STARTED|Clenbuterol Treatment - up to 12 Months||13
6343847|NCT00585546|7251086|FG000|COMPLETED|Clenbuterol Treatment - up to 12 Months||9
6343848|NCT00585546|7251086|FG000|NOT COMPLETED|Clenbuterol Treatment - up to 12 Months||4
6343849|NCT00585637|7251094|FG000|STARTED|Baseline||81
6343850|NCT00585637|7251095|FG001|STARTED|Baseline||81
6343851|NCT00585637|7251096|FG002|STARTED|Baseline||83
6343852|NCT00585637|7251097|FG003|STARTED|Baseline||83
6343853|NCT00585637|7251094|FG000|COMPLETED|Baseline||81
6343854|NCT00585637|7251095|FG001|COMPLETED|Baseline||81
6343855|NCT00585637|7251096|FG002|COMPLETED|Baseline||83
6343856|NCT00585637|7251097|FG003|COMPLETED|Baseline||83
6343857|NCT00585637|7251094|FG000|NOT COMPLETED|Baseline||0
6343858|NCT00585637|7251095|FG001|NOT COMPLETED|Baseline||0
6343859|NCT00585637|7251096|FG002|NOT COMPLETED|Baseline||0
6343860|NCT00585637|7251097|FG003|NOT COMPLETED|Baseline||0
6343861|NCT00585637|7251094|FG000|STARTED|3-month Time Point||81
6343862|NCT00585637|7251095|FG001|STARTED|3-month Time Point||81
6343863|NCT00585637|7251096|FG002|STARTED|3-month Time Point||83
6343864|NCT00585637|7251097|FG003|STARTED|3-month Time Point||83
6343865|NCT00585637|7251094|FG000|COMPLETED|3-month Time Point||71
6343866|NCT00585637|7251095|FG001|COMPLETED|3-month Time Point||67
6343867|NCT00585637|7251096|FG002|COMPLETED|3-month Time Point||76
6343868|NCT00585637|7251097|FG003|COMPLETED|3-month Time Point||78
6343869|NCT00585637|7251094|FG000|NOT COMPLETED|3-month Time Point||10
6343870|NCT00585637|7251095|FG001|NOT COMPLETED|3-month Time Point||14
6343871|NCT00585637|7251096|FG002|NOT COMPLETED|3-month Time Point||7
6559337|NCT01781299|7481986|FG001|COMPLETED|Overall Study||4
6559338|NCT01781299|7481985|FG000|NOT COMPLETED|Overall Study||0
6559339|NCT01781299|7481986|FG001|NOT COMPLETED|Overall Study||1
6343872|NCT00585637|7251097|FG003|NOT COMPLETED|3-month Time Point||5
6559340|NCT01781403|7481992|FG000|STARTED|Overall Study||2
6343873|NCT00585637|7251094|FG000|STARTED|6-month Time Point||81
6343874|NCT00585637|7251095|FG001|STARTED|6-month Time Point||81
6343875|NCT00585637|7251096|FG002|STARTED|6-month Time Point||83
6343876|NCT00585637|7251097|FG003|STARTED|6-month Time Point||83
6343877|NCT00585637|7251094|FG000|COMPLETED|6-month Time Point||75
6343878|NCT00585637|7251095|FG001|COMPLETED|6-month Time Point||68
6343879|NCT00585637|7251096|FG002|COMPLETED|6-month Time Point||72
6343880|NCT00585637|7251097|FG003|COMPLETED|6-month Time Point||77
6343881|NCT00585637|7251094|FG000|NOT COMPLETED|6-month Time Point||6
6343882|NCT00585637|7251095|FG001|NOT COMPLETED|6-month Time Point||13
6343883|NCT00585637|7251096|FG002|NOT COMPLETED|6-month Time Point||11
6343884|NCT00585637|7251097|FG003|NOT COMPLETED|6-month Time Point||6
6343885|NCT00585650|7251109|FG000|STARTED|Overall Study||8
6343886|NCT00585650|7251110|FG001|STARTED|Overall Study||12
6343887|NCT00585650|7251109|FG000|COMPLETED|Overall Study||8
6343888|NCT00585650|7251110|FG001|COMPLETED|Overall Study||12
6343889|NCT00585650|7251109|FG000|NOT COMPLETED|Overall Study||0
6559341|NCT01781403|7481993|FG001|STARTED|Overall Study||2
6559342|NCT01781403|7481994|FG002|STARTED|Overall Study||18
6343890|NCT00585650|7251110|FG001|NOT COMPLETED|Overall Study||0
6343891|NCT00585689|7251116|FG000|STARTED|Overall Study||29
6343892|NCT00585689|7251116|FG000|COMPLETED|Overall Study||22
6343893|NCT00585689|7251116|FG000|NOT COMPLETED|Overall Study||7
6343894|NCT00585715|7251122|FG000|STARTED|Overall Study||11
6343895|NCT00585715|7251123|FG001|STARTED|Overall Study||11
6343896|NCT00585715|7251122|FG000|COMPLETED|Overall Study||8
6343897|NCT00585715|7251123|FG001|COMPLETED|Overall Study||11
6343898|NCT00585715|7251122|FG000|NOT COMPLETED|Overall Study||3
6343899|NCT00585715|7251123|FG001|NOT COMPLETED|Overall Study||0
6343900|NCT00585780|7251133|FG000|STARTED|Overall Study||21
6343901|NCT00585780|7251134|FG001|STARTED|Overall Study||23
6343902|NCT00585780|7251135|FG002|STARTED|Overall Study||34
6343903|NCT00585780|7251136|FG003|STARTED|Overall Study||22
6343904|NCT00585780|7251133|FG000|COMPLETED|Overall Study||13
6343905|NCT00585780|7251134|FG001|COMPLETED|Overall Study||14
6343906|NCT00585780|7251135|FG002|COMPLETED|Overall Study||21
6343907|NCT00585780|7251136|FG003|COMPLETED|Overall Study||14
6343908|NCT00585780|7251133|FG000|NOT COMPLETED|Overall Study||8
6343909|NCT00585780|7251134|FG001|NOT COMPLETED|Overall Study||9
6343910|NCT00585780|7251135|FG002|NOT COMPLETED|Overall Study||13
6343911|NCT00585780|7251136|FG003|NOT COMPLETED|Overall Study||8
6343912|NCT00585910|7251150|FG000|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
6343913|NCT00585910|7251150|FG000|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
6343914|NCT00585910|7251150|FG000|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
6343915|NCT00585910|7251150|FG000|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
6343916|NCT00585910|7251150|FG000|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
6343917|NCT00585910|7251150|FG000|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
6343918|NCT00585923|7251157|FG000|STARTED|Overall Study||56
6343919|NCT00585923|7251158|FG001|STARTED|Overall Study||59
6343920|NCT00585923|7251157|FG000|COMPLETED|Overall Study||25
6343921|NCT00585923|7251158|FG001|COMPLETED|Overall Study||26
6343922|NCT00585923|7251157|FG000|NOT COMPLETED|Overall Study||31
6343923|NCT00585923|7251158|FG001|NOT COMPLETED|Overall Study||33
6343924|NCT00585975|7251166|FG000|STARTED|Overall Study||277
6343925|NCT00585975|7251167|FG001|STARTED|Overall Study||291
6343926|NCT00585975|7251166|FG000|COMPLETED|Overall Study||262
6343927|NCT00585975|7251167|FG001|COMPLETED|Overall Study||278
6343928|NCT00585975|7251166|FG000|NOT COMPLETED|Overall Study||15
6343929|NCT00585975|7251167|FG001|NOT COMPLETED|Overall Study||13
6343930|NCT00586001|7251175|FG000|STARTED|Overall Study||26
6343931|NCT00586001|7251176|FG001|STARTED|Overall Study||11
6343932|NCT00586001|7251175|FG000|COMPLETED|Overall Study||22
6343933|NCT00586001|7251176|FG001|COMPLETED|Overall Study||10
6343934|NCT00586001|7251175|FG000|NOT COMPLETED|Overall Study||4
6343935|NCT00586001|7251176|FG001|NOT COMPLETED|Overall Study||1
6343936|NCT00586066|7251185|FG000|STARTED|Overall Study||48
6343937|NCT00586066|7251186|FG001|STARTED|Overall Study||24
6343938|NCT00586066|7251185|FG000|COMPLETED|Overall Study||30
6343939|NCT00586066|7251186|FG001|COMPLETED|Overall Study||14
6343940|NCT00586066|7251185|FG000|NOT COMPLETED|Overall Study||18
6343941|NCT00586066|7251186|FG001|NOT COMPLETED|Overall Study||10
6343942|NCT00586105|7251192|FG000|STARTED|Overall Study||39
6343943|NCT00586105|7251192|FG000|COMPLETED|Overall Study||0
6343944|NCT00586105|7251192|FG000|NOT COMPLETED|Overall Study||39
6343945|NCT00586157|7251196|FG000|STARTED|First Intervention||15
6343946|NCT00586157|7251197|FG001|STARTED|First Intervention||15
6343947|NCT00586157|7251196|FG000|COMPLETED|First Intervention||14
6343948|NCT00586157|7251197|FG001|COMPLETED|First Intervention||15
6343949|NCT00586157|7251196|FG000|NOT COMPLETED|First Intervention||1
6343950|NCT00586157|7251197|FG001|NOT COMPLETED|First Intervention||0
6343951|NCT00586157|7251196|FG000|STARTED|Second Intervention||14
6343952|NCT00586157|7251197|FG001|STARTED|Second Intervention||15
6343953|NCT00586157|7251196|FG000|COMPLETED|Second Intervention||12
6343954|NCT00586157|7251197|FG001|COMPLETED|Second Intervention||14
6343955|NCT00586157|7251196|FG000|NOT COMPLETED|Second Intervention||2
6343956|NCT00586157|7251197|FG001|NOT COMPLETED|Second Intervention||1
6343957|NCT00586170|7251205|FG000|STARTED|Overall Study||5
6343958|NCT00586170|7251206|FG001|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
6343959|NCT00586170|7251205|FG000|COMPLETED|Overall Study||5
6343960|NCT00586170|7251206|FG001|COMPLETED|Overall Study||3
6343961|NCT00586170|7251205|FG000|NOT COMPLETED|Overall Study||0
6343962|NCT00586170|7251206|FG001|NOT COMPLETED|Overall Study||0
6343963|NCT00586196|7251214|FG000|STARTED|Overall Study||7
6343964|NCT00586196|7251215|FG001|STARTED|Overall Study||9
6343965|NCT00586196|7251214|FG000|COMPLETED|Overall Study||7
6343966|NCT00586196|7251215|FG001|COMPLETED|Overall Study||9
6343967|NCT00586196|7251214|FG000|NOT COMPLETED|Overall Study||0
6343968|NCT00586196|7251215|FG001|NOT COMPLETED|Overall Study||0
6343969|NCT00586261|7251223|FG000|STARTED|Overall Study||17
6343970|NCT00586261|7251224|FG001|STARTED|Overall Study||19
6343971|NCT00586261|7251223|FG000|COMPLETED|Overall Study||17
6343972|NCT00586261|7251224|FG001|COMPLETED|Overall Study||19
6343973|NCT00586261|7251223|FG000|NOT COMPLETED|Overall Study||0
6343974|NCT00586261|7251224|FG001|NOT COMPLETED|Overall Study||0
6343975|NCT00586313|7251230|FG000|STARTED|Overall Study||21
6343976|NCT00586313|7251230|FG000|COMPLETED|Overall Study||19
6343977|NCT00586313|7251230|FG000|NOT COMPLETED|Overall Study||2
6343978|NCT00586326|7251234|FG000|STARTED|Enrollment to Device Placement-Enrolled||133
6343979|NCT00586326|7251234|FG000|COMPLETED|Enrollment to Device Placement-Enrolled||118
6343980|NCT00586326|7251234|FG000|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
6343981|NCT00586326|7251234|FG000|STARTED|Device Placed toTreatment-ITT||118
6343982|NCT00586326|7251234|FG000|COMPLETED|Device Placed toTreatment-ITT||100
6343983|NCT00586326|7251234|FG000|NOT COMPLETED|Device Placed toTreatment-ITT||18
6343984|NCT00586326|7251234|FG000|STARTED|Treated Through 5-yr Follow Up-Treated||100
6343985|NCT00586326|7251234|FG000|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
6343986|NCT00586326|7251234|FG000|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
6343987|NCT00586339|7251245|FG000|STARTED|Overall Study||61
6343988|NCT00586339|7251246|FG001|STARTED|Overall Study||59
6343989|NCT00586339|7251247|FG002|STARTED|Overall Study||30
6343990|NCT00586339|7251245|FG000|COMPLETED|Overall Study||54
6343991|NCT00586339|7251246|FG001|COMPLETED|Overall Study||52
6343992|NCT00586339|7251247|FG002|COMPLETED|Overall Study||24
6343993|NCT00586339|7251245|FG000|NOT COMPLETED|Overall Study||7
6343994|NCT00586339|7251246|FG001|NOT COMPLETED|Overall Study||7
6343995|NCT00586339|7251247|FG002|NOT COMPLETED|Overall Study||6
6343996|NCT00586469|7251257|FG000|STARTED|Overall Study||500
6343997|NCT00586469|7251258|FG001|STARTED|Overall Study||500
6343998|NCT00586469|7251257|FG000|COMPLETED|Overall Study||500
6343999|NCT00586469|7251258|FG001|COMPLETED|Overall Study||499
6344000|NCT00586469|7251257|FG000|NOT COMPLETED|Overall Study||0
6344001|NCT00586469|7251258|FG001|NOT COMPLETED|Overall Study||1
6344002|NCT00586482|7251266|FG000|STARTED|Overall Study||22
6344003|NCT00586482|7251267|FG001|STARTED|Overall Study||24
6344004|NCT00586482|7251266|FG000|COMPLETED|Overall Study||22
6344005|NCT00586482|7251267|FG001|COMPLETED|Overall Study||24
6344006|NCT00586482|7251266|FG000|NOT COMPLETED|Overall Study||0
6344007|NCT00586482|7251267|FG001|NOT COMPLETED|Overall Study||0
6344008|NCT00586495|7251273|FG000|STARTED|Treatment Period||95
6344009|NCT00586495|7251273|FG000|COMPLETED|Treatment Period||0
6344010|NCT00586495|7251273|FG000|NOT COMPLETED|Treatment Period||95
6344011|NCT00586495|7251273|FG000|STARTED|Follow-up||92
6344012|NCT00586495|7251273|FG000|COMPLETED|Follow-up||0
6344013|NCT00586495|7251273|FG000|NOT COMPLETED|Follow-up||92
6344014|NCT00586508|7251279|FG000|STARTED|Overall Study||68
6344015|NCT00586508|7251280|FG001|STARTED|Overall Study||13
6344016|NCT00586508|7251279|FG000|Received at Least 1 Dose of Study Drug|Overall Study||68
6344017|NCT00586508|7251280|FG001|Received at Least 1 Dose of Study Drug|Overall Study||13
6344018|NCT00586508|7251279|FG000|COMPLETED|Overall Study||0
6344019|NCT00586508|7251280|FG001|COMPLETED|Overall Study||0
6344020|NCT00586508|7251279|FG000|NOT COMPLETED|Overall Study||68
6344021|NCT00586508|7251280|FG001|NOT COMPLETED|Overall Study||13
6344022|NCT00586521|7251286|FG000|STARTED|On Demand Treatment (Months 1-6)||20
6344023|NCT00586521|7251286|FG000|COMPLETED|On Demand Treatment (Months 1-6)||19
6344024|NCT00586521|7251286|FG000|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
6344025|NCT00586521|7251286|FG000|STARTED|Prophylactic Treatment (Months 8-13)||19
6344026|NCT00586521|7251286|FG000|COMPLETED|Prophylactic Treatment (Months 8-13)||19
6344027|NCT00586521|7251286|FG000|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
6344028|NCT00586573|7251290|FG000|STARTED|Overall Study||34
6344029|NCT00586573|7251290|FG000|COMPLETED|Overall Study||28
6344030|NCT00586573|7251290|FG000|NOT COMPLETED|Overall Study||6
6344031|NCT00586612|7251296|FG000|STARTED|Primary Phase||163
6344032|NCT00586612|7251297|FG001|STARTED|Primary Phase||150
6344033|NCT00586612|7251296|FG000|COMPLETED|Primary Phase||162
6344034|NCT00586612|7251297|FG001|COMPLETED|Primary Phase||147
6344035|NCT00586612|7251296|FG000|NOT COMPLETED|Primary Phase||1
6344036|NCT00586612|7251297|FG001|NOT COMPLETED|Primary Phase||3
6344037|NCT00586612|7251296|FG000|STARTED|Booster Phase||154
6344038|NCT00586612|7251297|FG001|STARTED|Booster Phase||144
6344039|NCT00586612|7251296|FG000|COMPLETED|Booster Phase||151
6344040|NCT00586612|7251297|FG001|COMPLETED|Booster Phase||143
6344041|NCT00586612|7251296|FG000|NOT COMPLETED|Booster Phase||3
6344042|NCT00586612|7251297|FG001|NOT COMPLETED|Booster Phase||1
6344043|NCT00586625|7251305|FG000|STARTED|Overall Study||575
6344044|NCT00586625|7251306|FG001|STARTED|Overall Study||286
6344045|NCT00586625|7251305|FG000|COMPLETED|Overall Study||532
6344046|NCT00586625|7251306|FG001|COMPLETED|Overall Study||269
6344047|NCT00586625|7251305|FG000|NOT COMPLETED|Overall Study||43
6344048|NCT00586625|7251306|FG001|NOT COMPLETED|Overall Study||17
6344049|NCT00586664|7251315|FG000|STARTED|Overall Study||43
6344050|NCT00586664|7251316|FG001|STARTED|Overall Study||43
6344051|NCT00586664|7251317|FG002|STARTED|Overall Study||44
6344052|NCT00586664|7251315|FG000|COMPLETED|Overall Study||38
6498474|NCT01410058|7417050|FG000|COMPLETED|Day 35||13
6344053|NCT00586664|7251316|FG001|COMPLETED|Overall Study||36
6498475|NCT01410058|7417051|FG001|COMPLETED|Day 35||6
6498476|NCT01410058|7417050|FG000|NOT COMPLETED|Day 35||0
6498477|NCT01410058|7417051|FG001|NOT COMPLETED|Day 35||0
6498478|NCT01410084|7417061|FG000|STARTED|Overall Study||38
6498479|NCT01410084|7417062|FG001|STARTED|Overall Study||30
6498480|NCT01410084|7417061|FG000|COMPLETED|Overall Study||37
6498481|NCT01410084|7417062|FG001|COMPLETED|Overall Study||27
6498482|NCT01410084|7417061|FG000|NOT COMPLETED|Overall Study||1
6344054|NCT00586664|7251317|FG002|COMPLETED|Overall Study||43
6344055|NCT00586664|7251315|FG000|NOT COMPLETED|Overall Study||5
6498483|NCT01410084|7417062|FG001|NOT COMPLETED|Overall Study||3
6344056|NCT00586664|7251316|FG001|NOT COMPLETED|Overall Study||7
6344057|NCT00586664|7251317|FG002|NOT COMPLETED|Overall Study||1
6344058|NCT00586690|7251327|FG000|STARTED|Overall Study|Four consented subjects were screen failures.|21
6344059|NCT00586690|7251328|FG001|STARTED|Overall Study||22
6344060|NCT00586690|7251327|FG000|COMPLETED|Overall Study||5
6344061|NCT00586690|7251328|FG001|COMPLETED|Overall Study||22
6344062|NCT00586690|7251327|FG000|NOT COMPLETED|Overall Study||16
6344063|NCT00586690|7251328|FG001|NOT COMPLETED|Overall Study||0
6344064|NCT00586703|7251333|FG000|STARTED|Overall Study||16
6344065|NCT00586703|7251333|FG000|COMPLETED|Overall Study||4
6344066|NCT00586703|7251333|FG000|NOT COMPLETED|Overall Study||12
6344067|NCT00586729|7251339|FG000|STARTED|Overall Study||14
6344068|NCT00586729|7251340|FG001|STARTED|Overall Study||9
6344069|NCT00586729|7251339|FG000|COMPLETED|Overall Study||11
6344070|NCT00586729|7251340|FG001|COMPLETED|Overall Study||8
6344071|NCT00586729|7251339|FG000|NOT COMPLETED|Overall Study||3
6344072|NCT00586729|7251340|FG001|NOT COMPLETED|Overall Study||1
6344073|NCT00586820|7251348|FG000|STARTED|Overall Study||12
6344074|NCT00586820|7251349|FG001|STARTED|Overall Study||11
6344075|NCT00586820|7251348|FG000|COMPLETED|Overall Study||11
6344076|NCT00586820|7251349|FG001|COMPLETED|Overall Study||11
6344077|NCT00586820|7251348|FG000|NOT COMPLETED|Overall Study||1
6344078|NCT00586820|7251349|FG001|NOT COMPLETED|Overall Study||0
6344079|NCT00586846|7251355|FG000|STARTED|Overall Study||40
6344080|NCT00586846|7251355|FG000|COMPLETED|Overall Study||34
6344081|NCT00586846|7251355|FG000|NOT COMPLETED|Overall Study||6
6344082|NCT00586898|7251359|FG000|STARTED|Overall Study||36
6344083|NCT00586898|7251359|FG000|COMPLETED|Overall Study||29
6344084|NCT00586898|7251359|FG000|NOT COMPLETED|Overall Study||7
6344085|NCT00587041|7251366|FG000|STARTED|Overall Study||12
6344086|NCT00587041|7251367|FG001|STARTED|Overall Study||14
6344087|NCT00587041|7251368|FG002|STARTED|Overall Study||14
6344088|NCT00587041|7251366|FG000|COMPLETED|Overall Study||12
6344089|NCT00587041|7251367|FG001|COMPLETED|Overall Study||14
6344090|NCT00587041|7251368|FG002|COMPLETED|Overall Study||14
6344091|NCT00587041|7251366|FG000|NOT COMPLETED|Overall Study||0
6344092|NCT00587041|7251367|FG001|NOT COMPLETED|Overall Study||0
6344093|NCT00587041|7251368|FG002|NOT COMPLETED|Overall Study||0
6344094|NCT00587054|7251376|FG000|STARTED|Overall Study||129
6344095|NCT00587054|7251376|FG000|COMPLETED|Overall Study||120
6344096|NCT00587054|7251376|FG000|NOT COMPLETED|Overall Study||9
6344097|NCT00587067|7251380|FG000|STARTED|Overall Study||34
6344098|NCT00587067|7251380|FG000|COMPLETED|Overall Study||34
6344099|NCT00587067|7251380|FG000|NOT COMPLETED|Overall Study||0
6344100|NCT00587132|7251388|FG000|STARTED|Overall Study||4
6344101|NCT00587132|7251389|FG001|STARTED|Overall Study||0
6344102|NCT00587132|7251390|FG002|STARTED|Overall Study||0
6344103|NCT00587132|7251391|FG003|STARTED|Overall Study||0
6344104|NCT00587132|7251388|FG000|COMPLETED|Overall Study||4
6344105|NCT00587132|7251389|FG001|COMPLETED|Overall Study||0
6344106|NCT00587132|7251390|FG002|COMPLETED|Overall Study||0
6344107|NCT00587132|7251391|FG003|COMPLETED|Overall Study||0
6344108|NCT00587132|7251388|FG000|NOT COMPLETED|Overall Study||0
6344109|NCT00587132|7251389|FG001|NOT COMPLETED|Overall Study||0
6344110|NCT00587132|7251390|FG002|NOT COMPLETED|Overall Study||0
6344111|NCT00587132|7251391|FG003|NOT COMPLETED|Overall Study||0
6344112|NCT00587158|7251403|FG000|STARTED|Overall Study||49
6344113|NCT00587158|7251404|FG001|STARTED|Overall Study||51
6344114|NCT00587158|7251403|FG000|Continued in Study|Overall Study||45
6344115|NCT00587158|7251404|FG001|Continued in Study|Overall Study||46
6344116|NCT00587158|7251403|FG000|COMPLETED|Overall Study||44
6344117|NCT00587158|7251404|FG001|COMPLETED|Overall Study||43
6344118|NCT00587158|7251403|FG000|NOT COMPLETED|Overall Study||5
6559343|NCT01781403|7481992|FG000|COMPLETED|Overall Study||2
6559344|NCT01781403|7481993|FG001|COMPLETED|Overall Study||2
6559345|NCT01781403|7481994|FG002|COMPLETED|Overall Study||18
6559346|NCT01781403|7481992|FG000|NOT COMPLETED|Overall Study||0
6559347|NCT01781403|7481993|FG001|NOT COMPLETED|Overall Study||0
6559348|NCT01781403|7481994|FG002|NOT COMPLETED|Overall Study||0
6559349|NCT01781429|7482019|FG000|STARTED|Overall Study||1
6559350|NCT01781429|7482020|FG001|STARTED|Overall Study||1
6559351|NCT01781429|7482021|FG002|STARTED|Overall Study||1
6559352|NCT01781429|7482022|FG003|STARTED|Overall Study||1
6559353|NCT01781429|7482023|FG004|STARTED|Overall Study||1
6344119|NCT00587158|7251404|FG001|NOT COMPLETED|Overall Study||8
6344120|NCT00587171|7251412|FG000|STARTED|Overall Study||9
6344121|NCT00587171|7251413|FG001|STARTED|Overall Study||10
6344122|NCT00587171|7251412|FG000|COMPLETED|Overall Study||8
6344123|NCT00587171|7251413|FG001|COMPLETED|Overall Study||9
6344124|NCT00587171|7251412|FG000|NOT COMPLETED|Overall Study||1
6344125|NCT00587171|7251413|FG001|NOT COMPLETED|Overall Study||1
6376582|NCT00760019|7287121|FG001|NOT COMPLETED|Overall Study||0
6376583|NCT00760019|7287122|FG002|NOT COMPLETED|Overall Study||0
6376584|NCT00760019|7287123|FG003|NOT COMPLETED|Overall Study||0
6376585|NCT00760084|7287129|FG000|STARTED|Overall Study||10
6376586|NCT00760084|7287129|FG000|COMPLETED|Overall Study||0
6376587|NCT00760084|7287129|FG000|NOT COMPLETED|Overall Study||10
6376588|NCT00760214|7287136|FG000|STARTED|Overall Study||295
6376589|NCT00760214|7287137|FG001|STARTED|Overall Study||294
6376590|NCT00760214|7287138|FG002|STARTED|Overall Study||296
6376591|NCT00760214|7287136|FG000|COMPLETED|Overall Study||265
6376592|NCT00760214|7287137|FG001|COMPLETED|Overall Study||264
6376593|NCT00760214|7287138|FG002|COMPLETED|Overall Study||255
6344126|NCT00587288|7251421|FG000|STARTED|Overall Study||53
6344127|NCT00587288|7251422|FG001|STARTED|Overall Study||53
6344128|NCT00587288|7251421|FG000|COMPLETED|Overall Study||50
6344129|NCT00587288|7251422|FG001|COMPLETED|Overall Study||44
6344130|NCT00587288|7251421|FG000|NOT COMPLETED|Overall Study||3
6344131|NCT00587288|7251422|FG001|NOT COMPLETED|Overall Study||9
6344132|NCT00587431|7251432|FG000|STARTED|Overall Study||63
6344133|NCT00587431|7251433|FG001|STARTED|Overall Study||39
6344134|NCT00587431|7251432|FG000|COMPLETED|Overall Study||62
6344135|NCT00587431|7251433|FG001|COMPLETED|Overall Study||38
6344136|NCT00587431|7251432|FG000|NOT COMPLETED|Overall Study||1
6344137|NCT00587431|7251433|FG001|NOT COMPLETED|Overall Study||1
6344138|NCT00587457|7251445|FG000|STARTED|Overall Study||3
6344139|NCT00587457|7251446|FG001|STARTED|Overall Study||3
6344140|NCT00587457|7251447|FG002|STARTED|Overall Study||5
6344141|NCT00587457|7251445|FG000|COMPLETED|Overall Study||0
6344142|NCT00587457|7251446|FG001|COMPLETED|Overall Study||0
6344143|NCT00587457|7251447|FG002|COMPLETED|Overall Study||0
6344144|NCT00587457|7251445|FG000|NOT COMPLETED|Overall Study||3
6344145|NCT00587457|7251446|FG001|NOT COMPLETED|Overall Study||3
6344146|NCT00587457|7251447|FG002|NOT COMPLETED|Overall Study||5
6344147|NCT00587483|7251458|FG000|STARTED|Overall Study||115
6344148|NCT00587483|7251459|FG001|STARTED|Overall Study||115
6344149|NCT00587483|7251460|FG002|STARTED|Overall Study||112
6344150|NCT00587483|7251458|FG000|COMPLETED|Overall Study||115
6344151|NCT00587483|7251459|FG001|COMPLETED|Overall Study||115
6344152|NCT00587483|7251460|FG002|COMPLETED|Overall Study||112
6344153|NCT00587483|7251458|FG000|NOT COMPLETED|Overall Study||0
6344154|NCT00587483|7251459|FG001|NOT COMPLETED|Overall Study||0
6344155|NCT00587483|7251460|FG002|NOT COMPLETED|Overall Study||0
6344156|NCT00587587|7251470|FG000|STARTED|Overall Study||17
6344157|NCT00587587|7251471|FG001|STARTED|Overall Study||13
6344158|NCT00587587|7251470|FG000|COMPLETED|Overall Study||11
6344159|NCT00587587|7251471|FG001|COMPLETED|Overall Study||12
6344160|NCT00587587|7251470|FG000|NOT COMPLETED|Overall Study||6
6344161|NCT00587587|7251471|FG001|NOT COMPLETED|Overall Study||1
6344162|NCT00587639|7251479|FG000|STARTED|Overall Study||8
6344163|NCT00587639|7251479|FG000|COMPLETED|Overall Study||7
6344164|NCT00587639|7251479|FG000|NOT COMPLETED|Overall Study||1
6344165|NCT00587678|7251486|FG000|STARTED|Overall Study||22
6344166|NCT00587678|7251487|FG001|STARTED|Overall Study||22
6344167|NCT00587678|7251488|FG002|STARTED|Overall Study||41
6344168|NCT00587678|7251486|FG000|COMPLETED|Overall Study||16
6344169|NCT00587678|7251487|FG001|COMPLETED|Overall Study||18
6344170|NCT00587678|7251488|FG002|COMPLETED|Overall Study||33
6344171|NCT00587678|7251486|FG000|NOT COMPLETED|Overall Study||6
6344172|NCT00587678|7251487|FG001|NOT COMPLETED|Overall Study||4
6344173|NCT00587678|7251488|FG002|NOT COMPLETED|Overall Study||8
6344174|NCT00587769|7251496|FG000|STARTED|Overall Study||38
6344175|NCT00587769|7251496|FG000|COMPLETED|Overall Study||38
6344176|NCT00587769|7251496|FG000|NOT COMPLETED|Overall Study||0
6344177|NCT00587834|7251500|FG000|STARTED|Overall Study||96
6344178|NCT00587834|7251500|FG000|COMPLETED|Overall Study||96
6344179|NCT00587834|7251500|FG000|NOT COMPLETED|Overall Study||0
6344180|NCT00587847|7251515|FG000|STARTED|Overall Study||12
6344181|NCT00587847|7251515|FG000|COMPLETED|Overall Study||5
6344182|NCT00587847|7251515|FG000|NOT COMPLETED|Overall Study||7
6376594|NCT00760214|7287136|FG000|NOT COMPLETED|Overall Study||30
6376595|NCT00760214|7287137|FG001|NOT COMPLETED|Overall Study||30
6376596|NCT00760214|7287138|FG002|NOT COMPLETED|Overall Study||41
6376597|NCT00760266|7287148|FG000|STARTED|Overall Study||228
6376598|NCT00760266|7287149|FG001|STARTED|Overall Study||223
6376599|NCT00760266|7287148|FG000|COMPLETED|Overall Study||204
6376600|NCT00760266|7287149|FG001|COMPLETED|Overall Study||205
6376601|NCT00760266|7287148|FG000|NOT COMPLETED|Overall Study||24
6376602|NCT00760266|7287149|FG001|NOT COMPLETED|Overall Study||18
6376603|NCT00760383|7287157|FG000|STARTED|Overall Study||21
6376604|NCT00760383|7287158|FG001|STARTED|Overall Study||19
6376605|NCT00760383|7287157|FG000|COMPLETED|Overall Study||16
6376606|NCT00760383|7287158|FG001|COMPLETED|Overall Study||12
6376607|NCT00760383|7287157|FG000|NOT COMPLETED|Overall Study||5
6376608|NCT00760383|7287158|FG001|NOT COMPLETED|Overall Study||7
6376609|NCT00760435|7287166|FG000|STARTED|Overall Study||98
6376610|NCT00760435|7287167|FG001|STARTED|Overall Study||98
6376611|NCT00760435|7287166|FG000|COMPLETED|Overall Study||94
6376612|NCT00760435|7287167|FG001|COMPLETED|Overall Study||93
6376613|NCT00760435|7287166|FG000|NOT COMPLETED|Overall Study||4
6376614|NCT00760435|7287167|FG001|NOT COMPLETED|Overall Study||5
6376615|NCT00760474|7287173|FG000|STARTED|Period 1 (P1)||13
6376616|NCT00760474|7287174|FG001|STARTED|Period 1 (P1)||14
6376617|NCT00760474|7287173|FG000|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
6376618|NCT00760474|7287174|FG001|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
6376619|NCT00760474|7287173|FG000|Overall Number of Unique Participants|Period 1 (P1)||12
6376620|NCT00760474|7287174|FG001|Overall Number of Unique Participants|Period 1 (P1)||13
6376621|NCT00760474|7287173|FG000|COMPLETED|Period 1 (P1)||12
6376622|NCT00760474|7287174|FG001|COMPLETED|Period 1 (P1)||13
6376623|NCT00760474|7287173|FG000|NOT COMPLETED|Period 1 (P1)||1
6376624|NCT00760474|7287174|FG001|NOT COMPLETED|Period 1 (P1)||1
6376625|NCT00760474|7287173|FG000|STARTED|Placebo Washout Period||12
6376626|NCT00760474|7287174|FG001|STARTED|Placebo Washout Period||13
6344183|NCT04545008|7251520|FG000|STARTED|Overall Study||2
6344184|NCT04545008|7251520|FG000|COMPLETED|Overall Study||2
6344185|NCT04545008|7251520|FG000|NOT COMPLETED|Overall Study||0
6344232|NCT03711266|7251578|FG000|STARTED|Overall Study||30
6344233|NCT03711266|7251578|FG000|COMPLETED|Overall Study||20
6344234|NCT03711266|7251578|FG000|NOT COMPLETED|Overall Study||10
6344235|NCT03630393|7251584|FG000|STARTED|Overall Study||68
6344236|NCT03630393|7251585|FG001|STARTED|Overall Study||71
6344237|NCT03630393|7251584|FG000|COMPLETED|Overall Study||67
6344238|NCT03630393|7251585|FG001|COMPLETED|Overall Study||71
6344239|NCT03630393|7251584|FG000|NOT COMPLETED|Overall Study||1
6344240|NCT03630393|7251585|FG001|NOT COMPLETED|Overall Study||0
6344241|NCT03531788|7251593|FG000|STARTED|Overall Study||12
6344242|NCT03531788|7251594|FG001|STARTED|Overall Study||6
6344243|NCT03531788|7251593|FG000|COMPLETED|Overall Study||11
6344244|NCT03531788|7251594|FG001|COMPLETED|Overall Study||6
6344245|NCT03531788|7251593|FG000|NOT COMPLETED|Overall Study||1
6344246|NCT03531788|7251594|FG001|NOT COMPLETED|Overall Study||0
6344247|NCT03359811|7251602|FG000|STARTED|Overall Study||35
6344248|NCT03359811|7251603|FG001|STARTED|Overall Study||35
6344249|NCT03359811|7251602|FG000|COMPLETED|Overall Study||33
6344250|NCT03359811|7251603|FG001|COMPLETED|Overall Study||35
6344251|NCT03359811|7251602|FG000|NOT COMPLETED|Overall Study||2
6344252|NCT03359811|7251603|FG001|NOT COMPLETED|Overall Study||0
6344265|NCT03241589|7251637|FG000|STARTED|Overall Study||109
6344266|NCT03241589|7251638|FG001|STARTED|Overall Study||357
6344267|NCT03241589|7251637|FG000|COMPLETED|Overall Study||109
6344268|NCT03241589|7251638|FG001|COMPLETED|Overall Study||357
6344269|NCT03241589|7251637|FG000|NOT COMPLETED|Overall Study||0
6344270|NCT03241589|7251638|FG001|NOT COMPLETED|Overall Study||0
6344271|NCT02959775|7251649|FG000|STARTED|Overall Study||160
6559354|NCT01781429|7482024|FG005|STARTED|Overall Study||4
6559355|NCT01781429|7482025|FG006|STARTED|Overall Study||7
6559356|NCT01781429|7482026|FG007|STARTED|Overall Study||4
6559357|NCT01781429|7482027|FG008|STARTED|Overall Study||7
6559358|NCT01781429|7482028|FG009|STARTED|Overall Study||24
6559359|NCT01781429|7482029|FG010|STARTED|Overall Study||18
6559360|NCT01781429|7482030|FG011|STARTED|Overall Study||21
6559361|NCT01781429|7482031|FG012|STARTED|Overall Study||22
6559362|NCT01781429|7482032|FG013|STARTED|Overall Study||8
6559363|NCT01781429|7482033|FG014|STARTED|Overall Study||16
6559364|NCT01781429|7482034|FG015|STARTED|Overall Study||0
6559365|NCT01781429|7482019|FG000|COMPLETED|Overall Study||0
6559366|NCT01781429|7482020|FG001|COMPLETED|Overall Study||0
6559367|NCT01781429|7482021|FG002|COMPLETED|Overall Study||0
6559368|NCT01781429|7482022|FG003|COMPLETED|Overall Study||0
6559369|NCT01781429|7482023|FG004|COMPLETED|Overall Study||0
6655043|NCT02450526|7585094|FG003|Safety Population|DB Period (Cycle 1)||21
6655044|NCT02450526|7585095|FG004|Safety Population|DB Period (Cycle 1)||0
6655045|NCT02450526|7585091|FG000|COMPLETED|DB Period (Cycle 1)||294
6655046|NCT02450526|7585092|FG001|COMPLETED|DB Period (Cycle 1)||63
6655047|NCT02450526|7585093|FG002|COMPLETED|DB Period (Cycle 1)||97
6559370|NCT01781429|7482024|FG005|COMPLETED|Overall Study||0
6655048|NCT02450526|7585094|FG003|COMPLETED|DB Period (Cycle 1)||20
6655049|NCT02450526|7585095|FG004|COMPLETED|DB Period (Cycle 1)|This arm was not included in DB Period (Cycle 1).|0
6655050|NCT02450526|7585091|FG000|NOT COMPLETED|DB Period (Cycle 1)||31
6655051|NCT02450526|7585092|FG001|NOT COMPLETED|DB Period (Cycle 1)||3
6655052|NCT02450526|7585093|FG002|NOT COMPLETED|DB Period (Cycle 1)||10
6655053|NCT02450526|7585094|FG003|NOT COMPLETED|DB Period (Cycle 1)||2
6655054|NCT02450526|7585095|FG004|NOT COMPLETED|DB Period (Cycle 1)||0
6655055|NCT02450526|7585091|FG000|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
6344272|NCT02959775|7251650|FG001|STARTED|Overall Study||160
6344273|NCT02959775|7251651|FG002|STARTED|Overall Study||160
6344274|NCT02959775|7251649|FG000|COMPLETED|Overall Study||133
6344275|NCT02959775|7251650|FG001|COMPLETED|Overall Study||133
6344276|NCT02959775|7251651|FG002|COMPLETED|Overall Study||124
6344277|NCT02959775|7251649|FG000|NOT COMPLETED|Overall Study||27
6344278|NCT02959775|7251650|FG001|NOT COMPLETED|Overall Study||27
6344279|NCT02959775|7251651|FG002|NOT COMPLETED|Overall Study||36
6344280|NCT02954406|7251670|FG000|STARTED|Overall Study||3
6344281|NCT02954406|7251671|FG001|STARTED|Overall Study||6
6344282|NCT02954406|7251672|FG002|STARTED|Overall Study||6
6344283|NCT02954406|7251673|FG003|STARTED|Overall Study||6
6344284|NCT02954406|7251674|FG004|STARTED|Overall Study||7
6344285|NCT02954406|7251675|FG005|STARTED|Overall Study||3
6344286|NCT02954406|7251676|FG006|STARTED|Overall Study||3
6559371|NCT01781429|7482025|FG006|COMPLETED|Overall Study||0
6655056|NCT02450526|7585092|FG001|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
6655057|NCT02450526|7585093|FG002|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
6655058|NCT02450526|7585094|FG003|STARTED|OL Period (Cycles 2-5)|This arm was not included in OL Period (Cycles 2-5).|0
6655059|NCT02450526|7585095|FG004|STARTED|OL Period (Cycles 2-5)|Nine subjects completed the DB Period but were not eligible for retreatment in the OL Period.|465
6655060|NCT02450526|7585091|FG000|Safety Population|OL Period (Cycles 2-5)||0
6655061|NCT02450526|7585092|FG001|Safety Population|OL Period (Cycles 2-5)||0
6655062|NCT02450526|7585093|FG002|Safety Population|OL Period (Cycles 2-5)||0
6655063|NCT02450526|7585094|FG003|Safety Population|OL Period (Cycles 2-5)||0
6655064|NCT02450526|7585095|FG004|Safety Population|OL Period (Cycles 2-5)||465
6655065|NCT02450526|7585091|FG000|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
6655066|NCT02450526|7585092|FG001|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
6655067|NCT02450526|7585093|FG002|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
6655068|NCT02450526|7585094|FG003|Discontinued During Cycle 2|OL Period (Cycles 2-5)||0
6655069|NCT02450526|7585095|FG004|Discontinued During Cycle 2|OL Period (Cycles 2-5)||28
6655070|NCT02450526|7585091|FG000|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
6655071|NCT02450526|7585092|FG001|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
6655072|NCT02450526|7585093|FG002|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
6655073|NCT02450526|7585094|FG003|Discontinued During Cycle 3|OL Period (Cycles 2-5)||0
6655074|NCT02450526|7585095|FG004|Discontinued During Cycle 3|OL Period (Cycles 2-5)||11
6655075|NCT02450526|7585091|FG000|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
6655076|NCT02450526|7585092|FG001|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
6655077|NCT02450526|7585093|FG002|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
6655078|NCT02450526|7585094|FG003|Discontinued During Cycle 4|OL Period (Cycles 2-5)||0
6655079|NCT02450526|7585095|FG004|Discontinued During Cycle 4|OL Period (Cycles 2-5)||2
6655080|NCT02450526|7585091|FG000|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6655081|NCT02450526|7585092|FG001|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6655082|NCT02450526|7585093|FG002|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6655083|NCT02450526|7585094|FG003|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6655084|NCT02450526|7585095|FG004|Discontinued During Cycle 5|OL Period (Cycles 2-5)||0
6655085|NCT02450526|7585091|FG000|COMPLETED|OL Period (Cycles 2-5)||0
6655086|NCT02450526|7585092|FG001|COMPLETED|OL Period (Cycles 2-5)||0
6344186|NCT04411680|7251526|FG000|STARTED|Treatment Period||78
6344187|NCT04411680|7251527|FG001|STARTED|Treatment Period||44
6344188|NCT04411680|7251526|FG000|COMPLETED|Treatment Period||49
6344189|NCT04411680|7251527|FG001|COMPLETED|Treatment Period||36
6344190|NCT04411680|7251526|FG000|NOT COMPLETED|Treatment Period||29
6344191|NCT04411680|7251527|FG001|NOT COMPLETED|Treatment Period||8
6344192|NCT04411680|7251526|FG000|STARTED|Follow up Period||78
6344193|NCT04411680|7251527|FG001|STARTED|Follow up Period||44
6344194|NCT04411680|7251526|FG000|COMPLETED|Follow up Period||60
6344195|NCT04411680|7251527|FG001|COMPLETED|Follow up Period||30
6344196|NCT04411680|7251526|FG000|NOT COMPLETED|Follow up Period||18
6344197|NCT04411680|7251527|FG001|NOT COMPLETED|Follow up Period||14
6344198|NCT04364984|7251536|FG000|STARTED|Overall Study||37
6344199|NCT04364984|7251537|FG001|STARTED|Overall Study||44
6344200|NCT04364984|7251538|FG002|STARTED|Overall Study||31
6344201|NCT04364984|7251536|FG000|COMPLETED|Overall Study||35
6344202|NCT04364984|7251537|FG001|COMPLETED|Overall Study||42
6344203|NCT04364984|7251538|FG002|COMPLETED|Overall Study||31
6344204|NCT04364984|7251536|FG000|NOT COMPLETED|Overall Study||2
6344205|NCT04364984|7251537|FG001|NOT COMPLETED|Overall Study||2
6344206|NCT04364984|7251538|FG002|NOT COMPLETED|Overall Study||0
6344207|NCT04363437|7251548|FG000|STARTED|Overall Study||10
6344208|NCT04363437|7251549|FG001|STARTED|Overall Study||11
6344209|NCT04363437|7251548|FG000|COMPLETED|Overall Study||10
6344210|NCT04363437|7251549|FG001|COMPLETED|Overall Study||11
6344211|NCT04363437|7251548|FG000|NOT COMPLETED|Overall Study||0
6344212|NCT04363437|7251549|FG001|NOT COMPLETED|Overall Study||0
6344213|NCT04033991|7251555|FG000|STARTED|Overall Study||684
6344214|NCT04033991|7251555|FG000|Participants Who Took First-line Sunitinib Therapy|Overall Study||622
6344215|NCT04033991|7251555|FG000|Participants Who Took Second-line Axitinib Therapy|Overall Study||121
6344216|NCT04033991|7251555|FG000|Participants Who Took First-line Sunitinib Therapy and Then Second-line Axitinib Therapy|Overall Study||59
6344217|NCT04033991|7251555|FG000|Participants Who Took Drugs Other Than Sunitinib as First-line and Then Second-line Axitinib Therapy|Overall Study||62
6344218|NCT04033991|7251555|FG000|COMPLETED|Overall Study||684
6344219|NCT04033991|7251555|FG000|NOT COMPLETED|Overall Study||0
6344220|NCT03930849|7251564|FG000|STARTED|Overall Study||17
6344221|NCT03930849|7251565|FG001|STARTED|Overall Study||18
6344222|NCT03930849|7251566|FG002|STARTED|Overall Study||18
6344223|NCT03930849|7251564|FG000|COMPLETED|Overall Study||13
6344224|NCT03930849|7251565|FG001|COMPLETED|Overall Study||18
6344225|NCT03930849|7251566|FG002|COMPLETED|Overall Study||14
6344226|NCT03930849|7251564|FG000|NOT COMPLETED|Overall Study||4
6344227|NCT03930849|7251565|FG001|NOT COMPLETED|Overall Study||0
6344228|NCT03930849|7251566|FG002|NOT COMPLETED|Overall Study||4
6344229|NCT03793439|7251574|FG000|STARTED|Overall Study||5
6344230|NCT03793439|7251574|FG000|COMPLETED|Overall Study||3
6344231|NCT03793439|7251574|FG000|NOT COMPLETED|Overall Study||2
6344287|NCT02954406|7251677|FG007|STARTED|Overall Study||2
6344288|NCT02954406|7251678|FG008|STARTED|Overall Study||4
6344289|NCT02954406|7251679|FG009|STARTED|Overall Study||3
6344290|NCT02954406|7251680|FG010|STARTED|Overall Study||0
6344291|NCT02954406|7251670|FG000|COMPLETED|Overall Study||0
6344292|NCT02954406|7251671|FG001|COMPLETED|Overall Study||0
6344293|NCT02954406|7251672|FG002|COMPLETED|Overall Study||0
6344294|NCT02954406|7251673|FG003|COMPLETED|Overall Study||0
6344295|NCT02954406|7251674|FG004|COMPLETED|Overall Study||0
6344296|NCT02954406|7251675|FG005|COMPLETED|Overall Study||0
6344297|NCT02954406|7251676|FG006|COMPLETED|Overall Study||0
6344298|NCT02954406|7251677|FG007|COMPLETED|Overall Study||0
6344299|NCT02954406|7251678|FG008|COMPLETED|Overall Study||0
6344300|NCT02954406|7251679|FG009|COMPLETED|Overall Study||0
6344301|NCT02954406|7251680|FG010|COMPLETED|Overall Study||0
6344302|NCT02954406|7251670|FG000|NOT COMPLETED|Overall Study||3
6344303|NCT02954406|7251671|FG001|NOT COMPLETED|Overall Study||6
6344304|NCT02954406|7251672|FG002|NOT COMPLETED|Overall Study||6
6344305|NCT02954406|7251673|FG003|NOT COMPLETED|Overall Study||6
6344306|NCT02954406|7251674|FG004|NOT COMPLETED|Overall Study||7
6344307|NCT02954406|7251675|FG005|NOT COMPLETED|Overall Study||3
6344308|NCT02954406|7251676|FG006|NOT COMPLETED|Overall Study||3
6344309|NCT02954406|7251677|FG007|NOT COMPLETED|Overall Study||2
6344310|NCT02954406|7251678|FG008|NOT COMPLETED|Overall Study||4
6344311|NCT02954406|7251679|FG009|NOT COMPLETED|Overall Study||3
6344312|NCT02954406|7251680|FG010|NOT COMPLETED|Overall Study||0
6344313|NCT02927145|7251715|FG000|STARTED|Initial Recruitment||12
6344314|NCT02927145|7251716|FG001|STARTED|Initial Recruitment||12
6344315|NCT02927145|7251717|FG002|STARTED|Initial Recruitment||12
6344316|NCT02927145|7251718|FG003|STARTED|Initial Recruitment||14
6344317|NCT02927145|7251719|FG004|STARTED|Initial Recruitment||17
6344318|NCT02927145|7251720|FG005|STARTED|Initial Recruitment||15
6344319|NCT02927145|7251721|FG006|STARTED|Initial Recruitment||0
6344320|NCT02927145|7251722|FG007|STARTED|Initial Recruitment||0
6344321|NCT02927145|7251723|FG008|STARTED|Initial Recruitment||6
6344322|NCT02927145|7251715|FG000|COMPLETED|Initial Recruitment||12
6344323|NCT02927145|7251716|FG001|COMPLETED|Initial Recruitment||11
6344324|NCT02927145|7251717|FG002|COMPLETED|Initial Recruitment||11
6344325|NCT02927145|7251718|FG003|COMPLETED|Initial Recruitment||10
6344326|NCT02927145|7251719|FG004|COMPLETED|Initial Recruitment||14
6344327|NCT02927145|7251720|FG005|COMPLETED|Initial Recruitment||14
6344328|NCT02927145|7251721|FG006|COMPLETED|Initial Recruitment||0
6344329|NCT02927145|7251722|FG007|COMPLETED|Initial Recruitment||0
6344330|NCT02927145|7251723|FG008|COMPLETED|Initial Recruitment||4
6559372|NCT01781429|7482026|FG007|COMPLETED|Overall Study||0
6559373|NCT01781429|7482027|FG008|COMPLETED|Overall Study||0
6559374|NCT01781429|7482028|FG009|COMPLETED|Overall Study||0
6559375|NCT01781429|7482029|FG010|COMPLETED|Overall Study||0
6559376|NCT01781429|7482030|FG011|COMPLETED|Overall Study||0
6559377|NCT01781429|7482031|FG012|COMPLETED|Overall Study||0
6344331|NCT02927145|7251715|FG000|NOT COMPLETED|Initial Recruitment||0
6344332|NCT02927145|7251716|FG001|NOT COMPLETED|Initial Recruitment||1
6344333|NCT02927145|7251717|FG002|NOT COMPLETED|Initial Recruitment||1
6344334|NCT02927145|7251718|FG003|NOT COMPLETED|Initial Recruitment||4
6344335|NCT02927145|7251719|FG004|NOT COMPLETED|Initial Recruitment||3
6344336|NCT02927145|7251720|FG005|NOT COMPLETED|Initial Recruitment||1
6344337|NCT02927145|7251721|FG006|NOT COMPLETED|Initial Recruitment||0
6344338|NCT02927145|7251722|FG007|NOT COMPLETED|Initial Recruitment||0
6344339|NCT02927145|7251723|FG008|NOT COMPLETED|Initial Recruitment||2
6559378|NCT01781429|7482032|FG013|COMPLETED|Overall Study||0
6559379|NCT01781429|7482033|FG014|COMPLETED|Overall Study||0
6344340|NCT02927145|7251715|FG000|STARTED|Invitation for Additional Challenge||0
6344341|NCT02927145|7251716|FG001|STARTED|Invitation for Additional Challenge||0
6344342|NCT02927145|7251717|FG002|STARTED|Invitation for Additional Challenge||0
6344343|NCT02927145|7251718|FG003|STARTED|Invitation for Additional Challenge||0
6344344|NCT02927145|7251719|FG004|STARTED|Invitation for Additional Challenge||0
6344345|NCT02927145|7251720|FG005|STARTED|Invitation for Additional Challenge||0
6344346|NCT02927145|7251721|FG006|STARTED|Invitation for Additional Challenge||9
6344347|NCT02927145|7251722|FG007|STARTED|Invitation for Additional Challenge||8
6344348|NCT02927145|7251723|FG008|STARTED|Invitation for Additional Challenge||0
6344349|NCT02927145|7251715|FG000|COMPLETED|Invitation for Additional Challenge||0
6344350|NCT02927145|7251716|FG001|COMPLETED|Invitation for Additional Challenge||0
6344351|NCT02927145|7251717|FG002|COMPLETED|Invitation for Additional Challenge||0
6344352|NCT02927145|7251718|FG003|COMPLETED|Invitation for Additional Challenge||0
6344353|NCT02927145|7251719|FG004|COMPLETED|Invitation for Additional Challenge||0
6344354|NCT02927145|7251720|FG005|COMPLETED|Invitation for Additional Challenge||0
6344355|NCT02927145|7251721|FG006|COMPLETED|Invitation for Additional Challenge||8
6344356|NCT02927145|7251722|FG007|COMPLETED|Invitation for Additional Challenge||8
6344357|NCT02927145|7251723|FG008|COMPLETED|Invitation for Additional Challenge||0
6344358|NCT02927145|7251715|FG000|NOT COMPLETED|Invitation for Additional Challenge||0
6344359|NCT02927145|7251716|FG001|NOT COMPLETED|Invitation for Additional Challenge||0
6344360|NCT02927145|7251717|FG002|NOT COMPLETED|Invitation for Additional Challenge||0
6344361|NCT02927145|7251718|FG003|NOT COMPLETED|Invitation for Additional Challenge||0
6344362|NCT02927145|7251719|FG004|NOT COMPLETED|Invitation for Additional Challenge||0
6344363|NCT02927145|7251720|FG005|NOT COMPLETED|Invitation for Additional Challenge||0
6344364|NCT02927145|7251721|FG006|NOT COMPLETED|Invitation for Additional Challenge||1
6344365|NCT02927145|7251722|FG007|NOT COMPLETED|Invitation for Additional Challenge||0
6559380|NCT01781429|7482034|FG015|COMPLETED|Overall Study||0
6559381|NCT01781429|7482019|FG000|NOT COMPLETED|Overall Study||1
6559382|NCT01781429|7482020|FG001|NOT COMPLETED|Overall Study||1
6559383|NCT01781429|7482021|FG002|NOT COMPLETED|Overall Study||1
6344366|NCT02927145|7251723|FG008|NOT COMPLETED|Invitation for Additional Challenge||0
6344367|NCT02910583|7251746|FG000|STARTED|Overall Study||159
6344368|NCT02910583|7251747|FG001|STARTED|Overall Study||164
6344369|NCT02910583|7251746|FG000|MRD Cohort/ Not Randomized|Overall Study|Not applicable to this cohort.|0
6344370|NCT02910583|7251747|FG001|MRD Cohort/ Not Randomized|Overall Study||15
6344371|NCT02910583|7251746|FG000|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study|Not applicable to this cohort.|0
6344372|NCT02910583|7251747|FG001|MRD Cohort/ Confirmed uMRD: Randomized to Ibrutinib (Blinded)|Overall Study||43
6344373|NCT02910583|7251746|FG000|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study|Not applicable to this cohort.|0
6344374|NCT02910583|7251747|FG001|MRD Cohort/ Confirmed uMRD: Randomized Placebo (Blinded)|Overall Study||43
6559384|NCT01781429|7482022|FG003|NOT COMPLETED|Overall Study||1
6559385|NCT01781429|7482023|FG004|NOT COMPLETED|Overall Study||1
6559386|NCT01781429|7482024|FG005|NOT COMPLETED|Overall Study||4
6344375|NCT02910583|7251746|FG000|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study|Not applicable to this cohort.|0
6344376|NCT02910583|7251747|FG001|MRD Cohort/uMRD Not Confirmed: Randomized to Ibrutinib (Open-Label)|Overall Study||31
6344377|NCT02910583|7251746|FG000|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study|Not applicable to this cohort.|0
6344378|NCT02910583|7251747|FG001|MRD Cohort/uMRD Not Confirmed: Randomized Ibrutinib + Venetoclax (Open-Label)|Overall Study||32
6344379|NCT02910583|7251746|FG000|COMPLETED|Overall Study||152
6344380|NCT02910583|7251747|FG001|COMPLETED|Overall Study||157
6344381|NCT02910583|7251746|FG000|NOT COMPLETED|Overall Study||7
6344382|NCT02910583|7251747|FG001|NOT COMPLETED|Overall Study||7
6344383|NCT02699060|7251784|FG000|STARTED|Overall Study||68
6344384|NCT02699060|7251784|FG000|COMPLETED|Overall Study||68
6344385|NCT02699060|7251784|FG000|NOT COMPLETED|Overall Study||0
6344386|NCT02598388|7251804|FG000|STARTED|Overall Study||40
6344387|NCT02598388|7251805|FG001|STARTED|Overall Study||10
6559387|NCT01781429|7482025|FG006|NOT COMPLETED|Overall Study||7
6559388|NCT01781429|7482026|FG007|NOT COMPLETED|Overall Study||4
6559389|NCT01781429|7482027|FG008|NOT COMPLETED|Overall Study||7
6559390|NCT01781429|7482028|FG009|NOT COMPLETED|Overall Study||24
6344388|NCT02598388|7251806|FG002|STARTED|Overall Study||20
6344389|NCT02598388|7251807|FG003|STARTED|Overall Study||5
6344390|NCT02598388|7251808|FG004|STARTED|Overall Study||161
6344391|NCT02598388|7251809|FG005|STARTED|Overall Study||39
6344392|NCT02598388|7251810|FG006|STARTED|Overall Study||161
6344393|NCT02598388|7251811|FG007|STARTED|Overall Study||39
6344394|NCT02598388|7251812|FG008|STARTED|Overall Study||39
6344395|NCT02598388|7251813|FG009|STARTED|Overall Study||10
6344396|NCT02598388|7251814|FG010|STARTED|Overall Study||40
6344397|NCT02598388|7251815|FG011|STARTED|Overall Study||10
6344398|NCT02598388|7251804|FG000|COMPLETED|Overall Study||39
6344399|NCT02598388|7251805|FG001|COMPLETED|Overall Study||10
6344400|NCT02598388|7251806|FG002|COMPLETED|Overall Study||18
6344401|NCT02598388|7251807|FG003|COMPLETED|Overall Study||5
6344402|NCT02598388|7251808|FG004|COMPLETED|Overall Study||151
6344403|NCT02598388|7251809|FG005|COMPLETED|Overall Study||38
6344404|NCT02598388|7251810|FG006|COMPLETED|Overall Study||156
6344405|NCT02598388|7251811|FG007|COMPLETED|Overall Study||38
6344406|NCT02598388|7251812|FG008|COMPLETED|Overall Study||39
6344407|NCT02598388|7251813|FG009|COMPLETED|Overall Study||9
6344408|NCT02598388|7251814|FG010|COMPLETED|Overall Study||39
6344409|NCT02598388|7251815|FG011|COMPLETED|Overall Study||10
6344410|NCT02598388|7251804|FG000|NOT COMPLETED|Overall Study||1
6344411|NCT02598388|7251805|FG001|NOT COMPLETED|Overall Study||0
6344412|NCT02598388|7251806|FG002|NOT COMPLETED|Overall Study||2
6344413|NCT02598388|7251807|FG003|NOT COMPLETED|Overall Study||0
6344414|NCT02598388|7251808|FG004|NOT COMPLETED|Overall Study||10
6344415|NCT02598388|7251809|FG005|NOT COMPLETED|Overall Study||1
6344416|NCT02598388|7251810|FG006|NOT COMPLETED|Overall Study||5
6344417|NCT02598388|7251811|FG007|NOT COMPLETED|Overall Study||1
6344418|NCT02598388|7251812|FG008|NOT COMPLETED|Overall Study||0
6344419|NCT02598388|7251813|FG009|NOT COMPLETED|Overall Study||1
6344420|NCT02598388|7251814|FG010|NOT COMPLETED|Overall Study||1
6344421|NCT02598388|7251815|FG011|NOT COMPLETED|Overall Study||0
6344422|NCT02493751|7251848|FG000|STARTED|Overall Study||16
6344423|NCT02493751|7251849|FG001|STARTED|Overall Study||39
6344424|NCT02493751|7251848|FG000|COMPLETED|Overall Study||0
6344425|NCT02493751|7251849|FG001|COMPLETED|Overall Study||0
6344426|NCT02493751|7251848|FG000|NOT COMPLETED|Overall Study||16
6344427|NCT02493751|7251849|FG001|NOT COMPLETED|Overall Study||39
6344428|NCT02285166|7251856|FG000|STARTED|Overall Study||15330
6344429|NCT02285166|7251856|FG000|COMPLETED|Overall Study||14364
6344430|NCT02285166|7251856|FG000|NOT COMPLETED|Overall Study||966
6344431|NCT02278120|7251864|FG000|STARTED|Overall Study||335
6344432|NCT02278120|7251865|FG001|STARTED|Overall Study||337
6344433|NCT02278120|7251864|FG000|COMPLETED|Overall Study||174
6344434|NCT02278120|7251865|FG001|COMPLETED|Overall Study||121
6559391|NCT01781429|7482029|FG010|NOT COMPLETED|Overall Study||18
6559392|NCT01781429|7482030|FG011|NOT COMPLETED|Overall Study||21
6559393|NCT01781429|7482031|FG012|NOT COMPLETED|Overall Study||22
6559394|NCT01781429|7482032|FG013|NOT COMPLETED|Overall Study||8
6559395|NCT01781429|7482033|FG014|NOT COMPLETED|Overall Study||16
6344435|NCT02278120|7251864|FG000|NOT COMPLETED|Overall Study||161
6344436|NCT02278120|7251865|FG001|NOT COMPLETED|Overall Study||216
6376627|NCT00760474|7287173|FG000|COMPLETED|Placebo Washout Period||12
6376628|NCT00760474|7287174|FG001|COMPLETED|Placebo Washout Period||12
6376629|NCT00760474|7287173|FG000|NOT COMPLETED|Placebo Washout Period||0
6376630|NCT00760474|7287174|FG001|NOT COMPLETED|Placebo Washout Period||1
6376631|NCT00760474|7287173|FG000|STARTED|Period 2 (P2)||12
6376632|NCT00760474|7287174|FG001|STARTED|Period 2 (P2)||12
6376633|NCT00760474|7287173|FG000|COMPLETED|Period 2 (P2)||11
6376634|NCT00760474|7287174|FG001|COMPLETED|Period 2 (P2)||11
6376635|NCT00760474|7287173|FG000|NOT COMPLETED|Period 2 (P2)||1
6376636|NCT00760474|7287174|FG001|NOT COMPLETED|Period 2 (P2)||1
6376637|NCT00760487|7287181|FG000|STARTED|Overall Study||120
6376638|NCT00760487|7287181|FG000|COMPLETED|Overall Study||117
6376639|NCT00760487|7287181|FG000|NOT COMPLETED|Overall Study||3
6376640|NCT00760513|7287187|FG000|STARTED|Overall Study||51
6376641|NCT00760513|7287188|FG001|STARTED|Overall Study||52
6376642|NCT00760513|7287187|FG000|COMPLETED|Overall Study||46
6376643|NCT00760513|7287188|FG001|COMPLETED|Overall Study||45
6376644|NCT00760513|7287187|FG000|NOT COMPLETED|Overall Study||5
6376645|NCT00760513|7287188|FG001|NOT COMPLETED|Overall Study||7
6376646|NCT00760526|7287198|FG000|STARTED|Overall Study||74
6376647|NCT00760526|7287199|FG001|STARTED|Overall Study||72
6376648|NCT00760526|7287198|FG000|COMPLETED|Overall Study||69
6376649|NCT00760526|7287199|FG001|COMPLETED|Overall Study||68
6376650|NCT00760526|7287198|FG000|NOT COMPLETED|Overall Study||5
6376651|NCT00760526|7287199|FG001|NOT COMPLETED|Overall Study||4
6376652|NCT00760552|7287214|FG000|STARTED|Overall Study||61
6376653|NCT00760552|7287215|FG001|STARTED|Overall Study||62
6376654|NCT00760552|7287214|FG000|COMPLETED|Overall Study||48
6376655|NCT00760552|7287215|FG001|COMPLETED|Overall Study||52
6376656|NCT00760552|7287214|FG000|NOT COMPLETED|Overall Study||13
6376657|NCT00760552|7287215|FG001|NOT COMPLETED|Overall Study||10
6376658|NCT00760578|7287225|FG000|STARTED|Overall Study||22
6376659|NCT00760578|7287226|FG001|STARTED|Overall Study||21
6376660|NCT00760578|7287227|FG002|STARTED|Overall Study||21
6376661|NCT00760578|7287228|FG003|STARTED|Overall Study||22
6376662|NCT00760578|7287225|FG000|Entered Drug Treatment Period|Overall Study||21
6376663|NCT00760578|7287226|FG001|Entered Drug Treatment Period|Overall Study||20
6376664|NCT00760578|7287227|FG002|Entered Drug Treatment Period|Overall Study||19
6376665|NCT00760578|7287228|FG003|Entered Drug Treatment Period|Overall Study||22
6376666|NCT00760578|7287225|FG000|COMPLETED|Overall Study||19
6376667|NCT00760578|7287226|FG001|COMPLETED|Overall Study||19
6376668|NCT00760578|7287227|FG002|COMPLETED|Overall Study||16
6376669|NCT00760578|7287228|FG003|COMPLETED|Overall Study||18
6376670|NCT00760578|7287225|FG000|NOT COMPLETED|Overall Study||3
6376671|NCT00760578|7287226|FG001|NOT COMPLETED|Overall Study||2
6376672|NCT00760578|7287227|FG002|NOT COMPLETED|Overall Study||5
6376673|NCT00760578|7287228|FG003|NOT COMPLETED|Overall Study||4
6376674|NCT00760617|7287246|FG000|STARTED|Overall Study||266
6376675|NCT00760617|7287247|FG001|STARTED|Overall Study||144
6376676|NCT00760617|7287248|FG002|STARTED|Overall Study||116
6376677|NCT00760617|7287246|FG000|COMPLETED|Overall Study||261
6376678|NCT00760617|7287247|FG001|COMPLETED|Overall Study||142
6376679|NCT00760617|7287248|FG002|COMPLETED|Overall Study||111
6376680|NCT00760617|7287246|FG000|NOT COMPLETED|Overall Study||5
6376681|NCT00760617|7287247|FG001|NOT COMPLETED|Overall Study||2
6376682|NCT00760617|7287248|FG002|NOT COMPLETED|Overall Study||5
6376683|NCT00760669|7287256|FG000|STARTED|Overall Study||1061
6376684|NCT00760669|7287256|FG000|COMPLETED|Overall Study||1031
6376685|NCT00760669|7287256|FG000|NOT COMPLETED|Overall Study||30
6376686|NCT00760747|7287262|FG000|STARTED|Study Period II||57
6376687|NCT00760747|7287263|FG001|STARTED|Study Period II||55
6376688|NCT00760747|7287262|FG000|Received at Least One Dose of Study Drug|Study Period II||57
6376689|NCT00760747|7287263|FG001|Received at Least One Dose of Study Drug|Study Period II||54
6376690|NCT00760747|7287262|FG000|COMPLETED|Study Period II||44
6376691|NCT00760747|7287263|FG001|COMPLETED|Study Period II||41
6376692|NCT00760747|7287262|FG000|NOT COMPLETED|Study Period II||13
6376693|NCT00760747|7287263|FG001|NOT COMPLETED|Study Period II||14
6376694|NCT00760747|7287262|FG000|STARTED|Study Period III||44
6376695|NCT00760747|7287263|FG001|STARTED|Study Period III||41
6376696|NCT00760747|7287262|FG000|COMPLETED|Study Period III||41
6376697|NCT00760747|7287263|FG001|COMPLETED|Study Period III||38
6376698|NCT00760747|7287262|FG000|NOT COMPLETED|Study Period III||3
6376699|NCT00760747|7287263|FG001|NOT COMPLETED|Study Period III||3
6376700|NCT00760838|7287271|FG000|STARTED|Overall Study||54
6376701|NCT00760838|7287272|FG001|STARTED|Overall Study||55
6376702|NCT00760838|7287271|FG000|COMPLETED|Overall Study||49
6376703|NCT00760838|7287272|FG001|COMPLETED|Overall Study||53
6376704|NCT00760838|7287271|FG000|NOT COMPLETED|Overall Study||5
6376705|NCT00760838|7287272|FG001|NOT COMPLETED|Overall Study||2
6376706|NCT00760877|7287280|FG000|STARTED|Overall Study||104
6376707|NCT00760877|7287281|FG001|STARTED|Overall Study||103
6376708|NCT00760877|7287280|FG000|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
6376709|NCT00760877|7287281|FG001|Cross-over to Nilotinib|Overall Study||46
6376710|NCT00760877|7287280|FG000|Safety Set|Overall Study||101
6376711|NCT00760877|7287281|FG001|Safety Set|Overall Study||103
6376712|NCT00760877|7287280|FG000|COMPLETED|Overall Study||59
6376713|NCT00760877|7287281|FG001|COMPLETED|Overall Study||77
6376714|NCT00760877|7287280|FG000|NOT COMPLETED|Overall Study||45
6344437|NCT02075593|7251871|FG000|STARTED|Overall Study||4
6344438|NCT02075593|7251871|FG000|Infants Born to Pregnant Women Who Received at Least One Dose of Study Treatment|Overall Study||4
6344439|NCT02075593|7251871|FG000|COMPLETED|Overall Study||1
6344440|NCT02075593|7251871|FG000|NOT COMPLETED|Overall Study||3
6344441|NCT00587860|7251879|FG000|STARTED|Overall Study||35
6344442|NCT00587860|7251880|FG001|STARTED|Overall Study||35
6344443|NCT00587860|7251879|FG000|COMPLETED|Overall Study||30
6344444|NCT00587860|7251880|FG001|COMPLETED|Overall Study||30
6344445|NCT00587860|7251879|FG000|NOT COMPLETED|Overall Study||5
6344446|NCT00587860|7251880|FG001|NOT COMPLETED|Overall Study||5
6344447|NCT00587964|7251886|FG000|STARTED|Overall Study||51
6344448|NCT00587964|7251886|FG000|COMPLETED|Overall Study||39
6344449|NCT00587964|7251886|FG000|NOT COMPLETED|Overall Study||12
6344450|NCT00587990|7251893|FG000|STARTED|Overall Study||2
6344451|NCT00587990|7251894|FG001|STARTED|Overall Study||4
6344452|NCT00587990|7251895|FG002|STARTED|Overall Study||3
6344453|NCT00587990|7251893|FG000|COMPLETED|Overall Study||2
6344454|NCT00587990|7251894|FG001|COMPLETED|Overall Study||4
6344455|NCT00587990|7251895|FG002|COMPLETED|Overall Study||2
6344456|NCT00587990|7251893|FG000|NOT COMPLETED|Overall Study||0
6344457|NCT00587990|7251894|FG001|NOT COMPLETED|Overall Study||0
6344458|NCT00587990|7251895|FG002|NOT COMPLETED|Overall Study||1
6344459|NCT00588094|7251903|FG000|STARTED|Overall Study||20
6344460|NCT00588094|7251903|FG000|COMPLETED|Overall Study||15
6344461|NCT00588094|7251903|FG000|NOT COMPLETED|Overall Study||5
6344462|NCT00588159|7251909|FG000|STARTED|Overall Study||72
6344463|NCT00588159|7251910|FG001|STARTED|Overall Study||74
6344464|NCT00588159|7251909|FG000|COMPLETED|Overall Study||57
6344465|NCT00588159|7251910|FG001|COMPLETED|Overall Study||63
6344466|NCT00588159|7251909|FG000|NOT COMPLETED|Overall Study||15
6344467|NCT00588159|7251910|FG001|NOT COMPLETED|Overall Study||11
6344468|NCT00588237|7251916|FG000|STARTED|Overall Study||42
6344469|NCT00588237|7251916|FG000|COMPLETED|Overall Study||38
6344470|NCT00588237|7251916|FG000|NOT COMPLETED|Overall Study||4
6344471|NCT00588341|7251920|FG000|STARTED|Overall Study||24
6344472|NCT00588341|7251920|FG000|COMPLETED|Overall Study||19
6344473|NCT00588341|7251920|FG000|NOT COMPLETED|Overall Study||5
6344474|NCT00588354|7251926|FG000|STARTED|Baseline to 2 Weeks||11
6344475|NCT00588354|7251927|FG001|STARTED|Baseline to 2 Weeks||15
6344476|NCT00588354|7251926|FG000|COMPLETED|Baseline to 2 Weeks||9
6344477|NCT00588354|7251927|FG001|COMPLETED|Baseline to 2 Weeks||15
6344478|NCT00588354|7251926|FG000|NOT COMPLETED|Baseline to 2 Weeks||2
6344479|NCT00588354|7251927|FG001|NOT COMPLETED|Baseline to 2 Weeks||0
6344480|NCT00588354|7251926|FG000|STARTED|Baseline to 4 Weeks||9
6344481|NCT00588354|7251927|FG001|STARTED|Baseline to 4 Weeks||15
6344482|NCT00588354|7251926|FG000|COMPLETED|Baseline to 4 Weeks||9
6344483|NCT00588354|7251927|FG001|COMPLETED|Baseline to 4 Weeks||14
6344484|NCT00588354|7251926|FG000|NOT COMPLETED|Baseline to 4 Weeks||0
6344485|NCT00588354|7251927|FG001|NOT COMPLETED|Baseline to 4 Weeks||1
6344486|NCT00588380|7251934|FG000|STARTED|Overall Study||88
6344487|NCT00588380|7251934|FG000|COMPLETED|Overall Study||88
6344488|NCT00588380|7251934|FG000|NOT COMPLETED|Overall Study||0
6344489|NCT00588406|7251941|FG000|STARTED|Overall Study||46
6344490|NCT00588406|7251942|FG001|STARTED|Overall Study||49
6344491|NCT00588406|7251941|FG000|COMPLETED|Overall Study||46
6344492|NCT00588406|7251942|FG001|COMPLETED|Overall Study||49
6344493|NCT00588406|7251941|FG000|NOT COMPLETED|Overall Study||0
6344494|NCT00588406|7251942|FG001|NOT COMPLETED|Overall Study||0
6344495|NCT00588445|7251948|FG000|STARTED|Overall Study||65
6344496|NCT00588445|7251948|FG000|COMPLETED|Overall Study||50
6344497|NCT00588445|7251948|FG000|NOT COMPLETED|Overall Study||15
6344498|NCT00588536|7251954|FG000|STARTED|Overall Study||5
6344499|NCT00588536|7251954|FG000|COMPLETED|Overall Study||5
6344500|NCT00588536|7251954|FG000|NOT COMPLETED|Overall Study||0
6344501|NCT00588640|7251958|FG000|STARTED|Overall Study||10
6344502|NCT00588640|7251958|FG000|COMPLETED|Overall Study||8
6344503|NCT00588640|7251958|FG000|NOT COMPLETED|Overall Study||2
6344504|NCT00588666|7251962|FG000|STARTED|Overall Study||51
6344505|NCT00588666|7251962|FG000|COMPLETED|Overall Study||47
6344506|NCT00588666|7251962|FG000|NOT COMPLETED|Overall Study||4
6344507|NCT00588692|7251968|FG000|STARTED|Overall Study||30
6344508|NCT00588692|7251969|FG001|STARTED|Overall Study||30
6344509|NCT00588692|7251968|FG000|COMPLETED|Overall Study||23
6344510|NCT00588692|7251969|FG001|COMPLETED|Overall Study||27
6344511|NCT00588692|7251968|FG000|NOT COMPLETED|Overall Study||7
6344512|NCT00588692|7251969|FG001|NOT COMPLETED|Overall Study||3
6344513|NCT00588731|7251979|FG000|STARTED|Overall Study||21
6344514|NCT00588731|7251980|FG001|STARTED|Overall Study||20
6344515|NCT00588731|7251979|FG000|COMPLETED|Overall Study||18
6344516|NCT00588731|7251980|FG001|COMPLETED|Overall Study||18
6344517|NCT00588731|7251979|FG000|NOT COMPLETED|Overall Study||3
6344518|NCT00588731|7251980|FG001|NOT COMPLETED|Overall Study||2
6344519|NCT00588809|7251986|FG000|STARTED|Overall Study||47
6344520|NCT00588809|7251986|FG000|COMPLETED|Overall Study||47
6344521|NCT00588809|7251986|FG000|NOT COMPLETED|Overall Study||0
6344522|NCT00588822|7251990|FG000|STARTED|Overall Study||21
6344523|NCT00588822|7251990|FG000|COMPLETED|Overall Study||13
6344524|NCT00588822|7251990|FG000|NOT COMPLETED|Overall Study||8
6344525|NCT00588848|7251996|FG000|STARTED|Overall Study||3
6344526|NCT00588848|7251997|FG001|STARTED|Overall Study||8
6344527|NCT00588848|7251996|FG000|COMPLETED|Overall Study||3
6344528|NCT00588848|7251997|FG001|COMPLETED|Overall Study||5
6344529|NCT00588848|7251996|FG000|NOT COMPLETED|Overall Study||0
6344530|NCT00588848|7251997|FG001|NOT COMPLETED|Overall Study||3
6344531|NCT00588900|7252005|FG000|STARTED|Overall Study||5
6344532|NCT00588900|7252005|FG000|COMPLETED|Overall Study||5
6344533|NCT00588900|7252005|FG000|NOT COMPLETED|Overall Study||0
6344534|NCT00588952|7252011|FG000|STARTED|Overall Study||29
6344535|NCT00588952|7252012|FG001|STARTED|Overall Study||70
6344536|NCT00588952|7252011|FG000|COMPLETED|Overall Study||26
6344537|NCT00588952|7252012|FG001|COMPLETED|Overall Study||63
6344538|NCT00588952|7252011|FG000|NOT COMPLETED|Overall Study||3
6344539|NCT00588952|7252012|FG001|NOT COMPLETED|Overall Study||7
6344540|NCT00588965|7252018|FG000|STARTED|Overall Study||35
6344541|NCT00588965|7252018|FG000|COMPLETED|Overall Study||35
6344542|NCT00588965|7252018|FG000|NOT COMPLETED|Overall Study||0
6344543|NCT00589056|7252024|FG000|STARTED|Overall Study||55
6344544|NCT00589056|7252024|FG000|COMPLETED|Overall Study||52
6344545|NCT00589056|7252024|FG000|NOT COMPLETED|Overall Study||3
6344546|NCT00589108|7252031|FG000|STARTED|Overall Study||80
6344547|NCT00589108|7252032|FG001|STARTED|Overall Study||80
6344548|NCT00589108|7252033|FG002|STARTED|Overall Study||80
6344549|NCT00589108|7252031|FG000|COMPLETED|Overall Study||76
6344550|NCT00589108|7252032|FG001|COMPLETED|Overall Study||76
6344551|NCT00589108|7252033|FG002|COMPLETED|Overall Study||75
6344552|NCT00589108|7252031|FG000|NOT COMPLETED|Overall Study||4
6344553|NCT00589108|7252032|FG001|NOT COMPLETED|Overall Study||4
6344554|NCT00589108|7252033|FG002|NOT COMPLETED|Overall Study||5
6344555|NCT00589121|7252043|FG000|STARTED|Overall Study||12
6344556|NCT00589121|7252044|FG001|STARTED|Overall Study||86
6344557|NCT00589121|7252043|FG000|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
6344558|NCT00589121|7252044|FG001|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
6344559|NCT00589121|7252043|FG000|NOT COMPLETED|Overall Study||2
6344560|NCT00589121|7252044|FG001|NOT COMPLETED|Overall Study||7
6344561|NCT00589277|7252055|FG000|STARTED|Overall Study||1222
6344562|NCT00589277|7252056|FG001|STARTED|Overall Study||810
6344563|NCT00589277|7252055|FG000|Completed 2 Week Follow Up|Overall Study||603
6344564|NCT00589277|7252056|FG001|Completed 2 Week Follow Up|Overall Study||424
6344565|NCT00589277|7252055|FG000|Completed 3 Month Follow Up|Overall Study||762
6344566|NCT00589277|7252056|FG001|Completed 3 Month Follow Up|Overall Study||524
6344567|NCT00589277|7252055|FG000|COMPLETED|Overall Study||762
6344568|NCT00589277|7252056|FG001|COMPLETED|Overall Study||524
6344569|NCT00589277|7252055|FG000|NOT COMPLETED|Overall Study||460
6344570|NCT00589277|7252056|FG001|NOT COMPLETED|Overall Study||286
6344571|NCT00589290|7252062|FG000|STARTED|Overall Study||41
6344572|NCT00589290|7252062|FG000|COMPLETED|Overall Study||40
6344573|NCT00589290|7252062|FG000|NOT COMPLETED|Overall Study||1
6344574|NCT00589303|7252070|FG000|STARTED|Overall Study||14
6344575|NCT00589303|7252071|FG001|STARTED|Overall Study||13
6344576|NCT00589303|7252070|FG000|COMPLETED|Overall Study||12
6344577|NCT00589303|7252071|FG001|COMPLETED|Overall Study||12
6344578|NCT00589303|7252070|FG000|NOT COMPLETED|Overall Study||2
6344579|NCT00589303|7252071|FG001|NOT COMPLETED|Overall Study||1
6344580|NCT00589329|7252079|FG000|STARTED|Overall Study||10
6344581|NCT00589329|7252080|FG001|STARTED|Overall Study||10
6344582|NCT00589329|7252079|FG000|COMPLETED|Overall Study||10
6344583|NCT00589329|7252080|FG001|COMPLETED|Overall Study||10
6344584|NCT00589329|7252079|FG000|NOT COMPLETED|Overall Study||0
6344585|NCT00589329|7252080|FG001|NOT COMPLETED|Overall Study||0
6344586|NCT00589472|7252087|FG000|STARTED|Overall Study||19
6344587|NCT00589472|7252087|FG000|COMPLETED|Overall Study||18
6344588|NCT00589472|7252087|FG000|NOT COMPLETED|Overall Study||1
6344589|NCT00589563|7252091|FG000|STARTED|Overall Study||32
6344590|NCT00589563|7252091|FG000|COMPLETED|Overall Study||32
6344591|NCT00589563|7252091|FG000|NOT COMPLETED|Overall Study||0
6344592|NCT00589602|7252095|FG000|STARTED|Overall Study||13
6344593|NCT00589602|7252095|FG000|COMPLETED|Overall Study||12
6344594|NCT00589602|7252095|FG000|NOT COMPLETED|Overall Study||1
6344595|NCT00589628|7252103|FG000|STARTED|Overall Study||7
6344596|NCT00589628|7252104|FG001|STARTED|Overall Study||6
6344597|NCT00589628|7252103|FG000|COMPLETED|Overall Study||7
6344598|NCT00589628|7252104|FG001|COMPLETED|Overall Study||5
6344599|NCT00589628|7252103|FG000|NOT COMPLETED|Overall Study||0
6344600|NCT00589628|7252104|FG001|NOT COMPLETED|Overall Study||1
6344601|NCT00589667|7252110|FG000|STARTED|Overall Study||26
6344602|NCT00589667|7252110|FG000|COMPLETED|Overall Study||23
6344603|NCT00589667|7252110|FG000|NOT COMPLETED|Overall Study||3
6344604|NCT00589693|7252116|FG000|STARTED|Overall Study||115
6344605|NCT00589693|7252117|FG001|STARTED|Overall Study||112
6344606|NCT00589693|7252116|FG000|COMPLETED|Overall Study||71
6344607|NCT00589693|7252117|FG001|COMPLETED|Overall Study||83
6344608|NCT00589693|7252116|FG000|NOT COMPLETED|Overall Study||44
6344609|NCT00589693|7252117|FG001|NOT COMPLETED|Overall Study||29
6344610|NCT00589784|7252125|FG000|STARTED|Overall Study||36
6344611|NCT00589784|7252126|FG001|STARTED|Overall Study||14
6344612|NCT00589784|7252125|FG000|COMPLETED|Overall Study||35
6344613|NCT00589784|7252126|FG001|COMPLETED|Overall Study||4
6344614|NCT00589784|7252125|FG000|NOT COMPLETED|Overall Study||1
6344615|NCT00589784|7252126|FG001|NOT COMPLETED|Overall Study||10
6344616|NCT00589797|7252133|FG000|STARTED|Overall Study||264
6344617|NCT00589797|7252134|FG001|STARTED|Overall Study||112
6344618|NCT00589797|7252133|FG000|Baseline|Overall Study||218
6344619|NCT00589797|7252134|FG001|Baseline|Overall Study||106
6344620|NCT00589797|7252133|FG000|24 Months|Overall Study||191
6344621|NCT00589797|7252134|FG001|24 Months|Overall Study||89
6344622|NCT00589797|7252133|FG000|COMPLETED|Overall Study||191
6344623|NCT00589797|7252134|FG001|COMPLETED|Overall Study||89
6344624|NCT00589797|7252133|FG000|NOT COMPLETED|Overall Study||73
6344625|NCT00589797|7252134|FG001|NOT COMPLETED|Overall Study||23
6344626|NCT00589836|7252140|FG000|STARTED|Overall Study||20
6344627|NCT00589836|7252140|FG000|COMPLETED|Overall Study||20
6344628|NCT00589836|7252140|FG000|NOT COMPLETED|Overall Study||0
6344629|NCT00589849|7252144|FG000|STARTED|Overall Study||32
6344630|NCT00589849|7252144|FG000|COMPLETED|Overall Study||32
6344631|NCT00589849|7252144|FG000|NOT COMPLETED|Overall Study||0
6344632|NCT00589888|7252148|FG000|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
6344633|NCT00589888|7252149|FG001|STARTED|Normal Saline @ 40cc/Hour||0
6344634|NCT00589888|7252150|FG002|STARTED|Normal Saline @ 40cc/Hour||0
6344635|NCT00589888|7252151|FG003|STARTED|Normal Saline @ 40cc/Hour||0
6344636|NCT00589888|7252152|FG004|STARTED|Normal Saline @ 40cc/Hour||0
6344637|NCT00589888|7252148|FG000|COMPLETED|Normal Saline @ 40cc/Hour||13
6344638|NCT00589888|7252149|FG001|COMPLETED|Normal Saline @ 40cc/Hour||0
6344639|NCT00589888|7252150|FG002|COMPLETED|Normal Saline @ 40cc/Hour||0
6344640|NCT00589888|7252151|FG003|COMPLETED|Normal Saline @ 40cc/Hour||0
6344641|NCT00589888|7252152|FG004|COMPLETED|Normal Saline @ 40cc/Hour||0
6344642|NCT00589888|7252148|FG000|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6344643|NCT00589888|7252149|FG001|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6344644|NCT00589888|7252150|FG002|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6344645|NCT00589888|7252151|FG003|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6344646|NCT00589888|7252152|FG004|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
6344647|NCT00589888|7252148|FG000|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
6344648|NCT00589888|7252149|FG001|STARTED|Intralipid 20% @ 20cc/hr||13
6344649|NCT00589888|7252150|FG002|STARTED|Intralipid 20% @ 20cc/hr||0
6344650|NCT00589888|7252151|FG003|STARTED|Intralipid 20% @ 20cc/hr||0
6344651|NCT00589888|7252152|FG004|STARTED|Intralipid 20% @ 20cc/hr||0
6344652|NCT00589888|7252148|FG000|COMPLETED|Intralipid 20% @ 20cc/hr||0
6344653|NCT00589888|7252149|FG001|COMPLETED|Intralipid 20% @ 20cc/hr||13
6344654|NCT00589888|7252150|FG002|COMPLETED|Intralipid 20% @ 20cc/hr||0
6344655|NCT00589888|7252151|FG003|COMPLETED|Intralipid 20% @ 20cc/hr||0
6344656|NCT00589888|7252152|FG004|COMPLETED|Intralipid 20% @ 20cc/hr||0
6344657|NCT00589888|7252148|FG000|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6344658|NCT00589888|7252149|FG001|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6344659|NCT00589888|7252150|FG002|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6344660|NCT00589888|7252151|FG003|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6344661|NCT00589888|7252152|FG004|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
6344662|NCT00589888|7252148|FG000|STARTED|Intralipid 20% @ 40cc/Hour||0
6344663|NCT00589888|7252149|FG001|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
6344664|NCT00589888|7252150|FG002|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
6344665|NCT00589888|7252151|FG003|STARTED|Intralipid 20% @ 40cc/Hour||0
6344666|NCT00589888|7252152|FG004|STARTED|Intralipid 20% @ 40cc/Hour||0
6344667|NCT00589888|7252148|FG000|COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344668|NCT00589888|7252149|FG001|COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344669|NCT00589888|7252150|FG002|COMPLETED|Intralipid 20% @ 40cc/Hour||13
6344670|NCT00589888|7252151|FG003|COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344671|NCT00589888|7252152|FG004|COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344672|NCT00589888|7252148|FG000|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344673|NCT00589888|7252149|FG001|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344674|NCT00589888|7252150|FG002|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344675|NCT00589888|7252151|FG003|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344676|NCT00589888|7252152|FG004|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
6344677|NCT00589888|7252148|FG000|STARTED|32-gram Oral Fat Load||0
6344678|NCT00589888|7252149|FG001|STARTED|32-gram Oral Fat Load||0
6344679|NCT00589888|7252150|FG002|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
6344680|NCT00589888|7252151|FG003|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
6344681|NCT00589888|7252152|FG004|STARTED|32-gram Oral Fat Load||0
6344682|NCT00589888|7252148|FG000|COMPLETED|32-gram Oral Fat Load||0
6344683|NCT00589888|7252149|FG001|COMPLETED|32-gram Oral Fat Load||0
6344684|NCT00589888|7252150|FG002|COMPLETED|32-gram Oral Fat Load||0
6344685|NCT00589888|7252151|FG003|COMPLETED|32-gram Oral Fat Load||13
6344686|NCT00589888|7252152|FG004|COMPLETED|32-gram Oral Fat Load||0
6344687|NCT00589888|7252148|FG000|NOT COMPLETED|32-gram Oral Fat Load||0
6344688|NCT00589888|7252149|FG001|NOT COMPLETED|32-gram Oral Fat Load||0
6344689|NCT00589888|7252150|FG002|NOT COMPLETED|32-gram Oral Fat Load||0
6344690|NCT00589888|7252151|FG003|NOT COMPLETED|32-gram Oral Fat Load||0
6344691|NCT00589888|7252152|FG004|NOT COMPLETED|32-gram Oral Fat Load||0
6344692|NCT00589888|7252148|FG000|STARTED|64-gram Oral Fat Load||0
6344693|NCT00589888|7252149|FG001|STARTED|64-gram Oral Fat Load||0
6344694|NCT00589888|7252150|FG002|STARTED|64-gram Oral Fat Load||0
6344695|NCT00589888|7252151|FG003|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
6344696|NCT00589888|7252152|FG004|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
6344697|NCT00589888|7252148|FG000|COMPLETED|64-gram Oral Fat Load||0
6344698|NCT00589888|7252149|FG001|COMPLETED|64-gram Oral Fat Load||0
6344699|NCT00589888|7252150|FG002|COMPLETED|64-gram Oral Fat Load||0
6344700|NCT00589888|7252151|FG003|COMPLETED|64-gram Oral Fat Load||0
6344701|NCT00589888|7252152|FG004|COMPLETED|64-gram Oral Fat Load||13
6344702|NCT00589888|7252148|FG000|NOT COMPLETED|64-gram Oral Fat Load||0
6344703|NCT00589888|7252149|FG001|NOT COMPLETED|64-gram Oral Fat Load||0
6344704|NCT00589888|7252150|FG002|NOT COMPLETED|64-gram Oral Fat Load||0
6344705|NCT00589888|7252151|FG003|NOT COMPLETED|64-gram Oral Fat Load||0
6344706|NCT00589888|7252152|FG004|NOT COMPLETED|64-gram Oral Fat Load||0
6376715|NCT00760877|7287281|FG001|NOT COMPLETED|Overall Study||26
6376716|NCT00760929|7287292|FG000|STARTED|Overall Study||26
6376717|NCT00760929|7287293|FG001|STARTED|Overall Study||29
6376718|NCT00760929|7287294|FG002|STARTED|Overall Study||59
6376719|NCT00760929|7287295|FG003|STARTED|Overall Study||57
6376720|NCT00760929|7287292|FG000|COMPLETED|Overall Study||0
6376721|NCT00760929|7287293|FG001|COMPLETED|Overall Study||1
6376722|NCT00760929|7287294|FG002|COMPLETED|Overall Study||1
6376723|NCT00760929|7287295|FG003|COMPLETED|Overall Study||2
6376724|NCT00760929|7287292|FG000|NOT COMPLETED|Overall Study||26
6376725|NCT00760929|7287293|FG001|NOT COMPLETED|Overall Study||28
6376726|NCT00760929|7287294|FG002|NOT COMPLETED|Overall Study||58
6376727|NCT00760929|7287295|FG003|NOT COMPLETED|Overall Study||55
6376728|NCT00760994|7287307|FG000|STARTED|Overall Study||29
6376729|NCT00760994|7287308|FG001|STARTED|Overall Study||31
6376730|NCT00760994|7287309|FG002|STARTED|Overall Study||20
6376731|NCT00760994|7287307|FG000|COMPLETED|Overall Study||25
6376732|NCT00760994|7287308|FG001|COMPLETED|Overall Study||27
6376733|NCT00760994|7287309|FG002|COMPLETED|Overall Study||17
6376734|NCT00760994|7287307|FG000|NOT COMPLETED|Overall Study||4
6376735|NCT00760994|7287308|FG001|NOT COMPLETED|Overall Study||4
6376736|NCT00760994|7287309|FG002|NOT COMPLETED|Overall Study||3
6376737|NCT00761007|7287323|FG000|STARTED|Overall Study||142
6376738|NCT00761007|7287324|FG001|STARTED|Overall Study||135
6376739|NCT00761007|7287325|FG002|STARTED|Overall Study||139
6376740|NCT00761007|7287326|FG003|STARTED|Overall Study||138
6376741|NCT00761007|7287323|FG000|Safety (>=1 Dose of Study Medication)|Overall Study||140
6376742|NCT00761007|7287324|FG001|Safety (>=1 Dose of Study Medication)|Overall Study||135
6376743|NCT00761007|7287325|FG002|Safety (>=1 Dose of Study Medication)|Overall Study||139
6376744|NCT00761007|7287326|FG003|Safety (>=1 Dose of Study Medication)|Overall Study||137
6376745|NCT00761007|7287323|FG000|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
6376746|NCT00761007|7287324|FG001|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
6376747|NCT00761007|7287325|FG002|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
6376748|NCT00761007|7287326|FG003|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
6376749|NCT00761007|7287323|FG000|COMPLETED|Overall Study||129
6376750|NCT00761007|7287324|FG001|COMPLETED|Overall Study||124
6376751|NCT00761007|7287325|FG002|COMPLETED|Overall Study||121
6376752|NCT00761007|7287326|FG003|COMPLETED|Overall Study||131
6376753|NCT00761007|7287323|FG000|NOT COMPLETED|Overall Study||13
6376754|NCT00761007|7287324|FG001|NOT COMPLETED|Overall Study||11
6376755|NCT00761007|7287325|FG002|NOT COMPLETED|Overall Study||18
6376756|NCT00761007|7287326|FG003|NOT COMPLETED|Overall Study||7
6376757|NCT00761085|7287340|FG000|STARTED|Overall Study||12
6376758|NCT00761085|7287341|FG001|STARTED|Overall Study||12
6376759|NCT00761085|7287342|FG002|STARTED|Overall Study||11
6376760|NCT00761085|7287343|FG003|STARTED|Overall Study||12
6376761|NCT00761085|7287340|FG000|COMPLETED|Overall Study||12
6376762|NCT00761085|7287341|FG001|COMPLETED|Overall Study||6
6376763|NCT00761085|7287342|FG002|COMPLETED|Overall Study||11
6376764|NCT00761085|7287343|FG003|COMPLETED|Overall Study||8
6376765|NCT00761085|7287340|FG000|NOT COMPLETED|Overall Study||0
6376766|NCT00761085|7287341|FG001|NOT COMPLETED|Overall Study||6
6376767|NCT00761085|7287342|FG002|NOT COMPLETED|Overall Study||0
6376768|NCT00761085|7287343|FG003|NOT COMPLETED|Overall Study||4
6376769|NCT00761137|7287353|FG000|STARTED|Overall Study||19
6376770|NCT00761137|7287353|FG000|Placebo|Overall Study||19
6376771|NCT00761137|7287353|FG000|0.3 mg Tropicamide|Overall Study||19
6376772|NCT00761137|7287353|FG000|1 mg Tropicamide|Overall Study||19
6376773|NCT00761137|7287353|FG000|3 mg Tropicamide|Overall Study||19
6376774|NCT00761137|7287353|FG000|COMPLETED|Overall Study||19
6559396|NCT01781429|7482034|FG015|NOT COMPLETED|Overall Study||0
6559397|NCT01781468|7482070|FG000|STARTED|Overall Study||109
6376775|NCT00761137|7287353|FG000|NOT COMPLETED|Overall Study||0
6376776|NCT00761150|7287363|FG000|STARTED|Open-label Period||308
6376777|NCT00761150|7287364|FG001|STARTED|Open-label Period||0
6376778|NCT00761150|7287365|FG002|STARTED|Open-label Period||0
6376779|NCT00761150|7287363|FG000|COMPLETED|Open-label Period||238
6376780|NCT00761150|7287364|FG001|COMPLETED|Open-label Period||0
6376781|NCT00761150|7287365|FG002|COMPLETED|Open-label Period||0
6376782|NCT00761150|7287363|FG000|NOT COMPLETED|Open-label Period||70
6376783|NCT00761150|7287364|FG001|NOT COMPLETED|Open-label Period||0
6376784|NCT00761150|7287365|FG002|NOT COMPLETED|Open-label Period||0
6376785|NCT00761150|7287363|FG000|STARTED|Double-blind Period||0
6376786|NCT00761150|7287364|FG001|STARTED|Double-blind Period||120
6559398|NCT01781468|7482071|FG001|STARTED|Overall Study||110
6376787|NCT00761150|7287365|FG002|STARTED|Double-blind Period||118
6376788|NCT00761150|7287363|FG000|COMPLETED|Double-blind Period||0
6376789|NCT00761150|7287364|FG001|COMPLETED|Double-blind Period||106
6376790|NCT00761150|7287365|FG002|COMPLETED|Double-blind Period||89
6376791|NCT00761150|7287363|FG000|NOT COMPLETED|Double-blind Period||0
6376792|NCT00761150|7287364|FG001|NOT COMPLETED|Double-blind Period||14
6344707|NCT00589914|7252171|FG000|STARTED|Overall Study||606
6344708|NCT00589914|7252172|FG001|STARTED|Overall Study||608
6344709|NCT00589914|7252171|FG000|COMPLETED|Overall Study||456
6344710|NCT00589914|7252172|FG001|COMPLETED|Overall Study||471
6344711|NCT00589914|7252171|FG000|NOT COMPLETED|Overall Study||150
6344712|NCT00589914|7252172|FG001|NOT COMPLETED|Overall Study||137
6344713|NCT00589979|7252180|FG000|STARTED|Run-In Period||169
6344714|NCT00589979|7252181|FG001|STARTED|Run-In Period||0
6344715|NCT00589979|7252182|FG002|STARTED|Run-In Period||0
6344716|NCT00589979|7252180|FG000|COMPLETED|Run-In Period||93
6344717|NCT00589979|7252181|FG001|COMPLETED|Run-In Period||0
6344718|NCT00589979|7252182|FG002|COMPLETED|Run-In Period||0
6344719|NCT00589979|7252180|FG000|NOT COMPLETED|Run-In Period||76
6344720|NCT00589979|7252181|FG001|NOT COMPLETED|Run-In Period||0
6344721|NCT00589979|7252182|FG002|NOT COMPLETED|Run-In Period||0
6344722|NCT00589979|7252180|FG000|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
6344723|NCT00589979|7252181|FG001|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
6344724|NCT00589979|7252182|FG002|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
6344725|NCT00589979|7252180|FG000|COMPLETED|Double-Blind Treatment Period 1||0
6344726|NCT00589979|7252181|FG001|COMPLETED|Double-Blind Treatment Period 1||48
6344727|NCT00589979|7252182|FG002|COMPLETED|Double-Blind Treatment Period 1||41
6344728|NCT00589979|7252180|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||0
6344729|NCT00589979|7252181|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||2
6344730|NCT00589979|7252182|FG002|NOT COMPLETED|Double-Blind Treatment Period 1||2
6344731|NCT00589979|7252180|FG000|STARTED|Double-Blind Treatment Period 2||0
6344732|NCT00589979|7252181|FG001|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
6344733|NCT00589979|7252182|FG002|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
6344734|NCT00589979|7252180|FG000|COMPLETED|Double-Blind Treatment Period 2||0
6344735|NCT00589979|7252181|FG001|COMPLETED|Double-Blind Treatment Period 2||47
6344736|NCT00589979|7252182|FG002|COMPLETED|Double-Blind Treatment Period 2||39
6344737|NCT00589979|7252180|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||0
6344738|NCT00589979|7252181|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||1
6344739|NCT00589979|7252182|FG002|NOT COMPLETED|Double-Blind Treatment Period 2||2
6344740|NCT00589979|7252180|FG000|STARTED|Double-Blind Treatment Period 3||0
6344741|NCT00589979|7252181|FG001|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
6344742|NCT00589979|7252182|FG002|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
6344743|NCT00589979|7252180|FG000|COMPLETED|Double-Blind Treatment Period 3||0
6344744|NCT00589979|7252181|FG001|COMPLETED|Double-Blind Treatment Period 3||46
6344745|NCT00589979|7252182|FG002|COMPLETED|Double-Blind Treatment Period 3||38
6344746|NCT00589979|7252180|FG000|NOT COMPLETED|Double-Blind Treatment Period 3||0
6344747|NCT00589979|7252181|FG001|NOT COMPLETED|Double-Blind Treatment Period 3||1
6344748|NCT00589979|7252182|FG002|NOT COMPLETED|Double-Blind Treatment Period 3||1
6344749|NCT00590005|7252194|FG000|STARTED|Overall Study||106
6344750|NCT00590005|7252195|FG001|STARTED|Overall Study||119
6344751|NCT00590005|7252194|FG000|COMPLETED|Overall Study||106
6344752|NCT00590005|7252195|FG001|COMPLETED|Overall Study||119
6344753|NCT00590005|7252194|FG000|NOT COMPLETED|Overall Study||0
6344754|NCT00590005|7252195|FG001|NOT COMPLETED|Overall Study||0
6344755|NCT00590018|7252203|FG000|STARTED|Overall Study||9
6344756|NCT00590018|7252204|FG001|STARTED|Overall Study||9
6344757|NCT00590018|7252203|FG000|COMPLETED|Overall Study||9
6344758|NCT00590018|7252204|FG001|COMPLETED|Overall Study||9
6344759|NCT00590018|7252203|FG000|NOT COMPLETED|Overall Study||0
6344760|NCT00590018|7252204|FG001|NOT COMPLETED|Overall Study||0
6344761|NCT00590031|7252210|FG000|STARTED|Overall Study||61
6344762|NCT00590031|7252210|FG000|COMPLETED|Overall Study||55
6344763|NCT00590031|7252210|FG000|NOT COMPLETED|Overall Study||6
6344764|NCT00590044|7252216|FG000|STARTED|Overall Study||38
6344765|NCT00590044|7252217|FG001|STARTED|Overall Study||36
6344766|NCT00590044|7252216|FG000|COMPLETED|Overall Study||34
6344767|NCT00590044|7252217|FG001|COMPLETED|Overall Study||34
6344768|NCT00590044|7252216|FG000|NOT COMPLETED|Overall Study||4
6344769|NCT00590044|7252217|FG001|NOT COMPLETED|Overall Study||2
6344770|NCT00590161|7252228|FG000|STARTED|Overall Study||26
6344771|NCT00590161|7252229|FG001|STARTED|Overall Study||29
6344772|NCT00590161|7252228|FG000|COMPLETED|Overall Study||23
6344773|NCT00590161|7252229|FG001|COMPLETED|Overall Study||26
6344774|NCT00590161|7252228|FG000|NOT COMPLETED|Overall Study||3
6344775|NCT00590161|7252229|FG001|NOT COMPLETED|Overall Study||3
6344776|NCT00590226|7252237|FG000|STARTED|Overall Study||67
6344777|NCT00590226|7252238|FG001|STARTED|Overall Study||63
6344778|NCT00590226|7252237|FG000|COMPLETED|Overall Study||67
6344779|NCT00590226|7252238|FG001|COMPLETED|Overall Study||63
6344780|NCT00590226|7252237|FG000|NOT COMPLETED|Overall Study||0
6344781|NCT00590226|7252238|FG001|NOT COMPLETED|Overall Study||0
6344782|NCT00590317|7252246|FG000|STARTED|Overall Study||32
6344783|NCT00590317|7252247|FG001|STARTED|Overall Study||32
6344784|NCT00590317|7252246|FG000|COMPLETED|Overall Study||31
6344785|NCT00590317|7252247|FG001|COMPLETED|Overall Study||27
6344786|NCT00590317|7252246|FG000|NOT COMPLETED|Overall Study||1
6344787|NCT00590317|7252247|FG001|NOT COMPLETED|Overall Study||5
6344788|NCT00590369|7252256|FG000|STARTED|Overall Study||6
6344789|NCT00590369|7252257|FG001|STARTED|Overall Study||5
6344790|NCT00590369|7252256|FG000|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
6344791|NCT00590369|7252257|FG001|COMPLETED|Overall Study||5
6344792|NCT00590369|7252256|FG000|NOT COMPLETED|Overall Study||0
6344793|NCT00590369|7252257|FG001|NOT COMPLETED|Overall Study||0
6344794|NCT00590395|7252263|FG000|STARTED|Overall Study||19
6344795|NCT00590395|7252263|FG000|COMPLETED|Overall Study||19
6344796|NCT00590395|7252263|FG000|NOT COMPLETED|Overall Study||0
6344797|NCT00590460|7252267|FG000|STARTED|Overall Study||5
6344798|NCT00590460|7252267|FG000|COMPLETED|Overall Study||5
6344799|NCT00590460|7252267|FG000|NOT COMPLETED|Overall Study||0
6344800|NCT00590564|7252275|FG000|STARTED|Overall Study||42
6344801|NCT00590564|7252275|FG000|COMPLETED|Overall Study||24
6344802|NCT00590564|7252275|FG000|NOT COMPLETED|Overall Study||18
6344803|NCT00590577|7252283|FG000|STARTED|Overall Study||160
6344804|NCT00590577|7252284|FG001|STARTED|Overall Study||165
6344805|NCT00590577|7252285|FG002|STARTED|Overall Study||163
6344806|NCT00590577|7252286|FG003|STARTED|Overall Study||164
6344807|NCT00590577|7252283|FG000|COMPLETED|Overall Study||83
6344808|NCT00590577|7252284|FG001|COMPLETED|Overall Study||89
6344809|NCT00590577|7252285|FG002|COMPLETED|Overall Study||90
6344810|NCT00590577|7252286|FG003|COMPLETED|Overall Study||71
6344811|NCT00590577|7252283|FG000|NOT COMPLETED|Overall Study||77
6344812|NCT00590577|7252284|FG001|NOT COMPLETED|Overall Study||76
6344813|NCT00590577|7252285|FG002|NOT COMPLETED|Overall Study||73
6344814|NCT00590577|7252286|FG003|NOT COMPLETED|Overall Study||93
6344815|NCT00590590|7252299|FG000|STARTED|Overall Study||39
6344816|NCT00590590|7252300|FG001|STARTED|Overall Study||39
6344817|NCT00590590|7252301|FG002|STARTED|Overall Study||27
6344818|NCT00590590|7252299|FG000|COMPLETED|Overall Study||32
6344819|NCT00590590|7252300|FG001|COMPLETED|Overall Study||33
6344820|NCT00590590|7252301|FG002|COMPLETED|Overall Study||21
6344821|NCT00590590|7252299|FG000|NOT COMPLETED|Overall Study||7
6344822|NCT00590590|7252300|FG001|NOT COMPLETED|Overall Study||6
6344823|NCT00590590|7252301|FG002|NOT COMPLETED|Overall Study||6
6344824|NCT00590681|7252309|FG000|STARTED|Overall Study||62
6344825|NCT00590681|7252309|FG000|COMPLETED|Overall Study|The forty-two participants who did proceed to the post-RT phase|42
6344826|NCT00590681|7252309|FG000|NOT COMPLETED|Overall Study||20
6344827|NCT00590707|7252315|FG000|STARTED|Overall Study||100
6344828|NCT00590707|7252316|FG001|STARTED|Overall Study||100
6344829|NCT00590707|7252315|FG000|COMPLETED|Overall Study||100
6344830|NCT00590707|7252316|FG001|COMPLETED|Overall Study||100
6344831|NCT00590707|7252315|FG000|NOT COMPLETED|Overall Study||0
6344832|NCT00590707|7252316|FG001|NOT COMPLETED|Overall Study||0
6344833|NCT00590720|7252324|FG000|STARTED|Overall Study||4
6344834|NCT00590720|7252325|FG001|STARTED|Overall Study||7
6344835|NCT00590720|7252324|FG000|COMPLETED|Overall Study||3
6344836|NCT00590720|7252325|FG001|COMPLETED|Overall Study||6
6344837|NCT00590720|7252324|FG000|NOT COMPLETED|Overall Study||1
6344838|NCT00590720|7252325|FG001|NOT COMPLETED|Overall Study||1
6344839|NCT00590759|7252331|FG000|STARTED|Overall Study||150
6344840|NCT00590759|7252331|FG000|COMPLETED|Overall Study||70
6344841|NCT00590759|7252331|FG000|NOT COMPLETED|Overall Study||80
6344842|NCT00590772|7252335|FG000|STARTED|Overall Study||31
6344843|NCT00590772|7252335|FG000|COMPLETED|Overall Study||31
6344844|NCT00590772|7252335|FG000|NOT COMPLETED|Overall Study||0
6344845|NCT00590824|7252345|FG000|STARTED|Overall Study||11
6344846|NCT00590824|7252346|FG001|STARTED|Overall Study||9
6344847|NCT00590824|7252347|FG002|STARTED|Overall Study||2
6344848|NCT00590824|7252348|FG003|STARTED|Overall Study||1
6344849|NCT00590824|7252345|FG000|COMPLETED|Overall Study||11
6344850|NCT00590824|7252346|FG001|COMPLETED|Overall Study||7
6344851|NCT00590824|7252347|FG002|COMPLETED|Overall Study||1
6344852|NCT00590824|7252348|FG003|COMPLETED|Overall Study||0
6344853|NCT00590824|7252345|FG000|NOT COMPLETED|Overall Study||0
6344854|NCT00590824|7252346|FG001|NOT COMPLETED|Overall Study||2
6344855|NCT00590824|7252347|FG002|NOT COMPLETED|Overall Study||1
6344856|NCT00590824|7252348|FG003|NOT COMPLETED|Overall Study||1
6344857|NCT00590863|7252361|FG000|STARTED|Overall Study||221
6344858|NCT00590863|7252362|FG001|STARTED|Overall Study||220
6344859|NCT00590863|7252363|FG002|STARTED|Overall Study||224
6344860|NCT00590863|7252361|FG000|COMPLETED|Overall Study||137
6344861|NCT00590863|7252362|FG001|COMPLETED|Overall Study||138
6344862|NCT00590863|7252363|FG002|COMPLETED|Overall Study||146
6344863|NCT00590863|7252361|FG000|NOT COMPLETED|Overall Study||84
6344864|NCT00590863|7252362|FG001|NOT COMPLETED|Overall Study||82
6344865|NCT00590863|7252363|FG002|NOT COMPLETED|Overall Study||78
6344866|NCT00590889|7252374|FG000|STARTED|Overall Study||404
6344867|NCT00590889|7252375|FG001|STARTED|Overall Study||403
6344868|NCT00590889|7252374|FG000|COMPLETED|Overall Study||118
6344869|NCT00590889|7252375|FG001|COMPLETED|Overall Study||104
6344870|NCT00590889|7252374|FG000|NOT COMPLETED|Overall Study||286
6344871|NCT00590889|7252375|FG001|NOT COMPLETED|Overall Study||299
6344872|NCT00590902|7252381|FG000|STARTED|Overall Study||81
6344873|NCT00590902|7252381|FG000|COMPLETED|Overall Study||80
6344874|NCT00590902|7252381|FG000|NOT COMPLETED|Overall Study||1
6344875|NCT00590954|7252385|FG000|STARTED|Overall Study||32
6344876|NCT00590954|7252385|FG000|COMPLETED|Overall Study||30
6344877|NCT00590954|7252385|FG000|NOT COMPLETED|Overall Study||2
6344878|NCT00590967|7252393|FG000|STARTED|Overall Study||44
6344879|NCT00590967|7252394|FG001|STARTED|Overall Study||25
6344880|NCT00590967|7252393|FG000|COMPLETED|Overall Study||41
6344881|NCT00590967|7252394|FG001|COMPLETED|Overall Study||20
6344882|NCT00590967|7252393|FG000|NOT COMPLETED|Overall Study||3
6344883|NCT00590967|7252394|FG001|NOT COMPLETED|Overall Study||5
6344884|NCT00590980|7252400|FG000|STARTED|Overall Study||82
6344885|NCT00590980|7252400|FG000|COMPLETED|Overall Study||72
6344886|NCT00590980|7252400|FG000|NOT COMPLETED|Overall Study||10
6344887|NCT00591006|7252404|FG000|STARTED|Overall Study||1
6344888|NCT00591006|7252405|FG001|STARTED|Overall Study||0
6344889|NCT00591006|7252406|FG002|STARTED|Overall Study||1
6344890|NCT00591006|7252407|FG003|STARTED|Overall Study||1
6344891|NCT00591006|7252408|FG004|STARTED|Overall Study||1
6344892|NCT00591006|7252409|FG005|STARTED|Overall Study||0
6344893|NCT00591006|7252410|FG006|STARTED|Overall Study||1
6344894|NCT00591006|7252411|FG007|STARTED|Overall Study||0
6344895|NCT00591006|7252412|FG008|STARTED|Overall Study||1
6344896|NCT00591006|7252413|FG009|STARTED|Overall Study||1
6344897|NCT00591006|7252414|FG010|STARTED|Overall Study||0
6344898|NCT00591006|7252415|FG011|STARTED|Overall Study||1
6344899|NCT00591006|7252416|FG012|STARTED|Overall Study||1
6344900|NCT00591006|7252417|FG013|STARTED|Overall Study||2
6344901|NCT00591006|7252418|FG014|STARTED|Overall Study||0
6344902|NCT00591006|7252419|FG015|STARTED|Overall Study||1
6344903|NCT00591006|7252420|FG016|STARTED|Overall Study||0
6344904|NCT00591006|7252421|FG017|STARTED|Overall Study||1
6344905|NCT00591006|7252422|FG018|STARTED|Overall Study||0
6344906|NCT00591006|7252423|FG019|STARTED|Overall Study||1
6344907|NCT00591006|7252424|FG020|STARTED|Overall Study||0
6344908|NCT00591006|7252425|FG021|STARTED|Overall Study||1
6344909|NCT00591006|7252426|FG022|STARTED|Overall Study||1
6344910|NCT00591006|7252427|FG023|STARTED|Overall Study||1
6344911|NCT00591006|7252404|FG000|Treatment #2|Overall Study||1
6344912|NCT00591006|7252405|FG001|Treatment #2|Overall Study||0
6344913|NCT00591006|7252406|FG002|Treatment #2|Overall Study||1
6344914|NCT00591006|7252407|FG003|Treatment #2|Overall Study||1
6344915|NCT00591006|7252408|FG004|Treatment #2|Overall Study||1
6344916|NCT00591006|7252409|FG005|Treatment #2|Overall Study||0
6344917|NCT00591006|7252410|FG006|Treatment #2|Overall Study||1
6344918|NCT00591006|7252411|FG007|Treatment #2|Overall Study||0
6344919|NCT00591006|7252412|FG008|Treatment #2|Overall Study||1
6344920|NCT00591006|7252413|FG009|Treatment #2|Overall Study||1
6344921|NCT00591006|7252414|FG010|Treatment #2|Overall Study||0
6344922|NCT00591006|7252415|FG011|Treatment #2|Overall Study||1
6344923|NCT00591006|7252416|FG012|Treatment #2|Overall Study||1
6344924|NCT00591006|7252417|FG013|Treatment #2|Overall Study||2
6344925|NCT00591006|7252418|FG014|Treatment #2|Overall Study||0
6344926|NCT00591006|7252419|FG015|Treatment #2|Overall Study||0
6344927|NCT00591006|7252420|FG016|Treatment #2|Overall Study||0
6344928|NCT00591006|7252421|FG017|Treatment #2|Overall Study||1
6344929|NCT00591006|7252422|FG018|Treatment #2|Overall Study||0
6344930|NCT00591006|7252423|FG019|Treatment #2|Overall Study||1
6344931|NCT00591006|7252424|FG020|Treatment #2|Overall Study||0
6344932|NCT00591006|7252425|FG021|Treatment #2|Overall Study||1
6344933|NCT00591006|7252426|FG022|Treatment #2|Overall Study||1
6344934|NCT00591006|7252427|FG023|Treatment #2|Overall Study||1
6344935|NCT00591006|7252404|FG000|Treatment #3|Overall Study||1
6559399|NCT01781468|7482072|FG002|STARTED|Overall Study||109
6559400|NCT01781468|7482070|FG000|COMPLETED|Overall Study||103
6559401|NCT01781468|7482071|FG001|COMPLETED|Overall Study||97
6559402|NCT01781468|7482072|FG002|COMPLETED|Overall Study||97
6559403|NCT01781468|7482070|FG000|NOT COMPLETED|Overall Study||6
6559404|NCT01781468|7482071|FG001|NOT COMPLETED|Overall Study||13
6559405|NCT01781468|7482072|FG002|NOT COMPLETED|Overall Study||12
6344936|NCT00591006|7252405|FG001|Treatment #3|Overall Study||0
6344937|NCT00591006|7252406|FG002|Treatment #3|Overall Study||1
6344938|NCT00591006|7252407|FG003|Treatment #3|Overall Study||1
6344939|NCT00591006|7252408|FG004|Treatment #3|Overall Study||1
6344940|NCT00591006|7252409|FG005|Treatment #3|Overall Study||0
6344941|NCT00591006|7252410|FG006|Treatment #3|Overall Study||1
6344942|NCT00591006|7252411|FG007|Treatment #3|Overall Study||0
6344943|NCT00591006|7252412|FG008|Treatment #3|Overall Study||1
6344944|NCT00591006|7252413|FG009|Treatment #3|Overall Study||1
6344945|NCT00591006|7252414|FG010|Treatment #3|Overall Study||0
6344946|NCT00591006|7252415|FG011|Treatment #3|Overall Study||1
6344947|NCT00591006|7252416|FG012|Treatment #3|Overall Study||1
6344948|NCT00591006|7252417|FG013|Treatment #3|Overall Study||2
6344949|NCT00591006|7252418|FG014|Treatment #3|Overall Study||0
6344950|NCT00591006|7252419|FG015|Treatment #3|Overall Study||0
6344951|NCT00591006|7252420|FG016|Treatment #3|Overall Study||0
6344952|NCT00591006|7252421|FG017|Treatment #3|Overall Study||1
6344953|NCT00591006|7252422|FG018|Treatment #3|Overall Study||0
6344954|NCT00591006|7252423|FG019|Treatment #3|Overall Study||1
6344955|NCT00591006|7252424|FG020|Treatment #3|Overall Study||0
6344956|NCT00591006|7252425|FG021|Treatment #3|Overall Study||1
6344957|NCT00591006|7252426|FG022|Treatment #3|Overall Study||1
6344958|NCT00591006|7252427|FG023|Treatment #3|Overall Study||1
6344959|NCT00591006|7252404|FG000|Treatment #4|Overall Study||1
6559406|NCT01781481|7482081|FG000|STARTED|Overall Study||148
6559407|NCT01781481|7482081|FG000|COMPLETED|Overall Study||148
6559408|NCT01781481|7482081|FG000|NOT COMPLETED|Overall Study||0
6344960|NCT00591006|7252405|FG001|Treatment #4|Overall Study||0
6344961|NCT00591006|7252406|FG002|Treatment #4|Overall Study||1
6344962|NCT00591006|7252407|FG003|Treatment #4|Overall Study||1
6344963|NCT00591006|7252408|FG004|Treatment #4|Overall Study||1
6344964|NCT00591006|7252409|FG005|Treatment #4|Overall Study||0
6344965|NCT00591006|7252410|FG006|Treatment #4|Overall Study||1
6344966|NCT00591006|7252411|FG007|Treatment #4|Overall Study||0
6344967|NCT00591006|7252412|FG008|Treatment #4|Overall Study||1
6344968|NCT00591006|7252413|FG009|Treatment #4|Overall Study||1
6344969|NCT00591006|7252414|FG010|Treatment #4|Overall Study||0
6344970|NCT00591006|7252415|FG011|Treatment #4|Overall Study||1
6344971|NCT00591006|7252416|FG012|Treatment #4|Overall Study||1
6344972|NCT00591006|7252417|FG013|Treatment #4|Overall Study||2
6344973|NCT00591006|7252418|FG014|Treatment #4|Overall Study||0
6344974|NCT00591006|7252419|FG015|Treatment #4|Overall Study||0
6344975|NCT00591006|7252420|FG016|Treatment #4|Overall Study||0
6344976|NCT00591006|7252421|FG017|Treatment #4|Overall Study||1
6344977|NCT00591006|7252422|FG018|Treatment #4|Overall Study||0
6344978|NCT00591006|7252423|FG019|Treatment #4|Overall Study||1
6344979|NCT00591006|7252424|FG020|Treatment #4|Overall Study||0
6344980|NCT00591006|7252425|FG021|Treatment #4|Overall Study||1
6344981|NCT00591006|7252426|FG022|Treatment #4|Overall Study||0
6344982|NCT00591006|7252427|FG023|Treatment #4|Overall Study||0
6344983|NCT00591006|7252404|FG000|COMPLETED|Overall Study||1
6344984|NCT00591006|7252405|FG001|COMPLETED|Overall Study||0
6344985|NCT00591006|7252406|FG002|COMPLETED|Overall Study||1
6344986|NCT00591006|7252407|FG003|COMPLETED|Overall Study||1
6344987|NCT00591006|7252408|FG004|COMPLETED|Overall Study||1
6344988|NCT00591006|7252409|FG005|COMPLETED|Overall Study||0
6344989|NCT00591006|7252410|FG006|COMPLETED|Overall Study||1
6344990|NCT00591006|7252411|FG007|COMPLETED|Overall Study||0
6344991|NCT00591006|7252412|FG008|COMPLETED|Overall Study||1
6344992|NCT00591006|7252413|FG009|COMPLETED|Overall Study||1
6344993|NCT00591006|7252414|FG010|COMPLETED|Overall Study||0
6344994|NCT00591006|7252415|FG011|COMPLETED|Overall Study||1
6344995|NCT00591006|7252416|FG012|COMPLETED|Overall Study||1
6344996|NCT00591006|7252417|FG013|COMPLETED|Overall Study||2
6344997|NCT00591006|7252418|FG014|COMPLETED|Overall Study||0
6344998|NCT00591006|7252419|FG015|COMPLETED|Overall Study||0
6344999|NCT00591006|7252420|FG016|COMPLETED|Overall Study||0
6345000|NCT00591006|7252421|FG017|COMPLETED|Overall Study||1
6345001|NCT00591006|7252422|FG018|COMPLETED|Overall Study||0
6345002|NCT00591006|7252423|FG019|COMPLETED|Overall Study||1
6345003|NCT00591006|7252424|FG020|COMPLETED|Overall Study||0
6345004|NCT00591006|7252425|FG021|COMPLETED|Overall Study||1
6345005|NCT00591006|7252426|FG022|COMPLETED|Overall Study||0
6345006|NCT00591006|7252427|FG023|COMPLETED|Overall Study||0
6345007|NCT00591006|7252404|FG000|NOT COMPLETED|Overall Study||0
6345008|NCT00591006|7252405|FG001|NOT COMPLETED|Overall Study||0
6345009|NCT00591006|7252406|FG002|NOT COMPLETED|Overall Study||0
6345010|NCT00591006|7252407|FG003|NOT COMPLETED|Overall Study||0
6345011|NCT00591006|7252408|FG004|NOT COMPLETED|Overall Study||0
6345012|NCT00591006|7252409|FG005|NOT COMPLETED|Overall Study||0
6345013|NCT00591006|7252410|FG006|NOT COMPLETED|Overall Study||0
6345014|NCT00591006|7252411|FG007|NOT COMPLETED|Overall Study||0
6345015|NCT00591006|7252412|FG008|NOT COMPLETED|Overall Study||0
6345016|NCT00591006|7252413|FG009|NOT COMPLETED|Overall Study||0
6345017|NCT00591006|7252414|FG010|NOT COMPLETED|Overall Study||0
6345018|NCT00591006|7252415|FG011|NOT COMPLETED|Overall Study||0
6345019|NCT00591006|7252416|FG012|NOT COMPLETED|Overall Study||0
6345020|NCT00591006|7252417|FG013|NOT COMPLETED|Overall Study||0
6345021|NCT00591006|7252418|FG014|NOT COMPLETED|Overall Study||0
6345022|NCT00591006|7252419|FG015|NOT COMPLETED|Overall Study||1
6345023|NCT00591006|7252420|FG016|NOT COMPLETED|Overall Study||0
6345024|NCT00591006|7252421|FG017|NOT COMPLETED|Overall Study||0
6345025|NCT00591006|7252422|FG018|NOT COMPLETED|Overall Study||0
6345026|NCT00591006|7252423|FG019|NOT COMPLETED|Overall Study||0
6345027|NCT00591006|7252424|FG020|NOT COMPLETED|Overall Study||0
6345028|NCT00591006|7252425|FG021|NOT COMPLETED|Overall Study||0
6345029|NCT00591006|7252426|FG022|NOT COMPLETED|Overall Study||1
6345030|NCT00591006|7252427|FG023|NOT COMPLETED|Overall Study||1
6345031|NCT00591019|7252444|FG000|STARTED|Baseline (1 Day)||3
6345032|NCT00591019|7252445|FG001|STARTED|Baseline (1 Day)||4
6345033|NCT00591019|7252444|FG000|COMPLETED|Baseline (1 Day)||3
6345034|NCT00591019|7252445|FG001|COMPLETED|Baseline (1 Day)||4
6345035|NCT00591019|7252444|FG000|NOT COMPLETED|Baseline (1 Day)||0
6345036|NCT00591019|7252445|FG001|NOT COMPLETED|Baseline (1 Day)||0
6345037|NCT00591019|7252444|FG000|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
6345038|NCT00591019|7252445|FG001|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
6345039|NCT00591019|7252444|FG000|COMPLETED|Intervention 1 (14 Days)||2
6345040|NCT00591019|7252445|FG001|COMPLETED|Intervention 1 (14 Days)||3
6345041|NCT00591019|7252444|FG000|NOT COMPLETED|Intervention 1 (14 Days)||0
6345042|NCT00591019|7252445|FG001|NOT COMPLETED|Intervention 1 (14 Days)||0
6345043|NCT00591019|7252444|FG000|STARTED|Intevention 2 (14 Days)||2
6345044|NCT00591019|7252445|FG001|STARTED|Intevention 2 (14 Days)||3
6345045|NCT00591019|7252444|FG000|COMPLETED|Intevention 2 (14 Days)||2
6345046|NCT00591019|7252445|FG001|COMPLETED|Intevention 2 (14 Days)||3
6345047|NCT00591019|7252444|FG000|NOT COMPLETED|Intevention 2 (14 Days)||0
6345048|NCT00591019|7252445|FG001|NOT COMPLETED|Intevention 2 (14 Days)||0
6345049|NCT00591123|7252453|FG000|STARTED|Overall Study||38
6345050|NCT00591123|7252453|FG000|COMPLETED|Overall Study|38 were analyzed for safety, 33 were included for efficacy.|38
6345051|NCT00591123|7252453|FG000|NOT COMPLETED|Overall Study||0
6345052|NCT00591149|7252457|FG000|STARTED|Overall Study||16
6345053|NCT00591149|7252457|FG000|COMPLETED|Overall Study||11
6345054|NCT00591149|7252457|FG000|NOT COMPLETED|Overall Study||5
6345055|NCT00591214|7252461|FG000|STARTED|Overall Study||10
6345056|NCT00591214|7252461|FG000|COMPLETED|Overall Study||2
6345057|NCT00591214|7252461|FG000|NOT COMPLETED|Overall Study||8
6345058|NCT00591240|7252467|FG000|STARTED|Overall Study||116
6345059|NCT00591240|7252468|FG001|STARTED|Overall Study||222
6345060|NCT00591240|7252467|FG000|COMPLETED|Overall Study||116
6345061|NCT00591240|7252468|FG001|COMPLETED|Overall Study||222
6345062|NCT00591240|7252467|FG000|NOT COMPLETED|Overall Study||0
6345063|NCT00591240|7252468|FG001|NOT COMPLETED|Overall Study||0
6345064|NCT00591253|7252477|FG000|STARTED|Overall Study|Randomized or Treated|140
6345065|NCT00591253|7252478|FG001|STARTED|Overall Study|Randomized or Treated|137
6345066|NCT00591253|7252479|FG002|STARTED|Overall Study|Randomized or Treated|138
6345067|NCT00591253|7252477|FG000|COMPLETED|Overall Study||126
6345068|NCT00591253|7252478|FG001|COMPLETED|Overall Study||116
6345069|NCT00591253|7252479|FG002|COMPLETED|Overall Study||123
6345070|NCT00591253|7252477|FG000|NOT COMPLETED|Overall Study||14
6345071|NCT00591253|7252478|FG001|NOT COMPLETED|Overall Study||21
6345072|NCT00591253|7252479|FG002|NOT COMPLETED|Overall Study||15
6345073|NCT00591266|7252490|FG000|STARTED|Overall Study|Randomized only|189
6345074|NCT00591266|7252491|FG001|STARTED|Overall Study|Randomized only|188
6345075|NCT00591266|7252492|FG002|STARTED|Overall Study|Randomized only|189
6345076|NCT00591266|7252490|FG000|COMPLETED|Overall Study||180
6345077|NCT00591266|7252491|FG001|COMPLETED|Overall Study||177
6345078|NCT00591266|7252492|FG002|COMPLETED|Overall Study||175
6345079|NCT00591266|7252490|FG000|NOT COMPLETED|Overall Study||9
6345080|NCT00591266|7252491|FG001|NOT COMPLETED|Overall Study||11
6345081|NCT00591266|7252492|FG002|NOT COMPLETED|Overall Study||14
6345082|NCT00591305|7252502|FG000|STARTED|Overall Study||1
6345083|NCT00591305|7252503|FG001|STARTED|Overall Study||0
6345084|NCT00591305|7252502|FG000|1st Follow-up in 2 Wks After Surgery|Overall Study||1
6345085|NCT00591305|7252503|FG001|1st Follow-up in 2 Wks After Surgery|Overall Study||0
6345086|NCT00591305|7252502|FG000|COMPLETED|Overall Study||1
6345087|NCT00591305|7252503|FG001|COMPLETED|Overall Study||0
6345088|NCT00591305|7252502|FG000|NOT COMPLETED|Overall Study||0
6345089|NCT00591305|7252503|FG001|NOT COMPLETED|Overall Study||0
6345090|NCT00591344|7252512|FG000|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
6345091|NCT00591344|7252513|FG001|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
6345092|NCT00591344|7252512|FG000|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
6345093|NCT00591344|7252513|FG001|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
6345094|NCT00591344|7252512|FG000|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
6345095|NCT00591344|7252513|FG001|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
6345096|NCT00591344|7252512|FG000|NOT COMPLETED|Overall Study||5
6345097|NCT00591344|7252513|FG001|NOT COMPLETED|Overall Study||8
6345098|NCT00591370|7252523|FG000|STARTED|Overall Study||51
6345099|NCT00591370|7252523|FG000|COMPLETED|Overall Study||49
6345100|NCT00591370|7252523|FG000|NOT COMPLETED|Overall Study||2
6345101|NCT00591409|7252537|FG000|STARTED|Overall Study||10
6345102|NCT00591409|7252538|FG001|STARTED|Overall Study||10
6345103|NCT00591409|7252539|FG002|STARTED|Overall Study||10
6345104|NCT00591409|7252540|FG003|STARTED|Overall Study||10
6345105|NCT00591409|7252541|FG004|STARTED|Overall Study||10
6345106|NCT00591409|7252542|FG005|STARTED|Overall Study||10
6345107|NCT00591409|7252543|FG006|STARTED|Overall Study||10
6345108|NCT00591409|7252544|FG007|STARTED|Overall Study||10
6345109|NCT00591409|7252545|FG008|STARTED|Overall Study||9
6345110|NCT00591409|7252546|FG009|STARTED|Overall Study||11
6345111|NCT00591409|7252537|FG000|Treated|Overall Study||10
6345112|NCT00591409|7252538|FG001|Treated|Overall Study||10
6345113|NCT00591409|7252539|FG002|Treated|Overall Study||10
6345114|NCT00591409|7252540|FG003|Treated|Overall Study||10
6345115|NCT00591409|7252541|FG004|Treated|Overall Study||9
6345116|NCT00591409|7252542|FG005|Treated|Overall Study||10
6345117|NCT00591409|7252543|FG006|Treated|Overall Study||10
6345118|NCT00591409|7252544|FG007|Treated|Overall Study||10
6345119|NCT00591409|7252545|FG008|Treated|Overall Study||9
6345120|NCT00591409|7252546|FG009|Treated|Overall Study||10
6345121|NCT00591409|7252537|FG000|COMPLETED|Overall Study||10
6345122|NCT00591409|7252538|FG001|COMPLETED|Overall Study||10
6345123|NCT00591409|7252539|FG002|COMPLETED|Overall Study||10
6345124|NCT00591409|7252540|FG003|COMPLETED|Overall Study||10
6345125|NCT00591409|7252541|FG004|COMPLETED|Overall Study||9
6345126|NCT00591409|7252542|FG005|COMPLETED|Overall Study||10
6345127|NCT00591409|7252543|FG006|COMPLETED|Overall Study||10
6345128|NCT00591409|7252544|FG007|COMPLETED|Overall Study||10
6345129|NCT00591409|7252545|FG008|COMPLETED|Overall Study||9
6345130|NCT00591409|7252546|FG009|COMPLETED|Overall Study||10
6345131|NCT00591409|7252537|FG000|NOT COMPLETED|Overall Study||0
6345132|NCT00591409|7252538|FG001|NOT COMPLETED|Overall Study||0
6345133|NCT00591409|7252539|FG002|NOT COMPLETED|Overall Study||0
6345134|NCT00591409|7252540|FG003|NOT COMPLETED|Overall Study||0
6345135|NCT00591409|7252541|FG004|NOT COMPLETED|Overall Study||1
6345136|NCT00591409|7252542|FG005|NOT COMPLETED|Overall Study||0
6345137|NCT00591409|7252543|FG006|NOT COMPLETED|Overall Study||0
6345138|NCT00591409|7252544|FG007|NOT COMPLETED|Overall Study||0
6559409|NCT01781572|7482137|FG000|STARTED|MEK162 45mg BID+LEE011 200mg||16
6559410|NCT01781572|7482138|FG001|STARTED|MEK162 45mg BID+LEE011 200mg||6
6559411|NCT01781572|7482139|FG002|STARTED|MEK162 45mg BID+LEE011 200mg||41
6559412|NCT01781572|7482137|FG000|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
6559413|NCT01781572|7482138|FG001|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
6559414|NCT01781572|7482139|FG002|COMPLETED|MEK162 45mg BID+LEE011 200mg||0
6345139|NCT00591409|7252545|FG008|NOT COMPLETED|Overall Study||0
6345140|NCT00591409|7252546|FG009|NOT COMPLETED|Overall Study||1
6345141|NCT00591565|7252568|FG000|STARTED|Overall Study||13
6345142|NCT00591565|7252568|FG000|COMPLETED|Overall Study||8
6345143|NCT00591565|7252568|FG000|NOT COMPLETED|Overall Study||5
6345144|NCT00591578|7252575|FG000|STARTED|Double-Blind Treatment Phase||327
6345145|NCT00591578|7252576|FG001|STARTED|Double-Blind Treatment Phase||329
6345146|NCT00591578|7252577|FG002|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
6345147|NCT00591578|7252575|FG000|COMPLETED|Double-Blind Treatment Phase||249
6345148|NCT00591578|7252576|FG001|COMPLETED|Double-Blind Treatment Phase||249
6345149|NCT00591578|7252577|FG002|COMPLETED|Double-Blind Treatment Phase||244
6345150|NCT00591578|7252575|FG000|NOT COMPLETED|Double-Blind Treatment Phase||78
6345151|NCT00591578|7252576|FG001|NOT COMPLETED|Double-Blind Treatment Phase||80
6345152|NCT00591578|7252577|FG002|NOT COMPLETED|Double-Blind Treatment Phase||84
6345153|NCT00591578|7252575|FG000|STARTED|Open-Label Extension Phase||55
6345154|NCT00591578|7252576|FG001|STARTED|Open-Label Extension Phase||115
6345155|NCT00591578|7252577|FG002|STARTED|Open-Label Extension Phase||0
6345156|NCT00591578|7252575|FG000|COMPLETED|Open-Label Extension Phase||49
6345157|NCT00591578|7252576|FG001|COMPLETED|Open-Label Extension Phase||105
6345158|NCT00591578|7252577|FG002|COMPLETED|Open-Label Extension Phase||0
6345159|NCT00591578|7252575|FG000|NOT COMPLETED|Open-Label Extension Phase||6
6345160|NCT00591578|7252576|FG001|NOT COMPLETED|Open-Label Extension Phase||10
6345161|NCT00591578|7252577|FG002|NOT COMPLETED|Open-Label Extension Phase||0
6345162|NCT00591591|7252588|FG000|STARTED|Overall Study||176
6345163|NCT00591591|7252589|FG001|STARTED|Overall Study||133
6345164|NCT00591591|7252588|FG000|COMPLETED|Overall Study||165
6345165|NCT00591591|7252589|FG001|COMPLETED|Overall Study||94
6345166|NCT00591591|7252588|FG000|NOT COMPLETED|Overall Study||11
6345167|NCT00591591|7252589|FG001|NOT COMPLETED|Overall Study||39
6345168|NCT00591630|7252599|FG000|STARTED|Overall Study||6
6345169|NCT00591630|7252600|FG001|STARTED|Overall Study||8
6345170|NCT00591630|7252601|FG002|STARTED|Overall Study||10
6345171|NCT00591630|7252602|FG003|STARTED|Overall Study||6
6345172|NCT00591630|7252599|FG000|COMPLETED|Overall Study||6
6345173|NCT00591630|7252600|FG001|COMPLETED|Overall Study||8
6345174|NCT00591630|7252601|FG002|COMPLETED|Overall Study||9
6345175|NCT00591630|7252602|FG003|COMPLETED|Overall Study||6
6345176|NCT00591630|7252599|FG000|NOT COMPLETED|Overall Study||0
6345177|NCT00591630|7252600|FG001|NOT COMPLETED|Overall Study||0
6345178|NCT00591630|7252601|FG002|NOT COMPLETED|Overall Study||1
6345179|NCT00591630|7252602|FG003|NOT COMPLETED|Overall Study||0
6345180|NCT00591721|7252614|FG000|STARTED|Overall Study||89
6345181|NCT00591721|7252615|FG001|STARTED|Overall Study||92
6345182|NCT00591721|7252614|FG000|COMPLETED|Overall Study||68
6345183|NCT00591721|7252615|FG001|COMPLETED|Overall Study||70
6559415|NCT01781572|7482137|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||16
6345184|NCT00591721|7252614|FG000|NOT COMPLETED|Overall Study||21
6345185|NCT00591721|7252615|FG001|NOT COMPLETED|Overall Study||22
6345186|NCT00591734|7252621|FG000|STARTED|Overall Study||57
6345187|NCT00591734|7252621|FG000|COMPLETED|Overall Study||4
6345188|NCT00591734|7252621|FG000|NOT COMPLETED|Overall Study||53
6345189|NCT00591760|7252627|FG000|STARTED|Overall Study||28
6345190|NCT00591760|7252628|FG001|STARTED|Overall Study||28
6345191|NCT00591760|7252627|FG000|COMPLETED|Overall Study||28
6345192|NCT00591760|7252628|FG001|COMPLETED|Overall Study||28
6345193|NCT00591760|7252627|FG000|NOT COMPLETED|Overall Study||0
6345194|NCT00591760|7252628|FG001|NOT COMPLETED|Overall Study||0
6345195|NCT00591773|7252637|FG000|STARTED|Overall Study||185
6345196|NCT00591773|7252638|FG001|STARTED|Overall Study||182
6345197|NCT00591773|7252639|FG002|STARTED|Overall Study||184
6345198|NCT00591773|7252637|FG000|COMPLETED|Overall Study||169
6345199|NCT00591773|7252638|FG001|COMPLETED|Overall Study||158
6345200|NCT00591773|7252639|FG002|COMPLETED|Overall Study||168
6345201|NCT00591773|7252637|FG000|NOT COMPLETED|Overall Study||16
6345202|NCT00591773|7252638|FG001|NOT COMPLETED|Overall Study||24
6345203|NCT00591773|7252639|FG002|NOT COMPLETED|Overall Study||16
6345204|NCT00591786|7252657|FG000|STARTED|Overall Study||9
6345205|NCT00591786|7252658|FG001|STARTED|Overall Study||9
6345206|NCT00591786|7252659|FG002|STARTED|Overall Study||11
6345207|NCT00591786|7252660|FG003|STARTED|Overall Study||11
6345208|NCT00591786|7252661|FG004|STARTED|Overall Study||10
6345209|NCT00591786|7252662|FG005|STARTED|Overall Study||10
6345210|NCT00591786|7252663|FG006|STARTED|Overall Study||10
6345211|NCT00591786|7252664|FG007|STARTED|Overall Study||10
6345212|NCT00591786|7252665|FG008|STARTED|Overall Study||10
6345213|NCT00591786|7252666|FG009|STARTED|Overall Study||10
6345214|NCT00591786|7252657|FG000|Treated Participants|Overall Study||9
6559416|NCT01781572|7482138|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||6
6345215|NCT00591786|7252658|FG001|Treated Participants|Overall Study||9
6345216|NCT00591786|7252659|FG002|Treated Participants|Overall Study||10
6345217|NCT00591786|7252660|FG003|Treated Participants|Overall Study||11
6345218|NCT00591786|7252661|FG004|Treated Participants|Overall Study||10
6345219|NCT00591786|7252662|FG005|Treated Participants|Overall Study||10
6345220|NCT00591786|7252663|FG006|Treated Participants|Overall Study||10
6345221|NCT00591786|7252664|FG007|Treated Participants|Overall Study||10
6345222|NCT00591786|7252665|FG008|Treated Participants|Overall Study||10
6345223|NCT00591786|7252666|FG009|Treated Participants|Overall Study||10
6345224|NCT00591786|7252657|FG000|COMPLETED|Overall Study||9
6345225|NCT00591786|7252658|FG001|COMPLETED|Overall Study||9
6345226|NCT00591786|7252659|FG002|COMPLETED|Overall Study||10
6345227|NCT00591786|7252660|FG003|COMPLETED|Overall Study||11
6345228|NCT00591786|7252661|FG004|COMPLETED|Overall Study||10
6345229|NCT00591786|7252662|FG005|COMPLETED|Overall Study||10
6345230|NCT00591786|7252663|FG006|COMPLETED|Overall Study||10
6345231|NCT00591786|7252664|FG007|COMPLETED|Overall Study||10
6345232|NCT00591786|7252665|FG008|COMPLETED|Overall Study||10
6345233|NCT00591786|7252666|FG009|COMPLETED|Overall Study||10
6345234|NCT00591786|7252657|FG000|NOT COMPLETED|Overall Study||0
6345235|NCT00591786|7252658|FG001|NOT COMPLETED|Overall Study||0
6345236|NCT00591786|7252659|FG002|NOT COMPLETED|Overall Study||1
6345237|NCT00591786|7252660|FG003|NOT COMPLETED|Overall Study||0
6345238|NCT00591786|7252661|FG004|NOT COMPLETED|Overall Study||0
6559417|NCT01781572|7482139|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 200mg||41
6559418|NCT01781572|7482137|FG000|STARTED|MEK162 45mg BID+LEE011 250mg||3
6559419|NCT01781572|7482138|FG001|STARTED|MEK162 45mg BID+LEE011 250mg||0
6559420|NCT01781572|7482139|FG002|STARTED|MEK162 45mg BID+LEE011 250mg||0
6559421|NCT01781572|7482137|FG000|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6559422|NCT01781572|7482138|FG001|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6345239|NCT00591786|7252662|FG005|NOT COMPLETED|Overall Study||0
6345240|NCT00591786|7252663|FG006|NOT COMPLETED|Overall Study||0
6345241|NCT00591786|7252664|FG007|NOT COMPLETED|Overall Study||0
6345242|NCT00591786|7252665|FG008|NOT COMPLETED|Overall Study||0
6345243|NCT00591786|7252666|FG009|NOT COMPLETED|Overall Study||0
6345244|NCT00591825|7252692|FG000|STARTED|Overall Study||14
6345245|NCT00591825|7252693|FG001|STARTED|Overall Study||13
6345246|NCT00591825|7252694|FG002|STARTED|Overall Study||13
6345247|NCT00591825|7252695|FG003|STARTED|Overall Study||14
6345248|NCT00591825|7252692|FG000|COMPLETED|Overall Study||14
6345249|NCT00591825|7252693|FG001|COMPLETED|Overall Study||13
6345250|NCT00591825|7252694|FG002|COMPLETED|Overall Study||13
6345251|NCT00591825|7252695|FG003|COMPLETED|Overall Study||14
6345252|NCT00591825|7252692|FG000|NOT COMPLETED|Overall Study||0
6345253|NCT00591825|7252693|FG001|NOT COMPLETED|Overall Study||0
6345254|NCT00591825|7252694|FG002|NOT COMPLETED|Overall Study||0
6345255|NCT00591825|7252695|FG003|NOT COMPLETED|Overall Study||0
6345256|NCT00591838|7252720|FG000|STARTED|Overall Study||5
6345257|NCT00591838|7252721|FG001|STARTED|Overall Study||6
6345258|NCT00591838|7252722|FG002|STARTED|Overall Study||6
6345259|NCT00591838|7252723|FG003|STARTED|Overall Study||6
6345260|NCT00591838|7252724|FG004|STARTED|Overall Study||51
6345261|NCT00591838|7252720|FG000|COMPLETED|Overall Study||5
6345262|NCT00591838|7252721|FG001|COMPLETED|Overall Study||6
6345263|NCT00591838|7252722|FG002|COMPLETED|Overall Study||6
6345264|NCT00591838|7252723|FG003|COMPLETED|Overall Study||5
6345265|NCT00591838|7252724|FG004|COMPLETED|Overall Study||51
6345266|NCT00591838|7252720|FG000|NOT COMPLETED|Overall Study||0
6345267|NCT00591838|7252721|FG001|NOT COMPLETED|Overall Study||0
6345268|NCT00591838|7252722|FG002|NOT COMPLETED|Overall Study||0
6345269|NCT00591838|7252723|FG003|NOT COMPLETED|Overall Study||1
6345270|NCT00591838|7252724|FG004|NOT COMPLETED|Overall Study||0
6345271|NCT00591851|7252737|FG000|STARTED|Overall Study||70
6345272|NCT00591851|7252737|FG000|COMPLETED|Overall Study||64
6345273|NCT00591851|7252737|FG000|NOT COMPLETED|Overall Study||6
6345274|NCT00591864|7252741|FG000|STARTED|Overall Study||89
6345275|NCT00591864|7252741|FG000|COMPLETED|Overall Study||84
6345276|NCT00591864|7252741|FG000|NOT COMPLETED|Overall Study||5
6345277|NCT00591942|7252746|FG000|STARTED|Overall Study||36
6345278|NCT00591942|7252747|FG001|STARTED|Overall Study||36
6345279|NCT00591942|7252746|FG000|COMPLETED|Overall Study||36
6345280|NCT00591942|7252747|FG001|COMPLETED|Overall Study||36
6345281|NCT00591942|7252746|FG000|NOT COMPLETED|Overall Study||0
6345282|NCT00591942|7252747|FG001|NOT COMPLETED|Overall Study||0
6345283|NCT00592072|7252753|FG000|STARTED|First Sequence||6
6345284|NCT00592072|7252754|FG001|STARTED|First Sequence||6
6345285|NCT00592072|7252753|FG000|COMPLETED|First Sequence||6
6345286|NCT00592072|7252754|FG001|COMPLETED|First Sequence||6
6345287|NCT00592072|7252753|FG000|NOT COMPLETED|First Sequence||0
6345288|NCT00592072|7252754|FG001|NOT COMPLETED|First Sequence||0
6345289|NCT00592072|7252753|FG000|STARTED|Wash Out Period||6
6345290|NCT00592072|7252754|FG001|STARTED|Wash Out Period||6
6345291|NCT00592072|7252753|FG000|COMPLETED|Wash Out Period||5
6345292|NCT00592072|7252754|FG001|COMPLETED|Wash Out Period||5
6345293|NCT00592072|7252753|FG000|NOT COMPLETED|Wash Out Period||1
6345294|NCT00592072|7252754|FG001|NOT COMPLETED|Wash Out Period||1
6345295|NCT00592072|7252753|FG000|STARTED|Second Sequence||5
6345296|NCT00592072|7252754|FG001|STARTED|Second Sequence||5
6345297|NCT00592072|7252753|FG000|COMPLETED|Second Sequence||5
6559423|NCT01781572|7482139|FG002|COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6559424|NCT01781572|7482137|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||3
6345298|NCT00592072|7252754|FG001|COMPLETED|Second Sequence||5
6345299|NCT00592072|7252753|FG000|NOT COMPLETED|Second Sequence||0
6345300|NCT00592072|7252754|FG001|NOT COMPLETED|Second Sequence||0
6345301|NCT00592124|7252766|FG000|STARTED|Overall Study||28
6345302|NCT00592124|7252767|FG001|STARTED|Overall Study||29
6345303|NCT00592124|7252768|FG002|STARTED|Overall Study||30
6345304|NCT00592124|7252769|FG003|STARTED|Overall Study||27
6345305|NCT00592124|7252770|FG004|STARTED|Overall Study||27
6345306|NCT00592124|7252771|FG005|STARTED|Overall Study||27
6345307|NCT00592124|7252766|FG000|COMPLETED|Overall Study||24
6345308|NCT00592124|7252767|FG001|COMPLETED|Overall Study||24
6345309|NCT00592124|7252768|FG002|COMPLETED|Overall Study||24
6345310|NCT00592124|7252769|FG003|COMPLETED|Overall Study||24
6345311|NCT00592124|7252770|FG004|COMPLETED|Overall Study||24
6345312|NCT00592124|7252771|FG005|COMPLETED|Overall Study||24
6345313|NCT00592124|7252766|FG000|NOT COMPLETED|Overall Study||4
6345314|NCT00592124|7252767|FG001|NOT COMPLETED|Overall Study||5
6345315|NCT00592124|7252768|FG002|NOT COMPLETED|Overall Study||6
6345316|NCT00592124|7252769|FG003|NOT COMPLETED|Overall Study||3
6345317|NCT00592124|7252770|FG004|NOT COMPLETED|Overall Study||3
6345318|NCT00592124|7252771|FG005|NOT COMPLETED|Overall Study||3
6345319|NCT00592176|7252781|FG000|STARTED|Overall Study||5
6345320|NCT00592176|7252781|FG000|COMPLETED|Overall Study||5
6345321|NCT00592176|7252781|FG000|NOT COMPLETED|Overall Study||0
6345322|NCT00592319|7252787|FG000|STARTED|Overall Study||2
6345323|NCT00592319|7252788|FG001|STARTED|Overall Study||8
6345324|NCT00592319|7252787|FG000|COMPLETED|Overall Study||2
6345325|NCT00592319|7252788|FG001|COMPLETED|Overall Study||5
6345326|NCT00592319|7252787|FG000|NOT COMPLETED|Overall Study||0
6345327|NCT00592319|7252788|FG001|NOT COMPLETED|Overall Study||3
6345328|NCT00592358|7252796|FG000|STARTED|Overall Study||17
6345329|NCT00592358|7252796|FG000|COMPLETED|Overall Study||11
6345330|NCT00592358|7252796|FG000|NOT COMPLETED|Overall Study||6
6345331|NCT00592384|7252802|FG000|STARTED|Overall Study||64
6345332|NCT00592384|7252803|FG001|STARTED|Overall Study||69
6345333|NCT00592384|7252802|FG000|COMPLETED|Overall Study||59
6345334|NCT00592384|7252803|FG001|COMPLETED|Overall Study||63
6345335|NCT00592384|7252802|FG000|NOT COMPLETED|Overall Study||5
6345336|NCT00592384|7252803|FG001|NOT COMPLETED|Overall Study||6
6345337|NCT00592475|7252812|FG000|STARTED|Overall Study||6
6345338|NCT00592475|7252813|FG001|STARTED|Overall Study||9
6345339|NCT00592475|7252814|FG002|STARTED|Overall Study||5
6345340|NCT00592475|7252812|FG000|COMPLETED|Overall Study||6
6345341|NCT00592475|7252813|FG001|COMPLETED|Overall Study||9
6345342|NCT00592475|7252814|FG002|COMPLETED|Overall Study||5
6345343|NCT00592475|7252812|FG000|NOT COMPLETED|Overall Study||0
6345344|NCT00592475|7252813|FG001|NOT COMPLETED|Overall Study||0
6559425|NCT01781572|7482138|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6559426|NCT01781572|7482139|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 250mg||0
6559427|NCT01781572|7482137|FG000|STARTED|MEK162 30mg BID+LEE011 300mg||4
6345345|NCT00592475|7252814|FG002|NOT COMPLETED|Overall Study||0
6345346|NCT00592488|7252824|FG000|STARTED|Overall Study||6
6345347|NCT00592488|7252825|FG001|STARTED|Overall Study||7
6345348|NCT00592488|7252824|FG000|COMPLETED|Overall Study||6
6345349|NCT00592488|7252825|FG001|COMPLETED|Overall Study||7
6345350|NCT00592488|7252824|FG000|NOT COMPLETED|Overall Study||0
6345351|NCT00592488|7252825|FG001|NOT COMPLETED|Overall Study||0
6345352|NCT00592501|7252833|FG000|STARTED|Overall Study||25
6345353|NCT00592501|7252833|FG000|COMPLETED|Overall Study||23
6345354|NCT00592501|7252833|FG000|NOT COMPLETED|Overall Study||2
6345355|NCT00592553|7252840|FG000|STARTED|Overall Study||60
6345356|NCT00592553|7252841|FG001|STARTED|Overall Study||57
6345357|NCT00592553|7252842|FG002|STARTED|Overall Study||57
6345358|NCT00592553|7252840|FG000|As-treated Population|Overall Study||60
6345359|NCT00592553|7252841|FG001|As-treated Population|Overall Study||57
6345360|NCT00592553|7252842|FG002|As-treated Population|Overall Study||57
6345361|NCT00592553|7252840|FG000|ITT Population|Overall Study||60
6345362|NCT00592553|7252841|FG001|ITT Population|Overall Study||57
6345363|NCT00592553|7252842|FG002|ITT Population|Overall Study||57
6345364|NCT00592553|7252840|FG000|COMPLETED|Overall Study||59
6345365|NCT00592553|7252841|FG001|COMPLETED|Overall Study||57
6345366|NCT00592553|7252842|FG002|COMPLETED|Overall Study||57
6345367|NCT00592553|7252840|FG000|NOT COMPLETED|Overall Study||1
6345368|NCT00592553|7252841|FG001|NOT COMPLETED|Overall Study||0
6345369|NCT00592553|7252842|FG002|NOT COMPLETED|Overall Study||0
6345370|NCT00592631|7252852|FG000|STARTED|Overall Study||16
6345371|NCT00592631|7252853|FG001|STARTED|Overall Study||11
6345372|NCT00592631|7252852|FG000|COMPLETED|Overall Study||16
6345373|NCT00592631|7252853|FG001|COMPLETED|Overall Study||9
6345374|NCT00592631|7252852|FG000|NOT COMPLETED|Overall Study||0
6345375|NCT00592631|7252853|FG001|NOT COMPLETED|Overall Study||2
6345376|NCT00592683|7252861|FG000|STARTED|Overall Study||10
6345377|NCT00592683|7252862|FG001|STARTED|Overall Study||10
6345378|NCT00592683|7252861|FG000|COMPLETED|Overall Study||6
6345379|NCT00592683|7252862|FG001|COMPLETED|Overall Study||6
6345380|NCT00592683|7252861|FG000|NOT COMPLETED|Overall Study||4
6345381|NCT00592683|7252862|FG001|NOT COMPLETED|Overall Study||4
6345382|NCT00592761|7252868|FG000|STARTED|First Intervention (2 Weeks)||9
6345383|NCT00592761|7252869|FG001|STARTED|First Intervention (2 Weeks)||9
6345384|NCT00592761|7252868|FG000|COMPLETED|First Intervention (2 Weeks)||9
6345385|NCT00592761|7252869|FG001|COMPLETED|First Intervention (2 Weeks)||9
6559428|NCT01781572|7482138|FG001|STARTED|MEK162 30mg BID+LEE011 300mg||2
6345386|NCT00592761|7252868|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6345387|NCT00592761|7252869|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
6345388|NCT00592761|7252868|FG000|STARTED|Second Intervention (2 Weeks)||9
6345389|NCT00592761|7252869|FG001|STARTED|Second Intervention (2 Weeks)||9
6345390|NCT00592761|7252868|FG000|COMPLETED|Second Intervention (2 Weeks)||9
6345391|NCT00592761|7252869|FG001|COMPLETED|Second Intervention (2 Weeks)||9
6345392|NCT00592761|7252868|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6345393|NCT00592761|7252869|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6345394|NCT00592774|7252880|FG000|STARTED|Overall Study||26
6345395|NCT00592774|7252881|FG001|STARTED|Overall Study||53
6345396|NCT00592774|7252882|FG002|STARTED|Overall Study||22
6345397|NCT00592774|7252883|FG003|STARTED|Overall Study||22
6345398|NCT00592774|7252884|FG004|STARTED|Overall Study||23
6345399|NCT00592774|7252880|FG000|COMPLETED|Overall Study||15
6345400|NCT00592774|7252881|FG001|COMPLETED|Overall Study||21
6345401|NCT00592774|7252882|FG002|COMPLETED|Overall Study||18
6345402|NCT00592774|7252883|FG003|COMPLETED|Overall Study||8
6345403|NCT00592774|7252884|FG004|COMPLETED|Overall Study||9
6345404|NCT00592774|7252880|FG000|NOT COMPLETED|Overall Study||11
6345405|NCT00592774|7252881|FG001|NOT COMPLETED|Overall Study||32
6345406|NCT00592774|7252882|FG002|NOT COMPLETED|Overall Study||4
6345407|NCT00592774|7252883|FG003|NOT COMPLETED|Overall Study||14
6345408|NCT00592774|7252884|FG004|NOT COMPLETED|Overall Study||14
6345409|NCT00592839|7252899|FG000|STARTED|Overall Study||53
6345410|NCT00592839|7252900|FG001|STARTED|Overall Study||52
6345411|NCT00592839|7252901|FG002|STARTED|Overall Study||52
6345412|NCT00592839|7252899|FG000|COMPLETED|Overall Study||51
6776401|NCT03834025|7704478|FG005|Sent Letter|Sent Recruitment Letter (Phase 1)||0
6776402|NCT03834025|7704479|FG006|Sent Letter|Sent Recruitment Letter (Phase 1)||0
6345413|NCT00592839|7252900|FG001|COMPLETED|Overall Study||48
6345414|NCT00592839|7252901|FG002|COMPLETED|Overall Study||46
6345415|NCT00592839|7252899|FG000|NOT COMPLETED|Overall Study||2
6345416|NCT00592839|7252900|FG001|NOT COMPLETED|Overall Study||4
6345417|NCT00592839|7252901|FG002|NOT COMPLETED|Overall Study||6
6345418|NCT00592852|7252909|FG000|STARTED|Overall Study||13
6345419|NCT00592852|7252909|FG000|COMPLETED|Overall Study||7
6345420|NCT00592852|7252909|FG000|NOT COMPLETED|Overall Study||6
6345421|NCT00592904|7252917|FG000|STARTED|Overall Study||57
6345422|NCT00592904|7252918|FG001|STARTED|Overall Study||148
6345423|NCT00592904|7252919|FG002|STARTED|Overall Study||27
6345424|NCT00592904|7252920|FG003|STARTED|Overall Study||30
6345425|NCT00592904|7252917|FG000|COMPLETED|Overall Study||32
6559429|NCT01781572|7482139|FG002|STARTED|MEK162 30mg BID+LEE011 300mg||0
6559430|NCT01781572|7482137|FG000|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
6345426|NCT00592904|7252918|FG001|COMPLETED|Overall Study||93
6345427|NCT00592904|7252919|FG002|COMPLETED|Overall Study||10
6345428|NCT00592904|7252920|FG003|COMPLETED|Overall Study||19
6345429|NCT00592904|7252917|FG000|NOT COMPLETED|Overall Study||25
6345430|NCT00592904|7252918|FG001|NOT COMPLETED|Overall Study||55
6345431|NCT00592904|7252919|FG002|NOT COMPLETED|Overall Study||17
6345432|NCT00592904|7252920|FG003|NOT COMPLETED|Overall Study||11
6345433|NCT00592943|7252932|FG000|STARTED|Overall Study||6
6345434|NCT00592943|7252933|FG001|STARTED|Overall Study||6
6345435|NCT00592943|7252932|FG000|COMPLETED|Overall Study||6
6345436|NCT00592943|7252933|FG001|COMPLETED|Overall Study||6
6345437|NCT00592943|7252932|FG000|NOT COMPLETED|Overall Study||0
6345438|NCT00592943|7252933|FG001|NOT COMPLETED|Overall Study||0
6345439|NCT00593112|7252941|FG000|STARTED|Overall Study||27
6345440|NCT00593112|7252942|FG001|STARTED|Overall Study||12
6345441|NCT00593112|7252941|FG000|COMPLETED|Overall Study||17
6345442|NCT00593112|7252942|FG001|COMPLETED|Overall Study||12
6345443|NCT00593112|7252941|FG000|NOT COMPLETED|Overall Study||10
6345444|NCT00593112|7252942|FG001|NOT COMPLETED|Overall Study||0
6345445|NCT00593333|7252950|FG000|STARTED|Overall Study||54
6345446|NCT00593333|7252951|FG001|STARTED|Overall Study||56
6345447|NCT00593333|7252950|FG000|COMPLETED|Overall Study||44
6345448|NCT00593333|7252951|FG001|COMPLETED|Overall Study||45
6345449|NCT00593333|7252950|FG000|NOT COMPLETED|Overall Study||10
6345450|NCT00593333|7252951|FG001|NOT COMPLETED|Overall Study||11
6345451|NCT00593346|7252957|FG000|STARTED|Overall Study||151
6345452|NCT00593346|7252957|FG000|COMPLETED|Overall Study||151
6345453|NCT00593346|7252957|FG000|NOT COMPLETED|Overall Study||0
6345454|NCT00593372|7252964|FG000|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
6345455|NCT00593372|7252965|FG001|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
6345456|NCT00593372|7252964|FG000|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
6345457|NCT00593372|7252965|FG001|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
6559431|NCT01781572|7482138|FG001|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
6776403|NCT03834025|7704473|FG000|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
6345458|NCT00593372|7252964|FG000|NOT COMPLETED|Overall Study||0
6345459|NCT00593372|7252965|FG001|NOT COMPLETED|Overall Study||0
6345460|NCT00593385|7252971|FG000|STARTED|Overall Study||165
6345461|NCT00593385|7252971|FG000|Intention to Treat (ITT) Population|Overall Study|Excludes 13 subjects who did not meet inclusion/exclusion criteria.|152
6345462|NCT00593385|7252971|FG000|COMPLETED|Overall Study|125 of 165 enrolled patients completed the study.|125
6345463|NCT00593385|7252971|FG000|NOT COMPLETED|Overall Study||40
6345464|NCT00593450|7252981|FG000|STARTED|Overall Study||301
6345465|NCT00593450|7252982|FG001|STARTED|Overall Study||286
6345466|NCT00593450|7252983|FG002|STARTED|Overall Study||298
6345467|NCT00593450|7252984|FG003|STARTED|Overall Study||300
6345468|NCT00593450|7252981|FG000|COMPLETED|Overall Study||284
6345469|NCT00593450|7252982|FG001|COMPLETED|Overall Study||265
6345470|NCT00593450|7252983|FG002|COMPLETED|Overall Study||285
6345471|NCT00593450|7252984|FG003|COMPLETED|Overall Study||271
6345472|NCT00593450|7252981|FG000|NOT COMPLETED|Overall Study||17
6345473|NCT00593450|7252982|FG001|NOT COMPLETED|Overall Study||21
6345474|NCT00593450|7252983|FG002|NOT COMPLETED|Overall Study||13
6345475|NCT00593450|7252984|FG003|NOT COMPLETED|Overall Study||29
6345476|NCT00593489|7252996|FG000|STARTED|Allocation|allocated to intervention group to receive the intervention|75
6345477|NCT00593489|7252997|FG001|STARTED|Allocation|allocated to usual care group|79
6345478|NCT00593489|7252996|FG000|COMPLETED|Allocation||73
6345479|NCT00593489|7252997|FG001|COMPLETED|Allocation||78
6345480|NCT00593489|7252996|FG000|NOT COMPLETED|Allocation||2
6345481|NCT00593489|7252997|FG001|NOT COMPLETED|Allocation||1
6345482|NCT00593489|7252996|FG000|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|73
6345483|NCT00593489|7252997|FG001|STARTED|Analysis|physician withdrawal (N=3) primary outcome set to 0|78
6345484|NCT00593489|7252996|FG000|COMPLETED|Analysis||73
6345485|NCT00593489|7252997|FG001|COMPLETED|Analysis||78
6345486|NCT00593489|7252996|FG000|NOT COMPLETED|Analysis||0
6345487|NCT00593489|7252997|FG001|NOT COMPLETED|Analysis||0
6345488|NCT00593554|7253007|FG000|STARTED|Overall Study||3
6345489|NCT00593554|7253008|FG001|STARTED|Overall Study||5
6345490|NCT00593554|7253007|FG000|COMPLETED|Overall Study||0
6345491|NCT00593554|7253008|FG001|COMPLETED|Overall Study||0
6345492|NCT00593554|7253007|FG000|NOT COMPLETED|Overall Study||3
6345493|NCT00593554|7253008|FG001|NOT COMPLETED|Overall Study||5
6345494|NCT00593606|7253014|FG000|STARTED|Overall Study||124
6345495|NCT00593606|7253014|FG000|Start of Treatment - Safety Set|Overall Study||116
6345496|NCT00593606|7253014|FG000|Full Analysis Set|Overall Study||114
6345497|NCT00593606|7253014|FG000|Treatment Period Completed|Overall Study||99
6345498|NCT00593606|7253014|FG000|COMPLETED|Overall Study||97
6345499|NCT00593606|7253014|FG000|NOT COMPLETED|Overall Study||27
6345500|NCT00593645|7253018|FG000|STARTED|Overall Study||7
6345501|NCT00593645|7253018|FG000|COMPLETED|Overall Study||7
6345502|NCT00593645|7253018|FG000|NOT COMPLETED|Overall Study||0
6345503|NCT00593684|7253024|FG000|STARTED|Overall Study||25
6345504|NCT00593684|7253025|FG001|STARTED|Overall Study||25
6345505|NCT00593684|7253024|FG000|COMPLETED|Overall Study||23
6345506|NCT00593684|7253025|FG001|COMPLETED|Overall Study||24
6345507|NCT00593684|7253024|FG000|NOT COMPLETED|Overall Study||2
6345508|NCT00593684|7253025|FG001|NOT COMPLETED|Overall Study||1
6345509|NCT00593736|7253035|FG000|STARTED|Screening Period and Placebo Run-in||0
6345510|NCT00593736|7253036|FG001|STARTED|Screening Period and Placebo Run-in||0
6345511|NCT00593736|7253037|FG002|STARTED|Screening Period and Placebo Run-in||0
6345512|NCT00593736|7253038|FG003|STARTED|Screening Period and Placebo Run-in||549
6345513|NCT00593736|7253035|FG000|COMPLETED|Screening Period and Placebo Run-in||0
6345514|NCT00593736|7253036|FG001|COMPLETED|Screening Period and Placebo Run-in||0
6345515|NCT00593736|7253037|FG002|COMPLETED|Screening Period and Placebo Run-in||0
6345516|NCT00593736|7253038|FG003|COMPLETED|Screening Period and Placebo Run-in||132
6345517|NCT00593736|7253035|FG000|NOT COMPLETED|Screening Period and Placebo Run-in||0
6345518|NCT00593736|7253036|FG001|NOT COMPLETED|Screening Period and Placebo Run-in||0
6345519|NCT00593736|7253037|FG002|NOT COMPLETED|Screening Period and Placebo Run-in||0
6345520|NCT00593736|7253038|FG003|NOT COMPLETED|Screening Period and Placebo Run-in||417
6345521|NCT00593736|7253035|FG000|STARTED|Treatment Period and Placebo Run-out||32
6345522|NCT00593736|7253036|FG001|STARTED|Treatment Period and Placebo Run-out||33
6345523|NCT00593736|7253037|FG002|STARTED|Treatment Period and Placebo Run-out||35
6345524|NCT00593736|7253038|FG003|STARTED|Treatment Period and Placebo Run-out||32
6345525|NCT00593736|7253035|FG000|COMPLETED|Treatment Period and Placebo Run-out||29
6345526|NCT00593736|7253036|FG001|COMPLETED|Treatment Period and Placebo Run-out||31
6345527|NCT00593736|7253037|FG002|COMPLETED|Treatment Period and Placebo Run-out||30
6345528|NCT00593736|7253038|FG003|COMPLETED|Treatment Period and Placebo Run-out||28
6345529|NCT00593736|7253035|FG000|NOT COMPLETED|Treatment Period and Placebo Run-out||3
6345530|NCT00593736|7253036|FG001|NOT COMPLETED|Treatment Period and Placebo Run-out||2
6345531|NCT00593736|7253037|FG002|NOT COMPLETED|Treatment Period and Placebo Run-out||5
6345532|NCT00593736|7253038|FG003|NOT COMPLETED|Treatment Period and Placebo Run-out||4
6345533|NCT00593814|7253050|FG000|STARTED|Overall Study||139
6345534|NCT00593814|7253051|FG001|STARTED|Overall Study||120
6345535|NCT00593814|7253050|FG000|COMPLETED|Overall Study||115
6345536|NCT00593814|7253051|FG001|COMPLETED|Overall Study||120
6345537|NCT00593814|7253050|FG000|NOT COMPLETED|Overall Study||24
6345538|NCT00593814|7253051|FG001|NOT COMPLETED|Overall Study||0
6345539|NCT00593827|7253059|FG000|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
6345540|NCT00593827|7253060|FG001|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
6345541|NCT00593827|7253059|FG000|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
6559432|NCT01781572|7482139|FG002|COMPLETED|MEK162 30mg BID+LEE011 300mg||0
6559433|NCT01781572|7482137|FG000|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||4
6345542|NCT00593827|7253060|FG001|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
6345543|NCT00593827|7253059|FG000|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
6345544|NCT00593827|7253060|FG001|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
6345545|NCT00593827|7253059|FG000|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
6345546|NCT00593827|7253060|FG001|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
6345547|NCT00593827|7253059|FG000|NOT COMPLETED|Overall Study||0
6345548|NCT00593827|7253060|FG001|NOT COMPLETED|Overall Study||2
6345549|NCT00593840|7253066|FG000|STARTED|Overall Study||73
6345550|NCT00593840|7253066|FG000|COMPLETED|Overall Study||72
6345551|NCT00593840|7253066|FG000|NOT COMPLETED|Overall Study||1
6345552|NCT00593866|7253070|FG000|STARTED|Overall Study||50
6345553|NCT00593866|7253070|FG000|COMPLETED|Overall Study||50
6345554|NCT00593866|7253070|FG000|NOT COMPLETED|Overall Study||0
6345555|NCT00593918|7253076|FG000|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
6345556|NCT00593918|7253077|FG001|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
6345557|NCT00593918|7253076|FG000|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
6345558|NCT00593918|7253077|FG001|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
6345559|NCT00593918|7253076|FG000|NOT COMPLETED|Overall Study||5
6345560|NCT00593918|7253077|FG001|NOT COMPLETED|Overall Study||24
6345561|NCT00593957|7253086|FG000|STARTED|Overall Study||13
6345562|NCT00593957|7253087|FG001|STARTED|Overall Study||13
6345563|NCT00593957|7253088|FG002|STARTED|Overall Study||12
6345564|NCT00593957|7253086|FG000|COMPLETED|Overall Study||13
6345565|NCT00593957|7253087|FG001|COMPLETED|Overall Study||12
6345566|NCT00593957|7253088|FG002|COMPLETED|Overall Study||10
6345567|NCT00593957|7253086|FG000|NOT COMPLETED|Overall Study||0
6345568|NCT00593957|7253087|FG001|NOT COMPLETED|Overall Study||1
6345569|NCT00593957|7253088|FG002|NOT COMPLETED|Overall Study||2
6345570|NCT00594009|7253110|FG000|STARTED|Overall Study||1
6345571|NCT00594009|7253110|FG000|COMPLETED|Overall Study||1
6345572|NCT00594009|7253110|FG000|NOT COMPLETED|Overall Study||0
6345573|NCT00594022|7253116|FG000|STARTED|Overall Study||176
6345574|NCT00594022|7253117|FG001|STARTED|Overall Study||173
6345575|NCT00594022|7253116|FG000|COMPLETED|Overall Study||176
6345576|NCT00594022|7253117|FG001|COMPLETED|Overall Study||173
6345577|NCT00594022|7253116|FG000|NOT COMPLETED|Overall Study||0
6345578|NCT00594022|7253117|FG001|NOT COMPLETED|Overall Study||0
6345579|NCT00594035|7253125|FG000|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
6345580|NCT00594035|7253126|FG001|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
6345581|NCT00594035|7253125|FG000|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
6345582|NCT00594035|7253126|FG001|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
6345583|NCT00594035|7253125|FG000|NOT COMPLETED|Overall Study||2
6345584|NCT00594035|7253126|FG001|NOT COMPLETED|Overall Study||3
6345585|NCT00594061|7253132|FG000|STARTED|Overall Study||9
6345586|NCT00594061|7253132|FG000|COMPLETED|Overall Study||9
6345587|NCT00594061|7253132|FG000|NOT COMPLETED|Overall Study||0
6345588|NCT00594100|7253136|FG000|STARTED|Procedure||245
6345589|NCT00594100|7253136|FG000|COMPLETED|Procedure||236
6345590|NCT00594100|7253136|FG000|NOT COMPLETED|Procedure||9
6345591|NCT00594100|7253136|FG000|STARTED|Follow-up Through 30 Days Post Procedure||236
6345592|NCT00594100|7253136|FG000|COMPLETED|Follow-up Through 30 Days Post Procedure||224
6345593|NCT00594100|7253136|FG000|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
6345594|NCT00594165|7253140|FG000|STARTED|Overall Study||217
6345595|NCT00594165|7253140|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
6345596|NCT00594165|7253140|FG000|NOT COMPLETED|Overall Study||217
6345597|NCT00594178|7253144|FG000|STARTED|Overall Study||17
6345598|NCT00594178|7253144|FG000|COMPLETED|Overall Study||12
6345599|NCT00594178|7253144|FG000|NOT COMPLETED|Overall Study||5
6345600|NCT00594204|7253150|FG000|STARTED|Overall Study||394
6345601|NCT00594204|7253151|FG001|STARTED|Overall Study||199
6345602|NCT00594204|7253150|FG000|Received Treatment|Overall Study||390
6345603|NCT00594204|7253151|FG001|Received Treatment|Overall Study||198
6345604|NCT00594204|7253150|FG000|COMPLETED|Overall Study||336
6345605|NCT00594204|7253151|FG001|COMPLETED|Overall Study||154
6345606|NCT00594204|7253150|FG000|NOT COMPLETED|Overall Study||58
6345607|NCT00594204|7253151|FG001|NOT COMPLETED|Overall Study||45
6345608|NCT00594230|7253159|FG000|STARTED|Overall Study||16
6345609|NCT00594230|7253160|FG001|STARTED|Overall Study||10
6345610|NCT00594230|7253159|FG000|COMPLETED|Overall Study||1
6345611|NCT00594230|7253160|FG001|COMPLETED|Overall Study||1
6345612|NCT00594230|7253159|FG000|NOT COMPLETED|Overall Study||15
6345613|NCT00594230|7253160|FG001|NOT COMPLETED|Overall Study||9
6345614|NCT00594256|7253166|FG000|STARTED|Overall Study||8
6345615|NCT00594256|7253166|FG000|COMPLETED|Overall Study||8
6345616|NCT00594256|7253166|FG000|NOT COMPLETED|Overall Study||0
6345617|NCT00594308|7253171|FG000|STARTED|Overall Study||10
6345618|NCT00594308|7253171|FG000|COMPLETED|Overall Study||10
6345619|NCT00594308|7253171|FG000|NOT COMPLETED|Overall Study||0
6376793|NCT00761150|7287365|FG002|NOT COMPLETED|Double-blind Period||29
6376794|NCT00761189|7287372|FG000|STARTED|Overall Study||491
6376795|NCT00761189|7287372|FG000|COMPLETED|Overall Study||306
6376796|NCT00761189|7287372|FG000|NOT COMPLETED|Overall Study||185
6376797|NCT00761202|7287378|FG000|STARTED|Overall Study||22
6376798|NCT00761202|7287379|FG001|STARTED|Overall Study||28
6345620|NCT00594386|7253175|FG000|STARTED|Overall Study||258
6345621|NCT00594386|7253175|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
6345622|NCT00594386|7253175|FG000|NOT COMPLETED|Overall Study||258
6345623|NCT00594399|7253181|FG000|STARTED|Initial 3 Month Counseling||180
6345624|NCT00594399|7253182|FG001|STARTED|Initial 3 Month Counseling||122
6345625|NCT00594399|7253183|FG002|STARTED|Initial 3 Month Counseling||0
6345626|NCT00594399|7253181|FG000|COMPLETED|Initial 3 Month Counseling||163
6345627|NCT00594399|7253182|FG001|COMPLETED|Initial 3 Month Counseling||118
6345628|NCT00594399|7253183|FG002|COMPLETED|Initial 3 Month Counseling||0
6345629|NCT00594399|7253181|FG000|NOT COMPLETED|Initial 3 Month Counseling||17
6345630|NCT00594399|7253182|FG001|NOT COMPLETED|Initial 3 Month Counseling||4
6345631|NCT00594399|7253183|FG002|NOT COMPLETED|Initial 3 Month Counseling||0
6345632|NCT00594399|7253181|FG000|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
6345633|NCT00594399|7253182|FG001|STARTED|Rerandomization Arm 1 Only||118
6345634|NCT00594399|7253183|FG002|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
6345635|NCT00594399|7253181|FG000|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
6345636|NCT00594399|7253182|FG001|Rerandomization|Rerandomization Arm 1 Only||114
6345637|NCT00594399|7253183|FG002|Rerandomization|Rerandomization Arm 1 Only||82
6345638|NCT00594399|7253181|FG000|COMPLETED|Rerandomization Arm 1 Only||79
6345639|NCT00594399|7253182|FG001|COMPLETED|Rerandomization Arm 1 Only||114
6345640|NCT00594399|7253183|FG002|COMPLETED|Rerandomization Arm 1 Only||82
6345641|NCT00594399|7253181|FG000|NOT COMPLETED|Rerandomization Arm 1 Only||2
6345642|NCT00594399|7253182|FG001|NOT COMPLETED|Rerandomization Arm 1 Only||4
6345643|NCT00594399|7253183|FG002|NOT COMPLETED|Rerandomization Arm 1 Only||0
6345644|NCT00594425|7253192|FG000|STARTED|Overall Study||50
6345645|NCT00594425|7253193|FG001|STARTED|Overall Study||48
6345646|NCT00594425|7253194|FG002|STARTED|Overall Study||52
6345647|NCT00594425|7253192|FG000|COMPLETED|Overall Study||43
6345648|NCT00594425|7253193|FG001|COMPLETED|Overall Study||34
6345649|NCT00594425|7253194|FG002|COMPLETED|Overall Study||42
6345650|NCT00594425|7253192|FG000|NOT COMPLETED|Overall Study||7
6345651|NCT00594425|7253193|FG001|NOT COMPLETED|Overall Study||14
6345652|NCT00594425|7253194|FG002|NOT COMPLETED|Overall Study||10
6345653|NCT00594464|7253202|FG000|STARTED|Overall Study||14
6345654|NCT00594464|7253202|FG000|COMPLETED|Overall Study||11
6345655|NCT00594464|7253202|FG000|NOT COMPLETED|Overall Study||3
6345656|NCT00594516|7253212|FG000|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
6345657|NCT00594516|7253213|FG001|STARTED|Open Label (OL): Tapentadol IR||0
6345658|NCT00594516|7253214|FG002|STARTED|Open Label (OL): Tapentadol IR||0
6345659|NCT00594516|7253212|FG000|COMPLETED|Open Label (OL): Tapentadol IR||87
6345660|NCT00594516|7253213|FG001|COMPLETED|Open Label (OL): Tapentadol IR||0
6345661|NCT00594516|7253214|FG002|COMPLETED|Open Label (OL): Tapentadol IR||0
6345662|NCT00594516|7253212|FG000|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
6345663|NCT00594516|7253213|FG001|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
6345664|NCT00594516|7253214|FG002|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
6345665|NCT00594516|7253212|FG000|STARTED|DB: Tapentadol IR to ER & ER to IR||0
6345666|NCT00594516|7253213|FG001|STARTED|DB: Tapentadol IR to ER & ER to IR||44
6345667|NCT00594516|7253214|FG002|STARTED|DB: Tapentadol IR to ER & ER to IR||43
6345668|NCT00594516|7253212|FG000|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
6345669|NCT00594516|7253213|FG001|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
6345670|NCT00594516|7253214|FG002|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
6345671|NCT00594516|7253212|FG000|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
6345672|NCT00594516|7253213|FG001|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
6345673|NCT00594516|7253214|FG002|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
6345674|NCT00594568|7253221|FG000|STARTED|Initial Treatment||501
6345675|NCT00594568|7253222|FG001|STARTED|Initial Treatment||507
6345676|NCT00594568|7253223|FG002|STARTED|Initial Treatment||529
6345677|NCT00594568|7253221|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
6345678|NCT00594568|7253222|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
6345679|NCT00594568|7253223|FG002|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
6345680|NCT00594568|7253221|FG000|COMPLETED|Initial Treatment||189
6345681|NCT00594568|7253222|FG001|COMPLETED|Initial Treatment||153
6345682|NCT00594568|7253223|FG002|COMPLETED|Initial Treatment||121
6345683|NCT00594568|7253221|FG000|NOT COMPLETED|Initial Treatment||312
6345684|NCT00594568|7253222|FG001|NOT COMPLETED|Initial Treatment||354
6345685|NCT00594568|7253223|FG002|NOT COMPLETED|Initial Treatment||408
6345686|NCT00594568|7253221|FG000|STARTED|Delayed Start||189
6345687|NCT00594568|7253222|FG001|STARTED|Delayed Start||153
6345688|NCT00594568|7253223|FG002|STARTED|Delayed Start||121
6345689|NCT00594568|7253221|FG000|COMPLETED|Delayed Start||91
6345690|NCT00594568|7253222|FG001|COMPLETED|Delayed Start||76
6345691|NCT00594568|7253223|FG002|COMPLETED|Delayed Start||55
6345692|NCT00594568|7253221|FG000|NOT COMPLETED|Delayed Start||98
6345693|NCT00594568|7253222|FG001|NOT COMPLETED|Delayed Start||77
6345694|NCT00594568|7253223|FG002|NOT COMPLETED|Delayed Start||66
6376799|NCT00761202|7287378|FG000|COMPLETED|Overall Study||21
6376800|NCT00761202|7287379|FG001|COMPLETED|Overall Study||26
6345695|NCT00594568|7253221|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
6345696|NCT00594568|7253222|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
6345697|NCT00594568|7253223|FG002|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
6345698|NCT00594568|7253221|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||229
6345699|NCT00594568|7253222|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||168
6345700|NCT00594568|7253223|FG002|COMPLETED|Safety Follow Up (SFU)-Optional||172
6345701|NCT00594568|7253221|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
6345702|NCT00594568|7253222|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
6345703|NCT00594568|7253223|FG002|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
6345704|NCT00594646|7253239|FG000|STARTED|Overall Study||100
6345705|NCT00594646|7253239|FG000|COMPLETED|Overall Study||84
6345706|NCT00594646|7253239|FG000|NOT COMPLETED|Overall Study||16
6345707|NCT00594659|7253247|FG000|STARTED|Overall Study||29
6345708|NCT00594659|7253248|FG001|STARTED|Overall Study||30
6345709|NCT00594659|7253249|FG002|STARTED|Overall Study||16
6345710|NCT00594659|7253247|FG000|COMPLETED|Overall Study||16
6345711|NCT00594659|7253248|FG001|COMPLETED|Overall Study||21
6345712|NCT00594659|7253249|FG002|COMPLETED|Overall Study||9
6345713|NCT00594659|7253247|FG000|NOT COMPLETED|Overall Study||13
6345714|NCT00594659|7253248|FG001|NOT COMPLETED|Overall Study||9
6345715|NCT00594659|7253249|FG002|NOT COMPLETED|Overall Study||7
6345716|NCT00594685|7253257|FG000|STARTED|Overall Study||10
6345717|NCT00594685|7253257|FG000|COMPLETED|Overall Study||10
6345718|NCT00594685|7253257|FG000|NOT COMPLETED|Overall Study||0
6345719|NCT00594815|7253261|FG000|STARTED|Overall Study||52
6345720|NCT00594815|7253261|FG000|COMPLETED|Overall Study||43
6345721|NCT00594815|7253261|FG000|NOT COMPLETED|Overall Study||9
6345722|NCT00594854|7253267|FG000|STARTED|Overall Study||9
6345723|NCT00594854|7253268|FG001|STARTED|Overall Study||11
6345724|NCT00594854|7253267|FG000|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
6345725|NCT00594854|7253268|FG001|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
6345726|NCT00594854|7253267|FG000|NOT COMPLETED|Overall Study||7
6345727|NCT00594854|7253268|FG001|NOT COMPLETED|Overall Study||10
6345728|NCT00594880|7253276|FG000|STARTED|Overall Study||12
6345729|NCT00594880|7253277|FG001|STARTED|Overall Study||11
6345730|NCT00594880|7253276|FG000|COMPLETED|Overall Study||10
6345731|NCT00594880|7253277|FG001|COMPLETED|Overall Study||10
6345732|NCT00594880|7253276|FG000|NOT COMPLETED|Overall Study||2
6345733|NCT00594880|7253277|FG001|NOT COMPLETED|Overall Study||1
6345734|NCT00594906|7253289|FG000|STARTED|Overall Study||7
6345735|NCT00594906|7253290|FG001|STARTED|Overall Study||3
6345736|NCT00594906|7253289|FG000|COMPLETED|Overall Study||6
6345737|NCT00594906|7253290|FG001|COMPLETED|Overall Study||1
6345738|NCT00594906|7253289|FG000|NOT COMPLETED|Overall Study||1
6345739|NCT00594906|7253290|FG001|NOT COMPLETED|Overall Study||2
6345740|NCT00594932|7253298|FG000|STARTED|First 3 Months||13
6345741|NCT00594932|7253299|FG001|STARTED|First 3 Months||14
6345742|NCT00594932|7253298|FG000|COMPLETED|First 3 Months||12
6345743|NCT00594932|7253299|FG001|COMPLETED|First 3 Months||11
6345744|NCT00594932|7253298|FG000|NOT COMPLETED|First 3 Months||1
6345745|NCT00594932|7253299|FG001|NOT COMPLETED|First 3 Months||3
6345746|NCT00594932|7253298|FG000|STARTED|Final 3 Months||12
6345747|NCT00594932|7253299|FG001|STARTED|Final 3 Months||11
6345748|NCT00594932|7253298|FG000|COMPLETED|Final 3 Months||8
6345749|NCT00594932|7253299|FG001|COMPLETED|Final 3 Months||8
6345750|NCT00594932|7253298|FG000|NOT COMPLETED|Final 3 Months||4
6345751|NCT00594932|7253299|FG001|NOT COMPLETED|Final 3 Months||3
6345752|NCT00594945|7253308|FG000|STARTED|Cohort 1 / Treatment Period 1||4
6345753|NCT00594945|7253309|FG001|STARTED|Cohort 1 / Treatment Period 1||0
6345754|NCT00594945|7253310|FG002|STARTED|Cohort 1 / Treatment Period 1||2
6345755|NCT00594945|7253308|FG000|COMPLETED|Cohort 1 / Treatment Period 1||4
6345756|NCT00594945|7253309|FG001|COMPLETED|Cohort 1 / Treatment Period 1||0
6345757|NCT00594945|7253310|FG002|COMPLETED|Cohort 1 / Treatment Period 1||2
6345758|NCT00594945|7253308|FG000|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
6345759|NCT00594945|7253309|FG001|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
6345760|NCT00594945|7253310|FG002|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
6345761|NCT00594945|7253308|FG000|STARTED|Cohort 2 / Treatment Period 2||0
6345762|NCT00594945|7253309|FG001|STARTED|Cohort 2 / Treatment Period 2||3
6345763|NCT00594945|7253310|FG002|STARTED|Cohort 2 / Treatment Period 2||2
6345764|NCT00594945|7253308|FG000|COMPLETED|Cohort 2 / Treatment Period 2||0
6345765|NCT00594945|7253309|FG001|COMPLETED|Cohort 2 / Treatment Period 2||3
6345766|NCT00594945|7253310|FG002|COMPLETED|Cohort 2 / Treatment Period 2||2
6345767|NCT00594945|7253308|FG000|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
6345768|NCT00594945|7253309|FG001|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
6345769|NCT00594945|7253310|FG002|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
6345770|NCT00594958|7253319|FG000|STARTED|Overall Study||214
6345771|NCT00594958|7253320|FG001|STARTED|Overall Study||213
6345772|NCT00594958|7253321|FG002|STARTED|Overall Study||212
6345773|NCT00594958|7253319|FG000|Randomized and at Least 1 Vaccination|Overall Study||212
6345774|NCT00594958|7253320|FG001|Randomized and at Least 1 Vaccination|Overall Study||213
6345775|NCT00594958|7253321|FG002|Randomized and at Least 1 Vaccination|Overall Study||211
6345776|NCT00594958|7253319|FG000|COMPLETED|Overall Study||200
6345777|NCT00594958|7253320|FG001|COMPLETED|Overall Study||210
6345778|NCT00594958|7253321|FG002|COMPLETED|Overall Study||202
6345779|NCT00594958|7253319|FG000|NOT COMPLETED|Overall Study||14
6345780|NCT00594958|7253320|FG001|NOT COMPLETED|Overall Study||3
6345781|NCT00594958|7253321|FG002|NOT COMPLETED|Overall Study||10
6345782|NCT00594997|7253331|FG000|STARTED|Overall Study||1562
6345783|NCT00594997|7253332|FG001|STARTED|Overall Study||2008
6345784|NCT00594997|7253331|FG000|COMPLETED|Overall Study||1562
6345785|NCT00594997|7253332|FG001|COMPLETED|Overall Study||2008
6345786|NCT00594997|7253331|FG000|NOT COMPLETED|Overall Study||0
6345787|NCT00594997|7253332|FG001|NOT COMPLETED|Overall Study||0
6345788|NCT00595075|7253342|FG000|STARTED|Overall Study||6
6345789|NCT00595075|7253343|FG001|STARTED|Overall Study||5
6345790|NCT00595075|7253342|FG000|COMPLETED|Overall Study||5
6345791|NCT00595075|7253343|FG001|COMPLETED|Overall Study||5
6345792|NCT00595075|7253342|FG000|NOT COMPLETED|Overall Study||1
6345793|NCT00595075|7253343|FG001|NOT COMPLETED|Overall Study||0
6345794|NCT00595088|7253349|FG000|STARTED|Overall Study||47
6345795|NCT00595088|7253349|FG000|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
6345796|NCT00595088|7253349|FG000|NOT COMPLETED|Overall Study||40
6345797|NCT00595101|7253357|FG000|STARTED|Overall Study||29
6345798|NCT00595101|7253358|FG001|STARTED|Overall Study||29
6345799|NCT00595101|7253359|FG002|STARTED|Overall Study||29
6345800|NCT00595101|7253360|FG003|STARTED|Overall Study||30
6345801|NCT00595101|7253357|FG000|COMPLETED|Overall Study||29
6345802|NCT00595101|7253358|FG001|COMPLETED|Overall Study||28
6345803|NCT00595101|7253359|FG002|COMPLETED|Overall Study||29
6345804|NCT00595101|7253360|FG003|COMPLETED|Overall Study||30
6345805|NCT00595101|7253357|FG000|NOT COMPLETED|Overall Study||0
6345806|NCT00595101|7253358|FG001|NOT COMPLETED|Overall Study||1
6345807|NCT00595101|7253359|FG002|NOT COMPLETED|Overall Study||0
6345808|NCT00595101|7253360|FG003|NOT COMPLETED|Overall Study||0
6345809|NCT00595114|7253372|FG000|STARTED|Overall Study||24
6345810|NCT00595114|7253373|FG001|STARTED|Overall Study||19
6345811|NCT00595114|7253372|FG000|COMPLETED|Overall Study||24
6345812|NCT00595114|7253373|FG001|COMPLETED|Overall Study||19
6345813|NCT00595114|7253372|FG000|NOT COMPLETED|Overall Study||0
6345814|NCT00595114|7253373|FG001|NOT COMPLETED|Overall Study||0
6345815|NCT00595127|7253379|FG000|STARTED|Overall Study||21
6345816|NCT00595127|7253379|FG000|COMPLETED|Overall Study||11
6345817|NCT00595127|7253379|FG000|NOT COMPLETED|Overall Study||10
6345818|NCT00595153|7253386|FG000|STARTED|Overall Study||24
6345819|NCT00595153|7253387|FG001|STARTED|Overall Study||42
6345820|NCT00595153|7253388|FG002|STARTED|Overall Study||61
6345821|NCT00595153|7253386|FG000|COMPLETED|Overall Study||20
6345822|NCT00595153|7253387|FG001|COMPLETED|Overall Study||26
6345823|NCT00595153|7253388|FG002|COMPLETED|Overall Study||36
6345824|NCT00595153|7253386|FG000|NOT COMPLETED|Overall Study||4
6345825|NCT00595153|7253387|FG001|NOT COMPLETED|Overall Study||16
6345826|NCT00595153|7253388|FG002|NOT COMPLETED|Overall Study||25
6345827|NCT00595231|7253398|FG000|STARTED|Overall Study||120
6345828|NCT00595231|7253399|FG001|STARTED|Overall Study||119
6345829|NCT00595231|7253398|FG000|COMPLETED|Overall Study||115
6345830|NCT00595231|7253399|FG001|COMPLETED|Overall Study||114
6345831|NCT00595231|7253398|FG000|NOT COMPLETED|Overall Study||5
6345832|NCT00595231|7253399|FG001|NOT COMPLETED|Overall Study||5
6345833|NCT00595270|7253408|FG000|STARTED|Overall Study||116
6345834|NCT00595270|7253409|FG001|STARTED|Overall Study||117
6345835|NCT00595270|7253410|FG002|STARTED|Overall Study||116
6345836|NCT00595270|7253408|FG000|COMPLETED|Overall Study||110
6345837|NCT00595270|7253409|FG001|COMPLETED|Overall Study||107
6345838|NCT00595270|7253410|FG002|COMPLETED|Overall Study||108
6345839|NCT00595270|7253408|FG000|NOT COMPLETED|Overall Study||6
6345840|NCT00595270|7253409|FG001|NOT COMPLETED|Overall Study||10
6345841|NCT00595270|7253410|FG002|NOT COMPLETED|Overall Study||8
6345842|NCT00595309|7253418|FG000|STARTED|Overall Study||198
6345843|NCT00595309|7253418|FG000|COMPLETED|Overall Study||194
6345844|NCT00595309|7253418|FG000|NOT COMPLETED|Overall Study||4
6345845|NCT00595335|7253424|FG000|STARTED|Baseline to Six Months||13
6345846|NCT00595335|7253425|FG001|STARTED|Baseline to Six Months||12
6345847|NCT00595335|7253424|FG000|COMPLETED|Baseline to Six Months||11
6345848|NCT00595335|7253425|FG001|COMPLETED|Baseline to Six Months||10
6345849|NCT00595335|7253424|FG000|NOT COMPLETED|Baseline to Six Months||2
6345850|NCT00595335|7253425|FG001|NOT COMPLETED|Baseline to Six Months||2
6345851|NCT00595335|7253424|FG000|STARTED|Six Months to Twelve Months||11
6345852|NCT00595335|7253425|FG001|STARTED|Six Months to Twelve Months||10
6345853|NCT00595335|7253424|FG000|COMPLETED|Six Months to Twelve Months||10
6345854|NCT00595335|7253425|FG001|COMPLETED|Six Months to Twelve Months||9
6345855|NCT00595335|7253424|FG000|NOT COMPLETED|Six Months to Twelve Months||1
6345856|NCT00595335|7253425|FG001|NOT COMPLETED|Six Months to Twelve Months||1
6345857|NCT00595361|7253437|FG000|STARTED|Overall Study||12
6345858|NCT00595361|7253438|FG001|STARTED|Overall Study||18
6345859|NCT00595361|7253437|FG000|COMPLETED|Overall Study||12
6345860|NCT00595361|7253438|FG001|COMPLETED|Overall Study||18
6345861|NCT00595361|7253437|FG000|NOT COMPLETED|Overall Study||0
6345862|NCT00595361|7253438|FG001|NOT COMPLETED|Overall Study||0
6345863|NCT00595413|7253448|FG000|STARTED|Overall Study||76
6345864|NCT00595413|7253449|FG001|STARTED|Overall Study||78
6345865|NCT00595413|7253450|FG002|STARTED|Overall Study||78
6345866|NCT00595413|7253451|FG003|STARTED|Overall Study||79
6345867|NCT00595413|7253448|FG000|COMPLETED|Overall Study||69
6345868|NCT00595413|7253449|FG001|COMPLETED|Overall Study||73
6345869|NCT00595413|7253450|FG002|COMPLETED|Overall Study||70
6345870|NCT00595413|7253451|FG003|COMPLETED|Overall Study||75
6345871|NCT00595413|7253448|FG000|NOT COMPLETED|Overall Study||7
6345872|NCT00595413|7253449|FG001|NOT COMPLETED|Overall Study||5
6345873|NCT00595413|7253450|FG002|NOT COMPLETED|Overall Study||8
6345874|NCT00595413|7253451|FG003|NOT COMPLETED|Overall Study||4
6345875|NCT00595465|7253464|FG000|STARTED|Overall Study||130
6345876|NCT00595465|7253465|FG001|STARTED|Overall Study||129
6345877|NCT00595465|7253466|FG002|STARTED|Overall Study||128
6345878|NCT00595465|7253464|FG000|COMPLETED|Overall Study||124
6345879|NCT00595465|7253465|FG001|COMPLETED|Overall Study||125
6345880|NCT00595465|7253466|FG002|COMPLETED|Overall Study||121
6345881|NCT00595465|7253464|FG000|NOT COMPLETED|Overall Study||6
6345882|NCT00595465|7253465|FG001|NOT COMPLETED|Overall Study||4
6345883|NCT00595465|7253466|FG002|NOT COMPLETED|Overall Study||7
6345884|NCT00595478|7253476|FG000|STARTED|Treatment||37
6345885|NCT00595478|7253477|FG001|STARTED|Treatment||38
6345886|NCT00595478|7253476|FG000|COMPLETED|Treatment||37
6345887|NCT00595478|7253477|FG001|COMPLETED|Treatment||38
6345888|NCT00595478|7253476|FG000|NOT COMPLETED|Treatment||0
6345889|NCT00595478|7253477|FG001|NOT COMPLETED|Treatment||0
6345890|NCT00595478|7253476|FG000|STARTED|36-week Follow-up Period||37
6345891|NCT00595478|7253477|FG001|STARTED|36-week Follow-up Period||38
6345892|NCT00595478|7253476|FG000|COMPLETED|36-week Follow-up Period||28
6345893|NCT00595478|7253477|FG001|COMPLETED|36-week Follow-up Period||30
6345894|NCT00595478|7253476|FG000|NOT COMPLETED|36-week Follow-up Period||9
6345895|NCT00595478|7253477|FG001|NOT COMPLETED|36-week Follow-up Period||8
6345896|NCT00595504|7253485|FG000|STARTED|Overall Study||16
6345897|NCT00595504|7253486|FG001|STARTED|Overall Study||9
6345898|NCT00595504|7253485|FG000|COMPLETED|Overall Study||14
6345899|NCT00595504|7253486|FG001|COMPLETED|Overall Study||6
6345900|NCT00595504|7253485|FG000|NOT COMPLETED|Overall Study||2
6345901|NCT00595504|7253486|FG001|NOT COMPLETED|Overall Study||3
6345902|NCT00595517|7253492|FG000|STARTED|Overall Study||130
6345903|NCT00595517|7253492|FG000|COMPLETED|Overall Study||111
6345904|NCT00595517|7253492|FG000|NOT COMPLETED|Overall Study||19
6345905|NCT00595530|7253496|FG000|STARTED|Overall Study||3
6345906|NCT00595530|7253496|FG000|COMPLETED|Overall Study||3
6345907|NCT00595530|7253496|FG000|NOT COMPLETED|Overall Study||0
6345908|NCT00595556|7253503|FG000|STARTED|Overall Study||20
6345909|NCT00595556|7253504|FG001|STARTED|Overall Study||20
6345910|NCT00595556|7253503|FG000|COMPLETED|Overall Study||17
6345911|NCT00595556|7253504|FG001|COMPLETED|Overall Study||19
6345912|NCT00595556|7253503|FG000|NOT COMPLETED|Overall Study||3
6345913|NCT00595556|7253504|FG001|NOT COMPLETED|Overall Study||1
6345914|NCT00595621|7253512|FG000|STARTED|Open Label Run in||22
6345915|NCT00595621|7253513|FG001|STARTED|Open Label Run in||0
6345916|NCT00595621|7253512|FG000|COMPLETED|Open Label Run in||19
6345917|NCT00595621|7253513|FG001|COMPLETED|Open Label Run in||0
6345918|NCT00595621|7253512|FG000|NOT COMPLETED|Open Label Run in||3
6345919|NCT00595621|7253513|FG001|NOT COMPLETED|Open Label Run in||0
6345920|NCT00595621|7253512|FG000|STARTED|Randomization and Study||10
6345921|NCT00595621|7253513|FG001|STARTED|Randomization and Study||9
6345922|NCT00595621|7253512|FG000|COMPLETED|Randomization and Study||8
6345923|NCT00595621|7253513|FG001|COMPLETED|Randomization and Study||8
6345924|NCT00595621|7253512|FG000|NOT COMPLETED|Randomization and Study||2
6345925|NCT00595621|7253513|FG001|NOT COMPLETED|Randomization and Study||1
6345926|NCT00595764|7253522|FG000|STARTED|Overall Study||71
6345927|NCT00595764|7253523|FG001|STARTED|Overall Study||70
6345928|NCT00595764|7253522|FG000|COMPLETED|Overall Study||32
6345929|NCT00595764|7253523|FG001|COMPLETED|Overall Study||27
6345930|NCT00595764|7253522|FG000|NOT COMPLETED|Overall Study||39
6345931|NCT00595764|7253523|FG001|NOT COMPLETED|Overall Study||43
6345932|NCT00595790|7253532|FG000|STARTED|Overall Study||125
6345933|NCT00595790|7253533|FG001|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
6345934|NCT00595790|7253534|FG002|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
6345935|NCT00595790|7253532|FG000|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
6345936|NCT00595790|7253533|FG001|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
6345937|NCT00595790|7253534|FG002|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
6345938|NCT00595790|7253532|FG000|NOT COMPLETED|Overall Study||2
6345939|NCT00595790|7253533|FG001|NOT COMPLETED|Overall Study||1
6345940|NCT00595790|7253534|FG002|NOT COMPLETED|Overall Study||3
6345941|NCT00595868|7253544|FG000|STARTED|Overall Study||107
6776404|NCT03834025|7704474|FG001|Responded to Letter|Sent Recruitment Letter (Phase 1)||36
6776405|NCT03834025|7704475|FG002|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
6776406|NCT03834025|7704476|FG003|Responded to Letter|Sent Recruitment Letter (Phase 1)||44
6776407|NCT03834025|7704477|FG004|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
6776408|NCT03834025|7704478|FG005|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
6776409|NCT03834025|7704479|FG006|Responded to Letter|Sent Recruitment Letter (Phase 1)||0
6776410|NCT03834025|7704473|FG000|COMPLETED|Sent Recruitment Letter (Phase 1)||36
6345942|NCT00595868|7253545|FG001|STARTED|Overall Study||111
6345943|NCT00595868|7253544|FG000|COMPLETED|Overall Study||62
6776411|NCT03834025|7704474|FG001|COMPLETED|Sent Recruitment Letter (Phase 1)||36
6345944|NCT00595868|7253545|FG001|COMPLETED|Overall Study||61
6345945|NCT00595868|7253544|FG000|NOT COMPLETED|Overall Study||45
6345946|NCT00595868|7253545|FG001|NOT COMPLETED|Overall Study||50
6345947|NCT00595881|7253551|FG000|STARTED|Overall Study||420
6345948|NCT00595881|7253551|FG000|COMPLETED|Overall Study||420
6345949|NCT00595881|7253551|FG000|NOT COMPLETED|Overall Study||0
6345950|NCT00595946|7253558|FG000|STARTED|Overall Study||218
6345951|NCT00595946|7253559|FG001|STARTED|Overall Study||221
6345952|NCT00595946|7253558|FG000|COMPLETED|Overall Study||154
6345953|NCT00595946|7253559|FG001|COMPLETED|Overall Study||152
6345954|NCT00595946|7253558|FG000|NOT COMPLETED|Overall Study||64
6345955|NCT00595946|7253559|FG001|NOT COMPLETED|Overall Study||69
6345956|NCT00595959|7253565|FG000|STARTED|Overall Study||65
6345957|NCT00595959|7253565|FG000|COMPLETED|Overall Study||63
6345958|NCT00595959|7253565|FG000|NOT COMPLETED|Overall Study||2
6345959|NCT00596011|7253571|FG000|STARTED|Overall Study||49
6345960|NCT00596011|7253572|FG001|STARTED|Overall Study||48
6345961|NCT00596011|7253571|FG000|COMPLETED|Overall Study||36
6345962|NCT00596011|7253572|FG001|COMPLETED|Overall Study||38
6345963|NCT00596011|7253571|FG000|NOT COMPLETED|Overall Study||13
6345964|NCT00596011|7253572|FG001|NOT COMPLETED|Overall Study||10
6345965|NCT00596102|7253581|FG000|STARTED|Up to Month 6||2283
6345966|NCT00596102|7253582|FG001|STARTED|Up to Month 6||338
6345967|NCT00596102|7253583|FG002|STARTED|Up to Month 6||637
6345968|NCT00596102|7253581|FG000|COMPLETED|Up to Month 6||2283
6345969|NCT00596102|7253582|FG001|COMPLETED|Up to Month 6||338
6345970|NCT00596102|7253583|FG002|COMPLETED|Up to Month 6||637
6345971|NCT00596102|7253581|FG000|NOT COMPLETED|Up to Month 6||0
6345972|NCT00596102|7253582|FG001|NOT COMPLETED|Up to Month 6||0
6345973|NCT00596102|7253583|FG002|NOT COMPLETED|Up to Month 6||0
6345974|NCT00596102|7253581|FG000|STARTED|Up to Month 60||2283
6345975|NCT00596102|7253582|FG001|STARTED|Up to Month 60||338
6345976|NCT00596102|7253583|FG002|STARTED|Up to Month 60||637
6345977|NCT00596102|7253581|FG000|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
6345978|NCT00596102|7253582|FG001|COMPLETED|Up to Month 60||0
6345979|NCT00596102|7253583|FG002|COMPLETED|Up to Month 60||0
6345980|NCT00596102|7253581|FG000|NOT COMPLETED|Up to Month 60||2181
6345981|NCT00596102|7253582|FG001|NOT COMPLETED|Up to Month 60||338
6345982|NCT00596102|7253583|FG002|NOT COMPLETED|Up to Month 60||637
6345983|NCT00596167|7253590|FG000|STARTED|Overall Study|All recruited subjects completed the study.|6
6345984|NCT00596167|7253590|FG000|COMPLETED|Overall Study||6
6345985|NCT00596167|7253590|FG000|NOT COMPLETED|Overall Study||0
6345986|NCT00596271|7253597|FG000|STARTED|Overall Study||65
6345987|NCT00596271|7253598|FG001|STARTED|Overall Study||65
6345988|NCT00596271|7253599|FG002|STARTED|Overall Study||62
6345989|NCT00596271|7253597|FG000|COMPLETED|Overall Study||60
6345990|NCT00596271|7253598|FG001|COMPLETED|Overall Study||59
6345991|NCT00596271|7253599|FG002|COMPLETED|Overall Study||61
6345992|NCT00596271|7253597|FG000|NOT COMPLETED|Overall Study||5
6345993|NCT00596271|7253598|FG001|NOT COMPLETED|Overall Study||6
6345994|NCT00596271|7253599|FG002|NOT COMPLETED|Overall Study||1
6345995|NCT00596362|7253608|FG000|STARTED|Overall Study||1
6345996|NCT00596362|7253608|FG000|COMPLETED|Overall Study||0
6345997|NCT00596362|7253608|FG000|NOT COMPLETED|Overall Study||1
6345998|NCT00596427|7253614|FG000|STARTED|Overall Study||30
6345999|NCT00596427|7253615|FG001|STARTED|Overall Study||30
6346000|NCT00596427|7253614|FG000|COMPLETED|Overall Study||26
6346001|NCT00596427|7253615|FG001|COMPLETED|Overall Study||28
6346002|NCT00596427|7253614|FG000|NOT COMPLETED|Overall Study||4
6346003|NCT00596427|7253615|FG001|NOT COMPLETED|Overall Study||2
6346004|NCT00596440|7253624|FG000|STARTED|Overall Study||113
6346005|NCT00596440|7253625|FG001|STARTED|Overall Study||121
6346006|NCT00596440|7253624|FG000|Showed to Eligibility Visit|Overall Study||85
6346007|NCT00596440|7253625|FG001|Showed to Eligibility Visit|Overall Study||72
6346008|NCT00596440|7253624|FG000|Showed to First Treatment Session|Overall Study||61
6346009|NCT00596440|7253625|FG001|Showed to First Treatment Session|Overall Study||52
6346010|NCT00596440|7253624|FG000|COMPLETED|Overall Study||48
6346011|NCT00596440|7253625|FG001|COMPLETED|Overall Study||41
6346012|NCT00596440|7253624|FG000|NOT COMPLETED|Overall Study||65
6346013|NCT00596440|7253625|FG001|NOT COMPLETED|Overall Study||80
6346014|NCT00596453|7253633|FG000|STARTED|Overall Study||13
6346015|NCT00596453|7253634|FG001|STARTED|Overall Study||15
6346016|NCT00596453|7253633|FG000|COMPLETED|Overall Study||12
6346017|NCT00596453|7253634|FG001|COMPLETED|Overall Study||12
6346018|NCT00596453|7253633|FG000|NOT COMPLETED|Overall Study||1
6346019|NCT00596453|7253634|FG001|NOT COMPLETED|Overall Study||3
6346020|NCT00596466|7253640|FG000|STARTED|Overall Study||75
6346021|NCT00596466|7253640|FG000|Enrolled, Treated|Overall Study||73
6346022|NCT00596466|7253640|FG000|COMPLETED|Overall Study||58
6346023|NCT00596466|7253640|FG000|NOT COMPLETED|Overall Study||17
6346024|NCT00596622|7253647|FG000|STARTED|Overall Study||46
6346025|NCT00596622|7253647|FG000|COMPLETED|Overall Study||33
6346026|NCT00596622|7253647|FG000|NOT COMPLETED|Overall Study||13
6346027|NCT00596635|7253659|FG000|STARTED|Overall Study||17
6346028|NCT00596635|7253660|FG001|STARTED|Overall Study||20
6346029|NCT00596635|7253661|FG002|STARTED|Overall Study||19
6346030|NCT00596635|7253659|FG000|COMPLETED|Overall Study||10
6346031|NCT00596635|7253660|FG001|COMPLETED|Overall Study||7
6346032|NCT00596635|7253661|FG002|COMPLETED|Overall Study||11
6346033|NCT00596635|7253659|FG000|NOT COMPLETED|Overall Study||7
6346034|NCT00596635|7253660|FG001|NOT COMPLETED|Overall Study||13
6346035|NCT00596635|7253661|FG002|NOT COMPLETED|Overall Study||8
6346036|NCT00596687|7253671|FG000|STARTED|Overall Study||118
6346037|NCT00596687|7253672|FG001|STARTED|Overall Study||116
6346038|NCT00596687|7253671|FG000|COMPLETED|Overall Study||104
6346039|NCT00596687|7253672|FG001|COMPLETED|Overall Study||107
6346040|NCT00596687|7253671|FG000|NOT COMPLETED|Overall Study||14
6346041|NCT00596687|7253672|FG001|NOT COMPLETED|Overall Study||9
6346042|NCT00596752|7253680|FG000|STARTED|Overall Study||415
6346043|NCT00596752|7253681|FG001|STARTED|Overall Study||425
6346044|NCT00596752|7253680|FG000|Randomized and Treated|Overall Study||415
6346045|NCT00596752|7253681|FG001|Randomized and Treated|Overall Study||424
6346046|NCT00596752|7253680|FG000|COMPLETED|Overall Study||289
6346047|NCT00596752|7253681|FG001|COMPLETED|Overall Study||282
6346048|NCT00596752|7253680|FG000|NOT COMPLETED|Overall Study||126
6346049|NCT00596752|7253681|FG001|NOT COMPLETED|Overall Study||143
6346050|NCT00596817|7253690|FG000|STARTED|Open-label Period||0
6346051|NCT00596817|7253691|FG001|STARTED|Open-label Period||639
6346052|NCT00596817|7253690|FG000|COMPLETED|Open-label Period||0
6346053|NCT00596817|7253691|FG001|COMPLETED|Open-label Period||492
6346054|NCT00596817|7253690|FG000|NOT COMPLETED|Open-label Period||0
6346055|NCT00596817|7253691|FG001|NOT COMPLETED|Open-label Period||147
6346056|NCT00596817|7253690|FG000|STARTED|Open-label Period to Double-blind Period||0
6346057|NCT00596817|7253691|FG001|STARTED|Open-label Period to Double-blind Period||492
6346058|NCT00596817|7253690|FG000|COMPLETED|Open-label Period to Double-blind Period||0
6346059|NCT00596817|7253691|FG001|COMPLETED|Open-label Period to Double-blind Period||400
6346060|NCT00596817|7253690|FG000|NOT COMPLETED|Open-label Period to Double-blind Period||0
6346061|NCT00596817|7253691|FG001|NOT COMPLETED|Open-label Period to Double-blind Period||92
6346062|NCT00596817|7253690|FG000|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
6346063|NCT00596817|7253691|FG001|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
6346064|NCT00596817|7253690|FG000|COMPLETED|Double-blind Period||104
6346065|NCT00596817|7253691|FG001|COMPLETED|Double-blind Period||125
6346066|NCT00596817|7253690|FG000|NOT COMPLETED|Double-blind Period||88
6346067|NCT00596817|7253691|FG001|NOT COMPLETED|Double-blind Period||79
6346068|NCT00596830|7253700|FG000|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
6346069|NCT00596830|7253701|FG001|STARTED|Overall Study||339
6346070|NCT00596830|7253700|FG000|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
6346071|NCT00596830|7253701|FG001|Treated|Overall Study||332
6346072|NCT00596830|7253700|FG000|COMPLETED|Overall Study||0
6346073|NCT00596830|7253701|FG001|COMPLETED|Overall Study||0
6346074|NCT00596830|7253700|FG000|NOT COMPLETED|Overall Study||342
6346075|NCT00596830|7253701|FG001|NOT COMPLETED|Overall Study||339
6346076|NCT00596934|7253707|FG000|STARTED|Overall Study||9
6346077|NCT00596934|7253707|FG000|COMPLETED|Overall Study||7
6346078|NCT00596934|7253707|FG000|NOT COMPLETED|Overall Study||2
6346079|NCT00596960|7253715|FG000|STARTED|Overall Study||70
6346080|NCT00596960|7253716|FG001|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
6346081|NCT00596960|7253715|FG000|COMPLETED|Overall Study||59
6346082|NCT00596960|7253716|FG001|COMPLETED|Overall Study||60
6346083|NCT00596960|7253715|FG000|NOT COMPLETED|Overall Study||11
6346084|NCT00596960|7253716|FG001|NOT COMPLETED|Overall Study||9
6346085|NCT00597012|7253724|FG000|STARTED|Overall Study||174
6346086|NCT00597012|7253725|FG001|STARTED|Overall Study||177
6346087|NCT00597012|7253724|FG000|COMPLETED|Overall Study||161
6346088|NCT00597012|7253725|FG001|COMPLETED|Overall Study||169
6776412|NCT03834025|7704475|FG002|COMPLETED|Sent Recruitment Letter (Phase 1)||44
6776413|NCT03834025|7704476|FG003|COMPLETED|Sent Recruitment Letter (Phase 1)||44
6776414|NCT03834025|7704477|FG004|COMPLETED|Sent Recruitment Letter (Phase 1)||0
6346089|NCT00597012|7253724|FG000|NOT COMPLETED|Overall Study||13
6346090|NCT00597012|7253725|FG001|NOT COMPLETED|Overall Study||8
6346091|NCT00597038|7253735|FG000|STARTED|Overall Study||16
6346092|NCT00597038|7253736|FG001|STARTED|Overall Study||34
6346093|NCT00597038|7253735|FG000|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
6346094|NCT00597038|7253736|FG001|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
6346095|NCT00597038|7253735|FG000|NOT COMPLETED|Overall Study||2
6346096|NCT00597038|7253736|FG001|NOT COMPLETED|Overall Study||4
6346097|NCT00597116|7253746|FG000|STARTED|Overall Study||14
6346098|NCT00597116|7253747|FG001|STARTED|Overall Study||11
6346099|NCT00597116|7253746|FG000|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
6346100|NCT00597116|7253747|FG001|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
6346101|NCT00597116|7253746|FG000|NOT COMPLETED|Overall Study||14
6346102|NCT00597116|7253747|FG001|NOT COMPLETED|Overall Study||11
6346103|NCT00597207|7253755|FG000|STARTED|Overall Study||2099
6346104|NCT00597207|7253756|FG001|STARTED|Overall Study||2132
6346105|NCT00597207|7253755|FG000|COMPLETED|Overall Study||2094
6346106|NCT00597207|7253756|FG001|COMPLETED|Overall Study||2125
6346107|NCT00597207|7253755|FG000|NOT COMPLETED|Overall Study||5
6346108|NCT00597207|7253756|FG001|NOT COMPLETED|Overall Study||7
6346109|NCT00597246|7253762|FG000|STARTED|Overall Study||30
6346110|NCT00597246|7253762|FG000|COMPLETED|Overall Study||30
6346111|NCT00597246|7253762|FG000|NOT COMPLETED|Overall Study||0
6346112|NCT00597272|7253773|FG000|STARTED|Overall Study||1
6559434|NCT01781572|7482138|FG001|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||2
6559435|NCT01781572|7482139|FG002|NOT COMPLETED|MEK162 30mg BID+LEE011 300mg||0
6559436|NCT01781572|7482137|FG000|STARTED|MEK162 45mg BID+LEE011 300mg||6
6346113|NCT00597272|7253774|FG001|STARTED|Overall Study||1
6346114|NCT00597272|7253775|FG002|STARTED|Overall Study||10
6346115|NCT00597272|7253776|FG003|STARTED|Overall Study||1
6498484|NCT01410097|7417070|FG000|STARTED|Overall Study||556
6498485|NCT01410097|7417071|FG001|STARTED|Overall Study||533
6498486|NCT01410097|7417070|FG000|COMPLETED|Overall Study||551
6498487|NCT01410097|7417071|FG001|COMPLETED|Overall Study||530
6498488|NCT01410097|7417070|FG000|NOT COMPLETED|Overall Study||5
6498489|NCT01410097|7417071|FG001|NOT COMPLETED|Overall Study||3
6498490|NCT01410110|7417079|FG000|STARTED|Overall Study||24
6498491|NCT01410110|7417080|FG001|STARTED|Overall Study||24
6346116|NCT00597272|7253777|FG004|STARTED|Overall Study||1
6346117|NCT00597272|7253778|FG005|STARTED|Overall Study||10
6346118|NCT00597272|7253779|FG006|STARTED|Overall Study||10
6346119|NCT00597272|7253773|FG000|COMPLETED|Overall Study||1
6346120|NCT00597272|7253774|FG001|COMPLETED|Overall Study||1
6346121|NCT00597272|7253775|FG002|COMPLETED|Overall Study||10
6346122|NCT00597272|7253776|FG003|COMPLETED|Overall Study||1
6346123|NCT00597272|7253777|FG004|COMPLETED|Overall Study||1
6346124|NCT00597272|7253778|FG005|COMPLETED|Overall Study||10
6346125|NCT00597272|7253779|FG006|COMPLETED|Overall Study||10
6346126|NCT00597272|7253773|FG000|NOT COMPLETED|Overall Study||0
6346127|NCT00597272|7253774|FG001|NOT COMPLETED|Overall Study||0
6346128|NCT00597272|7253775|FG002|NOT COMPLETED|Overall Study||0
6346129|NCT00597272|7253776|FG003|NOT COMPLETED|Overall Study||0
6346130|NCT00597272|7253777|FG004|NOT COMPLETED|Overall Study||0
6346131|NCT00597272|7253778|FG005|NOT COMPLETED|Overall Study||0
6346132|NCT00597272|7253779|FG006|NOT COMPLETED|Overall Study||0
6346133|NCT00597376|7253797|FG000|STARTED|Overall Study||51
6346134|NCT00597376|7253798|FG001|STARTED|Overall Study||53
6346135|NCT00597376|7253797|FG000|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
6346136|NCT00597376|7253798|FG001|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
6346137|NCT00597376|7253797|FG000|NOT COMPLETED|Overall Study||8
6346138|NCT00597376|7253798|FG001|NOT COMPLETED|Overall Study||4
6346139|NCT00597402|7253804|FG000|STARTED|Overall Study||125
6346140|NCT00597402|7253804|FG000|COMPLETED|Overall Study||125
6346141|NCT00597402|7253804|FG000|NOT COMPLETED|Overall Study||0
6346142|NCT00597428|7253810|FG000|STARTED|Overall Study||214
6346143|NCT00597428|7253811|FG001|STARTED|Overall Study||223
6346144|NCT00597428|7253810|FG000|COMPLETED|Overall Study||153
6346145|NCT00597428|7253811|FG001|COMPLETED|Overall Study||152
6346146|NCT00597428|7253810|FG000|NOT COMPLETED|Overall Study||61
6346147|NCT00597428|7253811|FG001|NOT COMPLETED|Overall Study||71
6346148|NCT00597493|7253817|FG000|STARTED|Overall Study||32
6346149|NCT00597493|7253817|FG000|COMPLETED|Overall Study||32
6346150|NCT00597493|7253817|FG000|NOT COMPLETED|Overall Study||0
6346151|NCT00597506|7253825|FG000|STARTED|Overall Study||50
6346152|NCT00597506|7253825|FG000|COMPLETED|Overall Study||49
6346153|NCT00597506|7253825|FG000|NOT COMPLETED|Overall Study||1
6346154|NCT00597519|7253829|FG000|STARTED|Overall Study||28
6346155|NCT00597519|7253829|FG000|COMPLETED|Overall Study||27
6346156|NCT00597519|7253829|FG000|NOT COMPLETED|Overall Study||1
6346157|NCT00597545|7253835|FG000|STARTED|Overall Study||4
6346158|NCT00597545|7253836|FG001|STARTED|Overall Study||6
6346159|NCT00597545|7253835|FG000|COMPLETED|Overall Study||4
6346160|NCT00597545|7253836|FG001|COMPLETED|Overall Study||6
6346161|NCT00597545|7253835|FG000|NOT COMPLETED|Overall Study||0
6346162|NCT00597545|7253836|FG001|NOT COMPLETED|Overall Study||0
6346163|NCT00597558|7253842|FG000|STARTED|Overall Study||13
6346164|NCT00597558|7253842|FG000|COMPLETED|Overall Study||9
6346165|NCT00597558|7253842|FG000|NOT COMPLETED|Overall Study||4
6346166|NCT00597584|7253848|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
6346167|NCT00597584|7253849|FG001|STARTED|Overall Study||274
6346168|NCT00597584|7253848|FG000|COMPLETED|Overall Study||421
6346169|NCT00597584|7253849|FG001|COMPLETED|Overall Study||211
6346170|NCT00597584|7253848|FG000|NOT COMPLETED|Overall Study||128
6346171|NCT00597584|7253849|FG001|NOT COMPLETED|Overall Study||63
6346172|NCT00597675|7253857|FG000|STARTED|Blinded Phase||4
6346173|NCT00597675|7253858|FG001|STARTED|Blinded Phase||6
6346174|NCT00597675|7253857|FG000|COMPLETED|Blinded Phase||2
6346175|NCT00597675|7253858|FG001|COMPLETED|Blinded Phase||5
6346176|NCT00597675|7253857|FG000|NOT COMPLETED|Blinded Phase||2
6346177|NCT00597675|7253858|FG001|NOT COMPLETED|Blinded Phase||1
6346178|NCT00597675|7253857|FG000|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
6346179|NCT00597675|7253858|FG001|STARTED|Open Label Phase||5
6346180|NCT00597675|7253857|FG000|COMPLETED|Open Label Phase||2
6346181|NCT00597675|7253858|FG001|COMPLETED|Open Label Phase||5
6346182|NCT00597675|7253857|FG000|NOT COMPLETED|Open Label Phase||0
6346183|NCT00597675|7253858|FG001|NOT COMPLETED|Open Label Phase||0
6346184|NCT00597701|7253868|FG000|STARTED|Overall Study||25
6346185|NCT00597701|7253869|FG001|STARTED|Overall Study||21
6346186|NCT00597701|7253868|FG000|COMPLETED|Overall Study||18
6346187|NCT00597701|7253869|FG001|COMPLETED|Overall Study||13
6346188|NCT00597701|7253868|FG000|NOT COMPLETED|Overall Study||7
6346189|NCT00597701|7253869|FG001|NOT COMPLETED|Overall Study||8
6346190|NCT00597714|7253877|FG000|STARTED|Overall Study||80
6346191|NCT00597714|7253878|FG001|STARTED|Overall Study||57
6346192|NCT00597714|7253879|FG002|STARTED|Overall Study||94
6346193|NCT00597714|7253877|FG000|COMPLETED|Overall Study||24
6346194|NCT00597714|7253878|FG001|COMPLETED|Overall Study||11
6346195|NCT00597714|7253879|FG002|COMPLETED|Overall Study||84
6346196|NCT00597714|7253877|FG000|NOT COMPLETED|Overall Study||56
6346197|NCT00597714|7253878|FG001|NOT COMPLETED|Overall Study||46
6346198|NCT00597714|7253879|FG002|NOT COMPLETED|Overall Study||10
6346199|NCT00597727|7253892|FG000|STARTED|12 Month Blinded Phase||14
6346200|NCT00597727|7253893|FG001|STARTED|12 Month Blinded Phase||15
6346201|NCT00597727|7253894|FG002|STARTED|12 Month Blinded Phase||0
6346202|NCT00597727|7253895|FG003|STARTED|12 Month Blinded Phase||27
6346203|NCT00597727|7253896|FG004|STARTED|12 Month Blinded Phase||4
6346204|NCT00597727|7253892|FG000|COMPLETED|12 Month Blinded Phase||14
6346205|NCT00597727|7253893|FG001|COMPLETED|12 Month Blinded Phase||15
6346206|NCT00597727|7253894|FG002|COMPLETED|12 Month Blinded Phase||0
6346207|NCT00597727|7253895|FG003|COMPLETED|12 Month Blinded Phase||17
6346208|NCT00597727|7253896|FG004|COMPLETED|12 Month Blinded Phase||3
6346209|NCT00597727|7253892|FG000|NOT COMPLETED|12 Month Blinded Phase||0
6346210|NCT00597727|7253893|FG001|NOT COMPLETED|12 Month Blinded Phase||0
6346211|NCT00597727|7253894|FG002|NOT COMPLETED|12 Month Blinded Phase||0
6346212|NCT00597727|7253895|FG003|NOT COMPLETED|12 Month Blinded Phase||10
6346213|NCT00597727|7253896|FG004|NOT COMPLETED|12 Month Blinded Phase||1
6346214|NCT00597727|7253892|FG000|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
6346215|NCT00597727|7253893|FG001|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
6346216|NCT00597727|7253894|FG002|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
6346217|NCT00597727|7253895|FG003|STARTED|Open-label Extended Maintenance Phase||17
6346218|NCT00597727|7253896|FG004|STARTED|Open-label Extended Maintenance Phase||3
6346219|NCT00597727|7253892|FG000|COMPLETED|Open-label Extended Maintenance Phase||0
6346220|NCT00597727|7253893|FG001|COMPLETED|Open-label Extended Maintenance Phase||0
6346221|NCT00597727|7253894|FG002|COMPLETED|Open-label Extended Maintenance Phase||23
6346222|NCT00597727|7253895|FG003|COMPLETED|Open-label Extended Maintenance Phase||14
6346223|NCT00597727|7253896|FG004|COMPLETED|Open-label Extended Maintenance Phase||1
6346224|NCT00597727|7253892|FG000|NOT COMPLETED|Open-label Extended Maintenance Phase||0
6346225|NCT00597727|7253893|FG001|NOT COMPLETED|Open-label Extended Maintenance Phase||0
6346226|NCT00597727|7253894|FG002|NOT COMPLETED|Open-label Extended Maintenance Phase||6
6346227|NCT00597727|7253895|FG003|NOT COMPLETED|Open-label Extended Maintenance Phase||3
6346228|NCT00597727|7253896|FG004|NOT COMPLETED|Open-label Extended Maintenance Phase||2
6346229|NCT00597753|7253912|FG000|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
6346230|NCT00597753|7253913|FG001|STARTED|Overall Study||271
6346231|NCT00597753|7253912|FG000|COMPLETED|Overall Study||366
6346232|NCT00597753|7253913|FG001|COMPLETED|Overall Study||202
6346233|NCT00597753|7253912|FG000|NOT COMPLETED|Overall Study||166
6346234|NCT00597753|7253913|FG001|NOT COMPLETED|Overall Study||69
6346235|NCT00597766|7253922|FG000|STARTED|Enrolled||9
6346236|NCT00597766|7253923|FG001|STARTED|Enrolled||9
6346237|NCT00597766|7253924|FG002|STARTED|Enrolled||10
6346238|NCT00597766|7253922|FG000|COMPLETED|Enrolled||9
6346239|NCT00597766|7253923|FG001|COMPLETED|Enrolled||9
6346240|NCT00597766|7253924|FG002|COMPLETED|Enrolled||10
6346241|NCT00597766|7253922|FG000|NOT COMPLETED|Enrolled||0
6346242|NCT00597766|7253923|FG001|NOT COMPLETED|Enrolled||0
6346243|NCT00597766|7253924|FG002|NOT COMPLETED|Enrolled||0
6346244|NCT00597766|7253922|FG000|STARTED|Follow-up 1, Week 4||9
6346245|NCT00597766|7253923|FG001|STARTED|Follow-up 1, Week 4||9
6346246|NCT00597766|7253924|FG002|STARTED|Follow-up 1, Week 4||10
6346247|NCT00597766|7253922|FG000|COMPLETED|Follow-up 1, Week 4||8
6346248|NCT00597766|7253923|FG001|COMPLETED|Follow-up 1, Week 4||9
6346249|NCT00597766|7253924|FG002|COMPLETED|Follow-up 1, Week 4||10
6346250|NCT00597766|7253922|FG000|NOT COMPLETED|Follow-up 1, Week 4||1
6346251|NCT00597766|7253923|FG001|NOT COMPLETED|Follow-up 1, Week 4||0
6346252|NCT00597766|7253924|FG002|NOT COMPLETED|Follow-up 1, Week 4||0
6346253|NCT00597766|7253922|FG000|STARTED|Follow-up 2, Week 8||8
6346254|NCT00597766|7253923|FG001|STARTED|Follow-up 2, Week 8||9
6346255|NCT00597766|7253924|FG002|STARTED|Follow-up 2, Week 8||10
6346256|NCT00597766|7253922|FG000|COMPLETED|Follow-up 2, Week 8||8
6346257|NCT00597766|7253923|FG001|COMPLETED|Follow-up 2, Week 8||9
6346258|NCT00597766|7253924|FG002|COMPLETED|Follow-up 2, Week 8||9
6346259|NCT00597766|7253922|FG000|NOT COMPLETED|Follow-up 2, Week 8||0
6346260|NCT00597766|7253923|FG001|NOT COMPLETED|Follow-up 2, Week 8||0
6346261|NCT00597766|7253924|FG002|NOT COMPLETED|Follow-up 2, Week 8||1
6346262|NCT00597766|7253922|FG000|STARTED|Follow-up 3, Week 12||8
6346263|NCT00597766|7253923|FG001|STARTED|Follow-up 3, Week 12||9
6346264|NCT00597766|7253924|FG002|STARTED|Follow-up 3, Week 12||9
6346265|NCT00597766|7253922|FG000|COMPLETED|Follow-up 3, Week 12||8
6346266|NCT00597766|7253923|FG001|COMPLETED|Follow-up 3, Week 12||9
6346267|NCT00597766|7253924|FG002|COMPLETED|Follow-up 3, Week 12||9
6346268|NCT00597766|7253922|FG000|NOT COMPLETED|Follow-up 3, Week 12||0
6346269|NCT00597766|7253923|FG001|NOT COMPLETED|Follow-up 3, Week 12||0
6346270|NCT00597766|7253924|FG002|NOT COMPLETED|Follow-up 3, Week 12||0
6346271|NCT00597818|7253936|FG000|STARTED|Overall Study||30
6346272|NCT00597818|7253937|FG001|STARTED|Overall Study||30
6346273|NCT00597818|7253938|FG002|STARTED|Overall Study||31
6346274|NCT00597818|7253939|FG003|STARTED|Overall Study||30
6346275|NCT00597818|7253936|FG000|COMPLETED|Overall Study||12
6346276|NCT00597818|7253937|FG001|COMPLETED|Overall Study||14
6346277|NCT00597818|7253938|FG002|COMPLETED|Overall Study||12
6346278|NCT00597818|7253939|FG003|COMPLETED|Overall Study||20
6346279|NCT00597818|7253936|FG000|NOT COMPLETED|Overall Study||18
6346280|NCT00597818|7253937|FG001|NOT COMPLETED|Overall Study||16
6346281|NCT00597818|7253938|FG002|NOT COMPLETED|Overall Study||19
6346282|NCT00597818|7253939|FG003|NOT COMPLETED|Overall Study||10
6346283|NCT00597896|7253951|FG000|STARTED|Overall Study||24
6346284|NCT00597896|7253952|FG001|STARTED|Overall Study||26
6346285|NCT00597896|7253951|FG000|COMPLETED|Overall Study||21
6346286|NCT00597896|7253952|FG001|COMPLETED|Overall Study||24
6346287|NCT00597896|7253951|FG000|NOT COMPLETED|Overall Study||3
6346288|NCT00597896|7253952|FG001|NOT COMPLETED|Overall Study||2
6346289|NCT00597935|7253963|FG000|STARTED|Randomized to Surgical and BPMT Arms||95
6346290|NCT00597935|7253964|FG001|STARTED|Randomized to Surgical and BPMT Arms||91
6346291|NCT00597935|7253965|FG002|STARTED|Randomized to Surgical and BPMT Arms||91
6346292|NCT00597935|7253966|FG003|STARTED|Randomized to Surgical and BPMT Arms||97
6346293|NCT00597935|7253963|FG000|COMPLETED|Randomized to Surgical and BPMT Arms||95
6346294|NCT00597935|7253964|FG001|COMPLETED|Randomized to Surgical and BPMT Arms||91
6346295|NCT00597935|7253965|FG002|COMPLETED|Randomized to Surgical and BPMT Arms||91
6346296|NCT00597935|7253966|FG003|COMPLETED|Randomized to Surgical and BPMT Arms||97
6346297|NCT00597935|7253963|FG000|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
6346298|NCT00597935|7253964|FG001|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
6346299|NCT00597935|7253965|FG002|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
6346300|NCT00597935|7253966|FG003|NOT COMPLETED|Randomized to Surgical and BPMT Arms||0
6346301|NCT00597935|7253963|FG000|STARTED|Baseline to 6-Months||95
6346302|NCT00597935|7253964|FG001|STARTED|Baseline to 6-Months||91
6346303|NCT00597935|7253965|FG002|STARTED|Baseline to 6-Months||91
6346304|NCT00597935|7253966|FG003|STARTED|Baseline to 6-Months||97
6346305|NCT00597935|7253963|FG000|COMPLETED|Baseline to 6-Months||93
6346306|NCT00597935|7253964|FG001|COMPLETED|Baseline to 6-Months||87
6346307|NCT00597935|7253965|FG002|COMPLETED|Baseline to 6-Months||87
6346308|NCT00597935|7253966|FG003|COMPLETED|Baseline to 6-Months||93
6346309|NCT00597935|7253963|FG000|NOT COMPLETED|Baseline to 6-Months||2
6346310|NCT00597935|7253964|FG001|NOT COMPLETED|Baseline to 6-Months||4
6346311|NCT00597935|7253965|FG002|NOT COMPLETED|Baseline to 6-Months||4
6346312|NCT00597935|7253966|FG003|NOT COMPLETED|Baseline to 6-Months||4
6346313|NCT00597935|7253963|FG000|STARTED|6-Months to 24-Months||93
6346314|NCT00597935|7253964|FG001|STARTED|6-Months to 24-Months||87
6346315|NCT00597935|7253965|FG002|STARTED|6-Months to 24-Months||87
6346316|NCT00597935|7253966|FG003|STARTED|6-Months to 24-Months||93
6346317|NCT00597935|7253963|FG000|COMPLETED|6-Months to 24-Months||76
6346318|NCT00597935|7253964|FG001|COMPLETED|6-Months to 24-Months||79
6346319|NCT00597935|7253965|FG002|COMPLETED|6-Months to 24-Months||77
6346320|NCT00597935|7253966|FG003|COMPLETED|6-Months to 24-Months||85
6346321|NCT00597935|7253963|FG000|NOT COMPLETED|6-Months to 24-Months||17
6346322|NCT00597935|7253964|FG001|NOT COMPLETED|6-Months to 24-Months||8
6346323|NCT00597935|7253965|FG002|NOT COMPLETED|6-Months to 24-Months||10
6346324|NCT00597935|7253966|FG003|NOT COMPLETED|6-Months to 24-Months||8
6346325|NCT00598078|7253976|FG000|STARTED|Period 1 (Day 1)||10
6346326|NCT00598078|7253977|FG001|STARTED|Period 1 (Day 1)||10
6346327|NCT00598078|7253976|FG000|COMPLETED|Period 1 (Day 1)||10
6346328|NCT00598078|7253977|FG001|COMPLETED|Period 1 (Day 1)||10
6346329|NCT00598078|7253976|FG000|NOT COMPLETED|Period 1 (Day 1)||0
6346330|NCT00598078|7253977|FG001|NOT COMPLETED|Period 1 (Day 1)||0
6346331|NCT00598078|7253976|FG000|STARTED|Period 2 (Day 2)||10
6346332|NCT00598078|7253977|FG001|STARTED|Period 2 (Day 2)||10
6346333|NCT00598078|7253976|FG000|COMPLETED|Period 2 (Day 2)||9
6346334|NCT00598078|7253977|FG001|COMPLETED|Period 2 (Day 2)||10
6346335|NCT00598078|7253976|FG000|NOT COMPLETED|Period 2 (Day 2)||1
6346336|NCT00598078|7253977|FG001|NOT COMPLETED|Period 2 (Day 2)||0
6346337|NCT00598078|7253976|FG000|STARTED|Period 3 (Day 3)||9
6346338|NCT00598078|7253977|FG001|STARTED|Period 3 (Day 3)||10
6346339|NCT00598078|7253976|FG000|COMPLETED|Period 3 (Day 3)||9
6346340|NCT00598078|7253977|FG001|COMPLETED|Period 3 (Day 3)||10
6346341|NCT00598078|7253976|FG000|NOT COMPLETED|Period 3 (Day 3)||0
6346342|NCT00598078|7253977|FG001|NOT COMPLETED|Period 3 (Day 3)||0
6346343|NCT00598273|7253988|FG000|STARTED|Overall Study||161
6346344|NCT00598273|7253989|FG001|STARTED|Overall Study||165
6346345|NCT00598273|7253990|FG002|STARTED|Overall Study||164
6346346|NCT00598273|7253988|FG000|COMPLETED|Overall Study||120
6346347|NCT00598273|7253989|FG001|COMPLETED|Overall Study||127
6346348|NCT00598273|7253990|FG002|COMPLETED|Overall Study||125
6346349|NCT00598273|7253988|FG000|NOT COMPLETED|Overall Study||41
6346350|NCT00598273|7253989|FG001|NOT COMPLETED|Overall Study||38
6346351|NCT00598273|7253990|FG002|NOT COMPLETED|Overall Study||39
6346352|NCT00598442|7254001|FG000|STARTED|Overall Study||167
6346353|NCT00598442|7254002|FG001|STARTED|Overall Study||163
6346354|NCT00598442|7254003|FG002|STARTED|Overall Study||163
6346355|NCT00598442|7254001|FG000|COMPLETED|Overall Study||124
6346356|NCT00598442|7254002|FG001|COMPLETED|Overall Study||124
6346357|NCT00598442|7254003|FG002|COMPLETED|Overall Study||139
6346358|NCT00598442|7254001|FG000|NOT COMPLETED|Overall Study||43
6346359|NCT00598442|7254002|FG001|NOT COMPLETED|Overall Study||39
6346360|NCT00598442|7254003|FG002|NOT COMPLETED|Overall Study||24
6346361|NCT00598481|7254011|FG000|STARTED|Baseline||12
6346362|NCT00598481|7254011|FG000|COMPLETED|Baseline||12
6346363|NCT00598481|7254011|FG000|NOT COMPLETED|Baseline||0
6346364|NCT00598481|7254011|FG000|STARTED|Treatment||12
6346365|NCT00598481|7254011|FG000|COMPLETED|Treatment||11
6346366|NCT00598481|7254011|FG000|NOT COMPLETED|Treatment||1
6346367|NCT00598507|7254018|FG000|STARTED|Overall Study||35
6346368|NCT00598507|7254018|FG000|COMPLETED|Overall Study||35
6346369|NCT00598507|7254018|FG000|NOT COMPLETED|Overall Study||0
6346370|NCT00598559|7254025|FG000|STARTED|Overall Study||92
6346371|NCT00598559|7254026|FG001|STARTED|Overall Study||91
6346372|NCT00598559|7254027|FG002|STARTED|Overall Study||30
6346373|NCT00598559|7254025|FG000|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
6346374|NCT00598559|7254026|FG001|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
6346375|NCT00598559|7254027|FG002|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
6346376|NCT00598559|7254025|FG000|NOT COMPLETED|Overall Study||27
6346377|NCT00598559|7254026|FG001|NOT COMPLETED|Overall Study||28
6346378|NCT00598559|7254027|FG002|NOT COMPLETED|Overall Study||3
6346379|NCT00598585|7254037|FG000|STARTED|Overall Study||6
6346380|NCT00598585|7254038|FG001|STARTED|Overall Study||6
6346381|NCT00598585|7254037|FG000|COMPLETED|Overall Study||5
6346382|NCT00598585|7254038|FG001|COMPLETED|Overall Study||6
6346383|NCT00598585|7254037|FG000|NOT COMPLETED|Overall Study||1
6346384|NCT00598585|7254038|FG001|NOT COMPLETED|Overall Study||0
6346385|NCT00598650|7254044|FG000|STARTED|Overall Study||108
6346386|NCT00598650|7254044|FG000|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
6346387|NCT00598650|7254044|FG000|NOT COMPLETED|Overall Study||27
6346388|NCT00598663|7254051|FG000|STARTED|First Intervention (6 Months)||76
6346389|NCT00598663|7254052|FG001|STARTED|First Intervention (6 Months)||77
6346390|NCT00598663|7254051|FG000|COMPLETED|First Intervention (6 Months)||73
6346391|NCT00598663|7254052|FG001|COMPLETED|First Intervention (6 Months)||71
6346392|NCT00598663|7254051|FG000|NOT COMPLETED|First Intervention (6 Months)||3
6346393|NCT00598663|7254052|FG001|NOT COMPLETED|First Intervention (6 Months)||6
6346394|NCT00598663|7254051|FG000|STARTED|Washout (4 Months)||73
6346395|NCT00598663|7254052|FG001|STARTED|Washout (4 Months)||71
6346396|NCT00598663|7254051|FG000|COMPLETED|Washout (4 Months)||73
6346397|NCT00598663|7254052|FG001|COMPLETED|Washout (4 Months)||70
6346398|NCT00598663|7254051|FG000|NOT COMPLETED|Washout (4 Months)||0
6346399|NCT00598663|7254052|FG001|NOT COMPLETED|Washout (4 Months)||1
6346400|NCT00598663|7254051|FG000|STARTED|Second Intervention (6 Months)||73
6346401|NCT00598663|7254052|FG001|STARTED|Second Intervention (6 Months)||70
6346402|NCT00598663|7254051|FG000|COMPLETED|Second Intervention (6 Months)||69
6346403|NCT00598663|7254052|FG001|COMPLETED|Second Intervention (6 Months)||69
6346404|NCT00598663|7254051|FG000|NOT COMPLETED|Second Intervention (6 Months)||4
6346405|NCT00598663|7254052|FG001|NOT COMPLETED|Second Intervention (6 Months)||1
6346406|NCT00598689|7254063|FG000|STARTED|Overall Study||40
6346407|NCT00598689|7254064|FG001|STARTED|Overall Study||40
6346408|NCT00598689|7254063|FG000|COMPLETED|Overall Study||40
6346409|NCT00598689|7254064|FG001|COMPLETED|Overall Study||40
6346410|NCT00598689|7254063|FG000|NOT COMPLETED|Overall Study||0
6346411|NCT00598689|7254064|FG001|NOT COMPLETED|Overall Study||0
6346412|NCT00598702|7254078|FG000|STARTED|Overall Study||1
6346413|NCT00598702|7254079|FG001|STARTED|Overall Study||3
6346414|NCT00598702|7254080|FG002|STARTED|Overall Study||7
6346415|NCT00598702|7254081|FG003|STARTED|Overall Study||33
6346416|NCT00598702|7254082|FG004|STARTED|Overall Study||9
6346417|NCT00598702|7254083|FG005|STARTED|Overall Study||42
6346418|NCT00598702|7254084|FG006|STARTED|Overall Study||1
6346419|NCT00598702|7254085|FG007|STARTED|Overall Study||4
6346420|NCT00598702|7254078|FG000|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
6346421|NCT00598702|7254079|FG001|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
6346422|NCT00598702|7254080|FG002|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
6346423|NCT00598702|7254081|FG003|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
6346424|NCT00598702|7254082|FG004|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
6346425|NCT00598702|7254083|FG005|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
6346426|NCT00598702|7254084|FG006|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
6346427|NCT00598702|7254085|FG007|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
6346428|NCT00598702|7254078|FG000|NOT COMPLETED|Overall Study||0
6346429|NCT00598702|7254079|FG001|NOT COMPLETED|Overall Study||2
6346430|NCT00598702|7254080|FG002|NOT COMPLETED|Overall Study||2
6346431|NCT00598702|7254081|FG003|NOT COMPLETED|Overall Study||8
6346432|NCT00598702|7254082|FG004|NOT COMPLETED|Overall Study||3
6346433|NCT00598702|7254083|FG005|NOT COMPLETED|Overall Study||12
6346434|NCT00598702|7254084|FG006|NOT COMPLETED|Overall Study||1
6346435|NCT00598702|7254085|FG007|NOT COMPLETED|Overall Study||0
6346436|NCT00598806|7254105|FG000|STARTED|Overall Study||402
6346437|NCT00598806|7254106|FG001|STARTED|Overall Study||410
6346438|NCT00598806|7254105|FG000|COMPLETED|Overall Study||329
6346439|NCT00598806|7254106|FG001|COMPLETED|Overall Study||346
6346440|NCT00598806|7254105|FG000|NOT COMPLETED|Overall Study||73
6346441|NCT00598806|7254106|FG001|NOT COMPLETED|Overall Study||64
6346442|NCT00598819|7254112|FG000|STARTED|Overall Study||14
6346443|NCT00598819|7254112|FG000|COMPLETED|Overall Study||14
6346444|NCT00598819|7254112|FG000|NOT COMPLETED|Overall Study||0
6346445|NCT00598832|7254118|FG000|STARTED|Overall Study||533
6346446|NCT00598832|7254119|FG001|STARTED|Overall Study||542
6346447|NCT00598832|7254118|FG000|COMPLETED|Overall Study||471
6346448|NCT00598832|7254119|FG001|COMPLETED|Overall Study||460
6346449|NCT00598832|7254118|FG000|NOT COMPLETED|Overall Study||62
6346450|NCT00598832|7254119|FG001|NOT COMPLETED|Overall Study||82
6346451|NCT00598871|7254127|FG000|STARTED|Overall Study||3
6346452|NCT00598871|7254128|FG001|STARTED|Overall Study||9
6346453|NCT00598871|7254127|FG000|COMPLETED|Overall Study||3
6346454|NCT00598871|7254128|FG001|COMPLETED|Overall Study||8
6346455|NCT00598871|7254127|FG000|NOT COMPLETED|Overall Study||0
6346456|NCT00598871|7254128|FG001|NOT COMPLETED|Overall Study||1
6346457|NCT00598975|7254136|FG000|STARTED|Overall Study||12
6346458|NCT00598975|7254137|FG001|STARTED|Overall Study||6
6346459|NCT00598975|7254136|FG000|Completed Cycle 1|Overall Study||12
6346460|NCT00598975|7254137|FG001|Completed Cycle 1|Overall Study||6
6346461|NCT00598975|7254136|FG000|COMPLETED|Overall Study||0
6346462|NCT00598975|7254137|FG001|COMPLETED|Overall Study||0
6346463|NCT00598975|7254136|FG000|NOT COMPLETED|Overall Study||12
6346464|NCT00598975|7254137|FG001|NOT COMPLETED|Overall Study||6
6346465|NCT00599014|7254145|FG000|STARTED|Overall Study||335
6346466|NCT00599014|7254145|FG000|COMPLETED|Overall Study||335
6346467|NCT00599014|7254145|FG000|NOT COMPLETED|Overall Study||0
6376801|NCT00761202|7287378|FG000|NOT COMPLETED|Overall Study||1
6376802|NCT00761202|7287379|FG001|NOT COMPLETED|Overall Study||2
6376803|NCT00761215|7287388|FG000|STARTED|Overall Study||64
6376804|NCT00761215|7287389|FG001|STARTED|Overall Study||64
6376805|NCT00761215|7287390|FG002|STARTED|Overall Study||64
6376806|NCT00761215|7287388|FG000|COMPLETED|Overall Study||55
6376807|NCT00761215|7287389|FG001|COMPLETED|Overall Study||60
6376808|NCT00761215|7287390|FG002|COMPLETED|Overall Study||56
6376809|NCT00761215|7287388|FG000|NOT COMPLETED|Overall Study||9
6376810|NCT00761215|7287389|FG001|NOT COMPLETED|Overall Study||4
6376811|NCT00761215|7287390|FG002|NOT COMPLETED|Overall Study||8
6377903|NCT00765856|7288584|FG000|COMPLETED|Titration Period||24
6377904|NCT00765856|7288584|FG000|NOT COMPLETED|Titration Period||3
6377905|NCT00765856|7288584|FG000|STARTED|Maintenance Period||24
6377906|NCT00765856|7288584|FG000|COMPLETED|Maintenance Period||18
6377907|NCT00765856|7288584|FG000|NOT COMPLETED|Maintenance Period||6
6377908|NCT00765882|7288594|FG000|STARTED|Overall Study||215
6377909|NCT00765882|7288595|FG001|STARTED|Overall Study||213
6377910|NCT00765882|7288596|FG002|STARTED|Overall Study||205
6377911|NCT00765882|7288594|FG000|COMPLETED|Overall Study||191
6377912|NCT00765882|7288595|FG001|COMPLETED|Overall Study||173
6377913|NCT00765882|7288596|FG002|COMPLETED|Overall Study||169
6377914|NCT00765882|7288594|FG000|NOT COMPLETED|Overall Study||24
6377915|NCT00765882|7288595|FG001|NOT COMPLETED|Overall Study||40
6377916|NCT00765882|7288596|FG002|NOT COMPLETED|Overall Study||36
6377917|NCT00765895|7288606|FG000|STARTED|Overall Study||65
6377918|NCT00765895|7288607|FG001|STARTED|Overall Study||65
6377919|NCT00765895|7288606|FG000|COMPLETED|Overall Study||65
6377920|NCT00765895|7288607|FG001|COMPLETED|Overall Study||65
6377921|NCT00765895|7288606|FG000|NOT COMPLETED|Overall Study||0
6377922|NCT00765895|7288607|FG001|NOT COMPLETED|Overall Study||0
6377923|NCT00765947|7288613|FG000|STARTED|Overall Study||256
6377924|NCT00765947|7288613|FG000|COMPLETED|Overall Study||232
6377925|NCT00765947|7288613|FG000|NOT COMPLETED|Overall Study||24
6377926|NCT00765999|7288619|FG000|STARTED|Overall Study||1554
6377927|NCT00765999|7288619|FG000|COMPLETED|Overall Study||770
6377928|NCT00765999|7288619|FG000|NOT COMPLETED|Overall Study||784
6377929|NCT00766038|7288627|FG000|STARTED|Overall Study||31
6377930|NCT00766038|7288628|FG001|STARTED|Overall Study||32
6377931|NCT00766038|7288627|FG000|COMPLETED|Overall Study||16
6377932|NCT00766038|7288628|FG001|COMPLETED|Overall Study||18
6377933|NCT00766038|7288627|FG000|NOT COMPLETED|Overall Study||15
6377934|NCT00766038|7288628|FG001|NOT COMPLETED|Overall Study||14
6377935|NCT00766051|7288638|FG000|STARTED|Overall Study||12
6377936|NCT00766051|7288639|FG001|STARTED|Overall Study||10
6377937|NCT00766051|7288638|FG000|COMPLETED|Overall Study||10
6377938|NCT00766051|7288639|FG001|COMPLETED|Overall Study||10
6377939|NCT00766051|7288638|FG000|NOT COMPLETED|Overall Study||2
6377940|NCT00766051|7288639|FG001|NOT COMPLETED|Overall Study||0
6377941|NCT00766090|7288649|FG000|STARTED|Treatment Period 1 (28 Days)||25
6377942|NCT00766090|7288650|FG001|STARTED|Treatment Period 1 (28 Days)||27
6377943|NCT00766090|7288651|FG002|STARTED|Treatment Period 1 (28 Days)||23
6377944|NCT00766090|7288652|FG003|STARTED|Treatment Period 1 (28 Days)||26
6377945|NCT00766090|7288653|FG004|STARTED|Treatment Period 1 (28 Days)||23
6377946|NCT00766090|7288654|FG005|STARTED|Treatment Period 1 (28 Days)||23
6377947|NCT00766090|7288655|FG006|STARTED|Treatment Period 1 (28 Days)||6
6377948|NCT00766090|7288656|FG007|STARTED|Treatment Period 1 (28 Days)||8
6377949|NCT00766090|7288657|FG008|STARTED|Treatment Period 1 (28 Days)||7
6377950|NCT00766090|7288658|FG009|STARTED|Treatment Period 1 (28 Days)||8
6377951|NCT00766090|7288659|FG010|STARTED|Treatment Period 1 (28 Days)||7
6377952|NCT00766090|7288660|FG011|STARTED|Treatment Period 1 (28 Days)||7
6377953|NCT00766090|7288649|FG000|COMPLETED|Treatment Period 1 (28 Days)||22
6377954|NCT00766090|7288650|FG001|COMPLETED|Treatment Period 1 (28 Days)||27
6377955|NCT00766090|7288651|FG002|COMPLETED|Treatment Period 1 (28 Days)||23
6346468|NCT00599053|7254151|FG000|STARTED|Overall Study||5
6346469|NCT00599053|7254152|FG001|STARTED|Overall Study||2
6346470|NCT00599053|7254151|FG000|COMPLETED|Overall Study||5
6346471|NCT00599053|7254152|FG001|COMPLETED|Overall Study||2
6346472|NCT00599053|7254151|FG000|NOT COMPLETED|Overall Study||0
6346473|NCT00599053|7254152|FG001|NOT COMPLETED|Overall Study||0
6346474|NCT00599196|7254158|FG000|STARTED|Overall Study||381
6346475|NCT00599196|7254158|FG000|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
6346476|NCT00599196|7254158|FG000|NOT COMPLETED|Overall Study||381
6346477|NCT00599248|7254164|FG000|STARTED|Overall Study||3
6346478|NCT00599248|7254165|FG001|STARTED|Overall Study||3
6346479|NCT00599248|7254166|FG002|STARTED|Overall Study||3
6346480|NCT00599248|7254167|FG003|STARTED|Overall Study||3
6346481|NCT00599248|7254164|FG000|COMPLETED|Overall Study||3
6346482|NCT00599248|7254165|FG001|COMPLETED|Overall Study||3
6346483|NCT00599248|7254166|FG002|COMPLETED|Overall Study||3
6346484|NCT00599248|7254167|FG003|COMPLETED|Overall Study||3
6346485|NCT00599248|7254164|FG000|NOT COMPLETED|Overall Study||0
6346486|NCT00599248|7254165|FG001|NOT COMPLETED|Overall Study||0
6346487|NCT00599248|7254166|FG002|NOT COMPLETED|Overall Study||0
6346488|NCT00599248|7254167|FG003|NOT COMPLETED|Overall Study||0
6346489|NCT00599313|7254176|FG000|STARTED|Overall Study||36
6346490|NCT00599313|7254176|FG000|COMPLETED|Overall Study||0
6346491|NCT00599313|7254176|FG000|NOT COMPLETED|Overall Study||36
6346492|NCT00599326|7254180|FG000|STARTED|Overall Study||10
6346493|NCT00599326|7254180|FG000|COMPLETED|Overall Study||8
6346494|NCT00599326|7254180|FG000|NOT COMPLETED|Overall Study||2
6346495|NCT00599339|7254184|FG000|STARTED|Overall Study||2195
6346496|NCT00599339|7254184|FG000|Safety Set|Overall Study||2179
6559437|NCT01781572|7482138|FG001|STARTED|MEK162 45mg BID+LEE011 300mg||4
6776415|NCT03834025|7704478|FG005|COMPLETED|Sent Recruitment Letter (Phase 1)||0
6776416|NCT03834025|7704479|FG006|COMPLETED|Sent Recruitment Letter (Phase 1)||0
6346497|NCT00599339|7254184|FG000|COMPLETED|Overall Study||1531
6346498|NCT00599339|7254184|FG000|NOT COMPLETED|Overall Study||664
6346499|NCT00599521|7254208|FG000|STARTED|Overall Study||535
6346500|NCT00599521|7254209|FG001|STARTED|Overall Study||531
6346501|NCT00599521|7254208|FG000|COMPLETED|Overall Study||475
6346502|NCT00599521|7254209|FG001|COMPLETED|Overall Study||462
6346503|NCT00599521|7254208|FG000|NOT COMPLETED|Overall Study||60
6346504|NCT00599521|7254209|FG001|NOT COMPLETED|Overall Study||69
6346505|NCT00599638|7254219|FG000|STARTED|First Intervention Period (2 Weeks)||16
6346506|NCT00599638|7254220|FG001|STARTED|First Intervention Period (2 Weeks)||14
6346507|NCT00599638|7254221|FG002|STARTED|First Intervention Period (2 Weeks)||20
6346508|NCT00599638|7254222|FG003|STARTED|First Intervention Period (2 Weeks)||22
6346509|NCT00599638|7254219|FG000|Treated|First Intervention Period (2 Weeks)||16
6346510|NCT00599638|7254220|FG001|Treated|First Intervention Period (2 Weeks)||13
6346511|NCT00599638|7254221|FG002|Treated|First Intervention Period (2 Weeks)||20
6346512|NCT00599638|7254222|FG003|Treated|First Intervention Period (2 Weeks)||21
6346513|NCT00599638|7254219|FG000|COMPLETED|First Intervention Period (2 Weeks)||14
6346514|NCT00599638|7254220|FG001|COMPLETED|First Intervention Period (2 Weeks)||12
6346515|NCT00599638|7254221|FG002|COMPLETED|First Intervention Period (2 Weeks)||17
6346516|NCT00599638|7254222|FG003|COMPLETED|First Intervention Period (2 Weeks)||17
6346517|NCT00599638|7254219|FG000|NOT COMPLETED|First Intervention Period (2 Weeks)||2
6346518|NCT00599638|7254220|FG001|NOT COMPLETED|First Intervention Period (2 Weeks)||2
6346519|NCT00599638|7254221|FG002|NOT COMPLETED|First Intervention Period (2 Weeks)||3
6346520|NCT00599638|7254222|FG003|NOT COMPLETED|First Intervention Period (2 Weeks)||5
6346521|NCT00599638|7254219|FG000|STARTED|Washout Period (2 Weeks)||14
6346522|NCT00599638|7254220|FG001|STARTED|Washout Period (2 Weeks)||12
6346523|NCT00599638|7254221|FG002|STARTED|Washout Period (2 Weeks)||17
6346524|NCT00599638|7254222|FG003|STARTED|Washout Period (2 Weeks)||17
6346525|NCT00599638|7254219|FG000|COMPLETED|Washout Period (2 Weeks)||13
6346526|NCT00599638|7254220|FG001|COMPLETED|Washout Period (2 Weeks)||11
6346527|NCT00599638|7254221|FG002|COMPLETED|Washout Period (2 Weeks)||17
6346528|NCT00599638|7254222|FG003|COMPLETED|Washout Period (2 Weeks)||14
6346529|NCT00599638|7254219|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
6346530|NCT00599638|7254220|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
6346531|NCT00599638|7254221|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
6346532|NCT00599638|7254222|FG003|NOT COMPLETED|Washout Period (2 Weeks)||3
6346533|NCT00599638|7254219|FG000|STARTED|Second Intervention Period (2 Weeks)||13
6346534|NCT00599638|7254220|FG001|STARTED|Second Intervention Period (2 Weeks)||11
6346535|NCT00599638|7254221|FG002|STARTED|Second Intervention Period (2 Weeks)||17
6346536|NCT00599638|7254222|FG003|STARTED|Second Intervention Period (2 Weeks)||14
6346537|NCT00599638|7254219|FG000|COMPLETED|Second Intervention Period (2 Weeks)||12
6776417|NCT03834025|7704473|FG000|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4114
6776418|NCT03834025|7704474|FG001|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3835
6776419|NCT03834025|7704475|FG002|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||4077
6776420|NCT03834025|7704476|FG003|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||3649
6776421|NCT03834025|7704477|FG004|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
6776422|NCT03834025|7704478|FG005|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
6776423|NCT03834025|7704479|FG006|NOT COMPLETED|Sent Recruitment Letter (Phase 1)||0
6776424|NCT03834025|7704473|FG000|STARTED|Randomized to Payment Condition(Phase 2)||0
6776425|NCT03834025|7704474|FG001|STARTED|Randomized to Payment Condition(Phase 2)||0
6780848|NCT02806960|7709411|FG003|NOT COMPLETED|Period 1||3
6346538|NCT00599638|7254220|FG001|COMPLETED|Second Intervention Period (2 Weeks)||11
6346539|NCT00599638|7254221|FG002|COMPLETED|Second Intervention Period (2 Weeks)||17
6346540|NCT00599638|7254222|FG003|COMPLETED|Second Intervention Period (2 Weeks)||14
6346541|NCT00599638|7254219|FG000|NOT COMPLETED|Second Intervention Period (2 Weeks)||1
6346542|NCT00599638|7254220|FG001|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
6346543|NCT00599638|7254221|FG002|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
6346544|NCT00599638|7254222|FG003|NOT COMPLETED|Second Intervention Period (2 Weeks)||0
6346545|NCT00599755|7254230|FG000|STARTED|Overall Study||68
6346546|NCT00599755|7254230|FG000|COMPLETED|Overall Study||49
6346547|NCT00599755|7254230|FG000|NOT COMPLETED|Overall Study||19
6346548|NCT00599872|7254236|FG000|STARTED|Overall Study||216
6346549|NCT00599872|7254237|FG001|STARTED|Overall Study||214
6346550|NCT00599872|7254236|FG000|COMPLETED|Overall Study||167
6346551|NCT00599872|7254237|FG001|COMPLETED|Overall Study||181
6346552|NCT00599872|7254236|FG000|NOT COMPLETED|Overall Study||49
6346553|NCT00599872|7254237|FG001|NOT COMPLETED|Overall Study||33
6346554|NCT00599924|7254254|FG000|STARTED|Overall Study||4
6346555|NCT00599924|7254255|FG001|STARTED|Overall Study||9
6346556|NCT00599924|7254256|FG002|STARTED|Overall Study||5
6346557|NCT00599924|7254257|FG003|STARTED|Overall Study||12
6346558|NCT00599924|7254258|FG004|STARTED|Overall Study||9
6346559|NCT00599924|7254259|FG005|STARTED|Overall Study||6
6346560|NCT00599924|7254260|FG006|STARTED|Overall Study||8
6346561|NCT00599924|7254254|FG000|COMPLETED|Overall Study||1
6346562|NCT00599924|7254255|FG001|COMPLETED|Overall Study||4
6346563|NCT00599924|7254256|FG002|COMPLETED|Overall Study||3
6346564|NCT00599924|7254257|FG003|COMPLETED|Overall Study||4
6346565|NCT00599924|7254258|FG004|COMPLETED|Overall Study||3
6346566|NCT00599924|7254259|FG005|COMPLETED|Overall Study||2
6346567|NCT00599924|7254260|FG006|COMPLETED|Overall Study||3
6346568|NCT00599924|7254254|FG000|NOT COMPLETED|Overall Study||3
6346569|NCT00599924|7254255|FG001|NOT COMPLETED|Overall Study||5
6346570|NCT00599924|7254256|FG002|NOT COMPLETED|Overall Study||2
6346571|NCT00599924|7254257|FG003|NOT COMPLETED|Overall Study||8
6346572|NCT00599924|7254258|FG004|NOT COMPLETED|Overall Study||6
6346573|NCT00599924|7254259|FG005|NOT COMPLETED|Overall Study||4
6346574|NCT00599924|7254260|FG006|NOT COMPLETED|Overall Study||5
6346575|NCT00600028|7254283|FG000|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
6346576|NCT00600028|7254284|FG001|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
6346577|NCT00600028|7254283|FG000|COMPLETED|First Intervention (12 Weeks)||12
6346578|NCT00600028|7254284|FG001|COMPLETED|First Intervention (12 Weeks)||10
6346579|NCT00600028|7254283|FG000|NOT COMPLETED|First Intervention (12 Weeks)||1
6346580|NCT00600028|7254284|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
6346581|NCT00600028|7254283|FG000|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
6346582|NCT00600028|7254284|FG001|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
6346583|NCT00600028|7254283|FG000|COMPLETED|Second Intervention (12 Weeks)||12
6346584|NCT00600028|7254284|FG001|COMPLETED|Second Intervention (12 Weeks)||8
6346585|NCT00600028|7254283|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
6346586|NCT00600028|7254284|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||2
6346587|NCT00600067|7254295|FG000|STARTED|Overall Study||55
6346588|NCT00600067|7254296|FG001|STARTED|Overall Study||75
6346589|NCT00600067|7254295|FG000|COMPLETED|Overall Study||52
6346590|NCT00600067|7254296|FG001|COMPLETED|Overall Study||68
6346591|NCT00600067|7254295|FG000|NOT COMPLETED|Overall Study||3
6346592|NCT00600067|7254296|FG001|NOT COMPLETED|Overall Study||7
6346593|NCT00600080|7254303|FG000|STARTED|Period 1: Baseline to One-week||28
6346594|NCT00600080|7254304|FG001|STARTED|Period 1: Baseline to One-week||32
6346595|NCT00600080|7254303|FG000|COMPLETED|Period 1: Baseline to One-week||28
6346596|NCT00600080|7254304|FG001|COMPLETED|Period 1: Baseline to One-week||32
6346597|NCT00600080|7254303|FG000|NOT COMPLETED|Period 1: Baseline to One-week||0
6346598|NCT00600080|7254304|FG001|NOT COMPLETED|Period 1: Baseline to One-week||0
6346599|NCT00600080|7254303|FG000|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
6346600|NCT00600080|7254304|FG001|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
6346601|NCT00600080|7254303|FG000|COMPLETED|Period 2: One-week to Two-weeks||28
6346602|NCT00600080|7254304|FG001|COMPLETED|Period 2: One-week to Two-weeks||32
6346603|NCT00600080|7254303|FG000|NOT COMPLETED|Period 2: One-week to Two-weeks||0
6346604|NCT00600080|7254304|FG001|NOT COMPLETED|Period 2: One-week to Two-weeks||0
6346605|NCT00600106|7254312|FG000|STARTED|Overall Study||18
6346606|NCT00600106|7254313|FG001|STARTED|Overall Study||19
6346607|NCT00600106|7254312|FG000|COMPLETED|Overall Study||17
6346608|NCT00600106|7254313|FG001|COMPLETED|Overall Study||18
6346609|NCT00600106|7254312|FG000|NOT COMPLETED|Overall Study||1
6346610|NCT00600106|7254313|FG001|NOT COMPLETED|Overall Study||1
6346611|NCT00600119|7254325|FG000|STARTED|Single-blind Placebo run-in Period||36
6346612|NCT00600119|7254326|FG001|STARTED|Single-blind Placebo run-in Period||35
6346613|NCT00600119|7254327|FG002|STARTED|Single-blind Placebo run-in Period||29
6346614|NCT00600119|7254328|FG003|STARTED|Single-blind Placebo run-in Period||31
6346615|NCT00600119|7254329|FG004|STARTED|Single-blind Placebo run-in Period||39
6346616|NCT00600119|7254330|FG005|STARTED|Single-blind Placebo run-in Period||37
6346617|NCT00600119|7254325|FG000|COMPLETED|Single-blind Placebo run-in Period||32
6346618|NCT00600119|7254326|FG001|COMPLETED|Single-blind Placebo run-in Period||33
6346619|NCT00600119|7254327|FG002|COMPLETED|Single-blind Placebo run-in Period||27
6346620|NCT00600119|7254328|FG003|COMPLETED|Single-blind Placebo run-in Period||30
6346621|NCT00600119|7254329|FG004|COMPLETED|Single-blind Placebo run-in Period||37
6346622|NCT00600119|7254330|FG005|COMPLETED|Single-blind Placebo run-in Period||35
6346623|NCT00600119|7254325|FG000|NOT COMPLETED|Single-blind Placebo run-in Period||4
6346624|NCT00600119|7254326|FG001|NOT COMPLETED|Single-blind Placebo run-in Period||2
6346625|NCT00600119|7254327|FG002|NOT COMPLETED|Single-blind Placebo run-in Period||2
6346626|NCT00600119|7254328|FG003|NOT COMPLETED|Single-blind Placebo run-in Period||1
6346627|NCT00600119|7254329|FG004|NOT COMPLETED|Single-blind Placebo run-in Period||2
6346628|NCT00600119|7254330|FG005|NOT COMPLETED|Single-blind Placebo run-in Period||2
6346629|NCT00600119|7254325|FG000|STARTED|Double-blind Treatment Period||32
6346630|NCT00600119|7254326|FG001|STARTED|Double-blind Treatment Period||33
6346631|NCT00600119|7254327|FG002|STARTED|Double-blind Treatment Period||27
6346632|NCT00600119|7254328|FG003|STARTED|Double-blind Treatment Period||30
6346633|NCT00600119|7254329|FG004|STARTED|Double-blind Treatment Period||37
6346634|NCT00600119|7254330|FG005|STARTED|Double-blind Treatment Period||35
6346635|NCT00600119|7254325|FG000|COMPLETED|Double-blind Treatment Period||27
6346636|NCT00600119|7254326|FG001|COMPLETED|Double-blind Treatment Period||28
6346637|NCT00600119|7254327|FG002|COMPLETED|Double-blind Treatment Period||27
6346638|NCT00600119|7254328|FG003|COMPLETED|Double-blind Treatment Period||28
6346639|NCT00600119|7254329|FG004|COMPLETED|Double-blind Treatment Period||31
6346640|NCT00600119|7254330|FG005|COMPLETED|Double-blind Treatment Period||21
6346641|NCT00600119|7254325|FG000|NOT COMPLETED|Double-blind Treatment Period||5
6346642|NCT00600119|7254326|FG001|NOT COMPLETED|Double-blind Treatment Period||5
6346643|NCT00600119|7254327|FG002|NOT COMPLETED|Double-blind Treatment Period||0
6346644|NCT00600119|7254328|FG003|NOT COMPLETED|Double-blind Treatment Period||2
6346645|NCT00600119|7254329|FG004|NOT COMPLETED|Double-blind Treatment Period||6
6346646|NCT00600119|7254330|FG005|NOT COMPLETED|Double-blind Treatment Period||14
6346647|NCT00600119|7254325|FG000|STARTED|Follow-up Period||27
6346648|NCT00600119|7254326|FG001|STARTED|Follow-up Period||28
6346649|NCT00600119|7254327|FG002|STARTED|Follow-up Period||27
6346650|NCT00600119|7254328|FG003|STARTED|Follow-up Period||28
6346651|NCT00600119|7254329|FG004|STARTED|Follow-up Period||31
6346652|NCT00600119|7254330|FG005|STARTED|Follow-up Period||21
6346653|NCT00600119|7254325|FG000|COMPLETED|Follow-up Period||26
6346654|NCT00600119|7254326|FG001|COMPLETED|Follow-up Period||28
6346655|NCT00600119|7254327|FG002|COMPLETED|Follow-up Period||27
6346656|NCT00600119|7254328|FG003|COMPLETED|Follow-up Period||28
6346657|NCT00600119|7254329|FG004|COMPLETED|Follow-up Period||31
6346658|NCT00600119|7254330|FG005|COMPLETED|Follow-up Period||20
6346659|NCT00600119|7254325|FG000|NOT COMPLETED|Follow-up Period||1
6346660|NCT00600119|7254326|FG001|NOT COMPLETED|Follow-up Period||0
6346661|NCT00600119|7254327|FG002|NOT COMPLETED|Follow-up Period||0
6346662|NCT00600119|7254328|FG003|NOT COMPLETED|Follow-up Period||0
6346663|NCT00600119|7254329|FG004|NOT COMPLETED|Follow-up Period||0
6346664|NCT00600119|7254330|FG005|NOT COMPLETED|Follow-up Period||1
6346665|NCT00600171|7254350|FG000|STARTED|Overall Study||102
6346666|NCT00600171|7254351|FG001|STARTED|Overall Study||101
6346667|NCT00600171|7254352|FG002|STARTED|Overall Study||101
6346668|NCT00600171|7254353|FG003|STARTED|Overall Study||100
6346669|NCT00600171|7254354|FG004|STARTED|Overall Study||101
6346670|NCT00600171|7254355|FG005|STARTED|Overall Study||102
6346671|NCT00600171|7254350|FG000|COMPLETED|Overall Study||86
6346672|NCT00600171|7254351|FG001|COMPLETED|Overall Study||84
6346673|NCT00600171|7254352|FG002|COMPLETED|Overall Study||91
6346674|NCT00600171|7254353|FG003|COMPLETED|Overall Study||88
6346675|NCT00600171|7254354|FG004|COMPLETED|Overall Study||93
6346676|NCT00600171|7254355|FG005|COMPLETED|Overall Study||97
6346677|NCT00600171|7254350|FG000|NOT COMPLETED|Overall Study||16
6346678|NCT00600171|7254351|FG001|NOT COMPLETED|Overall Study||17
6346679|NCT00600171|7254352|FG002|NOT COMPLETED|Overall Study||10
6346680|NCT00600171|7254353|FG003|NOT COMPLETED|Overall Study||12
6346681|NCT00600171|7254354|FG004|NOT COMPLETED|Overall Study||8
6346682|NCT00600171|7254355|FG005|NOT COMPLETED|Overall Study||5
6346683|NCT00600340|7254373|FG000|STARTED|Overall Study||285
6346684|NCT00600340|7254374|FG001|STARTED|Overall Study||279
6346685|NCT00600340|7254373|FG000|COMPLETED|Overall Study||285
6346686|NCT00600340|7254374|FG001|COMPLETED|Overall Study||279
6346687|NCT00600340|7254373|FG000|NOT COMPLETED|Overall Study||0
6346688|NCT00600340|7254374|FG001|NOT COMPLETED|Overall Study||0
6346689|NCT00600353|7254382|FG000|STARTED|Overall Study||10
6346690|NCT00600353|7254383|FG001|STARTED|Overall Study||10
6346691|NCT00600353|7254382|FG000|COMPLETED|Overall Study||9
6346692|NCT00600353|7254383|FG001|COMPLETED|Overall Study||9
6346693|NCT00600353|7254382|FG000|NOT COMPLETED|Overall Study||1
6346694|NCT00600353|7254383|FG001|NOT COMPLETED|Overall Study||1
6346695|NCT00600613|7254389|FG000|STARTED|Overall Study||6
6346696|NCT00600613|7254389|FG000|COMPLETED|Overall Study||5
6346697|NCT00600613|7254389|FG000|NOT COMPLETED|Overall Study||1
6346698|NCT00600704|7254395|FG000|STARTED|Overall Study||100
6346699|NCT00600704|7254396|FG001|STARTED|Overall Study||92
6346700|NCT00600704|7254395|FG000|COMPLETED|Overall Study||100
6559438|NCT01781572|7482139|FG002|STARTED|MEK162 45mg BID+LEE011 300mg||0
6559439|NCT01781572|7482137|FG000|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
6559440|NCT01781572|7482138|FG001|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
6559441|NCT01781572|7482139|FG002|COMPLETED|MEK162 45mg BID+LEE011 300mg||0
6559442|NCT01781572|7482137|FG000|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||6
6346701|NCT00600704|7254396|FG001|COMPLETED|Overall Study||92
6346702|NCT00600704|7254395|FG000|NOT COMPLETED|Overall Study||0
6346703|NCT00600704|7254396|FG001|NOT COMPLETED|Overall Study||0
6346704|NCT00600743|7254406|FG000|STARTED|Overall Study||4
6346705|NCT00600743|7254407|FG001|STARTED|Overall Study||4
6346706|NCT00600743|7254408|FG002|STARTED|Overall Study||8
6346707|NCT00600743|7254409|FG003|STARTED|Overall Study||7
6346708|NCT00600743|7254406|FG000|COMPLETED|Overall Study||4
6346709|NCT00600743|7254407|FG001|COMPLETED|Overall Study||4
6346710|NCT00600743|7254408|FG002|COMPLETED|Overall Study||8
6346711|NCT00600743|7254409|FG003|COMPLETED|Overall Study||7
6346712|NCT00600743|7254406|FG000|NOT COMPLETED|Overall Study||0
6346713|NCT00600743|7254407|FG001|NOT COMPLETED|Overall Study||0
6346714|NCT00600743|7254408|FG002|NOT COMPLETED|Overall Study||0
6346715|NCT00600743|7254409|FG003|NOT COMPLETED|Overall Study||0
6346716|NCT00600756|7254430|FG000|STARTED|Analysis After 6 Months||395
6346717|NCT00600756|7254431|FG001|STARTED|Analysis After 6 Months||403
6346718|NCT00600756|7254430|FG000|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
6346719|NCT00600756|7254431|FG001|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
6346720|NCT00600756|7254430|FG000|NOT COMPLETED|Analysis After 6 Months||131
6346721|NCT00600756|7254431|FG001|NOT COMPLETED|Analysis After 6 Months||120
6346722|NCT00600756|7254430|FG000|STARTED|Overall Study Analysis After 12 Months||395
6346723|NCT00600756|7254431|FG001|STARTED|Overall Study Analysis After 12 Months||403
6346724|NCT00600756|7254430|FG000|Randomized Analysis|Overall Study Analysis After 12 Months||395
6346725|NCT00600756|7254431|FG001|Randomized Analysis|Overall Study Analysis After 12 Months||403
6346726|NCT00600756|7254430|FG000|Safety Analysis|Overall Study Analysis After 12 Months||391
6346727|NCT00600756|7254431|FG001|Safety Analysis|Overall Study Analysis After 12 Months||402
6346728|NCT00600756|7254430|FG000|ITT Analysis|Overall Study Analysis After 12 Months||379
6346729|NCT00600756|7254431|FG001|ITT Analysis|Overall Study Analysis After 12 Months||392
6346730|NCT00600756|7254430|FG000|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
6346731|NCT00600756|7254431|FG001|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
6346732|NCT00600756|7254430|FG000|NOT COMPLETED|Overall Study Analysis After 12 Months||183
6346733|NCT00600756|7254431|FG001|NOT COMPLETED|Overall Study Analysis After 12 Months||176
6346734|NCT00600821|7254439|FG000|STARTED|Overall Study||58
6346735|NCT00600821|7254440|FG001|STARTED|Overall Study||60
6346736|NCT00600821|7254439|FG000|Treated|Overall Study||58
6346737|NCT00600821|7254440|FG001|Treated|Overall Study||59
6346738|NCT00600821|7254439|FG000|COMPLETED|Overall Study||0
6346739|NCT00600821|7254440|FG001|COMPLETED|Overall Study||0
6346740|NCT00600821|7254439|FG000|NOT COMPLETED|Overall Study||58
6346741|NCT00600821|7254440|FG001|NOT COMPLETED|Overall Study||60
6346742|NCT00600886|7254450|FG000|STARTED|Core Phase - Full Analysis Set (FAS)||176
6346743|NCT00600886|7254451|FG001|STARTED|Core Phase - Full Analysis Set (FAS)||182
6346744|NCT00600886|7254450|FG000|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
6346745|NCT00600886|7254451|FG001|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
6346746|NCT00600886|7254450|FG000|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
6346747|NCT00600886|7254451|FG001|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
6346748|NCT00600886|7254450|FG000|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
6346749|NCT00600886|7254451|FG001|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
6346750|NCT00600886|7254450|FG000|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
6346751|NCT00600886|7254451|FG001|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
6346752|NCT00600886|7254450|FG000|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
6346753|NCT00600886|7254451|FG001|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
6346754|NCT00600886|7254450|FG000|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
6346755|NCT00600886|7254451|FG001|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
6346756|NCT00600886|7254450|FG000|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
6346757|NCT00600886|7254451|FG001|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
6346758|NCT00600886|7254450|FG000|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
6346759|NCT00600886|7254451|FG001|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
6346760|NCT00600886|7254450|FG000|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
6346761|NCT00600886|7254451|FG001|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
6346762|NCT00600886|7254450|FG000|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
6346763|NCT00600886|7254451|FG001|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
6376812|NCT00761267|7287404|FG000|STARTED|Overall Study||20
6346764|NCT00600886|7254450|FG000|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
6346765|NCT00600886|7254451|FG001|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
6346766|NCT00600886|7254450|FG000|NOT COMPLETED|Extension - Same Treatment (FAS)||46
6346767|NCT00600886|7254451|FG001|NOT COMPLETED|Extension - Same Treatment (FAS)||11
6346768|NCT00600886|7254450|FG000|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
6346769|NCT00600886|7254451|FG001|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
6346770|NCT00600886|7254450|FG000|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
6346771|NCT00600886|7254451|FG001|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
6346772|NCT00600886|7254450|FG000|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
6346773|NCT00600886|7254451|FG001|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
6559443|NCT01781572|7482138|FG001|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||4
6559444|NCT01781572|7482139|FG002|NOT COMPLETED|MEK162 45mg BID+LEE011 300mg||0
6559445|NCT01781572|7482137|FG000|STARTED|MEK162 30mg LEE011 200mg||0
6559446|NCT01781572|7482138|FG001|STARTED|MEK162 30mg LEE011 200mg||5
6559447|NCT01781572|7482139|FG002|STARTED|MEK162 30mg LEE011 200mg||0
6559448|NCT01781572|7482137|FG000|COMPLETED|MEK162 30mg LEE011 200mg||0
6559449|NCT01781572|7482138|FG001|COMPLETED|MEK162 30mg LEE011 200mg||0
6559450|NCT01781572|7482139|FG002|COMPLETED|MEK162 30mg LEE011 200mg||0
6346774|NCT00600886|7254450|FG000|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
6346775|NCT00600886|7254451|FG001|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
6346776|NCT00600886|7254450|FG000|Discontinued After M26|Extension - After Crossover (CAS)||31
6346777|NCT00600886|7254451|FG001|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
6346778|NCT00600886|7254450|FG000|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
6346779|NCT00600886|7254451|FG001|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
6346780|NCT00600886|7254450|FG000|NOT COMPLETED|Extension - After Crossover (CAS)||62
6346781|NCT00600886|7254451|FG001|NOT COMPLETED|Extension - After Crossover (CAS)||13
6346782|NCT00600925|7254473|FG000|STARTED|Overall Study||300
6346783|NCT00600925|7254474|FG001|STARTED|Overall Study||302
6346784|NCT00600925|7254473|FG000|COMPLETED|Overall Study||300
6346785|NCT00600925|7254474|FG001|COMPLETED|Overall Study||302
6346786|NCT00600925|7254473|FG000|NOT COMPLETED|Overall Study||0
6346787|NCT00600925|7254474|FG001|NOT COMPLETED|Overall Study||0
6346788|NCT00600938|7254482|FG000|STARTED|Core Study||98
6346789|NCT00600938|7254483|FG001|STARTED|Core Study||99
6346790|NCT00600938|7254484|FG002|STARTED|Core Study||0
6346791|NCT00600938|7254485|FG003|STARTED|Core Study||0
6346792|NCT00600938|7254482|FG000|Core Safety Set|Core Study||96
6346793|NCT00600938|7254483|FG001|Core Safety Set|Core Study||91
6346794|NCT00600938|7254484|FG002|Core Safety Set|Core Study||0
6346795|NCT00600938|7254485|FG003|Core Safety Set|Core Study||0
6346796|NCT00600938|7254482|FG000|Per Protocol Set (PPS)|Core Study||91
6346797|NCT00600938|7254483|FG001|Per Protocol Set (PPS)|Core Study||81
6346798|NCT00600938|7254484|FG002|Per Protocol Set (PPS)|Core Study||0
6346799|NCT00600938|7254485|FG003|Per Protocol Set (PPS)|Core Study||0
6346800|NCT00600938|7254482|FG000|COMPLETED|Core Study||82
6346801|NCT00600938|7254483|FG001|COMPLETED|Core Study||78
6346802|NCT00600938|7254484|FG002|COMPLETED|Core Study||0
6346803|NCT00600938|7254485|FG003|COMPLETED|Core Study||0
6346804|NCT00600938|7254482|FG000|NOT COMPLETED|Core Study||16
6346805|NCT00600938|7254483|FG001|NOT COMPLETED|Core Study||21
6346806|NCT00600938|7254484|FG002|NOT COMPLETED|Core Study||0
6346807|NCT00600938|7254485|FG003|NOT COMPLETED|Core Study||0
6346808|NCT00600938|7254482|FG000|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
6346809|NCT00600938|7254483|FG001|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
6346810|NCT00600938|7254484|FG002|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
6346811|NCT00600938|7254485|FG003|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
6346812|NCT00600938|7254482|FG000|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
6346813|NCT00600938|7254483|FG001|Extension Safety Set|Extension Study||29
6346814|NCT00600938|7254484|FG002|Extension Safety Set|Extension Study||42
6346815|NCT00600938|7254485|FG003|Extension Safety Set|Extension Study||1
6346816|NCT00600938|7254482|FG000|COMPLETED|Extension Study||65
6346817|NCT00600938|7254483|FG001|COMPLETED|Extension Study||24
6346818|NCT00600938|7254484|FG002|COMPLETED|Extension Study||33
6346819|NCT00600938|7254485|FG003|COMPLETED|Extension Study||0
6346820|NCT00600938|7254482|FG000|NOT COMPLETED|Extension Study||9
6346821|NCT00600938|7254483|FG001|NOT COMPLETED|Extension Study||5
6346822|NCT00600938|7254484|FG002|NOT COMPLETED|Extension Study||9
6346823|NCT00600938|7254485|FG003|NOT COMPLETED|Extension Study||1
6346824|NCT00601107|7254514|FG000|STARTED|Overall Study|Randomized.|27
6346825|NCT00601107|7254515|FG001|STARTED|Overall Study||31
6346826|NCT00601107|7254516|FG002|STARTED|Overall Study||28
6346827|NCT00601107|7254517|FG003|STARTED|Overall Study||25
6346828|NCT00601107|7254514|FG000|Treated|Overall Study||27
6346829|NCT00601107|7254515|FG001|Treated|Overall Study||31
6346830|NCT00601107|7254516|FG002|Treated|Overall Study||28
6346831|NCT00601107|7254517|FG003|Treated|Overall Study||25
6346832|NCT00601107|7254514|FG000|COMPLETED|Overall Study||14
6346833|NCT00601107|7254515|FG001|COMPLETED|Overall Study||22
6346834|NCT00601107|7254516|FG002|COMPLETED|Overall Study||16
6346835|NCT00601107|7254517|FG003|COMPLETED|Overall Study||13
6346836|NCT00601107|7254514|FG000|NOT COMPLETED|Overall Study||13
6346837|NCT00601107|7254515|FG001|NOT COMPLETED|Overall Study||9
6346838|NCT00601107|7254516|FG002|NOT COMPLETED|Overall Study||12
6346839|NCT00601107|7254517|FG003|NOT COMPLETED|Overall Study||12
6346840|NCT00601146|7254527|FG000|STARTED|Overall Study||39
6346841|NCT00601146|7254527|FG000|COMPLETED|Overall Study||39
6346842|NCT00601146|7254527|FG000|NOT COMPLETED|Overall Study||0
6346843|NCT00601172|7254533|FG000|STARTED|Overall Study||355
6346844|NCT00601172|7254534|FG001|STARTED|Overall Study||355
6346845|NCT00601172|7254533|FG000|COMPLETED|Overall Study||214
6346846|NCT00601172|7254534|FG001|COMPLETED|Overall Study||228
6346847|NCT00601172|7254533|FG000|NOT COMPLETED|Overall Study||141
6346848|NCT00601172|7254534|FG001|NOT COMPLETED|Overall Study||127
6346849|NCT00601250|7254543|FG000|STARTED|Overall Study|number who started treatment|177
6346850|NCT00601250|7254544|FG001|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
6346851|NCT00601250|7254543|FG000|COMPLETED|Overall Study|number who completed treatment|163
6346852|NCT00601250|7254544|FG001|COMPLETED|Overall Study|number who completed treatment|484
6346853|NCT00601250|7254543|FG000|NOT COMPLETED|Overall Study||14
6346854|NCT00601250|7254544|FG001|NOT COMPLETED|Overall Study||39
6346855|NCT00601354|7254552|FG000|STARTED|Overall Study||8
6346856|NCT00601354|7254553|FG001|STARTED|Overall Study||9
6346857|NCT00601354|7254552|FG000|COMPLETED|Overall Study||4
6346858|NCT00601354|7254553|FG001|COMPLETED|Overall Study||4
6346859|NCT00601354|7254552|FG000|NOT COMPLETED|Overall Study||4
6346860|NCT00601354|7254553|FG001|NOT COMPLETED|Overall Study||5
6346861|NCT00601367|7254559|FG000|STARTED|Overall Study||480
6346862|NCT00601367|7254559|FG000|COMPLETED|Overall Study||293
6346863|NCT00601367|7254559|FG000|NOT COMPLETED|Overall Study||187
6346864|NCT00601419|7254563|FG000|STARTED|Overall Study||230
6346865|NCT00601419|7254563|FG000|COMPLETED|Overall Study||226
6346866|NCT00601419|7254563|FG000|NOT COMPLETED|Overall Study||4
6346867|NCT00601458|7254586|FG000|STARTED|Overall Study||36
6346868|NCT00601458|7254587|FG001|STARTED|Overall Study||34
6346869|NCT00601458|7254588|FG002|STARTED|Overall Study||30
6346870|NCT00601458|7254586|FG000|COMPLETED|Overall Study||32
6346871|NCT00601458|7254587|FG001|COMPLETED|Overall Study||29
6346872|NCT00601458|7254588|FG002|COMPLETED|Overall Study||28
6346873|NCT00601458|7254586|FG000|NOT COMPLETED|Overall Study||4
6346874|NCT00601458|7254587|FG001|NOT COMPLETED|Overall Study||5
6346875|NCT00601458|7254588|FG002|NOT COMPLETED|Overall Study||2
6346876|NCT00601484|7254598|FG000|STARTED|Overall Study||34
6776426|NCT03834025|7704475|FG002|STARTED|Randomized to Payment Condition(Phase 2)||0
6776427|NCT03834025|7704476|FG003|STARTED|Randomized to Payment Condition(Phase 2)||0
6776428|NCT03834025|7704477|FG004|STARTED|Randomized to Payment Condition(Phase 2)||24
6776429|NCT03834025|7704478|FG005|STARTED|Randomized to Payment Condition(Phase 2)||21
6776430|NCT03834025|7704479|FG006|STARTED|Randomized to Payment Condition(Phase 2)||28
6776431|NCT03834025|7704473|FG000|COMPLETED|Randomized to Payment Condition(Phase 2)||0
6776432|NCT03834025|7704474|FG001|COMPLETED|Randomized to Payment Condition(Phase 2)||0
6346877|NCT00601484|7254599|FG001|STARTED|Overall Study||31
6346878|NCT00601484|7254598|FG000|Treated|Overall Study||34
6346879|NCT00601484|7254599|FG001|Treated|Overall Study||30
6346880|NCT00601484|7254598|FG000|COMPLETED|Overall Study||29
6346881|NCT00601484|7254599|FG001|COMPLETED|Overall Study||23
6346882|NCT00601484|7254598|FG000|NOT COMPLETED|Overall Study||5
6346883|NCT00601484|7254599|FG001|NOT COMPLETED|Overall Study||8
6346884|NCT00601523|7254607|FG000|STARTED|Overall Study||368
6346885|NCT00601523|7254608|FG001|STARTED|Overall Study||143
6346886|NCT00601523|7254607|FG000|COMPLETED|Overall Study||291
6346887|NCT00601523|7254608|FG001|COMPLETED|Overall Study||117
6346888|NCT00601523|7254607|FG000|NOT COMPLETED|Overall Study||77
6346889|NCT00601523|7254608|FG001|NOT COMPLETED|Overall Study||26
6346890|NCT00601627|7254614|FG000|STARTED|Overall Study||51
6346891|NCT00601627|7254614|FG000|COMPLETED|Overall Study||51
6346892|NCT00601627|7254614|FG000|NOT COMPLETED|Overall Study||0
6346893|NCT00601640|7254621|FG000|STARTED|Overall Study||52
6346894|NCT00601640|7254622|FG001|STARTED|Overall Study||52
6346895|NCT00601640|7254623|FG002|STARTED|Overall Study||52
6346896|NCT00601640|7254621|FG000|COMPLETED|Overall Study||47
6346897|NCT00601640|7254622|FG001|COMPLETED|Overall Study||47
6346898|NCT00601640|7254623|FG002|COMPLETED|Overall Study||42
6346899|NCT00601640|7254621|FG000|NOT COMPLETED|Overall Study||5
6346900|NCT00601640|7254622|FG001|NOT COMPLETED|Overall Study||5
6346901|NCT00601640|7254623|FG002|NOT COMPLETED|Overall Study||10
6346902|NCT00601705|7254633|FG000|STARTED|Overall Study||61
6776433|NCT03834025|7704475|FG002|COMPLETED|Randomized to Payment Condition(Phase 2)||0
6776434|NCT03834025|7704476|FG003|COMPLETED|Randomized to Payment Condition(Phase 2)||0
6346903|NCT00601705|7254633|FG000|COMPLETED|Overall Study||60
6346904|NCT00601705|7254633|FG000|NOT COMPLETED|Overall Study||1
6346905|NCT00601718|7254638|FG000|STARTED|Overall Study||29
6346906|NCT00601718|7254638|FG000|COMPLETED|Overall Study||29
6346907|NCT00601718|7254638|FG000|NOT COMPLETED|Overall Study||0
6346908|NCT00601731|7254654|FG000|STARTED|Overall Study||143
6346909|NCT00601731|7254655|FG001|STARTED|Overall Study||43
6346910|NCT00601731|7254656|FG002|STARTED|Overall Study||166
6346911|NCT00601731|7254657|FG003|STARTED|Overall Study||30
6346912|NCT00601731|7254654|FG000|COMPLETED|Overall Study||120
6346913|NCT00601731|7254655|FG001|COMPLETED|Overall Study||43
6346914|NCT00601731|7254656|FG002|COMPLETED|Overall Study||151
6346915|NCT00601731|7254657|FG003|COMPLETED|Overall Study||29
6346916|NCT00601731|7254654|FG000|NOT COMPLETED|Overall Study||23
6346917|NCT00601731|7254655|FG001|NOT COMPLETED|Overall Study||0
6346918|NCT00601731|7254656|FG002|NOT COMPLETED|Overall Study||15
6346919|NCT00601731|7254657|FG003|NOT COMPLETED|Overall Study||1
6346920|NCT00601796|7254683|FG000|STARTED|Overall Study||24
6346921|NCT00601796|7254683|FG000|COMPLETED|Overall Study||24
6346922|NCT00601796|7254683|FG000|NOT COMPLETED|Overall Study||0
6346923|NCT00601835|7254689|FG000|STARTED|Overall Study||2950
6346924|NCT00601835|7254690|FG001|STARTED|Overall Study||700
6346925|NCT00601835|7254689|FG000|COMPLETED|Overall Study||2890
6346926|NCT00601835|7254690|FG001|COMPLETED|Overall Study||686
6346927|NCT00601835|7254689|FG000|NOT COMPLETED|Overall Study||60
6346928|NCT00601835|7254690|FG001|NOT COMPLETED|Overall Study||14
6346929|NCT00601926|7254696|FG000|STARTED|Overall Study||5
6346930|NCT00601926|7254696|FG000|COMPLETED|Overall Study||5
6346931|NCT00601926|7254696|FG000|NOT COMPLETED|Overall Study||0
6346932|NCT00601952|7254702|FG000|STARTED|Overall Study||14
6346933|NCT00601952|7254703|FG001|STARTED|Overall Study||17
6346934|NCT00601952|7254702|FG000|COMPLETED|Overall Study||12
6346935|NCT00601952|7254703|FG001|COMPLETED|Overall Study||17
6346936|NCT00601952|7254702|FG000|NOT COMPLETED|Overall Study||2
6346937|NCT00601952|7254703|FG001|NOT COMPLETED|Overall Study||0
6346938|NCT00601965|7254713|FG000|STARTED|Overall Study||18
6346939|NCT00601965|7254714|FG001|STARTED|Overall Study||18
6346940|NCT00601965|7254715|FG002|STARTED|Overall Study||19
6346941|NCT00601965|7254716|FG003|STARTED|Overall Study||18
6346942|NCT00601965|7254713|FG000|COMPLETED|Overall Study||18
6346943|NCT00601965|7254714|FG001|COMPLETED|Overall Study||16
6346944|NCT00601965|7254715|FG002|COMPLETED|Overall Study||19
6346945|NCT00601965|7254716|FG003|COMPLETED|Overall Study||17
6346946|NCT00601965|7254713|FG000|NOT COMPLETED|Overall Study||0
6346947|NCT00601965|7254714|FG001|NOT COMPLETED|Overall Study||2
6346948|NCT00601965|7254715|FG002|NOT COMPLETED|Overall Study||0
6346949|NCT00601965|7254716|FG003|NOT COMPLETED|Overall Study||1
6346950|NCT00602043|7254726|FG000|STARTED|Overall Study||20
6346951|NCT00602043|7254726|FG000|COMPLETED|Overall Study||15
6346952|NCT00602043|7254726|FG000|NOT COMPLETED|Overall Study||5
6346953|NCT00602225|7254733|FG000|STARTED|Overall Study||50
6346954|NCT00602225|7254733|FG000|COMPLETED|Overall Study||50
6346955|NCT00602225|7254733|FG000|NOT COMPLETED|Overall Study||0
6346956|NCT00602290|7254741|FG000|STARTED|Overall Study||48
6346957|NCT00602290|7254742|FG001|STARTED|Overall Study||48
6346958|NCT00602290|7254743|FG002|STARTED|Overall Study||47
6346959|NCT00602290|7254741|FG000|COMPLETED|Overall Study||46
6346960|NCT00602290|7254742|FG001|COMPLETED|Overall Study||46
6346961|NCT00602290|7254743|FG002|COMPLETED|Overall Study||46
6559451|NCT01781572|7482137|FG000|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
6559452|NCT01781572|7482138|FG001|NOT COMPLETED|MEK162 30mg LEE011 200mg||5
6559453|NCT01781572|7482139|FG002|NOT COMPLETED|MEK162 30mg LEE011 200mg||0
6559454|NCT01781572|7482137|FG000|STARTED|MEK162 45mg LEE011 450mg||0
6559455|NCT01781572|7482138|FG001|STARTED|MEK162 45mg LEE011 450mg||9
6346962|NCT00602290|7254741|FG000|NOT COMPLETED|Overall Study||2
6346963|NCT00602290|7254742|FG001|NOT COMPLETED|Overall Study||2
6346964|NCT00602290|7254743|FG002|NOT COMPLETED|Overall Study||1
6346965|NCT00602355|7254754|FG000|STARTED|Overall Study||53
6346966|NCT00602355|7254755|FG001|STARTED|Overall Study||56
6346967|NCT00602355|7254756|FG002|STARTED|Overall Study||53
6346968|NCT00602355|7254754|FG000|COMPLETED|Overall Study||44
6346969|NCT00602355|7254755|FG001|COMPLETED|Overall Study||38
6346970|NCT00602355|7254756|FG002|COMPLETED|Overall Study||43
6346971|NCT00602355|7254754|FG000|NOT COMPLETED|Overall Study||9
6346972|NCT00602355|7254755|FG001|NOT COMPLETED|Overall Study||18
6346973|NCT00602355|7254756|FG002|NOT COMPLETED|Overall Study||10
6346974|NCT00602420|7254766|FG000|STARTED|Overall Study||257
6346975|NCT00602420|7254767|FG001|STARTED|Overall Study||253
6346976|NCT00602420|7254766|FG000|COMPLETED|Overall Study||232
6346977|NCT00602420|7254767|FG001|COMPLETED|Overall Study||229
6346978|NCT00602420|7254766|FG000|NOT COMPLETED|Overall Study||25
6346979|NCT00602420|7254767|FG001|NOT COMPLETED|Overall Study||24
6346980|NCT00602446|7254773|FG000|STARTED|Overall Study||3
6346981|NCT00602446|7254773|FG000|COMPLETED|Overall Study||3
6346982|NCT00602446|7254773|FG000|NOT COMPLETED|Overall Study||0
6346983|NCT00602472|7254779|FG000|STARTED|Overall Study|3 randomised patients never took medication.|263
6346984|NCT00602472|7254780|FG001|STARTED|Overall Study|3 randomised patients never took medication.|792
6346985|NCT00602472|7254779|FG000|COMPLETED|Overall Study|number who completed treatment|242
6346986|NCT00602472|7254780|FG001|COMPLETED|Overall Study|number who completed treatment|734
6559456|NCT01781572|7482139|FG002|STARTED|MEK162 45mg LEE011 450mg||0
6346987|NCT00602472|7254779|FG000|NOT COMPLETED|Overall Study||21
6346988|NCT00602472|7254780|FG001|NOT COMPLETED|Overall Study||58
6346989|NCT00602537|7254788|FG000|STARTED|12 Week Double Blind Comparison||65
6346990|NCT00602537|7254789|FG001|STARTED|12 Week Double Blind Comparison||64
6346991|NCT00602537|7254788|FG000|Responded|12 Week Double Blind Comparison||44
6346992|NCT00602537|7254789|FG001|Responded|12 Week Double Blind Comparison||22
6346993|NCT00602537|7254788|FG000|COMPLETED|12 Week Double Blind Comparison||42
6346994|NCT00602537|7254789|FG001|COMPLETED|12 Week Double Blind Comparison||17
6346995|NCT00602537|7254788|FG000|NOT COMPLETED|12 Week Double Blind Comparison||23
6346996|NCT00602537|7254789|FG001|NOT COMPLETED|12 Week Double Blind Comparison||47
6346997|NCT00602537|7254788|FG000|STARTED|Follow Up Study Comparison||42
6346998|NCT00602537|7254789|FG001|STARTED|Follow Up Study Comparison||17
6346999|NCT00602537|7254788|FG000|COMPLETED|Follow Up Study Comparison||31
6347000|NCT00602537|7254789|FG001|COMPLETED|Follow Up Study Comparison||14
6347001|NCT00602537|7254788|FG000|NOT COMPLETED|Follow Up Study Comparison||11
6347002|NCT00602537|7254789|FG001|NOT COMPLETED|Follow Up Study Comparison||3
6347003|NCT00602771|7254797|FG000|STARTED|Overall Study||63
6347004|NCT00602771|7254798|FG001|STARTED|Overall Study||21
6347005|NCT00602771|7254797|FG000|COMPLETED|Overall Study||62
6347006|NCT00602771|7254798|FG001|COMPLETED|Overall Study||21
6347007|NCT00602771|7254797|FG000|NOT COMPLETED|Overall Study||1
6347008|NCT00602771|7254798|FG001|NOT COMPLETED|Overall Study||0
6347009|NCT00602797|7254804|FG000|STARTED|Overall Study||20
6347010|NCT00602797|7254804|FG000|COMPLETED|Overall Study||19
6347011|NCT00602797|7254804|FG000|NOT COMPLETED|Overall Study||1
6347012|NCT00602836|7254809|FG000|STARTED|Overall Study||44
6347013|NCT00602836|7254809|FG000|COMPLETED|Overall Study||39
6347014|NCT00602836|7254809|FG000|NOT COMPLETED|Overall Study||5
6347015|NCT00602927|7254815|FG000|STARTED|Period 1: 13 Days||19
6347016|NCT00602927|7254816|FG001|STARTED|Period 1: 13 Days||19
6347017|NCT00602927|7254815|FG000|COMPLETED|Period 1: 13 Days||15
6347018|NCT00602927|7254816|FG001|COMPLETED|Period 1: 13 Days||14
6347019|NCT00602927|7254815|FG000|NOT COMPLETED|Period 1: 13 Days||4
6347020|NCT00602927|7254816|FG001|NOT COMPLETED|Period 1: 13 Days||5
6347021|NCT00602927|7254815|FG000|STARTED|Period 2: 14 Days||15
6347022|NCT00602927|7254816|FG001|STARTED|Period 2: 14 Days||14
6347023|NCT00602927|7254815|FG000|COMPLETED|Period 2: 14 Days||15
6347024|NCT00602927|7254816|FG001|COMPLETED|Period 2: 14 Days||12
6347025|NCT00602927|7254815|FG000|NOT COMPLETED|Period 2: 14 Days||0
6347026|NCT00602927|7254816|FG001|NOT COMPLETED|Period 2: 14 Days||2
6347027|NCT00602927|7254815|FG000|STARTED|Period 3: 13 Days||15
6347028|NCT00602927|7254816|FG001|STARTED|Period 3: 13 Days||12
6347029|NCT00602927|7254815|FG000|COMPLETED|Period 3: 13 Days||13
6347030|NCT00602927|7254816|FG001|COMPLETED|Period 3: 13 Days||9
6347031|NCT00602927|7254815|FG000|NOT COMPLETED|Period 3: 13 Days||2
6347032|NCT00602927|7254816|FG001|NOT COMPLETED|Period 3: 13 Days||3
6347033|NCT00602953|7254827|FG000|STARTED|Overall Study||15
6347034|NCT00602953|7254828|FG001|STARTED|Overall Study||26
6347035|NCT00602953|7254829|FG002|STARTED|Overall Study||47
6347036|NCT00602953|7254830|FG003|STARTED|Overall Study||13
6347037|NCT00602953|7254831|FG004|STARTED|Overall Study||0
6347038|NCT00602953|7254827|FG000|COMPLETED|Overall Study||15
6347039|NCT00602953|7254828|FG001|COMPLETED|Overall Study||26
6347040|NCT00602953|7254829|FG002|COMPLETED|Overall Study||47
6347041|NCT00602953|7254830|FG003|COMPLETED|Overall Study||13
6347042|NCT00602953|7254831|FG004|COMPLETED|Overall Study||0
6347043|NCT00602953|7254827|FG000|NOT COMPLETED|Overall Study||0
6347044|NCT00602953|7254828|FG001|NOT COMPLETED|Overall Study||0
6347045|NCT00602953|7254829|FG002|NOT COMPLETED|Overall Study||0
6347046|NCT00602953|7254830|FG003|NOT COMPLETED|Overall Study||0
6347047|NCT00602953|7254831|FG004|NOT COMPLETED|Overall Study||0
6347048|NCT00602979|7254848|FG000|STARTED|Overall Study||48
6347049|NCT00602979|7254849|FG001|STARTED|Overall Study||48
6347050|NCT00602979|7254850|FG002|STARTED|Overall Study||48
6347051|NCT00602979|7254851|FG003|STARTED|Overall Study||48
6347052|NCT00602979|7254852|FG004|STARTED|Overall Study||48
6347053|NCT00602979|7254848|FG000|COMPLETED|Overall Study||45
6347054|NCT00602979|7254849|FG001|COMPLETED|Overall Study||45
6347055|NCT00602979|7254850|FG002|COMPLETED|Overall Study||45
6347056|NCT00602979|7254851|FG003|COMPLETED|Overall Study||45
6347057|NCT00602979|7254852|FG004|COMPLETED|Overall Study||45
6347058|NCT00602979|7254848|FG000|NOT COMPLETED|Overall Study||3
6347059|NCT00602979|7254849|FG001|NOT COMPLETED|Overall Study||3
6347060|NCT00602979|7254850|FG002|NOT COMPLETED|Overall Study||3
6347061|NCT00602979|7254851|FG003|NOT COMPLETED|Overall Study||3
6347062|NCT00602979|7254852|FG004|NOT COMPLETED|Overall Study||3
6347063|NCT00603018|7254864|FG000|STARTED|Overall Study||23
6347064|NCT00603018|7254864|FG000|COMPLETED|Overall Study||23
6347065|NCT00603018|7254864|FG000|NOT COMPLETED|Overall Study||0
6347066|NCT00603044|7254871|FG000|STARTED|Overall Study||11
6347067|NCT00603044|7254872|FG001|STARTED|Overall Study||13
6347068|NCT00603044|7254871|FG000|COMPLETED|Overall Study||11
6347069|NCT00603044|7254872|FG001|COMPLETED|Overall Study||13
6347070|NCT00603044|7254871|FG000|NOT COMPLETED|Overall Study||0
6347071|NCT00603044|7254872|FG001|NOT COMPLETED|Overall Study||0
6347072|NCT00603187|7254878|FG000|STARTED|Overall Study||4
6347073|NCT00603187|7254878|FG000|COMPLETED|Overall Study||4
6347074|NCT00603187|7254878|FG000|NOT COMPLETED|Overall Study||0
6347075|NCT00603239|7254884|FG000|STARTED|Overall Study||111
6347076|NCT00603239|7254885|FG001|STARTED|Overall Study||54
6347077|NCT00603239|7254884|FG000|COMPLETED|Overall Study||96
6347078|NCT00603239|7254885|FG001|COMPLETED|Overall Study||50
6347079|NCT00603239|7254884|FG000|NOT COMPLETED|Overall Study||15
6347080|NCT00603239|7254885|FG001|NOT COMPLETED|Overall Study||4
6347081|NCT00603265|7254894|FG000|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
6347082|NCT00603265|7254895|FG001|STARTED|Overall Study||78
6347083|NCT00603265|7254896|FG002|STARTED|Overall Study||72
6347084|NCT00603265|7254894|FG000|Received at Least 1 Dose of Study Drug|Overall Study||75
6347085|NCT00603265|7254895|FG001|Received at Least 1 Dose of Study Drug|Overall Study||78
6347086|NCT00603265|7254896|FG002|Received at Least 1 Dose of Study Drug|Overall Study||72
6347087|NCT00603265|7254894|FG000|COMPLETED|Overall Study||69
6347088|NCT00603265|7254895|FG001|COMPLETED|Overall Study||62
6347089|NCT00603265|7254896|FG002|COMPLETED|Overall Study||67
6347090|NCT00603265|7254894|FG000|NOT COMPLETED|Overall Study||7
6347091|NCT00603265|7254895|FG001|NOT COMPLETED|Overall Study||16
6347092|NCT00603265|7254896|FG002|NOT COMPLETED|Overall Study||5
6347093|NCT00603278|7254910|FG000|STARTED|Overall Study||107
6347094|NCT00603278|7254911|FG001|STARTED|Overall Study||105
6347095|NCT00603278|7254912|FG002|STARTED|Overall Study||101
6347096|NCT00603278|7254913|FG003|STARTED|Overall Study||103
6347097|NCT00603278|7254914|FG004|STARTED|Overall Study||99
6347098|NCT00603278|7254915|FG005|STARTED|Overall Study||100
6347099|NCT00603278|7254910|FG000|COMPLETED|Overall Study||66
6347100|NCT00603278|7254911|FG001|COMPLETED|Overall Study||88
6347101|NCT00603278|7254912|FG002|COMPLETED|Overall Study||87
6347102|NCT00603278|7254913|FG003|COMPLETED|Overall Study||92
6347103|NCT00603278|7254914|FG004|COMPLETED|Overall Study||86
6347104|NCT00603278|7254915|FG005|COMPLETED|Overall Study||81
6347105|NCT00603278|7254910|FG000|NOT COMPLETED|Overall Study||41
6347106|NCT00603278|7254911|FG001|NOT COMPLETED|Overall Study||17
6347107|NCT00603278|7254912|FG002|NOT COMPLETED|Overall Study||14
6347108|NCT00603278|7254913|FG003|NOT COMPLETED|Overall Study||11
6347109|NCT00603278|7254914|FG004|NOT COMPLETED|Overall Study||13
6347110|NCT00603278|7254915|FG005|NOT COMPLETED|Overall Study||19
6347111|NCT00603291|7254932|FG000|STARTED|Overall Study||95
6347112|NCT00603291|7254933|FG001|STARTED|Overall Study||256
6347113|NCT00603291|7254934|FG002|STARTED|Overall Study||253
6347114|NCT00603291|7254932|FG000|COMPLETED|Overall Study||75
6347115|NCT00603291|7254933|FG001|COMPLETED|Overall Study||169
6347116|NCT00603291|7254934|FG002|COMPLETED|Overall Study||157
6559457|NCT01781572|7482137|FG000|COMPLETED|MEK162 45mg LEE011 450mg||0
6559458|NCT01781572|7482138|FG001|COMPLETED|MEK162 45mg LEE011 450mg||0
6559459|NCT01781572|7482139|FG002|COMPLETED|MEK162 45mg LEE011 450mg||0
6347117|NCT00603291|7254932|FG000|NOT COMPLETED|Overall Study||20
6347118|NCT00603291|7254933|FG001|NOT COMPLETED|Overall Study||87
6347119|NCT00603291|7254934|FG002|NOT COMPLETED|Overall Study||96
6347120|NCT00603304|7254944|FG000|STARTED|Overall Study||183
6347121|NCT00603304|7254945|FG001|STARTED|Overall Study||186
6347122|NCT00603304|7254944|FG000|COMPLETED|Overall Study||151
6347123|NCT00603304|7254945|FG001|COMPLETED|Overall Study||155
6347124|NCT00603304|7254944|FG000|NOT COMPLETED|Overall Study||32
6347125|NCT00603304|7254945|FG001|NOT COMPLETED|Overall Study||31
6347126|NCT00603382|7254959|FG000|STARTED|Overall Study||94
6347127|NCT00603382|7254960|FG001|STARTED|Overall Study||97
6347128|NCT00603382|7254961|FG002|STARTED|Overall Study||100
6347129|NCT00603382|7254962|FG003|STARTED|Overall Study||110
6347130|NCT00603382|7254963|FG004|STARTED|Overall Study||95
6347131|NCT00603382|7254964|FG005|STARTED|Overall Study||102
6347132|NCT00603382|7254959|FG000|COMPLETED|Overall Study||76
6347133|NCT00603382|7254960|FG001|COMPLETED|Overall Study||83
6347134|NCT00603382|7254961|FG002|COMPLETED|Overall Study||91
6347135|NCT00603382|7254962|FG003|COMPLETED|Overall Study||98
6347136|NCT00603382|7254963|FG004|COMPLETED|Overall Study||86
6347137|NCT00603382|7254964|FG005|COMPLETED|Overall Study||84
6347138|NCT00603382|7254959|FG000|NOT COMPLETED|Overall Study||18
6347139|NCT00603382|7254960|FG001|NOT COMPLETED|Overall Study||14
6347140|NCT00603382|7254961|FG002|NOT COMPLETED|Overall Study||9
6347141|NCT00603382|7254962|FG003|NOT COMPLETED|Overall Study||12
6347142|NCT00603382|7254963|FG004|NOT COMPLETED|Overall Study||9
6347143|NCT00603382|7254964|FG005|NOT COMPLETED|Overall Study||18
6347144|NCT00603408|7254978|FG000|STARTED|Overall Study||5
6347145|NCT00603408|7254978|FG000|COMPLETED|Overall Study||5
6347146|NCT00603408|7254978|FG000|NOT COMPLETED|Overall Study||0
6347147|NCT00603447|7254990|FG000|STARTED|Overall Study||6
6347148|NCT00603447|7254991|FG001|STARTED|Overall Study||6
6347149|NCT00603447|7254992|FG002|STARTED|Overall Study||8
6347150|NCT00603447|7254993|FG003|STARTED|Overall Study||6
6347151|NCT00603447|7254994|FG004|STARTED|Overall Study||6
6347152|NCT00603447|7254995|FG005|STARTED|Overall Study||8
6347153|NCT00603447|7254996|FG006|STARTED|Overall Study||44
6347154|NCT00603447|7254990|FG000|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
6347155|NCT00603447|7254991|FG001|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
6347156|NCT00603447|7254992|FG002|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
6347157|NCT00603447|7254993|FG003|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
6347158|NCT00603447|7254994|FG004|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
6347159|NCT00603447|7254995|FG005|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
6559460|NCT01781572|7482137|FG000|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
6347160|NCT00603447|7254996|FG006|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
6347161|NCT00603447|7254990|FG000|NOT COMPLETED|Overall Study||0
6347162|NCT00603447|7254991|FG001|NOT COMPLETED|Overall Study||3
6347163|NCT00603447|7254992|FG002|NOT COMPLETED|Overall Study||2
6347164|NCT00603447|7254993|FG003|NOT COMPLETED|Overall Study||2
6347165|NCT00603447|7254994|FG004|NOT COMPLETED|Overall Study||5
6347166|NCT00603447|7254995|FG005|NOT COMPLETED|Overall Study||2
6347167|NCT00603447|7254996|FG006|NOT COMPLETED|Overall Study||24
6347168|NCT00603473|7255012|FG000|STARTED|Overall Study||89
6347169|NCT00603473|7255012|FG000|COMPLETED|Overall Study||80
6347170|NCT00603473|7255012|FG000|NOT COMPLETED|Overall Study||9
6347171|NCT00603512|7255021|FG000|STARTED|Overall Study||28
6347172|NCT00603512|7255022|FG001|STARTED|Overall Study||28
6347173|NCT00603512|7255023|FG002|STARTED|Overall Study||28
6347174|NCT00603512|7255024|FG003|STARTED|Overall Study||28
6347175|NCT00603512|7255025|FG004|STARTED|Overall Study||28
6347176|NCT00603512|7255021|FG000|Treated|Overall Study||28
6347177|NCT00603512|7255022|FG001|Treated|Overall Study||27
6347178|NCT00603512|7255023|FG002|Treated|Overall Study||27
6347179|NCT00603512|7255024|FG003|Treated|Overall Study||26
6347180|NCT00603512|7255025|FG004|Treated|Overall Study||28
6347181|NCT00603512|7255021|FG000|COMPLETED|Overall Study||26
6347182|NCT00603512|7255022|FG001|COMPLETED|Overall Study||23
6347183|NCT00603512|7255023|FG002|COMPLETED|Overall Study||23
6347184|NCT00603512|7255024|FG003|COMPLETED|Overall Study||21
6347185|NCT00603512|7255025|FG004|COMPLETED|Overall Study||23
6347186|NCT00603512|7255021|FG000|NOT COMPLETED|Overall Study||2
6347187|NCT00603512|7255022|FG001|NOT COMPLETED|Overall Study||5
6347188|NCT00603512|7255023|FG002|NOT COMPLETED|Overall Study||5
6347189|NCT00603512|7255024|FG003|NOT COMPLETED|Overall Study||7
6347190|NCT00603512|7255025|FG004|NOT COMPLETED|Overall Study||5
6347191|NCT00603525|7255039|FG000|STARTED|DB Treatment Period (24 Weeks)||84
6347192|NCT00603525|7255040|FG001|STARTED|DB Treatment Period (24 Weeks)||85
6347193|NCT00603525|7255041|FG002|STARTED|DB Treatment Period (24 Weeks)||0
6347194|NCT00603525|7255039|FG000|COMPLETED|DB Treatment Period (24 Weeks)||67
6347195|NCT00603525|7255040|FG001|COMPLETED|DB Treatment Period (24 Weeks)||63
6347196|NCT00603525|7255041|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
6347197|NCT00603525|7255039|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
6347198|NCT00603525|7255040|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
6347199|NCT00603525|7255041|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
6347200|NCT00603525|7255039|FG000|STARTED|OL Treatment Period (120 Weeks)||0
6347201|NCT00603525|7255040|FG001|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
6347202|NCT00603525|7255041|FG002|STARTED|OL Treatment Period (120 Weeks)||0
6347203|NCT00603525|7255039|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
6347204|NCT00603525|7255040|FG001|COMPLETED|OL Treatment Period (120 Weeks)||13
6347205|NCT00603525|7255041|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
6347206|NCT00603525|7255039|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
6347207|NCT00603525|7255040|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
6347208|NCT00603525|7255041|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
6347209|NCT00603525|7255039|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
6347210|NCT00603525|7255040|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
6347211|NCT00603525|7255041|FG002|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
6347212|NCT00603525|7255039|FG000|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
6347213|NCT00603525|7255040|FG001|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
6347214|NCT00603525|7255041|FG002|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
6347215|NCT00603525|7255039|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
6347216|NCT00603525|7255040|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
6347217|NCT00603525|7255041|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||13
6347218|NCT00603525|7255039|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
6347219|NCT00603525|7255040|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
6347220|NCT00603525|7255041|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
6347221|NCT00603538|7255055|FG000|STARTED|Overall Study||6
6347222|NCT00603538|7255056|FG001|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
6347223|NCT00603538|7255057|FG002|STARTED|Overall Study||6
6347224|NCT00603538|7255055|FG000|COMPLETED|Overall Study||3
6347225|NCT00603538|7255056|FG001|COMPLETED|Overall Study||3
6347226|NCT00603538|7255057|FG002|COMPLETED|Overall Study||4
6347227|NCT00603538|7255055|FG000|NOT COMPLETED|Overall Study||3
6347228|NCT00603538|7255056|FG001|NOT COMPLETED|Overall Study||4
6347229|NCT00603538|7255057|FG002|NOT COMPLETED|Overall Study||2
6347230|NCT00603564|7255070|FG000|STARTED|Overall Study|January 2006|20
6347231|NCT00603564|7255071|FG001|STARTED|Overall Study|January 2006|27
6347232|NCT00603564|7255070|FG000|COMPLETED|Overall Study|February 2008|20
6347233|NCT00603564|7255071|FG001|COMPLETED|Overall Study|February 2008|27
6347234|NCT00603564|7255070|FG000|NOT COMPLETED|Overall Study||0
6347235|NCT00603564|7255071|FG001|NOT COMPLETED|Overall Study||0
6347236|NCT00603590|7255079|FG000|STARTED|Overall Study||241
6347237|NCT00603590|7255080|FG001|STARTED|Overall Study||234
6347238|NCT00603590|7255079|FG000|One Month|Overall Study||204
6347239|NCT00603590|7255080|FG001|One Month|Overall Study||212
6347240|NCT00603590|7255079|FG000|Four Months|Overall Study||187
6347241|NCT00603590|7255080|FG001|Four Months|Overall Study||200
6347242|NCT00603590|7255079|FG000|Eight Months|Overall Study||178
6347243|NCT00603590|7255080|FG001|Eight Months|Overall Study||194
6347244|NCT00603590|7255079|FG000|COMPLETED|Overall Study||165
6347245|NCT00603590|7255080|FG001|COMPLETED|Overall Study||183
6347246|NCT00603590|7255079|FG000|NOT COMPLETED|Overall Study||76
6347247|NCT00603590|7255080|FG001|NOT COMPLETED|Overall Study||51
6347248|NCT00603642|7255088|FG000|STARTED|Overall Study||12
6347249|NCT00603642|7255089|FG001|STARTED|Overall Study||22
6347250|NCT00603642|7255088|FG000|COMPLETED|Overall Study||12
6347251|NCT00603642|7255089|FG001|COMPLETED|Overall Study||22
6347252|NCT00603642|7255088|FG000|NOT COMPLETED|Overall Study||0
6347253|NCT00603642|7255089|FG001|NOT COMPLETED|Overall Study||0
6347254|NCT00603720|7255100|FG000|STARTED|Overall Study||10
6347255|NCT00603720|7255101|FG001|STARTED|Overall Study||10
6347256|NCT00603720|7255102|FG002|STARTED|Overall Study||12
6347257|NCT00603720|7255103|FG003|STARTED|Overall Study||10
6347258|NCT00603720|7255104|FG004|STARTED|Overall Study||12
6347259|NCT00603720|7255100|FG000|COMPLETED|Overall Study||10
6347260|NCT00603720|7255101|FG001|COMPLETED|Overall Study||10
6347261|NCT00603720|7255102|FG002|COMPLETED|Overall Study||12
6347262|NCT00603720|7255103|FG003|COMPLETED|Overall Study||10
6347263|NCT00603720|7255104|FG004|COMPLETED|Overall Study||12
6347264|NCT00603720|7255100|FG000|NOT COMPLETED|Overall Study||0
6347265|NCT00603720|7255101|FG001|NOT COMPLETED|Overall Study||0
6347266|NCT00603720|7255102|FG002|NOT COMPLETED|Overall Study||0
6347267|NCT00603720|7255103|FG003|NOT COMPLETED|Overall Study||0
6347268|NCT00603720|7255104|FG004|NOT COMPLETED|Overall Study||0
6347269|NCT00603733|7255118|FG000|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
6347270|NCT00603733|7255119|FG001|STARTED|Active Phase ITT||95
6347271|NCT00603733|7255118|FG000|COMPLETED|Active Phase ITT||84
6347272|NCT00603733|7255119|FG001|COMPLETED|Active Phase ITT||78
6347273|NCT00603733|7255118|FG000|NOT COMPLETED|Active Phase ITT||11
6347274|NCT00603733|7255119|FG001|NOT COMPLETED|Active Phase ITT||17
6347275|NCT00603733|7255118|FG000|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
6347276|NCT00603733|7255119|FG001|STARTED|Run-In Phase - 4 Weeks||49
6347277|NCT00603733|7255118|FG000|COMPLETED|Run-In Phase - 4 Weeks||35
6347278|NCT00603733|7255119|FG001|COMPLETED|Run-In Phase - 4 Weeks||36
6347279|NCT00603733|7255118|FG000|NOT COMPLETED|Run-In Phase - 4 Weeks||14
6347280|NCT00603733|7255119|FG001|NOT COMPLETED|Run-In Phase - 4 Weeks||13
6347281|NCT00603733|7255118|FG000|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
6347282|NCT00603733|7255119|FG001|STARTED|Maintenance Phase ITT||82
6347283|NCT00603733|7255118|FG000|COMPLETED|Maintenance Phase ITT||61
6347284|NCT00603733|7255119|FG001|COMPLETED|Maintenance Phase ITT||66
6347285|NCT00603733|7255118|FG000|NOT COMPLETED|Maintenance Phase ITT||10
6347286|NCT00603733|7255119|FG001|NOT COMPLETED|Maintenance Phase ITT||16
6347287|NCT00603746|7255131|FG000|STARTED|Overall Study||103
6347288|NCT00603746|7255132|FG001|STARTED|Overall Study||99
6347289|NCT00603746|7255133|FG002|STARTED|Overall Study||101
6347290|NCT00603746|7255134|FG003|STARTED|Overall Study||107
6347291|NCT00603746|7255135|FG004|STARTED|Overall Study||102
6347292|NCT00603746|7255136|FG005|STARTED|Overall Study||110
6347293|NCT00603746|7255131|FG000|COMPLETED|Overall Study||65
6347294|NCT00603746|7255132|FG001|COMPLETED|Overall Study||81
6347295|NCT00603746|7255133|FG002|COMPLETED|Overall Study||93
6347296|NCT00603746|7255134|FG003|COMPLETED|Overall Study||94
6347297|NCT00603746|7255135|FG004|COMPLETED|Overall Study||85
6347298|NCT00603746|7255136|FG005|COMPLETED|Overall Study||97
6347299|NCT00603746|7255131|FG000|NOT COMPLETED|Overall Study||38
6347300|NCT00603746|7255132|FG001|NOT COMPLETED|Overall Study||18
6347301|NCT00603746|7255133|FG002|NOT COMPLETED|Overall Study||8
6347302|NCT00603746|7255134|FG003|NOT COMPLETED|Overall Study||13
6347303|NCT00603746|7255135|FG004|NOT COMPLETED|Overall Study||17
6347304|NCT00603746|7255136|FG005|NOT COMPLETED|Overall Study||13
6347305|NCT00603798|7255153|FG000|STARTED|Overall Study||162
6347306|NCT00603798|7255154|FG001|STARTED|Overall Study||164
6347307|NCT00603798|7255155|FG002|STARTED|Overall Study||164
6347308|NCT00603798|7255153|FG000|COMPLETED|Overall Study||152
6347309|NCT00603798|7255154|FG001|COMPLETED|Overall Study||157
6347310|NCT00603798|7255155|FG002|COMPLETED|Overall Study||154
6347311|NCT00603798|7255153|FG000|NOT COMPLETED|Overall Study||10
6347312|NCT00603798|7255154|FG001|NOT COMPLETED|Overall Study||7
6347313|NCT00603798|7255155|FG002|NOT COMPLETED|Overall Study||10
6347314|NCT00603837|7255165|FG000|STARTED|Overall Study||20
6347315|NCT00603837|7255166|FG001|STARTED|Overall Study||19
6347316|NCT00603837|7255165|FG000|COMPLETED|Overall Study||17
6347317|NCT00603837|7255166|FG001|COMPLETED|Overall Study||19
6347318|NCT00603837|7255165|FG000|NOT COMPLETED|Overall Study||3
6347319|NCT00603837|7255166|FG001|NOT COMPLETED|Overall Study||0
6347320|NCT00603889|7255172|FG000|STARTED|Overall Study||12
6347321|NCT00603889|7255172|FG000|COMPLETED|Overall Study||12
6347322|NCT00603889|7255172|FG000|NOT COMPLETED|Overall Study||0
6347323|NCT00603902|7255179|FG000|STARTED|Overall Study||802
6347324|NCT00603902|7255180|FG001|STARTED|Overall Study||1603
6347325|NCT00603902|7255181|FG002|STARTED|Overall Study||1603
6347326|NCT00603902|7255179|FG000|COMPLETED|Overall Study||473
6347327|NCT00603902|7255180|FG001|COMPLETED|Overall Study||917
6347328|NCT00603902|7255181|FG002|COMPLETED|Overall Study||834
6347329|NCT00603902|7255179|FG000|NOT COMPLETED|Overall Study||329
6347330|NCT00603902|7255180|FG001|NOT COMPLETED|Overall Study||686
6347331|NCT00603902|7255181|FG002|NOT COMPLETED|Overall Study||769
6347332|NCT00603915|7255189|FG000|STARTED|Overall Study||20
6347333|NCT00603915|7255189|FG000|COMPLETED|Overall Study||19
6347334|NCT00603915|7255189|FG000|NOT COMPLETED|Overall Study||1
6347335|NCT00603941|7255196|FG000|STARTED|Overall Study||7
6347336|NCT00603941|7255197|FG001|STARTED|Overall Study||10
6347337|NCT00603941|7255198|FG002|STARTED|Overall Study||2
6347338|NCT00603941|7255196|FG000|COMPLETED|Overall Study||0
6347339|NCT00603941|7255197|FG001|COMPLETED|Overall Study||0
6347340|NCT00603941|7255198|FG002|COMPLETED|Overall Study||0
6347341|NCT00603941|7255196|FG000|NOT COMPLETED|Overall Study||7
6347342|NCT00603941|7255197|FG001|NOT COMPLETED|Overall Study||10
6347343|NCT00603941|7255198|FG002|NOT COMPLETED|Overall Study||2
6347344|NCT00603980|7255207|FG000|STARTED|Study Qualification||31
6347345|NCT00603980|7255207|FG000|COMPLETED|Study Qualification||15
6347346|NCT00603980|7255207|FG000|NOT COMPLETED|Study Qualification||16
6347347|NCT00603980|7255207|FG000|STARTED|Main Study||15
6347348|NCT00603980|7255207|FG000|COMPLETED|Main Study||14
6347349|NCT00603980|7255207|FG000|NOT COMPLETED|Main Study||1
6347350|NCT00603993|7255227|FG000|STARTED|Overall Study||88
6347351|NCT00603993|7255227|FG000|COMPLETED|Overall Study||68
6347352|NCT00603993|7255227|FG000|NOT COMPLETED|Overall Study||20
6347353|NCT00604019|7255233|FG000|STARTED|Overall Study||134
6347354|NCT00604019|7255234|FG001|STARTED|Overall Study||118
6347355|NCT00604019|7255233|FG000|COMPLETED|Overall Study||134
6347356|NCT00604019|7255234|FG001|COMPLETED|Overall Study||118
6347357|NCT00604019|7255233|FG000|NOT COMPLETED|Overall Study||0
6347358|NCT00604019|7255234|FG001|NOT COMPLETED|Overall Study||0
6347359|NCT00604045|7255242|FG000|STARTED|Overall Study||15
6347360|NCT00604045|7255243|FG001|STARTED|Overall Study||10
6347361|NCT00604045|7255242|FG000|COMPLETED|Overall Study||14
6347362|NCT00604045|7255243|FG001|COMPLETED|Overall Study||9
6347363|NCT00604045|7255242|FG000|NOT COMPLETED|Overall Study||1
6347364|NCT00604045|7255243|FG001|NOT COMPLETED|Overall Study||1
6347365|NCT00604162|7255249|FG000|STARTED|Overall Study||332
6347366|NCT00604162|7255249|FG000|COMPLETED|Overall Study||328
6347367|NCT00604162|7255249|FG000|NOT COMPLETED|Overall Study||4
6347368|NCT00604175|7255259|FG000|STARTED|Entry Through Week 28||130
6347369|NCT00604175|7255260|FG001|STARTED|Entry Through Week 28||95
6347370|NCT00604175|7255261|FG002|STARTED|Entry Through Week 28||94
6347371|NCT00604175|7255259|FG000|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
6347372|NCT00604175|7255260|FG001|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
6347373|NCT00604175|7255261|FG002|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
6347374|NCT00604175|7255259|FG000|NOT COMPLETED|Entry Through Week 28||10
6347375|NCT00604175|7255260|FG001|NOT COMPLETED|Entry Through Week 28||3
6347376|NCT00604175|7255261|FG002|NOT COMPLETED|Entry Through Week 28||1
6347377|NCT00604175|7255259|FG000|STARTED|Week 29 Through Week 72||120
6347378|NCT00604175|7255260|FG001|STARTED|Week 29 Through Week 72||92
6347379|NCT00604175|7255261|FG002|STARTED|Week 29 Through Week 72||93
6347380|NCT00604175|7255259|FG000|COMPLETED|Week 29 Through Week 72||108
6347381|NCT00604175|7255260|FG001|COMPLETED|Week 29 Through Week 72||85
6347382|NCT00604175|7255261|FG002|COMPLETED|Week 29 Through Week 72||89
6347383|NCT00604175|7255259|FG000|NOT COMPLETED|Week 29 Through Week 72||12
6347384|NCT00604175|7255260|FG001|NOT COMPLETED|Week 29 Through Week 72||7
6347385|NCT00604175|7255261|FG002|NOT COMPLETED|Week 29 Through Week 72||4
6347386|NCT00604188|7255295|FG000|STARTED|Overall Study||93
6347387|NCT00604188|7255296|FG001|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
6347388|NCT00604188|7255295|FG000|COMPLETED|Overall Study||66
6347389|NCT00604188|7255296|FG001|COMPLETED|Overall Study||70
6347390|NCT00604188|7255295|FG000|NOT COMPLETED|Overall Study||27
6347391|NCT00604188|7255296|FG001|NOT COMPLETED|Overall Study||25
6347392|NCT00604214|7255304|FG000|STARTED|Baseline to Day 28||851
6347393|NCT00604214|7255305|FG001|STARTED|Baseline to Day 28||845
6347394|NCT00604214|7255304|FG000|Received Study Drug|Baseline to Day 28||833
6347395|NCT00604214|7255305|FG001|Received Study Drug|Baseline to Day 28||833
6347396|NCT00604214|7255304|FG000|COMPLETED|Baseline to Day 28||623
6347397|NCT00604214|7255305|FG001|COMPLETED|Baseline to Day 28||632
6347398|NCT00604214|7255304|FG000|NOT COMPLETED|Baseline to Day 28||228
6347399|NCT00604214|7255305|FG001|NOT COMPLETED|Baseline to Day 28||213
6347400|NCT00604214|7255304|FG000|STARTED|Day 29 to Day 90||623
6347401|NCT00604214|7255305|FG001|STARTED|Day 29 to Day 90||632
6347402|NCT00604214|7255304|FG000|COMPLETED|Day 29 to Day 90||555
6347403|NCT00604214|7255305|FG001|COMPLETED|Day 29 to Day 90||553
6347404|NCT00604214|7255304|FG000|NOT COMPLETED|Day 29 to Day 90||68
6347405|NCT00604214|7255305|FG001|NOT COMPLETED|Day 29 to Day 90||79
6347406|NCT00604214|7255304|FG000|STARTED|Day 91 to Day 180||555
6347407|NCT00604214|7255305|FG001|STARTED|Day 91 to Day 180||553
6347408|NCT00604214|7255304|FG000|COMPLETED|Day 91 to Day 180||529
6347409|NCT00604214|7255305|FG001|COMPLETED|Day 91 to Day 180||521
6347410|NCT00604214|7255304|FG000|NOT COMPLETED|Day 91 to Day 180||26
6347411|NCT00604214|7255305|FG001|NOT COMPLETED|Day 91 to Day 180||32
6347412|NCT00604279|7255313|FG000|STARTED|Overall Study||229
6347413|NCT00604279|7255314|FG001|STARTED|Overall Study||223
6347414|NCT00604279|7255313|FG000|COMPLETED|Overall Study||165
6347415|NCT00604279|7255314|FG001|COMPLETED|Overall Study||185
6347416|NCT00604279|7255313|FG000|NOT COMPLETED|Overall Study||64
6347417|NCT00604279|7255314|FG001|NOT COMPLETED|Overall Study||38
6347418|NCT00604383|7255322|FG000|STARTED|Overall Study||345
6347419|NCT00604383|7255323|FG001|STARTED|Overall Study||340
6347420|NCT00604383|7255322|FG000|Received at Least 1 Dose of Study Drug|Overall Study||345
6347421|NCT00604383|7255323|FG001|Received at Least 1 Dose of Study Drug|Overall Study||340
6347422|NCT00604383|7255322|FG000|Received Extended Treatment|Overall Study||136
6347423|NCT00604383|7255323|FG001|Received Extended Treatment|Overall Study||141
6347424|NCT00604383|7255322|FG000|COMPLETED|Overall Study||258
6347425|NCT00604383|7255323|FG001|COMPLETED|Overall Study||256
6347426|NCT00604383|7255322|FG000|NOT COMPLETED|Overall Study||87
6347427|NCT00604383|7255323|FG001|NOT COMPLETED|Overall Study||84
6347428|NCT00604461|7255329|FG000|STARTED|Overall Study||13
6347429|NCT00604461|7255329|FG000|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
6347430|NCT00604461|7255329|FG000|NOT COMPLETED|Overall Study||1
6347431|NCT00604552|7255335|FG000|STARTED|Overall Study||189
6347432|NCT00604552|7255336|FG001|STARTED|Overall Study||160
6347433|NCT00604552|7255335|FG000|COMPLETED|Overall Study||189
6347434|NCT00604552|7255336|FG001|COMPLETED|Overall Study||160
6347435|NCT00604552|7255335|FG000|NOT COMPLETED|Overall Study||0
6347436|NCT00604552|7255336|FG001|NOT COMPLETED|Overall Study||0
6376813|NCT00761267|7287405|FG001|STARTED|Overall Study||20
6376814|NCT00761267|7287406|FG002|STARTED|Overall Study||30
6376815|NCT00761267|7287404|FG000|Treated|Overall Study||19
6559461|NCT01781572|7482138|FG001|NOT COMPLETED|MEK162 45mg LEE011 450mg||9
6559462|NCT01781572|7482139|FG002|NOT COMPLETED|MEK162 45mg LEE011 450mg||0
6559463|NCT01781572|7482137|FG000|STARTED|MEK162 45mg LEE011 600mg||0
6559464|NCT01781572|7482138|FG001|STARTED|MEK162 45mg LEE011 600mg||6
6559465|NCT01781572|7482139|FG002|STARTED|MEK162 45mg LEE011 600mg||0
6559466|NCT01781572|7482137|FG000|COMPLETED|MEK162 45mg LEE011 600mg||0
6559467|NCT01781572|7482138|FG001|COMPLETED|MEK162 45mg LEE011 600mg||0
6559468|NCT01781572|7482139|FG002|COMPLETED|MEK162 45mg LEE011 600mg||0
6559469|NCT01781572|7482137|FG000|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
6559470|NCT01781572|7482138|FG001|NOT COMPLETED|MEK162 45mg LEE011 600mg||6
6559471|NCT01781572|7482139|FG002|NOT COMPLETED|MEK162 45mg LEE011 600mg||0
6559472|NCT01781611|7482170|FG000|STARTED|Overall Study||13
6559473|NCT01781611|7482171|FG001|STARTED|Overall Study||5
6559474|NCT01781611|7482170|FG000|COMPLETED|Overall Study||9
6559475|NCT01781611|7482171|FG001|COMPLETED|Overall Study||5
6559476|NCT01781611|7482170|FG000|NOT COMPLETED|Overall Study||4
6559477|NCT01781611|7482171|FG001|NOT COMPLETED|Overall Study||0
6559478|NCT01781806|7482179|FG000|STARTED|Overall Study||297
6559479|NCT01781806|7482180|FG001|STARTED|Overall Study||4
6559480|NCT01781806|7482179|FG000|Week 0|Overall Study||297
6559481|NCT01781806|7482180|FG001|Week 0|Overall Study||4
6559482|NCT01781806|7482179|FG000|Week 4|Overall Study||284
6559483|NCT01781806|7482180|FG001|Week 4|Overall Study||4
6559484|NCT01781806|7482179|FG000|Week 8|Overall Study||278
6559485|NCT01781806|7482180|FG001|Week 8|Overall Study||4
6559486|NCT01781806|7482179|FG000|Week 12|Overall Study||272
6559487|NCT01781806|7482180|FG001|Week 12|Overall Study||2
6559488|NCT01781806|7482179|FG000|Week 24|Overall Study||260
6559489|NCT01781806|7482180|FG001|Week 24|Overall Study||1
6559490|NCT01781806|7482179|FG000|Week 36|Overall Study||247
6559491|NCT01781806|7482180|FG001|Week 36|Overall Study||1
6559492|NCT01781806|7482179|FG000|Week 48|Overall Study||222
6559493|NCT01781806|7482180|FG001|Week 48|Overall Study||1
6559494|NCT01781806|7482179|FG000|COMPLETED|Overall Study||218
6376816|NCT00761267|7287405|FG001|Treated|Overall Study||19
6376817|NCT00761267|7287406|FG002|Treated|Overall Study||30
6376818|NCT00761267|7287404|FG000|COMPLETED|Overall Study||18
6376819|NCT00761267|7287405|FG001|COMPLETED|Overall Study||16
6376820|NCT00761267|7287406|FG002|COMPLETED|Overall Study||24
6376821|NCT00761267|7287404|FG000|NOT COMPLETED|Overall Study||2
6376822|NCT00761267|7287405|FG001|NOT COMPLETED|Overall Study||4
6376823|NCT00761267|7287406|FG002|NOT COMPLETED|Overall Study||6
6376824|NCT00761280|7287427|FG000|STARTED|Randomization to First Dose||14
6376825|NCT00761280|7287428|FG001|STARTED|Randomization to First Dose||13
6376826|NCT00761280|7287427|FG000|Catheter Surgery|Randomization to First Dose|Safety population|13
6376827|NCT00761280|7287428|FG001|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
6376828|NCT00761280|7287427|FG000|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
6376829|NCT00761280|7287428|FG001|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
6376830|NCT00761280|7287427|FG000|COMPLETED|Randomization to First Dose||12
6376831|NCT00761280|7287428|FG001|COMPLETED|Randomization to First Dose||11
6376832|NCT00761280|7287427|FG000|NOT COMPLETED|Randomization to First Dose||2
6376833|NCT00761280|7287428|FG001|NOT COMPLETED|Randomization to First Dose||2
6559495|NCT01781806|7482180|FG001|COMPLETED|Overall Study||1
6559496|NCT01781806|7482179|FG000|NOT COMPLETED|Overall Study||79
6559497|NCT01781806|7482180|FG001|NOT COMPLETED|Overall Study||3
6559498|NCT01781832|7482187|FG000|STARTED|Overall Study||26
6559499|NCT01781832|7482187|FG000|COMPLETED|Overall Study||25
6559500|NCT01781832|7482187|FG000|NOT COMPLETED|Overall Study||1
6376834|NCT00761280|7287427|FG000|STARTED|First Dose to End of Study||12
6559501|NCT01781962|7482191|FG000|STARTED|Overall Study||206
6559502|NCT01781962|7482191|FG000|COMPLETED|Overall Study||201
6559503|NCT01781962|7482191|FG000|NOT COMPLETED|Overall Study||5
6347437|NCT00604565|7255346|FG000|STARTED|Overall Study||4
6347438|NCT00604565|7255347|FG001|STARTED|Overall Study||7
6347439|NCT00604565|7255346|FG000|COMPLETED|Overall Study||4
6347440|NCT00604565|7255347|FG001|COMPLETED|Overall Study||4
6347441|NCT00604565|7255346|FG000|NOT COMPLETED|Overall Study||0
6347442|NCT00604565|7255347|FG001|NOT COMPLETED|Overall Study||3
6347443|NCT00604669|7255353|FG000|STARTED|Overall Study||170
6347444|NCT00604669|7255353|FG000|COMPLETED|Overall Study||163
6347445|NCT00604669|7255353|FG000|NOT COMPLETED|Overall Study||7
6347446|NCT00604695|7255359|FG000|STARTED|Overall Study||20
6347447|NCT00604695|7255360|FG001|STARTED|Overall Study||20
6347448|NCT00604695|7255359|FG000|COMPLETED|Overall Study||20
6347449|NCT00604695|7255360|FG001|COMPLETED|Overall Study||16
6347450|NCT00604695|7255359|FG000|NOT COMPLETED|Overall Study||0
6347451|NCT00604695|7255360|FG001|NOT COMPLETED|Overall Study||4
6347452|NCT00604708|7255368|FG000|STARTED|Overall Study||430
6347453|NCT00604708|7255369|FG001|STARTED|Overall Study||437
6347454|NCT00604708|7255368|FG000|COMPLETED|Overall Study||399
6347455|NCT00604708|7255369|FG001|COMPLETED|Overall Study||397
6347456|NCT00604708|7255368|FG000|NOT COMPLETED|Overall Study||31
6347457|NCT00604708|7255369|FG001|NOT COMPLETED|Overall Study||40
6347458|NCT00604721|7255375|FG000|STARTED|Overall Study||19
6347459|NCT00604721|7255375|FG000|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
6347460|NCT00604721|7255375|FG000|NOT COMPLETED|Overall Study||2
6559504|NCT01781975|7482197|FG000|STARTED|Overall Study||45
6559505|NCT01781975|7482198|FG001|STARTED|Overall Study||22
6559506|NCT01781975|7482197|FG000|Treatment Period|Overall Study||44
6347461|NCT00604786|7255382|FG000|STARTED|Overall Study||14
6347462|NCT00604786|7255383|FG001|STARTED|Overall Study||4
6347463|NCT00604786|7255382|FG000|COMPLETED|Overall Study||12
6347464|NCT00604786|7255383|FG001|COMPLETED|Overall Study||4
6347465|NCT00604786|7255382|FG000|NOT COMPLETED|Overall Study||2
6347466|NCT00604786|7255383|FG001|NOT COMPLETED|Overall Study||0
6347467|NCT00604825|7255393|FG000|STARTED|Overall Study||90
6347468|NCT00604825|7255394|FG001|STARTED|Overall Study||87
6347469|NCT00604825|7255395|FG002|STARTED|Overall Study||89
6347470|NCT00604825|7255396|FG003|STARTED|Overall Study||90
6347471|NCT00604825|7255393|FG000|COMPLETED|Overall Study||81
6347472|NCT00604825|7255394|FG001|COMPLETED|Overall Study||72
6347473|NCT00604825|7255395|FG002|COMPLETED|Overall Study||73
6347474|NCT00604825|7255396|FG003|COMPLETED|Overall Study||79
6347475|NCT00604825|7255393|FG000|NOT COMPLETED|Overall Study||9
6347476|NCT00604825|7255394|FG001|NOT COMPLETED|Overall Study||15
6347477|NCT00604825|7255395|FG002|NOT COMPLETED|Overall Study||16
6347478|NCT00604825|7255396|FG003|NOT COMPLETED|Overall Study||11
6347479|NCT00604890|7255410|FG000|STARTED|Overall Study||47
6347480|NCT00604890|7255411|FG001|STARTED|Overall Study||45
6347481|NCT00604890|7255412|FG002|STARTED|Overall Study||48
6347482|NCT00604890|7255413|FG003|STARTED|Overall Study||46
6347483|NCT00604890|7255410|FG000|COMPLETED|Overall Study||44
6347484|NCT00604890|7255411|FG001|COMPLETED|Overall Study||45
6347485|NCT00604890|7255412|FG002|COMPLETED|Overall Study||47
6347486|NCT00604890|7255413|FG003|COMPLETED|Overall Study||42
6347487|NCT00604890|7255410|FG000|NOT COMPLETED|Overall Study||3
6347488|NCT00604890|7255411|FG001|NOT COMPLETED|Overall Study||0
6347489|NCT00604890|7255412|FG002|NOT COMPLETED|Overall Study||1
6347490|NCT00604890|7255413|FG003|NOT COMPLETED|Overall Study||4
6347491|NCT00604968|7255424|FG000|STARTED|Overall Study||25
6347492|NCT00604968|7255424|FG000|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
6347493|NCT00604968|7255424|FG000|NOT COMPLETED|Overall Study||0
6347494|NCT00605033|7255430|FG000|STARTED|Overall Study||143
6347495|NCT00605033|7255431|FG001|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
6347496|NCT00605033|7255430|FG000|COMPLETED|Overall Study||136
6347497|NCT00605033|7255431|FG001|COMPLETED|Overall Study||90
6347498|NCT00605033|7255430|FG000|NOT COMPLETED|Overall Study||7
6347499|NCT00605033|7255431|FG001|NOT COMPLETED|Overall Study||8
6347500|NCT00605072|7255440|FG000|STARTED|Overall Study||18
6347501|NCT00605072|7255441|FG001|STARTED|Overall Study||20
6347502|NCT00605072|7255442|FG002|STARTED|Overall Study||15
6347503|NCT00605072|7255440|FG000|COMPLETED|Overall Study||11
6347504|NCT00605072|7255441|FG001|COMPLETED|Overall Study||9
6347505|NCT00605072|7255442|FG002|COMPLETED|Overall Study||11
6347506|NCT00605072|7255440|FG000|NOT COMPLETED|Overall Study||7
6347507|NCT00605072|7255441|FG001|NOT COMPLETED|Overall Study||11
6347508|NCT00605072|7255442|FG002|NOT COMPLETED|Overall Study||4
6347509|NCT00605085|7255452|FG000|STARTED|Overall Study||2012
6347510|NCT00605085|7255453|FG001|STARTED|Overall Study||663
6559507|NCT01781975|7482198|FG001|Treatment Period|Overall Study||22
6559508|NCT01781975|7482197|FG000|Follow-Up Period|Overall Study||43
6347511|NCT00605085|7255452|FG000|COMPLETED|Overall Study||1962
6347512|NCT00605085|7255453|FG001|COMPLETED|Overall Study||638
6347513|NCT00605085|7255452|FG000|NOT COMPLETED|Overall Study||50
6347514|NCT00605085|7255453|FG001|NOT COMPLETED|Overall Study||25
6347515|NCT00605176|7255462|FG000|STARTED|Overall Study||160
6347516|NCT00605176|7255463|FG001|STARTED|Overall Study||160
6347517|NCT00605176|7255464|FG002|STARTED|Overall Study||159
6347518|NCT00605176|7255462|FG000|COMPLETED|Overall Study||149
6347519|NCT00605176|7255463|FG001|COMPLETED|Overall Study||154
6347520|NCT00605176|7255464|FG002|COMPLETED|Overall Study||150
6347521|NCT00605176|7255462|FG000|NOT COMPLETED|Overall Study||11
6347522|NCT00605176|7255463|FG001|NOT COMPLETED|Overall Study||6
6347523|NCT00605176|7255464|FG002|NOT COMPLETED|Overall Study||9
6347524|NCT00605189|7255475|FG000|STARTED|Overall Study||20
6347525|NCT00605189|7255476|FG001|STARTED|Overall Study||21
6347526|NCT00605189|7255477|FG002|STARTED|Overall Study||9
6347527|NCT00605189|7255475|FG000|COMPLETED|Overall Study||17
6347528|NCT00605189|7255476|FG001|COMPLETED|Overall Study||19
6347529|NCT00605189|7255477|FG002|COMPLETED|Overall Study||9
6347530|NCT00605189|7255475|FG000|NOT COMPLETED|Overall Study||3
6347531|NCT00605189|7255476|FG001|NOT COMPLETED|Overall Study||2
6347532|NCT00605189|7255477|FG002|NOT COMPLETED|Overall Study||0
6347533|NCT00605202|7255485|FG000|STARTED|First Intervention||5
6347534|NCT00605202|7255486|FG001|STARTED|First Intervention||5
6347535|NCT00605202|7255485|FG000|COMPLETED|First Intervention||5
6347536|NCT00605202|7255486|FG001|COMPLETED|First Intervention||5
6347537|NCT00605202|7255485|FG000|NOT COMPLETED|First Intervention||0
6347538|NCT00605202|7255486|FG001|NOT COMPLETED|First Intervention||0
6347539|NCT00605202|7255485|FG000|STARTED|Washout Period of 3 Weeks||5
6347540|NCT00605202|7255486|FG001|STARTED|Washout Period of 3 Weeks||5
6347541|NCT00605202|7255485|FG000|COMPLETED|Washout Period of 3 Weeks||5
6347542|NCT00605202|7255486|FG001|COMPLETED|Washout Period of 3 Weeks||5
6347543|NCT00605202|7255485|FG000|NOT COMPLETED|Washout Period of 3 Weeks||0
6347544|NCT00605202|7255486|FG001|NOT COMPLETED|Washout Period of 3 Weeks||0
6347545|NCT00605202|7255485|FG000|STARTED|Second Intervention||5
6347546|NCT00605202|7255486|FG001|STARTED|Second Intervention||5
6347547|NCT00605202|7255485|FG000|COMPLETED|Second Intervention||5
6347548|NCT00605202|7255486|FG001|COMPLETED|Second Intervention||5
6347549|NCT00605202|7255485|FG000|NOT COMPLETED|Second Intervention||0
6347550|NCT00605202|7255486|FG001|NOT COMPLETED|Second Intervention||0
6347551|NCT00605267|7255494|FG000|STARTED|Overall Study||98
6347552|NCT00605267|7255495|FG001|STARTED|Overall Study||99
6347553|NCT00605267|7255494|FG000|COMPLETED|Overall Study|Breast surgery performed|95
6347554|NCT00605267|7255495|FG001|COMPLETED|Overall Study|Breast surgery performed|90
6347555|NCT00605267|7255494|FG000|NOT COMPLETED|Overall Study||3
6347556|NCT00605267|7255495|FG001|NOT COMPLETED|Overall Study||9
6347557|NCT00605280|7255505|FG000|STARTED|Year 1||145
6347558|NCT00605280|7255506|FG001|STARTED|Year 1||22
6347559|NCT00605280|7255507|FG002|STARTED|Year 1||7
6347560|NCT00605280|7255508|FG003|STARTED|Year 1||143
6347561|NCT00605280|7255505|FG000|Received 0.3 mg Treatment|Year 1||144
6347562|NCT00605280|7255506|FG001|Received 0.3 mg Treatment|Year 1||13
6347563|NCT00605280|7255507|FG002|Received 0.3 mg Treatment|Year 1||3
6347564|NCT00605280|7255508|FG003|Received 0.3 mg Treatment|Year 1||0
6347565|NCT00605280|7255505|FG000|COMPLETED|Year 1||126
6347566|NCT00605280|7255506|FG001|COMPLETED|Year 1||11
6347567|NCT00605280|7255507|FG002|COMPLETED|Year 1||6
6347568|NCT00605280|7255508|FG003|COMPLETED|Year 1||124
6347569|NCT00605280|7255505|FG000|NOT COMPLETED|Year 1||19
6347570|NCT00605280|7255506|FG001|NOT COMPLETED|Year 1||11
6347571|NCT00605280|7255507|FG002|NOT COMPLETED|Year 1||1
6347572|NCT00605280|7255508|FG003|NOT COMPLETED|Year 1||19
6347573|NCT00605280|7255505|FG000|STARTED|Year 2||126
6347574|NCT00605280|7255506|FG001|STARTED|Year 2||11
6347575|NCT00605280|7255507|FG002|STARTED|Year 2||6
6347576|NCT00605280|7255508|FG003|STARTED|Year 2||124
6347577|NCT00605280|7255505|FG000|Received 0.3 mg Treatment|Year 2||126
6347578|NCT00605280|7255506|FG001|Received 0.3 mg Treatment|Year 2||3
6347579|NCT00605280|7255507|FG002|Received 0.3 mg Treatment|Year 2||2
6347580|NCT00605280|7255508|FG003|Received 0.3 mg Treatment|Year 2||0
6347581|NCT00605280|7255505|FG000|COMPLETED|Year 2||102
6347582|NCT00605280|7255506|FG001|COMPLETED|Year 2||5
6347583|NCT00605280|7255507|FG002|COMPLETED|Year 2||0
6347584|NCT00605280|7255508|FG003|COMPLETED|Year 2||102
6347585|NCT00605280|7255505|FG000|NOT COMPLETED|Year 2||24
6347586|NCT00605280|7255506|FG001|NOT COMPLETED|Year 2||6
6347587|NCT00605280|7255507|FG002|NOT COMPLETED|Year 2||6
6347588|NCT00605280|7255508|FG003|NOT COMPLETED|Year 2||22
6347589|NCT00605280|7255505|FG000|STARTED|Year 3 Extension||46
6347590|NCT00605280|7255506|FG001|STARTED|Year 3 Extension||0
6347591|NCT00605280|7255507|FG002|STARTED|Year 3 Extension||0
6347592|NCT00605280|7255508|FG003|STARTED|Year 3 Extension||54
6347593|NCT00605280|7255505|FG000|Received 0.3 mg Treatment|Year 3 Extension||46
6347594|NCT00605280|7255506|FG001|Received 0.3 mg Treatment|Year 3 Extension||0
6347595|NCT00605280|7255507|FG002|Received 0.3 mg Treatment|Year 3 Extension||0
6347596|NCT00605280|7255508|FG003|Received 0.3 mg Treatment|Year 3 Extension||54
6347597|NCT00605280|7255505|FG000|COMPLETED|Year 3 Extension||38
6347598|NCT00605280|7255506|FG001|COMPLETED|Year 3 Extension||0
6347599|NCT00605280|7255507|FG002|COMPLETED|Year 3 Extension||0
6347600|NCT00605280|7255508|FG003|COMPLETED|Year 3 Extension||45
6347601|NCT00605280|7255505|FG000|NOT COMPLETED|Year 3 Extension||8
6347602|NCT00605280|7255506|FG001|NOT COMPLETED|Year 3 Extension||0
6347603|NCT00605280|7255507|FG002|NOT COMPLETED|Year 3 Extension||0
6347604|NCT00605280|7255508|FG003|NOT COMPLETED|Year 3 Extension||9
6347605|NCT00605293|7255520|FG000|STARTED|Overall Study||65
6347606|NCT00605293|7255521|FG001|STARTED|Overall Study||36
6347607|NCT00605293|7255520|FG000|COMPLETED|Overall Study||48
6347608|NCT00605293|7255521|FG001|COMPLETED|Overall Study||31
6347609|NCT00605293|7255520|FG000|NOT COMPLETED|Overall Study||17
6347610|NCT00605293|7255521|FG001|NOT COMPLETED|Overall Study||5
6347611|NCT00605306|7255529|FG000|STARTED|Overall Study||14
6347612|NCT00605306|7255530|FG001|STARTED|Overall Study||14
6347613|NCT00605306|7255529|FG000|COMPLETED|Overall Study||14
6347614|NCT00605306|7255530|FG001|COMPLETED|Overall Study||13
6347615|NCT00605306|7255529|FG000|NOT COMPLETED|Overall Study||0
6347616|NCT00605306|7255530|FG001|NOT COMPLETED|Overall Study||1
6347617|NCT00605319|7255536|FG000|STARTED|Overall Study||17
6347618|NCT00605319|7255536|FG000|COMPLETED|Overall Study||11
6347619|NCT00605319|7255536|FG000|NOT COMPLETED|Overall Study||6
6347620|NCT00605345|7255548|FG000|STARTED|Overall Study||46
6347621|NCT00605345|7255549|FG001|STARTED|Overall Study||25
6347622|NCT00605345|7255548|FG000|COMPLETED|Overall Study||45
6347623|NCT00605345|7255549|FG001|COMPLETED|Overall Study||22
6347624|NCT00605345|7255548|FG000|NOT COMPLETED|Overall Study||1
6347625|NCT00605345|7255549|FG001|NOT COMPLETED|Overall Study||3
6347626|NCT00605358|7255557|FG000|STARTED|Overall Study||81
6347627|NCT00605358|7255558|FG001|STARTED|Overall Study||80
6347628|NCT00605358|7255557|FG000|COMPLETED|Overall Study||81
6347629|NCT00605358|7255558|FG001|COMPLETED|Overall Study||80
6347630|NCT00605358|7255557|FG000|NOT COMPLETED|Overall Study||0
6347631|NCT00605358|7255558|FG001|NOT COMPLETED|Overall Study||0
6347632|NCT00605384|7255566|FG000|STARTED|Overall Study||1
6347633|NCT00605384|7255567|FG001|STARTED|Overall Study||1
6347634|NCT00605384|7255566|FG000|COMPLETED|Overall Study|study terminated early|0
6347635|NCT00605384|7255567|FG001|COMPLETED|Overall Study|study terminated early|0
6347636|NCT00605384|7255566|FG000|NOT COMPLETED|Overall Study||1
6347637|NCT00605384|7255567|FG001|NOT COMPLETED|Overall Study||1
6347638|NCT00605423|7255575|FG000|STARTED|Overall Study||4
6347639|NCT00605423|7255576|FG001|STARTED|Overall Study||2
6347640|NCT00605423|7255575|FG000|COMPLETED|Overall Study||4
6347641|NCT00605423|7255576|FG001|COMPLETED|Overall Study||2
6347642|NCT00605423|7255575|FG000|NOT COMPLETED|Overall Study||0
6347643|NCT00605423|7255576|FG001|NOT COMPLETED|Overall Study||0
6347644|NCT00605475|7255592|FG000|STARTED|Overall Study||10
6347645|NCT00605475|7255593|FG001|STARTED|Overall Study||5
6347646|NCT00605475|7255594|FG002|STARTED|Overall Study||45
6347647|NCT00605475|7255595|FG003|STARTED|Overall Study||45
6347648|NCT00605475|7255596|FG004|STARTED|Overall Study||25
6347649|NCT00605475|7255597|FG005|STARTED|Overall Study||24
6347650|NCT00605475|7255598|FG006|STARTED|Overall Study||23
6347651|NCT00605475|7255599|FG007|STARTED|Overall Study||24
6347652|NCT00605475|7255600|FG008|STARTED|Overall Study||20
6347653|NCT00605475|7255601|FG009|STARTED|Overall Study||10
6347654|NCT00605475|7255592|FG000|COMPLETED|Overall Study||10
6347655|NCT00605475|7255593|FG001|COMPLETED|Overall Study||5
6347656|NCT00605475|7255594|FG002|COMPLETED|Overall Study||45
6347657|NCT00605475|7255595|FG003|COMPLETED|Overall Study||45
6347658|NCT00605475|7255596|FG004|COMPLETED|Overall Study||24
6347659|NCT00605475|7255597|FG005|COMPLETED|Overall Study||22
6347660|NCT00605475|7255598|FG006|COMPLETED|Overall Study||22
6347661|NCT00605475|7255599|FG007|COMPLETED|Overall Study||24
6347662|NCT00605475|7255600|FG008|COMPLETED|Overall Study||18
6347663|NCT00605475|7255601|FG009|COMPLETED|Overall Study||8
6347664|NCT00605475|7255592|FG000|NOT COMPLETED|Overall Study||0
6347665|NCT00605475|7255593|FG001|NOT COMPLETED|Overall Study||0
6559509|NCT01781975|7482198|FG001|Follow-Up Period|Overall Study||21
6559510|NCT01781975|7482197|FG000|COMPLETED|Overall Study||43
6559511|NCT01781975|7482198|FG001|COMPLETED|Overall Study||21
6347666|NCT00605475|7255594|FG002|NOT COMPLETED|Overall Study||0
6347667|NCT00605475|7255595|FG003|NOT COMPLETED|Overall Study||0
6347668|NCT00605475|7255596|FG004|NOT COMPLETED|Overall Study||1
6347669|NCT00605475|7255597|FG005|NOT COMPLETED|Overall Study||2
6347670|NCT00605475|7255598|FG006|NOT COMPLETED|Overall Study||1
6347671|NCT00605475|7255599|FG007|NOT COMPLETED|Overall Study||0
6347672|NCT00605475|7255600|FG008|NOT COMPLETED|Overall Study||2
6347673|NCT00605475|7255601|FG009|NOT COMPLETED|Overall Study||2
6347674|NCT00605540|7255644|FG000|STARTED|Overall Study||133
6347675|NCT00605540|7255644|FG000|COMPLETED|Overall Study||95
6347676|NCT00605540|7255644|FG000|NOT COMPLETED|Overall Study||38
6347677|NCT00605566|7255648|FG000|STARTED|Overall Study||22
6347678|NCT00605566|7255648|FG000|COMPLETED|Overall Study||19
6347679|NCT00605566|7255648|FG000|NOT COMPLETED|Overall Study||3
6347680|NCT00605644|7255657|FG000|STARTED|Overall Study||29
6347681|NCT00605644|7255658|FG001|STARTED|Overall Study||19
6347682|NCT00605644|7255659|FG002|STARTED|Overall Study||20
6347683|NCT00605644|7255660|FG003|STARTED|Overall Study||30
6347684|NCT00605644|7255661|FG004|STARTED|Overall Study||30
6347685|NCT00605644|7255657|FG000|COMPLETED|Overall Study||28
6559512|NCT01781975|7482197|FG000|NOT COMPLETED|Overall Study||2
6559513|NCT01781975|7482198|FG001|NOT COMPLETED|Overall Study||1
6347686|NCT00605644|7255658|FG001|COMPLETED|Overall Study||18
6347687|NCT00605644|7255659|FG002|COMPLETED|Overall Study||18
6347688|NCT00605644|7255660|FG003|COMPLETED|Overall Study||25
6347689|NCT00605644|7255661|FG004|COMPLETED|Overall Study||22
6347690|NCT00605644|7255657|FG000|NOT COMPLETED|Overall Study||1
6347691|NCT00605644|7255658|FG001|NOT COMPLETED|Overall Study||1
6559514|NCT01782131|7482206|FG000|STARTED|Overall Study||293
6559515|NCT01782131|7482207|FG001|STARTED|Overall Study||292
6559516|NCT01782131|7482206|FG000|Treated|Overall Study||288
6347692|NCT00605644|7255659|FG002|NOT COMPLETED|Overall Study||2
6347693|NCT00605644|7255660|FG003|NOT COMPLETED|Overall Study||5
6347694|NCT00605644|7255661|FG004|NOT COMPLETED|Overall Study||8
6347695|NCT00605657|7255673|FG000|STARTED|Overall Study||5
6347696|NCT00605657|7255673|FG000|COMPLETED|Overall Study||3
6347697|NCT00605657|7255673|FG000|NOT COMPLETED|Overall Study||2
6347698|NCT00605696|7255679|FG000|STARTED|Overall Study||7
6347699|NCT00605696|7255680|FG001|STARTED|Overall Study||11
6347700|NCT00605696|7255679|FG000|COMPLETED|Overall Study||7
6347701|NCT00605696|7255680|FG001|COMPLETED|Overall Study||11
6347702|NCT00605696|7255679|FG000|NOT COMPLETED|Overall Study||0
6347703|NCT00605696|7255680|FG001|NOT COMPLETED|Overall Study||0
6347704|NCT00605722|7255686|FG000|STARTED|Overall Study||51
6347705|NCT00605722|7255686|FG000|COMPLETED|Overall Study|Completed=Completed Treatment.|0
6347706|NCT00605722|7255686|FG000|NOT COMPLETED|Overall Study||51
6347707|NCT00605813|7255690|FG000|STARTED|Overall Study||542
6347708|NCT00605813|7255690|FG000|COMPLETED|Overall Study||517
6347709|NCT00605813|7255690|FG000|NOT COMPLETED|Overall Study||25
6347710|NCT00605826|7255705|FG000|STARTED|Overall Study||136
6347711|NCT00605826|7255706|FG001|STARTED|Overall Study||70
6347712|NCT00605826|7255705|FG000|COMPLETED|Overall Study||129
6347713|NCT00605826|7255706|FG001|COMPLETED|Overall Study||60
6347714|NCT00605826|7255705|FG000|NOT COMPLETED|Overall Study||7
6347715|NCT00605826|7255706|FG001|NOT COMPLETED|Overall Study||10
6347716|NCT00605839|7255715|FG000|STARTED|Overall Study||40
6347717|NCT00605839|7255716|FG001|STARTED|Overall Study||37
6347718|NCT00605839|7255717|FG002|STARTED|Overall Study||28
6347719|NCT00605839|7255715|FG000|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
6347720|NCT00605839|7255716|FG001|COMPLETED|Overall Study||37
6347721|NCT00605839|7255717|FG002|COMPLETED|Overall Study||28
6347722|NCT00605839|7255715|FG000|NOT COMPLETED|Overall Study||1
6347723|NCT00605839|7255716|FG001|NOT COMPLETED|Overall Study||0
6347724|NCT00605839|7255717|FG002|NOT COMPLETED|Overall Study||0
6347725|NCT00605865|7255725|FG000|STARTED|Overall Study||2272
6347726|NCT00605865|7255725|FG000|COMPLETED|Overall Study||2157
6347727|NCT00605865|7255725|FG000|NOT COMPLETED|Overall Study||115
6347728|NCT00605904|7255759|FG000|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
6347729|NCT00605904|7255760|FG001|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
6347730|NCT00605904|7255759|FG000|COMPLETED|Baseline Data Collection and Dosing||13
6347731|NCT00605904|7255760|FG001|COMPLETED|Baseline Data Collection and Dosing||16
6347732|NCT00605904|7255759|FG000|NOT COMPLETED|Baseline Data Collection and Dosing||0
6347733|NCT00605904|7255760|FG001|NOT COMPLETED|Baseline Data Collection and Dosing||5
6347734|NCT00605904|7255759|FG000|STARTED|Infusion Sessions||13
6347735|NCT00605904|7255760|FG001|STARTED|Infusion Sessions||16
6347736|NCT00605904|7255759|FG000|Saline Infusion|Infusion Sessions||13
6347737|NCT00605904|7255760|FG001|Saline Infusion|Infusion Sessions||14
6347738|NCT00605904|7255759|FG000|mCPP Infusion|Infusion Sessions||12
6347739|NCT00605904|7255760|FG001|mCPP Infusion|Infusion Sessions||13
6347740|NCT00605904|7255759|FG000|Yohimbine Infusion|Infusion Sessions||12
6347741|NCT00605904|7255760|FG001|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
6347742|NCT00605904|7255759|FG000|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
6347743|NCT00605904|7255760|FG001|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
6347744|NCT00605904|7255759|FG000|NOT COMPLETED|Infusion Sessions||1
6347745|NCT00605904|7255760|FG001|NOT COMPLETED|Infusion Sessions||3
6347746|NCT00605917|7255766|FG000|STARTED|Overall Study||987
6347747|NCT00605917|7255766|FG000|COMPLETED|Overall Study||908
6347748|NCT00605917|7255766|FG000|NOT COMPLETED|Overall Study||79
6347749|NCT00606008|7255801|FG000|STARTED|Overall Study||30
6347750|NCT00606008|7255801|FG000|COMPLETED|Overall Study||25
6347751|NCT00606008|7255801|FG000|NOT COMPLETED|Overall Study||5
6347752|NCT00606021|7255811|FG000|STARTED|Induction Phase||106
6347753|NCT00606021|7255812|FG001|STARTED|Induction Phase||0
6347754|NCT00606021|7255813|FG002|STARTED|Induction Phase||0
6347755|NCT00606021|7255811|FG000|COMPLETED|Induction Phase||19
6347756|NCT00606021|7255812|FG001|COMPLETED|Induction Phase||0
6347757|NCT00606021|7255813|FG002|COMPLETED|Induction Phase||0
6347758|NCT00606021|7255811|FG000|NOT COMPLETED|Induction Phase||87
6347759|NCT00606021|7255812|FG001|NOT COMPLETED|Induction Phase||0
6347760|NCT00606021|7255813|FG002|NOT COMPLETED|Induction Phase||0
6347761|NCT00606021|7255811|FG000|STARTED|Maintenance Phase||0
6347762|NCT00606021|7255812|FG001|STARTED|Maintenance Phase||28
6347763|NCT00606021|7255813|FG002|STARTED|Maintenance Phase||27
6347764|NCT00606021|7255811|FG000|COMPLETED|Maintenance Phase||0
6347765|NCT00606021|7255812|FG001|COMPLETED|Maintenance Phase||5
6347766|NCT00606021|7255813|FG002|COMPLETED|Maintenance Phase||10
6347767|NCT00606021|7255811|FG000|NOT COMPLETED|Maintenance Phase||0
6347768|NCT00606021|7255812|FG001|NOT COMPLETED|Maintenance Phase||23
6347769|NCT00606021|7255813|FG002|NOT COMPLETED|Maintenance Phase||17
6347770|NCT00606034|7255821|FG000|STARTED|Overall Study||21
6347771|NCT00606034|7255821|FG000|COMPLETED|Overall Study||20
6347772|NCT00606034|7255821|FG000|NOT COMPLETED|Overall Study||1
6347773|NCT00606047|7255827|FG000|STARTED|Overall Study||200
6347774|NCT00606047|7255827|FG000|COMPLETED|Overall Study||200
6347775|NCT00606047|7255827|FG000|NOT COMPLETED|Overall Study||0
6347776|NCT00606086|7255833|FG000|STARTED|Overall Study||72
6347777|NCT00606086|7255834|FG001|STARTED|Overall Study||68
6347778|NCT00606086|7255833|FG000|COMPLETED|Overall Study||60
6347779|NCT00606086|7255834|FG001|COMPLETED|Overall Study||53
6347780|NCT00606086|7255833|FG000|NOT COMPLETED|Overall Study||12
6347781|NCT00606086|7255834|FG001|NOT COMPLETED|Overall Study||15
6347782|NCT00606138|7255842|FG000|STARTED|Overall Study||6
6347783|NCT00606138|7255843|FG001|STARTED|Overall Study||2
6347784|NCT00606138|7255842|FG000|COMPLETED|Overall Study||6
6347785|NCT00606138|7255843|FG001|COMPLETED|Overall Study||2
6347786|NCT00606138|7255842|FG000|NOT COMPLETED|Overall Study||0
6347787|NCT00606138|7255843|FG001|NOT COMPLETED|Overall Study||0
6347788|NCT00606177|7255851|FG000|STARTED|Overall Study||55
6347789|NCT00606177|7255852|FG001|STARTED|Overall Study||44
6347790|NCT00606177|7255851|FG000|COMPLETED|Overall Study||28
6347791|NCT00606177|7255852|FG001|COMPLETED|Overall Study||19
6347792|NCT00606177|7255851|FG000|NOT COMPLETED|Overall Study||27
6347793|NCT00606177|7255852|FG001|NOT COMPLETED|Overall Study||25
6347794|NCT00606229|7255858|FG000|STARTED|Overall Study||41
6347795|NCT00606229|7255858|FG000|COMPLETED|Overall Study||19
6347796|NCT00606229|7255858|FG000|NOT COMPLETED|Overall Study||22
6559517|NCT01782131|7482207|FG001|Treated|Overall Study||287
6559518|NCT01782131|7482206|FG000|COMPLETED|Overall Study||184
6347797|NCT00606281|7255864|FG000|STARTED|Overall Study||128
6347798|NCT00606281|7255865|FG001|STARTED|Overall Study||130
6347799|NCT00606281|7255864|FG000|COMPLETED|Overall Study||72
6347800|NCT00606281|7255865|FG001|COMPLETED|Overall Study||64
6347801|NCT00606281|7255864|FG000|NOT COMPLETED|Overall Study||56
6347802|NCT00606281|7255865|FG001|NOT COMPLETED|Overall Study||66
6347803|NCT00606294|7255873|FG000|STARTED|Overall Study||197
6347804|NCT00606294|7255874|FG001|STARTED|Overall Study||19
6347805|NCT00606294|7255873|FG000|COMPLETED|Overall Study||161
6347806|NCT00606294|7255874|FG001|COMPLETED|Overall Study||19
6347807|NCT00606294|7255873|FG000|NOT COMPLETED|Overall Study||36
6347808|NCT00606294|7255874|FG001|NOT COMPLETED|Overall Study||0
6347809|NCT00606307|7255880|FG000|STARTED|Overall Study||29
6347810|NCT00606307|7255880|FG000|COMPLETED|Overall Study||18
6347811|NCT00606307|7255880|FG000|NOT COMPLETED|Overall Study||11
6347812|NCT00606320|7255884|FG000|STARTED|Overall Study||59
6347813|NCT00606320|7255884|FG000|COMPLETED|Overall Study||22
6347814|NCT00606320|7255884|FG000|NOT COMPLETED|Overall Study||37
6347815|NCT00606489|7255890|FG000|STARTED|Overall Study||21
6347816|NCT00606489|7255891|FG001|STARTED|Overall Study||40
6347817|NCT00606489|7255890|FG000|COMPLETED|Overall Study||21
6347818|NCT00606489|7255891|FG001|COMPLETED|Overall Study||40
6347819|NCT00606489|7255890|FG000|NOT COMPLETED|Overall Study||0
6347820|NCT00606489|7255891|FG001|NOT COMPLETED|Overall Study||0
6347821|NCT00606502|7255899|FG000|STARTED|Randomization||100
6347822|NCT00606502|7255900|FG001|STARTED|Randomization||101
6347823|NCT00606502|7255899|FG000|COMPLETED|Randomization||97
6347824|NCT00606502|7255900|FG001|COMPLETED|Randomization||101
6347825|NCT00606502|7255899|FG000|NOT COMPLETED|Randomization||3
6347826|NCT00606502|7255900|FG001|NOT COMPLETED|Randomization||0
6347827|NCT00606502|7255899|FG000|STARTED|Treatment||97
6347828|NCT00606502|7255900|FG001|STARTED|Treatment||101
6347829|NCT00606502|7255899|FG000|COMPLETED|Treatment||97
6347830|NCT00606502|7255900|FG001|COMPLETED|Treatment||98
6347831|NCT00606502|7255899|FG000|NOT COMPLETED|Treatment||0
6347832|NCT00606502|7255900|FG001|NOT COMPLETED|Treatment||3
6347833|NCT00606554|7255908|FG000|STARTED|Overall Study||15
6347834|NCT00606554|7255909|FG001|STARTED|Overall Study||18
6347835|NCT00606554|7255908|FG000|COMPLETED|Overall Study||15
6347836|NCT00606554|7255909|FG001|COMPLETED|Overall Study||18
6347837|NCT00606554|7255908|FG000|NOT COMPLETED|Overall Study||0
6347838|NCT00606554|7255909|FG001|NOT COMPLETED|Overall Study||0
6347839|NCT00606580|7255922|FG000|STARTED|Overall Study||125
6347840|NCT00606580|7255923|FG001|STARTED|Overall Study||125
6347841|NCT00606580|7255924|FG002|STARTED|Overall Study||125
6347842|NCT00606580|7255922|FG000|COMPLETED|Overall Study||123
6347843|NCT00606580|7255923|FG001|COMPLETED|Overall Study||122
6347844|NCT00606580|7255924|FG002|COMPLETED|Overall Study||103
6347845|NCT00606580|7255922|FG000|NOT COMPLETED|Overall Study||2
6347846|NCT00606580|7255923|FG001|NOT COMPLETED|Overall Study||3
6347847|NCT00606580|7255924|FG002|NOT COMPLETED|Overall Study||22
6347848|NCT00606593|7255932|FG000|STARTED|Overall Study|Randomized participants|11
6347849|NCT00606593|7255933|FG001|STARTED|Overall Study|Randomized participants|11
6347850|NCT00606593|7255934|FG002|STARTED|Overall Study|Randomized participants|11
6347851|NCT00606593|7255935|FG003|STARTED|Overall Study|Randomized participants|11
6347852|NCT00606593|7255936|FG004|STARTED|Overall Study|Randomized participants|12
6347853|NCT00606593|7255937|FG005|STARTED|Overall Study|Randomized participants|11
6347854|NCT00606593|7255938|FG006|STARTED|Overall Study|Randomized participants|11
6347855|NCT00606593|7255939|FG007|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
6347856|NCT00606593|7255940|FG008|STARTED|Overall Study|Randomized participants|12
6347857|NCT00606593|7255941|FG009|STARTED|Overall Study|Randomized participants|11
6347858|NCT00606593|7255932|FG000|1st Double-blind Treatment|Overall Study||11
6347859|NCT00606593|7255933|FG001|1st Double-blind Treatment|Overall Study||11
6347860|NCT00606593|7255934|FG002|1st Double-blind Treatment|Overall Study||11
6347861|NCT00606593|7255935|FG003|1st Double-blind Treatment|Overall Study||11
6347862|NCT00606593|7255936|FG004|1st Double-blind Treatment|Overall Study||12
6347863|NCT00606593|7255937|FG005|1st Double-blind Treatment|Overall Study||11
6347864|NCT00606593|7255938|FG006|1st Double-blind Treatment|Overall Study||11
6347865|NCT00606593|7255939|FG007|1st Double-blind Treatment|Overall Study||11
6347866|NCT00606593|7255940|FG008|1st Double-blind Treatment|Overall Study||12
6347867|NCT00606593|7255941|FG009|1st Double-blind Treatment|Overall Study||11
6559519|NCT01782131|7482207|FG001|COMPLETED|Overall Study||177
6347868|NCT00606593|7255932|FG000|2nd Double-blind Treatment|Overall Study||11
6347869|NCT00606593|7255933|FG001|2nd Double-blind Treatment|Overall Study||11
6347870|NCT00606593|7255934|FG002|2nd Double-blind Treatment|Overall Study||11
6347871|NCT00606593|7255935|FG003|2nd Double-blind Treatment|Overall Study||10
6347872|NCT00606593|7255936|FG004|2nd Double-blind Treatment|Overall Study||12
6347873|NCT00606593|7255937|FG005|2nd Double-blind Treatment|Overall Study||11
6347874|NCT00606593|7255938|FG006|2nd Double-blind Treatment|Overall Study||10
6347875|NCT00606593|7255939|FG007|2nd Double-blind Treatment|Overall Study||9
6347876|NCT00606593|7255940|FG008|2nd Double-blind Treatment|Overall Study||12
6347877|NCT00606593|7255941|FG009|2nd Double-blind Treatment|Overall Study||11
6347878|NCT00606593|7255932|FG000|3rd Double-blind Treatment|Overall Study||11
6347879|NCT00606593|7255933|FG001|3rd Double-blind Treatment|Overall Study||11
6347880|NCT00606593|7255934|FG002|3rd Double-blind Treatment|Overall Study||10
6347881|NCT00606593|7255935|FG003|3rd Double-blind Treatment|Overall Study||10
6347882|NCT00606593|7255936|FG004|3rd Double-blind Treatment|Overall Study||11
6347883|NCT00606593|7255937|FG005|3rd Double-blind Treatment|Overall Study||11
6347884|NCT00606593|7255938|FG006|3rd Double-blind Treatment|Overall Study||10
6347885|NCT00606593|7255939|FG007|3rd Double-blind Treatment|Overall Study||9
6347886|NCT00606593|7255940|FG008|3rd Double-blind Treatment|Overall Study||12
6347887|NCT00606593|7255941|FG009|3rd Double-blind Treatment|Overall Study||11
6347888|NCT00606593|7255932|FG000|4th Double-blind Treatment|Overall Study||10
6347889|NCT00606593|7255933|FG001|4th Double-blind Treatment|Overall Study||11
6347890|NCT00606593|7255934|FG002|4th Double-blind Treatment|Overall Study||10
6347891|NCT00606593|7255935|FG003|4th Double-blind Treatment|Overall Study||10
6347892|NCT00606593|7255936|FG004|4th Double-blind Treatment|Overall Study||11
6347893|NCT00606593|7255937|FG005|4th Double-blind Treatment|Overall Study||11
6347894|NCT00606593|7255938|FG006|4th Double-blind Treatment|Overall Study||10
6347895|NCT00606593|7255939|FG007|4th Double-blind Treatment|Overall Study||9
6347896|NCT00606593|7255940|FG008|4th Double-blind Treatment|Overall Study||11
6347897|NCT00606593|7255941|FG009|4th Double-blind Treatment|Overall Study||11
6347898|NCT00606593|7255932|FG000|5th Double-blind Treatment|Overall Study||10
6347899|NCT00606593|7255933|FG001|5th Double-blind Treatment|Overall Study||11
6347900|NCT00606593|7255934|FG002|5th Double-blind Treatment|Overall Study||9
6347901|NCT00606593|7255935|FG003|5th Double-blind Treatment|Overall Study||10
6347902|NCT00606593|7255936|FG004|5th Double-blind Treatment|Overall Study||11
6347903|NCT00606593|7255937|FG005|5th Double-blind Treatment|Overall Study||11
6347904|NCT00606593|7255938|FG006|5th Double-blind Treatment|Overall Study||10
6347905|NCT00606593|7255939|FG007|5th Double-blind Treatment|Overall Study||9
6347906|NCT00606593|7255940|FG008|5th Double-blind Treatment|Overall Study||11
6347907|NCT00606593|7255941|FG009|5th Double-blind Treatment|Overall Study||11
6347908|NCT00606593|7255932|FG000|COMPLETED|Overall Study||10
6347909|NCT00606593|7255933|FG001|COMPLETED|Overall Study||11
6347910|NCT00606593|7255934|FG002|COMPLETED|Overall Study||9
6347911|NCT00606593|7255935|FG003|COMPLETED|Overall Study||10
6347912|NCT00606593|7255936|FG004|COMPLETED|Overall Study||11
6347913|NCT00606593|7255937|FG005|COMPLETED|Overall Study||11
6347914|NCT00606593|7255938|FG006|COMPLETED|Overall Study||10
6347915|NCT00606593|7255939|FG007|COMPLETED|Overall Study||9
6347916|NCT00606593|7255940|FG008|COMPLETED|Overall Study||11
6347917|NCT00606593|7255941|FG009|COMPLETED|Overall Study||11
6347918|NCT00606593|7255932|FG000|NOT COMPLETED|Overall Study||1
6347919|NCT00606593|7255933|FG001|NOT COMPLETED|Overall Study||0
6347920|NCT00606593|7255934|FG002|NOT COMPLETED|Overall Study||2
6347921|NCT00606593|7255935|FG003|NOT COMPLETED|Overall Study||1
6347922|NCT00606593|7255936|FG004|NOT COMPLETED|Overall Study||1
6347923|NCT00606593|7255937|FG005|NOT COMPLETED|Overall Study||0
6347924|NCT00606593|7255938|FG006|NOT COMPLETED|Overall Study||1
6347925|NCT00606593|7255939|FG007|NOT COMPLETED|Overall Study||2
6347926|NCT00606593|7255940|FG008|NOT COMPLETED|Overall Study||1
6347927|NCT00606593|7255941|FG009|NOT COMPLETED|Overall Study||0
6347928|NCT00606632|7255954|FG000|STARTED|Overall Study||226
6347929|NCT00606632|7255954|FG000|COMPLETED|Overall Study||204
6347930|NCT00606632|7255954|FG000|NOT COMPLETED|Overall Study||22
6347931|NCT00606684|7255969|FG000|STARTED|2-week Single-Blind Run-in Period||851
6347932|NCT00606684|7255970|FG001|STARTED|2-week Single-Blind Run-in Period||0
6347933|NCT00606684|7255971|FG002|STARTED|2-week Single-Blind Run-in Period||0
6347934|NCT00606684|7255972|FG003|STARTED|2-week Single-Blind Run-in Period||0
6347935|NCT00606684|7255973|FG004|STARTED|2-week Single-Blind Run-in Period||0
6347936|NCT00606684|7255974|FG005|STARTED|2-week Single-Blind Run-in Period||0
6347937|NCT00606684|7255975|FG006|STARTED|2-week Single-Blind Run-in Period||0
6347938|NCT00606684|7255969|FG000|COMPLETED|2-week Single-Blind Run-in Period||605
6347939|NCT00606684|7255970|FG001|COMPLETED|2-week Single-Blind Run-in Period||0
6347940|NCT00606684|7255971|FG002|COMPLETED|2-week Single-Blind Run-in Period||0
6347941|NCT00606684|7255972|FG003|COMPLETED|2-week Single-Blind Run-in Period||0
6347942|NCT00606684|7255973|FG004|COMPLETED|2-week Single-Blind Run-in Period||0
6347943|NCT00606684|7255974|FG005|COMPLETED|2-week Single-Blind Run-in Period||0
6347944|NCT00606684|7255975|FG006|COMPLETED|2-week Single-Blind Run-in Period||0
6347945|NCT00606684|7255969|FG000|NOT COMPLETED|2-week Single-Blind Run-in Period||246
6347946|NCT00606684|7255970|FG001|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6347947|NCT00606684|7255971|FG002|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6347948|NCT00606684|7255972|FG003|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6347949|NCT00606684|7255973|FG004|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6347950|NCT00606684|7255974|FG005|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6559520|NCT01782131|7482206|FG000|NOT COMPLETED|Overall Study||109
6559521|NCT01782131|7482207|FG001|NOT COMPLETED|Overall Study||115
6559522|NCT01782209|7482213|FG000|STARTED|Overall Study||335
6559523|NCT01782209|7482213|FG000|COMPLETED|Overall Study||225
6559524|NCT01782209|7482213|FG000|NOT COMPLETED|Overall Study||110
6559525|NCT01782222|7482220|FG000|STARTED|Overall Study||40
6559526|NCT01782222|7482221|FG001|STARTED|Overall Study||41
6559527|NCT01782222|7482222|FG002|STARTED|Overall Study||41
6559528|NCT01782222|7482220|FG000|COMPLETED|Overall Study||32
6559529|NCT01782222|7482221|FG001|COMPLETED|Overall Study||30
6559530|NCT01782222|7482222|FG002|COMPLETED|Overall Study||37
6559531|NCT01782222|7482220|FG000|NOT COMPLETED|Overall Study||8
6559532|NCT01782222|7482221|FG001|NOT COMPLETED|Overall Study||11
6559533|NCT01782222|7482222|FG002|NOT COMPLETED|Overall Study||4
6559534|NCT01782313|7482230|FG000|STARTED|Reached First Response/Completed 2 Cycle||58
6559535|NCT01782313|7482230|FG000|COMPLETED|Reached First Response/Completed 2 Cycle||52
6559536|NCT01782313|7482230|FG000|NOT COMPLETED|Reached First Response/Completed 2 Cycle||6
6559537|NCT01782313|7482230|FG000|STARTED|Treated Cycle 3||52
6559538|NCT01782313|7482230|FG000|COMPLETED|Treated Cycle 3||31
6559539|NCT01782313|7482230|FG000|NOT COMPLETED|Treated Cycle 3||21
6559540|NCT01782313|7482230|FG000|STARTED|Treated Cycle 4/Reached 16 Week Response||31
6559541|NCT01782313|7482230|FG000|COMPLETED|Treated Cycle 4/Reached 16 Week Response||25
6559542|NCT01782313|7482230|FG000|NOT COMPLETED|Treated Cycle 4/Reached 16 Week Response||6
6559543|NCT01782313|7482230|FG000|STARTED|Continued Treatment After 16 Weeks||25
6559544|NCT01782313|7482230|FG000|COMPLETED|Continued Treatment After 16 Weeks||18
6559545|NCT01782313|7482230|FG000|NOT COMPLETED|Continued Treatment After 16 Weeks||7
6559546|NCT01782313|7482230|FG000|STARTED|Survival Follow up||58
6559547|NCT01782313|7482230|FG000|COMPLETED|Survival Follow up||57
6559548|NCT01782313|7482230|FG000|NOT COMPLETED|Survival Follow up||1
6559549|NCT01782326|7482236|FG000|STARTED|Planned Treatment Epoch||1680
6347951|NCT00606684|7255975|FG006|NOT COMPLETED|2-week Single-Blind Run-in Period||0
6347952|NCT00606684|7255969|FG000|STARTED|Double-Blind Treatment Period||0
6347953|NCT00606684|7255970|FG001|STARTED|Double-Blind Treatment Period||101
6347954|NCT00606684|7255971|FG002|STARTED|Double-Blind Treatment Period||99
6347955|NCT00606684|7255972|FG003|STARTED|Double-Blind Treatment Period||101
6347956|NCT00606684|7255973|FG004|STARTED|Double-Blind Treatment Period||101
6347957|NCT00606684|7255974|FG005|STARTED|Double-Blind Treatment Period||101
6347958|NCT00606684|7255975|FG006|STARTED|Double-Blind Treatment Period||99
6347959|NCT00606684|7255969|FG000|COMPLETED|Double-Blind Treatment Period||0
6347960|NCT00606684|7255970|FG001|COMPLETED|Double-Blind Treatment Period||85
6347961|NCT00606684|7255971|FG002|COMPLETED|Double-Blind Treatment Period||88
6347962|NCT00606684|7255972|FG003|COMPLETED|Double-Blind Treatment Period||91
6347963|NCT00606684|7255973|FG004|COMPLETED|Double-Blind Treatment Period||92
6347964|NCT00606684|7255974|FG005|COMPLETED|Double-Blind Treatment Period||92
6347965|NCT00606684|7255975|FG006|COMPLETED|Double-Blind Treatment Period||91
6347966|NCT00606684|7255969|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6347967|NCT00606684|7255970|FG001|NOT COMPLETED|Double-Blind Treatment Period||16
6347968|NCT00606684|7255971|FG002|NOT COMPLETED|Double-Blind Treatment Period||11
6347969|NCT00606684|7255972|FG003|NOT COMPLETED|Double-Blind Treatment Period||10
6347970|NCT00606684|7255973|FG004|NOT COMPLETED|Double-Blind Treatment Period||9
6347971|NCT00606684|7255974|FG005|NOT COMPLETED|Double-Blind Treatment Period||9
6347972|NCT00606684|7255975|FG006|NOT COMPLETED|Double-Blind Treatment Period||8
6347973|NCT00606801|7255991|FG000|STARTED|Adaptation||17
6347974|NCT00606801|7255992|FG001|STARTED|Adaptation||17
6347975|NCT00606801|7255991|FG000|COMPLETED|Adaptation||17
6347976|NCT00606801|7255992|FG001|COMPLETED|Adaptation||17
6347977|NCT00606801|7255991|FG000|NOT COMPLETED|Adaptation||0
6347978|NCT00606801|7255992|FG001|NOT COMPLETED|Adaptation||0
6347979|NCT00606801|7255991|FG000|STARTED|Intervention||17
6347980|NCT00606801|7255992|FG001|STARTED|Intervention||17
6347981|NCT00606801|7255991|FG000|COMPLETED|Intervention||14
6347982|NCT00606801|7255992|FG001|COMPLETED|Intervention||14
6347983|NCT00606801|7255991|FG000|NOT COMPLETED|Intervention||3
6347984|NCT00606801|7255992|FG001|NOT COMPLETED|Intervention||3
6347985|NCT00606892|7256002|FG000|STARTED|Adaptation||9
6347986|NCT00606892|7256003|FG001|STARTED|Adaptation||8
6347987|NCT00606892|7256002|FG000|COMPLETED|Adaptation||9
6347988|NCT00606892|7256003|FG001|COMPLETED|Adaptation||8
6347989|NCT00606892|7256002|FG000|NOT COMPLETED|Adaptation||0
6347990|NCT00606892|7256003|FG001|NOT COMPLETED|Adaptation||0
6347991|NCT00606892|7256002|FG000|STARTED|First Intervention||9
6347992|NCT00606892|7256003|FG001|STARTED|First Intervention||8
6347993|NCT00606892|7256002|FG000|COMPLETED|First Intervention||8
6347994|NCT00606892|7256003|FG001|COMPLETED|First Intervention||4
6347995|NCT00606892|7256002|FG000|NOT COMPLETED|First Intervention||1
6347996|NCT00606892|7256003|FG001|NOT COMPLETED|First Intervention||4
6559550|NCT01782326|7482237|FG001|STARTED|Planned Treatment Epoch||1682
6559551|NCT01782326|7482236|FG000|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
6347997|NCT00606892|7256002|FG000|STARTED|Washout Period||8
6347998|NCT00606892|7256003|FG001|STARTED|Washout Period||4
6347999|NCT00606892|7256002|FG000|COMPLETED|Washout Period||8
6348000|NCT00606892|7256003|FG001|COMPLETED|Washout Period||4
6348001|NCT00606892|7256002|FG000|NOT COMPLETED|Washout Period||0
6348002|NCT00606892|7256003|FG001|NOT COMPLETED|Washout Period||0
6348003|NCT00606892|7256002|FG000|STARTED|Second Intervention||8
6348004|NCT00606892|7256003|FG001|STARTED|Second Intervention||4
6348005|NCT00606892|7256002|FG000|COMPLETED|Second Intervention||8
6348006|NCT00606892|7256003|FG001|COMPLETED|Second Intervention||4
6348007|NCT00606892|7256002|FG000|NOT COMPLETED|Second Intervention||0
6348008|NCT00606892|7256003|FG001|NOT COMPLETED|Second Intervention||0
6348009|NCT00606905|7256037|FG000|STARTED|Overall Study||38
6348010|NCT00606905|7256038|FG001|STARTED|Overall Study||39
6348011|NCT00606905|7256037|FG000|Pregnancy|Overall Study||29
6348012|NCT00606905|7256038|FG001|Pregnancy|Overall Study||33
6348013|NCT00606905|7256037|FG000|COMPLETED|Overall Study||23
6348014|NCT00606905|7256038|FG001|COMPLETED|Overall Study||24
6348015|NCT00606905|7256037|FG000|NOT COMPLETED|Overall Study||15
6348016|NCT00606905|7256038|FG001|NOT COMPLETED|Overall Study||15
6348017|NCT00606931|7256044|FG000|STARTED|Overall Study||22
6348018|NCT00606931|7256044|FG000|COMPLETED|Overall Study||19
6348019|NCT00606931|7256044|FG000|NOT COMPLETED|Overall Study||3
6348020|NCT00606944|7256050|FG000|STARTED|Overall Study||98
6348021|NCT00606944|7256051|FG001|STARTED|Overall Study||100
6348022|NCT00606944|7256050|FG000|COMPLETED|Overall Study||98
6348023|NCT00606944|7256051|FG001|COMPLETED|Overall Study||100
6348024|NCT00606944|7256050|FG000|NOT COMPLETED|Overall Study||0
6348025|NCT00606944|7256051|FG001|NOT COMPLETED|Overall Study||0
6348026|NCT00607022|7256060|FG000|STARTED|Overall Study||7
6348027|NCT00607022|7256061|FG001|STARTED|Overall Study||15
6348028|NCT00607022|7256062|FG002|STARTED|Overall Study||19
6348029|NCT00607022|7256060|FG000|COMPLETED|Overall Study||6
6348030|NCT00607022|7256061|FG001|COMPLETED|Overall Study||15
6348031|NCT00607022|7256062|FG002|COMPLETED|Overall Study||19
6348032|NCT00607022|7256060|FG000|NOT COMPLETED|Overall Study||1
6348033|NCT00607022|7256061|FG001|NOT COMPLETED|Overall Study||0
6348034|NCT00607022|7256062|FG002|NOT COMPLETED|Overall Study||0
6348035|NCT00607048|7256072|FG000|STARTED|Overall Study||3
6348036|NCT00607048|7256073|FG001|STARTED|Overall Study||6
6348037|NCT00607048|7256074|FG002|STARTED|Overall Study||7
6348038|NCT00607048|7256075|FG003|STARTED|Overall Study||3
6348039|NCT00607048|7256076|FG004|STARTED|Overall Study||6
6348040|NCT00607048|7256077|FG005|STARTED|Overall Study||7
6348041|NCT00607048|7256072|FG000|COMPLETED|Overall Study||0
6348042|NCT00607048|7256073|FG001|COMPLETED|Overall Study||2
6348043|NCT00607048|7256074|FG002|COMPLETED|Overall Study||3
6348044|NCT00607048|7256075|FG003|COMPLETED|Overall Study||0
6348045|NCT00607048|7256076|FG004|COMPLETED|Overall Study||0
6348046|NCT00607048|7256077|FG005|COMPLETED|Overall Study||2
6348047|NCT00607048|7256072|FG000|NOT COMPLETED|Overall Study||3
6348048|NCT00607048|7256073|FG001|NOT COMPLETED|Overall Study||4
6348049|NCT00607048|7256074|FG002|NOT COMPLETED|Overall Study||4
6348050|NCT00607048|7256075|FG003|NOT COMPLETED|Overall Study||3
6348051|NCT00607048|7256076|FG004|NOT COMPLETED|Overall Study||6
6348052|NCT00607048|7256077|FG005|NOT COMPLETED|Overall Study||5
6348053|NCT00607087|7256096|FG000|STARTED|Overall Study||99
6348054|NCT00607087|7256097|FG001|STARTED|Overall Study||95
6559552|NCT01782326|7482237|FG001|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
6559553|NCT01782326|7482236|FG000|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
6559554|NCT01782326|7482237|FG001|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
6559555|NCT01782326|7482236|FG000|Serial Spirometry Set|Planned Treatment Epoch||280
6559556|NCT01782326|7482237|FG001|Serial Spirometry Set|Planned Treatment Epoch||279
6559557|NCT01782326|7482236|FG000|Safety Set (SAF)|Planned Treatment Epoch||1678
6348055|NCT00607087|7256098|FG002|STARTED|Overall Study||94
6348056|NCT00607087|7256096|FG000|COMPLETED|Overall Study||84
6348057|NCT00607087|7256097|FG001|COMPLETED|Overall Study||84
6348058|NCT00607087|7256098|FG002|COMPLETED|Overall Study||84
6348059|NCT00607087|7256096|FG000|NOT COMPLETED|Overall Study||15
6348060|NCT00607087|7256097|FG001|NOT COMPLETED|Overall Study||11
6348061|NCT00607087|7256098|FG002|NOT COMPLETED|Overall Study||10
6348062|NCT00607087|7256096|FG000|STARTED|Period 1||99
6348063|NCT00607087|7256097|FG001|STARTED|Period 1||95
6348064|NCT00607087|7256098|FG002|STARTED|Period 1||94
6348065|NCT00607087|7256096|FG000|COMPLETED|Period 1||87
6348066|NCT00607087|7256097|FG001|COMPLETED|Period 1||89
6348067|NCT00607087|7256098|FG002|COMPLETED|Period 1||89
6348068|NCT00607087|7256096|FG000|NOT COMPLETED|Period 1||12
6348069|NCT00607087|7256097|FG001|NOT COMPLETED|Period 1||6
6348070|NCT00607087|7256098|FG002|NOT COMPLETED|Period 1||5
6348071|NCT00607087|7256096|FG000|STARTED|Period 2||87
6348072|NCT00607087|7256097|FG001|STARTED|Period 2||89
6348073|NCT00607087|7256098|FG002|STARTED|Period 2||89
6348074|NCT00607087|7256096|FG000|COMPLETED|Period 2||86
6348075|NCT00607087|7256097|FG001|COMPLETED|Period 2||86
6348076|NCT00607087|7256098|FG002|COMPLETED|Period 2||84
6348077|NCT00607087|7256096|FG000|NOT COMPLETED|Period 2||1
6348078|NCT00607087|7256097|FG001|NOT COMPLETED|Period 2||3
6348079|NCT00607087|7256098|FG002|NOT COMPLETED|Period 2||5
6348080|NCT00607087|7256096|FG000|STARTED|Period 3||86
6348081|NCT00607087|7256097|FG001|STARTED|Period 3||86
6348082|NCT00607087|7256098|FG002|STARTED|Period 3||84
6348083|NCT00607087|7256096|FG000|COMPLETED|Period 3||84
6348084|NCT00607087|7256097|FG001|COMPLETED|Period 3||84
6348085|NCT00607087|7256098|FG002|COMPLETED|Period 3||84
6348086|NCT00607087|7256096|FG000|NOT COMPLETED|Period 3||2
6348087|NCT00607087|7256097|FG001|NOT COMPLETED|Period 3||2
6348088|NCT00607087|7256098|FG002|NOT COMPLETED|Period 3||0
6348089|NCT00607113|7256108|FG000|STARTED|Overall Study||19
6348090|NCT00607113|7256109|FG001|STARTED|Overall Study||20
6348091|NCT00607113|7256108|FG000|COMPLETED|Overall Study||19
6348092|NCT00607113|7256109|FG001|COMPLETED|Overall Study||20
6348093|NCT00607113|7256108|FG000|NOT COMPLETED|Overall Study||0
6348094|NCT00607113|7256109|FG001|NOT COMPLETED|Overall Study||0
6348095|NCT00607126|7256116|FG000|STARTED|Overall Study||17
6348096|NCT00607126|7256117|FG001|STARTED|Overall Study||19
6348097|NCT00607126|7256116|FG000|COMPLETED|Overall Study||17
6348098|NCT00607126|7256117|FG001|COMPLETED|Overall Study||19
6348099|NCT00607126|7256116|FG000|NOT COMPLETED|Overall Study||0
6348100|NCT00607126|7256117|FG001|NOT COMPLETED|Overall Study||0
6348101|NCT00607243|7256125|FG000|STARTED|Initial Post-vaccination Period||82
6348102|NCT00607243|7256126|FG001|STARTED|Initial Post-vaccination Period||41
6348103|NCT00607243|7256125|FG000|COMPLETED|Initial Post-vaccination Period||82
6348104|NCT00607243|7256126|FG001|COMPLETED|Initial Post-vaccination Period||41
6348105|NCT00607243|7256125|FG000|NOT COMPLETED|Initial Post-vaccination Period||0
6348106|NCT00607243|7256126|FG001|NOT COMPLETED|Initial Post-vaccination Period||0
6348107|NCT00607243|7256125|FG000|STARTED|Telephone Safety Assessment Period||82
6348108|NCT00607243|7256126|FG001|STARTED|Telephone Safety Assessment Period||41
6348109|NCT00607243|7256125|FG000|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
6348110|NCT00607243|7256126|FG001|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
6348111|NCT00607243|7256125|FG000|NOT COMPLETED|Telephone Safety Assessment Period||5
6348112|NCT00607243|7256126|FG001|NOT COMPLETED|Telephone Safety Assessment Period||2
6348113|NCT00607269|7256134|FG000|STARTED|Overall Study||67
6348114|NCT00607269|7256135|FG001|STARTED|Overall Study||64
6348115|NCT00607269|7256134|FG000|COMPLETED|Overall Study||67
6348116|NCT00607269|7256135|FG001|COMPLETED|Overall Study||64
6348117|NCT00607269|7256134|FG000|NOT COMPLETED|Overall Study||0
6348118|NCT00607269|7256135|FG001|NOT COMPLETED|Overall Study||0
6348119|NCT00607321|7256141|FG000|STARTED|Overall Study||60
6348120|NCT00607321|7256141|FG000|COMPLETED|Overall Study||60
6348121|NCT00607321|7256141|FG000|NOT COMPLETED|Overall Study||0
6348122|NCT00607373|7256149|FG000|STARTED|Treatment Period||17
6348123|NCT00607373|7256150|FG001|STARTED|Treatment Period||34
6348124|NCT00607373|7256149|FG000|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
6348125|NCT00607373|7256150|FG001|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
6348126|NCT00607373|7256149|FG000|NOT COMPLETED|Treatment Period||0
6348127|NCT00607373|7256150|FG001|NOT COMPLETED|Treatment Period||6
6348128|NCT00607373|7256149|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
6348129|NCT00607373|7256150|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
6348130|NCT00607373|7256149|FG000|COMPLETED|Follow-up Period||0
6348131|NCT00607373|7256150|FG001|COMPLETED|Follow-up Period||6
6348132|NCT00607373|7256149|FG000|NOT COMPLETED|Follow-up Period||1
6348133|NCT00607373|7256150|FG001|NOT COMPLETED|Follow-up Period||5
6348134|NCT00607386|7256156|FG000|STARTED|Overall Study||28
6348135|NCT00607386|7256156|FG000|COMPLETED|Overall Study||27
6348136|NCT00607386|7256156|FG000|NOT COMPLETED|Overall Study||1
6348137|NCT00607594|7256160|FG000|STARTED|Overall Study||21
6348138|NCT00607594|7256160|FG000|COMPLETED|Overall Study||21
6348139|NCT00607594|7256160|FG000|NOT COMPLETED|Overall Study||0
6348140|NCT00607620|7256168|FG000|STARTED|Overall Study||409
6348141|NCT00607620|7256169|FG001|STARTED|Overall Study||469
6348142|NCT00607620|7256168|FG000|COMPLETED|Overall Study||409
6348143|NCT00607620|7256169|FG001|COMPLETED|Overall Study||469
6348144|NCT00607620|7256168|FG000|NOT COMPLETED|Overall Study||0
6348145|NCT00607620|7256169|FG001|NOT COMPLETED|Overall Study||0
6348146|NCT00607672|7256178|FG000|STARTED|Overall Study||32
6348147|NCT00607672|7256179|FG001|STARTED|Overall Study||27
6348148|NCT00607672|7256180|FG002|STARTED|Overall Study||27
6348149|NCT00607672|7256178|FG000|COMPLETED|Overall Study||28
6348150|NCT00607672|7256179|FG001|COMPLETED|Overall Study||24
6348151|NCT00607672|7256180|FG002|COMPLETED|Overall Study||22
6348152|NCT00607672|7256178|FG000|NOT COMPLETED|Overall Study||4
6348153|NCT00607672|7256179|FG001|NOT COMPLETED|Overall Study||3
6348154|NCT00607672|7256180|FG002|NOT COMPLETED|Overall Study||5
6348155|NCT00607724|7256198|FG000|STARTED|Stage 1: Dose Escalation||7
6348156|NCT00607724|7256199|FG001|STARTED|Stage 1: Dose Escalation||9
6348157|NCT00607724|7256200|FG002|STARTED|Stage 1: Dose Escalation||4
6348158|NCT00607724|7256201|FG003|STARTED|Stage 1: Dose Escalation||0
6348159|NCT00607724|7256202|FG004|STARTED|Stage 1: Dose Escalation||0
6348160|NCT00607724|7256203|FG005|STARTED|Stage 1: Dose Escalation||0
6348161|NCT00607724|7256204|FG006|STARTED|Stage 1: Dose Escalation||0
6348162|NCT00607724|7256198|FG000|COMPLETED|Stage 1: Dose Escalation||0
6348163|NCT00607724|7256199|FG001|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered 'completers'.|1
6348164|NCT00607724|7256200|FG002|COMPLETED|Stage 1: Dose Escalation||0
6348165|NCT00607724|7256201|FG003|COMPLETED|Stage 1: Dose Escalation||0
6348166|NCT00607724|7256202|FG004|COMPLETED|Stage 1: Dose Escalation||0
6348167|NCT00607724|7256203|FG005|COMPLETED|Stage 1: Dose Escalation||0
6348168|NCT00607724|7256204|FG006|COMPLETED|Stage 1: Dose Escalation||0
6348169|NCT00607724|7256198|FG000|NOT COMPLETED|Stage 1: Dose Escalation||7
6348170|NCT00607724|7256199|FG001|NOT COMPLETED|Stage 1: Dose Escalation||8
6348171|NCT00607724|7256200|FG002|NOT COMPLETED|Stage 1: Dose Escalation||4
6348172|NCT00607724|7256201|FG003|NOT COMPLETED|Stage 1: Dose Escalation||0
6348173|NCT00607724|7256202|FG004|NOT COMPLETED|Stage 1: Dose Escalation||0
6348174|NCT00607724|7256203|FG005|NOT COMPLETED|Stage 1: Dose Escalation||0
6348175|NCT00607724|7256204|FG006|NOT COMPLETED|Stage 1: Dose Escalation||0
6348176|NCT00607724|7256198|FG000|STARTED|Stage 2: Expanded Cohort||0
6348177|NCT00607724|7256199|FG001|STARTED|Stage 2: Expanded Cohort||0
6348178|NCT00607724|7256200|FG002|STARTED|Stage 2: Expanded Cohort||0
6348179|NCT00607724|7256201|FG003|STARTED|Stage 2: Expanded Cohort||6
6348180|NCT00607724|7256202|FG004|STARTED|Stage 2: Expanded Cohort||14
6348181|NCT00607724|7256203|FG005|STARTED|Stage 2: Expanded Cohort||12
6348182|NCT00607724|7256204|FG006|STARTED|Stage 2: Expanded Cohort||16
6348183|NCT00607724|7256198|FG000|COMPLETED|Stage 2: Expanded Cohort||0
6348184|NCT00607724|7256199|FG001|COMPLETED|Stage 2: Expanded Cohort||0
6348185|NCT00607724|7256200|FG002|COMPLETED|Stage 2: Expanded Cohort||0
6348186|NCT00607724|7256201|FG003|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|1
6348187|NCT00607724|7256202|FG004|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
6348188|NCT00607724|7256203|FG005|COMPLETED|Stage 2: Expanded Cohort||0
6348189|NCT00607724|7256204|FG006|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered 'completers'.|5
6348190|NCT00607724|7256198|FG000|NOT COMPLETED|Stage 2: Expanded Cohort||0
6348191|NCT00607724|7256199|FG001|NOT COMPLETED|Stage 2: Expanded Cohort||0
6348192|NCT00607724|7256200|FG002|NOT COMPLETED|Stage 2: Expanded Cohort||0
6348193|NCT00607724|7256201|FG003|NOT COMPLETED|Stage 2: Expanded Cohort||5
6348194|NCT00607724|7256202|FG004|NOT COMPLETED|Stage 2: Expanded Cohort||9
6348195|NCT00607724|7256203|FG005|NOT COMPLETED|Stage 2: Expanded Cohort||12
6348196|NCT00607724|7256204|FG006|NOT COMPLETED|Stage 2: Expanded Cohort||11
6348197|NCT00607789|7256230|FG000|STARTED|Overall Study|20 participants were randomized in each group|20
6348198|NCT00607789|7256231|FG001|STARTED|Overall Study||20
6348199|NCT00607789|7256230|FG000|COMPLETED|Overall Study||13
6348200|NCT00607789|7256231|FG001|COMPLETED|Overall Study||14
6348201|NCT00607789|7256230|FG000|NOT COMPLETED|Overall Study||7
6348202|NCT00607789|7256231|FG001|NOT COMPLETED|Overall Study||6
6348203|NCT00607815|7256239|FG000|STARTED|Overall Study||43
6348204|NCT00607815|7256240|FG001|STARTED|Overall Study||36
6348205|NCT00607815|7256239|FG000|COMPLETED|Overall Study||20
6348206|NCT00607815|7256240|FG001|COMPLETED|Overall Study||25
6348207|NCT00607815|7256239|FG000|NOT COMPLETED|Overall Study||23
6348208|NCT00607815|7256240|FG001|NOT COMPLETED|Overall Study||11
6348209|NCT00607867|7256250|FG000|STARTED|Overall Study||7
6348210|NCT00607867|7256251|FG001|STARTED|Overall Study||7
6348211|NCT00607867|7256250|FG000|COMPLETED|Overall Study||7
6348212|NCT00607867|7256251|FG001|COMPLETED|Overall Study||7
6348213|NCT00607867|7256250|FG000|NOT COMPLETED|Overall Study||0
6348214|NCT00607867|7256251|FG001|NOT COMPLETED|Overall Study||0
6348215|NCT00607880|7256259|FG000|STARTED|Overall Study||50
6348216|NCT00607880|7256260|FG001|STARTED|Overall Study||50
6348217|NCT00607880|7256259|FG000|COMPLETED|Overall Study||49
6348218|NCT00607880|7256260|FG001|COMPLETED|Overall Study||50
6348219|NCT00607880|7256259|FG000|NOT COMPLETED|Overall Study||1
6348220|NCT00607880|7256260|FG001|NOT COMPLETED|Overall Study||0
6348221|NCT00607893|7256268|FG000|STARTED|Overall Study||77
6348222|NCT00607893|7256269|FG001|STARTED|Overall Study||76
6348223|NCT00607893|7256268|FG000|Completed Baseline Visit|Overall Study||74
6348224|NCT00607893|7256269|FG001|Completed Baseline Visit|Overall Study||75
6348225|NCT00607893|7256268|FG000|Completed 8 Week Visit|Overall Study||71
6348226|NCT00607893|7256269|FG001|Completed 8 Week Visit|Overall Study||72
6348227|NCT00607893|7256268|FG000|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|0
6348228|NCT00607893|7256269|FG001|Completed 12 Week Visit|Overall Study|12 Week Visit only offered to participants on actual CPAP Treatment|29
6348229|NCT00607893|7256268|FG000|COMPLETED|Overall Study||71
6348230|NCT00607893|7256269|FG001|COMPLETED|Overall Study||72
6348231|NCT00607893|7256268|FG000|NOT COMPLETED|Overall Study||6
6348232|NCT00607893|7256269|FG001|NOT COMPLETED|Overall Study||4
6348233|NCT00607919|7256279|FG000|STARTED|Acute Phase||120
6348234|NCT00607919|7256280|FG001|STARTED|Acute Phase||89
6348235|NCT00607919|7256279|FG000|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
6348236|NCT00607919|7256280|FG001|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
6559558|NCT01782326|7482237|FG001|Safety Set (SAF)|Planned Treatment Epoch||1680
6559559|NCT01782326|7482236|FG000|Urine Cortisol Set|Planned Treatment Epoch||266
6559560|NCT01782326|7482237|FG001|Urine Cortisol Set|Planned Treatment Epoch||269
6559561|NCT01782326|7482236|FG000|COMPLETED|Planned Treatment Epoch||1478
6559562|NCT01782326|7482237|FG001|COMPLETED|Planned Treatment Epoch||1474
6559563|NCT01782326|7482236|FG000|NOT COMPLETED|Planned Treatment Epoch||202
6348237|NCT00607919|7256279|FG000|NOT COMPLETED|Acute Phase||34
6348238|NCT00607919|7256280|FG001|NOT COMPLETED|Acute Phase||16
6348239|NCT00607919|7256279|FG000|STARTED|Open-Label Phase||84
6348240|NCT00607919|7256280|FG001|STARTED|Open-Label Phase||71
6348241|NCT00607919|7256279|FG000|COMPLETED|Open-Label Phase||74
6348242|NCT00607919|7256280|FG001|COMPLETED|Open-Label Phase||59
6348243|NCT00607919|7256279|FG000|NOT COMPLETED|Open-Label Phase||10
6348244|NCT00607919|7256280|FG001|NOT COMPLETED|Open-Label Phase||12
6348245|NCT00607997|7256292|FG000|STARTED|Overall Study||29
6348246|NCT00607997|7256293|FG001|STARTED|Overall Study||35
6348247|NCT00607997|7256294|FG002|STARTED|Overall Study||29
6348248|NCT00607997|7256295|FG003|STARTED|Overall Study||20
6348249|NCT00607997|7256292|FG000|COMPLETED|Overall Study||2
6348250|NCT00607997|7256293|FG001|COMPLETED|Overall Study||8
6348251|NCT00607997|7256294|FG002|COMPLETED|Overall Study||5
6348252|NCT00607997|7256295|FG003|COMPLETED|Overall Study||4
6348253|NCT00607997|7256292|FG000|NOT COMPLETED|Overall Study||27
6348254|NCT00607997|7256293|FG001|NOT COMPLETED|Overall Study||27
6348255|NCT00607997|7256294|FG002|NOT COMPLETED|Overall Study||24
6348256|NCT00607997|7256295|FG003|NOT COMPLETED|Overall Study||16
6348257|NCT00608062|7256316|FG000|STARTED|Overall Study|25 women completed baseline testing, 4 women withdrew prior to randomization|12
6348258|NCT00608062|7256317|FG001|STARTED|Overall Study||12
6348259|NCT00608062|7256318|FG002|STARTED|Overall Study|43 women completed baseline testing, 3 women withdrew prior to randomization|19
6348260|NCT00608062|7256319|FG003|STARTED|Overall Study||21
6348261|NCT00608062|7256320|FG004|STARTED|Overall Study||13
6348262|NCT00608062|7256321|FG005|STARTED|Overall Study||15
6348263|NCT00608062|7256316|FG000|COMPLETED|Overall Study||12
6348264|NCT00608062|7256317|FG001|COMPLETED|Overall Study||12
6348265|NCT00608062|7256318|FG002|COMPLETED|Overall Study||19
6348266|NCT00608062|7256319|FG003|COMPLETED|Overall Study||21
6348267|NCT00608062|7256320|FG004|COMPLETED|Overall Study||13
6348268|NCT00608062|7256321|FG005|COMPLETED|Overall Study||15
6348269|NCT00608062|7256316|FG000|NOT COMPLETED|Overall Study||0
6348270|NCT00608062|7256317|FG001|NOT COMPLETED|Overall Study||0
6348271|NCT00608062|7256318|FG002|NOT COMPLETED|Overall Study||0
6348272|NCT00608062|7256319|FG003|NOT COMPLETED|Overall Study||0
6348273|NCT00608062|7256320|FG004|NOT COMPLETED|Overall Study||0
6348274|NCT00608062|7256321|FG005|NOT COMPLETED|Overall Study||0
6348275|NCT00608140|7256339|FG000|STARTED|Overall Study||1
6348276|NCT00608140|7256340|FG001|STARTED|Overall Study||1
6348277|NCT00608140|7256339|FG000|COMPLETED|Overall Study|Study ended early due to low enrollment|0
6348278|NCT00608140|7256340|FG001|COMPLETED|Overall Study|Study ended early due to low enrollment|0
6348279|NCT00608140|7256339|FG000|NOT COMPLETED|Overall Study||1
6348280|NCT00608140|7256340|FG001|NOT COMPLETED|Overall Study||1
6348281|NCT00608205|7256357|FG000|STARTED|Overall Study||35
6348282|NCT00608205|7256358|FG001|STARTED|Overall Study||34
6348283|NCT00608205|7256357|FG000|COMPLETED|Overall Study||32
6348284|NCT00608205|7256358|FG001|COMPLETED|Overall Study||31
6348285|NCT00608205|7256357|FG000|NOT COMPLETED|Overall Study||3
6348286|NCT00608205|7256358|FG001|NOT COMPLETED|Overall Study||3
6348287|NCT00608244|7256366|FG000|STARTED|Overall Study||59
6348288|NCT00608244|7256366|FG000|COMPLETED|Overall Study||57
6348289|NCT00608244|7256366|FG000|NOT COMPLETED|Overall Study||2
6348290|NCT00608322|7256374|FG000|STARTED|Overall Study||26
6348291|NCT00608322|7256375|FG001|STARTED|Overall Study||23
6348292|NCT00608322|7256374|FG000|COMPLETED|Overall Study||24
6348293|NCT00608322|7256375|FG001|COMPLETED|Overall Study||22
6348294|NCT00608322|7256374|FG000|NOT COMPLETED|Overall Study||2
6348295|NCT00608322|7256375|FG001|NOT COMPLETED|Overall Study||1
6348296|NCT00608426|7256383|FG000|STARTED|Overall Study||2604
6348297|NCT00608426|7256384|FG001|STARTED|Overall Study||2519
6348298|NCT00608426|7256383|FG000|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
6348299|NCT00608426|7256384|FG001|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
6348300|NCT00608426|7256383|FG000|NOT COMPLETED|Overall Study||836
6348301|NCT00608426|7256384|FG001|NOT COMPLETED|Overall Study||905
6348302|NCT00608491|7256392|FG000|STARTED|Overall Study||94
6348303|NCT00608491|7256393|FG001|STARTED|Overall Study||94
6348304|NCT00608491|7256392|FG000|COMPLETED|Overall Study||73
6348305|NCT00608491|7256393|FG001|COMPLETED|Overall Study||72
6348306|NCT00608491|7256392|FG000|NOT COMPLETED|Overall Study||21
6348307|NCT00608491|7256393|FG001|NOT COMPLETED|Overall Study||22
6348308|NCT00608517|7256402|FG000|STARTED|Overall Study||2
6348309|NCT00608517|7256403|FG001|STARTED|Overall Study||3
6348310|NCT00608517|7256404|FG002|STARTED|Overall Study||1
6348311|NCT00608517|7256402|FG000|COMPLETED|Overall Study||1
6348312|NCT00608517|7256403|FG001|COMPLETED|Overall Study||3
6348313|NCT00608517|7256404|FG002|COMPLETED|Overall Study||1
6348314|NCT00608517|7256402|FG000|NOT COMPLETED|Overall Study||1
6348315|NCT00608517|7256403|FG001|NOT COMPLETED|Overall Study||0
6348316|NCT00608517|7256404|FG002|NOT COMPLETED|Overall Study||0
6348317|NCT00608530|7256417|FG000|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
6348318|NCT00608530|7256418|FG001|STARTED|Study 1 Psychologist-delivered Treatment|Randomized|33
6348319|NCT00608530|7256419|FG002|STARTED|Study 1 Psychologist-delivered Treatment||0
6348320|NCT00608530|7256420|FG003|STARTED|Study 1 Psychologist-delivered Treatment||0
6348321|NCT00608530|7256417|FG000|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||28
6348322|NCT00608530|7256418|FG001|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||31
6348323|NCT00608530|7256419|FG002|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
6348324|NCT00608530|7256420|FG003|Attended > 0 Treatment Sessions|Study 1 Psychologist-delivered Treatment||0
6348325|NCT00608530|7256417|FG000|COMPLETED|Study 1 Psychologist-delivered Treatment||22
6348326|NCT00608530|7256418|FG001|COMPLETED|Study 1 Psychologist-delivered Treatment||28
6348327|NCT00608530|7256419|FG002|COMPLETED|Study 1 Psychologist-delivered Treatment||0
6348328|NCT00608530|7256420|FG003|COMPLETED|Study 1 Psychologist-delivered Treatment||0
6348329|NCT00608530|7256417|FG000|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||11
6348330|NCT00608530|7256418|FG001|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||5
6348331|NCT00608530|7256419|FG002|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
6376835|NCT00761280|7287428|FG001|STARTED|First Dose to End of Study||11
6348332|NCT00608530|7256420|FG003|NOT COMPLETED|Study 1 Psychologist-delivered Treatment||0
6348333|NCT00608530|7256417|FG000|STARTED|Study 2 Nurse-delivered Treatments||0
6348334|NCT00608530|7256418|FG001|STARTED|Study 2 Nurse-delivered Treatments||0
6348335|NCT00608530|7256419|FG002|STARTED|Study 2 Nurse-delivered Treatments||33
6348336|NCT00608530|7256420|FG003|STARTED|Study 2 Nurse-delivered Treatments||34
6348337|NCT00608530|7256417|FG000|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
6348338|NCT00608530|7256418|FG001|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||0
6348339|NCT00608530|7256419|FG002|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||30
6348340|NCT00608530|7256420|FG003|Attended > 0 Treatments|Study 2 Nurse-delivered Treatments||31
6348341|NCT00608530|7256417|FG000|COMPLETED|Study 2 Nurse-delivered Treatments||0
6348342|NCT00608530|7256418|FG001|COMPLETED|Study 2 Nurse-delivered Treatments||0
6348343|NCT00608530|7256419|FG002|COMPLETED|Study 2 Nurse-delivered Treatments||21
6348344|NCT00608530|7256420|FG003|COMPLETED|Study 2 Nurse-delivered Treatments||27
6348345|NCT00608530|7256417|FG000|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
6348346|NCT00608530|7256418|FG001|NOT COMPLETED|Study 2 Nurse-delivered Treatments||0
6348347|NCT00608530|7256419|FG002|NOT COMPLETED|Study 2 Nurse-delivered Treatments||12
6348348|NCT00608530|7256420|FG003|NOT COMPLETED|Study 2 Nurse-delivered Treatments||7
6348349|NCT00608543|7256435|FG000|STARTED|Overall Study||17
6348350|NCT00608543|7256435|FG000|COMPLETED|Overall Study||13
6348351|NCT00608543|7256435|FG000|NOT COMPLETED|Overall Study||4
6348352|NCT00608569|7256442|FG000|STARTED|Overall Study||129
6348353|NCT00608569|7256443|FG001|STARTED|Overall Study||128
6348354|NCT00608569|7256442|FG000|COMPLETED|Overall Study||119
6348355|NCT00608569|7256443|FG001|COMPLETED|Overall Study||119
6348356|NCT00608569|7256442|FG000|NOT COMPLETED|Overall Study||10
6348357|NCT00608569|7256443|FG001|NOT COMPLETED|Overall Study||9
6348358|NCT00608582|7256451|FG000|STARTED|Overall Study||14
6348359|NCT00608582|7256452|FG001|STARTED|Overall Study||11
6348360|NCT00608582|7256451|FG000|COMPLETED|Overall Study||10
6348361|NCT00608582|7256452|FG001|COMPLETED|Overall Study||7
6348362|NCT00608582|7256451|FG000|NOT COMPLETED|Overall Study||4
6348363|NCT00608582|7256452|FG001|NOT COMPLETED|Overall Study||4
6348364|NCT00608634|7256463|FG000|STARTED|Overall Study||28
6348365|NCT00608634|7256464|FG001|STARTED|Overall Study||27
6348366|NCT00608634|7256465|FG002|STARTED|Overall Study||28
6348367|NCT00608634|7256463|FG000|COMPLETED|Overall Study||26
6348368|NCT00608634|7256464|FG001|COMPLETED|Overall Study||26
6348369|NCT00608634|7256465|FG002|COMPLETED|Overall Study||27
6348370|NCT00608634|7256463|FG000|NOT COMPLETED|Overall Study||2
6348371|NCT00608634|7256464|FG001|NOT COMPLETED|Overall Study||1
6348372|NCT00608634|7256465|FG002|NOT COMPLETED|Overall Study||1
6348373|NCT00608829|7256475|FG000|STARTED|Overall Study||23
6348374|NCT00608829|7256475|FG000|COMPLETED|Overall Study||8
6348375|NCT00608829|7256475|FG000|NOT COMPLETED|Overall Study||15
6348376|NCT00608842|7256483|FG000|STARTED|Overall Study||15
6348377|NCT00608842|7256484|FG001|STARTED|Overall Study||15
6348378|NCT00608842|7256485|FG002|STARTED|Overall Study||15
6348379|NCT00608842|7256486|FG003|STARTED|Overall Study||17
6348380|NCT00608842|7256483|FG000|COMPLETED|Overall Study||14
6348381|NCT00608842|7256484|FG001|COMPLETED|Overall Study||14
6348382|NCT00608842|7256485|FG002|COMPLETED|Overall Study||13
6348383|NCT00608842|7256486|FG003|COMPLETED|Overall Study||16
6348384|NCT00608842|7256483|FG000|NOT COMPLETED|Overall Study||1
6348385|NCT00608842|7256484|FG001|NOT COMPLETED|Overall Study||1
6348386|NCT00608842|7256485|FG002|NOT COMPLETED|Overall Study||2
6348387|NCT00608842|7256486|FG003|NOT COMPLETED|Overall Study||1
6348388|NCT00608868|7256496|FG000|STARTED|Overall Study||156
6348389|NCT00608868|7256496|FG000|Enrolled|Overall Study||156
6348390|NCT00608868|7256496|FG000|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
6348391|NCT00608868|7256496|FG000|Treatment Completed|Overall Study||141
6348392|NCT00608868|7256496|FG000|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
6348393|NCT00608868|7256496|FG000|Per Protocol (PP) Population|Overall Study||121
6348394|NCT00608868|7256496|FG000|COMPLETED|Overall Study||141
6348395|NCT00608868|7256496|FG000|NOT COMPLETED|Overall Study||15
6348396|NCT00608881|7256502|FG000|STARTED|Overall Study||303
6348397|NCT00608881|7256503|FG001|STARTED|Overall Study||306
6348398|NCT00608881|7256502|FG000|COMPLETED|Overall Study||224
6348399|NCT00608881|7256503|FG001|COMPLETED|Overall Study||240
6348400|NCT00608881|7256502|FG000|NOT COMPLETED|Overall Study||79
6348401|NCT00608881|7256503|FG001|NOT COMPLETED|Overall Study||66
6348402|NCT00608894|7256511|FG000|STARTED|Overall Study||7
6348403|NCT00608894|7256512|FG001|STARTED|Overall Study||6
6348404|NCT00608894|7256511|FG000|COMPLETED|Overall Study||7
6348405|NCT00608894|7256512|FG001|COMPLETED|Overall Study|One patient was granted permission to crossover to LCP-Tacro due to treatment intolerance|4
6348406|NCT00608894|7256511|FG000|NOT COMPLETED|Overall Study||0
6348407|NCT00608894|7256512|FG001|NOT COMPLETED|Overall Study||2
6376836|NCT00761280|7287427|FG000|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
6376837|NCT00761280|7287428|FG001|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
6376838|NCT00761280|7287427|FG000|NOT COMPLETED|First Dose to End of Study||12
6376839|NCT00761280|7287428|FG001|NOT COMPLETED|First Dose to End of Study||11
6376840|NCT00761306|7287434|FG000|STARTED|Overall Study||74
6376841|NCT00761306|7287434|FG000|COMPLETED|Overall Study||54
6348408|NCT00608907|7256523|FG000|STARTED|Overall Study||30
6348409|NCT00608907|7256524|FG001|STARTED|Overall Study||13
6348410|NCT00608907|7256525|FG002|STARTED|Overall Study||18
6348411|NCT00608907|7256523|FG000|COMPLETED|Overall Study||18
6348412|NCT00608907|7256524|FG001|COMPLETED|Overall Study||13
6348413|NCT00608907|7256525|FG002|COMPLETED|Overall Study||17
6348414|NCT00608907|7256523|FG000|NOT COMPLETED|Overall Study||12
6348415|NCT00608907|7256524|FG001|NOT COMPLETED|Overall Study||0
6348416|NCT00608907|7256525|FG002|NOT COMPLETED|Overall Study||1
6498492|NCT01410110|7417079|FG000|Randomization|Overall Study||24
6498493|NCT01410110|7417080|FG001|Randomization|Overall Study||24
6498494|NCT01410110|7417079|FG000|3 Months (End of Intervention)|Overall Study||20
6498495|NCT01410110|7417080|FG001|3 Months (End of Intervention)|Overall Study||22
6348417|NCT00608959|7256535|FG000|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
6348418|NCT00608959|7256535|FG000|COMPLETED|Part 1||24
6348419|NCT00608959|7256535|FG000|NOT COMPLETED|Part 1||1
6348420|NCT00608959|7256535|FG000|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
6348421|NCT00608959|7256535|FG000|COMPLETED|Part 2||25
6348422|NCT00608959|7256535|FG000|NOT COMPLETED|Part 2||0
6348423|NCT00608985|7256549|FG000|STARTED|Overall Study|Randomized and started double-blind treatment|177
6348424|NCT00608985|7256550|FG001|STARTED|Overall Study|Randomized and started double-blind treatment|186
6348425|NCT00608985|7256551|FG002|STARTED|Overall Study|Randomized and started double-blind treatment|176
6348426|NCT00608985|7256552|FG003|STARTED|Overall Study|Randomized and started double-blind treatment|168
6348427|NCT00608985|7256549|FG000|Completed Double-blind Treatment|Overall Study||163
6348428|NCT00608985|7256550|FG001|Completed Double-blind Treatment|Overall Study||174
6348429|NCT00608985|7256551|FG002|Completed Double-blind Treatment|Overall Study||171
6348430|NCT00608985|7256552|FG003|Completed Double-blind Treatment|Overall Study||161
6348431|NCT00608985|7256549|FG000|COMPLETED|Overall Study|Completed follow-up|161
6348432|NCT00608985|7256550|FG001|COMPLETED|Overall Study|Completed follow-up|173
6348433|NCT00608985|7256551|FG002|COMPLETED|Overall Study|Completed follow-up|170
6348434|NCT00608985|7256552|FG003|COMPLETED|Overall Study|Completed follow-up|159
6348435|NCT00608985|7256549|FG000|NOT COMPLETED|Overall Study||16
6348436|NCT00608985|7256550|FG001|NOT COMPLETED|Overall Study||13
6348437|NCT00608985|7256551|FG002|NOT COMPLETED|Overall Study||6
6348438|NCT00608985|7256552|FG003|NOT COMPLETED|Overall Study||9
6348439|NCT00609128|7256562|FG000|STARTED|Overall Study||21
6348440|NCT00609128|7256562|FG000|COMPLETED|Overall Study||21
6348441|NCT00609128|7256562|FG000|NOT COMPLETED|Overall Study||0
6348442|NCT00609167|7256569|FG000|STARTED|Overall Study||33
6348443|NCT00609167|7256570|FG001|STARTED|Overall Study||30
6348444|NCT00609167|7256569|FG000|COMPLETED|Overall Study||25
6348445|NCT00609167|7256570|FG001|COMPLETED|Overall Study||23
6348446|NCT00609167|7256569|FG000|NOT COMPLETED|Overall Study||8
6348447|NCT00609167|7256570|FG001|NOT COMPLETED|Overall Study||7
6348448|NCT00609245|7256576|FG000|STARTED|Overall Study||13
6348449|NCT00609245|7256576|FG000|COMPLETED|Overall Study||12
6348450|NCT00609245|7256576|FG000|NOT COMPLETED|Overall Study||1
6348451|NCT00609271|7256584|FG000|STARTED|Overall Study||75
6348452|NCT00609271|7256585|FG001|STARTED|Overall Study||73
6348453|NCT00609271|7256584|FG000|COMPLETED|Overall Study||59
6348454|NCT00609271|7256585|FG001|COMPLETED|Overall Study||60
6348455|NCT00609271|7256584|FG000|NOT COMPLETED|Overall Study||16
6348456|NCT00609271|7256585|FG001|NOT COMPLETED|Overall Study||13
6348457|NCT00609336|7256591|FG000|STARTED|Overall Study||35
6348458|NCT00609336|7256591|FG000|Surgery|Overall Study||22
6348459|NCT00609336|7256591|FG000|COMPLETED|Overall Study||22
6348460|NCT00609336|7256591|FG000|NOT COMPLETED|Overall Study||13
6348461|NCT00609362|7256598|FG000|STARTED|Overall Study||29
6348462|NCT00609362|7256599|FG001|STARTED|Overall Study||28
6348463|NCT00609362|7256598|FG000|COMPLETED|Overall Study||26
6348464|NCT00609362|7256599|FG001|COMPLETED|Overall Study||27
6348465|NCT00609362|7256598|FG000|NOT COMPLETED|Overall Study||3
6348466|NCT00609362|7256599|FG001|NOT COMPLETED|Overall Study||1
6348467|NCT00609466|7256608|FG000|STARTED|Overall Study||96
6348468|NCT00609466|7256609|FG001|STARTED|Overall Study||96
6348469|NCT00609466|7256610|FG002|STARTED|Overall Study||99
6348470|NCT00609466|7256608|FG000|COMPLETED|Overall Study||94
6348471|NCT00609466|7256609|FG001|COMPLETED|Overall Study||90
6348472|NCT00609466|7256610|FG002|COMPLETED|Overall Study||95
6348473|NCT00609466|7256608|FG000|NOT COMPLETED|Overall Study||2
6348474|NCT00609466|7256609|FG001|NOT COMPLETED|Overall Study||6
6348475|NCT00609466|7256610|FG002|NOT COMPLETED|Overall Study||4
6348476|NCT00609492|7256621|FG000|STARTED|Overall Study||44
6348477|NCT00609492|7256622|FG001|STARTED|Overall Study||72
6348478|NCT00609492|7256623|FG002|STARTED|Overall Study||129
6348479|NCT00609492|7256621|FG000|COMPLETED|Overall Study||43
6348480|NCT00609492|7256622|FG001|COMPLETED|Overall Study||69
6348481|NCT00609492|7256623|FG002|COMPLETED|Overall Study||122
6348482|NCT00609492|7256621|FG000|NOT COMPLETED|Overall Study||1
6348483|NCT00609492|7256622|FG001|NOT COMPLETED|Overall Study||3
6348484|NCT00609492|7256623|FG002|NOT COMPLETED|Overall Study||7
6498496|NCT01410110|7417079|FG000|6 Month Follow-up|Overall Study||20
6498497|NCT01410110|7417080|FG001|6 Month Follow-up|Overall Study||22
6498498|NCT01410110|7417079|FG000|COMPLETED|Overall Study||20
6498499|NCT01410110|7417080|FG001|COMPLETED|Overall Study||22
6498500|NCT01410110|7417079|FG000|NOT COMPLETED|Overall Study||4
6498501|NCT01410110|7417080|FG001|NOT COMPLETED|Overall Study||2
6498502|NCT01410227|7417086|FG000|STARTED|Overall Study||8
6498503|NCT01410227|7417087|FG001|STARTED|Overall Study||8
6498504|NCT01410227|7417088|FG002|STARTED|Overall Study||15
6498505|NCT01410227|7417089|FG003|STARTED|Overall Study||6
6498506|NCT01410227|7417086|FG000|COMPLETED|Overall Study||4
6498507|NCT01410227|7417087|FG001|COMPLETED|Overall Study||8
6498508|NCT01410227|7417088|FG002|COMPLETED|Overall Study||13
6498509|NCT01410227|7417089|FG003|COMPLETED|Overall Study||5
6498510|NCT01410227|7417086|FG000|NOT COMPLETED|Overall Study||4
6498511|NCT01410227|7417087|FG001|NOT COMPLETED|Overall Study||0
6498512|NCT01410227|7417088|FG002|NOT COMPLETED|Overall Study||2
6498513|NCT01410227|7417089|FG003|NOT COMPLETED|Overall Study||1
6498514|NCT01410240|7417102|FG000|STARTED|Overall Study||53
6498515|NCT01410240|7417103|FG001|STARTED|Overall Study||53
6498516|NCT01410240|7417104|FG002|STARTED|Overall Study||12
6498517|NCT01410240|7417102|FG000|COMPLETED|Overall Study||52
6498518|NCT01410240|7417103|FG001|COMPLETED|Overall Study||52
6348485|NCT00609518|7256635|FG000|STARTED|Overall Study||54
6348486|NCT00609518|7256636|FG001|STARTED|Overall Study||57
6348487|NCT00609518|7256635|FG000|Completed 6 Treatment Cycles|Overall Study||19
6348488|NCT00609518|7256636|FG001|Completed 6 Treatment Cycles|Overall Study||22
6348489|NCT00609518|7256635|FG000|COMPLETED|Overall Study||11
6348490|NCT00609518|7256636|FG001|COMPLETED|Overall Study||17
6348491|NCT00609518|7256635|FG000|NOT COMPLETED|Overall Study||43
6348492|NCT00609518|7256636|FG001|NOT COMPLETED|Overall Study||40
6348493|NCT00609609|7256644|FG000|STARTED|Overall Study||30
6348494|NCT00609609|7256645|FG001|STARTED|Overall Study||51
6348495|NCT00609609|7256644|FG000|COMPLETED|Overall Study||24
6348496|NCT00609609|7256645|FG001|COMPLETED|Overall Study||49
6498519|NCT01410240|7417104|FG002|COMPLETED|Overall Study||10
6498520|NCT01410240|7417102|FG000|NOT COMPLETED|Overall Study||1
6498521|NCT01410240|7417103|FG001|NOT COMPLETED|Overall Study||1
6498522|NCT01410240|7417104|FG002|NOT COMPLETED|Overall Study||2
6498523|NCT01410344|7417113|FG000|STARTED|Overall Study||20
6498524|NCT01410344|7417113|FG000|COMPLETED|Overall Study||17
6498525|NCT01410344|7417113|FG000|NOT COMPLETED|Overall Study||3
6498526|NCT01410357|7417121|FG000|STARTED|Overall Study||100
6498527|NCT01410357|7417122|FG001|STARTED|Overall Study||100
6498528|NCT01410357|7417121|FG000|COMPLETED|Overall Study||74
6498529|NCT01410357|7417122|FG001|COMPLETED|Overall Study||76
6498530|NCT01410357|7417121|FG000|NOT COMPLETED|Overall Study||26
6348497|NCT00609609|7256644|FG000|NOT COMPLETED|Overall Study||6
6348498|NCT00609609|7256645|FG001|NOT COMPLETED|Overall Study||2
6348499|NCT00609622|7256653|FG000|STARTED|Overall Study||96
6348500|NCT00609622|7256654|FG001|STARTED|Overall Study||95
6348501|NCT00609622|7256653|FG000|COMPLETED|Overall Study||0
6348502|NCT00609622|7256654|FG001|COMPLETED|Overall Study||0
6348503|NCT00609622|7256653|FG000|NOT COMPLETED|Overall Study||96
6348504|NCT00609622|7256654|FG001|NOT COMPLETED|Overall Study||95
6348505|NCT00609674|7256662|FG000|STARTED|Overall Study||155
6348506|NCT00609674|7256663|FG001|STARTED|Overall Study||160
6348507|NCT00609674|7256662|FG000|COMPLETED|Overall Study||148
6348508|NCT00609674|7256663|FG001|COMPLETED|Overall Study||153
6348509|NCT00609674|7256662|FG000|NOT COMPLETED|Overall Study||7
6348510|NCT00609674|7256663|FG001|NOT COMPLETED|Overall Study||7
6348511|NCT00609739|7256669|FG000|STARTED|Overall Study||1
6348512|NCT00609739|7256669|FG000|COMPLETED|Overall Study||1
6348513|NCT00609739|7256669|FG000|NOT COMPLETED|Overall Study||0
6348514|NCT00609804|7256675|FG000|STARTED|Overall Study||25
6348515|NCT00609804|7256676|FG001|STARTED|Overall Study||28
6348516|NCT00609804|7256675|FG000|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
6348517|NCT00609804|7256676|FG001|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
6348518|NCT00609804|7256675|FG000|NOT COMPLETED|Overall Study||25
6348519|NCT00609804|7256676|FG001|NOT COMPLETED|Overall Study||28
6348520|NCT00609869|7256685|FG000|STARTED|Overall Study||29
6348521|NCT00609869|7256685|FG000|COMPLETED|Overall Study||18
6348522|NCT00609869|7256685|FG000|NOT COMPLETED|Overall Study||11
6348523|NCT00609947|7256689|FG000|STARTED|Overall Study||241
6348524|NCT00609947|7256689|FG000|COMPLETED|Overall Study|One death due to automobile accident.|240
6348525|NCT00609947|7256689|FG000|NOT COMPLETED|Overall Study||1
6348526|NCT00609973|7256696|FG000|STARTED|Overall Study||17
6348527|NCT00609973|7256697|FG001|STARTED|Overall Study||16
6348528|NCT00609973|7256696|FG000|COMPLETED|Overall Study||9
6348529|NCT00609973|7256697|FG001|COMPLETED|Overall Study||10
6348530|NCT00609973|7256696|FG000|NOT COMPLETED|Overall Study||8
6348531|NCT00609973|7256697|FG001|NOT COMPLETED|Overall Study||6
6348532|NCT00609986|7256705|FG000|STARTED|Overall Study||52
6348533|NCT00609986|7256706|FG001|STARTED|Overall Study||52
6498531|NCT01410357|7417122|FG001|NOT COMPLETED|Overall Study||24
6348534|NCT00609986|7256705|FG000|Received Transplant|Overall Study||44
6348535|NCT00609986|7256706|FG001|Received Transplant|Overall Study||49
6348536|NCT00609986|7256705|FG000|COMPLETED|Overall Study||44
6348537|NCT00609986|7256706|FG001|COMPLETED|Overall Study||49
6348538|NCT00609986|7256705|FG000|NOT COMPLETED|Overall Study||8
6348539|NCT00609986|7256706|FG001|NOT COMPLETED|Overall Study||3
6348540|NCT00610116|7256712|FG000|STARTED|Overall Study||305
6348541|NCT00610116|7256712|FG000|COMPLETED|Overall Study|Number of analyzable patients|292
6348542|NCT00610116|7256712|FG000|NOT COMPLETED|Overall Study||13
6348543|NCT00610129|7256716|FG000|STARTED|Overall Study||28
6348544|NCT00610129|7256716|FG000|COMPLETED|Overall Study||25
6348545|NCT00610129|7256716|FG000|NOT COMPLETED|Overall Study||3
6348546|NCT00610155|7256720|FG000|STARTED|Period 1||4
6348547|NCT00610155|7256721|FG001|STARTED|Period 1||3
6348548|NCT00610155|7256722|FG002|STARTED|Period 1||4
6348549|NCT00610155|7256723|FG003|STARTED|Period 1||3
6348550|NCT00610155|7256724|FG004|STARTED|Period 1||3
6348551|NCT00610155|7256725|FG005|STARTED|Period 1||1
6348552|NCT00610155|7256720|FG000|COMPLETED|Period 1||4
6348553|NCT00610155|7256721|FG001|COMPLETED|Period 1||3
6348554|NCT00610155|7256722|FG002|COMPLETED|Period 1||3
6348555|NCT00610155|7256723|FG003|COMPLETED|Period 1||3
6348556|NCT00610155|7256724|FG004|COMPLETED|Period 1||3
6348557|NCT00610155|7256725|FG005|COMPLETED|Period 1||1
6348558|NCT00610155|7256720|FG000|NOT COMPLETED|Period 1||0
6348559|NCT00610155|7256721|FG001|NOT COMPLETED|Period 1||0
6348560|NCT00610155|7256722|FG002|NOT COMPLETED|Period 1||1
6348561|NCT00610155|7256723|FG003|NOT COMPLETED|Period 1||0
6348562|NCT00610155|7256724|FG004|NOT COMPLETED|Period 1||0
6348563|NCT00610155|7256725|FG005|NOT COMPLETED|Period 1||0
6348564|NCT00610155|7256720|FG000|STARTED|Washout Period 1 (7 Days)||4
6348565|NCT00610155|7256721|FG001|STARTED|Washout Period 1 (7 Days)||3
6348566|NCT00610155|7256722|FG002|STARTED|Washout Period 1 (7 Days)||3
6348567|NCT00610155|7256723|FG003|STARTED|Washout Period 1 (7 Days)||3
6348568|NCT00610155|7256724|FG004|STARTED|Washout Period 1 (7 Days)||3
6348569|NCT00610155|7256725|FG005|STARTED|Washout Period 1 (7 Days)||1
6348570|NCT00610155|7256720|FG000|COMPLETED|Washout Period 1 (7 Days)||4
6348571|NCT00610155|7256721|FG001|COMPLETED|Washout Period 1 (7 Days)||3
6348572|NCT00610155|7256722|FG002|COMPLETED|Washout Period 1 (7 Days)||3
6348573|NCT00610155|7256723|FG003|COMPLETED|Washout Period 1 (7 Days)||3
6348574|NCT00610155|7256724|FG004|COMPLETED|Washout Period 1 (7 Days)||3
6348575|NCT00610155|7256725|FG005|COMPLETED|Washout Period 1 (7 Days)||1
6348576|NCT00610155|7256720|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6348577|NCT00610155|7256721|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6348578|NCT00610155|7256722|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6348579|NCT00610155|7256723|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6348580|NCT00610155|7256724|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
6348581|NCT00610155|7256725|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
6348582|NCT00610155|7256720|FG000|STARTED|Period 2||4
6348583|NCT00610155|7256721|FG001|STARTED|Period 2||3
6348584|NCT00610155|7256722|FG002|STARTED|Period 2||3
6348585|NCT00610155|7256723|FG003|STARTED|Period 2||3
6348586|NCT00610155|7256724|FG004|STARTED|Period 2||3
6348587|NCT00610155|7256725|FG005|STARTED|Period 2||1
6348588|NCT00610155|7256720|FG000|COMPLETED|Period 2||4
6348589|NCT00610155|7256721|FG001|COMPLETED|Period 2||3
6348590|NCT00610155|7256722|FG002|COMPLETED|Period 2||3
6348591|NCT00610155|7256723|FG003|COMPLETED|Period 2||3
6348592|NCT00610155|7256724|FG004|COMPLETED|Period 2||3
6348593|NCT00610155|7256725|FG005|COMPLETED|Period 2||1
6348594|NCT00610155|7256720|FG000|NOT COMPLETED|Period 2||0
6348595|NCT00610155|7256721|FG001|NOT COMPLETED|Period 2||0
6348596|NCT00610155|7256722|FG002|NOT COMPLETED|Period 2||0
6348597|NCT00610155|7256723|FG003|NOT COMPLETED|Period 2||0
6348598|NCT00610155|7256724|FG004|NOT COMPLETED|Period 2||0
6348599|NCT00610155|7256725|FG005|NOT COMPLETED|Period 2||0
6348600|NCT00610155|7256720|FG000|STARTED|Washout Period 2 (7 Days)||4
6348601|NCT00610155|7256721|FG001|STARTED|Washout Period 2 (7 Days)||3
6348602|NCT00610155|7256722|FG002|STARTED|Washout Period 2 (7 Days)||3
6348603|NCT00610155|7256723|FG003|STARTED|Washout Period 2 (7 Days)||3
6348604|NCT00610155|7256724|FG004|STARTED|Washout Period 2 (7 Days)||3
6348605|NCT00610155|7256725|FG005|STARTED|Washout Period 2 (7 Days)||1
6348606|NCT00610155|7256720|FG000|COMPLETED|Washout Period 2 (7 Days)||4
6348607|NCT00610155|7256721|FG001|COMPLETED|Washout Period 2 (7 Days)||3
6348608|NCT00610155|7256722|FG002|COMPLETED|Washout Period 2 (7 Days)||3
6348609|NCT00610155|7256723|FG003|COMPLETED|Washout Period 2 (7 Days)||3
6348610|NCT00610155|7256724|FG004|COMPLETED|Washout Period 2 (7 Days)||3
6348611|NCT00610155|7256725|FG005|COMPLETED|Washout Period 2 (7 Days)||1
6348612|NCT00610155|7256720|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6348613|NCT00610155|7256721|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6348614|NCT00610155|7256722|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6348615|NCT00610155|7256723|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6348616|NCT00610155|7256724|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6348617|NCT00610155|7256725|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6348618|NCT00610155|7256720|FG000|STARTED|Period 3||4
6348619|NCT00610155|7256721|FG001|STARTED|Period 3||3
6348620|NCT00610155|7256722|FG002|STARTED|Period 3||3
6348621|NCT00610155|7256723|FG003|STARTED|Period 3||3
6348622|NCT00610155|7256724|FG004|STARTED|Period 3||3
6348623|NCT00610155|7256725|FG005|STARTED|Period 3||1
6348624|NCT00610155|7256720|FG000|COMPLETED|Period 3||3
6348625|NCT00610155|7256721|FG001|COMPLETED|Period 3||3
6348626|NCT00610155|7256722|FG002|COMPLETED|Period 3||3
6348627|NCT00610155|7256723|FG003|COMPLETED|Period 3||3
6348628|NCT00610155|7256724|FG004|COMPLETED|Period 3||3
6348629|NCT00610155|7256725|FG005|COMPLETED|Period 3||1
6348630|NCT00610155|7256720|FG000|NOT COMPLETED|Period 3||1
6348631|NCT00610155|7256721|FG001|NOT COMPLETED|Period 3||0
6348632|NCT00610155|7256722|FG002|NOT COMPLETED|Period 3||0
6348633|NCT00610155|7256723|FG003|NOT COMPLETED|Period 3||0
6348634|NCT00610155|7256724|FG004|NOT COMPLETED|Period 3||0
6348635|NCT00610155|7256725|FG005|NOT COMPLETED|Period 3||0
6348636|NCT00610168|7256735|FG000|STARTED|Overall Study||75
6348637|NCT00610168|7256736|FG001|STARTED|Overall Study||7
6348638|NCT00610168|7256735|FG000|COMPLETED|Overall Study||73
6348639|NCT00610168|7256736|FG001|COMPLETED|Overall Study||7
6348640|NCT00610168|7256735|FG000|NOT COMPLETED|Overall Study||2
6348641|NCT00610168|7256736|FG001|NOT COMPLETED|Overall Study||0
6348642|NCT00610207|7256742|FG000|STARTED|Overall Study||21
6348643|NCT00610207|7256742|FG000|COMPLETED|Overall Study||18
6348644|NCT00610207|7256742|FG000|NOT COMPLETED|Overall Study||3
6348645|NCT00610311|7256746|FG000|STARTED|Overall Study||3
6348646|NCT00610311|7256746|FG000|COMPLETED|Overall Study||3
6348647|NCT00610311|7256746|FG000|NOT COMPLETED|Overall Study||0
6348648|NCT00610363|7256752|FG000|STARTED|Overall Study||42
6348649|NCT00610363|7256753|FG001|STARTED|Overall Study||41
6348650|NCT00610363|7256752|FG000|COMPLETED|Overall Study||31
6348651|NCT00610363|7256753|FG001|COMPLETED|Overall Study||38
6348652|NCT00610363|7256752|FG000|NOT COMPLETED|Overall Study||11
6348653|NCT00610363|7256753|FG001|NOT COMPLETED|Overall Study||3
6348654|NCT00610428|7256763|FG000|STARTED|Overall Study||24
6348655|NCT00610428|7256764|FG001|STARTED|Overall Study||24
6348656|NCT00610428|7256765|FG002|STARTED|Overall Study||27
6348657|NCT00610428|7256763|FG000|COMPLETED|Overall Study||24
6348658|NCT00610428|7256764|FG001|COMPLETED|Overall Study||23
6348659|NCT00610428|7256765|FG002|COMPLETED|Overall Study||25
6348660|NCT00610428|7256763|FG000|NOT COMPLETED|Overall Study||0
6348661|NCT00610428|7256764|FG001|NOT COMPLETED|Overall Study||1
6348662|NCT00610428|7256765|FG002|NOT COMPLETED|Overall Study||2
6348663|NCT00610441|7256777|FG000|STARTED|Treatment Period 1 - 3 Weeks||15
6348664|NCT00610441|7256778|FG001|STARTED|Treatment Period 1 - 3 Weeks||16
6348665|NCT00610441|7256779|FG002|STARTED|Treatment Period 1 - 3 Weeks||18
6348666|NCT00610441|7256780|FG003|STARTED|Treatment Period 1 - 3 Weeks||18
6348667|NCT00610441|7256777|FG000|COMPLETED|Treatment Period 1 - 3 Weeks||12
6348668|NCT00610441|7256778|FG001|COMPLETED|Treatment Period 1 - 3 Weeks||14
6348669|NCT00610441|7256779|FG002|COMPLETED|Treatment Period 1 - 3 Weeks||11
6348670|NCT00610441|7256780|FG003|COMPLETED|Treatment Period 1 - 3 Weeks||16
6348671|NCT00610441|7256777|FG000|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
6348672|NCT00610441|7256778|FG001|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
6348673|NCT00610441|7256779|FG002|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
6348674|NCT00610441|7256780|FG003|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
6348675|NCT00610441|7256777|FG000|STARTED|Placebo Washout Period - 2 Weeks||12
6348676|NCT00610441|7256778|FG001|STARTED|Placebo Washout Period - 2 Weeks||14
6348677|NCT00610441|7256779|FG002|STARTED|Placebo Washout Period - 2 Weeks||11
6348678|NCT00610441|7256780|FG003|STARTED|Placebo Washout Period - 2 Weeks||16
6348679|NCT00610441|7256777|FG000|COMPLETED|Placebo Washout Period - 2 Weeks||12
6348680|NCT00610441|7256778|FG001|COMPLETED|Placebo Washout Period - 2 Weeks||13
6348681|NCT00610441|7256779|FG002|COMPLETED|Placebo Washout Period - 2 Weeks||9
6348682|NCT00610441|7256780|FG003|COMPLETED|Placebo Washout Period - 2 Weeks||16
6348683|NCT00610441|7256777|FG000|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
6348684|NCT00610441|7256778|FG001|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
6348685|NCT00610441|7256779|FG002|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
6348686|NCT00610441|7256780|FG003|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
6348687|NCT00610441|7256777|FG000|STARTED|Treatment Period 2 - 3 Weeks||12
6348688|NCT00610441|7256778|FG001|STARTED|Treatment Period 2 - 3 Weeks||13
6348689|NCT00610441|7256779|FG002|STARTED|Treatment Period 2 - 3 Weeks||9
6348690|NCT00610441|7256780|FG003|STARTED|Treatment Period 2 - 3 Weeks||16
6348691|NCT00610441|7256777|FG000|COMPLETED|Treatment Period 2 - 3 Weeks||10
6348692|NCT00610441|7256778|FG001|COMPLETED|Treatment Period 2 - 3 Weeks||12
6348693|NCT00610441|7256779|FG002|COMPLETED|Treatment Period 2 - 3 Weeks||9
6348694|NCT00610441|7256780|FG003|COMPLETED|Treatment Period 2 - 3 Weeks||14
6348695|NCT00610441|7256777|FG000|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
6348696|NCT00610441|7256778|FG001|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
6348697|NCT00610441|7256779|FG002|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
6348698|NCT00610441|7256780|FG003|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
6348699|NCT00610480|7256794|FG000|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
6348700|NCT00610480|7256795|FG001|STARTED|Overall Study|10 assigned patients x 2 interventions.|10
6348701|NCT00610480|7256794|FG000|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
6348702|NCT00610480|7256795|FG001|COMPLETED|Overall Study|10 assigned patients x 2 interventions.|10
6348703|NCT00610480|7256794|FG000|NOT COMPLETED|Overall Study||0
6348704|NCT00610480|7256795|FG001|NOT COMPLETED|Overall Study||0
6348705|NCT00610649|7256812|FG000|STARTED|Overall Study||4
6348706|NCT00610649|7256813|FG001|STARTED|Overall Study||2
6348707|NCT00610649|7256814|FG002|STARTED|Overall Study||4
6348708|NCT00610649|7256815|FG003|STARTED|Overall Study||2
6348709|NCT00610649|7256816|FG004|STARTED|Overall Study||4
6348710|NCT00610649|7256817|FG005|STARTED|Overall Study||2
6348711|NCT00610649|7256818|FG006|STARTED|Overall Study||4
6348712|NCT00610649|7256819|FG007|STARTED|Overall Study||2
6348713|NCT00610649|7256820|FG008|STARTED|Overall Study||10
6348714|NCT00610649|7256821|FG009|STARTED|Overall Study||10
6348715|NCT00610649|7256822|FG010|STARTED|Overall Study||10
6348716|NCT00610649|7256812|FG000|COMPLETED|Overall Study||3
6348717|NCT00610649|7256813|FG001|COMPLETED|Overall Study||1
6348718|NCT00610649|7256814|FG002|COMPLETED|Overall Study||4
6348719|NCT00610649|7256815|FG003|COMPLETED|Overall Study||2
6348720|NCT00610649|7256816|FG004|COMPLETED|Overall Study||4
6348721|NCT00610649|7256817|FG005|COMPLETED|Overall Study||2
6348722|NCT00610649|7256818|FG006|COMPLETED|Overall Study||4
6348723|NCT00610649|7256819|FG007|COMPLETED|Overall Study||2
6348724|NCT00610649|7256820|FG008|COMPLETED|Overall Study||10
6348725|NCT00610649|7256821|FG009|COMPLETED|Overall Study||9
6348726|NCT00610649|7256822|FG010|COMPLETED|Overall Study||9
6348727|NCT00610649|7256812|FG000|NOT COMPLETED|Overall Study||1
6348728|NCT00610649|7256813|FG001|NOT COMPLETED|Overall Study||1
6348729|NCT00610649|7256814|FG002|NOT COMPLETED|Overall Study||0
6348730|NCT00610649|7256815|FG003|NOT COMPLETED|Overall Study||0
6348731|NCT00610649|7256816|FG004|NOT COMPLETED|Overall Study||0
6348732|NCT00610649|7256817|FG005|NOT COMPLETED|Overall Study||0
6348733|NCT00610649|7256818|FG006|NOT COMPLETED|Overall Study||0
6348734|NCT00610649|7256819|FG007|NOT COMPLETED|Overall Study||0
6348735|NCT00610649|7256820|FG008|NOT COMPLETED|Overall Study||0
6348736|NCT00610649|7256821|FG009|NOT COMPLETED|Overall Study||1
6348737|NCT00610649|7256822|FG010|NOT COMPLETED|Overall Study||1
6348738|NCT00610675|7256846|FG000|STARTED|Overall Study||346
6348739|NCT00610675|7256846|FG000|Treated|Overall Study||342
6348740|NCT00610675|7256846|FG000|COMPLETED|Overall Study||126
6348741|NCT00610675|7256846|FG000|NOT COMPLETED|Overall Study||220
6348742|NCT00610688|7256853|FG000|STARTED|Overall Study||64
6348743|NCT00610688|7256854|FG001|STARTED|Overall Study||65
6348744|NCT00610688|7256855|FG002|STARTED|Overall Study||63
6348745|NCT00610688|7256853|FG000|COMPLETED|Overall Study||55
6348746|NCT00610688|7256854|FG001|COMPLETED|Overall Study||52
6348747|NCT00610688|7256855|FG002|COMPLETED|Overall Study||55
6348748|NCT00610688|7256853|FG000|NOT COMPLETED|Overall Study||9
6348749|NCT00610688|7256854|FG001|NOT COMPLETED|Overall Study||13
6348750|NCT00610688|7256855|FG002|NOT COMPLETED|Overall Study||8
6348751|NCT00610701|7256865|FG000|STARTED|Overall Study||15
6348752|NCT00610701|7256866|FG001|STARTED|Overall Study||20
6348753|NCT00610701|7256865|FG000|COMPLETED|Overall Study||5
6348754|NCT00610701|7256866|FG001|COMPLETED|Overall Study||9
6348755|NCT00610701|7256865|FG000|NOT COMPLETED|Overall Study||10
6348756|NCT00610701|7256866|FG001|NOT COMPLETED|Overall Study||11
6348757|NCT00610714|7256874|FG000|STARTED|Overall Study||105
6348758|NCT00610714|7256875|FG001|STARTED|Overall Study||106
6348759|NCT00610714|7256874|FG000|COMPLETED|Overall Study||79
6348760|NCT00610714|7256875|FG001|COMPLETED|Overall Study||82
6348761|NCT00610714|7256874|FG000|NOT COMPLETED|Overall Study||26
6348762|NCT00610714|7256875|FG001|NOT COMPLETED|Overall Study||24
6348763|NCT00610727|7256887|FG000|STARTED|Overall Study||14
6348764|NCT00610727|7256888|FG001|STARTED|Overall Study||8
6348765|NCT00610727|7256889|FG002|STARTED|Overall Study||8
6348766|NCT00610727|7256890|FG003|STARTED|Overall Study||8
6348767|NCT00610727|7256891|FG004|STARTED|Overall Study||8
6348768|NCT00610727|7256892|FG005|STARTED|Overall Study||8
6348769|NCT00610727|7256887|FG000|COMPLETED|Overall Study||14
6348770|NCT00610727|7256888|FG001|COMPLETED|Overall Study||8
6348771|NCT00610727|7256889|FG002|COMPLETED|Overall Study||8
6348772|NCT00610727|7256890|FG003|COMPLETED|Overall Study||8
6348773|NCT00610727|7256891|FG004|COMPLETED|Overall Study||8
6348774|NCT00610727|7256892|FG005|COMPLETED|Overall Study||8
6348775|NCT00610727|7256887|FG000|NOT COMPLETED|Overall Study||0
6348776|NCT00610727|7256888|FG001|NOT COMPLETED|Overall Study||0
6348777|NCT00610727|7256889|FG002|NOT COMPLETED|Overall Study||0
6348778|NCT00610727|7256890|FG003|NOT COMPLETED|Overall Study||0
6348779|NCT00610727|7256891|FG004|NOT COMPLETED|Overall Study||0
6348780|NCT00610727|7256892|FG005|NOT COMPLETED|Overall Study||0
6348781|NCT00610740|7256910|FG000|STARTED|Overall Study||18
6348782|NCT00610740|7256910|FG000|COMPLETED|Overall Study||18
6348783|NCT00610740|7256910|FG000|NOT COMPLETED|Overall Study||0
6559564|NCT01782326|7482237|FG001|NOT COMPLETED|Planned Treatment Epoch||208
6559565|NCT01782326|7482236|FG000|STARTED|Double-blind Treatment||1678
6559566|NCT01782326|7482237|FG001|STARTED|Double-blind Treatment||1680
6348784|NCT00610857|7256914|FG000|STARTED|Overall Study||37
6348785|NCT00610857|7256914|FG000|COMPLETED|Overall Study||35
6348786|NCT00610857|7256914|FG000|NOT COMPLETED|Overall Study||2
6348787|NCT00610883|7256918|FG000|STARTED|Overall Study||17
6348788|NCT00610883|7256918|FG000|COMPLETED|Overall Study||17
6348789|NCT00610883|7256918|FG000|NOT COMPLETED|Overall Study||0
6348790|NCT00610935|7256924|FG000|STARTED|Overall Study||25
6348791|NCT00610935|7256925|FG001|STARTED|Overall Study||57
6348792|NCT00610935|7256924|FG000|ITTI Population|Overall Study||25
6348793|NCT00610935|7256925|FG001|ITTI Population|Overall Study||55
6348794|NCT00610935|7256924|FG000|ITT Population|Overall Study||25
6348795|NCT00610935|7256925|FG001|ITT Population|Overall Study||57
6348796|NCT00610935|7256924|FG000|COMPLETED|Overall Study||24
6348797|NCT00610935|7256925|FG001|COMPLETED|Overall Study||54
6348798|NCT00610935|7256924|FG000|NOT COMPLETED|Overall Study||1
6348799|NCT00610935|7256925|FG001|NOT COMPLETED|Overall Study||3
6348800|NCT00610987|7256933|FG000|STARTED|Overall Study||75
6348801|NCT00610987|7256934|FG001|STARTED|Overall Study||71
6559567|NCT01782326|7482236|FG000|COMPLETED|Double-blind Treatment||1400
6348802|NCT00610987|7256933|FG000|COMPLETED|Overall Study||75
6348803|NCT00610987|7256934|FG001|COMPLETED|Overall Study||71
6348804|NCT00610987|7256933|FG000|NOT COMPLETED|Overall Study||0
6348805|NCT00610987|7256934|FG001|NOT COMPLETED|Overall Study||0
6348806|NCT00611026|7256943|FG000|STARTED|Randomized to Double-blind Treatment||480
6348807|NCT00611026|7256944|FG001|STARTED|Randomized to Double-blind Treatment||974
6348808|NCT00611026|7256945|FG002|STARTED|Randomized to Double-blind Treatment||963
6348809|NCT00611026|7256943|FG000|COMPLETED|Randomized to Double-blind Treatment||478
6348810|NCT00611026|7256944|FG001|COMPLETED|Randomized to Double-blind Treatment||973
6348811|NCT00611026|7256945|FG002|COMPLETED|Randomized to Double-blind Treatment||960
6348812|NCT00611026|7256943|FG000|NOT COMPLETED|Randomized to Double-blind Treatment||2
6348813|NCT00611026|7256944|FG001|NOT COMPLETED|Randomized to Double-blind Treatment||1
6348814|NCT00611026|7256945|FG002|NOT COMPLETED|Randomized to Double-blind Treatment||3
6348815|NCT00611026|7256943|FG000|STARTED|Double-blind Treatment Period||478
6348816|NCT00611026|7256944|FG001|STARTED|Double-blind Treatment Period||973
6348817|NCT00611026|7256945|FG002|STARTED|Double-blind Treatment Period||960
6348818|NCT00611026|7256943|FG000|COMPLETED|Double-blind Treatment Period||431
6348819|NCT00611026|7256944|FG001|COMPLETED|Double-blind Treatment Period||885
6348820|NCT00611026|7256945|FG002|COMPLETED|Double-blind Treatment Period||862
6348821|NCT00611026|7256943|FG000|NOT COMPLETED|Double-blind Treatment Period||47
6348822|NCT00611026|7256944|FG001|NOT COMPLETED|Double-blind Treatment Period||88
6348823|NCT00611026|7256945|FG002|NOT COMPLETED|Double-blind Treatment Period||98
6348824|NCT00611130|7256957|FG000|STARTED|Overall Study||92
6348825|NCT00611130|7256958|FG001|STARTED|Overall Study||94
6348826|NCT00611130|7256957|FG000|Completed 12 Week Treatment Phase|Overall Study||61
6348827|NCT00611130|7256958|FG001|Completed 12 Week Treatment Phase|Overall Study||64
6348828|NCT00611130|7256957|FG000|COMPLETED|Overall Study||43
6348829|NCT00611130|7256958|FG001|COMPLETED|Overall Study||47
6348830|NCT00611130|7256957|FG000|NOT COMPLETED|Overall Study||49
6348831|NCT00611130|7256958|FG001|NOT COMPLETED|Overall Study||47
6348832|NCT00611247|7256967|FG000|STARTED|Overall Study||5
6348833|NCT00611247|7256968|FG001|STARTED|Overall Study||31
6348834|NCT00611247|7256967|FG000|COMPLETED|Overall Study||3
6348835|NCT00611247|7256968|FG001|COMPLETED|Overall Study||10
6348836|NCT00611247|7256967|FG000|NOT COMPLETED|Overall Study||2
6348837|NCT00611247|7256968|FG001|NOT COMPLETED|Overall Study||21
6348838|NCT00611325|7256977|FG000|STARTED|Overall Study||28
6348839|NCT00611325|7256978|FG001|STARTED|Overall Study||28
6348840|NCT00611325|7256977|FG000|COMPLETED|Overall Study||28
6348841|NCT00611325|7256978|FG001|COMPLETED|Overall Study||28
6348842|NCT00611325|7256977|FG000|NOT COMPLETED|Overall Study||0
6348843|NCT00611325|7256978|FG001|NOT COMPLETED|Overall Study||0
6348844|NCT00611351|7256984|FG000|STARTED|Overall Study||5
6348845|NCT00611351|7256984|FG000|COMPLETED|Overall Study||3
6348846|NCT00611351|7256984|FG000|NOT COMPLETED|Overall Study||2
6348847|NCT00611403|7256990|FG000|STARTED|Treatment Phase||68
6348848|NCT00611403|7256991|FG001|STARTED|Treatment Phase||69
6348849|NCT00611403|7256990|FG000|COMPLETED|Treatment Phase||62
6348850|NCT00611403|7256991|FG001|COMPLETED|Treatment Phase||58
6348851|NCT00611403|7256990|FG000|NOT COMPLETED|Treatment Phase||6
6348852|NCT00611403|7256991|FG001|NOT COMPLETED|Treatment Phase||11
6348853|NCT00611403|7256990|FG000|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
6348854|NCT00611403|7256991|FG001|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
6348855|NCT00611403|7256990|FG000|COMPLETED|Post Treatment Extension Phase||22
6348856|NCT00611403|7256991|FG001|COMPLETED|Post Treatment Extension Phase||24
6348857|NCT00611403|7256990|FG000|NOT COMPLETED|Post Treatment Extension Phase||4
6348858|NCT00611403|7256991|FG001|NOT COMPLETED|Post Treatment Extension Phase||1
6348859|NCT00611442|7256999|FG000|STARTED|Overall Study||95
6348860|NCT00611442|7257000|FG001|STARTED|Overall Study||96
6348861|NCT00611442|7256999|FG000|COMPLETED|Overall Study||94
6348862|NCT00611442|7257000|FG001|COMPLETED|Overall Study||94
6348863|NCT00611442|7256999|FG000|NOT COMPLETED|Overall Study||1
6348864|NCT00611442|7257000|FG001|NOT COMPLETED|Overall Study||2
6348865|NCT00611455|7257008|FG000|STARTED|DB Treatment Period (24 Weeks)||134
6348866|NCT00611455|7257009|FG001|STARTED|DB Treatment Period (24 Weeks)||131
6348867|NCT00611455|7257010|FG002|STARTED|DB Treatment Period (24 Weeks)||0
6348868|NCT00611455|7257008|FG000|COMPLETED|DB Treatment Period (24 Weeks)||121
6348869|NCT00611455|7257009|FG001|COMPLETED|DB Treatment Period (24 Weeks)||117
6348870|NCT00611455|7257010|FG002|COMPLETED|DB Treatment Period (24 Weeks)||0
6348871|NCT00611455|7257008|FG000|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
6348872|NCT00611455|7257009|FG001|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
6348873|NCT00611455|7257010|FG002|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
6348874|NCT00611455|7257008|FG000|STARTED|OL Treatment Period (120 Weeks)||0
6348875|NCT00611455|7257009|FG001|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
6348876|NCT00611455|7257010|FG002|STARTED|OL Treatment Period (120 Weeks)||0
6348877|NCT00611455|7257008|FG000|COMPLETED|OL Treatment Period (120 Weeks)||0
6348878|NCT00611455|7257009|FG001|COMPLETED|OL Treatment Period (120 Weeks)||52
6348879|NCT00611455|7257010|FG002|COMPLETED|OL Treatment Period (120 Weeks)||0
6348880|NCT00611455|7257008|FG000|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
6348881|NCT00611455|7257009|FG001|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
6348882|NCT00611455|7257010|FG002|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
6559568|NCT01782326|7482237|FG001|COMPLETED|Double-blind Treatment||1360
6559569|NCT01782326|7482236|FG000|NOT COMPLETED|Double-blind Treatment||278
6559570|NCT01782326|7482237|FG001|NOT COMPLETED|Double-blind Treatment||320
6559571|NCT01782378|7482245|FG000|STARTED|First Series||32
6559572|NCT01782378|7482246|FG001|STARTED|First Series||31
6559573|NCT01782378|7482245|FG000|COMPLETED|First Series||25
6559574|NCT01782378|7482246|FG001|COMPLETED|First Series||23
6559575|NCT01782378|7482245|FG000|NOT COMPLETED|First Series||7
6559576|NCT01782378|7482246|FG001|NOT COMPLETED|First Series||8
6559577|NCT01782378|7482245|FG000|STARTED|Second Series||31
6559578|NCT01782378|7482246|FG001|STARTED|Second Series||32
6559579|NCT01782378|7482245|FG000|COMPLETED|Second Series||5
6348883|NCT00611455|7257008|FG000|STARTED|Follow-up Period (Approximately 2 Years)||0
6348884|NCT00611455|7257009|FG001|STARTED|Follow-up Period (Approximately 2 Years)||0
6348885|NCT00611455|7257010|FG002|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
6348886|NCT00611455|7257008|FG000|COMPLETED|Follow-up Period (Approximately 2 Years)||0
6348887|NCT00611455|7257009|FG001|COMPLETED|Follow-up Period (Approximately 2 Years)||0
6348888|NCT00611455|7257010|FG002|COMPLETED|Follow-up Period (Approximately 2 Years)||49
6348889|NCT00611455|7257008|FG000|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
6348890|NCT00611455|7257009|FG001|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
6348891|NCT00611455|7257010|FG002|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
6348892|NCT00611468|7257020|FG000|STARTED|Overall Study||3
6348893|NCT00611468|7257021|FG001|STARTED|Overall Study||7
6348894|NCT00611468|7257022|FG002|STARTED|Overall Study||6
6348895|NCT00611468|7257023|FG003|STARTED|Overall Study||13
6348896|NCT00611468|7257020|FG000|COMPLETED|Overall Study||3
6348897|NCT00611468|7257021|FG001|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
6348898|NCT00611468|7257022|FG002|COMPLETED|Overall Study||6
6348899|NCT00611468|7257023|FG003|COMPLETED|Overall Study||13
6348900|NCT00611468|7257020|FG000|NOT COMPLETED|Overall Study||0
6348901|NCT00611468|7257021|FG001|NOT COMPLETED|Overall Study||1
6348902|NCT00611468|7257022|FG002|NOT COMPLETED|Overall Study||0
6348903|NCT00611468|7257023|FG003|NOT COMPLETED|Overall Study||0
6348904|NCT00611533|7257027|FG000|STARTED|First Intervention (6 Weeks)||8
6348905|NCT00611533|7257028|FG001|STARTED|First Intervention (6 Weeks)||8
6348906|NCT00611533|7257027|FG000|COMPLETED|First Intervention (6 Weeks)||8
6348907|NCT00611533|7257028|FG001|COMPLETED|First Intervention (6 Weeks)||6
6348908|NCT00611533|7257027|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
6348909|NCT00611533|7257028|FG001|NOT COMPLETED|First Intervention (6 Weeks)||2
6348910|NCT00611533|7257027|FG000|STARTED|Second Intervention (6 Weeks)||8
6348911|NCT00611533|7257028|FG001|STARTED|Second Intervention (6 Weeks)||6
6348912|NCT00611533|7257027|FG000|COMPLETED|Second Intervention (6 Weeks)||8
6348913|NCT00611533|7257028|FG001|COMPLETED|Second Intervention (6 Weeks)||4
6348914|NCT00611533|7257027|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6348915|NCT00611533|7257028|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||2
6348916|NCT00611559|7257038|FG000|STARTED|Overall Study||111
6348917|NCT00611559|7257039|FG001|STARTED|Overall Study||115
6348918|NCT00611559|7257040|FG002|STARTED|Overall Study||57
6348919|NCT00611559|7257038|FG000|COMPLETED|Overall Study||110
6348920|NCT00611559|7257039|FG001|COMPLETED|Overall Study||114
6348921|NCT00611559|7257040|FG002|COMPLETED|Overall Study||56
6348922|NCT00611559|7257038|FG000|NOT COMPLETED|Overall Study||1
6348923|NCT00611559|7257039|FG001|NOT COMPLETED|Overall Study||1
6348924|NCT00611559|7257040|FG002|NOT COMPLETED|Overall Study||1
6348925|NCT00611624|7257048|FG000|STARTED|Overall Study||28
6348926|NCT00611624|7257048|FG000|COMPLETED|Overall Study||28
6348927|NCT00611624|7257048|FG000|NOT COMPLETED|Overall Study||0
6348928|NCT00611715|7257055|FG000|STARTED|Overall Study||42
6348929|NCT00611715|7257056|FG001|STARTED|Overall Study||6
6348930|NCT00611715|7257055|FG000|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
6348931|NCT00611715|7257056|FG001|COMPLETED|Overall Study||0
6348932|NCT00611715|7257055|FG000|NOT COMPLETED|Overall Study||41
6348933|NCT00611715|7257056|FG001|NOT COMPLETED|Overall Study||6
6348934|NCT00611767|7257070|FG000|STARTED|Overall Study||49
6348935|NCT00611767|7257071|FG001|STARTED|Overall Study||24
6348936|NCT00611767|7257070|FG000|Thiopental Test Day|Overall Study||3
6348937|NCT00611767|7257071|FG001|Thiopental Test Day|Overall Study||1
6348938|NCT00611767|7257070|FG000|Placebo Test Day|Overall Study||6
6348939|NCT00611767|7257071|FG001|Placebo Test Day|Overall Study||1
6348940|NCT00611767|7257070|FG000|COMPLETED|Overall Study||40
6348941|NCT00611767|7257071|FG001|COMPLETED|Overall Study||22
6348942|NCT00611767|7257070|FG000|NOT COMPLETED|Overall Study||9
6348943|NCT00611767|7257071|FG001|NOT COMPLETED|Overall Study||2
6348944|NCT00611806|7257079|FG000|STARTED|Overall Study||94
6348945|NCT00611806|7257080|FG001|STARTED|Overall Study||46
6348946|NCT00611806|7257079|FG000|COMPLETED|Overall Study||78
6348947|NCT00611806|7257080|FG001|COMPLETED|Overall Study||43
6348948|NCT00611806|7257079|FG000|NOT COMPLETED|Overall Study||16
6348949|NCT00611806|7257080|FG001|NOT COMPLETED|Overall Study||3
6348950|NCT00611858|7257086|FG000|STARTED|Overall Study||13
6348951|NCT00611858|7257086|FG000|COMPLETED|Overall Study||9
6348952|NCT00611858|7257086|FG000|NOT COMPLETED|Overall Study||4
6348953|NCT00611884|7257096|FG000|STARTED|Overall Study||61
6348954|NCT00611884|7257097|FG001|STARTED|Overall Study||60
6348955|NCT00611884|7257098|FG002|STARTED|Overall Study||62
6348956|NCT00611884|7257099|FG003|STARTED|Overall Study||62
6348957|NCT00611884|7257096|FG000|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
6348958|NCT00611884|7257097|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
6348959|NCT00611884|7257098|FG002|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
6348960|NCT00611884|7257099|FG003|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
6559580|NCT01782378|7482246|FG001|COMPLETED|Second Series||0
6348961|NCT00611884|7257096|FG000|COMPLETED|Overall Study||52
6348962|NCT00611884|7257097|FG001|COMPLETED|Overall Study||51
6348963|NCT00611884|7257098|FG002|COMPLETED|Overall Study||58
6348964|NCT00611884|7257099|FG003|COMPLETED|Overall Study||56
6348965|NCT00611884|7257096|FG000|NOT COMPLETED|Overall Study||9
6348966|NCT00611884|7257097|FG001|NOT COMPLETED|Overall Study||9
6348967|NCT00611884|7257098|FG002|NOT COMPLETED|Overall Study||4
6348968|NCT00611884|7257099|FG003|NOT COMPLETED|Overall Study||6
6348969|NCT00611897|7257109|FG000|STARTED|Day 1: Initial Treatment||8
6348970|NCT00611897|7257110|FG001|STARTED|Day 1: Initial Treatment||8
6348971|NCT00611897|7257109|FG000|COMPLETED|Day 1: Initial Treatment||8
6348972|NCT00611897|7257110|FG001|COMPLETED|Day 1: Initial Treatment||8
6348973|NCT00611897|7257109|FG000|NOT COMPLETED|Day 1: Initial Treatment||0
6348974|NCT00611897|7257110|FG001|NOT COMPLETED|Day 1: Initial Treatment||0
6348975|NCT00611897|7257109|FG000|STARTED|Day 2: Crossover Treatment||8
6348976|NCT00611897|7257110|FG001|STARTED|Day 2: Crossover Treatment||8
6348977|NCT00611897|7257109|FG000|COMPLETED|Day 2: Crossover Treatment||8
6348978|NCT00611897|7257110|FG001|COMPLETED|Day 2: Crossover Treatment||8
6348979|NCT00611897|7257109|FG000|NOT COMPLETED|Day 2: Crossover Treatment||0
6348980|NCT00611897|7257110|FG001|NOT COMPLETED|Day 2: Crossover Treatment||0
6348981|NCT00611923|7257120|FG000|STARTED|Overall Study||12
6348982|NCT00611923|7257121|FG001|STARTED|Overall Study||13
6348983|NCT00611923|7257120|FG000|COMPLETED|Overall Study||10
6348984|NCT00611923|7257121|FG001|COMPLETED|Overall Study||11
6348985|NCT00611923|7257120|FG000|NOT COMPLETED|Overall Study||2
6348986|NCT00611923|7257121|FG001|NOT COMPLETED|Overall Study||2
6348987|NCT00611975|7257131|FG000|STARTED|Overall Study||45
6348988|NCT00611975|7257132|FG001|STARTED|Overall Study||38
6348989|NCT00611975|7257131|FG000|COMPLETED|Overall Study||40
6348990|NCT00611975|7257132|FG001|COMPLETED|Overall Study||30
6348991|NCT00611975|7257131|FG000|NOT COMPLETED|Overall Study||5
6348992|NCT00611975|7257132|FG001|NOT COMPLETED|Overall Study||8
6348993|NCT00612040|7257141|FG000|STARTED|Overall Study||60
6348994|NCT00612040|7257142|FG001|STARTED|Overall Study||59
6348995|NCT00612040|7257143|FG002|STARTED|Overall Study||59
6348996|NCT00612040|7257141|FG000|Exposed|Overall Study||60
6348997|NCT00612040|7257142|FG001|Exposed|Overall Study||59
6348998|NCT00612040|7257143|FG002|Exposed|Overall Study||59
6348999|NCT00612040|7257141|FG000|COMPLETED|Overall Study||55
6349000|NCT00612040|7257142|FG001|COMPLETED|Overall Study||52
6349001|NCT00612040|7257143|FG002|COMPLETED|Overall Study||52
6349002|NCT00612040|7257141|FG000|NOT COMPLETED|Overall Study||5
6349003|NCT00612040|7257142|FG001|NOT COMPLETED|Overall Study||7
6349004|NCT00612040|7257143|FG002|NOT COMPLETED|Overall Study||7
6349005|NCT00612066|7257151|FG000|STARTED|Overall Study||2
6349006|NCT00612066|7257151|FG000|COMPLETED|Overall Study||1
6349007|NCT00612066|7257151|FG000|NOT COMPLETED|Overall Study||1
6349008|NCT00612105|7257157|FG000|STARTED|Period Title 1: 6-Week Titration Phase||125
6349009|NCT00612105|7257158|FG001|STARTED|Period Title 1: 6-Week Titration Phase||62
6349010|NCT00612105|7257157|FG000|COMPLETED|Period Title 1: 6-Week Titration Phase||89
6349011|NCT00612105|7257158|FG001|COMPLETED|Period Title 1: 6-Week Titration Phase||57
6349012|NCT00612105|7257157|FG000|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
6349013|NCT00612105|7257158|FG001|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
6349014|NCT00612105|7257157|FG000|STARTED|Period Title 2: 4-Week Maintenance Phase||89
6349015|NCT00612105|7257158|FG001|STARTED|Period Title 2: 4-Week Maintenance Phase||57
6349016|NCT00612105|7257157|FG000|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
6349017|NCT00612105|7257158|FG001|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
6349018|NCT00612105|7257157|FG000|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
6349019|NCT00612105|7257158|FG001|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
6349020|NCT00612105|7257157|FG000|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
6349021|NCT00612105|7257158|FG001|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
6349022|NCT00612105|7257157|FG000|COMPLETED|Period Title 3: 3-Week Taper Phase||85
6349023|NCT00612105|7257158|FG001|COMPLETED|Period Title 3: 3-Week Taper Phase||58
6349024|NCT00612105|7257157|FG000|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
6349025|NCT00612105|7257158|FG001|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
6349026|NCT00612222|7257164|FG000|STARTED|Overall Study||4
6349027|NCT00612222|7257164|FG000|COMPLETED|Overall Study||4
6349028|NCT00612222|7257164|FG000|NOT COMPLETED|Overall Study||0
6349029|NCT00612235|7257172|FG000|STARTED|Overall Study||20
6349030|NCT00612235|7257173|FG001|STARTED|Overall Study||20
6349031|NCT00612235|7257174|FG002|STARTED|Overall Study||20
6349032|NCT00612235|7257175|FG003|STARTED|Overall Study||20
6349033|NCT00612235|7257172|FG000|COMPLETED|Overall Study||20
6349034|NCT00612235|7257173|FG001|COMPLETED|Overall Study||20
6349035|NCT00612235|7257174|FG002|COMPLETED|Overall Study||20
6349036|NCT00612235|7257175|FG003|COMPLETED|Overall Study||20
6349037|NCT00612235|7257172|FG000|NOT COMPLETED|Overall Study||0
6349038|NCT00612235|7257173|FG001|NOT COMPLETED|Overall Study||0
6349039|NCT00612235|7257174|FG002|NOT COMPLETED|Overall Study||0
6349040|NCT00612235|7257175|FG003|NOT COMPLETED|Overall Study||0
6349041|NCT00612313|7257188|FG000|STARTED|Overall Study||69
6349042|NCT00612313|7257189|FG001|STARTED|Overall Study||75
6349043|NCT00612313|7257188|FG000|COMPLETED|Overall Study||52
6349044|NCT00612313|7257189|FG001|COMPLETED|Overall Study||62
6349045|NCT00612313|7257188|FG000|NOT COMPLETED|Overall Study||17
6349046|NCT00612313|7257189|FG001|NOT COMPLETED|Overall Study||13
6349047|NCT00612339|7257201|FG000|STARTED|Overall Study||41
6349048|NCT00612339|7257201|FG000|COMPLETED|Overall Study||41
6349049|NCT00612339|7257201|FG000|NOT COMPLETED|Overall Study||0
6349050|NCT00612352|7257207|FG000|STARTED|Overall Study||65
6349051|NCT00612352|7257208|FG001|STARTED|Overall Study||115
6349052|NCT00612352|7257207|FG000|40%mg & 100%mg|Overall Study||1
6349053|NCT00612352|7257208|FG001|40%mg & 100%mg|Overall Study||1
6349054|NCT00612352|7257207|FG000|Placebo & 100%mg|Overall Study||1
6349055|NCT00612352|7257208|FG001|Placebo & 100%mg|Overall Study||0
6349056|NCT00612352|7257207|FG000|100%mg|Overall Study||2
6349057|NCT00612352|7257208|FG001|100%mg|Overall Study||1
6349058|NCT00612352|7257207|FG000|40%mg|Overall Study||1
6559581|NCT01782378|7482245|FG000|NOT COMPLETED|Second Series||26
6559582|NCT01782378|7482246|FG001|NOT COMPLETED|Second Series||32
6559583|NCT01782469|7482252|FG000|STARTED|Overall Study||16
6559584|NCT01782469|7482252|FG000|COMPLETED|Overall Study||15
6559585|NCT01782469|7482252|FG000|NOT COMPLETED|Overall Study||1
6559586|NCT01782482|7482258|FG000|STARTED|Overall Study||281
6349059|NCT00612352|7257208|FG001|40%mg|Overall Study||0
6349060|NCT00612352|7257207|FG000|Placebo|Overall Study||4
6349061|NCT00612352|7257208|FG001|Placebo|Overall Study||4
6349062|NCT00612352|7257207|FG000|COMPLETED|Overall Study||56
6349063|NCT00612352|7257208|FG001|COMPLETED|Overall Study||109
6349064|NCT00612352|7257207|FG000|NOT COMPLETED|Overall Study||9
6349065|NCT00612352|7257208|FG001|NOT COMPLETED|Overall Study||6
6349066|NCT00612430|7257216|FG000|STARTED|Overall Study||32
6349067|NCT00612430|7257217|FG001|STARTED|Overall Study||27
6349068|NCT00612430|7257216|FG000|COMPLETED|Overall Study||32
6349069|NCT00612430|7257217|FG001|COMPLETED|Overall Study||27
6349070|NCT00612430|7257216|FG000|NOT COMPLETED|Overall Study||0
6349071|NCT00612430|7257217|FG001|NOT COMPLETED|Overall Study||0
6349072|NCT00612456|7257228|FG000|STARTED|Overall Study||27
6349073|NCT00612456|7257229|FG001|STARTED|Overall Study||27
6349074|NCT00612456|7257230|FG002|STARTED|Overall Study||16
6349075|NCT00612456|7257228|FG000|COMPLETED|Overall Study||25
6349076|NCT00612456|7257229|FG001|COMPLETED|Overall Study||25
6349077|NCT00612456|7257230|FG002|COMPLETED|Overall Study||16
6349078|NCT00612456|7257228|FG000|NOT COMPLETED|Overall Study||2
6349079|NCT00612456|7257229|FG001|NOT COMPLETED|Overall Study||2
6559587|NCT01782482|7482259|FG001|STARTED|Overall Study||280
6559588|NCT01782482|7482258|FG000|COMPLETED|Overall Study||271
6559589|NCT01782482|7482259|FG001|COMPLETED|Overall Study||270
6559590|NCT01782482|7482258|FG000|NOT COMPLETED|Overall Study||10
6559591|NCT01782482|7482259|FG001|NOT COMPLETED|Overall Study||10
6559592|NCT01782495|7482276|FG000|STARTED|Overall Study||34
6349080|NCT00612456|7257230|FG002|NOT COMPLETED|Overall Study||0
6349081|NCT00612508|7257242|FG000|STARTED|Overall Study||7
6349082|NCT00612508|7257243|FG001|STARTED|Overall Study||7
6349083|NCT00612508|7257242|FG000|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
6349084|NCT00612508|7257243|FG001|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
6349085|NCT00612508|7257242|FG000|NOT COMPLETED|Overall Study||3
6349086|NCT00612508|7257243|FG001|NOT COMPLETED|Overall Study||4
6349087|NCT00612534|7257255|FG000|STARTED|Overall Study||24
6349088|NCT00612534|7257256|FG001|STARTED|Overall Study||26
6349089|NCT00612534|7257257|FG002|STARTED|Overall Study||20
6349090|NCT00612534|7257258|FG003|STARTED|Overall Study||24
6349091|NCT00612534|7257255|FG000|COMPLETED|Overall Study||11
6349092|NCT00612534|7257256|FG001|COMPLETED|Overall Study||9
6349093|NCT00612534|7257257|FG002|COMPLETED|Overall Study||13
6349094|NCT00612534|7257258|FG003|COMPLETED|Overall Study||7
6349095|NCT00612534|7257255|FG000|NOT COMPLETED|Overall Study||13
6349096|NCT00612534|7257256|FG001|NOT COMPLETED|Overall Study||17
6349097|NCT00612534|7257257|FG002|NOT COMPLETED|Overall Study||7
6349098|NCT00612534|7257258|FG003|NOT COMPLETED|Overall Study||17
6349099|NCT00612560|7257272|FG000|STARTED|Overall Study||7
6349100|NCT00612560|7257273|FG001|STARTED|Overall Study||7
6349101|NCT00612560|7257274|FG002|STARTED|Overall Study||8
6349102|NCT00612560|7257275|FG003|STARTED|Overall Study||6
6349103|NCT00612560|7257272|FG000|COMPLETED|Overall Study||7
6349104|NCT00612560|7257273|FG001|COMPLETED|Overall Study||7
6349105|NCT00612560|7257274|FG002|COMPLETED|Overall Study||8
6349106|NCT00612560|7257275|FG003|COMPLETED|Overall Study||6
6349107|NCT00612560|7257272|FG000|NOT COMPLETED|Overall Study||0
6349108|NCT00612560|7257273|FG001|NOT COMPLETED|Overall Study||0
6349109|NCT00612560|7257274|FG002|NOT COMPLETED|Overall Study||0
6349110|NCT00612560|7257275|FG003|NOT COMPLETED|Overall Study||0
6349111|NCT00612573|7257289|FG000|STARTED|Overall Study||64
6349112|NCT00612573|7257290|FG001|STARTED|Overall Study||65
6349113|NCT00612573|7257291|FG002|STARTED|Overall Study||61
6349114|NCT00612573|7257292|FG003|STARTED|Overall Study||67
6349115|NCT00612573|7257289|FG000|COMPLETED|Overall Study||52
6349116|NCT00612573|7257290|FG001|COMPLETED|Overall Study||51
6559593|NCT01782495|7482277|FG001|STARTED|Overall Study||27
6349117|NCT00612573|7257291|FG002|COMPLETED|Overall Study||52
6349118|NCT00612573|7257292|FG003|COMPLETED|Overall Study||54
6349119|NCT00612573|7257289|FG000|NOT COMPLETED|Overall Study||12
6349120|NCT00612573|7257290|FG001|NOT COMPLETED|Overall Study||14
6349121|NCT00612573|7257291|FG002|NOT COMPLETED|Overall Study||9
6559594|NCT01782495|7482278|FG002|STARTED|Overall Study||13
6559595|NCT01782495|7482279|FG003|STARTED|Overall Study||4
6559596|NCT01782495|7482280|FG004|STARTED|Overall Study||2
6349122|NCT00612573|7257292|FG003|NOT COMPLETED|Overall Study||13
6349123|NCT00612586|7257304|FG000|STARTED|Overall Study||58
6349124|NCT00612586|7257305|FG001|STARTED|Overall Study||59
6349125|NCT00612586|7257304|FG000|Received at Least 1 Dose|Overall Study||57
6349126|NCT00612586|7257305|FG001|Received at Least 1 Dose|Overall Study||58
6349127|NCT00612586|7257304|FG000|COMPLETED|Overall Study||15
6349128|NCT00612586|7257305|FG001|COMPLETED|Overall Study||18
6349129|NCT00612586|7257304|FG000|NOT COMPLETED|Overall Study||43
6349130|NCT00612586|7257305|FG001|NOT COMPLETED|Overall Study||41
6349131|NCT00612690|7257314|FG000|STARTED|Overall Study||275
6349132|NCT00612690|7257315|FG001|STARTED|Overall Study||207
6349133|NCT00612690|7257314|FG000|COMPLETED|Overall Study||160
6349134|NCT00612690|7257315|FG001|COMPLETED|Overall Study||89
6349135|NCT00612690|7257314|FG000|NOT COMPLETED|Overall Study||115
6349136|NCT00612690|7257315|FG001|NOT COMPLETED|Overall Study||118
6349137|NCT00612716|7257323|FG000|STARTED|Overall Study||6
6349138|NCT00612716|7257323|FG000|COMPLETED|Overall Study||6
6349139|NCT00612716|7257323|FG000|NOT COMPLETED|Overall Study||0
6349140|NCT00612768|7257327|FG000|STARTED|Overall Study||50
6349141|NCT00612768|7257327|FG000|COMPLETED|Overall Study||50
6349142|NCT00612768|7257327|FG000|NOT COMPLETED|Overall Study||0
6349143|NCT00612807|7257354|FG000|STARTED|Overall Study||14
6349144|NCT00612807|7257355|FG001|STARTED|Overall Study||28
6349145|NCT00612807|7257354|FG000|COMPLETED|Overall Study||12
6349146|NCT00612807|7257355|FG001|COMPLETED|Overall Study||28
6349147|NCT00612807|7257354|FG000|NOT COMPLETED|Overall Study||2
6349148|NCT00612807|7257355|FG001|NOT COMPLETED|Overall Study||0
6349149|NCT00612924|7257363|FG000|STARTED|Overall Study||101
6349150|NCT00612924|7257364|FG001|STARTED|Overall Study||94
6349151|NCT00612924|7257363|FG000|COMPLETED|Overall Study||94
6349152|NCT00612924|7257364|FG001|COMPLETED|Overall Study||85
6349153|NCT00612924|7257363|FG000|NOT COMPLETED|Overall Study||7
6349154|NCT00612924|7257364|FG001|NOT COMPLETED|Overall Study||9
6349155|NCT00613015|7257377|FG000|STARTED|Overall Study||13
6349156|NCT00613015|7257378|FG001|STARTED|Overall Study||12
6349157|NCT00613015|7257379|FG002|STARTED|Overall Study||26
6349158|NCT00613015|7257380|FG003|STARTED|Overall Study||24
6349159|NCT00613015|7257381|FG004|STARTED|Overall Study||15
6349160|NCT00613015|7257382|FG005|STARTED|Overall Study||19
6349161|NCT00613015|7257377|FG000|COMPLETED|Overall Study||13
6349162|NCT00613015|7257378|FG001|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
6349163|NCT00613015|7257379|FG002|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
6349164|NCT00613015|7257380|FG003|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
6349165|NCT00613015|7257381|FG004|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
6349166|NCT00613015|7257382|FG005|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
6349167|NCT00613015|7257377|FG000|NOT COMPLETED|Overall Study||0
6349168|NCT00613015|7257378|FG001|NOT COMPLETED|Overall Study||1
6349169|NCT00613015|7257379|FG002|NOT COMPLETED|Overall Study||3
6349170|NCT00613015|7257380|FG003|NOT COMPLETED|Overall Study||3
6349171|NCT00613015|7257381|FG004|NOT COMPLETED|Overall Study||2
6349172|NCT00613015|7257382|FG005|NOT COMPLETED|Overall Study||3
6349173|NCT00613028|7257398|FG000|STARTED|Overall Study||10
6349174|NCT00613028|7257399|FG001|STARTED|Overall Study||13
6349175|NCT00613028|7257398|FG000|COMPLETED|Overall Study||10
6349176|NCT00613028|7257399|FG001|COMPLETED|Overall Study||12
6349177|NCT00613028|7257398|FG000|NOT COMPLETED|Overall Study||0
6349178|NCT00613028|7257399|FG001|NOT COMPLETED|Overall Study||1
6349179|NCT00613080|7257405|FG000|STARTED|Overall Study||79
6349180|NCT00613080|7257405|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
6349181|NCT00613080|7257405|FG000|NOT COMPLETED|Overall Study||11
6349182|NCT00613106|7257411|FG000|STARTED|Overall Study||132
6349183|NCT00613106|7257412|FG001|STARTED|Overall Study||47
6559597|NCT01782495|7482281|FG005|STARTED|Overall Study||22
6559598|NCT01782495|7482282|FG006|STARTED|Overall Study||12
6559599|NCT01782495|7482283|FG007|STARTED|Overall Study||9
6559600|NCT01782495|7482284|FG008|STARTED|Overall Study||3
6559601|NCT01782495|7482285|FG009|STARTED|Overall Study||2
6559602|NCT01782495|7482286|FG010|STARTED|Overall Study||1
6559603|NCT01782495|7482276|FG000|COMPLETED|Overall Study||34
6559604|NCT01782495|7482277|FG001|COMPLETED|Overall Study||26
6559605|NCT01782495|7482278|FG002|COMPLETED|Overall Study||13
6559606|NCT01782495|7482279|FG003|COMPLETED|Overall Study||4
6559607|NCT01782495|7482280|FG004|COMPLETED|Overall Study||2
6559608|NCT01782495|7482281|FG005|COMPLETED|Overall Study||22
6349184|NCT00613106|7257411|FG000|COMPLETED|Overall Study||112
6349185|NCT00613106|7257412|FG001|COMPLETED|Overall Study||38
6349186|NCT00613106|7257411|FG000|NOT COMPLETED|Overall Study||20
6349187|NCT00613106|7257412|FG001|NOT COMPLETED|Overall Study||9
6349188|NCT00613171|7257418|FG000|STARTED|Overall Study||27
6349189|NCT00613171|7257418|FG000|COMPLETED|Overall Study||13
6349190|NCT00613171|7257418|FG000|NOT COMPLETED|Overall Study||14
6349191|NCT00613301|7257423|FG000|STARTED|Overall Study||416
6349192|NCT00613301|7257423|FG000|COMPLETED|Overall Study||188
6349193|NCT00613301|7257423|FG000|NOT COMPLETED|Overall Study||228
6349194|NCT00613314|7257428|FG000|STARTED|Overall Study||15268
6349195|NCT00613314|7257428|FG000|COMPLETED|Overall Study||15113
6349196|NCT00613314|7257428|FG000|NOT COMPLETED|Overall Study||155
6349197|NCT00613327|7257432|FG000|STARTED|Overall Study||345
6559609|NCT01782495|7482282|FG006|COMPLETED|Overall Study||12
6349198|NCT00613327|7257432|FG000|COMPLETED|Overall Study||244
6349199|NCT00613327|7257432|FG000|NOT COMPLETED|Overall Study||101
6349200|NCT00613366|7257438|FG000|STARTED|Overall Study||20
6349201|NCT00613366|7257439|FG001|STARTED|Overall Study||20
6349202|NCT00613366|7257438|FG000|COMPLETED|Overall Study||17
6349203|NCT00613366|7257439|FG001|COMPLETED|Overall Study||18
6349204|NCT00613366|7257438|FG000|NOT COMPLETED|Overall Study||3
6349205|NCT00613366|7257439|FG001|NOT COMPLETED|Overall Study||2
6349206|NCT00613379|7257448|FG000|STARTED|Overall Study||10
6349207|NCT00613379|7257449|FG001|STARTED|Overall Study||10
6349208|NCT00613379|7257450|FG002|STARTED|Overall Study||11
6349209|NCT00613379|7257448|FG000|COMPLETED|Overall Study||10
6349210|NCT00613379|7257449|FG001|COMPLETED|Overall Study||10
6349211|NCT00613379|7257450|FG002|COMPLETED|Overall Study||11
6349212|NCT00613379|7257448|FG000|NOT COMPLETED|Overall Study||0
6349213|NCT00613379|7257449|FG001|NOT COMPLETED|Overall Study||0
6349214|NCT00613379|7257450|FG002|NOT COMPLETED|Overall Study||0
6349215|NCT00613405|7257460|FG000|STARTED|Overall Study||45
6349216|NCT00613405|7257461|FG001|STARTED|Overall Study||42
6349217|NCT00613405|7257460|FG000|COMPLETED|Overall Study||45
6349218|NCT00613405|7257461|FG001|COMPLETED|Overall Study||42
6349219|NCT00613405|7257460|FG000|NOT COMPLETED|Overall Study||0
6349220|NCT00613405|7257461|FG001|NOT COMPLETED|Overall Study||0
6349221|NCT00613509|7257469|FG000|STARTED|Cycle 1||11
6349222|NCT00613509|7257470|FG001|STARTED|Cycle 1||12
6349223|NCT00613509|7257469|FG000|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
6349224|NCT00613509|7257470|FG001|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
6349225|NCT00613509|7257469|FG000|NOT COMPLETED|Cycle 1||5
6349226|NCT00613509|7257470|FG001|NOT COMPLETED|Cycle 1||8
6349227|NCT00613509|7257469|FG000|STARTED|Cycle 2 (Group 2 = Crossover)||11
6349228|NCT00613509|7257470|FG001|STARTED|Cycle 2 (Group 2 = Crossover)||4
6349229|NCT00613509|7257469|FG000|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
6349230|NCT00613509|7257470|FG001|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
6349231|NCT00613509|7257469|FG000|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
6349232|NCT00613509|7257470|FG001|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
6349233|NCT00613574|7257476|FG000|STARTED|Overall Study||407
6349234|NCT00613574|7257476|FG000|COMPLETED|Overall Study||401
6349235|NCT00613574|7257476|FG000|NOT COMPLETED|Overall Study||6
6349236|NCT00613626|7257483|FG000|STARTED|Overall Study||33
6349237|NCT00613626|7257484|FG001|STARTED|Overall Study||34
6349238|NCT00613626|7257485|FG002|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
6349239|NCT00613626|7257483|FG000|1st Dose ZD6474|Overall Study||33
6349240|NCT00613626|7257484|FG001|1st Dose ZD6474|Overall Study||34
6349241|NCT00613626|7257485|FG002|1st Dose ZD6474|Overall Study||7
6349242|NCT00613626|7257483|FG000|COMPLETED|Overall Study||33
6349243|NCT00613626|7257484|FG001|COMPLETED|Overall Study||33
6349244|NCT00613626|7257485|FG002|COMPLETED|Overall Study||7
6349245|NCT00613626|7257483|FG000|NOT COMPLETED|Overall Study||0
6349246|NCT00613626|7257484|FG001|NOT COMPLETED|Overall Study||1
6349247|NCT00613626|7257485|FG002|NOT COMPLETED|Overall Study||0
6349248|NCT00613821|7257494|FG000|STARTED|Overall Study||40
6349249|NCT00613821|7257495|FG001|STARTED|Overall Study||40
6349250|NCT00613821|7257494|FG000|COMPLETED|Overall Study||38
6349251|NCT00613821|7257495|FG001|COMPLETED|Overall Study||39
6349252|NCT00613821|7257494|FG000|NOT COMPLETED|Overall Study||2
6349253|NCT00613821|7257495|FG001|NOT COMPLETED|Overall Study||1
6349254|NCT00613834|7257503|FG000|STARTED|Overall Study||29
6559610|NCT01782495|7482283|FG007|COMPLETED|Overall Study||6
6559611|NCT01782495|7482284|FG008|COMPLETED|Overall Study||3
6559612|NCT01782495|7482285|FG009|COMPLETED|Overall Study||2
6559613|NCT01782495|7482286|FG010|COMPLETED|Overall Study||1
6559614|NCT01782495|7482276|FG000|NOT COMPLETED|Overall Study||0
6559615|NCT01782495|7482277|FG001|NOT COMPLETED|Overall Study||1
6349255|NCT00613834|7257504|FG001|STARTED|Overall Study||29
6349256|NCT00613834|7257503|FG000|COMPLETED|Overall Study||29
6349257|NCT00613834|7257504|FG001|COMPLETED|Overall Study||26
6349258|NCT00613834|7257503|FG000|NOT COMPLETED|Overall Study||0
6349259|NCT00613834|7257504|FG001|NOT COMPLETED|Overall Study||3
6349260|NCT00613925|7257514|FG000|STARTED|Overall Study||37
6349261|NCT00613925|7257515|FG001|STARTED|Overall Study||33
6349262|NCT00613925|7257514|FG000|COMPLETED|Overall Study||37
6349263|NCT00613925|7257515|FG001|COMPLETED|Overall Study||32
6349264|NCT00613925|7257514|FG000|NOT COMPLETED|Overall Study||0
6349265|NCT00613925|7257515|FG001|NOT COMPLETED|Overall Study||1
6349266|NCT00613938|7257525|FG000|STARTED|Overall Study||69
6349267|NCT00613938|7257526|FG001|STARTED|Overall Study||275
6349268|NCT00613938|7257527|FG002|STARTED|Overall Study||278
6349269|NCT00613938|7257528|FG003|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
6349270|NCT00613938|7257525|FG000|COMPLETED|Overall Study||49
6349271|NCT00613938|7257526|FG001|COMPLETED|Overall Study||247
6349272|NCT00613938|7257527|FG002|COMPLETED|Overall Study||255
6349273|NCT00613938|7257528|FG003|COMPLETED|Overall Study||253
6349274|NCT00613938|7257525|FG000|NOT COMPLETED|Overall Study||20
6349275|NCT00613938|7257526|FG001|NOT COMPLETED|Overall Study||28
6349276|NCT00613938|7257527|FG002|NOT COMPLETED|Overall Study||23
6559616|NCT01782495|7482278|FG002|NOT COMPLETED|Overall Study||0
6349277|NCT00613938|7257528|FG003|NOT COMPLETED|Overall Study||26
6376842|NCT00761306|7287434|FG000|NOT COMPLETED|Overall Study||20
6376843|NCT00761319|7287440|FG000|STARTED|Overall Study||353
6349278|NCT00613951|7257541|FG000|STARTED|Overall Study||61
6349279|NCT00613951|7257542|FG001|STARTED|Overall Study||59
6349280|NCT00613951|7257543|FG002|STARTED|Overall Study||62
6349281|NCT00613951|7257541|FG000|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
6349282|NCT00613951|7257542|FG001|Exposed|Overall Study||59
6349283|NCT00613951|7257543|FG002|Exposed|Overall Study||62
6349284|NCT00613951|7257541|FG000|COMPLETED|Overall Study||54
6349285|NCT00613951|7257542|FG001|COMPLETED|Overall Study||54
6349286|NCT00613951|7257543|FG002|COMPLETED|Overall Study||57
6349287|NCT00613951|7257541|FG000|NOT COMPLETED|Overall Study||7
6349288|NCT00613951|7257542|FG001|NOT COMPLETED|Overall Study||5
6349289|NCT00613951|7257543|FG002|NOT COMPLETED|Overall Study||5
6349290|NCT00614055|7257557|FG000|STARTED|Overall Study||59
6349291|NCT00614055|7257558|FG001|STARTED|Overall Study||59
6349292|NCT00614055|7257559|FG002|STARTED|Overall Study||60
6349293|NCT00614055|7257557|FG000|Exposed|Overall Study||59
6349294|NCT00614055|7257558|FG001|Exposed|Overall Study||59
6349295|NCT00614055|7257559|FG002|Exposed|Overall Study||60
6349296|NCT00614055|7257557|FG000|COMPLETED|Overall Study||55
6349297|NCT00614055|7257558|FG001|COMPLETED|Overall Study||53
6349298|NCT00614055|7257559|FG002|COMPLETED|Overall Study||55
6349299|NCT00614055|7257557|FG000|NOT COMPLETED|Overall Study||4
6349300|NCT00614055|7257558|FG001|NOT COMPLETED|Overall Study||6
6349301|NCT00614055|7257559|FG002|NOT COMPLETED|Overall Study||5
6349302|NCT00614120|7257574|FG000|STARTED|Overall Study|Randomised|231
6349303|NCT00614120|7257575|FG001|STARTED|Overall Study|Randomised|233
6349304|NCT00614120|7257576|FG002|STARTED|Overall Study|Randomised|234
6349305|NCT00614120|7257577|FG003|STARTED|Overall Study|Randomised|231
6349306|NCT00614120|7257574|FG000|Exposed to Study Drug|Overall Study||231
6349307|NCT00614120|7257575|FG001|Exposed to Study Drug|Overall Study||233
6349308|NCT00614120|7257576|FG002|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
6349309|NCT00614120|7257577|FG003|Exposed to Study Drug|Overall Study||231
6349310|NCT00614120|7257574|FG000|COMPLETED|Overall Study||202
6349311|NCT00614120|7257575|FG001|COMPLETED|Overall Study||187
6349312|NCT00614120|7257576|FG002|COMPLETED|Overall Study||175
6349313|NCT00614120|7257577|FG003|COMPLETED|Overall Study||215
6349314|NCT00614120|7257574|FG000|NOT COMPLETED|Overall Study||29
6349315|NCT00614120|7257575|FG001|NOT COMPLETED|Overall Study||46
6349316|NCT00614120|7257576|FG002|NOT COMPLETED|Overall Study||59
6349317|NCT00614120|7257577|FG003|NOT COMPLETED|Overall Study||16
6349318|NCT00614198|7257589|FG000|STARTED|Stage 1||38
6349319|NCT00614198|7257590|FG001|STARTED|Stage 1||34
6349320|NCT00614198|7257589|FG000|COMPLETED|Stage 1||26
6349321|NCT00614198|7257590|FG001|COMPLETED|Stage 1||29
6349322|NCT00614198|7257589|FG000|NOT COMPLETED|Stage 1||12
6349323|NCT00614198|7257590|FG001|NOT COMPLETED|Stage 1||5
6349324|NCT00614198|7257589|FG000|STARTED|Stage 2||26
6349325|NCT00614198|7257590|FG001|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
6349326|NCT00614198|7257589|FG000|COMPLETED|Stage 2||18
6349327|NCT00614198|7257590|FG001|COMPLETED|Stage 2||17
6349328|NCT00614198|7257589|FG000|NOT COMPLETED|Stage 2||8
6349329|NCT00614198|7257590|FG001|NOT COMPLETED|Stage 2||12
6349330|NCT00614315|7257596|FG000|STARTED|Overall Study||30
6349331|NCT00614315|7257596|FG000|COMPLETED|Overall Study||30
6349332|NCT00614315|7257596|FG000|NOT COMPLETED|Overall Study||0
6349333|NCT00614380|7257604|FG000|STARTED|Overall Study||564
6349334|NCT00614380|7257605|FG001|STARTED|Overall Study||206
6349335|NCT00614380|7257606|FG002|STARTED|Overall Study||25
6349336|NCT00614380|7257607|FG003|STARTED|Overall Study||181
6349337|NCT00614380|7257604|FG000|COMPLETED|Overall Study||529
6349338|NCT00614380|7257605|FG001|COMPLETED|Overall Study||198
6349339|NCT00614380|7257606|FG002|COMPLETED|Overall Study||24
6349340|NCT00614380|7257607|FG003|COMPLETED|Overall Study||179
6349341|NCT00614380|7257604|FG000|NOT COMPLETED|Overall Study||35
6349342|NCT00614380|7257605|FG001|NOT COMPLETED|Overall Study||8
6349343|NCT00614380|7257606|FG002|NOT COMPLETED|Overall Study||1
6349344|NCT00614380|7257607|FG003|NOT COMPLETED|Overall Study||2
6349345|NCT00614393|7257627|FG000|STARTED|Overall Study||180
6349346|NCT00614393|7257628|FG001|STARTED|Overall Study||8
6349347|NCT00614393|7257629|FG002|STARTED|Overall Study||10
6349348|NCT00614393|7257630|FG003|STARTED|Overall Study||180
6349349|NCT00614393|7257631|FG004|STARTED|Overall Study||180
6349350|NCT00614393|7257627|FG000|Treated|Overall Study||180
6349351|NCT00614393|7257628|FG001|Treated|Overall Study||8
6349352|NCT00614393|7257629|FG002|Treated|Overall Study||10
6349353|NCT00614393|7257630|FG003|Treated|Overall Study||180
6349354|NCT00614393|7257631|FG004|Treated|Overall Study||178
6349355|NCT00614393|7257627|FG000|COMPLETED|Overall Study||0
6349356|NCT00614393|7257628|FG001|COMPLETED|Overall Study||0
6349357|NCT00614393|7257629|FG002|COMPLETED|Overall Study||0
6349358|NCT00614393|7257630|FG003|COMPLETED|Overall Study||0
6349359|NCT00614393|7257631|FG004|COMPLETED|Overall Study||0
6349360|NCT00614393|7257627|FG000|NOT COMPLETED|Overall Study||180
6349361|NCT00614393|7257628|FG001|NOT COMPLETED|Overall Study||8
6349362|NCT00614393|7257629|FG002|NOT COMPLETED|Overall Study||10
6349363|NCT00614393|7257630|FG003|NOT COMPLETED|Overall Study||180
6349364|NCT00614393|7257631|FG004|NOT COMPLETED|Overall Study||180
6349365|NCT00614406|7257645|FG000|STARTED|Overall Study||7
6349366|NCT00614406|7257646|FG001|STARTED|Overall Study||4
6349367|NCT00614406|7257645|FG000|COMPLETED|Overall Study||7
6349368|NCT00614406|7257646|FG001|COMPLETED|Overall Study||4
6349369|NCT00614406|7257645|FG000|NOT COMPLETED|Overall Study||0
6349370|NCT00614406|7257646|FG001|NOT COMPLETED|Overall Study||0
6349371|NCT00614432|7257654|FG000|STARTED|Overall Study||4
6349372|NCT00614432|7257655|FG001|STARTED|Overall Study||6
6349373|NCT00614432|7257654|FG000|COMPLETED|Overall Study||4
6349374|NCT00614432|7257655|FG001|COMPLETED|Overall Study||6
6349375|NCT00614432|7257654|FG000|NOT COMPLETED|Overall Study||0
6349376|NCT00614432|7257655|FG001|NOT COMPLETED|Overall Study||0
6349377|NCT00614445|7257663|FG000|STARTED|Overall Study||140
6349378|NCT00614445|7257664|FG001|STARTED|Overall Study||140
6349379|NCT00614445|7257663|FG000|COMPLETED|Overall Study||112
6349380|NCT00614445|7257664|FG001|COMPLETED|Overall Study||91
6349381|NCT00614445|7257663|FG000|NOT COMPLETED|Overall Study||28
6349382|NCT00614445|7257664|FG001|NOT COMPLETED|Overall Study||49
6349383|NCT00614458|7257670|FG000|STARTED|Overall Study||6
6349384|NCT00614458|7257670|FG000|COMPLETED|Overall Study||6
6349385|NCT00614458|7257670|FG000|NOT COMPLETED|Overall Study||0
6349386|NCT00614484|7257674|FG000|STARTED|Overall Study||28
6349387|NCT00614484|7257674|FG000|COMPLETED|Overall Study||28
6349388|NCT00614484|7257674|FG000|NOT COMPLETED|Overall Study||0
6349389|NCT00614523|7257681|FG000|STARTED|Overall Study||83
6349390|NCT00614523|7257682|FG001|STARTED|Overall Study||167
6349391|NCT00614523|7257681|FG000|COMPLETED|Overall Study||20
6349392|NCT00614523|7257682|FG001|COMPLETED|Overall Study||36
6349393|NCT00614523|7257681|FG000|NOT COMPLETED|Overall Study||63
6349394|NCT00614523|7257682|FG001|NOT COMPLETED|Overall Study||131
6349395|NCT00614575|7257688|FG000|STARTED|Overall Study|The number of patients enrolled.|1089
6349396|NCT00614575|7257688|FG000|COMPLETED|Overall Study||861
6349397|NCT00614575|7257688|FG000|NOT COMPLETED|Overall Study||228
6349398|NCT00614614|7257694|FG000|STARTED|Primary Vaccination Phase||1272
6349399|NCT00614614|7257695|FG001|STARTED|Primary Vaccination Phase||282
6349400|NCT00614614|7257696|FG002|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6349401|NCT00614614|7257697|FG003|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6349402|NCT00614614|7257698|FG004|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6349403|NCT00614614|7257694|FG000|COMPLETED|Primary Vaccination Phase||1182
6349404|NCT00614614|7257695|FG001|COMPLETED|Primary Vaccination Phase||265
6349405|NCT00614614|7257696|FG002|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6349406|NCT00614614|7257697|FG003|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6349407|NCT00614614|7257698|FG004|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
6349408|NCT00614614|7257694|FG000|NOT COMPLETED|Primary Vaccination Phase||90
6349409|NCT00614614|7257695|FG001|NOT COMPLETED|Primary Vaccination Phase||17
6349410|NCT00614614|7257696|FG002|NOT COMPLETED|Primary Vaccination Phase||0
6349411|NCT00614614|7257697|FG003|NOT COMPLETED|Primary Vaccination Phase||0
6349412|NCT00614614|7257698|FG004|NOT COMPLETED|Primary Vaccination Phase||0
6349413|NCT00614614|7257694|FG000|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
6349414|NCT00614614|7257695|FG001|STARTED|Booster Vaccination Phase||233
6349415|NCT00614614|7257696|FG002|STARTED|Booster Vaccination Phase||432
6349416|NCT00614614|7257697|FG003|STARTED|Booster Vaccination Phase||229
6349417|NCT00614614|7257698|FG004|STARTED|Booster Vaccination Phase||409
6349418|NCT00614614|7257694|FG000|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
6349419|NCT00614614|7257695|FG001|COMPLETED|Booster Vaccination Phase||227
6349420|NCT00614614|7257696|FG002|COMPLETED|Booster Vaccination Phase||405
6349421|NCT00614614|7257697|FG003|COMPLETED|Booster Vaccination Phase||210
6349422|NCT00614614|7257698|FG004|COMPLETED|Booster Vaccination Phase||396
6349423|NCT00614614|7257694|FG000|NOT COMPLETED|Booster Vaccination Phase||0
6349424|NCT00614614|7257695|FG001|NOT COMPLETED|Booster Vaccination Phase||6
6349425|NCT00614614|7257696|FG002|NOT COMPLETED|Booster Vaccination Phase||27
6349426|NCT00614614|7257697|FG003|NOT COMPLETED|Booster Vaccination Phase||19
6349427|NCT00614614|7257698|FG004|NOT COMPLETED|Booster Vaccination Phase||13
6349428|NCT00614744|7257715|FG000|STARTED|Overall Study||83
6349429|NCT00614744|7257716|FG001|STARTED|Overall Study||85
6349430|NCT00614744|7257715|FG000|COMPLETED|Overall Study||78
6349431|NCT00614744|7257716|FG001|COMPLETED|Overall Study||79
6349432|NCT00614744|7257715|FG000|NOT COMPLETED|Overall Study||5
6349433|NCT00614744|7257716|FG001|NOT COMPLETED|Overall Study||6
6349434|NCT00614822|7257722|FG000|STARTED|Overall Study||50
6349435|NCT00614822|7257722|FG000|COMPLETED|Overall Study||47
6349436|NCT00614822|7257722|FG000|NOT COMPLETED|Overall Study||3
6349437|NCT00614874|7257727|FG000|STARTED|Overall Study||16
6349438|NCT00614874|7257727|FG000|COMPLETED|Overall Study||14
6349439|NCT00614874|7257727|FG000|NOT COMPLETED|Overall Study||2
6349440|NCT00614913|7257731|FG000|STARTED|Overall Study||76
6349441|NCT00614913|7257731|FG000|COMPLETED|Overall Study||76
6349442|NCT00614913|7257731|FG000|NOT COMPLETED|Overall Study||0
6349443|NCT00614926|7257737|FG000|STARTED|Overall Study||25
6349444|NCT00614926|7257738|FG001|STARTED|Overall Study||7
6349445|NCT00614926|7257737|FG000|COMPLETED|Overall Study||21
6349446|NCT00614926|7257738|FG001|COMPLETED|Overall Study||7
6349447|NCT00614926|7257737|FG000|NOT COMPLETED|Overall Study||4
6349448|NCT00614926|7257738|FG001|NOT COMPLETED|Overall Study||0
6349449|NCT00614939|7257746|FG000|STARTED|Overall Study|Randomized and treated|85
6349450|NCT00614939|7257747|FG001|STARTED|Overall Study|Randomized and treated|85
6349451|NCT00614939|7257746|FG000|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
6349452|NCT00614939|7257747|FG001|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
6349453|NCT00614939|7257746|FG000|NOT COMPLETED|Overall Study||35
6349454|NCT00614939|7257747|FG001|NOT COMPLETED|Overall Study||43
6349455|NCT00614991|7257759|FG000|STARTED|Overall Study||8
6349456|NCT00614991|7257760|FG001|STARTED|Overall Study||9
6349457|NCT00614991|7257761|FG002|STARTED|Overall Study||7
6349458|NCT00614991|7257762|FG003|STARTED|Overall Study||7
6349459|NCT00614991|7257763|FG004|STARTED|Overall Study||7
6349460|NCT00614991|7257764|FG005|STARTED|Overall Study||6
6349461|NCT00614991|7257759|FG000|COMPLETED|Overall Study||5
6349462|NCT00614991|7257760|FG001|COMPLETED|Overall Study||6
6349463|NCT00614991|7257761|FG002|COMPLETED|Overall Study||7
6349464|NCT00614991|7257762|FG003|COMPLETED|Overall Study||7
6349465|NCT00614991|7257763|FG004|COMPLETED|Overall Study||6
6349466|NCT00614991|7257764|FG005|COMPLETED|Overall Study||6
6349467|NCT00614991|7257759|FG000|NOT COMPLETED|Overall Study||3
6349468|NCT00614991|7257760|FG001|NOT COMPLETED|Overall Study||3
6349469|NCT00614991|7257761|FG002|NOT COMPLETED|Overall Study||0
6349470|NCT00614991|7257762|FG003|NOT COMPLETED|Overall Study||0
6349471|NCT00614991|7257763|FG004|NOT COMPLETED|Overall Study||1
6349472|NCT00614991|7257764|FG005|NOT COMPLETED|Overall Study||0
6349473|NCT00615017|7257789|FG000|STARTED|Overall Study|Patients received treatment|8
6349474|NCT00615017|7257790|FG001|STARTED|Overall Study|Patients received treatment|9
6349475|NCT00615017|7257791|FG002|STARTED|Overall Study|Patients received treatment|12
6349476|NCT00615017|7257792|FG003|STARTED|Overall Study|Patients received treatment|10
6349477|NCT00615017|7257793|FG004|STARTED|Overall Study|Patients received treatment|8
6349478|NCT00615017|7257794|FG005|STARTED|Overall Study|Patients received treatment|23
6349479|NCT00615017|7257789|FG000|COMPLETED|Overall Study|Patient completed the study drug|8
6349480|NCT00615017|7257790|FG001|COMPLETED|Overall Study|Patient completed the study drug|8
6349481|NCT00615017|7257791|FG002|COMPLETED|Overall Study|Patient completed the study drug|7
6349482|NCT00615017|7257792|FG003|COMPLETED|Overall Study|Patient completed the study drug|9
6349483|NCT00615017|7257793|FG004|COMPLETED|Overall Study|Patient completed the study drug|7
6349484|NCT00615017|7257794|FG005|COMPLETED|Overall Study|Patient completed the study drug|20
6349485|NCT00615017|7257789|FG000|NOT COMPLETED|Overall Study||0
6349486|NCT00615017|7257790|FG001|NOT COMPLETED|Overall Study||1
6349487|NCT00615017|7257791|FG002|NOT COMPLETED|Overall Study||5
6349488|NCT00615017|7257792|FG003|NOT COMPLETED|Overall Study||1
6349489|NCT00615017|7257793|FG004|NOT COMPLETED|Overall Study||1
6349490|NCT00615017|7257794|FG005|NOT COMPLETED|Overall Study||3
6349491|NCT00615030|7257808|FG000|STARTED|Period I||9
6349492|NCT00615030|7257809|FG001|STARTED|Period I||8
6349493|NCT00615030|7257810|FG002|STARTED|Period I||9
6349494|NCT00615030|7257811|FG003|STARTED|Period I||8
6349495|NCT00615030|7257812|FG004|STARTED|Period I||9
6349496|NCT00615030|7257813|FG005|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
6349497|NCT00615030|7257814|FG006|STARTED|Period I||7
6349498|NCT00615030|7257815|FG007|STARTED|Period I||7
6349499|NCT00615030|7257816|FG008|STARTED|Period I||9
6349500|NCT00615030|7257817|FG009|STARTED|Period I||8
6349501|NCT00615030|7257818|FG010|STARTED|Period I||8
6349502|NCT00615030|7257819|FG011|STARTED|Period I||7
6349503|NCT00615030|7257808|FG000|COMPLETED|Period I||8
6349504|NCT00615030|7257809|FG001|COMPLETED|Period I||8
6349505|NCT00615030|7257810|FG002|COMPLETED|Period I||9
6349506|NCT00615030|7257811|FG003|COMPLETED|Period I||8
6349507|NCT00615030|7257812|FG004|COMPLETED|Period I||8
6349508|NCT00615030|7257813|FG005|COMPLETED|Period I||5
6349509|NCT00615030|7257814|FG006|COMPLETED|Period I||7
6349510|NCT00615030|7257815|FG007|COMPLETED|Period I||7
6349511|NCT00615030|7257816|FG008|COMPLETED|Period I||8
6349512|NCT00615030|7257817|FG009|COMPLETED|Period I||8
6349513|NCT00615030|7257818|FG010|COMPLETED|Period I||7
6349514|NCT00615030|7257819|FG011|COMPLETED|Period I||6
6349515|NCT00615030|7257808|FG000|NOT COMPLETED|Period I||1
6349516|NCT00615030|7257809|FG001|NOT COMPLETED|Period I||0
6349517|NCT00615030|7257810|FG002|NOT COMPLETED|Period I||0
6349518|NCT00615030|7257811|FG003|NOT COMPLETED|Period I||0
6349519|NCT00615030|7257812|FG004|NOT COMPLETED|Period I||1
6349520|NCT00615030|7257813|FG005|NOT COMPLETED|Period I||1
6349521|NCT00615030|7257814|FG006|NOT COMPLETED|Period I||0
6349522|NCT00615030|7257815|FG007|NOT COMPLETED|Period I||0
6349523|NCT00615030|7257816|FG008|NOT COMPLETED|Period I||1
6349524|NCT00615030|7257817|FG009|NOT COMPLETED|Period I||0
6349525|NCT00615030|7257818|FG010|NOT COMPLETED|Period I||1
6349526|NCT00615030|7257819|FG011|NOT COMPLETED|Period I||1
6349527|NCT00615030|7257808|FG000|STARTED|Period II||8
6349528|NCT00615030|7257809|FG001|STARTED|Period II||8
6349529|NCT00615030|7257810|FG002|STARTED|Period II||9
6349530|NCT00615030|7257811|FG003|STARTED|Period II||8
6349531|NCT00615030|7257812|FG004|STARTED|Period II||8
6349532|NCT00615030|7257813|FG005|STARTED|Period II||5
6349533|NCT00615030|7257814|FG006|STARTED|Period II||7
6349534|NCT00615030|7257815|FG007|STARTED|Period II||7
6349535|NCT00615030|7257816|FG008|STARTED|Period II||8
6349536|NCT00615030|7257817|FG009|STARTED|Period II||8
6349537|NCT00615030|7257818|FG010|STARTED|Period II||7
6349538|NCT00615030|7257819|FG011|STARTED|Period II||6
6349539|NCT00615030|7257808|FG000|COMPLETED|Period II||8
6349540|NCT00615030|7257809|FG001|COMPLETED|Period II||8
6349541|NCT00615030|7257810|FG002|COMPLETED|Period II||8
6349542|NCT00615030|7257811|FG003|COMPLETED|Period II||7
6349543|NCT00615030|7257812|FG004|COMPLETED|Period II||8
6349544|NCT00615030|7257813|FG005|COMPLETED|Period II||5
6349545|NCT00615030|7257814|FG006|COMPLETED|Period II||6
6349546|NCT00615030|7257815|FG007|COMPLETED|Period II||7
6349547|NCT00615030|7257816|FG008|COMPLETED|Period II||7
6349548|NCT00615030|7257817|FG009|COMPLETED|Period II||8
6349549|NCT00615030|7257818|FG010|COMPLETED|Period II||7
6349550|NCT00615030|7257819|FG011|COMPLETED|Period II||6
6349551|NCT00615030|7257808|FG000|NOT COMPLETED|Period II||0
6349552|NCT00615030|7257809|FG001|NOT COMPLETED|Period II||0
6349553|NCT00615030|7257810|FG002|NOT COMPLETED|Period II||1
6349554|NCT00615030|7257811|FG003|NOT COMPLETED|Period II||1
6349555|NCT00615030|7257812|FG004|NOT COMPLETED|Period II||0
6349556|NCT00615030|7257813|FG005|NOT COMPLETED|Period II||0
6349557|NCT00615030|7257814|FG006|NOT COMPLETED|Period II||1
6349558|NCT00615030|7257815|FG007|NOT COMPLETED|Period II||0
6349559|NCT00615030|7257816|FG008|NOT COMPLETED|Period II||1
6349560|NCT00615030|7257817|FG009|NOT COMPLETED|Period II||0
6349561|NCT00615030|7257818|FG010|NOT COMPLETED|Period II||0
6349562|NCT00615030|7257819|FG011|NOT COMPLETED|Period II||0
6349563|NCT00615030|7257808|FG000|STARTED|Period III||8
6349564|NCT00615030|7257809|FG001|STARTED|Period III||8
6349565|NCT00615030|7257810|FG002|STARTED|Period III||8
6349566|NCT00615030|7257811|FG003|STARTED|Period III||7
6349567|NCT00615030|7257812|FG004|STARTED|Period III||8
6349568|NCT00615030|7257813|FG005|STARTED|Period III||5
6349569|NCT00615030|7257814|FG006|STARTED|Period III||6
6349570|NCT00615030|7257815|FG007|STARTED|Period III||7
6349571|NCT00615030|7257816|FG008|STARTED|Period III||7
6349572|NCT00615030|7257817|FG009|STARTED|Period III||8
6349573|NCT00615030|7257818|FG010|STARTED|Period III||7
6349574|NCT00615030|7257819|FG011|STARTED|Period III||6
6349575|NCT00615030|7257808|FG000|COMPLETED|Period III||7
6349576|NCT00615030|7257809|FG001|COMPLETED|Period III||8
6349577|NCT00615030|7257810|FG002|COMPLETED|Period III||8
6349578|NCT00615030|7257811|FG003|COMPLETED|Period III||6
6349579|NCT00615030|7257812|FG004|COMPLETED|Period III||8
6349580|NCT00615030|7257813|FG005|COMPLETED|Period III||5
6349581|NCT00615030|7257814|FG006|COMPLETED|Period III||6
6349582|NCT00615030|7257815|FG007|COMPLETED|Period III||7
6349583|NCT00615030|7257816|FG008|COMPLETED|Period III||7
6349584|NCT00615030|7257817|FG009|COMPLETED|Period III||8
6349585|NCT00615030|7257818|FG010|COMPLETED|Period III||7
6349586|NCT00615030|7257819|FG011|COMPLETED|Period III||6
6349587|NCT00615030|7257808|FG000|NOT COMPLETED|Period III||1
6349588|NCT00615030|7257809|FG001|NOT COMPLETED|Period III||0
6349589|NCT00615030|7257810|FG002|NOT COMPLETED|Period III||0
6349590|NCT00615030|7257811|FG003|NOT COMPLETED|Period III||1
6349591|NCT00615030|7257812|FG004|NOT COMPLETED|Period III||0
6349592|NCT00615030|7257813|FG005|NOT COMPLETED|Period III||0
6559617|NCT01782495|7482279|FG003|NOT COMPLETED|Overall Study||0
6559618|NCT01782495|7482280|FG004|NOT COMPLETED|Overall Study||0
6559619|NCT01782495|7482281|FG005|NOT COMPLETED|Overall Study||0
6559620|NCT01782495|7482282|FG006|NOT COMPLETED|Overall Study||0
6559621|NCT01782495|7482283|FG007|NOT COMPLETED|Overall Study||3
6559622|NCT01782495|7482284|FG008|NOT COMPLETED|Overall Study||0
6349593|NCT00615030|7257814|FG006|NOT COMPLETED|Period III||0
6349594|NCT00615030|7257815|FG007|NOT COMPLETED|Period III||0
6349595|NCT00615030|7257816|FG008|NOT COMPLETED|Period III||0
6349596|NCT00615030|7257817|FG009|NOT COMPLETED|Period III||0
6349597|NCT00615030|7257818|FG010|NOT COMPLETED|Period III||0
6349598|NCT00615030|7257819|FG011|NOT COMPLETED|Period III||0
6349599|NCT00615056|7257837|FG000|STARTED|Overall Study||49
6349600|NCT00615056|7257838|FG001|STARTED|Overall Study||51
6349601|NCT00615056|7257839|FG002|STARTED|Overall Study||36
6349602|NCT00615056|7257840|FG003|STARTED|Overall Study||35
6349603|NCT00615056|7257837|FG000|Treated|Overall Study||46
6349604|NCT00615056|7257838|FG001|Treated|Overall Study||51
6349605|NCT00615056|7257839|FG002|Treated|Overall Study||36
6559623|NCT01782495|7482285|FG009|NOT COMPLETED|Overall Study||0
6559624|NCT01782495|7482286|FG010|NOT COMPLETED|Overall Study||0
6349606|NCT00615056|7257840|FG003|Treated|Overall Study||35
6349607|NCT00615056|7257837|FG000|COMPLETED|Overall Study||0
6349608|NCT00615056|7257838|FG001|COMPLETED|Overall Study||0
6349609|NCT00615056|7257839|FG002|COMPLETED|Overall Study||0
6349610|NCT00615056|7257840|FG003|COMPLETED|Overall Study||0
6349611|NCT00615056|7257837|FG000|NOT COMPLETED|Overall Study||49
6349612|NCT00615056|7257838|FG001|NOT COMPLETED|Overall Study||51
6349613|NCT00615056|7257839|FG002|NOT COMPLETED|Overall Study||36
6349614|NCT00615056|7257840|FG003|NOT COMPLETED|Overall Study||35
6349615|NCT00615069|7257850|FG000|STARTED|Overall Study||35
6349616|NCT00615069|7257850|FG000|COMPLETED|Overall Study||19
6349617|NCT00615069|7257850|FG000|NOT COMPLETED|Overall Study||16
6349618|NCT00615108|7257854|FG000|STARTED|Overall Study||3148
6349619|NCT00615108|7257854|FG000|COMPLETED|Overall Study||2641
6349620|NCT00615108|7257854|FG000|NOT COMPLETED|Overall Study||507
6349621|NCT00615199|7257864|FG000|STARTED|Overall Study||34
6349622|NCT00615199|7257865|FG001|STARTED|Overall Study||36
6349623|NCT00615199|7257866|FG002|STARTED|Overall Study||34
6349624|NCT00615199|7257867|FG003|STARTED|Overall Study||35
6349625|NCT00615199|7257864|FG000|COMPLETED|Overall Study||26
6349626|NCT00615199|7257865|FG001|COMPLETED|Overall Study||34
6349627|NCT00615199|7257866|FG002|COMPLETED|Overall Study||33
6349628|NCT00615199|7257867|FG003|COMPLETED|Overall Study||33
6349629|NCT00615199|7257864|FG000|NOT COMPLETED|Overall Study||8
6349630|NCT00615199|7257865|FG001|NOT COMPLETED|Overall Study||2
6349631|NCT00615199|7257866|FG002|NOT COMPLETED|Overall Study||1
6349632|NCT00615199|7257867|FG003|NOT COMPLETED|Overall Study||2
6349633|NCT00615264|7257879|FG000|STARTED|Overall Study||225
6349634|NCT00615264|7257880|FG001|STARTED|Overall Study||232
6349635|NCT00615264|7257879|FG000|Received at Least One Dose (ITT)|Overall Study||225
6349636|NCT00615264|7257880|FG001|Received at Least One Dose (ITT)|Overall Study||231
6349637|NCT00615264|7257879|FG000|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
6349638|NCT00615264|7257880|FG001|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
6349639|NCT00615264|7257879|FG000|COMPLETED|Overall Study||175
6349640|NCT00615264|7257880|FG001|COMPLETED|Overall Study||180
6349641|NCT00615264|7257879|FG000|NOT COMPLETED|Overall Study||50
6349642|NCT00615264|7257880|FG001|NOT COMPLETED|Overall Study||52
6349643|NCT00615290|7257886|FG000|STARTED|Overall Study||42
6349644|NCT00615290|7257886|FG000|COMPLETED|Overall Study||34
6349645|NCT00615290|7257886|FG000|NOT COMPLETED|Overall Study||8
6349646|NCT00615420|7257892|FG000|STARTED|Overall Study||54
6349647|NCT00615420|7257893|FG001|STARTED|Overall Study||52
6349648|NCT00615420|7257892|FG000|COMPLETED|Overall Study||23
6349649|NCT00615420|7257893|FG001|COMPLETED|Overall Study||25
6349650|NCT00615420|7257892|FG000|NOT COMPLETED|Overall Study||31
6349651|NCT00615420|7257893|FG001|NOT COMPLETED|Overall Study||27
6349652|NCT00615433|7257903|FG000|STARTED|Overall Study||120
6349653|NCT00615433|7257904|FG001|STARTED|Overall Study||119
6349654|NCT00615433|7257905|FG002|STARTED|Overall Study||123
6349655|NCT00615433|7257906|FG003|STARTED|Overall Study||116
6349656|NCT00615433|7257903|FG000|COMPLETED|Overall Study||77
6349657|NCT00615433|7257904|FG001|COMPLETED|Overall Study||66
6349658|NCT00615433|7257905|FG002|COMPLETED|Overall Study||84
6349659|NCT00615433|7257906|FG003|COMPLETED|Overall Study||71
6349660|NCT00615433|7257903|FG000|NOT COMPLETED|Overall Study||43
6349661|NCT00615433|7257904|FG001|NOT COMPLETED|Overall Study||53
6349662|NCT00615433|7257905|FG002|NOT COMPLETED|Overall Study||39
6349663|NCT00615433|7257906|FG003|NOT COMPLETED|Overall Study||45
6349664|NCT00615459|7257917|FG000|STARTED|Period I||41
6349665|NCT00615459|7257918|FG001|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
6349666|NCT00615459|7257919|FG002|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
6349667|NCT00615459|7257920|FG003|STARTED|Period I||43
6349668|NCT00615459|7257917|FG000|COMPLETED|Period I||37
6349669|NCT00615459|7257918|FG001|COMPLETED|Period I||40
6349670|NCT00615459|7257919|FG002|COMPLETED|Period I||40
6349671|NCT00615459|7257920|FG003|COMPLETED|Period I||42
6349672|NCT00615459|7257917|FG000|NOT COMPLETED|Period I||4
6349673|NCT00615459|7257918|FG001|NOT COMPLETED|Period I||1
6349674|NCT00615459|7257919|FG002|NOT COMPLETED|Period I||2
6349675|NCT00615459|7257920|FG003|NOT COMPLETED|Period I||1
6349676|NCT00615459|7257917|FG000|STARTED|Period II||37
6349677|NCT00615459|7257918|FG001|STARTED|Period II||40
6349678|NCT00615459|7257919|FG002|STARTED|Period II||40
6349679|NCT00615459|7257920|FG003|STARTED|Period II||42
6349680|NCT00615459|7257917|FG000|COMPLETED|Period II||36
6349681|NCT00615459|7257918|FG001|COMPLETED|Period II||40
6349682|NCT00615459|7257919|FG002|COMPLETED|Period II||40
6349683|NCT00615459|7257920|FG003|COMPLETED|Period II||41
6349684|NCT00615459|7257917|FG000|NOT COMPLETED|Period II||1
6349685|NCT00615459|7257918|FG001|NOT COMPLETED|Period II||0
6349686|NCT00615459|7257919|FG002|NOT COMPLETED|Period II||0
6349687|NCT00615459|7257920|FG003|NOT COMPLETED|Period II||1
6349688|NCT00615459|7257917|FG000|STARTED|Period III||36
6349689|NCT00615459|7257918|FG001|STARTED|Period III||40
6349690|NCT00615459|7257919|FG002|STARTED|Period III||40
6349691|NCT00615459|7257920|FG003|STARTED|Period III||41
6349692|NCT00615459|7257917|FG000|COMPLETED|Period III||36
6349693|NCT00615459|7257918|FG001|COMPLETED|Period III||37
6349694|NCT00615459|7257919|FG002|COMPLETED|Period III||39
6349695|NCT00615459|7257920|FG003|COMPLETED|Period III||41
6349696|NCT00615459|7257917|FG000|NOT COMPLETED|Period III||0
6349697|NCT00615459|7257918|FG001|NOT COMPLETED|Period III||3
6349698|NCT00615459|7257919|FG002|NOT COMPLETED|Period III||1
6349699|NCT00615459|7257920|FG003|NOT COMPLETED|Period III||0
6349700|NCT00615472|7257932|FG000|STARTED|Overall Study||30
6349701|NCT00615472|7257933|FG001|STARTED|Overall Study||28
6349702|NCT00615472|7257932|FG000|COMPLETED|Overall Study||30
6349703|NCT00615472|7257933|FG001|COMPLETED|Overall Study||28
6349704|NCT00615472|7257932|FG000|NOT COMPLETED|Overall Study||0
6349705|NCT00615472|7257933|FG001|NOT COMPLETED|Overall Study||0
6349706|NCT00615550|7257941|FG000|STARTED|Overall Study||229
6349707|NCT00615550|7257942|FG001|STARTED|Overall Study||236
6349708|NCT00615550|7257941|FG000|COMPLETED|Overall Study||223
6349709|NCT00615550|7257942|FG001|COMPLETED|Overall Study||235
6349710|NCT00615550|7257941|FG000|NOT COMPLETED|Overall Study||6
6349711|NCT00615550|7257942|FG001|NOT COMPLETED|Overall Study||1
6349712|NCT00615589|7257948|FG000|STARTED|Overall Study||22
6349713|NCT00615589|7257948|FG000|COMPLETED|Overall Study||22
6349714|NCT00615589|7257948|FG000|NOT COMPLETED|Overall Study||0
6349715|NCT00615719|7257953|FG000|STARTED|Overall Study||35
6349716|NCT00615719|7257953|FG000|COMPLETED|Overall Study||30
6349717|NCT00615719|7257953|FG000|NOT COMPLETED|Overall Study||5
6349718|NCT00615784|7257957|FG000|STARTED|Overall Study||24
6349719|NCT00615784|7257957|FG000|COMPLETED|Overall Study||24
6349720|NCT00615784|7257957|FG000|NOT COMPLETED|Overall Study||0
6349721|NCT00615836|7257965|FG000|STARTED|Part I of Core Study (FE992026 CS29)||163
6349722|NCT00615836|7257966|FG001|STARTED|Part I of Core Study (FE992026 CS29)||158
6349723|NCT00615836|7257967|FG002|STARTED|Part I of Core Study (FE992026 CS29)||158
6349724|NCT00615836|7257968|FG003|STARTED|Part I of Core Study (FE992026 CS29)||160
6349725|NCT00615836|7257969|FG004|STARTED|Part I of Core Study (FE992026 CS29)||160
6349726|NCT00615836|7257965|FG000|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
6349727|NCT00615836|7257966|FG001|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
6349728|NCT00615836|7257967|FG002|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
6349729|NCT00615836|7257968|FG003|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
6349730|NCT00615836|7257969|FG004|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
6349731|NCT00615836|7257965|FG000|COMPLETED|Part I of Core Study (FE992026 CS29)||144
6349732|NCT00615836|7257966|FG001|COMPLETED|Part I of Core Study (FE992026 CS29)||148
6349733|NCT00615836|7257967|FG002|COMPLETED|Part I of Core Study (FE992026 CS29)||138
6349734|NCT00615836|7257968|FG003|COMPLETED|Part I of Core Study (FE992026 CS29)||135
6349735|NCT00615836|7257969|FG004|COMPLETED|Part I of Core Study (FE992026 CS29)||145
6349736|NCT00615836|7257965|FG000|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
6349737|NCT00615836|7257966|FG001|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
6349738|NCT00615836|7257967|FG002|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
6349739|NCT00615836|7257968|FG003|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
6349740|NCT00615836|7257969|FG004|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
6349741|NCT00615836|7257965|FG000|STARTED|Extension Study (FE992026 CS31)||141
6349742|NCT00615836|7257966|FG001|STARTED|Extension Study (FE992026 CS31)||144
6349743|NCT00615836|7257967|FG002|STARTED|Extension Study (FE992026 CS31)||132
6349744|NCT00615836|7257968|FG003|STARTED|Extension Study (FE992026 CS31)||137
6349745|NCT00615836|7257969|FG004|STARTED|Extension Study (FE992026 CS31)||0
6349746|NCT00615836|7257965|FG000|COMPLETED|Extension Study (FE992026 CS31)||0
6349747|NCT00615836|7257966|FG001|COMPLETED|Extension Study (FE992026 CS31)||58
6349748|NCT00615836|7257967|FG002|COMPLETED|Extension Study (FE992026 CS31)||59
6349749|NCT00615836|7257968|FG003|COMPLETED|Extension Study (FE992026 CS31)||53
6349750|NCT00615836|7257969|FG004|COMPLETED|Extension Study (FE992026 CS31)||0
6349751|NCT00615836|7257965|FG000|NOT COMPLETED|Extension Study (FE992026 CS31)||141
6349752|NCT00615836|7257966|FG001|NOT COMPLETED|Extension Study (FE992026 CS31)||86
6349753|NCT00615836|7257967|FG002|NOT COMPLETED|Extension Study (FE992026 CS31)||73
6349754|NCT00615836|7257968|FG003|NOT COMPLETED|Extension Study (FE992026 CS31)||84
6349755|NCT00615836|7257969|FG004|NOT COMPLETED|Extension Study (FE992026 CS31)||0
6349756|NCT00615901|7257985|FG000|STARTED|Overall Study||38
6349757|NCT00615901|7257985|FG000|COMPLETED|Overall Study||29
6349758|NCT00615901|7257985|FG000|NOT COMPLETED|Overall Study||9
6349759|NCT00615914|7257989|FG000|STARTED|Overall Study|The number of patients enrolled|1645
6349760|NCT00615914|7257989|FG000|COMPLETED|Overall Study||1008
6349761|NCT00615914|7257989|FG000|NOT COMPLETED|Overall Study||637
6349762|NCT00615927|7257996|FG000|STARTED|Overall Study||32
6349763|NCT00615927|7257997|FG001|STARTED|Overall Study||32
6349764|NCT00615927|7257996|FG000|COMPLETED|Overall Study||32
6349765|NCT00615927|7257997|FG001|COMPLETED|Overall Study||32
6349766|NCT00615927|7257996|FG000|NOT COMPLETED|Overall Study||0
6349767|NCT00615927|7257997|FG001|NOT COMPLETED|Overall Study||0
6349768|NCT00615992|7258003|FG000|STARTED|Overall Study||754
6349769|NCT00615992|7258003|FG000|COMPLETED|Overall Study||687
6349770|NCT00615992|7258003|FG000|NOT COMPLETED|Overall Study||67
6349771|NCT00616018|7258007|FG000|STARTED|Overall Study||27
6349772|NCT00616018|7258007|FG000|COMPLETED|Overall Study||24
6349773|NCT00616018|7258007|FG000|NOT COMPLETED|Overall Study||3
6349774|NCT00616109|7258012|FG000|STARTED|Overall Study||16
6349775|NCT00616109|7258012|FG000|COMPLETED|Overall Study||16
6349776|NCT00616109|7258012|FG000|NOT COMPLETED|Overall Study||0
6349777|NCT00616122|7258017|FG000|STARTED|Overall Study||4
6349778|NCT00616122|7258018|FG001|STARTED|Overall Study||7
6349779|NCT00616122|7258019|FG002|STARTED|Overall Study||10
6349780|NCT00616122|7258020|FG003|STARTED|Overall Study||11
6349781|NCT00616122|7258017|FG000|COMPLETED|Overall Study||4
6349782|NCT00616122|7258018|FG001|COMPLETED|Overall Study||7
6349783|NCT00616122|7258019|FG002|COMPLETED|Overall Study||10
6349784|NCT00616122|7258020|FG003|COMPLETED|Overall Study||0
6349785|NCT00616122|7258017|FG000|NOT COMPLETED|Overall Study||0
6349786|NCT00616122|7258018|FG001|NOT COMPLETED|Overall Study||0
6349787|NCT00616122|7258019|FG002|NOT COMPLETED|Overall Study||0
6349788|NCT00616122|7258020|FG003|NOT COMPLETED|Overall Study||11
6349789|NCT00616200|7258027|FG000|STARTED|Two Week Standard Diet||17
6349790|NCT00616200|7258027|FG000|COMPLETED|Two Week Standard Diet||16
6349791|NCT00616200|7258027|FG000|NOT COMPLETED|Two Week Standard Diet||1
6349792|NCT00616200|7258027|FG000|STARTED|Four Week Very Low Carbohydrate Diet||16
6349793|NCT00616200|7258027|FG000|COMPLETED|Four Week Very Low Carbohydrate Diet||13
6349794|NCT00616200|7258027|FG000|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
6349795|NCT00616239|7258031|FG000|STARTED|Overall Study||20
6349796|NCT00616239|7258031|FG000|COMPLETED|Overall Study||18
6349797|NCT00616239|7258031|FG000|NOT COMPLETED|Overall Study||2
6349798|NCT00616421|7258038|FG000|STARTED|Overall Study||359
6349799|NCT00616421|7258039|FG001|STARTED|Overall Study||1278
6349800|NCT00616421|7258040|FG002|STARTED|Overall Study||1270
6349801|NCT00616421|7258038|FG000|COMPLETED|Overall Study||333
6349802|NCT00616421|7258039|FG001|COMPLETED|Overall Study||1240
6349803|NCT00616421|7258040|FG002|COMPLETED|Overall Study||1229
6349804|NCT00616421|7258038|FG000|NOT COMPLETED|Overall Study||26
6349805|NCT00616421|7258039|FG001|NOT COMPLETED|Overall Study||38
6349806|NCT00616421|7258040|FG002|NOT COMPLETED|Overall Study||41
6349807|NCT00616434|7258064|FG000|STARTED|Overall Study||62
6349808|NCT00616434|7258065|FG001|STARTED|Overall Study||61
6349809|NCT00616434|7258064|FG000|COMPLETED|Overall Study||56
6349810|NCT00616434|7258065|FG001|COMPLETED|Overall Study||53
6349811|NCT00616434|7258064|FG000|NOT COMPLETED|Overall Study||6
6349812|NCT00616434|7258065|FG001|NOT COMPLETED|Overall Study||8
6349813|NCT00616629|7258076|FG000|STARTED|Overall Study|Two patients never received study drug|13
6349814|NCT00616629|7258077|FG001|STARTED|Overall Study|Two patients never received study drug|14
6349815|NCT00616629|7258078|FG002|STARTED|Overall Study|One patient never received study drug|14
6349816|NCT00616629|7258079|FG003|STARTED|Overall Study||2
6349817|NCT00616629|7258080|FG004|STARTED|Overall Study||12
6349818|NCT00616629|7258076|FG000|COMPLETED|Overall Study||11
6349819|NCT00616629|7258077|FG001|COMPLETED|Overall Study||12
6349820|NCT00616629|7258078|FG002|COMPLETED|Overall Study||13
6349821|NCT00616629|7258079|FG003|COMPLETED|Overall Study||2
6349822|NCT00616629|7258080|FG004|COMPLETED|Overall Study||12
6349823|NCT00616629|7258076|FG000|NOT COMPLETED|Overall Study||2
6349824|NCT00616629|7258077|FG001|NOT COMPLETED|Overall Study||2
6349825|NCT00616629|7258078|FG002|NOT COMPLETED|Overall Study||1
6349826|NCT00616629|7258079|FG003|NOT COMPLETED|Overall Study||0
6349827|NCT00616629|7258080|FG004|NOT COMPLETED|Overall Study||0
6349828|NCT00616655|7258095|FG000|STARTED|Overall Study||152
6349829|NCT00616655|7258096|FG001|STARTED|Overall Study||153
6349830|NCT00616655|7258097|FG002|STARTED|Overall Study||151
6349831|NCT00616655|7258095|FG000|COMPLETED|Overall Study||117
6349832|NCT00616655|7258096|FG001|COMPLETED|Overall Study||112
6349833|NCT00616655|7258097|FG002|COMPLETED|Overall Study||103
6349834|NCT00616655|7258095|FG000|NOT COMPLETED|Overall Study||35
6349835|NCT00616655|7258096|FG001|NOT COMPLETED|Overall Study||41
6349836|NCT00616655|7258097|FG002|NOT COMPLETED|Overall Study||48
6349837|NCT00616772|7258107|FG000|STARTED|Overall Study||340
6349838|NCT00616772|7258108|FG001|STARTED|Overall Study||342
6349839|NCT00616772|7258107|FG000|Treated|Overall Study||337
6349840|NCT00616772|7258108|FG001|Treated|Overall Study||339
6349841|NCT00616772|7258107|FG000|COMPLETED|Overall Study||225
6349842|NCT00616772|7258108|FG001|COMPLETED|Overall Study||240
6349843|NCT00616772|7258107|FG000|NOT COMPLETED|Overall Study||115
6349844|NCT00616772|7258108|FG001|NOT COMPLETED|Overall Study||102
6349845|NCT00616902|7258116|FG000|STARTED|Overall Study||6
6349846|NCT00616902|7258117|FG001|STARTED|Overall Study||6
6349847|NCT00616902|7258116|FG000|COMPLETED|Overall Study||0
6349848|NCT00616902|7258117|FG001|COMPLETED|Overall Study||0
6349849|NCT00616902|7258116|FG000|NOT COMPLETED|Overall Study||6
6349850|NCT00616902|7258117|FG001|NOT COMPLETED|Overall Study||6
6349851|NCT00616928|7258127|FG000|STARTED|Overall Study||2304
6349852|NCT00616928|7258128|FG001|STARTED|Overall Study||768
6349853|NCT00616928|7258129|FG002|STARTED|Overall Study||1118
6349854|NCT00616928|7258130|FG003|STARTED|Overall Study||371
6349855|NCT00616928|7258127|FG000|COMPLETED|Overall Study||2242
6349856|NCT00616928|7258128|FG001|COMPLETED|Overall Study||750
6349857|NCT00616928|7258129|FG002|COMPLETED|Overall Study||1101
6349858|NCT00616928|7258130|FG003|COMPLETED|Overall Study||364
6349859|NCT00616928|7258127|FG000|NOT COMPLETED|Overall Study||62
6349860|NCT00616928|7258128|FG001|NOT COMPLETED|Overall Study||18
6349861|NCT00616928|7258129|FG002|NOT COMPLETED|Overall Study||17
6349862|NCT00616928|7258130|FG003|NOT COMPLETED|Overall Study||7
6349863|NCT00616941|7258155|FG000|STARTED|Overall Study||4
6349864|NCT00616941|7258156|FG001|STARTED|Overall Study||13
6349865|NCT00616941|7258157|FG002|STARTED|Overall Study||11
6349866|NCT00616941|7258155|FG000|COMPLETED|Overall Study||3
6349867|NCT00616941|7258156|FG001|COMPLETED|Overall Study||8
6349868|NCT00616941|7258157|FG002|COMPLETED|Overall Study||5
6349869|NCT00616941|7258155|FG000|NOT COMPLETED|Overall Study||1
6349870|NCT00616941|7258156|FG001|NOT COMPLETED|Overall Study||5
6349871|NCT00616941|7258157|FG002|NOT COMPLETED|Overall Study||6
6349872|NCT00617058|7258168|FG000|STARTED|Overall Study||1
6349873|NCT00617058|7258169|FG001|STARTED|Overall Study||0
6349874|NCT00617058|7258170|FG002|STARTED|Overall Study||0
6349875|NCT00617058|7258168|FG000|COMPLETED|Overall Study||1
6349876|NCT00617058|7258169|FG001|COMPLETED|Overall Study||0
6349877|NCT00617058|7258170|FG002|COMPLETED|Overall Study||0
6349878|NCT00617058|7258168|FG000|NOT COMPLETED|Overall Study||0
6349879|NCT00617058|7258169|FG001|NOT COMPLETED|Overall Study||0
6349880|NCT00617058|7258170|FG002|NOT COMPLETED|Overall Study||0
6349881|NCT00617084|7258180|FG000|STARTED|Overall Study||1140
6349882|NCT00617084|7258181|FG001|STARTED|Overall Study||1152
6349883|NCT00617084|7258180|FG000|COMPLETED|Overall Study||1119
6349884|NCT00617084|7258181|FG001|COMPLETED|Overall Study||1126
6349885|NCT00617084|7258180|FG000|NOT COMPLETED|Overall Study||21
6349886|NCT00617084|7258181|FG001|NOT COMPLETED|Overall Study||26
6349887|NCT00617097|7258189|FG000|STARTED|Overall Study||25
6349888|NCT00617097|7258190|FG001|STARTED|Overall Study||25
6349889|NCT00617097|7258189|FG000|COMPLETED|Overall Study||25
6349890|NCT00617097|7258190|FG001|COMPLETED|Overall Study||25
6349891|NCT00617097|7258189|FG000|NOT COMPLETED|Overall Study||0
6349892|NCT00617097|7258190|FG001|NOT COMPLETED|Overall Study||0
6349893|NCT00617123|7258200|FG000|STARTED|Referral Screening Period||137
6349894|NCT00617123|7258201|FG001|STARTED|Referral Screening Period||121
6349895|NCT00617123|7258200|FG000|COMPLETED|Referral Screening Period||98
6349896|NCT00617123|7258201|FG001|COMPLETED|Referral Screening Period||95
6349897|NCT00617123|7258200|FG000|NOT COMPLETED|Referral Screening Period||39
6349898|NCT00617123|7258201|FG001|NOT COMPLETED|Referral Screening Period||26
6349899|NCT00617123|7258200|FG000|STARTED|Study Treatment Period||98
6349900|NCT00617123|7258201|FG001|STARTED|Study Treatment Period||95
6349901|NCT00617123|7258200|FG000|Treated|Study Treatment Period|1 participant was not treated|97
6349902|NCT00617123|7258201|FG001|Treated|Study Treatment Period||95
6349903|NCT00617123|7258200|FG000|COMPLETED|Study Treatment Period||81
6349904|NCT00617123|7258201|FG001|COMPLETED|Study Treatment Period||79
6349905|NCT00617123|7258200|FG000|NOT COMPLETED|Study Treatment Period||17
6349906|NCT00617123|7258201|FG001|NOT COMPLETED|Study Treatment Period||16
6349907|NCT00617175|7258209|FG000|STARTED|Overall Study||954
6349908|NCT00617175|7258210|FG001|STARTED|Overall Study||948
6349909|NCT00617175|7258209|FG000|COMPLETED|Overall Study||954
6349910|NCT00617175|7258210|FG001|COMPLETED|Overall Study||948
6349911|NCT00617175|7258209|FG000|NOT COMPLETED|Overall Study||0
6349912|NCT00617175|7258210|FG001|NOT COMPLETED|Overall Study||0
6349913|NCT00617188|7258216|FG000|STARTED|Overall Study||26
6349914|NCT00617188|7258216|FG000|COMPLETED|Overall Study||26
6349915|NCT00617188|7258216|FG000|NOT COMPLETED|Overall Study||0
6349916|NCT00617201|7258222|FG000|STARTED|Overall Study||25
6349917|NCT00617201|7258223|FG001|STARTED|Overall Study||25
6349918|NCT00617201|7258222|FG000|COMPLETED|Overall Study||16
6349919|NCT00617201|7258223|FG001|COMPLETED|Overall Study||12
6349920|NCT00617201|7258222|FG000|NOT COMPLETED|Overall Study||9
6349921|NCT00617201|7258223|FG001|NOT COMPLETED|Overall Study||13
6559625|NCT01782664|7482316|FG000|STARTED|Overall Study||14
6559626|NCT01782664|7482317|FG001|STARTED|Overall Study||15
6559627|NCT01782664|7482318|FG002|STARTED|Overall Study||16
6559628|NCT01782664|7482319|FG003|STARTED|Overall Study||14
6559629|NCT01782664|7482320|FG004|STARTED|Overall Study||6
6559630|NCT01782664|7482321|FG005|STARTED|Overall Study||2
6559631|NCT01782664|7482316|FG000|COMPLETED|Overall Study||8
6349922|NCT00617240|7258233|FG000|STARTED|Overall Study||5
6349923|NCT00617240|7258234|FG001|STARTED|Overall Study||4
6349924|NCT00617240|7258233|FG000|COMPLETED|Overall Study||4
6349925|NCT00617240|7258234|FG001|COMPLETED|Overall Study||4
6349926|NCT00617240|7258233|FG000|NOT COMPLETED|Overall Study||1
6349927|NCT00617240|7258234|FG001|NOT COMPLETED|Overall Study||0
6349928|NCT00617279|7258242|FG000|STARTED|Overall Study||14
6349929|NCT00617279|7258243|FG001|STARTED|Overall Study||17
6349930|NCT00617279|7258242|FG000|COMPLETED|Overall Study||0
6349931|NCT00617279|7258243|FG001|COMPLETED|Overall Study||0
6349932|NCT00617279|7258242|FG000|NOT COMPLETED|Overall Study||14
6349933|NCT00617279|7258243|FG001|NOT COMPLETED|Overall Study||17
6349934|NCT00617305|7258252|FG000|STARTED|Overall Study||33
6349935|NCT00617305|7258253|FG001|STARTED|Overall Study||4
6349936|NCT00617305|7258254|FG002|STARTED|Overall Study||1
6349937|NCT00617305|7258252|FG000|Completed 24-week Primary Analysis|Overall Study||31
6349938|NCT00617305|7258253|FG001|Completed 24-week Primary Analysis|Overall Study||4
6349939|NCT00617305|7258254|FG002|Completed 24-week Primary Analysis|Overall Study||0
6349940|NCT00617305|7258252|FG000|COMPLETED|Overall Study||25
6349941|NCT00617305|7258253|FG001|COMPLETED|Overall Study||4
6349942|NCT00617305|7258254|FG002|COMPLETED|Overall Study||0
6349943|NCT00617305|7258252|FG000|NOT COMPLETED|Overall Study||8
6349944|NCT00617305|7258253|FG001|NOT COMPLETED|Overall Study||0
6349945|NCT00617305|7258254|FG002|NOT COMPLETED|Overall Study||1
6349946|NCT00617344|7258268|FG000|STARTED|Overall Study||104
6349947|NCT00617344|7258269|FG001|STARTED|Overall Study||103
6349948|NCT00617344|7258270|FG002|STARTED|Overall Study||53
6349949|NCT00617344|7258268|FG000|Received Vaccination 1|Overall Study||104
6349950|NCT00617344|7258269|FG001|Received Vaccination 1|Overall Study||103
6349951|NCT00617344|7258270|FG002|Received Vaccination 1|Overall Study||53
6349952|NCT00617344|7258268|FG000|Received Vaccination 2|Overall Study||86
6349953|NCT00617344|7258269|FG001|Received Vaccination 2|Overall Study||85
6349954|NCT00617344|7258270|FG002|Received Vaccination 2|Overall Study||46
6349955|NCT00617344|7258268|FG000|Received Vaccination 3|Overall Study||79
6349956|NCT00617344|7258269|FG001|Received Vaccination 3|Overall Study||81
6349957|NCT00617344|7258270|FG002|Received Vaccination 3|Overall Study||45
6349958|NCT00617344|7258268|FG000|COMPLETED|Overall Study||79
6349959|NCT00617344|7258269|FG001|COMPLETED|Overall Study||81
6349960|NCT00617344|7258270|FG002|COMPLETED|Overall Study||45
6349961|NCT00617344|7258268|FG000|NOT COMPLETED|Overall Study||25
6349962|NCT00617344|7258269|FG001|NOT COMPLETED|Overall Study||22
6349963|NCT00617344|7258270|FG002|NOT COMPLETED|Overall Study||8
6349964|NCT00617357|7258278|FG000|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
6349965|NCT00617357|7258278|FG000|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
6559632|NCT01782664|7482317|FG001|COMPLETED|Overall Study||10
6559633|NCT01782664|7482318|FG002|COMPLETED|Overall Study||12
6349966|NCT00617357|7258278|FG000|NOT COMPLETED|Overall Study||16
6349967|NCT00617396|7258283|FG000|STARTED|Overall Study||25
6349968|NCT00617396|7258283|FG000|COMPLETED|Overall Study||25
6349969|NCT00617396|7258283|FG000|NOT COMPLETED|Overall Study||0
6349970|NCT00617409|7258290|FG000|STARTED|Overall Study||18
6349971|NCT00617409|7258291|FG001|STARTED|Overall Study||20
6349972|NCT00617409|7258292|FG002|STARTED|Overall Study||31
6349973|NCT00617409|7258290|FG000|COMPLETED|Overall Study||2
6349974|NCT00617409|7258291|FG001|COMPLETED|Overall Study||2
6349975|NCT00617409|7258292|FG002|COMPLETED|Overall Study||4
6349976|NCT00617409|7258290|FG000|NOT COMPLETED|Overall Study||16
6349977|NCT00617409|7258291|FG001|NOT COMPLETED|Overall Study||18
6349978|NCT00617409|7258292|FG002|NOT COMPLETED|Overall Study||27
6349979|NCT00617461|7258301|FG000|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
6349980|NCT00617461|7258302|FG001|STARTED|First Treatment Intervention Period||44
6349981|NCT00617461|7258301|FG000|COMPLETED|First Treatment Intervention Period||42
6349982|NCT00617461|7258302|FG001|COMPLETED|First Treatment Intervention Period||41
6349983|NCT00617461|7258301|FG000|NOT COMPLETED|First Treatment Intervention Period||10
6349984|NCT00617461|7258302|FG001|NOT COMPLETED|First Treatment Intervention Period||3
6349985|NCT00617461|7258301|FG000|STARTED|4-Day Crossover Period||42
6349986|NCT00617461|7258302|FG001|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
6349987|NCT00617461|7258301|FG000|COMPLETED|4-Day Crossover Period||41
6349988|NCT00617461|7258302|FG001|COMPLETED|4-Day Crossover Period||40
6349989|NCT00617461|7258301|FG000|NOT COMPLETED|4-Day Crossover Period||1
6349990|NCT00617461|7258302|FG001|NOT COMPLETED|4-Day Crossover Period||0
6349991|NCT00617461|7258301|FG000|STARTED|Second Treatment Intervention Period||41
6349992|NCT00617461|7258302|FG001|STARTED|Second Treatment Intervention Period||41
6349993|NCT00617461|7258301|FG000|COMPLETED|Second Treatment Intervention Period||41
6349994|NCT00617461|7258302|FG001|COMPLETED|Second Treatment Intervention Period||37
6349995|NCT00617461|7258301|FG000|NOT COMPLETED|Second Treatment Intervention Period||0
6349996|NCT00617461|7258302|FG001|NOT COMPLETED|Second Treatment Intervention Period||4
6349997|NCT00617461|7258301|FG000|STARTED|6-Day Down-Titration Period||41
6349998|NCT00617461|7258302|FG001|STARTED|6-Day Down-Titration Period||37
6349999|NCT00617461|7258301|FG000|COMPLETED|6-Day Down-Titration Period||39
6350000|NCT00617461|7258302|FG001|COMPLETED|6-Day Down-Titration Period||35
6350001|NCT00617461|7258301|FG000|NOT COMPLETED|6-Day Down-Titration Period||2
6350002|NCT00617461|7258302|FG001|NOT COMPLETED|6-Day Down-Titration Period||2
6350003|NCT00617539|7258324|FG000|STARTED|Overall Study||30
6350004|NCT00617539|7258324|FG000|COMPLETED|Overall Study||30
6350005|NCT00617539|7258324|FG000|NOT COMPLETED|Overall Study||0
6350006|NCT00617591|7258329|FG000|STARTED|Overall Study||57
6350007|NCT00617591|7258329|FG000|COMPLETED|Overall Study||47
6350008|NCT00617591|7258329|FG000|NOT COMPLETED|Overall Study||10
6350009|NCT00617604|7258336|FG000|STARTED|Overall Study||110
6350010|NCT00617604|7258337|FG001|STARTED|Overall Study||108
6350011|NCT00617604|7258336|FG000|Received Treatment|Overall Study||107
6350012|NCT00617604|7258337|FG001|Received Treatment|Overall Study||105
6350013|NCT00617604|7258336|FG000|Completed 12 Weeks of Treatment|Overall Study||89
6350014|NCT00617604|7258337|FG001|Completed 12 Weeks of Treatment|Overall Study||83
6350015|NCT00617604|7258336|FG000|COMPLETED|Overall Study|Completed Month 6 assessment|92
6350016|NCT00617604|7258337|FG001|COMPLETED|Overall Study|Completed Month 6 assessment|88
6350017|NCT00617604|7258336|FG000|NOT COMPLETED|Overall Study||18
6350018|NCT00617604|7258337|FG001|NOT COMPLETED|Overall Study||20
6350019|NCT00617669|7258345|FG000|STARTED|Overall Study||524
6350020|NCT00617669|7258346|FG001|STARTED|Overall Study||528
6350021|NCT00617669|7258345|FG000|Patients Who Received IP|Overall Study||522
6350022|NCT00617669|7258346|FG001|Patients Who Received IP|Overall Study||525
6350023|NCT00617669|7258345|FG000|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
6350024|NCT00617669|7258346|FG001|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
6350025|NCT00617669|7258345|FG000|NOT COMPLETED|Overall Study||430
6350026|NCT00617669|7258346|FG001|NOT COMPLETED|Overall Study||451
6350027|NCT00617734|7258354|FG000|STARTED|Overall Study||49
6350028|NCT00617734|7258355|FG001|STARTED|Overall Study||48
6350029|NCT00617734|7258354|FG000|Received at Least 1 Dose of Study Drug|Overall Study||47
6350030|NCT00617734|7258355|FG001|Received at Least 1 Dose of Study Drug|Overall Study||44
6350031|NCT00617734|7258354|FG000|COMPLETED|Overall Study||41
6350032|NCT00617734|7258355|FG001|COMPLETED|Overall Study||42
6350033|NCT00617734|7258354|FG000|NOT COMPLETED|Overall Study||8
6350034|NCT00617734|7258355|FG001|NOT COMPLETED|Overall Study||6
6350035|NCT00617773|7258361|FG000|STARTED|Overall Study||31
6350036|NCT00617773|7258361|FG000|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
6350037|NCT00617773|7258361|FG000|NOT COMPLETED|Overall Study||24
6350038|NCT00617851|7258369|FG000|STARTED|Overall Study||430
6350039|NCT00617851|7258370|FG001|STARTED|Overall Study||431
6350040|NCT00617851|7258371|FG002|STARTED|Overall Study||429
6350041|NCT00617851|7258372|FG003|STARTED|Overall Study||217
6350042|NCT00617851|7258369|FG000|COMPLETED|Overall Study||383
6350043|NCT00617851|7258370|FG001|COMPLETED|Overall Study||391
6350044|NCT00617851|7258371|FG002|COMPLETED|Overall Study||384
6350045|NCT00617851|7258372|FG003|COMPLETED|Overall Study||192
6350046|NCT00617851|7258369|FG000|NOT COMPLETED|Overall Study||47
6350047|NCT00617851|7258370|FG001|NOT COMPLETED|Overall Study||40
6350048|NCT00617851|7258371|FG002|NOT COMPLETED|Overall Study||45
6350049|NCT00617851|7258372|FG003|NOT COMPLETED|Overall Study||25
6350050|NCT00617890|7258396|FG000|STARTED|Overall Study||35
6350051|NCT00617890|7258397|FG001|STARTED|Overall Study||33
6350052|NCT00617890|7258398|FG002|STARTED|Overall Study||35
6350053|NCT00617890|7258399|FG003|STARTED|Overall Study||116
6350054|NCT00617890|7258396|FG000|Received Treatment|Overall Study||34
6350055|NCT00617890|7258397|FG001|Received Treatment|Overall Study||33
6350056|NCT00617890|7258398|FG002|Received Treatment|Overall Study||34
6350057|NCT00617890|7258399|FG003|Received Treatment|Overall Study||115
6350058|NCT00617890|7258396|FG000|COMPLETED|Overall Study||4
6350059|NCT00617890|7258397|FG001|COMPLETED|Overall Study||5
6350060|NCT00617890|7258398|FG002|COMPLETED|Overall Study||0
6350061|NCT00617890|7258399|FG003|COMPLETED|Overall Study||1
6350062|NCT00617890|7258396|FG000|NOT COMPLETED|Overall Study||31
6350063|NCT00617890|7258397|FG001|NOT COMPLETED|Overall Study||28
6350064|NCT00617890|7258398|FG002|NOT COMPLETED|Overall Study||35
6350065|NCT00617890|7258399|FG003|NOT COMPLETED|Overall Study||115
6350066|NCT00617903|7258414|FG000|STARTED|Overall Study||41
6350067|NCT00617903|7258415|FG001|STARTED|Overall Study||42
6350068|NCT00617903|7258414|FG000|COMPLETED|Overall Study||38
6350069|NCT00617903|7258415|FG001|COMPLETED|Overall Study||35
6350070|NCT00617903|7258414|FG000|NOT COMPLETED|Overall Study||3
6350071|NCT00617903|7258415|FG001|NOT COMPLETED|Overall Study||7
6350072|NCT00617929|7258421|FG000|STARTED|Overall Study||12
6350073|NCT00617929|7258421|FG000|COMPLETED|Overall Study||11
6350074|NCT00617929|7258421|FG000|NOT COMPLETED|Overall Study||1
6350075|NCT00617942|7258427|FG000|STARTED|Overall Study||37
6350076|NCT00617942|7258428|FG001|STARTED|Overall Study||23
6350077|NCT00617942|7258427|FG000|COMPLETED|Overall Study||29
6350078|NCT00617942|7258428|FG001|COMPLETED|Overall Study||19
6350079|NCT00617942|7258427|FG000|NOT COMPLETED|Overall Study||8
6350080|NCT00617942|7258428|FG001|NOT COMPLETED|Overall Study||4
6350081|NCT00617981|7258442|FG000|STARTED|Overall Study||354
6350082|NCT00617981|7258443|FG001|STARTED|Overall Study||347
6350083|NCT00617981|7258442|FG000|COMPLETED|Overall Study||244
6350084|NCT00617981|7258443|FG001|COMPLETED|Overall Study||245
6350085|NCT00617981|7258442|FG000|NOT COMPLETED|Overall Study||110
6350086|NCT00617981|7258443|FG001|NOT COMPLETED|Overall Study||102
6350087|NCT00618072|7258452|FG000|STARTED|Overall Study||16
6350088|NCT00618072|7258453|FG001|STARTED|Overall Study||15
6350089|NCT00618072|7258454|FG002|STARTED|Overall Study||15
6350090|NCT00618072|7258452|FG000|COMPLETED|Overall Study||14
6350091|NCT00618072|7258453|FG001|COMPLETED|Overall Study||14
6350092|NCT00618072|7258454|FG002|COMPLETED|Overall Study||11
6350093|NCT00618072|7258452|FG000|NOT COMPLETED|Overall Study||2
6350094|NCT00618072|7258453|FG001|NOT COMPLETED|Overall Study||1
6350095|NCT00618072|7258454|FG002|NOT COMPLETED|Overall Study||4
6350096|NCT00618332|7258464|FG000|STARTED|Overall Study||20
6350097|NCT00618332|7258465|FG001|STARTED|Overall Study||20
6350098|NCT00618332|7258464|FG000|COMPLETED|Overall Study||20
6350099|NCT00618332|7258465|FG001|COMPLETED|Overall Study||20
6350100|NCT00618332|7258464|FG000|NOT COMPLETED|Overall Study||0
6350101|NCT00618332|7258465|FG001|NOT COMPLETED|Overall Study||0
6350102|NCT00618371|7258471|FG000|STARTED|Overall Study||12
6350103|NCT00618371|7258471|FG000|COMPLETED|Overall Study||10
6350104|NCT00618371|7258471|FG000|NOT COMPLETED|Overall Study||2
6350105|NCT00618410|7258476|FG000|STARTED|First Intervention||7
6350106|NCT00618410|7258477|FG001|STARTED|First Intervention||6
6350107|NCT00618410|7258476|FG000|COMPLETED|First Intervention||7
6350108|NCT00618410|7258477|FG001|COMPLETED|First Intervention||6
6350109|NCT00618410|7258476|FG000|NOT COMPLETED|First Intervention||0
6350110|NCT00618410|7258477|FG001|NOT COMPLETED|First Intervention||0
6350111|NCT00618410|7258476|FG000|STARTED|Washout Period (2 Weeks)||7
6350112|NCT00618410|7258477|FG001|STARTED|Washout Period (2 Weeks)||6
6350113|NCT00618410|7258476|FG000|COMPLETED|Washout Period (2 Weeks)||7
6350114|NCT00618410|7258477|FG001|COMPLETED|Washout Period (2 Weeks)||5
6350115|NCT00618410|7258476|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
6350116|NCT00618410|7258477|FG001|NOT COMPLETED|Washout Period (2 Weeks)||1
6350117|NCT00618410|7258476|FG000|STARTED|Second Intervention||7
6350118|NCT00618410|7258477|FG001|STARTED|Second Intervention||5
6350119|NCT00618410|7258476|FG000|COMPLETED|Second Intervention||7
6350120|NCT00618410|7258477|FG001|COMPLETED|Second Intervention||5
6350121|NCT00618410|7258476|FG000|NOT COMPLETED|Second Intervention||0
6350122|NCT00618410|7258477|FG001|NOT COMPLETED|Second Intervention||0
6350123|NCT00618436|7258485|FG000|STARTED|Overall Study||34
6350124|NCT00618436|7258486|FG001|STARTED|Overall Study||18
6350125|NCT00618436|7258485|FG000|COMPLETED|Overall Study||34
6350126|NCT00618436|7258486|FG001|COMPLETED|Overall Study||18
6350127|NCT00618436|7258485|FG000|NOT COMPLETED|Overall Study||0
6350128|NCT00618436|7258486|FG001|NOT COMPLETED|Overall Study||0
6350129|NCT00618449|7258494|FG000|STARTED|Overall Study||679
6350130|NCT00618449|7258495|FG001|STARTED|Overall Study||668
6350131|NCT00618449|7258494|FG000|1-month, Post-treatment|Overall Study||666
6350132|NCT00618449|7258495|FG001|1-month, Post-treatment|Overall Study||656
6350133|NCT00618449|7258494|FG000|1-year, Post-treatment|Overall Study||581
6350134|NCT00618449|7258495|FG001|1-year, Post-treatment|Overall Study||558
6350135|NCT00618449|7258494|FG000|COMPLETED|Overall Study||581
6350136|NCT00618449|7258495|FG001|COMPLETED|Overall Study||558
6350137|NCT00618449|7258494|FG000|NOT COMPLETED|Overall Study||98
6350138|NCT00618449|7258495|FG001|NOT COMPLETED|Overall Study||110
6350139|NCT00618514|7258503|FG000|STARTED|Overall Study||36
6350140|NCT00618514|7258504|FG001|STARTED|Overall Study||38
6350141|NCT00618514|7258505|FG002|STARTED|Overall Study||16
6350142|NCT00618514|7258503|FG000|COMPLETED|Overall Study||25
6350143|NCT00618514|7258504|FG001|COMPLETED|Overall Study||26
6350144|NCT00618514|7258505|FG002|COMPLETED|Overall Study||12
6350145|NCT00618514|7258503|FG000|NOT COMPLETED|Overall Study||11
6350146|NCT00618514|7258504|FG001|NOT COMPLETED|Overall Study||12
6350147|NCT00618514|7258505|FG002|NOT COMPLETED|Overall Study||4
6350148|NCT00618540|7258511|FG000|STARTED|Overall Study||1
6350149|NCT00618540|7258511|FG000|COMPLETED|Overall Study||1
6350150|NCT00618540|7258511|FG000|NOT COMPLETED|Overall Study||0
6350151|NCT00618618|7258520|FG000|STARTED|Overall Study||24
6350152|NCT00618618|7258521|FG001|STARTED|Overall Study||14
6350153|NCT00618618|7258522|FG002|STARTED|Overall Study||21
6350154|NCT00618618|7258523|FG003|STARTED|Overall Study||14
6350155|NCT00618618|7258520|FG000|Received Treatment|Overall Study||24
6350156|NCT00618618|7258521|FG001|Received Treatment|Overall Study||13
6350157|NCT00618618|7258522|FG002|Received Treatment|Overall Study||20
6350158|NCT00618618|7258523|FG003|Received Treatment|Overall Study||14
6350159|NCT00618618|7258520|FG000|COMPLETED|Overall Study||20
6350160|NCT00618618|7258521|FG001|COMPLETED|Overall Study||11
6350161|NCT00618618|7258522|FG002|COMPLETED|Overall Study||18
6350162|NCT00618618|7258523|FG003|COMPLETED|Overall Study||13
6350163|NCT00618618|7258520|FG000|NOT COMPLETED|Overall Study||4
6350164|NCT00618618|7258521|FG001|NOT COMPLETED|Overall Study||3
6350165|NCT00618618|7258522|FG002|NOT COMPLETED|Overall Study||3
6350166|NCT00618618|7258523|FG003|NOT COMPLETED|Overall Study||1
6350167|NCT00618722|7258538|FG000|STARTED|Overall Study||21
6350168|NCT00618722|7258539|FG001|STARTED|Overall Study||20
6350169|NCT00618722|7258540|FG002|STARTED|Overall Study||22
6350170|NCT00618722|7258541|FG003|STARTED|Overall Study||22
6350171|NCT00618722|7258538|FG000|Received Treatment|Overall Study||20
6350172|NCT00618722|7258539|FG001|Received Treatment|Overall Study||20
6350173|NCT00618722|7258540|FG002|Received Treatment|Overall Study||22
6350174|NCT00618722|7258541|FG003|Received Treatment|Overall Study||22
6350175|NCT00618722|7258538|FG000|COMPLETED|Overall Study||18
6350176|NCT00618722|7258539|FG001|COMPLETED|Overall Study||18
6350177|NCT00618722|7258540|FG002|COMPLETED|Overall Study||19
6350178|NCT00618722|7258541|FG003|COMPLETED|Overall Study||18
6350179|NCT00618722|7258538|FG000|NOT COMPLETED|Overall Study||3
6350180|NCT00618722|7258539|FG001|NOT COMPLETED|Overall Study||2
6350181|NCT00618722|7258540|FG002|NOT COMPLETED|Overall Study||3
6350182|NCT00618722|7258541|FG003|NOT COMPLETED|Overall Study||4
6350183|NCT00618748|7258554|FG000|STARTED|Overall Study||56
6350184|NCT00618748|7258555|FG001|STARTED|Overall Study||25
6350185|NCT00618748|7258556|FG002|STARTED|Overall Study||20
6350186|NCT00618748|7258554|FG000|COMPLETED|Overall Study||45
6350187|NCT00618748|7258555|FG001|COMPLETED|Overall Study||20
6350188|NCT00618748|7258556|FG002|COMPLETED|Overall Study||6
6350189|NCT00618748|7258554|FG000|NOT COMPLETED|Overall Study||11
6350190|NCT00618748|7258555|FG001|NOT COMPLETED|Overall Study||5
6350191|NCT00618748|7258556|FG002|NOT COMPLETED|Overall Study||14
6350192|NCT00618774|7258566|FG000|STARTED|Overall Study||211
6350193|NCT00618774|7258567|FG001|STARTED|Overall Study||48
6350194|NCT00618774|7258566|FG000|COMPLETED|Overall Study||205
6350195|NCT00618774|7258567|FG001|COMPLETED|Overall Study||45
6350196|NCT00618774|7258566|FG000|NOT COMPLETED|Overall Study||6
6350197|NCT00618774|7258567|FG001|NOT COMPLETED|Overall Study||3
6350198|NCT00618787|7258575|FG000|STARTED|Overall Study||22
6350199|NCT00618787|7258576|FG001|STARTED|Overall Study||23
6350200|NCT00618787|7258575|FG000|COMPLETED|Overall Study||19
6350201|NCT00618787|7258576|FG001|COMPLETED|Overall Study||21
6350202|NCT00618787|7258575|FG000|NOT COMPLETED|Overall Study||3
6350203|NCT00618787|7258576|FG001|NOT COMPLETED|Overall Study||2
6350204|NCT00618813|7258582|FG000|STARTED|Overall Study||35
6350205|NCT00618813|7258582|FG000|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
6350206|NCT00618813|7258582|FG000|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
6350207|NCT00618813|7258582|FG000|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
6350208|NCT00618813|7258582|FG000|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
6350209|NCT00618813|7258582|FG000|COMPLETED|Overall Study||31
6350210|NCT00618813|7258582|FG000|NOT COMPLETED|Overall Study||4
6350211|NCT00618826|7258586|FG000|STARTED|Overall Study||14
6350212|NCT00618826|7258586|FG000|COMPLETED|Overall Study||13
6350213|NCT00618826|7258586|FG000|NOT COMPLETED|Overall Study||1
6350214|NCT00618839|7258591|FG000|STARTED|Overall Study||15
6350215|NCT00618839|7258591|FG000|COMPLETED|Overall Study||15
6350216|NCT00618839|7258591|FG000|NOT COMPLETED|Overall Study||0
6350217|NCT00618917|7258601|FG000|STARTED|Overall Study||4
6655087|NCT02450526|7585093|FG002|COMPLETED|OL Period (Cycles 2-5)||0
6350218|NCT00618917|7258602|FG001|STARTED|Overall Study||3
6350219|NCT00618917|7258603|FG002|STARTED|Overall Study||11
6350220|NCT00618917|7258601|FG000|COMPLETED|Overall Study||3
6350221|NCT00618917|7258602|FG001|COMPLETED|Overall Study||3
6350222|NCT00618917|7258603|FG002|COMPLETED|Overall Study||11
6350223|NCT00618917|7258601|FG000|NOT COMPLETED|Overall Study||1
6350224|NCT00618917|7258602|FG001|NOT COMPLETED|Overall Study||0
6350225|NCT00618917|7258603|FG002|NOT COMPLETED|Overall Study||0
6350226|NCT00618956|7258613|FG000|STARTED|Overall Study||111
6350227|NCT00618956|7258614|FG001|STARTED|Overall Study||210
6350228|NCT00618956|7258613|FG000|COMPLETED|Overall Study||86
6350229|NCT00618956|7258614|FG001|COMPLETED|Overall Study||160
6350230|NCT00618956|7258613|FG000|NOT COMPLETED|Overall Study||25
6350231|NCT00618956|7258614|FG001|NOT COMPLETED|Overall Study||50
6350232|NCT00618982|7258626|FG000|STARTED|Overall Study||83
6350233|NCT00618982|7258626|FG000|COMPLETED|Overall Study||33
6350234|NCT00618982|7258626|FG000|NOT COMPLETED|Overall Study||50
6350235|NCT00618995|7258633|FG000|STARTED|Period 1||6
6350236|NCT00618995|7258634|FG001|STARTED|Period 1||7
6350237|NCT00618995|7258635|FG002|STARTED|Period 1||7
6350238|NCT00618995|7258636|FG003|STARTED|Period 1||6
6350239|NCT00618995|7258633|FG000|COMPLETED|Period 1||6
6350240|NCT00618995|7258634|FG001|COMPLETED|Period 1||6
6350241|NCT00618995|7258635|FG002|COMPLETED|Period 1||5
6350242|NCT00618995|7258636|FG003|COMPLETED|Period 1||6
6350243|NCT00618995|7258633|FG000|NOT COMPLETED|Period 1||0
6350244|NCT00618995|7258634|FG001|NOT COMPLETED|Period 1||1
6350245|NCT00618995|7258635|FG002|NOT COMPLETED|Period 1||2
6350246|NCT00618995|7258636|FG003|NOT COMPLETED|Period 1||0
6350247|NCT00618995|7258633|FG000|STARTED|Period 2||6
6350248|NCT00618995|7258634|FG001|STARTED|Period 2||6
6350249|NCT00618995|7258635|FG002|STARTED|Period 2||5
6350250|NCT00618995|7258636|FG003|STARTED|Period 2||6
6350251|NCT00618995|7258633|FG000|COMPLETED|Period 2||6
6350252|NCT00618995|7258634|FG001|COMPLETED|Period 2||6
6350253|NCT00618995|7258635|FG002|COMPLETED|Period 2||4
6350254|NCT00618995|7258636|FG003|COMPLETED|Period 2||6
6350255|NCT00618995|7258633|FG000|NOT COMPLETED|Period 2||0
6350256|NCT00618995|7258634|FG001|NOT COMPLETED|Period 2||0
6350257|NCT00618995|7258635|FG002|NOT COMPLETED|Period 2||1
6350258|NCT00618995|7258636|FG003|NOT COMPLETED|Period 2||0
6350259|NCT00618995|7258633|FG000|STARTED|Period 3||6
6350260|NCT00618995|7258634|FG001|STARTED|Period 3||6
6350261|NCT00618995|7258635|FG002|STARTED|Period 3||4
6350262|NCT00618995|7258636|FG003|STARTED|Period 3||6
6350263|NCT00618995|7258633|FG000|COMPLETED|Period 3||6
6350264|NCT00618995|7258634|FG001|COMPLETED|Period 3||6
6350265|NCT00618995|7258635|FG002|COMPLETED|Period 3||4
6350266|NCT00618995|7258636|FG003|COMPLETED|Period 3||6
6350267|NCT00618995|7258633|FG000|NOT COMPLETED|Period 3||0
6350268|NCT00618995|7258634|FG001|NOT COMPLETED|Period 3||0
6350269|NCT00618995|7258635|FG002|NOT COMPLETED|Period 3||0
6350270|NCT00618995|7258636|FG003|NOT COMPLETED|Period 3||0
6350271|NCT00618995|7258633|FG000|STARTED|Period 4||6
6350272|NCT00618995|7258634|FG001|STARTED|Period 4||6
6350273|NCT00618995|7258635|FG002|STARTED|Period 4||4
6350274|NCT00618995|7258636|FG003|STARTED|Period 4||6
6350275|NCT00618995|7258633|FG000|COMPLETED|Period 4||5
6350276|NCT00618995|7258634|FG001|COMPLETED|Period 4||6
6350277|NCT00618995|7258635|FG002|COMPLETED|Period 4||4
6350278|NCT00618995|7258636|FG003|COMPLETED|Period 4||6
6350279|NCT00618995|7258633|FG000|NOT COMPLETED|Period 4||1
6350280|NCT00618995|7258634|FG001|NOT COMPLETED|Period 4||0
6350281|NCT00618995|7258635|FG002|NOT COMPLETED|Period 4||0
6350282|NCT00618995|7258636|FG003|NOT COMPLETED|Period 4||0
6350283|NCT00619060|7258646|FG000|STARTED|Overall Study||10
6350284|NCT00619060|7258647|FG001|STARTED|Overall Study||12
6350285|NCT00619060|7258646|FG000|COMPLETED|Overall Study||10
6350286|NCT00619060|7258647|FG001|COMPLETED|Overall Study||12
6350287|NCT00619060|7258646|FG000|NOT COMPLETED|Overall Study||0
6350288|NCT00619060|7258647|FG001|NOT COMPLETED|Overall Study||0
6350289|NCT00619073|7258655|FG000|STARTED|First Intervention - 60 Days||8
6350290|NCT00619073|7258656|FG001|STARTED|First Intervention - 60 Days||8
6350291|NCT00619073|7258655|FG000|COMPLETED|First Intervention - 60 Days||8
6350292|NCT00619073|7258656|FG001|COMPLETED|First Intervention - 60 Days||8
6350293|NCT00619073|7258655|FG000|NOT COMPLETED|First Intervention - 60 Days||0
6350294|NCT00619073|7258656|FG001|NOT COMPLETED|First Intervention - 60 Days||0
6350295|NCT00619073|7258655|FG000|STARTED|Washout Period (30 Days)||8
6350296|NCT00619073|7258656|FG001|STARTED|Washout Period (30 Days)||8
6350297|NCT00619073|7258655|FG000|COMPLETED|Washout Period (30 Days)||8
6350298|NCT00619073|7258656|FG001|COMPLETED|Washout Period (30 Days)||8
6350299|NCT00619073|7258655|FG000|NOT COMPLETED|Washout Period (30 Days)||0
6350300|NCT00619073|7258656|FG001|NOT COMPLETED|Washout Period (30 Days)||0
6350301|NCT00619073|7258655|FG000|STARTED|Second Intervention - 60 Days||8
6350302|NCT00619073|7258656|FG001|STARTED|Second Intervention - 60 Days||8
6350303|NCT00619073|7258655|FG000|COMPLETED|Second Intervention - 60 Days||8
6350304|NCT00619073|7258656|FG001|COMPLETED|Second Intervention - 60 Days||8
6350305|NCT00619073|7258655|FG000|NOT COMPLETED|Second Intervention - 60 Days||0
6350306|NCT00619073|7258656|FG001|NOT COMPLETED|Second Intervention - 60 Days||0
6350307|NCT00619099|7258664|FG000|STARTED|Overall Study|All randomized subjects|44
6350308|NCT00619099|7258665|FG001|STARTED|Overall Study|All randomized subjects|23
6350309|NCT00619099|7258664|FG000|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
6350310|NCT00619099|7258665|FG001|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
6350311|NCT00619099|7258664|FG000|COMPLETED|Overall Study||11
6350312|NCT00619099|7258665|FG001|COMPLETED|Overall Study||4
6350313|NCT00619099|7258664|FG000|NOT COMPLETED|Overall Study||33
6350314|NCT00619099|7258665|FG001|NOT COMPLETED|Overall Study||19
6350315|NCT00619112|7258673|FG000|STARTED|Overall Study||40
6350316|NCT00619112|7258674|FG001|STARTED|Overall Study||20
6350317|NCT00619112|7258673|FG000|COMPLETED|Overall Study|Data from patient who didn't complete study was still included in the final analysis.|39
6350318|NCT00619112|7258674|FG001|COMPLETED|Overall Study|Data from patients who didn't complete study was still included in the final analysis.|18
6350319|NCT00619112|7258673|FG000|NOT COMPLETED|Overall Study||1
6350320|NCT00619112|7258674|FG001|NOT COMPLETED|Overall Study||2
6350321|NCT00619177|7258683|FG000|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
6350322|NCT00619177|7258683|FG000|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
6350323|NCT00619177|7258683|FG000|NOT COMPLETED|Overall Study||508
6350324|NCT00619190|7258689|FG000|STARTED|Overall Study||21
6350325|NCT00619190|7258690|FG001|STARTED|Overall Study||9
6350326|NCT00619190|7258689|FG000|COMPLETED|Overall Study||20
6350327|NCT00619190|7258690|FG001|COMPLETED|Overall Study||9
6350328|NCT00619190|7258689|FG000|NOT COMPLETED|Overall Study||1
6350329|NCT00619190|7258690|FG001|NOT COMPLETED|Overall Study||0
6350330|NCT00619229|7258698|FG000|STARTED|Overall Study||18
6350331|NCT00619229|7258699|FG001|STARTED|Overall Study||18
6350332|NCT00619229|7258698|FG000|Full Analysis Set (FAS)|Overall Study||16
6350333|NCT00619229|7258699|FG001|Full Analysis Set (FAS)|Overall Study||17
6350334|NCT00619229|7258698|FG000|COMPLETED|Overall Study||14
6350335|NCT00619229|7258699|FG001|COMPLETED|Overall Study||16
6350336|NCT00619229|7258698|FG000|NOT COMPLETED|Overall Study||4
6350337|NCT00619229|7258699|FG001|NOT COMPLETED|Overall Study||2
6350338|NCT00619255|7258707|FG000|STARTED|Overall Study||59
6350339|NCT00619255|7258708|FG001|STARTED|Overall Study||61
6350340|NCT00619255|7258707|FG000|COMPLETED|Overall Study||57
6350341|NCT00619255|7258708|FG001|COMPLETED|Overall Study||61
6350342|NCT00619255|7258707|FG000|NOT COMPLETED|Overall Study||2
6350343|NCT00619255|7258708|FG001|NOT COMPLETED|Overall Study||0
6350344|NCT00619307|7258716|FG000|STARTED|Overall Study||60
6350345|NCT00619307|7258717|FG001|STARTED|Overall Study||57
6350346|NCT00619307|7258716|FG000|COMPLETED|Overall Study||56
6350347|NCT00619307|7258717|FG001|COMPLETED|Overall Study||53
6350348|NCT00619307|7258716|FG000|NOT COMPLETED|Overall Study||4
6350349|NCT00619307|7258717|FG001|NOT COMPLETED|Overall Study||4
6350350|NCT00619359|7258725|FG000|STARTED|Overall Study||1147
6350351|NCT00619359|7258726|FG001|STARTED|Overall Study||1175
6350352|NCT00619359|7258725|FG000|COMPLETED|Overall Study||1080
6350353|NCT00619359|7258726|FG001|COMPLETED|Overall Study||1094
6350354|NCT00619359|7258725|FG000|NOT COMPLETED|Overall Study||67
6350355|NCT00619359|7258726|FG001|NOT COMPLETED|Overall Study||81
6350356|NCT00619385|7258735|FG000|STARTED|Overall Study||7
6350357|NCT00619385|7258736|FG001|STARTED|Overall Study||8
6350358|NCT00619385|7258737|FG002|STARTED|Overall Study||10
6350359|NCT00619385|7258735|FG000|COMPLETED|Overall Study||6
6350360|NCT00619385|7258736|FG001|COMPLETED|Overall Study||6
6350361|NCT00619385|7258737|FG002|COMPLETED|Overall Study||6
6350362|NCT00619385|7258735|FG000|NOT COMPLETED|Overall Study||1
6350363|NCT00619385|7258736|FG001|NOT COMPLETED|Overall Study||2
6350364|NCT00619385|7258737|FG002|NOT COMPLETED|Overall Study||4
6350365|NCT00619476|7258752|FG000|STARTED|Overall Study||95
6350366|NCT00619476|7258753|FG001|STARTED|Overall Study||107
6350367|NCT00619476|7258754|FG002|STARTED|Overall Study||84
6350368|NCT00619476|7258755|FG003|STARTED|Overall Study||90
6350369|NCT00619476|7258752|FG000|Intent-to-Treat Population|Overall Study||95
6350370|NCT00619476|7258753|FG001|Intent-to-Treat Population|Overall Study||107
6350371|NCT00619476|7258754|FG002|Intent-to-Treat Population|Overall Study||82
6350372|NCT00619476|7258755|FG003|Intent-to-Treat Population|Overall Study||87
6350373|NCT00619476|7258752|FG000|Safety Population|Overall Study||95
6350374|NCT00619476|7258753|FG001|Safety Population|Overall Study||107
6350375|NCT00619476|7258754|FG002|Safety Population|Overall Study||82
6350376|NCT00619476|7258755|FG003|Safety Population|Overall Study||87
6350377|NCT00619476|7258752|FG000|COMPLETED|Overall Study||64
6350378|NCT00619476|7258753|FG001|COMPLETED|Overall Study||85
6350379|NCT00619476|7258754|FG002|COMPLETED|Overall Study||60
6350380|NCT00619476|7258755|FG003|COMPLETED|Overall Study||56
6350381|NCT00619476|7258752|FG000|NOT COMPLETED|Overall Study||31
6350382|NCT00619476|7258753|FG001|NOT COMPLETED|Overall Study||22
6350383|NCT00619476|7258754|FG002|NOT COMPLETED|Overall Study||24
6350384|NCT00619476|7258755|FG003|NOT COMPLETED|Overall Study||34
6350385|NCT00619489|7258767|FG000|STARTED|Overall Study||37
6350386|NCT00619489|7258768|FG001|STARTED|Overall Study||35
6350387|NCT00619489|7258767|FG000|COMPLETED|Overall Study||14
6350388|NCT00619489|7258768|FG001|COMPLETED|Overall Study||1
6350389|NCT00619489|7258767|FG000|NOT COMPLETED|Overall Study||23
6350390|NCT00619489|7258768|FG001|NOT COMPLETED|Overall Study||34
6350391|NCT00619502|7258776|FG000|STARTED|Overall Study||130
6350392|NCT00619502|7258777|FG001|STARTED|Overall Study||124
6350393|NCT00619502|7258776|FG000|COMPLETED|Overall Study||122
6350394|NCT00619502|7258777|FG001|COMPLETED|Overall Study||114
6350395|NCT00619502|7258776|FG000|NOT COMPLETED|Overall Study||8
6350396|NCT00619502|7258777|FG001|NOT COMPLETED|Overall Study||10
6350397|NCT00619619|7258793|FG000|STARTED|Overall Study||6
6350398|NCT00619619|7258794|FG001|STARTED|Overall Study||7
6350399|NCT00619619|7258795|FG002|STARTED|Overall Study||9
6350400|NCT00619619|7258796|FG003|STARTED|Overall Study||7
6350401|NCT00619619|7258797|FG004|STARTED|Overall Study||7
6350402|NCT00619619|7258798|FG005|STARTED|Overall Study||7
6350403|NCT00619619|7258799|FG006|STARTED|Overall Study||8
6350404|NCT00619619|7258800|FG007|STARTED|Overall Study||8
6376844|NCT00761319|7287441|FG001|STARTED|Overall Study||352
6350405|NCT00619619|7258793|FG000|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
6350406|NCT00619619|7258794|FG001|Entered the Extension Study|Overall Study||5
6350407|NCT00619619|7258795|FG002|Entered the Extension Study|Overall Study||8
6350408|NCT00619619|7258796|FG003|Entered the Extension Study|Overall Study||3
6350409|NCT00619619|7258797|FG004|Entered the Extension Study|Overall Study||7
6350410|NCT00619619|7258798|FG005|Entered the Extension Study|Overall Study||6
6350411|NCT00619619|7258799|FG006|Entered the Extension Study|Overall Study||6
6350412|NCT00619619|7258800|FG007|Entered the Extension Study|Overall Study||7
6350413|NCT00619619|7258793|FG000|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
6350414|NCT00619619|7258794|FG001|COMPLETED|Overall Study||7
6350415|NCT00619619|7258795|FG002|COMPLETED|Overall Study||8
6350416|NCT00619619|7258796|FG003|COMPLETED|Overall Study||6
6350417|NCT00619619|7258797|FG004|COMPLETED|Overall Study||5
6350418|NCT00619619|7258798|FG005|COMPLETED|Overall Study||7
6350419|NCT00619619|7258799|FG006|COMPLETED|Overall Study||7
6350420|NCT00619619|7258800|FG007|COMPLETED|Overall Study||5
6350421|NCT00619619|7258793|FG000|NOT COMPLETED|Overall Study||0
6350422|NCT00619619|7258794|FG001|NOT COMPLETED|Overall Study||0
6350423|NCT00619619|7258795|FG002|NOT COMPLETED|Overall Study||1
6350424|NCT00619619|7258796|FG003|NOT COMPLETED|Overall Study||1
6350425|NCT00619619|7258797|FG004|NOT COMPLETED|Overall Study||2
6350426|NCT00619619|7258798|FG005|NOT COMPLETED|Overall Study||0
6350427|NCT00619619|7258799|FG006|NOT COMPLETED|Overall Study||1
6350428|NCT00619619|7258800|FG007|NOT COMPLETED|Overall Study||3
6350429|NCT00619645|7258821|FG000|STARTED|Overall Study||8
6350430|NCT00619645|7258821|FG000|COMPLETED|Overall Study||7
6350431|NCT00619645|7258821|FG000|NOT COMPLETED|Overall Study||1
6350432|NCT00619684|7258825|FG000|STARTED|Overall Study||18
6350433|NCT00619684|7258825|FG000|COMPLETED|Overall Study||18
6350434|NCT00619684|7258825|FG000|NOT COMPLETED|Overall Study||0
6350435|NCT00619723|7258831|FG000|STARTED|Overall Study||63
6350436|NCT00619723|7258832|FG001|STARTED|Overall Study||67
6350437|NCT00619723|7258831|FG000|COMPLETED|Overall Study||61
6350438|NCT00619723|7258832|FG001|COMPLETED|Overall Study||61
6350439|NCT00619723|7258831|FG000|NOT COMPLETED|Overall Study||2
6350440|NCT00619723|7258832|FG001|NOT COMPLETED|Overall Study||6
6350441|NCT00619762|7258838|FG000|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
6350442|NCT00619762|7258838|FG000|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
6350443|NCT00619762|7258838|FG000|NOT COMPLETED|Overall Study||3
6350444|NCT00619801|7258845|FG000|STARTED|Overall Study||59
6350445|NCT00619801|7258846|FG001|STARTED|Overall Study||114
6350446|NCT00619801|7258845|FG000|Safety Population|Overall Study||59
6350447|NCT00619801|7258846|FG001|Safety Population|Overall Study||114
6350448|NCT00619801|7258845|FG000|COMPLETED|Overall Study||58
6350449|NCT00619801|7258846|FG001|COMPLETED|Overall Study||111
6350450|NCT00619801|7258845|FG000|NOT COMPLETED|Overall Study||1
6350451|NCT00619801|7258846|FG001|NOT COMPLETED|Overall Study||3
6350452|NCT00619827|7258854|FG000|STARTED|Overall Study||45
6350453|NCT00619827|7258855|FG001|STARTED|Overall Study||44
6350454|NCT00619827|7258854|FG000|COMPLETED|Overall Study||42
6350455|NCT00619827|7258855|FG001|COMPLETED|Overall Study||40
6350456|NCT00619827|7258854|FG000|NOT COMPLETED|Overall Study||3
6350457|NCT00619827|7258855|FG001|NOT COMPLETED|Overall Study||4
6350458|NCT00619866|7258864|FG000|STARTED|Weeks 1 - 12||52
6350459|NCT00619866|7258865|FG001|STARTED|Weeks 1 - 12||51
6350460|NCT00619866|7258866|FG002|STARTED|Weeks 1 - 12||52
6350461|NCT00619866|7258867|FG003|STARTED|Weeks 1 - 12||0
6350462|NCT00619866|7258868|FG004|STARTED|Weeks 1 - 12||0
6350463|NCT00619866|7258864|FG000|COMPLETED|Weeks 1 - 12||38
6350464|NCT00619866|7258865|FG001|COMPLETED|Weeks 1 - 12||45
6350465|NCT00619866|7258866|FG002|COMPLETED|Weeks 1 - 12||42
6350466|NCT00619866|7258867|FG003|COMPLETED|Weeks 1 - 12||0
6350467|NCT00619866|7258868|FG004|COMPLETED|Weeks 1 - 12||0
6350468|NCT00619866|7258864|FG000|NOT COMPLETED|Weeks 1 - 12||14
6350469|NCT00619866|7258865|FG001|NOT COMPLETED|Weeks 1 - 12||6
6350470|NCT00619866|7258866|FG002|NOT COMPLETED|Weeks 1 - 12||10
6350471|NCT00619866|7258867|FG003|NOT COMPLETED|Weeks 1 - 12||0
6350472|NCT00619866|7258868|FG004|NOT COMPLETED|Weeks 1 - 12||0
6350473|NCT00619866|7258864|FG000|STARTED|Weeks 13 - 24||0
6350474|NCT00619866|7258865|FG001|STARTED|Weeks 13 - 24||45
6350475|NCT00619866|7258866|FG002|STARTED|Weeks 13 - 24||42
6350476|NCT00619866|7258867|FG003|STARTED|Weeks 13 - 24||18
6350477|NCT00619866|7258868|FG004|STARTED|Weeks 13 - 24||20
6350478|NCT00619866|7258864|FG000|COMPLETED|Weeks 13 - 24||0
6350479|NCT00619866|7258865|FG001|COMPLETED|Weeks 13 - 24||38
6350480|NCT00619866|7258866|FG002|COMPLETED|Weeks 13 - 24||37
6350481|NCT00619866|7258867|FG003|COMPLETED|Weeks 13 - 24||14
6350482|NCT00619866|7258868|FG004|COMPLETED|Weeks 13 - 24||18
6350483|NCT00619866|7258864|FG000|NOT COMPLETED|Weeks 13 - 24||0
6350484|NCT00619866|7258865|FG001|NOT COMPLETED|Weeks 13 - 24||7
6350485|NCT00619866|7258866|FG002|NOT COMPLETED|Weeks 13 - 24||5
6350486|NCT00619866|7258867|FG003|NOT COMPLETED|Weeks 13 - 24||4
6350487|NCT00619866|7258868|FG004|NOT COMPLETED|Weeks 13 - 24||2
6350488|NCT00619892|7258882|FG000|STARTED|Overall Study||13
6350489|NCT00619892|7258883|FG001|STARTED|Overall Study||13
6350490|NCT00619892|7258882|FG000|COMPLETED|Overall Study||10
6350491|NCT00619892|7258883|FG001|COMPLETED|Overall Study||11
6350492|NCT00619892|7258882|FG000|NOT COMPLETED|Overall Study||3
6350493|NCT00619892|7258883|FG001|NOT COMPLETED|Overall Study||2
6350494|NCT00619918|7258893|FG000|STARTED|Overall Study||230
6350495|NCT00619918|7258894|FG001|STARTED|Overall Study||217
6350496|NCT00619918|7258893|FG000|COMPLETED|Overall Study||210
6350497|NCT00619918|7258894|FG001|COMPLETED|Overall Study||195
6350498|NCT00619918|7258893|FG000|NOT COMPLETED|Overall Study||20
6350499|NCT00619918|7258894|FG001|NOT COMPLETED|Overall Study||22
6350500|NCT00619957|7258902|FG000|STARTED|Month 24 Double-Blind||93
6350501|NCT00619957|7258903|FG001|STARTED|Month 24 Double-Blind||192
6350502|NCT00619957|7258902|FG000|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
6350503|NCT00619957|7258903|FG001|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
6350504|NCT00619957|7258902|FG000|COMPLETED|Month 24 Double-Blind||75
6350505|NCT00619957|7258903|FG001|COMPLETED|Month 24 Double-Blind||175
6350506|NCT00619957|7258902|FG000|NOT COMPLETED|Month 24 Double-Blind||18
6350507|NCT00619957|7258903|FG001|NOT COMPLETED|Month 24 Double-Blind||17
6350508|NCT00619957|7258902|FG000|STARTED|Month 48 Open-Label||67
6350509|NCT00619957|7258903|FG001|STARTED|Month 48 Open-Label||151
6350510|NCT00619957|7258902|FG000|COMPLETED|Month 48 Open-Label||55
6350511|NCT00619957|7258903|FG001|COMPLETED|Month 48 Open-Label||134
6350512|NCT00619957|7258902|FG000|NOT COMPLETED|Month 48 Open-Label||12
6350513|NCT00619957|7258903|FG001|NOT COMPLETED|Month 48 Open-Label||17
6350514|NCT00619970|7258914|FG000|STARTED|Overall Study||40
6350515|NCT00619970|7258915|FG001|STARTED|Overall Study||49
6350516|NCT00619970|7258916|FG002|STARTED|Overall Study||26
6350517|NCT00619970|7258914|FG000|COMPLETED|Overall Study||40
6350518|NCT00619970|7258915|FG001|COMPLETED|Overall Study||46
6350519|NCT00619970|7258916|FG002|COMPLETED|Overall Study||24
6350520|NCT00619970|7258914|FG000|NOT COMPLETED|Overall Study||0
6350521|NCT00619970|7258915|FG001|NOT COMPLETED|Overall Study||3
6350522|NCT00619970|7258916|FG002|NOT COMPLETED|Overall Study||2
6350523|NCT00619983|7258930|FG000|STARTED|Test Drug Alone||5
6350524|NCT00619983|7258931|FG001|STARTED|Test Drug Alone||5
6350525|NCT00619983|7258932|FG002|STARTED|Test Drug Alone||6
6350526|NCT00619983|7258933|FG003|STARTED|Test Drug Alone||6
6350527|NCT00619983|7258930|FG000|COMPLETED|Test Drug Alone||3
6350528|NCT00619983|7258931|FG001|COMPLETED|Test Drug Alone||4
6350529|NCT00619983|7258932|FG002|COMPLETED|Test Drug Alone||4
6350530|NCT00619983|7258933|FG003|COMPLETED|Test Drug Alone||3
6350531|NCT00619983|7258930|FG000|NOT COMPLETED|Test Drug Alone||2
6350532|NCT00619983|7258931|FG001|NOT COMPLETED|Test Drug Alone||1
6350533|NCT00619983|7258932|FG002|NOT COMPLETED|Test Drug Alone||2
6350534|NCT00619983|7258933|FG003|NOT COMPLETED|Test Drug Alone||3
6350535|NCT00619983|7258930|FG000|STARTED|Test Drug Plus Gabapentin||3
6350536|NCT00619983|7258931|FG001|STARTED|Test Drug Plus Gabapentin||4
6350537|NCT00619983|7258932|FG002|STARTED|Test Drug Plus Gabapentin||4
6350538|NCT00619983|7258933|FG003|STARTED|Test Drug Plus Gabapentin||3
6350539|NCT00619983|7258930|FG000|COMPLETED|Test Drug Plus Gabapentin||3
6350540|NCT00619983|7258931|FG001|COMPLETED|Test Drug Plus Gabapentin||4
6350541|NCT00619983|7258932|FG002|COMPLETED|Test Drug Plus Gabapentin||4
6350542|NCT00619983|7258933|FG003|COMPLETED|Test Drug Plus Gabapentin||3
6350543|NCT00619983|7258930|FG000|NOT COMPLETED|Test Drug Plus Gabapentin||0
6350544|NCT00619983|7258931|FG001|NOT COMPLETED|Test Drug Plus Gabapentin||0
6350545|NCT00619983|7258932|FG002|NOT COMPLETED|Test Drug Plus Gabapentin||0
6350546|NCT00619983|7258933|FG003|NOT COMPLETED|Test Drug Plus Gabapentin||0
6350547|NCT00619983|7258930|FG000|STARTED|Gabapentin Alone||3
6350548|NCT00619983|7258931|FG001|STARTED|Gabapentin Alone||4
6350549|NCT00619983|7258932|FG002|STARTED|Gabapentin Alone||4
6350550|NCT00619983|7258933|FG003|STARTED|Gabapentin Alone||3
6350551|NCT00619983|7258930|FG000|COMPLETED|Gabapentin Alone||3
6350552|NCT00619983|7258931|FG001|COMPLETED|Gabapentin Alone||4
6350553|NCT00619983|7258932|FG002|COMPLETED|Gabapentin Alone||4
6350554|NCT00619983|7258933|FG003|COMPLETED|Gabapentin Alone||3
6350555|NCT00619983|7258930|FG000|NOT COMPLETED|Gabapentin Alone||0
6350556|NCT00619983|7258931|FG001|NOT COMPLETED|Gabapentin Alone||0
6350557|NCT00619983|7258932|FG002|NOT COMPLETED|Gabapentin Alone||0
6350558|NCT00619983|7258933|FG003|NOT COMPLETED|Gabapentin Alone||0
6350559|NCT00620022|7258943|FG000|STARTED|Treatment Period 1||46
6350560|NCT00620022|7258944|FG001|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
6350561|NCT00620022|7258943|FG000|COMPLETED|Treatment Period 1||41
6350562|NCT00620022|7258944|FG001|COMPLETED|Treatment Period 1||37
6350563|NCT00620022|7258943|FG000|NOT COMPLETED|Treatment Period 1||5
6350564|NCT00620022|7258944|FG001|NOT COMPLETED|Treatment Period 1||6
6350565|NCT00620022|7258943|FG000|STARTED|Treatment Period 2||41
6350566|NCT00620022|7258944|FG001|STARTED|Treatment Period 2||37
6350567|NCT00620022|7258943|FG000|COMPLETED|Treatment Period 2||39
6350568|NCT00620022|7258944|FG001|COMPLETED|Treatment Period 2||35
6350569|NCT00620022|7258943|FG000|NOT COMPLETED|Treatment Period 2||2
6350570|NCT00620022|7258944|FG001|NOT COMPLETED|Treatment Period 2||2
6350571|NCT00620061|7258950|FG000|STARTED|Overall Study||439
6350572|NCT00620061|7258950|FG000|COMPLETED|Overall Study||286
6350573|NCT00620061|7258950|FG000|NOT COMPLETED|Overall Study||153
6350574|NCT00620074|7258955|FG000|STARTED|Overall Study||6
6350575|NCT00620074|7258955|FG000|COMPLETED|Overall Study||5
6350576|NCT00620074|7258955|FG000|NOT COMPLETED|Overall Study||1
6350577|NCT00620113|7258963|FG000|STARTED|Overall Study||73
6350578|NCT00620113|7258964|FG001|STARTED|Overall Study||74
6350579|NCT00620113|7258965|FG002|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
6350580|NCT00620113|7258966|FG003|STARTED|Overall Study||69
6350581|NCT00620113|7258963|FG000|Efficacy/Safety Population|Overall Study||73
6350582|NCT00620113|7258964|FG001|Efficacy/Safety Population|Overall Study||74
6350583|NCT00620113|7258965|FG002|Efficacy/Safety Population|Overall Study||70
6350584|NCT00620113|7258966|FG003|Efficacy/Safety Population|Overall Study||69
6350585|NCT00620113|7258963|FG000|COMPLETED|Overall Study||60
6350586|NCT00620113|7258964|FG001|COMPLETED|Overall Study||67
6350587|NCT00620113|7258965|FG002|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
6350588|NCT00620113|7258966|FG003|COMPLETED|Overall Study||59
6350589|NCT00620113|7258963|FG000|NOT COMPLETED|Overall Study||13
6350590|NCT00620113|7258964|FG001|NOT COMPLETED|Overall Study||7
6350591|NCT00620113|7258965|FG002|NOT COMPLETED|Overall Study||5
6350592|NCT00620113|7258966|FG003|NOT COMPLETED|Overall Study||10
6350593|NCT00620126|7258978|FG000|STARTED|Overall Study||25
6350594|NCT00620126|7258979|FG001|STARTED|Overall Study||22
6350595|NCT00620126|7258978|FG000|COMPLETED|Overall Study||14
6350596|NCT00620126|7258979|FG001|COMPLETED|Overall Study||17
6350597|NCT00620126|7258978|FG000|NOT COMPLETED|Overall Study||11
6350598|NCT00620126|7258979|FG001|NOT COMPLETED|Overall Study||5
6350599|NCT00620191|7258987|FG000|STARTED|Overall Study||40
6350600|NCT00620191|7258988|FG001|STARTED|Overall Study||40
6350601|NCT00620191|7258987|FG000|3 Month Follow-up|Overall Study||39
6350602|NCT00620191|7258988|FG001|3 Month Follow-up|Overall Study||39
6350603|NCT00620191|7258987|FG000|6 Month Follow-up|Overall Study||38
6350604|NCT00620191|7258988|FG001|6 Month Follow-up|Overall Study||36
6350605|NCT00620191|7258987|FG000|9 Month Follow-up|Overall Study||37
6350606|NCT00620191|7258988|FG001|9 Month Follow-up|Overall Study||34
6350607|NCT00620191|7258987|FG000|COMPLETED|Overall Study|12 month follow-up|33
6350608|NCT00620191|7258988|FG001|COMPLETED|Overall Study|12 month follow-up|32
6350609|NCT00620191|7258987|FG000|NOT COMPLETED|Overall Study||7
6350610|NCT00620191|7258988|FG001|NOT COMPLETED|Overall Study||8
6350611|NCT00620282|7259002|FG000|STARTED|Overall Study||16
6350612|NCT00620282|7259003|FG001|STARTED|Overall Study||16
6350613|NCT00620282|7259004|FG002|STARTED|Overall Study||17
6350614|NCT00620282|7259002|FG000|COMPLETED|Overall Study||16
6350615|NCT00620282|7259003|FG001|COMPLETED|Overall Study||14
6350616|NCT00620282|7259004|FG002|COMPLETED|Overall Study||16
6350617|NCT00620282|7259002|FG000|NOT COMPLETED|Overall Study||0
6350618|NCT00620282|7259003|FG001|NOT COMPLETED|Overall Study||2
6350619|NCT00620282|7259004|FG002|NOT COMPLETED|Overall Study||1
6350620|NCT00620321|7259014|FG000|STARTED|Overall Study||8
6350621|NCT00620321|7259015|FG001|STARTED|Overall Study||16
6350622|NCT00620321|7259014|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6350623|NCT00620321|7259015|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
6350624|NCT00620321|7259014|FG000|COMPLETED|Overall Study||0
6350625|NCT00620321|7259015|FG001|COMPLETED|Overall Study||0
6350626|NCT00620321|7259014|FG000|NOT COMPLETED|Overall Study||8
6350627|NCT00620321|7259015|FG001|NOT COMPLETED|Overall Study||16
6350628|NCT00620373|7259021|FG000|STARTED|Overall Study||969
6350629|NCT00620373|7259021|FG000|COMPLETED|Overall Study||936
6350630|NCT00620373|7259021|FG000|NOT COMPLETED|Overall Study||33
6350631|NCT00620425|7259028|FG000|STARTED|Overall Study||18
6350632|NCT00620425|7259028|FG000|COMPLETED|Overall Study||18
6350633|NCT00620425|7259028|FG000|NOT COMPLETED|Overall Study||0
6350634|NCT00620503|7259039|FG000|STARTED|Screening (up to 21 Days)||2
6350635|NCT00620503|7259040|FG001|STARTED|Screening (up to 21 Days)||2
6350636|NCT00620503|7259041|FG002|STARTED|Screening (up to 21 Days)||2
6350637|NCT00620503|7259042|FG003|STARTED|Screening (up to 21 Days)||2
6350638|NCT00620503|7259043|FG004|STARTED|Screening (up to 21 Days)||2
6350639|NCT00620503|7259044|FG005|STARTED|Screening (up to 21 Days)||2
6350640|NCT00620503|7259039|FG000|COMPLETED|Screening (up to 21 Days)||2
6350641|NCT00620503|7259040|FG001|COMPLETED|Screening (up to 21 Days)||2
6350642|NCT00620503|7259041|FG002|COMPLETED|Screening (up to 21 Days)||2
6350643|NCT00620503|7259042|FG003|COMPLETED|Screening (up to 21 Days)||2
6350644|NCT00620503|7259043|FG004|COMPLETED|Screening (up to 21 Days)||2
6350645|NCT00620503|7259044|FG005|COMPLETED|Screening (up to 21 Days)||2
6350646|NCT00620503|7259039|FG000|NOT COMPLETED|Screening (up to 21 Days)||0
6350647|NCT00620503|7259040|FG001|NOT COMPLETED|Screening (up to 21 Days)||0
6350648|NCT00620503|7259041|FG002|NOT COMPLETED|Screening (up to 21 Days)||0
6350649|NCT00620503|7259042|FG003|NOT COMPLETED|Screening (up to 21 Days)||0
6350650|NCT00620503|7259043|FG004|NOT COMPLETED|Screening (up to 21 Days)||0
6350651|NCT00620503|7259044|FG005|NOT COMPLETED|Screening (up to 21 Days)||0
6350652|NCT00620503|7259039|FG000|STARTED|Treatment Period 1 (TP1) (7days)||2
6350653|NCT00620503|7259040|FG001|STARTED|Treatment Period 1 (TP1) (7days)||2
6350654|NCT00620503|7259041|FG002|STARTED|Treatment Period 1 (TP1) (7days)||2
6350655|NCT00620503|7259042|FG003|STARTED|Treatment Period 1 (TP1) (7days)||2
6350656|NCT00620503|7259043|FG004|STARTED|Treatment Period 1 (TP1) (7days)||2
6350657|NCT00620503|7259044|FG005|STARTED|Treatment Period 1 (TP1) (7days)||2
6350658|NCT00620503|7259039|FG000|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6350659|NCT00620503|7259040|FG001|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6350660|NCT00620503|7259041|FG002|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6350661|NCT00620503|7259042|FG003|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6350662|NCT00620503|7259043|FG004|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6350663|NCT00620503|7259044|FG005|COMPLETED|Treatment Period 1 (TP1) (7days)||2
6350664|NCT00620503|7259039|FG000|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6350665|NCT00620503|7259040|FG001|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6350666|NCT00620503|7259041|FG002|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6350667|NCT00620503|7259042|FG003|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6350668|NCT00620503|7259043|FG004|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6350669|NCT00620503|7259044|FG005|NOT COMPLETED|Treatment Period 1 (TP1) (7days)||0
6350670|NCT00620503|7259039|FG000|STARTED|Washout (at Least 1 Day)||2
6350671|NCT00620503|7259040|FG001|STARTED|Washout (at Least 1 Day)||2
6350672|NCT00620503|7259041|FG002|STARTED|Washout (at Least 1 Day)||2
6350673|NCT00620503|7259042|FG003|STARTED|Washout (at Least 1 Day)||2
6350674|NCT00620503|7259043|FG004|STARTED|Washout (at Least 1 Day)||2
6350675|NCT00620503|7259044|FG005|STARTED|Washout (at Least 1 Day)||2
6350676|NCT00620503|7259039|FG000|COMPLETED|Washout (at Least 1 Day)||2
6350677|NCT00620503|7259040|FG001|COMPLETED|Washout (at Least 1 Day)||2
6350678|NCT00620503|7259041|FG002|COMPLETED|Washout (at Least 1 Day)||2
6350679|NCT00620503|7259042|FG003|COMPLETED|Washout (at Least 1 Day)||2
6350680|NCT00620503|7259043|FG004|COMPLETED|Washout (at Least 1 Day)||2
6350681|NCT00620503|7259044|FG005|COMPLETED|Washout (at Least 1 Day)||2
6350682|NCT00620503|7259039|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
6350683|NCT00620503|7259040|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
6350684|NCT00620503|7259041|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
6350685|NCT00620503|7259042|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
6350686|NCT00620503|7259043|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
6350687|NCT00620503|7259044|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
6350688|NCT00620503|7259039|FG000|STARTED|Treatment Period 2 (TP2) (7days)||2
6350689|NCT00620503|7259040|FG001|STARTED|Treatment Period 2 (TP2) (7days)||2
6350690|NCT00620503|7259041|FG002|STARTED|Treatment Period 2 (TP2) (7days)||2
6350691|NCT00620503|7259042|FG003|STARTED|Treatment Period 2 (TP2) (7days)||2
6350692|NCT00620503|7259043|FG004|STARTED|Treatment Period 2 (TP2) (7days)||2
6350693|NCT00620503|7259044|FG005|STARTED|Treatment Period 2 (TP2) (7days)||2
6350694|NCT00620503|7259039|FG000|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6350695|NCT00620503|7259040|FG001|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6350696|NCT00620503|7259041|FG002|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6350697|NCT00620503|7259042|FG003|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6350698|NCT00620503|7259043|FG004|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6350699|NCT00620503|7259044|FG005|COMPLETED|Treatment Period 2 (TP2) (7days)||2
6350700|NCT00620503|7259039|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6350701|NCT00620503|7259040|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6350702|NCT00620503|7259041|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6350703|NCT00620503|7259042|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6350704|NCT00620503|7259043|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6350705|NCT00620503|7259044|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (7days)||0
6350706|NCT00620503|7259039|FG000|STARTED|Washout (at Least 1 Day)||2
6350707|NCT00620503|7259040|FG001|STARTED|Washout (at Least 1 Day)||2
6350708|NCT00620503|7259041|FG002|STARTED|Washout (at Least 1 Day)||2
6350709|NCT00620503|7259042|FG003|STARTED|Washout (at Least 1 Day)||2
6350710|NCT00620503|7259043|FG004|STARTED|Washout (at Least 1 Day)||2
6350711|NCT00620503|7259044|FG005|STARTED|Washout (at Least 1 Day)||2
6350712|NCT00620503|7259039|FG000|COMPLETED|Washout (at Least 1 Day)||2
6350713|NCT00620503|7259040|FG001|COMPLETED|Washout (at Least 1 Day)||2
6350714|NCT00620503|7259041|FG002|COMPLETED|Washout (at Least 1 Day)||2
6350715|NCT00620503|7259042|FG003|COMPLETED|Washout (at Least 1 Day)||2
6350716|NCT00620503|7259043|FG004|COMPLETED|Washout (at Least 1 Day)||2
6350717|NCT00620503|7259044|FG005|COMPLETED|Washout (at Least 1 Day)||2
6350718|NCT00620503|7259039|FG000|NOT COMPLETED|Washout (at Least 1 Day)||0
6350719|NCT00620503|7259040|FG001|NOT COMPLETED|Washout (at Least 1 Day)||0
6350720|NCT00620503|7259041|FG002|NOT COMPLETED|Washout (at Least 1 Day)||0
6350721|NCT00620503|7259042|FG003|NOT COMPLETED|Washout (at Least 1 Day)||0
6350722|NCT00620503|7259043|FG004|NOT COMPLETED|Washout (at Least 1 Day)||0
6350723|NCT00620503|7259044|FG005|NOT COMPLETED|Washout (at Least 1 Day)||0
6350724|NCT00620503|7259039|FG000|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6350725|NCT00620503|7259040|FG001|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6350726|NCT00620503|7259041|FG002|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6350727|NCT00620503|7259042|FG003|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6350728|NCT00620503|7259043|FG004|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6350729|NCT00620503|7259044|FG005|STARTED|Treatment Period 3 (TP3) (7 Days)||2
6350730|NCT00620503|7259039|FG000|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6350731|NCT00620503|7259040|FG001|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6350732|NCT00620503|7259041|FG002|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6350733|NCT00620503|7259042|FG003|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6350734|NCT00620503|7259043|FG004|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6350735|NCT00620503|7259044|FG005|COMPLETED|Treatment Period 3 (TP3) (7 Days)||2
6350736|NCT00620503|7259039|FG000|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6350737|NCT00620503|7259040|FG001|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6350738|NCT00620503|7259041|FG002|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6350739|NCT00620503|7259042|FG003|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6350740|NCT00620503|7259043|FG004|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6350741|NCT00620503|7259044|FG005|NOT COMPLETED|Treatment Period 3 (TP3) (7 Days)||0
6350742|NCT00620503|7259039|FG000|STARTED|Follow-up (up to 14 Days)||2
6350743|NCT00620503|7259040|FG001|STARTED|Follow-up (up to 14 Days)||2
6350744|NCT00620503|7259041|FG002|STARTED|Follow-up (up to 14 Days)||2
6350745|NCT00620503|7259042|FG003|STARTED|Follow-up (up to 14 Days)||2
6350746|NCT00620503|7259043|FG004|STARTED|Follow-up (up to 14 Days)||2
6350747|NCT00620503|7259044|FG005|STARTED|Follow-up (up to 14 Days)||2
6350748|NCT00620503|7259039|FG000|COMPLETED|Follow-up (up to 14 Days)||2
6350749|NCT00620503|7259040|FG001|COMPLETED|Follow-up (up to 14 Days)||2
6350750|NCT00620503|7259041|FG002|COMPLETED|Follow-up (up to 14 Days)||2
6350751|NCT00620503|7259042|FG003|COMPLETED|Follow-up (up to 14 Days)||2
6350752|NCT00620503|7259043|FG004|COMPLETED|Follow-up (up to 14 Days)||2
6350753|NCT00620503|7259044|FG005|COMPLETED|Follow-up (up to 14 Days)||2
6350754|NCT00620503|7259039|FG000|NOT COMPLETED|Follow-up (up to 14 Days)||0
6350755|NCT00620503|7259040|FG001|NOT COMPLETED|Follow-up (up to 14 Days)||0
6350756|NCT00620503|7259041|FG002|NOT COMPLETED|Follow-up (up to 14 Days)||0
6350757|NCT00620503|7259042|FG003|NOT COMPLETED|Follow-up (up to 14 Days)||0
6350758|NCT00620503|7259043|FG004|NOT COMPLETED|Follow-up (up to 14 Days)||0
6350759|NCT00620503|7259044|FG005|NOT COMPLETED|Follow-up (up to 14 Days)||0
6350760|NCT00620542|7259054|FG000|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
6350761|NCT00620542|7259055|FG001|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
6350762|NCT00620542|7259056|FG002|STARTED|Part A (Run-in - 2 Weeks)||0
6350763|NCT00620542|7259057|FG003|STARTED|Part A (Run-in - 2 Weeks)||0
6350764|NCT00620542|7259054|FG000|Received Treatment|Part A (Run-in - 2 Weeks)||783
6350765|NCT00620542|7259055|FG001|Received Treatment|Part A (Run-in - 2 Weeks)||795
6350766|NCT00620542|7259056|FG002|Received Treatment|Part A (Run-in - 2 Weeks)||0
6350767|NCT00620542|7259057|FG003|Received Treatment|Part A (Run-in - 2 Weeks)||0
6350768|NCT00620542|7259054|FG000|COMPLETED|Part A (Run-in - 2 Weeks)||695
6350769|NCT00620542|7259055|FG001|COMPLETED|Part A (Run-in - 2 Weeks)||690
6350770|NCT00620542|7259056|FG002|COMPLETED|Part A (Run-in - 2 Weeks)||0
6350771|NCT00620542|7259057|FG003|COMPLETED|Part A (Run-in - 2 Weeks)||0
6350772|NCT00620542|7259054|FG000|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
6350773|NCT00620542|7259055|FG001|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
6350774|NCT00620542|7259056|FG002|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
6350775|NCT00620542|7259057|FG003|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
6350776|NCT00620542|7259054|FG000|STARTED|Part B (2 Year Core Study)||0
6350777|NCT00620542|7259055|FG001|STARTED|Part B (2 Year Core Study)||0
6350778|NCT00620542|7259056|FG002|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
6350779|NCT00620542|7259057|FG003|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
6350780|NCT00620542|7259054|FG000|Received Treatment|Part B (2 Year Core Study)||0
6350781|NCT00620542|7259055|FG001|Received Treatment|Part B (2 Year Core Study)||0
6350782|NCT00620542|7259056|FG002|Received Treatment|Part B (2 Year Core Study)||691
6350783|NCT00620542|7259057|FG003|Received Treatment|Part B (2 Year Core Study)||689
6350784|NCT00620542|7259054|FG000|Intent-to-treat Population|Part B (2 Year Core Study)||0
6350785|NCT00620542|7259055|FG001|Intent-to-treat Population|Part B (2 Year Core Study)||0
6350786|NCT00620542|7259056|FG002|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
6350787|NCT00620542|7259057|FG003|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
6350788|NCT00620542|7259054|FG000|COMPLETED|Part B (2 Year Core Study)||0
6350789|NCT00620542|7259055|FG001|COMPLETED|Part B (2 Year Core Study)||0
6350790|NCT00620542|7259056|FG002|COMPLETED|Part B (2 Year Core Study)||546
6350791|NCT00620542|7259057|FG003|COMPLETED|Part B (2 Year Core Study)||547
6350792|NCT00620542|7259054|FG000|NOT COMPLETED|Part B (2 Year Core Study)||0
6350793|NCT00620542|7259055|FG001|NOT COMPLETED|Part B (2 Year Core Study)||0
6350794|NCT00620542|7259056|FG002|NOT COMPLETED|Part B (2 Year Core Study)||148
6350795|NCT00620542|7259057|FG003|NOT COMPLETED|Part B (2 Year Core Study)||144
6350796|NCT00620555|7259065|FG000|STARTED|Overall Study||65
6350797|NCT00620555|7259065|FG000|COMPLETED|Overall Study||44
6350798|NCT00620555|7259065|FG000|NOT COMPLETED|Overall Study||21
6350799|NCT00620659|7259069|FG000|STARTED|Treatment Period 1||21
6350800|NCT00620659|7259070|FG001|STARTED|Treatment Period 1||21
6350801|NCT00620659|7259071|FG002|STARTED|Treatment Period 1||21
6350802|NCT00620659|7259072|FG003|STARTED|Treatment Period 1||21
6350803|NCT00620659|7259073|FG004|STARTED|Treatment Period 1||21
6350804|NCT00620659|7259074|FG005|STARTED|Treatment Period 1||20
6350805|NCT00620659|7259069|FG000|COMPLETED|Treatment Period 1||18
6350806|NCT00620659|7259070|FG001|COMPLETED|Treatment Period 1||21
6350807|NCT00620659|7259071|FG002|COMPLETED|Treatment Period 1||20
6350808|NCT00620659|7259072|FG003|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
6350809|NCT00620659|7259073|FG004|COMPLETED|Treatment Period 1||20
6350810|NCT00620659|7259074|FG005|COMPLETED|Treatment Period 1||20
6350811|NCT00620659|7259069|FG000|NOT COMPLETED|Treatment Period 1||3
6350812|NCT00620659|7259070|FG001|NOT COMPLETED|Treatment Period 1||0
6350813|NCT00620659|7259071|FG002|NOT COMPLETED|Treatment Period 1||1
6350814|NCT00620659|7259072|FG003|NOT COMPLETED|Treatment Period 1||3
6350815|NCT00620659|7259073|FG004|NOT COMPLETED|Treatment Period 1||1
6350816|NCT00620659|7259074|FG005|NOT COMPLETED|Treatment Period 1||0
6350817|NCT00620659|7259069|FG000|STARTED|Placebo Washout Period 1||18
6350818|NCT00620659|7259070|FG001|STARTED|Placebo Washout Period 1||21
6350819|NCT00620659|7259071|FG002|STARTED|Placebo Washout Period 1||20
6350820|NCT00620659|7259072|FG003|STARTED|Placebo Washout Period 1||19
6350821|NCT00620659|7259073|FG004|STARTED|Placebo Washout Period 1||20
6350822|NCT00620659|7259074|FG005|STARTED|Placebo Washout Period 1||20
6350823|NCT00620659|7259069|FG000|COMPLETED|Placebo Washout Period 1||18
6350824|NCT00620659|7259070|FG001|COMPLETED|Placebo Washout Period 1||21
6350825|NCT00620659|7259071|FG002|COMPLETED|Placebo Washout Period 1||20
6350826|NCT00620659|7259072|FG003|COMPLETED|Placebo Washout Period 1||18
6350827|NCT00620659|7259073|FG004|COMPLETED|Placebo Washout Period 1||20
6350828|NCT00620659|7259074|FG005|COMPLETED|Placebo Washout Period 1||20
6350829|NCT00620659|7259069|FG000|NOT COMPLETED|Placebo Washout Period 1||0
6350830|NCT00620659|7259070|FG001|NOT COMPLETED|Placebo Washout Period 1||0
6350831|NCT00620659|7259071|FG002|NOT COMPLETED|Placebo Washout Period 1||0
6350832|NCT00620659|7259072|FG003|NOT COMPLETED|Placebo Washout Period 1||1
6350833|NCT00620659|7259073|FG004|NOT COMPLETED|Placebo Washout Period 1||0
6350834|NCT00620659|7259074|FG005|NOT COMPLETED|Placebo Washout Period 1||0
6350835|NCT00620659|7259069|FG000|STARTED|Treatment Period 2||18
6350836|NCT00620659|7259070|FG001|STARTED|Treatment Period 2||21
6350837|NCT00620659|7259071|FG002|STARTED|Treatment Period 2||20
6350838|NCT00620659|7259072|FG003|STARTED|Treatment Period 2||18
6350839|NCT00620659|7259073|FG004|STARTED|Treatment Period 2||20
6350840|NCT00620659|7259074|FG005|STARTED|Treatment Period 2||20
6350841|NCT00620659|7259069|FG000|COMPLETED|Treatment Period 2||18
6350842|NCT00620659|7259070|FG001|COMPLETED|Treatment Period 2||18
6350843|NCT00620659|7259071|FG002|COMPLETED|Treatment Period 2||19
6350844|NCT00620659|7259072|FG003|COMPLETED|Treatment Period 2||18
6350845|NCT00620659|7259073|FG004|COMPLETED|Treatment Period 2||15
6350846|NCT00620659|7259074|FG005|COMPLETED|Treatment Period 2||20
6350847|NCT00620659|7259069|FG000|NOT COMPLETED|Treatment Period 2||0
6350848|NCT00620659|7259070|FG001|NOT COMPLETED|Treatment Period 2||3
6350849|NCT00620659|7259071|FG002|NOT COMPLETED|Treatment Period 2||1
6350850|NCT00620659|7259072|FG003|NOT COMPLETED|Treatment Period 2||0
6350851|NCT00620659|7259073|FG004|NOT COMPLETED|Treatment Period 2||5
6350852|NCT00620659|7259074|FG005|NOT COMPLETED|Treatment Period 2||0
6350853|NCT00620659|7259069|FG000|STARTED|Placebo Washout Period 2||18
6350854|NCT00620659|7259070|FG001|STARTED|Placebo Washout Period 2||18
6350855|NCT00620659|7259071|FG002|STARTED|Placebo Washout Period 2||19
6350856|NCT00620659|7259072|FG003|STARTED|Placebo Washout Period 2||18
6350857|NCT00620659|7259073|FG004|STARTED|Placebo Washout Period 2||15
6350858|NCT00620659|7259074|FG005|STARTED|Placebo Washout Period 2||20
6350859|NCT00620659|7259069|FG000|COMPLETED|Placebo Washout Period 2||16
6350860|NCT00620659|7259070|FG001|COMPLETED|Placebo Washout Period 2||18
6350861|NCT00620659|7259071|FG002|COMPLETED|Placebo Washout Period 2||19
6350862|NCT00620659|7259072|FG003|COMPLETED|Placebo Washout Period 2||18
6350863|NCT00620659|7259073|FG004|COMPLETED|Placebo Washout Period 2||15
6350864|NCT00620659|7259074|FG005|COMPLETED|Placebo Washout Period 2||20
6350865|NCT00620659|7259069|FG000|NOT COMPLETED|Placebo Washout Period 2||2
6350866|NCT00620659|7259070|FG001|NOT COMPLETED|Placebo Washout Period 2||0
6350867|NCT00620659|7259071|FG002|NOT COMPLETED|Placebo Washout Period 2||0
6350868|NCT00620659|7259072|FG003|NOT COMPLETED|Placebo Washout Period 2||0
6350869|NCT00620659|7259073|FG004|NOT COMPLETED|Placebo Washout Period 2||0
6350870|NCT00620659|7259074|FG005|NOT COMPLETED|Placebo Washout Period 2||0
6350871|NCT00620659|7259069|FG000|STARTED|Treatment Period 3||16
6350872|NCT00620659|7259070|FG001|STARTED|Treatment Period 3||18
6350873|NCT00620659|7259071|FG002|STARTED|Treatment Period 3||19
6350874|NCT00620659|7259072|FG003|STARTED|Treatment Period 3||18
6350875|NCT00620659|7259073|FG004|STARTED|Treatment Period 3||15
6350876|NCT00620659|7259074|FG005|STARTED|Treatment Period 3||20
6350877|NCT00620659|7259069|FG000|COMPLETED|Treatment Period 3||16
6350878|NCT00620659|7259070|FG001|COMPLETED|Treatment Period 3||16
6350879|NCT00620659|7259071|FG002|COMPLETED|Treatment Period 3||19
6350880|NCT00620659|7259072|FG003|COMPLETED|Treatment Period 3||17
6350881|NCT00620659|7259073|FG004|COMPLETED|Treatment Period 3||15
6350882|NCT00620659|7259074|FG005|COMPLETED|Treatment Period 3||20
6350883|NCT00620659|7259069|FG000|NOT COMPLETED|Treatment Period 3||0
6350884|NCT00620659|7259070|FG001|NOT COMPLETED|Treatment Period 3||2
6350885|NCT00620659|7259071|FG002|NOT COMPLETED|Treatment Period 3||0
6350886|NCT00620659|7259072|FG003|NOT COMPLETED|Treatment Period 3||1
6350887|NCT00620659|7259073|FG004|NOT COMPLETED|Treatment Period 3||0
6350888|NCT00620659|7259074|FG005|NOT COMPLETED|Treatment Period 3||0
6350889|NCT00620698|7259087|FG000|STARTED|Overall Study||89
6350890|NCT00620698|7259087|FG000|COMPLETED|Overall Study||60
6350891|NCT00620698|7259087|FG000|NOT COMPLETED|Overall Study||29
6350892|NCT00620711|7259091|FG000|STARTED|Overall Study||4
6350893|NCT00620711|7259091|FG000|COMPLETED|Overall Study||4
6350894|NCT00620711|7259091|FG000|NOT COMPLETED|Overall Study||0
6350895|NCT00620750|7259095|FG000|STARTED|Overall Study||65
6350896|NCT00620750|7259095|FG000|COMPLETED|Overall Study||40
6350897|NCT00620750|7259095|FG000|NOT COMPLETED|Overall Study||25
6350898|NCT00620763|7259099|FG000|STARTED|Period: First Intervention||10
6350899|NCT00620763|7259100|FG001|STARTED|Period: First Intervention||12
6350900|NCT00620763|7259099|FG000|COMPLETED|Period: First Intervention||10
6350901|NCT00620763|7259100|FG001|COMPLETED|Period: First Intervention||7
6559634|NCT01782664|7482319|FG003|COMPLETED|Overall Study||9
6559635|NCT01782664|7482320|FG004|COMPLETED|Overall Study||6
6350902|NCT00620763|7259099|FG000|NOT COMPLETED|Period: First Intervention||0
6350903|NCT00620763|7259100|FG001|NOT COMPLETED|Period: First Intervention||5
6350904|NCT00620763|7259099|FG000|STARTED|Period: Washout Period of 1 Week||10
6350905|NCT00620763|7259100|FG001|STARTED|Period: Washout Period of 1 Week||7
6350906|NCT00620763|7259099|FG000|COMPLETED|Period: Washout Period of 1 Week||10
6350907|NCT00620763|7259100|FG001|COMPLETED|Period: Washout Period of 1 Week||7
6350908|NCT00620763|7259099|FG000|NOT COMPLETED|Period: Washout Period of 1 Week||0
6350909|NCT00620763|7259100|FG001|NOT COMPLETED|Period: Washout Period of 1 Week||0
6350910|NCT00620763|7259099|FG000|STARTED|Period: Second Intervention||10
6350911|NCT00620763|7259100|FG001|STARTED|Period: Second Intervention||7
6350912|NCT00620763|7259099|FG000|COMPLETED|Period: Second Intervention||9
6350913|NCT00620763|7259100|FG001|COMPLETED|Period: Second Intervention||7
6350914|NCT00620763|7259099|FG000|NOT COMPLETED|Period: Second Intervention||1
6350915|NCT00620763|7259100|FG001|NOT COMPLETED|Period: Second Intervention||0
6350916|NCT00620776|7259108|FG000|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
6350917|NCT00620776|7259109|FG001|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
6350918|NCT00620776|7259108|FG000|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
6350919|NCT00620776|7259109|FG001|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
6350920|NCT00620776|7259108|FG000|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
6350921|NCT00620776|7259109|FG001|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
6350922|NCT00620776|7259108|FG000|NOT COMPLETED|Overall Study||12
6350923|NCT00620776|7259109|FG001|NOT COMPLETED|Overall Study||16
6350924|NCT00620815|7259118|FG000|STARTED|Overall Study||199
6350925|NCT00620815|7259119|FG001|STARTED|Overall Study||203
6350926|NCT00620815|7259120|FG002|STARTED|Overall Study||199
6350927|NCT00620815|7259118|FG000|COMPLETED|Overall Study||195
6350928|NCT00620815|7259119|FG001|COMPLETED|Overall Study||192
6350929|NCT00620815|7259120|FG002|COMPLETED|Overall Study||192
6350930|NCT00620815|7259118|FG000|NOT COMPLETED|Overall Study||4
6350931|NCT00620815|7259119|FG001|NOT COMPLETED|Overall Study||11
6350932|NCT00620815|7259120|FG002|NOT COMPLETED|Overall Study||7
6350933|NCT00620828|7259146|FG000|STARTED|Overall Study||32
6350934|NCT00620828|7259147|FG001|STARTED|Overall Study||35
6350935|NCT00620828|7259146|FG000|Number of Subjects Enrolled = 67|Overall Study||32
6350936|NCT00620828|7259147|FG001|Number of Subjects Enrolled = 67|Overall Study||35
6350937|NCT00620828|7259146|FG000|COMPLETED|Overall Study||32
6350938|NCT00620828|7259147|FG001|COMPLETED|Overall Study||35
6350939|NCT00620828|7259146|FG000|NOT COMPLETED|Overall Study||0
6350940|NCT00620828|7259147|FG001|NOT COMPLETED|Overall Study||0
6350941|NCT00620854|7259159|FG000|STARTED|Period 1||4
6350942|NCT00620854|7259160|FG001|STARTED|Period 1||4
6350943|NCT00620854|7259161|FG002|STARTED|Period 1||4
6350944|NCT00620854|7259162|FG003|STARTED|Period 1||4
6350945|NCT00620854|7259163|FG004|STARTED|Period 1||4
6350946|NCT00620854|7259164|FG005|STARTED|Period 1||4
6350947|NCT00620854|7259159|FG000|COMPLETED|Period 1||4
6350948|NCT00620854|7259160|FG001|COMPLETED|Period 1||4
6350949|NCT00620854|7259161|FG002|COMPLETED|Period 1||4
6350950|NCT00620854|7259162|FG003|COMPLETED|Period 1||4
6350951|NCT00620854|7259163|FG004|COMPLETED|Period 1||4
6350952|NCT00620854|7259164|FG005|COMPLETED|Period 1||4
6350953|NCT00620854|7259159|FG000|NOT COMPLETED|Period 1||0
6350954|NCT00620854|7259160|FG001|NOT COMPLETED|Period 1||0
6350955|NCT00620854|7259161|FG002|NOT COMPLETED|Period 1||0
6350956|NCT00620854|7259162|FG003|NOT COMPLETED|Period 1||0
6350957|NCT00620854|7259163|FG004|NOT COMPLETED|Period 1||0
6350958|NCT00620854|7259164|FG005|NOT COMPLETED|Period 1||0
6350959|NCT00620854|7259159|FG000|STARTED|Washout 1||4
6350960|NCT00620854|7259160|FG001|STARTED|Washout 1||4
6350961|NCT00620854|7259161|FG002|STARTED|Washout 1||4
6350962|NCT00620854|7259162|FG003|STARTED|Washout 1||4
6350963|NCT00620854|7259163|FG004|STARTED|Washout 1||4
6350964|NCT00620854|7259164|FG005|STARTED|Washout 1||4
6350965|NCT00620854|7259159|FG000|COMPLETED|Washout 1||4
6350966|NCT00620854|7259160|FG001|COMPLETED|Washout 1||4
6350967|NCT00620854|7259161|FG002|COMPLETED|Washout 1||3
6350968|NCT00620854|7259162|FG003|COMPLETED|Washout 1||3
6350969|NCT00620854|7259163|FG004|COMPLETED|Washout 1||4
6350970|NCT00620854|7259164|FG005|COMPLETED|Washout 1||4
6350971|NCT00620854|7259159|FG000|NOT COMPLETED|Washout 1||0
6350972|NCT00620854|7259160|FG001|NOT COMPLETED|Washout 1||0
6350973|NCT00620854|7259161|FG002|NOT COMPLETED|Washout 1||1
6350974|NCT00620854|7259162|FG003|NOT COMPLETED|Washout 1||1
6350975|NCT00620854|7259163|FG004|NOT COMPLETED|Washout 1||0
6350976|NCT00620854|7259164|FG005|NOT COMPLETED|Washout 1||0
6350977|NCT00620854|7259159|FG000|STARTED|Period 2||4
6350978|NCT00620854|7259160|FG001|STARTED|Period 2||4
6350979|NCT00620854|7259161|FG002|STARTED|Period 2||3
6350980|NCT00620854|7259162|FG003|STARTED|Period 2||3
6350981|NCT00620854|7259163|FG004|STARTED|Period 2||4
6350982|NCT00620854|7259164|FG005|STARTED|Period 2||4
6350983|NCT00620854|7259159|FG000|COMPLETED|Period 2||4
6350984|NCT00620854|7259160|FG001|COMPLETED|Period 2||4
6350985|NCT00620854|7259161|FG002|COMPLETED|Period 2||3
6350986|NCT00620854|7259162|FG003|COMPLETED|Period 2||3
6350987|NCT00620854|7259163|FG004|COMPLETED|Period 2||4
6350988|NCT00620854|7259164|FG005|COMPLETED|Period 2||4
6350989|NCT00620854|7259159|FG000|NOT COMPLETED|Period 2||0
6350990|NCT00620854|7259160|FG001|NOT COMPLETED|Period 2||0
6350991|NCT00620854|7259161|FG002|NOT COMPLETED|Period 2||0
6350992|NCT00620854|7259162|FG003|NOT COMPLETED|Period 2||0
6350993|NCT00620854|7259163|FG004|NOT COMPLETED|Period 2||0
6350994|NCT00620854|7259164|FG005|NOT COMPLETED|Period 2||0
6350995|NCT00620854|7259159|FG000|STARTED|Washout 2||4
6350996|NCT00620854|7259160|FG001|STARTED|Washout 2||4
6350997|NCT00620854|7259161|FG002|STARTED|Washout 2||3
6350998|NCT00620854|7259162|FG003|STARTED|Washout 2||3
6350999|NCT00620854|7259163|FG004|STARTED|Washout 2||4
6351000|NCT00620854|7259164|FG005|STARTED|Washout 2||4
6351001|NCT00620854|7259159|FG000|COMPLETED|Washout 2||4
6351002|NCT00620854|7259160|FG001|COMPLETED|Washout 2||4
6351003|NCT00620854|7259161|FG002|COMPLETED|Washout 2||3
6351004|NCT00620854|7259162|FG003|COMPLETED|Washout 2||3
6351005|NCT00620854|7259163|FG004|COMPLETED|Washout 2||4
6351006|NCT00620854|7259164|FG005|COMPLETED|Washout 2||4
6351007|NCT00620854|7259159|FG000|NOT COMPLETED|Washout 2||0
6351008|NCT00620854|7259160|FG001|NOT COMPLETED|Washout 2||0
6351009|NCT00620854|7259161|FG002|NOT COMPLETED|Washout 2||0
6351010|NCT00620854|7259162|FG003|NOT COMPLETED|Washout 2||0
6351011|NCT00620854|7259163|FG004|NOT COMPLETED|Washout 2||0
6351012|NCT00620854|7259164|FG005|NOT COMPLETED|Washout 2||0
6351013|NCT00620854|7259159|FG000|STARTED|Period 3||4
6351014|NCT00620854|7259160|FG001|STARTED|Period 3||4
6351015|NCT00620854|7259161|FG002|STARTED|Period 3||3
6351016|NCT00620854|7259162|FG003|STARTED|Period 3||3
6351017|NCT00620854|7259163|FG004|STARTED|Period 3||4
6351018|NCT00620854|7259164|FG005|STARTED|Period 3||4
6351019|NCT00620854|7259159|FG000|COMPLETED|Period 3||4
6351020|NCT00620854|7259160|FG001|COMPLETED|Period 3||4
6351021|NCT00620854|7259161|FG002|COMPLETED|Period 3||3
6351022|NCT00620854|7259162|FG003|COMPLETED|Period 3||3
6351023|NCT00620854|7259163|FG004|COMPLETED|Period 3||4
6351024|NCT00620854|7259164|FG005|COMPLETED|Period 3||4
6351025|NCT00620854|7259159|FG000|NOT COMPLETED|Period 3||0
6351026|NCT00620854|7259160|FG001|NOT COMPLETED|Period 3||0
6351027|NCT00620854|7259161|FG002|NOT COMPLETED|Period 3||0
6351028|NCT00620854|7259162|FG003|NOT COMPLETED|Period 3||0
6351029|NCT00620854|7259163|FG004|NOT COMPLETED|Period 3||0
6351030|NCT00620854|7259164|FG005|NOT COMPLETED|Period 3||0
6351031|NCT00620945|7259175|FG000|STARTED|Overall Study|Total number in the study|87
6351032|NCT00620945|7259175|FG000|COMPLETED|Overall Study||87
6351033|NCT00620945|7259175|FG000|NOT COMPLETED|Overall Study||0
6351034|NCT00621023|7259179|FG000|STARTED|Overall Study||6
6351035|NCT00621023|7259179|FG000|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
6351036|NCT00621023|7259179|FG000|NOT COMPLETED|Overall Study||6
6351037|NCT00621049|7259185|FG000|STARTED|Adjuvant Treatment||55
6351038|NCT00621049|7259186|FG001|STARTED|Adjuvant Treatment||57
6351039|NCT00621049|7259185|FG000|COMPLETED|Adjuvant Treatment||52
6351040|NCT00621049|7259186|FG001|COMPLETED|Adjuvant Treatment||47
6351041|NCT00621049|7259185|FG000|NOT COMPLETED|Adjuvant Treatment||3
6351042|NCT00621049|7259186|FG001|NOT COMPLETED|Adjuvant Treatment||10
6351043|NCT00621049|7259185|FG000|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
6351044|NCT00621049|7259186|FG001|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
6351045|NCT00621049|7259185|FG000|COMPLETED|Maintenance Treatment||34
6351046|NCT00621049|7259186|FG001|COMPLETED|Maintenance Treatment||0
6351047|NCT00621049|7259185|FG000|NOT COMPLETED|Maintenance Treatment||15
6351048|NCT00621049|7259186|FG001|NOT COMPLETED|Maintenance Treatment||0
6351049|NCT00621140|7259194|FG000|STARTED|Overall Study|number who started treatment|167
6351050|NCT00621140|7259195|FG001|STARTED|Overall Study|number who started treatment|336
6351051|NCT00621140|7259194|FG000|COMPLETED|Overall Study|number who completed treatment|152
6351052|NCT00621140|7259195|FG001|COMPLETED|Overall Study|number who completed treatment|318
6351053|NCT00621140|7259194|FG000|NOT COMPLETED|Overall Study||15
6351054|NCT00621140|7259195|FG001|NOT COMPLETED|Overall Study||18
6351055|NCT00621153|7259203|FG000|STARTED|Overall Study|randomised|117
6351056|NCT00621153|7259204|FG001|STARTED|Overall Study|randomised|116
6351057|NCT00621153|7259203|FG000|Discontinued|Overall Study||20
6351058|NCT00621153|7259204|FG001|Discontinued|Overall Study||15
6351059|NCT00621153|7259203|FG000|COMPLETED|Overall Study|completed|97
6351060|NCT00621153|7259204|FG001|COMPLETED|Overall Study|completed|101
6351061|NCT00621153|7259203|FG000|NOT COMPLETED|Overall Study||20
6351062|NCT00621153|7259204|FG001|NOT COMPLETED|Overall Study||15
6351063|NCT00621179|7259214|FG000|STARTED|Overall Study||12
6351064|NCT00621179|7259215|FG001|STARTED|Overall Study||8
6351065|NCT00621179|7259216|FG002|STARTED|Overall Study||7
6351066|NCT00621179|7259217|FG003|STARTED|Overall Study||10
6351067|NCT00621179|7259214|FG000|COMPLETED|Overall Study||12
6351068|NCT00621179|7259215|FG001|COMPLETED|Overall Study||8
6351069|NCT00621179|7259216|FG002|COMPLETED|Overall Study||6
6351070|NCT00621179|7259217|FG003|COMPLETED|Overall Study||9
6351071|NCT00621179|7259214|FG000|NOT COMPLETED|Overall Study||0
6351072|NCT00621179|7259215|FG001|NOT COMPLETED|Overall Study||0
6351073|NCT00621179|7259216|FG002|NOT COMPLETED|Overall Study||1
6351074|NCT00621179|7259217|FG003|NOT COMPLETED|Overall Study||1
6351075|NCT00621192|7259231|FG000|STARTED|Overall Study||39
6351076|NCT00621192|7259232|FG001|STARTED|Overall Study||103
6351077|NCT00621192|7259233|FG002|STARTED|Overall Study||31
6351078|NCT00621192|7259234|FG003|STARTED|Overall Study||27
6351079|NCT00621192|7259231|FG000|Safety Population|Overall Study||39
6351080|NCT00621192|7259232|FG001|Safety Population|Overall Study||103
6351081|NCT00621192|7259233|FG002|Safety Population|Overall Study||31
6351082|NCT00621192|7259234|FG003|Safety Population|Overall Study||27
6351083|NCT00621192|7259231|FG000|Efficacy Population|Overall Study||39
6351084|NCT00621192|7259232|FG001|Efficacy Population|Overall Study||101
6351085|NCT00621192|7259233|FG002|Efficacy Population|Overall Study||28
6351086|NCT00621192|7259234|FG003|Efficacy Population|Overall Study||27
6351087|NCT00621192|7259231|FG000|COMPLETED|Overall Study||35
6351088|NCT00621192|7259232|FG001|COMPLETED|Overall Study||94
6559636|NCT01782664|7482321|FG005|COMPLETED|Overall Study||2
6559637|NCT01782664|7482316|FG000|NOT COMPLETED|Overall Study||6
6559638|NCT01782664|7482317|FG001|NOT COMPLETED|Overall Study||5
6559639|NCT01782664|7482318|FG002|NOT COMPLETED|Overall Study||4
6559640|NCT01782664|7482319|FG003|NOT COMPLETED|Overall Study||5
6351089|NCT00621192|7259233|FG002|COMPLETED|Overall Study||26
6351090|NCT00621192|7259234|FG003|COMPLETED|Overall Study||24
6351091|NCT00621192|7259231|FG000|NOT COMPLETED|Overall Study||4
6351092|NCT00621192|7259232|FG001|NOT COMPLETED|Overall Study||9
6351093|NCT00621192|7259233|FG002|NOT COMPLETED|Overall Study||5
6351094|NCT00621192|7259234|FG003|NOT COMPLETED|Overall Study||3
6351095|NCT00621244|7259248|FG000|STARTED|Overall Study||86
6351096|NCT00621244|7259249|FG001|STARTED|Overall Study||34
6351097|NCT00621244|7259250|FG002|STARTED|Overall Study||33
6351098|NCT00621244|7259251|FG003|STARTED|Overall Study||23
6351099|NCT00621244|7259248|FG000|COMPLETED|Overall Study||0
6351100|NCT00621244|7259249|FG001|COMPLETED|Overall Study||0
6351101|NCT00621244|7259250|FG002|COMPLETED|Overall Study||0
6351102|NCT00621244|7259251|FG003|COMPLETED|Overall Study||0
6351103|NCT00621244|7259248|FG000|NOT COMPLETED|Overall Study||86
6351104|NCT00621244|7259249|FG001|NOT COMPLETED|Overall Study||34
6351105|NCT00621244|7259250|FG002|NOT COMPLETED|Overall Study||33
6351106|NCT00621244|7259251|FG003|NOT COMPLETED|Overall Study||23
6351107|NCT00621257|7259330|FG000|STARTED|Overall Study||24
6351108|NCT00621257|7259331|FG001|STARTED|Overall Study||24
6351109|NCT00621257|7259332|FG002|STARTED|Overall Study||23
6351110|NCT00621257|7259333|FG003|STARTED|Overall Study||32
6351111|NCT00621257|7259334|FG004|STARTED|Overall Study||31
6351112|NCT00621257|7259330|FG000|COMPLETED|Overall Study||20
6351113|NCT00621257|7259331|FG001|COMPLETED|Overall Study||21
6351114|NCT00621257|7259332|FG002|COMPLETED|Overall Study||20
6351115|NCT00621257|7259333|FG003|COMPLETED|Overall Study||26
6351116|NCT00621257|7259334|FG004|COMPLETED|Overall Study||22
6351117|NCT00621257|7259330|FG000|NOT COMPLETED|Overall Study||4
6351118|NCT00621257|7259331|FG001|NOT COMPLETED|Overall Study||3
6351119|NCT00621257|7259332|FG002|NOT COMPLETED|Overall Study||3
6351120|NCT00621257|7259333|FG003|NOT COMPLETED|Overall Study||6
6351121|NCT00621257|7259334|FG004|NOT COMPLETED|Overall Study||9
6351122|NCT00621296|7259346|FG000|STARTED|Overall Study||15
6351123|NCT00621296|7259346|FG000|COMPLETED|Overall Study||1
6351124|NCT00621296|7259346|FG000|NOT COMPLETED|Overall Study||14
6351125|NCT00621309|7259350|FG000|STARTED|Overall Study||6
6351126|NCT00621309|7259351|FG001|STARTED|Overall Study||4
6351127|NCT00621309|7259352|FG002|STARTED|Overall Study||5
6351128|NCT00621309|7259353|FG003|STARTED|Overall Study||6
6351129|NCT00621309|7259354|FG004|STARTED|Overall Study||4
6351130|NCT00621309|7259355|FG005|STARTED|Overall Study||4
6351131|NCT00621309|7259350|FG000|COMPLETED|Overall Study||4
6351132|NCT00621309|7259351|FG001|COMPLETED|Overall Study||4
6351133|NCT00621309|7259352|FG002|COMPLETED|Overall Study||4
6351134|NCT00621309|7259353|FG003|COMPLETED|Overall Study||5
6351135|NCT00621309|7259354|FG004|COMPLETED|Overall Study||3
6351136|NCT00621309|7259355|FG005|COMPLETED|Overall Study||3
6351137|NCT00621309|7259350|FG000|NOT COMPLETED|Overall Study||2
6351138|NCT00621309|7259351|FG001|NOT COMPLETED|Overall Study||0
6351139|NCT00621309|7259352|FG002|NOT COMPLETED|Overall Study||1
6351140|NCT00621309|7259353|FG003|NOT COMPLETED|Overall Study||1
6351141|NCT00621309|7259354|FG004|NOT COMPLETED|Overall Study||1
6351142|NCT00621309|7259355|FG005|NOT COMPLETED|Overall Study||1
6351143|NCT00621322|7259367|FG000|STARTED|Overall Study||10
6351144|NCT00621322|7259368|FG001|STARTED|Overall Study||10
6351145|NCT00621322|7259369|FG002|STARTED|Overall Study||40
6351146|NCT00621322|7259370|FG003|STARTED|Overall Study||40
6351147|NCT00621322|7259371|FG004|STARTED|Overall Study||40
6351148|NCT00621322|7259372|FG005|STARTED|Overall Study||40
6351149|NCT00621322|7259367|FG000|COMPLETED|Overall Study||9
6351150|NCT00621322|7259368|FG001|COMPLETED|Overall Study||10
6351151|NCT00621322|7259369|FG002|COMPLETED|Overall Study||38
6351152|NCT00621322|7259370|FG003|COMPLETED|Overall Study||37
6351153|NCT00621322|7259371|FG004|COMPLETED|Overall Study||39
6351154|NCT00621322|7259372|FG005|COMPLETED|Overall Study||36
6351155|NCT00621322|7259367|FG000|NOT COMPLETED|Overall Study||1
6351156|NCT00621322|7259368|FG001|NOT COMPLETED|Overall Study||0
6351157|NCT00621322|7259369|FG002|NOT COMPLETED|Overall Study||2
6351158|NCT00621322|7259370|FG003|NOT COMPLETED|Overall Study||3
6351159|NCT00621322|7259371|FG004|NOT COMPLETED|Overall Study||1
6351160|NCT00621322|7259372|FG005|NOT COMPLETED|Overall Study||4
6351161|NCT00621348|7259389|FG000|STARTED|Overall Study||58
6559641|NCT01782664|7482320|FG004|NOT COMPLETED|Overall Study||0
6351162|NCT00621348|7259390|FG001|STARTED|Overall Study||53
6351163|NCT00621348|7259391|FG002|STARTED|Overall Study||56
6351164|NCT00621348|7259389|FG000|COMPLETED|Overall Study||58
6351165|NCT00621348|7259390|FG001|COMPLETED|Overall Study||53
6351166|NCT00621348|7259391|FG002|COMPLETED|Overall Study||56
6351167|NCT00621348|7259389|FG000|NOT COMPLETED|Overall Study||0
6351168|NCT00621348|7259390|FG001|NOT COMPLETED|Overall Study||0
6351169|NCT00621348|7259391|FG002|NOT COMPLETED|Overall Study||0
6351170|NCT00621504|7259401|FG000|STARTED|Overall Study||299
6351171|NCT00621504|7259402|FG001|STARTED|Overall Study||307
6351172|NCT00621504|7259401|FG000|COMPLETED|Overall Study||273
6351173|NCT00621504|7259402|FG001|COMPLETED|Overall Study||282
6351174|NCT00621504|7259401|FG000|NOT COMPLETED|Overall Study||26
6351175|NCT00621504|7259402|FG001|NOT COMPLETED|Overall Study||25
6351176|NCT00621517|7259410|FG000|STARTED|Overall Study||29
6351177|NCT00621517|7259411|FG001|STARTED|Overall Study||31
6351178|NCT00621517|7259410|FG000|COMPLETED|Overall Study||22
6351179|NCT00621517|7259411|FG001|COMPLETED|Overall Study||24
6351180|NCT00621517|7259410|FG000|NOT COMPLETED|Overall Study||7
6351181|NCT00621517|7259411|FG001|NOT COMPLETED|Overall Study||7
6351182|NCT00621530|7259419|FG000|STARTED|Overall Study||30
6351183|NCT00621530|7259420|FG001|STARTED|Overall Study||32
6351184|NCT00621530|7259419|FG000|COMPLETED|Overall Study||28
6351185|NCT00621530|7259420|FG001|COMPLETED|Overall Study||29
6351186|NCT00621530|7259419|FG000|NOT COMPLETED|Overall Study||2
6351187|NCT00621530|7259420|FG001|NOT COMPLETED|Overall Study||3
6351188|NCT00621543|7259429|FG000|STARTED|Overall Study||120
6351189|NCT00621543|7259429|FG000|COMPLETED|Overall Study||97
6351190|NCT00621543|7259429|FG000|NOT COMPLETED|Overall Study||23
6351191|NCT00621582|7259433|FG000|STARTED|Overall Study||4918
6351192|NCT00621582|7259433|FG000|COMPLETED|Overall Study||4812
6351193|NCT00621582|7259433|FG000|NOT COMPLETED|Overall Study||106
6351194|NCT00621621|7259440|FG000|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
6351195|NCT00621621|7259441|FG001|STARTED|Overall Study||705
6351196|NCT00621621|7259440|FG000|COMPLETED|Overall Study|Treated with the experimental catheter|75
6351197|NCT00621621|7259441|FG001|COMPLETED|Overall Study||705
6351198|NCT00621621|7259440|FG000|NOT COMPLETED|Overall Study||30
6351199|NCT00621621|7259441|FG001|NOT COMPLETED|Overall Study||0
6351200|NCT00621686|7259451|FG000|STARTED|Overall Study||19
6351201|NCT00621686|7259452|FG001|STARTED|Overall Study||35
6351202|NCT00621686|7259451|FG000|COMPLETED|Overall Study||19
6351203|NCT00621686|7259452|FG001|COMPLETED|Overall Study||35
6351204|NCT00621686|7259451|FG000|NOT COMPLETED|Overall Study||0
6351205|NCT00621686|7259452|FG001|NOT COMPLETED|Overall Study||0
6351206|NCT00621764|7259463|FG000|STARTED|Overall Study||50
6351207|NCT00621764|7259464|FG001|STARTED|Overall Study||50
6351208|NCT00621764|7259465|FG002|STARTED|Overall Study||101
6351209|NCT00621764|7259466|FG003|STARTED|Overall Study||99
6351210|NCT00621764|7259463|FG000|COMPLETED|Overall Study||50
6351211|NCT00621764|7259464|FG001|COMPLETED|Overall Study||50
6351212|NCT00621764|7259465|FG002|COMPLETED|Overall Study||101
6351213|NCT00621764|7259466|FG003|COMPLETED|Overall Study||98
6351214|NCT00621764|7259463|FG000|NOT COMPLETED|Overall Study||0
6351215|NCT00621764|7259464|FG001|NOT COMPLETED|Overall Study||0
6351216|NCT00621764|7259465|FG002|NOT COMPLETED|Overall Study||0
6351217|NCT00621764|7259466|FG003|NOT COMPLETED|Overall Study||1
6351218|NCT00621777|7259479|FG000|STARTED|Open Phase||203
6351219|NCT00621777|7259480|FG001|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
6351220|NCT00621777|7259479|FG000|COMPLETED|Open Phase||87
6351221|NCT00621777|7259480|FG001|COMPLETED|Open Phase||0
6351222|NCT00621777|7259479|FG000|NOT COMPLETED|Open Phase||116
6351223|NCT00621777|7259480|FG001|NOT COMPLETED|Open Phase||0
6351224|NCT00621777|7259479|FG000|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
6351225|NCT00621777|7259480|FG001|STARTED|Randomized Phase||47
6351226|NCT00621777|7259479|FG000|COMPLETED|Randomized Phase||33
6351227|NCT00621777|7259480|FG001|COMPLETED|Randomized Phase||28
6351228|NCT00621777|7259479|FG000|NOT COMPLETED|Randomized Phase||7
6351229|NCT00621777|7259480|FG001|NOT COMPLETED|Randomized Phase||19
6351230|NCT00621842|7259488|FG000|STARTED|Overall Study||57
6351231|NCT00621842|7259488|FG000|COMPLETED|Overall Study||38
6351232|NCT00621842|7259488|FG000|NOT COMPLETED|Overall Study||19
6351233|NCT00621855|7259497|FG000|STARTED|Overall Study|Started means randomised to treatment|372
6351234|NCT00621855|7259498|FG001|STARTED|Overall Study|Started means randomised to treatment|371
6351235|NCT00621855|7259499|FG002|STARTED|Overall Study|Started means randomised to treatment|411
6351236|NCT00621855|7259500|FG003|STARTED|Overall Study|Started means randomised to treatment|351
6351237|NCT00621855|7259501|FG004|STARTED|Overall Study|Started means randomised to treatment|373
6351238|NCT00621855|7259497|FG000|COMPLETED|Overall Study|Completed means completed treatment|296
6351239|NCT00621855|7259498|FG001|COMPLETED|Overall Study|Completed means completed treatment|310
6351240|NCT00621855|7259499|FG002|COMPLETED|Overall Study|Completed means completed treatment|330
6351241|NCT00621855|7259500|FG003|COMPLETED|Overall Study|Completed means completed treatment|284
6351242|NCT00621855|7259501|FG004|COMPLETED|Overall Study|Completed means completed treatment|318
6351243|NCT00621855|7259497|FG000|NOT COMPLETED|Overall Study||76
6351244|NCT00621855|7259498|FG001|NOT COMPLETED|Overall Study||61
6351245|NCT00621855|7259499|FG002|NOT COMPLETED|Overall Study||81
6351246|NCT00621855|7259500|FG003|NOT COMPLETED|Overall Study||67
6351247|NCT00621855|7259501|FG004|NOT COMPLETED|Overall Study||55
6351248|NCT00621933|7259513|FG000|STARTED|Overall Study||399
6351249|NCT00621933|7259513|FG000|COMPLETED|Overall Study||399
6351250|NCT00621933|7259513|FG000|NOT COMPLETED|Overall Study||0
6351251|NCT00621946|7259519|FG000|STARTED|Overall Study||13
6351252|NCT00621946|7259520|FG001|STARTED|Overall Study||13
6351253|NCT00621946|7259519|FG000|COMPLETED|Overall Study||13
6351254|NCT00621946|7259520|FG001|COMPLETED|Overall Study||12
6351255|NCT00621946|7259519|FG000|NOT COMPLETED|Overall Study||0
6351256|NCT00621946|7259520|FG001|NOT COMPLETED|Overall Study||1
6351257|NCT00621959|7259529|FG000|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
6351258|NCT00621959|7259530|FG001|STARTED|Overall Study||301
6351259|NCT00621959|7259529|FG000|COMPLETED|Overall Study||288
6351260|NCT00621959|7259530|FG001|COMPLETED|Overall Study||292
6351261|NCT00621959|7259529|FG000|NOT COMPLETED|Overall Study||7
6351262|NCT00621959|7259530|FG001|NOT COMPLETED|Overall Study||9
6351263|NCT00621985|7259536|FG000|STARTED|Hydrocortisone Admission||5
6351264|NCT00621985|7259536|FG000|COMPLETED|Hydrocortisone Admission||5
6351265|NCT00621985|7259536|FG000|NOT COMPLETED|Hydrocortisone Admission||0
6351266|NCT00621985|7259536|FG000|STARTED|Dexamethasone Admission||5
6351267|NCT00621985|7259536|FG000|COMPLETED|Dexamethasone Admission||4
6351268|NCT00621985|7259536|FG000|NOT COMPLETED|Dexamethasone Admission||1
6351269|NCT00622180|7259542|FG000|STARTED|Overall Study||6
6351270|NCT00622180|7259543|FG001|STARTED|Overall Study||7
6351271|NCT00622180|7259542|FG000|COMPLETED|Overall Study||5
6351272|NCT00622180|7259543|FG001|COMPLETED|Overall Study||5
6351273|NCT00622180|7259542|FG000|NOT COMPLETED|Overall Study||1
6351274|NCT00622180|7259543|FG001|NOT COMPLETED|Overall Study||2
6351275|NCT00622284|7259551|FG000|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
6351276|NCT00622284|7259552|FG001|STARTED|Overall Study|Number who started treatment.|775
6351277|NCT00622284|7259551|FG000|COMPLETED|Overall Study|Number who completed treatment.|587
6351278|NCT00622284|7259552|FG001|COMPLETED|Overall Study|Number who completed treatment.|604
6351279|NCT00622284|7259551|FG000|NOT COMPLETED|Overall Study||189
6351280|NCT00622284|7259552|FG001|NOT COMPLETED|Overall Study||171
6351281|NCT00622336|7259558|FG000|STARTED|Treatment Phase||330
6351282|NCT00622336|7259558|FG000|Safety Population|Treatment Phase||330
6351283|NCT00622336|7259558|FG000|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
6351284|NCT00622336|7259558|FG000|NOT COMPLETED|Treatment Phase||309
6351285|NCT00622336|7259558|FG000|STARTED|Extension Phase||21
6351286|NCT00622336|7259558|FG000|COMPLETED|Extension Phase||0
6351287|NCT00622336|7259558|FG000|NOT COMPLETED|Extension Phase||21
6351288|NCT00622388|7259564|FG000|STARTED|Overall Study||81
6351289|NCT00622388|7259564|FG000|COMPLETED|Overall Study||9
6351290|NCT00622388|7259564|FG000|NOT COMPLETED|Overall Study||72
6351291|NCT00622401|7259572|FG000|STARTED|Overall Study||6
6351292|NCT00622401|7259573|FG001|STARTED|Overall Study||2
6351293|NCT00622401|7259574|FG002|STARTED|Overall Study|Never Opened|0
6351294|NCT00622401|7259572|FG000|COMPLETED|Overall Study||3
6351295|NCT00622401|7259573|FG001|COMPLETED|Overall Study||0
6351296|NCT00622401|7259574|FG002|COMPLETED|Overall Study||0
6351297|NCT00622401|7259572|FG000|NOT COMPLETED|Overall Study||3
6351298|NCT00622401|7259573|FG001|NOT COMPLETED|Overall Study||2
6351299|NCT00622401|7259574|FG002|NOT COMPLETED|Overall Study||0
6351300|NCT00622427|7259583|FG000|STARTED|Overall Study||16
6351301|NCT00622427|7259584|FG001|STARTED|Overall Study||16
6351302|NCT00622427|7259583|FG000|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
6351303|NCT00622427|7259584|FG001|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
6351304|NCT00622427|7259583|FG000|NOT COMPLETED|Overall Study||0
6351305|NCT00622427|7259584|FG001|NOT COMPLETED|Overall Study||0
6351306|NCT00622440|7259594|FG000|STARTED|Baseline - Week 12 (Treatment)||35
6351307|NCT00622440|7259595|FG001|STARTED|Baseline - Week 12 (Treatment)||35
6351308|NCT00622440|7259594|FG000|COMPLETED|Baseline - Week 12 (Treatment)||31
6351309|NCT00622440|7259595|FG001|COMPLETED|Baseline - Week 12 (Treatment)||34
6351310|NCT00622440|7259594|FG000|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
6351311|NCT00622440|7259595|FG001|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
6351312|NCT00622440|7259594|FG000|STARTED|Week 12 - Week 48 (Treatment)||31
6351313|NCT00622440|7259595|FG001|STARTED|Week 12 - Week 48 (Treatment)||34
6351314|NCT00622440|7259594|FG000|COMPLETED|Week 12 - Week 48 (Treatment)||28
6351315|NCT00622440|7259595|FG001|COMPLETED|Week 12 - Week 48 (Treatment)||28
6351316|NCT00622440|7259594|FG000|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
6351317|NCT00622440|7259595|FG001|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
6351318|NCT00622440|7259594|FG000|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
6351319|NCT00622440|7259595|FG001|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
6351320|NCT00622440|7259594|FG000|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
6351321|NCT00622440|7259595|FG001|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
6351322|NCT00622440|7259594|FG000|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
6351323|NCT00622440|7259595|FG001|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
6351324|NCT00622466|7259601|FG000|STARTED|Overall Study||20
6351325|NCT00622466|7259601|FG000|COMPLETED|Overall Study||16
6351326|NCT00622466|7259601|FG000|NOT COMPLETED|Overall Study||4
6351327|NCT00622505|7259607|FG000|STARTED|Overall Study||79
6351328|NCT00622505|7259608|FG001|STARTED|Overall Study||42
6351329|NCT00622505|7259607|FG000|COMPLETED|Overall Study||50
6351330|NCT00622505|7259608|FG001|COMPLETED|Overall Study||19
6351331|NCT00622505|7259607|FG000|NOT COMPLETED|Overall Study||29
6351332|NCT00622505|7259608|FG001|NOT COMPLETED|Overall Study||23
6351333|NCT00622518|7259616|FG000|STARTED|Overall Study||59
6351334|NCT00622518|7259617|FG001|STARTED|Overall Study||60
6351335|NCT00622518|7259616|FG000|COMPLETED|Overall Study||59
6351336|NCT00622518|7259617|FG001|COMPLETED|Overall Study||60
6351337|NCT00622518|7259616|FG000|NOT COMPLETED|Overall Study||0
6351338|NCT00622518|7259617|FG001|NOT COMPLETED|Overall Study||0
6351339|NCT00622544|7259623|FG000|STARTED|Overall Study||44
6351340|NCT00622544|7259623|FG000|COMPLETED|Overall Study|35|35
6351341|NCT00622544|7259623|FG000|NOT COMPLETED|Overall Study||9
6351342|NCT00622635|7259627|FG000|STARTED|Treatment Period 1||13
6351343|NCT00622635|7259628|FG001|STARTED|Treatment Period 1||11
6351344|NCT00622635|7259629|FG002|STARTED|Treatment Period 1||11
6351345|NCT00622635|7259630|FG003|STARTED|Treatment Period 1||13
6351346|NCT00622635|7259631|FG004|STARTED|Treatment Period 1||10
6351347|NCT00622635|7259632|FG005|STARTED|Treatment Period 1||10
6351348|NCT00622635|7259627|FG000|COMPLETED|Treatment Period 1||13
6351349|NCT00622635|7259628|FG001|COMPLETED|Treatment Period 1||10
6351350|NCT00622635|7259629|FG002|COMPLETED|Treatment Period 1||10
6351351|NCT00622635|7259630|FG003|COMPLETED|Treatment Period 1||13
6351352|NCT00622635|7259631|FG004|COMPLETED|Treatment Period 1||9
6351353|NCT00622635|7259632|FG005|COMPLETED|Treatment Period 1||10
6351354|NCT00622635|7259627|FG000|NOT COMPLETED|Treatment Period 1||0
6351355|NCT00622635|7259628|FG001|NOT COMPLETED|Treatment Period 1||1
6351356|NCT00622635|7259629|FG002|NOT COMPLETED|Treatment Period 1||1
6351357|NCT00622635|7259630|FG003|NOT COMPLETED|Treatment Period 1||0
6351358|NCT00622635|7259631|FG004|NOT COMPLETED|Treatment Period 1||1
6351359|NCT00622635|7259632|FG005|NOT COMPLETED|Treatment Period 1||0
6351360|NCT00622635|7259627|FG000|STARTED|Treatment Period 2||13
6351361|NCT00622635|7259628|FG001|STARTED|Treatment Period 2||10
6351362|NCT00622635|7259629|FG002|STARTED|Treatment Period 2||10
6351363|NCT00622635|7259630|FG003|STARTED|Treatment Period 2||13
6351364|NCT00622635|7259631|FG004|STARTED|Treatment Period 2||9
6351365|NCT00622635|7259632|FG005|STARTED|Treatment Period 2||10
6351366|NCT00622635|7259627|FG000|COMPLETED|Treatment Period 2||12
6351367|NCT00622635|7259628|FG001|COMPLETED|Treatment Period 2||10
6351368|NCT00622635|7259629|FG002|COMPLETED|Treatment Period 2||10
6351369|NCT00622635|7259630|FG003|COMPLETED|Treatment Period 2||13
6351370|NCT00622635|7259631|FG004|COMPLETED|Treatment Period 2||9
6351371|NCT00622635|7259632|FG005|COMPLETED|Treatment Period 2||10
6351372|NCT00622635|7259627|FG000|NOT COMPLETED|Treatment Period 2||1
6351373|NCT00622635|7259628|FG001|NOT COMPLETED|Treatment Period 2||0
6351374|NCT00622635|7259629|FG002|NOT COMPLETED|Treatment Period 2||0
6351375|NCT00622635|7259630|FG003|NOT COMPLETED|Treatment Period 2||0
6351376|NCT00622635|7259631|FG004|NOT COMPLETED|Treatment Period 2||0
6351377|NCT00622635|7259632|FG005|NOT COMPLETED|Treatment Period 2||0
6351378|NCT00622635|7259627|FG000|STARTED|Treatment Period 3||12
6351379|NCT00622635|7259628|FG001|STARTED|Treatment Period 3||10
6351380|NCT00622635|7259629|FG002|STARTED|Treatment Period 3||10
6351381|NCT00622635|7259630|FG003|STARTED|Treatment Period 3||13
6351382|NCT00622635|7259631|FG004|STARTED|Treatment Period 3||9
6351383|NCT00622635|7259632|FG005|STARTED|Treatment Period 3||10
6351384|NCT00622635|7259627|FG000|COMPLETED|Treatment Period 3||12
6351385|NCT00622635|7259628|FG001|COMPLETED|Treatment Period 3||10
6351386|NCT00622635|7259629|FG002|COMPLETED|Treatment Period 3||10
6351387|NCT00622635|7259630|FG003|COMPLETED|Treatment Period 3||10
6351388|NCT00622635|7259631|FG004|COMPLETED|Treatment Period 3||9
6351389|NCT00622635|7259632|FG005|COMPLETED|Treatment Period 3||10
6351390|NCT00622635|7259627|FG000|NOT COMPLETED|Treatment Period 3||0
6351391|NCT00622635|7259628|FG001|NOT COMPLETED|Treatment Period 3||0
6351392|NCT00622635|7259629|FG002|NOT COMPLETED|Treatment Period 3||0
6351393|NCT00622635|7259630|FG003|NOT COMPLETED|Treatment Period 3||3
6351394|NCT00622635|7259631|FG004|NOT COMPLETED|Treatment Period 3||0
6351395|NCT00622635|7259632|FG005|NOT COMPLETED|Treatment Period 3||0
6351396|NCT00622700|7259643|FG000|STARTED|Core Treatment Period||197
6351397|NCT00622700|7259644|FG001|STARTED|Core Treatment Period||205
6351398|NCT00622700|7259645|FG002|STARTED|Core Treatment Period||216
6351399|NCT00622700|7259646|FG003|STARTED|Core Treatment Period||0
6351400|NCT00622700|7259647|FG004|STARTED|Core Treatment Period||0
6351401|NCT00622700|7259648|FG005|STARTED|Core Treatment Period||0
6351402|NCT00622700|7259649|FG006|STARTED|Core Treatment Period||0
6351403|NCT00622700|7259643|FG000|Treated|Core Treatment Period||197
6351404|NCT00622700|7259644|FG001|Treated|Core Treatment Period||203
6351405|NCT00622700|7259645|FG002|Treated|Core Treatment Period||214
6351406|NCT00622700|7259646|FG003|Treated|Core Treatment Period||0
6351407|NCT00622700|7259647|FG004|Treated|Core Treatment Period||0
6351408|NCT00622700|7259648|FG005|Treated|Core Treatment Period||0
6351409|NCT00622700|7259649|FG006|Treated|Core Treatment Period||0
6351410|NCT00622700|7259643|FG000|COMPLETED|Core Treatment Period||141
6351411|NCT00622700|7259644|FG001|COMPLETED|Core Treatment Period||150
6351412|NCT00622700|7259645|FG002|COMPLETED|Core Treatment Period||163
6351413|NCT00622700|7259646|FG003|COMPLETED|Core Treatment Period||0
6351414|NCT00622700|7259647|FG004|COMPLETED|Core Treatment Period||0
6351415|NCT00622700|7259648|FG005|COMPLETED|Core Treatment Period||0
6351416|NCT00622700|7259649|FG006|COMPLETED|Core Treatment Period||0
6351417|NCT00622700|7259643|FG000|NOT COMPLETED|Core Treatment Period||56
6351418|NCT00622700|7259644|FG001|NOT COMPLETED|Core Treatment Period||55
6351419|NCT00622700|7259645|FG002|NOT COMPLETED|Core Treatment Period||53
6351420|NCT00622700|7259646|FG003|NOT COMPLETED|Core Treatment Period||0
6351421|NCT00622700|7259647|FG004|NOT COMPLETED|Core Treatment Period||0
6351422|NCT00622700|7259648|FG005|NOT COMPLETED|Core Treatment Period||0
6351423|NCT00622700|7259649|FG006|NOT COMPLETED|Core Treatment Period||0
6351424|NCT00622700|7259643|FG000|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
6351425|NCT00622700|7259644|FG001|STARTED|Extension Treatment Period||0
6351426|NCT00622700|7259645|FG002|STARTED|Extension Treatment Period||0
6351427|NCT00622700|7259646|FG003|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
6351428|NCT00622700|7259647|FG004|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
6351429|NCT00622700|7259648|FG005|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
6351430|NCT00622700|7259649|FG006|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
6351431|NCT00622700|7259643|FG000|COMPLETED|Extension Treatment Period||0
6351432|NCT00622700|7259644|FG001|COMPLETED|Extension Treatment Period||0
6351433|NCT00622700|7259645|FG002|COMPLETED|Extension Treatment Period||0
6351434|NCT00622700|7259646|FG003|COMPLETED|Extension Treatment Period||43
6351435|NCT00622700|7259647|FG004|COMPLETED|Extension Treatment Period||103
6351436|NCT00622700|7259648|FG005|COMPLETED|Extension Treatment Period||50
6351437|NCT00622700|7259649|FG006|COMPLETED|Extension Treatment Period||120
6351438|NCT00622700|7259643|FG000|NOT COMPLETED|Extension Treatment Period||0
6351439|NCT00622700|7259644|FG001|NOT COMPLETED|Extension Treatment Period||0
6351440|NCT00622700|7259645|FG002|NOT COMPLETED|Extension Treatment Period||0
6351441|NCT00622700|7259646|FG003|NOT COMPLETED|Extension Treatment Period||21
6351442|NCT00622700|7259647|FG004|NOT COMPLETED|Extension Treatment Period||39
6351443|NCT00622700|7259648|FG005|NOT COMPLETED|Extension Treatment Period||17
6351444|NCT00622700|7259649|FG006|NOT COMPLETED|Extension Treatment Period||30
6351445|NCT00622713|7259666|FG000|STARTED|Overall Study||228
6351446|NCT00622713|7259666|FG000|Exposed to Study Drug|Overall Study||226
6351447|NCT00622713|7259666|FG000|Intent to Treat (ITT) Population|Overall Study||218
6351448|NCT00622713|7259666|FG000|COMPLETED|Overall Study||169
6351449|NCT00622713|7259666|FG000|NOT COMPLETED|Overall Study||59
6351450|NCT00622726|7259672|FG000|STARTED|March, 2008 to August, 2010||75
6351451|NCT00622726|7259673|FG001|STARTED|March, 2008 to August, 2010||75
6351452|NCT00622726|7259672|FG000|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
6351453|NCT00622726|7259673|FG001|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
6351454|NCT00622726|7259672|FG000|NOT COMPLETED|March, 2008 to August, 2010||5
6351455|NCT00622726|7259673|FG001|NOT COMPLETED|March, 2008 to August, 2010||2
6351456|NCT00622726|7259672|FG000|STARTED|August, 2010 to April, 2013||70
6351457|NCT00622726|7259673|FG001|STARTED|August, 2010 to April, 2013||73
6351458|NCT00622726|7259672|FG000|COMPLETED|August, 2010 to April, 2013||69
6351459|NCT00622726|7259673|FG001|COMPLETED|August, 2010 to April, 2013||68
6351460|NCT00622726|7259672|FG000|NOT COMPLETED|August, 2010 to April, 2013||1
6351461|NCT00622726|7259673|FG001|NOT COMPLETED|August, 2010 to April, 2013||5
6351462|NCT00622739|7259685|FG000|STARTED|Overall Study||13
6351463|NCT00622739|7259686|FG001|STARTED|Overall Study||15
6351464|NCT00622739|7259685|FG000|COMPLETED|Overall Study||11
6351465|NCT00622739|7259686|FG001|COMPLETED|Overall Study||9
6351466|NCT00622739|7259685|FG000|NOT COMPLETED|Overall Study||2
6351467|NCT00622739|7259686|FG001|NOT COMPLETED|Overall Study||6
6351468|NCT00622869|7259697|FG000|STARTED|Overall Study||245
6351469|NCT00622869|7259698|FG001|STARTED|Overall Study||231
6351470|NCT00622869|7259699|FG002|STARTED|Overall Study||243
6351471|NCT00622869|7259697|FG000|COMPLETED|Overall Study||202
6351472|NCT00622869|7259698|FG001|COMPLETED|Overall Study||174
6351473|NCT00622869|7259699|FG002|COMPLETED|Overall Study||204
6351474|NCT00622869|7259697|FG000|NOT COMPLETED|Overall Study||43
6351475|NCT00622869|7259698|FG001|NOT COMPLETED|Overall Study||57
6351476|NCT00622869|7259699|FG002|NOT COMPLETED|Overall Study||39
6351477|NCT00622895|7259707|FG000|STARTED|Overall Study||3
6351478|NCT00622895|7259707|FG000|COMPLETED|Overall Study||3
6351479|NCT00622895|7259707|FG000|NOT COMPLETED|Overall Study||0
6351480|NCT00622908|7259716|FG000|STARTED|Overall Study|Intent to treat population|137
6351481|NCT00622908|7259717|FG001|STARTED|Overall Study|Intent to treat population|132
6351482|NCT00622908|7259716|FG000|COMPLETED|Overall Study||134
6351483|NCT00622908|7259717|FG001|COMPLETED|Overall Study||122
6351484|NCT00622908|7259716|FG000|NOT COMPLETED|Overall Study||3
6351485|NCT00622908|7259717|FG001|NOT COMPLETED|Overall Study||10
6351486|NCT00623012|7259723|FG000|STARTED|Overall Study||2
6351487|NCT00623012|7259723|FG000|COMPLETED|Overall Study||2
6351488|NCT00623012|7259723|FG000|NOT COMPLETED|Overall Study||0
6376845|NCT00761319|7287440|FG000|COMPLETED|Overall Study||305
6376846|NCT00761319|7287441|FG001|COMPLETED|Overall Study||318
6376847|NCT00761319|7287440|FG000|NOT COMPLETED|Overall Study||48
6376848|NCT00761319|7287441|FG001|NOT COMPLETED|Overall Study||34
6376849|NCT00761345|7287447|FG000|STARTED|Overall Study||27
6376850|NCT00761345|7287447|FG000|COMPLETED|Overall Study||24
6376851|NCT00761345|7287447|FG000|NOT COMPLETED|Overall Study||3
6376852|NCT00761462|7287453|FG000|STARTED|Treatment|Patients enrolled in study group|510
6376853|NCT00761462|7287454|FG001|STARTED|Treatment|Patients enrolled in study group|519
6376854|NCT00761462|7287453|FG000|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
6376855|NCT00761462|7287454|FG001|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
6376856|NCT00761462|7287453|FG000|NOT COMPLETED|Treatment||23
6376857|NCT00761462|7287454|FG001|NOT COMPLETED|Treatment||12
6376858|NCT00761462|7287453|FG000|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
6377956|NCT00766090|7288652|FG003|COMPLETED|Treatment Period 1 (28 Days)||25
6351489|NCT00623103|7259729|FG000|STARTED|Overall Study||295
6351490|NCT00623103|7259730|FG001|STARTED|Overall Study||288
6351491|NCT00623103|7259729|FG000|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
6351492|NCT00623103|7259730|FG001|Safety Set: Received Study Drug|Overall Study||288
6351493|NCT00623103|7259729|FG000|COMPLETED|Overall Study||184
6351494|NCT00623103|7259730|FG001|COMPLETED|Overall Study||175
6351495|NCT00623103|7259729|FG000|NOT COMPLETED|Overall Study||111
6351496|NCT00623103|7259730|FG001|NOT COMPLETED|Overall Study||113
6351497|NCT00623181|7259738|FG000|STARTED|Overall Study||56
6351498|NCT00623181|7259739|FG001|STARTED|Overall Study||54
6351499|NCT00623181|7259738|FG000|COMPLETED|Overall Study||56
6351500|NCT00623181|7259739|FG001|COMPLETED|Overall Study||54
6351501|NCT00623181|7259738|FG000|NOT COMPLETED|Overall Study||0
6351502|NCT00623181|7259739|FG001|NOT COMPLETED|Overall Study||0
6351503|NCT00623194|7259749|FG000|STARTED|Overall Study||146
6351504|NCT00623194|7259749|FG000|COMPLETED|Overall Study||141
6351505|NCT00623194|7259749|FG000|NOT COMPLETED|Overall Study||5
6351506|NCT00623233|7259753|FG000|STARTED|Overall Study||52
6351507|NCT00623233|7259753|FG000|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
6351508|NCT00623233|7259753|FG000|NOT COMPLETED|Overall Study||24
6351509|NCT00623363|7259759|FG000|STARTED|Overall Study||7
6351510|NCT00623363|7259760|FG001|STARTED|Overall Study||20
6351511|NCT00623363|7259759|FG000|COMPLETED|Overall Study||5
6351512|NCT00623363|7259760|FG001|COMPLETED|Overall Study||18
6351513|NCT00623363|7259759|FG000|NOT COMPLETED|Overall Study||2
6351514|NCT00623363|7259760|FG001|NOT COMPLETED|Overall Study||2
6351515|NCT00623428|7259769|FG000|STARTED|Treatment Period||95
6351516|NCT00623428|7259770|FG001|STARTED|Treatment Period||93
6351517|NCT00623428|7259769|FG000|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
6351518|NCT00623428|7259770|FG001|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
6351519|NCT00623428|7259769|FG000|NOT COMPLETED|Treatment Period||0
6351520|NCT00623428|7259770|FG001|NOT COMPLETED|Treatment Period||27
6351521|NCT00623428|7259769|FG000|STARTED|Follow-up Period||95
6559642|NCT01782664|7482321|FG005|NOT COMPLETED|Overall Study||0
6559643|NCT01782690|7482335|FG000|STARTED|Overall Study||338
6559644|NCT01782690|7482335|FG000|COMPLETED|Overall Study||39
6559645|NCT01782690|7482335|FG000|NOT COMPLETED|Overall Study||299
6351522|NCT00623428|7259770|FG001|STARTED|Follow-up Period||93
6351523|NCT00623428|7259769|FG000|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
6351524|NCT00623428|7259770|FG001|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
6351525|NCT00623428|7259769|FG000|NOT COMPLETED|Follow-up Period||29
6351526|NCT00623428|7259770|FG001|NOT COMPLETED|Follow-up Period||15
6351527|NCT00623441|7259776|FG000|STARTED|Overall Study||8314
6351528|NCT00623441|7259776|FG000|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
6351529|NCT00623441|7259776|FG000|NOT COMPLETED|Overall Study||0
6351530|NCT00623467|7259780|FG000|STARTED|Overall Study||343
6351531|NCT00623467|7259780|FG000|COMPLETED|Overall Study||336
6351532|NCT00623467|7259780|FG000|NOT COMPLETED|Overall Study||7
6351533|NCT00623480|7259788|FG000|STARTED|Overall Study||42
6351534|NCT00623480|7259789|FG001|STARTED|Overall Study||42
6351535|NCT00623480|7259788|FG000|COMPLETED|Overall Study||35
6351536|NCT00623480|7259789|FG001|COMPLETED|Overall Study||35
6351537|NCT00623480|7259788|FG000|NOT COMPLETED|Overall Study||7
6351538|NCT00623480|7259789|FG001|NOT COMPLETED|Overall Study||7
6351539|NCT00623506|7259797|FG000|STARTED|Overall Study||15
6351540|NCT00623506|7259798|FG001|STARTED|Overall Study||15
6351541|NCT00623506|7259797|FG000|Week 4|Overall Study||11
6351542|NCT00623506|7259798|FG001|Week 4|Overall Study||11
6351543|NCT00623506|7259797|FG000|COMPLETED|Overall Study||11
6351544|NCT00623506|7259798|FG001|COMPLETED|Overall Study||11
6351545|NCT00623506|7259797|FG000|NOT COMPLETED|Overall Study||4
6351546|NCT00623506|7259798|FG001|NOT COMPLETED|Overall Study||4
6351547|NCT00623545|7259804|FG000|STARTED|Overall Study||28
6351548|NCT00623545|7259804|FG000|COMPLETED|Overall Study||18
6351549|NCT00623545|7259804|FG000|NOT COMPLETED|Overall Study||10
6351550|NCT00623597|7259811|FG000|STARTED|Overall Study||5
6351551|NCT00623597|7259812|FG001|STARTED|Overall Study||13
6351552|NCT00623597|7259811|FG000|COMPLETED|Overall Study||4
6351553|NCT00623597|7259812|FG001|COMPLETED|Overall Study||13
6351554|NCT00623597|7259811|FG000|NOT COMPLETED|Overall Study||1
6351555|NCT00623597|7259812|FG001|NOT COMPLETED|Overall Study||0
6351556|NCT00623623|7259822|FG000|STARTED|Overall Study||950
6351557|NCT00623623|7259823|FG001|STARTED|Overall Study||949
6351558|NCT00623623|7259822|FG000|COMPLETED|Overall Study||949
6351559|NCT00623623|7259823|FG001|COMPLETED|Overall Study||948
6351560|NCT00623623|7259822|FG000|NOT COMPLETED|Overall Study||1
6351561|NCT00623623|7259823|FG001|NOT COMPLETED|Overall Study||1
6351562|NCT00623636|7259831|FG000|STARTED|Double Blind||452
6351563|NCT00623636|7259832|FG001|STARTED|Double Blind||450
6351564|NCT00623636|7259831|FG000|COMPLETED|Double Blind||419
6351565|NCT00623636|7259832|FG001|COMPLETED|Double Blind||422
6351566|NCT00623636|7259831|FG000|NOT COMPLETED|Double Blind||33
6351567|NCT00623636|7259832|FG001|NOT COMPLETED|Double Blind||28
6351568|NCT00623636|7259831|FG000|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
6351569|NCT00623636|7259832|FG001|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
6559646|NCT01782742|7482341|FG000|STARTED|Double-blind Treatment Phase||16
6351570|NCT00623636|7259831|FG000|COMPLETED|Open Label||0
6351571|NCT00623636|7259832|FG001|COMPLETED|Open Label||263
6351572|NCT00623636|7259831|FG000|NOT COMPLETED|Open Label||0
6351573|NCT00623636|7259832|FG001|NOT COMPLETED|Open Label||412
6351574|NCT00623714|7259839|FG000|STARTED|Period 1||6
6351575|NCT00623714|7259840|FG001|STARTED|Period 1||7
6351576|NCT00623714|7259839|FG000|COMPLETED|Period 1||6
6351577|NCT00623714|7259840|FG001|COMPLETED|Period 1||7
6351578|NCT00623714|7259839|FG000|NOT COMPLETED|Period 1||0
6351579|NCT00623714|7259840|FG001|NOT COMPLETED|Period 1||0
6351580|NCT00623714|7259839|FG000|STARTED|Period 2||6
6351581|NCT00623714|7259840|FG001|STARTED|Period 2||7
6351582|NCT00623714|7259839|FG000|COMPLETED|Period 2||6
6351583|NCT00623714|7259840|FG001|COMPLETED|Period 2||7
6351584|NCT00623714|7259839|FG000|NOT COMPLETED|Period 2||0
6351585|NCT00623714|7259840|FG001|NOT COMPLETED|Period 2||0
6351586|NCT00623727|7259848|FG000|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
6351587|NCT00623727|7259849|FG001|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
6351588|NCT00623727|7259848|FG000|Participants Received Treatment|Double Blind (DB)||67
6351589|NCT00623727|7259849|FG001|Participants Received Treatment|Double Blind (DB)||72
6351590|NCT00623727|7259848|FG000|COMPLETED|Double Blind (DB)||34
6351591|NCT00623727|7259849|FG001|COMPLETED|Double Blind (DB)||41
6351592|NCT00623727|7259848|FG000|NOT COMPLETED|Double Blind (DB)||36
6351593|NCT00623727|7259849|FG001|NOT COMPLETED|Double Blind (DB)||32
6351594|NCT00623727|7259848|FG000|STARTED|Open Label Follow-up||0
6351595|NCT00623727|7259849|FG001|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
6351596|NCT00623727|7259848|FG000|COMPLETED|Open Label Follow-up||0
6351597|NCT00623727|7259849|FG001|COMPLETED|Open Label Follow-up||18
6351598|NCT00623727|7259848|FG000|NOT COMPLETED|Open Label Follow-up||0
6351599|NCT00623727|7259849|FG001|NOT COMPLETED|Open Label Follow-up||8
6351600|NCT00623727|7259848|FG000|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
6351601|NCT00623727|7259849|FG001|STARTED|Open Label Extension Period||0
6351602|NCT00623727|7259848|FG000|COMPLETED|Open Label Extension Period||20
6351603|NCT00623727|7259849|FG001|COMPLETED|Open Label Extension Period||0
6351604|NCT00623727|7259848|FG000|NOT COMPLETED|Open Label Extension Period||0
6351605|NCT00623727|7259849|FG001|NOT COMPLETED|Open Label Extension Period||0
6351606|NCT00623766|7259859|FG000|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
6351607|NCT00623766|7259860|FG001|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
6351608|NCT00623766|7259859|FG000|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
6351609|NCT00623766|7259860|FG001|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
6351610|NCT00623766|7259859|FG000|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
6351611|NCT00623766|7259860|FG001|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
6351612|NCT00623766|7259859|FG000|STARTED|Maintenance Phase (Week 24 to Year 2)||11
6351613|NCT00623766|7259860|FG001|STARTED|Maintenance Phase (Week 24 to Year 2)||2
6351614|NCT00623766|7259859|FG000|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
6351615|NCT00623766|7259860|FG001|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
6351616|NCT00623766|7259859|FG000|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
6351617|NCT00623766|7259860|FG001|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
6351618|NCT00623779|7259873|FG000|STARTED|Overall Study||41
6351619|NCT00623779|7259874|FG001|STARTED|Overall Study||42
6351620|NCT00623779|7259875|FG002|STARTED|Overall Study||45
6351621|NCT00623779|7259873|FG000|COMPLETED|Overall Study||38
6351622|NCT00623779|7259874|FG001|COMPLETED|Overall Study||39
6351623|NCT00623779|7259875|FG002|COMPLETED|Overall Study||44
6351624|NCT00623779|7259873|FG000|NOT COMPLETED|Overall Study||3
6351625|NCT00623779|7259874|FG001|NOT COMPLETED|Overall Study||3
6351626|NCT00623779|7259875|FG002|NOT COMPLETED|Overall Study||1
6351627|NCT00623805|7259885|FG000|STARTED|Overall Study||62
6351628|NCT00623805|7259886|FG001|STARTED|Overall Study||61
6351629|NCT00623805|7259885|FG000|COMPLETED|Overall Study||42
6351630|NCT00623805|7259886|FG001|COMPLETED|Overall Study||39
6351631|NCT00623805|7259885|FG000|NOT COMPLETED|Overall Study||20
6351632|NCT00623805|7259886|FG001|NOT COMPLETED|Overall Study||22
6351633|NCT00623831|7259894|FG000|STARTED|Overall Study||13
6351634|NCT00623831|7259895|FG001|STARTED|Overall Study||4
6351635|NCT00623831|7259894|FG000|COMPLETED|Overall Study||12
6351636|NCT00623831|7259895|FG001|COMPLETED|Overall Study||3
6351637|NCT00623831|7259894|FG000|NOT COMPLETED|Overall Study||1
6351638|NCT00623831|7259895|FG001|NOT COMPLETED|Overall Study||1
6351639|NCT00623935|7259904|FG000|STARTED|Overall Study||56
6351640|NCT00623935|7259904|FG000|COMPLETED|Overall Study||54
6351641|NCT00623935|7259904|FG000|NOT COMPLETED|Overall Study||2
6351642|NCT00624013|7259910|FG000|STARTED|Overall Study||44
6351643|NCT00624013|7259911|FG001|STARTED|Overall Study||45
6351644|NCT00624013|7259910|FG000|COMPLETED|Overall Study||36
6351645|NCT00624013|7259911|FG001|COMPLETED|Overall Study||39
6351646|NCT00624013|7259910|FG000|NOT COMPLETED|Overall Study||8
6351647|NCT00624013|7259911|FG001|NOT COMPLETED|Overall Study||6
6351648|NCT00624052|7259923|FG000|STARTED|Overall Study||219
6351649|NCT00624052|7259924|FG001|STARTED|Overall Study||436
6351650|NCT00624052|7259925|FG002|STARTED|Overall Study||91
6351651|NCT00624052|7259926|FG003|STARTED|Overall Study||92
6351652|NCT00624052|7259923|FG000|COMPLETED|Overall Study||204
6351653|NCT00624052|7259924|FG001|COMPLETED|Overall Study||422
6351654|NCT00624052|7259925|FG002|COMPLETED|Overall Study||88
6351655|NCT00624052|7259926|FG003|COMPLETED|Overall Study||88
6351656|NCT00624052|7259923|FG000|NOT COMPLETED|Overall Study||15
6351657|NCT00624052|7259924|FG001|NOT COMPLETED|Overall Study||14
6351658|NCT00624052|7259925|FG002|NOT COMPLETED|Overall Study||3
6351659|NCT00624052|7259926|FG003|NOT COMPLETED|Overall Study||4
6351660|NCT00624065|7259942|FG000|STARTED|Overall Study||216
6351661|NCT00624065|7259943|FG001|STARTED|Overall Study||216
6351662|NCT00624065|7259942|FG000|COMPLETED|Overall Study||197
6351663|NCT00624065|7259943|FG001|COMPLETED|Overall Study||192
6351664|NCT00624065|7259942|FG000|NOT COMPLETED|Overall Study||19
6351665|NCT00624065|7259943|FG001|NOT COMPLETED|Overall Study||24
6351666|NCT00624195|7259951|FG000|STARTED|Overall Study||29
6351667|NCT00624195|7259952|FG001|STARTED|Overall Study||30
6351668|NCT00624195|7259951|FG000|COMPLETED|Overall Study||26
6351669|NCT00624195|7259952|FG001|COMPLETED|Overall Study||23
6351670|NCT00624195|7259951|FG000|NOT COMPLETED|Overall Study||3
6351671|NCT00624195|7259952|FG001|NOT COMPLETED|Overall Study||7
6351672|NCT00624221|7259960|FG000|STARTED|Overall Study||20
6351673|NCT00624221|7259961|FG001|STARTED|Overall Study||20
6351674|NCT00624221|7259960|FG000|COMPLETED|Overall Study||20
6351675|NCT00624221|7259961|FG001|COMPLETED|Overall Study||20
6351676|NCT00624221|7259960|FG000|NOT COMPLETED|Overall Study||0
6351677|NCT00624221|7259961|FG001|NOT COMPLETED|Overall Study||0
6351678|NCT00624234|7259973|FG000|STARTED|Overall Study||8
6351679|NCT00624234|7259974|FG001|STARTED|Overall Study||9
6351680|NCT00624234|7259975|FG002|STARTED|Overall Study||26
6351681|NCT00624234|7259976|FG003|STARTED|Overall Study||14
6351682|NCT00624234|7259977|FG004|STARTED|Overall Study||18
6351683|NCT00624234|7259978|FG005|STARTED|Overall Study||14
6351684|NCT00624234|7259973|FG000|COMPLETED|Overall Study||8
6351685|NCT00624234|7259974|FG001|COMPLETED|Overall Study||9
6351686|NCT00624234|7259975|FG002|COMPLETED|Overall Study||26
6351687|NCT00624234|7259976|FG003|COMPLETED|Overall Study||14
6351688|NCT00624234|7259977|FG004|COMPLETED|Overall Study||18
6351689|NCT00624234|7259978|FG005|COMPLETED|Overall Study||14
6351690|NCT00624234|7259973|FG000|NOT COMPLETED|Overall Study||0
6351691|NCT00624234|7259974|FG001|NOT COMPLETED|Overall Study||0
6351692|NCT00624234|7259975|FG002|NOT COMPLETED|Overall Study||0
6351693|NCT00624234|7259976|FG003|NOT COMPLETED|Overall Study||0
6351694|NCT00624234|7259977|FG004|NOT COMPLETED|Overall Study||0
6351695|NCT00624234|7259978|FG005|NOT COMPLETED|Overall Study||0
6351696|NCT00624286|7259994|FG000|STARTED|Overall Study||211
6351697|NCT00624286|7259995|FG001|STARTED|Overall Study||205
6351698|NCT00624286|7259994|FG000|COMPLETED|Overall Study||186
6351699|NCT00624286|7259995|FG001|COMPLETED|Overall Study||178
6351700|NCT00624286|7259994|FG000|NOT COMPLETED|Overall Study||25
6351701|NCT00624286|7259995|FG001|NOT COMPLETED|Overall Study||27
6351702|NCT00624338|7260004|FG000|STARTED|Overall Study||159
6351703|NCT00624338|7260005|FG001|STARTED|Overall Study||145
6351704|NCT00624338|7260006|FG002|STARTED|Overall Study||157
6351705|NCT00624338|7260004|FG000|Treated|Overall Study||157
6351706|NCT00624338|7260005|FG001|Treated|Overall Study||144
6351707|NCT00624338|7260006|FG002|Treated|Overall Study||154
6351708|NCT00624338|7260004|FG000|COMPLETED|Overall Study||112
6559647|NCT01782742|7482342|FG001|STARTED|Double-blind Treatment Phase||4
6559648|NCT01782742|7482341|FG000|COMPLETED|Double-blind Treatment Phase||15
6559649|NCT01782742|7482342|FG001|COMPLETED|Double-blind Treatment Phase||4
6351709|NCT00624338|7260005|FG001|COMPLETED|Overall Study||62
6351710|NCT00624338|7260006|FG002|COMPLETED|Overall Study||111
6351711|NCT00624338|7260004|FG000|NOT COMPLETED|Overall Study||47
6351712|NCT00624338|7260005|FG001|NOT COMPLETED|Overall Study||83
6351713|NCT00624338|7260006|FG002|NOT COMPLETED|Overall Study||46
6351714|NCT00624377|7260014|FG000|STARTED|Overall Study||2031
6351715|NCT00624377|7260014|FG000|COMPLETED|Overall Study||1387
6351716|NCT00624377|7260014|FG000|NOT COMPLETED|Overall Study||644
6351717|NCT00624416|7260018|FG000|STARTED|Overall Study||10
6351718|NCT00624416|7260018|FG000|COMPLETED|Overall Study||10
6351719|NCT00624416|7260018|FG000|NOT COMPLETED|Overall Study||0
6351720|NCT00624442|7260027|FG000|STARTED|Overall Study||8
6351721|NCT00624442|7260028|FG001|STARTED|Overall Study||9
6351722|NCT00624442|7260029|FG002|STARTED|Overall Study||10
6351723|NCT00624442|7260030|FG003|STARTED|Overall Study||8
6351724|NCT00624442|7260031|FG004|STARTED|Overall Study||10
6351725|NCT00624442|7260027|FG000|COMPLETED|Overall Study||8
6351726|NCT00624442|7260028|FG001|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
6351727|NCT00624442|7260029|FG002|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
6351728|NCT00624442|7260030|FG003|COMPLETED|Overall Study||8
6351729|NCT00624442|7260031|FG004|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
6351730|NCT00624442|7260027|FG000|NOT COMPLETED|Overall Study||0
6351731|NCT00624442|7260028|FG001|NOT COMPLETED|Overall Study||1
6351732|NCT00624442|7260029|FG002|NOT COMPLETED|Overall Study||2
6351733|NCT00624442|7260030|FG003|NOT COMPLETED|Overall Study||0
6351734|NCT00624442|7260031|FG004|NOT COMPLETED|Overall Study||2
6351735|NCT00624468|7260066|FG000|STARTED|Double-blind Period||17
6351736|NCT00624468|7260067|FG001|STARTED|Double-blind Period||17
6351737|NCT00624468|7260068|FG002|STARTED|Double-blind Period||0
6351738|NCT00624468|7260069|FG003|STARTED|Double-blind Period||0
6351739|NCT00624468|7260066|FG000|COMPLETED|Double-blind Period||3
6351740|NCT00624468|7260067|FG001|COMPLETED|Double-blind Period||4
6351741|NCT00624468|7260068|FG002|COMPLETED|Double-blind Period||0
6351742|NCT00624468|7260069|FG003|COMPLETED|Double-blind Period||0
6351743|NCT00624468|7260066|FG000|NOT COMPLETED|Double-blind Period||14
6351744|NCT00624468|7260067|FG001|NOT COMPLETED|Double-blind Period||13
6351745|NCT00624468|7260068|FG002|NOT COMPLETED|Double-blind Period||0
6351746|NCT00624468|7260069|FG003|NOT COMPLETED|Double-blind Period||0
6351747|NCT00624468|7260066|FG000|STARTED|Safety Follow-up (SFU) Period||0
6351748|NCT00624468|7260067|FG001|STARTED|Safety Follow-up (SFU) Period||0
6351749|NCT00624468|7260068|FG002|STARTED|Safety Follow-up (SFU) Period||13
6351750|NCT00624468|7260069|FG003|STARTED|Safety Follow-up (SFU) Period||14
6351751|NCT00624468|7260066|FG000|COMPLETED|Safety Follow-up (SFU) Period||0
6351752|NCT00624468|7260067|FG001|COMPLETED|Safety Follow-up (SFU) Period||0
6351753|NCT00624468|7260068|FG002|COMPLETED|Safety Follow-up (SFU) Period||11
6351754|NCT00624468|7260069|FG003|COMPLETED|Safety Follow-up (SFU) Period||11
6351755|NCT00624468|7260066|FG000|NOT COMPLETED|Safety Follow-up (SFU) Period||0
6351756|NCT00624468|7260067|FG001|NOT COMPLETED|Safety Follow-up (SFU) Period||0
6351757|NCT00624468|7260068|FG002|NOT COMPLETED|Safety Follow-up (SFU) Period||2
6351758|NCT00624468|7260069|FG003|NOT COMPLETED|Safety Follow-up (SFU) Period||3
6351759|NCT00624520|7260079|FG000|STARTED|Overall Study||56
6351760|NCT00624520|7260080|FG001|STARTED|Overall Study||47
6351761|NCT00624520|7260079|FG000|COMPLETED|Overall Study||44
6351762|NCT00624520|7260080|FG001|COMPLETED|Overall Study||39
6351763|NCT00624520|7260079|FG000|NOT COMPLETED|Overall Study||12
6351764|NCT00624520|7260080|FG001|NOT COMPLETED|Overall Study||8
6351765|NCT00624559|7260090|FG000|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
6351766|NCT00624559|7260091|FG001|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
6351767|NCT00624559|7260092|FG002|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
6351768|NCT00624559|7260093|FG003|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
6351769|NCT00624559|7260090|FG000|COMPLETED|Overall Study||3
6351770|NCT00624559|7260091|FG001|COMPLETED|Overall Study||3
6351771|NCT00624559|7260092|FG002|COMPLETED|Overall Study||3
6351772|NCT00624559|7260093|FG003|COMPLETED|Overall Study||3
6351773|NCT00624559|7260090|FG000|NOT COMPLETED|Overall Study||0
6351774|NCT00624559|7260091|FG001|NOT COMPLETED|Overall Study||0
6351775|NCT00624559|7260092|FG002|NOT COMPLETED|Overall Study||0
6351776|NCT00624559|7260093|FG003|NOT COMPLETED|Overall Study||0
6351777|NCT00624585|7260103|FG000|STARTED|Overall Study||18
6351778|NCT00624585|7260103|FG000|COMPLETED|Overall Study||6
6351779|NCT00624585|7260103|FG000|NOT COMPLETED|Overall Study||12
6351780|NCT00624780|7260113|FG000|STARTED|Treatment Optimization (Up to Week 12)||154
6351781|NCT00624780|7260114|FG001|STARTED|Treatment Optimization (Up to Week 12)||52
6351782|NCT00624780|7260115|FG002|STARTED|Treatment Optimization (Up to Week 12)||154
6351783|NCT00624780|7260116|FG003|STARTED|Treatment Optimization (Up to Week 12)||52
6351784|NCT00624780|7260117|FG004|STARTED|Treatment Optimization (Up to Week 12)||153
6351785|NCT00624780|7260118|FG005|STARTED|Treatment Optimization (Up to Week 12)||50
6351786|NCT00624780|7260113|FG000|COMPLETED|Treatment Optimization (Up to Week 12)||121
6351787|NCT00624780|7260114|FG001|COMPLETED|Treatment Optimization (Up to Week 12)||39
6351788|NCT00624780|7260115|FG002|COMPLETED|Treatment Optimization (Up to Week 12)||112
6351789|NCT00624780|7260116|FG003|COMPLETED|Treatment Optimization (Up to Week 12)||38
6351790|NCT00624780|7260117|FG004|COMPLETED|Treatment Optimization (Up to Week 12)||114
6351791|NCT00624780|7260118|FG005|COMPLETED|Treatment Optimization (Up to Week 12)||39
6351792|NCT00624780|7260113|FG000|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
6351793|NCT00624780|7260114|FG001|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
6351794|NCT00624780|7260115|FG002|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
6351795|NCT00624780|7260116|FG003|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
6351796|NCT00624780|7260117|FG004|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
6351797|NCT00624780|7260118|FG005|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
6351798|NCT00624780|7260113|FG000|STARTED|Fixed Dosing (Week 13 to Week 24)||121
6351799|NCT00624780|7260114|FG001|STARTED|Fixed Dosing (Week 13 to Week 24)||39
6351800|NCT00624780|7260115|FG002|STARTED|Fixed Dosing (Week 13 to Week 24)||112
6351801|NCT00624780|7260116|FG003|STARTED|Fixed Dosing (Week 13 to Week 24)||38
6351802|NCT00624780|7260117|FG004|STARTED|Fixed Dosing (Week 13 to Week 24)||114
6351803|NCT00624780|7260118|FG005|STARTED|Fixed Dosing (Week 13 to Week 24)||39
6351804|NCT00624780|7260113|FG000|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
6351805|NCT00624780|7260114|FG001|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
6351806|NCT00624780|7260115|FG002|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
6351807|NCT00624780|7260116|FG003|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
6351808|NCT00624780|7260117|FG004|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
6351809|NCT00624780|7260118|FG005|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
6351810|NCT00624780|7260113|FG000|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
6351811|NCT00624780|7260114|FG001|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
6351812|NCT00624780|7260115|FG002|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
6351813|NCT00624780|7260116|FG003|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
6351814|NCT00624780|7260117|FG004|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
6351815|NCT00624780|7260118|FG005|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
6351816|NCT00624780|7260113|FG000|STARTED|Treatment Discontinuation (Week 25)||106
6351817|NCT00624780|7260114|FG001|STARTED|Treatment Discontinuation (Week 25)||28
6351818|NCT00624780|7260115|FG002|STARTED|Treatment Discontinuation (Week 25)||94
6351819|NCT00624780|7260116|FG003|STARTED|Treatment Discontinuation (Week 25)||27
6351820|NCT00624780|7260117|FG004|STARTED|Treatment Discontinuation (Week 25)||95
6351821|NCT00624780|7260118|FG005|STARTED|Treatment Discontinuation (Week 25)||30
6351822|NCT00624780|7260113|FG000|COMPLETED|Treatment Discontinuation (Week 25)||104
6351823|NCT00624780|7260114|FG001|COMPLETED|Treatment Discontinuation (Week 25)||28
6351824|NCT00624780|7260115|FG002|COMPLETED|Treatment Discontinuation (Week 25)||91
6351825|NCT00624780|7260116|FG003|COMPLETED|Treatment Discontinuation (Week 25)||26
6351826|NCT00624780|7260117|FG004|COMPLETED|Treatment Discontinuation (Week 25)||95
6351827|NCT00624780|7260118|FG005|COMPLETED|Treatment Discontinuation (Week 25)||29
6351828|NCT00624780|7260113|FG000|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
6351829|NCT00624780|7260114|FG001|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
6351830|NCT00624780|7260115|FG002|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
6351831|NCT00624780|7260116|FG003|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
6351832|NCT00624780|7260117|FG004|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
6351833|NCT00624780|7260118|FG005|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
6351834|NCT00624780|7260113|FG000|STARTED|Follow-up (Week 26)||104
6351835|NCT00624780|7260114|FG001|STARTED|Follow-up (Week 26)||28
6351836|NCT00624780|7260115|FG002|STARTED|Follow-up (Week 26)||91
6351837|NCT00624780|7260116|FG003|STARTED|Follow-up (Week 26)||26
6351838|NCT00624780|7260117|FG004|STARTED|Follow-up (Week 26)||95
6351839|NCT00624780|7260118|FG005|STARTED|Follow-up (Week 26)||29
6351840|NCT00624780|7260113|FG000|COMPLETED|Follow-up (Week 26)||102
6351841|NCT00624780|7260114|FG001|COMPLETED|Follow-up (Week 26)||27
6351842|NCT00624780|7260115|FG002|COMPLETED|Follow-up (Week 26)||89
6351843|NCT00624780|7260116|FG003|COMPLETED|Follow-up (Week 26)||26
6351844|NCT00624780|7260117|FG004|COMPLETED|Follow-up (Week 26)||93
6351845|NCT00624780|7260118|FG005|COMPLETED|Follow-up (Week 26)||29
6351846|NCT00624780|7260113|FG000|NOT COMPLETED|Follow-up (Week 26)||2
6351847|NCT00624780|7260114|FG001|NOT COMPLETED|Follow-up (Week 26)||1
6351848|NCT00624780|7260115|FG002|NOT COMPLETED|Follow-up (Week 26)||2
6351849|NCT00624780|7260116|FG003|NOT COMPLETED|Follow-up (Week 26)||0
6351850|NCT00624780|7260117|FG004|NOT COMPLETED|Follow-up (Week 26)||2
6351851|NCT00624780|7260118|FG005|NOT COMPLETED|Follow-up (Week 26)||0
6351852|NCT00624806|7260137|FG000|STARTED|Overall Study||10
6351853|NCT00624806|7260138|FG001|STARTED|Overall Study||8
6351854|NCT00624806|7260137|FG000|COMPLETED|Overall Study||10
6351855|NCT00624806|7260138|FG001|COMPLETED|Overall Study||8
6351856|NCT00624806|7260137|FG000|NOT COMPLETED|Overall Study||0
6351857|NCT00624806|7260138|FG001|NOT COMPLETED|Overall Study||0
6351858|NCT00624819|7260148|FG000|STARTED|Follow-up Period: Year 1||391
6351859|NCT00624819|7260149|FG001|STARTED|Follow-up Period: Year 1||31
6351860|NCT00624819|7260150|FG002|STARTED|Follow-up Period: Year 1||102
6351861|NCT00624819|7260151|FG003|STARTED|Follow-up Period: Year 1||0
6351862|NCT00624819|7260148|FG000|COMPLETED|Follow-up Period: Year 1||391
6351863|NCT00624819|7260149|FG001|COMPLETED|Follow-up Period: Year 1||31
6351864|NCT00624819|7260150|FG002|COMPLETED|Follow-up Period: Year 1||102
6351865|NCT00624819|7260151|FG003|COMPLETED|Follow-up Period: Year 1||0
6351866|NCT00624819|7260148|FG000|NOT COMPLETED|Follow-up Period: Year 1||0
6351867|NCT00624819|7260149|FG001|NOT COMPLETED|Follow-up Period: Year 1||0
6351868|NCT00624819|7260150|FG002|NOT COMPLETED|Follow-up Period: Year 1||0
6351869|NCT00624819|7260151|FG003|NOT COMPLETED|Follow-up Period: Year 1||0
6351870|NCT00624819|7260148|FG000|STARTED|Follow-up Period: Year 2||370
6351871|NCT00624819|7260149|FG001|STARTED|Follow-up Period: Year 2||31
6351872|NCT00624819|7260150|FG002|STARTED|Follow-up Period: Year 2||96
6351873|NCT00624819|7260151|FG003|STARTED|Follow-up Period: Year 2||0
6351874|NCT00624819|7260148|FG000|COMPLETED|Follow-up Period: Year 2||370
6351875|NCT00624819|7260149|FG001|COMPLETED|Follow-up Period: Year 2||31
6351876|NCT00624819|7260150|FG002|COMPLETED|Follow-up Period: Year 2||96
6351877|NCT00624819|7260151|FG003|COMPLETED|Follow-up Period: Year 2||0
6351878|NCT00624819|7260148|FG000|NOT COMPLETED|Follow-up Period: Year 2||0
6351879|NCT00624819|7260149|FG001|NOT COMPLETED|Follow-up Period: Year 2||0
6351880|NCT00624819|7260150|FG002|NOT COMPLETED|Follow-up Period: Year 2||0
6351881|NCT00624819|7260151|FG003|NOT COMPLETED|Follow-up Period: Year 2||0
6351882|NCT00624819|7260148|FG000|STARTED|Follow-up Period: Year 4||264
6351883|NCT00624819|7260149|FG001|STARTED|Follow-up Period: Year 4||20
6351884|NCT00624819|7260150|FG002|STARTED|Follow-up Period: Year 4||65
6351885|NCT00624819|7260151|FG003|STARTED|Follow-up Period: Year 4||100
6351886|NCT00624819|7260148|FG000|COMPLETED|Follow-up Period: Year 4||263
6351887|NCT00624819|7260149|FG001|COMPLETED|Follow-up Period: Year 4||19
6351888|NCT00624819|7260150|FG002|COMPLETED|Follow-up Period: Year 4||64
6351889|NCT00624819|7260151|FG003|COMPLETED|Follow-up Period: Year 4||100
6351890|NCT00624819|7260148|FG000|NOT COMPLETED|Follow-up Period: Year 4||1
6351891|NCT00624819|7260149|FG001|NOT COMPLETED|Follow-up Period: Year 4||1
6351892|NCT00624819|7260150|FG002|NOT COMPLETED|Follow-up Period: Year 4||1
6351893|NCT00624819|7260151|FG003|NOT COMPLETED|Follow-up Period: Year 4||0
6351894|NCT00624832|7260165|FG000|STARTED|Overall Study||18
6351895|NCT00624832|7260166|FG001|STARTED|Overall Study||16
6351896|NCT00624832|7260167|FG002|STARTED|Overall Study||10
6351897|NCT00624832|7260168|FG003|STARTED|Overall Study||16
6351898|NCT00624832|7260165|FG000|COMPLETED|Overall Study||16
6351899|NCT00624832|7260166|FG001|COMPLETED|Overall Study||15
6351900|NCT00624832|7260167|FG002|COMPLETED|Overall Study||10
6351901|NCT00624832|7260168|FG003|COMPLETED|Overall Study||15
6351902|NCT00624832|7260165|FG000|NOT COMPLETED|Overall Study||2
6351903|NCT00624832|7260166|FG001|NOT COMPLETED|Overall Study||1
6351904|NCT00624832|7260167|FG002|NOT COMPLETED|Overall Study||0
6351905|NCT00624832|7260168|FG003|NOT COMPLETED|Overall Study||1
6351906|NCT00624910|7260180|FG000|STARTED|Overall Study||28
6351907|NCT00624910|7260181|FG001|STARTED|Overall Study||15
6351908|NCT00624910|7260182|FG002|STARTED|Overall Study||11
6351909|NCT00624910|7260180|FG000|COMPLETED|Overall Study||28
6351910|NCT00624910|7260181|FG001|COMPLETED|Overall Study||15
6351911|NCT00624910|7260182|FG002|COMPLETED|Overall Study||11
6351912|NCT00624910|7260180|FG000|NOT COMPLETED|Overall Study||0
6351913|NCT00624910|7260181|FG001|NOT COMPLETED|Overall Study||0
6351914|NCT00624910|7260182|FG002|NOT COMPLETED|Overall Study||0
6351915|NCT00624923|7260192|FG000|STARTED|Overall Study||127
6351916|NCT00624923|7260193|FG001|STARTED|Overall Study||124
6351917|NCT00624923|7260192|FG000|COMPLETED|Overall Study||89
6351918|NCT00624923|7260193|FG001|COMPLETED|Overall Study||101
6351919|NCT00624923|7260192|FG000|NOT COMPLETED|Overall Study||38
6351920|NCT00624923|7260193|FG001|NOT COMPLETED|Overall Study||23
6351921|NCT00625131|7260203|FG000|STARTED|Overall Study||38
6351922|NCT00625131|7260204|FG001|STARTED|Overall Study||44
6351923|NCT00625131|7260205|FG002|STARTED|Overall Study|These participants were not included in any analyses.|5
6351924|NCT00625131|7260203|FG000|COMPLETED|Overall Study||34
6351925|NCT00625131|7260204|FG001|COMPLETED|Overall Study||42
6351926|NCT00625131|7260205|FG002|COMPLETED|Overall Study||0
6351927|NCT00625131|7260203|FG000|NOT COMPLETED|Overall Study||4
6351928|NCT00625131|7260204|FG001|NOT COMPLETED|Overall Study||2
6351929|NCT00625131|7260205|FG002|NOT COMPLETED|Overall Study||5
6351930|NCT00625183|7260211|FG000|STARTED|Overall Study||5
6351931|NCT00625183|7260211|FG000|COMPLETED|Overall Study||4
6351932|NCT00625183|7260211|FG000|NOT COMPLETED|Overall Study||1
6351933|NCT00625365|7260217|FG000|STARTED|Overall Study||1060
6351934|NCT00625365|7260217|FG000|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
6351935|NCT00625365|7260217|FG000|NOT COMPLETED|Overall Study||7
6351936|NCT00625391|7260225|FG000|STARTED|Overall Study||44
6351937|NCT00625391|7260226|FG001|STARTED|Overall Study||47
6351938|NCT00625391|7260227|FG002|STARTED|Overall Study||42
6351939|NCT00625391|7260228|FG003|STARTED|Overall Study||38
6351940|NCT00625391|7260225|FG000|COMPLETED|Overall Study||37
6351941|NCT00625391|7260226|FG001|COMPLETED|Overall Study||39
6351942|NCT00625391|7260227|FG002|COMPLETED|Overall Study||37
6351943|NCT00625391|7260228|FG003|COMPLETED|Overall Study||37
6351944|NCT00625391|7260225|FG000|NOT COMPLETED|Overall Study||7
6351945|NCT00625391|7260226|FG001|NOT COMPLETED|Overall Study||8
6351946|NCT00625391|7260227|FG002|NOT COMPLETED|Overall Study||5
6351947|NCT00625391|7260228|FG003|NOT COMPLETED|Overall Study||1
6351948|NCT00625404|7260240|FG000|STARTED|Overall Study||1062
6351949|NCT00625404|7260241|FG001|STARTED|Overall Study||1058
6351950|NCT00625404|7260240|FG000|COMPLETED|Overall Study||855
6351951|NCT00625404|7260241|FG001|COMPLETED|Overall Study||885
6351952|NCT00625404|7260240|FG000|NOT COMPLETED|Overall Study||207
6351953|NCT00625404|7260241|FG001|NOT COMPLETED|Overall Study||173
6351954|NCT00625443|7260254|FG000|STARTED|Overall Study||12
6351955|NCT00625443|7260255|FG001|STARTED|Overall Study||26
6351956|NCT00625443|7260256|FG002|STARTED|Overall Study||15
6351957|NCT00625443|7260254|FG000|COMPLETED|Overall Study||10
6351958|NCT00625443|7260255|FG001|COMPLETED|Overall Study||15
6351959|NCT00625443|7260256|FG002|COMPLETED|Overall Study||10
6351960|NCT00625443|7260254|FG000|NOT COMPLETED|Overall Study||2
6351961|NCT00625443|7260255|FG001|NOT COMPLETED|Overall Study||11
6351962|NCT00625443|7260256|FG002|NOT COMPLETED|Overall Study||5
6351963|NCT00625729|7260267|FG000|STARTED|Overall Study||6
6351964|NCT00625729|7260267|FG000|COMPLETED|Overall Study||6
6351965|NCT00625729|7260267|FG000|NOT COMPLETED|Overall Study||0
6351966|NCT00625807|7260274|FG000|STARTED|Overall Study||22
6351967|NCT00625807|7260275|FG001|STARTED|Overall Study||28
6351968|NCT00625807|7260274|FG000|COMPLETED|Overall Study||20
6351969|NCT00625807|7260275|FG001|COMPLETED|Overall Study||20
6351970|NCT00625807|7260274|FG000|NOT COMPLETED|Overall Study||2
6351971|NCT00625807|7260275|FG001|NOT COMPLETED|Overall Study||8
6351972|NCT00625820|7260283|FG000|STARTED|Overall Study||17
6351973|NCT00625820|7260283|FG000|COMPLETED|Overall Study||16
6351974|NCT00625820|7260283|FG000|NOT COMPLETED|Overall Study||1
6351975|NCT00625846|7260292|FG000|STARTED|Overall Study||39
6351976|NCT00625846|7260293|FG001|STARTED|Overall Study||35
6351977|NCT00625846|7260294|FG002|STARTED|Overall Study||16
6351978|NCT00625846|7260295|FG003|STARTED|Overall Study||62
6351979|NCT00625846|7260292|FG000|COMPLETED|Overall Study||37
6351980|NCT00625846|7260293|FG001|COMPLETED|Overall Study||35
6351981|NCT00625846|7260294|FG002|COMPLETED|Overall Study||15
6351982|NCT00625846|7260295|FG003|COMPLETED|Overall Study||60
6351983|NCT00625846|7260292|FG000|NOT COMPLETED|Overall Study||2
6351984|NCT00625846|7260293|FG001|NOT COMPLETED|Overall Study||0
6351985|NCT00625846|7260294|FG002|NOT COMPLETED|Overall Study||1
6351986|NCT00625846|7260295|FG003|NOT COMPLETED|Overall Study||2
6351987|NCT00625872|7260311|FG000|STARTED|Overall Study||12
6351988|NCT00625872|7260312|FG001|STARTED|Overall Study||11
6351989|NCT00625872|7260311|FG000|Treated|Overall Study||12
6351990|NCT00625872|7260312|FG001|Treated|Overall Study||10
6351991|NCT00625872|7260311|FG000|COMPLETED|Overall Study||8
6351992|NCT00625872|7260312|FG001|COMPLETED|Overall Study||5
6351993|NCT00625872|7260311|FG000|NOT COMPLETED|Overall Study||4
6351994|NCT00625872|7260312|FG001|NOT COMPLETED|Overall Study||6
6351995|NCT00625989|7260318|FG000|STARTED|Overall Study||6
6351996|NCT00625989|7260319|FG001|STARTED|Overall Study||6
6351997|NCT00625989|7260318|FG000|COMPLETED|Overall Study||6
6351998|NCT00625989|7260319|FG001|COMPLETED|Overall Study||6
6351999|NCT00625989|7260318|FG000|NOT COMPLETED|Overall Study||0
6352000|NCT00625989|7260319|FG001|NOT COMPLETED|Overall Study||0
6352001|NCT00626028|7260326|FG000|STARTED|Overall Study||68
6352002|NCT00626028|7260327|FG001|STARTED|Overall Study||68
6352003|NCT00626028|7260326|FG000|COMPLETED|Overall Study||62
6352004|NCT00626028|7260327|FG001|COMPLETED|Overall Study||59
6352005|NCT00626028|7260326|FG000|NOT COMPLETED|Overall Study||6
6352006|NCT00626028|7260327|FG001|NOT COMPLETED|Overall Study||9
6352007|NCT00626093|7260333|FG000|STARTED|Overall Study||77
6352008|NCT00626093|7260333|FG000|COMPLETED|Overall Study||54
6352009|NCT00626093|7260333|FG000|NOT COMPLETED|Overall Study||23
6352010|NCT00626197|7260340|FG000|STARTED|Overall Study||127
6352011|NCT00626197|7260341|FG001|STARTED|Overall Study||128
6352012|NCT00626197|7260342|FG002|STARTED|Overall Study||126
6352013|NCT00626197|7260340|FG000|COMPLETED|Overall Study||83
6352014|NCT00626197|7260341|FG001|COMPLETED|Overall Study||74
6352015|NCT00626197|7260342|FG002|COMPLETED|Overall Study||49
6352016|NCT00626197|7260340|FG000|NOT COMPLETED|Overall Study||44
6352017|NCT00626197|7260341|FG001|NOT COMPLETED|Overall Study||54
6776435|NCT03834025|7704477|FG004|COMPLETED|Randomized to Payment Condition(Phase 2)||24
6352018|NCT00626197|7260342|FG002|NOT COMPLETED|Overall Study||77
6352019|NCT00626210|7260356|FG000|STARTED|Overall Study||2
6352020|NCT00626210|7260356|FG000|COMPLETED|Overall Study||2
6352021|NCT00626210|7260356|FG000|NOT COMPLETED|Overall Study||0
6352022|NCT00626275|7260360|FG000|STARTED|Part A - Treatment Period 1||7
6352023|NCT00626275|7260361|FG001|STARTED|Part A - Treatment Period 1||7
6352024|NCT00626275|7260362|FG002|STARTED|Part A - Treatment Period 1||7
6352025|NCT00626275|7260363|FG003|STARTED|Part A - Treatment Period 1||8
6352026|NCT00626275|7260364|FG004|STARTED|Part A - Treatment Period 1||9
6352027|NCT00626275|7260365|FG005|STARTED|Part A - Treatment Period 1||8
6352028|NCT00626275|7260366|FG006|STARTED|Part A - Treatment Period 1||0
6352029|NCT00626275|7260367|FG007|STARTED|Part A - Treatment Period 1||0
6352030|NCT00626275|7260360|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
6352031|NCT00626275|7260361|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
6352032|NCT00626275|7260362|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
6352033|NCT00626275|7260363|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
6352034|NCT00626275|7260364|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
6352035|NCT00626275|7260365|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
6352036|NCT00626275|7260366|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
6352037|NCT00626275|7260367|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
6352038|NCT00626275|7260360|FG000|COMPLETED|Part A - Treatment Period 1||6
6352039|NCT00626275|7260361|FG001|COMPLETED|Part A - Treatment Period 1||7
6352040|NCT00626275|7260362|FG002|COMPLETED|Part A - Treatment Period 1||6
6352041|NCT00626275|7260363|FG003|COMPLETED|Part A - Treatment Period 1||8
6352042|NCT00626275|7260364|FG004|COMPLETED|Part A - Treatment Period 1||9
6352043|NCT00626275|7260365|FG005|COMPLETED|Part A - Treatment Period 1||8
6352044|NCT00626275|7260366|FG006|COMPLETED|Part A - Treatment Period 1||0
6352045|NCT00626275|7260367|FG007|COMPLETED|Part A - Treatment Period 1||0
6352046|NCT00626275|7260360|FG000|NOT COMPLETED|Part A - Treatment Period 1||1
6352047|NCT00626275|7260361|FG001|NOT COMPLETED|Part A - Treatment Period 1||0
6352048|NCT00626275|7260362|FG002|NOT COMPLETED|Part A - Treatment Period 1||1
6352049|NCT00626275|7260363|FG003|NOT COMPLETED|Part A - Treatment Period 1||0
6352050|NCT00626275|7260364|FG004|NOT COMPLETED|Part A - Treatment Period 1||0
6352051|NCT00626275|7260365|FG005|NOT COMPLETED|Part A - Treatment Period 1||0
6352052|NCT00626275|7260366|FG006|NOT COMPLETED|Part A - Treatment Period 1||0
6352053|NCT00626275|7260367|FG007|NOT COMPLETED|Part A - Treatment Period 1||0
6352054|NCT00626275|7260360|FG000|STARTED|Part A - Washout Period 1||6
6352055|NCT00626275|7260361|FG001|STARTED|Part A - Washout Period 1||7
6352056|NCT00626275|7260362|FG002|STARTED|Part A - Washout Period 1||6
6352057|NCT00626275|7260363|FG003|STARTED|Part A - Washout Period 1||8
6352058|NCT00626275|7260364|FG004|STARTED|Part A - Washout Period 1||9
6352059|NCT00626275|7260365|FG005|STARTED|Part A - Washout Period 1||8
6352060|NCT00626275|7260366|FG006|STARTED|Part A - Washout Period 1||0
6352061|NCT00626275|7260367|FG007|STARTED|Part A - Washout Period 1||0
6352062|NCT00626275|7260360|FG000|COMPLETED|Part A - Washout Period 1||6
6352063|NCT00626275|7260361|FG001|COMPLETED|Part A - Washout Period 1||7
6352064|NCT00626275|7260362|FG002|COMPLETED|Part A - Washout Period 1||6
6352065|NCT00626275|7260363|FG003|COMPLETED|Part A - Washout Period 1||8
6352066|NCT00626275|7260364|FG004|COMPLETED|Part A - Washout Period 1||9
6352067|NCT00626275|7260365|FG005|COMPLETED|Part A - Washout Period 1||8
6352068|NCT00626275|7260366|FG006|COMPLETED|Part A - Washout Period 1||0
6352069|NCT00626275|7260367|FG007|COMPLETED|Part A - Washout Period 1||0
6352070|NCT00626275|7260360|FG000|NOT COMPLETED|Part A - Washout Period 1||0
6352071|NCT00626275|7260361|FG001|NOT COMPLETED|Part A - Washout Period 1||0
6352072|NCT00626275|7260362|FG002|NOT COMPLETED|Part A - Washout Period 1||0
6352073|NCT00626275|7260363|FG003|NOT COMPLETED|Part A - Washout Period 1||0
6352074|NCT00626275|7260364|FG004|NOT COMPLETED|Part A - Washout Period 1||0
6352075|NCT00626275|7260365|FG005|NOT COMPLETED|Part A - Washout Period 1||0
6352076|NCT00626275|7260366|FG006|NOT COMPLETED|Part A - Washout Period 1||0
6352077|NCT00626275|7260367|FG007|NOT COMPLETED|Part A - Washout Period 1||0
6352078|NCT00626275|7260360|FG000|STARTED|Part A - Treatment Period 2||6
6352079|NCT00626275|7260361|FG001|STARTED|Part A - Treatment Period 2||7
6352080|NCT00626275|7260362|FG002|STARTED|Part A - Treatment Period 2||6
6352081|NCT00626275|7260363|FG003|STARTED|Part A - Treatment Period 2||8
6352082|NCT00626275|7260364|FG004|STARTED|Part A - Treatment Period 2||9
6352083|NCT00626275|7260365|FG005|STARTED|Part A - Treatment Period 2||8
6352084|NCT00626275|7260366|FG006|STARTED|Part A - Treatment Period 2||0
6352085|NCT00626275|7260367|FG007|STARTED|Part A - Treatment Period 2||0
6352086|NCT00626275|7260360|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
6352087|NCT00626275|7260361|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
6352088|NCT00626275|7260362|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
6352089|NCT00626275|7260363|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
6352090|NCT00626275|7260364|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
6352091|NCT00626275|7260365|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
6352092|NCT00626275|7260366|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
6352093|NCT00626275|7260367|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
6352094|NCT00626275|7260360|FG000|COMPLETED|Part A - Treatment Period 2||6
6352095|NCT00626275|7260361|FG001|COMPLETED|Part A - Treatment Period 2||7
6352096|NCT00626275|7260362|FG002|COMPLETED|Part A - Treatment Period 2||6
6352097|NCT00626275|7260363|FG003|COMPLETED|Part A - Treatment Period 2||8
6352098|NCT00626275|7260364|FG004|COMPLETED|Part A - Treatment Period 2||9
6352099|NCT00626275|7260365|FG005|COMPLETED|Part A - Treatment Period 2||8
6352100|NCT00626275|7260366|FG006|COMPLETED|Part A - Treatment Period 2||0
6352101|NCT00626275|7260367|FG007|COMPLETED|Part A - Treatment Period 2||0
6352102|NCT00626275|7260360|FG000|NOT COMPLETED|Part A - Treatment Period 2||0
6352103|NCT00626275|7260361|FG001|NOT COMPLETED|Part A - Treatment Period 2||0
6352104|NCT00626275|7260362|FG002|NOT COMPLETED|Part A - Treatment Period 2||0
6352105|NCT00626275|7260363|FG003|NOT COMPLETED|Part A - Treatment Period 2||0
6352106|NCT00626275|7260364|FG004|NOT COMPLETED|Part A - Treatment Period 2||0
6352107|NCT00626275|7260365|FG005|NOT COMPLETED|Part A - Treatment Period 2||0
6352108|NCT00626275|7260366|FG006|NOT COMPLETED|Part A - Treatment Period 2||0
6352109|NCT00626275|7260367|FG007|NOT COMPLETED|Part A - Treatment Period 2||0
6352110|NCT00626275|7260360|FG000|STARTED|Part A - Washout Period 2||6
6352111|NCT00626275|7260361|FG001|STARTED|Part A - Washout Period 2||7
6352112|NCT00626275|7260362|FG002|STARTED|Part A - Washout Period 2||6
6352113|NCT00626275|7260363|FG003|STARTED|Part A - Washout Period 2||8
6352114|NCT00626275|7260364|FG004|STARTED|Part A - Washout Period 2||9
6352115|NCT00626275|7260365|FG005|STARTED|Part A - Washout Period 2||8
6352116|NCT00626275|7260366|FG006|STARTED|Part A - Washout Period 2||0
6352117|NCT00626275|7260367|FG007|STARTED|Part A - Washout Period 2||0
6352118|NCT00626275|7260360|FG000|COMPLETED|Part A - Washout Period 2||6
6352119|NCT00626275|7260361|FG001|COMPLETED|Part A - Washout Period 2||7
6352120|NCT00626275|7260362|FG002|COMPLETED|Part A - Washout Period 2||6
6352121|NCT00626275|7260363|FG003|COMPLETED|Part A - Washout Period 2||8
6352122|NCT00626275|7260364|FG004|COMPLETED|Part A - Washout Period 2||9
6352123|NCT00626275|7260365|FG005|COMPLETED|Part A - Washout Period 2||8
6352124|NCT00626275|7260366|FG006|COMPLETED|Part A - Washout Period 2||0
6352125|NCT00626275|7260367|FG007|COMPLETED|Part A - Washout Period 2||0
6352126|NCT00626275|7260360|FG000|NOT COMPLETED|Part A - Washout Period 2||0
6352127|NCT00626275|7260361|FG001|NOT COMPLETED|Part A - Washout Period 2||0
6352128|NCT00626275|7260362|FG002|NOT COMPLETED|Part A - Washout Period 2||0
6352129|NCT00626275|7260363|FG003|NOT COMPLETED|Part A - Washout Period 2||0
6352130|NCT00626275|7260364|FG004|NOT COMPLETED|Part A - Washout Period 2||0
6352131|NCT00626275|7260365|FG005|NOT COMPLETED|Part A - Washout Period 2||0
6352132|NCT00626275|7260366|FG006|NOT COMPLETED|Part A - Washout Period 2||0
6352133|NCT00626275|7260367|FG007|NOT COMPLETED|Part A - Washout Period 2||0
6352134|NCT00626275|7260360|FG000|STARTED|Part A - Treatment Period 3||6
6352135|NCT00626275|7260361|FG001|STARTED|Part A - Treatment Period 3||7
6352136|NCT00626275|7260362|FG002|STARTED|Part A - Treatment Period 3||6
6352137|NCT00626275|7260363|FG003|STARTED|Part A - Treatment Period 3||8
6352138|NCT00626275|7260364|FG004|STARTED|Part A - Treatment Period 3||9
6352139|NCT00626275|7260365|FG005|STARTED|Part A - Treatment Period 3||8
6352140|NCT00626275|7260366|FG006|STARTED|Part A - Treatment Period 3||0
6352141|NCT00626275|7260367|FG007|STARTED|Part A - Treatment Period 3||0
6352142|NCT00626275|7260360|FG000|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
6352143|NCT00626275|7260361|FG001|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
6352144|NCT00626275|7260362|FG002|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
6352145|NCT00626275|7260363|FG003|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
6352146|NCT00626275|7260364|FG004|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
6352147|NCT00626275|7260365|FG005|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
6377957|NCT00766090|7288653|FG004|COMPLETED|Treatment Period 1 (28 Days)||23
6352148|NCT00626275|7260366|FG006|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
6352149|NCT00626275|7260367|FG007|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
6352150|NCT00626275|7260360|FG000|COMPLETED|Part A - Treatment Period 3||6
6352151|NCT00626275|7260361|FG001|COMPLETED|Part A - Treatment Period 3||7
6352152|NCT00626275|7260362|FG002|COMPLETED|Part A - Treatment Period 3||6
6352153|NCT00626275|7260363|FG003|COMPLETED|Part A - Treatment Period 3||8
6352154|NCT00626275|7260364|FG004|COMPLETED|Part A - Treatment Period 3||9
6352155|NCT00626275|7260365|FG005|COMPLETED|Part A - Treatment Period 3||8
6352156|NCT00626275|7260366|FG006|COMPLETED|Part A - Treatment Period 3||0
6352157|NCT00626275|7260367|FG007|COMPLETED|Part A - Treatment Period 3||0
6352158|NCT00626275|7260360|FG000|NOT COMPLETED|Part A - Treatment Period 3||0
6352159|NCT00626275|7260361|FG001|NOT COMPLETED|Part A - Treatment Period 3||0
6352160|NCT00626275|7260362|FG002|NOT COMPLETED|Part A - Treatment Period 3||0
6352161|NCT00626275|7260363|FG003|NOT COMPLETED|Part A - Treatment Period 3||0
6352162|NCT00626275|7260364|FG004|NOT COMPLETED|Part A - Treatment Period 3||0
6352163|NCT00626275|7260365|FG005|NOT COMPLETED|Part A - Treatment Period 3||0
6352164|NCT00626275|7260366|FG006|NOT COMPLETED|Part A - Treatment Period 3||0
6352165|NCT00626275|7260367|FG007|NOT COMPLETED|Part A - Treatment Period 3||0
6352166|NCT00626275|7260360|FG000|STARTED|Re-randomization Period for Part B||0
6352167|NCT00626275|7260361|FG001|STARTED|Re-randomization Period for Part B||0
6352168|NCT00626275|7260362|FG002|STARTED|Re-randomization Period for Part B||0
6352169|NCT00626275|7260363|FG003|STARTED|Re-randomization Period for Part B||0
6352170|NCT00626275|7260364|FG004|STARTED|Re-randomization Period for Part B||0
6352171|NCT00626275|7260365|FG005|STARTED|Re-randomization Period for Part B||0
6776436|NCT03834025|7704478|FG005|COMPLETED|Randomized to Payment Condition(Phase 2)||21
6776437|NCT03834025|7704479|FG006|COMPLETED|Randomized to Payment Condition(Phase 2)||27
6776438|NCT03834025|7704473|FG000|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
6776439|NCT03834025|7704474|FG001|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
6776440|NCT03834025|7704475|FG002|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
6776441|NCT03834025|7704476|FG003|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
6352172|NCT00626275|7260366|FG006|STARTED|Re-randomization Period for Part B||20
6352173|NCT00626275|7260367|FG007|STARTED|Re-randomization Period for Part B||24
6352174|NCT00626275|7260360|FG000|COMPLETED|Re-randomization Period for Part B||0
6352175|NCT00626275|7260361|FG001|COMPLETED|Re-randomization Period for Part B||0
6352176|NCT00626275|7260362|FG002|COMPLETED|Re-randomization Period for Part B||0
6352177|NCT00626275|7260363|FG003|COMPLETED|Re-randomization Period for Part B||0
6352178|NCT00626275|7260364|FG004|COMPLETED|Re-randomization Period for Part B||0
6352179|NCT00626275|7260365|FG005|COMPLETED|Re-randomization Period for Part B||0
6352180|NCT00626275|7260366|FG006|COMPLETED|Re-randomization Period for Part B||20
6352181|NCT00626275|7260367|FG007|COMPLETED|Re-randomization Period for Part B||24
6352182|NCT00626275|7260360|FG000|NOT COMPLETED|Re-randomization Period for Part B||0
6352183|NCT00626275|7260361|FG001|NOT COMPLETED|Re-randomization Period for Part B||0
6352184|NCT00626275|7260362|FG002|NOT COMPLETED|Re-randomization Period for Part B||0
6352185|NCT00626275|7260363|FG003|NOT COMPLETED|Re-randomization Period for Part B||0
6352186|NCT00626275|7260364|FG004|NOT COMPLETED|Re-randomization Period for Part B||0
6352187|NCT00626275|7260365|FG005|NOT COMPLETED|Re-randomization Period for Part B||0
6352188|NCT00626275|7260366|FG006|NOT COMPLETED|Re-randomization Period for Part B||0
6352189|NCT00626275|7260367|FG007|NOT COMPLETED|Re-randomization Period for Part B||0
6352190|NCT00626275|7260360|FG000|STARTED|Part B||0
6352191|NCT00626275|7260361|FG001|STARTED|Part B||0
6352192|NCT00626275|7260362|FG002|STARTED|Part B||0
6352193|NCT00626275|7260363|FG003|STARTED|Part B||0
6352194|NCT00626275|7260364|FG004|STARTED|Part B||0
6352195|NCT00626275|7260365|FG005|STARTED|Part B||0
6352196|NCT00626275|7260366|FG006|STARTED|Part B||20
6352197|NCT00626275|7260367|FG007|STARTED|Part B||24
6352198|NCT00626275|7260360|FG000|COMPLETED|Part B||0
6352199|NCT00626275|7260361|FG001|COMPLETED|Part B||0
6352200|NCT00626275|7260362|FG002|COMPLETED|Part B||0
6352201|NCT00626275|7260363|FG003|COMPLETED|Part B||0
6352202|NCT00626275|7260364|FG004|COMPLETED|Part B||0
6352203|NCT00626275|7260365|FG005|COMPLETED|Part B||0
6352204|NCT00626275|7260366|FG006|COMPLETED|Part B||19
6352205|NCT00626275|7260367|FG007|COMPLETED|Part B||23
6352206|NCT00626275|7260360|FG000|NOT COMPLETED|Part B||0
6352207|NCT00626275|7260361|FG001|NOT COMPLETED|Part B||0
6352208|NCT00626275|7260362|FG002|NOT COMPLETED|Part B||0
6352209|NCT00626275|7260363|FG003|NOT COMPLETED|Part B||0
6352210|NCT00626275|7260364|FG004|NOT COMPLETED|Part B||0
6352211|NCT00626275|7260365|FG005|NOT COMPLETED|Part B||0
6352212|NCT00626275|7260366|FG006|NOT COMPLETED|Part B||1
6559650|NCT01782742|7482341|FG000|NOT COMPLETED|Double-blind Treatment Phase||1
6559651|NCT01782742|7482342|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
6559652|NCT01782742|7482341|FG000|STARTED|Open Label Phase||19
6776442|NCT03834025|7704477|FG004|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
6352213|NCT00626275|7260367|FG007|NOT COMPLETED|Part B||1
6352214|NCT00626327|7260384|FG000|STARTED|Overall Study||504
6352215|NCT00626327|7260385|FG001|STARTED|Overall Study||616
6352216|NCT00626327|7260386|FG002|STARTED|Overall Study||510
6352217|NCT00626327|7260384|FG000|COMPLETED|Overall Study||426
6352218|NCT00626327|7260385|FG001|COMPLETED|Overall Study||557
6352219|NCT00626327|7260386|FG002|COMPLETED|Overall Study||422
6352220|NCT00626327|7260384|FG000|NOT COMPLETED|Overall Study||78
6352221|NCT00626327|7260385|FG001|NOT COMPLETED|Overall Study||59
6352222|NCT00626327|7260386|FG002|NOT COMPLETED|Overall Study||88
6352223|NCT00626340|7260402|FG000|STARTED|Overall Study||18
6352224|NCT00626340|7260402|FG000|COMPLETED|Overall Study||18
6352225|NCT00626340|7260402|FG000|NOT COMPLETED|Overall Study||0
6352226|NCT00626366|7260408|FG000|STARTED|Overall Study||9
6352227|NCT00626366|7260409|FG001|STARTED|Overall Study||9
6352228|NCT00626366|7260408|FG000|COMPLETED|Overall Study||9
6352229|NCT00626366|7260409|FG001|COMPLETED|Overall Study||9
6352230|NCT00626366|7260408|FG000|NOT COMPLETED|Overall Study||0
6352231|NCT00626366|7260409|FG001|NOT COMPLETED|Overall Study||0
6352232|NCT00626392|7260421|FG000|STARTED|Run-in Period||45
6352233|NCT00626392|7260422|FG001|STARTED|Run-in Period||44
6352234|NCT00626392|7260423|FG002|STARTED|Run-in Period||44
6352235|NCT00626392|7260424|FG003|STARTED|Run-in Period||44
6352236|NCT00626392|7260425|FG004|STARTED|Run-in Period||45
6352237|NCT00626392|7260426|FG005|STARTED|Run-in Period||45
6352238|NCT00626392|7260421|FG000|COMPLETED|Run-in Period||44
6352239|NCT00626392|7260422|FG001|COMPLETED|Run-in Period||43
6352240|NCT00626392|7260423|FG002|COMPLETED|Run-in Period||41
6352241|NCT00626392|7260424|FG003|COMPLETED|Run-in Period||43
6352242|NCT00626392|7260425|FG004|COMPLETED|Run-in Period||41
6352243|NCT00626392|7260426|FG005|COMPLETED|Run-in Period||44
6352244|NCT00626392|7260421|FG000|NOT COMPLETED|Run-in Period||1
6352245|NCT00626392|7260422|FG001|NOT COMPLETED|Run-in Period||1
6352246|NCT00626392|7260423|FG002|NOT COMPLETED|Run-in Period||3
6352247|NCT00626392|7260424|FG003|NOT COMPLETED|Run-in Period||1
6352248|NCT00626392|7260425|FG004|NOT COMPLETED|Run-in Period||4
6352249|NCT00626392|7260426|FG005|NOT COMPLETED|Run-in Period||1
6352250|NCT00626392|7260421|FG000|STARTED|Coadministration Period||44
6352251|NCT00626392|7260422|FG001|STARTED|Coadministration Period||43
6352252|NCT00626392|7260423|FG002|STARTED|Coadministration Period||41
6352253|NCT00626392|7260424|FG003|STARTED|Coadministration Period||43
6352254|NCT00626392|7260425|FG004|STARTED|Coadministration Period||41
6352255|NCT00626392|7260426|FG005|STARTED|Coadministration Period||44
6352256|NCT00626392|7260421|FG000|COMPLETED|Coadministration Period||40
6352257|NCT00626392|7260422|FG001|COMPLETED|Coadministration Period||38
6352258|NCT00626392|7260423|FG002|COMPLETED|Coadministration Period||31
6352259|NCT00626392|7260424|FG003|COMPLETED|Coadministration Period||36
6352260|NCT00626392|7260425|FG004|COMPLETED|Coadministration Period||36
6352261|NCT00626392|7260426|FG005|COMPLETED|Coadministration Period||38
6352262|NCT00626392|7260421|FG000|NOT COMPLETED|Coadministration Period||4
6352263|NCT00626392|7260422|FG001|NOT COMPLETED|Coadministration Period||5
6352264|NCT00626392|7260423|FG002|NOT COMPLETED|Coadministration Period||10
6352265|NCT00626392|7260424|FG003|NOT COMPLETED|Coadministration Period||7
6352266|NCT00626392|7260425|FG004|NOT COMPLETED|Coadministration Period||5
6352267|NCT00626392|7260426|FG005|NOT COMPLETED|Coadministration Period||6
6352268|NCT00626405|7260434|FG000|STARTED|Overall Study||43
6352269|NCT00626405|7260435|FG001|STARTED|Overall Study||52
6352270|NCT00626405|7260434|FG000|COMPLETED|Overall Study||42
6352271|NCT00626405|7260435|FG001|COMPLETED|Overall Study||51
6352272|NCT00626405|7260434|FG000|NOT COMPLETED|Overall Study||1
6352273|NCT00626405|7260435|FG001|NOT COMPLETED|Overall Study||1
6352274|NCT00626431|7260443|FG000|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
6352275|NCT00626431|7260444|FG001|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
6352276|NCT00626431|7260443|FG000|COMPLETED|Overall Study||134
6352277|NCT00626431|7260444|FG001|COMPLETED|Overall Study||114
6352278|NCT00626431|7260443|FG000|NOT COMPLETED|Overall Study||17
6352279|NCT00626431|7260444|FG001|NOT COMPLETED|Overall Study||45
6352280|NCT00626522|7260456|FG000|STARTED|Overall Study||121
6352281|NCT00626522|7260457|FG001|STARTED|Overall Study||120
6352282|NCT00626522|7260458|FG002|STARTED|Overall Study||125
6352283|NCT00626522|7260459|FG003|STARTED|Overall Study||76
6352284|NCT00626522|7260460|FG004|STARTED|Overall Study||65
6352285|NCT00626522|7260461|FG005|STARTED|Overall Study||59
6352286|NCT00626522|7260456|FG000|COMPLETED|Overall Study||115
6352287|NCT00626522|7260457|FG001|COMPLETED|Overall Study||113
6352288|NCT00626522|7260458|FG002|COMPLETED|Overall Study||117
6352289|NCT00626522|7260459|FG003|COMPLETED|Overall Study||74
6352290|NCT00626522|7260460|FG004|COMPLETED|Overall Study||58
6352291|NCT00626522|7260461|FG005|COMPLETED|Overall Study||57
6352292|NCT00626522|7260456|FG000|NOT COMPLETED|Overall Study||6
6352293|NCT00626522|7260457|FG001|NOT COMPLETED|Overall Study||7
6352294|NCT00626522|7260458|FG002|NOT COMPLETED|Overall Study||8
6352295|NCT00626522|7260459|FG003|NOT COMPLETED|Overall Study||2
6352296|NCT00626522|7260460|FG004|NOT COMPLETED|Overall Study||7
6352297|NCT00626522|7260461|FG005|NOT COMPLETED|Overall Study||2
6352298|NCT00626548|7260477|FG000|STARTED|Overall Study||705
6352299|NCT00626548|7260478|FG001|STARTED|Overall Study||716
6352300|NCT00626548|7260477|FG000|Patients Received Treatment|Overall Study||703
6352301|NCT00626548|7260478|FG001|Patients Received Treatment|Overall Study||712
6352302|NCT00626548|7260477|FG000|COMPLETED|Overall Study||0
6352303|NCT00626548|7260478|FG001|COMPLETED|Overall Study||0
6352304|NCT00626548|7260477|FG000|NOT COMPLETED|Overall Study||705
6352305|NCT00626548|7260478|FG001|NOT COMPLETED|Overall Study||716
6352306|NCT00626574|7260486|FG000|STARTED|Overall Study||2
6352307|NCT00626574|7260487|FG001|STARTED|Overall Study||1
6352308|NCT00626574|7260486|FG000|COMPLETED|Overall Study||2
6352309|NCT00626574|7260487|FG001|COMPLETED|Overall Study||1
6352310|NCT00626574|7260486|FG000|NOT COMPLETED|Overall Study||0
6352311|NCT00626574|7260487|FG001|NOT COMPLETED|Overall Study||0
6352312|NCT00626626|7260497|FG000|STARTED|Overall Study||5
6352313|NCT00626626|7260498|FG001|STARTED|Overall Study||3
6352314|NCT00626626|7260497|FG000|COMPLETED|Overall Study||5
6352315|NCT00626626|7260498|FG001|COMPLETED|Overall Study||3
6352316|NCT00626626|7260497|FG000|NOT COMPLETED|Overall Study||0
6352317|NCT00626626|7260498|FG001|NOT COMPLETED|Overall Study||0
6352318|NCT00626639|7260507|FG000|STARTED|Overall Study||2
6352319|NCT00626639|7260508|FG001|STARTED|Overall Study||3
6352320|NCT00626639|7260507|FG000|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
6352321|NCT00626639|7260508|FG001|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
6352322|NCT00626639|7260507|FG000|NOT COMPLETED|Overall Study||2
6352323|NCT00626639|7260508|FG001|NOT COMPLETED|Overall Study||2
6352324|NCT00626743|7260518|FG000|STARTED|Treatment Period 1||6
6352325|NCT00626743|7260519|FG001|STARTED|Treatment Period 1||7
6352326|NCT00626743|7260518|FG000|COMPLETED|Treatment Period 1||6
6352327|NCT00626743|7260519|FG001|COMPLETED|Treatment Period 1||6
6352328|NCT00626743|7260518|FG000|NOT COMPLETED|Treatment Period 1||0
6352329|NCT00626743|7260519|FG001|NOT COMPLETED|Treatment Period 1||1
6352330|NCT00626743|7260518|FG000|STARTED|Wash-out Period of 6 Days||6
6352331|NCT00626743|7260519|FG001|STARTED|Wash-out Period of 6 Days||6
6352332|NCT00626743|7260518|FG000|COMPLETED|Wash-out Period of 6 Days||6
6352333|NCT00626743|7260519|FG001|COMPLETED|Wash-out Period of 6 Days||6
6352334|NCT00626743|7260518|FG000|NOT COMPLETED|Wash-out Period of 6 Days||0
6352335|NCT00626743|7260519|FG001|NOT COMPLETED|Wash-out Period of 6 Days||0
6352336|NCT00626743|7260518|FG000|STARTED|Treatment Period 2||6
6352337|NCT00626743|7260519|FG001|STARTED|Treatment Period 2||6
6352338|NCT00626743|7260518|FG000|COMPLETED|Treatment Period 2||6
6352339|NCT00626743|7260519|FG001|COMPLETED|Treatment Period 2||6
6352340|NCT00626743|7260518|FG000|NOT COMPLETED|Treatment Period 2||0
6352341|NCT00626743|7260519|FG001|NOT COMPLETED|Treatment Period 2||0
6352342|NCT00626782|7260527|FG000|STARTED|Overall Study||12
6352343|NCT00626782|7260528|FG001|STARTED|Overall Study||12
6352344|NCT00626782|7260527|FG000|COMPLETED|Overall Study||12
6352345|NCT00626782|7260528|FG001|COMPLETED|Overall Study||12
6352346|NCT00626782|7260527|FG000|NOT COMPLETED|Overall Study||0
6352347|NCT00626782|7260528|FG001|NOT COMPLETED|Overall Study||0
6352348|NCT00626795|7260539|FG000|STARTED|Open-label TD1414 Cream TID Treatment||0
6352349|NCT00626795|7260540|FG001|STARTED|Open-label TD1414 Cream TID Treatment||65
6352350|NCT00626795|7260541|FG002|STARTED|Open-label TD1414 Cream TID Treatment||0
6352351|NCT00626795|7260539|FG000|COMPLETED|Open-label TD1414 Cream TID Treatment||0
6352352|NCT00626795|7260540|FG001|COMPLETED|Open-label TD1414 Cream TID Treatment||64
6352353|NCT00626795|7260541|FG002|COMPLETED|Open-label TD1414 Cream TID Treatment||0
6352354|NCT00626795|7260539|FG000|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
6352355|NCT00626795|7260540|FG001|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||1
6352356|NCT00626795|7260541|FG002|NOT COMPLETED|Open-label TD1414 Cream TID Treatment||0
6352357|NCT00626795|7260539|FG000|STARTED|Blinded Treatment||204
6352358|NCT00626795|7260540|FG001|STARTED|Blinded Treatment||205
6352359|NCT00626795|7260541|FG002|STARTED|Blinded Treatment||205
6352360|NCT00626795|7260539|FG000|COMPLETED|Blinded Treatment||194
6352361|NCT00626795|7260540|FG001|COMPLETED|Blinded Treatment||200
6352362|NCT00626795|7260541|FG002|COMPLETED|Blinded Treatment||196
6352363|NCT00626795|7260539|FG000|NOT COMPLETED|Blinded Treatment||10
6352364|NCT00626795|7260540|FG001|NOT COMPLETED|Blinded Treatment||5
6352365|NCT00626795|7260541|FG002|NOT COMPLETED|Blinded Treatment||9
6352366|NCT00626808|7260557|FG000|STARTED|Overall Study||254464
6352367|NCT00626808|7260558|FG001|STARTED|Overall Study||34316
6352368|NCT00626808|7260559|FG002|STARTED|Overall Study||30011
6352369|NCT00626808|7260560|FG003|STARTED|Overall Study||2906
6352370|NCT00626808|7260557|FG000|COMPLETED|Overall Study||254464
6352371|NCT00626808|7260558|FG001|COMPLETED|Overall Study||34316
6352372|NCT00626808|7260559|FG002|COMPLETED|Overall Study||30011
6352373|NCT00626808|7260560|FG003|COMPLETED|Overall Study||2906
6352374|NCT00626808|7260557|FG000|NOT COMPLETED|Overall Study||0
6352375|NCT00626808|7260558|FG001|NOT COMPLETED|Overall Study||0
6352376|NCT00626808|7260559|FG002|NOT COMPLETED|Overall Study||0
6352377|NCT00626808|7260560|FG003|NOT COMPLETED|Overall Study||0
6352378|NCT00626821|7260570|FG000|STARTED|Overall Study||3017
6352379|NCT00626821|7260570|FG000|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
6352380|NCT00626821|7260570|FG000|COMPLETED|Overall Study||2796
6352381|NCT00626821|7260570|FG000|NOT COMPLETED|Overall Study||221
6352382|NCT00626886|7260576|FG000|STARTED|Overall Study||24
6352383|NCT00626886|7260577|FG001|STARTED|Overall Study||29
6352384|NCT00626886|7260576|FG000|COMPLETED|Overall Study||24
6352385|NCT00626886|7260577|FG001|COMPLETED|Overall Study||29
6352386|NCT00626886|7260576|FG000|NOT COMPLETED|Overall Study||0
6352387|NCT00626886|7260577|FG001|NOT COMPLETED|Overall Study||0
6352388|NCT00626912|7260585|FG000|STARTED|Overall Study||222
6352389|NCT00626912|7260586|FG001|STARTED|Overall Study||225
6352390|NCT00626912|7260585|FG000|COMPLETED|Overall Study||220
6352391|NCT00626912|7260586|FG001|COMPLETED|Overall Study||215
6352392|NCT00626912|7260585|FG000|NOT COMPLETED|Overall Study||2
6352393|NCT00626912|7260586|FG001|NOT COMPLETED|Overall Study||10
6352394|NCT00626925|7260594|FG000|STARTED|Overall Study||67
6352395|NCT00626925|7260595|FG001|STARTED|Overall Study||71
6352396|NCT00626925|7260594|FG000|COMPLETED|Overall Study||55
6352397|NCT00626925|7260595|FG001|COMPLETED|Overall Study||62
6352398|NCT00626925|7260594|FG000|NOT COMPLETED|Overall Study||12
6352399|NCT00626925|7260595|FG001|NOT COMPLETED|Overall Study||9
6352400|NCT00627016|7260617|FG000|STARTED|Overall Study||153
6352401|NCT00627016|7260618|FG001|STARTED|Overall Study||152
6352402|NCT00627016|7260617|FG000|COMPLETED|Overall Study||147
6352403|NCT00627016|7260618|FG001|COMPLETED|Overall Study||146
6352404|NCT00627016|7260617|FG000|NOT COMPLETED|Overall Study||6
6352405|NCT00627016|7260618|FG001|NOT COMPLETED|Overall Study||6
6352406|NCT00627042|7260624|FG000|STARTED|Overall Study||42
6352407|NCT00627042|7260624|FG000|Received at Least 1 Dose of Study Drug|Overall Study||42
6352408|NCT00627042|7260624|FG000|COMPLETED|Overall Study||40
6352409|NCT00627042|7260624|FG000|NOT COMPLETED|Overall Study||2
6352410|NCT00627094|7260630|FG000|STARTED|Overall Study||60
6352411|NCT00627094|7260631|FG001|STARTED|Overall Study||60
6352412|NCT00627094|7260630|FG000|COMPLETED|Overall Study||48
6352413|NCT00627094|7260631|FG001|COMPLETED|Overall Study||45
6352414|NCT00627094|7260630|FG000|NOT COMPLETED|Overall Study||12
6352415|NCT00627094|7260631|FG001|NOT COMPLETED|Overall Study||15
6352416|NCT00627367|7260641|FG000|STARTED|Overall Study||112
6352417|NCT00627367|7260642|FG001|STARTED|Overall Study||112
6352418|NCT00627367|7260641|FG000|COMPLETED|Overall Study||112
6352419|NCT00627367|7260642|FG001|COMPLETED|Overall Study||112
6352420|NCT00627367|7260641|FG000|NOT COMPLETED|Overall Study||0
6352421|NCT00627367|7260642|FG001|NOT COMPLETED|Overall Study||0
6352422|NCT00627393|7260651|FG000|STARTED|Intention-To-Treat Analysis||58
6352423|NCT00627393|7260652|FG001|STARTED|Intention-To-Treat Analysis||56
6352424|NCT00627393|7260651|FG000|COMPLETED|Intention-To-Treat Analysis||49
6352425|NCT00627393|7260652|FG001|COMPLETED|Intention-To-Treat Analysis||48
6352426|NCT00627393|7260651|FG000|NOT COMPLETED|Intention-To-Treat Analysis||9
6352427|NCT00627393|7260652|FG001|NOT COMPLETED|Intention-To-Treat Analysis||8
6352428|NCT00627393|7260651|FG000|STARTED|Per-Protocol Analysis||49
6352429|NCT00627393|7260652|FG001|STARTED|Per-Protocol Analysis||48
6352430|NCT00627393|7260651|FG000|COMPLETED|Per-Protocol Analysis||39
6352431|NCT00627393|7260652|FG001|COMPLETED|Per-Protocol Analysis||35
6352432|NCT00627393|7260651|FG000|NOT COMPLETED|Per-Protocol Analysis||10
6559653|NCT01782742|7482342|FG001|STARTED|Open Label Phase||0
6559654|NCT01782742|7482341|FG000|COMPLETED|Open Label Phase||19
6559655|NCT01782742|7482342|FG001|COMPLETED|Open Label Phase||0
6559656|NCT01782742|7482341|FG000|NOT COMPLETED|Open Label Phase||0
6559657|NCT01782742|7482342|FG001|NOT COMPLETED|Open Label Phase||0
6559658|NCT01782833|7482350|FG000|STARTED|Overall Study||3635
6559659|NCT01782833|7482350|FG000|COMPLETED|Overall Study||3365
6559660|NCT01782833|7482350|FG000|NOT COMPLETED|Overall Study||270
6559661|NCT01782859|7482356|FG000|STARTED|Overall Study||20
6559662|NCT01782859|7482357|FG001|STARTED|Overall Study||20
6352433|NCT00627393|7260652|FG001|NOT COMPLETED|Per-Protocol Analysis||13
6352434|NCT00627406|7260664|FG000|STARTED|Overall Study||60
6352435|NCT00627406|7260665|FG001|STARTED|Overall Study||58
6352436|NCT00627406|7260666|FG002|STARTED|Overall Study||125
6352437|NCT00627406|7260667|FG003|STARTED|Overall Study||141
6352438|NCT00627406|7260664|FG000|COMPLETED|Overall Study||60
6352439|NCT00627406|7260665|FG001|COMPLETED|Overall Study||58
6352440|NCT00627406|7260666|FG002|COMPLETED|Overall Study||125
6352441|NCT00627406|7260667|FG003|COMPLETED|Overall Study||141
6352442|NCT00627406|7260664|FG000|NOT COMPLETED|Overall Study||0
6352443|NCT00627406|7260665|FG001|NOT COMPLETED|Overall Study||0
6352444|NCT00627406|7260666|FG002|NOT COMPLETED|Overall Study||0
6352445|NCT00627406|7260667|FG003|NOT COMPLETED|Overall Study||0
6352446|NCT00627445|7260679|FG000|STARTED|Overall Study||219
6352447|NCT00627445|7260680|FG001|STARTED|Overall Study||222
6352448|NCT00627445|7260679|FG000|Exposed to Study Drug|Overall Study||219
6352449|NCT00627445|7260680|FG001|Exposed to Study Drug|Overall Study||222
6352450|NCT00627445|7260679|FG000|COMPLETED|Overall Study||210
6352451|NCT00627445|7260680|FG001|COMPLETED|Overall Study||210
6352452|NCT00627445|7260679|FG000|NOT COMPLETED|Overall Study||9
6352453|NCT00627445|7260680|FG001|NOT COMPLETED|Overall Study||12
6352454|NCT00627458|7260691|FG000|STARTED|Overall Study||127
6352455|NCT00627458|7260692|FG001|STARTED|Overall Study||137
6352456|NCT00627458|7260693|FG002|STARTED|Overall Study||139
6352457|NCT00627458|7260691|FG000|COMPLETED|Overall Study||123
6352458|NCT00627458|7260692|FG001|COMPLETED|Overall Study||130
6352459|NCT00627458|7260693|FG002|COMPLETED|Overall Study||133
6352460|NCT00627458|7260691|FG000|NOT COMPLETED|Overall Study||4
6352461|NCT00627458|7260692|FG001|NOT COMPLETED|Overall Study||7
6352462|NCT00627458|7260693|FG002|NOT COMPLETED|Overall Study||6
6352463|NCT00627497|7260706|FG000|STARTED|Overall Study||14
6352464|NCT00627497|7260707|FG001|STARTED|Overall Study||12
6352465|NCT00627497|7260708|FG002|STARTED|Overall Study||4
6352466|NCT00627497|7260709|FG003|STARTED|Overall Study||2
6352467|NCT00627497|7260706|FG000|COMPLETED|Overall Study||13
6352468|NCT00627497|7260707|FG001|COMPLETED|Overall Study||11
6352469|NCT00627497|7260708|FG002|COMPLETED|Overall Study||4
6352470|NCT00627497|7260709|FG003|COMPLETED|Overall Study||2
6352471|NCT00627497|7260706|FG000|NOT COMPLETED|Overall Study||1
6352472|NCT00627497|7260707|FG001|NOT COMPLETED|Overall Study||1
6352473|NCT00627497|7260708|FG002|NOT COMPLETED|Overall Study||0
6352474|NCT00627497|7260709|FG003|NOT COMPLETED|Overall Study||0
6559663|NCT01782859|7482356|FG000|COMPLETED|Overall Study||14
6559664|NCT01782859|7482357|FG001|COMPLETED|Overall Study||13
6352475|NCT00627523|7260721|FG000|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
6352476|NCT00627523|7260722|FG001|STARTED|Overall Study||22
6352477|NCT00627523|7260721|FG000|COMPLETED|Overall Study||19
6352478|NCT00627523|7260722|FG001|COMPLETED|Overall Study||20
6352479|NCT00627523|7260721|FG000|NOT COMPLETED|Overall Study||2
6352480|NCT00627523|7260722|FG001|NOT COMPLETED|Overall Study||2
6352481|NCT00627679|7260728|FG000|STARTED|Overall Study||4
6352482|NCT00627679|7260729|FG001|STARTED|Overall Study||4
6352483|NCT00627679|7260730|FG002|STARTED|Overall Study||4
6352484|NCT00627679|7260731|FG003|STARTED|Overall Study||4
6352485|NCT00627679|7260728|FG000|COMPLETED|Overall Study||4
6352486|NCT00627679|7260729|FG001|COMPLETED|Overall Study||4
6352487|NCT00627679|7260730|FG002|COMPLETED|Overall Study||4
6352488|NCT00627679|7260731|FG003|COMPLETED|Overall Study||4
6352489|NCT00627679|7260728|FG000|NOT COMPLETED|Overall Study||0
6352490|NCT00627679|7260729|FG001|NOT COMPLETED|Overall Study||0
6352491|NCT00627679|7260730|FG002|NOT COMPLETED|Overall Study||0
6352492|NCT00627679|7260731|FG003|NOT COMPLETED|Overall Study||0
6352493|NCT00627705|7260743|FG000|STARTED|Overall Study||15
6352494|NCT00627705|7260744|FG001|STARTED|Overall Study||18
6352495|NCT00627705|7260743|FG000|COMPLETED|Overall Study||13
6352496|NCT00627705|7260744|FG001|COMPLETED|Overall Study||12
6352497|NCT00627705|7260743|FG000|NOT COMPLETED|Overall Study||2
6352498|NCT00627705|7260744|FG001|NOT COMPLETED|Overall Study||6
6352499|NCT00627861|7260750|FG000|STARTED|Overall Study||1
6352500|NCT00627861|7260750|FG000|COMPLETED|Overall Study||1
6352501|NCT00627861|7260750|FG000|NOT COMPLETED|Overall Study||0
6352502|NCT00627926|7260759|FG000|STARTED|Overall Study||361
6352503|NCT00627926|7260760|FG001|STARTED|Overall Study||364
6352504|NCT00627926|7260761|FG002|STARTED|Overall Study||363
6352505|NCT00627926|7260759|FG000|COMPLETED|Overall Study||202
6352506|NCT00627926|7260760|FG001|COMPLETED|Overall Study||260
6352507|NCT00627926|7260761|FG002|COMPLETED|Overall Study||268
6352508|NCT00627926|7260759|FG000|NOT COMPLETED|Overall Study||159
6352509|NCT00627926|7260760|FG001|NOT COMPLETED|Overall Study||104
6352510|NCT00627926|7260761|FG002|NOT COMPLETED|Overall Study||95
6352511|NCT00627978|7260771|FG000|STARTED|Overall Study||10
6352512|NCT00627978|7260772|FG001|STARTED|Overall Study||5
6352513|NCT00627978|7260771|FG000|COMPLETED|Overall Study||10
6352514|NCT00627978|7260772|FG001|COMPLETED|Overall Study||5
6352515|NCT00627978|7260771|FG000|NOT COMPLETED|Overall Study||0
6352516|NCT00627978|7260772|FG001|NOT COMPLETED|Overall Study||0
6352517|NCT00628030|7260780|FG000|STARTED|Baseline to Post-Assessment||92
6352518|NCT00628030|7260781|FG001|STARTED|Baseline to Post-Assessment||92
6352519|NCT00628030|7260780|FG000|COMPLETED|Baseline to Post-Assessment||59
6352520|NCT00628030|7260781|FG001|COMPLETED|Baseline to Post-Assessment||63
6352521|NCT00628030|7260780|FG000|NOT COMPLETED|Baseline to Post-Assessment||33
6352522|NCT00628030|7260781|FG001|NOT COMPLETED|Baseline to Post-Assessment||29
6352523|NCT00628030|7260780|FG000|STARTED|Post to 6 Month Follow-up||59
6352524|NCT00628030|7260781|FG001|STARTED|Post to 6 Month Follow-up||63
6352525|NCT00628030|7260780|FG000|COMPLETED|Post to 6 Month Follow-up||27
6352526|NCT00628030|7260781|FG001|COMPLETED|Post to 6 Month Follow-up||33
6352527|NCT00628030|7260780|FG000|NOT COMPLETED|Post to 6 Month Follow-up||32
6352528|NCT00628030|7260781|FG001|NOT COMPLETED|Post to 6 Month Follow-up||30
6352529|NCT00628108|7260789|FG000|STARTED|Overall Study||23
6352530|NCT00628108|7260790|FG001|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
6352531|NCT00628108|7260789|FG000|Safety Population|Overall Study||24
6352532|NCT00628108|7260790|FG001|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
6559665|NCT01782859|7482356|FG000|NOT COMPLETED|Overall Study||6
6559666|NCT01782859|7482357|FG001|NOT COMPLETED|Overall Study||7
6352533|NCT00628108|7260789|FG000|COMPLETED|Overall Study||22
6352534|NCT00628108|7260790|FG001|COMPLETED|Overall Study||43
6352535|NCT00628108|7260789|FG000|NOT COMPLETED|Overall Study||1
6352536|NCT00628108|7260790|FG001|NOT COMPLETED|Overall Study||3
6352537|NCT00628134|7260796|FG000|STARTED|Overall Study||4
6352538|NCT00628134|7260797|FG001|STARTED|Overall Study||4
6352539|NCT00628134|7260796|FG000|COMPLETED|Overall Study||4
6352540|NCT00628134|7260797|FG001|COMPLETED|Overall Study||4
6352541|NCT00628134|7260796|FG000|NOT COMPLETED|Overall Study||0
6352542|NCT00628134|7260797|FG001|NOT COMPLETED|Overall Study||0
6352543|NCT00628147|7260805|FG000|STARTED|Overall Study||142
6352544|NCT00628147|7260806|FG001|STARTED|Overall Study||142
6352545|NCT00628147|7260805|FG000|COMPLETED|Overall Study||135
6352546|NCT00628147|7260806|FG001|COMPLETED|Overall Study||141
6352547|NCT00628147|7260805|FG000|NOT COMPLETED|Overall Study||7
6352548|NCT00628147|7260806|FG001|NOT COMPLETED|Overall Study||1
6352549|NCT00628212|7260816|FG000|STARTED|Overall Study||80
6352550|NCT00628212|7260817|FG001|STARTED|Overall Study||84
6352551|NCT00628212|7260818|FG002|STARTED|Overall Study||79
6352552|NCT00628212|7260819|FG003|STARTED|Overall Study||81
6352553|NCT00628212|7260816|FG000|COMPLETED|Overall Study||77
6352554|NCT00628212|7260817|FG001|COMPLETED|Overall Study||83
6352555|NCT00628212|7260818|FG002|COMPLETED|Overall Study||76
6352556|NCT00628212|7260819|FG003|COMPLETED|Overall Study||76
6352557|NCT00628212|7260816|FG000|NOT COMPLETED|Overall Study||3
6352558|NCT00628212|7260817|FG001|NOT COMPLETED|Overall Study||1
6352559|NCT00628212|7260818|FG002|NOT COMPLETED|Overall Study||3
6352560|NCT00628212|7260819|FG003|NOT COMPLETED|Overall Study||5
6559667|NCT01782872|7482368|FG000|STARTED|Overall Study||20
6352561|NCT00628251|7260832|FG000|STARTED|Randomised Part|Patients randomised|32
6352562|NCT00628251|7260833|FG001|STARTED|Randomised Part|Patients randomised|32
6352563|NCT00628251|7260834|FG002|STARTED|Randomised Part|Patients randomised|33
6352564|NCT00628251|7260832|FG000|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
6352565|NCT00628251|7260833|FG001|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
6352566|NCT00628251|7260834|FG002|COMPLETED|Randomised Part|1 of 33 patients did not receive Liposomal Doxorubicin. Patient voluntarily discontinued|32
6352567|NCT00628251|7260832|FG000|NOT COMPLETED|Randomised Part||0
6352568|NCT00628251|7260833|FG001|NOT COMPLETED|Randomised Part||0
6352569|NCT00628251|7260834|FG002|NOT COMPLETED|Randomised Part||1
6352570|NCT00628251|7260832|FG000|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
6352571|NCT00628251|7260833|FG001|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received treatment|32
6352572|NCT00628251|7260834|FG002|STARTED|Ongoing Initial Study Treatment at DCO|Patients who received Liposomal doxorubicin 50 mg/m2|32
6352573|NCT00628251|7260832|FG000|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||22
6352574|NCT00628251|7260833|FG001|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||20
6352575|NCT00628251|7260834|FG002|Discontinued Initial Study Treatment|Ongoing Initial Study Treatment at DCO||25
6352576|NCT00628251|7260832|FG000|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
6352577|NCT00628251|7260833|FG001|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO||0
6352578|NCT00628251|7260834|FG002|Crossover to Olaparib|Ongoing Initial Study Treatment at DCO|Crossover dosage was 400 mg bd Olaparib|14
6352579|NCT00628251|7260832|FG000|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
6352580|NCT00628251|7260833|FG001|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||0
6352581|NCT00628251|7260834|FG002|Ongoing Crossover at DCO|Ongoing Initial Study Treatment at DCO||5
6352582|NCT00628251|7260832|FG000|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
6352583|NCT00628251|7260833|FG001|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||0
6352584|NCT00628251|7260834|FG002|Discontinued Crossover|Ongoing Initial Study Treatment at DCO||9
6352585|NCT00628251|7260832|FG000|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|10
6352586|NCT00628251|7260833|FG001|COMPLETED|Ongoing Initial Study Treatment at DCO|Ongoing initial study treatment at primary data cut-off|12
6352587|NCT00628251|7260834|FG002|COMPLETED|Ongoing Initial Study Treatment at DCO|Patients ongoing initial study treatment (Liposomal doxorubicin)|7
6352588|NCT00628251|7260832|FG000|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||22
6352589|NCT00628251|7260833|FG001|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||20
6352590|NCT00628251|7260834|FG002|NOT COMPLETED|Ongoing Initial Study Treatment at DCO||25
6352591|NCT00628355|7260846|FG000|STARTED|Overall Study||15
6352592|NCT00628355|7260847|FG001|STARTED|Overall Study||15
6352593|NCT00628355|7260846|FG000|COMPLETED|Overall Study||14
6352594|NCT00628355|7260847|FG001|COMPLETED|Overall Study||14
6352595|NCT00628355|7260846|FG000|NOT COMPLETED|Overall Study||1
6352596|NCT00628355|7260847|FG001|NOT COMPLETED|Overall Study||1
6376859|NCT00761462|7287454|FG001|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
6376860|NCT00761462|7287453|FG000|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
6376861|NCT00761462|7287454|FG001|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
6376862|NCT00761462|7287453|FG000|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
6376863|NCT00761462|7287454|FG001|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
6376864|NCT00761462|7287453|FG000|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
6376865|NCT00761462|7287454|FG001|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
6376866|NCT00761462|7287453|FG000|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
6376867|NCT00761462|7287454|FG001|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
6376868|NCT00761514|7287460|FG000|STARTED|Overall Study||14
6376869|NCT00761514|7287460|FG000|COMPLETED|Overall Study||7
6376870|NCT00761514|7287460|FG000|NOT COMPLETED|Overall Study||7
6376871|NCT00761579|7287464|FG000|STARTED|Overall Study||190
6376872|NCT00761579|7287464|FG000|COMPLETED|Overall Study||98
6376873|NCT00761579|7287464|FG000|NOT COMPLETED|Overall Study||92
6376874|NCT00761592|7287472|FG000|STARTED|Overall Study||32
6376875|NCT00761592|7287473|FG001|STARTED|Overall Study||33
6376876|NCT00761592|7287472|FG000|COMPLETED|Overall Study||31
6376877|NCT00761592|7287473|FG001|COMPLETED|Overall Study||32
6376878|NCT00761592|7287472|FG000|NOT COMPLETED|Overall Study||1
6376879|NCT00761592|7287473|FG001|NOT COMPLETED|Overall Study||1
6376880|NCT00761605|7287479|FG000|STARTED|Overall Study||387
6376881|NCT00761605|7287479|FG000|COMPLETED|Overall Study||246
6376882|NCT00761605|7287479|FG000|NOT COMPLETED|Overall Study||141
6376883|NCT00761631|7287491|FG000|STARTED|Overall Study||126
6559668|NCT01782872|7482369|FG001|STARTED|Overall Study||20
6559669|NCT01782872|7482370|FG002|STARTED|Overall Study||20
6559670|NCT01782872|7482371|FG003|STARTED|Overall Study||20
6559671|NCT01782872|7482368|FG000|COMPLETED|Overall Study||20
6376884|NCT00761631|7287492|FG001|STARTED|Overall Study||181
6376885|NCT00761631|7287493|FG002|STARTED|Overall Study||176
6376886|NCT00761631|7287494|FG003|STARTED|Overall Study||119
6376887|NCT00761631|7287495|FG004|STARTED|Overall Study||299
6376888|NCT00761631|7287496|FG005|STARTED|Overall Study||299
6559672|NCT01782872|7482369|FG001|COMPLETED|Overall Study||19
6559673|NCT01782872|7482370|FG002|COMPLETED|Overall Study||20
6352597|NCT00628394|7260858|FG000|STARTED|Overall Study||14
6352598|NCT00628394|7260859|FG001|STARTED|Overall Study||13
6352599|NCT00628394|7260860|FG002|STARTED|Overall Study||13
6352600|NCT00628394|7260861|FG003|STARTED|Overall Study||13
6352601|NCT00628394|7260858|FG000|COMPLETED|Overall Study||10
6352602|NCT00628394|7260859|FG001|COMPLETED|Overall Study||9
6352603|NCT00628394|7260860|FG002|COMPLETED|Overall Study||11
6352604|NCT00628394|7260861|FG003|COMPLETED|Overall Study||10
6352605|NCT00628394|7260858|FG000|NOT COMPLETED|Overall Study||4
6352606|NCT00628394|7260859|FG001|NOT COMPLETED|Overall Study||4
6352607|NCT00628394|7260860|FG002|NOT COMPLETED|Overall Study||2
6352608|NCT00628394|7260861|FG003|NOT COMPLETED|Overall Study||3
6352609|NCT00628407|7260871|FG000|STARTED|Overall Study||13
6352610|NCT00628407|7260871|FG000|COMPLETED|Overall Study||13
6352611|NCT00628407|7260871|FG000|NOT COMPLETED|Overall Study||0
6352612|NCT00628498|7260875|FG000|STARTED|Overall Study||1206
6352613|NCT00628498|7260875|FG000|COMPLETED|Overall Study||1154
6352614|NCT00628498|7260875|FG000|NOT COMPLETED|Overall Study||52
6352615|NCT00628589|7260882|FG000|STARTED|Overall Study||115
6352616|NCT00628589|7260883|FG001|STARTED|Overall Study||116
6352617|NCT00628589|7260884|FG002|STARTED|Overall Study||113
6352618|NCT00628589|7260882|FG000|COMPLETED|Overall Study||114
6352619|NCT00628589|7260883|FG001|COMPLETED|Overall Study||114
6352620|NCT00628589|7260884|FG002|COMPLETED|Overall Study||110
6352621|NCT00628589|7260882|FG000|NOT COMPLETED|Overall Study||1
6352622|NCT00628589|7260883|FG001|NOT COMPLETED|Overall Study||2
6352623|NCT00628589|7260884|FG002|NOT COMPLETED|Overall Study||3
6352624|NCT00628628|7260894|FG000|STARTED|Overall Study||40
6352625|NCT00628628|7260895|FG001|STARTED|Overall Study||40
6352626|NCT00628628|7260894|FG000|COMPLETED|Overall Study||40
6352627|NCT00628628|7260895|FG001|COMPLETED|Overall Study||40
6352628|NCT00628628|7260894|FG000|NOT COMPLETED|Overall Study||0
6352629|NCT00628628|7260895|FG001|NOT COMPLETED|Overall Study||0
6352630|NCT00628758|7260903|FG000|STARTED|Overall Study||209
6352631|NCT00628758|7260904|FG001|STARTED|Overall Study||221
6352632|NCT00628758|7260903|FG000|COMPLETED|Overall Study||165
6352633|NCT00628758|7260904|FG001|COMPLETED|Overall Study||179
6352634|NCT00628758|7260903|FG000|NOT COMPLETED|Overall Study||44
6352635|NCT00628758|7260904|FG001|NOT COMPLETED|Overall Study||42
6352636|NCT00628862|7260915|FG000|STARTED|Overall Study|randomised patients|206
6352637|NCT00628862|7260916|FG001|STARTED|Overall Study|randomised patients|199
6352638|NCT00628862|7260917|FG002|STARTED|Overall Study|randomised patients|208
6352639|NCT00628862|7260915|FG000|COMPLETED|Overall Study|randomised patients|195
6352640|NCT00628862|7260916|FG001|COMPLETED|Overall Study|randomised patients|182
6352641|NCT00628862|7260917|FG002|COMPLETED|Overall Study|randomised patients|186
6352642|NCT00628862|7260915|FG000|NOT COMPLETED|Overall Study||11
6352643|NCT00628862|7260916|FG001|NOT COMPLETED|Overall Study||17
6352644|NCT00628862|7260917|FG002|NOT COMPLETED|Overall Study||22
6352645|NCT00628901|7260927|FG000|STARTED|Overall Study||30
6352646|NCT00628901|7260928|FG001|STARTED|Overall Study||30
6352647|NCT00628901|7260927|FG000|COMPLETED|Overall Study||27
6352648|NCT00628901|7260928|FG001|COMPLETED|Overall Study||29
6352649|NCT00628901|7260927|FG000|NOT COMPLETED|Overall Study||3
6352650|NCT00628901|7260928|FG001|NOT COMPLETED|Overall Study||1
6352651|NCT00628927|7260936|FG000|STARTED|Overall Study||183
6352652|NCT00628927|7260937|FG001|STARTED|Overall Study||30
6352653|NCT00628927|7260936|FG000|COMPLETED|Overall Study||175
6352654|NCT00628927|7260937|FG001|COMPLETED|Overall Study||30
6352655|NCT00628927|7260936|FG000|NOT COMPLETED|Overall Study||8
6352656|NCT00628927|7260937|FG001|NOT COMPLETED|Overall Study||0
6352657|NCT00629018|7260950|FG000|STARTED|Overall Study||55
6352658|NCT00629018|7260951|FG001|STARTED|Overall Study||55
6352659|NCT00629018|7260950|FG000|COMPLETED|Overall Study||55
6352660|NCT00629018|7260951|FG001|COMPLETED|Overall Study||55
6352661|NCT00629018|7260950|FG000|NOT COMPLETED|Overall Study||0
6352662|NCT00629018|7260951|FG001|NOT COMPLETED|Overall Study||0
6352663|NCT00629083|7260959|FG000|STARTED|Overall Study||228
6352664|NCT00629083|7260960|FG001|STARTED|Overall Study||117
6352665|NCT00629083|7260959|FG000|COMPLETED|Overall Study||200
6352666|NCT00629083|7260960|FG001|COMPLETED|Overall Study||103
6352667|NCT00629083|7260959|FG000|NOT COMPLETED|Overall Study||28
6352668|NCT00629083|7260960|FG001|NOT COMPLETED|Overall Study||14
6352669|NCT00629122|7260970|FG000|STARTED|First Period: Day 1- 3 (Sublingual)||2
6352670|NCT00629122|7260971|FG001|STARTED|First Period: Day 1- 3 (Sublingual)||3
6352671|NCT00629122|7260970|FG000|COMPLETED|First Period: Day 1- 3 (Sublingual)||2
6352672|NCT00629122|7260971|FG001|COMPLETED|First Period: Day 1- 3 (Sublingual)||3
6352673|NCT00629122|7260970|FG000|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
6352674|NCT00629122|7260971|FG001|NOT COMPLETED|First Period: Day 1- 3 (Sublingual)||0
6352675|NCT00629122|7260970|FG000|STARTED|Second Period: Day 3-5 (Washout)||2
6352676|NCT00629122|7260971|FG001|STARTED|Second Period: Day 3-5 (Washout)||3
6352677|NCT00629122|7260970|FG000|COMPLETED|Second Period: Day 3-5 (Washout)||2
6352678|NCT00629122|7260971|FG001|COMPLETED|Second Period: Day 3-5 (Washout)||3
6352679|NCT00629122|7260970|FG000|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
6352680|NCT00629122|7260971|FG001|NOT COMPLETED|Second Period: Day 3-5 (Washout)||0
6352681|NCT00629122|7260970|FG000|STARTED|Third Period: Day 6-8 (Oral)||2
6352682|NCT00629122|7260971|FG001|STARTED|Third Period: Day 6-8 (Oral)||3
6352683|NCT00629122|7260970|FG000|COMPLETED|Third Period: Day 6-8 (Oral)||2
6352684|NCT00629122|7260971|FG001|COMPLETED|Third Period: Day 6-8 (Oral)||3
6352685|NCT00629122|7260970|FG000|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
6352686|NCT00629122|7260971|FG001|NOT COMPLETED|Third Period: Day 6-8 (Oral)||0
6352687|NCT00629239|7260979|FG000|STARTED|Overall Study||34
6352688|NCT00629239|7260980|FG001|STARTED|Overall Study||32
6352689|NCT00629239|7260979|FG000|COMPLETED|Overall Study||26
6352690|NCT00629239|7260980|FG001|COMPLETED|Overall Study||28
6352691|NCT00629239|7260979|FG000|NOT COMPLETED|Overall Study||8
6352692|NCT00629239|7260980|FG001|NOT COMPLETED|Overall Study||4
6352693|NCT00629265|7260988|FG000|STARTED|Overall Study||116
6352694|NCT00629265|7260989|FG001|STARTED|Overall Study||54
6352695|NCT00629265|7260988|FG000|COMPLETED|Overall Study||84
6352696|NCT00629265|7260989|FG001|COMPLETED|Overall Study||34
6352697|NCT00629265|7260988|FG000|NOT COMPLETED|Overall Study||32
6352698|NCT00629265|7260989|FG001|NOT COMPLETED|Overall Study||20
6352699|NCT00629499|7260995|FG000|STARTED|Overall Study||63
6352700|NCT00629499|7260995|FG000|COMPLETED|Overall Study||63
6352701|NCT00629499|7260995|FG000|NOT COMPLETED|Overall Study||0
6352702|NCT00629525|7260999|FG000|STARTED|Overall Study||35
6352703|NCT00629525|7260999|FG000|COMPLETED|Overall Study||32
6352704|NCT00629525|7260999|FG000|NOT COMPLETED|Overall Study||3
6352705|NCT00629707|7261005|FG000|STARTED|Overall Study||10
6352706|NCT00629707|7261006|FG001|STARTED|Overall Study||10
6352707|NCT00629707|7261005|FG000|COMPLETED|Overall Study||10
6352708|NCT00629707|7261006|FG001|COMPLETED|Overall Study||8
6352709|NCT00629707|7261005|FG000|NOT COMPLETED|Overall Study||0
6352710|NCT00629707|7261006|FG001|NOT COMPLETED|Overall Study||2
6352711|NCT00629772|7261014|FG000|STARTED|First Intervention - Day 0 - Week 14||12
6352712|NCT00629772|7261015|FG001|STARTED|First Intervention - Day 0 - Week 14||12
6352713|NCT00629772|7261014|FG000|COMPLETED|First Intervention - Day 0 - Week 14||12
6352714|NCT00629772|7261015|FG001|COMPLETED|First Intervention - Day 0 - Week 14||12
6352715|NCT00629772|7261014|FG000|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
6352716|NCT00629772|7261015|FG001|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
6352717|NCT00629772|7261014|FG000|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
6352718|NCT00629772|7261015|FG001|STARTED|Second Intervention Week 14 - Week 26||12
6352719|NCT00629772|7261014|FG000|COMPLETED|Second Intervention Week 14 - Week 26||11
6352720|NCT00629772|7261015|FG001|COMPLETED|Second Intervention Week 14 - Week 26||10
6352721|NCT00629772|7261014|FG000|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
6352722|NCT00629772|7261015|FG001|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
6352723|NCT00630032|7261024|FG000|STARTED|Overall Study||398
6352724|NCT00630032|7261025|FG001|STARTED|Overall Study||364
6352725|NCT00630032|7261024|FG000|COMPLETED|Overall Study||308
6352726|NCT00630032|7261025|FG001|COMPLETED|Overall Study||269
6352727|NCT00630032|7261024|FG000|NOT COMPLETED|Overall Study||90
6352728|NCT00630032|7261025|FG001|NOT COMPLETED|Overall Study||95
6352729|NCT00630058|7261033|FG000|STARTED|Overall Study||10
6352730|NCT00630058|7261034|FG001|STARTED|Overall Study||10
6352731|NCT00630058|7261033|FG000|COMPLETED|Overall Study||6
6352732|NCT00630058|7261034|FG001|COMPLETED|Overall Study||6
6352733|NCT00630058|7261033|FG000|NOT COMPLETED|Overall Study||4
6352734|NCT00630058|7261034|FG001|NOT COMPLETED|Overall Study||4
6352735|NCT00630253|7261043|FG000|STARTED|Overall Study||16
6352736|NCT00630253|7261044|FG001|STARTED|Overall Study||9
6352737|NCT00630253|7261045|FG002|STARTED|Overall Study||6
6352738|NCT00630253|7261043|FG000|COMPLETED|Overall Study||16
6352739|NCT00630253|7261044|FG001|COMPLETED|Overall Study||9
6352740|NCT00630253|7261045|FG002|COMPLETED|Overall Study||6
6352741|NCT00630253|7261043|FG000|NOT COMPLETED|Overall Study||0
6352742|NCT00630253|7261044|FG001|NOT COMPLETED|Overall Study||0
6352743|NCT00630253|7261045|FG002|NOT COMPLETED|Overall Study||0
6352744|NCT00630305|7261053|FG000|STARTED|Overall Study||37
6352745|NCT00630305|7261053|FG000|COMPLETED|Overall Study||35
6352746|NCT00630305|7261053|FG000|NOT COMPLETED|Overall Study||2
6352747|NCT00630331|7261069|FG000|STARTED|Overall Study||3828
6352748|NCT00630331|7261070|FG001|STARTED|Overall Study||3676
6352749|NCT00630331|7261071|FG002|STARTED|Overall Study||3900
6352750|NCT00630331|7261069|FG000|COMPLETED|Overall Study||3622
6352751|NCT00630331|7261070|FG001|COMPLETED|Overall Study||3510
6352752|NCT00630331|7261071|FG002|COMPLETED|Overall Study||3712
6352753|NCT00630331|7261069|FG000|NOT COMPLETED|Overall Study||206
6352754|NCT00630331|7261070|FG001|NOT COMPLETED|Overall Study||166
6352755|NCT00630331|7261071|FG002|NOT COMPLETED|Overall Study||188
6352756|NCT00630344|7261079|FG000|STARTED|Overall Study||36
6352757|NCT00630344|7261079|FG000|COMPLETED|Overall Study||0
6352758|NCT00630344|7261079|FG000|NOT COMPLETED|Overall Study||36
6352759|NCT00630396|7261084|FG000|STARTED|Overall Study||60
6352760|NCT00630396|7261084|FG000|COMPLETED|Overall Study||53
6352761|NCT00630396|7261084|FG000|NOT COMPLETED|Overall Study||7
6352762|NCT00630409|7261088|FG000|STARTED|Overall Study||5
6352763|NCT00630409|7261088|FG000|COMPLETED|Overall Study||4
6352764|NCT00630409|7261088|FG000|NOT COMPLETED|Overall Study||1
6352765|NCT00630539|7261097|FG000|STARTED|Overall Study||34
6352766|NCT00630539|7261098|FG001|STARTED|Overall Study||33
6352767|NCT00630539|7261099|FG002|STARTED|Overall Study||29
6352768|NCT00630539|7261100|FG003|STARTED|Overall Study||30
6352769|NCT00630539|7261097|FG000|COMPLETED|Overall Study||33
6352770|NCT00630539|7261098|FG001|COMPLETED|Overall Study||29
6352771|NCT00630539|7261099|FG002|COMPLETED|Overall Study||28
6352772|NCT00630539|7261100|FG003|COMPLETED|Overall Study||27
6352773|NCT00630539|7261097|FG000|NOT COMPLETED|Overall Study||1
6352774|NCT00630539|7261098|FG001|NOT COMPLETED|Overall Study||4
6352775|NCT00630539|7261099|FG002|NOT COMPLETED|Overall Study||1
6352776|NCT00630539|7261100|FG003|NOT COMPLETED|Overall Study||3
6352777|NCT00630734|7261120|FG000|STARTED|Overall Study||11
6352778|NCT00630734|7261121|FG001|STARTED|Overall Study||13
6352779|NCT00630734|7261122|FG002|STARTED|Overall Study||8
6352780|NCT00630734|7261120|FG000|COMPLETED|Overall Study||9
6352781|NCT00630734|7261121|FG001|COMPLETED|Overall Study||12
6352782|NCT00630734|7261122|FG002|COMPLETED|Overall Study||7
6352783|NCT00630734|7261120|FG000|NOT COMPLETED|Overall Study||2
6352784|NCT00630734|7261121|FG001|NOT COMPLETED|Overall Study||1
6352785|NCT00630734|7261122|FG002|NOT COMPLETED|Overall Study||1
6352786|NCT00630747|7261132|FG000|STARTED|Overall Study||94
6352787|NCT00630747|7261132|FG000|Participants Treated in Phase I of Study|Overall Study||94
6352788|NCT00630747|7261132|FG000|COMPLETED|Overall Study||85
6352789|NCT00630747|7261132|FG000|NOT COMPLETED|Overall Study||9
6352790|NCT00630786|7261139|FG000|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
6352791|NCT00630786|7261140|FG001|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
6352792|NCT00630786|7261141|FG002|STARTED|Overall Study|All patients were enrolled in Part 2.|9
6352793|NCT00630786|7261139|FG000|Received Study Medication|Overall Study||19
6352794|NCT00630786|7261140|FG001|Received Study Medication|Overall Study||25
6352795|NCT00630786|7261141|FG002|Received Study Medication|Overall Study||8
6352796|NCT00630786|7261139|FG000|COMPLETED|Overall Study|Completed study defined as participant death|18
6352797|NCT00630786|7261140|FG001|COMPLETED|Overall Study|Completed study defined as participant death|23
6352798|NCT00630786|7261141|FG002|COMPLETED|Overall Study|Completed study defined as participant death|7
6352799|NCT00630786|7261139|FG000|NOT COMPLETED|Overall Study||1
6352800|NCT00630786|7261140|FG001|NOT COMPLETED|Overall Study||2
6352801|NCT00630786|7261141|FG002|NOT COMPLETED|Overall Study||2
6352802|NCT00630812|7261149|FG000|STARTED|Randomisation to First Dose||192
6352803|NCT00630812|7261150|FG001|STARTED|Randomisation to First Dose||126
6352804|NCT00630812|7261149|FG000|COMPLETED|Randomisation to First Dose||184
6352805|NCT00630812|7261150|FG001|COMPLETED|Randomisation to First Dose||121
6352806|NCT00630812|7261149|FG000|NOT COMPLETED|Randomisation to First Dose||8
6352807|NCT00630812|7261150|FG001|NOT COMPLETED|Randomisation to First Dose||5
6352808|NCT00630812|7261149|FG000|STARTED|Double Blind Treatment Period||184
6352809|NCT00630812|7261150|FG001|STARTED|Double Blind Treatment Period||121
6352810|NCT00630812|7261149|FG000|COMPLETED|Double Blind Treatment Period||153
6352811|NCT00630812|7261150|FG001|COMPLETED|Double Blind Treatment Period||107
6352812|NCT00630812|7261149|FG000|NOT COMPLETED|Double Blind Treatment Period||31
6352813|NCT00630812|7261150|FG001|NOT COMPLETED|Double Blind Treatment Period||14
6352814|NCT00630825|7261160|FG000|STARTED|Overall Study||65
6352815|NCT00630825|7261161|FG001|STARTED|Overall Study||65
6352816|NCT00630825|7261162|FG002|STARTED|Overall Study||66
6352817|NCT00630825|7261163|FG003|STARTED|Overall Study||66
6352818|NCT00630825|7261160|FG000|Received at Least One Dose of Study Drug|Overall Study||65
6352819|NCT00630825|7261161|FG001|Received at Least One Dose of Study Drug|Overall Study||65
6352820|NCT00630825|7261162|FG002|Received at Least One Dose of Study Drug|Overall Study||66
6352821|NCT00630825|7261163|FG003|Received at Least One Dose of Study Drug|Overall Study||66
6352822|NCT00630825|7261160|FG000|COMPLETED|Overall Study||56
6352823|NCT00630825|7261161|FG001|COMPLETED|Overall Study||58
6352824|NCT00630825|7261162|FG002|COMPLETED|Overall Study||58
6352825|NCT00630825|7261163|FG003|COMPLETED|Overall Study||60
6352826|NCT00630825|7261160|FG000|NOT COMPLETED|Overall Study||9
6352827|NCT00630825|7261161|FG001|NOT COMPLETED|Overall Study||7
6352828|NCT00630825|7261162|FG002|NOT COMPLETED|Overall Study||8
6352829|NCT00630825|7261163|FG003|NOT COMPLETED|Overall Study||6
6352830|NCT00630838|7261175|FG000|STARTED|Overall Study||32
6352831|NCT00630838|7261176|FG001|STARTED|Overall Study||30
6352832|NCT00630838|7261175|FG000|COMPLETED|Overall Study||32
6352833|NCT00630838|7261176|FG001|COMPLETED|Overall Study||28
6352834|NCT00630838|7261175|FG000|NOT COMPLETED|Overall Study||0
6352835|NCT00630838|7261176|FG001|NOT COMPLETED|Overall Study||2
6352836|NCT00630864|7261184|FG000|STARTED|Part 1 (up to Week 6)||21
6352837|NCT00630864|7261184|FG000|COMPLETED|Part 1 (up to Week 6)||20
6352838|NCT00630864|7261184|FG000|NOT COMPLETED|Part 1 (up to Week 6)||1
6352839|NCT00630864|7261184|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||20
6352840|NCT00630864|7261184|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
6352841|NCT00630864|7261184|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
6352842|NCT00630877|7261191|FG000|STARTED|Overall Study|For all arms, started means treated.|91
6352843|NCT00630877|7261192|FG001|STARTED|Overall Study||90
6352844|NCT00630877|7261193|FG002|STARTED|Overall Study||90
6352845|NCT00630877|7261191|FG000|COMPLETED|Overall Study||72
6352846|NCT00630877|7261192|FG001|COMPLETED|Overall Study||75
6352847|NCT00630877|7261193|FG002|COMPLETED|Overall Study||80
6352848|NCT00630877|7261191|FG000|NOT COMPLETED|Overall Study||19
6352849|NCT00630877|7261192|FG001|NOT COMPLETED|Overall Study||15
6352850|NCT00630877|7261193|FG002|NOT COMPLETED|Overall Study||10
6352851|NCT00630916|7261205|FG000|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
6352852|NCT00630916|7261205|FG000|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
6352853|NCT00630916|7261205|FG000|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
6352854|NCT00630916|7261205|FG000|NOT COMPLETED|Overall Study||210
6352855|NCT00630955|7261212|FG000|STARTED|Overall Study||34
6352856|NCT00630955|7261213|FG001|STARTED|Overall Study||37
6352857|NCT00630955|7261214|FG002|STARTED|Overall Study||40
6352858|NCT00630955|7261212|FG000|COMPLETED|Overall Study||31
6352859|NCT00630955|7261213|FG001|COMPLETED|Overall Study||31
6352860|NCT00630955|7261214|FG002|COMPLETED|Overall Study||28
6352861|NCT00630955|7261212|FG000|NOT COMPLETED|Overall Study||3
6352862|NCT00630955|7261213|FG001|NOT COMPLETED|Overall Study||6
6352863|NCT00630955|7261214|FG002|NOT COMPLETED|Overall Study||12
6352864|NCT00630994|7261222|FG000|STARTED|Overall Study||4
6352865|NCT00630994|7261222|FG000|COMPLETED|Overall Study||0
6352866|NCT00630994|7261222|FG000|NOT COMPLETED|Overall Study||4
6352867|NCT00631007|7261232|FG000|STARTED|Overall Study||60
6352868|NCT00631007|7261233|FG001|STARTED|Overall Study||61
6352869|NCT00631007|7261234|FG002|STARTED|Overall Study||63
6352870|NCT00631007|7261235|FG003|STARTED|Overall Study||62
6352871|NCT00631007|7261236|FG004|STARTED|Overall Study||60
6352872|NCT00631007|7261237|FG005|STARTED|Overall Study||61
6352873|NCT00631007|7261232|FG000|COMPLETED|Overall Study||49
6352874|NCT00631007|7261233|FG001|COMPLETED|Overall Study||50
6352875|NCT00631007|7261234|FG002|COMPLETED|Overall Study||53
6352876|NCT00631007|7261235|FG003|COMPLETED|Overall Study||53
6352877|NCT00631007|7261236|FG004|COMPLETED|Overall Study||48
6352878|NCT00631007|7261237|FG005|COMPLETED|Overall Study||46
6352879|NCT00631007|7261232|FG000|NOT COMPLETED|Overall Study||11
6352880|NCT00631007|7261233|FG001|NOT COMPLETED|Overall Study||11
6352881|NCT00631007|7261234|FG002|NOT COMPLETED|Overall Study||10
6352882|NCT00631007|7261235|FG003|NOT COMPLETED|Overall Study||9
6352883|NCT00631007|7261236|FG004|NOT COMPLETED|Overall Study||12
6352884|NCT00631007|7261237|FG005|NOT COMPLETED|Overall Study||15
6352885|NCT00631020|7261251|FG000|STARTED|Overall Study||34
6352886|NCT00631020|7261251|FG000|COMPLETED|Overall Study||26
6352887|NCT00631020|7261251|FG000|NOT COMPLETED|Overall Study||8
6352888|NCT00631163|7261255|FG000|STARTED|Number of Participants in Year 1||102
6352889|NCT00631163|7261255|FG000|COMPLETED|Number of Participants in Year 1||68
6352890|NCT00631163|7261255|FG000|NOT COMPLETED|Number of Participants in Year 1||34
6352891|NCT00631163|7261255|FG000|STARTED|Number of Participants in Year 2||57
6352892|NCT00631163|7261255|FG000|COMPLETED|Number of Participants in Year 2||52
6352893|NCT00631163|7261255|FG000|NOT COMPLETED|Number of Participants in Year 2||5
6352894|NCT00631189|7261270|FG000|STARTED|Initial Phase||668
6352895|NCT00631189|7261271|FG001|STARTED|Initial Phase||0
6352896|NCT00631189|7261272|FG002|STARTED|Initial Phase||0
6352897|NCT00631189|7261273|FG003|STARTED|Initial Phase||0
6352898|NCT00631189|7261270|FG000|COMPLETED|Initial Phase||317
6352899|NCT00631189|7261271|FG001|COMPLETED|Initial Phase||0
6352900|NCT00631189|7261272|FG002|COMPLETED|Initial Phase||0
6352901|NCT00631189|7261273|FG003|COMPLETED|Initial Phase||0
6352902|NCT00631189|7261270|FG000|NOT COMPLETED|Initial Phase||351
6352903|NCT00631189|7261271|FG001|NOT COMPLETED|Initial Phase||0
6352904|NCT00631189|7261272|FG002|NOT COMPLETED|Initial Phase||0
6352905|NCT00631189|7261273|FG003|NOT COMPLETED|Initial Phase||0
6352906|NCT00631189|7261270|FG000|STARTED|Treatment Phase||0
6352907|NCT00631189|7261271|FG001|STARTED|Treatment Phase||104
6352908|NCT00631189|7261272|FG002|STARTED|Treatment Phase||103
6352909|NCT00631189|7261273|FG003|STARTED|Treatment Phase||110
6352910|NCT00631189|7261270|FG000|COMPLETED|Treatment Phase||0
6352911|NCT00631189|7261271|FG001|COMPLETED|Treatment Phase||97
6352912|NCT00631189|7261272|FG002|COMPLETED|Treatment Phase||92
6352913|NCT00631189|7261273|FG003|COMPLETED|Treatment Phase||103
6352914|NCT00631189|7261270|FG000|NOT COMPLETED|Treatment Phase||0
6352915|NCT00631189|7261271|FG001|NOT COMPLETED|Treatment Phase||7
6352916|NCT00631189|7261272|FG002|NOT COMPLETED|Treatment Phase||11
6352917|NCT00631189|7261273|FG003|NOT COMPLETED|Treatment Phase||7
6352918|NCT00631319|7261285|FG000|STARTED|Conversion and Titration Phase||343
6352919|NCT00631319|7261286|FG001|STARTED|Conversion and Titration Phase|Per the study design, no patients received placebo during this phase.|0
6352920|NCT00631319|7261285|FG000|COMPLETED|Conversion and Titration Phase||200
6352921|NCT00631319|7261286|FG001|COMPLETED|Conversion and Titration Phase||0
6352922|NCT00631319|7261285|FG000|NOT COMPLETED|Conversion and Titration Phase||143
6352923|NCT00631319|7261286|FG001|NOT COMPLETED|Conversion and Titration Phase||0
6352924|NCT00631319|7261285|FG000|STARTED|Double-blind Phase||100
6352925|NCT00631319|7261286|FG001|STARTED|Double-blind Phase||100
6352926|NCT00631319|7261285|FG000|COMPLETED|Double-blind Phase||60
6352927|NCT00631319|7261286|FG001|COMPLETED|Double-blind Phase||65
6352928|NCT00631319|7261285|FG000|NOT COMPLETED|Double-blind Phase||40
6352929|NCT00631319|7261286|FG001|NOT COMPLETED|Double-blind Phase||35
6352930|NCT00631358|7261295|FG000|STARTED|Overall Study||50
6352931|NCT00631358|7261296|FG001|STARTED|Overall Study||47
6352932|NCT00631358|7261295|FG000|COMPLETED|Overall Study||44
6352933|NCT00631358|7261296|FG001|COMPLETED|Overall Study||45
6352934|NCT00631358|7261295|FG000|NOT COMPLETED|Overall Study||6
6352935|NCT00631358|7261296|FG001|NOT COMPLETED|Overall Study||2
6352936|NCT00631371|7261304|FG000|STARTED|Overall Study||400
6352937|NCT00631371|7261305|FG001|STARTED|Overall Study||391
6352938|NCT00631371|7261304|FG000|Treated|Overall Study||393
6352939|NCT00631371|7261305|FG001|Treated|Overall Study||391
6352940|NCT00631371|7261304|FG000|COMPLETED|Overall Study||0
6352941|NCT00631371|7261305|FG001|COMPLETED|Overall Study||0
6352942|NCT00631371|7261304|FG000|NOT COMPLETED|Overall Study||400
6352943|NCT00631371|7261305|FG001|NOT COMPLETED|Overall Study||391
6352944|NCT00631410|7261313|FG000|STARTED|Overall Study||6
6352945|NCT00631410|7261314|FG001|STARTED|Overall Study||6
6352946|NCT00631410|7261313|FG000|COMPLETED|Overall Study||0
6352947|NCT00631410|7261314|FG001|COMPLETED|Overall Study||0
6352948|NCT00631410|7261313|FG000|NOT COMPLETED|Overall Study||6
6352949|NCT00631410|7261314|FG001|NOT COMPLETED|Overall Study||6
6352950|NCT00631449|7261325|FG000|STARTED|Overall Study||15
6352951|NCT00631449|7261326|FG001|STARTED|Overall Study||15
6352952|NCT00631449|7261325|FG000|COMPLETED|Overall Study||15
6352953|NCT00631449|7261326|FG001|COMPLETED|Overall Study||15
6352954|NCT00631449|7261325|FG000|NOT COMPLETED|Overall Study||0
6352955|NCT00631449|7261326|FG001|NOT COMPLETED|Overall Study||0
6352956|NCT00631475|7261334|FG000|STARTED|Overall Study||128
6352957|NCT00631475|7261334|FG000|COMPLETED|Overall Study||83
6352958|NCT00631475|7261334|FG000|NOT COMPLETED|Overall Study||45
6352959|NCT00631488|7261341|FG000|STARTED|Overall Study||48
6352960|NCT00631488|7261342|FG001|STARTED|Overall Study||49
6352961|NCT00631488|7261343|FG002|STARTED|Overall Study||49
6352962|NCT00631488|7261341|FG000|Completed Post-Treatment Period|Overall Study||44
6352963|NCT00631488|7261342|FG001|Completed Post-Treatment Period|Overall Study||47
6352964|NCT00631488|7261343|FG002|Completed Post-Treatment Period|Overall Study||47
6352965|NCT00631488|7261341|FG000|COMPLETED|Overall Study||44
6352966|NCT00631488|7261342|FG001|COMPLETED|Overall Study||47
6352967|NCT00631488|7261343|FG002|COMPLETED|Overall Study||47
6352968|NCT00631488|7261341|FG000|NOT COMPLETED|Overall Study||4
6352969|NCT00631488|7261342|FG001|NOT COMPLETED|Overall Study||2
6352970|NCT00631488|7261343|FG002|NOT COMPLETED|Overall Study||2
6352971|NCT00631540|7261351|FG000|STARTED|Overall Study||100
6352972|NCT00631540|7261351|FG000|COMPLETED|Overall Study||86
6559674|NCT01782872|7482371|FG003|COMPLETED|Overall Study||19
6559675|NCT01782872|7482368|FG000|NOT COMPLETED|Overall Study||0
6559676|NCT01782872|7482369|FG001|NOT COMPLETED|Overall Study||1
6352973|NCT00631540|7261351|FG000|NOT COMPLETED|Overall Study||14
6352974|NCT00631566|7261358|FG000|STARTED|Overall Study||21
6352975|NCT00631566|7261359|FG001|STARTED|Overall Study||28
6352976|NCT00631566|7261360|FG002|STARTED|Overall Study||501
6352977|NCT00631566|7261358|FG000|COMPLETED|Overall Study||19
6352978|NCT00631566|7261359|FG001|COMPLETED|Overall Study||24
6352979|NCT00631566|7261360|FG002|COMPLETED|Overall Study||501
6352980|NCT00631566|7261358|FG000|NOT COMPLETED|Overall Study||2
6352981|NCT00631566|7261359|FG001|NOT COMPLETED|Overall Study||4
6352982|NCT00631566|7261360|FG002|NOT COMPLETED|Overall Study||0
6352983|NCT00631657|7261370|FG000|STARTED|6-Month Treatment Period||344
6352984|NCT00631657|7261371|FG001|STARTED|6-Month Treatment Period||0
6352985|NCT00631657|7261372|FG002|STARTED|6-Month Treatment Period||116
6352986|NCT00631657|7261370|FG000|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
6352987|NCT00631657|7261371|FG001|Treated|6-Month Treatment Period||0
6352988|NCT00631657|7261372|FG002|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
6352989|NCT00631657|7261370|FG000|COMPLETED|6-Month Treatment Period||203
6352990|NCT00631657|7261371|FG001|COMPLETED|6-Month Treatment Period||0
6352991|NCT00631657|7261372|FG002|COMPLETED|6-Month Treatment Period||66
6352992|NCT00631657|7261370|FG000|NOT COMPLETED|6-Month Treatment Period||141
6352993|NCT00631657|7261371|FG001|NOT COMPLETED|6-Month Treatment Period||0
6352994|NCT00631657|7261372|FG002|NOT COMPLETED|6-Month Treatment Period||50
6352995|NCT00631657|7261370|FG000|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
6352996|NCT00631657|7261371|FG001|STARTED|7-Day Discontinuation Period||137
6352997|NCT00631657|7261372|FG002|STARTED|7-Day Discontinuation Period||66
6352998|NCT00631657|7261370|FG000|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
6352999|NCT00631657|7261371|FG001|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
6353000|NCT00631657|7261372|FG002|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
6353001|NCT00631657|7261370|FG000|COMPLETED|7-Day Discontinuation Period||65
6353002|NCT00631657|7261371|FG001|COMPLETED|7-Day Discontinuation Period||136
6353003|NCT00631657|7261372|FG002|COMPLETED|7-Day Discontinuation Period||65
6353004|NCT00631657|7261370|FG000|NOT COMPLETED|7-Day Discontinuation Period||2
6353005|NCT00631657|7261371|FG001|NOT COMPLETED|7-Day Discontinuation Period||1
6353006|NCT00631657|7261372|FG002|NOT COMPLETED|7-Day Discontinuation Period||1
6353007|NCT00631670|7261385|FG000|STARTED|Overall Study||21
6353008|NCT00631670|7261386|FG001|STARTED|Overall Study||0
6353009|NCT00631670|7261385|FG000|COMPLETED|Overall Study||21
6353010|NCT00631670|7261386|FG001|COMPLETED|Overall Study||0
6353011|NCT00631670|7261385|FG000|NOT COMPLETED|Overall Study||0
6353012|NCT00631670|7261386|FG001|NOT COMPLETED|Overall Study||0
6353013|NCT00631696|7261398|FG000|STARTED|Overall Study||112
6353014|NCT00631696|7261399|FG001|STARTED|Overall Study||110
6353015|NCT00631696|7261398|FG000|Received Study Treatment (Tx)|Overall Study||111
6353016|NCT00631696|7261399|FG001|Received Study Treatment (Tx)|Overall Study||109
6353017|NCT00631696|7261398|FG000|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
6353018|NCT00631696|7261399|FG001|Ongoing at Database Release 18Oct2011|Overall Study||0
6353019|NCT00631696|7261398|FG000|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
6353020|NCT00631696|7261399|FG001|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
6353021|NCT00631696|7261398|FG000|NOT COMPLETED|Overall Study||37
6353022|NCT00631696|7261399|FG001|NOT COMPLETED|Overall Study||40
6353023|NCT00631748|7261407|FG000|STARTED|Overall Study||29
6353024|NCT00631748|7261408|FG001|STARTED|Overall Study||31
6353025|NCT00631748|7261407|FG000|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
6353026|NCT00631748|7261408|FG001|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
6353027|NCT00631748|7261407|FG000|NOT COMPLETED|Overall Study||18
6353028|NCT00631748|7261408|FG001|NOT COMPLETED|Overall Study||22
6353029|NCT00631852|7261415|FG000|STARTED|Overall Study|Seventeen subjects were consented and 16 were considered enrolled and treated under the protocol. One was a screen fail.|16
6353030|NCT00631852|7261415|FG000|COMPLETED|Overall Study|2 patients were administratively withdrawn after treatment had been completed as they declined sharing of data after PI transfer.|16
6353031|NCT00631852|7261415|FG000|NOT COMPLETED|Overall Study||0
6353032|NCT00631917|7261421|FG000|STARTED|Overall Study||375
6353033|NCT00631917|7261422|FG001|STARTED|Overall Study||399
6353034|NCT00631917|7261421|FG000|COMPLETED|Overall Study||287
6353035|NCT00631917|7261422|FG001|COMPLETED|Overall Study||291
6353036|NCT00631917|7261421|FG000|NOT COMPLETED|Overall Study||88
6353037|NCT00631917|7261422|FG001|NOT COMPLETED|Overall Study||108
6353038|NCT00631969|7261430|FG000|STARTED|Overall Study||186
6353039|NCT00631969|7261431|FG001|STARTED|Overall Study||176
6353040|NCT00631969|7261430|FG000|Received Treatment|Overall Study|safety population|184
6353041|NCT00631969|7261431|FG001|Received Treatment|Overall Study|safety population|174
6353042|NCT00631969|7261430|FG000|COMPLETED|Overall Study||171
6353043|NCT00631969|7261431|FG001|COMPLETED|Overall Study||155
6353044|NCT00631969|7261430|FG000|NOT COMPLETED|Overall Study||15
6353045|NCT00631969|7261431|FG001|NOT COMPLETED|Overall Study||21
6353046|NCT00632021|7261441|FG000|STARTED|Overall Study||432
6353047|NCT00632021|7261442|FG001|STARTED|Overall Study||430
6353048|NCT00632021|7261441|FG000|COMPLETED|Overall Study||428
6353049|NCT00632021|7261442|FG001|COMPLETED|Overall Study||423
6353050|NCT00632021|7261441|FG000|NOT COMPLETED|Overall Study||4
6353051|NCT00632021|7261442|FG001|NOT COMPLETED|Overall Study||7
6353052|NCT00632099|7261451|FG000|STARTED|Overall Study||10
6353053|NCT00632099|7261452|FG001|STARTED|Overall Study||11
6353054|NCT00632099|7261451|FG000|COMPLETED|Overall Study||7
6353055|NCT00632099|7261452|FG001|COMPLETED|Overall Study||8
6353056|NCT00632099|7261451|FG000|NOT COMPLETED|Overall Study||3
6353057|NCT00632099|7261452|FG001|NOT COMPLETED|Overall Study||3
6353058|NCT00632125|7261458|FG000|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
6353059|NCT00632125|7261458|FG000|COMPLETED|Overall Study||1393
6353060|NCT00632125|7261458|FG000|NOT COMPLETED|Overall Study||302
6353061|NCT00632203|7261464|FG000|STARTED|Overall Study||26
6353062|NCT00632203|7261465|FG001|STARTED|Overall Study||27
6353063|NCT00632203|7261464|FG000|COMPLETED|Overall Study||25
6353064|NCT00632203|7261465|FG001|COMPLETED|Overall Study||27
6353065|NCT00632203|7261464|FG000|NOT COMPLETED|Overall Study||1
6353066|NCT00632203|7261465|FG001|NOT COMPLETED|Overall Study||0
6353067|NCT00632229|7261473|FG000|STARTED|Overall Study||17
6353068|NCT00632229|7261474|FG001|STARTED|Overall Study||17
6353069|NCT00632229|7261473|FG000|COMPLETED|Overall Study||11
6353070|NCT00632229|7261474|FG001|COMPLETED|Overall Study||11
6353071|NCT00632229|7261473|FG000|NOT COMPLETED|Overall Study||6
6353072|NCT00632229|7261474|FG001|NOT COMPLETED|Overall Study||6
6353073|NCT00632281|7261480|FG000|STARTED|Overall Study||38
6353074|NCT00632281|7261480|FG000|COMPLETED|Overall Study||38
6353075|NCT00632281|7261480|FG000|NOT COMPLETED|Overall Study||0
6353076|NCT00632359|7261484|FG000|STARTED|Overall Study||33
6353077|NCT00632359|7261484|FG000|COMPLETED|Overall Study||31
6353078|NCT00632359|7261484|FG000|NOT COMPLETED|Overall Study||2
6353079|NCT00632411|7261491|FG000|STARTED|Overall Study||649
6353080|NCT00632411|7261492|FG001|STARTED|Overall Study||649
6353081|NCT00632411|7261491|FG000|COMPLETED|Overall Study||489
6353082|NCT00632411|7261492|FG001|COMPLETED|Overall Study||473
6353083|NCT00632411|7261491|FG000|NOT COMPLETED|Overall Study||160
6353084|NCT00632411|7261492|FG001|NOT COMPLETED|Overall Study||176
6353085|NCT00632424|7261501|FG000|STARTED|Overall Study||18
6353086|NCT00632424|7261501|FG000|COMPLETED|Overall Study||0
6353087|NCT00632424|7261501|FG000|NOT COMPLETED|Overall Study||18
6353088|NCT00632463|7261518|FG000|STARTED|Overall Study||7
6353089|NCT00632463|7261519|FG001|STARTED|Overall Study||7
6353090|NCT00632463|7261520|FG002|STARTED|Overall Study||7
6353091|NCT00632463|7261518|FG000|COMPLETED|Overall Study||7
6353092|NCT00632463|7261519|FG001|COMPLETED|Overall Study||6
6353093|NCT00632463|7261520|FG002|COMPLETED|Overall Study||7
6353094|NCT00632463|7261518|FG000|NOT COMPLETED|Overall Study||0
6353095|NCT00632463|7261519|FG001|NOT COMPLETED|Overall Study||1
6353096|NCT00632463|7261520|FG002|NOT COMPLETED|Overall Study||0
6353097|NCT00632489|7261531|FG000|STARTED|Overall Study||15
6353098|NCT00632489|7261532|FG001|STARTED|Overall Study||5
6353099|NCT00632489|7261533|FG002|STARTED|Overall Study||0
6353100|NCT00632489|7261531|FG000|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
6353101|NCT00632489|7261532|FG001|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
6353102|NCT00632489|7261533|FG002|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
6353103|NCT00632489|7261531|FG000|NOT COMPLETED|Overall Study||15
6353104|NCT00632489|7261532|FG001|NOT COMPLETED|Overall Study||5
6353105|NCT00632489|7261533|FG002|NOT COMPLETED|Overall Study||0
6353106|NCT00632502|7261543|FG000|STARTED|Overall Study||25
6353107|NCT00632502|7261544|FG001|STARTED|Overall Study||12
6353108|NCT00632502|7261543|FG000|Treated|Overall Study||22
6353109|NCT00632502|7261544|FG001|Treated|Overall Study||12
6353110|NCT00632502|7261543|FG000|Completed Treatment|Overall Study||19
6353111|NCT00632502|7261544|FG001|Completed Treatment|Overall Study||9
6353112|NCT00632502|7261543|FG000|COMPLETED|Overall Study||22
6353113|NCT00632502|7261544|FG001|COMPLETED|Overall Study||11
6353114|NCT00632502|7261543|FG000|NOT COMPLETED|Overall Study||3
6353115|NCT00632502|7261544|FG001|NOT COMPLETED|Overall Study||1
6353116|NCT00632541|7261551|FG000|STARTED|Overall Study|18 subjects were accrued to the study|18
6353117|NCT00632541|7261551|FG000|COMPLETED|Overall Study||11
6353118|NCT00632541|7261551|FG000|NOT COMPLETED|Overall Study||7
6353119|NCT00632619|7261557|FG000|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
6353120|NCT00632619|7261558|FG001|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
6353121|NCT00632619|7261557|FG000|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|25
6353122|NCT00632619|7261558|FG001|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10~nd cohort completed follow up 7/18/11"|31
6353123|NCT00632619|7261557|FG000|NOT COMPLETED|Overall Study||8
6353124|NCT00632619|7261558|FG001|NOT COMPLETED|Overall Study||4
6353125|NCT00632632|7261566|FG000|STARTED|Overall Study||13
6353126|NCT00632632|7261567|FG001|STARTED|Overall Study||12
6353127|NCT00632632|7261566|FG000|COMPLETED|Overall Study||13
6353128|NCT00632632|7261567|FG001|COMPLETED|Overall Study||9
6353129|NCT00632632|7261566|FG000|NOT COMPLETED|Overall Study||0
6353130|NCT00632632|7261567|FG001|NOT COMPLETED|Overall Study||3
6353131|NCT00632736|7261573|FG000|STARTED|Overall Study||419
6353132|NCT00632736|7261573|FG000|COMPLETED|Overall Study||151
6353133|NCT00632736|7261573|FG000|NOT COMPLETED|Overall Study||268
6353134|NCT00632749|7261591|FG000|STARTED|Overall Study||4
6353135|NCT00632749|7261592|FG001|STARTED|Overall Study||5
6353136|NCT00632749|7261593|FG002|STARTED|Overall Study||3
6353137|NCT00632749|7261594|FG003|STARTED|Overall Study||4
6353138|NCT00632749|7261595|FG004|STARTED|Overall Study||7
6353139|NCT00632749|7261596|FG005|STARTED|Overall Study||8
6353140|NCT00632749|7261597|FG006|STARTED|Overall Study||5
6353141|NCT00632749|7261598|FG007|STARTED|Overall Study||4
6353142|NCT00632749|7261599|FG008|STARTED|Overall Study||5
6353143|NCT00632749|7261600|FG009|STARTED|Overall Study||3
6353144|NCT00632749|7261601|FG010|STARTED|Overall Study||7
6353145|NCT00632749|7261602|FG011|STARTED|Overall Study||4
6559677|NCT01782872|7482370|FG002|NOT COMPLETED|Overall Study||0
6559678|NCT01782872|7482371|FG003|NOT COMPLETED|Overall Study||1
6353146|NCT00632749|7261603|FG012|STARTED|Overall Study||3
6353147|NCT00632749|7261604|FG013|STARTED|Overall Study||6
6353148|NCT00632749|7261591|FG000|Treated|Overall Study||4
6353149|NCT00632749|7261592|FG001|Treated|Overall Study||3
6353150|NCT00632749|7261593|FG002|Treated|Overall Study||3
6353151|NCT00632749|7261594|FG003|Treated|Overall Study||4
6353152|NCT00632749|7261595|FG004|Treated|Overall Study||7
6353153|NCT00632749|7261596|FG005|Treated|Overall Study||7
6353154|NCT00632749|7261597|FG006|Treated|Overall Study||4
6353155|NCT00632749|7261598|FG007|Treated|Overall Study||4
6353156|NCT00632749|7261599|FG008|Treated|Overall Study||5
6353157|NCT00632749|7261600|FG009|Treated|Overall Study||3
6353158|NCT00632749|7261601|FG010|Treated|Overall Study||7
6353159|NCT00632749|7261602|FG011|Treated|Overall Study||4
6353160|NCT00632749|7261603|FG012|Treated|Overall Study||3
6353161|NCT00632749|7261604|FG013|Treated|Overall Study||6
6353162|NCT00632749|7261591|FG000|Not Treated|Overall Study||0
6353163|NCT00632749|7261592|FG001|Not Treated|Overall Study||2
6353164|NCT00632749|7261593|FG002|Not Treated|Overall Study||0
6353165|NCT00632749|7261594|FG003|Not Treated|Overall Study||0
6353166|NCT00632749|7261595|FG004|Not Treated|Overall Study||0
6353167|NCT00632749|7261596|FG005|Not Treated|Overall Study||1
6353168|NCT00632749|7261597|FG006|Not Treated|Overall Study||1
6353169|NCT00632749|7261598|FG007|Not Treated|Overall Study||0
6559679|NCT01782885|7482383|FG000|STARTED|Overall Study||36
6559680|NCT01782885|7482384|FG001|STARTED|Overall Study||39
6353170|NCT00632749|7261599|FG008|Not Treated|Overall Study||0
6353171|NCT00632749|7261600|FG009|Not Treated|Overall Study||0
6353172|NCT00632749|7261601|FG010|Not Treated|Overall Study||0
6353173|NCT00632749|7261602|FG011|Not Treated|Overall Study||0
6353174|NCT00632749|7261603|FG012|Not Treated|Overall Study||0
6353175|NCT00632749|7261604|FG013|Not Treated|Overall Study||0
6353176|NCT00632749|7261591|FG000|COMPLETED|Overall Study||0
6353177|NCT00632749|7261592|FG001|COMPLETED|Overall Study||0
6353178|NCT00632749|7261593|FG002|COMPLETED|Overall Study||0
6353179|NCT00632749|7261594|FG003|COMPLETED|Overall Study||0
6353180|NCT00632749|7261595|FG004|COMPLETED|Overall Study||0
6353181|NCT00632749|7261596|FG005|COMPLETED|Overall Study||0
6353182|NCT00632749|7261597|FG006|COMPLETED|Overall Study||0
6353183|NCT00632749|7261598|FG007|COMPLETED|Overall Study||0
6353184|NCT00632749|7261599|FG008|COMPLETED|Overall Study||0
6353185|NCT00632749|7261600|FG009|COMPLETED|Overall Study||0
6353186|NCT00632749|7261601|FG010|COMPLETED|Overall Study||0
6353187|NCT00632749|7261602|FG011|COMPLETED|Overall Study||0
6353188|NCT00632749|7261603|FG012|COMPLETED|Overall Study||0
6353189|NCT00632749|7261604|FG013|COMPLETED|Overall Study||0
6353190|NCT00632749|7261591|FG000|NOT COMPLETED|Overall Study||4
6353191|NCT00632749|7261592|FG001|NOT COMPLETED|Overall Study||5
6353192|NCT00632749|7261593|FG002|NOT COMPLETED|Overall Study||3
6559681|NCT01782885|7482383|FG000|COMPLETED|Overall Study||32
6353193|NCT00632749|7261594|FG003|NOT COMPLETED|Overall Study||4
6353194|NCT00632749|7261595|FG004|NOT COMPLETED|Overall Study||7
6353195|NCT00632749|7261596|FG005|NOT COMPLETED|Overall Study||8
6353196|NCT00632749|7261597|FG006|NOT COMPLETED|Overall Study||5
6353197|NCT00632749|7261598|FG007|NOT COMPLETED|Overall Study||4
6353198|NCT00632749|7261599|FG008|NOT COMPLETED|Overall Study||5
6353199|NCT00632749|7261600|FG009|NOT COMPLETED|Overall Study||3
6353200|NCT00632749|7261601|FG010|NOT COMPLETED|Overall Study||7
6353201|NCT00632749|7261602|FG011|NOT COMPLETED|Overall Study||4
6353202|NCT00632749|7261603|FG012|NOT COMPLETED|Overall Study||3
6353203|NCT00632749|7261604|FG013|NOT COMPLETED|Overall Study||6
6353204|NCT00632814|7261643|FG000|STARTED|Overall Study||11
6353205|NCT00632814|7261644|FG001|STARTED|Overall Study||13
6353206|NCT00632814|7261645|FG002|STARTED|Overall Study||8
6353207|NCT00632814|7261643|FG000|COMPLETED|Overall Study||11
6353208|NCT00632814|7261644|FG001|COMPLETED|Overall Study||13
6353209|NCT00632814|7261645|FG002|COMPLETED|Overall Study||8
6353210|NCT00632814|7261643|FG000|NOT COMPLETED|Overall Study||0
6353211|NCT00632814|7261644|FG001|NOT COMPLETED|Overall Study||0
6353212|NCT00632814|7261645|FG002|NOT COMPLETED|Overall Study||0
6353213|NCT00632827|7261653|FG000|STARTED|Overall Study||21
6353214|NCT00632827|7261653|FG000|Received GVD|Overall Study||21
6353215|NCT00632827|7261653|FG000|Received M-CHOP|Overall Study||18
6353216|NCT00632827|7261653|FG000|Evaluated Post Stem Cell Transplant|Overall Study||16
6353217|NCT00632827|7261653|FG000|COMPLETED|Overall Study||11
6353218|NCT00632827|7261653|FG000|NOT COMPLETED|Overall Study||10
6353219|NCT00632931|7261658|FG000|STARTED|Part 1, Period 1||13
6353220|NCT00632931|7261659|FG001|STARTED|Part 1, Period 1||12
6353221|NCT00632931|7261660|FG002|STARTED|Part 1, Period 1||0
6353222|NCT00632931|7261658|FG000|COMPLETED|Part 1, Period 1||11
6353223|NCT00632931|7261659|FG001|COMPLETED|Part 1, Period 1||12
6353224|NCT00632931|7261660|FG002|COMPLETED|Part 1, Period 1||0
6353225|NCT00632931|7261658|FG000|NOT COMPLETED|Part 1, Period 1||2
6353226|NCT00632931|7261659|FG001|NOT COMPLETED|Part 1, Period 1||0
6353227|NCT00632931|7261660|FG002|NOT COMPLETED|Part 1, Period 1||0
6353228|NCT00632931|7261658|FG000|STARTED|Part 1, Washout||11
6353229|NCT00632931|7261659|FG001|STARTED|Part 1, Washout||12
6353230|NCT00632931|7261660|FG002|STARTED|Part 1, Washout||0
6353231|NCT00632931|7261658|FG000|COMPLETED|Part 1, Washout||11
6353232|NCT00632931|7261659|FG001|COMPLETED|Part 1, Washout||12
6353233|NCT00632931|7261660|FG002|COMPLETED|Part 1, Washout||0
6353234|NCT00632931|7261658|FG000|NOT COMPLETED|Part 1, Washout||0
6353235|NCT00632931|7261659|FG001|NOT COMPLETED|Part 1, Washout||0
6353236|NCT00632931|7261660|FG002|NOT COMPLETED|Part 1, Washout||0
6353237|NCT00632931|7261658|FG000|STARTED|Part 1, Period 2||11
6353238|NCT00632931|7261659|FG001|STARTED|Part 1, Period 2||12
6353239|NCT00632931|7261660|FG002|STARTED|Part 1, Period 2||0
6353240|NCT00632931|7261658|FG000|COMPLETED|Part 1, Period 2||11
6353241|NCT00632931|7261659|FG001|COMPLETED|Part 1, Period 2||12
6353242|NCT00632931|7261660|FG002|COMPLETED|Part 1, Period 2||0
6353243|NCT00632931|7261658|FG000|NOT COMPLETED|Part 1, Period 2||0
6353244|NCT00632931|7261659|FG001|NOT COMPLETED|Part 1, Period 2||0
6353245|NCT00632931|7261660|FG002|NOT COMPLETED|Part 1, Period 2||0
6353246|NCT00632931|7261658|FG000|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
6353247|NCT00632931|7261659|FG001|STARTED|Post-Part 1 Washout||12
6353248|NCT00632931|7261660|FG002|STARTED|Post-Part 1 Washout||0
6353249|NCT00632931|7261658|FG000|COMPLETED|Post-Part 1 Washout||12
6353250|NCT00632931|7261659|FG001|COMPLETED|Post-Part 1 Washout||12
6353251|NCT00632931|7261660|FG002|COMPLETED|Post-Part 1 Washout||0
6353252|NCT00632931|7261658|FG000|NOT COMPLETED|Post-Part 1 Washout||0
6353253|NCT00632931|7261659|FG001|NOT COMPLETED|Post-Part 1 Washout||0
6353254|NCT00632931|7261660|FG002|NOT COMPLETED|Post-Part 1 Washout||0
6353255|NCT00632931|7261658|FG000|STARTED|Part 2||0
6353256|NCT00632931|7261659|FG001|STARTED|Part 2||0
6353257|NCT00632931|7261660|FG002|STARTED|Part 2||24
6353258|NCT00632931|7261658|FG000|COMPLETED|Part 2||0
6353259|NCT00632931|7261659|FG001|COMPLETED|Part 2||0
6353260|NCT00632931|7261660|FG002|COMPLETED|Part 2||0
6353261|NCT00632931|7261658|FG000|NOT COMPLETED|Part 2||0
6353262|NCT00632931|7261659|FG001|NOT COMPLETED|Part 2||0
6353263|NCT00632931|7261660|FG002|NOT COMPLETED|Part 2||24
6353264|NCT00632970|7261667|FG000|STARTED|Overall Study||3
6353265|NCT00632970|7261668|FG001|STARTED|Overall Study||3
6353266|NCT00632970|7261667|FG000|COMPLETED|Overall Study||3
6353267|NCT00632970|7261668|FG001|COMPLETED|Overall Study||3
6353268|NCT00632970|7261667|FG000|NOT COMPLETED|Overall Study||0
6353269|NCT00632970|7261668|FG001|NOT COMPLETED|Overall Study||0
6353270|NCT00633009|7261677|FG000|STARTED|Overall Study||12
6353271|NCT00633009|7261678|FG001|STARTED|Overall Study||27
6353272|NCT00633009|7261679|FG002|STARTED|Overall Study||11
6353273|NCT00633009|7261677|FG000|COMPLETED|Overall Study||8
6353274|NCT00633009|7261678|FG001|COMPLETED|Overall Study||23
6353275|NCT00633009|7261679|FG002|COMPLETED|Overall Study||10
6353276|NCT00633009|7261677|FG000|NOT COMPLETED|Overall Study||4
6353277|NCT00633009|7261678|FG001|NOT COMPLETED|Overall Study||4
6353278|NCT00633009|7261679|FG002|NOT COMPLETED|Overall Study||1
6353279|NCT00633022|7261693|FG000|STARTED|Overall Study||34
6353280|NCT00633022|7261694|FG001|STARTED|Overall Study||33
6353281|NCT00633022|7261695|FG002|STARTED|Overall Study||32
6353282|NCT00633022|7261693|FG000|COMPLETED|Overall Study||33
6353283|NCT00633022|7261694|FG001|COMPLETED|Overall Study||32
6353284|NCT00633022|7261695|FG002|COMPLETED|Overall Study||27
6353285|NCT00633022|7261693|FG000|NOT COMPLETED|Overall Study||1
6353286|NCT00633022|7261694|FG001|NOT COMPLETED|Overall Study||1
6353287|NCT00633022|7261695|FG002|NOT COMPLETED|Overall Study||5
6353288|NCT00633074|7261705|FG000|STARTED|Overall Study||360
6353289|NCT00633074|7261706|FG001|STARTED|Overall Study||360
6353290|NCT00633074|7261705|FG000|COMPLETED|Overall Study||359
6353291|NCT00633074|7261706|FG001|COMPLETED|Overall Study||360
6353292|NCT00633074|7261705|FG000|NOT COMPLETED|Overall Study||1
6353293|NCT00633074|7261706|FG001|NOT COMPLETED|Overall Study||0
6353294|NCT00633126|7261712|FG000|STARTED|Overall Study||9
6353295|NCT00633126|7261712|FG000|COMPLETED|Overall Study||8
6353296|NCT00633126|7261712|FG000|NOT COMPLETED|Overall Study||1
6353297|NCT00633139|7261719|FG000|STARTED|Overall Study||4
6353298|NCT00633139|7261720|FG001|STARTED|Overall Study||5
6353299|NCT00633139|7261721|FG002|STARTED|Overall Study||4
6353300|NCT00633139|7261719|FG000|COMPLETED|Overall Study||4
6353301|NCT00633139|7261720|FG001|COMPLETED|Overall Study||4
6353302|NCT00633139|7261721|FG002|COMPLETED|Overall Study||3
6353303|NCT00633139|7261719|FG000|NOT COMPLETED|Overall Study||0
6353304|NCT00633139|7261720|FG001|NOT COMPLETED|Overall Study||1
6353305|NCT00633139|7261721|FG002|NOT COMPLETED|Overall Study||1
6353306|NCT00633152|7261731|FG000|STARTED|Overall Study||103
6353307|NCT00633152|7261732|FG001|STARTED|Overall Study||47
6353308|NCT00633152|7261731|FG000|MITT and Safety Population|Overall Study||98
6353309|NCT00633152|7261732|FG001|MITT and Safety Population|Overall Study||45
6353310|NCT00633152|7261731|FG000|Clinically Evaluable Population|Overall Study||86
6353311|NCT00633152|7261732|FG001|Clinically Evaluable Population|Overall Study||39
6353312|NCT00633152|7261731|FG000|COMPLETED|Overall Study||89
6353313|NCT00633152|7261732|FG001|COMPLETED|Overall Study||41
6353314|NCT00633152|7261731|FG000|NOT COMPLETED|Overall Study||14
6353315|NCT00633152|7261732|FG001|NOT COMPLETED|Overall Study||6
6353316|NCT00633217|7261742|FG000|STARTED|Overall Study||121
6353317|NCT00633217|7261743|FG001|STARTED|Overall Study||126
6353318|NCT00633217|7261742|FG000|COMPLETED|Overall Study||106
6353319|NCT00633217|7261743|FG001|COMPLETED|Overall Study||103
6353320|NCT00633217|7261742|FG000|NOT COMPLETED|Overall Study||15
6353321|NCT00633217|7261743|FG001|NOT COMPLETED|Overall Study||23
6353322|NCT00633243|7261751|FG000|STARTED|Overall Study||12
6353323|NCT00633243|7261752|FG001|STARTED|Overall Study||9
6353324|NCT00633243|7261751|FG000|COMPLETED|Overall Study||11
6353325|NCT00633243|7261752|FG001|COMPLETED|Overall Study||2
6353326|NCT00633243|7261751|FG000|NOT COMPLETED|Overall Study||1
6353327|NCT00633243|7261752|FG001|NOT COMPLETED|Overall Study||7
6353328|NCT00633256|7261760|FG000|STARTED|Overall Study||12
6353329|NCT00633256|7261761|FG001|STARTED|Overall Study||13
6353330|NCT00633256|7261760|FG000|COMPLETED|Overall Study||8
6353331|NCT00633256|7261761|FG001|COMPLETED|Overall Study||10
6353332|NCT00633256|7261760|FG000|NOT COMPLETED|Overall Study||4
6353333|NCT00633256|7261761|FG001|NOT COMPLETED|Overall Study||3
6353334|NCT00633360|7261769|FG000|STARTED|Overall Study||16
6353335|NCT00633360|7261770|FG001|STARTED|Overall Study||16
6353336|NCT00633360|7261769|FG000|COMPLETED|Overall Study||12
6559682|NCT01782885|7482384|FG001|COMPLETED|Overall Study||33
6559683|NCT01782885|7482383|FG000|NOT COMPLETED|Overall Study||4
6559684|NCT01782885|7482384|FG001|NOT COMPLETED|Overall Study||6
6559685|NCT01782898|7482392|FG000|STARTED|Overall Study||35
6559686|NCT01782898|7482393|FG001|STARTED|Overall Study||35
6559687|NCT01782898|7482392|FG000|COMPLETED|Overall Study||29
6559688|NCT01782898|7482393|FG001|COMPLETED|Overall Study||29
6353337|NCT00633360|7261770|FG001|COMPLETED|Overall Study||13
6353338|NCT00633360|7261769|FG000|NOT COMPLETED|Overall Study||4
6353339|NCT00633360|7261770|FG001|NOT COMPLETED|Overall Study||3
6353340|NCT00633399|7261780|FG000|STARTED|Overall Study||71
6353341|NCT00633399|7261781|FG001|STARTED|Overall Study||68
6353342|NCT00633399|7261780|FG000|COMPLETED|Overall Study||49
6353343|NCT00633399|7261781|FG001|COMPLETED|Overall Study||53
6353344|NCT00633399|7261780|FG000|NOT COMPLETED|Overall Study||22
6353345|NCT00633399|7261781|FG001|NOT COMPLETED|Overall Study||15
6353346|NCT00633464|7261789|FG000|STARTED|Overall Study||40
6353347|NCT00633464|7261790|FG001|STARTED|Overall Study||39
6353348|NCT00633464|7261789|FG000|Treated|Overall Study||40
6353349|NCT00633464|7261790|FG001|Treated|Overall Study||37
6353350|NCT00633464|7261789|FG000|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
6353351|NCT00633464|7261790|FG001|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
6353352|NCT00633464|7261789|FG000|NOT COMPLETED|Overall Study||0
6353353|NCT00633464|7261790|FG001|NOT COMPLETED|Overall Study||2
6353354|NCT00633477|7261798|FG000|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
6353355|NCT00633477|7261799|FG001|STARTED|Overall Study||11
6353356|NCT00633477|7261798|FG000|Randomized But Not Treated|Overall Study||1
6353357|NCT00633477|7261799|FG001|Randomized But Not Treated|Overall Study||0
6353358|NCT00633477|7261798|FG000|Prematurely Discontinued Study Drug|Overall Study||1
6353359|NCT00633477|7261799|FG001|Prematurely Discontinued Study Drug|Overall Study||0
6353360|NCT00633477|7261798|FG000|Completed Study Through Day 28|Overall Study||4
6353361|NCT00633477|7261799|FG001|Completed Study Through Day 28|Overall Study||8
6353362|NCT00633477|7261798|FG000|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
6376889|NCT00761631|7287491|FG000|Vaccinated Dose 1|Overall Study||124
6559689|NCT01782898|7482392|FG000|NOT COMPLETED|Overall Study||6
6353363|NCT00633477|7261799|FG001|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
6353364|NCT00633477|7261798|FG000|NOT COMPLETED|Overall Study||2
6353365|NCT00633477|7261799|FG001|NOT COMPLETED|Overall Study||0
6353366|NCT00633594|7261808|FG000|STARTED|Overall Study||5
6353367|NCT00633594|7261809|FG001|STARTED|Overall Study||8
6353368|NCT00633594|7261810|FG002|STARTED|Overall Study||26
6353369|NCT00633594|7261808|FG000|COMPLETED|Overall Study||5
6353370|NCT00633594|7261809|FG001|COMPLETED|Overall Study||3
6353371|NCT00633594|7261810|FG002|COMPLETED|Overall Study||16
6353372|NCT00633594|7261808|FG000|NOT COMPLETED|Overall Study||0
6353373|NCT00633594|7261809|FG001|NOT COMPLETED|Overall Study||5
6353374|NCT00633594|7261810|FG002|NOT COMPLETED|Overall Study||10
6353375|NCT00633750|7261821|FG000|STARTED|Overall Study||47
6353376|NCT00633750|7261821|FG000|COMPLETED|Overall Study||42
6353377|NCT00633750|7261821|FG000|NOT COMPLETED|Overall Study||5
6353378|NCT00633867|7261829|FG000|STARTED|Overall Study||60
6353379|NCT00633867|7261830|FG001|STARTED|Overall Study||60
6353380|NCT00633867|7261829|FG000|COMPLETED|Overall Study||60
6353381|NCT00633867|7261830|FG001|COMPLETED|Overall Study||60
6353382|NCT00633867|7261829|FG000|NOT COMPLETED|Overall Study||0
6353383|NCT00633867|7261830|FG001|NOT COMPLETED|Overall Study||0
6353384|NCT00633880|7261839|FG000|STARTED|Open Label Titration||181
6353385|NCT00633880|7261840|FG001|STARTED|Open Label Titration||0
6353386|NCT00633880|7261841|FG002|STARTED|Open Label Titration||0
6353387|NCT00633880|7261839|FG000|COMPLETED|Open Label Titration||101
6353388|NCT00633880|7261840|FG001|COMPLETED|Open Label Titration||0
6353389|NCT00633880|7261841|FG002|COMPLETED|Open Label Titration||0
6353390|NCT00633880|7261839|FG000|NOT COMPLETED|Open Label Titration||80
6353391|NCT00633880|7261840|FG001|NOT COMPLETED|Open Label Titration||0
6353392|NCT00633880|7261841|FG002|NOT COMPLETED|Open Label Titration||0
6353393|NCT00633880|7261839|FG000|STARTED|Randomized Double Blind||0
6353394|NCT00633880|7261840|FG001|STARTED|Randomized Double Blind||50
6353395|NCT00633880|7261841|FG002|STARTED|Randomized Double Blind||51
6353396|NCT00633880|7261839|FG000|COMPLETED|Randomized Double Blind||0
6353397|NCT00633880|7261840|FG001|COMPLETED|Randomized Double Blind||50
6353398|NCT00633880|7261841|FG002|COMPLETED|Randomized Double Blind||51
6353399|NCT00633880|7261839|FG000|NOT COMPLETED|Randomized Double Blind||0
6353400|NCT00633880|7261840|FG001|NOT COMPLETED|Randomized Double Blind||0
6353401|NCT00633880|7261841|FG002|NOT COMPLETED|Randomized Double Blind||0
6353402|NCT00633893|7261851|FG000|STARTED|Overall Study||840
6353403|NCT00633893|7261852|FG001|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
6353404|NCT00633893|7261853|FG002|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
6353405|NCT00633893|7261851|FG000|COMPLETED|Overall Study||726
6353406|NCT00633893|7261852|FG001|COMPLETED|Overall Study||684
6353407|NCT00633893|7261853|FG002|COMPLETED|Overall Study||641
6353408|NCT00633893|7261851|FG000|NOT COMPLETED|Overall Study||114
6353409|NCT00633893|7261852|FG001|NOT COMPLETED|Overall Study||129
6353410|NCT00633893|7261853|FG002|NOT COMPLETED|Overall Study||188
6353411|NCT00633919|7261863|FG000|STARTED|Overall Study||63
6353412|NCT00633919|7261864|FG001|STARTED|Overall Study||61
6353413|NCT00633919|7261863|FG000|COMPLETED|Overall Study||36
6353414|NCT00633919|7261864|FG001|COMPLETED|Overall Study||39
6353415|NCT00633919|7261863|FG000|NOT COMPLETED|Overall Study||27
6353416|NCT00633919|7261864|FG001|NOT COMPLETED|Overall Study||22
6353417|NCT00633932|7261873|FG000|STARTED|Overall Study|Randomised|191
6353418|NCT00633932|7261874|FG001|STARTED|Overall Study|Randomised|190
6353419|NCT00633932|7261875|FG002|STARTED|Overall Study|Randomised|191
6353420|NCT00633932|7261873|FG000|COMPLETED|Overall Study||179
6353421|NCT00633932|7261874|FG001|COMPLETED|Overall Study||176
6353422|NCT00633932|7261875|FG002|COMPLETED|Overall Study||180
6353423|NCT00633932|7261873|FG000|NOT COMPLETED|Overall Study||12
6353424|NCT00633932|7261874|FG001|NOT COMPLETED|Overall Study||14
6353425|NCT00633932|7261875|FG002|NOT COMPLETED|Overall Study||11
6353426|NCT00633945|7261883|FG000|STARTED|Overall Study||5
6353427|NCT00633945|7261883|FG000|COMPLETED|Overall Study||3
6353428|NCT00633945|7261883|FG000|NOT COMPLETED|Overall Study||2
6376890|NCT00761631|7287492|FG001|Vaccinated Dose 1|Overall Study||179
6376891|NCT00761631|7287493|FG002|Vaccinated Dose 1|Overall Study||175
6376892|NCT00761631|7287494|FG003|Vaccinated Dose 1|Overall Study||118
6376893|NCT00761631|7287495|FG004|Vaccinated Dose 1|Overall Study||294
6376894|NCT00761631|7287496|FG005|Vaccinated Dose 1|Overall Study||298
6376895|NCT00761631|7287491|FG000|Vaccinated Dose 2|Overall Study||112
6376896|NCT00761631|7287492|FG001|Vaccinated Dose 2|Overall Study||0
6376897|NCT00761631|7287493|FG002|Vaccinated Dose 2|Overall Study||165
6376898|NCT00761631|7287494|FG003|Vaccinated Dose 2|Overall Study||0
6376899|NCT00761631|7287495|FG004|Vaccinated Dose 2|Overall Study||0
6376900|NCT00761631|7287496|FG005|Vaccinated Dose 2|Overall Study||0
6376901|NCT00761631|7287491|FG000|COMPLETED|Overall Study||111
6376902|NCT00761631|7287492|FG001|COMPLETED|Overall Study||174
6376903|NCT00761631|7287493|FG002|COMPLETED|Overall Study||160
6376904|NCT00761631|7287494|FG003|COMPLETED|Overall Study||116
6376905|NCT00761631|7287495|FG004|COMPLETED|Overall Study||277
6376906|NCT00761631|7287496|FG005|COMPLETED|Overall Study||294
6376907|NCT00761631|7287491|FG000|NOT COMPLETED|Overall Study||15
6376908|NCT00761631|7287492|FG001|NOT COMPLETED|Overall Study||7
6376909|NCT00761631|7287493|FG002|NOT COMPLETED|Overall Study||16
6376910|NCT00761631|7287494|FG003|NOT COMPLETED|Overall Study||3
6376911|NCT00761631|7287495|FG004|NOT COMPLETED|Overall Study||22
6376912|NCT00761631|7287496|FG005|NOT COMPLETED|Overall Study||5
6353429|NCT00633984|7261891|FG000|STARTED|Overall Study||87
6353430|NCT00633984|7261892|FG001|STARTED|Overall Study||82
6353431|NCT00633984|7261891|FG000|COMPLETED|Overall Study||78
6353432|NCT00633984|7261892|FG001|COMPLETED|Overall Study||69
6353433|NCT00633984|7261891|FG000|NOT COMPLETED|Overall Study||9
6353434|NCT00633984|7261892|FG001|NOT COMPLETED|Overall Study||13
6353435|NCT00634036|7261900|FG000|STARTED|Overall Study||12
6353436|NCT00634036|7261901|FG001|STARTED|Overall Study||11
6353437|NCT00634036|7261900|FG000|COMPLETED|Overall Study||10
6353438|NCT00634036|7261901|FG001|COMPLETED|Overall Study||9
6353439|NCT00634036|7261900|FG000|NOT COMPLETED|Overall Study||2
6353440|NCT00634036|7261901|FG001|NOT COMPLETED|Overall Study||2
6353441|NCT00634049|7261907|FG000|STARTED|Overall Study||149
6353442|NCT00634049|7261907|FG000|COMPLETED|Overall Study||146
6353443|NCT00634049|7261907|FG000|NOT COMPLETED|Overall Study||3
6353444|NCT00634088|7261944|FG000|STARTED|Time Period 1: Dose Level 1||6
6353445|NCT00634088|7261945|FG001|STARTED|Time Period 1: Dose Level 1||0
6353446|NCT00634088|7261946|FG002|STARTED|Time Period 1: Dose Level 1||0
6353447|NCT00634088|7261947|FG003|STARTED|Time Period 1: Dose Level 1||0
6353448|NCT00634088|7261944|FG000|COMPLETED|Time Period 1: Dose Level 1||0
6353449|NCT00634088|7261945|FG001|COMPLETED|Time Period 1: Dose Level 1||0
6353450|NCT00634088|7261946|FG002|COMPLETED|Time Period 1: Dose Level 1||0
6353451|NCT00634088|7261947|FG003|COMPLETED|Time Period 1: Dose Level 1||0
6353452|NCT00634088|7261944|FG000|NOT COMPLETED|Time Period 1: Dose Level 1||6
6353453|NCT00634088|7261945|FG001|NOT COMPLETED|Time Period 1: Dose Level 1||0
6353454|NCT00634088|7261946|FG002|NOT COMPLETED|Time Period 1: Dose Level 1||0
6353455|NCT00634088|7261947|FG003|NOT COMPLETED|Time Period 1: Dose Level 1||0
6353456|NCT00634088|7261944|FG000|STARTED|Time Period 2: Dose Level 2||0
6353457|NCT00634088|7261945|FG001|STARTED|Time Period 2: Dose Level 2||3
6353458|NCT00634088|7261946|FG002|STARTED|Time Period 2: Dose Level 2||0
6353459|NCT00634088|7261947|FG003|STARTED|Time Period 2: Dose Level 2||0
6353460|NCT00634088|7261944|FG000|COMPLETED|Time Period 2: Dose Level 2||0
6353461|NCT00634088|7261945|FG001|COMPLETED|Time Period 2: Dose Level 2||0
6353462|NCT00634088|7261946|FG002|COMPLETED|Time Period 2: Dose Level 2||0
6353463|NCT00634088|7261947|FG003|COMPLETED|Time Period 2: Dose Level 2||0
6353464|NCT00634088|7261944|FG000|NOT COMPLETED|Time Period 2: Dose Level 2||0
6353465|NCT00634088|7261945|FG001|NOT COMPLETED|Time Period 2: Dose Level 2||3
6353466|NCT00634088|7261946|FG002|NOT COMPLETED|Time Period 2: Dose Level 2||0
6353467|NCT00634088|7261947|FG003|NOT COMPLETED|Time Period 2: Dose Level 2||0
6353468|NCT00634088|7261944|FG000|STARTED|Time Period 3: Dose Level 3||0
6353469|NCT00634088|7261945|FG001|STARTED|Time Period 3: Dose Level 3||0
6353470|NCT00634088|7261946|FG002|STARTED|Time Period 3: Dose Level 3||1
6353471|NCT00634088|7261947|FG003|STARTED|Time Period 3: Dose Level 3||0
6353472|NCT00634088|7261944|FG000|COMPLETED|Time Period 3: Dose Level 3||0
6353473|NCT00634088|7261945|FG001|COMPLETED|Time Period 3: Dose Level 3||0
6353474|NCT00634088|7261946|FG002|COMPLETED|Time Period 3: Dose Level 3||0
6353475|NCT00634088|7261947|FG003|COMPLETED|Time Period 3: Dose Level 3||0
6353476|NCT00634088|7261944|FG000|NOT COMPLETED|Time Period 3: Dose Level 3||0
6353477|NCT00634088|7261945|FG001|NOT COMPLETED|Time Period 3: Dose Level 3||0
6353478|NCT00634088|7261946|FG002|NOT COMPLETED|Time Period 3: Dose Level 3||1
6353479|NCT00634088|7261947|FG003|NOT COMPLETED|Time Period 3: Dose Level 3||0
6353480|NCT00634088|7261944|FG000|STARTED|Time Period 4: Triplet Combination||0
6353481|NCT00634088|7261945|FG001|STARTED|Time Period 4: Triplet Combination||0
6353482|NCT00634088|7261946|FG002|STARTED|Time Period 4: Triplet Combination||0
6353483|NCT00634088|7261947|FG003|STARTED|Time Period 4: Triplet Combination||0
6353484|NCT00634088|7261944|FG000|COMPLETED|Time Period 4: Triplet Combination||0
6353485|NCT00634088|7261945|FG001|COMPLETED|Time Period 4: Triplet Combination||0
6353486|NCT00634088|7261946|FG002|COMPLETED|Time Period 4: Triplet Combination||0
6353487|NCT00634088|7261947|FG003|COMPLETED|Time Period 4: Triplet Combination||0
6353488|NCT00634088|7261944|FG000|NOT COMPLETED|Time Period 4: Triplet Combination||0
6353489|NCT00634088|7261945|FG001|NOT COMPLETED|Time Period 4: Triplet Combination||0
6353490|NCT00634088|7261946|FG002|NOT COMPLETED|Time Period 4: Triplet Combination||0
6353491|NCT00634088|7261947|FG003|NOT COMPLETED|Time Period 4: Triplet Combination||0
6353492|NCT00634101|7261959|FG000|STARTED|Overall Study||66
6353493|NCT00634101|7261960|FG001|STARTED|Overall Study||59
6353494|NCT00634101|7261959|FG000|COMPLETED|Overall Study||61
6353495|NCT00634101|7261960|FG001|COMPLETED|Overall Study||56
6353496|NCT00634101|7261959|FG000|NOT COMPLETED|Overall Study||5
6353497|NCT00634101|7261960|FG001|NOT COMPLETED|Overall Study||3
6353498|NCT00634114|7261969|FG000|STARTED|Overall Study|Randomised|188
6353499|NCT00634114|7261970|FG001|STARTED|Overall Study|Randomised|189
6353500|NCT00634114|7261971|FG002|STARTED|Overall Study|Randomised|187
6353501|NCT00634114|7261969|FG000|COMPLETED|Overall Study|Completed|160
6353502|NCT00634114|7261970|FG001|COMPLETED|Overall Study|Completed|154
6353503|NCT00634114|7261971|FG002|COMPLETED|Overall Study|Completed|148
6353504|NCT00634114|7261969|FG000|NOT COMPLETED|Overall Study||28
6353505|NCT00634114|7261970|FG001|NOT COMPLETED|Overall Study||35
6353506|NCT00634114|7261971|FG002|NOT COMPLETED|Overall Study||39
6353507|NCT00634166|7261981|FG000|STARTED|Overall Study||82
6353508|NCT00634166|7261982|FG001|STARTED|Overall Study||138
6353509|NCT00634166|7261981|FG000|COMPLETED|Overall Study||22
6353510|NCT00634166|7261982|FG001|COMPLETED|Overall Study||78
6353511|NCT00634166|7261981|FG000|NOT COMPLETED|Overall Study||60
6353512|NCT00634166|7261982|FG001|NOT COMPLETED|Overall Study||60
6353513|NCT00634179|7261988|FG000|STARTED|Phase I: Induction||19
6353514|NCT00634179|7261988|FG000|COMPLETED|Phase I: Induction||19
6353515|NCT00634179|7261988|FG000|NOT COMPLETED|Phase I: Induction||0
6353516|NCT00634179|7261988|FG000|STARTED|Phase II: Maintenance||30
6353517|NCT00634179|7261988|FG000|COMPLETED|Phase II: Maintenance||29
6353518|NCT00634179|7261988|FG000|NOT COMPLETED|Phase II: Maintenance||1
6353519|NCT00634244|7261998|FG000|STARTED|Overall Study||35
6353520|NCT00634244|7261999|FG001|STARTED|Overall Study||37
6353521|NCT00634244|7262000|FG002|STARTED|Overall Study||20
6353522|NCT00634244|7261998|FG000|Eligible and Treated|Overall Study||35
6353523|NCT00634244|7261999|FG001|Eligible and Treated|Overall Study||36
6353524|NCT00634244|7262000|FG002|Eligible and Treated|Overall Study||20
6353525|NCT00634244|7261998|FG000|COMPLETED|Overall Study||34
6353526|NCT00634244|7261999|FG001|COMPLETED|Overall Study||24
6353527|NCT00634244|7262000|FG002|COMPLETED|Overall Study||20
6353528|NCT00634244|7261998|FG000|NOT COMPLETED|Overall Study||1
6353529|NCT00634244|7261999|FG001|NOT COMPLETED|Overall Study||13
6353530|NCT00634244|7262000|FG002|NOT COMPLETED|Overall Study||0
6353531|NCT00634270|7262010|FG000|STARTED|Overall Study|February 12, 2008|49
6353532|NCT00634270|7262011|FG001|STARTED|Overall Study||13
6353533|NCT00634270|7262010|FG000|COMPLETED|Overall Study||46
6353534|NCT00634270|7262011|FG001|COMPLETED|Overall Study||12
6353535|NCT00634270|7262010|FG000|NOT COMPLETED|Overall Study||3
6353536|NCT00634270|7262011|FG001|NOT COMPLETED|Overall Study||1
6353537|NCT00634283|7262023|FG000|STARTED|Overall Study||6
6353538|NCT00634283|7262023|FG000|COMPLETED|Overall Study||6
6353539|NCT00634283|7262023|FG000|NOT COMPLETED|Overall Study||0
6353540|NCT00634504|7262031|FG000|STARTED|Overall Study||11
6353541|NCT00634504|7262032|FG001|STARTED|Overall Study||9
6353542|NCT00634504|7262031|FG000|COMPLETED|Overall Study||10
6353543|NCT00634504|7262032|FG001|COMPLETED|Overall Study||9
6353544|NCT00634504|7262031|FG000|NOT COMPLETED|Overall Study||1
6353545|NCT00634504|7262032|FG001|NOT COMPLETED|Overall Study||0
6353546|NCT00634543|7262040|FG000|STARTED|Overall Study||78
6353547|NCT00634543|7262041|FG001|STARTED|Overall Study||84
6353548|NCT00634543|7262040|FG000|Treated|Overall Study||76
6353549|NCT00634543|7262041|FG001|Treated|Overall Study||80
6353550|NCT00634543|7262040|FG000|COMPLETED|Overall Study||59
6353551|NCT00634543|7262041|FG001|COMPLETED|Overall Study||63
6353552|NCT00634543|7262040|FG000|NOT COMPLETED|Overall Study||19
6353553|NCT00634543|7262041|FG001|NOT COMPLETED|Overall Study||21
6353554|NCT00634569|7262049|FG000|STARTED|Overall Study||14
6353555|NCT00634569|7262050|FG001|STARTED|Overall Study||10
6353556|NCT00634569|7262049|FG000|COMPLETED|Overall Study||14
6353557|NCT00634569|7262050|FG001|COMPLETED|Overall Study||5
6353558|NCT00634569|7262049|FG000|NOT COMPLETED|Overall Study||0
6353559|NCT00634569|7262050|FG001|NOT COMPLETED|Overall Study||5
6353560|NCT00634621|7262056|FG000|STARTED|Overall Study||283
6353561|NCT00634621|7262056|FG000|COMPLETED|Overall Study||283
6353562|NCT00634621|7262056|FG000|NOT COMPLETED|Overall Study||0
6353563|NCT00634647|7262064|FG000|STARTED|Overall Study||24
6353564|NCT00634647|7262064|FG000|COMPLETED|Overall Study||17
6353565|NCT00634647|7262064|FG000|NOT COMPLETED|Overall Study||7
6353566|NCT00634751|7262072|FG000|STARTED|Phase I: 200mg Sorafenib+2DOC||9
6353567|NCT00634751|7262073|FG001|STARTED|Phase I: 200mg Sorafenib+2DOC||0
6353568|NCT00634751|7262074|FG002|STARTED|Phase I: 200mg Sorafenib+2DOC||0
6353569|NCT00634751|7262075|FG003|STARTED|Phase I: 200mg Sorafenib+2DOC||0
6353570|NCT00634751|7262072|FG000|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
6353571|NCT00634751|7262073|FG001|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6353572|NCT00634751|7262074|FG002|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6353573|NCT00634751|7262075|FG003|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6353574|NCT00634751|7262072|FG000|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
6353575|NCT00634751|7262073|FG001|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6353576|NCT00634751|7262074|FG002|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6353577|NCT00634751|7262075|FG003|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
6353578|NCT00634751|7262072|FG000|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
6353579|NCT00634751|7262073|FG001|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
6353580|NCT00634751|7262074|FG002|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
6353581|NCT00634751|7262075|FG003|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
6353582|NCT00634751|7262072|FG000|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6353583|NCT00634751|7262073|FG001|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
6353584|NCT00634751|7262074|FG002|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6353585|NCT00634751|7262075|FG003|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6353586|NCT00634751|7262072|FG000|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6353587|NCT00634751|7262073|FG001|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
6353588|NCT00634751|7262074|FG002|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6353589|NCT00634751|7262075|FG003|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
6353590|NCT00634751|7262072|FG000|STARTED|Pancreatic and Bilial Tract Cancer||0
6353591|NCT00634751|7262073|FG001|STARTED|Pancreatic and Bilial Tract Cancer||0
6353592|NCT00634751|7262074|FG002|STARTED|Pancreatic and Bilial Tract Cancer||24
6353593|NCT00634751|7262075|FG003|STARTED|Pancreatic and Bilial Tract Cancer||8
6353594|NCT00634751|7262072|FG000|COMPLETED|Pancreatic and Bilial Tract Cancer||0
6353595|NCT00634751|7262073|FG001|COMPLETED|Pancreatic and Bilial Tract Cancer||0
6353596|NCT00634751|7262074|FG002|COMPLETED|Pancreatic and Bilial Tract Cancer||23
6353597|NCT00634751|7262075|FG003|COMPLETED|Pancreatic and Bilial Tract Cancer||7
6353598|NCT00634751|7262072|FG000|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
6353599|NCT00634751|7262073|FG001|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
6353600|NCT00634751|7262074|FG002|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
6353601|NCT00634751|7262075|FG003|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
6353602|NCT00634803|7262088|FG000|STARTED|Overall Study||30
6353603|NCT00634803|7262089|FG001|STARTED|Overall Study||30
6353604|NCT00634803|7262090|FG002|STARTED|Overall Study||30
6353605|NCT00634803|7262088|FG000|Month 1|Overall Study||29
6353606|NCT00634803|7262089|FG001|Month 1|Overall Study||29
6353607|NCT00634803|7262090|FG002|Month 1|Overall Study||29
6353608|NCT00634803|7262088|FG000|Month 2|Overall Study||26
6353609|NCT00634803|7262089|FG001|Month 2|Overall Study||26
6353610|NCT00634803|7262090|FG002|Month 2|Overall Study||28
6353611|NCT00634803|7262088|FG000|Month 3|Overall Study||25
6353612|NCT00634803|7262089|FG001|Month 3|Overall Study||23
6353613|NCT00634803|7262090|FG002|Month 3|Overall Study||26
6353614|NCT00634803|7262088|FG000|COMPLETED|Overall Study||24
6353615|NCT00634803|7262089|FG001|COMPLETED|Overall Study||23
6353616|NCT00634803|7262090|FG002|COMPLETED|Overall Study||23
6353617|NCT00634803|7262088|FG000|NOT COMPLETED|Overall Study||6
6353618|NCT00634803|7262089|FG001|NOT COMPLETED|Overall Study||7
6353619|NCT00634803|7262090|FG002|NOT COMPLETED|Overall Study||7
6353620|NCT00634842|7262100|FG000|STARTED|Overall Study||122
6353621|NCT00634842|7262101|FG001|STARTED|Overall Study||122
6353622|NCT00634842|7262100|FG000|COMPLETED|Overall Study||107
6353623|NCT00634842|7262101|FG001|COMPLETED|Overall Study||104
6353624|NCT00634842|7262100|FG000|NOT COMPLETED|Overall Study||15
6353625|NCT00634842|7262101|FG001|NOT COMPLETED|Overall Study||18
6353626|NCT00634907|7262109|FG000|STARTED|Overall Study||131
6353627|NCT00634907|7262110|FG001|STARTED|Overall Study||132
6353628|NCT00634907|7262109|FG000|COMPLETED|Overall Study||114
6353629|NCT00634907|7262110|FG001|COMPLETED|Overall Study||115
6353630|NCT00634907|7262109|FG000|NOT COMPLETED|Overall Study||17
6353631|NCT00634907|7262110|FG001|NOT COMPLETED|Overall Study||17
6353632|NCT00634920|7262119|FG000|STARTED|Period 1 - Pre-Randomization||0
6353633|NCT00634920|7262120|FG001|STARTED|Period 1 - Pre-Randomization||0
6353634|NCT00634920|7262121|FG002|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
6353635|NCT00634920|7262119|FG000|COMPLETED|Period 1 - Pre-Randomization||0
6353636|NCT00634920|7262120|FG001|COMPLETED|Period 1 - Pre-Randomization||0
6353637|NCT00634920|7262121|FG002|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
6353638|NCT00634920|7262119|FG000|NOT COMPLETED|Period 1 - Pre-Randomization||0
6353639|NCT00634920|7262120|FG001|NOT COMPLETED|Period 1 - Pre-Randomization||0
6353640|NCT00634920|7262121|FG002|NOT COMPLETED|Period 1 - Pre-Randomization||137
6353641|NCT00634920|7262119|FG000|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
6353642|NCT00634920|7262120|FG001|STARTED|Period 2 - Post-Randomization||100
6353643|NCT00634920|7262121|FG002|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
6353644|NCT00634920|7262119|FG000|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
6353645|NCT00634920|7262120|FG001|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
6353646|NCT00634920|7262121|FG002|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
6353647|NCT00634920|7262119|FG000|COMPLETED|Period 2 - Post-Randomization||43
6353648|NCT00634920|7262120|FG001|COMPLETED|Period 2 - Post-Randomization||68
6353649|NCT00634920|7262121|FG002|COMPLETED|Period 2 - Post-Randomization||0
6353650|NCT00634920|7262119|FG000|NOT COMPLETED|Period 2 - Post-Randomization||61
6353651|NCT00634920|7262120|FG001|NOT COMPLETED|Period 2 - Post-Randomization||32
6353652|NCT00634920|7262121|FG002|NOT COMPLETED|Period 2 - Post-Randomization||0
6353653|NCT00634933|7262130|FG000|STARTED|Part A: Baseline to Week 24||74
6353654|NCT00634933|7262131|FG001|STARTED|Part A: Baseline to Week 24||75
6353655|NCT00634933|7262132|FG002|STARTED|Part A: Baseline to Week 24||73
6353656|NCT00634933|7262133|FG003|STARTED|Part A: Baseline to Week 24||0
6353657|NCT00634933|7262134|FG004|STARTED|Part A: Baseline to Week 24||0
6353658|NCT00634933|7262130|FG000|COMPLETED|Part A: Baseline to Week 24||63
6353659|NCT00634933|7262131|FG001|COMPLETED|Part A: Baseline to Week 24||57
6353660|NCT00634933|7262132|FG002|COMPLETED|Part A: Baseline to Week 24||55
6353661|NCT00634933|7262133|FG003|COMPLETED|Part A: Baseline to Week 24||0
6353662|NCT00634933|7262134|FG004|COMPLETED|Part A: Baseline to Week 24||0
6353663|NCT00634933|7262130|FG000|NOT COMPLETED|Part A: Baseline to Week 24||11
6353664|NCT00634933|7262131|FG001|NOT COMPLETED|Part A: Baseline to Week 24||18
6353665|NCT00634933|7262132|FG002|NOT COMPLETED|Part A: Baseline to Week 24||18
6353666|NCT00634933|7262133|FG003|NOT COMPLETED|Part A: Baseline to Week 24||0
6353667|NCT00634933|7262134|FG004|NOT COMPLETED|Part A: Baseline to Week 24||0
6353668|NCT00634933|7262130|FG000|STARTED|Between Part A and Part B||0
6353669|NCT00634933|7262131|FG001|STARTED|Between Part A and Part B||57
6353670|NCT00634933|7262132|FG002|STARTED|Between Part A and Part B||55
6353671|NCT00634933|7262133|FG003|STARTED|Between Part A and Part B||31
6353672|NCT00634933|7262134|FG004|STARTED|Between Part A and Part B||32
6353673|NCT00634933|7262130|FG000|COMPLETED|Between Part A and Part B||0
6353674|NCT00634933|7262131|FG001|COMPLETED|Between Part A and Part B||56
6353675|NCT00634933|7262132|FG002|COMPLETED|Between Part A and Part B||55
6353676|NCT00634933|7262133|FG003|COMPLETED|Between Part A and Part B||31
6353677|NCT00634933|7262134|FG004|COMPLETED|Between Part A and Part B||32
6353678|NCT00634933|7262130|FG000|NOT COMPLETED|Between Part A and Part B||0
6353679|NCT00634933|7262131|FG001|NOT COMPLETED|Between Part A and Part B||1
6353680|NCT00634933|7262132|FG002|NOT COMPLETED|Between Part A and Part B||0
6353681|NCT00634933|7262133|FG003|NOT COMPLETED|Between Part A and Part B||0
6353682|NCT00634933|7262134|FG004|NOT COMPLETED|Between Part A and Part B||0
6353683|NCT00634933|7262130|FG000|STARTED|Part B: Week 24 to Week 52||0
6353684|NCT00634933|7262131|FG001|STARTED|Part B: Week 24 to Week 52||56
6353685|NCT00634933|7262132|FG002|STARTED|Part B: Week 24 to Week 52||55
6353686|NCT00634933|7262133|FG003|STARTED|Part B: Week 24 to Week 52||31
6353687|NCT00634933|7262134|FG004|STARTED|Part B: Week 24 to Week 52||32
6353688|NCT00634933|7262130|FG000|COMPLETED|Part B: Week 24 to Week 52||0
6353689|NCT00634933|7262131|FG001|COMPLETED|Part B: Week 24 to Week 52||42
6353690|NCT00634933|7262132|FG002|COMPLETED|Part B: Week 24 to Week 52||33
6353691|NCT00634933|7262133|FG003|COMPLETED|Part B: Week 24 to Week 52||25
6353692|NCT00634933|7262134|FG004|COMPLETED|Part B: Week 24 to Week 52||22
6353693|NCT00634933|7262130|FG000|NOT COMPLETED|Part B: Week 24 to Week 52||0
6353694|NCT00634933|7262131|FG001|NOT COMPLETED|Part B: Week 24 to Week 52||14
6353695|NCT00634933|7262132|FG002|NOT COMPLETED|Part B: Week 24 to Week 52||22
6353696|NCT00634933|7262133|FG003|NOT COMPLETED|Part B: Week 24 to Week 52||6
6353697|NCT00634933|7262134|FG004|NOT COMPLETED|Part B: Week 24 to Week 52||10
6353698|NCT00635024|7262146|FG000|STARTED|Overall Study||1
6353699|NCT00635024|7262146|FG000|COMPLETED|Overall Study||0
6353700|NCT00635024|7262146|FG000|NOT COMPLETED|Overall Study||1
6353701|NCT00635050|7262150|FG000|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
6353702|NCT00635050|7262150|FG000|COMPLETED|Overall Study|Followup through 10 years planned.|31
6353703|NCT00635050|7262150|FG000|NOT COMPLETED|Overall Study||1
6353704|NCT00635089|7262157|FG000|STARTED|Overall Study||190
6353705|NCT00635089|7262157|FG000|Completed >/= 16 Weeks of Study|Overall Study||181
6353706|NCT00635089|7262157|FG000|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
6353707|NCT00635089|7262157|FG000|NOT COMPLETED|Overall Study||78
6353708|NCT00635102|7262176|FG000|STARTED|Overall Study||27
6353709|NCT00635102|7262177|FG001|STARTED|Overall Study||30
6353710|NCT00635102|7262176|FG000|COMPLETED|Overall Study||20
6353711|NCT00635102|7262177|FG001|COMPLETED|Overall Study||22
6353712|NCT00635102|7262176|FG000|NOT COMPLETED|Overall Study||7
6353713|NCT00635102|7262177|FG001|NOT COMPLETED|Overall Study||8
6353714|NCT00635128|7262185|FG000|STARTED|Overall Study||351
6353715|NCT00635128|7262186|FG001|STARTED|Overall Study||64
6353716|NCT00635128|7262185|FG000|COMPLETED|Overall Study||351
6353717|NCT00635128|7262186|FG001|COMPLETED|Overall Study||64
6353718|NCT00635128|7262185|FG000|NOT COMPLETED|Overall Study||0
6353719|NCT00635128|7262186|FG001|NOT COMPLETED|Overall Study||0
6353720|NCT00635154|7262194|FG000|STARTED|Overall Study||54
6353721|NCT00635154|7262194|FG000|COMPLETED|Overall Study||21
6353722|NCT00635154|7262194|FG000|NOT COMPLETED|Overall Study||33
6353723|NCT00635219|7262205|FG000|STARTED|Overall Study||148
6353724|NCT00635219|7262206|FG001|STARTED|Overall Study||155
6353725|NCT00635219|7262207|FG002|STARTED|Overall Study||157
6353726|NCT00635219|7262208|FG003|STARTED|Overall Study||151
6353727|NCT00635219|7262209|FG004|STARTED|Overall Study||155
6353728|NCT00635219|7262205|FG000|COMPLETED|Overall Study||123
6353729|NCT00635219|7262206|FG001|COMPLETED|Overall Study||130
6353730|NCT00635219|7262207|FG002|COMPLETED|Overall Study||122
6353731|NCT00635219|7262208|FG003|COMPLETED|Overall Study||117
6353732|NCT00635219|7262209|FG004|COMPLETED|Overall Study||113
6353733|NCT00635219|7262205|FG000|NOT COMPLETED|Overall Study||25
6353734|NCT00635219|7262206|FG001|NOT COMPLETED|Overall Study||25
6353735|NCT00635219|7262207|FG002|NOT COMPLETED|Overall Study||35
6353736|NCT00635219|7262208|FG003|NOT COMPLETED|Overall Study||34
6353737|NCT00635219|7262209|FG004|NOT COMPLETED|Overall Study||42
6353738|NCT00635232|7262226|FG000|STARTED|Overall Study||58
6353739|NCT00635232|7262227|FG001|STARTED|Overall Study||59
6353740|NCT00635232|7262228|FG002|STARTED|Overall Study||58
6353741|NCT00635232|7262229|FG003|STARTED|Overall Study||58
6353742|NCT00635232|7262230|FG004|STARTED|Overall Study||28
6353743|NCT00635232|7262226|FG000|COMPLETED|Overall Study||44
6353744|NCT00635232|7262227|FG001|COMPLETED|Overall Study||39
6353745|NCT00635232|7262228|FG002|COMPLETED|Overall Study||55
6353746|NCT00635232|7262229|FG003|COMPLETED|Overall Study||48
6353747|NCT00635232|7262230|FG004|COMPLETED|Overall Study||20
6353748|NCT00635232|7262226|FG000|NOT COMPLETED|Overall Study||14
6353749|NCT00635232|7262227|FG001|NOT COMPLETED|Overall Study||20
6353750|NCT00635232|7262228|FG002|NOT COMPLETED|Overall Study||3
6353751|NCT00635232|7262229|FG003|NOT COMPLETED|Overall Study||10
6353752|NCT00635232|7262230|FG004|NOT COMPLETED|Overall Study||8
6353753|NCT00635349|7262244|FG000|STARTED|Overall Study||73
6353754|NCT00635349|7262245|FG001|STARTED|Overall Study||67
6353755|NCT00635349|7262244|FG000|COMPLETED|Overall Study||29
6353756|NCT00635349|7262245|FG001|COMPLETED|Overall Study||19
6353757|NCT00635349|7262244|FG000|NOT COMPLETED|Overall Study||44
6353758|NCT00635349|7262245|FG001|NOT COMPLETED|Overall Study||48
6353759|NCT00635362|7262253|FG000|STARTED|Overall Study||22
6353760|NCT00635362|7262254|FG001|STARTED|Overall Study||20
6353761|NCT00635362|7262253|FG000|COMPLETED|Overall Study||9
6353762|NCT00635362|7262254|FG001|COMPLETED|Overall Study||12
6353763|NCT00635362|7262253|FG000|NOT COMPLETED|Overall Study||13
6353764|NCT00635362|7262254|FG001|NOT COMPLETED|Overall Study||8
6353765|NCT00635427|7262265|FG000|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
6353766|NCT00635427|7262266|FG001|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
6353767|NCT00635427|7262267|FG002|STARTED|Overall Study||16
6353768|NCT00635427|7262268|FG003|STARTED|Overall Study||16
6353769|NCT00635427|7262269|FG004|STARTED|Overall Study||38
6353770|NCT00635427|7262265|FG000|COMPLETED|Overall Study||1
6353771|NCT00635427|7262266|FG001|COMPLETED|Overall Study||6
6353772|NCT00635427|7262267|FG002|COMPLETED|Overall Study||5
6353773|NCT00635427|7262268|FG003|COMPLETED|Overall Study||7
6353774|NCT00635427|7262269|FG004|COMPLETED|Overall Study||30
6353775|NCT00635427|7262265|FG000|NOT COMPLETED|Overall Study||12
6353776|NCT00635427|7262266|FG001|NOT COMPLETED|Overall Study||6
6353777|NCT00635427|7262267|FG002|NOT COMPLETED|Overall Study||11
6353778|NCT00635427|7262268|FG003|NOT COMPLETED|Overall Study||9
6559690|NCT01782898|7482393|FG001|NOT COMPLETED|Overall Study||6
6559691|NCT01782963|7482399|FG000|STARTED|Overall Study||50
6559692|NCT01782963|7482399|FG000|COMPLETED|Overall Study||50
6559693|NCT01782963|7482399|FG000|NOT COMPLETED|Overall Study||0
6559694|NCT01783054|7482407|FG000|STARTED|Overall Study||2
6559695|NCT01783054|7482407|FG000|COMPLETED|Overall Study||2
6559696|NCT01783054|7482407|FG000|NOT COMPLETED|Overall Study||0
6559697|NCT01783080|7482411|FG000|STARTED|Overall Study||16
6559698|NCT01783080|7482411|FG000|COMPLETED|Overall Study||16
6559699|NCT01783080|7482411|FG000|NOT COMPLETED|Overall Study||0
6559700|NCT01783236|7482417|FG000|STARTED|Overall Study||8
6559701|NCT01783236|7482418|FG001|STARTED|Overall Study||8
6559702|NCT01783236|7482417|FG000|COMPLETED|Overall Study||6
6559703|NCT01783236|7482418|FG001|COMPLETED|Overall Study||8
6559704|NCT01783236|7482417|FG000|NOT COMPLETED|Overall Study||2
6559705|NCT01783236|7482418|FG001|NOT COMPLETED|Overall Study||0
6559706|NCT01783418|7482426|FG000|STARTED|Overall Study||8
6559707|NCT01783418|7482427|FG001|STARTED|Overall Study||6
6559708|NCT01783418|7482426|FG000|COMPLETED|Overall Study||7
6559709|NCT01783418|7482427|FG001|COMPLETED|Overall Study||6
6559710|NCT01783418|7482426|FG000|NOT COMPLETED|Overall Study||1
6559711|NCT01783418|7482427|FG001|NOT COMPLETED|Overall Study||0
6559712|NCT01783444|7482436|FG000|STARTED|Treatment Phase||104
6559713|NCT01783444|7482437|FG001|STARTED|Treatment Phase||103
6559714|NCT01783444|7482438|FG002|STARTED|Treatment Phase||102
6559715|NCT01783444|7482436|FG000|Safety Set|Treatment Phase||104
6559716|NCT01783444|7482437|FG001|Safety Set|Treatment Phase||103
6559717|NCT01783444|7482438|FG002|Safety Set|Treatment Phase||102
6559718|NCT01783444|7482436|FG000|COMPLETED|Treatment Phase||0
6559719|NCT01783444|7482437|FG001|COMPLETED|Treatment Phase||0
6559720|NCT01783444|7482438|FG002|COMPLETED|Treatment Phase||0
6559721|NCT01783444|7482436|FG000|NOT COMPLETED|Treatment Phase||104
6559722|NCT01783444|7482437|FG001|NOT COMPLETED|Treatment Phase||103
6559723|NCT01783444|7482438|FG002|NOT COMPLETED|Treatment Phase||102
6559724|NCT01783444|7482436|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|96
6559725|NCT01783444|7482437|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|93
6559726|NCT01783444|7482438|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Follow-Up Phase|91
6559727|NCT01783444|7482436|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6559728|NCT01783444|7482437|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6559729|NCT01783444|7482438|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6559730|NCT01783444|7482436|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||96
6559731|NCT01783444|7482437|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||93
6559732|NCT01783444|7482438|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||91
6559733|NCT01783470|7482447|FG000|STARTED|Overall Study||6
6559734|NCT01783470|7482448|FG001|STARTED|Overall Study|Single-dose|6
6559735|NCT01783470|7482447|FG000|COMPLETED|Overall Study||6
6559736|NCT01783470|7482448|FG001|COMPLETED|Overall Study||6
6559737|NCT01783470|7482447|FG000|NOT COMPLETED|Overall Study||0
6559738|NCT01783470|7482448|FG001|NOT COMPLETED|Overall Study||0
6559739|NCT01783483|7482457|FG000|STARTED|Overall Study||120
6559740|NCT01783483|7482458|FG001|STARTED|Overall Study||116
6559741|NCT01783483|7482457|FG000|COMPLETED|Overall Study||100
6559742|NCT01783483|7482458|FG001|COMPLETED|Overall Study||101
6559743|NCT01783483|7482457|FG000|NOT COMPLETED|Overall Study||20
6559744|NCT01783483|7482458|FG001|NOT COMPLETED|Overall Study||15
6559745|NCT01783496|7482470|FG000|STARTED|Overall Study||10
6559746|NCT01783496|7482471|FG001|STARTED|Overall Study||10
6559747|NCT01783496|7482472|FG002|STARTED|Overall Study||10
6559748|NCT01783496|7482473|FG003|STARTED|Overall Study||10
6559749|NCT01783496|7482474|FG004|STARTED|Overall Study||5
6559750|NCT01783496|7482475|FG005|STARTED|Overall Study||5
6559751|NCT01783496|7482470|FG000|COMPLETED|Overall Study||9
6559752|NCT01783496|7482471|FG001|COMPLETED|Overall Study||10
6559753|NCT01783496|7482472|FG002|COMPLETED|Overall Study||10
6559754|NCT01783496|7482473|FG003|COMPLETED|Overall Study||8
6559755|NCT01783496|7482474|FG004|COMPLETED|Overall Study||5
6353779|NCT00635427|7262269|FG004|NOT COMPLETED|Overall Study||8
6353780|NCT00635453|7262281|FG000|STARTED|Overall Study||360
6353781|NCT00635453|7262282|FG001|STARTED|Overall Study||355
6353782|NCT00635453|7262281|FG000|6 Months Assessment|Overall Study||322
6559756|NCT01783496|7482475|FG005|COMPLETED|Overall Study||4
6559757|NCT01783496|7482470|FG000|NOT COMPLETED|Overall Study||1
6559758|NCT01783496|7482471|FG001|NOT COMPLETED|Overall Study||0
6559759|NCT01783496|7482472|FG002|NOT COMPLETED|Overall Study||0
6559760|NCT01783496|7482473|FG003|NOT COMPLETED|Overall Study||2
6559761|NCT01783496|7482474|FG004|NOT COMPLETED|Overall Study||0
6559762|NCT01783496|7482475|FG005|NOT COMPLETED|Overall Study||1
6559763|NCT01783522|7482491|FG000|STARTED|Overall Study||4
6559764|NCT01783522|7482492|FG001|STARTED|Overall Study||5
6559765|NCT01783522|7482491|FG000|COMPLETED|Overall Study||4
6559766|NCT01783522|7482492|FG001|COMPLETED|Overall Study||5
6559767|NCT01783522|7482491|FG000|NOT COMPLETED|Overall Study||0
6559768|NCT01783522|7482492|FG001|NOT COMPLETED|Overall Study||0
6559769|NCT01783548|7482500|FG000|STARTED|Overall Study|Randomized|362
6559770|NCT01783548|7482501|FG001|STARTED|Overall Study|Randomized|185
6559771|NCT01783548|7482500|FG000|Full Analysis Set (FAS)|Overall Study||358
6559772|NCT01783548|7482501|FG001|Full Analysis Set (FAS)|Overall Study||184
6559773|NCT01783548|7482500|FG000|COMPLETED|Overall Study||328
6559774|NCT01783548|7482501|FG001|COMPLETED|Overall Study||167
6559775|NCT01783548|7482500|FG000|NOT COMPLETED|Overall Study||34
6559776|NCT01783548|7482501|FG001|NOT COMPLETED|Overall Study||18
6559777|NCT01783561|7482509|FG000|STARTED|Overall Study||11
6559778|NCT01783561|7482510|FG001|STARTED|Overall Study||10
6559779|NCT01783561|7482509|FG000|COMPLETED|Overall Study||11
6559780|NCT01783561|7482510|FG001|COMPLETED|Overall Study||10
6559781|NCT01783561|7482509|FG000|NOT COMPLETED|Overall Study||0
6559782|NCT01783561|7482510|FG001|NOT COMPLETED|Overall Study||0
6559783|NCT01783574|7482518|FG000|STARTED|Overall Study||51
6559784|NCT01783574|7482519|FG001|STARTED|Overall Study||50
6559785|NCT01783574|7482518|FG000|COMPLETED|Overall Study||46
6559786|NCT01783574|7482519|FG001|COMPLETED|Overall Study||41
6559787|NCT01783574|7482518|FG000|NOT COMPLETED|Overall Study||5
6559788|NCT01783574|7482519|FG001|NOT COMPLETED|Overall Study||9
6559789|NCT01783639|7482525|FG000|STARTED|Overall Study||120
6559790|NCT01783639|7482525|FG000|COMPLETED|Overall Study||120
6559791|NCT01783639|7482525|FG000|NOT COMPLETED|Overall Study||0
6559792|NCT01783678|7482535|FG000|STARTED|Overall Study||19
6559793|NCT01783678|7482536|FG001|STARTED|Overall Study||112
6559794|NCT01783678|7482537|FG002|STARTED|Overall Study||6
6559795|NCT01783678|7482538|FG003|STARTED|Overall Study||58
6559796|NCT01783678|7482539|FG004|STARTED|Overall Study||49
6559797|NCT01783678|7482540|FG005|STARTED|Overall Study||31
6559798|NCT01783678|7482535|FG000|COMPLETED|Overall Study||17
6559799|NCT01783678|7482536|FG001|COMPLETED|Overall Study||94
6559800|NCT01783678|7482537|FG002|COMPLETED|Overall Study||5
6559801|NCT01783678|7482538|FG003|COMPLETED|Overall Study||50
6559802|NCT01783678|7482539|FG004|COMPLETED|Overall Study||42
6353783|NCT00635453|7262282|FG001|6 Months Assessment|Overall Study||311
6353784|NCT00635453|7262281|FG000|12 Months Assessment|Overall Study||285
6353785|NCT00635453|7262282|FG001|12 Months Assessment|Overall Study||260
6353786|NCT00635453|7262281|FG000|3 Years Assessment|Overall Study||246
6353787|NCT00635453|7262282|FG001|3 Years Assessment|Overall Study||204
6353788|NCT00635453|7262281|FG000|COMPLETED|Overall Study||206
6353789|NCT00635453|7262282|FG001|COMPLETED|Overall Study||181
6353790|NCT00635453|7262281|FG000|NOT COMPLETED|Overall Study||154
6353791|NCT00635453|7262282|FG001|NOT COMPLETED|Overall Study||174
6353792|NCT00635479|7262290|FG000|STARTED|Overall Study||55
6353793|NCT00635479|7262291|FG001|STARTED|Overall Study||60
6353794|NCT00635479|7262290|FG000|COMPLETED|Overall Study||49
6353795|NCT00635479|7262291|FG001|COMPLETED|Overall Study||42
6559803|NCT01783678|7482540|FG005|COMPLETED|Overall Study||26
6559804|NCT01783678|7482535|FG000|NOT COMPLETED|Overall Study||2
6559805|NCT01783678|7482536|FG001|NOT COMPLETED|Overall Study||18
6559806|NCT01783678|7482537|FG002|NOT COMPLETED|Overall Study||1
6559807|NCT01783678|7482538|FG003|NOT COMPLETED|Overall Study||8
6559808|NCT01783678|7482539|FG004|NOT COMPLETED|Overall Study||7
6353796|NCT00635479|7262290|FG000|NOT COMPLETED|Overall Study||6
6353797|NCT00635479|7262291|FG001|NOT COMPLETED|Overall Study||18
6353798|NCT00635492|7262299|FG000|STARTED|Overall Study|This population consists of the analysis population.|1114
6353799|NCT00635492|7262300|FG001|STARTED|Overall Study|This population consists of the analysis population.|1274
6353800|NCT00635492|7262299|FG000|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
6353801|NCT00635492|7262300|FG001|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
6353802|NCT00635492|7262299|FG000|NOT COMPLETED|Overall Study||279
6353803|NCT00635492|7262300|FG001|NOT COMPLETED|Overall Study||282
6353804|NCT00635570|7262312|FG000|STARTED|Overall Study||136
6353805|NCT00635570|7262313|FG001|STARTED|Overall Study||137
6353806|NCT00635570|7262312|FG000|COMPLETED|Overall Study||121
6353807|NCT00635570|7262313|FG001|COMPLETED|Overall Study||126
6353808|NCT00635570|7262312|FG000|NOT COMPLETED|Overall Study||15
6353809|NCT00635570|7262313|FG001|NOT COMPLETED|Overall Study||11
6353810|NCT00635609|7262321|FG000|STARTED|Overall Study||48
6353811|NCT00635609|7262322|FG001|STARTED|Overall Study||45
6559809|NCT01783678|7482540|FG005|NOT COMPLETED|Overall Study||5
6559810|NCT01783730|7482555|FG000|STARTED|Overall Study||163
6559811|NCT01783730|7482555|FG000|COMPLETED|Overall Study||157
6559812|NCT01783730|7482555|FG000|NOT COMPLETED|Overall Study||6
6559813|NCT01783743|7482561|FG000|STARTED|Screening of Subjects by CTA During MDA||13509
6559814|NCT01783743|7482562|FG001|STARTED|Screening of Subjects by CTA During MDA||13964
6559815|NCT01783743|7482561|FG000|COMPLETED|Screening of Subjects by CTA During MDA||10082
6559816|NCT01783743|7482562|FG001|COMPLETED|Screening of Subjects by CTA During MDA||9525
6559817|NCT01783743|7482561|FG000|NOT COMPLETED|Screening of Subjects by CTA During MDA||3427
6562868|NCT01803269|7485763|FG000|NOT COMPLETED|Overall Study||3
6353812|NCT00635609|7262321|FG000|COMPLETED|Overall Study||41
6353813|NCT00635609|7262322|FG001|COMPLETED|Overall Study||42
6353814|NCT00635609|7262321|FG000|NOT COMPLETED|Overall Study||7
6353815|NCT00635609|7262322|FG001|NOT COMPLETED|Overall Study||3
6353816|NCT00635648|7262328|FG000|STARTED|Overall Study||63
6353817|NCT00635648|7262328|FG000|COMPLETED|Overall Study||26
6353818|NCT00635648|7262328|FG000|NOT COMPLETED|Overall Study||37
6353819|NCT00635661|7262332|FG000|STARTED|Overall Study||34
6353820|NCT00635661|7262332|FG000|COMPLETED|Overall Study||30
6353821|NCT00635661|7262332|FG000|NOT COMPLETED|Overall Study||4
6353822|NCT00635700|7262338|FG000|STARTED|Overall Study||24
6353823|NCT00635700|7262339|FG001|STARTED|Overall Study||27
6353824|NCT00635700|7262338|FG000|COMPLETED|Overall Study||9
6353825|NCT00635700|7262339|FG001|COMPLETED|Overall Study||13
6353826|NCT00635700|7262338|FG000|NOT COMPLETED|Overall Study||15
6353827|NCT00635700|7262339|FG001|NOT COMPLETED|Overall Study||14
6353828|NCT00635739|7262347|FG000|STARTED|Overall Study||42
6353829|NCT00635739|7262348|FG001|STARTED|Overall Study||38
6353830|NCT00635739|7262347|FG000|COMPLETED|Overall Study||39
6353831|NCT00635739|7262348|FG001|COMPLETED|Overall Study||36
6353832|NCT00635739|7262347|FG000|NOT COMPLETED|Overall Study||3
6353833|NCT00635739|7262348|FG001|NOT COMPLETED|Overall Study||2
6353834|NCT00635778|7262361|FG000|STARTED|Overall Study||1
6353835|NCT00635778|7262362|FG001|STARTED|Overall Study||3
6353836|NCT00635778|7262363|FG002|STARTED|Overall Study||3
6353837|NCT00635778|7262364|FG003|STARTED|Overall Study||8
6353838|NCT00635778|7262365|FG004|STARTED|Overall Study||8
6353839|NCT00635778|7262366|FG005|STARTED|Overall Study||21
6353840|NCT00635778|7262367|FG006|STARTED|Overall Study||6
6353841|NCT00635778|7262361|FG000|COMPLETED|Overall Study||0
6353842|NCT00635778|7262362|FG001|COMPLETED|Overall Study||0
6353843|NCT00635778|7262363|FG002|COMPLETED|Overall Study||0
6353844|NCT00635778|7262364|FG003|COMPLETED|Overall Study||0
6353845|NCT00635778|7262365|FG004|COMPLETED|Overall Study||0
6353846|NCT00635778|7262366|FG005|COMPLETED|Overall Study||0
6353847|NCT00635778|7262367|FG006|COMPLETED|Overall Study||0
6353848|NCT00635778|7262361|FG000|NOT COMPLETED|Overall Study||1
6353849|NCT00635778|7262362|FG001|NOT COMPLETED|Overall Study||3
6353850|NCT00635778|7262363|FG002|NOT COMPLETED|Overall Study||3
6353851|NCT00635778|7262364|FG003|NOT COMPLETED|Overall Study||8
6353852|NCT00635778|7262365|FG004|NOT COMPLETED|Overall Study||8
6353853|NCT00635778|7262366|FG005|NOT COMPLETED|Overall Study||21
6353854|NCT00635778|7262367|FG006|NOT COMPLETED|Overall Study||6
6353855|NCT00635804|7262392|FG000|STARTED|Overall Study||7
6353856|NCT00635804|7262393|FG001|STARTED|Overall Study||6
6353857|NCT00635804|7262394|FG002|STARTED|Overall Study||6
6353858|NCT00635804|7262395|FG003|STARTED|Overall Study||6
6353859|NCT00635804|7262396|FG004|STARTED|Overall Study||6
6353860|NCT00635804|7262397|FG005|STARTED|Overall Study||12
6353861|NCT00635804|7262398|FG006|STARTED|Overall Study||3
6353862|NCT00635804|7262399|FG007|STARTED|Overall Study||14
6353863|NCT00635804|7262392|FG000|COMPLETED|Overall Study||6
6353864|NCT00635804|7262393|FG001|COMPLETED|Overall Study||6
6353865|NCT00635804|7262394|FG002|COMPLETED|Overall Study||6
6353866|NCT00635804|7262395|FG003|COMPLETED|Overall Study||6
6353867|NCT00635804|7262396|FG004|COMPLETED|Overall Study||6
6353868|NCT00635804|7262397|FG005|COMPLETED|Overall Study||11
6353869|NCT00635804|7262398|FG006|COMPLETED|Overall Study||3
6353870|NCT00635804|7262399|FG007|COMPLETED|Overall Study||14
6353871|NCT00635804|7262392|FG000|NOT COMPLETED|Overall Study||1
6353872|NCT00635804|7262393|FG001|NOT COMPLETED|Overall Study||0
6353873|NCT00635804|7262394|FG002|NOT COMPLETED|Overall Study||0
6353874|NCT00635804|7262395|FG003|NOT COMPLETED|Overall Study||0
6353875|NCT00635804|7262396|FG004|NOT COMPLETED|Overall Study||0
6353876|NCT00635804|7262397|FG005|NOT COMPLETED|Overall Study||1
6353877|NCT00635804|7262398|FG006|NOT COMPLETED|Overall Study||0
6353878|NCT00635804|7262399|FG007|NOT COMPLETED|Overall Study||0
6353879|NCT00635817|7262424|FG000|STARTED|Overall Study||21
6353880|NCT00635817|7262425|FG001|STARTED|Overall Study||21
6353881|NCT00635817|7262426|FG002|STARTED|Overall Study||21
6353882|NCT00635817|7262427|FG003|STARTED|Overall Study||21
6353883|NCT00635817|7262424|FG000|COMPLETED|Overall Study||15
6353884|NCT00635817|7262425|FG001|COMPLETED|Overall Study||19
6353885|NCT00635817|7262426|FG002|COMPLETED|Overall Study||19
6353886|NCT00635817|7262427|FG003|COMPLETED|Overall Study||21
6353887|NCT00635817|7262424|FG000|NOT COMPLETED|Overall Study||6
6353888|NCT00635817|7262425|FG001|NOT COMPLETED|Overall Study||2
6776443|NCT03834025|7704478|FG005|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||0
6776444|NCT03834025|7704479|FG006|NOT COMPLETED|Randomized to Payment Condition(Phase 2)||1
6776445|NCT03836677|7704495|FG000|STARTED|Period 1||13
6776446|NCT03836677|7704496|FG001|STARTED|Period 1||10
6353889|NCT00635817|7262426|FG002|NOT COMPLETED|Overall Study||2
6353890|NCT00635817|7262427|FG003|NOT COMPLETED|Overall Study||0
6353891|NCT00635830|7262441|FG000|STARTED|Overall Study||20
6353892|NCT00635830|7262442|FG001|STARTED|Overall Study||20
6353893|NCT00635830|7262441|FG000|COMPLETED|Overall Study||20
6353894|NCT00635830|7262442|FG001|COMPLETED|Overall Study||20
6353895|NCT00635830|7262441|FG000|NOT COMPLETED|Overall Study||0
6353896|NCT00635830|7262442|FG001|NOT COMPLETED|Overall Study||0
6353897|NCT00635999|7262451|FG000|STARTED|Overall Study||27
6353898|NCT00635999|7262452|FG001|STARTED|Overall Study||25
6353899|NCT00635999|7262453|FG002|STARTED|Overall Study||24
6353900|NCT00635999|7262451|FG000|COMPLETED|Overall Study||23
6353901|NCT00635999|7262452|FG001|COMPLETED|Overall Study||23
6353902|NCT00635999|7262453|FG002|COMPLETED|Overall Study||23
6353903|NCT00635999|7262451|FG000|NOT COMPLETED|Overall Study||4
6353904|NCT00635999|7262452|FG001|NOT COMPLETED|Overall Study||2
6353905|NCT00635999|7262453|FG002|NOT COMPLETED|Overall Study||1
6353906|NCT00636077|7262461|FG000|STARTED|Week 1||3
6353907|NCT00636077|7262462|FG001|STARTED|Week 1||3
6353908|NCT00636077|7262463|FG002|STARTED|Week 1||3
6353909|NCT00636077|7262464|FG003|STARTED|Week 1||3
6353910|NCT00636077|7262461|FG000|COMPLETED|Week 1||3
6353911|NCT00636077|7262462|FG001|COMPLETED|Week 1||3
6353912|NCT00636077|7262463|FG002|COMPLETED|Week 1||3
6353913|NCT00636077|7262464|FG003|COMPLETED|Week 1||3
6353914|NCT00636077|7262461|FG000|NOT COMPLETED|Week 1||0
6353915|NCT00636077|7262462|FG001|NOT COMPLETED|Week 1||0
6353916|NCT00636077|7262463|FG002|NOT COMPLETED|Week 1||0
6559818|NCT01783743|7482562|FG001|NOT COMPLETED|Screening of Subjects by CTA During MDA||4439
6559819|NCT01783743|7482561|FG000|STARTED|Rescreening of Subjects by Senior Grader||13509
6559820|NCT01783743|7482562|FG001|STARTED|Rescreening of Subjects by Senior Grader||13964
6353917|NCT00636077|7262464|FG003|NOT COMPLETED|Week 1||0
6353918|NCT00636077|7262461|FG000|STARTED|Week 2||3
6353919|NCT00636077|7262462|FG001|STARTED|Week 2||3
6353920|NCT00636077|7262463|FG002|STARTED|Week 2||3
6353921|NCT00636077|7262464|FG003|STARTED|Week 2||3
6353922|NCT00636077|7262461|FG000|COMPLETED|Week 2||3
6353923|NCT00636077|7262462|FG001|COMPLETED|Week 2||3
6353924|NCT00636077|7262463|FG002|COMPLETED|Week 2||3
6353925|NCT00636077|7262464|FG003|COMPLETED|Week 2||3
6353926|NCT00636077|7262461|FG000|NOT COMPLETED|Week 2||0
6353927|NCT00636077|7262462|FG001|NOT COMPLETED|Week 2||0
6353928|NCT00636077|7262463|FG002|NOT COMPLETED|Week 2||0
6353929|NCT00636077|7262464|FG003|NOT COMPLETED|Week 2||0
6353930|NCT00636077|7262461|FG000|STARTED|Week 3||3
6353931|NCT00636077|7262462|FG001|STARTED|Week 3||3
6353932|NCT00636077|7262463|FG002|STARTED|Week 3||3
6353933|NCT00636077|7262464|FG003|STARTED|Week 3||3
6353934|NCT00636077|7262461|FG000|COMPLETED|Week 3||3
6559821|NCT01783743|7482561|FG000|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||46
6353935|NCT00636077|7262462|FG001|COMPLETED|Week 3||3
6353936|NCT00636077|7262463|FG002|COMPLETED|Week 3||3
6353937|NCT00636077|7262464|FG003|COMPLETED|Week 3||3
6353938|NCT00636077|7262461|FG000|NOT COMPLETED|Week 3||0
6353939|NCT00636077|7262462|FG001|NOT COMPLETED|Week 3||0
6353940|NCT00636077|7262463|FG002|NOT COMPLETED|Week 3||0
6353941|NCT00636077|7262464|FG003|NOT COMPLETED|Week 3||0
6353942|NCT00636077|7262461|FG000|STARTED|Week 4||3
6353943|NCT00636077|7262462|FG001|STARTED|Week 4||3
6353944|NCT00636077|7262463|FG002|STARTED|Week 4||3
6353945|NCT00636077|7262464|FG003|STARTED|Week 4||3
6353946|NCT00636077|7262461|FG000|COMPLETED|Week 4||3
6353947|NCT00636077|7262462|FG001|COMPLETED|Week 4||3
6353948|NCT00636077|7262463|FG002|COMPLETED|Week 4||3
6353949|NCT00636077|7262464|FG003|COMPLETED|Week 4||3
6353950|NCT00636077|7262461|FG000|NOT COMPLETED|Week 4||0
6353951|NCT00636077|7262462|FG001|NOT COMPLETED|Week 4||0
6353952|NCT00636077|7262463|FG002|NOT COMPLETED|Week 4||0
6353953|NCT00636077|7262464|FG003|NOT COMPLETED|Week 4||0
6353954|NCT00636155|7262474|FG000|STARTED|Overall Study||20
6353955|NCT00636155|7262474|FG000|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
6353956|NCT00636155|7262474|FG000|NOT COMPLETED|Overall Study||18
6353957|NCT00636168|7262480|FG000|STARTED|Randomized to Study Drug||475
6353958|NCT00636168|7262481|FG001|STARTED|Randomized to Study Drug||476
6353959|NCT00636168|7262480|FG000|COMPLETED|Randomized to Study Drug||471
6353960|NCT00636168|7262481|FG001|COMPLETED|Randomized to Study Drug||474
6353961|NCT00636168|7262480|FG000|NOT COMPLETED|Randomized to Study Drug||4
6353962|NCT00636168|7262481|FG001|NOT COMPLETED|Randomized to Study Drug||2
6353963|NCT00636168|7262480|FG000|STARTED|Treated With Study Drug||471
6353964|NCT00636168|7262481|FG001|STARTED|Treated With Study Drug||474
6353965|NCT00636168|7262480|FG000|COMPLETED|Treated With Study Drug||63
6353966|NCT00636168|7262481|FG001|COMPLETED|Treated With Study Drug||143
6353967|NCT00636168|7262480|FG000|NOT COMPLETED|Treated With Study Drug||408
6353968|NCT00636168|7262481|FG001|NOT COMPLETED|Treated With Study Drug||331
6353969|NCT00636168|7262480|FG000|STARTED|Long Term Follow-Up||141
6353970|NCT00636168|7262481|FG001|STARTED|Long Term Follow-Up||143
6353971|NCT00636168|7262480|FG000|COMPLETED|Long Term Follow-Up||130
6353972|NCT00636168|7262481|FG001|COMPLETED|Long Term Follow-Up||129
6353973|NCT00636168|7262480|FG000|NOT COMPLETED|Long Term Follow-Up||11
6353974|NCT00636168|7262481|FG001|NOT COMPLETED|Long Term Follow-Up||14
6559822|NCT01783743|7482562|FG001|TT Positive Cases Screened by CTA|Rescreening of Subjects by Senior Grader||409
6353975|NCT00636181|7262490|FG000|STARTED|Overall Study||54
6353976|NCT00636181|7262491|FG001|STARTED|Overall Study||53
6353977|NCT00636181|7262492|FG002|STARTED|Overall Study||57
6353978|NCT00636181|7262490|FG000|COMPLETED|Overall Study||46
6353979|NCT00636181|7262491|FG001|COMPLETED|Overall Study||47
6353980|NCT00636181|7262492|FG002|COMPLETED|Overall Study||47
6353981|NCT00636181|7262490|FG000|NOT COMPLETED|Overall Study||8
6353982|NCT00636181|7262491|FG001|NOT COMPLETED|Overall Study||6
6353983|NCT00636181|7262492|FG002|NOT COMPLETED|Overall Study||10
6353984|NCT00636194|7262502|FG000|STARTED|Overall Study||175
6353985|NCT00636194|7262503|FG001|STARTED|Overall Study||175
6353986|NCT00636194|7262502|FG000|COMPLETED|Overall Study||172
6353987|NCT00636194|7262503|FG001|COMPLETED|Overall Study||175
6353988|NCT00636194|7262502|FG000|NOT COMPLETED|Overall Study||3
6353989|NCT00636194|7262503|FG001|NOT COMPLETED|Overall Study||0
6353990|NCT00636207|7262512|FG000|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
6353991|NCT00636207|7262513|FG001|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
6353992|NCT00636207|7262514|FG002|STARTED|Overall Study||18
6353993|NCT00636207|7262515|FG003|STARTED|Overall Study||6
6353994|NCT00636207|7262516|FG004|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
6353995|NCT00636207|7262517|FG005|STARTED|Overall Study||1
6353996|NCT00636207|7262518|FG006|STARTED|Overall Study||3
6353997|NCT00636207|7262512|FG000|COMPLETED|Overall Study||0
6353998|NCT00636207|7262513|FG001|COMPLETED|Overall Study||7
6353999|NCT00636207|7262514|FG002|COMPLETED|Overall Study||18
6354000|NCT00636207|7262515|FG003|COMPLETED|Overall Study||6
6354001|NCT00636207|7262516|FG004|COMPLETED|Overall Study||8
6354002|NCT00636207|7262517|FG005|COMPLETED|Overall Study||1
6354003|NCT00636207|7262518|FG006|COMPLETED|Overall Study||3
6354004|NCT00636207|7262512|FG000|NOT COMPLETED|Overall Study||1
6354005|NCT00636207|7262513|FG001|NOT COMPLETED|Overall Study||1
6354006|NCT00636207|7262514|FG002|NOT COMPLETED|Overall Study||0
6354007|NCT00636207|7262515|FG003|NOT COMPLETED|Overall Study||0
6354008|NCT00636207|7262516|FG004|NOT COMPLETED|Overall Study||1
6354009|NCT00636207|7262517|FG005|NOT COMPLETED|Overall Study||0
6354010|NCT00636207|7262518|FG006|NOT COMPLETED|Overall Study||0
6354011|NCT00636220|7262539|FG000|STARTED|Overall Study||101
6354012|NCT00636220|7262539|FG000|COMPLETED|Overall Study||101
6354013|NCT00636220|7262539|FG000|NOT COMPLETED|Overall Study||0
6354014|NCT00636363|7262546|FG000|STARTED|Overall Study||178
6354015|NCT00636363|7262547|FG001|STARTED|Overall Study||176
6354016|NCT00636363|7262548|FG002|STARTED|Overall Study||181
6354017|NCT00636363|7262546|FG000|COMPLETED|Overall Study||165
6354018|NCT00636363|7262547|FG001|COMPLETED|Overall Study||156
6354019|NCT00636363|7262548|FG002|COMPLETED|Overall Study||163
6354020|NCT00636363|7262546|FG000|NOT COMPLETED|Overall Study||13
6354021|NCT00636363|7262547|FG001|NOT COMPLETED|Overall Study||20
6354022|NCT00636363|7262548|FG002|NOT COMPLETED|Overall Study||18
6354023|NCT00636389|7262556|FG000|STARTED|Period 1 - 1 Week||7
6354024|NCT00636389|7262557|FG001|STARTED|Period 1 - 1 Week||5
6354025|NCT00636389|7262556|FG000|COMPLETED|Period 1 - 1 Week||7
6354026|NCT00636389|7262557|FG001|COMPLETED|Period 1 - 1 Week||5
6354027|NCT00636389|7262556|FG000|NOT COMPLETED|Period 1 - 1 Week||0
6354028|NCT00636389|7262557|FG001|NOT COMPLETED|Period 1 - 1 Week||0
6354029|NCT00636389|7262556|FG000|STARTED|Period 2 - 1 Week||7
6354030|NCT00636389|7262557|FG001|STARTED|Period 2 - 1 Week||5
6354031|NCT00636389|7262556|FG000|COMPLETED|Period 2 - 1 Week||7
6354032|NCT00636389|7262557|FG001|COMPLETED|Period 2 - 1 Week||5
6354033|NCT00636389|7262556|FG000|NOT COMPLETED|Period 2 - 1 Week||0
6354034|NCT00636389|7262557|FG001|NOT COMPLETED|Period 2 - 1 Week||0
6354035|NCT00636441|7262570|FG000|STARTED|Overall Study||6
6354036|NCT00636441|7262571|FG001|STARTED|Overall Study||7
6354037|NCT00636441|7262572|FG002|STARTED|Overall Study||6
6354038|NCT00636441|7262573|FG003|STARTED|Overall Study||6
6354039|NCT00636441|7262574|FG004|STARTED|Overall Study||6
6354040|NCT00636441|7262575|FG005|STARTED|Overall Study||7
6354041|NCT00636441|7262576|FG006|STARTED|Overall Study||18
6354042|NCT00636441|7262570|FG000|Assigned Treatment|Overall Study||6
6354043|NCT00636441|7262571|FG001|Assigned Treatment|Overall Study||7
6354044|NCT00636441|7262572|FG002|Assigned Treatment|Overall Study||6
6354045|NCT00636441|7262573|FG003|Assigned Treatment|Overall Study||6
6354046|NCT00636441|7262574|FG004|Assigned Treatment|Overall Study||6
6354047|NCT00636441|7262575|FG005|Assigned Treatment|Overall Study||7
6354048|NCT00636441|7262576|FG006|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
6354049|NCT00636441|7262570|FG000|COMPLETED|Overall Study||6
6354050|NCT00636441|7262571|FG001|COMPLETED|Overall Study||6
6354051|NCT00636441|7262572|FG002|COMPLETED|Overall Study||5
6354052|NCT00636441|7262573|FG003|COMPLETED|Overall Study||6
6354053|NCT00636441|7262574|FG004|COMPLETED|Overall Study||6
6354054|NCT00636441|7262575|FG005|COMPLETED|Overall Study||6
6354055|NCT00636441|7262576|FG006|COMPLETED|Overall Study||0
6354056|NCT00636441|7262570|FG000|NOT COMPLETED|Overall Study||0
6354057|NCT00636441|7262571|FG001|NOT COMPLETED|Overall Study||1
6354058|NCT00636441|7262572|FG002|NOT COMPLETED|Overall Study||1
6354059|NCT00636441|7262573|FG003|NOT COMPLETED|Overall Study||0
6354060|NCT00636441|7262574|FG004|NOT COMPLETED|Overall Study||0
6354061|NCT00636441|7262575|FG005|NOT COMPLETED|Overall Study||1
6354062|NCT00636441|7262576|FG006|NOT COMPLETED|Overall Study||18
6354063|NCT00636506|7262587|FG000|STARTED|Overall Study||76
6354064|NCT00636506|7262587|FG000|COMPLETED|Overall Study||60
6354065|NCT00636506|7262587|FG000|NOT COMPLETED|Overall Study||16
6354066|NCT00636610|7262611|FG000|STARTED|Overall Study||98
6354067|NCT00636610|7262612|FG001|STARTED|Overall Study||101
6354068|NCT00636610|7262611|FG000|COMPLETED|Overall Study||6
6354069|NCT00636610|7262612|FG001|COMPLETED|Overall Study||18
6354070|NCT00636610|7262611|FG000|NOT COMPLETED|Overall Study||92
6354071|NCT00636610|7262612|FG001|NOT COMPLETED|Overall Study||83
6354072|NCT00636636|7262622|FG000|STARTED|Overall Study||221
6354073|NCT00636636|7262623|FG001|STARTED|Overall Study||231
6354074|NCT00636636|7262622|FG000|Safety & Efficacy of Gabapentin ER|Overall Study||186
6354075|NCT00636636|7262623|FG001|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
6354076|NCT00636636|7262622|FG000|379|Overall Study||186
6376913|NCT00761657|7287528|FG000|STARTED|Part 1 (up to Day 57)||0
6354077|NCT00636636|7262623|FG001|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
6354078|NCT00636636|7262622|FG000|COMPLETED|Overall Study||185
6354079|NCT00636636|7262623|FG001|COMPLETED|Overall Study||192
6354080|NCT00636636|7262622|FG000|NOT COMPLETED|Overall Study||36
6354081|NCT00636636|7262623|FG001|NOT COMPLETED|Overall Study||39
6354082|NCT00636649|7262631|FG000|STARTED|Overall Study||20
6354083|NCT00636649|7262632|FG001|STARTED|Overall Study||20
6354084|NCT00636649|7262631|FG000|COMPLETED|Overall Study||20
6559823|NCT01783743|7482561|FG000|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1721
6559824|NCT01783743|7482562|FG001|Random Sample From Non TT Cases by CTA|Rescreening of Subjects by Senior Grader||1786
6559825|NCT01783743|7482561|FG000|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||846
6559826|NCT01783743|7482562|FG001|Random Sample From Subject Absent at MDA|Rescreening of Subjects by Senior Grader||849
6559827|NCT01783743|7482561|FG000|COMPLETED|Rescreening of Subjects by Senior Grader||2613
6559828|NCT01783743|7482562|FG001|COMPLETED|Rescreening of Subjects by Senior Grader||3044
6559829|NCT01783743|7482561|FG000|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10896
6559830|NCT01783743|7482562|FG001|NOT COMPLETED|Rescreening of Subjects by Senior Grader||10920
6559831|NCT01783821|7482570|FG000|STARTED|Overall Study||30
6559832|NCT01783821|7482571|FG001|STARTED|Overall Study||31
6559833|NCT01783821|7482570|FG000|COMPLETED|Overall Study||29
6559834|NCT01783821|7482571|FG001|COMPLETED|Overall Study||30
6559835|NCT01783821|7482570|FG000|NOT COMPLETED|Overall Study||1
6559836|NCT01783821|7482571|FG001|NOT COMPLETED|Overall Study||1
6559837|NCT01783847|7482580|FG000|STARTED|Overall Study||85
6354085|NCT00636649|7262632|FG001|COMPLETED|Overall Study||20
6354086|NCT00636649|7262631|FG000|NOT COMPLETED|Overall Study||0
6354087|NCT00636649|7262632|FG001|NOT COMPLETED|Overall Study||0
6354088|NCT00636675|7262644|FG000|STARTED|Overall Study||951
6354089|NCT00636675|7262645|FG001|STARTED|Overall Study||775
6354090|NCT00636675|7262644|FG000|COMPLETED|Overall Study||811
6354091|NCT00636675|7262645|FG001|COMPLETED|Overall Study||734
6354092|NCT00636675|7262644|FG000|NOT COMPLETED|Overall Study||140
6354093|NCT00636675|7262645|FG001|NOT COMPLETED|Overall Study||41
6354094|NCT00636701|7262653|FG000|STARTED|Overall Study||2
6354095|NCT00636701|7262654|FG001|STARTED|Overall Study||2
6354096|NCT00636701|7262653|FG000|COMPLETED|Overall Study||2
6354097|NCT00636701|7262654|FG001|COMPLETED|Overall Study||2
6354098|NCT00636701|7262653|FG000|NOT COMPLETED|Overall Study||0
6354099|NCT00636701|7262654|FG001|NOT COMPLETED|Overall Study||0
6354100|NCT00636792|7262660|FG000|STARTED|Overall Study||73
6354101|NCT00636792|7262660|FG000|COMPLETED|Overall Study||40
6354102|NCT00636792|7262660|FG000|NOT COMPLETED|Overall Study||33
6354103|NCT00636805|7262664|FG000|STARTED|Overall Study||63
6354104|NCT00636805|7262664|FG000|COMPLETED|Overall Study||63
6354105|NCT00636805|7262664|FG000|NOT COMPLETED|Overall Study||0
6354106|NCT00636818|7262668|FG000|STARTED|Overall Study||45
6354107|NCT00636818|7262668|FG000|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
6354108|NCT00636818|7262668|FG000|COMPLETED|Overall Study||34
6354109|NCT00636818|7262668|FG000|NOT COMPLETED|Overall Study||11
6354110|NCT00636961|7262674|FG000|STARTED|Period 1||14
6354111|NCT00636961|7262675|FG001|STARTED|Period 1||13
6354112|NCT00636961|7262674|FG000|COMPLETED|Period 1||13
6354113|NCT00636961|7262675|FG001|COMPLETED|Period 1||12
6354114|NCT00636961|7262674|FG000|NOT COMPLETED|Period 1||1
6354115|NCT00636961|7262675|FG001|NOT COMPLETED|Period 1||1
6354116|NCT00636961|7262674|FG000|STARTED|Period 2||13
6354117|NCT00636961|7262675|FG001|STARTED|Period 2||12
6354118|NCT00636961|7262674|FG000|COMPLETED|Period 2||12
6354119|NCT00636961|7262675|FG001|COMPLETED|Period 2||12
6354120|NCT00636961|7262674|FG000|NOT COMPLETED|Period 2||1
6354121|NCT00636961|7262675|FG001|NOT COMPLETED|Period 2||0
6354122|NCT00636987|7262681|FG000|STARTED|Overall Study||297
6354123|NCT00636987|7262681|FG000|COMPLETED|Overall Study||108
6354124|NCT00636987|7262681|FG000|NOT COMPLETED|Overall Study||189
6354125|NCT00637000|7262691|FG000|STARTED|Overall Study|Randomized and treated|20
6354126|NCT00637000|7262692|FG001|STARTED|Overall Study|Randomized and treated|18
6354127|NCT00637000|7262691|FG000|Evaluable|Overall Study||18
6354128|NCT00637000|7262692|FG001|Evaluable|Overall Study||16
6354129|NCT00637000|7262691|FG000|COMPLETED|Overall Study||16
6354130|NCT00637000|7262692|FG001|COMPLETED|Overall Study||15
6354131|NCT00637000|7262691|FG000|NOT COMPLETED|Overall Study||4
6354132|NCT00637000|7262692|FG001|NOT COMPLETED|Overall Study||3
6354133|NCT00637156|7262700|FG000|STARTED|Overall Study||209
6354134|NCT00637156|7262701|FG001|STARTED|Overall Study||188
6354135|NCT00637156|7262700|FG000|COMPLETED|Overall Study||199
6354136|NCT00637156|7262701|FG001|COMPLETED|Overall Study||164
6354137|NCT00637156|7262700|FG000|NOT COMPLETED|Overall Study||10
6354138|NCT00637156|7262701|FG001|NOT COMPLETED|Overall Study||24
6354139|NCT00637195|7262709|FG000|STARTED|Overall Study||76
6354140|NCT00637195|7262710|FG001|STARTED|Overall Study||76
6354141|NCT00637195|7262709|FG000|COMPLETED|Overall Study||73
6354142|NCT00637195|7262710|FG001|COMPLETED|Overall Study||75
6559838|NCT01783847|7482581|FG001|STARTED|Overall Study||16
6354143|NCT00637195|7262709|FG000|NOT COMPLETED|Overall Study||3
6354144|NCT00637195|7262710|FG001|NOT COMPLETED|Overall Study||1
6354145|NCT00637247|7262718|FG000|STARTED|Overall Study||72
6354146|NCT00637247|7262719|FG001|STARTED|Overall Study||70
6354147|NCT00637247|7262718|FG000|COMPLETED|Overall Study||72
6559839|NCT01783847|7482582|FG002|STARTED|Overall Study||16
6354148|NCT00637247|7262719|FG001|COMPLETED|Overall Study||70
6354149|NCT00637247|7262718|FG000|NOT COMPLETED|Overall Study||0
6354150|NCT00637247|7262719|FG001|NOT COMPLETED|Overall Study||0
6354151|NCT00637273|7262730|FG000|STARTED|Overall Study||170
6354152|NCT00637273|7262731|FG001|STARTED|Overall Study||172
6354153|NCT00637273|7262732|FG002|STARTED|Overall Study||172
6354154|NCT00637273|7262730|FG000|Intent to Treat (ITT)|Overall Study||160
6354155|NCT00637273|7262731|FG001|Intent to Treat (ITT)|Overall Study||166
6354156|NCT00637273|7262732|FG002|Intent to Treat (ITT)|Overall Study||165
6354157|NCT00637273|7262730|FG000|COMPLETED|Overall Study||127
6354158|NCT00637273|7262731|FG001|COMPLETED|Overall Study||144
6354159|NCT00637273|7262732|FG002|COMPLETED|Overall Study||131
6354160|NCT00637273|7262730|FG000|NOT COMPLETED|Overall Study||43
6354161|NCT00637273|7262731|FG001|NOT COMPLETED|Overall Study||28
6354162|NCT00637273|7262732|FG002|NOT COMPLETED|Overall Study||41
6354163|NCT00637299|7262742|FG000|STARTED|Overall Study||10
6354164|NCT00637299|7262743|FG001|STARTED|Overall Study||10
6354165|NCT00637299|7262742|FG000|COMPLETED|Overall Study||10
6354166|NCT00637299|7262743|FG001|COMPLETED|Overall Study||10
6354167|NCT00637299|7262742|FG000|NOT COMPLETED|Overall Study||0
6354168|NCT00637299|7262743|FG001|NOT COMPLETED|Overall Study||0
6354169|NCT00637377|7262753|FG000|STARTED|Overall Study||303
6354170|NCT00637377|7262754|FG001|STARTED|Overall Study||313
6354171|NCT00637377|7262755|FG002|STARTED|Overall Study||311
6354172|NCT00637377|7262756|FG003|STARTED|Overall Study||313
6354173|NCT00637377|7262753|FG000|Participants Received Treatment|Overall Study|safety population|291
6354174|NCT00637377|7262754|FG001|Participants Received Treatment|Overall Study|safety population|309
6354175|NCT00637377|7262755|FG002|Participants Received Treatment|Overall Study|safety population|297
6354176|NCT00637377|7262756|FG003|Participants Received Treatment|Overall Study|safety population|307
6354177|NCT00637377|7262753|FG000|Participants Treated (FAS)|Overall Study||291
6354178|NCT00637377|7262754|FG001|Participants Treated (FAS)|Overall Study||309
6354179|NCT00637377|7262755|FG002|Participants Treated (FAS)|Overall Study||296
6354180|NCT00637377|7262756|FG003|Participants Treated (FAS)|Overall Study||306
6354181|NCT00637377|7262753|FG000|COMPLETED|Overall Study||276
6354182|NCT00637377|7262754|FG001|COMPLETED|Overall Study||281
6354183|NCT00637377|7262755|FG002|COMPLETED|Overall Study||274
6354184|NCT00637377|7262756|FG003|COMPLETED|Overall Study||284
6354185|NCT00637377|7262753|FG000|NOT COMPLETED|Overall Study||27
6354186|NCT00637377|7262754|FG001|NOT COMPLETED|Overall Study||32
6354187|NCT00637377|7262755|FG002|NOT COMPLETED|Overall Study||37
6354188|NCT00637377|7262756|FG003|NOT COMPLETED|Overall Study||29
6354189|NCT00637494|7262768|FG000|STARTED|Overall Study||141
6354190|NCT00637494|7262769|FG001|STARTED|Overall Study||151
6354191|NCT00637494|7262768|FG000|COMPLETED|Overall Study||109
6354192|NCT00637494|7262769|FG001|COMPLETED|Overall Study||108
6354193|NCT00637494|7262768|FG000|NOT COMPLETED|Overall Study||32
6354194|NCT00637494|7262769|FG001|NOT COMPLETED|Overall Study||43
6354195|NCT00637572|7262777|FG000|STARTED|Overall Study||32
6354196|NCT00637572|7262778|FG001|STARTED|Overall Study||31
6354197|NCT00637572|7262777|FG000|COMPLETED|Overall Study||29
6354198|NCT00637572|7262778|FG001|COMPLETED|Overall Study||24
6354199|NCT00637572|7262777|FG000|NOT COMPLETED|Overall Study||3
6354200|NCT00637572|7262778|FG001|NOT COMPLETED|Overall Study||7
6354201|NCT00637780|7262784|FG000|STARTED|Overall Study||2
6354202|NCT00637780|7262784|FG000|COMPLETED|Overall Study||2
6354203|NCT00637780|7262784|FG000|NOT COMPLETED|Overall Study||0
6354204|NCT00637923|7262790|FG000|STARTED|Overall Study||75
6354205|NCT00637923|7262791|FG001|STARTED|Overall Study||37
6354206|NCT00637923|7262790|FG000|COMPLETED|Overall Study||45
6559840|NCT01783847|7482580|FG000|COMPLETED|Overall Study||69
6559841|NCT01783847|7482581|FG001|COMPLETED|Overall Study||15
6559842|NCT01783847|7482582|FG002|COMPLETED|Overall Study||16
6559843|NCT01783847|7482580|FG000|NOT COMPLETED|Overall Study||16
6559844|NCT01783847|7482581|FG001|NOT COMPLETED|Overall Study||1
6559845|NCT01783847|7482582|FG002|NOT COMPLETED|Overall Study||0
6559846|NCT01783860|7482595|FG000|STARTED|Overall Study||50
6559847|NCT01783860|7482596|FG001|STARTED|Overall Study||50
6559848|NCT01783860|7482595|FG000|COMPLETED|Overall Study||50
6559849|NCT01783860|7482596|FG001|COMPLETED|Overall Study||50
6354207|NCT00637923|7262791|FG001|COMPLETED|Overall Study||18
6354208|NCT00637923|7262790|FG000|NOT COMPLETED|Overall Study||30
6354209|NCT00637923|7262791|FG001|NOT COMPLETED|Overall Study||19
6354210|NCT00638014|7262799|FG000|STARTED|Overall Study||23
6354211|NCT00638014|7262800|FG001|STARTED|Overall Study||28
6354212|NCT00638014|7262799|FG000|COMPLETED|Overall Study||23
6354213|NCT00638014|7262800|FG001|COMPLETED|Overall Study||28
6354214|NCT00638014|7262799|FG000|NOT COMPLETED|Overall Study||0
6354215|NCT00638014|7262800|FG001|NOT COMPLETED|Overall Study||0
6354216|NCT00638027|7262808|FG000|STARTED|Overall Study||11
6354217|NCT00638027|7262809|FG001|STARTED|Overall Study||10
6354218|NCT00638027|7262808|FG000|COMPLETED|Overall Study||11
6354219|NCT00638027|7262809|FG001|COMPLETED|Overall Study|all 10 included in analyses|8
6354220|NCT00638027|7262808|FG000|NOT COMPLETED|Overall Study||0
6354221|NCT00638027|7262809|FG001|NOT COMPLETED|Overall Study||2
6354222|NCT00638157|7262817|FG000|STARTED|Overall Study||12
6559850|NCT01783860|7482595|FG000|NOT COMPLETED|Overall Study||0
6559851|NCT01783860|7482596|FG001|NOT COMPLETED|Overall Study||0
6559852|NCT01783886|7482605|FG000|STARTED|Overall Study||127
6354223|NCT00638157|7262818|FG001|STARTED|Overall Study||12
6354224|NCT00638157|7262817|FG000|Treated|Overall Study||10
6559853|NCT01783886|7482606|FG001|STARTED|Overall Study||127
6354225|NCT00638157|7262818|FG001|Treated|Overall Study||12
6354226|NCT00638157|7262817|FG000|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
6354227|NCT00638157|7262818|FG001|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
6354228|NCT00638157|7262817|FG000|NOT COMPLETED|Overall Study||7
6354229|NCT00638157|7262818|FG001|NOT COMPLETED|Overall Study||4
6354230|NCT00638183|7262825|FG000|STARTED|Overall Study||385
6354231|NCT00638183|7262825|FG000|COMPLETED|Overall Study||266
6354232|NCT00638183|7262825|FG000|NOT COMPLETED|Overall Study||119
6354233|NCT00638235|7262838|FG000|STARTED|Overall Study||141
6354234|NCT00638235|7262839|FG001|STARTED|Overall Study||26
6354235|NCT00638235|7262840|FG002|STARTED|Overall Study||81
6354236|NCT00638235|7262841|FG003|STARTED|Overall Study||56
6354237|NCT00638235|7262842|FG004|STARTED|Overall Study||55
6354238|NCT00638235|7262843|FG005|STARTED|Overall Study||139
6354239|NCT00638235|7262844|FG006|STARTED|Overall Study||23
6354240|NCT00638235|7262845|FG007|STARTED|Overall Study||35
6354241|NCT00638235|7262846|FG008|STARTED|Overall Study||142
6354242|NCT00638235|7262838|FG000|COMPLETED|Overall Study||110
6354243|NCT00638235|7262839|FG001|COMPLETED|Overall Study||23
6354244|NCT00638235|7262840|FG002|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
6354245|NCT00638235|7262841|FG003|COMPLETED|Overall Study||46
6354246|NCT00638235|7262842|FG004|COMPLETED|Overall Study||42
6354247|NCT00638235|7262843|FG005|COMPLETED|Overall Study||113
6354248|NCT00638235|7262844|FG006|COMPLETED|Overall Study||23
6354249|NCT00638235|7262845|FG007|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
6354250|NCT00638235|7262846|FG008|COMPLETED|Overall Study||124
6354251|NCT00638235|7262838|FG000|NOT COMPLETED|Overall Study||31
6354252|NCT00638235|7262839|FG001|NOT COMPLETED|Overall Study||3
6354253|NCT00638235|7262840|FG002|NOT COMPLETED|Overall Study||18
6354254|NCT00638235|7262841|FG003|NOT COMPLETED|Overall Study||10
6354255|NCT00638235|7262842|FG004|NOT COMPLETED|Overall Study||13
6354256|NCT00638235|7262843|FG005|NOT COMPLETED|Overall Study||26
6354257|NCT00638235|7262844|FG006|NOT COMPLETED|Overall Study||0
6354258|NCT00638235|7262845|FG007|NOT COMPLETED|Overall Study||1
6354259|NCT00638235|7262846|FG008|NOT COMPLETED|Overall Study||18
6354260|NCT00638274|7262875|FG000|STARTED|Overall Study||179
6354261|NCT00638274|7262876|FG001|STARTED|Overall Study||177
6354262|NCT00638274|7262875|FG000|COMPLETED|Overall Study||173
6354263|NCT00638274|7262876|FG001|COMPLETED|Overall Study||172
6354264|NCT00638274|7262875|FG000|NOT COMPLETED|Overall Study||6
6354265|NCT00638274|7262876|FG001|NOT COMPLETED|Overall Study||5
6354266|NCT00638365|7262885|FG000|STARTED|Overall Study||9
6354267|NCT00638365|7262886|FG001|STARTED|Overall Study||10
6354268|NCT00638365|7262887|FG002|STARTED|Overall Study||8
6354269|NCT00638365|7262885|FG000|COMPLETED|Overall Study||9
6354270|NCT00638365|7262886|FG001|COMPLETED|Overall Study||10
6354271|NCT00638365|7262887|FG002|COMPLETED|Overall Study||8
6354272|NCT00638365|7262885|FG000|NOT COMPLETED|Overall Study||0
6354273|NCT00638365|7262886|FG001|NOT COMPLETED|Overall Study||0
6354274|NCT00638365|7262887|FG002|NOT COMPLETED|Overall Study||0
6354275|NCT00638378|7262895|FG000|STARTED|Overall Study||22
6354276|NCT00638378|7262895|FG000|COMPLETED|Overall Study||0
6354277|NCT00638378|7262895|FG000|NOT COMPLETED|Overall Study||22
6354278|NCT00638404|7262901|FG000|STARTED|Overall Study||200
6354279|NCT00638404|7262902|FG001|STARTED|Overall Study||100
6354280|NCT00638404|7262901|FG000|COMPLETED|Overall Study||192
6354281|NCT00638404|7262902|FG001|COMPLETED|Overall Study||100
6354282|NCT00638404|7262901|FG000|NOT COMPLETED|Overall Study||8
6354283|NCT00638404|7262902|FG001|NOT COMPLETED|Overall Study||0
6354284|NCT00638443|7262912|FG000|STARTED|First Intervention||14
6354285|NCT00638443|7262913|FG001|STARTED|First Intervention||15
6354286|NCT00638443|7262912|FG000|COMPLETED|First Intervention||12
6354287|NCT00638443|7262913|FG001|COMPLETED|First Intervention||14
6354288|NCT00638443|7262912|FG000|NOT COMPLETED|First Intervention||2
6354289|NCT00638443|7262913|FG001|NOT COMPLETED|First Intervention||1
6354290|NCT00638443|7262912|FG000|STARTED|Washout||12
6354291|NCT00638443|7262913|FG001|STARTED|Washout||14
6354292|NCT00638443|7262912|FG000|COMPLETED|Washout||12
6354293|NCT00638443|7262913|FG001|COMPLETED|Washout||14
6354294|NCT00638443|7262912|FG000|NOT COMPLETED|Washout||0
6354295|NCT00638443|7262913|FG001|NOT COMPLETED|Washout||0
6354296|NCT00638443|7262912|FG000|STARTED|Second Intervention||12
6354297|NCT00638443|7262913|FG001|STARTED|Second Intervention||14
6354298|NCT00638443|7262912|FG000|COMPLETED|Second Intervention||12
6354299|NCT00638443|7262913|FG001|COMPLETED|Second Intervention||14
6354300|NCT00638443|7262912|FG000|NOT COMPLETED|Second Intervention||0
6354301|NCT00638443|7262913|FG001|NOT COMPLETED|Second Intervention||0
6354302|NCT00638456|7262923|FG000|STARTED|Overall Study||21
6354303|NCT00638456|7262924|FG001|STARTED|Overall Study||11
6354304|NCT00638456|7262923|FG000|COMPLETED|Overall Study||15
6354305|NCT00638456|7262924|FG001|COMPLETED|Overall Study||9
6354306|NCT00638456|7262923|FG000|NOT COMPLETED|Overall Study||6
6354307|NCT00638456|7262924|FG001|NOT COMPLETED|Overall Study||2
6354308|NCT00638508|7262932|FG000|STARTED|Overall Study||35
6354309|NCT00638508|7262933|FG001|STARTED|Overall Study||32
6354310|NCT00638508|7262932|FG000|COMPLETED|Overall Study||30
6354311|NCT00638508|7262933|FG001|COMPLETED|Overall Study||30
6354312|NCT00638508|7262932|FG000|NOT COMPLETED|Overall Study||5
6354313|NCT00638508|7262933|FG001|NOT COMPLETED|Overall Study||2
6354314|NCT00638651|7262943|FG000|STARTED|Overall Study||3
6354315|NCT00638651|7262943|FG000|COMPLETED|Overall Study||3
6354316|NCT00638651|7262943|FG000|NOT COMPLETED|Overall Study||0
6354317|NCT00638690|7262950|FG000|STARTED|Overall Study||797
6354318|NCT00638690|7262951|FG001|STARTED|Overall Study||398
6354319|NCT00638690|7262950|FG000|COMPLETED|Overall Study||116
6354320|NCT00638690|7262951|FG001|COMPLETED|Overall Study||56
6354321|NCT00638690|7262950|FG000|NOT COMPLETED|Overall Study||681
6354322|NCT00638690|7262951|FG001|NOT COMPLETED|Overall Study||342
6354323|NCT00638716|7262961|FG000|STARTED|Overall Study||50
6354324|NCT00638716|7262962|FG001|STARTED|Overall Study||52
6354325|NCT00638716|7262963|FG002|STARTED|Overall Study||58
6354326|NCT00638716|7262961|FG000|COMPLETED|Overall Study||43
6354327|NCT00638716|7262962|FG001|COMPLETED|Overall Study||37
6354328|NCT00638716|7262963|FG002|COMPLETED|Overall Study||46
6354329|NCT00638716|7262961|FG000|NOT COMPLETED|Overall Study||7
6354330|NCT00638716|7262962|FG001|NOT COMPLETED|Overall Study||15
6354331|NCT00638716|7262963|FG002|NOT COMPLETED|Overall Study||12
6354332|NCT00638820|7262971|FG000|STARTED|Overall Study||3
6354333|NCT00638820|7262971|FG000|COMPLETED|Overall Study||3
6354334|NCT00638820|7262971|FG000|NOT COMPLETED|Overall Study||0
6354335|NCT00638846|7262977|FG000|STARTED|Overall Study||137
6354336|NCT00638846|7262978|FG001|STARTED|Overall Study||139
6354337|NCT00638846|7262977|FG000|COMPLETED|Overall Study||133
6354338|NCT00638846|7262978|FG001|COMPLETED|Overall Study||133
6354339|NCT00638846|7262977|FG000|NOT COMPLETED|Overall Study||4
6354340|NCT00638846|7262978|FG001|NOT COMPLETED|Overall Study||6
6354341|NCT00638885|7262984|FG000|STARTED|Overall Study||142
6354342|NCT00638885|7262984|FG000|COMPLETED|Overall Study||142
6354343|NCT00638885|7262984|FG000|NOT COMPLETED|Overall Study||0
6354344|NCT00638924|7262988|FG000|STARTED|Overall Study||40
6354345|NCT00638924|7262988|FG000|2 Months|Overall Study||40
6354346|NCT00638924|7262988|FG000|COMPLETED|Overall Study||40
6354347|NCT00638924|7262988|FG000|NOT COMPLETED|Overall Study||0
6354348|NCT00638937|7262992|FG000|STARTED|Overall Study||37
6354349|NCT00638937|7262992|FG000|COMPLETED|Overall Study||37
6354350|NCT00638937|7262992|FG000|NOT COMPLETED|Overall Study||0
6354351|NCT00638963|7263000|FG000|STARTED|Overall Study|Received randomized treatment assignment|3
6354352|NCT00638963|7263001|FG001|STARTED|Overall Study|Received randomized treatment assignment|3
6354353|NCT00638963|7263000|FG000|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
6354354|NCT00638963|7263001|FG001|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
6354355|NCT00638963|7263000|FG000|NOT COMPLETED|Overall Study||1
6354356|NCT00638963|7263001|FG001|NOT COMPLETED|Overall Study||0
6376914|NCT00761657|7287529|FG001|STARTED|Part 1 (up to Day 57)||0
6376915|NCT00761657|7287530|FG002|STARTED|Part 1 (up to Day 57)||12
6376916|NCT00761657|7287531|FG003|STARTED|Part 1 (up to Day 57)||10
6376917|NCT00761657|7287532|FG004|STARTED|Part 1 (up to Day 57)||0
6376918|NCT00761657|7287533|FG005|STARTED|Part 1 (up to Day 57)||0
6376919|NCT00761657|7287534|FG006|STARTED|Part 1 (up to Day 57)||1
6376920|NCT00761657|7287535|FG007|STARTED|Part 1 (up to Day 57)||2
6376921|NCT00761657|7287536|FG008|STARTED|Part 1 (up to Day 57)||10
6376922|NCT00761657|7287528|FG000|Safety Population|Part 1 (up to Day 57)||0
6376923|NCT00761657|7287529|FG001|Safety Population|Part 1 (up to Day 57)||0
6376924|NCT00761657|7287530|FG002|Safety Population|Part 1 (up to Day 57)||12
6376925|NCT00761657|7287531|FG003|Safety Population|Part 1 (up to Day 57)||9
6376926|NCT00761657|7287532|FG004|Safety Population|Part 1 (up to Day 57)||0
6376927|NCT00761657|7287533|FG005|Safety Population|Part 1 (up to Day 57)||0
6376928|NCT00761657|7287534|FG006|Safety Population|Part 1 (up to Day 57)||1
6376929|NCT00761657|7287535|FG007|Safety Population|Part 1 (up to Day 57)||2
6376930|NCT00761657|7287536|FG008|Safety Population|Part 1 (up to Day 57)||10
6376931|NCT00761657|7287528|FG000|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
6376932|NCT00761657|7287529|FG001|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
6376933|NCT00761657|7287530|FG002|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
6376934|NCT00761657|7287531|FG003|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||5
6376935|NCT00761657|7287532|FG004|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
6376936|NCT00761657|7287533|FG005|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
6376937|NCT00761657|7287534|FG006|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||0
6376938|NCT00761657|7287535|FG007|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||1
6376939|NCT00761657|7287536|FG008|Efficacy Evaluable (EE) Population|Part 1 (up to Day 57)||6
6376940|NCT00761657|7287528|FG000|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
6376941|NCT00761657|7287529|FG001|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
6376942|NCT00761657|7287530|FG002|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||5
6376943|NCT00761657|7287531|FG003|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||3
6376944|NCT00761657|7287532|FG004|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
6376945|NCT00761657|7287533|FG005|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
6376946|NCT00761657|7287534|FG006|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||1
6376947|NCT00761657|7287535|FG007|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||2
6376948|NCT00761657|7287536|FG008|Pharmacokinetic (PK) Population|Part 1 (up to Day 57)||0
6376949|NCT00761657|7287528|FG000|COMPLETED|Part 1 (up to Day 57)||0
6376950|NCT00761657|7287529|FG001|COMPLETED|Part 1 (up to Day 57)||0
6376951|NCT00761657|7287530|FG002|COMPLETED|Part 1 (up to Day 57)||8
6376952|NCT00761657|7287531|FG003|COMPLETED|Part 1 (up to Day 57)||4
6376953|NCT00761657|7287532|FG004|COMPLETED|Part 1 (up to Day 57)||0
6354357|NCT00638989|7263010|FG000|STARTED|Overall Study||10
6354358|NCT00638989|7263011|FG001|STARTED|Overall Study||10
6354359|NCT00638989|7263012|FG002|STARTED|Overall Study||10
6354360|NCT00638989|7263010|FG000|COMPLETED|Overall Study||10
6354361|NCT00638989|7263011|FG001|COMPLETED|Overall Study||10
6354362|NCT00638989|7263012|FG002|COMPLETED|Overall Study||9
6354363|NCT00638989|7263010|FG000|NOT COMPLETED|Overall Study||0
6354364|NCT00638989|7263011|FG001|NOT COMPLETED|Overall Study||0
6354365|NCT00638989|7263012|FG002|NOT COMPLETED|Overall Study||1
6354366|NCT00639002|7263022|FG000|STARTED|Overall Study||13
6354367|NCT00639002|7263022|FG000|Received Ruxolitinib|Overall Study||13
6354368|NCT00639002|7263022|FG000|Received Ruxolitinib + Dexamethasone|Overall Study||7
6354369|NCT00639002|7263022|FG000|COMPLETED|Overall Study||0
6354370|NCT00639002|7263022|FG000|NOT COMPLETED|Overall Study||13
6354371|NCT00639093|7263029|FG000|STARTED|Overall Study|45|45
6354372|NCT00639093|7263030|FG001|STARTED|Overall Study|46|46
6354373|NCT00639093|7263029|FG000|COMPLETED|Overall Study|45|45
6354374|NCT00639093|7263030|FG001|COMPLETED|Overall Study|46|46
6354375|NCT00639093|7263029|FG000|NOT COMPLETED|Overall Study||0
6354376|NCT00639093|7263030|FG001|NOT COMPLETED|Overall Study||0
6354377|NCT00639158|7263038|FG000|STARTED|Overall Study|All randomized subjects were treated.|272
6354378|NCT00639158|7263039|FG001|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
6354379|NCT00639158|7263038|FG000|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
6354380|NCT00639158|7263039|FG001|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
6354381|NCT00639158|7263038|FG000|NOT COMPLETED|Overall Study||26
6354382|NCT00639158|7263039|FG001|NOT COMPLETED|Overall Study||30
6354383|NCT00639223|7263047|FG000|STARTED|Overall Study||22
6354384|NCT00639223|7263048|FG001|STARTED|Overall Study||21
6354385|NCT00639223|7263047|FG000|COMPLETED|Overall Study||22
6354386|NCT00639223|7263048|FG001|COMPLETED|Overall Study||19
6354387|NCT00639223|7263047|FG000|NOT COMPLETED|Overall Study||0
6354388|NCT00639223|7263048|FG001|NOT COMPLETED|Overall Study||2
6354389|NCT00639379|7263054|FG000|STARTED|Period 1 - 2 Weeks||44
6354390|NCT00639379|7263055|FG001|STARTED|Period 1 - 2 Weeks||45
6354391|NCT00639379|7263054|FG000|COMPLETED|Period 1 - 2 Weeks||39
6354392|NCT00639379|7263055|FG001|COMPLETED|Period 1 - 2 Weeks||45
6354393|NCT00639379|7263054|FG000|NOT COMPLETED|Period 1 - 2 Weeks||5
6354394|NCT00639379|7263055|FG001|NOT COMPLETED|Period 1 - 2 Weeks||0
6354395|NCT00639379|7263054|FG000|STARTED|Period 2 - 2 Weeks||39
6354396|NCT00639379|7263055|FG001|STARTED|Period 2 - 2 Weeks||45
6354397|NCT00639379|7263054|FG000|COMPLETED|Period 2 - 2 Weeks||39
6354398|NCT00639379|7263055|FG001|COMPLETED|Period 2 - 2 Weeks||45
6354399|NCT00639379|7263054|FG000|NOT COMPLETED|Period 2 - 2 Weeks||0
6354400|NCT00639379|7263055|FG001|NOT COMPLETED|Period 2 - 2 Weeks||0
6354401|NCT00639418|7263065|FG000|STARTED|Overall Study||28101
6354402|NCT00639418|7263066|FG001|STARTED|Overall Study||35967
6354403|NCT00639418|7263067|FG002|STARTED|Overall Study||36496
6354404|NCT00639418|7263068|FG003|STARTED|Overall Study||46930
6354405|NCT00639418|7263065|FG000|COMPLETED|Overall Study||28101
6354406|NCT00639418|7263066|FG001|COMPLETED|Overall Study||35967
6354407|NCT00639418|7263067|FG002|COMPLETED|Overall Study||36496
6354408|NCT00639418|7263068|FG003|COMPLETED|Overall Study||46930
6354409|NCT00639418|7263065|FG000|NOT COMPLETED|Overall Study||0
6354410|NCT00639418|7263066|FG001|NOT COMPLETED|Overall Study||0
6354411|NCT00639418|7263067|FG002|NOT COMPLETED|Overall Study||0
6354412|NCT00639418|7263068|FG003|NOT COMPLETED|Overall Study||0
6354413|NCT00639457|7263084|FG000|STARTED|Overall Study||22
6354414|NCT00639457|7263085|FG001|STARTED|Overall Study||22
6354415|NCT00639457|7263084|FG000|COMPLETED|Overall Study||20
6354416|NCT00639457|7263085|FG001|COMPLETED|Overall Study||19
6354417|NCT00639457|7263084|FG000|NOT COMPLETED|Overall Study||2
6354418|NCT00639457|7263085|FG001|NOT COMPLETED|Overall Study||3
6354419|NCT00639509|7263091|FG000|STARTED|Overall Study||24
6354420|NCT00639509|7263091|FG000|COMPLETED|Overall Study||23
6354421|NCT00639509|7263091|FG000|NOT COMPLETED|Overall Study||1
6354422|NCT00639678|7263099|FG000|STARTED|Overall Study||74
6354423|NCT00639678|7263100|FG001|STARTED|Overall Study||6
6354424|NCT00639678|7263101|FG002|STARTED|Overall Study||217
6354425|NCT00639678|7263102|FG003|STARTED|Overall Study||23
6354426|NCT00639678|7263099|FG000|COMPLETED|Overall Study||70
6354427|NCT00639678|7263100|FG001|COMPLETED|Overall Study||5
6354428|NCT00639678|7263101|FG002|COMPLETED|Overall Study||206
6354429|NCT00639678|7263102|FG003|COMPLETED|Overall Study||23
6354430|NCT00639678|7263099|FG000|NOT COMPLETED|Overall Study||4
6354431|NCT00639678|7263100|FG001|NOT COMPLETED|Overall Study||1
6354432|NCT00639678|7263101|FG002|NOT COMPLETED|Overall Study||11
6354433|NCT00639678|7263102|FG003|NOT COMPLETED|Overall Study||0
6354434|NCT00639717|7263114|FG000|STARTED|Overall Study||48
6354435|NCT00639717|7263114|FG000|COMPLETED|Overall Study||48
6354436|NCT00639717|7263114|FG000|NOT COMPLETED|Overall Study||0
6354437|NCT00639769|7263118|FG000|STARTED|Overall Study||40
6354438|NCT00639769|7263118|FG000|COMPLETED|Overall Study||0
6354439|NCT00639769|7263118|FG000|NOT COMPLETED|Overall Study||40
6354440|NCT00639860|7263122|FG000|STARTED|Overall Study||10
6354441|NCT00639860|7263122|FG000|COMPLETED|Overall Study||10
6354442|NCT00639860|7263122|FG000|NOT COMPLETED|Overall Study||0
6354443|NCT00640016|7263130|FG000|STARTED|Overall Study||3
6354444|NCT00640016|7263131|FG001|STARTED|Overall Study||3
6354445|NCT00640016|7263132|FG002|STARTED|Overall Study||4
6354446|NCT00640016|7263133|FG003|STARTED|Overall Study||4
6354447|NCT00640016|7263130|FG000|Treated|Overall Study||3
6354448|NCT00640016|7263131|FG001|Treated|Overall Study||2
6354449|NCT00640016|7263132|FG002|Treated|Overall Study||4
6354450|NCT00640016|7263133|FG003|Treated|Overall Study||4
6354451|NCT00640016|7263130|FG000|COMPLETED|Overall Study||1
6354452|NCT00640016|7263131|FG001|COMPLETED|Overall Study||1
6354453|NCT00640016|7263132|FG002|COMPLETED|Overall Study||1
6354454|NCT00640016|7263133|FG003|COMPLETED|Overall Study||1
6354455|NCT00640016|7263130|FG000|NOT COMPLETED|Overall Study||2
6354456|NCT00640016|7263131|FG001|NOT COMPLETED|Overall Study||2
6354457|NCT00640016|7263132|FG002|NOT COMPLETED|Overall Study||3
6354458|NCT00640016|7263133|FG003|NOT COMPLETED|Overall Study||3
6354459|NCT00640042|7263150|FG000|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
6354460|NCT00640042|7263150|FG000|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
6354461|NCT00640042|7263150|FG000|NOT COMPLETED|Enrollment||83
6354462|NCT00640042|7263150|FG000|STARTED|Treatment||1487
6354463|NCT00640042|7263150|FG000|COMPLETED|Treatment||561
6354464|NCT00640042|7263150|FG000|NOT COMPLETED|Treatment||926
6354465|NCT00640133|7263156|FG000|STARTED|Randomization Phase (Baseline-Month 3)||15
6354466|NCT00640133|7263157|FG001|STARTED|Randomization Phase (Baseline-Month 3)||12
6354467|NCT00640133|7263156|FG000|COMPLETED|Randomization Phase (Baseline-Month 3)||15
6354468|NCT00640133|7263157|FG001|COMPLETED|Randomization Phase (Baseline-Month 3)||12
6354469|NCT00640133|7263156|FG000|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
6354470|NCT00640133|7263157|FG001|NOT COMPLETED|Randomization Phase (Baseline-Month 3)||0
6354471|NCT00640133|7263156|FG000|STARTED|Open Label Phase (Month 4-12)||27
6354472|NCT00640133|7263157|FG001|STARTED|Open Label Phase (Month 4-12)||0
6354473|NCT00640133|7263156|FG000|COMPLETED|Open Label Phase (Month 4-12)||24
6354474|NCT00640133|7263157|FG001|COMPLETED|Open Label Phase (Month 4-12)||0
6559854|NCT01783886|7482607|FG002|STARTED|Overall Study||127
6559855|NCT01783886|7482605|FG000|Participants Received Treatment|Overall Study||127
6559856|NCT01783886|7482606|FG001|Participants Received Treatment|Overall Study||127
6559857|NCT01783886|7482607|FG002|Participants Received Treatment|Overall Study||124
6559858|NCT01783886|7482605|FG000|COMPLETED|Overall Study||122
6559859|NCT01783886|7482606|FG001|COMPLETED|Overall Study||116
6559860|NCT01783886|7482607|FG002|COMPLETED|Overall Study||117
6559861|NCT01783886|7482605|FG000|NOT COMPLETED|Overall Study||5
6354475|NCT00640133|7263156|FG000|NOT COMPLETED|Open Label Phase (Month 4-12)||3
6354476|NCT00640133|7263157|FG001|NOT COMPLETED|Open Label Phase (Month 4-12)||0
6354477|NCT00640146|7263167|FG000|STARTED|Overall Study||19
6354478|NCT00640146|7263168|FG001|STARTED|Overall Study||18
6354479|NCT00640146|7263167|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
6354480|NCT00640146|7263168|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
6354481|NCT00640146|7263167|FG000|COMPLETED|Overall Study||15
6354482|NCT00640146|7263168|FG001|COMPLETED|Overall Study||12
6354483|NCT00640146|7263167|FG000|NOT COMPLETED|Overall Study||4
6354484|NCT00640146|7263168|FG001|NOT COMPLETED|Overall Study||6
6354485|NCT00640224|7263178|FG000|STARTED|Overall Study||23
6354486|NCT00640224|7263179|FG001|STARTED|Overall Study||23
6354487|NCT00640224|7263180|FG002|STARTED|Overall Study||0
6559862|NCT01783886|7482606|FG001|NOT COMPLETED|Overall Study||11
6559863|NCT01783886|7482607|FG002|NOT COMPLETED|Overall Study||10
6559864|NCT01783912|7482618|FG000|STARTED|Overall Study||118
6559865|NCT01783912|7482619|FG001|STARTED|Overall Study||104
6559866|NCT01783912|7482620|FG002|STARTED|Overall Study||48
6559867|NCT01783912|7482618|FG000|COMPLETED|Overall Study||88
6559868|NCT01783912|7482619|FG001|COMPLETED|Overall Study||58
6559869|NCT01783912|7482620|FG002|COMPLETED|Overall Study||25
6776447|NCT03836677|7704495|FG000|COMPLETED|Period 1||13
6776448|NCT03836677|7704496|FG001|COMPLETED|Period 1||9
6354488|NCT00640224|7263181|FG003|STARTED|Overall Study||0
6354489|NCT00640224|7263178|FG000|COMPLETED|Overall Study||17
6354490|NCT00640224|7263179|FG001|COMPLETED|Overall Study||20
6354491|NCT00640224|7263180|FG002|COMPLETED|Overall Study||0
6354492|NCT00640224|7263181|FG003|COMPLETED|Overall Study||0
6354493|NCT00640224|7263178|FG000|NOT COMPLETED|Overall Study||6
6354494|NCT00640224|7263179|FG001|NOT COMPLETED|Overall Study||3
6354495|NCT00640224|7263180|FG002|NOT COMPLETED|Overall Study||0
6354496|NCT00640224|7263181|FG003|NOT COMPLETED|Overall Study||0
6354497|NCT00640250|7263191|FG000|STARTED|Overall Study||48
6354498|NCT00640250|7263191|FG000|COMPLETED|Overall Study||48
6354499|NCT00640250|7263191|FG000|NOT COMPLETED|Overall Study||0
6354500|NCT00640289|7263294|FG000|STARTED|Overall Study||72
6354501|NCT00640289|7263294|FG000|COMPLETED|Overall Study||59
6354502|NCT00640289|7263294|FG000|NOT COMPLETED|Overall Study||13
6354503|NCT00640315|7263300|FG000|STARTED|Overall Study||10
6354504|NCT00640315|7263301|FG001|STARTED|Overall Study||13
6354505|NCT00640315|7263300|FG000|Participants Received Treatment|Overall Study||10
6354506|NCT00640315|7263301|FG001|Participants Received Treatment|Overall Study||13
6354507|NCT00640315|7263300|FG000|COMPLETED|Overall Study||10
6354508|NCT00640315|7263301|FG001|COMPLETED|Overall Study||12
6354509|NCT00640315|7263300|FG000|NOT COMPLETED|Overall Study||0
6354510|NCT00640315|7263301|FG001|NOT COMPLETED|Overall Study||1
6354511|NCT00640328|7263313|FG000|STARTED|First Treatment Period (Weeks 0-24)||8
6559870|NCT01783912|7482618|FG000|NOT COMPLETED|Overall Study||30
6559871|NCT01783912|7482619|FG001|NOT COMPLETED|Overall Study||46
6559872|NCT01783912|7482620|FG002|NOT COMPLETED|Overall Study||23
6776449|NCT03836677|7704495|FG000|NOT COMPLETED|Period 1||0
6354512|NCT00640328|7263314|FG001|STARTED|First Treatment Period (Weeks 0-24)||11
6354513|NCT00640328|7263315|FG002|STARTED|First Treatment Period (Weeks 0-24)||7
6354514|NCT00640328|7263316|FG003|STARTED|First Treatment Period (Weeks 0-24)||4
6354515|NCT00640328|7263317|FG004|STARTED|First Treatment Period (Weeks 0-24)||4
6354516|NCT00640328|7263318|FG005|STARTED|First Treatment Period (Weeks 0-24)||4
6354517|NCT00640328|7263313|FG000|COMPLETED|First Treatment Period (Weeks 0-24)||8
6354518|NCT00640328|7263314|FG001|COMPLETED|First Treatment Period (Weeks 0-24)||10
6354519|NCT00640328|7263315|FG002|COMPLETED|First Treatment Period (Weeks 0-24)||7
6354520|NCT00640328|7263316|FG003|COMPLETED|First Treatment Period (Weeks 0-24)||4
6354521|NCT00640328|7263317|FG004|COMPLETED|First Treatment Period (Weeks 0-24)||4
6354522|NCT00640328|7263318|FG005|COMPLETED|First Treatment Period (Weeks 0-24)||4
6354523|NCT00640328|7263313|FG000|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6354524|NCT00640328|7263314|FG001|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
6354525|NCT00640328|7263315|FG002|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6354526|NCT00640328|7263316|FG003|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6354527|NCT00640328|7263317|FG004|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6354528|NCT00640328|7263318|FG005|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
6354529|NCT00640328|7263313|FG000|STARTED|Second Treatment Period (Weeks 24-48)||8
6354530|NCT00640328|7263314|FG001|STARTED|Second Treatment Period (Weeks 24-48)||10
6354531|NCT00640328|7263315|FG002|STARTED|Second Treatment Period (Weeks 24-48)||7
6354532|NCT00640328|7263316|FG003|STARTED|Second Treatment Period (Weeks 24-48)||4
6354533|NCT00640328|7263317|FG004|STARTED|Second Treatment Period (Weeks 24-48)||4
6354534|NCT00640328|7263318|FG005|STARTED|Second Treatment Period (Weeks 24-48)||4
6354535|NCT00640328|7263313|FG000|COMPLETED|Second Treatment Period (Weeks 24-48)||8
6354536|NCT00640328|7263314|FG001|COMPLETED|Second Treatment Period (Weeks 24-48)||10
6354537|NCT00640328|7263315|FG002|COMPLETED|Second Treatment Period (Weeks 24-48)||7
6354538|NCT00640328|7263316|FG003|COMPLETED|Second Treatment Period (Weeks 24-48)||4
6354539|NCT00640328|7263317|FG004|COMPLETED|Second Treatment Period (Weeks 24-48)||3
6354540|NCT00640328|7263318|FG005|COMPLETED|Second Treatment Period (Weeks 24-48)||4
6354541|NCT00640328|7263313|FG000|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6354542|NCT00640328|7263314|FG001|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6354543|NCT00640328|7263315|FG002|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6354544|NCT00640328|7263316|FG003|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6354545|NCT00640328|7263317|FG004|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
6354546|NCT00640328|7263318|FG005|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
6354547|NCT00640328|7263313|FG000|STARTED|IFUP (Week 48 to Individual Termination)||8
6354548|NCT00640328|7263314|FG001|STARTED|IFUP (Week 48 to Individual Termination)||11
6354549|NCT00640328|7263315|FG002|STARTED|IFUP (Week 48 to Individual Termination)||7
6354550|NCT00640328|7263316|FG003|STARTED|IFUP (Week 48 to Individual Termination)||4
6354551|NCT00640328|7263317|FG004|STARTED|IFUP (Week 48 to Individual Termination)||4
6354552|NCT00640328|7263318|FG005|STARTED|IFUP (Week 48 to Individual Termination)||4
6354553|NCT00640328|7263313|FG000|COMPLETED|IFUP (Week 48 to Individual Termination)||8
6354554|NCT00640328|7263314|FG001|COMPLETED|IFUP (Week 48 to Individual Termination)||10
6354555|NCT00640328|7263315|FG002|COMPLETED|IFUP (Week 48 to Individual Termination)||6
6354556|NCT00640328|7263316|FG003|COMPLETED|IFUP (Week 48 to Individual Termination)||3
6354557|NCT00640328|7263317|FG004|COMPLETED|IFUP (Week 48 to Individual Termination)||4
6354558|NCT00640328|7263318|FG005|COMPLETED|IFUP (Week 48 to Individual Termination)||4
6354559|NCT00640328|7263313|FG000|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
6354560|NCT00640328|7263314|FG001|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
6354561|NCT00640328|7263315|FG002|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
6354562|NCT00640328|7263316|FG003|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
6354563|NCT00640328|7263317|FG004|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
6354564|NCT00640328|7263318|FG005|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
6354565|NCT00640341|7263342|FG000|STARTED|Overall Study|All Starting participants were dispensed lenses|170
6354566|NCT00640341|7263343|FG001|STARTED|Overall Study||170
6354567|NCT00640341|7263344|FG002|STARTED|Overall Study||170
6354568|NCT00640341|7263342|FG000|Eligible Participants at Baseline|Overall Study||165
6354569|NCT00640341|7263343|FG001|Eligible Participants at Baseline|Overall Study||167
6354570|NCT00640341|7263344|FG002|Eligible Participants at Baseline|Overall Study||168
6354571|NCT00640341|7263342|FG000|COMPLETED|Overall Study||149
6354572|NCT00640341|7263343|FG001|COMPLETED|Overall Study||165
6354573|NCT00640341|7263344|FG002|COMPLETED|Overall Study||163
6354574|NCT00640341|7263342|FG000|NOT COMPLETED|Overall Study||21
6354575|NCT00640341|7263343|FG001|NOT COMPLETED|Overall Study||5
6354576|NCT00640341|7263344|FG002|NOT COMPLETED|Overall Study||7
6354577|NCT00640393|7263352|FG000|STARTED|Part 1||99
6354578|NCT00640393|7263353|FG001|STARTED|Part 1||0
6354579|NCT00640393|7263354|FG002|STARTED|Part 1||0
6354580|NCT00640393|7263352|FG000|COMPLETED|Part 1||94
6354581|NCT00640393|7263353|FG001|COMPLETED|Part 1||0
6354582|NCT00640393|7263354|FG002|COMPLETED|Part 1||0
6354583|NCT00640393|7263352|FG000|NOT COMPLETED|Part 1||5
6354584|NCT00640393|7263353|FG001|NOT COMPLETED|Part 1||0
6354585|NCT00640393|7263354|FG002|NOT COMPLETED|Part 1||0
6354586|NCT00640393|7263352|FG000|STARTED|Randomization||94
6354587|NCT00640393|7263353|FG001|STARTED|Randomization||0
6354588|NCT00640393|7263354|FG002|STARTED|Randomization||0
6354589|NCT00640393|7263352|FG000|COMPLETED|Randomization||75
6354590|NCT00640393|7263353|FG001|COMPLETED|Randomization||0
6354591|NCT00640393|7263354|FG002|COMPLETED|Randomization||0
6354592|NCT00640393|7263352|FG000|NOT COMPLETED|Randomization||19
6354593|NCT00640393|7263353|FG001|NOT COMPLETED|Randomization||0
6354594|NCT00640393|7263354|FG002|NOT COMPLETED|Randomization||0
6354595|NCT00640393|7263352|FG000|STARTED|Part 2||0
6354596|NCT00640393|7263353|FG001|STARTED|Part 2||37
6354597|NCT00640393|7263354|FG002|STARTED|Part 2||38
6354598|NCT00640393|7263352|FG000|COMPLETED|Part 2||0
6354599|NCT00640393|7263353|FG001|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
6354600|NCT00640393|7263354|FG002|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
6354601|NCT00640393|7263352|FG000|NOT COMPLETED|Part 2||0
6354602|NCT00640393|7263353|FG001|NOT COMPLETED|Part 2||10
6354603|NCT00640393|7263354|FG002|NOT COMPLETED|Part 2||3
6354604|NCT00640510|7263364|FG000|STARTED|Overall Study||17
6354605|NCT00640510|7263365|FG001|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
6354606|NCT00640510|7263364|FG000|COMPLETED|Overall Study||16
6354607|NCT00640510|7263365|FG001|COMPLETED|Overall Study||15
6354608|NCT00640510|7263364|FG000|NOT COMPLETED|Overall Study||1
6354609|NCT00640510|7263365|FG001|NOT COMPLETED|Overall Study||2
6354610|NCT00640562|7263373|FG000|STARTED|Overall Study||109
6354611|NCT00640562|7263374|FG001|STARTED|Overall Study||107
6354612|NCT00640562|7263373|FG000|COMPLETED|Overall Study||91
6354613|NCT00640562|7263374|FG001|COMPLETED|Overall Study||81
6354614|NCT00640562|7263373|FG000|NOT COMPLETED|Overall Study||18
6354615|NCT00640562|7263374|FG001|NOT COMPLETED|Overall Study||26
6354616|NCT00640601|7263380|FG000|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
6354617|NCT00640601|7263380|FG000|COMPLETED|Overall Study||183
6354618|NCT00640601|7263380|FG000|NOT COMPLETED|Overall Study||112
6354619|NCT00640614|7263386|FG000|STARTED|Overall Study||125
6354620|NCT00640614|7263387|FG001|STARTED|Overall Study||110
6354621|NCT00640614|7263386|FG000|COMPLETED|Overall Study||124
6354622|NCT00640614|7263387|FG001|COMPLETED|Overall Study||110
6354623|NCT00640614|7263386|FG000|NOT COMPLETED|Overall Study||1
6354624|NCT00640614|7263387|FG001|NOT COMPLETED|Overall Study||0
6354625|NCT00640653|7263421|FG000|STARTED|Overall Study||131
6354626|NCT00640653|7263422|FG001|STARTED|Overall Study||134
6354627|NCT00640653|7263423|FG002|STARTED|Overall Study||129
6354628|NCT00640653|7263424|FG003|STARTED|Overall Study||134
6354629|NCT00640653|7263425|FG004|STARTED|Overall Study||134
6354630|NCT00640653|7263421|FG000|Followed-up at 3 mo|Overall Study||126
6354631|NCT00640653|7263422|FG001|Followed-up at 3 mo|Overall Study||127
6354632|NCT00640653|7263423|FG002|Followed-up at 3 mo|Overall Study||125
6354633|NCT00640653|7263424|FG003|Followed-up at 3 mo|Overall Study||129
6354634|NCT00640653|7263425|FG004|Followed-up at 3 mo|Overall Study||126
6354635|NCT00640653|7263421|FG000|Followed-up at 6 mo|Overall Study||127
6354636|NCT00640653|7263422|FG001|Followed-up at 6 mo|Overall Study||130
6354637|NCT00640653|7263423|FG002|Followed-up at 6 mo|Overall Study||124
6354638|NCT00640653|7263424|FG003|Followed-up at 6 mo|Overall Study||130
6354639|NCT00640653|7263425|FG004|Followed-up at 6 mo|Overall Study||125
6354640|NCT00640653|7263421|FG000|Followed-up at 12 mo|Overall Study||124
6354641|NCT00640653|7263422|FG001|Followed-up at 12 mo|Overall Study||121
6354642|NCT00640653|7263423|FG002|Followed-up at 12 mo|Overall Study||115
6354643|NCT00640653|7263424|FG003|Followed-up at 12 mo|Overall Study||122
6354644|NCT00640653|7263425|FG004|Followed-up at 12 mo|Overall Study||116
6354645|NCT00640653|7263421|FG000|Followed-up at 18 mo|Overall Study||118
6354646|NCT00640653|7263422|FG001|Followed-up at 18 mo|Overall Study||112
6354647|NCT00640653|7263423|FG002|Followed-up at 18 mo|Overall Study||113
6354648|NCT00640653|7263424|FG003|Followed-up at 18 mo|Overall Study||117
6354649|NCT00640653|7263425|FG004|Followed-up at 18 mo|Overall Study||117
6354650|NCT00640653|7263421|FG000|Followed-up at 24 mo|Overall Study||114
6354651|NCT00640653|7263422|FG001|Followed-up at 24 mo|Overall Study||116
6354652|NCT00640653|7263423|FG002|Followed-up at 24 mo|Overall Study||105
6354653|NCT00640653|7263424|FG003|Followed-up at 24 mo|Overall Study||112
6354654|NCT00640653|7263425|FG004|Followed-up at 24 mo|Overall Study||112
6354655|NCT00640653|7263421|FG000|COMPLETED|Overall Study||128
6354656|NCT00640653|7263422|FG001|COMPLETED|Overall Study||131
6354657|NCT00640653|7263423|FG002|COMPLETED|Overall Study||129
6354658|NCT00640653|7263424|FG003|COMPLETED|Overall Study||132
6354659|NCT00640653|7263425|FG004|COMPLETED|Overall Study||129
6354660|NCT00640653|7263421|FG000|NOT COMPLETED|Overall Study||3
6354661|NCT00640653|7263422|FG001|NOT COMPLETED|Overall Study||3
6354662|NCT00640653|7263423|FG002|NOT COMPLETED|Overall Study||0
6354663|NCT00640653|7263424|FG003|NOT COMPLETED|Overall Study||2
6354664|NCT00640653|7263425|FG004|NOT COMPLETED|Overall Study||5
6354665|NCT00640822|7263440|FG000|STARTED|Overall Study||322
6354666|NCT00640822|7263441|FG001|STARTED|Overall Study||317
6354667|NCT00640822|7263442|FG002|STARTED|Overall Study||102
6354668|NCT00640822|7263440|FG000|COMPLETED|Overall Study||279
6354669|NCT00640822|7263441|FG001|COMPLETED|Overall Study||258
6354670|NCT00640822|7263442|FG002|COMPLETED|Overall Study||77
6354671|NCT00640822|7263440|FG000|NOT COMPLETED|Overall Study||43
6354672|NCT00640822|7263441|FG001|NOT COMPLETED|Overall Study||59
6354673|NCT00640822|7263442|FG002|NOT COMPLETED|Overall Study||25
6354674|NCT00640835|7263452|FG000|STARTED|Overall Study||194
6354675|NCT00640835|7263453|FG001|STARTED|Overall Study||188
6354676|NCT00640835|7263452|FG000|COMPLETED|Overall Study||118
6354677|NCT00640835|7263453|FG001|COMPLETED|Overall Study||131
6354678|NCT00640835|7263452|FG000|NOT COMPLETED|Overall Study||76
6354679|NCT00640835|7263453|FG001|NOT COMPLETED|Overall Study||57
6354680|NCT00640926|7263462|FG000|STARTED|Overall Study||53
6354681|NCT00640926|7263463|FG001|STARTED|Overall Study||52
6354682|NCT00640926|7263464|FG002|STARTED|Overall Study||53
6354683|NCT00640926|7263462|FG000|COMPLETED|Overall Study||45
6354684|NCT00640926|7263463|FG001|COMPLETED|Overall Study||46
6354685|NCT00640926|7263464|FG002|COMPLETED|Overall Study||45
6354686|NCT00640926|7263462|FG000|NOT COMPLETED|Overall Study||8
6354687|NCT00640926|7263463|FG001|NOT COMPLETED|Overall Study||6
6354688|NCT00640926|7263464|FG002|NOT COMPLETED|Overall Study||8
6354689|NCT00640978|7263472|FG000|STARTED|Overall Study||15
6354690|NCT00640978|7263472|FG000|COMPLETED|Overall Study||15
6354691|NCT00640978|7263472|FG000|NOT COMPLETED|Overall Study||0
6354692|NCT00641043|7263478|FG000|STARTED|Overall Study|number who started treatment|130
6354693|NCT00641043|7263479|FG001|STARTED|Overall Study|number who started treatment|259
6354694|NCT00641043|7263478|FG000|COMPLETED|Overall Study|number who completed treatment|111
6354695|NCT00641043|7263479|FG001|COMPLETED|Overall Study|number who completed treatment|244
6354696|NCT00641043|7263478|FG000|NOT COMPLETED|Overall Study||19
6354697|NCT00641043|7263479|FG001|NOT COMPLETED|Overall Study||15
6354698|NCT00641056|7263487|FG000|STARTED|Overall Study||233
6354699|NCT00641056|7263488|FG001|STARTED|Overall Study||234
6354700|NCT00641056|7263487|FG000|Intent to Treat (ITT)|Overall Study||233
6354701|NCT00641056|7263488|FG001|Intent to Treat (ITT)|Overall Study||223
6354702|NCT00641056|7263487|FG000|COMPLETED|Overall Study||204
6354703|NCT00641056|7263488|FG001|COMPLETED|Overall Study||209
6354704|NCT00641056|7263487|FG000|NOT COMPLETED|Overall Study||29
6354705|NCT00641056|7263488|FG001|NOT COMPLETED|Overall Study||25
6354706|NCT00641147|7263500|FG000|STARTED|Completed 4 Months.||21
6354707|NCT00641147|7263501|FG001|STARTED|Completed 4 Months.||23
6354708|NCT00641147|7263500|FG000|COMPLETED|Completed 4 Months.||19
6354709|NCT00641147|7263501|FG001|COMPLETED|Completed 4 Months.||23
6354710|NCT00641147|7263500|FG000|NOT COMPLETED|Completed 4 Months.||2
6354711|NCT00641147|7263501|FG001|NOT COMPLETED|Completed 4 Months.||0
6354712|NCT00641147|7263500|FG000|STARTED|Completed 8 Months.||19
6354713|NCT00641147|7263501|FG001|STARTED|Completed 8 Months.||23
6354714|NCT00641147|7263500|FG000|COMPLETED|Completed 8 Months.||16
6354715|NCT00641147|7263501|FG001|COMPLETED|Completed 8 Months.||21
6354716|NCT00641147|7263500|FG000|NOT COMPLETED|Completed 8 Months.||3
6354717|NCT00641147|7263501|FG001|NOT COMPLETED|Completed 8 Months.||2
6354718|NCT00641147|7263500|FG000|STARTED|Completed 12 Months.||16
6354719|NCT00641147|7263501|FG001|STARTED|Completed 12 Months.||21
6354720|NCT00641147|7263500|FG000|COMPLETED|Completed 12 Months.||15
6354721|NCT00641147|7263501|FG001|COMPLETED|Completed 12 Months.||19
6354722|NCT00641147|7263500|FG000|NOT COMPLETED|Completed 12 Months.||1
6354723|NCT00641147|7263501|FG001|NOT COMPLETED|Completed 12 Months.||2
6354724|NCT00641147|7263500|FG000|STARTED|Completed 16 Months.||15
6354725|NCT00641147|7263501|FG001|STARTED|Completed 16 Months.||19
6354726|NCT00641147|7263500|FG000|COMPLETED|Completed 16 Months.||13
6354727|NCT00641147|7263501|FG001|COMPLETED|Completed 16 Months.||19
6354728|NCT00641147|7263500|FG000|NOT COMPLETED|Completed 16 Months.||2
6354729|NCT00641147|7263501|FG001|NOT COMPLETED|Completed 16 Months.||0
6354730|NCT00641563|7263511|FG000|STARTED|Infusion 1||5
6354731|NCT00641563|7263512|FG001|STARTED|Infusion 1||5
6354732|NCT00641563|7263511|FG000|COMPLETED|Infusion 1||5
6354733|NCT00641563|7263512|FG001|COMPLETED|Infusion 1||5
6354734|NCT00641563|7263511|FG000|NOT COMPLETED|Infusion 1||0
6354735|NCT00641563|7263512|FG001|NOT COMPLETED|Infusion 1||0
6354736|NCT00641563|7263511|FG000|STARTED|Infusion 2||5
6354737|NCT00641563|7263512|FG001|STARTED|Infusion 2||5
6354738|NCT00641563|7263511|FG000|COMPLETED|Infusion 2||5
6354739|NCT00641563|7263512|FG001|COMPLETED|Infusion 2||5
6354740|NCT00641563|7263511|FG000|NOT COMPLETED|Infusion 2||0
6354741|NCT00641563|7263512|FG001|NOT COMPLETED|Infusion 2||0
6354742|NCT00641641|7263518|FG000|STARTED|Overall Study||16
6354743|NCT00641641|7263518|FG000|COMPLETED|Overall Study||16
6354744|NCT00641641|7263518|FG000|NOT COMPLETED|Overall Study||0
6354745|NCT00641667|7263522|FG000|STARTED|Overall Study||66
6354746|NCT00641667|7263522|FG000|COMPLETED|Overall Study||60
6354747|NCT00641667|7263522|FG000|NOT COMPLETED|Overall Study||6
6354748|NCT00641706|7263528|FG000|STARTED|Overall Study||37
6354749|NCT00641706|7263529|FG001|STARTED|Overall Study||7
6354750|NCT00641706|7263528|FG000|COMPLETED|Overall Study||28
6354751|NCT00641706|7263529|FG001|COMPLETED|Overall Study||4
6354752|NCT00641706|7263528|FG000|NOT COMPLETED|Overall Study||9
6354753|NCT00641706|7263529|FG001|NOT COMPLETED|Overall Study||3
6354754|NCT00641719|7263537|FG000|STARTED|Overall Study||129
6354755|NCT00641719|7263538|FG001|STARTED|Overall Study||129
6354756|NCT00641719|7263537|FG000|COMPLETED|Overall Study||99
6354757|NCT00641719|7263538|FG001|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
6354758|NCT00641719|7263537|FG000|NOT COMPLETED|Overall Study||30
6354759|NCT00641719|7263538|FG001|NOT COMPLETED|Overall Study||37
6354760|NCT00641745|7263546|FG000|STARTED|Overall Study||427
6354761|NCT00641745|7263547|FG001|STARTED|Overall Study||202
6354762|NCT00641745|7263546|FG000|COMPLETED|Overall Study||147
6354763|NCT00641745|7263547|FG001|COMPLETED|Overall Study||89
6354764|NCT00641745|7263546|FG000|NOT COMPLETED|Overall Study||280
6354765|NCT00641745|7263547|FG001|NOT COMPLETED|Overall Study||113
6354766|NCT00641797|7263555|FG000|STARTED|Overall Study||11
6354767|NCT00641797|7263556|FG001|STARTED|Overall Study||15
6354768|NCT00641797|7263555|FG000|COMPLETED|Overall Study||11
6354769|NCT00641797|7263556|FG001|COMPLETED|Overall Study||15
6354770|NCT00641797|7263555|FG000|NOT COMPLETED|Overall Study||0
6354771|NCT00641797|7263556|FG001|NOT COMPLETED|Overall Study||0
6354772|NCT00641862|7263564|FG000|STARTED|Overall Study||183
6354773|NCT00641862|7263565|FG001|STARTED|Overall Study||183
6354774|NCT00641862|7263564|FG000|COMPLETED|Overall Study||139
6354775|NCT00641862|7263565|FG001|COMPLETED|Overall Study||145
6354776|NCT00641862|7263564|FG000|NOT COMPLETED|Overall Study||44
6354777|NCT00641862|7263565|FG001|NOT COMPLETED|Overall Study||38
6354778|NCT00642018|7263573|FG000|STARTED|Overall Study||52
6354779|NCT00642018|7263574|FG001|STARTED|Overall Study||102
6354780|NCT00642018|7263573|FG000|Received at Least One Dose of Study Drug|Overall Study||51
6354781|NCT00642018|7263574|FG001|Received at Least One Dose of Study Drug|Overall Study||98
6354782|NCT00642018|7263573|FG000|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|24
6354783|NCT00642018|7263574|FG001|COMPLETED|Overall Study|Participants who completed 10 cycles of treatment.|23
6354784|NCT00642018|7263573|FG000|NOT COMPLETED|Overall Study||28
6354785|NCT00642018|7263574|FG001|NOT COMPLETED|Overall Study||79
6354786|NCT00642174|7263583|FG000|STARTED|Period 1 - Initial Drug||18
6354787|NCT00642174|7263584|FG001|STARTED|Period 1 - Initial Drug||17
6354788|NCT00642174|7263583|FG000|COMPLETED|Period 1 - Initial Drug||18
6354789|NCT00642174|7263584|FG001|COMPLETED|Period 1 - Initial Drug||16
6354790|NCT00642174|7263583|FG000|NOT COMPLETED|Period 1 - Initial Drug||0
6354791|NCT00642174|7263584|FG001|NOT COMPLETED|Period 1 - Initial Drug||1
6354792|NCT00642174|7263583|FG000|STARTED|Period 2 - Crossover Drug||18
6354793|NCT00642174|7263584|FG001|STARTED|Period 2 - Crossover Drug||16
6354794|NCT00642174|7263583|FG000|COMPLETED|Period 2 - Crossover Drug||18
6354795|NCT00642174|7263584|FG001|COMPLETED|Period 2 - Crossover Drug||16
6354796|NCT00642174|7263583|FG000|NOT COMPLETED|Period 2 - Crossover Drug||0
6354797|NCT00642174|7263584|FG001|NOT COMPLETED|Period 2 - Crossover Drug||0
6354798|NCT00642278|7263597|FG000|STARTED|Overall Study||65
6354799|NCT00642278|7263598|FG001|STARTED|Overall Study||64
6354800|NCT00642278|7263599|FG002|STARTED|Overall Study||64
6354801|NCT00642278|7263600|FG003|STARTED|Overall Study||65
6354802|NCT00642278|7263601|FG004|STARTED|Overall Study||64
6354803|NCT00642278|7263602|FG005|STARTED|Overall Study||64
6354804|NCT00642278|7263603|FG006|STARTED|Overall Study||65
6354805|NCT00642278|7263597|FG000|COMPLETED|Overall Study||55
6354806|NCT00642278|7263598|FG001|COMPLETED|Overall Study||59
6354807|NCT00642278|7263599|FG002|COMPLETED|Overall Study||59
6354808|NCT00642278|7263600|FG003|COMPLETED|Overall Study||56
6354809|NCT00642278|7263601|FG004|COMPLETED|Overall Study||56
6354810|NCT00642278|7263602|FG005|COMPLETED|Overall Study||57
6354811|NCT00642278|7263603|FG006|COMPLETED|Overall Study||60
6354812|NCT00642278|7263597|FG000|NOT COMPLETED|Overall Study||10
6354813|NCT00642278|7263598|FG001|NOT COMPLETED|Overall Study||5
6354814|NCT00642278|7263599|FG002|NOT COMPLETED|Overall Study||5
6354815|NCT00642278|7263600|FG003|NOT COMPLETED|Overall Study||9
6354816|NCT00642278|7263601|FG004|NOT COMPLETED|Overall Study||8
6354817|NCT00642278|7263602|FG005|NOT COMPLETED|Overall Study||7
6354818|NCT00642278|7263603|FG006|NOT COMPLETED|Overall Study||5
6354819|NCT00642304|7263619|FG000|STARTED|Overall Study||20
6354820|NCT00642304|7263619|FG000|COMPLETED|Overall Study||14
6354821|NCT00642304|7263619|FG000|NOT COMPLETED|Overall Study||6
6354822|NCT00642356|7263625|FG000|STARTED|Overall Study||7
6354823|NCT00642356|7263626|FG001|STARTED|Overall Study||7
6354824|NCT00642356|7263625|FG000|COMPLETED|Overall Study||5
6354825|NCT00642356|7263626|FG001|COMPLETED|Overall Study||4
6354826|NCT00642356|7263625|FG000|NOT COMPLETED|Overall Study||2
6354827|NCT00642356|7263626|FG001|NOT COMPLETED|Overall Study||3
6354828|NCT00642369|7263634|FG000|STARTED|Overall Study||30
6354829|NCT00642369|7263635|FG001|STARTED|Overall Study||30
6354830|NCT00642369|7263634|FG000|COMPLETED|Overall Study||25
6354831|NCT00642369|7263635|FG001|COMPLETED|Overall Study||24
6354832|NCT00642369|7263634|FG000|NOT COMPLETED|Overall Study||5
6354833|NCT00642369|7263635|FG001|NOT COMPLETED|Overall Study||6
6354834|NCT00642460|7263645|FG000|STARTED|Part I: 12 Week Double-Blind||37
6354835|NCT00642460|7263646|FG001|STARTED|Part I: 12 Week Double-Blind||38
6354836|NCT00642460|7263647|FG002|STARTED|Part I: 12 Week Double-Blind||37
6354837|NCT00642460|7263648|FG003|STARTED|Part I: 12 Week Double-Blind||0
6354838|NCT00642460|7263649|FG004|STARTED|Part I: 12 Week Double-Blind||0
6354839|NCT00642460|7263650|FG005|STARTED|Part I: 12 Week Double-Blind||0
6354840|NCT00642460|7263645|FG000|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
6354841|NCT00642460|7263646|FG001|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
6354842|NCT00642460|7263647|FG002|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
6354843|NCT00642460|7263648|FG003|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
6354844|NCT00642460|7263649|FG004|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
6354845|NCT00642460|7263650|FG005|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
6354846|NCT00642460|7263645|FG000|COMPLETED|Part I: 12 Week Double-Blind||36
6354847|NCT00642460|7263646|FG001|COMPLETED|Part I: 12 Week Double-Blind||37
6354848|NCT00642460|7263647|FG002|COMPLETED|Part I: 12 Week Double-Blind||36
6354849|NCT00642460|7263648|FG003|COMPLETED|Part I: 12 Week Double-Blind||0
6354850|NCT00642460|7263649|FG004|COMPLETED|Part I: 12 Week Double-Blind||0
6354851|NCT00642460|7263650|FG005|COMPLETED|Part I: 12 Week Double-Blind||0
6354852|NCT00642460|7263645|FG000|NOT COMPLETED|Part I: 12 Week Double-Blind||1
6354853|NCT00642460|7263646|FG001|NOT COMPLETED|Part I: 12 Week Double-Blind||1
6354854|NCT00642460|7263647|FG002|NOT COMPLETED|Part I: 12 Week Double-Blind||1
6354855|NCT00642460|7263648|FG003|NOT COMPLETED|Part I: 12 Week Double-Blind||0
6354856|NCT00642460|7263649|FG004|NOT COMPLETED|Part I: 12 Week Double-Blind||0
6354857|NCT00642460|7263650|FG005|NOT COMPLETED|Part I: 12 Week Double-Blind||0
6354858|NCT00642460|7263645|FG000|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
6354859|NCT00642460|7263646|FG001|STARTED|Part II: Open-Label Up to Week 92||40
6354860|NCT00642460|7263647|FG002|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
6354861|NCT00642460|7263648|FG003|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
6354862|NCT00642460|7263649|FG004|STARTED|Part II: Open-Label Up to Week 92||0
6354863|NCT00642460|7263650|FG005|STARTED|Part II: Open-Label Up to Week 92||0
6354864|NCT00642460|7263645|FG000|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
6354865|NCT00642460|7263646|FG001|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
6354866|NCT00642460|7263647|FG002|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
6354867|NCT00642460|7263648|FG003|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
6354868|NCT00642460|7263649|FG004|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
6354869|NCT00642460|7263650|FG005|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
6354870|NCT00642460|7263645|FG000|COMPLETED|Part II: Open-Label Up to Week 92||43
6354871|NCT00642460|7263646|FG001|COMPLETED|Part II: Open-Label Up to Week 92||32
6354872|NCT00642460|7263647|FG002|COMPLETED|Part II: Open-Label Up to Week 92||0
6354873|NCT00642460|7263648|FG003|COMPLETED|Part II: Open-Label Up to Week 92||17
6354874|NCT00642460|7263649|FG004|COMPLETED|Part II: Open-Label Up to Week 92||0
6354875|NCT00642460|7263650|FG005|COMPLETED|Part II: Open-Label Up to Week 92||0
6354876|NCT00642460|7263645|FG000|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
6354877|NCT00642460|7263646|FG001|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
6354878|NCT00642460|7263647|FG002|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
6354879|NCT00642460|7263648|FG003|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
6354880|NCT00642460|7263649|FG004|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
6354881|NCT00642460|7263650|FG005|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
6354882|NCT00642460|7263645|FG000|STARTED|Part III: Open-Label Up to Week 260||0
6354883|NCT00642460|7263646|FG001|STARTED|Part III: Open-Label Up to Week 260||0
6354884|NCT00642460|7263647|FG002|STARTED|Part III: Open-Label Up to Week 260||0
6354885|NCT00642460|7263648|FG003|STARTED|Part III: Open-Label Up to Week 260||0
6354886|NCT00642460|7263649|FG004|STARTED|Part III: Open-Label Up to Week 260||53
6354887|NCT00642460|7263650|FG005|STARTED|Part III: Open-Label Up to Week 260||59
6354888|NCT00642460|7263645|FG000|COMPLETED|Part III: Open-Label Up to Week 260||0
6354889|NCT00642460|7263646|FG001|COMPLETED|Part III: Open-Label Up to Week 260||0
6354890|NCT00642460|7263647|FG002|COMPLETED|Part III: Open-Label Up to Week 260||0
6354891|NCT00642460|7263648|FG003|COMPLETED|Part III: Open-Label Up to Week 260||0
6354892|NCT00642460|7263649|FG004|COMPLETED|Part III: Open-Label Up to Week 260||28
6354893|NCT00642460|7263650|FG005|COMPLETED|Part III: Open-Label Up to Week 260||38
6354894|NCT00642460|7263645|FG000|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
6354895|NCT00642460|7263646|FG001|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
6354896|NCT00642460|7263647|FG002|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
6354897|NCT00642460|7263648|FG003|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
6354898|NCT00642460|7263649|FG004|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
6354899|NCT00642460|7263650|FG005|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
6354900|NCT00642473|7263662|FG000|STARTED|Overall Study||18
6354901|NCT00642473|7263663|FG001|STARTED|Overall Study||16
6354902|NCT00642473|7263662|FG000|COMPLETED|Overall Study||14
6354903|NCT00642473|7263663|FG001|COMPLETED|Overall Study||5
6354904|NCT00642473|7263662|FG000|NOT COMPLETED|Overall Study||4
6354905|NCT00642473|7263663|FG001|NOT COMPLETED|Overall Study||11
6354906|NCT00642616|7263676|FG000|STARTED|Overall Study||9
6354907|NCT00642616|7263677|FG001|STARTED|Overall Study||8
6354908|NCT00642616|7263678|FG002|STARTED|Overall Study||9
6354909|NCT00642616|7263679|FG003|STARTED|Overall Study||8
6354910|NCT00642616|7263676|FG000|COMPLETED|Overall Study||0
6354911|NCT00642616|7263677|FG001|COMPLETED|Overall Study||1
6354912|NCT00642616|7263678|FG002|COMPLETED|Overall Study||0
6354913|NCT00642616|7263679|FG003|COMPLETED|Overall Study||1
6354914|NCT00642616|7263676|FG000|NOT COMPLETED|Overall Study||9
6354915|NCT00642616|7263677|FG001|NOT COMPLETED|Overall Study||7
6354916|NCT00642616|7263678|FG002|NOT COMPLETED|Overall Study||9
6354917|NCT00642616|7263679|FG003|NOT COMPLETED|Overall Study||7
6354918|NCT00642642|7263691|FG000|STARTED|Biopsy & Product Manufacture||122
6354919|NCT00642642|7263691|FG000|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
6354920|NCT00642642|7263691|FG000|NOT COMPLETED|Biopsy & Product Manufacture||13
6354921|NCT00642642|7263691|FG000|STARTED|Treatment & Follow Up||109
6354922|NCT00642642|7263691|FG000|COMPLETED|Treatment & Follow Up||92
6354923|NCT00642642|7263691|FG000|NOT COMPLETED|Treatment & Follow Up||17
6354924|NCT00642668|7263701|FG000|STARTED|Overall Study||35
6354925|NCT00642668|7263701|FG000|COMPLETED|Overall Study||21
6354926|NCT00642668|7263701|FG000|NOT COMPLETED|Overall Study||14
6354927|NCT00642694|7263707|FG000|STARTED|Overall Study||14
6354928|NCT00642694|7263708|FG001|STARTED|Overall Study||15
6354929|NCT00642694|7263707|FG000|COMPLETED|Overall Study||8
6354930|NCT00642694|7263708|FG001|COMPLETED|Overall Study||11
6354931|NCT00642694|7263707|FG000|NOT COMPLETED|Overall Study||6
6354932|NCT00642694|7263708|FG001|NOT COMPLETED|Overall Study||4
6354933|NCT00642707|7263718|FG000|STARTED|Overall Study||11
6354934|NCT00642707|7263719|FG001|STARTED|Overall Study||11
6354935|NCT00642707|7263720|FG002|STARTED|Overall Study||12
6354936|NCT00642707|7263721|FG003|STARTED|Overall Study||10
6354937|NCT00642707|7263718|FG000|COMPLETED|Overall Study||10
6354938|NCT00642707|7263719|FG001|COMPLETED|Overall Study||11
6354939|NCT00642707|7263720|FG002|COMPLETED|Overall Study||12
6354940|NCT00642707|7263721|FG003|COMPLETED|Overall Study||8
6354941|NCT00642707|7263718|FG000|NOT COMPLETED|Overall Study||1
6354942|NCT00642707|7263719|FG001|NOT COMPLETED|Overall Study||0
6354943|NCT00642707|7263720|FG002|NOT COMPLETED|Overall Study||0
6354944|NCT00642707|7263721|FG003|NOT COMPLETED|Overall Study||2
6354945|NCT00642746|7263733|FG000|STARTED|Overall Study||10
6354946|NCT00642746|7263734|FG001|STARTED|Overall Study||1
6354947|NCT00642746|7263733|FG000|COMPLETED|Overall Study||9
6354948|NCT00642746|7263734|FG001|COMPLETED|Overall Study||1
6354949|NCT00642746|7263733|FG000|NOT COMPLETED|Overall Study||1
6354950|NCT00642746|7263734|FG001|NOT COMPLETED|Overall Study||0
6354951|NCT00642759|7263740|FG000|STARTED|Overall Study||36
6354952|NCT00642759|7263740|FG000|COMPLETED|Overall Study||35
6354953|NCT00642759|7263740|FG000|NOT COMPLETED|Overall Study||1
6354954|NCT00642772|7263745|FG000|STARTED|Overall Study||24
6354955|NCT00642772|7263745|FG000|COMPLETED|Overall Study||14
6354956|NCT00642772|7263745|FG000|NOT COMPLETED|Overall Study||10
6354957|NCT00642811|7263755|FG000|STARTED|Overall Study||20
6354958|NCT00642811|7263756|FG001|STARTED|Overall Study||21
6354959|NCT00642811|7263757|FG002|STARTED|Overall Study||13
6354960|NCT00642811|7263758|FG003|STARTED|Overall Study||16
6354961|NCT00642811|7263759|FG004|STARTED|Overall Study||14
6354962|NCT00642811|7263760|FG005|STARTED|Overall Study||14
6354963|NCT00642811|7263755|FG000|COMPLETED|Overall Study||17
6354964|NCT00642811|7263756|FG001|COMPLETED|Overall Study||17
6354965|NCT00642811|7263757|FG002|COMPLETED|Overall Study||13
6354966|NCT00642811|7263758|FG003|COMPLETED|Overall Study||15
6354967|NCT00642811|7263759|FG004|COMPLETED|Overall Study||13
6354968|NCT00642811|7263760|FG005|COMPLETED|Overall Study||13
6354969|NCT00642811|7263755|FG000|NOT COMPLETED|Overall Study||3
6354970|NCT00642811|7263756|FG001|NOT COMPLETED|Overall Study||4
6354971|NCT00642811|7263757|FG002|NOT COMPLETED|Overall Study||0
6354972|NCT00642811|7263758|FG003|NOT COMPLETED|Overall Study||1
6354973|NCT00642811|7263759|FG004|NOT COMPLETED|Overall Study||1
6354974|NCT00642811|7263760|FG005|NOT COMPLETED|Overall Study||1
6354975|NCT00642850|7263774|FG000|STARTED|Overall Study||188
6354976|NCT00642850|7263774|FG000|COMPLETED|Overall Study||155
6354977|NCT00642850|7263774|FG000|NOT COMPLETED|Overall Study||33
6354978|NCT00642902|7263782|FG000|STARTED|Overall Study||63
6354979|NCT00642902|7263783|FG001|STARTED|Overall Study||63
6354980|NCT00642902|7263784|FG002|STARTED|Overall Study||64
6354981|NCT00642902|7263785|FG003|STARTED|Overall Study||65
6354982|NCT00642902|7263782|FG000|Treated|Overall Study||63
6354983|NCT00642902|7263783|FG001|Treated|Overall Study||63
6354984|NCT00642902|7263784|FG002|Treated|Overall Study||63
6354985|NCT00642902|7263785|FG003|Treated|Overall Study||65
6354986|NCT00642902|7263782|FG000|COMPLETED|Overall Study||23
6354987|NCT00642902|7263783|FG001|COMPLETED|Overall Study||21
6354988|NCT00642902|7263784|FG002|COMPLETED|Overall Study||21
6354989|NCT00642902|7263785|FG003|COMPLETED|Overall Study||25
6354990|NCT00642902|7263782|FG000|NOT COMPLETED|Overall Study||40
6354991|NCT00642902|7263783|FG001|NOT COMPLETED|Overall Study||42
6354992|NCT00642902|7263784|FG002|NOT COMPLETED|Overall Study||43
6354993|NCT00642902|7263785|FG003|NOT COMPLETED|Overall Study||40
6354994|NCT00642941|7263807|FG000|STARTED|Overall Study||70
6354995|NCT00642941|7263808|FG001|STARTED|Overall Study||54
6354996|NCT00642941|7263809|FG002|STARTED|Overall Study||7
6354997|NCT00642941|7263810|FG003|STARTED|Overall Study||40
6354998|NCT00642941|7263811|FG004|STARTED|Overall Study||25
6354999|NCT00642941|7263812|FG005|STARTED|Overall Study||41
6355000|NCT00642941|7263813|FG006|STARTED|Overall Study||23
6355001|NCT00642941|7263814|FG007|STARTED|Overall Study||14
6355002|NCT00642941|7263815|FG008|STARTED|Overall Study||11
6355003|NCT00642941|7263816|FG009|STARTED|Overall Study||9
6355004|NCT00642941|7263817|FG010|STARTED|Overall Study||12
6355005|NCT00642941|7263818|FG011|STARTED|Overall Study||11
6355006|NCT00642941|7263807|FG000|COMPLETED|Overall Study||0
6355007|NCT00642941|7263808|FG001|COMPLETED|Overall Study||0
6355008|NCT00642941|7263809|FG002|COMPLETED|Overall Study||0
6355009|NCT00642941|7263810|FG003|COMPLETED|Overall Study||0
6355010|NCT00642941|7263811|FG004|COMPLETED|Overall Study||0
6355011|NCT00642941|7263812|FG005|COMPLETED|Overall Study||0
6355012|NCT00642941|7263813|FG006|COMPLETED|Overall Study||0
6355013|NCT00642941|7263814|FG007|COMPLETED|Overall Study||0
6355014|NCT00642941|7263815|FG008|COMPLETED|Overall Study||0
6355015|NCT00642941|7263816|FG009|COMPLETED|Overall Study||0
6355016|NCT00642941|7263817|FG010|COMPLETED|Overall Study||0
6355017|NCT00642941|7263818|FG011|COMPLETED|Overall Study||0
6355018|NCT00642941|7263807|FG000|NOT COMPLETED|Overall Study||70
6355019|NCT00642941|7263808|FG001|NOT COMPLETED|Overall Study||54
6355020|NCT00642941|7263809|FG002|NOT COMPLETED|Overall Study||7
6355021|NCT00642941|7263810|FG003|NOT COMPLETED|Overall Study||40
6355022|NCT00642941|7263811|FG004|NOT COMPLETED|Overall Study||25
6355023|NCT00642941|7263812|FG005|NOT COMPLETED|Overall Study||41
6355024|NCT00642941|7263813|FG006|NOT COMPLETED|Overall Study||23
6355025|NCT00642941|7263814|FG007|NOT COMPLETED|Overall Study||14
6355026|NCT00642941|7263815|FG008|NOT COMPLETED|Overall Study||11
6355027|NCT00642941|7263816|FG009|NOT COMPLETED|Overall Study||9
6355028|NCT00642941|7263817|FG010|NOT COMPLETED|Overall Study||12
6355029|NCT00642941|7263818|FG011|NOT COMPLETED|Overall Study||11
6355030|NCT00642954|7263870|FG000|STARTED|Overall Study||4
6355031|NCT00642954|7263871|FG001|STARTED|Overall Study||4
6355032|NCT00642954|7263872|FG002|STARTED|Overall Study||3
6355033|NCT00642954|7263873|FG003|STARTED|Overall Study||3
6355034|NCT00642954|7263874|FG004|STARTED|Overall Study||17
6355035|NCT00642954|7263870|FG000|COMPLETED|Overall Study||0
6355036|NCT00642954|7263871|FG001|COMPLETED|Overall Study||0
6355037|NCT00642954|7263872|FG002|COMPLETED|Overall Study||0
6355038|NCT00642954|7263873|FG003|COMPLETED|Overall Study||0
6355039|NCT00642954|7263874|FG004|COMPLETED|Overall Study||1
6355040|NCT00642954|7263870|FG000|NOT COMPLETED|Overall Study||4
6355041|NCT00642954|7263871|FG001|NOT COMPLETED|Overall Study||4
6355042|NCT00642954|7263872|FG002|NOT COMPLETED|Overall Study||3
6355043|NCT00642954|7263873|FG003|NOT COMPLETED|Overall Study||3
6355044|NCT00642954|7263874|FG004|NOT COMPLETED|Overall Study||16
6355045|NCT00642993|7263888|FG000|STARTED|Overall Study||267
6355046|NCT00642993|7263889|FG001|STARTED|Overall Study||134
6355047|NCT00642993|7263888|FG000|COMPLETED|Overall Study||161
6355048|NCT00642993|7263889|FG001|COMPLETED|Overall Study||118
6355049|NCT00642993|7263888|FG000|NOT COMPLETED|Overall Study||106
6355050|NCT00642993|7263889|FG001|NOT COMPLETED|Overall Study||16
6355051|NCT00643006|7263897|FG000|STARTED|Overall Study||34
6355052|NCT00643006|7263898|FG001|STARTED|Overall Study||33
6355053|NCT00643006|7263897|FG000|COMPLETED|Overall Study||29
6355054|NCT00643006|7263898|FG001|COMPLETED|Overall Study||29
6355055|NCT00643006|7263897|FG000|NOT COMPLETED|Overall Study||5
6355056|NCT00643006|7263898|FG001|NOT COMPLETED|Overall Study||4
6355057|NCT00643097|7263909|FG000|STARTED|Overall Study||18
6355058|NCT00643097|7263910|FG001|STARTED|Overall Study||12
6355059|NCT00643097|7263911|FG002|STARTED|Overall Study||10
6355060|NCT00643097|7263909|FG000|COMPLETED|Overall Study||18
6355061|NCT00643097|7263910|FG001|COMPLETED|Overall Study||12
6355062|NCT00643097|7263911|FG002|COMPLETED|Overall Study||10
6355063|NCT00643097|7263909|FG000|NOT COMPLETED|Overall Study||0
6355064|NCT00643097|7263910|FG001|NOT COMPLETED|Overall Study||0
6355065|NCT00643097|7263911|FG002|NOT COMPLETED|Overall Study||0
6355066|NCT00643123|7263921|FG000|STARTED|Overall Study||15
6355067|NCT00643123|7263922|FG001|STARTED|Overall Study||12
6355068|NCT00643123|7263921|FG000|COMPLETED|Overall Study||10
6355069|NCT00643123|7263922|FG001|COMPLETED|Overall Study||11
6355070|NCT00643123|7263921|FG000|NOT COMPLETED|Overall Study||5
6355071|NCT00643123|7263922|FG001|NOT COMPLETED|Overall Study||1
6355072|NCT00643162|7263930|FG000|STARTED|Overall Study||7
6355073|NCT00643162|7263931|FG001|STARTED|Overall Study||5
6355074|NCT00643162|7263930|FG000|COMPLETED|Overall Study||6
6355075|NCT00643162|7263931|FG001|COMPLETED|Overall Study||4
6355076|NCT00643162|7263930|FG000|NOT COMPLETED|Overall Study||1
6355077|NCT00643162|7263931|FG001|NOT COMPLETED|Overall Study||1
6355078|NCT00643201|7263939|FG000|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
6355079|NCT00643201|7263940|FG001|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
6355080|NCT00643201|7263939|FG000|COMPLETED|Randomized, Completed 6 Months of Study||2314
6355081|NCT00643201|7263940|FG001|COMPLETED|Randomized, Completed 6 Months of Study||2291
6355082|NCT00643201|7263939|FG000|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
6355083|NCT00643201|7263940|FG001|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
6355084|NCT00643201|7263939|FG000|STARTED|Completed Study Follow Up||2617
6355085|NCT00643201|7263940|FG001|STARTED|Completed Study Follow Up||2639
6355086|NCT00643201|7263939|FG000|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
6355087|NCT00643201|7263940|FG001|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
6355088|NCT00643201|7263939|FG000|NOT COMPLETED|Completed Study Follow Up||70
6355089|NCT00643201|7263940|FG001|NOT COMPLETED|Completed Study Follow Up||79
6355090|NCT00643279|7263950|FG000|STARTED|Overall Study||134
6355091|NCT00643279|7263951|FG001|STARTED|Overall Study||140
6355092|NCT00643279|7263950|FG000|COMPLETED|Overall Study||118
6355093|NCT00643279|7263951|FG001|COMPLETED|Overall Study||127
6355094|NCT00643279|7263950|FG000|NOT COMPLETED|Overall Study||16
6355095|NCT00643279|7263951|FG001|NOT COMPLETED|Overall Study||13
6355096|NCT00643448|7263962|FG000|STARTED|Overall Study||21
6355097|NCT00643448|7263963|FG001|STARTED|Overall Study||22
6355098|NCT00643448|7263964|FG002|STARTED|Overall Study||22
6355099|NCT00643448|7263962|FG000|COMPLETED|Overall Study||17
6355100|NCT00643448|7263963|FG001|COMPLETED|Overall Study||17
6355101|NCT00643448|7263964|FG002|COMPLETED|Overall Study||16
6355102|NCT00643448|7263962|FG000|NOT COMPLETED|Overall Study||4
6355103|NCT00643448|7263963|FG001|NOT COMPLETED|Overall Study||5
6355104|NCT00643448|7263964|FG002|NOT COMPLETED|Overall Study||6
6355105|NCT00643487|7263974|FG000|STARTED|Overall Study||8
6355106|NCT00643487|7263974|FG000|COMPLETED|Overall Study||5
6355107|NCT00643487|7263974|FG000|NOT COMPLETED|Overall Study||3
6355108|NCT00643565|7263980|FG000|STARTED|Overall Study||80
6355109|NCT00643565|7263981|FG001|STARTED|Overall Study||74
6355110|NCT00643565|7263980|FG000|COMPLETED|Overall Study||7
6355111|NCT00643565|7263981|FG001|COMPLETED|Overall Study||7
6355112|NCT00643565|7263980|FG000|NOT COMPLETED|Overall Study||73
6355113|NCT00643565|7263981|FG001|NOT COMPLETED|Overall Study||67
6355114|NCT00643578|7263988|FG000|STARTED|Overall Study||6
6355115|NCT00643578|7263989|FG001|STARTED|Overall Study||6
6355116|NCT00643578|7263988|FG000|COMPLETED|Overall Study||4
6355117|NCT00643578|7263989|FG001|COMPLETED|Overall Study||6
6355118|NCT00643578|7263988|FG000|NOT COMPLETED|Overall Study||2
6355119|NCT00643578|7263989|FG001|NOT COMPLETED|Overall Study||0
6355120|NCT00643604|7263997|FG000|STARTED|Overall Study||7
6355121|NCT00643604|7263997|FG000|COMPLETED|Overall Study||6
6355122|NCT00643604|7263997|FG000|NOT COMPLETED|Overall Study||1
6355123|NCT00643682|7264003|FG000|STARTED|Overall Study||999
6355124|NCT00643682|7264004|FG001|STARTED|Overall Study||1001
6355125|NCT00643682|7264003|FG000|COMPLETED|Overall Study||477
6355126|NCT00643682|7264004|FG001|COMPLETED|Overall Study||492
6355127|NCT00643682|7264003|FG000|NOT COMPLETED|Overall Study||522
6355128|NCT00643682|7264004|FG001|NOT COMPLETED|Overall Study||509
6355129|NCT00643760|7264015|FG000|STARTED|Overall Study||120
6355130|NCT00643760|7264016|FG001|STARTED|Overall Study||62
6355131|NCT00643760|7264017|FG002|STARTED|Overall Study||56
6355132|NCT00643760|7264018|FG003|STARTED|Overall Study||117
6355133|NCT00643760|7264019|FG004|STARTED|Overall Study||66
6355134|NCT00643760|7264015|FG000|Safety Population/Treated With Drug|Overall Study||120
6355135|NCT00643760|7264016|FG001|Safety Population/Treated With Drug|Overall Study||62
6355136|NCT00643760|7264017|FG002|Safety Population/Treated With Drug|Overall Study||56
6355137|NCT00643760|7264018|FG003|Safety Population/Treated With Drug|Overall Study||116
6355138|NCT00643760|7264019|FG004|Safety Population/Treated With Drug|Overall Study||66
6355139|NCT00643760|7264015|FG000|ITT Population|Overall Study||120
6355140|NCT00643760|7264016|FG001|ITT Population|Overall Study||62
6355141|NCT00643760|7264017|FG002|ITT Population|Overall Study||56
6559873|NCT01783938|7482630|FG000|STARTED|Overall Study||68
6559874|NCT01783938|7482631|FG001|STARTED|Overall Study||70
6559875|NCT01783938|7482630|FG000|COMPLETED|Overall Study||11
6559876|NCT01783938|7482631|FG001|COMPLETED|Overall Study||9
6559877|NCT01783938|7482630|FG000|NOT COMPLETED|Overall Study||57
6355142|NCT00643760|7264018|FG003|ITT Population|Overall Study||116
6355143|NCT00643760|7264019|FG004|ITT Population|Overall Study||66
6355144|NCT00643760|7264015|FG000|COMPLETED|Overall Study||90
6355145|NCT00643760|7264016|FG001|COMPLETED|Overall Study||47
6355146|NCT00643760|7264017|FG002|COMPLETED|Overall Study||37
6355147|NCT00643760|7264018|FG003|COMPLETED|Overall Study||79
6355148|NCT00643760|7264019|FG004|COMPLETED|Overall Study||47
6355149|NCT00643760|7264015|FG000|NOT COMPLETED|Overall Study||30
6355150|NCT00643760|7264016|FG001|NOT COMPLETED|Overall Study||15
6355151|NCT00643760|7264017|FG002|NOT COMPLETED|Overall Study||19
6355152|NCT00643760|7264018|FG003|NOT COMPLETED|Overall Study||38
6355153|NCT00643760|7264019|FG004|NOT COMPLETED|Overall Study||19
6355154|NCT00643851|7264034|FG000|STARTED|Overall Study||194
6355155|NCT00643851|7264035|FG001|STARTED|Overall Study||203
6355156|NCT00643851|7264036|FG002|STARTED|Overall Study||201
6355157|NCT00643851|7264034|FG000|COMPLETED|Overall Study||177
6355158|NCT00643851|7264035|FG001|COMPLETED|Overall Study||170
6355159|NCT00643851|7264036|FG002|COMPLETED|Overall Study||171
6355160|NCT00643851|7264034|FG000|NOT COMPLETED|Overall Study||17
6355161|NCT00643851|7264035|FG001|NOT COMPLETED|Overall Study||33
6355162|NCT00643851|7264036|FG002|NOT COMPLETED|Overall Study||30
6355163|NCT00643916|7264050|FG000|STARTED|Overall Study||55
6355164|NCT00643916|7264051|FG001|STARTED|Overall Study||67
6355165|NCT00643916|7264052|FG002|STARTED|Overall Study||68
6355166|NCT00643916|7264053|FG003|STARTED|Overall Study||62
6355167|NCT00643916|7264054|FG004|STARTED|Overall Study||59
6355168|NCT00643916|7264055|FG005|STARTED|Overall Study||67
6355169|NCT00643916|7264050|FG000|COMPLETED|Overall Study||51
6355170|NCT00643916|7264051|FG001|COMPLETED|Overall Study||61
6355171|NCT00643916|7264052|FG002|COMPLETED|Overall Study||62
6355172|NCT00643916|7264053|FG003|COMPLETED|Overall Study||60
6355173|NCT00643916|7264054|FG004|COMPLETED|Overall Study||57
6355174|NCT00643916|7264055|FG005|COMPLETED|Overall Study||66
6355175|NCT00643916|7264050|FG000|NOT COMPLETED|Overall Study||4
6355176|NCT00643916|7264051|FG001|NOT COMPLETED|Overall Study||6
6355177|NCT00643916|7264052|FG002|NOT COMPLETED|Overall Study||6
6355178|NCT00643916|7264053|FG003|NOT COMPLETED|Overall Study||2
6355179|NCT00643916|7264054|FG004|NOT COMPLETED|Overall Study||2
6355180|NCT00643916|7264055|FG005|NOT COMPLETED|Overall Study||1
6355181|NCT00644059|7264072|FG000|STARTED|Overall Study||2019
6355182|NCT00644059|7264073|FG001|STARTED|Overall Study||1849
6355183|NCT00644059|7264074|FG002|STARTED|Overall Study||1034
6355184|NCT00644059|7264072|FG000|COMPLETED|Overall Study||1895
6355185|NCT00644059|7264073|FG001|COMPLETED|Overall Study||1726
6355186|NCT00644059|7264074|FG002|COMPLETED|Overall Study||969
6355187|NCT00644059|7264072|FG000|NOT COMPLETED|Overall Study||124
6355188|NCT00644059|7264073|FG001|NOT COMPLETED|Overall Study||123
6355189|NCT00644059|7264074|FG002|NOT COMPLETED|Overall Study||65
6355190|NCT00644189|7264123|FG000|STARTED|Phase I||3
6355191|NCT00644189|7264124|FG001|STARTED|Phase I||3
6355192|NCT00644189|7264125|FG002|STARTED|Phase I||6
6559878|NCT01783938|7482631|FG001|NOT COMPLETED|Overall Study||61
6559879|NCT01783990|7482639|FG000|STARTED|Overall Study||130
6559880|NCT01783990|7482640|FG001|STARTED|Overall Study||20
6355193|NCT00644189|7264126|FG003|STARTED|Phase I||18
6355194|NCT00644189|7264123|FG000|COMPLETED|Phase I||3
6355195|NCT00644189|7264124|FG001|COMPLETED|Phase I||3
6355196|NCT00644189|7264125|FG002|COMPLETED|Phase I||6
6355197|NCT00644189|7264126|FG003|COMPLETED|Phase I||18
6355198|NCT00644189|7264123|FG000|NOT COMPLETED|Phase I||0
6355199|NCT00644189|7264124|FG001|NOT COMPLETED|Phase I||0
6355200|NCT00644189|7264125|FG002|NOT COMPLETED|Phase I||0
6355201|NCT00644189|7264126|FG003|NOT COMPLETED|Phase I||0
6355202|NCT00644189|7264123|FG000|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
6355203|NCT00644189|7264124|FG001|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
6355204|NCT00644189|7264125|FG002|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
6355205|NCT00644189|7264126|FG003|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
6355206|NCT00644189|7264123|FG000|Completed All 6 Cycles of Treatment|Phase II||0
6355207|NCT00644189|7264124|FG001|Completed All 6 Cycles of Treatment|Phase II||0
6355208|NCT00644189|7264125|FG002|Completed All 6 Cycles of Treatment|Phase II||0
6355209|NCT00644189|7264126|FG003|Completed All 6 Cycles of Treatment|Phase II||19
6355210|NCT00644189|7264123|FG000|COMPLETED|Phase II||0
6355211|NCT00644189|7264124|FG001|COMPLETED|Phase II||0
6355212|NCT00644189|7264125|FG002|COMPLETED|Phase II||0
6355213|NCT00644189|7264126|FG003|COMPLETED|Phase II||50
6355214|NCT00644189|7264123|FG000|NOT COMPLETED|Phase II||0
6355215|NCT00644189|7264124|FG001|NOT COMPLETED|Phase II||0
6355216|NCT00644189|7264125|FG002|NOT COMPLETED|Phase II||0
6355217|NCT00644189|7264126|FG003|NOT COMPLETED|Phase II||0
6355218|NCT00644280|7264134|FG000|STARTED|Overall Study||6
6355219|NCT00644280|7264135|FG001|STARTED|Overall Study||5
6355220|NCT00644280|7264134|FG000|COMPLETED|Overall Study||6
6355221|NCT00644280|7264135|FG001|COMPLETED|Overall Study||5
6355222|NCT00644280|7264134|FG000|NOT COMPLETED|Overall Study||0
6355223|NCT00644280|7264135|FG001|NOT COMPLETED|Overall Study||0
6355224|NCT00644332|7264141|FG000|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
6355225|NCT00644332|7264141|FG000|COMPLETED|Overall Study||150
6355226|NCT00644332|7264141|FG000|NOT COMPLETED|Overall Study||21
6355227|NCT00644358|7264145|FG000|STARTED|Overall Study||616
6355228|NCT00644358|7264145|FG000|COMPLETED|Overall Study||254
6355229|NCT00644358|7264145|FG000|NOT COMPLETED|Overall Study||362
6355230|NCT00644423|7264151|FG000|STARTED|Overall Study||6
6355231|NCT00644423|7264152|FG001|STARTED|Overall Study||5
6355232|NCT00644423|7264151|FG000|COMPLETED|Overall Study||5
6355233|NCT00644423|7264152|FG001|COMPLETED|Overall Study||4
6355234|NCT00644423|7264151|FG000|NOT COMPLETED|Overall Study||1
6355235|NCT00644423|7264152|FG001|NOT COMPLETED|Overall Study||1
6355236|NCT00644592|7264160|FG000|STARTED|Overall Study||5
6355237|NCT00644592|7264161|FG001|STARTED|Overall Study||6
6355238|NCT00644592|7264160|FG000|COMPLETED|Overall Study||5
6355239|NCT00644592|7264161|FG001|COMPLETED|Overall Study||6
6355240|NCT00644592|7264160|FG000|NOT COMPLETED|Overall Study||0
6355241|NCT00644592|7264161|FG001|NOT COMPLETED|Overall Study||0
6355242|NCT00644657|7264167|FG000|STARTED|Overall Study||27
6355243|NCT00644657|7264167|FG000|COMPLETED|Overall Study||27
6355244|NCT00644657|7264167|FG000|NOT COMPLETED|Overall Study||0
6355245|NCT00644787|7264171|FG000|STARTED|Period 1: Titration Phase||156
6355246|NCT00644787|7264172|FG001|STARTED|Period 1: Titration Phase||0
6355247|NCT00644787|7264173|FG002|STARTED|Period 1: Titration Phase||0
6355248|NCT00644787|7264171|FG000|COMPLETED|Period 1: Titration Phase||129
6355249|NCT00644787|7264172|FG001|COMPLETED|Period 1: Titration Phase||0
6355250|NCT00644787|7264173|FG002|COMPLETED|Period 1: Titration Phase||0
6355251|NCT00644787|7264171|FG000|NOT COMPLETED|Period 1: Titration Phase||27
6355252|NCT00644787|7264172|FG001|NOT COMPLETED|Period 1: Titration Phase||0
6355253|NCT00644787|7264173|FG002|NOT COMPLETED|Period 1: Titration Phase||0
6355254|NCT00644787|7264171|FG000|STARTED|Period 2: Double Blind Phase||0
6355255|NCT00644787|7264172|FG001|STARTED|Period 2: Double Blind Phase||58
6355256|NCT00644787|7264173|FG002|STARTED|Period 2: Double Blind Phase||62
6355257|NCT00644787|7264171|FG000|COMPLETED|Period 2: Double Blind Phase||0
6355258|NCT00644787|7264172|FG001|COMPLETED|Period 2: Double Blind Phase||49
6355259|NCT00644787|7264173|FG002|COMPLETED|Period 2: Double Blind Phase||55
6355260|NCT00644787|7264171|FG000|NOT COMPLETED|Period 2: Double Blind Phase||0
6355261|NCT00644787|7264172|FG001|NOT COMPLETED|Period 2: Double Blind Phase||9
6355262|NCT00644787|7264173|FG002|NOT COMPLETED|Period 2: Double Blind Phase||7
6355263|NCT00644878|7264181|FG000|STARTED|Overall Study||18
6355264|NCT00644878|7264181|FG000|COMPLETED|Overall Study||0
6355265|NCT00644878|7264181|FG000|NOT COMPLETED|Overall Study||18
6355266|NCT00644917|7264185|FG000|STARTED|Overall Study||38
6355267|NCT00644917|7264185|FG000|COMPLETED|Overall Study||36
6355268|NCT00644917|7264185|FG000|NOT COMPLETED|Overall Study||2
6355269|NCT00644969|7264195|FG000|STARTED|Treatment Phase||85
6355270|NCT00644969|7264196|FG001|STARTED|Treatment Phase||43
6355271|NCT00644969|7264195|FG000|COMPLETED|Treatment Phase||71
6355272|NCT00644969|7264196|FG001|COMPLETED|Treatment Phase||40
6355273|NCT00644969|7264195|FG000|NOT COMPLETED|Treatment Phase||14
6355274|NCT00644969|7264196|FG001|NOT COMPLETED|Treatment Phase||3
6355275|NCT00644969|7264195|FG000|STARTED|Post Treatment Phase||71
6355276|NCT00644969|7264196|FG001|STARTED|Post Treatment Phase||40
6355277|NCT00644969|7264195|FG000|COMPLETED|Post Treatment Phase||61
6355278|NCT00644969|7264196|FG001|COMPLETED|Post Treatment Phase||37
6355279|NCT00644969|7264195|FG000|NOT COMPLETED|Post Treatment Phase||10
6355280|NCT00644969|7264196|FG001|NOT COMPLETED|Post Treatment Phase||3
6355281|NCT00644995|7264204|FG000|STARTED|Overall Study||25
6355282|NCT00644995|7264205|FG001|STARTED|Overall Study||27
6355283|NCT00644995|7264204|FG000|Completed 4 Month Assessment|Overall Study||23
6355284|NCT00644995|7264205|FG001|Completed 4 Month Assessment|Overall Study||24
6355285|NCT00644995|7264204|FG000|COMPLETED|Overall Study|Completed 6 month assessment|23
6355286|NCT00644995|7264205|FG001|COMPLETED|Overall Study||23
6355287|NCT00644995|7264204|FG000|NOT COMPLETED|Overall Study||2
6355288|NCT00644995|7264205|FG001|NOT COMPLETED|Overall Study||4
6355289|NCT00645047|7264215|FG000|STARTED|Overall Study||103
6355290|NCT00645047|7264216|FG001|STARTED|Overall Study||104
6355291|NCT00645047|7264215|FG000|Post|Overall Study||74
6355292|NCT00645047|7264216|FG001|Post|Overall Study||80
6355293|NCT00645047|7264215|FG000|COMPLETED|Overall Study|6 month follow up|60
6355294|NCT00645047|7264216|FG001|COMPLETED|Overall Study||65
6355295|NCT00645047|7264215|FG000|NOT COMPLETED|Overall Study||43
6355296|NCT00645047|7264216|FG001|NOT COMPLETED|Overall Study||39
6355297|NCT00645099|7264224|FG000|STARTED|Overall Study||239
6355298|NCT00645099|7264225|FG001|STARTED|Overall Study||220
6355299|NCT00645099|7264224|FG000|COMPLETED|Overall Study||168
6355300|NCT00645099|7264225|FG001|COMPLETED|Overall Study||178
6355301|NCT00645099|7264224|FG000|NOT COMPLETED|Overall Study||71
6355302|NCT00645099|7264225|FG001|NOT COMPLETED|Overall Study||42
6355303|NCT00645164|7264231|FG000|STARTED|Overall Study||59
6355304|NCT00645164|7264231|FG000|COMPLETED|Overall Study||52
6355305|NCT00645164|7264231|FG000|NOT COMPLETED|Overall Study||7
6355306|NCT00645333|7264235|FG000|STARTED|Overall Study||30
6355307|NCT00645333|7264235|FG000|COMPLETED|Overall Study||30
6355308|NCT00645333|7264235|FG000|NOT COMPLETED|Overall Study||0
6355309|NCT00645411|7264243|FG000|STARTED|Overall Study||656
6355310|NCT00645411|7264244|FG001|STARTED|Overall Study||318
6355311|NCT00645411|7264245|FG002|STARTED|Overall Study||1608
6355312|NCT00645411|7264246|FG003|STARTED|Overall Study||1022
6355313|NCT00645411|7264243|FG000|COMPLETED|Overall Study||643
6355314|NCT00645411|7264244|FG001|COMPLETED|Overall Study||312
6355315|NCT00645411|7264245|FG002|COMPLETED|Overall Study||1457
6355316|NCT00645411|7264246|FG003|COMPLETED|Overall Study||919
6355317|NCT00645411|7264243|FG000|NOT COMPLETED|Overall Study||13
6355318|NCT00645411|7264244|FG001|NOT COMPLETED|Overall Study||6
6355319|NCT00645411|7264245|FG002|NOT COMPLETED|Overall Study||151
6355320|NCT00645411|7264246|FG003|NOT COMPLETED|Overall Study||103
6355321|NCT00645450|7264265|FG000|STARTED|Overall Study||5
6355322|NCT00645450|7264266|FG001|STARTED|Overall Study||4
6355323|NCT00645450|7264265|FG000|COMPLETED|Overall Study||5
6355324|NCT00645450|7264266|FG001|COMPLETED|Overall Study||4
6355325|NCT00645450|7264265|FG000|NOT COMPLETED|Overall Study||0
6355326|NCT00645450|7264266|FG001|NOT COMPLETED|Overall Study||0
6376954|NCT00761657|7287533|FG005|COMPLETED|Part 1 (up to Day 57)||0
6376955|NCT00761657|7287534|FG006|COMPLETED|Part 1 (up to Day 57)||0
6376956|NCT00761657|7287535|FG007|COMPLETED|Part 1 (up to Day 57)||1
6376957|NCT00761657|7287536|FG008|COMPLETED|Part 1 (up to Day 57)||9
6376958|NCT00761657|7287528|FG000|NOT COMPLETED|Part 1 (up to Day 57)||0
6376959|NCT00761657|7287529|FG001|NOT COMPLETED|Part 1 (up to Day 57)||0
6376960|NCT00761657|7287530|FG002|NOT COMPLETED|Part 1 (up to Day 57)||4
6376961|NCT00761657|7287531|FG003|NOT COMPLETED|Part 1 (up to Day 57)||6
6376962|NCT00761657|7287532|FG004|NOT COMPLETED|Part 1 (up to Day 57)||0
6376963|NCT00761657|7287533|FG005|NOT COMPLETED|Part 1 (up to Day 57)||0
6376964|NCT00761657|7287534|FG006|NOT COMPLETED|Part 1 (up to Day 57)||1
6376965|NCT00761657|7287535|FG007|NOT COMPLETED|Part 1 (up to Day 57)||1
6376966|NCT00761657|7287536|FG008|NOT COMPLETED|Part 1 (up to Day 57)||1
6376967|NCT00761657|7287528|FG000|STARTED|Part 2 (up to Day 114)||10
6376968|NCT00761657|7287529|FG001|STARTED|Part 2 (up to Day 114)||13
6376969|NCT00761657|7287530|FG002|STARTED|Part 2 (up to Day 114)||0
6376970|NCT00761657|7287531|FG003|STARTED|Part 2 (up to Day 114)||0
6376971|NCT00761657|7287532|FG004|STARTED|Part 2 (up to Day 114)||10
6376972|NCT00761657|7287533|FG005|STARTED|Part 2 (up to Day 114)||11
6376973|NCT00761657|7287534|FG006|STARTED|Part 2 (up to Day 114)||10
6376974|NCT00761657|7287535|FG007|STARTED|Part 2 (up to Day 114)||10
6376975|NCT00761657|7287536|FG008|STARTED|Part 2 (up to Day 114)||18
6376976|NCT00761657|7287528|FG000|Safety Population|Part 2 (up to Day 114)||10
6376977|NCT00761657|7287529|FG001|Safety Population|Part 2 (up to Day 114)||13
6376978|NCT00761657|7287530|FG002|Safety Population|Part 2 (up to Day 114)||0
6376979|NCT00761657|7287531|FG003|Safety Population|Part 2 (up to Day 114)||0
6376980|NCT00761657|7287532|FG004|Safety Population|Part 2 (up to Day 114)||10
6376981|NCT00761657|7287533|FG005|Safety Population|Part 2 (up to Day 114)||11
6376982|NCT00761657|7287534|FG006|Safety Population|Part 2 (up to Day 114)||10
6376983|NCT00761657|7287535|FG007|Safety Population|Part 2 (up to Day 114)||10
6376984|NCT00761657|7287536|FG008|Safety Population|Part 2 (up to Day 114)||18
6376985|NCT00761657|7287528|FG000|EE Population|Part 2 (up to Day 114)||10
6376986|NCT00761657|7287529|FG001|EE Population|Part 2 (up to Day 114)||12
6376987|NCT00761657|7287530|FG002|EE Population|Part 2 (up to Day 114)||0
6376988|NCT00761657|7287531|FG003|EE Population|Part 2 (up to Day 114)||0
6376989|NCT00761657|7287532|FG004|EE Population|Part 2 (up to Day 114)||10
6376990|NCT00761657|7287533|FG005|EE Population|Part 2 (up to Day 114)||11
6376991|NCT00761657|7287534|FG006|EE Population|Part 2 (up to Day 114)||10
6376992|NCT00761657|7287535|FG007|EE Population|Part 2 (up to Day 114)||10
6355327|NCT00645528|7264272|FG000|STARTED|Overall Study||39
6355328|NCT00645528|7264272|FG000|COMPLETED|Overall Study||32
6355329|NCT00645528|7264272|FG000|NOT COMPLETED|Overall Study||7
6355330|NCT00645593|7264278|FG000|STARTED|Overall Study||29
6355331|NCT00645593|7264279|FG001|STARTED|Overall Study||60
6355332|NCT00645593|7264278|FG000|COMPLETED|Overall Study||28
6355333|NCT00645593|7264279|FG001|COMPLETED|Overall Study||60
6355334|NCT00645593|7264278|FG000|NOT COMPLETED|Overall Study||1
6355335|NCT00645593|7264279|FG001|NOT COMPLETED|Overall Study||0
6355336|NCT00645671|7264287|FG000|STARTED|Overall Study||201
6355337|NCT00645671|7264288|FG001|STARTED|Overall Study||199
6355338|NCT00645671|7264287|FG000|COMPLETED|Overall Study||200
6355339|NCT00645671|7264288|FG001|COMPLETED|Overall Study||193
6355340|NCT00645671|7264287|FG000|NOT COMPLETED|Overall Study||1
6355341|NCT00645671|7264288|FG001|NOT COMPLETED|Overall Study||6
6355342|NCT00645710|7264297|FG000|STARTED|Overall Study||3
6355343|NCT00645710|7264298|FG001|STARTED|Overall Study||3
6355344|NCT00645710|7264299|FG002|STARTED|Overall Study||10
6355345|NCT00645710|7264297|FG000|COMPLETED|Overall Study||3
6355346|NCT00645710|7264298|FG001|COMPLETED|Overall Study||3
6355347|NCT00645710|7264299|FG002|COMPLETED|Overall Study||10
6355348|NCT00645710|7264297|FG000|NOT COMPLETED|Overall Study||0
6355349|NCT00645710|7264298|FG001|NOT COMPLETED|Overall Study||0
6355350|NCT00645710|7264299|FG002|NOT COMPLETED|Overall Study||0
6355351|NCT00645762|7264308|FG000|STARTED|Overall Study||71
6355352|NCT00645762|7264308|FG000|COMPLETED|Overall Study||67
6355353|NCT00645762|7264308|FG000|NOT COMPLETED|Overall Study||4
6355354|NCT00645788|7264318|FG000|STARTED|Overall Study||94
6355355|NCT00645788|7264319|FG001|STARTED|Overall Study||94
6355356|NCT00645788|7264320|FG002|STARTED|Overall Study||65
6355357|NCT00645788|7264321|FG003|STARTED|Overall Study||35
6355358|NCT00645788|7264318|FG000|Participants Receive Treatment|Overall Study||93
6355359|NCT00645788|7264319|FG001|Participants Receive Treatment|Overall Study||93
6355360|NCT00645788|7264320|FG002|Participants Receive Treatment|Overall Study||65
6355361|NCT00645788|7264321|FG003|Participants Receive Treatment|Overall Study||35
6355362|NCT00645788|7264318|FG000|COMPLETED|Overall Study||74
6355363|NCT00645788|7264319|FG001|COMPLETED|Overall Study||67
6355364|NCT00645788|7264320|FG002|COMPLETED|Overall Study||47
6355365|NCT00645788|7264321|FG003|COMPLETED|Overall Study||21
6355366|NCT00645788|7264318|FG000|NOT COMPLETED|Overall Study||20
6355367|NCT00645788|7264319|FG001|NOT COMPLETED|Overall Study||27
6355368|NCT00645788|7264320|FG002|NOT COMPLETED|Overall Study||18
6355369|NCT00645788|7264321|FG003|NOT COMPLETED|Overall Study||14
6355370|NCT00645827|7264333|FG000|STARTED|Overall Study||14
6355371|NCT00645827|7264334|FG001|STARTED|Overall Study||17
6355372|NCT00645827|7264333|FG000|COMPLETED|Overall Study||14
6355373|NCT00645827|7264334|FG001|COMPLETED|Overall Study||17
6355374|NCT00645827|7264333|FG000|NOT COMPLETED|Overall Study||0
6355375|NCT00645827|7264334|FG001|NOT COMPLETED|Overall Study||0
6355376|NCT00645840|7264340|FG000|STARTED|Overall Study||15
6355377|NCT00645840|7264340|FG000|COMPLETED|Overall Study||12
6355378|NCT00645840|7264340|FG000|NOT COMPLETED|Overall Study||3
6355379|NCT00645853|7264346|FG000|STARTED|Overall Study||288
6355380|NCT00645853|7264347|FG001|STARTED|Overall Study||235
6355381|NCT00645853|7264346|FG000|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
6355382|NCT00645853|7264347|FG001|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
6355383|NCT00645853|7264346|FG000|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
6355384|NCT00645853|7264347|FG001|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
6355385|NCT00645853|7264346|FG000|AZ Study Closure in Hungary|Overall Study||60
6355386|NCT00645853|7264347|FG001|AZ Study Closure in Hungary|Overall Study||40
6355387|NCT00645853|7264346|FG000|COMPLETED|Overall Study||196
6355388|NCT00645853|7264347|FG001|COMPLETED|Overall Study||178
6355389|NCT00645853|7264346|FG000|NOT COMPLETED|Overall Study||92
6355390|NCT00645853|7264347|FG001|NOT COMPLETED|Overall Study||57
6355391|NCT00645944|7264355|FG000|STARTED|Randomized||20
6355392|NCT00645944|7264356|FG001|STARTED|Randomized||19
6355393|NCT00645944|7264355|FG000|COMPLETED|Randomized||19
6355394|NCT00645944|7264356|FG001|COMPLETED|Randomized||17
6355395|NCT00645944|7264355|FG000|NOT COMPLETED|Randomized||1
6355396|NCT00645944|7264356|FG001|NOT COMPLETED|Randomized||2
6355397|NCT00645944|7264355|FG000|STARTED|Received Medication||19
6355398|NCT00645944|7264356|FG001|STARTED|Received Medication||17
6355399|NCT00645944|7264355|FG000|COMPLETED|Received Medication||13
6355400|NCT00645944|7264356|FG001|COMPLETED|Received Medication||14
6355401|NCT00645944|7264355|FG000|NOT COMPLETED|Received Medication||6
6355402|NCT00645944|7264356|FG001|NOT COMPLETED|Received Medication||3
6355403|NCT00645970|7264364|FG000|STARTED|Overall Study||141
6355404|NCT00645970|7264365|FG001|STARTED|Overall Study||218
6355405|NCT00645970|7264364|FG000|6 Months|Overall Study||58
6355406|NCT00645970|7264365|FG001|6 Months|Overall Study||97
6355407|NCT00645970|7264364|FG000|1 Year|Overall Study||37
6355408|NCT00645970|7264365|FG001|1 Year|Overall Study||42
6355409|NCT00645970|7264364|FG000|COMPLETED|Overall Study||32
6355410|NCT00645970|7264365|FG001|COMPLETED|Overall Study||32
6355411|NCT00645970|7264364|FG000|NOT COMPLETED|Overall Study||109
6355412|NCT00645970|7264365|FG001|NOT COMPLETED|Overall Study||186
6355413|NCT00646048|7264371|FG000|STARTED|Overall Study||43
6355414|NCT00646048|7264371|FG000|COMPLETED|Overall Study||27
6355415|NCT00646048|7264371|FG000|NOT COMPLETED|Overall Study||16
6355416|NCT00646113|7264375|FG000|STARTED|Overall Study|3 of the 72 enrolled participants were excluded before surgery.|69
6355417|NCT00646113|7264375|FG000|COMPLETED|Overall Study||61
6355418|NCT00646113|7264375|FG000|NOT COMPLETED|Overall Study||8
6355419|NCT00646399|7264381|FG000|STARTED|Overall Study||792
6355420|NCT00646399|7264382|FG001|STARTED|Overall Study||787
6355421|NCT00646399|7264381|FG000|COMPLETED|Overall Study||709
6355422|NCT00646399|7264382|FG001|COMPLETED|Overall Study||713
6355423|NCT00646399|7264381|FG000|NOT COMPLETED|Overall Study||83
6355424|NCT00646399|7264382|FG001|NOT COMPLETED|Overall Study||74
6355425|NCT00646451|7264388|FG000|STARTED|Overall Study||10
6355426|NCT00646451|7264389|FG001|STARTED|Overall Study||10
6355427|NCT00646451|7264388|FG000|COMPLETED|Overall Study||6
6355428|NCT00646451|7264389|FG001|COMPLETED|Overall Study||10
6355429|NCT00646451|7264388|FG000|NOT COMPLETED|Overall Study||4
6355430|NCT00646451|7264389|FG001|NOT COMPLETED|Overall Study||0
6355431|NCT00646581|7264399|FG000|STARTED|Overall Study||15
6355432|NCT00646581|7264400|FG001|STARTED|Overall Study||15
6355433|NCT00646581|7264399|FG000|COMPLETED|Overall Study||15
6355434|NCT00646581|7264400|FG001|COMPLETED|Overall Study||15
6355435|NCT00646581|7264399|FG000|NOT COMPLETED|Overall Study||0
6355436|NCT00646581|7264400|FG001|NOT COMPLETED|Overall Study||0
6355437|NCT00646646|7264410|FG000|STARTED|Overall Study||15
6355438|NCT00646646|7264411|FG001|STARTED|Overall Study||15
6355439|NCT00646646|7264412|FG002|STARTED|Overall Study||15
6355440|NCT00646646|7264413|FG003|STARTED|Overall Study||20
6355441|NCT00646646|7264410|FG000|COMPLETED|Overall Study||15
6355442|NCT00646646|7264411|FG001|COMPLETED|Overall Study||15
6355443|NCT00646646|7264412|FG002|COMPLETED|Overall Study||15
6355444|NCT00646646|7264413|FG003|COMPLETED|Overall Study||20
6355445|NCT00646646|7264410|FG000|NOT COMPLETED|Overall Study||0
6355446|NCT00646646|7264411|FG001|NOT COMPLETED|Overall Study||0
6355447|NCT00646646|7264412|FG002|NOT COMPLETED|Overall Study||0
6355448|NCT00646646|7264413|FG003|NOT COMPLETED|Overall Study||0
6355449|NCT00646763|7264425|FG000|STARTED|Overall Study||18
6355450|NCT00646763|7264426|FG001|STARTED|Overall Study||17
6355451|NCT00646763|7264425|FG000|COMPLETED|Overall Study||18
6355452|NCT00646763|7264426|FG001|COMPLETED|Overall Study||17
6355453|NCT00646763|7264425|FG000|NOT COMPLETED|Overall Study||0
6355454|NCT00646763|7264426|FG001|NOT COMPLETED|Overall Study||0
6355455|NCT00646776|7264434|FG000|STARTED|Overall Study|Treated on Day 1|15
6355456|NCT00646776|7264435|FG001|STARTED|Overall Study|Treated on Day 1|18
6355457|NCT00646776|7264434|FG000|COMPLETED|Overall Study||14
6355458|NCT00646776|7264435|FG001|COMPLETED|Overall Study||5
6355459|NCT00646776|7264434|FG000|NOT COMPLETED|Overall Study||1
6355460|NCT00646776|7264435|FG001|NOT COMPLETED|Overall Study||13
6355461|NCT00646906|7264448|FG000|STARTED|Crossover Period 1||9
6355462|NCT00646906|7264449|FG001|STARTED|Crossover Period 1||9
6355463|NCT00646906|7264450|FG002|STARTED|Crossover Period 1||10
6355464|NCT00646906|7264451|FG003|STARTED|Crossover Period 1||9
6355465|NCT00646906|7264452|FG004|STARTED|Crossover Period 1||8
6355466|NCT00646906|7264453|FG005|STARTED|Crossover Period 1||5
6355467|NCT00646906|7264454|FG006|STARTED|Crossover Period 1||5
6355468|NCT00646906|7264448|FG000|COMPLETED|Crossover Period 1||8
6355469|NCT00646906|7264449|FG001|COMPLETED|Crossover Period 1||9
6355470|NCT00646906|7264450|FG002|COMPLETED|Crossover Period 1||10
6355471|NCT00646906|7264451|FG003|COMPLETED|Crossover Period 1||9
6355472|NCT00646906|7264452|FG004|COMPLETED|Crossover Period 1|Phase 1b had only one treatment period and no crossover. Phase 1b ended here.|8
6355473|NCT00646906|7264453|FG005|COMPLETED|Crossover Period 1||4
6355474|NCT00646906|7264454|FG006|COMPLETED|Crossover Period 1||5
6355475|NCT00646906|7264448|FG000|NOT COMPLETED|Crossover Period 1||1
6355476|NCT00646906|7264449|FG001|NOT COMPLETED|Crossover Period 1||0
6355477|NCT00646906|7264450|FG002|NOT COMPLETED|Crossover Period 1||0
6355478|NCT00646906|7264451|FG003|NOT COMPLETED|Crossover Period 1||0
6355479|NCT00646906|7264452|FG004|NOT COMPLETED|Crossover Period 1||0
6355480|NCT00646906|7264453|FG005|NOT COMPLETED|Crossover Period 1||1
6355481|NCT00646906|7264454|FG006|NOT COMPLETED|Crossover Period 1||0
6355482|NCT00646906|7264448|FG000|STARTED|Washout (>/= 14 Days)||8
6355483|NCT00646906|7264449|FG001|STARTED|Washout (>/= 14 Days)||9
6355484|NCT00646906|7264450|FG002|STARTED|Washout (>/= 14 Days)||10
6355485|NCT00646906|7264451|FG003|STARTED|Washout (>/= 14 Days)||9
6355486|NCT00646906|7264452|FG004|STARTED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
6355487|NCT00646906|7264453|FG005|STARTED|Washout (>/= 14 Days)||4
6355488|NCT00646906|7264454|FG006|STARTED|Washout (>/= 14 Days)||5
6355489|NCT00646906|7264448|FG000|COMPLETED|Washout (>/= 14 Days)||8
6355490|NCT00646906|7264449|FG001|COMPLETED|Washout (>/= 14 Days)||9
6355491|NCT00646906|7264450|FG002|COMPLETED|Washout (>/= 14 Days)||10
6355492|NCT00646906|7264451|FG003|COMPLETED|Washout (>/= 14 Days)||9
6355493|NCT00646906|7264452|FG004|COMPLETED|Washout (>/= 14 Days)|Phase 1b had only one treatment period and no crossover.|0
6355494|NCT00646906|7264453|FG005|COMPLETED|Washout (>/= 14 Days)||4
6355495|NCT00646906|7264454|FG006|COMPLETED|Washout (>/= 14 Days)||5
6355496|NCT00646906|7264448|FG000|NOT COMPLETED|Washout (>/= 14 Days)||0
6355497|NCT00646906|7264449|FG001|NOT COMPLETED|Washout (>/= 14 Days)||0
6355498|NCT00646906|7264450|FG002|NOT COMPLETED|Washout (>/= 14 Days)||0
6355499|NCT00646906|7264451|FG003|NOT COMPLETED|Washout (>/= 14 Days)||0
6355500|NCT00646906|7264452|FG004|NOT COMPLETED|Washout (>/= 14 Days)||0
6355501|NCT00646906|7264453|FG005|NOT COMPLETED|Washout (>/= 14 Days)||0
6355502|NCT00646906|7264454|FG006|NOT COMPLETED|Washout (>/= 14 Days)||0
6355503|NCT00646906|7264448|FG000|STARTED|Crossover Period 2||8
6355504|NCT00646906|7264449|FG001|STARTED|Crossover Period 2||9
6355505|NCT00646906|7264450|FG002|STARTED|Crossover Period 2||10
6355506|NCT00646906|7264451|FG003|STARTED|Crossover Period 2||9
6355507|NCT00646906|7264452|FG004|STARTED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
6355508|NCT00646906|7264453|FG005|STARTED|Crossover Period 2||4
6355509|NCT00646906|7264454|FG006|STARTED|Crossover Period 2||5
6355510|NCT00646906|7264448|FG000|COMPLETED|Crossover Period 2||8
6355511|NCT00646906|7264449|FG001|COMPLETED|Crossover Period 2||8
6355512|NCT00646906|7264450|FG002|COMPLETED|Crossover Period 2||8
6355513|NCT00646906|7264451|FG003|COMPLETED|Crossover Period 2||8
6355514|NCT00646906|7264452|FG004|COMPLETED|Crossover Period 2|Phase 1b had only one treatment period and no crossover.|0
6355515|NCT00646906|7264453|FG005|COMPLETED|Crossover Period 2||4
6355516|NCT00646906|7264454|FG006|COMPLETED|Crossover Period 2||4
6355517|NCT00646906|7264448|FG000|NOT COMPLETED|Crossover Period 2||0
6355518|NCT00646906|7264449|FG001|NOT COMPLETED|Crossover Period 2||1
6355519|NCT00646906|7264450|FG002|NOT COMPLETED|Crossover Period 2||2
6355520|NCT00646906|7264451|FG003|NOT COMPLETED|Crossover Period 2||1
6355521|NCT00646906|7264452|FG004|NOT COMPLETED|Crossover Period 2||0
6355522|NCT00646906|7264453|FG005|NOT COMPLETED|Crossover Period 2||0
6355523|NCT00646906|7264454|FG006|NOT COMPLETED|Crossover Period 2||1
6355524|NCT00646958|7264470|FG000|STARTED|Overall Study|Number (No.) Participants Randomized|51
6355525|NCT00646958|7264471|FG001|STARTED|Overall Study|No. Participants Randomized|50
6355526|NCT00646958|7264472|FG002|STARTED|Overall Study|No. Participants Randomized|49
6355527|NCT00646958|7264470|FG000|COMPLETED|Overall Study||40
6355528|NCT00646958|7264471|FG001|COMPLETED|Overall Study||41
6355529|NCT00646958|7264472|FG002|COMPLETED|Overall Study||40
6355530|NCT00646958|7264470|FG000|NOT COMPLETED|Overall Study||11
6355531|NCT00646958|7264471|FG001|NOT COMPLETED|Overall Study||9
6355532|NCT00646958|7264472|FG002|NOT COMPLETED|Overall Study||9
6355533|NCT00647270|7264483|FG000|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
6355534|NCT00647270|7264484|FG001|STARTED|Period 1, Placebo-control (12 Weeks)||159
6355535|NCT00647270|7264485|FG002|STARTED|Period 1, Placebo-control (12 Weeks)||205
6355536|NCT00647270|7264483|FG000|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
6355537|NCT00647270|7264484|FG001|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
6355538|NCT00647270|7264485|FG002|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
6355539|NCT00647270|7264483|FG000|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
6355540|NCT00647270|7264484|FG001|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
6355541|NCT00647270|7264485|FG002|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
6355542|NCT00647270|7264483|FG000|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
6355543|NCT00647270|7264484|FG001|STARTED|Period 2, Placebo Switched to Adalimumab||146
6355544|NCT00647270|7264485|FG002|STARTED|Period 2, Placebo Switched to Adalimumab||182
6355545|NCT00647270|7264483|FG000|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
6355546|NCT00647270|7264484|FG001|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
6355547|NCT00647270|7264485|FG002|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
6355548|NCT00647270|7264483|FG000|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
6355549|NCT00647270|7264484|FG001|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
6355550|NCT00647270|7264485|FG002|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
6355551|NCT00647296|7264500|FG000|STARTED|Part 1: 12-week Double-Blind Treatment||27
6559881|NCT01783990|7482639|FG000|COMPLETED|Overall Study||125
6559882|NCT01783990|7482640|FG001|COMPLETED|Overall Study||18
6559883|NCT01783990|7482639|FG000|NOT COMPLETED|Overall Study||5
6355552|NCT00647296|7264501|FG001|STARTED|Part 1: 12-week Double-Blind Treatment||23
6355553|NCT00647296|7264502|FG002|STARTED|Part 1: 12-week Double-Blind Treatment||26
6355554|NCT00647296|7264503|FG003|STARTED|Part 1: 12-week Double-Blind Treatment||26
6355555|NCT00647296|7264500|FG000|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
6355556|NCT00647296|7264501|FG001|COMPLETED|Part 1: 12-week Double-Blind Treatment||22
6355557|NCT00647296|7264502|FG002|COMPLETED|Part 1: 12-week Double-Blind Treatment||26
6355558|NCT00647296|7264503|FG003|COMPLETED|Part 1: 12-week Double-Blind Treatment||24
6355559|NCT00647296|7264500|FG000|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
6355560|NCT00647296|7264501|FG001|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||1
6355561|NCT00647296|7264502|FG002|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||0
6355562|NCT00647296|7264503|FG003|NOT COMPLETED|Part 1: 12-week Double-Blind Treatment||2
6355563|NCT00647296|7264500|FG000|STARTED|Part 2: 4-week Placebo Washout||97
6559884|NCT01783990|7482640|FG001|NOT COMPLETED|Overall Study||2
6355564|NCT00647296|7264501|FG001|STARTED|Part 2: 4-week Placebo Washout||0
6355565|NCT00647296|7264502|FG002|STARTED|Part 2: 4-week Placebo Washout||0
6355566|NCT00647296|7264503|FG003|STARTED|Part 2: 4-week Placebo Washout||0
6355567|NCT00647296|7264500|FG000|COMPLETED|Part 2: 4-week Placebo Washout||92
6355568|NCT00647296|7264501|FG001|COMPLETED|Part 2: 4-week Placebo Washout||0
6355569|NCT00647296|7264502|FG002|COMPLETED|Part 2: 4-week Placebo Washout||0
6559885|NCT01784029|7482651|FG000|STARTED|Overall Study||61
6559886|NCT01784029|7482652|FG001|STARTED|Overall Study||59
6559887|NCT01784029|7482653|FG002|STARTED|Overall Study||63
6559888|NCT01784029|7482651|FG000|COMPLETED|Overall Study||42
6559889|NCT01784029|7482652|FG001|COMPLETED|Overall Study||39
6559890|NCT01784029|7482653|FG002|COMPLETED|Overall Study||41
6355570|NCT00647296|7264503|FG003|COMPLETED|Part 2: 4-week Placebo Washout||0
6355571|NCT00647296|7264500|FG000|NOT COMPLETED|Part 2: 4-week Placebo Washout||5
6355572|NCT00647296|7264501|FG001|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
6355573|NCT00647296|7264502|FG002|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
6355574|NCT00647296|7264503|FG003|NOT COMPLETED|Part 2: 4-week Placebo Washout||0
6355575|NCT00647296|7264500|FG000|STARTED|Part 2: 76-week Double-Blind Treatment||0
6355576|NCT00647296|7264501|FG001|STARTED|Part 2: 76-week Double-Blind Treatment||48
6355577|NCT00647296|7264502|FG002|STARTED|Part 2: 76-week Double-Blind Treatment||0
6355578|NCT00647296|7264503|FG003|STARTED|Part 2: 76-week Double-Blind Treatment||44
6355579|NCT00647296|7264500|FG000|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
6355580|NCT00647296|7264501|FG001|COMPLETED|Part 2: 76-week Double-Blind Treatment||33
6355581|NCT00647296|7264502|FG002|COMPLETED|Part 2: 76-week Double-Blind Treatment||0
6355582|NCT00647296|7264503|FG003|COMPLETED|Part 2: 76-week Double-Blind Treatment||30
6355583|NCT00647296|7264500|FG000|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
6355584|NCT00647296|7264501|FG001|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||15
6355585|NCT00647296|7264502|FG002|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||0
6355586|NCT00647296|7264503|FG003|NOT COMPLETED|Part 2: 76-week Double-Blind Treatment||14
6355587|NCT00647348|7264527|FG000|STARTED|Overall Study||70
6355588|NCT00647348|7264528|FG001|STARTED|Overall Study||70
6355589|NCT00647348|7264527|FG000|COMPLETED|Overall Study||67
6355590|NCT00647348|7264528|FG001|COMPLETED|Overall Study||64
6355591|NCT00647348|7264527|FG000|NOT COMPLETED|Overall Study||3
6355592|NCT00647348|7264528|FG001|NOT COMPLETED|Overall Study||6
6355593|NCT00647400|7264536|FG000|STARTED|Overall Study||89
6355594|NCT00647400|7264537|FG001|STARTED|Overall Study||58
6355595|NCT00647400|7264536|FG000|COMPLETED|Overall Study||67
6355596|NCT00647400|7264537|FG001|COMPLETED|Overall Study||45
6355597|NCT00647400|7264536|FG000|NOT COMPLETED|Overall Study||22
6355598|NCT00647400|7264537|FG001|NOT COMPLETED|Overall Study||13
6355599|NCT00647556|7264545|FG000|STARTED|Overall Study||15
6355600|NCT00647556|7264546|FG001|STARTED|Overall Study||15
6355601|NCT00647556|7264545|FG000|COMPLETED|Overall Study||12
6355602|NCT00647556|7264546|FG001|COMPLETED|Overall Study||13
6355603|NCT00647556|7264545|FG000|NOT COMPLETED|Overall Study||3
6355604|NCT00647556|7264546|FG001|NOT COMPLETED|Overall Study||2
6355605|NCT00647699|7264554|FG000|STARTED|Overall Study||73
6355606|NCT00647699|7264555|FG001|STARTED|Overall Study||74
6355607|NCT00647699|7264554|FG000|COMPLETED|Overall Study||65
6355608|NCT00647699|7264555|FG001|COMPLETED|Overall Study||62
6355609|NCT00647699|7264554|FG000|NOT COMPLETED|Overall Study||8
6355610|NCT00647699|7264555|FG001|NOT COMPLETED|Overall Study||12
6355611|NCT00647998|7264563|FG000|STARTED|Overall Study||9
6355612|NCT00647998|7264564|FG001|STARTED|Overall Study||9
6355613|NCT00647998|7264563|FG000|COMPLETED|Overall Study||9
6355614|NCT00647998|7264564|FG001|COMPLETED|Overall Study||9
6355615|NCT00647998|7264563|FG000|NOT COMPLETED|Overall Study||0
6355616|NCT00647998|7264564|FG001|NOT COMPLETED|Overall Study||0
6355617|NCT00648037|7264572|FG000|STARTED|Overall Study||26
6355618|NCT00648037|7264572|FG000|COMPLETED|Overall Study||10
6355619|NCT00648037|7264572|FG000|NOT COMPLETED|Overall Study||16
6355620|NCT00648115|7264579|FG000|STARTED|Overall Study||42
6355621|NCT00648115|7264580|FG001|STARTED|Overall Study||42
6355622|NCT00648115|7264581|FG002|STARTED|Overall Study||27
6355623|NCT00648115|7264579|FG000|COMPLETED|Overall Study||42
6355624|NCT00648115|7264580|FG001|COMPLETED|Overall Study||42
6355625|NCT00648115|7264581|FG002|COMPLETED|Overall Study||27
6355626|NCT00648115|7264579|FG000|NOT COMPLETED|Overall Study||0
6355627|NCT00648115|7264580|FG001|NOT COMPLETED|Overall Study||0
6355628|NCT00648115|7264581|FG002|NOT COMPLETED|Overall Study||0
6355629|NCT00648167|7264589|FG000|STARTED|Overall Study||55
6355630|NCT00648167|7264589|FG000|Start Dose 4.5 g/Day|Overall Study||34
6355631|NCT00648167|7264589|FG000|Start Dose 6 g/Day|Overall Study||21
6355632|NCT00648167|7264589|FG000|COMPLETED|Overall Study||48
6355633|NCT00648167|7264589|FG000|NOT COMPLETED|Overall Study||7
6355634|NCT00648375|7264595|FG000|STARTED|Overall Study||1
6355635|NCT00648375|7264596|FG001|STARTED|Overall Study||2
6355636|NCT00648375|7264595|FG000|COMPLETED|Overall Study||1
6355637|NCT00648375|7264596|FG001|COMPLETED|Overall Study||2
6355638|NCT00648375|7264595|FG000|NOT COMPLETED|Overall Study||0
6355639|NCT00648375|7264596|FG001|NOT COMPLETED|Overall Study||0
6355640|NCT00648648|7264630|FG000|STARTED|Overall Study||3
6355641|NCT00648648|7264631|FG001|STARTED|Overall Study||3
6355642|NCT00648648|7264632|FG002|STARTED|Overall Study||3
6355643|NCT00648648|7264633|FG003|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|4
6355644|NCT00648648|7264634|FG004|STARTED|Overall Study||9
6355645|NCT00648648|7264635|FG005|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
6355646|NCT00648648|7264636|FG006|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|10
6355647|NCT00648648|7264637|FG007|STARTED|Overall Study|Does not include two Part 1 participants who were randomized to this arm.|1
6355648|NCT00648648|7264638|FG008|STARTED|Overall Study|Does not include one Part 1 participant who was randomized to this arm.|3
6355649|NCT00648648|7264639|FG009|STARTED|Overall Study||10
6355650|NCT00648648|7264640|FG010|STARTED|Overall Study||6
6355651|NCT00648648|7264641|FG011|STARTED|Overall Study||13
6355652|NCT00648648|7264642|FG012|STARTED|Overall Study||6
6355653|NCT00648648|7264643|FG013|STARTED|Overall Study||5
6355654|NCT00648648|7264644|FG014|STARTED|Overall Study||4
6355655|NCT00648648|7264645|FG015|STARTED|Overall Study||11
6355656|NCT00648648|7264646|FG016|STARTED|Overall Study||16
6355657|NCT00648648|7264647|FG017|STARTED|Overall Study||6
6355658|NCT00648648|7264648|FG018|STARTED|Overall Study||5
6355659|NCT00648648|7264649|FG019|STARTED|Overall Study||7
6355660|NCT00648648|7264650|FG020|STARTED|Overall Study||6
6355661|NCT00648648|7264651|FG021|STARTED|Overall Study||10
6355662|NCT00648648|7264652|FG022|STARTED|Overall Study||14
6355663|NCT00648648|7264653|FG023|STARTED|Overall Study||4
6355664|NCT00648648|7264654|FG024|STARTED|Overall Study||4
6355665|NCT00648648|7264655|FG025|STARTED|Overall Study||4
6355666|NCT00648648|7264656|FG026|STARTED|Overall Study||26
6355667|NCT00648648|7264657|FG027|STARTED|Overall Study||12
6355668|NCT00648648|7264630|FG000|Treated|Overall Study||3
6355669|NCT00648648|7264631|FG001|Treated|Overall Study||3
6355670|NCT00648648|7264632|FG002|Treated|Overall Study||3
6355671|NCT00648648|7264633|FG003|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|4
6355672|NCT00648648|7264634|FG004|Treated|Overall Study||8
6355673|NCT00648648|7264635|FG005|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
6355674|NCT00648648|7264636|FG006|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
6355675|NCT00648648|7264637|FG007|Treated|Overall Study|Does not include two Part 1 participants who were treated in this arm.|1
6355676|NCT00648648|7264638|FG008|Treated|Overall Study|Does not include one Part 1 participant who was treated in this arm.|3
6355677|NCT00648648|7264639|FG009|Treated|Overall Study|Does not include one treated participant who was excluded from analysis.|9
6355678|NCT00648648|7264640|FG010|Treated|Overall Study||6
6355679|NCT00648648|7264641|FG011|Treated|Overall Study||13
6355680|NCT00648648|7264642|FG012|Treated|Overall Study||6
6355681|NCT00648648|7264643|FG013|Treated|Overall Study||5
6355682|NCT00648648|7264644|FG014|Treated|Overall Study||4
6355683|NCT00648648|7264645|FG015|Treated|Overall Study||11
6355684|NCT00648648|7264646|FG016|Treated|Overall Study||16
6355685|NCT00648648|7264647|FG017|Treated|Overall Study||6
6355686|NCT00648648|7264648|FG018|Treated|Overall Study||4
6355687|NCT00648648|7264649|FG019|Treated|Overall Study||7
6355688|NCT00648648|7264650|FG020|Treated|Overall Study||6
6355689|NCT00648648|7264651|FG021|Treated|Overall Study||10
6355690|NCT00648648|7264652|FG022|Treated|Overall Study||14
6355691|NCT00648648|7264653|FG023|Treated|Overall Study||4
6355692|NCT00648648|7264654|FG024|Treated|Overall Study||4
6355693|NCT00648648|7264655|FG025|Treated|Overall Study||4
6355694|NCT00648648|7264656|FG026|Treated|Overall Study||26
6355695|NCT00648648|7264657|FG027|Treated|Overall Study||12
6355696|NCT00648648|7264630|FG000|COMPLETED|Overall Study||3
6355697|NCT00648648|7264631|FG001|COMPLETED|Overall Study||3
6355698|NCT00648648|7264632|FG002|COMPLETED|Overall Study||3
6355699|NCT00648648|7264633|FG003|COMPLETED|Overall Study||0
6355700|NCT00648648|7264634|FG004|COMPLETED|Overall Study||0
6355701|NCT00648648|7264635|FG005|COMPLETED|Overall Study||0
6355702|NCT00648648|7264636|FG006|COMPLETED|Overall Study||0
6355703|NCT00648648|7264637|FG007|COMPLETED|Overall Study||0
6355704|NCT00648648|7264638|FG008|COMPLETED|Overall Study||0
6355705|NCT00648648|7264639|FG009|COMPLETED|Overall Study||0
6355706|NCT00648648|7264640|FG010|COMPLETED|Overall Study||0
6355707|NCT00648648|7264641|FG011|COMPLETED|Overall Study||0
6355708|NCT00648648|7264642|FG012|COMPLETED|Overall Study||0
6355709|NCT00648648|7264643|FG013|COMPLETED|Overall Study||0
6355710|NCT00648648|7264644|FG014|COMPLETED|Overall Study||0
6355711|NCT00648648|7264645|FG015|COMPLETED|Overall Study||0
6355712|NCT00648648|7264646|FG016|COMPLETED|Overall Study||2
6355713|NCT00648648|7264647|FG017|COMPLETED|Overall Study||0
6355714|NCT00648648|7264648|FG018|COMPLETED|Overall Study||0
6355715|NCT00648648|7264649|FG019|COMPLETED|Overall Study||0
6355716|NCT00648648|7264650|FG020|COMPLETED|Overall Study||0
6355717|NCT00648648|7264651|FG021|COMPLETED|Overall Study||0
6355718|NCT00648648|7264652|FG022|COMPLETED|Overall Study||0
6355719|NCT00648648|7264653|FG023|COMPLETED|Overall Study||0
6355720|NCT00648648|7264654|FG024|COMPLETED|Overall Study||0
6355721|NCT00648648|7264655|FG025|COMPLETED|Overall Study||0
6355722|NCT00648648|7264656|FG026|COMPLETED|Overall Study||0
6355723|NCT00648648|7264657|FG027|COMPLETED|Overall Study||0
6355724|NCT00648648|7264630|FG000|NOT COMPLETED|Overall Study||0
6355725|NCT00648648|7264631|FG001|NOT COMPLETED|Overall Study||0
6355726|NCT00648648|7264632|FG002|NOT COMPLETED|Overall Study||0
6355727|NCT00648648|7264633|FG003|NOT COMPLETED|Overall Study||4
6355728|NCT00648648|7264634|FG004|NOT COMPLETED|Overall Study||9
6355729|NCT00648648|7264635|FG005|NOT COMPLETED|Overall Study||1
6355730|NCT00648648|7264636|FG006|NOT COMPLETED|Overall Study||10
6355731|NCT00648648|7264637|FG007|NOT COMPLETED|Overall Study||1
6355732|NCT00648648|7264638|FG008|NOT COMPLETED|Overall Study||3
6355733|NCT00648648|7264639|FG009|NOT COMPLETED|Overall Study||10
6355734|NCT00648648|7264640|FG010|NOT COMPLETED|Overall Study||6
6355735|NCT00648648|7264641|FG011|NOT COMPLETED|Overall Study||13
6355736|NCT00648648|7264642|FG012|NOT COMPLETED|Overall Study||6
6355737|NCT00648648|7264643|FG013|NOT COMPLETED|Overall Study||5
6355738|NCT00648648|7264644|FG014|NOT COMPLETED|Overall Study||4
6355739|NCT00648648|7264645|FG015|NOT COMPLETED|Overall Study||11
6355740|NCT00648648|7264646|FG016|NOT COMPLETED|Overall Study||14
6355741|NCT00648648|7264647|FG017|NOT COMPLETED|Overall Study||6
6355742|NCT00648648|7264648|FG018|NOT COMPLETED|Overall Study||5
6355743|NCT00648648|7264649|FG019|NOT COMPLETED|Overall Study||7
6559891|NCT01784029|7482651|FG000|NOT COMPLETED|Overall Study||19
6559892|NCT01784029|7482652|FG001|NOT COMPLETED|Overall Study||20
6559893|NCT01784029|7482653|FG002|NOT COMPLETED|Overall Study||22
6559894|NCT01784055|7482661|FG000|STARTED|Overall Study||126
6559895|NCT01784055|7482661|FG000|COMPLETED|Overall Study||100
6559896|NCT01784055|7482661|FG000|NOT COMPLETED|Overall Study||26
6559897|NCT01784068|7482665|FG000|STARTED|NTCS Phase||215
6355744|NCT00648648|7264650|FG020|NOT COMPLETED|Overall Study||6
6355745|NCT00648648|7264651|FG021|NOT COMPLETED|Overall Study||10
6355746|NCT00648648|7264652|FG022|NOT COMPLETED|Overall Study||14
6355747|NCT00648648|7264653|FG023|NOT COMPLETED|Overall Study||4
6355748|NCT00648648|7264654|FG024|NOT COMPLETED|Overall Study||4
6355749|NCT00648648|7264655|FG025|NOT COMPLETED|Overall Study||4
6355750|NCT00648648|7264656|FG026|NOT COMPLETED|Overall Study||26
6355751|NCT00648648|7264657|FG027|NOT COMPLETED|Overall Study||12
6355752|NCT00648739|7264715|FG000|STARTED|Overall Study||4
6355753|NCT00648739|7264716|FG001|STARTED|Overall Study||5
6355754|NCT00648739|7264717|FG002|STARTED|Overall Study||3
6355755|NCT00648739|7264718|FG003|STARTED|Overall Study||3
6355756|NCT00648739|7264719|FG004|STARTED|Overall Study||3
6355757|NCT00648739|7264720|FG005|STARTED|Overall Study||7
6355758|NCT00648739|7264721|FG006|STARTED|Overall Study||1
6355759|NCT00648739|7264715|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
6355760|NCT00648739|7264716|FG001|Received at Least 1 Dose of Study Drug|Overall Study||5
6355761|NCT00648739|7264717|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6355762|NCT00648739|7264718|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6355763|NCT00648739|7264719|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
6355764|NCT00648739|7264720|FG005|Received at Least 1 Dose of Study Drug|Overall Study||7
6355765|NCT00648739|7264721|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
6355766|NCT00648739|7264715|FG000|COMPLETED|Overall Study||2
6355767|NCT00648739|7264716|FG001|COMPLETED|Overall Study||3
6355768|NCT00648739|7264717|FG002|COMPLETED|Overall Study||0
6355769|NCT00648739|7264718|FG003|COMPLETED|Overall Study||1
6355770|NCT00648739|7264719|FG004|COMPLETED|Overall Study||1
6355771|NCT00648739|7264720|FG005|COMPLETED|Overall Study||2
6355772|NCT00648739|7264721|FG006|COMPLETED|Overall Study||0
6355773|NCT00648739|7264715|FG000|NOT COMPLETED|Overall Study||2
6355774|NCT00648739|7264716|FG001|NOT COMPLETED|Overall Study||2
6355775|NCT00648739|7264717|FG002|NOT COMPLETED|Overall Study||3
6355776|NCT00648739|7264718|FG003|NOT COMPLETED|Overall Study||2
6355777|NCT00648739|7264719|FG004|NOT COMPLETED|Overall Study||2
6355778|NCT00648739|7264720|FG005|NOT COMPLETED|Overall Study||5
6355779|NCT00648739|7264721|FG006|NOT COMPLETED|Overall Study||1
6355780|NCT00648908|7264742|FG000|STARTED|Overall Study||269
6355781|NCT00648908|7264742|FG000|COMPLETED|Overall Study||154
6355782|NCT00648908|7264742|FG000|NOT COMPLETED|Overall Study||115
6355783|NCT00649220|7264747|FG000|STARTED|Overall Study||19
6355784|NCT00649220|7264747|FG000|COMPLETED|Overall Study||16
6355785|NCT00649220|7264747|FG000|NOT COMPLETED|Overall Study||3
6355786|NCT00649389|7264755|FG000|STARTED|Overall Study||628
6355787|NCT00649389|7264756|FG001|STARTED|Overall Study||637
6355788|NCT00649389|7264757|FG002|STARTED|Overall Study||600
6355789|NCT00649389|7264758|FG003|STARTED|Overall Study||627
6355790|NCT00649389|7264755|FG000|COMPLETED|Overall Study||557
6355791|NCT00649389|7264756|FG001|COMPLETED|Overall Study||531
6355792|NCT00649389|7264757|FG002|COMPLETED|Overall Study||512
6355793|NCT00649389|7264758|FG003|COMPLETED|Overall Study||516
6355794|NCT00649389|7264755|FG000|NOT COMPLETED|Overall Study||71
6355795|NCT00649389|7264756|FG001|NOT COMPLETED|Overall Study||106
6355796|NCT00649389|7264757|FG002|NOT COMPLETED|Overall Study||88
6355797|NCT00649389|7264758|FG003|NOT COMPLETED|Overall Study||111
6355798|NCT00649428|7264770|FG000|STARTED|Overall Study||100
6355799|NCT00649428|7264771|FG001|STARTED|Overall Study||103
6355800|NCT00649428|7264770|FG000|COMPLETED|Overall Study||80
6355801|NCT00649428|7264771|FG001|COMPLETED|Overall Study||88
6355802|NCT00649428|7264770|FG000|NOT COMPLETED|Overall Study||20
6355803|NCT00649428|7264771|FG001|NOT COMPLETED|Overall Study||15
6355804|NCT00649792|7264778|FG000|STARTED|Overall Study||214
6355805|NCT00649792|7264778|FG000|COMPLETED|Overall Study||146
6355806|NCT00649792|7264778|FG000|NOT COMPLETED|Overall Study||68
6355807|NCT00649961|7264782|FG000|STARTED|Overall Study||18
6355808|NCT00649961|7264782|FG000|COMPLETED|Overall Study||18
6355809|NCT00649961|7264782|FG000|NOT COMPLETED|Overall Study||0
6355810|NCT00650078|7264788|FG000|STARTED|Overall Study||231
6355811|NCT00650078|7264789|FG001|STARTED|Overall Study||119
6559898|NCT01784068|7482666|FG001|STARTED|NTCS Phase||0
6559899|NCT01784068|7482665|FG000|NTRI Phase|NTCS Phase||86
6559900|NCT01784068|7482666|FG001|NTRI Phase|NTCS Phase||0
6559901|NCT01784068|7482665|FG000|NTCT Phase|NTCS Phase||13
6559902|NCT01784068|7482666|FG001|NTCT Phase|NTCS Phase||0
6559903|NCT01784068|7482665|FG000|TFR-2 Phase|NTCS Phase||8
6355812|NCT00650078|7264788|FG000|COMPLETED|Overall Study||217
6559904|NCT01784068|7482666|FG001|TFR-2 Phase|NTCS Phase||0
6559905|NCT01784068|7482665|FG000|NTCT-P Phase|NTCS Phase||2
6559906|NCT01784068|7482666|FG001|NTCT-P Phase|NTCS Phase||0
6355813|NCT00650078|7264789|FG001|COMPLETED|Overall Study||106
6355814|NCT00650078|7264788|FG000|NOT COMPLETED|Overall Study||14
6355815|NCT00650078|7264789|FG001|NOT COMPLETED|Overall Study||13
6355816|NCT00650091|7264797|FG000|STARTED|Initial Study Design - Interim Analysis||81
6559907|NCT01784068|7482665|FG000|NTRI-2|NTCS Phase||0
6559908|NCT01784068|7482666|FG001|NTRI-2|NTCS Phase||0
6559909|NCT01784068|7482665|FG000|COMPLETED|NTCS Phase||0
6559910|NCT01784068|7482666|FG001|COMPLETED|NTCS Phase||0
6559911|NCT01784068|7482665|FG000|NOT COMPLETED|NTCS Phase||215
6559912|NCT01784068|7482666|FG001|NOT COMPLETED|NTCS Phase||0
6559913|NCT01784068|7482665|FG000|STARTED|TFR Phase||0
6559914|NCT01784068|7482666|FG001|STARTED|TFR Phase||190
6559915|NCT01784068|7482665|FG000|COMPLETED|TFR Phase||0
6559916|NCT01784068|7482666|FG001|COMPLETED|TFR Phase||97
6559917|NCT01784068|7482665|FG000|NOT COMPLETED|TFR Phase||0
6355817|NCT00650091|7264798|FG001|STARTED|Initial Study Design - Interim Analysis||78
6355818|NCT00650091|7264799|FG002|STARTED|Initial Study Design - Interim Analysis||77
6355819|NCT00650091|7264797|FG000|COMPLETED|Initial Study Design - Interim Analysis||81
6355820|NCT00650091|7264798|FG001|COMPLETED|Initial Study Design - Interim Analysis||78
6355821|NCT00650091|7264799|FG002|COMPLETED|Initial Study Design - Interim Analysis||77
6355822|NCT00650091|7264797|FG000|NOT COMPLETED|Initial Study Design - Interim Analysis||0
6355823|NCT00650091|7264798|FG001|NOT COMPLETED|Initial Study Design - Interim Analysis||0
6355824|NCT00650091|7264799|FG002|NOT COMPLETED|Initial Study Design - Interim Analysis||0
6355825|NCT00650091|7264797|FG000|STARTED|Amended Study Design||133
6776450|NCT03836677|7704496|FG001|NOT COMPLETED|Period 1||1
6776451|NCT03836677|7704495|FG000|STARTED|Washout||13
6776452|NCT03836677|7704496|FG001|STARTED|Washout||9
6355826|NCT00650091|7264798|FG001|STARTED|Amended Study Design||131
6355827|NCT00650091|7264799|FG002|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
6355828|NCT00650091|7264797|FG000|COMPLETED|Amended Study Design||110
6355829|NCT00650091|7264798|FG001|COMPLETED|Amended Study Design||111
6355830|NCT00650091|7264799|FG002|COMPLETED|Amended Study Design||0
6355831|NCT00650091|7264797|FG000|NOT COMPLETED|Amended Study Design||23
6355832|NCT00650091|7264798|FG001|NOT COMPLETED|Amended Study Design||20
6355833|NCT00650091|7264799|FG002|NOT COMPLETED|Amended Study Design||0
6355834|NCT00650104|7264807|FG000|STARTED|Overall Study||83
6355835|NCT00650104|7264807|FG000|COMPLETED|Overall Study||42
6355836|NCT00650104|7264807|FG000|NOT COMPLETED|Overall Study||41
6355837|NCT00650260|7264813|FG000|STARTED|Overall Study||21
6355838|NCT00650260|7264814|FG001|STARTED|Overall Study||21
6355839|NCT00650260|7264813|FG000|COMPLETED|Overall Study||21
6355840|NCT00650260|7264814|FG001|COMPLETED|Overall Study||21
6355841|NCT00650260|7264813|FG000|NOT COMPLETED|Overall Study||0
6355842|NCT00650260|7264814|FG001|NOT COMPLETED|Overall Study||0
6355843|NCT00650546|7264820|FG000|STARTED|Overall Study||8
6355844|NCT00650546|7264820|FG000|COMPLETED|Overall Study||8
6355845|NCT00650546|7264820|FG000|NOT COMPLETED|Overall Study||0
6355846|NCT00650585|7264827|FG000|STARTED|Overall Study||4348
6355847|NCT00650585|7264828|FG001|STARTED|Overall Study||3990
6355848|NCT00650585|7264827|FG000|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
6355849|NCT00650585|7264828|FG001|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
6355850|NCT00650585|7264827|FG000|NOT COMPLETED|Overall Study||1797
6355851|NCT00650585|7264828|FG001|NOT COMPLETED|Overall Study||1477
6355852|NCT00650767|7264838|FG000|STARTED|Overall Study||51
6355853|NCT00650767|7264839|FG001|STARTED|Overall Study||50
6355854|NCT00650767|7264840|FG002|STARTED|Overall Study||50
6355855|NCT00650767|7264841|FG003|STARTED|Overall Study||50
6355856|NCT00650767|7264838|FG000|COMPLETED|Overall Study||46
6355857|NCT00650767|7264839|FG001|COMPLETED|Overall Study||41
6355858|NCT00650767|7264840|FG002|COMPLETED|Overall Study||36
6355859|NCT00650767|7264841|FG003|COMPLETED|Overall Study||39
6355860|NCT00650767|7264838|FG000|NOT COMPLETED|Overall Study||5
6355861|NCT00650767|7264839|FG001|NOT COMPLETED|Overall Study||9
6355862|NCT00650767|7264840|FG002|NOT COMPLETED|Overall Study||14
6355863|NCT00650767|7264841|FG003|NOT COMPLETED|Overall Study||11
6355864|NCT00650806|7264855|FG000|STARTED|Overall Study||89
6355865|NCT00650806|7264856|FG001|STARTED|Overall Study||98
6355866|NCT00650806|7264857|FG002|STARTED|Overall Study||93
6355867|NCT00650806|7264858|FG003|STARTED|Overall Study||96
6355868|NCT00650806|7264855|FG000|COMPLETED|Overall Study||71
6355869|NCT00650806|7264856|FG001|COMPLETED|Overall Study||77
6355870|NCT00650806|7264857|FG002|COMPLETED|Overall Study||64
6355871|NCT00650806|7264858|FG003|COMPLETED|Overall Study||70
6355872|NCT00650806|7264855|FG000|NOT COMPLETED|Overall Study||18
6355873|NCT00650806|7264856|FG001|NOT COMPLETED|Overall Study||21
6355874|NCT00650806|7264857|FG002|NOT COMPLETED|Overall Study||29
6355875|NCT00650806|7264858|FG003|NOT COMPLETED|Overall Study||26
6355876|NCT00650845|7264872|FG000|STARTED|Overall Study||75
6355877|NCT00650845|7264873|FG001|STARTED|Overall Study||57
6355878|NCT00650845|7264872|FG000|COMPLETED|Overall Study||70
6355879|NCT00650845|7264873|FG001|COMPLETED|Overall Study||44
6355880|NCT00650845|7264872|FG000|NOT COMPLETED|Overall Study||5
6355881|NCT00650845|7264873|FG001|NOT COMPLETED|Overall Study||13
6355882|NCT00650858|7264883|FG000|STARTED|Overall Study||8
6355883|NCT00650858|7264884|FG001|STARTED|Overall Study||8
6355884|NCT00650858|7264885|FG002|STARTED|Overall Study||36
6355885|NCT00650858|7264883|FG000|COMPLETED|Overall Study||8
6559918|NCT01784068|7482666|FG001|NOT COMPLETED|TFR Phase||93
6355886|NCT00650858|7264884|FG001|COMPLETED|Overall Study||8
6559919|NCT01784211|7482679|FG000|STARTED|Part A (Days 1-15)||38
6776453|NCT03836677|7704495|FG000|COMPLETED|Washout||13
6776454|NCT03836677|7704496|FG001|COMPLETED|Washout||9
6776455|NCT03836677|7704495|FG000|NOT COMPLETED|Washout||0
6559920|NCT01784211|7482680|FG001|STARTED|Part A (Days 1-15)||38
6355887|NCT00650858|7264885|FG002|COMPLETED|Overall Study||36
6355888|NCT00650858|7264883|FG000|NOT COMPLETED|Overall Study||0
6355889|NCT00650858|7264884|FG001|NOT COMPLETED|Overall Study||0
6355890|NCT00650858|7264885|FG002|NOT COMPLETED|Overall Study||0
6355891|NCT00650936|7264893|FG000|STARTED|Overall Study||1000
6355892|NCT00650936|7264893|FG000|COMPLETED|Overall Study||930
6355893|NCT00650936|7264893|FG000|NOT COMPLETED|Overall Study||70
6355894|NCT00651040|7264899|FG000|STARTED|Overall Study||16
6355895|NCT00651040|7264900|FG001|STARTED|Overall Study||15
6355896|NCT00651040|7264899|FG000|COMPLETED|Overall Study||13
6355897|NCT00651040|7264900|FG001|COMPLETED|Overall Study||14
6355898|NCT00651040|7264899|FG000|NOT COMPLETED|Overall Study||3
6355899|NCT00651040|7264900|FG001|NOT COMPLETED|Overall Study||1
6355900|NCT00651118|7264910|FG000|STARTED|Overall Study||207
6355901|NCT00651118|7264911|FG001|STARTED|Overall Study||207
6355902|NCT00651118|7264912|FG002|STARTED|Overall Study||208
6355903|NCT00651118|7264913|FG003|STARTED|Overall Study||210
6355904|NCT00651118|7264910|FG000|COMPLETED|Overall Study||198
6355905|NCT00651118|7264911|FG001|COMPLETED|Overall Study||200
6355906|NCT00651118|7264912|FG002|COMPLETED|Overall Study||197
6355907|NCT00651118|7264913|FG003|COMPLETED|Overall Study||203
6355908|NCT00651118|7264910|FG000|NOT COMPLETED|Overall Study||9
6355909|NCT00651118|7264911|FG001|NOT COMPLETED|Overall Study||7
6355910|NCT00651118|7264912|FG002|NOT COMPLETED|Overall Study||11
6355911|NCT00651118|7264913|FG003|NOT COMPLETED|Overall Study||7
6355912|NCT00651157|7264926|FG000|STARTED|Overall Study||23
6355913|NCT00651157|7264926|FG000|COMPLETED|Overall Study||21
6355914|NCT00651157|7264926|FG000|NOT COMPLETED|Overall Study||2
6355915|NCT00651183|7264932|FG000|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
6355916|NCT00651183|7264933|FG001|STARTED|Overall Study||97
6355917|NCT00651183|7264932|FG000|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
6355918|NCT00651183|7264933|FG001|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
6355919|NCT00651183|7264932|FG000|NOT COMPLETED|Overall Study||20
6355920|NCT00651183|7264933|FG001|NOT COMPLETED|Overall Study||10
6355921|NCT00651261|7264941|FG000|STARTED|Overall Study||360
6355922|NCT00651261|7264942|FG001|STARTED|Overall Study||357
6355923|NCT00651261|7264941|FG000|COMPLETED|Overall Study||69
6355924|NCT00651261|7264942|FG001|COMPLETED|Overall Study||51
6355925|NCT00651261|7264941|FG000|NOT COMPLETED|Overall Study||291
6355926|NCT00651261|7264942|FG001|NOT COMPLETED|Overall Study||306
6355927|NCT00651313|7264950|FG000|STARTED|Overall Study||41
6355928|NCT00651313|7264951|FG001|STARTED|Overall Study||43
6355929|NCT00651313|7264950|FG000|COMPLETED|Overall Study||35
6355930|NCT00651313|7264951|FG001|COMPLETED|Overall Study||37
6355931|NCT00651313|7264950|FG000|NOT COMPLETED|Overall Study||6
6355932|NCT00651313|7264951|FG001|NOT COMPLETED|Overall Study||6
6355933|NCT00651482|7264957|FG000|STARTED|Overall Study||10
6355934|NCT00651482|7264957|FG000|COMPLETED|Overall Study||10
6355935|NCT00651482|7264957|FG000|NOT COMPLETED|Overall Study||0
6355936|NCT00651573|7264964|FG000|STARTED|Overall Study||365
6355937|NCT00651573|7264965|FG001|STARTED|Overall Study||357
6355938|NCT00651573|7264964|FG000|COMPLETED|Overall Study||363
6355939|NCT00651573|7264965|FG001|COMPLETED|Overall Study||354
6355940|NCT00651573|7264964|FG000|NOT COMPLETED|Overall Study||2
6355941|NCT00651573|7264965|FG001|NOT COMPLETED|Overall Study||3
6355942|NCT00651625|7264973|FG000|STARTED|Overall Study||219
6355943|NCT00651625|7264974|FG001|STARTED|Overall Study||218
6355944|NCT00651625|7264973|FG000|COMPLETED|Overall Study||219
6355945|NCT00651625|7264974|FG001|COMPLETED|Overall Study||218
6355946|NCT00651625|7264973|FG000|NOT COMPLETED|Overall Study||0
6355947|NCT00651625|7264974|FG001|NOT COMPLETED|Overall Study||0
6355948|NCT00651664|7264990|FG000|STARTED|Overall Study||3
6355949|NCT00651664|7264991|FG001|STARTED|Overall Study||3
6355950|NCT00651664|7264992|FG002|STARTED|Overall Study||3
6355951|NCT00651664|7264993|FG003|STARTED|Overall Study||14
6355952|NCT00651664|7264994|FG004|STARTED|Overall Study||6
6355953|NCT00651664|7264995|FG005|STARTED|Overall Study||3
6355954|NCT00651664|7264996|FG006|STARTED|Overall Study||6
6355955|NCT00651664|7264997|FG007|STARTED|Overall Study||7
6355956|NCT00651664|7264998|FG008|STARTED|Overall Study||7
6355957|NCT00651664|7264999|FG009|STARTED|Overall Study||7
6355958|NCT00651664|7264990|FG000|COMPLETED|Overall Study||0
6355959|NCT00651664|7264991|FG001|COMPLETED|Overall Study||0
6355960|NCT00651664|7264992|FG002|COMPLETED|Overall Study||0
6355961|NCT00651664|7264993|FG003|COMPLETED|Overall Study||0
6355962|NCT00651664|7264994|FG004|COMPLETED|Overall Study||0
6355963|NCT00651664|7264995|FG005|COMPLETED|Overall Study||0
6355964|NCT00651664|7264996|FG006|COMPLETED|Overall Study||0
6355965|NCT00651664|7264997|FG007|COMPLETED|Overall Study||0
6355966|NCT00651664|7264998|FG008|COMPLETED|Overall Study||0
6355967|NCT00651664|7264999|FG009|COMPLETED|Overall Study||0
6355968|NCT00651664|7264990|FG000|NOT COMPLETED|Overall Study||3
6355969|NCT00651664|7264991|FG001|NOT COMPLETED|Overall Study||3
6355970|NCT00651664|7264992|FG002|NOT COMPLETED|Overall Study||3
6355971|NCT00651664|7264993|FG003|NOT COMPLETED|Overall Study||14
6355972|NCT00651664|7264994|FG004|NOT COMPLETED|Overall Study||6
6355973|NCT00651664|7264995|FG005|NOT COMPLETED|Overall Study||3
6355974|NCT00651664|7264996|FG006|NOT COMPLETED|Overall Study||6
6355975|NCT00651664|7264997|FG007|NOT COMPLETED|Overall Study||7
6355976|NCT00651664|7264998|FG008|NOT COMPLETED|Overall Study||7
6355977|NCT00651664|7264999|FG009|NOT COMPLETED|Overall Study||7
6355978|NCT00651755|7265025|FG000|STARTED|Cycle 1 (First 21 Days)||11
6355979|NCT00651755|7265026|FG001|STARTED|Cycle 1 (First 21 Days)||9
6355980|NCT00651755|7265025|FG000|COMPLETED|Cycle 1 (First 21 Days)||10
6355981|NCT00651755|7265026|FG001|COMPLETED|Cycle 1 (First 21 Days)||9
6355982|NCT00651755|7265025|FG000|NOT COMPLETED|Cycle 1 (First 21 Days)||1
6355983|NCT00651755|7265026|FG001|NOT COMPLETED|Cycle 1 (First 21 Days)||0
6355984|NCT00651755|7265025|FG000|STARTED|Cycle 2 (Second 21 Days)||10
6355985|NCT00651755|7265026|FG001|STARTED|Cycle 2 (Second 21 Days)||9
6355986|NCT00651755|7265025|FG000|COMPLETED|Cycle 2 (Second 21 Days)||10
6355987|NCT00651755|7265026|FG001|COMPLETED|Cycle 2 (Second 21 Days)||8
6355988|NCT00651755|7265025|FG000|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
6355989|NCT00651755|7265026|FG001|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
6355990|NCT00651794|7265036|FG000|STARTED|Overall Study||36
6355991|NCT00651794|7265037|FG001|STARTED|Overall Study||31
6355992|NCT00651794|7265038|FG002|STARTED|Overall Study||31
6355993|NCT00651794|7265036|FG000|COMPLETED|Overall Study||15
6355994|NCT00651794|7265037|FG001|COMPLETED|Overall Study||9
6355995|NCT00651794|7265038|FG002|COMPLETED|Overall Study||10
6355996|NCT00651794|7265036|FG000|NOT COMPLETED|Overall Study||21
6355997|NCT00651794|7265037|FG001|NOT COMPLETED|Overall Study||22
6355998|NCT00651794|7265038|FG002|NOT COMPLETED|Overall Study||21
6355999|NCT00651820|7265046|FG000|STARTED|Overall Study||28
6356000|NCT00651820|7265046|FG000|COMPLETED|Overall Study||26
6356001|NCT00651820|7265046|FG000|NOT COMPLETED|Overall Study||2
6356002|NCT00651924|7265054|FG000|STARTED|Overall Study||18
6356003|NCT00651924|7265055|FG001|STARTED|Overall Study||9
6356004|NCT00651924|7265054|FG000|COMPLETED|Overall Study||18
6356005|NCT00651924|7265055|FG001|COMPLETED|Overall Study||2
6356006|NCT00651924|7265054|FG000|NOT COMPLETED|Overall Study||0
6356007|NCT00651924|7265055|FG001|NOT COMPLETED|Overall Study||7
6356008|NCT00651937|7265063|FG000|STARTED|Overall Study||39
6356009|NCT00651937|7265064|FG001|STARTED|Overall Study||41
6356010|NCT00651937|7265063|FG000|COMPLETED|Overall Study||35
6356011|NCT00651937|7265064|FG001|COMPLETED|Overall Study||40
6356012|NCT00651937|7265063|FG000|NOT COMPLETED|Overall Study||4
6356013|NCT00651937|7265064|FG001|NOT COMPLETED|Overall Study||1
6356014|NCT00652028|7265074|FG000|STARTED|Overall Study||16
6356015|NCT00652028|7265075|FG001|STARTED|Overall Study||14
6356016|NCT00652028|7265076|FG002|STARTED|Overall Study||15
6356017|NCT00652028|7265077|FG003|STARTED|Overall Study||14
6356018|NCT00652028|7265074|FG000|COMPLETED|Overall Study||15
6356019|NCT00652028|7265075|FG001|COMPLETED|Overall Study||13
6356020|NCT00652028|7265076|FG002|COMPLETED|Overall Study||14
6356021|NCT00652028|7265077|FG003|COMPLETED|Overall Study||14
6356022|NCT00652028|7265074|FG000|NOT COMPLETED|Overall Study||1
6559921|NCT01784211|7482681|FG002|STARTED|Part A (Days 1-15)||0
6559922|NCT01784211|7482682|FG003|STARTED|Part A (Days 1-15)||0
6356023|NCT00652028|7265075|FG001|NOT COMPLETED|Overall Study||1
6356024|NCT00652028|7265076|FG002|NOT COMPLETED|Overall Study||1
6356025|NCT00652028|7265077|FG003|NOT COMPLETED|Overall Study||0
6356026|NCT00652080|7265087|FG000|STARTED|Overall Study||35
6356027|NCT00652080|7265087|FG000|COMPLETED|Overall Study||31
6356028|NCT00652080|7265087|FG000|NOT COMPLETED|Overall Study||4
6356029|NCT00652093|7265099|FG000|STARTED|Overall Study||4
6356030|NCT00652093|7265100|FG001|STARTED|Overall Study||4
6356031|NCT00652093|7265101|FG002|STARTED|Overall Study||4
6356032|NCT00652093|7265102|FG003|STARTED|Overall Study||4
6356033|NCT00652093|7265103|FG004|STARTED|Overall Study||4
6356034|NCT00652093|7265104|FG005|STARTED|Overall Study||4
6356035|NCT00652093|7265099|FG000|COMPLETED|Overall Study||4
6356036|NCT00652093|7265100|FG001|COMPLETED|Overall Study||4
6356037|NCT00652093|7265101|FG002|COMPLETED|Overall Study||3
6356038|NCT00652093|7265102|FG003|COMPLETED|Overall Study||4
6356039|NCT00652093|7265103|FG004|COMPLETED|Overall Study||2
6356040|NCT00652093|7265104|FG005|COMPLETED|Overall Study||4
6356041|NCT00652093|7265099|FG000|NOT COMPLETED|Overall Study||0
6356042|NCT00652093|7265100|FG001|NOT COMPLETED|Overall Study||0
6356043|NCT00652093|7265101|FG002|NOT COMPLETED|Overall Study||1
6356044|NCT00652093|7265102|FG003|NOT COMPLETED|Overall Study||0
6356045|NCT00652093|7265103|FG004|NOT COMPLETED|Overall Study||2
6356046|NCT00652093|7265104|FG005|NOT COMPLETED|Overall Study||0
6356047|NCT00652145|7265120|FG000|STARTED|Overall Study||26
6356048|NCT00652145|7265121|FG001|STARTED|Overall Study||26
6356049|NCT00652145|7265120|FG000|COMPLETED|Overall Study||26
6356050|NCT00652145|7265121|FG001|COMPLETED|Overall Study||26
6356051|NCT00652145|7265120|FG000|NOT COMPLETED|Overall Study||0
6356052|NCT00652145|7265121|FG001|NOT COMPLETED|Overall Study||0
6356053|NCT00652314|7265131|FG000|STARTED|Overall Study||62
6356054|NCT00652314|7265132|FG001|STARTED|Overall Study||35
6356055|NCT00652314|7265131|FG000|COMPLETED|Overall Study||53
6356056|NCT00652314|7265132|FG001|COMPLETED|Overall Study||26
6356057|NCT00652314|7265131|FG000|NOT COMPLETED|Overall Study||9
6356058|NCT00652314|7265132|FG001|NOT COMPLETED|Overall Study||9
6356059|NCT00652340|7265140|FG000|STARTED|Overall Study||78
6356060|NCT00652340|7265141|FG001|STARTED|Overall Study||42
6356061|NCT00652340|7265140|FG000|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
6356062|NCT00652340|7265141|FG001|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
6356063|NCT00652340|7265140|FG000|NOT COMPLETED|Overall Study||4
6356064|NCT00652340|7265141|FG001|NOT COMPLETED|Overall Study||3
6356065|NCT00652366|7265152|FG000|STARTED|Overall Study||106
6356066|NCT00652366|7265153|FG001|STARTED|Overall Study||75
6356067|NCT00652366|7265154|FG002|STARTED|Overall Study||71
6356068|NCT00652366|7265155|FG003|STARTED|Overall Study||179
6356069|NCT00652366|7265156|FG004|STARTED|Overall Study||36
6356070|NCT00652366|7265152|FG000|COMPLETED|Overall Study||0
6356071|NCT00652366|7265153|FG001|COMPLETED|Overall Study||0
6356072|NCT00652366|7265154|FG002|COMPLETED|Overall Study||0
6356073|NCT00652366|7265155|FG003|COMPLETED|Overall Study||0
6356074|NCT00652366|7265156|FG004|COMPLETED|Overall Study||0
6356075|NCT00652366|7265152|FG000|NOT COMPLETED|Overall Study||106
6356076|NCT00652366|7265153|FG001|NOT COMPLETED|Overall Study||75
6356077|NCT00652366|7265154|FG002|NOT COMPLETED|Overall Study||71
6356078|NCT00652366|7265155|FG003|NOT COMPLETED|Overall Study||179
6356079|NCT00652366|7265156|FG004|NOT COMPLETED|Overall Study||36
6356080|NCT00652626|7265177|FG000|STARTED|Initial Treatment Phase||5
6356081|NCT00652626|7265178|FG001|STARTED|Initial Treatment Phase||5
6356082|NCT00652626|7265179|FG002|STARTED|Initial Treatment Phase||7
6356083|NCT00652626|7265180|FG003|STARTED|Initial Treatment Phase||6
6356084|NCT00652626|7265181|FG004|STARTED|Initial Treatment Phase||8
6559923|NCT01784211|7482683|FG004|STARTED|Part A (Days 1-15)||0
6559924|NCT01784211|7482684|FG005|STARTED|Part A (Days 1-15)||0
6559925|NCT01784211|7482679|FG000|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||37
6559926|NCT01784211|7482680|FG001|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||38
6559927|NCT01784211|7482681|FG002|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
6559928|NCT01784211|7482682|FG003|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
6559929|NCT01784211|7482683|FG004|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
6562869|NCT01803269|7485764|FG001|NOT COMPLETED|Overall Study||0
6356085|NCT00652626|7265182|FG005|STARTED|Initial Treatment Phase||0
6356086|NCT00652626|7265183|FG006|STARTED|Initial Treatment Phase||0
6356087|NCT00652626|7265177|FG000|Received Study Drug|Initial Treatment Phase||5
6356088|NCT00652626|7265178|FG001|Received Study Drug|Initial Treatment Phase||5
6356089|NCT00652626|7265179|FG002|Received Study Drug|Initial Treatment Phase||6
6356090|NCT00652626|7265180|FG003|Received Study Drug|Initial Treatment Phase||5
6356091|NCT00652626|7265181|FG004|Received Study Drug|Initial Treatment Phase||6
6356092|NCT00652626|7265182|FG005|Received Study Drug|Initial Treatment Phase||0
6356093|NCT00652626|7265183|FG006|Received Study Drug|Initial Treatment Phase||0
6356094|NCT00652626|7265177|FG000|COMPLETED|Initial Treatment Phase||5
6356095|NCT00652626|7265178|FG001|COMPLETED|Initial Treatment Phase||5
6356096|NCT00652626|7265179|FG002|COMPLETED|Initial Treatment Phase||6
6356097|NCT00652626|7265180|FG003|COMPLETED|Initial Treatment Phase||5
6356098|NCT00652626|7265181|FG004|COMPLETED|Initial Treatment Phase||5
6356099|NCT00652626|7265182|FG005|COMPLETED|Initial Treatment Phase||0
6356100|NCT00652626|7265183|FG006|COMPLETED|Initial Treatment Phase||0
6356101|NCT00652626|7265177|FG000|NOT COMPLETED|Initial Treatment Phase||0
6356102|NCT00652626|7265178|FG001|NOT COMPLETED|Initial Treatment Phase||0
6356103|NCT00652626|7265179|FG002|NOT COMPLETED|Initial Treatment Phase||1
6356104|NCT00652626|7265180|FG003|NOT COMPLETED|Initial Treatment Phase||1
6356105|NCT00652626|7265181|FG004|NOT COMPLETED|Initial Treatment Phase||3
6356106|NCT00652626|7265182|FG005|NOT COMPLETED|Initial Treatment Phase||0
6356107|NCT00652626|7265183|FG006|NOT COMPLETED|Initial Treatment Phase||0
6356108|NCT00652626|7265177|FG000|STARTED|Extension Phase||0
6356109|NCT00652626|7265178|FG001|STARTED|Extension Phase||0
6356110|NCT00652626|7265179|FG002|STARTED|Extension Phase||0
6356111|NCT00652626|7265180|FG003|STARTED|Extension Phase||0
6356112|NCT00652626|7265181|FG004|STARTED|Extension Phase||0
6356113|NCT00652626|7265182|FG005|STARTED|Extension Phase||14
6356114|NCT00652626|7265183|FG006|STARTED|Extension Phase||4
6356115|NCT00652626|7265177|FG000|COMPLETED|Extension Phase||0
6356116|NCT00652626|7265178|FG001|COMPLETED|Extension Phase||0
6356117|NCT00652626|7265179|FG002|COMPLETED|Extension Phase||0
6356118|NCT00652626|7265180|FG003|COMPLETED|Extension Phase||0
6356119|NCT00652626|7265181|FG004|COMPLETED|Extension Phase||0
6356120|NCT00652626|7265182|FG005|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
6356121|NCT00652626|7265183|FG006|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
6356122|NCT00652626|7265177|FG000|NOT COMPLETED|Extension Phase||0
6356123|NCT00652626|7265178|FG001|NOT COMPLETED|Extension Phase||0
6356124|NCT00652626|7265179|FG002|NOT COMPLETED|Extension Phase||0
6356125|NCT00652626|7265180|FG003|NOT COMPLETED|Extension Phase||0
6356126|NCT00652626|7265181|FG004|NOT COMPLETED|Extension Phase||0
6356127|NCT00652626|7265182|FG005|NOT COMPLETED|Extension Phase||12
6356128|NCT00652626|7265183|FG006|NOT COMPLETED|Extension Phase||3
6356129|NCT00652743|7265204|FG000|STARTED|Months 12-18||219
6356130|NCT00652743|7265205|FG001|STARTED|Months 12-18||188
6356131|NCT00652743|7265206|FG002|STARTED|Months 12-18||437
6356132|NCT00652743|7265204|FG000|COMPLETED|Months 12-18||218
6356133|NCT00652743|7265205|FG001|COMPLETED|Months 12-18||186
6356134|NCT00652743|7265206|FG002|COMPLETED|Months 12-18||430
6356135|NCT00652743|7265204|FG000|NOT COMPLETED|Months 12-18||1
6356136|NCT00652743|7265205|FG001|NOT COMPLETED|Months 12-18||2
6356137|NCT00652743|7265206|FG002|NOT COMPLETED|Months 12-18||7
6356138|NCT00652743|7265204|FG000|STARTED|Months 24-30||212
6356139|NCT00652743|7265205|FG001|STARTED|Months 24-30||186
6356140|NCT00652743|7265206|FG002|STARTED|Months 24-30||433
6356141|NCT00652743|7265204|FG000|COMPLETED|Months 24-30||207
6356142|NCT00652743|7265205|FG001|COMPLETED|Months 24-30||185
6356143|NCT00652743|7265206|FG002|COMPLETED|Months 24-30||422
6356144|NCT00652743|7265204|FG000|NOT COMPLETED|Months 24-30||5
6559930|NCT01784211|7482684|FG005|Received at Least 1 Dose of Study Drug|Part A (Days 1-15)||0
6559931|NCT01784211|7482679|FG000|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|19
6559932|NCT01784211|7482680|FG001|Entered Part B|Part A (Days 1-15)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|21
6559933|NCT01784211|7482681|FG002|Entered Part B|Part A (Days 1-15)||0
6559934|NCT01784211|7482682|FG003|Entered Part B|Part A (Days 1-15)||0
6356145|NCT00652743|7265205|FG001|NOT COMPLETED|Months 24-30||1
6356146|NCT00652743|7265206|FG002|NOT COMPLETED|Months 24-30||11
6356147|NCT00652743|7265204|FG000|STARTED|Months 36-42||216
6356148|NCT00652743|7265205|FG001|STARTED|Months 36-42||185
6356149|NCT00652743|7265206|FG002|STARTED|Months 36-42||390
6356150|NCT00652743|7265204|FG000|COMPLETED|Months 36-42||210
6356151|NCT00652743|7265205|FG001|COMPLETED|Months 36-42||180
6356152|NCT00652743|7265206|FG002|COMPLETED|Months 36-42||381
6356153|NCT00652743|7265204|FG000|NOT COMPLETED|Months 36-42||6
6356154|NCT00652743|7265205|FG001|NOT COMPLETED|Months 36-42||5
6356155|NCT00652743|7265206|FG002|NOT COMPLETED|Months 36-42||9
6356156|NCT00652743|7265204|FG000|STARTED|Months 42-48||196
6356157|NCT00652743|7265205|FG001|STARTED|Months 42-48||170
6356158|NCT00652743|7265206|FG002|STARTED|Months 42-48||367
6356159|NCT00652743|7265204|FG000|COMPLETED|Months 42-48||196
6356160|NCT00652743|7265205|FG001|COMPLETED|Months 42-48||170
6356161|NCT00652743|7265206|FG002|COMPLETED|Months 42-48||367
6356162|NCT00652743|7265204|FG000|NOT COMPLETED|Months 42-48||0
6356163|NCT00652743|7265205|FG001|NOT COMPLETED|Months 42-48||0
6356164|NCT00652743|7265206|FG002|NOT COMPLETED|Months 42-48||0
6356165|NCT00652834|7265217|FG000|STARTED|Overall Study||23
6356166|NCT00652834|7265217|FG000|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
6356167|NCT00652834|7265217|FG000|NOT COMPLETED|Overall Study||5
6356168|NCT00652899|7265221|FG000|STARTED|Overall Study||14
6356169|NCT00652899|7265221|FG000|COMPLETED|Overall Study||12
6356170|NCT00652899|7265221|FG000|NOT COMPLETED|Overall Study||2
6356171|NCT00652938|7265232|FG000|STARTED|Overall Study||247
6356172|NCT00652938|7265233|FG001|STARTED|Overall Study||247
6356173|NCT00652938|7265234|FG002|STARTED|Overall Study||247
6356174|NCT00652938|7265232|FG000|COMPLETED|Overall Study||246
6356175|NCT00652938|7265233|FG001|COMPLETED|Overall Study||240
6356176|NCT00652938|7265234|FG002|COMPLETED|Overall Study||242
6356177|NCT00652938|7265232|FG000|NOT COMPLETED|Overall Study||1
6356178|NCT00652938|7265233|FG001|NOT COMPLETED|Overall Study||7
6356179|NCT00652938|7265234|FG002|NOT COMPLETED|Overall Study||5
6356180|NCT00652951|7265245|FG000|STARTED|Primary Phase||260
6356181|NCT00652951|7265246|FG001|STARTED|Primary Phase||260
6356182|NCT00652951|7265247|FG002|STARTED|Primary Phase||260
6356183|NCT00652951|7265245|FG000|COMPLETED|Primary Phase||260
6356184|NCT00652951|7265246|FG001|COMPLETED|Primary Phase||260
6356185|NCT00652951|7265247|FG002|COMPLETED|Primary Phase||260
6356186|NCT00652951|7265245|FG000|NOT COMPLETED|Primary Phase||0
6356187|NCT00652951|7265246|FG001|NOT COMPLETED|Primary Phase||0
6356188|NCT00652951|7265247|FG002|NOT COMPLETED|Primary Phase||0
6356189|NCT00652951|7265245|FG000|STARTED|Booster Phase||257
6356190|NCT00652951|7265246|FG001|STARTED|Booster Phase||259
6356191|NCT00652951|7265247|FG002|STARTED|Booster Phase||258
6356192|NCT00652951|7265245|FG000|COMPLETED|Booster Phase||256
6356193|NCT00652951|7265246|FG001|COMPLETED|Booster Phase||258
6356194|NCT00652951|7265247|FG002|COMPLETED|Booster Phase||258
6356195|NCT00652951|7265245|FG000|NOT COMPLETED|Booster Phase||1
6356196|NCT00652951|7265246|FG001|NOT COMPLETED|Booster Phase||1
6356197|NCT00652951|7265247|FG002|NOT COMPLETED|Booster Phase||0
6356198|NCT00653133|7265257|FG000|STARTED|Overall Study||1324
6356199|NCT00653133|7265258|FG001|STARTED|Overall Study||497
6356200|NCT00653133|7265257|FG000|COMPLETED|Overall Study||1324
6356201|NCT00653133|7265258|FG001|COMPLETED|Overall Study||497
6356202|NCT00653133|7265257|FG000|NOT COMPLETED|Overall Study||0
6356203|NCT00653133|7265258|FG001|NOT COMPLETED|Overall Study||0
6356204|NCT00653159|7265266|FG000|STARTED|Overall Study||11
6356205|NCT00653159|7265267|FG001|STARTED|Overall Study||12
6356206|NCT00653159|7265266|FG000|COMPLETED|Overall Study||6
6356207|NCT00653159|7265267|FG001|COMPLETED|Overall Study||9
6356208|NCT00653159|7265266|FG000|NOT COMPLETED|Overall Study||5
6356209|NCT00653159|7265267|FG001|NOT COMPLETED|Overall Study||3
6356210|NCT00653224|7265275|FG000|STARTED|Overall Study||293
6356211|NCT00653224|7265276|FG001|STARTED|Overall Study||287
6356212|NCT00653224|7265275|FG000|COMPLETED|Overall Study||286
6356213|NCT00653224|7265276|FG001|COMPLETED|Overall Study||280
6356214|NCT00653224|7265275|FG000|NOT COMPLETED|Overall Study||7
6356215|NCT00653224|7265276|FG001|NOT COMPLETED|Overall Study||7
6356216|NCT00653263|7265282|FG000|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
6356217|NCT00653263|7265282|FG000|COMPLETED|Overall Study||6
6356218|NCT00653263|7265282|FG000|NOT COMPLETED|Overall Study||2
6356219|NCT00653328|7265286|FG000|STARTED|Overall Study||15
6356220|NCT00653328|7265286|FG000|COMPLETED|Overall Study||0
6356221|NCT00653328|7265286|FG000|NOT COMPLETED|Overall Study||15
6356222|NCT00653432|7265292|FG000|STARTED|Overall Study||184
6356223|NCT00653432|7265293|FG001|STARTED|Overall Study||185
6356224|NCT00653432|7265292|FG000|Intend-to-treat ITT|Overall Study|3 of 184 excluded from ITT group for not having at least 1 post-injection visit. ITT=181 subjects|181
6356225|NCT00653432|7265293|FG001|Intend-to-treat ITT|Overall Study|1 of 185 excluded from ITT group for not having at least 1 post-injection visit. ITT=184 subjects|184
6356226|NCT00653432|7265292|FG000|COMPLETED|Overall Study||162
6356227|NCT00653432|7265293|FG001|COMPLETED|Overall Study||169
6356228|NCT00653432|7265292|FG000|NOT COMPLETED|Overall Study||22
6356229|NCT00653432|7265293|FG001|NOT COMPLETED|Overall Study||16
6356230|NCT00653861|7265299|FG000|STARTED|Overall Study||72
6356231|NCT00653861|7265299|FG000|COMPLETED|Overall Study||72
6356232|NCT00653861|7265299|FG000|NOT COMPLETED|Overall Study||0
6356233|NCT00653939|7265310|FG000|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
6356234|NCT00653939|7265311|FG001|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
6356235|NCT00653939|7265310|FG000|COMPLETED|Overall Study||19
6356236|NCT00653939|7265311|FG001|COMPLETED|Overall Study||17
6356237|NCT00653939|7265310|FG000|NOT COMPLETED|Overall Study||12
6356238|NCT00653939|7265311|FG001|NOT COMPLETED|Overall Study||15
6356239|NCT00653991|7265321|FG000|STARTED|3 Month Follow-up||444
6356240|NCT00653991|7265322|FG001|STARTED|3 Month Follow-up||491
6356241|NCT00653991|7265321|FG000|COMPLETED|3 Month Follow-up||294
6559935|NCT01784211|7482683|FG004|Entered Part B|Part A (Days 1-15)||0
6559936|NCT01784211|7482684|FG005|Entered Part B|Part A (Days 1-15)||0
6559937|NCT01784211|7482679|FG000|COMPLETED|Part A (Days 1-15)||35
6559938|NCT01784211|7482680|FG001|COMPLETED|Part A (Days 1-15)||36
6559939|NCT01784211|7482681|FG002|COMPLETED|Part A (Days 1-15)||0
6356242|NCT00653991|7265322|FG001|COMPLETED|3 Month Follow-up||334
6356243|NCT00653991|7265321|FG000|NOT COMPLETED|3 Month Follow-up||150
6356244|NCT00653991|7265322|FG001|NOT COMPLETED|3 Month Follow-up||157
6356245|NCT00653991|7265321|FG000|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|444
6356246|NCT00653991|7265322|FG001|STARTED|6 Month Follow-up|Completion of 3 month follow-up was not required for 6-month eligibility.|491
6356247|NCT00653991|7265321|FG000|COMPLETED|6 Month Follow-up||311
6356248|NCT00653991|7265322|FG001|COMPLETED|6 Month Follow-up||350
6356249|NCT00653991|7265321|FG000|NOT COMPLETED|6 Month Follow-up||133
6356250|NCT00653991|7265322|FG001|NOT COMPLETED|6 Month Follow-up||141
6356251|NCT00654004|7265332|FG000|STARTED|Overall Study||14
6356252|NCT00654004|7265333|FG001|STARTED|Overall Study||12
6356253|NCT00654004|7265332|FG000|COMPLETED|Overall Study||13
6356254|NCT00654004|7265333|FG001|COMPLETED|Overall Study||12
6356255|NCT00654004|7265332|FG000|NOT COMPLETED|Overall Study||1
6356256|NCT00654004|7265333|FG001|NOT COMPLETED|Overall Study||0
6356257|NCT00654030|7265339|FG000|STARTED|Overall Study||12
6356258|NCT00654030|7265339|FG000|COMPLETED|Overall Study||11
6356259|NCT00654030|7265339|FG000|NOT COMPLETED|Overall Study||1
6356260|NCT00654069|7265346|FG000|STARTED|Overall Study||136
6356261|NCT00654069|7265347|FG001|STARTED|Overall Study||135
6356262|NCT00654069|7265348|FG002|STARTED|Overall Study||134
6356263|NCT00654069|7265346|FG000|COMPLETED|Overall Study||119
6356264|NCT00654069|7265347|FG001|COMPLETED|Overall Study||124
6356265|NCT00654069|7265348|FG002|COMPLETED|Overall Study||116
6356266|NCT00654069|7265346|FG000|NOT COMPLETED|Overall Study||17
6356267|NCT00654069|7265347|FG001|NOT COMPLETED|Overall Study||11
6356268|NCT00654069|7265348|FG002|NOT COMPLETED|Overall Study||18
6356269|NCT00654147|7265358|FG000|STARTED|Overall Study||21
6356270|NCT00654147|7265359|FG001|STARTED|Overall Study||23
6356271|NCT00654147|7265358|FG000|COMPLETED|Overall Study||19
6356272|NCT00654147|7265359|FG001|COMPLETED|Overall Study||19
6356273|NCT00654147|7265358|FG000|NOT COMPLETED|Overall Study||2
6356274|NCT00654147|7265359|FG001|NOT COMPLETED|Overall Study||4
6356275|NCT00654186|7265365|FG000|STARTED|Overall Study||32
6356276|NCT00654186|7265365|FG000|COMPLETED|Overall Study||27
6356277|NCT00654186|7265365|FG000|NOT COMPLETED|Overall Study||5
6356278|NCT00654238|7265369|FG000|STARTED|Overall Study||59
6559940|NCT01784211|7482682|FG003|COMPLETED|Part A (Days 1-15)||0
6559941|NCT01784211|7482683|FG004|COMPLETED|Part A (Days 1-15)||0
6559942|NCT01784211|7482684|FG005|COMPLETED|Part A (Days 1-15)||0
6559943|NCT01784211|7482679|FG000|NOT COMPLETED|Part A (Days 1-15)||3
6559944|NCT01784211|7482680|FG001|NOT COMPLETED|Part A (Days 1-15)||2
6559945|NCT01784211|7482681|FG002|NOT COMPLETED|Part A (Days 1-15)||0
6559946|NCT01784211|7482682|FG003|NOT COMPLETED|Part A (Days 1-15)||0
6559947|NCT01784211|7482683|FG004|NOT COMPLETED|Part A (Days 1-15)||0
6559948|NCT01784211|7482684|FG005|NOT COMPLETED|Part A (Days 1-15)||0
6559949|NCT01784211|7482679|FG000|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
6559950|NCT01784211|7482680|FG001|STARTED|Part B (Days 16-21)|Participants who completed Part A and met certain criteria had the option of continuing to Part B.|0
6559951|NCT01784211|7482681|FG002|STARTED|Part B (Days 16-21)||10
6559952|NCT01784211|7482682|FG003|STARTED|Part B (Days 16-21)||9
6559953|NCT01784211|7482683|FG004|STARTED|Part B (Days 16-21)||11
6559954|NCT01784211|7482684|FG005|STARTED|Part B (Days 16-21)||10
6559955|NCT01784211|7482679|FG000|COMPLETED|Part B (Days 16-21)||0
6559956|NCT01784211|7482680|FG001|COMPLETED|Part B (Days 16-21)||0
6559957|NCT01784211|7482681|FG002|COMPLETED|Part B (Days 16-21)||10
6559958|NCT01784211|7482682|FG003|COMPLETED|Part B (Days 16-21)||9
6559959|NCT01784211|7482683|FG004|COMPLETED|Part B (Days 16-21)||11
6559960|NCT01784211|7482684|FG005|COMPLETED|Part B (Days 16-21)||10
6559961|NCT01784211|7482679|FG000|NOT COMPLETED|Part B (Days 16-21)||0
6559962|NCT01784211|7482680|FG001|NOT COMPLETED|Part B (Days 16-21)||0
6559963|NCT01784211|7482681|FG002|NOT COMPLETED|Part B (Days 16-21)||0
6559964|NCT01784211|7482682|FG003|NOT COMPLETED|Part B (Days 16-21)||0
6559965|NCT01784211|7482683|FG004|NOT COMPLETED|Part B (Days 16-21)||0
6559966|NCT01784211|7482684|FG005|NOT COMPLETED|Part B (Days 16-21)||0
6356279|NCT00654238|7265369|FG000|COMPLETED|Overall Study||55
6356280|NCT00654238|7265369|FG000|NOT COMPLETED|Overall Study||4
6356281|NCT00654329|7265378|FG000|STARTED|Overall Study||23
6356282|NCT00654329|7265379|FG001|STARTED|Overall Study||28
6356283|NCT00654329|7265380|FG002|STARTED|Overall Study||23
6356284|NCT00654329|7265381|FG003|STARTED|Overall Study||27
6356285|NCT00654329|7265378|FG000|COMPLETED|Overall Study||23
6356286|NCT00654329|7265379|FG001|COMPLETED|Overall Study||28
6356287|NCT00654329|7265380|FG002|COMPLETED|Overall Study||23
6356288|NCT00654329|7265381|FG003|COMPLETED|Overall Study||27
6356289|NCT00654329|7265378|FG000|NOT COMPLETED|Overall Study||0
6356290|NCT00654329|7265379|FG001|NOT COMPLETED|Overall Study||0
6356291|NCT00654329|7265380|FG002|NOT COMPLETED|Overall Study||0
6356292|NCT00654329|7265381|FG003|NOT COMPLETED|Overall Study||0
6356293|NCT00654355|7265393|FG000|STARTED|Overall Study||15
6356294|NCT00654355|7265394|FG001|STARTED|Overall Study||15
6356295|NCT00654355|7265393|FG000|COMPLETED|Overall Study||13
6356296|NCT00654355|7265394|FG001|COMPLETED|Overall Study||13
6356297|NCT00654355|7265393|FG000|NOT COMPLETED|Overall Study||2
6356298|NCT00654355|7265394|FG001|NOT COMPLETED|Overall Study||2
6356299|NCT00654368|7265403|FG000|STARTED|Overall Study||53
6356300|NCT00654368|7265404|FG001|STARTED|Overall Study||98
6356301|NCT00654368|7265405|FG002|STARTED|Overall Study||107
6356302|NCT00654368|7265403|FG000|COMPLETED|Overall Study||0
6356303|NCT00654368|7265404|FG001|COMPLETED|Overall Study||50
6356304|NCT00654368|7265405|FG002|COMPLETED|Overall Study||75
6356305|NCT00654368|7265403|FG000|NOT COMPLETED|Overall Study||53
6356306|NCT00654368|7265404|FG001|NOT COMPLETED|Overall Study||48
6356307|NCT00654368|7265405|FG002|NOT COMPLETED|Overall Study||32
6356308|NCT00654381|7265416|FG000|STARTED|1st Stage||39
6356309|NCT00654381|7265417|FG001|STARTED|1st Stage||41
6356310|NCT00654381|7265418|FG002|STARTED|1st Stage||159
6356311|NCT00654381|7265419|FG003|STARTED|1st Stage||160
6356312|NCT00654381|7265420|FG004|STARTED|1st Stage||81
6356313|NCT00654381|7265421|FG005|STARTED|1st Stage||81
6356314|NCT00654381|7265416|FG000|COMPLETED|1st Stage||36
6356315|NCT00654381|7265417|FG001|COMPLETED|1st Stage||38
6356316|NCT00654381|7265418|FG002|COMPLETED|1st Stage||156
6356317|NCT00654381|7265419|FG003|COMPLETED|1st Stage||155
6356318|NCT00654381|7265420|FG004|COMPLETED|1st Stage||79
6356319|NCT00654381|7265421|FG005|COMPLETED|1st Stage||79
6356320|NCT00654381|7265416|FG000|NOT COMPLETED|1st Stage||3
6356321|NCT00654381|7265417|FG001|NOT COMPLETED|1st Stage||3
6356322|NCT00654381|7265418|FG002|NOT COMPLETED|1st Stage||3
6356323|NCT00654381|7265419|FG003|NOT COMPLETED|1st Stage||5
6356324|NCT00654381|7265420|FG004|NOT COMPLETED|1st Stage||2
6356325|NCT00654381|7265421|FG005|NOT COMPLETED|1st Stage||2
6356326|NCT00654381|7265416|FG000|STARTED|2nd Stage||36
6356327|NCT00654381|7265417|FG001|STARTED|2nd Stage||38
6356328|NCT00654381|7265418|FG002|STARTED|2nd Stage||156
6356329|NCT00654381|7265419|FG003|STARTED|2nd Stage||155
6356330|NCT00654381|7265420|FG004|STARTED|2nd Stage||79
6356331|NCT00654381|7265421|FG005|STARTED|2nd Stage||79
6356332|NCT00654381|7265416|FG000|COMPLETED|2nd Stage||34
6356333|NCT00654381|7265417|FG001|COMPLETED|2nd Stage||38
6356334|NCT00654381|7265418|FG002|COMPLETED|2nd Stage||153
6356335|NCT00654381|7265419|FG003|COMPLETED|2nd Stage||151
6356336|NCT00654381|7265420|FG004|COMPLETED|2nd Stage||71
6356337|NCT00654381|7265421|FG005|COMPLETED|2nd Stage||76
6356338|NCT00654381|7265416|FG000|NOT COMPLETED|2nd Stage||2
6356339|NCT00654381|7265417|FG001|NOT COMPLETED|2nd Stage||0
6356340|NCT00654381|7265418|FG002|NOT COMPLETED|2nd Stage||3
6356341|NCT00654381|7265419|FG003|NOT COMPLETED|2nd Stage||4
6356342|NCT00654381|7265420|FG004|NOT COMPLETED|2nd Stage||8
6356343|NCT00654381|7265421|FG005|NOT COMPLETED|2nd Stage||3
6356344|NCT00654381|7265416|FG000|STARTED|Extension Stage||34
6356345|NCT00654381|7265417|FG001|STARTED|Extension Stage||38
6356346|NCT00654381|7265418|FG002|STARTED|Extension Stage||153
6356347|NCT00654381|7265419|FG003|STARTED|Extension Stage||151
6356348|NCT00654381|7265420|FG004|STARTED|Extension Stage||71
6356349|NCT00654381|7265421|FG005|STARTED|Extension Stage||76
6356350|NCT00654381|7265416|FG000|COMPLETED|Extension Stage||33
6356351|NCT00654381|7265417|FG001|COMPLETED|Extension Stage||36
6356352|NCT00654381|7265418|FG002|COMPLETED|Extension Stage||142
6356353|NCT00654381|7265419|FG003|COMPLETED|Extension Stage||142
6356354|NCT00654381|7265420|FG004|COMPLETED|Extension Stage||68
6356355|NCT00654381|7265421|FG005|COMPLETED|Extension Stage||73
6356356|NCT00654381|7265416|FG000|NOT COMPLETED|Extension Stage||1
6356357|NCT00654381|7265417|FG001|NOT COMPLETED|Extension Stage||2
6356358|NCT00654381|7265418|FG002|NOT COMPLETED|Extension Stage||11
6356359|NCT00654381|7265419|FG003|NOT COMPLETED|Extension Stage||9
6356360|NCT00654381|7265420|FG004|NOT COMPLETED|Extension Stage||3
6356361|NCT00654381|7265421|FG005|NOT COMPLETED|Extension Stage||3
6356362|NCT00654420|7265442|FG000|STARTED|Phase I (Dose Escalation)||4
6356363|NCT00654420|7265443|FG001|STARTED|Phase I (Dose Escalation)||16
6356364|NCT00654420|7265444|FG002|STARTED|Phase I (Dose Escalation)||0
6356365|NCT00654420|7265445|FG003|STARTED|Phase I (Dose Escalation)||0
6356366|NCT00654420|7265442|FG000|COMPLETED|Phase I (Dose Escalation)||0
6356367|NCT00654420|7265443|FG001|COMPLETED|Phase I (Dose Escalation)||0
6356368|NCT00654420|7265444|FG002|COMPLETED|Phase I (Dose Escalation)||0
6356369|NCT00654420|7265445|FG003|COMPLETED|Phase I (Dose Escalation)||0
6356370|NCT00654420|7265442|FG000|NOT COMPLETED|Phase I (Dose Escalation)||4
6356371|NCT00654420|7265443|FG001|NOT COMPLETED|Phase I (Dose Escalation)||16
6356372|NCT00654420|7265444|FG002|NOT COMPLETED|Phase I (Dose Escalation)||0
6356373|NCT00654420|7265445|FG003|NOT COMPLETED|Phase I (Dose Escalation)||0
6356374|NCT00654420|7265442|FG000|STARTED|Phase II||0
6356375|NCT00654420|7265443|FG001|STARTED|Phase II||0
6356376|NCT00654420|7265444|FG002|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
6356377|NCT00654420|7265445|FG003|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
6356378|NCT00654420|7265442|FG000|COMPLETED|Phase II||0
6356379|NCT00654420|7265443|FG001|COMPLETED|Phase II||0
6356380|NCT00654420|7265444|FG002|COMPLETED|Phase II||0
6356381|NCT00654420|7265445|FG003|COMPLETED|Phase II||0
6356382|NCT00654420|7265442|FG000|NOT COMPLETED|Phase II||0
6356383|NCT00654420|7265443|FG001|NOT COMPLETED|Phase II||0
6356384|NCT00654420|7265444|FG002|NOT COMPLETED|Phase II||37
6356385|NCT00654420|7265445|FG003|NOT COMPLETED|Phase II||38
6356386|NCT00654498|7265457|FG000|STARTED|Overall Study||203
6356387|NCT00654498|7265458|FG001|STARTED|Overall Study||103
6356388|NCT00654498|7265457|FG000|COMPLETED|Overall Study||189
6356389|NCT00654498|7265458|FG001|COMPLETED|Overall Study||91
6356390|NCT00654498|7265457|FG000|NOT COMPLETED|Overall Study||14
6356391|NCT00654498|7265458|FG001|NOT COMPLETED|Overall Study||12
6376993|NCT00761657|7287536|FG008|EE Population|Part 2 (up to Day 114)||11
6376994|NCT00761657|7287528|FG000|PK Population|Part 2 (up to Day 114)||10
6376995|NCT00761657|7287529|FG001|PK Population|Part 2 (up to Day 114)||13
6376996|NCT00761657|7287530|FG002|PK Population|Part 2 (up to Day 114)||0
6559967|NCT01784419|7482696|FG000|STARTED|Overall Study||10
6559968|NCT01784419|7482696|FG000|COMPLETED|Overall Study||7
6559969|NCT01784419|7482696|FG000|NOT COMPLETED|Overall Study||3
6559970|NCT01784523|7482702|FG000|STARTED|Overall Study||7
6559971|NCT01784523|7482703|FG001|STARTED|Overall Study||4
6559972|NCT01784523|7482702|FG000|COMPLETED|Overall Study||0
6559973|NCT01784523|7482703|FG001|COMPLETED|Overall Study||0
6559974|NCT01784523|7482702|FG000|NOT COMPLETED|Overall Study||7
6559975|NCT01784523|7482703|FG001|NOT COMPLETED|Overall Study||4
6559976|NCT01784588|7482711|FG000|STARTED|Overall Study||141
6559977|NCT01784588|7482712|FG001|STARTED|Overall Study||140
6559978|NCT01784588|7482711|FG000|COMPLETED|Overall Study||104
6376997|NCT00761657|7287531|FG003|PK Population|Part 2 (up to Day 114)||0
6376998|NCT00761657|7287532|FG004|PK Population|Part 2 (up to Day 114)||10
6376999|NCT00761657|7287533|FG005|PK Population|Part 2 (up to Day 114)||11
6377000|NCT00761657|7287534|FG006|PK Population|Part 2 (up to Day 114)||10
6377001|NCT00761657|7287535|FG007|PK Population|Part 2 (up to Day 114)||10
6377002|NCT00761657|7287536|FG008|PK Population|Part 2 (up to Day 114)||0
6377003|NCT00761657|7287528|FG000|COMPLETED|Part 2 (up to Day 114)||10
6377004|NCT00761657|7287529|FG001|COMPLETED|Part 2 (up to Day 114)||13
6377005|NCT00761657|7287530|FG002|COMPLETED|Part 2 (up to Day 114)||0
6377006|NCT00761657|7287531|FG003|COMPLETED|Part 2 (up to Day 114)||0
6377007|NCT00761657|7287532|FG004|COMPLETED|Part 2 (up to Day 114)||10
6377008|NCT00761657|7287533|FG005|COMPLETED|Part 2 (up to Day 114)||11
6377009|NCT00761657|7287534|FG006|COMPLETED|Part 2 (up to Day 114)||10
6377010|NCT00761657|7287535|FG007|COMPLETED|Part 2 (up to Day 114)||10
6377011|NCT00761657|7287536|FG008|COMPLETED|Part 2 (up to Day 114)||17
6377012|NCT00761657|7287528|FG000|NOT COMPLETED|Part 2 (up to Day 114)||0
6377013|NCT00761657|7287529|FG001|NOT COMPLETED|Part 2 (up to Day 114)||0
6377014|NCT00761657|7287530|FG002|NOT COMPLETED|Part 2 (up to Day 114)||0
6377015|NCT00761657|7287531|FG003|NOT COMPLETED|Part 2 (up to Day 114)||0
6377016|NCT00761657|7287532|FG004|NOT COMPLETED|Part 2 (up to Day 114)||0
6377017|NCT00761657|7287533|FG005|NOT COMPLETED|Part 2 (up to Day 114)||0
6377018|NCT00761657|7287534|FG006|NOT COMPLETED|Part 2 (up to Day 114)||0
6377019|NCT00761657|7287535|FG007|NOT COMPLETED|Part 2 (up to Day 114)||0
6377020|NCT00761657|7287536|FG008|NOT COMPLETED|Part 2 (up to Day 114)||1
6377021|NCT00761735|7287566|FG000|STARTED|Overall Study||94
6377022|NCT00761735|7287566|FG000|COMPLETED|Overall Study||80
6377023|NCT00761735|7287566|FG000|NOT COMPLETED|Overall Study||14
6377024|NCT00761748|7287574|FG000|STARTED|First Intervention (21 +/- 3 Days)||20
6377025|NCT00761748|7287575|FG001|STARTED|First Intervention (21 +/- 3 Days)||10
6377026|NCT00761748|7287574|FG000|COMPLETED|First Intervention (21 +/- 3 Days)||17
6377027|NCT00761748|7287575|FG001|COMPLETED|First Intervention (21 +/- 3 Days)||7
6377028|NCT00761748|7287574|FG000|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
6377029|NCT00761748|7287575|FG001|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
6377030|NCT00761748|7287574|FG000|STARTED|Second Intervention (21 +/- 3 Days)||17
6377031|NCT00761748|7287575|FG001|STARTED|Second Intervention (21 +/- 3 Days)||7
6377032|NCT00761748|7287574|FG000|COMPLETED|Second Intervention (21 +/- 3 Days)||17
6377033|NCT00761748|7287575|FG001|COMPLETED|Second Intervention (21 +/- 3 Days)||7
6377034|NCT00761748|7287574|FG000|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
6377035|NCT00761748|7287575|FG001|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
6377036|NCT00761761|7287583|FG000|STARTED|Overall Study||30
6377037|NCT00761761|7287584|FG001|STARTED|Overall Study||30
6377038|NCT00761761|7287583|FG000|COMPLETED|Overall Study||24
6377039|NCT00761761|7287584|FG001|COMPLETED|Overall Study||29
6377040|NCT00761761|7287583|FG000|NOT COMPLETED|Overall Study||6
6377041|NCT00761761|7287584|FG001|NOT COMPLETED|Overall Study||1
6377042|NCT00761774|7287592|FG000|STARTED|Overall Study||108
6377043|NCT00761774|7287592|FG000|COMPLETED|Overall Study||29
6559979|NCT01784588|7482712|FG001|COMPLETED|Overall Study||108
6559980|NCT01784588|7482711|FG000|NOT COMPLETED|Overall Study||37
6559981|NCT01784588|7482712|FG001|NOT COMPLETED|Overall Study||32
6356392|NCT00654511|7265468|FG000|STARTED|Overall Study||26
6356393|NCT00654511|7265469|FG001|STARTED|Overall Study||25
6356394|NCT00654511|7265470|FG002|STARTED|Overall Study||25
6356395|NCT00654511|7265471|FG003|STARTED|Overall Study||25
6356396|NCT00654511|7265468|FG000|COMPLETED|Overall Study||26
6356397|NCT00654511|7265469|FG001|COMPLETED|Overall Study||25
6356398|NCT00654511|7265470|FG002|COMPLETED|Overall Study||25
6356399|NCT00654511|7265471|FG003|COMPLETED|Overall Study||25
6356400|NCT00654511|7265468|FG000|NOT COMPLETED|Overall Study||0
6356401|NCT00654511|7265469|FG001|NOT COMPLETED|Overall Study||0
6356402|NCT00654511|7265470|FG002|NOT COMPLETED|Overall Study||0
6356403|NCT00654511|7265471|FG003|NOT COMPLETED|Overall Study||0
6356404|NCT00654615|7265487|FG000|STARTED|Overall Study||30
6356405|NCT00654615|7265488|FG001|STARTED|Overall Study||30
6559982|NCT01784614|7482718|FG000|STARTED|Period 1||3
6559983|NCT01784614|7482719|FG001|STARTED|Period 1||3
6559984|NCT01784614|7482720|FG002|STARTED|Period 1||3
6356406|NCT00654615|7265487|FG000|COMPLETED|Overall Study||22
6356407|NCT00654615|7265488|FG001|COMPLETED|Overall Study||23
6356408|NCT00654615|7265487|FG000|NOT COMPLETED|Overall Study||8
6356409|NCT00654615|7265488|FG001|NOT COMPLETED|Overall Study||7
6356410|NCT00654641|7265496|FG000|STARTED|Overall Study||28
6356411|NCT00654641|7265497|FG001|STARTED|Overall Study||26
6356412|NCT00654641|7265496|FG000|COMPLETED|Overall Study||26
6356413|NCT00654641|7265497|FG001|COMPLETED|Overall Study||23
6356414|NCT00654641|7265496|FG000|NOT COMPLETED|Overall Study||2
6356415|NCT00654641|7265497|FG001|NOT COMPLETED|Overall Study||3
6356416|NCT00654654|7265503|FG000|STARTED|Overall Study||50
6356417|NCT00654654|7265503|FG000|COMPLETED|Overall Study||43
6356418|NCT00654654|7265503|FG000|NOT COMPLETED|Overall Study||7
6356419|NCT00654732|7265509|FG000|STARTED|Overall Study||26
6356420|NCT00654732|7265510|FG001|STARTED|Overall Study||32
6356421|NCT00654732|7265509|FG000|COMPLETED|Overall Study||22
6356422|NCT00654732|7265510|FG001|COMPLETED|Overall Study||26
6356423|NCT00654732|7265509|FG000|NOT COMPLETED|Overall Study||4
6356424|NCT00654732|7265510|FG001|NOT COMPLETED|Overall Study||6
6356425|NCT00654745|7265516|FG000|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
6356426|NCT00654745|7265516|FG000|COMPLETED|Overall Study||164
6356427|NCT00654745|7265516|FG000|NOT COMPLETED|Overall Study||43
6356428|NCT00654784|7265528|FG000|STARTED|Overall Study||13
6356429|NCT00654784|7265529|FG001|STARTED|Overall Study||8
6356430|NCT00654784|7265528|FG000|COMPLETED|Overall Study||13
6356431|NCT00654784|7265529|FG001|COMPLETED|Overall Study||8
6356432|NCT00654784|7265528|FG000|NOT COMPLETED|Overall Study||0
6356433|NCT00654784|7265529|FG001|NOT COMPLETED|Overall Study||0
6356434|NCT00654836|7265535|FG000|STARTED|Overall Study||32
6356435|NCT00654836|7265535|FG000|COMPLETED|Overall Study||32
6356436|NCT00654836|7265535|FG000|NOT COMPLETED|Overall Study||0
6356437|NCT00654875|7265541|FG000|STARTED|Overall Study||164
6356438|NCT00654875|7265542|FG001|STARTED|Overall Study||164
6356439|NCT00654875|7265541|FG000|COMPLETED|Overall Study||147
6356440|NCT00654875|7265542|FG001|COMPLETED|Overall Study||147
6356441|NCT00654875|7265541|FG000|NOT COMPLETED|Overall Study||17
6356442|NCT00654875|7265542|FG001|NOT COMPLETED|Overall Study||17
6356443|NCT00654901|7265552|FG000|STARTED|Overall Study||254
6356444|NCT00654901|7265553|FG001|STARTED|Overall Study||262
6356445|NCT00654901|7265554|FG002|STARTED|Overall Study||252
6356446|NCT00654901|7265555|FG003|STARTED|Overall Study||113
6356447|NCT00654901|7265552|FG000|COMPLETED|Overall Study||250
6356448|NCT00654901|7265553|FG001|COMPLETED|Overall Study||262
6356449|NCT00654901|7265554|FG002|COMPLETED|Overall Study||250
6356450|NCT00654901|7265555|FG003|COMPLETED|Overall Study||113
6356451|NCT00654901|7265552|FG000|NOT COMPLETED|Overall Study||4
6356452|NCT00654901|7265553|FG001|NOT COMPLETED|Overall Study||0
6356453|NCT00654901|7265554|FG002|NOT COMPLETED|Overall Study||2
6356454|NCT00654901|7265555|FG003|NOT COMPLETED|Overall Study||0
6356455|NCT00654927|7265565|FG000|STARTED|Overall Study||177
6356456|NCT00654927|7265565|FG000|COMPLETED|Overall Study||70
6356457|NCT00654927|7265565|FG000|NOT COMPLETED|Overall Study||107
6356458|NCT00654940|7265571|FG000|STARTED|Period 1|Assigned to study treatment.|13
6356459|NCT00654940|7265572|FG001|STARTED|Period 1|Assigned to study treatment.|12
6559985|NCT01784614|7482721|FG003|STARTED|Period 1||3
6559986|NCT01784614|7482722|FG004|STARTED|Period 1||3
6559987|NCT01784614|7482723|FG005|STARTED|Period 1||3
6559988|NCT01784614|7482724|FG006|STARTED|Period 1||3
6559989|NCT01784614|7482725|FG007|STARTED|Period 1||3
6559990|NCT01784614|7482718|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
6356460|NCT00654940|7265571|FG000|Received Study Treatment|Period 1||12
6356461|NCT00654940|7265572|FG001|Received Study Treatment|Period 1||12
6356462|NCT00654940|7265571|FG000|COMPLETED|Period 1||12
6356463|NCT00654940|7265572|FG001|COMPLETED|Period 1||11
6356464|NCT00654940|7265571|FG000|NOT COMPLETED|Period 1||1
6356465|NCT00654940|7265572|FG001|NOT COMPLETED|Period 1||1
6356466|NCT00654940|7265571|FG000|STARTED|Washout Period of 2 Weeks||12
6356467|NCT00654940|7265572|FG001|STARTED|Washout Period of 2 Weeks||11
6356468|NCT00654940|7265571|FG000|COMPLETED|Washout Period of 2 Weeks||12
6356469|NCT00654940|7265572|FG001|COMPLETED|Washout Period of 2 Weeks||11
6356470|NCT00654940|7265571|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6356471|NCT00654940|7265572|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6559991|NCT01784614|7482719|FG001|Received at Least 1 Dose of Study Drug|Period 1||3
6559992|NCT01784614|7482720|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
6356472|NCT00654940|7265571|FG000|STARTED|Period 2||12
6356473|NCT00654940|7265572|FG001|STARTED|Period 2||11
6356474|NCT00654940|7265571|FG000|COMPLETED|Period 2||12
6356475|NCT00654940|7265572|FG001|COMPLETED|Period 2||11
6356476|NCT00654940|7265571|FG000|NOT COMPLETED|Period 2||0
6356477|NCT00654940|7265572|FG001|NOT COMPLETED|Period 2||0
6356478|NCT00654953|7265587|FG000|STARTED|Overall Study||36
6356479|NCT00654953|7265588|FG001|STARTED|Overall Study||36
6356480|NCT00654953|7265589|FG002|STARTED|Overall Study||30
6356481|NCT00654953|7265587|FG000|COMPLETED|Overall Study||6
6356482|NCT00654953|7265588|FG001|COMPLETED|Overall Study||8
6356483|NCT00654953|7265589|FG002|COMPLETED|Overall Study||8
6356484|NCT00654953|7265587|FG000|NOT COMPLETED|Overall Study||30
6559993|NCT01784614|7482721|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
6559994|NCT01784614|7482722|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
6559995|NCT01784614|7482723|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
6559996|NCT01784614|7482724|FG006|Received at Least 1 Dose of Study Drug|Period 1||3
6356485|NCT00654953|7265588|FG001|NOT COMPLETED|Overall Study||28
6356486|NCT00654953|7265589|FG002|NOT COMPLETED|Overall Study||22
6356487|NCT00655083|7265599|FG000|STARTED|Overall Study||12
6356488|NCT00655083|7265600|FG001|STARTED|Overall Study||8
6356489|NCT00655083|7265599|FG000|COMPLETED|Overall Study||12
6356490|NCT00655083|7265600|FG001|COMPLETED|Overall Study||8
6356491|NCT00655083|7265599|FG000|NOT COMPLETED|Overall Study||0
6356492|NCT00655083|7265600|FG001|NOT COMPLETED|Overall Study||0
6356493|NCT00655356|7265608|FG000|STARTED|Overall Study||110
6356494|NCT00655356|7265609|FG001|STARTED|Overall Study||108
6356495|NCT00655356|7265608|FG000|COMPLETED|Overall Study||93
6356496|NCT00655356|7265609|FG001|COMPLETED|Overall Study||98
6356497|NCT00655356|7265608|FG000|NOT COMPLETED|Overall Study||17
6356498|NCT00655356|7265609|FG001|NOT COMPLETED|Overall Study||10
6356499|NCT00655473|7265617|FG000|STARTED|Overall Study||64
6356500|NCT00655473|7265618|FG001|STARTED|Overall Study||66
6356501|NCT00655473|7265617|FG000|COMPLETED|Overall Study||53
6356502|NCT00655473|7265618|FG001|COMPLETED|Overall Study||51
6356503|NCT00655473|7265617|FG000|NOT COMPLETED|Overall Study||11
6356504|NCT00655473|7265618|FG001|NOT COMPLETED|Overall Study||15
6356505|NCT00655486|7265624|FG000|STARTED|Overall Study||97
6356506|NCT00655486|7265624|FG000|COMPLETED|Overall Study||69
6356507|NCT00655486|7265624|FG000|NOT COMPLETED|Overall Study||28
6356508|NCT00655499|7265628|FG000|STARTED|Overall Study||69
6356509|NCT00655499|7265628|FG000|COMPLETED|Overall Study||65
6356510|NCT00655499|7265628|FG000|NOT COMPLETED|Overall Study||4
6356511|NCT00655538|7265635|FG000|STARTED|Overall Study||238
6356512|NCT00655538|7265636|FG001|STARTED|Overall Study||238
6356513|NCT00655538|7265635|FG000|COMPLETED|Overall Study||214
6356514|NCT00655538|7265636|FG001|COMPLETED|Overall Study||211
6356515|NCT00655538|7265635|FG000|NOT COMPLETED|Overall Study||24
6356516|NCT00655538|7265636|FG001|NOT COMPLETED|Overall Study||27
6356517|NCT00655551|7265645|FG000|STARTED|All Periods Combined||25
6356518|NCT00655551|7265646|FG001|STARTED|All Periods Combined||50
6356519|NCT00655551|7265647|FG002|STARTED|All Periods Combined||25
6356520|NCT00655551|7265645|FG000|COMPLETED|All Periods Combined||25
6356521|NCT00655551|7265646|FG001|COMPLETED|All Periods Combined||47
6356522|NCT00655551|7265647|FG002|COMPLETED|All Periods Combined||21
6356523|NCT00655551|7265645|FG000|NOT COMPLETED|All Periods Combined||0
6356524|NCT00655551|7265646|FG001|NOT COMPLETED|All Periods Combined||3
6356525|NCT00655551|7265647|FG002|NOT COMPLETED|All Periods Combined||4
6356526|NCT00655551|7265645|FG000|STARTED|Period 1 (up to 7 Days)||25
6356527|NCT00655551|7265646|FG001|STARTED|Period 1 (up to 7 Days)||0
6356528|NCT00655551|7265647|FG002|STARTED|Period 1 (up to 7 Days)||0
6356529|NCT00655551|7265645|FG000|COMPLETED|Period 1 (up to 7 Days)||25
6356530|NCT00655551|7265646|FG001|COMPLETED|Period 1 (up to 7 Days)||0
6356531|NCT00655551|7265647|FG002|COMPLETED|Period 1 (up to 7 Days)||0
6356532|NCT00655551|7265645|FG000|NOT COMPLETED|Period 1 (up to 7 Days)||0
6356533|NCT00655551|7265646|FG001|NOT COMPLETED|Period 1 (up to 7 Days)||0
6356534|NCT00655551|7265647|FG002|NOT COMPLETED|Period 1 (up to 7 Days)||0
6356535|NCT00655551|7265645|FG000|STARTED|Period 2 (up to 7 Days)||0
6356536|NCT00655551|7265646|FG001|STARTED|Period 2 (up to 7 Days)||25
6356537|NCT00655551|7265647|FG002|STARTED|Period 2 (up to 7 Days)||0
6356538|NCT00655551|7265645|FG000|COMPLETED|Period 2 (up to 7 Days)||0
6356539|NCT00655551|7265646|FG001|COMPLETED|Period 2 (up to 7 Days)||24
6356540|NCT00655551|7265647|FG002|COMPLETED|Period 2 (up to 7 Days)||0
6356541|NCT00655551|7265645|FG000|NOT COMPLETED|Period 2 (up to 7 Days)||0
6356542|NCT00655551|7265646|FG001|NOT COMPLETED|Period 2 (up to 7 Days)||1
6356543|NCT00655551|7265647|FG002|NOT COMPLETED|Period 2 (up to 7 Days)||0
6356544|NCT00655551|7265645|FG000|STARTED|Period 3 (up to 7 Days)||0
6356545|NCT00655551|7265646|FG001|STARTED|Period 3 (up to 7 Days)||0
6356546|NCT00655551|7265647|FG002|STARTED|Period 3 (up to 7 Days)||25
6356547|NCT00655551|7265645|FG000|COMPLETED|Period 3 (up to 7 Days)||0
6356548|NCT00655551|7265646|FG001|COMPLETED|Period 3 (up to 7 Days)||0
6356549|NCT00655551|7265647|FG002|COMPLETED|Period 3 (up to 7 Days)||21
6356550|NCT00655551|7265645|FG000|NOT COMPLETED|Period 3 (up to 7 Days)||0
6356551|NCT00655551|7265646|FG001|NOT COMPLETED|Period 3 (up to 7 Days)||0
6356552|NCT00655551|7265647|FG002|NOT COMPLETED|Period 3 (up to 7 Days)||4
6356553|NCT00655551|7265645|FG000|STARTED|Period 4 (up to 7 Days)||0
6356554|NCT00655551|7265646|FG001|STARTED|Period 4 (up to 7 Days)||25
6356555|NCT00655551|7265647|FG002|STARTED|Period 4 (up to 7 Days)||0
6356556|NCT00655551|7265645|FG000|COMPLETED|Period 4 (up to 7 Days)||0
6776456|NCT03836677|7704496|FG001|NOT COMPLETED|Washout||0
6776457|NCT03836677|7704495|FG000|STARTED|Period 2||13
6776458|NCT03836677|7704496|FG001|STARTED|Period 2||9
6776459|NCT03836677|7704495|FG000|COMPLETED|Period 2||12
6776460|NCT03836677|7704496|FG001|COMPLETED|Period 2||9
6776461|NCT03836677|7704495|FG000|NOT COMPLETED|Period 2||1
6776462|NCT03836677|7704496|FG001|NOT COMPLETED|Period 2||0
6776463|NCT03836989|7704504|FG000|STARTED|Overall Study||4
6776464|NCT03836989|7704505|FG001|STARTED|Overall Study||0
6776465|NCT03836989|7704504|FG000|Subjects > 60 Years Old With Complete Paralysis|Overall Study||1
6776466|NCT03836989|7704505|FG001|Subjects > 60 Years Old With Complete Paralysis|Overall Study||0
6776467|NCT03836989|7704504|FG000|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||1
6776468|NCT03836989|7704505|FG001|Subjects > 60 Years Old With Incomplete Paralysis|Overall Study||0
6776469|NCT03836989|7704504|FG000|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||1
6776470|NCT03836989|7704505|FG001|Subject < 60 Years Old + Complete Paralysis < 15 Days Duration|Overall Study||0
6776471|NCT03836989|7704504|FG000|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||1
6776472|NCT03836989|7704505|FG001|Subjects < 60 Years Old + Complete Paralysis > 15 Days|Overall Study||0
6776473|NCT03836989|7704504|FG000|COMPLETED|Overall Study||4
6776474|NCT03836989|7704505|FG001|COMPLETED|Overall Study||0
6776475|NCT03836989|7704504|FG000|NOT COMPLETED|Overall Study||0
6776476|NCT03836989|7704505|FG001|NOT COMPLETED|Overall Study||0
6776477|NCT03827564|7704516|FG000|STARTED|Overall Study||9
6776478|NCT03827564|7704517|FG001|STARTED|Overall Study||5
6776479|NCT03827564|7704516|FG000|COMPLETED|Overall Study||8
6776480|NCT03827564|7704517|FG001|COMPLETED|Overall Study||5
6776481|NCT03827564|7704516|FG000|NOT COMPLETED|Overall Study||1
6776482|NCT03827564|7704517|FG001|NOT COMPLETED|Overall Study||0
6776483|NCT03824236|7704526|FG000|STARTED|Overall Study||25
6776484|NCT03824236|7704527|FG001|STARTED|Overall Study||24
6776485|NCT03824236|7704528|FG002|STARTED|Overall Study||12
6776486|NCT03824236|7704526|FG000|COMPLETED|Overall Study||25
6776487|NCT03824236|7704527|FG001|COMPLETED|Overall Study||24
6776488|NCT03824236|7704528|FG002|COMPLETED|Overall Study||11
6776489|NCT03824236|7704526|FG000|NOT COMPLETED|Overall Study||0
6776490|NCT03824236|7704527|FG001|NOT COMPLETED|Overall Study||0
6776491|NCT03824236|7704528|FG002|NOT COMPLETED|Overall Study||1
6776492|NCT03811951|7704538|FG000|STARTED|First Intervention (1 Day)||2
6776493|NCT03811951|7704539|FG001|STARTED|First Intervention (1 Day)||2
6776494|NCT03811951|7704538|FG000|COMPLETED|First Intervention (1 Day)||2
6776495|NCT03811951|7704539|FG001|COMPLETED|First Intervention (1 Day)||2
6776496|NCT03811951|7704538|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6776497|NCT03811951|7704539|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6776498|NCT03811951|7704538|FG000|STARTED|Washout (1 Week)||2
6776499|NCT03811951|7704539|FG001|STARTED|Washout (1 Week)||2
6776500|NCT03811951|7704538|FG000|COMPLETED|Washout (1 Week)||2
6356557|NCT00655551|7265646|FG001|COMPLETED|Period 4 (up to 7 Days)||23
6356558|NCT00655551|7265647|FG002|COMPLETED|Period 4 (up to 7 Days)||0
6356559|NCT00655551|7265645|FG000|NOT COMPLETED|Period 4 (up to 7 Days)||0
6356560|NCT00655551|7265646|FG001|NOT COMPLETED|Period 4 (up to 7 Days)||2
6356561|NCT00655551|7265647|FG002|NOT COMPLETED|Period 4 (up to 7 Days)||0
6356562|NCT00655564|7265655|FG000|STARTED|Overall Study||15
6356563|NCT00655564|7265655|FG000|COMPLETED|Overall Study||12
6356564|NCT00655564|7265655|FG000|NOT COMPLETED|Overall Study||3
6356565|NCT00655629|7265662|FG000|STARTED|Overall Study||172
6356566|NCT00655629|7265663|FG001|STARTED|Overall Study||167
6356567|NCT00655629|7265662|FG000|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
6356568|NCT00655629|7265663|FG001|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
6356569|NCT00655629|7265662|FG000|COMPLETED|Overall Study||151
6356570|NCT00655629|7265663|FG001|COMPLETED|Overall Study||144
6356571|NCT00655629|7265662|FG000|NOT COMPLETED|Overall Study||21
6356572|NCT00655629|7265663|FG001|NOT COMPLETED|Overall Study||23
6776501|NCT03811951|7704539|FG001|COMPLETED|Washout (1 Week)||2
6776502|NCT03811951|7704538|FG000|NOT COMPLETED|Washout (1 Week)||0
6776503|NCT03811951|7704539|FG001|NOT COMPLETED|Washout (1 Week)||0
6776504|NCT03811951|7704538|FG000|STARTED|Second Intervention (1 Day)||2
6776505|NCT03811951|7704539|FG001|STARTED|Second Intervention (1 Day)||2
6776506|NCT03811951|7704538|FG000|COMPLETED|Second Intervention (1 Day)||2
6776507|NCT03811951|7704539|FG001|COMPLETED|Second Intervention (1 Day)||2
6776508|NCT03811951|7704538|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6776509|NCT03811951|7704539|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6776510|NCT03810235|7704549|FG000|STARTED|Overall Study||32
6776511|NCT03810235|7704550|FG001|STARTED|Overall Study||31
6776512|NCT03810235|7704549|FG000|Participant Data Analyzed|Overall Study||30
6776513|NCT03810235|7704550|FG001|Participant Data Analyzed|Overall Study||31
6776514|NCT03810235|7704549|FG000|COMPLETED|Overall Study||30
6776515|NCT03810235|7704550|FG001|COMPLETED|Overall Study||31
6776516|NCT03810235|7704549|FG000|NOT COMPLETED|Overall Study||2
6776517|NCT03810235|7704550|FG001|NOT COMPLETED|Overall Study||0
6776518|NCT03806556|7704559|FG000|STARTED|Overall Study||6
6776519|NCT03806556|7704560|FG001|STARTED|Overall Study||5
6776520|NCT03806556|7704559|FG000|COMPLETED|Overall Study||6
6776521|NCT03806556|7704560|FG001|COMPLETED|Overall Study||5
6776522|NCT03806556|7704559|FG000|NOT COMPLETED|Overall Study||0
6776523|NCT03806556|7704560|FG001|NOT COMPLETED|Overall Study||0
6776524|NCT03836664|7704569|FG000|STARTED|Overall Study||14
6356573|NCT00655642|7265673|FG000|STARTED|Overall Study||42
6356574|NCT00655642|7265674|FG001|STARTED|Overall Study||43
6356575|NCT00655642|7265675|FG002|STARTED|Overall Study||45
6356576|NCT00655642|7265676|FG003|STARTED|Overall Study||41
6356577|NCT00655642|7265673|FG000|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
6356578|NCT00655642|7265674|FG001|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
6356579|NCT00655642|7265675|FG002|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
6356580|NCT00655642|7265676|FG003|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
6356581|NCT00655642|7265673|FG000|NOT COMPLETED|Overall Study||1
6356582|NCT00655642|7265674|FG001|NOT COMPLETED|Overall Study||3
6356583|NCT00655642|7265675|FG002|NOT COMPLETED|Overall Study||2
6356584|NCT00655642|7265676|FG003|NOT COMPLETED|Overall Study||2
6356585|NCT00655668|7265686|FG000|STARTED|Overall Study|Planned enrollment: 80 participants|54
6356586|NCT00655668|7265686|FG000|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
6356587|NCT00655668|7265686|FG000|NOT COMPLETED|Overall Study||54
6356588|NCT00655707|7265690|FG000|STARTED|Overall Study||5
6356589|NCT00655707|7265690|FG000|COMPLETED|Overall Study||5
6356590|NCT00655707|7265690|FG000|NOT COMPLETED|Overall Study||0
6356591|NCT00655733|7265697|FG000|STARTED|Overall Study||51
6356592|NCT00655733|7265698|FG001|STARTED|Overall Study||50
6356593|NCT00655733|7265697|FG000|COMPLETED|Overall Study||44
6356594|NCT00655733|7265698|FG001|COMPLETED|Overall Study||42
6356595|NCT00655733|7265697|FG000|NOT COMPLETED|Overall Study||7
6356596|NCT00655733|7265698|FG001|NOT COMPLETED|Overall Study||8
6356597|NCT00655746|7265706|FG000|STARTED|Overall Study||14
6356598|NCT00655746|7265706|FG000|COMPLETED|Overall Study||13
6356599|NCT00655746|7265706|FG000|NOT COMPLETED|Overall Study||1
6356600|NCT00655811|7265714|FG000|STARTED|Overall Study||40
6559997|NCT01784614|7482725|FG007|Received at Least 1 Dose of Study Drug|Period 1||3
6559998|NCT01784614|7482718|FG000|COMPLETED|Period 1||3
6559999|NCT01784614|7482719|FG001|COMPLETED|Period 1||3
6560000|NCT01784614|7482720|FG002|COMPLETED|Period 1||3
6560001|NCT01784614|7482721|FG003|COMPLETED|Period 1||3
6560002|NCT01784614|7482722|FG004|COMPLETED|Period 1||3
6560003|NCT01784614|7482723|FG005|COMPLETED|Period 1||3
6560004|NCT01784614|7482724|FG006|COMPLETED|Period 1||3
6560005|NCT01784614|7482725|FG007|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
6560006|NCT01784614|7482718|FG000|NOT COMPLETED|Period 1||0
6560007|NCT01784614|7482719|FG001|NOT COMPLETED|Period 1||0
6560008|NCT01784614|7482720|FG002|NOT COMPLETED|Period 1||0
6560009|NCT01784614|7482721|FG003|NOT COMPLETED|Period 1||0
6560010|NCT01784614|7482722|FG004|NOT COMPLETED|Period 1||0
6560011|NCT01784614|7482723|FG005|NOT COMPLETED|Period 1||0
6560012|NCT01784614|7482724|FG006|NOT COMPLETED|Period 1||0
6560013|NCT01784614|7482725|FG007|NOT COMPLETED|Period 1||0
6560014|NCT01784614|7482718|FG000|STARTED|Period 2||3
6560015|NCT01784614|7482719|FG001|STARTED|Period 2||3
6560016|NCT01784614|7482720|FG002|STARTED|Period 2||3
6560017|NCT01784614|7482721|FG003|STARTED|Period 2||3
6560018|NCT01784614|7482722|FG004|STARTED|Period 2||3
6560019|NCT01784614|7482723|FG005|STARTED|Period 2||3
6560020|NCT01784614|7482724|FG006|STARTED|Period 2||3
6560021|NCT01784614|7482725|FG007|STARTED|Period 2||2
6560022|NCT01784614|7482718|FG000|COMPLETED|Period 2||3
6560023|NCT01784614|7482719|FG001|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
6560024|NCT01784614|7482720|FG002|COMPLETED|Period 2||3
6560025|NCT01784614|7482721|FG003|COMPLETED|Period 2||3
6560026|NCT01784614|7482722|FG004|COMPLETED|Period 2||3
6560027|NCT01784614|7482723|FG005|COMPLETED|Period 2||3
6560028|NCT01784614|7482724|FG006|COMPLETED|Period 2||3
6560029|NCT01784614|7482725|FG007|COMPLETED|Period 2||2
6560030|NCT01784614|7482718|FG000|NOT COMPLETED|Period 2||0
6560031|NCT01784614|7482719|FG001|NOT COMPLETED|Period 2||0
6560032|NCT01784614|7482720|FG002|NOT COMPLETED|Period 2||0
6560033|NCT01784614|7482721|FG003|NOT COMPLETED|Period 2||0
6560034|NCT01784614|7482722|FG004|NOT COMPLETED|Period 2||0
6560035|NCT01784614|7482723|FG005|NOT COMPLETED|Period 2||0
6560036|NCT01784614|7482724|FG006|NOT COMPLETED|Period 2||0
6560037|NCT01784614|7482725|FG007|NOT COMPLETED|Period 2||0
6560038|NCT01784614|7482718|FG000|STARTED|Period 3||3
6560039|NCT01784614|7482719|FG001|STARTED|Period 3||2
6560040|NCT01784614|7482720|FG002|STARTED|Period 3||3
6560041|NCT01784614|7482721|FG003|STARTED|Period 3||3
6560042|NCT01784614|7482722|FG004|STARTED|Period 3||3
6560043|NCT01784614|7482723|FG005|STARTED|Period 3||3
6560044|NCT01784614|7482724|FG006|STARTED|Period 3||3
6560045|NCT01784614|7482725|FG007|STARTED|Period 3||2
6560046|NCT01784614|7482718|FG000|COMPLETED|Period 3||3
6560047|NCT01784614|7482719|FG001|COMPLETED|Period 3||2
6560048|NCT01784614|7482720|FG002|COMPLETED|Period 3||3
6356601|NCT00655811|7265714|FG000|COMPLETED|Overall Study||40
6356602|NCT00655811|7265714|FG000|NOT COMPLETED|Overall Study||0
6560049|NCT01784614|7482721|FG003|COMPLETED|Period 3||3
6560050|NCT01784614|7482722|FG004|COMPLETED|Period 3||3
6560051|NCT01784614|7482723|FG005|COMPLETED|Period 3||3
6560052|NCT01784614|7482724|FG006|COMPLETED|Period 3||3
6560053|NCT01784614|7482725|FG007|COMPLETED|Period 3||2
6560054|NCT01784614|7482718|FG000|NOT COMPLETED|Period 3||0
6560055|NCT01784614|7482719|FG001|NOT COMPLETED|Period 3||0
6560056|NCT01784614|7482720|FG002|NOT COMPLETED|Period 3||0
6560057|NCT01784614|7482721|FG003|NOT COMPLETED|Period 3||0
6560058|NCT01784614|7482722|FG004|NOT COMPLETED|Period 3||0
6560059|NCT01784614|7482723|FG005|NOT COMPLETED|Period 3||0
6560060|NCT01784614|7482724|FG006|NOT COMPLETED|Period 3||0
6560061|NCT01784614|7482725|FG007|NOT COMPLETED|Period 3||0
6560062|NCT01784614|7482718|FG000|STARTED|Period 4||3
6560063|NCT01784614|7482719|FG001|STARTED|Period 4||2
6560064|NCT01784614|7482720|FG002|STARTED|Period 4||3
6560065|NCT01784614|7482721|FG003|STARTED|Period 4||3
6560066|NCT01784614|7482722|FG004|STARTED|Period 4||3
6560067|NCT01784614|7482723|FG005|STARTED|Period 4||3
6560068|NCT01784614|7482724|FG006|STARTED|Period 4||3
6560069|NCT01784614|7482725|FG007|STARTED|Period 4||2
6560070|NCT01784614|7482718|FG000|COMPLETED|Period 4||3
6560071|NCT01784614|7482719|FG001|COMPLETED|Period 4||2
6560072|NCT01784614|7482720|FG002|COMPLETED|Period 4||3
6560073|NCT01784614|7482721|FG003|COMPLETED|Period 4||3
6356603|NCT00655850|7265724|FG000|STARTED|Overall Study||39
6356604|NCT00655850|7265724|FG000|COMPLETED|Overall Study||36
6356605|NCT00655850|7265724|FG000|NOT COMPLETED|Overall Study||3
6356606|NCT00655863|7265733|FG000|STARTED|Overall Study||24
6356607|NCT00655863|7265734|FG001|STARTED|Overall Study||25
6356608|NCT00655863|7265735|FG002|STARTED|Overall Study||22
6356609|NCT00655863|7265733|FG000|COMPLETED|Overall Study||24
6356610|NCT00655863|7265734|FG001|COMPLETED|Overall Study||25
6356611|NCT00655863|7265735|FG002|COMPLETED|Overall Study||21
6356612|NCT00655863|7265733|FG000|NOT COMPLETED|Overall Study||0
6356613|NCT00655863|7265734|FG001|NOT COMPLETED|Overall Study||0
6356614|NCT00655863|7265735|FG002|NOT COMPLETED|Overall Study||1
6356615|NCT00655876|7265745|FG000|STARTED|Overall Study||168
6356616|NCT00655876|7265746|FG001|STARTED|Overall Study||176
6356617|NCT00655876|7265745|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|159
6356618|NCT00655876|7265746|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|169
6356619|NCT00655876|7265745|FG000|NOT COMPLETED|Overall Study||9
6356620|NCT00655876|7265746|FG001|NOT COMPLETED|Overall Study||7
6356621|NCT00655889|7265752|FG000|STARTED|Overall Study||13
6356622|NCT00655889|7265752|FG000|COMPLETED|Overall Study||11
6356623|NCT00655889|7265752|FG000|NOT COMPLETED|Overall Study||2
6356624|NCT00655928|7265758|FG000|STARTED|Overall Study||26
6356625|NCT00655928|7265759|FG001|STARTED|Overall Study||26
6356626|NCT00655928|7265758|FG000|COMPLETED|Overall Study||23
6356627|NCT00655928|7265759|FG001|COMPLETED|Overall Study||24
6356628|NCT00655928|7265758|FG000|NOT COMPLETED|Overall Study||3
6356629|NCT00655928|7265759|FG001|NOT COMPLETED|Overall Study||2
6356630|NCT00655980|7265768|FG000|STARTED|Overall Study||276
6356631|NCT00655980|7265769|FG001|STARTED|Overall Study||281
6356632|NCT00655980|7265770|FG002|STARTED|Overall Study||130
6356633|NCT00655980|7265768|FG000|COMPLETED|Overall Study||250
6356634|NCT00655980|7265769|FG001|COMPLETED|Overall Study||250
6356635|NCT00655980|7265770|FG002|COMPLETED|Overall Study||125
6356636|NCT00655980|7265768|FG000|NOT COMPLETED|Overall Study||26
6356637|NCT00655980|7265769|FG001|NOT COMPLETED|Overall Study||31
6356638|NCT00655980|7265770|FG002|NOT COMPLETED|Overall Study||5
6356639|NCT00656019|7265785|FG000|STARTED|Overall Study||29
6356640|NCT00656019|7265786|FG001|STARTED|Overall Study||19
6356641|NCT00656019|7265787|FG002|STARTED|Overall Study||11
6356642|NCT00656019|7265788|FG003|STARTED|Overall Study||4
6356643|NCT00656019|7265785|FG000|COMPLETED|Overall Study||15
6356644|NCT00656019|7265786|FG001|COMPLETED|Overall Study||18
6356645|NCT00656019|7265787|FG002|COMPLETED|Overall Study||11
6356646|NCT00656019|7265788|FG003|COMPLETED|Overall Study||4
6356647|NCT00656019|7265785|FG000|NOT COMPLETED|Overall Study||14
6356648|NCT00656019|7265786|FG001|NOT COMPLETED|Overall Study||1
6356649|NCT00656019|7265787|FG002|NOT COMPLETED|Overall Study||0
6356650|NCT00656019|7265788|FG003|NOT COMPLETED|Overall Study||0
6560074|NCT01784614|7482722|FG004|COMPLETED|Period 4||3
6560075|NCT01784614|7482723|FG005|COMPLETED|Period 4||3
6560076|NCT01784614|7482724|FG006|COMPLETED|Period 4||3
6560077|NCT01784614|7482725|FG007|COMPLETED|Period 4||2
6356651|NCT00656058|7265798|FG000|STARTED|Overall Study||25
6356652|NCT00656058|7265798|FG000|COMPLETED|Overall Study||19
6356653|NCT00656058|7265798|FG000|NOT COMPLETED|Overall Study||6
6356654|NCT00656084|7265802|FG000|STARTED|Overall Study||16
6356655|NCT00656084|7265802|FG000|COMPLETED|Overall Study||9
6356656|NCT00656084|7265802|FG000|NOT COMPLETED|Overall Study||7
6356657|NCT00656136|7265808|FG000|STARTED|Overall Study|Randomised patients.|195
6356658|NCT00656136|7265809|FG001|STARTED|Overall Study|Randomised patients.|390
6356659|NCT00656136|7265808|FG000|COMPLETED|Overall Study||0
6356660|NCT00656136|7265809|FG001|COMPLETED|Overall Study||0
6356661|NCT00656136|7265808|FG000|NOT COMPLETED|Overall Study||195
6356662|NCT00656136|7265809|FG001|NOT COMPLETED|Overall Study||390
6356663|NCT00656175|7265817|FG000|STARTED|Overall Study||18
6560078|NCT01784614|7482718|FG000|NOT COMPLETED|Period 4||0
6560079|NCT01784614|7482719|FG001|NOT COMPLETED|Period 4||0
6356664|NCT00656175|7265818|FG001|STARTED|Overall Study||21
6356665|NCT00656175|7265817|FG000|COMPLETED|Overall Study||17
6356666|NCT00656175|7265818|FG001|COMPLETED|Overall Study||20
6560080|NCT01784614|7482720|FG002|NOT COMPLETED|Period 4||0
6560081|NCT01784614|7482721|FG003|NOT COMPLETED|Period 4||0
6560082|NCT01784614|7482722|FG004|NOT COMPLETED|Period 4||0
6560083|NCT01784614|7482723|FG005|NOT COMPLETED|Period 4||0
6560084|NCT01784614|7482724|FG006|NOT COMPLETED|Period 4||0
6356667|NCT00656175|7265817|FG000|NOT COMPLETED|Overall Study||1
6356668|NCT00656175|7265818|FG001|NOT COMPLETED|Overall Study||1
6356669|NCT00656201|7265826|FG000|STARTED|Overall Study||235
6356670|NCT00656201|7265827|FG001|STARTED|Overall Study||233
6356671|NCT00656201|7265826|FG000|COMPLETED|Overall Study||206
6356672|NCT00656201|7265827|FG001|COMPLETED|Overall Study||201
6356673|NCT00656201|7265826|FG000|NOT COMPLETED|Overall Study||29
6356674|NCT00656201|7265827|FG001|NOT COMPLETED|Overall Study||32
6356675|NCT00656292|7265835|FG000|STARTED|Overall Study||32
6356676|NCT00656292|7265836|FG001|STARTED|Overall Study||29
6356677|NCT00656292|7265835|FG000|COMPLETED|Overall Study||29
6356678|NCT00656292|7265836|FG001|COMPLETED|Overall Study||24
6356679|NCT00656292|7265835|FG000|NOT COMPLETED|Overall Study||3
6356680|NCT00656292|7265836|FG001|NOT COMPLETED|Overall Study||5
6356681|NCT00656305|7265844|FG000|STARTED|Overall Study||87
6356682|NCT00656305|7265845|FG001|STARTED|Overall Study||28
6356683|NCT00656305|7265844|FG000|COMPLETED|Overall Study||65
6356684|NCT00656305|7265845|FG001|COMPLETED|Overall Study||21
6356685|NCT00656305|7265844|FG000|NOT COMPLETED|Overall Study||22
6356686|NCT00656305|7265845|FG001|NOT COMPLETED|Overall Study||7
6356687|NCT00656370|7265851|FG000|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
6356688|NCT00656370|7265851|FG000|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1 (received both NS and LR).|15
6356689|NCT00656370|7265851|FG000|NOT COMPLETED|Overall Study||10
6356690|NCT00656448|7265859|FG000|STARTED|Overall Study||25
6356691|NCT00656448|7265860|FG001|STARTED|Overall Study||25
6356692|NCT00656448|7265859|FG000|COMPLETED|Overall Study||25
6356693|NCT00656448|7265860|FG001|COMPLETED|Overall Study||25
6356694|NCT00656448|7265859|FG000|NOT COMPLETED|Overall Study||0
6356695|NCT00656448|7265860|FG001|NOT COMPLETED|Overall Study||0
6356696|NCT00656474|7265867|FG000|STARTED|Overall Study||12
6356697|NCT00656474|7265867|FG000|COMPLETED|Overall Study||11
6356698|NCT00656474|7265867|FG000|NOT COMPLETED|Overall Study||1
6356699|NCT00656487|7265875|FG000|STARTED|Overall Study||23
6356700|NCT00656487|7265876|FG001|STARTED|Overall Study||23
6356701|NCT00656487|7265877|FG002|STARTED|Overall Study||20
6356702|NCT00656487|7265875|FG000|COMPLETED|Overall Study||21
6356703|NCT00656487|7265876|FG001|COMPLETED|Overall Study||19
6356704|NCT00656487|7265877|FG002|COMPLETED|Overall Study||20
6356705|NCT00656487|7265875|FG000|NOT COMPLETED|Overall Study||2
6356706|NCT00656487|7265876|FG001|NOT COMPLETED|Overall Study||4
6356707|NCT00656487|7265877|FG002|NOT COMPLETED|Overall Study||0
6560085|NCT01784614|7482725|FG007|NOT COMPLETED|Period 4||0
6560086|NCT01784666|7482748|FG000|STARTED|Overall Study||1
6560087|NCT01784666|7482749|FG001|STARTED|Overall Study||0
6560088|NCT01784666|7482750|FG002|STARTED|Overall Study||1
6560089|NCT01784666|7482748|FG000|COMPLETED|Overall Study||1
6560090|NCT01784666|7482749|FG001|COMPLETED|Overall Study||0
6560091|NCT01784666|7482750|FG002|COMPLETED|Overall Study||1
6560092|NCT01784666|7482748|FG000|NOT COMPLETED|Overall Study||0
6560093|NCT01784666|7482749|FG001|NOT COMPLETED|Overall Study||0
6560094|NCT01784666|7482750|FG002|NOT COMPLETED|Overall Study||0
6356708|NCT00656513|7265888|FG000|STARTED|Overall Study||48
6356709|NCT00656513|7265889|FG001|STARTED|Overall Study||73
6356710|NCT00656513|7265890|FG002|STARTED|Overall Study||75
6356711|NCT00656513|7265888|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
6356712|NCT00656513|7265889|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
6356713|NCT00656513|7265890|FG002|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
6356714|NCT00656513|7265888|FG000|NOT COMPLETED|Overall Study||4
6356715|NCT00656513|7265889|FG001|NOT COMPLETED|Overall Study||30
6356716|NCT00656513|7265890|FG002|NOT COMPLETED|Overall Study||22
6356717|NCT00656617|7265898|FG000|STARTED|Overall Study||106
6356718|NCT00656617|7265898|FG000|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
6356719|NCT00656617|7265898|FG000|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
6356720|NCT00656617|7265898|FG000|COMPLETED|Overall Study||99
6356721|NCT00656617|7265898|FG000|NOT COMPLETED|Overall Study||7
6356722|NCT00656630|7265906|FG000|STARTED|Overall Study||22
6356723|NCT00656630|7265907|FG001|STARTED|Overall Study||27
6356724|NCT00656630|7265908|FG002|STARTED|Overall Study||19
6356725|NCT00656630|7265906|FG000|COMPLETED|Overall Study||20
6356726|NCT00656630|7265907|FG001|COMPLETED|Overall Study||25
6356727|NCT00656630|7265908|FG002|COMPLETED|Overall Study||17
6356728|NCT00656630|7265906|FG000|NOT COMPLETED|Overall Study||2
6356729|NCT00656630|7265907|FG001|NOT COMPLETED|Overall Study||2
6356730|NCT00656630|7265908|FG002|NOT COMPLETED|Overall Study||2
6356731|NCT00656656|7265916|FG000|STARTED|Overall Study||23
6356732|NCT00656656|7265916|FG000|COMPLETED|Overall Study||23
6356733|NCT00656656|7265916|FG000|NOT COMPLETED|Overall Study||0
6356734|NCT00656669|7265920|FG000|STARTED|Single Agent Sunitinib (Cycle 1)||23
6560095|NCT01784770|7482758|FG000|STARTED|Overall Study||21
6356735|NCT00656669|7265920|FG000|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
6560096|NCT01784770|7482758|FG000|COMPLETED|Overall Study||21
6560097|NCT01784770|7482758|FG000|NOT COMPLETED|Overall Study||0
6560098|NCT01784796|7482764|FG000|STARTED|Overall Study|These are participants who provided informed consent|87
6560099|NCT01784796|7482765|FG001|STARTED|Overall Study|These are participants who provided informed consent|77
6356736|NCT00656669|7265920|FG000|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
6356737|NCT00656669|7265920|FG000|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
6356738|NCT00656669|7265920|FG000|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
6356739|NCT00656669|7265920|FG000|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
6356740|NCT00656669|7265920|FG000|STARTED|AC (Cycles 6-9)||17
6356741|NCT00656669|7265920|FG000|COMPLETED|AC (Cycles 6-9)||15
6356742|NCT00656669|7265920|FG000|NOT COMPLETED|AC (Cycles 6-9)||2
6356743|NCT00656799|7265929|FG000|STARTED|Overall Study||6
6356744|NCT00656799|7265929|FG000|COMPLETED|Overall Study||4
6356745|NCT00656799|7265929|FG000|NOT COMPLETED|Overall Study||2
6356746|NCT00656851|7265935|FG000|STARTED|Overall Study||12
6356747|NCT00656851|7265936|FG001|STARTED|Overall Study||12
6356748|NCT00656851|7265935|FG000|COMPLETED|Overall Study||12
6498532|NCT01410409|7417132|FG000|STARTED|Overall Study||50
6498533|NCT01410409|7417133|FG001|STARTED|Overall Study||50
6498534|NCT01410409|7417132|FG000|COMPLETED|Overall Study||49
6498535|NCT01410409|7417133|FG001|COMPLETED|Overall Study||46
6498536|NCT01410409|7417132|FG000|NOT COMPLETED|Overall Study||1
6498537|NCT01410409|7417133|FG001|NOT COMPLETED|Overall Study||4
6498538|NCT01410448|7417141|FG000|STARTED|Overall Study||193
6498539|NCT01410448|7417142|FG001|STARTED|Overall Study||190
6498540|NCT01410448|7417141|FG000|Intent-to Treat (ITT) Analysis Set|Overall Study||193
6498541|NCT01410448|7417142|FG001|Intent-to Treat (ITT) Analysis Set|Overall Study||190
6498542|NCT01410448|7417141|FG000|Modified ITT Analysis Set|Overall Study||161
6498543|NCT01410448|7417142|FG001|Modified ITT Analysis Set|Overall Study||149
6498544|NCT01410448|7417141|FG000|COMPLETED|Overall Study||181
6498545|NCT01410448|7417142|FG001|COMPLETED|Overall Study||155
6356749|NCT00656851|7265936|FG001|COMPLETED|Overall Study||8
6356750|NCT00656851|7265935|FG000|NOT COMPLETED|Overall Study||0
6356751|NCT00656851|7265936|FG001|NOT COMPLETED|Overall Study||4
6356752|NCT00656968|7265944|FG000|STARTED|Overall Study||115
6356753|NCT00656968|7265945|FG001|STARTED|Overall Study||117
6356754|NCT00656968|7265944|FG000|COMPLETED|Overall Study||115
6356755|NCT00656968|7265945|FG001|COMPLETED|Overall Study||117
6356756|NCT00656968|7265944|FG000|NOT COMPLETED|Overall Study||0
6356757|NCT00656968|7265945|FG001|NOT COMPLETED|Overall Study||0
6356758|NCT00657020|7265951|FG000|STARTED|PERIOD 1||11
6356759|NCT00657020|7265952|FG001|STARTED|PERIOD 1||12
6356760|NCT00657020|7265951|FG000|COMPLETED|PERIOD 1||11
6356761|NCT00657020|7265952|FG001|COMPLETED|PERIOD 1||11
6356762|NCT00657020|7265951|FG000|NOT COMPLETED|PERIOD 1||0
6356763|NCT00657020|7265952|FG001|NOT COMPLETED|PERIOD 1||1
6356764|NCT00657020|7265951|FG000|STARTED|PERIOD 2||11
6356765|NCT00657020|7265952|FG001|STARTED|PERIOD 2||11
6356766|NCT00657020|7265951|FG000|COMPLETED|PERIOD 2||11
6356767|NCT00657020|7265952|FG001|COMPLETED|PERIOD 2||11
6356768|NCT00657020|7265951|FG000|NOT COMPLETED|PERIOD 2||0
6356769|NCT00657020|7265952|FG001|NOT COMPLETED|PERIOD 2||0
6356770|NCT00657046|7265967|FG000|STARTED|Overall Study||30
6356771|NCT00657046|7265968|FG001|STARTED|Overall Study||32
6356772|NCT00657046|7265969|FG002|STARTED|Overall Study||23
6356773|NCT00657046|7265967|FG000|Had at Least 1 Post Baseline Visit|Overall Study||30
6356774|NCT00657046|7265968|FG001|Had at Least 1 Post Baseline Visit|Overall Study||31
6356775|NCT00657046|7265969|FG002|Had at Least 1 Post Baseline Visit|Overall Study||23
6356776|NCT00657046|7265967|FG000|Had Visits up to Visit 18|Overall Study||28
6356777|NCT00657046|7265968|FG001|Had Visits up to Visit 18|Overall Study||30
6356778|NCT00657046|7265969|FG002|Had Visits up to Visit 18|Overall Study||23
6356779|NCT00657046|7265967|FG000|COMPLETED|Overall Study||26
6356780|NCT00657046|7265968|FG001|COMPLETED|Overall Study||29
6356781|NCT00657046|7265969|FG002|COMPLETED|Overall Study||21
6356782|NCT00657046|7265967|FG000|NOT COMPLETED|Overall Study||4
6356783|NCT00657046|7265968|FG001|NOT COMPLETED|Overall Study||3
6356784|NCT00657046|7265969|FG002|NOT COMPLETED|Overall Study||2
6356785|NCT00657150|7265979|FG000|STARTED|Overall Study||1010
6356786|NCT00657150|7265980|FG001|STARTED|Overall Study||1003
6356787|NCT00657150|7265979|FG000|COMPLETED|Overall Study||895
6356788|NCT00657150|7265980|FG001|COMPLETED|Overall Study||910
6356789|NCT00657150|7265979|FG000|NOT COMPLETED|Overall Study||115
6356790|NCT00657150|7265980|FG001|NOT COMPLETED|Overall Study||93
6356791|NCT00657150|7265979|FG000|STARTED|Treatment||1010
6356792|NCT00657150|7265980|FG001|STARTED|Treatment||1003
6356793|NCT00657150|7265979|FG000|COMPLETED|Treatment||903
6356794|NCT00657150|7265980|FG001|COMPLETED|Treatment||906
6356795|NCT00657150|7265979|FG000|NOT COMPLETED|Treatment||107
6356796|NCT00657150|7265980|FG001|NOT COMPLETED|Treatment||97
6356797|NCT00657267|7265986|FG000|STARTED|Overall Study||58
6356798|NCT00657267|7265986|FG000|COMPLETED|Overall Study||4
6356799|NCT00657267|7265986|FG000|NOT COMPLETED|Overall Study||54
6356800|NCT00657280|7265992|FG000|STARTED|Overall Study||16
6356801|NCT00657280|7265992|FG000|COMPLETED|Overall Study||16
6356802|NCT00657280|7265992|FG000|NOT COMPLETED|Overall Study||0
6356803|NCT00657358|7265996|FG000|STARTED|Overall Study||22
6356804|NCT00657358|7265996|FG000|COMPLETED|Overall Study||16
6356805|NCT00657358|7265996|FG000|NOT COMPLETED|Overall Study||6
6498546|NCT01410448|7417141|FG000|NOT COMPLETED|Overall Study||12
6356806|NCT00657371|7266001|FG000|STARTED|Overall Study||288
6356807|NCT00657371|7266001|FG000|COMPLETED|Overall Study||249
6356808|NCT00657371|7266001|FG000|NOT COMPLETED|Overall Study||39
6356809|NCT00657540|7266007|FG000|STARTED|Overall Study||29
6356810|NCT00657540|7266008|FG001|STARTED|Overall Study||31
6356811|NCT00657540|7266007|FG000|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|28
6356812|NCT00657540|7266008|FG001|COMPLETED|Overall Study|All subjects had a known treatment failure disposition at time of loss to follow-up.|27
6356813|NCT00657540|7266007|FG000|NOT COMPLETED|Overall Study||1
6356814|NCT00657540|7266008|FG001|NOT COMPLETED|Overall Study||4
6356815|NCT00657605|7266014|FG000|STARTED|Overall Study||3
6356816|NCT00657605|7266014|FG000|COMPLETED|Overall Study||3
6356817|NCT00657605|7266014|FG000|NOT COMPLETED|Overall Study||0
6356818|NCT00657618|7266018|FG000|STARTED|Overall Study||77
6356819|NCT00657618|7266018|FG000|COMPLETED|Overall Study||34
6356820|NCT00657618|7266018|FG000|NOT COMPLETED|Overall Study||43
6356821|NCT00657657|7266022|FG000|STARTED|Overall Study||29
6356822|NCT00657657|7266022|FG000|COMPLETED|Overall Study||29
6356823|NCT00657657|7266022|FG000|NOT COMPLETED|Overall Study||0
6356824|NCT00657709|7266031|FG000|STARTED|Overall Study||833
6356825|NCT00657709|7266032|FG001|STARTED|Overall Study||828
6356826|NCT00657709|7266033|FG002|STARTED|Overall Study||820
6356827|NCT00657709|7266034|FG003|STARTED|Overall Study||659
6356828|NCT00657709|7266035|FG004|STARTED|Overall Study||490
6356829|NCT00657709|7266031|FG000|COMPLETED|Overall Study||810
6356830|NCT00657709|7266032|FG001|COMPLETED|Overall Study||795
6356831|NCT00657709|7266033|FG002|COMPLETED|Overall Study||792
6356832|NCT00657709|7266034|FG003|COMPLETED|Overall Study||645
6356833|NCT00657709|7266035|FG004|COMPLETED|Overall Study||457
6356834|NCT00657709|7266031|FG000|NOT COMPLETED|Overall Study||23
6356835|NCT00657709|7266032|FG001|NOT COMPLETED|Overall Study||33
6356836|NCT00657709|7266033|FG002|NOT COMPLETED|Overall Study||28
6356837|NCT00657709|7266034|FG003|NOT COMPLETED|Overall Study||14
6356838|NCT00657709|7266035|FG004|NOT COMPLETED|Overall Study||33
6356839|NCT00657917|7266057|FG000|STARTED|Overall Study||1
6356840|NCT00657917|7266057|FG000|COMPLETED|Overall Study||1
6356841|NCT00657917|7266057|FG000|NOT COMPLETED|Overall Study||0
6356842|NCT00658021|7266064|FG000|STARTED|28-Week Treatment Period||42
6356843|NCT00658021|7266065|FG001|STARTED|28-Week Treatment Period||38
6356844|NCT00658021|7266066|FG002|STARTED|28-Week Treatment Period||42
6356845|NCT00658021|7266064|FG000|Received Treatment|28-Week Treatment Period||40
6356846|NCT00658021|7266065|FG001|Received Treatment|28-Week Treatment Period||38
6356847|NCT00658021|7266066|FG002|Received Treatment|28-Week Treatment Period||42
6356848|NCT00658021|7266064|FG000|COMPLETED|28-Week Treatment Period||31
6356849|NCT00658021|7266065|FG001|COMPLETED|28-Week Treatment Period||25
6356850|NCT00658021|7266066|FG002|COMPLETED|28-Week Treatment Period||25
6356851|NCT00658021|7266064|FG000|NOT COMPLETED|28-Week Treatment Period||11
6356852|NCT00658021|7266065|FG001|NOT COMPLETED|28-Week Treatment Period||13
6356853|NCT00658021|7266066|FG002|NOT COMPLETED|28-Week Treatment Period||17
6356854|NCT00658021|7266064|FG000|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
6356855|NCT00658021|7266065|FG001|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|5
6356856|NCT00658021|7266066|FG002|STARTED|Long-term Safety Follow-up Period|Entered safety follow-up period.|7
6356857|NCT00658021|7266064|FG000|COMPLETED|Long-term Safety Follow-up Period||7
6356858|NCT00658021|7266065|FG001|COMPLETED|Long-term Safety Follow-up Period||2
6356859|NCT00658021|7266066|FG002|COMPLETED|Long-term Safety Follow-up Period||7
6356860|NCT00658021|7266064|FG000|NOT COMPLETED|Long-term Safety Follow-up Period||0
6356861|NCT00658021|7266065|FG001|NOT COMPLETED|Long-term Safety Follow-up Period||3
6356862|NCT00658021|7266066|FG002|NOT COMPLETED|Long-term Safety Follow-up Period||0
6356863|NCT00658112|7266076|FG000|STARTED|Overall Study||20
6356864|NCT00658112|7266076|FG000|COMPLETED|Overall Study||11
6356865|NCT00658112|7266076|FG000|NOT COMPLETED|Overall Study||9
6356866|NCT00658138|7266080|FG000|STARTED|Overall Study||61
6356867|NCT00658138|7266080|FG000|COMPLETED|Overall Study||40
6356868|NCT00658138|7266080|FG000|NOT COMPLETED|Overall Study||21
6356869|NCT00658320|7266087|FG000|STARTED|Core Study: 12 Months||61
6356870|NCT00658320|7266088|FG001|STARTED|Core Study: 12 Months||61
6356871|NCT00658320|7266087|FG000|COMPLETED|Core Study: 12 Months||56
6356872|NCT00658320|7266088|FG001|COMPLETED|Core Study: 12 Months||58
6356873|NCT00658320|7266087|FG000|NOT COMPLETED|Core Study: 12 Months||5
6356874|NCT00658320|7266088|FG001|NOT COMPLETED|Core Study: 12 Months||3
6356875|NCT00658320|7266087|FG000|STARTED|Extension Study: Month 12 to Month 24||53
6356876|NCT00658320|7266088|FG001|STARTED|Extension Study: Month 12 to Month 24||57
6356877|NCT00658320|7266087|FG000|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
6356878|NCT00658320|7266088|FG001|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
6356879|NCT00658320|7266087|FG000|COMPLETED|Extension Study: Month 12 to Month 24||47
6356880|NCT00658320|7266088|FG001|COMPLETED|Extension Study: Month 12 to Month 24||50
6356881|NCT00658320|7266087|FG000|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
6356882|NCT00658320|7266088|FG001|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
6356883|NCT00658320|7266087|FG000|STARTED|Extension Study: After Month 24||44
6356884|NCT00658320|7266088|FG001|STARTED|Extension Study: After Month 24||0
6356885|NCT00658320|7266087|FG000|COMPLETED|Extension Study: After Month 24||42
6356886|NCT00658320|7266088|FG001|COMPLETED|Extension Study: After Month 24||0
6356887|NCT00658320|7266087|FG000|NOT COMPLETED|Extension Study: After Month 24||2
6356888|NCT00658320|7266088|FG001|NOT COMPLETED|Extension Study: After Month 24||0
6356889|NCT00658333|7266098|FG000|STARTED|Overall Study||15
6356890|NCT00658333|7266099|FG001|STARTED|Overall Study||15
6356891|NCT00658333|7266098|FG000|COMPLETED|Overall Study||13
6356892|NCT00658333|7266099|FG001|COMPLETED|Overall Study||14
6356893|NCT00658333|7266098|FG000|NOT COMPLETED|Overall Study||2
6356894|NCT00658333|7266099|FG001|NOT COMPLETED|Overall Study||1
6356895|NCT00658359|7266108|FG000|STARTED|Overall Study||64
6356896|NCT00658359|7266109|FG001|STARTED|Overall Study||60
6356897|NCT00658359|7266110|FG002|STARTED|Overall Study||54
6356898|NCT00658359|7266108|FG000|COMPLETED|Overall Study||36
6356899|NCT00658359|7266109|FG001|COMPLETED|Overall Study||15
6560100|NCT01784796|7482764|FG000|Baseline Data Collected|Overall Study||75
6560101|NCT01784796|7482765|FG001|Baseline Data Collected|Overall Study||61
6356900|NCT00658359|7266110|FG002|COMPLETED|Overall Study||8
6356901|NCT00658359|7266108|FG000|NOT COMPLETED|Overall Study||28
6356902|NCT00658359|7266109|FG001|NOT COMPLETED|Overall Study||45
6356903|NCT00658359|7266110|FG002|NOT COMPLETED|Overall Study||46
6356904|NCT00658385|7266120|FG000|STARTED|Overall Study||5
6356905|NCT00658385|7266120|FG000|COMPLETED|Overall Study||5
6356906|NCT00658385|7266120|FG000|NOT COMPLETED|Overall Study||0
6356907|NCT00658411|7266124|FG000|STARTED|Overall Study||5
6356908|NCT00658411|7266124|FG000|COMPLETED|Overall Study||5
6356909|NCT00658411|7266124|FG000|NOT COMPLETED|Overall Study||0
6356910|NCT00658515|7266134|FG000|STARTED|Overall Study||7938
6356911|NCT00658515|7266135|FG001|STARTED|Overall Study||7933
6356912|NCT00658515|7266134|FG000|COMPLETED|Overall Study||7626
6356913|NCT00658515|7266135|FG001|COMPLETED|Overall Study||7668
6356914|NCT00658515|7266134|FG000|NOT COMPLETED|Overall Study||312
6356915|NCT00658515|7266135|FG001|NOT COMPLETED|Overall Study||265
6356916|NCT00658528|7266143|FG000|STARTED|Overall Study|Treated|531
6356917|NCT00658528|7266144|FG001|STARTED|Overall Study|Treated|524
6356918|NCT00658528|7266143|FG000|COMPLETED|Overall Study||491
6356919|NCT00658528|7266144|FG001|COMPLETED|Overall Study||479
6356920|NCT00658528|7266143|FG000|NOT COMPLETED|Overall Study||40
6356921|NCT00658528|7266144|FG001|NOT COMPLETED|Overall Study||45
6356922|NCT00658541|7266150|FG000|STARTED|First Intervention||19
6356923|NCT00658541|7266151|FG001|STARTED|First Intervention||19
6356924|NCT00658541|7266150|FG000|COMPLETED|First Intervention||19
6356925|NCT00658541|7266151|FG001|COMPLETED|First Intervention||19
6356926|NCT00658541|7266150|FG000|NOT COMPLETED|First Intervention||0
6356927|NCT00658541|7266151|FG001|NOT COMPLETED|First Intervention||0
6356928|NCT00658541|7266150|FG000|STARTED|Washout Period of 7 Days||19
6356929|NCT00658541|7266151|FG001|STARTED|Washout Period of 7 Days||19
6356930|NCT00658541|7266150|FG000|COMPLETED|Washout Period of 7 Days||18
6356931|NCT00658541|7266151|FG001|COMPLETED|Washout Period of 7 Days||17
6356932|NCT00658541|7266150|FG000|NOT COMPLETED|Washout Period of 7 Days||1
6356933|NCT00658541|7266151|FG001|NOT COMPLETED|Washout Period of 7 Days||2
6356934|NCT00658541|7266150|FG000|STARTED|Second Intervention||18
6356935|NCT00658541|7266151|FG001|STARTED|Second Intervention||17
6356936|NCT00658541|7266150|FG000|COMPLETED|Second Intervention||18
6356937|NCT00658541|7266151|FG001|COMPLETED|Second Intervention||17
6356938|NCT00658541|7266150|FG000|NOT COMPLETED|Second Intervention||0
6356939|NCT00658541|7266151|FG001|NOT COMPLETED|Second Intervention||0
6356940|NCT00658567|7266160|FG000|STARTED|Overall Study||40
6356941|NCT00658567|7266161|FG001|STARTED|Overall Study||42
6356942|NCT00658567|7266162|FG002|STARTED|Overall Study||41
6356943|NCT00658567|7266160|FG000|COMPLETED|Overall Study||32
6356944|NCT00658567|7266161|FG001|COMPLETED|Overall Study||38
6356945|NCT00658567|7266162|FG002|COMPLETED|Overall Study||35
6356946|NCT00658567|7266160|FG000|NOT COMPLETED|Overall Study||8
6356947|NCT00658567|7266161|FG001|NOT COMPLETED|Overall Study||4
6356948|NCT00658567|7266162|FG002|NOT COMPLETED|Overall Study||6
6356949|NCT00658606|7266172|FG000|STARTED|Overall Study||49
6356950|NCT00658606|7266173|FG001|STARTED|Overall Study||49
6356951|NCT00658606|7266172|FG000|Completed Treatment|Overall Study||42
6356952|NCT00658606|7266173|FG001|Completed Treatment|Overall Study||44
6356953|NCT00658606|7266172|FG000|COMPLETED|Overall Study|Represents patients who completed follow-up|33
6356954|NCT00658606|7266173|FG001|COMPLETED|Overall Study|Represents patients who completed follow-up|26
6356955|NCT00658606|7266172|FG000|NOT COMPLETED|Overall Study||16
6356956|NCT00658606|7266173|FG001|NOT COMPLETED|Overall Study||23
6356957|NCT00658619|7266184|FG000|STARTED|Overall Study||3
6356958|NCT00658619|7266185|FG001|STARTED|Overall Study||3
6356959|NCT00658619|7266186|FG002|STARTED|Overall Study||41
6356960|NCT00658619|7266187|FG003|STARTED|Overall Study||49
6356961|NCT00658619|7266188|FG004|STARTED|Overall Study||23
6356962|NCT00658619|7266184|FG000|COMPLETED|Overall Study||3
6356963|NCT00658619|7266185|FG001|COMPLETED|Overall Study||2
6356964|NCT00658619|7266186|FG002|COMPLETED|Overall Study||31
6560102|NCT01784796|7482764|FG000|4 Week Data Collection|Overall Study||48
6356965|NCT00658619|7266187|FG003|COMPLETED|Overall Study||37
6356966|NCT00658619|7266188|FG004|COMPLETED|Overall Study||21
6356967|NCT00658619|7266184|FG000|NOT COMPLETED|Overall Study||0
6356968|NCT00658619|7266185|FG001|NOT COMPLETED|Overall Study||1
6356969|NCT00658619|7266186|FG002|NOT COMPLETED|Overall Study||10
6356970|NCT00658619|7266187|FG003|NOT COMPLETED|Overall Study||12
6356971|NCT00658619|7266188|FG004|NOT COMPLETED|Overall Study||2
6356972|NCT00658632|7266199|FG000|STARTED|Overall Study|Treated|682
6356973|NCT00658632|7266200|FG001|STARTED|Overall Study|Treated|698
6356974|NCT00658632|7266199|FG000|COMPLETED|Overall Study||618
6356975|NCT00658632|7266200|FG001|COMPLETED|Overall Study||633
6356976|NCT00658632|7266199|FG000|NOT COMPLETED|Overall Study||64
6356977|NCT00658632|7266200|FG001|NOT COMPLETED|Overall Study||65
6356978|NCT00658658|7266211|FG000|STARTED|Overall Study||6
6356979|NCT00658658|7266212|FG001|STARTED|Overall Study||7
6356980|NCT00658658|7266213|FG002|STARTED|Overall Study||4
6560103|NCT01784796|7482765|FG001|4 Week Data Collection|Overall Study||41
6356981|NCT00658658|7266214|FG003|STARTED|Overall Study||6
6356982|NCT00658658|7266215|FG004|STARTED|Overall Study||8
6356983|NCT00658658|7266211|FG000|COMPLETED|Overall Study||1
6356984|NCT00658658|7266212|FG001|COMPLETED|Overall Study||5
6356985|NCT00658658|7266213|FG002|COMPLETED|Overall Study||4
6356986|NCT00658658|7266214|FG003|COMPLETED|Overall Study||4
6356987|NCT00658658|7266215|FG004|COMPLETED|Overall Study||3
6356988|NCT00658658|7266211|FG000|NOT COMPLETED|Overall Study||5
6356989|NCT00658658|7266212|FG001|NOT COMPLETED|Overall Study||2
6356990|NCT00658658|7266213|FG002|NOT COMPLETED|Overall Study||0
6356991|NCT00658658|7266214|FG003|NOT COMPLETED|Overall Study||2
6356992|NCT00658658|7266215|FG004|NOT COMPLETED|Overall Study||5
6356993|NCT00658684|7266230|FG000|STARTED|Overall Study||152
6356994|NCT00658684|7266231|FG001|STARTED|Overall Study||99
6356995|NCT00658684|7266232|FG002|STARTED|Overall Study||25
6356996|NCT00658684|7266233|FG003|STARTED|Overall Study||28
6356997|NCT00658684|7266230|FG000|COMPLETED|Overall Study||133
6356998|NCT00658684|7266231|FG001|COMPLETED|Overall Study||84
6356999|NCT00658684|7266232|FG002|COMPLETED|Overall Study||22
6357000|NCT00658684|7266233|FG003|COMPLETED|Overall Study||27
6357001|NCT00658684|7266230|FG000|NOT COMPLETED|Overall Study||19
6357002|NCT00658684|7266231|FG001|NOT COMPLETED|Overall Study||15
6357003|NCT00658684|7266232|FG002|NOT COMPLETED|Overall Study||3
6357004|NCT00658684|7266233|FG003|NOT COMPLETED|Overall Study||1
6357005|NCT00658697|7266243|FG000|STARTED|Overall Study||41
6357006|NCT00658697|7266243|FG000|COMPLETED|Overall Study||41
6357007|NCT00658697|7266243|FG000|NOT COMPLETED|Overall Study||0
6357008|NCT00658723|7266251|FG000|STARTED|Overall Study||60
6357009|NCT00658723|7266252|FG001|STARTED|Overall Study||30
6357010|NCT00658723|7266253|FG002|STARTED|Overall Study||51
6560104|NCT01784796|7482764|FG000|8 wk Data Collection|Overall Study||50
6560105|NCT01784796|7482765|FG001|8 wk Data Collection|Overall Study||46
6560106|NCT01784796|7482764|FG000|COMPLETED|Overall Study||39
6560107|NCT01784796|7482765|FG001|COMPLETED|Overall Study||34
6560108|NCT01784796|7482764|FG000|NOT COMPLETED|Overall Study||48
6560109|NCT01784796|7482765|FG001|NOT COMPLETED|Overall Study||43
6560110|NCT01784861|7482778|FG000|STARTED|Overall Study||3
6560111|NCT01784861|7482779|FG001|STARTED|Overall Study||3
6560112|NCT01784861|7482780|FG002|STARTED|Overall Study||4
6560113|NCT01784861|7482781|FG003|STARTED|Overall Study||8
6560114|NCT01784861|7482782|FG004|STARTED|Overall Study||3
6560115|NCT01784861|7482783|FG005|STARTED|Overall Study||2
6560116|NCT01784861|7482778|FG000|COMPLETED|Overall Study||3
6560117|NCT01784861|7482779|FG001|COMPLETED|Overall Study||3
6560118|NCT01784861|7482780|FG002|COMPLETED|Overall Study||3
6357011|NCT00658723|7266251|FG000|COMPLETED|Overall Study||56
6357012|NCT00658723|7266252|FG001|COMPLETED|Overall Study||26
6357013|NCT00658723|7266253|FG002|COMPLETED|Overall Study||44
6357014|NCT00658723|7266251|FG000|NOT COMPLETED|Overall Study||4
6357015|NCT00658723|7266252|FG001|NOT COMPLETED|Overall Study||4
6357016|NCT00658723|7266253|FG002|NOT COMPLETED|Overall Study||7
6357017|NCT00658736|7266266|FG000|STARTED|Overall Study||19
6357018|NCT00658736|7266267|FG001|STARTED|Overall Study||21
6357019|NCT00658736|7266266|FG000|COMPLETED|Overall Study||13
6357020|NCT00658736|7266267|FG001|COMPLETED|Overall Study||19
6357021|NCT00658736|7266266|FG000|NOT COMPLETED|Overall Study||6
6357022|NCT00658736|7266267|FG001|NOT COMPLETED|Overall Study||2
6357023|NCT00658775|7266275|FG000|STARTED|Overall Study|Treated|537
6357024|NCT00658775|7266276|FG001|STARTED|Overall Study|Treated|528
6357025|NCT00658775|7266275|FG000|COMPLETED|Overall Study||495
6357026|NCT00658775|7266276|FG001|COMPLETED|Overall Study||485
6357027|NCT00658775|7266275|FG000|NOT COMPLETED|Overall Study||42
6357028|NCT00658775|7266276|FG001|NOT COMPLETED|Overall Study||43
6357029|NCT00658788|7266282|FG000|STARTED|Overall Study||305
6357030|NCT00658788|7266282|FG000|COMPLETED|Overall Study||231
6357031|NCT00658788|7266282|FG000|NOT COMPLETED|Overall Study||74
6357032|NCT00658879|7266295|FG000|STARTED|Overall Study||251
6357033|NCT00658879|7266295|FG000|COMPLETED|Overall Study||250
6357034|NCT00658879|7266295|FG000|NOT COMPLETED|Overall Study||1
6357035|NCT00658996|7266299|FG000|STARTED|First Intervention||109
6357036|NCT00658996|7266300|FG001|STARTED|First Intervention||107
6357037|NCT00658996|7266299|FG000|COMPLETED|First Intervention||108
6357038|NCT00658996|7266300|FG001|COMPLETED|First Intervention||106
6357039|NCT00658996|7266299|FG000|NOT COMPLETED|First Intervention||1
6357040|NCT00658996|7266300|FG001|NOT COMPLETED|First Intervention||1
6357041|NCT00658996|7266299|FG000|STARTED|Crossover Period||108
6357042|NCT00658996|7266300|FG001|STARTED|Crossover Period||106
6357043|NCT00658996|7266299|FG000|COMPLETED|Crossover Period||106
6357044|NCT00658996|7266300|FG001|COMPLETED|Crossover Period||105
6357045|NCT00658996|7266299|FG000|NOT COMPLETED|Crossover Period||2
6357046|NCT00658996|7266300|FG001|NOT COMPLETED|Crossover Period||1
6357047|NCT00658996|7266299|FG000|STARTED|Second Intervention||106
6560119|NCT01784861|7482781|FG003|COMPLETED|Overall Study||3
6560120|NCT01784861|7482782|FG004|COMPLETED|Overall Study||2
6560121|NCT01784861|7482783|FG005|COMPLETED|Overall Study||1
6560122|NCT01784861|7482778|FG000|NOT COMPLETED|Overall Study||0
6357048|NCT00658996|7266300|FG001|STARTED|Second Intervention||105
6357049|NCT00658996|7266299|FG000|COMPLETED|Second Intervention||105
6357050|NCT00658996|7266300|FG001|COMPLETED|Second Intervention||104
6357051|NCT00658996|7266299|FG000|NOT COMPLETED|Second Intervention||1
6357052|NCT00658996|7266300|FG001|NOT COMPLETED|Second Intervention||1
6357053|NCT00659165|7266308|FG000|STARTED|Overall Study||5
6357054|NCT00659165|7266309|FG001|STARTED|Overall Study||5
6357055|NCT00659165|7266308|FG000|COMPLETED|Overall Study||5
6357056|NCT00659165|7266309|FG001|COMPLETED|Overall Study||5
6357057|NCT00659165|7266308|FG000|NOT COMPLETED|Overall Study||0
6357058|NCT00659165|7266309|FG001|NOT COMPLETED|Overall Study||0
6357059|NCT00659230|7266317|FG000|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
6357060|NCT00659230|7266318|FG001|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
6357061|NCT00659230|7266317|FG000|COMPLETED|Overall Study||42
6357062|NCT00659230|7266318|FG001|COMPLETED|Overall Study||37
6357063|NCT00659230|7266317|FG000|NOT COMPLETED|Overall Study||9
6357064|NCT00659230|7266318|FG001|NOT COMPLETED|Overall Study||12
6357065|NCT00659269|7266326|FG000|STARTED|Overall Study||157
6357066|NCT00659269|7266327|FG001|STARTED|Overall Study||162
6357067|NCT00659269|7266326|FG000|Group 1 (Heavy Metals)|Overall Study||52
6357068|NCT00659269|7266327|FG001|Group 1 (Heavy Metals)|Overall Study||52
6357069|NCT00659269|7266326|FG000|Group 2 (Vinca Alkaloids)|Overall Study||12
6357070|NCT00659269|7266327|FG001|Group 2 (Vinca Alkaloids)|Overall Study||12
6357071|NCT00659269|7266326|FG000|Group 3 (Taxanes)|Overall Study||92
6357072|NCT00659269|7266327|FG001|Group 3 (Taxanes)|Overall Study||97
6357073|NCT00659269|7266326|FG000|COMPLETED|Overall Study||156
6357074|NCT00659269|7266327|FG001|COMPLETED|Overall Study||161
6357075|NCT00659269|7266326|FG000|NOT COMPLETED|Overall Study||1
6357076|NCT00659269|7266327|FG001|NOT COMPLETED|Overall Study||1
6357077|NCT00659295|7266344|FG000|STARTED|Overall Study||13529
6357078|NCT00659295|7266345|FG001|STARTED|Overall Study||37641
6357079|NCT00659295|7266344|FG000|COMPLETED|Overall Study||10821
6357080|NCT00659295|7266345|FG001|COMPLETED|Overall Study||32038
6357081|NCT00659295|7266344|FG000|NOT COMPLETED|Overall Study||2708
6357082|NCT00659295|7266345|FG001|NOT COMPLETED|Overall Study||5603
6357083|NCT00659334|7266358|FG000|STARTED|Overall Study||46
6357084|NCT00659334|7266359|FG001|STARTED|Overall Study||41
6357085|NCT00659334|7266360|FG002|STARTED|Overall Study||5
6357086|NCT00659334|7266361|FG003|STARTED|Overall Study||2
6357087|NCT00659334|7266362|FG004|STARTED|Overall Study||1
6357088|NCT00659334|7266363|FG005|STARTED|Overall Study||0
6357089|NCT00659334|7266364|FG006|STARTED|Overall Study||21
6357090|NCT00659334|7266358|FG000|COMPLETED|Overall Study|8 Screen failures|38
6357091|NCT00659334|7266359|FG001|COMPLETED|Overall Study|5 Screen failures|36
6357092|NCT00659334|7266360|FG002|COMPLETED|Overall Study||5
6357093|NCT00659334|7266361|FG003|COMPLETED|Overall Study||2
6357094|NCT00659334|7266362|FG004|COMPLETED|Overall Study||1
6357095|NCT00659334|7266363|FG005|COMPLETED|Overall Study||0
6357096|NCT00659334|7266364|FG006|COMPLETED|Overall Study|1 screen failure|20
6357097|NCT00659334|7266358|FG000|NOT COMPLETED|Overall Study||8
6357098|NCT00659334|7266359|FG001|NOT COMPLETED|Overall Study||5
6357099|NCT00659334|7266360|FG002|NOT COMPLETED|Overall Study||0
6357100|NCT00659334|7266361|FG003|NOT COMPLETED|Overall Study||0
6357101|NCT00659334|7266362|FG004|NOT COMPLETED|Overall Study||0
6357102|NCT00659334|7266363|FG005|NOT COMPLETED|Overall Study||0
6357103|NCT00659334|7266364|FG006|NOT COMPLETED|Overall Study||1
6357104|NCT00659360|7266380|FG000|STARTED|Overall Study||17
6357105|NCT00659360|7266380|FG000|COMPLETED|Overall Study||17
6357106|NCT00659360|7266380|FG000|NOT COMPLETED|Overall Study||0
6357107|NCT00659373|7266388|FG000|STARTED|Overall Study||25
6357108|NCT00659373|7266389|FG001|STARTED|Overall Study||61
6357109|NCT00659373|7266388|FG000|COMPLETED|Overall Study||20
6357110|NCT00659373|7266389|FG001|COMPLETED|Overall Study||54
6357111|NCT00659373|7266388|FG000|NOT COMPLETED|Overall Study||5
6357112|NCT00659373|7266389|FG001|NOT COMPLETED|Overall Study||7
6357113|NCT00659425|7266405|FG000|STARTED|Overall Study||1
6357114|NCT00659425|7266406|FG001|STARTED|Overall Study||1
6357115|NCT00659425|7266407|FG002|STARTED|Overall Study||1
6357116|NCT00659425|7266408|FG003|STARTED|Overall Study||4
6357117|NCT00659425|7266409|FG004|STARTED|Overall Study||4
6357118|NCT00659425|7266410|FG005|STARTED|Overall Study||5
6357119|NCT00659425|7266411|FG006|STARTED|Overall Study||8
6357120|NCT00659425|7266412|FG007|STARTED|Overall Study||11
6357121|NCT00659425|7266413|FG008|STARTED|Overall Study||6
6357122|NCT00659425|7266414|FG009|STARTED|Overall Study||14
6357123|NCT00659425|7266405|FG000|COMPLETED|Overall Study||0
6357124|NCT00659425|7266406|FG001|COMPLETED|Overall Study||0
6357125|NCT00659425|7266407|FG002|COMPLETED|Overall Study||0
6357126|NCT00659425|7266408|FG003|COMPLETED|Overall Study||0
6357127|NCT00659425|7266409|FG004|COMPLETED|Overall Study||0
6357128|NCT00659425|7266410|FG005|COMPLETED|Overall Study||1
6357129|NCT00659425|7266411|FG006|COMPLETED|Overall Study||0
6357130|NCT00659425|7266412|FG007|COMPLETED|Overall Study||0
6357131|NCT00659425|7266413|FG008|COMPLETED|Overall Study||0
6357132|NCT00659425|7266414|FG009|COMPLETED|Overall Study||1
6357133|NCT00659425|7266405|FG000|NOT COMPLETED|Overall Study||1
6357134|NCT00659425|7266406|FG001|NOT COMPLETED|Overall Study||1
6357135|NCT00659425|7266407|FG002|NOT COMPLETED|Overall Study||1
6357136|NCT00659425|7266408|FG003|NOT COMPLETED|Overall Study||4
6357137|NCT00659425|7266409|FG004|NOT COMPLETED|Overall Study||4
6357138|NCT00659425|7266410|FG005|NOT COMPLETED|Overall Study||4
6357139|NCT00659425|7266411|FG006|NOT COMPLETED|Overall Study||8
6357140|NCT00659425|7266412|FG007|NOT COMPLETED|Overall Study||11
6357141|NCT00659425|7266413|FG008|NOT COMPLETED|Overall Study||6
6357142|NCT00659425|7266414|FG009|NOT COMPLETED|Overall Study||13
6357143|NCT00659438|7266451|FG000|STARTED|Overall Study||47
6357144|NCT00659438|7266452|FG001|STARTED|Overall Study||48
6357145|NCT00659438|7266451|FG000|Assessable Set : Primary Analysis|Overall Study||44
6357146|NCT00659438|7266452|FG001|Assessable Set : Primary Analysis|Overall Study||45
6357147|NCT00659438|7266451|FG000|Secondary Analysis Set|Overall Study||47
6357148|NCT00659438|7266452|FG001|Secondary Analysis Set|Overall Study||48
6560123|NCT01784861|7482779|FG001|NOT COMPLETED|Overall Study||0
6776525|NCT03836664|7704570|FG001|STARTED|Overall Study||11
6776526|NCT03836664|7704569|FG000|COMPLETED|Overall Study||11
6776527|NCT03836664|7704570|FG001|COMPLETED|Overall Study||8
6776528|NCT03836664|7704569|FG000|NOT COMPLETED|Overall Study||3
6776529|NCT03836664|7704570|FG001|NOT COMPLETED|Overall Study||3
6357149|NCT00659438|7266451|FG000|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
6357150|NCT00659438|7266452|FG001|Safety Analysis Set|Overall Study||47
6357151|NCT00659438|7266451|FG000|COMPLETED|Overall Study||33
6357152|NCT00659438|7266452|FG001|COMPLETED|Overall Study||40
6357153|NCT00659438|7266451|FG000|NOT COMPLETED|Overall Study||14
6357154|NCT00659438|7266452|FG001|NOT COMPLETED|Overall Study||8
6377044|NCT00761774|7287592|FG000|NOT COMPLETED|Overall Study||79
6377045|NCT00761813|7287600|FG000|STARTED|Overall Study||557
6377046|NCT00761813|7287601|FG001|STARTED|Overall Study||551
6377047|NCT00761813|7287600|FG000|COMPLETED|Overall Study||542
6377048|NCT00761813|7287601|FG001|COMPLETED|Overall Study||537
6377049|NCT00761813|7287600|FG000|NOT COMPLETED|Overall Study||15
6377050|NCT00761813|7287601|FG001|NOT COMPLETED|Overall Study||14
6377051|NCT00761865|7287609|FG000|STARTED|Overall Study||16
6377052|NCT00761865|7287610|FG001|STARTED|Overall Study||18
6377053|NCT00761865|7287609|FG000|COMPLETED|Overall Study||8
6377054|NCT00761865|7287610|FG001|COMPLETED|Overall Study||11
6377055|NCT00761865|7287609|FG000|NOT COMPLETED|Overall Study||8
6377056|NCT00761865|7287610|FG001|NOT COMPLETED|Overall Study||7
6377057|NCT00761891|7287616|FG000|STARTED|Overall Study||64
6377058|NCT00761891|7287616|FG000|COMPLETED|Overall Study||54
6377059|NCT00761891|7287616|FG000|NOT COMPLETED|Overall Study||10
6377060|NCT00761930|7287624|FG000|STARTED|Overall Study||34
6377061|NCT00761930|7287625|FG001|STARTED|Overall Study||34
6377062|NCT00761930|7287626|FG002|STARTED|Overall Study||35
6377063|NCT00761930|7287624|FG000|COMPLETED|Overall Study||34
6377064|NCT00761930|7287625|FG001|COMPLETED|Overall Study||34
6377065|NCT00761930|7287626|FG002|COMPLETED|Overall Study||35
6377066|NCT00761930|7287624|FG000|NOT COMPLETED|Overall Study||0
6377067|NCT00761930|7287625|FG001|NOT COMPLETED|Overall Study||0
6377068|NCT00761930|7287626|FG002|NOT COMPLETED|Overall Study||0
6377069|NCT00761956|7287636|FG000|STARTED|Overall Study||87
6377070|NCT00761956|7287637|FG001|STARTED|Overall Study||102
6377071|NCT00761956|7287636|FG000|COMPLETED|Overall Study||52
6377072|NCT00761956|7287637|FG001|COMPLETED|Overall Study||48
6377073|NCT00761956|7287636|FG000|NOT COMPLETED|Overall Study||35
6377074|NCT00761956|7287637|FG001|NOT COMPLETED|Overall Study||54
6377075|NCT00761969|7287645|FG000|STARTED|Overall Study||742
6377076|NCT00761969|7287646|FG001|STARTED|Overall Study||713
6377077|NCT00761969|7287645|FG000|COMPLETED|Overall Study||542
6377078|NCT00761969|7287646|FG001|COMPLETED|Overall Study||573
6377079|NCT00761969|7287645|FG000|NOT COMPLETED|Overall Study||200
6377080|NCT00761969|7287646|FG001|NOT COMPLETED|Overall Study||140
6776530|NCT03832738|7704583|FG000|STARTED|Overall Study||51
6776531|NCT03832738|7704584|FG001|STARTED|Overall Study||50
6776532|NCT03832738|7704585|FG002|STARTED|Overall Study||51
6776533|NCT03832738|7704583|FG000|COMPLETED|Overall Study||43
6776534|NCT03832738|7704584|FG001|COMPLETED|Overall Study||38
6776535|NCT03832738|7704585|FG002|COMPLETED|Overall Study||32
6776536|NCT03832738|7704583|FG000|NOT COMPLETED|Overall Study||8
6776537|NCT03832738|7704584|FG001|NOT COMPLETED|Overall Study||12
6776538|NCT03832738|7704585|FG002|NOT COMPLETED|Overall Study||19
6776539|NCT03823391|7704595|FG000|STARTED|Period 1: Week 1 to Week 12||17
6377081|NCT00762021|7287654|FG000|STARTED|Overall Study||52
6377082|NCT00762021|7287655|FG001|STARTED|Overall Study||52
6377083|NCT00762021|7287654|FG000|COMPLETED|Overall Study||44
6377084|NCT00762021|7287655|FG001|COMPLETED|Overall Study||44
6377085|NCT00762021|7287654|FG000|NOT COMPLETED|Overall Study||8
6377086|NCT00762021|7287655|FG001|NOT COMPLETED|Overall Study||8
6377087|NCT00762034|7287663|FG000|STARTED|Induction Period||472
6377088|NCT00762034|7287664|FG001|STARTED|Induction Period||467
6377089|NCT00762034|7287663|FG000|Received at Least 1 Dose of Study Drug|Induction Period||442
6377090|NCT00762034|7287664|FG001|Received at Least 1 Dose of Study Drug|Induction Period||443
6377091|NCT00762034|7287663|FG000|COMPLETED|Induction Period||294
6377092|NCT00762034|7287664|FG001|COMPLETED|Induction Period||298
6377093|NCT00762034|7287663|FG000|NOT COMPLETED|Induction Period||178
6377094|NCT00762034|7287664|FG001|NOT COMPLETED|Induction Period||169
6377095|NCT00762034|7287663|FG000|STARTED|Maintenance Period||294
6377096|NCT00762034|7287664|FG001|STARTED|Maintenance Period||298
6377097|NCT00762034|7287663|FG000|Received at Least 1 Dose of Study Drug|Maintenance Period||294
6377098|NCT00762034|7287664|FG001|Received at Least 1 Dose of Study Drug|Maintenance Period||298
6560124|NCT01784861|7482780|FG002|NOT COMPLETED|Overall Study||1
6776540|NCT03823391|7704596|FG001|STARTED|Period 1: Week 1 to Week 12||31
6377099|NCT00762034|7287663|FG000|COMPLETED|Maintenance Period||0
6377100|NCT00762034|7287664|FG001|COMPLETED|Maintenance Period||0
6377101|NCT00762034|7287663|FG000|NOT COMPLETED|Maintenance Period||294
6377102|NCT00762034|7287664|FG001|NOT COMPLETED|Maintenance Period||298
6377103|NCT00762073|7287682|FG000|STARTED|Overall Study||21
6357155|NCT00659490|7266461|FG000|STARTED|Overall Study||61
6357156|NCT00659490|7266462|FG001|STARTED|Overall Study||59
6357157|NCT00659490|7266463|FG002|STARTED|Overall Study||31
6357158|NCT00659490|7266461|FG000|COMPLETED|Overall Study||59
6357159|NCT00659490|7266462|FG001|COMPLETED|Overall Study||59
6357160|NCT00659490|7266463|FG002|COMPLETED|Overall Study||30
6776541|NCT03823391|7704595|FG000|COMPLETED|Period 1: Week 1 to Week 12||17
6776542|NCT03823391|7704596|FG001|COMPLETED|Period 1: Week 1 to Week 12||31
6776543|NCT03823391|7704595|FG000|NOT COMPLETED|Period 1: Week 1 to Week 12||0
6776544|NCT03823391|7704596|FG001|NOT COMPLETED|Period 1: Week 1 to Week 12||0
6776545|NCT03823391|7704595|FG000|STARTED|Period 2: Weeks 12 to Week 24||17
6357161|NCT00659490|7266461|FG000|NOT COMPLETED|Overall Study||2
6357162|NCT00659490|7266462|FG001|NOT COMPLETED|Overall Study||0
6357163|NCT00659490|7266463|FG002|NOT COMPLETED|Overall Study||1
6357164|NCT00659529|7266471|FG000|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
6357165|NCT00659529|7266471|FG000|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
6357166|NCT00659529|7266471|FG000|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
6357167|NCT00659529|7266471|FG000|NOT COMPLETED|Overall Study||16
6357168|NCT00659581|7266475|FG000|STARTED|Overall Study||20994
6357169|NCT00659581|7266475|FG000|COMPLETED|Overall Study||12412
6357170|NCT00659581|7266475|FG000|NOT COMPLETED|Overall Study||8582
6357171|NCT00659607|7266479|FG000|STARTED|Overall Study||3932
6357172|NCT00659607|7266479|FG000|COMPLETED|Overall Study||3616
6357173|NCT00659607|7266479|FG000|NOT COMPLETED|Overall Study||316
6357174|NCT00659633|7266485|FG000|STARTED|Overall Study||10
6357175|NCT00659633|7266485|FG000|COMPLETED|Overall Study||10
6357176|NCT00659633|7266485|FG000|NOT COMPLETED|Overall Study||0
6357177|NCT00659724|7266489|FG000|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
6357178|NCT00659724|7266489|FG000|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
6357179|NCT00659724|7266489|FG000|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
6357180|NCT00659724|7266489|FG000|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
6357181|NCT00659724|7266489|FG000|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
6357182|NCT00659724|7266489|FG000|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
6357183|NCT00659737|7266497|FG000|STARTED|Overall Study||57
6357184|NCT00659737|7266498|FG001|STARTED|Overall Study||58
6357185|NCT00659737|7266497|FG000|COMPLETED|Overall Study||57
6357186|NCT00659737|7266498|FG001|COMPLETED|Overall Study||58
6357187|NCT00659737|7266497|FG000|NOT COMPLETED|Overall Study||0
6357188|NCT00659737|7266498|FG001|NOT COMPLETED|Overall Study||0
6357189|NCT00659789|7266506|FG000|STARTED|Overall Study||93
6357190|NCT00659789|7266507|FG001|STARTED|Overall Study||43
6357191|NCT00659789|7266506|FG000|COMPLETED|Overall Study||86
6357192|NCT00659789|7266507|FG001|COMPLETED|Overall Study||36
6357193|NCT00659789|7266506|FG000|NOT COMPLETED|Overall Study||7
6357194|NCT00659789|7266507|FG001|NOT COMPLETED|Overall Study||7
6357195|NCT00659802|7266516|FG000|STARTED|Overall Study||74
6357196|NCT00659802|7266517|FG001|STARTED|Overall Study|One patient was incorrectly randomized and was excluded from the efficacy analyses.|75
6357197|NCT00659802|7266518|FG002|STARTED|Overall Study||75
6357198|NCT00659802|7266516|FG000|COMPLETED|Overall Study||59
6357199|NCT00659802|7266517|FG001|COMPLETED|Overall Study||57
6357200|NCT00659802|7266518|FG002|COMPLETED|Overall Study||64
6357201|NCT00659802|7266516|FG000|NOT COMPLETED|Overall Study||15
6357202|NCT00659802|7266517|FG001|NOT COMPLETED|Overall Study||18
6357203|NCT00659802|7266518|FG002|NOT COMPLETED|Overall Study||11
6357204|NCT00659815|7266528|FG000|STARTED|Overall Study||157
6357205|NCT00659815|7266529|FG001|STARTED|Overall Study||151
6357206|NCT00659815|7266528|FG000|COMPLETED|Overall Study||153
6357207|NCT00659815|7266529|FG001|COMPLETED|Overall Study||147
6357208|NCT00659815|7266528|FG000|NOT COMPLETED|Overall Study||4
6357209|NCT00659815|7266529|FG001|NOT COMPLETED|Overall Study||4
6357210|NCT00659828|7266535|FG000|STARTED|Overall Study||1
6357211|NCT00659828|7266535|FG000|COMPLETED|Overall Study||1
6357212|NCT00659828|7266535|FG000|NOT COMPLETED|Overall Study||0
6357213|NCT00659880|7266539|FG000|STARTED|Overall Study||9
6357214|NCT00659880|7266539|FG000|6 Weeks|Overall Study||9
6357215|NCT00659880|7266539|FG000|6 Months|Overall Study||9
6357216|NCT00659880|7266539|FG000|12 Months|Overall Study||7
6357217|NCT00659880|7266539|FG000|24 Months|Overall Study||6
6357218|NCT00659880|7266539|FG000|COMPLETED|Overall Study|60 months|4
6357219|NCT00659880|7266539|FG000|NOT COMPLETED|Overall Study||5
6357220|NCT00659945|7266546|FG000|STARTED|Overall Study||75
6357221|NCT00659945|7266547|FG001|STARTED|Overall Study||75
6357222|NCT00659945|7266546|FG000|COMPLETED|Overall Study||75
6357223|NCT00659945|7266547|FG001|COMPLETED|Overall Study||75
6357224|NCT00659945|7266546|FG000|NOT COMPLETED|Overall Study||0
6357225|NCT00659945|7266547|FG001|NOT COMPLETED|Overall Study||0
6357226|NCT00659984|7266553|FG000|STARTED|Overall Study||15
6357227|NCT00659984|7266553|FG000|COMPLETED|Overall Study||14
6357228|NCT00659984|7266553|FG000|NOT COMPLETED|Overall Study||1
6357229|NCT00660010|7266563|FG000|STARTED|Overall Study||55
6357230|NCT00660010|7266563|FG000|COMPLETED|Overall Study||46
6776546|NCT03823391|7704596|FG001|STARTED|Period 2: Weeks 12 to Week 24||31
6776547|NCT03823391|7704595|FG000|COMPLETED|Period 2: Weeks 12 to Week 24||15
6357231|NCT00660010|7266563|FG000|NOT COMPLETED|Overall Study||9
6357232|NCT00660023|7266567|FG000|STARTED|Overall Study||124
6357233|NCT00660023|7266567|FG000|Treated|Overall Study||114
6357234|NCT00660023|7266567|FG000|COMPLETED|Overall Study||95
6357235|NCT00660023|7266567|FG000|NOT COMPLETED|Overall Study||29
6357236|NCT00660049|7266571|FG000|STARTED|Overall Study||12
6357237|NCT00660049|7266571|FG000|COMPLETED|Overall Study||6
6357238|NCT00660049|7266571|FG000|NOT COMPLETED|Overall Study||6
6357239|NCT00660075|7266577|FG000|STARTED|First Intervention (Week 1 to Week 6)||18
6357240|NCT00660075|7266578|FG001|STARTED|First Intervention (Week 1 to Week 6)||18
6357241|NCT00660075|7266577|FG000|COMPLETED|First Intervention (Week 1 to Week 6)||18
6357242|NCT00660075|7266578|FG001|COMPLETED|First Intervention (Week 1 to Week 6)||18
6357243|NCT00660075|7266577|FG000|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
6357244|NCT00660075|7266578|FG001|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
6357245|NCT00660075|7266577|FG000|STARTED|Washout Period (Week 7 to Week 10)||18
6357246|NCT00660075|7266578|FG001|STARTED|Washout Period (Week 7 to Week 10)||18
6357247|NCT00660075|7266577|FG000|COMPLETED|Washout Period (Week 7 to Week 10)||18
6357248|NCT00660075|7266578|FG001|COMPLETED|Washout Period (Week 7 to Week 10)||18
6357249|NCT00660075|7266577|FG000|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
6357250|NCT00660075|7266578|FG001|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
6357251|NCT00660075|7266577|FG000|STARTED|Second Intervention (Week 11 to Week 16||18
6357252|NCT00660075|7266578|FG001|STARTED|Second Intervention (Week 11 to Week 16||18
6357253|NCT00660075|7266577|FG000|COMPLETED|Second Intervention (Week 11 to Week 16||18
6357254|NCT00660075|7266578|FG001|COMPLETED|Second Intervention (Week 11 to Week 16||18
6357255|NCT00660075|7266577|FG000|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
6357256|NCT00660075|7266578|FG001|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
6357257|NCT00660179|7266587|FG000|STARTED|Overall Study||250
6357258|NCT00660179|7266588|FG001|STARTED|Overall Study||250
6357259|NCT00660179|7266589|FG002|STARTED|Overall Study||242
6357260|NCT00660179|7266587|FG000|COMPLETED|Overall Study||194
6357261|NCT00660179|7266588|FG001|COMPLETED|Overall Study||192
6357262|NCT00660179|7266589|FG002|COMPLETED|Overall Study||201
6357263|NCT00660179|7266587|FG000|NOT COMPLETED|Overall Study||56
6357264|NCT00660179|7266588|FG001|NOT COMPLETED|Overall Study||58
6357265|NCT00660179|7266589|FG002|NOT COMPLETED|Overall Study||41
6357266|NCT00660192|7266599|FG000|STARTED|Overall Study||12
6357267|NCT00660192|7266600|FG001|STARTED|Overall Study||13
6357268|NCT00660192|7266599|FG000|COMPLETED|Overall Study||10
6357269|NCT00660192|7266600|FG001|COMPLETED|Overall Study||10
6357270|NCT00660192|7266599|FG000|NOT COMPLETED|Overall Study||2
6357271|NCT00660192|7266600|FG001|NOT COMPLETED|Overall Study||3
6357272|NCT00660309|7266608|FG000|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
6357273|NCT00660309|7266609|FG001|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
6357274|NCT00660309|7266608|FG000|Treated With Aliskiren or Irbesartan|Overall Study||22
6357275|NCT00660309|7266609|FG001|Treated With Aliskiren or Irbesartan|Overall Study||21
6357276|NCT00660309|7266608|FG000|Pharmacodynamic Analysis Set|Overall Study||22
6357277|NCT00660309|7266609|FG001|Pharmacodynamic Analysis Set|Overall Study||20
6357278|NCT00660309|7266608|FG000|COMPLETED|Overall Study||21
6357279|NCT00660309|7266609|FG001|COMPLETED|Overall Study||19
6357280|NCT00660309|7266608|FG000|NOT COMPLETED|Overall Study||2
6357281|NCT00660309|7266609|FG001|NOT COMPLETED|Overall Study||3
6357282|NCT00660387|7266618|FG000|STARTED|Overall Study||37
6357283|NCT00660387|7266619|FG001|STARTED|Overall Study||34
6357284|NCT00660387|7266618|FG000|COMPLETED|Overall Study||35
6357285|NCT00660387|7266619|FG001|COMPLETED|Overall Study||31
6357286|NCT00660387|7266618|FG000|NOT COMPLETED|Overall Study||2
6357287|NCT00660387|7266619|FG001|NOT COMPLETED|Overall Study||3
6357288|NCT00660400|7266625|FG000|STARTED|Overall Study||25
6357289|NCT00660400|7266625|FG000|COMPLETED|Overall Study||21
6357290|NCT00660400|7266625|FG000|NOT COMPLETED|Overall Study||4
6357291|NCT00660504|7266631|FG000|STARTED|Overall Study||149
6357292|NCT00660504|7266632|FG001|STARTED|Overall Study||151
6357293|NCT00660504|7266631|FG000|COMPLETED|Overall Study||149
6357294|NCT00660504|7266632|FG001|COMPLETED|Overall Study||150
6357295|NCT00660504|7266631|FG000|NOT COMPLETED|Overall Study||0
6357296|NCT00660504|7266632|FG001|NOT COMPLETED|Overall Study||1
6560125|NCT01784861|7482781|FG003|NOT COMPLETED|Overall Study||5
6560126|NCT01784861|7482782|FG004|NOT COMPLETED|Overall Study||1
6560127|NCT01784861|7482783|FG005|NOT COMPLETED|Overall Study||1
6560128|NCT01784926|7482801|FG000|STARTED|Overall Study||54
6560129|NCT01784926|7482802|FG001|STARTED|Overall Study||50
6560130|NCT01784926|7482801|FG000|COMPLETED|Overall Study||43
6560131|NCT01784926|7482802|FG001|COMPLETED|Overall Study||42
6560132|NCT01784926|7482801|FG000|NOT COMPLETED|Overall Study||11
6560133|NCT01784926|7482802|FG001|NOT COMPLETED|Overall Study||8
6357297|NCT00660517|7266642|FG000|STARTED|Overall Study||153
6357298|NCT00660517|7266643|FG001|STARTED|Overall Study||152
6357299|NCT00660517|7266644|FG002|STARTED|Overall Study||151
6357300|NCT00660517|7266645|FG003|STARTED|Overall Study||151
6357301|NCT00660517|7266642|FG000|COMPLETED|Overall Study||145
6357302|NCT00660517|7266643|FG001|COMPLETED|Overall Study||144
6357303|NCT00660517|7266644|FG002|COMPLETED|Overall Study||144
6357304|NCT00660517|7266645|FG003|COMPLETED|Overall Study||144
6357305|NCT00660517|7266642|FG000|NOT COMPLETED|Overall Study||8
6357306|NCT00660517|7266643|FG001|NOT COMPLETED|Overall Study||8
6560134|NCT01784965|7482810|FG000|STARTED|Overall Study||33
6560135|NCT01784965|7482811|FG001|STARTED|Overall Study||35
6560136|NCT01784965|7482810|FG000|COMPLETED|Overall Study||27
6357307|NCT00660517|7266644|FG002|NOT COMPLETED|Overall Study||7
6357308|NCT00660517|7266645|FG003|NOT COMPLETED|Overall Study||7
6357309|NCT00660530|7266656|FG000|STARTED|Overall Study||11
6357310|NCT00660530|7266656|FG000|COMPLETED|Overall Study||11
6357311|NCT00660530|7266656|FG000|NOT COMPLETED|Overall Study||0
6357312|NCT00660543|7266662|FG000|STARTED|Overall Study||14
6357313|NCT00660543|7266662|FG000|COMPLETED|Overall Study||14
6357314|NCT00660543|7266662|FG000|NOT COMPLETED|Overall Study||0
6357315|NCT00660660|7266673|FG000|STARTED|Overall Study|Randomized|143
6357316|NCT00660660|7266674|FG001|STARTED|Overall Study|Randomized|133
6357317|NCT00660660|7266673|FG000|Met Criteria for MITT Population|Overall Study||137
6357318|NCT00660660|7266674|FG001|Met Criteria for MITT Population|Overall Study||125
6357319|NCT00660660|7266673|FG000|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
6357320|NCT00660660|7266674|FG001|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
6357321|NCT00660660|7266673|FG000|NOT COMPLETED|Overall Study||5
6357322|NCT00660660|7266674|FG001|NOT COMPLETED|Overall Study||9
6357323|NCT00660699|7266680|FG000|STARTED|Overall Study||50
6357324|NCT00660699|7266680|FG000|COMPLETED|Overall Study||48
6357325|NCT00660699|7266680|FG000|NOT COMPLETED|Overall Study||2
6357326|NCT00660790|7266684|FG000|STARTED|Baseline to 3 Months||97
6357327|NCT00660790|7266684|FG000|COMPLETED|Baseline to 3 Months||94
6357328|NCT00660790|7266684|FG000|NOT COMPLETED|Baseline to 3 Months||3
6357329|NCT00660790|7266684|FG000|STARTED|3 Months to 2 Years||94
6357330|NCT00660790|7266684|FG000|COMPLETED|3 Months to 2 Years||77
6357331|NCT00660790|7266684|FG000|NOT COMPLETED|3 Months to 2 Years||17
6357332|NCT00660816|7266690|FG000|STARTED|Overall Study||24
6357333|NCT00660816|7266691|FG001|STARTED|Overall Study||22
6357334|NCT00660816|7266690|FG000|COMPLETED|Overall Study||4
6357335|NCT00660816|7266691|FG001|COMPLETED|Overall Study||3
6357336|NCT00660816|7266690|FG000|NOT COMPLETED|Overall Study||20
6357337|NCT00660816|7266691|FG001|NOT COMPLETED|Overall Study||19
6357338|NCT00660829|7266699|FG000|STARTED|Overall Study|2 subjects were randomized in error|268
6357339|NCT00660829|7266700|FG001|STARTED|Overall Study|2 subjects were randomized in error|268
6357340|NCT00660829|7266699|FG000|COMPLETED|Overall Study||250
6357341|NCT00660829|7266700|FG001|COMPLETED|Overall Study||249
6357342|NCT00660829|7266699|FG000|NOT COMPLETED|Overall Study||18
6357343|NCT00660829|7266700|FG001|NOT COMPLETED|Overall Study||19
6357344|NCT00660907|7266708|FG000|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
6357345|NCT00660907|7266709|FG001|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
6357346|NCT00660907|7266708|FG000|COMPLETED|Overall Study||322
6357347|NCT00660907|7266709|FG001|COMPLETED|Overall Study||314
6357348|NCT00660907|7266708|FG000|NOT COMPLETED|Overall Study||84
6357349|NCT00660907|7266709|FG001|NOT COMPLETED|Overall Study||94
6357350|NCT00660985|7266717|FG000|STARTED|Overall Study||26
6357351|NCT00660985|7266718|FG001|STARTED|Overall Study||25
6357352|NCT00660985|7266717|FG000|COMPLETED|Overall Study||25
6357353|NCT00660985|7266718|FG001|COMPLETED|Overall Study||25
6357354|NCT00660985|7266717|FG000|NOT COMPLETED|Overall Study||1
6357355|NCT00660985|7266718|FG001|NOT COMPLETED|Overall Study||0
6357356|NCT00661037|7266726|FG000|STARTED|Overall Study||836
6357357|NCT00661037|7266727|FG001|STARTED|Overall Study||1284
6357358|NCT00661037|7266726|FG000|Witdrawn|Overall Study||47
6357359|NCT00661037|7266727|FG001|Witdrawn|Overall Study||68
6357360|NCT00661037|7266726|FG000|Deaths|Overall Study||108
6357361|NCT00661037|7266727|FG001|Deaths|Overall Study||188
6357362|NCT00661037|7266726|FG000|COMPLETED|Overall Study||682
6357363|NCT00661037|7266727|FG001|COMPLETED|Overall Study||1027
6357364|NCT00661037|7266726|FG000|NOT COMPLETED|Overall Study||154
6357365|NCT00661037|7266727|FG001|NOT COMPLETED|Overall Study||257
6357366|NCT00661089|7266737|FG000|STARTED|Overall Study||10
6357367|NCT00661089|7266738|FG001|STARTED|Overall Study||11
6357368|NCT00661089|7266737|FG000|COMPLETED|Overall Study||10
6357369|NCT00661089|7266738|FG001|COMPLETED|Overall Study||9
6357370|NCT00661089|7266737|FG000|NOT COMPLETED|Overall Study||0
6357371|NCT00661089|7266738|FG001|NOT COMPLETED|Overall Study||2
6357372|NCT00661141|7266748|FG000|STARTED|Overall Study||8
6357373|NCT00661141|7266749|FG001|STARTED|Overall Study||8
6357374|NCT00661141|7266750|FG002|STARTED|Overall Study||4
6357375|NCT00661141|7266751|FG003|STARTED|Overall Study||4
6357376|NCT00661141|7266752|FG004|STARTED|Overall Study||4
6357377|NCT00661141|7266753|FG005|STARTED|Overall Study||4
6357378|NCT00661141|7266748|FG000|Administered 30 Minutes Prior to Ethanol|Overall Study||6
6357379|NCT00661141|7266749|FG001|Administered 30 Minutes Prior to Ethanol|Overall Study||6
6357380|NCT00661141|7266750|FG002|Administered 30 Minutes Prior to Ethanol|Overall Study||2
6357381|NCT00661141|7266751|FG003|Administered 30 Minutes Prior to Ethanol|Overall Study||2
6357382|NCT00661141|7266752|FG004|Administered 30 Minutes Prior to Ethanol|Overall Study||4
6357383|NCT00661141|7266753|FG005|Administered 30 Minutes Prior to Ethanol|Overall Study||4
6357384|NCT00661141|7266748|FG000|Administered 30 Minutes After Ethanol|Overall Study||2
6357385|NCT00661141|7266749|FG001|Administered 30 Minutes After Ethanol|Overall Study||2
6357386|NCT00661141|7266750|FG002|Administered 30 Minutes After Ethanol|Overall Study||2
6357387|NCT00661141|7266751|FG003|Administered 30 Minutes After Ethanol|Overall Study||2
6357388|NCT00661141|7266752|FG004|Administered 30 Minutes After Ethanol|Overall Study||0
6357389|NCT00661141|7266753|FG005|Administered 30 Minutes After Ethanol|Overall Study||0
6357390|NCT00661141|7266748|FG000|COMPLETED|Overall Study||8
6357391|NCT00661141|7266749|FG001|COMPLETED|Overall Study||8
6357392|NCT00661141|7266750|FG002|COMPLETED|Overall Study||4
6357393|NCT00661141|7266751|FG003|COMPLETED|Overall Study||4
6357394|NCT00661141|7266752|FG004|COMPLETED|Overall Study||4
6357395|NCT00661141|7266753|FG005|COMPLETED|Overall Study||4
6357396|NCT00661141|7266748|FG000|NOT COMPLETED|Overall Study||0
6357397|NCT00661141|7266749|FG001|NOT COMPLETED|Overall Study||0
6357398|NCT00661141|7266750|FG002|NOT COMPLETED|Overall Study||0
6357399|NCT00661141|7266751|FG003|NOT COMPLETED|Overall Study||0
6357400|NCT00661141|7266752|FG004|NOT COMPLETED|Overall Study||0
6357401|NCT00661141|7266753|FG005|NOT COMPLETED|Overall Study||0
6560137|NCT01784965|7482811|FG001|COMPLETED|Overall Study||24
6560138|NCT01784965|7482810|FG000|NOT COMPLETED|Overall Study||6
6560139|NCT01784965|7482811|FG001|NOT COMPLETED|Overall Study||11
6560140|NCT01785069|7482823|FG000|STARTED|Overall Study||107
6560141|NCT01785069|7482824|FG001|STARTED|Overall Study||76
6560142|NCT01785069|7482825|FG002|STARTED|Overall Study||104
6357402|NCT00661193|7266774|FG000|STARTED|Overall Study||33
6357403|NCT00661193|7266775|FG001|STARTED|Overall Study||26
6357404|NCT00661193|7266774|FG000|COMPLETED|Overall Study||0
6357405|NCT00661193|7266775|FG001|COMPLETED|Overall Study||0
6357406|NCT00661193|7266774|FG000|NOT COMPLETED|Overall Study||33
6357407|NCT00661193|7266775|FG001|NOT COMPLETED|Overall Study||26
6357408|NCT00661258|7266783|FG000|STARTED|Overall Study||34
6357409|NCT00661258|7266784|FG001|STARTED|Overall Study||34
6357410|NCT00661258|7266783|FG000|COMPLETED|Overall Study||31
6357411|NCT00661258|7266784|FG001|COMPLETED|Overall Study||33
6357412|NCT00661258|7266783|FG000|NOT COMPLETED|Overall Study||3
6357413|NCT00661258|7266784|FG001|NOT COMPLETED|Overall Study||1
6357414|NCT00661271|7266792|FG000|STARTED|Overall Study||48
6357415|NCT00661271|7266793|FG001|STARTED|Overall Study||45
6357416|NCT00661271|7266792|FG000|COMPLETED|Overall Study||20
6357417|NCT00661271|7266793|FG001|COMPLETED|Overall Study||20
6357418|NCT00661271|7266792|FG000|NOT COMPLETED|Overall Study||28
6357419|NCT00661271|7266793|FG001|NOT COMPLETED|Overall Study||25
6357420|NCT00661362|7266801|FG000|STARTED|Overall Study|Randomized and treated|283
6357421|NCT00661362|7266802|FG001|STARTED|Overall Study|Randomized and treated|287
6357422|NCT00661362|7266801|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
6357423|NCT00661362|7266802|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
6357424|NCT00661362|7266801|FG000|NOT COMPLETED|Overall Study||29
6357425|NCT00661362|7266802|FG001|NOT COMPLETED|Overall Study||40
6357426|NCT00661388|7266808|FG000|STARTED|Overall Study||75
6357427|NCT00661388|7266808|FG000|COMPLETED|Overall Study||51
6357428|NCT00661388|7266808|FG000|NOT COMPLETED|Overall Study||24
6357429|NCT00661427|7266814|FG000|STARTED|Overall Study||35
6357430|NCT00661427|7266815|FG001|STARTED|Overall Study||26
6357431|NCT00661427|7266814|FG000|COMPLETED|Overall Study||30
6357432|NCT00661427|7266815|FG001|COMPLETED|Overall Study||19
6357433|NCT00661427|7266814|FG000|NOT COMPLETED|Overall Study||5
6357434|NCT00661427|7266815|FG001|NOT COMPLETED|Overall Study||7
6357435|NCT00661453|7266821|FG000|STARTED|Overall Study||38
6357436|NCT00661453|7266821|FG000|COMPLETED|Overall Study||25
6357437|NCT00661453|7266821|FG000|NOT COMPLETED|Overall Study||13
6357438|NCT00661479|7266829|FG000|STARTED|Overall Study||12
6357439|NCT00661479|7266830|FG001|STARTED|Overall Study||3
6357440|NCT00661479|7266831|FG002|STARTED|Overall Study||3
6357441|NCT00661479|7266832|FG003|STARTED|Overall Study||3
6357442|NCT00661479|7266829|FG000|COMPLETED|Overall Study||12
6357443|NCT00661479|7266830|FG001|COMPLETED|Overall Study||3
6357444|NCT00661479|7266831|FG002|COMPLETED|Overall Study||3
6357445|NCT00661479|7266832|FG003|COMPLETED|Overall Study||3
6357446|NCT00661479|7266829|FG000|NOT COMPLETED|Overall Study||0
6357447|NCT00661479|7266830|FG001|NOT COMPLETED|Overall Study||0
6357448|NCT00661479|7266831|FG002|NOT COMPLETED|Overall Study||0
6357449|NCT00661479|7266832|FG003|NOT COMPLETED|Overall Study||0
6357450|NCT00661492|7266843|FG000|STARTED|Overall Study||75
6357451|NCT00661492|7266844|FG001|STARTED|Overall Study||40
6357452|NCT00661492|7266843|FG000|COMPLETED|Overall Study||7
6357453|NCT00661492|7266844|FG001|COMPLETED|Overall Study||11
6357454|NCT00661492|7266843|FG000|NOT COMPLETED|Overall Study||68
6357455|NCT00661492|7266844|FG001|NOT COMPLETED|Overall Study||29
6357456|NCT00661505|7266850|FG000|STARTED|Overall Study||132
6357457|NCT00661505|7266850|FG000|COMPLETED|Overall Study||102
6357458|NCT00661505|7266850|FG000|NOT COMPLETED|Overall Study||30
6357459|NCT00661531|7266855|FG000|STARTED|Overall Study||11
6357460|NCT00661531|7266855|FG000|COMPLETED|Overall Study||8
6560143|NCT01785069|7482826|FG003|STARTED|Overall Study||68
6357461|NCT00661531|7266855|FG000|NOT COMPLETED|Overall Study||3
6357462|NCT00661544|7266859|FG000|STARTED|Overall Study||48
6357463|NCT00661544|7266859|FG000|COMPLETED|Overall Study||48
6357464|NCT00661544|7266859|FG000|NOT COMPLETED|Overall Study||0
6560144|NCT01785069|7482823|FG000|COMPLETED|Overall Study||95
6560145|NCT01785069|7482824|FG001|COMPLETED|Overall Study||64
6560146|NCT01785069|7482825|FG002|COMPLETED|Overall Study||91
6560147|NCT01785069|7482826|FG003|COMPLETED|Overall Study||54
6357465|NCT00661557|7266865|FG000|STARTED|Overall Study||192
6357466|NCT00661557|7266866|FG001|STARTED|Overall Study||79
6357467|NCT00661557|7266865|FG000|COMPLETED|Overall Study||183
6357468|NCT00661557|7266866|FG001|COMPLETED|Overall Study||79
6357469|NCT00661557|7266865|FG000|NOT COMPLETED|Overall Study||9
6357470|NCT00661557|7266866|FG001|NOT COMPLETED|Overall Study||0
6357471|NCT00661570|7266872|FG000|STARTED|Overall Study||26
6357472|NCT00661570|7266872|FG000|COMPLETED|Overall Study||26
6357473|NCT00661570|7266872|FG000|NOT COMPLETED|Overall Study||0
6357474|NCT00661583|7266879|FG000|STARTED|Overall Study||10
6357475|NCT00661583|7266880|FG001|STARTED|Overall Study||10
6357476|NCT00661583|7266881|FG002|STARTED|Overall Study||10
6357477|NCT00661583|7266879|FG000|COMPLETED|Overall Study||10
6357478|NCT00661583|7266880|FG001|COMPLETED|Overall Study||10
6357479|NCT00661583|7266881|FG002|COMPLETED|Overall Study||10
6357480|NCT00661583|7266879|FG000|NOT COMPLETED|Overall Study||0
6357481|NCT00661583|7266880|FG001|NOT COMPLETED|Overall Study||0
6357482|NCT00661583|7266881|FG002|NOT COMPLETED|Overall Study||0
6357483|NCT00661609|7266889|FG000|STARTED|Overall Study|All dosed patients|41
6357484|NCT00661609|7266889|FG000|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
6357485|NCT00661609|7266889|FG000|NOT COMPLETED|Overall Study||41
6357486|NCT00661622|7266895|FG000|STARTED|Overall Study||26
6357487|NCT00661622|7266896|FG001|STARTED|Overall Study||27
6357488|NCT00661622|7266895|FG000|COMPLETED|Overall Study||25
6357489|NCT00661622|7266896|FG001|COMPLETED|Overall Study||27
6357490|NCT00661622|7266895|FG000|NOT COMPLETED|Overall Study||1
6357491|NCT00661622|7266896|FG001|NOT COMPLETED|Overall Study||0
6357492|NCT00661661|7266905|FG000|STARTED|Overall Study||382
6357493|NCT00661661|7266906|FG001|STARTED|Overall Study||105
6357494|NCT00661661|7266905|FG000|COMPLETED|Overall Study||242
6357495|NCT00661661|7266906|FG001|COMPLETED|Overall Study||66
6357496|NCT00661661|7266905|FG000|NOT COMPLETED|Overall Study||140
6357497|NCT00661661|7266906|FG001|NOT COMPLETED|Overall Study||39
6357498|NCT00661674|7266914|FG000|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
6357499|NCT00661674|7266915|FG001|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
6357500|NCT00661674|7266916|FG002|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
6357501|NCT00661674|7266917|FG003|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
6357502|NCT00661674|7266918|FG004|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
6357503|NCT00661674|7266919|FG005|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
6357504|NCT00661674|7266914|FG000|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
6357505|NCT00661674|7266915|FG001|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
6357506|NCT00661674|7266916|FG002|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
6357507|NCT00661674|7266917|FG003|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
6357508|NCT00661674|7266918|FG004|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
6357509|NCT00661674|7266919|FG005|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
6357510|NCT00661674|7266914|FG000|NOT COMPLETED|Overall Study||0
6357511|NCT00661674|7266915|FG001|NOT COMPLETED|Overall Study||0
6357512|NCT00661674|7266916|FG002|NOT COMPLETED|Overall Study||0
6357513|NCT00661674|7266917|FG003|NOT COMPLETED|Overall Study||0
6357514|NCT00661674|7266918|FG004|NOT COMPLETED|Overall Study||0
6357515|NCT00661674|7266919|FG005|NOT COMPLETED|Overall Study||0
6357516|NCT00661687|7266927|FG000|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
6357517|NCT00661687|7266927|FG000|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
6357518|NCT00661687|7266927|FG000|NOT COMPLETED|Overall Study||15
6357519|NCT00661713|7266941|FG000|STARTED|Overall Study||128
6357520|NCT00661713|7266942|FG001|STARTED|Overall Study||247
6357521|NCT00661713|7266943|FG002|STARTED|Overall Study||128
6357522|NCT00661713|7266944|FG003|STARTED|Overall Study||247
6357523|NCT00661713|7266945|FG004|STARTED|Overall Study||127
6357524|NCT00661713|7266946|FG005|STARTED|Overall Study||253
6357525|NCT00661713|7266947|FG006|STARTED|Overall Study||373
6357526|NCT00661713|7266948|FG007|STARTED|Overall Study||128
6357527|NCT00661713|7266941|FG000|COMPLETED|Overall Study||112
6357528|NCT00661713|7266942|FG001|COMPLETED|Overall Study||208
6357529|NCT00661713|7266943|FG002|COMPLETED|Overall Study||111
6357530|NCT00661713|7266944|FG003|COMPLETED|Overall Study||219
6357531|NCT00661713|7266945|FG004|COMPLETED|Overall Study||107
6357532|NCT00661713|7266946|FG005|COMPLETED|Overall Study||216
6357533|NCT00661713|7266947|FG006|COMPLETED|Overall Study||309
6357534|NCT00661713|7266948|FG007|COMPLETED|Overall Study||117
6357535|NCT00661713|7266941|FG000|NOT COMPLETED|Overall Study||16
6357536|NCT00661713|7266942|FG001|NOT COMPLETED|Overall Study||39
6357537|NCT00661713|7266943|FG002|NOT COMPLETED|Overall Study||17
6357538|NCT00661713|7266944|FG003|NOT COMPLETED|Overall Study||28
6357539|NCT00661713|7266945|FG004|NOT COMPLETED|Overall Study||20
6357540|NCT00661713|7266946|FG005|NOT COMPLETED|Overall Study||37
6357541|NCT00661713|7266947|FG006|NOT COMPLETED|Overall Study||64
6357542|NCT00661713|7266948|FG007|NOT COMPLETED|Overall Study||11
6357543|NCT00661726|7266968|FG000|STARTED|Overall Study||6
6357544|NCT00661726|7266968|FG000|COMPLETED|Overall Study||5
6357545|NCT00661726|7266968|FG000|NOT COMPLETED|Overall Study||1
6357546|NCT00661778|7266972|FG000|STARTED|Overall Study||50
6357547|NCT00661778|7266972|FG000|COMPLETED|Overall Study||0
6357548|NCT00661778|7266972|FG000|NOT COMPLETED|Overall Study||50
6357549|NCT00661830|7266978|FG000|STARTED|Overall Study||49
6357550|NCT00661830|7266979|FG001|STARTED|Overall Study||48
6357551|NCT00661830|7266978|FG000|COMPLETED|Overall Study||9
6357552|NCT00661830|7266979|FG001|COMPLETED|Overall Study||6
6357553|NCT00661830|7266978|FG000|NOT COMPLETED|Overall Study||40
6357554|NCT00661830|7266979|FG001|NOT COMPLETED|Overall Study||42
6357555|NCT00661895|7266987|FG000|STARTED|Overall Study||49
6357556|NCT00661895|7266988|FG001|STARTED|Overall Study||50
6357557|NCT00661895|7266987|FG000|COMPLETED|Overall Study||49
6357558|NCT00661895|7266988|FG001|COMPLETED|Overall Study||50
6357559|NCT00661895|7266987|FG000|NOT COMPLETED|Overall Study||0
6357560|NCT00661895|7266988|FG001|NOT COMPLETED|Overall Study||0
6357561|NCT00661960|7266997|FG000|STARTED|Overall Study||5
6357562|NCT00661960|7266998|FG001|STARTED|Overall Study||10
6357563|NCT00661960|7266999|FG002|STARTED|Overall Study||10
6357564|NCT00661960|7266997|FG000|COMPLETED|Overall Study||5
6357565|NCT00661960|7266998|FG001|COMPLETED|Overall Study||7
6357566|NCT00661960|7266999|FG002|COMPLETED|Overall Study||9
6357567|NCT00661960|7266997|FG000|NOT COMPLETED|Overall Study||0
6357568|NCT00661960|7266998|FG001|NOT COMPLETED|Overall Study||3
6357569|NCT00661960|7266999|FG002|NOT COMPLETED|Overall Study||1
6357570|NCT00661999|7267010|FG000|STARTED|Overall Study||164
6357571|NCT00661999|7267011|FG001|STARTED|Overall Study||163
6357572|NCT00661999|7267012|FG002|STARTED|Overall Study||163
6357573|NCT00661999|7267010|FG000|COMPLETED|Overall Study||105
6357574|NCT00661999|7267011|FG001|COMPLETED|Overall Study||113
6357575|NCT00661999|7267012|FG002|COMPLETED|Overall Study||106
6357576|NCT00661999|7267010|FG000|NOT COMPLETED|Overall Study||59
6357577|NCT00661999|7267011|FG001|NOT COMPLETED|Overall Study||50
6357578|NCT00661999|7267012|FG002|NOT COMPLETED|Overall Study||57
6357579|NCT00662012|7267020|FG000|STARTED|Overall Study||414
6357580|NCT00662012|7267020|FG000|COMPLETED|Overall Study||327
6357581|NCT00662012|7267020|FG000|NOT COMPLETED|Overall Study||87
6357582|NCT00662025|7267024|FG000|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
6357583|NCT00662025|7267024|FG000|COMPLETED|Overall Study||0
6357584|NCT00662025|7267024|FG000|NOT COMPLETED|Overall Study||63
6357585|NCT00662038|7267028|FG000|STARTED|Overall Study||1058
6357586|NCT00662038|7267028|FG000|COMPLETED|Overall Study||427
6357587|NCT00662038|7267028|FG000|NOT COMPLETED|Overall Study||631
6357588|NCT00662129|7267032|FG000|STARTED|Overall Study||50
6357589|NCT00662129|7267032|FG000|COMPLETED|Overall Study||47
6357590|NCT00662129|7267032|FG000|NOT COMPLETED|Overall Study||3
6357591|NCT00662155|7267040|FG000|STARTED|Overall Study||16
6357592|NCT00662155|7267041|FG001|STARTED|Overall Study||20
6357593|NCT00662155|7267042|FG002|STARTED|Overall Study||20
6357594|NCT00662155|7267043|FG003|STARTED|Overall Study||18
6357595|NCT00662155|7267040|FG000|COMPLETED|Overall Study||13
6357596|NCT00662155|7267041|FG001|COMPLETED|Overall Study||15
6357597|NCT00662155|7267042|FG002|COMPLETED|Overall Study||13
6357598|NCT00662155|7267043|FG003|COMPLETED|Overall Study||14
6357599|NCT00662155|7267040|FG000|NOT COMPLETED|Overall Study||3
6357600|NCT00662155|7267041|FG001|NOT COMPLETED|Overall Study||5
6357601|NCT00662155|7267042|FG002|NOT COMPLETED|Overall Study||7
6357602|NCT00662155|7267043|FG003|NOT COMPLETED|Overall Study||4
6776548|NCT03823391|7704596|FG001|COMPLETED|Period 2: Weeks 12 to Week 24||30
6776549|NCT03823391|7704595|FG000|NOT COMPLETED|Period 2: Weeks 12 to Week 24||2
6776550|NCT03823391|7704596|FG001|NOT COMPLETED|Period 2: Weeks 12 to Week 24||1
6776551|NCT03820258|7704604|FG000|STARTED|Overall Study||21
6776552|NCT03820258|7704604|FG000|COMPLETED|Overall Study||21
6776553|NCT03820258|7704604|FG000|NOT COMPLETED|Overall Study||0
6776554|NCT03819491|7704610|FG000|STARTED|Before Randomization||24
6776555|NCT03819491|7704611|FG001|STARTED|Before Randomization||0
6357603|NCT00662207|7267053|FG000|STARTED|Overall Study||3
6357604|NCT00662207|7267053|FG000|COMPLETED|Overall Study||3
6357605|NCT00662207|7267053|FG000|NOT COMPLETED|Overall Study||0
6357606|NCT00662259|7267059|FG000|STARTED|Overall Study||21
6357607|NCT00662259|7267060|FG001|STARTED|Overall Study||11
6357608|NCT00662259|7267059|FG000|COMPLETED|Overall Study||19
6357609|NCT00662259|7267060|FG001|COMPLETED|Overall Study||11
6357610|NCT00662259|7267059|FG000|NOT COMPLETED|Overall Study||2
6357611|NCT00662259|7267060|FG001|NOT COMPLETED|Overall Study||0
6357612|NCT00662298|7267066|FG000|STARTED|Overall Study||5
6357613|NCT00662298|7267066|FG000|COMPLETED|Overall Study||5
6357614|NCT00662298|7267066|FG000|NOT COMPLETED|Overall Study||0
6357615|NCT00662311|7267073|FG000|STARTED|Overall Study||5
6357616|NCT00662311|7267074|FG001|STARTED|Overall Study||0
6357617|NCT00662311|7267075|FG002|STARTED|Overall Study||0
6357618|NCT00662311|7267073|FG000|COMPLETED|Overall Study||4
6357619|NCT00662311|7267074|FG001|COMPLETED|Overall Study||0
6357620|NCT00662311|7267075|FG002|COMPLETED|Overall Study||0
6357621|NCT00662311|7267073|FG000|NOT COMPLETED|Overall Study||1
6357622|NCT00662311|7267074|FG001|NOT COMPLETED|Overall Study||0
6357623|NCT00662311|7267075|FG002|NOT COMPLETED|Overall Study||0
6357624|NCT00662363|7267085|FG000|STARTED|Overall Study||32
6357625|NCT00662363|7267086|FG001|STARTED|Overall Study||32
6357626|NCT00662363|7267085|FG000|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
6357627|NCT00662363|7267086|FG001|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
6357628|NCT00662363|7267085|FG000|NOT COMPLETED|Overall Study||11
6357629|NCT00662363|7267086|FG001|NOT COMPLETED|Overall Study||10
6357630|NCT00662532|7267096|FG000|STARTED|Overall Study||22
6357631|NCT00662532|7267097|FG001|STARTED|Overall Study||22
6357632|NCT00662532|7267096|FG000|COMPLETED|Overall Study||22
6357633|NCT00662532|7267097|FG001|COMPLETED|Overall Study||20
6357634|NCT00662532|7267096|FG000|NOT COMPLETED|Overall Study||0
6357635|NCT00662532|7267097|FG001|NOT COMPLETED|Overall Study||2
6357636|NCT00662545|7267105|FG000|STARTED|Overall Study||5
6357637|NCT00662545|7267106|FG001|STARTED|Overall Study||5
6357638|NCT00662545|7267105|FG000|COMPLETED|Overall Study||5
6357639|NCT00662545|7267106|FG001|COMPLETED|Overall Study||5
6357640|NCT00662545|7267105|FG000|NOT COMPLETED|Overall Study||0
6357641|NCT00662545|7267106|FG001|NOT COMPLETED|Overall Study||0
6357642|NCT00662558|7267114|FG000|STARTED|Overall Study||398
6357643|NCT00662558|7267115|FG001|STARTED|Overall Study||404
6357644|NCT00662558|7267114|FG000|Received Treatment|Overall Study||396
6357645|NCT00662558|7267115|FG001|Received Treatment|Overall Study||396
6357646|NCT00662558|7267114|FG000|COMPLETED|Overall Study||342
6357647|NCT00662558|7267115|FG001|COMPLETED|Overall Study||294
6357648|NCT00662558|7267114|FG000|NOT COMPLETED|Overall Study||56
6357649|NCT00662558|7267115|FG001|NOT COMPLETED|Overall Study||110
6357650|NCT00662649|7267125|FG000|STARTED|Core Study (24 Months)||429
6357651|NCT00662649|7267126|FG001|STARTED|Core Study (24 Months)||425
6357652|NCT00662649|7267127|FG002|STARTED|Core Study (24 Months)||418
6357653|NCT00662649|7267128|FG003|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
6357654|NCT00662649|7267129|FG004|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
6357655|NCT00662649|7267125|FG000|Intent to Treat (ITT)|Core Study (24 Months)||429
6357656|NCT00662649|7267126|FG001|Intent to Treat (ITT)|Core Study (24 Months)||425
6357657|NCT00662649|7267127|FG002|Intent to Treat (ITT)|Core Study (24 Months)||418
6357658|NCT00662649|7267128|FG003|Intent to Treat (ITT)|Core Study (24 Months)||0
6357659|NCT00662649|7267129|FG004|Intent to Treat (ITT)|Core Study (24 Months)||0
6357660|NCT00662649|7267125|FG000|COMPLETED|Core Study (24 Months)||332
6357661|NCT00662649|7267126|FG001|COMPLETED|Core Study (24 Months)||369
6357662|NCT00662649|7267127|FG002|COMPLETED|Core Study (24 Months)||332
6357663|NCT00662649|7267128|FG003|COMPLETED|Core Study (24 Months)||0
6357664|NCT00662649|7267129|FG004|COMPLETED|Core Study (24 Months)||0
6357665|NCT00662649|7267125|FG000|NOT COMPLETED|Core Study (24 Months)||97
6357666|NCT00662649|7267126|FG001|NOT COMPLETED|Core Study (24 Months)||56
6776556|NCT03819491|7704610|FG000|COMPLETED|Before Randomization||24
6776557|NCT03819491|7704611|FG001|COMPLETED|Before Randomization||0
6357667|NCT00662649|7267127|FG002|NOT COMPLETED|Core Study (24 Months)||86
6357668|NCT00662649|7267128|FG003|NOT COMPLETED|Core Study (24 Months)||0
6357669|NCT00662649|7267129|FG004|NOT COMPLETED|Core Study (24 Months)||0
6357670|NCT00662649|7267125|FG000|STARTED|Extension Study (Month 24 to 60)||289
6357671|NCT00662649|7267126|FG001|STARTED|Extension Study (Month 24 to 60)||331
6357672|NCT00662649|7267127|FG002|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
6357673|NCT00662649|7267128|FG003|STARTED|Extension Study (Month 24 to 60)||145
6357674|NCT00662649|7267129|FG004|STARTED|Extension Study (Month 24 to 60)||155
6357675|NCT00662649|7267125|FG000|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
6357676|NCT00662649|7267126|FG001|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
6357677|NCT00662649|7267127|FG002|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
6357678|NCT00662649|7267128|FG003|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
6357679|NCT00662649|7267129|FG004|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
6357680|NCT00662649|7267125|FG000|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
6357681|NCT00662649|7267126|FG001|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
6357682|NCT00662649|7267127|FG002|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
6357683|NCT00662649|7267128|FG003|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
6357684|NCT00662649|7267129|FG004|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
6357685|NCT00662649|7267125|FG000|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
6357686|NCT00662649|7267126|FG001|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
6357687|NCT00662649|7267127|FG002|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
6357688|NCT00662649|7267128|FG003|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
6776558|NCT03819491|7704610|FG000|NOT COMPLETED|Before Randomization||0
6357689|NCT00662649|7267129|FG004|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
6357690|NCT00662649|7267125|FG000|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
6357691|NCT00662649|7267126|FG001|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
6357692|NCT00662649|7267127|FG002|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
6357693|NCT00662649|7267128|FG003|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
6357694|NCT00662649|7267129|FG004|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
6357695|NCT00662649|7267125|FG000|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
6357696|NCT00662649|7267126|FG001|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
6357697|NCT00662649|7267127|FG002|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
6357698|NCT00662649|7267128|FG003|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
6357699|NCT00662649|7267129|FG004|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
6357700|NCT00662649|7267125|FG000|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
6357701|NCT00662649|7267126|FG001|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
6357702|NCT00662649|7267127|FG002|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
6357703|NCT00662649|7267128|FG003|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
6357704|NCT00662649|7267129|FG004|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
6357705|NCT00662649|7267125|FG000|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
6357706|NCT00662649|7267126|FG001|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
6357707|NCT00662649|7267127|FG002|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
6357708|NCT00662649|7267128|FG003|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
6357709|NCT00662649|7267129|FG004|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
6357710|NCT00662649|7267125|FG000|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
6357711|NCT00662649|7267126|FG001|COMPLETED|Extension Study (Month 24 to 60)||290
6357712|NCT00662649|7267127|FG002|COMPLETED|Extension Study (Month 24 to 60)||0
6357713|NCT00662649|7267128|FG003|COMPLETED|Extension Study (Month 24 to 60)||112
6357714|NCT00662649|7267129|FG004|COMPLETED|Extension Study (Month 24 to 60)||126
6357715|NCT00662649|7267125|FG000|NOT COMPLETED|Extension Study (Month 24 to 60)||44
6357716|NCT00662649|7267126|FG001|NOT COMPLETED|Extension Study (Month 24 to 60)||41
6357717|NCT00662649|7267127|FG002|NOT COMPLETED|Extension Study (Month 24 to 60)||0
6357718|NCT00662649|7267128|FG003|NOT COMPLETED|Extension Study (Month 24 to 60)||33
6357719|NCT00662649|7267129|FG004|NOT COMPLETED|Extension Study (Month 24 to 60)||29
6357720|NCT00662675|7267145|FG000|STARTED|Overall Study||20
6357721|NCT00662675|7267146|FG001|STARTED|Overall Study||20
6357722|NCT00662675|7267145|FG000|COMPLETED|Overall Study||20
6357723|NCT00662675|7267146|FG001|COMPLETED|Overall Study||20
6357724|NCT00662675|7267145|FG000|NOT COMPLETED|Overall Study||0
6357725|NCT00662675|7267146|FG001|NOT COMPLETED|Overall Study||0
6357726|NCT00662818|7267154|FG000|STARTED|Period 1 (6 Weeks)||84
6357727|NCT00662818|7267155|FG001|STARTED|Period 1 (6 Weeks)||81
6357728|NCT00662818|7267154|FG000|Treated|Period 1 (6 Weeks)||56
6357729|NCT00662818|7267155|FG001|Treated|Period 1 (6 Weeks)||58
6357730|NCT00662818|7267154|FG000|COMPLETED|Period 1 (6 Weeks)||56
6357731|NCT00662818|7267155|FG001|COMPLETED|Period 1 (6 Weeks)||58
6357732|NCT00662818|7267154|FG000|NOT COMPLETED|Period 1 (6 Weeks)||28
6357733|NCT00662818|7267155|FG001|NOT COMPLETED|Period 1 (6 Weeks)||23
6357734|NCT00662818|7267154|FG000|STARTED|Wash-Out (14 Days)||56
6357735|NCT00662818|7267155|FG001|STARTED|Wash-Out (14 Days)||58
6357736|NCT00662818|7267154|FG000|COMPLETED|Wash-Out (14 Days)||51
6357737|NCT00662818|7267155|FG001|COMPLETED|Wash-Out (14 Days)||53
6357738|NCT00662818|7267154|FG000|NOT COMPLETED|Wash-Out (14 Days)||5
6357739|NCT00662818|7267155|FG001|NOT COMPLETED|Wash-Out (14 Days)||5
6357740|NCT00662818|7267154|FG000|STARTED|Period 2 (6 Weeks)||51
6357741|NCT00662818|7267155|FG001|STARTED|Period 2 (6 Weeks)||53
6357742|NCT00662818|7267154|FG000|COMPLETED|Period 2 (6 Weeks)||38
6357743|NCT00662818|7267155|FG001|COMPLETED|Period 2 (6 Weeks)||41
6357744|NCT00662818|7267154|FG000|NOT COMPLETED|Period 2 (6 Weeks)||13
6357745|NCT00662818|7267155|FG001|NOT COMPLETED|Period 2 (6 Weeks)||12
6357746|NCT00662831|7267165|FG000|STARTED|Overall Study||184
6357747|NCT00662831|7267166|FG001|STARTED|Overall Study||92
6357748|NCT00662831|7267165|FG000|COMPLETED|Overall Study||78
6357749|NCT00662831|7267166|FG001|COMPLETED|Overall Study||33
6357750|NCT00662831|7267165|FG000|NOT COMPLETED|Overall Study||106
6357751|NCT00662831|7267166|FG001|NOT COMPLETED|Overall Study||59
6357752|NCT00662857|7267172|FG000|STARTED|TI Dosing Period 1 (1 Day)||13
6357753|NCT00662857|7267173|FG001|STARTED|TI Dosing Period 1 (1 Day)||16
6357754|NCT00662857|7267172|FG000|COMPLETED|TI Dosing Period 1 (1 Day)||13
6357755|NCT00662857|7267173|FG001|COMPLETED|TI Dosing Period 1 (1 Day)||16
6357756|NCT00662857|7267172|FG000|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
6357757|NCT00662857|7267173|FG001|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
6357758|NCT00662857|7267172|FG000|STARTED|Washout 1 (3 - 14 Days)||13
6357759|NCT00662857|7267173|FG001|STARTED|Washout 1 (3 - 14 Days)||16
6357760|NCT00662857|7267172|FG000|COMPLETED|Washout 1 (3 - 14 Days)||13
6357761|NCT00662857|7267173|FG001|COMPLETED|Washout 1 (3 - 14 Days)||14
6357762|NCT00662857|7267172|FG000|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
6357763|NCT00662857|7267173|FG001|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
6357764|NCT00662857|7267172|FG000|STARTED|TI Dosing Period 2 (1 Day)||13
6357765|NCT00662857|7267173|FG001|STARTED|TI Dosing Period 2 (1 Day)||14
6357766|NCT00662857|7267172|FG000|COMPLETED|TI Dosing Period 2 (1 Day)||13
6357767|NCT00662857|7267173|FG001|COMPLETED|TI Dosing Period 2 (1 Day)||14
6357768|NCT00662857|7267172|FG000|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
6357769|NCT00662857|7267173|FG001|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
6357770|NCT00662857|7267172|FG000|STARTED|Washout 2 (3 - 14 Days)||13
6357771|NCT00662857|7267173|FG001|STARTED|Washout 2 (3 - 14 Days)||14
6357772|NCT00662857|7267172|FG000|COMPLETED|Washout 2 (3 - 14 Days)||12
6357773|NCT00662857|7267173|FG001|COMPLETED|Washout 2 (3 - 14 Days)||14
6357774|NCT00662857|7267172|FG000|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
6357775|NCT00662857|7267173|FG001|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
6357776|NCT00662857|7267172|FG000|STARTED|Lispro Dosing Period (1 Day)||12
6357777|NCT00662857|7267173|FG001|STARTED|Lispro Dosing Period (1 Day)||14
6357778|NCT00662857|7267172|FG000|COMPLETED|Lispro Dosing Period (1 Day)||12
6357779|NCT00662857|7267173|FG001|COMPLETED|Lispro Dosing Period (1 Day)||14
6357780|NCT00662857|7267172|FG000|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
6357781|NCT00662857|7267173|FG001|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
6357782|NCT00662909|7267185|FG000|STARTED|Overall Study||454
6357783|NCT00662909|7267186|FG001|STARTED|Overall Study||442
6357784|NCT00662909|7267187|FG002|STARTED|Overall Study||433
6357785|NCT00662909|7267185|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
6357786|NCT00662909|7267186|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
6357787|NCT00662909|7267187|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
6357788|NCT00662909|7267185|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
6357789|NCT00662909|7267186|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
6357790|NCT00662909|7267187|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
6357791|NCT00662909|7267185|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
6357792|NCT00662909|7267186|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
6357793|NCT00662909|7267187|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
6357794|NCT00662909|7267185|FG000|COMPLETED|Overall Study||385
6357795|NCT00662909|7267186|FG001|COMPLETED|Overall Study||383
6357796|NCT00662909|7267187|FG002|COMPLETED|Overall Study||380
6357797|NCT00662909|7267185|FG000|NOT COMPLETED|Overall Study||69
6357798|NCT00662909|7267186|FG001|NOT COMPLETED|Overall Study||59
6357799|NCT00662909|7267187|FG002|NOT COMPLETED|Overall Study||53
6357800|NCT00663026|7267198|FG000|STARTED|Overall Study||19
6357801|NCT00663026|7267199|FG001|STARTED|Overall Study||29
6357802|NCT00663026|7267200|FG002|STARTED|Overall Study||31
6357803|NCT00663026|7267198|FG000|COMPLETED|Overall Study||17
6357804|NCT00663026|7267199|FG001|COMPLETED|Overall Study||23
6357805|NCT00663026|7267200|FG002|COMPLETED|Overall Study||27
6357806|NCT00663026|7267198|FG000|NOT COMPLETED|Overall Study||2
6357807|NCT00663026|7267199|FG001|NOT COMPLETED|Overall Study||6
6357808|NCT00663026|7267200|FG002|NOT COMPLETED|Overall Study||4
6357809|NCT00663039|7267210|FG000|STARTED|Overall Study||14
6357810|NCT00663039|7267211|FG001|STARTED|Overall Study||13
6357811|NCT00663039|7267210|FG000|COMPLETED|Overall Study||10
6357812|NCT00663039|7267211|FG001|COMPLETED|Overall Study||9
6357813|NCT00663039|7267210|FG000|NOT COMPLETED|Overall Study||4
6357814|NCT00663039|7267211|FG001|NOT COMPLETED|Overall Study||4
6357815|NCT00663117|7267219|FG000|STARTED|Overall Study||20
6357816|NCT00663117|7267220|FG001|STARTED|Overall Study||20
6357817|NCT00663117|7267219|FG000|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
6357818|NCT00663117|7267220|FG001|COMPLETED|Overall Study||20
6357819|NCT00663117|7267219|FG000|NOT COMPLETED|Overall Study||1
6357820|NCT00663117|7267220|FG001|NOT COMPLETED|Overall Study||0
6357821|NCT00663169|7267234|FG000|STARTED|Overall Study||3
6357822|NCT00663169|7267235|FG001|STARTED|Overall Study||3
6357823|NCT00663169|7267234|FG000|COMPLETED|Overall Study||3
6357824|NCT00663169|7267235|FG001|COMPLETED|Overall Study||3
6357825|NCT00663169|7267234|FG000|NOT COMPLETED|Overall Study||0
6357826|NCT00663169|7267235|FG001|NOT COMPLETED|Overall Study||0
6357827|NCT00663208|7267248|FG000|STARTED|Treatment Period||4
6357828|NCT00663208|7267249|FG001|STARTED|Treatment Period||4
6357829|NCT00663208|7267250|FG002|STARTED|Treatment Period||4
6776559|NCT03819491|7704611|FG001|NOT COMPLETED|Before Randomization||0
6776560|NCT03819491|7704610|FG000|STARTED|After Randomization||12
6357830|NCT00663208|7267251|FG003|STARTED|Treatment Period||4
6357831|NCT00663208|7267252|FG004|STARTED|Treatment Period||4
6357832|NCT00663208|7267253|FG005|STARTED|Treatment Period||4
6357833|NCT00663208|7267254|FG006|STARTED|Treatment Period||6
6357834|NCT00663208|7267248|FG000|COMPLETED|Treatment Period||4
6357835|NCT00663208|7267249|FG001|COMPLETED|Treatment Period||3
6357836|NCT00663208|7267250|FG002|COMPLETED|Treatment Period||4
6357837|NCT00663208|7267251|FG003|COMPLETED|Treatment Period||4
6357838|NCT00663208|7267252|FG004|COMPLETED|Treatment Period||4
6357839|NCT00663208|7267253|FG005|COMPLETED|Treatment Period||4
6357840|NCT00663208|7267254|FG006|COMPLETED|Treatment Period||6
6357841|NCT00663208|7267248|FG000|NOT COMPLETED|Treatment Period||0
6357842|NCT00663208|7267249|FG001|NOT COMPLETED|Treatment Period||1
6357843|NCT00663208|7267250|FG002|NOT COMPLETED|Treatment Period||0
6357844|NCT00663208|7267251|FG003|NOT COMPLETED|Treatment Period||0
6357845|NCT00663208|7267252|FG004|NOT COMPLETED|Treatment Period||0
6357846|NCT00663208|7267253|FG005|NOT COMPLETED|Treatment Period||0
6357847|NCT00663208|7267254|FG006|NOT COMPLETED|Treatment Period||0
6357848|NCT00663208|7267248|FG000|STARTED|Follow-up Period||4
6357849|NCT00663208|7267249|FG001|STARTED|Follow-up Period||3
6357850|NCT00663208|7267250|FG002|STARTED|Follow-up Period||4
6357851|NCT00663208|7267251|FG003|STARTED|Follow-up Period||4
6357852|NCT00663208|7267252|FG004|STARTED|Follow-up Period||4
6357853|NCT00663208|7267253|FG005|STARTED|Follow-up Period||4
6357854|NCT00663208|7267254|FG006|STARTED|Follow-up Period||6
6357855|NCT00663208|7267248|FG000|COMPLETED|Follow-up Period||1
6357856|NCT00663208|7267249|FG001|COMPLETED|Follow-up Period||3
6357857|NCT00663208|7267250|FG002|COMPLETED|Follow-up Period||1
6357858|NCT00663208|7267251|FG003|COMPLETED|Follow-up Period||2
6357859|NCT00663208|7267252|FG004|COMPLETED|Follow-up Period||4
6357860|NCT00663208|7267253|FG005|COMPLETED|Follow-up Period||4
6357861|NCT00663208|7267254|FG006|COMPLETED|Follow-up Period||5
6357862|NCT00663208|7267248|FG000|NOT COMPLETED|Follow-up Period||3
6357863|NCT00663208|7267249|FG001|NOT COMPLETED|Follow-up Period||0
6357864|NCT00663208|7267250|FG002|NOT COMPLETED|Follow-up Period||3
6357865|NCT00663208|7267251|FG003|NOT COMPLETED|Follow-up Period||2
6357866|NCT00663208|7267252|FG004|NOT COMPLETED|Follow-up Period||0
6357867|NCT00663208|7267253|FG005|NOT COMPLETED|Follow-up Period||0
6357868|NCT00663208|7267254|FG006|NOT COMPLETED|Follow-up Period||1
6357869|NCT00663234|7267272|FG000|STARTED|Overall Study||28
6357870|NCT00663234|7267272|FG000|Dose Increased to 20 mg at Week 8|Overall Study||10
6357871|NCT00663234|7267272|FG000|COMPLETED|Overall Study||27
6357872|NCT00663234|7267272|FG000|NOT COMPLETED|Overall Study||1
6357873|NCT00663260|7267283|FG000|STARTED|Overall Study||84
6357874|NCT00663260|7267284|FG001|STARTED|Overall Study||83
6357875|NCT00663260|7267285|FG002|STARTED|Overall Study||85
6357876|NCT00663260|7267283|FG000|COMPLETED|Overall Study||63
6357877|NCT00663260|7267284|FG001|COMPLETED|Overall Study||72
6357878|NCT00663260|7267285|FG002|COMPLETED|Overall Study||69
6357879|NCT00663260|7267283|FG000|NOT COMPLETED|Overall Study||21
6357880|NCT00663260|7267284|FG001|NOT COMPLETED|Overall Study||11
6357881|NCT00663260|7267285|FG002|NOT COMPLETED|Overall Study||16
6357882|NCT00663403|7267293|FG000|STARTED|Overall Study||8
6357883|NCT00663403|7267293|FG000|COMPLETED|Overall Study||8
6357884|NCT00663403|7267293|FG000|NOT COMPLETED|Overall Study||0
6357885|NCT00663702|7267299|FG000|STARTED|Overall Study||52
6357886|NCT00663702|7267300|FG001|STARTED|Overall Study||71
6560148|NCT01785069|7482823|FG000|NOT COMPLETED|Overall Study||12
6560149|NCT01785069|7482824|FG001|NOT COMPLETED|Overall Study||12
6560150|NCT01785069|7482825|FG002|NOT COMPLETED|Overall Study||13
6357887|NCT00663702|7267299|FG000|COMPLETED|Overall Study||34
6357888|NCT00663702|7267300|FG001|COMPLETED|Overall Study||61
6357889|NCT00663702|7267299|FG000|NOT COMPLETED|Overall Study||18
6357890|NCT00663702|7267300|FG001|NOT COMPLETED|Overall Study||10
6357891|NCT00663793|7267308|FG000|STARTED|Overall Study||8
6357892|NCT00663793|7267309|FG001|STARTED|Overall Study||8
6357893|NCT00663793|7267308|FG000|COMPLETED|Overall Study||8
6357894|NCT00663793|7267309|FG001|COMPLETED|Overall Study||8
6357895|NCT00663793|7267308|FG000|NOT COMPLETED|Overall Study||0
6357896|NCT00663793|7267309|FG001|NOT COMPLETED|Overall Study||0
6357897|NCT00663819|7267317|FG000|STARTED|Overall Study||123
6357898|NCT00663819|7267318|FG001|STARTED|Overall Study||135
6357899|NCT00663819|7267317|FG000|COMPLETED|Overall Study||123
6357900|NCT00663819|7267318|FG001|COMPLETED|Overall Study||135
6357901|NCT00663819|7267317|FG000|NOT COMPLETED|Overall Study||0
6357902|NCT00663819|7267318|FG001|NOT COMPLETED|Overall Study||0
6357903|NCT00663858|7267329|FG000|STARTED|Overall Study||212
6357904|NCT00663858|7267330|FG001|STARTED|Overall Study||106
6357905|NCT00663858|7267331|FG002|STARTED|Overall Study||102
6357906|NCT00663858|7267329|FG000|COMPLETED|Overall Study||178
6357907|NCT00663858|7267330|FG001|COMPLETED|Overall Study||96
6357908|NCT00663858|7267331|FG002|COMPLETED|Overall Study||82
6357909|NCT00663858|7267329|FG000|NOT COMPLETED|Overall Study||34
6357910|NCT00663858|7267330|FG001|NOT COMPLETED|Overall Study||10
6357911|NCT00663858|7267331|FG002|NOT COMPLETED|Overall Study||20
6357912|NCT00663871|7267341|FG000|STARTED|Overall Study||134
6357913|NCT00663871|7267342|FG001|STARTED|Overall Study||138
6357914|NCT00663871|7267341|FG000|COMPLETED|Overall Study||124
6357915|NCT00663871|7267342|FG001|COMPLETED|Overall Study||131
6357916|NCT00663871|7267341|FG000|NOT COMPLETED|Overall Study||10
6357917|NCT00663871|7267342|FG001|NOT COMPLETED|Overall Study||7
6357918|NCT00663923|7267350|FG000|STARTED|Overall Study||50
6357919|NCT00663923|7267350|FG000|COMPLETED|Overall Study||48
6357920|NCT00663923|7267350|FG000|NOT COMPLETED|Overall Study||2
6357921|NCT00663962|7267358|FG000|STARTED|Overall Study||7
6357922|NCT00663962|7267359|FG001|STARTED|Overall Study||8
6357923|NCT00663962|7267358|FG000|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
6357924|NCT00663962|7267359|FG001|COMPLETED|Overall Study||8
6357925|NCT00663962|7267358|FG000|NOT COMPLETED|Overall Study||1
6357926|NCT00663962|7267359|FG001|NOT COMPLETED|Overall Study||0
6357927|NCT00664105|7267365|FG000|STARTED|Overall Study||63
6357928|NCT00664105|7267365|FG000|COMPLETED|Overall Study||39
6357929|NCT00664105|7267365|FG000|NOT COMPLETED|Overall Study||24
6357930|NCT00664209|7267370|FG000|STARTED|Motor Fluctuations Screen||13
6357931|NCT00664209|7267370|FG000|COMPLETED|Motor Fluctuations Screen||6
6357932|NCT00664209|7267370|FG000|NOT COMPLETED|Motor Fluctuations Screen||7
6357933|NCT00664209|7267370|FG000|STARTED|Study Treatment Period||6
6357934|NCT00664209|7267370|FG000|COMPLETED|Study Treatment Period||0
6357935|NCT00664209|7267370|FG000|NOT COMPLETED|Study Treatment Period||6
6377104|NCT00762073|7287683|FG001|STARTED|Overall Study||21
6377105|NCT00762073|7287684|FG002|STARTED|Overall Study||20
6377106|NCT00762073|7287685|FG003|STARTED|Overall Study||20
6377107|NCT00762073|7287682|FG000|COMPLETED|Overall Study||17
6377108|NCT00762073|7287683|FG001|COMPLETED|Overall Study||17
6377109|NCT00762073|7287684|FG002|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
6377110|NCT00762073|7287685|FG003|COMPLETED|Overall Study||17
6377111|NCT00762073|7287682|FG000|NOT COMPLETED|Overall Study||4
6377112|NCT00762073|7287683|FG001|NOT COMPLETED|Overall Study||4
6377113|NCT00762073|7287684|FG002|NOT COMPLETED|Overall Study||2
6377114|NCT00762073|7287685|FG003|NOT COMPLETED|Overall Study||3
6377115|NCT00762086|7287704|FG000|STARTED|Overall Study||39
6377116|NCT00762086|7287705|FG001|STARTED|Overall Study||28
6377117|NCT00762086|7287704|FG000|COMPLETED|Overall Study||33
6377118|NCT00762086|7287705|FG001|COMPLETED|Overall Study||24
6377119|NCT00762086|7287704|FG000|NOT COMPLETED|Overall Study||6
6377120|NCT00762086|7287705|FG001|NOT COMPLETED|Overall Study||4
6377121|NCT00762164|7287713|FG000|STARTED|Overall Study||17
6377122|NCT00762164|7287714|FG001|STARTED|Overall Study||17
6377123|NCT00762164|7287713|FG000|COMPLETED|Overall Study||14
6357936|NCT00664326|7267375|FG000|STARTED|Overall Study||49
6357937|NCT00664326|7267375|FG000|COMPLETED|Overall Study|transitioned to rollover study|1
6357938|NCT00664326|7267375|FG000|NOT COMPLETED|Overall Study||48
6357939|NCT00664430|7267379|FG000|STARTED|Overall Study||13
6357940|NCT00664430|7267379|FG000|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
6357941|NCT00664430|7267379|FG000|NOT COMPLETED|Overall Study||13
6357942|NCT00664521|7267385|FG000|STARTED|Overall Study||18
6357943|NCT00664521|7267386|FG001|STARTED|Overall Study||9
6357944|NCT00664521|7267385|FG000|COMPLETED|Overall Study||12
6357945|NCT00664521|7267386|FG001|COMPLETED|Overall Study||8
6357946|NCT00664521|7267385|FG000|NOT COMPLETED|Overall Study||6
6357947|NCT00664521|7267386|FG001|NOT COMPLETED|Overall Study||1
6357948|NCT00664534|7267394|FG000|STARTED|Overall Study||173
6357949|NCT00664534|7267395|FG001|STARTED|Overall Study||171
6357950|NCT00664534|7267394|FG000|COMPLETED|Overall Study||132
6357951|NCT00664534|7267395|FG001|COMPLETED|Overall Study||138
6357952|NCT00664534|7267394|FG000|NOT COMPLETED|Overall Study||41
6357953|NCT00664534|7267395|FG001|NOT COMPLETED|Overall Study||33
6357954|NCT00664560|7267404|FG000|STARTED|Overall Study|Safety Population|247
6357955|NCT00664560|7267405|FG001|STARTED|Overall Study|Safety Population|243
6357956|NCT00664560|7267406|FG002|STARTED|Overall Study|Safety Population|124
6357957|NCT00664560|7267404|FG000|COMPLETED|Overall Study||208
6357958|NCT00664560|7267405|FG001|COMPLETED|Overall Study||208
6357959|NCT00664560|7267406|FG002|COMPLETED|Overall Study||105
6357960|NCT00664560|7267404|FG000|NOT COMPLETED|Overall Study||39
6357961|NCT00664560|7267405|FG001|NOT COMPLETED|Overall Study||35
6357962|NCT00664560|7267406|FG002|NOT COMPLETED|Overall Study||19
6357963|NCT00664742|7267414|FG000|STARTED|Overall Study||607
6357964|NCT00664742|7267414|FG000|COMPLETED|Overall Study||481
6357965|NCT00664742|7267414|FG000|NOT COMPLETED|Overall Study||126
6357966|NCT00664755|7267420|FG000|STARTED|Overall Study||67
6357967|NCT00664755|7267421|FG001|STARTED|Overall Study||73
6357968|NCT00664755|7267420|FG000|COMPLETED|Overall Study||67
6357969|NCT00664755|7267421|FG001|COMPLETED|Overall Study||73
6357970|NCT00664755|7267420|FG000|NOT COMPLETED|Overall Study||0
6357971|NCT00664755|7267421|FG001|NOT COMPLETED|Overall Study||0
6357972|NCT00664859|7267430|FG000|STARTED|Overall Study||51
6357973|NCT00664859|7267431|FG001|STARTED|Overall Study||45
6357974|NCT00664859|7267432|FG002|STARTED|Overall Study||44
6357975|NCT00664859|7267430|FG000|COMPLETED|Overall Study||34
6357976|NCT00664859|7267431|FG001|COMPLETED|Overall Study||35
6357977|NCT00664859|7267432|FG002|COMPLETED|Overall Study||23
6357978|NCT00664859|7267430|FG000|NOT COMPLETED|Overall Study||17
6357979|NCT00664859|7267431|FG001|NOT COMPLETED|Overall Study||10
6357980|NCT00664859|7267432|FG002|NOT COMPLETED|Overall Study||21
6357981|NCT00665002|7267440|FG000|STARTED|Overall Study||16
6357982|NCT00665002|7267440|FG000|COMPLETED|Overall Study||4
6357983|NCT00665002|7267440|FG000|NOT COMPLETED|Overall Study||12
6357984|NCT00665132|7267444|FG000|STARTED|Overall Study||10
6357985|NCT00665132|7267444|FG000|COMPLETED|Overall Study||10
6357986|NCT00665132|7267444|FG000|NOT COMPLETED|Overall Study||0
6357987|NCT00665353|7267448|FG000|STARTED|Study Step 1||19
6357988|NCT00665353|7267448|FG000|COMPLETED|Study Step 1||16
6357989|NCT00665353|7267448|FG000|NOT COMPLETED|Study Step 1||3
6357990|NCT00665353|7267448|FG000|STARTED|Study Step 2||16
6357991|NCT00665353|7267448|FG000|COMPLETED|Study Step 2||2
6357992|NCT00665353|7267448|FG000|NOT COMPLETED|Study Step 2||14
6357993|NCT00665366|7267454|FG000|STARTED|Overall Study|Participants randomized|189
6357994|NCT00665366|7267455|FG001|STARTED|Overall Study|Participants randomized|181
6357995|NCT00665366|7267454|FG000|COMPLETED|Overall Study||131
6357996|NCT00665366|7267455|FG001|COMPLETED|Overall Study||122
6357997|NCT00665366|7267454|FG000|NOT COMPLETED|Overall Study||58
6357998|NCT00665366|7267455|FG001|NOT COMPLETED|Overall Study||59
6357999|NCT00665392|7267461|FG000|STARTED|Overall Study||42
6358000|NCT00665392|7267461|FG000|COMPLETED|Overall Study||41
6358001|NCT00665392|7267461|FG000|NOT COMPLETED|Overall Study||1
6358002|NCT00665431|7267469|FG000|STARTED|Overall Study|Safety population|243
6358003|NCT00665431|7267470|FG001|STARTED|Overall Study|Safety population|245
6358004|NCT00665431|7267471|FG002|STARTED|Overall Study|Safety population|122
6358005|NCT00665431|7267469|FG000|COMPLETED|Overall Study||203
6358006|NCT00665431|7267470|FG001|COMPLETED|Overall Study||188
6358007|NCT00665431|7267471|FG002|COMPLETED|Overall Study||98
6358008|NCT00665431|7267469|FG000|NOT COMPLETED|Overall Study||40
6358009|NCT00665431|7267470|FG001|NOT COMPLETED|Overall Study||57
6358010|NCT00665431|7267471|FG002|NOT COMPLETED|Overall Study||24
6358011|NCT00665457|7267479|FG000|STARTED|Overall Study||3
6358012|NCT00665457|7267479|FG000|COMPLETED|Overall Study||3
6358013|NCT00665457|7267479|FG000|NOT COMPLETED|Overall Study||0
6358014|NCT00665470|7267485|FG000|STARTED|Overall Study||10
6358015|NCT00665470|7267486|FG001|STARTED|Overall Study||0
6358016|NCT00665470|7267485|FG000|COMPLETED|Overall Study||10
6358017|NCT00665470|7267486|FG001|COMPLETED|Overall Study||0
6358018|NCT00665470|7267485|FG000|NOT COMPLETED|Overall Study||0
6358019|NCT00665470|7267486|FG001|NOT COMPLETED|Overall Study||0
6358020|NCT00665561|7267494|FG000|STARTED|Overall Study||1316
6358021|NCT00665561|7267495|FG001|STARTED|Overall Study||1130
6358022|NCT00665561|7267494|FG000|COMPLETED|Overall Study||814
6358023|NCT00665561|7267495|FG001|COMPLETED|Overall Study||596
6358024|NCT00665561|7267494|FG000|NOT COMPLETED|Overall Study||502
6358025|NCT00665561|7267495|FG001|NOT COMPLETED|Overall Study||534
6358026|NCT00665626|7267503|FG000|STARTED|Overall Study|Participants randomized|73
6358027|NCT00665626|7267504|FG001|STARTED|Overall Study|Participants randomized|146
6358028|NCT00665626|7267503|FG000|COMPLETED|Overall Study|Participants completed the study|63
6358029|NCT00665626|7267504|FG001|COMPLETED|Overall Study|Participants completed the study|124
6358030|NCT00665626|7267503|FG000|NOT COMPLETED|Overall Study||10
6358031|NCT00665626|7267504|FG001|NOT COMPLETED|Overall Study||22
6358032|NCT00665652|7267510|FG000|STARTED|Overall Study||8
6358033|NCT00665652|7267510|FG000|COMPLETED|Overall Study||2
6358034|NCT00665652|7267510|FG000|NOT COMPLETED|Overall Study||6
6358035|NCT00665704|7267514|FG000|STARTED|Overall Study||9
6358036|NCT00665704|7267514|FG000|COMPLETED|Overall Study||9
6358037|NCT00665704|7267514|FG000|NOT COMPLETED|Overall Study||0
6358038|NCT00665847|7267518|FG000|STARTED|Overall Study||101
6358039|NCT00665847|7267518|FG000|COMPLETED|Overall Study||76
6358040|NCT00665847|7267518|FG000|NOT COMPLETED|Overall Study||25
6358041|NCT00665925|7267526|FG000|STARTED|Overall Study|Participants randomized|77
6358042|NCT00665925|7267527|FG001|STARTED|Overall Study|Participants randomized|76
6358043|NCT00665925|7267528|FG002|STARTED|Overall Study|Participants randomized|152
6358044|NCT00665925|7267529|FG003|STARTED|Overall Study|Participants randomized|152
6358045|NCT00665925|7267526|FG000|COMPLETED|Overall Study|Participants completed the study|62
6358046|NCT00665925|7267527|FG001|COMPLETED|Overall Study|Participants completed the study|59
6358047|NCT00665925|7267528|FG002|COMPLETED|Overall Study|Participants completed the study|126
6358048|NCT00665925|7267529|FG003|COMPLETED|Overall Study|Participants completed the study|131
6358049|NCT00665925|7267526|FG000|NOT COMPLETED|Overall Study||15
6358050|NCT00665925|7267527|FG001|NOT COMPLETED|Overall Study||17
6358051|NCT00665925|7267528|FG002|NOT COMPLETED|Overall Study||26
6358052|NCT00665925|7267529|FG003|NOT COMPLETED|Overall Study||21
6358053|NCT00666029|7267542|FG000|STARTED|Overall Study||20
6358054|NCT00666029|7267543|FG001|STARTED|Overall Study||20
6358055|NCT00666029|7267542|FG000|COMPLETED|Overall Study||19
6358056|NCT00666029|7267543|FG001|COMPLETED|Overall Study||20
6358057|NCT00666029|7267542|FG000|NOT COMPLETED|Overall Study||1
6358058|NCT00666029|7267543|FG001|NOT COMPLETED|Overall Study||0
6358059|NCT00666198|7267550|FG000|STARTED|Overall Study||3337
6560151|NCT01785069|7482826|FG003|NOT COMPLETED|Overall Study||14
6560152|NCT01785095|7482836|FG000|STARTED|Overall Study||27
6358060|NCT00666198|7267550|FG000|COMPLETED|Overall Study||3304
6358061|NCT00666198|7267550|FG000|NOT COMPLETED|Overall Study||33
6358062|NCT00666211|7267556|FG000|STARTED|Overall Study||42
6358063|NCT00666211|7267557|FG001|STARTED|Overall Study||56
6358064|NCT00666211|7267556|FG000|COMPLETED|Overall Study||22
6358065|NCT00666211|7267557|FG001|COMPLETED|Overall Study||18
6358066|NCT00666211|7267556|FG000|NOT COMPLETED|Overall Study||20
6358067|NCT00666211|7267557|FG001|NOT COMPLETED|Overall Study||38
6358068|NCT00666224|7267565|FG000|STARTED|Double-Blind||243
6358069|NCT00666224|7267566|FG001|STARTED|Double-Blind||238
6358070|NCT00666224|7267565|FG000|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
6358071|NCT00666224|7267566|FG001|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
6358072|NCT00666224|7267565|FG000|NOT COMPLETED|Double-Blind||45
6358073|NCT00666224|7267566|FG001|NOT COMPLETED|Double-Blind||27
6358074|NCT00666224|7267565|FG000|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
6358075|NCT00666224|7267566|FG001|STARTED|Open-Label||211
6358076|NCT00666224|7267565|FG000|COMPLETED|Open-Label||163
6358077|NCT00666224|7267566|FG001|COMPLETED|Open-Label||126
6358078|NCT00666224|7267565|FG000|NOT COMPLETED|Open-Label||35
6358079|NCT00666224|7267566|FG001|NOT COMPLETED|Open-Label||85
6358080|NCT00666263|7267573|FG000|STARTED|Study Part 1 (Stabilization Phase 1)||22
6358081|NCT00666263|7267574|FG001|STARTED|Study Part 1 (Stabilization Phase 1)||22
6358082|NCT00666263|7267573|FG000|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
6358083|NCT00666263|7267574|FG001|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
6358084|NCT00666263|7267573|FG000|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
6358085|NCT00666263|7267574|FG001|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
6358086|NCT00666263|7267573|FG000|STARTED|Study Part 2 (Cross-over Period 1)||22
6358087|NCT00666263|7267574|FG001|STARTED|Study Part 2 (Cross-over Period 1)||21
6358088|NCT00666263|7267573|FG000|COMPLETED|Study Part 2 (Cross-over Period 1)||22
6358089|NCT00666263|7267574|FG001|COMPLETED|Study Part 2 (Cross-over Period 1)||21
6358090|NCT00666263|7267573|FG000|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
6358091|NCT00666263|7267574|FG001|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
6358092|NCT00666263|7267573|FG000|STARTED|Study Part 3 (Stabilization Phase 2)||22
6358093|NCT00666263|7267574|FG001|STARTED|Study Part 3 (Stabilization Phase 2)||21
6358094|NCT00666263|7267573|FG000|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
6358095|NCT00666263|7267574|FG001|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
6358096|NCT00666263|7267573|FG000|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
6358097|NCT00666263|7267574|FG001|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
6358098|NCT00666263|7267573|FG000|STARTED|Study Part 4 (Cross-over Period 2)||22
6358099|NCT00666263|7267574|FG001|STARTED|Study Part 4 (Cross-over Period 2)||21
6358100|NCT00666263|7267573|FG000|COMPLETED|Study Part 4 (Cross-over Period 2)||21
6358101|NCT00666263|7267574|FG001|COMPLETED|Study Part 4 (Cross-over Period 2)||21
6358102|NCT00666263|7267573|FG000|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
6358103|NCT00666263|7267574|FG001|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
6358104|NCT00666263|7267573|FG000|STARTED|Study Part 5 (Stabilization Phase 3)||21
6358105|NCT00666263|7267574|FG001|STARTED|Study Part 5 (Stabilization Phase 3)||21
6358106|NCT00666263|7267573|FG000|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
6358107|NCT00666263|7267574|FG001|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
6358108|NCT00666263|7267573|FG000|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
6358109|NCT00666263|7267574|FG001|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
6776561|NCT03819491|7704611|FG001|STARTED|After Randomization||12
6776562|NCT03819491|7704610|FG000|COMPLETED|After Randomization||12
6776563|NCT03819491|7704611|FG001|COMPLETED|After Randomization||12
6776564|NCT03819491|7704610|FG000|NOT COMPLETED|After Randomization||0
6358110|NCT00666263|7267573|FG000|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
6358111|NCT00666263|7267574|FG001|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
6358112|NCT00666263|7267573|FG000|COMPLETED|End of Study Visit||22
6358113|NCT00666263|7267574|FG001|COMPLETED|End of Study Visit||22
6358114|NCT00666263|7267573|FG000|NOT COMPLETED|End of Study Visit||0
6358115|NCT00666263|7267574|FG001|NOT COMPLETED|End of Study Visit||0
6358116|NCT00666276|7267619|FG000|STARTED|Overall Study||1004
6358117|NCT00666276|7267619|FG000|COMPLETED|Overall Study||970
6358118|NCT00666276|7267619|FG000|NOT COMPLETED|Overall Study||34
6358119|NCT00666328|7267642|FG000|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
6358120|NCT00666328|7267642|FG000|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
6358121|NCT00666328|7267642|FG000|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
6358122|NCT00666328|7267642|FG000|NOT COMPLETED|Overall Study||5
6358123|NCT00666406|7267648|FG000|STARTED|First PK Infusion||6
6358124|NCT00666406|7267649|FG001|STARTED|First PK Infusion||3
6358125|NCT00666406|7267648|FG000|COMPLETED|First PK Infusion||6
6358126|NCT00666406|7267649|FG001|COMPLETED|First PK Infusion||3
6358127|NCT00666406|7267648|FG000|NOT COMPLETED|First PK Infusion||0
6358128|NCT00666406|7267649|FG001|NOT COMPLETED|First PK Infusion||0
6358129|NCT00666406|7267648|FG000|STARTED|Second PK Infusion||6
6358130|NCT00666406|7267649|FG001|STARTED|Second PK Infusion||3
6358131|NCT00666406|7267648|FG000|COMPLETED|Second PK Infusion||6
6358132|NCT00666406|7267649|FG001|COMPLETED|Second PK Infusion||3
6560153|NCT01785095|7482836|FG000|COMPLETED|Overall Study||24
6560154|NCT01785095|7482836|FG000|NOT COMPLETED|Overall Study||3
6560155|NCT01785134|7482845|FG000|STARTED|Overall Study||41
6560156|NCT01785134|7482846|FG001|STARTED|Overall Study||40
6560157|NCT01785134|7482845|FG000|COMPLETED|Overall Study||29
6358133|NCT00666406|7267648|FG000|NOT COMPLETED|Second PK Infusion||0
6358134|NCT00666406|7267649|FG001|NOT COMPLETED|Second PK Infusion||0
6358135|NCT00666458|7267656|FG000|STARTED|Overall Study|Randomized and treated|403
6358136|NCT00666458|7267657|FG001|STARTED|Overall Study|Randomized and treated|398
6358137|NCT00666458|7267656|FG000|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
6358138|NCT00666458|7267657|FG001|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
6358139|NCT00666458|7267656|FG000|NOT COMPLETED|Overall Study||38
6358140|NCT00666458|7267657|FG001|NOT COMPLETED|Overall Study||24
6358141|NCT00666536|7267665|FG000|STARTED|Overall Study||369
6358142|NCT00666536|7267666|FG001|STARTED|Overall Study||359
6358143|NCT00666536|7267665|FG000|COMPLETED|Overall Study||336
6358144|NCT00666536|7267666|FG001|COMPLETED|Overall Study||322
6358145|NCT00666536|7267665|FG000|NOT COMPLETED|Overall Study||33
6358146|NCT00666536|7267666|FG001|NOT COMPLETED|Overall Study||37
6358147|NCT00666562|7267675|FG000|STARTED|Overall Study||11
6358148|NCT00666562|7267676|FG001|STARTED|Overall Study||10
6358149|NCT00666562|7267677|FG002|STARTED|Overall Study||10
6358150|NCT00666562|7267675|FG000|COMPLETED|Overall Study||11
6358151|NCT00666562|7267676|FG001|COMPLETED|Overall Study||8
6358152|NCT00666562|7267677|FG002|COMPLETED|Overall Study||10
6358153|NCT00666562|7267675|FG000|NOT COMPLETED|Overall Study||0
6358154|NCT00666562|7267676|FG001|NOT COMPLETED|Overall Study||2
6358155|NCT00666562|7267677|FG002|NOT COMPLETED|Overall Study||0
6358156|NCT00666588|7267696|FG000|STARTED|Overall Study||18
6358157|NCT00666588|7267697|FG001|STARTED|Overall Study||6
6358158|NCT00666588|7267698|FG002|STARTED|Overall Study||6
6358159|NCT00666588|7267699|FG003|STARTED|Overall Study||22
6358160|NCT00666588|7267696|FG000|COMPLETED|Overall Study||14
6358161|NCT00666588|7267697|FG001|COMPLETED|Overall Study||6
6358162|NCT00666588|7267698|FG002|COMPLETED|Overall Study||6
6358163|NCT00666588|7267699|FG003|COMPLETED|Overall Study||20
6358164|NCT00666588|7267696|FG000|NOT COMPLETED|Overall Study||4
6358165|NCT00666588|7267697|FG001|NOT COMPLETED|Overall Study||0
6358166|NCT00666588|7267698|FG002|NOT COMPLETED|Overall Study||0
6358167|NCT00666588|7267699|FG003|NOT COMPLETED|Overall Study||2
6358168|NCT00666666|7267709|FG000|STARTED|Overall Study||55
6358169|NCT00666666|7267709|FG000|COMPLETED|Overall Study||55
6358170|NCT00666666|7267709|FG000|NOT COMPLETED|Overall Study||0
6358171|NCT00666679|7267715|FG000|STARTED|First Intervention||66
6358172|NCT00666679|7267716|FG001|STARTED|First Intervention||68
6358173|NCT00666679|7267715|FG000|COMPLETED|First Intervention||62
6358174|NCT00666679|7267716|FG001|COMPLETED|First Intervention||67
6358175|NCT00666679|7267715|FG000|NOT COMPLETED|First Intervention||4
6358176|NCT00666679|7267716|FG001|NOT COMPLETED|First Intervention||1
6358177|NCT00666679|7267715|FG000|STARTED|Washout Period of 1 Week||62
6358178|NCT00666679|7267716|FG001|STARTED|Washout Period of 1 Week||67
6358179|NCT00666679|7267715|FG000|COMPLETED|Washout Period of 1 Week||62
6358180|NCT00666679|7267716|FG001|COMPLETED|Washout Period of 1 Week||65
6358181|NCT00666679|7267715|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6358182|NCT00666679|7267716|FG001|NOT COMPLETED|Washout Period of 1 Week||2
6358183|NCT00666679|7267715|FG000|STARTED|Second Intervention||62
6358184|NCT00666679|7267716|FG001|STARTED|Second Intervention||65
6358185|NCT00666679|7267715|FG000|COMPLETED|Second Intervention||61
6358186|NCT00666679|7267716|FG001|COMPLETED|Second Intervention||64
6358187|NCT00666679|7267715|FG000|NOT COMPLETED|Second Intervention||1
6358188|NCT00666679|7267716|FG001|NOT COMPLETED|Second Intervention||1
6358189|NCT00666705|7267722|FG000|STARTED|Overall Study||18
6358190|NCT00666705|7267722|FG000|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
6358191|NCT00666705|7267722|FG000|Washout (Days 4 - 5)|Overall Study||18
6358192|NCT00666705|7267722|FG000|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
6358193|NCT00666705|7267722|FG000|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
6358194|NCT00666705|7267722|FG000|COMPLETED|Overall Study||17
6358195|NCT00666705|7267722|FG000|NOT COMPLETED|Overall Study||1
6358196|NCT00666718|7267733|FG000|STARTED|Overall Study||187
6358197|NCT00666718|7267734|FG001|STARTED|Overall Study||187
6358198|NCT00666718|7267733|FG000|COMPLETED|Overall Study||175
6358199|NCT00666718|7267734|FG001|COMPLETED|Overall Study||169
6358200|NCT00666718|7267733|FG000|NOT COMPLETED|Overall Study||12
6358201|NCT00666718|7267734|FG001|NOT COMPLETED|Overall Study||18
6358202|NCT00666757|7267742|FG000|STARTED|Overall Study||372
6358203|NCT00666757|7267743|FG001|STARTED|Overall Study||378
6358204|NCT00666757|7267742|FG000|COMPLETED|Overall Study||272
6358205|NCT00666757|7267743|FG001|COMPLETED|Overall Study||281
6358206|NCT00666757|7267742|FG000|NOT COMPLETED|Overall Study||100
6358207|NCT00666757|7267743|FG001|NOT COMPLETED|Overall Study||97
6358208|NCT00666835|7267754|FG000|STARTED|Overall Study||314
6358209|NCT00666835|7267755|FG001|STARTED|Overall Study||164
6358210|NCT00666835|7267754|FG000|COMPLETED|Overall Study||261
6358211|NCT00666835|7267755|FG001|COMPLETED|Overall Study||142
6358212|NCT00666835|7267754|FG000|NOT COMPLETED|Overall Study||53
6358213|NCT00666835|7267755|FG001|NOT COMPLETED|Overall Study||22
6358214|NCT00666848|7267765|FG000|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
6358215|NCT00666848|7267766|FG001|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
6358216|NCT00666848|7267767|FG002|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
6358217|NCT00666848|7267765|FG000|COMPLETED|Overall Study|finished Aim 2|8
6358218|NCT00666848|7267766|FG001|COMPLETED|Overall Study|finished Aim 1|9
6358219|NCT00666848|7267767|FG002|COMPLETED|Overall Study|finished Aim 3|7
6358220|NCT00666848|7267765|FG000|NOT COMPLETED|Overall Study||0
6358221|NCT00666848|7267766|FG001|NOT COMPLETED|Overall Study||0
6358222|NCT00666848|7267767|FG002|NOT COMPLETED|Overall Study||0
6358223|NCT00666926|7267775|FG000|STARTED|Overall Study||2
6358224|NCT00666926|7267776|FG001|STARTED|Overall Study||4
6358225|NCT00666926|7267777|FG002|STARTED|Overall Study||3
6358226|NCT00666926|7267778|FG003|STARTED|Overall Study||4
6358227|NCT00666926|7267779|FG004|STARTED|Overall Study||3
6358228|NCT00666926|7267780|FG005|STARTED|Overall Study||4
6358229|NCT00666926|7267781|FG006|STARTED|Overall Study||4
6358230|NCT00666926|7267782|FG007|STARTED|Overall Study||1
6358231|NCT00666926|7267783|FG008|STARTED|Overall Study||3
6358232|NCT00666926|7267784|FG009|STARTED|Overall Study||10
6358233|NCT00666926|7267785|FG010|STARTED|Overall Study||6
6358234|NCT00666926|7267786|FG011|STARTED|Overall Study||33
6358235|NCT00666926|7267787|FG012|STARTED|Overall Study||3
6358236|NCT00666926|7267788|FG013|STARTED|Overall Study||4
6358237|NCT00666926|7267789|FG014|STARTED|Overall Study||7
6358238|NCT00666926|7267790|FG015|STARTED|Overall Study||8
6358239|NCT00666926|7267775|FG000|COMPLETED|Overall Study||0
6358240|NCT00666926|7267776|FG001|COMPLETED|Overall Study||0
6358241|NCT00666926|7267777|FG002|COMPLETED|Overall Study||0
6358242|NCT00666926|7267778|FG003|COMPLETED|Overall Study||0
6358243|NCT00666926|7267779|FG004|COMPLETED|Overall Study||0
6358244|NCT00666926|7267780|FG005|COMPLETED|Overall Study||0
6358245|NCT00666926|7267781|FG006|COMPLETED|Overall Study||0
6358246|NCT00666926|7267782|FG007|COMPLETED|Overall Study||0
6358247|NCT00666926|7267783|FG008|COMPLETED|Overall Study||0
6358248|NCT00666926|7267784|FG009|COMPLETED|Overall Study||0
6358249|NCT00666926|7267785|FG010|COMPLETED|Overall Study||0
6358250|NCT00666926|7267786|FG011|COMPLETED|Overall Study||0
6358251|NCT00666926|7267787|FG012|COMPLETED|Overall Study||0
6358252|NCT00666926|7267788|FG013|COMPLETED|Overall Study||0
6358253|NCT00666926|7267789|FG014|COMPLETED|Overall Study||0
6358254|NCT00666926|7267790|FG015|COMPLETED|Overall Study||0
6358255|NCT00666926|7267775|FG000|NOT COMPLETED|Overall Study||2
6358256|NCT00666926|7267776|FG001|NOT COMPLETED|Overall Study||4
6358257|NCT00666926|7267777|FG002|NOT COMPLETED|Overall Study||3
6358258|NCT00666926|7267778|FG003|NOT COMPLETED|Overall Study||4
6358259|NCT00666926|7267779|FG004|NOT COMPLETED|Overall Study||3
6358260|NCT00666926|7267780|FG005|NOT COMPLETED|Overall Study||4
6358261|NCT00666926|7267781|FG006|NOT COMPLETED|Overall Study||4
6358262|NCT00666926|7267782|FG007|NOT COMPLETED|Overall Study||1
6358263|NCT00666926|7267783|FG008|NOT COMPLETED|Overall Study||3
6560158|NCT01785134|7482846|FG001|COMPLETED|Overall Study||33
6560159|NCT01785134|7482845|FG000|NOT COMPLETED|Overall Study||12
6560160|NCT01785134|7482846|FG001|NOT COMPLETED|Overall Study||7
6358264|NCT00666926|7267784|FG009|NOT COMPLETED|Overall Study||10
6358265|NCT00666926|7267785|FG010|NOT COMPLETED|Overall Study||6
6358266|NCT00666926|7267786|FG011|NOT COMPLETED|Overall Study||33
6358267|NCT00666926|7267787|FG012|NOT COMPLETED|Overall Study||3
6358268|NCT00666926|7267788|FG013|NOT COMPLETED|Overall Study||4
6358269|NCT00666926|7267789|FG014|NOT COMPLETED|Overall Study||7
6358270|NCT00666926|7267790|FG015|NOT COMPLETED|Overall Study||8
6358271|NCT00666965|7267845|FG000|STARTED|Overall Study||58
6358272|NCT00666965|7267846|FG001|STARTED|Overall Study||57
6358273|NCT00666965|7267847|FG002|STARTED|Overall Study||58
6358274|NCT00666965|7267848|FG003|STARTED|Overall Study||57
6358275|NCT00666965|7267845|FG000|COMPLETED|Overall Study||55
6358276|NCT00666965|7267846|FG001|COMPLETED|Overall Study||53
6358277|NCT00666965|7267847|FG002|COMPLETED|Overall Study||56
6358278|NCT00666965|7267848|FG003|COMPLETED|Overall Study||42
6560161|NCT01785160|7482852|FG000|STARTED|Treatment Period 1: Raltegravir||25
6560162|NCT01785160|7482852|FG000|COMPLETED|Treatment Period 1: Raltegravir||24
6560163|NCT01785160|7482852|FG000|NOT COMPLETED|Treatment Period 1: Raltegravir||1
6560164|NCT01785160|7482852|FG000|STARTED|Washout Period of at Least 7 Days||24
6776565|NCT03819491|7704611|FG001|NOT COMPLETED|After Randomization||0
6776566|NCT03808298|7704618|FG000|STARTED|Overall Study||57
6358279|NCT00666965|7267845|FG000|NOT COMPLETED|Overall Study||3
6358280|NCT00666965|7267846|FG001|NOT COMPLETED|Overall Study||4
6358281|NCT00666965|7267847|FG002|NOT COMPLETED|Overall Study||2
6358282|NCT00666965|7267848|FG003|NOT COMPLETED|Overall Study||15
6358283|NCT00666978|7267860|FG000|STARTED|Overall Study||270
6358284|NCT00666978|7267861|FG001|STARTED|Overall Study||270
6358285|NCT00666978|7267860|FG000|COMPLETED|Overall Study||192
6358286|NCT00666978|7267861|FG001|COMPLETED|Overall Study||187
6358287|NCT00666978|7267860|FG000|NOT COMPLETED|Overall Study||78
6358288|NCT00666978|7267861|FG001|NOT COMPLETED|Overall Study||83
6358289|NCT00667004|7267871|FG000|STARTED|Overall Study||95
6358290|NCT00667004|7267872|FG001|STARTED|Overall Study||88
6358291|NCT00667004|7267871|FG000|COMPLETED|Overall Study||93
6358292|NCT00667004|7267872|FG001|COMPLETED|Overall Study||85
6358293|NCT00667004|7267871|FG000|NOT COMPLETED|Overall Study||2
6358294|NCT00667004|7267872|FG001|NOT COMPLETED|Overall Study||3
6358295|NCT00667095|7267880|FG000|STARTED|Overall Study||11
6358296|NCT00667095|7267881|FG001|STARTED|Overall Study||10
6358297|NCT00667095|7267880|FG000|COMPLETED|Overall Study||11
6358298|NCT00667095|7267881|FG001|COMPLETED|Overall Study||9
6358299|NCT00667095|7267880|FG000|NOT COMPLETED|Overall Study||0
6358300|NCT00667095|7267881|FG001|NOT COMPLETED|Overall Study||1
6358301|NCT00667186|7267889|FG000|STARTED|Overall Study||4692
6358302|NCT00667186|7267890|FG001|STARTED|Overall Study||4880
6358303|NCT00667186|7267889|FG000|COMPLETED|Overall Study||4692
6358304|NCT00667186|7267890|FG001|COMPLETED|Overall Study||4880
6358305|NCT00667186|7267889|FG000|NOT COMPLETED|Overall Study||0
6358306|NCT00667186|7267890|FG001|NOT COMPLETED|Overall Study||0
6358307|NCT00667225|7267898|FG000|STARTED|Overall Study||16
6358308|NCT00667225|7267899|FG001|STARTED|Overall Study||13
6358309|NCT00667225|7267898|FG000|COMPLETED|Overall Study||15
6358310|NCT00667225|7267899|FG001|COMPLETED|Overall Study||12
6358311|NCT00667225|7267898|FG000|NOT COMPLETED|Overall Study||1
6358312|NCT00667225|7267899|FG001|NOT COMPLETED|Overall Study||1
6358313|NCT00667277|7267905|FG000|STARTED|Overall Study||13
6358314|NCT00667277|7267905|FG000|COMPLETED|Overall Study||11
6358315|NCT00667277|7267905|FG000|NOT COMPLETED|Overall Study||2
6358316|NCT00667342|7267912|FG000|STARTED|Overall Study||31
6358317|NCT00667342|7267913|FG001|STARTED|Overall Study||0
6358318|NCT00667342|7267914|FG002|STARTED|Overall Study||12
6358319|NCT00667342|7267912|FG000|COMPLETED|Overall Study||17
6358320|NCT00667342|7267913|FG001|COMPLETED|Overall Study||0
6358321|NCT00667342|7267914|FG002|COMPLETED|Overall Study||3
6358322|NCT00667342|7267912|FG000|NOT COMPLETED|Overall Study||14
6358323|NCT00667342|7267913|FG001|NOT COMPLETED|Overall Study||0
6358324|NCT00667342|7267914|FG002|NOT COMPLETED|Overall Study||9
6358325|NCT00667355|7267928|FG000|STARTED|Overall Study||41
6776567|NCT03808298|7704618|FG000|COMPLETED|Overall Study||49
6776568|NCT03808298|7704618|FG000|NOT COMPLETED|Overall Study||8
6776569|NCT03836729|7704647|FG000|STARTED|Treatment Period 1 (Up to Day 14)||16
6776570|NCT03836729|7704647|FG000|COMPLETED|Treatment Period 1 (Up to Day 14)||16
6776571|NCT03836729|7704647|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 14)||0
6358326|NCT00667355|7267928|FG000|COMPLETED|Overall Study||30
6358327|NCT00667355|7267928|FG000|NOT COMPLETED|Overall Study||11
6358328|NCT00667368|7267934|FG000|STARTED|Overall Study||682
6358329|NCT00667368|7267935|FG001|STARTED|Overall Study||683
6358330|NCT00667368|7267934|FG000|COMPLETED|Overall Study||482
6358331|NCT00667368|7267935|FG001|COMPLETED|Overall Study||511
6358332|NCT00667368|7267934|FG000|NOT COMPLETED|Overall Study||200
6358333|NCT00667368|7267935|FG001|NOT COMPLETED|Overall Study||172
6358334|NCT00667381|7267943|FG000|STARTED|Overall Study||501
6358335|NCT00667381|7267944|FG001|STARTED|Overall Study||503
6358336|NCT00667381|7267943|FG000|COMPLETED|Overall Study||501
6358337|NCT00667381|7267944|FG001|COMPLETED|Overall Study||503
6358338|NCT00667381|7267943|FG000|NOT COMPLETED|Overall Study||0
6560165|NCT01785160|7482852|FG000|COMPLETED|Washout Period of at Least 7 Days||23
6560166|NCT01785160|7482852|FG000|NOT COMPLETED|Washout Period of at Least 7 Days||1
6358339|NCT00667381|7267944|FG001|NOT COMPLETED|Overall Study||0
6358340|NCT00667394|7267952|FG000|STARTED|Overall Study||41
6358341|NCT00667394|7267953|FG001|STARTED|Overall Study||1
6358342|NCT00667394|7267952|FG000|COMPLETED|Overall Study||37
6358343|NCT00667394|7267953|FG001|COMPLETED|Overall Study||1
6358344|NCT00667394|7267952|FG000|NOT COMPLETED|Overall Study||4
6358345|NCT00667394|7267953|FG001|NOT COMPLETED|Overall Study||0
6358346|NCT00667420|7267959|FG000|STARTED|Overall Study||17
6358347|NCT00667420|7267959|FG000|Completion of Pre-operative EOX-P|Overall Study||15
6358348|NCT00667420|7267959|FG000|Completion of Surgery/Re-staging|Overall Study||11
6358349|NCT00667420|7267959|FG000|COMPLETED|Overall Study||7
6358350|NCT00667420|7267959|FG000|NOT COMPLETED|Overall Study||10
6358351|NCT00667446|7267966|FG000|STARTED|Treatment Period (36 Months)||34
6358352|NCT00667446|7267967|FG001|STARTED|Treatment Period (36 Months)||38
6358353|NCT00667446|7267966|FG000|COMPLETED|Treatment Period (36 Months)||11
6358354|NCT00667446|7267967|FG001|COMPLETED|Treatment Period (36 Months)||13
6358355|NCT00667446|7267966|FG000|NOT COMPLETED|Treatment Period (36 Months)||23
6358356|NCT00667446|7267967|FG001|NOT COMPLETED|Treatment Period (36 Months)||25
6358357|NCT00667446|7267966|FG000|STARTED|Safety Follow-up Period (12 Weeks)||28
6358358|NCT00667446|7267967|FG001|STARTED|Safety Follow-up Period (12 Weeks)||26
6358359|NCT00667446|7267966|FG000|COMPLETED|Safety Follow-up Period (12 Weeks)||28
6358360|NCT00667446|7267967|FG001|COMPLETED|Safety Follow-up Period (12 Weeks)||25
6358361|NCT00667446|7267966|FG000|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
6358362|NCT00667446|7267967|FG001|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
6358363|NCT00667459|7267975|FG000|STARTED|Overall Study||280
6358364|NCT00667459|7267976|FG001|STARTED|Overall Study||265
6358365|NCT00667459|7267975|FG000|COMPLETED|Overall Study||272
6358366|NCT00667459|7267976|FG001|COMPLETED|Overall Study||220
6358367|NCT00667459|7267975|FG000|NOT COMPLETED|Overall Study||8
6358368|NCT00667459|7267976|FG001|NOT COMPLETED|Overall Study||45
6358369|NCT00667511|7267982|FG000|STARTED|Intervention 1: Home DHD||58
6358370|NCT00667511|7267982|FG000|COMPLETED|Intervention 1: Home DHD||51
6358371|NCT00667511|7267982|FG000|NOT COMPLETED|Intervention 1: Home DHD||7
6358372|NCT00667511|7267982|FG000|STARTED|Training/Transition Period||51
6358373|NCT00667511|7267982|FG000|COMPLETED|Training/Transition Period||43
6358374|NCT00667511|7267982|FG000|NOT COMPLETED|Training/Transition Period||8
6358375|NCT00667511|7267982|FG000|STARTED|Intervention 2: Home NHD||43
6358376|NCT00667511|7267982|FG000|COMPLETED|Intervention 2: Home NHD||39
6358377|NCT00667511|7267982|FG000|NOT COMPLETED|Intervention 2: Home NHD||4
6358378|NCT00667563|7267988|FG000|STARTED|Overall Study||150
6358379|NCT00667563|7267988|FG000|COMPLETED|Overall Study||126
6358380|NCT00667563|7267988|FG000|NOT COMPLETED|Overall Study||24
6358381|NCT00667576|7267997|FG000|STARTED|Overall Study||30
6358382|NCT00667576|7267998|FG001|STARTED|Overall Study||31
6358383|NCT00667576|7267999|FG002|STARTED|Overall Study||31
6358384|NCT00667576|7268000|FG003|STARTED|Overall Study||31
6358385|NCT00667576|7268001|FG004|STARTED|Overall Study||30
6358386|NCT00667576|7267997|FG000|COMPLETED|Overall Study||28
6358387|NCT00667576|7267998|FG001|COMPLETED|Overall Study||30
6358388|NCT00667576|7267999|FG002|COMPLETED|Overall Study||29
6358389|NCT00667576|7268000|FG003|COMPLETED|Overall Study||27
6358390|NCT00667576|7268001|FG004|COMPLETED|Overall Study||29
6358391|NCT00667576|7267997|FG000|NOT COMPLETED|Overall Study||2
6358392|NCT00667576|7267998|FG001|NOT COMPLETED|Overall Study||1
6358393|NCT00667576|7267999|FG002|NOT COMPLETED|Overall Study||2
6358394|NCT00667576|7268000|FG003|NOT COMPLETED|Overall Study||4
6358395|NCT00667576|7268001|FG004|NOT COMPLETED|Overall Study||1
6358396|NCT00667589|7268017|FG000|STARTED|Overall Study||1
6358397|NCT00667589|7268018|FG001|STARTED|Overall Study||0
6358398|NCT00667589|7268019|FG002|STARTED|Overall Study||3
6358399|NCT00667589|7268020|FG003|STARTED|Overall Study||2
6358400|NCT00667589|7268017|FG000|COMPLETED|Overall Study||0
6358401|NCT00667589|7268018|FG001|COMPLETED|Overall Study||0
6358402|NCT00667589|7268019|FG002|COMPLETED|Overall Study||0
6358403|NCT00667589|7268020|FG003|COMPLETED|Overall Study||1
6358404|NCT00667589|7268017|FG000|NOT COMPLETED|Overall Study||1
6358405|NCT00667589|7268018|FG001|NOT COMPLETED|Overall Study||0
6358406|NCT00667589|7268019|FG002|NOT COMPLETED|Overall Study||3
6358407|NCT00667589|7268020|FG003|NOT COMPLETED|Overall Study||1
6358408|NCT00667602|7268033|FG000|STARTED|Overall Study||219
6358409|NCT00667602|7268034|FG001|STARTED|Overall Study||228
6358410|NCT00667602|7268035|FG002|STARTED|Overall Study||215
6358411|NCT00667602|7268033|FG000|COMPLETED|Overall Study||211
6358412|NCT00667602|7268034|FG001|COMPLETED|Overall Study||213
6358413|NCT00667602|7268035|FG002|COMPLETED|Overall Study||197
6358414|NCT00667602|7268033|FG000|NOT COMPLETED|Overall Study||8
6358415|NCT00667602|7268034|FG001|NOT COMPLETED|Overall Study||15
6358416|NCT00667602|7268035|FG002|NOT COMPLETED|Overall Study||18
6358417|NCT00667615|7268048|FG000|STARTED|Overall Study||30
6358418|NCT00667615|7268048|FG000|COMPLETED|Overall Study||30
6358419|NCT00667615|7268048|FG000|NOT COMPLETED|Overall Study||0
6358420|NCT00667693|7268054|FG000|STARTED|Overall Study||49
6358421|NCT00667693|7268055|FG001|STARTED|Overall Study||52
6358422|NCT00667693|7268054|FG000|COMPLETED|Overall Study||49
6358423|NCT00667693|7268055|FG001|COMPLETED|Overall Study||50
6358424|NCT00667693|7268054|FG000|NOT COMPLETED|Overall Study||0
6358425|NCT00667693|7268055|FG001|NOT COMPLETED|Overall Study||2
6358426|NCT00667719|7268061|FG000|STARTED|Overall Study||564
6358427|NCT00667719|7268061|FG000|COMPLETED|Overall Study||493
6560167|NCT01785160|7482852|FG000|STARTED|Treatment Period 2: Raltegravir + Faldap||23
6560168|NCT01785160|7482852|FG000|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
6560169|NCT01785160|7482852|FG000|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
6358428|NCT00667719|7268061|FG000|NOT COMPLETED|Overall Study||71
6358429|NCT00667732|7268072|FG000|STARTED|Run -In (8 Weeks)||41
6358430|NCT00667732|7268073|FG001|STARTED|Run -In (8 Weeks)||0
6358431|NCT00667732|7268074|FG002|STARTED|Run -In (8 Weeks)||0
6358432|NCT00667732|7268072|FG000|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
6358433|NCT00667732|7268073|FG001|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
6560170|NCT01785186|7482863|FG000|STARTED|Overall Study||59
6560171|NCT01785186|7482864|FG001|STARTED|Overall Study||63
6560172|NCT01785186|7482865|FG002|STARTED|Overall Study||57
6560173|NCT01785186|7482866|FG003|STARTED|Overall Study||63
6560174|NCT01785186|7482867|FG004|STARTED|Overall Study||123
6560175|NCT01785186|7482863|FG000|COMPLETED|Overall Study||53
6358434|NCT00667732|7268074|FG002|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
6358435|NCT00667732|7268072|FG000|COMPLETED|Run -In (8 Weeks)||34
6358436|NCT00667732|7268073|FG001|COMPLETED|Run -In (8 Weeks)||0
6358437|NCT00667732|7268074|FG002|COMPLETED|Run -In (8 Weeks)||0
6358438|NCT00667732|7268072|FG000|NOT COMPLETED|Run -In (8 Weeks)||7
6358439|NCT00667732|7268073|FG001|NOT COMPLETED|Run -In (8 Weeks)||0
6358440|NCT00667732|7268074|FG002|NOT COMPLETED|Run -In (8 Weeks)||0
6358441|NCT00667732|7268072|FG000|STARTED|Randomization (24 Weeks)||0
6358442|NCT00667732|7268073|FG001|STARTED|Randomization (24 Weeks)||17
6358443|NCT00667732|7268074|FG002|STARTED|Randomization (24 Weeks)||17
6358444|NCT00667732|7268072|FG000|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
6358445|NCT00667732|7268073|FG001|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
6358446|NCT00667732|7268074|FG002|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
6358447|NCT00667732|7268072|FG000|COMPLETED|Randomization (24 Weeks)||0
6358448|NCT00667732|7268073|FG001|COMPLETED|Randomization (24 Weeks)||16
6358449|NCT00667732|7268074|FG002|COMPLETED|Randomization (24 Weeks)||17
6358450|NCT00667732|7268072|FG000|NOT COMPLETED|Randomization (24 Weeks)||0
6358451|NCT00667732|7268073|FG001|NOT COMPLETED|Randomization (24 Weeks)||1
6358452|NCT00667732|7268074|FG002|NOT COMPLETED|Randomization (24 Weeks)||0
6358453|NCT00667732|7268072|FG000|STARTED|Extension (26 Weeks)||0
6358454|NCT00667732|7268073|FG001|STARTED|Extension (26 Weeks)||14
6358455|NCT00667732|7268074|FG002|STARTED|Extension (26 Weeks)||17
6358456|NCT00667732|7268072|FG000|COMPLETED|Extension (26 Weeks)||0
6358457|NCT00667732|7268073|FG001|COMPLETED|Extension (26 Weeks)||14
6358458|NCT00667732|7268074|FG002|COMPLETED|Extension (26 Weeks)||17
6358459|NCT00667732|7268072|FG000|NOT COMPLETED|Extension (26 Weeks)||0
6358460|NCT00667732|7268073|FG001|NOT COMPLETED|Extension (26 Weeks)||0
6358461|NCT00667732|7268074|FG002|NOT COMPLETED|Extension (26 Weeks)||0
6358462|NCT00667745|7268086|FG000|STARTED|Overall Study||141
6358463|NCT00667745|7268087|FG001|STARTED|Overall Study||142
6358464|NCT00667745|7268086|FG000|COMPLETED|Overall Study||116
6358465|NCT00667745|7268087|FG001|COMPLETED|Overall Study||121
6358466|NCT00667745|7268086|FG000|NOT COMPLETED|Overall Study||25
6358467|NCT00667745|7268087|FG001|NOT COMPLETED|Overall Study||21
6358468|NCT00667810|7268098|FG000|STARTED|Overall Study||269
6358469|NCT00667810|7268099|FG001|STARTED|Overall Study||264
6358470|NCT00667810|7268100|FG002|STARTED|Overall Study||346
6358471|NCT00667810|7268101|FG003|STARTED|Overall Study||11
6358472|NCT00667810|7268098|FG000|Treated|Overall Study||267
6358473|NCT00667810|7268099|FG001|Treated|Overall Study||263
6358474|NCT00667810|7268100|FG002|Treated|Overall Study||344
6358475|NCT00667810|7268101|FG003|Treated|Overall Study||11
6358476|NCT00667810|7268098|FG000|COMPLETED|Overall Study||102
6358477|NCT00667810|7268099|FG001|COMPLETED|Overall Study||94
6358478|NCT00667810|7268100|FG002|COMPLETED|Overall Study||124
6358479|NCT00667810|7268101|FG003|COMPLETED|Overall Study||9
6358480|NCT00667810|7268098|FG000|NOT COMPLETED|Overall Study||167
6358481|NCT00667810|7268099|FG001|NOT COMPLETED|Overall Study||170
6358482|NCT00667810|7268100|FG002|NOT COMPLETED|Overall Study||222
6358483|NCT00667810|7268101|FG003|NOT COMPLETED|Overall Study||2
6358484|NCT00667849|7268118|FG000|STARTED|Overall Study||250
6358485|NCT00667849|7268119|FG001|STARTED|Overall Study||251
6358486|NCT00667849|7268118|FG000|COMPLETED|Overall Study||142
6358487|NCT00667849|7268119|FG001|COMPLETED|Overall Study||130
6358488|NCT00667849|7268118|FG000|NOT COMPLETED|Overall Study||108
6358489|NCT00667849|7268119|FG001|NOT COMPLETED|Overall Study||121
6358490|NCT00667862|7268128|FG000|STARTED|Overall Study||35
6358491|NCT00667862|7268128|FG000|COMPLETED|Overall Study||0
6358492|NCT00667862|7268128|FG000|NOT COMPLETED|Overall Study||35
6358493|NCT00667875|7268135|FG000|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
6358494|NCT00667875|7268136|FG001|STARTED|Overall Study||21
6358495|NCT00667875|7268137|FG002|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
6358496|NCT00667875|7268135|FG000|Subjects Included in Analysisd|Overall Study||20
6358497|NCT00667875|7268136|FG001|Subjects Included in Analysisd|Overall Study||21
6358498|NCT00667875|7268137|FG002|Subjects Included in Analysisd|Overall Study||19
6358499|NCT00667875|7268135|FG000|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
6358500|NCT00667875|7268136|FG001|COMPLETED|Overall Study||10
6358501|NCT00667875|7268137|FG002|COMPLETED|Overall Study||8
6358502|NCT00667875|7268135|FG000|NOT COMPLETED|Overall Study||10
6560176|NCT01785186|7482864|FG001|COMPLETED|Overall Study||57
6358503|NCT00667875|7268136|FG001|NOT COMPLETED|Overall Study||11
6358504|NCT00667875|7268137|FG002|NOT COMPLETED|Overall Study||13
6358505|NCT00667888|7268153|FG000|STARTED|Overall Study||111
6358506|NCT00667888|7268154|FG001|STARTED|Overall Study||111
6358507|NCT00667888|7268153|FG000|COMPLETED|Overall Study||101
6358508|NCT00667888|7268154|FG001|COMPLETED|Overall Study||102
6358509|NCT00667888|7268153|FG000|NOT COMPLETED|Overall Study||10
6358510|NCT00667888|7268154|FG001|NOT COMPLETED|Overall Study||9
6358511|NCT00667992|7268162|FG000|STARTED|First Intervention 100 Mcg Twice Daily||49
6358512|NCT00667992|7268163|FG001|STARTED|First Intervention 100 Mcg Twice Daily||50
6358513|NCT00667992|7268162|FG000|COMPLETED|First Intervention 100 Mcg Twice Daily||44
6358514|NCT00667992|7268163|FG001|COMPLETED|First Intervention 100 Mcg Twice Daily||45
6358515|NCT00667992|7268162|FG000|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
6358516|NCT00667992|7268163|FG001|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
6358517|NCT00667992|7268162|FG000|STARTED|Second Intervention 400 Mcg Twice Daily||44
6358518|NCT00667992|7268163|FG001|STARTED|Second Intervention 400 Mcg Twice Daily||45
6358519|NCT00667992|7268162|FG000|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
6358520|NCT00667992|7268163|FG001|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
6358521|NCT00667992|7268162|FG000|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
6358522|NCT00667992|7268163|FG001|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
6358523|NCT00667992|7268162|FG000|STARTED|Wash-out||41
6358524|NCT00667992|7268163|FG001|STARTED|Wash-out||41
6358525|NCT00667992|7268162|FG000|COMPLETED|Wash-out||34
6358526|NCT00667992|7268163|FG001|COMPLETED|Wash-out||36
6358527|NCT00667992|7268162|FG000|NOT COMPLETED|Wash-out||7
6358528|NCT00667992|7268163|FG001|NOT COMPLETED|Wash-out||5
6358529|NCT00667992|7268162|FG000|STARTED|Third Intervention 100 Mcg Twice Daily||34
6358530|NCT00667992|7268163|FG001|STARTED|Third Intervention 100 Mcg Twice Daily||36
6358531|NCT00667992|7268162|FG000|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
6358532|NCT00667992|7268163|FG001|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
6358533|NCT00667992|7268162|FG000|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
6358534|NCT00667992|7268163|FG001|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
6358535|NCT00667992|7268162|FG000|STARTED|Forth Intervention 400 Mcg Twice Daily||33
6358536|NCT00667992|7268163|FG001|STARTED|Forth Intervention 400 Mcg Twice Daily||35
6358537|NCT00667992|7268162|FG000|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
6358538|NCT00667992|7268163|FG001|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
6358539|NCT00667992|7268162|FG000|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
6358540|NCT00667992|7268163|FG001|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
6358541|NCT00668148|7268179|FG000|STARTED|Overall Study||113
6358542|NCT00668148|7268179|FG000|Received at Least 1 Dose of Study Drug|Overall Study||111
6358543|NCT00668148|7268179|FG000|COMPLETED|Overall Study||103
6358544|NCT00668148|7268179|FG000|NOT COMPLETED|Overall Study||10
6358545|NCT00668200|7268194|FG000|STARTED|Overall Study||80
6358546|NCT00668200|7268194|FG000|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
6358547|NCT00668200|7268194|FG000|Intent to Treat (ITT)|Overall Study||80
6358548|NCT00668200|7268194|FG000|COMPLETED|Overall Study||77
6358549|NCT00668200|7268194|FG000|NOT COMPLETED|Overall Study||3
6358550|NCT00668317|7268198|FG000|STARTED|Overall Study||5
6358551|NCT00668317|7268198|FG000|COMPLETED|Overall Study||3
6358552|NCT00668317|7268198|FG000|NOT COMPLETED|Overall Study||2
6358553|NCT00668382|7268202|FG000|STARTED|Overall Study|beginning of trial|11
6358554|NCT00668382|7268202|FG000|COMPLETED|Overall Study||11
6358555|NCT00668382|7268202|FG000|NOT COMPLETED|Overall Study||0
6358556|NCT00668395|7268209|FG000|STARTED|Overall Study||45
6358557|NCT00668395|7268210|FG001|STARTED|Overall Study||22
6358558|NCT00668395|7268211|FG002|STARTED|Overall Study||6
6358559|NCT00668395|7268209|FG000|COMPLETED|Overall Study||39
6358560|NCT00668395|7268210|FG001|COMPLETED|Overall Study||16
6358561|NCT00668395|7268211|FG002|COMPLETED|Overall Study||5
6358562|NCT00668395|7268209|FG000|NOT COMPLETED|Overall Study||6
6358563|NCT00668395|7268210|FG001|NOT COMPLETED|Overall Study||6
6358564|NCT00668395|7268211|FG002|NOT COMPLETED|Overall Study||1
6358565|NCT00668434|7268221|FG000|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
6358566|NCT00668434|7268222|FG001|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
6358567|NCT00668434|7268221|FG000|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
6358568|NCT00668434|7268222|FG001|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
6358569|NCT00668434|7268221|FG000|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
6358570|NCT00668434|7268222|FG001|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
6358571|NCT00668434|7268221|FG000|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
6358572|NCT00668434|7268222|FG001|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
6358573|NCT00668434|7268221|FG000|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
6358574|NCT00668434|7268222|FG001|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
6358575|NCT00668434|7268221|FG000|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
6358576|NCT00668434|7268222|FG001|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
6358577|NCT00668525|7268231|FG000|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
6358578|NCT00668525|7268232|FG001|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
6358579|NCT00668525|7268233|FG002|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
6358580|NCT00668525|7268231|FG000|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
6358581|NCT00668525|7268232|FG001|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
6358582|NCT00668525|7268233|FG002|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
6358583|NCT00668525|7268231|FG000|NOT COMPLETED|Overall Study||77
6358584|NCT00668525|7268232|FG001|NOT COMPLETED|Overall Study||93
6358585|NCT00668525|7268233|FG002|NOT COMPLETED|Overall Study||53
6358586|NCT00668564|7268241|FG000|STARTED|Overall Study||18
6358587|NCT00668564|7268241|FG000|COMPLETED|Overall Study||18
6358588|NCT00668564|7268241|FG000|NOT COMPLETED|Overall Study||0
6358589|NCT00668707|7268247|FG000|STARTED|Overall Study||356
6358590|NCT00668707|7268248|FG001|STARTED|Overall Study||353
6358591|NCT00668707|7268247|FG000|COMPLETED|Overall Study||157
6358592|NCT00668707|7268248|FG001|COMPLETED|Overall Study||173
6358593|NCT00668707|7268247|FG000|NOT COMPLETED|Overall Study||199
6358594|NCT00668707|7268248|FG001|NOT COMPLETED|Overall Study||180
6358595|NCT00668733|7268261|FG000|STARTED|Overall Study||89
6358596|NCT00668733|7268262|FG001|STARTED|Overall Study||90
6358597|NCT00668733|7268261|FG000|COMPLETED|Overall Study||87
6358598|NCT00668733|7268262|FG001|COMPLETED|Overall Study||83
6358599|NCT00668733|7268261|FG000|NOT COMPLETED|Overall Study||2
6358600|NCT00668733|7268262|FG001|NOT COMPLETED|Overall Study||7
6358601|NCT00668746|7268270|FG000|STARTED|Overall Study||23
6358602|NCT00668746|7268271|FG001|STARTED|Overall Study||12
6358603|NCT00668746|7268270|FG000|COMPLETED|Overall Study||21
6358604|NCT00668746|7268271|FG001|COMPLETED|Overall Study||11
6358605|NCT00668746|7268270|FG000|NOT COMPLETED|Overall Study||2
6358606|NCT00668746|7268271|FG001|NOT COMPLETED|Overall Study||1
6358607|NCT00668811|7268287|FG000|STARTED|Overall Study||23
6358608|NCT00668811|7268287|FG000|COMPLETED|Overall Study||23
6358609|NCT00668811|7268287|FG000|NOT COMPLETED|Overall Study||0
6358610|NCT00668863|7268291|FG000|STARTED|Overall Study||71
6358611|NCT00668863|7268291|FG000|COMPLETED|Overall Study||0
6358612|NCT00668863|7268291|FG000|NOT COMPLETED|Overall Study||71
6358613|NCT00668902|7268298|FG000|STARTED|Overall Study||10
6358614|NCT00668902|7268299|FG001|STARTED|Overall Study||10
6358615|NCT00668902|7268300|FG002|STARTED|Overall Study||5
6358616|NCT00668902|7268298|FG000|COMPLETED|Overall Study||10
6358617|NCT00668902|7268299|FG001|COMPLETED|Overall Study||10
6358618|NCT00668902|7268300|FG002|COMPLETED|Overall Study||5
6358619|NCT00668902|7268298|FG000|NOT COMPLETED|Overall Study||0
6358620|NCT00668902|7268299|FG001|NOT COMPLETED|Overall Study||0
6358621|NCT00668902|7268300|FG002|NOT COMPLETED|Overall Study||0
6358622|NCT00669019|7268308|FG000|STARTED|Overall Study||23
6358623|NCT00669019|7268308|FG000|COMPLETED|Overall Study||23
6358624|NCT00669019|7268308|FG000|NOT COMPLETED|Overall Study||0
6358625|NCT00669032|7268314|FG000|STARTED|Overall Study||153
6358626|NCT00669032|7268315|FG001|STARTED|Overall Study||153
6358627|NCT00669032|7268314|FG000|COMPLETED|Overall Study||109
6358628|NCT00669032|7268315|FG001|COMPLETED|Overall Study||94
6358629|NCT00669032|7268314|FG000|NOT COMPLETED|Overall Study||44
6358630|NCT00669032|7268315|FG001|NOT COMPLETED|Overall Study||59
6358631|NCT00669071|7268321|FG000|STARTED|Overall Study||56
6358632|NCT00669071|7268321|FG000|COMPLETED|Overall Study||52
6358633|NCT00669071|7268321|FG000|NOT COMPLETED|Overall Study||4
6358634|NCT00669110|7268329|FG000|STARTED|Overall Study||20
6358635|NCT00669110|7268330|FG001|STARTED|Overall Study||20
6358636|NCT00669110|7268329|FG000|COMPLETED|Overall Study||12
6358637|NCT00669110|7268330|FG001|COMPLETED|Overall Study||7
6358638|NCT00669110|7268329|FG000|NOT COMPLETED|Overall Study||8
6358639|NCT00669110|7268330|FG001|NOT COMPLETED|Overall Study||13
6358640|NCT00669162|7268336|FG000|STARTED|Overall Study||27
6358641|NCT00669162|7268336|FG000|COMPLETED|Overall Study||26
6358642|NCT00669162|7268336|FG000|NOT COMPLETED|Overall Study||1
6358643|NCT00669214|7268342|FG000|STARTED|Double-Blind Treatment Period (Week 12)||27
6358644|NCT00669214|7268343|FG001|STARTED|Double-Blind Treatment Period (Week 12)||62
6358645|NCT00669214|7268342|FG000|COMPLETED|Double-Blind Treatment Period (Week 12)||22
6358646|NCT00669214|7268343|FG001|COMPLETED|Double-Blind Treatment Period (Week 12)||55
6358647|NCT00669214|7268342|FG000|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
6358648|NCT00669214|7268343|FG001|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
6358649|NCT00669214|7268342|FG000|STARTED|Open-Label Treatment Period (Week 24)||22
6358650|NCT00669214|7268343|FG001|STARTED|Open-Label Treatment Period (Week 24)||55
6358651|NCT00669214|7268342|FG000|COMPLETED|Open-Label Treatment Period (Week 24)||18
6358652|NCT00669214|7268343|FG001|COMPLETED|Open-Label Treatment Period (Week 24)||46
6358653|NCT00669214|7268342|FG000|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
6358654|NCT00669214|7268343|FG001|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
6358655|NCT00669240|7268353|FG000|STARTED|Overall Study||567
6358656|NCT00669240|7268353|FG000|Assigned to Treatment|Overall Study||566
6358657|NCT00669240|7268353|FG000|Received Treatment|Overall Study||551
6358658|NCT00669240|7268353|FG000|COMPLETED|Overall Study||402
6358659|NCT00669240|7268353|FG000|NOT COMPLETED|Overall Study||165
6358660|NCT00669279|7268359|FG000|STARTED|Overall Study||22
6358661|NCT00669279|7268360|FG001|STARTED|Overall Study||19
6358662|NCT00669279|7268359|FG000|COMPLETED|Overall Study||22
6358663|NCT00669279|7268360|FG001|COMPLETED|Overall Study||19
6358664|NCT00669279|7268359|FG000|NOT COMPLETED|Overall Study||0
6358665|NCT00669279|7268360|FG001|NOT COMPLETED|Overall Study||0
6358666|NCT00669318|7268366|FG000|STARTED|Overall Study||41
6358667|NCT00669318|7268366|FG000|COMPLETED|Overall Study||39
6358668|NCT00669318|7268366|FG000|NOT COMPLETED|Overall Study||2
6358669|NCT00669331|7268372|FG000|STARTED|Randomisation to First Dose||244
6358670|NCT00669331|7268373|FG001|STARTED|Randomisation to First Dose||241
6358671|NCT00669331|7268372|FG000|COMPLETED|Randomisation to First Dose||233
6358672|NCT00669331|7268373|FG001|COMPLETED|Randomisation to First Dose||228
6358673|NCT00669331|7268372|FG000|NOT COMPLETED|Randomisation to First Dose||11
6358674|NCT00669331|7268373|FG001|NOT COMPLETED|Randomisation to First Dose||13
6358675|NCT00669331|7268372|FG000|STARTED|Blinded Treatment Period||233
6358676|NCT00669331|7268373|FG001|STARTED|Blinded Treatment Period||228
6358677|NCT00669331|7268372|FG000|COMPLETED|Blinded Treatment Period||191
6358678|NCT00669331|7268373|FG001|COMPLETED|Blinded Treatment Period||189
6358679|NCT00669331|7268372|FG000|NOT COMPLETED|Blinded Treatment Period||42
6358680|NCT00669331|7268373|FG001|NOT COMPLETED|Blinded Treatment Period||39
6358681|NCT00669383|7268383|FG000|STARTED|Overall Study||44
6358682|NCT00669383|7268384|FG001|STARTED|Overall Study||41
6358683|NCT00669383|7268383|FG000|COMPLETED|Overall Study||44
6358684|NCT00669383|7268384|FG001|COMPLETED|Overall Study||41
6358685|NCT00669383|7268383|FG000|NOT COMPLETED|Overall Study||0
6358686|NCT00669383|7268384|FG001|NOT COMPLETED|Overall Study||0
6358687|NCT00669396|7268392|FG000|STARTED|Overall Study||23
6358688|NCT00669396|7268393|FG001|STARTED|Overall Study||34
6358689|NCT00669396|7268392|FG000|COMPLETED|Overall Study||13
6358690|NCT00669396|7268393|FG001|COMPLETED|Overall Study||22
6358691|NCT00669396|7268392|FG000|NOT COMPLETED|Overall Study||10
6358692|NCT00669396|7268393|FG001|NOT COMPLETED|Overall Study||12
6358693|NCT00669409|7268405|FG000|STARTED|Part 1||6
6358694|NCT00669409|7268406|FG001|STARTED|Part 1||6
6358695|NCT00669409|7268407|FG002|STARTED|Part 1||6
6358696|NCT00669409|7268408|FG003|STARTED|Part 1||6
6358697|NCT00669409|7268409|FG004|STARTED|Part 1||6
6358698|NCT00669409|7268410|FG005|STARTED|Part 1||12
6358699|NCT00669409|7268411|FG006|STARTED|Part 1||0
6358700|NCT00669409|7268412|FG007|STARTED|Part 1||0
6358701|NCT00669409|7268413|FG008|STARTED|Part 1||0
6358702|NCT00669409|7268414|FG009|STARTED|Part 1||0
6358703|NCT00669409|7268415|FG010|STARTED|Part 1||0
6358704|NCT00669409|7268405|FG000|COMPLETED|Part 1||6
6358705|NCT00669409|7268406|FG001|COMPLETED|Part 1||6
6358706|NCT00669409|7268407|FG002|COMPLETED|Part 1||6
6358707|NCT00669409|7268408|FG003|COMPLETED|Part 1||6
6358708|NCT00669409|7268409|FG004|COMPLETED|Part 1||6
6358709|NCT00669409|7268410|FG005|COMPLETED|Part 1||12
6358710|NCT00669409|7268411|FG006|COMPLETED|Part 1||0
6358711|NCT00669409|7268412|FG007|COMPLETED|Part 1||0
6358712|NCT00669409|7268413|FG008|COMPLETED|Part 1||0
6358713|NCT00669409|7268414|FG009|COMPLETED|Part 1||0
6358714|NCT00669409|7268415|FG010|COMPLETED|Part 1||0
6358715|NCT00669409|7268405|FG000|NOT COMPLETED|Part 1||0
6358716|NCT00669409|7268406|FG001|NOT COMPLETED|Part 1||0
6358717|NCT00669409|7268407|FG002|NOT COMPLETED|Part 1||0
6358718|NCT00669409|7268408|FG003|NOT COMPLETED|Part 1||0
6358719|NCT00669409|7268409|FG004|NOT COMPLETED|Part 1||0
6358720|NCT00669409|7268410|FG005|NOT COMPLETED|Part 1||0
6358721|NCT00669409|7268411|FG006|NOT COMPLETED|Part 1||0
6358722|NCT00669409|7268412|FG007|NOT COMPLETED|Part 1||0
6358723|NCT00669409|7268413|FG008|NOT COMPLETED|Part 1||0
6358724|NCT00669409|7268414|FG009|NOT COMPLETED|Part 1||0
6358725|NCT00669409|7268415|FG010|NOT COMPLETED|Part 1||0
6358726|NCT00669409|7268405|FG000|STARTED|Part 2||0
6358727|NCT00669409|7268406|FG001|STARTED|Part 2||0
6358728|NCT00669409|7268407|FG002|STARTED|Part 2||0
6358729|NCT00669409|7268408|FG003|STARTED|Part 2||0
6358730|NCT00669409|7268409|FG004|STARTED|Part 2||0
6358731|NCT00669409|7268410|FG005|STARTED|Part 2||0
6358732|NCT00669409|7268411|FG006|STARTED|Part 2||9
6358733|NCT00669409|7268412|FG007|STARTED|Part 2||9
6358734|NCT00669409|7268413|FG008|STARTED|Part 2||9
6358735|NCT00669409|7268414|FG009|STARTED|Part 2||10
6358736|NCT00669409|7268415|FG010|STARTED|Part 2||4
6358737|NCT00669409|7268405|FG000|COMPLETED|Part 2||0
6358738|NCT00669409|7268406|FG001|COMPLETED|Part 2||0
6358739|NCT00669409|7268407|FG002|COMPLETED|Part 2||0
6358740|NCT00669409|7268408|FG003|COMPLETED|Part 2||0
6358741|NCT00669409|7268409|FG004|COMPLETED|Part 2||0
6358742|NCT00669409|7268410|FG005|COMPLETED|Part 2||0
6358743|NCT00669409|7268411|FG006|COMPLETED|Part 2||9
6358744|NCT00669409|7268412|FG007|COMPLETED|Part 2||9
6358745|NCT00669409|7268413|FG008|COMPLETED|Part 2||9
6358746|NCT00669409|7268414|FG009|COMPLETED|Part 2||9
6358747|NCT00669409|7268415|FG010|COMPLETED|Part 2||4
6358748|NCT00669409|7268405|FG000|NOT COMPLETED|Part 2||0
6358749|NCT00669409|7268406|FG001|NOT COMPLETED|Part 2||0
6358750|NCT00669409|7268407|FG002|NOT COMPLETED|Part 2||0
6358751|NCT00669409|7268408|FG003|NOT COMPLETED|Part 2||0
6358752|NCT00669409|7268409|FG004|NOT COMPLETED|Part 2||0
6358753|NCT00669409|7268410|FG005|NOT COMPLETED|Part 2||0
6358754|NCT00669409|7268411|FG006|NOT COMPLETED|Part 2||0
6358755|NCT00669409|7268412|FG007|NOT COMPLETED|Part 2||0
6358756|NCT00669409|7268413|FG008|NOT COMPLETED|Part 2||0
6358757|NCT00669409|7268414|FG009|NOT COMPLETED|Part 2||1
6358758|NCT00669409|7268415|FG010|NOT COMPLETED|Part 2||0
6377124|NCT00762164|7287714|FG001|COMPLETED|Overall Study||15
6377125|NCT00762164|7287713|FG000|NOT COMPLETED|Overall Study||3
6377126|NCT00762164|7287714|FG001|NOT COMPLETED|Overall Study||2
6377127|NCT00762177|7287723|FG000|STARTED|1st Treatment Period||8
6377128|NCT00762177|7287724|FG001|STARTED|1st Treatment Period||8
6377129|NCT00762177|7287725|FG002|STARTED|1st Treatment Period||8
6377130|NCT00762177|7287723|FG000|COMPLETED|1st Treatment Period||8
6377131|NCT00762177|7287724|FG001|COMPLETED|1st Treatment Period||8
6358759|NCT00669539|7268444|FG000|STARTED|Overall Study||94
6358760|NCT00669539|7268445|FG001|STARTED|Overall Study||52
6358761|NCT00669539|7268444|FG000|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
6358762|NCT00669539|7268445|FG001|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
6358763|NCT00669539|7268444|FG000|NOT COMPLETED|Overall Study||8
6358764|NCT00669539|7268445|FG001|NOT COMPLETED|Overall Study||9
6358765|NCT00669552|7268451|FG000|STARTED|Overall Study||11
6358766|NCT00669552|7268451|FG000|COMPLETED|Overall Study||11
6358767|NCT00669552|7268451|FG000|NOT COMPLETED|Overall Study||0
6358768|NCT00669578|7268457|FG000|STARTED|Overall Study||12
6358769|NCT00669578|7268458|FG001|STARTED|Overall Study||65
6358770|NCT00669578|7268457|FG000|COMPLETED|Overall Study||12
6358771|NCT00669578|7268458|FG001|COMPLETED|Overall Study||65
6358772|NCT00669578|7268457|FG000|NOT COMPLETED|Overall Study||0
6358773|NCT00669578|7268458|FG001|NOT COMPLETED|Overall Study||0
6358774|NCT00669617|7268465|FG000|STARTED|Period 1||18
6358775|NCT00669617|7268466|FG001|STARTED|Period 1||17
6358776|NCT00669617|7268467|FG002|STARTED|Period 1||18
6358777|NCT00669617|7268468|FG003|STARTED|Period 1||18
6358778|NCT00669617|7268469|FG004|STARTED|Period 1||18
6358779|NCT00669617|7268465|FG000|COMPLETED|Period 1||18
6358780|NCT00669617|7268466|FG001|COMPLETED|Period 1||17
6358781|NCT00669617|7268467|FG002|COMPLETED|Period 1||17
6358782|NCT00669617|7268468|FG003|COMPLETED|Period 1||18
6358783|NCT00669617|7268469|FG004|COMPLETED|Period 1||17
6358784|NCT00669617|7268465|FG000|NOT COMPLETED|Period 1||0
6358785|NCT00669617|7268466|FG001|NOT COMPLETED|Period 1||0
6358786|NCT00669617|7268467|FG002|NOT COMPLETED|Period 1||1
6358787|NCT00669617|7268468|FG003|NOT COMPLETED|Period 1||0
6358788|NCT00669617|7268469|FG004|NOT COMPLETED|Period 1||1
6358789|NCT00669617|7268465|FG000|STARTED|Period 2||18
6358790|NCT00669617|7268466|FG001|STARTED|Period 2||17
6358791|NCT00669617|7268467|FG002|STARTED|Period 2||17
6358792|NCT00669617|7268468|FG003|STARTED|Period 2||18
6358793|NCT00669617|7268469|FG004|STARTED|Period 2||17
6358794|NCT00669617|7268465|FG000|COMPLETED|Period 2||18
6358795|NCT00669617|7268466|FG001|COMPLETED|Period 2||17
6358796|NCT00669617|7268467|FG002|COMPLETED|Period 2||17
6358797|NCT00669617|7268468|FG003|COMPLETED|Period 2||18
6358798|NCT00669617|7268469|FG004|COMPLETED|Period 2||17
6358799|NCT00669617|7268465|FG000|NOT COMPLETED|Period 2||0
6358800|NCT00669617|7268466|FG001|NOT COMPLETED|Period 2||0
6358801|NCT00669617|7268467|FG002|NOT COMPLETED|Period 2||0
6358802|NCT00669617|7268468|FG003|NOT COMPLETED|Period 2||0
6358803|NCT00669617|7268469|FG004|NOT COMPLETED|Period 2||0
6358804|NCT00669617|7268465|FG000|STARTED|Period 3||18
6358805|NCT00669617|7268466|FG001|STARTED|Period 3||17
6358806|NCT00669617|7268467|FG002|STARTED|Period 3||17
6358807|NCT00669617|7268468|FG003|STARTED|Period 3||18
6358808|NCT00669617|7268469|FG004|STARTED|Period 3||17
6358809|NCT00669617|7268465|FG000|COMPLETED|Period 3||17
6358810|NCT00669617|7268466|FG001|COMPLETED|Period 3||17
6358811|NCT00669617|7268467|FG002|COMPLETED|Period 3||17
6358812|NCT00669617|7268468|FG003|COMPLETED|Period 3||18
6358813|NCT00669617|7268469|FG004|COMPLETED|Period 3||17
6358814|NCT00669617|7268465|FG000|NOT COMPLETED|Period 3||1
6358815|NCT00669617|7268466|FG001|NOT COMPLETED|Period 3||0
6358816|NCT00669617|7268467|FG002|NOT COMPLETED|Period 3||0
6358817|NCT00669617|7268468|FG003|NOT COMPLETED|Period 3||0
6358818|NCT00669617|7268469|FG004|NOT COMPLETED|Period 3||0
6358819|NCT00669617|7268465|FG000|STARTED|Period 4||17
6358820|NCT00669617|7268466|FG001|STARTED|Period 4||17
6358821|NCT00669617|7268467|FG002|STARTED|Period 4||17
6358822|NCT00669617|7268468|FG003|STARTED|Period 4||18
6358823|NCT00669617|7268469|FG004|STARTED|Period 4||17
6358824|NCT00669617|7268465|FG000|COMPLETED|Period 4||17
6358825|NCT00669617|7268466|FG001|COMPLETED|Period 4||17
6358826|NCT00669617|7268467|FG002|COMPLETED|Period 4||17
6358827|NCT00669617|7268468|FG003|COMPLETED|Period 4||18
6358828|NCT00669617|7268469|FG004|COMPLETED|Period 4||17
6358829|NCT00669617|7268465|FG000|NOT COMPLETED|Period 4||0
6358830|NCT00669617|7268466|FG001|NOT COMPLETED|Period 4||0
6358831|NCT00669617|7268467|FG002|NOT COMPLETED|Period 4||0
6358832|NCT00669617|7268468|FG003|NOT COMPLETED|Period 4||0
6358833|NCT00669617|7268469|FG004|NOT COMPLETED|Period 4||0
6358834|NCT00669617|7268465|FG000|STARTED|Period 5||17
6358835|NCT00669617|7268466|FG001|STARTED|Period 5||17
6358836|NCT00669617|7268467|FG002|STARTED|Period 5||17
6358837|NCT00669617|7268468|FG003|STARTED|Period 5||18
6358838|NCT00669617|7268469|FG004|STARTED|Period 5||17
6358839|NCT00669617|7268465|FG000|COMPLETED|Period 5||17
6358840|NCT00669617|7268466|FG001|COMPLETED|Period 5||17
6358841|NCT00669617|7268467|FG002|COMPLETED|Period 5||17
6358842|NCT00669617|7268468|FG003|COMPLETED|Period 5||18
6358843|NCT00669617|7268469|FG004|COMPLETED|Period 5||17
6358844|NCT00669617|7268465|FG000|NOT COMPLETED|Period 5||0
6358845|NCT00669617|7268466|FG001|NOT COMPLETED|Period 5||0
6358846|NCT00669617|7268467|FG002|NOT COMPLETED|Period 5||0
6358847|NCT00669617|7268468|FG003|NOT COMPLETED|Period 5||0
6358848|NCT00669617|7268469|FG004|NOT COMPLETED|Period 5||0
6358849|NCT00669682|7268481|FG000|STARTED|Overall Study||9
6358850|NCT00669682|7268481|FG000|COMPLETED|Overall Study||9
6358851|NCT00669682|7268481|FG000|NOT COMPLETED|Overall Study||0
6358852|NCT00669864|7268486|FG000|STARTED|Overall Study||293
6358853|NCT00669864|7268486|FG000|COMPLETED|Overall Study||284
6358854|NCT00669864|7268486|FG000|NOT COMPLETED|Overall Study||9
6358855|NCT00669877|7268490|FG000|STARTED|Overall Study||56
6358856|NCT00669877|7268490|FG000|COMPLETED|Overall Study||52
6358857|NCT00669877|7268490|FG000|NOT COMPLETED|Overall Study||4
6358858|NCT00669903|7268498|FG000|STARTED|Overall Study||23
6358859|NCT00669903|7268499|FG001|STARTED|Overall Study||37
6358860|NCT00669903|7268500|FG002|STARTED|Overall Study||18
6358861|NCT00669903|7268501|FG003|STARTED|Overall Study||22
6358862|NCT00669903|7268498|FG000|Completed Treatment Period|Overall Study||23
6358863|NCT00669903|7268499|FG001|Completed Treatment Period|Overall Study||33
6358864|NCT00669903|7268500|FG002|Completed Treatment Period|Overall Study||13
6358865|NCT00669903|7268501|FG003|Completed Treatment Period|Overall Study||19
6358866|NCT00669903|7268498|FG000|COMPLETED|Overall Study||22
6358867|NCT00669903|7268499|FG001|COMPLETED|Overall Study||32
6358868|NCT00669903|7268500|FG002|COMPLETED|Overall Study||13
6358869|NCT00669903|7268501|FG003|COMPLETED|Overall Study||18
6358870|NCT00669903|7268498|FG000|NOT COMPLETED|Overall Study||1
6358871|NCT00669903|7268499|FG001|NOT COMPLETED|Overall Study||5
6358872|NCT00669903|7268500|FG002|NOT COMPLETED|Overall Study||5
6358873|NCT00669903|7268501|FG003|NOT COMPLETED|Overall Study||4
6358874|NCT00669916|7268513|FG000|STARTED|Overall Study||18
6358875|NCT00669916|7268514|FG001|STARTED|Overall Study||18
6358876|NCT00669916|7268513|FG000|COMPLETED|Overall Study||18
6358877|NCT00669916|7268514|FG001|COMPLETED|Overall Study||18
6358878|NCT00669916|7268513|FG000|NOT COMPLETED|Overall Study||0
6358879|NCT00669916|7268514|FG001|NOT COMPLETED|Overall Study||0
6358880|NCT00669942|7268532|FG000|STARTED|Part 1||6
6358881|NCT00669942|7268533|FG001|STARTED|Part 1||6
6358882|NCT00669942|7268534|FG002|STARTED|Part 1||6
6358883|NCT00669942|7268535|FG003|STARTED|Part 1||6
6358884|NCT00669942|7268536|FG004|STARTED|Part 1||8
6358885|NCT00669942|7268537|FG005|STARTED|Part 1||0
6358886|NCT00669942|7268538|FG006|STARTED|Part 1||0
6358887|NCT00669942|7268539|FG007|STARTED|Part 1||0
6358888|NCT00669942|7268540|FG008|STARTED|Part 1||0
6358889|NCT00669942|7268541|FG009|STARTED|Part 1||0
6358890|NCT00669942|7268542|FG010|STARTED|Part 1||0
6358891|NCT00669942|7268543|FG011|STARTED|Part 1||0
6358892|NCT00669942|7268532|FG000|COMPLETED|Part 1||6
6358893|NCT00669942|7268533|FG001|COMPLETED|Part 1||6
6358894|NCT00669942|7268534|FG002|COMPLETED|Part 1||6
6358895|NCT00669942|7268535|FG003|COMPLETED|Part 1||6
6358896|NCT00669942|7268536|FG004|COMPLETED|Part 1||8
6358897|NCT00669942|7268537|FG005|COMPLETED|Part 1||0
6560177|NCT01785186|7482865|FG002|COMPLETED|Overall Study||52
6560178|NCT01785186|7482866|FG003|COMPLETED|Overall Study||58
6560179|NCT01785186|7482867|FG004|COMPLETED|Overall Study||117
6560180|NCT01785186|7482863|FG000|NOT COMPLETED|Overall Study||6
6560181|NCT01785186|7482864|FG001|NOT COMPLETED|Overall Study||6
6358898|NCT00669942|7268538|FG006|COMPLETED|Part 1||0
6358899|NCT00669942|7268539|FG007|COMPLETED|Part 1||0
6358900|NCT00669942|7268540|FG008|COMPLETED|Part 1||0
6358901|NCT00669942|7268541|FG009|COMPLETED|Part 1||0
6358902|NCT00669942|7268542|FG010|COMPLETED|Part 1||0
6358903|NCT00669942|7268543|FG011|COMPLETED|Part 1||0
6358904|NCT00669942|7268532|FG000|NOT COMPLETED|Part 1||0
6358905|NCT00669942|7268533|FG001|NOT COMPLETED|Part 1||0
6358906|NCT00669942|7268534|FG002|NOT COMPLETED|Part 1||0
6358907|NCT00669942|7268535|FG003|NOT COMPLETED|Part 1||0
6358908|NCT00669942|7268536|FG004|NOT COMPLETED|Part 1||0
6358909|NCT00669942|7268537|FG005|NOT COMPLETED|Part 1||0
6358910|NCT00669942|7268538|FG006|NOT COMPLETED|Part 1||0
6358911|NCT00669942|7268539|FG007|NOT COMPLETED|Part 1||0
6358912|NCT00669942|7268540|FG008|NOT COMPLETED|Part 1||0
6358913|NCT00669942|7268541|FG009|NOT COMPLETED|Part 1||0
6358914|NCT00669942|7268542|FG010|NOT COMPLETED|Part 1||0
6358915|NCT00669942|7268543|FG011|NOT COMPLETED|Part 1||0
6358916|NCT00669942|7268532|FG000|STARTED|Parts 2 and 3||0
6358917|NCT00669942|7268533|FG001|STARTED|Parts 2 and 3||0
6358918|NCT00669942|7268534|FG002|STARTED|Parts 2 and 3||0
6358919|NCT00669942|7268535|FG003|STARTED|Parts 2 and 3||0
6358920|NCT00669942|7268536|FG004|STARTED|Parts 2 and 3||0
6358921|NCT00669942|7268537|FG005|STARTED|Parts 2 and 3||6
6358922|NCT00669942|7268538|FG006|STARTED|Parts 2 and 3||6
6358923|NCT00669942|7268539|FG007|STARTED|Parts 2 and 3||26
6358924|NCT00669942|7268540|FG008|STARTED|Parts 2 and 3||26
6358925|NCT00669942|7268541|FG009|STARTED|Parts 2 and 3||0
6560182|NCT01785186|7482865|FG002|NOT COMPLETED|Overall Study||5
6358926|NCT00669942|7268542|FG010|STARTED|Parts 2 and 3||0
6358927|NCT00669942|7268543|FG011|STARTED|Parts 2 and 3||0
6358928|NCT00669942|7268532|FG000|COMPLETED|Parts 2 and 3||0
6358929|NCT00669942|7268533|FG001|COMPLETED|Parts 2 and 3||0
6358930|NCT00669942|7268534|FG002|COMPLETED|Parts 2 and 3||0
6358931|NCT00669942|7268535|FG003|COMPLETED|Parts 2 and 3||0
6358932|NCT00669942|7268536|FG004|COMPLETED|Parts 2 and 3||0
6358933|NCT00669942|7268537|FG005|COMPLETED|Parts 2 and 3||4
6358934|NCT00669942|7268538|FG006|COMPLETED|Parts 2 and 3||6
6358935|NCT00669942|7268539|FG007|COMPLETED|Parts 2 and 3||24
6358936|NCT00669942|7268540|FG008|COMPLETED|Parts 2 and 3||23
6358937|NCT00669942|7268541|FG009|COMPLETED|Parts 2 and 3||0
6358938|NCT00669942|7268542|FG010|COMPLETED|Parts 2 and 3||0
6358939|NCT00669942|7268543|FG011|COMPLETED|Parts 2 and 3||0
6358940|NCT00669942|7268532|FG000|NOT COMPLETED|Parts 2 and 3||0
6358941|NCT00669942|7268533|FG001|NOT COMPLETED|Parts 2 and 3||0
6358942|NCT00669942|7268534|FG002|NOT COMPLETED|Parts 2 and 3||0
6358943|NCT00669942|7268535|FG003|NOT COMPLETED|Parts 2 and 3||0
6358944|NCT00669942|7268536|FG004|NOT COMPLETED|Parts 2 and 3||0
6560183|NCT01785186|7482866|FG003|NOT COMPLETED|Overall Study||5
6560184|NCT01785186|7482867|FG004|NOT COMPLETED|Overall Study||6
6358945|NCT00669942|7268537|FG005|NOT COMPLETED|Parts 2 and 3||2
6358946|NCT00669942|7268538|FG006|NOT COMPLETED|Parts 2 and 3||0
6358947|NCT00669942|7268539|FG007|NOT COMPLETED|Parts 2 and 3||2
6358948|NCT00669942|7268540|FG008|NOT COMPLETED|Parts 2 and 3||3
6358949|NCT00669942|7268541|FG009|NOT COMPLETED|Parts 2 and 3||0
6358950|NCT00669942|7268542|FG010|NOT COMPLETED|Parts 2 and 3||0
6358951|NCT00669942|7268543|FG011|NOT COMPLETED|Parts 2 and 3||0
6358952|NCT00669942|7268532|FG000|STARTED|Healthy Volunteers||0
6358953|NCT00669942|7268533|FG001|STARTED|Healthy Volunteers||0
6358954|NCT00669942|7268534|FG002|STARTED|Healthy Volunteers||0
6358955|NCT00669942|7268535|FG003|STARTED|Healthy Volunteers||0
6358956|NCT00669942|7268536|FG004|STARTED|Healthy Volunteers||0
6358957|NCT00669942|7268537|FG005|STARTED|Healthy Volunteers||0
6358958|NCT00669942|7268538|FG006|STARTED|Healthy Volunteers||0
6358959|NCT00669942|7268539|FG007|STARTED|Healthy Volunteers||0
6358960|NCT00669942|7268540|FG008|STARTED|Healthy Volunteers||0
6358961|NCT00669942|7268541|FG009|STARTED|Healthy Volunteers||3
6358962|NCT00669942|7268542|FG010|STARTED|Healthy Volunteers||3
6358963|NCT00669942|7268543|FG011|STARTED|Healthy Volunteers||2
6358964|NCT00669942|7268532|FG000|COMPLETED|Healthy Volunteers||0
6358965|NCT00669942|7268533|FG001|COMPLETED|Healthy Volunteers||0
6358966|NCT00669942|7268534|FG002|COMPLETED|Healthy Volunteers||0
6358967|NCT00669942|7268535|FG003|COMPLETED|Healthy Volunteers||0
6358968|NCT00669942|7268536|FG004|COMPLETED|Healthy Volunteers||0
6358969|NCT00669942|7268537|FG005|COMPLETED|Healthy Volunteers||0
6358970|NCT00669942|7268538|FG006|COMPLETED|Healthy Volunteers||0
6358971|NCT00669942|7268539|FG007|COMPLETED|Healthy Volunteers||0
6358972|NCT00669942|7268540|FG008|COMPLETED|Healthy Volunteers||0
6358973|NCT00669942|7268541|FG009|COMPLETED|Healthy Volunteers||3
6358974|NCT00669942|7268542|FG010|COMPLETED|Healthy Volunteers||2
6358975|NCT00669942|7268543|FG011|COMPLETED|Healthy Volunteers||2
6358976|NCT00669942|7268532|FG000|NOT COMPLETED|Healthy Volunteers||0
6358977|NCT00669942|7268533|FG001|NOT COMPLETED|Healthy Volunteers||0
6358978|NCT00669942|7268534|FG002|NOT COMPLETED|Healthy Volunteers||0
6358979|NCT00669942|7268535|FG003|NOT COMPLETED|Healthy Volunteers||0
6358980|NCT00669942|7268536|FG004|NOT COMPLETED|Healthy Volunteers||0
6358981|NCT00669942|7268537|FG005|NOT COMPLETED|Healthy Volunteers||0
6358982|NCT00669942|7268538|FG006|NOT COMPLETED|Healthy Volunteers||0
6358983|NCT00669942|7268539|FG007|NOT COMPLETED|Healthy Volunteers||0
6358984|NCT00669942|7268540|FG008|NOT COMPLETED|Healthy Volunteers||0
6358985|NCT00669942|7268541|FG009|NOT COMPLETED|Healthy Volunteers||0
6358986|NCT00669942|7268542|FG010|NOT COMPLETED|Healthy Volunteers||1
6358987|NCT00669942|7268543|FG011|NOT COMPLETED|Healthy Volunteers||0
6358988|NCT00669955|7268568|FG000|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
6358989|NCT00669955|7268569|FG001|STARTED|Overall Study||222
6358990|NCT00669955|7268568|FG000|COMPLETED|Overall Study||204
6358991|NCT00669955|7268569|FG001|COMPLETED|Overall Study||195
6358992|NCT00669955|7268568|FG000|NOT COMPLETED|Overall Study||14
6358993|NCT00669955|7268569|FG001|NOT COMPLETED|Overall Study||27
6358994|NCT00670007|7268575|FG000|STARTED|Overall Study||140
6358995|NCT00670007|7268575|FG000|COMPLETED|Overall Study||131
6358996|NCT00670007|7268575|FG000|NOT COMPLETED|Overall Study||9
6358997|NCT00670046|7268582|FG000|STARTED|Overall Study||7
6358998|NCT00670046|7268583|FG001|STARTED|Overall Study||8
6358999|NCT00670046|7268582|FG000|COMPLETED|Overall Study||6
6359000|NCT00670046|7268583|FG001|COMPLETED|Overall Study||6
6359001|NCT00670046|7268582|FG000|NOT COMPLETED|Overall Study||1
6359002|NCT00670046|7268583|FG001|NOT COMPLETED|Overall Study||2
6359003|NCT00670111|7268592|FG000|STARTED|Enrollment to One Month||5
6359004|NCT00670111|7268593|FG001|STARTED|Enrollment to One Month||8
6359005|NCT00670111|7268594|FG002|STARTED|Enrollment to One Month||19
6359006|NCT00670111|7268592|FG000|COMPLETED|Enrollment to One Month||4
6359007|NCT00670111|7268593|FG001|COMPLETED|Enrollment to One Month||8
6359008|NCT00670111|7268594|FG002|COMPLETED|Enrollment to One Month||0
6359009|NCT00670111|7268592|FG000|NOT COMPLETED|Enrollment to One Month||1
6776572|NCT03836729|7704647|FG000|STARTED|Treatment Period 2 (Up to Day 7)||16
6776573|NCT03836729|7704647|FG000|COMPLETED|Treatment Period 2 (Up to Day 7)||15
6776574|NCT03836729|7704647|FG000|NOT COMPLETED|Treatment Period 2 (Up to Day 7)||1
6776575|NCT03835975|7704660|FG000|STARTED|Overall Study||253
6776576|NCT03835975|7704661|FG001|STARTED|Overall Study||122
6776577|NCT03835975|7704662|FG002|STARTED|Overall Study||248
6776578|NCT03835975|7704663|FG003|STARTED|Overall Study||127
6776579|NCT03835975|7704664|FG004|STARTED|Overall Study||125
6776580|NCT03835975|7704660|FG000|Vaccinated|Overall Study||253
6776581|NCT03835975|7704661|FG001|Vaccinated|Overall Study||122
6776582|NCT03835975|7704662|FG002|Vaccinated|Overall Study||246
6776583|NCT03835975|7704663|FG003|Vaccinated|Overall Study||127
6776584|NCT03835975|7704664|FG004|Vaccinated|Overall Study||125
6776585|NCT03835975|7704660|FG000|Safety Population|Overall Study||253
6776586|NCT03835975|7704661|FG001|Safety Population|Overall Study||122
6359010|NCT00670111|7268593|FG001|NOT COMPLETED|Enrollment to One Month||0
6359011|NCT00670111|7268594|FG002|NOT COMPLETED|Enrollment to One Month||19
6359012|NCT00670111|7268592|FG000|STARTED|One Month Period A||4
6359013|NCT00670111|7268593|FG001|STARTED|One Month Period A||8
6359014|NCT00670111|7268594|FG002|STARTED|One Month Period A||0
6359015|NCT00670111|7268592|FG000|COMPLETED|One Month Period A||4
6359016|NCT00670111|7268593|FG001|COMPLETED|One Month Period A||8
6776587|NCT03835975|7704662|FG002|Safety Population|Overall Study||246
6359017|NCT00670111|7268594|FG002|COMPLETED|One Month Period A||0
6359018|NCT00670111|7268592|FG000|NOT COMPLETED|One Month Period A||0
6359019|NCT00670111|7268593|FG001|NOT COMPLETED|One Month Period A||0
6359020|NCT00670111|7268594|FG002|NOT COMPLETED|One Month Period A||0
6359021|NCT00670111|7268592|FG000|STARTED|One Month Period B||4
6359022|NCT00670111|7268593|FG001|STARTED|One Month Period B||8
6359023|NCT00670111|7268594|FG002|STARTED|One Month Period B||0
6359024|NCT00670111|7268592|FG000|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
6359025|NCT00670111|7268593|FG001|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
6359026|NCT00670111|7268594|FG002|COMPLETED|One Month Period B||0
6359027|NCT00670111|7268592|FG000|NOT COMPLETED|One Month Period B||0
6359028|NCT00670111|7268593|FG001|NOT COMPLETED|One Month Period B||0
6359029|NCT00670111|7268594|FG002|NOT COMPLETED|One Month Period B||0
6359030|NCT00670111|7268592|FG000|STARTED|One Month to Six Months||4
6359031|NCT00670111|7268593|FG001|STARTED|One Month to Six Months||8
6359032|NCT00670111|7268594|FG002|STARTED|One Month to Six Months||0
6359033|NCT00670111|7268592|FG000|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
6359034|NCT00670111|7268593|FG001|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
6359035|NCT00670111|7268594|FG002|COMPLETED|One Month to Six Months||0
6359036|NCT00670111|7268592|FG000|NOT COMPLETED|One Month to Six Months||0
6359037|NCT00670111|7268593|FG001|NOT COMPLETED|One Month to Six Months||0
6359038|NCT00670111|7268594|FG002|NOT COMPLETED|One Month to Six Months||0
6359039|NCT00670111|7268592|FG000|STARTED|Six Months to Twelve Months||4
6359040|NCT00670111|7268593|FG001|STARTED|Six Months to Twelve Months||8
6359041|NCT00670111|7268594|FG002|STARTED|Six Months to Twelve Months||0
6359042|NCT00670111|7268592|FG000|COMPLETED|Six Months to Twelve Months||4
6359043|NCT00670111|7268593|FG001|COMPLETED|Six Months to Twelve Months||8
6359044|NCT00670111|7268594|FG002|COMPLETED|Six Months to Twelve Months||0
6359045|NCT00670111|7268592|FG000|NOT COMPLETED|Six Months to Twelve Months||0
6359046|NCT00670111|7268593|FG001|NOT COMPLETED|Six Months to Twelve Months||0
6359047|NCT00670111|7268594|FG002|NOT COMPLETED|Six Months to Twelve Months||0
6776588|NCT03835975|7704663|FG003|Safety Population|Overall Study||127
6776589|NCT03835975|7704664|FG004|Safety Population|Overall Study||125
6776590|NCT03835975|7704660|FG000|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||247
6776591|NCT03835975|7704661|FG001|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
6776592|NCT03835975|7704662|FG002|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||243
6776593|NCT03835975|7704663|FG003|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||0
6776594|NCT03835975|7704664|FG004|Evaluable Immunogenicity Population (for 20vPnC Cohorts)|Overall Study||121
6776595|NCT03835975|7704660|FG000|COMPLETED|Overall Study||250
6776596|NCT03835975|7704661|FG001|COMPLETED|Overall Study||119
6776597|NCT03835975|7704662|FG002|COMPLETED|Overall Study||245
6776598|NCT03835975|7704663|FG003|COMPLETED|Overall Study||126
6776599|NCT03835975|7704664|FG004|COMPLETED|Overall Study||125
6776600|NCT03835975|7704660|FG000|NOT COMPLETED|Overall Study||3
6776601|NCT03835975|7704661|FG001|NOT COMPLETED|Overall Study||3
6776602|NCT03835975|7704662|FG002|NOT COMPLETED|Overall Study||3
6776603|NCT03835975|7704663|FG003|NOT COMPLETED|Overall Study||1
6776604|NCT03835975|7704664|FG004|NOT COMPLETED|Overall Study||0
6776605|NCT03821259|7704678|FG000|STARTED|Overall Study||88
6776606|NCT03821259|7704678|FG000|COMPLETED|Overall Study||88
6776607|NCT03821259|7704678|FG000|NOT COMPLETED|Overall Study||0
6776608|NCT03803085|7704684|FG000|STARTED|Overall Study||30
6776609|NCT03803085|7704685|FG001|STARTED|Overall Study||30
6776610|NCT03803085|7704684|FG000|COMPLETED|Overall Study||28
6776611|NCT03803085|7704685|FG001|COMPLETED|Overall Study||28
6776612|NCT03803085|7704684|FG000|NOT COMPLETED|Overall Study||2
6776613|NCT03803085|7704685|FG001|NOT COMPLETED|Overall Study||2
6776614|NCT03801473|7704694|FG000|STARTED|Overall Study||21
6776615|NCT03801473|7704695|FG001|STARTED|Overall Study||21
6776616|NCT03801473|7704694|FG000|COMPLETED|Overall Study||18
6776617|NCT03801473|7704695|FG001|COMPLETED|Overall Study||19
6776618|NCT03801473|7704694|FG000|NOT COMPLETED|Overall Study||3
6776619|NCT03801473|7704695|FG001|NOT COMPLETED|Overall Study||2
6776620|NCT03834168|7704703|FG000|STARTED|Overall Study||19
6776621|NCT03834168|7704704|FG001|STARTED|Overall Study||23
6776622|NCT03834168|7704703|FG000|Total Participant Screened for the Purpose of Eligibility|Overall Study||22
6776623|NCT03834168|7704704|FG001|Total Participant Screened for the Purpose of Eligibility|Overall Study||30
6776624|NCT03834168|7704703|FG000|Ineligible Participants|Overall Study||3
6776625|NCT03834168|7704704|FG001|Ineligible Participants|Overall Study||7
6776626|NCT03834168|7704703|FG000|Unable to Complete the Protocol|Overall Study||0
6776627|NCT03834168|7704704|FG001|Unable to Complete the Protocol|Overall Study||1
6776628|NCT03834168|7704703|FG000|Study Dropouts|Overall Study||1
6776629|NCT03834168|7704704|FG001|Study Dropouts|Overall Study||0
6776630|NCT03834168|7704703|FG000|Participants Received 5 Days of Standardized Meals|Overall Study||19
6776631|NCT03834168|7704704|FG001|Participants Received 5 Days of Standardized Meals|Overall Study||23
6776632|NCT03834168|7704703|FG000|Participants Returned for the 24-h Inpatient Protocol|Overall Study||18
6776633|NCT03834168|7704704|FG001|Participants Returned for the 24-h Inpatient Protocol|Overall Study||23
6776634|NCT03834168|7704703|FG000|COMPLETED|Overall Study||18
6776635|NCT03834168|7704704|FG001|COMPLETED|Overall Study||22
6359048|NCT00670202|7268604|FG000|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
6359049|NCT00670202|7268605|FG001|STARTED|Overall Study||0
6359050|NCT00670202|7268604|FG000|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
6359051|NCT00670202|7268605|FG001|COMPLETED|Overall Study||0
6359052|NCT00670202|7268604|FG000|NOT COMPLETED|Overall Study||0
6359053|NCT00670202|7268605|FG001|NOT COMPLETED|Overall Study||0
6359054|NCT00670228|7268613|FG000|STARTED|Overall Study||18
6359055|NCT00670228|7268614|FG001|STARTED|Overall Study||15
6359056|NCT00670228|7268613|FG000|COMPLETED|Overall Study||13
6359057|NCT00670228|7268614|FG001|COMPLETED|Overall Study||12
6359058|NCT00670228|7268613|FG000|NOT COMPLETED|Overall Study||5
6359059|NCT00670228|7268614|FG001|NOT COMPLETED|Overall Study||3
6560185|NCT01785459|7482883|FG000|STARTED|Overall Study||11
6560186|NCT01785459|7482884|FG001|STARTED|Overall Study||12
6560187|NCT01785459|7482883|FG000|COMPLETED|Overall Study||11
6359060|NCT00670241|7268623|FG000|STARTED|Overall Study||183
6359061|NCT00670241|7268624|FG001|STARTED|Overall Study||184
6359062|NCT00670241|7268625|FG002|STARTED|Overall Study||91
6359063|NCT00670241|7268623|FG000|COMPLETED|Overall Study||171
6359064|NCT00670241|7268624|FG001|COMPLETED|Overall Study||163
6359065|NCT00670241|7268625|FG002|COMPLETED|Overall Study||64
6359066|NCT00670241|7268623|FG000|NOT COMPLETED|Overall Study||12
6359067|NCT00670241|7268624|FG001|NOT COMPLETED|Overall Study||21
6359068|NCT00670241|7268625|FG002|NOT COMPLETED|Overall Study||27
6359069|NCT00670267|7268633|FG000|STARTED|Overall Study||10
6359070|NCT00670267|7268633|FG000|COMPLETED|Overall Study||9
6359071|NCT00670267|7268633|FG000|NOT COMPLETED|Overall Study||1
6359072|NCT00670306|7268639|FG000|STARTED|Overall Study||528
6359073|NCT00670306|7268639|FG000|COMPLETED|Overall Study||473
6359074|NCT00670306|7268639|FG000|NOT COMPLETED|Overall Study||55
6359075|NCT00670449|7268647|FG000|STARTED|Overall Study||47
6359076|NCT00670449|7268648|FG001|STARTED|Overall Study||46
6359077|NCT00670449|7268649|FG002|STARTED|Overall Study||27
6359078|NCT00670449|7268650|FG003|STARTED|Overall Study||23
6359079|NCT00670449|7268647|FG000|Switched to 0.5mg (Open Label)|Overall Study||45
6359080|NCT00670449|7268648|FG001|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
6359081|NCT00670449|7268649|FG002|Switched to 0.5mg (Open Label)|Overall Study||23
6359082|NCT00670449|7268650|FG003|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
6359083|NCT00670449|7268647|FG000|COMPLETED|Overall Study||38
6359084|NCT00670449|7268648|FG001|COMPLETED|Overall Study||36
6359085|NCT00670449|7268649|FG002|COMPLETED|Overall Study||18
6359086|NCT00670449|7268650|FG003|COMPLETED|Overall Study||15
6359087|NCT00670449|7268647|FG000|NOT COMPLETED|Overall Study||9
6359088|NCT00670449|7268648|FG001|NOT COMPLETED|Overall Study||10
6359089|NCT00670449|7268649|FG002|NOT COMPLETED|Overall Study||9
6359090|NCT00670449|7268650|FG003|NOT COMPLETED|Overall Study||8
6359091|NCT00670462|7268661|FG000|STARTED|Overall Study||106
6359092|NCT00670462|7268662|FG001|STARTED|Overall Study||107
6359093|NCT00670462|7268661|FG000|COMPLETED|Overall Study||76
6359094|NCT00670462|7268662|FG001|COMPLETED|Overall Study||76
6359095|NCT00670462|7268661|FG000|NOT COMPLETED|Overall Study||30
6359096|NCT00670462|7268662|FG001|NOT COMPLETED|Overall Study||31
6359097|NCT00670488|7268680|FG000|STARTED|Overall Study||3
6359098|NCT00670488|7268681|FG001|STARTED|Overall Study||58
6359099|NCT00670488|7268682|FG002|STARTED|Overall Study||3
6359100|NCT00670488|7268683|FG003|STARTED|Overall Study||7
6359101|NCT00670488|7268684|FG004|STARTED|Overall Study||3
6359102|NCT00670488|7268685|FG005|STARTED|Overall Study||5
6359103|NCT00670488|7268686|FG006|STARTED|Overall Study||17
6359104|NCT00670488|7268687|FG007|STARTED|Overall Study||3
6359105|NCT00670488|7268688|FG008|STARTED|Overall Study||3
6359106|NCT00670488|7268689|FG009|STARTED|Overall Study||2
6359107|NCT00670488|7268680|FG000|COMPLETED|Overall Study||0
6359108|NCT00670488|7268681|FG001|COMPLETED|Overall Study||0
6655088|NCT02450526|7585094|FG003|COMPLETED|OL Period (Cycles 2-5)||0
6776636|NCT03834168|7704703|FG000|NOT COMPLETED|Overall Study||1
6359109|NCT00670488|7268682|FG002|COMPLETED|Overall Study||0
6359110|NCT00670488|7268683|FG003|COMPLETED|Overall Study||0
6359111|NCT00670488|7268684|FG004|COMPLETED|Overall Study||0
6359112|NCT00670488|7268685|FG005|COMPLETED|Overall Study||0
6359113|NCT00670488|7268686|FG006|COMPLETED|Overall Study||0
6359114|NCT00670488|7268687|FG007|COMPLETED|Overall Study||0
6359115|NCT00670488|7268688|FG008|COMPLETED|Overall Study||0
6359116|NCT00670488|7268689|FG009|COMPLETED|Overall Study||0
6359117|NCT00670488|7268680|FG000|NOT COMPLETED|Overall Study||3
6359118|NCT00670488|7268681|FG001|NOT COMPLETED|Overall Study||58
6359119|NCT00670488|7268682|FG002|NOT COMPLETED|Overall Study||3
6359120|NCT00670488|7268683|FG003|NOT COMPLETED|Overall Study||7
6359121|NCT00670488|7268684|FG004|NOT COMPLETED|Overall Study||3
6359122|NCT00670488|7268685|FG005|NOT COMPLETED|Overall Study||5
6359123|NCT00670488|7268686|FG006|NOT COMPLETED|Overall Study||17
6359124|NCT00670488|7268687|FG007|NOT COMPLETED|Overall Study||3
6359125|NCT00670488|7268688|FG008|NOT COMPLETED|Overall Study||3
6359126|NCT00670488|7268689|FG009|NOT COMPLETED|Overall Study||2
6359127|NCT00670540|7268711|FG000|STARTED|Overall Study||8256
6359128|NCT00670540|7268711|FG000|COMPLETED|Overall Study|total recruited for the follow up|4931
6560188|NCT01785459|7482884|FG001|COMPLETED|Overall Study||12
6560189|NCT01785459|7482883|FG000|NOT COMPLETED|Overall Study||0
6359129|NCT00670540|7268711|FG000|NOT COMPLETED|Overall Study||3325
6359130|NCT00670709|7268717|FG000|STARTED|Overall Study||27
6359131|NCT00670709|7268718|FG001|STARTED|Overall Study||15
6359132|NCT00670709|7268717|FG000|COMPLETED|Overall Study||27
6359133|NCT00670709|7268718|FG001|COMPLETED|Overall Study||15
6359134|NCT00670709|7268717|FG000|NOT COMPLETED|Overall Study||0
6359135|NCT00670709|7268718|FG001|NOT COMPLETED|Overall Study||0
6359136|NCT00670748|7268728|FG000|STARTED|Overall Study||17
6359137|NCT00670748|7268729|FG001|STARTED|Overall Study||16
6359138|NCT00670748|7268730|FG002|STARTED|Overall Study||7
6359139|NCT00670748|7268731|FG003|STARTED|Overall Study||5
6359140|NCT00670748|7268728|FG000|COMPLETED|Overall Study||14
6359141|NCT00670748|7268729|FG001|COMPLETED|Overall Study||14
6359142|NCT00670748|7268730|FG002|COMPLETED|Overall Study||5
6359143|NCT00670748|7268731|FG003|COMPLETED|Overall Study||4
6359144|NCT00670748|7268728|FG000|NOT COMPLETED|Overall Study||3
6359145|NCT00670748|7268729|FG001|NOT COMPLETED|Overall Study||2
6359146|NCT00670748|7268730|FG002|NOT COMPLETED|Overall Study||2
6359147|NCT00670748|7268731|FG003|NOT COMPLETED|Overall Study||1
6359148|NCT00670774|7268741|FG000|STARTED|Overall Study||26
6359149|NCT00670774|7268741|FG000|COMPLETED|Overall Study||26
6359150|NCT00670774|7268741|FG000|NOT COMPLETED|Overall Study||0
6359151|NCT00670800|7268747|FG000|STARTED|Overall Study||7
6359152|NCT00670800|7268748|FG001|STARTED|Overall Study||7
6359153|NCT00670800|7268747|FG000|COMPLETED|Overall Study||7
6359154|NCT00670800|7268748|FG001|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
6560190|NCT01785459|7482884|FG001|NOT COMPLETED|Overall Study||0
6560191|NCT01785472|7482893|FG000|STARTED|Overall Study||479
6560192|NCT01785472|7482894|FG001|STARTED|Overall Study||473
6560193|NCT01785472|7482895|FG002|STARTED|Overall Study||486
6359155|NCT00670800|7268747|FG000|NOT COMPLETED|Overall Study||0
6359156|NCT00670800|7268748|FG001|NOT COMPLETED|Overall Study||2
6359157|NCT00670930|7268758|FG000|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
6359158|NCT00670930|7268759|FG001|STARTED|Overall Study||13
6359159|NCT00670930|7268758|FG000|Intent to Treat (ITT) Population|Overall Study||23
6359160|NCT00670930|7268759|FG001|Intent to Treat (ITT) Population|Overall Study||12
6359161|NCT00670930|7268758|FG000|COMPLETED|Overall Study||22
6359162|NCT00670930|7268759|FG001|COMPLETED|Overall Study||12
6359163|NCT00670930|7268758|FG000|NOT COMPLETED|Overall Study||1
6359164|NCT00670930|7268759|FG001|NOT COMPLETED|Overall Study||1
6359165|NCT00670956|7268765|FG000|STARTED|Overall Study||1
6359166|NCT00670956|7268765|FG000|COMPLETED|Overall Study||1
6359167|NCT00670956|7268765|FG000|NOT COMPLETED|Overall Study||0
6359168|NCT00670982|7268771|FG000|STARTED|Overall Study||22
6359169|NCT00670982|7268772|FG001|STARTED|Overall Study||7
6359170|NCT00670982|7268771|FG000|COMPLETED|Overall Study||22
6359171|NCT00670982|7268772|FG001|COMPLETED|Overall Study||7
6359172|NCT00670982|7268771|FG000|NOT COMPLETED|Overall Study||0
6359173|NCT00670982|7268772|FG001|NOT COMPLETED|Overall Study||0
6359174|NCT00671034|7268780|FG000|STARTED|Overall Study||69
6359175|NCT00671034|7268781|FG001|STARTED|Overall Study||42
6359176|NCT00671034|7268782|FG002|STARTED|Overall Study||55
6359177|NCT00671034|7268780|FG000|COMPLETED|Overall Study||30
6359178|NCT00671034|7268781|FG001|COMPLETED|Overall Study||22
6359179|NCT00671034|7268782|FG002|COMPLETED|Overall Study||31
6359180|NCT00671034|7268780|FG000|NOT COMPLETED|Overall Study||39
6359181|NCT00671034|7268781|FG001|NOT COMPLETED|Overall Study||20
6359182|NCT00671034|7268782|FG002|NOT COMPLETED|Overall Study||24
6359183|NCT00671060|7268793|FG000|STARTED|Overall Study||77
6359184|NCT00671060|7268794|FG001|STARTED|Overall Study||76
6359185|NCT00671060|7268793|FG000|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
6359186|NCT00671060|7268794|FG001|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
6359187|NCT00671060|7268793|FG000|NOT COMPLETED|Overall Study||1
6359188|NCT00671060|7268794|FG001|NOT COMPLETED|Overall Study||1
6359189|NCT00671177|7268802|FG000|STARTED|Overall Study||114
6359190|NCT00671177|7268803|FG001|STARTED|Overall Study||115
6359191|NCT00671177|7268802|FG000|COMPLETED|Overall Study||112
6359192|NCT00671177|7268803|FG001|COMPLETED|Overall Study||114
6359193|NCT00671177|7268802|FG000|NOT COMPLETED|Overall Study||2
6359194|NCT00671177|7268803|FG001|NOT COMPLETED|Overall Study||1
6359195|NCT00671437|7268809|FG000|STARTED|Overall Study||42
6359196|NCT00671437|7268809|FG000|COMPLETED|Overall Study||27
6359197|NCT00671437|7268809|FG000|NOT COMPLETED|Overall Study||15
6359198|NCT00671502|7268824|FG000|STARTED|Overall Study||281
6359199|NCT00671502|7268825|FG001|STARTED|Overall Study||280
6359200|NCT00671502|7268826|FG002|STARTED|Overall Study||279
6359201|NCT00671502|7268824|FG000|COMPLETED|Overall Study||242
6359202|NCT00671502|7268825|FG001|COMPLETED|Overall Study||241
6359203|NCT00671502|7268826|FG002|COMPLETED|Overall Study||252
6359204|NCT00671502|7268824|FG000|NOT COMPLETED|Overall Study||39
6359205|NCT00671502|7268825|FG001|NOT COMPLETED|Overall Study||39
6359206|NCT00671502|7268826|FG002|NOT COMPLETED|Overall Study||27
6359207|NCT00671515|7268834|FG000|STARTED|Phase 1||23
6359208|NCT00671515|7268834|FG000|COMPLETED|Phase 1||20
6359209|NCT00671515|7268834|FG000|NOT COMPLETED|Phase 1||3
6359210|NCT00671515|7268834|FG000|STARTED|Phase 2||13
6359211|NCT00671515|7268834|FG000|COMPLETED|Phase 2||9
6359212|NCT00671515|7268834|FG000|NOT COMPLETED|Phase 2||4
6359213|NCT00671554|7268838|FG000|STARTED|Overall Study||3
6359214|NCT00671554|7268838|FG000|COMPLETED|Overall Study||0
6359215|NCT00671554|7268838|FG000|NOT COMPLETED|Overall Study||3
6359216|NCT00671658|7268843|FG000|STARTED|Overall Study||220
6359217|NCT00671658|7268843|FG000|COMPLETED|Overall Study||215
6359218|NCT00671658|7268843|FG000|NOT COMPLETED|Overall Study||5
6359219|NCT00671671|7268849|FG000|STARTED|Overall Study||10
6359220|NCT00671671|7268850|FG001|STARTED|Overall Study||10
6359221|NCT00671671|7268849|FG000|COMPLETED|Overall Study||10
6359222|NCT00671671|7268850|FG001|COMPLETED|Overall Study||10
6359223|NCT00671671|7268849|FG000|NOT COMPLETED|Overall Study||0
6359224|NCT00671671|7268850|FG001|NOT COMPLETED|Overall Study||0
6359225|NCT00671723|7268860|FG000|STARTED|Overall Study||11
6359226|NCT00671723|7268861|FG001|STARTED|Overall Study||11
6359227|NCT00671723|7268862|FG002|STARTED|Overall Study||11
6359228|NCT00671723|7268860|FG000|COMPLETED|Overall Study||11
6359229|NCT00671723|7268861|FG001|COMPLETED|Overall Study||11
6359230|NCT00671723|7268862|FG002|COMPLETED|Overall Study||11
6359231|NCT00671723|7268860|FG000|NOT COMPLETED|Overall Study||0
6359232|NCT00671723|7268861|FG001|NOT COMPLETED|Overall Study||0
6359233|NCT00671723|7268862|FG002|NOT COMPLETED|Overall Study||0
6359234|NCT00671749|7268870|FG000|STARTED|Overall Study||100
6359235|NCT00671749|7268870|FG000|COMPLETED|Overall Study||92
6359236|NCT00671749|7268870|FG000|NOT COMPLETED|Overall Study||8
6359237|NCT00671788|7268874|FG000|STARTED|Overall Study||35
6359238|NCT00671788|7268874|FG000|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
6359239|NCT00671788|7268874|FG000|NOT COMPLETED|Overall Study||14
6359240|NCT00671853|7268880|FG000|STARTED|Overall Study||46
6359241|NCT00671853|7268881|FG001|STARTED|Overall Study||45
6359242|NCT00671853|7268880|FG000|COMPLETED|Overall Study||26
6359243|NCT00671853|7268881|FG001|COMPLETED|Overall Study||18
6359244|NCT00671853|7268880|FG000|NOT COMPLETED|Overall Study||20
6359245|NCT00671853|7268881|FG001|NOT COMPLETED|Overall Study||27
6359246|NCT00671879|7268892|FG000|STARTED|Overall Study||281
6359247|NCT00671879|7268893|FG001|STARTED|Overall Study||279
6359248|NCT00671879|7268894|FG002|STARTED|Overall Study||280
6359249|NCT00671879|7268892|FG000|COMPLETED|Overall Study||281
6359250|NCT00671879|7268893|FG001|COMPLETED|Overall Study||275
6359251|NCT00671879|7268894|FG002|COMPLETED|Overall Study||274
6359252|NCT00671879|7268892|FG000|NOT COMPLETED|Overall Study||0
6359253|NCT00671879|7268893|FG001|NOT COMPLETED|Overall Study||4
6359254|NCT00671879|7268894|FG002|NOT COMPLETED|Overall Study||6
6359255|NCT00671918|7268903|FG000|STARTED|Overall Study||186
6359256|NCT00671918|7268903|FG000|COMPLETED|Overall Study||169
6359257|NCT00671918|7268903|FG000|NOT COMPLETED|Overall Study||17
6359258|NCT00671931|7268913|FG000|STARTED|Overall Study||9
6560194|NCT01785472|7482893|FG000|Full Analysis Set (FAS)|Overall Study||479
6560195|NCT01785472|7482894|FG001|Full Analysis Set (FAS)|Overall Study||472
6560196|NCT01785472|7482895|FG002|Full Analysis Set (FAS)|Overall Study||484
6560197|NCT01785472|7482893|FG000|Safety Set (SAF)|Overall Study||478
6560198|NCT01785472|7482894|FG001|Safety Set (SAF)|Overall Study||472
6560199|NCT01785472|7482895|FG002|Safety Set (SAF)|Overall Study||484
6560200|NCT01785472|7482893|FG000|COMPLETED|Overall Study||455
6560201|NCT01785472|7482894|FG001|COMPLETED|Overall Study||454
6560202|NCT01785472|7482895|FG002|COMPLETED|Overall Study||464
6560203|NCT01785472|7482893|FG000|NOT COMPLETED|Overall Study||24
6560204|NCT01785472|7482894|FG001|NOT COMPLETED|Overall Study||19
6560205|NCT01785472|7482895|FG002|NOT COMPLETED|Overall Study||22
6560206|NCT01785524|7482907|FG000|STARTED|Overall Study||7
6560207|NCT01785524|7482908|FG001|STARTED|Overall Study||4
6560208|NCT01785524|7482907|FG000|COMPLETED|Overall Study||5
6359259|NCT00671931|7268914|FG001|STARTED|Overall Study||8
6359260|NCT00671931|7268915|FG002|STARTED|Overall Study||9
6359261|NCT00671931|7268916|FG003|STARTED|Overall Study||10
6359262|NCT00671931|7268917|FG004|STARTED|Overall Study||8
6359263|NCT00671931|7268913|FG000|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
6359264|NCT00671931|7268914|FG001|COMPLETED|Overall Study|All completed|8
6359265|NCT00671931|7268915|FG002|COMPLETED|Overall Study|all completed|9
6359266|NCT00671931|7268916|FG003|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
6359267|NCT00671931|7268917|FG004|COMPLETED|Overall Study|Low heart rate requiring treatment|7
6359268|NCT00671931|7268913|FG000|NOT COMPLETED|Overall Study||1
6359269|NCT00671931|7268914|FG001|NOT COMPLETED|Overall Study||0
6359270|NCT00671931|7268915|FG002|NOT COMPLETED|Overall Study||0
6359271|NCT00671931|7268916|FG003|NOT COMPLETED|Overall Study||2
6359272|NCT00671931|7268917|FG004|NOT COMPLETED|Overall Study||1
6359273|NCT00671970|7268931|FG000|STARTED|Overall Study||32
6359274|NCT00671970|7268932|FG001|STARTED|Overall Study||25
6359275|NCT00671970|7268931|FG000|COMPLETED|Overall Study||32
6359276|NCT00671970|7268932|FG001|COMPLETED|Overall Study||25
6359277|NCT00671970|7268931|FG000|NOT COMPLETED|Overall Study||0
6359278|NCT00671970|7268932|FG001|NOT COMPLETED|Overall Study||0
6359279|NCT00672100|7268953|FG000|STARTED|Overall Study||12
6359280|NCT00672100|7268954|FG001|STARTED|Overall Study||12
6359281|NCT00672100|7268955|FG002|STARTED|Overall Study||12
6359282|NCT00672100|7268953|FG000|PACU (Within 8 Hours)|Overall Study||12
6359283|NCT00672100|7268954|FG001|PACU (Within 8 Hours)|Overall Study||12
6359284|NCT00672100|7268955|FG002|PACU (Within 8 Hours)|Overall Study||12
6359285|NCT00672100|7268953|FG000|COMPLETED|Overall Study||12
6359286|NCT00672100|7268954|FG001|COMPLETED|Overall Study||12
6560209|NCT01785524|7482908|FG001|COMPLETED|Overall Study||2
6560210|NCT01785524|7482907|FG000|NOT COMPLETED|Overall Study||2
6560211|NCT01785524|7482908|FG001|NOT COMPLETED|Overall Study||2
6359287|NCT00672100|7268955|FG002|COMPLETED|Overall Study||12
6359288|NCT00672100|7268953|FG000|NOT COMPLETED|Overall Study||0
6359289|NCT00672100|7268954|FG001|NOT COMPLETED|Overall Study||0
6359290|NCT00672100|7268955|FG002|NOT COMPLETED|Overall Study||0
6359291|NCT00672139|7268969|FG000|STARTED|Overall Study|Three of 60 enrolled subjects did not receive study drug.|57
6359292|NCT00672139|7268970|FG001|STARTED|Overall Study|Four of 96 enrolled subjects did not receive study drug.|92
6359293|NCT00672139|7268969|FG000|COMPLETED|Overall Study||27
6359294|NCT00672139|7268970|FG001|COMPLETED|Overall Study||47
6359295|NCT00672139|7268969|FG000|NOT COMPLETED|Overall Study||30
6359296|NCT00672139|7268970|FG001|NOT COMPLETED|Overall Study||45
6359297|NCT00672204|7268976|FG000|STARTED|Overall Study||23
6359298|NCT00672204|7268976|FG000|COMPLETED|Overall Study||3
6359299|NCT00672204|7268976|FG000|NOT COMPLETED|Overall Study||20
6359300|NCT00672243|7268980|FG000|STARTED|Overall Study||32
6359301|NCT00672243|7268980|FG000|COMPLETED|Overall Study||32
6359302|NCT00672243|7268980|FG000|NOT COMPLETED|Overall Study||0
6359303|NCT00672256|7268985|FG000|STARTED|Overall Study|January 2007|62
6359304|NCT00672256|7268985|FG000|COMPLETED|Overall Study||18
6359305|NCT00672256|7268985|FG000|NOT COMPLETED|Overall Study||44
6359306|NCT00672438|7268991|FG000|STARTED|Infusion 1||119
6359307|NCT00672438|7268992|FG001|STARTED|Infusion 1||118
6359308|NCT00672438|7268991|FG000|COMPLETED|Infusion 1||119
6359309|NCT00672438|7268992|FG001|COMPLETED|Infusion 1||118
6359310|NCT00672438|7268991|FG000|NOT COMPLETED|Infusion 1||0
6359311|NCT00672438|7268992|FG001|NOT COMPLETED|Infusion 1||0
6359312|NCT00672438|7268991|FG000|STARTED|Washout||119
6359313|NCT00672438|7268992|FG001|STARTED|Washout||118
6359314|NCT00672438|7268991|FG000|COMPLETED|Washout||119
6359315|NCT00672438|7268992|FG001|COMPLETED|Washout||118
6359316|NCT00672438|7268991|FG000|NOT COMPLETED|Washout||0
6359317|NCT00672438|7268992|FG001|NOT COMPLETED|Washout||0
6359318|NCT00672438|7268991|FG000|STARTED|Infusion 2||119
6359319|NCT00672438|7268992|FG001|STARTED|Infusion 2||118
6359320|NCT00672438|7268991|FG000|COMPLETED|Infusion 2||119
6359321|NCT00672438|7268992|FG001|COMPLETED|Infusion 2||118
6359322|NCT00672438|7268991|FG000|NOT COMPLETED|Infusion 2||0
6359323|NCT00672438|7268992|FG001|NOT COMPLETED|Infusion 2||0
6359324|NCT00672451|7269000|FG000|STARTED|Overall Study||1
6359325|NCT00672451|7269001|FG001|STARTED|Overall Study||2
6359326|NCT00672451|7269000|FG000|COMPLETED|Overall Study||1
6359327|NCT00672451|7269001|FG001|COMPLETED|Overall Study||2
6359328|NCT00672451|7269000|FG000|NOT COMPLETED|Overall Study||0
6359329|NCT00672451|7269001|FG001|NOT COMPLETED|Overall Study||0
6359330|NCT00672477|7269009|FG000|STARTED|Overall Study|120 subjects were randomized to this group, but only 116 subjects received study drug.|116
6359331|NCT00672477|7269010|FG001|STARTED|Overall Study|117 subjects were randomized to this group, but only 114 subjects received study drug.|114
6359332|NCT00672477|7269009|FG000|COMPLETED|Overall Study|One subject had missing data as reason for study termination - not counted as early termination.|89
6359333|NCT00672477|7269010|FG001|COMPLETED|Overall Study||88
6359334|NCT00672477|7269009|FG000|NOT COMPLETED|Overall Study||27
6359335|NCT00672477|7269010|FG001|NOT COMPLETED|Overall Study||26
6359336|NCT00672490|7269018|FG000|STARTED|Overall Study||187
6359337|NCT00672490|7269019|FG001|STARTED|Overall Study||189
6359338|NCT00672490|7269018|FG000|COMPLETED|Overall Study||163
6359339|NCT00672490|7269019|FG001|COMPLETED|Overall Study||157
6359340|NCT00672490|7269018|FG000|NOT COMPLETED|Overall Study||24
6359341|NCT00672490|7269019|FG001|NOT COMPLETED|Overall Study||32
6359342|NCT00672555|7269025|FG000|STARTED|Overall Study||70
6359343|NCT00672555|7269025|FG000|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
6359344|NCT00672555|7269025|FG000|NOT COMPLETED|Overall Study||6
6359345|NCT00672594|7269029|FG000|STARTED|Overall Study||30
6359346|NCT00672594|7269029|FG000|COMPLETED|Overall Study||27
6359347|NCT00672594|7269029|FG000|NOT COMPLETED|Overall Study||3
6359348|NCT00672620|7269037|FG000|STARTED|Overall Study||153
6359349|NCT00672620|7269038|FG001|STARTED|Overall Study||153
6359350|NCT00672620|7269039|FG002|STARTED|Overall Study||153
6359351|NCT00672620|7269040|FG003|STARTED|Overall Study||152
6359352|NCT00672620|7269037|FG000|Treated|Overall Study||151
6359353|NCT00672620|7269038|FG001|Treated|Overall Study||149
6359354|NCT00672620|7269039|FG002|Treated|Overall Study||153
6359355|NCT00672620|7269040|FG003|Treated|Overall Study||150
6359356|NCT00672620|7269037|FG000|COMPLETED|Overall Study||120
6359357|NCT00672620|7269038|FG001|COMPLETED|Overall Study||99
6359358|NCT00672620|7269039|FG002|COMPLETED|Overall Study||122
6359359|NCT00672620|7269040|FG003|COMPLETED|Overall Study||110
6359360|NCT00672620|7269037|FG000|NOT COMPLETED|Overall Study||33
6359361|NCT00672620|7269038|FG001|NOT COMPLETED|Overall Study||54
6359362|NCT00672620|7269039|FG002|NOT COMPLETED|Overall Study||31
6359363|NCT00672620|7269040|FG003|NOT COMPLETED|Overall Study||42
6359364|NCT00672633|7269052|FG000|STARTED|Overall Study||12
6359365|NCT00672633|7269053|FG001|STARTED|Overall Study||13
6359366|NCT00672633|7269052|FG000|COMPLETED|Overall Study||12
6359367|NCT00672633|7269053|FG001|COMPLETED|Overall Study||12
6359368|NCT00672633|7269052|FG000|NOT COMPLETED|Overall Study||0
6359369|NCT00672633|7269053|FG001|NOT COMPLETED|Overall Study||1
6359370|NCT00672646|7269062|FG000|STARTED|Overall Study||40
6359371|NCT00672646|7269063|FG001|STARTED|Overall Study||23
6359372|NCT00672646|7269064|FG002|STARTED|Overall Study||40
6359373|NCT00672646|7269062|FG000|COMPLETED|Overall Study||40
6359374|NCT00672646|7269063|FG001|COMPLETED|Overall Study||22
6359375|NCT00672646|7269064|FG002|COMPLETED|Overall Study||37
6359376|NCT00672646|7269062|FG000|NOT COMPLETED|Overall Study||0
6359377|NCT00672646|7269063|FG001|NOT COMPLETED|Overall Study||1
6359378|NCT00672646|7269064|FG002|NOT COMPLETED|Overall Study||3
6359379|NCT00672737|7269072|FG000|STARTED|Overall Study||56
6359380|NCT00672737|7269072|FG000|COMPLETED|Overall Study||48
6359381|NCT00672737|7269072|FG000|NOT COMPLETED|Overall Study||8
6359382|NCT00672841|7269079|FG000|STARTED|Overall Study||17
6359383|NCT00672841|7269080|FG001|STARTED|Overall Study||47
6359384|NCT00672841|7269079|FG000|COMPLETED|Overall Study||16
6359385|NCT00672841|7269080|FG001|COMPLETED|Overall Study||32
6359386|NCT00672841|7269079|FG000|NOT COMPLETED|Overall Study||1
6359387|NCT00672841|7269080|FG001|NOT COMPLETED|Overall Study||15
6359388|NCT00672854|7269091|FG000|STARTED|Overall Study||49
6359389|NCT00672854|7269092|FG001|STARTED|Overall Study||51
6359390|NCT00672854|7269091|FG000|COMPLETED|Overall Study||49
6359391|NCT00672854|7269092|FG001|COMPLETED|Overall Study||51
6359392|NCT00672854|7269091|FG000|NOT COMPLETED|Overall Study||0
6359393|NCT00672854|7269092|FG001|NOT COMPLETED|Overall Study||0
6359394|NCT00672932|7269102|FG000|STARTED|Overall Study||9
6359395|NCT00672932|7269103|FG001|STARTED|Overall Study||9
6359396|NCT00672932|7269102|FG000|Completed Initial 12-week Assignment|Overall Study||9
6359397|NCT00672932|7269103|FG001|Completed Initial 12-week Assignment|Overall Study||9
6359398|NCT00672932|7269102|FG000|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
6359399|NCT00672932|7269103|FG001|Provided Analyzable Blood and CSF Sample|Overall Study||9
6359400|NCT00672932|7269102|FG000|Rolled Over to Raltegravir|Overall Study||0
6359401|NCT00672932|7269103|FG001|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
6359402|NCT00672932|7269102|FG000|COMPLETED|Overall Study||9
6359403|NCT00672932|7269103|FG001|COMPLETED|Overall Study||9
6359404|NCT00672932|7269102|FG000|NOT COMPLETED|Overall Study||0
6359405|NCT00672932|7269103|FG001|NOT COMPLETED|Overall Study||0
6359406|NCT00672958|7269111|FG000|STARTED|Overall Study||300
6359407|NCT00672958|7269112|FG001|STARTED|Overall Study||300
6359408|NCT00672958|7269111|FG000|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
6359409|NCT00672958|7269112|FG001|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
6359410|NCT00672958|7269111|FG000|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
6359411|NCT00672958|7269112|FG001|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
6359412|NCT00672958|7269111|FG000|COMPLETED|Overall Study||236
6359413|NCT00672958|7269112|FG001|COMPLETED|Overall Study||244
6359414|NCT00672958|7269111|FG000|NOT COMPLETED|Overall Study||64
6359415|NCT00672958|7269112|FG001|NOT COMPLETED|Overall Study||56
6359416|NCT00672984|7269121|FG000|STARTED|First Intervention||31
6359417|NCT00672984|7269122|FG001|STARTED|First Intervention||25
6359418|NCT00672984|7269123|FG002|STARTED|First Intervention||27
6359419|NCT00672984|7269121|FG000|COMPLETED|First Intervention||22
6359420|NCT00672984|7269122|FG001|COMPLETED|First Intervention||23
6359421|NCT00672984|7269123|FG002|COMPLETED|First Intervention||25
6359422|NCT00672984|7269121|FG000|NOT COMPLETED|First Intervention||9
6359423|NCT00672984|7269122|FG001|NOT COMPLETED|First Intervention||2
6359424|NCT00672984|7269123|FG002|NOT COMPLETED|First Intervention||2
6359425|NCT00672984|7269121|FG000|STARTED|Second Intervention||22
6359426|NCT00672984|7269122|FG001|STARTED|Second Intervention||23
6359427|NCT00672984|7269123|FG002|STARTED|Second Intervention||25
6359428|NCT00672984|7269121|FG000|COMPLETED|Second Intervention||22
6776637|NCT03834168|7704704|FG001|NOT COMPLETED|Overall Study||1
6776638|NCT03828149|7704712|FG000|STARTED|First Intervention (Single Dose)||9
6776639|NCT03828149|7704713|FG001|STARTED|First Intervention (Single Dose)||8
6776640|NCT03828149|7704712|FG000|COMPLETED|First Intervention (Single Dose)||9
6776641|NCT03828149|7704713|FG001|COMPLETED|First Intervention (Single Dose)||8
6776642|NCT03828149|7704712|FG000|NOT COMPLETED|First Intervention (Single Dose)||0
6776643|NCT03828149|7704713|FG001|NOT COMPLETED|First Intervention (Single Dose)||0
6776644|NCT03828149|7704712|FG000|STARTED|Washout (6 Days)||9
6776645|NCT03828149|7704713|FG001|STARTED|Washout (6 Days)||8
6776646|NCT03828149|7704712|FG000|COMPLETED|Washout (6 Days)||9
6776647|NCT03828149|7704713|FG001|COMPLETED|Washout (6 Days)||8
6776648|NCT03828149|7704712|FG000|NOT COMPLETED|Washout (6 Days)||0
6776649|NCT03828149|7704713|FG001|NOT COMPLETED|Washout (6 Days)||0
6776650|NCT03828149|7704712|FG000|STARTED|Second Intervention (Single Dose)||9
6776651|NCT03828149|7704713|FG001|STARTED|Second Intervention (Single Dose)||8
6776652|NCT03828149|7704712|FG000|COMPLETED|Second Intervention (Single Dose)||9
6776653|NCT03828149|7704713|FG001|COMPLETED|Second Intervention (Single Dose)||8
6776654|NCT03828149|7704712|FG000|NOT COMPLETED|Second Intervention (Single Dose)||0
6776655|NCT03828149|7704713|FG001|NOT COMPLETED|Second Intervention (Single Dose)||0
6776656|NCT03835221|7704719|FG000|STARTED|Methafilcon A||43
6776657|NCT03835221|7704719|FG000|COMPLETED|Methafilcon A||42
6776658|NCT03835221|7704719|FG000|NOT COMPLETED|Methafilcon A||1
6776659|NCT03835221|7704719|FG000|STARTED|Fanfilcon A||42
6776660|NCT03835221|7704719|FG000|COMPLETED|Fanfilcon A||42
6776661|NCT03835221|7704719|FG000|NOT COMPLETED|Fanfilcon A||0
6776662|NCT03819634|7704725|FG000|STARTED|Overall Study||24
6776663|NCT03819634|7704725|FG000|COMPLETED|Overall Study||22
6776664|NCT03819634|7704725|FG000|NOT COMPLETED|Overall Study||2
6776665|NCT03812679|7704729|FG000|STARTED|Overall Study||22
6359429|NCT00672984|7269122|FG001|COMPLETED|Second Intervention||17
6359430|NCT00672984|7269123|FG002|COMPLETED|Second Intervention||24
6359431|NCT00672984|7269121|FG000|NOT COMPLETED|Second Intervention||0
6359432|NCT00672984|7269122|FG001|NOT COMPLETED|Second Intervention||6
6359433|NCT00672984|7269123|FG002|NOT COMPLETED|Second Intervention||1
6359434|NCT00672984|7269121|FG000|STARTED|Third Intervention||22
6359435|NCT00672984|7269122|FG001|STARTED|Third Intervention||17
6359436|NCT00672984|7269123|FG002|STARTED|Third Intervention||24
6359437|NCT00672984|7269121|FG000|COMPLETED|Third Intervention||21
6359438|NCT00672984|7269122|FG001|COMPLETED|Third Intervention||17
6359439|NCT00672984|7269123|FG002|COMPLETED|Third Intervention||23
6359440|NCT00672984|7269121|FG000|NOT COMPLETED|Third Intervention||1
6359441|NCT00672984|7269122|FG001|NOT COMPLETED|Third Intervention||0
6359442|NCT00672984|7269123|FG002|NOT COMPLETED|Third Intervention||1
6359443|NCT00673049|7269135|FG000|STARTED|Before Progression on Erlotinib||292
6359444|NCT00673049|7269136|FG001|STARTED|Before Progression on Erlotinib||290
6359445|NCT00673049|7269137|FG002|STARTED|Before Progression on Erlotinib||1
6359446|NCT00673049|7269138|FG003|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
6359447|NCT00673049|7269135|FG000|Treated|Before Progression on Erlotinib||289
6359448|NCT00673049|7269136|FG001|Treated|Before Progression on Erlotinib||289
6359449|NCT00673049|7269137|FG002|Treated|Before Progression on Erlotinib||1
6359450|NCT00673049|7269138|FG003|Treated|Before Progression on Erlotinib||0
6359451|NCT00673049|7269135|FG000|COMPLETED|Before Progression on Erlotinib||0
6359452|NCT00673049|7269136|FG001|COMPLETED|Before Progression on Erlotinib||0
6359453|NCT00673049|7269137|FG002|COMPLETED|Before Progression on Erlotinib||0
6359454|NCT00673049|7269138|FG003|COMPLETED|Before Progression on Erlotinib||0
6359455|NCT00673049|7269135|FG000|NOT COMPLETED|Before Progression on Erlotinib||292
6359456|NCT00673049|7269136|FG001|NOT COMPLETED|Before Progression on Erlotinib||290
6359457|NCT00673049|7269137|FG002|NOT COMPLETED|Before Progression on Erlotinib||1
6359458|NCT00673049|7269138|FG003|NOT COMPLETED|Before Progression on Erlotinib||0
6359459|NCT00673049|7269135|FG000|STARTED|After Progression on Erlotinib||0
6359460|NCT00673049|7269136|FG001|STARTED|After Progression on Erlotinib||0
6359461|NCT00673049|7269137|FG002|STARTED|After Progression on Erlotinib||0
6359462|NCT00673049|7269138|FG003|STARTED|After Progression on Erlotinib||83
6359463|NCT00673049|7269135|FG000|COMPLETED|After Progression on Erlotinib||0
6359464|NCT00673049|7269136|FG001|COMPLETED|After Progression on Erlotinib||0
6359465|NCT00673049|7269137|FG002|COMPLETED|After Progression on Erlotinib||0
6359466|NCT00673049|7269138|FG003|COMPLETED|After Progression on Erlotinib||0
6359467|NCT00673049|7269135|FG000|NOT COMPLETED|After Progression on Erlotinib||0
6359468|NCT00673049|7269136|FG001|NOT COMPLETED|After Progression on Erlotinib||0
6359469|NCT00673049|7269137|FG002|NOT COMPLETED|After Progression on Erlotinib||0
6359470|NCT00673049|7269138|FG003|NOT COMPLETED|After Progression on Erlotinib||83
6359471|NCT00673075|7269148|FG000|STARTED|Overall Study||21
6359472|NCT00673075|7269149|FG001|STARTED|Overall Study||18
6359473|NCT00673075|7269148|FG000|COMPLETED|Overall Study||12
6359474|NCT00673075|7269149|FG001|COMPLETED|Overall Study||11
6359475|NCT00673075|7269148|FG000|NOT COMPLETED|Overall Study||9
6359476|NCT00673075|7269149|FG001|NOT COMPLETED|Overall Study||7
6359477|NCT00673114|7269157|FG000|STARTED|Overall Study||3
6359478|NCT00673114|7269157|FG000|COMPLETED|Overall Study||3
6359479|NCT00673114|7269157|FG000|NOT COMPLETED|Overall Study||0
6359480|NCT00673127|7269161|FG000|STARTED|Overall Study||57
6359481|NCT00673127|7269161|FG000|COMPLETED|Overall Study||57
6359482|NCT00673127|7269161|FG000|NOT COMPLETED|Overall Study||0
6359483|NCT00673153|7269166|FG000|STARTED|Overall Study||31
6359484|NCT00673153|7269166|FG000|COMPLETED|Overall Study||30
6359485|NCT00673153|7269166|FG000|NOT COMPLETED|Overall Study||1
6359486|NCT00673231|7269174|FG000|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
6359487|NCT00673231|7269175|FG001|STARTED|Overall Study|All 202 were included in the full analysis set|202
6359488|NCT00673231|7269176|FG002|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
6359489|NCT00673231|7269177|FG003|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
6359490|NCT00673231|7269174|FG000|COMPLETED|Overall Study||168
6359491|NCT00673231|7269175|FG001|COMPLETED|Overall Study||180
6359492|NCT00673231|7269176|FG002|COMPLETED|Overall Study||186
6359493|NCT00673231|7269177|FG003|COMPLETED|Overall Study||178
6359494|NCT00673231|7269174|FG000|NOT COMPLETED|Overall Study||29
6359495|NCT00673231|7269175|FG001|NOT COMPLETED|Overall Study||22
6359496|NCT00673231|7269176|FG002|NOT COMPLETED|Overall Study||26
6359497|NCT00673231|7269177|FG003|NOT COMPLETED|Overall Study||18
6359498|NCT00673244|7269189|FG000|STARTED|Overall Study||52
6359499|NCT00673244|7269190|FG001|STARTED|Overall Study||25
6359500|NCT00673244|7269189|FG000|COMPLETED|Overall Study||52
6359501|NCT00673244|7269190|FG001|COMPLETED|Overall Study||25
6359502|NCT00673244|7269189|FG000|NOT COMPLETED|Overall Study||0
6359503|NCT00673244|7269190|FG001|NOT COMPLETED|Overall Study||0
6359504|NCT00673257|7269196|FG000|STARTED|Overall Study||107
6359505|NCT00673257|7269196|FG000|COMPLETED|Overall Study||102
6359506|NCT00673257|7269196|FG000|NOT COMPLETED|Overall Study||5
6359507|NCT00673387|7269208|FG000|STARTED|Overall Study||75
6359508|NCT00673387|7269209|FG001|STARTED|Overall Study||77
6359509|NCT00673387|7269210|FG002|STARTED|Overall Study||72
6359510|NCT00673387|7269211|FG003|STARTED|Overall Study||75
6359511|NCT00673387|7269212|FG004|STARTED|Overall Study||78
6359512|NCT00673387|7269213|FG005|STARTED|Overall Study||78
6359513|NCT00673387|7269214|FG006|STARTED|Overall Study||78
6359514|NCT00673387|7269215|FG007|STARTED|Overall Study||75
6359515|NCT00673387|7269208|FG000|COMPLETED|Overall Study||46
6359516|NCT00673387|7269209|FG001|COMPLETED|Overall Study||54
6359517|NCT00673387|7269210|FG002|COMPLETED|Overall Study||41
6359518|NCT00673387|7269211|FG003|COMPLETED|Overall Study||49
6359519|NCT00673387|7269212|FG004|COMPLETED|Overall Study||48
6359520|NCT00673387|7269213|FG005|COMPLETED|Overall Study||44
6359521|NCT00673387|7269214|FG006|COMPLETED|Overall Study||48
6359522|NCT00673387|7269215|FG007|COMPLETED|Overall Study||40
6359523|NCT00673387|7269208|FG000|NOT COMPLETED|Overall Study||29
6359524|NCT00673387|7269209|FG001|NOT COMPLETED|Overall Study||23
6359525|NCT00673387|7269210|FG002|NOT COMPLETED|Overall Study||31
6359526|NCT00673387|7269211|FG003|NOT COMPLETED|Overall Study||26
6359527|NCT00673387|7269212|FG004|NOT COMPLETED|Overall Study||30
6359528|NCT00673387|7269213|FG005|NOT COMPLETED|Overall Study||34
6359529|NCT00673387|7269214|FG006|NOT COMPLETED|Overall Study||30
6359530|NCT00673387|7269215|FG007|NOT COMPLETED|Overall Study||35
6359531|NCT00673400|7269243|FG000|STARTED|Overall Study||52
6359532|NCT00673400|7269243|FG000|COMPLETED|Overall Study||52
6359533|NCT00673400|7269243|FG000|NOT COMPLETED|Overall Study||0
6359534|NCT00673439|7269253|FG000|STARTED|Overall Study||3
6359535|NCT00673439|7269253|FG000|COMPLETED|Overall Study||3
6359536|NCT00673439|7269253|FG000|NOT COMPLETED|Overall Study||0
6359537|NCT00673452|7269260|FG000|STARTED|Acute Double-Blind Phase||263
6359538|NCT00673452|7269261|FG001|STARTED|Acute Double-Blind Phase||267
6359539|NCT00673452|7269260|FG000|COMPLETED|Acute Double-Blind Phase||176
6359540|NCT00673452|7269261|FG001|COMPLETED|Acute Double-Blind Phase||187
6359541|NCT00673452|7269260|FG000|NOT COMPLETED|Acute Double-Blind Phase||87
6359542|NCT00673452|7269261|FG001|NOT COMPLETED|Acute Double-Blind Phase||80
6359543|NCT00673452|7269260|FG000|STARTED|Continuation Double-Blind Phase||176
6359544|NCT00673452|7269261|FG001|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
6359545|NCT00673452|7269260|FG000|COMPLETED|Continuation Double-Blind Phase||151
6359546|NCT00673452|7269261|FG001|COMPLETED|Continuation Double-Blind Phase||153
6359547|NCT00673452|7269260|FG000|NOT COMPLETED|Continuation Double-Blind Phase||25
6359548|NCT00673452|7269261|FG001|NOT COMPLETED|Continuation Double-Blind Phase||34
6359549|NCT00673465|7269267|FG000|STARTED|Part 1/Period 1 (United States)||3
6359550|NCT00673465|7269268|FG001|STARTED|Part 1/Period 1 (United States)||3
6359551|NCT00673465|7269269|FG002|STARTED|Part 1/Period 1 (United States)||3
6359552|NCT00673465|7269270|FG003|STARTED|Part 1/Period 1 (United States)||3
6359553|NCT00673465|7269271|FG004|STARTED|Part 1/Period 1 (United States)||3
6359554|NCT00673465|7269272|FG005|STARTED|Part 1/Period 1 (United States)||2
6359555|NCT00673465|7269273|FG006|STARTED|Part 1/Period 1 (United States)||0
6359556|NCT00673465|7269274|FG007|STARTED|Part 1/Period 1 (United States)||0
6359557|NCT00673465|7269275|FG008|STARTED|Part 1/Period 1 (United States)||0
6359558|NCT00673465|7269276|FG009|STARTED|Part 1/Period 1 (United States)||0
6359559|NCT00673465|7269277|FG010|STARTED|Part 1/Period 1 (United States)||0
6359560|NCT00673465|7269278|FG011|STARTED|Part 1/Period 1 (United States)||0
6359561|NCT00673465|7269267|FG000|COMPLETED|Part 1/Period 1 (United States)||3
6359562|NCT00673465|7269268|FG001|COMPLETED|Part 1/Period 1 (United States)||3
6359563|NCT00673465|7269269|FG002|COMPLETED|Part 1/Period 1 (United States)||3
6776666|NCT03812679|7704729|FG000|COMPLETED|Overall Study||14
6776667|NCT03812679|7704729|FG000|NOT COMPLETED|Overall Study||8
6776668|NCT03809052|7704744|FG000|STARTED|Overall Study||6
6776669|NCT03809052|7704745|FG001|STARTED|Overall Study||6
6776670|NCT03809052|7704746|FG002|STARTED|Overall Study||6
6776671|NCT03809052|7704747|FG003|STARTED|Overall Study||6
6776672|NCT03809052|7704748|FG004|STARTED|Overall Study||6
6776673|NCT03809052|7704749|FG005|STARTED|Overall Study||6
6776674|NCT03809052|7704750|FG006|STARTED|Overall Study||6
6776675|NCT03809052|7704751|FG007|STARTED|Overall Study||14
6776676|NCT03809052|7704752|FG008|STARTED|Overall Study||8
6776677|NCT03809052|7704753|FG009|STARTED|Overall Study||8
6776678|NCT03809052|7704754|FG010|STARTED|Overall Study||6
6776679|NCT03809052|7704744|FG000|COMPLETED|Overall Study||6
6776680|NCT03809052|7704745|FG001|COMPLETED|Overall Study||6
6776681|NCT03809052|7704746|FG002|COMPLETED|Overall Study||6
6776682|NCT03809052|7704747|FG003|COMPLETED|Overall Study||6
6776683|NCT03809052|7704748|FG004|COMPLETED|Overall Study||6
6776684|NCT03809052|7704749|FG005|COMPLETED|Overall Study||6
6776685|NCT03809052|7704750|FG006|COMPLETED|Overall Study||6
6776686|NCT03809052|7704751|FG007|COMPLETED|Overall Study||14
6776687|NCT03809052|7704752|FG008|COMPLETED|Overall Study||8
6776688|NCT03809052|7704753|FG009|COMPLETED|Overall Study||8
6776689|NCT03809052|7704754|FG010|COMPLETED|Overall Study||6
6776690|NCT03809052|7704744|FG000|NOT COMPLETED|Overall Study||0
6776691|NCT03809052|7704745|FG001|NOT COMPLETED|Overall Study||0
6776692|NCT03809052|7704746|FG002|NOT COMPLETED|Overall Study||0
6776693|NCT03809052|7704747|FG003|NOT COMPLETED|Overall Study||0
6359564|NCT00673465|7269270|FG003|COMPLETED|Part 1/Period 1 (United States)||3
6359565|NCT00673465|7269271|FG004|COMPLETED|Part 1/Period 1 (United States)||2
6359566|NCT00673465|7269272|FG005|COMPLETED|Part 1/Period 1 (United States)||1
6359567|NCT00673465|7269273|FG006|COMPLETED|Part 1/Period 1 (United States)||0
6359568|NCT00673465|7269274|FG007|COMPLETED|Part 1/Period 1 (United States)||0
6359569|NCT00673465|7269275|FG008|COMPLETED|Part 1/Period 1 (United States)||0
6359570|NCT00673465|7269276|FG009|COMPLETED|Part 1/Period 1 (United States)||0
6359571|NCT00673465|7269277|FG010|COMPLETED|Part 1/Period 1 (United States)||0
6359572|NCT00673465|7269278|FG011|COMPLETED|Part 1/Period 1 (United States)||0
6359573|NCT00673465|7269267|FG000|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359574|NCT00673465|7269268|FG001|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359575|NCT00673465|7269269|FG002|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359576|NCT00673465|7269270|FG003|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359577|NCT00673465|7269271|FG004|NOT COMPLETED|Part 1/Period 1 (United States)||1
6359578|NCT00673465|7269272|FG005|NOT COMPLETED|Part 1/Period 1 (United States)||1
6359579|NCT00673465|7269273|FG006|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359580|NCT00673465|7269274|FG007|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359581|NCT00673465|7269275|FG008|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359582|NCT00673465|7269276|FG009|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359583|NCT00673465|7269277|FG010|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359584|NCT00673465|7269278|FG011|NOT COMPLETED|Part 1/Period 1 (United States)||0
6359585|NCT00673465|7269267|FG000|STARTED|Part 1/Period 2 (United States)||3
6359586|NCT00673465|7269268|FG001|STARTED|Part 1/Period 2 (United States)||3
6359587|NCT00673465|7269269|FG002|STARTED|Part 1/Period 2 (United States)||3
6359588|NCT00673465|7269270|FG003|STARTED|Part 1/Period 2 (United States)||3
6359589|NCT00673465|7269271|FG004|STARTED|Part 1/Period 2 (United States)||2
6359590|NCT00673465|7269272|FG005|STARTED|Part 1/Period 2 (United States)||1
6359591|NCT00673465|7269273|FG006|STARTED|Part 1/Period 2 (United States)||0
6359592|NCT00673465|7269274|FG007|STARTED|Part 1/Period 2 (United States)||0
6359593|NCT00673465|7269275|FG008|STARTED|Part 1/Period 2 (United States)||0
6359594|NCT00673465|7269276|FG009|STARTED|Part 1/Period 2 (United States)||0
6359595|NCT00673465|7269277|FG010|STARTED|Part 1/Period 2 (United States)||0
6359596|NCT00673465|7269278|FG011|STARTED|Part 1/Period 2 (United States)||0
6359597|NCT00673465|7269267|FG000|COMPLETED|Part 1/Period 2 (United States)||3
6359598|NCT00673465|7269268|FG001|COMPLETED|Part 1/Period 2 (United States)||3
6359599|NCT00673465|7269269|FG002|COMPLETED|Part 1/Period 2 (United States)||3
6359600|NCT00673465|7269270|FG003|COMPLETED|Part 1/Period 2 (United States)||3
6359601|NCT00673465|7269271|FG004|COMPLETED|Part 1/Period 2 (United States)||1
6359602|NCT00673465|7269272|FG005|COMPLETED|Part 1/Period 2 (United States)||1
6359603|NCT00673465|7269273|FG006|COMPLETED|Part 1/Period 2 (United States)||0
6359604|NCT00673465|7269274|FG007|COMPLETED|Part 1/Period 2 (United States)||0
6359605|NCT00673465|7269275|FG008|COMPLETED|Part 1/Period 2 (United States)||0
6359606|NCT00673465|7269276|FG009|COMPLETED|Part 1/Period 2 (United States)||0
6359607|NCT00673465|7269277|FG010|COMPLETED|Part 1/Period 2 (United States)||0
6359608|NCT00673465|7269278|FG011|COMPLETED|Part 1/Period 2 (United States)||0
6359609|NCT00673465|7269267|FG000|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359610|NCT00673465|7269268|FG001|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359611|NCT00673465|7269269|FG002|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359612|NCT00673465|7269270|FG003|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359613|NCT00673465|7269271|FG004|NOT COMPLETED|Part 1/Period 2 (United States)||1
6359614|NCT00673465|7269272|FG005|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359615|NCT00673465|7269273|FG006|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359616|NCT00673465|7269274|FG007|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359617|NCT00673465|7269275|FG008|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359618|NCT00673465|7269276|FG009|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359619|NCT00673465|7269277|FG010|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359620|NCT00673465|7269278|FG011|NOT COMPLETED|Part 1/Period 2 (United States)||0
6359621|NCT00673465|7269267|FG000|STARTED|Part 1/Period 3 (United States)||3
6359622|NCT00673465|7269268|FG001|STARTED|Part 1/Period 3 (United States)||3
6359623|NCT00673465|7269269|FG002|STARTED|Part 1/Period 3 (United States)||3
6359624|NCT00673465|7269270|FG003|STARTED|Part 1/Period 3 (United States)||3
6359625|NCT00673465|7269271|FG004|STARTED|Part 1/Period 3 (United States)||1
6359626|NCT00673465|7269272|FG005|STARTED|Part 1/Period 3 (United States)||1
6359627|NCT00673465|7269273|FG006|STARTED|Part 1/Period 3 (United States)||0
6359628|NCT00673465|7269274|FG007|STARTED|Part 1/Period 3 (United States)||0
6359629|NCT00673465|7269275|FG008|STARTED|Part 1/Period 3 (United States)||0
6359630|NCT00673465|7269276|FG009|STARTED|Part 1/Period 3 (United States)||0
6359631|NCT00673465|7269277|FG010|STARTED|Part 1/Period 3 (United States)||0
6359632|NCT00673465|7269278|FG011|STARTED|Part 1/Period 3 (United States)||0
6359633|NCT00673465|7269267|FG000|COMPLETED|Part 1/Period 3 (United States)||3
6359634|NCT00673465|7269268|FG001|COMPLETED|Part 1/Period 3 (United States)||3
6359635|NCT00673465|7269269|FG002|COMPLETED|Part 1/Period 3 (United States)||3
6359636|NCT00673465|7269270|FG003|COMPLETED|Part 1/Period 3 (United States)||3
6359637|NCT00673465|7269271|FG004|COMPLETED|Part 1/Period 3 (United States)||1
6359638|NCT00673465|7269272|FG005|COMPLETED|Part 1/Period 3 (United States)||1
6359639|NCT00673465|7269273|FG006|COMPLETED|Part 1/Period 3 (United States)||0
6359640|NCT00673465|7269274|FG007|COMPLETED|Part 1/Period 3 (United States)||0
6359641|NCT00673465|7269275|FG008|COMPLETED|Part 1/Period 3 (United States)||0
6359642|NCT00673465|7269276|FG009|COMPLETED|Part 1/Period 3 (United States)||0
6359643|NCT00673465|7269277|FG010|COMPLETED|Part 1/Period 3 (United States)||0
6359644|NCT00673465|7269278|FG011|COMPLETED|Part 1/Period 3 (United States)||0
6359645|NCT00673465|7269267|FG000|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359646|NCT00673465|7269268|FG001|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359647|NCT00673465|7269269|FG002|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359648|NCT00673465|7269270|FG003|NOT COMPLETED|Part 1/Period 3 (United States)||0
6776694|NCT03809052|7704748|FG004|NOT COMPLETED|Overall Study||0
6776695|NCT03809052|7704749|FG005|NOT COMPLETED|Overall Study||0
6776696|NCT03809052|7704750|FG006|NOT COMPLETED|Overall Study||0
6776697|NCT03809052|7704751|FG007|NOT COMPLETED|Overall Study||0
6776698|NCT03809052|7704752|FG008|NOT COMPLETED|Overall Study||0
6776699|NCT03809052|7704753|FG009|NOT COMPLETED|Overall Study||0
6776700|NCT03809052|7704754|FG010|NOT COMPLETED|Overall Study||0
6776701|NCT03801148|7704784|FG000|STARTED|Period 1 (2 Days)||31
6776702|NCT03801148|7704785|FG001|STARTED|Period 1 (2 Days)||31
6776703|NCT03801148|7704786|FG002|STARTED|Period 1 (2 Days)||30
6776704|NCT03801148|7704787|FG003|STARTED|Period 1 (2 Days)||30
6776705|NCT03801148|7704784|FG000|COMPLETED|Period 1 (2 Days)||30
6776706|NCT03801148|7704785|FG001|COMPLETED|Period 1 (2 Days)||30
6359649|NCT00673465|7269271|FG004|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359650|NCT00673465|7269272|FG005|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359651|NCT00673465|7269273|FG006|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359652|NCT00673465|7269274|FG007|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359653|NCT00673465|7269275|FG008|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359654|NCT00673465|7269276|FG009|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359655|NCT00673465|7269277|FG010|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359656|NCT00673465|7269278|FG011|NOT COMPLETED|Part 1/Period 3 (United States)||0
6359657|NCT00673465|7269267|FG000|STARTED|Part 2 (India)||0
6359658|NCT00673465|7269268|FG001|STARTED|Part 2 (India)||0
6359659|NCT00673465|7269269|FG002|STARTED|Part 2 (India)||0
6359660|NCT00673465|7269270|FG003|STARTED|Part 2 (India)||0
6359661|NCT00673465|7269271|FG004|STARTED|Part 2 (India)||0
6359662|NCT00673465|7269272|FG005|STARTED|Part 2 (India)||0
6359663|NCT00673465|7269273|FG006|STARTED|Part 2 (India)||0
6359664|NCT00673465|7269274|FG007|STARTED|Part 2 (India)||0
6359665|NCT00673465|7269275|FG008|STARTED|Part 2 (India)||0
6359666|NCT00673465|7269276|FG009|STARTED|Part 2 (India)||0
6359667|NCT00673465|7269277|FG010|STARTED|Part 2 (India)||0
6359668|NCT00673465|7269278|FG011|STARTED|Part 2 (India)||0
6359669|NCT00673465|7269267|FG000|COMPLETED|Part 2 (India)||0
6359670|NCT00673465|7269268|FG001|COMPLETED|Part 2 (India)||0
6359671|NCT00673465|7269269|FG002|COMPLETED|Part 2 (India)||0
6359672|NCT00673465|7269270|FG003|COMPLETED|Part 2 (India)||0
6359673|NCT00673465|7269271|FG004|COMPLETED|Part 2 (India)||0
6359674|NCT00673465|7269272|FG005|COMPLETED|Part 2 (India)||0
6359675|NCT00673465|7269273|FG006|COMPLETED|Part 2 (India)||0
6359676|NCT00673465|7269274|FG007|COMPLETED|Part 2 (India)||0
6359677|NCT00673465|7269275|FG008|COMPLETED|Part 2 (India)||0
6359678|NCT00673465|7269276|FG009|COMPLETED|Part 2 (India)||0
6359679|NCT00673465|7269277|FG010|COMPLETED|Part 2 (India)||0
6359680|NCT00673465|7269278|FG011|COMPLETED|Part 2 (India)||0
6359681|NCT00673465|7269267|FG000|NOT COMPLETED|Part 2 (India)||0
6359682|NCT00673465|7269268|FG001|NOT COMPLETED|Part 2 (India)||0
6359683|NCT00673465|7269269|FG002|NOT COMPLETED|Part 2 (India)||0
6359684|NCT00673465|7269270|FG003|NOT COMPLETED|Part 2 (India)||0
6776707|NCT03801148|7704786|FG002|COMPLETED|Period 1 (2 Days)||30
6776708|NCT03801148|7704787|FG003|COMPLETED|Period 1 (2 Days)||30
6776709|NCT03801148|7704784|FG000|NOT COMPLETED|Period 1 (2 Days)||1
6776710|NCT03801148|7704785|FG001|NOT COMPLETED|Period 1 (2 Days)||1
6776711|NCT03801148|7704786|FG002|NOT COMPLETED|Period 1 (2 Days)||0
6776712|NCT03801148|7704787|FG003|NOT COMPLETED|Period 1 (2 Days)||0
6776713|NCT03801148|7704784|FG000|STARTED|Washout Period (at Least 5 Days)||30
6776714|NCT03801148|7704785|FG001|STARTED|Washout Period (at Least 5 Days)||30
6776715|NCT03801148|7704786|FG002|STARTED|Washout Period (at Least 5 Days)||30
6776716|NCT03801148|7704787|FG003|STARTED|Washout Period (at Least 5 Days)||30
6776717|NCT03801148|7704784|FG000|COMPLETED|Washout Period (at Least 5 Days)||30
6776718|NCT03801148|7704785|FG001|COMPLETED|Washout Period (at Least 5 Days)||30
6776719|NCT03801148|7704786|FG002|COMPLETED|Washout Period (at Least 5 Days)||29
6776720|NCT03801148|7704787|FG003|COMPLETED|Washout Period (at Least 5 Days)||29
6776721|NCT03801148|7704784|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||0
6776722|NCT03801148|7704785|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||0
6776723|NCT03801148|7704786|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||1
6776724|NCT03801148|7704787|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||1
6776725|NCT03801148|7704784|FG000|STARTED|Period 2 (2 Days)||30
6776726|NCT03801148|7704785|FG001|STARTED|Period 2 (2 Days)||30
6776727|NCT03801148|7704786|FG002|STARTED|Period 2 (2 Days)||29
6776728|NCT03801148|7704787|FG003|STARTED|Period 2 (2 Days)||29
6776729|NCT03801148|7704784|FG000|COMPLETED|Period 2 (2 Days)||30
6776730|NCT03801148|7704785|FG001|COMPLETED|Period 2 (2 Days)||30
6776731|NCT03801148|7704786|FG002|COMPLETED|Period 2 (2 Days)||29
6776732|NCT03801148|7704787|FG003|COMPLETED|Period 2 (2 Days)||29
6776733|NCT03801148|7704784|FG000|NOT COMPLETED|Period 2 (2 Days)||0
6776734|NCT03801148|7704785|FG001|NOT COMPLETED|Period 2 (2 Days)||0
6776735|NCT03801148|7704786|FG002|NOT COMPLETED|Period 2 (2 Days)||0
6359685|NCT00673465|7269271|FG004|NOT COMPLETED|Part 2 (India)||0
6359686|NCT00673465|7269272|FG005|NOT COMPLETED|Part 2 (India)||0
6359687|NCT00673465|7269273|FG006|NOT COMPLETED|Part 2 (India)||0
6359688|NCT00673465|7269274|FG007|NOT COMPLETED|Part 2 (India)||0
6359689|NCT00673465|7269275|FG008|NOT COMPLETED|Part 2 (India)||0
6359690|NCT00673465|7269276|FG009|NOT COMPLETED|Part 2 (India)||0
6359691|NCT00673465|7269277|FG010|NOT COMPLETED|Part 2 (India)||0
6359692|NCT00673465|7269278|FG011|NOT COMPLETED|Part 2 (India)||0
6359693|NCT00673660|7269286|FG000|STARTED|Overall Study||375
6359694|NCT00673660|7269286|FG000|COMPLETED|Overall Study||268
6359695|NCT00673660|7269286|FG000|NOT COMPLETED|Overall Study||107
6359696|NCT00673673|7269295|FG000|STARTED|Overall Study||39
6359697|NCT00673673|7269295|FG000|COMPLETED|Overall Study||3
6359698|NCT00673673|7269295|FG000|NOT COMPLETED|Overall Study||36
6359699|NCT00673712|7269301|FG000|STARTED|Overall Study||321
6359700|NCT00673712|7269302|FG001|STARTED|Overall Study||326
6359701|NCT00673712|7269301|FG000|COMPLETED|Overall Study||321
6359702|NCT00673712|7269302|FG001|COMPLETED|Overall Study||326
6359703|NCT00673712|7269301|FG000|NOT COMPLETED|Overall Study||0
6359704|NCT00673712|7269302|FG001|NOT COMPLETED|Overall Study||0
6359705|NCT00673738|7269308|FG000|STARTED|Overall Study||27
6359706|NCT00673738|7269308|FG000|COMPLETED|Overall Study||27
6359707|NCT00673738|7269308|FG000|NOT COMPLETED|Overall Study||0
6359708|NCT00673764|7269312|FG000|STARTED|Overall Study||24
6359709|NCT00673764|7269313|FG001|STARTED|Overall Study||24
6359710|NCT00673764|7269312|FG000|COMPLETED|Overall Study||24
6359711|NCT00673764|7269313|FG001|COMPLETED|Overall Study||24
6359712|NCT00673764|7269312|FG000|NOT COMPLETED|Overall Study||0
6359713|NCT00673764|7269313|FG001|NOT COMPLETED|Overall Study||0
6359714|NCT00673790|7269322|FG000|STARTED|Overall Study||223
6359715|NCT00673790|7269323|FG001|STARTED|Overall Study||212
6359716|NCT00673790|7269324|FG002|STARTED|Overall Study||102
6359717|NCT00673790|7269322|FG000|COMPLETED|Overall Study||178
6359718|NCT00673790|7269323|FG001|COMPLETED|Overall Study||174
6359719|NCT00673790|7269324|FG002|COMPLETED|Overall Study||90
6359720|NCT00673790|7269322|FG000|NOT COMPLETED|Overall Study||45
6359721|NCT00673790|7269323|FG001|NOT COMPLETED|Overall Study||38
6359722|NCT00673790|7269324|FG002|NOT COMPLETED|Overall Study||12
6359723|NCT00673816|7269333|FG000|STARTED|Overall Study||2
6359724|NCT00673816|7269333|FG000|COMPLETED|Overall Study||0
6359725|NCT00673816|7269333|FG000|NOT COMPLETED|Overall Study||2
6359726|NCT00673855|7269338|FG000|STARTED|First Intervention||10
6359727|NCT00673855|7269339|FG001|STARTED|First Intervention||10
6359728|NCT00673855|7269338|FG000|COMPLETED|First Intervention||10
6359729|NCT00673855|7269339|FG001|COMPLETED|First Intervention||10
6359730|NCT00673855|7269338|FG000|NOT COMPLETED|First Intervention||0
6359731|NCT00673855|7269339|FG001|NOT COMPLETED|First Intervention||0
6359732|NCT00673855|7269338|FG000|STARTED|Second Intervention||10
6359733|NCT00673855|7269339|FG001|STARTED|Second Intervention||10
6359734|NCT00673855|7269338|FG000|COMPLETED|Second Intervention||10
6359735|NCT00673855|7269339|FG001|COMPLETED|Second Intervention||10
6359736|NCT00673855|7269338|FG000|NOT COMPLETED|Second Intervention||0
6359737|NCT00673855|7269339|FG001|NOT COMPLETED|Second Intervention||0
6359738|NCT00673881|7269345|FG000|STARTED|Overall Study||25
6359739|NCT00673881|7269345|FG000|COMPLETED|Overall Study||24
6359740|NCT00673881|7269345|FG000|NOT COMPLETED|Overall Study||1
6359741|NCT00673894|7269351|FG000|STARTED|First Intervention 4 Weeks||8
6359742|NCT00673894|7269352|FG001|STARTED|First Intervention 4 Weeks||7
6359743|NCT00673894|7269351|FG000|COMPLETED|First Intervention 4 Weeks||6
6359744|NCT00673894|7269352|FG001|COMPLETED|First Intervention 4 Weeks||7
6359745|NCT00673894|7269351|FG000|NOT COMPLETED|First Intervention 4 Weeks||2
6359746|NCT00673894|7269352|FG001|NOT COMPLETED|First Intervention 4 Weeks||0
6359747|NCT00673894|7269351|FG000|STARTED|Washout 4-6 Weeks||6
6359748|NCT00673894|7269352|FG001|STARTED|Washout 4-6 Weeks||7
6359749|NCT00673894|7269351|FG000|COMPLETED|Washout 4-6 Weeks||6
6359750|NCT00673894|7269352|FG001|COMPLETED|Washout 4-6 Weeks||7
6359751|NCT00673894|7269351|FG000|NOT COMPLETED|Washout 4-6 Weeks||0
6359752|NCT00673894|7269352|FG001|NOT COMPLETED|Washout 4-6 Weeks||0
6359753|NCT00673894|7269351|FG000|STARTED|Second Intervention 4 Weeks||6
6359754|NCT00673894|7269352|FG001|STARTED|Second Intervention 4 Weeks||7
6359755|NCT00673894|7269351|FG000|COMPLETED|Second Intervention 4 Weeks||6
6359756|NCT00673894|7269352|FG001|COMPLETED|Second Intervention 4 Weeks||7
6359757|NCT00673894|7269351|FG000|NOT COMPLETED|Second Intervention 4 Weeks||0
6359758|NCT00673894|7269352|FG001|NOT COMPLETED|Second Intervention 4 Weeks||0
6359759|NCT00673920|7269366|FG000|STARTED|Baseline up to Week 48||64
6359760|NCT00673920|7269367|FG001|STARTED|Baseline up to Week 48||117
6359761|NCT00673920|7269368|FG002|STARTED|Baseline up to Week 48||133
6359762|NCT00673920|7269369|FG003|STARTED|Baseline up to Week 48||0
6359763|NCT00673920|7269370|FG004|STARTED|Baseline up to Week 48||0
6359764|NCT00673920|7269371|FG005|STARTED|Baseline up to Week 48||0
6359765|NCT00673920|7269372|FG006|STARTED|Baseline up to Week 48||0
6359766|NCT00673920|7269373|FG007|STARTED|Baseline up to Week 48||0
6359767|NCT00673920|7269366|FG000|COMPLETED|Baseline up to Week 48||60
6359768|NCT00673920|7269367|FG001|COMPLETED|Baseline up to Week 48||114
6359769|NCT00673920|7269368|FG002|COMPLETED|Baseline up to Week 48||126
6359770|NCT00673920|7269369|FG003|COMPLETED|Baseline up to Week 48||0
6359771|NCT00673920|7269370|FG004|COMPLETED|Baseline up to Week 48||0
6359772|NCT00673920|7269371|FG005|COMPLETED|Baseline up to Week 48||0
6359773|NCT00673920|7269372|FG006|COMPLETED|Baseline up to Week 48||0
6359774|NCT00673920|7269373|FG007|COMPLETED|Baseline up to Week 48||0
6359775|NCT00673920|7269366|FG000|NOT COMPLETED|Baseline up to Week 48||4
6359776|NCT00673920|7269367|FG001|NOT COMPLETED|Baseline up to Week 48||3
6359777|NCT00673920|7269368|FG002|NOT COMPLETED|Baseline up to Week 48||7
6359778|NCT00673920|7269369|FG003|NOT COMPLETED|Baseline up to Week 48||0
6359779|NCT00673920|7269370|FG004|NOT COMPLETED|Baseline up to Week 48||0
6359780|NCT00673920|7269371|FG005|NOT COMPLETED|Baseline up to Week 48||0
6359781|NCT00673920|7269372|FG006|NOT COMPLETED|Baseline up to Week 48||0
6359782|NCT00673920|7269373|FG007|NOT COMPLETED|Baseline up to Week 48||0
6359783|NCT00673920|7269366|FG000|STARTED|Week 24 to Week 48||0
6359784|NCT00673920|7269367|FG001|STARTED|Week 24 to Week 48||0
6359785|NCT00673920|7269368|FG002|STARTED|Week 24 to Week 48||0
6359786|NCT00673920|7269369|FG003|STARTED|Week 24 to Week 48||61
6359787|NCT00673920|7269370|FG004|STARTED|Week 24 to Week 48||61
6359788|NCT00673920|7269371|FG005|STARTED|Week 24 to Week 48||109
6359789|NCT00673920|7269372|FG006|STARTED|Week 24 to Week 48||29
6359790|NCT00673920|7269373|FG007|STARTED|Week 24 to Week 48||28
6359791|NCT00673920|7269366|FG000|COMPLETED|Week 24 to Week 48||0
6359792|NCT00673920|7269367|FG001|COMPLETED|Week 24 to Week 48||0
6359793|NCT00673920|7269368|FG002|COMPLETED|Week 24 to Week 48||0
6359794|NCT00673920|7269369|FG003|COMPLETED|Week 24 to Week 48||60
6359795|NCT00673920|7269370|FG004|COMPLETED|Week 24 to Week 48||61
6359796|NCT00673920|7269371|FG005|COMPLETED|Week 24 to Week 48||106
6359797|NCT00673920|7269372|FG006|COMPLETED|Week 24 to Week 48||28
6359798|NCT00673920|7269373|FG007|COMPLETED|Week 24 to Week 48||28
6359799|NCT00673920|7269366|FG000|NOT COMPLETED|Week 24 to Week 48||0
6359800|NCT00673920|7269367|FG001|NOT COMPLETED|Week 24 to Week 48||0
6359801|NCT00673920|7269368|FG002|NOT COMPLETED|Week 24 to Week 48||0
6359802|NCT00673920|7269369|FG003|NOT COMPLETED|Week 24 to Week 48||1
6359803|NCT00673920|7269370|FG004|NOT COMPLETED|Week 24 to Week 48||0
6359804|NCT00673920|7269371|FG005|NOT COMPLETED|Week 24 to Week 48||3
6359805|NCT00673920|7269372|FG006|NOT COMPLETED|Week 24 to Week 48||1
6359806|NCT00673920|7269373|FG007|NOT COMPLETED|Week 24 to Week 48||0
6359807|NCT00673933|7269395|FG000|STARTED|Overall Study||20
6359808|NCT00673933|7269395|FG000|COMPLETED|Overall Study||17
6359809|NCT00673933|7269395|FG000|NOT COMPLETED|Overall Study||3
6359810|NCT00673959|7269401|FG000|STARTED|Overall Study||10
6359811|NCT00673959|7269402|FG001|STARTED|Overall Study||10
6359812|NCT00673959|7269401|FG000|COMPLETED|Overall Study||10
6776736|NCT03801148|7704787|FG003|NOT COMPLETED|Period 2 (2 Days)||0
6776737|NCT03801148|7704784|FG000|STARTED|Follow-Up (12 Days)||30
6776738|NCT03801148|7704785|FG001|STARTED|Follow-Up (12 Days)||30
6776739|NCT03801148|7704786|FG002|STARTED|Follow-Up (12 Days)||29
6776740|NCT03801148|7704787|FG003|STARTED|Follow-Up (12 Days)||29
6776741|NCT03801148|7704784|FG000|COMPLETED|Follow-Up (12 Days)||30
6359813|NCT00673959|7269402|FG001|COMPLETED|Overall Study||10
6359814|NCT00673959|7269401|FG000|NOT COMPLETED|Overall Study||0
6359815|NCT00673959|7269402|FG001|NOT COMPLETED|Overall Study||0
6359816|NCT00674115|7269408|FG000|STARTED|First Intervention||14
6359817|NCT00674115|7269409|FG001|STARTED|First Intervention||16
6359818|NCT00674115|7269410|FG002|STARTED|First Intervention||14
6359819|NCT00674115|7269411|FG003|STARTED|First Intervention||16
6359820|NCT00674115|7269408|FG000|COMPLETED|First Intervention||14
6359821|NCT00674115|7269409|FG001|COMPLETED|First Intervention||16
6359822|NCT00674115|7269410|FG002|COMPLETED|First Intervention||14
6359823|NCT00674115|7269411|FG003|COMPLETED|First Intervention||16
6359824|NCT00674115|7269408|FG000|NOT COMPLETED|First Intervention||0
6359825|NCT00674115|7269409|FG001|NOT COMPLETED|First Intervention||0
6359826|NCT00674115|7269410|FG002|NOT COMPLETED|First Intervention||0
6359827|NCT00674115|7269411|FG003|NOT COMPLETED|First Intervention||0
6359828|NCT00674115|7269408|FG000|STARTED|Washout Period of 2 Weeks||14
6359829|NCT00674115|7269409|FG001|STARTED|Washout Period of 2 Weeks||16
6359830|NCT00674115|7269410|FG002|STARTED|Washout Period of 2 Weeks||14
6359831|NCT00674115|7269411|FG003|STARTED|Washout Period of 2 Weeks||16
6359832|NCT00674115|7269408|FG000|COMPLETED|Washout Period of 2 Weeks||14
6359833|NCT00674115|7269409|FG001|COMPLETED|Washout Period of 2 Weeks||16
6359834|NCT00674115|7269410|FG002|COMPLETED|Washout Period of 2 Weeks||14
6359835|NCT00674115|7269411|FG003|COMPLETED|Washout Period of 2 Weeks||16
6359836|NCT00674115|7269408|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6776742|NCT03801148|7704785|FG001|COMPLETED|Follow-Up (12 Days)||29
6776743|NCT03801148|7704786|FG002|COMPLETED|Follow-Up (12 Days)||28
6776744|NCT03801148|7704787|FG003|COMPLETED|Follow-Up (12 Days)||29
6776745|NCT03801148|7704784|FG000|NOT COMPLETED|Follow-Up (12 Days)||0
6776746|NCT03801148|7704785|FG001|NOT COMPLETED|Follow-Up (12 Days)||1
6776747|NCT03801148|7704786|FG002|NOT COMPLETED|Follow-Up (12 Days)||1
6776748|NCT03801148|7704787|FG003|NOT COMPLETED|Follow-Up (12 Days)||0
6776749|NCT03832907|7704797|FG000|STARTED|Overall Study||101
6776750|NCT03832907|7704797|FG000|COMPLETED|Overall Study||91
6776751|NCT03832907|7704797|FG000|NOT COMPLETED|Overall Study||10
6776752|NCT03832322|7704803|FG000|STARTED|Overall Study||89
6776753|NCT03832322|7704804|FG001|STARTED|Overall Study||87
6776754|NCT03832322|7704803|FG000|COMPLETED|Overall Study||86
6776755|NCT03832322|7704804|FG001|COMPLETED|Overall Study||86
6776756|NCT03832322|7704803|FG000|NOT COMPLETED|Overall Study||3
6776757|NCT03832322|7704804|FG001|NOT COMPLETED|Overall Study||1
6776758|NCT03832387|7704814|FG000|STARTED|Overall Study||38
6776759|NCT03832387|7704815|FG001|STARTED|Overall Study||39
6359837|NCT00674115|7269409|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6359838|NCT00674115|7269410|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
6359839|NCT00674115|7269411|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
6776760|NCT03832387|7704814|FG000|COMPLETED|Overall Study||33
6776761|NCT03832387|7704815|FG001|COMPLETED|Overall Study||32
6776762|NCT03832387|7704814|FG000|NOT COMPLETED|Overall Study||5
6776763|NCT03832387|7704815|FG001|NOT COMPLETED|Overall Study||7
6359840|NCT00674115|7269408|FG000|STARTED|Second Intervention||14
6359841|NCT00674115|7269409|FG001|STARTED|Second Intervention||16
6359842|NCT00674115|7269410|FG002|STARTED|Second Intervention||14
6359843|NCT00674115|7269411|FG003|STARTED|Second Intervention||16
6359844|NCT00674115|7269408|FG000|COMPLETED|Second Intervention||14
6359845|NCT00674115|7269409|FG001|COMPLETED|Second Intervention||16
6359846|NCT00674115|7269410|FG002|COMPLETED|Second Intervention||14
6359847|NCT00674115|7269411|FG003|COMPLETED|Second Intervention||16
6359848|NCT00674115|7269408|FG000|NOT COMPLETED|Second Intervention||0
6560212|NCT01785602|7482916|FG000|STARTED|Overall Study||76
6560213|NCT01785602|7482917|FG001|STARTED|Overall Study||27
6560214|NCT01785602|7482916|FG000|COMPLETED|Overall Study||63
6560215|NCT01785602|7482917|FG001|COMPLETED|Overall Study||18
6776764|NCT03831971|7704821|FG000|STARTED|Overall Study||12
6776765|NCT03831971|7704821|FG000|COMPLETED|Overall Study||12
6359849|NCT00674115|7269409|FG001|NOT COMPLETED|Second Intervention||0
6359850|NCT00674115|7269410|FG002|NOT COMPLETED|Second Intervention||0
6359851|NCT00674115|7269411|FG003|NOT COMPLETED|Second Intervention||0
6359852|NCT00674115|7269408|FG000|STARTED|Washout Period of 2 Weeks||14
6359853|NCT00674115|7269409|FG001|STARTED|Washout Period of 2 Weeks||16
6359854|NCT00674115|7269410|FG002|STARTED|Washout Period of 2 Weeks||0
6359855|NCT00674115|7269411|FG003|STARTED|Washout Period of 2 Weeks||0
6359856|NCT00674115|7269408|FG000|COMPLETED|Washout Period of 2 Weeks||14
6359857|NCT00674115|7269409|FG001|COMPLETED|Washout Period of 2 Weeks||16
6359858|NCT00674115|7269410|FG002|COMPLETED|Washout Period of 2 Weeks||0
6359859|NCT00674115|7269411|FG003|COMPLETED|Washout Period of 2 Weeks||0
6359860|NCT00674115|7269408|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6359861|NCT00674115|7269409|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6359862|NCT00674115|7269410|FG002|NOT COMPLETED|Washout Period of 2 Weeks||0
6359863|NCT00674115|7269411|FG003|NOT COMPLETED|Washout Period of 2 Weeks||0
6359864|NCT00674115|7269408|FG000|STARTED|Third Intervention||14
6359865|NCT00674115|7269409|FG001|STARTED|Third Intervention||16
6359866|NCT00674115|7269410|FG002|STARTED|Third Intervention||0
6359867|NCT00674115|7269411|FG003|STARTED|Third Intervention||0
6359868|NCT00674115|7269408|FG000|COMPLETED|Third Intervention||14
6359869|NCT00674115|7269409|FG001|COMPLETED|Third Intervention||16
6359870|NCT00674115|7269410|FG002|COMPLETED|Third Intervention||0
6359871|NCT00674115|7269411|FG003|COMPLETED|Third Intervention||0
6359872|NCT00674115|7269408|FG000|NOT COMPLETED|Third Intervention||0
6359873|NCT00674115|7269409|FG001|NOT COMPLETED|Third Intervention||0
6359874|NCT00674115|7269410|FG002|NOT COMPLETED|Third Intervention||0
6359875|NCT00674115|7269411|FG003|NOT COMPLETED|Third Intervention||0
6359876|NCT00674128|7269422|FG000|STARTED|Overall Study||50
6359877|NCT00674128|7269423|FG001|STARTED|Overall Study||44
6359878|NCT00674128|7269422|FG000|COMPLETED|Overall Study||25
6359879|NCT00674128|7269423|FG001|COMPLETED|Overall Study||21
6359880|NCT00674128|7269422|FG000|NOT COMPLETED|Overall Study||25
6359881|NCT00674128|7269423|FG001|NOT COMPLETED|Overall Study||23
6359882|NCT00674154|7269431|FG000|STARTED|Overall Study||23
6359883|NCT00674154|7269432|FG001|STARTED|Overall Study||23
6359884|NCT00674154|7269431|FG000|COMPLETED|Overall Study||20
6359885|NCT00674154|7269432|FG001|COMPLETED|Overall Study||20
6359886|NCT00674154|7269431|FG000|NOT COMPLETED|Overall Study||3
6359887|NCT00674154|7269432|FG001|NOT COMPLETED|Overall Study||3
6359888|NCT00674206|7269438|FG000|STARTED|Overall Study||6
6359889|NCT00674206|7269438|FG000|COMPLETED|Overall Study||6
6359890|NCT00674206|7269438|FG000|NOT COMPLETED|Overall Study||0
6359891|NCT00674219|7269444|FG000|STARTED|Overall Study||10
6359892|NCT00674219|7269445|FG001|STARTED|Overall Study||7
6560216|NCT01785602|7482916|FG000|NOT COMPLETED|Overall Study||13
6776766|NCT03831971|7704821|FG000|NOT COMPLETED|Overall Study||0
6776767|NCT03831854|7704827|FG000|STARTED|Overall Study||23
6776768|NCT03831854|7704828|FG001|STARTED|Overall Study||23
6776769|NCT03831854|7704827|FG000|COMPLETED|Overall Study||23
6776770|NCT03831854|7704828|FG001|COMPLETED|Overall Study||23
6776771|NCT03831854|7704827|FG000|NOT COMPLETED|Overall Study||0
6776772|NCT03831854|7704828|FG001|NOT COMPLETED|Overall Study||0
6776773|NCT03807739|7704838|FG000|STARTED|Overall Study||9
6776774|NCT03807739|7704839|FG001|STARTED|Overall Study||10
6776775|NCT03807739|7704840|FG002|STARTED|Overall Study||9
6776776|NCT03807739|7704841|FG003|STARTED|Overall Study||10
6776777|NCT03807739|7704838|FG000|COMPLETED|Overall Study||7
6776778|NCT03807739|7704839|FG001|COMPLETED|Overall Study||10
6776779|NCT03807739|7704840|FG002|COMPLETED|Overall Study||9
6776780|NCT03807739|7704841|FG003|COMPLETED|Overall Study||10
6776781|NCT03807739|7704838|FG000|NOT COMPLETED|Overall Study||2
6776782|NCT03807739|7704839|FG001|NOT COMPLETED|Overall Study||0
6776783|NCT03807739|7704840|FG002|NOT COMPLETED|Overall Study||0
6776784|NCT03807739|7704841|FG003|NOT COMPLETED|Overall Study||0
6776785|NCT03831282|7704851|FG000|STARTED|Overall Study||12
6776786|NCT03831282|7704851|FG000|COMPLETED|Overall Study||11
6776787|NCT03831282|7704851|FG000|NOT COMPLETED|Overall Study||1
6776788|NCT03824912|7704858|FG000|STARTED|Overall Study||332
6776789|NCT03824912|7704859|FG001|STARTED|Overall Study||335
6359893|NCT00674219|7269444|FG000|COMPLETED|Overall Study||10
6359894|NCT00674219|7269445|FG001|COMPLETED|Overall Study||7
6359895|NCT00674219|7269444|FG000|NOT COMPLETED|Overall Study||0
6359896|NCT00674219|7269445|FG001|NOT COMPLETED|Overall Study||0
6359897|NCT00674297|7269451|FG000|STARTED|Overall Study||18
6359898|NCT00674297|7269452|FG001|STARTED|Overall Study||7
6359899|NCT00674297|7269453|FG002|STARTED|Overall Study||9
6359900|NCT00674297|7269454|FG003|STARTED|Overall Study||7
6359901|NCT00674297|7269451|FG000|COMPLETED|Overall Study||8
6359902|NCT00674297|7269452|FG001|COMPLETED|Overall Study||7
6359903|NCT00674297|7269453|FG002|COMPLETED|Overall Study||5
6359904|NCT00674297|7269454|FG003|COMPLETED|Overall Study||4
6359905|NCT00674297|7269451|FG000|NOT COMPLETED|Overall Study||10
6359906|NCT00674297|7269452|FG001|NOT COMPLETED|Overall Study||0
6359907|NCT00674297|7269453|FG002|NOT COMPLETED|Overall Study||4
6359908|NCT00674297|7269454|FG003|NOT COMPLETED|Overall Study||3
6359909|NCT00674323|7269464|FG000|STARTED|Overall Study||19
6359910|NCT00674323|7269465|FG001|STARTED|Overall Study||21
6359911|NCT00674323|7269466|FG002|STARTED|Overall Study||21
6359912|NCT00674323|7269464|FG000|COMPLETED|Overall Study||18
6359913|NCT00674323|7269465|FG001|COMPLETED|Overall Study||20
6359914|NCT00674323|7269466|FG002|COMPLETED|Overall Study||21
6359915|NCT00674323|7269464|FG000|NOT COMPLETED|Overall Study||1
6359916|NCT00674323|7269465|FG001|NOT COMPLETED|Overall Study||1
6359917|NCT00674323|7269466|FG002|NOT COMPLETED|Overall Study||0
6377132|NCT00762177|7287725|FG002|COMPLETED|1st Treatment Period||8
6377133|NCT00762177|7287723|FG000|NOT COMPLETED|1st Treatment Period||0
6377134|NCT00762177|7287724|FG001|NOT COMPLETED|1st Treatment Period||0
6377135|NCT00762177|7287725|FG002|NOT COMPLETED|1st Treatment Period||0
6377136|NCT00762177|7287723|FG000|STARTED|Washout After 1st Treatment||8
6377137|NCT00762177|7287724|FG001|STARTED|Washout After 1st Treatment||8
6377138|NCT00762177|7287725|FG002|STARTED|Washout After 1st Treatment||8
6377139|NCT00762177|7287723|FG000|COMPLETED|Washout After 1st Treatment||8
6377140|NCT00762177|7287724|FG001|COMPLETED|Washout After 1st Treatment||8
6377141|NCT00762177|7287725|FG002|COMPLETED|Washout After 1st Treatment||8
6377142|NCT00762177|7287723|FG000|NOT COMPLETED|Washout After 1st Treatment||0
6377143|NCT00762177|7287724|FG001|NOT COMPLETED|Washout After 1st Treatment||0
6377144|NCT00762177|7287725|FG002|NOT COMPLETED|Washout After 1st Treatment||0
6377145|NCT00762177|7287723|FG000|STARTED|2nd Treatment Period||8
6377146|NCT00762177|7287724|FG001|STARTED|2nd Treatment Period||8
6377147|NCT00762177|7287725|FG002|STARTED|2nd Treatment Period||8
6377148|NCT00762177|7287723|FG000|COMPLETED|2nd Treatment Period||8
6377149|NCT00762177|7287724|FG001|COMPLETED|2nd Treatment Period||8
6377150|NCT00762177|7287725|FG002|COMPLETED|2nd Treatment Period||8
6377151|NCT00762177|7287723|FG000|NOT COMPLETED|2nd Treatment Period||0
6377152|NCT00762177|7287724|FG001|NOT COMPLETED|2nd Treatment Period||0
6377153|NCT00762177|7287725|FG002|NOT COMPLETED|2nd Treatment Period||0
6377154|NCT00762177|7287723|FG000|STARTED|Washout After 2nd Treatment||8
6377155|NCT00762177|7287724|FG001|STARTED|Washout After 2nd Treatment||8
6377156|NCT00762177|7287725|FG002|STARTED|Washout After 2nd Treatment||8
6377157|NCT00762177|7287723|FG000|COMPLETED|Washout After 2nd Treatment||8
6377158|NCT00762177|7287724|FG001|COMPLETED|Washout After 2nd Treatment||8
6377159|NCT00762177|7287725|FG002|COMPLETED|Washout After 2nd Treatment||8
6377160|NCT00762177|7287723|FG000|NOT COMPLETED|Washout After 2nd Treatment||0
6377161|NCT00762177|7287724|FG001|NOT COMPLETED|Washout After 2nd Treatment||0
6377162|NCT00762177|7287725|FG002|NOT COMPLETED|Washout After 2nd Treatment||0
6377163|NCT00762177|7287723|FG000|STARTED|3rd Treatment Period||8
6377164|NCT00762177|7287724|FG001|STARTED|3rd Treatment Period||8
6377165|NCT00762177|7287725|FG002|STARTED|3rd Treatment Period||8
6377166|NCT00762177|7287723|FG000|COMPLETED|3rd Treatment Period||8
6377167|NCT00762177|7287724|FG001|COMPLETED|3rd Treatment Period||8
6377168|NCT00762177|7287725|FG002|COMPLETED|3rd Treatment Period||8
6377169|NCT00762177|7287723|FG000|NOT COMPLETED|3rd Treatment Period||0
6377170|NCT00762177|7287724|FG001|NOT COMPLETED|3rd Treatment Period||0
6377171|NCT00762177|7287725|FG002|NOT COMPLETED|3rd Treatment Period||0
6377172|NCT00762216|7287736|FG000|STARTED|Overall Study||71
6776790|NCT03824912|7704860|FG002|STARTED|Overall Study||164
6776791|NCT03824912|7704858|FG000|COMPLETED|Overall Study||192
6776792|NCT03824912|7704859|FG001|COMPLETED|Overall Study||201
6776793|NCT03824912|7704860|FG002|COMPLETED|Overall Study||96
6776794|NCT03824912|7704858|FG000|NOT COMPLETED|Overall Study||140
6776795|NCT03824912|7704859|FG001|NOT COMPLETED|Overall Study||134
6776796|NCT03824912|7704860|FG002|NOT COMPLETED|Overall Study||68
6776797|NCT03822884|7704874|FG000|STARTED|Overall Study||4
6776798|NCT03822884|7704875|FG001|STARTED|Overall Study||4
6776799|NCT03822884|7704876|FG002|STARTED|Overall Study||4
6776800|NCT03822884|7704877|FG003|STARTED|Overall Study||4
6776801|NCT03822884|7704878|FG004|STARTED|Overall Study||4
6776802|NCT03822884|7704879|FG005|STARTED|Overall Study||4
6776803|NCT03822884|7704874|FG000|COMPLETED|Overall Study||4
6776804|NCT03822884|7704875|FG001|COMPLETED|Overall Study||4
6776805|NCT03822884|7704876|FG002|COMPLETED|Overall Study||4
6776806|NCT03822884|7704877|FG003|COMPLETED|Overall Study||4
6776807|NCT03822884|7704878|FG004|COMPLETED|Overall Study||3
6776808|NCT03822884|7704879|FG005|COMPLETED|Overall Study||4
6377173|NCT00762216|7287736|FG000|COMPLETED|Overall Study||71
6377174|NCT00762216|7287736|FG000|NOT COMPLETED|Overall Study||0
6377175|NCT00762229|7287742|FG000|STARTED|Overall Study||15
6377176|NCT00762229|7287743|FG001|STARTED|Overall Study||24
6776809|NCT03822884|7704874|FG000|NOT COMPLETED|Overall Study||0
6776810|NCT03822884|7704875|FG001|NOT COMPLETED|Overall Study||0
6377177|NCT00762229|7287742|FG000|COMPLETED|Overall Study||14
6377178|NCT00762229|7287743|FG001|COMPLETED|Overall Study||22
6377179|NCT00762229|7287742|FG000|NOT COMPLETED|Overall Study||1
6377180|NCT00762229|7287743|FG001|NOT COMPLETED|Overall Study||2
6377181|NCT00762268|7287751|FG000|STARTED|Overall Study||12
6377182|NCT00762268|7287752|FG001|STARTED|Overall Study||11
6776811|NCT03822884|7704876|FG002|NOT COMPLETED|Overall Study||0
6776812|NCT03822884|7704877|FG003|NOT COMPLETED|Overall Study||0
6560217|NCT01785602|7482917|FG001|NOT COMPLETED|Overall Study||9
6560218|NCT01785615|7482926|FG000|STARTED|Dietary Phase||0
6560219|NCT01785615|7482927|FG001|STARTED|Dietary Phase||0
6560220|NCT01785615|7482928|FG002|STARTED|Dietary Phase||35
6560221|NCT01785615|7482929|FG003|STARTED|Dietary Phase||140
6560222|NCT01785615|7482926|FG000|COMPLETED|Dietary Phase||0
6560223|NCT01785615|7482927|FG001|COMPLETED|Dietary Phase||0
6560224|NCT01785615|7482928|FG002|COMPLETED|Dietary Phase||35
6560225|NCT01785615|7482929|FG003|COMPLETED|Dietary Phase||116
6560226|NCT01785615|7482926|FG000|NOT COMPLETED|Dietary Phase||0
6560227|NCT01785615|7482927|FG001|NOT COMPLETED|Dietary Phase||0
6560228|NCT01785615|7482928|FG002|NOT COMPLETED|Dietary Phase||0
6560229|NCT01785615|7482929|FG003|NOT COMPLETED|Dietary Phase||24
6560230|NCT01785615|7482926|FG000|STARTED|Atorvastatin Phase||44
6560231|NCT01785615|7482927|FG001|STARTED|Atorvastatin Phase||44
6776813|NCT03822884|7704878|FG004|NOT COMPLETED|Overall Study||1
6776814|NCT03822884|7704879|FG005|NOT COMPLETED|Overall Study||0
6359918|NCT00674362|7269476|FG000|STARTED|Double Blind||96
6359919|NCT00674362|7269477|FG001|STARTED|Double Blind||98
6359920|NCT00674362|7269476|FG000|COMPLETED|Double Blind||84
6359921|NCT00674362|7269477|FG001|COMPLETED|Double Blind||80
6359922|NCT00674362|7269476|FG000|NOT COMPLETED|Double Blind||12
6359923|NCT00674362|7269477|FG001|NOT COMPLETED|Double Blind||18
6359924|NCT00674362|7269476|FG000|STARTED|Open Label||20
6359925|NCT00674362|7269477|FG001|STARTED|Open Label||7
6359926|NCT00674362|7269476|FG000|COMPLETED|Open Label||18
6359927|NCT00674362|7269477|FG001|COMPLETED|Open Label||7
6359928|NCT00674362|7269476|FG000|NOT COMPLETED|Open Label||2
6359929|NCT00674362|7269477|FG001|NOT COMPLETED|Open Label||0
6359930|NCT00674466|7269487|FG000|STARTED|Overall Study||30
6359931|NCT00674466|7269488|FG001|STARTED|Overall Study||30
6359932|NCT00674466|7269489|FG002|STARTED|Overall Study||30
6359933|NCT00674466|7269487|FG000|COMPLETED|Overall Study||23
6359934|NCT00674466|7269488|FG001|COMPLETED|Overall Study||22
6359935|NCT00674466|7269489|FG002|COMPLETED|Overall Study||21
6359936|NCT00674466|7269487|FG000|NOT COMPLETED|Overall Study||7
6359937|NCT00674466|7269488|FG001|NOT COMPLETED|Overall Study||8
6359938|NCT00674466|7269489|FG002|NOT COMPLETED|Overall Study||9
6359939|NCT00674479|7269497|FG000|STARTED|Overall Study||51
6359940|NCT00674479|7269497|FG000|COMPLETED|Overall Study||51
6359941|NCT00674479|7269497|FG000|NOT COMPLETED|Overall Study||0
6359942|NCT00674492|7269501|FG000|STARTED|Overall Study||21
6359943|NCT00674492|7269501|FG000|COMPLETED|Overall Study||21
6359944|NCT00674492|7269501|FG000|NOT COMPLETED|Overall Study||0
6359945|NCT00674570|7269508|FG000|STARTED|Overall Study||37
6359946|NCT00674570|7269509|FG001|STARTED|Overall Study||34
6359947|NCT00674570|7269510|FG002|STARTED|Overall Study||35
6359948|NCT00674570|7269508|FG000|COMPLETED|Overall Study||37
6359949|NCT00674570|7269509|FG001|COMPLETED|Overall Study||32
6359950|NCT00674570|7269510|FG002|COMPLETED|Overall Study||35
6359951|NCT00674570|7269508|FG000|NOT COMPLETED|Overall Study||0
6359952|NCT00674570|7269509|FG001|NOT COMPLETED|Overall Study||2
6776815|NCT03816709|7704887|FG000|STARTED|Overall Study||25
6776816|NCT03816709|7704887|FG000|COMPLETED|Overall Study||25
6776817|NCT03816709|7704887|FG000|NOT COMPLETED|Overall Study||0
6776818|NCT03810014|7704895|FG000|STARTED|Overall Study||215
6776819|NCT03810014|7704896|FG001|STARTED|Overall Study||204
6776820|NCT03810014|7704897|FG002|STARTED|Overall Study||210
6776821|NCT03810014|7704898|FG003|STARTED|Overall Study||213
6776822|NCT03810014|7704895|FG000|COMPLETED|Overall Study||213
6776823|NCT03810014|7704896|FG001|COMPLETED|Overall Study||202
6776824|NCT03810014|7704897|FG002|COMPLETED|Overall Study||210
6776825|NCT03810014|7704898|FG003|COMPLETED|Overall Study||211
6776826|NCT03810014|7704895|FG000|NOT COMPLETED|Overall Study||2
6776827|NCT03810014|7704896|FG001|NOT COMPLETED|Overall Study||2
6776828|NCT03810014|7704897|FG002|NOT COMPLETED|Overall Study||0
6776829|NCT03810014|7704898|FG003|NOT COMPLETED|Overall Study||2
6776830|NCT03806270|7704911|FG000|STARTED|Overall Study||15
6776831|NCT03806270|7704912|FG001|STARTED|Overall Study||15
6776832|NCT03806270|7704913|FG002|STARTED|Overall Study||15
6359953|NCT00674570|7269510|FG002|NOT COMPLETED|Overall Study||0
6359954|NCT00674583|7269520|FG000|STARTED|Overall Study||311
6359955|NCT00674583|7269521|FG001|STARTED|Overall Study||103
6359956|NCT00674583|7269520|FG000|COMPLETED|Overall Study||311
6359957|NCT00674583|7269521|FG001|COMPLETED|Overall Study||103
6359958|NCT00674583|7269520|FG000|NOT COMPLETED|Overall Study||0
6359959|NCT00674583|7269521|FG001|NOT COMPLETED|Overall Study||0
6560232|NCT01785615|7482928|FG002|STARTED|Atorvastatin Phase||0
6560233|NCT01785615|7482929|FG003|STARTED|Atorvastatin Phase||0
6560234|NCT01785615|7482926|FG000|COMPLETED|Atorvastatin Phase||44
6776833|NCT03806270|7704911|FG000|COMPLETED|Overall Study||15
6776834|NCT03806270|7704912|FG001|COMPLETED|Overall Study||15
6776835|NCT03806270|7704913|FG002|COMPLETED|Overall Study||15
6776836|NCT03806270|7704911|FG000|NOT COMPLETED|Overall Study||0
6776837|NCT03806270|7704912|FG001|NOT COMPLETED|Overall Study||0
6359960|NCT00674609|7269534|FG000|STARTED|Overall Study||60
6560235|NCT01785615|7482927|FG001|COMPLETED|Atorvastatin Phase||44
6776838|NCT03806270|7704913|FG002|NOT COMPLETED|Overall Study||0
6359961|NCT00674609|7269535|FG001|STARTED|Overall Study||58
6359962|NCT00674609|7269536|FG002|STARTED|Overall Study||59
6359963|NCT00674609|7269534|FG000|COMPLETED|Overall Study||48
6359964|NCT00674609|7269535|FG001|COMPLETED|Overall Study||45
6359965|NCT00674609|7269536|FG002|COMPLETED|Overall Study||51
6776839|NCT03830892|7704923|FG000|STARTED|Overall Study||25
6359966|NCT00674609|7269534|FG000|NOT COMPLETED|Overall Study||12
6359967|NCT00674609|7269535|FG001|NOT COMPLETED|Overall Study||13
6359968|NCT00674609|7269536|FG002|NOT COMPLETED|Overall Study||8
6359969|NCT00674622|7269547|FG000|STARTED|Overall Study||22
6359970|NCT00674622|7269548|FG001|STARTED|Overall Study||22
6359971|NCT00674622|7269549|FG002|STARTED|Overall Study||22
6359972|NCT00674622|7269547|FG000|COMPLETED|Overall Study||21
6359973|NCT00674622|7269548|FG001|COMPLETED|Overall Study||18
6359974|NCT00674622|7269549|FG002|COMPLETED|Overall Study||22
6359975|NCT00674622|7269547|FG000|NOT COMPLETED|Overall Study||1
6359976|NCT00674622|7269548|FG001|NOT COMPLETED|Overall Study||4
6359977|NCT00674622|7269549|FG002|NOT COMPLETED|Overall Study||0
6359978|NCT00674661|7269559|FG000|STARTED|Overall Study||67
6359979|NCT00674661|7269560|FG001|STARTED|Overall Study||63
6359980|NCT00674661|7269559|FG000|COMPLETED|Overall Study||56
6359981|NCT00674661|7269560|FG001|COMPLETED|Overall Study||48
6359982|NCT00674661|7269559|FG000|NOT COMPLETED|Overall Study||11
6359983|NCT00674661|7269560|FG001|NOT COMPLETED|Overall Study||15
6359984|NCT00674700|7269569|FG000|STARTED|Year 1||170
6359985|NCT00674700|7269570|FG001|STARTED|Year 1||169
6359986|NCT00674700|7269571|FG002|STARTED|Year 1||170
6359987|NCT00674700|7269569|FG000|COMPLETED|Year 1||139
6359988|NCT00674700|7269570|FG001|COMPLETED|Year 1||135
6359989|NCT00674700|7269571|FG002|COMPLETED|Year 1||153
6359990|NCT00674700|7269569|FG000|NOT COMPLETED|Year 1||31
6359991|NCT00674700|7269570|FG001|NOT COMPLETED|Year 1||34
6359992|NCT00674700|7269571|FG002|NOT COMPLETED|Year 1||17
6359993|NCT00674700|7269569|FG000|STARTED|Year 2 Follow-up Without Treatment||139
6359994|NCT00674700|7269570|FG001|STARTED|Year 2 Follow-up Without Treatment||135
6359995|NCT00674700|7269571|FG002|STARTED|Year 2 Follow-up Without Treatment||153
6359996|NCT00674700|7269569|FG000|COMPLETED|Year 2 Follow-up Without Treatment||133
6359997|NCT00674700|7269570|FG001|COMPLETED|Year 2 Follow-up Without Treatment||123
6359998|NCT00674700|7269571|FG002|COMPLETED|Year 2 Follow-up Without Treatment||141
6359999|NCT00674700|7269569|FG000|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
6360000|NCT00674700|7269570|FG001|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
6360001|NCT00674700|7269571|FG002|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
6360002|NCT00674739|7269582|FG000|STARTED|Overall Study||178
6360003|NCT00674739|7269583|FG001|STARTED|Overall Study||195
6360004|NCT00674739|7269584|FG002|STARTED|Overall Study||97
6360005|NCT00674739|7269582|FG000|COMPLETED|Overall Study||121
6360006|NCT00674739|7269583|FG001|COMPLETED|Overall Study||136
6360007|NCT00674739|7269584|FG002|COMPLETED|Overall Study||65
6360008|NCT00674739|7269582|FG000|NOT COMPLETED|Overall Study||57
6360009|NCT00674739|7269583|FG001|NOT COMPLETED|Overall Study||59
6360010|NCT00674739|7269584|FG002|NOT COMPLETED|Overall Study||32
6360011|NCT00674765|7269594|FG000|STARTED|Overall Study||81
6360012|NCT00674765|7269595|FG001|STARTED|Overall Study||75
6360013|NCT00674765|7269594|FG000|COMPLETED|Overall Study||45
6360014|NCT00674765|7269595|FG001|COMPLETED|Overall Study||46
6360015|NCT00674765|7269594|FG000|NOT COMPLETED|Overall Study||36
6360016|NCT00674765|7269595|FG001|NOT COMPLETED|Overall Study||29
6360017|NCT00674817|7269601|FG000|STARTED|Period 1||44
6776840|NCT03830892|7704924|FG001|STARTED|Overall Study||23
6776841|NCT03830892|7704923|FG000|15 Watts, 10 mg Nicotine|Overall Study||19
6776842|NCT03830892|7704924|FG001|15 Watts, 10 mg Nicotine|Overall Study||17
6776843|NCT03830892|7704923|FG000|15 Watts, 30 mg Nicotine|Overall Study||19
6776844|NCT03830892|7704924|FG001|15 Watts, 30 mg Nicotine|Overall Study||17
6776845|NCT03830892|7704923|FG000|30 Watts, 10 mg Nicotine|Overall Study||19
6776846|NCT03830892|7704924|FG001|30 Watts, 10 mg Nicotine|Overall Study||17
6776847|NCT03830892|7704923|FG000|30 Watts, 30 mg Nicotine|Overall Study||19
6776848|NCT03830892|7704924|FG001|30 Watts, 30 mg Nicotine|Overall Study||17
6776849|NCT03830892|7704923|FG000|Own Brand|Overall Study||19
6776850|NCT03830892|7704924|FG001|Own Brand|Overall Study||17
6776851|NCT03830892|7704923|FG000|COMPLETED|Overall Study||19
6776852|NCT03830892|7704924|FG001|COMPLETED|Overall Study||17
6776853|NCT03830892|7704923|FG000|NOT COMPLETED|Overall Study||6
6776854|NCT03830892|7704924|FG001|NOT COMPLETED|Overall Study||6
6776855|NCT03830307|7704930|FG000|STARTED|Overall Study||5
6776856|NCT03830307|7704930|FG000|COMPLETED|Overall Study||5
6776857|NCT03830307|7704930|FG000|NOT COMPLETED|Overall Study||0
6776858|NCT03825042|7704936|FG000|STARTED|Overall Study||40
6776859|NCT03825042|7704937|FG001|STARTED|Overall Study||40
6776860|NCT03825042|7704936|FG000|COMPLETED|Overall Study||38
6776861|NCT03825042|7704937|FG001|COMPLETED|Overall Study||40
6776862|NCT03825042|7704936|FG000|NOT COMPLETED|Overall Study||2
6776863|NCT03825042|7704937|FG001|NOT COMPLETED|Overall Study||0
6776864|NCT03823378|7704949|FG000|STARTED|Overall Study||28
6360018|NCT00674817|7269601|FG000|COMPLETED|Period 1||41
6776865|NCT03823378|7704950|FG001|STARTED|Overall Study||16
6776866|NCT03823378|7704951|FG002|STARTED|Overall Study||12
6776867|NCT03823378|7704952|FG003|STARTED|Overall Study||12
6360019|NCT00674817|7269601|FG000|NOT COMPLETED|Period 1||3
6360020|NCT00674817|7269601|FG000|STARTED|Period 2||41
6360021|NCT00674817|7269601|FG000|COMPLETED|Period 2||41
6360022|NCT00674817|7269601|FG000|NOT COMPLETED|Period 2||0
6360023|NCT00674817|7269601|FG000|STARTED|Period 3||41
6360024|NCT00674817|7269601|FG000|COMPLETED|Period 3||39
6360025|NCT00674817|7269601|FG000|NOT COMPLETED|Period 3||2
6360026|NCT00674817|7269601|FG000|STARTED|Period 4||39
6360027|NCT00674817|7269601|FG000|COMPLETED|Period 4||38
6360028|NCT00674817|7269601|FG000|NOT COMPLETED|Period 4||1
6360029|NCT00674817|7269601|FG000|STARTED|Period 5||38
6360030|NCT00674817|7269601|FG000|COMPLETED|Period 5||38
6360031|NCT00674817|7269601|FG000|NOT COMPLETED|Period 5||0
6360032|NCT00674817|7269601|FG000|STARTED|Period 6||38
6360033|NCT00674817|7269601|FG000|COMPLETED|Period 6||38
6360034|NCT00674817|7269601|FG000|NOT COMPLETED|Period 6||0
6360035|NCT00674973|7269617|FG000|STARTED|Overall Study||103
6360036|NCT00674973|7269618|FG001|STARTED|Overall Study||104
6360037|NCT00674973|7269617|FG000|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
6360038|NCT00674973|7269618|FG001|Switch to Open-Label Erlotinib|Overall Study||0
6360039|NCT00674973|7269617|FG000|COMPLETED|Overall Study|Completed double-blind treatment.|3
6360040|NCT00674973|7269618|FG001|COMPLETED|Overall Study|Completed double-blind treatment.|2
6360041|NCT00674973|7269617|FG000|NOT COMPLETED|Overall Study||100
6360042|NCT00674973|7269618|FG001|NOT COMPLETED|Overall Study||102
6360043|NCT00674986|7269626|FG000|STARTED|Overall Study||230
6360044|NCT00674986|7269627|FG001|STARTED|Overall Study||269
6360045|NCT00674986|7269626|FG000|Intent to Treat Population|Overall Study||227
6360046|NCT00674986|7269627|FG001|Intent to Treat Population|Overall Study||256
6360047|NCT00674986|7269626|FG000|COMPLETED|Overall Study||187
6360048|NCT00674986|7269627|FG001|COMPLETED|Overall Study||188
6360049|NCT00674986|7269626|FG000|NOT COMPLETED|Overall Study||43
6360050|NCT00674986|7269627|FG001|NOT COMPLETED|Overall Study||81
6360051|NCT00675025|7269636|FG000|STARTED|Overall Study||54
6360052|NCT00675025|7269637|FG001|STARTED|Overall Study||63
6360053|NCT00675025|7269636|FG000|COMPLETED|Overall Study||0
6360054|NCT00675025|7269637|FG001|COMPLETED|Overall Study||0
6360055|NCT00675025|7269636|FG000|NOT COMPLETED|Overall Study||54
6360056|NCT00675025|7269637|FG001|NOT COMPLETED|Overall Study||63
6360057|NCT00675103|7269643|FG000|STARTED|Overall Study||7
6360058|NCT00675103|7269643|FG000|COMPLETED|Overall Study||4
6360059|NCT00675103|7269643|FG000|NOT COMPLETED|Overall Study||3
6360060|NCT00675259|7269647|FG000|STARTED|Overall Study||33
6360061|NCT00675259|7269647|FG000|COMPLETED|Overall Study||19
6360062|NCT00675259|7269647|FG000|NOT COMPLETED|Overall Study||14
6360063|NCT00675415|7269657|FG000|STARTED|Overall Study||132
6360064|NCT00675415|7269658|FG001|STARTED|Overall Study||131
6360065|NCT00675415|7269657|FG000|COMPLETED|Overall Study||124
6360066|NCT00675415|7269658|FG001|COMPLETED|Overall Study||123
6360067|NCT00675415|7269657|FG000|NOT COMPLETED|Overall Study||8
6360068|NCT00675415|7269658|FG001|NOT COMPLETED|Overall Study||8
6360069|NCT00675428|7269666|FG000|STARTED|Overall Study||3
6360070|NCT00675428|7269667|FG001|STARTED|Overall Study||3
6360071|NCT00675428|7269666|FG000|COMPLETED|Overall Study||0
6360072|NCT00675428|7269667|FG001|COMPLETED|Overall Study||0
6360073|NCT00675428|7269666|FG000|NOT COMPLETED|Overall Study||3
6360074|NCT00675428|7269667|FG001|NOT COMPLETED|Overall Study||3
6776868|NCT03823378|7704953|FG004|STARTED|Overall Study||20
6776869|NCT03823378|7704954|FG005|STARTED|Overall Study||9
6776870|NCT03823378|7704949|FG000|COMPLETED|Overall Study||7
6776871|NCT03823378|7704950|FG001|COMPLETED|Overall Study||0
6776872|NCT03823378|7704951|FG002|COMPLETED|Overall Study||2
6776873|NCT03823378|7704952|FG003|COMPLETED|Overall Study||2
6776874|NCT03823378|7704953|FG004|COMPLETED|Overall Study||2
6776875|NCT03823378|7704954|FG005|COMPLETED|Overall Study||1
6776876|NCT03823378|7704949|FG000|NOT COMPLETED|Overall Study||21
6776877|NCT03823378|7704950|FG001|NOT COMPLETED|Overall Study||16
6776878|NCT03823378|7704951|FG002|NOT COMPLETED|Overall Study||10
6776879|NCT03823378|7704952|FG003|NOT COMPLETED|Overall Study||10
6776880|NCT03823378|7704953|FG004|NOT COMPLETED|Overall Study||18
6776881|NCT03823378|7704954|FG005|NOT COMPLETED|Overall Study||8
6776882|NCT03831191|7704972|FG000|STARTED|Induction Period (16 Weeks)||33
6776883|NCT03831191|7704973|FG001|STARTED|Induction Period (16 Weeks)||35
6776884|NCT03831191|7704974|FG002|STARTED|Induction Period (16 Weeks)||34
6776885|NCT03831191|7704975|FG003|STARTED|Induction Period (16 Weeks)||34
6776886|NCT03831191|7704976|FG004|STARTED|Induction Period (16 Weeks)||0
6776887|NCT03831191|7704977|FG005|STARTED|Induction Period (16 Weeks)||0
6776888|NCT03831191|7704978|FG006|STARTED|Induction Period (16 Weeks)||0
6776889|NCT03831191|7704979|FG007|STARTED|Induction Period (16 Weeks)||0
6776890|NCT03831191|7704980|FG008|STARTED|Induction Period (16 Weeks)||0
6776891|NCT03831191|7704981|FG009|STARTED|Induction Period (16 Weeks)||0
6776892|NCT03831191|7704982|FG010|STARTED|Induction Period (16 Weeks)||0
6776893|NCT03831191|7704983|FG011|STARTED|Induction Period (16 Weeks)||0
6360075|NCT00675441|7269673|FG000|STARTED|Overall Study||5
6360076|NCT00675441|7269673|FG000|COMPLETED|Overall Study||2
6360077|NCT00675441|7269673|FG000|NOT COMPLETED|Overall Study||3
6360078|NCT00675506|7269679|FG000|STARTED|Overall Study||31
6360079|NCT00675506|7269680|FG001|STARTED|Overall Study||29
6360080|NCT00675506|7269679|FG000|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
6360081|NCT00675506|7269680|FG001|Received Intervention|Overall Study||29
6360082|NCT00675506|7269679|FG000|COMPLETED|Overall Study||19
6360083|NCT00675506|7269680|FG001|COMPLETED|Overall Study||17
6360084|NCT00675506|7269679|FG000|NOT COMPLETED|Overall Study||12
6360085|NCT00675506|7269680|FG001|NOT COMPLETED|Overall Study||12
6360086|NCT00675558|7269690|FG000|STARTED|Surgery||10
6360087|NCT00675558|7269691|FG001|STARTED|Surgery||10
6776894|NCT03831191|7704984|FG012|STARTED|Induction Period (16 Weeks)||0
6776895|NCT03831191|7704985|FG013|STARTED|Induction Period (16 Weeks)||0
6360088|NCT00675558|7269692|FG002|STARTED|Surgery||30
6360089|NCT00675558|7269690|FG000|COMPLETED|Surgery||10
6360090|NCT00675558|7269691|FG001|COMPLETED|Surgery||10
6360091|NCT00675558|7269692|FG002|COMPLETED|Surgery||30
6360092|NCT00675558|7269690|FG000|NOT COMPLETED|Surgery||0
6360093|NCT00675558|7269691|FG001|NOT COMPLETED|Surgery||0
6360094|NCT00675558|7269692|FG002|NOT COMPLETED|Surgery||0
6360095|NCT00675558|7269690|FG000|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
6360096|NCT00675558|7269691|FG001|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
6360097|NCT00675558|7269692|FG002|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
6360098|NCT00675558|7269690|FG000|COMPLETED|Second Operation||0
6360099|NCT00675558|7269691|FG001|COMPLETED|Second Operation||0
6360100|NCT00675558|7269692|FG002|COMPLETED|Second Operation||10
6360101|NCT00675558|7269690|FG000|NOT COMPLETED|Second Operation||0
6360102|NCT00675558|7269691|FG001|NOT COMPLETED|Second Operation||0
6360103|NCT00675558|7269692|FG002|NOT COMPLETED|Second Operation||0
6360104|NCT00675584|7269702|FG000|STARTED|Overall Study||139
6360105|NCT00675584|7269703|FG001|STARTED|Overall Study||139
6360106|NCT00675584|7269702|FG000|COMPLETED|Overall Study||100
6360107|NCT00675584|7269703|FG001|COMPLETED|Overall Study||113
6360108|NCT00675584|7269702|FG000|NOT COMPLETED|Overall Study||39
6360109|NCT00675584|7269703|FG001|NOT COMPLETED|Overall Study||26
6360110|NCT00675597|7269709|FG000|STARTED|Overall Study||26
6360111|NCT00675597|7269709|FG000|COMPLETED|Overall Study||23
6360112|NCT00675597|7269709|FG000|NOT COMPLETED|Overall Study||3
6360113|NCT00675766|7269717|FG000|STARTED|Overall Study||106
6360114|NCT00675766|7269718|FG001|STARTED|Overall Study||30
6360115|NCT00675766|7269719|FG002|STARTED|Overall Study||50
6360116|NCT00675766|7269720|FG003|STARTED|Overall Study||37
6360117|NCT00675766|7269717|FG000|Year 2|Overall Study||105
6360118|NCT00675766|7269718|FG001|Year 2|Overall Study||28
6360119|NCT00675766|7269719|FG002|Year 2|Overall Study||34
6360120|NCT00675766|7269720|FG003|Year 2|Overall Study||20
6360121|NCT00675766|7269717|FG000|Year 3|Overall Study||100
6360122|NCT00675766|7269718|FG001|Year 3|Overall Study||25
6360123|NCT00675766|7269719|FG002|Year 3|Overall Study||29
6360124|NCT00675766|7269720|FG003|Year 3|Overall Study||11
6360125|NCT00675766|7269717|FG000|COMPLETED|Overall Study||100
6360126|NCT00675766|7269718|FG001|COMPLETED|Overall Study||25
6360127|NCT00675766|7269719|FG002|COMPLETED|Overall Study||29
6360128|NCT00675766|7269720|FG003|COMPLETED|Overall Study||11
6360129|NCT00675766|7269717|FG000|NOT COMPLETED|Overall Study||6
6360130|NCT00675766|7269718|FG001|NOT COMPLETED|Overall Study||5
6360131|NCT00675766|7269719|FG002|NOT COMPLETED|Overall Study||21
6360132|NCT00675766|7269720|FG003|NOT COMPLETED|Overall Study||26
6360133|NCT00675792|7269732|FG000|STARTED|Overall Study||51
6360134|NCT00675792|7269733|FG001|STARTED|Overall Study||49
6360135|NCT00675792|7269732|FG000|COMPLETED|Overall Study||51
6360136|NCT00675792|7269733|FG001|COMPLETED|Overall Study||49
6360137|NCT00675792|7269732|FG000|NOT COMPLETED|Overall Study||0
6360138|NCT00675792|7269733|FG001|NOT COMPLETED|Overall Study||0
6360139|NCT00675909|7269742|FG000|STARTED|Overall Study||60
6360140|NCT00675909|7269743|FG001|STARTED|Overall Study||60
6360141|NCT00675909|7269744|FG002|STARTED|Overall Study||60
6360142|NCT00675909|7269742|FG000|COMPLETED|Overall Study||60
6360143|NCT00675909|7269743|FG001|COMPLETED|Overall Study||60
6360144|NCT00675909|7269744|FG002|COMPLETED|Overall Study||60
6360145|NCT00675909|7269742|FG000|NOT COMPLETED|Overall Study||0
6360146|NCT00675909|7269743|FG001|NOT COMPLETED|Overall Study||0
6360147|NCT00675909|7269744|FG002|NOT COMPLETED|Overall Study||0
6360148|NCT00675922|7269752|FG000|STARTED|Overall Study||98
6360149|NCT00675922|7269752|FG000|COMPLETED|Overall Study||98
6360150|NCT00675922|7269752|FG000|NOT COMPLETED|Overall Study||0
6360151|NCT00675948|7269759|FG000|STARTED|Overall Study||39
6360152|NCT00675948|7269760|FG001|STARTED|Overall Study||4
6360153|NCT00675948|7269759|FG000|COMPLETED|Overall Study||0
6776896|NCT03831191|7704986|FG014|STARTED|Induction Period (16 Weeks)||0
6776897|NCT03831191|7704972|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
6776898|NCT03831191|7704973|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||35
6776899|NCT03831191|7704974|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||34
6776900|NCT03831191|7704975|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||33
6776901|NCT03831191|7704976|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776902|NCT03831191|7704977|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776903|NCT03831191|7704978|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776904|NCT03831191|7704979|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776905|NCT03831191|7704980|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776906|NCT03831191|7704981|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6360154|NCT00675948|7269760|FG001|COMPLETED|Overall Study||1
6360155|NCT00675948|7269759|FG000|NOT COMPLETED|Overall Study||39
6360156|NCT00675948|7269760|FG001|NOT COMPLETED|Overall Study||3
6360157|NCT00675987|7269769|FG000|STARTED|Overall Study||26
6360158|NCT00675987|7269770|FG001|STARTED|Overall Study||27
6360159|NCT00675987|7269769|FG000|COMPLETED|Overall Study||26
6360160|NCT00675987|7269770|FG001|COMPLETED|Overall Study||27
6360161|NCT00675987|7269769|FG000|NOT COMPLETED|Overall Study||0
6360162|NCT00675987|7269770|FG001|NOT COMPLETED|Overall Study||0
6360163|NCT00676013|7269778|FG000|STARTED|Overall Study||158
6360164|NCT00676013|7269778|FG000|COMPLETED|Overall Study||157
6360165|NCT00676013|7269778|FG000|NOT COMPLETED|Overall Study||1
6360166|NCT00676052|7269791|FG000|STARTED|Overall Study||96
6360167|NCT00676052|7269792|FG001|STARTED|Overall Study||95
6360168|NCT00676052|7269793|FG002|STARTED|Overall Study||96
6360169|NCT00676052|7269794|FG003|STARTED|Overall Study||97
6360170|NCT00676052|7269795|FG004|STARTED|Overall Study||95
6360171|NCT00676052|7269796|FG005|STARTED|Overall Study||97
6360172|NCT00676052|7269791|FG000|COMPLETED|Overall Study||87
6360173|NCT00676052|7269792|FG001|COMPLETED|Overall Study||88
6360174|NCT00676052|7269793|FG002|COMPLETED|Overall Study||90
6360175|NCT00676052|7269794|FG003|COMPLETED|Overall Study||92
6360176|NCT00676052|7269795|FG004|COMPLETED|Overall Study||89
6360177|NCT00676052|7269796|FG005|COMPLETED|Overall Study||91
6360178|NCT00676052|7269791|FG000|NOT COMPLETED|Overall Study||9
6360179|NCT00676052|7269792|FG001|NOT COMPLETED|Overall Study||7
6360180|NCT00676052|7269793|FG002|NOT COMPLETED|Overall Study||6
6360181|NCT00676052|7269794|FG003|NOT COMPLETED|Overall Study||5
6360182|NCT00676052|7269795|FG004|NOT COMPLETED|Overall Study||6
6360183|NCT00676052|7269796|FG005|NOT COMPLETED|Overall Study||6
6360184|NCT00676065|7269813|FG000|STARTED|Overall Study||16534
6360185|NCT00676065|7269814|FG001|STARTED|Overall Study||15428
6360186|NCT00676065|7269815|FG002|STARTED|Overall Study||26341
6360187|NCT00676065|7269813|FG000|COMPLETED|Overall Study||16534
6360188|NCT00676065|7269814|FG001|COMPLETED|Overall Study||15428
6360189|NCT00676065|7269815|FG002|COMPLETED|Overall Study||26341
6360190|NCT00676065|7269813|FG000|NOT COMPLETED|Overall Study||0
6360191|NCT00676065|7269814|FG001|NOT COMPLETED|Overall Study||0
6360192|NCT00676065|7269815|FG002|NOT COMPLETED|Overall Study||0
6360193|NCT00676091|7269825|FG000|STARTED|Infant Series||177
6360194|NCT00676091|7269826|FG001|STARTED|Infant Series||177
6360195|NCT00676091|7269825|FG000|Vaccinated Dose 1|Infant Series||163
6360196|NCT00676091|7269826|FG001|Vaccinated Dose 1|Infant Series||162
6360197|NCT00676091|7269825|FG000|Vaccinated Dose 2|Infant Series||159
6360198|NCT00676091|7269826|FG001|Vaccinated Dose 2|Infant Series||162
6360199|NCT00676091|7269825|FG000|Vaccinated Dose 3|Infant Series||158
6360200|NCT00676091|7269826|FG001|Vaccinated Dose 3|Infant Series||161
6360201|NCT00676091|7269825|FG000|COMPLETED|Infant Series||157
6360202|NCT00676091|7269826|FG001|COMPLETED|Infant Series||159
6360203|NCT00676091|7269825|FG000|NOT COMPLETED|Infant Series||20
6360204|NCT00676091|7269826|FG001|NOT COMPLETED|Infant Series||18
6360205|NCT00676091|7269825|FG000|STARTED|After Infant Series||157
6360206|NCT00676091|7269826|FG001|STARTED|After Infant Series||159
6360207|NCT00676091|7269825|FG000|COMPLETED|After Infant Series||156
6360208|NCT00676091|7269826|FG001|COMPLETED|After Infant Series||156
6360209|NCT00676091|7269825|FG000|NOT COMPLETED|After Infant Series||1
6360210|NCT00676091|7269826|FG001|NOT COMPLETED|After Infant Series||3
6360211|NCT00676091|7269825|FG000|STARTED|Toddler Dose||156
6360212|NCT00676091|7269826|FG001|STARTED|Toddler Dose||156
6360213|NCT00676091|7269825|FG000|COMPLETED|Toddler Dose||153
6360214|NCT00676091|7269826|FG001|COMPLETED|Toddler Dose||156
6360215|NCT00676091|7269825|FG000|NOT COMPLETED|Toddler Dose||3
6360216|NCT00676091|7269826|FG001|NOT COMPLETED|Toddler Dose||0
6360217|NCT00676130|7269838|FG000|STARTED|Overall Study||76
6360218|NCT00676130|7269839|FG001|STARTED|Overall Study||77
6360219|NCT00676130|7269838|FG000|COMPLETED|Overall Study||73
6360220|NCT00676130|7269839|FG001|COMPLETED|Overall Study||73
6560236|NCT01785615|7482928|FG002|COMPLETED|Atorvastatin Phase||0
6560237|NCT01785615|7482929|FG003|COMPLETED|Atorvastatin Phase||0
6560238|NCT01785615|7482926|FG000|NOT COMPLETED|Atorvastatin Phase||0
6560239|NCT01785615|7482927|FG001|NOT COMPLETED|Atorvastatin Phase||0
6560240|NCT01785615|7482928|FG002|NOT COMPLETED|Atorvastatin Phase||0
6360221|NCT00676130|7269838|FG000|NOT COMPLETED|Overall Study||3
6360222|NCT00676130|7269839|FG001|NOT COMPLETED|Overall Study||4
6360223|NCT00676143|7269847|FG000|STARTED|Overall Study||441
6360224|NCT00676143|7269848|FG001|STARTED|Overall Study||658
6360225|NCT00676143|7269847|FG000|Treated|Overall Study||439
6360226|NCT00676143|7269848|FG001|Treated|Overall Study||654
6360227|NCT00676143|7269847|FG000|COMPLETED|Overall Study||285
6360228|NCT00676143|7269848|FG001|COMPLETED|Overall Study||398
6360229|NCT00676143|7269847|FG000|NOT COMPLETED|Overall Study||156
6360230|NCT00676143|7269848|FG001|NOT COMPLETED|Overall Study||260
6360231|NCT00676182|7269857|FG000|STARTED|Overall Study||75
6360232|NCT00676182|7269857|FG000|COMPLETED|Overall Study||75
6360233|NCT00676182|7269857|FG000|NOT COMPLETED|Overall Study||0
6360234|NCT00676195|7269867|FG000|STARTED|Overall Study||24
6360235|NCT00676195|7269867|FG000|COMPLETED|Overall Study||21
6360236|NCT00676195|7269867|FG000|NOT COMPLETED|Overall Study||3
6360237|NCT00676208|7269874|FG000|STARTED|Overall Study||14
6360238|NCT00676208|7269875|FG001|STARTED|Overall Study||19
6360239|NCT00676208|7269874|FG000|COMPLETED|Overall Study||12
6360240|NCT00676208|7269875|FG001|COMPLETED|Overall Study||13
6360241|NCT00676208|7269874|FG000|NOT COMPLETED|Overall Study||2
6360242|NCT00676208|7269875|FG001|NOT COMPLETED|Overall Study||6
6360243|NCT00676338|7269887|FG000|STARTED|Overall Study||248
6360244|NCT00676338|7269888|FG001|STARTED|Overall Study||246
6360245|NCT00676338|7269889|FG002|STARTED|Overall Study||163
6360246|NCT00676338|7269890|FG003|STARTED|Overall Study||163
6360247|NCT00676338|7269887|FG000|COMPLETED|Overall Study||210
6360248|NCT00676338|7269888|FG001|COMPLETED|Overall Study||213
6360249|NCT00676338|7269889|FG002|COMPLETED|Overall Study||133
6560241|NCT01785615|7482929|FG003|NOT COMPLETED|Atorvastatin Phase||0
6360250|NCT00676338|7269890|FG003|COMPLETED|Overall Study||140
6360251|NCT00676338|7269887|FG000|NOT COMPLETED|Overall Study||38
6360252|NCT00676338|7269888|FG001|NOT COMPLETED|Overall Study||33
6360253|NCT00676338|7269889|FG002|NOT COMPLETED|Overall Study||30
6360254|NCT00676338|7269890|FG003|NOT COMPLETED|Overall Study||23
6360255|NCT00676364|7269902|FG000|STARTED|Overall Study||57
6360256|NCT00676364|7269903|FG001|STARTED|Overall Study||57
6360257|NCT00676364|7269902|FG000|COMPLETED|Overall Study||57
6360258|NCT00676364|7269903|FG001|COMPLETED|Overall Study||57
6360259|NCT00676364|7269902|FG000|NOT COMPLETED|Overall Study||0
6360260|NCT00676364|7269903|FG001|NOT COMPLETED|Overall Study||0
6360261|NCT00676403|7269917|FG000|STARTED|Overall Study||23
6360262|NCT00676403|7269918|FG001|STARTED|Overall Study||22
6360263|NCT00676403|7269919|FG002|STARTED|Overall Study||23
6360264|NCT00676403|7269920|FG003|STARTED|Overall Study||22
6360265|NCT00676403|7269921|FG004|STARTED|Overall Study||24
6360266|NCT00676403|7269922|FG005|STARTED|Overall Study||23
6360267|NCT00676403|7269917|FG000|COMPLETED|Overall Study||21
6360268|NCT00676403|7269918|FG001|COMPLETED|Overall Study||20
6360269|NCT00676403|7269919|FG002|COMPLETED|Overall Study||22
6360270|NCT00676403|7269920|FG003|COMPLETED|Overall Study||17
6360271|NCT00676403|7269921|FG004|COMPLETED|Overall Study||23
6360272|NCT00676403|7269922|FG005|COMPLETED|Overall Study||18
6360273|NCT00676403|7269917|FG000|NOT COMPLETED|Overall Study||2
6360274|NCT00676403|7269918|FG001|NOT COMPLETED|Overall Study||2
6360275|NCT00676403|7269919|FG002|NOT COMPLETED|Overall Study||1
6360276|NCT00676403|7269920|FG003|NOT COMPLETED|Overall Study||5
6360277|NCT00676403|7269921|FG004|NOT COMPLETED|Overall Study||1
6360278|NCT00676403|7269922|FG005|NOT COMPLETED|Overall Study||5
6360279|NCT00676520|7269942|FG000|STARTED|Overall Study||8040
6360280|NCT00676520|7269942|FG000|COMPLETED|Overall Study||7309
6360281|NCT00676520|7269942|FG000|NOT COMPLETED|Overall Study||731
6360282|NCT00676572|7269953|FG000|STARTED|Overall Study||6
6360283|NCT00676572|7269954|FG001|STARTED|Overall Study||6
6360284|NCT00676572|7269953|FG000|COMPLETED|Overall Study||6
6360285|NCT00676572|7269954|FG001|COMPLETED|Overall Study||6
6360286|NCT00676572|7269953|FG000|NOT COMPLETED|Overall Study||0
6360287|NCT00676572|7269954|FG001|NOT COMPLETED|Overall Study||0
6360288|NCT00676585|7269962|FG000|STARTED|Overall Study||25
6360289|NCT00676585|7269963|FG001|STARTED|Overall Study||25
6360290|NCT00676585|7269962|FG000|COMPLETED|Overall Study||25
6360291|NCT00676585|7269963|FG001|COMPLETED|Overall Study||25
6360292|NCT00676585|7269962|FG000|NOT COMPLETED|Overall Study||0
6360293|NCT00676585|7269963|FG001|NOT COMPLETED|Overall Study||0
6360294|NCT00676650|7269971|FG000|STARTED|Overall Study||584
6360295|NCT00676650|7269972|FG001|STARTED|Overall Study||289
6360296|NCT00676650|7269971|FG000|Treated|Overall Study||581
6360297|NCT00676650|7269972|FG001|Treated|Overall Study||285
6360298|NCT00676650|7269971|FG000|COMPLETED|Overall Study||0
6360299|NCT00676650|7269972|FG001|COMPLETED|Overall Study||0
6360300|NCT00676650|7269971|FG000|NOT COMPLETED|Overall Study||584
6360301|NCT00676650|7269972|FG001|NOT COMPLETED|Overall Study||289
6360302|NCT00676663|7269980|FG000|STARTED|Overall Study||66
6360303|NCT00676663|7269981|FG001|STARTED|Overall Study||64
6360304|NCT00676663|7269980|FG000|COMPLETED|Overall Study||21
6360305|NCT00676663|7269981|FG001|COMPLETED|Overall Study||26
6360306|NCT00676663|7269980|FG000|NOT COMPLETED|Overall Study||45
6360307|NCT00676663|7269981|FG001|NOT COMPLETED|Overall Study||38
6360308|NCT00676676|7269989|FG000|STARTED|Overall Study||9
6360309|NCT00676676|7269989|FG000|COMPLETED|Overall Study||9
6360310|NCT00676676|7269989|FG000|NOT COMPLETED|Overall Study||0
6360311|NCT00676689|7269993|FG000|STARTED|Overall Study||81
6360312|NCT00676689|7269993|FG000|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
6360313|NCT00676689|7269993|FG000|30 Day Follow-up|Overall Study||78
6360314|NCT00676689|7269993|FG000|1 Year Follow-up|Overall Study||64
6360315|NCT00676689|7269993|FG000|COMPLETED|Overall Study||20
6360316|NCT00676689|7269993|FG000|NOT COMPLETED|Overall Study||61
6360317|NCT00676780|7269997|FG000|STARTED|Overall Study||33
6360318|NCT00676780|7269997|FG000|COMPLETED|Overall Study||26
6360319|NCT00676780|7269997|FG000|NOT COMPLETED|Overall Study||7
6360320|NCT00676793|7270003|FG000|STARTED|Overall Study||32
6360321|NCT00676793|7270003|FG000|COMPLETED|Overall Study||19
6360322|NCT00676793|7270003|FG000|NOT COMPLETED|Overall Study||13
6360323|NCT00676806|7270010|FG000|STARTED|Overall Study||3
6360324|NCT00676806|7270011|FG001|STARTED|Overall Study||3
6360325|NCT00676806|7270010|FG000|COMPLETED|Overall Study||3
6360326|NCT00676806|7270011|FG001|COMPLETED|Overall Study||3
6360327|NCT00676806|7270010|FG000|NOT COMPLETED|Overall Study||0
6360328|NCT00676806|7270011|FG001|NOT COMPLETED|Overall Study||0
6360329|NCT00676897|7270023|FG000|STARTED|Overall Study||8
6360330|NCT00676897|7270024|FG001|STARTED|Overall Study||10
6360331|NCT00676897|7270023|FG000|COMPLETED|Overall Study||8
6360332|NCT00676897|7270024|FG001|COMPLETED|Overall Study||10
6360333|NCT00676897|7270023|FG000|NOT COMPLETED|Overall Study||0
6360334|NCT00676897|7270024|FG001|NOT COMPLETED|Overall Study||0
6360335|NCT00677014|7270033|FG000|STARTED|Overall Study||325
6360336|NCT00677014|7270034|FG001|STARTED|Overall Study||323
6360337|NCT00677014|7270035|FG002|STARTED|Overall Study||332
6360338|NCT00677014|7270033|FG000|COMPLETED|Overall Study||281
6360339|NCT00677014|7270034|FG001|COMPLETED|Overall Study||282
6360340|NCT00677014|7270035|FG002|COMPLETED|Overall Study||283
6360341|NCT00677014|7270033|FG000|NOT COMPLETED|Overall Study||44
6360342|NCT00677014|7270034|FG001|NOT COMPLETED|Overall Study||41
6360343|NCT00677014|7270035|FG002|NOT COMPLETED|Overall Study||49
6360344|NCT00677040|7270043|FG000|STARTED|Overall Study||20
6360345|NCT00677040|7270043|FG000|COMPLETED|Overall Study||20
6360346|NCT00677040|7270043|FG000|NOT COMPLETED|Overall Study||0
6360347|NCT00677092|7270048|FG000|STARTED|Overall Study||12
6360348|NCT00677092|7270048|FG000|Received Study Treatment|Overall Study||11
6360349|NCT00677092|7270048|FG000|COMPLETED|Overall Study||6
6360350|NCT00677092|7270048|FG000|NOT COMPLETED|Overall Study||6
6360351|NCT00677235|7270055|FG000|STARTED|Overall Study||138
6360352|NCT00677235|7270056|FG001|STARTED|Overall Study||132
6360353|NCT00677235|7270055|FG000|COMPLETED|Overall Study||97
6360354|NCT00677235|7270056|FG001|COMPLETED|Overall Study||94
6360355|NCT00677235|7270055|FG000|NOT COMPLETED|Overall Study||41
6360356|NCT00677235|7270056|FG001|NOT COMPLETED|Overall Study||38
6360357|NCT00677352|7270064|FG000|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
6360358|NCT00677352|7270065|FG001|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
6360359|NCT00677352|7270064|FG000|COMPLETED|Treatment Phase||132
6360360|NCT00677352|7270065|FG001|COMPLETED|Treatment Phase||122
6360361|NCT00677352|7270064|FG000|NOT COMPLETED|Treatment Phase||25
6360362|NCT00677352|7270065|FG001|NOT COMPLETED|Treatment Phase||42
6360363|NCT00677352|7270064|FG000|STARTED|Tapering Phase||132
6360364|NCT00677352|7270065|FG001|STARTED|Tapering Phase||122
6360365|NCT00677352|7270064|FG000|COMPLETED|Tapering Phase||126
6360366|NCT00677352|7270065|FG001|COMPLETED|Tapering Phase||112
6360367|NCT00677352|7270064|FG000|NOT COMPLETED|Tapering Phase||6
6360368|NCT00677352|7270065|FG001|NOT COMPLETED|Tapering Phase||10
6776907|NCT03831191|7704982|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776908|NCT03831191|7704983|FG011|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776909|NCT03831191|7704984|FG012|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776910|NCT03831191|7704985|FG013|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776911|NCT03831191|7704986|FG014|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6776912|NCT03831191|7704972|FG000|COMPLETED|Induction Period (16 Weeks)||10
6776913|NCT03831191|7704973|FG001|COMPLETED|Induction Period (16 Weeks)||14
6776914|NCT03831191|7704974|FG002|COMPLETED|Induction Period (16 Weeks)||13
6776915|NCT03831191|7704975|FG003|COMPLETED|Induction Period (16 Weeks)||11
6776916|NCT03831191|7704976|FG004|COMPLETED|Induction Period (16 Weeks)||0
6776917|NCT03831191|7704977|FG005|COMPLETED|Induction Period (16 Weeks)||0
6776918|NCT03831191|7704978|FG006|COMPLETED|Induction Period (16 Weeks)||0
6776919|NCT03831191|7704979|FG007|COMPLETED|Induction Period (16 Weeks)||0
6776920|NCT03831191|7704980|FG008|COMPLETED|Induction Period (16 Weeks)||0
6776921|NCT03831191|7704981|FG009|COMPLETED|Induction Period (16 Weeks)||0
6776922|NCT03831191|7704982|FG010|COMPLETED|Induction Period (16 Weeks)||0
6776923|NCT03831191|7704983|FG011|COMPLETED|Induction Period (16 Weeks)||0
6776924|NCT03831191|7704984|FG012|COMPLETED|Induction Period (16 Weeks)||0
6776925|NCT03831191|7704985|FG013|COMPLETED|Induction Period (16 Weeks)||0
6776926|NCT03831191|7704986|FG014|COMPLETED|Induction Period (16 Weeks)||0
6776927|NCT03831191|7704972|FG000|NOT COMPLETED|Induction Period (16 Weeks)||23
6776928|NCT03831191|7704973|FG001|NOT COMPLETED|Induction Period (16 Weeks)||21
6776929|NCT03831191|7704974|FG002|NOT COMPLETED|Induction Period (16 Weeks)||21
6776930|NCT03831191|7704975|FG003|NOT COMPLETED|Induction Period (16 Weeks)||23
6776931|NCT03831191|7704976|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
6776932|NCT03831191|7704977|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
6776933|NCT03831191|7704978|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
6776934|NCT03831191|7704979|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
6776935|NCT03831191|7704980|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
6776936|NCT03831191|7704981|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
6776937|NCT03831191|7704982|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
6776938|NCT03831191|7704983|FG011|NOT COMPLETED|Induction Period (16 Weeks)||0
6776939|NCT03831191|7704984|FG012|NOT COMPLETED|Induction Period (16 Weeks)||0
6776940|NCT03831191|7704985|FG013|NOT COMPLETED|Induction Period (16 Weeks)||0
6776941|NCT03831191|7704986|FG014|NOT COMPLETED|Induction Period (16 Weeks)||0
6776942|NCT03831191|7704972|FG000|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
6776943|NCT03831191|7704973|FG001|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
6776944|NCT03831191|7704974|FG002|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
6776945|NCT03831191|7704975|FG003|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during induction period.|0
6776946|NCT03831191|7704976|FG004|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
6776947|NCT03831191|7704977|FG005|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|5
6776948|NCT03831191|7704978|FG006|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|2
6776949|NCT03831191|7704979|FG007|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
6360369|NCT00677365|7270075|FG000|STARTED|Overall Study||37
6360370|NCT00677365|7270076|FG001|STARTED|Overall Study||38
6360371|NCT00677365|7270077|FG002|STARTED|Overall Study||37
6360372|NCT00677365|7270078|FG003|STARTED|Overall Study||39
6360373|NCT00677365|7270075|FG000|COMPLETED|Overall Study||35
6360374|NCT00677365|7270076|FG001|COMPLETED|Overall Study||37
6360375|NCT00677365|7270077|FG002|COMPLETED|Overall Study||35
6360376|NCT00677365|7270078|FG003|COMPLETED|Overall Study||36
6360377|NCT00677365|7270075|FG000|NOT COMPLETED|Overall Study||2
6360378|NCT00677365|7270076|FG001|NOT COMPLETED|Overall Study||1
6360379|NCT00677365|7270077|FG002|NOT COMPLETED|Overall Study||2
6360380|NCT00677365|7270078|FG003|NOT COMPLETED|Overall Study||3
6360381|NCT00677534|7270088|FG000|STARTED|Washout (Weeks 1-4)||10
6560242|NCT01785628|7482943|FG000|STARTED|Overall Study||15
6560243|NCT01785628|7482944|FG001|STARTED|Overall Study||15
6560244|NCT01785628|7482943|FG000|COMPLETED|Overall Study||13
6560245|NCT01785628|7482944|FG001|COMPLETED|Overall Study||12
6560246|NCT01785628|7482943|FG000|NOT COMPLETED|Overall Study||2
6776950|NCT03831191|7704980|FG008|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
6360382|NCT00677534|7270088|FG000|COMPLETED|Washout (Weeks 1-4)||7
6360383|NCT00677534|7270088|FG000|NOT COMPLETED|Washout (Weeks 1-4)||3
6360384|NCT00677534|7270088|FG000|STARTED|Cholecalciferol (Weeks 5-12)||7
6360385|NCT00677534|7270088|FG000|COMPLETED|Cholecalciferol (Weeks 5-12)||7
6360386|NCT00677534|7270088|FG000|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
6360387|NCT00677534|7270088|FG000|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
6360388|NCT00677534|7270088|FG000|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
6360389|NCT00677534|7270088|FG000|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
6360390|NCT00677690|7270094|FG000|STARTED|Overall Study||42
6360391|NCT00677690|7270095|FG001|STARTED|Overall Study||41
6360392|NCT00677690|7270094|FG000|COMPLETED|Overall Study||42
6360393|NCT00677690|7270095|FG001|COMPLETED|Overall Study||41
6360394|NCT00677690|7270094|FG000|NOT COMPLETED|Overall Study||0
6360395|NCT00677690|7270095|FG001|NOT COMPLETED|Overall Study||0
6360396|NCT00677807|7270104|FG000|STARTED|Overall Study||144
6360397|NCT00677807|7270105|FG001|STARTED|Overall Study||146
6360398|NCT00677807|7270106|FG002|STARTED|Overall Study||125
6360399|NCT00677807|7270104|FG000|Safety/ITT: Received Study Drug|Overall Study||144
6360400|NCT00677807|7270105|FG001|Safety/ITT: Received Study Drug|Overall Study||146
6360401|NCT00677807|7270106|FG002|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
6360402|NCT00677807|7270104|FG000|COMPLETED|Overall Study||126
6360403|NCT00677807|7270105|FG001|COMPLETED|Overall Study||135
6360404|NCT00677807|7270106|FG002|COMPLETED|Overall Study||105
6360405|NCT00677807|7270104|FG000|NOT COMPLETED|Overall Study||18
6360406|NCT00677807|7270105|FG001|NOT COMPLETED|Overall Study||11
6360407|NCT00677807|7270106|FG002|NOT COMPLETED|Overall Study||20
6360408|NCT00677820|7270116|FG000|STARTED|Overall Study||240
6776951|NCT03831191|7704981|FG009|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
6776952|NCT03831191|7704982|FG010|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|4
6776953|NCT03831191|7704983|FG011|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|8
6776954|NCT03831191|7704984|FG012|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
6776955|NCT03831191|7704985|FG013|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|1
6776956|NCT03831191|7704986|FG014|STARTED|Maintenance Period (36 Weeks)|Participants were assigned to this arm during maintenance period.|9
6776957|NCT03831191|7704972|FG000|COMPLETED|Maintenance Period (36 Weeks)||0
6776958|NCT03831191|7704973|FG001|COMPLETED|Maintenance Period (36 Weeks)||0
6776959|NCT03831191|7704974|FG002|COMPLETED|Maintenance Period (36 Weeks)||0
6776960|NCT03831191|7704975|FG003|COMPLETED|Maintenance Period (36 Weeks)||0
6776961|NCT03831191|7704976|FG004|COMPLETED|Maintenance Period (36 Weeks)||0
6776962|NCT03831191|7704977|FG005|COMPLETED|Maintenance Period (36 Weeks)||0
6776963|NCT03831191|7704978|FG006|COMPLETED|Maintenance Period (36 Weeks)||0
6776964|NCT03831191|7704979|FG007|COMPLETED|Maintenance Period (36 Weeks)||0
6776965|NCT03831191|7704980|FG008|COMPLETED|Maintenance Period (36 Weeks)||0
6776966|NCT03831191|7704981|FG009|COMPLETED|Maintenance Period (36 Weeks)||0
6776967|NCT03831191|7704982|FG010|COMPLETED|Maintenance Period (36 Weeks)||0
6776968|NCT03831191|7704983|FG011|COMPLETED|Maintenance Period (36 Weeks)||1
6776969|NCT03831191|7704984|FG012|COMPLETED|Maintenance Period (36 Weeks)||0
6776970|NCT03831191|7704985|FG013|COMPLETED|Maintenance Period (36 Weeks)||0
6776971|NCT03831191|7704986|FG014|COMPLETED|Maintenance Period (36 Weeks)||0
6776972|NCT03831191|7704972|FG000|NOT COMPLETED|Maintenance Period (36 Weeks)||0
6776973|NCT03831191|7704973|FG001|NOT COMPLETED|Maintenance Period (36 Weeks)||0
6776974|NCT03831191|7704974|FG002|NOT COMPLETED|Maintenance Period (36 Weeks)||0
6776975|NCT03831191|7704975|FG003|NOT COMPLETED|Maintenance Period (36 Weeks)||0
6776976|NCT03831191|7704976|FG004|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6776977|NCT03831191|7704977|FG005|NOT COMPLETED|Maintenance Period (36 Weeks)||5
6776978|NCT03831191|7704978|FG006|NOT COMPLETED|Maintenance Period (36 Weeks)||2
6776979|NCT03831191|7704979|FG007|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6776980|NCT03831191|7704980|FG008|NOT COMPLETED|Maintenance Period (36 Weeks)||8
6776981|NCT03831191|7704981|FG009|NOT COMPLETED|Maintenance Period (36 Weeks)||1
6776982|NCT03831191|7704982|FG010|NOT COMPLETED|Maintenance Period (36 Weeks)||4
6776983|NCT03831191|7704983|FG011|NOT COMPLETED|Maintenance Period (36 Weeks)||7
6776984|NCT03831191|7704984|FG012|NOT COMPLETED|Maintenance Period (36 Weeks)||1
6776985|NCT03831191|7704985|FG013|NOT COMPLETED|Maintenance Period (36 Weeks)||1
6776986|NCT03831191|7704986|FG014|NOT COMPLETED|Maintenance Period (36 Weeks)||9
6776987|NCT03831191|7704972|FG000|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776988|NCT03831191|7704973|FG001|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6560247|NCT01785628|7482944|FG001|NOT COMPLETED|Overall Study||3
6560248|NCT01785680|7482952|FG000|STARTED|Overall Study||1100
6360409|NCT00677820|7270117|FG001|STARTED|Overall Study||60
6360410|NCT00677820|7270116|FG000|COMPLETED|Overall Study||239
6360411|NCT00677820|7270117|FG001|COMPLETED|Overall Study||60
6360412|NCT00677820|7270116|FG000|NOT COMPLETED|Overall Study||1
6360413|NCT00677820|7270117|FG001|NOT COMPLETED|Overall Study||0
6360414|NCT00677833|7270127|FG000|STARTED|Overall Study||55
6360415|NCT00677833|7270128|FG001|STARTED|Overall Study||51
6360416|NCT00677833|7270129|FG002|STARTED|Overall Study||124
6560249|NCT01785680|7482953|FG001|STARTED|Overall Study||857
6560250|NCT01785680|7482952|FG000|COMPLETED|Overall Study||1100
6776989|NCT03831191|7704974|FG002|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776990|NCT03831191|7704975|FG003|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776991|NCT03831191|7704976|FG004|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776992|NCT03831191|7704977|FG005|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6360417|NCT00677833|7270130|FG003|STARTED|Overall Study||131
6360418|NCT00677833|7270127|FG000|COMPLETED|Overall Study||51
6360419|NCT00677833|7270128|FG001|COMPLETED|Overall Study||51
6360420|NCT00677833|7270129|FG002|COMPLETED|Overall Study||122
6360421|NCT00677833|7270130|FG003|COMPLETED|Overall Study||128
6360422|NCT00677833|7270127|FG000|NOT COMPLETED|Overall Study||4
6360423|NCT00677833|7270128|FG001|NOT COMPLETED|Overall Study||0
6360424|NCT00677833|7270129|FG002|NOT COMPLETED|Overall Study||2
6360425|NCT00677833|7270130|FG003|NOT COMPLETED|Overall Study||3
6360426|NCT00677898|7270140|FG000|STARTED|Overall Study||119
6360427|NCT00677898|7270141|FG001|STARTED|Overall Study||120
6360428|NCT00677898|7270140|FG000|COMPLETED|Overall Study||99
6360429|NCT00677898|7270141|FG001|COMPLETED|Overall Study||102
6776993|NCT03831191|7704978|FG006|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776994|NCT03831191|7704979|FG007|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776995|NCT03831191|7704980|FG008|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776996|NCT03831191|7704981|FG009|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776997|NCT03831191|7704982|FG010|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6776998|NCT03831191|7704983|FG011|STARTED|Post-Treatment Follow-Up Period(8 Weeks)|No participant entered the post follow-up period.|0
6776999|NCT03831191|7704984|FG012|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777000|NCT03831191|7704985|FG013|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777001|NCT03831191|7704986|FG014|STARTED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777002|NCT03831191|7704972|FG000|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777003|NCT03831191|7704973|FG001|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777004|NCT03831191|7704974|FG002|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777005|NCT03831191|7704975|FG003|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777006|NCT03831191|7704976|FG004|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777007|NCT03831191|7704977|FG005|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777008|NCT03831191|7704978|FG006|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777009|NCT03831191|7704979|FG007|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777010|NCT03831191|7704980|FG008|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777011|NCT03831191|7704981|FG009|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777012|NCT03831191|7704982|FG010|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777013|NCT03831191|7704983|FG011|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777014|NCT03831191|7704984|FG012|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777015|NCT03831191|7704985|FG013|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777016|NCT03831191|7704986|FG014|COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777017|NCT03831191|7704972|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777018|NCT03831191|7704973|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777019|NCT03831191|7704974|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777020|NCT03831191|7704975|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777021|NCT03831191|7704976|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777022|NCT03831191|7704977|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777023|NCT03831191|7704978|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777024|NCT03831191|7704979|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777025|NCT03831191|7704980|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777026|NCT03831191|7704981|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777027|NCT03831191|7704982|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777028|NCT03831191|7704983|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777029|NCT03831191|7704984|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777030|NCT03831191|7704985|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777031|NCT03831191|7704986|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period(8 Weeks)||0
6777032|NCT03830281|7705021|FG000|STARTED|Lead-in Period (2 Weeks)||471
6777033|NCT03830281|7705022|FG001|STARTED|Lead-in Period (2 Weeks)||0
6777034|NCT03830281|7705021|FG000|COMPLETED|Lead-in Period (2 Weeks)||432
6777035|NCT03830281|7705022|FG001|COMPLETED|Lead-in Period (2 Weeks)||0
6360430|NCT00677898|7270140|FG000|NOT COMPLETED|Overall Study||20
6360431|NCT00677898|7270141|FG001|NOT COMPLETED|Overall Study||18
6360432|NCT00677924|7270149|FG000|STARTED|Overall Study||3
6360433|NCT00677924|7270150|FG001|STARTED|Overall Study||6
6360434|NCT00677924|7270149|FG000|COMPLETED|Overall Study||3
6360435|NCT00677924|7270150|FG001|COMPLETED|Overall Study||6
6360436|NCT00677924|7270149|FG000|NOT COMPLETED|Overall Study||0
6560251|NCT01785680|7482953|FG001|COMPLETED|Overall Study||857
6560252|NCT01785680|7482952|FG000|NOT COMPLETED|Overall Study||0
6360437|NCT00677924|7270150|FG001|NOT COMPLETED|Overall Study||0
6360438|NCT00678015|7270156|FG000|STARTED|Overall Study||12
6360439|NCT00678015|7270156|FG000|COMPLETED|Overall Study||12
6360440|NCT00678015|7270156|FG000|NOT COMPLETED|Overall Study||0
6360441|NCT00678080|7270162|FG000|STARTED|Overall Study||11
6360442|NCT00678080|7270163|FG001|STARTED|Overall Study||14
6360443|NCT00678080|7270162|FG000|COMPLETED|Overall Study||8
6360444|NCT00678080|7270163|FG001|COMPLETED|Overall Study||13
6360445|NCT00678080|7270162|FG000|NOT COMPLETED|Overall Study||3
6360446|NCT00678080|7270163|FG001|NOT COMPLETED|Overall Study||1
6560253|NCT01785680|7482953|FG001|NOT COMPLETED|Overall Study||0
6560254|NCT01785810|7482959|FG000|STARTED|Overall Study||37
6777036|NCT03830281|7705021|FG000|NOT COMPLETED|Lead-in Period (2 Weeks)||39
6777037|NCT03830281|7705022|FG001|NOT COMPLETED|Lead-in Period (2 Weeks)||0
6777038|NCT03830281|7705021|FG000|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|217
6777039|NCT03830281|7705022|FG001|STARTED|Treatment Period (16 Weeks)|Pts who completed lead-in period randomized to Humalog or Ultra-Rapid Lispro in treatment period.|215
6360447|NCT00678210|7270173|FG000|STARTED|Overall Study||49
6360448|NCT00678210|7270174|FG001|STARTED|Overall Study||49
6360449|NCT00678210|7270175|FG002|STARTED|Overall Study||49
6360450|NCT00678210|7270176|FG003|STARTED|Overall Study||50
6360451|NCT00678210|7270173|FG000|COMPLETED|Overall Study||38
6360452|NCT00678210|7270174|FG001|COMPLETED|Overall Study||38
6360453|NCT00678210|7270175|FG002|COMPLETED|Overall Study||43
6360454|NCT00678210|7270176|FG003|COMPLETED|Overall Study||30
6360455|NCT00678210|7270173|FG000|NOT COMPLETED|Overall Study||11
6360456|NCT00678210|7270174|FG001|NOT COMPLETED|Overall Study||11
6360457|NCT00678210|7270175|FG002|NOT COMPLETED|Overall Study||6
6360458|NCT00678210|7270176|FG003|NOT COMPLETED|Overall Study||20
6360459|NCT00678249|7270189|FG000|STARTED|Overall Study||97
6360460|NCT00678249|7270190|FG001|STARTED|Overall Study||93
6360461|NCT00678249|7270191|FG002|STARTED|Overall Study||37
6360462|NCT00678249|7270189|FG000|COMPLETED|Overall Study||97
6360463|NCT00678249|7270190|FG001|COMPLETED|Overall Study||93
6360464|NCT00678249|7270191|FG002|COMPLETED|Overall Study||37
6360465|NCT00678249|7270189|FG000|NOT COMPLETED|Overall Study||0
6360466|NCT00678249|7270190|FG001|NOT COMPLETED|Overall Study||0
6360467|NCT00678249|7270191|FG002|NOT COMPLETED|Overall Study||0
6777040|NCT03830281|7705021|FG000|COMPLETED|Treatment Period (16 Weeks)||205
6777041|NCT03830281|7705022|FG001|COMPLETED|Treatment Period (16 Weeks)||198
6777042|NCT03830281|7705021|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||12
6777043|NCT03830281|7705022|FG001|NOT COMPLETED|Treatment Period (16 Weeks)||17
6777044|NCT03828734|7705029|FG000|STARTED|Baseline||32
6777045|NCT03828734|7705030|FG001|STARTED|Baseline||26
6777046|NCT03828734|7705029|FG000|COMPLETED|Baseline||32
6777047|NCT03828734|7705030|FG001|COMPLETED|Baseline||26
6777048|NCT03828734|7705029|FG000|NOT COMPLETED|Baseline||0
6777049|NCT03828734|7705030|FG001|NOT COMPLETED|Baseline||0
6777050|NCT03828734|7705029|FG000|STARTED|Pre-Randomization (1 Week)||32
6777051|NCT03828734|7705030|FG001|STARTED|Pre-Randomization (1 Week)||26
6777052|NCT03828734|7705029|FG000|COMPLETED|Pre-Randomization (1 Week)||29
6777053|NCT03828734|7705030|FG001|COMPLETED|Pre-Randomization (1 Week)||25
6777054|NCT03828734|7705029|FG000|NOT COMPLETED|Pre-Randomization (1 Week)||3
6777055|NCT03828734|7705030|FG001|NOT COMPLETED|Pre-Randomization (1 Week)||1
6777056|NCT03828734|7705029|FG000|STARTED|First Intervention||29
6777057|NCT03828734|7705030|FG001|STARTED|First Intervention||25
6777058|NCT03828734|7705029|FG000|COMPLETED|First Intervention||25
6777059|NCT03828734|7705030|FG001|COMPLETED|First Intervention||25
6777060|NCT03828734|7705029|FG000|NOT COMPLETED|First Intervention||4
6777061|NCT03828734|7705030|FG001|NOT COMPLETED|First Intervention||0
6777062|NCT03828734|7705029|FG000|STARTED|First Washout (1 Week)||25
6777063|NCT03828734|7705030|FG001|STARTED|First Washout (1 Week)||25
6777064|NCT03828734|7705029|FG000|COMPLETED|First Washout (1 Week)||25
6777065|NCT03828734|7705030|FG001|COMPLETED|First Washout (1 Week)||24
6777066|NCT03828734|7705029|FG000|NOT COMPLETED|First Washout (1 Week)||0
6777067|NCT03828734|7705030|FG001|NOT COMPLETED|First Washout (1 Week)||1
6777068|NCT03828734|7705029|FG000|STARTED|Second Intervention||25
6777069|NCT03828734|7705030|FG001|STARTED|Second Intervention||24
6777070|NCT03828734|7705029|FG000|COMPLETED|Second Intervention||25
6777071|NCT03828734|7705030|FG001|COMPLETED|Second Intervention||24
6777072|NCT03828734|7705029|FG000|NOT COMPLETED|Second Intervention||0
6777073|NCT03828734|7705030|FG001|NOT COMPLETED|Second Intervention||0
6777074|NCT03827395|7705038|FG000|STARTED|Overall Study||20
6777075|NCT03827395|7705039|FG001|STARTED|Overall Study||5
6777076|NCT03827395|7705038|FG000|COMPLETED|Overall Study||17
6360468|NCT00678301|7270201|FG000|STARTED|Overall Study||239
6360469|NCT00678301|7270202|FG001|STARTED|Overall Study||118
6360470|NCT00678301|7270201|FG000|COMPLETED|Overall Study||231
6360471|NCT00678301|7270202|FG001|COMPLETED|Overall Study||116
6360472|NCT00678301|7270201|FG000|NOT COMPLETED|Overall Study||8
6360473|NCT00678301|7270202|FG001|NOT COMPLETED|Overall Study||2
6360474|NCT00678379|7270211|FG000|STARTED|Overall Study||40
6360475|NCT00678379|7270212|FG001|STARTED|Overall Study||40
6360476|NCT00678379|7270213|FG002|STARTED|Overall Study||40
6360477|NCT00678379|7270211|FG000|COMPLETED|Overall Study||34
6360478|NCT00678379|7270212|FG001|COMPLETED|Overall Study||37
6360479|NCT00678379|7270213|FG002|COMPLETED|Overall Study||36
6560255|NCT01785810|7482959|FG000|COMPLETED|Overall Study||29
6560256|NCT01785810|7482959|FG000|NOT COMPLETED|Overall Study||8
6360480|NCT00678379|7270211|FG000|NOT COMPLETED|Overall Study||6
6360481|NCT00678379|7270212|FG001|NOT COMPLETED|Overall Study||3
6360482|NCT00678379|7270213|FG002|NOT COMPLETED|Overall Study||4
6360483|NCT00678392|7270223|FG000|STARTED|Overall Study||361
6360484|NCT00678392|7270224|FG001|STARTED|Overall Study||362
6360485|NCT00678392|7270223|FG000|Treated|Overall Study||359
6360486|NCT00678392|7270224|FG001|Treated|Overall Study||355
6360487|NCT00678392|7270223|FG000|COMPLETED|Overall Study||0
6360488|NCT00678392|7270224|FG001|COMPLETED|Overall Study||0
6360489|NCT00678392|7270223|FG000|NOT COMPLETED|Overall Study||361
6360490|NCT00678392|7270224|FG001|NOT COMPLETED|Overall Study||362
6360491|NCT00678418|7270232|FG000|STARTED|Part A (Double Blind)||126
6360492|NCT00678418|7270233|FG001|STARTED|Part A (Double Blind)||124
6360493|NCT00678418|7270232|FG000|COMPLETED|Part A (Double Blind)||67
6360494|NCT00678418|7270233|FG001|COMPLETED|Part A (Double Blind)||47
6360495|NCT00678418|7270232|FG000|NOT COMPLETED|Part A (Double Blind)||59
6777077|NCT03827395|7705039|FG001|COMPLETED|Overall Study||3
6777078|NCT03827395|7705038|FG000|NOT COMPLETED|Overall Study||3
6777079|NCT03827395|7705039|FG001|NOT COMPLETED|Overall Study||2
6777080|NCT03819218|7705045|FG000|STARTED|Overall Study||7
6777081|NCT03819218|7705045|FG000|COMPLETED|Overall Study||6
6777082|NCT03819218|7705045|FG000|NOT COMPLETED|Overall Study||1
6777083|NCT03818815|7705051|FG000|STARTED|Overall Study||56
6777084|NCT03818815|7705052|FG001|STARTED|Overall Study||47
6777085|NCT03818815|7705051|FG000|COMPLETED|Overall Study||48
6777086|NCT03818815|7705052|FG001|COMPLETED|Overall Study||42
6777087|NCT03818815|7705051|FG000|NOT COMPLETED|Overall Study||8
6777088|NCT03818815|7705052|FG001|NOT COMPLETED|Overall Study||5
6777089|NCT03828487|7705058|FG000|STARTED|Overall Study||8
6777090|NCT03828487|7705058|FG000|COMPLETED|Overall Study||7
6777091|NCT03828487|7705058|FG000|NOT COMPLETED|Overall Study||1
6777092|NCT03828617|7705066|FG000|STARTED|Overall Study||489
6777093|NCT03828617|7705067|FG001|STARTED|Overall Study||490
6777094|NCT03828617|7705068|FG002|STARTED|Overall Study||486
6777095|NCT03828617|7705069|FG003|STARTED|Overall Study||245
6777096|NCT03828617|7705066|FG000|Vaccinated|Overall Study||488
6777097|NCT03828617|7705067|FG001|Vaccinated|Overall Study||489
6777098|NCT03828617|7705068|FG002|Vaccinated|Overall Study||486
6777099|NCT03828617|7705069|FG003|Vaccinated|Overall Study||245
6777100|NCT03828617|7705066|FG000|Safety Population|Overall Study||488
6777101|NCT03828617|7705067|FG001|Safety Population|Overall Study||489
6777102|NCT03828617|7705068|FG002|Safety Population|Overall Study||486
6777103|NCT03828617|7705069|FG003|Safety Population|Overall Study||245
6777104|NCT03828617|7705066|FG000|Evaluable Immunogenicity Population(EIP)|Overall Study||463
6777105|NCT03828617|7705067|FG001|Evaluable Immunogenicity Population(EIP)|Overall Study||473
6777106|NCT03828617|7705068|FG002|Evaluable Immunogenicity Population(EIP)|Overall Study||456
6777107|NCT03828617|7705069|FG003|Evaluable Immunogenicity Population(EIP)|Overall Study||232
6777108|NCT03828617|7705066|FG000|COMPLETED|Overall Study||465
6777109|NCT03828617|7705067|FG001|COMPLETED|Overall Study||475
6777110|NCT03828617|7705068|FG002|COMPLETED|Overall Study||460
6777111|NCT03828617|7705069|FG003|COMPLETED|Overall Study||235
6777112|NCT03828617|7705066|FG000|NOT COMPLETED|Overall Study||24
6777113|NCT03828617|7705067|FG001|NOT COMPLETED|Overall Study||15
6777114|NCT03828617|7705068|FG002|NOT COMPLETED|Overall Study||26
6777115|NCT03828617|7705069|FG003|NOT COMPLETED|Overall Study||10
6777116|NCT03828539|7705080|FG000|STARTED|Overall Study||389
6777117|NCT03828539|7705081|FG001|STARTED|Overall Study||388
6777118|NCT03828539|7705080|FG000|Full Analysis Set (FAS)|Overall Study||388
6777119|NCT03828539|7705081|FG001|Full Analysis Set (FAS)|Overall Study||388
6777120|NCT03828539|7705080|FG000|Safety Analysis Set (SAF)|Overall Study||388
6777121|NCT03828539|7705081|FG001|Safety Analysis Set (SAF)|Overall Study||388
6777122|NCT03828539|7705080|FG000|COMPLETED|Overall Study||373
6777123|NCT03828539|7705081|FG001|COMPLETED|Overall Study||366
6777124|NCT03828539|7705080|FG000|NOT COMPLETED|Overall Study||16
6777125|NCT03828539|7705081|FG001|NOT COMPLETED|Overall Study||22
6777126|NCT03824704|7705087|FG000|STARTED|Overall Study||1
6777127|NCT03824704|7705087|FG000|COMPLETED|Overall Study||0
6777128|NCT03824704|7705087|FG000|NOT COMPLETED|Overall Study||1
6777129|NCT03823937|7705093|FG000|STARTED|Overall Study||30
6777130|NCT03823937|7705094|FG001|STARTED|Overall Study||20
6777131|NCT03823937|7705093|FG000|COMPLETED|Overall Study||30
6777132|NCT03823937|7705094|FG001|COMPLETED|Overall Study||20
6777133|NCT03823937|7705093|FG000|NOT COMPLETED|Overall Study||0
6777134|NCT03823937|7705094|FG001|NOT COMPLETED|Overall Study||0
6777135|NCT03817879|7705102|FG000|STARTED|Overall Study||35
6777136|NCT03817879|7705103|FG001|STARTED|Overall Study||35
6777137|NCT03817879|7705102|FG000|COMPLETED|Overall Study||30
6360496|NCT00678418|7270233|FG001|NOT COMPLETED|Part A (Double Blind)||77
6360497|NCT00678418|7270232|FG000|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
6360498|NCT00678418|7270233|FG001|STARTED|Part B (Open Label)||0
6360499|NCT00678418|7270232|FG000|COMPLETED|Part B (Open Label)||71
6360500|NCT00678418|7270233|FG001|COMPLETED|Part B (Open Label)||0
6777138|NCT03817879|7705103|FG001|COMPLETED|Overall Study||22
6777139|NCT03817879|7705102|FG000|NOT COMPLETED|Overall Study||5
6777140|NCT03817879|7705103|FG001|NOT COMPLETED|Overall Study||13
6777141|NCT03811834|7705109|FG000|STARTED|Period 1 ( 7 Days)||7
6777142|NCT03811834|7705109|FG000|COMPLETED|Period 1 ( 7 Days)||6
6777143|NCT03811834|7705109|FG000|NOT COMPLETED|Period 1 ( 7 Days)||1
6360501|NCT00678418|7270232|FG000|NOT COMPLETED|Part B (Open Label)||43
6360502|NCT00678418|7270233|FG001|NOT COMPLETED|Part B (Open Label)||0
6360503|NCT00678444|7270241|FG000|STARTED|Overall Study||100
6360504|NCT00678444|7270242|FG001|STARTED|Overall Study||99
6360505|NCT00678444|7270241|FG000|COMPLETED|Overall Study||100
6360506|NCT00678444|7270242|FG001|COMPLETED|Overall Study||99
6360507|NCT00678444|7270241|FG000|NOT COMPLETED|Overall Study||0
6360508|NCT00678444|7270242|FG001|NOT COMPLETED|Overall Study||0
6360509|NCT00678470|7270248|FG000|STARTED|Overall Study||18
6360510|NCT00678470|7270248|FG000|COMPLETED|Overall Study||14
6360511|NCT00678470|7270248|FG000|NOT COMPLETED|Overall Study||4
6360512|NCT00678496|7270254|FG000|STARTED|Overall Study||12
6360513|NCT00678496|7270255|FG001|STARTED|Overall Study||12
6360514|NCT00678496|7270254|FG000|Completed 8 Weeks Follow-up|Overall Study||9
6360515|NCT00678496|7270255|FG001|Completed 8 Weeks Follow-up|Overall Study||12
6360516|NCT00678496|7270254|FG000|COMPLETED|Overall Study||10
6360517|NCT00678496|7270255|FG001|COMPLETED|Overall Study||8
6360518|NCT00678496|7270254|FG000|NOT COMPLETED|Overall Study||2
6360519|NCT00678496|7270255|FG001|NOT COMPLETED|Overall Study||4
6360520|NCT00678535|7270265|FG000|STARTED|Overall Study|ITT population|455
6360521|NCT00678535|7270266|FG001|STARTED|Overall Study|ITT population|449
6360522|NCT00678535|7270265|FG000|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
6360523|NCT00678535|7270266|FG001|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
6360524|NCT00678535|7270265|FG000|NOT COMPLETED|Overall Study||93
6360525|NCT00678535|7270266|FG001|NOT COMPLETED|Overall Study||98
6360526|NCT00678561|7270280|FG000|STARTED|Overall Study||6
6360527|NCT00678561|7270281|FG001|STARTED|Overall Study||6
6360528|NCT00678561|7270282|FG002|STARTED|Overall Study||8
6360529|NCT00678561|7270283|FG003|STARTED|Overall Study||4
6360530|NCT00678561|7270284|FG004|STARTED|Overall Study||17
6360531|NCT00678561|7270285|FG005|STARTED|Overall Study||17
6360532|NCT00678561|7270286|FG006|STARTED|Overall Study||15
6360533|NCT00678561|7270287|FG007|STARTED|Overall Study||8
6777144|NCT03811834|7705109|FG000|STARTED|Washout Period (9 Days)||6
6777145|NCT03811834|7705109|FG000|COMPLETED|Washout Period (9 Days)||6
6777146|NCT03811834|7705109|FG000|NOT COMPLETED|Washout Period (9 Days)||0
6777147|NCT03811834|7705109|FG000|STARTED|Period 2 (10 Days)||6
6777148|NCT03811834|7705109|FG000|COMPLETED|Period 2 (10 Days)||6
6777149|NCT03811834|7705109|FG000|NOT COMPLETED|Period 2 (10 Days)||0
6780849|NCT02806960|7709408|FG000|STARTED|Period 2||0
6780850|NCT02806960|7709409|FG001|STARTED|Period 2||0
6780851|NCT02806960|7709410|FG002|STARTED|Period 2||0
6780852|NCT02806960|7709411|FG003|STARTED|Period 2||0
6780853|NCT02806960|7709408|FG000|COMPLETED|Period 2||0
6780854|NCT02806960|7709409|FG001|COMPLETED|Period 2||0
6780855|NCT02806960|7709410|FG002|COMPLETED|Period 2||0
6780856|NCT02806960|7709411|FG003|COMPLETED|Period 2||0
6780857|NCT02806960|7709408|FG000|NOT COMPLETED|Period 2||0
6780858|NCT02806960|7709409|FG001|NOT COMPLETED|Period 2||0
6780859|NCT02806960|7709410|FG002|NOT COMPLETED|Period 2||0
6780860|NCT02806960|7709411|FG003|NOT COMPLETED|Period 2||0
6780861|NCT02806960|7709408|FG000|STARTED|Period 3||0
6780862|NCT02806960|7709409|FG001|STARTED|Period 3||0
6780863|NCT02806960|7709410|FG002|STARTED|Period 3||0
6780864|NCT02806960|7709411|FG003|STARTED|Period 3||0
6780865|NCT02806960|7709408|FG000|COMPLETED|Period 3||0
6780866|NCT02806960|7709409|FG001|COMPLETED|Period 3||0
6780867|NCT02806960|7709410|FG002|COMPLETED|Period 3||0
6780868|NCT02806960|7709411|FG003|COMPLETED|Period 3||0
6780869|NCT02806960|7709408|FG000|NOT COMPLETED|Period 3||0
6780870|NCT02806960|7709409|FG001|NOT COMPLETED|Period 3||0
6780871|NCT02806960|7709410|FG002|NOT COMPLETED|Period 3||0
6780872|NCT02806960|7709411|FG003|NOT COMPLETED|Period 3||0
6780873|NCT02806960|7709408|FG000|STARTED|Period 4||0
6780874|NCT02806960|7709409|FG001|STARTED|Period 4||0
6780875|NCT02806960|7709410|FG002|STARTED|Period 4||0
6780876|NCT02806960|7709411|FG003|STARTED|Period 4||0
6780877|NCT02806960|7709408|FG000|COMPLETED|Period 4||0
6780878|NCT02806960|7709409|FG001|COMPLETED|Period 4||0
6780879|NCT02806960|7709410|FG002|COMPLETED|Period 4||0
6780880|NCT02806960|7709411|FG003|COMPLETED|Period 4||0
6780881|NCT02806960|7709408|FG000|NOT COMPLETED|Period 4||0
6780882|NCT02806960|7709409|FG001|NOT COMPLETED|Period 4||0
6780883|NCT02806960|7709410|FG002|NOT COMPLETED|Period 4||0
6780884|NCT02806960|7709411|FG003|NOT COMPLETED|Period 4||0
6780885|NCT02815397|7709421|FG000|STARTED|Overall Study||2
6780886|NCT02815397|7709421|FG000|COMPLETED|Overall Study||0
6780887|NCT02815397|7709421|FG000|NOT COMPLETED|Overall Study||2
6780888|NCT02802592|7709425|FG000|STARTED|Overall Study||4
6780889|NCT02802592|7709425|FG000|COMPLETED|Overall Study||0
6780890|NCT02802592|7709425|FG000|NOT COMPLETED|Overall Study||4
6360534|NCT00678561|7270280|FG000|COMPLETED|Overall Study||6
6360535|NCT00678561|7270281|FG001|COMPLETED|Overall Study||5
6360536|NCT00678561|7270282|FG002|COMPLETED|Overall Study||7
6360537|NCT00678561|7270283|FG003|COMPLETED|Overall Study||4
6360538|NCT00678561|7270284|FG004|COMPLETED|Overall Study||15
6780891|NCT02774148|7709432|FG000|STARTED|Overall Study||0
6780892|NCT02774148|7709433|FG001|STARTED|Overall Study||0
6780893|NCT02774148|7709432|FG000|COMPLETED|Overall Study||0
6780894|NCT02774148|7709433|FG001|COMPLETED|Overall Study||0
6360539|NCT00678561|7270285|FG005|COMPLETED|Overall Study||16
6360540|NCT00678561|7270286|FG006|COMPLETED|Overall Study||15
6360541|NCT00678561|7270287|FG007|COMPLETED|Overall Study||7
6780895|NCT02774148|7709432|FG000|NOT COMPLETED|Overall Study||0
6780896|NCT02774148|7709433|FG001|NOT COMPLETED|Overall Study||0
6360542|NCT00678561|7270280|FG000|NOT COMPLETED|Overall Study||0
6360543|NCT00678561|7270281|FG001|NOT COMPLETED|Overall Study||1
6360544|NCT00678561|7270282|FG002|NOT COMPLETED|Overall Study||1
6360545|NCT00678561|7270283|FG003|NOT COMPLETED|Overall Study||0
6360546|NCT00678561|7270284|FG004|NOT COMPLETED|Overall Study||2
6360547|NCT00678561|7270285|FG005|NOT COMPLETED|Overall Study||1
6360548|NCT00678561|7270286|FG006|NOT COMPLETED|Overall Study||0
6360549|NCT00678561|7270287|FG007|NOT COMPLETED|Overall Study||1
6360550|NCT00678587|7270314|FG000|STARTED|Overall Study||147
6360551|NCT00678587|7270315|FG001|STARTED|Overall Study||145
6360552|NCT00678587|7270314|FG000|COMPLETED|Overall Study||127
6360553|NCT00678587|7270315|FG001|COMPLETED|Overall Study||127
6360554|NCT00678587|7270314|FG000|NOT COMPLETED|Overall Study||20
6360555|NCT00678587|7270315|FG001|NOT COMPLETED|Overall Study||18
6360556|NCT00678639|7270324|FG000|STARTED|Overall Study||53
6360557|NCT00678639|7270325|FG001|STARTED|Overall Study||57
6360558|NCT00678639|7270324|FG000|Hospital Discharge|Overall Study||53
6360559|NCT00678639|7270325|FG001|Hospital Discharge|Overall Study||57
6360560|NCT00678639|7270324|FG000|COMPLETED|Overall Study||51
6360561|NCT00678639|7270325|FG001|COMPLETED|Overall Study||57
6360562|NCT00678639|7270324|FG000|NOT COMPLETED|Overall Study||2
6360563|NCT00678639|7270325|FG001|NOT COMPLETED|Overall Study||0
6360564|NCT00678652|7270336|FG000|STARTED|Overall Study||9
6360565|NCT00678652|7270337|FG001|STARTED|Overall Study||9
6360566|NCT00678652|7270338|FG002|STARTED|Overall Study||9
6360567|NCT00678652|7270339|FG003|STARTED|Overall Study||9
6360568|NCT00678652|7270336|FG000|COMPLETED|Overall Study||6
6360569|NCT00678652|7270337|FG001|COMPLETED|Overall Study||9
6360570|NCT00678652|7270338|FG002|COMPLETED|Overall Study||8
6360571|NCT00678652|7270339|FG003|COMPLETED|Overall Study||9
6777150|NCT03806127|7705124|FG000|STARTED|Overall Study||111
6777151|NCT03806127|7705125|FG001|STARTED|Overall Study||111
6777152|NCT03806127|7705124|FG000|COMPLETED|Overall Study||90
6777153|NCT03806127|7705125|FG001|COMPLETED|Overall Study||99
6777154|NCT03806127|7705124|FG000|NOT COMPLETED|Overall Study||21
6777155|NCT03806127|7705125|FG001|NOT COMPLETED|Overall Study||12
6777156|NCT03827473|7705133|FG000|STARTED|Overall Study||1
6777157|NCT03827473|7705134|FG001|STARTED|Overall Study||0
6777158|NCT03827473|7705133|FG000|COMPLETED|Overall Study||0
6777159|NCT03827473|7705134|FG001|COMPLETED|Overall Study||0
6777160|NCT03827473|7705133|FG000|NOT COMPLETED|Overall Study||1
6777161|NCT03827473|7705134|FG001|NOT COMPLETED|Overall Study||0
6777162|NCT03826914|7705142|FG000|STARTED|Overall Study||35
6777163|NCT03826914|7705143|FG001|STARTED|Overall Study||34
6777164|NCT03826914|7705142|FG000|COMPLETED|Overall Study||34
6777165|NCT03826914|7705143|FG001|COMPLETED|Overall Study||33
6777166|NCT03826914|7705142|FG000|NOT COMPLETED|Overall Study||1
6777167|NCT03826914|7705143|FG001|NOT COMPLETED|Overall Study||1
6777168|NCT03812328|7705154|FG000|STARTED|Overall Study||55
6777169|NCT03812328|7705155|FG001|STARTED|Overall Study||63
6777170|NCT03812328|7705156|FG002|STARTED|Overall Study||89
6777171|NCT03812328|7705154|FG000|Modified Intent-to-Treat (mITT) Population|Overall Study||48
6777172|NCT03812328|7705155|FG001|Modified Intent-to-Treat (mITT) Population|Overall Study||61
6777173|NCT03812328|7705156|FG002|Modified Intent-to-Treat (mITT) Population|Overall Study||84
6777174|NCT03812328|7705154|FG000|Safety Population|Overall Study||55
6777175|NCT03812328|7705155|FG001|Safety Population|Overall Study||63
6777176|NCT03812328|7705156|FG002|Safety Population|Overall Study||88
6777177|NCT03812328|7705154|FG000|COMPLETED|Overall Study||55
6777178|NCT03812328|7705155|FG001|COMPLETED|Overall Study||60
6777179|NCT03812328|7705156|FG002|COMPLETED|Overall Study||88
6777180|NCT03812328|7705154|FG000|NOT COMPLETED|Overall Study||0
6777181|NCT03812328|7705155|FG001|NOT COMPLETED|Overall Study||3
6777182|NCT03812328|7705156|FG002|NOT COMPLETED|Overall Study||1
6777183|NCT03808688|7705166|FG000|STARTED|Overall Study||99
6777184|NCT03808688|7705167|FG001|STARTED|Overall Study||161
6777185|NCT03808688|7705166|FG000|COMPLETED|Overall Study||81
6777186|NCT03808688|7705167|FG001|COMPLETED|Overall Study||138
6777187|NCT03808688|7705166|FG000|NOT COMPLETED|Overall Study||18
6777188|NCT03808688|7705167|FG001|NOT COMPLETED|Overall Study||23
6777189|NCT03811093|7705177|FG000|STARTED|Overall Study||20
6777190|NCT03811093|7705178|FG001|STARTED|Overall Study||19
6777191|NCT03811093|7705177|FG000|COMPLETED|Overall Study||18
6777192|NCT03811093|7705178|FG001|COMPLETED|Overall Study||15
6777193|NCT03811093|7705177|FG000|NOT COMPLETED|Overall Study||2
6777194|NCT03811093|7705178|FG001|NOT COMPLETED|Overall Study||4
6777195|NCT03822182|7705190|FG000|STARTED|Overall Study||26
6777196|NCT03822182|7705191|FG001|STARTED|Overall Study||25
6360572|NCT00678652|7270336|FG000|NOT COMPLETED|Overall Study||3
6360573|NCT00678652|7270337|FG001|NOT COMPLETED|Overall Study||0
6360574|NCT00678652|7270338|FG002|NOT COMPLETED|Overall Study||1
6360575|NCT00678652|7270339|FG003|NOT COMPLETED|Overall Study||0
6360576|NCT00678691|7270351|FG000|STARTED|Overall Study||27
6360577|NCT00678691|7270352|FG001|STARTED|Overall Study||28
6360578|NCT00678691|7270351|FG000|COMPLETED|Overall Study||21
6360579|NCT00678691|7270352|FG001|COMPLETED|Overall Study||24
6360580|NCT00678691|7270351|FG000|NOT COMPLETED|Overall Study||6
6360581|NCT00678691|7270352|FG001|NOT COMPLETED|Overall Study||4
6777197|NCT03822182|7705192|FG002|STARTED|Overall Study||27
6777198|NCT03822182|7705190|FG000|COMPLETED|Overall Study||26
6777199|NCT03822182|7705191|FG001|COMPLETED|Overall Study||24
6777200|NCT03822182|7705192|FG002|COMPLETED|Overall Study||26
6777201|NCT03822182|7705190|FG000|NOT COMPLETED|Overall Study||0
6360582|NCT00678795|7270360|FG000|STARTED|Overall Study||67
6360583|NCT00678795|7270361|FG001|STARTED|Overall Study||68
6360584|NCT00678795|7270360|FG000|COMPLETED|Overall Study||56
6360585|NCT00678795|7270361|FG001|COMPLETED|Overall Study||62
6360586|NCT00678795|7270360|FG000|NOT COMPLETED|Overall Study||11
6360587|NCT00678795|7270361|FG001|NOT COMPLETED|Overall Study||6
6360588|NCT00678834|7270370|FG000|STARTED|Overall Study||40
6360589|NCT00678834|7270371|FG001|STARTED|Overall Study||15
6360590|NCT00678834|7270372|FG002|STARTED|Overall Study||25
6360591|NCT00678834|7270370|FG000|COMPLETED|Overall Study||24
6360592|NCT00678834|7270371|FG001|COMPLETED|Overall Study||15
6360593|NCT00678834|7270372|FG002|COMPLETED|Overall Study||16
6360594|NCT00678834|7270370|FG000|NOT COMPLETED|Overall Study||16
6360595|NCT00678834|7270371|FG001|NOT COMPLETED|Overall Study||0
6360596|NCT00678834|7270372|FG002|NOT COMPLETED|Overall Study||9
6360597|NCT00678886|7270392|FG000|STARTED|Overall Study||10
6360598|NCT00678886|7270393|FG001|STARTED|Overall Study||19
6360599|NCT00678886|7270394|FG002|STARTED|Overall Study||81
6360600|NCT00678886|7270395|FG003|STARTED|Overall Study||162
6360601|NCT00678886|7270392|FG000|COMPLETED|Overall Study||10
6777202|NCT03822182|7705191|FG001|NOT COMPLETED|Overall Study||1
6777203|NCT03822182|7705192|FG002|NOT COMPLETED|Overall Study||1
6777204|NCT03822416|7705203|FG000|STARTED|Overall Study||19
6777205|NCT03822416|7705204|FG001|STARTED|Overall Study||19
6777206|NCT03822416|7705203|FG000|COMPLETED|Overall Study||18
6777207|NCT03822416|7705204|FG001|COMPLETED|Overall Study||18
6777208|NCT03822416|7705203|FG000|NOT COMPLETED|Overall Study||1
6777209|NCT03822416|7705204|FG001|NOT COMPLETED|Overall Study||1
6777210|NCT03809104|7705210|FG000|STARTED|Overall Study||43
6777211|NCT03809104|7705210|FG000|COMPLETED|Overall Study||40
6777212|NCT03809104|7705210|FG000|NOT COMPLETED|Overall Study||3
6777213|NCT03807089|7705216|FG000|STARTED|Overall Study||101
6777214|NCT03807089|7705217|FG001|STARTED|Overall Study||93
6777215|NCT03807089|7705216|FG000|COMPLETED|Overall Study||101
6777216|NCT03807089|7705217|FG001|COMPLETED|Overall Study||93
6777217|NCT03807089|7705216|FG000|NOT COMPLETED|Overall Study||0
6777218|NCT03807089|7705217|FG001|NOT COMPLETED|Overall Study||0
6777219|NCT03806231|7705225|FG000|STARTED|Overall Study||4
6777220|NCT03806231|7705226|FG001|STARTED|Overall Study||4
6777221|NCT03806231|7705225|FG000|COMPLETED|Overall Study||2
6777222|NCT03806231|7705226|FG001|COMPLETED|Overall Study||4
6777223|NCT03806231|7705225|FG000|NOT COMPLETED|Overall Study||2
6777224|NCT03806231|7705226|FG001|NOT COMPLETED|Overall Study||0
6777225|NCT03804710|7705234|FG000|STARTED|Overall Study||75
6777226|NCT03804710|7705235|FG001|STARTED|Overall Study||74
6777227|NCT03804710|7705234|FG000|COMPLETED|Overall Study||73
6777228|NCT03804710|7705235|FG001|COMPLETED|Overall Study||69
6777229|NCT03804710|7705234|FG000|NOT COMPLETED|Overall Study||2
6777230|NCT03804710|7705235|FG001|NOT COMPLETED|Overall Study||5
6777231|NCT03822377|7705247|FG000|STARTED|Overall Study||65
6777232|NCT03822377|7705248|FG001|STARTED|Overall Study||65
6777233|NCT03822377|7705247|FG000|COMPLETED|Overall Study||65
6777234|NCT03822377|7705248|FG001|COMPLETED|Overall Study||65
6777235|NCT03822377|7705247|FG000|NOT COMPLETED|Overall Study||0
6777236|NCT03822377|7705248|FG001|NOT COMPLETED|Overall Study||0
6777237|NCT03820388|7705259|FG000|STARTED|Overall Study||25
6777238|NCT03820388|7705260|FG001|STARTED|Overall Study||25
6777239|NCT03820388|7705261|FG002|STARTED|Overall Study||25
6777240|NCT03820388|7705259|FG000|COMPLETED|Overall Study||25
6777241|NCT03820388|7705260|FG001|COMPLETED|Overall Study||25
6777242|NCT03820388|7705261|FG002|COMPLETED|Overall Study||25
6777243|NCT03820388|7705259|FG000|NOT COMPLETED|Overall Study||0
6777244|NCT03820388|7705260|FG001|NOT COMPLETED|Overall Study||0
6777245|NCT03820388|7705261|FG002|NOT COMPLETED|Overall Study||0
6777246|NCT03816696|7705269|FG000|STARTED|Period 1 (Up to Day 5)||16
6777247|NCT03816696|7705269|FG000|COMPLETED|Period 1 (Up to Day 5)||16
6777248|NCT03816696|7705269|FG000|NOT COMPLETED|Period 1 (Up to Day 5)||0
6777249|NCT03816696|7705269|FG000|STARTED|Wash Out Period (Days 6 to 9)||16
6777250|NCT03816696|7705269|FG000|COMPLETED|Wash Out Period (Days 6 to 9)||16
6777251|NCT03816696|7705269|FG000|NOT COMPLETED|Wash Out Period (Days 6 to 9)||0
6777252|NCT03816696|7705269|FG000|STARTED|Period 2 (Up to Day 7)||16
6777253|NCT03816696|7705269|FG000|COMPLETED|Period 2 (Up to Day 7)||16
6777254|NCT03816696|7705269|FG000|NOT COMPLETED|Period 2 (Up to Day 7)||0
6777255|NCT03816696|7705269|FG000|STARTED|Period 3 (Up to Day 11)||16
6777256|NCT03816696|7705269|FG000|COMPLETED|Period 3 (Up to Day 11)||16
6777257|NCT03816696|7705269|FG000|NOT COMPLETED|Period 3 (Up to Day 11)||0
6777258|NCT03821064|7705279|FG000|STARTED|Overall Study||11
6777259|NCT03821064|7705279|FG000|COMPLETED|Overall Study||10
6360602|NCT00678886|7270393|FG001|COMPLETED|Overall Study||19
6360603|NCT00678886|7270394|FG002|COMPLETED|Overall Study||72
6360604|NCT00678886|7270395|FG003|COMPLETED|Overall Study||153
6777260|NCT03821064|7705279|FG000|NOT COMPLETED|Overall Study||1
6777261|NCT03820544|7705285|FG000|STARTED|Overall Study||2
6777262|NCT03820544|7705286|FG001|STARTED|Overall Study||2
6777263|NCT03820544|7705285|FG000|COMPLETED|Overall Study||2
6777264|NCT03820544|7705286|FG001|COMPLETED|Overall Study||2
6777265|NCT03820544|7705285|FG000|NOT COMPLETED|Overall Study||0
6777266|NCT03820544|7705286|FG001|NOT COMPLETED|Overall Study||0
6777267|NCT03820024|7705294|FG000|STARTED|Overall Study||19
6777268|NCT03820024|7705295|FG001|STARTED|Overall Study||20
6777269|NCT03820024|7705294|FG000|COMPLETED|Overall Study||18
6777270|NCT03820024|7705295|FG001|COMPLETED|Overall Study||18
6360605|NCT00678886|7270392|FG000|NOT COMPLETED|Overall Study||0
6360606|NCT00678886|7270393|FG001|NOT COMPLETED|Overall Study||0
6360607|NCT00678886|7270394|FG002|NOT COMPLETED|Overall Study||9
6360608|NCT00678886|7270395|FG003|NOT COMPLETED|Overall Study||9
6360609|NCT00678899|7270404|FG000|STARTED|Overall Study||50
6360610|NCT00678899|7270404|FG000|COMPLETED|Overall Study||49
6360611|NCT00678899|7270404|FG000|NOT COMPLETED|Overall Study||1
6360612|NCT00679029|7270409|FG000|STARTED|Overall Study||15
6360613|NCT00679029|7270409|FG000|COMPLETED|Overall Study||10
6360614|NCT00679029|7270409|FG000|NOT COMPLETED|Overall Study||5
6360615|NCT00679042|7270413|FG000|STARTED|Transplant + 1 Year Follow Up||21
6360616|NCT00679042|7270413|FG000|COMPLETED|Transplant + 1 Year Follow Up||19
6360617|NCT00679042|7270413|FG000|NOT COMPLETED|Transplant + 1 Year Follow Up||2
6360618|NCT00679042|7270413|FG000|STARTED|5-Year Follow Up||19
6360619|NCT00679042|7270413|FG000|COMPLETED|5-Year Follow Up||5
6360620|NCT00679042|7270413|FG000|NOT COMPLETED|5-Year Follow Up||14
6360621|NCT00679042|7270413|FG000|STARTED|10-Year Follow Up||5
6360622|NCT00679042|7270413|FG000|COMPLETED|10-Year Follow Up||0
6360623|NCT00679042|7270413|FG000|NOT COMPLETED|10-Year Follow Up||5
6360624|NCT00679055|7270419|FG000|STARTED|Overall Study||8
6360625|NCT00679055|7270420|FG001|STARTED|Overall Study||6
6360626|NCT00679055|7270419|FG000|COMPLETED|Overall Study||6
6360627|NCT00679055|7270420|FG001|COMPLETED|Overall Study||1
6360628|NCT00679055|7270419|FG000|NOT COMPLETED|Overall Study||2
6360629|NCT00679055|7270420|FG001|NOT COMPLETED|Overall Study||5
6560257|NCT01785849|7482965|FG000|STARTED|Overall Study||254
6560258|NCT01785849|7482966|FG001|STARTED|Overall Study||254
6560259|NCT01785849|7482965|FG000|Received Treatment|Overall Study||254
6560260|NCT01785849|7482966|FG001|Received Treatment|Overall Study||251
6560261|NCT01785849|7482965|FG000|COMPLETED|Overall Study||193
6777271|NCT03820024|7705294|FG000|NOT COMPLETED|Overall Study||1
6777272|NCT03820024|7705295|FG001|NOT COMPLETED|Overall Study||2
6777273|NCT03807544|7705301|FG000|STARTED|Overall Study||17
6777274|NCT03807544|7705301|FG000|COMPLETED|Overall Study||17
6777275|NCT03807544|7705301|FG000|NOT COMPLETED|Overall Study||0
6777276|NCT03809182|7705308|FG000|STARTED|Overall Study||20
6777277|NCT03809182|7705309|FG001|STARTED|Overall Study||20
6777278|NCT03809182|7705308|FG000|COMPLETED|Overall Study||20
6777279|NCT03809182|7705309|FG001|COMPLETED|Overall Study||20
6777280|NCT03809182|7705308|FG000|NOT COMPLETED|Overall Study||0
6777281|NCT03809182|7705309|FG001|NOT COMPLETED|Overall Study||0
6777282|NCT03816761|7705320|FG000|STARTED|First Treatment Period (7 Days)||4
6777283|NCT03816761|7705321|FG001|STARTED|First Treatment Period (7 Days)||4
6777284|NCT03816761|7705322|FG002|STARTED|First Treatment Period (7 Days)||4
6777285|NCT03816761|7705323|FG003|STARTED|First Treatment Period (7 Days)||4
6777286|NCT03816761|7705324|FG004|STARTED|First Treatment Period (7 Days)||4
6777287|NCT03816761|7705325|FG005|STARTED|First Treatment Period (7 Days)||4
6777288|NCT03816761|7705320|FG000|COMPLETED|First Treatment Period (7 Days)||4
6777289|NCT03816761|7705321|FG001|COMPLETED|First Treatment Period (7 Days)||4
6777290|NCT03816761|7705322|FG002|COMPLETED|First Treatment Period (7 Days)||4
6777291|NCT03816761|7705323|FG003|COMPLETED|First Treatment Period (7 Days)||4
6777292|NCT03816761|7705324|FG004|COMPLETED|First Treatment Period (7 Days)||4
6777293|NCT03816761|7705325|FG005|COMPLETED|First Treatment Period (7 Days)||3
6777294|NCT03816761|7705320|FG000|NOT COMPLETED|First Treatment Period (7 Days)||0
6777295|NCT03816761|7705321|FG001|NOT COMPLETED|First Treatment Period (7 Days)||0
6777296|NCT03816761|7705322|FG002|NOT COMPLETED|First Treatment Period (7 Days)||0
6777297|NCT03816761|7705323|FG003|NOT COMPLETED|First Treatment Period (7 Days)||0
6777298|NCT03816761|7705324|FG004|NOT COMPLETED|First Treatment Period (7 Days)||0
6777299|NCT03816761|7705325|FG005|NOT COMPLETED|First Treatment Period (7 Days)||1
6777300|NCT03816761|7705320|FG000|STARTED|Second Treatment Period (7 Days)||4
6777301|NCT03816761|7705321|FG001|STARTED|Second Treatment Period (7 Days)||4
6777302|NCT03816761|7705322|FG002|STARTED|Second Treatment Period (7 Days)||4
6777303|NCT03816761|7705323|FG003|STARTED|Second Treatment Period (7 Days)||4
6777304|NCT03816761|7705324|FG004|STARTED|Second Treatment Period (7 Days)||4
6777305|NCT03816761|7705325|FG005|STARTED|Second Treatment Period (7 Days)||3
6777306|NCT03816761|7705320|FG000|COMPLETED|Second Treatment Period (7 Days)||4
6777307|NCT03816761|7705321|FG001|COMPLETED|Second Treatment Period (7 Days)||4
6777308|NCT03816761|7705322|FG002|COMPLETED|Second Treatment Period (7 Days)||4
6777309|NCT03816761|7705323|FG003|COMPLETED|Second Treatment Period (7 Days)||3
6777310|NCT03816761|7705324|FG004|COMPLETED|Second Treatment Period (7 Days)||4
6777311|NCT03816761|7705325|FG005|COMPLETED|Second Treatment Period (7 Days)||3
6777312|NCT03816761|7705320|FG000|NOT COMPLETED|Second Treatment Period (7 Days)||0
6777313|NCT03816761|7705321|FG001|NOT COMPLETED|Second Treatment Period (7 Days)||0
6777314|NCT03816761|7705322|FG002|NOT COMPLETED|Second Treatment Period (7 Days)||0
6777315|NCT03816761|7705323|FG003|NOT COMPLETED|Second Treatment Period (7 Days)||1
6777316|NCT03816761|7705324|FG004|NOT COMPLETED|Second Treatment Period (7 Days)||0
6777317|NCT03816761|7705325|FG005|NOT COMPLETED|Second Treatment Period (7 Days)||0
6777318|NCT03801044|7705347|FG000|STARTED|Overall Study||21
6777319|NCT03801044|7705347|FG000|COMPLETED|Overall Study||21
6777320|NCT03801044|7705347|FG000|NOT COMPLETED|Overall Study||0
6777321|NCT03805672|7705357|FG000|STARTED|Overall Study||2
6777322|NCT03805672|7705358|FG001|STARTED|Overall Study||2
6777323|NCT03805672|7705357|FG000|COMPLETED|Overall Study||2
6360630|NCT00679081|7270426|FG000|STARTED|Overall Study|Study design was within-subject control.|15
6360631|NCT00679081|7270426|FG000|COMPLETED|Overall Study||14
6560262|NCT01785849|7482966|FG001|COMPLETED|Overall Study||220
6777324|NCT03805672|7705358|FG001|COMPLETED|Overall Study||2
6360632|NCT00679081|7270426|FG000|NOT COMPLETED|Overall Study||1
6360633|NCT00679172|7270439|FG000|STARTED|Overall Study||37
6360634|NCT00679172|7270440|FG001|STARTED|Overall Study||38
6360635|NCT00679172|7270441|FG002|STARTED|Overall Study||36
6360636|NCT00679172|7270442|FG003|STARTED|Overall Study||39
6360637|NCT00679172|7270443|FG004|STARTED|Overall Study||37
6360638|NCT00679172|7270439|FG000|COMPLETED|Overall Study||36
6360639|NCT00679172|7270440|FG001|COMPLETED|Overall Study||37
6360640|NCT00679172|7270441|FG002|COMPLETED|Overall Study||35
6360641|NCT00679172|7270442|FG003|COMPLETED|Overall Study||38
6360642|NCT00679172|7270443|FG004|COMPLETED|Overall Study||37
6360643|NCT00679172|7270439|FG000|NOT COMPLETED|Overall Study||1
6360644|NCT00679172|7270440|FG001|NOT COMPLETED|Overall Study||1
6360645|NCT00679172|7270441|FG002|NOT COMPLETED|Overall Study||1
6360646|NCT00679172|7270442|FG003|NOT COMPLETED|Overall Study||1
6360647|NCT00679172|7270443|FG004|NOT COMPLETED|Overall Study||0
6360648|NCT00679211|7270458|FG000|STARTED|Overall Study||110
6360649|NCT00679211|7270458|FG000|COMPLETED|Overall Study||0
6360650|NCT00679211|7270458|FG000|NOT COMPLETED|Overall Study||110
6360651|NCT00679263|7270467|FG000|STARTED|Visit 3/Dose 2||10
6360652|NCT00679263|7270468|FG001|STARTED|Visit 3/Dose 2||11
6360653|NCT00679263|7270469|FG002|STARTED|Visit 3/Dose 2||11
6360654|NCT00679263|7270467|FG000|COMPLETED|Visit 3/Dose 2||9
6360655|NCT00679263|7270468|FG001|COMPLETED|Visit 3/Dose 2||6
6360656|NCT00679263|7270469|FG002|COMPLETED|Visit 3/Dose 2||11
6360657|NCT00679263|7270467|FG000|NOT COMPLETED|Visit 3/Dose 2||1
6360658|NCT00679263|7270468|FG001|NOT COMPLETED|Visit 3/Dose 2||5
6360659|NCT00679263|7270469|FG002|NOT COMPLETED|Visit 3/Dose 2||0
6360660|NCT00679263|7270467|FG000|STARTED|Visit 2/Dose 1||11
6360661|NCT00679263|7270468|FG001|STARTED|Visit 2/Dose 1||6
6360662|NCT00679263|7270469|FG002|STARTED|Visit 2/Dose 1||11
6360663|NCT00679263|7270467|FG000|COMPLETED|Visit 2/Dose 1||9
6360664|NCT00679263|7270468|FG001|COMPLETED|Visit 2/Dose 1||5
6360665|NCT00679263|7270469|FG002|COMPLETED|Visit 2/Dose 1||11
6360666|NCT00679263|7270467|FG000|NOT COMPLETED|Visit 2/Dose 1||2
6360667|NCT00679263|7270468|FG001|NOT COMPLETED|Visit 2/Dose 1||1
6360668|NCT00679263|7270469|FG002|NOT COMPLETED|Visit 2/Dose 1||0
6360669|NCT00679289|7270480|FG000|STARTED|Overall Study||6
6360670|NCT00679289|7270481|FG001|STARTED|Overall Study||6
6360671|NCT00679289|7270482|FG002|STARTED|Overall Study||24
6360672|NCT00679289|7270480|FG000|COMPLETED|Overall Study||1
6360673|NCT00679289|7270481|FG001|COMPLETED|Overall Study||0
6360674|NCT00679289|7270482|FG002|COMPLETED|Overall Study||1
6360675|NCT00679289|7270480|FG000|NOT COMPLETED|Overall Study||5
6360676|NCT00679289|7270481|FG001|NOT COMPLETED|Overall Study||6
6360677|NCT00679289|7270482|FG002|NOT COMPLETED|Overall Study||23
6360678|NCT00679302|7270494|FG000|STARTED|Overall Study||84
6360679|NCT00679302|7270495|FG001|STARTED|Overall Study||77
6360680|NCT00679302|7270494|FG000|COMPLETED|Overall Study||76
6360681|NCT00679302|7270495|FG001|COMPLETED|Overall Study||73
6560263|NCT01785849|7482965|FG000|NOT COMPLETED|Overall Study||61
6777325|NCT03805672|7705357|FG000|NOT COMPLETED|Overall Study||0
6777326|NCT03805672|7705358|FG001|NOT COMPLETED|Overall Study||0
6777327|NCT03808493|7705368|FG000|STARTED|Overall Study||12
6777328|NCT03808493|7705369|FG001|STARTED|Overall Study||12
6777329|NCT03808493|7705370|FG002|STARTED|Overall Study||12
6777330|NCT03808493|7705371|FG003|STARTED|Overall Study||12
6777331|NCT03808493|7705368|FG000|COMPLETED|Overall Study||12
6777332|NCT03808493|7705369|FG001|COMPLETED|Overall Study||12
6777333|NCT03808493|7705370|FG002|COMPLETED|Overall Study||12
6777334|NCT03808493|7705371|FG003|COMPLETED|Overall Study||12
6777335|NCT03808493|7705368|FG000|NOT COMPLETED|Overall Study||0
6777336|NCT03808493|7705369|FG001|NOT COMPLETED|Overall Study||0
6777337|NCT03808493|7705370|FG002|NOT COMPLETED|Overall Study||0
6777338|NCT03808493|7705371|FG003|NOT COMPLETED|Overall Study||0
6777339|NCT03815292|7705383|FG000|STARTED|Overall Study||135
6777340|NCT03815292|7705384|FG001|STARTED|Overall Study||140
6777341|NCT03815292|7705383|FG000|COMPLETED|Overall Study||135
6777342|NCT03815292|7705384|FG001|COMPLETED|Overall Study||140
6777343|NCT03815292|7705383|FG000|NOT COMPLETED|Overall Study||0
6777344|NCT03815292|7705384|FG001|NOT COMPLETED|Overall Study||0
6777345|NCT03812510|7705390|FG000|STARTED|Overall Study||426
6777346|NCT03812510|7705390|FG000|COMPLETED|Overall Study||274
6777347|NCT03812510|7705390|FG000|NOT COMPLETED|Overall Study||152
6777348|NCT03802994|7705400|FG000|STARTED|Overall Study||9
6777349|NCT03802994|7705401|FG001|STARTED|Overall Study||12
6360682|NCT00679302|7270494|FG000|NOT COMPLETED|Overall Study||8
6360683|NCT00679302|7270495|FG001|NOT COMPLETED|Overall Study||4
6360684|NCT00679341|7270503|FG000|STARTED|Overall Study||67
6360685|NCT00679341|7270504|FG001|STARTED|Overall Study||70
6360686|NCT00679341|7270503|FG000|COMPLETED|Overall Study||14
6360687|NCT00679341|7270504|FG001|COMPLETED|Overall Study||19
6360688|NCT00679341|7270503|FG000|NOT COMPLETED|Overall Study||53
6777350|NCT03802994|7705402|FG002|STARTED|Overall Study||15
6360689|NCT00679341|7270504|FG001|NOT COMPLETED|Overall Study||51
6360690|NCT00679354|7270511|FG000|STARTED|Overall Study||30
6360691|NCT00679354|7270511|FG000|COMPLETED|Overall Study||0
6777351|NCT03802994|7705403|FG003|STARTED|Overall Study||11
6777352|NCT03802994|7705404|FG004|STARTED|Overall Study||10
6777353|NCT03802994|7705400|FG000|COMPLETED|Overall Study||9
6777354|NCT03802994|7705401|FG001|COMPLETED|Overall Study||10
6777355|NCT03802994|7705402|FG002|COMPLETED|Overall Study||12
6360692|NCT00679354|7270511|FG000|NOT COMPLETED|Overall Study||30
6360693|NCT00679367|7270516|FG000|STARTED|Overall Study||16
6360694|NCT00679367|7270516|FG000|COMPLETED|Overall Study||4
6360695|NCT00679367|7270516|FG000|NOT COMPLETED|Overall Study||12
6377183|NCT00762268|7287751|FG000|COMPLETED|Overall Study||9
6377184|NCT00762268|7287752|FG001|COMPLETED|Overall Study||8
6377185|NCT00762268|7287751|FG000|NOT COMPLETED|Overall Study||3
6498547|NCT01410448|7417142|FG001|NOT COMPLETED|Overall Study||35
6777356|NCT03802994|7705403|FG003|COMPLETED|Overall Study||9
6777357|NCT03802994|7705404|FG004|COMPLETED|Overall Study||8
6777358|NCT03802994|7705400|FG000|NOT COMPLETED|Overall Study||0
6777359|NCT03802994|7705401|FG001|NOT COMPLETED|Overall Study||2
6777360|NCT03802994|7705402|FG002|NOT COMPLETED|Overall Study||3
6777361|NCT03802994|7705403|FG003|NOT COMPLETED|Overall Study||2
6777362|NCT03802994|7705404|FG004|NOT COMPLETED|Overall Study||2
6777363|NCT03810183|7705429|FG000|STARTED|Overall Study||6
6777364|NCT03810183|7705430|FG001|STARTED|Overall Study||3
6777365|NCT03810183|7705429|FG000|COMPLETED|Overall Study||4
6777366|NCT03810183|7705430|FG001|COMPLETED|Overall Study||2
6777367|NCT03810183|7705429|FG000|NOT COMPLETED|Overall Study||2
6777368|NCT03810183|7705430|FG001|NOT COMPLETED|Overall Study||1
6777369|NCT03809910|7705437|FG000|STARTED|Period 1 (Visit 2)||20
6777370|NCT03809910|7705438|FG001|STARTED|Period 1 (Visit 2)||19
6777371|NCT03809910|7705437|FG000|COMPLETED|Period 1 (Visit 2)||20
6777372|NCT03809910|7705438|FG001|COMPLETED|Period 1 (Visit 2)||19
6777373|NCT03809910|7705437|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
6777374|NCT03809910|7705438|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
6777375|NCT03809910|7705437|FG000|STARTED|Washout Period 1 (3 Days)||20
6777376|NCT03809910|7705438|FG001|STARTED|Washout Period 1 (3 Days)||19
6777377|NCT03809910|7705437|FG000|COMPLETED|Washout Period 1 (3 Days)||20
6777378|NCT03809910|7705438|FG001|COMPLETED|Washout Period 1 (3 Days)||19
6777379|NCT03809910|7705437|FG000|NOT COMPLETED|Washout Period 1 (3 Days)||0
6777380|NCT03809910|7705438|FG001|NOT COMPLETED|Washout Period 1 (3 Days)||0
6777381|NCT03809910|7705437|FG000|STARTED|Period 2 (Visit 3)||20
6777382|NCT03809910|7705438|FG001|STARTED|Period 2 (Visit 3)||19
6777383|NCT03809910|7705437|FG000|COMPLETED|Period 2 (Visit 3)||20
6777384|NCT03809910|7705438|FG001|COMPLETED|Period 2 (Visit 3)||19
6777385|NCT03809910|7705437|FG000|NOT COMPLETED|Period 2 (Visit 3)||0
6777386|NCT03809910|7705438|FG001|NOT COMPLETED|Period 2 (Visit 3)||0
6777387|NCT03809910|7705437|FG000|STARTED|Washout Period 2 (3 Days)||20
6777388|NCT03809910|7705438|FG001|STARTED|Washout Period 2 (3 Days)||19
6777389|NCT03809910|7705437|FG000|COMPLETED|Washout Period 2 (3 Days)||20
6777390|NCT03809910|7705438|FG001|COMPLETED|Washout Period 2 (3 Days)||19
6777391|NCT03809910|7705437|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
6777392|NCT03809910|7705438|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
6777393|NCT03809910|7705437|FG000|STARTED|Period 3 (Visit 4)||20
6777394|NCT03809910|7705438|FG001|STARTED|Period 3 (Visit 4)||19
6777395|NCT03809910|7705437|FG000|COMPLETED|Period 3 (Visit 4)||20
6777396|NCT03809910|7705438|FG001|COMPLETED|Period 3 (Visit 4)||19
6777397|NCT03809910|7705437|FG000|NOT COMPLETED|Period 3 (Visit 4)||0
6777398|NCT03809910|7705438|FG001|NOT COMPLETED|Period 3 (Visit 4)||0
6777399|NCT03806790|7705450|FG000|STARTED|Overall Study||87
6777400|NCT03806790|7705451|FG001|STARTED|Overall Study||95
6777401|NCT03806790|7705450|FG000|COMPLETED|Overall Study||87
6777402|NCT03806790|7705451|FG001|COMPLETED|Overall Study||95
6777403|NCT03806790|7705450|FG000|NOT COMPLETED|Overall Study||0
6777404|NCT03806790|7705451|FG001|NOT COMPLETED|Overall Study||0
6777405|NCT03809611|7705459|FG000|STARTED|Overall Study||62
6777406|NCT03809611|7705460|FG001|STARTED|Overall Study||62
6777407|NCT03809611|7705459|FG000|COMPLETED|Overall Study||61
6777408|NCT03809611|7705460|FG001|COMPLETED|Overall Study||61
6777409|NCT03809611|7705459|FG000|NOT COMPLETED|Overall Study||1
6777410|NCT03809611|7705460|FG001|NOT COMPLETED|Overall Study||1
6777411|NCT03807245|7705470|FG000|STARTED|Overall Study||24
6777412|NCT03807245|7705471|FG001|STARTED|Overall Study||24
6777413|NCT03807245|7705472|FG002|STARTED|Overall Study||12
6777414|NCT03807245|7705470|FG000|COMPLETED|Overall Study||23
6777415|NCT03807245|7705471|FG001|COMPLETED|Overall Study||24
6777416|NCT03807245|7705472|FG002|COMPLETED|Overall Study||12
6777417|NCT03807245|7705470|FG000|NOT COMPLETED|Overall Study||1
6777418|NCT03807245|7705471|FG001|NOT COMPLETED|Overall Study||0
6777419|NCT03807245|7705472|FG002|NOT COMPLETED|Overall Study||0
6777420|NCT03805971|7705480|FG000|STARTED|Overall Study||65
6777421|NCT03805971|7705480|FG000|COMPLETED|Overall Study||62
6777422|NCT03805971|7705480|FG000|NOT COMPLETED|Overall Study||3
6777423|NCT03802916|7705487|FG000|STARTED|Overall Study||15
6777424|NCT03802916|7705488|FG001|STARTED|Overall Study||15
6377186|NCT00762268|7287752|FG001|NOT COMPLETED|Overall Study||3
6377187|NCT00762307|7287762|FG000|STARTED|Overall Study||28
6377188|NCT00762307|7287763|FG001|STARTED|Overall Study||11
6498548|NCT01410474|7417150|FG000|STARTED|Overall Study||173
6777425|NCT03802916|7705487|FG000|COMPLETED|Overall Study||15
6777426|NCT03802916|7705488|FG001|COMPLETED|Overall Study||13
6777427|NCT03802916|7705487|FG000|NOT COMPLETED|Overall Study||0
6777428|NCT03802916|7705488|FG001|NOT COMPLETED|Overall Study||2
6777429|NCT03809039|7705505|FG000|STARTED|Part 1|11 subjects (2 subjects in each of Part 1 MT-6345 1 mg, 5 mg, 20 mg, 60 mg, 240 mg, and 1 subject in Part 1 MT-6345 120 mg) received a matching placebo per their respective dose. The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 Placebo.|11
6498549|NCT01410474|7417151|FG001|STARTED|Overall Study||168
6360696|NCT00679380|7270525|FG000|STARTED|Overall Study||109
6360697|NCT00679380|7270526|FG001|STARTED|Overall Study||109
6777430|NCT03809039|7705506|FG001|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
6777431|NCT03809039|7705507|FG002|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
6777432|NCT03809039|7705508|FG003|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms except for Part 2 MT-6345 20mg.|6
6777433|NCT03809039|7705509|FG004|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|6
6777434|NCT03809039|7705510|FG005|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|4
6777435|NCT03809039|7705511|FG006|STARTED|Part 1|The subjects are unique subjects, and were not counted more than once across any arms.|5
6777436|NCT03809039|7705512|FG007|STARTED|Part 1||0
6777437|NCT03809039|7705513|FG008|STARTED|Part 1||0
6777438|NCT03809039|7705505|FG000|COMPLETED|Part 1||10
6777439|NCT03809039|7705506|FG001|COMPLETED|Part 1||6
6777440|NCT03809039|7705507|FG002|COMPLETED|Part 1||6
6777441|NCT03809039|7705508|FG003|COMPLETED|Part 1||5
6777442|NCT03809039|7705509|FG004|COMPLETED|Part 1||6
6777443|NCT03809039|7705510|FG005|COMPLETED|Part 1||4
6777444|NCT03809039|7705511|FG006|COMPLETED|Part 1||5
6777445|NCT03809039|7705512|FG007|COMPLETED|Part 1||0
6777446|NCT03809039|7705513|FG008|COMPLETED|Part 1||0
6777447|NCT03809039|7705505|FG000|NOT COMPLETED|Part 1||1
6777448|NCT03809039|7705506|FG001|NOT COMPLETED|Part 1||0
6777449|NCT03809039|7705507|FG002|NOT COMPLETED|Part 1||0
6777450|NCT03809039|7705508|FG003|NOT COMPLETED|Part 1||1
6777451|NCT03809039|7705509|FG004|NOT COMPLETED|Part 1||0
6777452|NCT03809039|7705510|FG005|NOT COMPLETED|Part 1||0
6777453|NCT03809039|7705511|FG006|NOT COMPLETED|Part 1||0
6777454|NCT03809039|7705512|FG007|NOT COMPLETED|Part 1||0
6777455|NCT03809039|7705513|FG008|NOT COMPLETED|Part 1||0
6777456|NCT03809039|7705505|FG000|STARTED|Part 2|2 subjects who received a matching placebo per Part 1 MT-6345 20mg were selected to return for Part 2. Out of 2 subjects, only 1 subject received the placebo, and another subject withdrew the consent after Part 1. Therefore, this 1 subject is not a unique subject and was not counted again in the total number of exposed subjects.|1
6777457|NCT03809039|7705506|FG001|STARTED|Part 2||0
6777458|NCT03809039|7705507|FG002|STARTED|Part 2||0
6777459|NCT03809039|7705508|FG003|STARTED|Part 2|6 subjects in Part 1 MT-6345 20mg were selected to return for Part 2. Out of 6 subjects, only 5 subjects received MT-6345, and 1 subject withdrew the consent after Part 1. Therefore, these 5 subjects are not a unique subject and were not counted again in the total number of exposed subjects.|5
6777460|NCT03809039|7705509|FG004|STARTED|Part 2||0
6777461|NCT03809039|7705510|FG005|STARTED|Part 2||0
6777462|NCT03809039|7705511|FG006|STARTED|Part 2||0
6777463|NCT03809039|7705512|FG007|STARTED|Part 2||0
6777464|NCT03809039|7705513|FG008|STARTED|Part 2||0
6777465|NCT03809039|7705505|FG000|COMPLETED|Part 2||1
6777466|NCT03809039|7705506|FG001|COMPLETED|Part 2||0
6777467|NCT03809039|7705507|FG002|COMPLETED|Part 2||0
6777468|NCT03809039|7705508|FG003|COMPLETED|Part 2||5
6777469|NCT03809039|7705509|FG004|COMPLETED|Part 2||0
6777470|NCT03809039|7705510|FG005|COMPLETED|Part 2||0
6777471|NCT03809039|7705511|FG006|COMPLETED|Part 2||0
6777472|NCT03809039|7705512|FG007|COMPLETED|Part 2||0
6777473|NCT03809039|7705513|FG008|COMPLETED|Part 2||0
6777474|NCT03809039|7705505|FG000|NOT COMPLETED|Part 2||0
6777475|NCT03809039|7705506|FG001|NOT COMPLETED|Part 2||0
6777476|NCT03809039|7705507|FG002|NOT COMPLETED|Part 2||0
6777477|NCT03809039|7705508|FG003|NOT COMPLETED|Part 2||0
6777478|NCT03809039|7705509|FG004|NOT COMPLETED|Part 2||0
6777479|NCT03809039|7705510|FG005|NOT COMPLETED|Part 2||0
6777480|NCT03809039|7705511|FG006|NOT COMPLETED|Part 2||0
6777481|NCT03809039|7705512|FG007|NOT COMPLETED|Part 2||0
6777482|NCT03809039|7705513|FG008|NOT COMPLETED|Part 2||0
6777483|NCT03809039|7705505|FG000|STARTED|Part 3||0
6777484|NCT03809039|7705506|FG001|STARTED|Part 3||0
6777485|NCT03809039|7705507|FG002|STARTED|Part 3||0
6777486|NCT03809039|7705508|FG003|STARTED|Part 3||0
6777487|NCT03809039|7705509|FG004|STARTED|Part 3||0
6777488|NCT03809039|7705510|FG005|STARTED|Part 3||0
6777489|NCT03809039|7705511|FG006|STARTED|Part 3||0
6777490|NCT03809039|7705512|FG007|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|2
6777491|NCT03809039|7705513|FG008|STARTED|Part 3|The subjects are unique subjects, and were not counted more than once across any arms.|6
6777492|NCT03809039|7705505|FG000|COMPLETED|Part 3||0
6777493|NCT03809039|7705506|FG001|COMPLETED|Part 3||0
6777494|NCT03809039|7705507|FG002|COMPLETED|Part 3||0
6777495|NCT03809039|7705508|FG003|COMPLETED|Part 3||0
6777496|NCT03809039|7705509|FG004|COMPLETED|Part 3||0
6777497|NCT03809039|7705510|FG005|COMPLETED|Part 3||0
6777498|NCT03809039|7705511|FG006|COMPLETED|Part 3||0
6777499|NCT03809039|7705512|FG007|COMPLETED|Part 3||0
6777500|NCT03809039|7705513|FG008|COMPLETED|Part 3||0
6777501|NCT03809039|7705505|FG000|NOT COMPLETED|Part 3||0
6777502|NCT03809039|7705506|FG001|NOT COMPLETED|Part 3||0
6777503|NCT03809039|7705507|FG002|NOT COMPLETED|Part 3||0
6777504|NCT03809039|7705508|FG003|NOT COMPLETED|Part 3||0
6777505|NCT03809039|7705509|FG004|NOT COMPLETED|Part 3||0
6777506|NCT03809039|7705510|FG005|NOT COMPLETED|Part 3||0
6777507|NCT03809039|7705511|FG006|NOT COMPLETED|Part 3||0
6777508|NCT03809039|7705512|FG007|NOT COMPLETED|Part 3||2
6777509|NCT03809039|7705513|FG008|NOT COMPLETED|Part 3||6
6777510|NCT03807700|7705548|FG000|STARTED|Overall Study||60
6777511|NCT03807700|7705549|FG001|STARTED|Overall Study||59
6777512|NCT03807700|7705548|FG000|COMPLETED|Overall Study||58
6360698|NCT00679380|7270527|FG002|STARTED|Overall Study||103
6360699|NCT00679380|7270528|FG003|STARTED|Overall Study||89
6360700|NCT00679380|7270525|FG000|COMPLETED|Overall Study||67
6360701|NCT00679380|7270526|FG001|COMPLETED|Overall Study||76
6360702|NCT00679380|7270527|FG002|COMPLETED|Overall Study||68
6360703|NCT00679380|7270528|FG003|COMPLETED|Overall Study||61
6360704|NCT00679380|7270525|FG000|NOT COMPLETED|Overall Study||42
6360705|NCT00679380|7270526|FG001|NOT COMPLETED|Overall Study||33
6360706|NCT00679380|7270527|FG002|NOT COMPLETED|Overall Study||35
6360707|NCT00679380|7270528|FG003|NOT COMPLETED|Overall Study||28
6360708|NCT00679432|7270542|FG000|STARTED|Overall Study||126
6360709|NCT00679432|7270543|FG001|STARTED|Overall Study||127
6360710|NCT00679432|7270544|FG002|STARTED|Overall Study||129
6360711|NCT00679432|7270545|FG003|STARTED|Overall Study||127
6360712|NCT00679432|7270542|FG000|COMPLETED|Overall Study||89
6360713|NCT00679432|7270543|FG001|COMPLETED|Overall Study||89
6360714|NCT00679432|7270544|FG002|COMPLETED|Overall Study||76
6360715|NCT00679432|7270545|FG003|COMPLETED|Overall Study||95
6360716|NCT00679432|7270542|FG000|NOT COMPLETED|Overall Study||37
6360717|NCT00679432|7270543|FG001|NOT COMPLETED|Overall Study||38
6360718|NCT00679432|7270544|FG002|NOT COMPLETED|Overall Study||53
6360719|NCT00679432|7270545|FG003|NOT COMPLETED|Overall Study||32
6360720|NCT00679549|7270557|FG000|STARTED|Overall Study||75
6360721|NCT00679549|7270558|FG001|STARTED|Overall Study||75
6360722|NCT00679549|7270557|FG000|COMPLETED|Overall Study||69
6360723|NCT00679549|7270558|FG001|COMPLETED|Overall Study|4 dropouts in the control arm; 5 missing echocardiograms in the control arm|66
6360724|NCT00679549|7270557|FG000|NOT COMPLETED|Overall Study||6
6360725|NCT00679549|7270558|FG001|NOT COMPLETED|Overall Study||9
6360726|NCT00679627|7270566|FG000|STARTED|Overall Study||1021
6360727|NCT00679627|7270567|FG001|STARTED|Overall Study||1024
6360728|NCT00679627|7270566|FG000|COMPLETED|Overall Study||322
6360729|NCT00679627|7270567|FG001|COMPLETED|Overall Study||339
6360730|NCT00679627|7270566|FG000|NOT COMPLETED|Overall Study||699
6360731|NCT00679627|7270567|FG001|NOT COMPLETED|Overall Study||685
6360732|NCT00679913|7270575|FG000|STARTED|Overall Study||101
6360733|NCT00679913|7270576|FG001|STARTED|Overall Study||99
6360734|NCT00679913|7270575|FG000|COMPLETED|Overall Study||83
6360735|NCT00679913|7270576|FG001|COMPLETED|Overall Study||86
6360736|NCT00679913|7270575|FG000|NOT COMPLETED|Overall Study||18
6360737|NCT00679913|7270576|FG001|NOT COMPLETED|Overall Study||13
6360738|NCT00679939|7270585|FG000|STARTED|52-Week Double-Blind (DB) Period||114
6360739|NCT00679939|7270586|FG001|STARTED|52-Week Double-Blind (DB) Period||112
6360740|NCT00679939|7270585|FG000|COMPLETED|52-Week Double-Blind (DB) Period||77
6360741|NCT00679939|7270586|FG001|COMPLETED|52-Week Double-Blind (DB) Period||85
6360742|NCT00679939|7270585|FG000|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
6360743|NCT00679939|7270586|FG001|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
6360744|NCT00679939|7270585|FG000|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
6360745|NCT00679939|7270586|FG001|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
6360746|NCT00679939|7270585|FG000|COMPLETED|24-Week Open-Label (OL) Period||69
6360747|NCT00679939|7270586|FG001|COMPLETED|24-Week Open-Label (OL) Period||80
6777513|NCT03807700|7705549|FG001|COMPLETED|Overall Study||58
6777514|NCT03807700|7705548|FG000|NOT COMPLETED|Overall Study||2
6777515|NCT03807700|7705549|FG001|NOT COMPLETED|Overall Study||1
6777516|NCT03804918|7705556|FG000|STARTED|Overall Study||17
6777517|NCT03804918|7705556|FG000|COMPLETED|Overall Study||16
6777518|NCT03804918|7705556|FG000|NOT COMPLETED|Overall Study||1
6777519|NCT03805386|7705562|FG000|STARTED|Overall Study||32
6777520|NCT03805386|7705563|FG001|STARTED|Overall Study||33
6777521|NCT03805386|7705562|FG000|COMPLETED|Overall Study||32
6777522|NCT03805386|7705563|FG001|COMPLETED|Overall Study||33
6777523|NCT03805386|7705562|FG000|NOT COMPLETED|Overall Study||0
6777524|NCT03805386|7705563|FG001|NOT COMPLETED|Overall Study||0
6777525|NCT03803475|7705572|FG000|STARTED|Overall Study||485
6560264|NCT01785849|7482966|FG001|NOT COMPLETED|Overall Study||34
6560265|NCT01785875|7482972|FG000|STARTED|Overall Study||384
6560266|NCT01785875|7482973|FG001|STARTED|Overall Study||384
6560267|NCT01785875|7482974|FG002|STARTED|Overall Study||123
6560268|NCT01785875|7482972|FG000|Received Etelcalcetide|Overall Study||383
6360748|NCT00679939|7270585|FG000|NOT COMPLETED|24-Week Open-Label (OL) Period||7
6360749|NCT00679939|7270586|FG001|NOT COMPLETED|24-Week Open-Label (OL) Period||4
6360750|NCT00679952|7270598|FG000|STARTED|Overall Study||86
6360751|NCT00679952|7270599|FG001|STARTED|Overall Study||82
6360752|NCT00679952|7270598|FG000|COMPLETED|Overall Study||86
6360753|NCT00679952|7270599|FG001|COMPLETED|Overall Study||82
6360754|NCT00679952|7270598|FG000|NOT COMPLETED|Overall Study||0
6360755|NCT00679952|7270599|FG001|NOT COMPLETED|Overall Study||0
6360756|NCT00680017|7270607|FG000|STARTED|Overall Study||140
6360757|NCT00680017|7270608|FG001|STARTED|Overall Study||140
6360758|NCT00680017|7270607|FG000|COMPLETED|Overall Study||123
6360759|NCT00680017|7270608|FG001|COMPLETED|Overall Study||128
6360760|NCT00680017|7270607|FG000|NOT COMPLETED|Overall Study||17
6360761|NCT00680017|7270608|FG001|NOT COMPLETED|Overall Study||12
6360762|NCT00680043|7270617|FG000|STARTED|Overall Study||39
6777526|NCT03803475|7705572|FG000|COMPLETED|Overall Study||484
6777527|NCT03803475|7705572|FG000|NOT COMPLETED|Overall Study||1
6777528|NCT03802227|7705578|FG000|STARTED|Overall Study||4
6777529|NCT03802227|7705579|FG001|STARTED|Overall Study||4
6777530|NCT03802227|7705578|FG000|COMPLETED|Overall Study||4
6360763|NCT00680043|7270618|FG001|STARTED|Overall Study||37
6777531|NCT03802227|7705579|FG001|COMPLETED|Overall Study||4
6777532|NCT03802227|7705578|FG000|NOT COMPLETED|Overall Study||0
6777533|NCT03802227|7705579|FG001|NOT COMPLETED|Overall Study||0
6777534|NCT03802864|7705589|FG000|STARTED|Overall Study||25
6777535|NCT03802864|7705590|FG001|STARTED|Overall Study||25
6777536|NCT03802864|7705589|FG000|COMPLETED|Overall Study||25
6777537|NCT03802864|7705590|FG001|COMPLETED|Overall Study||25
6777538|NCT03802864|7705589|FG000|NOT COMPLETED|Overall Study||0
6777539|NCT03802864|7705590|FG001|NOT COMPLETED|Overall Study||0
6777540|NCT03801265|7705598|FG000|STARTED|Overall Study||23
6777541|NCT03801265|7705599|FG001|STARTED|Overall Study||23
6777542|NCT03801265|7705598|FG000|COMPLETED|Overall Study||23
6777543|NCT03801265|7705599|FG001|COMPLETED|Overall Study||23
6777544|NCT03801265|7705598|FG000|NOT COMPLETED|Overall Study||0
6777545|NCT03801265|7705599|FG001|NOT COMPLETED|Overall Study||0
6777546|NCT03802344|7705608|FG000|STARTED|Overall Study||213
6777547|NCT03802344|7705609|FG001|STARTED|Overall Study||209
6777548|NCT03802344|7705610|FG002|STARTED|Overall Study||68
6777549|NCT03802344|7705608|FG000|COMPLETED|Overall Study||205
6777550|NCT03802344|7705609|FG001|COMPLETED|Overall Study||203
6777551|NCT03802344|7705610|FG002|COMPLETED|Overall Study||55
6777552|NCT03802344|7705608|FG000|NOT COMPLETED|Overall Study||8
6777553|NCT03802344|7705609|FG001|NOT COMPLETED|Overall Study||6
6777554|NCT03802344|7705610|FG002|NOT COMPLETED|Overall Study||13
6777555|NCT03801928|7705625|FG000|STARTED|Overall Study||18
6777556|NCT03801928|7705626|FG001|STARTED|Overall Study||21
6777557|NCT03801928|7705627|FG002|STARTED|Overall Study||9
6777558|NCT03801928|7705628|FG003|STARTED|Overall Study||21
6777559|NCT03801928|7705629|FG004|STARTED|Overall Study||36
6777560|NCT03801928|7705630|FG005|STARTED|Overall Study||10
6777561|NCT03801928|7705625|FG000|COMPLETED|Overall Study||12
6777562|NCT03801928|7705626|FG001|COMPLETED|Overall Study||18
6777563|NCT03801928|7705627|FG002|COMPLETED|Overall Study||4
6777564|NCT03801928|7705628|FG003|COMPLETED|Overall Study||13
6777565|NCT03801928|7705629|FG004|COMPLETED|Overall Study||32
6777566|NCT03801928|7705630|FG005|COMPLETED|Overall Study||5
6777567|NCT03801928|7705625|FG000|NOT COMPLETED|Overall Study||6
6777568|NCT03801928|7705626|FG001|NOT COMPLETED|Overall Study||3
6777569|NCT03801928|7705627|FG002|NOT COMPLETED|Overall Study||5
6777570|NCT03801928|7705628|FG003|NOT COMPLETED|Overall Study||8
6777571|NCT03801928|7705629|FG004|NOT COMPLETED|Overall Study||4
6777572|NCT03801928|7705630|FG005|NOT COMPLETED|Overall Study||5
6777573|NCT03800173|7705652|FG000|STARTED|Overall Study||8
6777574|NCT03800173|7705653|FG001|STARTED|Overall Study||6
6777575|NCT03800173|7705654|FG002|STARTED|Overall Study||6
6777576|NCT03800173|7705655|FG003|STARTED|Overall Study||6
6777577|NCT03800173|7705656|FG004|STARTED|Overall Study||6
6777578|NCT03800173|7705652|FG000|Safety Population|Overall Study||8
6777579|NCT03800173|7705653|FG001|Safety Population|Overall Study||6
6777580|NCT03800173|7705654|FG002|Safety Population|Overall Study||6
6777581|NCT03800173|7705655|FG003|Safety Population|Overall Study||6
6777582|NCT03800173|7705656|FG004|Safety Population|Overall Study||6
6777583|NCT03800173|7705652|FG000|PK Population|Overall Study||0
6777584|NCT03800173|7705653|FG001|PK Population|Overall Study||6
6777585|NCT03800173|7705654|FG002|PK Population|Overall Study||6
6777586|NCT03800173|7705655|FG003|PK Population|Overall Study||6
6777587|NCT03800173|7705656|FG004|PK Population|Overall Study||6
6777588|NCT03800173|7705652|FG000|COMPLETED|Overall Study||8
6777589|NCT03800173|7705653|FG001|COMPLETED|Overall Study||6
6777590|NCT03800173|7705654|FG002|COMPLETED|Overall Study||6
6777591|NCT03800173|7705655|FG003|COMPLETED|Overall Study||6
6777592|NCT03800173|7705656|FG004|COMPLETED|Overall Study||5
6777593|NCT03800173|7705652|FG000|NOT COMPLETED|Overall Study||0
6777594|NCT03800173|7705653|FG001|NOT COMPLETED|Overall Study||0
6777595|NCT03800173|7705654|FG002|NOT COMPLETED|Overall Study||0
6777596|NCT03800173|7705655|FG003|NOT COMPLETED|Overall Study||0
6777597|NCT03800173|7705656|FG004|NOT COMPLETED|Overall Study||1
6777598|NCT03799783|7705672|FG000|STARTED|Overall Study||19
6777599|NCT03799783|7705672|FG000|COMPLETED|Overall Study||19
6777600|NCT03799783|7705672|FG000|NOT COMPLETED|Overall Study||0
6777601|NCT03800030|7705676|FG000|STARTED|Baseline||4
6777602|NCT03800030|7705677|FG001|STARTED|Baseline||4
6777603|NCT03800030|7705678|FG002|STARTED|Baseline||4
6777604|NCT03800030|7705679|FG003|STARTED|Baseline||6
6777605|NCT03800030|7705680|FG004|STARTED|Baseline||4
6777606|NCT03800030|7705681|FG005|STARTED|Baseline||4
6360764|NCT00680043|7270619|FG002|STARTED|Overall Study||38
6777607|NCT03800030|7705676|FG000|COMPLETED|Baseline||4
6777608|NCT03800030|7705677|FG001|COMPLETED|Baseline||4
6777609|NCT03800030|7705678|FG002|COMPLETED|Baseline||4
6777610|NCT03800030|7705679|FG003|COMPLETED|Baseline||6
6777611|NCT03800030|7705680|FG004|COMPLETED|Baseline||4
6777612|NCT03800030|7705681|FG005|COMPLETED|Baseline||4
6777613|NCT03800030|7705676|FG000|NOT COMPLETED|Baseline||0
6777614|NCT03800030|7705677|FG001|NOT COMPLETED|Baseline||0
6777615|NCT03800030|7705678|FG002|NOT COMPLETED|Baseline||0
6777616|NCT03800030|7705679|FG003|NOT COMPLETED|Baseline||0
6777617|NCT03800030|7705680|FG004|NOT COMPLETED|Baseline||0
6777618|NCT03800030|7705681|FG005|NOT COMPLETED|Baseline||0
6777619|NCT03800030|7705676|FG000|STARTED|Pre-Randomization Period (1 Week)||4
6777620|NCT03800030|7705677|FG001|STARTED|Pre-Randomization Period (1 Week)||4
6777621|NCT03800030|7705678|FG002|STARTED|Pre-Randomization Period (1 Week)||4
6777622|NCT03800030|7705679|FG003|STARTED|Pre-Randomization Period (1 Week)||6
6360765|NCT00680043|7270617|FG000|COMPLETED|Overall Study||37
6360766|NCT00680043|7270618|FG001|COMPLETED|Overall Study||36
6360767|NCT00680043|7270619|FG002|COMPLETED|Overall Study||34
6560269|NCT01785875|7482973|FG001|Received Etelcalcetide|Overall Study||384
6560270|NCT01785875|7482974|FG002|Received Etelcalcetide|Overall Study||123
6560271|NCT01785875|7482972|FG000|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
6777623|NCT03800030|7705680|FG004|STARTED|Pre-Randomization Period (1 Week)||4
6777624|NCT03800030|7705681|FG005|STARTED|Pre-Randomization Period (1 Week)||4
6777625|NCT03800030|7705676|FG000|COMPLETED|Pre-Randomization Period (1 Week)||4
6777626|NCT03800030|7705677|FG001|COMPLETED|Pre-Randomization Period (1 Week)||4
6777627|NCT03800030|7705678|FG002|COMPLETED|Pre-Randomization Period (1 Week)||4
6777628|NCT03800030|7705679|FG003|COMPLETED|Pre-Randomization Period (1 Week)||6
6777629|NCT03800030|7705680|FG004|COMPLETED|Pre-Randomization Period (1 Week)||4
6777630|NCT03800030|7705681|FG005|COMPLETED|Pre-Randomization Period (1 Week)||4
6777631|NCT03800030|7705676|FG000|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6777632|NCT03800030|7705677|FG001|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6777633|NCT03800030|7705678|FG002|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6777634|NCT03800030|7705679|FG003|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6777635|NCT03800030|7705680|FG004|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6777636|NCT03800030|7705681|FG005|NOT COMPLETED|Pre-Randomization Period (1 Week)||0
6777637|NCT03800030|7705676|FG000|STARTED|First Intervention||4
6777638|NCT03800030|7705677|FG001|STARTED|First Intervention||4
6777639|NCT03800030|7705678|FG002|STARTED|First Intervention||4
6777640|NCT03800030|7705679|FG003|STARTED|First Intervention||6
6777641|NCT03800030|7705680|FG004|STARTED|First Intervention||4
6777642|NCT03800030|7705681|FG005|STARTED|First Intervention||4
6777643|NCT03800030|7705676|FG000|COMPLETED|First Intervention||4
6777644|NCT03800030|7705677|FG001|COMPLETED|First Intervention||4
6777645|NCT03800030|7705678|FG002|COMPLETED|First Intervention||4
6777646|NCT03800030|7705679|FG003|COMPLETED|First Intervention||6
6777647|NCT03800030|7705680|FG004|COMPLETED|First Intervention||4
6777648|NCT03800030|7705681|FG005|COMPLETED|First Intervention||4
6777649|NCT03800030|7705676|FG000|NOT COMPLETED|First Intervention||0
6777650|NCT03800030|7705677|FG001|NOT COMPLETED|First Intervention||0
6777651|NCT03800030|7705678|FG002|NOT COMPLETED|First Intervention||0
6777652|NCT03800030|7705679|FG003|NOT COMPLETED|First Intervention||0
6777653|NCT03800030|7705680|FG004|NOT COMPLETED|First Intervention||0
6777654|NCT03800030|7705681|FG005|NOT COMPLETED|First Intervention||0
6777655|NCT03800030|7705676|FG000|STARTED|First Washout (1 Week)||4
6777656|NCT03800030|7705677|FG001|STARTED|First Washout (1 Week)||4
6777657|NCT03800030|7705678|FG002|STARTED|First Washout (1 Week)||4
6777658|NCT03800030|7705679|FG003|STARTED|First Washout (1 Week)||6
6777659|NCT03800030|7705680|FG004|STARTED|First Washout (1 Week)||4
6777660|NCT03800030|7705681|FG005|STARTED|First Washout (1 Week)||4
6777661|NCT03800030|7705676|FG000|COMPLETED|First Washout (1 Week)||4
6777662|NCT03800030|7705677|FG001|COMPLETED|First Washout (1 Week)||4
6777663|NCT03800030|7705678|FG002|COMPLETED|First Washout (1 Week)||4
6777664|NCT03800030|7705679|FG003|COMPLETED|First Washout (1 Week)||6
6777665|NCT03800030|7705680|FG004|COMPLETED|First Washout (1 Week)||4
6777666|NCT03800030|7705681|FG005|COMPLETED|First Washout (1 Week)||4
6777667|NCT03800030|7705676|FG000|NOT COMPLETED|First Washout (1 Week)||0
6777668|NCT03800030|7705677|FG001|NOT COMPLETED|First Washout (1 Week)||0
6777669|NCT03800030|7705678|FG002|NOT COMPLETED|First Washout (1 Week)||0
6777670|NCT03800030|7705679|FG003|NOT COMPLETED|First Washout (1 Week)||0
6777671|NCT03800030|7705680|FG004|NOT COMPLETED|First Washout (1 Week)||0
6777672|NCT03800030|7705681|FG005|NOT COMPLETED|First Washout (1 Week)||0
6777673|NCT03800030|7705676|FG000|STARTED|Second Intervention||4
6777674|NCT03800030|7705677|FG001|STARTED|Second Intervention||4
6777675|NCT03800030|7705678|FG002|STARTED|Second Intervention||4
6777676|NCT03800030|7705679|FG003|STARTED|Second Intervention||6
6777677|NCT03800030|7705680|FG004|STARTED|Second Intervention||4
6777678|NCT03800030|7705681|FG005|STARTED|Second Intervention||4
6777679|NCT03800030|7705676|FG000|COMPLETED|Second Intervention||4
6560272|NCT01785875|7482973|FG001|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
6560273|NCT01785875|7482974|FG002|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
6560274|NCT01785875|7482972|FG000|NOT COMPLETED|Overall Study||294
6560275|NCT01785875|7482973|FG001|NOT COMPLETED|Overall Study||289
6560276|NCT01785875|7482974|FG002|NOT COMPLETED|Overall Study||107
6560277|NCT01786109|7482988|FG000|STARTED|Overall Study||24
6560278|NCT01786109|7482989|FG001|STARTED|Overall Study||24
6560279|NCT01786109|7482990|FG002|STARTED|Overall Study||27
6560280|NCT01786109|7482988|FG000|COMPLETED|Overall Study||23
6777680|NCT03800030|7705677|FG001|COMPLETED|Second Intervention||4
6777681|NCT03800030|7705678|FG002|COMPLETED|Second Intervention||4
6777682|NCT03800030|7705679|FG003|COMPLETED|Second Intervention||5
6360768|NCT00680043|7270617|FG000|NOT COMPLETED|Overall Study||2
6360769|NCT00680043|7270618|FG001|NOT COMPLETED|Overall Study||1
6777683|NCT03800030|7705680|FG004|COMPLETED|Second Intervention||4
6777684|NCT03800030|7705681|FG005|COMPLETED|Second Intervention||4
6777685|NCT03800030|7705676|FG000|NOT COMPLETED|Second Intervention||0
6777686|NCT03800030|7705677|FG001|NOT COMPLETED|Second Intervention||0
6777687|NCT03800030|7705678|FG002|NOT COMPLETED|Second Intervention||0
6777688|NCT03800030|7705679|FG003|NOT COMPLETED|Second Intervention||1
6777689|NCT03800030|7705680|FG004|NOT COMPLETED|Second Intervention||0
6360770|NCT00680043|7270619|FG002|NOT COMPLETED|Overall Study||4
6360771|NCT00680056|7270629|FG000|STARTED|First Intervention||16
6360772|NCT00680056|7270630|FG001|STARTED|First Intervention||17
6360773|NCT00680056|7270629|FG000|COMPLETED|First Intervention||15
6360774|NCT00680056|7270630|FG001|COMPLETED|First Intervention||15
6360775|NCT00680056|7270629|FG000|NOT COMPLETED|First Intervention||1
6360776|NCT00680056|7270630|FG001|NOT COMPLETED|First Intervention||2
6360777|NCT00680056|7270629|FG000|STARTED|Washout Period of One Week||15
6360778|NCT00680056|7270630|FG001|STARTED|Washout Period of One Week||15
6360779|NCT00680056|7270629|FG000|COMPLETED|Washout Period of One Week||15
6360780|NCT00680056|7270630|FG001|COMPLETED|Washout Period of One Week||15
6360781|NCT00680056|7270629|FG000|NOT COMPLETED|Washout Period of One Week||0
6360782|NCT00680056|7270630|FG001|NOT COMPLETED|Washout Period of One Week||0
6360783|NCT00680056|7270629|FG000|STARTED|Second Intervention||15
6560281|NCT01786109|7482989|FG001|COMPLETED|Overall Study||24
6560282|NCT01786109|7482990|FG002|COMPLETED|Overall Study||25
6560283|NCT01786109|7482988|FG000|NOT COMPLETED|Overall Study||1
6560284|NCT01786109|7482989|FG001|NOT COMPLETED|Overall Study||0
6560285|NCT01786109|7482990|FG002|NOT COMPLETED|Overall Study||2
6560286|NCT01786148|7483000|FG000|STARTED|Overall Study||77
6560287|NCT01786148|7483001|FG001|STARTED|Overall Study||72
6560288|NCT01786148|7483000|FG000|COMPLETED|Overall Study||55
6560289|NCT01786148|7483001|FG001|COMPLETED|Overall Study||50
6560290|NCT01786148|7483000|FG000|NOT COMPLETED|Overall Study||22
6560291|NCT01786148|7483001|FG001|NOT COMPLETED|Overall Study||22
6560292|NCT01786161|7483009|FG000|STARTED|Overall Study||22
6560293|NCT01786161|7483010|FG001|STARTED|Overall Study||22
6560294|NCT01786161|7483009|FG000|COMPLETED|Overall Study||22
6560295|NCT01786161|7483010|FG001|COMPLETED|Overall Study||22
6560296|NCT01786161|7483009|FG000|NOT COMPLETED|Overall Study||0
6560297|NCT01786161|7483010|FG001|NOT COMPLETED|Overall Study||0
6560298|NCT01786174|7483020|FG000|STARTED|Overall Study||18
6560299|NCT01786174|7483021|FG001|STARTED|Overall Study||10
6560300|NCT01786174|7483020|FG000|Randomized|Overall Study||19
6560301|NCT01786174|7483021|FG001|Randomized|Overall Study||11
6560302|NCT01786174|7483020|FG000|COMPLETED|Overall Study||16
6560303|NCT01786174|7483021|FG001|COMPLETED|Overall Study||10
6560304|NCT01786174|7483020|FG000|NOT COMPLETED|Overall Study||2
6560305|NCT01786174|7483021|FG001|NOT COMPLETED|Overall Study||0
6560306|NCT01786187|7483029|FG000|STARTED|Overall Study||40
6560307|NCT01786187|7483030|FG001|STARTED|Overall Study||47
6560308|NCT01786187|7483029|FG000|COMPLETED|Overall Study||35
6560309|NCT01786187|7483030|FG001|COMPLETED|Overall Study||37
6560310|NCT01786187|7483029|FG000|NOT COMPLETED|Overall Study||5
6560311|NCT01786187|7483030|FG001|NOT COMPLETED|Overall Study||10
6560312|NCT01786239|7483041|FG000|STARTED|Overall Study||25
6560313|NCT01786239|7483042|FG001|STARTED|Overall Study||25
6560314|NCT01786239|7483041|FG000|COMPLETED|Overall Study||14
6560315|NCT01786239|7483042|FG001|COMPLETED|Overall Study||14
6560316|NCT01786239|7483041|FG000|NOT COMPLETED|Overall Study||11
6560317|NCT01786239|7483042|FG001|NOT COMPLETED|Overall Study||11
6560318|NCT01786252|7483050|FG000|STARTED|Overall Study||7
6560319|NCT01786252|7483051|FG001|STARTED|Overall Study||8
6560320|NCT01786252|7483050|FG000|COMPLETED|Overall Study||7
6560321|NCT01786252|7483051|FG001|COMPLETED|Overall Study||8
6560322|NCT01786252|7483050|FG000|NOT COMPLETED|Overall Study||0
6560323|NCT01786252|7483051|FG001|NOT COMPLETED|Overall Study||0
6560324|NCT01786330|7483059|FG000|STARTED|Overall Study||30
6560325|NCT01786330|7483060|FG001|STARTED|Overall Study||30
6560326|NCT01786330|7483059|FG000|COMPLETED|Overall Study||29
6560327|NCT01786330|7483060|FG001|COMPLETED|Overall Study||27
6560328|NCT01786330|7483059|FG000|NOT COMPLETED|Overall Study||1
6560329|NCT01786330|7483060|FG001|NOT COMPLETED|Overall Study||3
6560330|NCT01786343|7483068|FG000|STARTED|Overall Study||28
6777690|NCT03800030|7705681|FG005|NOT COMPLETED|Second Intervention||0
6777691|NCT03800030|7705676|FG000|STARTED|Second Washout (1 Week)||4
6777692|NCT03800030|7705677|FG001|STARTED|Second Washout (1 Week)||4
6777693|NCT03800030|7705678|FG002|STARTED|Second Washout (1 Week)||4
6777694|NCT03800030|7705679|FG003|STARTED|Second Washout (1 Week)||5
6777695|NCT03800030|7705680|FG004|STARTED|Second Washout (1 Week)||4
6777696|NCT03800030|7705681|FG005|STARTED|Second Washout (1 Week)||4
6777697|NCT03800030|7705676|FG000|COMPLETED|Second Washout (1 Week)||4
6777698|NCT03800030|7705677|FG001|COMPLETED|Second Washout (1 Week)||4
6777699|NCT03800030|7705678|FG002|COMPLETED|Second Washout (1 Week)||4
6777700|NCT03800030|7705679|FG003|COMPLETED|Second Washout (1 Week)||4
6777701|NCT03800030|7705680|FG004|COMPLETED|Second Washout (1 Week)||4
6777702|NCT03800030|7705681|FG005|COMPLETED|Second Washout (1 Week)||4
6777703|NCT03800030|7705676|FG000|NOT COMPLETED|Second Washout (1 Week)||0
6777704|NCT03800030|7705677|FG001|NOT COMPLETED|Second Washout (1 Week)||0
6360784|NCT00680056|7270630|FG001|STARTED|Second Intervention||15
6360785|NCT00680056|7270629|FG000|COMPLETED|Second Intervention||12
6360786|NCT00680056|7270630|FG001|COMPLETED|Second Intervention||14
6360787|NCT00680056|7270629|FG000|NOT COMPLETED|Second Intervention||3
6560331|NCT01786343|7483069|FG001|STARTED|Overall Study||46
6560332|NCT01786343|7483068|FG000|COMPLETED|Overall Study||28
6560333|NCT01786343|7483069|FG001|COMPLETED|Overall Study||46
6360788|NCT00680056|7270630|FG001|NOT COMPLETED|Second Intervention||1
6560334|NCT01786343|7483068|FG000|NOT COMPLETED|Overall Study||0
6777705|NCT03800030|7705678|FG002|NOT COMPLETED|Second Washout (1 Week)||0
6777706|NCT03800030|7705679|FG003|NOT COMPLETED|Second Washout (1 Week)||1
6360789|NCT00680121|7270639|FG000|STARTED|Overall Study||60
6360790|NCT00680121|7270640|FG001|STARTED|Overall Study||60
6360791|NCT00680121|7270639|FG000|COMPLETED|Overall Study||33
6360792|NCT00680121|7270640|FG001|COMPLETED|Overall Study||37
6777707|NCT03800030|7705680|FG004|NOT COMPLETED|Second Washout (1 Week)||0
6777708|NCT03800030|7705681|FG005|NOT COMPLETED|Second Washout (1 Week)||0
6777709|NCT03800030|7705676|FG000|STARTED|Third Intervention||4
6777710|NCT03800030|7705677|FG001|STARTED|Third Intervention||4
6777711|NCT03800030|7705678|FG002|STARTED|Third Intervention||4
6777712|NCT03800030|7705679|FG003|STARTED|Third Intervention||4
6777713|NCT03800030|7705680|FG004|STARTED|Third Intervention||4
6777714|NCT03800030|7705681|FG005|STARTED|Third Intervention||4
6777715|NCT03800030|7705676|FG000|COMPLETED|Third Intervention||4
6777716|NCT03800030|7705677|FG001|COMPLETED|Third Intervention||4
6777717|NCT03800030|7705678|FG002|COMPLETED|Third Intervention||4
6777718|NCT03800030|7705679|FG003|COMPLETED|Third Intervention||4
6777719|NCT03800030|7705680|FG004|COMPLETED|Third Intervention||4
6777720|NCT03800030|7705681|FG005|COMPLETED|Third Intervention||4
6777721|NCT03800030|7705676|FG000|NOT COMPLETED|Third Intervention||0
6777722|NCT03800030|7705677|FG001|NOT COMPLETED|Third Intervention||0
6777723|NCT03800030|7705678|FG002|NOT COMPLETED|Third Intervention||0
6777724|NCT03800030|7705679|FG003|NOT COMPLETED|Third Intervention||0
6777725|NCT03800030|7705680|FG004|NOT COMPLETED|Third Intervention||0
6777726|NCT03800030|7705681|FG005|NOT COMPLETED|Third Intervention||0
6777727|NCT03799211|7705691|FG000|STARTED|Overall Study||36
6777728|NCT03799211|7705692|FG001|STARTED|Overall Study||40
6777729|NCT03799211|7705691|FG000|COMPLETED|Overall Study||32
6777730|NCT03799211|7705692|FG001|COMPLETED|Overall Study||27
6777731|NCT03799211|7705691|FG000|NOT COMPLETED|Overall Study||4
6777732|NCT03799211|7705692|FG001|NOT COMPLETED|Overall Study||13
6777733|NCT03798717|7705706|FG000|STARTED|Overall Study||4
6777734|NCT03798717|7705707|FG001|STARTED|Overall Study||3
6777735|NCT03798717|7705708|FG002|STARTED|Overall Study||3
6777736|NCT03798717|7705709|FG003|STARTED|Overall Study||4
6777737|NCT03798717|7705710|FG004|STARTED|Overall Study||3
6777738|NCT03798717|7705711|FG005|STARTED|Overall Study||3
6777739|NCT03798717|7705706|FG000|COMPLETED|Overall Study||2
6777740|NCT03798717|7705707|FG001|COMPLETED|Overall Study||2
6777741|NCT03798717|7705708|FG002|COMPLETED|Overall Study||2
6777742|NCT03798717|7705709|FG003|COMPLETED|Overall Study||2
6777743|NCT03798717|7705710|FG004|COMPLETED|Overall Study||2
6777744|NCT03798717|7705711|FG005|COMPLETED|Overall Study||2
6777745|NCT03798717|7705706|FG000|NOT COMPLETED|Overall Study||2
6777746|NCT03798717|7705707|FG001|NOT COMPLETED|Overall Study||1
6777747|NCT03798717|7705708|FG002|NOT COMPLETED|Overall Study||1
6777748|NCT03798717|7705709|FG003|NOT COMPLETED|Overall Study||2
6777749|NCT03798717|7705710|FG004|NOT COMPLETED|Overall Study||1
6777750|NCT03798717|7705711|FG005|NOT COMPLETED|Overall Study||1
6777751|NCT03798483|7705720|FG000|STARTED|Overall Study||15
6777752|NCT03798483|7705720|FG000|Returned All Follow-up Outcome Data|Overall Study||11
6777753|NCT03798483|7705720|FG000|COMPLETED|Overall Study||13
6777754|NCT03798483|7705720|FG000|NOT COMPLETED|Overall Study||2
6777755|NCT03798366|7705730|FG000|STARTED|Overall Study||21
6777756|NCT03798366|7705731|FG001|STARTED|Overall Study||12
6777757|NCT03798366|7705730|FG000|COMPLETED|Overall Study||21
6777758|NCT03798366|7705731|FG001|COMPLETED|Overall Study||11
6777759|NCT03798366|7705730|FG000|NOT COMPLETED|Overall Study||0
6777760|NCT03798366|7705731|FG001|NOT COMPLETED|Overall Study||1
6777761|NCT03799952|7705739|FG000|STARTED|Overall Study||31
6777762|NCT03799952|7705740|FG001|STARTED|Overall Study||31
6777763|NCT03799952|7705739|FG000|COMPLETED|Overall Study||30
6777764|NCT03799952|7705740|FG001|COMPLETED|Overall Study||29
6777765|NCT03799952|7705739|FG000|NOT COMPLETED|Overall Study||1
6777766|NCT03799952|7705740|FG001|NOT COMPLETED|Overall Study||2
6777767|NCT03797872|7705748|FG000|STARTED|Overall Study||1
6777768|NCT03797872|7705749|FG001|STARTED|Overall Study||0
6777769|NCT03797872|7705748|FG000|COMPLETED|Overall Study||0
6777770|NCT03797872|7705749|FG001|COMPLETED|Overall Study||0
6777771|NCT03797872|7705748|FG000|NOT COMPLETED|Overall Study||1
6777772|NCT03797872|7705749|FG001|NOT COMPLETED|Overall Study||0
6777773|NCT03799614|7705757|FG000|STARTED|Overall Study||15
6360793|NCT00680121|7270639|FG000|NOT COMPLETED|Overall Study||27
6777774|NCT03799614|7705758|FG001|STARTED|Overall Study||15
6777775|NCT03799614|7705757|FG000|COMPLETED|Overall Study||15
6777776|NCT03799614|7705758|FG001|COMPLETED|Overall Study||15
6777777|NCT03799614|7705757|FG000|NOT COMPLETED|Overall Study||0
6777778|NCT03799614|7705758|FG001|NOT COMPLETED|Overall Study||0
6777779|NCT03799484|7705767|FG000|STARTED|Overall Study||14
6777780|NCT03799484|7705767|FG000|COMPLETED|Overall Study||14
6777781|NCT03799484|7705767|FG000|NOT COMPLETED|Overall Study||0
6777782|NCT03796728|7705774|FG000|STARTED|Overall Study||60
6777783|NCT03796728|7705774|FG000|COMPLETED|Overall Study||36
6777784|NCT03796728|7705774|FG000|NOT COMPLETED|Overall Study||24
6777785|NCT03797144|7705780|FG000|STARTED|Enrollment||16
6777786|NCT03797144|7705781|FG001|STARTED|Enrollment||11
6777787|NCT03797144|7705780|FG000|COMPLETED|Enrollment||12
6777788|NCT03797144|7705781|FG001|COMPLETED|Enrollment||10
6777789|NCT03797144|7705780|FG000|NOT COMPLETED|Enrollment||4
6777790|NCT03797144|7705781|FG001|NOT COMPLETED|Enrollment||1
6777791|NCT03797144|7705780|FG000|STARTED|Surgery||12
6777792|NCT03797144|7705781|FG001|STARTED|Surgery||10
6777793|NCT03797144|7705780|FG000|COMPLETED|Surgery||11
6777794|NCT03797144|7705781|FG001|COMPLETED|Surgery||10
6360794|NCT00680121|7270640|FG001|NOT COMPLETED|Overall Study||23
6360795|NCT00680186|7270648|FG000|STARTED|Overall Study|Started treatment.|1280
6360796|NCT00680186|7270649|FG001|STARTED|Overall Study|Started treatment.|1288
6360797|NCT00680186|7270648|FG000|COMPLETED|Overall Study|Completed planned observation time.|1155
6360798|NCT00680186|7270649|FG001|COMPLETED|Overall Study|Completed planned observation time.|1172
6360799|NCT00680186|7270648|FG000|NOT COMPLETED|Overall Study||125
6360800|NCT00680186|7270649|FG001|NOT COMPLETED|Overall Study||116
6360801|NCT00680225|7270655|FG000|STARTED|Overall Study||10
6360802|NCT00680225|7270655|FG000|COMPLETED|Overall Study||8
6360803|NCT00680225|7270655|FG000|NOT COMPLETED|Overall Study||2
6360804|NCT00680368|7270659|FG000|STARTED|Overall Study||112
6360805|NCT00680368|7270659|FG000|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
6360806|NCT00680368|7270659|FG000|NOT COMPLETED|Overall Study||15
6360807|NCT00680407|7270668|FG000|STARTED|Overall Study||26
6360808|NCT00680407|7270669|FG001|STARTED|Overall Study||27
6360809|NCT00680407|7270670|FG002|STARTED|Overall Study||25
6360810|NCT00680407|7270668|FG000|COMPLETED|Overall Study||18
6360811|NCT00680407|7270669|FG001|COMPLETED|Overall Study||22
6360812|NCT00680407|7270670|FG002|COMPLETED|Overall Study||22
6360813|NCT00680407|7270668|FG000|NOT COMPLETED|Overall Study||8
6360814|NCT00680407|7270669|FG001|NOT COMPLETED|Overall Study||5
6360815|NCT00680407|7270670|FG002|NOT COMPLETED|Overall Study||3
6360816|NCT00680459|7270680|FG000|STARTED|Overall Study||7
6360817|NCT00680459|7270681|FG001|STARTED|Overall Study||6
6360818|NCT00680459|7270680|FG000|COMPLETED|Overall Study||7
6360819|NCT00680459|7270681|FG001|COMPLETED|Overall Study||6
6360820|NCT00680459|7270680|FG000|NOT COMPLETED|Overall Study||0
6360821|NCT00680459|7270681|FG001|NOT COMPLETED|Overall Study||0
6360822|NCT00680524|7270687|FG000|STARTED|Overall Study||20
6360823|NCT00680524|7270687|FG000|COMPLETED|Overall Study||17
6360824|NCT00680524|7270687|FG000|NOT COMPLETED|Overall Study||3
6360825|NCT00680628|7270693|FG000|STARTED|Overall Study||43
6360826|NCT00680628|7270694|FG001|STARTED|Overall Study||40
6360827|NCT00680628|7270693|FG000|COMPLETED|Overall Study||43
6360828|NCT00680628|7270694|FG001|COMPLETED|Overall Study||40
6360829|NCT00680628|7270693|FG000|NOT COMPLETED|Overall Study||0
6360830|NCT00680628|7270694|FG001|NOT COMPLETED|Overall Study||0
6360831|NCT00680706|7270702|FG000|STARTED|Overall Study||70
6360832|NCT00680706|7270703|FG001|STARTED|Overall Study||60
6360833|NCT00680706|7270702|FG000|COMPLETED|Overall Study||63
6360834|NCT00680706|7270703|FG001|COMPLETED|Overall Study||55
6360835|NCT00680706|7270702|FG000|NOT COMPLETED|Overall Study||7
6360836|NCT00680706|7270703|FG001|NOT COMPLETED|Overall Study||5
6360837|NCT00680745|7270713|FG000|STARTED|Overall Study|Safety Analysis Set|154
6360838|NCT00680745|7270714|FG001|STARTED|Overall Study|Safety Analysis Set|145
6360839|NCT00680745|7270715|FG002|STARTED|Overall Study|Safety Analysis Set|151
6360840|NCT00680745|7270716|FG003|STARTED|Overall Study|Safety Analysis Set|146
6360841|NCT00680745|7270713|FG000|COMPLETED|Overall Study||140
6360842|NCT00680745|7270714|FG001|COMPLETED|Overall Study||132
6360843|NCT00680745|7270715|FG002|COMPLETED|Overall Study||141
6360844|NCT00680745|7270716|FG003|COMPLETED|Overall Study||133
6360845|NCT00680745|7270713|FG000|NOT COMPLETED|Overall Study||14
6360846|NCT00680745|7270714|FG001|NOT COMPLETED|Overall Study||13
6360847|NCT00680745|7270715|FG002|NOT COMPLETED|Overall Study||10
6360848|NCT00680745|7270716|FG003|NOT COMPLETED|Overall Study||13
6360849|NCT00680771|7270729|FG000|STARTED|Overall Study||15
6360850|NCT00680771|7270730|FG001|STARTED|Overall Study||13
6360851|NCT00680771|7270729|FG000|COMPLETED|Overall Study||9
6360852|NCT00680771|7270730|FG001|COMPLETED|Overall Study||11
6777795|NCT03797144|7705780|FG000|NOT COMPLETED|Surgery||1
6777796|NCT03797144|7705781|FG001|NOT COMPLETED|Surgery||0
6777797|NCT03797144|7705780|FG000|STARTED|3 Month||11
6777798|NCT03797144|7705781|FG001|STARTED|3 Month||10
6777799|NCT03797144|7705780|FG000|COMPLETED|3 Month||9
6777800|NCT03797144|7705781|FG001|COMPLETED|3 Month||10
6777801|NCT03797144|7705780|FG000|NOT COMPLETED|3 Month||2
6777802|NCT03797144|7705781|FG001|NOT COMPLETED|3 Month||0
6777803|NCT03797144|7705780|FG000|STARTED|12 Month||9
6777804|NCT03797144|7705781|FG001|STARTED|12 Month||10
6777805|NCT03797144|7705780|FG000|COMPLETED|12 Month||1
6777806|NCT03797144|7705781|FG001|COMPLETED|12 Month||1
6360853|NCT00680771|7270729|FG000|NOT COMPLETED|Overall Study||6
6360854|NCT00680771|7270730|FG001|NOT COMPLETED|Overall Study||2
6360855|NCT00680797|7270740|FG000|STARTED|Overall Study||9
6360856|NCT00680797|7270741|FG001|STARTED|Overall Study||8
6360857|NCT00680797|7270742|FG002|STARTED|Overall Study||8
6360858|NCT00680797|7270743|FG003|STARTED|Overall Study||8
6360859|NCT00680797|7270740|FG000|COMPLETED|Overall Study||9
6360860|NCT00680797|7270741|FG001|COMPLETED|Overall Study||8
6360861|NCT00680797|7270742|FG002|COMPLETED|Overall Study||8
6360862|NCT00680797|7270743|FG003|COMPLETED|Overall Study||8
6360863|NCT00680797|7270740|FG000|NOT COMPLETED|Overall Study||0
6360864|NCT00680797|7270741|FG001|NOT COMPLETED|Overall Study||0
6360865|NCT00680797|7270742|FG002|NOT COMPLETED|Overall Study||0
6360866|NCT00680797|7270743|FG003|NOT COMPLETED|Overall Study||0
6360867|NCT00680823|7270756|FG000|STARTED|Overall Study||50
6360868|NCT00680823|7270757|FG001|STARTED|Overall Study||50
6360869|NCT00680823|7270758|FG002|STARTED|Overall Study||50
6360870|NCT00680823|7270756|FG000|COMPLETED|Overall Study||50
6360871|NCT00680823|7270757|FG001|COMPLETED|Overall Study||50
6777807|NCT03797144|7705780|FG000|NOT COMPLETED|12 Month||8
6360872|NCT00680823|7270758|FG002|COMPLETED|Overall Study||50
6360873|NCT00680823|7270756|FG000|NOT COMPLETED|Overall Study||0
6360874|NCT00680823|7270757|FG001|NOT COMPLETED|Overall Study||0
6360875|NCT00680823|7270758|FG002|NOT COMPLETED|Overall Study||0
6360876|NCT00680836|7270768|FG000|STARTED|Overall Study||27
6360877|NCT00680836|7270769|FG001|STARTED|Overall Study||27
6360878|NCT00680836|7270768|FG000|COMPLETED|Overall Study||19
6360879|NCT00680836|7270769|FG001|COMPLETED|Overall Study||25
6360880|NCT00680836|7270768|FG000|NOT COMPLETED|Overall Study||8
6360881|NCT00680836|7270769|FG001|NOT COMPLETED|Overall Study||2
6360882|NCT00680862|7270776|FG000|STARTED|Overall Study||25
6360883|NCT00680862|7270776|FG000|COMPLETED|Overall Study||25
6360884|NCT00680862|7270776|FG000|NOT COMPLETED|Overall Study||0
6360885|NCT00680914|7270782|FG000|STARTED|Overall Study||374
6360886|NCT00680914|7270783|FG001|STARTED|Overall Study||129
6360887|NCT00680914|7270782|FG000|COMPLETED|Overall Study||364
6360888|NCT00680914|7270783|FG001|COMPLETED|Overall Study||125
6360889|NCT00680914|7270782|FG000|NOT COMPLETED|Overall Study||10
6360890|NCT00680914|7270783|FG001|NOT COMPLETED|Overall Study||4
6360891|NCT00680953|7270792|FG000|STARTED|Overall Study||500
6360892|NCT00680953|7270793|FG001|STARTED|Overall Study||511
6360893|NCT00680953|7270794|FG002|STARTED|Overall Study||251
6360894|NCT00680953|7270792|FG000|COMPLETED|Overall Study||414
6360895|NCT00680953|7270793|FG001|COMPLETED|Overall Study||416
6360896|NCT00680953|7270794|FG002|COMPLETED|Overall Study||204
6360897|NCT00680953|7270792|FG000|NOT COMPLETED|Overall Study||86
6360898|NCT00680953|7270793|FG001|NOT COMPLETED|Overall Study||95
6360899|NCT00680953|7270794|FG002|NOT COMPLETED|Overall Study||47
6360900|NCT00680992|7270805|FG000|STARTED|Overall Study||268
6360901|NCT00680992|7270806|FG001|STARTED|Overall Study||252
6360902|NCT00680992|7270807|FG002|STARTED|Overall Study||12
6360903|NCT00680992|7270805|FG000|Safety Analysis Set|Overall Study||265
6360904|NCT00680992|7270806|FG001|Safety Analysis Set|Overall Study||249
6360905|NCT00680992|7270807|FG002|Safety Analysis Set|Overall Study||12
6360906|NCT00680992|7270805|FG000|Efficacy Analysis Set|Overall Study||260
6360907|NCT00680992|7270806|FG001|Efficacy Analysis Set|Overall Study||242
6360908|NCT00680992|7270807|FG002|Efficacy Analysis Set|Overall Study||11
6360909|NCT00680992|7270805|FG000|COMPLETED|Overall Study||0
6360910|NCT00680992|7270806|FG001|COMPLETED|Overall Study||0
6360911|NCT00680992|7270807|FG002|COMPLETED|Overall Study||0
6360912|NCT00680992|7270805|FG000|NOT COMPLETED|Overall Study||268
6360913|NCT00680992|7270806|FG001|NOT COMPLETED|Overall Study||252
6360914|NCT00680992|7270807|FG002|NOT COMPLETED|Overall Study||12
6360915|NCT00681031|7270816|FG000|STARTED|Overall Study||96
6360916|NCT00681031|7270816|FG000|COMPLETED|Overall Study||96
6360917|NCT00681031|7270816|FG000|NOT COMPLETED|Overall Study||0
6360918|NCT00681083|7270820|FG000|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
6360919|NCT00681083|7270821|FG001|STARTED|Night 1|26 participants were initially consented (this is the total for the study).|13
6360920|NCT00681083|7270820|FG000|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
6360921|NCT00681083|7270821|FG001|COMPLETED|Night 1|20 in total completed study. 10 randomized to arm 1 and arm 2 then crossed over to other arm.|10
6360922|NCT00681083|7270820|FG000|NOT COMPLETED|Night 1||3
6360923|NCT00681083|7270821|FG001|NOT COMPLETED|Night 1||3
6360924|NCT00681083|7270820|FG000|STARTED|Night 2 (Crossover of Night 1)||10
6360925|NCT00681083|7270821|FG001|STARTED|Night 2 (Crossover of Night 1)||10
6360926|NCT00681083|7270820|FG000|COMPLETED|Night 2 (Crossover of Night 1)||10
6360927|NCT00681083|7270821|FG001|COMPLETED|Night 2 (Crossover of Night 1)||10
6360928|NCT00681083|7270820|FG000|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
6360929|NCT00681083|7270821|FG001|NOT COMPLETED|Night 2 (Crossover of Night 1)||0
6360930|NCT00681109|7270830|FG000|STARTED|Overall Study||30
6360931|NCT00681109|7270831|FG001|STARTED|Overall Study||30
6360932|NCT00681109|7270832|FG002|STARTED|Overall Study||15
6360933|NCT00681109|7270830|FG000|COMPLETED|Overall Study||28
6360934|NCT00681109|7270831|FG001|COMPLETED|Overall Study||24
6360935|NCT00681109|7270832|FG002|COMPLETED|Overall Study||15
6360936|NCT00681109|7270830|FG000|NOT COMPLETED|Overall Study||2
6360937|NCT00681109|7270831|FG001|NOT COMPLETED|Overall Study||6
6360938|NCT00681109|7270832|FG002|NOT COMPLETED|Overall Study||0
6360939|NCT00681187|7270845|FG000|STARTED|Overall Study||11
6360940|NCT00681187|7270846|FG001|STARTED|Overall Study||15
6360941|NCT00681187|7270845|FG000|COMPLETED|Overall Study||10
6360942|NCT00681187|7270846|FG001|COMPLETED|Overall Study||13
6360943|NCT00681187|7270845|FG000|NOT COMPLETED|Overall Study||1
6360944|NCT00681187|7270846|FG001|NOT COMPLETED|Overall Study||2
6360945|NCT00681265|7270865|FG000|STARTED|Overall Study||16
6360946|NCT00681265|7270865|FG000|COMPLETED|Overall Study||16
6360947|NCT00681265|7270865|FG000|NOT COMPLETED|Overall Study||0
6360948|NCT00681291|7270873|FG000|STARTED|Overall Study||88
6360949|NCT00681291|7270874|FG001|STARTED|Overall Study||84
6360950|NCT00681291|7270873|FG000|COMPLETED|Overall Study||75
6360951|NCT00681291|7270874|FG001|COMPLETED|Overall Study||57
6360952|NCT00681291|7270873|FG000|NOT COMPLETED|Overall Study||13
6360953|NCT00681291|7270874|FG001|NOT COMPLETED|Overall Study||27
6360954|NCT00681473|7270880|FG000|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
6360955|NCT00681473|7270880|FG000|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
6360956|NCT00681473|7270880|FG000|NOT COMPLETED|Overall Study||0
6360957|NCT00681538|7270886|FG000|STARTED|Phase A- 4 Weeks Single Blind||572
6360958|NCT00681538|7270887|FG001|STARTED|Phase A- 4 Weeks Single Blind||0
6360959|NCT00681538|7270886|FG000|COMPLETED|Phase A- 4 Weeks Single Blind||538
6360960|NCT00681538|7270887|FG001|COMPLETED|Phase A- 4 Weeks Single Blind||0
6360961|NCT00681538|7270886|FG000|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
6360962|NCT00681538|7270887|FG001|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
6360963|NCT00681538|7270886|FG000|STARTED|Phase B- Responders;12 Week Double-blind||124
6360964|NCT00681538|7270887|FG001|STARTED|Phase B- Responders;12 Week Double-blind||117
6360965|NCT00681538|7270886|FG000|COMPLETED|Phase B- Responders;12 Week Double-blind||109
6360966|NCT00681538|7270887|FG001|COMPLETED|Phase B- Responders;12 Week Double-blind||115
6360967|NCT00681538|7270886|FG000|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
6360968|NCT00681538|7270887|FG001|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
6360969|NCT00681564|7270895|FG000|STARTED|Overall Study||47
6360970|NCT00681564|7270896|FG001|STARTED|Overall Study||55
6360971|NCT00681564|7270895|FG000|COMPLETED|Overall Study||41
6360972|NCT00681564|7270896|FG001|COMPLETED|Overall Study||47
6360973|NCT00681564|7270895|FG000|NOT COMPLETED|Overall Study||6
6360974|NCT00681564|7270896|FG001|NOT COMPLETED|Overall Study||8
6360975|NCT00681590|7270904|FG000|STARTED|Overall Study||34
6360976|NCT00681590|7270905|FG001|STARTED|Overall Study||71
6360977|NCT00681590|7270904|FG000|COMPLETED|Overall Study||32
6360978|NCT00681590|7270905|FG001|COMPLETED|Overall Study||59
6360979|NCT00681590|7270904|FG000|NOT COMPLETED|Overall Study||2
6360980|NCT00681590|7270905|FG001|NOT COMPLETED|Overall Study||12
6360981|NCT00681668|7270911|FG000|STARTED|Overall Study||5
6360982|NCT00681668|7270911|FG000|COMPLETED|Overall Study||3
6360983|NCT00681668|7270911|FG000|NOT COMPLETED|Overall Study||2
6360984|NCT00681811|7270917|FG000|STARTED|Overall Study||6
6360985|NCT00681811|7270918|FG001|STARTED|Overall Study||5
6360986|NCT00681811|7270917|FG000|COMPLETED|Overall Study||3
6360987|NCT00681811|7270918|FG001|COMPLETED|Overall Study||1
6360988|NCT00681811|7270917|FG000|NOT COMPLETED|Overall Study||3
6360989|NCT00681811|7270918|FG001|NOT COMPLETED|Overall Study||4
6360990|NCT00681824|7270938|FG000|STARTED|Overall Study||28
6360991|NCT00681824|7270939|FG001|STARTED|Overall Study||13
6360992|NCT00681824|7270940|FG002|STARTED|Overall Study||34
6360993|NCT00681824|7270938|FG000|COMPLETED|Overall Study||27
6360994|NCT00681824|7270939|FG001|COMPLETED|Overall Study||12
6360995|NCT00681824|7270940|FG002|COMPLETED|Overall Study||33
6360996|NCT00681824|7270938|FG000|NOT COMPLETED|Overall Study||1
6360997|NCT00681824|7270939|FG001|NOT COMPLETED|Overall Study||1
6360998|NCT00681824|7270940|FG002|NOT COMPLETED|Overall Study||1
6360999|NCT00681863|7270948|FG000|STARTED|Overall Study||45
6361000|NCT00681863|7270948|FG000|COMPLETED|Overall Study||22
6361001|NCT00681863|7270948|FG000|NOT COMPLETED|Overall Study||23
6361002|NCT00681889|7270952|FG000|STARTED|Overall Study||9
6361003|NCT00681889|7270952|FG000|COMPLETED|Overall Study||9
6361004|NCT00681889|7270952|FG000|NOT COMPLETED|Overall Study||0
6361005|NCT00682357|7270959|FG000|STARTED|Overall Study||10
6361006|NCT00682357|7270960|FG001|STARTED|Overall Study||10
6361007|NCT00682357|7270961|FG002|STARTED|Overall Study||5
6361008|NCT00682357|7270959|FG000|COMPLETED|Overall Study||10
6361009|NCT00682357|7270960|FG001|COMPLETED|Overall Study||10
6361010|NCT00682357|7270961|FG002|COMPLETED|Overall Study||5
6361011|NCT00682357|7270959|FG000|NOT COMPLETED|Overall Study||0
6361012|NCT00682357|7270960|FG001|NOT COMPLETED|Overall Study||0
6361013|NCT00682357|7270961|FG002|NOT COMPLETED|Overall Study||0
6361014|NCT00682435|7270969|FG000|STARTED|Overall Study||230
6361015|NCT00682435|7270969|FG000|Ensured Enrolled Only Once|Overall Study||228
6361016|NCT00682435|7270969|FG000|Sufficient Data to Carry Out Analysis|Overall Study||223
6361017|NCT00682435|7270969|FG000|COMPLETED|Overall Study||223
6361018|NCT00682435|7270969|FG000|NOT COMPLETED|Overall Study||7
6361019|NCT00682448|7270975|FG000|STARTED|Overall Study||12
6361020|NCT00682448|7270976|FG001|STARTED|Overall Study||13
6361021|NCT00682448|7270975|FG000|COMPLETED|Overall Study||7
6361022|NCT00682448|7270976|FG001|COMPLETED|Overall Study||7
6361023|NCT00682448|7270975|FG000|NOT COMPLETED|Overall Study||5
6361024|NCT00682448|7270976|FG001|NOT COMPLETED|Overall Study||6
6361025|NCT00682461|7270984|FG000|STARTED|Overall Study||100
6361026|NCT00682461|7270985|FG001|STARTED|Overall Study||100
6361027|NCT00682461|7270984|FG000|COMPLETED|Overall Study||75
6361028|NCT00682461|7270985|FG001|COMPLETED|Overall Study||69
6361029|NCT00682461|7270984|FG000|NOT COMPLETED|Overall Study||25
6361030|NCT00682461|7270985|FG001|NOT COMPLETED|Overall Study||31
6361031|NCT00682539|7270995|FG000|STARTED|Bevacizumab vs Triamcinolone||18
6361032|NCT00682539|7270996|FG001|STARTED|Bevacizumab vs Triamcinolone||16
6361033|NCT00682539|7270997|FG002|STARTED|Bevacizumab vs Triamcinolone||0
6361034|NCT00682539|7270995|FG000|COMPLETED|Bevacizumab vs Triamcinolone||15
6361035|NCT00682539|7270996|FG001|COMPLETED|Bevacizumab vs Triamcinolone||15
6361036|NCT00682539|7270997|FG002|COMPLETED|Bevacizumab vs Triamcinolone||0
6361037|NCT00682539|7270995|FG000|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
6361038|NCT00682539|7270996|FG001|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
6361039|NCT00682539|7270997|FG002|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
6361040|NCT00682539|7270995|FG000|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
6361041|NCT00682539|7270996|FG001|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
6361042|NCT00682539|7270997|FG002|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
6361043|NCT00682539|7270995|FG000|COMPLETED|Ranibizumab vs Triamcinolone||0
6361044|NCT00682539|7270996|FG001|COMPLETED|Ranibizumab vs Triamcinolone||15
6361045|NCT00682539|7270997|FG002|COMPLETED|Ranibizumab vs Triamcinolone||10
6361046|NCT00682539|7270995|FG000|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
6361047|NCT00682539|7270996|FG001|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
6361048|NCT00682539|7270997|FG002|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
6361049|NCT00682565|7271008|FG000|STARTED|Overall Study||31
6361050|NCT00682565|7271009|FG001|STARTED|Overall Study||35
6361051|NCT00682565|7271010|FG002|STARTED|Overall Study||29
6361052|NCT00682565|7271008|FG000|COMPLETED|Overall Study||30
6361053|NCT00682565|7271009|FG001|COMPLETED|Overall Study||32
6361054|NCT00682565|7271010|FG002|COMPLETED|Overall Study||29
6361055|NCT00682565|7271008|FG000|NOT COMPLETED|Overall Study||1
6361056|NCT00682565|7271009|FG001|NOT COMPLETED|Overall Study||3
6361057|NCT00682565|7271010|FG002|NOT COMPLETED|Overall Study||0
6361058|NCT00682617|7271021|FG000|STARTED|Overall Study||13
6361059|NCT00682617|7271022|FG001|STARTED|Overall Study||28
6361060|NCT00682617|7271021|FG000|COMPLETED|Overall Study||10
6361061|NCT00682617|7271022|FG001|COMPLETED|Overall Study||21
6361062|NCT00682617|7271021|FG000|NOT COMPLETED|Overall Study||3
6361063|NCT00682617|7271022|FG001|NOT COMPLETED|Overall Study||7
6361064|NCT00682643|7271030|FG000|STARTED|Overall Study||182
6361065|NCT00682643|7271031|FG001|STARTED|Overall Study||368
6361066|NCT00682643|7271030|FG000|COMPLETED|Overall Study||104
6361067|NCT00682643|7271031|FG001|COMPLETED|Overall Study||199
6361068|NCT00682643|7271030|FG000|NOT COMPLETED|Overall Study||78
6361069|NCT00682643|7271031|FG001|NOT COMPLETED|Overall Study||169
6361070|NCT00682734|7271041|FG000|STARTED|Emergency Department Portion||113
6361071|NCT00682734|7271042|FG001|STARTED|Emergency Department Portion||118
6361072|NCT00682734|7271043|FG002|STARTED|Emergency Department Portion||118
6361073|NCT00682734|7271041|FG000|COMPLETED|Emergency Department Portion||113
6361074|NCT00682734|7271042|FG001|COMPLETED|Emergency Department Portion||117
6361075|NCT00682734|7271043|FG002|COMPLETED|Emergency Department Portion||117
6361076|NCT00682734|7271041|FG000|NOT COMPLETED|Emergency Department Portion||0
6361077|NCT00682734|7271042|FG001|NOT COMPLETED|Emergency Department Portion||1
6361078|NCT00682734|7271043|FG002|NOT COMPLETED|Emergency Department Portion||1
6361079|NCT00682734|7271041|FG000|STARTED|48 Hour Follow-up||113
6361080|NCT00682734|7271042|FG001|STARTED|48 Hour Follow-up||117
6361081|NCT00682734|7271043|FG002|STARTED|48 Hour Follow-up||117
6361082|NCT00682734|7271041|FG000|COMPLETED|48 Hour Follow-up||107
6361083|NCT00682734|7271042|FG001|COMPLETED|48 Hour Follow-up||111
6560335|NCT01786343|7483069|FG001|NOT COMPLETED|Overall Study||0
6560336|NCT01786512|7483086|FG000|STARTED|Overall Study||11
6560337|NCT01786512|7483087|FG001|STARTED|Overall Study||11
6560338|NCT01786512|7483088|FG002|STARTED|Overall Study||14
6560339|NCT01786512|7483089|FG003|STARTED|Overall Study||13
6560340|NCT01786512|7483090|FG004|STARTED|Overall Study||10
6560341|NCT01786512|7483091|FG005|STARTED|Overall Study||11
6560342|NCT01786512|7483092|FG006|STARTED|Overall Study||12
6560343|NCT01786512|7483093|FG007|STARTED|Overall Study||14
6361084|NCT00682734|7271043|FG002|COMPLETED|48 Hour Follow-up||106
6361085|NCT00682734|7271041|FG000|NOT COMPLETED|48 Hour Follow-up||6
6361086|NCT00682734|7271042|FG001|NOT COMPLETED|48 Hour Follow-up||6
6361087|NCT00682734|7271043|FG002|NOT COMPLETED|48 Hour Follow-up||11
6361088|NCT00682786|7271053|FG000|STARTED|Overall Study||98
6361089|NCT00682786|7271054|FG001|STARTED|Overall Study||37
6361090|NCT00682786|7271053|FG000|COMPLETED|Overall Study||96
6361091|NCT00682786|7271054|FG001|COMPLETED|Overall Study||34
6361092|NCT00682786|7271053|FG000|NOT COMPLETED|Overall Study||2
6361093|NCT00682786|7271054|FG001|NOT COMPLETED|Overall Study||3
6361094|NCT00682838|7271070|FG000|STARTED|Overall Study||65
6361095|NCT00682838|7271071|FG001|STARTED|Overall Study||67
6361096|NCT00682838|7271072|FG002|STARTED|Overall Study||75
6361097|NCT00682838|7271073|FG003|STARTED|Overall Study||73
6361098|NCT00682838|7271070|FG000|COMPLETED|Overall Study||65
6361099|NCT00682838|7271071|FG001|COMPLETED|Overall Study||67
6361100|NCT00682838|7271072|FG002|COMPLETED|Overall Study||75
6361101|NCT00682838|7271073|FG003|COMPLETED|Overall Study||73
6361102|NCT00682838|7271070|FG000|NOT COMPLETED|Overall Study||0
6361103|NCT00682838|7271071|FG001|NOT COMPLETED|Overall Study||0
6361104|NCT00682838|7271072|FG002|NOT COMPLETED|Overall Study||0
6361105|NCT00682838|7271073|FG003|NOT COMPLETED|Overall Study||0
6361106|NCT00682851|7271085|FG000|STARTED|Overall Study||251
6361107|NCT00682851|7271086|FG001|STARTED|Overall Study||268
6560344|NCT01786512|7483094|FG008|STARTED|Overall Study||149
6560345|NCT01786512|7483095|FG009|STARTED|Overall Study||150
6560346|NCT01786512|7483096|FG010|STARTED|Overall Study||149
6361108|NCT00682851|7271085|FG000|COMPLETED|Overall Study||251
6361109|NCT00682851|7271086|FG001|COMPLETED|Overall Study||268
6361110|NCT00682851|7271085|FG000|NOT COMPLETED|Overall Study||0
6361111|NCT00682851|7271086|FG001|NOT COMPLETED|Overall Study||0
6361112|NCT00682890|7271094|FG000|STARTED|Overall Study||12
6361113|NCT00682890|7271095|FG001|STARTED|Overall Study||11
6361114|NCT00682890|7271094|FG000|COMPLETED|Overall Study||10
6361115|NCT00682890|7271095|FG001|COMPLETED|Overall Study||9
6361116|NCT00682890|7271094|FG000|NOT COMPLETED|Overall Study||2
6361117|NCT00682890|7271095|FG001|NOT COMPLETED|Overall Study||2
6361118|NCT00682929|7271104|FG000|STARTED|Overall Study||13
6361119|NCT00682929|7271105|FG001|STARTED|Overall Study||14
6361120|NCT00682929|7271106|FG002|STARTED|Overall Study||14
6361121|NCT00682929|7271104|FG000|COMPLETED|Overall Study||7
6560347|NCT01786512|7483086|FG000|Received Study Treatment|Overall Study||11
6361122|NCT00682929|7271105|FG001|COMPLETED|Overall Study||9
6361123|NCT00682929|7271106|FG002|COMPLETED|Overall Study||12
6361124|NCT00682929|7271104|FG000|NOT COMPLETED|Overall Study||6
6361125|NCT00682929|7271105|FG001|NOT COMPLETED|Overall Study||5
6361126|NCT00682929|7271106|FG002|NOT COMPLETED|Overall Study||2
6361127|NCT00683020|7271116|FG000|STARTED|Overall Study||182
6361128|NCT00683020|7271117|FG001|STARTED|Overall Study||180
6361129|NCT00683020|7271116|FG000|COMPLETED|Overall Study||127
6361130|NCT00683020|7271117|FG001|COMPLETED|Overall Study||125
6361131|NCT00683020|7271116|FG000|NOT COMPLETED|Overall Study||55
6361132|NCT00683020|7271117|FG001|NOT COMPLETED|Overall Study||55
6361133|NCT00683046|7271123|FG000|STARTED|Overall Study||204
6361134|NCT00683046|7271123|FG000|COMPLETED|Overall Study||204
6361135|NCT00683046|7271123|FG000|NOT COMPLETED|Overall Study||0
6361136|NCT00683085|7271127|FG000|STARTED|Overall Study||2
6361137|NCT00683085|7271127|FG000|COMPLETED|Overall Study||2
6361138|NCT00683085|7271127|FG000|NOT COMPLETED|Overall Study||0
6361139|NCT00683163|7271133|FG000|STARTED|Overall Study||22
6361140|NCT00683163|7271134|FG001|STARTED|Overall Study||22
6361141|NCT00683163|7271133|FG000|COMPLETED|Overall Study||22
6361142|NCT00683163|7271134|FG001|COMPLETED|Overall Study||22
6361143|NCT00683163|7271133|FG000|NOT COMPLETED|Overall Study||0
6361144|NCT00683163|7271134|FG001|NOT COMPLETED|Overall Study||0
6361145|NCT00683293|7271142|FG000|STARTED|Overall Study||50
6361146|NCT00683293|7271143|FG001|STARTED|Overall Study||50
6361147|NCT00683293|7271142|FG000|COMPLETED|Overall Study||48
6361148|NCT00683293|7271143|FG001|COMPLETED|Overall Study||47
6361149|NCT00683293|7271142|FG000|NOT COMPLETED|Overall Study||2
6361150|NCT00683293|7271143|FG001|NOT COMPLETED|Overall Study||3
6361151|NCT00683332|7271149|FG000|STARTED|Overall Study||621
6361152|NCT00683332|7271149|FG000|COMPLETED|Overall Study||621
6361153|NCT00683332|7271149|FG000|NOT COMPLETED|Overall Study||0
6361154|NCT00683384|7271153|FG000|STARTED|Overall Study||93
6361155|NCT00683384|7271153|FG000|COMPLETED|Overall Study||91
6361156|NCT00683384|7271153|FG000|NOT COMPLETED|Overall Study||2
6361157|NCT00683410|7271157|FG000|STARTED|Overall Study||3366
6361158|NCT00683410|7271157|FG000|Vaccinated Dose 1|Overall Study||3240
6361159|NCT00683410|7271157|FG000|Vaccinated Dose 2|Overall Study||1623
6361160|NCT00683410|7271157|FG000|Vaccinated Dose 3|Overall Study||817
6361161|NCT00683410|7271157|FG000|Vaccinated Dose 4|Overall Study||175
6361162|NCT00683410|7271157|FG000|COMPLETED|Overall Study||3366
6361163|NCT00683410|7271157|FG000|NOT COMPLETED|Overall Study||0
6361164|NCT00683449|7271166|FG000|STARTED|Overall Study||5
6361165|NCT00683449|7271167|FG001|STARTED|Overall Study||13
6361166|NCT00683449|7271168|FG002|STARTED|Overall Study||3
6361167|NCT00683449|7271169|FG003|STARTED|Overall Study||6
6361168|NCT00683449|7271170|FG004|STARTED|Overall Study||2
6361169|NCT00683449|7271166|FG000|COMPLETED|Overall Study||5
6361170|NCT00683449|7271167|FG001|COMPLETED|Overall Study||12
6361171|NCT00683449|7271168|FG002|COMPLETED|Overall Study||3
6361172|NCT00683449|7271169|FG003|COMPLETED|Overall Study||6
6361173|NCT00683449|7271170|FG004|COMPLETED|Overall Study||2
6361174|NCT00683449|7271166|FG000|NOT COMPLETED|Overall Study||0
6361175|NCT00683449|7271167|FG001|NOT COMPLETED|Overall Study||1
6361176|NCT00683449|7271168|FG002|NOT COMPLETED|Overall Study||0
6361177|NCT00683449|7271169|FG003|NOT COMPLETED|Overall Study||0
6361178|NCT00683449|7271170|FG004|NOT COMPLETED|Overall Study||0
6361179|NCT00683475|7271189|FG000|STARTED|Overall Study||69
6361180|NCT00683475|7271190|FG001|STARTED|Overall Study||69
6361181|NCT00683475|7271189|FG000|Received Any Quantity of Study Drug|Overall Study||66
6361182|NCT00683475|7271190|FG001|Received Any Quantity of Study Drug|Overall Study||66
6361183|NCT00683475|7271189|FG000|COMPLETED|Overall Study||65
6361184|NCT00683475|7271190|FG001|COMPLETED|Overall Study||66
6361185|NCT00683475|7271189|FG000|NOT COMPLETED|Overall Study||4
6361186|NCT00683475|7271190|FG001|NOT COMPLETED|Overall Study||3
6361187|NCT00683592|7271199|FG000|STARTED|Overall Study||240
6361188|NCT00683592|7271200|FG001|STARTED|Overall Study||241
6361189|NCT00683592|7271199|FG000|Intent to Treat Population|Overall Study||231
6361190|NCT00683592|7271200|FG001|Intent to Treat Population|Overall Study||232
6361191|NCT00683592|7271199|FG000|Safety Population|Overall Study||235
6361192|NCT00683592|7271200|FG001|Safety Population|Overall Study||233
6361193|NCT00683592|7271199|FG000|COMPLETED|Overall Study||193
6361194|NCT00683592|7271200|FG001|COMPLETED|Overall Study||195
6361195|NCT00683592|7271199|FG000|NOT COMPLETED|Overall Study||47
6361196|NCT00683592|7271200|FG001|NOT COMPLETED|Overall Study||46
6361197|NCT00683618|7271209|FG000|STARTED|Randomised Treatment Period||145
6361198|NCT00683618|7271210|FG001|STARTED|Randomised Treatment Period||145
6361199|NCT00683618|7271211|FG002|STARTED|Randomised Treatment Period||146
6361200|NCT00683618|7271209|FG000|COMPLETED|Randomised Treatment Period||139
6361201|NCT00683618|7271210|FG001|COMPLETED|Randomised Treatment Period||143
6361202|NCT00683618|7271211|FG002|COMPLETED|Randomised Treatment Period||140
6361203|NCT00683618|7271209|FG000|NOT COMPLETED|Randomised Treatment Period||6
6361204|NCT00683618|7271210|FG001|NOT COMPLETED|Randomised Treatment Period||2
6361205|NCT00683618|7271211|FG002|NOT COMPLETED|Randomised Treatment Period||6
6361206|NCT00683618|7271209|FG000|STARTED|Extension Treatment Period||36
6361207|NCT00683618|7271210|FG001|STARTED|Extension Treatment Period||23
6361208|NCT00683618|7271211|FG002|STARTED|Extension Treatment Period||0
6361209|NCT00683618|7271209|FG000|COMPLETED|Extension Treatment Period||33
6361210|NCT00683618|7271210|FG001|COMPLETED|Extension Treatment Period||23
6361211|NCT00683618|7271211|FG002|COMPLETED|Extension Treatment Period||0
6361212|NCT00683618|7271209|FG000|NOT COMPLETED|Extension Treatment Period||3
6361213|NCT00683618|7271210|FG001|NOT COMPLETED|Extension Treatment Period||0
6361214|NCT00683618|7271211|FG002|NOT COMPLETED|Extension Treatment Period||0
6361215|NCT00683644|7271223|FG000|STARTED|Overall Study||58
6361216|NCT00683644|7271224|FG001|STARTED|Overall Study||58
6361217|NCT00683644|7271223|FG000|COMPLETED|Overall Study||45
6361218|NCT00683644|7271224|FG001|COMPLETED|Overall Study||44
6361219|NCT00683644|7271223|FG000|NOT COMPLETED|Overall Study||13
6361220|NCT00683644|7271224|FG001|NOT COMPLETED|Overall Study||14
6361221|NCT00683657|7271236|FG000|STARTED|Overall Study||46
6361222|NCT00683657|7271237|FG001|STARTED|Overall Study||47
6361223|NCT00683657|7271236|FG000|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
6361224|NCT00683657|7271237|FG001|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
6361225|NCT00683657|7271236|FG000|COMPLETED|Overall Study||45
6361226|NCT00683657|7271237|FG001|COMPLETED|Overall Study||46
6361227|NCT00683657|7271236|FG000|NOT COMPLETED|Overall Study||1
6361228|NCT00683657|7271237|FG001|NOT COMPLETED|Overall Study||1
6361229|NCT00683696|7271245|FG000|STARTED|Overall Study||404
6361230|NCT00683696|7271246|FG001|STARTED|Overall Study||405
6361231|NCT00683696|7271245|FG000|COMPLETED|Overall Study||0
6361232|NCT00683696|7271246|FG001|COMPLETED|Overall Study||0
6560348|NCT01786512|7483087|FG001|Received Study Treatment|Overall Study||10
6560349|NCT01786512|7483088|FG002|Received Study Treatment|Overall Study||14
6361233|NCT00683696|7271245|FG000|NOT COMPLETED|Overall Study||404
6361234|NCT00683696|7271246|FG001|NOT COMPLETED|Overall Study||405
6361235|NCT00683774|7271255|FG000|STARTED|Overall Study||11
6361236|NCT00683774|7271256|FG001|STARTED|Overall Study||10
6361237|NCT00683774|7271255|FG000|COMPLETED|Overall Study||8
6361238|NCT00683774|7271256|FG001|COMPLETED|Overall Study||9
6361239|NCT00683774|7271255|FG000|NOT COMPLETED|Overall Study||3
6361240|NCT00683774|7271256|FG001|NOT COMPLETED|Overall Study||1
6361241|NCT00683800|7271264|FG000|STARTED|Overall Study||1101
6361242|NCT00683800|7271265|FG001|STARTED|Overall Study||1085
6361243|NCT00683800|7271264|FG000|Treated|Overall Study||1066
6361244|NCT00683800|7271265|FG001|Treated|Overall Study||1052
6361245|NCT00683800|7271264|FG000|COMPLETED|Overall Study||669
6361246|NCT00683800|7271265|FG001|COMPLETED|Overall Study||719
6361247|NCT00683800|7271264|FG000|NOT COMPLETED|Overall Study||432
6361248|NCT00683800|7271265|FG001|NOT COMPLETED|Overall Study||366
6361249|NCT00683826|7271274|FG000|STARTED|Overall Study||8
6361250|NCT00683826|7271274|FG000|0g Leucine|Overall Study||8
6361251|NCT00683826|7271274|FG000|8g Leucine|Overall Study||8
6361252|NCT00683826|7271274|FG000|4g Leucine|Overall Study||7
6361253|NCT00683826|7271274|FG000|COMPLETED|Overall Study||7
6361254|NCT00683826|7271274|FG000|NOT COMPLETED|Overall Study||1
6361255|NCT00683852|7271284|FG000|STARTED|30-Day Phase 1 Period||56
6361256|NCT00683852|7271285|FG001|STARTED|30-Day Phase 1 Period||84
6361257|NCT00683852|7271286|FG002|STARTED|30-Day Phase 1 Period||85
6361258|NCT00683852|7271284|FG000|COMPLETED|30-Day Phase 1 Period||54
6361259|NCT00683852|7271285|FG001|COMPLETED|30-Day Phase 1 Period||83
6361260|NCT00683852|7271286|FG002|COMPLETED|30-Day Phase 1 Period||84
6361261|NCT00683852|7271284|FG000|NOT COMPLETED|30-Day Phase 1 Period||2
6361262|NCT00683852|7271285|FG001|NOT COMPLETED|30-Day Phase 1 Period||1
6361263|NCT00683852|7271286|FG002|NOT COMPLETED|30-Day Phase 1 Period||1
6361264|NCT00683852|7271284|FG000|STARTED|30-Day Phase 2 Period||54
6361265|NCT00683852|7271285|FG001|STARTED|30-Day Phase 2 Period||83
6361266|NCT00683852|7271286|FG002|STARTED|30-Day Phase 2 Period||84
6361267|NCT00683852|7271284|FG000|COMPLETED|30-Day Phase 2 Period||48
6361268|NCT00683852|7271285|FG001|COMPLETED|30-Day Phase 2 Period||78
6361269|NCT00683852|7271286|FG002|COMPLETED|30-Day Phase 2 Period||75
6361270|NCT00683852|7271284|FG000|NOT COMPLETED|30-Day Phase 2 Period||6
6361271|NCT00683852|7271285|FG001|NOT COMPLETED|30-Day Phase 2 Period||5
6361272|NCT00683852|7271286|FG002|NOT COMPLETED|30-Day Phase 2 Period||9
6361273|NCT00683878|7271304|FG000|STARTED|Overall Study||139
6560350|NCT01786512|7483089|FG003|Received Study Treatment|Overall Study||13
6560351|NCT01786512|7483090|FG004|Received Study Treatment|Overall Study||10
6361274|NCT00683878|7271305|FG001|STARTED|Overall Study||141
6361275|NCT00683878|7271306|FG002|STARTED|Overall Study||140
6361276|NCT00683878|7271304|FG000|COMPLETED|Overall Study||116
6361277|NCT00683878|7271305|FG001|COMPLETED|Overall Study||125
6361278|NCT00683878|7271306|FG002|COMPLETED|Overall Study||126
6361279|NCT00683878|7271304|FG000|NOT COMPLETED|Overall Study||23
6361280|NCT00683878|7271305|FG001|NOT COMPLETED|Overall Study||16
6361281|NCT00683878|7271306|FG002|NOT COMPLETED|Overall Study||14
6361282|NCT00683904|7271316|FG000|STARTED|Dose Level 1||6
6361283|NCT00683904|7271317|FG001|STARTED|Dose Level 1||0
6361284|NCT00683904|7271316|FG000|COMPLETED|Dose Level 1||3
6361285|NCT00683904|7271317|FG001|COMPLETED|Dose Level 1||0
6361286|NCT00683904|7271316|FG000|NOT COMPLETED|Dose Level 1||3
6361287|NCT00683904|7271317|FG001|NOT COMPLETED|Dose Level 1||0
6361288|NCT00683904|7271316|FG000|STARTED|Dose Level 2||0
6361289|NCT00683904|7271317|FG001|STARTED|Dose Level 2||6
6361290|NCT00683904|7271316|FG000|COMPLETED|Dose Level 2||0
6361291|NCT00683904|7271317|FG001|COMPLETED|Dose Level 2||4
6361292|NCT00683904|7271316|FG000|NOT COMPLETED|Dose Level 2||0
6361293|NCT00683904|7271317|FG001|NOT COMPLETED|Dose Level 2||2
6361294|NCT00683930|7271332|FG000|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
6361295|NCT00683930|7271333|FG001|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
6361296|NCT00683930|7271334|FG002|STARTED|Overall Study||37
6361297|NCT00683930|7271332|FG000|COMPLETED|Overall Study||29
6361298|NCT00683930|7271333|FG001|COMPLETED|Overall Study||18
6361299|NCT00683930|7271334|FG002|COMPLETED|Overall Study||28
6361300|NCT00683930|7271332|FG000|NOT COMPLETED|Overall Study||7
6361301|NCT00683930|7271333|FG001|NOT COMPLETED|Overall Study||3
6361302|NCT00683930|7271334|FG002|NOT COMPLETED|Overall Study||9
6361303|NCT00684021|7271347|FG000|STARTED|Overall Study||43
6361304|NCT00684021|7271348|FG001|STARTED|Overall Study||24
6361305|NCT00684021|7271349|FG002|STARTED|Overall Study||36
6361306|NCT00684021|7271350|FG003|STARTED|Overall Study||17
6361307|NCT00684021|7271347|FG000|COMPLETED|Overall Study||41
6361308|NCT00684021|7271348|FG001|COMPLETED|Overall Study||22
6361309|NCT00684021|7271349|FG002|COMPLETED|Overall Study||34
6361310|NCT00684021|7271350|FG003|COMPLETED|Overall Study||15
6560352|NCT01786512|7483091|FG005|Received Study Treatment|Overall Study||11
6560353|NCT01786512|7483092|FG006|Received Study Treatment|Overall Study||11
6361311|NCT00684021|7271347|FG000|NOT COMPLETED|Overall Study||2
6361312|NCT00684021|7271348|FG001|NOT COMPLETED|Overall Study||2
6361313|NCT00684021|7271349|FG002|NOT COMPLETED|Overall Study||2
6361314|NCT00684021|7271350|FG003|NOT COMPLETED|Overall Study||2
6361315|NCT00684047|7271363|FG000|STARTED|Overall Study||72
6361316|NCT00684047|7271364|FG001|STARTED|Overall Study||110
6361317|NCT00684047|7271365|FG002|STARTED|Overall Study||57
6361318|NCT00684047|7271363|FG000|COMPLETED|Overall Study||59
6361319|NCT00684047|7271364|FG001|COMPLETED|Overall Study||94
6361320|NCT00684047|7271365|FG002|COMPLETED|Overall Study||52
6361321|NCT00684047|7271363|FG000|NOT COMPLETED|Overall Study||13
6361322|NCT00684047|7271364|FG001|NOT COMPLETED|Overall Study||16
6361323|NCT00684047|7271365|FG002|NOT COMPLETED|Overall Study||5
6361324|NCT00684060|7271375|FG000|STARTED|Overall Study||58
6361325|NCT00684060|7271376|FG001|STARTED|Overall Study||29
6361326|NCT00684060|7271375|FG000|COMPLETED|Overall Study||55
6361327|NCT00684060|7271376|FG001|COMPLETED|Overall Study||26
6361328|NCT00684060|7271375|FG000|NOT COMPLETED|Overall Study||3
6361329|NCT00684060|7271376|FG001|NOT COMPLETED|Overall Study||3
6361330|NCT00684073|7271382|FG000|STARTED|Selection||60
6361331|NCT00684073|7271382|FG000|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
6361332|NCT00684073|7271382|FG000|NOT COMPLETED|Selection||7
6361333|NCT00684073|7271382|FG000|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
6361334|NCT00684073|7271382|FG000|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
6361335|NCT00684073|7271382|FG000|NOT COMPLETED|Treatment (Days 1 Through 5)||1
6361336|NCT00684138|7271392|FG000|STARTED|Overall Study||141
6361337|NCT00684138|7271393|FG001|STARTED|Overall Study||139
6361338|NCT00684138|7271392|FG000|COMPLETED|Overall Study||138
6361339|NCT00684138|7271393|FG001|COMPLETED|Overall Study||131
6361340|NCT00684138|7271392|FG000|NOT COMPLETED|Overall Study||3
6361341|NCT00684138|7271393|FG001|NOT COMPLETED|Overall Study||8
6361342|NCT00684177|7271403|FG000|STARTED|Overall Study||343
6361343|NCT00684177|7271404|FG001|STARTED|Overall Study||164
6361344|NCT00684177|7271403|FG000|COMPLETED|Overall Study||322
6361345|NCT00684177|7271404|FG001|COMPLETED|Overall Study||141
6361346|NCT00684177|7271403|FG000|NOT COMPLETED|Overall Study||21
6361347|NCT00684177|7271404|FG001|NOT COMPLETED|Overall Study||23
6361348|NCT00684203|7271416|FG000|STARTED|Overall Study||40
6361349|NCT00684203|7271417|FG001|STARTED|Overall Study||31
6361350|NCT00684203|7271418|FG002|STARTED|Overall Study||21
6361351|NCT00684203|7271419|FG003|STARTED|Overall Study||6
6361352|NCT00684203|7271420|FG004|STARTED|Overall Study||17
6361353|NCT00684203|7271421|FG005|STARTED|Overall Study||2
6361354|NCT00684203|7271416|FG000|COMPLETED|Overall Study||31
6361355|NCT00684203|7271417|FG001|COMPLETED|Overall Study||23
6361356|NCT00684203|7271418|FG002|COMPLETED|Overall Study||12
6361357|NCT00684203|7271419|FG003|COMPLETED|Overall Study||6
6361358|NCT00684203|7271420|FG004|COMPLETED|Overall Study||17
6361359|NCT00684203|7271421|FG005|COMPLETED|Overall Study||2
6361360|NCT00684203|7271416|FG000|NOT COMPLETED|Overall Study||9
6361361|NCT00684203|7271417|FG001|NOT COMPLETED|Overall Study||8
6361362|NCT00684203|7271418|FG002|NOT COMPLETED|Overall Study||9
6560354|NCT01786512|7483093|FG007|Received Study Treatment|Overall Study||14
6361363|NCT00684203|7271419|FG003|NOT COMPLETED|Overall Study||0
6361364|NCT00684203|7271420|FG004|NOT COMPLETED|Overall Study||0
6361365|NCT00684203|7271421|FG005|NOT COMPLETED|Overall Study||0
6361366|NCT00684242|7271442|FG000|STARTED|Overall Study||3
6361367|NCT00684242|7271442|FG000|COMPLETED|Overall Study||3
6361368|NCT00684242|7271442|FG000|NOT COMPLETED|Overall Study||0
6361369|NCT00684307|7271451|FG000|STARTED|Overall Study|Patients who received treatment|164
6361370|NCT00684307|7271452|FG001|STARTED|Overall Study||151
6361371|NCT00684307|7271453|FG002|STARTED|Overall Study||156
6361372|NCT00684307|7271454|FG003|STARTED|Overall Study||160
6361373|NCT00684307|7271455|FG004|STARTED|Overall Study||318
6361374|NCT00684307|7271451|FG000|On Treatment Period Started|Overall Study||164
6361375|NCT00684307|7271452|FG001|On Treatment Period Started|Overall Study||151
6361376|NCT00684307|7271453|FG002|On Treatment Period Started|Overall Study||156
6361377|NCT00684307|7271454|FG003|On Treatment Period Started|Overall Study||160
6361378|NCT00684307|7271455|FG004|On Treatment Period Started|Overall Study||318
6361379|NCT00684307|7271451|FG000|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
6361380|NCT00684307|7271452|FG001|On Treatment Period Completed|Overall Study||129
6361381|NCT00684307|7271453|FG002|On Treatment Period Completed|Overall Study||128
6361382|NCT00684307|7271454|FG003|On Treatment Period Completed|Overall Study||128
6361383|NCT00684307|7271455|FG004|On Treatment Period Completed|Overall Study||293
6361384|NCT00684307|7271451|FG000|COMPLETED|Overall Study||140
6361385|NCT00684307|7271452|FG001|COMPLETED|Overall Study||129
6361386|NCT00684307|7271453|FG002|COMPLETED|Overall Study||128
6361387|NCT00684307|7271454|FG003|COMPLETED|Overall Study||128
6361388|NCT00684307|7271455|FG004|COMPLETED|Overall Study||293
6361389|NCT00684307|7271451|FG000|NOT COMPLETED|Overall Study||24
6361390|NCT00684307|7271452|FG001|NOT COMPLETED|Overall Study||22
6560355|NCT01786512|7483094|FG008|Received Study Treatment|Overall Study||149
6560356|NCT01786512|7483095|FG009|Received Study Treatment|Overall Study||150
6560357|NCT01786512|7483096|FG010|Received Study Treatment|Overall Study||146
6361391|NCT00684307|7271453|FG002|NOT COMPLETED|Overall Study||28
6361392|NCT00684307|7271454|FG003|NOT COMPLETED|Overall Study||32
6361393|NCT00684307|7271455|FG004|NOT COMPLETED|Overall Study||25
6361394|NCT00684320|7271469|FG000|STARTED|Overall Study||26
6361395|NCT00684320|7271470|FG001|STARTED|Overall Study||22
6361396|NCT00684320|7271469|FG000|COMPLETED|Overall Study||22
6361397|NCT00684320|7271470|FG001|COMPLETED|Overall Study||22
6361398|NCT00684320|7271469|FG000|NOT COMPLETED|Overall Study||4
6361399|NCT00684320|7271470|FG001|NOT COMPLETED|Overall Study||0
6361400|NCT00684411|7271476|FG000|STARTED|Overall Study||12
6361401|NCT00684411|7271476|FG000|Disease Evaluable|Overall Study||11
6361402|NCT00684411|7271476|FG000|COMPLETED|Overall Study||0
6361403|NCT00684411|7271476|FG000|NOT COMPLETED|Overall Study||12
6361404|NCT00684424|7271480|FG000|STARTED|Overall Study||199
6361405|NCT00684424|7271480|FG000|COMPLETED|Overall Study||194
6361406|NCT00684424|7271480|FG000|NOT COMPLETED|Overall Study||5
6361407|NCT00684515|7271488|FG000|STARTED|Overall Study||33
6361408|NCT00684515|7271489|FG001|STARTED|Overall Study||29
6361409|NCT00684515|7271490|FG002|STARTED|Overall Study||28
6361410|NCT00684515|7271488|FG000|COMPLETED|Overall Study||29
6361411|NCT00684515|7271489|FG001|COMPLETED|Overall Study||26
6361412|NCT00684515|7271490|FG002|COMPLETED|Overall Study||27
6361413|NCT00684515|7271488|FG000|NOT COMPLETED|Overall Study||4
6361414|NCT00684515|7271489|FG001|NOT COMPLETED|Overall Study||3
6361415|NCT00684515|7271490|FG002|NOT COMPLETED|Overall Study||1
6361416|NCT00684541|7271500|FG000|STARTED|Overall Study||23
6361417|NCT00684541|7271501|FG001|STARTED|Overall Study||26
6361418|NCT00684541|7271500|FG000|COMPLETED|Overall Study||20
6361419|NCT00684541|7271501|FG001|COMPLETED|Overall Study||23
6361420|NCT00684541|7271500|FG000|NOT COMPLETED|Overall Study||3
6361421|NCT00684541|7271501|FG001|NOT COMPLETED|Overall Study||3
6361422|NCT00684554|7271510|FG000|STARTED|Overall Study||10
6361423|NCT00684554|7271511|FG001|STARTED|Overall Study||10
6361424|NCT00684554|7271510|FG000|COMPLETED|Overall Study||10
6361425|NCT00684554|7271511|FG001|COMPLETED|Overall Study||10
6361426|NCT00684554|7271510|FG000|NOT COMPLETED|Overall Study||0
6361427|NCT00684554|7271511|FG001|NOT COMPLETED|Overall Study||0
6361428|NCT00684567|7271517|FG000|STARTED|Concomitant Radiotherapy Period||30
6361429|NCT00684567|7271517|FG000|COMPLETED|Concomitant Radiotherapy Period||28
6361430|NCT00684567|7271517|FG000|NOT COMPLETED|Concomitant Radiotherapy Period||2
6361431|NCT00684567|7271517|FG000|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
6361432|NCT00684567|7271517|FG000|COMPLETED|Monotherapy Period||9
6361433|NCT00684567|7271517|FG000|NOT COMPLETED|Monotherapy Period||14
6361434|NCT00684593|7271523|FG000|STARTED|Overall Study||21
6361435|NCT00684593|7271524|FG001|STARTED|Overall Study||10
6361436|NCT00684593|7271523|FG000|COMPLETED|Overall Study||21
6361437|NCT00684593|7271524|FG001|COMPLETED|Overall Study||8
6361438|NCT00684593|7271523|FG000|NOT COMPLETED|Overall Study||0
6361439|NCT00684593|7271524|FG001|NOT COMPLETED|Overall Study||2
6361440|NCT00684645|7271530|FG000|STARTED|Overall Study||186
6361441|NCT00684645|7271530|FG000|COMPLETED|Overall Study||72
6361442|NCT00684645|7271530|FG000|NOT COMPLETED|Overall Study||114
6361443|NCT00684671|7271537|FG000|STARTED|Overall Study||172
6361444|NCT00684671|7271538|FG001|STARTED|Overall Study||170
6361445|NCT00684671|7271539|FG002|STARTED|Overall Study||164
6361446|NCT00684671|7271537|FG000|COMPLETED|Overall Study||169
6361447|NCT00684671|7271538|FG001|COMPLETED|Overall Study||170
6560358|NCT01786512|7483086|FG000|COMPLETED|Overall Study||11
6361448|NCT00684671|7271539|FG002|COMPLETED|Overall Study||164
6361449|NCT00684671|7271537|FG000|NOT COMPLETED|Overall Study||3
6361450|NCT00684671|7271538|FG001|NOT COMPLETED|Overall Study||0
6361451|NCT00684671|7271539|FG002|NOT COMPLETED|Overall Study||0
6361452|NCT00684723|7271547|FG000|STARTED|First Intervention||27
6361453|NCT00684723|7271548|FG001|STARTED|First Intervention||27
6361454|NCT00684723|7271547|FG000|COMPLETED|First Intervention||27
6361455|NCT00684723|7271548|FG001|COMPLETED|First Intervention||27
6361456|NCT00684723|7271547|FG000|NOT COMPLETED|First Intervention||0
6361457|NCT00684723|7271548|FG001|NOT COMPLETED|First Intervention||0
6361458|NCT00684723|7271547|FG000|STARTED|Washout Period of 7 Days||27
6361459|NCT00684723|7271548|FG001|STARTED|Washout Period of 7 Days||27
6361460|NCT00684723|7271547|FG000|COMPLETED|Washout Period of 7 Days||27
6361461|NCT00684723|7271548|FG001|COMPLETED|Washout Period of 7 Days||27
6361462|NCT00684723|7271547|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6361463|NCT00684723|7271548|FG001|NOT COMPLETED|Washout Period of 7 Days||0
6361464|NCT00684723|7271547|FG000|STARTED|Second Intervention||27
6361465|NCT00684723|7271548|FG001|STARTED|Second Intervention||27
6361466|NCT00684723|7271547|FG000|COMPLETED|Second Intervention||27
6361467|NCT00684723|7271548|FG001|COMPLETED|Second Intervention||27
6361468|NCT00684723|7271547|FG000|NOT COMPLETED|Second Intervention||0
6361469|NCT00684723|7271548|FG001|NOT COMPLETED|Second Intervention||0
6361470|NCT00684749|7271554|FG000|STARTED|Overall Study||142
6361471|NCT00684749|7271554|FG000|COMPLETED|Overall Study||142
6361472|NCT00684749|7271554|FG000|NOT COMPLETED|Overall Study||0
6377189|NCT00762307|7287764|FG002|STARTED|Overall Study||11
6377190|NCT00762307|7287765|FG003|STARTED|Overall Study||10
6377191|NCT00762307|7287762|FG000|COMPLETED|Overall Study||26
6377192|NCT00762307|7287763|FG001|COMPLETED|Overall Study||11
6377193|NCT00762307|7287764|FG002|COMPLETED|Overall Study||11
6377194|NCT00762307|7287765|FG003|COMPLETED|Overall Study||9
6377195|NCT00762307|7287762|FG000|NOT COMPLETED|Overall Study||2
6377196|NCT00762307|7287763|FG001|NOT COMPLETED|Overall Study||0
6377197|NCT00762307|7287764|FG002|NOT COMPLETED|Overall Study||0
6377198|NCT00762307|7287765|FG003|NOT COMPLETED|Overall Study||1
6377199|NCT00762320|7287786|FG000|STARTED|Overall Study||8
6377200|NCT00762320|7287786|FG000|COMPLETED|Overall Study||8
6377201|NCT00762320|7287786|FG000|NOT COMPLETED|Overall Study||0
6377202|NCT00762359|7287797|FG000|STARTED|Overall Study||226
6377203|NCT00762359|7287798|FG001|STARTED|Overall Study||235
6377204|NCT00762359|7287797|FG000|COMPLETED|Overall Study||167
6377205|NCT00762359|7287798|FG001|COMPLETED|Overall Study||178
6377206|NCT00762359|7287797|FG000|NOT COMPLETED|Overall Study||59
6377207|NCT00762359|7287798|FG001|NOT COMPLETED|Overall Study||57
6377208|NCT00762372|7287807|FG000|STARTED|Overall Study|N=114 enrolled but 3 participant's discontinued before start of study drug administration.|111
6377209|NCT00762372|7287808|FG001|STARTED|Overall Study|N=57 enrolled but 2 participant's discontinued before start of study drug administration.|55
6377210|NCT00762372|7287809|FG002|STARTED|Overall Study|N=53 enrolled but 3 participant's discontinued before start of study drug administration.|50
6377211|NCT00762372|7287807|FG000|COMPLETED|Overall Study||110
6377212|NCT00762372|7287808|FG001|COMPLETED|Overall Study||55
6560359|NCT01786512|7483087|FG001|COMPLETED|Overall Study||10
6560360|NCT01786512|7483088|FG002|COMPLETED|Overall Study||14
6560361|NCT01786512|7483089|FG003|COMPLETED|Overall Study||13
6560362|NCT01786512|7483090|FG004|COMPLETED|Overall Study||10
6560363|NCT01786512|7483091|FG005|COMPLETED|Overall Study||11
6560364|NCT01786512|7483092|FG006|COMPLETED|Overall Study||11
6560365|NCT01786512|7483093|FG007|COMPLETED|Overall Study||14
6560366|NCT01786512|7483094|FG008|COMPLETED|Overall Study||145
6560367|NCT01786512|7483095|FG009|COMPLETED|Overall Study||145
6560368|NCT01786512|7483096|FG010|COMPLETED|Overall Study||137
6560369|NCT01786512|7483086|FG000|NOT COMPLETED|Overall Study||0
6560370|NCT01786512|7483087|FG001|NOT COMPLETED|Overall Study||1
6560371|NCT01786512|7483088|FG002|NOT COMPLETED|Overall Study||0
6560372|NCT01786512|7483089|FG003|NOT COMPLETED|Overall Study||0
6560373|NCT01786512|7483090|FG004|NOT COMPLETED|Overall Study||0
6560374|NCT01786512|7483091|FG005|NOT COMPLETED|Overall Study||0
6560375|NCT01786512|7483092|FG006|NOT COMPLETED|Overall Study||1
6560376|NCT01786512|7483093|FG007|NOT COMPLETED|Overall Study||0
6560377|NCT01786512|7483094|FG008|NOT COMPLETED|Overall Study||4
6560378|NCT01786512|7483095|FG009|NOT COMPLETED|Overall Study||5
6560379|NCT01786512|7483096|FG010|NOT COMPLETED|Overall Study||12
6560380|NCT01786551|7483128|FG000|STARTED|Overall Study||16
6560381|NCT01786551|7483128|FG000|COMPLETED|Overall Study||14
6560382|NCT01786551|7483128|FG000|NOT COMPLETED|Overall Study||2
6560383|NCT01786564|7483132|FG000|STARTED|Overall Study||120
6560384|NCT01786564|7483132|FG000|COMPLETED|Overall Study||56
6560385|NCT01786564|7483132|FG000|NOT COMPLETED|Overall Study||64
6560386|NCT01786603|7483138|FG000|STARTED|Overall Study||60
6560387|NCT01786603|7483139|FG001|STARTED|Overall Study||20
6560388|NCT01786603|7483138|FG000|COMPLETED|Overall Study||42
6560389|NCT01786603|7483139|FG001|COMPLETED|Overall Study||8
6560390|NCT01786603|7483138|FG000|NOT COMPLETED|Overall Study||18
6560391|NCT01786603|7483139|FG001|NOT COMPLETED|Overall Study||12
6560392|NCT01786629|7483147|FG000|STARTED|Overall Study||169
6560393|NCT01786629|7483148|FG001|STARTED|Overall Study||169
6560394|NCT01786629|7483147|FG000|COMPLETED|Overall Study||169
6560395|NCT01786629|7483148|FG001|COMPLETED|Overall Study||164
6560396|NCT01786629|7483147|FG000|NOT COMPLETED|Overall Study||0
6560397|NCT01786629|7483148|FG001|NOT COMPLETED|Overall Study||5
6560398|NCT01786668|7483158|FG000|STARTED|Overall Study||52
6560399|NCT01786668|7483159|FG001|STARTED|Overall Study||52
6560400|NCT01786668|7483160|FG002|STARTED|Overall Study||52
6560401|NCT01786668|7483161|FG003|STARTED|Overall Study||51
6560402|NCT01786668|7483158|FG000|COMPLETED|Overall Study||51
6560403|NCT01786668|7483159|FG001|COMPLETED|Overall Study||51
6560404|NCT01786668|7483160|FG002|COMPLETED|Overall Study||47
6377213|NCT00762372|7287809|FG002|COMPLETED|Overall Study||50
6377214|NCT00762372|7287807|FG000|NOT COMPLETED|Overall Study||1
6377215|NCT00762372|7287808|FG001|NOT COMPLETED|Overall Study||0
6377216|NCT00762372|7287809|FG002|NOT COMPLETED|Overall Study||0
6377217|NCT00762385|7287823|FG000|STARTED|First Intervention||51
6377218|NCT00762385|7287824|FG001|STARTED|First Intervention||46
6377219|NCT00762385|7287823|FG000|COMPLETED|First Intervention||49
6377220|NCT00762385|7287824|FG001|COMPLETED|First Intervention||42
6377221|NCT00762385|7287823|FG000|NOT COMPLETED|First Intervention||2
6377222|NCT00762385|7287824|FG001|NOT COMPLETED|First Intervention||4
6560405|NCT01786668|7483161|FG003|COMPLETED|Overall Study||47
6560406|NCT01786668|7483158|FG000|NOT COMPLETED|Overall Study||1
6560407|NCT01786668|7483159|FG001|NOT COMPLETED|Overall Study||1
6560408|NCT01786668|7483160|FG002|NOT COMPLETED|Overall Study||5
6560409|NCT01786668|7483161|FG003|NOT COMPLETED|Overall Study||4
6560410|NCT01786707|7483173|FG000|STARTED|Overall Study||1
6560411|NCT01786707|7483174|FG001|STARTED|Overall Study||1
6560412|NCT01786707|7483173|FG000|COMPLETED|Overall Study||0
6560413|NCT01786707|7483174|FG001|COMPLETED|Overall Study||0
6560414|NCT01786707|7483173|FG000|NOT COMPLETED|Overall Study||1
6560415|NCT01786707|7483174|FG001|NOT COMPLETED|Overall Study||1
6560416|NCT01786876|7483180|FG000|STARTED|Overall Study||6
6560417|NCT01786876|7483180|FG000|COMPLETED|Overall Study||6
6560418|NCT01786876|7483180|FG000|NOT COMPLETED|Overall Study||0
6560419|NCT01786902|7483186|FG000|STARTED|Overall Study||36
6560420|NCT01786902|7483187|FG001|STARTED|Overall Study||34
6560421|NCT01786902|7483186|FG000|COMPLETED|Overall Study||32
6560422|NCT01786902|7483187|FG001|COMPLETED|Overall Study||31
6560423|NCT01786902|7483186|FG000|NOT COMPLETED|Overall Study||4
6560424|NCT01786902|7483187|FG001|NOT COMPLETED|Overall Study||3
6560425|NCT01786954|7483193|FG000|STARTED|Overall Study||34
6560426|NCT01786954|7483194|FG001|STARTED|Overall Study||34
6560427|NCT01786954|7483193|FG000|COMPLETED|Overall Study||34
6560428|NCT01786954|7483194|FG001|COMPLETED|Overall Study||34
6560429|NCT01786954|7483193|FG000|NOT COMPLETED|Overall Study||0
6560430|NCT01786954|7483194|FG001|NOT COMPLETED|Overall Study||0
6560431|NCT01786967|7483204|FG000|STARTED|Overall Study||61
6560432|NCT01786967|7483204|FG000|Extensive Metabolizers|Overall Study||54
6560433|NCT01786967|7483204|FG000|Poor Metabolizers|Overall Study||4
6560434|NCT01786967|7483204|FG000|Metabolizer Status Undetermined|Overall Study||3
6560435|NCT01786967|7483204|FG000|COMPLETED|Overall Study||61
6560436|NCT01786967|7483204|FG000|NOT COMPLETED|Overall Study||0
6560437|NCT01786993|7483215|FG000|STARTED|Overall Study||201
6560438|NCT01786993|7483216|FG001|STARTED|Overall Study||180
6560439|NCT01786993|7483215|FG000|Per Protocol Population at 9 Months|Overall Study||189
6560440|NCT01786993|7483216|FG001|Per Protocol Population at 9 Months|Overall Study||170
6560441|NCT01786993|7483215|FG000|COMPLETED|Overall Study||189
6560442|NCT01786993|7483216|FG001|COMPLETED|Overall Study||170
6560443|NCT01786993|7483215|FG000|NOT COMPLETED|Overall Study||12
6560444|NCT01786993|7483216|FG001|NOT COMPLETED|Overall Study||10
6560445|NCT01787006|7483225|FG000|STARTED|Overall Study||35
6560446|NCT01787006|7483226|FG001|STARTED|Overall Study||39
6560447|NCT01787006|7483225|FG000|COMPLETED|Overall Study||32
6560448|NCT01787006|7483226|FG001|COMPLETED|Overall Study||36
6560449|NCT01787006|7483225|FG000|NOT COMPLETED|Overall Study||3
6560450|NCT01787006|7483226|FG001|NOT COMPLETED|Overall Study||3
6560451|NCT01787032|7483238|FG000|STARTED|Overall Study||3
6560452|NCT01787032|7483239|FG001|STARTED|Overall Study||3
6560453|NCT01787032|7483240|FG002|STARTED|Overall Study||3
6560454|NCT01787032|7483241|FG003|STARTED|Overall Study||3
6560455|NCT01787032|7483242|FG004|STARTED|Overall Study||4
6560456|NCT01787032|7483243|FG005|STARTED|Overall Study||4
6560457|NCT01787032|7483238|FG000|Received R|Overall Study||3
6560458|NCT01787032|7483239|FG001|Received R|Overall Study||3
6560459|NCT01787032|7483240|FG002|Received R|Overall Study||3
6560460|NCT01787032|7483241|FG003|Received R|Overall Study||3
6560461|NCT01787032|7483242|FG004|Received R|Overall Study||4
6560462|NCT01787032|7483243|FG005|Received R|Overall Study||3
6560463|NCT01787032|7483238|FG000|Received T1|Overall Study||3
6560464|NCT01787032|7483239|FG001|Received T1|Overall Study||3
6560465|NCT01787032|7483240|FG002|Received T1|Overall Study||3
6560466|NCT01787032|7483241|FG003|Received T1|Overall Study||3
6560467|NCT01787032|7483242|FG004|Received T1|Overall Study||3
6560468|NCT01787032|7483243|FG005|Received T1|Overall Study||4
6560469|NCT01787032|7483238|FG000|Received T2|Overall Study||3
6560470|NCT01787032|7483239|FG001|Received T2|Overall Study||3
6560471|NCT01787032|7483240|FG002|Received T2|Overall Study||3
6560472|NCT01787032|7483241|FG003|Received T2|Overall Study||3
6560473|NCT01787032|7483242|FG004|Received T2|Overall Study||4
6777808|NCT03797144|7705781|FG001|NOT COMPLETED|12 Month||9
6777809|NCT03797144|7705780|FG000|STARTED|24 Month||1
6361473|NCT00684762|7271558|FG000|STARTED|First Intervention||16
6361474|NCT00684762|7271559|FG001|STARTED|First Intervention||16
6361475|NCT00684762|7271558|FG000|COMPLETED|First Intervention||16
6361476|NCT00684762|7271559|FG001|COMPLETED|First Intervention||16
6361477|NCT00684762|7271558|FG000|NOT COMPLETED|First Intervention||0
6560474|NCT01787032|7483243|FG005|Received T2|Overall Study||4
6560475|NCT01787032|7483238|FG000|COMPLETED|Overall Study||3
6560476|NCT01787032|7483239|FG001|COMPLETED|Overall Study||3
6560477|NCT01787032|7483240|FG002|COMPLETED|Overall Study||3
6560478|NCT01787032|7483241|FG003|COMPLETED|Overall Study||3
6560479|NCT01787032|7483242|FG004|COMPLETED|Overall Study||3
6560480|NCT01787032|7483243|FG005|COMPLETED|Overall Study||3
6560481|NCT01787032|7483238|FG000|NOT COMPLETED|Overall Study||0
6560482|NCT01787032|7483239|FG001|NOT COMPLETED|Overall Study||0
6560483|NCT01787032|7483240|FG002|NOT COMPLETED|Overall Study||0
6560484|NCT01787032|7483241|FG003|NOT COMPLETED|Overall Study||0
6560485|NCT01787032|7483242|FG004|NOT COMPLETED|Overall Study||1
6777810|NCT03797144|7705781|FG001|STARTED|24 Month||1
6361478|NCT00684762|7271559|FG001|NOT COMPLETED|First Intervention||0
6560486|NCT01787032|7483243|FG005|NOT COMPLETED|Overall Study||1
6560487|NCT01787097|7483253|FG000|STARTED|Overall Study|Study started in 2012/2013|8
6560488|NCT01787097|7483254|FG001|STARTED|Overall Study||7
6560489|NCT01787097|7483255|FG002|STARTED|Overall Study||7
6560490|NCT01787097|7483256|FG003|STARTED|Overall Study||9
6560491|NCT01787097|7483253|FG000|COMPLETED|Overall Study|Study completed|7
6560492|NCT01787097|7483254|FG001|COMPLETED|Overall Study||7
6777811|NCT03797144|7705780|FG000|COMPLETED|24 Month||0
6361479|NCT00684762|7271558|FG000|STARTED|Washout Period of 7 Days||16
6361480|NCT00684762|7271559|FG001|STARTED|Washout Period of 7 Days||16
6361481|NCT00684762|7271558|FG000|COMPLETED|Washout Period of 7 Days||14
6361482|NCT00684762|7271559|FG001|COMPLETED|Washout Period of 7 Days||14
6361483|NCT00684762|7271558|FG000|NOT COMPLETED|Washout Period of 7 Days||2
6361484|NCT00684762|7271559|FG001|NOT COMPLETED|Washout Period of 7 Days||2
6361485|NCT00684762|7271558|FG000|STARTED|Second Intervention||14
6361486|NCT00684762|7271559|FG001|STARTED|Second Intervention||14
6361487|NCT00684762|7271558|FG000|COMPLETED|Second Intervention||14
6361488|NCT00684762|7271559|FG001|COMPLETED|Second Intervention||14
6361489|NCT00684762|7271558|FG000|NOT COMPLETED|Second Intervention||0
6361490|NCT00684762|7271559|FG001|NOT COMPLETED|Second Intervention||0
6361491|NCT00684775|7271567|FG000|STARTED|Overall Study||19
6361492|NCT00684775|7271568|FG001|STARTED|Overall Study||19
6361493|NCT00684775|7271567|FG000|COMPLETED|Overall Study||19
6361494|NCT00684775|7271568|FG001|COMPLETED|Overall Study||19
6361495|NCT00684775|7271567|FG000|NOT COMPLETED|Overall Study||0
6361496|NCT00684775|7271568|FG001|NOT COMPLETED|Overall Study||0
6361497|NCT00684788|7271584|FG000|STARTED|Overall Study||17
6361498|NCT00684788|7271585|FG001|STARTED|Overall Study||18
6361499|NCT00684788|7271584|FG000|COMPLETED|Overall Study||17
6361500|NCT00684788|7271585|FG001|COMPLETED|Overall Study||18
6361501|NCT00684788|7271584|FG000|NOT COMPLETED|Overall Study||0
6361502|NCT00684788|7271585|FG001|NOT COMPLETED|Overall Study||0
6361503|NCT00684814|7271597|FG000|STARTED|First Intervention||19
6361504|NCT00684814|7271598|FG001|STARTED|First Intervention||19
6361505|NCT00684814|7271597|FG000|COMPLETED|First Intervention||19
6361506|NCT00684814|7271598|FG001|COMPLETED|First Intervention||19
6361507|NCT00684814|7271597|FG000|NOT COMPLETED|First Intervention||0
6361508|NCT00684814|7271598|FG001|NOT COMPLETED|First Intervention||0
6361509|NCT00684814|7271597|FG000|STARTED|Washout Period of 7 Days||19
6361510|NCT00684814|7271598|FG001|STARTED|Washout Period of 7 Days||19
6361511|NCT00684814|7271597|FG000|COMPLETED|Washout Period of 7 Days||17
6361512|NCT00684814|7271598|FG001|COMPLETED|Washout Period of 7 Days||15
6361513|NCT00684814|7271597|FG000|NOT COMPLETED|Washout Period of 7 Days||2
6361514|NCT00684814|7271598|FG001|NOT COMPLETED|Washout Period of 7 Days||4
6361515|NCT00684814|7271597|FG000|STARTED|Second Intervention||17
6361516|NCT00684814|7271598|FG001|STARTED|Second Intervention||15
6361517|NCT00684814|7271597|FG000|COMPLETED|Second Intervention||16
6361518|NCT00684814|7271598|FG001|COMPLETED|Second Intervention||15
6361519|NCT00684814|7271597|FG000|NOT COMPLETED|Second Intervention||1
6361520|NCT00684814|7271598|FG001|NOT COMPLETED|Second Intervention||0
6361521|NCT00684983|7271606|FG000|STARTED|Overall Study||19
6361522|NCT00684983|7271607|FG001|STARTED|Overall Study||45
6361523|NCT00684983|7271606|FG000|COMPLETED|Overall Study||19
6361524|NCT00684983|7271607|FG001|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
6361525|NCT00684983|7271606|FG000|NOT COMPLETED|Overall Study||0
6361526|NCT00684983|7271607|FG001|NOT COMPLETED|Overall Study||0
6361527|NCT00684996|7271615|FG000|STARTED|Overall Study||5
6361528|NCT00684996|7271615|FG000|Eligible|Overall Study||5
6361529|NCT00684996|7271615|FG000|COMPLETED|Overall Study||0
6361530|NCT00684996|7271615|FG000|NOT COMPLETED|Overall Study||5
6361531|NCT00685035|7271622|FG000|STARTED|Period 1: First Intervention: 30 Minutes||9
6361532|NCT00685035|7271623|FG001|STARTED|Period 1: First Intervention: 30 Minutes||8
6361533|NCT00685035|7271622|FG000|COMPLETED|Period 1: First Intervention: 30 Minutes||8
6361534|NCT00685035|7271623|FG001|COMPLETED|Period 1: First Intervention: 30 Minutes||8
6361535|NCT00685035|7271622|FG000|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
6361536|NCT00685035|7271623|FG001|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
6361537|NCT00685035|7271622|FG000|STARTED|Period 2: 2-day Washout||8
6361538|NCT00685035|7271623|FG001|STARTED|Period 2: 2-day Washout||8
6361539|NCT00685035|7271622|FG000|COMPLETED|Period 2: 2-day Washout||8
6361540|NCT00685035|7271623|FG001|COMPLETED|Period 2: 2-day Washout||8
6361541|NCT00685035|7271622|FG000|NOT COMPLETED|Period 2: 2-day Washout||0
6361542|NCT00685035|7271623|FG001|NOT COMPLETED|Period 2: 2-day Washout||0
6361543|NCT00685035|7271622|FG000|STARTED|Period 3: 2nd Intervention||8
6361544|NCT00685035|7271623|FG001|STARTED|Period 3: 2nd Intervention||8
6361545|NCT00685035|7271622|FG000|COMPLETED|Period 3: 2nd Intervention||8
6361546|NCT00685035|7271623|FG001|COMPLETED|Period 3: 2nd Intervention||8
6361547|NCT00685035|7271622|FG000|NOT COMPLETED|Period 3: 2nd Intervention||0
6361548|NCT00685035|7271623|FG001|NOT COMPLETED|Period 3: 2nd Intervention||0
6361549|NCT00685139|7271647|FG000|STARTED|First Intervention||17
6361550|NCT00685139|7271648|FG001|STARTED|First Intervention||17
6361551|NCT00685139|7271647|FG000|COMPLETED|First Intervention||17
6361552|NCT00685139|7271648|FG001|COMPLETED|First Intervention||17
6361553|NCT00685139|7271647|FG000|NOT COMPLETED|First Intervention||0
6361554|NCT00685139|7271648|FG001|NOT COMPLETED|First Intervention||0
6361555|NCT00685139|7271647|FG000|STARTED|Washout Period of 28 Days||17
6361556|NCT00685139|7271648|FG001|STARTED|Washout Period of 28 Days||17
6361557|NCT00685139|7271647|FG000|COMPLETED|Washout Period of 28 Days||17
6361558|NCT00685139|7271648|FG001|COMPLETED|Washout Period of 28 Days||17
6361559|NCT00685139|7271647|FG000|NOT COMPLETED|Washout Period of 28 Days||0
6361560|NCT00685139|7271648|FG001|NOT COMPLETED|Washout Period of 28 Days||0
6361561|NCT00685139|7271647|FG000|STARTED|Second Intervention||17
6361562|NCT00685139|7271648|FG001|STARTED|Second Intervention||17
6361563|NCT00685139|7271647|FG000|COMPLETED|Second Intervention||17
6361564|NCT00685139|7271648|FG001|COMPLETED|Second Intervention||17
6361565|NCT00685139|7271647|FG000|NOT COMPLETED|Second Intervention||0
6361566|NCT00685139|7271648|FG001|NOT COMPLETED|Second Intervention||0
6361567|NCT00685165|7271654|FG000|STARTED|First Intervention||11
6361568|NCT00685165|7271655|FG001|STARTED|First Intervention||11
6361569|NCT00685165|7271654|FG000|COMPLETED|First Intervention||11
6361570|NCT00685165|7271655|FG001|COMPLETED|First Intervention||11
6361571|NCT00685165|7271654|FG000|NOT COMPLETED|First Intervention||0
6361572|NCT00685165|7271655|FG001|NOT COMPLETED|First Intervention||0
6361573|NCT00685165|7271654|FG000|STARTED|Washout Period of 14 Days||11
6361574|NCT00685165|7271655|FG001|STARTED|Washout Period of 14 Days||11
6361575|NCT00685165|7271654|FG000|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
6361576|NCT00685165|7271655|FG001|COMPLETED|Washout Period of 14 Days||11
6361577|NCT00685165|7271654|FG000|NOT COMPLETED|Washout Period of 14 Days||1
6361578|NCT00685165|7271655|FG001|NOT COMPLETED|Washout Period of 14 Days||0
6361579|NCT00685165|7271654|FG000|STARTED|Second Intervention||10
6361580|NCT00685165|7271655|FG001|STARTED|Second Intervention||11
6361581|NCT00685165|7271654|FG000|COMPLETED|Second Intervention||10
6361582|NCT00685165|7271655|FG001|COMPLETED|Second Intervention||11
6361583|NCT00685165|7271654|FG000|NOT COMPLETED|Second Intervention||0
6361584|NCT00685165|7271655|FG001|NOT COMPLETED|Second Intervention||0
6361585|NCT00685178|7271665|FG000|STARTED|Overall Study||40
6361586|NCT00685178|7271666|FG001|STARTED|Overall Study||45
6361587|NCT00685178|7271667|FG002|STARTED|Overall Study||39
6361588|NCT00685178|7271668|FG003|STARTED|Overall Study||47
6361589|NCT00685178|7271665|FG000|COMPLETED|Overall Study||27
6361590|NCT00685178|7271666|FG001|COMPLETED|Overall Study||26
6361591|NCT00685178|7271667|FG002|COMPLETED|Overall Study||27
6361592|NCT00685178|7271668|FG003|COMPLETED|Overall Study||33
6361593|NCT00685178|7271665|FG000|NOT COMPLETED|Overall Study||13
6361594|NCT00685178|7271666|FG001|NOT COMPLETED|Overall Study||19
6361595|NCT00685178|7271667|FG002|NOT COMPLETED|Overall Study||12
6361596|NCT00685178|7271668|FG003|NOT COMPLETED|Overall Study||14
6361597|NCT00685295|7271680|FG000|STARTED|Overall Study||30
6361598|NCT00685295|7271681|FG001|STARTED|Overall Study||30
6361599|NCT00685295|7271680|FG000|COMPLETED|Overall Study||30
6361600|NCT00685295|7271681|FG001|COMPLETED|Overall Study||30
6361601|NCT00685295|7271680|FG000|NOT COMPLETED|Overall Study||0
6361602|NCT00685295|7271681|FG001|NOT COMPLETED|Overall Study||0
6361603|NCT00685334|7271691|FG000|STARTED|Overall Study||12
6361604|NCT00685334|7271692|FG001|STARTED|Overall Study||10
6361605|NCT00685334|7271691|FG000|COMPLETED|Overall Study||2
6361606|NCT00685334|7271692|FG001|COMPLETED|Overall Study||3
6361607|NCT00685334|7271691|FG000|NOT COMPLETED|Overall Study||10
6361608|NCT00685334|7271692|FG001|NOT COMPLETED|Overall Study||7
6361609|NCT00685373|7271698|FG000|STARTED|Overall Study||166
6361610|NCT00685373|7271698|FG000|COMPLETED|Overall Study||151
6361611|NCT00685373|7271698|FG000|NOT COMPLETED|Overall Study||15
6361612|NCT00685399|7271709|FG000|STARTED|Treatment Period 1||16
6361613|NCT00685399|7271710|FG001|STARTED|Treatment Period 1||0
6361614|NCT00685399|7271711|FG002|STARTED|Treatment Period 1||0
6361615|NCT00685399|7271712|FG003|STARTED|Treatment Period 1||0
6361616|NCT00685399|7271713|FG004|STARTED|Treatment Period 1||0
6361617|NCT00685399|7271714|FG005|STARTED|Treatment Period 1||0
6361618|NCT00685399|7271715|FG006|STARTED|Treatment Period 1||0
6361619|NCT00685399|7271716|FG007|STARTED|Treatment Period 1||0
6361620|NCT00685399|7271709|FG000|COMPLETED|Treatment Period 1||10
6361621|NCT00685399|7271710|FG001|COMPLETED|Treatment Period 1||0
6361622|NCT00685399|7271711|FG002|COMPLETED|Treatment Period 1||0
6361623|NCT00685399|7271712|FG003|COMPLETED|Treatment Period 1||0
6361624|NCT00685399|7271713|FG004|COMPLETED|Treatment Period 1||0
6361625|NCT00685399|7271714|FG005|COMPLETED|Treatment Period 1||0
6361626|NCT00685399|7271715|FG006|COMPLETED|Treatment Period 1||0
6361627|NCT00685399|7271716|FG007|COMPLETED|Treatment Period 1||0
6361628|NCT00685399|7271709|FG000|NOT COMPLETED|Treatment Period 1||6
6361629|NCT00685399|7271710|FG001|NOT COMPLETED|Treatment Period 1||0
6361630|NCT00685399|7271711|FG002|NOT COMPLETED|Treatment Period 1||0
6361631|NCT00685399|7271712|FG003|NOT COMPLETED|Treatment Period 1||0
6361632|NCT00685399|7271713|FG004|NOT COMPLETED|Treatment Period 1||0
6361633|NCT00685399|7271714|FG005|NOT COMPLETED|Treatment Period 1||0
6361634|NCT00685399|7271715|FG006|NOT COMPLETED|Treatment Period 1||0
6361635|NCT00685399|7271716|FG007|NOT COMPLETED|Treatment Period 1||0
6361636|NCT00685399|7271709|FG000|STARTED|Treatment Period 2||0
6361637|NCT00685399|7271710|FG001|STARTED|Treatment Period 2||14
6361638|NCT00685399|7271711|FG002|STARTED|Treatment Period 2||5
6361639|NCT00685399|7271712|FG003|STARTED|Treatment Period 2|in extension period only|0
6361640|NCT00685399|7271713|FG004|STARTED|Treatment Period 2||4
6361641|NCT00685399|7271714|FG005|STARTED|Treatment Period 2||12
6361642|NCT00685399|7271715|FG006|STARTED|Treatment Period 2||13
6361643|NCT00685399|7271716|FG007|STARTED|Treatment Period 2||12
6361644|NCT00685399|7271709|FG000|COMPLETED|Treatment Period 2||0
6361645|NCT00685399|7271710|FG001|COMPLETED|Treatment Period 2||2
6361646|NCT00685399|7271711|FG002|COMPLETED|Treatment Period 2||2
6361647|NCT00685399|7271712|FG003|COMPLETED|Treatment Period 2|in extension period only|0
6361648|NCT00685399|7271713|FG004|COMPLETED|Treatment Period 2||4
6361649|NCT00685399|7271714|FG005|COMPLETED|Treatment Period 2||10
6361650|NCT00685399|7271715|FG006|COMPLETED|Treatment Period 2||13
6361651|NCT00685399|7271716|FG007|COMPLETED|Treatment Period 2||10
6361652|NCT00685399|7271709|FG000|NOT COMPLETED|Treatment Period 2||0
6361653|NCT00685399|7271710|FG001|NOT COMPLETED|Treatment Period 2||12
6361654|NCT00685399|7271711|FG002|NOT COMPLETED|Treatment Period 2||3
6361655|NCT00685399|7271712|FG003|NOT COMPLETED|Treatment Period 2||0
6361656|NCT00685399|7271713|FG004|NOT COMPLETED|Treatment Period 2||0
6361657|NCT00685399|7271714|FG005|NOT COMPLETED|Treatment Period 2||2
6361658|NCT00685399|7271715|FG006|NOT COMPLETED|Treatment Period 2||0
6361659|NCT00685399|7271716|FG007|NOT COMPLETED|Treatment Period 2||2
6361660|NCT00685399|7271709|FG000|STARTED|Extension||0
6361661|NCT00685399|7271710|FG001|STARTED|Extension||0
6361662|NCT00685399|7271711|FG002|STARTED|Extension||0
6361663|NCT00685399|7271712|FG003|STARTED|Extension||28
6361664|NCT00685399|7271713|FG004|STARTED|Extension||0
6361665|NCT00685399|7271714|FG005|STARTED|Extension||0
6361666|NCT00685399|7271715|FG006|STARTED|Extension||0
6361667|NCT00685399|7271716|FG007|STARTED|Extension||0
6361668|NCT00685399|7271709|FG000|COMPLETED|Extension||0
6361669|NCT00685399|7271710|FG001|COMPLETED|Extension||0
6361670|NCT00685399|7271711|FG002|COMPLETED|Extension||0
6361671|NCT00685399|7271712|FG003|COMPLETED|Extension||21
6361672|NCT00685399|7271713|FG004|COMPLETED|Extension||0
6361673|NCT00685399|7271714|FG005|COMPLETED|Extension||0
6361674|NCT00685399|7271715|FG006|COMPLETED|Extension||0
6361675|NCT00685399|7271716|FG007|COMPLETED|Extension||0
6361676|NCT00685399|7271709|FG000|NOT COMPLETED|Extension||0
6361677|NCT00685399|7271710|FG001|NOT COMPLETED|Extension||0
6361678|NCT00685399|7271711|FG002|NOT COMPLETED|Extension||0
6361679|NCT00685399|7271712|FG003|NOT COMPLETED|Extension||7
6361680|NCT00685399|7271713|FG004|NOT COMPLETED|Extension||0
6361681|NCT00685399|7271714|FG005|NOT COMPLETED|Extension||0
6361682|NCT00685399|7271715|FG006|NOT COMPLETED|Extension||0
6361683|NCT00685399|7271716|FG007|NOT COMPLETED|Extension||0
6361684|NCT00685477|7271743|FG000|STARTED|Overall Study||10
6361685|NCT00685477|7271744|FG001|STARTED|Overall Study||10
6361686|NCT00685477|7271745|FG002|STARTED|Overall Study||10
6361687|NCT00685477|7271746|FG003|STARTED|Overall Study||10
6361688|NCT00685477|7271747|FG004|STARTED|Overall Study||10
6361689|NCT00685477|7271748|FG005|STARTED|Overall Study||10
6361690|NCT00685477|7271743|FG000|COMPLETED|Overall Study||10
6361691|NCT00685477|7271744|FG001|COMPLETED|Overall Study||10
6361692|NCT00685477|7271745|FG002|COMPLETED|Overall Study||10
6361693|NCT00685477|7271746|FG003|COMPLETED|Overall Study||10
6361694|NCT00685477|7271747|FG004|COMPLETED|Overall Study||10
6361695|NCT00685477|7271748|FG005|COMPLETED|Overall Study||10
6361696|NCT00685477|7271743|FG000|NOT COMPLETED|Overall Study||0
6361697|NCT00685477|7271744|FG001|NOT COMPLETED|Overall Study||0
6361698|NCT00685477|7271745|FG002|NOT COMPLETED|Overall Study||0
6361699|NCT00685477|7271746|FG003|NOT COMPLETED|Overall Study||0
6361700|NCT00685477|7271747|FG004|NOT COMPLETED|Overall Study||0
6361701|NCT00685477|7271748|FG005|NOT COMPLETED|Overall Study||0
6361702|NCT00685516|7271760|FG000|STARTED|Overall Study||42
6361703|NCT00685516|7271761|FG001|STARTED|Overall Study||38
6361704|NCT00685516|7271762|FG002|STARTED|Overall Study||33
6361705|NCT00685516|7271760|FG000|COMPLETED|Overall Study||34
6361706|NCT00685516|7271761|FG001|COMPLETED|Overall Study||33
6361707|NCT00685516|7271762|FG002|COMPLETED|Overall Study||26
6361708|NCT00685516|7271760|FG000|NOT COMPLETED|Overall Study||8
6361709|NCT00685516|7271761|FG001|NOT COMPLETED|Overall Study||5
6361710|NCT00685516|7271762|FG002|NOT COMPLETED|Overall Study||7
6361711|NCT00685659|7271776|FG000|STARTED|Overall Study||108
6361712|NCT00685659|7271777|FG001|STARTED|Overall Study||106
6361713|NCT00685659|7271778|FG002|STARTED|Overall Study||107
6361714|NCT00685659|7271776|FG000|COMPLETED|Overall Study||77
6361715|NCT00685659|7271777|FG001|COMPLETED|Overall Study||81
6361716|NCT00685659|7271778|FG002|COMPLETED|Overall Study||92
6361717|NCT00685659|7271776|FG000|NOT COMPLETED|Overall Study||31
6361718|NCT00685659|7271777|FG001|NOT COMPLETED|Overall Study||25
6361719|NCT00685659|7271778|FG002|NOT COMPLETED|Overall Study||15
6560493|NCT01787097|7483255|FG002|COMPLETED|Overall Study||7
6560494|NCT01787097|7483256|FG003|COMPLETED|Overall Study||9
6560495|NCT01787097|7483253|FG000|NOT COMPLETED|Overall Study||1
6560496|NCT01787097|7483254|FG001|NOT COMPLETED|Overall Study||0
6560497|NCT01787097|7483255|FG002|NOT COMPLETED|Overall Study||0
6560498|NCT01787097|7483256|FG003|NOT COMPLETED|Overall Study||0
6560499|NCT01787175|7483278|FG000|STARTED|Overall Study||30
6560500|NCT01787175|7483279|FG001|STARTED|Overall Study||28
6560501|NCT01787175|7483278|FG000|COMPLETED|Overall Study||30
6560502|NCT01787175|7483279|FG001|COMPLETED|Overall Study||28
6361720|NCT00685685|7271786|FG000|STARTED|First Intervention||27
6361721|NCT00685685|7271787|FG001|STARTED|First Intervention||27
6361722|NCT00685685|7271786|FG000|COMPLETED|First Intervention||27
6361723|NCT00685685|7271787|FG001|COMPLETED|First Intervention||27
6361724|NCT00685685|7271786|FG000|NOT COMPLETED|First Intervention||0
6361725|NCT00685685|7271787|FG001|NOT COMPLETED|First Intervention||0
6361726|NCT00685685|7271786|FG000|STARTED|Washout Period of 7 Days||27
6361727|NCT00685685|7271787|FG001|STARTED|Washout Period of 7 Days||27
6560503|NCT01787175|7483278|FG000|NOT COMPLETED|Overall Study||0
6361728|NCT00685685|7271786|FG000|COMPLETED|Washout Period of 7 Days||25
6361729|NCT00685685|7271787|FG001|COMPLETED|Washout Period of 7 Days||26
6361730|NCT00685685|7271786|FG000|NOT COMPLETED|Washout Period of 7 Days||2
6361731|NCT00685685|7271787|FG001|NOT COMPLETED|Washout Period of 7 Days||1
6361732|NCT00685685|7271786|FG000|STARTED|Second Intervention||25
6361733|NCT00685685|7271787|FG001|STARTED|Second Intervention||26
6361734|NCT00685685|7271786|FG000|COMPLETED|Second Intervention||25
6361735|NCT00685685|7271787|FG001|COMPLETED|Second Intervention||26
6361736|NCT00685685|7271786|FG000|NOT COMPLETED|Second Intervention||0
6361737|NCT00685685|7271787|FG001|NOT COMPLETED|Second Intervention||0
6361738|NCT00685698|7271793|FG000|STARTED|Overall Study||38
6361739|NCT00685698|7271793|FG000|COMPLETED|Overall Study||25
6361740|NCT00685698|7271793|FG000|NOT COMPLETED|Overall Study||13
6361741|NCT00685750|7271816|FG000|STARTED|Overall Study||17
6361742|NCT00685750|7271817|FG001|STARTED|Overall Study||3
6361743|NCT00685750|7271818|FG002|STARTED|Overall Study||21
6361744|NCT00685750|7271819|FG003|STARTED|Overall Study||2
6361745|NCT00685750|7271820|FG004|STARTED|Overall Study||15
6361746|NCT00685750|7271821|FG005|STARTED|Overall Study||20
6361747|NCT00685750|7271822|FG006|STARTED|Overall Study||10
6560504|NCT01787175|7483279|FG001|NOT COMPLETED|Overall Study||0
6560505|NCT01787188|7483288|FG000|STARTED|Overall Study||139
6560506|NCT01787188|7483289|FG001|STARTED|Overall Study||130
6560507|NCT01787188|7483290|FG002|STARTED|Overall Study||134
6361748|NCT00685750|7271816|FG000|COMPLETED|Overall Study||17
6361749|NCT00685750|7271817|FG001|COMPLETED|Overall Study||3
6361750|NCT00685750|7271818|FG002|COMPLETED|Overall Study||19
6361751|NCT00685750|7271819|FG003|COMPLETED|Overall Study||2
6361752|NCT00685750|7271820|FG004|COMPLETED|Overall Study||15
6361753|NCT00685750|7271821|FG005|COMPLETED|Overall Study||20
6361754|NCT00685750|7271822|FG006|COMPLETED|Overall Study||9
6361755|NCT00685750|7271816|FG000|NOT COMPLETED|Overall Study||0
6361756|NCT00685750|7271817|FG001|NOT COMPLETED|Overall Study||0
6361757|NCT00685750|7271818|FG002|NOT COMPLETED|Overall Study||2
6361758|NCT00685750|7271819|FG003|NOT COMPLETED|Overall Study||0
6361759|NCT00685750|7271820|FG004|NOT COMPLETED|Overall Study||0
6361760|NCT00685750|7271821|FG005|NOT COMPLETED|Overall Study||0
6361761|NCT00685750|7271822|FG006|NOT COMPLETED|Overall Study||1
6361762|NCT00685763|7271842|FG000|STARTED|Overall Study||13
6361763|NCT00685763|7271842|FG000|COMPLETED|Overall Study||11
6361764|NCT00685763|7271842|FG000|NOT COMPLETED|Overall Study||2
6361765|NCT00685802|7271846|FG000|STARTED|First Intervention||16
6361766|NCT00685802|7271847|FG001|STARTED|First Intervention||16
6361767|NCT00685802|7271846|FG000|COMPLETED|First Intervention||16
6361768|NCT00685802|7271847|FG001|COMPLETED|First Intervention||16
6361769|NCT00685802|7271846|FG000|NOT COMPLETED|First Intervention||0
6361770|NCT00685802|7271847|FG001|NOT COMPLETED|First Intervention||0
6361771|NCT00685802|7271846|FG000|STARTED|Washout Period of 7 Days||16
6361772|NCT00685802|7271847|FG001|STARTED|Washout Period of 7 Days||16
6361773|NCT00685802|7271846|FG000|COMPLETED|Washout Period of 7 Days||14
6361774|NCT00685802|7271847|FG001|COMPLETED|Washout Period of 7 Days||15
6361775|NCT00685802|7271846|FG000|NOT COMPLETED|Washout Period of 7 Days||2
6361776|NCT00685802|7271847|FG001|NOT COMPLETED|Washout Period of 7 Days||1
6361777|NCT00685802|7271846|FG000|STARTED|Second Intervention||14
6361778|NCT00685802|7271847|FG001|STARTED|Second Intervention||15
6361779|NCT00685802|7271846|FG000|COMPLETED|Second Intervention||14
6361780|NCT00685802|7271847|FG001|COMPLETED|Second Intervention||15
6361781|NCT00685802|7271846|FG000|NOT COMPLETED|Second Intervention||0
6361782|NCT00685802|7271847|FG001|NOT COMPLETED|Second Intervention||0
6361783|NCT00685932|7271855|FG000|STARTED|Overall Study||76
6361784|NCT00685932|7271856|FG001|STARTED|Overall Study||78
6361785|NCT00685932|7271855|FG000|COMPLETED|Overall Study||55
6361786|NCT00685932|7271856|FG001|COMPLETED|Overall Study||58
6361787|NCT00685932|7271855|FG000|NOT COMPLETED|Overall Study||21
6361788|NCT00685932|7271856|FG001|NOT COMPLETED|Overall Study||20
6361789|NCT00685945|7271862|FG000|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
6361790|NCT00685945|7271862|FG000|COMPLETED|Control (Bradykinin Infusion)||24
6361791|NCT00685945|7271862|FG000|NOT COMPLETED|Control (Bradykinin Infusion)||0
6361792|NCT00685945|7271862|FG000|STARTED|L-NMMA + Bradykinin||24
6361793|NCT00685945|7271862|FG000|COMPLETED|L-NMMA + Bradykinin||23
6361794|NCT00685945|7271862|FG000|NOT COMPLETED|L-NMMA + Bradykinin||1
6361795|NCT00685945|7271862|FG000|STARTED|Isosorbide + L-NMMA + Bradykinin||11
6361796|NCT00685945|7271862|FG000|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
6361797|NCT00685945|7271862|FG000|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
6361798|NCT00685945|7271862|FG000|STARTED|Sildenafil + L-NMMA + Bradykinin||12
6361799|NCT00685945|7271862|FG000|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
6361800|NCT00685945|7271862|FG000|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
6361801|NCT00686075|7271882|FG000|STARTED|Overall Study||79
6361802|NCT00686075|7271883|FG001|STARTED|Overall Study||81
6361803|NCT00686075|7271884|FG002|STARTED|Overall Study||80
6361804|NCT00686075|7271885|FG003|STARTED|Overall Study||80
6361805|NCT00686075|7271886|FG004|STARTED|Overall Study||40
6361806|NCT00686075|7271887|FG005|STARTED|Overall Study||40
6361807|NCT00686075|7271888|FG006|STARTED|Overall Study||82
6361808|NCT00686075|7271889|FG007|STARTED|Overall Study||78
6560508|NCT01787188|7483288|FG000|COMPLETED|Overall Study||122
6361809|NCT00686075|7271890|FG008|STARTED|Overall Study||81
6361810|NCT00686075|7271891|FG009|STARTED|Overall Study||79
6361811|NCT00686075|7271882|FG000|Treated|Overall Study||78
6361812|NCT00686075|7271883|FG001|Treated|Overall Study||79
6361813|NCT00686075|7271884|FG002|Treated|Overall Study||80
6361814|NCT00686075|7271885|FG003|Treated|Overall Study||80
6361815|NCT00686075|7271886|FG004|Treated|Overall Study||40
6361816|NCT00686075|7271887|FG005|Treated|Overall Study||40
6361817|NCT00686075|7271888|FG006|Treated|Overall Study||82
6361818|NCT00686075|7271889|FG007|Treated|Overall Study||77
6361819|NCT00686075|7271890|FG008|Treated|Overall Study||80
6361820|NCT00686075|7271891|FG009|Treated|Overall Study||78
6361821|NCT00686075|7271882|FG000|COMPLETED|Overall Study||71
6361822|NCT00686075|7271883|FG001|COMPLETED|Overall Study||71
6361823|NCT00686075|7271884|FG002|COMPLETED|Overall Study||74
6361824|NCT00686075|7271885|FG003|COMPLETED|Overall Study||71
6361825|NCT00686075|7271886|FG004|COMPLETED|Overall Study||36
6361826|NCT00686075|7271887|FG005|COMPLETED|Overall Study||37
6361827|NCT00686075|7271888|FG006|COMPLETED|Overall Study||82
6361828|NCT00686075|7271889|FG007|COMPLETED|Overall Study||76
6361829|NCT00686075|7271890|FG008|COMPLETED|Overall Study||75
6361830|NCT00686075|7271891|FG009|COMPLETED|Overall Study||69
6361831|NCT00686075|7271882|FG000|NOT COMPLETED|Overall Study||8
6361832|NCT00686075|7271883|FG001|NOT COMPLETED|Overall Study||10
6361833|NCT00686075|7271884|FG002|NOT COMPLETED|Overall Study||6
6361834|NCT00686075|7271885|FG003|NOT COMPLETED|Overall Study||9
6361835|NCT00686075|7271886|FG004|NOT COMPLETED|Overall Study||4
6361836|NCT00686075|7271887|FG005|NOT COMPLETED|Overall Study||3
6361837|NCT00686075|7271888|FG006|NOT COMPLETED|Overall Study||0
6361838|NCT00686075|7271889|FG007|NOT COMPLETED|Overall Study||2
6361839|NCT00686075|7271890|FG008|NOT COMPLETED|Overall Study||6
6361840|NCT00686075|7271891|FG009|NOT COMPLETED|Overall Study||10
6361841|NCT00686127|7271915|FG000|STARTED|Overall Study||14
6361842|NCT00686127|7271916|FG001|STARTED|Overall Study||7
6361843|NCT00686127|7271915|FG000|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
6361844|NCT00686127|7271916|FG001|COMPLETED|Overall Study||1
6361845|NCT00686127|7271915|FG000|NOT COMPLETED|Overall Study||14
6361846|NCT00686127|7271916|FG001|NOT COMPLETED|Overall Study||6
6361847|NCT00686166|7271922|FG000|STARTED|Overall Study||83
6361848|NCT00686166|7271922|FG000|Eligible|Overall Study||78
6361849|NCT00686166|7271922|FG000|Eligible and Began Protocol Therapy|Overall Study||74
6361850|NCT00686166|7271922|FG000|COMPLETED|Overall Study||63
6361851|NCT00686166|7271922|FG000|NOT COMPLETED|Overall Study||20
6361852|NCT00686205|7271933|FG000|STARTED|Overall Study||21606
6361853|NCT00686205|7271934|FG001|STARTED|Overall Study||2505
6361854|NCT00686205|7271933|FG000|COMPLETED|Overall Study||15599
6361855|NCT00686205|7271934|FG001|COMPLETED|Overall Study||1524
6361856|NCT00686205|7271933|FG000|NOT COMPLETED|Overall Study||6007
6361857|NCT00686205|7271934|FG001|NOT COMPLETED|Overall Study||981
6361858|NCT00686231|7271940|FG000|STARTED|Dose Test - Visit 1||12
6361859|NCT00686231|7271941|FG001|STARTED|Dose Test - Visit 1||7
6361860|NCT00686231|7271942|FG002|STARTED|Dose Test - Visit 1||0
6361861|NCT00686231|7271943|FG003|STARTED|Dose Test - Visit 1||0
6361862|NCT00686231|7271940|FG000|COMPLETED|Dose Test - Visit 1||12
6361863|NCT00686231|7271941|FG001|COMPLETED|Dose Test - Visit 1||7
6361864|NCT00686231|7271942|FG002|COMPLETED|Dose Test - Visit 1||0
6361865|NCT00686231|7271943|FG003|COMPLETED|Dose Test - Visit 1||0
6361866|NCT00686231|7271940|FG000|NOT COMPLETED|Dose Test - Visit 1||0
6361867|NCT00686231|7271941|FG001|NOT COMPLETED|Dose Test - Visit 1||0
6361868|NCT00686231|7271942|FG002|NOT COMPLETED|Dose Test - Visit 1||0
6361869|NCT00686231|7271943|FG003|NOT COMPLETED|Dose Test - Visit 1||0
6361870|NCT00686231|7271940|FG000|STARTED|Combination Test - Visit 2||0
6361871|NCT00686231|7271941|FG001|STARTED|Combination Test - Visit 2||0
6361872|NCT00686231|7271942|FG002|STARTED|Combination Test - Visit 2||10
6361873|NCT00686231|7271943|FG003|STARTED|Combination Test - Visit 2||9
6361874|NCT00686231|7271940|FG000|COMPLETED|Combination Test - Visit 2||0
6361875|NCT00686231|7271941|FG001|COMPLETED|Combination Test - Visit 2||0
6361876|NCT00686231|7271942|FG002|COMPLETED|Combination Test - Visit 2||10
6361877|NCT00686231|7271943|FG003|COMPLETED|Combination Test - Visit 2||9
6361878|NCT00686231|7271940|FG000|NOT COMPLETED|Combination Test - Visit 2||0
6361879|NCT00686231|7271941|FG001|NOT COMPLETED|Combination Test - Visit 2||0
6361880|NCT00686231|7271942|FG002|NOT COMPLETED|Combination Test - Visit 2||0
6361881|NCT00686231|7271943|FG003|NOT COMPLETED|Combination Test - Visit 2||0
6361882|NCT00686257|7271955|FG000|STARTED|Overall Study||29
6361883|NCT00686257|7271956|FG001|STARTED|Overall Study||31
6361884|NCT00686257|7271955|FG000|COMPLETED|Overall Study||29
6361885|NCT00686257|7271956|FG001|COMPLETED|Overall Study||31
6361886|NCT00686257|7271955|FG000|NOT COMPLETED|Overall Study||0
6361887|NCT00686257|7271956|FG001|NOT COMPLETED|Overall Study||0
6361888|NCT00686335|7271964|FG000|STARTED|Run-in Period||12
6361889|NCT00686335|7271964|FG000|COMPLETED|Run-in Period||7
6361890|NCT00686335|7271964|FG000|NOT COMPLETED|Run-in Period||5
6361891|NCT00686335|7271964|FG000|STARTED|Treatment Period||7
6361892|NCT00686335|7271964|FG000|COMPLETED|Treatment Period||7
6361893|NCT00686335|7271964|FG000|NOT COMPLETED|Treatment Period||0
6361894|NCT00686517|7271973|FG000|STARTED|Treatment||44
6361895|NCT00686517|7271974|FG001|STARTED|Treatment||43
6361896|NCT00686517|7271975|FG002|STARTED|Treatment||43
6361897|NCT00686517|7271973|FG000|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
6361898|NCT00686517|7271974|FG001|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
6361899|NCT00686517|7271975|FG002|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
6361900|NCT00686517|7271973|FG000|COMPLETED|Treatment||38
6361901|NCT00686517|7271974|FG001|COMPLETED|Treatment||40
6361902|NCT00686517|7271975|FG002|COMPLETED|Treatment||42
6361903|NCT00686517|7271973|FG000|NOT COMPLETED|Treatment||6
6361904|NCT00686517|7271974|FG001|NOT COMPLETED|Treatment||3
6361905|NCT00686517|7271975|FG002|NOT COMPLETED|Treatment||1
6361906|NCT00686517|7271973|FG000|STARTED|Follow-up||37
6361907|NCT00686517|7271974|FG001|STARTED|Follow-up||38
6361908|NCT00686517|7271975|FG002|STARTED|Follow-up||39
6361909|NCT00686517|7271973|FG000|COMPLETED|Follow-up||29
6361910|NCT00686517|7271974|FG001|COMPLETED|Follow-up||28
6361911|NCT00686517|7271975|FG002|COMPLETED|Follow-up||29
6361912|NCT00686517|7271973|FG000|NOT COMPLETED|Follow-up||8
6361913|NCT00686517|7271974|FG001|NOT COMPLETED|Follow-up||10
6361914|NCT00686517|7271975|FG002|NOT COMPLETED|Follow-up||10
6361915|NCT00686543|7271987|FG000|STARTED|Overall Study||14
6361916|NCT00686543|7271988|FG001|STARTED|Overall Study||21
6361917|NCT00686543|7271989|FG002|STARTED|Overall Study||20
6361918|NCT00686543|7271990|FG003|STARTED|Overall Study||20
6361919|NCT00686543|7271987|FG000|COMPLETED|Overall Study||0
6361920|NCT00686543|7271988|FG001|COMPLETED|Overall Study||20
6361921|NCT00686543|7271989|FG002|COMPLETED|Overall Study||15
6361922|NCT00686543|7271990|FG003|COMPLETED|Overall Study||17
6361923|NCT00686543|7271987|FG000|NOT COMPLETED|Overall Study||14
6361924|NCT00686543|7271988|FG001|NOT COMPLETED|Overall Study||1
6361925|NCT00686543|7271989|FG002|NOT COMPLETED|Overall Study||5
6361926|NCT00686543|7271990|FG003|NOT COMPLETED|Overall Study||3
6361927|NCT00686582|7272003|FG000|STARTED|Overall Study||92
6361928|NCT00686582|7272004|FG001|STARTED|Overall Study||91
6361929|NCT00686582|7272005|FG002|STARTED|Overall Study||121
6361930|NCT00686582|7272003|FG000|Booster Vaccination|Overall Study||75
6361931|NCT00686582|7272004|FG001|Booster Vaccination|Overall Study||77
6361932|NCT00686582|7272005|FG002|Booster Vaccination|Overall Study||0
6361933|NCT00686582|7272003|FG000|COMPLETED|Overall Study||74
6361934|NCT00686582|7272004|FG001|COMPLETED|Overall Study||77
6361935|NCT00686582|7272005|FG002|COMPLETED|Overall Study||121
6361936|NCT00686582|7272003|FG000|NOT COMPLETED|Overall Study||18
6361937|NCT00686582|7272004|FG001|NOT COMPLETED|Overall Study||14
6361938|NCT00686582|7272005|FG002|NOT COMPLETED|Overall Study||0
6361939|NCT00686595|7272011|FG000|STARTED|Overall Study||38
6361940|NCT00686595|7272011|FG000|COMPLETED|Overall Study||31
6361941|NCT00686595|7272011|FG000|NOT COMPLETED|Overall Study||7
6361942|NCT00686634|7272015|FG000|STARTED|Overall Study||108
6361943|NCT00686634|7272015|FG000|COMPLETED|Overall Study||102
6361944|NCT00686634|7272015|FG000|NOT COMPLETED|Overall Study||6
6361945|NCT00686647|7272020|FG000|STARTED|Overall Study||93
6361946|NCT00686647|7272020|FG000|COMPLETED|Overall Study||91
6361947|NCT00686647|7272020|FG000|NOT COMPLETED|Overall Study||2
6361948|NCT00686686|7272025|FG000|STARTED|Overall Study||23
6361949|NCT00686686|7272025|FG000|COMPLETED|Overall Study||17
6361950|NCT00686686|7272025|FG000|NOT COMPLETED|Overall Study||6
6361951|NCT00686699|7272031|FG000|STARTED|Treatment Period 1||4
6361952|NCT00686699|7272032|FG001|STARTED|Treatment Period 1||7
6361953|NCT00686699|7272031|FG000|COMPLETED|Treatment Period 1||4
6361954|NCT00686699|7272032|FG001|COMPLETED|Treatment Period 1||5
6361955|NCT00686699|7272031|FG000|NOT COMPLETED|Treatment Period 1||0
6361956|NCT00686699|7272032|FG001|NOT COMPLETED|Treatment Period 1||2
6361957|NCT00686699|7272031|FG000|STARTED|Treatment Period 2||4
6361958|NCT00686699|7272032|FG001|STARTED|Treatment Period 2||5
6361959|NCT00686699|7272031|FG000|COMPLETED|Treatment Period 2||4
6361960|NCT00686699|7272032|FG001|COMPLETED|Treatment Period 2||5
6361961|NCT00686699|7272031|FG000|NOT COMPLETED|Treatment Period 2||0
6361962|NCT00686699|7272032|FG001|NOT COMPLETED|Treatment Period 2||0
6361963|NCT00686712|7272041|FG000|STARTED|Overall Study||30
6361964|NCT00686712|7272042|FG001|STARTED|Overall Study||25
6361965|NCT00686712|7272043|FG002|STARTED|Overall Study||30
6361966|NCT00686712|7272041|FG000|COMPLETED|Overall Study||20
6361967|NCT00686712|7272042|FG001|COMPLETED|Overall Study||14
6361968|NCT00686712|7272043|FG002|COMPLETED|Overall Study||17
6361969|NCT00686712|7272041|FG000|NOT COMPLETED|Overall Study||10
6361970|NCT00686712|7272042|FG001|NOT COMPLETED|Overall Study||11
6361971|NCT00686712|7272043|FG002|NOT COMPLETED|Overall Study||13
6361972|NCT00686725|7272056|FG000|STARTED|Overall Study||47
6361973|NCT00686725|7272057|FG001|STARTED|Overall Study||52
6361974|NCT00686725|7272056|FG000|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
6361975|NCT00686725|7272057|FG001|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
6361976|NCT00686725|7272056|FG000|NOT COMPLETED|Overall Study||46
6361977|NCT00686725|7272057|FG001|NOT COMPLETED|Overall Study||42
6361978|NCT00686777|7272063|FG000|STARTED|Overall Study||75
6361979|NCT00686777|7272063|FG000|Completed 24 Weeks of Treatment|Overall Study||69
6361980|NCT00686777|7272063|FG000|Completed 48 Weeks of Treatment|Overall Study||65
6361981|NCT00686777|7272063|FG000|Included in Follow-up (All Treated)|Overall Study||75
6361982|NCT00686777|7272063|FG000|Completed 24 Weeks of Follow-up|Overall Study||70
6361983|NCT00686777|7272063|FG000|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
6361984|NCT00686777|7272063|FG000|NOT COMPLETED|Overall Study||10
6361985|NCT00686790|7272067|FG000|STARTED|Overall Study||48
6361986|NCT00686790|7272067|FG000|COMPLETED|Overall Study||32
6361987|NCT00686790|7272067|FG000|NOT COMPLETED|Overall Study||16
6361988|NCT00686803|7272074|FG000|STARTED|Overall Study||6
6361989|NCT00686803|7272075|FG001|STARTED|Overall Study||12
6361990|NCT00686803|7272076|FG002|STARTED|Overall Study||3
6361991|NCT00686803|7272074|FG000|COMPLETED|Overall Study||6
6361992|NCT00686803|7272075|FG001|COMPLETED|Overall Study||12
6361993|NCT00686803|7272076|FG002|COMPLETED|Overall Study||3
6361994|NCT00686803|7272074|FG000|NOT COMPLETED|Overall Study||0
6361995|NCT00686803|7272075|FG001|NOT COMPLETED|Overall Study||0
6361996|NCT00686803|7272076|FG002|NOT COMPLETED|Overall Study||0
6361997|NCT00686829|7272084|FG000|STARTED|Overall Study||79
6361998|NCT00686829|7272084|FG000|COMPLETED|Overall Study||0
6361999|NCT00686829|7272084|FG000|NOT COMPLETED|Overall Study||79
6362000|NCT00686842|7272088|FG000|STARTED|Overall Study||17
6362001|NCT00686842|7272088|FG000|COMPLETED|Overall Study||17
6560509|NCT01787188|7483289|FG001|COMPLETED|Overall Study||112
6560510|NCT01787188|7483290|FG002|COMPLETED|Overall Study||116
6560511|NCT01787188|7483288|FG000|NOT COMPLETED|Overall Study||17
6362002|NCT00686842|7272088|FG000|NOT COMPLETED|Overall Study||0
6362003|NCT00686855|7272094|FG000|STARTED|Overall Study||28
6362004|NCT00686855|7272095|FG001|STARTED|Overall Study||18
6362005|NCT00686855|7272094|FG000|COMPLETED|Overall Study||27
6362006|NCT00686855|7272095|FG001|COMPLETED|Overall Study||17
6362007|NCT00686855|7272094|FG000|NOT COMPLETED|Overall Study||1
6362008|NCT00686855|7272095|FG001|NOT COMPLETED|Overall Study||1
6362009|NCT00686881|7272103|FG000|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
6362010|NCT00686881|7272104|FG001|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
6362011|NCT00686881|7272103|FG000|COMPLETED|Overall Study||45
6362012|NCT00686881|7272104|FG001|COMPLETED|Overall Study||53
6362013|NCT00686881|7272103|FG000|NOT COMPLETED|Overall Study||82
6362014|NCT00686881|7272104|FG001|NOT COMPLETED|Overall Study||81
6362015|NCT00686894|7272112|FG000|STARTED|Overall Study||7
6362016|NCT00686894|7272112|FG000|COMPLETED|Overall Study||1
6362017|NCT00686894|7272112|FG000|NOT COMPLETED|Overall Study||6
6362018|NCT00686920|7272118|FG000|STARTED|Overall Study||252
6362019|NCT00686920|7272119|FG001|STARTED|Overall Study||70
6362020|NCT00686920|7272118|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||252
6362021|NCT00686920|7272119|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||70
6362022|NCT00686920|7272118|FG000|COMPLETED|Overall Study||120
6362023|NCT00686920|7272119|FG001|COMPLETED|Overall Study||34
6362024|NCT00686920|7272118|FG000|NOT COMPLETED|Overall Study||132
6362025|NCT00686920|7272119|FG001|NOT COMPLETED|Overall Study||36
6362026|NCT00686959|7272127|FG000|STARTED|Overall Study||301
6362027|NCT00686959|7272128|FG001|STARTED|Overall Study||297
6362028|NCT00686959|7272127|FG000|Received at Least One Dose of Study Drug|Overall Study||283
6362029|NCT00686959|7272128|FG001|Received at Least One Dose of Study Drug|Overall Study||272
6362030|NCT00686959|7272127|FG000|Entered Consolidation Phase|Overall Study||229
6362031|NCT00686959|7272128|FG001|Entered Consolidation Phase|Overall Study||202
6362032|NCT00686959|7272127|FG000|COMPLETED|Overall Study|Study completion includes death due to any cause|177
6362033|NCT00686959|7272128|FG001|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
6362034|NCT00686959|7272127|FG000|NOT COMPLETED|Overall Study||124
6362035|NCT00686959|7272128|FG001|NOT COMPLETED|Overall Study||117
6362036|NCT00686998|7272137|FG000|STARTED|Overall Study|Randomized & received study medication|43
6362037|NCT00686998|7272138|FG001|STARTED|Overall Study|Randomized & received study medication|41
6362038|NCT00686998|7272139|FG002|STARTED|Overall Study|Randomized & received study medication|22
6362039|NCT00686998|7272137|FG000|Randomized|Overall Study||43
6362040|NCT00686998|7272138|FG001|Randomized|Overall Study||41
6362041|NCT00686998|7272139|FG002|Randomized|Overall Study||22
6362042|NCT00686998|7272137|FG000|Received Treatment|Overall Study||43
6362043|NCT00686998|7272138|FG001|Received Treatment|Overall Study||41
6362044|NCT00686998|7272139|FG002|Received Treatment|Overall Study||22
6362045|NCT00686998|7272137|FG000|Eligible for Efficacy Analysis|Overall Study||42
6362046|NCT00686998|7272138|FG001|Eligible for Efficacy Analysis|Overall Study||39
6362047|NCT00686998|7272139|FG002|Eligible for Efficacy Analysis|Overall Study||21
6560512|NCT01787188|7483289|FG001|NOT COMPLETED|Overall Study||18
6560513|NCT01787188|7483290|FG002|NOT COMPLETED|Overall Study||18
6560514|NCT01787240|7483300|FG000|STARTED|Overall Study||15
6560515|NCT01787240|7483301|FG001|STARTED|Overall Study||5
6560516|NCT01787240|7483300|FG000|COMPLETED|Overall Study||10
6560517|NCT01787240|7483301|FG001|COMPLETED|Overall Study||4
6560518|NCT01787240|7483300|FG000|NOT COMPLETED|Overall Study||5
6560519|NCT01787240|7483301|FG001|NOT COMPLETED|Overall Study||1
6362048|NCT00686998|7272137|FG000|Completed Scheduled Treatment|Overall Study||30
6362049|NCT00686998|7272138|FG001|Completed Scheduled Treatment|Overall Study||33
6362050|NCT00686998|7272139|FG002|Completed Scheduled Treatment|Overall Study||18
6362051|NCT00686998|7272137|FG000|COMPLETED|Overall Study||30
6362052|NCT00686998|7272138|FG001|COMPLETED|Overall Study||33
6362053|NCT00686998|7272139|FG002|COMPLETED|Overall Study||18
6362054|NCT00686998|7272137|FG000|NOT COMPLETED|Overall Study||13
6362055|NCT00686998|7272138|FG001|NOT COMPLETED|Overall Study||8
6362056|NCT00686998|7272139|FG002|NOT COMPLETED|Overall Study||4
6362057|NCT00687076|7272149|FG000|STARTED|Overall Study||51
6362058|NCT00687076|7272150|FG001|STARTED|Overall Study||51
6362059|NCT00687076|7272149|FG000|COMPLETED|Overall Study||19
6362060|NCT00687076|7272150|FG001|COMPLETED|Overall Study||21
6362061|NCT00687076|7272149|FG000|NOT COMPLETED|Overall Study||32
6362062|NCT00687076|7272150|FG001|NOT COMPLETED|Overall Study||30
6362063|NCT00687102|7272158|FG000|STARTED|Overall Study||733
6560520|NCT01787279|7483310|FG000|STARTED|Overall Study||59
6560521|NCT01787279|7483310|FG000|COMPLETED|Overall Study||56
6560522|NCT01787279|7483310|FG000|NOT COMPLETED|Overall Study||3
6362064|NCT00687102|7272159|FG001|STARTED|Overall Study||765
6362065|NCT00687102|7272158|FG000|COMPLETED|Overall Study||733
6362066|NCT00687102|7272159|FG001|COMPLETED|Overall Study||765
6362067|NCT00687102|7272158|FG000|NOT COMPLETED|Overall Study||0
6362068|NCT00687102|7272159|FG001|NOT COMPLETED|Overall Study||0
6362069|NCT00687167|7272165|FG000|STARTED|First Intervention||17
6362070|NCT00687167|7272166|FG001|STARTED|First Intervention||17
6362071|NCT00687167|7272165|FG000|COMPLETED|First Intervention||17
6362072|NCT00687167|7272166|FG001|COMPLETED|First Intervention||17
6362073|NCT00687167|7272165|FG000|NOT COMPLETED|First Intervention||0
6362074|NCT00687167|7272166|FG001|NOT COMPLETED|First Intervention||0
6362075|NCT00687167|7272165|FG000|STARTED|Washout Period of 28 Days||17
6362076|NCT00687167|7272166|FG001|STARTED|Washout Period of 28 Days||17
6362077|NCT00687167|7272165|FG000|COMPLETED|Washout Period of 28 Days||17
6362078|NCT00687167|7272166|FG001|COMPLETED|Washout Period of 28 Days||17
6362079|NCT00687167|7272165|FG000|NOT COMPLETED|Washout Period of 28 Days||0
6362080|NCT00687167|7272166|FG001|NOT COMPLETED|Washout Period of 28 Days||0
6362081|NCT00687167|7272165|FG000|STARTED|Second Intervention||17
6362082|NCT00687167|7272166|FG001|STARTED|Second Intervention||17
6362083|NCT00687167|7272165|FG000|COMPLETED|Second Intervention||17
6362084|NCT00687167|7272166|FG001|COMPLETED|Second Intervention||17
6362085|NCT00687167|7272165|FG000|NOT COMPLETED|Second Intervention||0
6362086|NCT00687167|7272166|FG001|NOT COMPLETED|Second Intervention||0
6362087|NCT00687193|7272178|FG000|STARTED|Overall Study||53
6362088|NCT00687193|7272179|FG001|STARTED|Overall Study||53
6362089|NCT00687193|7272180|FG002|STARTED|Overall Study||52
6362090|NCT00687193|7272181|FG003|STARTED|Overall Study||53
6362091|NCT00687193|7272182|FG004|STARTED|Overall Study||54
6362092|NCT00687193|7272183|FG005|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
6362093|NCT00687193|7272178|FG000|COMPLETED|Overall Study||51
6362094|NCT00687193|7272179|FG001|COMPLETED|Overall Study||49
6362095|NCT00687193|7272180|FG002|COMPLETED|Overall Study||50
6362096|NCT00687193|7272181|FG003|COMPLETED|Overall Study||49
6362097|NCT00687193|7272182|FG004|COMPLETED|Overall Study||52
6362098|NCT00687193|7272183|FG005|COMPLETED|Overall Study||48
6362099|NCT00687193|7272178|FG000|NOT COMPLETED|Overall Study||2
6362100|NCT00687193|7272179|FG001|NOT COMPLETED|Overall Study||4
6362101|NCT00687193|7272180|FG002|NOT COMPLETED|Overall Study||2
6560523|NCT01787292|7483314|FG000|STARTED|Crossover Exercise Interventions|Participants in this group performed aerobic training prior to cross-over to balance training.|17
6560524|NCT01787292|7483315|FG001|STARTED|Crossover Exercise Interventions|Participants in this group performed balance training prior to cross-over to aerobic training.|16
6560525|NCT01787292|7483314|FG000|COMPLETED|Crossover Exercise Interventions|Participants completed the 12-week in-house program and cross-over into the balance program.|15
6560526|NCT01787292|7483315|FG001|COMPLETED|Crossover Exercise Interventions|These participants completed the 12-week in-house program and cross-over into the balance program.|14
6560527|NCT01787292|7483314|FG000|NOT COMPLETED|Crossover Exercise Interventions||2
6560528|NCT01787292|7483315|FG001|NOT COMPLETED|Crossover Exercise Interventions||2
6362102|NCT00687193|7272181|FG003|NOT COMPLETED|Overall Study||4
6362103|NCT00687193|7272182|FG004|NOT COMPLETED|Overall Study||2
6362104|NCT00687193|7272183|FG005|NOT COMPLETED|Overall Study||4
6362105|NCT00687219|7272200|FG000|STARTED|Overall Study||102
6362106|NCT00687219|7272200|FG000|COMPLETED|Overall Study||51
6362107|NCT00687219|7272200|FG000|NOT COMPLETED|Overall Study||51
6362108|NCT00687271|7272208|FG000|STARTED|Overall Study||94
6362109|NCT00687271|7272209|FG001|STARTED|Overall Study||96
6362110|NCT00687271|7272210|FG002|STARTED|Overall Study||96
6362111|NCT00687271|7272211|FG003|STARTED|Overall Study||48
6362112|NCT00687271|7272208|FG000|Treated|Overall Study||94
6362113|NCT00687271|7272209|FG001|Treated|Overall Study||95
6362114|NCT00687271|7272210|FG002|Treated|Overall Study||96
6362115|NCT00687271|7272211|FG003|Treated|Overall Study||48
6362116|NCT00687271|7272208|FG000|COMPLETED|Overall Study||91
6362117|NCT00687271|7272209|FG001|COMPLETED|Overall Study||90
6362118|NCT00687271|7272210|FG002|COMPLETED|Overall Study||91
6362119|NCT00687271|7272211|FG003|COMPLETED|Overall Study||48
6560529|NCT01787292|7483314|FG000|STARTED|Home Based Exercise Program||15
6560530|NCT01787292|7483315|FG001|STARTED|Home Based Exercise Program||14
6560531|NCT01787292|7483314|FG000|COMPLETED|Home Based Exercise Program||12
6362120|NCT00687271|7272208|FG000|NOT COMPLETED|Overall Study||3
6362121|NCT00687271|7272209|FG001|NOT COMPLETED|Overall Study||6
6362122|NCT00687271|7272210|FG002|NOT COMPLETED|Overall Study||5
6362123|NCT00687271|7272211|FG003|NOT COMPLETED|Overall Study||0
6362124|NCT00687297|7272223|FG000|STARTED|Randomization||80
6362125|NCT00687297|7272224|FG001|STARTED|Randomization||82
6362126|NCT00687297|7272223|FG000|COMPLETED|Randomization||77
6362127|NCT00687297|7272224|FG001|COMPLETED|Randomization||81
6362128|NCT00687297|7272223|FG000|NOT COMPLETED|Randomization||3
6362129|NCT00687297|7272224|FG001|NOT COMPLETED|Randomization||1
6362130|NCT00687297|7272223|FG000|STARTED|Induction||77
6362131|NCT00687297|7272224|FG001|STARTED|Induction||81
6362132|NCT00687297|7272223|FG000|COMPLETED|Induction||32
6362133|NCT00687297|7272224|FG001|COMPLETED|Induction||26
6362134|NCT00687297|7272223|FG000|NOT COMPLETED|Induction||45
6362135|NCT00687297|7272224|FG001|NOT COMPLETED|Induction||55
6362136|NCT00687297|7272223|FG000|STARTED|Maintenance||32
6362137|NCT00687297|7272224|FG001|STARTED|Maintenance||26
6362138|NCT00687297|7272223|FG000|COMPLETED|Maintenance||29
6362139|NCT00687297|7272224|FG001|COMPLETED|Maintenance||25
6362140|NCT00687297|7272223|FG000|NOT COMPLETED|Maintenance||3
6362141|NCT00687297|7272224|FG001|NOT COMPLETED|Maintenance||1
6362142|NCT00687323|7272232|FG000|STARTED|Overall Study|Number of screened participants|195
6362143|NCT00687323|7272232|FG000|Received Treatment|Overall Study||47
6362144|NCT00687323|7272232|FG000|COMPLETED|Overall Study|Number of participants alive at one year|15
6362145|NCT00687323|7272232|FG000|NOT COMPLETED|Overall Study||180
6362146|NCT00687362|7272236|FG000|STARTED|Overall Study||22
6362147|NCT00687362|7272236|FG000|COMPLETED|Overall Study|Completed protocol at Week 24|19
6362148|NCT00687362|7272236|FG000|NOT COMPLETED|Overall Study||3
6362149|NCT00687401|7272240|FG000|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
6362150|NCT00687401|7272240|FG000|COMPLETED|Overall Study||129
6362151|NCT00687401|7272240|FG000|NOT COMPLETED|Overall Study||30
6362152|NCT00687440|7272245|FG000|STARTED|Overall Study|Number of screened participants|27
6362153|NCT00687440|7272245|FG000|COMPLETED|Overall Study||15
6362154|NCT00687440|7272245|FG000|NOT COMPLETED|Overall Study||12
6362155|NCT00687453|7272251|FG000|STARTED|Overall Study||11
6362156|NCT00687453|7272252|FG001|STARTED|Overall Study||13
6362157|NCT00687453|7272251|FG000|COMPLETED|Overall Study||8
6362158|NCT00687453|7272252|FG001|COMPLETED|Overall Study||7
6362159|NCT00687453|7272251|FG000|NOT COMPLETED|Overall Study||3
6362160|NCT00687453|7272252|FG001|NOT COMPLETED|Overall Study||6
6362161|NCT00687544|7272258|FG000|STARTED|Overall Study||11
6362162|NCT00687544|7272258|FG000|COMPLETED|Overall Study||0
6362163|NCT00687544|7272258|FG000|NOT COMPLETED|Overall Study||11
6362164|NCT00687609|7272262|FG000|STARTED|Overall Study||7
6362165|NCT00687609|7272262|FG000|COMPLETED|Overall Study||4
6362166|NCT00687609|7272262|FG000|NOT COMPLETED|Overall Study||3
6362167|NCT00687674|7272266|FG000|STARTED|Overall Study||13
6362168|NCT00687674|7272266|FG000|COMPLETED|Overall Study||11
6362169|NCT00687674|7272266|FG000|NOT COMPLETED|Overall Study||2
6362170|NCT00687713|7272272|FG000|STARTED|Overall Study||100
6362171|NCT00687713|7272273|FG001|STARTED|Overall Study||104
6362172|NCT00687713|7272272|FG000|COMPLETED|Overall Study||68
6362173|NCT00687713|7272273|FG001|COMPLETED|Overall Study||64
6362174|NCT00687713|7272272|FG000|NOT COMPLETED|Overall Study||32
6362175|NCT00687713|7272273|FG001|NOT COMPLETED|Overall Study||40
6362176|NCT00687739|7272285|FG000|STARTED|Overall Study||25
6362177|NCT00687739|7272286|FG001|STARTED|Overall Study||15
6362178|NCT00687739|7272287|FG002|STARTED|Overall Study||25
6362179|NCT00687739|7272288|FG003|STARTED|Overall Study||14
6362180|NCT00687739|7272285|FG000|COMPLETED|Overall Study||23
6362181|NCT00687739|7272286|FG001|COMPLETED|Overall Study||12
6362182|NCT00687739|7272287|FG002|COMPLETED|Overall Study||23
6362183|NCT00687739|7272288|FG003|COMPLETED|Overall Study||12
6362184|NCT00687739|7272285|FG000|NOT COMPLETED|Overall Study||2
6362185|NCT00687739|7272286|FG001|NOT COMPLETED|Overall Study||3
6362186|NCT00687739|7272287|FG002|NOT COMPLETED|Overall Study||2
6362187|NCT00687739|7272288|FG003|NOT COMPLETED|Overall Study||2
6362188|NCT00687804|7272303|FG000|STARTED|Core Study||116
6362189|NCT00687804|7272304|FG001|STARTED|Core Study||118
6362190|NCT00687804|7272305|FG002|STARTED|Core Study||111
6362191|NCT00687804|7272303|FG000|COMPLETED|Core Study||102
6362192|NCT00687804|7272304|FG001|COMPLETED|Core Study||103
6362193|NCT00687804|7272305|FG002|COMPLETED|Core Study||98
6362194|NCT00687804|7272303|FG000|NOT COMPLETED|Core Study||14
6362195|NCT00687804|7272304|FG001|NOT COMPLETED|Core Study||15
6362196|NCT00687804|7272305|FG002|NOT COMPLETED|Core Study||13
6362197|NCT00687804|7272303|FG000|STARTED|Open-Label Extension Study||83
6362198|NCT00687804|7272304|FG001|STARTED|Open-Label Extension Study||83
6362199|NCT00687804|7272305|FG002|STARTED|Open-Label Extension Study||74
6362200|NCT00687804|7272303|FG000|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
6362201|NCT00687804|7272304|FG001|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
6362202|NCT00687804|7272305|FG002|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
6362203|NCT00687804|7272303|FG000|COMPLETED|Open-Label Extension Study||73
6362204|NCT00687804|7272304|FG001|COMPLETED|Open-Label Extension Study||72
6362205|NCT00687804|7272305|FG002|COMPLETED|Open-Label Extension Study||63
6362206|NCT00687804|7272303|FG000|NOT COMPLETED|Open-Label Extension Study||10
6362207|NCT00687804|7272304|FG001|NOT COMPLETED|Open-Label Extension Study||11
6362208|NCT00687804|7272305|FG002|NOT COMPLETED|Open-Label Extension Study||11
6362209|NCT00687830|7272321|FG000|STARTED|Overall Study||68
6362210|NCT00687830|7272322|FG001|STARTED|Overall Study||68
6362211|NCT00687830|7272321|FG000|COMPLETED|Overall Study||68
6362212|NCT00687830|7272322|FG001|COMPLETED|Overall Study||68
6362213|NCT00687830|7272321|FG000|NOT COMPLETED|Overall Study||0
6362214|NCT00687830|7272322|FG001|NOT COMPLETED|Overall Study||0
6362215|NCT00687856|7272328|FG000|STARTED|Overall Study||211
6362216|NCT00687856|7272328|FG000|COMPLETED|Overall Study||211
6362217|NCT00687856|7272328|FG000|NOT COMPLETED|Overall Study||0
6362218|NCT00687908|7272334|FG000|STARTED|Overall Study||123
6362219|NCT00687908|7272335|FG001|STARTED|Overall Study||120
6362220|NCT00687908|7272334|FG000|COMPLETED|Overall Study||105
6362221|NCT00687908|7272335|FG001|COMPLETED|Overall Study||78
6362222|NCT00687908|7272334|FG000|NOT COMPLETED|Overall Study||18
6362223|NCT00687908|7272335|FG001|NOT COMPLETED|Overall Study||42
6362224|NCT00687973|7272343|FG000|STARTED|Overall Study||193
6362225|NCT00687973|7272344|FG001|STARTED|Overall Study||200
6362226|NCT00687973|7272343|FG000|COMPLETED|Overall Study||169
6362227|NCT00687973|7272344|FG001|COMPLETED|Overall Study||162
6362228|NCT00687973|7272343|FG000|NOT COMPLETED|Overall Study||24
6362229|NCT00687973|7272344|FG001|NOT COMPLETED|Overall Study||38
6362230|NCT00688064|7272353|FG000|STARTED|Overall Study||232
6362231|NCT00688064|7272354|FG001|STARTED|Overall Study||227
6362232|NCT00688064|7272353|FG000|COMPLETED|Overall Study||211
6362233|NCT00688064|7272354|FG001|COMPLETED|Overall Study||201
6362234|NCT00688064|7272353|FG000|NOT COMPLETED|Overall Study||21
6362235|NCT00688064|7272354|FG001|NOT COMPLETED|Overall Study||26
6362236|NCT00688103|7272362|FG000|STARTED|Overall Study||74
6362237|NCT00688103|7272363|FG001|STARTED|Overall Study||77
6362238|NCT00688103|7272362|FG000|Actually Treated|Overall Study||71
6362239|NCT00688103|7272363|FG001|Actually Treated|Overall Study||76
6362240|NCT00688103|7272362|FG000|COMPLETED|Overall Study||44
6362241|NCT00688103|7272363|FG001|COMPLETED|Overall Study||64
6362242|NCT00688103|7272362|FG000|NOT COMPLETED|Overall Study||30
6362243|NCT00688103|7272363|FG001|NOT COMPLETED|Overall Study||13
6362244|NCT00688155|7272375|FG000|STARTED|Overall Study||18
6362245|NCT00688155|7272376|FG001|STARTED|Overall Study||18
6362246|NCT00688155|7272377|FG002|STARTED|Overall Study||19
6362247|NCT00688155|7272378|FG003|STARTED|Overall Study||18
6362248|NCT00688155|7272375|FG000|COMPLETED|Overall Study||16
6362249|NCT00688155|7272376|FG001|COMPLETED|Overall Study||16
6362250|NCT00688155|7272377|FG002|COMPLETED|Overall Study||18
6362251|NCT00688155|7272378|FG003|COMPLETED|Overall Study||17
6362252|NCT00688155|7272375|FG000|NOT COMPLETED|Overall Study||2
6362253|NCT00688155|7272376|FG001|NOT COMPLETED|Overall Study||2
6362254|NCT00688155|7272377|FG002|NOT COMPLETED|Overall Study||1
6362255|NCT00688155|7272378|FG003|NOT COMPLETED|Overall Study||1
6362256|NCT00688181|7272388|FG000|STARTED|Overall Study||36
6362257|NCT00688181|7272388|FG000|COMPLETED|Overall Study||13
6362258|NCT00688181|7272388|FG000|NOT COMPLETED|Overall Study||23
6362259|NCT00688259|7272396|FG000|STARTED|Overall Study||44
6362260|NCT00688259|7272397|FG001|STARTED|Overall Study||44
6362261|NCT00688259|7272396|FG000|End to Active Treatment,|Overall Study||37
6362262|NCT00688259|7272397|FG001|End to Active Treatment,|Overall Study||37
6362263|NCT00688259|7272396|FG000|COMPLETED|Overall Study||37
6362264|NCT00688259|7272397|FG001|COMPLETED|Overall Study||36
6362265|NCT00688259|7272396|FG000|NOT COMPLETED|Overall Study||7
6362266|NCT00688259|7272397|FG001|NOT COMPLETED|Overall Study||8
6362267|NCT00688324|7272403|FG000|STARTED|Overall Study||36
6362268|NCT00688324|7272403|FG000|COMPLETED|Overall Study||28
6362269|NCT00688324|7272403|FG000|NOT COMPLETED|Overall Study||8
6362270|NCT00688467|7272410|FG000|STARTED|Treatment Period 1||9
6362271|NCT00688467|7272411|FG001|STARTED|Treatment Period 1||10
6362272|NCT00688467|7272410|FG000|COMPLETED|Treatment Period 1||7
6362273|NCT00688467|7272411|FG001|COMPLETED|Treatment Period 1||8
6362274|NCT00688467|7272410|FG000|NOT COMPLETED|Treatment Period 1||2
6362275|NCT00688467|7272411|FG001|NOT COMPLETED|Treatment Period 1||2
6362276|NCT00688467|7272410|FG000|STARTED|Treatment Period 2||7
6362277|NCT00688467|7272411|FG001|STARTED|Treatment Period 2||8
6362278|NCT00688467|7272410|FG000|COMPLETED|Treatment Period 2||7
6362279|NCT00688467|7272411|FG001|COMPLETED|Treatment Period 2||6
6362280|NCT00688467|7272410|FG000|NOT COMPLETED|Treatment Period 2||0
6362281|NCT00688467|7272411|FG001|NOT COMPLETED|Treatment Period 2||2
6362282|NCT00688519|7272419|FG000|STARTED|Overall Study||223
6362283|NCT00688519|7272420|FG001|STARTED|Overall Study||113
6362284|NCT00688519|7272419|FG000|COMPLETED|Overall Study||204
6362285|NCT00688519|7272420|FG001|COMPLETED|Overall Study||98
6362286|NCT00688519|7272419|FG000|NOT COMPLETED|Overall Study||19
6362287|NCT00688519|7272420|FG001|NOT COMPLETED|Overall Study||15
6362288|NCT00688545|7272428|FG000|STARTED|Overall Study||55
6362289|NCT00688545|7272429|FG001|STARTED|Overall Study||219
6362290|NCT00688545|7272428|FG000|Switched Treatment at Least Once|Overall Study||6
6362291|NCT00688545|7272429|FG001|Switched Treatment at Least Once|Overall Study||13
6362292|NCT00688545|7272428|FG000|COMPLETED|Overall Study||50
6362293|NCT00688545|7272429|FG001|COMPLETED|Overall Study||204
6362294|NCT00688545|7272428|FG000|NOT COMPLETED|Overall Study||5
6362295|NCT00688545|7272429|FG001|NOT COMPLETED|Overall Study||15
6362296|NCT00688597|7272440|FG000|STARTED|Overall Study||3
6362297|NCT00688597|7272441|FG001|STARTED|Overall Study||0
6362298|NCT00688597|7272442|FG002|STARTED|Overall Study||0
6362299|NCT00688597|7272440|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6362300|NCT00688597|7272441|FG001|Received at Least 1 Dose of Study Drug|Overall Study||0
6362301|NCT00688597|7272442|FG002|Received at Least 1 Dose of Study Drug|Overall Study||0
6362302|NCT00688597|7272440|FG000|COMPLETED|Overall Study||0
6362303|NCT00688597|7272441|FG001|COMPLETED|Overall Study||0
6362304|NCT00688597|7272442|FG002|COMPLETED|Overall Study||0
6362305|NCT00688597|7272440|FG000|NOT COMPLETED|Overall Study||3
6362306|NCT00688597|7272441|FG001|NOT COMPLETED|Overall Study||0
6362307|NCT00688597|7272442|FG002|NOT COMPLETED|Overall Study||0
6362308|NCT00688623|7272450|FG000|STARTED|Overall Study|Intent to treat (ITT)|73
6362309|NCT00688623|7272450|FG000|Safety Analysis Set|Overall Study|received at least one dose of study drug and had at least one post-baseline safety assessment|73
6362310|NCT00688623|7272450|FG000|Per Protocol (PP)|Overall Study|no major protocol deviation and 50% of planned dose of 8 weeks or d/c due to disease progression|60
6362311|NCT00688623|7272450|FG000|COMPLETED|Overall Study||18
6362312|NCT00688623|7272450|FG000|NOT COMPLETED|Overall Study||55
6362313|NCT00688636|7272456|FG000|STARTED|Overall Study||11
6362314|NCT00688636|7272457|FG001|STARTED|Overall Study||13
6362315|NCT00688636|7272456|FG000|COMPLETED|Overall Study||9
6362316|NCT00688636|7272457|FG001|COMPLETED|Overall Study||12
6362317|NCT00688636|7272456|FG000|NOT COMPLETED|Overall Study||2
6362318|NCT00688636|7272457|FG001|NOT COMPLETED|Overall Study||1
6362319|NCT00688662|7272465|FG000|STARTED|Overall Study||141
6362320|NCT00688662|7272466|FG001|STARTED|Overall Study||73
6362321|NCT00688662|7272465|FG000|COMPLETED|Overall Study||118
6362322|NCT00688662|7272466|FG001|COMPLETED|Overall Study||55
6362323|NCT00688662|7272465|FG000|NOT COMPLETED|Overall Study||23
6362324|NCT00688662|7272466|FG001|NOT COMPLETED|Overall Study||18
6362325|NCT00688688|7272476|FG000|STARTED|Overall Study||815
6362326|NCT00688688|7272477|FG001|STARTED|Overall Study||824
6362327|NCT00688688|7272478|FG002|STARTED|Overall Study||813
6362328|NCT00688688|7272476|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
6362329|NCT00688688|7272477|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
6362330|NCT00688688|7272478|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
6362331|NCT00688688|7272476|FG000|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
6362332|NCT00688688|7272477|FG001|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
6362333|NCT00688688|7272478|FG002|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
6362334|NCT00688688|7272476|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
6362335|NCT00688688|7272477|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
6362336|NCT00688688|7272478|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
6362337|NCT00688688|7272476|FG000|COMPLETED|Overall Study||629
6362338|NCT00688688|7272477|FG001|COMPLETED|Overall Study||645
6362339|NCT00688688|7272478|FG002|COMPLETED|Overall Study||621
6362340|NCT00688688|7272476|FG000|NOT COMPLETED|Overall Study||186
6362341|NCT00688688|7272477|FG001|NOT COMPLETED|Overall Study||179
6362342|NCT00688688|7272478|FG002|NOT COMPLETED|Overall Study||192
6362343|NCT00688701|7272489|FG000|STARTED|Overall Study|Randomized|61
6362344|NCT00688701|7272490|FG001|STARTED|Overall Study||61
6362345|NCT00688701|7272491|FG002|STARTED|Overall Study||120
6362346|NCT00688701|7272492|FG003|STARTED|Overall Study||119
6362347|NCT00688701|7272489|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
6362348|NCT00688701|7272490|FG001|Treated/Safety Population|Overall Study||61
6362349|NCT00688701|7272491|FG002|Treated/Safety Population|Overall Study||120
6362350|NCT00688701|7272492|FG003|Treated/Safety Population|Overall Study||119
6362351|NCT00688701|7272489|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
6362352|NCT00688701|7272490|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||60
6362353|NCT00688701|7272491|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||120
6362354|NCT00688701|7272492|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||118
6362355|NCT00688701|7272489|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
6362356|NCT00688701|7272490|FG001|Subgroup for Standardized Meal Test|Overall Study||35
6362357|NCT00688701|7272491|FG002|Subgroup for Standardized Meal Test|Overall Study||60
6362358|NCT00688701|7272492|FG003|Subgroup for Standardized Meal Test|Overall Study||65
6362359|NCT00688701|7272489|FG000|COMPLETED|Overall Study||57
6362360|NCT00688701|7272490|FG001|COMPLETED|Overall Study||56
6362361|NCT00688701|7272491|FG002|COMPLETED|Overall Study||110
6362362|NCT00688701|7272492|FG003|COMPLETED|Overall Study||108
6362363|NCT00688701|7272489|FG000|NOT COMPLETED|Overall Study||4
6362364|NCT00688701|7272490|FG001|NOT COMPLETED|Overall Study||5
6362365|NCT00688701|7272491|FG002|NOT COMPLETED|Overall Study||10
6362366|NCT00688701|7272492|FG003|NOT COMPLETED|Overall Study||11
6362367|NCT00688740|7272505|FG000|STARTED|Overall Study||745
6362368|NCT00688740|7272506|FG001|STARTED|Overall Study||746
6362369|NCT00688740|7272505|FG000|COMPLETED|Overall Study||679
6362370|NCT00688740|7272506|FG001|COMPLETED|Overall Study||711
6362371|NCT00688740|7272505|FG000|NOT COMPLETED|Overall Study||66
6362372|NCT00688740|7272506|FG001|NOT COMPLETED|Overall Study||35
6362373|NCT00688753|7272512|FG000|STARTED|Overall Study||92
6362374|NCT00688753|7272512|FG000|COMPLETED|Overall Study||0
6362375|NCT00688753|7272512|FG000|NOT COMPLETED|Overall Study||92
6362376|NCT00688844|7272516|FG000|STARTED|Overall Study||58
6362377|NCT00688844|7272516|FG000|COMPLETED|Overall Study||48
6362378|NCT00688844|7272516|FG000|NOT COMPLETED|Overall Study||10
6362379|NCT00688870|7272522|FG000|STARTED|Infant Series||84
6362380|NCT00688870|7272523|FG001|STARTED|Infant Series||84
6362381|NCT00688870|7272522|FG000|Vaccinated Dose 1|Infant Series||83
6362382|NCT00688870|7272523|FG001|Vaccinated Dose 1|Infant Series||84
6362383|NCT00688870|7272522|FG000|Vaccinated Dose 2|Infant Series||80
6362384|NCT00688870|7272523|FG001|Vaccinated Dose 2|Infant Series||84
6362385|NCT00688870|7272522|FG000|Vaccinated Dose 3|Infant Series||80
6362386|NCT00688870|7272523|FG001|Vaccinated Dose 3|Infant Series||84
6362387|NCT00688870|7272522|FG000|COMPLETED|Infant Series||80
6362388|NCT00688870|7272523|FG001|COMPLETED|Infant Series||84
6362389|NCT00688870|7272522|FG000|NOT COMPLETED|Infant Series||4
6362390|NCT00688870|7272523|FG001|NOT COMPLETED|Infant Series||0
6362391|NCT00688870|7272522|FG000|STARTED|After Infant Series||80
6362392|NCT00688870|7272523|FG001|STARTED|After Infant Series||84
6362393|NCT00688870|7272522|FG000|COMPLETED|After Infant Series||80
6362394|NCT00688870|7272523|FG001|COMPLETED|After Infant Series||84
6362395|NCT00688870|7272522|FG000|NOT COMPLETED|After Infant Series||0
6362396|NCT00688870|7272523|FG001|NOT COMPLETED|After Infant Series||0
6362397|NCT00688870|7272522|FG000|STARTED|Toddler Dose||80
6362398|NCT00688870|7272523|FG001|STARTED|Toddler Dose||84
6362399|NCT00688870|7272522|FG000|COMPLETED|Toddler Dose||80
6362400|NCT00688870|7272523|FG001|COMPLETED|Toddler Dose||84
6362401|NCT00688870|7272522|FG000|NOT COMPLETED|Toddler Dose||0
6362402|NCT00688870|7272523|FG001|NOT COMPLETED|Toddler Dose||0
6362403|NCT00688909|7272533|FG000|STARTED|Overall Study||261
6362404|NCT00688909|7272533|FG000|COMPLETED|Overall Study||228
6362405|NCT00688909|7272533|FG000|NOT COMPLETED|Overall Study||33
6362406|NCT00689026|7272540|FG000|STARTED|Overall Study||30
6362407|NCT00689026|7272541|FG001|STARTED|Overall Study||30
6362408|NCT00689026|7272540|FG000|COMPLETED|Overall Study||17
6362409|NCT00689026|7272541|FG001|COMPLETED|Overall Study||24
6362410|NCT00689026|7272540|FG000|NOT COMPLETED|Overall Study||13
6362411|NCT00689026|7272541|FG001|NOT COMPLETED|Overall Study||6
6362412|NCT00689078|7272551|FG000|STARTED|Overall Study||9
6362413|NCT00689078|7272552|FG001|STARTED|Overall Study||9
6362414|NCT00689078|7272553|FG002|STARTED|Overall Study||9
6362415|NCT00689078|7272554|FG003|STARTED|Overall Study||9
6362416|NCT00689078|7272551|FG000|Intent to Treat|Overall Study||9
6362417|NCT00689078|7272552|FG001|Intent to Treat|Overall Study||7
6362418|NCT00689078|7272553|FG002|Intent to Treat|Overall Study||8
6362419|NCT00689078|7272554|FG003|Intent to Treat|Overall Study||8
6362420|NCT00689078|7272551|FG000|COMPLETED|Overall Study||9
6362421|NCT00689078|7272552|FG001|COMPLETED|Overall Study||7
6362422|NCT00689078|7272553|FG002|COMPLETED|Overall Study||8
6362423|NCT00689078|7272554|FG003|COMPLETED|Overall Study||8
6362424|NCT00689078|7272551|FG000|NOT COMPLETED|Overall Study||0
6362425|NCT00689078|7272552|FG001|NOT COMPLETED|Overall Study||2
6362426|NCT00689078|7272553|FG002|NOT COMPLETED|Overall Study||1
6362427|NCT00689078|7272554|FG003|NOT COMPLETED|Overall Study||1
6362428|NCT00689091|7272566|FG000|STARTED|Overall Study||10831
6362429|NCT00689091|7272567|FG001|STARTED|Overall Study||10770
6362430|NCT00689091|7272566|FG000|COMPLETED|Overall Study||9460
6362431|NCT00689091|7272567|FG001|COMPLETED|Overall Study||9376
6362432|NCT00689091|7272566|FG000|NOT COMPLETED|Overall Study||1371
6362433|NCT00689091|7272567|FG001|NOT COMPLETED|Overall Study||1394
6362434|NCT00689104|7272581|FG000|STARTED|Overall Study||497
6362435|NCT00689104|7272582|FG001|STARTED|Overall Study||497
6362436|NCT00689104|7272583|FG002|STARTED|Overall Study||498
6362437|NCT00689104|7272584|FG003|STARTED|Overall Study||495
6362438|NCT00689104|7272581|FG000|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
6362439|NCT00689104|7272582|FG001|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
6362440|NCT00689104|7272583|FG002|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
6362441|NCT00689104|7272584|FG003|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
6362442|NCT00689104|7272581|FG000|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
6362443|NCT00689104|7272582|FG001|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
6362444|NCT00689104|7272583|FG002|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
6362445|NCT00689104|7272584|FG003|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
6362446|NCT00689104|7272581|FG000|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
6362447|NCT00689104|7272582|FG001|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
6362448|NCT00689104|7272583|FG002|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
6362449|NCT00689104|7272584|FG003|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
6362450|NCT00689104|7272581|FG000|COMPLETED|Overall Study||453
6362451|NCT00689104|7272582|FG001|COMPLETED|Overall Study||440
6362452|NCT00689104|7272583|FG002|COMPLETED|Overall Study||453
6362453|NCT00689104|7272584|FG003|COMPLETED|Overall Study||445
6362454|NCT00689104|7272581|FG000|NOT COMPLETED|Overall Study||44
6362455|NCT00689104|7272582|FG001|NOT COMPLETED|Overall Study||57
6362456|NCT00689104|7272583|FG002|NOT COMPLETED|Overall Study||45
6362457|NCT00689104|7272584|FG003|NOT COMPLETED|Overall Study||50
6362458|NCT00689117|7272598|FG000|STARTED|Overall Study||476
6362459|NCT00689117|7272599|FG001|STARTED|Overall Study||467
6362460|NCT00689117|7272600|FG002|STARTED|Overall Study||464
6362461|NCT00689117|7272601|FG003|STARTED|Overall Study||242
6362462|NCT00689117|7272598|FG000|COMPLETED|Overall Study||414
6362463|NCT00689117|7272599|FG001|COMPLETED|Overall Study||416
6362464|NCT00689117|7272600|FG002|COMPLETED|Overall Study||405
6362465|NCT00689117|7272601|FG003|COMPLETED|Overall Study||211
6362466|NCT00689117|7272598|FG000|NOT COMPLETED|Overall Study||62
6362467|NCT00689117|7272599|FG001|NOT COMPLETED|Overall Study||51
6362468|NCT00689117|7272600|FG002|NOT COMPLETED|Overall Study||59
6362469|NCT00689117|7272601|FG003|NOT COMPLETED|Overall Study||31
6362470|NCT00689221|7272613|FG000|STARTED|Overall Study||272
6362471|NCT00689221|7272614|FG001|STARTED|Overall Study||273
6362472|NCT00689221|7272613|FG000|COMPLETED|Overall Study||233
6362473|NCT00689221|7272614|FG001|COMPLETED|Overall Study||237
6362474|NCT00689221|7272613|FG000|NOT COMPLETED|Overall Study||39
6362475|NCT00689221|7272614|FG001|NOT COMPLETED|Overall Study||36
6377223|NCT00762385|7287823|FG000|STARTED|Second Intervention||49
6377224|NCT00762385|7287824|FG001|STARTED|Second Intervention||42
6377225|NCT00762385|7287823|FG000|COMPLETED|Second Intervention||46
6377226|NCT00762385|7287824|FG001|COMPLETED|Second Intervention||39
6377227|NCT00762385|7287823|FG000|NOT COMPLETED|Second Intervention||3
6377228|NCT00762385|7287824|FG001|NOT COMPLETED|Second Intervention||3
6377229|NCT00762411|7287835|FG000|STARTED|Initial Treatment||556
6377230|NCT00762411|7287836|FG001|STARTED|Initial Treatment||555
6377231|NCT00762411|7287835|FG000|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
6377232|NCT00762411|7287836|FG001|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
6377233|NCT00762411|7287835|FG000|COMPLETED|Initial Treatment||22
6377234|NCT00762411|7287836|FG001|COMPLETED|Initial Treatment||34
6377235|NCT00762411|7287835|FG000|NOT COMPLETED|Initial Treatment||534
6377236|NCT00762411|7287836|FG001|NOT COMPLETED|Initial Treatment||521
6377237|NCT00762411|7287835|FG000|STARTED|Delayed Start||22
6377238|NCT00762411|7287836|FG001|STARTED|Delayed Start||34
6377239|NCT00762411|7287835|FG000|COMPLETED|Delayed Start||5
6377240|NCT00762411|7287836|FG001|COMPLETED|Delayed Start||8
6377241|NCT00762411|7287835|FG000|NOT COMPLETED|Delayed Start||17
6377242|NCT00762411|7287836|FG001|NOT COMPLETED|Delayed Start||26
6377243|NCT00762411|7287835|FG000|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
6377244|NCT00762411|7287836|FG001|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
6377245|NCT00762411|7287835|FG000|COMPLETED|Safety Follow Up (SFU)-Optional||228
6377246|NCT00762411|7287836|FG001|COMPLETED|Safety Follow Up (SFU)-Optional||312
6377247|NCT00762411|7287835|FG000|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
6377248|NCT00762411|7287836|FG001|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
6377249|NCT00762424|7287848|FG000|STARTED|Overall Study||28
6377250|NCT00762424|7287849|FG001|STARTED|Overall Study||25
6377251|NCT00762424|7287848|FG000|COMPLETED|Overall Study||28
6377252|NCT00762424|7287849|FG001|COMPLETED|Overall Study||25
6377253|NCT00762424|7287848|FG000|NOT COMPLETED|Overall Study||0
6377254|NCT00762424|7287849|FG001|NOT COMPLETED|Overall Study||0
6377255|NCT00762450|7287858|FG000|STARTED|1st Treatment Period||2
6377256|NCT00762450|7287859|FG001|STARTED|1st Treatment Period||2
6377257|NCT00762450|7287860|FG002|STARTED|1st Treatment Period||2
6377258|NCT00762450|7287858|FG000|COMPLETED|1st Treatment Period||2
6377259|NCT00762450|7287859|FG001|COMPLETED|1st Treatment Period||2
6377260|NCT00762450|7287860|FG002|COMPLETED|1st Treatment Period||2
6377261|NCT00762450|7287858|FG000|NOT COMPLETED|1st Treatment Period||0
6377262|NCT00762450|7287859|FG001|NOT COMPLETED|1st Treatment Period||0
6377263|NCT00762450|7287860|FG002|NOT COMPLETED|1st Treatment Period||0
6377264|NCT00762450|7287858|FG000|STARTED|Washout After 1st Treatment Period||2
6377265|NCT00762450|7287859|FG001|STARTED|Washout After 1st Treatment Period||2
6377266|NCT00762450|7287860|FG002|STARTED|Washout After 1st Treatment Period||2
6377267|NCT00762450|7287858|FG000|COMPLETED|Washout After 1st Treatment Period||2
6377268|NCT00762450|7287859|FG001|COMPLETED|Washout After 1st Treatment Period||2
6377269|NCT00762450|7287860|FG002|COMPLETED|Washout After 1st Treatment Period||2
6377270|NCT00762450|7287858|FG000|NOT COMPLETED|Washout After 1st Treatment Period||0
6377271|NCT00762450|7287859|FG001|NOT COMPLETED|Washout After 1st Treatment Period||0
6377272|NCT00762450|7287860|FG002|NOT COMPLETED|Washout After 1st Treatment Period||0
6377273|NCT00762450|7287858|FG000|STARTED|2nd Treatment Period||2
6377274|NCT00762450|7287859|FG001|STARTED|2nd Treatment Period||2
6377275|NCT00762450|7287860|FG002|STARTED|2nd Treatment Period||2
6377276|NCT00762450|7287858|FG000|COMPLETED|2nd Treatment Period||2
6377277|NCT00762450|7287859|FG001|COMPLETED|2nd Treatment Period||2
6377278|NCT00762450|7287860|FG002|COMPLETED|2nd Treatment Period||2
6377279|NCT00762450|7287858|FG000|NOT COMPLETED|2nd Treatment Period||0
6377280|NCT00762450|7287859|FG001|NOT COMPLETED|2nd Treatment Period||0
6377281|NCT00762450|7287860|FG002|NOT COMPLETED|2nd Treatment Period||0
6377282|NCT00762450|7287858|FG000|STARTED|Washout After 2nd Treatment Period||2
6377283|NCT00762450|7287859|FG001|STARTED|Washout After 2nd Treatment Period||2
6377284|NCT00762450|7287860|FG002|STARTED|Washout After 2nd Treatment Period||2
6377285|NCT00762450|7287858|FG000|COMPLETED|Washout After 2nd Treatment Period||2
6377286|NCT00762450|7287859|FG001|COMPLETED|Washout After 2nd Treatment Period||2
6377287|NCT00762450|7287860|FG002|COMPLETED|Washout After 2nd Treatment Period||2
6377288|NCT00762450|7287858|FG000|NOT COMPLETED|Washout After 2nd Treatment Period||0
6377289|NCT00762450|7287859|FG001|NOT COMPLETED|Washout After 2nd Treatment Period||0
6377290|NCT00762450|7287860|FG002|NOT COMPLETED|Washout After 2nd Treatment Period||0
6377291|NCT00762450|7287858|FG000|STARTED|3rd Treatment Period||2
6377292|NCT00762450|7287859|FG001|STARTED|3rd Treatment Period||2
6377293|NCT00762450|7287860|FG002|STARTED|3rd Treatment Period||2
6377294|NCT00762450|7287858|FG000|COMPLETED|3rd Treatment Period||2
6377295|NCT00762450|7287859|FG001|COMPLETED|3rd Treatment Period||2
6377296|NCT00762450|7287860|FG002|COMPLETED|3rd Treatment Period||2
6377297|NCT00762450|7287858|FG000|NOT COMPLETED|3rd Treatment Period||0
6377298|NCT00762450|7287859|FG001|NOT COMPLETED|3rd Treatment Period||0
6362476|NCT00689260|7272622|FG000|STARTED|Overall Study||21
6362477|NCT00689260|7272623|FG001|STARTED|Overall Study||21
6362478|NCT00689260|7272622|FG000|COMPLETED|Overall Study||19
6362479|NCT00689260|7272623|FG001|COMPLETED|Overall Study||21
6362480|NCT00689260|7272622|FG000|NOT COMPLETED|Overall Study||2
6362481|NCT00689260|7272623|FG001|NOT COMPLETED|Overall Study||0
6362482|NCT00689273|7272634|FG000|STARTED|Overall Study||79
6362483|NCT00689273|7272635|FG001|STARTED|Overall Study||78
6362484|NCT00689273|7272634|FG000|Treated|Overall Study||78
6362485|NCT00689273|7272635|FG001|Treated|Overall Study||78
6362486|NCT00689273|7272634|FG000|COMPLETED|Overall Study||66
6362487|NCT00689273|7272635|FG001|COMPLETED|Overall Study||73
6362488|NCT00689273|7272634|FG000|NOT COMPLETED|Overall Study||13
6362489|NCT00689273|7272635|FG001|NOT COMPLETED|Overall Study||5
6362490|NCT00689299|7272644|FG000|STARTED|Overall Study||58
6362491|NCT00689299|7272645|FG001|STARTED|Overall Study||57
6362492|NCT00689299|7272646|FG002|STARTED|Overall Study||54
6362493|NCT00689299|7272644|FG000|COMPLETED|Overall Study||51
6362494|NCT00689299|7272645|FG001|COMPLETED|Overall Study||54
6362495|NCT00689299|7272646|FG002|COMPLETED|Overall Study||49
6362496|NCT00689299|7272644|FG000|NOT COMPLETED|Overall Study||7
6362497|NCT00689299|7272645|FG001|NOT COMPLETED|Overall Study||3
6362498|NCT00689299|7272646|FG002|NOT COMPLETED|Overall Study||5
6362499|NCT00689338|7272654|FG000|STARTED|Overall Study||216
6362500|NCT00689338|7272654|FG000|COMPLETED|Overall Study||73
6362501|NCT00689338|7272654|FG000|NOT COMPLETED|Overall Study||143
6362502|NCT00689351|7272660|FG000|STARTED|Infant Series of Dosing||91
6362503|NCT00689351|7272661|FG001|STARTED|Infant Series of Dosing||89
6362504|NCT00689351|7272660|FG000|Vaccinated Dose 1|Infant Series of Dosing||88
6362505|NCT00689351|7272661|FG001|Vaccinated Dose 1|Infant Series of Dosing||89
6362506|NCT00689351|7272660|FG000|Vaccinated Dose 2|Infant Series of Dosing||86
6362507|NCT00689351|7272661|FG001|Vaccinated Dose 2|Infant Series of Dosing||88
6362508|NCT00689351|7272660|FG000|Vaccinated Dose 3|Infant Series of Dosing||85
6362509|NCT00689351|7272661|FG001|Vaccinated Dose 3|Infant Series of Dosing||88
6362510|NCT00689351|7272660|FG000|COMPLETED|Infant Series of Dosing||85
6362511|NCT00689351|7272661|FG001|COMPLETED|Infant Series of Dosing||88
6362512|NCT00689351|7272660|FG000|NOT COMPLETED|Infant Series of Dosing||6
6362513|NCT00689351|7272661|FG001|NOT COMPLETED|Infant Series of Dosing||1
6362514|NCT00689351|7272660|FG000|STARTED|After Infant Series||85
6362515|NCT00689351|7272661|FG001|STARTED|After Infant Series||88
6362516|NCT00689351|7272660|FG000|COMPLETED|After Infant Series||84
6362517|NCT00689351|7272661|FG001|COMPLETED|After Infant Series||88
6362518|NCT00689351|7272660|FG000|NOT COMPLETED|After Infant Series||1
6362519|NCT00689351|7272661|FG001|NOT COMPLETED|After Infant Series||0
6362520|NCT00689351|7272660|FG000|STARTED|Toddler Dose||84
6362521|NCT00689351|7272661|FG001|STARTED|Toddler Dose||88
6362522|NCT00689351|7272660|FG000|COMPLETED|Toddler Dose||84
6362523|NCT00689351|7272661|FG001|COMPLETED|Toddler Dose||88
6362524|NCT00689351|7272660|FG000|NOT COMPLETED|Toddler Dose||0
6362525|NCT00689351|7272661|FG001|NOT COMPLETED|Toddler Dose||0
6362526|NCT00689390|7272673|FG000|STARTED|Overall Study||1907
6362527|NCT00689390|7272674|FG001|STARTED|Overall Study||47
6362528|NCT00689390|7272673|FG000|COMPLETED|Overall Study||1481
6362529|NCT00689390|7272674|FG001|COMPLETED|Overall Study||37
6362530|NCT00689390|7272673|FG000|NOT COMPLETED|Overall Study||426
6362531|NCT00689390|7272674|FG001|NOT COMPLETED|Overall Study||10
6362532|NCT00689481|7272687|FG000|STARTED|Overall Study||214
6362533|NCT00689481|7272688|FG001|STARTED|Overall Study||109
6362534|NCT00689481|7272687|FG000|COMPLETED|Overall Study||190
6362535|NCT00689481|7272688|FG001|COMPLETED|Overall Study||95
6362536|NCT00689481|7272687|FG000|NOT COMPLETED|Overall Study||24
6362537|NCT00689481|7272688|FG001|NOT COMPLETED|Overall Study||14
6362538|NCT00689572|7272696|FG000|STARTED|Overall Study||53
6362539|NCT00689572|7272697|FG001|STARTED|Overall Study||55
6362540|NCT00689572|7272696|FG000|COMPLETED|Overall Study||39
6560532|NCT01787292|7483315|FG001|COMPLETED|Home Based Exercise Program||13
6362541|NCT00689572|7272697|FG001|COMPLETED|Overall Study||34
6362542|NCT00689572|7272696|FG000|NOT COMPLETED|Overall Study||14
6362543|NCT00689572|7272697|FG001|NOT COMPLETED|Overall Study||21
6362544|NCT00689611|7272705|FG000|STARTED|Overall Study||200
6362545|NCT00689611|7272706|FG001|STARTED|Overall Study||192
6362546|NCT00689611|7272705|FG000|COMPLETED|Overall Study||159
6362547|NCT00689611|7272706|FG001|COMPLETED|Overall Study||146
6362548|NCT00689611|7272705|FG000|NOT COMPLETED|Overall Study||41
6362549|NCT00689611|7272706|FG001|NOT COMPLETED|Overall Study||46
6362550|NCT00689728|7272715|FG000|STARTED|Double-Blind Treatment||35
6362551|NCT00689728|7272716|FG001|STARTED|Double-Blind Treatment||30
6362552|NCT00689728|7272717|FG002|STARTED|Double-Blind Treatment||35
6362553|NCT00689728|7272715|FG000|COMPLETED|Double-Blind Treatment||31
6362554|NCT00689728|7272716|FG001|COMPLETED|Double-Blind Treatment||26
6362555|NCT00689728|7272717|FG002|COMPLETED|Double-Blind Treatment||30
6362556|NCT00689728|7272715|FG000|NOT COMPLETED|Double-Blind Treatment||4
6362557|NCT00689728|7272716|FG001|NOT COMPLETED|Double-Blind Treatment||4
6362558|NCT00689728|7272717|FG002|NOT COMPLETED|Double-Blind Treatment||5
6362559|NCT00689728|7272715|FG000|STARTED|Rescue||31
6362560|NCT00689728|7272716|FG001|STARTED|Rescue||26
6362561|NCT00689728|7272717|FG002|STARTED|Rescue||30
6362562|NCT00689728|7272715|FG000|COMPLETED|Rescue||30
6362563|NCT00689728|7272716|FG001|COMPLETED|Rescue||24
6362564|NCT00689728|7272717|FG002|COMPLETED|Rescue||29
6362565|NCT00689728|7272715|FG000|NOT COMPLETED|Rescue||1
6362566|NCT00689728|7272716|FG001|NOT COMPLETED|Rescue||2
6362567|NCT00689728|7272717|FG002|NOT COMPLETED|Rescue||1
6362568|NCT00689728|7272715|FG000|STARTED|Optional Follow-Up|21 participants who completed the rescue period did not enter the optional follow-up period.|9
6362569|NCT00689728|7272716|FG001|STARTED|Optional Follow-Up|13 participants who completed the rescue period did not enter the optional follow-up period.|11
6362570|NCT00689728|7272717|FG002|STARTED|Optional Follow-Up|19 participants who completed the rescue period did not enter the optional follow-up period.|10
6362571|NCT00689728|7272715|FG000|COMPLETED|Optional Follow-Up||6
6362572|NCT00689728|7272716|FG001|COMPLETED|Optional Follow-Up||5
6362573|NCT00689728|7272717|FG002|COMPLETED|Optional Follow-Up||4
6362574|NCT00689728|7272715|FG000|NOT COMPLETED|Optional Follow-Up||3
6362575|NCT00689728|7272716|FG001|NOT COMPLETED|Optional Follow-Up||6
6362576|NCT00689728|7272717|FG002|NOT COMPLETED|Optional Follow-Up||6
6362577|NCT00689793|7272748|FG000|STARTED|Overall Study||78
6362578|NCT00689793|7272749|FG001|STARTED|Overall Study||76
6362579|NCT00689793|7272748|FG000|COMPLETED|Overall Study||74
6362580|NCT00689793|7272749|FG001|COMPLETED|Overall Study||71
6362581|NCT00689793|7272748|FG000|NOT COMPLETED|Overall Study||4
6362582|NCT00689793|7272749|FG001|NOT COMPLETED|Overall Study||5
6362583|NCT00689819|7272759|FG000|STARTED|Overall Study||65
6362584|NCT00689819|7272760|FG001|STARTED|Overall Study||58
6362585|NCT00689819|7272759|FG000|COMPLETED|Overall Study||45
6362586|NCT00689819|7272760|FG001|COMPLETED|Overall Study||43
6362587|NCT00689819|7272759|FG000|NOT COMPLETED|Overall Study||20
6362588|NCT00689819|7272760|FG001|NOT COMPLETED|Overall Study||15
6362589|NCT00689871|7272770|FG000|STARTED|Overall Study|908 Implants|455
6362590|NCT00689871|7272771|FG001|STARTED|Overall Study|127 Implants|98
6362591|NCT00689871|7272772|FG002|STARTED|Overall Study|288 Implants|147
6362592|NCT00689871|7272773|FG003|STARTED|Overall Study|25 Implants|15
6362593|NCT00689871|7272770|FG000|COMPLETED|Overall Study|35 Patients discontinued|280
6362594|NCT00689871|7272771|FG001|COMPLETED|Overall Study|35 Patients discontinued|46
6362595|NCT00689871|7272772|FG002|COMPLETED|Overall Study|28 Patients discontinued|74
6362596|NCT00689871|7272773|FG003|COMPLETED|Overall Study|4 Patients discontinued|8
6362597|NCT00689871|7272770|FG000|NOT COMPLETED|Overall Study||175
6362598|NCT00689871|7272771|FG001|NOT COMPLETED|Overall Study||52
6362599|NCT00689871|7272772|FG002|NOT COMPLETED|Overall Study||73
6362600|NCT00689871|7272773|FG003|NOT COMPLETED|Overall Study||7
6362601|NCT00689936|7272786|FG000|STARTED|Active Treatment Phase||535
6362602|NCT00689936|7272787|FG001|STARTED|Active Treatment Phase||541
6362603|NCT00689936|7272788|FG002|STARTED|Active Treatment Phase||547
6362604|NCT00689936|7272786|FG000|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
6362605|NCT00689936|7272787|FG001|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
6362606|NCT00689936|7272788|FG002|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
6362607|NCT00689936|7272786|FG000|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
6362608|NCT00689936|7272787|FG001|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
6362609|NCT00689936|7272788|FG002|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
6362610|NCT00689936|7272786|FG000|COMPLETED|Active Treatment Phase||0
6362611|NCT00689936|7272787|FG001|COMPLETED|Active Treatment Phase||0
6362612|NCT00689936|7272788|FG002|COMPLETED|Active Treatment Phase||0
6362613|NCT00689936|7272786|FG000|NOT COMPLETED|Active Treatment Phase||535
6362614|NCT00689936|7272787|FG001|NOT COMPLETED|Active Treatment Phase||541
6362615|NCT00689936|7272788|FG002|NOT COMPLETED|Active Treatment Phase||547
6362616|NCT00689936|7272786|FG000|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
6362617|NCT00689936|7272787|FG001|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
6362618|NCT00689936|7272788|FG002|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
6362619|NCT00689936|7272786|FG000|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
6362620|NCT00689936|7272787|FG001|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
6362621|NCT00689936|7272788|FG002|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
6362622|NCT00689936|7272786|FG000|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
6362623|NCT00689936|7272787|FG001|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
6362624|NCT00689936|7272788|FG002|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
6362625|NCT00689936|7272786|FG000|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
6362626|NCT00689936|7272787|FG001|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
6362627|NCT00689936|7272788|FG002|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
6362628|NCT00689936|7272786|FG000|COMPLETED|Long-Term Follow Up Phase||255
6362629|NCT00689936|7272787|FG001|COMPLETED|Long-Term Follow Up Phase||275
6362630|NCT00689936|7272788|FG002|COMPLETED|Long-Term Follow Up Phase||315
6362631|NCT00689936|7272786|FG000|NOT COMPLETED|Long-Term Follow Up Phase||127
6362632|NCT00689936|7272787|FG001|NOT COMPLETED|Long-Term Follow Up Phase||188
6362633|NCT00689936|7272788|FG002|NOT COMPLETED|Long-Term Follow Up Phase||144
6362634|NCT00690040|7272798|FG000|STARTED|Overall Study||145
6362635|NCT00690040|7272799|FG001|STARTED|Overall Study||148
6362636|NCT00690040|7272798|FG000|COMPLETED|Overall Study||145
6362637|NCT00690040|7272799|FG001|COMPLETED|Overall Study||148
6362638|NCT00690040|7272798|FG000|NOT COMPLETED|Overall Study||0
6362639|NCT00690040|7272799|FG001|NOT COMPLETED|Overall Study||0
6362640|NCT00690235|7272807|FG000|STARTED|Overall Study||17
6362641|NCT00690235|7272808|FG001|STARTED|Overall Study||16
6362642|NCT00690235|7272807|FG000|COMPLETED|Overall Study||12
6362643|NCT00690235|7272808|FG001|COMPLETED|Overall Study||12
6362644|NCT00690235|7272807|FG000|NOT COMPLETED|Overall Study||5
6362645|NCT00690235|7272808|FG001|NOT COMPLETED|Overall Study||4
6362646|NCT00690274|7272816|FG000|STARTED|Overall Study||29
6362647|NCT00690274|7272817|FG001|STARTED|Overall Study||23
6362648|NCT00690274|7272816|FG000|COMPLETED|Overall Study||23
6362649|NCT00690274|7272817|FG001|COMPLETED|Overall Study||15
6362650|NCT00690274|7272816|FG000|NOT COMPLETED|Overall Study||6
6362651|NCT00690274|7272817|FG001|NOT COMPLETED|Overall Study||8
6362652|NCT00690339|7272827|FG000|STARTED|Overall Study||492
6362653|NCT00690339|7272828|FG001|STARTED|Overall Study||225
6362654|NCT00690339|7272829|FG002|STARTED|Overall Study||156
6362655|NCT00690339|7272830|FG003|STARTED|Overall Study||68
6362656|NCT00690339|7272827|FG000|COMPLETED|Overall Study||375
6362657|NCT00690339|7272828|FG001|COMPLETED|Overall Study||144
6362658|NCT00690339|7272829|FG002|COMPLETED|Overall Study||99
6362659|NCT00690339|7272830|FG003|COMPLETED|Overall Study||43
6362660|NCT00690339|7272827|FG000|NOT COMPLETED|Overall Study||117
6362661|NCT00690339|7272828|FG001|NOT COMPLETED|Overall Study||81
6362662|NCT00690339|7272829|FG002|NOT COMPLETED|Overall Study||57
6362663|NCT00690339|7272830|FG003|NOT COMPLETED|Overall Study||25
6362664|NCT00690378|7272842|FG000|STARTED|Overall Study|Randomized|69
6362665|NCT00690378|7272843|FG001|STARTED|Overall Study|Randomized|68
6362666|NCT00690378|7272842|FG000|Treated|Overall Study||68
6362667|NCT00690378|7272843|FG001|Treated|Overall Study||67
6362668|NCT00690378|7272842|FG000|COMPLETED|Overall Study|Up to Late follow up (LFU) visit|49
6362669|NCT00690378|7272843|FG001|COMPLETED|Overall Study|Up to LFU visit|54
6362670|NCT00690378|7272842|FG000|NOT COMPLETED|Overall Study||20
6362671|NCT00690378|7272843|FG001|NOT COMPLETED|Overall Study||14
6362672|NCT00690430|7272851|FG000|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
6362673|NCT00690430|7272852|FG001|STARTED|Core Phase||57
6362674|NCT00690430|7272853|FG002|STARTED|Core Phase|This arm belongs to Extension Phase.|0
6362675|NCT00690430|7272851|FG000|COMPLETED|Core Phase||35
6362676|NCT00690430|7272852|FG001|COMPLETED|Core Phase||34
6362677|NCT00690430|7272853|FG002|COMPLETED|Core Phase||0
6362678|NCT00690430|7272851|FG000|NOT COMPLETED|Core Phase||18
6362679|NCT00690430|7272852|FG001|NOT COMPLETED|Core Phase||23
6362680|NCT00690430|7272853|FG002|NOT COMPLETED|Core Phase||0
6362681|NCT00690430|7272851|FG000|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
6362682|NCT00690430|7272852|FG001|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
6362683|NCT00690430|7272853|FG002|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
6362684|NCT00690430|7272851|FG000|COMPLETED|Extension Phase||2
6362685|NCT00690430|7272852|FG001|COMPLETED|Extension Phase||1
6362686|NCT00690430|7272853|FG002|COMPLETED|Extension Phase||2
6362687|NCT00690430|7272851|FG000|NOT COMPLETED|Extension Phase||18
6362688|NCT00690430|7272852|FG001|NOT COMPLETED|Extension Phase||5
6362689|NCT00690430|7272853|FG002|NOT COMPLETED|Extension Phase||13
6362690|NCT00690443|7272864|FG000|STARTED|Overall Study||23
6362691|NCT00690443|7272865|FG001|STARTED|Overall Study||21
6362692|NCT00690443|7272864|FG000|COMPLETED|Overall Study||22
6362693|NCT00690443|7272865|FG001|COMPLETED|Overall Study||19
6362694|NCT00690443|7272864|FG000|NOT COMPLETED|Overall Study||1
6362695|NCT00690443|7272865|FG001|NOT COMPLETED|Overall Study||2
6362696|NCT00690482|7272873|FG000|STARTED|Overall Study||61
6362697|NCT00690482|7272874|FG001|STARTED|Overall Study||57
6362698|NCT00690482|7272873|FG000|COMPLETED|Overall Study||57
6362699|NCT00690482|7272874|FG001|COMPLETED|Overall Study||54
6362700|NCT00690482|7272873|FG000|NOT COMPLETED|Overall Study||4
6362701|NCT00690482|7272874|FG001|NOT COMPLETED|Overall Study||3
6362702|NCT00690495|7272882|FG000|STARTED|Overall Study||50
6362703|NCT00690495|7272883|FG001|STARTED|Overall Study||50
6362704|NCT00690495|7272882|FG000|Primary Endpoint|Overall Study||50
6362705|NCT00690495|7272883|FG001|Primary Endpoint|Overall Study||50
6362706|NCT00690495|7272882|FG000|COMPLETED|Overall Study||50
6362707|NCT00690495|7272883|FG001|COMPLETED|Overall Study||50
6362708|NCT00690495|7272882|FG000|NOT COMPLETED|Overall Study||0
6362709|NCT00690495|7272883|FG001|NOT COMPLETED|Overall Study||0
6362710|NCT00690573|7272889|FG000|STARTED|Overall Study||25
6362711|NCT00690573|7272889|FG000|COMPLETED|Overall Study||16
6362712|NCT00690573|7272889|FG000|NOT COMPLETED|Overall Study||9
6362713|NCT00690612|7272893|FG000|STARTED|Overall Study||35
6362714|NCT00690612|7272893|FG000|COMPLETED|Overall Study||32
6362715|NCT00690612|7272893|FG000|NOT COMPLETED|Overall Study||3
6362716|NCT00690755|7272904|FG000|STARTED|Overall Study||30
6362717|NCT00690755|7272905|FG001|STARTED|Overall Study||0
6362718|NCT00690755|7272906|FG002|STARTED|Overall Study||97
6362719|NCT00690755|7272907|FG003|STARTED|Overall Study||20
6362720|NCT00690755|7272908|FG004|STARTED|Overall Study||0
6362721|NCT00690755|7272909|FG005|STARTED|Overall Study||10
6362722|NCT00690755|7272910|FG006|STARTED|Overall Study||0
6362723|NCT00690755|7272904|FG000|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
6560533|NCT01787292|7483314|FG000|NOT COMPLETED|Home Based Exercise Program||3
6560534|NCT01787292|7483315|FG001|NOT COMPLETED|Home Based Exercise Program||1
6560535|NCT01787331|7483326|FG000|STARTED|Overall Study||21
6362724|NCT00690755|7272905|FG001|COMPLETED|Overall Study||0
6362725|NCT00690755|7272906|FG002|COMPLETED|Overall Study||51
6362726|NCT00690755|7272907|FG003|COMPLETED|Overall Study||15
6362727|NCT00690755|7272908|FG004|COMPLETED|Overall Study||0
6362728|NCT00690755|7272909|FG005|COMPLETED|Overall Study||6
6362729|NCT00690755|7272910|FG006|COMPLETED|Overall Study||0
6362730|NCT00690755|7272904|FG000|NOT COMPLETED|Overall Study||2
6362731|NCT00690755|7272905|FG001|NOT COMPLETED|Overall Study||0
6362732|NCT00690755|7272906|FG002|NOT COMPLETED|Overall Study||46
6362733|NCT00690755|7272907|FG003|NOT COMPLETED|Overall Study||5
6362734|NCT00690755|7272908|FG004|NOT COMPLETED|Overall Study||0
6362735|NCT00690755|7272909|FG005|NOT COMPLETED|Overall Study||4
6362736|NCT00690755|7272910|FG006|NOT COMPLETED|Overall Study||0
6362737|NCT00690794|7272928|FG000|STARTED|Overall Study||363
6362738|NCT00690794|7272929|FG001|STARTED|Overall Study||363
6362739|NCT00690794|7272928|FG000|COMPLETED|Overall Study||342
6362740|NCT00690794|7272929|FG001|COMPLETED|Overall Study||328
6362741|NCT00690794|7272928|FG000|NOT COMPLETED|Overall Study||21
6362742|NCT00690794|7272929|FG001|NOT COMPLETED|Overall Study||35
6362743|NCT00690820|7272937|FG000|STARTED|Period 1||8
6362744|NCT00690820|7272938|FG001|STARTED|Period 1||9
6362745|NCT00690820|7272937|FG000|COMPLETED|Period 1||8
6362746|NCT00690820|7272938|FG001|COMPLETED|Period 1||8
6362747|NCT00690820|7272937|FG000|NOT COMPLETED|Period 1||0
6362748|NCT00690820|7272938|FG001|NOT COMPLETED|Period 1||1
6362749|NCT00690820|7272937|FG000|STARTED|Period 2||8
6362750|NCT00690820|7272938|FG001|STARTED|Period 2||8
6362751|NCT00690820|7272937|FG000|COMPLETED|Period 2||8
6362752|NCT00690820|7272938|FG001|COMPLETED|Period 2||8
6362753|NCT00690820|7272937|FG000|NOT COMPLETED|Period 2||0
6362754|NCT00690820|7272938|FG001|NOT COMPLETED|Period 2||0
6362755|NCT00690833|7272944|FG000|STARTED|Overall Study||41
6362756|NCT00690833|7272944|FG000|COMPLETED|Overall Study||39
6362757|NCT00690833|7272944|FG000|NOT COMPLETED|Overall Study||2
6362758|NCT00690898|7272948|FG000|STARTED|SCREENING|Total of patients screened for the study.|108
6362759|NCT00690898|7272948|FG000|COMPLETED|SCREENING|Number of patients included in the study.|90
6362760|NCT00690898|7272948|FG000|NOT COMPLETED|SCREENING||18
6362761|NCT00690898|7272948|FG000|STARTED|TREATMENT|Total number of patients treated.|90
6362762|NCT00690898|7272948|FG000|COMPLETED|TREATMENT||64
6362763|NCT00690898|7272948|FG000|NOT COMPLETED|TREATMENT||26
6362764|NCT00690924|7272952|FG000|STARTED|Overall Study||16
6362765|NCT00690924|7272952|FG000|COMPLETED|Overall Study||16
6362766|NCT00690924|7272952|FG000|NOT COMPLETED|Overall Study||0
6362767|NCT00691002|7272960|FG000|STARTED|8-week, Double-blind, 4-arm||353
6362768|NCT00691002|7272961|FG001|STARTED|8-week, Double-blind, 4-arm||342
6362769|NCT00691002|7272962|FG002|STARTED|8-week, Double-blind, 4-arm||363
6362770|NCT00691002|7272963|FG003|STARTED|8-week, Double-blind, 4-arm||181
6362771|NCT00691002|7272964|FG004|STARTED|8-week, Double-blind, 4-arm||0
6362772|NCT00691002|7272960|FG000|COMPLETED|8-week, Double-blind, 4-arm||325
6362773|NCT00691002|7272961|FG001|COMPLETED|8-week, Double-blind, 4-arm||308
6362774|NCT00691002|7272962|FG002|COMPLETED|8-week, Double-blind, 4-arm||340
6362775|NCT00691002|7272963|FG003|COMPLETED|8-week, Double-blind, 4-arm||169
6362776|NCT00691002|7272964|FG004|COMPLETED|8-week, Double-blind, 4-arm||0
6362777|NCT00691002|7272960|FG000|NOT COMPLETED|8-week, Double-blind, 4-arm||28
6362778|NCT00691002|7272961|FG001|NOT COMPLETED|8-week, Double-blind, 4-arm||34
6362779|NCT00691002|7272962|FG002|NOT COMPLETED|8-week, Double-blind, 4-arm||23
6362780|NCT00691002|7272963|FG003|NOT COMPLETED|8-week, Double-blind, 4-arm||12
6362781|NCT00691002|7272964|FG004|NOT COMPLETED|8-week, Double-blind, 4-arm||0
6362782|NCT00691002|7272960|FG000|STARTED|52-week, Open-label, Single Arm||454
6362783|NCT00691002|7272961|FG001|STARTED|52-week, Open-label, Single Arm||0
6362784|NCT00691002|7272962|FG002|STARTED|52-week, Open-label, Single Arm||0
6362785|NCT00691002|7272963|FG003|STARTED|52-week, Open-label, Single Arm||0
6362786|NCT00691002|7272964|FG004|STARTED|52-week, Open-label, Single Arm||0
6362787|NCT00691002|7272960|FG000|COMPLETED|52-week, Open-label, Single Arm||403
6362788|NCT00691002|7272961|FG001|COMPLETED|52-week, Open-label, Single Arm||0
6362789|NCT00691002|7272962|FG002|COMPLETED|52-week, Open-label, Single Arm||0
6362790|NCT00691002|7272963|FG003|COMPLETED|52-week, Open-label, Single Arm||0
6362791|NCT00691002|7272964|FG004|COMPLETED|52-week, Open-label, Single Arm||0
6362792|NCT00691002|7272960|FG000|NOT COMPLETED|52-week, Open-label, Single Arm||51
6362793|NCT00691002|7272961|FG001|NOT COMPLETED|52-week, Open-label, Single Arm||0
6362794|NCT00691002|7272962|FG002|NOT COMPLETED|52-week, Open-label, Single Arm||0
6362795|NCT00691002|7272963|FG003|NOT COMPLETED|52-week, Open-label, Single Arm||0
6362796|NCT00691002|7272964|FG004|NOT COMPLETED|52-week, Open-label, Single Arm||0
6362797|NCT00691015|7272975|FG000|STARTED|Overall Study||48
6362798|NCT00691015|7272975|FG000|COMPLETED|Overall Study||47
6362799|NCT00691015|7272975|FG000|NOT COMPLETED|Overall Study||1
6362800|NCT00691028|7272982|FG000|STARTED|Open-label Period||0
6362801|NCT00691028|7272983|FG001|STARTED|Open-label Period||0
6362802|NCT00691028|7272984|FG002|STARTED|Open-label Period||0
6362803|NCT00691028|7272985|FG003|STARTED|Open-label Period||327
6362804|NCT00691028|7272982|FG000|COMPLETED|Open-label Period||0
6362805|NCT00691028|7272983|FG001|COMPLETED|Open-label Period||0
6362806|NCT00691028|7272984|FG002|COMPLETED|Open-label Period||0
6362807|NCT00691028|7272985|FG003|COMPLETED|Open-label Period||307
6362808|NCT00691028|7272982|FG000|NOT COMPLETED|Open-label Period||0
6362809|NCT00691028|7272983|FG001|NOT COMPLETED|Open-label Period||0
6362810|NCT00691028|7272984|FG002|NOT COMPLETED|Open-label Period||0
6362811|NCT00691028|7272985|FG003|NOT COMPLETED|Open-label Period||20
6362812|NCT00691028|7272982|FG000|STARTED|Double-blind Period||99
6362813|NCT00691028|7272983|FG001|STARTED|Double-blind Period||104
6362814|NCT00691028|7272984|FG002|STARTED|Double-blind Period||104
6362815|NCT00691028|7272985|FG003|STARTED|Double-blind Period||0
6362816|NCT00691028|7272982|FG000|COMPLETED|Double-blind Period||86
6362817|NCT00691028|7272983|FG001|COMPLETED|Double-blind Period||91
6362818|NCT00691028|7272984|FG002|COMPLETED|Double-blind Period||95
6362819|NCT00691028|7272985|FG003|COMPLETED|Double-blind Period||0
6362820|NCT00691028|7272982|FG000|NOT COMPLETED|Double-blind Period||13
6362821|NCT00691028|7272983|FG001|NOT COMPLETED|Double-blind Period||13
6362822|NCT00691028|7272984|FG002|NOT COMPLETED|Double-blind Period||9
6362823|NCT00691028|7272985|FG003|NOT COMPLETED|Double-blind Period||0
6362824|NCT00691054|7272997|FG000|STARTED|Overall Study||20
6777812|NCT03797144|7705781|FG001|COMPLETED|24 Month||0
6777813|NCT03797144|7705780|FG000|NOT COMPLETED|24 Month||1
6777814|NCT03797144|7705781|FG001|NOT COMPLETED|24 Month||1
6777815|NCT03782571|7705788|FG000|STARTED|Period 1||6
6777816|NCT03782571|7705789|FG001|STARTED|Period 1||6
6362825|NCT00691054|7272997|FG000|COMPLETED|Overall Study||19
6560536|NCT01787331|7483326|FG000|COMPLETED|Overall Study||19
6560537|NCT01787331|7483326|FG000|NOT COMPLETED|Overall Study||2
6560538|NCT01787383|7483332|FG000|STARTED|Overall Study||101
6560539|NCT01787383|7483333|FG001|STARTED|Overall Study||98
6560540|NCT01787383|7483332|FG000|COMPLETED|Overall Study||92
6560541|NCT01787383|7483333|FG001|COMPLETED|Overall Study||76
6362826|NCT00691054|7272997|FG000|NOT COMPLETED|Overall Study||1
6362827|NCT00691093|7273003|FG000|STARTED|Overall Study||823
6362828|NCT00691093|7273003|FG000|COMPLETED|Overall Study||816
6362829|NCT00691093|7273003|FG000|NOT COMPLETED|Overall Study||7
6362830|NCT00691132|7273014|FG000|STARTED|Overall Study||53
6362831|NCT00691132|7273015|FG001|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
6655089|NCT02450526|7585095|FG004|COMPLETED|OL Period (Cycles 2-5)||424
6655090|NCT02450526|7585091|FG000|NOT COMPLETED|OL Period (Cycles 2-5)||0
6655091|NCT02450526|7585092|FG001|NOT COMPLETED|OL Period (Cycles 2-5)||0
6655092|NCT02450526|7585093|FG002|NOT COMPLETED|OL Period (Cycles 2-5)||0
6777817|NCT03782571|7705790|FG002|STARTED|Period 1||6
6777818|NCT03782571|7705791|FG003|STARTED|Period 1||7
6362832|NCT00691132|7273014|FG000|COMPLETED|Overall Study||41
6362833|NCT00691132|7273015|FG001|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
6362834|NCT00691132|7273014|FG000|NOT COMPLETED|Overall Study||12
6362835|NCT00691132|7273015|FG001|NOT COMPLETED|Overall Study||13
6362836|NCT00691197|7273033|FG000|STARTED|Overall Study||166
6362837|NCT00691197|7273034|FG001|STARTED|Overall Study||80
6362838|NCT00691197|7273033|FG000|COMPLETED|Overall Study||155
6362839|NCT00691197|7273034|FG001|COMPLETED|Overall Study||75
6362840|NCT00691197|7273033|FG000|NOT COMPLETED|Overall Study||11
6362841|NCT00691197|7273034|FG001|NOT COMPLETED|Overall Study||5
6362842|NCT00691210|7273048|FG000|STARTED|Overall Study||3
6362843|NCT00691210|7273049|FG001|STARTED|Overall Study||5
6362844|NCT00691210|7273050|FG002|STARTED|Overall Study||3
6362845|NCT00691210|7273051|FG003|STARTED|Overall Study||9
6362846|NCT00691210|7273052|FG004|STARTED|Overall Study||5
6362847|NCT00691210|7273053|FG005|STARTED|Overall Study||7
6362848|NCT00691210|7273054|FG006|STARTED|Overall Study||6
6362849|NCT00691210|7273055|FG007|STARTED|Overall Study||0
6362850|NCT00691210|7273048|FG000|COMPLETED|Overall Study||3
6362851|NCT00691210|7273049|FG001|COMPLETED|Overall Study||5
6362852|NCT00691210|7273050|FG002|COMPLETED|Overall Study||3
6362853|NCT00691210|7273051|FG003|COMPLETED|Overall Study||6
6362854|NCT00691210|7273052|FG004|COMPLETED|Overall Study||5
6362855|NCT00691210|7273053|FG005|COMPLETED|Overall Study||6
6362856|NCT00691210|7273054|FG006|COMPLETED|Overall Study||6
6362857|NCT00691210|7273055|FG007|COMPLETED|Overall Study||0
6362858|NCT00691210|7273048|FG000|NOT COMPLETED|Overall Study||0
6362859|NCT00691210|7273049|FG001|NOT COMPLETED|Overall Study||0
6362860|NCT00691210|7273050|FG002|NOT COMPLETED|Overall Study||0
6362861|NCT00691210|7273051|FG003|NOT COMPLETED|Overall Study||3
6362862|NCT00691210|7273052|FG004|NOT COMPLETED|Overall Study||0
6362863|NCT00691210|7273053|FG005|NOT COMPLETED|Overall Study||1
6362864|NCT00691210|7273054|FG006|NOT COMPLETED|Overall Study||0
6362865|NCT00691210|7273055|FG007|NOT COMPLETED|Overall Study||0
6362866|NCT00691301|7273073|FG000|STARTED|Overall Study||55
6560542|NCT01787383|7483332|FG000|NOT COMPLETED|Overall Study||9
6777819|NCT03782571|7705788|FG000|COMPLETED|Period 1||5
6362867|NCT00691301|7273073|FG000|COMPLETED|Overall Study||1
6362868|NCT00691301|7273073|FG000|NOT COMPLETED|Overall Study||54
6362869|NCT00691327|7273085|FG000|STARTED|Overall Study||45055
6362870|NCT00691327|7273086|FG001|STARTED|Overall Study||39274
6362871|NCT00691327|7273085|FG000|COMPLETED|Overall Study||42214
6362872|NCT00691327|7273086|FG001|COMPLETED|Overall Study||36766
6362873|NCT00691327|7273085|FG000|NOT COMPLETED|Overall Study||2841
6560543|NCT01787383|7483333|FG001|NOT COMPLETED|Overall Study||22
6560544|NCT01787461|7483349|FG000|STARTED|Overall Study||96
6362874|NCT00691327|7273086|FG001|NOT COMPLETED|Overall Study||2508
6362875|NCT00691483|7273094|FG000|STARTED|Overall Study||493
6560545|NCT01787461|7483350|FG001|STARTED|Overall Study||98
6560546|NCT01787461|7483349|FG000|COMPLETED|Overall Study||82
6362876|NCT00691483|7273095|FG001|STARTED|Overall Study||166
6362877|NCT00691483|7273094|FG000|Received Treatment|Overall Study||486
6362878|NCT00691483|7273095|FG001|Received Treatment|Overall Study||165
6362879|NCT00691483|7273094|FG000|COMPLETED|Overall Study|Completed refers to completion of the study.|425
6362880|NCT00691483|7273095|FG001|COMPLETED|Overall Study||141
6362881|NCT00691483|7273094|FG000|NOT COMPLETED|Overall Study||68
6362882|NCT00691483|7273095|FG001|NOT COMPLETED|Overall Study||25
6362883|NCT00691600|7273103|FG000|STARTED|Overall Study||12
6362884|NCT00691600|7273104|FG001|STARTED|Overall Study||11
6362885|NCT00691600|7273103|FG000|COMPLETED|Overall Study||12
6362886|NCT00691600|7273104|FG001|COMPLETED|Overall Study||11
6362887|NCT00691600|7273103|FG000|NOT COMPLETED|Overall Study||0
6362888|NCT00691600|7273104|FG001|NOT COMPLETED|Overall Study||0
6362889|NCT00691665|7273112|FG000|STARTED|Overall Study||65
6362890|NCT00691665|7273113|FG001|STARTED|Overall Study||65
6362891|NCT00691665|7273112|FG000|COMPLETED|Overall Study||65
6362892|NCT00691665|7273113|FG001|COMPLETED|Overall Study||65
6362893|NCT00691665|7273112|FG000|NOT COMPLETED|Overall Study||0
6362894|NCT00691665|7273113|FG001|NOT COMPLETED|Overall Study||0
6362895|NCT00691704|7273119|FG000|STARTED|Induction Therapy||18
6362896|NCT00691704|7273119|FG000|COMPLETED|Induction Therapy||16
6362897|NCT00691704|7273119|FG000|NOT COMPLETED|Induction Therapy||2
6362898|NCT00691704|7273119|FG000|STARTED|Two Years of Maintenance Therapy||16
6362899|NCT00691704|7273119|FG000|COMPLETED|Two Years of Maintenance Therapy||3
6362900|NCT00691704|7273119|FG000|NOT COMPLETED|Two Years of Maintenance Therapy||13
6362901|NCT00691808|7273126|FG000|STARTED|Overall Study||35
6362902|NCT00691808|7273127|FG001|STARTED|Overall Study||36
6362903|NCT00691808|7273128|FG002|STARTED|Overall Study||32
6362904|NCT00691808|7273126|FG000|COMPLETED|Overall Study||35
6362905|NCT00691808|7273127|FG001|COMPLETED|Overall Study||35
6362906|NCT00691808|7273128|FG002|COMPLETED|Overall Study||32
6362907|NCT00691808|7273126|FG000|NOT COMPLETED|Overall Study||0
6362908|NCT00691808|7273127|FG001|NOT COMPLETED|Overall Study||1
6362909|NCT00691808|7273128|FG002|NOT COMPLETED|Overall Study||0
6362910|NCT00691938|7273143|FG000|STARTED|Overall Study||5
6362911|NCT00691938|7273144|FG001|STARTED|Overall Study||3
6362912|NCT00691938|7273145|FG002|STARTED|Overall Study||6
6362913|NCT00691938|7273146|FG003|STARTED|Overall Study||8
6362914|NCT00691938|7273147|FG004|STARTED|Overall Study||10
6362915|NCT00691938|7273148|FG005|STARTED|Overall Study||6
6362916|NCT00691938|7273149|FG006|STARTED|Overall Study||14
6362917|NCT00691938|7273143|FG000|COMPLETED|Overall Study||4
6362918|NCT00691938|7273144|FG001|COMPLETED|Overall Study||3
6362919|NCT00691938|7273145|FG002|COMPLETED|Overall Study||6
6362920|NCT00691938|7273146|FG003|COMPLETED|Overall Study||8
6362921|NCT00691938|7273147|FG004|COMPLETED|Overall Study||10
6362922|NCT00691938|7273148|FG005|COMPLETED|Overall Study||6
6362923|NCT00691938|7273149|FG006|COMPLETED|Overall Study||14
6362924|NCT00691938|7273143|FG000|NOT COMPLETED|Overall Study||1
6362925|NCT00691938|7273144|FG001|NOT COMPLETED|Overall Study||0
6362926|NCT00691938|7273145|FG002|NOT COMPLETED|Overall Study||0
6362927|NCT00691938|7273146|FG003|NOT COMPLETED|Overall Study||0
6362928|NCT00691938|7273147|FG004|NOT COMPLETED|Overall Study||0
6362929|NCT00691938|7273148|FG005|NOT COMPLETED|Overall Study||0
6362930|NCT00691938|7273149|FG006|NOT COMPLETED|Overall Study||0
6362931|NCT00692185|7273162|FG000|STARTED|Overall Study||11
6362932|NCT00692185|7273163|FG001|STARTED|Overall Study||12
6362933|NCT00692185|7273162|FG000|COMPLETED|Overall Study||8
6362934|NCT00692185|7273163|FG001|COMPLETED|Overall Study||9
6362935|NCT00692185|7273162|FG000|NOT COMPLETED|Overall Study||3
6362936|NCT00692185|7273163|FG001|NOT COMPLETED|Overall Study||3
6362937|NCT00692198|7273173|FG000|STARTED|Overall Study||368
6362938|NCT00692198|7273174|FG001|STARTED|Overall Study||370
6362939|NCT00692198|7273173|FG000|COMPLETED|Overall Study||368
6362940|NCT00692198|7273174|FG001|COMPLETED|Overall Study||370
6362941|NCT00692198|7273173|FG000|NOT COMPLETED|Overall Study||0
6362942|NCT00692198|7273174|FG001|NOT COMPLETED|Overall Study||0
6362943|NCT00692211|7273183|FG000|STARTED|Overall Study||202
6362944|NCT00692211|7273184|FG001|STARTED|Overall Study||202
6362945|NCT00692211|7273183|FG000|COMPLETED|Overall Study||202
6362946|NCT00692211|7273184|FG001|COMPLETED|Overall Study||202
6362947|NCT00692211|7273183|FG000|NOT COMPLETED|Overall Study||0
6362948|NCT00692211|7273184|FG001|NOT COMPLETED|Overall Study||0
6362949|NCT00692237|7273192|FG000|STARTED|Overall Study||30
6362950|NCT00692237|7273193|FG001|STARTED|Overall Study||29
6362951|NCT00692237|7273192|FG000|COMPLETED|Overall Study||29
6362952|NCT00692237|7273193|FG001|COMPLETED|Overall Study||25
6362953|NCT00692237|7273192|FG000|NOT COMPLETED|Overall Study||1
6362954|NCT00692237|7273193|FG001|NOT COMPLETED|Overall Study||4
6362955|NCT00692276|7273201|FG000|STARTED|Randomized Population||190
6362956|NCT00692276|7273202|FG001|STARTED|Randomized Population||201
6362957|NCT00692276|7273201|FG000|COMPLETED|Randomized Population||190
6362958|NCT00692276|7273202|FG001|COMPLETED|Randomized Population||201
6362959|NCT00692276|7273201|FG000|NOT COMPLETED|Randomized Population||0
6362960|NCT00692276|7273202|FG001|NOT COMPLETED|Randomized Population||0
6362961|NCT00692276|7273201|FG000|STARTED|Completed 24 Months||190
6362962|NCT00692276|7273202|FG001|STARTED|Completed 24 Months||201
6362963|NCT00692276|7273201|FG000|COMPLETED|Completed 24 Months||183
6362964|NCT00692276|7273202|FG001|COMPLETED|Completed 24 Months||187
6362965|NCT00692276|7273201|FG000|NOT COMPLETED|Completed 24 Months||7
6362966|NCT00692276|7273202|FG001|NOT COMPLETED|Completed 24 Months||14
6362967|NCT00692341|7273211|FG000|STARTED|Overall Study||8
6362968|NCT00692341|7273212|FG001|STARTED|Overall Study||8
6362969|NCT00692341|7273213|FG002|STARTED|Overall Study||8
6362970|NCT00692341|7273211|FG000|COMPLETED|Overall Study||8
6362971|NCT00692341|7273212|FG001|COMPLETED|Overall Study||8
6362972|NCT00692341|7273213|FG002|COMPLETED|Overall Study||8
6362973|NCT00692341|7273211|FG000|NOT COMPLETED|Overall Study||0
6362974|NCT00692341|7273212|FG001|NOT COMPLETED|Overall Study||0
6362975|NCT00692341|7273213|FG002|NOT COMPLETED|Overall Study||0
6362976|NCT00692406|7273221|FG000|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
6362977|NCT00692406|7273221|FG000|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
6362978|NCT00692406|7273221|FG000|NOT COMPLETED|Overall Study||57
6362979|NCT00692419|7273227|FG000|STARTED|Overall Study||100
6362980|NCT00692419|7273228|FG001|STARTED|Overall Study||120
6362981|NCT00692419|7273227|FG000|COMPLETED|Overall Study||84
6362982|NCT00692419|7273228|FG001|COMPLETED|Overall Study||102
6362983|NCT00692419|7273227|FG000|NOT COMPLETED|Overall Study||16
6362984|NCT00692419|7273228|FG001|NOT COMPLETED|Overall Study||18
6362985|NCT00692692|7273238|FG000|STARTED|Overall Study||20
6362986|NCT00692692|7273239|FG001|STARTED|Overall Study||16
6362987|NCT00692692|7273238|FG000|COMPLETED|Overall Study||20
6362988|NCT00692692|7273239|FG001|COMPLETED|Overall Study||16
6362989|NCT00692692|7273238|FG000|NOT COMPLETED|Overall Study||0
6362990|NCT00692692|7273239|FG001|NOT COMPLETED|Overall Study||0
6362991|NCT00692770|7273247|FG000|STARTED|Overall Study||556
6362992|NCT00692770|7273248|FG001|STARTED|Overall Study||558
6362993|NCT00692770|7273247|FG000|Participants Received Treatment|Overall Study||553
6362994|NCT00692770|7273248|FG001|Participants Received Treatment|Overall Study||554
6362995|NCT00692770|7273247|FG000|COMPLETED|Overall Study||0
6362996|NCT00692770|7273248|FG001|COMPLETED|Overall Study||0
6362997|NCT00692770|7273247|FG000|NOT COMPLETED|Overall Study||556
6362998|NCT00692770|7273248|FG001|NOT COMPLETED|Overall Study||558
6362999|NCT00692978|7273262|FG000|STARTED|FP From Active 250 ug MDI Inhaler||15
6363000|NCT00692978|7273263|FG001|STARTED|FP From Active 250 ug MDI Inhaler||15
6363001|NCT00692978|7273262|FG000|COMPLETED|FP From Active 250 ug MDI Inhaler||15
6363002|NCT00692978|7273263|FG001|COMPLETED|FP From Active 250 ug MDI Inhaler||15
6363003|NCT00692978|7273262|FG000|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
6363004|NCT00692978|7273263|FG001|NOT COMPLETED|FP From Active 250 ug MDI Inhaler||0
6363005|NCT00692978|7273262|FG000|STARTED|FP1.5 Microns Size With MDI Inhaler||15
6363006|NCT00692978|7273263|FG001|STARTED|FP1.5 Microns Size With MDI Inhaler||15
6363007|NCT00692978|7273262|FG000|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
6363008|NCT00692978|7273263|FG001|COMPLETED|FP1.5 Microns Size With MDI Inhaler||15
6363009|NCT00692978|7273262|FG000|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
6363010|NCT00692978|7273263|FG001|NOT COMPLETED|FP1.5 Microns Size With MDI Inhaler||0
6363011|NCT00692978|7273262|FG000|STARTED|FP 3 Microns Size With MDI Inhaler||15
6363012|NCT00692978|7273263|FG001|STARTED|FP 3 Microns Size With MDI Inhaler||15
6363013|NCT00692978|7273262|FG000|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
6363014|NCT00692978|7273263|FG001|COMPLETED|FP 3 Microns Size With MDI Inhaler||15
6363015|NCT00692978|7273262|FG000|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
6363016|NCT00692978|7273263|FG001|NOT COMPLETED|FP 3 Microns Size With MDI Inhaler||0
6363017|NCT00692978|7273262|FG000|STARTED|FP 6 Microns Size With MDI Inhaler||15
6363018|NCT00692978|7273263|FG001|STARTED|FP 6 Microns Size With MDI Inhaler||15
6363019|NCT00692978|7273262|FG000|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
6363020|NCT00692978|7273263|FG001|COMPLETED|FP 6 Microns Size With MDI Inhaler||15
6363021|NCT00692978|7273262|FG000|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
6363022|NCT00692978|7273263|FG001|NOT COMPLETED|FP 6 Microns Size With MDI Inhaler||0
6363023|NCT00693160|7273283|FG000|STARTED|Overall Study||14
6363024|NCT00693160|7273284|FG001|STARTED|Overall Study||16
6363025|NCT00693160|7273283|FG000|COMPLETED|Overall Study||14
6363026|NCT00693160|7273284|FG001|COMPLETED|Overall Study||16
6363027|NCT00693160|7273283|FG000|NOT COMPLETED|Overall Study||0
6363028|NCT00693160|7273284|FG001|NOT COMPLETED|Overall Study||0
6363029|NCT00693225|7273292|FG000|STARTED|Overall Study||43
6363030|NCT00693225|7273293|FG001|STARTED|Overall Study||48
6363031|NCT00693225|7273292|FG000|COMPLETED|Overall Study||41
6363032|NCT00693225|7273293|FG001|COMPLETED|Overall Study||43
6363033|NCT00693225|7273292|FG000|NOT COMPLETED|Overall Study||2
6363034|NCT00693225|7273293|FG001|NOT COMPLETED|Overall Study||5
6363035|NCT00693303|7273299|FG000|STARTED|Overall Study||21
6363036|NCT00693303|7273299|FG000|COMPLETED|Overall Study||21
6363037|NCT00693303|7273299|FG000|NOT COMPLETED|Overall Study||0
6363038|NCT00693420|7273305|FG000|STARTED|Overall Study||137
6363039|NCT00693420|7273306|FG001|STARTED|Overall Study||141
6363040|NCT00693420|7273305|FG000|COMPLETED|Overall Study||131
6363041|NCT00693420|7273306|FG001|COMPLETED|Overall Study||126
6363042|NCT00693420|7273305|FG000|NOT COMPLETED|Overall Study||6
6363043|NCT00693420|7273306|FG001|NOT COMPLETED|Overall Study||15
6363044|NCT00693472|7273316|FG000|STARTED|Part 1||19
6363045|NCT00693472|7273317|FG001|STARTED|Part 1||13
6363046|NCT00693472|7273318|FG002|STARTED|Part 1||0
6363047|NCT00693472|7273319|FG003|STARTED|Part 1||0
6363048|NCT00693472|7273316|FG000|COMPLETED|Part 1||13
6363049|NCT00693472|7273317|FG001|COMPLETED|Part 1||9
6363050|NCT00693472|7273318|FG002|COMPLETED|Part 1||0
6363051|NCT00693472|7273319|FG003|COMPLETED|Part 1||0
6363052|NCT00693472|7273316|FG000|NOT COMPLETED|Part 1||6
6363053|NCT00693472|7273317|FG001|NOT COMPLETED|Part 1||4
6363054|NCT00693472|7273318|FG002|NOT COMPLETED|Part 1||0
6363055|NCT00693472|7273319|FG003|NOT COMPLETED|Part 1||0
6363056|NCT00693472|7273316|FG000|STARTED|Part 2||0
6363057|NCT00693472|7273317|FG001|STARTED|Part 2||0
6363058|NCT00693472|7273318|FG002|STARTED|Part 2||8
6363059|NCT00693472|7273319|FG003|STARTED|Part 2||6
6363060|NCT00693472|7273316|FG000|COMPLETED|Part 2||0
6363061|NCT00693472|7273317|FG001|COMPLETED|Part 2||0
6363062|NCT00693472|7273318|FG002|COMPLETED|Part 2||6
6363063|NCT00693472|7273319|FG003|COMPLETED|Part 2||4
6363064|NCT00693472|7273316|FG000|NOT COMPLETED|Part 2||0
6363065|NCT00693472|7273317|FG001|NOT COMPLETED|Part 2||0
6363066|NCT00693472|7273318|FG002|NOT COMPLETED|Part 2||2
6363067|NCT00693472|7273319|FG003|NOT COMPLETED|Part 2||2
6363068|NCT00693485|7273332|FG000|STARTED|Overall Study||25
6363069|NCT00693485|7273333|FG001|STARTED|Overall Study||21
6363070|NCT00693485|7273334|FG002|STARTED|Overall Study||24
6363071|NCT00693485|7273332|FG000|COMPLETED|Overall Study||25
6363072|NCT00693485|7273333|FG001|COMPLETED|Overall Study||19
6363073|NCT00693485|7273334|FG002|COMPLETED|Overall Study||24
6363074|NCT00693485|7273332|FG000|NOT COMPLETED|Overall Study||0
6363075|NCT00693485|7273333|FG001|NOT COMPLETED|Overall Study||2
6363076|NCT00693485|7273334|FG002|NOT COMPLETED|Overall Study||0
6363077|NCT00693498|7273344|FG000|STARTED|Overall Study||81
6363078|NCT00693498|7273345|FG001|STARTED|Overall Study||81
6363079|NCT00693498|7273344|FG000|COMPLETED|Overall Study||81
6777820|NCT03782571|7705789|FG001|COMPLETED|Period 1||6
6777821|NCT03782571|7705790|FG002|COMPLETED|Period 1||6
6777822|NCT03782571|7705791|FG003|COMPLETED|Period 1||7
6777823|NCT03782571|7705788|FG000|NOT COMPLETED|Period 1||1
6777824|NCT03782571|7705789|FG001|NOT COMPLETED|Period 1||0
6363080|NCT00693498|7273345|FG001|COMPLETED|Overall Study||81
6363081|NCT00693498|7273344|FG000|NOT COMPLETED|Overall Study||0
6363082|NCT00693498|7273345|FG001|NOT COMPLETED|Overall Study||0
6363083|NCT00693654|7273353|FG000|STARTED|Overall Study||14
6363084|NCT00693654|7273354|FG001|STARTED|Overall Study||14
6363085|NCT00693654|7273353|FG000|COMPLETED|Overall Study||14
6363086|NCT00693654|7273354|FG001|COMPLETED|Overall Study||14
6363087|NCT00693654|7273353|FG000|NOT COMPLETED|Overall Study||0
6363088|NCT00693654|7273354|FG001|NOT COMPLETED|Overall Study||0
6363089|NCT00693693|7273364|FG000|STARTED|Overall Study||7
6363090|NCT00693693|7273365|FG001|STARTED|Overall Study||9
6363091|NCT00693693|7273366|FG002|STARTED|Overall Study||9
6363092|NCT00693693|7273364|FG000|COMPLETED|Overall Study||6
6363093|NCT00693693|7273365|FG001|COMPLETED|Overall Study||8
6363094|NCT00693693|7273366|FG002|COMPLETED|Overall Study||7
6363095|NCT00693693|7273364|FG000|NOT COMPLETED|Overall Study||1
6363096|NCT00693693|7273365|FG001|NOT COMPLETED|Overall Study||1
6363097|NCT00693693|7273366|FG002|NOT COMPLETED|Overall Study||2
6363098|NCT00693706|7273376|FG000|STARTED|Overall Study||101
6363099|NCT00693706|7273377|FG001|STARTED|Overall Study||99
6363100|NCT00693706|7273376|FG000|COMPLETED|Overall Study||101
6560547|NCT01787461|7483350|FG001|COMPLETED|Overall Study||89
6560548|NCT01787461|7483349|FG000|NOT COMPLETED|Overall Study||14
6363101|NCT00693706|7273377|FG001|COMPLETED|Overall Study||98
6363102|NCT00693706|7273376|FG000|NOT COMPLETED|Overall Study||0
6363103|NCT00693706|7273377|FG001|NOT COMPLETED|Overall Study||1
6363104|NCT00693719|7273383|FG000|STARTED|Overall Study||31
6363105|NCT00693719|7273383|FG000|COMPLETED|Overall Study||31
6363106|NCT00693719|7273383|FG000|NOT COMPLETED|Overall Study||0
6363107|NCT00693784|7273387|FG000|STARTED|Overall Study||15
6363108|NCT00693784|7273387|FG000|26-Week Primary Endpoint|Overall Study||15
6363109|NCT00693784|7273387|FG000|52-week Extended Follow-up|Overall Study||13
6363110|NCT00693784|7273387|FG000|104-week Extended Follow-up|Overall Study||11
6363111|NCT00693784|7273387|FG000|COMPLETED|Overall Study||11
6363112|NCT00693784|7273387|FG000|NOT COMPLETED|Overall Study||4
6363113|NCT00693992|7273393|FG000|STARTED|Overall Study||106
6363114|NCT00693992|7273394|FG001|STARTED|Overall Study||104
6363115|NCT00693992|7273393|FG000|COMPLETED|Overall Study||106
6363116|NCT00693992|7273394|FG001|COMPLETED|Overall Study||104
6363117|NCT00693992|7273393|FG000|NOT COMPLETED|Overall Study||0
6363118|NCT00693992|7273394|FG001|NOT COMPLETED|Overall Study||0
6363119|NCT00694018|7273402|FG000|STARTED|Overall Study||118
6363120|NCT00694018|7273403|FG001|STARTED|Overall Study||111
6363121|NCT00694018|7273402|FG000|6 Months|Overall Study||106
6363122|NCT00694018|7273403|FG001|6 Months|Overall Study||101
6363123|NCT00694018|7273402|FG000|COMPLETED|Overall Study||105
6363124|NCT00694018|7273403|FG001|COMPLETED|Overall Study||102
6363125|NCT00694018|7273402|FG000|NOT COMPLETED|Overall Study||13
6363126|NCT00694018|7273403|FG001|NOT COMPLETED|Overall Study||9
6363127|NCT00694070|7273409|FG000|STARTED|Overall Study||51
6363128|NCT00694070|7273409|FG000|COMPLETED|Overall Study||51
6560549|NCT01787461|7483350|FG001|NOT COMPLETED|Overall Study||9
6560550|NCT01787591|7483358|FG000|STARTED|Period 1 (Cross-over Arm 1)||5
6777825|NCT03782571|7705790|FG002|NOT COMPLETED|Period 1||0
6777826|NCT03782571|7705791|FG003|NOT COMPLETED|Period 1||0
6363129|NCT00694070|7273409|FG000|NOT COMPLETED|Overall Study||0
6363130|NCT00694096|7273413|FG000|STARTED|Overall Study||25
6363131|NCT00694096|7273413|FG000|COMPLETED|Overall Study||20
6363132|NCT00694096|7273413|FG000|NOT COMPLETED|Overall Study||5
6363133|NCT00694109|7273417|FG000|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
6363134|NCT00694109|7273417|FG000|Treated|Overall Study||141
6363135|NCT00694109|7273417|FG000|Consented 2 Years Additional Treatment|Overall Study||42
6363136|NCT00694109|7273417|FG000|Completed Consented Length of Treatment|Overall Study||60
6363137|NCT00694109|7273417|FG000|COMPLETED|Overall Study||25
6363138|NCT00694109|7273417|FG000|NOT COMPLETED|Overall Study||117
6363139|NCT00694122|7273422|FG000|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
6363140|NCT00694122|7273423|FG001|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
6363141|NCT00694122|7273422|FG000|COMPLETED|First Intervention (3-4 Weeks)||10
6363142|NCT00694122|7273423|FG001|COMPLETED|First Intervention (3-4 Weeks)||5
6363143|NCT00694122|7273422|FG000|NOT COMPLETED|First Intervention (3-4 Weeks)||10
6363144|NCT00694122|7273423|FG001|NOT COMPLETED|First Intervention (3-4 Weeks)||2
6363145|NCT00694122|7273422|FG000|STARTED|Washout (1 Day)||10
6363146|NCT00694122|7273423|FG001|STARTED|Washout (1 Day)||5
6363147|NCT00694122|7273422|FG000|COMPLETED|Washout (1 Day)||10
6363148|NCT00694122|7273423|FG001|COMPLETED|Washout (1 Day)||5
6363149|NCT00694122|7273422|FG000|NOT COMPLETED|Washout (1 Day)||0
6363150|NCT00694122|7273423|FG001|NOT COMPLETED|Washout (1 Day)||0
6363151|NCT00694122|7273422|FG000|STARTED|Second Intervention (3-4 Weeks)||10
6363152|NCT00694122|7273423|FG001|STARTED|Second Intervention (3-4 Weeks)||5
6363153|NCT00694122|7273422|FG000|COMPLETED|Second Intervention (3-4 Weeks)||10
6363154|NCT00694122|7273423|FG001|COMPLETED|Second Intervention (3-4 Weeks)||5
6363155|NCT00694122|7273422|FG000|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
6363156|NCT00694122|7273423|FG001|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
6363157|NCT00694161|7273434|FG000|STARTED|Part 1 (up to Week 6)||35
6363158|NCT00694161|7273434|FG000|COMPLETED|Part 1 (up to Week 6)||35
6363159|NCT00694161|7273434|FG000|NOT COMPLETED|Part 1 (up to Week 6)||0
6363160|NCT00694161|7273434|FG000|STARTED|Part 2 (After Week 6 up to Month 12)||35
6363161|NCT00694161|7273434|FG000|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
6560551|NCT01787591|7483359|FG001|STARTED|Period 1 (Cross-over Arm 1)||5
6560552|NCT01787591|7483360|FG002|STARTED|Period 1 (Cross-over Arm 1)||5
6560553|NCT01787591|7483361|FG003|STARTED|Period 1 (Cross-over Arm 1)||6
6363162|NCT00694161|7273434|FG000|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
6363163|NCT00694304|7273438|FG000|STARTED|Overall Study||535
6363164|NCT00694304|7273438|FG000|COMPLETED|Overall Study||328
6363165|NCT00694304|7273438|FG000|NOT COMPLETED|Overall Study||207
6363166|NCT00694356|7273445|FG000|STARTED|Overall Study||3
6363167|NCT00694356|7273446|FG001|STARTED|Overall Study||6
6363168|NCT00694356|7273447|FG002|STARTED|Overall Study||6
6363169|NCT00694356|7273445|FG000|COMPLETED|Overall Study||0
6363170|NCT00694356|7273446|FG001|COMPLETED|Overall Study||0
6363171|NCT00694356|7273447|FG002|COMPLETED|Overall Study||0
6363172|NCT00694356|7273445|FG000|NOT COMPLETED|Overall Study||3
6363173|NCT00694356|7273446|FG001|NOT COMPLETED|Overall Study||6
6363174|NCT00694356|7273447|FG002|NOT COMPLETED|Overall Study||6
6363175|NCT00694473|7273455|FG000|STARTED|Overall Study|Aug 2008|76
6363176|NCT00694473|7273455|FG000|COMPLETED|Overall Study|Dec 2010|69
6363177|NCT00694473|7273455|FG000|NOT COMPLETED|Overall Study||7
6363178|NCT00694551|7273462|FG000|STARTED|Overall Study||10
6363179|NCT00694551|7273463|FG001|STARTED|Overall Study||10
6363180|NCT00694551|7273464|FG002|STARTED|Overall Study||9
6363181|NCT00694551|7273462|FG000|COMPLETED|Overall Study||9
6363182|NCT00694551|7273463|FG001|COMPLETED|Overall Study||10
6363183|NCT00694551|7273464|FG002|COMPLETED|Overall Study||8
6363184|NCT00694551|7273462|FG000|NOT COMPLETED|Overall Study||1
6363185|NCT00694551|7273463|FG001|NOT COMPLETED|Overall Study||0
6363186|NCT00694551|7273464|FG002|NOT COMPLETED|Overall Study||1
6363187|NCT00694564|7273473|FG000|STARTED|Overall Study||8
6363188|NCT00694564|7273473|FG000|COMPLETED|Overall Study||6
6363189|NCT00694564|7273473|FG000|NOT COMPLETED|Overall Study||2
6363190|NCT00694603|7273477|FG000|STARTED|Overall Study||18
6363191|NCT00694603|7273477|FG000|COMPLETED|Overall Study||18
6363192|NCT00694603|7273477|FG000|NOT COMPLETED|Overall Study||0
6363193|NCT00694707|7273486|FG000|STARTED|Overall Study||151
6363194|NCT00694707|7273487|FG001|STARTED|Overall Study||145
6363195|NCT00694707|7273488|FG002|STARTED|Overall Study||147
6363196|NCT00694707|7273489|FG003|STARTED|Overall Study||148
6363197|NCT00694707|7273490|FG004|STARTED|Overall Study||141
6363198|NCT00694707|7273486|FG000|COMPLETED|Overall Study||79
6560554|NCT01787591|7483358|FG000|COMPLETED|Period 1 (Cross-over Arm 1)||5
6560555|NCT01787591|7483359|FG001|COMPLETED|Period 1 (Cross-over Arm 1)||5
6560556|NCT01787591|7483360|FG002|COMPLETED|Period 1 (Cross-over Arm 1)||5
6560557|NCT01787591|7483361|FG003|COMPLETED|Period 1 (Cross-over Arm 1)||5
6363199|NCT00694707|7273487|FG001|COMPLETED|Overall Study||90
6363200|NCT00694707|7273488|FG002|COMPLETED|Overall Study||96
6363201|NCT00694707|7273489|FG003|COMPLETED|Overall Study||98
6363202|NCT00694707|7273490|FG004|COMPLETED|Overall Study||101
6363203|NCT00694707|7273486|FG000|NOT COMPLETED|Overall Study||72
6363204|NCT00694707|7273487|FG001|NOT COMPLETED|Overall Study||55
6363205|NCT00694707|7273488|FG002|NOT COMPLETED|Overall Study||51
6363206|NCT00694707|7273489|FG003|NOT COMPLETED|Overall Study||50
6363207|NCT00694707|7273490|FG004|NOT COMPLETED|Overall Study||40
6363208|NCT00695019|7273505|FG000|STARTED|Overall Study||59
6363209|NCT00695019|7273506|FG001|STARTED|Overall Study||53
6363210|NCT00695019|7273507|FG002|STARTED|Overall Study||57
6363211|NCT00695019|7273505|FG000|COMPLETED|Overall Study||46
6363212|NCT00695019|7273506|FG001|COMPLETED|Overall Study||39
6363213|NCT00695019|7273507|FG002|COMPLETED|Overall Study||47
6363214|NCT00695019|7273505|FG000|NOT COMPLETED|Overall Study||13
6363215|NCT00695019|7273506|FG001|NOT COMPLETED|Overall Study||14
6363216|NCT00695019|7273507|FG002|NOT COMPLETED|Overall Study||10
6363217|NCT00695097|7273517|FG000|STARTED|Overall Study||10
6363218|NCT00695097|7273518|FG001|STARTED|Overall Study||5
6363219|NCT00695097|7273517|FG000|COMPLETED|Overall Study||9
6363220|NCT00695097|7273518|FG001|COMPLETED|Overall Study||5
6363221|NCT00695097|7273517|FG000|NOT COMPLETED|Overall Study||1
6363222|NCT00695097|7273518|FG001|NOT COMPLETED|Overall Study||0
6363223|NCT00695110|7273524|FG000|STARTED|Treatment Period 1||29
6363224|NCT00695110|7273524|FG000|COMPLETED|Treatment Period 1||26
6363225|NCT00695110|7273524|FG000|NOT COMPLETED|Treatment Period 1||3
6363226|NCT00695110|7273524|FG000|STARTED|Treatment Period 2||26
6363227|NCT00695110|7273524|FG000|COMPLETED|Treatment Period 2||26
6363228|NCT00695110|7273524|FG000|NOT COMPLETED|Treatment Period 2||0
6363229|NCT00695110|7273524|FG000|STARTED|Treatment Period 3||26
6363230|NCT00695110|7273524|FG000|COMPLETED|Treatment Period 3||25
6363231|NCT00695110|7273524|FG000|NOT COMPLETED|Treatment Period 3||1
6363232|NCT00695110|7273524|FG000|STARTED|Treatment Period 4||25
6363233|NCT00695110|7273524|FG000|COMPLETED|Treatment Period 4||24
6363234|NCT00695110|7273524|FG000|NOT COMPLETED|Treatment Period 4||1
6363235|NCT00695136|7273531|FG000|STARTED|Overall Study|7|7
6363236|NCT00695136|7273531|FG000|COMPLETED|Overall Study||5
6363237|NCT00695136|7273531|FG000|NOT COMPLETED|Overall Study||2
6377299|NCT00762450|7287860|FG002|NOT COMPLETED|3rd Treatment Period||0
6377300|NCT00762463|7287870|FG000|STARTED|Double-blind Phase (Baseline to Week 6)||120
6377301|NCT00762463|7287871|FG001|STARTED|Double-blind Phase (Baseline to Week 6)||120
6377302|NCT00762463|7287872|FG002|STARTED|Double-blind Phase (Baseline to Week 6)||0
6377303|NCT00762463|7287873|FG003|STARTED|Double-blind Phase (Baseline to Week 6)||0
6377304|NCT00762463|7287870|FG000|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
6377305|NCT00762463|7287871|FG001|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
6377306|NCT00762463|7287872|FG002|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
6377307|NCT00762463|7287873|FG003|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
6377308|NCT00762463|7287870|FG000|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
6377309|NCT00762463|7287871|FG001|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
6377310|NCT00762463|7287872|FG002|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
6377311|NCT00762463|7287873|FG003|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
6377312|NCT00762463|7287870|FG000|STARTED|Enrollment in Extension Phase (Week 6)||113
6377313|NCT00762463|7287871|FG001|STARTED|Enrollment in Extension Phase (Week 6)||110
6377314|NCT00762463|7287872|FG002|STARTED|Enrollment in Extension Phase (Week 6)||0
6377315|NCT00762463|7287873|FG003|STARTED|Enrollment in Extension Phase (Week 6)||0
6377316|NCT00762463|7287870|FG000|COMPLETED|Enrollment in Extension Phase (Week 6)||109
6377317|NCT00762463|7287871|FG001|COMPLETED|Enrollment in Extension Phase (Week 6)||109
6377318|NCT00762463|7287872|FG002|COMPLETED|Enrollment in Extension Phase (Week 6)||0
6377319|NCT00762463|7287873|FG003|COMPLETED|Enrollment in Extension Phase (Week 6)||0
6377320|NCT00762463|7287870|FG000|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
6377321|NCT00762463|7287871|FG001|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
6377322|NCT00762463|7287872|FG002|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
6377323|NCT00762463|7287873|FG003|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
6377324|NCT00762463|7287870|FG000|STARTED|Extension Phase (Week 6 to Week 12)||55
6377325|NCT00762463|7287871|FG001|STARTED|Extension Phase (Week 6 to Week 12)||55
6377326|NCT00762463|7287872|FG002|STARTED|Extension Phase (Week 6 to Week 12)||54
6377327|NCT00762463|7287873|FG003|STARTED|Extension Phase (Week 6 to Week 12)||54
6377328|NCT00762463|7287870|FG000|COMPLETED|Extension Phase (Week 6 to Week 12)||52
6377329|NCT00762463|7287871|FG001|COMPLETED|Extension Phase (Week 6 to Week 12)||54
6377330|NCT00762463|7287872|FG002|COMPLETED|Extension Phase (Week 6 to Week 12)||50
6377331|NCT00762463|7287873|FG003|COMPLETED|Extension Phase (Week 6 to Week 12)||52
6377332|NCT00762463|7287870|FG000|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
6377333|NCT00762463|7287871|FG001|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
6377334|NCT00762463|7287872|FG002|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
6377335|NCT00762463|7287873|FG003|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
6377336|NCT00762476|7287888|FG000|STARTED|Overall Study||206
6377337|NCT00762476|7287889|FG001|STARTED|Overall Study||205
6377338|NCT00762476|7287888|FG000|COMPLETED|Overall Study||183
6377339|NCT00762476|7287889|FG001|COMPLETED|Overall Study||169
6377340|NCT00762476|7287888|FG000|NOT COMPLETED|Overall Study||23
6377341|NCT00762476|7287889|FG001|NOT COMPLETED|Overall Study||36
6377342|NCT00762502|7287899|FG000|STARTED|Baseline to Month 3 (Period 1)||36
6377343|NCT00762502|7287900|FG001|STARTED|Baseline to Month 3 (Period 1)||25
6377344|NCT00762502|7287901|FG002|STARTED|Baseline to Month 3 (Period 1)||51
6377345|NCT00762502|7287899|FG000|COMPLETED|Baseline to Month 3 (Period 1)||26
6377346|NCT00762502|7287900|FG001|COMPLETED|Baseline to Month 3 (Period 1)||19
6377347|NCT00762502|7287901|FG002|COMPLETED|Baseline to Month 3 (Period 1)||32
6377348|NCT00762502|7287899|FG000|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
6377349|NCT00762502|7287900|FG001|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
6377350|NCT00762502|7287901|FG002|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
6377351|NCT00762502|7287899|FG000|STARTED|Month 3 to Month 6 (Period 2)||9
6377352|NCT00762502|7287900|FG001|STARTED|Month 3 to Month 6 (Period 2)||5
6377353|NCT00762502|7287901|FG002|STARTED|Month 3 to Month 6 (Period 2)||23
6377354|NCT00762502|7287899|FG000|COMPLETED|Month 3 to Month 6 (Period 2)||9
6377355|NCT00762502|7287900|FG001|COMPLETED|Month 3 to Month 6 (Period 2)||4
6377356|NCT00762502|7287901|FG002|COMPLETED|Month 3 to Month 6 (Period 2)||23
6363238|NCT00695188|7273537|FG000|STARTED|Overall Study||10
6363239|NCT00695188|7273538|FG001|STARTED|Overall Study||9
6363240|NCT00695188|7273537|FG000|COMPLETED|Overall Study||10
6363241|NCT00695188|7273538|FG001|COMPLETED|Overall Study||9
6363242|NCT00695188|7273537|FG000|NOT COMPLETED|Overall Study||0
6363243|NCT00695188|7273538|FG001|NOT COMPLETED|Overall Study||0
6363244|NCT00695253|7273544|FG000|STARTED|Overall Study|75 patients were screened and a total of 49 were enrolled in the study.|49
6363245|NCT00695253|7273544|FG000|COMPLETED|Overall Study|Eighteen (18) completed the study up to the 5 year followup.|18
6363246|NCT00695253|7273544|FG000|NOT COMPLETED|Overall Study||31
6363247|NCT00695292|7273549|FG000|STARTED|Overall Study||37
6363248|NCT00695292|7273549|FG000|COMPLETED|Overall Study||37
6363249|NCT00695292|7273549|FG000|NOT COMPLETED|Overall Study||0
6363250|NCT00695318|7273555|FG000|STARTED|Overall Study||10
6363251|NCT00695318|7273556|FG001|STARTED|Overall Study||7
6363252|NCT00695318|7273555|FG000|COMPLETED|Overall Study||5
6363253|NCT00695318|7273556|FG001|COMPLETED|Overall Study||6
6363254|NCT00695318|7273555|FG000|NOT COMPLETED|Overall Study||5
6363255|NCT00695318|7273556|FG001|NOT COMPLETED|Overall Study||1
6363256|NCT00695396|7273570|FG000|STARTED|Overall Study||8
6363257|NCT00695396|7273571|FG001|STARTED|Overall Study||8
6363258|NCT00695396|7273572|FG002|STARTED|Overall Study||9
6363259|NCT00695396|7273570|FG000|COMPLETED|Overall Study||1
6363260|NCT00695396|7273571|FG001|COMPLETED|Overall Study||0
6363261|NCT00695396|7273572|FG002|COMPLETED|Overall Study||1
6363262|NCT00695396|7273570|FG000|NOT COMPLETED|Overall Study||7
6363263|NCT00695396|7273571|FG001|NOT COMPLETED|Overall Study||8
6363264|NCT00695396|7273572|FG002|NOT COMPLETED|Overall Study||8
6363265|NCT00695409|7273580|FG000|STARTED|Overall Study||122
6363266|NCT00695409|7273580|FG000|COMPLETED|Overall Study||122
6363267|NCT00695409|7273580|FG000|NOT COMPLETED|Overall Study||0
6363268|NCT00695435|7273585|FG000|STARTED|Overall Study||7
6363269|NCT00695435|7273586|FG001|STARTED|Overall Study||7
6363270|NCT00695435|7273587|FG002|STARTED|Overall Study||7
6363271|NCT00695435|7273585|FG000|COMPLETED|Overall Study||7
6363272|NCT00695435|7273586|FG001|COMPLETED|Overall Study||7
6363273|NCT00695435|7273587|FG002|COMPLETED|Overall Study||7
6363274|NCT00695435|7273585|FG000|NOT COMPLETED|Overall Study||0
6363275|NCT00695435|7273586|FG001|NOT COMPLETED|Overall Study||0
6363276|NCT00695435|7273587|FG002|NOT COMPLETED|Overall Study||0
6363277|NCT00695500|7273597|FG000|STARTED|Overall Study||24
6363278|NCT00695500|7273598|FG001|STARTED|Overall Study||22
6363279|NCT00695500|7273597|FG000|COMPLETED|Overall Study||21
6363280|NCT00695500|7273598|FG001|COMPLETED|Overall Study||17
6363281|NCT00695500|7273597|FG000|NOT COMPLETED|Overall Study||3
6363282|NCT00695500|7273598|FG001|NOT COMPLETED|Overall Study||5
6363283|NCT00695565|7273606|FG000|STARTED|Overall Study||90
6363284|NCT00695565|7273607|FG001|STARTED|Overall Study||90
6363285|NCT00695565|7273606|FG000|COMPLETED|Overall Study||77
6363286|NCT00695565|7273607|FG001|COMPLETED|Overall Study||81
6363287|NCT00695565|7273606|FG000|NOT COMPLETED|Overall Study||13
6363288|NCT00695565|7273607|FG001|NOT COMPLETED|Overall Study||9
6363289|NCT00695578|7273615|FG000|STARTED|Overall Study||10
6363290|NCT00695578|7273616|FG001|STARTED|Overall Study||10
6363291|NCT00695578|7273615|FG000|COMPLETED|Overall Study||10
6363292|NCT00695578|7273616|FG001|COMPLETED|Overall Study||10
6363293|NCT00695578|7273615|FG000|NOT COMPLETED|Overall Study||0
6363294|NCT00695578|7273616|FG001|NOT COMPLETED|Overall Study||0
6363295|NCT00695669|7273626|FG000|STARTED|Overall Study||78
6363296|NCT00695669|7273627|FG001|STARTED|Overall Study||78
6363297|NCT00695669|7273628|FG002|STARTED|Overall Study||78
6363298|NCT00695669|7273629|FG003|STARTED|Overall Study||78
6363299|NCT00695669|7273626|FG000|COMPLETED|Overall Study||74
6363300|NCT00695669|7273627|FG001|COMPLETED|Overall Study||74
6363301|NCT00695669|7273628|FG002|COMPLETED|Overall Study||75
6363302|NCT00695669|7273629|FG003|COMPLETED|Overall Study||74
6363303|NCT00695669|7273626|FG000|NOT COMPLETED|Overall Study||4
6363304|NCT00695669|7273627|FG001|NOT COMPLETED|Overall Study||4
6363305|NCT00695669|7273628|FG002|NOT COMPLETED|Overall Study||3
6363306|NCT00695669|7273629|FG003|NOT COMPLETED|Overall Study||4
6363307|NCT00695786|7273646|FG000|STARTED|Overall Study||2
6363308|NCT00695786|7273647|FG001|STARTED|Overall Study||79
6363309|NCT00695786|7273648|FG002|STARTED|Overall Study||31
6363310|NCT00695786|7273649|FG003|STARTED|Overall Study||44
6363311|NCT00695786|7273646|FG000|COMPLETED|Overall Study||1
6363312|NCT00695786|7273647|FG001|COMPLETED|Overall Study||67
6363313|NCT00695786|7273648|FG002|COMPLETED|Overall Study||23
6363314|NCT00695786|7273649|FG003|COMPLETED|Overall Study||36
6363315|NCT00695786|7273646|FG000|NOT COMPLETED|Overall Study||1
6363316|NCT00695786|7273647|FG001|NOT COMPLETED|Overall Study||12
6363317|NCT00695786|7273648|FG002|NOT COMPLETED|Overall Study||8
6363318|NCT00695786|7273649|FG003|NOT COMPLETED|Overall Study||8
6377357|NCT00762502|7287899|FG000|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
6377358|NCT00762502|7287900|FG001|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
6377359|NCT00762502|7287901|FG002|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
6377360|NCT00762515|7287909|FG000|STARTED|Overall Study||22
6377361|NCT00762515|7287910|FG001|STARTED|Overall Study||22
6377362|NCT00762515|7287909|FG000|COMPLETED|Overall Study||22
6377363|NCT00762515|7287910|FG001|COMPLETED|Overall Study||22
6377364|NCT00762515|7287909|FG000|NOT COMPLETED|Overall Study||0
6377365|NCT00762515|7287910|FG001|NOT COMPLETED|Overall Study||0
6377366|NCT00762528|7287918|FG000|STARTED|Overall Study||24
6363319|NCT00695864|7273659|FG000|STARTED|Placebo||14
6363320|NCT00695864|7273659|FG000|COMPLETED|Placebo||9
6363321|NCT00695864|7273659|FG000|NOT COMPLETED|Placebo||5
6363322|NCT00695864|7273659|FG000|STARTED|Ondansetron||14
6363323|NCT00695864|7273659|FG000|COMPLETED|Ondansetron||9
6363324|NCT00695864|7273659|FG000|NOT COMPLETED|Ondansetron||5
6363325|NCT00695903|7273667|FG000|STARTED|Had End of Therapy (EOT) Assessment||19
6363326|NCT00695903|7273668|FG001|STARTED|Had End of Therapy (EOT) Assessment||19
6363327|NCT00695903|7273667|FG000|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
6363328|NCT00695903|7273668|FG001|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
6363329|NCT00695903|7273667|FG000|COMPLETED|Had End of Therapy (EOT) Assessment||7
6363330|NCT00695903|7273668|FG001|COMPLETED|Had End of Therapy (EOT) Assessment||4
6363331|NCT00695903|7273667|FG000|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
6363332|NCT00695903|7273668|FG001|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
6363333|NCT00695903|7273667|FG000|STARTED|Had Test of Cure (TOC) Assessment||7
6363334|NCT00695903|7273668|FG001|STARTED|Had Test of Cure (TOC) Assessment||4
6363335|NCT00695903|7273667|FG000|COMPLETED|Had Test of Cure (TOC) Assessment||5
6363336|NCT00695903|7273668|FG001|COMPLETED|Had Test of Cure (TOC) Assessment||3
6363337|NCT00695903|7273667|FG000|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
6363338|NCT00695903|7273668|FG001|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
6363339|NCT00695955|7273674|FG000|STARTED|Cohort 1||362
6363340|NCT00695955|7273674|FG000|COMPLETED|Cohort 1||260
6363341|NCT00695955|7273674|FG000|NOT COMPLETED|Cohort 1||102
6363342|NCT00695955|7273674|FG000|STARTED|Cohort 2||307
6363343|NCT00695955|7273674|FG000|COMPLETED|Cohort 2||203
6363344|NCT00695955|7273674|FG000|NOT COMPLETED|Cohort 2||104
6363345|NCT00696020|7273684|FG000|STARTED|Overall Study||90
6363346|NCT00696020|7273685|FG001|STARTED|Overall Study||89
6363347|NCT00696020|7273686|FG002|STARTED|Overall Study||93
6363348|NCT00696020|7273687|FG003|STARTED|Overall Study||88
6363349|NCT00696020|7273684|FG000|COMPLETED|Overall Study||86
6363350|NCT00696020|7273685|FG001|COMPLETED|Overall Study||87
6363351|NCT00696020|7273686|FG002|COMPLETED|Overall Study||90
6363352|NCT00696020|7273687|FG003|COMPLETED|Overall Study||84
6363353|NCT00696020|7273684|FG000|NOT COMPLETED|Overall Study||4
6363354|NCT00696020|7273685|FG001|NOT COMPLETED|Overall Study||2
6363355|NCT00696020|7273686|FG002|NOT COMPLETED|Overall Study||3
6363356|NCT00696020|7273687|FG003|NOT COMPLETED|Overall Study||4
6363357|NCT00696072|7273701|FG000|STARTED|Overall Study||57
6363358|NCT00696072|7273702|FG001|STARTED|Overall Study||63
6363359|NCT00696072|7273701|FG000|COMPLETED|Overall Study||0
6363360|NCT00696072|7273702|FG001|COMPLETED|Overall Study||0
6363361|NCT00696072|7273701|FG000|NOT COMPLETED|Overall Study||57
6363362|NCT00696072|7273702|FG001|NOT COMPLETED|Overall Study||63
6363363|NCT00696137|7273709|FG000|STARTED|Overall Study||5
6363364|NCT00696137|7273709|FG000|COMPLETED|Overall Study||3
6363365|NCT00696137|7273709|FG000|NOT COMPLETED|Overall Study||2
6363366|NCT00696241|7273718|FG000|STARTED|Overall Study||283
6363367|NCT00696241|7273719|FG001|STARTED|Overall Study||283
6363368|NCT00696241|7273720|FG002|STARTED|Overall Study||285
6363369|NCT00696241|7273721|FG003|STARTED|Overall Study||282
6363370|NCT00696241|7273722|FG004|STARTED|Overall Study||142
6363371|NCT00696241|7273718|FG000|COMPLETED|Overall Study||259
6363372|NCT00696241|7273719|FG001|COMPLETED|Overall Study||261
6363373|NCT00696241|7273720|FG002|COMPLETED|Overall Study||261
6363374|NCT00696241|7273721|FG003|COMPLETED|Overall Study||268
6363375|NCT00696241|7273722|FG004|COMPLETED|Overall Study||130
6363376|NCT00696241|7273718|FG000|NOT COMPLETED|Overall Study||24
6363377|NCT00696241|7273719|FG001|NOT COMPLETED|Overall Study||22
6363378|NCT00696241|7273720|FG002|NOT COMPLETED|Overall Study||24
6363379|NCT00696241|7273721|FG003|NOT COMPLETED|Overall Study||14
6363380|NCT00696241|7273722|FG004|NOT COMPLETED|Overall Study||12
6363381|NCT00696293|7273734|FG000|STARTED|Overall Study||30
6363382|NCT00696293|7273734|FG000|COMPLETED|Overall Study||28
6363383|NCT00696293|7273734|FG000|NOT COMPLETED|Overall Study||2
6363384|NCT00696384|7273739|FG000|STARTED|Open Label Phase||418
6363385|NCT00696384|7273740|FG001|STARTED|Open Label Phase||0
6363386|NCT00696384|7273741|FG002|STARTED|Open Label Phase||0
6363387|NCT00696384|7273739|FG000|COMPLETED|Open Label Phase||299
6363388|NCT00696384|7273740|FG001|COMPLETED|Open Label Phase||0
6363389|NCT00696384|7273741|FG002|COMPLETED|Open Label Phase||0
6363390|NCT00696384|7273739|FG000|NOT COMPLETED|Open Label Phase||119
6363391|NCT00696384|7273740|FG001|NOT COMPLETED|Open Label Phase||0
6363392|NCT00696384|7273741|FG002|NOT COMPLETED|Open Label Phase||0
6363393|NCT00696384|7273739|FG000|STARTED|Double Blind Phase||0
6363394|NCT00696384|7273740|FG001|STARTED|Double Blind Phase||148
6363395|NCT00696384|7273741|FG002|STARTED|Double Blind Phase||151
6363396|NCT00696384|7273739|FG000|COMPLETED|Double Blind Phase||0
6363397|NCT00696384|7273740|FG001|COMPLETED|Double Blind Phase||137
6363398|NCT00696384|7273741|FG002|COMPLETED|Double Blind Phase||145
6363399|NCT00696384|7273739|FG000|NOT COMPLETED|Double Blind Phase||0
6363400|NCT00696384|7273740|FG001|NOT COMPLETED|Double Blind Phase||11
6363401|NCT00696384|7273741|FG002|NOT COMPLETED|Double Blind Phase||6
6363402|NCT00696410|7273752|FG000|STARTED|Overall Study||38
6363403|NCT00696410|7273753|FG001|STARTED|Overall Study||10
6363404|NCT00696410|7273752|FG000|COMPLETED|Overall Study||25
6363405|NCT00696410|7273753|FG001|COMPLETED|Overall Study||10
6363406|NCT00696410|7273752|FG000|NOT COMPLETED|Overall Study||13
6363407|NCT00696410|7273753|FG001|NOT COMPLETED|Overall Study||0
6363408|NCT00696423|7273766|FG000|STARTED|Overall Study||244
6363409|NCT00696423|7273767|FG001|STARTED|Overall Study||223
6363410|NCT00696423|7273766|FG000|COMPLETED|Overall Study||244
6363411|NCT00696423|7273767|FG001|COMPLETED|Overall Study||218
6363412|NCT00696423|7273766|FG000|NOT COMPLETED|Overall Study||0
6363413|NCT00696423|7273767|FG001|NOT COMPLETED|Overall Study||5
6363414|NCT00696436|7273778|FG000|STARTED|Overall Study|Randomized participants only.|280
6363415|NCT00696436|7273779|FG001|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
6363416|NCT00696436|7273780|FG002|STARTED|Overall Study|Randomized participants only.|282
6363417|NCT00696436|7273781|FG003|STARTED|Overall Study|Randomized participants only.|290
6363418|NCT00696436|7273782|FG004|STARTED|Overall Study|Randomized participants only.|154
6363419|NCT00696436|7273778|FG000|COMPLETED|Overall Study||257
6363420|NCT00696436|7273779|FG001|COMPLETED|Overall Study||255
6363421|NCT00696436|7273780|FG002|COMPLETED|Overall Study||254
6363422|NCT00696436|7273781|FG003|COMPLETED|Overall Study||268
6363423|NCT00696436|7273782|FG004|COMPLETED|Overall Study||141
6363424|NCT00696436|7273778|FG000|NOT COMPLETED|Overall Study||23
6363425|NCT00696436|7273779|FG001|NOT COMPLETED|Overall Study||30
6363426|NCT00696436|7273780|FG002|NOT COMPLETED|Overall Study||28
6363427|NCT00696436|7273781|FG003|NOT COMPLETED|Overall Study||22
6363428|NCT00696436|7273782|FG004|NOT COMPLETED|Overall Study||13
6363429|NCT00696449|7273798|FG000|STARTED|Overall Study||15
6363430|NCT00696449|7273799|FG001|STARTED|Overall Study||15
6363431|NCT00696449|7273800|FG002|STARTED|Overall Study||15
6363432|NCT00696449|7273801|FG003|STARTED|Overall Study||16
6363433|NCT00696449|7273798|FG000|COMPLETED|Overall Study||12
6363434|NCT00696449|7273799|FG001|COMPLETED|Overall Study||9
6363435|NCT00696449|7273800|FG002|COMPLETED|Overall Study||14
6363436|NCT00696449|7273801|FG003|COMPLETED|Overall Study||13
6363437|NCT00696449|7273798|FG000|NOT COMPLETED|Overall Study||3
6363438|NCT00696449|7273799|FG001|NOT COMPLETED|Overall Study||6
6363439|NCT00696449|7273800|FG002|NOT COMPLETED|Overall Study||1
6363440|NCT00696449|7273801|FG003|NOT COMPLETED|Overall Study||3
6363441|NCT00696488|7273811|FG000|STARTED|Overall Study||20
6363442|NCT00696488|7273811|FG000|COMPLETED|Overall Study||20
6363443|NCT00696488|7273811|FG000|NOT COMPLETED|Overall Study||0
6363444|NCT00696618|7273818|FG000|STARTED|Overall Study||3
6363445|NCT00696618|7273819|FG001|STARTED|Overall Study||3
6363446|NCT00696618|7273820|FG002|STARTED|Overall Study||3
6363447|NCT00696618|7273818|FG000|COMPLETED|Overall Study||3
6363448|NCT00696618|7273819|FG001|COMPLETED|Overall Study||3
6363449|NCT00696618|7273820|FG002|COMPLETED|Overall Study||3
6363450|NCT00696618|7273818|FG000|NOT COMPLETED|Overall Study||0
6363451|NCT00696618|7273819|FG001|NOT COMPLETED|Overall Study||0
6363452|NCT00696618|7273820|FG002|NOT COMPLETED|Overall Study||0
6363453|NCT00696657|7273837|FG000|STARTED|Overall Study||46
6363454|NCT00696657|7273838|FG001|STARTED|Overall Study||47
6363455|NCT00696657|7273839|FG002|STARTED|Overall Study||44
6363456|NCT00696657|7273840|FG003|STARTED|Overall Study||49
6363457|NCT00696657|7273841|FG004|STARTED|Overall Study||44
6363458|NCT00696657|7273842|FG005|STARTED|Overall Study||45
6363459|NCT00696657|7273843|FG006|STARTED|Overall Study||45
6363460|NCT00696657|7273844|FG007|STARTED|Overall Study||45
6363461|NCT00696657|7273845|FG008|STARTED|Overall Study||50
6363462|NCT00696657|7273837|FG000|EXPOSED|Overall Study||46
6363463|NCT00696657|7273838|FG001|EXPOSED|Overall Study||47
6363464|NCT00696657|7273839|FG002|EXPOSED|Overall Study||43
6363465|NCT00696657|7273840|FG003|EXPOSED|Overall Study||48
6363466|NCT00696657|7273841|FG004|EXPOSED|Overall Study||44
6363467|NCT00696657|7273842|FG005|EXPOSED|Overall Study||43
6363468|NCT00696657|7273843|FG006|EXPOSED|Overall Study||45
6363469|NCT00696657|7273844|FG007|EXPOSED|Overall Study||45
6363470|NCT00696657|7273845|FG008|EXPOSED|Overall Study||50
6363471|NCT00696657|7273837|FG000|COMPLETED|Overall Study||45
6363472|NCT00696657|7273838|FG001|COMPLETED|Overall Study||42
6363473|NCT00696657|7273839|FG002|COMPLETED|Overall Study||36
6363474|NCT00696657|7273840|FG003|COMPLETED|Overall Study||38
6363475|NCT00696657|7273841|FG004|COMPLETED|Overall Study||34
6363476|NCT00696657|7273842|FG005|COMPLETED|Overall Study||33
6363477|NCT00696657|7273843|FG006|COMPLETED|Overall Study||30
6363478|NCT00696657|7273844|FG007|COMPLETED|Overall Study||42
6363479|NCT00696657|7273845|FG008|COMPLETED|Overall Study||41
6363480|NCT00696657|7273837|FG000|NOT COMPLETED|Overall Study||1
6363481|NCT00696657|7273838|FG001|NOT COMPLETED|Overall Study||5
6363482|NCT00696657|7273839|FG002|NOT COMPLETED|Overall Study||8
6363483|NCT00696657|7273840|FG003|NOT COMPLETED|Overall Study||11
6363484|NCT00696657|7273841|FG004|NOT COMPLETED|Overall Study||10
6363485|NCT00696657|7273842|FG005|NOT COMPLETED|Overall Study||12
6363486|NCT00696657|7273843|FG006|NOT COMPLETED|Overall Study||15
6363487|NCT00696657|7273844|FG007|NOT COMPLETED|Overall Study||3
6363488|NCT00696657|7273845|FG008|NOT COMPLETED|Overall Study||9
6363489|NCT00696696|7273865|FG000|STARTED|Overall Study||44
6363490|NCT00696696|7273865|FG000|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
6363491|NCT00696696|7273865|FG000|NOT COMPLETED|Overall Study||18
6363492|NCT00696709|7273874|FG000|STARTED|Overall Study||65
6363493|NCT00696709|7273875|FG001|STARTED|Overall Study||63
6363494|NCT00696709|7273876|FG002|STARTED|Overall Study||33
6363495|NCT00696709|7273877|FG003|STARTED|Overall Study||64
6363496|NCT00696709|7273878|FG004|STARTED|Overall Study||65
6363497|NCT00696709|7273874|FG000|Vaccination 1 (Day 1)|Overall Study||65
6363498|NCT00696709|7273875|FG001|Vaccination 1 (Day 1)|Overall Study||63
6363499|NCT00696709|7273876|FG002|Vaccination 1 (Day 1)|Overall Study||32
6363500|NCT00696709|7273877|FG003|Vaccination 1 (Day 1)|Overall Study||64
6363501|NCT00696709|7273878|FG004|Vaccination 1 (Day 1)|Overall Study||65
6363502|NCT00696709|7273874|FG000|Vaccination 2 (~Day 30)|Overall Study||64
6363503|NCT00696709|7273875|FG001|Vaccination 2 (~Day 30)|Overall Study||60
6363504|NCT00696709|7273876|FG002|Vaccination 2 (~Day 30)|Overall Study||32
6363505|NCT00696709|7273877|FG003|Vaccination 2 (~Day 30)|Overall Study||61
6363506|NCT00696709|7273878|FG004|Vaccination 2 (~Day 30)|Overall Study||64
6363507|NCT00696709|7273874|FG000|Vaccination 3 (~Day 60)|Overall Study||64
6363508|NCT00696709|7273875|FG001|Vaccination 3 (~Day 60)|Overall Study||60
6363509|NCT00696709|7273876|FG002|Vaccination 3 (~Day 60)|Overall Study||32
6363510|NCT00696709|7273877|FG003|Vaccination 3 (~Day 60)|Overall Study||59
6363511|NCT00696709|7273878|FG004|Vaccination 3 (~Day 60)|Overall Study||63
6363512|NCT00696709|7273874|FG000|Vaccination 4 (~Day 90)|Overall Study||62
6363513|NCT00696709|7273875|FG001|Vaccination 4 (~Day 90)|Overall Study||60
6363514|NCT00696709|7273876|FG002|Vaccination 4 (~Day 90)|Overall Study||32
6363515|NCT00696709|7273877|FG003|Vaccination 4 (~Day 90)|Overall Study||59
6363516|NCT00696709|7273878|FG004|Vaccination 4 (~Day 90)|Overall Study||63
6363517|NCT00696709|7273874|FG000|COMPLETED|Overall Study||62
6363518|NCT00696709|7273875|FG001|COMPLETED|Overall Study||60
6363519|NCT00696709|7273876|FG002|COMPLETED|Overall Study||32
6363520|NCT00696709|7273877|FG003|COMPLETED|Overall Study||59
6363521|NCT00696709|7273878|FG004|COMPLETED|Overall Study||62
6363522|NCT00696709|7273874|FG000|NOT COMPLETED|Overall Study||3
6363523|NCT00696709|7273875|FG001|NOT COMPLETED|Overall Study||3
6363524|NCT00696709|7273876|FG002|NOT COMPLETED|Overall Study||1
6363525|NCT00696709|7273877|FG003|NOT COMPLETED|Overall Study||5
6363526|NCT00696709|7273878|FG004|NOT COMPLETED|Overall Study||3
6363527|NCT00696761|7273898|FG000|STARTED|Overall Study||61
6363528|NCT00696761|7273899|FG001|STARTED|Overall Study||76
6363529|NCT00696761|7273900|FG002|STARTED|Overall Study||41
6363530|NCT00696761|7273901|FG003|STARTED|Overall Study||54
6363531|NCT00696761|7273898|FG000|COMPLETED|Overall Study||41
6363532|NCT00696761|7273899|FG001|COMPLETED|Overall Study||50
6363533|NCT00696761|7273900|FG002|COMPLETED|Overall Study||30
6363534|NCT00696761|7273901|FG003|COMPLETED|Overall Study||44
6363535|NCT00696761|7273898|FG000|NOT COMPLETED|Overall Study||20
6363536|NCT00696761|7273899|FG001|NOT COMPLETED|Overall Study||26
6363537|NCT00696761|7273900|FG002|NOT COMPLETED|Overall Study||11
6363538|NCT00696761|7273901|FG003|NOT COMPLETED|Overall Study||10
6363539|NCT00696774|7273922|FG000|STARTED|Period II||115
6363540|NCT00696774|7273923|FG001|STARTED|Period II||91
6363541|NCT00696774|7273924|FG002|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
6363542|NCT00696774|7273922|FG000|COMPLETED|Period II||115
6363543|NCT00696774|7273923|FG001|COMPLETED|Period II||91
6363544|NCT00696774|7273924|FG002|COMPLETED|Period II||0
6363545|NCT00696774|7273922|FG000|NOT COMPLETED|Period II||0
6363546|NCT00696774|7273923|FG001|NOT COMPLETED|Period II||0
6363547|NCT00696774|7273924|FG002|NOT COMPLETED|Period II||36
6363548|NCT00696774|7273922|FG000|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
6363549|NCT00696774|7273923|FG001|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
6363550|NCT00696774|7273924|FG002|STARTED|Period III||0
6363551|NCT00696774|7273922|FG000|COMPLETED|Period III||106
6363552|NCT00696774|7273923|FG001|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
6363553|NCT00696774|7273924|FG002|COMPLETED|Period III||0
6363554|NCT00696774|7273922|FG000|NOT COMPLETED|Period III||7
6363555|NCT00696774|7273923|FG001|NOT COMPLETED|Period III||7
6363556|NCT00696774|7273924|FG002|NOT COMPLETED|Period III||0
6363557|NCT00696787|7273935|FG000|STARTED|Overall Study||40
6363558|NCT00696787|7273936|FG001|STARTED|Overall Study||42
6363559|NCT00696787|7273937|FG002|STARTED|Overall Study||43
6363560|NCT00696787|7273935|FG000|COMPLETED|Overall Study||25
6363561|NCT00696787|7273936|FG001|COMPLETED|Overall Study||22
6363562|NCT00696787|7273937|FG002|COMPLETED|Overall Study||17
6363563|NCT00696787|7273935|FG000|NOT COMPLETED|Overall Study||15
6363564|NCT00696787|7273936|FG001|NOT COMPLETED|Overall Study||20
6363565|NCT00696787|7273937|FG002|NOT COMPLETED|Overall Study||26
6363566|NCT00697073|7273945|FG000|STARTED|Overall Study||68
6363567|NCT00697073|7273945|FG000|COMPLETED|Overall Study||59
6363568|NCT00697073|7273945|FG000|NOT COMPLETED|Overall Study||9
6363569|NCT00697112|7273949|FG000|STARTED|Overall Study||53
6363570|NCT00697112|7273949|FG000|Met the Inclusion Criteria|Overall Study||52
6363571|NCT00697112|7273949|FG000|COMPLETED|Overall Study||43
6363572|NCT00697112|7273949|FG000|NOT COMPLETED|Overall Study||10
6363573|NCT00697190|7273953|FG000|STARTED|First Intervention||19
6363574|NCT00697190|7273954|FG001|STARTED|First Intervention||20
6363575|NCT00697190|7273953|FG000|COMPLETED|First Intervention||19
6363576|NCT00697190|7273954|FG001|COMPLETED|First Intervention||20
6363577|NCT00697190|7273953|FG000|NOT COMPLETED|First Intervention||0
6363578|NCT00697190|7273954|FG001|NOT COMPLETED|First Intervention||0
6363579|NCT00697190|7273953|FG000|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
6363580|NCT00697190|7273954|FG001|STARTED|Second Intervention||20
6363581|NCT00697190|7273953|FG000|COMPLETED|Second Intervention||18
6363582|NCT00697190|7273954|FG001|COMPLETED|Second Intervention||20
6363583|NCT00697190|7273953|FG000|NOT COMPLETED|Second Intervention||0
6363584|NCT00697190|7273954|FG001|NOT COMPLETED|Second Intervention||0
6363585|NCT00697203|7273968|FG000|STARTED|Overall Study||76
6363586|NCT00697203|7273969|FG001|STARTED|Overall Study||68
6363587|NCT00697203|7273970|FG002|STARTED|Overall Study||74
6363588|NCT00697203|7273971|FG003|STARTED|Overall Study||74
6363589|NCT00697203|7273968|FG000|COMPLETED|Overall Study||67
6363590|NCT00697203|7273969|FG001|COMPLETED|Overall Study||62
6363591|NCT00697203|7273970|FG002|COMPLETED|Overall Study||66
6363592|NCT00697203|7273971|FG003|COMPLETED|Overall Study||67
6363593|NCT00697203|7273968|FG000|NOT COMPLETED|Overall Study||9
6363594|NCT00697203|7273969|FG001|NOT COMPLETED|Overall Study||6
6363595|NCT00697203|7273970|FG002|NOT COMPLETED|Overall Study||8
6363596|NCT00697203|7273971|FG003|NOT COMPLETED|Overall Study||7
6363597|NCT00697346|7273984|FG000|STARTED|Overall Study||28
6363598|NCT00697346|7273985|FG001|STARTED|Overall Study||28
6363599|NCT00697346|7273986|FG002|STARTED|Overall Study||2
6363600|NCT00697346|7273984|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
6363601|NCT00697346|7273985|FG001|COMPLETED|Overall Study|2 participants were ongoing as of primary completion date 27 Dec 2011 and have now completed.|2
6363602|NCT00697346|7273986|FG002|COMPLETED|Overall Study|1 participant was ongoing as of primary completion date 27 Dec 2011 and has now completed.|1
6363603|NCT00697346|7273984|FG000|NOT COMPLETED|Overall Study||28
6363604|NCT00697346|7273985|FG001|NOT COMPLETED|Overall Study||26
6363605|NCT00697346|7273986|FG002|NOT COMPLETED|Overall Study||1
6363606|NCT00697463|7274013|FG000|STARTED|Overall Study||22
6363607|NCT00697463|7274013|FG000|COMPLETED|Overall Study||21
6363608|NCT00697463|7274013|FG000|NOT COMPLETED|Overall Study||1
6363609|NCT00697515|7274017|FG000|STARTED|Dose Optimization Period||142
6363610|NCT00697515|7274018|FG001|STARTED|Dose Optimization Period||0
6363611|NCT00697515|7274017|FG000|COMPLETED|Dose Optimization Period||127
6363612|NCT00697515|7274018|FG001|COMPLETED|Dose Optimization Period||0
6363613|NCT00697515|7274017|FG000|NOT COMPLETED|Dose Optimization Period||15
6363614|NCT00697515|7274018|FG001|NOT COMPLETED|Dose Optimization Period||0
6363615|NCT00697515|7274017|FG000|STARTED|First Intervention (Crossover Period)||63
6363616|NCT00697515|7274018|FG001|STARTED|First Intervention (Crossover Period)||64
6363617|NCT00697515|7274017|FG000|COMPLETED|First Intervention (Crossover Period)||53
6363618|NCT00697515|7274018|FG001|COMPLETED|First Intervention (Crossover Period)||52
6363619|NCT00697515|7274017|FG000|NOT COMPLETED|First Intervention (Crossover Period)||10
6363620|NCT00697515|7274018|FG001|NOT COMPLETED|First Intervention (Crossover Period)||12
6363621|NCT00697515|7274017|FG000|STARTED|Second Intervention (Crossover Period)||53
6363622|NCT00697515|7274018|FG001|STARTED|Second Intervention (Crossover Period)||52
6363623|NCT00697515|7274017|FG000|COMPLETED|Second Intervention (Crossover Period)||52
6363624|NCT00697515|7274018|FG001|COMPLETED|Second Intervention (Crossover Period)||51
6363625|NCT00697515|7274017|FG000|NOT COMPLETED|Second Intervention (Crossover Period)||1
6363626|NCT00697515|7274018|FG001|NOT COMPLETED|Second Intervention (Crossover Period)||1
6363627|NCT00697541|7274026|FG000|STARTED|Overall Study||10
6363628|NCT00697541|7274027|FG001|STARTED|Overall Study||10
6363629|NCT00697541|7274026|FG000|COMPLETED|Overall Study||8
6363630|NCT00697541|7274027|FG001|COMPLETED|Overall Study||9
6363631|NCT00697541|7274026|FG000|NOT COMPLETED|Overall Study||2
6363632|NCT00697541|7274027|FG001|NOT COMPLETED|Overall Study||1
6363633|NCT00697593|7274034|FG000|STARTED|Overall Study||70
6363634|NCT00697593|7274034|FG000|COMPLETED|Overall Study||51
6363635|NCT00697593|7274034|FG000|NOT COMPLETED|Overall Study||19
6363636|NCT00697619|7274040|FG000|STARTED|Overall Study||30
6363637|NCT00697619|7274041|FG001|STARTED|Overall Study||30
6363638|NCT00697619|7274040|FG000|COMPLETED|Overall Study||24
6363639|NCT00697619|7274041|FG001|COMPLETED|Overall Study||22
6363640|NCT00697619|7274040|FG000|NOT COMPLETED|Overall Study||6
6363641|NCT00697619|7274041|FG001|NOT COMPLETED|Overall Study||8
6363642|NCT00697697|7274049|FG000|STARTED|Overall Study||94
6363643|NCT00697697|7274050|FG001|STARTED|Overall Study||98
6363644|NCT00697697|7274049|FG000|COMPLETED|Overall Study||45
6363645|NCT00697697|7274050|FG001|COMPLETED|Overall Study||44
6363646|NCT00697697|7274049|FG000|NOT COMPLETED|Overall Study||49
6363647|NCT00697697|7274050|FG001|NOT COMPLETED|Overall Study||54
6363648|NCT00697788|7274056|FG000|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
6363649|NCT00697788|7274057|FG001|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
6363650|NCT00697788|7274058|FG002|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
6363651|NCT00697788|7274059|FG003|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6363652|NCT00697788|7274060|FG004|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6363653|NCT00697788|7274061|FG005|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6363654|NCT00697788|7274062|FG006|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6363655|NCT00697788|7274063|FG007|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
6363656|NCT00697788|7274056|FG000|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
6363657|NCT00697788|7274057|FG001|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363658|NCT00697788|7274058|FG002|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363659|NCT00697788|7274059|FG003|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363660|NCT00697788|7274060|FG004|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363661|NCT00697788|7274061|FG005|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363662|NCT00697788|7274062|FG006|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363663|NCT00697788|7274063|FG007|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363664|NCT00697788|7274056|FG000|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6377367|NCT00762528|7287919|FG001|STARTED|Overall Study||25
6363665|NCT00697788|7274057|FG001|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363666|NCT00697788|7274058|FG002|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363667|NCT00697788|7274059|FG003|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363668|NCT00697788|7274060|FG004|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363669|NCT00697788|7274061|FG005|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363670|NCT00697788|7274062|FG006|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363671|NCT00697788|7274063|FG007|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
6363672|NCT00697788|7274056|FG000|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363673|NCT00697788|7274057|FG001|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
6363674|NCT00697788|7274058|FG002|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363675|NCT00697788|7274059|FG003|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363676|NCT00697788|7274060|FG004|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363677|NCT00697788|7274061|FG005|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363678|NCT00697788|7274062|FG006|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363679|NCT00697788|7274063|FG007|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363680|NCT00697788|7274056|FG000|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363681|NCT00697788|7274057|FG001|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
6363682|NCT00697788|7274058|FG002|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363683|NCT00697788|7274059|FG003|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363684|NCT00697788|7274060|FG004|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363685|NCT00697788|7274061|FG005|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363686|NCT00697788|7274062|FG006|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363687|NCT00697788|7274063|FG007|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363688|NCT00697788|7274056|FG000|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363689|NCT00697788|7274057|FG001|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
6363690|NCT00697788|7274058|FG002|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363691|NCT00697788|7274059|FG003|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363692|NCT00697788|7274060|FG004|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363693|NCT00697788|7274061|FG005|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363694|NCT00697788|7274062|FG006|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363695|NCT00697788|7274063|FG007|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
6363696|NCT00697788|7274056|FG000|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363697|NCT00697788|7274057|FG001|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363698|NCT00697788|7274058|FG002|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
6363699|NCT00697788|7274059|FG003|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363700|NCT00697788|7274060|FG004|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363701|NCT00697788|7274061|FG005|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363702|NCT00697788|7274062|FG006|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363703|NCT00697788|7274063|FG007|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363704|NCT00697788|7274056|FG000|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363705|NCT00697788|7274057|FG001|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363706|NCT00697788|7274058|FG002|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
6363707|NCT00697788|7274059|FG003|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363708|NCT00697788|7274060|FG004|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363709|NCT00697788|7274061|FG005|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363710|NCT00697788|7274062|FG006|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363711|NCT00697788|7274063|FG007|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363712|NCT00697788|7274056|FG000|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363713|NCT00697788|7274057|FG001|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363714|NCT00697788|7274058|FG002|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363715|NCT00697788|7274059|FG003|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363716|NCT00697788|7274060|FG004|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363717|NCT00697788|7274061|FG005|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363718|NCT00697788|7274062|FG006|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363719|NCT00697788|7274063|FG007|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
6363720|NCT00697788|7274056|FG000|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363721|NCT00697788|7274057|FG001|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363722|NCT00697788|7274058|FG002|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363723|NCT00697788|7274059|FG003|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
6363724|NCT00697788|7274060|FG004|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363725|NCT00697788|7274061|FG005|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363726|NCT00697788|7274062|FG006|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363727|NCT00697788|7274063|FG007|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363728|NCT00697788|7274056|FG000|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363729|NCT00697788|7274057|FG001|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363730|NCT00697788|7274058|FG002|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363731|NCT00697788|7274059|FG003|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
6363732|NCT00697788|7274060|FG004|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363733|NCT00697788|7274061|FG005|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363734|NCT00697788|7274062|FG006|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363735|NCT00697788|7274063|FG007|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363736|NCT00697788|7274056|FG000|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363737|NCT00697788|7274057|FG001|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363738|NCT00697788|7274058|FG002|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363739|NCT00697788|7274059|FG003|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363740|NCT00697788|7274060|FG004|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363741|NCT00697788|7274061|FG005|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363742|NCT00697788|7274062|FG006|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363743|NCT00697788|7274063|FG007|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
6363744|NCT00697788|7274056|FG000|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363745|NCT00697788|7274057|FG001|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363746|NCT00697788|7274058|FG002|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363747|NCT00697788|7274059|FG003|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363748|NCT00697788|7274060|FG004|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
6363749|NCT00697788|7274061|FG005|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363750|NCT00697788|7274062|FG006|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363751|NCT00697788|7274063|FG007|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363752|NCT00697788|7274056|FG000|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363753|NCT00697788|7274057|FG001|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363754|NCT00697788|7274058|FG002|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363755|NCT00697788|7274059|FG003|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363756|NCT00697788|7274060|FG004|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
6363757|NCT00697788|7274061|FG005|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363758|NCT00697788|7274062|FG006|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363759|NCT00697788|7274063|FG007|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363760|NCT00697788|7274056|FG000|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363761|NCT00697788|7274057|FG001|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363762|NCT00697788|7274058|FG002|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363763|NCT00697788|7274059|FG003|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363764|NCT00697788|7274060|FG004|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
6363765|NCT00697788|7274061|FG005|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363766|NCT00697788|7274062|FG006|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363767|NCT00697788|7274063|FG007|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
6363768|NCT00697788|7274056|FG000|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363769|NCT00697788|7274057|FG001|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363770|NCT00697788|7274058|FG002|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363771|NCT00697788|7274059|FG003|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363772|NCT00697788|7274060|FG004|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363773|NCT00697788|7274061|FG005|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
6363774|NCT00697788|7274062|FG006|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363775|NCT00697788|7274063|FG007|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363776|NCT00697788|7274056|FG000|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363777|NCT00697788|7274057|FG001|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363778|NCT00697788|7274058|FG002|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363779|NCT00697788|7274059|FG003|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363780|NCT00697788|7274060|FG004|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363781|NCT00697788|7274061|FG005|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
6363782|NCT00697788|7274062|FG006|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363783|NCT00697788|7274063|FG007|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363784|NCT00697788|7274056|FG000|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363785|NCT00697788|7274057|FG001|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363786|NCT00697788|7274058|FG002|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363787|NCT00697788|7274059|FG003|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363788|NCT00697788|7274060|FG004|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363789|NCT00697788|7274061|FG005|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363790|NCT00697788|7274062|FG006|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363791|NCT00697788|7274063|FG007|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
6363792|NCT00697788|7274056|FG000|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363793|NCT00697788|7274057|FG001|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363794|NCT00697788|7274058|FG002|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363795|NCT00697788|7274059|FG003|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363796|NCT00697788|7274060|FG004|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363797|NCT00697788|7274061|FG005|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363798|NCT00697788|7274062|FG006|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
6363799|NCT00697788|7274063|FG007|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363800|NCT00697788|7274056|FG000|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363801|NCT00697788|7274057|FG001|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363802|NCT00697788|7274058|FG002|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363803|NCT00697788|7274059|FG003|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363804|NCT00697788|7274060|FG004|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363805|NCT00697788|7274061|FG005|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363806|NCT00697788|7274062|FG006|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
6560558|NCT01787591|7483358|FG000|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
6560559|NCT01787591|7483359|FG001|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
6560560|NCT01787591|7483360|FG002|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
6363807|NCT00697788|7274063|FG007|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363808|NCT00697788|7274056|FG000|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363809|NCT00697788|7274057|FG001|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363810|NCT00697788|7274058|FG002|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363811|NCT00697788|7274059|FG003|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363812|NCT00697788|7274060|FG004|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363813|NCT00697788|7274061|FG005|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363814|NCT00697788|7274062|FG006|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363815|NCT00697788|7274063|FG007|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
6363816|NCT00697788|7274056|FG000|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363817|NCT00697788|7274057|FG001|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363818|NCT00697788|7274058|FG002|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363819|NCT00697788|7274059|FG003|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363820|NCT00697788|7274060|FG004|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363821|NCT00697788|7274061|FG005|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363822|NCT00697788|7274062|FG006|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363823|NCT00697788|7274063|FG007|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
6363824|NCT00697788|7274056|FG000|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363825|NCT00697788|7274057|FG001|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363826|NCT00697788|7274058|FG002|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363827|NCT00697788|7274059|FG003|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363828|NCT00697788|7274060|FG004|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363829|NCT00697788|7274061|FG005|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363830|NCT00697788|7274062|FG006|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363831|NCT00697788|7274063|FG007|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
6363832|NCT00697788|7274056|FG000|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363833|NCT00697788|7274057|FG001|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363834|NCT00697788|7274058|FG002|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363835|NCT00697788|7274059|FG003|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363836|NCT00697788|7274060|FG004|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363837|NCT00697788|7274061|FG005|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363838|NCT00697788|7274062|FG006|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363839|NCT00697788|7274063|FG007|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
6363840|NCT00697801|7274093|FG000|STARTED|Overall Study||69
6363841|NCT00697801|7274094|FG001|STARTED|Overall Study||70
6363842|NCT00697801|7274095|FG002|STARTED|Overall Study||69
6363843|NCT00697801|7274093|FG000|COMPLETED|Overall Study||57
6363844|NCT00697801|7274094|FG001|COMPLETED|Overall Study||58
6363845|NCT00697801|7274095|FG002|COMPLETED|Overall Study||45
6363846|NCT00697801|7274093|FG000|NOT COMPLETED|Overall Study||12
6363847|NCT00697801|7274094|FG001|NOT COMPLETED|Overall Study||12
6363848|NCT00697801|7274095|FG002|NOT COMPLETED|Overall Study||24
6363849|NCT00697827|7274105|FG000|STARTED|Overall Study||28
6363850|NCT00697827|7274106|FG001|STARTED|Overall Study||16
6363851|NCT00697827|7274105|FG000|COMPLETED|Overall Study||26
6363852|NCT00697827|7274106|FG001|COMPLETED|Overall Study||15
6363853|NCT00697827|7274105|FG000|NOT COMPLETED|Overall Study||2
6363854|NCT00697827|7274106|FG001|NOT COMPLETED|Overall Study||1
6363855|NCT00698035|7274114|FG000|STARTED|Overall Study||39
6363856|NCT00698035|7274115|FG001|STARTED|Overall Study||36
6363857|NCT00698035|7274114|FG000|COMPLETED|Overall Study||35
6363858|NCT00698035|7274115|FG001|COMPLETED|Overall Study||34
6363859|NCT00698035|7274114|FG000|NOT COMPLETED|Overall Study||4
6363860|NCT00698035|7274115|FG001|NOT COMPLETED|Overall Study||2
6363861|NCT00698139|7274127|FG000|STARTED|Overall Study||1
6363862|NCT00698139|7274128|FG001|STARTED|Overall Study||1
6363863|NCT00698139|7274129|FG002|STARTED|Overall Study||1
6363864|NCT00698139|7274127|FG000|2nd Visit|Overall Study||1
6363865|NCT00698139|7274128|FG001|2nd Visit|Overall Study||1
6363866|NCT00698139|7274129|FG002|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
6363867|NCT00698139|7274127|FG000|COMPLETED|Overall Study||1
6363868|NCT00698139|7274128|FG001|COMPLETED|Overall Study||1
6363869|NCT00698139|7274129|FG002|COMPLETED|Overall Study||1
6363870|NCT00698139|7274127|FG000|NOT COMPLETED|Overall Study||0
6363871|NCT00698139|7274128|FG001|NOT COMPLETED|Overall Study||0
6363872|NCT00698139|7274129|FG002|NOT COMPLETED|Overall Study||0
6363873|NCT00698204|7274139|FG000|STARTED|Overall Study||20
6363874|NCT00698204|7274140|FG001|STARTED|Overall Study||20
6363875|NCT00698204|7274139|FG000|COMPLETED|Overall Study||19
6363876|NCT00698204|7274140|FG001|COMPLETED|Overall Study||20
6363877|NCT00698204|7274139|FG000|NOT COMPLETED|Overall Study||1
6363878|NCT00698204|7274140|FG001|NOT COMPLETED|Overall Study||0
6363879|NCT00698451|7274148|FG000|STARTED|Overall Study||54
6363880|NCT00698451|7274148|FG000|COMPLETED|Overall Study||15
6363881|NCT00698451|7274148|FG000|NOT COMPLETED|Overall Study||39
6363882|NCT00698516|7274152|FG000|STARTED|Overall Study||50
6363883|NCT00698516|7274152|FG000|COMPLETED|Overall Study||45
6363884|NCT00698516|7274152|FG000|NOT COMPLETED|Overall Study||5
6363885|NCT00698581|7274162|FG000|STARTED|Overall Study||68
6363886|NCT00698581|7274163|FG001|STARTED|Overall Study||20
6363887|NCT00698581|7274162|FG000|COMPLETED|Overall Study||23
6363888|NCT00698581|7274163|FG001|COMPLETED|Overall Study||8
6363889|NCT00698581|7274162|FG000|NOT COMPLETED|Overall Study||45
6363890|NCT00698581|7274163|FG001|NOT COMPLETED|Overall Study||12
6363891|NCT00698646|7274173|FG000|STARTED|Overall Study||128
6363892|NCT00698646|7274174|FG001|STARTED|Overall Study||128
6363893|NCT00698646|7274175|FG002|STARTED|Overall Study||128
6363894|NCT00698646|7274173|FG000|COMPLETED|Overall Study||92
6363895|NCT00698646|7274174|FG001|COMPLETED|Overall Study||97
6363896|NCT00698646|7274175|FG002|COMPLETED|Overall Study||99
6363897|NCT00698646|7274173|FG000|NOT COMPLETED|Overall Study||36
6363898|NCT00698646|7274174|FG001|NOT COMPLETED|Overall Study||31
6363899|NCT00698646|7274175|FG002|NOT COMPLETED|Overall Study||29
6363900|NCT00698685|7274183|FG000|STARTED|Overall Study||14
6363901|NCT00698685|7274183|FG000|COMPLETED|Overall Study||12
6363902|NCT00698685|7274183|FG000|NOT COMPLETED|Overall Study||2
6363903|NCT00698841|7274187|FG000|STARTED|Overall Study||51
6363904|NCT00698841|7274187|FG000|COMPLETED|Overall Study||33
6363905|NCT00698841|7274187|FG000|NOT COMPLETED|Overall Study||18
6363906|NCT00698867|7274191|FG000|STARTED|Overall Study||118
6363907|NCT00698867|7274191|FG000|Subjects With 1 Year Data|Overall Study||68
6363908|NCT00698867|7274191|FG000|Subjects With 2 Year Data|Overall Study||55
6363909|NCT00698867|7274191|FG000|Subjects With 3 Year Data|Overall Study||35
6363910|NCT00698867|7274191|FG000|Subjects With 4 Year Data|Overall Study||34
6363911|NCT00698867|7274191|FG000|COMPLETED|Overall Study||27
6363912|NCT00698867|7274191|FG000|NOT COMPLETED|Overall Study||91
6363913|NCT00698932|7274197|FG000|STARTED|Overall Study|Randomized and treated|284
6363914|NCT00698932|7274198|FG001|STARTED|Overall Study|Randomized and treated|284
6363915|NCT00698932|7274197|FG000|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
6363916|NCT00698932|7274198|FG001|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
6363917|NCT00698932|7274197|FG000|NOT COMPLETED|Overall Study||22
6363918|NCT00698932|7274198|FG001|NOT COMPLETED|Overall Study||36
6363919|NCT00698997|7274206|FG000|STARTED|Overall Study|1 enrollment|55
6363920|NCT00698997|7274207|FG001|STARTED|Overall Study|1 enrollment|63
6363921|NCT00698997|7274206|FG000|COMPLETED|Overall Study|45 - final participant assessment completed|45
6363922|NCT00698997|7274207|FG001|COMPLETED|Overall Study|36 - final assessment completed|36
6363923|NCT00698997|7274206|FG000|NOT COMPLETED|Overall Study||10
6363924|NCT00698997|7274207|FG001|NOT COMPLETED|Overall Study||27
6363925|NCT00699010|7274216|FG000|STARTED|Overall Study||15
6363926|NCT00699010|7274217|FG001|STARTED|Overall Study||15
6363927|NCT00699010|7274216|FG000|COMPLETED|Overall Study||15
6363928|NCT00699010|7274217|FG001|COMPLETED|Overall Study||15
6363929|NCT00699010|7274216|FG000|NOT COMPLETED|Overall Study||0
6363930|NCT00699010|7274217|FG001|NOT COMPLETED|Overall Study||0
6363931|NCT00699140|7274223|FG000|STARTED|Overall Study||18
6363932|NCT00699140|7274223|FG000|COMPLETED|Overall Study||18
6363933|NCT00699140|7274223|FG000|NOT COMPLETED|Overall Study||0
6363934|NCT00699153|7274233|FG000|STARTED|Overall Study|Intent to treat population|203
6363935|NCT00699153|7274234|FG001|STARTED|Overall Study|Intent to treat population|202
6363936|NCT00699153|7274233|FG000|COMPLETED|Overall Study||200
6363937|NCT00699153|7274234|FG001|COMPLETED|Overall Study||200
6363938|NCT00699153|7274233|FG000|NOT COMPLETED|Overall Study||3
6363939|NCT00699153|7274234|FG001|NOT COMPLETED|Overall Study||2
6363940|NCT00699192|7274243|FG000|STARTED|Overall Study||275
6363941|NCT00699192|7274244|FG001|STARTED|Overall Study||272
6363942|NCT00699192|7274245|FG002|STARTED|Overall Study||272
6363943|NCT00699192|7274243|FG000|COMPLETED|Overall Study||259
6363944|NCT00699192|7274244|FG001|COMPLETED|Overall Study||260
6363945|NCT00699192|7274245|FG002|COMPLETED|Overall Study||261
6363946|NCT00699192|7274243|FG000|NOT COMPLETED|Overall Study||16
6363947|NCT00699192|7274244|FG001|NOT COMPLETED|Overall Study||12
6363948|NCT00699192|7274245|FG002|NOT COMPLETED|Overall Study||11
6363949|NCT00699218|7274253|FG000|STARTED|Overall Study||15
6363950|NCT00699218|7274253|FG000|COMPLETED|Overall Study||15
6363951|NCT00699218|7274253|FG000|NOT COMPLETED|Overall Study||0
6363952|NCT00699283|7274259|FG000|STARTED|Overall Study||47
6363953|NCT00699283|7274260|FG001|STARTED|Overall Study||15
6363954|NCT00699283|7274259|FG000|COMPLETED|Overall Study||14
6363955|NCT00699283|7274260|FG001|COMPLETED|Overall Study||7
6363956|NCT00699283|7274259|FG000|NOT COMPLETED|Overall Study||33
6363957|NCT00699283|7274260|FG001|NOT COMPLETED|Overall Study||8
6363958|NCT00699335|7274265|FG000|STARTED|Overall Study||5308
6363959|NCT00699335|7274265|FG000|COMPLETED|Overall Study||5080
6363960|NCT00699335|7274265|FG000|NOT COMPLETED|Overall Study||228
6363961|NCT00699348|7274272|FG000|STARTED|Overall Study||351
6363962|NCT00699348|7274272|FG000|COMPLETED|Overall Study||261
6363963|NCT00699348|7274272|FG000|NOT COMPLETED|Overall Study||90
6363964|NCT00699374|7274278|FG000|STARTED|Overall Study||530
6363965|NCT00699374|7274279|FG001|STARTED|Overall Study||544
6363966|NCT00699374|7274278|FG000|Treated|Overall Study||526
6363967|NCT00699374|7274279|FG001|Treated|Overall Study||542
6363968|NCT00699374|7274278|FG000|COMPLETED|Overall Study||0
6363969|NCT00699374|7274279|FG001|COMPLETED|Overall Study||0
6363970|NCT00699374|7274278|FG000|NOT COMPLETED|Overall Study||530
6363971|NCT00699374|7274279|FG001|NOT COMPLETED|Overall Study||544
6363972|NCT00699400|7274288|FG000|STARTED|Overall Study||42
6363973|NCT00699400|7274289|FG001|STARTED|Overall Study||3
6363974|NCT00699400|7274290|FG002|STARTED|Overall Study||138
6363975|NCT00699400|7274291|FG003|STARTED|Overall Study||6
6363976|NCT00699400|7274292|FG004|STARTED|Overall Study||4
6363977|NCT00699400|7274293|FG005|STARTED|Overall Study||11
6363978|NCT00699400|7274288|FG000|COMPLETED|Overall Study||42
6363979|NCT00699400|7274289|FG001|COMPLETED|Overall Study||3
6363980|NCT00699400|7274290|FG002|COMPLETED|Overall Study||138
6363981|NCT00699400|7274291|FG003|COMPLETED|Overall Study||6
6363982|NCT00699400|7274292|FG004|COMPLETED|Overall Study||4
6363983|NCT00699400|7274293|FG005|COMPLETED|Overall Study||0
6363984|NCT00699400|7274288|FG000|NOT COMPLETED|Overall Study||0
6363985|NCT00699400|7274289|FG001|NOT COMPLETED|Overall Study||0
6363986|NCT00699400|7274290|FG002|NOT COMPLETED|Overall Study||0
6363987|NCT00699400|7274291|FG003|NOT COMPLETED|Overall Study||0
6363988|NCT00699400|7274292|FG004|NOT COMPLETED|Overall Study||0
6363989|NCT00699400|7274293|FG005|NOT COMPLETED|Overall Study||11
6363990|NCT00699491|7274307|FG000|STARTED|Overall Study||3
6363991|NCT00699491|7274308|FG001|STARTED|Overall Study||2
6363992|NCT00699491|7274309|FG002|STARTED|Overall Study||7
6363993|NCT00699491|7274310|FG003|STARTED|Overall Study||6
6363994|NCT00699491|7274311|FG004|STARTED|Overall Study||8
6363995|NCT00699491|7274312|FG005|STARTED|Overall Study||22
6363996|NCT00699491|7274307|FG000|COMPLETED|Overall Study||3
6363997|NCT00699491|7274308|FG001|COMPLETED|Overall Study||2
6363998|NCT00699491|7274309|FG002|COMPLETED|Overall Study||7
6363999|NCT00699491|7274310|FG003|COMPLETED|Overall Study||6
6364000|NCT00699491|7274311|FG004|COMPLETED|Overall Study||8
6364001|NCT00699491|7274312|FG005|COMPLETED|Overall Study||22
6364002|NCT00699491|7274307|FG000|NOT COMPLETED|Overall Study||0
6364003|NCT00699491|7274308|FG001|NOT COMPLETED|Overall Study||0
6364004|NCT00699491|7274309|FG002|NOT COMPLETED|Overall Study||0
6364005|NCT00699491|7274310|FG003|NOT COMPLETED|Overall Study||0
6364006|NCT00699491|7274311|FG004|NOT COMPLETED|Overall Study||0
6364007|NCT00699491|7274312|FG005|NOT COMPLETED|Overall Study||0
6364008|NCT00699556|7274326|FG000|STARTED|First Intervention (1 Day)||11
6364009|NCT00699556|7274327|FG001|STARTED|First Intervention (1 Day)||11
6364010|NCT00699556|7274326|FG000|COMPLETED|First Intervention (1 Day)||11
6364011|NCT00699556|7274327|FG001|COMPLETED|First Intervention (1 Day)||11
6364012|NCT00699556|7274326|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6364013|NCT00699556|7274327|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6364014|NCT00699556|7274326|FG000|STARTED|Second Intervention (1 Day)||11
6364015|NCT00699556|7274327|FG001|STARTED|Second Intervention (1 Day)||11
6364016|NCT00699556|7274326|FG000|COMPLETED|Second Intervention (1 Day)||11
6364017|NCT00699556|7274327|FG001|COMPLETED|Second Intervention (1 Day)||11
6364018|NCT00699556|7274326|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6364019|NCT00699556|7274327|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6364020|NCT00699582|7274337|FG000|STARTED|Overall Study||138
6364021|NCT00699582|7274338|FG001|STARTED|Overall Study||130
6364022|NCT00699582|7274339|FG002|STARTED|Overall Study||121
6364023|NCT00699582|7274337|FG000|COMPLETED|Overall Study||120
6364024|NCT00699582|7274338|FG001|COMPLETED|Overall Study||108
6364025|NCT00699582|7274339|FG002|COMPLETED|Overall Study||93
6364026|NCT00699582|7274337|FG000|NOT COMPLETED|Overall Study||18
6364027|NCT00699582|7274338|FG001|NOT COMPLETED|Overall Study||22
6364028|NCT00699582|7274339|FG002|NOT COMPLETED|Overall Study||28
6364029|NCT00699608|7274347|FG000|STARTED|First Intervention||16
6364030|NCT00699608|7274348|FG001|STARTED|First Intervention||15
6364031|NCT00699608|7274349|FG002|STARTED|First Intervention||15
6364032|NCT00699608|7274350|FG003|STARTED|First Intervention||15
6364033|NCT00699608|7274351|FG004|STARTED|First Intervention||15
6364034|NCT00699608|7274352|FG005|STARTED|First Intervention||15
6364035|NCT00699608|7274347|FG000|COMPLETED|First Intervention||16
6364036|NCT00699608|7274348|FG001|COMPLETED|First Intervention||15
6364037|NCT00699608|7274349|FG002|COMPLETED|First Intervention||14
6364038|NCT00699608|7274350|FG003|COMPLETED|First Intervention||15
6364039|NCT00699608|7274351|FG004|COMPLETED|First Intervention||14
6364040|NCT00699608|7274352|FG005|COMPLETED|First Intervention||15
6364041|NCT00699608|7274347|FG000|NOT COMPLETED|First Intervention||0
6364042|NCT00699608|7274348|FG001|NOT COMPLETED|First Intervention||0
6364043|NCT00699608|7274349|FG002|NOT COMPLETED|First Intervention||1
6364044|NCT00699608|7274350|FG003|NOT COMPLETED|First Intervention||0
6364045|NCT00699608|7274351|FG004|NOT COMPLETED|First Intervention||1
6364046|NCT00699608|7274352|FG005|NOT COMPLETED|First Intervention||0
6364047|NCT00699608|7274347|FG000|STARTED|First 4-14 Day Washout Period||16
6364048|NCT00699608|7274348|FG001|STARTED|First 4-14 Day Washout Period||15
6364049|NCT00699608|7274349|FG002|STARTED|First 4-14 Day Washout Period||14
6364050|NCT00699608|7274350|FG003|STARTED|First 4-14 Day Washout Period||15
6364051|NCT00699608|7274351|FG004|STARTED|First 4-14 Day Washout Period||14
6364052|NCT00699608|7274352|FG005|STARTED|First 4-14 Day Washout Period||15
6364053|NCT00699608|7274347|FG000|COMPLETED|First 4-14 Day Washout Period||16
6364054|NCT00699608|7274348|FG001|COMPLETED|First 4-14 Day Washout Period||15
6364055|NCT00699608|7274349|FG002|COMPLETED|First 4-14 Day Washout Period||14
6364056|NCT00699608|7274350|FG003|COMPLETED|First 4-14 Day Washout Period||15
6364057|NCT00699608|7274351|FG004|COMPLETED|First 4-14 Day Washout Period||14
6364058|NCT00699608|7274352|FG005|COMPLETED|First 4-14 Day Washout Period||15
6364059|NCT00699608|7274347|FG000|NOT COMPLETED|First 4-14 Day Washout Period||0
6364060|NCT00699608|7274348|FG001|NOT COMPLETED|First 4-14 Day Washout Period||0
6364061|NCT00699608|7274349|FG002|NOT COMPLETED|First 4-14 Day Washout Period||0
6364062|NCT00699608|7274350|FG003|NOT COMPLETED|First 4-14 Day Washout Period||0
6364063|NCT00699608|7274351|FG004|NOT COMPLETED|First 4-14 Day Washout Period||0
6364064|NCT00699608|7274352|FG005|NOT COMPLETED|First 4-14 Day Washout Period||0
6364065|NCT00699608|7274347|FG000|STARTED|Second Intervention||16
6364066|NCT00699608|7274348|FG001|STARTED|Second Intervention||15
6364067|NCT00699608|7274349|FG002|STARTED|Second Intervention||14
6364068|NCT00699608|7274350|FG003|STARTED|Second Intervention||15
6364069|NCT00699608|7274351|FG004|STARTED|Second Intervention||14
6364070|NCT00699608|7274352|FG005|STARTED|Second Intervention||15
6364071|NCT00699608|7274347|FG000|COMPLETED|Second Intervention||16
6364072|NCT00699608|7274348|FG001|COMPLETED|Second Intervention||15
6364073|NCT00699608|7274349|FG002|COMPLETED|Second Intervention||13
6364074|NCT00699608|7274350|FG003|COMPLETED|Second Intervention||14
6364075|NCT00699608|7274351|FG004|COMPLETED|Second Intervention||14
6364076|NCT00699608|7274352|FG005|COMPLETED|Second Intervention||15
6364077|NCT00699608|7274347|FG000|NOT COMPLETED|Second Intervention||0
6364078|NCT00699608|7274348|FG001|NOT COMPLETED|Second Intervention||0
6364079|NCT00699608|7274349|FG002|NOT COMPLETED|Second Intervention||1
6364080|NCT00699608|7274350|FG003|NOT COMPLETED|Second Intervention||1
6364081|NCT00699608|7274351|FG004|NOT COMPLETED|Second Intervention||0
6364082|NCT00699608|7274352|FG005|NOT COMPLETED|Second Intervention||0
6364083|NCT00699608|7274347|FG000|STARTED|Second 4-14 Day Washout Period||16
6364084|NCT00699608|7274348|FG001|STARTED|Second 4-14 Day Washout Period||15
6364085|NCT00699608|7274349|FG002|STARTED|Second 4-14 Day Washout Period||13
6364086|NCT00699608|7274350|FG003|STARTED|Second 4-14 Day Washout Period||14
6364087|NCT00699608|7274351|FG004|STARTED|Second 4-14 Day Washout Period||14
6364088|NCT00699608|7274352|FG005|STARTED|Second 4-14 Day Washout Period||15
6364089|NCT00699608|7274347|FG000|COMPLETED|Second 4-14 Day Washout Period||16
6364090|NCT00699608|7274348|FG001|COMPLETED|Second 4-14 Day Washout Period||15
6364091|NCT00699608|7274349|FG002|COMPLETED|Second 4-14 Day Washout Period||13
6364092|NCT00699608|7274350|FG003|COMPLETED|Second 4-14 Day Washout Period||14
6364093|NCT00699608|7274351|FG004|COMPLETED|Second 4-14 Day Washout Period||14
6364094|NCT00699608|7274352|FG005|COMPLETED|Second 4-14 Day Washout Period||15
6364095|NCT00699608|7274347|FG000|NOT COMPLETED|Second 4-14 Day Washout Period||0
6364096|NCT00699608|7274348|FG001|NOT COMPLETED|Second 4-14 Day Washout Period||0
6364097|NCT00699608|7274349|FG002|NOT COMPLETED|Second 4-14 Day Washout Period||0
6364098|NCT00699608|7274350|FG003|NOT COMPLETED|Second 4-14 Day Washout Period||0
6364099|NCT00699608|7274351|FG004|NOT COMPLETED|Second 4-14 Day Washout Period||0
6364100|NCT00699608|7274352|FG005|NOT COMPLETED|Second 4-14 Day Washout Period||0
6364101|NCT00699608|7274347|FG000|STARTED|Third Intervention||16
6364102|NCT00699608|7274348|FG001|STARTED|Third Intervention||15
6364103|NCT00699608|7274349|FG002|STARTED|Third Intervention||13
6364104|NCT00699608|7274350|FG003|STARTED|Third Intervention||14
6364105|NCT00699608|7274351|FG004|STARTED|Third Intervention||14
6364106|NCT00699608|7274352|FG005|STARTED|Third Intervention||15
6364107|NCT00699608|7274347|FG000|COMPLETED|Third Intervention||16
6364108|NCT00699608|7274348|FG001|COMPLETED|Third Intervention||15
6364109|NCT00699608|7274349|FG002|COMPLETED|Third Intervention||13
6364110|NCT00699608|7274350|FG003|COMPLETED|Third Intervention||14
6364111|NCT00699608|7274351|FG004|COMPLETED|Third Intervention||14
6364112|NCT00699608|7274352|FG005|COMPLETED|Third Intervention||15
6364113|NCT00699608|7274347|FG000|NOT COMPLETED|Third Intervention||0
6364114|NCT00699608|7274348|FG001|NOT COMPLETED|Third Intervention||0
6364115|NCT00699608|7274349|FG002|NOT COMPLETED|Third Intervention||0
6364116|NCT00699608|7274350|FG003|NOT COMPLETED|Third Intervention||0
6364117|NCT00699608|7274351|FG004|NOT COMPLETED|Third Intervention||0
6364118|NCT00699608|7274352|FG005|NOT COMPLETED|Third Intervention||0
6364119|NCT00699660|7274362|FG000|STARTED|Overall Study||190
6364120|NCT00699660|7274363|FG001|STARTED|Overall Study||216
6364121|NCT00699660|7274362|FG000|COMPLETED|Overall Study||176
6364122|NCT00699660|7274363|FG001|COMPLETED|Overall Study||208
6364123|NCT00699660|7274362|FG000|NOT COMPLETED|Overall Study||14
6364124|NCT00699660|7274363|FG001|NOT COMPLETED|Overall Study||8
6364125|NCT00699699|7274369|FG000|STARTED|Overall Study||1280
6364126|NCT00699699|7274369|FG000|COMPLETED|Overall Study||1223
6364127|NCT00699699|7274369|FG000|NOT COMPLETED|Overall Study||57
6364128|NCT00699751|7274375|FG000|STARTED|Period 1: Without/Before Drug Switch||614
6364129|NCT00699751|7274376|FG001|STARTED|Period 1: Without/Before Drug Switch||307
6364130|NCT00699751|7274375|FG000|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
6364131|NCT00699751|7274376|FG001|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
6364132|NCT00699751|7274375|FG000|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
6364133|NCT00699751|7274376|FG001|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
6364134|NCT00699751|7274375|FG000|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
6364135|NCT00699751|7274376|FG001|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
6364136|NCT00699751|7274375|FG000|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
6364137|NCT00699751|7274376|FG001|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
6364138|NCT00699751|7274375|FG000|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
6364139|NCT00699751|7274376|FG001|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
6364140|NCT00699751|7274375|FG000|STARTED|Period 2:Switched From Placebo to Xofigo||0
6364141|NCT00699751|7274376|FG001|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
6364142|NCT00699751|7274375|FG000|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
6364143|NCT00699751|7274376|FG001|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
6377368|NCT00762528|7287918|FG000|COMPLETED|Overall Study||24
6364144|NCT00699751|7274375|FG000|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
6364145|NCT00699751|7274376|FG001|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
6364146|NCT00699751|7274375|FG000|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
6364147|NCT00699751|7274376|FG001|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
6364148|NCT00699751|7274375|FG000|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
6364149|NCT00699751|7274376|FG001|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
6364150|NCT00699751|7274375|FG000|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
6364151|NCT00699751|7274376|FG001|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
6364152|NCT00699803|7274385|FG000|STARTED|Overall Study||32
6364153|NCT00699803|7274386|FG001|STARTED|Overall Study||32
6364154|NCT00699803|7274385|FG000|COMPLETED|Overall Study||30
6364155|NCT00699803|7274386|FG001|COMPLETED|Overall Study||26
6364156|NCT00699803|7274385|FG000|NOT COMPLETED|Overall Study||2
6364157|NCT00699803|7274386|FG001|NOT COMPLETED|Overall Study||6
6364158|NCT00699816|7274394|FG000|STARTED|Overall Study||115
6364159|NCT00699816|7274395|FG001|STARTED|Overall Study||115
6364160|NCT00699816|7274394|FG000|COMPLETED|Overall Study||114
6364161|NCT00699816|7274395|FG001|COMPLETED|Overall Study||112
6364162|NCT00699816|7274394|FG000|NOT COMPLETED|Overall Study||1
6364163|NCT00699816|7274395|FG001|NOT COMPLETED|Overall Study||3
6364164|NCT00699907|7274404|FG000|STARTED|Overall Study||14
6364165|NCT00699907|7274405|FG001|STARTED|Overall Study||57
6364166|NCT00699907|7274406|FG002|STARTED|Overall Study||56
6364167|NCT00699907|7274404|FG000|COMPLETED|Overall Study||12
6364168|NCT00699907|7274405|FG001|COMPLETED|Overall Study||47
6364169|NCT00699907|7274406|FG002|COMPLETED|Overall Study||48
6364170|NCT00699907|7274404|FG000|NOT COMPLETED|Overall Study||2
6364171|NCT00699907|7274405|FG001|NOT COMPLETED|Overall Study||10
6364172|NCT00699907|7274406|FG002|NOT COMPLETED|Overall Study||8
6364173|NCT00699972|7274417|FG000|STARTED|Overall Study||122
6364174|NCT00699972|7274418|FG001|STARTED|Overall Study||133
6364175|NCT00699972|7274419|FG002|STARTED|Overall Study||135
6364176|NCT00699972|7274417|FG000|COMPLETED|Overall Study||106
6364177|NCT00699972|7274418|FG001|COMPLETED|Overall Study||114
6364178|NCT00699972|7274419|FG002|COMPLETED|Overall Study||100
6364179|NCT00699972|7274417|FG000|NOT COMPLETED|Overall Study||16
6364180|NCT00699972|7274418|FG001|NOT COMPLETED|Overall Study||19
6364181|NCT00699972|7274419|FG002|NOT COMPLETED|Overall Study||35
6364182|NCT00699998|7274431|FG000|STARTED|Overall Study||3620
6364183|NCT00699998|7274432|FG001|STARTED|Overall Study||1043
6364184|NCT00699998|7274433|FG002|STARTED|Overall Study||3623
6364185|NCT00699998|7274434|FG003|STARTED|Overall Study||1040
6364186|NCT00699998|7274431|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3590
6364187|NCT00699998|7274432|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1033
6364188|NCT00699998|7274433|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3590
6364189|NCT00699998|7274434|FG003|Received at Least 1 Dose of Study Drug|Overall Study||1027
6364190|NCT00699998|7274431|FG000|COMPLETED|Overall Study||3421
6364191|NCT00699998|7274432|FG001|COMPLETED|Overall Study||957
6364192|NCT00699998|7274433|FG002|COMPLETED|Overall Study||3417
6364193|NCT00699998|7274434|FG003|COMPLETED|Overall Study||958
6364194|NCT00699998|7274431|FG000|NOT COMPLETED|Overall Study||199
6364195|NCT00699998|7274432|FG001|NOT COMPLETED|Overall Study||86
6364196|NCT00699998|7274433|FG002|NOT COMPLETED|Overall Study||206
6364197|NCT00699998|7274434|FG003|NOT COMPLETED|Overall Study||82
6364198|NCT00700011|7274451|FG000|STARTED|Overall Study||8
6364199|NCT00700011|7274452|FG001|STARTED|Overall Study||2
6364200|NCT00700011|7274451|FG000|COMPLETED|Overall Study||8
6364201|NCT00700011|7274452|FG001|COMPLETED|Overall Study||1
6364202|NCT00700011|7274451|FG000|NOT COMPLETED|Overall Study||0
6364203|NCT00700011|7274452|FG001|NOT COMPLETED|Overall Study||1
6364204|NCT00700063|7274466|FG000|STARTED|Overall Study||33
6364205|NCT00700063|7274467|FG001|STARTED|Overall Study||34
6364206|NCT00700063|7274468|FG002|STARTED|Overall Study||33
6364207|NCT00700063|7274469|FG003|STARTED|Overall Study||33
6364208|NCT00700063|7274470|FG004|STARTED|Overall Study||33
6364209|NCT00700063|7274471|FG005|STARTED|Overall Study||34
6364210|NCT00700063|7274472|FG006|STARTED|Overall Study||32
6364211|NCT00700063|7274473|FG007|STARTED|Overall Study||33
6364212|NCT00700063|7274466|FG000|COMPLETED|Overall Study||32
6364213|NCT00700063|7274467|FG001|COMPLETED|Overall Study||34
6364214|NCT00700063|7274468|FG002|COMPLETED|Overall Study||33
6364215|NCT00700063|7274469|FG003|COMPLETED|Overall Study||31
6364216|NCT00700063|7274470|FG004|COMPLETED|Overall Study||31
6364217|NCT00700063|7274471|FG005|COMPLETED|Overall Study||34
6364218|NCT00700063|7274472|FG006|COMPLETED|Overall Study||32
6364219|NCT00700063|7274473|FG007|COMPLETED|Overall Study||33
6364220|NCT00700063|7274466|FG000|NOT COMPLETED|Overall Study||1
6364221|NCT00700063|7274467|FG001|NOT COMPLETED|Overall Study||0
6364222|NCT00700063|7274468|FG002|NOT COMPLETED|Overall Study||0
6364223|NCT00700063|7274469|FG003|NOT COMPLETED|Overall Study||2
6364224|NCT00700063|7274470|FG004|NOT COMPLETED|Overall Study||2
6364225|NCT00700063|7274471|FG005|NOT COMPLETED|Overall Study||0
6364226|NCT00700063|7274472|FG006|NOT COMPLETED|Overall Study||0
6364227|NCT00700063|7274473|FG007|NOT COMPLETED|Overall Study||0
6364228|NCT00700102|7274493|FG000|STARTED|Overall Study||411
6364229|NCT00700102|7274494|FG001|STARTED|Overall Study||409
6364230|NCT00700102|7274493|FG000|Intention to Treat|Overall Study||410
6364231|NCT00700102|7274494|FG001|Intention to Treat|Overall Study||409
6364232|NCT00700102|7274493|FG000|Received at Least One Dose|Overall Study||407
6364233|NCT00700102|7274494|FG001|Received at Least One Dose|Overall Study||403
6364234|NCT00700102|7274493|FG000|COMPLETED|Overall Study||9
6364235|NCT00700102|7274494|FG001|COMPLETED|Overall Study||14
6364236|NCT00700102|7274493|FG000|NOT COMPLETED|Overall Study||402
6364237|NCT00700102|7274494|FG001|NOT COMPLETED|Overall Study||395
6364238|NCT00700115|7274502|FG000|STARTED|Overall Study||40
6364239|NCT00700115|7274503|FG001|STARTED|Overall Study||20
6364240|NCT00700115|7274502|FG000|COMPLETED|Overall Study||39
6560561|NCT01787591|7483361|FG003|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
6560562|NCT01787591|7483358|FG000|STARTED|Period 2 (Cross-over Arm 2)||5
6560563|NCT01787591|7483359|FG001|STARTED|Period 2 (Cross-over Arm 2)||5
6560564|NCT01787591|7483360|FG002|STARTED|Period 2 (Cross-over Arm 2)||5
6560565|NCT01787591|7483361|FG003|STARTED|Period 2 (Cross-over Arm 2)||5
6560566|NCT01787591|7483358|FG000|COMPLETED|Period 2 (Cross-over Arm 2)||5
6560567|NCT01787591|7483359|FG001|COMPLETED|Period 2 (Cross-over Arm 2)||5
6560568|NCT01787591|7483360|FG002|COMPLETED|Period 2 (Cross-over Arm 2)||5
6560569|NCT01787591|7483361|FG003|COMPLETED|Period 2 (Cross-over Arm 2)||5
6560570|NCT01787591|7483358|FG000|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
6560571|NCT01787591|7483359|FG001|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
6560572|NCT01787591|7483360|FG002|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
6560573|NCT01787591|7483361|FG003|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
6560574|NCT01787591|7483358|FG000|STARTED|Period 3 (Cross-over Arm 3)||5
6560575|NCT01787591|7483359|FG001|STARTED|Period 3 (Cross-over Arm 3)||5
6560576|NCT01787591|7483360|FG002|STARTED|Period 3 (Cross-over Arm 3)||5
6560577|NCT01787591|7483361|FG003|STARTED|Period 3 (Cross-over Arm 3)||5
6560578|NCT01787591|7483358|FG000|COMPLETED|Period 3 (Cross-over Arm 3)||5
6560579|NCT01787591|7483359|FG001|COMPLETED|Period 3 (Cross-over Arm 3)||5
6560580|NCT01787591|7483360|FG002|COMPLETED|Period 3 (Cross-over Arm 3)||5
6560581|NCT01787591|7483361|FG003|COMPLETED|Period 3 (Cross-over Arm 3)||5
6560582|NCT01787591|7483358|FG000|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
6560583|NCT01787591|7483359|FG001|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
6560584|NCT01787591|7483360|FG002|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
6560585|NCT01787591|7483361|FG003|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
6560586|NCT01787591|7483358|FG000|STARTED|Period 4 (Cross-over Arm 4)||5
6560587|NCT01787591|7483359|FG001|STARTED|Period 4 (Cross-over Arm 4)||5
6560588|NCT01787591|7483360|FG002|STARTED|Period 4 (Cross-over Arm 4)||5
6560589|NCT01787591|7483361|FG003|STARTED|Period 4 (Cross-over Arm 4)||5
6560590|NCT01787591|7483358|FG000|COMPLETED|Period 4 (Cross-over Arm 4)||5
6560591|NCT01787591|7483359|FG001|COMPLETED|Period 4 (Cross-over Arm 4)||5
6560592|NCT01787591|7483360|FG002|COMPLETED|Period 4 (Cross-over Arm 4)||5
6560593|NCT01787591|7483361|FG003|COMPLETED|Period 4 (Cross-over Arm 4)||5
6560594|NCT01787591|7483358|FG000|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
6560595|NCT01787591|7483359|FG001|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
6560596|NCT01787591|7483360|FG002|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
6560597|NCT01787591|7483361|FG003|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
6560598|NCT01787604|7483374|FG000|STARTED|Overall Study||32
6560599|NCT01787604|7483375|FG001|STARTED|Overall Study||32
6560600|NCT01787604|7483374|FG000|COMPLETED|Overall Study||28
6560601|NCT01787604|7483375|FG001|COMPLETED|Overall Study||28
6560602|NCT01787604|7483374|FG000|NOT COMPLETED|Overall Study||4
6560603|NCT01787604|7483375|FG001|NOT COMPLETED|Overall Study||4
6560604|NCT01787760|7483384|FG000|STARTED|Overall Study||51
6560605|NCT01787760|7483385|FG001|STARTED|Overall Study||50
6560606|NCT01787760|7483386|FG002|STARTED|Overall Study||51
6560607|NCT01787760|7483384|FG000|COMPLETED|Overall Study||25
6560608|NCT01787760|7483385|FG001|COMPLETED|Overall Study||34
6560609|NCT01787760|7483386|FG002|COMPLETED|Overall Study||46
6560610|NCT01787760|7483384|FG000|NOT COMPLETED|Overall Study||26
6560611|NCT01787760|7483385|FG001|NOT COMPLETED|Overall Study||16
6560612|NCT01787760|7483386|FG002|NOT COMPLETED|Overall Study||5
6560613|NCT01787799|7483395|FG000|STARTED|Overall Study||100
6560614|NCT01787799|7483395|FG000|COMPLETED|Overall Study||100
6560615|NCT01787799|7483395|FG000|NOT COMPLETED|Overall Study||0
6560616|NCT01787825|7483399|FG000|STARTED|Overall Study||60
6560617|NCT01787825|7483400|FG001|STARTED|Overall Study||61
6560618|NCT01787825|7483399|FG000|COMPLETED|Overall Study||54
6560619|NCT01787825|7483400|FG001|COMPLETED|Overall Study||60
6560620|NCT01787825|7483399|FG000|NOT COMPLETED|Overall Study||6
6560621|NCT01787825|7483400|FG001|NOT COMPLETED|Overall Study||1
6560622|NCT01787838|7483407|FG000|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
6560623|NCT01787838|7483407|FG000|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
6560624|NCT01787838|7483407|FG000|NOT COMPLETED|Overall Study||1413
6560625|NCT01787916|7483411|FG000|STARTED|First Intervention (24 Weeks)||8
6560626|NCT01787916|7483412|FG001|STARTED|First Intervention (24 Weeks)||7
6560627|NCT01787916|7483411|FG000|COMPLETED|First Intervention (24 Weeks)||8
6560628|NCT01787916|7483412|FG001|COMPLETED|First Intervention (24 Weeks)||7
6560629|NCT01787916|7483411|FG000|NOT COMPLETED|First Intervention (24 Weeks)||0
6560630|NCT01787916|7483412|FG001|NOT COMPLETED|First Intervention (24 Weeks)||0
6560631|NCT01787916|7483411|FG000|STARTED|Washout (4 Weeks)||8
6560632|NCT01787916|7483412|FG001|STARTED|Washout (4 Weeks)||7
6560633|NCT01787916|7483411|FG000|COMPLETED|Washout (4 Weeks)||8
6364241|NCT00700115|7274503|FG001|COMPLETED|Overall Study||19
6364242|NCT00700115|7274502|FG000|NOT COMPLETED|Overall Study||1
6560634|NCT01787916|7483412|FG001|COMPLETED|Washout (4 Weeks)||7
6560635|NCT01787916|7483411|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6560636|NCT01787916|7483412|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6560637|NCT01787916|7483411|FG000|STARTED|Second Intervention (24 Weeks)||8
6560638|NCT01787916|7483412|FG001|STARTED|Second Intervention (24 Weeks)||7
6560639|NCT01787916|7483411|FG000|COMPLETED|Second Intervention (24 Weeks)||8
6560640|NCT01787916|7483412|FG001|COMPLETED|Second Intervention (24 Weeks)||7
6560641|NCT01787916|7483411|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
6560642|NCT01787916|7483412|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
6562870|NCT01803269|7485765|FG002|NOT COMPLETED|Overall Study||0
6364243|NCT00700115|7274503|FG001|NOT COMPLETED|Overall Study||1
6364244|NCT00700141|7274509|FG000|STARTED|Overall Study||482
6364245|NCT00700141|7274509|FG000|COMPLETED|Overall Study||482
6364246|NCT00700141|7274509|FG000|NOT COMPLETED|Overall Study||0
6364247|NCT00700180|7274515|FG000|STARTED|Overall Study||154
6364248|NCT00700180|7274516|FG001|STARTED|Overall Study||149
6364249|NCT00700180|7274515|FG000|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
6364250|NCT00700180|7274516|FG001|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
6364251|NCT00700180|7274515|FG000|NOT COMPLETED|Overall Study||154
6364252|NCT00700180|7274516|FG001|NOT COMPLETED|Overall Study||149
6364253|NCT00700271|7274524|FG000|STARTED|Overall Study||278
6364254|NCT00700271|7274525|FG001|STARTED|Overall Study||268
6364255|NCT00700271|7274524|FG000|COMPLETED|Overall Study||264
6364256|NCT00700271|7274525|FG001|COMPLETED|Overall Study||256
6364257|NCT00700271|7274524|FG000|NOT COMPLETED|Overall Study||14
6364258|NCT00700271|7274525|FG001|NOT COMPLETED|Overall Study||12
6364259|NCT00700310|7274535|FG000|STARTED|Overall Study||187
6364260|NCT00700310|7274536|FG001|STARTED|Overall Study||180
6364261|NCT00700310|7274537|FG002|STARTED|Overall Study||174
6364262|NCT00700310|7274538|FG003|STARTED|Overall Study||171
6364263|NCT00700310|7274535|FG000|COMPLETED|Overall Study||166
6364264|NCT00700310|7274536|FG001|COMPLETED|Overall Study||154
6364265|NCT00700310|7274537|FG002|COMPLETED|Overall Study||158
6364266|NCT00700310|7274538|FG003|COMPLETED|Overall Study||145
6364267|NCT00700310|7274535|FG000|NOT COMPLETED|Overall Study||21
6364268|NCT00700310|7274536|FG001|NOT COMPLETED|Overall Study||26
6364269|NCT00700310|7274537|FG002|NOT COMPLETED|Overall Study||16
6364270|NCT00700310|7274538|FG003|NOT COMPLETED|Overall Study||26
6364271|NCT00700336|7274551|FG000|STARTED|Overall Study||40
6364272|NCT00700336|7274552|FG001|STARTED|Overall Study||23
6364273|NCT00700336|7274553|FG002|STARTED|Overall Study||6
6364274|NCT00700336|7274551|FG000|COMPLETED|Overall Study||40
6364275|NCT00700336|7274552|FG001|COMPLETED|Overall Study||23
6364276|NCT00700336|7274553|FG002|COMPLETED|Overall Study||6
6364277|NCT00700336|7274551|FG000|NOT COMPLETED|Overall Study||0
6364278|NCT00700336|7274552|FG001|NOT COMPLETED|Overall Study||0
6364279|NCT00700336|7274553|FG002|NOT COMPLETED|Overall Study||0
6364280|NCT00700375|7274562|FG000|STARTED|Overall Study||30
6364281|NCT00700375|7274563|FG001|STARTED|Overall Study||29
6364282|NCT00700375|7274562|FG000|2 Days After Creatinine Mesurement|Overall Study||30
6364283|NCT00700375|7274563|FG001|2 Days After Creatinine Mesurement|Overall Study||29
6364284|NCT00700375|7274562|FG000|COMPLETED|Overall Study||30
6364285|NCT00700375|7274563|FG001|COMPLETED|Overall Study||29
6364286|NCT00700375|7274562|FG000|NOT COMPLETED|Overall Study||0
6364287|NCT00700375|7274563|FG001|NOT COMPLETED|Overall Study||0
6364288|NCT00700401|7274569|FG000|STARTED|Overall Study||262
6364289|NCT00700401|7274569|FG000|COMPLETED|Overall Study||168
6364290|NCT00700401|7274569|FG000|NOT COMPLETED|Overall Study||94
6364291|NCT00700427|7274573|FG000|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
6364292|NCT00700427|7274574|FG001|STARTED|Study Period 2 (Open-Label Acute Trx)||0
6364293|NCT00700427|7274575|FG002|STARTED|Study Period 2 (Open-Label Acute Trx)||0
6364294|NCT00700427|7274576|FG003|STARTED|Study Period 2 (Open-Label Acute Trx)||0
6364295|NCT00700427|7274577|FG004|STARTED|Study Period 2 (Open-Label Acute Trx)||0
6364296|NCT00700427|7274573|FG000|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
6364297|NCT00700427|7274574|FG001|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
6562871|NCT01803282|7485785|FG000|STARTED|Overall Study||4
6562872|NCT01803282|7485786|FG001|STARTED|Overall Study||3
6562873|NCT01803282|7485787|FG002|STARTED|Overall Study||6
6562874|NCT01803282|7485788|FG003|STARTED|Overall Study||36
6562875|NCT01803282|7485789|FG004|STARTED|Overall Study||11
6562876|NCT01803282|7485790|FG005|STARTED|Overall Study||10
6562877|NCT01803282|7485791|FG006|STARTED|Overall Study||41
6562878|NCT01803282|7485792|FG007|STARTED|Overall Study||46
6562879|NCT01803282|7485793|FG008|STARTED|Overall Study||11
6562880|NCT01803282|7485794|FG009|STARTED|Overall Study||45
6562881|NCT01803282|7485795|FG010|STARTED|Overall Study||8
6562882|NCT01803282|7485796|FG011|STARTED|Overall Study||15
6562883|NCT01803282|7485785|FG000|COMPLETED|Overall Study||0
6562884|NCT01803282|7485786|FG001|COMPLETED|Overall Study||0
6562885|NCT01803282|7485787|FG002|COMPLETED|Overall Study||0
6364298|NCT00700427|7274575|FG002|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
6364299|NCT00700427|7274576|FG003|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
6364300|NCT00700427|7274577|FG004|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
6377369|NCT00762528|7287919|FG001|COMPLETED|Overall Study||25
6562886|NCT01803282|7485788|FG003|COMPLETED|Overall Study||0
6562887|NCT01803282|7485789|FG004|COMPLETED|Overall Study||0
6562888|NCT01803282|7485790|FG005|COMPLETED|Overall Study||0
6777827|NCT03782571|7705788|FG000|STARTED|Period 2||5
6777828|NCT03782571|7705789|FG001|STARTED|Period 2||6
6777829|NCT03782571|7705790|FG002|STARTED|Period 2||6
6777830|NCT03782571|7705791|FG003|STARTED|Period 2||7
6777831|NCT03782571|7705788|FG000|COMPLETED|Period 2||5
6777832|NCT03782571|7705789|FG001|COMPLETED|Period 2||6
6777833|NCT03782571|7705790|FG002|COMPLETED|Period 2||6
6777834|NCT03782571|7705791|FG003|COMPLETED|Period 2||7
6364301|NCT00700427|7274573|FG000|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
6364302|NCT00700427|7274574|FG001|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6560643|NCT01788046|7483420|FG000|STARTED|Overall Study||260
6560644|NCT01788046|7483421|FG001|STARTED|Overall Study||255
6560645|NCT01788046|7483420|FG000|Received Treatment|Overall Study||259
6560646|NCT01788046|7483421|FG001|Received Treatment|Overall Study||252
6560647|NCT01788046|7483420|FG000|COMPLETED|Overall Study||204
6560648|NCT01788046|7483421|FG001|COMPLETED|Overall Study||218
6560649|NCT01788046|7483420|FG000|NOT COMPLETED|Overall Study||56
6364303|NCT00700427|7274575|FG002|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6364304|NCT00700427|7274576|FG003|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6364305|NCT00700427|7274577|FG004|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6364306|NCT00700427|7274573|FG000|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
6364307|NCT00700427|7274574|FG001|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6364308|NCT00700427|7274575|FG002|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6364309|NCT00700427|7274576|FG003|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6364310|NCT00700427|7274577|FG004|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
6364311|NCT00700427|7274573|FG000|STARTED|Study Period 3A (Blinded Maintenance)||0
6364312|NCT00700427|7274574|FG001|STARTED|Study Period 3A (Blinded Maintenance)||1005
6364313|NCT00700427|7274575|FG002|STARTED|Study Period 3A (Blinded Maintenance)||0
6364314|NCT00700427|7274576|FG003|STARTED|Study Period 3A (Blinded Maintenance)||0
6364315|NCT00700427|7274577|FG004|STARTED|Study Period 3A (Blinded Maintenance)||0
6364316|NCT00700427|7274573|FG000|COMPLETED|Study Period 3A (Blinded Maintenance)||0
6364317|NCT00700427|7274574|FG001|COMPLETED|Study Period 3A (Blinded Maintenance)||524
6364318|NCT00700427|7274575|FG002|COMPLETED|Study Period 3A (Blinded Maintenance)||0
6364319|NCT00700427|7274576|FG003|COMPLETED|Study Period 3A (Blinded Maintenance)||0
6364320|NCT00700427|7274577|FG004|COMPLETED|Study Period 3A (Blinded Maintenance)||0
6364321|NCT00700427|7274573|FG000|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
6364322|NCT00700427|7274574|FG001|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
6364323|NCT00700427|7274575|FG002|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
6364324|NCT00700427|7274576|FG003|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
6364325|NCT00700427|7274577|FG004|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
6364326|NCT00700427|7274573|FG000|STARTED|Study Period 3B (Randomized Withdrawal)||0
6364327|NCT00700427|7274574|FG001|STARTED|Study Period 3B (Randomized Withdrawal)||0
6364328|NCT00700427|7274575|FG002|STARTED|Study Period 3B (Randomized Withdrawal)||266
6364329|NCT00700427|7274576|FG003|STARTED|Study Period 3B (Randomized Withdrawal)||258
6364330|NCT00700427|7274577|FG004|STARTED|Study Period 3B (Randomized Withdrawal)||0
6364331|NCT00700427|7274573|FG000|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6364332|NCT00700427|7274574|FG001|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6364333|NCT00700427|7274575|FG002|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
6364334|NCT00700427|7274576|FG003|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
6364335|NCT00700427|7274577|FG004|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6364336|NCT00700427|7274573|FG000|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6364337|NCT00700427|7274574|FG001|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6364338|NCT00700427|7274575|FG002|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
6364339|NCT00700427|7274576|FG003|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
6364340|NCT00700427|7274577|FG004|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
6364341|NCT00700427|7274573|FG000|STARTED|Study Period 4 (Open-Label Extension)||0
6364342|NCT00700427|7274574|FG001|STARTED|Study Period 4 (Open-Label Extension)||0
6364343|NCT00700427|7274575|FG002|STARTED|Study Period 4 (Open-Label Extension)||0
6364344|NCT00700427|7274576|FG003|STARTED|Study Period 4 (Open-Label Extension)||0
6364345|NCT00700427|7274577|FG004|STARTED|Study Period 4 (Open-Label Extension)||180
6364346|NCT00700427|7274573|FG000|COMPLETED|Study Period 4 (Open-Label Extension)||0
6364347|NCT00700427|7274574|FG001|COMPLETED|Study Period 4 (Open-Label Extension)||0
6364348|NCT00700427|7274575|FG002|COMPLETED|Study Period 4 (Open-Label Extension)||0
6364349|NCT00700427|7274576|FG003|COMPLETED|Study Period 4 (Open-Label Extension)||0
6364350|NCT00700427|7274577|FG004|COMPLETED|Study Period 4 (Open-Label Extension)||96
6364351|NCT00700427|7274573|FG000|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
6364352|NCT00700427|7274574|FG001|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
6364353|NCT00700427|7274575|FG002|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
6364354|NCT00700427|7274576|FG003|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
6364355|NCT00700427|7274577|FG004|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
6364356|NCT00700440|7274585|FG000|STARTED|Overall Study||100
6364357|NCT00700440|7274585|FG000|COMPLETED|Overall Study||100
6560650|NCT01788046|7483421|FG001|NOT COMPLETED|Overall Study||37
6560651|NCT01788150|7483429|FG000|STARTED|Overall Study||108
6777835|NCT03782571|7705788|FG000|NOT COMPLETED|Period 2||0
6777836|NCT03782571|7705789|FG001|NOT COMPLETED|Period 2||0
6777837|NCT03782571|7705790|FG002|NOT COMPLETED|Period 2||0
6364358|NCT00700440|7274585|FG000|NOT COMPLETED|Overall Study||0
6364359|NCT00700570|7274591|FG000|STARTED|Overall Study||19
6364360|NCT00700570|7274592|FG001|STARTED|Overall Study||26
6364361|NCT00700570|7274591|FG000|COMPLETED|Overall Study||8
6364362|NCT00700570|7274592|FG001|COMPLETED|Overall Study||0
6364363|NCT00700570|7274591|FG000|NOT COMPLETED|Overall Study||11
6364364|NCT00700570|7274592|FG001|NOT COMPLETED|Overall Study||26
6364365|NCT00700622|7274600|FG000|STARTED|Overall Study||65
6364366|NCT00700622|7274601|FG001|STARTED|Overall Study||65
6364367|NCT00700622|7274600|FG000|COMPLETED|Overall Study||52
6364368|NCT00700622|7274601|FG001|COMPLETED|Overall Study||60
6364369|NCT00700622|7274600|FG000|NOT COMPLETED|Overall Study||13
6364370|NCT00700622|7274601|FG001|NOT COMPLETED|Overall Study||5
6364371|NCT00700635|7274610|FG000|STARTED|Overall Study||111
6364372|NCT00700635|7274611|FG001|STARTED|Overall Study||111
6364373|NCT00700635|7274612|FG002|STARTED|Overall Study||111
6364374|NCT00700635|7274610|FG000|COMPLETED|Overall Study||100
6364375|NCT00700635|7274611|FG001|COMPLETED|Overall Study||103
6364376|NCT00700635|7274612|FG002|COMPLETED|Overall Study||110
6364377|NCT00700635|7274610|FG000|NOT COMPLETED|Overall Study||11
6364378|NCT00700635|7274611|FG001|NOT COMPLETED|Overall Study||8
6364379|NCT00700635|7274612|FG002|NOT COMPLETED|Overall Study||1
6364380|NCT00700713|7274623|FG000|STARTED|Overall Study||48
6364381|NCT00700713|7274624|FG001|STARTED|Overall Study||66
6364382|NCT00700713|7274625|FG002|STARTED|Overall Study||67
6364383|NCT00700713|7274623|FG000|COMPLETED|Overall Study||47
6364384|NCT00700713|7274624|FG001|COMPLETED|Overall Study||66
6364385|NCT00700713|7274625|FG002|COMPLETED|Overall Study||65
6364386|NCT00700713|7274623|FG000|NOT COMPLETED|Overall Study||1
6364387|NCT00700713|7274624|FG001|NOT COMPLETED|Overall Study||0
6364388|NCT00700713|7274625|FG002|NOT COMPLETED|Overall Study||2
6364389|NCT00700739|7274635|FG000|STARTED|Overall Study||22
6560652|NCT01788150|7483430|FG001|STARTED|Overall Study||51
6560653|NCT01788150|7483429|FG000|COMPLETED|Overall Study||95
6560654|NCT01788150|7483430|FG001|COMPLETED|Overall Study||48
6560655|NCT01788150|7483429|FG000|NOT COMPLETED|Overall Study||13
6560656|NCT01788150|7483430|FG001|NOT COMPLETED|Overall Study||3
6560657|NCT01788163|7483445|FG000|STARTED|Overall Study||1458
6560658|NCT01788163|7483446|FG001|STARTED|Overall Study||271
6560659|NCT01788163|7483447|FG002|STARTED|Overall Study||62
6560660|NCT01788163|7483448|FG003|STARTED|Overall Study||71
6560661|NCT01788163|7483449|FG004|STARTED|Overall Study||94
6560662|NCT01788163|7483450|FG005|STARTED|Overall Study||102
6560663|NCT01788163|7483451|FG006|STARTED|Overall Study||50
6560664|NCT01788163|7483452|FG007|STARTED|Overall Study||302
6560665|NCT01788163|7483453|FG008|STARTED|Overall Study||972
6560666|NCT01788163|7483445|FG000|COMPLETED|Overall Study||1403
6560667|NCT01788163|7483446|FG001|COMPLETED|Overall Study||271
6560668|NCT01788163|7483447|FG002|COMPLETED|Overall Study||62
6560669|NCT01788163|7483448|FG003|COMPLETED|Overall Study||71
6560670|NCT01788163|7483449|FG004|COMPLETED|Overall Study||94
6560671|NCT01788163|7483450|FG005|COMPLETED|Overall Study||95
6560672|NCT01788163|7483451|FG006|COMPLETED|Overall Study||49
6560673|NCT01788163|7483452|FG007|COMPLETED|Overall Study||254
6560674|NCT01788163|7483453|FG008|COMPLETED|Overall Study||956
6560675|NCT01788163|7483445|FG000|NOT COMPLETED|Overall Study||55
6560676|NCT01788163|7483446|FG001|NOT COMPLETED|Overall Study||0
6560677|NCT01788163|7483447|FG002|NOT COMPLETED|Overall Study||0
6560678|NCT01788163|7483448|FG003|NOT COMPLETED|Overall Study||0
6560679|NCT01788163|7483449|FG004|NOT COMPLETED|Overall Study||0
6560680|NCT01788163|7483450|FG005|NOT COMPLETED|Overall Study||7
6364390|NCT00700739|7274636|FG001|STARTED|Overall Study||16
6364391|NCT00700739|7274635|FG000|COMPLETED|Overall Study||18
6364392|NCT00700739|7274636|FG001|COMPLETED|Overall Study||12
6364393|NCT00700739|7274635|FG000|NOT COMPLETED|Overall Study||4
6364394|NCT00700739|7274636|FG001|NOT COMPLETED|Overall Study||4
6364395|NCT00700752|7274643|FG000|STARTED|First Intervention||20
6364396|NCT00700752|7274644|FG001|STARTED|First Intervention||20
6364397|NCT00700752|7274643|FG000|COMPLETED|First Intervention||20
6364398|NCT00700752|7274644|FG001|COMPLETED|First Intervention||18
6364399|NCT00700752|7274643|FG000|NOT COMPLETED|First Intervention||0
6364400|NCT00700752|7274644|FG001|NOT COMPLETED|First Intervention||2
6560681|NCT01788163|7483451|FG006|NOT COMPLETED|Overall Study||1
6560682|NCT01788163|7483452|FG007|NOT COMPLETED|Overall Study||48
6560683|NCT01788163|7483453|FG008|NOT COMPLETED|Overall Study||16
6364401|NCT00700752|7274643|FG000|STARTED|Second Intervention||20
6364402|NCT00700752|7274644|FG001|STARTED|Second Intervention||18
6364403|NCT00700752|7274643|FG000|COMPLETED|Second Intervention||20
6364404|NCT00700752|7274644|FG001|COMPLETED|Second Intervention||18
6364405|NCT00700752|7274643|FG000|NOT COMPLETED|Second Intervention||0
6364406|NCT00700752|7274644|FG001|NOT COMPLETED|Second Intervention||0
6364407|NCT00700804|7274652|FG000|STARTED|Overall Study||17
6364408|NCT00700804|7274653|FG001|STARTED|Overall Study||17
6364409|NCT00700804|7274652|FG000|COMPLETED|Overall Study||14
6364410|NCT00700804|7274653|FG001|COMPLETED|Overall Study||13
6364411|NCT00700804|7274652|FG000|NOT COMPLETED|Overall Study||3
6364412|NCT00700804|7274653|FG001|NOT COMPLETED|Overall Study||4
6364413|NCT00700817|7274664|FG000|STARTED|Week 0-26 (Main Period)|Randomised|225
6364414|NCT00700817|7274665|FG001|STARTED|Week 0-26 (Main Period)|Randomised|221
6560684|NCT01788215|7483534|FG000|STARTED|Overall Study||5
6560685|NCT01788215|7483535|FG001|STARTED|Overall Study||5
6560686|NCT01788215|7483534|FG000|12 Weeks of Doxycycline or Placebo|Overall Study||5
6364415|NCT00700817|7274666|FG002|STARTED|Week 0-26 (Main Period)|Randomised|219
6364416|NCT00700817|7274667|FG003|STARTED|Week 0-26 (Main Period)||0
6364417|NCT00700817|7274668|FG004|STARTED|Week 0-26 (Main Period)||0
6364418|NCT00700817|7274664|FG000|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
6364419|NCT00700817|7274665|FG001|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
6364420|NCT00700817|7274666|FG002|Exposed|Week 0-26 (Main Period)||219
6364421|NCT00700817|7274667|FG003|Exposed|Week 0-26 (Main Period)||0
6364422|NCT00700817|7274668|FG004|Exposed|Week 0-26 (Main Period)||0
6364423|NCT00700817|7274664|FG000|COMPLETED|Week 0-26 (Main Period)||169
6364424|NCT00700817|7274665|FG001|COMPLETED|Week 0-26 (Main Period)||191
6364425|NCT00700817|7274666|FG002|COMPLETED|Week 0-26 (Main Period)||194
6364426|NCT00700817|7274667|FG003|COMPLETED|Week 0-26 (Main Period)||0
6364427|NCT00700817|7274668|FG004|COMPLETED|Week 0-26 (Main Period)||0
6364428|NCT00700817|7274664|FG000|NOT COMPLETED|Week 0-26 (Main Period)||56
6364429|NCT00700817|7274665|FG001|NOT COMPLETED|Week 0-26 (Main Period)||30
6364430|NCT00700817|7274666|FG002|NOT COMPLETED|Week 0-26 (Main Period)||25
6364431|NCT00700817|7274667|FG003|NOT COMPLETED|Week 0-26 (Main Period)||0
6364432|NCT00700817|7274668|FG004|NOT COMPLETED|Week 0-26 (Main Period)||0
6364433|NCT00700817|7274664|FG000|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
6364434|NCT00700817|7274665|FG001|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
6364435|NCT00700817|7274666|FG002|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
6364436|NCT00700817|7274667|FG003|STARTED|Week 26-52 (Extension Period 1)||0
6364437|NCT00700817|7274668|FG004|STARTED|Week 26-52 (Extension Period 1)||0
6364438|NCT00700817|7274664|FG000|COMPLETED|Week 26-52 (Extension Period 1)||135
6364439|NCT00700817|7274665|FG001|COMPLETED|Week 26-52 (Extension Period 1)||150
6364440|NCT00700817|7274666|FG002|COMPLETED|Week 26-52 (Extension Period 1)||151
6364441|NCT00700817|7274667|FG003|COMPLETED|Week 26-52 (Extension Period 1)||0
6364442|NCT00700817|7274668|FG004|COMPLETED|Week 26-52 (Extension Period 1)||0
6364443|NCT00700817|7274664|FG000|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
6364444|NCT00700817|7274665|FG001|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
6364445|NCT00700817|7274666|FG002|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
6364446|NCT00700817|7274667|FG003|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
6364447|NCT00700817|7274668|FG004|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
6364448|NCT00700817|7274664|FG000|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
6364449|NCT00700817|7274665|FG001|STARTED|Week 52-78 (Extension Period 2)||150
6364450|NCT00700817|7274666|FG002|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
6364451|NCT00700817|7274667|FG003|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
6364452|NCT00700817|7274668|FG004|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
6364453|NCT00700817|7274664|FG000|COMPLETED|Week 52-78 (Extension Period 2)||124
6364454|NCT00700817|7274665|FG001|COMPLETED|Week 52-78 (Extension Period 2)||135
6364455|NCT00700817|7274666|FG002|COMPLETED|Week 52-78 (Extension Period 2)||0
6364456|NCT00700817|7274667|FG003|COMPLETED|Week 52-78 (Extension Period 2)||59
6364457|NCT00700817|7274668|FG004|COMPLETED|Week 52-78 (Extension Period 2)||63
6364458|NCT00700817|7274664|FG000|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
6364459|NCT00700817|7274665|FG001|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
6364460|NCT00700817|7274666|FG002|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
6364461|NCT00700817|7274667|FG003|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
6364462|NCT00700817|7274668|FG004|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
6364463|NCT00700882|7274678|FG000|STARTED|Overall Study||81
6364464|NCT00700882|7274678|FG000|Received Protocol Therapy|Overall Study||75
6364465|NCT00700882|7274678|FG000|Eligible and Treated Patients|Overall Study||73
6364466|NCT00700882|7274678|FG000|Eligible, Treated and KIT+ Patients|Overall Study||22
6364467|NCT00700882|7274678|FG000|COMPLETED|Overall Study||22
6364468|NCT00700882|7274678|FG000|NOT COMPLETED|Overall Study||59
6364469|NCT00700973|7274684|FG000|STARTED|Overall Study||71
6364470|NCT00700973|7274685|FG001|STARTED|Overall Study||70
6364471|NCT00700973|7274684|FG000|COMPLETED|Overall Study||63
6364472|NCT00700973|7274685|FG001|COMPLETED|Overall Study||63
6364473|NCT00700973|7274684|FG000|NOT COMPLETED|Overall Study||8
6364474|NCT00700973|7274685|FG001|NOT COMPLETED|Overall Study||7
6364475|NCT00700999|7274693|FG000|STARTED|Overall Study||36
6777838|NCT03782571|7705791|FG003|NOT COMPLETED|Period 2||0
6777839|NCT03782571|7705788|FG000|STARTED|Period 3||5
6777840|NCT03782571|7705789|FG001|STARTED|Period 3||6
6777841|NCT03782571|7705790|FG002|STARTED|Period 3||6
6364476|NCT00700999|7274694|FG001|STARTED|Overall Study||29
6364477|NCT00700999|7274693|FG000|First MRI Scan|Overall Study||29
6364478|NCT00700999|7274694|FG001|First MRI Scan|Overall Study||22
6364479|NCT00700999|7274693|FG000|Second MRI Scan|Overall Study||19
6364480|NCT00700999|7274694|FG001|Second MRI Scan|Overall Study||18
6364481|NCT00700999|7274693|FG000|COMPLETED|Overall Study||21
6364482|NCT00700999|7274694|FG001|COMPLETED|Overall Study||20
6364483|NCT00700999|7274693|FG000|NOT COMPLETED|Overall Study||15
6364484|NCT00700999|7274694|FG001|NOT COMPLETED|Overall Study||9
6364485|NCT00701038|7274702|FG000|STARTED|Overall Study||27
6364486|NCT00701038|7274703|FG001|STARTED|Overall Study||27
6777842|NCT03782571|7705791|FG003|STARTED|Period 3||7
6777843|NCT03782571|7705788|FG000|COMPLETED|Period 3||3
6364487|NCT00701038|7274702|FG000|COMPLETED|Overall Study||23
6364488|NCT00701038|7274703|FG001|COMPLETED|Overall Study||23
6364489|NCT00701038|7274702|FG000|NOT COMPLETED|Overall Study||4
6364490|NCT00701038|7274703|FG001|NOT COMPLETED|Overall Study||4
6364491|NCT00701051|7274711|FG000|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
6364492|NCT00701051|7274712|FG001|STARTED|Screening||0
6364493|NCT00701051|7274713|FG002|STARTED|Screening||0
6364494|NCT00701051|7274711|FG000|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
6364495|NCT00701051|7274712|FG001|COMPLETED|Screening||0
6364496|NCT00701051|7274713|FG002|COMPLETED|Screening||0
6364497|NCT00701051|7274711|FG000|NOT COMPLETED|Screening||59
6364498|NCT00701051|7274712|FG001|NOT COMPLETED|Screening||0
6364499|NCT00701051|7274713|FG002|NOT COMPLETED|Screening||0
6364500|NCT00701051|7274711|FG000|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
6364501|NCT00701051|7274712|FG001|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
6364502|NCT00701051|7274713|FG002|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
6364503|NCT00701051|7274711|FG000|COMPLETED|Exercise Intervention||0
6364504|NCT00701051|7274712|FG001|COMPLETED|Exercise Intervention||14
6364505|NCT00701051|7274713|FG002|COMPLETED|Exercise Intervention||9
6364506|NCT00701051|7274711|FG000|NOT COMPLETED|Exercise Intervention||0
6364507|NCT00701051|7274712|FG001|NOT COMPLETED|Exercise Intervention||5
6364508|NCT00701051|7274713|FG002|NOT COMPLETED|Exercise Intervention||3
6364509|NCT00701051|7274711|FG000|STARTED|Detraining Intervention (Optional)||0
6364510|NCT00701051|7274712|FG001|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
6364511|NCT00701051|7274713|FG002|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
6364512|NCT00701051|7274711|FG000|COMPLETED|Detraining Intervention (Optional)||0
6364513|NCT00701051|7274712|FG001|COMPLETED|Detraining Intervention (Optional)||6
6364514|NCT00701051|7274713|FG002|COMPLETED|Detraining Intervention (Optional)||6
6364515|NCT00701051|7274711|FG000|NOT COMPLETED|Detraining Intervention (Optional)||0
6364516|NCT00701051|7274712|FG001|NOT COMPLETED|Detraining Intervention (Optional)||0
6364517|NCT00701051|7274713|FG002|NOT COMPLETED|Detraining Intervention (Optional)||0
6364518|NCT00701064|7274721|FG000|STARTED|Overall Study||35
6364519|NCT00701064|7274722|FG001|STARTED|Overall Study||36
6364520|NCT00701064|7274721|FG000|COMPLETED|Overall Study||31
6364521|NCT00701064|7274722|FG001|COMPLETED|Overall Study||32
6364522|NCT00701064|7274721|FG000|NOT COMPLETED|Overall Study||4
6364523|NCT00701064|7274722|FG001|NOT COMPLETED|Overall Study||4
6364524|NCT00701090|7274730|FG000|STARTED|Overall Study||516
6364525|NCT00701090|7274731|FG001|STARTED|Overall Study||519
6364526|NCT00701090|7274730|FG000|COMPLETED|Overall Study||468
6364527|NCT00701090|7274731|FG001|COMPLETED|Overall Study||468
6364528|NCT00701090|7274730|FG000|NOT COMPLETED|Overall Study||48
6364529|NCT00701090|7274731|FG001|NOT COMPLETED|Overall Study||51
6364530|NCT00701103|7274748|FG000|STARTED|Overall Study||5
6560687|NCT01788215|7483535|FG001|12 Weeks of Doxycycline or Placebo|Overall Study||5
6560688|NCT01788215|7483534|FG000|COMPLETED|Overall Study||3
6560689|NCT01788215|7483535|FG001|COMPLETED|Overall Study||4
6364531|NCT00701103|7274749|FG001|STARTED|Overall Study||3
6364532|NCT00701103|7274750|FG002|STARTED|Overall Study||8
6364533|NCT00701103|7274751|FG003|STARTED|Overall Study||6
6364534|NCT00701103|7274752|FG004|STARTED|Overall Study||6
6364535|NCT00701103|7274753|FG005|STARTED|Overall Study||6
6364536|NCT00701103|7274754|FG006|STARTED|Overall Study||8
6364537|NCT00701103|7274755|FG007|STARTED|Overall Study||7
6560690|NCT01788215|7483534|FG000|NOT COMPLETED|Overall Study||2
6560691|NCT01788215|7483535|FG001|NOT COMPLETED|Overall Study||1
6364538|NCT00701103|7274756|FG008|STARTED|Overall Study||9
6364539|NCT00701103|7274757|FG009|STARTED|Overall Study||11
6364540|NCT00701103|7274758|FG010|STARTED|Overall Study||11
6364541|NCT00701103|7274748|FG000|COMPLETED|Overall Study||0
6364542|NCT00701103|7274749|FG001|COMPLETED|Overall Study||0
6364543|NCT00701103|7274750|FG002|COMPLETED|Overall Study||0
6364544|NCT00701103|7274751|FG003|COMPLETED|Overall Study||0
6364545|NCT00701103|7274752|FG004|COMPLETED|Overall Study||0
6364546|NCT00701103|7274753|FG005|COMPLETED|Overall Study||0
6364547|NCT00701103|7274754|FG006|COMPLETED|Overall Study||0
6364548|NCT00701103|7274755|FG007|COMPLETED|Overall Study||0
6364549|NCT00701103|7274756|FG008|COMPLETED|Overall Study||0
6364550|NCT00701103|7274757|FG009|COMPLETED|Overall Study||0
6364551|NCT00701103|7274758|FG010|COMPLETED|Overall Study||0
6364552|NCT00701103|7274748|FG000|NOT COMPLETED|Overall Study||5
6364553|NCT00701103|7274749|FG001|NOT COMPLETED|Overall Study||3
6364554|NCT00701103|7274750|FG002|NOT COMPLETED|Overall Study||8
6364555|NCT00701103|7274751|FG003|NOT COMPLETED|Overall Study||6
6364556|NCT00701103|7274752|FG004|NOT COMPLETED|Overall Study||6
6364557|NCT00701103|7274753|FG005|NOT COMPLETED|Overall Study||6
6364558|NCT00701103|7274754|FG006|NOT COMPLETED|Overall Study||8
6364559|NCT00701103|7274755|FG007|NOT COMPLETED|Overall Study||7
6364560|NCT00701103|7274756|FG008|NOT COMPLETED|Overall Study||9
6364561|NCT00701103|7274757|FG009|NOT COMPLETED|Overall Study||11
6364562|NCT00701103|7274758|FG010|NOT COMPLETED|Overall Study||11
6364563|NCT00701129|7274786|FG000|STARTED|Overall Study||4
6364564|NCT00701129|7274786|FG000|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
6364565|NCT00701129|7274786|FG000|COMPLETED|Overall Study||2
6364566|NCT00701129|7274786|FG000|NOT COMPLETED|Overall Study||2
6364567|NCT00701311|7274790|FG000|STARTED|Overall Study||17
6364568|NCT00701311|7274790|FG000|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
6364569|NCT00701311|7274790|FG000|NOT COMPLETED|Overall Study||8
6377370|NCT00762528|7287918|FG000|NOT COMPLETED|Overall Study||0
6377371|NCT00762528|7287919|FG001|NOT COMPLETED|Overall Study||0
6377372|NCT00762606|7287927|FG000|STARTED|Overall Study||55
6377373|NCT00762606|7287928|FG001|STARTED|Overall Study||51
6377374|NCT00762606|7287927|FG000|COMPLETED|Overall Study||37
6377375|NCT00762606|7287928|FG001|COMPLETED|Overall Study||38
6377376|NCT00762606|7287927|FG000|NOT COMPLETED|Overall Study||18
6377377|NCT00762606|7287928|FG001|NOT COMPLETED|Overall Study||13
6377378|NCT00762619|7287936|FG000|STARTED|Overall Study||55
6377379|NCT00762619|7287937|FG001|STARTED|Overall Study||50
6377380|NCT00762619|7287936|FG000|COMPLETED|Overall Study||55
6377381|NCT00762619|7287937|FG001|COMPLETED|Overall Study||50
6377382|NCT00762619|7287936|FG000|NOT COMPLETED|Overall Study||0
6377383|NCT00762619|7287937|FG001|NOT COMPLETED|Overall Study||0
6377384|NCT00762645|7287947|FG000|STARTED|Overall Study||16
6377385|NCT00762645|7287948|FG001|STARTED|Overall Study||14
6377386|NCT00762645|7287947|FG000|COMPLETED|Overall Study||12
6377387|NCT00762645|7287948|FG001|COMPLETED|Overall Study||12
6377388|NCT00762645|7287947|FG000|NOT COMPLETED|Overall Study||4
6377389|NCT00762645|7287948|FG001|NOT COMPLETED|Overall Study||2
6377390|NCT00762710|7287956|FG000|STARTED|Overall Study||48
6377391|NCT00762710|7287957|FG001|STARTED|Overall Study||44
6377392|NCT00762710|7287956|FG000|COMPLETED|Overall Study||27
6377393|NCT00762710|7287957|FG001|COMPLETED|Overall Study||29
6377394|NCT00762710|7287956|FG000|NOT COMPLETED|Overall Study||21
6377395|NCT00762710|7287957|FG001|NOT COMPLETED|Overall Study||15
6377396|NCT00762762|7287965|FG000|STARTED|Overall Study||30
6377397|NCT00762762|7287966|FG001|STARTED|Overall Study||30
6377398|NCT00762762|7287965|FG000|COMPLETED|Overall Study||22
6377399|NCT00762762|7287966|FG001|COMPLETED|Overall Study||20
6377400|NCT00762762|7287965|FG000|NOT COMPLETED|Overall Study||8
6377401|NCT00762762|7287966|FG001|NOT COMPLETED|Overall Study||10
6377402|NCT00762788|7287978|FG000|STARTED|Overall Study||55
6377403|NCT00762788|7287979|FG001|STARTED|Overall Study||58
6377404|NCT00762788|7287980|FG002|STARTED|Overall Study||42
6377405|NCT00762788|7287981|FG003|STARTED|Overall Study||64
6377406|NCT00762788|7287982|FG004|STARTED|Overall Study||43
6377407|NCT00762788|7287983|FG005|STARTED|Overall Study||52
6377408|NCT00762788|7287978|FG000|COMPLETED|Overall Study||29
6377409|NCT00762788|7287979|FG001|COMPLETED|Overall Study||21
6377410|NCT00762788|7287980|FG002|COMPLETED|Overall Study||21
6377411|NCT00762788|7287981|FG003|COMPLETED|Overall Study||38
6377412|NCT00762788|7287982|FG004|COMPLETED|Overall Study||30
6377413|NCT00762788|7287983|FG005|COMPLETED|Overall Study||31
6377414|NCT00762788|7287978|FG000|NOT COMPLETED|Overall Study||26
6377415|NCT00762788|7287979|FG001|NOT COMPLETED|Overall Study||37
6377416|NCT00762788|7287980|FG002|NOT COMPLETED|Overall Study||21
6377417|NCT00762788|7287981|FG003|NOT COMPLETED|Overall Study||26
6377418|NCT00762788|7287982|FG004|NOT COMPLETED|Overall Study||13
6377419|NCT00762788|7287983|FG005|NOT COMPLETED|Overall Study||21
6377420|NCT00762853|7287999|FG000|STARTED|First Treatment Period||10
6377421|NCT00762853|7288000|FG001|STARTED|First Treatment Period||10
6377422|NCT00762853|7287999|FG000|COMPLETED|First Treatment Period||10
6377423|NCT00762853|7288000|FG001|COMPLETED|First Treatment Period||10
6377424|NCT00762853|7287999|FG000|NOT COMPLETED|First Treatment Period||0
6377425|NCT00762853|7288000|FG001|NOT COMPLETED|First Treatment Period||0
6377426|NCT00762853|7287999|FG000|STARTED|1 Week Washout After Treatment 1||10
6377427|NCT00762853|7288000|FG001|STARTED|1 Week Washout After Treatment 1||10
6377428|NCT00762853|7287999|FG000|COMPLETED|1 Week Washout After Treatment 1||10
6377429|NCT00762853|7288000|FG001|COMPLETED|1 Week Washout After Treatment 1||10
6377430|NCT00762853|7287999|FG000|NOT COMPLETED|1 Week Washout After Treatment 1||0
6377431|NCT00762853|7288000|FG001|NOT COMPLETED|1 Week Washout After Treatment 1||0
6377432|NCT00762853|7287999|FG000|STARTED|Second Treatment Period||10
6377433|NCT00762853|7288000|FG001|STARTED|Second Treatment Period||10
6377434|NCT00762853|7287999|FG000|COMPLETED|Second Treatment Period||10
6377435|NCT00762853|7288000|FG001|COMPLETED|Second Treatment Period||10
6377436|NCT00762853|7287999|FG000|NOT COMPLETED|Second Treatment Period||0
6377437|NCT00762853|7288000|FG001|NOT COMPLETED|Second Treatment Period||0
6377438|NCT00762892|7288008|FG000|STARTED|Overall Study||14
6377439|NCT00762892|7288009|FG001|STARTED|Overall Study||14
6377440|NCT00762892|7288008|FG000|COMPLETED|Overall Study||9
6377441|NCT00762892|7288009|FG001|COMPLETED|Overall Study||8
6377442|NCT00762892|7288008|FG000|NOT COMPLETED|Overall Study||5
6377443|NCT00762892|7288009|FG001|NOT COMPLETED|Overall Study||6
6377444|NCT00762931|7288015|FG000|STARTED|Overall Study||25
6377445|NCT00762931|7288015|FG000|COMPLETED|Overall Study||23
6377446|NCT00762931|7288015|FG000|NOT COMPLETED|Overall Study||2
6377447|NCT00762970|7288022|FG000|STARTED|Overall Study||46
6377448|NCT00762970|7288023|FG001|STARTED|Overall Study||44
6377449|NCT00762970|7288024|FG002|STARTED|Overall Study||47
6377450|NCT00762970|7288022|FG000|COMPLETED|Overall Study||34
6377451|NCT00762970|7288023|FG001|COMPLETED|Overall Study||35
6377452|NCT00762970|7288024|FG002|COMPLETED|Overall Study||46
6377453|NCT00762970|7288022|FG000|NOT COMPLETED|Overall Study||12
6377454|NCT00762970|7288023|FG001|NOT COMPLETED|Overall Study||9
6377455|NCT00762970|7288024|FG002|NOT COMPLETED|Overall Study||1
6364570|NCT00701363|7274798|FG000|STARTED|Screening (Pre-assignment) Phase||128
6364571|NCT00701363|7274799|FG001|STARTED|Screening (Pre-assignment) Phase||0
6364572|NCT00701363|7274800|FG002|STARTED|Screening (Pre-assignment) Phase||0
6364573|NCT00701363|7274801|FG003|STARTED|Screening (Pre-assignment) Phase||0
6364574|NCT00701363|7274798|FG000|COMPLETED|Screening (Pre-assignment) Phase||124
6364575|NCT00701363|7274799|FG001|COMPLETED|Screening (Pre-assignment) Phase||0
6364576|NCT00701363|7274800|FG002|COMPLETED|Screening (Pre-assignment) Phase||0
6364577|NCT00701363|7274801|FG003|COMPLETED|Screening (Pre-assignment) Phase||0
6364578|NCT00701363|7274798|FG000|NOT COMPLETED|Screening (Pre-assignment) Phase||4
6364579|NCT00701363|7274799|FG001|NOT COMPLETED|Screening (Pre-assignment) Phase||0
6364580|NCT00701363|7274800|FG002|NOT COMPLETED|Screening (Pre-assignment) Phase||0
6364581|NCT00701363|7274801|FG003|NOT COMPLETED|Screening (Pre-assignment) Phase||0
6364582|NCT00701363|7274798|FG000|STARTED|Treatment Phase 1||124
6364583|NCT00701363|7274799|FG001|STARTED|Treatment Phase 1||0
6364584|NCT00701363|7274800|FG002|STARTED|Treatment Phase 1||0
6364585|NCT00701363|7274801|FG003|STARTED|Treatment Phase 1||0
6364586|NCT00701363|7274798|FG000|COMPLETED|Treatment Phase 1||109
6364587|NCT00701363|7274799|FG001|COMPLETED|Treatment Phase 1||0
6364588|NCT00701363|7274800|FG002|COMPLETED|Treatment Phase 1||0
6364589|NCT00701363|7274801|FG003|COMPLETED|Treatment Phase 1||0
6364590|NCT00701363|7274798|FG000|NOT COMPLETED|Treatment Phase 1||15
6364591|NCT00701363|7274799|FG001|NOT COMPLETED|Treatment Phase 1||0
6364592|NCT00701363|7274800|FG002|NOT COMPLETED|Treatment Phase 1||0
6364593|NCT00701363|7274801|FG003|NOT COMPLETED|Treatment Phase 1||0
6364594|NCT00701363|7274798|FG000|STARTED|Treatment Phase 2||0
6364595|NCT00701363|7274799|FG001|STARTED|Treatment Phase 2||13
6364596|NCT00701363|7274800|FG002|STARTED|Treatment Phase 2||70
6364597|NCT00701363|7274801|FG003|STARTED|Treatment Phase 2||26
6364598|NCT00701363|7274798|FG000|COMPLETED|Treatment Phase 2||0
6364599|NCT00701363|7274799|FG001|COMPLETED|Treatment Phase 2||13
6364600|NCT00701363|7274800|FG002|COMPLETED|Treatment Phase 2||68
6364601|NCT00701363|7274801|FG003|COMPLETED|Treatment Phase 2||26
6364602|NCT00701363|7274798|FG000|NOT COMPLETED|Treatment Phase 2||0
6364603|NCT00701363|7274799|FG001|NOT COMPLETED|Treatment Phase 2||0
6364604|NCT00701363|7274800|FG002|NOT COMPLETED|Treatment Phase 2||2
6364605|NCT00701363|7274801|FG003|NOT COMPLETED|Treatment Phase 2||0
6364606|NCT00701376|7274821|FG000|STARTED|Overall Study||106
6364607|NCT00701376|7274821|FG000|COMPLETED|Overall Study||105
6364608|NCT00701376|7274821|FG000|NOT COMPLETED|Overall Study||1
6364609|NCT00701389|7274826|FG000|STARTED|Period 1||6
6364610|NCT00701389|7274827|FG001|STARTED|Period 1||6
6364611|NCT00701389|7274828|FG002|STARTED|Period 1||6
6364612|NCT00701389|7274829|FG003|STARTED|Period 1||6
6364613|NCT00701389|7274826|FG000|COMPLETED|Period 1||6
6364614|NCT00701389|7274827|FG001|COMPLETED|Period 1||6
6364615|NCT00701389|7274828|FG002|COMPLETED|Period 1||6
6364616|NCT00701389|7274829|FG003|COMPLETED|Period 1||6
6364617|NCT00701389|7274826|FG000|NOT COMPLETED|Period 1||0
6364618|NCT00701389|7274827|FG001|NOT COMPLETED|Period 1||0
6364619|NCT00701389|7274828|FG002|NOT COMPLETED|Period 1||0
6364620|NCT00701389|7274829|FG003|NOT COMPLETED|Period 1||0
6364621|NCT00701389|7274826|FG000|STARTED|Period 2||6
6364622|NCT00701389|7274827|FG001|STARTED|Period 2||6
6364623|NCT00701389|7274828|FG002|STARTED|Period 2||6
6364624|NCT00701389|7274829|FG003|STARTED|Period 2||6
6364625|NCT00701389|7274826|FG000|COMPLETED|Period 2||6
6364626|NCT00701389|7274827|FG001|COMPLETED|Period 2||6
6364627|NCT00701389|7274828|FG002|COMPLETED|Period 2||6
6364628|NCT00701389|7274829|FG003|COMPLETED|Period 2||6
6364629|NCT00701389|7274826|FG000|NOT COMPLETED|Period 2||0
6364630|NCT00701389|7274827|FG001|NOT COMPLETED|Period 2||0
6560692|NCT01788228|7483543|FG000|STARTED|Overall Study||49
6560693|NCT01788228|7483544|FG001|STARTED|Overall Study||1
6560694|NCT01788228|7483543|FG000|COMPLETED|Overall Study||48
6560695|NCT01788228|7483544|FG001|COMPLETED|Overall Study||1
6560696|NCT01788228|7483543|FG000|NOT COMPLETED|Overall Study||1
6560697|NCT01788228|7483544|FG001|NOT COMPLETED|Overall Study||0
6364631|NCT00701389|7274828|FG002|NOT COMPLETED|Period 2||0
6364632|NCT00701389|7274829|FG003|NOT COMPLETED|Period 2||0
6364633|NCT00701389|7274826|FG000|STARTED|Period 3||6
6364634|NCT00701389|7274827|FG001|STARTED|Period 3||6
6364635|NCT00701389|7274828|FG002|STARTED|Period 3||6
6364636|NCT00701389|7274829|FG003|STARTED|Period 3||6
6364637|NCT00701389|7274826|FG000|COMPLETED|Period 3||6
6364638|NCT00701389|7274827|FG001|COMPLETED|Period 3||6
6364639|NCT00701389|7274828|FG002|COMPLETED|Period 3||6
6560698|NCT01788358|7483553|FG000|STARTED|Overall Study||508
6560699|NCT01788358|7483553|FG000|Treated|Overall Study||508
6364640|NCT00701389|7274829|FG003|COMPLETED|Period 3||6
6364641|NCT00701389|7274826|FG000|NOT COMPLETED|Period 3||0
6560700|NCT01788358|7483553|FG000|Completed Week 28|Overall Study||417
6364642|NCT00701389|7274827|FG001|NOT COMPLETED|Period 3||0
6364643|NCT00701389|7274828|FG002|NOT COMPLETED|Period 3||0
6364644|NCT00701389|7274829|FG003|NOT COMPLETED|Period 3||0
6364645|NCT00701389|7274826|FG000|STARTED|Period 4||6
6364646|NCT00701389|7274827|FG001|STARTED|Period 4||6
6364647|NCT00701389|7274828|FG002|STARTED|Period 4||6
6364648|NCT00701389|7274829|FG003|STARTED|Period 4||6
6364649|NCT00701389|7274826|FG000|COMPLETED|Period 4||6
6364650|NCT00701389|7274827|FG001|COMPLETED|Period 4||6
6364651|NCT00701389|7274828|FG002|COMPLETED|Period 4||6
6364652|NCT00701389|7274829|FG003|COMPLETED|Period 4||6
6364653|NCT00701389|7274826|FG000|NOT COMPLETED|Period 4||0
6364654|NCT00701389|7274827|FG001|NOT COMPLETED|Period 4||0
6364655|NCT00701389|7274828|FG002|NOT COMPLETED|Period 4||0
6364656|NCT00701389|7274829|FG003|NOT COMPLETED|Period 4||0
6364657|NCT00701415|7274845|FG000|STARTED|Overall Study||16
6364658|NCT00701415|7274846|FG001|STARTED|Overall Study||15
6364659|NCT00701415|7274845|FG000|COMPLETED|Overall Study||15
6364660|NCT00701415|7274846|FG001|COMPLETED|Overall Study||14
6364661|NCT00701415|7274845|FG000|NOT COMPLETED|Overall Study||1
6364662|NCT00701415|7274846|FG001|NOT COMPLETED|Overall Study||1
6364663|NCT00701441|7274854|FG000|STARTED|Overall Study||9
6364664|NCT00701441|7274855|FG001|STARTED|Overall Study||16
6364665|NCT00701441|7274854|FG000|COMPLETED|Overall Study||9
6364666|NCT00701441|7274855|FG001|COMPLETED|Overall Study||12
6364667|NCT00701441|7274854|FG000|NOT COMPLETED|Overall Study||0
6364668|NCT00701441|7274855|FG001|NOT COMPLETED|Overall Study||4
6364669|NCT00701558|7274865|FG000|STARTED|Overall Study||19
6364670|NCT00701558|7274865|FG000|COMPLETED|Overall Study||4
6364671|NCT00701558|7274865|FG000|NOT COMPLETED|Overall Study||15
6364672|NCT00701636|7274871|FG000|STARTED|Overall Study||15
6364673|NCT00701636|7274872|FG001|STARTED|Overall Study||15
6364674|NCT00701636|7274871|FG000|COMPLETED|Overall Study||15
6364675|NCT00701636|7274872|FG001|COMPLETED|Overall Study||15
6364676|NCT00701636|7274871|FG000|NOT COMPLETED|Overall Study||0
6364677|NCT00701636|7274872|FG001|NOT COMPLETED|Overall Study||0
6364678|NCT00701662|7274877|FG000|STARTED|Overall Study||8
6364679|NCT00701662|7274877|FG000|COMPLETED|Overall Study||7
6364680|NCT00701662|7274877|FG000|NOT COMPLETED|Overall Study||1
6364681|NCT00701675|7274884|FG000|STARTED|Overall Study||14
6364682|NCT00701675|7274885|FG001|STARTED|Overall Study||14
6364683|NCT00701675|7274886|FG002|STARTED|Overall Study||14
6364684|NCT00701675|7274884|FG000|COMPLETED|Overall Study||10
6364685|NCT00701675|7274885|FG001|COMPLETED|Overall Study||6
6364686|NCT00701675|7274886|FG002|COMPLETED|Overall Study||7
6364687|NCT00701675|7274884|FG000|NOT COMPLETED|Overall Study||4
6364688|NCT00701675|7274885|FG001|NOT COMPLETED|Overall Study||8
6364689|NCT00701675|7274886|FG002|NOT COMPLETED|Overall Study||7
6364690|NCT00701701|7274896|FG000|STARTED|Overall Study||1
6364691|NCT00701701|7274897|FG001|STARTED|Overall Study||3
6364692|NCT00701701|7274896|FG000|COMPLETED|Overall Study||1
6364693|NCT00701701|7274897|FG001|COMPLETED|Overall Study||1
6364694|NCT00701701|7274896|FG000|NOT COMPLETED|Overall Study||0
6364695|NCT00701701|7274897|FG001|NOT COMPLETED|Overall Study||2
6364696|NCT00701714|7274906|FG000|STARTED|Treatment Period (up to 1 Year)||174
6364697|NCT00701714|7274907|FG001|STARTED|Treatment Period (up to 1 Year)||163
6364698|NCT00701714|7274906|FG000|COMPLETED|Treatment Period (up to 1 Year)||37
6364699|NCT00701714|7274907|FG001|COMPLETED|Treatment Period (up to 1 Year)||29
6364700|NCT00701714|7274906|FG000|NOT COMPLETED|Treatment Period (up to 1 Year)||137
6364701|NCT00701714|7274907|FG001|NOT COMPLETED|Treatment Period (up to 1 Year)||134
6364702|NCT00701714|7274906|FG000|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|151
6364703|NCT00701714|7274907|FG001|STARTED|Safety Follow-up Period (6 Months)|Study terminated prematurely, all available randomized patients followed-up 6 months for safety|119
6364704|NCT00701714|7274906|FG000|COMPLETED|Safety Follow-up Period (6 Months)||144
6364705|NCT00701714|7274907|FG001|COMPLETED|Safety Follow-up Period (6 Months)||112
6364706|NCT00701714|7274906|FG000|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
6364707|NCT00701714|7274907|FG001|NOT COMPLETED|Safety Follow-up Period (6 Months)||7
6364708|NCT00701727|7274917|FG000|STARTED|First Treatment Period||16
6364709|NCT00701727|7274918|FG001|STARTED|First Treatment Period||15
6364710|NCT00701727|7274917|FG000|COMPLETED|First Treatment Period||15
6364711|NCT00701727|7274918|FG001|COMPLETED|First Treatment Period||13
6364712|NCT00701727|7274917|FG000|NOT COMPLETED|First Treatment Period||1
6364713|NCT00701727|7274918|FG001|NOT COMPLETED|First Treatment Period||2
6364714|NCT00701727|7274917|FG000|STARTED|Second Treatment Period||15
6364715|NCT00701727|7274918|FG001|STARTED|Second Treatment Period||13
6364716|NCT00701727|7274917|FG000|COMPLETED|Second Treatment Period||13
6364717|NCT00701727|7274918|FG001|COMPLETED|Second Treatment Period||13
6364718|NCT00701727|7274917|FG000|NOT COMPLETED|Second Treatment Period||2
6364719|NCT00701727|7274918|FG001|NOT COMPLETED|Second Treatment Period||0
6364720|NCT00701779|7274924|FG000|STARTED|Overall Study||63
6364721|NCT00701779|7274924|FG000|3 Month|Overall Study||60
6364722|NCT00701779|7274924|FG000|6 Month|Overall Study||58
6364723|NCT00701779|7274924|FG000|9 Month|Overall Study||56
6364724|NCT00701779|7274924|FG000|12 Month|Overall Study||54
6364725|NCT00701779|7274924|FG000|COMPLETED|Overall Study||54
6364726|NCT00701779|7274924|FG000|NOT COMPLETED|Overall Study||9
6364727|NCT00701805|7274932|FG000|STARTED|Overall Study||26
6364728|NCT00701805|7274933|FG001|STARTED|Overall Study||29
6364729|NCT00701805|7274934|FG002|STARTED|Overall Study||23
6364730|NCT00701805|7274935|FG003|STARTED|Overall Study||26
6364731|NCT00701805|7274932|FG000|COMPLETED|Overall Study||23
6364732|NCT00701805|7274933|FG001|COMPLETED|Overall Study||25
6364733|NCT00701805|7274934|FG002|COMPLETED|Overall Study||16
6364734|NCT00701805|7274935|FG003|COMPLETED|Overall Study||22
6364735|NCT00701805|7274932|FG000|NOT COMPLETED|Overall Study||3
6364736|NCT00701805|7274933|FG001|NOT COMPLETED|Overall Study||4
6364737|NCT00701805|7274934|FG002|NOT COMPLETED|Overall Study||7
6364738|NCT00701805|7274935|FG003|NOT COMPLETED|Overall Study||4
6364739|NCT00701896|7274947|FG000|STARTED|Overall Study|Includes those eligible but declined to participate|143
6377456|NCT00762996|7288032|FG000|STARTED|Period One||15
6364740|NCT00701896|7274948|FG001|STARTED|Overall Study|Includes those eligible but declined to participate|151
6364741|NCT00701896|7274947|FG000|COMPLETED|Overall Study||110
6364742|NCT00701896|7274948|FG001|COMPLETED|Overall Study||118
6364743|NCT00701896|7274947|FG000|NOT COMPLETED|Overall Study||33
6364744|NCT00701896|7274948|FG001|NOT COMPLETED|Overall Study||33
6364745|NCT00701935|7274956|FG000|STARTED|Overall Study||43
6364746|NCT00701935|7274957|FG001|STARTED|Overall Study||37
6364747|NCT00701935|7274956|FG000|COMPLETED|Overall Study||27
6364748|NCT00701935|7274957|FG001|COMPLETED|Overall Study||26
6364749|NCT00701935|7274956|FG000|NOT COMPLETED|Overall Study||16
6364750|NCT00701935|7274957|FG001|NOT COMPLETED|Overall Study||11
6364751|NCT00702052|7274963|FG000|STARTED|Overall Study||58
6364752|NCT00702052|7274963|FG000|COMPLETED|Overall Study||0
6364753|NCT00702052|7274963|FG000|NOT COMPLETED|Overall Study||58
6364754|NCT00702143|7274970|FG000|STARTED|Overall Study||45
6364755|NCT00702143|7274971|FG001|STARTED|Overall Study||60
6364756|NCT00702143|7274972|FG002|STARTED|Overall Study||79
6364757|NCT00702143|7274970|FG000|COMPLETED|Overall Study||45
6364758|NCT00702143|7274971|FG001|COMPLETED|Overall Study||60
6364759|NCT00702143|7274972|FG002|COMPLETED|Overall Study||78
6364760|NCT00702143|7274970|FG000|NOT COMPLETED|Overall Study||0
6364761|NCT00702143|7274971|FG001|NOT COMPLETED|Overall Study||0
6364762|NCT00702143|7274972|FG002|NOT COMPLETED|Overall Study||1
6364763|NCT00702208|7274978|FG000|STARTED|Overall Study||198
6364764|NCT00702208|7274978|FG000|COMPLETED|Overall Study||167
6364765|NCT00702208|7274978|FG000|NOT COMPLETED|Overall Study||31
6364766|NCT00702221|7274985|FG000|STARTED|Overall Study||10
6364767|NCT00702221|7274986|FG001|STARTED|Overall Study||10
6364768|NCT00702221|7274985|FG000|COMPLETED|Overall Study||6
6364769|NCT00702221|7274986|FG001|COMPLETED|Overall Study||7
6364770|NCT00702221|7274985|FG000|NOT COMPLETED|Overall Study||4
6364771|NCT00702221|7274986|FG001|NOT COMPLETED|Overall Study||3
6364772|NCT00702299|7274992|FG000|STARTED|Overall Study||15
6364773|NCT00702299|7274992|FG000|COMPLETED|Overall Study||15
6364774|NCT00702299|7274992|FG000|NOT COMPLETED|Overall Study||0
6560701|NCT01788358|7483553|FG000|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
6560702|NCT01788358|7483553|FG000|Completed Week 52|Overall Study||193
6560703|NCT01788358|7483553|FG000|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
6560704|NCT01788358|7483553|FG000|NOT COMPLETED|Overall Study||98
6364775|NCT00702325|7275001|FG000|STARTED|Overall Study|Randomized|156
6364776|NCT00702325|7275002|FG001|STARTED|Overall Study|Randomized|155
6364777|NCT00702325|7275001|FG000|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
6364778|NCT00702325|7275002|FG001|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
6364779|NCT00702325|7275001|FG000|NOT COMPLETED|Overall Study||38
6364780|NCT00702325|7275002|FG001|NOT COMPLETED|Overall Study||53
6364781|NCT00702364|7275010|FG000|STARTED|Overall Study||26
6364782|NCT00702364|7275011|FG001|STARTED|Overall Study||29
6364783|NCT00702364|7275010|FG000|COMPLETED|Overall Study||24
6364784|NCT00702364|7275011|FG001|COMPLETED|Overall Study||25
6364785|NCT00702364|7275010|FG000|NOT COMPLETED|Overall Study||2
6364786|NCT00702364|7275011|FG001|NOT COMPLETED|Overall Study||4
6364787|NCT00702377|7275019|FG000|STARTED|Overall Study||53
6364788|NCT00702377|7275020|FG001|STARTED|Overall Study||56
6364789|NCT00702377|7275019|FG000|COMPLETED|Overall Study||52
6364790|NCT00702377|7275020|FG001|COMPLETED|Overall Study||53
6364791|NCT00702377|7275019|FG000|NOT COMPLETED|Overall Study||1
6364792|NCT00702377|7275020|FG001|NOT COMPLETED|Overall Study||3
6364793|NCT00702403|7275026|FG000|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
6364794|NCT00702403|7275026|FG000|Ineligible for Study Drug|From Consent to Engraftment||17
6364795|NCT00702403|7275026|FG000|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
6364796|NCT00702403|7275026|FG000|NOT COMPLETED|From Consent to Engraftment||17
6364797|NCT00702403|7275026|FG000|STARTED|From Engraftment to Study Completion||40
6364798|NCT00702403|7275026|FG000|Patient Drop-outs|From Engraftment to Study Completion||27
6364799|NCT00702403|7275026|FG000|COMPLETED|From Engraftment to Study Completion||13
6364800|NCT00702403|7275026|FG000|NOT COMPLETED|From Engraftment to Study Completion||27
6364801|NCT00702468|7275035|FG000|STARTED|Overall Study||18
6364802|NCT00702468|7275036|FG001|STARTED|Overall Study||18
6364803|NCT00702468|7275035|FG000|COMPLETED|Overall Study||15
6364804|NCT00702468|7275036|FG001|COMPLETED|Overall Study||2
6364805|NCT00702468|7275035|FG000|NOT COMPLETED|Overall Study||3
6364806|NCT00702468|7275036|FG001|NOT COMPLETED|Overall Study||16
6364807|NCT00702507|7275042|FG000|STARTED|Initial Treatment Phase||200
6364808|NCT00702507|7275042|FG000|COMPLETED|Initial Treatment Phase||159
6364809|NCT00702507|7275042|FG000|NOT COMPLETED|Initial Treatment Phase||41
6364810|NCT00702507|7275042|FG000|STARTED|Follow-up Phase||159
6364811|NCT00702507|7275042|FG000|COMPLETED|Follow-up Phase||132
6364812|NCT00702507|7275042|FG000|NOT COMPLETED|Follow-up Phase||27
6364813|NCT00702650|7275047|FG000|STARTED|Overall Study||155
6364814|NCT00702650|7275047|FG000|COMPLETED|Overall Study||135
6364815|NCT00702650|7275047|FG000|NOT COMPLETED|Overall Study||20
6364816|NCT00702689|7275051|FG000|STARTED|Overall Study||20
6364817|NCT00702689|7275051|FG000|COMPLETED|Overall Study||14
6364818|NCT00702689|7275051|FG000|NOT COMPLETED|Overall Study||6
6364819|NCT00702715|7275057|FG000|STARTED|Overall Study||35
6364820|NCT00702715|7275058|FG001|STARTED|Overall Study|One subject was enrolled but did not start study|33
6364821|NCT00702715|7275057|FG000|COMPLETED|Overall Study||34
6364822|NCT00702715|7275058|FG001|COMPLETED|Overall Study||33
6364823|NCT00702715|7275057|FG000|NOT COMPLETED|Overall Study||1
6364824|NCT00702715|7275058|FG001|NOT COMPLETED|Overall Study||0
6364825|NCT00702754|7275064|FG000|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
6364826|NCT00702754|7275064|FG000|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
6364827|NCT00702754|7275064|FG000|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
6364828|NCT00702754|7275064|FG000|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
6364829|NCT00702754|7275064|FG000|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
6364830|NCT00702754|7275064|FG000|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
6364831|NCT00702754|7275064|FG000|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
6364832|NCT00702754|7275064|FG000|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
6364833|NCT00702754|7275064|FG000|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
6364834|NCT00702754|7275064|FG000|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
6364835|NCT00702754|7275064|FG000|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
6364836|NCT00702754|7275064|FG000|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
6364837|NCT00702754|7275064|FG000|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
6364838|NCT00702754|7275064|FG000|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
6364839|NCT00702754|7275064|FG000|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
6364840|NCT00702754|7275064|FG000|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
6364841|NCT00702754|7275064|FG000|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
6364842|NCT00702754|7275064|FG000|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
6364843|NCT00702754|7275064|FG000|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
6364844|NCT00702754|7275064|FG000|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
6364845|NCT00702754|7275064|FG000|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
6364846|NCT00702754|7275064|FG000|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
6364847|NCT00702754|7275064|FG000|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
6364848|NCT00702754|7275064|FG000|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
6364849|NCT00702780|7275070|FG000|STARTED|Overall Study||37
6364850|NCT00702780|7275071|FG001|STARTED|Overall Study||37
6364851|NCT00702780|7275070|FG000|COMPLETED|Overall Study||28
6364852|NCT00702780|7275071|FG001|COMPLETED|Overall Study||29
6364853|NCT00702780|7275070|FG000|NOT COMPLETED|Overall Study||9
6364854|NCT00702780|7275071|FG001|NOT COMPLETED|Overall Study||8
6364855|NCT00702884|7275077|FG000|STARTED|Overall Study||25
6364856|NCT00702884|7275077|FG000|COMPLETED|Overall Study||25
6364857|NCT00702884|7275077|FG000|NOT COMPLETED|Overall Study||0
6364858|NCT00702923|7275084|FG000|STARTED|Overall Study||12
6364859|NCT00702923|7275084|FG000|COMPLETED|Overall Study||11
6364860|NCT00702923|7275084|FG000|NOT COMPLETED|Overall Study||1
6364861|NCT00702949|7275092|FG000|STARTED|Overall Study||63
6364862|NCT00702949|7275093|FG001|STARTED|Overall Study||66
6364863|NCT00702949|7275094|FG002|STARTED|Overall Study||62
6364864|NCT00702949|7275092|FG000|Evaluable for Primary Endpoint|Overall Study||56
6364865|NCT00702949|7275093|FG001|Evaluable for Primary Endpoint|Overall Study||56
6364866|NCT00702949|7275094|FG002|Evaluable for Primary Endpoint|Overall Study||51
6364867|NCT00702949|7275092|FG000|COMPLETED|Overall Study||58
6364868|NCT00702949|7275093|FG001|COMPLETED|Overall Study||57
6364869|NCT00702949|7275094|FG002|COMPLETED|Overall Study||54
6364870|NCT00702949|7275092|FG000|NOT COMPLETED|Overall Study||5
6364871|NCT00702949|7275093|FG001|NOT COMPLETED|Overall Study||9
6364872|NCT00702949|7275094|FG002|NOT COMPLETED|Overall Study||8
6364873|NCT00703053|7275113|FG000|STARTED|Overall Study||27
6364874|NCT00703053|7275114|FG001|STARTED|Overall Study||26
6364875|NCT00703053|7275115|FG002|STARTED|Overall Study||51
6364876|NCT00703053|7275116|FG003|STARTED|Overall Study||49
6364877|NCT00703053|7275117|FG004|STARTED|Overall Study||51
6364878|NCT00703053|7275118|FG005|STARTED|Overall Study||49
6364879|NCT00703053|7275119|FG006|STARTED|Overall Study||52
6364880|NCT00703053|7275120|FG007|STARTED|Overall Study||97
6364881|NCT00703053|7275121|FG008|STARTED|Overall Study||103
6364882|NCT00703053|7275113|FG000|COMPLETED|Overall Study||26
6364883|NCT00703053|7275114|FG001|COMPLETED|Overall Study||24
6364884|NCT00703053|7275115|FG002|COMPLETED|Overall Study||48
6364885|NCT00703053|7275116|FG003|COMPLETED|Overall Study||46
6364886|NCT00703053|7275117|FG004|COMPLETED|Overall Study||50
6364887|NCT00703053|7275118|FG005|COMPLETED|Overall Study||43
6364888|NCT00703053|7275119|FG006|COMPLETED|Overall Study||45
6364889|NCT00703053|7275120|FG007|COMPLETED|Overall Study||91
6364890|NCT00703053|7275121|FG008|COMPLETED|Overall Study||102
6364891|NCT00703053|7275113|FG000|NOT COMPLETED|Overall Study||1
6364892|NCT00703053|7275114|FG001|NOT COMPLETED|Overall Study||2
6364893|NCT00703053|7275115|FG002|NOT COMPLETED|Overall Study||3
6364894|NCT00703053|7275116|FG003|NOT COMPLETED|Overall Study||3
6364895|NCT00703053|7275117|FG004|NOT COMPLETED|Overall Study||1
6364896|NCT00703053|7275118|FG005|NOT COMPLETED|Overall Study||6
6364897|NCT00703053|7275119|FG006|NOT COMPLETED|Overall Study||7
6364898|NCT00703053|7275120|FG007|NOT COMPLETED|Overall Study||6
6364899|NCT00703053|7275121|FG008|NOT COMPLETED|Overall Study||1
6364900|NCT00703118|7275146|FG000|STARTED|Overall Study||266
6364901|NCT00703118|7275147|FG001|STARTED|Overall Study||264
6364902|NCT00703118|7275148|FG002|STARTED|Overall Study||132
6364903|NCT00703118|7275146|FG000|COMPLETED|Overall Study||245
6364904|NCT00703118|7275147|FG001|COMPLETED|Overall Study||248
6364905|NCT00703118|7275148|FG002|COMPLETED|Overall Study||110
6364906|NCT00703118|7275146|FG000|NOT COMPLETED|Overall Study||21
6364907|NCT00703118|7275147|FG001|NOT COMPLETED|Overall Study||16
6364908|NCT00703118|7275148|FG002|NOT COMPLETED|Overall Study||22
6364909|NCT00703157|7275161|FG000|STARTED|Overall Study||26
6364910|NCT00703157|7275162|FG001|STARTED|Overall Study||26
6364911|NCT00703157|7275161|FG000|6 Months FU|Overall Study||25
6364912|NCT00703157|7275162|FG001|6 Months FU|Overall Study||25
6364913|NCT00703157|7275161|FG000|24 Months FU|Overall Study||22
6364914|NCT00703157|7275162|FG001|24 Months FU|Overall Study||24
6364915|NCT00703157|7275161|FG000|COMPLETED|Overall Study||22
6364916|NCT00703157|7275162|FG001|COMPLETED|Overall Study||24
6364917|NCT00703157|7275161|FG000|NOT COMPLETED|Overall Study||4
6364918|NCT00703157|7275162|FG001|NOT COMPLETED|Overall Study||2
6364919|NCT00703261|7275172|FG000|STARTED|Overall Study||42
6364920|NCT00703261|7275173|FG001|STARTED|Overall Study||41
6364921|NCT00703261|7275172|FG000|COMPLETED|Overall Study||36
6364922|NCT00703261|7275173|FG001|COMPLETED|Overall Study||35
6364923|NCT00703261|7275172|FG000|NOT COMPLETED|Overall Study||6
6364924|NCT00703261|7275173|FG001|NOT COMPLETED|Overall Study||6
6364925|NCT00703391|7275182|FG000|STARTED|Overall Study||12
6364926|NCT00703391|7275183|FG001|STARTED|Overall Study||6
6364927|NCT00703391|7275182|FG000|COMPLETED|Overall Study||12
6364928|NCT00703391|7275183|FG001|COMPLETED|Overall Study||6
6364929|NCT00703391|7275182|FG000|NOT COMPLETED|Overall Study||0
6364930|NCT00703391|7275183|FG001|NOT COMPLETED|Overall Study||0
6364931|NCT00703508|7275189|FG000|STARTED|Overall Study||26
6364932|NCT00703508|7275189|FG000|COMPLETED|Overall Study||26
6364933|NCT00703508|7275189|FG000|NOT COMPLETED|Overall Study||0
6364934|NCT00703664|7275198|FG000|STARTED|Overall Study||22
6364935|NCT00703664|7275199|FG001|STARTED|Overall Study||4
6364936|NCT00703664|7275200|FG002|STARTED|Overall Study||39
6364937|NCT00703664|7275198|FG000|COMPLETED|Overall Study||22
6364938|NCT00703664|7275199|FG001|COMPLETED|Overall Study||4
6364939|NCT00703664|7275200|FG002|COMPLETED|Overall Study||39
6364940|NCT00703664|7275198|FG000|NOT COMPLETED|Overall Study||0
6364941|NCT00703664|7275199|FG001|NOT COMPLETED|Overall Study||0
6364942|NCT00703664|7275200|FG002|NOT COMPLETED|Overall Study||0
6364943|NCT00703677|7275208|FG000|STARTED|Overall Study||17
6364944|NCT00703677|7275208|FG000|COMPLETED|Overall Study||14
6364945|NCT00703677|7275208|FG000|NOT COMPLETED|Overall Study||3
6364946|NCT00703729|7275214|FG000|STARTED|Overall Study||25
6364947|NCT00703729|7275215|FG001|STARTED|Overall Study||24
6364948|NCT00703729|7275214|FG000|COMPLETED|Overall Study||25
6364949|NCT00703729|7275215|FG001|COMPLETED|Overall Study||21
6364950|NCT00703729|7275214|FG000|NOT COMPLETED|Overall Study||0
6560705|NCT01788423|7483560|FG000|STARTED|Overall Study||53
6560706|NCT01788423|7483561|FG001|STARTED|Overall Study||55
6560707|NCT01788423|7483562|FG002|STARTED|Overall Study||55
6364951|NCT00703729|7275215|FG001|NOT COMPLETED|Overall Study||3
6364952|NCT00703781|7275223|FG000|STARTED|Overall Study||63
6364953|NCT00703781|7275224|FG001|STARTED|Overall Study||63
6364954|NCT00703781|7275223|FG000|COMPLETED|Overall Study||61
6364955|NCT00703781|7275224|FG001|COMPLETED|Overall Study||61
6364956|NCT00703781|7275223|FG000|NOT COMPLETED|Overall Study||2
6364957|NCT00703781|7275224|FG001|NOT COMPLETED|Overall Study||2
6364958|NCT00703820|7275232|FG000|STARTED|Overall Study||133
6364959|NCT00703820|7275233|FG001|STARTED|Overall Study||129
6364960|NCT00703820|7275232|FG000|COMPLETED|Overall Study||98
6364961|NCT00703820|7275233|FG001|COMPLETED|Overall Study||95
6364962|NCT00703820|7275232|FG000|NOT COMPLETED|Overall Study||35
6364963|NCT00703820|7275233|FG001|NOT COMPLETED|Overall Study||34
6364964|NCT00703846|7275241|FG000|STARTED|Overall Study||500
6364965|NCT00703846|7275241|FG000|COMPLETED|Overall Study||363
6364966|NCT00703846|7275241|FG000|NOT COMPLETED|Overall Study||137
6364967|NCT00703911|7275245|FG000|STARTED|Overall Study||102
6364968|NCT00703911|7275245|FG000|COMPLETED|Overall Study||92
6364969|NCT00703911|7275245|FG000|NOT COMPLETED|Overall Study||10
6364970|NCT00703924|7275251|FG000|STARTED|Overall Study||50
6364971|NCT00703924|7275252|FG001|STARTED|Overall Study||42
6364972|NCT00703924|7275251|FG000|COMPLETED|Overall Study||49
6364973|NCT00703924|7275252|FG001|COMPLETED|Overall Study||41
6364974|NCT00703924|7275251|FG000|NOT COMPLETED|Overall Study||1
6364975|NCT00703924|7275252|FG001|NOT COMPLETED|Overall Study||1
6364976|NCT00703937|7275264|FG000|STARTED|Overall Study||343
6364977|NCT00703937|7275265|FG001|STARTED|Overall Study||360
6364978|NCT00703937|7275264|FG000|COMPLETED|Overall Study||278
6364979|NCT00703937|7275265|FG001|COMPLETED|Overall Study||267
6560708|NCT01788423|7483560|FG000|COMPLETED|Overall Study||53
6364980|NCT00703937|7275264|FG000|NOT COMPLETED|Overall Study||65
6364981|NCT00703937|7275265|FG001|NOT COMPLETED|Overall Study||93
6364982|NCT00703963|7275273|FG000|STARTED|Overall Study||100
6364983|NCT00703963|7275274|FG001|STARTED|Overall Study||100
6364984|NCT00703963|7275273|FG000|COMPLETED|Overall Study||93
6562889|NCT01803282|7485791|FG006|COMPLETED|Overall Study||0
6364985|NCT00703963|7275274|FG001|COMPLETED|Overall Study||86
6364986|NCT00703963|7275273|FG000|NOT COMPLETED|Overall Study||7
6364987|NCT00703963|7275274|FG001|NOT COMPLETED|Overall Study||14
6364988|NCT00703976|7275282|FG000|STARTED|Overall Study||37
6364989|NCT00703976|7275283|FG001|STARTED|Overall Study||41
6364990|NCT00703976|7275282|FG000|COMPLETED|Overall Study||37
6364991|NCT00703976|7275283|FG001|COMPLETED|Overall Study||41
6364992|NCT00703976|7275282|FG000|NOT COMPLETED|Overall Study||0
6364993|NCT00703976|7275283|FG001|NOT COMPLETED|Overall Study||0
6364994|NCT00704028|7275293|FG000|STARTED|Overall Study||82
6364995|NCT00704028|7275294|FG001|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
6364996|NCT00704028|7275293|FG000|COMPLETED|Overall Study||70
6364997|NCT00704028|7275294|FG001|COMPLETED|Overall Study||57
6364998|NCT00704028|7275293|FG000|NOT COMPLETED|Overall Study||12
6364999|NCT00704028|7275294|FG001|NOT COMPLETED|Overall Study||21
6365000|NCT00704132|7275302|FG000|STARTED|Overall Study||26
6365001|NCT00704132|7275303|FG001|STARTED|Overall Study||24
6365002|NCT00704132|7275302|FG000|COMPLETED|Overall Study||25
6365003|NCT00704132|7275303|FG001|COMPLETED|Overall Study||22
6365004|NCT00704132|7275302|FG000|NOT COMPLETED|Overall Study||1
6365005|NCT00704132|7275303|FG001|NOT COMPLETED|Overall Study||2
6365006|NCT00704171|7275311|FG000|STARTED|Overall Study||62
6560709|NCT01788423|7483561|FG001|COMPLETED|Overall Study|Four participants were unable to self-select hearing aids.|51
6560710|NCT01788423|7483562|FG002|COMPLETED|Overall Study|Three people developed unrelated health problems and two were unable to fit/use hearing aids.|50
6560711|NCT01788423|7483560|FG000|NOT COMPLETED|Overall Study||0
6560712|NCT01788423|7483561|FG001|NOT COMPLETED|Overall Study||4
6560713|NCT01788423|7483562|FG002|NOT COMPLETED|Overall Study||5
6560714|NCT01788566|7483570|FG000|STARTED|Overall Study||61
6560715|NCT01788566|7483570|FG000|COMPLETED|Overall Study||53
6560716|NCT01788566|7483570|FG000|NOT COMPLETED|Overall Study||8
6365007|NCT00704171|7275312|FG001|STARTED|Overall Study||59
6365008|NCT00704171|7275311|FG000|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
6365009|NCT00704171|7275312|FG001|COMPLETED|Overall Study|All control subjects completed the study.|59
6365010|NCT00704171|7275311|FG000|NOT COMPLETED|Overall Study||1
6365011|NCT00704171|7275312|FG001|NOT COMPLETED|Overall Study||0
6365012|NCT00704184|7275323|FG000|STARTED|Double-Blind Treatment||20
6560717|NCT01788631|7483576|FG000|STARTED|Overall Study||52
6560718|NCT01788631|7483577|FG001|STARTED|Overall Study||44
6560719|NCT01788631|7483576|FG000|Randomized|Overall Study||53
6560720|NCT01788631|7483577|FG001|Randomized|Overall Study||47
6560721|NCT01788631|7483576|FG000|COMPLETED|Overall Study||49
6560722|NCT01788631|7483577|FG001|COMPLETED|Overall Study||43
6365013|NCT00704184|7275324|FG001|STARTED|Double-Blind Treatment||18
6365014|NCT00704184|7275325|FG002|STARTED|Double-Blind Treatment||20
6365015|NCT00704184|7275326|FG003|STARTED|Double-Blind Treatment||18
6365016|NCT00704184|7275327|FG004|STARTED|Double-Blind Treatment||19
6365017|NCT00704184|7275323|FG000|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
6365018|NCT00704184|7275324|FG001|Treated|Double-Blind Treatment||18
6365019|NCT00704184|7275325|FG002|Treated|Double-Blind Treatment||20
6365020|NCT00704184|7275326|FG003|Treated|Double-Blind Treatment||18
6365021|NCT00704184|7275327|FG004|Treated|Double-Blind Treatment||19
6365022|NCT00704184|7275323|FG000|COMPLETED|Double-Blind Treatment||19
6365023|NCT00704184|7275324|FG001|COMPLETED|Double-Blind Treatment||18
6365024|NCT00704184|7275325|FG002|COMPLETED|Double-Blind Treatment||20
6365025|NCT00704184|7275326|FG003|COMPLETED|Double-Blind Treatment||18
6365026|NCT00704184|7275327|FG004|COMPLETED|Double-Blind Treatment||19
6365027|NCT00704184|7275323|FG000|NOT COMPLETED|Double-Blind Treatment||1
6365028|NCT00704184|7275324|FG001|NOT COMPLETED|Double-Blind Treatment||0
6365029|NCT00704184|7275325|FG002|NOT COMPLETED|Double-Blind Treatment||0
6365030|NCT00704184|7275326|FG003|NOT COMPLETED|Double-Blind Treatment||0
6365031|NCT00704184|7275327|FG004|NOT COMPLETED|Double-Blind Treatment||0
6365032|NCT00704184|7275323|FG000|STARTED|Open-Label Treatment||19
6365033|NCT00704184|7275324|FG001|STARTED|Open-Label Treatment||18
6365034|NCT00704184|7275325|FG002|STARTED|Open-Label Treatment||20
6365035|NCT00704184|7275326|FG003|STARTED|Open-Label Treatment||18
6365036|NCT00704184|7275327|FG004|STARTED|Open-Label Treatment||19
6365037|NCT00704184|7275323|FG000|COMPLETED|Open-Label Treatment||18
6365038|NCT00704184|7275324|FG001|COMPLETED|Open-Label Treatment||16
6365039|NCT00704184|7275325|FG002|COMPLETED|Open-Label Treatment||16
6365040|NCT00704184|7275326|FG003|COMPLETED|Open-Label Treatment||13
6365041|NCT00704184|7275327|FG004|COMPLETED|Open-Label Treatment||16
6365042|NCT00704184|7275323|FG000|NOT COMPLETED|Open-Label Treatment||1
6365043|NCT00704184|7275324|FG001|NOT COMPLETED|Open-Label Treatment||2
6365044|NCT00704184|7275325|FG002|NOT COMPLETED|Open-Label Treatment||4
6365045|NCT00704184|7275326|FG003|NOT COMPLETED|Open-Label Treatment||5
6365046|NCT00704184|7275327|FG004|NOT COMPLETED|Open-Label Treatment||3
6365047|NCT00704262|7275339|FG000|STARTED|Overall Study||33
6365048|NCT00704262|7275339|FG000|COMPLETED|Overall Study||31
6365049|NCT00704262|7275339|FG000|NOT COMPLETED|Overall Study||2
6365050|NCT00704340|7275345|FG000|STARTED|Overall Study||120
6365051|NCT00704340|7275346|FG001|STARTED|Overall Study||117
6365052|NCT00704340|7275345|FG000|COMPLETED|Overall Study||118
6560723|NCT01788631|7483576|FG000|NOT COMPLETED|Overall Study||3
6560724|NCT01788631|7483577|FG001|NOT COMPLETED|Overall Study||1
6560725|NCT01788943|7483585|FG000|STARTED|Overall Study|Recruitment for study began.|13
6560726|NCT01788943|7483586|FG001|STARTED|Overall Study||12
6560727|NCT01788943|7483585|FG000|COMPLETED|Overall Study|2FA-PET Brain Image Analysis Completion Date|12
6365053|NCT00704340|7275346|FG001|COMPLETED|Overall Study||115
6365054|NCT00704340|7275345|FG000|NOT COMPLETED|Overall Study||2
6365055|NCT00704340|7275346|FG001|NOT COMPLETED|Overall Study||2
6560728|NCT01788943|7483586|FG001|COMPLETED|Overall Study||12
6365056|NCT00704353|7275354|FG000|STARTED|Overall Study||366
6365057|NCT00704353|7275355|FG001|STARTED|Overall Study||369
6365058|NCT00704353|7275354|FG000|COMPLETED|Overall Study||268
6365059|NCT00704353|7275355|FG001|COMPLETED|Overall Study||255
6365060|NCT00704353|7275354|FG000|NOT COMPLETED|Overall Study||98
6365061|NCT00704353|7275355|FG001|NOT COMPLETED|Overall Study||114
6365062|NCT00704379|7275363|FG000|STARTED|Overall Study||46
6365063|NCT00704379|7275364|FG001|STARTED|Overall Study||48
6365064|NCT00704379|7275363|FG000|COMPLETED|Overall Study||39
6365065|NCT00704379|7275364|FG001|COMPLETED|Overall Study||41
6365066|NCT00704379|7275363|FG000|NOT COMPLETED|Overall Study||7
6365067|NCT00704379|7275364|FG001|NOT COMPLETED|Overall Study||7
6365068|NCT00704405|7275377|FG000|STARTED|Overall Study (NC Population)||42
6365069|NCT00704405|7275378|FG001|STARTED|Overall Study (NC Population)||44
6365070|NCT00704405|7275379|FG002|STARTED|Overall Study (NC Population)||41
6365071|NCT00704405|7275380|FG003|STARTED|Overall Study (NC Population)||42
6365072|NCT00704405|7275381|FG004|STARTED|Overall Study (NC Population)||42
6365073|NCT00704405|7275377|FG000|COMPLETED|Overall Study (NC Population)||37
6365074|NCT00704405|7275378|FG001|COMPLETED|Overall Study (NC Population)||40
6365075|NCT00704405|7275379|FG002|COMPLETED|Overall Study (NC Population)||38
6365076|NCT00704405|7275380|FG003|COMPLETED|Overall Study (NC Population)||38
6365077|NCT00704405|7275381|FG004|COMPLETED|Overall Study (NC Population)||37
6365078|NCT00704405|7275377|FG000|NOT COMPLETED|Overall Study (NC Population)||5
6365079|NCT00704405|7275378|FG001|NOT COMPLETED|Overall Study (NC Population)||4
6365080|NCT00704405|7275379|FG002|NOT COMPLETED|Overall Study (NC Population)||3
6365081|NCT00704405|7275380|FG003|NOT COMPLETED|Overall Study (NC Population)||4
6365082|NCT00704405|7275381|FG004|NOT COMPLETED|Overall Study (NC Population)||5
6365083|NCT00704405|7275377|FG000|STARTED|Overall Study (C Population)||16
6365084|NCT00704405|7275378|FG001|STARTED|Overall Study (C Population)||14
6365085|NCT00704405|7275379|FG002|STARTED|Overall Study (C Population)||15
6365086|NCT00704405|7275380|FG003|STARTED|Overall Study (C Population)||15
6365087|NCT00704405|7275381|FG004|STARTED|Overall Study (C Population)||14
6365088|NCT00704405|7275377|FG000|COMPLETED|Overall Study (C Population)||15
6365089|NCT00704405|7275378|FG001|COMPLETED|Overall Study (C Population)||11
6365090|NCT00704405|7275379|FG002|COMPLETED|Overall Study (C Population)||14
6365091|NCT00704405|7275380|FG003|COMPLETED|Overall Study (C Population)||14
6365092|NCT00704405|7275381|FG004|COMPLETED|Overall Study (C Population)||14
6365093|NCT00704405|7275377|FG000|NOT COMPLETED|Overall Study (C Population)||1
6365094|NCT00704405|7275378|FG001|NOT COMPLETED|Overall Study (C Population)||3
6365095|NCT00704405|7275379|FG002|NOT COMPLETED|Overall Study (C Population)||1
6365096|NCT00704405|7275380|FG003|NOT COMPLETED|Overall Study (C Population)||1
6365097|NCT00704405|7275381|FG004|NOT COMPLETED|Overall Study (C Population)||0
6365098|NCT00704418|7275401|FG000|STARTED|Overall Study||78
6365099|NCT00704418|7275402|FG001|STARTED|Overall Study||78
6365100|NCT00704418|7275401|FG000|COMPLETED|Overall Study||73
6365101|NCT00704418|7275402|FG001|COMPLETED|Overall Study||72
6365102|NCT00704418|7275401|FG000|NOT COMPLETED|Overall Study||5
6365103|NCT00704418|7275402|FG001|NOT COMPLETED|Overall Study||6
6365104|NCT00704522|7275410|FG000|STARTED|Overall Study||481
6365105|NCT00704522|7275411|FG001|STARTED|Overall Study||120
6365106|NCT00704522|7275410|FG000|COMPLETED|Overall Study||298
6365107|NCT00704522|7275411|FG001|COMPLETED|Overall Study||75
6365108|NCT00704522|7275410|FG000|NOT COMPLETED|Overall Study||183
6365109|NCT00704522|7275411|FG001|NOT COMPLETED|Overall Study||45
6365110|NCT00704717|7275416|FG000|STARTED|Overall Study||185
6365111|NCT00704717|7275416|FG000|COMPLETED|Overall Study||185
6365112|NCT00704717|7275416|FG000|NOT COMPLETED|Overall Study||0
6365113|NCT00704730|7275422|FG000|STARTED|Overall Study|Randomized|219
6365114|NCT00704730|7275423|FG001|STARTED|Overall Study|Randomized|111
6365115|NCT00704730|7275422|FG000|COMPLETED|Overall Study|Continuing treatment at data cutoff for primary analysis, but subsequently discontinued study|98
6365116|NCT00704730|7275423|FG001|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
6365117|NCT00704730|7275422|FG000|NOT COMPLETED|Overall Study||121
6365118|NCT00704730|7275423|FG001|NOT COMPLETED|Overall Study||96
6365119|NCT00704808|7275430|FG000|STARTED|Overall Study||180
6365120|NCT00704808|7275430|FG000|COMPLETED|Overall Study||49
6365121|NCT00704808|7275430|FG000|NOT COMPLETED|Overall Study||131
6365122|NCT00704847|7275436|FG000|STARTED|Overall Study||521
6365123|NCT00704847|7275437|FG001|STARTED|Overall Study||509
6365124|NCT00704847|7275436|FG000|COMPLETED|Overall Study||300
6365125|NCT00704847|7275437|FG001|COMPLETED|Overall Study||339
6365126|NCT00704847|7275436|FG000|NOT COMPLETED|Overall Study||221
6365127|NCT00704847|7275437|FG001|NOT COMPLETED|Overall Study||170
6365128|NCT00704912|7275446|FG000|STARTED|Overall Study||50
6365129|NCT00704912|7275447|FG001|STARTED|Overall Study||49
6365130|NCT00704912|7275448|FG002|STARTED|Overall Study||50
6365131|NCT00704912|7275446|FG000|COMPLETED|Overall Study||44
6365132|NCT00704912|7275447|FG001|COMPLETED|Overall Study||45
6365133|NCT00704912|7275448|FG002|COMPLETED|Overall Study||43
6365134|NCT00704912|7275446|FG000|NOT COMPLETED|Overall Study||6
6365135|NCT00704912|7275447|FG001|NOT COMPLETED|Overall Study||4
6365136|NCT00704912|7275448|FG002|NOT COMPLETED|Overall Study||7
6365137|NCT00704938|7275458|FG000|STARTED|Overall Study||2
6365138|NCT00704938|7275459|FG001|STARTED|Overall Study||1
6365139|NCT00704938|7275458|FG000|COMPLETED|Overall Study||2
6365140|NCT00704938|7275459|FG001|COMPLETED|Overall Study||1
6365141|NCT00704938|7275458|FG000|NOT COMPLETED|Overall Study||0
6365142|NCT00704938|7275459|FG001|NOT COMPLETED|Overall Study||0
6365143|NCT00704964|7275465|FG000|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
6365144|NCT00704964|7275465|FG000|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
6365145|NCT00704964|7275465|FG000|NOT COMPLETED|Overall Study||328
6365146|NCT00705003|7275472|FG000|STARTED|Enrolled||71
6365147|NCT00705003|7275473|FG001|STARTED|Enrolled||37
6365148|NCT00705003|7275474|FG002|STARTED|Enrolled||34
6365149|NCT00705003|7275472|FG000|COMPLETED|Enrolled||67
6365150|NCT00705003|7275473|FG001|COMPLETED|Enrolled||34
6365151|NCT00705003|7275474|FG002|COMPLETED|Enrolled||33
6365152|NCT00705003|7275472|FG000|NOT COMPLETED|Enrolled||4
6365153|NCT00705003|7275473|FG001|NOT COMPLETED|Enrolled||3
6365154|NCT00705003|7275474|FG002|NOT COMPLETED|Enrolled||1
6365155|NCT00705003|7275472|FG000|STARTED|Treated||67
6365156|NCT00705003|7275473|FG001|STARTED|Treated||34
6365157|NCT00705003|7275474|FG002|STARTED|Treated||33
6365158|NCT00705003|7275472|FG000|COMPLETED|Treated||54
6365159|NCT00705003|7275473|FG001|COMPLETED|Treated||28
6365160|NCT00705003|7275474|FG002|COMPLETED|Treated||30
6365161|NCT00705003|7275472|FG000|NOT COMPLETED|Treated||13
6365162|NCT00705003|7275473|FG001|NOT COMPLETED|Treated||6
6365163|NCT00705003|7275474|FG002|NOT COMPLETED|Treated||3
6365164|NCT00705016|7275486|FG000|STARTED|Overall Study||62
6365165|NCT00705016|7275487|FG001|STARTED|Overall Study||60
6365166|NCT00705016|7275488|FG002|STARTED|Overall Study||62
6365167|NCT00705016|7275486|FG000|COMPLETED|Overall Study||2
6365168|NCT00705016|7275487|FG001|COMPLETED|Overall Study||2
6365169|NCT00705016|7275488|FG002|COMPLETED|Overall Study||4
6365170|NCT00705016|7275486|FG000|NOT COMPLETED|Overall Study||60
6365171|NCT00705016|7275487|FG001|NOT COMPLETED|Overall Study||58
6365172|NCT00705016|7275488|FG002|NOT COMPLETED|Overall Study||58
6365173|NCT00705107|7275496|FG000|STARTED|Overall Study||267
6365174|NCT00705107|7275496|FG000|COMPLETED|Overall Study||218
6365175|NCT00705107|7275496|FG000|NOT COMPLETED|Overall Study||49
6365176|NCT00705133|7275500|FG000|STARTED|Overall Study||15
6365177|NCT00705133|7275500|FG000|COMPLETED|Overall Study||15
6365178|NCT00705133|7275500|FG000|NOT COMPLETED|Overall Study||0
6365179|NCT00705146|7275506|FG000|STARTED|Overall Study||32
6365180|NCT00705146|7275507|FG001|STARTED|Overall Study||24
6365181|NCT00705146|7275506|FG000|COMPLETED|Overall Study||31
6365182|NCT00705146|7275507|FG001|COMPLETED|Overall Study||23
6365183|NCT00705146|7275506|FG000|NOT COMPLETED|Overall Study||1
6365184|NCT00705146|7275507|FG001|NOT COMPLETED|Overall Study||1
6365185|NCT00705159|7275517|FG000|STARTED|Overall Study||34
6365186|NCT00705159|7275518|FG001|STARTED|Overall Study||35
6365187|NCT00705159|7275519|FG002|STARTED|Overall Study||34
6365188|NCT00705159|7275520|FG003|STARTED|Overall Study||34
6365189|NCT00705159|7275517|FG000|COMPLETED|Overall Study||34
6365190|NCT00705159|7275518|FG001|COMPLETED|Overall Study||33
6365191|NCT00705159|7275519|FG002|COMPLETED|Overall Study||29
6365192|NCT00705159|7275520|FG003|COMPLETED|Overall Study||30
6365193|NCT00705159|7275517|FG000|NOT COMPLETED|Overall Study||0
6365194|NCT00705159|7275518|FG001|NOT COMPLETED|Overall Study||2
6365195|NCT00705159|7275519|FG002|NOT COMPLETED|Overall Study||5
6365196|NCT00705159|7275520|FG003|NOT COMPLETED|Overall Study||4
6365197|NCT00705224|7275530|FG000|STARTED|Overall Study||250
6365198|NCT00705224|7275530|FG000|COMPLETED|Overall Study||239
6365199|NCT00705224|7275530|FG000|NOT COMPLETED|Overall Study||11
6365200|NCT00705250|7275537|FG000|STARTED|Overall Study||36
6365201|NCT00705250|7275537|FG000|COMPLETED|Overall Study||34
6365202|NCT00705250|7275537|FG000|NOT COMPLETED|Overall Study||2
6365203|NCT00705263|7275541|FG000|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
6365204|NCT00705263|7275541|FG000|COMPLETED|Overall Study||108
6365205|NCT00705263|7275541|FG000|NOT COMPLETED|Overall Study||2
6365206|NCT00705289|7275545|FG000|STARTED|Overall Study||728
6365207|NCT00705289|7275545|FG000|COMPLETED|Overall Study||597
6365208|NCT00705289|7275545|FG000|NOT COMPLETED|Overall Study||131
6365209|NCT00705341|7275568|FG000|STARTED|Phase 1:Control Challenge||126
6365210|NCT00705341|7275569|FG001|STARTED|Phase 1:Control Challenge||93
6365211|NCT00705341|7275570|FG002|STARTED|Phase 1:Control Challenge||0
6365212|NCT00705341|7275571|FG003|STARTED|Phase 1:Control Challenge||0
6365213|NCT00705341|7275568|FG000|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
6365214|NCT00705341|7275569|FG001|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
6365215|NCT00705341|7275570|FG002|COMPLETED|Phase 1:Control Challenge||0
6365216|NCT00705341|7275571|FG003|COMPLETED|Phase 1:Control Challenge||0
6365217|NCT00705341|7275568|FG000|NOT COMPLETED|Phase 1:Control Challenge||0
6365218|NCT00705341|7275569|FG001|NOT COMPLETED|Phase 1:Control Challenge||0
6365219|NCT00705341|7275570|FG002|NOT COMPLETED|Phase 1:Control Challenge||0
6365220|NCT00705341|7275571|FG003|NOT COMPLETED|Phase 1:Control Challenge||0
6365221|NCT00705341|7275568|FG000|STARTED|Phase 2: Trial||0
6365222|NCT00705341|7275569|FG001|STARTED|Phase 2: Trial||0
6365223|NCT00705341|7275570|FG002|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
6365224|NCT00705341|7275571|FG003|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
6365225|NCT00705341|7275568|FG000|COMPLETED|Phase 2: Trial||0
6365226|NCT00705341|7275569|FG001|COMPLETED|Phase 2: Trial||0
6365227|NCT00705341|7275570|FG002|COMPLETED|Phase 2: Trial||23
6365228|NCT00705341|7275571|FG003|COMPLETED|Phase 2: Trial||28
6365229|NCT00705341|7275568|FG000|NOT COMPLETED|Phase 2: Trial||0
6365230|NCT00705341|7275569|FG001|NOT COMPLETED|Phase 2: Trial||0
6365231|NCT00705341|7275570|FG002|NOT COMPLETED|Phase 2: Trial||7
6365232|NCT00705341|7275571|FG003|NOT COMPLETED|Phase 2: Trial||4
6365233|NCT00705367|7275581|FG000|STARTED|Short-term Period||6
6365234|NCT00705367|7275582|FG001|STARTED|Short-term Period||3
6365235|NCT00705367|7275581|FG000|COMPLETED|Short-term Period||6
6365236|NCT00705367|7275582|FG001|COMPLETED|Short-term Period||3
6365237|NCT00705367|7275581|FG000|NOT COMPLETED|Short-term Period||0
6365238|NCT00705367|7275582|FG001|NOT COMPLETED|Short-term Period||0
6365239|NCT00705367|7275581|FG000|STARTED|Long-term Extension Period||9
6365240|NCT00705367|7275582|FG001|STARTED|Long-term Extension Period||0
6365241|NCT00705367|7275581|FG000|COMPLETED|Long-term Extension Period||0
6365242|NCT00705367|7275582|FG001|COMPLETED|Long-term Extension Period||0
6365243|NCT00705367|7275581|FG000|NOT COMPLETED|Long-term Extension Period||9
6365244|NCT00705367|7275582|FG001|NOT COMPLETED|Long-term Extension Period||0
6365245|NCT00705406|7275592|FG000|STARTED|Overall Study||203
6365246|NCT00705406|7275593|FG001|STARTED|Overall Study||202
6365247|NCT00705406|7275592|FG000|COMPLETED|Overall Study||199
6365248|NCT00705406|7275593|FG001|COMPLETED|Overall Study||197
6365249|NCT00705406|7275592|FG000|NOT COMPLETED|Overall Study||4
6365250|NCT00705406|7275593|FG001|NOT COMPLETED|Overall Study||5
6365251|NCT00705432|7275606|FG000|STARTED|Treatment Period||311
6365252|NCT00705432|7275607|FG001|STARTED|Treatment Period||316
6365253|NCT00705432|7275608|FG002|STARTED|Treatment Period||311
6365254|NCT00705432|7275609|FG003|STARTED|Treatment Period||52
6365255|NCT00705432|7275610|FG004|STARTED|Treatment Period||52
6365256|NCT00705432|7275611|FG005|STARTED|Treatment Period||55
6365257|NCT00705432|7275606|FG000|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
6365258|NCT00705432|7275607|FG001|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
6365259|NCT00705432|7275608|FG002|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
6365260|NCT00705432|7275609|FG003|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
6365261|NCT00705432|7275610|FG004|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
6365262|NCT00705432|7275611|FG005|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
6365263|NCT00705432|7275606|FG000|COMPLETED|Treatment Period||148
6365264|NCT00705432|7275607|FG001|COMPLETED|Treatment Period||205
6365265|NCT00705432|7275608|FG002|COMPLETED|Treatment Period||190
6365266|NCT00705432|7275609|FG003|COMPLETED|Treatment Period||11
6365267|NCT00705432|7275610|FG004|COMPLETED|Treatment Period||24
6365268|NCT00705432|7275611|FG005|COMPLETED|Treatment Period||25
6365269|NCT00705432|7275606|FG000|NOT COMPLETED|Treatment Period||163
6365270|NCT00705432|7275607|FG001|NOT COMPLETED|Treatment Period||111
6365271|NCT00705432|7275608|FG002|NOT COMPLETED|Treatment Period||121
6365272|NCT00705432|7275609|FG003|NOT COMPLETED|Treatment Period||41
6365273|NCT00705432|7275610|FG004|NOT COMPLETED|Treatment Period||28
6365274|NCT00705432|7275611|FG005|NOT COMPLETED|Treatment Period||30
6365275|NCT00705432|7275606|FG000|STARTED|Follow-up Period (Upto Week 72)||278
6365276|NCT00705432|7275607|FG001|STARTED|Follow-up Period (Upto Week 72)||295
6365277|NCT00705432|7275608|FG002|STARTED|Follow-up Period (Upto Week 72)||291
6365278|NCT00705432|7275609|FG003|STARTED|Follow-up Period (Upto Week 72)||42
6365279|NCT00705432|7275610|FG004|STARTED|Follow-up Period (Upto Week 72)||44
6365280|NCT00705432|7275611|FG005|STARTED|Follow-up Period (Upto Week 72)||53
6365281|NCT00705432|7275606|FG000|COMPLETED|Follow-up Period (Upto Week 72)||207
6365282|NCT00705432|7275607|FG001|COMPLETED|Follow-up Period (Upto Week 72)||252
6365283|NCT00705432|7275608|FG002|COMPLETED|Follow-up Period (Upto Week 72)||266
6365284|NCT00705432|7275609|FG003|COMPLETED|Follow-up Period (Upto Week 72)||28
6365285|NCT00705432|7275610|FG004|COMPLETED|Follow-up Period (Upto Week 72)||38
6365286|NCT00705432|7275611|FG005|COMPLETED|Follow-up Period (Upto Week 72)||46
6365287|NCT00705432|7275606|FG000|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
6365288|NCT00705432|7275607|FG001|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
6365289|NCT00705432|7275608|FG002|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
6365290|NCT00705432|7275609|FG003|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
6365291|NCT00705432|7275610|FG004|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
6365292|NCT00705432|7275611|FG005|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
6365293|NCT00705484|7275624|FG000|STARTED|Overall Study|Number Enrolled|1059
6365294|NCT00705484|7275625|FG001|STARTED|Overall Study|Number Enrolled|1180
6365295|NCT00705484|7275624|FG000|Follow-up Period|Overall Study||1059
6365296|NCT00705484|7275625|FG001|Follow-up Period|Overall Study|Switched From Standard Therapy to Remicade|296
6365297|NCT00705484|7275624|FG000|COMPLETED|Overall Study||677
6365298|NCT00705484|7275625|FG001|COMPLETED|Overall Study||772
6365299|NCT00705484|7275624|FG000|NOT COMPLETED|Overall Study||382
6365300|NCT00705484|7275625|FG001|NOT COMPLETED|Overall Study||408
6365301|NCT00705523|7275635|FG000|STARTED|Overall Study||19
6365302|NCT00705523|7275636|FG001|STARTED|Overall Study||21
6365303|NCT00705523|7275635|FG000|COMPLETED|Overall Study||17
6365304|NCT00705523|7275636|FG001|COMPLETED|Overall Study||18
6365305|NCT00705523|7275635|FG000|NOT COMPLETED|Overall Study||2
6365306|NCT00705523|7275636|FG001|NOT COMPLETED|Overall Study||3
6365307|NCT00705536|7275644|FG000|STARTED|Start Period 1||6
6365308|NCT00705536|7275645|FG001|STARTED|Start Period 1||6
6365309|NCT00705536|7275646|FG002|STARTED|Start Period 1||7
6365310|NCT00705536|7275647|FG003|STARTED|Start Period 1||7
6365311|NCT00705536|7275644|FG000|Received at Least 1 Dose of Study Drug|Start Period 1||6
6365312|NCT00705536|7275645|FG001|Received at Least 1 Dose of Study Drug|Start Period 1||6
6365313|NCT00705536|7275646|FG002|Received at Least 1 Dose of Study Drug|Start Period 1||7
6365314|NCT00705536|7275647|FG003|Received at Least 1 Dose of Study Drug|Start Period 1||7
6365315|NCT00705536|7275644|FG000|COMPLETED|Start Period 1||6
6365316|NCT00705536|7275645|FG001|COMPLETED|Start Period 1||6
6365317|NCT00705536|7275646|FG002|COMPLETED|Start Period 1||7
6365318|NCT00705536|7275647|FG003|COMPLETED|Start Period 1||6
6365319|NCT00705536|7275644|FG000|NOT COMPLETED|Start Period 1||0
6365320|NCT00705536|7275645|FG001|NOT COMPLETED|Start Period 1||0
6365321|NCT00705536|7275646|FG002|NOT COMPLETED|Start Period 1||0
6365322|NCT00705536|7275647|FG003|NOT COMPLETED|Start Period 1||1
6365323|NCT00705536|7275644|FG000|STARTED|Washout Period of at Least 6 Days||6
6365324|NCT00705536|7275645|FG001|STARTED|Washout Period of at Least 6 Days||6
6365325|NCT00705536|7275646|FG002|STARTED|Washout Period of at Least 6 Days||7
6365326|NCT00705536|7275647|FG003|STARTED|Washout Period of at Least 6 Days||6
6365327|NCT00705536|7275644|FG000|COMPLETED|Washout Period of at Least 6 Days||6
6365328|NCT00705536|7275645|FG001|COMPLETED|Washout Period of at Least 6 Days||6
6365329|NCT00705536|7275646|FG002|COMPLETED|Washout Period of at Least 6 Days||7
6365330|NCT00705536|7275647|FG003|COMPLETED|Washout Period of at Least 6 Days||6
6365331|NCT00705536|7275644|FG000|NOT COMPLETED|Washout Period of at Least 6 Days||0
6365332|NCT00705536|7275645|FG001|NOT COMPLETED|Washout Period of at Least 6 Days||0
6365333|NCT00705536|7275646|FG002|NOT COMPLETED|Washout Period of at Least 6 Days||0
6365334|NCT00705536|7275647|FG003|NOT COMPLETED|Washout Period of at Least 6 Days||0
6365335|NCT00705536|7275644|FG000|STARTED|Start Period 2||6
6365336|NCT00705536|7275645|FG001|STARTED|Start Period 2||6
6365337|NCT00705536|7275646|FG002|STARTED|Start Period 2||7
6365338|NCT00705536|7275647|FG003|STARTED|Start Period 2||6
6365339|NCT00705536|7275644|FG000|COMPLETED|Start Period 2||6
6365340|NCT00705536|7275645|FG001|COMPLETED|Start Period 2||6
6365341|NCT00705536|7275646|FG002|COMPLETED|Start Period 2||7
6365342|NCT00705536|7275647|FG003|COMPLETED|Start Period 2||6
6365343|NCT00705536|7275644|FG000|NOT COMPLETED|Start Period 2||0
6365344|NCT00705536|7275645|FG001|NOT COMPLETED|Start Period 2||0
6365345|NCT00705536|7275646|FG002|NOT COMPLETED|Start Period 2||0
6365346|NCT00705536|7275647|FG003|NOT COMPLETED|Start Period 2||0
6365347|NCT00705536|7275644|FG000|STARTED|Completed Study||6
6365348|NCT00705536|7275645|FG001|STARTED|Completed Study||6
6365349|NCT00705536|7275646|FG002|STARTED|Completed Study||7
6365350|NCT00705536|7275647|FG003|STARTED|Completed Study||6
6365351|NCT00705536|7275644|FG000|COMPLETED|Completed Study||6
6365352|NCT00705536|7275645|FG001|COMPLETED|Completed Study||6
6365353|NCT00705536|7275646|FG002|COMPLETED|Completed Study||7
6365354|NCT00705536|7275647|FG003|COMPLETED|Completed Study||6
6365355|NCT00705536|7275644|FG000|NOT COMPLETED|Completed Study||0
6365356|NCT00705536|7275645|FG001|NOT COMPLETED|Completed Study||0
6365357|NCT00705536|7275646|FG002|NOT COMPLETED|Completed Study||0
6365358|NCT00705536|7275647|FG003|NOT COMPLETED|Completed Study||0
6365359|NCT00705575|7275668|FG000|STARTED|Overall Study||349
6365360|NCT00705575|7275669|FG001|STARTED|Overall Study||339
6365361|NCT00705575|7275668|FG000|COMPLETED|Overall Study||326
6365362|NCT00705575|7275669|FG001|COMPLETED|Overall Study||293
6365363|NCT00705575|7275668|FG000|NOT COMPLETED|Overall Study||23
6365364|NCT00705575|7275669|FG001|NOT COMPLETED|Overall Study||46
6365365|NCT00705614|7275677|FG000|STARTED|Initial Intervention||1541
6365366|NCT00705614|7275678|FG001|STARTED|Initial Intervention||1121
6365367|NCT00705614|7275677|FG000|COMPLETED|Initial Intervention||1023
6365368|NCT00705614|7275678|FG001|COMPLETED|Initial Intervention||800
6365369|NCT00705614|7275677|FG000|NOT COMPLETED|Initial Intervention||518
6365370|NCT00705614|7275678|FG001|NOT COMPLETED|Initial Intervention||321
6365371|NCT00705614|7275677|FG000|STARTED|Switch to Remicade||0
6365372|NCT00705614|7275678|FG001|STARTED|Switch to Remicade||298
6365373|NCT00705614|7275677|FG000|COMPLETED|Switch to Remicade||0
6365374|NCT00705614|7275678|FG001|COMPLETED|Switch to Remicade||249
6365375|NCT00705614|7275677|FG000|NOT COMPLETED|Switch to Remicade||0
6365376|NCT00705614|7275678|FG001|NOT COMPLETED|Switch to Remicade||49
6365377|NCT00705653|7275686|FG000|STARTED|Overall Study||46
6365378|NCT00705653|7275686|FG000|COMPLETED|Overall Study||46
6365379|NCT00705653|7275686|FG000|NOT COMPLETED|Overall Study||0
6365380|NCT00705666|7275690|FG000|STARTED|Overall Study||789
6365381|NCT00705666|7275690|FG000|COMPLETED|Overall Study||450
6365382|NCT00705666|7275690|FG000|NOT COMPLETED|Overall Study||339
6365383|NCT00705679|7275699|FG000|STARTED|Overall Study||1007
6365384|NCT00705679|7275700|FG001|STARTED|Overall Study||1003
6365385|NCT00705679|7275701|FG002|STARTED|Overall Study||1009
6365386|NCT00705679|7275702|FG003|STARTED|Overall Study||1007
6365387|NCT00705679|7275703|FG004|STARTED|Overall Study||1003
6365388|NCT00705679|7275699|FG000|COMPLETED|Overall Study||942
6365389|NCT00705679|7275700|FG001|COMPLETED|Overall Study||864
6365390|NCT00705679|7275701|FG002|COMPLETED|Overall Study||894
6365391|NCT00705679|7275702|FG003|COMPLETED|Overall Study||927
6365392|NCT00705679|7275703|FG004|COMPLETED|Overall Study||934
6365393|NCT00705679|7275699|FG000|NOT COMPLETED|Overall Study||65
6365394|NCT00705679|7275700|FG001|NOT COMPLETED|Overall Study||139
6365395|NCT00705679|7275701|FG002|NOT COMPLETED|Overall Study||115
6365396|NCT00705679|7275702|FG003|NOT COMPLETED|Overall Study||80
6365397|NCT00705679|7275703|FG004|NOT COMPLETED|Overall Study||69
6365398|NCT00705718|7275722|FG000|STARTED|Overall Study||44
6365399|NCT00705718|7275723|FG001|STARTED|Overall Study||150
6365400|NCT00705718|7275722|FG000|1 Month Follow up|Overall Study|1 Death|43
6365401|NCT00705718|7275723|FG001|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
6365402|NCT00705718|7275722|FG000|6 Month Follow up|Overall Study|3 Deaths|40
6365403|NCT00705718|7275723|FG001|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
6365404|NCT00705718|7275722|FG000|12 Month Follow up|Overall Study|2 Deaths|37
6365405|NCT00705718|7275723|FG001|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
6365406|NCT00705718|7275722|FG000|COMPLETED|Overall Study||37
6365407|NCT00705718|7275723|FG001|COMPLETED|Overall Study||128
6365408|NCT00705718|7275722|FG000|NOT COMPLETED|Overall Study||7
6365409|NCT00705718|7275723|FG001|NOT COMPLETED|Overall Study||22
6365410|NCT00705757|7275732|FG000|STARTED|Overall Study||32
6365411|NCT00705757|7275733|FG001|STARTED|Overall Study||29
6365412|NCT00705757|7275734|FG002|STARTED|Overall Study||28
6365413|NCT00705757|7275732|FG000|COMPLETED|Overall Study||19
6365414|NCT00705757|7275733|FG001|COMPLETED|Overall Study||21
6365415|NCT00705757|7275734|FG002|COMPLETED|Overall Study||17
6365416|NCT00705757|7275732|FG000|NOT COMPLETED|Overall Study||13
6365417|NCT00705757|7275733|FG001|NOT COMPLETED|Overall Study||8
6365418|NCT00705757|7275734|FG002|NOT COMPLETED|Overall Study||11
6365419|NCT00705783|7275744|FG000|STARTED|Conversion Phase||633
6365420|NCT00705783|7275745|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6365421|NCT00705783|7275746|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6365422|NCT00705783|7275744|FG000|Received Study Medication|Conversion Phase||632
6365423|NCT00705783|7275745|FG001|Received Study Medication|Conversion Phase||0
6365424|NCT00705783|7275746|FG002|Received Study Medication|Conversion Phase||0
6365425|NCT00705783|7275744|FG000|COMPLETED|Conversion Phase||500
6365426|NCT00705783|7275745|FG001|COMPLETED|Conversion Phase||0
6365427|NCT00705783|7275746|FG002|COMPLETED|Conversion Phase||0
6365428|NCT00705783|7275744|FG000|NOT COMPLETED|Conversion Phase||133
6365429|NCT00705783|7275745|FG001|NOT COMPLETED|Conversion Phase||0
6365430|NCT00705783|7275746|FG002|NOT COMPLETED|Conversion Phase||0
6365431|NCT00705783|7275744|FG000|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
6365432|NCT00705783|7275745|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6365433|NCT00705783|7275746|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6365434|NCT00705783|7275744|FG000|Received Study Medication|Oral Stabilization Phase||709
6365435|NCT00705783|7275745|FG001|Received Study Medication|Oral Stabilization Phase||0
6365436|NCT00705783|7275746|FG002|Received Study Medication|Oral Stabilization Phase||0
6365437|NCT00705783|7275744|FG000|COMPLETED|Oral Stabilization Phase||576
6365438|NCT00705783|7275745|FG001|COMPLETED|Oral Stabilization Phase||0
6365439|NCT00705783|7275746|FG002|COMPLETED|Oral Stabilization Phase||0
6365440|NCT00705783|7275744|FG000|NOT COMPLETED|Oral Stabilization Phase||134
6365441|NCT00705783|7275745|FG001|NOT COMPLETED|Oral Stabilization Phase||0
6365442|NCT00705783|7275746|FG002|NOT COMPLETED|Oral Stabilization Phase||0
6365443|NCT00705783|7275744|FG000|STARTED|Depot Stabilization Phase||576
6365444|NCT00705783|7275745|FG001|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6365445|NCT00705783|7275746|FG002|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6365446|NCT00705783|7275744|FG000|COMPLETED|Depot Stabilization Phase||403
6365447|NCT00705783|7275745|FG001|COMPLETED|Depot Stabilization Phase||0
6365448|NCT00705783|7275746|FG002|COMPLETED|Depot Stabilization Phase||0
6365449|NCT00705783|7275744|FG000|NOT COMPLETED|Depot Stabilization Phase||173
6365450|NCT00705783|7275745|FG001|NOT COMPLETED|Depot Stabilization Phase||0
6365451|NCT00705783|7275746|FG002|NOT COMPLETED|Depot Stabilization Phase||0
6365452|NCT00705783|7275744|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
6365453|NCT00705783|7275745|FG001|STARTED|Depot Maintenance Phase||269
6365454|NCT00705783|7275746|FG002|STARTED|Depot Maintenance Phase||134
6365455|NCT00705783|7275744|FG000|COMPLETED|Depot Maintenance Phase||0
6365456|NCT00705783|7275745|FG001|COMPLETED|Depot Maintenance Phase||23
6365457|NCT00705783|7275746|FG002|COMPLETED|Depot Maintenance Phase||3
6365458|NCT00705783|7275744|FG000|NOT COMPLETED|Depot Maintenance Phase||0
6365459|NCT00705783|7275745|FG001|NOT COMPLETED|Depot Maintenance Phase||246
6365460|NCT00705783|7275746|FG002|NOT COMPLETED|Depot Maintenance Phase||131
6365461|NCT00705874|7275762|FG000|STARTED|Overall Study||12
6365462|NCT00705874|7275763|FG001|STARTED|Overall Study||9
6365463|NCT00705874|7275764|FG002|STARTED|Overall Study||34
6365464|NCT00705874|7275765|FG003|STARTED|Overall Study||34
6365465|NCT00705874|7275766|FG004|STARTED|Overall Study||48
6365466|NCT00705874|7275767|FG005|STARTED|Overall Study||32
6365467|NCT00705874|7275768|FG006|STARTED|Overall Study||3
6365468|NCT00705874|7275762|FG000|COMPLETED|Overall Study||10
6365469|NCT00705874|7275763|FG001|COMPLETED|Overall Study||8
6365470|NCT00705874|7275764|FG002|COMPLETED|Overall Study||32
6365471|NCT00705874|7275765|FG003|COMPLETED|Overall Study||33
6365472|NCT00705874|7275766|FG004|COMPLETED|Overall Study||36
6365473|NCT00705874|7275767|FG005|COMPLETED|Overall Study||28
6365474|NCT00705874|7275768|FG006|COMPLETED|Overall Study||3
6365475|NCT00705874|7275762|FG000|NOT COMPLETED|Overall Study||2
6365476|NCT00705874|7275763|FG001|NOT COMPLETED|Overall Study||1
6365477|NCT00705874|7275764|FG002|NOT COMPLETED|Overall Study||2
6365478|NCT00705874|7275765|FG003|NOT COMPLETED|Overall Study||1
6365479|NCT00705874|7275766|FG004|NOT COMPLETED|Overall Study||12
6365480|NCT00705874|7275767|FG005|NOT COMPLETED|Overall Study||4
6365481|NCT00705874|7275768|FG006|NOT COMPLETED|Overall Study||0
6365482|NCT00705939|7275787|FG000|STARTED|Overall Study||12
6365483|NCT00705939|7275788|FG001|STARTED|Overall Study||14
6365484|NCT00705939|7275789|FG002|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
6365485|NCT00705939|7275787|FG000|COMPLETED|Overall Study||12
6365486|NCT00705939|7275788|FG001|COMPLETED|Overall Study||12
6365487|NCT00705939|7275789|FG002|COMPLETED|Overall Study||14
6365488|NCT00705939|7275787|FG000|NOT COMPLETED|Overall Study||0
6365489|NCT00705939|7275788|FG001|NOT COMPLETED|Overall Study||2
6365490|NCT00705939|7275789|FG002|NOT COMPLETED|Overall Study||4
6365491|NCT00706004|7275798|FG000|STARTED|Overall Study||9
6365492|NCT00706004|7275798|FG000|COMPLETED|Overall Study||7
6365493|NCT00706004|7275798|FG000|NOT COMPLETED|Overall Study||2
6365494|NCT00706030|7275807|FG000|STARTED|Overall Study||6
6365495|NCT00706030|7275808|FG001|STARTED|Overall Study||6
6365496|NCT00706030|7275809|FG002|STARTED|Overall Study||64
6365497|NCT00706030|7275810|FG003|STARTED|Overall Study||16
6365498|NCT00706030|7275807|FG000|Treated|Overall Study||6
6365499|NCT00706030|7275808|FG001|Treated|Overall Study||6
6365500|NCT00706030|7275809|FG002|Treated|Overall Study||64
6365501|NCT00706030|7275810|FG003|Treated|Overall Study||15
6365502|NCT00706030|7275807|FG000|COMPLETED|Overall Study||0
6365503|NCT00706030|7275808|FG001|COMPLETED|Overall Study||0
6365504|NCT00706030|7275809|FG002|COMPLETED|Overall Study||4
6365505|NCT00706030|7275810|FG003|COMPLETED|Overall Study||0
6365506|NCT00706030|7275807|FG000|NOT COMPLETED|Overall Study||6
6365507|NCT00706030|7275808|FG001|NOT COMPLETED|Overall Study||6
6365508|NCT00706030|7275809|FG002|NOT COMPLETED|Overall Study||60
6365509|NCT00706030|7275810|FG003|NOT COMPLETED|Overall Study||16
6365510|NCT00706095|7275824|FG000|STARTED|Overall Study||6
6365511|NCT00706095|7275825|FG001|STARTED|Overall Study||7
6365512|NCT00706095|7275826|FG002|STARTED|Overall Study||5
6365513|NCT00706095|7275824|FG000|COMPLETED|Overall Study||0
6365514|NCT00706095|7275825|FG001|COMPLETED|Overall Study||0
6365515|NCT00706095|7275826|FG002|COMPLETED|Overall Study||0
6365516|NCT00706095|7275824|FG000|NOT COMPLETED|Overall Study||6
6365517|NCT00706095|7275825|FG001|NOT COMPLETED|Overall Study||7
6365518|NCT00706095|7275826|FG002|NOT COMPLETED|Overall Study||5
6377457|NCT00762996|7288033|FG001|STARTED|Period One||16
6377458|NCT00762996|7288034|FG002|STARTED|Period One||17
6377459|NCT00762996|7288035|FG003|STARTED|Period One||17
6377460|NCT00762996|7288032|FG000|COMPLETED|Period One||15
6377461|NCT00762996|7288033|FG001|COMPLETED|Period One||16
6377462|NCT00762996|7288034|FG002|COMPLETED|Period One||13
6377463|NCT00762996|7288035|FG003|COMPLETED|Period One||16
6377464|NCT00762996|7288032|FG000|NOT COMPLETED|Period One||0
6377465|NCT00762996|7288033|FG001|NOT COMPLETED|Period One||0
6377466|NCT00762996|7288034|FG002|NOT COMPLETED|Period One||4
6377467|NCT00762996|7288035|FG003|NOT COMPLETED|Period One||1
6377468|NCT00762996|7288032|FG000|STARTED|Period Two||15
6377469|NCT00762996|7288033|FG001|STARTED|Period Two||16
6377470|NCT00762996|7288034|FG002|STARTED|Period Two||13
6377471|NCT00762996|7288035|FG003|STARTED|Period Two||16
6377472|NCT00762996|7288032|FG000|COMPLETED|Period Two||15
6377473|NCT00762996|7288033|FG001|COMPLETED|Period Two||16
6377474|NCT00762996|7288034|FG002|COMPLETED|Period Two||13
6377475|NCT00762996|7288035|FG003|COMPLETED|Period Two||16
6377476|NCT00762996|7288032|FG000|NOT COMPLETED|Period Two||0
6377477|NCT00762996|7288033|FG001|NOT COMPLETED|Period Two||0
6377478|NCT00762996|7288034|FG002|NOT COMPLETED|Period Two||0
6377479|NCT00762996|7288035|FG003|NOT COMPLETED|Period Two||0
6377480|NCT00763035|7288043|FG000|STARTED|First Intervention||10
6377481|NCT00763035|7288044|FG001|STARTED|First Intervention||4
6377482|NCT00763035|7288043|FG000|COMPLETED|First Intervention||9
6377483|NCT00763035|7288044|FG001|COMPLETED|First Intervention||3
6377484|NCT00763035|7288043|FG000|NOT COMPLETED|First Intervention||1
6377485|NCT00763035|7288044|FG001|NOT COMPLETED|First Intervention||1
6377486|NCT00763035|7288043|FG000|STARTED|Second Intervention||9
6377487|NCT00763035|7288044|FG001|STARTED|Second Intervention||3
6377488|NCT00763035|7288043|FG000|COMPLETED|Second Intervention||6
6377489|NCT00763035|7288044|FG001|COMPLETED|Second Intervention||3
6377490|NCT00763035|7288043|FG000|NOT COMPLETED|Second Intervention||3
6377491|NCT00763035|7288044|FG001|NOT COMPLETED|Second Intervention||0
6377492|NCT00763048|7288052|FG000|STARTED|Overall Study||21
6377493|NCT00763048|7288053|FG001|STARTED|Overall Study||18
6377494|NCT00763048|7288052|FG000|COMPLETED|Overall Study||21
6377495|NCT00763048|7288053|FG001|COMPLETED|Overall Study||18
6377496|NCT00763048|7288052|FG000|NOT COMPLETED|Overall Study||0
6377497|NCT00763048|7288053|FG001|NOT COMPLETED|Overall Study||0
6377498|NCT00763061|7288061|FG000|STARTED|Overall Study||54
6377499|NCT00763061|7288062|FG001|STARTED|Overall Study||57
6377500|NCT00763061|7288061|FG000|COMPLETED|Overall Study||49
6377501|NCT00763061|7288062|FG001|COMPLETED|Overall Study||44
6377502|NCT00763061|7288061|FG000|NOT COMPLETED|Overall Study||5
6377503|NCT00763061|7288062|FG001|NOT COMPLETED|Overall Study||13
6377504|NCT00763139|7288068|FG000|STARTED|Overall Study||17
6377505|NCT00763139|7288069|FG001|STARTED|Overall Study||17
6377506|NCT00763139|7288068|FG000|COMPLETED|Overall Study||12
6377507|NCT00763139|7288069|FG001|COMPLETED|Overall Study||14
6377508|NCT00763139|7288068|FG000|NOT COMPLETED|Overall Study||5
6377509|NCT00763139|7288069|FG001|NOT COMPLETED|Overall Study||3
6377510|NCT00763243|7288080|FG000|STARTED|Waiting Period||9
6377511|NCT00763243|7288080|FG000|COMPLETED|Waiting Period||9
6377512|NCT00763243|7288080|FG000|NOT COMPLETED|Waiting Period||0
6365519|NCT00706121|7275838|FG000|STARTED|Overall Study||2039
6365520|NCT00706121|7275839|FG001|STARTED|Overall Study||2096
6365521|NCT00706121|7275840|FG002|STARTED|Overall Study||2030
6365522|NCT00706121|7275841|FG003|STARTED|Overall Study||1929
6365523|NCT00706121|7275838|FG000|COMPLETED|Overall Study||1643
6365524|NCT00706121|7275839|FG001|COMPLETED|Overall Study||1700
6365525|NCT00706121|7275840|FG002|COMPLETED|Overall Study||1626
6365526|NCT00706121|7275841|FG003|COMPLETED|Overall Study||1577
6365527|NCT00706121|7275838|FG000|NOT COMPLETED|Overall Study||396
6365528|NCT00706121|7275839|FG001|NOT COMPLETED|Overall Study||396
6365529|NCT00706121|7275840|FG002|NOT COMPLETED|Overall Study||404
6365530|NCT00706121|7275841|FG003|NOT COMPLETED|Overall Study||352
6365531|NCT00706134|7275863|FG000|STARTED|Overall Study||189
6365532|NCT00706134|7275864|FG001|STARTED|Overall Study||192
6365533|NCT00706134|7275865|FG002|STARTED|Overall Study||189
6365534|NCT00706134|7275866|FG003|STARTED|Overall Study||186
6365535|NCT00706134|7275863|FG000|Entered Double-blind Period|Overall Study||187
6365536|NCT00706134|7275864|FG001|Entered Double-blind Period|Overall Study||192
6365537|NCT00706134|7275865|FG002|Entered Double-blind Period|Overall Study||189
6365538|NCT00706134|7275866|FG003|Entered Double-blind Period|Overall Study||186
6365539|NCT00706134|7275863|FG000|COMPLETED|Overall Study||169
6365540|NCT00706134|7275864|FG001|COMPLETED|Overall Study||173
6365541|NCT00706134|7275865|FG002|COMPLETED|Overall Study||183
6365542|NCT00706134|7275866|FG003|COMPLETED|Overall Study||175
6365543|NCT00706134|7275863|FG000|NOT COMPLETED|Overall Study||20
6365544|NCT00706134|7275864|FG001|NOT COMPLETED|Overall Study||19
6365545|NCT00706134|7275865|FG002|NOT COMPLETED|Overall Study||6
6365546|NCT00706134|7275866|FG003|NOT COMPLETED|Overall Study||11
6365547|NCT00706238|7275876|FG000|STARTED|Overall Study||5
6365548|NCT00706238|7275876|FG000|COMPLETED|Overall Study||0
6365549|NCT00706238|7275876|FG000|NOT COMPLETED|Overall Study||5
6365550|NCT00706264|7275882|FG000|STARTED|Overall Study||193
6365551|NCT00706264|7275883|FG001|STARTED|Overall Study||192
6365552|NCT00706264|7275882|FG000|COMPLETED|Overall Study||190
6365553|NCT00706264|7275883|FG001|COMPLETED|Overall Study||190
6365554|NCT00706264|7275882|FG000|NOT COMPLETED|Overall Study||3
6365555|NCT00706264|7275883|FG001|NOT COMPLETED|Overall Study||2
6365556|NCT00706342|7275891|FG000|STARTED|Overall Study||18
6365557|NCT00706342|7275891|FG000|COMPLETED|Overall Study||0
6365558|NCT00706342|7275891|FG000|NOT COMPLETED|Overall Study||18
6365559|NCT00706355|7275899|FG000|STARTED|Period 1: PF-04217903 50 mg||3
6365560|NCT00706355|7275900|FG001|STARTED|Period 1: PF-04217903 50 mg||0
6365561|NCT00706355|7275901|FG002|STARTED|Period 1: PF-04217903 50 mg||0
6365562|NCT00706355|7275902|FG003|STARTED|Period 1: PF-04217903 50 mg||0
6365563|NCT00706355|7275899|FG000|COMPLETED|Period 1: PF-04217903 50 mg||0
6365564|NCT00706355|7275900|FG001|COMPLETED|Period 1: PF-04217903 50 mg||0
6365565|NCT00706355|7275901|FG002|COMPLETED|Period 1: PF-04217903 50 mg||0
6365566|NCT00706355|7275902|FG003|COMPLETED|Period 1: PF-04217903 50 mg||0
6365567|NCT00706355|7275899|FG000|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
6365568|NCT00706355|7275900|FG001|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
6365569|NCT00706355|7275901|FG002|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
6365570|NCT00706355|7275902|FG003|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
6365571|NCT00706355|7275899|FG000|STARTED|Period 2: PF-04217903 100 mg||0
6365572|NCT00706355|7275900|FG001|STARTED|Period 2: PF-04217903 100 mg||7
6365573|NCT00706355|7275901|FG002|STARTED|Period 2: PF-04217903 100 mg||0
6365574|NCT00706355|7275902|FG003|STARTED|Period 2: PF-04217903 100 mg||0
6365575|NCT00706355|7275899|FG000|COMPLETED|Period 2: PF-04217903 100 mg||0
6365576|NCT00706355|7275900|FG001|COMPLETED|Period 2: PF-04217903 100 mg||0
6365577|NCT00706355|7275901|FG002|COMPLETED|Period 2: PF-04217903 100 mg||0
6365578|NCT00706355|7275902|FG003|COMPLETED|Period 2: PF-04217903 100 mg||0
6365579|NCT00706355|7275899|FG000|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
6365580|NCT00706355|7275900|FG001|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
6365581|NCT00706355|7275901|FG002|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
6365582|NCT00706355|7275902|FG003|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
6365583|NCT00706355|7275899|FG000|STARTED|Period 3: PF-04217903 200 mg||0
6365584|NCT00706355|7275900|FG001|STARTED|Period 3: PF-04217903 200 mg||0
6365585|NCT00706355|7275901|FG002|STARTED|Period 3: PF-04217903 200 mg||2
6365586|NCT00706355|7275902|FG003|STARTED|Period 3: PF-04217903 200 mg||0
6365587|NCT00706355|7275899|FG000|COMPLETED|Period 3: PF-04217903 200 mg||0
6365588|NCT00706355|7275900|FG001|COMPLETED|Period 3: PF-04217903 200 mg||0
6365589|NCT00706355|7275901|FG002|COMPLETED|Period 3: PF-04217903 200 mg||0
6365590|NCT00706355|7275902|FG003|COMPLETED|Period 3: PF-04217903 200 mg||0
6365591|NCT00706355|7275899|FG000|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
6365592|NCT00706355|7275900|FG001|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
6365593|NCT00706355|7275901|FG002|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
6777844|NCT03782571|7705789|FG001|COMPLETED|Period 3||6
6777845|NCT03782571|7705790|FG002|COMPLETED|Period 3||6
6365594|NCT00706355|7275902|FG003|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
6365595|NCT00706355|7275899|FG000|STARTED|Period 4: PF-04217903 150 mg||0
6365596|NCT00706355|7275900|FG001|STARTED|Period 4: PF-04217903 150 mg||0
6365597|NCT00706355|7275901|FG002|STARTED|Period 4: PF-04217903 150 mg||0
6365598|NCT00706355|7275902|FG003|STARTED|Period 4: PF-04217903 150 mg||4
6365599|NCT00706355|7275899|FG000|COMPLETED|Period 4: PF-04217903 150 mg||0
6365600|NCT00706355|7275900|FG001|COMPLETED|Period 4: PF-04217903 150 mg||0
6365601|NCT00706355|7275901|FG002|COMPLETED|Period 4: PF-04217903 150 mg||0
6365602|NCT00706355|7275902|FG003|COMPLETED|Period 4: PF-04217903 150 mg||0
6365603|NCT00706355|7275899|FG000|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
6365604|NCT00706355|7275900|FG001|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
6365605|NCT00706355|7275901|FG002|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
6365606|NCT00706355|7275902|FG003|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
6365607|NCT00706381|7275918|FG000|STARTED|Overall Study||10
6365608|NCT00706381|7275919|FG001|STARTED|Overall Study||6
6365609|NCT00706381|7275920|FG002|STARTED|Overall Study||6
6365610|NCT00706381|7275921|FG003|STARTED|Overall Study||9
6365611|NCT00706381|7275918|FG000|Intervention 1 (1 Day)|Overall Study||10
6365612|NCT00706381|7275919|FG001|Intervention 1 (1 Day)|Overall Study||6
6365613|NCT00706381|7275920|FG002|Intervention 1 (1 Day)|Overall Study||6
6365614|NCT00706381|7275921|FG003|Intervention 1 (1 Day)|Overall Study||9
6365615|NCT00706381|7275918|FG000|Intervention 2 (1 Day)|Overall Study||10
6365616|NCT00706381|7275919|FG001|Intervention 2 (1 Day)|Overall Study||6
6365617|NCT00706381|7275920|FG002|Intervention 2 (1 Day)|Overall Study||6
6365618|NCT00706381|7275921|FG003|Intervention 2 (1 Day)|Overall Study||9
6365619|NCT00706381|7275918|FG000|Intervention 3 (1 Day)|Overall Study||10
6365620|NCT00706381|7275919|FG001|Intervention 3 (1 Day)|Overall Study||6
6365621|NCT00706381|7275920|FG002|Intervention 3 (1 Day)|Overall Study||6
6365622|NCT00706381|7275921|FG003|Intervention 3 (1 Day)|Overall Study||9
6365623|NCT00706381|7275918|FG000|Intervention 4 (1 Day)|Overall Study||10
6365624|NCT00706381|7275919|FG001|Intervention 4 (1 Day)|Overall Study||5
6365625|NCT00706381|7275920|FG002|Intervention 4 (1 Day)|Overall Study||6
6777846|NCT03782571|7705791|FG003|COMPLETED|Period 3||7
6777847|NCT03782571|7705788|FG000|NOT COMPLETED|Period 3||2
6777848|NCT03782571|7705789|FG001|NOT COMPLETED|Period 3||0
6777849|NCT03782571|7705790|FG002|NOT COMPLETED|Period 3||0
6365626|NCT00706381|7275921|FG003|Intervention 4 (1 Day)|Overall Study||9
6365627|NCT00706381|7275918|FG000|Intervention 5 (1 Day)|Overall Study||10
6365628|NCT00706381|7275919|FG001|Intervention 5 (1 Day)|Overall Study||5
6365629|NCT00706381|7275920|FG002|Intervention 5 (1 Day)|Overall Study||5
6365630|NCT00706381|7275921|FG003|Intervention 5 (1 Day)|Overall Study||9
6365631|NCT00706381|7275918|FG000|COMPLETED|Overall Study||10
6365632|NCT00706381|7275919|FG001|COMPLETED|Overall Study||5
6365633|NCT00706381|7275920|FG002|COMPLETED|Overall Study||5
6365634|NCT00706381|7275921|FG003|COMPLETED|Overall Study||9
6365635|NCT00706381|7275918|FG000|NOT COMPLETED|Overall Study||0
6365636|NCT00706381|7275919|FG001|NOT COMPLETED|Overall Study||1
6365637|NCT00706381|7275920|FG002|NOT COMPLETED|Overall Study||1
6365638|NCT00706381|7275921|FG003|NOT COMPLETED|Overall Study||0
6365639|NCT00706394|7275934|FG000|STARTED|Overall Study||19
6365640|NCT00706394|7275934|FG000|COMPLETED|Overall Study||8
6365641|NCT00706394|7275934|FG000|NOT COMPLETED|Overall Study||11
6365642|NCT00706407|7275940|FG000|STARTED|Overall Study||42
6365643|NCT00706407|7275940|FG000|COMPLETED|Overall Study||33
6365644|NCT00706407|7275940|FG000|NOT COMPLETED|Overall Study||9
6365645|NCT00706433|7275951|FG000|STARTED|Overall Study||68
6365646|NCT00706433|7275952|FG001|STARTED|Overall Study||65
6365647|NCT00706433|7275953|FG002|STARTED|Overall Study||67
6365648|NCT00706433|7275954|FG003|STARTED|Overall Study||66
6365649|NCT00706433|7275951|FG000|COMPLETED|Overall Study||63
6365650|NCT00706433|7275952|FG001|COMPLETED|Overall Study||62
6365651|NCT00706433|7275953|FG002|COMPLETED|Overall Study||57
6365652|NCT00706433|7275954|FG003|COMPLETED|Overall Study||64
6365653|NCT00706433|7275951|FG000|NOT COMPLETED|Overall Study||5
6365654|NCT00706433|7275952|FG001|NOT COMPLETED|Overall Study||3
6365655|NCT00706433|7275953|FG002|NOT COMPLETED|Overall Study||10
6365656|NCT00706433|7275954|FG003|NOT COMPLETED|Overall Study||2
6365657|NCT00706446|7275970|FG000|STARTED|Overall Study||29
6365658|NCT00706446|7275971|FG001|STARTED|Overall Study||57
6365659|NCT00706446|7275972|FG002|STARTED|Overall Study||44
6365660|NCT00706446|7275973|FG003|STARTED|Overall Study||26
6365661|NCT00706446|7275974|FG004|STARTED|Overall Study||54
6365662|NCT00706446|7275975|FG005|STARTED|Overall Study||45
6365663|NCT00706446|7275970|FG000|COMPLETED|Overall Study||3
6365664|NCT00706446|7275971|FG001|COMPLETED|Overall Study||8
6365665|NCT00706446|7275972|FG002|COMPLETED|Overall Study||7
6365666|NCT00706446|7275973|FG003|COMPLETED|Overall Study||4
6365667|NCT00706446|7275974|FG004|COMPLETED|Overall Study||10
6365668|NCT00706446|7275975|FG005|COMPLETED|Overall Study||7
6365669|NCT00706446|7275970|FG000|NOT COMPLETED|Overall Study||26
6365670|NCT00706446|7275971|FG001|NOT COMPLETED|Overall Study||49
6365671|NCT00706446|7275972|FG002|NOT COMPLETED|Overall Study||37
6365672|NCT00706446|7275973|FG003|NOT COMPLETED|Overall Study||22
6365673|NCT00706446|7275974|FG004|NOT COMPLETED|Overall Study||44
6365674|NCT00706446|7275975|FG005|NOT COMPLETED|Overall Study||38
6365675|NCT00706485|7275989|FG000|STARTED|Overall Study||5
6365676|NCT00706485|7275989|FG000|COMPLETED|Overall Study||5
6365677|NCT00706485|7275989|FG000|NOT COMPLETED|Overall Study||0
6365678|NCT00706511|7275997|FG000|STARTED|Overall Study||10
6777850|NCT03782571|7705791|FG003|NOT COMPLETED|Period 3||0
6777851|NCT03782571|7705788|FG000|STARTED|Period 4||3
6365679|NCT00706511|7275998|FG001|STARTED|Overall Study||4
6365680|NCT00706511|7275999|FG002|STARTED|Overall Study||3
6365681|NCT00706511|7276000|FG003|STARTED|Overall Study||10
6365682|NCT00706511|7275997|FG000|COMPLETED|Overall Study||9
6365683|NCT00706511|7275998|FG001|COMPLETED|Overall Study||4
6365684|NCT00706511|7275999|FG002|COMPLETED|Overall Study||3
6777852|NCT03782571|7705789|FG001|STARTED|Period 4||6
6365685|NCT00706511|7276000|FG003|COMPLETED|Overall Study||10
6365686|NCT00706511|7275997|FG000|NOT COMPLETED|Overall Study||1
6365687|NCT00706511|7275998|FG001|NOT COMPLETED|Overall Study||0
6365688|NCT00706511|7275999|FG002|NOT COMPLETED|Overall Study||0
6365689|NCT00706511|7276000|FG003|NOT COMPLETED|Overall Study||0
6365690|NCT00706550|7276010|FG000|STARTED|Overall Study||43
6365691|NCT00706550|7276011|FG001|STARTED|Overall Study||64
6365692|NCT00706550|7276010|FG000|COMPLETED|Overall Study||36
6365693|NCT00706550|7276011|FG001|COMPLETED|Overall Study||36
6365694|NCT00706550|7276010|FG000|NOT COMPLETED|Overall Study||7
6365695|NCT00706550|7276011|FG001|NOT COMPLETED|Overall Study||28
6365696|NCT00706563|7276020|FG000|STARTED|Overall Study||61
6365697|NCT00706563|7276021|FG001|STARTED|Overall Study||59
6365698|NCT00706563|7276020|FG000|COMPLETED|Overall Study||61
6365699|NCT00706563|7276021|FG001|COMPLETED|Overall Study||59
6365700|NCT00706563|7276020|FG000|NOT COMPLETED|Overall Study||0
6365701|NCT00706563|7276021|FG001|NOT COMPLETED|Overall Study||0
6365702|NCT00706589|7276029|FG000|STARTED|Overall Study||32
6365703|NCT00706589|7276030|FG001|STARTED|Overall Study||29
6365704|NCT00706589|7276029|FG000|COMPLETED|Overall Study||29
6365705|NCT00706589|7276030|FG001|COMPLETED|Overall Study||25
6365706|NCT00706589|7276029|FG000|NOT COMPLETED|Overall Study||3
6365707|NCT00706589|7276030|FG001|NOT COMPLETED|Overall Study||4
6365708|NCT00706628|7276040|FG000|STARTED|Overall Study||47
6365709|NCT00706628|7276041|FG001|STARTED|Overall Study||21
6365710|NCT00706628|7276042|FG002|STARTED|Overall Study||16
6365711|NCT00706628|7276043|FG003|STARTED|Overall Study||3
6365712|NCT00706628|7276040|FG000|COMPLETED|Overall Study||0
6365713|NCT00706628|7276041|FG001|COMPLETED|Overall Study||0
6365714|NCT00706628|7276042|FG002|COMPLETED|Overall Study||0
6365715|NCT00706628|7276043|FG003|COMPLETED|Overall Study||0
6365716|NCT00706628|7276040|FG000|NOT COMPLETED|Overall Study||47
6365717|NCT00706628|7276041|FG001|NOT COMPLETED|Overall Study||21
6365718|NCT00706628|7276042|FG002|NOT COMPLETED|Overall Study||16
6365719|NCT00706628|7276043|FG003|NOT COMPLETED|Overall Study||3
6365720|NCT00706641|7276056|FG000|STARTED|Dasatinib Administration||25
6365721|NCT00706641|7276056|FG000|Toxicity Evaluation|Dasatinib Administration||24
6365722|NCT00706641|7276056|FG000|COMPLETED|Dasatinib Administration||23
6365723|NCT00706641|7276056|FG000|NOT COMPLETED|Dasatinib Administration||2
6365724|NCT00706641|7276056|FG000|STARTED|Radical Cystectomy||23
6365725|NCT00706641|7276056|FG000|COMPLETED|Radical Cystectomy||22
6365726|NCT00706641|7276056|FG000|NOT COMPLETED|Radical Cystectomy||1
6365727|NCT00706654|7276063|FG000|STARTED|Conversion Phase||709
6365728|NCT00706654|7276064|FG001|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6365729|NCT00706654|7276065|FG002|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6365730|NCT00706654|7276066|FG003|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
6365731|NCT00706654|7276063|FG000|COMPLETED|Conversion Phase||614
6365732|NCT00706654|7276064|FG001|COMPLETED|Conversion Phase||0
6365733|NCT00706654|7276065|FG002|COMPLETED|Conversion Phase||0
6365734|NCT00706654|7276066|FG003|COMPLETED|Conversion Phase||0
6365735|NCT00706654|7276063|FG000|NOT COMPLETED|Conversion Phase||95
6365736|NCT00706654|7276064|FG001|NOT COMPLETED|Conversion Phase||0
6365737|NCT00706654|7276065|FG002|NOT COMPLETED|Conversion Phase||0
6365738|NCT00706654|7276066|FG003|NOT COMPLETED|Conversion Phase||0
6365739|NCT00706654|7276063|FG000|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
6365740|NCT00706654|7276064|FG001|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6365741|NCT00706654|7276065|FG002|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6365742|NCT00706654|7276066|FG003|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
6365743|NCT00706654|7276063|FG000|COMPLETED|Oral Stabilization Phase||662
6365744|NCT00706654|7276064|FG001|COMPLETED|Oral Stabilization Phase||0
6365745|NCT00706654|7276065|FG002|COMPLETED|Oral Stabilization Phase||0
6365746|NCT00706654|7276066|FG003|COMPLETED|Oral Stabilization Phase||0
6365747|NCT00706654|7276063|FG000|NOT COMPLETED|Oral Stabilization Phase||180
6365748|NCT00706654|7276064|FG001|NOT COMPLETED|Oral Stabilization Phase||0
6365749|NCT00706654|7276065|FG002|NOT COMPLETED|Oral Stabilization Phase||0
6365750|NCT00706654|7276066|FG003|NOT COMPLETED|Oral Stabilization Phase||0
6365751|NCT00706654|7276063|FG000|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
6365752|NCT00706654|7276064|FG001|STARTED|Depot Maintenance Phase||265
6365753|NCT00706654|7276065|FG002|STARTED|Depot Maintenance Phase||266
6365754|NCT00706654|7276066|FG003|STARTED|Depot Maintenance Phase||131
6365755|NCT00706654|7276063|FG000|COMPLETED|Depot Maintenance Phase||0
6365756|NCT00706654|7276064|FG001|COMPLETED|Depot Maintenance Phase||196
6365757|NCT00706654|7276065|FG002|COMPLETED|Depot Maintenance Phase||178
6365758|NCT00706654|7276066|FG003|COMPLETED|Depot Maintenance Phase||61
6365759|NCT00706654|7276063|FG000|NOT COMPLETED|Depot Maintenance Phase||0
6365760|NCT00706654|7276064|FG001|NOT COMPLETED|Depot Maintenance Phase||69
6365761|NCT00706654|7276065|FG002|NOT COMPLETED|Depot Maintenance Phase||88
6365762|NCT00706654|7276066|FG003|NOT COMPLETED|Depot Maintenance Phase||70
6365763|NCT00706706|7276076|FG000|STARTED|Overall Study||105
6365764|NCT00706706|7276076|FG000|COMPLETED|Overall Study||0
6365765|NCT00706706|7276076|FG000|NOT COMPLETED|Overall Study||105
6365766|NCT00706719|7276083|FG000|STARTED|Overall Study||5
6365767|NCT00706719|7276084|FG001|STARTED|Overall Study||7
6365768|NCT00706719|7276085|FG002|STARTED|Overall Study||5
6365769|NCT00706719|7276083|FG000|COMPLETED|Overall Study||5
6365770|NCT00706719|7276084|FG001|COMPLETED|Overall Study||6
6365771|NCT00706719|7276085|FG002|COMPLETED|Overall Study||1
6365772|NCT00706719|7276083|FG000|NOT COMPLETED|Overall Study||0
6365773|NCT00706719|7276084|FG001|NOT COMPLETED|Overall Study||1
6365774|NCT00706719|7276085|FG002|NOT COMPLETED|Overall Study||4
6365775|NCT00706784|7276094|FG000|STARTED|Overall Study||3
6365776|NCT00706784|7276095|FG001|STARTED|Overall Study||3
6365777|NCT00706784|7276094|FG000|COMPLETED|Overall Study||3
6365778|NCT00706784|7276095|FG001|COMPLETED|Overall Study||3
6365779|NCT00706784|7276094|FG000|NOT COMPLETED|Overall Study||0
6365780|NCT00706784|7276095|FG001|NOT COMPLETED|Overall Study||0
6365781|NCT00706810|7276101|FG000|STARTED|Overall Study||8
6365782|NCT00706810|7276101|FG000|COMPLETED|Overall Study||7
6365783|NCT00706810|7276101|FG000|NOT COMPLETED|Overall Study||1
6365784|NCT00706823|7276108|FG000|STARTED|Overall Study||25
6365785|NCT00706823|7276109|FG001|STARTED|Overall Study||25
6365786|NCT00706823|7276108|FG000|COMPLETED|Overall Study||25
6365787|NCT00706823|7276109|FG001|COMPLETED|Overall Study||25
6365788|NCT00706823|7276108|FG000|NOT COMPLETED|Overall Study||0
6365789|NCT00706823|7276109|FG001|NOT COMPLETED|Overall Study||0
6365790|NCT00706836|7276115|FG000|STARTED|Overall Study||16
6365791|NCT00706836|7276115|FG000|COMPLETED|Overall Study||16
6365792|NCT00706836|7276115|FG000|NOT COMPLETED|Overall Study||0
6365793|NCT00706849|7276125|FG000|STARTED|Treatment Period||41
6365794|NCT00706849|7276126|FG001|STARTED|Treatment Period||83
6365795|NCT00706849|7276125|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
6365796|NCT00706849|7276126|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
6365797|NCT00706849|7276125|FG000|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
6365798|NCT00706849|7276126|FG001|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
6365799|NCT00706849|7276125|FG000|NOT COMPLETED|Treatment Period||0
6365800|NCT00706849|7276126|FG001|NOT COMPLETED|Treatment Period||10
6365801|NCT00706849|7276125|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
6365802|NCT00706849|7276126|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
6365803|NCT00706849|7276125|FG000|COMPLETED|Follow-up Period||3
6365804|NCT00706849|7276126|FG001|COMPLETED|Follow-up Period||25
6365805|NCT00706849|7276125|FG000|NOT COMPLETED|Follow-up Period||0
6365806|NCT00706849|7276126|FG001|NOT COMPLETED|Follow-up Period||3
6365807|NCT00706901|7276135|FG000|STARTED|Overall Study||59
6365808|NCT00706901|7276136|FG001|STARTED|Overall Study||62
6365809|NCT00706901|7276137|FG002|STARTED|Overall Study||59
6365810|NCT00706901|7276135|FG000|COMPLETED|Overall Study||51
6365811|NCT00706901|7276136|FG001|COMPLETED|Overall Study||57
6365812|NCT00706901|7276137|FG002|COMPLETED|Overall Study||51
6365813|NCT00706901|7276135|FG000|NOT COMPLETED|Overall Study||8
6365814|NCT00706901|7276136|FG001|NOT COMPLETED|Overall Study||5
6365815|NCT00706901|7276137|FG002|NOT COMPLETED|Overall Study||8
6365816|NCT00706914|7276149|FG000|STARTED|Overall Study||63
6365817|NCT00706914|7276150|FG001|STARTED|Overall Study||62
6365818|NCT00706914|7276151|FG002|STARTED|Overall Study||31
6365819|NCT00706914|7276149|FG000|COMPLETED|Overall Study||57
6365820|NCT00706914|7276150|FG001|COMPLETED|Overall Study||58
6365821|NCT00706914|7276151|FG002|COMPLETED|Overall Study||30
6365822|NCT00706914|7276149|FG000|NOT COMPLETED|Overall Study||6
6365823|NCT00706914|7276150|FG001|NOT COMPLETED|Overall Study||4
6365824|NCT00706914|7276151|FG002|NOT COMPLETED|Overall Study||1
6365825|NCT00706966|7276159|FG000|STARTED|Overall Study||10
6365826|NCT00706966|7276159|FG000|COMPLETED|Overall Study||9
6365827|NCT00706966|7276159|FG000|NOT COMPLETED|Overall Study||1
6365828|NCT00706979|7276193|FG000|STARTED|Overall Study||426
6365829|NCT00706979|7276194|FG001|STARTED|Overall Study||423
6365830|NCT00706979|7276193|FG000|COMPLETED|Overall Study||426
6365831|NCT00706979|7276194|FG001|COMPLETED|Overall Study||423
6365832|NCT00706979|7276193|FG000|NOT COMPLETED|Overall Study||0
6365833|NCT00706979|7276194|FG001|NOT COMPLETED|Overall Study||0
6365834|NCT00706992|7276207|FG000|STARTED|Overall Study||8
6365835|NCT00706992|7276208|FG001|STARTED|Overall Study||8
6365836|NCT00706992|7276209|FG002|STARTED|Overall Study||9
6365837|NCT00706992|7276210|FG003|STARTED|Overall Study||8
6365838|NCT00706992|7276211|FG004|STARTED|Overall Study||6
6560729|NCT01788943|7483585|FG000|NOT COMPLETED|Overall Study||1
6365839|NCT00706992|7276212|FG005|STARTED|Overall Study||5
6365840|NCT00706992|7276213|FG006|STARTED|Overall Study||6
6365841|NCT00706992|7276207|FG000|COMPLETED|Overall Study||3
6365842|NCT00706992|7276208|FG001|COMPLETED|Overall Study||3
6365843|NCT00706992|7276209|FG002|COMPLETED|Overall Study||3
6365844|NCT00706992|7276210|FG003|COMPLETED|Overall Study||6
6365845|NCT00706992|7276211|FG004|COMPLETED|Overall Study||2
6365846|NCT00706992|7276212|FG005|COMPLETED|Overall Study||3
6365847|NCT00706992|7276213|FG006|COMPLETED|Overall Study||3
6365848|NCT00706992|7276207|FG000|NOT COMPLETED|Overall Study||5
6365849|NCT00706992|7276208|FG001|NOT COMPLETED|Overall Study||5
6365850|NCT00706992|7276209|FG002|NOT COMPLETED|Overall Study||6
6560730|NCT01788943|7483586|FG001|NOT COMPLETED|Overall Study||0
6365851|NCT00706992|7276210|FG003|NOT COMPLETED|Overall Study||2
6365852|NCT00706992|7276211|FG004|NOT COMPLETED|Overall Study||4
6365853|NCT00706992|7276212|FG005|NOT COMPLETED|Overall Study||2
6365854|NCT00706992|7276213|FG006|NOT COMPLETED|Overall Study||3
6365855|NCT00707031|7276232|FG000|STARTED|Overall Study|Randomized|320
6365856|NCT00707031|7276233|FG001|STARTED|Overall Study||319
6365857|NCT00707031|7276232|FG000|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
6365858|NCT00707031|7276233|FG001|Treated/Safety Population|Overall Study||316
6365859|NCT00707031|7276232|FG000|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
6365860|NCT00707031|7276233|FG001|Modified Intent-to-Treat Population|Overall Study||315
6365861|NCT00707031|7276232|FG000|COMPLETED|Overall Study||216
6365862|NCT00707031|7276233|FG001|COMPLETED|Overall Study||220
6365863|NCT00707031|7276232|FG000|NOT COMPLETED|Overall Study||104
6365864|NCT00707031|7276233|FG001|NOT COMPLETED|Overall Study||99
6365865|NCT00707057|7276242|FG000|STARTED|Overall Study||169
6365866|NCT00707057|7276243|FG001|STARTED|Overall Study||87
6365867|NCT00707057|7276242|FG000|COMPLETED|Overall Study||161
6365868|NCT00707057|7276243|FG001|COMPLETED|Overall Study||83
6365869|NCT00707057|7276242|FG000|NOT COMPLETED|Overall Study||8
6365870|NCT00707057|7276243|FG001|NOT COMPLETED|Overall Study||4
6365871|NCT00707174|7276251|FG000|STARTED|Overall Study||46
6365872|NCT00707174|7276252|FG001|STARTED|Overall Study||44
6365873|NCT00707174|7276251|FG000|COMPLETED|Overall Study||41
6365874|NCT00707174|7276252|FG001|COMPLETED|Overall Study||37
6365875|NCT00707174|7276251|FG000|NOT COMPLETED|Overall Study||5
6365876|NCT00707174|7276252|FG001|NOT COMPLETED|Overall Study||7
6365877|NCT00707239|7276261|FG000|STARTED|Overall Study||37
6365878|NCT00707239|7276262|FG001|STARTED|Overall Study||36
6365879|NCT00707239|7276263|FG002|STARTED|Overall Study||35
6365880|NCT00707239|7276261|FG000|Treated|Overall Study||36
6365881|NCT00707239|7276262|FG001|Treated|Overall Study||35
6365882|NCT00707239|7276263|FG002|Treated|Overall Study||34
6365883|NCT00707239|7276261|FG000|COMPLETED|Overall Study||18
6365884|NCT00707239|7276262|FG001|COMPLETED|Overall Study||25
6365885|NCT00707239|7276263|FG002|COMPLETED|Overall Study||21
6365886|NCT00707239|7276261|FG000|NOT COMPLETED|Overall Study||19
6365887|NCT00707239|7276262|FG001|NOT COMPLETED|Overall Study||11
6365888|NCT00707239|7276263|FG002|NOT COMPLETED|Overall Study||14
6365889|NCT00707343|7276274|FG000|STARTED|Overall Study||15
6365890|NCT00707343|7276274|FG000|COMPLETED|Overall Study||15
6365891|NCT00707343|7276274|FG000|NOT COMPLETED|Overall Study||0
6365892|NCT00707447|7276280|FG000|STARTED|Overall Study||89
6365893|NCT00707447|7276281|FG001|STARTED|Overall Study||93
6498550|NCT01410474|7417150|FG000|COMPLETED|Overall Study||173
6498551|NCT01410474|7417151|FG001|COMPLETED|Overall Study||167
6498552|NCT01410474|7417150|FG000|NOT COMPLETED|Overall Study||0
6655093|NCT02450526|7585094|FG003|NOT COMPLETED|OL Period (Cycles 2-5)||0
6655094|NCT02450526|7585095|FG004|NOT COMPLETED|OL Period (Cycles 2-5)||41
6655095|NCT02450539|7585117|FG000|STARTED|Overall Study||106
6655096|NCT02450539|7585118|FG001|STARTED|Overall Study||53
6655097|NCT02450539|7585117|FG000|Received at Least One Dose of Study Drug|Overall Study||106
6655098|NCT02450539|7585118|FG001|Received at Least One Dose of Study Drug|Overall Study||52
6655099|NCT02450539|7585117|FG000|COMPLETED|Overall Study||90
6655100|NCT02450539|7585118|FG001|COMPLETED|Overall Study||46
6655101|NCT02450539|7585117|FG000|NOT COMPLETED|Overall Study||16
6655102|NCT02450539|7585118|FG001|NOT COMPLETED|Overall Study||7
6560731|NCT01789047|7483594|FG000|STARTED|Overall Study||21
6560732|NCT01789047|7483595|FG001|STARTED|Overall Study||21
6560733|NCT01789047|7483594|FG000|COMPLETED|Overall Study||17
6655103|NCT02450552|7585130|FG000|STARTED|Overall Study||19
6655104|NCT02450552|7585131|FG001|STARTED|Overall Study||23
6655105|NCT02450552|7585132|FG002|STARTED|Overall Study||23
6655106|NCT02450552|7585130|FG000|COMPLETED|Overall Study||14
6655107|NCT02450552|7585131|FG001|COMPLETED|Overall Study||23
6655108|NCT02450552|7585132|FG002|COMPLETED|Overall Study||18
6655109|NCT02450552|7585130|FG000|NOT COMPLETED|Overall Study||5
6655110|NCT02450552|7585131|FG001|NOT COMPLETED|Overall Study||0
6655111|NCT02450552|7585132|FG002|NOT COMPLETED|Overall Study||5
6655112|NCT02450578|7585144|FG000|STARTED|Overall Study||6
6365894|NCT00707447|7276280|FG000|COMPLETED|Overall Study||81
6365895|NCT00707447|7276281|FG001|COMPLETED|Overall Study||85
6498553|NCT01410474|7417151|FG001|NOT COMPLETED|Overall Study||1
6365896|NCT00707447|7276280|FG000|NOT COMPLETED|Overall Study||8
6498554|NCT01410552|7417164|FG000|STARTED|Overall Study||1013
6498555|NCT01410552|7417164|FG000|COMPLETED|Overall Study||877
6498556|NCT01410552|7417164|FG000|NOT COMPLETED|Overall Study||136
6498557|NCT01410565|7417170|FG000|STARTED|Open Label Phase Apaziquone||0
6498558|NCT01410565|7417171|FG001|STARTED|Open Label Phase Apaziquone||0
6498559|NCT01410565|7417172|FG002|STARTED|Open Label Phase Apaziquone||66
6365897|NCT00707447|7276281|FG001|NOT COMPLETED|Overall Study||8
6365898|NCT00707486|7276287|FG000|STARTED|Overall Study||72
6365899|NCT00707486|7276287|FG000|COMPLETED|Overall Study||71
6560734|NCT01789047|7483595|FG001|COMPLETED|Overall Study||17
6560735|NCT01789047|7483594|FG000|NOT COMPLETED|Overall Study||4
6560736|NCT01789047|7483595|FG001|NOT COMPLETED|Overall Study||4
6560737|NCT01789138|7483603|FG000|STARTED|Overall Study||254
6560738|NCT01789138|7483604|FG001|STARTED|Overall Study||258
6560739|NCT01789138|7483603|FG000|COMPLETED|Overall Study||213
6560740|NCT01789138|7483604|FG001|COMPLETED|Overall Study||206
6498560|NCT01410565|7417170|FG000|COMPLETED|Open Label Phase Apaziquone||0
6498561|NCT01410565|7417171|FG001|COMPLETED|Open Label Phase Apaziquone||0
6498562|NCT01410565|7417172|FG002|COMPLETED|Open Label Phase Apaziquone||58
6498563|NCT01410565|7417170|FG000|NOT COMPLETED|Open Label Phase Apaziquone||0
6498564|NCT01410565|7417171|FG001|NOT COMPLETED|Open Label Phase Apaziquone||0
6498565|NCT01410565|7417172|FG002|NOT COMPLETED|Open Label Phase Apaziquone||8
6498566|NCT01410565|7417170|FG000|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
6498567|NCT01410565|7417171|FG001|STARTED|Double Blind Phase||15
6498568|NCT01410565|7417172|FG002|STARTED|Double Blind Phase||0
6560741|NCT01789138|7483603|FG000|NOT COMPLETED|Overall Study||41
6560742|NCT01789138|7483604|FG001|NOT COMPLETED|Overall Study||52
6560743|NCT01789203|7483612|FG000|STARTED|Overall Study||133
6498569|NCT01410565|7417170|FG000|COMPLETED|Double Blind Phase||0
6498570|NCT01410565|7417171|FG001|COMPLETED|Double Blind Phase||0
6498571|NCT01410565|7417172|FG002|COMPLETED|Double Blind Phase||0
6498572|NCT01410565|7417170|FG000|NOT COMPLETED|Double Blind Phase||13
6498573|NCT01410565|7417171|FG001|NOT COMPLETED|Double Blind Phase||15
6365900|NCT00707486|7276287|FG000|NOT COMPLETED|Overall Study||1
6365901|NCT00707577|7276295|FG000|STARTED|Overall Study||174
6365902|NCT00707577|7276296|FG001|STARTED|Overall Study||156
6365903|NCT00707577|7276295|FG000|COMPLETED|Overall Study||120
6560744|NCT01789203|7483613|FG001|STARTED|Overall Study||67
6560745|NCT01789203|7483612|FG000|COMPLETED|Overall Study||124
6560746|NCT01789203|7483613|FG001|COMPLETED|Overall Study||63
6560747|NCT01789203|7483612|FG000|NOT COMPLETED|Overall Study||9
6560748|NCT01789203|7483613|FG001|NOT COMPLETED|Overall Study||4
6365904|NCT00707577|7276296|FG001|COMPLETED|Overall Study||118
6365905|NCT00707577|7276295|FG000|NOT COMPLETED|Overall Study||54
6365906|NCT00707577|7276296|FG001|NOT COMPLETED|Overall Study||38
6365907|NCT00707655|7276304|FG000|STARTED|Overall Study||3
6365908|NCT00707655|7276305|FG001|STARTED|Overall Study||5
6365909|NCT00707655|7276304|FG000|COMPLETED|Overall Study||3
6365910|NCT00707655|7276305|FG001|COMPLETED|Overall Study||3
6365911|NCT00707655|7276304|FG000|NOT COMPLETED|Overall Study||0
6365912|NCT00707655|7276305|FG001|NOT COMPLETED|Overall Study||2
6365913|NCT00707746|7276315|FG000|STARTED|Treatment Period||12
6365914|NCT00707746|7276316|FG001|STARTED|Treatment Period||22
6365915|NCT00707746|7276315|FG000|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
6365916|NCT00707746|7276316|FG001|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
6365917|NCT00707746|7276315|FG000|COMPLETED|Treatment Period||10
6365918|NCT00707746|7276316|FG001|COMPLETED|Treatment Period||17
6365919|NCT00707746|7276315|FG000|NOT COMPLETED|Treatment Period||2
6365920|NCT00707746|7276316|FG001|NOT COMPLETED|Treatment Period||5
6365921|NCT00707746|7276315|FG000|STARTED|Follow-up Period||12
6365922|NCT00707746|7276316|FG001|STARTED|Follow-up Period||21
6365923|NCT00707746|7276315|FG000|COMPLETED|Follow-up Period||12
6365924|NCT00707746|7276316|FG001|COMPLETED|Follow-up Period||21
6365925|NCT00707746|7276315|FG000|NOT COMPLETED|Follow-up Period||0
6365926|NCT00707746|7276316|FG001|NOT COMPLETED|Follow-up Period||0
6365927|NCT00707759|7276324|FG000|STARTED|Overall Study||14
6365928|NCT00707759|7276325|FG001|STARTED|Overall Study||14
6365929|NCT00707759|7276324|FG000|COMPLETED|Overall Study||12
6365930|NCT00707759|7276325|FG001|COMPLETED|Overall Study||12
6365931|NCT00707759|7276324|FG000|NOT COMPLETED|Overall Study||2
6365932|NCT00707759|7276325|FG001|NOT COMPLETED|Overall Study||2
6365933|NCT00707863|7276333|FG000|STARTED|Overall Study||6
6365934|NCT00707863|7276334|FG001|STARTED|Overall Study||11
6365935|NCT00707863|7276333|FG000|COMPLETED|Overall Study||6
6365936|NCT00707863|7276334|FG001|COMPLETED|Overall Study||8
6365937|NCT00707863|7276333|FG000|NOT COMPLETED|Overall Study||0
6365938|NCT00707863|7276334|FG001|NOT COMPLETED|Overall Study||3
6365939|NCT00707915|7276340|FG000|STARTED|Overall Study||30
6365940|NCT00707915|7276340|FG000|Effects of Discontinuing Benzodiazepine|Overall Study||30
6365941|NCT00707915|7276340|FG000|COMPLETED|Overall Study||30
6365942|NCT00707915|7276340|FG000|NOT COMPLETED|Overall Study||0
6365943|NCT00707954|7276349|FG000|STARTED|Overall Study||12
6365944|NCT00707954|7276350|FG001|STARTED|Overall Study||12
6365945|NCT00707954|7276351|FG002|STARTED|Overall Study||14
6365946|NCT00707954|7276352|FG003|STARTED|Overall Study||13
6365947|NCT00707954|7276353|FG004|STARTED|Overall Study||10
6365948|NCT00707954|7276349|FG000|COMPLETED|Overall Study||12
6365949|NCT00707954|7276350|FG001|COMPLETED|Overall Study||12
6365950|NCT00707954|7276351|FG002|COMPLETED|Overall Study||14
6365951|NCT00707954|7276352|FG003|COMPLETED|Overall Study||13
6365952|NCT00707954|7276353|FG004|COMPLETED|Overall Study||9
6365953|NCT00707954|7276349|FG000|NOT COMPLETED|Overall Study||0
6365954|NCT00707954|7276350|FG001|NOT COMPLETED|Overall Study||0
6365955|NCT00707954|7276351|FG002|NOT COMPLETED|Overall Study||0
6365956|NCT00707954|7276352|FG003|NOT COMPLETED|Overall Study||0
6365957|NCT00707954|7276353|FG004|NOT COMPLETED|Overall Study||1
6365958|NCT00707967|7276368|FG000|STARTED|Overall Study||22
6365959|NCT00707967|7276369|FG001|STARTED|Overall Study||8
6365960|NCT00707967|7276370|FG002|STARTED|Overall Study||7
6365961|NCT00707967|7276368|FG000|COMPLETED|Overall Study||22
6498574|NCT01410565|7417172|FG002|NOT COMPLETED|Double Blind Phase||0
6498575|NCT01410604|7417180|FG000|STARTED|Overall Study||15
6560749|NCT01789255|7483621|FG000|STARTED|Overall Study||12
6560750|NCT01789255|7483621|FG000|COMPLETED|Overall Study||12
6365962|NCT00707967|7276369|FG001|COMPLETED|Overall Study||8
6365963|NCT00707967|7276370|FG002|COMPLETED|Overall Study||7
6365964|NCT00707967|7276368|FG000|NOT COMPLETED|Overall Study||0
6365965|NCT00707967|7276369|FG001|NOT COMPLETED|Overall Study||0
6365966|NCT00707967|7276370|FG002|NOT COMPLETED|Overall Study||0
6365967|NCT00707980|7276378|FG000|STARTED|Overall Study||836
6365968|NCT00707980|7276378|FG000|Received Treatment|Overall Study||834
6365969|NCT00707980|7276378|FG000|COMPLETED|Overall Study||526
6365970|NCT00707980|7276378|FG000|NOT COMPLETED|Overall Study||310
6365971|NCT00707993|7276384|FG000|STARTED|Overall Study||222
6365972|NCT00707993|7276385|FG001|STARTED|Overall Study||219
6365973|NCT00707993|7276384|FG000|COMPLETED|Overall Study||133
6365974|NCT00707993|7276385|FG001|COMPLETED|Overall Study||125
6365975|NCT00707993|7276384|FG000|NOT COMPLETED|Overall Study||89
6365976|NCT00707993|7276385|FG001|NOT COMPLETED|Overall Study||94
6365977|NCT00708019|7276393|FG000|STARTED|Overall Study||92
6365978|NCT00708019|7276394|FG001|STARTED|Overall Study||93
6365979|NCT00708019|7276393|FG000|COMPLETED|Overall Study||77
6365980|NCT00708019|7276394|FG001|COMPLETED|Overall Study||78
6365981|NCT00708019|7276393|FG000|NOT COMPLETED|Overall Study||15
6365982|NCT00708019|7276394|FG001|NOT COMPLETED|Overall Study||15
6560751|NCT01789255|7483621|FG000|NOT COMPLETED|Overall Study||0
6560752|NCT01789281|7483627|FG000|STARTED|Overall Study||22
6560753|NCT01789281|7483628|FG001|STARTED|Overall Study||12
6365983|NCT00708032|7276402|FG000|STARTED|Overall Study||36
6365984|NCT00708032|7276403|FG001|STARTED|Overall Study||38
6365985|NCT00708032|7276402|FG000|COMPLETED|Overall Study||26
6365986|NCT00708032|7276403|FG001|COMPLETED|Overall Study||22
6365987|NCT00708032|7276402|FG000|NOT COMPLETED|Overall Study||10
6365988|NCT00708032|7276403|FG001|NOT COMPLETED|Overall Study||16
6365989|NCT00708071|7276409|FG000|STARTED|Overall Study|Randomized and treated|45
6365990|NCT00708071|7276409|FG000|COMPLETED|Overall Study||45
6365991|NCT00708071|7276409|FG000|NOT COMPLETED|Overall Study||0
6365992|NCT00708097|7276443|FG000|STARTED|Period 1||11
6365993|NCT00708097|7276444|FG001|STARTED|Period 1||12
6365994|NCT00708097|7276445|FG002|STARTED|Period 1||12
6365995|NCT00708097|7276446|FG003|STARTED|Period 1||11
6365996|NCT00708097|7276447|FG004|STARTED|Period 1||11
6365997|NCT00708097|7276443|FG000|COMPLETED|Period 1||11
6365998|NCT00708097|7276444|FG001|COMPLETED|Period 1||11
6365999|NCT00708097|7276445|FG002|COMPLETED|Period 1||12
6366000|NCT00708097|7276446|FG003|COMPLETED|Period 1||9
6366001|NCT00708097|7276447|FG004|COMPLETED|Period 1||10
6366002|NCT00708097|7276443|FG000|NOT COMPLETED|Period 1||0
6366003|NCT00708097|7276444|FG001|NOT COMPLETED|Period 1||1
6366004|NCT00708097|7276445|FG002|NOT COMPLETED|Period 1||0
6366005|NCT00708097|7276446|FG003|NOT COMPLETED|Period 1||2
6366006|NCT00708097|7276447|FG004|NOT COMPLETED|Period 1||1
6366007|NCT00708097|7276443|FG000|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
6366008|NCT00708097|7276444|FG001|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
6366009|NCT00708097|7276445|FG002|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
6366010|NCT00708097|7276446|FG003|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
6366011|NCT00708097|7276447|FG004|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
6366012|NCT00708097|7276443|FG000|COMPLETED|Period 2||10
6366013|NCT00708097|7276444|FG001|COMPLETED|Period 2||11
6366014|NCT00708097|7276445|FG002|COMPLETED|Period 2||9
6366015|NCT00708097|7276446|FG003|COMPLETED|Period 2||10
6366016|NCT00708097|7276447|FG004|COMPLETED|Period 2||10
6366017|NCT00708097|7276443|FG000|NOT COMPLETED|Period 2||0
6366018|NCT00708097|7276444|FG001|NOT COMPLETED|Period 2||1
6366019|NCT00708097|7276445|FG002|NOT COMPLETED|Period 2||1
6366020|NCT00708097|7276446|FG003|NOT COMPLETED|Period 2||1
6366021|NCT00708097|7276447|FG004|NOT COMPLETED|Period 2||0
6366022|NCT00708097|7276443|FG000|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
6366023|NCT00708097|7276444|FG001|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
6366024|NCT00708097|7276445|FG002|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
6366025|NCT00708097|7276446|FG003|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
6366026|NCT00708097|7276447|FG004|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
6366027|NCT00708097|7276443|FG000|COMPLETED|Period 3||9
6366028|NCT00708097|7276444|FG001|COMPLETED|Period 3||11
6366029|NCT00708097|7276445|FG002|COMPLETED|Period 3||10
6560754|NCT01789281|7483627|FG000|COMPLETED|Overall Study||0
6366030|NCT00708097|7276446|FG003|COMPLETED|Period 3||10
6366031|NCT00708097|7276447|FG004|COMPLETED|Period 3||10
6366032|NCT00708097|7276443|FG000|NOT COMPLETED|Period 3||0
6366033|NCT00708097|7276444|FG001|NOT COMPLETED|Period 3||0
6366034|NCT00708097|7276445|FG002|NOT COMPLETED|Period 3||0
6366035|NCT00708097|7276446|FG003|NOT COMPLETED|Period 3||0
6366036|NCT00708097|7276447|FG004|NOT COMPLETED|Period 3||0
6366037|NCT00708097|7276443|FG000|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
6366038|NCT00708097|7276444|FG001|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
6560755|NCT01789281|7483628|FG001|COMPLETED|Overall Study||2
6560756|NCT01789281|7483627|FG000|NOT COMPLETED|Overall Study||22
6560757|NCT01789281|7483628|FG001|NOT COMPLETED|Overall Study||10
6560758|NCT01789320|7483635|FG000|STARTED|Overall Study||11
6560759|NCT01789320|7483635|FG000|COMPLETED|Overall Study||9
6560760|NCT01789320|7483635|FG000|NOT COMPLETED|Overall Study||2
6560761|NCT01789476|7483641|FG000|STARTED|Overall Study||34
6560762|NCT01789476|7483642|FG001|STARTED|Overall Study||17
6366039|NCT00708097|7276445|FG002|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
6366040|NCT00708097|7276446|FG003|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
6366041|NCT00708097|7276447|FG004|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
6366042|NCT00708097|7276443|FG000|COMPLETED|Period 4||12
6366043|NCT00708097|7276444|FG001|COMPLETED|Period 4||9
6366044|NCT00708097|7276445|FG002|COMPLETED|Period 4||10
6366045|NCT00708097|7276446|FG003|COMPLETED|Period 4||11
6366046|NCT00708097|7276447|FG004|COMPLETED|Period 4||8
6366047|NCT00708097|7276443|FG000|NOT COMPLETED|Period 4||0
6366048|NCT00708097|7276444|FG001|NOT COMPLETED|Period 4||0
6366049|NCT00708097|7276445|FG002|NOT COMPLETED|Period 4||0
6366050|NCT00708097|7276446|FG003|NOT COMPLETED|Period 4||0
6366051|NCT00708097|7276447|FG004|NOT COMPLETED|Period 4||0
6366052|NCT00708097|7276443|FG000|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
6366053|NCT00708097|7276444|FG001|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
6366054|NCT00708097|7276445|FG002|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
6366055|NCT00708097|7276446|FG003|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
6366056|NCT00708097|7276447|FG004|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
6366057|NCT00708097|7276443|FG000|COMPLETED|Period 5||8
6366058|NCT00708097|7276444|FG001|COMPLETED|Period 5||9
6366059|NCT00708097|7276445|FG002|COMPLETED|Period 5||11
6366060|NCT00708097|7276446|FG003|COMPLETED|Period 5||10
6366061|NCT00708097|7276447|FG004|COMPLETED|Period 5||12
6366062|NCT00708097|7276443|FG000|NOT COMPLETED|Period 5||0
6366063|NCT00708097|7276444|FG001|NOT COMPLETED|Period 5||0
6366064|NCT00708097|7276445|FG002|NOT COMPLETED|Period 5||0
6366065|NCT00708097|7276446|FG003|NOT COMPLETED|Period 5||0
6366066|NCT00708097|7276447|FG004|NOT COMPLETED|Period 5||0
6366067|NCT00708110|7276468|FG000|STARTED|Overall Study||7
6366068|NCT00708110|7276469|FG001|STARTED|Overall Study||9
6366069|NCT00708110|7276470|FG002|STARTED|Overall Study||9
6366070|NCT00708110|7276471|FG003|STARTED|Overall Study||10
6366071|NCT00708110|7276468|FG000|COMPLETED|Overall Study||7
6366072|NCT00708110|7276469|FG001|COMPLETED|Overall Study||9
6366073|NCT00708110|7276470|FG002|COMPLETED|Overall Study||9
6366074|NCT00708110|7276471|FG003|COMPLETED|Overall Study||10
6366075|NCT00708110|7276468|FG000|NOT COMPLETED|Overall Study||0
6366076|NCT00708110|7276469|FG001|NOT COMPLETED|Overall Study||0
6366077|NCT00708110|7276470|FG002|NOT COMPLETED|Overall Study||0
6366078|NCT00708110|7276471|FG003|NOT COMPLETED|Overall Study||0
6366079|NCT00708123|7276481|FG000|STARTED|Period 1||12
6366080|NCT00708123|7276482|FG001|STARTED|Period 1||12
6366081|NCT00708123|7276483|FG002|STARTED|Period 1||12
6366082|NCT00708123|7276484|FG003|STARTED|Period 1||12
6366083|NCT00708123|7276485|FG004|STARTED|Period 1||12
6366084|NCT00708123|7276481|FG000|COMPLETED|Period 1||12
6366085|NCT00708123|7276482|FG001|COMPLETED|Period 1||11
6366086|NCT00708123|7276483|FG002|COMPLETED|Period 1||11
6366087|NCT00708123|7276484|FG003|COMPLETED|Period 1||11
6366088|NCT00708123|7276485|FG004|COMPLETED|Period 1||12
6366089|NCT00708123|7276481|FG000|NOT COMPLETED|Period 1||0
6366090|NCT00708123|7276482|FG001|NOT COMPLETED|Period 1||1
6366091|NCT00708123|7276483|FG002|NOT COMPLETED|Period 1||1
6366092|NCT00708123|7276484|FG003|NOT COMPLETED|Period 1||1
6366093|NCT00708123|7276485|FG004|NOT COMPLETED|Period 1||0
6366094|NCT00708123|7276481|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
6366095|NCT00708123|7276482|FG001|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
6366096|NCT00708123|7276483|FG002|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
6366097|NCT00708123|7276484|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
6366098|NCT00708123|7276485|FG004|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
6366099|NCT00708123|7276481|FG000|COMPLETED|Period 2||10
6366100|NCT00708123|7276482|FG001|COMPLETED|Period 2||12
6366101|NCT00708123|7276483|FG002|COMPLETED|Period 2||12
6560763|NCT01789476|7483641|FG000|COMPLETED|Overall Study||26
6560764|NCT01789476|7483642|FG001|COMPLETED|Overall Study||15
6560765|NCT01789476|7483641|FG000|NOT COMPLETED|Overall Study||8
6560766|NCT01789476|7483642|FG001|NOT COMPLETED|Overall Study||2
6560767|NCT01789567|7483648|FG000|STARTED|Overall Study||20
6366102|NCT00708123|7276484|FG003|COMPLETED|Period 2||10
6560768|NCT01789567|7483648|FG000|COMPLETED|Overall Study||14
6560769|NCT01789567|7483648|FG000|NOT COMPLETED|Overall Study||6
6560770|NCT01789606|7483654|FG000|STARTED|Overall Study||251
6560771|NCT01789606|7483655|FG001|STARTED|Overall Study||832
6366103|NCT00708123|7276485|FG004|COMPLETED|Period 2||11
6366104|NCT00708123|7276481|FG000|NOT COMPLETED|Period 2||1
6366105|NCT00708123|7276482|FG001|NOT COMPLETED|Period 2||0
6366106|NCT00708123|7276483|FG002|NOT COMPLETED|Period 2||0
6366107|NCT00708123|7276484|FG003|NOT COMPLETED|Period 2||1
6366108|NCT00708123|7276485|FG004|NOT COMPLETED|Period 2||0
6366109|NCT00708123|7276481|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
6366110|NCT00708123|7276482|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
6366111|NCT00708123|7276483|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
6366112|NCT00708123|7276484|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
6366113|NCT00708123|7276485|FG004|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
6366114|NCT00708123|7276481|FG000|COMPLETED|Period 3||12
6366115|NCT00708123|7276482|FG001|COMPLETED|Period 3||10
6366116|NCT00708123|7276483|FG002|COMPLETED|Period 3||10
6366117|NCT00708123|7276484|FG003|COMPLETED|Period 3||11
6366118|NCT00708123|7276485|FG004|COMPLETED|Period 3||10
6366119|NCT00708123|7276481|FG000|NOT COMPLETED|Period 3||0
6366120|NCT00708123|7276482|FG001|NOT COMPLETED|Period 3||0
6366121|NCT00708123|7276483|FG002|NOT COMPLETED|Period 3||1
6366122|NCT00708123|7276484|FG003|NOT COMPLETED|Period 3||1
6366123|NCT00708123|7276485|FG004|NOT COMPLETED|Period 3||0
6366124|NCT00708123|7276481|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
6366125|NCT00708123|7276482|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
6366126|NCT00708123|7276483|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
6366127|NCT00708123|7276484|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
6366128|NCT00708123|7276485|FG004|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
6366129|NCT00708123|7276481|FG000|COMPLETED|Period 4||10
6366130|NCT00708123|7276482|FG001|COMPLETED|Period 4||11
6366131|NCT00708123|7276483|FG002|COMPLETED|Period 4||10
6366132|NCT00708123|7276484|FG003|COMPLETED|Period 4||10
6366133|NCT00708123|7276485|FG004|COMPLETED|Period 4||11
6366134|NCT00708123|7276481|FG000|NOT COMPLETED|Period 4||0
6366135|NCT00708123|7276482|FG001|NOT COMPLETED|Period 4||1
6366136|NCT00708123|7276483|FG002|NOT COMPLETED|Period 4||0
6366137|NCT00708123|7276484|FG003|NOT COMPLETED|Period 4||0
6366138|NCT00708123|7276485|FG004|NOT COMPLETED|Period 4||0
6366139|NCT00708123|7276481|FG000|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
6366140|NCT00708123|7276482|FG001|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
6366141|NCT00708123|7276483|FG002|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
6366142|NCT00708123|7276484|FG003|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
6366143|NCT00708123|7276485|FG004|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
6366144|NCT00708123|7276481|FG000|COMPLETED|Period 5||10
6366145|NCT00708123|7276482|FG001|COMPLETED|Period 5||10
6366146|NCT00708123|7276483|FG002|COMPLETED|Period 5||11
6366147|NCT00708123|7276484|FG003|COMPLETED|Period 5||11
6366148|NCT00708123|7276485|FG004|COMPLETED|Period 5||10
6366149|NCT00708123|7276481|FG000|NOT COMPLETED|Period 5||0
6366150|NCT00708123|7276482|FG001|NOT COMPLETED|Period 5||0
6366151|NCT00708123|7276483|FG002|NOT COMPLETED|Period 5||0
6366152|NCT00708123|7276484|FG003|NOT COMPLETED|Period 5||0
6366153|NCT00708123|7276485|FG004|NOT COMPLETED|Period 5||0
6366154|NCT00708162|7276503|FG000|STARTED|Randomized Phase||361
6366155|NCT00708162|7276504|FG001|STARTED|Randomized Phase||363
6366156|NCT00708162|7276503|FG000|Randomized and Treated|Randomized Phase||354
6366157|NCT00708162|7276504|FG001|Randomized and Treated|Randomized Phase||358
6366158|NCT00708162|7276503|FG000|COMPLETED|Randomized Phase||205
6366159|NCT00708162|7276504|FG001|COMPLETED|Randomized Phase||209
6366160|NCT00708162|7276503|FG000|NOT COMPLETED|Randomized Phase||156
6366161|NCT00708162|7276504|FG001|NOT COMPLETED|Randomized Phase||154
6366162|NCT00708162|7276503|FG000|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
6366163|NCT00708162|7276504|FG001|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
6366164|NCT00708162|7276503|FG000|COMPLETED|Open-Label Phase||152
6366165|NCT00708162|7276504|FG001|COMPLETED|Open-Label Phase||121
6366166|NCT00708162|7276503|FG000|NOT COMPLETED|Open-Label Phase||44
6366167|NCT00708162|7276504|FG001|NOT COMPLETED|Open-Label Phase||30
6366168|NCT00708175|7276513|FG000|STARTED|Overall Study||78
6366169|NCT00708175|7276514|FG001|STARTED|Overall Study||78
6366170|NCT00708175|7276513|FG000|COMPLETED|Overall Study||60
6366171|NCT00708175|7276514|FG001|COMPLETED|Overall Study||57
6366172|NCT00708175|7276513|FG000|NOT COMPLETED|Overall Study||18
6366173|NCT00708175|7276514|FG001|NOT COMPLETED|Overall Study||21
6366174|NCT00708201|7276522|FG000|STARTED|Overall Study||137
6366175|NCT00708201|7276523|FG001|STARTED|Overall Study||143
6366176|NCT00708201|7276522|FG000|Received at Least 1 Dose of Study Drug|Overall Study||130
6366177|NCT00708201|7276523|FG001|Received at Least 1 Dose of Study Drug|Overall Study||137
6366178|NCT00708201|7276522|FG000|COMPLETED|Overall Study||130
6366179|NCT00708201|7276523|FG001|COMPLETED|Overall Study||137
6366180|NCT00708201|7276522|FG000|NOT COMPLETED|Overall Study||7
6366181|NCT00708201|7276523|FG001|NOT COMPLETED|Overall Study||6
6366182|NCT00708214|7276532|FG000|STARTED|Overall Study||7
6366183|NCT00708214|7276533|FG001|STARTED|Overall Study||13
6366184|NCT00708214|7276534|FG002|STARTED|Overall Study||8
6366185|NCT00708214|7276532|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
6366186|NCT00708214|7276533|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
6366187|NCT00708214|7276534|FG002|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
6366188|NCT00708214|7276532|FG000|NOT COMPLETED|Overall Study||7
6366189|NCT00708214|7276533|FG001|NOT COMPLETED|Overall Study||13
6366190|NCT00708214|7276534|FG002|NOT COMPLETED|Overall Study||8
6366191|NCT00708227|7276551|FG000|STARTED|Overall Study||19
6366192|NCT00708227|7276552|FG001|STARTED|Overall Study||26
6366193|NCT00708227|7276553|FG002|STARTED|Overall Study||18
6366194|NCT00708227|7276554|FG003|STARTED|Overall Study||25
6366195|NCT00708227|7276551|FG000|COMPLETED|Overall Study||18
6366196|NCT00708227|7276552|FG001|COMPLETED|Overall Study||21
6366197|NCT00708227|7276553|FG002|COMPLETED|Overall Study||17
6366198|NCT00708227|7276554|FG003|COMPLETED|Overall Study||22
6366199|NCT00708227|7276551|FG000|NOT COMPLETED|Overall Study||1
6366200|NCT00708227|7276552|FG001|NOT COMPLETED|Overall Study||5
6366201|NCT00708227|7276553|FG002|NOT COMPLETED|Overall Study||1
6366202|NCT00708227|7276554|FG003|NOT COMPLETED|Overall Study||3
6366203|NCT00708305|7276584|FG000|STARTED|Period 1||16
6366204|NCT00708305|7276585|FG001|STARTED|Period 1||16
6366205|NCT00708305|7276586|FG002|STARTED|Period 1||17
6366206|NCT00708305|7276587|FG003|STARTED|Period 1||16
6366207|NCT00708305|7276584|FG000|COMPLETED|Period 1||15
6366208|NCT00708305|7276585|FG001|COMPLETED|Period 1||16
6366209|NCT00708305|7276586|FG002|COMPLETED|Period 1||16
6366210|NCT00708305|7276587|FG003|COMPLETED|Period 1||14
6366211|NCT00708305|7276584|FG000|NOT COMPLETED|Period 1||1
6366212|NCT00708305|7276585|FG001|NOT COMPLETED|Period 1||0
6366213|NCT00708305|7276586|FG002|NOT COMPLETED|Period 1||1
6366214|NCT00708305|7276587|FG003|NOT COMPLETED|Period 1||2
6366215|NCT00708305|7276584|FG000|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
6366216|NCT00708305|7276585|FG001|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
6366217|NCT00708305|7276586|FG002|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
6366218|NCT00708305|7276587|FG003|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
6366219|NCT00708305|7276584|FG000|COMPLETED|Period 2||14
6366220|NCT00708305|7276585|FG001|COMPLETED|Period 2||13
6366221|NCT00708305|7276586|FG002|COMPLETED|Period 2||16
6366222|NCT00708305|7276587|FG003|COMPLETED|Period 2||14
6366223|NCT00708305|7276584|FG000|NOT COMPLETED|Period 2||1
6366224|NCT00708305|7276585|FG001|NOT COMPLETED|Period 2||2
6366225|NCT00708305|7276586|FG002|NOT COMPLETED|Period 2||0
6366226|NCT00708305|7276587|FG003|NOT COMPLETED|Period 2||1
6366227|NCT00708305|7276584|FG000|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
6366228|NCT00708305|7276585|FG001|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
6366229|NCT00708305|7276586|FG002|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
6366230|NCT00708305|7276587|FG003|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
6366231|NCT00708305|7276584|FG000|COMPLETED|Period 3||14
6366232|NCT00708305|7276585|FG001|COMPLETED|Period 3||12
6366233|NCT00708305|7276586|FG002|COMPLETED|Period 3||14
6366234|NCT00708305|7276587|FG003|COMPLETED|Period 3||14
6366235|NCT00708305|7276584|FG000|NOT COMPLETED|Period 3||1
6366236|NCT00708305|7276585|FG001|NOT COMPLETED|Period 3||2
6366237|NCT00708305|7276586|FG002|NOT COMPLETED|Period 3||0
6366238|NCT00708305|7276587|FG003|NOT COMPLETED|Period 3||0
6366239|NCT00708305|7276584|FG000|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
6366240|NCT00708305|7276585|FG001|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
6366241|NCT00708305|7276586|FG002|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
6366242|NCT00708305|7276587|FG003|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
6366243|NCT00708305|7276584|FG000|COMPLETED|Period 4||12
6366244|NCT00708305|7276585|FG001|COMPLETED|Period 4||14
6366245|NCT00708305|7276586|FG002|COMPLETED|Period 4||14
6366246|NCT00708305|7276587|FG003|COMPLETED|Period 4||14
6366247|NCT00708305|7276584|FG000|NOT COMPLETED|Period 4||0
6366248|NCT00708305|7276585|FG001|NOT COMPLETED|Period 4||0
6366249|NCT00708305|7276586|FG002|NOT COMPLETED|Period 4||0
6366250|NCT00708305|7276587|FG003|NOT COMPLETED|Period 4||0
6366251|NCT00708422|7276602|FG000|STARTED|Overall Study||116
6366252|NCT00708422|7276603|FG001|STARTED|Overall Study||115
6366253|NCT00708422|7276602|FG000|COMPLETED|Overall Study||112
6366254|NCT00708422|7276603|FG001|COMPLETED|Overall Study||114
6366255|NCT00708422|7276602|FG000|NOT COMPLETED|Overall Study||4
6366256|NCT00708422|7276603|FG001|NOT COMPLETED|Overall Study||1
6366257|NCT00708435|7276611|FG000|STARTED|Overall Study||107
6366258|NCT00708435|7276612|FG001|STARTED|Overall Study||109
6366259|NCT00708435|7276611|FG000|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
6366260|NCT00708435|7276612|FG001|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
6366261|NCT00708435|7276611|FG000|NOT COMPLETED|Overall Study||25
6366262|NCT00708435|7276612|FG001|NOT COMPLETED|Overall Study||17
6366263|NCT00708461|7276622|FG000|STARTED|Overall Study||752
6366264|NCT00708461|7276623|FG001|STARTED|Overall Study||995
6366265|NCT00708461|7276622|FG000|COMPLETED|Overall Study||611
6366266|NCT00708461|7276623|FG001|COMPLETED|Overall Study||795
6366267|NCT00708461|7276622|FG000|NOT COMPLETED|Overall Study||141
6366268|NCT00708461|7276623|FG001|NOT COMPLETED|Overall Study||200
6366269|NCT00708500|7276632|FG000|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
6366270|NCT00708500|7276633|FG001|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
6366271|NCT00708500|7276634|FG002|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
6366272|NCT00708500|7276632|FG000|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
6366273|NCT00708500|7276633|FG001|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
6366274|NCT00708500|7276634|FG002|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
6366275|NCT00708500|7276632|FG000|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
6366276|NCT00708500|7276633|FG001|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
6366277|NCT00708500|7276634|FG002|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
6366278|NCT00708500|7276632|FG000|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
6366279|NCT00708500|7276633|FG001|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
6366280|NCT00708500|7276634|FG002|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
6366281|NCT00708500|7276632|FG000|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
6366282|NCT00708500|7276633|FG001|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
6366283|NCT00708500|7276634|FG002|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
6366284|NCT00708500|7276632|FG000|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
6366285|NCT00708500|7276633|FG001|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
6366286|NCT00708500|7276634|FG002|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
6366287|NCT00708500|7276632|FG000|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
6366288|NCT00708500|7276633|FG001|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
6366289|NCT00708500|7276634|FG002|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
6366290|NCT00708500|7276632|FG000|STARTED|FOLLOWUP||77
6366291|NCT00708500|7276633|FG001|STARTED|FOLLOWUP||151
6366292|NCT00708500|7276634|FG002|STARTED|FOLLOWUP||158
6366293|NCT00708500|7276632|FG000|COMPLETED|FOLLOWUP||37
6366294|NCT00708500|7276633|FG001|COMPLETED|FOLLOWUP||136
6366295|NCT00708500|7276634|FG002|COMPLETED|FOLLOWUP||143
6366296|NCT00708500|7276632|FG000|NOT COMPLETED|FOLLOWUP||40
6366297|NCT00708500|7276633|FG001|NOT COMPLETED|FOLLOWUP||15
6366298|NCT00708500|7276634|FG002|NOT COMPLETED|FOLLOWUP||15
6366299|NCT00708526|7276644|FG000|STARTED|Wake up After Anesthesia||11
6366300|NCT00708526|7276645|FG001|STARTED|Wake up After Anesthesia||11
6366301|NCT00708526|7276644|FG000|COMPLETED|Wake up After Anesthesia||11
6366302|NCT00708526|7276645|FG001|COMPLETED|Wake up After Anesthesia||11
6366303|NCT00708526|7276644|FG000|NOT COMPLETED|Wake up After Anesthesia||0
6366304|NCT00708526|7276645|FG001|NOT COMPLETED|Wake up After Anesthesia||0
6366305|NCT00708526|7276644|FG000|STARTED|Return of Cognitive Function||11
6366306|NCT00708526|7276645|FG001|STARTED|Return of Cognitive Function||11
6366307|NCT00708526|7276644|FG000|COMPLETED|Return of Cognitive Function||11
6366308|NCT00708526|7276645|FG001|COMPLETED|Return of Cognitive Function||11
6366309|NCT00708526|7276644|FG000|NOT COMPLETED|Return of Cognitive Function||0
6366310|NCT00708526|7276645|FG001|NOT COMPLETED|Return of Cognitive Function||0
6366311|NCT00708552|7276655|FG000|STARTED|Overall Study||145
6366312|NCT00708552|7276656|FG001|STARTED|Overall Study||145
6366313|NCT00708552|7276657|FG002|STARTED|Overall Study||133
6366314|NCT00708552|7276658|FG003|STARTED|Overall Study||151
6366315|NCT00708552|7276655|FG000|COMPLETED|Overall Study||118
6366316|NCT00708552|7276656|FG001|COMPLETED|Overall Study||127
6366317|NCT00708552|7276657|FG002|COMPLETED|Overall Study||118
6366318|NCT00708552|7276658|FG003|COMPLETED|Overall Study||130
6366319|NCT00708552|7276655|FG000|NOT COMPLETED|Overall Study||27
6366320|NCT00708552|7276656|FG001|NOT COMPLETED|Overall Study||18
6366321|NCT00708552|7276657|FG002|NOT COMPLETED|Overall Study||15
6366322|NCT00708552|7276658|FG003|NOT COMPLETED|Overall Study||21
6366323|NCT00708643|7276674|FG000|STARTED|Overall Study||40
6366324|NCT00708643|7276675|FG001|STARTED|Overall Study||40
6366325|NCT00708643|7276674|FG000|COMPLETED|Overall Study||40
6366326|NCT00708643|7276675|FG001|COMPLETED|Overall Study||39
6366327|NCT00708643|7276674|FG000|NOT COMPLETED|Overall Study||0
6366328|NCT00708643|7276675|FG001|NOT COMPLETED|Overall Study||1
6366329|NCT00708682|7276681|FG000|STARTED|Infant Series||225
6366330|NCT00708682|7276681|FG000|Vaccinated Dose 1|Infant Series||223
6366331|NCT00708682|7276681|FG000|Vaccinated Dose 2|Infant Series||214
6366332|NCT00708682|7276681|FG000|Vaccinated Dose 3|Infant Series||194
6366333|NCT00708682|7276681|FG000|COMPLETED|Infant Series||192
6366334|NCT00708682|7276681|FG000|NOT COMPLETED|Infant Series||33
6366335|NCT00708682|7276681|FG000|STARTED|After Infant Series||192
6366336|NCT00708682|7276681|FG000|COMPLETED|After Infant Series||191
6366337|NCT00708682|7276681|FG000|NOT COMPLETED|After Infant Series||1
6366338|NCT00708682|7276681|FG000|STARTED|Toddler Dose||191
6366339|NCT00708682|7276681|FG000|COMPLETED|Toddler Dose||183
6366340|NCT00708682|7276681|FG000|NOT COMPLETED|Toddler Dose||8
6366341|NCT00708708|7276687|FG000|STARTED|Overall Study||955
6366342|NCT00708708|7276687|FG000|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
6366343|NCT00708708|7276687|FG000|NOT COMPLETED|Overall Study||742
6366344|NCT00708721|7276694|FG000|STARTED|Overall Study||2
6366345|NCT00708721|7276695|FG001|STARTED|Overall Study||4
6366346|NCT00708721|7276696|FG002|STARTED|Overall Study||3
6366347|NCT00708721|7276697|FG003|STARTED|Overall Study||2
6366348|NCT00708721|7276694|FG000|COMPLETED|Overall Study||2
6366349|NCT00708721|7276695|FG001|COMPLETED|Overall Study||4
6366350|NCT00708721|7276696|FG002|COMPLETED|Overall Study||3
6366351|NCT00708721|7276697|FG003|COMPLETED|Overall Study||2
6366352|NCT00708721|7276694|FG000|NOT COMPLETED|Overall Study||0
6366353|NCT00708721|7276695|FG001|NOT COMPLETED|Overall Study||0
6366354|NCT00708721|7276696|FG002|NOT COMPLETED|Overall Study||0
6366355|NCT00708721|7276697|FG003|NOT COMPLETED|Overall Study||0
6366356|NCT00708851|7276708|FG000|STARTED|Overall Study||12
6366357|NCT00708851|7276708|FG000|COMPLETED|Overall Study||12
6366358|NCT00708851|7276708|FG000|NOT COMPLETED|Overall Study||0
6366359|NCT00708877|7276714|FG000|STARTED|Overall Study||5
6366360|NCT00708877|7276714|FG000|COMPLETED|Overall Study||5
6366361|NCT00708877|7276714|FG000|NOT COMPLETED|Overall Study||0
6366362|NCT00708942|7276723|FG000|STARTED|Overall Study||47
6366363|NCT00708942|7276724|FG001|STARTED|Overall Study||12
6366364|NCT00708942|7276725|FG002|STARTED|Overall Study||11
6366365|NCT00708942|7276726|FG003|STARTED|Overall Study||10
6366366|NCT00708942|7276727|FG004|STARTED|Overall Study||3
6366367|NCT00708942|7276723|FG000|COMPLETED|Overall Study||40
6366368|NCT00708942|7276724|FG001|COMPLETED|Overall Study||11
6366369|NCT00708942|7276725|FG002|COMPLETED|Overall Study||9
6366370|NCT00708942|7276726|FG003|COMPLETED|Overall Study||10
6366371|NCT00708942|7276727|FG004|COMPLETED|Overall Study||2
6366372|NCT00708942|7276723|FG000|NOT COMPLETED|Overall Study||7
6366373|NCT00708942|7276724|FG001|NOT COMPLETED|Overall Study||1
6366374|NCT00708942|7276725|FG002|NOT COMPLETED|Overall Study||2
6366375|NCT00708942|7276726|FG003|NOT COMPLETED|Overall Study||0
6366376|NCT00708942|7276727|FG004|NOT COMPLETED|Overall Study||1
6366377|NCT00709059|7276739|FG000|STARTED|Overall Study||538
6366378|NCT00709059|7276739|FG000|COMPLETED|Overall Study||444
6366379|NCT00709059|7276739|FG000|NOT COMPLETED|Overall Study||94
6366380|NCT00709098|7276746|FG000|STARTED|Double-blind Period||25
6366381|NCT00709098|7276747|FG001|STARTED|Double-blind Period||24
6366382|NCT00709098|7276748|FG002|STARTED|Double-blind Period||0
6366383|NCT00709098|7276746|FG000|COMPLETED|Double-blind Period||19
6366384|NCT00709098|7276747|FG001|COMPLETED|Double-blind Period||16
6366385|NCT00709098|7276748|FG002|COMPLETED|Double-blind Period||0
6366386|NCT00709098|7276746|FG000|NOT COMPLETED|Double-blind Period||6
6366387|NCT00709098|7276747|FG001|NOT COMPLETED|Double-blind Period||8
6366388|NCT00709098|7276748|FG002|NOT COMPLETED|Double-blind Period||0
6366389|NCT00709098|7276746|FG000|STARTED|Open-label Period||0
6366390|NCT00709098|7276747|FG001|STARTED|Open-label Period||0
6366391|NCT00709098|7276748|FG002|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
6366392|NCT00709098|7276746|FG000|COMPLETED|Open-label Period||0
6366393|NCT00709098|7276747|FG001|COMPLETED|Open-label Period||0
6366394|NCT00709098|7276748|FG002|COMPLETED|Open-label Period||18
6366395|NCT00709098|7276746|FG000|NOT COMPLETED|Open-label Period||0
6560772|NCT01789606|7483654|FG000|COMPLETED|Overall Study||228
6560773|NCT01789606|7483655|FG001|COMPLETED|Overall Study||382
6560774|NCT01789606|7483654|FG000|NOT COMPLETED|Overall Study||23
6560775|NCT01789606|7483655|FG001|NOT COMPLETED|Overall Study||450
6560776|NCT01789775|7483662|FG000|STARTED|Overall Study||55
6560777|NCT01789775|7483663|FG001|STARTED|Overall Study||57
6560778|NCT01789775|7483662|FG000|COMPLETED|Overall Study||53
6560779|NCT01789775|7483663|FG001|COMPLETED|Overall Study||50
6560780|NCT01789775|7483662|FG000|NOT COMPLETED|Overall Study||2
6560781|NCT01789775|7483663|FG001|NOT COMPLETED|Overall Study||7
6560782|NCT01789814|7483671|FG000|STARTED|Overall Study||12
6560783|NCT01789814|7483672|FG001|STARTED|Overall Study||12
6560784|NCT01789814|7483671|FG000|COMPLETED|Overall Study||12
6560785|NCT01789814|7483672|FG001|COMPLETED|Overall Study||12
6560786|NCT01789814|7483671|FG000|NOT COMPLETED|Overall Study||0
6560787|NCT01789814|7483672|FG001|NOT COMPLETED|Overall Study||0
6560788|NCT01789840|7483680|FG000|STARTED|Overall Study||52
6560789|NCT01789840|7483681|FG001|STARTED|Overall Study||7
6560790|NCT01789840|7483680|FG000|COMPLETED|Overall Study||52
6366396|NCT00709098|7276747|FG001|NOT COMPLETED|Open-label Period||0
6366397|NCT00709098|7276748|FG002|NOT COMPLETED|Open-label Period||14
6366398|NCT00709111|7276757|FG000|STARTED|Overall Study||34
6366399|NCT00709111|7276757|FG000|Week 22/24|Overall Study||33
6366400|NCT00709111|7276757|FG000|COMPLETED|Overall Study||32
6366401|NCT00709111|7276757|FG000|NOT COMPLETED|Overall Study||2
6366402|NCT00709124|7276763|FG000|STARTED|Overall Study||16
6366403|NCT00709124|7276764|FG001|STARTED|Overall Study||18
6366404|NCT00709124|7276763|FG000|COMPLETED|Overall Study||12
6366405|NCT00709124|7276764|FG001|COMPLETED|Overall Study||17
6366406|NCT00709124|7276763|FG000|NOT COMPLETED|Overall Study||4
6366407|NCT00709124|7276764|FG001|NOT COMPLETED|Overall Study||1
6366408|NCT00709202|7276776|FG000|STARTED|Overall Study||19
6560791|NCT01789840|7483681|FG001|COMPLETED|Overall Study||6
6560792|NCT01789840|7483680|FG000|NOT COMPLETED|Overall Study||0
6560793|NCT01789840|7483681|FG001|NOT COMPLETED|Overall Study||1
6366409|NCT00709202|7276777|FG001|STARTED|Overall Study||21
6366410|NCT00709202|7276776|FG000|COMPLETED|Overall Study||13
6366411|NCT00709202|7276777|FG001|COMPLETED|Overall Study||15
6366412|NCT00709202|7276776|FG000|NOT COMPLETED|Overall Study||6
6366413|NCT00709202|7276777|FG001|NOT COMPLETED|Overall Study||6
6366414|NCT00709228|7276784|FG000|STARTED|Overall Study||496
6560794|NCT01789905|7483689|FG000|STARTED|Overall Study||116
6560795|NCT01789905|7483689|FG000|COMPLETED|Overall Study||116
6560796|NCT01789905|7483689|FG000|NOT COMPLETED|Overall Study||0
6366415|NCT00709228|7276784|FG000|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
6366416|NCT00709228|7276784|FG000|NOT COMPLETED|Overall Study||332
6366417|NCT00709306|7276792|FG000|STARTED|Overall Study||48
6366418|NCT00709306|7276793|FG001|STARTED|Overall Study||44
6366419|NCT00709306|7276794|FG002|STARTED|Overall Study||58
6366420|NCT00709306|7276795|FG003|STARTED|Overall Study||47
6366421|NCT00709306|7276792|FG000|COMPLETED|Overall Study||39
6366422|NCT00709306|7276793|FG001|COMPLETED|Overall Study||30
6366423|NCT00709306|7276794|FG002|COMPLETED|Overall Study||48
6366424|NCT00709306|7276795|FG003|COMPLETED|Overall Study||37
6366425|NCT00709306|7276792|FG000|NOT COMPLETED|Overall Study||9
6366426|NCT00709306|7276793|FG001|NOT COMPLETED|Overall Study||14
6366427|NCT00709306|7276794|FG002|NOT COMPLETED|Overall Study||10
6366428|NCT00709306|7276795|FG003|NOT COMPLETED|Overall Study||10
6366429|NCT00709319|7276805|FG000|STARTED|Overall Study||87
6366430|NCT00709319|7276805|FG000|COMPLETED|Overall Study||81
6366431|NCT00709319|7276805|FG000|NOT COMPLETED|Overall Study||6
6366432|NCT00709592|7276811|FG000|STARTED|Overall Study||19
6366433|NCT00709592|7276812|FG001|STARTED|Overall Study||23
6366434|NCT00709592|7276811|FG000|COMPLETED|Overall Study||19
6366435|NCT00709592|7276812|FG001|COMPLETED|Overall Study||22
6366436|NCT00709592|7276811|FG000|NOT COMPLETED|Overall Study||0
6366437|NCT00709592|7276812|FG001|NOT COMPLETED|Overall Study||1
6366438|NCT00709618|7276818|FG000|STARTED|Overall Study||44
6366439|NCT00709618|7276818|FG000|COMPLETED|Overall Study||14
6366440|NCT00709618|7276818|FG000|NOT COMPLETED|Overall Study||30
6366441|NCT00709696|7276824|FG000|STARTED|Overall Study||4
6366442|NCT00709696|7276825|FG001|STARTED|Overall Study||3
6366443|NCT00709696|7276824|FG000|COMPLETED|Overall Study||4
6366444|NCT00709696|7276825|FG001|COMPLETED|Overall Study||3
6366445|NCT00709696|7276824|FG000|NOT COMPLETED|Overall Study||0
6366446|NCT00709696|7276825|FG001|NOT COMPLETED|Overall Study||0
6366447|NCT00709722|7276831|FG000|STARTED|Overall Study||21
6366448|NCT00709722|7276831|FG000|COMPLETED|Overall Study||20
6366449|NCT00709722|7276831|FG000|NOT COMPLETED|Overall Study||1
6366450|NCT00709735|7276837|FG000|STARTED|Overall Study||11
6560797|NCT01789970|7483695|FG000|STARTED|Open-label Titration Period||625
6560798|NCT01789970|7483696|FG001|STARTED|Open-label Titration Period||0
6560799|NCT01789970|7483697|FG002|STARTED|Open-label Titration Period||0
6560800|NCT01789970|7483695|FG000|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
6560801|NCT01789970|7483696|FG001|Safety Analysis Set|Open-label Titration Period||0
6366451|NCT00709735|7276838|FG001|STARTED|Overall Study||12
6366452|NCT00709735|7276837|FG000|COMPLETED|Overall Study||8
6366453|NCT00709735|7276838|FG001|COMPLETED|Overall Study||10
6366454|NCT00709735|7276837|FG000|NOT COMPLETED|Overall Study||3
6366455|NCT00709735|7276838|FG001|NOT COMPLETED|Overall Study||2
6366456|NCT00709761|7276844|FG000|STARTED|Overall Study||60
6366457|NCT00709761|7276844|FG000|COMPLETED|Overall Study||33
6366458|NCT00709761|7276844|FG000|NOT COMPLETED|Overall Study||27
6366459|NCT00709826|7276850|FG000|STARTED|Overall Study||70
6366460|NCT00709826|7276851|FG001|STARTED|Overall Study||39
6366461|NCT00709826|7276850|FG000|COMPLETED|Overall Study||68
6366462|NCT00709826|7276851|FG001|COMPLETED|Overall Study||38
6366463|NCT00709826|7276850|FG000|NOT COMPLETED|Overall Study||2
6366464|NCT00709826|7276851|FG001|NOT COMPLETED|Overall Study||1
6366465|NCT00709852|7276857|FG000|STARTED|Period 1||228
6366466|NCT00709852|7276858|FG001|STARTED|Period 1||174
6366467|NCT00709852|7276857|FG000|COMPLETED|Period 1||220
6366468|NCT00709852|7276858|FG001|COMPLETED|Period 1||171
6366469|NCT00709852|7276857|FG000|NOT COMPLETED|Period 1||8
6366470|NCT00709852|7276858|FG001|NOT COMPLETED|Period 1||3
6366471|NCT00709852|7276857|FG000|STARTED|Period 2||220
6366472|NCT00709852|7276858|FG001|STARTED|Period 2||171
6366473|NCT00709852|7276857|FG000|COMPLETED|Period 2||211
6366474|NCT00709852|7276858|FG001|COMPLETED|Period 2||169
6366475|NCT00709852|7276857|FG000|NOT COMPLETED|Period 2||9
6366476|NCT00709852|7276858|FG001|NOT COMPLETED|Period 2||2
6366477|NCT00709878|7276877|FG000|STARTED|Overall Study||8
6366478|NCT00709878|7276878|FG001|STARTED|Overall Study||8
6366479|NCT00709878|7276879|FG002|STARTED|Overall Study||8
6366480|NCT00709878|7276880|FG003|STARTED|Overall Study||8
6366481|NCT00709878|7276877|FG000|COMPLETED|Overall Study||8
6366482|NCT00709878|7276878|FG001|COMPLETED|Overall Study||8
6366483|NCT00709878|7276879|FG002|COMPLETED|Overall Study||8
6366484|NCT00709878|7276880|FG003|COMPLETED|Overall Study||8
6366485|NCT00709878|7276877|FG000|NOT COMPLETED|Overall Study||0
6366486|NCT00709878|7276878|FG001|NOT COMPLETED|Overall Study||0
6366487|NCT00709878|7276879|FG002|NOT COMPLETED|Overall Study||0
6366488|NCT00709878|7276880|FG003|NOT COMPLETED|Overall Study||0
6366489|NCT00709891|7276890|FG000|STARTED|Baseline, Cross-sectional Phase||47208
6366490|NCT00709891|7276890|FG000|COMPLETED|Baseline, Cross-sectional Phase||45758
6366491|NCT00709891|7276890|FG000|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
6366492|NCT00709891|7276890|FG000|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
6366493|NCT00709891|7276890|FG000|COMPLETED|Longitudinal Follow-up Phase||5020
6366494|NCT00709891|7276890|FG000|NOT COMPLETED|Longitudinal Follow-up Phase||4982
6366495|NCT00709956|7276896|FG000|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
6366496|NCT00709956|7276897|FG001|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
6366497|NCT00709956|7276896|FG000|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
6366498|NCT00709956|7276897|FG001|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
6366499|NCT00709956|7276896|FG000|COMPLETED|Overall Study||30
6366500|NCT00709956|7276897|FG001|COMPLETED|Overall Study||33
6366501|NCT00709956|7276896|FG000|NOT COMPLETED|Overall Study||3
6366502|NCT00709956|7276897|FG001|NOT COMPLETED|Overall Study||4
6366503|NCT00709995|7276907|FG000|STARTED|Overall Study||11
6366504|NCT00709995|7276908|FG001|STARTED|Overall Study||6
6366505|NCT00709995|7276907|FG000|Progressive Disease|Overall Study||6
6366506|NCT00709995|7276908|FG001|Progressive Disease|Overall Study||1
6366507|NCT00709995|7276907|FG000|COMPLETED|Overall Study||6
6366508|NCT00709995|7276908|FG001|COMPLETED|Overall Study||1
6366509|NCT00709995|7276907|FG000|NOT COMPLETED|Overall Study||5
6366510|NCT00709995|7276908|FG001|NOT COMPLETED|Overall Study||5
6366511|NCT00710021|7276920|FG000|STARTED|Overall Study||19
6366512|NCT00710021|7276921|FG001|STARTED|Overall Study||19
6366513|NCT00710021|7276922|FG002|STARTED|Overall Study||19
6366514|NCT00710021|7276920|FG000|Modified Intent-to-Treat (mITT)|Overall Study||19
6366515|NCT00710021|7276921|FG001|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
6366516|NCT00710021|7276922|FG002|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
6366517|NCT00710021|7276920|FG000|COMPLETED|Overall Study||18
6366518|NCT00710021|7276921|FG001|COMPLETED|Overall Study||16
6366519|NCT00710021|7276922|FG002|COMPLETED|Overall Study||18
6366520|NCT00710021|7276920|FG000|NOT COMPLETED|Overall Study||1
6366521|NCT00710021|7276921|FG001|NOT COMPLETED|Overall Study||3
6366522|NCT00710021|7276922|FG002|NOT COMPLETED|Overall Study||1
6366523|NCT00710034|7276933|FG000|STARTED|Completed 6 Weeks of Treatment||195
6366524|NCT00710034|7276934|FG001|STARTED|Completed 6 Weeks of Treatment||196
6366525|NCT00710034|7276933|FG000|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=154|154
6366526|NCT00710034|7276934|FG001|COMPLETED|Completed 6 Weeks of Treatment|Completed 6 weeks of treatment for primary outcome assessment: N=149|149
6366527|NCT00710034|7276933|FG000|NOT COMPLETED|Completed 6 Weeks of Treatment||41
6366528|NCT00710034|7276934|FG001|NOT COMPLETED|Completed 6 Weeks of Treatment||47
6366529|NCT00710034|7276933|FG000|STARTED|Completed 12 Weeks of Treatment||154
6366530|NCT00710034|7276934|FG001|STARTED|Completed 12 Weeks of Treatment||149
6366531|NCT00710034|7276933|FG000|COMPLETED|Completed 12 Weeks of Treatment||141
6366532|NCT00710034|7276934|FG001|COMPLETED|Completed 12 Weeks of Treatment||138
6366533|NCT00710034|7276933|FG000|NOT COMPLETED|Completed 12 Weeks of Treatment||13
6366534|NCT00710034|7276934|FG001|NOT COMPLETED|Completed 12 Weeks of Treatment||11
6366535|NCT00710203|7276940|FG000|STARTED|Overall Study||10
6366536|NCT00710203|7276940|FG000|COMPLETED|Overall Study||10
6366537|NCT00710203|7276940|FG000|NOT COMPLETED|Overall Study||0
6366538|NCT00710385|7276950|FG000|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
6366539|NCT00710385|7276950|FG000|COMPLETED|Overall Study||12
6366540|NCT00710385|7276950|FG000|NOT COMPLETED|Overall Study||5
6366541|NCT00710424|7276962|FG000|STARTED|Overall Study||149
6366542|NCT00710424|7276963|FG001|STARTED|Overall Study||148
6366543|NCT00710424|7276962|FG000|COMPLETED|Overall Study||105
6366544|NCT00710424|7276963|FG001|COMPLETED|Overall Study||125
6366545|NCT00710424|7276962|FG000|NOT COMPLETED|Overall Study||44
6366546|NCT00710424|7276963|FG001|NOT COMPLETED|Overall Study||23
6366547|NCT00710554|7276971|FG000|STARTED|Overall Study||128
6366548|NCT00710554|7276972|FG001|STARTED|Overall Study||118
6366549|NCT00710554|7276971|FG000|COMPLETED|Overall Study||79
6366550|NCT00710554|7276972|FG001|COMPLETED|Overall Study||94
6366551|NCT00710554|7276971|FG000|NOT COMPLETED|Overall Study||49
6366552|NCT00710554|7276972|FG001|NOT COMPLETED|Overall Study||24
6366553|NCT00710593|7276980|FG000|STARTED|Overall Study||69
6366554|NCT00710593|7276981|FG001|STARTED|Overall Study||30
6366555|NCT00710593|7276980|FG000|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
6366556|NCT00710593|7276981|FG001|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
6366557|NCT00710593|7276980|FG000|NOT COMPLETED|Overall Study||15
6366558|NCT00710593|7276981|FG001|NOT COMPLETED|Overall Study||5
6377513|NCT00763243|7288080|FG000|STARTED|Training Period||9
6377514|NCT00763243|7288080|FG000|COMPLETED|Training Period||9
6377515|NCT00763243|7288080|FG000|NOT COMPLETED|Training Period||0
6377516|NCT00763243|7288080|FG000|STARTED|1-Month Follow-Up Period||9
6377517|NCT00763243|7288080|FG000|COMPLETED|1-Month Follow-Up Period||9
6377518|NCT00763243|7288080|FG000|NOT COMPLETED|1-Month Follow-Up Period||0
6377519|NCT00763243|7288080|FG000|STARTED|6-Month Follow-Up Period||9
6377520|NCT00763243|7288080|FG000|COMPLETED|6-Month Follow-Up Period||9
6377521|NCT00763243|7288080|FG000|NOT COMPLETED|6-Month Follow-Up Period||0
6377522|NCT00763256|7288094|FG000|STARTED|Overall Study||15
6377523|NCT00763256|7288095|FG001|STARTED|Overall Study||18
6377524|NCT00763256|7288094|FG000|COMPLETED|Overall Study||8
6377525|NCT00763256|7288095|FG001|COMPLETED|Overall Study||8
6560802|NCT01789970|7483697|FG002|Safety Analysis Set|Open-label Titration Period||0
6560803|NCT01789970|7483695|FG000|COMPLETED|Open-label Titration Period||371
6560804|NCT01789970|7483696|FG001|COMPLETED|Open-label Titration Period||0
6366559|NCT00710606|7277005|FG000|STARTED|Overall Study||20
6366560|NCT00710606|7277006|FG001|STARTED|Overall Study||20
6366561|NCT00710606|7277005|FG000|COMPLETED|Overall Study||20
6366562|NCT00710606|7277006|FG001|COMPLETED|Overall Study||18
6366563|NCT00710606|7277005|FG000|NOT COMPLETED|Overall Study||0
6366564|NCT00710606|7277006|FG001|NOT COMPLETED|Overall Study||2
6366565|NCT00710684|7277017|FG000|STARTED|Overall Study||225
6366566|NCT00710684|7277018|FG001|STARTED|Overall Study||221
6366567|NCT00710684|7277019|FG002|STARTED|Overall Study||236
6366568|NCT00710684|7277017|FG000|COMPLETED|Overall Study||151
6366569|NCT00710684|7277018|FG001|COMPLETED|Overall Study||147
6366570|NCT00710684|7277019|FG002|COMPLETED|Overall Study||172
6366571|NCT00710684|7277017|FG000|NOT COMPLETED|Overall Study||74
6366572|NCT00710684|7277018|FG001|NOT COMPLETED|Overall Study||74
6366573|NCT00710684|7277019|FG002|NOT COMPLETED|Overall Study||64
6366574|NCT00710749|7277033|FG000|STARTED|Clinic Baseline Recording||30
6366575|NCT00710749|7277034|FG001|STARTED|Clinic Baseline Recording||30
6366576|NCT00710749|7277033|FG000|COMPLETED|Clinic Baseline Recording||30
6366577|NCT00710749|7277034|FG001|COMPLETED|Clinic Baseline Recording||30
6366578|NCT00710749|7277033|FG000|NOT COMPLETED|Clinic Baseline Recording||0
6366579|NCT00710749|7277034|FG001|NOT COMPLETED|Clinic Baseline Recording||0
6366580|NCT00710749|7277033|FG000|STARTED|First Intervention||30
6366581|NCT00710749|7277034|FG001|STARTED|First Intervention||30
6366582|NCT00710749|7277033|FG000|COMPLETED|First Intervention||29
6366583|NCT00710749|7277034|FG001|COMPLETED|First Intervention||30
6366584|NCT00710749|7277033|FG000|NOT COMPLETED|First Intervention||1
6366585|NCT00710749|7277034|FG001|NOT COMPLETED|First Intervention||0
6366586|NCT00710749|7277033|FG000|STARTED|Second Intervention||29
6366587|NCT00710749|7277034|FG001|STARTED|Second Intervention||30
6366588|NCT00710749|7277033|FG000|COMPLETED|Second Intervention||29
6366589|NCT00710749|7277034|FG001|COMPLETED|Second Intervention||30
6366590|NCT00710749|7277033|FG000|NOT COMPLETED|Second Intervention||0
6366591|NCT00710749|7277034|FG001|NOT COMPLETED|Second Intervention||0
6366592|NCT00710762|7277044|FG000|STARTED|Overall Study||44
6366593|NCT00710762|7277045|FG001|STARTED|Overall Study||40
6366594|NCT00710762|7277044|FG000|COMPLETED|Overall Study||5
6366595|NCT00710762|7277045|FG001|COMPLETED|Overall Study||0
6366596|NCT00710762|7277044|FG000|NOT COMPLETED|Overall Study||39
6366597|NCT00710762|7277045|FG001|NOT COMPLETED|Overall Study||40
6366598|NCT00710814|7277053|FG000|STARTED|Overall Study||15
6366599|NCT00710814|7277054|FG001|STARTED|Overall Study||16
6366600|NCT00710814|7277053|FG000|COMPLETED|Overall Study||14
6366601|NCT00710814|7277054|FG001|COMPLETED|Overall Study||13
6366602|NCT00710814|7277053|FG000|NOT COMPLETED|Overall Study||1
6366603|NCT00710814|7277054|FG001|NOT COMPLETED|Overall Study||3
6366604|NCT00710840|7277062|FG000|STARTED|Overall Study||22
6366605|NCT00710840|7277063|FG001|STARTED|Overall Study||22
6366606|NCT00710840|7277062|FG000|COMPLETED|Overall Study||22
6366607|NCT00710840|7277063|FG001|COMPLETED|Overall Study||19
6366608|NCT00710840|7277062|FG000|NOT COMPLETED|Overall Study||0
6366609|NCT00710840|7277063|FG001|NOT COMPLETED|Overall Study||3
6366610|NCT00710866|7277071|FG000|STARTED|Overall Study||133
6366611|NCT00710866|7277072|FG001|STARTED|Overall Study||134
6366612|NCT00710866|7277071|FG000|COMPLETED|Overall Study||124
6366613|NCT00710866|7277072|FG001|COMPLETED|Overall Study||128
6366614|NCT00710866|7277071|FG000|NOT COMPLETED|Overall Study||9
6366615|NCT00710866|7277072|FG001|NOT COMPLETED|Overall Study||6
6366616|NCT00710879|7277080|FG000|STARTED|Overall Study||60
6366617|NCT00710879|7277081|FG001|STARTED|Overall Study||117
6366618|NCT00710879|7277080|FG000|COMPLETED|Overall Study||58
6366619|NCT00710879|7277081|FG001|COMPLETED|Overall Study||113
6366620|NCT00710879|7277080|FG000|NOT COMPLETED|Overall Study||2
6366621|NCT00710879|7277081|FG001|NOT COMPLETED|Overall Study||4
6366622|NCT00710905|7277087|FG000|STARTED|Overall Study||50
6366623|NCT00710905|7277087|FG000|COMPLETED|Overall Study||34
6366624|NCT00710905|7277087|FG000|NOT COMPLETED|Overall Study||16
6366625|NCT00710931|7277091|FG000|STARTED|Overall Study||34
6366626|NCT00710931|7277091|FG000|COMPLETED|Overall Study||29
6366627|NCT00710931|7277091|FG000|NOT COMPLETED|Overall Study||5
6366628|NCT00710944|7277098|FG000|STARTED|Overall Study||55
6366629|NCT00710944|7277099|FG001|STARTED|Overall Study||58
6366630|NCT00710944|7277100|FG002|STARTED|Overall Study||19
6366631|NCT00710944|7277098|FG000|COMPLETED|Overall Study||45
6366632|NCT00710944|7277099|FG001|COMPLETED|Overall Study||49
6366633|NCT00710944|7277100|FG002|COMPLETED|Overall Study||17
6366634|NCT00710944|7277098|FG000|NOT COMPLETED|Overall Study||10
6560805|NCT01789970|7483697|FG002|COMPLETED|Open-label Titration Period||0
6366635|NCT00710944|7277099|FG001|NOT COMPLETED|Overall Study||9
6366636|NCT00710944|7277100|FG002|NOT COMPLETED|Overall Study||2
6366637|NCT00710996|7277111|FG000|STARTED|Overall Study||17
6366638|NCT00710996|7277112|FG001|STARTED|Overall Study||20
6366639|NCT00710996|7277113|FG002|STARTED|Overall Study||21
6366640|NCT00710996|7277111|FG000|COMPLETED|Overall Study||16
6366641|NCT00710996|7277112|FG001|COMPLETED|Overall Study||16
6366642|NCT00710996|7277113|FG002|COMPLETED|Overall Study||21
6366643|NCT00710996|7277111|FG000|NOT COMPLETED|Overall Study||1
6366644|NCT00710996|7277112|FG001|NOT COMPLETED|Overall Study||4
6366645|NCT00710996|7277113|FG002|NOT COMPLETED|Overall Study||0
6366646|NCT00711009|7277123|FG000|STARTED|Overall Study||105
6366647|NCT00711009|7277124|FG001|STARTED|Overall Study||101
6366648|NCT00711009|7277123|FG000|COMPLETED|Overall Study||90
6366649|NCT00711009|7277124|FG001|COMPLETED|Overall Study||82
6366650|NCT00711009|7277123|FG000|NOT COMPLETED|Overall Study||15
6366651|NCT00711009|7277124|FG001|NOT COMPLETED|Overall Study||19
6366652|NCT00711022|7277130|FG000|STARTED|Overall Study||51
6366653|NCT00711022|7277130|FG000|COMPLETED|Overall Study||40
6366654|NCT00711022|7277130|FG000|NOT COMPLETED|Overall Study||11
6366655|NCT00711100|7277134|FG000|STARTED|Overall Study||104
6366656|NCT00711100|7277134|FG000|COMPLETED|Overall Study||91
6366657|NCT00711100|7277134|FG000|NOT COMPLETED|Overall Study||13
6366658|NCT00711113|7277150|FG000|STARTED|Overall Study||47
6366659|NCT00711113|7277150|FG000|COMPLETED|Overall Study||36
6366660|NCT00711113|7277150|FG000|NOT COMPLETED|Overall Study||11
6366661|NCT00711191|7277157|FG000|STARTED|Overall Study||3
6366662|NCT00711191|7277158|FG001|STARTED|Overall Study||6
6366663|NCT00711191|7277159|FG002|STARTED|Overall Study||13
6366664|NCT00711191|7277157|FG000|COMPLETED|Overall Study||0
6366665|NCT00711191|7277158|FG001|COMPLETED|Overall Study||1
6366666|NCT00711191|7277159|FG002|COMPLETED|Overall Study||1
6366667|NCT00711191|7277157|FG000|NOT COMPLETED|Overall Study||3
6366668|NCT00711191|7277158|FG001|NOT COMPLETED|Overall Study||5
6366669|NCT00711191|7277159|FG002|NOT COMPLETED|Overall Study||12
6366670|NCT00711243|7277176|FG000|STARTED|Registed and Started Treatment||3
6366671|NCT00711243|7277177|FG001|STARTED|Registed and Started Treatment||3
6366672|NCT00711243|7277178|FG002|STARTED|Registed and Started Treatment||3
6366673|NCT00711243|7277179|FG003|STARTED|Registed and Started Treatment||3
6366674|NCT00711243|7277180|FG004|STARTED|Registed and Started Treatment||3
6366675|NCT00711243|7277181|FG005|STARTED|Registed and Started Treatment||44
6366676|NCT00711243|7277176|FG000|Registered to Study|Registed and Started Treatment||3
6366677|NCT00711243|7277177|FG001|Registered to Study|Registed and Started Treatment||3
6366678|NCT00711243|7277178|FG002|Registered to Study|Registed and Started Treatment||3
6366679|NCT00711243|7277179|FG003|Registered to Study|Registed and Started Treatment||3
6366680|NCT00711243|7277180|FG004|Registered to Study|Registed and Started Treatment||3
6366681|NCT00711243|7277181|FG005|Registered to Study|Registed and Started Treatment||44
6366682|NCT00711243|7277176|FG000|Started Treatment|Registed and Started Treatment||3
6366683|NCT00711243|7277177|FG001|Started Treatment|Registed and Started Treatment||3
6366684|NCT00711243|7277178|FG002|Started Treatment|Registed and Started Treatment||3
6366685|NCT00711243|7277179|FG003|Started Treatment|Registed and Started Treatment||3
6366686|NCT00711243|7277180|FG004|Started Treatment|Registed and Started Treatment||3
6366687|NCT00711243|7277181|FG005|Started Treatment|Registed and Started Treatment||43
6366688|NCT00711243|7277176|FG000|COMPLETED|Registed and Started Treatment||3
6366689|NCT00711243|7277177|FG001|COMPLETED|Registed and Started Treatment||3
6366690|NCT00711243|7277178|FG002|COMPLETED|Registed and Started Treatment||3
6366691|NCT00711243|7277179|FG003|COMPLETED|Registed and Started Treatment||3
6366692|NCT00711243|7277180|FG004|COMPLETED|Registed and Started Treatment||3
6366693|NCT00711243|7277181|FG005|COMPLETED|Registed and Started Treatment||43
6366694|NCT00711243|7277176|FG000|NOT COMPLETED|Registed and Started Treatment||0
6366695|NCT00711243|7277177|FG001|NOT COMPLETED|Registed and Started Treatment||0
6366696|NCT00711243|7277178|FG002|NOT COMPLETED|Registed and Started Treatment||0
6366697|NCT00711243|7277179|FG003|NOT COMPLETED|Registed and Started Treatment||0
6366698|NCT00711243|7277180|FG004|NOT COMPLETED|Registed and Started Treatment||0
6366699|NCT00711243|7277181|FG005|NOT COMPLETED|Registed and Started Treatment||1
6366700|NCT00711243|7277176|FG000|STARTED|Reached First Response/4 Cycles||3
6366701|NCT00711243|7277177|FG001|STARTED|Reached First Response/4 Cycles||3
6560806|NCT01789970|7483695|FG000|NOT COMPLETED|Open-label Titration Period||254
6560807|NCT01789970|7483696|FG001|NOT COMPLETED|Open-label Titration Period||0
6560808|NCT01789970|7483697|FG002|NOT COMPLETED|Open-label Titration Period||0
6366702|NCT00711243|7277178|FG002|STARTED|Reached First Response/4 Cycles||3
6366703|NCT00711243|7277179|FG003|STARTED|Reached First Response/4 Cycles||3
6366704|NCT00711243|7277180|FG004|STARTED|Reached First Response/4 Cycles||3
6366705|NCT00711243|7277181|FG005|STARTED|Reached First Response/4 Cycles||43
6366706|NCT00711243|7277176|FG000|COMPLETED|Reached First Response/4 Cycles||3
6366707|NCT00711243|7277177|FG001|COMPLETED|Reached First Response/4 Cycles||3
6366708|NCT00711243|7277178|FG002|COMPLETED|Reached First Response/4 Cycles||3
6366709|NCT00711243|7277179|FG003|COMPLETED|Reached First Response/4 Cycles||2
6366710|NCT00711243|7277180|FG004|COMPLETED|Reached First Response/4 Cycles||3
6366711|NCT00711243|7277181|FG005|COMPLETED|Reached First Response/4 Cycles||41
6366712|NCT00711243|7277176|FG000|NOT COMPLETED|Reached First Response/4 Cycles||0
6366713|NCT00711243|7277177|FG001|NOT COMPLETED|Reached First Response/4 Cycles||0
6366714|NCT00711243|7277178|FG002|NOT COMPLETED|Reached First Response/4 Cycles||0
6366715|NCT00711243|7277179|FG003|NOT COMPLETED|Reached First Response/4 Cycles||1
6366716|NCT00711243|7277180|FG004|NOT COMPLETED|Reached First Response/4 Cycles||0
6366717|NCT00711243|7277181|FG005|NOT COMPLETED|Reached First Response/4 Cycles||2
6366718|NCT00711243|7277176|FG000|STARTED|Treated Cycle 5 After First Response||3
6366719|NCT00711243|7277177|FG001|STARTED|Treated Cycle 5 After First Response||3
6366720|NCT00711243|7277178|FG002|STARTED|Treated Cycle 5 After First Response||3
6366721|NCT00711243|7277179|FG003|STARTED|Treated Cycle 5 After First Response||2
6366722|NCT00711243|7277180|FG004|STARTED|Treated Cycle 5 After First Response||3
6560809|NCT01789970|7483695|FG000|STARTED|Double-blind Treatment Period (12 Weeks)||0
6560810|NCT01789970|7483696|FG001|STARTED|Double-blind Treatment Period (12 Weeks)||180
6560811|NCT01789970|7483697|FG002|STARTED|Double-blind Treatment Period (12 Weeks)||191
6560812|NCT01789970|7483695|FG000|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
6560813|NCT01789970|7483696|FG001|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
6560814|NCT01789970|7483697|FG002|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
6560815|NCT01789970|7483695|FG000|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
6560816|NCT01789970|7483696|FG001|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
6366723|NCT00711243|7277181|FG005|STARTED|Treated Cycle 5 After First Response||41
6366724|NCT00711243|7277176|FG000|COMPLETED|Treated Cycle 5 After First Response||2
6366725|NCT00711243|7277177|FG001|COMPLETED|Treated Cycle 5 After First Response||1
6366726|NCT00711243|7277178|FG002|COMPLETED|Treated Cycle 5 After First Response||3
6366727|NCT00711243|7277179|FG003|COMPLETED|Treated Cycle 5 After First Response||2
6366728|NCT00711243|7277180|FG004|COMPLETED|Treated Cycle 5 After First Response||2
6366729|NCT00711243|7277181|FG005|COMPLETED|Treated Cycle 5 After First Response||37
6366730|NCT00711243|7277176|FG000|NOT COMPLETED|Treated Cycle 5 After First Response||1
6366731|NCT00711243|7277177|FG001|NOT COMPLETED|Treated Cycle 5 After First Response||2
6366732|NCT00711243|7277178|FG002|NOT COMPLETED|Treated Cycle 5 After First Response||0
6366733|NCT00711243|7277179|FG003|NOT COMPLETED|Treated Cycle 5 After First Response||0
6366734|NCT00711243|7277180|FG004|NOT COMPLETED|Treated Cycle 5 After First Response||1
6366735|NCT00711243|7277181|FG005|NOT COMPLETED|Treated Cycle 5 After First Response||4
6366736|NCT00711243|7277176|FG000|STARTED|Follow up Every 3 Months Until Death||3
6366737|NCT00711243|7277177|FG001|STARTED|Follow up Every 3 Months Until Death||3
6366738|NCT00711243|7277178|FG002|STARTED|Follow up Every 3 Months Until Death||3
6366739|NCT00711243|7277179|FG003|STARTED|Follow up Every 3 Months Until Death||3
6366740|NCT00711243|7277180|FG004|STARTED|Follow up Every 3 Months Until Death||3
6366741|NCT00711243|7277181|FG005|STARTED|Follow up Every 3 Months Until Death|4 patients died whilst on study and 1 patient did not get treated on study|39
6366742|NCT00711243|7277176|FG000|COMPLETED|Follow up Every 3 Months Until Death||3
6366743|NCT00711243|7277177|FG001|COMPLETED|Follow up Every 3 Months Until Death||3
6366744|NCT00711243|7277178|FG002|COMPLETED|Follow up Every 3 Months Until Death||3
6366745|NCT00711243|7277179|FG003|COMPLETED|Follow up Every 3 Months Until Death||3
6366746|NCT00711243|7277180|FG004|COMPLETED|Follow up Every 3 Months Until Death||3
6366747|NCT00711243|7277181|FG005|COMPLETED|Follow up Every 3 Months Until Death||37
6366748|NCT00711243|7277176|FG000|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6366749|NCT00711243|7277177|FG001|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6366750|NCT00711243|7277178|FG002|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6366751|NCT00711243|7277179|FG003|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6366752|NCT00711243|7277180|FG004|NOT COMPLETED|Follow up Every 3 Months Until Death||0
6366753|NCT00711243|7277181|FG005|NOT COMPLETED|Follow up Every 3 Months Until Death||2
6366754|NCT00711347|7277199|FG000|STARTED|Overall Study||14
6366755|NCT00711347|7277200|FG001|STARTED|Overall Study||14
6366756|NCT00711347|7277199|FG000|COMPLETED|Overall Study||14
6366757|NCT00711347|7277200|FG001|COMPLETED|Overall Study||14
6366758|NCT00711347|7277199|FG000|NOT COMPLETED|Overall Study||0
6366759|NCT00711347|7277200|FG001|NOT COMPLETED|Overall Study||0
6366760|NCT00711412|7277206|FG000|STARTED|Induction Treatment||44
6366761|NCT00711412|7277206|FG000|Registered to Study|Induction Treatment||44
6366762|NCT00711412|7277206|FG000|Started Induction Treatment|Induction Treatment||43
6366763|NCT00711412|7277206|FG000|COMPLETED|Induction Treatment||40
6366764|NCT00711412|7277206|FG000|NOT COMPLETED|Induction Treatment||4
6366765|NCT00711412|7277206|FG000|STARTED|Evaluated for Combination Treatment||40
6366766|NCT00711412|7277206|FG000|COMPLETED|Evaluated for Combination Treatment||34
6366767|NCT00711412|7277206|FG000|NOT COMPLETED|Evaluated for Combination Treatment||6
6366768|NCT00711412|7277206|FG000|STARTED|Combination Treatment||34
6366769|NCT00711412|7277206|FG000|COMPLETED|Combination Treatment||33
6366770|NCT00711412|7277206|FG000|NOT COMPLETED|Combination Treatment||1
6366771|NCT00711412|7277206|FG000|STARTED|Evaluation for Response and Surgery|1 patient only completed 2 cycles of therapy was evaluated and eligible for surgical resection.|34
6366772|NCT00711412|7277206|FG000|COMPLETED|Evaluation for Response and Surgery||28
6366773|NCT00711412|7277206|FG000|NOT COMPLETED|Evaluation for Response and Surgery||6
6366774|NCT00711412|7277206|FG000|STARTED|Survival Follow up Until Death|All patients that received treatment went into follow up period.|38
6366775|NCT00711412|7277206|FG000|COMPLETED|Survival Follow up Until Death||26
6366776|NCT00711412|7277206|FG000|NOT COMPLETED|Survival Follow up Until Death||12
6366777|NCT00711425|7277211|FG000|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
6366778|NCT00711425|7277211|FG000|COMPLETED|Overall Study||41
6366779|NCT00711425|7277211|FG000|NOT COMPLETED|Overall Study||4
6366780|NCT00711464|7277215|FG000|STARTED|Overall Study||29
6366781|NCT00711464|7277215|FG000|COMPLETED|Overall Study||29
6366782|NCT00711464|7277215|FG000|NOT COMPLETED|Overall Study||0
6366783|NCT00711477|7277227|FG000|STARTED|Overall Study||23
6366784|NCT00711477|7277228|FG001|STARTED|Overall Study||23
6366785|NCT00711477|7277227|FG000|COMPLETED|Overall Study||20
6366786|NCT00711477|7277228|FG001|COMPLETED|Overall Study||20
6366787|NCT00711477|7277227|FG000|NOT COMPLETED|Overall Study||3
6366788|NCT00711477|7277228|FG001|NOT COMPLETED|Overall Study||3
6366789|NCT00711490|7277236|FG000|STARTED|Overall Study||5
6366790|NCT00711490|7277236|FG000|COMPLETED|Overall Study||5
6366791|NCT00711490|7277236|FG000|NOT COMPLETED|Overall Study||0
6366792|NCT00711516|7277243|FG000|STARTED|Overall Study||21
6366793|NCT00711516|7277244|FG001|STARTED|Overall Study||19
6366794|NCT00711516|7277243|FG000|COMPLETED|Overall Study||20
6366795|NCT00711516|7277244|FG001|COMPLETED|Overall Study||16
6366796|NCT00711516|7277243|FG000|NOT COMPLETED|Overall Study||1
6366797|NCT00711516|7277244|FG001|NOT COMPLETED|Overall Study||3
6366798|NCT00711529|7277252|FG000|STARTED|Overall Study||13
6366799|NCT00711529|7277253|FG001|STARTED|Overall Study||14
6560817|NCT01789970|7483697|FG002|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
6366800|NCT00711529|7277252|FG000|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
6366801|NCT00711529|7277253|FG001|COMPLETED|Overall Study||8
6366802|NCT00711529|7277252|FG000|NOT COMPLETED|Overall Study||4
6366803|NCT00711529|7277253|FG001|NOT COMPLETED|Overall Study||6
6366804|NCT00711594|7277263|FG000|STARTED|Overall Study||3
6366805|NCT00711594|7277264|FG001|STARTED|Overall Study||3
6366806|NCT00711594|7277265|FG002|STARTED|Overall Study||6
6366807|NCT00711594|7277266|FG003|STARTED|Overall Study||62
6366808|NCT00711594|7277263|FG000|COMPLETED|Overall Study||0
6366809|NCT00711594|7277264|FG001|COMPLETED|Overall Study||0
6366810|NCT00711594|7277265|FG002|COMPLETED|Overall Study||0
6366811|NCT00711594|7277266|FG003|COMPLETED|Overall Study||0
6366812|NCT00711594|7277263|FG000|NOT COMPLETED|Overall Study||3
6366813|NCT00711594|7277264|FG001|NOT COMPLETED|Overall Study||3
6366814|NCT00711594|7277265|FG002|NOT COMPLETED|Overall Study||6
6366815|NCT00711594|7277266|FG003|NOT COMPLETED|Overall Study||62
6366816|NCT00711646|7277280|FG000|STARTED|Overall Study||124
6366817|NCT00711646|7277281|FG001|STARTED|Overall Study||65
6366818|NCT00711646|7277280|FG000|COMPLETED|Overall Study||112
6366819|NCT00711646|7277281|FG001|COMPLETED|Overall Study||62
6366820|NCT00711646|7277280|FG000|NOT COMPLETED|Overall Study||12
6366821|NCT00711646|7277281|FG001|NOT COMPLETED|Overall Study||3
6366822|NCT00711711|7277289|FG000|STARTED|Overall Study||30
6366823|NCT00711711|7277290|FG001|STARTED|Overall Study||30
6366824|NCT00711711|7277289|FG000|Second Postsurgical Day|Overall Study||30
6366825|NCT00711711|7277290|FG001|Second Postsurgical Day|Overall Study||30
6366826|NCT00711711|7277289|FG000|Seventh Postsurgical Day|Overall Study||29
6366827|NCT00711711|7277290|FG001|Seventh Postsurgical Day|Overall Study||27
6366828|NCT00711711|7277289|FG000|COMPLETED|Overall Study||29
6366829|NCT00711711|7277290|FG001|COMPLETED|Overall Study||24
6366830|NCT00711711|7277289|FG000|NOT COMPLETED|Overall Study||1
6366831|NCT00711711|7277290|FG001|NOT COMPLETED|Overall Study||6
6366832|NCT00711802|7277306|FG000|STARTED|Overall Study||75
6366833|NCT00711802|7277307|FG001|STARTED|Overall Study||38
6366834|NCT00711802|7277308|FG002|STARTED|Overall Study||75
6366835|NCT00711802|7277309|FG003|STARTED|Overall Study||38
6366836|NCT00711802|7277310|FG004|STARTED|Overall Study||83
6366837|NCT00711802|7277311|FG005|STARTED|Overall Study||42
6366838|NCT00711802|7277312|FG006|STARTED|Overall Study||30
6366839|NCT00711802|7277313|FG007|STARTED|Overall Study||15
6366840|NCT00711802|7277306|FG000|Received at Least 1 Dose of Study Drug|Overall Study||73
6366841|NCT00711802|7277307|FG001|Received at Least 1 Dose of Study Drug|Overall Study||37
6366842|NCT00711802|7277308|FG002|Received at Least 1 Dose of Study Drug|Overall Study||73
6366843|NCT00711802|7277309|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
6366844|NCT00711802|7277310|FG004|Received at Least 1 Dose of Study Drug|Overall Study||81
6366845|NCT00711802|7277311|FG005|Received at Least 1 Dose of Study Drug|Overall Study||42
6366846|NCT00711802|7277312|FG006|Received at Least 1 Dose of Study Drug|Overall Study||30
6366847|NCT00711802|7277313|FG007|Received at Least 1 Dose of Study Drug|Overall Study||15
6366848|NCT00711802|7277306|FG000|COMPLETED|Overall Study||73
6366849|NCT00711802|7277307|FG001|COMPLETED|Overall Study||32
6366850|NCT00711802|7277308|FG002|COMPLETED|Overall Study||69
6366851|NCT00711802|7277309|FG003|COMPLETED|Overall Study||35
6366852|NCT00711802|7277310|FG004|COMPLETED|Overall Study||69
6366853|NCT00711802|7277311|FG005|COMPLETED|Overall Study||34
6366854|NCT00711802|7277312|FG006|COMPLETED|Overall Study||25
6366855|NCT00711802|7277313|FG007|COMPLETED|Overall Study||13
6366856|NCT00711802|7277306|FG000|NOT COMPLETED|Overall Study||2
6366857|NCT00711802|7277307|FG001|NOT COMPLETED|Overall Study||6
6366858|NCT00711802|7277308|FG002|NOT COMPLETED|Overall Study||6
6366859|NCT00711802|7277309|FG003|NOT COMPLETED|Overall Study||3
6366860|NCT00711802|7277310|FG004|NOT COMPLETED|Overall Study||14
6366861|NCT00711802|7277311|FG005|NOT COMPLETED|Overall Study||8
6366862|NCT00711802|7277312|FG006|NOT COMPLETED|Overall Study||5
6366863|NCT00711802|7277313|FG007|NOT COMPLETED|Overall Study||2
6366864|NCT00711828|7277334|FG000|STARTED|Overall Study||21
6366865|NCT00711828|7277334|FG000|COMPLETED|Overall Study||21
6366866|NCT00711828|7277334|FG000|NOT COMPLETED|Overall Study||0
6366867|NCT00711867|7277340|FG000|STARTED|Overall Study||30
6366868|NCT00711867|7277341|FG001|STARTED|Overall Study||25
6366869|NCT00711867|7277340|FG000|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
6366870|NCT00711867|7277341|FG001|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
6366871|NCT00711867|7277340|FG000|NOT COMPLETED|Overall Study||5
6366872|NCT00711867|7277341|FG001|NOT COMPLETED|Overall Study||4
6366873|NCT00711880|7277349|FG000|STARTED|Overall Study||63
6366874|NCT00711880|7277350|FG001|STARTED|Overall Study||62
6560818|NCT01789970|7483695|FG000|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
6366875|NCT00711880|7277349|FG000|COMPLETED|Overall Study||50
6366876|NCT00711880|7277350|FG001|COMPLETED|Overall Study||55
6366877|NCT00711880|7277349|FG000|NOT COMPLETED|Overall Study||13
6366878|NCT00711880|7277350|FG001|NOT COMPLETED|Overall Study||7
6366879|NCT00711958|7277358|FG000|STARTED|Overall Study||74
6366880|NCT00711958|7277359|FG001|STARTED|Overall Study||40
6366881|NCT00711958|7277358|FG000|COMPLETED|Overall Study||41
6366882|NCT00711958|7277359|FG001|COMPLETED|Overall Study||17
6366883|NCT00711958|7277358|FG000|NOT COMPLETED|Overall Study||33
6366884|NCT00711958|7277359|FG001|NOT COMPLETED|Overall Study||23
6366885|NCT00711971|7277368|FG000|STARTED|Overall Study||42
6366886|NCT00711971|7277369|FG001|STARTED|Overall Study||42
6366887|NCT00711971|7277370|FG002|STARTED|Overall Study||42
6366888|NCT00711971|7277368|FG000|COMPLETED|Overall Study||39
6366889|NCT00711971|7277369|FG001|COMPLETED|Overall Study||38
6366890|NCT00711971|7277370|FG002|COMPLETED|Overall Study||41
6366891|NCT00711971|7277368|FG000|NOT COMPLETED|Overall Study||3
6366892|NCT00711971|7277369|FG001|NOT COMPLETED|Overall Study||4
6366893|NCT00711971|7277370|FG002|NOT COMPLETED|Overall Study||1
6366894|NCT00711997|7277384|FG000|STARTED|Overall Study||3
6366895|NCT00711997|7277385|FG001|STARTED|Overall Study||6
6366896|NCT00711997|7277384|FG000|COMPLETED|Overall Study||3
6366897|NCT00711997|7277385|FG001|COMPLETED|Overall Study||6
6366898|NCT00711997|7277384|FG000|NOT COMPLETED|Overall Study||0
6366899|NCT00711997|7277385|FG001|NOT COMPLETED|Overall Study||0
6366900|NCT00712010|7277393|FG000|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
6366901|NCT00712010|7277393|FG000|COMPLETED|1st Protein Testing (1 Day)||24
6366902|NCT00712010|7277393|FG000|NOT COMPLETED|1st Protein Testing (1 Day)||0
6366903|NCT00712010|7277393|FG000|STARTED|Washout (7 Days)||24
6366904|NCT00712010|7277393|FG000|COMPLETED|Washout (7 Days)||24
6366905|NCT00712010|7277393|FG000|NOT COMPLETED|Washout (7 Days)||0
6366906|NCT00712010|7277393|FG000|STARTED|2nd Protein Testing (1 Day)||24
6366907|NCT00712010|7277393|FG000|COMPLETED|2nd Protein Testing (1 Day)||24
6366908|NCT00712010|7277393|FG000|NOT COMPLETED|2nd Protein Testing (1 Day)||0
6366909|NCT00712010|7277393|FG000|STARTED|Washout (7 Days)||24
6366910|NCT00712010|7277393|FG000|COMPLETED|Washout (7 Days)||24
6366911|NCT00712010|7277393|FG000|NOT COMPLETED|Washout (7 Days)||0
6366912|NCT00712010|7277393|FG000|STARTED|3rd Protein Testing (1 Day)||24
6560819|NCT01789970|7483696|FG001|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
6777853|NCT03782571|7705790|FG002|STARTED|Period 4||6
6777854|NCT03782571|7705791|FG003|STARTED|Period 4||7
6366913|NCT00712010|7277393|FG000|COMPLETED|3rd Protein Testing (1 Day)||24
6366914|NCT00712010|7277393|FG000|NOT COMPLETED|3rd Protein Testing (1 Day)||0
6366915|NCT00712010|7277393|FG000|STARTED|Washout (7 Days)||24
6366916|NCT00712010|7277393|FG000|COMPLETED|Washout (7 Days)||24
6366917|NCT00712010|7277393|FG000|NOT COMPLETED|Washout (7 Days)||0
6366918|NCT00712010|7277393|FG000|STARTED|4th Protein Testing (1 Day)||24
6366919|NCT00712010|7277393|FG000|COMPLETED|4th Protein Testing (1 Day)||24
6366920|NCT00712010|7277393|FG000|NOT COMPLETED|4th Protein Testing (1 Day)||0
6366921|NCT00712010|7277393|FG000|STARTED|Washout (7 Days)||24
6366922|NCT00712010|7277393|FG000|COMPLETED|Washout (7 Days)||23
6366923|NCT00712010|7277393|FG000|NOT COMPLETED|Washout (7 Days)||1
6366924|NCT00712010|7277393|FG000|STARTED|5th Protein Testing (1 Day)||23
6366925|NCT00712010|7277393|FG000|COMPLETED|5th Protein Testing (1 Day)||23
6366926|NCT00712010|7277393|FG000|NOT COMPLETED|5th Protein Testing (1 Day)||0
6366927|NCT00712010|7277393|FG000|STARTED|Washout (7 Days)||23
6777855|NCT03782571|7705788|FG000|COMPLETED|Period 4||3
6777856|NCT03782571|7705789|FG001|COMPLETED|Period 4||6
6366928|NCT00712010|7277393|FG000|COMPLETED|Washout (7 Days)||23
6366929|NCT00712010|7277393|FG000|NOT COMPLETED|Washout (7 Days)||0
6366930|NCT00712010|7277393|FG000|STARTED|6th Protein Testing (1 Day)||23
6366931|NCT00712010|7277393|FG000|COMPLETED|6th Protein Testing (1 Day)||23
6366932|NCT00712010|7277393|FG000|NOT COMPLETED|6th Protein Testing (1 Day)||0
6366933|NCT00712010|7277393|FG000|STARTED|Washout (7 Days)||23
6366934|NCT00712010|7277393|FG000|COMPLETED|Washout (7 Days)||23
6366935|NCT00712010|7277393|FG000|NOT COMPLETED|Washout (7 Days)||0
6366936|NCT00712010|7277393|FG000|STARTED|7th and Last Protein Testing (1 Day)||23
6366937|NCT00712010|7277393|FG000|COMPLETED|7th and Last Protein Testing (1 Day)||23
6366938|NCT00712010|7277393|FG000|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
6366939|NCT00712075|7277412|FG000|STARTED|Overall Study||22
6366940|NCT00712075|7277413|FG001|STARTED|Overall Study||30
6366941|NCT00712075|7277414|FG002|STARTED|Overall Study||25
6366942|NCT00712075|7277412|FG000|COMPLETED|Overall Study||17
6366943|NCT00712075|7277413|FG001|COMPLETED|Overall Study||26
6366944|NCT00712075|7277414|FG002|COMPLETED|Overall Study||14
6366945|NCT00712075|7277412|FG000|NOT COMPLETED|Overall Study||5
6366946|NCT00712075|7277413|FG001|NOT COMPLETED|Overall Study||4
6560820|NCT01789970|7483697|FG002|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
6777857|NCT03782571|7705790|FG002|COMPLETED|Period 4||6
6777858|NCT03782571|7705791|FG003|COMPLETED|Period 4||7
6366947|NCT00712075|7277414|FG002|NOT COMPLETED|Overall Study||11
6366948|NCT00712166|7277424|FG000|STARTED|Overall Study||81
6366949|NCT00712166|7277425|FG001|STARTED|Overall Study||76
6366950|NCT00712166|7277424|FG000|COMPLETED|Overall Study||81
6366951|NCT00712166|7277425|FG001|COMPLETED|Overall Study||75
6366952|NCT00712166|7277424|FG000|NOT COMPLETED|Overall Study||0
6366953|NCT00712166|7277425|FG001|NOT COMPLETED|Overall Study||1
6777859|NCT03782571|7705788|FG000|NOT COMPLETED|Period 4||0
6366954|NCT00712179|7277433|FG000|STARTED|Overall Study||49
6366955|NCT00712179|7277433|FG000|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
6366956|NCT00712179|7277433|FG000|NOT COMPLETED|Overall Study||12
6366957|NCT00712244|7277441|FG000|STARTED|Overall Study||29
6366958|NCT00712244|7277442|FG001|STARTED|Overall Study||29
6366959|NCT00712244|7277443|FG002|STARTED|Overall Study||27
6366960|NCT00712244|7277444|FG003|STARTED|Overall Study||27
6560821|NCT01790048|7483713|FG000|STARTED|Overall Study||1156
6560822|NCT01790048|7483714|FG001|STARTED|Overall Study||1103
6560823|NCT01790048|7483713|FG000|COMPLETED|Overall Study||1144
6366961|NCT00712244|7277441|FG000|COMPLETED|Overall Study||25
6366962|NCT00712244|7277442|FG001|COMPLETED|Overall Study||28
6366963|NCT00712244|7277443|FG002|COMPLETED|Overall Study||25
6366964|NCT00712244|7277444|FG003|COMPLETED|Overall Study||26
6366965|NCT00712244|7277441|FG000|NOT COMPLETED|Overall Study||4
6366966|NCT00712244|7277442|FG001|NOT COMPLETED|Overall Study||1
6366967|NCT00712244|7277443|FG002|NOT COMPLETED|Overall Study||2
6366968|NCT00712244|7277444|FG003|NOT COMPLETED|Overall Study||1
6366969|NCT00712270|7277457|FG000|STARTED|Overall Study||21
6366970|NCT00712270|7277457|FG000|COMPLETED|Overall Study||7
6366971|NCT00712270|7277457|FG000|NOT COMPLETED|Overall Study||14
6366972|NCT00712296|7277471|FG000|STARTED|Phase I ( 1 Week)||12
6366973|NCT00712296|7277472|FG001|STARTED|Phase I ( 1 Week)||8
6366974|NCT00712296|7277473|FG002|STARTED|Phase I ( 1 Week)||0
6366975|NCT00712296|7277474|FG003|STARTED|Phase I ( 1 Week)||0
6366976|NCT00712296|7277475|FG004|STARTED|Phase I ( 1 Week)||0
6366977|NCT00712296|7277471|FG000|COMPLETED|Phase I ( 1 Week)||12
6366978|NCT00712296|7277472|FG001|COMPLETED|Phase I ( 1 Week)||8
6366979|NCT00712296|7277473|FG002|COMPLETED|Phase I ( 1 Week)||0
6366980|NCT00712296|7277474|FG003|COMPLETED|Phase I ( 1 Week)||0
6366981|NCT00712296|7277475|FG004|COMPLETED|Phase I ( 1 Week)||0
6366982|NCT00712296|7277471|FG000|NOT COMPLETED|Phase I ( 1 Week)||0
6366983|NCT00712296|7277472|FG001|NOT COMPLETED|Phase I ( 1 Week)||0
6366984|NCT00712296|7277473|FG002|NOT COMPLETED|Phase I ( 1 Week)||0
6366985|NCT00712296|7277474|FG003|NOT COMPLETED|Phase I ( 1 Week)||0
6366986|NCT00712296|7277475|FG004|NOT COMPLETED|Phase I ( 1 Week)||0
6366987|NCT00712296|7277471|FG000|STARTED|Phase II (28 Weeks)||0
6366988|NCT00712296|7277472|FG001|STARTED|Phase II (28 Weeks)||0
6366989|NCT00712296|7277473|FG002|STARTED|Phase II (28 Weeks)||15
6366990|NCT00712296|7277474|FG003|STARTED|Phase II (28 Weeks)||16
6366991|NCT00712296|7277475|FG004|STARTED|Phase II (28 Weeks)||15
6366992|NCT00712296|7277471|FG000|COMPLETED|Phase II (28 Weeks)||0
6366993|NCT00712296|7277472|FG001|COMPLETED|Phase II (28 Weeks)||0
6366994|NCT00712296|7277473|FG002|COMPLETED|Phase II (28 Weeks)|ASHMI/Placebo was discontinued on 9/29/10.20 participants were re-randomized into the Phase II.|2
6366995|NCT00712296|7277474|FG003|COMPLETED|Phase II (28 Weeks)||1
6366996|NCT00712296|7277475|FG004|COMPLETED|Phase II (28 Weeks)||3
6366997|NCT00712296|7277471|FG000|NOT COMPLETED|Phase II (28 Weeks)||0
6366998|NCT00712296|7277472|FG001|NOT COMPLETED|Phase II (28 Weeks)||0
6366999|NCT00712296|7277473|FG002|NOT COMPLETED|Phase II (28 Weeks)||13
6367000|NCT00712296|7277474|FG003|NOT COMPLETED|Phase II (28 Weeks)||15
6367001|NCT00712296|7277475|FG004|NOT COMPLETED|Phase II (28 Weeks)||12
6367002|NCT00712335|7277511|FG000|STARTED|Overall Study||8
6367003|NCT00712335|7277512|FG001|STARTED|Overall Study||32
6367004|NCT00712335|7277513|FG002|STARTED|Overall Study||11
6367005|NCT00712335|7277514|FG003|STARTED|Overall Study||24
6367006|NCT00712335|7277515|FG004|STARTED|Overall Study||30
6367007|NCT00712335|7277511|FG000|COMPLETED|Overall Study||5
6367008|NCT00712335|7277512|FG001|COMPLETED|Overall Study||15
6367009|NCT00712335|7277513|FG002|COMPLETED|Overall Study||6
6367010|NCT00712335|7277514|FG003|COMPLETED|Overall Study||19
6367011|NCT00712335|7277515|FG004|COMPLETED|Overall Study||30
6367012|NCT00712335|7277511|FG000|NOT COMPLETED|Overall Study||3
6367013|NCT00712335|7277512|FG001|NOT COMPLETED|Overall Study||17
6367014|NCT00712335|7277513|FG002|NOT COMPLETED|Overall Study||5
6367015|NCT00712335|7277514|FG003|NOT COMPLETED|Overall Study||5
6367016|NCT00712335|7277515|FG004|NOT COMPLETED|Overall Study||0
6367017|NCT00712348|7277527|FG000|STARTED|Overall Study||31
6367018|NCT00712348|7277527|FG000|COMPLETED|Overall Study||30
6367019|NCT00712348|7277527|FG000|NOT COMPLETED|Overall Study||1
6367020|NCT00712530|7277534|FG000|STARTED|Overall Study||3
6367021|NCT00712530|7277535|FG001|STARTED|Overall Study||3
6367022|NCT00712530|7277536|FG002|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
6367023|NCT00712530|7277534|FG000|COMPLETED|Overall Study||3
6367024|NCT00712530|7277535|FG001|COMPLETED|Overall Study||3
6367025|NCT00712530|7277536|FG002|COMPLETED|Overall Study||3
6367026|NCT00712530|7277534|FG000|NOT COMPLETED|Overall Study||0
6367027|NCT00712530|7277535|FG001|NOT COMPLETED|Overall Study||0
6367028|NCT00712530|7277536|FG002|NOT COMPLETED|Overall Study||0
6367029|NCT00712543|7277546|FG000|STARTED|Day 1-7||23
6367030|NCT00712543|7277547|FG001|STARTED|Day 1-7||27
6367031|NCT00712543|7277546|FG000|COMPLETED|Day 1-7||23
6367032|NCT00712543|7277547|FG001|COMPLETED|Day 1-7||27
6367033|NCT00712543|7277546|FG000|NOT COMPLETED|Day 1-7||0
6367034|NCT00712543|7277547|FG001|NOT COMPLETED|Day 1-7||0
6367035|NCT00712543|7277546|FG000|STARTED|Day 8-14||23
6367036|NCT00712543|7277547|FG001|STARTED|Day 8-14||27
6367037|NCT00712543|7277546|FG000|COMPLETED|Day 8-14||23
6367038|NCT00712543|7277547|FG001|COMPLETED|Day 8-14||25
6367039|NCT00712543|7277546|FG000|NOT COMPLETED|Day 8-14||0
6367040|NCT00712543|7277547|FG001|NOT COMPLETED|Day 8-14||2
6367041|NCT00712673|7277556|FG000|STARTED|Overall Study|Randomized.|85
6367042|NCT00712673|7277557|FG001|STARTED|Overall Study||85
6367043|NCT00712673|7277558|FG002|STARTED|Overall Study||255
6367044|NCT00712673|7277559|FG003|STARTED|Overall Study||255
6367045|NCT00712673|7277556|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
6367046|NCT00712673|7277557|FG001|Safety Population|Overall Study||85
6367047|NCT00712673|7277558|FG002|Safety Population|Overall Study||255
6367048|NCT00712673|7277559|FG003|Safety Population|Overall Study||255
6367049|NCT00712673|7277556|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
6367050|NCT00712673|7277557|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||85
6367051|NCT00712673|7277558|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||255
6367052|NCT00712673|7277559|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||255
6367053|NCT00712673|7277556|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
6367054|NCT00712673|7277557|FG001|Subgroup for Standardized Meal Test|Overall Study||0
6367055|NCT00712673|7277558|FG002|Subgroup for Standardized Meal Test|Overall Study||255
6367056|NCT00712673|7277559|FG003|Subgroup for Standardized Meal Test|Overall Study||0
6367057|NCT00712673|7277556|FG000|COMPLETED|Overall Study||64
6367058|NCT00712673|7277557|FG001|COMPLETED|Overall Study||64
6367059|NCT00712673|7277558|FG002|COMPLETED|Overall Study||198
6367060|NCT00712673|7277559|FG003|COMPLETED|Overall Study||185
6367061|NCT00712673|7277556|FG000|NOT COMPLETED|Overall Study||21
6367062|NCT00712673|7277557|FG001|NOT COMPLETED|Overall Study||21
6367063|NCT00712673|7277558|FG002|NOT COMPLETED|Overall Study||57
6367064|NCT00712673|7277559|FG003|NOT COMPLETED|Overall Study||70
6367065|NCT00712712|7277578|FG000|STARTED|Overall Study||78
6367066|NCT00712712|7277578|FG000|COMPLETED|Overall Study||55
6367067|NCT00712712|7277578|FG000|NOT COMPLETED|Overall Study||23
6367068|NCT00712725|7277590|FG000|STARTED|Overall Study||169
6367069|NCT00712725|7277591|FG001|STARTED|Overall Study||39
6367070|NCT00712725|7277592|FG002|STARTED|Overall Study||57
6367071|NCT00712725|7277593|FG003|STARTED|Overall Study||84
6367072|NCT00712725|7277594|FG004|STARTED|Overall Study||86
6367073|NCT00712725|7277595|FG005|STARTED|Overall Study||84
6367074|NCT00712725|7277596|FG006|STARTED|Overall Study||83
6367075|NCT00712725|7277597|FG007|STARTED|Overall Study||74
6367076|NCT00712725|7277590|FG000|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
6367077|NCT00712725|7277591|FG001|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
6367078|NCT00712725|7277592|FG002|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
6367079|NCT00712725|7277593|FG003|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
6367080|NCT00712725|7277594|FG004|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
6367081|NCT00712725|7277595|FG005|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
6367082|NCT00712725|7277596|FG006|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
6367083|NCT00712725|7277597|FG007|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
6367084|NCT00712725|7277590|FG000|NOT COMPLETED|Overall Study||29
6367085|NCT00712725|7277591|FG001|NOT COMPLETED|Overall Study||6
6367086|NCT00712725|7277592|FG002|NOT COMPLETED|Overall Study||10
6367087|NCT00712725|7277593|FG003|NOT COMPLETED|Overall Study||17
6367088|NCT00712725|7277594|FG004|NOT COMPLETED|Overall Study||19
6367089|NCT00712725|7277595|FG005|NOT COMPLETED|Overall Study||16
6367090|NCT00712725|7277596|FG006|NOT COMPLETED|Overall Study||22
6367091|NCT00712725|7277597|FG007|NOT COMPLETED|Overall Study||11
6367092|NCT00712920|7277618|FG000|STARTED|Overall Study||192
6367093|NCT00712920|7277619|FG001|STARTED|Overall Study|3 subjects were randomized in error|197
6367094|NCT00712920|7277620|FG002|STARTED|Overall Study||192
6367095|NCT00712920|7277618|FG000|COMPLETED|Overall Study||175
6367096|NCT00712920|7277619|FG001|COMPLETED|Overall Study||180
6367097|NCT00712920|7277620|FG002|COMPLETED|Overall Study||180
6367098|NCT00712920|7277618|FG000|NOT COMPLETED|Overall Study||17
6367099|NCT00712920|7277619|FG001|NOT COMPLETED|Overall Study||17
6367100|NCT00712920|7277620|FG002|NOT COMPLETED|Overall Study||12
6367101|NCT00712959|7277630|FG000|STARTED|Overall Study||361
6367102|NCT00712959|7277631|FG001|STARTED|Overall Study||407
6367103|NCT00712959|7277630|FG000|COMPLETED|Overall Study||342
6367104|NCT00712959|7277631|FG001|COMPLETED|Overall Study||404
6367105|NCT00712959|7277630|FG000|NOT COMPLETED|Overall Study||19
6367106|NCT00712959|7277631|FG001|NOT COMPLETED|Overall Study||3
6367107|NCT00712985|7277637|FG000|STARTED|Overall Study||18
6367108|NCT00712985|7277637|FG000|COMPLETED|Overall Study||13
6367109|NCT00712985|7277637|FG000|NOT COMPLETED|Overall Study||5
6560824|NCT01790048|7483714|FG001|COMPLETED|Overall Study||1086
6560825|NCT01790048|7483713|FG000|NOT COMPLETED|Overall Study||12
6367110|NCT00713219|7277641|FG000|STARTED|Overall Study||14
6367111|NCT00713219|7277641|FG000|COMPLETED|Overall Study||12
6367112|NCT00713219|7277641|FG000|NOT COMPLETED|Overall Study||2
6367113|NCT00713284|7277645|FG000|STARTED|Overall Study|29 participants were screened but only 13 eligible for conversion and continue in the study.|29
6367114|NCT00713284|7277645|FG000|COMPLETED|Overall Study||13
6560826|NCT01790048|7483714|FG001|NOT COMPLETED|Overall Study||17
6367115|NCT00713284|7277645|FG000|NOT COMPLETED|Overall Study||16
6367116|NCT00713310|7277651|FG000|STARTED|Overall Study||41
6367117|NCT00713310|7277652|FG001|STARTED|Overall Study||42
6367118|NCT00713310|7277651|FG000|mITT Population|Overall Study||41
6367119|NCT00713310|7277652|FG001|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
6367120|NCT00713310|7277651|FG000|COMPLETED|Overall Study||36
6367121|NCT00713310|7277652|FG001|COMPLETED|Overall Study||36
6367122|NCT00713310|7277651|FG000|NOT COMPLETED|Overall Study||5
6367123|NCT00713310|7277652|FG001|NOT COMPLETED|Overall Study||6
6367124|NCT00713323|7277658|FG000|STARTED|Overall Study||380
6367125|NCT00713323|7277658|FG000|COMPLETED|Overall Study||234
6367126|NCT00713323|7277658|FG000|NOT COMPLETED|Overall Study||146
6367127|NCT00713349|7277662|FG000|STARTED|Overall Study||25
6367128|NCT00713349|7277662|FG000|COMPLETED|Overall Study||24
6367129|NCT00713349|7277662|FG000|NOT COMPLETED|Overall Study||1
6367130|NCT00713427|7277668|FG000|STARTED|Overall Study||70
6367131|NCT00713427|7277668|FG000|COMPLETED|Overall Study||66
6367132|NCT00713427|7277668|FG000|NOT COMPLETED|Overall Study||4
6367133|NCT00713479|7277672|FG000|STARTED|First Medication Condition||6
6367134|NCT00713479|7277673|FG001|STARTED|First Medication Condition||6
6367135|NCT00713479|7277672|FG000|COMPLETED|First Medication Condition||2
6367136|NCT00713479|7277673|FG001|COMPLETED|First Medication Condition||6
6367137|NCT00713479|7277672|FG000|NOT COMPLETED|First Medication Condition||4
6367138|NCT00713479|7277673|FG001|NOT COMPLETED|First Medication Condition||0
6367139|NCT00713479|7277672|FG000|STARTED|Washout||2
6367140|NCT00713479|7277673|FG001|STARTED|Washout||6
6367141|NCT00713479|7277672|FG000|COMPLETED|Washout||2
6367142|NCT00713479|7277673|FG001|COMPLETED|Washout||6
6367143|NCT00713479|7277672|FG000|NOT COMPLETED|Washout||0
6367144|NCT00713479|7277673|FG001|NOT COMPLETED|Washout||0
6367145|NCT00713479|7277672|FG000|STARTED|Next Medication Condition||2
6367146|NCT00713479|7277673|FG001|STARTED|Next Medication Condition||6
6367147|NCT00713479|7277672|FG000|COMPLETED|Next Medication Condition||2
6367148|NCT00713479|7277673|FG001|COMPLETED|Next Medication Condition||6
6367149|NCT00713479|7277672|FG000|NOT COMPLETED|Next Medication Condition||0
6367150|NCT00713479|7277673|FG001|NOT COMPLETED|Next Medication Condition||0
6367151|NCT00713544|7277687|FG000|STARTED|Overall Study||52
6367152|NCT00713544|7277688|FG001|STARTED|Overall Study||52
6367153|NCT00713544|7277689|FG002|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
6367154|NCT00713544|7277690|FG003|STARTED|Overall Study||76
6367155|NCT00713544|7277691|FG004|STARTED|Overall Study||65
6367156|NCT00713544|7277692|FG005|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
6367157|NCT00713544|7277687|FG000|COMPLETED|Overall Study||45
6367158|NCT00713544|7277688|FG001|COMPLETED|Overall Study||46
6367159|NCT00713544|7277689|FG002|COMPLETED|Overall Study||41
6367160|NCT00713544|7277690|FG003|COMPLETED|Overall Study||66
6367161|NCT00713544|7277691|FG004|COMPLETED|Overall Study||57
6367162|NCT00713544|7277692|FG005|COMPLETED|Overall Study||67
6367163|NCT00713544|7277687|FG000|NOT COMPLETED|Overall Study||7
6367164|NCT00713544|7277688|FG001|NOT COMPLETED|Overall Study||6
6367165|NCT00713544|7277689|FG002|NOT COMPLETED|Overall Study||11
6367166|NCT00713544|7277690|FG003|NOT COMPLETED|Overall Study||10
6367167|NCT00713544|7277691|FG004|NOT COMPLETED|Overall Study||8
6367168|NCT00713544|7277692|FG005|NOT COMPLETED|Overall Study||9
6367169|NCT00713583|7277708|FG000|STARTED|Overall Study||45
6367170|NCT00713583|7277709|FG001|STARTED|Overall Study||40
6367171|NCT00713583|7277708|FG000|COMPLETED|Overall Study||45
6367172|NCT00713583|7277709|FG001|COMPLETED|Overall Study||40
6367173|NCT00713583|7277708|FG000|NOT COMPLETED|Overall Study||0
6367174|NCT00713583|7277709|FG001|NOT COMPLETED|Overall Study||0
6367175|NCT00713609|7277721|FG000|STARTED|Overall Study||106
6367176|NCT00713609|7277722|FG001|STARTED|Overall Study||105
6367177|NCT00713609|7277723|FG002|STARTED|Overall Study||107
6367178|NCT00713609|7277724|FG003|STARTED|Overall Study||108
6367179|NCT00713609|7277725|FG004|STARTED|Overall Study||106
6367180|NCT00713609|7277726|FG005|STARTED|Overall Study||55
6367181|NCT00713609|7277721|FG000|COMPLETED|Overall Study||85
6367182|NCT00713609|7277722|FG001|COMPLETED|Overall Study||90
6367183|NCT00713609|7277723|FG002|COMPLETED|Overall Study||92
6367184|NCT00713609|7277724|FG003|COMPLETED|Overall Study||99
6367185|NCT00713609|7277725|FG004|COMPLETED|Overall Study||87
6367186|NCT00713609|7277726|FG005|COMPLETED|Overall Study||47
6367187|NCT00713609|7277721|FG000|NOT COMPLETED|Overall Study||21
6367188|NCT00713609|7277722|FG001|NOT COMPLETED|Overall Study||15
6367189|NCT00713609|7277723|FG002|NOT COMPLETED|Overall Study||15
6367190|NCT00713609|7277724|FG003|NOT COMPLETED|Overall Study||9
6367191|NCT00713609|7277725|FG004|NOT COMPLETED|Overall Study||19
6367192|NCT00713609|7277726|FG005|NOT COMPLETED|Overall Study||8
6367193|NCT00713648|7277740|FG000|STARTED|Overall Study||41
6367194|NCT00713648|7277740|FG000|COMPLETED|Overall Study||33
6367195|NCT00713648|7277740|FG000|NOT COMPLETED|Overall Study||8
6367196|NCT00713661|7277748|FG000|STARTED|Overall Study||7
6367197|NCT00713661|7277749|FG001|STARTED|Overall Study||9
6367198|NCT00713661|7277750|FG002|STARTED|Overall Study||4
6367199|NCT00713661|7277751|FG003|STARTED|Overall Study||5
6367200|NCT00713661|7277748|FG000|COMPLETED|Overall Study||7
6367201|NCT00713661|7277749|FG001|COMPLETED|Overall Study||9
6367202|NCT00713661|7277750|FG002|COMPLETED|Overall Study||4
6367203|NCT00713661|7277751|FG003|COMPLETED|Overall Study||5
6367204|NCT00713661|7277748|FG000|NOT COMPLETED|Overall Study||0
6367205|NCT00713661|7277749|FG001|NOT COMPLETED|Overall Study||0
6367206|NCT00713661|7277750|FG002|NOT COMPLETED|Overall Study||0
6367207|NCT00713661|7277751|FG003|NOT COMPLETED|Overall Study||0
6367208|NCT00713700|7277761|FG000|STARTED|Overall Study||192
6367209|NCT00713700|7277761|FG000|COMPLETED|Overall Study||188
6367210|NCT00713700|7277761|FG000|NOT COMPLETED|Overall Study||4
6367211|NCT00713817|7277767|FG000|STARTED|Overall Study||10
6367212|NCT00713817|7277768|FG001|STARTED|Overall Study||9
6367213|NCT00713817|7277767|FG000|COMPLETED|Overall Study||10
6367214|NCT00713817|7277768|FG001|COMPLETED|Overall Study||9
6367215|NCT00713817|7277767|FG000|NOT COMPLETED|Overall Study||0
6367216|NCT00713817|7277768|FG001|NOT COMPLETED|Overall Study||0
6367217|NCT00713830|7277776|FG000|STARTED|Overall Study|Randomized.|286
6367218|NCT00713830|7277777|FG001|STARTED|Overall Study||573
6367219|NCT00713830|7277776|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
6367220|NCT00713830|7277777|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||570
6367221|NCT00713830|7277776|FG000|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
6367222|NCT00713830|7277777|FG001|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
6367223|NCT00713830|7277776|FG000|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
6367224|NCT00713830|7277777|FG001|Subgroup for Standardized Meal Test|Overall Study||313
6367225|NCT00713830|7277776|FG000|COMPLETED|Overall Study||204
6367226|NCT00713830|7277777|FG001|COMPLETED|Overall Study||396
6367227|NCT00713830|7277776|FG000|NOT COMPLETED|Overall Study||82
6367228|NCT00713830|7277777|FG001|NOT COMPLETED|Overall Study||177
6367229|NCT00714051|7277785|FG000|STARTED|Overall Study||27
6367230|NCT00714051|7277786|FG001|STARTED|Overall Study||28
6367231|NCT00714051|7277785|FG000|COMPLETED|Overall Study||26
6367232|NCT00714051|7277786|FG001|COMPLETED|Overall Study||27
6367233|NCT00714051|7277785|FG000|NOT COMPLETED|Overall Study||1
6367234|NCT00714051|7277786|FG001|NOT COMPLETED|Overall Study||1
6367235|NCT00714168|7277794|FG000|STARTED|Overall Study||165
6367236|NCT00714168|7277795|FG001|STARTED|Overall Study||198
6367237|NCT00714168|7277794|FG000|COMPLETED|Overall Study||121
6367238|NCT00714168|7277795|FG001|COMPLETED|Overall Study||139
6367239|NCT00714168|7277794|FG000|NOT COMPLETED|Overall Study||44
6367240|NCT00714168|7277795|FG001|NOT COMPLETED|Overall Study||59
6367241|NCT00714233|7277805|FG000|STARTED|Overall Study||10
6367242|NCT00714233|7277806|FG001|STARTED|Overall Study||11
6367243|NCT00714233|7277807|FG002|STARTED|Overall Study||11
6367244|NCT00714233|7277808|FG003|STARTED|Overall Study||10
6367245|NCT00714233|7277805|FG000|COMPLETED|Overall Study||6
6367246|NCT00714233|7277806|FG001|COMPLETED|Overall Study||10
6367247|NCT00714233|7277807|FG002|COMPLETED|Overall Study||10
6367248|NCT00714233|7277808|FG003|COMPLETED|Overall Study||6
6367249|NCT00714233|7277805|FG000|NOT COMPLETED|Overall Study||4
6367250|NCT00714233|7277806|FG001|NOT COMPLETED|Overall Study||1
6367251|NCT00714233|7277807|FG002|NOT COMPLETED|Overall Study||1
6367252|NCT00714233|7277808|FG003|NOT COMPLETED|Overall Study||4
6367253|NCT00714259|7277823|FG000|STARTED|Overall Study||5
6367254|NCT00714259|7277823|FG000|COMPLETED|Overall Study||3
6367255|NCT00714259|7277823|FG000|NOT COMPLETED|Overall Study||2
6367256|NCT00714272|7277829|FG000|STARTED|Overall Study||2
6367257|NCT00714272|7277830|FG001|STARTED|Overall Study||2
6367258|NCT00714272|7277829|FG000|COMPLETED|Overall Study||2
6367259|NCT00714272|7277830|FG001|COMPLETED|Overall Study||2
6367260|NCT00714272|7277829|FG000|NOT COMPLETED|Overall Study||0
6367261|NCT00714272|7277830|FG001|NOT COMPLETED|Overall Study||0
6367262|NCT00714285|7277840|FG000|STARTED|Overall Study||105
6367263|NCT00714285|7277841|FG001|STARTED|Overall Study||105
6367264|NCT00714285|7277842|FG002|STARTED|Overall Study||105
6367265|NCT00714285|7277843|FG003|STARTED|Overall Study||105
6367266|NCT00714285|7277840|FG000|COMPLETED|Overall Study|Completed upto Day 180|105
6560827|NCT01790113|7483724|FG000|STARTED|Overall Study||79
6560828|NCT01790113|7483725|FG001|STARTED|Overall Study||224
6560829|NCT01790113|7483724|FG000|COMPLETED|Overall Study||76
6560830|NCT01790113|7483725|FG001|COMPLETED|Overall Study||149
6655113|NCT02450578|7585145|FG001|STARTED|Overall Study||6
6655114|NCT02450578|7585146|FG002|STARTED|Overall Study||6
6655115|NCT02450578|7585147|FG003|STARTED|Overall Study||4
6655116|NCT02450578|7585144|FG000|COMPLETED|Overall Study||5
6655117|NCT02450578|7585145|FG001|COMPLETED|Overall Study||6
6367267|NCT00714285|7277841|FG001|COMPLETED|Overall Study|Completed upto Day 180|102
6367268|NCT00714285|7277842|FG002|COMPLETED|Overall Study|Completed upto Day 180|105
6367269|NCT00714285|7277843|FG003|COMPLETED|Overall Study|Completed upto Day 180|104
6367270|NCT00714285|7277840|FG000|NOT COMPLETED|Overall Study||0
6367271|NCT00714285|7277841|FG001|NOT COMPLETED|Overall Study||3
6367272|NCT00714285|7277842|FG002|NOT COMPLETED|Overall Study||0
6367273|NCT00714285|7277843|FG003|NOT COMPLETED|Overall Study||1
6367274|NCT00714311|7277857|FG000|STARTED|Overall Study||52
6367275|NCT00714311|7277858|FG001|STARTED|Overall Study||52
6367276|NCT00714311|7277857|FG000|COMPLETED|Overall Study||39
6367277|NCT00714311|7277858|FG001|COMPLETED|Overall Study||30
6367278|NCT00714311|7277857|FG000|NOT COMPLETED|Overall Study||13
6367279|NCT00714311|7277858|FG001|NOT COMPLETED|Overall Study||22
6367280|NCT00714389|7277864|FG000|STARTED|Overall Study||12
6560831|NCT01790113|7483724|FG000|NOT COMPLETED|Overall Study||3
6655118|NCT02450578|7585146|FG002|COMPLETED|Overall Study||6
6367281|NCT00714389|7277864|FG000|COMPLETED|Overall Study||12
6367282|NCT00714389|7277864|FG000|NOT COMPLETED|Overall Study||0
6367283|NCT00714415|7277870|FG000|STARTED|Overall Study||25
6367284|NCT00714415|7277871|FG001|STARTED|Overall Study||55
6367285|NCT00714415|7277870|FG000|COMPLETED|Overall Study||23
6367286|NCT00714415|7277871|FG001|COMPLETED|Overall Study||55
6367287|NCT00714415|7277870|FG000|NOT COMPLETED|Overall Study||2
6367288|NCT00714415|7277871|FG001|NOT COMPLETED|Overall Study||0
6367289|NCT00714493|7277877|FG000|STARTED|Overall Study||203
6367290|NCT00714493|7277877|FG000|COMPLETED|Overall Study||154
6367291|NCT00714493|7277877|FG000|NOT COMPLETED|Overall Study||49
6367292|NCT00714571|7277887|FG000|STARTED|Stage 1||12
6367293|NCT00714571|7277888|FG001|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
6367294|NCT00714571|7277889|FG002|STARTED|Stage 1||11
6367295|NCT00714571|7277890|FG003|STARTED|Stage 1||14
6367296|NCT00714571|7277891|FG004|STARTED|Stage 1||0
6367297|NCT00714571|7277892|FG005|STARTED|Stage 1||0
6367298|NCT00714571|7277887|FG000|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
6367299|NCT00714571|7277888|FG001|COMPLETED|Stage 1||15
6367300|NCT00714571|7277889|FG002|COMPLETED|Stage 1||10
6367301|NCT00714571|7277890|FG003|COMPLETED|Stage 1||14
6367302|NCT00714571|7277891|FG004|COMPLETED|Stage 1||0
6367303|NCT00714571|7277892|FG005|COMPLETED|Stage 1||0
6367304|NCT00714571|7277887|FG000|NOT COMPLETED|Stage 1||0
6367305|NCT00714571|7277888|FG001|NOT COMPLETED|Stage 1||0
6367306|NCT00714571|7277889|FG002|NOT COMPLETED|Stage 1||1
6367307|NCT00714571|7277890|FG003|NOT COMPLETED|Stage 1||0
6367308|NCT00714571|7277891|FG004|NOT COMPLETED|Stage 1||0
6367309|NCT00714571|7277892|FG005|NOT COMPLETED|Stage 1||0
6367310|NCT00714571|7277887|FG000|STARTED|Stage 2||0
6367311|NCT00714571|7277888|FG001|STARTED|Stage 2||0
6367312|NCT00714571|7277889|FG002|STARTED|Stage 2||0
6367313|NCT00714571|7277890|FG003|STARTED|Stage 2||0
6367314|NCT00714571|7277891|FG004|STARTED|Stage 2||15
6367315|NCT00714571|7277892|FG005|STARTED|Stage 2||15
6367316|NCT00714571|7277887|FG000|COMPLETED|Stage 2||0
6367317|NCT00714571|7277888|FG001|COMPLETED|Stage 2||0
6367318|NCT00714571|7277889|FG002|COMPLETED|Stage 2||0
6367319|NCT00714571|7277890|FG003|COMPLETED|Stage 2||0
6367320|NCT00714571|7277891|FG004|COMPLETED|Stage 2||15
6367321|NCT00714571|7277892|FG005|COMPLETED|Stage 2||15
6367322|NCT00714571|7277887|FG000|NOT COMPLETED|Stage 2||0
6367323|NCT00714571|7277888|FG001|NOT COMPLETED|Stage 2||0
6367324|NCT00714571|7277889|FG002|NOT COMPLETED|Stage 2||0
6367325|NCT00714571|7277890|FG003|NOT COMPLETED|Stage 2||0
6367326|NCT00714571|7277891|FG004|NOT COMPLETED|Stage 2||0
6367327|NCT00714571|7277892|FG005|NOT COMPLETED|Stage 2||0
6367328|NCT00714688|7277909|FG000|STARTED|Overall Study||97
6367329|NCT00714688|7277910|FG001|STARTED|Overall Study||90
6367330|NCT00714688|7277911|FG002|STARTED|Overall Study||92
6367331|NCT00714688|7277909|FG000|COMPLETED|Overall Study||68
6367332|NCT00714688|7277910|FG001|COMPLETED|Overall Study||55
6367333|NCT00714688|7277911|FG002|COMPLETED|Overall Study||55
6367334|NCT00714688|7277909|FG000|NOT COMPLETED|Overall Study||29
6367335|NCT00714688|7277910|FG001|NOT COMPLETED|Overall Study||35
6367336|NCT00714688|7277911|FG002|NOT COMPLETED|Overall Study||37
6367337|NCT00714714|7277919|FG000|STARTED|Overall Study||25
6367338|NCT00714714|7277919|FG000|COMPLETED|Overall Study||24
6367339|NCT00714714|7277919|FG000|NOT COMPLETED|Overall Study||1
6367340|NCT00714753|7277925|FG000|STARTED|Overall Study||5
6367341|NCT00714753|7277925|FG000|HDR Brachytherapy|Overall Study||5
6367342|NCT00714753|7277925|FG000|External Beam Radiotherapy (EBRT)|Overall Study||1
6367343|NCT00714753|7277925|FG000|COMPLETED|Overall Study||5
6367344|NCT00714753|7277925|FG000|NOT COMPLETED|Overall Study||0
6367345|NCT00714792|7277931|FG000|STARTED|Overall Study||10
6367346|NCT00714792|7277932|FG001|STARTED|Overall Study||8
6367347|NCT00714792|7277931|FG000|COMPLETED|Overall Study||10
6367348|NCT00714792|7277932|FG001|COMPLETED|Overall Study||8
6367349|NCT00714792|7277931|FG000|NOT COMPLETED|Overall Study||0
6367350|NCT00714792|7277932|FG001|NOT COMPLETED|Overall Study||0
6367351|NCT00714870|7277940|FG000|STARTED|Overall Study||49
6367352|NCT00714870|7277941|FG001|STARTED|Overall Study||27
6367353|NCT00714870|7277940|FG000|COMPLETED|Overall Study||22
6367354|NCT00714870|7277941|FG001|COMPLETED|Overall Study||22
6367355|NCT00714870|7277940|FG000|NOT COMPLETED|Overall Study||27
6367356|NCT00714870|7277941|FG001|NOT COMPLETED|Overall Study||5
6367357|NCT00715026|7277947|FG000|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
6367358|NCT00715026|7277947|FG000|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
6367359|NCT00715026|7277947|FG000|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
6367360|NCT00715026|7277947|FG000|NOT COMPLETED|Overall Study||10
6367361|NCT00715078|7277954|FG000|STARTED|Overall Study||41
6367362|NCT00715078|7277955|FG001|STARTED|Overall Study||40
6367363|NCT00715078|7277956|FG002|STARTED|Overall Study||41
6367364|NCT00715078|7277954|FG000|Received ≥ 1 Study Infusion|Overall Study||40
6367365|NCT00715078|7277955|FG001|Received ≥ 1 Study Infusion|Overall Study||40
6367366|NCT00715078|7277956|FG002|Received ≥ 1 Study Infusion|Overall Study||39
6367367|NCT00715078|7277954|FG000|Received ≥ 1 Leukapheresis|Overall Study||40
6367368|NCT00715078|7277955|FG001|Received ≥ 1 Leukapheresis|Overall Study||40
6367369|NCT00715078|7277956|FG002|Received ≥ 1 Leukapheresis|Overall Study||40
6367370|NCT00715078|7277954|FG000|COMPLETED|Overall Study||11
6367371|NCT00715078|7277955|FG001|COMPLETED|Overall Study||4
6367372|NCT00715078|7277956|FG002|COMPLETED|Overall Study||3
6367373|NCT00715078|7277954|FG000|NOT COMPLETED|Overall Study||30
6367374|NCT00715078|7277955|FG001|NOT COMPLETED|Overall Study||36
6367375|NCT00715078|7277956|FG002|NOT COMPLETED|Overall Study||38
6367376|NCT00715104|7277967|FG000|STARTED|Overall Study||18
6367377|NCT00715104|7277968|FG001|STARTED|Overall Study||16
6367378|NCT00715104|7277969|FG002|STARTED|Overall Study||8
6367379|NCT00715104|7277967|FG000|COMPLETED|Overall Study||18
6367380|NCT00715104|7277968|FG001|COMPLETED|Overall Study||16
6367381|NCT00715104|7277969|FG002|COMPLETED|Overall Study||8
6367382|NCT00715104|7277967|FG000|NOT COMPLETED|Overall Study||0
6367383|NCT00715104|7277968|FG001|NOT COMPLETED|Overall Study||0
6367384|NCT00715104|7277969|FG002|NOT COMPLETED|Overall Study||0
6367385|NCT00715117|7278013|FG000|STARTED|Overall Study||6
6367386|NCT00715117|7278014|FG001|STARTED|Overall Study||6
6367387|NCT00715117|7278013|FG000|Completion fo 8 Week Study|Overall Study||6
6367388|NCT00715117|7278014|FG001|Completion fo 8 Week Study|Overall Study||6
6367389|NCT00715117|7278013|FG000|COMPLETED|Overall Study||6
6367390|NCT00715117|7278014|FG001|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
6367391|NCT00715117|7278013|FG000|NOT COMPLETED|Overall Study||0
6367392|NCT00715117|7278014|FG001|NOT COMPLETED|Overall Study||1
6367393|NCT00715208|7278027|FG000|STARTED|Overall Study||7
6367394|NCT00715208|7278028|FG001|STARTED|Overall Study||48
6367395|NCT00715208|7278027|FG000|COMPLETED|Overall Study||6
6367396|NCT00715208|7278028|FG001|COMPLETED|Overall Study||39
6367397|NCT00715208|7278027|FG000|NOT COMPLETED|Overall Study||1
6367398|NCT00715208|7278028|FG001|NOT COMPLETED|Overall Study||9
6367399|NCT00715299|7278034|FG000|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
6367400|NCT00715299|7278034|FG000|COMPLETED|Overall Study||30
6367401|NCT00715299|7278034|FG000|NOT COMPLETED|Overall Study||6
6367402|NCT00715390|7278038|FG000|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
6367403|NCT00715390|7278038|FG000|Eligible|Overall Study||234
6367404|NCT00715390|7278038|FG000|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
6367405|NCT00715390|7278038|FG000|NOT COMPLETED|Overall Study||0
6367406|NCT00715403|7278049|FG000|STARTED|Overall Study||1
6367407|NCT00715403|7278050|FG001|STARTED|Overall Study||1
6367408|NCT00715403|7278051|FG002|STARTED|Overall Study||4
6367409|NCT00715403|7278052|FG003|STARTED|Overall Study||9
6367410|NCT00715403|7278053|FG004|STARTED|Overall Study||6
6367411|NCT00715403|7278054|FG005|STARTED|Overall Study||19
6367412|NCT00715403|7278055|FG006|STARTED|Overall Study||1
6367413|NCT00715403|7278049|FG000|COMPLETED|Overall Study||0
6367414|NCT00715403|7278050|FG001|COMPLETED|Overall Study||0
6367415|NCT00715403|7278051|FG002|COMPLETED|Overall Study||0
6367416|NCT00715403|7278052|FG003|COMPLETED|Overall Study||0
6367417|NCT00715403|7278053|FG004|COMPLETED|Overall Study||0
6367418|NCT00715403|7278054|FG005|COMPLETED|Overall Study||0
6367419|NCT00715403|7278055|FG006|COMPLETED|Overall Study||0
6367420|NCT00715403|7278049|FG000|NOT COMPLETED|Overall Study||1
6367421|NCT00715403|7278050|FG001|NOT COMPLETED|Overall Study||1
6367422|NCT00715403|7278051|FG002|NOT COMPLETED|Overall Study||4
6367423|NCT00715403|7278052|FG003|NOT COMPLETED|Overall Study||9
6367424|NCT00715403|7278053|FG004|NOT COMPLETED|Overall Study||6
6367425|NCT00715403|7278054|FG005|NOT COMPLETED|Overall Study||19
6367426|NCT00715403|7278055|FG006|NOT COMPLETED|Overall Study||1
6367427|NCT00715429|7278073|FG000|STARTED|Overall Study||7
6367428|NCT00715429|7278074|FG001|STARTED|Overall Study||7
6367429|NCT00715429|7278073|FG000|COMPLETED|Overall Study||7
6367430|NCT00715429|7278074|FG001|COMPLETED|Overall Study||6
6367431|NCT00715429|7278073|FG000|NOT COMPLETED|Overall Study||0
6367432|NCT00715429|7278074|FG001|NOT COMPLETED|Overall Study||1
6367433|NCT00715520|7278083|FG000|STARTED|Overall Study||20
6367434|NCT00715520|7278084|FG001|STARTED|Overall Study||10
6367435|NCT00715520|7278085|FG002|STARTED|Overall Study||3
6367436|NCT00715520|7278083|FG000|COMPLETED|Overall Study||10
6367437|NCT00715520|7278084|FG001|COMPLETED|Overall Study||9
6367438|NCT00715520|7278085|FG002|COMPLETED|Overall Study||1
6367439|NCT00715520|7278083|FG000|NOT COMPLETED|Overall Study||10
6367440|NCT00715520|7278084|FG001|NOT COMPLETED|Overall Study||1
6367441|NCT00715520|7278085|FG002|NOT COMPLETED|Overall Study||2
6367442|NCT00715559|7278093|FG000|STARTED|Overall Study||3
6367443|NCT00715559|7278093|FG000|COMPLETED|Overall Study||2
6367444|NCT00715559|7278093|FG000|NOT COMPLETED|Overall Study||1
6367445|NCT00715624|7278099|FG000|STARTED|Overall Study|Randomized|167
6367446|NCT00715624|7278100|FG001|STARTED|Overall Study||329
6367447|NCT00715624|7278099|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
6367448|NCT00715624|7278100|FG001|Treated/Safety Population|Overall Study||328
6367449|NCT00715624|7278099|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
6367450|NCT00715624|7278100|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||327
6367451|NCT00715624|7278099|FG000|COMPLETED|Overall Study||115
6367452|NCT00715624|7278100|FG001|COMPLETED|Overall Study||213
6367453|NCT00715624|7278099|FG000|NOT COMPLETED|Overall Study||52
6367454|NCT00715624|7278100|FG001|NOT COMPLETED|Overall Study||116
6367455|NCT00715650|7278108|FG000|STARTED|Intervention||47
6367456|NCT00715650|7278109|FG001|STARTED|Intervention||45
6367457|NCT00715650|7278108|FG000|Received Any Session|Intervention||39
6367458|NCT00715650|7278109|FG001|Received Any Session|Intervention||38
6367459|NCT00715650|7278108|FG000|Attended ≥ 2 Sessions|Intervention||36
6367460|NCT00715650|7278109|FG001|Attended ≥ 2 Sessions|Intervention||33
6367461|NCT00715650|7278108|FG000|Attended ≥ 3 Sessions|Intervention||23
6367462|NCT00715650|7278109|FG001|Attended ≥ 3 Sessions|Intervention||17
6367463|NCT00715650|7278108|FG000|COMPLETED|Intervention||42
6367464|NCT00715650|7278109|FG001|COMPLETED|Intervention||42
6367465|NCT00715650|7278108|FG000|NOT COMPLETED|Intervention||5
6367466|NCT00715650|7278109|FG001|NOT COMPLETED|Intervention||3
6367467|NCT00715650|7278108|FG000|STARTED|Follow-up||42
6367468|NCT00715650|7278109|FG001|STARTED|Follow-up||42
6367469|NCT00715650|7278108|FG000|Completed Month 1 Follow-up|Follow-up||40
6367470|NCT00715650|7278109|FG001|Completed Month 1 Follow-up|Follow-up||38
6367471|NCT00715650|7278108|FG000|Completed Month 3 Follow-up|Follow-up||35
6367472|NCT00715650|7278109|FG001|Completed Month 3 Follow-up|Follow-up||40
6367473|NCT00715650|7278108|FG000|Completed Month 6 Follow-up|Follow-up||29
6367474|NCT00715650|7278109|FG001|Completed Month 6 Follow-up|Follow-up||37
6367475|NCT00715650|7278108|FG000|COMPLETED|Follow-up||29
6367476|NCT00715650|7278109|FG001|COMPLETED|Follow-up||37
6367477|NCT00715650|7278108|FG000|NOT COMPLETED|Follow-up||13
6367478|NCT00715650|7278109|FG001|NOT COMPLETED|Follow-up||5
6367479|NCT00715676|7278118|FG000|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
6367480|NCT00715676|7278119|FG001|STARTED|Overall Study||54
6367481|NCT00715676|7278120|FG002|STARTED|Overall Study||53
6367482|NCT00715676|7278118|FG000|COMPLETED|Overall Study||43
6367483|NCT00715676|7278119|FG001|COMPLETED|Overall Study||43
6367484|NCT00715676|7278120|FG002|COMPLETED|Overall Study||21
6367485|NCT00715676|7278118|FG000|NOT COMPLETED|Overall Study||6
6367486|NCT00715676|7278119|FG001|NOT COMPLETED|Overall Study||11
6367487|NCT00715676|7278120|FG002|NOT COMPLETED|Overall Study||32
6367488|NCT00715728|7278130|FG000|STARTED|Overall Study||14
6367489|NCT00715728|7278131|FG001|STARTED|Overall Study||14
6367490|NCT00715728|7278130|FG000|COMPLETED|Overall Study||14
6367491|NCT00715728|7278131|FG001|COMPLETED|Overall Study||14
6367492|NCT00715728|7278130|FG000|NOT COMPLETED|Overall Study||0
6367493|NCT00715728|7278131|FG001|NOT COMPLETED|Overall Study||0
6367494|NCT00715741|7278143|FG000|STARTED|Overall Study||25
6367495|NCT00715741|7278144|FG001|STARTED|Overall Study||25
6367496|NCT00715741|7278145|FG002|STARTED|Overall Study||25
6367497|NCT00715741|7278146|FG003|STARTED|Overall Study||25
6367498|NCT00715741|7278143|FG000|COMPLETED|Overall Study||25
6367499|NCT00715741|7278144|FG001|COMPLETED|Overall Study||25
6367500|NCT00715741|7278145|FG002|COMPLETED|Overall Study||25
6367501|NCT00715741|7278146|FG003|COMPLETED|Overall Study||25
6367502|NCT00715741|7278143|FG000|NOT COMPLETED|Overall Study||0
6367503|NCT00715741|7278144|FG001|NOT COMPLETED|Overall Study||0
6367504|NCT00715741|7278145|FG002|NOT COMPLETED|Overall Study||0
6367505|NCT00715741|7278146|FG003|NOT COMPLETED|Overall Study||0
6377526|NCT00763256|7288094|FG000|NOT COMPLETED|Overall Study||7
6377527|NCT00763256|7288095|FG001|NOT COMPLETED|Overall Study||10
6377528|NCT00763269|7288103|FG000|STARTED|Overall Study||314
6377529|NCT00763269|7288104|FG001|STARTED|Overall Study||312
6377530|NCT00763269|7288103|FG000|COMPLETED|Overall Study||302
6377531|NCT00763269|7288104|FG001|COMPLETED|Overall Study||299
6377532|NCT00763269|7288103|FG000|NOT COMPLETED|Overall Study||12
6377533|NCT00763269|7288104|FG001|NOT COMPLETED|Overall Study||13
6377534|NCT00763282|7288112|FG000|STARTED|Overall Study||72
6377535|NCT00763282|7288113|FG001|STARTED|Overall Study||72
6377536|NCT00763282|7288112|FG000|COMPLETED|Overall Study||40
6377537|NCT00763282|7288113|FG001|COMPLETED|Overall Study||38
6377538|NCT00763282|7288112|FG000|NOT COMPLETED|Overall Study||32
6377539|NCT00763282|7288113|FG001|NOT COMPLETED|Overall Study||34
6377540|NCT00763321|7288124|FG000|STARTED|Open-label Period||285
6377541|NCT00763321|7288125|FG001|STARTED|Open-label Period||0
6377542|NCT00763321|7288126|FG002|STARTED|Open-label Period||0
6655119|NCT02450578|7585147|FG003|COMPLETED|Overall Study||4
6655120|NCT02450578|7585144|FG000|NOT COMPLETED|Overall Study||1
6655121|NCT02450578|7585145|FG001|NOT COMPLETED|Overall Study||0
6655122|NCT02450578|7585146|FG002|NOT COMPLETED|Overall Study||0
6377543|NCT00763321|7288124|FG000|COMPLETED|Open-label Period||222
6377544|NCT00763321|7288125|FG001|COMPLETED|Open-label Period||0
6560832|NCT01790113|7483725|FG001|NOT COMPLETED|Overall Study||75
6560833|NCT01790126|7483734|FG000|STARTED|Overall Study||30
6560834|NCT01790126|7483735|FG001|STARTED|Overall Study||29
6560835|NCT01790126|7483736|FG002|STARTED|Overall Study||31
6377545|NCT00763321|7288126|FG002|COMPLETED|Open-label Period||0
6377546|NCT00763321|7288124|FG000|NOT COMPLETED|Open-label Period||63
6377547|NCT00763321|7288125|FG001|NOT COMPLETED|Open-label Period||0
6377548|NCT00763321|7288126|FG002|NOT COMPLETED|Open-label Period||0
6560836|NCT01790126|7483734|FG000|Treated|Overall Study||29
6377549|NCT00763321|7288124|FG000|STARTED|Double-blind Period||0
6377550|NCT00763321|7288125|FG001|STARTED|Double-blind Period||109
6377551|NCT00763321|7288126|FG002|STARTED|Double-blind Period||113
6377552|NCT00763321|7288124|FG000|COMPLETED|Double-blind Period||0
6377553|NCT00763321|7288125|FG001|COMPLETED|Double-blind Period||88
6377554|NCT00763321|7288126|FG002|COMPLETED|Double-blind Period||84
6377555|NCT00763321|7288124|FG000|NOT COMPLETED|Double-blind Period||0
6377556|NCT00763321|7288125|FG001|NOT COMPLETED|Double-blind Period||21
6377557|NCT00763321|7288126|FG002|NOT COMPLETED|Double-blind Period||29
6560837|NCT01790126|7483735|FG001|Treated|Overall Study||29
6655123|NCT02450578|7585147|FG003|NOT COMPLETED|Overall Study||0
6367506|NCT00715754|7278156|FG000|STARTED|Overall Study||47
6367507|NCT00715754|7278156|FG000|COMPLETED|Overall Study||47
6367508|NCT00715754|7278156|FG000|NOT COMPLETED|Overall Study||0
6367509|NCT00715793|7278160|FG000|STARTED|Phase 1 RP2D DAC + TMZ||4
6367510|NCT00715793|7278161|FG001|STARTED|Phase 1 RP2D DAC + TMZ||6
6367511|NCT00715793|7278160|FG000|COMPLETED|Phase 1 RP2D DAC + TMZ||3
6367512|NCT00715793|7278161|FG001|COMPLETED|Phase 1 RP2D DAC + TMZ||6
6367513|NCT00715793|7278160|FG000|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||1
6367514|NCT00715793|7278161|FG001|NOT COMPLETED|Phase 1 RP2D DAC + TMZ||0
6367515|NCT00715793|7278160|FG000|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
6367516|NCT00715793|7278161|FG001|STARTED|Phase 2 DAC (0.15 mg/kg) + TMZ||29
6367517|NCT00715793|7278160|FG000|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
6367518|NCT00715793|7278161|FG001|COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||27
6367519|NCT00715793|7278160|FG000|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||0
6367520|NCT00715793|7278161|FG001|NOT COMPLETED|Phase 2 DAC (0.15 mg/kg) + TMZ||2
6367521|NCT00715884|7278170|FG000|STARTED|Overall Study||452
6367522|NCT00715884|7278171|FG001|STARTED|Overall Study||226
6367523|NCT00715884|7278170|FG000|COMPLETED|Overall Study||444
6367524|NCT00715884|7278171|FG001|COMPLETED|Overall Study||225
6367525|NCT00715884|7278170|FG000|NOT COMPLETED|Overall Study||8
6367526|NCT00715884|7278171|FG001|NOT COMPLETED|Overall Study||1
6367527|NCT00715910|7278181|FG000|STARTED|Year 1||433
6367528|NCT00715910|7278182|FG001|STARTED|Year 1||147
6367529|NCT00715910|7278183|FG002|STARTED|Year 1||68
6367530|NCT00715910|7278184|FG003|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
6367531|NCT00715910|7278185|FG004|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
6367532|NCT00715910|7278186|FG005|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
6367533|NCT00715910|7278181|FG000|COMPLETED|Year 1||433
6367534|NCT00715910|7278182|FG001|COMPLETED|Year 1||147
6367535|NCT00715910|7278183|FG002|COMPLETED|Year 1||68
6367536|NCT00715910|7278184|FG003|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
6367537|NCT00715910|7278185|FG004|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
6367538|NCT00715910|7278186|FG005|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
6367539|NCT00715910|7278181|FG000|NOT COMPLETED|Year 1||0
6367540|NCT00715910|7278182|FG001|NOT COMPLETED|Year 1||0
6367541|NCT00715910|7278183|FG002|NOT COMPLETED|Year 1||0
6367542|NCT00715910|7278184|FG003|NOT COMPLETED|Year 1||0
6367543|NCT00715910|7278185|FG004|NOT COMPLETED|Year 1||0
6367544|NCT00715910|7278186|FG005|NOT COMPLETED|Year 1||0
6367545|NCT00715910|7278181|FG000|STARTED|Year 3||345
6367546|NCT00715910|7278182|FG001|STARTED|Year 3||86
6367547|NCT00715910|7278183|FG002|STARTED|Year 3||56
6367548|NCT00715910|7278184|FG003|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
6367549|NCT00715910|7278185|FG004|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
6367550|NCT00715910|7278186|FG005|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
6367551|NCT00715910|7278181|FG000|COMPLETED|Year 3||345
6367552|NCT00715910|7278182|FG001|COMPLETED|Year 3||86
6367553|NCT00715910|7278183|FG002|COMPLETED|Year 3||56
6367554|NCT00715910|7278184|FG003|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
6367555|NCT00715910|7278185|FG004|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
6367556|NCT00715910|7278186|FG005|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
6367557|NCT00715910|7278181|FG000|NOT COMPLETED|Year 3||0
6367558|NCT00715910|7278182|FG001|NOT COMPLETED|Year 3||0
6367559|NCT00715910|7278183|FG002|NOT COMPLETED|Year 3||0
6367560|NCT00715910|7278184|FG003|NOT COMPLETED|Year 3||0
6367561|NCT00715910|7278185|FG004|NOT COMPLETED|Year 3||0
6367562|NCT00715910|7278186|FG005|NOT COMPLETED|Year 3||0
6367563|NCT00715910|7278181|FG000|STARTED|Year 5||218
6367564|NCT00715910|7278182|FG001|STARTED|Year 5||56
6367565|NCT00715910|7278183|FG002|STARTED|Year 5||38
6367566|NCT00715910|7278184|FG003|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
6367567|NCT00715910|7278185|FG004|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
6367568|NCT00715910|7278186|FG005|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
6367569|NCT00715910|7278181|FG000|COMPLETED|Year 5||218
6367570|NCT00715910|7278182|FG001|COMPLETED|Year 5||56
6367571|NCT00715910|7278183|FG002|COMPLETED|Year 5||38
6367572|NCT00715910|7278184|FG003|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
6367573|NCT00715910|7278185|FG004|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
6367574|NCT00715910|7278186|FG005|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
6367575|NCT00715910|7278181|FG000|NOT COMPLETED|Year 5||0
6367576|NCT00715910|7278182|FG001|NOT COMPLETED|Year 5||0
6367577|NCT00715910|7278183|FG002|NOT COMPLETED|Year 5||0
6367578|NCT00715910|7278184|FG003|NOT COMPLETED|Year 5||0
6367579|NCT00715910|7278185|FG004|NOT COMPLETED|Year 5||0
6367580|NCT00715910|7278186|FG005|NOT COMPLETED|Year 5||0
6367581|NCT00715910|7278181|FG000|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
6367582|NCT00715910|7278182|FG001|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
6367583|NCT00715910|7278183|FG002|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
6367584|NCT00715910|7278184|FG003|STARTED|Booster and ESFU Phase||183
6367585|NCT00715910|7278185|FG004|STARTED|Booster and ESFU Phase||38
6367586|NCT00715910|7278186|FG005|STARTED|Booster and ESFU Phase||101
6367587|NCT00715910|7278181|FG000|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
6367588|NCT00715910|7278182|FG001|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
6367589|NCT00715910|7278183|FG002|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
6367590|NCT00715910|7278184|FG003|COMPLETED|Booster and ESFU Phase||172
6367591|NCT00715910|7278185|FG004|COMPLETED|Booster and ESFU Phase||36
6367592|NCT00715910|7278186|FG005|COMPLETED|Booster and ESFU Phase||88
6367593|NCT00715910|7278181|FG000|NOT COMPLETED|Booster and ESFU Phase||0
6367594|NCT00715910|7278182|FG001|NOT COMPLETED|Booster and ESFU Phase||0
6367595|NCT00715910|7278183|FG002|NOT COMPLETED|Booster and ESFU Phase||0
6367596|NCT00715910|7278184|FG003|NOT COMPLETED|Booster and ESFU Phase||11
6367597|NCT00715910|7278185|FG004|NOT COMPLETED|Booster and ESFU Phase||2
6367598|NCT00715910|7278186|FG005|NOT COMPLETED|Booster and ESFU Phase||13
6367599|NCT00715949|7278202|FG000|STARTED|Overall Study|4 dropped because could not finish first test|120
6367600|NCT00715949|7278202|FG000|COMPLETED|Overall Study|116 patients completed first test|116
6367601|NCT00715949|7278202|FG000|NOT COMPLETED|Overall Study||4
6367602|NCT00715962|7278208|FG000|STARTED|Overall Study||50
6367603|NCT00715962|7278209|FG001|STARTED|Overall Study||50
6367604|NCT00715962|7278208|FG000|COMPLETED|Overall Study||44
6367605|NCT00715962|7278209|FG001|COMPLETED|Overall Study||48
6367606|NCT00715962|7278208|FG000|NOT COMPLETED|Overall Study||6
6367607|NCT00715962|7278209|FG001|NOT COMPLETED|Overall Study||2
6367608|NCT00716079|7278218|FG000|STARTED|Overall Study||1403
6367609|NCT00716079|7278219|FG001|STARTED|Overall Study||1436
6367610|NCT00716079|7278218|FG000|COMPLETED|Overall Study||1394
6367611|NCT00716079|7278219|FG001|COMPLETED|Overall Study||1421
6367612|NCT00716079|7278218|FG000|NOT COMPLETED|Overall Study||9
6367613|NCT00716079|7278219|FG001|NOT COMPLETED|Overall Study||15
6367614|NCT00716092|7278228|FG000|STARTED|Overall Study||40
6367615|NCT00716092|7278229|FG001|STARTED|Overall Study||40
6367616|NCT00716092|7278230|FG002|STARTED|Overall Study||41
6367617|NCT00716092|7278228|FG000|COMPLETED|Overall Study||38
6367618|NCT00716092|7278229|FG001|COMPLETED|Overall Study||39
6367619|NCT00716092|7278230|FG002|COMPLETED|Overall Study||41
6367620|NCT00716092|7278228|FG000|NOT COMPLETED|Overall Study||2
6367621|NCT00716092|7278229|FG001|NOT COMPLETED|Overall Study||1
6367622|NCT00716092|7278230|FG002|NOT COMPLETED|Overall Study||0
6367623|NCT00716144|7278242|FG000|STARTED|Overall Study||41
6367624|NCT00716144|7278243|FG001|STARTED|Overall Study||45
6367625|NCT00716144|7278244|FG002|STARTED|Overall Study||45
6367626|NCT00716144|7278245|FG003|STARTED|Overall Study||45
6367627|NCT00716144|7278242|FG000|COMPLETED|Overall Study||32
6367628|NCT00716144|7278243|FG001|COMPLETED|Overall Study||38
6367629|NCT00716144|7278244|FG002|COMPLETED|Overall Study||33
6367630|NCT00716144|7278245|FG003|COMPLETED|Overall Study||33
6367631|NCT00716144|7278242|FG000|NOT COMPLETED|Overall Study||9
6367632|NCT00716144|7278243|FG001|NOT COMPLETED|Overall Study||7
6367633|NCT00716144|7278244|FG002|NOT COMPLETED|Overall Study||12
6367634|NCT00716144|7278245|FG003|NOT COMPLETED|Overall Study||12
6367635|NCT00716274|7278258|FG000|STARTED|Study Period II (16-Weeks)||45
6367636|NCT00716274|7278259|FG001|STARTED|Study Period II (16-Weeks)||44
6367637|NCT00716274|7278260|FG002|STARTED|Study Period II (16-Weeks)||0
6367638|NCT00716274|7278261|FG003|STARTED|Study Period II (16-Weeks)||0
6367639|NCT00716274|7278262|FG004|STARTED|Study Period II (16-Weeks)||0
6367640|NCT00716274|7278263|FG005|STARTED|Study Period II (16-Weeks)||21
6367641|NCT00716274|7278258|FG000|COMPLETED|Study Period II (16-Weeks)||36
6367642|NCT00716274|7278259|FG001|COMPLETED|Study Period II (16-Weeks)||35
6367643|NCT00716274|7278260|FG002|COMPLETED|Study Period II (16-Weeks)||0
6367644|NCT00716274|7278261|FG003|COMPLETED|Study Period II (16-Weeks)||0
6367645|NCT00716274|7278262|FG004|COMPLETED|Study Period II (16-Weeks)||0
6367646|NCT00716274|7278263|FG005|COMPLETED|Study Period II (16-Weeks)||19
6367647|NCT00716274|7278258|FG000|NOT COMPLETED|Study Period II (16-Weeks)||9
6367648|NCT00716274|7278259|FG001|NOT COMPLETED|Study Period II (16-Weeks)||9
6367649|NCT00716274|7278260|FG002|NOT COMPLETED|Study Period II (16-Weeks)||0
6367650|NCT00716274|7278261|FG003|NOT COMPLETED|Study Period II (16-Weeks)||0
6367651|NCT00716274|7278262|FG004|NOT COMPLETED|Study Period II (16-Weeks)||0
6367652|NCT00716274|7278263|FG005|NOT COMPLETED|Study Period II (16-Weeks)||2
6367653|NCT00716274|7278258|FG000|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
6367654|NCT00716274|7278259|FG001|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|0
6367655|NCT00716274|7278260|FG002|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
6367656|NCT00716274|7278261|FG003|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|18
6367657|NCT00716274|7278262|FG004|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|35
6367658|NCT00716274|7278263|FG005|STARTED|Study Period III (16-Weeks)|Participants were assessed for maintenance of benefit after discontinuation of atomoxetine.|19
6367659|NCT00716274|7278258|FG000|COMPLETED|Study Period III (16-Weeks)||0
6367660|NCT00716274|7278259|FG001|COMPLETED|Study Period III (16-Weeks)||0
6367661|NCT00716274|7278260|FG002|COMPLETED|Study Period III (16-Weeks)||16
6367662|NCT00716274|7278261|FG003|COMPLETED|Study Period III (16-Weeks)||17
6367663|NCT00716274|7278262|FG004|COMPLETED|Study Period III (16-Weeks)||32
6367664|NCT00716274|7278263|FG005|COMPLETED|Study Period III (16-Weeks)||19
6367665|NCT00716274|7278258|FG000|NOT COMPLETED|Study Period III (16-Weeks)||0
6367666|NCT00716274|7278259|FG001|NOT COMPLETED|Study Period III (16-Weeks)||0
6367667|NCT00716274|7278260|FG002|NOT COMPLETED|Study Period III (16-Weeks)||2
6367668|NCT00716274|7278261|FG003|NOT COMPLETED|Study Period III (16-Weeks)||1
6367669|NCT00716274|7278262|FG004|NOT COMPLETED|Study Period III (16-Weeks)||3
6367670|NCT00716274|7278263|FG005|NOT COMPLETED|Study Period III (16-Weeks)||0
6367671|NCT00716417|7278290|FG000|STARTED|Overall Study||3
6367672|NCT00716417|7278291|FG001|STARTED|Overall Study||6
6367673|NCT00716417|7278292|FG002|STARTED|Overall Study||5
6367674|NCT00716417|7278293|FG003|STARTED|Overall Study||11
6367675|NCT00716417|7278294|FG004|STARTED|Overall Study||1
6367676|NCT00716417|7278295|FG005|STARTED|Overall Study||3
6367677|NCT00716417|7278296|FG006|STARTED|Overall Study||7
6367678|NCT00716417|7278297|FG007|STARTED|Overall Study||3
6367679|NCT00716417|7278298|FG008|STARTED|Overall Study||5
6367680|NCT00716417|7278299|FG009|STARTED|Overall Study||3
6367681|NCT00716417|7278290|FG000|COMPLETED|Overall Study||0
6367682|NCT00716417|7278291|FG001|COMPLETED|Overall Study||0
6367683|NCT00716417|7278292|FG002|COMPLETED|Overall Study||0
6367684|NCT00716417|7278293|FG003|COMPLETED|Overall Study||0
6367685|NCT00716417|7278294|FG004|COMPLETED|Overall Study||0
6367686|NCT00716417|7278295|FG005|COMPLETED|Overall Study||0
6367687|NCT00716417|7278296|FG006|COMPLETED|Overall Study||0
6367688|NCT00716417|7278297|FG007|COMPLETED|Overall Study||0
6367689|NCT00716417|7278298|FG008|COMPLETED|Overall Study||0
6367690|NCT00716417|7278299|FG009|COMPLETED|Overall Study||0
6367691|NCT00716417|7278290|FG000|NOT COMPLETED|Overall Study||3
6367692|NCT00716417|7278291|FG001|NOT COMPLETED|Overall Study||6
6367693|NCT00716417|7278292|FG002|NOT COMPLETED|Overall Study||5
6367694|NCT00716417|7278293|FG003|NOT COMPLETED|Overall Study||11
6367695|NCT00716417|7278294|FG004|NOT COMPLETED|Overall Study||1
6367696|NCT00716417|7278295|FG005|NOT COMPLETED|Overall Study||3
6367697|NCT00716417|7278296|FG006|NOT COMPLETED|Overall Study||7
6367698|NCT00716417|7278297|FG007|NOT COMPLETED|Overall Study||3
6367699|NCT00716417|7278298|FG008|NOT COMPLETED|Overall Study||5
6367700|NCT00716417|7278299|FG009|NOT COMPLETED|Overall Study||3
6367701|NCT00716443|7278323|FG000|STARTED|Overall Study||51
6367702|NCT00716443|7278323|FG000|COMPLETED|Overall Study||51
6367703|NCT00716443|7278323|FG000|NOT COMPLETED|Overall Study||0
6367704|NCT00716456|7278331|FG000|STARTED|Overall Study||3
6367705|NCT00716456|7278332|FG001|STARTED|Overall Study||5
6367706|NCT00716456|7278333|FG002|STARTED|Overall Study||13
6367707|NCT00716456|7278331|FG000|COMPLETED|Overall Study||3
6367708|NCT00716456|7278332|FG001|COMPLETED|Overall Study||3
6367709|NCT00716456|7278333|FG002|COMPLETED|Overall Study||13
6367710|NCT00716456|7278331|FG000|NOT COMPLETED|Overall Study||0
6367711|NCT00716456|7278332|FG001|NOT COMPLETED|Overall Study||2
6367712|NCT00716456|7278333|FG002|NOT COMPLETED|Overall Study||0
6367713|NCT00716482|7278341|FG000|STARTED|Overall Study||1681
6367714|NCT00716482|7278341|FG000|COMPLETED|Overall Study||1562
6367715|NCT00716482|7278341|FG000|NOT COMPLETED|Overall Study||119
6367716|NCT00716586|7278351|FG000|STARTED|Overall Study||44
6367717|NCT00716586|7278351|FG000|COMPLETED|Overall Study||44
6367718|NCT00716586|7278351|FG000|NOT COMPLETED|Overall Study||0
6367719|NCT00716625|7278356|FG000|STARTED|Overall Study||1674
6367720|NCT00716625|7278356|FG000|COMPLETED|Overall Study||1673
6367721|NCT00716625|7278356|FG000|NOT COMPLETED|Overall Study||1
6367722|NCT00716742|7278377|FG000|STARTED|Baseline||364
6367723|NCT00716742|7278378|FG001|STARTED|Baseline||370
6367724|NCT00716742|7278379|FG002|STARTED|Baseline||365
6367725|NCT00716742|7278377|FG000|COMPLETED|Baseline||347
6367726|NCT00716742|7278378|FG001|COMPLETED|Baseline||356
6367727|NCT00716742|7278379|FG002|COMPLETED|Baseline||352
6367728|NCT00716742|7278377|FG000|NOT COMPLETED|Baseline||17
6367729|NCT00716742|7278378|FG001|NOT COMPLETED|Baseline||14
6367730|NCT00716742|7278379|FG002|NOT COMPLETED|Baseline||13
6367731|NCT00716742|7278377|FG000|STARTED|1 Year Follow-up||347
6367732|NCT00716742|7278378|FG001|STARTED|1 Year Follow-up||356
6367733|NCT00716742|7278379|FG002|STARTED|1 Year Follow-up||352
6367734|NCT00716742|7278377|FG000|COMPLETED|1 Year Follow-up||160
6367735|NCT00716742|7278378|FG001|COMPLETED|1 Year Follow-up||163
6367736|NCT00716742|7278379|FG002|COMPLETED|1 Year Follow-up||152
6367737|NCT00716742|7278377|FG000|NOT COMPLETED|1 Year Follow-up||187
6367738|NCT00716742|7278378|FG001|NOT COMPLETED|1 Year Follow-up||193
6367739|NCT00716742|7278379|FG002|NOT COMPLETED|1 Year Follow-up||200
6367740|NCT00716742|7278377|FG000|STARTED|2 Year Follow-up||160
6367741|NCT00716742|7278378|FG001|STARTED|2 Year Follow-up||163
6367742|NCT00716742|7278379|FG002|STARTED|2 Year Follow-up||152
6367743|NCT00716742|7278377|FG000|COMPLETED|2 Year Follow-up||56
6367744|NCT00716742|7278378|FG001|COMPLETED|2 Year Follow-up||67
6367745|NCT00716742|7278379|FG002|COMPLETED|2 Year Follow-up||50
6367746|NCT00716742|7278377|FG000|NOT COMPLETED|2 Year Follow-up||104
6367747|NCT00716742|7278378|FG001|NOT COMPLETED|2 Year Follow-up||96
6367748|NCT00716742|7278379|FG002|NOT COMPLETED|2 Year Follow-up||102
6367749|NCT00716742|7278377|FG000|STARTED|3 Year Follow-up||56
6367750|NCT00716742|7278378|FG001|STARTED|3 Year Follow-up||67
6367751|NCT00716742|7278379|FG002|STARTED|3 Year Follow-up||50
6367752|NCT00716742|7278377|FG000|COMPLETED|3 Year Follow-up||26
6367753|NCT00716742|7278378|FG001|COMPLETED|3 Year Follow-up||35
6367754|NCT00716742|7278379|FG002|COMPLETED|3 Year Follow-up||29
6367755|NCT00716742|7278377|FG000|NOT COMPLETED|3 Year Follow-up||30
6367756|NCT00716742|7278378|FG001|NOT COMPLETED|3 Year Follow-up||32
6367757|NCT00716742|7278379|FG002|NOT COMPLETED|3 Year Follow-up||21
6367758|NCT00716820|7278387|FG000|STARTED|Overall Study||472
6367759|NCT00716820|7278387|FG000|COMPLETED|Overall Study||472
6367760|NCT00716820|7278387|FG000|NOT COMPLETED|Overall Study||0
6367761|NCT00716859|7278414|FG000|STARTED|Overall Study||70
6367762|NCT00716859|7278415|FG001|STARTED|Overall Study||69
6367763|NCT00716859|7278414|FG000|Received Treatment|Overall Study||69
6367764|NCT00716859|7278415|FG001|Received Treatment|Overall Study||68
6367765|NCT00716859|7278414|FG000|COMPLETED|Overall Study||61
6367766|NCT00716859|7278415|FG001|COMPLETED|Overall Study||64
6367767|NCT00716859|7278414|FG000|NOT COMPLETED|Overall Study||9
6367768|NCT00716859|7278415|FG001|NOT COMPLETED|Overall Study||5
6367769|NCT00716963|7278421|FG000|STARTED|Overall Study||2
6367770|NCT00716963|7278422|FG001|STARTED|Overall Study||1
6367771|NCT00716963|7278423|FG002|STARTED|Overall Study||1
6367772|NCT00716963|7278424|FG003|STARTED|Overall Study||1
6367773|NCT00716963|7278425|FG004|STARTED|Overall Study||1
6367774|NCT00716963|7278426|FG005|STARTED|Overall Study||1
6367775|NCT00716963|7278421|FG000|COMPLETED|Overall Study||1
6367776|NCT00716963|7278422|FG001|COMPLETED|Overall Study||1
6367777|NCT00716963|7278423|FG002|COMPLETED|Overall Study||1
6367778|NCT00716963|7278424|FG003|COMPLETED|Overall Study||1
6367779|NCT00716963|7278425|FG004|COMPLETED|Overall Study||1
6367780|NCT00716963|7278426|FG005|COMPLETED|Overall Study||1
6367781|NCT00716963|7278421|FG000|NOT COMPLETED|Overall Study||1
6367782|NCT00716963|7278422|FG001|NOT COMPLETED|Overall Study||0
6367783|NCT00716963|7278423|FG002|NOT COMPLETED|Overall Study||0
6367784|NCT00716963|7278424|FG003|NOT COMPLETED|Overall Study||0
6367785|NCT00716963|7278425|FG004|NOT COMPLETED|Overall Study||0
6367786|NCT00716963|7278426|FG005|NOT COMPLETED|Overall Study||0
6367787|NCT00716976|7278436|FG000|STARTED|Overall Study||65
6367788|NCT00716976|7278437|FG001|STARTED|Overall Study||66
6367789|NCT00716976|7278436|FG000|COMPLETED|Overall Study||45
6367790|NCT00716976|7278437|FG001|COMPLETED|Overall Study||57
6367791|NCT00716976|7278436|FG000|NOT COMPLETED|Overall Study||20
6367792|NCT00716976|7278437|FG001|NOT COMPLETED|Overall Study||9
6367793|NCT00717041|7278445|FG000|STARTED|Overall Study||1206
6367794|NCT00717041|7278445|FG000|COMPLETED|Overall Study||1206
6367795|NCT00717041|7278445|FG000|NOT COMPLETED|Overall Study||0
6367796|NCT00717054|7278453|FG000|STARTED|Overall Study||58
6367797|NCT00717054|7278454|FG001|STARTED|Overall Study||57
6367798|NCT00717054|7278453|FG000|COMPLETED|Overall Study||58
6367799|NCT00717054|7278454|FG001|COMPLETED|Overall Study||57
6367800|NCT00717054|7278453|FG000|NOT COMPLETED|Overall Study||0
6367801|NCT00717054|7278454|FG001|NOT COMPLETED|Overall Study||0
6367802|NCT00717067|7278466|FG000|STARTED|Part 1a: Normal/Mild/Moderate Group||6
6367803|NCT00717067|7278467|FG001|STARTED|Part 1a: Normal/Mild/Moderate Group||6
6367804|NCT00717067|7278468|FG002|STARTED|Part 1a: Normal/Mild/Moderate Group||6
6367805|NCT00717067|7278469|FG003|STARTED|Part 1a: Normal/Mild/Moderate Group||0
6367806|NCT00717067|7278470|FG004|STARTED|Part 1a: Normal/Mild/Moderate Group||0
6367807|NCT00717067|7278466|FG000|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
6367808|NCT00717067|7278467|FG001|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
6367809|NCT00717067|7278468|FG002|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
6367810|NCT00717067|7278469|FG003|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6367811|NCT00717067|7278470|FG004|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6367812|NCT00717067|7278466|FG000|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6367813|NCT00717067|7278467|FG001|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6367814|NCT00717067|7278468|FG002|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
6367815|NCT00717067|7278469|FG003|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6367816|NCT00717067|7278470|FG004|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
6367817|NCT00717067|7278466|FG000|STARTED|Part 1b: Severe Renal Impairment||0
6367818|NCT00717067|7278467|FG001|STARTED|Part 1b: Severe Renal Impairment||0
6367819|NCT00717067|7278468|FG002|STARTED|Part 1b: Severe Renal Impairment||0
6367820|NCT00717067|7278469|FG003|STARTED|Part 1b: Severe Renal Impairment||6
6367821|NCT00717067|7278470|FG004|STARTED|Part 1b: Severe Renal Impairment||0
6367822|NCT00717067|7278466|FG000|COMPLETED|Part 1b: Severe Renal Impairment||0
6367823|NCT00717067|7278467|FG001|COMPLETED|Part 1b: Severe Renal Impairment||0
6367824|NCT00717067|7278468|FG002|COMPLETED|Part 1b: Severe Renal Impairment||0
6367825|NCT00717067|7278469|FG003|COMPLETED|Part 1b: Severe Renal Impairment||6
6367826|NCT00717067|7278470|FG004|COMPLETED|Part 1b: Severe Renal Impairment||0
6367827|NCT00717067|7278466|FG000|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6367828|NCT00717067|7278467|FG001|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6367829|NCT00717067|7278468|FG002|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6367830|NCT00717067|7278469|FG003|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6367831|NCT00717067|7278470|FG004|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
6367832|NCT00717067|7278466|FG000|STARTED|Part 2: End Stage Renal Disease||0
6367833|NCT00717067|7278467|FG001|STARTED|Part 2: End Stage Renal Disease||0
6367834|NCT00717067|7278468|FG002|STARTED|Part 2: End Stage Renal Disease||0
6367835|NCT00717067|7278469|FG003|STARTED|Part 2: End Stage Renal Disease||0
6367836|NCT00717067|7278470|FG004|STARTED|Part 2: End Stage Renal Disease||6
6367837|NCT00717067|7278466|FG000|COMPLETED|Part 2: End Stage Renal Disease||0
6367838|NCT00717067|7278467|FG001|COMPLETED|Part 2: End Stage Renal Disease||0
6367839|NCT00717067|7278468|FG002|COMPLETED|Part 2: End Stage Renal Disease||0
6367840|NCT00717067|7278469|FG003|COMPLETED|Part 2: End Stage Renal Disease||0
6367841|NCT00717067|7278470|FG004|COMPLETED|Part 2: End Stage Renal Disease||6
6367842|NCT00717067|7278466|FG000|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6367843|NCT00717067|7278467|FG001|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6367844|NCT00717067|7278468|FG002|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6367845|NCT00717067|7278469|FG003|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6367846|NCT00717067|7278470|FG004|NOT COMPLETED|Part 2: End Stage Renal Disease||0
6367847|NCT00717093|7278494|FG000|STARTED|Overall Study||214
6367848|NCT00717093|7278495|FG001|STARTED|Overall Study||218
6367849|NCT00717093|7278494|FG000|Received Treatment|Overall Study||213
6367850|NCT00717093|7278495|FG001|Received Treatment|Overall Study||218
6367851|NCT00717093|7278494|FG000|COMPLETED|Overall Study||170
6367852|NCT00717093|7278495|FG001|COMPLETED|Overall Study||170
6367853|NCT00717093|7278494|FG000|NOT COMPLETED|Overall Study||44
6367854|NCT00717093|7278495|FG001|NOT COMPLETED|Overall Study||48
6367855|NCT00717197|7278501|FG000|STARTED|Overall Study||30
6367856|NCT00717197|7278501|FG000|COMPLETED|Overall Study||23
6367857|NCT00717197|7278501|FG000|NOT COMPLETED|Overall Study||7
6367858|NCT00717236|7278507|FG000|STARTED|Double-Blind Period||851
6367859|NCT00717236|7278508|FG001|STARTED|Double-Blind Period||212
6367860|NCT00717236|7278507|FG000|COMPLETED|Double-Blind Period||771
6367861|NCT00717236|7278508|FG001|COMPLETED|Double-Blind Period||184
6367862|NCT00717236|7278507|FG000|NOT COMPLETED|Double-Blind Period||80
6367863|NCT00717236|7278508|FG001|NOT COMPLETED|Double-Blind Period||28
6367864|NCT00717236|7278507|FG000|STARTED|Open-Label Period||771
6367865|NCT00717236|7278508|FG001|STARTED|Open-Label Period||184
6367866|NCT00717236|7278507|FG000|COMPLETED|Open-Label Period||646
6367867|NCT00717236|7278508|FG001|COMPLETED|Open-Label Period||163
6367868|NCT00717236|7278507|FG000|NOT COMPLETED|Open-Label Period||125
6367869|NCT00717236|7278508|FG001|NOT COMPLETED|Open-Label Period||21
6367870|NCT00717249|7278518|FG000|STARTED|Overall Study||326
6367871|NCT00717249|7278519|FG001|STARTED|Overall Study||165
6367872|NCT00717249|7278518|FG000|COMPLETED|Overall Study||304
6367873|NCT00717249|7278519|FG001|COMPLETED|Overall Study||150
6367874|NCT00717249|7278518|FG000|NOT COMPLETED|Overall Study||22
6367875|NCT00717249|7278519|FG001|NOT COMPLETED|Overall Study||15
6367876|NCT00717288|7278528|FG000|STARTED|Overall Study||28
6367877|NCT00717288|7278529|FG001|STARTED|Overall Study||29
6367878|NCT00717288|7278530|FG002|STARTED|Overall Study||25
6367879|NCT00717288|7278528|FG000|COMPLETED|Overall Study||28
6367880|NCT00717288|7278529|FG001|COMPLETED|Overall Study||29
6367881|NCT00717288|7278530|FG002|COMPLETED|Overall Study||25
6367882|NCT00717288|7278528|FG000|NOT COMPLETED|Overall Study||0
6367883|NCT00717288|7278529|FG001|NOT COMPLETED|Overall Study||0
6367884|NCT00717288|7278530|FG002|NOT COMPLETED|Overall Study||0
6367885|NCT00717314|7278546|FG000|STARTED|Overall Study||43
6367886|NCT00717314|7278547|FG001|STARTED|Overall Study||44
6367887|NCT00717314|7278546|FG000|COMPLETED|Overall Study||37
6367888|NCT00717314|7278547|FG001|COMPLETED|Overall Study||34
6367889|NCT00717314|7278546|FG000|NOT COMPLETED|Overall Study||6
6367890|NCT00717314|7278547|FG001|NOT COMPLETED|Overall Study||10
6367891|NCT00717366|7278555|FG000|STARTED|Core Study Period (20 Weeks)||16
6367892|NCT00717366|7278556|FG001|STARTED|Core Study Period (20 Weeks)||48
6367893|NCT00717366|7278555|FG000|COMPLETED|Core Study Period (20 Weeks)||12
6367894|NCT00717366|7278556|FG001|COMPLETED|Core Study Period (20 Weeks)||35
6367895|NCT00717366|7278555|FG000|NOT COMPLETED|Core Study Period (20 Weeks)||4
6367896|NCT00717366|7278556|FG001|NOT COMPLETED|Core Study Period (20 Weeks)||13
6367897|NCT00717366|7278555|FG000|STARTED|Extension Period (52 Weeks)||9
6367898|NCT00717366|7278556|FG001|STARTED|Extension Period (52 Weeks)||28
6367899|NCT00717366|7278555|FG000|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||8
6367900|NCT00717366|7278556|FG001|Received Visit/Week 21 Dose|Extension Period (52 Weeks)||28
6367901|NCT00717366|7278555|FG000|COMPLETED|Extension Period (52 Weeks)||5
6367902|NCT00717366|7278556|FG001|COMPLETED|Extension Period (52 Weeks)||12
6367903|NCT00717366|7278555|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
6367904|NCT00717366|7278556|FG001|NOT COMPLETED|Extension Period (52 Weeks)||16
6367905|NCT00717405|7278562|FG000|STARTED|Overall Study||52
6367906|NCT00717405|7278562|FG000|COMPLETED|Overall Study||52
6367907|NCT00717405|7278562|FG000|NOT COMPLETED|Overall Study||0
6367908|NCT00717418|7278570|FG000|STARTED|Baseline||180
6367909|NCT00717418|7278571|FG001|STARTED|Baseline||74
6367910|NCT00717418|7278572|FG002|STARTED|Baseline||508
6367911|NCT00717418|7278573|FG003|STARTED|Baseline||19
6367912|NCT00717418|7278570|FG000|COMPLETED|Baseline||180
6367913|NCT00717418|7278571|FG001|COMPLETED|Baseline||74
6367914|NCT00717418|7278572|FG002|COMPLETED|Baseline||508
6367915|NCT00717418|7278573|FG003|COMPLETED|Baseline||4
6367916|NCT00717418|7278570|FG000|NOT COMPLETED|Baseline||0
6367917|NCT00717418|7278571|FG001|NOT COMPLETED|Baseline||0
6367918|NCT00717418|7278572|FG002|NOT COMPLETED|Baseline||0
6367919|NCT00717418|7278573|FG003|NOT COMPLETED|Baseline||15
6367920|NCT00717418|7278570|FG000|STARTED|1-Year Follow-Up||180
6367921|NCT00717418|7278571|FG001|STARTED|1-Year Follow-Up||74
6367922|NCT00717418|7278572|FG002|STARTED|1-Year Follow-Up||508
6367923|NCT00717418|7278573|FG003|STARTED|1-Year Follow-Up||4
6367924|NCT00717418|7278570|FG000|COMPLETED|1-Year Follow-Up||33
6367925|NCT00717418|7278571|FG001|COMPLETED|1-Year Follow-Up||23
6367926|NCT00717418|7278572|FG002|COMPLETED|1-Year Follow-Up||74
6367927|NCT00717418|7278573|FG003|COMPLETED|1-Year Follow-Up||0
6367928|NCT00717418|7278570|FG000|NOT COMPLETED|1-Year Follow-Up||147
6367929|NCT00717418|7278571|FG001|NOT COMPLETED|1-Year Follow-Up||51
6367930|NCT00717418|7278572|FG002|NOT COMPLETED|1-Year Follow-Up||434
6367931|NCT00717418|7278573|FG003|NOT COMPLETED|1-Year Follow-Up||4
6367932|NCT00717522|7278577|FG000|STARTED|Overall Study||7
6367933|NCT00717522|7278577|FG000|COMPLETED|Overall Study||0
6367934|NCT00717522|7278577|FG000|NOT COMPLETED|Overall Study||7
6367935|NCT00717574|7278583|FG000|STARTED|Overall Study||16
6367936|NCT00717574|7278584|FG001|STARTED|Overall Study||16
6367937|NCT00717574|7278583|FG000|COMPLETED|Overall Study||14
6367938|NCT00717574|7278584|FG001|COMPLETED|Overall Study||14
6367939|NCT00717574|7278583|FG000|NOT COMPLETED|Overall Study||2
6367940|NCT00717574|7278584|FG001|NOT COMPLETED|Overall Study||2
6367941|NCT00717626|7278590|FG000|STARTED|Overall Study||14
6367942|NCT00717626|7278590|FG000|COMPLETED|Overall Study||14
6367943|NCT00717626|7278590|FG000|NOT COMPLETED|Overall Study||0
6367944|NCT00717756|7278594|FG000|STARTED|Overall Study||41
6367945|NCT00717756|7278594|FG000|COMPLETED|Overall Study||40
6367946|NCT00717756|7278594|FG000|NOT COMPLETED|Overall Study||1
6367947|NCT00717769|7278601|FG000|STARTED|Overall Study||120
6367948|NCT00717769|7278602|FG001|STARTED|Overall Study||120
6367949|NCT00717769|7278603|FG002|STARTED|Overall Study||30
6367950|NCT00717769|7278601|FG000|COMPLETED|Overall Study||104
6367951|NCT00717769|7278602|FG001|COMPLETED|Overall Study||102
6367952|NCT00717769|7278603|FG002|COMPLETED|Overall Study||19
6367953|NCT00717769|7278601|FG000|NOT COMPLETED|Overall Study||16
6367954|NCT00717769|7278602|FG001|NOT COMPLETED|Overall Study||18
6367955|NCT00717769|7278603|FG002|NOT COMPLETED|Overall Study||11
6367956|NCT00717860|7278615|FG000|STARTED|Overall Study||61
6367957|NCT00717860|7278616|FG001|STARTED|Overall Study||60
6367958|NCT00717860|7278615|FG000|COMPLETED|Overall Study||34
6367959|NCT00717860|7278616|FG001|COMPLETED|Overall Study||32
6367960|NCT00717860|7278615|FG000|NOT COMPLETED|Overall Study||27
6367961|NCT00717860|7278616|FG001|NOT COMPLETED|Overall Study||28
6367962|NCT00717873|7278624|FG000|STARTED|Overall Study||46
6367963|NCT00717873|7278625|FG001|STARTED|Overall Study||59
6367964|NCT00717873|7278624|FG000|COMPLETED|Overall Study||46
6367965|NCT00717873|7278625|FG001|COMPLETED|Overall Study||59
6367966|NCT00717873|7278624|FG000|NOT COMPLETED|Overall Study||0
6367967|NCT00717873|7278625|FG001|NOT COMPLETED|Overall Study||0
6367968|NCT00717886|7278631|FG000|STARTED|Overall Study||13
6367969|NCT00717886|7278631|FG000|COMPLETED|Overall Study||9
6367970|NCT00717886|7278631|FG000|NOT COMPLETED|Overall Study||4
6367971|NCT00717912|7278635|FG000|STARTED|Overall Study||1
6367972|NCT00717912|7278636|FG001|STARTED|Overall Study||1
6367973|NCT00717912|7278637|FG002|STARTED|Overall Study||1
6367974|NCT00717912|7278638|FG003|STARTED|Overall Study||1
6367975|NCT00717912|7278639|FG004|STARTED|Overall Study||1
6367976|NCT00717912|7278640|FG005|STARTED|Overall Study||1
6367977|NCT00717912|7278635|FG000|COMPLETED|Overall Study||1
6367978|NCT00717912|7278636|FG001|COMPLETED|Overall Study||1
6367979|NCT00717912|7278637|FG002|COMPLETED|Overall Study||1
6367980|NCT00717912|7278638|FG003|COMPLETED|Overall Study||1
6367981|NCT00717912|7278639|FG004|COMPLETED|Overall Study||1
6367982|NCT00717912|7278640|FG005|COMPLETED|Overall Study||1
6367983|NCT00717912|7278635|FG000|NOT COMPLETED|Overall Study||0
6367984|NCT00717912|7278636|FG001|NOT COMPLETED|Overall Study||0
6367985|NCT00717912|7278637|FG002|NOT COMPLETED|Overall Study||0
6367986|NCT00717912|7278638|FG003|NOT COMPLETED|Overall Study||0
6367987|NCT00717912|7278639|FG004|NOT COMPLETED|Overall Study||0
6367988|NCT00717912|7278640|FG005|NOT COMPLETED|Overall Study||0
6367989|NCT00717977|7278649|FG000|STARTED|Overall Study||74
6367990|NCT00717977|7278649|FG000|COMPLETED|Overall Study||74
6367991|NCT00717977|7278649|FG000|NOT COMPLETED|Overall Study||0
6367992|NCT00718042|7278659|FG000|STARTED|ABBOTT PRISM Chagas Testing||16313
6367993|NCT00718042|7278660|FG001|STARTED|ABBOTT PRISM Chagas Testing||289
6367994|NCT00718042|7278661|FG002|STARTED|ABBOTT PRISM Chagas Testing||525
6367995|NCT00718042|7278662|FG003|STARTED|ABBOTT PRISM Chagas Testing||110
6367996|NCT00718042|7278663|FG004|STARTED|ABBOTT PRISM Chagas Testing||25549
6367997|NCT00718042|7278664|FG005|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
6367998|NCT00718042|7278659|FG000|COMPLETED|ABBOTT PRISM Chagas Testing||16249
6367999|NCT00718042|7278660|FG001|COMPLETED|ABBOTT PRISM Chagas Testing||287
6368000|NCT00718042|7278661|FG002|COMPLETED|ABBOTT PRISM Chagas Testing||524
6368001|NCT00718042|7278662|FG003|COMPLETED|ABBOTT PRISM Chagas Testing||110
6368002|NCT00718042|7278663|FG004|COMPLETED|ABBOTT PRISM Chagas Testing||25511
6368003|NCT00718042|7278664|FG005|COMPLETED|ABBOTT PRISM Chagas Testing||0
6368004|NCT00718042|7278659|FG000|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
6368005|NCT00718042|7278660|FG001|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
6368006|NCT00718042|7278661|FG002|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
6368007|NCT00718042|7278662|FG003|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
6368008|NCT00718042|7278663|FG004|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
6368009|NCT00718042|7278664|FG005|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
6368010|NCT00718042|7278659|FG000|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
6368011|NCT00718042|7278660|FG001|STARTED|ESA Chagas Testing||287
6368012|NCT00718042|7278661|FG002|STARTED|ESA Chagas Testing||524
6368013|NCT00718042|7278662|FG003|STARTED|ESA Chagas Testing||110
6368014|NCT00718042|7278663|FG004|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
6368015|NCT00718042|7278664|FG005|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
6368016|NCT00718042|7278659|FG000|COMPLETED|ESA Chagas Testing||36
6368017|NCT00718042|7278660|FG001|COMPLETED|ESA Chagas Testing||287
6368018|NCT00718042|7278661|FG002|COMPLETED|ESA Chagas Testing||524
6368019|NCT00718042|7278662|FG003|COMPLETED|ESA Chagas Testing||110
6368020|NCT00718042|7278663|FG004|COMPLETED|ESA Chagas Testing||43
6368021|NCT00718042|7278664|FG005|COMPLETED|ESA Chagas Testing||330
6368022|NCT00718042|7278659|FG000|NOT COMPLETED|ESA Chagas Testing||0
6368023|NCT00718042|7278660|FG001|NOT COMPLETED|ESA Chagas Testing||0
6368024|NCT00718042|7278661|FG002|NOT COMPLETED|ESA Chagas Testing||0
6368025|NCT00718042|7278662|FG003|NOT COMPLETED|ESA Chagas Testing||0
6368026|NCT00718042|7278663|FG004|NOT COMPLETED|ESA Chagas Testing||0
6368027|NCT00718042|7278664|FG005|NOT COMPLETED|ESA Chagas Testing||0
6368028|NCT00718042|7278659|FG000|STARTED|Donor Follow-up||36
6368029|NCT00718042|7278660|FG001|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
6368030|NCT00718042|7278661|FG002|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
6368031|NCT00718042|7278662|FG003|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
6368032|NCT00718042|7278663|FG004|STARTED|Donor Follow-up||43
6368033|NCT00718042|7278664|FG005|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
6368034|NCT00718042|7278659|FG000|COMPLETED|Donor Follow-up||23
6368035|NCT00718042|7278660|FG001|COMPLETED|Donor Follow-up||0
6368036|NCT00718042|7278661|FG002|COMPLETED|Donor Follow-up||0
6368037|NCT00718042|7278662|FG003|COMPLETED|Donor Follow-up||0
6368038|NCT00718042|7278663|FG004|COMPLETED|Donor Follow-up||24
6368039|NCT00718042|7278664|FG005|COMPLETED|Donor Follow-up||0
6368040|NCT00718042|7278659|FG000|NOT COMPLETED|Donor Follow-up||13
6368041|NCT00718042|7278660|FG001|NOT COMPLETED|Donor Follow-up||0
6368042|NCT00718042|7278661|FG002|NOT COMPLETED|Donor Follow-up||0
6368043|NCT00718042|7278662|FG003|NOT COMPLETED|Donor Follow-up||0
6368044|NCT00718042|7278663|FG004|NOT COMPLETED|Donor Follow-up||19
6368045|NCT00718042|7278664|FG005|NOT COMPLETED|Donor Follow-up||0
6368046|NCT00718081|7278679|FG000|STARTED|Overall Study||29
6368047|NCT00718081|7278680|FG001|STARTED|Overall Study||29
6368048|NCT00718081|7278681|FG002|STARTED|Overall Study||30
6368049|NCT00718081|7278679|FG000|COMPLETED|Overall Study||22
6368050|NCT00718081|7278680|FG001|COMPLETED|Overall Study||25
6368051|NCT00718081|7278681|FG002|COMPLETED|Overall Study||9
6368052|NCT00718081|7278679|FG000|NOT COMPLETED|Overall Study||7
6368053|NCT00718081|7278680|FG001|NOT COMPLETED|Overall Study||4
6368054|NCT00718081|7278681|FG002|NOT COMPLETED|Overall Study||21
6368055|NCT00718094|7278691|FG000|STARTED|Overall Study||15
6368056|NCT00718094|7278692|FG001|STARTED|Overall Study||5
6368057|NCT00718094|7278691|FG000|COMPLETED|Overall Study||15
6368058|NCT00718094|7278692|FG001|COMPLETED|Overall Study||5
6368059|NCT00718094|7278691|FG000|NOT COMPLETED|Overall Study||0
6368060|NCT00718094|7278692|FG001|NOT COMPLETED|Overall Study||0
6368061|NCT00718120|7278700|FG000|STARTED|Overall Study||55
6368062|NCT00718120|7278701|FG001|STARTED|Overall Study||55
6368063|NCT00718120|7278700|FG000|COMPLETED|Overall Study||55
6368064|NCT00718120|7278701|FG001|COMPLETED|Overall Study||55
6368065|NCT00718120|7278700|FG000|NOT COMPLETED|Overall Study||0
6368066|NCT00718120|7278701|FG001|NOT COMPLETED|Overall Study||0
6368067|NCT00718159|7278714|FG000|STARTED|Overall Study||3
6368068|NCT00718159|7278715|FG001|STARTED|Overall Study||3
6368069|NCT00718159|7278716|FG002|STARTED|Overall Study||3
6368070|NCT00718159|7278717|FG003|STARTED|Overall Study||4
6368071|NCT00718159|7278718|FG004|STARTED|Overall Study||8
6368072|NCT00718159|7278719|FG005|STARTED|Overall Study||1
6368073|NCT00718159|7278720|FG006|STARTED|Overall Study||1
6368074|NCT00718159|7278714|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6368075|NCT00718159|7278715|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6368076|NCT00718159|7278716|FG002|Received at Least 1 Dose of Study Drug|Overall Study||3
6368077|NCT00718159|7278717|FG003|Received at Least 1 Dose of Study Drug|Overall Study||4
6368078|NCT00718159|7278718|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
6368079|NCT00718159|7278719|FG005|Received at Least 1 Dose of Study Drug|Overall Study||1
6368080|NCT00718159|7278720|FG006|Received at Least 1 Dose of Study Drug|Overall Study||1
6368081|NCT00718159|7278714|FG000|COMPLETED|Overall Study||0
6368082|NCT00718159|7278715|FG001|COMPLETED|Overall Study||0
6368083|NCT00718159|7278716|FG002|COMPLETED|Overall Study||0
6368084|NCT00718159|7278717|FG003|COMPLETED|Overall Study||0
6368085|NCT00718159|7278718|FG004|COMPLETED|Overall Study||0
6368086|NCT00718159|7278719|FG005|COMPLETED|Overall Study||0
6368087|NCT00718159|7278720|FG006|COMPLETED|Overall Study||0
6368088|NCT00718159|7278714|FG000|NOT COMPLETED|Overall Study||3
6368089|NCT00718159|7278715|FG001|NOT COMPLETED|Overall Study||3
6368090|NCT00718159|7278716|FG002|NOT COMPLETED|Overall Study||3
6368091|NCT00718159|7278717|FG003|NOT COMPLETED|Overall Study||4
6368092|NCT00718159|7278718|FG004|NOT COMPLETED|Overall Study||8
6368093|NCT00718159|7278719|FG005|NOT COMPLETED|Overall Study||1
6368094|NCT00718159|7278720|FG006|NOT COMPLETED|Overall Study||1
6368095|NCT00718237|7278738|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
6368096|NCT00718237|7278739|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
6368097|NCT00718237|7278738|FG000|Vaccinated at Visit 1|Overall Study||380
6368098|NCT00718237|7278739|FG001|Vaccinated at Visit 1|Overall Study||381
6368099|NCT00718237|7278738|FG000|Vaccinated at Visit 2|Overall Study||373
6368100|NCT00718237|7278739|FG001|Vaccinated at Visit 2|Overall Study||374
6368101|NCT00718237|7278738|FG000|Vaccinated at Visit 3|Overall Study||371
6368102|NCT00718237|7278739|FG001|Vaccinated at Visit 3|Overall Study||369
6368103|NCT00718237|7278738|FG000|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
6368104|NCT00718237|7278739|FG001|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
6368105|NCT00718237|7278738|FG000|NOT COMPLETED|Overall Study||13
6368106|NCT00718237|7278739|FG001|NOT COMPLETED|Overall Study||15
6368107|NCT00718302|7278749|FG000|STARTED|Overall Study||119
6368108|NCT00718302|7278750|FG001|STARTED|Overall Study||114
6368109|NCT00718302|7278749|FG000|COMPLETED|Overall Study||119
6368110|NCT00718302|7278750|FG001|COMPLETED|Overall Study||114
6368111|NCT00718302|7278749|FG000|NOT COMPLETED|Overall Study||0
6368112|NCT00718302|7278750|FG001|NOT COMPLETED|Overall Study||0
6368113|NCT00718315|7278761|FG000|STARTED|Overall Study||67
6368114|NCT00718315|7278762|FG001|STARTED|Overall Study||67
6368115|NCT00718315|7278763|FG002|STARTED|Overall Study||67
6368116|NCT00718315|7278761|FG000|COMPLETED|Overall Study||48
6368117|NCT00718315|7278762|FG001|COMPLETED|Overall Study||45
6368118|NCT00718315|7278763|FG002|COMPLETED|Overall Study||46
6368119|NCT00718315|7278761|FG000|NOT COMPLETED|Overall Study||19
6368120|NCT00718315|7278762|FG001|NOT COMPLETED|Overall Study||22
6368121|NCT00718315|7278763|FG002|NOT COMPLETED|Overall Study||21
6368122|NCT00718328|7278773|FG000|STARTED|Overall Study||1
6368123|NCT00718328|7278774|FG001|STARTED|Overall Study||0
6368124|NCT00718328|7278773|FG000|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
6368125|NCT00718328|7278774|FG001|COMPLETED|Overall Study|Terminated due to poor enrollment|0
6368126|NCT00718328|7278773|FG000|NOT COMPLETED|Overall Study||1
6368127|NCT00718328|7278774|FG001|NOT COMPLETED|Overall Study||0
6368128|NCT00718419|7278782|FG000|STARTED|Overall Study||14
6368129|NCT00718419|7278783|FG001|STARTED|Overall Study||42
6368130|NCT00718419|7278782|FG000|Received at Least One Dose of Study Drug|Overall Study||14
6368131|NCT00718419|7278783|FG001|Received at Least One Dose of Study Drug|Overall Study||42
6368132|NCT00718419|7278782|FG000|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|1
6368133|NCT00718419|7278783|FG001|COMPLETED|Overall Study|Participants who completed 8 cycles of treatment.|3
6368134|NCT00718419|7278782|FG000|NOT COMPLETED|Overall Study||13
6368135|NCT00718419|7278783|FG001|NOT COMPLETED|Overall Study||39
6368136|NCT00718510|7278791|FG000|STARTED|First Intervention (3 Weeks)||7
6368137|NCT00718510|7278792|FG001|STARTED|First Intervention (3 Weeks)||8
6368138|NCT00718510|7278791|FG000|Received Intervention|First Intervention (3 Weeks)||7
6368139|NCT00718510|7278792|FG001|Received Intervention|First Intervention (3 Weeks)||7
6368140|NCT00718510|7278791|FG000|COMPLETED|First Intervention (3 Weeks)||7
6368141|NCT00718510|7278792|FG001|COMPLETED|First Intervention (3 Weeks)||7
6368142|NCT00718510|7278791|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
6368143|NCT00718510|7278792|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
6368144|NCT00718510|7278791|FG000|STARTED|Washout (5 Days)||7
6368145|NCT00718510|7278792|FG001|STARTED|Washout (5 Days)||7
6368146|NCT00718510|7278791|FG000|COMPLETED|Washout (5 Days)||7
6368147|NCT00718510|7278792|FG001|COMPLETED|Washout (5 Days)||7
6368148|NCT00718510|7278791|FG000|NOT COMPLETED|Washout (5 Days)||0
6368149|NCT00718510|7278792|FG001|NOT COMPLETED|Washout (5 Days)||0
6368150|NCT00718510|7278791|FG000|STARTED|Second Intervention (3 Weeks)||7
6368151|NCT00718510|7278792|FG001|STARTED|Second Intervention (3 Weeks)||7
6368152|NCT00718510|7278791|FG000|COMPLETED|Second Intervention (3 Weeks)||6
6368153|NCT00718510|7278792|FG001|COMPLETED|Second Intervention (3 Weeks)||7
6368154|NCT00718510|7278791|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
6368155|NCT00718510|7278792|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6368156|NCT00718523|7278800|FG000|STARTED|Overall Study||84
6368157|NCT00718523|7278801|FG001|STARTED|Overall Study||86
6368158|NCT00718523|7278800|FG000|COMPLETED|Overall Study||66
6368159|NCT00718523|7278801|FG001|COMPLETED|Overall Study||62
6368160|NCT00718523|7278800|FG000|NOT COMPLETED|Overall Study||18
6368161|NCT00718523|7278801|FG001|NOT COMPLETED|Overall Study||24
6368162|NCT00718549|7278807|FG000|STARTED|Induction Phase||128
6368163|NCT00718549|7278808|FG001|STARTED|Induction Phase||0
6368164|NCT00718549|7278809|FG002|STARTED|Induction Phase||0
6368165|NCT00718549|7278807|FG000|COMPLETED|Induction Phase||66
6368166|NCT00718549|7278808|FG001|COMPLETED|Induction Phase||0
6368167|NCT00718549|7278809|FG002|COMPLETED|Induction Phase||0
6368168|NCT00718549|7278807|FG000|NOT COMPLETED|Induction Phase||62
6368169|NCT00718549|7278808|FG001|NOT COMPLETED|Induction Phase||0
6368170|NCT00718549|7278809|FG002|NOT COMPLETED|Induction Phase||0
6368171|NCT00718549|7278807|FG000|STARTED|Maintenance/ Observation Phase||0
6368172|NCT00718549|7278808|FG001|STARTED|Maintenance/ Observation Phase||33
6368173|NCT00718549|7278809|FG002|STARTED|Maintenance/ Observation Phase||33
6368174|NCT00718549|7278807|FG000|COMPLETED|Maintenance/ Observation Phase||0
6368175|NCT00718549|7278808|FG001|COMPLETED|Maintenance/ Observation Phase||5
6368176|NCT00718549|7278809|FG002|COMPLETED|Maintenance/ Observation Phase||3
6368177|NCT00718549|7278807|FG000|NOT COMPLETED|Maintenance/ Observation Phase||0
6368178|NCT00718549|7278808|FG001|NOT COMPLETED|Maintenance/ Observation Phase||28
6368179|NCT00718549|7278809|FG002|NOT COMPLETED|Maintenance/ Observation Phase||30
6368180|NCT00718666|7278825|FG000|STARTED|Persistence Phase Year 1||118
6368181|NCT00718666|7278826|FG001|STARTED|Persistence Phase Year 1||130
6368182|NCT00718666|7278827|FG002|STARTED|Persistence Phase Year 1||0
6368183|NCT00718666|7278825|FG000|COMPLETED|Persistence Phase Year 1||118
6368184|NCT00718666|7278826|FG001|COMPLETED|Persistence Phase Year 1||130
6368185|NCT00718666|7278827|FG002|COMPLETED|Persistence Phase Year 1|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
6368186|NCT00718666|7278825|FG000|NOT COMPLETED|Persistence Phase Year 1||0
6368187|NCT00718666|7278826|FG001|NOT COMPLETED|Persistence Phase Year 1||0
6368188|NCT00718666|7278827|FG002|NOT COMPLETED|Persistence Phase Year 1||0
6368189|NCT00718666|7278825|FG000|STARTED|Persistence Phase Year 3||98
6368190|NCT00718666|7278826|FG001|STARTED|Persistence Phase Year 3||104
6368191|NCT00718666|7278827|FG002|STARTED|Persistence Phase Year 3||0
6368192|NCT00718666|7278825|FG000|COMPLETED|Persistence Phase Year 3||98
6368193|NCT00718666|7278826|FG001|COMPLETED|Persistence Phase Year 3||104
6368194|NCT00718666|7278827|FG002|COMPLETED|Persistence Phase Year 3|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
6368195|NCT00718666|7278825|FG000|NOT COMPLETED|Persistence Phase Year 3||0
6368196|NCT00718666|7278826|FG001|NOT COMPLETED|Persistence Phase Year 3||0
6368197|NCT00718666|7278827|FG002|NOT COMPLETED|Persistence Phase Year 3||0
6368198|NCT00718666|7278825|FG000|STARTED|Persistence Phase Year 5||70
6368199|NCT00718666|7278826|FG001|STARTED|Persistence Phase Year 5||82
6368200|NCT00718666|7278827|FG002|STARTED|Persistence Phase Year 5||0
6368201|NCT00718666|7278825|FG000|COMPLETED|Persistence Phase Year 5||70
6368202|NCT00718666|7278826|FG001|COMPLETED|Persistence Phase Year 5||82
6368203|NCT00718666|7278827|FG002|COMPLETED|Persistence Phase Year 5|Subjects enrolled to receive Nimenrix vaccine as primary vaccination only at Booster Phase-Year 5.|0
6368204|NCT00718666|7278825|FG000|NOT COMPLETED|Persistence Phase Year 5||0
6368205|NCT00718666|7278826|FG001|NOT COMPLETED|Persistence Phase Year 5||0
6368206|NCT00718666|7278827|FG002|NOT COMPLETED|Persistence Phase Year 5||0
6368207|NCT00718666|7278825|FG000|STARTED|Booster Phase Year 5||38
6368208|NCT00718666|7278826|FG001|STARTED|Booster Phase Year 5||46
6368209|NCT00718666|7278827|FG002|STARTED|Booster Phase Year 5||100
6368210|NCT00718666|7278825|FG000|COMPLETED|Booster Phase Year 5||36
6368211|NCT00718666|7278826|FG001|COMPLETED|Booster Phase Year 5||46
6368212|NCT00718666|7278827|FG002|COMPLETED|Booster Phase Year 5||94
6368213|NCT00718666|7278825|FG000|NOT COMPLETED|Booster Phase Year 5||2
6368214|NCT00718666|7278826|FG001|NOT COMPLETED|Booster Phase Year 5||0
6368215|NCT00718666|7278827|FG002|NOT COMPLETED|Booster Phase Year 5||6
6368216|NCT00718718|7278852|FG000|STARTED|Prior to Week 12||19
6368217|NCT00718718|7278853|FG001|STARTED|Prior to Week 12||0
6368218|NCT00718718|7278854|FG002|STARTED|Prior to Week 12||17
6368219|NCT00718718|7278855|FG003|STARTED|Prior to Week 12||0
6368220|NCT00718718|7278856|FG004|STARTED|Prior to Week 12||30
6368221|NCT00718718|7278857|FG005|STARTED|Prior to Week 12||0
6368222|NCT00718718|7278858|FG006|STARTED|Prior to Week 12||30
6368223|NCT00718718|7278859|FG007|STARTED|Prior to Week 12||30
6368224|NCT00718718|7278860|FG008|STARTED|Prior to Week 12||30
6368225|NCT00718718|7278861|FG009|STARTED|Prior to Week 12||31
6368226|NCT00718718|7278852|FG000|COMPLETED|Prior to Week 12||18
6368227|NCT00718718|7278853|FG001|COMPLETED|Prior to Week 12||0
6368228|NCT00718718|7278854|FG002|COMPLETED|Prior to Week 12||16
6368229|NCT00718718|7278855|FG003|COMPLETED|Prior to Week 12||0
6368230|NCT00718718|7278856|FG004|COMPLETED|Prior to Week 12||27
6368231|NCT00718718|7278857|FG005|COMPLETED|Prior to Week 12||0
6368232|NCT00718718|7278858|FG006|COMPLETED|Prior to Week 12||29
6368233|NCT00718718|7278859|FG007|COMPLETED|Prior to Week 12||28
6368234|NCT00718718|7278860|FG008|COMPLETED|Prior to Week 12||28
6368235|NCT00718718|7278861|FG009|COMPLETED|Prior to Week 12||31
6368236|NCT00718718|7278852|FG000|NOT COMPLETED|Prior to Week 12||1
6368237|NCT00718718|7278853|FG001|NOT COMPLETED|Prior to Week 12||0
6368238|NCT00718718|7278854|FG002|NOT COMPLETED|Prior to Week 12||1
6368239|NCT00718718|7278855|FG003|NOT COMPLETED|Prior to Week 12||0
6368240|NCT00718718|7278856|FG004|NOT COMPLETED|Prior to Week 12||3
6368241|NCT00718718|7278857|FG005|NOT COMPLETED|Prior to Week 12||0
6368242|NCT00718718|7278858|FG006|NOT COMPLETED|Prior to Week 12||1
6368243|NCT00718718|7278859|FG007|NOT COMPLETED|Prior to Week 12||2
6368244|NCT00718718|7278860|FG008|NOT COMPLETED|Prior to Week 12||2
6560838|NCT01790126|7483736|FG002|Treated|Overall Study||31
6560839|NCT01790126|7483734|FG000|COMPLETED|Overall Study||0
6560840|NCT01790126|7483735|FG001|COMPLETED|Overall Study||0
6560841|NCT01790126|7483736|FG002|COMPLETED|Overall Study||0
6560842|NCT01790126|7483734|FG000|NOT COMPLETED|Overall Study||30
6560843|NCT01790126|7483735|FG001|NOT COMPLETED|Overall Study||29
6560844|NCT01790126|7483736|FG002|NOT COMPLETED|Overall Study||31
6560845|NCT01790178|7483747|FG000|STARTED|Overall Study||16
6560846|NCT01790178|7483748|FG001|STARTED|Overall Study||24
6368245|NCT00718718|7278861|FG009|NOT COMPLETED|Prior to Week 12||0
6368246|NCT00718718|7278852|FG000|STARTED|Week 12 to End of Study||0
6368247|NCT00718718|7278853|FG001|STARTED|Week 12 to End of Study||18
6368248|NCT00718718|7278854|FG002|STARTED|Week 12 to End of Study||0
6368249|NCT00718718|7278855|FG003|STARTED|Week 12 to End of Study||16
6368250|NCT00718718|7278856|FG004|STARTED|Week 12 to End of Study||0
6368251|NCT00718718|7278857|FG005|STARTED|Week 12 to End of Study||27
6368252|NCT00718718|7278858|FG006|STARTED|Week 12 to End of Study||29
6368253|NCT00718718|7278859|FG007|STARTED|Week 12 to End of Study||28
6368254|NCT00718718|7278860|FG008|STARTED|Week 12 to End of Study||28
6368255|NCT00718718|7278861|FG009|STARTED|Week 12 to End of Study||31
6368256|NCT00718718|7278852|FG000|Treated|Week 12 to End of Study||0
6368257|NCT00718718|7278853|FG001|Treated|Week 12 to End of Study||18
6368258|NCT00718718|7278854|FG002|Treated|Week 12 to End of Study||0
6368259|NCT00718718|7278855|FG003|Treated|Week 12 to End of Study||16
6560847|NCT01790178|7483747|FG000|COMPLETED|Overall Study||16
6560848|NCT01790178|7483748|FG001|COMPLETED|Overall Study||24
6560849|NCT01790178|7483747|FG000|NOT COMPLETED|Overall Study||0
6560850|NCT01790178|7483748|FG001|NOT COMPLETED|Overall Study||0
6368260|NCT00718718|7278856|FG004|Treated|Week 12 to End of Study||0
6368261|NCT00718718|7278857|FG005|Treated|Week 12 to End of Study||26
6368262|NCT00718718|7278858|FG006|Treated|Week 12 to End of Study||29
6368263|NCT00718718|7278859|FG007|Treated|Week 12 to End of Study||28
6368264|NCT00718718|7278860|FG008|Treated|Week 12 to End of Study||28
6368265|NCT00718718|7278861|FG009|Treated|Week 12 to End of Study||31
6368266|NCT00718718|7278852|FG000|COMPLETED|Week 12 to End of Study||0
6368267|NCT00718718|7278853|FG001|COMPLETED|Week 12 to End of Study||17
6368268|NCT00718718|7278854|FG002|COMPLETED|Week 12 to End of Study||0
6368269|NCT00718718|7278855|FG003|COMPLETED|Week 12 to End of Study||15
6368270|NCT00718718|7278856|FG004|COMPLETED|Week 12 to End of Study||0
6368271|NCT00718718|7278857|FG005|COMPLETED|Week 12 to End of Study||24
6368272|NCT00718718|7278858|FG006|COMPLETED|Week 12 to End of Study||27
6368273|NCT00718718|7278859|FG007|COMPLETED|Week 12 to End of Study||27
6368274|NCT00718718|7278860|FG008|COMPLETED|Week 12 to End of Study||27
6368275|NCT00718718|7278861|FG009|COMPLETED|Week 12 to End of Study||31
6368276|NCT00718718|7278852|FG000|NOT COMPLETED|Week 12 to End of Study||0
6368277|NCT00718718|7278853|FG001|NOT COMPLETED|Week 12 to End of Study||1
6368278|NCT00718718|7278854|FG002|NOT COMPLETED|Week 12 to End of Study||0
6368279|NCT00718718|7278855|FG003|NOT COMPLETED|Week 12 to End of Study||1
6368280|NCT00718718|7278856|FG004|NOT COMPLETED|Week 12 to End of Study||0
6368281|NCT00718718|7278857|FG005|NOT COMPLETED|Week 12 to End of Study||3
6368282|NCT00718718|7278858|FG006|NOT COMPLETED|Week 12 to End of Study||2
6368283|NCT00718718|7278859|FG007|NOT COMPLETED|Week 12 to End of Study||1
6368284|NCT00718718|7278860|FG008|NOT COMPLETED|Week 12 to End of Study||1
6368285|NCT00718718|7278861|FG009|NOT COMPLETED|Week 12 to End of Study||0
6368286|NCT00718770|7278887|FG000|STARTED|Overall Study||10
6368287|NCT00718770|7278887|FG000|COMPLETED|Overall Study||2
6368288|NCT00718770|7278887|FG000|NOT COMPLETED|Overall Study||8
6368289|NCT00718809|7278893|FG000|STARTED|Overall Study||12
6368290|NCT00718809|7278894|FG001|STARTED|Overall Study||9
6368291|NCT00718809|7278893|FG000|COMPLETED|Overall Study||0
6368292|NCT00718809|7278894|FG001|COMPLETED|Overall Study||0
6368293|NCT00718809|7278893|FG000|NOT COMPLETED|Overall Study||12
6368294|NCT00718809|7278894|FG001|NOT COMPLETED|Overall Study||9
6368295|NCT00718861|7278902|FG000|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
6368296|NCT00718861|7278903|FG001|STARTED|Overall Study||95
6368297|NCT00718861|7278902|FG000|Safety Set|Overall Study|3 patients randomized but never received study drug|92
6368298|NCT00718861|7278903|FG001|Safety Set|Overall Study||95
6368299|NCT00718861|7278902|FG000|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
6368300|NCT00718861|7278903|FG001|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
6368301|NCT00718861|7278902|FG000|COMPLETED|Overall Study||74
6368302|NCT00718861|7278903|FG001|COMPLETED|Overall Study||77
6368303|NCT00718861|7278902|FG000|NOT COMPLETED|Overall Study||21
6368304|NCT00718861|7278903|FG001|NOT COMPLETED|Overall Study||18
6368305|NCT00718887|7278911|FG000|STARTED|Overall Study|Participants who received treatment.|89
6368306|NCT00718887|7278912|FG001|STARTED|Overall Study|Participants who received treatment.|77
6368307|NCT00718887|7278911|FG000|COMPLETED|Overall Study|Continued in study after 48 weeks|84
6368308|NCT00718887|7278912|FG001|COMPLETED|Overall Study||68
6368309|NCT00718887|7278911|FG000|NOT COMPLETED|Overall Study||5
6368310|NCT00718887|7278912|FG001|NOT COMPLETED|Overall Study||9
6368311|NCT00719043|7278931|FG000|STARTED|Overall Study||120
6368312|NCT00719043|7278932|FG001|STARTED|Overall Study||121
6368313|NCT00719043|7278933|FG002|STARTED|Overall Study||119
6368314|NCT00719043|7278934|FG003|STARTED|Overall Study||119
6368315|NCT00719043|7278935|FG004|STARTED|Overall Study||122
6368316|NCT00719043|7278936|FG005|STARTED|Overall Study||120
6368317|NCT00719043|7278937|FG006|STARTED|Overall Study||120
6368318|NCT00719043|7278931|FG000|COMPLETED|Overall Study|Up to Day 909|88
6368319|NCT00719043|7278932|FG001|COMPLETED|Overall Study|Up to Day 909|96
6368320|NCT00719043|7278933|FG002|COMPLETED|Overall Study|Up to Day 909|99
6368321|NCT00719043|7278934|FG003|COMPLETED|Overall Study|Up to Day 909|96
6368322|NCT00719043|7278935|FG004|COMPLETED|Overall Study|Up to Day 909|95
6368323|NCT00719043|7278936|FG005|COMPLETED|Overall Study|Up to Day 909|86
6368324|NCT00719043|7278937|FG006|COMPLETED|Overall Study|Up to Day 909|92
6368325|NCT00719043|7278931|FG000|NOT COMPLETED|Overall Study||32
6368326|NCT00719043|7278932|FG001|NOT COMPLETED|Overall Study||25
6368327|NCT00719043|7278933|FG002|NOT COMPLETED|Overall Study||20
6368328|NCT00719043|7278934|FG003|NOT COMPLETED|Overall Study||23
6368329|NCT00719043|7278935|FG004|NOT COMPLETED|Overall Study||27
6368330|NCT00719043|7278936|FG005|NOT COMPLETED|Overall Study||34
6368331|NCT00719043|7278937|FG006|NOT COMPLETED|Overall Study||28
6368332|NCT00719134|7278965|FG000|STARTED|Overall Study||76
6368333|NCT00719134|7278965|FG000|COMPLETED|Overall Study||66
6368334|NCT00719134|7278965|FG000|NOT COMPLETED|Overall Study||10
6368335|NCT00719160|7278970|FG000|STARTED|Overall Study||6
6368336|NCT00719160|7278971|FG001|STARTED|Overall Study||6
6368337|NCT00719160|7278970|FG000|COMPLETED|Overall Study||6
6368338|NCT00719160|7278971|FG001|COMPLETED|Overall Study||6
6368339|NCT00719160|7278970|FG000|NOT COMPLETED|Overall Study||0
6368340|NCT00719160|7278971|FG001|NOT COMPLETED|Overall Study||0
6368341|NCT00719186|7278980|FG000|STARTED|Overall Study||376
6368342|NCT00719186|7278981|FG001|STARTED|Overall Study||374
6368343|NCT00719186|7278980|FG000|COMPLETED|Overall Study||376
6368344|NCT00719186|7278981|FG001|COMPLETED|Overall Study||374
6368345|NCT00719186|7278980|FG000|NOT COMPLETED|Overall Study||0
6368346|NCT00719186|7278981|FG001|NOT COMPLETED|Overall Study||0
6368347|NCT00719212|7278987|FG000|STARTED|Overall Study||61
6368348|NCT00719212|7278987|FG000|COMPLETED|Overall Study||17
6368349|NCT00719212|7278987|FG000|NOT COMPLETED|Overall Study||44
6368350|NCT00719264|7278993|FG000|STARTED|Overall Study||182
6368351|NCT00719264|7278994|FG001|STARTED|Overall Study||183
6368352|NCT00719264|7278993|FG000|Full Analysis Set|Overall Study||182
6368353|NCT00719264|7278994|FG001|Full Analysis Set|Overall Study||183
6368354|NCT00719264|7278993|FG000|Safety Set|Overall Study||180
6368355|NCT00719264|7278994|FG001|Safety Set|Overall Study||181
6368356|NCT00719264|7278993|FG000|COMPLETED|Overall Study||0
6368357|NCT00719264|7278994|FG001|COMPLETED|Overall Study||0
6368358|NCT00719264|7278993|FG000|NOT COMPLETED|Overall Study||182
6368359|NCT00719264|7278994|FG001|NOT COMPLETED|Overall Study||183
6368360|NCT00719329|7279003|FG000|STARTED|Overall Study||705
6368361|NCT00719329|7279004|FG001|STARTED|Overall Study||571
6368362|NCT00719329|7279005|FG002|STARTED|Overall Study||647
6368363|NCT00719329|7279003|FG000|Day 1 Swab|Overall Study||705
6368364|NCT00719329|7279004|FG001|Day 1 Swab|Overall Study||569
6368365|NCT00719329|7279005|FG002|Day 1 Swab|Overall Study||646
6368366|NCT00719329|7279003|FG000|Day 3 Swab|Overall Study||614
6368367|NCT00719329|7279004|FG001|Day 3 Swab|Overall Study||501
6368368|NCT00719329|7279005|FG002|Day 3 Swab|Overall Study||578
6368369|NCT00719329|7279003|FG000|Day 7 Swab|Overall Study||593
6368370|NCT00719329|7279004|FG001|Day 7 Swab|Overall Study||467
6368371|NCT00719329|7279005|FG002|Day 7 Swab|Overall Study||561
6368372|NCT00719329|7279003|FG000|COMPLETED|Overall Study||705
6368373|NCT00719329|7279004|FG001|COMPLETED|Overall Study||569
6368374|NCT00719329|7279005|FG002|COMPLETED|Overall Study||646
6368375|NCT00719329|7279003|FG000|NOT COMPLETED|Overall Study||0
6368376|NCT00719329|7279004|FG001|NOT COMPLETED|Overall Study||2
6368377|NCT00719329|7279005|FG002|NOT COMPLETED|Overall Study||1
6368378|NCT00719355|7279018|FG000|STARTED|Overall Study||51
6368379|NCT00719355|7279019|FG001|STARTED|Overall Study||52
6368380|NCT00719355|7279018|FG000|Completed 6 Weeks|Overall Study||49
6368381|NCT00719355|7279019|FG001|Completed 6 Weeks|Overall Study||48
6368382|NCT00719355|7279018|FG000|Completed 12 Weeks|Overall Study||43
6368383|NCT00719355|7279019|FG001|Completed 12 Weeks|Overall Study||46
6368384|NCT00719355|7279018|FG000|Completed 24 Weeks|Overall Study||34
6368385|NCT00719355|7279019|FG001|Completed 24 Weeks|Overall Study||43
6368386|NCT00719355|7279018|FG000|Completed 32 Weeks|Overall Study||33
6368387|NCT00719355|7279019|FG001|Completed 32 Weeks|Overall Study||39
6368388|NCT00719355|7279018|FG000|COMPLETED|Overall Study||33
6368389|NCT00719355|7279019|FG001|COMPLETED|Overall Study||39
6368390|NCT00719355|7279018|FG000|NOT COMPLETED|Overall Study||18
6368391|NCT00719355|7279019|FG001|NOT COMPLETED|Overall Study||13
6368392|NCT00719472|7279025|FG000|STARTED|Enrolled in Study||451
6368393|NCT00719472|7279025|FG000|COMPLETED|Enrolled in Study||425
6368394|NCT00719472|7279025|FG000|NOT COMPLETED|Enrolled in Study||26
6368395|NCT00719472|7279025|FG000|STARTED|Received Cycle 1 Treatment||425
6368396|NCT00719472|7279025|FG000|COMPLETED|Received Cycle 1 Treatment||372
6368397|NCT00719472|7279025|FG000|NOT COMPLETED|Received Cycle 1 Treatment||53
6368398|NCT00719472|7279025|FG000|STARTED|Received Cycle 2 Treatment||372
6368399|NCT00719472|7279025|FG000|COMPLETED|Received Cycle 2 Treatment||304
6368400|NCT00719472|7279025|FG000|NOT COMPLETED|Received Cycle 2 Treatment||68
6368401|NCT00719537|7279031|FG000|STARTED|Overall Study||2
6368402|NCT00719537|7279032|FG001|STARTED|Overall Study||1
6368403|NCT00719537|7279031|FG000|COMPLETED|Overall Study||1
6368404|NCT00719537|7279032|FG001|COMPLETED|Overall Study||0
6368405|NCT00719537|7279031|FG000|NOT COMPLETED|Overall Study||1
6368406|NCT00719537|7279032|FG001|NOT COMPLETED|Overall Study||1
6368407|NCT00719563|7279040|FG000|STARTED|Overall Study||171
6368408|NCT00719563|7279041|FG001|STARTED|Overall Study||170
6368409|NCT00719563|7279040|FG000|COMPLETED|Overall Study||133
6368410|NCT00719563|7279041|FG001|COMPLETED|Overall Study||128
6368411|NCT00719563|7279040|FG000|NOT COMPLETED|Overall Study||38
6368412|NCT00719563|7279041|FG001|NOT COMPLETED|Overall Study||42
6368413|NCT00719576|7279050|FG000|STARTED|Overall Study||72
6368414|NCT00719576|7279051|FG001|STARTED|Overall Study||72
6368415|NCT00719576|7279050|FG000|COMPLETED|Overall Study||70
6368416|NCT00719576|7279051|FG001|COMPLETED|Overall Study||67
6368417|NCT00719576|7279050|FG000|NOT COMPLETED|Overall Study||2
6368418|NCT00719576|7279051|FG001|NOT COMPLETED|Overall Study||5
6368419|NCT00719615|7279062|FG000|STARTED|Overall Study||42
6368420|NCT00719615|7279063|FG001|STARTED|Overall Study||45
6368421|NCT00719615|7279064|FG002|STARTED|Overall Study||24
6368422|NCT00719615|7279062|FG000|COMPLETED|Overall Study||42
6368423|NCT00719615|7279063|FG001|COMPLETED|Overall Study||45
6368424|NCT00719615|7279064|FG002|COMPLETED|Overall Study||24
6368425|NCT00719615|7279062|FG000|NOT COMPLETED|Overall Study||0
6368426|NCT00719615|7279063|FG001|NOT COMPLETED|Overall Study||0
6368427|NCT00719615|7279064|FG002|NOT COMPLETED|Overall Study||0
6368428|NCT00719680|7279072|FG000|STARTED|Overall Study||21
6368429|NCT00719680|7279072|FG000|COMPLETED|Overall Study||16
6368430|NCT00719680|7279072|FG000|NOT COMPLETED|Overall Study||5
6368431|NCT00719706|7279078|FG000|STARTED|Overall Study||20
6368432|NCT00719706|7279079|FG001|STARTED|Overall Study||20
6368433|NCT00719706|7279078|FG000|COMPLETED|Overall Study||11
6368434|NCT00719706|7279079|FG001|COMPLETED|Overall Study||14
6368435|NCT00719706|7279078|FG000|NOT COMPLETED|Overall Study||9
6368436|NCT00719706|7279079|FG001|NOT COMPLETED|Overall Study||6
6368437|NCT00719732|7279085|FG000|STARTED|Overall Study||218
6368438|NCT00719732|7279085|FG000|COMPLETED|Overall Study||196
6368439|NCT00719732|7279085|FG000|NOT COMPLETED|Overall Study||22
6368440|NCT00719810|7279092|FG000|STARTED|Overall Study||49
6368441|NCT00719810|7279093|FG001|STARTED|Overall Study||51
6368442|NCT00719810|7279094|FG002|STARTED|Overall Study||50
6368443|NCT00719810|7279092|FG000|COMPLETED|Overall Study||46
6368444|NCT00719810|7279093|FG001|COMPLETED|Overall Study||47
6368445|NCT00719810|7279094|FG002|COMPLETED|Overall Study||42
6368446|NCT00719810|7279092|FG000|NOT COMPLETED|Overall Study||3
6368447|NCT00719810|7279093|FG001|NOT COMPLETED|Overall Study||4
6368448|NCT00719810|7279094|FG002|NOT COMPLETED|Overall Study||8
6368449|NCT00719849|7279104|FG000|STARTED|Overall Study||4
6368450|NCT00719849|7279105|FG001|STARTED|Overall Study||9
6368451|NCT00719849|7279104|FG000|COMPLETED|Overall Study||4
6368452|NCT00719849|7279105|FG001|COMPLETED|Overall Study||8
6368453|NCT00719849|7279104|FG000|NOT COMPLETED|Overall Study||0
6368454|NCT00719849|7279105|FG001|NOT COMPLETED|Overall Study||1
6368455|NCT00719862|7279113|FG000|STARTED|Overall Study||242
6368456|NCT00719862|7279114|FG001|STARTED|Overall Study|1 subject was randomized in error|239
6368457|NCT00719862|7279113|FG000|COMPLETED|Overall Study||234
6368458|NCT00719862|7279114|FG001|COMPLETED|Overall Study||233
6368459|NCT00719862|7279113|FG000|NOT COMPLETED|Overall Study||8
6368460|NCT00719862|7279114|FG001|NOT COMPLETED|Overall Study||6
6368461|NCT00719901|7279120|FG000|STARTED|Overall Study||11
6368462|NCT00719901|7279120|FG000|COMPLETED|Overall Study||0
6368463|NCT00719901|7279120|FG000|NOT COMPLETED|Overall Study||11
6368464|NCT00719953|7279124|FG000|STARTED|Overall Study||30
6368465|NCT00719953|7279124|FG000|COMPLETED|Overall Study||26
6368466|NCT00719953|7279124|FG000|NOT COMPLETED|Overall Study||4
6368467|NCT00720057|7279130|FG000|STARTED|Overall Study||153
6368468|NCT00720057|7279131|FG001|STARTED|Overall Study||159
6368469|NCT00720057|7279130|FG000|COMPLETED|Overall Study||152
6368470|NCT00720057|7279131|FG001|COMPLETED|Overall Study||156
6368471|NCT00720057|7279130|FG000|NOT COMPLETED|Overall Study||1
6368472|NCT00720057|7279131|FG001|NOT COMPLETED|Overall Study||3
6368473|NCT00720096|7279139|FG000|STARTED|Overall Study||2
6368474|NCT00720096|7279140|FG001|STARTED|Overall Study||2
6368475|NCT00720096|7279139|FG000|COMPLETED|Overall Study||2
6368476|NCT00720096|7279140|FG001|COMPLETED|Overall Study||0
6368477|NCT00720096|7279139|FG000|NOT COMPLETED|Overall Study||0
6368478|NCT00720096|7279140|FG001|NOT COMPLETED|Overall Study||2
6368479|NCT00720109|7279146|FG000|STARTED|Induction Period||63
6368480|NCT00720109|7279147|FG001|STARTED|Induction Period||0
6368481|NCT00720109|7279148|FG002|STARTED|Induction Period||0
6368482|NCT00720109|7279146|FG000|COMPLETED|Induction Period||57
6368483|NCT00720109|7279147|FG001|COMPLETED|Induction Period||0
6368484|NCT00720109|7279148|FG002|COMPLETED|Induction Period||0
6368485|NCT00720109|7279146|FG000|NOT COMPLETED|Induction Period||6
6368486|NCT00720109|7279147|FG001|NOT COMPLETED|Induction Period||0
6368487|NCT00720109|7279148|FG002|NOT COMPLETED|Induction Period||0
6368488|NCT00720109|7279146|FG000|STARTED|Risk Stratification Period||0
6368489|NCT00720109|7279147|FG001|STARTED|Risk Stratification Period||48
6368490|NCT00720109|7279148|FG002|STARTED|Risk Stratification Period||9
6368491|NCT00720109|7279146|FG000|COMPLETED|Risk Stratification Period||0
6368492|NCT00720109|7279147|FG001|COMPLETED|Risk Stratification Period||33
6368493|NCT00720109|7279148|FG002|COMPLETED|Risk Stratification Period||1
6368494|NCT00720109|7279146|FG000|NOT COMPLETED|Risk Stratification Period||0
6368495|NCT00720109|7279147|FG001|NOT COMPLETED|Risk Stratification Period||15
6368496|NCT00720109|7279148|FG002|NOT COMPLETED|Risk Stratification Period||8
6368497|NCT00720122|7279157|FG000|STARTED|Overall Study||28
6368498|NCT00720122|7279157|FG000|COMPLETED|Overall Study||19
6368499|NCT00720122|7279157|FG000|NOT COMPLETED|Overall Study||9
6368500|NCT00720213|7279161|FG000|STARTED|Screening Phase With Diagnostic PSG||44
6368501|NCT00720213|7279162|FG001|STARTED|Screening Phase With Diagnostic PSG||0
6368502|NCT00720213|7279163|FG002|STARTED|Screening Phase With Diagnostic PSG||0
6368503|NCT00720213|7279161|FG000|COMPLETED|Screening Phase With Diagnostic PSG||37
6368504|NCT00720213|7279162|FG001|COMPLETED|Screening Phase With Diagnostic PSG||0
6368505|NCT00720213|7279163|FG002|COMPLETED|Screening Phase With Diagnostic PSG||0
6368506|NCT00720213|7279161|FG000|NOT COMPLETED|Screening Phase With Diagnostic PSG||7
6368507|NCT00720213|7279162|FG001|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
6368508|NCT00720213|7279163|FG002|NOT COMPLETED|Screening Phase With Diagnostic PSG||0
6368509|NCT00720213|7279161|FG000|STARTED|Treatment Period||0
6368510|NCT00720213|7279162|FG001|STARTED|Treatment Period||20
6368511|NCT00720213|7279163|FG002|STARTED|Treatment Period||17
6368512|NCT00720213|7279161|FG000|COMPLETED|Treatment Period||0
6368513|NCT00720213|7279162|FG001|COMPLETED|Treatment Period||20
6368514|NCT00720213|7279163|FG002|COMPLETED|Treatment Period||17
6368515|NCT00720213|7279161|FG000|NOT COMPLETED|Treatment Period||0
6368516|NCT00720213|7279162|FG001|NOT COMPLETED|Treatment Period||0
6368517|NCT00720213|7279163|FG002|NOT COMPLETED|Treatment Period||0
6368518|NCT00720226|7279173|FG000|STARTED|Overall Study||54
6368519|NCT00720226|7279174|FG001|STARTED|Overall Study||52
6368520|NCT00720226|7279173|FG000|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
6368521|NCT00720226|7279174|FG001|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
6368522|NCT00720226|7279173|FG000|NOT COMPLETED|Overall Study||7
6368523|NCT00720226|7279174|FG001|NOT COMPLETED|Overall Study||4
6368524|NCT00720278|7279183|FG000|STARTED|Overall Study|1 subject was randomized in error|178
6368525|NCT00720278|7279184|FG001|STARTED|Overall Study|1 subject was randomized in error|170
6368526|NCT00720278|7279185|FG002|STARTED|Overall Study|1 subject was randomized in error|178
6368527|NCT00720278|7279183|FG000|COMPLETED|Overall Study||171
6368528|NCT00720278|7279184|FG001|COMPLETED|Overall Study||166
6368529|NCT00720278|7279185|FG002|COMPLETED|Overall Study||172
6368530|NCT00720278|7279183|FG000|NOT COMPLETED|Overall Study||7
6368531|NCT00720278|7279184|FG001|NOT COMPLETED|Overall Study||4
6368532|NCT00720278|7279185|FG002|NOT COMPLETED|Overall Study||6
6368533|NCT00720330|7279196|FG000|STARTED|Overall Study||5
6368534|NCT00720330|7279197|FG001|STARTED|Overall Study||4
6368535|NCT00720330|7279198|FG002|STARTED|Overall Study||3
6368536|NCT00720330|7279196|FG000|COMPLETED|Overall Study||5
6368537|NCT00720330|7279197|FG001|COMPLETED|Overall Study||4
6368538|NCT00720330|7279198|FG002|COMPLETED|Overall Study||3
6368539|NCT00720330|7279196|FG000|NOT COMPLETED|Overall Study||0
6368540|NCT00720330|7279197|FG001|NOT COMPLETED|Overall Study||0
6368541|NCT00720330|7279198|FG002|NOT COMPLETED|Overall Study||0
6368542|NCT00720356|7279206|FG000|STARTED|Registration to Study||115
6368543|NCT00720356|7279206|FG000|Completed Registration Step 1|Registration to Study||115
6368544|NCT00720356|7279206|FG000|Completed Registration Step 2|Registration to Study||48
6368545|NCT00720356|7279206|FG000|COMPLETED|Registration to Study||48
6368546|NCT00720356|7279206|FG000|NOT COMPLETED|Registration to Study||67
6368547|NCT00720356|7279206|FG000|STARTED|Reached 1st Response/2 Cycles||48
6368548|NCT00720356|7279206|FG000|COMPLETED|Reached 1st Response/2 Cycles||46
6368549|NCT00720356|7279206|FG000|NOT COMPLETED|Reached 1st Response/2 Cycles||2
6368550|NCT00720356|7279206|FG000|STARTED|Went on to be Treated Cycle 3||46
6368551|NCT00720356|7279206|FG000|COMPLETED|Went on to be Treated Cycle 3||44
6368552|NCT00720356|7279206|FG000|NOT COMPLETED|Went on to be Treated Cycle 3||2
6368553|NCT00720356|7279206|FG000|STARTED|Follow up Until Death|All patients that are treated on study go into the follow up period|48
6368554|NCT00720356|7279206|FG000|COMPLETED|Follow up Until Death||43
6368555|NCT00720356|7279206|FG000|NOT COMPLETED|Follow up Until Death||5
6368556|NCT00720369|7279212|FG000|STARTED|Overall Study||11
6368557|NCT00720369|7279213|FG001|STARTED|Overall Study||8
6368558|NCT00720369|7279212|FG000|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
6368559|NCT00720369|7279213|FG001|COMPLETED|Overall Study||8
6368560|NCT00720369|7279212|FG000|NOT COMPLETED|Overall Study||1
6368561|NCT00720369|7279213|FG001|NOT COMPLETED|Overall Study||0
6368562|NCT00720382|7279223|FG000|STARTED|Overall Study||466
6368563|NCT00720382|7279224|FG001|STARTED|Overall Study||237
6368564|NCT00720382|7279223|FG000|COMPLETED|Overall Study||290
6368565|NCT00720382|7279224|FG001|COMPLETED|Overall Study||178
6368566|NCT00720382|7279223|FG000|NOT COMPLETED|Overall Study||176
6368567|NCT00720382|7279224|FG001|NOT COMPLETED|Overall Study||59
6368568|NCT00720434|7279234|FG000|STARTED|Double-Blind Period (Week 1-4)||10
6368569|NCT00720434|7279235|FG001|STARTED|Double-Blind Period (Week 1-4)||9
6368570|NCT00720434|7279236|FG002|STARTED|Double-Blind Period (Week 1-4)||8
6368571|NCT00720434|7279237|FG003|STARTED|Double-Blind Period (Week 1-4)||8
6368572|NCT00720434|7279234|FG000|COMPLETED|Double-Blind Period (Week 1-4)||10
6368573|NCT00720434|7279235|FG001|COMPLETED|Double-Blind Period (Week 1-4)||8
6368574|NCT00720434|7279236|FG002|COMPLETED|Double-Blind Period (Week 1-4)||8
6368575|NCT00720434|7279237|FG003|COMPLETED|Double-Blind Period (Week 1-4)||8
6368576|NCT00720434|7279234|FG000|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
6368577|NCT00720434|7279235|FG001|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
6368578|NCT00720434|7279236|FG002|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
6368579|NCT00720434|7279237|FG003|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
6368580|NCT00720434|7279234|FG000|STARTED|Open-Label Period (Week 5-72)||10
6368581|NCT00720434|7279235|FG001|STARTED|Open-Label Period (Week 5-72)||8
6368582|NCT00720434|7279236|FG002|STARTED|Open-Label Period (Week 5-72)||8
6368583|NCT00720434|7279237|FG003|STARTED|Open-Label Period (Week 5-72)||8
6368584|NCT00720434|7279234|FG000|COMPLETED|Open-Label Period (Week 5-72)||4
6368585|NCT00720434|7279235|FG001|COMPLETED|Open-Label Period (Week 5-72)||5
6368586|NCT00720434|7279236|FG002|COMPLETED|Open-Label Period (Week 5-72)||4
6368587|NCT00720434|7279237|FG003|COMPLETED|Open-Label Period (Week 5-72)||4
6368588|NCT00720434|7279234|FG000|NOT COMPLETED|Open-Label Period (Week 5-72)||6
6368589|NCT00720434|7279235|FG001|NOT COMPLETED|Open-Label Period (Week 5-72)||3
6368590|NCT00720434|7279236|FG002|NOT COMPLETED|Open-Label Period (Week 5-72)||4
6368591|NCT00720434|7279237|FG003|NOT COMPLETED|Open-Label Period (Week 5-72)||4
6368592|NCT00720473|7279249|FG000|STARTED|Overall Study||45
6368593|NCT00720473|7279250|FG001|STARTED|Overall Study||24
6368594|NCT00720473|7279249|FG000|COMPLETED|Overall Study||15
6368595|NCT00720473|7279250|FG001|COMPLETED|Overall Study||16
6368596|NCT00720473|7279249|FG000|NOT COMPLETED|Overall Study||30
6368597|NCT00720473|7279250|FG001|NOT COMPLETED|Overall Study||8
6368598|NCT00720499|7279257|FG000|STARTED|Treatment Period 1 (4 Weeks)||69
6368599|NCT00720499|7279258|FG001|STARTED|Treatment Period 1 (4 Weeks)||72
6368600|NCT00720499|7279257|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||66
6368601|NCT00720499|7279258|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||70
6368602|NCT00720499|7279257|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
6368603|NCT00720499|7279258|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
6368604|NCT00720499|7279257|FG000|STARTED|Washout Period (2 Weeks)||66
6368605|NCT00720499|7279258|FG001|STARTED|Washout Period (2 Weeks)||70
6368606|NCT00720499|7279257|FG000|COMPLETED|Washout Period (2 Weeks)||66
6368607|NCT00720499|7279258|FG001|COMPLETED|Washout Period (2 Weeks)||70
6368608|NCT00720499|7279257|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
6368609|NCT00720499|7279258|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
6368610|NCT00720499|7279257|FG000|STARTED|Treatment Period 2 (4 Weeks)||66
6368611|NCT00720499|7279258|FG001|STARTED|Treatment Period 2 (4 Weeks)||70
6368612|NCT00720499|7279257|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||64
6368613|NCT00720499|7279258|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||67
6368614|NCT00720499|7279257|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
6368615|NCT00720499|7279258|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
6368616|NCT00720629|7279265|FG000|STARTED|Overall Study||8
6368617|NCT00720629|7279265|FG000|COMPLETED|Overall Study||8
6368618|NCT00720629|7279265|FG000|NOT COMPLETED|Overall Study||0
6368619|NCT00720759|7279275|FG000|STARTED|Overall Study||6
6368620|NCT00720759|7279276|FG001|STARTED|Overall Study||6
6368621|NCT00720759|7279277|FG002|STARTED|Overall Study||6
6368622|NCT00720759|7279278|FG003|STARTED|Overall Study||6
6368623|NCT00720759|7279275|FG000|COMPLETED|Overall Study||6
6368624|NCT00720759|7279276|FG001|COMPLETED|Overall Study||5
6368625|NCT00720759|7279277|FG002|COMPLETED|Overall Study||5
6368626|NCT00720759|7279278|FG003|COMPLETED|Overall Study||6
6368627|NCT00720759|7279275|FG000|NOT COMPLETED|Overall Study||0
6368628|NCT00720759|7279276|FG001|NOT COMPLETED|Overall Study||1
6368629|NCT00720759|7279277|FG002|NOT COMPLETED|Overall Study||1
6368630|NCT00720759|7279278|FG003|NOT COMPLETED|Overall Study||0
6368631|NCT00720798|7279288|FG000|STARTED|Overall Study||2067
6368632|NCT00720798|7279288|FG000|COMPLETED|Overall Study||1311
6368633|NCT00720798|7279288|FG000|NOT COMPLETED|Overall Study||756
6377558|NCT00763360|7288136|FG000|STARTED|Overall Study||61
6377559|NCT00763360|7288137|FG001|STARTED|Overall Study||60
6377560|NCT00763360|7288138|FG002|STARTED|Overall Study||63
6377561|NCT00763360|7288136|FG000|COMPLETED|Overall Study||61
6377562|NCT00763360|7288137|FG001|COMPLETED|Overall Study||58
6377563|NCT00763360|7288138|FG002|COMPLETED|Overall Study||63
6377564|NCT00763360|7288136|FG000|NOT COMPLETED|Overall Study||0
6377565|NCT00763360|7288137|FG001|NOT COMPLETED|Overall Study||2
6377566|NCT00763360|7288138|FG002|NOT COMPLETED|Overall Study||0
6377567|NCT00763386|7288148|FG000|STARTED|Overall Study||164
6377568|NCT00763386|7288149|FG001|STARTED|Overall Study||167
6377569|NCT00763386|7288148|FG000|COMPLETED|Overall Study||116
6377570|NCT00763386|7288149|FG001|COMPLETED|Overall Study||127
6377571|NCT00763386|7288148|FG000|NOT COMPLETED|Overall Study||48
6377572|NCT00763386|7288149|FG001|NOT COMPLETED|Overall Study||40
6377573|NCT00763412|7288157|FG000|STARTED|Overall Study||8
6377574|NCT00763412|7288158|FG001|STARTED|Overall Study||8
6377575|NCT00763412|7288157|FG000|COMPLETED|Overall Study||4
6377576|NCT00763412|7288158|FG001|COMPLETED|Overall Study||4
6377577|NCT00763412|7288157|FG000|NOT COMPLETED|Overall Study||4
6377578|NCT00763412|7288158|FG001|NOT COMPLETED|Overall Study||4
6377579|NCT00763451|7288168|FG000|STARTED|Overall Study|Randomized.|80
6377580|NCT00763451|7288169|FG001|STARTED|Overall Study||82
6377581|NCT00763451|7288170|FG002|STARTED|Overall Study||161
6377582|NCT00763451|7288171|FG003|STARTED|Overall Study||161
6377583|NCT00763451|7288168|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
6377584|NCT00763451|7288169|FG001|Treated/Safety Population|Overall Study||81
6377585|NCT00763451|7288170|FG002|Treated/Safety Population|Overall Study||161
6377586|NCT00763451|7288171|FG003|Treated/Safety Population|Overall Study||161
6377587|NCT00763451|7288168|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
6377588|NCT00763451|7288169|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||80
6377589|NCT00763451|7288170|FG002|Modified Intent-to-Treat(mITT)Population|Overall Study||160
6377590|NCT00763451|7288171|FG003|Modified Intent-to-Treat(mITT)Population|Overall Study||160
6377591|NCT00763451|7288168|FG000|COMPLETED|Overall Study||67
6377592|NCT00763451|7288169|FG001|COMPLETED|Overall Study||60
6377593|NCT00763451|7288170|FG002|COMPLETED|Overall Study||121
6377594|NCT00763451|7288171|FG003|COMPLETED|Overall Study||131
6377595|NCT00763451|7288168|FG000|NOT COMPLETED|Overall Study||13
6377596|NCT00763451|7288169|FG001|NOT COMPLETED|Overall Study||22
6377597|NCT00763451|7288170|FG002|NOT COMPLETED|Overall Study||40
6377598|NCT00763451|7288171|FG003|NOT COMPLETED|Overall Study||30
6377599|NCT00763490|7288182|FG000|STARTED|Overall Study||20
6377600|NCT00763490|7288182|FG000|COMPLETED|Overall Study||20
6377601|NCT00763490|7288182|FG000|NOT COMPLETED|Overall Study||0
6377602|NCT00763698|7288186|FG000|STARTED|Overall Study||86
6377603|NCT00763698|7288186|FG000|COMPLETED|Overall Study||76
6377604|NCT00763698|7288186|FG000|NOT COMPLETED|Overall Study||10
6377605|NCT00763750|7288191|FG000|STARTED|Overall Study||25
6377606|NCT00763750|7288191|FG000|COMPLETED|Overall Study||25
6377607|NCT00763750|7288191|FG000|NOT COMPLETED|Overall Study||0
6377608|NCT00763815|7288197|FG000|STARTED|Overall Study|Randomized.|161
6377609|NCT00763815|7288198|FG001|STARTED|Overall Study||323
6377610|NCT00763815|7288197|FG000|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
6377611|NCT00763815|7288198|FG001|Treated/Safety Population|Overall Study||323
6377612|NCT00763815|7288197|FG000|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
6377613|NCT00763815|7288198|FG001|Modified Intent-to-Treat(mITT)Population|Overall Study||320
6377614|NCT00763815|7288197|FG000|COMPLETED|Overall Study||109
6368634|NCT00720876|7279292|FG000|STARTED|Overall Study||30
6368635|NCT00720876|7279292|FG000|COMPLETED|Overall Study||28
6368636|NCT00720876|7279292|FG000|NOT COMPLETED|Overall Study||2
6368637|NCT00720941|7279298|FG000|STARTED|Overall Study||557
6368638|NCT00720941|7279299|FG001|STARTED|Overall Study||553
6368639|NCT00720941|7279298|FG000|Ongoing|Overall Study||34
6368640|NCT00720941|7279299|FG001|Ongoing|Overall Study||23
6368641|NCT00720941|7279298|FG000|COMPLETED|Overall Study||144
6368642|NCT00720941|7279299|FG001|COMPLETED|Overall Study||138
6368643|NCT00720941|7279298|FG000|NOT COMPLETED|Overall Study||413
6368644|NCT00720941|7279299|FG001|NOT COMPLETED|Overall Study||415
6368645|NCT00721110|7279309|FG000|STARTED|Overall Study||16
6368646|NCT00721110|7279310|FG001|STARTED|Overall Study||16
6368647|NCT00721110|7279311|FG002|STARTED|Overall Study||16
6368648|NCT00721110|7279312|FG003|STARTED|Overall Study||16
6368649|NCT00721110|7279309|FG000|COMPLETED|Overall Study||15
6368650|NCT00721110|7279310|FG001|COMPLETED|Overall Study||16
6368651|NCT00721110|7279311|FG002|COMPLETED|Overall Study||15
6368652|NCT00721110|7279312|FG003|COMPLETED|Overall Study||16
6368653|NCT00721110|7279309|FG000|NOT COMPLETED|Overall Study||1
6368654|NCT00721110|7279310|FG001|NOT COMPLETED|Overall Study||0
6368655|NCT00721110|7279311|FG002|NOT COMPLETED|Overall Study||1
6368656|NCT00721110|7279312|FG003|NOT COMPLETED|Overall Study||0
6368657|NCT00721123|7279322|FG000|STARTED|Overall Study||538
6368658|NCT00721123|7279322|FG000|COMPLETED|Overall Study||355
6368659|NCT00721123|7279322|FG000|NOT COMPLETED|Overall Study||183
6368660|NCT00721136|7279346|FG000|STARTED|Overall Study||42
6368661|NCT00721136|7279347|FG001|STARTED|Overall Study||42
6368662|NCT00721136|7279348|FG002|STARTED|Overall Study||8
6368663|NCT00721136|7279349|FG003|STARTED|Overall Study||8
6368664|NCT00721136|7279346|FG000|COMPLETED|Overall Study||42
6368665|NCT00721136|7279347|FG001|COMPLETED|Overall Study||42
6368666|NCT00721136|7279348|FG002|COMPLETED|Overall Study||8
6368667|NCT00721136|7279349|FG003|COMPLETED|Overall Study||8
6368668|NCT00721136|7279346|FG000|NOT COMPLETED|Overall Study||0
6368669|NCT00721136|7279347|FG001|NOT COMPLETED|Overall Study||0
6368670|NCT00721136|7279348|FG002|NOT COMPLETED|Overall Study||0
6368671|NCT00721136|7279349|FG003|NOT COMPLETED|Overall Study||0
6368672|NCT00721149|7279363|FG000|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
6368673|NCT00721149|7279363|FG000|COMPLETED|Overall Study||9
6368674|NCT00721149|7279363|FG000|NOT COMPLETED|Overall Study||1
6368675|NCT00721162|7279367|FG000|STARTED|Overall Study||60
6368676|NCT00721162|7279367|FG000|Received Any Amount of Study Drug|Overall Study||60
6368677|NCT00721162|7279367|FG000|COMPLETED|Overall Study||60
6368678|NCT00721162|7279367|FG000|NOT COMPLETED|Overall Study||0
6368679|NCT00721175|7279373|FG000|STARTED|Overall Study||54
6368680|NCT00721175|7279374|FG001|STARTED|Overall Study||54
6368681|NCT00721175|7279373|FG000|COMPLETED|Overall Study||54
6368682|NCT00721175|7279374|FG001|COMPLETED|Overall Study||54
6368683|NCT00721175|7279373|FG000|NOT COMPLETED|Overall Study||0
6368684|NCT00721175|7279374|FG001|NOT COMPLETED|Overall Study||0
6368685|NCT00721188|7279380|FG000|STARTED|Overall Study||11
6368686|NCT00721188|7279380|FG000|COMPLETED|Overall Study||11
6368687|NCT00721188|7279380|FG000|NOT COMPLETED|Overall Study||0
6368688|NCT00721214|7279384|FG000|STARTED|Overall Study||16
6368689|NCT00721214|7279384|FG000|COMPLETED|Overall Study||12
6368690|NCT00721214|7279384|FG000|NOT COMPLETED|Overall Study||4
6368691|NCT00721227|7279390|FG000|STARTED|Overall Study||9
6368692|NCT00721227|7279391|FG001|STARTED|Overall Study||6
6368693|NCT00721227|7279390|FG000|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
6368694|NCT00721227|7279391|FG001|COMPLETED|Overall Study||6
6368695|NCT00721227|7279390|FG000|NOT COMPLETED|Overall Study||4
6368696|NCT00721227|7279391|FG001|NOT COMPLETED|Overall Study||0
6368697|NCT00721253|7279399|FG000|STARTED|Overall Study||20
6368698|NCT00721253|7279400|FG001|STARTED|Overall Study||22
6368699|NCT00721253|7279401|FG002|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
6368700|NCT00721253|7279399|FG000|COMPLETED|Overall Study||20
6368701|NCT00721253|7279400|FG001|COMPLETED|Overall Study||22
6368702|NCT00721253|7279401|FG002|COMPLETED|Overall Study||0
6368703|NCT00721253|7279399|FG000|NOT COMPLETED|Overall Study||0
6368704|NCT00721253|7279400|FG001|NOT COMPLETED|Overall Study||0
6368705|NCT00721253|7279401|FG002|NOT COMPLETED|Overall Study||0
6368706|NCT00721279|7279409|FG000|STARTED|Overall Study||452
6368707|NCT00721279|7279410|FG001|STARTED|Overall Study||97
6368708|NCT00721279|7279409|FG000|COMPLETED|Overall Study||416
6368709|NCT00721279|7279410|FG001|COMPLETED|Overall Study||73
6368710|NCT00721279|7279409|FG000|NOT COMPLETED|Overall Study||36
6368711|NCT00721279|7279410|FG001|NOT COMPLETED|Overall Study||24
6368712|NCT00721357|7279419|FG000|STARTED|Overall Study||15
6368713|NCT00721357|7279420|FG001|STARTED|Overall Study||15
6368714|NCT00721357|7279419|FG000|COMPLETED|Overall Study||15
6368715|NCT00721357|7279420|FG001|COMPLETED|Overall Study||15
6368716|NCT00721357|7279419|FG000|NOT COMPLETED|Overall Study||0
6368717|NCT00721357|7279420|FG001|NOT COMPLETED|Overall Study||0
6368718|NCT00721396|7279432|FG000|STARTED|Overall Study||627
6368719|NCT00721396|7279433|FG001|STARTED|Overall Study||628
6368720|NCT00721396|7279434|FG002|STARTED|Overall Study||318
6368721|NCT00721396|7279435|FG003|STARTED|Overall Study||312
6368722|NCT00721396|7279432|FG000|COMPLETED|Overall Study||597
6368723|NCT00721396|7279433|FG001|COMPLETED|Overall Study||592
6368724|NCT00721396|7279434|FG002|COMPLETED|Overall Study||308
6368725|NCT00721396|7279435|FG003|COMPLETED|Overall Study||302
6368726|NCT00721396|7279432|FG000|NOT COMPLETED|Overall Study||30
6368727|NCT00721396|7279433|FG001|NOT COMPLETED|Overall Study||36
6368728|NCT00721396|7279434|FG002|NOT COMPLETED|Overall Study||10
6368729|NCT00721396|7279435|FG003|NOT COMPLETED|Overall Study||10
6368730|NCT00721409|7279453|FG000|STARTED|Overall Study||12
6368731|NCT00721409|7279454|FG001|STARTED|Overall Study||84
6368732|NCT00721409|7279455|FG002|STARTED|Overall Study||81
6368733|NCT00721409|7279453|FG000|Treated|Overall Study||12
6368734|NCT00721409|7279454|FG001|Treated|Overall Study||83
6368735|NCT00721409|7279455|FG002|Treated|Overall Study||77
6368736|NCT00721409|7279453|FG000|COMPLETED|Overall Study||0
6368737|NCT00721409|7279454|FG001|COMPLETED|Overall Study||2
6368738|NCT00721409|7279455|FG002|COMPLETED|Overall Study||2
6368739|NCT00721409|7279453|FG000|NOT COMPLETED|Overall Study||12
6368740|NCT00721409|7279454|FG001|NOT COMPLETED|Overall Study||82
6368741|NCT00721409|7279455|FG002|NOT COMPLETED|Overall Study||79
6368742|NCT00721500|7279479|FG000|STARTED|Period One||6
6368743|NCT00721500|7279480|FG001|STARTED|Period One||7
6368744|NCT00721500|7279481|FG002|STARTED|Period One||6
6368745|NCT00721500|7279482|FG003|STARTED|Period One||6
6368746|NCT00721500|7279479|FG000|COMPLETED|Period One||6
6368747|NCT00721500|7279480|FG001|COMPLETED|Period One||7
6368748|NCT00721500|7279481|FG002|COMPLETED|Period One||6
6368749|NCT00721500|7279482|FG003|COMPLETED|Period One||6
6368750|NCT00721500|7279479|FG000|NOT COMPLETED|Period One||0
6368751|NCT00721500|7279480|FG001|NOT COMPLETED|Period One||0
6368752|NCT00721500|7279481|FG002|NOT COMPLETED|Period One||0
6368753|NCT00721500|7279482|FG003|NOT COMPLETED|Period One||0
6368754|NCT00721500|7279479|FG000|STARTED|Period Two||6
6368755|NCT00721500|7279480|FG001|STARTED|Period Two||7
6368756|NCT00721500|7279481|FG002|STARTED|Period Two||6
6368757|NCT00721500|7279482|FG003|STARTED|Period Two||6
6368758|NCT00721500|7279479|FG000|COMPLETED|Period Two||6
6368759|NCT00721500|7279480|FG001|COMPLETED|Period Two||7
6368760|NCT00721500|7279481|FG002|COMPLETED|Period Two||6
6368761|NCT00721500|7279482|FG003|COMPLETED|Period Two||6
6368762|NCT00721500|7279479|FG000|NOT COMPLETED|Period Two||0
6368763|NCT00721500|7279480|FG001|NOT COMPLETED|Period Two||0
6368764|NCT00721500|7279481|FG002|NOT COMPLETED|Period Two||0
6368765|NCT00721500|7279482|FG003|NOT COMPLETED|Period Two||0
6368766|NCT00721500|7279479|FG000|STARTED|Period Three||6
6368767|NCT00721500|7279480|FG001|STARTED|Period Three||7
6368768|NCT00721500|7279481|FG002|STARTED|Period Three||6
6368769|NCT00721500|7279482|FG003|STARTED|Period Three||6
6368770|NCT00721500|7279479|FG000|COMPLETED|Period Three||6
6368771|NCT00721500|7279480|FG001|COMPLETED|Period Three||7
6368772|NCT00721500|7279481|FG002|COMPLETED|Period Three||6
6368773|NCT00721500|7279482|FG003|COMPLETED|Period Three||6
6368774|NCT00721500|7279479|FG000|NOT COMPLETED|Period Three||0
6368775|NCT00721500|7279480|FG001|NOT COMPLETED|Period Three||0
6368776|NCT00721500|7279481|FG002|NOT COMPLETED|Period Three||0
6368777|NCT00721500|7279482|FG003|NOT COMPLETED|Period Three||0
6368778|NCT00721513|7279494|FG000|STARTED|Overall Study||20
6368779|NCT00721513|7279494|FG000|COMPLETED|Overall Study||20
6368780|NCT00721513|7279494|FG000|NOT COMPLETED|Overall Study||0
6368781|NCT00721539|7279498|FG000|STARTED|Overall Study||9
6368782|NCT00721539|7279498|FG000|COMPLETED|Overall Study||9
6368783|NCT00721539|7279498|FG000|NOT COMPLETED|Overall Study||0
6368784|NCT00721578|7279502|FG000|STARTED|Overall Study||12
6368785|NCT00721578|7279503|FG001|STARTED|Overall Study||11
6368786|NCT00721578|7279502|FG000|COMPLETED|Overall Study||10
6368787|NCT00721578|7279503|FG001|COMPLETED|Overall Study||9
6560851|NCT01790243|7483756|FG000|STARTED|Overall Study||1029
6560852|NCT01790243|7483757|FG001|STARTED|Overall Study||160
6560853|NCT01790243|7483756|FG000|COMPLETED|Overall Study||739
6777860|NCT03782571|7705789|FG001|NOT COMPLETED|Period 4||0
6777861|NCT03782571|7705790|FG002|NOT COMPLETED|Period 4||0
6368788|NCT00721578|7279502|FG000|NOT COMPLETED|Overall Study||2
6368789|NCT00721578|7279503|FG001|NOT COMPLETED|Overall Study||2
6368790|NCT00721617|7279509|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
6368791|NCT00721617|7279509|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
6368792|NCT00721617|7279509|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
6368793|NCT00721617|7279509|FG000|STARTED|4 Hours Into Saline Infusion||12
6368794|NCT00721617|7279509|FG000|COMPLETED|4 Hours Into Saline Infusion||12
6368795|NCT00721617|7279509|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
6368796|NCT00721617|7279509|FG000|STARTED|8 Hours Into Saline Infusion||12
6368797|NCT00721617|7279509|FG000|COMPLETED|8 Hours Into Saline Infusion||12
6368798|NCT00721617|7279509|FG000|NOT COMPLETED|8 Hours Into Saline Infusion||0
6560854|NCT01790243|7483757|FG001|COMPLETED|Overall Study||117
6560855|NCT01790243|7483756|FG000|NOT COMPLETED|Overall Study||290
6777862|NCT03782571|7705791|FG003|NOT COMPLETED|Period 4||0
6368799|NCT00721617|7279509|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
6368800|NCT00721617|7279509|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
6368801|NCT00721617|7279509|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
6368802|NCT00721617|7279509|FG000|STARTED|4 Hours Into Intralipid Infusion||12
6368803|NCT00721617|7279509|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
6368804|NCT00721617|7279509|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
6368805|NCT00721617|7279509|FG000|STARTED|8 Hours Into Intralipid Infusion||12
6560856|NCT01790243|7483757|FG001|NOT COMPLETED|Overall Study||43
6777863|NCT03796260|7705805|FG000|STARTED|Period 1||7
6368806|NCT00721617|7279509|FG000|COMPLETED|8 Hours Into Intralipid Infusion||12
6368807|NCT00721617|7279509|FG000|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
6368808|NCT00721617|7279509|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
6368809|NCT00721617|7279509|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
6368810|NCT00721617|7279509|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
6368811|NCT00721617|7279509|FG000|STARTED|4 Hours Into Dextrose Infusion||12
6368812|NCT00721617|7279509|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
6368813|NCT00721617|7279509|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
6368814|NCT00721617|7279509|FG000|STARTED|8 Hours Into Dextrose Infusion||12
6368815|NCT00721617|7279509|FG000|COMPLETED|8 Hours Into Dextrose Infusion||12
6368816|NCT00721617|7279509|FG000|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
6368817|NCT00721617|7279509|FG000|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
6368818|NCT00721617|7279509|FG000|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
6368819|NCT00721617|7279509|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
6368820|NCT00721617|7279509|FG000|STARTED|4 Hours Into Intralipid/Dextrose||12
6368821|NCT00721617|7279509|FG000|COMPLETED|4 Hours Into Intralipid/Dextrose||12
6368822|NCT00721617|7279509|FG000|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
6368823|NCT00721617|7279509|FG000|STARTED|8 Hours Into Intralipid/Dextrose||12
6368824|NCT00721617|7279509|FG000|COMPLETED|8 Hours Into Intralipid/Dextrose||12
6368825|NCT00721617|7279509|FG000|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
6368826|NCT00721630|7279514|FG000|STARTED|Overall Study||24
6368827|NCT00721630|7279514|FG000|COMPLETED|Overall Study||23
6368828|NCT00721630|7279514|FG000|NOT COMPLETED|Overall Study||1
6368829|NCT00721734|7279523|FG000|STARTED|Overall Study||12
6368830|NCT00721734|7279524|FG001|STARTED|Overall Study||12
6368831|NCT00721734|7279525|FG002|STARTED|Overall Study||10
6368832|NCT00721734|7279526|FG003|STARTED|Overall Study||8
6368833|NCT00721734|7279527|FG004|STARTED|Overall Study||8
6368834|NCT00721734|7279523|FG000|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
6368835|NCT00721734|7279524|FG001|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
6368836|NCT00721734|7279525|FG002|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
6368837|NCT00721734|7279526|FG003|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
6368838|NCT00721734|7279527|FG004|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
6368839|NCT00721734|7279523|FG000|NOT COMPLETED|Overall Study||8
6368840|NCT00721734|7279524|FG001|NOT COMPLETED|Overall Study||12
6368841|NCT00721734|7279525|FG002|NOT COMPLETED|Overall Study||8
6368842|NCT00721734|7279526|FG003|NOT COMPLETED|Overall Study||6
6368843|NCT00721734|7279527|FG004|NOT COMPLETED|Overall Study||6
6368844|NCT00721799|7279539|FG000|STARTED|Overall Study||33
6368845|NCT00721799|7279539|FG000|Recieved FLT PET Scan 1|Overall Study||26
6368846|NCT00721799|7279539|FG000|Received FLT PET Scan #2|Overall Study||25
6368847|NCT00721799|7279539|FG000|COMPLETED|Overall Study||25
6368848|NCT00721799|7279539|FG000|NOT COMPLETED|Overall Study||8
6368849|NCT00721955|7279546|FG000|STARTED|Overall Study||105
6368850|NCT00721955|7279547|FG001|STARTED|Overall Study||104
6368851|NCT00721955|7279548|FG002|STARTED|Overall Study||105
6368852|NCT00721955|7279546|FG000|COMPLETED|Overall Study||105
6368853|NCT00721955|7279547|FG001|COMPLETED|Overall Study||104
6368854|NCT00721955|7279548|FG002|COMPLETED|Overall Study||103
6368855|NCT00721955|7279546|FG000|NOT COMPLETED|Overall Study||0
6368856|NCT00721955|7279547|FG001|NOT COMPLETED|Overall Study||0
6368857|NCT00721955|7279548|FG002|NOT COMPLETED|Overall Study||2
6368858|NCT00721968|7279558|FG000|STARTED|Overall Study||27
6368859|NCT00721968|7279559|FG001|STARTED|Overall Study||17
6368860|NCT00721968|7279558|FG000|COMPLETED|Overall Study||25
6368861|NCT00721968|7279559|FG001|COMPLETED|Overall Study||17
6368862|NCT00721968|7279558|FG000|NOT COMPLETED|Overall Study||2
6368863|NCT00721968|7279559|FG001|NOT COMPLETED|Overall Study||0
6368864|NCT00722007|7279565|FG000|STARTED|Overall Study||147
6368865|NCT00722007|7279565|FG000|COMPLETED|Overall Study||117
6368866|NCT00722007|7279565|FG000|NOT COMPLETED|Overall Study||30
6368867|NCT00722020|7279572|FG000|STARTED|Overall Study||19
6368868|NCT00722020|7279573|FG001|STARTED|Overall Study||24
6368869|NCT00722020|7279572|FG000|COMPLETED|Overall Study||19
6368870|NCT00722020|7279573|FG001|COMPLETED|Overall Study||24
6368871|NCT00722020|7279572|FG000|NOT COMPLETED|Overall Study||0
6368872|NCT00722020|7279573|FG001|NOT COMPLETED|Overall Study||0
6368873|NCT00722072|7279581|FG000|STARTED|Overall Study||12
6368874|NCT00722072|7279581|FG000|COMPLETED|Overall Study||9
6777864|NCT03796260|7705806|FG001|STARTED|Period 1||7
6777865|NCT03796260|7705805|FG000|COMPLETED|Period 1||7
6777866|NCT03796260|7705806|FG001|COMPLETED|Period 1||7
6777867|NCT03796260|7705805|FG000|NOT COMPLETED|Period 1||0
6777868|NCT03796260|7705806|FG001|NOT COMPLETED|Period 1||0
6777869|NCT03796260|7705805|FG000|STARTED|Period 2||7
6368875|NCT00722072|7279581|FG000|NOT COMPLETED|Overall Study||3
6368876|NCT00722111|7279587|FG000|STARTED|Overall Study||11
6368877|NCT00722111|7279588|FG001|STARTED|Overall Study||72
6368878|NCT00722111|7279587|FG000|COMPLETED|Overall Study||11
6368879|NCT00722111|7279588|FG001|COMPLETED|Overall Study||72
6368880|NCT00722111|7279587|FG000|NOT COMPLETED|Overall Study||0
6777870|NCT03796260|7705806|FG001|STARTED|Period 2||7
6777871|NCT03796260|7705805|FG000|COMPLETED|Period 2||7
6368881|NCT00722111|7279588|FG001|NOT COMPLETED|Overall Study||0
6368882|NCT00722124|7279597|FG000|STARTED|Overall Study||40
6368883|NCT00722124|7279598|FG001|STARTED|Overall Study||40
6368884|NCT00722124|7279599|FG002|STARTED|Overall Study||40
6368885|NCT00722124|7279597|FG000|COMPLETED|Overall Study||23
6368886|NCT00722124|7279598|FG001|COMPLETED|Overall Study||26
6368887|NCT00722124|7279599|FG002|COMPLETED|Overall Study||20
6368888|NCT00722124|7279597|FG000|NOT COMPLETED|Overall Study||17
6368889|NCT00722124|7279598|FG001|NOT COMPLETED|Overall Study||14
6368890|NCT00722124|7279599|FG002|NOT COMPLETED|Overall Study||20
6368891|NCT00722137|7279609|FG000|STARTED|Overall Study||244
6368892|NCT00722137|7279610|FG001|STARTED|Overall Study||243
6368893|NCT00722137|7279609|FG000|COMPLETED|Overall Study||199
6368894|NCT00722137|7279610|FG001|COMPLETED|Overall Study||195
6368895|NCT00722137|7279609|FG000|NOT COMPLETED|Overall Study||45
6368896|NCT00722137|7279610|FG001|NOT COMPLETED|Overall Study||48
6368897|NCT00722371|7279623|FG000|STARTED|Overall Study||231
6368898|NCT00722371|7279624|FG001|STARTED|Overall Study||230
6368899|NCT00722371|7279625|FG002|STARTED|Overall Study||233
6368900|NCT00722371|7279626|FG003|STARTED|Overall Study||230
6368901|NCT00722371|7279627|FG004|STARTED|Overall Study||230
6368902|NCT00722371|7279628|FG005|STARTED|Overall Study||231
6368903|NCT00722371|7279629|FG006|STARTED|Overall Study||230
6368904|NCT00722371|7279623|FG000|COMPLETED|Overall Study||175
6368905|NCT00722371|7279624|FG001|COMPLETED|Overall Study||158
6368906|NCT00722371|7279625|FG002|COMPLETED|Overall Study||168
6368907|NCT00722371|7279626|FG003|COMPLETED|Overall Study||167
6368908|NCT00722371|7279627|FG004|COMPLETED|Overall Study||182
6368909|NCT00722371|7279628|FG005|COMPLETED|Overall Study||178
6368910|NCT00722371|7279629|FG006|COMPLETED|Overall Study||179
6368911|NCT00722371|7279623|FG000|NOT COMPLETED|Overall Study||56
6368912|NCT00722371|7279624|FG001|NOT COMPLETED|Overall Study||72
6368913|NCT00722371|7279625|FG002|NOT COMPLETED|Overall Study||65
6368914|NCT00722371|7279626|FG003|NOT COMPLETED|Overall Study||63
6368915|NCT00722371|7279627|FG004|NOT COMPLETED|Overall Study||48
6368916|NCT00722371|7279628|FG005|NOT COMPLETED|Overall Study||53
6368917|NCT00722371|7279629|FG006|NOT COMPLETED|Overall Study||51
6368918|NCT00722423|7279647|FG000|STARTED|Overall Study||182
6368919|NCT00722423|7279648|FG001|STARTED|Overall Study||182
6368920|NCT00722423|7279647|FG000|COMPLETED|Overall Study||182
6368921|NCT00722423|7279648|FG001|COMPLETED|Overall Study||181
6368922|NCT00722423|7279647|FG000|NOT COMPLETED|Overall Study||0
6368923|NCT00722423|7279648|FG001|NOT COMPLETED|Overall Study||1
6368924|NCT00722436|7279658|FG000|STARTED|Overall Study||9
6368925|NCT00722436|7279659|FG001|STARTED|Overall Study||11
6368926|NCT00722436|7279658|FG000|COMPLETED|Overall Study||9
6368927|NCT00722436|7279659|FG001|COMPLETED|Overall Study||11
6368928|NCT00722436|7279658|FG000|NOT COMPLETED|Overall Study||0
6368929|NCT00722436|7279659|FG001|NOT COMPLETED|Overall Study||0
6368930|NCT00722553|7279665|FG000|STARTED|Overall Study||30
6368931|NCT00722553|7279665|FG000|COMPLETED|Overall Study||30
6368932|NCT00722553|7279665|FG000|NOT COMPLETED|Overall Study||0
6368933|NCT00722566|7279673|FG000|STARTED|Overall Study|One patient randomized and not dosed|148
6368934|NCT00722566|7279674|FG001|STARTED|Overall Study||74
6368935|NCT00722566|7279673|FG000|COMPLETED|Overall Study|Completed 8 cycles|81
6368936|NCT00722566|7279674|FG001|COMPLETED|Overall Study|Completed 8 cycles|39
6368937|NCT00722566|7279673|FG000|NOT COMPLETED|Overall Study||67
6368938|NCT00722566|7279674|FG001|NOT COMPLETED|Overall Study||35
6368939|NCT00722722|7279685|FG000|STARTED|Overall Study||3
6368940|NCT00722722|7279686|FG001|STARTED|Overall Study||5
6655124|NCT02450747|7585161|FG000|STARTED|Overall Study||39
6655125|NCT02450747|7585161|FG000|COMPLETED|Overall Study||39
6655126|NCT02450747|7585161|FG000|NOT COMPLETED|Overall Study||0
6655127|NCT02450799|7585172|FG000|STARTED|Overall Study||31
6655128|NCT02450799|7585173|FG001|STARTED|Overall Study||37
6655129|NCT02450799|7585174|FG002|STARTED|Overall Study||30
6655130|NCT02450799|7585172|FG000|COMPLETED|Overall Study||31
6655131|NCT02450799|7585173|FG001|COMPLETED|Overall Study||37
6368941|NCT00722722|7279687|FG002|STARTED|Overall Study||10
6368942|NCT00722722|7279685|FG000|COMPLETED|Overall Study||3
6368943|NCT00722722|7279686|FG001|COMPLETED|Overall Study||5
6368944|NCT00722722|7279687|FG002|COMPLETED|Overall Study||10
6368945|NCT00722722|7279685|FG000|NOT COMPLETED|Overall Study||0
6368946|NCT00722722|7279686|FG001|NOT COMPLETED|Overall Study||0
6368947|NCT00722722|7279687|FG002|NOT COMPLETED|Overall Study||0
6368948|NCT00722761|7279697|FG000|STARTED|Overall Study||16
6368949|NCT00722761|7279698|FG001|STARTED|Overall Study||14
6368950|NCT00722761|7279697|FG000|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
6368951|NCT00722761|7279698|FG001|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
6368952|NCT00722761|7279697|FG000|COMPLETED|Overall Study||10
6368953|NCT00722761|7279698|FG001|COMPLETED|Overall Study||8
6368954|NCT00722761|7279697|FG000|NOT COMPLETED|Overall Study||6
6368955|NCT00722761|7279698|FG001|NOT COMPLETED|Overall Study||6
6368956|NCT00722800|7279706|FG000|STARTED|Overall Study||2
6368957|NCT00722800|7279707|FG001|STARTED|Overall Study||2
6368958|NCT00722800|7279706|FG000|COMPLETED|Overall Study||0
6368959|NCT00722800|7279707|FG001|COMPLETED|Overall Study||2
6655132|NCT02450799|7585174|FG002|COMPLETED|Overall Study||30
6368960|NCT00722800|7279706|FG000|NOT COMPLETED|Overall Study||2
6368961|NCT00722800|7279707|FG001|NOT COMPLETED|Overall Study||0
6368962|NCT00722865|7279713|FG000|STARTED|Overall Study||25
6368963|NCT00722865|7279713|FG000|COMPLETED|Overall Study||23
6368964|NCT00722865|7279713|FG000|NOT COMPLETED|Overall Study||2
6368965|NCT00723008|7279719|FG000|STARTED|Enrollment||11
6368966|NCT00723008|7279720|FG001|STARTED|Enrollment||9
6368967|NCT00723008|7279719|FG000|COMPLETED|Enrollment||10
6368968|NCT00723008|7279720|FG001|COMPLETED|Enrollment||9
6368969|NCT00723008|7279719|FG000|NOT COMPLETED|Enrollment||1
6368970|NCT00723008|7279720|FG001|NOT COMPLETED|Enrollment||0
6368971|NCT00723008|7279719|FG000|STARTED|4-Week Double Blinded||10
6368972|NCT00723008|7279720|FG001|STARTED|4-Week Double Blinded||9
6368973|NCT00723008|7279719|FG000|COMPLETED|4-Week Double Blinded||5
6368974|NCT00723008|7279720|FG001|COMPLETED|4-Week Double Blinded||4
6368975|NCT00723008|7279719|FG000|NOT COMPLETED|4-Week Double Blinded||5
6368976|NCT00723008|7279720|FG001|NOT COMPLETED|4-Week Double Blinded||5
6368977|NCT00723008|7279719|FG000|STARTED|4-Week Unblinded Treatment||5
6368978|NCT00723008|7279720|FG001|STARTED|4-Week Unblinded Treatment||4
6368979|NCT00723008|7279719|FG000|COMPLETED|4-Week Unblinded Treatment||4
6368980|NCT00723008|7279720|FG001|COMPLETED|4-Week Unblinded Treatment||3
6368981|NCT00723008|7279719|FG000|NOT COMPLETED|4-Week Unblinded Treatment||1
6368982|NCT00723008|7279720|FG001|NOT COMPLETED|4-Week Unblinded Treatment||1
6368983|NCT00723021|7279734|FG000|STARTED|Intervention Period 1||3
6368984|NCT00723021|7279735|FG001|STARTED|Intervention Period 1||3
6368985|NCT00723021|7279736|FG002|STARTED|Intervention Period 1||3
6368986|NCT00723021|7279737|FG003|STARTED|Intervention Period 1||3
6368987|NCT00723021|7279738|FG004|STARTED|Intervention Period 1||3
6368988|NCT00723021|7279734|FG000|COMPLETED|Intervention Period 1||3
6368989|NCT00723021|7279735|FG001|COMPLETED|Intervention Period 1||3
6368990|NCT00723021|7279736|FG002|COMPLETED|Intervention Period 1||3
6368991|NCT00723021|7279737|FG003|COMPLETED|Intervention Period 1||3
6368992|NCT00723021|7279738|FG004|COMPLETED|Intervention Period 1||3
6368993|NCT00723021|7279734|FG000|NOT COMPLETED|Intervention Period 1||0
6368994|NCT00723021|7279735|FG001|NOT COMPLETED|Intervention Period 1||0
6368995|NCT00723021|7279736|FG002|NOT COMPLETED|Intervention Period 1||0
6368996|NCT00723021|7279737|FG003|NOT COMPLETED|Intervention Period 1||0
6368997|NCT00723021|7279738|FG004|NOT COMPLETED|Intervention Period 1||0
6368998|NCT00723021|7279734|FG000|STARTED|Intervention Period 2||3
6368999|NCT00723021|7279735|FG001|STARTED|Intervention Period 2||3
6369000|NCT00723021|7279736|FG002|STARTED|Intervention Period 2||3
6369001|NCT00723021|7279737|FG003|STARTED|Intervention Period 2||3
6369002|NCT00723021|7279738|FG004|STARTED|Intervention Period 2||3
6369003|NCT00723021|7279734|FG000|COMPLETED|Intervention Period 2||3
6369004|NCT00723021|7279735|FG001|COMPLETED|Intervention Period 2||3
6369005|NCT00723021|7279736|FG002|COMPLETED|Intervention Period 2||3
6369006|NCT00723021|7279737|FG003|COMPLETED|Intervention Period 2||3
6369007|NCT00723021|7279738|FG004|COMPLETED|Intervention Period 2||3
6369008|NCT00723021|7279734|FG000|NOT COMPLETED|Intervention Period 2||0
6369009|NCT00723021|7279735|FG001|NOT COMPLETED|Intervention Period 2||0
6369010|NCT00723021|7279736|FG002|NOT COMPLETED|Intervention Period 2||0
6369011|NCT00723021|7279737|FG003|NOT COMPLETED|Intervention Period 2||0
6369012|NCT00723021|7279738|FG004|NOT COMPLETED|Intervention Period 2||0
6369013|NCT00723021|7279734|FG000|STARTED|Intervention Period 3||3
6369014|NCT00723021|7279735|FG001|STARTED|Intervention Period 3||3
6369015|NCT00723021|7279736|FG002|STARTED|Intervention Period 3||3
6369016|NCT00723021|7279737|FG003|STARTED|Intervention Period 3||3
6369017|NCT00723021|7279738|FG004|STARTED|Intervention Period 3||3
6369018|NCT00723021|7279734|FG000|COMPLETED|Intervention Period 3||3
6369019|NCT00723021|7279735|FG001|COMPLETED|Intervention Period 3||3
6369020|NCT00723021|7279736|FG002|COMPLETED|Intervention Period 3||3
6369021|NCT00723021|7279737|FG003|COMPLETED|Intervention Period 3||3
6369022|NCT00723021|7279738|FG004|COMPLETED|Intervention Period 3||3
6369023|NCT00723021|7279734|FG000|NOT COMPLETED|Intervention Period 3||0
6369024|NCT00723021|7279735|FG001|NOT COMPLETED|Intervention Period 3||0
6369025|NCT00723021|7279736|FG002|NOT COMPLETED|Intervention Period 3||0
6369026|NCT00723021|7279737|FG003|NOT COMPLETED|Intervention Period 3||0
6369027|NCT00723021|7279738|FG004|NOT COMPLETED|Intervention Period 3||0
6369028|NCT00723021|7279734|FG000|STARTED|Intervention Period 4||3
6369029|NCT00723021|7279735|FG001|STARTED|Intervention Period 4||3
6369030|NCT00723021|7279736|FG002|STARTED|Intervention Period 4||3
6369031|NCT00723021|7279737|FG003|STARTED|Intervention Period 4||3
6369032|NCT00723021|7279738|FG004|STARTED|Intervention Period 4||3
6369033|NCT00723021|7279734|FG000|COMPLETED|Intervention Period 4||3
6369034|NCT00723021|7279735|FG001|COMPLETED|Intervention Period 4||3
6560857|NCT01790295|7483763|FG000|STARTED|Overall Study||21
6560858|NCT01790295|7483763|FG000|COMPLETED|Overall Study||10
6560859|NCT01790295|7483763|FG000|NOT COMPLETED|Overall Study||11
6560860|NCT01790438|7483770|FG000|STARTED|Overall Study||428
6560861|NCT01790438|7483771|FG001|STARTED|Overall Study||213
6560862|NCT01790438|7483770|FG000|Received at Least One Dose of Study Drug|Overall Study||427
6560863|NCT01790438|7483771|FG001|Received at Least One Dose of Study Drug|Overall Study||212
6560864|NCT01790438|7483770|FG000|COMPLETED|Overall Study||393
6369035|NCT00723021|7279736|FG002|COMPLETED|Intervention Period 4||3
6369036|NCT00723021|7279737|FG003|COMPLETED|Intervention Period 4||3
6369037|NCT00723021|7279738|FG004|COMPLETED|Intervention Period 4||2
6560865|NCT01790438|7483771|FG001|COMPLETED|Overall Study||202
6560866|NCT01790438|7483770|FG000|NOT COMPLETED|Overall Study||35
6369038|NCT00723021|7279734|FG000|NOT COMPLETED|Intervention Period 4||0
6369039|NCT00723021|7279735|FG001|NOT COMPLETED|Intervention Period 4||0
6369040|NCT00723021|7279736|FG002|NOT COMPLETED|Intervention Period 4||0
6369041|NCT00723021|7279737|FG003|NOT COMPLETED|Intervention Period 4||0
6560867|NCT01790438|7483771|FG001|NOT COMPLETED|Overall Study||11
6369042|NCT00723021|7279738|FG004|NOT COMPLETED|Intervention Period 4||1
6369043|NCT00723021|7279734|FG000|STARTED|Intervention Period 5||3
6369044|NCT00723021|7279735|FG001|STARTED|Intervention Period 5||3
6369045|NCT00723021|7279736|FG002|STARTED|Intervention Period 5||3
6369046|NCT00723021|7279737|FG003|STARTED|Intervention Period 5||3
6369047|NCT00723021|7279738|FG004|STARTED|Intervention Period 5||2
6369048|NCT00723021|7279734|FG000|COMPLETED|Intervention Period 5||3
6369049|NCT00723021|7279735|FG001|COMPLETED|Intervention Period 5||3
6369050|NCT00723021|7279736|FG002|COMPLETED|Intervention Period 5||3
6369051|NCT00723021|7279737|FG003|COMPLETED|Intervention Period 5||3
6369052|NCT00723021|7279738|FG004|COMPLETED|Intervention Period 5||2
6369053|NCT00723021|7279734|FG000|NOT COMPLETED|Intervention Period 5||0
6369054|NCT00723021|7279735|FG001|NOT COMPLETED|Intervention Period 5||0
6369055|NCT00723021|7279736|FG002|NOT COMPLETED|Intervention Period 5||0
6369056|NCT00723021|7279737|FG003|NOT COMPLETED|Intervention Period 5||0
6369057|NCT00723021|7279738|FG004|NOT COMPLETED|Intervention Period 5||0
6369058|NCT00723073|7279759|FG000|STARTED|Overall Study||149
6369059|NCT00723073|7279760|FG001|STARTED|Overall Study||174
6369060|NCT00723073|7279759|FG000|COMPLETED|Overall Study||149
6369061|NCT00723073|7279760|FG001|COMPLETED|Overall Study||174
6369062|NCT00723073|7279759|FG000|NOT COMPLETED|Overall Study||0
6369063|NCT00723073|7279760|FG001|NOT COMPLETED|Overall Study||0
6369064|NCT00723099|7279766|FG000|STARTED|Overall Study||73
6369065|NCT00723099|7279766|FG000|COMPLETED|Overall Study||72
6369066|NCT00723099|7279766|FG000|NOT COMPLETED|Overall Study||1
6369067|NCT00723125|7279773|FG000|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
6369068|NCT00723125|7279774|FG001|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
6369069|NCT00723125|7279773|FG000|COMPLETED|Overall Study||15
6369070|NCT00723125|7279774|FG001|COMPLETED|Overall Study||21
6369071|NCT00723125|7279773|FG000|NOT COMPLETED|Overall Study||18
6369072|NCT00723125|7279774|FG001|NOT COMPLETED|Overall Study||6
6369073|NCT00723177|7279789|FG000|STARTED|Overall Study||15
6369074|NCT00723177|7279790|FG001|STARTED|Overall Study||14
6369075|NCT00723177|7279791|FG002|STARTED|Overall Study||15
6369076|NCT00723177|7279789|FG000|COMPLETED|Overall Study||10
6369077|NCT00723177|7279790|FG001|COMPLETED|Overall Study||10
6560868|NCT01790490|7483782|FG000|STARTED|Overall Study||3
6560869|NCT01790490|7483783|FG001|STARTED|Overall Study||3
6560870|NCT01790490|7483784|FG002|STARTED|Overall Study||2
6560871|NCT01790490|7483782|FG000|COMPLETED|Overall Study||3
6560872|NCT01790490|7483783|FG001|COMPLETED|Overall Study||3
6560873|NCT01790490|7483784|FG002|COMPLETED|Overall Study||2
6369078|NCT00723177|7279791|FG002|COMPLETED|Overall Study||10
6369079|NCT00723177|7279789|FG000|NOT COMPLETED|Overall Study||5
6369080|NCT00723177|7279790|FG001|NOT COMPLETED|Overall Study||4
6369081|NCT00723177|7279791|FG002|NOT COMPLETED|Overall Study||5
6369082|NCT00723190|7279799|FG000|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
6369083|NCT00723190|7279799|FG000|SAFETY POPULATION|Overall Study||301
6369084|NCT00723190|7279799|FG000|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
6369085|NCT00723190|7279799|FG000|NOT COMPLETED|Overall Study||142
6369086|NCT00723203|7279803|FG000|STARTED|Overall Study||16
6369087|NCT00723203|7279803|FG000|COMPLETED|Overall Study||13
6369088|NCT00723203|7279803|FG000|NOT COMPLETED|Overall Study||3
6369089|NCT00723229|7279809|FG000|STARTED|First Intervention||25
6369090|NCT00723229|7279810|FG001|STARTED|First Intervention||23
6369091|NCT00723229|7279809|FG000|COMPLETED|First Intervention||18
6369092|NCT00723229|7279810|FG001|COMPLETED|First Intervention||20
6369093|NCT00723229|7279809|FG000|NOT COMPLETED|First Intervention||7
6369094|NCT00723229|7279810|FG001|NOT COMPLETED|First Intervention||3
6369095|NCT00723229|7279809|FG000|STARTED|Second Intervention||18
6369096|NCT00723229|7279810|FG001|STARTED|Second Intervention||20
6369097|NCT00723229|7279809|FG000|COMPLETED|Second Intervention||18
6560874|NCT01790490|7483782|FG000|NOT COMPLETED|Overall Study||0
6560875|NCT01790490|7483783|FG001|NOT COMPLETED|Overall Study||0
6560876|NCT01790490|7483784|FG002|NOT COMPLETED|Overall Study||0
6560877|NCT01790503|7483806|FG000|STARTED|Overall Study||3
6560878|NCT01790503|7483807|FG001|STARTED|Overall Study||1
6369098|NCT00723229|7279810|FG001|COMPLETED|Second Intervention||20
6369099|NCT00723229|7279809|FG000|NOT COMPLETED|Second Intervention||0
6369100|NCT00723229|7279810|FG001|NOT COMPLETED|Second Intervention||0
6369101|NCT00723255|7279816|FG000|STARTED|Overall Study||53
6369102|NCT00723255|7279816|FG000|COMPLETED|Overall Study|Eligible and treated patients|49
6369103|NCT00723255|7279816|FG000|NOT COMPLETED|Overall Study||4
6369104|NCT00723294|7279832|FG000|STARTED|Overall Study||99
6369105|NCT00723294|7279832|FG000|COMPLETED|Overall Study||86
6369106|NCT00723294|7279832|FG000|NOT COMPLETED|Overall Study||13
6369107|NCT00723398|7279841|FG000|STARTED|Overall Study||53
6369108|NCT00723398|7279842|FG001|STARTED|Overall Study||53
6369109|NCT00723398|7279843|FG002|STARTED|Overall Study||53
6369110|NCT00723398|7279844|FG003|STARTED|Overall Study||54
6369111|NCT00723398|7279845|FG004|STARTED|Overall Study||53
6369112|NCT00723398|7279841|FG000|COMPLETED|Overall Study||47
6369113|NCT00723398|7279842|FG001|COMPLETED|Overall Study||38
6560879|NCT01790503|7483808|FG002|STARTED|Overall Study||1
6369114|NCT00723398|7279843|FG002|COMPLETED|Overall Study||36
6369115|NCT00723398|7279844|FG003|COMPLETED|Overall Study||49
6369116|NCT00723398|7279845|FG004|COMPLETED|Overall Study||44
6369117|NCT00723398|7279841|FG000|NOT COMPLETED|Overall Study||6
6369118|NCT00723398|7279842|FG001|NOT COMPLETED|Overall Study||15
6369119|NCT00723398|7279843|FG002|NOT COMPLETED|Overall Study||17
6369120|NCT00723398|7279844|FG003|NOT COMPLETED|Overall Study||5
6369121|NCT00723398|7279845|FG004|NOT COMPLETED|Overall Study||9
6369122|NCT00723450|7279859|FG000|STARTED|Open-Label Phase||298
6369123|NCT00723450|7279860|FG001|STARTED|Open-Label Phase||0
6369124|NCT00723450|7279861|FG002|STARTED|Open-Label Phase||0
6369125|NCT00723450|7279859|FG000|COMPLETED|Open-Label Phase||173
6369126|NCT00723450|7279860|FG001|COMPLETED|Open-Label Phase||0
6369127|NCT00723450|7279861|FG002|COMPLETED|Open-Label Phase||0
6369128|NCT00723450|7279859|FG000|NOT COMPLETED|Open-Label Phase||125
6369129|NCT00723450|7279860|FG001|NOT COMPLETED|Open-Label Phase||0
6369130|NCT00723450|7279861|FG002|NOT COMPLETED|Open-Label Phase||0
6369131|NCT00723450|7279859|FG000|STARTED|Randomized Phase||0
6369132|NCT00723450|7279860|FG001|STARTED|Randomized Phase||86
6369133|NCT00723450|7279861|FG002|STARTED|Randomized Phase||87
6369134|NCT00723450|7279859|FG000|COMPLETED|Randomized Phase||0
6369135|NCT00723450|7279860|FG001|COMPLETED|Randomized Phase||21
6369136|NCT00723450|7279861|FG002|COMPLETED|Randomized Phase||20
6369137|NCT00723450|7279859|FG000|NOT COMPLETED|Randomized Phase||0
6369138|NCT00723450|7279860|FG001|NOT COMPLETED|Randomized Phase||65
6369139|NCT00723450|7279861|FG002|NOT COMPLETED|Randomized Phase||67
6369140|NCT00723489|7279874|FG000|STARTED|Overall Study||21
6369141|NCT00723489|7279875|FG001|STARTED|Overall Study||19
6369142|NCT00723489|7279876|FG002|STARTED|Overall Study||19
6369143|NCT00723489|7279877|FG003|STARTED|Overall Study||23
6369144|NCT00723489|7279874|FG000|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
6369145|NCT00723489|7279875|FG001|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
6369146|NCT00723489|7279876|FG002|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
6369147|NCT00723489|7279877|FG003|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
6369148|NCT00723489|7279874|FG000|NOT COMPLETED|Overall Study||1
6369149|NCT00723489|7279875|FG001|NOT COMPLETED|Overall Study||4
6369150|NCT00723489|7279876|FG002|NOT COMPLETED|Overall Study||0
6369151|NCT00723489|7279877|FG003|NOT COMPLETED|Overall Study||3
6369152|NCT00723528|7279890|FG000|STARTED|Period 1: Controlled Period (CP)||32
6369153|NCT00723528|7279891|FG001|STARTED|Period 1: Controlled Period (CP)||64
6369154|NCT00723528|7279892|FG002|STARTED|Period 1: Controlled Period (CP)||62
6369155|NCT00723528|7279893|FG003|STARTED|Period 1: Controlled Period (CP)||0
6369156|NCT00723528|7279894|FG004|STARTED|Period 1: Controlled Period (CP)||0
6369157|NCT00723528|7279895|FG005|STARTED|Period 1: Controlled Period (CP)||0
6369158|NCT00723528|7279896|FG006|STARTED|Period 1: Controlled Period (CP)||0
6369159|NCT00723528|7279890|FG000|COMPLETED|Period 1: Controlled Period (CP)||28
6369160|NCT00723528|7279891|FG001|COMPLETED|Period 1: Controlled Period (CP)||64
6369161|NCT00723528|7279892|FG002|COMPLETED|Period 1: Controlled Period (CP)||58
6369162|NCT00723528|7279893|FG003|COMPLETED|Period 1: Controlled Period (CP)||0
6369163|NCT00723528|7279894|FG004|COMPLETED|Period 1: Controlled Period (CP)||0
6369164|NCT00723528|7279895|FG005|COMPLETED|Period 1: Controlled Period (CP)||0
6369165|NCT00723528|7279896|FG006|COMPLETED|Period 1: Controlled Period (CP)||0
6369166|NCT00723528|7279890|FG000|NOT COMPLETED|Period 1: Controlled Period (CP)||4
6369167|NCT00723528|7279891|FG001|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6369168|NCT00723528|7279892|FG002|NOT COMPLETED|Period 1: Controlled Period (CP)||4
6369169|NCT00723528|7279893|FG003|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6369170|NCT00723528|7279894|FG004|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6369171|NCT00723528|7279895|FG005|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6560880|NCT01790503|7483809|FG003|STARTED|Overall Study||2
6560881|NCT01790503|7483810|FG004|STARTED|Overall Study||5
6560882|NCT01790503|7483811|FG005|STARTED|Overall Study||5
6560883|NCT01790503|7483812|FG006|STARTED|Overall Study||1
6560884|NCT01790503|7483813|FG007|STARTED|Overall Study||1
6369172|NCT00723528|7279896|FG006|NOT COMPLETED|Period 1: Controlled Period (CP)||0
6369173|NCT00723528|7279890|FG000|STARTED|Period 2: After Controlled Period||0
6369174|NCT00723528|7279891|FG001|STARTED|Period 2: After Controlled Period||0
6369175|NCT00723528|7279892|FG002|STARTED|Period 2: After Controlled Period||0
6369176|NCT00723528|7279893|FG003|STARTED|Period 2: After Controlled Period||15
6369177|NCT00723528|7279894|FG004|STARTED|Period 2: After Controlled Period||13
6369178|NCT00723528|7279895|FG005|STARTED|Period 2: After Controlled Period||64
6369179|NCT00723528|7279896|FG006|STARTED|Period 2: After Controlled Period||58
6369180|NCT00723528|7279890|FG000|COMPLETED|Period 2: After Controlled Period||0
6369181|NCT00723528|7279891|FG001|COMPLETED|Period 2: After Controlled Period||0
6369182|NCT00723528|7279892|FG002|COMPLETED|Period 2: After Controlled Period||0
6369183|NCT00723528|7279893|FG003|COMPLETED|Period 2: After Controlled Period||14
6369184|NCT00723528|7279894|FG004|COMPLETED|Period 2: After Controlled Period||11
6369185|NCT00723528|7279895|FG005|COMPLETED|Period 2: After Controlled Period||58
6369186|NCT00723528|7279896|FG006|COMPLETED|Period 2: After Controlled Period||54
6369187|NCT00723528|7279890|FG000|NOT COMPLETED|Period 2: After Controlled Period||0
6369188|NCT00723528|7279891|FG001|NOT COMPLETED|Period 2: After Controlled Period||0
6369189|NCT00723528|7279892|FG002|NOT COMPLETED|Period 2: After Controlled Period||0
6369190|NCT00723528|7279893|FG003|NOT COMPLETED|Period 2: After Controlled Period||1
6369191|NCT00723528|7279894|FG004|NOT COMPLETED|Period 2: After Controlled Period||2
6377615|NCT00763815|7288198|FG001|COMPLETED|Overall Study||239
6560885|NCT01790503|7483814|FG008|STARTED|Overall Study||3
6369192|NCT00723528|7279895|FG005|NOT COMPLETED|Period 2: After Controlled Period||6
6369193|NCT00723528|7279896|FG006|NOT COMPLETED|Period 2: After Controlled Period||4
6369194|NCT00723554|7279912|FG000|STARTED|Overall Study||63
6369195|NCT00723554|7279912|FG000|COMPLETED|Overall Study||34
6369196|NCT00723554|7279912|FG000|NOT COMPLETED|Overall Study||29
6369197|NCT00723580|7279918|FG000|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
6369198|NCT00723580|7279918|FG000|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
6369199|NCT00723580|7279918|FG000|COMPLETED|Overall Study|Completion of repeated Measurements|1
6369200|NCT00723580|7279918|FG000|NOT COMPLETED|Overall Study||0
6369201|NCT00723606|7279924|FG000|STARTED|Overall Study||189
6369202|NCT00723606|7279925|FG001|STARTED|Overall Study||187
6369203|NCT00723606|7279924|FG000|COMPLETED|Overall Study||185
6369204|NCT00723606|7279925|FG001|COMPLETED|Overall Study||180
6369205|NCT00723606|7279924|FG000|NOT COMPLETED|Overall Study||4
6369206|NCT00723606|7279925|FG001|NOT COMPLETED|Overall Study||7
6369207|NCT00723632|7279931|FG000|STARTED|Overall Study||901
6369208|NCT00723632|7279931|FG000|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
6369209|NCT00723632|7279931|FG000|NOT COMPLETED|Overall Study||203
6369210|NCT00723645|7279935|FG000|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
6369211|NCT00723645|7279935|FG000|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
6369212|NCT00723645|7279935|FG000|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
6369213|NCT00723645|7279935|FG000|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
6369214|NCT00723645|7279935|FG000|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
6369215|NCT00723645|7279935|FG000|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
6369216|NCT00723645|7279935|FG000|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
6369217|NCT00723645|7279935|FG000|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
6369218|NCT00723645|7279935|FG000|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
6369219|NCT00723697|7279939|FG000|STARTED|Overall Study||1307
6369220|NCT00723697|7279939|FG000|COMPLETED|Overall Study||1289
6369221|NCT00723697|7279939|FG000|NOT COMPLETED|Overall Study||18
6369222|NCT00723710|7279946|FG000|STARTED|Overall Study||294
6369223|NCT00723710|7279946|FG000|COMPLETED|Overall Study||120
6369224|NCT00723710|7279946|FG000|NOT COMPLETED|Overall Study||174
6369225|NCT00723749|7279950|FG000|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
6369226|NCT00723749|7279950|FG000|COMPLETED|Overall Study||182
6369227|NCT00723749|7279950|FG000|NOT COMPLETED|Overall Study||163
6369228|NCT00723788|7279954|FG000|STARTED|Overall Study||21
6369229|NCT00723788|7279954|FG000|COMPLETED|Overall Study||21
6369230|NCT00723788|7279954|FG000|NOT COMPLETED|Overall Study||0
6369231|NCT00723801|7279962|FG000|STARTED|Overall Study||20
6369232|NCT00723801|7279963|FG001|STARTED|Overall Study||20
6369233|NCT00723801|7279962|FG000|COMPLETED|Overall Study||17
6369234|NCT00723801|7279963|FG001|COMPLETED|Overall Study||17
6369235|NCT00723801|7279962|FG000|NOT COMPLETED|Overall Study||3
6369236|NCT00723801|7279963|FG001|NOT COMPLETED|Overall Study||3
6369237|NCT00723827|7279969|FG000|STARTED|Overall Study||682
6369238|NCT00723827|7279969|FG000|COMPLETED|Overall Study||682
6369239|NCT00723827|7279969|FG000|NOT COMPLETED|Overall Study||0
6369240|NCT00723840|7279973|FG000|STARTED|Overall Study||245
6369241|NCT00723840|7279973|FG000|COMPLETED|Overall Study||163
6369242|NCT00723840|7279973|FG000|NOT COMPLETED|Overall Study||82
6369243|NCT00723892|7279986|FG000|STARTED|Overall Study||313
6369244|NCT00723892|7279987|FG001|STARTED|Overall Study||255
6369245|NCT00723892|7279986|FG000|COMPLETED|Overall Study||206
6369246|NCT00723892|7279987|FG001|COMPLETED|Overall Study||168
6369247|NCT00723892|7279986|FG000|NOT COMPLETED|Overall Study||107
6369248|NCT00723892|7279987|FG001|NOT COMPLETED|Overall Study||87
6369249|NCT00723931|7279993|FG000|STARTED|Overall Study||1267
6369250|NCT00723931|7279993|FG000|COMPLETED|Overall Study||1267
6369251|NCT00723931|7279993|FG000|NOT COMPLETED|Overall Study||0
6369252|NCT00723957|7279999|FG000|STARTED|Overall Study|Randomized|98
6369253|NCT00723957|7280000|FG001|STARTED|Overall Study|Randomized|99
6369254|NCT00723957|7279999|FG000|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
6369255|NCT00723957|7280000|FG001|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
6369256|NCT00723957|7279999|FG000|NOT COMPLETED|Overall Study||51
6369257|NCT00723957|7280000|FG001|NOT COMPLETED|Overall Study||53
6369258|NCT00724009|7280006|FG000|STARTED|Overall Study||29
6369259|NCT00724009|7280006|FG000|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
6560886|NCT01790503|7483815|FG009|STARTED|Overall Study||27
6560887|NCT01790503|7483816|FG010|STARTED|Overall Study||16
6560888|NCT01790503|7483806|FG000|COMPLETED|Overall Study||0
6369260|NCT00724009|7280006|FG000|NOT COMPLETED|Overall Study||0
6369261|NCT00724061|7280010|FG000|STARTED|Dose Escalation Phase||7
6369262|NCT00724061|7280010|FG000|COMPLETED|Dose Escalation Phase||2
6369263|NCT00724061|7280010|FG000|NOT COMPLETED|Dose Escalation Phase||5
6369264|NCT00724061|7280010|FG000|STARTED|Maintenance Therapy||2
6560889|NCT01790503|7483807|FG001|COMPLETED|Overall Study||0
6369265|NCT00724061|7280010|FG000|COMPLETED|Maintenance Therapy||2
6369266|NCT00724061|7280010|FG000|NOT COMPLETED|Maintenance Therapy||0
6369267|NCT00724126|7280016|FG000|STARTED|Overall Study||321
6369268|NCT00724126|7280017|FG001|STARTED|Overall Study||316
6369269|NCT00724126|7280016|FG000|COMPLETED|Overall Study||302
6369270|NCT00724126|7280017|FG001|COMPLETED|Overall Study||301
6369271|NCT00724126|7280016|FG000|NOT COMPLETED|Overall Study||19
6369272|NCT00724126|7280017|FG001|NOT COMPLETED|Overall Study||15
6369273|NCT00724152|7280028|FG000|STARTED|Two-arm Study Period||14
6369274|NCT00724152|7280029|FG001|STARTED|Two-arm Study Period||11
6369275|NCT00724152|7280030|FG002|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
6369276|NCT00724152|7280028|FG000|COMPLETED|Two-arm Study Period||11
6369277|NCT00724152|7280029|FG001|COMPLETED|Two-arm Study Period||9
6369278|NCT00724152|7280030|FG002|COMPLETED|Two-arm Study Period||0
6369279|NCT00724152|7280028|FG000|NOT COMPLETED|Two-arm Study Period||3
6369280|NCT00724152|7280029|FG001|NOT COMPLETED|Two-arm Study Period||2
6369281|NCT00724152|7280030|FG002|NOT COMPLETED|Two-arm Study Period||0
6369282|NCT00724152|7280028|FG000|STARTED|Three-arm Study Period (+Standard Care)||4
6369283|NCT00724152|7280029|FG001|STARTED|Three-arm Study Period (+Standard Care)||2
6369284|NCT00724152|7280030|FG002|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
6369285|NCT00724152|7280028|FG000|COMPLETED|Three-arm Study Period (+Standard Care)||3
6369286|NCT00724152|7280029|FG001|COMPLETED|Three-arm Study Period (+Standard Care)||0
6369287|NCT00724152|7280030|FG002|COMPLETED|Three-arm Study Period (+Standard Care)||1
6369288|NCT00724152|7280028|FG000|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
6369289|NCT00724152|7280029|FG001|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
6369290|NCT00724152|7280030|FG002|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
6369291|NCT00724243|7280040|FG000|STARTED|Overall Study||33
6369292|NCT00724243|7280040|FG000|COMPLETED|Overall Study||18
6369293|NCT00724243|7280040|FG000|NOT COMPLETED|Overall Study||15
6369294|NCT00724308|7280046|FG000|STARTED|Overall Study||270
6369295|NCT00724308|7280047|FG001|STARTED|Overall Study||307
6369296|NCT00724308|7280046|FG000|COMPLETED|Overall Study||190
6369297|NCT00724308|7280047|FG001|COMPLETED|Overall Study||210
6369298|NCT00724308|7280046|FG000|NOT COMPLETED|Overall Study||80
6369299|NCT00724308|7280047|FG001|NOT COMPLETED|Overall Study||97
6369300|NCT00724347|7280053|FG000|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
6369301|NCT00724347|7280053|FG000|Baseline Testing|Overall Study||18
6369302|NCT00724347|7280053|FG000|COMPLETED|Overall Study||16
6369303|NCT00724347|7280053|FG000|NOT COMPLETED|Overall Study||2
6369304|NCT00724373|7280057|FG000|STARTED|Overall Study||442
6369305|NCT00724373|7280057|FG000|COMPLETED|Overall Study||271
6369306|NCT00724373|7280057|FG000|NOT COMPLETED|Overall Study||171
6369307|NCT00724451|7280061|FG000|STARTED|Overall Study||1128
6369308|NCT00724451|7280061|FG000|Received Antiviral Treatment|Overall Study||500
6369309|NCT00724451|7280061|FG000|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
6369310|NCT00724451|7280061|FG000|NOT COMPLETED|Overall Study||802
6369311|NCT00724464|7280065|FG000|STARTED|Overall Study||332
6369312|NCT00724464|7280065|FG000|COMPLETED|Overall Study||309
6369313|NCT00724464|7280065|FG000|NOT COMPLETED|Overall Study||23
6369314|NCT00724503|7280072|FG000|STARTED|Overall Study||267
6369315|NCT00724503|7280073|FG001|STARTED|Overall Study||263
6369316|NCT00724503|7280072|FG000|COMPLETED|Overall Study||57
6369317|NCT00724503|7280073|FG001|COMPLETED|Overall Study||43
6369318|NCT00724503|7280072|FG000|NOT COMPLETED|Overall Study||210
6369319|NCT00724503|7280073|FG001|NOT COMPLETED|Overall Study||220
6369320|NCT00724568|7280081|FG000|STARTED|Overall Study||42
6369321|NCT00724568|7280082|FG001|STARTED|Overall Study||32
6369322|NCT00724568|7280081|FG000|COMPLETED|Overall Study||42
6369323|NCT00724568|7280082|FG001|COMPLETED|Overall Study||32
6369324|NCT00724568|7280081|FG000|NOT COMPLETED|Overall Study||0
6369325|NCT00724568|7280082|FG001|NOT COMPLETED|Overall Study||0
6369326|NCT00724594|7280090|FG000|STARTED|Overall Study||12
6369327|NCT00724594|7280091|FG001|STARTED|Overall Study||12
6369328|NCT00724594|7280092|FG002|STARTED|Overall Study||11
6369329|NCT00724594|7280093|FG003|STARTED|Overall Study||11
6369330|NCT00724594|7280090|FG000|COMPLETED|Overall Study||12
6369331|NCT00724594|7280091|FG001|COMPLETED|Overall Study||12
6369332|NCT00724594|7280092|FG002|COMPLETED|Overall Study||11
6369333|NCT00724594|7280093|FG003|COMPLETED|Overall Study||10
6369334|NCT00724594|7280090|FG000|NOT COMPLETED|Overall Study||0
6369335|NCT00724594|7280091|FG001|NOT COMPLETED|Overall Study||0
6369336|NCT00724594|7280092|FG002|NOT COMPLETED|Overall Study||0
6369337|NCT00724594|7280093|FG003|NOT COMPLETED|Overall Study||1
6369338|NCT00724711|7280120|FG000|STARTED|Overall Study||155
6369339|NCT00724711|7280121|FG001|STARTED|Overall Study||156
6369340|NCT00724711|7280120|FG000|COMPLETED|Overall Study||138
6369341|NCT00724711|7280121|FG001|COMPLETED|Overall Study||139
6369342|NCT00724711|7280120|FG000|NOT COMPLETED|Overall Study||17
6369343|NCT00724711|7280121|FG001|NOT COMPLETED|Overall Study||17
6369344|NCT00724750|7280129|FG000|STARTED|Overall Study||45
6369345|NCT00724750|7280130|FG001|STARTED|Overall Study||42
6369346|NCT00724750|7280129|FG000|COMPLETED|Overall Study||45
6369347|NCT00724750|7280130|FG001|COMPLETED|Overall Study||42
6369348|NCT00724750|7280129|FG000|NOT COMPLETED|Overall Study||0
6369349|NCT00724750|7280130|FG001|NOT COMPLETED|Overall Study||0
6369350|NCT00724815|7280138|FG000|STARTED|Overall Study|subjects randomized|265
6369351|NCT00724815|7280139|FG001|STARTED|Overall Study|subjects randomized|265
6369352|NCT00724815|7280138|FG000|COMPLETED|Overall Study||222
6369353|NCT00724815|7280139|FG001|COMPLETED|Overall Study||226
6369354|NCT00724815|7280138|FG000|NOT COMPLETED|Overall Study||43
6369355|NCT00724815|7280139|FG001|NOT COMPLETED|Overall Study||39
6369356|NCT00724854|7280147|FG000|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
6369357|NCT00724854|7280148|FG001|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
6369358|NCT00724854|7280147|FG000|COMPLETED|Overall Study||607
6369359|NCT00724854|7280148|FG001|COMPLETED|Overall Study||41
6369360|NCT00724854|7280147|FG000|NOT COMPLETED|Overall Study||403
6369361|NCT00724854|7280148|FG001|NOT COMPLETED|Overall Study||31
6369362|NCT00724867|7280155|FG000|STARTED|Overall Study||268
6369363|NCT00724867|7280155|FG000|COMPLETED|Overall Study||140
6369364|NCT00724867|7280155|FG000|NOT COMPLETED|Overall Study||128
6369365|NCT00724893|7280164|FG000|STARTED|Overall Study||1302
6369366|NCT00724893|7280165|FG001|STARTED|Overall Study||1128
6369367|NCT00724893|7280164|FG000|COMPLETED|Overall Study||938
6369368|NCT00724893|7280165|FG001|COMPLETED|Overall Study||670
6369369|NCT00724893|7280164|FG000|NOT COMPLETED|Overall Study||364
6369370|NCT00724893|7280165|FG001|NOT COMPLETED|Overall Study||458
6369371|NCT00724932|7280188|FG000|STARTED|Overall Study||70
6369372|NCT00724932|7280189|FG001|STARTED|Overall Study||70
6369373|NCT00724932|7280188|FG000|COMPLETED|Overall Study||65
6369374|NCT00724932|7280189|FG001|COMPLETED|Overall Study||67
6369375|NCT00724932|7280188|FG000|NOT COMPLETED|Overall Study||5
6369376|NCT00724932|7280189|FG001|NOT COMPLETED|Overall Study||3
6369377|NCT00724945|7280197|FG000|STARTED|Period 1||58
6369378|NCT00724945|7280198|FG001|STARTED|Period 1||55
6369379|NCT00724945|7280197|FG000|COMPLETED|Period 1||55
6369380|NCT00724945|7280198|FG001|COMPLETED|Period 1||54
6369381|NCT00724945|7280197|FG000|NOT COMPLETED|Period 1||3
6369382|NCT00724945|7280198|FG001|NOT COMPLETED|Period 1||1
6369383|NCT00724945|7280197|FG000|STARTED|Period 2||55
6369384|NCT00724945|7280198|FG001|STARTED|Period 2||54
6369385|NCT00724945|7280197|FG000|COMPLETED|Period 2||51
6369386|NCT00724945|7280198|FG001|COMPLETED|Period 2||54
6369387|NCT00724945|7280197|FG000|NOT COMPLETED|Period 2||4
6369388|NCT00724945|7280198|FG001|NOT COMPLETED|Period 2||0
6369389|NCT00724958|7280204|FG000|STARTED|Overall Study||348
6369390|NCT00724958|7280204|FG000|COMPLETED|Overall Study||166
6369391|NCT00724958|7280204|FG000|NOT COMPLETED|Overall Study||182
6369392|NCT00724971|7280208|FG000|STARTED|Overall Study||10
6369393|NCT00724971|7280208|FG000|COMPLETED|Overall Study||4
6369394|NCT00724971|7280208|FG000|NOT COMPLETED|Overall Study||6
6369395|NCT00724984|7280218|FG000|STARTED|Overall Study||5
6560890|NCT01790503|7483808|FG002|COMPLETED|Overall Study||0
6560891|NCT01790503|7483809|FG003|COMPLETED|Overall Study||0
6560892|NCT01790503|7483810|FG004|COMPLETED|Overall Study||0
6560893|NCT01790503|7483811|FG005|COMPLETED|Overall Study||0
6369396|NCT00724984|7280219|FG001|STARTED|Overall Study||8
6369397|NCT00724984|7280220|FG002|STARTED|Overall Study||3
6369398|NCT00724984|7280221|FG003|STARTED|Overall Study||9
6369399|NCT00724984|7280222|FG004|STARTED|Overall Study||16
6369400|NCT00724984|7280223|FG005|STARTED|Overall Study||14
6369401|NCT00724984|7280218|FG000|COMPLETED|Overall Study||4
6369402|NCT00724984|7280219|FG001|COMPLETED|Overall Study||7
6369403|NCT00724984|7280220|FG002|COMPLETED|Overall Study||3
6369404|NCT00724984|7280221|FG003|COMPLETED|Overall Study||7
6369405|NCT00724984|7280222|FG004|COMPLETED|Overall Study||12
6369406|NCT00724984|7280223|FG005|COMPLETED|Overall Study||9
6369407|NCT00724984|7280218|FG000|NOT COMPLETED|Overall Study||1
6369408|NCT00724984|7280219|FG001|NOT COMPLETED|Overall Study||1
6369409|NCT00724984|7280220|FG002|NOT COMPLETED|Overall Study||0
6369410|NCT00724984|7280221|FG003|NOT COMPLETED|Overall Study||2
6369411|NCT00724984|7280222|FG004|NOT COMPLETED|Overall Study||4
6369412|NCT00724984|7280223|FG005|NOT COMPLETED|Overall Study||5
6369413|NCT00725010|7280237|FG000|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
6369414|NCT00725010|7280237|FG000|COMPLETED|Overall Study||25
6369415|NCT00725010|7280237|FG000|NOT COMPLETED|Overall Study||25
6369416|NCT00725075|7280246|FG000|STARTED|Overall Study||72
6369417|NCT00725075|7280247|FG001|STARTED|Overall Study||73
6369418|NCT00725075|7280248|FG002|STARTED|Overall Study||70
6369419|NCT00725075|7280246|FG000|Treated|Overall Study||71
6369420|NCT00725075|7280247|FG001|Treated|Overall Study||73
6369421|NCT00725075|7280248|FG002|Treated|Overall Study||70
6369422|NCT00725075|7280246|FG000|COMPLETED|Overall Study||61
6369423|NCT00725075|7280247|FG001|COMPLETED|Overall Study||65
6369424|NCT00725075|7280248|FG002|COMPLETED|Overall Study||61
6369425|NCT00725075|7280246|FG000|NOT COMPLETED|Overall Study||11
6369426|NCT00725075|7280247|FG001|NOT COMPLETED|Overall Study||8
6369427|NCT00725075|7280248|FG002|NOT COMPLETED|Overall Study||9
6369428|NCT00725101|7280256|FG000|STARTED|Overall Study||1700
6369429|NCT00725101|7280256|FG000|COMPLETED|Overall Study||1205
6369430|NCT00725101|7280256|FG000|NOT COMPLETED|Overall Study||495
6369431|NCT00725153|7280260|FG000|STARTED|Period One, 10 Hours of Wear||27
6369432|NCT00725153|7280261|FG001|STARTED|Period One, 10 Hours of Wear||28
6369433|NCT00725153|7280260|FG000|COMPLETED|Period One, 10 Hours of Wear||27
6369434|NCT00725153|7280261|FG001|COMPLETED|Period One, 10 Hours of Wear||28
6369435|NCT00725153|7280260|FG000|NOT COMPLETED|Period One, 10 Hours of Wear||0
6369436|NCT00725153|7280261|FG001|NOT COMPLETED|Period One, 10 Hours of Wear||0
6369437|NCT00725153|7280260|FG000|STARTED|Period Two, 10 Hours of Wear||27
6369438|NCT00725153|7280261|FG001|STARTED|Period Two, 10 Hours of Wear||28
6369439|NCT00725153|7280260|FG000|COMPLETED|Period Two, 10 Hours of Wear||27
6369440|NCT00725153|7280261|FG001|COMPLETED|Period Two, 10 Hours of Wear||28
6560894|NCT01790503|7483812|FG006|COMPLETED|Overall Study||0
6369441|NCT00725153|7280260|FG000|NOT COMPLETED|Period Two, 10 Hours of Wear||0
6369442|NCT00725153|7280261|FG001|NOT COMPLETED|Period Two, 10 Hours of Wear||0
6369443|NCT00725205|7280267|FG000|STARTED|Overall Study||294
6369444|NCT00725205|7280267|FG000|COMPLETED|Overall Study||207
6369445|NCT00725205|7280267|FG000|NOT COMPLETED|Overall Study||87
6377616|NCT00763815|7288197|FG000|NOT COMPLETED|Overall Study||52
6377617|NCT00763815|7288198|FG001|NOT COMPLETED|Overall Study||84
6377618|NCT00763867|7288206|FG000|STARTED|Overall Study||103
6377619|NCT00763867|7288207|FG001|STARTED|Overall Study||113
6377620|NCT00763867|7288206|FG000|COMPLETED|Overall Study||98
6377621|NCT00763867|7288207|FG001|COMPLETED|Overall Study||101
6377622|NCT00763867|7288206|FG000|NOT COMPLETED|Overall Study||5
6377623|NCT00763867|7288207|FG001|NOT COMPLETED|Overall Study||12
6377624|NCT00763919|7288213|FG000|STARTED|Overall Study||43
6377625|NCT00763919|7288213|FG000|COMPLETED|Overall Study||30
6377626|NCT00763919|7288213|FG000|NOT COMPLETED|Overall Study||13
6377627|NCT00763958|7288219|FG000|STARTED|Overall Study||28
6377628|NCT00763958|7288220|FG001|STARTED|Overall Study||16
6377629|NCT00763958|7288219|FG000|COMPLETED|Overall Study||14
6377630|NCT00763958|7288220|FG001|COMPLETED|Overall Study||5
6377631|NCT00763958|7288219|FG000|NOT COMPLETED|Overall Study||14
6377632|NCT00763958|7288220|FG001|NOT COMPLETED|Overall Study||11
6377633|NCT00763971|7288230|FG000|STARTED|Overall Study||113
6377634|NCT00763971|7288231|FG001|STARTED|Overall Study||112
6377635|NCT00763971|7288232|FG002|STARTED|Overall Study||111
6377636|NCT00763971|7288230|FG000|COMPLETED|Overall Study||80
6377637|NCT00763971|7288231|FG001|COMPLETED|Overall Study||74
6377638|NCT00763971|7288232|FG002|COMPLETED|Overall Study||42
6377639|NCT00763971|7288230|FG000|NOT COMPLETED|Overall Study||33
6377640|NCT00763971|7288231|FG001|NOT COMPLETED|Overall Study||38
6377641|NCT00763971|7288232|FG002|NOT COMPLETED|Overall Study||69
6377642|NCT00764309|7288240|FG000|STARTED|Overall Study|Number of participants treated.|31
6377643|NCT00764309|7288240|FG000|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
6377644|NCT00764309|7288240|FG000|NOT COMPLETED|Overall Study||0
6377645|NCT00764322|7288246|FG000|STARTED|Overall Study||500
6377646|NCT00764322|7288246|FG000|COMPLETED|Overall Study||480
6377647|NCT00764322|7288246|FG000|NOT COMPLETED|Overall Study||20
6377648|NCT00764361|7288265|FG000|STARTED|Overall Study||8
6377649|NCT00764361|7288266|FG001|STARTED|Overall Study||7
6377650|NCT00764361|7288265|FG000|COMPLETED|Overall Study||6
6377651|NCT00764361|7288266|FG001|COMPLETED|Overall Study||3
6377652|NCT00764361|7288265|FG000|NOT COMPLETED|Overall Study||2
6377653|NCT00764361|7288266|FG001|NOT COMPLETED|Overall Study||4
6377654|NCT00764465|7288278|FG000|STARTED|Overall Study||9
6377655|NCT00764465|7288279|FG001|STARTED|Overall Study||7
6377656|NCT00764465|7288280|FG002|STARTED|Overall Study||7
6377657|NCT00764465|7288281|FG003|STARTED|Overall Study||7
6377658|NCT00764465|7288282|FG004|STARTED|Overall Study||7
6377659|NCT00764465|7288283|FG005|STARTED|Overall Study||8
6377660|NCT00764465|7288278|FG000|COMPLETED|Overall Study||7
6377661|NCT00764465|7288279|FG001|COMPLETED|Overall Study||6
6377662|NCT00764465|7288280|FG002|COMPLETED|Overall Study||6
6377663|NCT00764465|7288281|FG003|COMPLETED|Overall Study||6
6377664|NCT00764465|7288282|FG004|COMPLETED|Overall Study||6
6377665|NCT00764465|7288283|FG005|COMPLETED|Overall Study||7
6377666|NCT00764465|7288278|FG000|NOT COMPLETED|Overall Study||2
6377667|NCT00764465|7288279|FG001|NOT COMPLETED|Overall Study||1
6377668|NCT00764465|7288280|FG002|NOT COMPLETED|Overall Study||1
6377669|NCT00764465|7288281|FG003|NOT COMPLETED|Overall Study||1
6377670|NCT00764465|7288282|FG004|NOT COMPLETED|Overall Study||1
6377671|NCT00764465|7288283|FG005|NOT COMPLETED|Overall Study||1
6377672|NCT00764491|7288302|FG000|STARTED|Overall Study||123
6377673|NCT00764491|7288303|FG001|STARTED|Overall Study||33
6377674|NCT00764491|7288302|FG000|COMPLETED|Overall Study||88
6377675|NCT00764491|7288303|FG001|COMPLETED|Overall Study||16
6377676|NCT00764491|7288302|FG000|NOT COMPLETED|Overall Study||35
6377677|NCT00764491|7288303|FG001|NOT COMPLETED|Overall Study||17
6377678|NCT00764504|7288312|FG000|STARTED|Overall Study||141
6377679|NCT00764504|7288313|FG001|STARTED|Overall Study||141
6377680|NCT00764504|7288314|FG002|STARTED|Overall Study||234
6377681|NCT00764504|7288312|FG000|COMPLETED|Overall Study||75
6560895|NCT01790503|7483813|FG007|COMPLETED|Overall Study||0
6560896|NCT01790503|7483814|FG008|COMPLETED|Overall Study||0
6560897|NCT01790503|7483815|FG009|COMPLETED|Overall Study||1
6560898|NCT01790503|7483816|FG010|COMPLETED|Overall Study||0
6560899|NCT01790503|7483806|FG000|NOT COMPLETED|Overall Study||3
6377682|NCT00764504|7288313|FG001|COMPLETED|Overall Study||71
6377683|NCT00764504|7288314|FG002|COMPLETED|Overall Study||131
6377684|NCT00764504|7288312|FG000|NOT COMPLETED|Overall Study||66
6377685|NCT00764504|7288313|FG001|NOT COMPLETED|Overall Study||70
6377686|NCT00764504|7288314|FG002|NOT COMPLETED|Overall Study||103
6377687|NCT00764517|7288324|FG000|STARTED|Overall Study||39
6377688|NCT00764517|7288325|FG001|STARTED|Overall Study||18
6377689|NCT00764517|7288324|FG000|COMPLETED|Overall Study||24
6377690|NCT00764517|7288325|FG001|COMPLETED|Overall Study||4
6377691|NCT00764517|7288324|FG000|NOT COMPLETED|Overall Study||15
6560900|NCT01790503|7483807|FG001|NOT COMPLETED|Overall Study||1
6560901|NCT01790503|7483808|FG002|NOT COMPLETED|Overall Study||1
6377692|NCT00764517|7288325|FG001|NOT COMPLETED|Overall Study||14
6377693|NCT00764660|7288333|FG000|STARTED|Overall Study||75
6377694|NCT00764660|7288334|FG001|STARTED|Overall Study||66
6369446|NCT00725270|7280273|FG000|STARTED|Overall Study||5
6369447|NCT00725270|7280274|FG001|STARTED|Overall Study||7
6369448|NCT00725270|7280273|FG000|COMPLETED|Overall Study||5
6369449|NCT00725270|7280274|FG001|COMPLETED|Overall Study||7
6369450|NCT00725270|7280273|FG000|NOT COMPLETED|Overall Study||0
6369451|NCT00725270|7280274|FG001|NOT COMPLETED|Overall Study||0
6369452|NCT00725283|7280280|FG000|STARTED|Overall Study||34
6369453|NCT00725283|7280280|FG000|COMPLETED|Overall Study||10
6369454|NCT00725283|7280280|FG000|NOT COMPLETED|Overall Study||24
6369455|NCT00725296|7280284|FG000|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
6369456|NCT00725296|7280284|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
6369457|NCT00725296|7280284|FG000|NOT COMPLETED|Overall Study||62
6369458|NCT00725322|7280291|FG000|STARTED|First Injection Visit||15
6369459|NCT00725322|7280292|FG001|STARTED|First Injection Visit||15
6369460|NCT00725322|7280291|FG000|COMPLETED|First Injection Visit||15
6369461|NCT00725322|7280292|FG001|COMPLETED|First Injection Visit||15
6369462|NCT00725322|7280291|FG000|NOT COMPLETED|First Injection Visit||0
6369463|NCT00725322|7280292|FG001|NOT COMPLETED|First Injection Visit||0
6369464|NCT00725322|7280291|FG000|STARTED|Washout (28 Days)||15
6369465|NCT00725322|7280292|FG001|STARTED|Washout (28 Days)||15
6369466|NCT00725322|7280291|FG000|COMPLETED|Washout (28 Days)||13
6369467|NCT00725322|7280292|FG001|COMPLETED|Washout (28 Days)||14
6369468|NCT00725322|7280291|FG000|NOT COMPLETED|Washout (28 Days)||2
6369469|NCT00725322|7280292|FG001|NOT COMPLETED|Washout (28 Days)||1
6369470|NCT00725322|7280291|FG000|STARTED|Second Injection Visit||13
6369471|NCT00725322|7280292|FG001|STARTED|Second Injection Visit||14
6369472|NCT00725322|7280291|FG000|COMPLETED|Second Injection Visit||13
6369473|NCT00725322|7280292|FG001|COMPLETED|Second Injection Visit||14
6369474|NCT00725322|7280291|FG000|NOT COMPLETED|Second Injection Visit||0
6369475|NCT00725322|7280292|FG001|NOT COMPLETED|Second Injection Visit||0
6369476|NCT00725361|7280298|FG000|STARTED|Overall Study||20
6369477|NCT00725361|7280298|FG000|COMPLETED|Overall Study||16
6369478|NCT00725361|7280298|FG000|NOT COMPLETED|Overall Study||4
6369479|NCT00725452|7280302|FG000|STARTED|Overall Study||26
6369480|NCT00725452|7280302|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
6369481|NCT00725452|7280302|FG000|NOT COMPLETED|Overall Study||11
6369482|NCT00725504|7280306|FG000|STARTED|Overall Study||71
6369483|NCT00725504|7280306|FG000|COMPLETED|Overall Study||71
6369484|NCT00725504|7280306|FG000|NOT COMPLETED|Overall Study||0
6369485|NCT00725530|7280313|FG000|STARTED|First Intervention, 7 Days (+0/-1)||27
6369486|NCT00725530|7280314|FG001|STARTED|First Intervention, 7 Days (+0/-1)||27
6369487|NCT00725530|7280313|FG000|COMPLETED|First Intervention, 7 Days (+0/-1)||27
6369488|NCT00725530|7280314|FG001|COMPLETED|First Intervention, 7 Days (+0/-1)||27
6369489|NCT00725530|7280313|FG000|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
6369490|NCT00725530|7280314|FG001|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
6369491|NCT00725530|7280313|FG000|STARTED|Second Intervention, 7 Days (+0/-1)||27
6369492|NCT00725530|7280314|FG001|STARTED|Second Intervention, 7 Days (+0/-1)||27
6369493|NCT00725530|7280313|FG000|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
6777872|NCT03796260|7705806|FG001|COMPLETED|Period 2||7
6777873|NCT03796260|7705805|FG000|NOT COMPLETED|Period 2||0
6777874|NCT03796260|7705806|FG001|NOT COMPLETED|Period 2||0
6777875|NCT03796039|7705814|FG000|STARTED|Overall Study||50
6777876|NCT03796039|7705815|FG001|STARTED|Overall Study||47
6777877|NCT03796039|7705814|FG000|COMPLETED|Overall Study||41
6777878|NCT03796039|7705815|FG001|COMPLETED|Overall Study||42
6777879|NCT03796039|7705814|FG000|NOT COMPLETED|Overall Study||9
6369494|NCT00725530|7280314|FG001|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
6369495|NCT00725530|7280313|FG000|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
6369496|NCT00725530|7280314|FG001|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
6369497|NCT00725543|7280320|FG000|STARTED|Overall Study||358
6369498|NCT00725543|7280320|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
6369499|NCT00725543|7280320|FG000|NOT COMPLETED|Overall Study||153
6369500|NCT00725608|7280324|FG000|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
6369501|NCT00725608|7280324|FG000|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
6369502|NCT00725608|7280324|FG000|NOT COMPLETED|Overall Study||167
6369503|NCT00725621|7280328|FG000|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
6369504|NCT00725621|7280328|FG000|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
6369505|NCT00725621|7280328|FG000|NOT COMPLETED|Overall Study||271
6369506|NCT00725712|7280338|FG000|STARTED|Overall Study||48
6369507|NCT00725712|7280339|FG001|STARTED|Overall Study||26
6369508|NCT00725712|7280338|FG000|COMPLETED|Overall Study||0
6369509|NCT00725712|7280339|FG001|COMPLETED|Overall Study||0
6369510|NCT00725712|7280338|FG000|NOT COMPLETED|Overall Study||48
6369511|NCT00725712|7280339|FG001|NOT COMPLETED|Overall Study||26
6369512|NCT00725725|7280352|FG000|STARTED|Overall Study||14
6369513|NCT00725725|7280353|FG001|STARTED|Overall Study||15
6369514|NCT00725725|7280354|FG002|STARTED|Overall Study||17
6777880|NCT03796039|7705815|FG001|NOT COMPLETED|Overall Study||5
6777881|NCT03783780|7705821|FG000|STARTED|Overall Study||21
6777882|NCT03783780|7705821|FG000|COMPLETED|Overall Study||20
6777883|NCT03783780|7705821|FG000|NOT COMPLETED|Overall Study||1
6369515|NCT00725725|7280352|FG000|Treated|Overall Study||11
6369516|NCT00725725|7280353|FG001|Treated|Overall Study||15
6369517|NCT00725725|7280354|FG002|Treated|Overall Study||14
6369518|NCT00725725|7280352|FG000|COMPLETED|Overall Study||10
6369519|NCT00725725|7280353|FG001|COMPLETED|Overall Study||11
6369520|NCT00725725|7280354|FG002|COMPLETED|Overall Study||12
6369521|NCT00725725|7280352|FG000|NOT COMPLETED|Overall Study||4
6369522|NCT00725725|7280353|FG001|NOT COMPLETED|Overall Study||4
6369523|NCT00725725|7280354|FG002|NOT COMPLETED|Overall Study||5
6369524|NCT00725751|7280364|FG000|STARTED|Overall Study||90
6369525|NCT00725751|7280365|FG001|STARTED|Overall Study||258
6369526|NCT00725751|7280364|FG000|COMPLETED|Overall Study||56
6369527|NCT00725751|7280365|FG001|COMPLETED|Overall Study||150
6369528|NCT00725751|7280364|FG000|NOT COMPLETED|Overall Study||34
6369529|NCT00725751|7280365|FG001|NOT COMPLETED|Overall Study||108
6369530|NCT00725764|7280372|FG000|STARTED|Overall Study||14
6369531|NCT00725764|7280372|FG000|COMPLETED|Overall Study||0
6369532|NCT00725764|7280372|FG000|NOT COMPLETED|Overall Study||14
6369533|NCT00725842|7280377|FG000|STARTED|Overall Study||97
6369534|NCT00725842|7280377|FG000|Participants Eligible for Analysis|Overall Study||90
6369535|NCT00725842|7280377|FG000|COMPLETED|Overall Study||57
6369536|NCT00725842|7280377|FG000|NOT COMPLETED|Overall Study||40
6369537|NCT00725920|7280383|FG000|STARTED|Overall Study||17
6369538|NCT00725920|7280384|FG001|STARTED|Overall Study||18
6369539|NCT00725920|7280383|FG000|COMPLETED|Overall Study||14
6369540|NCT00725920|7280384|FG001|COMPLETED|Overall Study||12
6369541|NCT00725920|7280383|FG000|NOT COMPLETED|Overall Study||3
6369542|NCT00725920|7280384|FG001|NOT COMPLETED|Overall Study||6
6369543|NCT00725959|7280392|FG000|STARTED|Overall Study||942
6369544|NCT00725959|7280393|FG001|STARTED|Overall Study||636
6369545|NCT00725959|7280392|FG000|COMPLETED|Overall Study||653
6369546|NCT00725959|7280393|FG001|COMPLETED|Overall Study||439
6369547|NCT00725959|7280392|FG000|NOT COMPLETED|Overall Study||289
6369548|NCT00725959|7280393|FG001|NOT COMPLETED|Overall Study||197
6369549|NCT00726232|7280405|FG000|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
6369550|NCT00726232|7280406|FG001|STARTED|Initial Phase (Dose-finding)||8
6369551|NCT00726232|7280407|FG002|STARTED|Initial Phase (Dose-finding)||7
6369552|NCT00726232|7280408|FG003|STARTED|Initial Phase (Dose-finding)||8
6369553|NCT00726232|7280409|FG004|STARTED|Initial Phase (Dose-finding)|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
6369554|NCT00726232|7280410|FG005|STARTED|Initial Phase (Dose-finding)||9
6369555|NCT00726232|7280411|FG006|STARTED|Initial Phase (Dose-finding)||0
6369556|NCT00726232|7280412|FG007|STARTED|Initial Phase (Dose-finding)||0
6369557|NCT00726232|7280405|FG000|Safety Evaluable Participants|Initial Phase (Dose-finding)||19
6369558|NCT00726232|7280406|FG001|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
6369559|NCT00726232|7280407|FG002|Safety Evaluable Participants|Initial Phase (Dose-finding)||7
6369560|NCT00726232|7280408|FG003|Safety Evaluable Participants|Initial Phase (Dose-finding)||8
6369561|NCT00726232|7280409|FG004|Safety Evaluable Participants|Initial Phase (Dose-finding)||22
6369562|NCT00726232|7280410|FG005|Safety Evaluable Participants|Initial Phase (Dose-finding)||9
6369563|NCT00726232|7280411|FG006|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
6369564|NCT00726232|7280412|FG007|Safety Evaluable Participants|Initial Phase (Dose-finding)||0
6560902|NCT01790503|7483809|FG003|NOT COMPLETED|Overall Study||2
6560903|NCT01790503|7483810|FG004|NOT COMPLETED|Overall Study||5
6560904|NCT01790503|7483811|FG005|NOT COMPLETED|Overall Study||5
6560905|NCT01790503|7483812|FG006|NOT COMPLETED|Overall Study||1
6560906|NCT01790503|7483813|FG007|NOT COMPLETED|Overall Study||1
6560907|NCT01790503|7483814|FG008|NOT COMPLETED|Overall Study||3
6369565|NCT00726232|7280405|FG000|ITT Participants|Initial Phase (Dose-finding)||19
6369566|NCT00726232|7280406|FG001|ITT Participants|Initial Phase (Dose-finding)||8
6369567|NCT00726232|7280407|FG002|ITT Participants|Initial Phase (Dose-finding)||7
6369568|NCT00726232|7280408|FG003|ITT Participants|Initial Phase (Dose-finding)||8
6369569|NCT00726232|7280409|FG004|ITT Participants|Initial Phase (Dose-finding)||22
6369570|NCT00726232|7280410|FG005|ITT Participants|Initial Phase (Dose-finding)||9
6369571|NCT00726232|7280411|FG006|ITT Participants|Initial Phase (Dose-finding)||0
6369572|NCT00726232|7280412|FG007|ITT Participants|Initial Phase (Dose-finding)||0
6369573|NCT00726232|7280405|FG000|COMPLETED|Initial Phase (Dose-finding)||6
6560908|NCT01790503|7483815|FG009|NOT COMPLETED|Overall Study||26
6560909|NCT01790503|7483816|FG010|NOT COMPLETED|Overall Study||16
6560910|NCT01790516|7483855|FG000|STARTED|Overall Study||1
6560911|NCT01790516|7483856|FG001|STARTED|Overall Study||1
6560912|NCT01790516|7483855|FG000|COMPLETED|Overall Study||0
6560913|NCT01790516|7483856|FG001|COMPLETED|Overall Study||1
6560914|NCT01790516|7483855|FG000|NOT COMPLETED|Overall Study||1
6369574|NCT00726232|7280406|FG001|COMPLETED|Initial Phase (Dose-finding)||2
6369575|NCT00726232|7280407|FG002|COMPLETED|Initial Phase (Dose-finding)||2
6369576|NCT00726232|7280408|FG003|COMPLETED|Initial Phase (Dose-finding)||0
6369577|NCT00726232|7280409|FG004|COMPLETED|Initial Phase (Dose-finding)||1
6369578|NCT00726232|7280410|FG005|COMPLETED|Initial Phase (Dose-finding)||0
6369579|NCT00726232|7280411|FG006|COMPLETED|Initial Phase (Dose-finding)||0
6369580|NCT00726232|7280412|FG007|COMPLETED|Initial Phase (Dose-finding)||0
6369581|NCT00726232|7280405|FG000|NOT COMPLETED|Initial Phase (Dose-finding)||13
6377695|NCT00764660|7288333|FG000|COMPLETED|Overall Study||53
6560915|NCT01790516|7483856|FG001|NOT COMPLETED|Overall Study||0
6369582|NCT00726232|7280406|FG001|NOT COMPLETED|Initial Phase (Dose-finding)||6
6369583|NCT00726232|7280407|FG002|NOT COMPLETED|Initial Phase (Dose-finding)||5
6369584|NCT00726232|7280408|FG003|NOT COMPLETED|Initial Phase (Dose-finding)||8
6369585|NCT00726232|7280409|FG004|NOT COMPLETED|Initial Phase (Dose-finding)||21
6369586|NCT00726232|7280410|FG005|NOT COMPLETED|Initial Phase (Dose-finding)||9
6369587|NCT00726232|7280411|FG006|NOT COMPLETED|Initial Phase (Dose-finding)||0
6369588|NCT00726232|7280412|FG007|NOT COMPLETED|Initial Phase (Dose-finding)||0
6369589|NCT00726232|7280405|FG000|STARTED|Expansion Phase||0
6369590|NCT00726232|7280406|FG001|STARTED|Expansion Phase||0
6369591|NCT00726232|7280407|FG002|STARTED|Expansion Phase||0
6369592|NCT00726232|7280408|FG003|STARTED|Expansion Phase||0
6369593|NCT00726232|7280409|FG004|STARTED|Expansion Phase||0
6369594|NCT00726232|7280410|FG005|STARTED|Expansion Phase||0
6369595|NCT00726232|7280411|FG006|STARTED|Expansion Phase||34
6369596|NCT00726232|7280412|FG007|STARTED|Expansion Phase||39
6369597|NCT00726232|7280405|FG000|Safety Evaluable Participants|Expansion Phase||0
6369598|NCT00726232|7280406|FG001|Safety Evaluable Participants|Expansion Phase||0
6369599|NCT00726232|7280407|FG002|Safety Evaluable Participants|Expansion Phase||0
6369600|NCT00726232|7280408|FG003|Safety Evaluable Participants|Expansion Phase||0
6369601|NCT00726232|7280409|FG004|Safety Evaluable Participants|Expansion Phase||0
6369602|NCT00726232|7280410|FG005|Safety Evaluable Participants|Expansion Phase||0
6369603|NCT00726232|7280411|FG006|Safety Evaluable Participants|Expansion Phase||34
6369604|NCT00726232|7280412|FG007|Safety Evaluable Participants|Expansion Phase||39
6369605|NCT00726232|7280405|FG000|ITT Participants|Expansion Phase||0
6369606|NCT00726232|7280406|FG001|ITT Participants|Expansion Phase||0
6369607|NCT00726232|7280407|FG002|ITT Participants|Expansion Phase||0
6369608|NCT00726232|7280408|FG003|ITT Participants|Expansion Phase||0
6369609|NCT00726232|7280409|FG004|ITT Participants|Expansion Phase||0
6369610|NCT00726232|7280410|FG005|ITT Participants|Expansion Phase||0
6369611|NCT00726232|7280411|FG006|ITT Participants|Expansion Phase||34
6369612|NCT00726232|7280412|FG007|ITT Participants|Expansion Phase||39
6369613|NCT00726232|7280405|FG000|COMPLETED|Expansion Phase||0
6369614|NCT00726232|7280406|FG001|COMPLETED|Expansion Phase||0
6369615|NCT00726232|7280407|FG002|COMPLETED|Expansion Phase||0
6369616|NCT00726232|7280408|FG003|COMPLETED|Expansion Phase||0
6369617|NCT00726232|7280409|FG004|COMPLETED|Expansion Phase||0
6369618|NCT00726232|7280410|FG005|COMPLETED|Expansion Phase||0
6369619|NCT00726232|7280411|FG006|COMPLETED|Expansion Phase||10
6369620|NCT00726232|7280412|FG007|COMPLETED|Expansion Phase||1
6369621|NCT00726232|7280405|FG000|NOT COMPLETED|Expansion Phase||0
6369622|NCT00726232|7280406|FG001|NOT COMPLETED|Expansion Phase||0
6369623|NCT00726232|7280407|FG002|NOT COMPLETED|Expansion Phase||0
6369624|NCT00726232|7280408|FG003|NOT COMPLETED|Expansion Phase||0
6369625|NCT00726232|7280409|FG004|NOT COMPLETED|Expansion Phase||0
6369626|NCT00726232|7280410|FG005|NOT COMPLETED|Expansion Phase||0
6369627|NCT00726232|7280411|FG006|NOT COMPLETED|Expansion Phase||24
6369628|NCT00726232|7280412|FG007|NOT COMPLETED|Expansion Phase||38
6369629|NCT00726323|7280433|FG000|STARTED|Overall Study||37
6369630|NCT00726323|7280434|FG001|STARTED|Overall Study||37
6369631|NCT00726323|7280433|FG000|COMPLETED|Overall Study||0
6369632|NCT00726323|7280434|FG001|COMPLETED|Overall Study||6
6369633|NCT00726323|7280433|FG000|NOT COMPLETED|Overall Study||37
6369634|NCT00726323|7280434|FG001|NOT COMPLETED|Overall Study||31
6369635|NCT00726375|7280440|FG000|STARTED|Overall Study||34
6369636|NCT00726375|7280440|FG000|COMPLETED|Overall Study||34
6369637|NCT00726375|7280440|FG000|NOT COMPLETED|Overall Study||0
6369638|NCT00726388|7280444|FG000|STARTED|Overall Study||1050
6369639|NCT00726388|7280444|FG000|Treated|Overall Study||971
6369640|NCT00726388|7280444|FG000|COMPLETED|Overall Study||943
6369641|NCT00726388|7280444|FG000|NOT COMPLETED|Overall Study||107
6369642|NCT00726414|7280448|FG000|STARTED|First Intervention||11
6369643|NCT00726414|7280449|FG001|STARTED|First Intervention||11
6369644|NCT00726414|7280448|FG000|COMPLETED|First Intervention||11
6369645|NCT00726414|7280449|FG001|COMPLETED|First Intervention||11
6369646|NCT00726414|7280448|FG000|NOT COMPLETED|First Intervention||0
6369647|NCT00726414|7280449|FG001|NOT COMPLETED|First Intervention||0
6369648|NCT00726414|7280448|FG000|STARTED|Washout Period of 7 Days||11
6369649|NCT00726414|7280449|FG001|STARTED|Washout Period of 7 Days||11
6369650|NCT00726414|7280448|FG000|COMPLETED|Washout Period of 7 Days||11
6369651|NCT00726414|7280449|FG001|COMPLETED|Washout Period of 7 Days||11
6369652|NCT00726414|7280448|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6369653|NCT00726414|7280449|FG001|NOT COMPLETED|Washout Period of 7 Days||0
6369654|NCT00726414|7280448|FG000|STARTED|Second Intervention||11
6369655|NCT00726414|7280449|FG001|STARTED|Second Intervention||11
6369656|NCT00726414|7280448|FG000|COMPLETED|Second Intervention||11
6369657|NCT00726414|7280449|FG001|COMPLETED|Second Intervention||11
6369658|NCT00726414|7280448|FG000|NOT COMPLETED|Second Intervention||0
6369659|NCT00726414|7280449|FG001|NOT COMPLETED|Second Intervention||0
6369660|NCT00726453|7280457|FG000|STARTED|Primary Enrollment Group||1402
6369661|NCT00726453|7280458|FG001|STARTED|Primary Enrollment Group||0
6369662|NCT00726453|7280457|FG000|COMPLETED|Primary Enrollment Group||1371
6369663|NCT00726453|7280458|FG001|COMPLETED|Primary Enrollment Group||0
6369664|NCT00726453|7280457|FG000|NOT COMPLETED|Primary Enrollment Group||31
6369665|NCT00726453|7280458|FG001|NOT COMPLETED|Primary Enrollment Group||0
6369666|NCT00726453|7280457|FG000|STARTED|38 mm Length Group||0
6369667|NCT00726453|7280458|FG001|STARTED|38 mm Length Group||114
6369668|NCT00726453|7280457|FG000|COMPLETED|38 mm Length Group||0
6369669|NCT00726453|7280458|FG001|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
6369670|NCT00726453|7280457|FG000|NOT COMPLETED|38 mm Length Group||0
6369671|NCT00726453|7280458|FG001|NOT COMPLETED|38 mm Length Group||3
6369672|NCT00726557|7280463|FG000|STARTED|Overall Study||246
6369673|NCT00726557|7280463|FG000|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
6369674|NCT00726557|7280463|FG000|NOT COMPLETED|Overall Study||128
6369675|NCT00726609|7280468|FG000|STARTED|Overall Study||214
6369676|NCT00726609|7280468|FG000|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
6369677|NCT00726609|7280468|FG000|NOT COMPLETED|Overall Study||98
6369678|NCT00726622|7280474|FG000|STARTED|Overall Study||243
6369679|NCT00726622|7280475|FG001|STARTED|Overall Study||243
6369680|NCT00726622|7280474|FG000|COMPLETED|Overall Study||225
6369681|NCT00726622|7280475|FG001|COMPLETED|Overall Study||240
6369682|NCT00726622|7280474|FG000|NOT COMPLETED|Overall Study||18
6369683|NCT00726622|7280475|FG001|NOT COMPLETED|Overall Study||3
6369684|NCT00726661|7280483|FG000|STARTED|Overall Study||832
6369685|NCT00726661|7280484|FG001|STARTED|Overall Study||435
6777884|NCT03780959|7705829|FG000|STARTED|Part 1||69
6777885|NCT03780959|7705830|FG001|STARTED|Part 1||0
6777886|NCT03780959|7705831|FG002|STARTED|Part 1||0
6777887|NCT03780959|7705829|FG000|COMPLETED|Part 1||64
6369686|NCT00726661|7280483|FG000|COMPLETED|Overall Study||18
6369687|NCT00726661|7280484|FG001|COMPLETED|Overall Study||17
6369688|NCT00726661|7280483|FG000|NOT COMPLETED|Overall Study||814
6369689|NCT00726661|7280484|FG001|NOT COMPLETED|Overall Study||418
6369690|NCT00726713|7280493|FG000|STARTED|Overall Study||106
6369691|NCT00726713|7280494|FG001|STARTED|Overall Study||108
6369692|NCT00726713|7280493|FG000|COMPLETED|Overall Study||99
6369693|NCT00726713|7280494|FG001|COMPLETED|Overall Study||101
6369694|NCT00726713|7280493|FG000|NOT COMPLETED|Overall Study||7
6369695|NCT00726713|7280494|FG001|NOT COMPLETED|Overall Study||7
6369696|NCT00726739|7280503|FG000|STARTED|Overall Study||11
6369697|NCT00726739|7280504|FG001|STARTED|Overall Study||10
6369698|NCT00726739|7280503|FG000|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
6369699|NCT00726739|7280504|FG001|COMPLETED|Overall Study||10
6369700|NCT00726739|7280503|FG000|NOT COMPLETED|Overall Study||1
6369701|NCT00726739|7280504|FG001|NOT COMPLETED|Overall Study||0
6369702|NCT00726752|7280511|FG000|STARTED|Overall Study||6
6369703|NCT00726752|7280511|FG000|COMPLETED|Overall Study||0
6369704|NCT00726752|7280511|FG000|NOT COMPLETED|Overall Study||6
6369705|NCT00726882|7280515|FG000|STARTED|Overall Study||35
6369706|NCT00726882|7280515|FG000|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
6369707|NCT00726882|7280515|FG000|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
6369708|NCT00726882|7280515|FG000|COMPLETED|Overall Study||13
6369709|NCT00726882|7280515|FG000|NOT COMPLETED|Overall Study||22
6369710|NCT00726895|7280521|FG000|STARTED|First Intervention||12
6369711|NCT00726895|7280522|FG001|STARTED|First Intervention||12
6369712|NCT00726895|7280521|FG000|COMPLETED|First Intervention||12
6369713|NCT00726895|7280522|FG001|COMPLETED|First Intervention||12
6369714|NCT00726895|7280521|FG000|NOT COMPLETED|First Intervention||0
6369715|NCT00726895|7280522|FG001|NOT COMPLETED|First Intervention||0
6369716|NCT00726895|7280521|FG000|STARTED|Washout Period of 7 Days||12
6369717|NCT00726895|7280522|FG001|STARTED|Washout Period of 7 Days||12
6369718|NCT00726895|7280521|FG000|COMPLETED|Washout Period of 7 Days||12
6369719|NCT00726895|7280522|FG001|COMPLETED|Washout Period of 7 Days||11
6369720|NCT00726895|7280521|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6369721|NCT00726895|7280522|FG001|NOT COMPLETED|Washout Period of 7 Days||1
6369722|NCT00726895|7280521|FG000|STARTED|Second Intervention||12
6369723|NCT00726895|7280522|FG001|STARTED|Second Intervention||11
6369724|NCT00726895|7280521|FG000|COMPLETED|Second Intervention||12
6369725|NCT00726895|7280522|FG001|COMPLETED|Second Intervention||11
6369726|NCT00726895|7280521|FG000|NOT COMPLETED|Second Intervention||0
6369727|NCT00726895|7280522|FG001|NOT COMPLETED|Second Intervention||0
6369728|NCT00726986|7280529|FG000|STARTED|Induction Phase||18
6369729|NCT00726986|7280529|FG000|Maintance|Induction Phase||3
6369730|NCT00726986|7280529|FG000|COMPLETED|Induction Phase||3
6369731|NCT00726986|7280529|FG000|NOT COMPLETED|Induction Phase||15
6369732|NCT00726986|7280529|FG000|STARTED|Maintenance Phase||3
6369733|NCT00726986|7280529|FG000|COMPLETED|Maintenance Phase||0
6369734|NCT00726986|7280529|FG000|NOT COMPLETED|Maintenance Phase||3
6369735|NCT00726999|7280535|FG000|STARTED|Overall Study||32
6369736|NCT00726999|7280536|FG001|STARTED|Overall Study||31
6369737|NCT00726999|7280535|FG000|COMPLETED|Overall Study||29
6369738|NCT00726999|7280536|FG001|COMPLETED|Overall Study||30
6369739|NCT00726999|7280535|FG000|NOT COMPLETED|Overall Study||3
6369740|NCT00726999|7280536|FG001|NOT COMPLETED|Overall Study||1
6369741|NCT00727025|7280544|FG000|STARTED|Overall Study||74
6369742|NCT00727025|7280544|FG000|COMPLETED|Overall Study||51
6369743|NCT00727025|7280544|FG000|NOT COMPLETED|Overall Study||23
6369744|NCT00727064|7280554|FG000|STARTED|Overall Study||7
6369745|NCT00727064|7280555|FG001|STARTED|Overall Study||7
6369746|NCT00727064|7280554|FG000|COMPLETED|Overall Study||7
6369747|NCT00727064|7280555|FG001|COMPLETED|Overall Study||7
6369748|NCT00727064|7280554|FG000|NOT COMPLETED|Overall Study||0
6777888|NCT03780959|7705830|FG001|COMPLETED|Part 1||0
6777889|NCT03780959|7705831|FG002|COMPLETED|Part 1||0
6369749|NCT00727064|7280555|FG001|NOT COMPLETED|Overall Study||0
6369750|NCT00727194|7280561|FG000|STARTED|Screening Period||7
6369751|NCT00727194|7280562|FG001|STARTED|Screening Period||7
6369752|NCT00727194|7280563|FG002|STARTED|Screening Period||16
6369753|NCT00727194|7280561|FG000|COMPLETED|Screening Period||7
6369754|NCT00727194|7280562|FG001|COMPLETED|Screening Period||7
6369755|NCT00727194|7280563|FG002|COMPLETED|Screening Period||0
6369756|NCT00727194|7280561|FG000|NOT COMPLETED|Screening Period||0
6369757|NCT00727194|7280562|FG001|NOT COMPLETED|Screening Period||0
6369758|NCT00727194|7280563|FG002|NOT COMPLETED|Screening Period||16
6369759|NCT00727194|7280561|FG000|STARTED|Treatment Period 1||7
6369760|NCT00727194|7280562|FG001|STARTED|Treatment Period 1||7
6369761|NCT00727194|7280563|FG002|STARTED|Treatment Period 1||0
6369762|NCT00727194|7280561|FG000|COMPLETED|Treatment Period 1||7
6369763|NCT00727194|7280562|FG001|COMPLETED|Treatment Period 1||7
6369764|NCT00727194|7280563|FG002|COMPLETED|Treatment Period 1||0
6369765|NCT00727194|7280561|FG000|NOT COMPLETED|Treatment Period 1||0
6369766|NCT00727194|7280562|FG001|NOT COMPLETED|Treatment Period 1||0
6369767|NCT00727194|7280563|FG002|NOT COMPLETED|Treatment Period 1||0
6369768|NCT00727194|7280561|FG000|STARTED|Washout Period||7
6369769|NCT00727194|7280562|FG001|STARTED|Washout Period||7
6369770|NCT00727194|7280563|FG002|STARTED|Washout Period||0
6369771|NCT00727194|7280561|FG000|COMPLETED|Washout Period||7
6369772|NCT00727194|7280562|FG001|COMPLETED|Washout Period||7
6369773|NCT00727194|7280563|FG002|COMPLETED|Washout Period||0
6369774|NCT00727194|7280561|FG000|NOT COMPLETED|Washout Period||0
6369775|NCT00727194|7280562|FG001|NOT COMPLETED|Washout Period||0
6369776|NCT00727194|7280563|FG002|NOT COMPLETED|Washout Period||0
6369777|NCT00727194|7280561|FG000|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
6369778|NCT00727194|7280562|FG001|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
6369779|NCT00727194|7280563|FG002|STARTED|Treatment Period 2||0
6369780|NCT00727194|7280561|FG000|COMPLETED|Treatment Period 2||6
6369781|NCT00727194|7280562|FG001|COMPLETED|Treatment Period 2||5
6369782|NCT00727194|7280563|FG002|COMPLETED|Treatment Period 2||0
6369783|NCT00727194|7280561|FG000|NOT COMPLETED|Treatment Period 2||0
6369784|NCT00727194|7280562|FG001|NOT COMPLETED|Treatment Period 2||1
6369785|NCT00727194|7280563|FG002|NOT COMPLETED|Treatment Period 2||0
6369786|NCT00727220|7280579|FG000|STARTED|Overall Study||21
6369787|NCT00727220|7280580|FG001|STARTED|Overall Study||21
6369788|NCT00727220|7280579|FG000|COMPLETED|Overall Study||20
6369789|NCT00727220|7280580|FG001|COMPLETED|Overall Study||17
6369790|NCT00727220|7280579|FG000|NOT COMPLETED|Overall Study||1
6369791|NCT00727220|7280580|FG001|NOT COMPLETED|Overall Study||4
6369792|NCT00727246|7280590|FG000|STARTED|Overall Study||3
6369793|NCT00727246|7280591|FG001|STARTED|Overall Study||3
6369794|NCT00727246|7280592|FG002|STARTED|Overall Study||8
6369795|NCT00727246|7280593|FG003|STARTED|Overall Study||5
6369796|NCT00727246|7280590|FG000|COMPLETED|Overall Study||3
6369797|NCT00727246|7280591|FG001|COMPLETED|Overall Study||2
6369798|NCT00727246|7280592|FG002|COMPLETED|Overall Study||7
6369799|NCT00727246|7280593|FG003|COMPLETED|Overall Study||3
6369800|NCT00727246|7280590|FG000|NOT COMPLETED|Overall Study||0
6369801|NCT00727246|7280591|FG001|NOT COMPLETED|Overall Study||1
6369802|NCT00727246|7280592|FG002|NOT COMPLETED|Overall Study||1
6369803|NCT00727246|7280593|FG003|NOT COMPLETED|Overall Study||2
6369804|NCT00727259|7280603|FG000|STARTED|Overall Study||1995
6369805|NCT00727259|7280603|FG000|COMPLETED|Overall Study||940
6369806|NCT00727259|7280603|FG000|NOT COMPLETED|Overall Study||1055
6369807|NCT00727272|7280608|FG000|STARTED|Period I||9
6369808|NCT00727272|7280609|FG001|STARTED|Period I||9
6369809|NCT00727272|7280610|FG002|STARTED|Period I||9
6369810|NCT00727272|7280608|FG000|COMPLETED|Period I||9
6369811|NCT00727272|7280609|FG001|COMPLETED|Period I||9
6369812|NCT00727272|7280610|FG002|COMPLETED|Period I||9
6369813|NCT00727272|7280608|FG000|NOT COMPLETED|Period I||0
6369814|NCT00727272|7280609|FG001|NOT COMPLETED|Period I||0
6369815|NCT00727272|7280610|FG002|NOT COMPLETED|Period I||0
6369816|NCT00727272|7280608|FG000|STARTED|Washout Period A||9
6369817|NCT00727272|7280609|FG001|STARTED|Washout Period A||9
6369818|NCT00727272|7280610|FG002|STARTED|Washout Period A||9
6369819|NCT00727272|7280608|FG000|COMPLETED|Washout Period A||9
6369820|NCT00727272|7280609|FG001|COMPLETED|Washout Period A||9
6369821|NCT00727272|7280610|FG002|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
6369822|NCT00727272|7280608|FG000|NOT COMPLETED|Washout Period A||0
6369823|NCT00727272|7280609|FG001|NOT COMPLETED|Washout Period A||0
6369824|NCT00727272|7280610|FG002|NOT COMPLETED|Washout Period A||1
6369825|NCT00727272|7280608|FG000|STARTED|Period II||9
6369826|NCT00727272|7280609|FG001|STARTED|Period II||9
6369827|NCT00727272|7280610|FG002|STARTED|Period II||8
6369828|NCT00727272|7280608|FG000|COMPLETED|Period II||9
6369829|NCT00727272|7280609|FG001|COMPLETED|Period II||9
6369830|NCT00727272|7280610|FG002|COMPLETED|Period II||8
6369831|NCT00727272|7280608|FG000|NOT COMPLETED|Period II||0
6369832|NCT00727272|7280609|FG001|NOT COMPLETED|Period II||0
6369833|NCT00727272|7280610|FG002|NOT COMPLETED|Period II||0
6369834|NCT00727272|7280608|FG000|STARTED|Washout Period B||9
6369835|NCT00727272|7280609|FG001|STARTED|Washout Period B||9
6369836|NCT00727272|7280610|FG002|STARTED|Washout Period B||8
6369837|NCT00727272|7280608|FG000|COMPLETED|Washout Period B||9
6369838|NCT00727272|7280609|FG001|COMPLETED|Washout Period B||9
6369839|NCT00727272|7280610|FG002|COMPLETED|Washout Period B|personal reasons|7
6369840|NCT00727272|7280608|FG000|NOT COMPLETED|Washout Period B||0
6369841|NCT00727272|7280609|FG001|NOT COMPLETED|Washout Period B||0
6369842|NCT00727272|7280610|FG002|NOT COMPLETED|Washout Period B||1
6369843|NCT00727272|7280608|FG000|STARTED|Period III||9
6369844|NCT00727272|7280609|FG001|STARTED|Period III||9
6369845|NCT00727272|7280610|FG002|STARTED|Period III||7
6369846|NCT00727272|7280608|FG000|COMPLETED|Period III||9
6369847|NCT00727272|7280609|FG001|COMPLETED|Period III||9
6369848|NCT00727272|7280610|FG002|COMPLETED|Period III||7
6369849|NCT00727272|7280608|FG000|NOT COMPLETED|Period III||0
6369850|NCT00727272|7280609|FG001|NOT COMPLETED|Period III||0
6369851|NCT00727272|7280610|FG002|NOT COMPLETED|Period III||0
6369852|NCT00727298|7280620|FG000|STARTED|Overall Study||4485
6369853|NCT00727298|7280620|FG000|COMPLETED|Overall Study||3228
6369854|NCT00727298|7280620|FG000|NOT COMPLETED|Overall Study||1257
6369855|NCT00727311|7280624|FG000|STARTED|Overall Study||2302
6369856|NCT00727311|7280624|FG000|COMPLETED|Overall Study||1195
6369857|NCT00727311|7280624|FG000|NOT COMPLETED|Overall Study||1107
6369858|NCT00727337|7280632|FG000|STARTED|Overall Study||68
6369859|NCT00727337|7280633|FG001|STARTED|Overall Study||65
6369860|NCT00727337|7280634|FG002|STARTED|Overall Study||73
6369861|NCT00727337|7280635|FG003|STARTED|Overall Study||73
6369862|NCT00727337|7280632|FG000|COMPLETED|Overall Study||61
6369863|NCT00727337|7280633|FG001|COMPLETED|Overall Study||55
6369864|NCT00727337|7280634|FG002|COMPLETED|Overall Study||63
6369865|NCT00727337|7280635|FG003|COMPLETED|Overall Study||64
6369866|NCT00727337|7280632|FG000|NOT COMPLETED|Overall Study||7
6369867|NCT00727337|7280633|FG001|NOT COMPLETED|Overall Study||10
6369868|NCT00727337|7280634|FG002|NOT COMPLETED|Overall Study||10
6369869|NCT00727337|7280635|FG003|NOT COMPLETED|Overall Study||9
6369870|NCT00727402|7280650|FG000|STARTED|Overall Study||205
6369871|NCT00727402|7280650|FG000|COMPLETED|Overall Study||89
6369872|NCT00727402|7280650|FG000|NOT COMPLETED|Overall Study||116
6369873|NCT00727415|7280654|FG000|STARTED|Phase I||9
6369874|NCT00727415|7280654|FG000|COMPLETED|Phase I||7
6369875|NCT00727415|7280654|FG000|NOT COMPLETED|Phase I||2
6369876|NCT00727415|7280654|FG000|STARTED|Phase II||33
6369877|NCT00727415|7280654|FG000|COMPLETED|Phase II||33
6369878|NCT00727415|7280654|FG000|NOT COMPLETED|Phase II||0
6369879|NCT00727441|7280661|FG000|STARTED|Overall Study||29
6369880|NCT00727441|7280662|FG001|STARTED|Overall Study||28
6369881|NCT00727441|7280663|FG002|STARTED|Overall Study||30
6369882|NCT00727441|7280661|FG000|COMPLETED|Overall Study||11
6369883|NCT00727441|7280662|FG001|COMPLETED|Overall Study||6
6369884|NCT00727441|7280663|FG002|COMPLETED|Overall Study||5
6369885|NCT00727441|7280661|FG000|NOT COMPLETED|Overall Study||18
6369886|NCT00727441|7280662|FG001|NOT COMPLETED|Overall Study||22
6369887|NCT00727441|7280663|FG002|NOT COMPLETED|Overall Study||25
6369888|NCT00727506|7280680|FG000|STARTED|Overall Study|Entered|6
6369889|NCT00727506|7280681|FG001|STARTED|Overall Study|Entered|8
6369890|NCT00727506|7280682|FG002|STARTED|Overall Study|Entered|18
6369891|NCT00727506|7280683|FG003|STARTED|Overall Study|Randomized|39
6369892|NCT00727506|7280684|FG004|STARTED|Overall Study|Randomized|41
6369893|NCT00727506|7280685|FG005|STARTED|Overall Study|Randomized|39
6369894|NCT00727506|7280680|FG000|COMPLETED|Overall Study||0
6369895|NCT00727506|7280681|FG001|COMPLETED|Overall Study||0
6369896|NCT00727506|7280682|FG002|COMPLETED|Overall Study||0
6369897|NCT00727506|7280683|FG003|COMPLETED|Overall Study||0
6369898|NCT00727506|7280684|FG004|COMPLETED|Overall Study||0
6369899|NCT00727506|7280685|FG005|COMPLETED|Overall Study||0
6369900|NCT00727506|7280680|FG000|NOT COMPLETED|Overall Study||6
6369901|NCT00727506|7280681|FG001|NOT COMPLETED|Overall Study||8
6369902|NCT00727506|7280682|FG002|NOT COMPLETED|Overall Study||18
6369903|NCT00727506|7280683|FG003|NOT COMPLETED|Overall Study||39
6369904|NCT00727506|7280684|FG004|NOT COMPLETED|Overall Study||41
6369905|NCT00727506|7280685|FG005|NOT COMPLETED|Overall Study||39
6369906|NCT00727532|7280705|FG000|STARTED|Overall Study||9
6369907|NCT00727532|7280705|FG000|COMPLETED|Overall Study||7
6369908|NCT00727532|7280705|FG000|NOT COMPLETED|Overall Study||2
6369909|NCT00727558|7280711|FG000|STARTED|Overall Study||127
6369910|NCT00727558|7280712|FG001|STARTED|Overall Study||121
6369911|NCT00727558|7280711|FG000|COMPLETED|Overall Study||125
6369912|NCT00727558|7280712|FG001|COMPLETED|Overall Study||118
6369913|NCT00727558|7280711|FG000|NOT COMPLETED|Overall Study||2
6369914|NCT00727558|7280712|FG001|NOT COMPLETED|Overall Study||3
6369915|NCT00727571|7280722|FG000|STARTED|Overall Study||232
6369916|NCT00727571|7280723|FG001|STARTED|Overall Study||228
6369917|NCT00727571|7280724|FG002|STARTED|Overall Study||165
6369918|NCT00727571|7280725|FG003|STARTED|Overall Study||169
6369919|NCT00727571|7280722|FG000|COMPLETED|Overall Study||231
6369920|NCT00727571|7280723|FG001|COMPLETED|Overall Study||173
6369921|NCT00727571|7280724|FG002|COMPLETED|Overall Study||135
6369922|NCT00727571|7280725|FG003|COMPLETED|Overall Study||163
6369923|NCT00727571|7280722|FG000|NOT COMPLETED|Overall Study||1
6369924|NCT00727571|7280723|FG001|NOT COMPLETED|Overall Study||55
6369925|NCT00727571|7280724|FG002|NOT COMPLETED|Overall Study||30
6369926|NCT00727571|7280725|FG003|NOT COMPLETED|Overall Study||6
6369927|NCT00727597|7280737|FG000|STARTED|Overall Study||51
6369928|NCT00727597|7280738|FG001|STARTED|Overall Study||50
6369929|NCT00727597|7280737|FG000|COMPLETED|Overall Study||51
6369930|NCT00727597|7280738|FG001|COMPLETED|Overall Study||50
6369931|NCT00727597|7280737|FG000|NOT COMPLETED|Overall Study||0
6369932|NCT00727597|7280738|FG001|NOT COMPLETED|Overall Study||0
6369933|NCT00727636|7280746|FG000|STARTED|Overall Study||37
6369934|NCT00727636|7280747|FG001|STARTED|Overall Study||15
6369935|NCT00727636|7280746|FG000|COMPLETED|Overall Study||33
6369936|NCT00727636|7280747|FG001|COMPLETED|Overall Study||15
6369937|NCT00727636|7280746|FG000|NOT COMPLETED|Overall Study||4
6369938|NCT00727636|7280747|FG001|NOT COMPLETED|Overall Study||0
6369939|NCT00727649|7280755|FG000|STARTED|First Intervention (4-weeks)||37
6369940|NCT00727649|7280756|FG001|STARTED|First Intervention (4-weeks)||43
6369941|NCT00727649|7280755|FG000|COMPLETED|First Intervention (4-weeks)||34
6369942|NCT00727649|7280756|FG001|COMPLETED|First Intervention (4-weeks)||40
6369943|NCT00727649|7280755|FG000|NOT COMPLETED|First Intervention (4-weeks)||3
6369944|NCT00727649|7280756|FG001|NOT COMPLETED|First Intervention (4-weeks)||3
6369945|NCT00727649|7280755|FG000|STARTED|Wash-out (2-weeks)||34
6369946|NCT00727649|7280756|FG001|STARTED|Wash-out (2-weeks)||40
6369947|NCT00727649|7280755|FG000|COMPLETED|Wash-out (2-weeks)||30
6369948|NCT00727649|7280756|FG001|COMPLETED|Wash-out (2-weeks)||37
6369949|NCT00727649|7280755|FG000|NOT COMPLETED|Wash-out (2-weeks)||4
6369950|NCT00727649|7280756|FG001|NOT COMPLETED|Wash-out (2-weeks)||3
6369951|NCT00727649|7280755|FG000|STARTED|Second Intervention (4-weeks)||30
6369952|NCT00727649|7280756|FG001|STARTED|Second Intervention (4-weeks)||37
6369953|NCT00727649|7280755|FG000|COMPLETED|Second Intervention (4-weeks)||29
6369954|NCT00727649|7280756|FG001|COMPLETED|Second Intervention (4-weeks)||34
6369955|NCT00727649|7280755|FG000|NOT COMPLETED|Second Intervention (4-weeks)||1
6369956|NCT00727649|7280756|FG001|NOT COMPLETED|Second Intervention (4-weeks)||3
6369957|NCT00727714|7280764|FG000|STARTED|Overall Study||95
6369958|NCT00727714|7280764|FG000|COMPLETED|Overall Study||93
6369959|NCT00727714|7280764|FG000|NOT COMPLETED|Overall Study||2
6369960|NCT00727740|7280770|FG000|STARTED|Overall Study||56
6369961|NCT00727740|7280771|FG001|STARTED|Overall Study||61
6369962|NCT00727740|7280770|FG000|COMPLETED|Overall Study||56
6369963|NCT00727740|7280771|FG001|COMPLETED|Overall Study||61
6369964|NCT00727740|7280770|FG000|NOT COMPLETED|Overall Study||0
6369965|NCT00727740|7280771|FG001|NOT COMPLETED|Overall Study||0
6369966|NCT00727844|7280779|FG000|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
6369967|NCT00727844|7280780|FG001|STARTED|Initial Randomization||20
6369968|NCT00727844|7280781|FG002|STARTED|Initial Randomization||0
6369969|NCT00727844|7280782|FG003|STARTED|Initial Randomization||0
6369970|NCT00727844|7280779|FG000|Included in MITT Analysis|Initial Randomization||19
6369971|NCT00727844|7280780|FG001|Included in MITT Analysis|Initial Randomization||20
6369972|NCT00727844|7280781|FG002|Included in MITT Analysis|Initial Randomization||0
6369973|NCT00727844|7280782|FG003|Included in MITT Analysis|Initial Randomization||0
6369974|NCT00727844|7280779|FG000|COMPLETED|Initial Randomization||19
6369975|NCT00727844|7280780|FG001|COMPLETED|Initial Randomization||20
6369976|NCT00727844|7280781|FG002|COMPLETED|Initial Randomization||0
6369977|NCT00727844|7280782|FG003|COMPLETED|Initial Randomization||0
6369978|NCT00727844|7280779|FG000|NOT COMPLETED|Initial Randomization||2
6369979|NCT00727844|7280780|FG001|NOT COMPLETED|Initial Randomization||0
6369980|NCT00727844|7280781|FG002|NOT COMPLETED|Initial Randomization||0
6369981|NCT00727844|7280782|FG003|NOT COMPLETED|Initial Randomization||0
6369982|NCT00727844|7280779|FG000|STARTED|Second Randomization||0
6369983|NCT00727844|7280780|FG001|STARTED|Second Randomization||0
6369984|NCT00727844|7280781|FG002|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
6369985|NCT00727844|7280782|FG003|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
6369986|NCT00727844|7280779|FG000|COMPLETED|Second Randomization||0
6369987|NCT00727844|7280780|FG001|COMPLETED|Second Randomization||0
6369988|NCT00727844|7280781|FG002|COMPLETED|Second Randomization||17
6369989|NCT00727844|7280782|FG003|COMPLETED|Second Randomization||16
6369990|NCT00727844|7280779|FG000|NOT COMPLETED|Second Randomization||0
6369991|NCT00727844|7280780|FG001|NOT COMPLETED|Second Randomization||0
6369992|NCT00727844|7280781|FG002|NOT COMPLETED|Second Randomization||0
6369993|NCT00727844|7280782|FG003|NOT COMPLETED|Second Randomization||0
6369994|NCT00727857|7280790|FG000|STARTED|Overall Study||201
6369995|NCT00727857|7280791|FG001|STARTED|Overall Study||189
6369996|NCT00727857|7280792|FG002|STARTED|Overall Study||210
6369997|NCT00727857|7280790|FG000|COMPLETED|Overall Study||157
6369998|NCT00727857|7280791|FG001|COMPLETED|Overall Study||125
6369999|NCT00727857|7280792|FG002|COMPLETED|Overall Study||142
6370000|NCT00727857|7280790|FG000|NOT COMPLETED|Overall Study||44
6370001|NCT00727857|7280791|FG001|NOT COMPLETED|Overall Study||64
6370002|NCT00727857|7280792|FG002|NOT COMPLETED|Overall Study||68
6370003|NCT00727909|7280801|FG000|STARTED|Overall Study||65
6370004|NCT00727909|7280802|FG001|STARTED|Overall Study||72
6370005|NCT00727909|7280803|FG002|STARTED|Overall Study||67
6370006|NCT00727909|7280804|FG003|STARTED|Overall Study||75
6370007|NCT00727909|7280801|FG000|COMPLETED|Overall Study||60
6370008|NCT00727909|7280802|FG001|COMPLETED|Overall Study||61
6370009|NCT00727909|7280803|FG002|COMPLETED|Overall Study||58
6370010|NCT00727909|7280804|FG003|COMPLETED|Overall Study||70
6370011|NCT00727909|7280801|FG000|NOT COMPLETED|Overall Study||5
6370012|NCT00727909|7280802|FG001|NOT COMPLETED|Overall Study||11
6370013|NCT00727909|7280803|FG002|NOT COMPLETED|Overall Study||9
6370014|NCT00727909|7280804|FG003|NOT COMPLETED|Overall Study||5
6370015|NCT00727961|7280808|FG000|STARTED|Overall Study||58
6560916|NCT01790568|7483862|FG000|STARTED|Overall Study||12
6560917|NCT01790568|7483863|FG001|STARTED|Overall Study||26
6560918|NCT01790568|7483862|FG000|COMPLETED|Overall Study||12
6370016|NCT00727961|7280808|FG000|COMPLETED|Overall Study||21
6370017|NCT00727961|7280808|FG000|NOT COMPLETED|Overall Study||37
6370018|NCT00728130|7280812|FG000|STARTED|Overall Study||22
6370019|NCT00728130|7280812|FG000|COMPLETED|Overall Study||19
6370020|NCT00728130|7280812|FG000|NOT COMPLETED|Overall Study||3
6370021|NCT00728182|7280818|FG000|STARTED|Overall Study||92
6370022|NCT00728182|7280819|FG001|STARTED|Overall Study||93
6370023|NCT00728182|7280818|FG000|COMPLETED|Overall Study||89
6370024|NCT00728182|7280819|FG001|COMPLETED|Overall Study||90
6370025|NCT00728182|7280818|FG000|NOT COMPLETED|Overall Study||3
6370026|NCT00728182|7280819|FG001|NOT COMPLETED|Overall Study||3
6370027|NCT00728260|7280827|FG000|STARTED|Overall Study||1421
6370028|NCT00728260|7280827|FG000|COMPLETED|Overall Study||1421
6370029|NCT00728260|7280827|FG000|NOT COMPLETED|Overall Study||0
6370030|NCT00728468|7280831|FG000|STARTED|Overall Study||16
6370031|NCT00728468|7280831|FG000|Treated|Overall Study||15
6370032|NCT00728468|7280831|FG000|COMPLETED|Overall Study||0
6370033|NCT00728468|7280831|FG000|NOT COMPLETED|Overall Study||16
6370034|NCT00728481|7280837|FG000|STARTED|Overall Study||19
6370035|NCT00728481|7280838|FG001|STARTED|Overall Study||32
6370036|NCT00728481|7280837|FG000|COMPLETED|Overall Study||18
6370037|NCT00728481|7280838|FG001|COMPLETED|Overall Study||28
6370038|NCT00728481|7280837|FG000|NOT COMPLETED|Overall Study||1
6370039|NCT00728481|7280838|FG001|NOT COMPLETED|Overall Study||4
6370040|NCT00728494|7280846|FG000|STARTED|Overall Study||60
6370041|NCT00728494|7280847|FG001|STARTED|Overall Study||39
6370042|NCT00728494|7280846|FG000|COMPLETED|Overall Study||51
6370043|NCT00728494|7280847|FG001|COMPLETED|Overall Study||32
6370044|NCT00728494|7280846|FG000|NOT COMPLETED|Overall Study||9
6560919|NCT01790568|7483863|FG001|COMPLETED|Overall Study||25
6560920|NCT01790568|7483862|FG000|NOT COMPLETED|Overall Study||0
6560921|NCT01790568|7483863|FG001|NOT COMPLETED|Overall Study||1
6560922|NCT01790581|7483869|FG000|STARTED|Overall Study||12
6370045|NCT00728494|7280847|FG001|NOT COMPLETED|Overall Study||7
6370046|NCT00728507|7280855|FG000|STARTED|Overall Study||62
6370047|NCT00728507|7280856|FG001|STARTED|Overall Study||59
6370048|NCT00728507|7280855|FG000|COMPLETED|Overall Study||60
6370049|NCT00728507|7280856|FG001|COMPLETED|Overall Study||51
6370050|NCT00728507|7280855|FG000|NOT COMPLETED|Overall Study||2
6370051|NCT00728507|7280856|FG001|NOT COMPLETED|Overall Study||8
6370052|NCT00728689|7280864|FG000|STARTED|First Intervention (Days 1 - 3)||6
6370053|NCT00728689|7280865|FG001|STARTED|First Intervention (Days 1 - 3)||6
6370054|NCT00728689|7280864|FG000|COMPLETED|First Intervention (Days 1 - 3)||6
6370055|NCT00728689|7280865|FG001|COMPLETED|First Intervention (Days 1 - 3)||6
6370056|NCT00728689|7280864|FG000|NOT COMPLETED|First Intervention (Days 1 - 3)||0
6370057|NCT00728689|7280865|FG001|NOT COMPLETED|First Intervention (Days 1 - 3)||0
6370058|NCT00728689|7280864|FG000|STARTED|Washout Period (Days 4 - 10)||6
6370059|NCT00728689|7280865|FG001|STARTED|Washout Period (Days 4 - 10)||6
6370060|NCT00728689|7280864|FG000|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
6370061|NCT00728689|7280865|FG001|COMPLETED|Washout Period (Days 4 - 10)||6
6370062|NCT00728689|7280864|FG000|NOT COMPLETED|Washout Period (Days 4 - 10)||1
6370063|NCT00728689|7280865|FG001|NOT COMPLETED|Washout Period (Days 4 - 10)||0
6370064|NCT00728689|7280864|FG000|STARTED|Second Intervention (Days 11 - 13)||5
6370065|NCT00728689|7280865|FG001|STARTED|Second Intervention (Days 11 - 13)||6
6370066|NCT00728689|7280864|FG000|COMPLETED|Second Intervention (Days 11 - 13)||5
6370067|NCT00728689|7280865|FG001|COMPLETED|Second Intervention (Days 11 - 13)||6
6370068|NCT00728689|7280864|FG000|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
6370069|NCT00728689|7280865|FG001|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
6370070|NCT00728728|7280875|FG000|STARTED|Overall Study||42
6370071|NCT00728728|7280876|FG001|STARTED|Overall Study||46
6370072|NCT00728728|7280875|FG000|COMPLETED|Overall Study||38
6370073|NCT00728728|7280876|FG001|COMPLETED|Overall Study||34
6370074|NCT00728728|7280875|FG000|NOT COMPLETED|Overall Study||4
6370075|NCT00728728|7280876|FG001|NOT COMPLETED|Overall Study||12
6370076|NCT00728819|7280885|FG000|STARTED|Overall Study||171
6370077|NCT00728819|7280886|FG001|STARTED|Overall Study||168
6370078|NCT00728819|7280885|FG000|COMPLETED|Overall Study||135
6370079|NCT00728819|7280886|FG001|COMPLETED|Overall Study||139
6370080|NCT00728819|7280885|FG000|NOT COMPLETED|Overall Study||36
6370081|NCT00728819|7280886|FG001|NOT COMPLETED|Overall Study||29
6370082|NCT00728910|7280892|FG000|STARTED|Atorvastatin||25
6370083|NCT00728910|7280892|FG000|COMPLETED|Atorvastatin||22
6370084|NCT00728910|7280892|FG000|NOT COMPLETED|Atorvastatin||3
6370085|NCT00728910|7280892|FG000|STARTED|Atorvastatin+ABT335||22
6370086|NCT00728910|7280892|FG000|COMPLETED|Atorvastatin+ABT335||22
6370087|NCT00728910|7280892|FG000|NOT COMPLETED|Atorvastatin+ABT335||0
6370088|NCT00728910|7280892|FG000|STARTED|Atorvastatin+ABT335+ER Niacin||22
6370089|NCT00728910|7280892|FG000|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
6370090|NCT00728910|7280892|FG000|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
6370091|NCT00728923|7280901|FG000|STARTED|Overall Study||9
6370092|NCT00728923|7280901|FG000|COMPLETED|Overall Study||9
6370093|NCT00728923|7280901|FG000|NOT COMPLETED|Overall Study||0
6370094|NCT00728936|7280912|FG000|STARTED|Overall Study||10
6370095|NCT00728936|7280913|FG001|STARTED|Overall Study||8
6370096|NCT00728936|7280914|FG002|STARTED|Overall Study||9
6370097|NCT00728936|7280915|FG003|STARTED|Overall Study||8
6370098|NCT00728936|7280916|FG004|STARTED|Overall Study||8
6370099|NCT00728936|7280917|FG005|STARTED|Overall Study||8
6370100|NCT00728936|7280918|FG006|STARTED|Overall Study||7
6370101|NCT00728936|7280912|FG000|COMPLETED|Overall Study||10
6370102|NCT00728936|7280913|FG001|COMPLETED|Overall Study||8
6370103|NCT00728936|7280914|FG002|COMPLETED|Overall Study||9
6370104|NCT00728936|7280915|FG003|COMPLETED|Overall Study||8
6370105|NCT00728936|7280916|FG004|COMPLETED|Overall Study||8
6370106|NCT00728936|7280917|FG005|COMPLETED|Overall Study||7
6370107|NCT00728936|7280918|FG006|COMPLETED|Overall Study||7
6370108|NCT00728936|7280912|FG000|NOT COMPLETED|Overall Study||0
6370109|NCT00728936|7280913|FG001|NOT COMPLETED|Overall Study||0
6370110|NCT00728936|7280914|FG002|NOT COMPLETED|Overall Study||0
6370111|NCT00728936|7280915|FG003|NOT COMPLETED|Overall Study||0
6370112|NCT00728936|7280916|FG004|NOT COMPLETED|Overall Study||0
6370113|NCT00728936|7280917|FG005|NOT COMPLETED|Overall Study||1
6370114|NCT00728936|7280918|FG006|NOT COMPLETED|Overall Study||0
6370115|NCT00728949|7280936|FG000|STARTED|Overall Study||62
6370116|NCT00728949|7280937|FG001|STARTED|Overall Study||31
6370117|NCT00728949|7280936|FG000|COMPLETED|Overall Study||51
6370118|NCT00728949|7280937|FG001|COMPLETED|Overall Study||27
6370119|NCT00728949|7280936|FG000|NOT COMPLETED|Overall Study||11
6370120|NCT00728949|7280937|FG001|NOT COMPLETED|Overall Study||4
6370121|NCT00728988|7280945|FG000|STARTED|Overall Study||247
6370122|NCT00728988|7280946|FG001|STARTED|Overall Study||252
6370123|NCT00728988|7280945|FG000|Treated|Overall Study||245
6370124|NCT00728988|7280946|FG001|Treated|Overall Study||250
6370125|NCT00728988|7280945|FG000|Full Analysis Set|Overall Study||163
6370126|NCT00728988|7280946|FG001|Full Analysis Set|Overall Study||172
6370127|NCT00728988|7280945|FG000|COMPLETED|Overall Study||154
6370128|NCT00728988|7280946|FG001|COMPLETED|Overall Study||164
6370129|NCT00728988|7280945|FG000|NOT COMPLETED|Overall Study||93
6370130|NCT00728988|7280946|FG001|NOT COMPLETED|Overall Study||88
6370131|NCT00729053|7280957|FG000|STARTED|Overall Study||23
6370132|NCT00729053|7280958|FG001|STARTED|Overall Study||23
6370133|NCT00729053|7280959|FG002|STARTED|Overall Study||23
6370134|NCT00729053|7280960|FG003|STARTED|Overall Study||23
6370135|NCT00729053|7280957|FG000|COMPLETED|Overall Study||23
6370136|NCT00729053|7280958|FG001|COMPLETED|Overall Study||23
6370137|NCT00729053|7280959|FG002|COMPLETED|Overall Study||23
6370138|NCT00729053|7280960|FG003|COMPLETED|Overall Study||23
6370139|NCT00729053|7280957|FG000|NOT COMPLETED|Overall Study||0
6370140|NCT00729053|7280958|FG001|NOT COMPLETED|Overall Study||0
6370141|NCT00729053|7280959|FG002|NOT COMPLETED|Overall Study||0
6370142|NCT00729053|7280960|FG003|NOT COMPLETED|Overall Study||0
6370143|NCT00729157|7280970|FG000|STARTED|Overall Study||41
6370144|NCT00729157|7280970|FG000|COMPLETED|Overall Study||40
6370145|NCT00729157|7280970|FG000|NOT COMPLETED|Overall Study||1
6370146|NCT00729183|7280976|FG000|STARTED|Overall Study||109
6370147|NCT00729183|7280977|FG001|STARTED|Overall Study||105
6370148|NCT00729183|7280976|FG000|COMPLETED|Overall Study|Completed 24 month visit|84
6370149|NCT00729183|7280977|FG001|COMPLETED|Overall Study|Completed 24 month visit|90
6370150|NCT00729183|7280976|FG000|NOT COMPLETED|Overall Study||25
6370151|NCT00729183|7280977|FG001|NOT COMPLETED|Overall Study||15
6370152|NCT00729248|7280983|FG000|STARTED|Overall Study||12
6370153|NCT00729248|7280983|FG000|COMPLETED|Overall Study||10
6370154|NCT00729248|7280983|FG000|NOT COMPLETED|Overall Study||2
6370155|NCT00729326|7280990|FG000|STARTED|Overall Study||41
6370156|NCT00729326|7280991|FG001|STARTED|Overall Study||42
6370157|NCT00729326|7280990|FG000|COMPLETED|Overall Study||31
6370158|NCT00729326|7280991|FG001|COMPLETED|Overall Study||33
6370159|NCT00729326|7280990|FG000|NOT COMPLETED|Overall Study||10
6370160|NCT00729326|7280991|FG001|NOT COMPLETED|Overall Study||9
6370161|NCT00729378|7280999|FG000|STARTED|Baseline||430
6370162|NCT00729378|7281000|FG001|STARTED|Baseline||309
6370163|NCT00729378|7280999|FG000|COMPLETED|Baseline||292
6370164|NCT00729378|7281000|FG001|COMPLETED|Baseline||217
6370165|NCT00729378|7280999|FG000|NOT COMPLETED|Baseline||138
6370166|NCT00729378|7281000|FG001|NOT COMPLETED|Baseline||92
6370167|NCT00729378|7280999|FG000|STARTED|12-months||292
6370168|NCT00729378|7281000|FG001|STARTED|12-months||217
6370169|NCT00729378|7280999|FG000|COMPLETED|12-months||192
6370170|NCT00729378|7281000|FG001|COMPLETED|12-months||152
6370171|NCT00729378|7280999|FG000|NOT COMPLETED|12-months||100
6370172|NCT00729378|7281000|FG001|NOT COMPLETED|12-months||65
6370173|NCT00729378|7280999|FG000|STARTED|24-months||192
6370174|NCT00729378|7281000|FG001|STARTED|24-months||152
6370175|NCT00729378|7280999|FG000|COMPLETED|24-months||120
6370176|NCT00729378|7281000|FG001|COMPLETED|24-months||101
6370177|NCT00729378|7280999|FG000|NOT COMPLETED|24-months||72
6370178|NCT00729378|7281000|FG001|NOT COMPLETED|24-months||51
6370179|NCT00729378|7280999|FG000|STARTED|36-months||120
6370180|NCT00729378|7281000|FG001|STARTED|36-months||101
6370181|NCT00729378|7280999|FG000|COMPLETED|36-months||105
6370182|NCT00729378|7281000|FG001|COMPLETED|36-months||95
6370183|NCT00729378|7280999|FG000|NOT COMPLETED|36-months||15
6370184|NCT00729378|7281000|FG001|NOT COMPLETED|36-months||6
6370185|NCT00729430|7281011|FG000|STARTED|Overall Study||180
6370186|NCT00729430|7281012|FG001|STARTED|Overall Study||178
6370187|NCT00729430|7281011|FG000|COMPLETED|Overall Study||133
6370188|NCT00729430|7281012|FG001|COMPLETED|Overall Study||128
6370189|NCT00729430|7281011|FG000|NOT COMPLETED|Overall Study||47
6370190|NCT00729430|7281012|FG001|NOT COMPLETED|Overall Study||50
6370191|NCT00729469|7281021|FG000|STARTED|Overall Study||456
6370192|NCT00729469|7281022|FG001|STARTED|Overall Study||463
6370193|NCT00729469|7281021|FG000|COMPLETED|Overall Study||403
6370194|NCT00729469|7281022|FG001|COMPLETED|Overall Study||416
6370195|NCT00729469|7281021|FG000|NOT COMPLETED|Overall Study||53
6370196|NCT00729469|7281022|FG001|NOT COMPLETED|Overall Study||47
6370197|NCT00729482|7281028|FG000|STARTED|Overall Study||54
6370198|NCT00729482|7281028|FG000|COMPLETED|Overall Study||54
6370199|NCT00729482|7281028|FG000|NOT COMPLETED|Overall Study||0
6370200|NCT00729521|7281035|FG000|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
6370201|NCT00729521|7281036|FG001|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
6370202|NCT00729521|7281037|FG002|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
6370203|NCT00729521|7281035|FG000|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
6370204|NCT00729521|7281036|FG001|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
6370205|NCT00729521|7281037|FG002|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
6370206|NCT00729521|7281035|FG000|NOT COMPLETED|Overall Study||0
6370207|NCT00729521|7281036|FG001|NOT COMPLETED|Overall Study||0
6370208|NCT00729521|7281037|FG002|NOT COMPLETED|Overall Study||0
6370209|NCT00729586|7281047|FG000|STARTED|Overall Study||51
6370210|NCT00729586|7281048|FG001|STARTED|Overall Study||22
6370211|NCT00729586|7281047|FG000|COMPLETED|Overall Study|Eligible and treated patients|50
6370212|NCT00729586|7281048|FG001|COMPLETED|Overall Study|Eligible and treated patients|21
6370213|NCT00729586|7281047|FG000|NOT COMPLETED|Overall Study||1
6370214|NCT00729586|7281048|FG001|NOT COMPLETED|Overall Study||1
6370215|NCT00729612|7281055|FG000|STARTED|Overall Study||63
6370216|NCT00729612|7281055|FG000|Died Before Cycle 1|Overall Study||1
6370217|NCT00729612|7281055|FG000|Received Cycle 1|Overall Study||62
6370218|NCT00729612|7281055|FG000|Did Not Receive Cycle 2|Overall Study||7
6370219|NCT00729612|7281055|FG000|Received Cycle 2|Overall Study||54
6370220|NCT00729612|7281055|FG000|Died After Cycle 2 Before Response Eval|Overall Study||1
6370221|NCT00729612|7281055|FG000|COMPLETED|Overall Study||53
6370222|NCT00729612|7281055|FG000|NOT COMPLETED|Overall Study||10
6370223|NCT00729677|7281059|FG000|STARTED|Overall Study||64
6370224|NCT00729677|7281059|FG000|COMPLETED|Overall Study||64
6370225|NCT00729677|7281059|FG000|NOT COMPLETED|Overall Study||0
6370226|NCT00729690|7281073|FG000|STARTED|Overall Study||16
6370227|NCT00729690|7281074|FG001|STARTED|Overall Study||16
6370228|NCT00729690|7281075|FG002|STARTED|Overall Study||16
6370229|NCT00729690|7281073|FG000|COMPLETED|Overall Study||16
6370230|NCT00729690|7281074|FG001|COMPLETED|Overall Study||14
6370231|NCT00729690|7281075|FG002|COMPLETED|Overall Study||14
6370232|NCT00729690|7281073|FG000|NOT COMPLETED|Overall Study||0
6370233|NCT00729690|7281074|FG001|NOT COMPLETED|Overall Study||2
6370234|NCT00729690|7281075|FG002|NOT COMPLETED|Overall Study||2
6370235|NCT00729781|7281083|FG000|STARTED|Original Study||45
6370236|NCT00729781|7281083|FG000|COMPLETED|Original Study||45
6370237|NCT00729781|7281083|FG000|NOT COMPLETED|Original Study||0
6370238|NCT00729781|7281083|FG000|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
6370239|NCT00729781|7281083|FG000|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
6370240|NCT00729781|7281083|FG000|NOT COMPLETED|Long-term Follow-up Study||0
6370241|NCT00729807|7281087|FG000|STARTED|Overall Study||6
6370242|NCT00729807|7281087|FG000|COMPLETED|Overall Study||6
6370243|NCT00729807|7281087|FG000|NOT COMPLETED|Overall Study||0
6370244|NCT00729833|7281091|FG000|STARTED|Overall Study||20
6370245|NCT00729833|7281092|FG001|STARTED|Overall Study||7
6370246|NCT00729833|7281093|FG002|STARTED|Overall Study||12
6370247|NCT00729833|7281094|FG003|STARTED|Overall Study||6
6370248|NCT00729833|7281091|FG000|COMPLETED|Overall Study||0
6370249|NCT00729833|7281092|FG001|COMPLETED|Overall Study||0
6370250|NCT00729833|7281093|FG002|COMPLETED|Overall Study||0
6370251|NCT00729833|7281094|FG003|COMPLETED|Overall Study||0
6370252|NCT00729833|7281091|FG000|NOT COMPLETED|Overall Study||20
6370253|NCT00729833|7281092|FG001|NOT COMPLETED|Overall Study||7
6370254|NCT00729833|7281093|FG002|NOT COMPLETED|Overall Study||12
6370255|NCT00729833|7281094|FG003|NOT COMPLETED|Overall Study||6
6370256|NCT00729846|7281107|FG000|STARTED|Overall Study||11
6370257|NCT00729846|7281108|FG001|STARTED|Overall Study||11
6370258|NCT00729846|7281107|FG000|COMPLETED|Overall Study||11
6370259|NCT00729846|7281108|FG001|COMPLETED|Overall Study||11
6370260|NCT00729846|7281107|FG000|NOT COMPLETED|Overall Study||0
6370261|NCT00729846|7281108|FG001|NOT COMPLETED|Overall Study||0
6370262|NCT00729859|7281117|FG000|STARTED|Overall Study||8
6370263|NCT00729859|7281118|FG001|STARTED|Overall Study||8
6370264|NCT00729859|7281119|FG002|STARTED|Overall Study||8
6370265|NCT00729859|7281117|FG000|COMPLETED|Overall Study||8
6370266|NCT00729859|7281118|FG001|COMPLETED|Overall Study||6
6370267|NCT00729859|7281119|FG002|COMPLETED|Overall Study||8
6370268|NCT00729859|7281117|FG000|NOT COMPLETED|Overall Study||0
6370269|NCT00729859|7281118|FG001|NOT COMPLETED|Overall Study||2
6370270|NCT00729859|7281119|FG002|NOT COMPLETED|Overall Study||0
6370271|NCT00729924|7281135|FG000|STARTED|Overall Study||40
6370272|NCT00729924|7281135|FG000|COMPLETED|Overall Study||40
6370273|NCT00729924|7281135|FG000|NOT COMPLETED|Overall Study||0
6370274|NCT00729937|7281148|FG000|STARTED|Overall Study||629
6370275|NCT00729937|7281149|FG001|STARTED|Overall Study||636
6370276|NCT00729937|7281150|FG002|STARTED|Overall Study||251
6370277|NCT00729937|7281151|FG003|STARTED|Overall Study||249
6370278|NCT00729937|7281152|FG004|STARTED|Overall Study||249
6370279|NCT00729937|7281153|FG005|STARTED|Overall Study||251
6370280|NCT00729937|7281148|FG000|COMPLETED|Overall Study||555
6370281|NCT00729937|7281149|FG001|COMPLETED|Overall Study||548
6370282|NCT00729937|7281150|FG002|COMPLETED|Overall Study||222
6370283|NCT00729937|7281151|FG003|COMPLETED|Overall Study||215
6370284|NCT00729937|7281152|FG004|COMPLETED|Overall Study||221
6370285|NCT00729937|7281153|FG005|COMPLETED|Overall Study||214
6370286|NCT00729937|7281148|FG000|NOT COMPLETED|Overall Study||74
6370287|NCT00729937|7281149|FG001|NOT COMPLETED|Overall Study||88
6370288|NCT00729937|7281150|FG002|NOT COMPLETED|Overall Study||29
6370289|NCT00729937|7281151|FG003|NOT COMPLETED|Overall Study||34
6370290|NCT00729937|7281152|FG004|NOT COMPLETED|Overall Study||28
6370291|NCT00729937|7281153|FG005|NOT COMPLETED|Overall Study||37
6370292|NCT00730015|7281170|FG000|STARTED|Overall Study||217
6370293|NCT00730015|7281171|FG001|STARTED|Overall Study||217
6370294|NCT00730015|7281172|FG002|STARTED|Overall Study||209
6370295|NCT00730015|7281170|FG000|COMPLETED|Overall Study||186
6370296|NCT00730015|7281171|FG001|COMPLETED|Overall Study||177
6370297|NCT00730015|7281172|FG002|COMPLETED|Overall Study||177
6370298|NCT00730015|7281170|FG000|NOT COMPLETED|Overall Study||31
6370299|NCT00730015|7281171|FG001|NOT COMPLETED|Overall Study||40
6370300|NCT00730015|7281172|FG002|NOT COMPLETED|Overall Study||32
6370301|NCT00730028|7281190|FG000|STARTED|Overall Study||264
6370302|NCT00730028|7281191|FG001|STARTED|Overall Study||260
6370303|NCT00730028|7281192|FG002|STARTED|Overall Study||266
6370304|NCT00730028|7281193|FG003|STARTED|Overall Study||263
6370305|NCT00730028|7281194|FG004|STARTED|Overall Study||257
6370306|NCT00730028|7281190|FG000|COMPLETED|Overall Study||204
6370307|NCT00730028|7281191|FG001|COMPLETED|Overall Study||194
6370308|NCT00730028|7281192|FG002|COMPLETED|Overall Study||221
6370309|NCT00730028|7281193|FG003|COMPLETED|Overall Study||207
6370310|NCT00730028|7281194|FG004|COMPLETED|Overall Study||175
6370311|NCT00730028|7281190|FG000|NOT COMPLETED|Overall Study||60
6370312|NCT00730028|7281191|FG001|NOT COMPLETED|Overall Study||66
6370313|NCT00730028|7281192|FG002|NOT COMPLETED|Overall Study||45
6370314|NCT00730028|7281193|FG003|NOT COMPLETED|Overall Study||56
6370315|NCT00730028|7281194|FG004|NOT COMPLETED|Overall Study||82
6370316|NCT00730041|7281208|FG000|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
6370317|NCT00730041|7281209|FG001|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
6370318|NCT00730041|7281208|FG000|COMPLETED|Overall Study||26
6370319|NCT00730041|7281209|FG001|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
6370320|NCT00730041|7281208|FG000|NOT COMPLETED|Overall Study||0
6370321|NCT00730041|7281209|FG001|NOT COMPLETED|Overall Study||2
6377696|NCT00764660|7288334|FG001|COMPLETED|Overall Study||55
6377697|NCT00764660|7288333|FG000|NOT COMPLETED|Overall Study||22
6377698|NCT00764660|7288334|FG001|NOT COMPLETED|Overall Study||11
6377699|NCT00764673|7288340|FG000|STARTED|Overall Study||71
6377700|NCT00764673|7288340|FG000|COMPLETED|Overall Study||59
6377701|NCT00764673|7288340|FG000|NOT COMPLETED|Overall Study||12
6377702|NCT00764738|7288348|FG000|STARTED|Overall Study||24
6377703|NCT00764738|7288349|FG001|STARTED|Overall Study||28
6377704|NCT00764738|7288350|FG002|STARTED|Overall Study||15
6377705|NCT00764738|7288351|FG003|STARTED|Overall Study||24
6377706|NCT00764738|7288348|FG000|COMPLETED|Overall Study||22
6377707|NCT00764738|7288349|FG001|COMPLETED|Overall Study||25
6377708|NCT00764738|7288350|FG002|COMPLETED|Overall Study||12
6377709|NCT00764738|7288351|FG003|COMPLETED|Overall Study||18
6377710|NCT00764738|7288348|FG000|NOT COMPLETED|Overall Study||2
6377711|NCT00764738|7288349|FG001|NOT COMPLETED|Overall Study||3
6377712|NCT00764738|7288350|FG002|NOT COMPLETED|Overall Study||3
6377713|NCT00764738|7288351|FG003|NOT COMPLETED|Overall Study||6
6377714|NCT00764751|7288363|FG000|STARTED|Overall Study||39
6377715|NCT00764751|7288364|FG001|STARTED|Overall Study||12
6377716|NCT00764751|7288363|FG000|COMPLETED|Overall Study||37
6377717|NCT00764751|7288364|FG001|COMPLETED|Overall Study||11
6377718|NCT00764751|7288363|FG000|NOT COMPLETED|Overall Study||2
6377719|NCT00764751|7288364|FG001|NOT COMPLETED|Overall Study||1
6377720|NCT00764790|7288378|FG000|STARTED|Overall Study||1107
6377721|NCT00764790|7288379|FG001|STARTED|Overall Study||1106
6377722|NCT00764790|7288380|FG002|STARTED|Overall Study||1104
6377723|NCT00764790|7288378|FG000|COMPLETED|Overall Study||1069
6377724|NCT00764790|7288379|FG001|COMPLETED|Overall Study||1065
6377725|NCT00764790|7288380|FG002|COMPLETED|Overall Study||1074
6377726|NCT00764790|7288378|FG000|NOT COMPLETED|Overall Study||38
6377727|NCT00764790|7288379|FG001|NOT COMPLETED|Overall Study||41
6377728|NCT00764790|7288380|FG002|NOT COMPLETED|Overall Study||30
6377729|NCT00764868|7288388|FG000|STARTED|Overall Study||269
6377730|NCT00764868|7288388|FG000|COMPLETED|Overall Study||156
6377731|NCT00764868|7288388|FG000|NOT COMPLETED|Overall Study||113
6377732|NCT00764881|7288394|FG000|STARTED|Overall Study||108
6377733|NCT00764881|7288395|FG001|STARTED|Overall Study||109
6377734|NCT00764881|7288394|FG000|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
6377735|NCT00764881|7288395|FG001|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
6377736|NCT00764881|7288394|FG000|COMPLETED|Overall Study||92
6377737|NCT00764881|7288395|FG001|COMPLETED|Overall Study||99
6377738|NCT00764881|7288394|FG000|NOT COMPLETED|Overall Study||16
6377739|NCT00764881|7288395|FG001|NOT COMPLETED|Overall Study||10
6370322|NCT00730158|7281217|FG000|STARTED|Overall Study||17
6370323|NCT00730158|7281218|FG001|STARTED|Overall Study||16
6370324|NCT00730158|7281217|FG000|COMPLETED|Overall Study||16
6370325|NCT00730158|7281218|FG001|COMPLETED|Overall Study||15
6370326|NCT00730158|7281217|FG000|NOT COMPLETED|Overall Study||1
6370327|NCT00730158|7281218|FG001|NOT COMPLETED|Overall Study||1
6370328|NCT00730171|7281228|FG000|STARTED|Overall Study||1725
6370329|NCT00730171|7281228|FG000|CC Safety Population|Overall Study||607
6370330|NCT00730171|7281228|FG000|IBS-C Safety Population|Overall Study||1119
6370331|NCT00730171|7281228|FG000|COMPLETED|Overall Study||954
6370332|NCT00730171|7281228|FG000|NOT COMPLETED|Overall Study||771
6370333|NCT00730236|7281236|FG000|STARTED|Overall Study||29
6370334|NCT00730236|7281236|FG000|COMPLETED|Overall Study||23
6370335|NCT00730236|7281236|FG000|NOT COMPLETED|Overall Study||6
6370336|NCT00730275|7281244|FG000|STARTED|Overall Study||9
6370337|NCT00730275|7281245|FG001|STARTED|Overall Study||9
6370338|NCT00730275|7281246|FG002|STARTED|Overall Study||8
6370339|NCT00730275|7281247|FG003|STARTED|Overall Study||9
6370340|NCT00730275|7281244|FG000|COMPLETED|Overall Study||9
6370341|NCT00730275|7281245|FG001|COMPLETED|Overall Study||9
6370342|NCT00730275|7281246|FG002|COMPLETED|Overall Study||8
6370343|NCT00730275|7281247|FG003|COMPLETED|Overall Study||8
6370344|NCT00730275|7281244|FG000|NOT COMPLETED|Overall Study||0
6370345|NCT00730275|7281245|FG001|NOT COMPLETED|Overall Study||0
6370346|NCT00730275|7281246|FG002|NOT COMPLETED|Overall Study||0
6370347|NCT00730275|7281247|FG003|NOT COMPLETED|Overall Study||1
6370348|NCT00730327|7281260|FG000|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
6370349|NCT00730327|7281261|FG001|STARTED|Overall Study||130
6370350|NCT00730327|7281260|FG000|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
6370351|NCT00730327|7281261|FG001|Completed Week 26|Overall Study||99
6370352|NCT00730327|7281260|FG000|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
6370353|NCT00730327|7281261|FG001|COMPLETED|Overall Study||93
6370354|NCT00730327|7281260|FG000|NOT COMPLETED|Overall Study||27
6370355|NCT00730327|7281261|FG001|NOT COMPLETED|Overall Study||37
6370356|NCT00730353|7281267|FG000|STARTED|Overall Study||28
6370357|NCT00730353|7281267|FG000|COMPLETED|Overall Study||28
6370358|NCT00730353|7281267|FG000|NOT COMPLETED|Overall Study||0
6370359|NCT00730405|7281276|FG000|STARTED|Overall Study-Treatment Phase||116
6370360|NCT00730405|7281277|FG001|STARTED|Overall Study-Treatment Phase||117
6370361|NCT00730405|7281278|FG002|STARTED|Overall Study-Treatment Phase||117
6370362|NCT00730405|7281279|FG003|STARTED|Overall Study-Treatment Phase||117
6370363|NCT00730405|7281280|FG004|STARTED|Overall Study-Treatment Phase||115
6370364|NCT00730405|7281276|FG000|COMPLETED|Overall Study-Treatment Phase||97
6370365|NCT00730405|7281277|FG001|COMPLETED|Overall Study-Treatment Phase||96
6370366|NCT00730405|7281278|FG002|COMPLETED|Overall Study-Treatment Phase||96
6370367|NCT00730405|7281279|FG003|COMPLETED|Overall Study-Treatment Phase||98
6370368|NCT00730405|7281280|FG004|COMPLETED|Overall Study-Treatment Phase||95
6370369|NCT00730405|7281276|FG000|NOT COMPLETED|Overall Study-Treatment Phase||19
6370370|NCT00730405|7281277|FG001|NOT COMPLETED|Overall Study-Treatment Phase||21
6370371|NCT00730405|7281278|FG002|NOT COMPLETED|Overall Study-Treatment Phase||21
6370372|NCT00730405|7281279|FG003|NOT COMPLETED|Overall Study-Treatment Phase||19
6370373|NCT00730405|7281280|FG004|NOT COMPLETED|Overall Study-Treatment Phase||20
6370374|NCT00730405|7281276|FG000|STARTED|Overall Study-follow-up Phase||116
6370375|NCT00730405|7281277|FG001|STARTED|Overall Study-follow-up Phase||117
6370376|NCT00730405|7281278|FG002|STARTED|Overall Study-follow-up Phase||117
6370377|NCT00730405|7281279|FG003|STARTED|Overall Study-follow-up Phase||117
6370378|NCT00730405|7281280|FG004|STARTED|Overall Study-follow-up Phase||115
6370379|NCT00730405|7281276|FG000|COMPLETED|Overall Study-follow-up Phase||95
6370380|NCT00730405|7281277|FG001|COMPLETED|Overall Study-follow-up Phase||96
6370381|NCT00730405|7281278|FG002|COMPLETED|Overall Study-follow-up Phase||94
6370382|NCT00730405|7281279|FG003|COMPLETED|Overall Study-follow-up Phase||100
6370383|NCT00730405|7281280|FG004|COMPLETED|Overall Study-follow-up Phase||93
6370384|NCT00730405|7281276|FG000|NOT COMPLETED|Overall Study-follow-up Phase||21
6370385|NCT00730405|7281277|FG001|NOT COMPLETED|Overall Study-follow-up Phase||21
6370386|NCT00730405|7281278|FG002|NOT COMPLETED|Overall Study-follow-up Phase||23
6370387|NCT00730405|7281279|FG003|NOT COMPLETED|Overall Study-follow-up Phase||17
6370388|NCT00730405|7281280|FG004|NOT COMPLETED|Overall Study-follow-up Phase||22
6370389|NCT00730483|7281294|FG000|STARTED|Overall Study||13
6370390|NCT00730483|7281294|FG000|1 Month After First DEB-TACE|Overall Study||13
6370391|NCT00730483|7281294|FG000|6 Months After First DEB-TACE|Overall Study||10
6370392|NCT00730483|7281294|FG000|COMPLETED|Overall Study||6
6370393|NCT00730483|7281294|FG000|NOT COMPLETED|Overall Study||7
6370394|NCT00730522|7281301|FG000|STARTED|Overall Study||28
6370395|NCT00730522|7281302|FG001|STARTED|Overall Study||27
6370396|NCT00730522|7281301|FG000|COMPLETED|Overall Study||28
6370397|NCT00730522|7281302|FG001|COMPLETED|Overall Study||27
6370398|NCT00730522|7281301|FG000|NOT COMPLETED|Overall Study||0
6370399|NCT00730522|7281302|FG001|NOT COMPLETED|Overall Study||0
6370400|NCT00730691|7281315|FG000|STARTED|Overall Study||157
6370401|NCT00730691|7281316|FG001|STARTED|Overall Study||156
6370402|NCT00730691|7281317|FG002|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
6370403|NCT00730691|7281318|FG003|STARTED|Overall Study||156
6370404|NCT00730691|7281319|FG004|STARTED|Overall Study||156
6370405|NCT00730691|7281315|FG000|COMPLETED|Overall Study||121
6370406|NCT00730691|7281316|FG001|COMPLETED|Overall Study||120
6370407|NCT00730691|7281317|FG002|COMPLETED|Overall Study||117
6370408|NCT00730691|7281318|FG003|COMPLETED|Overall Study||111
6370409|NCT00730691|7281319|FG004|COMPLETED|Overall Study||106
6370410|NCT00730691|7281315|FG000|NOT COMPLETED|Overall Study||36
6370411|NCT00730691|7281316|FG001|NOT COMPLETED|Overall Study||36
6370412|NCT00730691|7281317|FG002|NOT COMPLETED|Overall Study||39
6370413|NCT00730691|7281318|FG003|NOT COMPLETED|Overall Study||45
6370414|NCT00730691|7281319|FG004|NOT COMPLETED|Overall Study||50
6370415|NCT00730730|7281331|FG000|STARTED|Overall Study||50
6370416|NCT00730730|7281331|FG000|COMPLETED|Overall Study||50
6370417|NCT00730730|7281331|FG000|NOT COMPLETED|Overall Study||0
6370418|NCT00730756|7281337|FG000|STARTED|Overall Study||49
6370419|NCT00730756|7281338|FG001|STARTED|Overall Study||53
6370420|NCT00730756|7281337|FG000|COMPLETED|Overall Study||45
6370421|NCT00730756|7281338|FG001|COMPLETED|Overall Study||48
6370422|NCT00730756|7281337|FG000|NOT COMPLETED|Overall Study||4
6370423|NCT00730756|7281338|FG001|NOT COMPLETED|Overall Study||5
6370424|NCT00730847|7281344|FG000|STARTED|Overall Study||596
6370425|NCT00730847|7281344|FG000|COMPLETED|Overall Study||465
6370426|NCT00730847|7281344|FG000|NOT COMPLETED|Overall Study||131
6370427|NCT00730912|7281351|FG000|STARTED|Overall Study||53
6370428|NCT00730912|7281352|FG001|STARTED|Overall Study||104
6370429|NCT00730912|7281353|FG002|STARTED|Overall Study||104
6370430|NCT00730912|7281351|FG000|COMPLETED|Overall Study||53
6370431|NCT00730912|7281352|FG001|COMPLETED|Overall Study||104
6370432|NCT00730912|7281353|FG002|COMPLETED|Overall Study||103
6370433|NCT00730912|7281351|FG000|NOT COMPLETED|Overall Study||0
6370434|NCT00730912|7281352|FG001|NOT COMPLETED|Overall Study||0
6370435|NCT00730912|7281353|FG002|NOT COMPLETED|Overall Study||1
6370436|NCT00730925|7281361|FG000|STARTED|Overall Study||41
6370437|NCT00730925|7281361|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
6370438|NCT00730925|7281361|FG000|NOT COMPLETED|Overall Study||41
6370439|NCT00730964|7281365|FG000|STARTED|Overall Study||1039
6370440|NCT00730964|7281365|FG000|COMPLETED|Overall Study||1039
6370441|NCT00730964|7281365|FG000|NOT COMPLETED|Overall Study||0
6370442|NCT00731042|7281372|FG000|STARTED|First Intervention||16
6370443|NCT00731042|7281373|FG001|STARTED|First Intervention||17
6370444|NCT00731042|7281372|FG000|COMPLETED|First Intervention||16
6370445|NCT00731042|7281373|FG001|COMPLETED|First Intervention||17
6370446|NCT00731042|7281372|FG000|NOT COMPLETED|First Intervention||0
6370447|NCT00731042|7281373|FG001|NOT COMPLETED|First Intervention||0
6370448|NCT00731042|7281372|FG000|STARTED|Wash-out||16
6370449|NCT00731042|7281373|FG001|STARTED|Wash-out||17
6370450|NCT00731042|7281372|FG000|COMPLETED|Wash-out||16
6370451|NCT00731042|7281373|FG001|COMPLETED|Wash-out||17
6370452|NCT00731042|7281372|FG000|NOT COMPLETED|Wash-out||0
6370453|NCT00731042|7281373|FG001|NOT COMPLETED|Wash-out||0
6370454|NCT00731042|7281372|FG000|STARTED|Second Intervention||16
6370455|NCT00731042|7281373|FG001|STARTED|Second Intervention||17
6370456|NCT00731042|7281372|FG000|COMPLETED|Second Intervention||16
6370457|NCT00731042|7281373|FG001|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
6370458|NCT00731042|7281372|FG000|NOT COMPLETED|Second Intervention||0
6370459|NCT00731042|7281373|FG001|NOT COMPLETED|Second Intervention||2
6370460|NCT00731055|7281379|FG000|STARTED|Overall Study|This is a within-subjects study design.|16
6370461|NCT00731055|7281379|FG000|Received Placebo|Overall Study||16
6370462|NCT00731055|7281379|FG000|Received Varenicline 0.5 mg|Overall Study||16
6370463|NCT00731055|7281379|FG000|Received Varenicline 1.0 mg|Overall Study||16
6370464|NCT00731055|7281379|FG000|Received Varenicline 2.0 mg|Overall Study||16
6370465|NCT00731055|7281379|FG000|COMPLETED|Overall Study||16
6370466|NCT00731055|7281379|FG000|NOT COMPLETED|Overall Study||0
6370467|NCT00731094|7281388|FG000|STARTED|Overall Study||116
6370468|NCT00731094|7281389|FG001|STARTED|Overall Study||116
6560923|NCT01790581|7483870|FG001|STARTED|Overall Study||12
6560924|NCT01790581|7483869|FG000|COMPLETED|Overall Study||12
6560925|NCT01790581|7483870|FG001|COMPLETED|Overall Study||12
6560926|NCT01790581|7483869|FG000|NOT COMPLETED|Overall Study||0
6560927|NCT01790581|7483870|FG001|NOT COMPLETED|Overall Study||0
6560928|NCT01790594|7483878|FG000|STARTED|Overall Study||22
6560929|NCT01790594|7483879|FG001|STARTED|Overall Study||21
6560930|NCT01790594|7483880|FG002|STARTED|Overall Study||3
6560931|NCT01790594|7483878|FG000|COMPLETED|Overall Study||17
6560932|NCT01790594|7483879|FG001|COMPLETED|Overall Study||18
6560933|NCT01790594|7483880|FG002|COMPLETED|Overall Study||0
6560934|NCT01790594|7483878|FG000|NOT COMPLETED|Overall Study||5
6560935|NCT01790594|7483879|FG001|NOT COMPLETED|Overall Study||3
6370469|NCT00731094|7281388|FG000|Month 6|Overall Study||101
6370470|NCT00731094|7281389|FG001|Month 6|Overall Study||107
6370471|NCT00731094|7281388|FG000|COMPLETED|Overall Study||98
6370472|NCT00731094|7281389|FG001|COMPLETED|Overall Study||105
6370473|NCT00731094|7281388|FG000|NOT COMPLETED|Overall Study||18
6370474|NCT00731094|7281389|FG001|NOT COMPLETED|Overall Study||11
6370475|NCT00731120|7281398|FG000|STARTED|Overall Study||153
6370476|NCT00731120|7281399|FG001|STARTED|Overall Study||152
6370477|NCT00731120|7281400|FG002|STARTED|Overall Study||152
6370478|NCT00731120|7281398|FG000|Treated|Overall Study||153
6370479|NCT00731120|7281399|FG001|Treated|Overall Study||151
6370480|NCT00731120|7281400|FG002|Treated|Overall Study||152
6370481|NCT00731120|7281398|FG000|COMPLETED|Overall Study||111
6370482|NCT00731120|7281399|FG001|COMPLETED|Overall Study||109
6370483|NCT00731120|7281400|FG002|COMPLETED|Overall Study||116
6370484|NCT00731120|7281398|FG000|NOT COMPLETED|Overall Study||42
6370485|NCT00731120|7281399|FG001|NOT COMPLETED|Overall Study||43
6370486|NCT00731120|7281400|FG002|NOT COMPLETED|Overall Study||36
6370487|NCT00731133|7281408|FG000|STARTED|Overall Study||15
6370488|NCT00731133|7281408|FG000|COMPLETED|Overall Study||5
6370489|NCT00731133|7281408|FG000|NOT COMPLETED|Overall Study||10
6370490|NCT00731198|7281414|FG000|STARTED|Overall Study||325
6370491|NCT00731198|7281415|FG001|STARTED|Overall Study||325
6370492|NCT00731198|7281414|FG000|COMPLETED|Overall Study||319
6370493|NCT00731198|7281415|FG001|COMPLETED|Overall Study||319
6370494|NCT00731198|7281414|FG000|NOT COMPLETED|Overall Study||6
6370495|NCT00731198|7281415|FG001|NOT COMPLETED|Overall Study||6
6560936|NCT01790594|7483880|FG002|NOT COMPLETED|Overall Study||3
6560937|NCT01790633|7483889|FG000|STARTED|Overall Study||163
6560938|NCT01790633|7483890|FG001|STARTED|Overall Study||164
6560939|NCT01790633|7483889|FG000|COMPLETED|Overall Study||115
6560940|NCT01790633|7483890|FG001|COMPLETED|Overall Study||159
6560941|NCT01790633|7483889|FG000|NOT COMPLETED|Overall Study||48
6560942|NCT01790633|7483890|FG001|NOT COMPLETED|Overall Study||5
6560943|NCT01790659|7483899|FG000|STARTED|Overall Study||201
6560944|NCT01790659|7483900|FG001|STARTED|Overall Study||198
6560945|NCT01790659|7483899|FG000|COMPLETED|Overall Study||195
6560946|NCT01790659|7483900|FG001|COMPLETED|Overall Study||192
6560947|NCT01790659|7483899|FG000|NOT COMPLETED|Overall Study||6
6560948|NCT01790659|7483900|FG001|NOT COMPLETED|Overall Study||6
6560949|NCT01790685|7483908|FG000|STARTED|Overall Study||23
6560950|NCT01790685|7483909|FG001|STARTED|Overall Study||17
6560951|NCT01790685|7483908|FG000|COMPLETED|Overall Study||23
6560952|NCT01790685|7483909|FG001|COMPLETED|Overall Study||17
6560953|NCT01790685|7483908|FG000|NOT COMPLETED|Overall Study||0
6370496|NCT00731211|7281421|FG000|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
6370497|NCT00731211|7281421|FG000|COMPLETED|Overall Study||55
6370498|NCT00731211|7281421|FG000|NOT COMPLETED|Overall Study||0
6370499|NCT00731341|7281425|FG000|STARTED|Overall Study||3
6370500|NCT00731341|7281425|FG000|COMPLETED|Overall Study||3
6370501|NCT00731341|7281425|FG000|NOT COMPLETED|Overall Study||0
6370502|NCT00731484|7281429|FG000|STARTED|Overall Study||233
6370503|NCT00731484|7281429|FG000|COMPLETED|Overall Study||233
6370504|NCT00731484|7281429|FG000|NOT COMPLETED|Overall Study||0
6370505|NCT00731549|7281433|FG000|STARTED|Overall Study||1081
6370506|NCT00731549|7281433|FG000|COMPLETED|Overall Study||858
6370507|NCT00731549|7281433|FG000|NOT COMPLETED|Overall Study||223
6370508|NCT00731588|7281439|FG000|STARTED|Overall Study||9
6370509|NCT00731588|7281440|FG001|STARTED|Overall Study||95
6370510|NCT00731588|7281439|FG000|COMPLETED|Overall Study||9
6370511|NCT00731588|7281440|FG001|COMPLETED|Overall Study||53
6370512|NCT00731588|7281439|FG000|NOT COMPLETED|Overall Study||0
6370513|NCT00731588|7281440|FG001|NOT COMPLETED|Overall Study||42
6370514|NCT00731614|7281449|FG000|STARTED|Overall Study||23
6370515|NCT00731614|7281450|FG001|STARTED|Overall Study||31
6370516|NCT00731614|7281449|FG000|End of Treatment|Overall Study||16
6370517|NCT00731614|7281450|FG001|End of Treatment|Overall Study||24
6370518|NCT00731614|7281449|FG000|12 Weeks Posttreatment|Overall Study||18
6370519|NCT00731614|7281450|FG001|12 Weeks Posttreatment|Overall Study||23
6370520|NCT00731614|7281449|FG000|COMPLETED|Overall Study||16
6370521|NCT00731614|7281450|FG001|COMPLETED|Overall Study||18
6370522|NCT00731614|7281449|FG000|NOT COMPLETED|Overall Study||7
6370523|NCT00731614|7281450|FG001|NOT COMPLETED|Overall Study||13
6370524|NCT00731640|7281458|FG000|STARTED|Overall Study||20
6370525|NCT00731640|7281459|FG001|STARTED|Overall Study||32
6370526|NCT00731640|7281458|FG000|COMPLETED|Overall Study||20
6370527|NCT00731640|7281459|FG001|COMPLETED|Overall Study||32
6370528|NCT00731640|7281458|FG000|NOT COMPLETED|Overall Study||0
6370529|NCT00731640|7281459|FG001|NOT COMPLETED|Overall Study||0
6370530|NCT00731653|7281465|FG000|STARTED|Overall Study||81
6370531|NCT00731653|7281465|FG000|COMPLETED|Overall Study||72
6370532|NCT00731653|7281465|FG000|NOT COMPLETED|Overall Study||9
6370533|NCT00731666|7281469|FG000|STARTED|Overall Study||40
6370534|NCT00731666|7281469|FG000|COMPLETED|Overall Study||28
6370535|NCT00731666|7281469|FG000|NOT COMPLETED|Overall Study||12
6370536|NCT00731679|7281475|FG000|STARTED|Overall Study||314
6370537|NCT00731679|7281476|FG001|STARTED|Overall Study||309
6560954|NCT01790685|7483909|FG001|NOT COMPLETED|Overall Study||0
6560955|NCT01790750|7483915|FG000|STARTED|Overall Study||50
6370538|NCT00731679|7281475|FG000|COMPLETED|Overall Study||292
6370539|NCT00731679|7281476|FG001|COMPLETED|Overall Study||283
6370540|NCT00731679|7281475|FG000|NOT COMPLETED|Overall Study||22
6370541|NCT00731679|7281476|FG001|NOT COMPLETED|Overall Study||26
6370542|NCT00731692|7281485|FG000|STARTED|Core Study (36 Months)||147
6370543|NCT00731692|7281486|FG001|STARTED|Core Study (36 Months)||336
6370544|NCT00731692|7281487|FG002|STARTED|Core Study (36 Months)||487
6370545|NCT00731692|7281485|FG000|Safety Set (SAF)|Core Study (36 Months)||0
6370546|NCT00731692|7281486|FG001|Safety Set (SAF)|Core Study (36 Months)||336
6370547|NCT00731692|7281487|FG002|Safety Set (SAF)|Core Study (36 Months)||487
6370548|NCT00731692|7281485|FG000|Full Analysis Set (FAS)|Core Study (36 Months)||0
6370549|NCT00731692|7281486|FG001|Full Analysis Set (FAS)|Core Study (36 Months)||336
6370550|NCT00731692|7281487|FG002|Full Analysis Set (FAS)|Core Study (36 Months)||487
6560956|NCT01790750|7483915|FG000|COMPLETED|Overall Study||50
6560957|NCT01790750|7483915|FG000|NOT COMPLETED|Overall Study||0
6560958|NCT01790828|7483920|FG000|STARTED|Overall Study||42
6370551|NCT00731692|7281485|FG000|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
6370552|NCT00731692|7281486|FG001|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
6370553|NCT00731692|7281487|FG002|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
6370554|NCT00731692|7281485|FG000|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
6370555|NCT00731692|7281486|FG001|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
6370556|NCT00731692|7281487|FG002|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
6370557|NCT00731692|7281485|FG000|COMPLETED|Core Study (36 Months)||79
6370558|NCT00731692|7281486|FG001|COMPLETED|Core Study (36 Months)||220
6370559|NCT00731692|7281487|FG002|COMPLETED|Core Study (36 Months)||317
6370560|NCT00731692|7281485|FG000|NOT COMPLETED|Core Study (36 Months)||68
6370561|NCT00731692|7281486|FG001|NOT COMPLETED|Core Study (36 Months)||116
6370562|NCT00731692|7281487|FG002|NOT COMPLETED|Core Study (36 Months)||170
6370563|NCT00731692|7281485|FG000|STARTED|Extension Phase||74
6370564|NCT00731692|7281486|FG001|STARTED|Extension Phase||196
6370565|NCT00731692|7281487|FG002|STARTED|Extension Phase||301
6370566|NCT00731692|7281485|FG000|COMPLETED|Extension Phase||0
6370567|NCT00731692|7281486|FG001|COMPLETED|Extension Phase||0
6370568|NCT00731692|7281487|FG002|COMPLETED|Extension Phase||0
6370569|NCT00731692|7281485|FG000|NOT COMPLETED|Extension Phase||74
6370570|NCT00731692|7281486|FG001|NOT COMPLETED|Extension Phase||196
6370571|NCT00731692|7281487|FG002|NOT COMPLETED|Extension Phase||301
6370572|NCT00731783|7281505|FG000|STARTED|One Month Follow-Up Visit||92
6370573|NCT00731783|7281506|FG001|STARTED|One Month Follow-Up Visit||91
6370574|NCT00731783|7281505|FG000|COMPLETED|One Month Follow-Up Visit||78
6370575|NCT00731783|7281506|FG001|COMPLETED|One Month Follow-Up Visit||69
6370576|NCT00731783|7281505|FG000|NOT COMPLETED|One Month Follow-Up Visit||14
6370577|NCT00731783|7281506|FG001|NOT COMPLETED|One Month Follow-Up Visit||22
6370578|NCT00731783|7281505|FG000|STARTED|Three Month Follow-Up Visit||79
6370579|NCT00731783|7281506|FG001|STARTED|Three Month Follow-Up Visit||73
6370580|NCT00731783|7281505|FG000|COMPLETED|Three Month Follow-Up Visit||72
6370581|NCT00731783|7281506|FG001|COMPLETED|Three Month Follow-Up Visit||57
6370582|NCT00731783|7281505|FG000|NOT COMPLETED|Three Month Follow-Up Visit||7
6370583|NCT00731783|7281506|FG001|NOT COMPLETED|Three Month Follow-Up Visit||16
6370584|NCT00731783|7281505|FG000|STARTED|Six Month Follow-Up Visit||77
6370585|NCT00731783|7281506|FG001|STARTED|Six Month Follow-Up Visit||67
6370586|NCT00731783|7281505|FG000|COMPLETED|Six Month Follow-Up Visit||71
6370587|NCT00731783|7281506|FG001|COMPLETED|Six Month Follow-Up Visit||64
6370588|NCT00731783|7281505|FG000|NOT COMPLETED|Six Month Follow-Up Visit||6
6370589|NCT00731783|7281506|FG001|NOT COMPLETED|Six Month Follow-Up Visit||3
6370590|NCT00731783|7281505|FG000|STARTED|12 Month Follow-Up Visit||74
6370591|NCT00731783|7281506|FG001|STARTED|12 Month Follow-Up Visit||65
6370592|NCT00731783|7281505|FG000|COMPLETED|12 Month Follow-Up Visit||68
6370593|NCT00731783|7281506|FG001|COMPLETED|12 Month Follow-Up Visit||58
6370594|NCT00731783|7281505|FG000|NOT COMPLETED|12 Month Follow-Up Visit||6
6560959|NCT01790828|7483920|FG000|COMPLETED|Overall Study||8
6560960|NCT01790828|7483920|FG000|NOT COMPLETED|Overall Study||34
6560961|NCT01790932|7483924|FG000|STARTED|Overall Study||50
6560962|NCT01790932|7483924|FG000|COMPLETED|Overall Study||0
6560963|NCT01790932|7483924|FG000|NOT COMPLETED|Overall Study||50
6560964|NCT01790984|7483930|FG000|STARTED|First Dietary Intervention (12 Weeks)||6
6560965|NCT01790984|7483931|FG001|STARTED|First Dietary Intervention (12 Weeks)||8
6560966|NCT01790984|7483932|FG002|STARTED|First Dietary Intervention (12 Weeks)||6
6560967|NCT01790984|7483933|FG003|STARTED|First Dietary Intervention (12 Weeks)||7
6370595|NCT00731783|7281506|FG001|NOT COMPLETED|12 Month Follow-Up Visit||7
6370596|NCT00731822|7281514|FG000|STARTED|Overall Study||20
6370597|NCT00731822|7281515|FG001|STARTED|Overall Study||40
6370598|NCT00731822|7281514|FG000|COMPLETED|Overall Study||16
6370599|NCT00731822|7281515|FG001|COMPLETED|Overall Study||39
6370600|NCT00731822|7281514|FG000|NOT COMPLETED|Overall Study||4
6370601|NCT00731822|7281515|FG001|NOT COMPLETED|Overall Study||1
6370602|NCT00731874|7281523|FG000|STARTED|Overall Study||10
6370603|NCT00731874|7281524|FG001|STARTED|Overall Study||13
6370604|NCT00731874|7281523|FG000|COMPLETED|Overall Study||10
6370605|NCT00731874|7281524|FG001|COMPLETED|Overall Study||13
6370606|NCT00731874|7281523|FG000|NOT COMPLETED|Overall Study||0
6370607|NCT00731874|7281524|FG001|NOT COMPLETED|Overall Study||0
6370608|NCT00731939|7281530|FG000|STARTED|Overall Study||124
6370609|NCT00731939|7281530|FG000|COMPLETED|Overall Study||90
6370610|NCT00731939|7281530|FG000|NOT COMPLETED|Overall Study||34
6370611|NCT00732030|7281534|FG000|STARTED|Overall Study||26
6370612|NCT00732030|7281534|FG000|COMPLETED|Overall Study||24
6560968|NCT01790984|7483930|FG000|COMPLETED|First Dietary Intervention (12 Weeks)||5
6560969|NCT01790984|7483931|FG001|COMPLETED|First Dietary Intervention (12 Weeks)||7
6370613|NCT00732030|7281534|FG000|NOT COMPLETED|Overall Study||2
6370614|NCT00732069|7281538|FG000|STARTED|First Study Drug||3
6370615|NCT00732069|7281539|FG001|STARTED|First Study Drug||3
6370616|NCT00732069|7281540|FG002|STARTED|First Study Drug||3
6370617|NCT00732069|7281541|FG003|STARTED|First Study Drug||2
6370618|NCT00732069|7281542|FG004|STARTED|First Study Drug||3
6370619|NCT00732069|7281543|FG005|STARTED|First Study Drug||2
6370620|NCT00732069|7281538|FG000|COMPLETED|First Study Drug||3
6370621|NCT00732069|7281539|FG001|COMPLETED|First Study Drug||3
6370622|NCT00732069|7281540|FG002|COMPLETED|First Study Drug||3
6370623|NCT00732069|7281541|FG003|COMPLETED|First Study Drug||2
6370624|NCT00732069|7281542|FG004|COMPLETED|First Study Drug||3
6370625|NCT00732069|7281543|FG005|COMPLETED|First Study Drug||2
6370626|NCT00732069|7281538|FG000|NOT COMPLETED|First Study Drug||0
6370627|NCT00732069|7281539|FG001|NOT COMPLETED|First Study Drug||0
6370628|NCT00732069|7281540|FG002|NOT COMPLETED|First Study Drug||0
6370629|NCT00732069|7281541|FG003|NOT COMPLETED|First Study Drug||0
6370630|NCT00732069|7281542|FG004|NOT COMPLETED|First Study Drug||0
6560970|NCT01790984|7483932|FG002|COMPLETED|First Dietary Intervention (12 Weeks)||6
6560971|NCT01790984|7483933|FG003|COMPLETED|First Dietary Intervention (12 Weeks)||7
6370631|NCT00732069|7281543|FG005|NOT COMPLETED|First Study Drug||0
6370632|NCT00732069|7281538|FG000|STARTED|Washout After First Study Drug||3
6370633|NCT00732069|7281539|FG001|STARTED|Washout After First Study Drug||3
6370634|NCT00732069|7281540|FG002|STARTED|Washout After First Study Drug||3
6370635|NCT00732069|7281541|FG003|STARTED|Washout After First Study Drug||2
6370636|NCT00732069|7281542|FG004|STARTED|Washout After First Study Drug||3
6370637|NCT00732069|7281543|FG005|STARTED|Washout After First Study Drug||2
6370638|NCT00732069|7281538|FG000|COMPLETED|Washout After First Study Drug||2
6370639|NCT00732069|7281539|FG001|COMPLETED|Washout After First Study Drug||3
6370640|NCT00732069|7281540|FG002|COMPLETED|Washout After First Study Drug||3
6370641|NCT00732069|7281541|FG003|COMPLETED|Washout After First Study Drug||2
6370642|NCT00732069|7281542|FG004|COMPLETED|Washout After First Study Drug||3
6370643|NCT00732069|7281543|FG005|COMPLETED|Washout After First Study Drug||2
6370644|NCT00732069|7281538|FG000|NOT COMPLETED|Washout After First Study Drug||1
6370645|NCT00732069|7281539|FG001|NOT COMPLETED|Washout After First Study Drug||0
6370646|NCT00732069|7281540|FG002|NOT COMPLETED|Washout After First Study Drug||0
6370647|NCT00732069|7281541|FG003|NOT COMPLETED|Washout After First Study Drug||0
6370648|NCT00732069|7281542|FG004|NOT COMPLETED|Washout After First Study Drug||0
6370649|NCT00732069|7281543|FG005|NOT COMPLETED|Washout After First Study Drug||0
6370650|NCT00732069|7281538|FG000|STARTED|Second Study Drug||2
6370651|NCT00732069|7281539|FG001|STARTED|Second Study Drug||3
6370652|NCT00732069|7281540|FG002|STARTED|Second Study Drug||3
6370653|NCT00732069|7281541|FG003|STARTED|Second Study Drug||2
6370654|NCT00732069|7281542|FG004|STARTED|Second Study Drug||3
6370655|NCT00732069|7281543|FG005|STARTED|Second Study Drug||2
6370656|NCT00732069|7281538|FG000|COMPLETED|Second Study Drug||2
6370657|NCT00732069|7281539|FG001|COMPLETED|Second Study Drug||3
6370658|NCT00732069|7281540|FG002|COMPLETED|Second Study Drug||3
6370659|NCT00732069|7281541|FG003|COMPLETED|Second Study Drug||2
6370660|NCT00732069|7281542|FG004|COMPLETED|Second Study Drug||3
6370661|NCT00732069|7281543|FG005|COMPLETED|Second Study Drug||2
6370662|NCT00732069|7281538|FG000|NOT COMPLETED|Second Study Drug||0
6370663|NCT00732069|7281539|FG001|NOT COMPLETED|Second Study Drug||0
6370664|NCT00732069|7281540|FG002|NOT COMPLETED|Second Study Drug||0
6370665|NCT00732069|7281541|FG003|NOT COMPLETED|Second Study Drug||0
6370666|NCT00732069|7281542|FG004|NOT COMPLETED|Second Study Drug||0
6370667|NCT00732069|7281543|FG005|NOT COMPLETED|Second Study Drug||0
6370668|NCT00732069|7281538|FG000|STARTED|Washout After Second Study Drug||2
6370669|NCT00732069|7281539|FG001|STARTED|Washout After Second Study Drug||3
6370670|NCT00732069|7281540|FG002|STARTED|Washout After Second Study Drug||3
6370671|NCT00732069|7281541|FG003|STARTED|Washout After Second Study Drug||2
6370672|NCT00732069|7281542|FG004|STARTED|Washout After Second Study Drug||3
6370673|NCT00732069|7281543|FG005|STARTED|Washout After Second Study Drug||2
6370674|NCT00732069|7281538|FG000|COMPLETED|Washout After Second Study Drug||2
6370675|NCT00732069|7281539|FG001|COMPLETED|Washout After Second Study Drug||3
6370676|NCT00732069|7281540|FG002|COMPLETED|Washout After Second Study Drug||3
6370677|NCT00732069|7281541|FG003|COMPLETED|Washout After Second Study Drug||2
6370678|NCT00732069|7281542|FG004|COMPLETED|Washout After Second Study Drug||3
6370679|NCT00732069|7281543|FG005|COMPLETED|Washout After Second Study Drug||2
6370680|NCT00732069|7281538|FG000|NOT COMPLETED|Washout After Second Study Drug||0
6370681|NCT00732069|7281539|FG001|NOT COMPLETED|Washout After Second Study Drug||0
6370682|NCT00732069|7281540|FG002|NOT COMPLETED|Washout After Second Study Drug||0
6370683|NCT00732069|7281541|FG003|NOT COMPLETED|Washout After Second Study Drug||0
6370684|NCT00732069|7281542|FG004|NOT COMPLETED|Washout After Second Study Drug||0
6370685|NCT00732069|7281543|FG005|NOT COMPLETED|Washout After Second Study Drug||0
6370686|NCT00732069|7281538|FG000|STARTED|Third Study Drug||2
6370687|NCT00732069|7281539|FG001|STARTED|Third Study Drug||3
6370688|NCT00732069|7281540|FG002|STARTED|Third Study Drug||3
6370689|NCT00732069|7281541|FG003|STARTED|Third Study Drug||2
6370690|NCT00732069|7281542|FG004|STARTED|Third Study Drug||3
6370691|NCT00732069|7281543|FG005|STARTED|Third Study Drug||2
6370692|NCT00732069|7281538|FG000|COMPLETED|Third Study Drug||2
6370693|NCT00732069|7281539|FG001|COMPLETED|Third Study Drug||3
6370694|NCT00732069|7281540|FG002|COMPLETED|Third Study Drug||3
6370695|NCT00732069|7281541|FG003|COMPLETED|Third Study Drug||2
6370696|NCT00732069|7281542|FG004|COMPLETED|Third Study Drug||3
6370697|NCT00732069|7281543|FG005|COMPLETED|Third Study Drug||2
6562890|NCT01803282|7485792|FG007|COMPLETED|Overall Study||0
6370698|NCT00732069|7281538|FG000|NOT COMPLETED|Third Study Drug||0
6370699|NCT00732069|7281539|FG001|NOT COMPLETED|Third Study Drug||0
6370700|NCT00732069|7281540|FG002|NOT COMPLETED|Third Study Drug||0
6370701|NCT00732069|7281541|FG003|NOT COMPLETED|Third Study Drug||0
6370702|NCT00732069|7281542|FG004|NOT COMPLETED|Third Study Drug||0
6370703|NCT00732069|7281543|FG005|NOT COMPLETED|Third Study Drug||0
6370704|NCT00732160|7281555|FG000|STARTED|Overall Study||7
6370705|NCT00732160|7281556|FG001|STARTED|Overall Study||5
6370706|NCT00732160|7281557|FG002|STARTED|Overall Study||6
6370707|NCT00732160|7281558|FG003|STARTED|Overall Study||5
6370708|NCT00732160|7281555|FG000|HS Vehicle|Overall Study||7
6370709|NCT00732160|7281556|FG001|HS Vehicle|Overall Study||5
6370710|NCT00732160|7281557|FG002|HS Vehicle|Overall Study||3
6370711|NCT00732160|7281558|FG003|HS Vehicle|Overall Study||3
6370712|NCT00732160|7281555|FG000|HS Aldosterone|Overall Study||7
6370713|NCT00732160|7281556|FG001|HS Aldosterone|Overall Study||5
6370714|NCT00732160|7281557|FG002|HS Aldosterone|Overall Study||3
6370715|NCT00732160|7281558|FG003|HS Aldosterone|Overall Study||3
6370716|NCT00732160|7281555|FG000|LS Vehicle|Overall Study||2
6370717|NCT00732160|7281556|FG001|LS Vehicle|Overall Study||1
6370718|NCT00732160|7281557|FG002|LS Vehicle|Overall Study||6
6370719|NCT00732160|7281558|FG003|LS Vehicle|Overall Study||5
6370720|NCT00732160|7281555|FG000|LS Aldosterone|Overall Study||2
6370721|NCT00732160|7281556|FG001|LS Aldosterone|Overall Study||1
6370722|NCT00732160|7281557|FG002|LS Aldosterone|Overall Study||6
6370723|NCT00732160|7281558|FG003|LS Aldosterone|Overall Study||5
6370724|NCT00732160|7281555|FG000|COMPLETED|Overall Study||2
6370725|NCT00732160|7281556|FG001|COMPLETED|Overall Study||1
6370726|NCT00732160|7281557|FG002|COMPLETED|Overall Study||3
6370727|NCT00732160|7281558|FG003|COMPLETED|Overall Study||3
6370728|NCT00732160|7281555|FG000|NOT COMPLETED|Overall Study||5
6370729|NCT00732160|7281556|FG001|NOT COMPLETED|Overall Study||4
6370730|NCT00732160|7281557|FG002|NOT COMPLETED|Overall Study||3
6370731|NCT00732160|7281558|FG003|NOT COMPLETED|Overall Study||2
6370732|NCT00732199|7281570|FG000|STARTED|Overall Study||50
6370733|NCT00732199|7281571|FG001|STARTED|Overall Study||42
6370734|NCT00732199|7281570|FG000|COMPLETED|Overall Study||16
6370735|NCT00732199|7281571|FG001|COMPLETED|Overall Study||16
6370736|NCT00732199|7281570|FG000|NOT COMPLETED|Overall Study||34
6370737|NCT00732199|7281571|FG001|NOT COMPLETED|Overall Study||26
6370738|NCT00732212|7281584|FG000|STARTED|Overall Study||112
6370739|NCT00732212|7281585|FG001|STARTED|Overall Study||123
6370740|NCT00732212|7281584|FG000|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
6370741|NCT00732212|7281585|FG001|Temporarily Suspended|Overall Study||50
6370742|NCT00732212|7281584|FG000|COMPLETED|Overall Study||112
6370743|NCT00732212|7281585|FG001|COMPLETED|Overall Study||123
6370744|NCT00732212|7281584|FG000|NOT COMPLETED|Overall Study||0
6370745|NCT00732212|7281585|FG001|NOT COMPLETED|Overall Study||0
6370746|NCT00732225|7281620|FG000|STARTED|Overall Study|76 eyes of 71 patients|71
6370747|NCT00732225|7281621|FG001|STARTED|Overall Study|41 eyes of 40 patients|40
6370748|NCT00732225|7281622|FG002|STARTED|Overall Study|26 eyes of 26 patients|26
6370749|NCT00732225|7281623|FG003|STARTED|Overall Study|33 eyes of 33 patients|33
6370750|NCT00732225|7281624|FG004|STARTED|Overall Study|55 eyes of 54 patients|54
6370751|NCT00732225|7281620|FG000|COMPLETED|Overall Study|64 eyes of 60 patients|60
6370752|NCT00732225|7281621|FG001|COMPLETED|Overall Study|33 eyes of 32 patients|32
6370753|NCT00732225|7281622|FG002|COMPLETED|Overall Study|23 eyes of 23 patients|23
6370754|NCT00732225|7281623|FG003|COMPLETED|Overall Study|29 eyes of 29 patients|29
6370755|NCT00732225|7281624|FG004|COMPLETED|Overall Study|48 eyes of 48 patients|48
6370756|NCT00732225|7281620|FG000|NOT COMPLETED|Overall Study||11
6370757|NCT00732225|7281621|FG001|NOT COMPLETED|Overall Study||8
6370758|NCT00732225|7281622|FG002|NOT COMPLETED|Overall Study||3
6370759|NCT00732225|7281623|FG003|NOT COMPLETED|Overall Study||4
6370760|NCT00732225|7281624|FG004|NOT COMPLETED|Overall Study||6
6370761|NCT00732238|7281638|FG000|STARTED|Overall Study||33
6370762|NCT00732238|7281639|FG001|STARTED|Overall Study||28
6370763|NCT00732238|7281638|FG000|COMPLETED|Overall Study||28
6370764|NCT00732238|7281639|FG001|COMPLETED|Overall Study||27
6370765|NCT00732238|7281638|FG000|NOT COMPLETED|Overall Study||5
6370766|NCT00732238|7281639|FG001|NOT COMPLETED|Overall Study||1
6370767|NCT00732251|7281647|FG000|STARTED|Overall Study||8
6370768|NCT00732251|7281647|FG000|COMPLETED|Overall Study||1
6370769|NCT00732251|7281647|FG000|NOT COMPLETED|Overall Study||7
6370770|NCT00732303|7281651|FG000|STARTED|Overall Study||8
6370771|NCT00732303|7281651|FG000|COMPLETED|Overall Study||6
6370772|NCT00732303|7281651|FG000|NOT COMPLETED|Overall Study||2
6370773|NCT00732472|7281659|FG000|STARTED|Overall Study||9
6370774|NCT00732472|7281660|FG001|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
6370775|NCT00732472|7281661|FG002|STARTED|Overall Study||10
6370776|NCT00732472|7281662|FG003|STARTED|Overall Study||9
6370777|NCT00732472|7281659|FG000|COMPLETED|Overall Study||9
6370778|NCT00732472|7281660|FG001|COMPLETED|Overall Study||7
6370779|NCT00732472|7281661|FG002|COMPLETED|Overall Study||9
6370780|NCT00732472|7281662|FG003|COMPLETED|Overall Study||6
6370781|NCT00732472|7281659|FG000|NOT COMPLETED|Overall Study||0
6370782|NCT00732472|7281660|FG001|NOT COMPLETED|Overall Study||3
6370783|NCT00732472|7281661|FG002|NOT COMPLETED|Overall Study||1
6370784|NCT00732472|7281662|FG003|NOT COMPLETED|Overall Study||3
6560972|NCT01790984|7483930|FG000|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
6560973|NCT01790984|7483931|FG001|NOT COMPLETED|First Dietary Intervention (12 Weeks)||1
6560974|NCT01790984|7483932|FG002|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
6560975|NCT01790984|7483933|FG003|NOT COMPLETED|First Dietary Intervention (12 Weeks)||0
6370785|NCT00732498|7281673|FG000|STARTED|Overall Study||28
6370786|NCT00732498|7281673|FG000|COMPLETED|Overall Study||22
6370787|NCT00732498|7281673|FG000|NOT COMPLETED|Overall Study||6
6370788|NCT00732615|7281679|FG000|STARTED|Overall Study||40
6370789|NCT00732615|7281680|FG001|STARTED|Overall Study||84
6370790|NCT00732615|7281679|FG000|COMPLETED|Overall Study||33
6370791|NCT00732615|7281680|FG001|COMPLETED|Overall Study||79
6370792|NCT00732615|7281679|FG000|NOT COMPLETED|Overall Study||7
6370793|NCT00732615|7281680|FG001|NOT COMPLETED|Overall Study||5
6370794|NCT00732641|7281689|FG000|STARTED|Overall Study||123
6370795|NCT00732641|7281690|FG001|STARTED|Overall Study||121
6370796|NCT00732641|7281689|FG000|COMPLETED|Overall Study||17
6370797|NCT00732641|7281690|FG001|COMPLETED|Overall Study||9
6370798|NCT00732641|7281689|FG000|NOT COMPLETED|Overall Study||106
6370799|NCT00732641|7281690|FG001|NOT COMPLETED|Overall Study||112
6370800|NCT00732654|7281699|FG000|STARTED|Overall Study||10
6560976|NCT01790984|7483930|FG000|STARTED|Wash-out (4 Weeks)||5
6560977|NCT01790984|7483931|FG001|STARTED|Wash-out (4 Weeks)||7
6560978|NCT01790984|7483932|FG002|STARTED|Wash-out (4 Weeks)||6
6560979|NCT01790984|7483933|FG003|STARTED|Wash-out (4 Weeks)||7
6560980|NCT01790984|7483930|FG000|COMPLETED|Wash-out (4 Weeks)||5
6370801|NCT00732654|7281700|FG001|STARTED|Overall Study||10
6370802|NCT00732654|7281701|FG002|STARTED|Overall Study||10
6370803|NCT00732654|7281699|FG000|COMPLETED|Overall Study||10
6370804|NCT00732654|7281700|FG001|COMPLETED|Overall Study||9
6370805|NCT00732654|7281701|FG002|COMPLETED|Overall Study||10
6370806|NCT00732654|7281699|FG000|NOT COMPLETED|Overall Study||0
6370807|NCT00732654|7281700|FG001|NOT COMPLETED|Overall Study||1
6370808|NCT00732654|7281701|FG002|NOT COMPLETED|Overall Study||0
6370809|NCT00732758|7281711|FG000|STARTED|Overall Study||78
6370810|NCT00732758|7281712|FG001|STARTED|Overall Study||79
6370811|NCT00732758|7281711|FG000|COMPLETED|Overall Study||70
6370812|NCT00732758|7281712|FG001|COMPLETED|Overall Study||63
6370813|NCT00732758|7281711|FG000|NOT COMPLETED|Overall Study||8
6370814|NCT00732758|7281712|FG001|NOT COMPLETED|Overall Study||16
6370815|NCT00732875|7281718|FG000|STARTED|Overall Study||92
6370816|NCT00732875|7281718|FG000|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
6370817|NCT00732875|7281718|FG000|NOT COMPLETED|Overall Study||35
6370818|NCT00732901|7281724|FG000|STARTED|Overall Study||11
6370819|NCT00732901|7281725|FG001|STARTED|Overall Study||12
6370820|NCT00732901|7281724|FG000|COMPLETED|Overall Study||11
6370821|NCT00732901|7281725|FG001|COMPLETED|Overall Study||12
6370822|NCT00732901|7281724|FG000|NOT COMPLETED|Overall Study||0
6370823|NCT00732901|7281725|FG001|NOT COMPLETED|Overall Study||0
6370824|NCT00732940|7281733|FG000|STARTED|Overall Study||28
6370825|NCT00732940|7281734|FG001|STARTED|Overall Study||28
6370826|NCT00732940|7281733|FG000|COMPLETED|Overall Study||26
6370827|NCT00732940|7281734|FG001|COMPLETED|Overall Study||25
6370828|NCT00732940|7281733|FG000|NOT COMPLETED|Overall Study||2
6370829|NCT00732940|7281734|FG001|NOT COMPLETED|Overall Study||3
6370830|NCT00732992|7281742|FG000|STARTED|Overall Study||6
6370831|NCT00732992|7281743|FG001|STARTED|Overall Study||6
6370832|NCT00732992|7281742|FG000|COMPLETED|Overall Study||0
6370833|NCT00732992|7281743|FG001|COMPLETED|Overall Study||0
6370834|NCT00732992|7281742|FG000|NOT COMPLETED|Overall Study||6
6370835|NCT00732992|7281743|FG001|NOT COMPLETED|Overall Study||6
6370836|NCT00733096|7281753|FG000|STARTED|Overall Study||28
6370837|NCT00733096|7281754|FG001|STARTED|Overall Study||26
6370838|NCT00733096|7281755|FG002|STARTED|Overall Study||30
6370839|NCT00733096|7281753|FG000|COMPLETED|Overall Study||28
6370840|NCT00733096|7281754|FG001|COMPLETED|Overall Study||26
6370841|NCT00733096|7281755|FG002|COMPLETED|Overall Study||30
6370842|NCT00733096|7281753|FG000|NOT COMPLETED|Overall Study||0
6370843|NCT00733096|7281754|FG001|NOT COMPLETED|Overall Study||0
6370844|NCT00733096|7281755|FG002|NOT COMPLETED|Overall Study||0
6370845|NCT00733135|7281763|FG000|STARTED|Overall Study||133
6370846|NCT00733135|7281763|FG000|COMPLETED|Overall Study||131
6370847|NCT00733135|7281763|FG000|NOT COMPLETED|Overall Study||2
6370848|NCT00733226|7281771|FG000|STARTED|Overall Study||40
6370849|NCT00733226|7281772|FG001|STARTED|Overall Study||40
6370850|NCT00733226|7281771|FG000|COMPLETED|Overall Study||35
6370851|NCT00733226|7281772|FG001|COMPLETED|Overall Study||40
6370852|NCT00733226|7281771|FG000|NOT COMPLETED|Overall Study||5
6370853|NCT00733226|7281772|FG001|NOT COMPLETED|Overall Study||0
6370854|NCT00733278|7281778|FG000|STARTED|Overall Study||7
6370855|NCT00733278|7281778|FG000|COMPLETED|Overall Study||7
6370856|NCT00733278|7281778|FG000|NOT COMPLETED|Overall Study||0
6370857|NCT00733291|7281785|FG000|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
6370858|NCT00733291|7281786|FG001|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
6370859|NCT00733291|7281787|FG002|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
6370860|NCT00733291|7281788|FG003|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
6370861|NCT00733291|7281785|FG000|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
6370862|NCT00733291|7281786|FG001|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
6370863|NCT00733291|7281787|FG002|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
6370864|NCT00733291|7281788|FG003|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
6370865|NCT00733291|7281785|FG000|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
6370866|NCT00733291|7281786|FG001|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
6370867|NCT00733291|7281787|FG002|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
6370868|NCT00733291|7281788|FG003|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
6370869|NCT00733291|7281785|FG000|STARTED|Washout Period, 3 Days (+/-1 Day)||13
6370870|NCT00733291|7281786|FG001|STARTED|Washout Period, 3 Days (+/-1 Day)||17
6370871|NCT00733291|7281787|FG002|STARTED|Washout Period, 3 Days (+/-1 Day)||17
6370872|NCT00733291|7281788|FG003|STARTED|Washout Period, 3 Days (+/-1 Day)||17
6370873|NCT00733291|7281785|FG000|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
6370874|NCT00733291|7281786|FG001|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
6370875|NCT00733291|7281787|FG002|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
6370876|NCT00733291|7281788|FG003|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
6370877|NCT00733291|7281785|FG000|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
6370878|NCT00733291|7281786|FG001|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
6370879|NCT00733291|7281787|FG002|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
6370880|NCT00733291|7281788|FG003|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
6370881|NCT00733291|7281785|FG000|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
6370882|NCT00733291|7281786|FG001|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6370883|NCT00733291|7281787|FG002|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6370884|NCT00733291|7281788|FG003|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6370885|NCT00733291|7281785|FG000|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
6370886|NCT00733291|7281786|FG001|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6370887|NCT00733291|7281787|FG002|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6370888|NCT00733291|7281788|FG003|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
6370889|NCT00733291|7281785|FG000|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
6370890|NCT00733291|7281786|FG001|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
6655133|NCT02450799|7585172|FG000|NOT COMPLETED|Overall Study||0
6655134|NCT02450799|7585173|FG001|NOT COMPLETED|Overall Study||0
6655135|NCT02450799|7585174|FG002|NOT COMPLETED|Overall Study||0
6370891|NCT00733291|7281787|FG002|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
6370892|NCT00733291|7281788|FG003|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
6370893|NCT00733304|7281802|FG000|STARTED|Overall Study||19
6370894|NCT00733304|7281803|FG001|STARTED|Overall Study||15
6370895|NCT00733304|7281804|FG002|STARTED|Overall Study||8
6370896|NCT00733304|7281802|FG000|COMPLETED|Overall Study||12
6370897|NCT00733304|7281803|FG001|COMPLETED|Overall Study||12
6370898|NCT00733304|7281804|FG002|COMPLETED|Overall Study||3
6370899|NCT00733304|7281802|FG000|NOT COMPLETED|Overall Study||7
6370900|NCT00733304|7281803|FG001|NOT COMPLETED|Overall Study||3
6370901|NCT00733304|7281804|FG002|NOT COMPLETED|Overall Study||5
6370902|NCT00733330|7281814|FG000|STARTED|Overall Study||32
6370903|NCT00733330|7281815|FG001|STARTED|Overall Study||52
6370904|NCT00733330|7281814|FG000|COMPLETED|Overall Study||30
6370905|NCT00733330|7281815|FG001|COMPLETED|Overall Study||48
6370906|NCT00733330|7281814|FG000|NOT COMPLETED|Overall Study||2
6370907|NCT00733330|7281815|FG001|NOT COMPLETED|Overall Study||4
6370908|NCT00733343|7281825|FG000|STARTED|Overall Study||666
6370909|NCT00733343|7281826|FG001|STARTED|Overall Study||659
6370910|NCT00733343|7281825|FG000|COMPLETED|Overall Study||583
6370911|NCT00733343|7281826|FG001|COMPLETED|Overall Study||578
6370912|NCT00733343|7281825|FG000|NOT COMPLETED|Overall Study||83
6370913|NCT00733343|7281826|FG001|NOT COMPLETED|Overall Study||81
6370914|NCT00733356|7281833|FG000|STARTED|Vyvanse Dose Titration||28
6370915|NCT00733356|7281833|FG000|COMPLETED|Vyvanse Dose Titration||26
6370916|NCT00733356|7281833|FG000|NOT COMPLETED|Vyvanse Dose Titration||2
6370917|NCT00733356|7281833|FG000|STARTED|Modified Lab School, Reading Evaluation||26
6370918|NCT00733356|7281833|FG000|COMPLETED|Modified Lab School, Reading Evaluation||26
6370919|NCT00733356|7281833|FG000|NOT COMPLETED|Modified Lab School, Reading Evaluation||0
6370920|NCT00733369|7281839|FG000|STARTED|Overall Study||50
6370921|NCT00733369|7281840|FG001|STARTED|Overall Study||56
6370922|NCT00733369|7281839|FG000|COMPLETED|Overall Study||40
6370923|NCT00733369|7281840|FG001|COMPLETED|Overall Study||47
6370924|NCT00733369|7281839|FG000|NOT COMPLETED|Overall Study||10
6370925|NCT00733369|7281840|FG001|NOT COMPLETED|Overall Study||9
6370926|NCT00733408|7281846|FG000|STARTED|Overall Study||59
6370927|NCT00733408|7281846|FG000|COMPLETED|Overall Study||55
6370928|NCT00733408|7281846|FG000|NOT COMPLETED|Overall Study||4
6370929|NCT00733421|7281852|FG000|STARTED|Overall Study|November 2008|50
6370930|NCT00733421|7281853|FG001|STARTED|Overall Study|November 2008|50
6370931|NCT00733421|7281852|FG000|COMPLETED|Overall Study|All but one randomsied patient|49
6370932|NCT00733421|7281853|FG001|COMPLETED|Overall Study|All but one randomised patient|49
6370933|NCT00733421|7281852|FG000|NOT COMPLETED|Overall Study||1
6370934|NCT00733421|7281853|FG001|NOT COMPLETED|Overall Study||1
6370935|NCT00733499|7281861|FG000|STARTED|Pre-operative||102
6370936|NCT00733499|7281862|FG001|STARTED|Pre-operative|A death occurred prior to surgery which left a total of 102 participants|103
6370937|NCT00733499|7281861|FG000|COMPLETED|Pre-operative||102
6370938|NCT00733499|7281862|FG001|COMPLETED|Pre-operative||102
6370939|NCT00733499|7281861|FG000|NOT COMPLETED|Pre-operative||0
6370940|NCT00733499|7281862|FG001|NOT COMPLETED|Pre-operative||1
6370941|NCT00733499|7281861|FG000|STARTED|3 Months Follow-up||102
6370942|NCT00733499|7281862|FG001|STARTED|3 Months Follow-up||102
6370943|NCT00733499|7281861|FG000|COMPLETED|3 Months Follow-up||101
6370944|NCT00733499|7281862|FG001|COMPLETED|3 Months Follow-up||100
6370945|NCT00733499|7281861|FG000|NOT COMPLETED|3 Months Follow-up||1
6370946|NCT00733499|7281862|FG001|NOT COMPLETED|3 Months Follow-up||2
6370947|NCT00733499|7281861|FG000|STARTED|6 Months Follow-up||101
6370948|NCT00733499|7281862|FG001|STARTED|6 Months Follow-up||100
6370949|NCT00733499|7281861|FG000|COMPLETED|6 Months Follow-up||101
6370950|NCT00733499|7281862|FG001|COMPLETED|6 Months Follow-up||97
6370951|NCT00733499|7281861|FG000|NOT COMPLETED|6 Months Follow-up||0
6370952|NCT00733499|7281862|FG001|NOT COMPLETED|6 Months Follow-up||3
6370953|NCT00733499|7281861|FG000|STARTED|12 Months Follow-up||101
6370954|NCT00733499|7281862|FG001|STARTED|12 Months Follow-up||97
6370955|NCT00733499|7281861|FG000|COMPLETED|12 Months Follow-up||99
6370956|NCT00733499|7281862|FG001|COMPLETED|12 Months Follow-up||96
6370957|NCT00733499|7281861|FG000|NOT COMPLETED|12 Months Follow-up||2
6370958|NCT00733499|7281862|FG001|NOT COMPLETED|12 Months Follow-up||1
6370959|NCT00733499|7281861|FG000|STARTED|24 Months Follow-up||99
6370960|NCT00733499|7281862|FG001|STARTED|24 Months Follow-up||96
6370961|NCT00733499|7281861|FG000|COMPLETED|24 Months Follow-up||99
6370962|NCT00733499|7281862|FG001|COMPLETED|24 Months Follow-up||95
6370963|NCT00733499|7281861|FG000|NOT COMPLETED|24 Months Follow-up||0
6370964|NCT00733499|7281862|FG001|NOT COMPLETED|24 Months Follow-up||1
6370965|NCT00733499|7281861|FG000|STARTED|5 Year Followup||91
6370966|NCT00733499|7281862|FG001|STARTED|5 Year Followup||78
6370967|NCT00733499|7281861|FG000|COMPLETED|5 Year Followup||70
6370968|NCT00733499|7281862|FG001|COMPLETED|5 Year Followup||53
6370969|NCT00733499|7281861|FG000|NOT COMPLETED|5 Year Followup||21
6370970|NCT00733499|7281862|FG001|NOT COMPLETED|5 Year Followup||25
6370971|NCT00733499|7281861|FG000|STARTED|10 Year Followup||46
6370972|NCT00733499|7281862|FG001|STARTED|10 Year Followup||32
6370973|NCT00733499|7281861|FG000|COMPLETED|10 Year Followup||26
6370974|NCT00733499|7281862|FG001|COMPLETED|10 Year Followup||13
6370975|NCT00733499|7281861|FG000|NOT COMPLETED|10 Year Followup||20
6370976|NCT00733499|7281862|FG001|NOT COMPLETED|10 Year Followup||19
6370977|NCT00733512|7281868|FG000|STARTED|Overall Study||146
6370978|NCT00733512|7281868|FG000|COMPLETED|Overall Study||146
6370979|NCT00733512|7281868|FG000|NOT COMPLETED|Overall Study||0
6370980|NCT00733746|7281872|FG000|STARTED|Overall Study||119
6370981|NCT00733746|7281872|FG000|COMPLETED|Overall Study||114
6370982|NCT00733746|7281872|FG000|NOT COMPLETED|Overall Study||5
6370983|NCT00733824|7281881|FG000|STARTED|Phase I||10
6370984|NCT00733824|7281882|FG001|STARTED|Phase I||3
6370985|NCT00733824|7281883|FG002|STARTED|Phase I||6
6370986|NCT00733824|7281884|FG003|STARTED|Phase I||6
6370987|NCT00733824|7281885|FG004|STARTED|Phase I||0
6370988|NCT00733824|7281881|FG000|COMPLETED|Phase I||9
6370989|NCT00733824|7281882|FG001|COMPLETED|Phase I||3
6370990|NCT00733824|7281883|FG002|COMPLETED|Phase I||6
6370991|NCT00733824|7281884|FG003|COMPLETED|Phase I||6
6370992|NCT00733824|7281885|FG004|COMPLETED|Phase I||0
6370993|NCT00733824|7281881|FG000|NOT COMPLETED|Phase I||1
6370994|NCT00733824|7281882|FG001|NOT COMPLETED|Phase I||0
6370995|NCT00733824|7281883|FG002|NOT COMPLETED|Phase I||0
6370996|NCT00733824|7281884|FG003|NOT COMPLETED|Phase I||0
6370997|NCT00733824|7281885|FG004|NOT COMPLETED|Phase I||0
6370998|NCT00733824|7281881|FG000|STARTED|Phase II||0
6370999|NCT00733824|7281882|FG001|STARTED|Phase II||0
6371000|NCT00733824|7281883|FG002|STARTED|Phase II||0
6371001|NCT00733824|7281884|FG003|STARTED|Phase II||0
6371002|NCT00733824|7281885|FG004|STARTED|Phase II||36
6371003|NCT00733824|7281881|FG000|COMPLETED|Phase II||0
6371004|NCT00733824|7281882|FG001|COMPLETED|Phase II||0
6371005|NCT00733824|7281883|FG002|COMPLETED|Phase II||0
6371006|NCT00733824|7281884|FG003|COMPLETED|Phase II||0
6371007|NCT00733824|7281885|FG004|COMPLETED|Phase II||36
6371008|NCT00733824|7281881|FG000|NOT COMPLETED|Phase II||0
6371009|NCT00733824|7281882|FG001|NOT COMPLETED|Phase II||0
6371010|NCT00733824|7281883|FG002|NOT COMPLETED|Phase II||0
6371011|NCT00733824|7281884|FG003|NOT COMPLETED|Phase II||0
6371012|NCT00733824|7281885|FG004|NOT COMPLETED|Phase II||0
6371013|NCT00733902|7281903|FG000|STARTED|Overall Study||174
6371014|NCT00733902|7281904|FG001|STARTED|Overall Study||174
6371015|NCT00733902|7281905|FG002|STARTED|Overall Study||174
6371016|NCT00733902|7281906|FG003|STARTED|Overall Study||175
6371017|NCT00733902|7281903|FG000|Treated|Overall Study||172
6371018|NCT00733902|7281904|FG001|Treated|Overall Study||172
6371019|NCT00733902|7281905|FG002|Treated|Overall Study||172
6371020|NCT00733902|7281906|FG003|Treated|Overall Study||174
6371021|NCT00733902|7281903|FG000|COMPLETED|Overall Study||10
6371022|NCT00733902|7281904|FG001|COMPLETED|Overall Study||12
6371023|NCT00733902|7281905|FG002|COMPLETED|Overall Study||13
6371024|NCT00733902|7281906|FG003|COMPLETED|Overall Study||11
6371025|NCT00733902|7281903|FG000|NOT COMPLETED|Overall Study||164
6371026|NCT00733902|7281904|FG001|NOT COMPLETED|Overall Study||162
6371027|NCT00733902|7281905|FG002|NOT COMPLETED|Overall Study||161
6371028|NCT00733902|7281906|FG003|NOT COMPLETED|Overall Study||164
6371029|NCT00733954|7281918|FG000|STARTED|Overall Study||124
6371030|NCT00733954|7281919|FG001|STARTED|Overall Study||125
6371031|NCT00733954|7281918|FG000|COMPLETED|Overall Study||116
6371032|NCT00733954|7281919|FG001|COMPLETED|Overall Study||123
6371033|NCT00733954|7281918|FG000|NOT COMPLETED|Overall Study||8
6371034|NCT00733954|7281919|FG001|NOT COMPLETED|Overall Study||2
6371035|NCT00733980|7281927|FG000|STARTED|Overall Study||74
6371036|NCT00733980|7281928|FG001|STARTED|Overall Study||76
6371037|NCT00733980|7281927|FG000|COMPLETED|Overall Study||52
6371038|NCT00733980|7281928|FG001|COMPLETED|Overall Study||55
6371039|NCT00733980|7281927|FG000|NOT COMPLETED|Overall Study||22
6371040|NCT00733980|7281928|FG001|NOT COMPLETED|Overall Study||21
6371041|NCT00733993|7281937|FG000|STARTED|Overall Study||13
6371042|NCT00733993|7281938|FG001|STARTED|Overall Study||10
6371043|NCT00733993|7281937|FG000|COMPLETED|Overall Study||13
6371044|NCT00733993|7281938|FG001|COMPLETED|Overall Study||10
6371045|NCT00733993|7281937|FG000|NOT COMPLETED|Overall Study||0
6371046|NCT00733993|7281938|FG001|NOT COMPLETED|Overall Study||0
6371047|NCT00734032|7281953|FG000|STARTED|Overall Study||25
6371048|NCT00734032|7281954|FG001|STARTED|Overall Study||28
6371049|NCT00734032|7281955|FG002|STARTED|Overall Study||28
6371050|NCT00734032|7281956|FG003|STARTED|Overall Study||26
6371051|NCT00734032|7281953|FG000|COMPLETED|Overall Study||25
6371052|NCT00734032|7281954|FG001|COMPLETED|Overall Study||27
6371053|NCT00734032|7281955|FG002|COMPLETED|Overall Study||28
6371054|NCT00734032|7281956|FG003|COMPLETED|Overall Study||26
6371055|NCT00734032|7281953|FG000|NOT COMPLETED|Overall Study||0
6371056|NCT00734032|7281954|FG001|NOT COMPLETED|Overall Study||1
6371057|NCT00734032|7281955|FG002|NOT COMPLETED|Overall Study||0
6371058|NCT00734032|7281956|FG003|NOT COMPLETED|Overall Study||0
6371059|NCT00734071|7281968|FG000|STARTED|Overall Study||152
6371060|NCT00734071|7281969|FG001|STARTED|Overall Study||152
6560981|NCT01790984|7483931|FG001|COMPLETED|Wash-out (4 Weeks)||7
6560982|NCT01790984|7483932|FG002|COMPLETED|Wash-out (4 Weeks)||6
6560983|NCT01790984|7483933|FG003|COMPLETED|Wash-out (4 Weeks)||7
6371061|NCT00734071|7281968|FG000|Treated|Overall Study||151
6371062|NCT00734071|7281969|FG001|Treated|Overall Study||148
6371063|NCT00734071|7281968|FG000|COMPLETED|Overall Study||114
6371064|NCT00734071|7281969|FG001|COMPLETED|Overall Study||125
6371065|NCT00734071|7281968|FG000|NOT COMPLETED|Overall Study||38
6371066|NCT00734071|7281969|FG001|NOT COMPLETED|Overall Study||27
6371067|NCT00734097|7281975|FG000|STARTED|Screening||337
6371068|NCT00734097|7281975|FG000|COMPLETED|Screening|20 participants were screening failure.|317
6371069|NCT00734097|7281975|FG000|NOT COMPLETED|Screening||20
6371070|NCT00734097|7281975|FG000|STARTED|Open Label|Full analysis performed in 311|317
6371071|NCT00734097|7281975|FG000|Safety Analysis|Open Label||317
6371072|NCT00734097|7281975|FG000|Full Analysis|Open Label||311
6371073|NCT00734097|7281975|FG000|Per Protocol|Open Label||301
6371074|NCT00734097|7281975|FG000|COMPLETED|Open Label|16 patients discontinued after randomization|301
6371075|NCT00734097|7281975|FG000|NOT COMPLETED|Open Label||16
6371076|NCT00734149|7281979|FG000|STARTED|Overall Study||45
6371077|NCT00734149|7281979|FG000|COMPLETED|Overall Study||44
6371078|NCT00734149|7281979|FG000|NOT COMPLETED|Overall Study||1
6371079|NCT00734162|7281989|FG000|STARTED|Randomized Phase (Through Week 72)||10
6371080|NCT00734162|7281990|FG001|STARTED|Randomized Phase (Through Week 72)||42
6371081|NCT00734162|7281991|FG002|STARTED|Randomized Phase (Through Week 72)||13
6371082|NCT00734162|7281992|FG003|STARTED|Randomized Phase (Through Week 72)||41
6371083|NCT00734162|7281989|FG000|COMPLETED|Randomized Phase (Through Week 72)||10
6371084|NCT00734162|7281990|FG001|COMPLETED|Randomized Phase (Through Week 72)||41
6371085|NCT00734162|7281991|FG002|COMPLETED|Randomized Phase (Through Week 72)||13
6371086|NCT00734162|7281992|FG003|COMPLETED|Randomized Phase (Through Week 72)||37
6371087|NCT00734162|7281989|FG000|NOT COMPLETED|Randomized Phase (Through Week 72)||0
6371088|NCT00734162|7281990|FG001|NOT COMPLETED|Randomized Phase (Through Week 72)||1
6371089|NCT00734162|7281991|FG002|NOT COMPLETED|Randomized Phase (Through Week 72)||0
6371090|NCT00734162|7281992|FG003|NOT COMPLETED|Randomized Phase (Through Week 72)||4
6371091|NCT00734162|7281989|FG000|STARTED|Open-Label Phase||10
6371092|NCT00734162|7281990|FG001|STARTED|Open-Label Phase||41
6371093|NCT00734162|7281991|FG002|STARTED|Open-Label Phase||13
6371094|NCT00734162|7281992|FG003|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
6371095|NCT00734162|7281989|FG000|COMPLETED|Open-Label Phase||7
6371096|NCT00734162|7281990|FG001|COMPLETED|Open-Label Phase||39
6371097|NCT00734162|7281991|FG002|COMPLETED|Open-Label Phase||12
6371098|NCT00734162|7281992|FG003|COMPLETED|Open-Label Phase||36
6371099|NCT00734162|7281989|FG000|NOT COMPLETED|Open-Label Phase||3
6371100|NCT00734162|7281990|FG001|NOT COMPLETED|Open-Label Phase||2
6371101|NCT00734162|7281991|FG002|NOT COMPLETED|Open-Label Phase||1
6371102|NCT00734162|7281992|FG003|NOT COMPLETED|Open-Label Phase||3
6371103|NCT00734214|7282008|FG000|STARTED|Overall Study||128
6371104|NCT00734214|7282009|FG001|STARTED|Overall Study||130
6371105|NCT00734214|7282008|FG000|COMPLETED|Overall Study||124
6371106|NCT00734214|7282009|FG001|COMPLETED|Overall Study||126
6371107|NCT00734214|7282008|FG000|NOT COMPLETED|Overall Study||4
6371108|NCT00734214|7282009|FG001|NOT COMPLETED|Overall Study||4
6560984|NCT01790984|7483930|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
6560985|NCT01790984|7483931|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
6560986|NCT01790984|7483932|FG002|NOT COMPLETED|Wash-out (4 Weeks)||0
6560987|NCT01790984|7483933|FG003|NOT COMPLETED|Wash-out (4 Weeks)||0
6560988|NCT01790984|7483930|FG000|STARTED|Second Dietary Intervention (12 Weeks)||5
6560989|NCT01790984|7483931|FG001|STARTED|Second Dietary Intervention (12 Weeks)||7
6560990|NCT01790984|7483932|FG002|STARTED|Second Dietary Intervention (12 Weeks)||6
6560991|NCT01790984|7483933|FG003|STARTED|Second Dietary Intervention (12 Weeks)||7
6560992|NCT01790984|7483930|FG000|COMPLETED|Second Dietary Intervention (12 Weeks)||5
6560993|NCT01790984|7483931|FG001|COMPLETED|Second Dietary Intervention (12 Weeks)||7
6777890|NCT03780959|7705829|FG000|NOT COMPLETED|Part 1||5
6777891|NCT03780959|7705830|FG001|NOT COMPLETED|Part 1||0
6371109|NCT00734305|7282017|FG000|STARTED|Overall Study||7
6371110|NCT00734305|7282018|FG001|STARTED|Overall Study||3
6371111|NCT00734305|7282019|FG002|STARTED|Overall Study||4
6371112|NCT00734305|7282020|FG003|STARTED|Overall Study||3
6371113|NCT00734305|7282021|FG004|STARTED|Overall Study||5
6371114|NCT00734305|7282022|FG005|STARTED|Overall Study||4
6371115|NCT00734305|7282023|FG006|STARTED|Overall Study||18
6371116|NCT00734305|7282017|FG000|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
6371117|NCT00734305|7282018|FG001|COMPLETED|Overall Study||3
6560994|NCT01790984|7483932|FG002|COMPLETED|Second Dietary Intervention (12 Weeks)||6
6371118|NCT00734305|7282019|FG002|COMPLETED|Overall Study||4
6371119|NCT00734305|7282020|FG003|COMPLETED|Overall Study||3
6371120|NCT00734305|7282021|FG004|COMPLETED|Overall Study||5
6371121|NCT00734305|7282022|FG005|COMPLETED|Overall Study||4
6371122|NCT00734305|7282023|FG006|COMPLETED|Overall Study||18
6371123|NCT00734305|7282017|FG000|NOT COMPLETED|Overall Study||1
6371124|NCT00734305|7282018|FG001|NOT COMPLETED|Overall Study||0
6371125|NCT00734305|7282019|FG002|NOT COMPLETED|Overall Study||0
6371126|NCT00734305|7282020|FG003|NOT COMPLETED|Overall Study||0
6371127|NCT00734305|7282021|FG004|NOT COMPLETED|Overall Study||0
6371128|NCT00734305|7282022|FG005|NOT COMPLETED|Overall Study||0
6371129|NCT00734305|7282023|FG006|NOT COMPLETED|Overall Study||0
6371130|NCT00734344|7282043|FG000|STARTED|Overall Study||9
6371131|NCT00734344|7282044|FG001|STARTED|Overall Study||9
6371132|NCT00734344|7282043|FG000|COMPLETED|Overall Study||9
6371133|NCT00734344|7282044|FG001|COMPLETED|Overall Study||9
6371134|NCT00734344|7282043|FG000|NOT COMPLETED|Overall Study||0
6371135|NCT00734344|7282044|FG001|NOT COMPLETED|Overall Study||0
6371136|NCT00734409|7282054|FG000|STARTED|Overall Study||155
6371137|NCT00734409|7282055|FG001|STARTED|Overall Study||145
6371138|NCT00734409|7282054|FG000|COMPLETED|Overall Study||155
6371139|NCT00734409|7282055|FG001|COMPLETED|Overall Study||145
6371140|NCT00734409|7282054|FG000|NOT COMPLETED|Overall Study||0
6371141|NCT00734409|7282055|FG001|NOT COMPLETED|Overall Study||0
6371142|NCT00734474|7282070|FG000|STARTED|Overall Study||15
6371143|NCT00734474|7282071|FG001|STARTED|Overall Study||30
6371144|NCT00734474|7282072|FG002|STARTED|Overall Study||304
6371145|NCT00734474|7282073|FG003|STARTED|Overall Study||10
6371146|NCT00734474|7282074|FG004|STARTED|Overall Study||302
6371147|NCT00734474|7282075|FG005|STARTED|Overall Study||25
6371148|NCT00734474|7282076|FG006|STARTED|Overall Study||24
6371149|NCT00734474|7282077|FG007|STARTED|Overall Study||315
6371150|NCT00734474|7282078|FG008|STARTED|Overall Study||177
6371151|NCT00734474|7282070|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
6371152|NCT00734474|7282071|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
6371153|NCT00734474|7282072|FG002|Received at Least 1 Dose of Study Drug|Overall Study||304
6371154|NCT00734474|7282073|FG003|Received at Least 1 Dose of Study Drug|Overall Study||10
6371155|NCT00734474|7282074|FG004|Received at Least 1 Dose of Study Drug|Overall Study||302
6371156|NCT00734474|7282075|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
6371157|NCT00734474|7282076|FG006|Received at Least 1 Dose of Study Drug|Overall Study||24
6371158|NCT00734474|7282077|FG007|Received at Least 1 Dose of Study Drug|Overall Study||315
6560995|NCT01790984|7483933|FG003|COMPLETED|Second Dietary Intervention (12 Weeks)||7
6560996|NCT01790984|7483930|FG000|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
6560997|NCT01790984|7483931|FG001|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
6560998|NCT01790984|7483932|FG002|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
6560999|NCT01790984|7483933|FG003|NOT COMPLETED|Second Dietary Intervention (12 Weeks)||0
6371159|NCT00734474|7282078|FG008|Received at Least 1 Dose of Study Drug|Overall Study||177
6371160|NCT00734474|7282070|FG000|Entered Study Before Dose Decision Point|Overall Study||15
6371161|NCT00734474|7282071|FG001|Entered Study Before Dose Decision Point|Overall Study||30
6371162|NCT00734474|7282072|FG002|Entered Study Before Dose Decision Point|Overall Study||25
6371163|NCT00734474|7282073|FG003|Entered Study Before Dose Decision Point|Overall Study||10
6371164|NCT00734474|7282074|FG004|Entered Study Before Dose Decision Point|Overall Study||21
6371165|NCT00734474|7282075|FG005|Entered Study Before Dose Decision Point|Overall Study||25
6371166|NCT00734474|7282076|FG006|Entered Study Before Dose Decision Point|Overall Study||24
6371167|NCT00734474|7282077|FG007|Entered Study Before Dose Decision Point|Overall Study||42
6371168|NCT00734474|7282078|FG008|Entered Study Before Dose Decision Point|Overall Study||38
6371169|NCT00734474|7282070|FG000|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
6371170|NCT00734474|7282071|FG001|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
6371171|NCT00734474|7282072|FG002|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
6371172|NCT00734474|7282073|FG003|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
6371173|NCT00734474|7282074|FG004|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
6371174|NCT00734474|7282075|FG005|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
6371175|NCT00734474|7282076|FG006|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
6371176|NCT00734474|7282077|FG007|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
6371177|NCT00734474|7282078|FG008|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
6371178|NCT00734474|7282070|FG000|Entered Study After Dose Decision Point|Overall Study||0
6371179|NCT00734474|7282071|FG001|Entered Study After Dose Decision Point|Overall Study||0
6371180|NCT00734474|7282072|FG002|Entered Study After Dose Decision Point|Overall Study||279
6371181|NCT00734474|7282073|FG003|Entered Study After Dose Decision Point|Overall Study||0
6561000|NCT01791127|7483956|FG000|STARTED|Overall Study||1758
6561001|NCT01791127|7483956|FG000|COMPLETED|Overall Study||286
6561002|NCT01791127|7483956|FG000|NOT COMPLETED|Overall Study||1472
6655136|NCT02450903|7585185|FG000|STARTED|Overall Study||20
6655137|NCT02450903|7585185|FG000|Entered Post-treatment Effic. f/u Phase|Overall Study||4
6655138|NCT02450903|7585185|FG000|Entered Survival Follow-up Phase|Overall Study||15
6655139|NCT02450903|7585185|FG000|COMPLETED|Overall Study||0
6655140|NCT02450903|7585185|FG000|NOT COMPLETED|Overall Study||20
6655141|NCT02451007|7585189|FG000|STARTED|Overall Study||39
6655142|NCT02451007|7585189|FG000|COMPLETED|Overall Study||32
6655143|NCT02451007|7585189|FG000|NOT COMPLETED|Overall Study||7
6655144|NCT02451124|7585193|FG000|STARTED|Overall Study||156
6655145|NCT02451124|7585193|FG000|COMPLETED|Overall Study||155
6561003|NCT01791153|7483977|FG000|STARTED|Part 1: Blinded Period||100
6561004|NCT01791153|7483978|FG001|STARTED|Part 1: Blinded Period||49
6561005|NCT01791153|7483979|FG002|STARTED|Part 1: Blinded Period||50
6561006|NCT01791153|7483980|FG003|STARTED|Part 1: Blinded Period||51
6561007|NCT01791153|7483981|FG004|STARTED|Part 1: Blinded Period||0
6561008|NCT01791153|7483982|FG005|STARTED|Part 1: Blinded Period||0
6561009|NCT01791153|7483983|FG006|STARTED|Part 1: Blinded Period||0
6561010|NCT01791153|7483984|FG007|STARTED|Part 1: Blinded Period||0
6561011|NCT01791153|7483977|FG000|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|85
6561012|NCT01791153|7483978|FG001|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|41
6561013|NCT01791153|7483979|FG002|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|44
6561014|NCT01791153|7483980|FG003|COMPLETED|Part 1: Blinded Period|Completed Study to Week 52|46
6561015|NCT01791153|7483981|FG004|COMPLETED|Part 1: Blinded Period||0
6561016|NCT01791153|7483982|FG005|COMPLETED|Part 1: Blinded Period||0
6561017|NCT01791153|7483983|FG006|COMPLETED|Part 1: Blinded Period||0
6561018|NCT01791153|7483984|FG007|COMPLETED|Part 1: Blinded Period||0
6561019|NCT01791153|7483977|FG000|NOT COMPLETED|Part 1: Blinded Period||15
6561020|NCT01791153|7483978|FG001|NOT COMPLETED|Part 1: Blinded Period||8
6777892|NCT03780959|7705831|FG002|NOT COMPLETED|Part 1||0
6777893|NCT03780959|7705829|FG000|STARTED|Part 2||0
6777894|NCT03780959|7705830|FG001|STARTED|Part 2||26
6655146|NCT02451124|7585193|FG000|NOT COMPLETED|Overall Study||1
6655147|NCT02451137|7585203|FG000|STARTED|Overall Study||1651
6655148|NCT02451137|7585204|FG001|STARTED|Overall Study||1653
6655149|NCT02451137|7585203|FG000|Treated|Overall Study||1632
6655150|NCT02451137|7585204|FG001|Treated|Overall Study||1626
6655151|NCT02451137|7585203|FG000|Safety Population|Overall Study|4 participants received Standard of Care instead of Toujeo.|1637
6655152|NCT02451137|7585204|FG001|Safety Population|Overall Study|9 participants received Toujeo instead of Standard of Care.|1621
6655153|NCT02451137|7585203|FG000|COMPLETED|Overall Study||1405
6655154|NCT02451137|7585204|FG001|COMPLETED|Overall Study||1355
6655155|NCT02451137|7585203|FG000|NOT COMPLETED|Overall Study||246
6655156|NCT02451137|7585204|FG001|NOT COMPLETED|Overall Study||298
6655157|NCT02451150|7585212|FG000|STARTED|Overall Study||3
6655158|NCT02451150|7585213|FG001|STARTED|Overall Study||3
6655159|NCT02451150|7585212|FG000|COMPLETED|Overall Study||3
6655160|NCT02451150|7585213|FG001|COMPLETED|Overall Study||3
6655161|NCT02451150|7585212|FG000|NOT COMPLETED|Overall Study||0
6655162|NCT02451150|7585213|FG001|NOT COMPLETED|Overall Study||0
6655163|NCT02451202|7585221|FG000|STARTED|Overall Study||51
6655164|NCT02451202|7585222|FG001|STARTED|Overall Study||51
6655165|NCT02451202|7585221|FG000|COMPLETED|Overall Study||49
6655166|NCT02451202|7585222|FG001|COMPLETED|Overall Study||48
6655167|NCT02451202|7585221|FG000|NOT COMPLETED|Overall Study||2
6655168|NCT02451202|7585222|FG001|NOT COMPLETED|Overall Study||3
6777895|NCT03780959|7705831|FG002|STARTED|Part 2||25
6777896|NCT03780959|7705829|FG000|COMPLETED|Part 2||0
6777897|NCT03780959|7705830|FG001|COMPLETED|Part 2||7
6777898|NCT03780959|7705831|FG002|COMPLETED|Part 2||19
6777899|NCT03780959|7705829|FG000|NOT COMPLETED|Part 2||0
6777900|NCT03780959|7705830|FG001|NOT COMPLETED|Part 2||19
6777901|NCT03780959|7705831|FG002|NOT COMPLETED|Part 2||6
6777902|NCT03796182|7705841|FG000|STARTED|Period 1||6
6777903|NCT03796182|7705842|FG001|STARTED|Period 1||6
6655169|NCT02451488|7585232|FG000|STARTED|Overall Study||4
6655170|NCT02451488|7585233|FG001|STARTED|Overall Study||4
6655171|NCT02451488|7585232|FG000|COMPLETED|Overall Study||4
6655172|NCT02451488|7585233|FG001|COMPLETED|Overall Study||4
6655173|NCT02451488|7585232|FG000|NOT COMPLETED|Overall Study||0
6655174|NCT02451488|7585233|FG001|NOT COMPLETED|Overall Study||0
6655175|NCT02451514|7585242|FG000|STARTED|Overall Study||33
6655176|NCT02451514|7585243|FG001|STARTED|Overall Study||46
6655177|NCT02451514|7585244|FG002|STARTED|Overall Study||50
6655178|NCT02451514|7585242|FG000|COMPLETED|Overall Study||33
6655179|NCT02451514|7585243|FG001|COMPLETED|Overall Study||46
6655180|NCT02451514|7585244|FG002|COMPLETED|Overall Study||50
6655181|NCT02451514|7585242|FG000|NOT COMPLETED|Overall Study||0
6655182|NCT02451514|7585243|FG001|NOT COMPLETED|Overall Study||0
6655183|NCT02451514|7585244|FG002|NOT COMPLETED|Overall Study||0
6561021|NCT01791153|7483979|FG002|NOT COMPLETED|Part 1: Blinded Period||6
6655184|NCT02451670|7585262|FG000|STARTED|Overall Study||5264
6655185|NCT02451670|7585263|FG001|STARTED|Overall Study||5083
6655186|NCT02451670|7585262|FG000|COMPLETED|Overall Study||4550
6655187|NCT02451670|7585263|FG001|COMPLETED|Overall Study||4387
6655188|NCT02451670|7585262|FG000|NOT COMPLETED|Overall Study||714
6655189|NCT02451670|7585263|FG001|NOT COMPLETED|Overall Study||696
6655190|NCT02451696|7585271|FG000|STARTED|Overall Study||5
6655191|NCT02451696|7585272|FG001|STARTED|Overall Study||10
6777904|NCT03796182|7705841|FG000|COMPLETED|Period 1||6
6777905|NCT03796182|7705842|FG001|COMPLETED|Period 1||6
6777906|NCT03796182|7705841|FG000|NOT COMPLETED|Period 1||0
6655192|NCT02451696|7585271|FG000|COMPLETED|Overall Study||4
6655193|NCT02451696|7585272|FG001|COMPLETED|Overall Study||10
6655194|NCT02451696|7585271|FG000|NOT COMPLETED|Overall Study||1
6655195|NCT02451696|7585272|FG001|NOT COMPLETED|Overall Study||0
6655196|NCT02451839|7585280|FG000|STARTED|Overall Study||72
6655197|NCT02451839|7585281|FG001|STARTED|Overall Study||59
6655198|NCT02451839|7585282|FG002|STARTED|Overall Study||37
6655199|NCT02451839|7585280|FG000|Baseline WHODAS Data Recorded|Overall Study||70
6655200|NCT02451839|7585281|FG001|Baseline WHODAS Data Recorded|Overall Study||57
6655201|NCT02451839|7585282|FG002|Baseline WHODAS Data Recorded|Overall Study||37
6655202|NCT02451839|7585280|FG000|COMPLETED|Overall Study||44
6655203|NCT02451839|7585281|FG001|COMPLETED|Overall Study||40
6655204|NCT02451839|7585282|FG002|COMPLETED|Overall Study||30
6655205|NCT02451839|7585280|FG000|NOT COMPLETED|Overall Study||28
6655206|NCT02451839|7585281|FG001|NOT COMPLETED|Overall Study||19
6655207|NCT02451839|7585282|FG002|NOT COMPLETED|Overall Study||7
6655208|NCT02451917|7585292|FG000|STARTED|First Intervention (24 Weeks)||16
6655209|NCT02451917|7585293|FG001|STARTED|First Intervention (24 Weeks)||18
6655210|NCT02451917|7585292|FG000|COMPLETED|First Intervention (24 Weeks)||14
6655211|NCT02451917|7585293|FG001|COMPLETED|First Intervention (24 Weeks)||15
6655212|NCT02451917|7585292|FG000|NOT COMPLETED|First Intervention (24 Weeks)||2
6655213|NCT02451917|7585293|FG001|NOT COMPLETED|First Intervention (24 Weeks)||3
6655214|NCT02451917|7585292|FG000|STARTED|Second Intervention (24 Weeks)||14
6655215|NCT02451917|7585293|FG001|STARTED|Second Intervention (24 Weeks)||15
6655216|NCT02451917|7585292|FG000|COMPLETED|Second Intervention (24 Weeks)||14
6655217|NCT02451917|7585293|FG001|COMPLETED|Second Intervention (24 Weeks)||15
6655218|NCT02451917|7585292|FG000|NOT COMPLETED|Second Intervention (24 Weeks)||0
6655219|NCT02451917|7585293|FG001|NOT COMPLETED|Second Intervention (24 Weeks)||0
6655220|NCT02451930|7585305|FG000|STARTED|Overall Study||3
6655221|NCT02451930|7585306|FG001|STARTED|Overall Study||68
6655222|NCT02451930|7585305|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6655223|NCT02451930|7585306|FG001|Received at Least One Dose of Study Drug|Overall Study||68
6655224|NCT02451930|7585305|FG000|Part A Cohort 2 Participants|Overall Study||0
6655225|NCT02451930|7585306|FG001|Part A Cohort 2 Participants|Overall Study||6
6655226|NCT02451930|7585305|FG000|Part B Participants|Overall Study||0
6655227|NCT02451930|7585306|FG001|Part B Participants|Overall Study||55
6655228|NCT02451930|7585305|FG000|Part C Participants|Overall Study||0
6655229|NCT02451930|7585306|FG001|Part C Participants|Overall Study||7
6655230|NCT02451930|7585305|FG000|COMPLETED|Overall Study||1
6655231|NCT02451930|7585306|FG001|COMPLETED|Overall Study||38
6655232|NCT02451930|7585305|FG000|NOT COMPLETED|Overall Study||2
6655233|NCT02451930|7585306|FG001|NOT COMPLETED|Overall Study||30
6655234|NCT02451995|7585324|FG000|STARTED|Overall Study||42
6655235|NCT02451995|7585325|FG001|STARTED|Overall Study||41
6655236|NCT02451995|7585324|FG000|COMPLETED|Overall Study||42
6655237|NCT02451995|7585325|FG001|COMPLETED|Overall Study||41
6655238|NCT02451995|7585324|FG000|NOT COMPLETED|Overall Study||0
6655239|NCT02451995|7585325|FG001|NOT COMPLETED|Overall Study||0
6655240|NCT02452034|7585337|FG000|STARTED|Overall Study||16
6655241|NCT02452034|7585338|FG001|STARTED|Overall Study||21
6655242|NCT02452034|7585339|FG002|STARTED|Overall Study||15
6655243|NCT02452034|7585340|FG003|STARTED|Overall Study||17
6655244|NCT02452034|7585341|FG004|STARTED|Overall Study||20
6655245|NCT02452034|7585342|FG005|STARTED|Overall Study||29
6655246|NCT02452034|7585337|FG000|Treated|Overall Study||14
6655247|NCT02452034|7585338|FG001|Treated|Overall Study||21
6655248|NCT02452034|7585339|FG002|Treated|Overall Study||15
6655249|NCT02452034|7585340|FG003|Treated|Overall Study||16
6655250|NCT02452034|7585341|FG004|Treated|Overall Study||20
6655251|NCT02452034|7585342|FG005|Treated|Overall Study||29
6655252|NCT02452034|7585337|FG000|COMPLETED|Overall Study||14
6655253|NCT02452034|7585338|FG001|COMPLETED|Overall Study||20
6655254|NCT02452034|7585339|FG002|COMPLETED|Overall Study||14
6655255|NCT02452034|7585340|FG003|COMPLETED|Overall Study||16
6655256|NCT02452034|7585341|FG004|COMPLETED|Overall Study||19
6655257|NCT02452034|7585342|FG005|COMPLETED|Overall Study||26
6655258|NCT02452034|7585337|FG000|NOT COMPLETED|Overall Study||2
6655259|NCT02452034|7585338|FG001|NOT COMPLETED|Overall Study||1
6655260|NCT02452034|7585339|FG002|NOT COMPLETED|Overall Study||1
6655261|NCT02452034|7585340|FG003|NOT COMPLETED|Overall Study||1
6655262|NCT02452034|7585341|FG004|NOT COMPLETED|Overall Study||1
6655263|NCT02452034|7585342|FG005|NOT COMPLETED|Overall Study||3
6655264|NCT02452047|7585359|FG000|STARTED|Overall Study||31
6655265|NCT02452047|7585360|FG001|STARTED|Overall Study||16
6655266|NCT02452047|7585361|FG002|STARTED|Overall Study||3
6655267|NCT02452047|7585359|FG000|COMPLETED|Overall Study||27
6655268|NCT02452047|7585360|FG001|COMPLETED|Overall Study||11
6655269|NCT02452047|7585361|FG002|COMPLETED|Overall Study||1
6371182|NCT00734474|7282074|FG004|Entered Study After Dose Decision Point|Overall Study||281
6371183|NCT00734474|7282075|FG005|Entered Study After Dose Decision Point|Overall Study||0
6655270|NCT02452047|7585359|FG000|NOT COMPLETED|Overall Study||4
6655271|NCT02452047|7585360|FG001|NOT COMPLETED|Overall Study||5
6655272|NCT02452047|7585361|FG002|NOT COMPLETED|Overall Study||2
6655273|NCT02452060|7585371|FG000|STARTED|Overall Study||46
6655274|NCT02452060|7585372|FG001|STARTED|Overall Study||44
6655275|NCT02452060|7585371|FG000|COMPLETED|Overall Study||46
6655276|NCT02452060|7585372|FG001|COMPLETED|Overall Study||44
6655277|NCT02452060|7585371|FG000|NOT COMPLETED|Overall Study||0
6371184|NCT00734474|7282076|FG006|Entered Study After Dose Decision Point|Overall Study||0
6371185|NCT00734474|7282077|FG007|Entered Study After Dose Decision Point|Overall Study||273
6371186|NCT00734474|7282078|FG008|Entered Study After Dose Decision Point|Overall Study||139
6371187|NCT00734474|7282070|FG000|Completed 26-Week Visit|Overall Study||0
6371188|NCT00734474|7282071|FG001|Completed 26-Week Visit|Overall Study||0
6371189|NCT00734474|7282072|FG002|Completed 26-Week Visit|Overall Study||258
6371190|NCT00734474|7282073|FG003|Completed 26-Week Visit|Overall Study||2
6561022|NCT01791153|7483980|FG003|NOT COMPLETED|Part 1: Blinded Period||5
6561023|NCT01791153|7483981|FG004|NOT COMPLETED|Part 1: Blinded Period||0
6561024|NCT01791153|7483982|FG005|NOT COMPLETED|Part 1: Blinded Period||0
6371191|NCT00734474|7282074|FG004|Completed 26-Week Visit|Overall Study||268
6371192|NCT00734474|7282075|FG005|Completed 26-Week Visit|Overall Study||2
6371193|NCT00734474|7282076|FG006|Completed 26-Week Visit|Overall Study||2
6371194|NCT00734474|7282077|FG007|Completed 26-Week Visit|Overall Study||270
6371195|NCT00734474|7282078|FG008|Completed 26-Week Visit|Overall Study||124
6371196|NCT00734474|7282070|FG000|Completed 52-Week Visit|Overall Study||0
6371197|NCT00734474|7282071|FG001|Completed 52-Week Visit|Overall Study||0
6371198|NCT00734474|7282072|FG002|Completed 52-Week Visit|Overall Study||238
6371199|NCT00734474|7282073|FG003|Completed 52-Week Visit|Overall Study||0
6371200|NCT00734474|7282074|FG004|Completed 52-Week Visit|Overall Study||243
6371201|NCT00734474|7282075|FG005|Completed 52-Week Visit|Overall Study||0
6371202|NCT00734474|7282076|FG006|Completed 52-Week Visit|Overall Study||0
6371203|NCT00734474|7282077|FG007|Completed 52-Week Visit|Overall Study||238
6371204|NCT00734474|7282078|FG008|Completed 52-Week Visit|Overall Study||112
6371205|NCT00734474|7282070|FG000|COMPLETED|Overall Study||0
6371206|NCT00734474|7282071|FG001|COMPLETED|Overall Study||0
6371207|NCT00734474|7282072|FG002|COMPLETED|Overall Study||192
6371208|NCT00734474|7282073|FG003|COMPLETED|Overall Study||0
6371209|NCT00734474|7282074|FG004|COMPLETED|Overall Study||184
6371210|NCT00734474|7282075|FG005|COMPLETED|Overall Study||0
6371211|NCT00734474|7282076|FG006|COMPLETED|Overall Study||0
6371212|NCT00734474|7282077|FG007|COMPLETED|Overall Study||186
6371213|NCT00734474|7282078|FG008|COMPLETED|Overall Study||95
6371214|NCT00734474|7282070|FG000|NOT COMPLETED|Overall Study||15
6371215|NCT00734474|7282071|FG001|NOT COMPLETED|Overall Study||30
6371216|NCT00734474|7282072|FG002|NOT COMPLETED|Overall Study||112
6371217|NCT00734474|7282073|FG003|NOT COMPLETED|Overall Study||10
6371218|NCT00734474|7282074|FG004|NOT COMPLETED|Overall Study||118
6371219|NCT00734474|7282075|FG005|NOT COMPLETED|Overall Study||25
6371220|NCT00734474|7282076|FG006|NOT COMPLETED|Overall Study||24
6371221|NCT00734474|7282077|FG007|NOT COMPLETED|Overall Study||129
6371222|NCT00734474|7282078|FG008|NOT COMPLETED|Overall Study||82
6371223|NCT00734500|7282104|FG000|STARTED|Overall Study||15
6371224|NCT00734500|7282104|FG000|COMPLETED|Overall Study||14
6371225|NCT00734500|7282104|FG000|NOT COMPLETED|Overall Study||1
6371226|NCT00734539|7282110|FG000|STARTED|Main Study||189
6371227|NCT00734539|7282111|FG001|STARTED|Main Study||173
6371228|NCT00734539|7282110|FG000|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
6371229|NCT00734539|7282111|FG001|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
6371230|NCT00734539|7282110|FG000|NOT COMPLETED|Main Study||37
6371231|NCT00734539|7282111|FG001|NOT COMPLETED|Main Study||35
6371232|NCT00734539|7282110|FG000|STARTED|Long Term Follow up||152
6371233|NCT00734539|7282111|FG001|STARTED|Long Term Follow up||138
6371234|NCT00734539|7282110|FG000|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
6371235|NCT00734539|7282111|FG001|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
6371236|NCT00734539|7282110|FG000|NOT COMPLETED|Long Term Follow up||34
6371237|NCT00734539|7282111|FG001|NOT COMPLETED|Long Term Follow up||31
6371238|NCT00734578|7282123|FG000|STARTED|Overall Study||154
6371239|NCT00734578|7282124|FG001|STARTED|Overall Study||153
6371240|NCT00734578|7282125|FG002|STARTED|Overall Study||154
6371241|NCT00734578|7282123|FG000|COMPLETED|Overall Study||121
6371242|NCT00734578|7282124|FG001|COMPLETED|Overall Study||128
6371243|NCT00734578|7282125|FG002|COMPLETED|Overall Study||129
6371244|NCT00734578|7282123|FG000|NOT COMPLETED|Overall Study||33
6371245|NCT00734578|7282124|FG001|NOT COMPLETED|Overall Study||25
6371246|NCT00734578|7282125|FG002|NOT COMPLETED|Overall Study||25
6371247|NCT00734591|7282135|FG000|STARTED|Retrospective Period||3875
6371248|NCT00734591|7282136|FG001|STARTED|Retrospective Period||3564
6371249|NCT00734591|7282135|FG000|COMPLETED|Retrospective Period||3875
6371250|NCT00734591|7282136|FG001|COMPLETED|Retrospective Period||3564
6371251|NCT00734591|7282135|FG000|NOT COMPLETED|Retrospective Period||0
6371252|NCT00734591|7282136|FG001|NOT COMPLETED|Retrospective Period||0
6371253|NCT00734591|7282135|FG000|STARTED|Screening for Prospective Period||3875
6371254|NCT00734591|7282136|FG001|STARTED|Screening for Prospective Period||3564
6371255|NCT00734591|7282135|FG000|COMPLETED|Screening for Prospective Period||1358
6371256|NCT00734591|7282136|FG001|COMPLETED|Screening for Prospective Period||1273
6371257|NCT00734591|7282135|FG000|NOT COMPLETED|Screening for Prospective Period||2517
6371258|NCT00734591|7282136|FG001|NOT COMPLETED|Screening for Prospective Period||2291
6371259|NCT00734591|7282135|FG000|STARTED|Prospective Period||1358
6371260|NCT00734591|7282136|FG001|STARTED|Prospective Period||1273
6371261|NCT00734591|7282135|FG000|COMPLETED|Prospective Period||1307
6371262|NCT00734591|7282136|FG001|COMPLETED|Prospective Period||1229
6371263|NCT00734591|7282135|FG000|NOT COMPLETED|Prospective Period||51
6371264|NCT00734591|7282136|FG001|NOT COMPLETED|Prospective Period||44
6371265|NCT00734604|7282148|FG000|STARTED|Overall Study||62
6371266|NCT00734604|7282149|FG001|STARTED|Overall Study||63
6371267|NCT00734604|7282150|FG002|STARTED|Overall Study||63
6371268|NCT00734604|7282151|FG003|STARTED|Overall Study||63
6371269|NCT00734604|7282152|FG004|STARTED|Overall Study||63
6371270|NCT00734604|7282153|FG005|STARTED|Overall Study||64
6371271|NCT00734604|7282148|FG000|COMPLETED|Overall Study||59
6371272|NCT00734604|7282149|FG001|COMPLETED|Overall Study||51
6371273|NCT00734604|7282150|FG002|COMPLETED|Overall Study||57
6371274|NCT00734604|7282151|FG003|COMPLETED|Overall Study||54
6371275|NCT00734604|7282152|FG004|COMPLETED|Overall Study||55
6371276|NCT00734604|7282153|FG005|COMPLETED|Overall Study||58
6371277|NCT00734604|7282148|FG000|NOT COMPLETED|Overall Study||3
6371278|NCT00734604|7282149|FG001|NOT COMPLETED|Overall Study||12
6371279|NCT00734604|7282150|FG002|NOT COMPLETED|Overall Study||6
6777907|NCT03796182|7705842|FG001|NOT COMPLETED|Period 1||0
6777908|NCT03796182|7705841|FG000|STARTED|Washout Period||6
6777909|NCT03796182|7705842|FG001|STARTED|Washout Period||6
6777910|NCT03796182|7705841|FG000|COMPLETED|Washout Period||6
6777911|NCT03796182|7705842|FG001|COMPLETED|Washout Period||6
6777912|NCT03796182|7705841|FG000|NOT COMPLETED|Washout Period||0
6777913|NCT03796182|7705842|FG001|NOT COMPLETED|Washout Period||0
6777914|NCT03796182|7705841|FG000|STARTED|Period 2||6
6777915|NCT03796182|7705842|FG001|STARTED|Period 2||6
6777916|NCT03796182|7705841|FG000|COMPLETED|Period 2||6
6777917|NCT03796182|7705842|FG001|COMPLETED|Period 2||6
6777918|NCT03796182|7705841|FG000|NOT COMPLETED|Period 2||0
6777919|NCT03796182|7705842|FG001|NOT COMPLETED|Period 2||0
6777920|NCT03796013|7705850|FG000|STARTED|Period 1||14
6777921|NCT03796013|7705851|FG001|STARTED|Period 1||14
6777922|NCT03796013|7705850|FG000|COMPLETED|Period 1||14
6777923|NCT03796013|7705851|FG001|COMPLETED|Period 1||14
6777924|NCT03796013|7705850|FG000|NOT COMPLETED|Period 1||0
6777925|NCT03796013|7705851|FG001|NOT COMPLETED|Period 1||0
6777926|NCT03796013|7705850|FG000|STARTED|Period 2||14
6777927|NCT03796013|7705851|FG001|STARTED|Period 2||14
6371280|NCT00734604|7282151|FG003|NOT COMPLETED|Overall Study||9
6371281|NCT00734604|7282152|FG004|NOT COMPLETED|Overall Study||8
6371282|NCT00734604|7282153|FG005|NOT COMPLETED|Overall Study||6
6371283|NCT00734617|7282166|FG000|STARTED|Overall Study||249
6371284|NCT00734617|7282167|FG001|STARTED|Overall Study||230
6371285|NCT00734617|7282166|FG000|COMPLETED|Overall Study||142
6371286|NCT00734617|7282167|FG001|COMPLETED|Overall Study||128
6371287|NCT00734617|7282166|FG000|NOT COMPLETED|Overall Study||107
6371288|NCT00734617|7282167|FG001|NOT COMPLETED|Overall Study||102
6371289|NCT00734630|7282175|FG000|STARTED|Overall Study||258
6371290|NCT00734630|7282176|FG001|STARTED|Overall Study||233
6371291|NCT00734630|7282175|FG000|COMPLETED|Overall Study||229
6561025|NCT01791153|7483983|FG006|NOT COMPLETED|Part 1: Blinded Period||0
6561026|NCT01791153|7483984|FG007|NOT COMPLETED|Part 1: Blinded Period||0
6561027|NCT01791153|7483977|FG000|STARTED|Part 2: Open-label Period||0
6561028|NCT01791153|7483978|FG001|STARTED|Part 2: Open-label Period||0
6777928|NCT03796013|7705850|FG000|COMPLETED|Period 2||14
6777929|NCT03796013|7705851|FG001|COMPLETED|Period 2||14
6371292|NCT00734630|7282176|FG001|COMPLETED|Overall Study||200
6371293|NCT00734630|7282175|FG000|NOT COMPLETED|Overall Study||29
6371294|NCT00734630|7282176|FG001|NOT COMPLETED|Overall Study||33
6371295|NCT00734656|7282182|FG000|STARTED|Lab Session 1||24
6371296|NCT00734656|7282183|FG001|STARTED|Lab Session 1||23
6371297|NCT00734656|7282184|FG002|STARTED|Lab Session 1||26
6371298|NCT00734656|7282185|FG003|STARTED|Lab Session 1||21
6371299|NCT00734656|7282182|FG000|COMPLETED|Lab Session 1||22
6371300|NCT00734656|7282183|FG001|COMPLETED|Lab Session 1||23
6371301|NCT00734656|7282184|FG002|COMPLETED|Lab Session 1||26
6371302|NCT00734656|7282185|FG003|COMPLETED|Lab Session 1||21
6371303|NCT00734656|7282182|FG000|NOT COMPLETED|Lab Session 1||2
6371304|NCT00734656|7282183|FG001|NOT COMPLETED|Lab Session 1||0
6371305|NCT00734656|7282184|FG002|NOT COMPLETED|Lab Session 1||0
6371306|NCT00734656|7282185|FG003|NOT COMPLETED|Lab Session 1||0
6371307|NCT00734656|7282182|FG000|STARTED|Washout 1||22
6371308|NCT00734656|7282183|FG001|STARTED|Washout 1||23
6371309|NCT00734656|7282184|FG002|STARTED|Washout 1||26
6371310|NCT00734656|7282185|FG003|STARTED|Washout 1||21
6371311|NCT00734656|7282182|FG000|COMPLETED|Washout 1||21
6777930|NCT03796013|7705850|FG000|NOT COMPLETED|Period 2||0
6561029|NCT01791153|7483979|FG002|STARTED|Part 2: Open-label Period||0
6777931|NCT03796013|7705851|FG001|NOT COMPLETED|Period 2||0
6777932|NCT03795753|7705859|FG000|STARTED|Overall Study||23
6777933|NCT03795753|7705860|FG001|STARTED|Overall Study||13
6777934|NCT03795753|7705859|FG000|COMPLETED|Overall Study||23
6777935|NCT03795753|7705860|FG001|COMPLETED|Overall Study||13
6777936|NCT03795753|7705859|FG000|NOT COMPLETED|Overall Study||0
6777937|NCT03795753|7705860|FG001|NOT COMPLETED|Overall Study||0
6371312|NCT00734656|7282183|FG001|COMPLETED|Washout 1||18
6371313|NCT00734656|7282184|FG002|COMPLETED|Washout 1||24
6371314|NCT00734656|7282185|FG003|COMPLETED|Washout 1||18
6371315|NCT00734656|7282182|FG000|NOT COMPLETED|Washout 1||1
6371316|NCT00734656|7282183|FG001|NOT COMPLETED|Washout 1||5
6371317|NCT00734656|7282184|FG002|NOT COMPLETED|Washout 1||2
6371318|NCT00734656|7282185|FG003|NOT COMPLETED|Washout 1||3
6371319|NCT00734656|7282182|FG000|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
6777938|NCT03792477|7705871|FG000|STARTED|Overall Study||6
6777939|NCT03792477|7705872|FG001|STARTED|Overall Study||6
6371320|NCT00734656|7282183|FG001|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
6371321|NCT00734656|7282184|FG002|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
6371322|NCT00734656|7282185|FG003|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
6371323|NCT00734656|7282182|FG000|COMPLETED|Lab Session 2||18
6371324|NCT00734656|7282183|FG001|COMPLETED|Lab Session 2||21
6371325|NCT00734656|7282184|FG002|COMPLETED|Lab Session 2||21
6371326|NCT00734656|7282185|FG003|COMPLETED|Lab Session 2||19
6371327|NCT00734656|7282182|FG000|NOT COMPLETED|Lab Session 2||1
6371328|NCT00734656|7282183|FG001|NOT COMPLETED|Lab Session 2||0
6371329|NCT00734656|7282184|FG002|NOT COMPLETED|Lab Session 2||0
6371330|NCT00734656|7282185|FG003|NOT COMPLETED|Lab Session 2||1
6371331|NCT00734656|7282182|FG000|STARTED|Washout 2||18
6371332|NCT00734656|7282183|FG001|STARTED|Washout 2||21
6371333|NCT00734656|7282184|FG002|STARTED|Washout 2||21
6371334|NCT00734656|7282185|FG003|STARTED|Washout 2||19
6371335|NCT00734656|7282182|FG000|COMPLETED|Washout 2||17
6371336|NCT00734656|7282183|FG001|COMPLETED|Washout 2||20
6371337|NCT00734656|7282184|FG002|COMPLETED|Washout 2||20
6371338|NCT00734656|7282185|FG003|COMPLETED|Washout 2||19
6371339|NCT00734656|7282182|FG000|NOT COMPLETED|Washout 2||1
6371340|NCT00734656|7282183|FG001|NOT COMPLETED|Washout 2||1
6371341|NCT00734656|7282184|FG002|NOT COMPLETED|Washout 2||1
6371342|NCT00734656|7282185|FG003|NOT COMPLETED|Washout 2||0
6371343|NCT00734656|7282182|FG000|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
6371344|NCT00734656|7282183|FG001|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
6371345|NCT00734656|7282184|FG002|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
6371346|NCT00734656|7282185|FG003|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
6371347|NCT00734656|7282182|FG000|COMPLETED|Lab Session 3||18
6371348|NCT00734656|7282183|FG001|COMPLETED|Lab Session 3||19
6371349|NCT00734656|7282184|FG002|COMPLETED|Lab Session 3||20
6371350|NCT00734656|7282185|FG003|COMPLETED|Lab Session 3||19
6371351|NCT00734656|7282182|FG000|NOT COMPLETED|Lab Session 3||0
6371352|NCT00734656|7282183|FG001|NOT COMPLETED|Lab Session 3||0
6371353|NCT00734656|7282184|FG002|NOT COMPLETED|Lab Session 3||0
6371354|NCT00734656|7282185|FG003|NOT COMPLETED|Lab Session 3||0
6371355|NCT00734656|7282182|FG000|STARTED|Washout 3||18
6371356|NCT00734656|7282183|FG001|STARTED|Washout 3||19
6371357|NCT00734656|7282184|FG002|STARTED|Washout 3||20
6371358|NCT00734656|7282185|FG003|STARTED|Washout 3||19
6371359|NCT00734656|7282182|FG000|COMPLETED|Washout 3||17
6371360|NCT00734656|7282183|FG001|COMPLETED|Washout 3||19
6371361|NCT00734656|7282184|FG002|COMPLETED|Washout 3||20
6371362|NCT00734656|7282185|FG003|COMPLETED|Washout 3||18
6371363|NCT00734656|7282182|FG000|NOT COMPLETED|Washout 3||1
6371364|NCT00734656|7282183|FG001|NOT COMPLETED|Washout 3||0
6371365|NCT00734656|7282184|FG002|NOT COMPLETED|Washout 3||0
6371366|NCT00734656|7282185|FG003|NOT COMPLETED|Washout 3||1
6371367|NCT00734656|7282182|FG000|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
6371368|NCT00734656|7282183|FG001|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
6371369|NCT00734656|7282184|FG002|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
6371370|NCT00734656|7282185|FG003|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
6371371|NCT00734656|7282182|FG000|COMPLETED|Lab Session 4||20
6371372|NCT00734656|7282183|FG001|COMPLETED|Lab Session 4||18
6371373|NCT00734656|7282184|FG002|COMPLETED|Lab Session 4||16
6371374|NCT00734656|7282185|FG003|COMPLETED|Lab Session 4||19
6371375|NCT00734656|7282182|FG000|NOT COMPLETED|Lab Session 4||0
6371376|NCT00734656|7282183|FG001|NOT COMPLETED|Lab Session 4||0
6371377|NCT00734656|7282184|FG002|NOT COMPLETED|Lab Session 4||0
6371378|NCT00734656|7282185|FG003|NOT COMPLETED|Lab Session 4||1
6371379|NCT00734734|7282195|FG000|STARTED|Overall Study||64
6371380|NCT00734734|7282195|FG000|COMPLETED|Overall Study||64
6371381|NCT00734734|7282195|FG000|NOT COMPLETED|Overall Study||0
6561030|NCT01791153|7483980|FG003|STARTED|Part 2: Open-label Period||0
6561031|NCT01791153|7483981|FG004|STARTED|Part 2: Open-label Period||40
6561032|NCT01791153|7483982|FG005|STARTED|Part 2: Open-label Period||58
6561033|NCT01791153|7483983|FG006|STARTED|Part 2: Open-label Period||50
6371382|NCT00734747|7282200|FG000|STARTED|SRS Procedure||72
6371383|NCT00734747|7282200|FG000|COMPLETED|SRS Procedure||69
6371384|NCT00734747|7282200|FG000|NOT COMPLETED|SRS Procedure||3
6371385|NCT00734747|7282200|FG000|STARTED|6 Month Follow-up||69
6371386|NCT00734747|7282200|FG000|COMPLETED|6 Month Follow-up||66
6371387|NCT00734747|7282200|FG000|NOT COMPLETED|6 Month Follow-up||3
6371388|NCT00734799|7282206|FG000|STARTED|Overall Study||9
6371389|NCT00734799|7282207|FG001|STARTED|Overall Study||13
6371390|NCT00734799|7282206|FG000|COMPLETED|Overall Study||9
6371391|NCT00734799|7282207|FG001|COMPLETED|Overall Study||9
6371392|NCT00734799|7282206|FG000|NOT COMPLETED|Overall Study||0
6371393|NCT00734799|7282207|FG001|NOT COMPLETED|Overall Study||4
6371394|NCT00734851|7282213|FG000|STARTED|Overall Study||34
6371395|NCT00734851|7282213|FG000|COMPLETED|Overall Study||13
6371396|NCT00734851|7282213|FG000|NOT COMPLETED|Overall Study||21
6561034|NCT01791153|7483984|FG007|STARTED|Part 2: Open-label Period||67
6371397|NCT00734903|7282219|FG000|STARTED|Overall Study||33
6371398|NCT00734903|7282220|FG001|STARTED|Overall Study||33
6371399|NCT00734903|7282219|FG000|Completed End of Treatment Assessment|Overall Study||21
6371400|NCT00734903|7282220|FG001|Completed End of Treatment Assessment|Overall Study||23
6371401|NCT00734903|7282219|FG000|Completed 3-month Followup|Overall Study||14
6371402|NCT00734903|7282220|FG001|Completed 3-month Followup|Overall Study||15
6371403|NCT00734903|7282219|FG000|COMPLETED|Overall Study||30
6371404|NCT00734903|7282220|FG001|COMPLETED|Overall Study||32
6371405|NCT00734903|7282219|FG000|NOT COMPLETED|Overall Study||3
6371406|NCT00734903|7282220|FG001|NOT COMPLETED|Overall Study||1
6371407|NCT00734929|7282228|FG000|STARTED|Overall Study||57
6371408|NCT00734929|7282229|FG001|STARTED|Overall Study||58
6371409|NCT00734929|7282228|FG000|COMPLETED|Overall Study||51
6371410|NCT00734929|7282229|FG001|COMPLETED|Overall Study||53
6371411|NCT00734929|7282228|FG000|NOT COMPLETED|Overall Study||6
6371412|NCT00734929|7282229|FG001|NOT COMPLETED|Overall Study||5
6377740|NCT00764946|7288404|FG000|STARTED|Overall Study||98
6377741|NCT00764946|7288405|FG001|STARTED|Overall Study||89
6377742|NCT00764946|7288406|FG002|STARTED|Overall Study||22
6377743|NCT00764946|7288404|FG000|TREATED|Overall Study||97
6377744|NCT00764946|7288405|FG001|TREATED|Overall Study||88
6377745|NCT00764946|7288406|FG002|TREATED|Overall Study||21
6377746|NCT00764946|7288404|FG000|COMPLETED|Overall Study||85
6377747|NCT00764946|7288405|FG001|COMPLETED|Overall Study||72
6377748|NCT00764946|7288406|FG002|COMPLETED|Overall Study||18
6377749|NCT00764946|7288404|FG000|NOT COMPLETED|Overall Study||13
6377750|NCT00764946|7288405|FG001|NOT COMPLETED|Overall Study||17
6377751|NCT00764946|7288406|FG002|NOT COMPLETED|Overall Study||4
6377752|NCT00765037|7288420|FG000|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
6377753|NCT00765037|7288420|FG000|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
6377754|NCT00765037|7288420|FG000|NOT COMPLETED|Overall Study||6
6377755|NCT00765063|7288424|FG000|STARTED|Overall Study||62
6377756|NCT00765063|7288424|FG000|COMPLETED|Overall Study||30
6377757|NCT00765063|7288424|FG000|NOT COMPLETED|Overall Study||32
6377758|NCT00765076|7288431|FG000|STARTED|Overall Study||69
6377759|NCT00765076|7288432|FG001|STARTED|Overall Study||73
6377760|NCT00765076|7288433|FG002|STARTED|Overall Study||50
6377761|NCT00765076|7288431|FG000|COMPLETED|Overall Study||68
6377762|NCT00765076|7288432|FG001|COMPLETED|Overall Study||73
6377763|NCT00765076|7288433|FG002|COMPLETED|Overall Study||49
6377764|NCT00765076|7288431|FG000|NOT COMPLETED|Overall Study||1
6377765|NCT00765076|7288432|FG001|NOT COMPLETED|Overall Study||0
6377766|NCT00765076|7288433|FG002|NOT COMPLETED|Overall Study||1
6377767|NCT00765102|7288441|FG000|STARTED|Overall Study||32
6377768|NCT00765102|7288441|FG000|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
6377769|NCT00765102|7288441|FG000|NOT COMPLETED|Overall Study||31
6377770|NCT00765128|7288449|FG000|STARTED|Overall Study||8
6377771|NCT00765128|7288450|FG001|STARTED|Overall Study||9
6377772|NCT00765128|7288449|FG000|COMPLETED|Overall Study||8
6377773|NCT00765128|7288450|FG001|COMPLETED|Overall Study||9
6377774|NCT00765128|7288449|FG000|NOT COMPLETED|Overall Study||0
6377775|NCT00765128|7288450|FG001|NOT COMPLETED|Overall Study||0
6377776|NCT00765193|7288456|FG000|STARTED|Problem Area Examination||14381
6377777|NCT00765193|7288456|FG000|COMPLETED|Problem Area Examination||14381
6377778|NCT00765193|7288456|FG000|NOT COMPLETED|Problem Area Examination||0
6377779|NCT00765193|7288456|FG000|STARTED|Full Body Examination||14381
6777940|NCT03792477|7705873|FG002|STARTED|Overall Study||21
6777941|NCT03792477|7705874|FG003|STARTED|Overall Study||21
6777942|NCT03792477|7705875|FG004|STARTED|Overall Study||20
6777943|NCT03792477|7705871|FG000|COMPLETED|Overall Study||6
6777944|NCT03792477|7705872|FG001|COMPLETED|Overall Study||6
6777945|NCT03792477|7705873|FG002|COMPLETED|Overall Study||19
6777946|NCT03792477|7705874|FG003|COMPLETED|Overall Study||20
6777947|NCT03792477|7705875|FG004|COMPLETED|Overall Study||19
6777948|NCT03792477|7705871|FG000|NOT COMPLETED|Overall Study||0
6777949|NCT03792477|7705872|FG001|NOT COMPLETED|Overall Study||0
6777950|NCT03792477|7705873|FG002|NOT COMPLETED|Overall Study||2
6777951|NCT03792477|7705874|FG003|NOT COMPLETED|Overall Study||1
6777952|NCT03792477|7705875|FG004|NOT COMPLETED|Overall Study||1
6377780|NCT00765193|7288456|FG000|COMPLETED|Full Body Examination||14381
6377781|NCT00765193|7288456|FG000|NOT COMPLETED|Full Body Examination||0
6377782|NCT00765206|7288461|FG000|STARTED|First Intervention||15
6377783|NCT00765206|7288462|FG001|STARTED|First Intervention||15
6377784|NCT00765206|7288463|FG002|STARTED|First Intervention||15
6377785|NCT00765206|7288464|FG003|STARTED|First Intervention||15
6377786|NCT00765206|7288461|FG000|COMPLETED|First Intervention||15
6377787|NCT00765206|7288462|FG001|COMPLETED|First Intervention||15
6777953|NCT03783962|7705883|FG000|STARTED|Overall Study||28
6777954|NCT03783962|7705884|FG001|STARTED|Overall Study||28
6777955|NCT03783962|7705883|FG000|COMPLETED|Overall Study||25
6777956|NCT03783962|7705884|FG001|COMPLETED|Overall Study||21
6777957|NCT03783962|7705883|FG000|NOT COMPLETED|Overall Study||3
6777958|NCT03783962|7705884|FG001|NOT COMPLETED|Overall Study||7
6777959|NCT03782272|7705892|FG000|STARTED|Overall Study||6
6777960|NCT03782272|7705893|FG001|STARTED|Overall Study||6
6377788|NCT00765206|7288463|FG002|COMPLETED|First Intervention||15
6377789|NCT00765206|7288464|FG003|COMPLETED|First Intervention||15
6777961|NCT03782272|7705892|FG000|COMPLETED|Overall Study||6
6777962|NCT03782272|7705893|FG001|COMPLETED|Overall Study||6
6371413|NCT00734968|7282239|FG000|STARTED|Overall Study||77
6371414|NCT00734968|7282240|FG001|STARTED|Overall Study||76
6371415|NCT00734968|7282239|FG000|COMPLETED|Overall Study||76
6371416|NCT00734968|7282240|FG001|COMPLETED|Overall Study||75
6371417|NCT00734968|7282239|FG000|NOT COMPLETED|Overall Study||1
6371418|NCT00734968|7282240|FG001|NOT COMPLETED|Overall Study||1
6371419|NCT00734994|7282246|FG000|STARTED|Overall Study||15
6371420|NCT00734994|7282246|FG000|COMPLETED|Overall Study||14
6371421|NCT00734994|7282246|FG000|NOT COMPLETED|Overall Study||1
6371422|NCT00735007|7282251|FG000|STARTED|Overall Study||106
6371423|NCT00735007|7282251|FG000|COMPLETED|Overall Study||101
6371424|NCT00735007|7282251|FG000|NOT COMPLETED|Overall Study||5
6371425|NCT00735072|7282257|FG000|STARTED|Overall Study||23
6371426|NCT00735072|7282258|FG001|STARTED|Overall Study||22
6371427|NCT00735072|7282257|FG000|COMPLETED|Overall Study||22
6371428|NCT00735072|7282258|FG001|COMPLETED|Overall Study||21
6371429|NCT00735072|7282257|FG000|NOT COMPLETED|Overall Study||1
6371430|NCT00735072|7282258|FG001|NOT COMPLETED|Overall Study||1
6371431|NCT00735306|7282266|FG000|STARTED|Overall Study||12
6371432|NCT00735306|7282266|FG000|COMPLETED|Overall Study||12
6371433|NCT00735306|7282266|FG000|NOT COMPLETED|Overall Study||0
6371434|NCT00735371|7282275|FG000|STARTED|Overall Study||78
6371435|NCT00735371|7282276|FG001|STARTED|Overall Study||79
6371436|NCT00735371|7282277|FG002|STARTED|Overall Study||78
6371437|NCT00735371|7282278|FG003|STARTED|Overall Study||79
6371438|NCT00735371|7282275|FG000|COMPLETED|Overall Study||63
6371439|NCT00735371|7282276|FG001|COMPLETED|Overall Study||66
6371440|NCT00735371|7282277|FG002|COMPLETED|Overall Study||67
6371441|NCT00735371|7282278|FG003|COMPLETED|Overall Study||69
6371442|NCT00735371|7282275|FG000|NOT COMPLETED|Overall Study||15
6371443|NCT00735371|7282276|FG001|NOT COMPLETED|Overall Study||13
6371444|NCT00735371|7282277|FG002|NOT COMPLETED|Overall Study||11
6371445|NCT00735371|7282278|FG003|NOT COMPLETED|Overall Study||10
6371446|NCT00735397|7282288|FG000|STARTED|Overall Study||1218
6371447|NCT00735397|7282288|FG000|COMPLETED|Overall Study||35
6371448|NCT00735397|7282288|FG000|NOT COMPLETED|Overall Study||1183
6371449|NCT00735436|7282295|FG000|STARTED|Overall Study||18
6371450|NCT00735436|7282295|FG000|COMPLETED|Overall Study||18
6371451|NCT00735436|7282295|FG000|NOT COMPLETED|Overall Study||0
6371452|NCT00735449|7282302|FG000|STARTED|Overall Study||102
6371453|NCT00735449|7282303|FG001|STARTED|Overall Study||102
6371454|NCT00735449|7282302|FG000|COMPLETED|Overall Study||95
6371455|NCT00735449|7282303|FG001|COMPLETED|Overall Study||96
6371456|NCT00735449|7282302|FG000|NOT COMPLETED|Overall Study||7
6371457|NCT00735449|7282303|FG001|NOT COMPLETED|Overall Study||6
6371458|NCT00735462|7282312|FG000|STARTED|Overall Study||202
6371459|NCT00735462|7282313|FG001|STARTED|Overall Study||204
6371460|NCT00735462|7282314|FG002|STARTED|Overall Study||105
6371461|NCT00735462|7282312|FG000|COMPLETED|Overall Study||139
6371462|NCT00735462|7282313|FG001|COMPLETED|Overall Study||149
6371463|NCT00735462|7282314|FG002|COMPLETED|Overall Study||77
6371464|NCT00735462|7282312|FG000|NOT COMPLETED|Overall Study||63
6371465|NCT00735462|7282313|FG001|NOT COMPLETED|Overall Study||55
6371466|NCT00735462|7282314|FG002|NOT COMPLETED|Overall Study||28
6371467|NCT00735475|7282324|FG000|STARTED|Overall Study||631
6371468|NCT00735475|7282325|FG001|STARTED|Overall Study||637
6371469|NCT00735475|7282324|FG000|COMPLETED|Overall Study||623
6777963|NCT03782272|7705892|FG000|NOT COMPLETED|Overall Study||0
6777964|NCT03782272|7705893|FG001|NOT COMPLETED|Overall Study||0
6777965|NCT03779724|7705902|FG000|STARTED|Overall Study||25
6777966|NCT03779724|7705903|FG001|STARTED|Overall Study||25
6777967|NCT03779724|7705902|FG000|COMPLETED|Overall Study||19
6777968|NCT03779724|7705903|FG001|COMPLETED|Overall Study||21
6777969|NCT03779724|7705902|FG000|NOT COMPLETED|Overall Study||6
6777970|NCT03779724|7705903|FG001|NOT COMPLETED|Overall Study||4
6777971|NCT03775915|7705913|FG000|STARTED|Overall Study||12
6777972|NCT03775915|7705914|FG001|STARTED|Overall Study||12
6777973|NCT03775915|7705913|FG000|COMPLETED|Overall Study||12
6777974|NCT03775915|7705914|FG001|COMPLETED|Overall Study||12
6777975|NCT03775915|7705913|FG000|NOT COMPLETED|Overall Study||0
6777976|NCT03775915|7705914|FG001|NOT COMPLETED|Overall Study||0
6777977|NCT03794752|7705920|FG000|STARTED|Overall Study||8
6777978|NCT03794752|7705920|FG000|COMPLETED|Overall Study||8
6777979|NCT03794752|7705920|FG000|NOT COMPLETED|Overall Study||0
6777980|NCT03794024|7705930|FG000|STARTED|Overall Study||1
6371470|NCT00735475|7282325|FG001|COMPLETED|Overall Study||626
6371471|NCT00735475|7282324|FG000|NOT COMPLETED|Overall Study||8
6371472|NCT00735475|7282325|FG001|NOT COMPLETED|Overall Study||11
6371473|NCT00735618|7282331|FG000|STARTED|Overall Study||19
6371474|NCT00735618|7282331|FG000|COMPLETED|Overall Study||19
6371475|NCT00735618|7282331|FG000|NOT COMPLETED|Overall Study||0
6371476|NCT00735644|7282340|FG000|STARTED|Overall Study||303
6777981|NCT03794024|7705931|FG001|STARTED|Overall Study||0
6777982|NCT03794024|7705930|FG000|COMPLETED|Overall Study||0
6777983|NCT03794024|7705931|FG001|COMPLETED|Overall Study||0
6777984|NCT03794024|7705930|FG000|NOT COMPLETED|Overall Study||1
6777985|NCT03794024|7705931|FG001|NOT COMPLETED|Overall Study||0
6777986|NCT03793751|7705939|FG000|STARTED|Overall Study||60
6777987|NCT03793751|7705940|FG001|STARTED|Overall Study||60
6777988|NCT03793751|7705939|FG000|COMPLETED|Overall Study||60
6777989|NCT03793751|7705940|FG001|COMPLETED|Overall Study||60
6371477|NCT00735644|7282341|FG001|STARTED|Overall Study||300
6371478|NCT00735644|7282342|FG002|STARTED|Overall Study||296
6371479|NCT00735644|7282343|FG003|STARTED|Overall Study||199
6777990|NCT03793751|7705939|FG000|NOT COMPLETED|Overall Study||0
6777991|NCT03793751|7705940|FG001|NOT COMPLETED|Overall Study||0
6777992|NCT03793556|7705948|FG000|STARTED|Overall Study||35
6777993|NCT03793556|7705949|FG001|STARTED|Overall Study||36
6371480|NCT00735644|7282344|FG004|STARTED|Overall Study||102
6371481|NCT00735644|7282340|FG000|COMPLETED|Overall Study||303
6371482|NCT00735644|7282341|FG001|COMPLETED|Overall Study||298
6371483|NCT00735644|7282342|FG002|COMPLETED|Overall Study||295
6371484|NCT00735644|7282343|FG003|COMPLETED|Overall Study||198
6371485|NCT00735644|7282344|FG004|COMPLETED|Overall Study||102
6371486|NCT00735644|7282340|FG000|NOT COMPLETED|Overall Study||0
6371487|NCT00735644|7282341|FG001|NOT COMPLETED|Overall Study||2
6371488|NCT00735644|7282342|FG002|NOT COMPLETED|Overall Study||1
6371489|NCT00735644|7282343|FG003|NOT COMPLETED|Overall Study||1
6371490|NCT00735644|7282344|FG004|NOT COMPLETED|Overall Study||0
6371491|NCT00735670|7282365|FG000|STARTED|Overall Study||10
6371492|NCT00735670|7282366|FG001|STARTED|Overall Study||11
6371493|NCT00735670|7282365|FG000|COMPLETED|Overall Study||6
6371494|NCT00735670|7282366|FG001|COMPLETED|Overall Study||6
6371495|NCT00735670|7282365|FG000|NOT COMPLETED|Overall Study||4
6371496|NCT00735670|7282366|FG001|NOT COMPLETED|Overall Study||5
6371497|NCT00735696|7282372|FG000|STARTED|Overall Study||41
6371498|NCT00735696|7282372|FG000|Received Any Quantity of Study Drug|Overall Study||40
6371499|NCT00735696|7282372|FG000|COMPLETED|Overall Study||39
6371500|NCT00735696|7282372|FG000|NOT COMPLETED|Overall Study||2
6371501|NCT00735709|7282380|FG000|STARTED|Overall Study||140
6371502|NCT00735709|7282381|FG001|STARTED|Overall Study||140
6371503|NCT00735709|7282382|FG002|STARTED|Overall Study||140
6371504|NCT00735709|7282383|FG003|STARTED|Overall Study||140
6371505|NCT00735709|7282380|FG000|Treated|Overall Study||140
6371506|NCT00735709|7282381|FG001|Treated|Overall Study||140
6371507|NCT00735709|7282382|FG002|Treated|Overall Study||140
6371508|NCT00735709|7282383|FG003|Treated|Overall Study||139
6371509|NCT00735709|7282380|FG000|COMPLETED|Overall Study||127
6371510|NCT00735709|7282381|FG001|COMPLETED|Overall Study||127
6371511|NCT00735709|7282382|FG002|COMPLETED|Overall Study||129
6371512|NCT00735709|7282383|FG003|COMPLETED|Overall Study||122
6371513|NCT00735709|7282380|FG000|NOT COMPLETED|Overall Study||13
6371514|NCT00735709|7282381|FG001|NOT COMPLETED|Overall Study||13
6371515|NCT00735709|7282382|FG002|NOT COMPLETED|Overall Study||11
6371516|NCT00735709|7282383|FG003|NOT COMPLETED|Overall Study||18
6371517|NCT00735787|7282395|FG000|STARTED|Period 1||23
6371518|NCT00735787|7282396|FG001|STARTED|Period 1||49
6371519|NCT00735787|7282395|FG000|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
6371520|NCT00735787|7282396|FG001|COMPLETED|Period 1||41
6371521|NCT00735787|7282395|FG000|NOT COMPLETED|Period 1||6
6371522|NCT00735787|7282396|FG001|NOT COMPLETED|Period 1||8
6371523|NCT00735787|7282395|FG000|STARTED|Period 2||18
6371524|NCT00735787|7282396|FG001|STARTED|Period 2||41
6371525|NCT00735787|7282395|FG000|COMPLETED|Period 2||13
6371526|NCT00735787|7282396|FG001|COMPLETED|Period 2||40
6371527|NCT00735787|7282395|FG000|NOT COMPLETED|Period 2||5
6371528|NCT00735787|7282396|FG001|NOT COMPLETED|Period 2||1
6371529|NCT00735826|7282402|FG000|STARTED|Overall Study||10
6371530|NCT00735826|7282402|FG000|COMPLETED|Overall Study||10
6371531|NCT00735826|7282402|FG000|NOT COMPLETED|Overall Study||0
6371532|NCT00735839|7282410|FG000|STARTED|Overall Study||30
6371533|NCT00735839|7282411|FG001|STARTED|Overall Study||10
6371534|NCT00735839|7282410|FG000|COMPLETED|Overall Study||30
6371535|NCT00735839|7282411|FG001|COMPLETED|Overall Study||10
6371536|NCT00735839|7282410|FG000|NOT COMPLETED|Overall Study||0
6371537|NCT00735839|7282411|FG001|NOT COMPLETED|Overall Study||0
6371538|NCT00735878|7282420|FG000|STARTED|Phase I- Dose Determination|13 subjects enrolled. One subject withdrew consent prior to receiving therapy & was replaced.|1
6371539|NCT00735878|7282421|FG001|STARTED|Phase I- Dose Determination||7
6371540|NCT00735878|7282422|FG002|STARTED|Phase I- Dose Determination||5
6371541|NCT00735878|7282420|FG000|COMPLETED|Phase I- Dose Determination|12 subjects received at least one cycle of treatment and were evaluable per the protocol.|1
6371542|NCT00735878|7282421|FG001|COMPLETED|Phase I- Dose Determination||7
6371543|NCT00735878|7282422|FG002|COMPLETED|Phase I- Dose Determination||4
6371544|NCT00735878|7282420|FG000|NOT COMPLETED|Phase I- Dose Determination||0
6371545|NCT00735878|7282421|FG001|NOT COMPLETED|Phase I- Dose Determination||0
6371546|NCT00735878|7282422|FG002|NOT COMPLETED|Phase I- Dose Determination||1
6371547|NCT00735878|7282420|FG000|STARTED|Phase II- Determined Dose||0
6371548|NCT00735878|7282421|FG001|STARTED|Phase II- Determined Dose||7
6371549|NCT00735878|7282422|FG002|STARTED|Phase II- Determined Dose||0
6371550|NCT00735878|7282420|FG000|COMPLETED|Phase II- Determined Dose|Seven subjects completed therapy within the Phase II portion of the trial.|0
6371551|NCT00735878|7282421|FG001|COMPLETED|Phase II- Determined Dose||7
6371552|NCT00735878|7282422|FG002|COMPLETED|Phase II- Determined Dose||0
6371553|NCT00735878|7282420|FG000|NOT COMPLETED|Phase II- Determined Dose||0
6371554|NCT00735878|7282421|FG001|NOT COMPLETED|Phase II- Determined Dose||0
6777994|NCT03793556|7705948|FG000|COMPLETED|Overall Study||22
6371555|NCT00735878|7282422|FG002|NOT COMPLETED|Phase II- Determined Dose||0
6371556|NCT00735904|7282433|FG000|STARTED|Overall Study||38
6371557|NCT00735904|7282433|FG000|COMPLETED|Overall Study||0
6371558|NCT00735904|7282433|FG000|NOT COMPLETED|Overall Study||38
6371559|NCT00735917|7282437|FG000|STARTED|Overall Study||19
6371560|NCT00735917|7282437|FG000|COMPLETED|Overall Study||19
6777995|NCT03793556|7705949|FG001|COMPLETED|Overall Study||34
6777996|NCT03793556|7705948|FG000|NOT COMPLETED|Overall Study||13
6371561|NCT00735917|7282437|FG000|NOT COMPLETED|Overall Study||0
6371562|NCT00735943|7282441|FG000|STARTED|Overall Study||22
6371563|NCT00735943|7282441|FG000|COMPLETED|Overall Study||20
6371564|NCT00735943|7282441|FG000|NOT COMPLETED|Overall Study||2
6371565|NCT00735969|7282445|FG000|STARTED|Overall Study||21
6371566|NCT00735969|7282445|FG000|COMPLETED|Overall Study||21
6371567|NCT00735969|7282445|FG000|NOT COMPLETED|Overall Study||0
6371568|NCT00736034|7282449|FG000|STARTED|Overall Study||18
6371569|NCT00736034|7282449|FG000|COMPLETED|Overall Study||16
6371570|NCT00736034|7282449|FG000|NOT COMPLETED|Overall Study||2
6371571|NCT00736073|7282455|FG000|STARTED|Overall Study||34
6371572|NCT00736073|7282456|FG001|STARTED|Overall Study||39
6371573|NCT00736073|7282455|FG000|COMPLETED|Overall Study||34
6371574|NCT00736073|7282456|FG001|COMPLETED|Overall Study||39
6371575|NCT00736073|7282455|FG000|NOT COMPLETED|Overall Study||0
6371576|NCT00736073|7282456|FG001|NOT COMPLETED|Overall Study||0
6371577|NCT00736099|7282465|FG000|STARTED|Overall Study|Number who started treatment.|1532
6371578|NCT00736099|7282466|FG001|STARTED|Overall Study|Number who started treatment.|589
6371579|NCT00736099|7282465|FG000|COMPLETED|Overall Study|Number who completed treatment.|1349
6371580|NCT00736099|7282466|FG001|COMPLETED|Overall Study|Number who completed treatment.|531
6371581|NCT00736099|7282465|FG000|NOT COMPLETED|Overall Study||183
6371582|NCT00736099|7282466|FG001|NOT COMPLETED|Overall Study||58
6371583|NCT00736125|7282474|FG000|STARTED|Overall Study||10
6371584|NCT00736125|7282475|FG001|STARTED|Overall Study||10
6371585|NCT00736125|7282474|FG000|COMPLETED|Overall Study||9
6371586|NCT00736125|7282475|FG001|COMPLETED|Overall Study||8
6371587|NCT00736125|7282474|FG000|NOT COMPLETED|Overall Study||1
6371588|NCT00736125|7282475|FG001|NOT COMPLETED|Overall Study||2
6371589|NCT00736190|7282481|FG000|STARTED|Overall Study||90
6371590|NCT00736190|7282481|FG000|COMPLETED|Overall Study||87
6371591|NCT00736190|7282481|FG000|NOT COMPLETED|Overall Study||3
6371592|NCT00736229|7282488|FG000|STARTED|Overall Study|Actively Enrolled|40
6371593|NCT00736229|7282489|FG001|STARTED|Overall Study|Historic control|71
6371594|NCT00736229|7282490|FG002|STARTED|Overall Study|Historic Control|84
6371595|NCT00736229|7282488|FG000|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
6371596|NCT00736229|7282489|FG001|COMPLETED|Overall Study||71
6371597|NCT00736229|7282490|FG002|COMPLETED|Overall Study||84
6371598|NCT00736229|7282488|FG000|NOT COMPLETED|Overall Study||0
6371599|NCT00736229|7282489|FG001|NOT COMPLETED|Overall Study||0
6371600|NCT00736229|7282490|FG002|NOT COMPLETED|Overall Study||0
6371601|NCT00736242|7282499|FG000|STARTED|Overall Study||232
6371602|NCT00736242|7282499|FG000|Participants in Safety Analysis Set|Overall Study||229
6371603|NCT00736242|7282499|FG000|COMPLETED|Overall Study||107
6371604|NCT00736242|7282499|FG000|NOT COMPLETED|Overall Study||125
6371605|NCT00736255|7282505|FG000|STARTED|Overall Study||17
6371606|NCT00736255|7282506|FG001|STARTED|Overall Study||15
6371607|NCT00736255|7282505|FG000|COMPLETED|Overall Study||14
6371608|NCT00736255|7282506|FG001|COMPLETED|Overall Study||14
6371609|NCT00736255|7282505|FG000|NOT COMPLETED|Overall Study||3
6371610|NCT00736255|7282506|FG001|NOT COMPLETED|Overall Study||1
6371611|NCT00736333|7282512|FG000|STARTED|Overall Study||167
6371612|NCT00736333|7282512|FG000|COMPLETED|Overall Study||56
6371613|NCT00736333|7282512|FG000|NOT COMPLETED|Overall Study||111
6371614|NCT00736450|7282516|FG000|STARTED|Overall Study||37
6371615|NCT00736450|7282516|FG000|COMPLETED|Overall Study||12
6371616|NCT00736450|7282516|FG000|NOT COMPLETED|Overall Study||25
6371617|NCT00736476|7282522|FG000|STARTED|Overall Study||36
6371618|NCT00736476|7282523|FG001|STARTED|Overall Study||27
6371619|NCT00736476|7282522|FG000|COMPLETED|Overall Study||35
6371620|NCT00736476|7282523|FG001|COMPLETED|Overall Study||27
6371621|NCT00736476|7282522|FG000|NOT COMPLETED|Overall Study||1
6371622|NCT00736476|7282523|FG001|NOT COMPLETED|Overall Study||0
6371623|NCT00736489|7282535|FG000|STARTED|Period 1|Cross-over study|6
6371624|NCT00736489|7282536|FG001|STARTED|Period 1||5
6371625|NCT00736489|7282537|FG002|STARTED|Period 1||6
6371626|NCT00736489|7282538|FG003|STARTED|Period 1||7
6371627|NCT00736489|7282539|FG004|STARTED|Period 1||7
6371628|NCT00736489|7282540|FG005|STARTED|Period 1||6
6371629|NCT00736489|7282535|FG000|COMPLETED|Period 1||5
6371630|NCT00736489|7282536|FG001|COMPLETED|Period 1||5
6371631|NCT00736489|7282537|FG002|COMPLETED|Period 1||6
6371632|NCT00736489|7282538|FG003|COMPLETED|Period 1||7
6371633|NCT00736489|7282539|FG004|COMPLETED|Period 1||7
6371634|NCT00736489|7282540|FG005|COMPLETED|Period 1||5
6371635|NCT00736489|7282535|FG000|NOT COMPLETED|Period 1||1
6371636|NCT00736489|7282536|FG001|NOT COMPLETED|Period 1||0
6371637|NCT00736489|7282537|FG002|NOT COMPLETED|Period 1||0
6371638|NCT00736489|7282538|FG003|NOT COMPLETED|Period 1||0
6371639|NCT00736489|7282539|FG004|NOT COMPLETED|Period 1||0
6371640|NCT00736489|7282540|FG005|NOT COMPLETED|Period 1||1
6371641|NCT00736489|7282535|FG000|STARTED|Period 2||5
6371642|NCT00736489|7282536|FG001|STARTED|Period 2||5
6371643|NCT00736489|7282537|FG002|STARTED|Period 2||6
6371644|NCT00736489|7282538|FG003|STARTED|Period 2||7
6371645|NCT00736489|7282539|FG004|STARTED|Period 2||7
6371646|NCT00736489|7282540|FG005|STARTED|Period 2||5
6371647|NCT00736489|7282535|FG000|COMPLETED|Period 2||5
6371648|NCT00736489|7282536|FG001|COMPLETED|Period 2||5
6371649|NCT00736489|7282537|FG002|COMPLETED|Period 2||6
6371650|NCT00736489|7282538|FG003|COMPLETED|Period 2||7
6371651|NCT00736489|7282539|FG004|COMPLETED|Period 2||7
6371652|NCT00736489|7282540|FG005|COMPLETED|Period 2||5
6371653|NCT00736489|7282535|FG000|NOT COMPLETED|Period 2||0
6371654|NCT00736489|7282536|FG001|NOT COMPLETED|Period 2||0
6371655|NCT00736489|7282537|FG002|NOT COMPLETED|Period 2||0
6371656|NCT00736489|7282538|FG003|NOT COMPLETED|Period 2||0
6371657|NCT00736489|7282539|FG004|NOT COMPLETED|Period 2||0
6371658|NCT00736489|7282540|FG005|NOT COMPLETED|Period 2||0
6371659|NCT00736489|7282535|FG000|STARTED|Period 3||5
6371660|NCT00736489|7282536|FG001|STARTED|Period 3||5
6371661|NCT00736489|7282537|FG002|STARTED|Period 3||6
6371662|NCT00736489|7282538|FG003|STARTED|Period 3||7
6371663|NCT00736489|7282539|FG004|STARTED|Period 3||7
6371664|NCT00736489|7282540|FG005|STARTED|Period 3||5
6371665|NCT00736489|7282535|FG000|COMPLETED|Period 3||5
6371666|NCT00736489|7282536|FG001|COMPLETED|Period 3||5
6371667|NCT00736489|7282537|FG002|COMPLETED|Period 3||6
6371668|NCT00736489|7282538|FG003|COMPLETED|Period 3||7
6371669|NCT00736489|7282539|FG004|COMPLETED|Period 3||7
6371670|NCT00736489|7282540|FG005|COMPLETED|Period 3||5
6371671|NCT00736489|7282535|FG000|NOT COMPLETED|Period 3||0
6371672|NCT00736489|7282536|FG001|NOT COMPLETED|Period 3||0
6371673|NCT00736489|7282537|FG002|NOT COMPLETED|Period 3||0
6371674|NCT00736489|7282538|FG003|NOT COMPLETED|Period 3||0
6371675|NCT00736489|7282539|FG004|NOT COMPLETED|Period 3||0
6371676|NCT00736489|7282540|FG005|NOT COMPLETED|Period 3||0
6371677|NCT00736489|7282535|FG000|STARTED|Period 4||5
6371678|NCT00736489|7282536|FG001|STARTED|Period 4||5
6371679|NCT00736489|7282537|FG002|STARTED|Period 4||6
6371680|NCT00736489|7282538|FG003|STARTED|Period 4||7
6371681|NCT00736489|7282539|FG004|STARTED|Period 4||7
6371682|NCT00736489|7282540|FG005|STARTED|Period 4||5
6371683|NCT00736489|7282535|FG000|COMPLETED|Period 4||5
6371684|NCT00736489|7282536|FG001|COMPLETED|Period 4||5
6371685|NCT00736489|7282537|FG002|COMPLETED|Period 4||6
6371686|NCT00736489|7282538|FG003|COMPLETED|Period 4||7
6371687|NCT00736489|7282539|FG004|COMPLETED|Period 4||7
6371688|NCT00736489|7282540|FG005|COMPLETED|Period 4||5
6371689|NCT00736489|7282535|FG000|NOT COMPLETED|Period 4||0
6371690|NCT00736489|7282536|FG001|NOT COMPLETED|Period 4||0
6371691|NCT00736489|7282537|FG002|NOT COMPLETED|Period 4||0
6371692|NCT00736489|7282538|FG003|NOT COMPLETED|Period 4||0
6371693|NCT00736489|7282539|FG004|NOT COMPLETED|Period 4||0
6371694|NCT00736489|7282540|FG005|NOT COMPLETED|Period 4||0
6371695|NCT00736489|7282535|FG000|STARTED|Period 5||5
6371696|NCT00736489|7282536|FG001|STARTED|Period 5||5
6371697|NCT00736489|7282537|FG002|STARTED|Period 5||6
6371698|NCT00736489|7282538|FG003|STARTED|Period 5||7
6371699|NCT00736489|7282539|FG004|STARTED|Period 5||7
6371700|NCT00736489|7282540|FG005|STARTED|Period 5||5
6371701|NCT00736489|7282535|FG000|COMPLETED|Period 5||5
6371702|NCT00736489|7282536|FG001|COMPLETED|Period 5||5
6371703|NCT00736489|7282537|FG002|COMPLETED|Period 5||6
6371704|NCT00736489|7282538|FG003|COMPLETED|Period 5||7
6371705|NCT00736489|7282539|FG004|COMPLETED|Period 5||7
6371706|NCT00736489|7282540|FG005|COMPLETED|Period 5||5
6371707|NCT00736489|7282535|FG000|NOT COMPLETED|Period 5||0
6371708|NCT00736489|7282536|FG001|NOT COMPLETED|Period 5||0
6371709|NCT00736489|7282537|FG002|NOT COMPLETED|Period 5||0
6371710|NCT00736489|7282538|FG003|NOT COMPLETED|Period 5||0
6371711|NCT00736489|7282539|FG004|NOT COMPLETED|Period 5||0
6371712|NCT00736489|7282540|FG005|NOT COMPLETED|Period 5||0
6371713|NCT00736489|7282535|FG000|STARTED|Period 6||5
6371714|NCT00736489|7282536|FG001|STARTED|Period 6||5
6371715|NCT00736489|7282537|FG002|STARTED|Period 6||6
6371716|NCT00736489|7282538|FG003|STARTED|Period 6||7
6371717|NCT00736489|7282539|FG004|STARTED|Period 6||7
6371718|NCT00736489|7282540|FG005|STARTED|Period 6||5
6371719|NCT00736489|7282535|FG000|COMPLETED|Period 6||5
6371720|NCT00736489|7282536|FG001|COMPLETED|Period 6||5
6371721|NCT00736489|7282537|FG002|COMPLETED|Period 6||6
6371722|NCT00736489|7282538|FG003|COMPLETED|Period 6||7
6371723|NCT00736489|7282539|FG004|COMPLETED|Period 6||7
6371724|NCT00736489|7282540|FG005|COMPLETED|Period 6||5
6371725|NCT00736489|7282535|FG000|NOT COMPLETED|Period 6||0
6371726|NCT00736489|7282536|FG001|NOT COMPLETED|Period 6||0
6371727|NCT00736489|7282537|FG002|NOT COMPLETED|Period 6||0
6371728|NCT00736489|7282538|FG003|NOT COMPLETED|Period 6||0
6371729|NCT00736489|7282539|FG004|NOT COMPLETED|Period 6||0
6371730|NCT00736489|7282540|FG005|NOT COMPLETED|Period 6||0
6371731|NCT00736502|7282554|FG000|STARTED|Overall Study|Entered and treated.|278
6371732|NCT00736502|7282554|FG000|COMPLETED|Overall Study||213
6371733|NCT00736502|7282554|FG000|NOT COMPLETED|Overall Study||65
6371734|NCT00736580|7282560|FG000|STARTED|Overall Study||117
6371735|NCT00736580|7282561|FG001|STARTED|Overall Study||123
6371736|NCT00736580|7282560|FG000|COMPLETED|Overall Study||117
6371737|NCT00736580|7282561|FG001|COMPLETED|Overall Study||123
6371738|NCT00736580|7282560|FG000|NOT COMPLETED|Overall Study||0
6371739|NCT00736580|7282561|FG001|NOT COMPLETED|Overall Study||0
6371740|NCT00736632|7282570|FG000|STARTED|Overall Study||44
6371741|NCT00736632|7282571|FG001|STARTED|Overall Study||50
6371742|NCT00736632|7282572|FG002|STARTED|Overall Study||31
6371743|NCT00736632|7282570|FG000|COMPLETED|Overall Study||44
6371744|NCT00736632|7282571|FG001|COMPLETED|Overall Study||50
6371745|NCT00736632|7282572|FG002|COMPLETED|Overall Study||31
6371746|NCT00736632|7282570|FG000|NOT COMPLETED|Overall Study||0
6371747|NCT00736632|7282571|FG001|NOT COMPLETED|Overall Study||0
6371748|NCT00736632|7282572|FG002|NOT COMPLETED|Overall Study||0
6371749|NCT00736645|7282582|FG000|STARTED|Overall Study||13
6371750|NCT00736645|7282583|FG001|STARTED|Overall Study||15
6371751|NCT00736645|7282584|FG002|STARTED|Overall Study||14
6371752|NCT00736645|7282585|FG003|STARTED|Overall Study||13
6371753|NCT00736645|7282582|FG000|COMPLETED|Overall Study||13
6371754|NCT00736645|7282583|FG001|COMPLETED|Overall Study||13
6371755|NCT00736645|7282584|FG002|COMPLETED|Overall Study||14
6371756|NCT00736645|7282585|FG003|COMPLETED|Overall Study||13
6371757|NCT00736645|7282582|FG000|NOT COMPLETED|Overall Study||0
6371758|NCT00736645|7282583|FG001|NOT COMPLETED|Overall Study||2
6371759|NCT00736645|7282584|FG002|NOT COMPLETED|Overall Study||0
6371760|NCT00736645|7282585|FG003|NOT COMPLETED|Overall Study||0
6371761|NCT00736723|7282597|FG000|STARTED|Overall Study||30
6371762|NCT00736723|7282598|FG001|STARTED|Overall Study||21
6371763|NCT00736723|7282597|FG000|COMPLETED|Overall Study||26
6371764|NCT00736723|7282598|FG001|COMPLETED|Overall Study||18
6371765|NCT00736723|7282597|FG000|NOT COMPLETED|Overall Study||4
6371766|NCT00736723|7282598|FG001|NOT COMPLETED|Overall Study||3
6371767|NCT00736840|7282604|FG000|STARTED|Overall Study||414
6371768|NCT00736840|7282604|FG000|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
6371769|NCT00736840|7282604|FG000|NOT COMPLETED|Overall Study||13
6371770|NCT00736853|7282608|FG000|STARTED|Open-Label Period||319
6371771|NCT00736853|7282609|FG001|STARTED|Open-Label Period||0
6371772|NCT00736853|7282610|FG002|STARTED|Open-Label Period||0
6371773|NCT00736853|7282608|FG000|Treated|Open-Label Period||277
6371774|NCT00736853|7282609|FG001|Treated|Open-Label Period||0
6371775|NCT00736853|7282610|FG002|Treated|Open-Label Period||0
6371776|NCT00736853|7282608|FG000|COMPLETED|Open-Label Period||187
6371777|NCT00736853|7282609|FG001|COMPLETED|Open-Label Period||0
6371778|NCT00736853|7282610|FG002|COMPLETED|Open-Label Period||0
6371779|NCT00736853|7282608|FG000|NOT COMPLETED|Open-Label Period||132
6371780|NCT00736853|7282609|FG001|NOT COMPLETED|Open-Label Period||0
6371781|NCT00736853|7282610|FG002|NOT COMPLETED|Open-Label Period||0
6371782|NCT00736853|7282608|FG000|STARTED|Double-Blind Period||0
6371783|NCT00736853|7282609|FG001|STARTED|Double-Blind Period||94
6371784|NCT00736853|7282610|FG002|STARTED|Double-Blind Period||93
6371785|NCT00736853|7282608|FG000|COMPLETED|Double-Blind Period||0
6371786|NCT00736853|7282609|FG001|COMPLETED|Double-Blind Period||70
6371787|NCT00736853|7282610|FG002|COMPLETED|Double-Blind Period||45
6371788|NCT00736853|7282608|FG000|NOT COMPLETED|Double-Blind Period||0
6371789|NCT00736853|7282609|FG001|NOT COMPLETED|Double-Blind Period||24
6371790|NCT00736853|7282610|FG002|NOT COMPLETED|Double-Blind Period||48
6371791|NCT00736879|7282623|FG000|STARTED|Double Blind Treatment Period||68
6371792|NCT00736879|7282624|FG001|STARTED|Double Blind Treatment Period||72
6371793|NCT00736879|7282625|FG002|STARTED|Double Blind Treatment Period||74
6371794|NCT00736879|7282626|FG003|STARTED|Double Blind Treatment Period||68
6371795|NCT00736879|7282623|FG000|COMPLETED|Double Blind Treatment Period||65
6371796|NCT00736879|7282624|FG001|COMPLETED|Double Blind Treatment Period||68
6371797|NCT00736879|7282625|FG002|COMPLETED|Double Blind Treatment Period||67
6371798|NCT00736879|7282626|FG003|COMPLETED|Double Blind Treatment Period||63
6371799|NCT00736879|7282623|FG000|NOT COMPLETED|Double Blind Treatment Period||3
6371800|NCT00736879|7282624|FG001|NOT COMPLETED|Double Blind Treatment Period||4
6371801|NCT00736879|7282625|FG002|NOT COMPLETED|Double Blind Treatment Period||7
6371802|NCT00736879|7282626|FG003|NOT COMPLETED|Double Blind Treatment Period||5
6371803|NCT00736879|7282623|FG000|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
6371804|NCT00736879|7282624|FG001|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
6371805|NCT00736879|7282625|FG002|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
6371806|NCT00736879|7282626|FG003|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
6371807|NCT00736879|7282623|FG000|COMPLETED|Follow up Period - No Drug Treatment||65
6371808|NCT00736879|7282624|FG001|COMPLETED|Follow up Period - No Drug Treatment||67
6371809|NCT00736879|7282625|FG002|COMPLETED|Follow up Period - No Drug Treatment||66
6371810|NCT00736879|7282626|FG003|COMPLETED|Follow up Period - No Drug Treatment||62
6371811|NCT00736879|7282623|FG000|NOT COMPLETED|Follow up Period - No Drug Treatment||1
6371812|NCT00736879|7282624|FG001|NOT COMPLETED|Follow up Period - No Drug Treatment||3
6371813|NCT00736879|7282625|FG002|NOT COMPLETED|Follow up Period - No Drug Treatment||0
6561035|NCT01791153|7483977|FG000|COMPLETED|Part 2: Open-label Period||0
6561036|NCT01791153|7483978|FG001|COMPLETED|Part 2: Open-label Period||0
6561037|NCT01791153|7483979|FG002|COMPLETED|Part 2: Open-label Period||0
6561038|NCT01791153|7483980|FG003|COMPLETED|Part 2: Open-label Period||0
6561039|NCT01791153|7483981|FG004|COMPLETED|Part 2: Open-label Period||38
6371814|NCT00736879|7282626|FG003|NOT COMPLETED|Follow up Period - No Drug Treatment||0
6371815|NCT00736944|7282639|FG000|STARTED|Induction||30
6371816|NCT00736944|7282639|FG000|COMPLETED|Induction||29
6371817|NCT00736944|7282639|FG000|NOT COMPLETED|Induction||1
6371818|NCT00736944|7282639|FG000|STARTED|Definitive Treatment||29
6371819|NCT00736944|7282639|FG000|COMPLETED|Definitive Treatment||28
6371820|NCT00736944|7282639|FG000|NOT COMPLETED|Definitive Treatment||1
6371821|NCT00736957|7282646|FG000|STARTED|Overall Study||219
6371822|NCT00736957|7282646|FG000|Treated|Overall Study||190
6371823|NCT00736957|7282646|FG000|COMPLETED|Overall Study||97
6371824|NCT00736957|7282646|FG000|NOT COMPLETED|Overall Study||122
6561040|NCT01791153|7483982|FG005|COMPLETED|Part 2: Open-label Period||54
6371825|NCT00736996|7282653|FG000|STARTED|Overall Study||25
6371826|NCT00736996|7282654|FG001|STARTED|Overall Study||26
6371827|NCT00736996|7282655|FG002|STARTED|Overall Study||27
6371828|NCT00736996|7282653|FG000|COMPLETED|Overall Study||24
6371829|NCT00736996|7282654|FG001|COMPLETED|Overall Study||17
6371830|NCT00736996|7282655|FG002|COMPLETED|Overall Study||25
6371831|NCT00736996|7282653|FG000|NOT COMPLETED|Overall Study||1
6371832|NCT00736996|7282654|FG001|NOT COMPLETED|Overall Study||9
6371833|NCT00736996|7282655|FG002|NOT COMPLETED|Overall Study||2
6371834|NCT00737048|7282666|FG000|STARTED|Overall Study||132
6371835|NCT00737048|7282667|FG001|STARTED|Overall Study||66
6371836|NCT00737048|7282668|FG002|STARTED|Overall Study||130
6371837|NCT00737048|7282666|FG000|COMPLETED|Overall Study||129
6371838|NCT00737048|7282667|FG001|COMPLETED|Overall Study||60
6371839|NCT00737048|7282668|FG002|COMPLETED|Overall Study||126
6371840|NCT00737048|7282666|FG000|NOT COMPLETED|Overall Study||3
6371841|NCT00737048|7282667|FG001|NOT COMPLETED|Overall Study||6
6371842|NCT00737048|7282668|FG002|NOT COMPLETED|Overall Study||4
6371843|NCT00737061|7282676|FG000|STARTED|Waiting Period||645
6371844|NCT00737061|7282676|FG000|COMPLETED|Waiting Period||570
6371845|NCT00737061|7282676|FG000|NOT COMPLETED|Waiting Period||75
6371846|NCT00737061|7282676|FG000|STARTED|1 Year Wearing Period||570
6371847|NCT00737061|7282676|FG000|COMPLETED|1 Year Wearing Period||553
6371848|NCT00737061|7282676|FG000|NOT COMPLETED|1 Year Wearing Period||17
6371849|NCT00737100|7282683|FG000|STARTED|Overall Study||168
6371850|NCT00737100|7282684|FG001|STARTED|Overall Study||166
6371851|NCT00737100|7282685|FG002|STARTED|Overall Study||176
6371852|NCT00737100|7282683|FG000|COMPLETED|Overall Study||161
6371853|NCT00737100|7282684|FG001|COMPLETED|Overall Study||159
6371854|NCT00737100|7282685|FG002|COMPLETED|Overall Study||169
6371855|NCT00737100|7282683|FG000|NOT COMPLETED|Overall Study||7
6371856|NCT00737100|7282684|FG001|NOT COMPLETED|Overall Study||7
6371857|NCT00737100|7282685|FG002|NOT COMPLETED|Overall Study||7
6371858|NCT00737178|7282697|FG000|STARTED|Overall Study||71
6371859|NCT00737178|7282698|FG001|STARTED|Overall Study||85
6371860|NCT00737178|7282697|FG000|COMPLETED|Overall Study||66
6371861|NCT00737178|7282698|FG001|COMPLETED|Overall Study||76
6371862|NCT00737178|7282697|FG000|NOT COMPLETED|Overall Study||5
6371863|NCT00737178|7282698|FG001|NOT COMPLETED|Overall Study||9
6371864|NCT00737204|7282706|FG000|STARTED|Overall Study||36
6371865|NCT00737204|7282707|FG001|STARTED|Overall Study||34
6371866|NCT00737204|7282706|FG000|COMPLETED|Overall Study||36
6371867|NCT00737204|7282707|FG001|COMPLETED|Overall Study||28
6371868|NCT00737204|7282706|FG000|NOT COMPLETED|Overall Study||0
6371869|NCT00737204|7282707|FG001|NOT COMPLETED|Overall Study||6
6371870|NCT00737243|7282713|FG000|STARTED|Overall Study||289
6371871|NCT00737243|7282713|FG000|Successful Assay Performed|Overall Study||252
6371872|NCT00737243|7282713|FG000|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
6371873|NCT00737243|7282713|FG000|Treated|Overall Study||223
6371874|NCT00737243|7282713|FG000|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
6371875|NCT00737243|7282713|FG000|Site Specific Therapy More Responsive|Overall Study||115
6371876|NCT00737243|7282713|FG000|Site Specific Therapy Less Responsive|Overall Study||79
6371877|NCT00737243|7282713|FG000|Empiric CUP Therapy|Overall Study||29
6371878|NCT00737243|7282713|FG000|COMPLETED|Overall Study||194
6371879|NCT00737243|7282713|FG000|NOT COMPLETED|Overall Study||95
6371880|NCT00737360|7282719|FG000|STARTED|Overall Study||27
6371881|NCT00737360|7282719|FG000|COMPLETED|Overall Study||27
6371882|NCT00737360|7282719|FG000|NOT COMPLETED|Overall Study||0
6371883|NCT00737438|7282723|FG000|STARTED|Overall Study||23
6371884|NCT00737438|7282723|FG000|COMPLETED|Overall Study||20
6371885|NCT00737438|7282723|FG000|NOT COMPLETED|Overall Study||3
6371886|NCT00737464|7282727|FG000|STARTED|Overall Study||132
6371887|NCT00737464|7282727|FG000|COMPLETED|Overall Study||114
6371888|NCT00737464|7282727|FG000|NOT COMPLETED|Overall Study||18
6371889|NCT00737477|7282731|FG000|STARTED|Overall Study||96
6371890|NCT00737477|7282731|FG000|COMPLETED|Overall Study||62
6371891|NCT00737477|7282731|FG000|NOT COMPLETED|Overall Study||34
6371892|NCT00737529|7282735|FG000|STARTED|Overall Study||134
6371893|NCT00737529|7282735|FG000|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 30 March 2017|1
6371894|NCT00737529|7282735|FG000|NOT COMPLETED|Overall Study||133
6371895|NCT00737568|7282741|FG000|STARTED|Treatment Period Through Week 240||141
6371896|NCT00737568|7282742|FG001|STARTED|Treatment Period Through Week 240||139
6371897|NCT00737568|7282741|FG000|COMPLETED|Treatment Period Through Week 240||121
6371898|NCT00737568|7282742|FG001|COMPLETED|Treatment Period Through Week 240||118
6371899|NCT00737568|7282741|FG000|NOT COMPLETED|Treatment Period Through Week 240||20
6371900|NCT00737568|7282742|FG001|NOT COMPLETED|Treatment Period Through Week 240||21
6371901|NCT00737568|7282741|FG000|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
6371902|NCT00737568|7282742|FG001|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
6371903|NCT00737568|7282741|FG000|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
6371904|NCT00737568|7282742|FG001|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
6371905|NCT00737568|7282741|FG000|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
6371906|NCT00737568|7282742|FG001|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
6371907|NCT00737633|7282750|FG000|STARTED|Overall Study||44
6371908|NCT00737633|7282751|FG001|STARTED|Overall Study||57
6371909|NCT00737633|7282750|FG000|COMPLETED|Overall Study||0
6371910|NCT00737633|7282751|FG001|COMPLETED|Overall Study||0
6371911|NCT00737633|7282750|FG000|NOT COMPLETED|Overall Study||44
6371912|NCT00737633|7282751|FG001|NOT COMPLETED|Overall Study||57
6371913|NCT00737672|7282759|FG000|STARTED|Overall Study||145
6371914|NCT00737672|7282760|FG001|STARTED|Overall Study||148
6371915|NCT00737672|7282759|FG000|Exclusions Due to Protocol Deviations|Overall Study||14
6561041|NCT01791153|7483983|FG006|COMPLETED|Part 2: Open-label Period||44
6561042|NCT01791153|7483984|FG007|COMPLETED|Part 2: Open-label Period||61
6561043|NCT01791153|7483977|FG000|NOT COMPLETED|Part 2: Open-label Period||0
6561044|NCT01791153|7483978|FG001|NOT COMPLETED|Part 2: Open-label Period||0
6561045|NCT01791153|7483979|FG002|NOT COMPLETED|Part 2: Open-label Period||0
6561046|NCT01791153|7483980|FG003|NOT COMPLETED|Part 2: Open-label Period||0
6561047|NCT01791153|7483981|FG004|NOT COMPLETED|Part 2: Open-label Period||2
6561048|NCT01791153|7483982|FG005|NOT COMPLETED|Part 2: Open-label Period||4
6561049|NCT01791153|7483983|FG006|NOT COMPLETED|Part 2: Open-label Period||6
6777997|NCT03793556|7705949|FG001|NOT COMPLETED|Overall Study||2
6777998|NCT03785548|7705960|FG000|STARTED|Overall Study||73
6777999|NCT03785548|7705961|FG001|STARTED|Overall Study||74
6371916|NCT00737672|7282760|FG001|Exclusions Due to Protocol Deviations|Overall Study||10
6371917|NCT00737672|7282759|FG000|Per Protocol Population|Overall Study||131
6371918|NCT00737672|7282760|FG001|Per Protocol Population|Overall Study||138
6371919|NCT00737672|7282759|FG000|COMPLETED|Overall Study||65
6371920|NCT00737672|7282760|FG001|COMPLETED|Overall Study||65
6371921|NCT00737672|7282759|FG000|NOT COMPLETED|Overall Study||80
6371922|NCT00737672|7282760|FG001|NOT COMPLETED|Overall Study||83
6371923|NCT00737698|7282769|FG000|STARTED|Overall Study||23
6371924|NCT00737698|7282770|FG001|STARTED|Overall Study||42
6371925|NCT00737698|7282771|FG002|STARTED|Overall Study||21
6371926|NCT00737698|7282769|FG000|COMPLETED|Overall Study||17
6371927|NCT00737698|7282770|FG001|COMPLETED|Overall Study||37
6371928|NCT00737698|7282771|FG002|COMPLETED|Overall Study||17
6371929|NCT00737698|7282769|FG000|NOT COMPLETED|Overall Study||6
6371930|NCT00737698|7282770|FG001|NOT COMPLETED|Overall Study||5
6371931|NCT00737698|7282771|FG002|NOT COMPLETED|Overall Study||4
6371932|NCT00737711|7282779|FG000|STARTED|Overall Study||189
6371933|NCT00737711|7282779|FG000|COMPLETED|Overall Study||158
6371934|NCT00737711|7282779|FG000|NOT COMPLETED|Overall Study||31
6371935|NCT00737737|7282785|FG000|STARTED|Overall Study||2
6371936|NCT00737737|7282786|FG001|STARTED|Overall Study||2
6371937|NCT00737737|7282785|FG000|COMPLETED|Overall Study||2
6371938|NCT00737737|7282786|FG001|COMPLETED|Overall Study||2
6371939|NCT00737737|7282785|FG000|NOT COMPLETED|Overall Study||0
6371940|NCT00737737|7282786|FG001|NOT COMPLETED|Overall Study||0
6371941|NCT00737893|7282794|FG000|STARTED|Overall Study||29
6371942|NCT00737893|7282795|FG001|STARTED|Overall Study||27
6371943|NCT00737893|7282794|FG000|COMPLETED|Overall Study||29
6371944|NCT00737893|7282795|FG001|COMPLETED|Overall Study||27
6371945|NCT00737893|7282794|FG000|NOT COMPLETED|Overall Study||0
6371946|NCT00737893|7282795|FG001|NOT COMPLETED|Overall Study||0
6371947|NCT00738023|7282803|FG000|STARTED|Intralipid Infusion||19
6371948|NCT00738023|7282804|FG001|STARTED|Intralipid Infusion||13
6371949|NCT00738023|7282803|FG000|COMPLETED|Intralipid Infusion||19
6371950|NCT00738023|7282804|FG001|COMPLETED|Intralipid Infusion||13
6371951|NCT00738023|7282803|FG000|NOT COMPLETED|Intralipid Infusion||0
6371952|NCT00738023|7282804|FG001|NOT COMPLETED|Intralipid Infusion||0
6371953|NCT00738023|7282803|FG000|STARTED|Saline Infusion||19
6371954|NCT00738023|7282804|FG001|STARTED|Saline Infusion||0
6371955|NCT00738023|7282803|FG000|COMPLETED|Saline Infusion||19
6371956|NCT00738023|7282804|FG001|COMPLETED|Saline Infusion||0
6371957|NCT00738023|7282803|FG000|NOT COMPLETED|Saline Infusion||0
6371958|NCT00738023|7282804|FG001|NOT COMPLETED|Saline Infusion||0
6778000|NCT03785548|7705960|FG000|COMPLETED|Overall Study||71
6778001|NCT03785548|7705961|FG001|COMPLETED|Overall Study||74
6778002|NCT03785548|7705960|FG000|NOT COMPLETED|Overall Study||2
6778003|NCT03785548|7705961|FG001|NOT COMPLETED|Overall Study||0
6778004|NCT03782701|7705967|FG000|STARTED|Overall Study||43
6778005|NCT03782701|7705967|FG000|Lumify|Overall Study||43
6778006|NCT03782701|7705967|FG000|Saline Solution|Overall Study||43
6778007|NCT03782701|7705967|FG000|COMPLETED|Overall Study||43
6371959|NCT00738023|7282803|FG000|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
6371960|NCT00738023|7282804|FG001|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
6371961|NCT00738023|7282803|FG000|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
6371962|NCT00738023|7282804|FG001|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
6371963|NCT00738023|7282803|FG000|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
6371964|NCT00738023|7282804|FG001|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
6371965|NCT00738049|7282813|FG000|STARTED|1st Intervention(14 Days)||13
6371966|NCT00738049|7282814|FG001|STARTED|1st Intervention(14 Days)||7
6371967|NCT00738049|7282813|FG000|COMPLETED|1st Intervention(14 Days)||13
6371968|NCT00738049|7282814|FG001|COMPLETED|1st Intervention(14 Days)||7
6371969|NCT00738049|7282813|FG000|NOT COMPLETED|1st Intervention(14 Days)||0
6371970|NCT00738049|7282814|FG001|NOT COMPLETED|1st Intervention(14 Days)||0
6371971|NCT00738049|7282813|FG000|STARTED|2nd Intervention(14 Days)||13
6371972|NCT00738049|7282814|FG001|STARTED|2nd Intervention(14 Days)||7
6561050|NCT01791153|7483984|FG007|NOT COMPLETED|Part 2: Open-label Period||6
6561051|NCT01791205|7484001|FG000|STARTED|Phase I||152
6561052|NCT01791205|7484002|FG001|STARTED|Phase I||152
6778008|NCT03782701|7705967|FG000|NOT COMPLETED|Overall Study||0
6778009|NCT03773133|7705973|FG000|STARTED|Overall Study||8
6371973|NCT00738049|7282813|FG000|COMPLETED|2nd Intervention(14 Days)||13
6371974|NCT00738049|7282814|FG001|COMPLETED|2nd Intervention(14 Days)||7
6371975|NCT00738049|7282813|FG000|NOT COMPLETED|2nd Intervention(14 Days)||0
6371976|NCT00738049|7282814|FG001|NOT COMPLETED|2nd Intervention(14 Days)||0
6371977|NCT00738049|7282813|FG000|STARTED|Washout||13
6371978|NCT00738049|7282814|FG001|STARTED|Washout||7
6371979|NCT00738049|7282813|FG000|COMPLETED|Washout||13
6371980|NCT00738049|7282814|FG001|COMPLETED|Washout||7
6371981|NCT00738049|7282813|FG000|NOT COMPLETED|Washout||0
6371982|NCT00738049|7282814|FG001|NOT COMPLETED|Washout||0
6371983|NCT00738062|7282829|FG000|STARTED|Open Label Treatment||103
6371984|NCT00738062|7282830|FG001|STARTED|Open Label Treatment||0
6371985|NCT00738062|7282831|FG002|STARTED|Open Label Treatment||0
6371986|NCT00738062|7282829|FG000|COMPLETED|Open Label Treatment||75
6371987|NCT00738062|7282830|FG001|COMPLETED|Open Label Treatment||0
6371988|NCT00738062|7282831|FG002|COMPLETED|Open Label Treatment||0
6371989|NCT00738062|7282829|FG000|NOT COMPLETED|Open Label Treatment||28
6371990|NCT00738062|7282830|FG001|NOT COMPLETED|Open Label Treatment||0
6371991|NCT00738062|7282831|FG002|NOT COMPLETED|Open Label Treatment||0
6371992|NCT00738062|7282829|FG000|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
6371993|NCT00738062|7282830|FG001|STARTED|2 Week Randomized Withdrawal||38
6561053|NCT01791205|7484001|FG000|COMPLETED|Phase I||152
6561054|NCT01791205|7484002|FG001|COMPLETED|Phase I||152
6561055|NCT01791205|7484001|FG000|NOT COMPLETED|Phase I||0
6561056|NCT01791205|7484002|FG001|NOT COMPLETED|Phase I||0
6561057|NCT01791205|7484001|FG000|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
6561058|NCT01791205|7484002|FG001|STARTED|Phase II||0
6561059|NCT01791205|7484001|FG000|COMPLETED|Phase II||92
6561060|NCT01791205|7484002|FG001|COMPLETED|Phase II||0
6371994|NCT00738062|7282831|FG002|STARTED|2 Week Randomized Withdrawal||37
6371995|NCT00738062|7282829|FG000|COMPLETED|2 Week Randomized Withdrawal||0
6371996|NCT00738062|7282830|FG001|COMPLETED|2 Week Randomized Withdrawal||38
6371997|NCT00738062|7282831|FG002|COMPLETED|2 Week Randomized Withdrawal||37
6371998|NCT00738062|7282829|FG000|NOT COMPLETED|2 Week Randomized Withdrawal||0
6371999|NCT00738062|7282830|FG001|NOT COMPLETED|2 Week Randomized Withdrawal||0
6372000|NCT00738062|7282831|FG002|NOT COMPLETED|2 Week Randomized Withdrawal||0
6372001|NCT00738062|7282829|FG000|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
6372002|NCT00738062|7282830|FG001|STARTED|Open-Label Extension||0
6372003|NCT00738062|7282831|FG002|STARTED|Open-Label Extension||0
6372004|NCT00738062|7282829|FG000|COMPLETED|Open-Label Extension||57
6372005|NCT00738062|7282830|FG001|COMPLETED|Open-Label Extension||0
6372006|NCT00738062|7282831|FG002|COMPLETED|Open-Label Extension||0
6372007|NCT00738062|7282829|FG000|NOT COMPLETED|Open-Label Extension||17
6372008|NCT00738062|7282830|FG001|NOT COMPLETED|Open-Label Extension||0
6372009|NCT00738062|7282831|FG002|NOT COMPLETED|Open-Label Extension||0
6372010|NCT00738101|7282840|FG000|STARTED|Overall Study||293
6372011|NCT00738101|7282840|FG000|COMPLETED|Overall Study|7 exclusions. 5 primary liver or unrelated disease, 1 died before Omegaven, 1 repeat enrollment|286
6372012|NCT00738101|7282840|FG000|NOT COMPLETED|Overall Study||7
6372013|NCT00738283|7282844|FG000|STARTED|Overall Study||17
6372014|NCT00738283|7282844|FG000|COMPLETED|Overall Study||13
6372015|NCT00738283|7282844|FG000|NOT COMPLETED|Overall Study||4
6372016|NCT00738361|7282848|FG000|STARTED|Overall Study||4
6372017|NCT00738361|7282848|FG000|COMPLETED|Overall Study||4
6372018|NCT00738361|7282848|FG000|NOT COMPLETED|Overall Study||0
6372019|NCT00738374|7282856|FG000|STARTED|Induction Treatment Phase||97
6372020|NCT00738374|7282857|FG001|STARTED|Induction Treatment Phase||0
6372021|NCT00738374|7282858|FG002|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
6372022|NCT00738374|7282859|FG003|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
6372023|NCT00738374|7282856|FG000|COMPLETED|Induction Treatment Phase||73
6372024|NCT00738374|7282857|FG001|COMPLETED|Induction Treatment Phase||0
6372025|NCT00738374|7282858|FG002|COMPLETED|Induction Treatment Phase||0
6372026|NCT00738374|7282859|FG003|COMPLETED|Induction Treatment Phase||0
6372027|NCT00738374|7282856|FG000|NOT COMPLETED|Induction Treatment Phase||24
6372028|NCT00738374|7282857|FG001|NOT COMPLETED|Induction Treatment Phase||0
6372029|NCT00738374|7282858|FG002|NOT COMPLETED|Induction Treatment Phase||0
6372030|NCT00738374|7282859|FG003|NOT COMPLETED|Induction Treatment Phase||0
6372031|NCT00738374|7282856|FG000|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
6372032|NCT00738374|7282857|FG001|STARTED|Maintenance Treatment/Observation Phase||7
6372033|NCT00738374|7282858|FG002|STARTED|Maintenance Treatment/Observation Phase||34
6372034|NCT00738374|7282859|FG003|STARTED|Maintenance Treatment/Observation Phase||32
6372035|NCT00738374|7282856|FG000|COMPLETED|Maintenance Treatment/Observation Phase||0
6372036|NCT00738374|7282857|FG001|COMPLETED|Maintenance Treatment/Observation Phase||0
6372037|NCT00738374|7282858|FG002|COMPLETED|Maintenance Treatment/Observation Phase||27
6372038|NCT00738374|7282859|FG003|COMPLETED|Maintenance Treatment/Observation Phase||20
6372039|NCT00738374|7282856|FG000|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
6372040|NCT00738374|7282857|FG001|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
6372041|NCT00738374|7282858|FG002|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
6372042|NCT00738374|7282859|FG003|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
6372043|NCT00738400|7282870|FG000|STARTED|Overall Study||76
6372044|NCT00738400|7282871|FG001|STARTED|Overall Study||74
6372045|NCT00738400|7282870|FG000|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
6372046|NCT00738400|7282871|FG001|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
6372047|NCT00738400|7282870|FG000|ITT (Intent To Treatment) Population|Overall Study||75
6372048|NCT00738400|7282871|FG001|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
6372049|NCT00738400|7282870|FG000|COMPLETED|Overall Study||72
6372050|NCT00738400|7282871|FG001|COMPLETED|Overall Study||67
6372051|NCT00738400|7282870|FG000|NOT COMPLETED|Overall Study||4
6372052|NCT00738400|7282871|FG001|NOT COMPLETED|Overall Study||7
6372053|NCT00738426|7282879|FG000|STARTED|Overall Study||37
6372054|NCT00738426|7282880|FG001|STARTED|Overall Study||35
6372055|NCT00738426|7282879|FG000|COMPLETED|Overall Study||35
6372056|NCT00738426|7282880|FG001|COMPLETED|Overall Study||32
6372057|NCT00738426|7282879|FG000|NOT COMPLETED|Overall Study||2
6372058|NCT00738426|7282880|FG001|NOT COMPLETED|Overall Study||3
6372059|NCT00738530|7282888|FG000|STARTED|Overall Study||327
6372060|NCT00738530|7282889|FG001|STARTED|Overall Study||322
6372061|NCT00738530|7282888|FG000|Treated|Overall Study||325
6372062|NCT00738530|7282889|FG001|Treated|Overall Study||316
6372063|NCT00738530|7282888|FG000|COMPLETED|Overall Study||93
6372064|NCT00738530|7282889|FG001|COMPLETED|Overall Study||84
6372065|NCT00738530|7282888|FG000|NOT COMPLETED|Overall Study||234
6372066|NCT00738530|7282889|FG001|NOT COMPLETED|Overall Study||238
6372067|NCT00738543|7282895|FG000|STARTED|Povidone Iodine||48
6372068|NCT00738543|7282895|FG000|COMPLETED|Povidone Iodine||48
6372069|NCT00738543|7282895|FG000|NOT COMPLETED|Povidone Iodine||0
6372070|NCT00738543|7282895|FG000|STARTED|Sodium Hypochlorite||48
6372071|NCT00738543|7282895|FG000|COMPLETED|Sodium Hypochlorite||48
6372072|NCT00738543|7282895|FG000|NOT COMPLETED|Sodium Hypochlorite||0
6372073|NCT00738543|7282895|FG000|STARTED|Control||48
6372074|NCT00738543|7282895|FG000|COMPLETED|Control||48
6372075|NCT00738543|7282895|FG000|NOT COMPLETED|Control||0
6372076|NCT00738673|7282901|FG000|STARTED|Overall Study||25
6372077|NCT00738673|7282902|FG001|STARTED|Overall Study||12
6372078|NCT00738673|7282901|FG000|Intent to Treat Population|Overall Study||24
6372079|NCT00738673|7282902|FG001|Intent to Treat Population|Overall Study||12
6372080|NCT00738673|7282901|FG000|COMPLETED|Overall Study||1
6372081|NCT00738673|7282902|FG001|COMPLETED|Overall Study||1
6372082|NCT00738673|7282901|FG000|NOT COMPLETED|Overall Study||24
6372083|NCT00738673|7282902|FG001|NOT COMPLETED|Overall Study||11
6372084|NCT00738699|7282910|FG000|STARTED|Overall Study||275
6372085|NCT00738699|7282911|FG001|STARTED|Overall Study||140
6372086|NCT00738699|7282910|FG000|Participants Not Treated|Overall Study||2
6372087|NCT00738699|7282911|FG001|Participants Not Treated|Overall Study||1
6372088|NCT00738699|7282910|FG000|Participants Treated|Overall Study||273
6372089|NCT00738699|7282911|FG001|Participants Treated|Overall Study||139
6372090|NCT00738699|7282910|FG000|COMPLETED|Overall Study||0
6372091|NCT00738699|7282911|FG001|COMPLETED|Overall Study||0
6372092|NCT00738699|7282910|FG000|NOT COMPLETED|Overall Study||275
6372093|NCT00738699|7282911|FG001|NOT COMPLETED|Overall Study||140
6372094|NCT00738881|7282919|FG000|STARTED|Overall Study||11
6372095|NCT00738881|7282920|FG001|STARTED|Overall Study||12
6372096|NCT00738881|7282919|FG000|COMPLETED|Overall Study||11
6372097|NCT00738881|7282920|FG001|COMPLETED|Overall Study||10
6372098|NCT00738881|7282919|FG000|NOT COMPLETED|Overall Study||0
6372099|NCT00738881|7282920|FG001|NOT COMPLETED|Overall Study||2
6372100|NCT00738894|7282928|FG000|STARTED|Overall Study||441
6372101|NCT00738894|7282929|FG001|STARTED|Overall Study||223
6372102|NCT00738894|7282928|FG000|COMPLETED|Overall Study||402
6372103|NCT00738894|7282929|FG001|COMPLETED|Overall Study||190
6372104|NCT00738894|7282928|FG000|NOT COMPLETED|Overall Study||39
6372105|NCT00738894|7282929|FG001|NOT COMPLETED|Overall Study||33
6372106|NCT00739102|7282935|FG000|STARTED|Overall Study||250
6372107|NCT00739102|7282935|FG000|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
6372108|NCT00739102|7282935|FG000|NOT COMPLETED|Overall Study||15
6372109|NCT00739297|7282939|FG000|STARTED|First Intervention (Visit 3 to Visit 4)||17
6372110|NCT00739297|7282940|FG001|STARTED|First Intervention (Visit 3 to Visit 4)||11
6372111|NCT00739297|7282941|FG002|STARTED|First Intervention (Visit 3 to Visit 4)||6
6372112|NCT00739297|7282942|FG003|STARTED|First Intervention (Visit 3 to Visit 4)||19
6372113|NCT00739297|7282943|FG004|STARTED|First Intervention (Visit 3 to Visit 4)||6
6372114|NCT00739297|7282944|FG005|STARTED|First Intervention (Visit 3 to Visit 4)||9
6372115|NCT00739297|7282945|FG006|STARTED|First Intervention (Visit 3 to Visit 4)||68
6372116|NCT00739297|7282939|FG000|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
6372117|NCT00739297|7282940|FG001|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
6372118|NCT00739297|7282941|FG002|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
6372119|NCT00739297|7282942|FG003|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
6372120|NCT00739297|7282943|FG004|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
6372121|NCT00739297|7282944|FG005|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
6372122|NCT00739297|7282945|FG006|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
6372123|NCT00739297|7282939|FG000|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6372124|NCT00739297|7282940|FG001|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6372125|NCT00739297|7282941|FG002|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6372126|NCT00739297|7282942|FG003|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6372127|NCT00739297|7282943|FG004|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6372128|NCT00739297|7282944|FG005|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6372129|NCT00739297|7282945|FG006|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
6372130|NCT00739297|7282939|FG000|STARTED|First Washout Period of 4-7 Days||17
6372131|NCT00739297|7282940|FG001|STARTED|First Washout Period of 4-7 Days||11
6372132|NCT00739297|7282941|FG002|STARTED|First Washout Period of 4-7 Days||6
6372133|NCT00739297|7282942|FG003|STARTED|First Washout Period of 4-7 Days||19
6372134|NCT00739297|7282943|FG004|STARTED|First Washout Period of 4-7 Days||6
6372135|NCT00739297|7282944|FG005|STARTED|First Washout Period of 4-7 Days||9
6372136|NCT00739297|7282945|FG006|STARTED|First Washout Period of 4-7 Days||68
6372137|NCT00739297|7282939|FG000|COMPLETED|First Washout Period of 4-7 Days||17
6372138|NCT00739297|7282940|FG001|COMPLETED|First Washout Period of 4-7 Days||11
6372139|NCT00739297|7282941|FG002|COMPLETED|First Washout Period of 4-7 Days||6
6372140|NCT00739297|7282942|FG003|COMPLETED|First Washout Period of 4-7 Days||17
6372141|NCT00739297|7282943|FG004|COMPLETED|First Washout Period of 4-7 Days||6
6372142|NCT00739297|7282944|FG005|COMPLETED|First Washout Period of 4-7 Days||9
6372143|NCT00739297|7282945|FG006|COMPLETED|First Washout Period of 4-7 Days||66
6372144|NCT00739297|7282939|FG000|NOT COMPLETED|First Washout Period of 4-7 Days||0
6372145|NCT00739297|7282940|FG001|NOT COMPLETED|First Washout Period of 4-7 Days||0
6372146|NCT00739297|7282941|FG002|NOT COMPLETED|First Washout Period of 4-7 Days||0
6372147|NCT00739297|7282942|FG003|NOT COMPLETED|First Washout Period of 4-7 Days||2
6372148|NCT00739297|7282943|FG004|NOT COMPLETED|First Washout Period of 4-7 Days||0
6372149|NCT00739297|7282944|FG005|NOT COMPLETED|First Washout Period of 4-7 Days||0
6372150|NCT00739297|7282945|FG006|NOT COMPLETED|First Washout Period of 4-7 Days||2
6372151|NCT00739297|7282939|FG000|STARTED|Second Intervention (Visit 5 to Visit 6)||18
6372152|NCT00739297|7282940|FG001|STARTED|Second Intervention (Visit 5 to Visit 6)||8
6372153|NCT00739297|7282941|FG002|STARTED|Second Intervention (Visit 5 to Visit 6)||10
6372154|NCT00739297|7282942|FG003|STARTED|Second Intervention (Visit 5 to Visit 6)||14
6372155|NCT00739297|7282943|FG004|STARTED|Second Intervention (Visit 5 to Visit 6)||6
6372156|NCT00739297|7282944|FG005|STARTED|Second Intervention (Visit 5 to Visit 6)||10
6372157|NCT00739297|7282945|FG006|STARTED|Second Intervention (Visit 5 to Visit 6)||66
6372158|NCT00739297|7282939|FG000|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
6372159|NCT00739297|7282940|FG001|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
6372160|NCT00739297|7282941|FG002|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
6372161|NCT00739297|7282942|FG003|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
6372162|NCT00739297|7282943|FG004|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
6372163|NCT00739297|7282944|FG005|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
6372164|NCT00739297|7282945|FG006|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
6372165|NCT00739297|7282939|FG000|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6372166|NCT00739297|7282940|FG001|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6372167|NCT00739297|7282941|FG002|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6372168|NCT00739297|7282942|FG003|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6372169|NCT00739297|7282943|FG004|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6372170|NCT00739297|7282944|FG005|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6372171|NCT00739297|7282945|FG006|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
6372172|NCT00739297|7282939|FG000|STARTED|Second Washout Period of 4-7 Days||18
6372173|NCT00739297|7282940|FG001|STARTED|Second Washout Period of 4-7 Days||8
6372174|NCT00739297|7282941|FG002|STARTED|Second Washout Period of 4-7 Days||10
6372175|NCT00739297|7282942|FG003|STARTED|Second Washout Period of 4-7 Days||14
6372176|NCT00739297|7282943|FG004|STARTED|Second Washout Period of 4-7 Days||6
6372177|NCT00739297|7282944|FG005|STARTED|Second Washout Period of 4-7 Days||10
6372178|NCT00739297|7282945|FG006|STARTED|Second Washout Period of 4-7 Days||66
6372179|NCT00739297|7282939|FG000|COMPLETED|Second Washout Period of 4-7 Days||18
6372180|NCT00739297|7282940|FG001|COMPLETED|Second Washout Period of 4-7 Days||8
6372181|NCT00739297|7282941|FG002|COMPLETED|Second Washout Period of 4-7 Days||10
6372182|NCT00739297|7282942|FG003|COMPLETED|Second Washout Period of 4-7 Days||14
6372183|NCT00739297|7282943|FG004|COMPLETED|Second Washout Period of 4-7 Days||6
6372184|NCT00739297|7282944|FG005|COMPLETED|Second Washout Period of 4-7 Days||10
6372185|NCT00739297|7282945|FG006|COMPLETED|Second Washout Period of 4-7 Days||66
6372186|NCT00739297|7282939|FG000|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6372187|NCT00739297|7282940|FG001|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6372188|NCT00739297|7282941|FG002|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6778010|NCT03773133|7705973|FG000|Received the Screening IIP|Overall Study||8
6778011|NCT03773133|7705973|FG000|Received the Therapeutic IRPP|Overall Study||0
6778012|NCT03773133|7705973|FG000|COMPLETED|Overall Study||0
6778013|NCT03773133|7705973|FG000|NOT COMPLETED|Overall Study||8
6778014|NCT03792672|7705978|FG000|STARTED|Treatment Period 1 (1 Day)||4
6372189|NCT00739297|7282942|FG003|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6372190|NCT00739297|7282943|FG004|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6372191|NCT00739297|7282944|FG005|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6372192|NCT00739297|7282945|FG006|NOT COMPLETED|Second Washout Period of 4-7 Days||0
6372193|NCT00739297|7282939|FG000|STARTED|Third Intervention (Visit 7 to Visit 8)||16
6377790|NCT00765206|7288461|FG000|NOT COMPLETED|First Intervention||0
6778015|NCT03792672|7705979|FG001|STARTED|Treatment Period 1 (1 Day)||4
6372194|NCT00739297|7282940|FG001|STARTED|Third Intervention (Visit 7 to Visit 8)||12
6372195|NCT00739297|7282941|FG002|STARTED|Third Intervention (Visit 7 to Visit 8)||6
6372196|NCT00739297|7282942|FG003|STARTED|Third Intervention (Visit 7 to Visit 8)||18
6372197|NCT00739297|7282943|FG004|STARTED|Third Intervention (Visit 7 to Visit 8)||6
6372198|NCT00739297|7282944|FG005|STARTED|Third Intervention (Visit 7 to Visit 8)||8
6372199|NCT00739297|7282945|FG006|STARTED|Third Intervention (Visit 7 to Visit 8)||66
6372200|NCT00739297|7282939|FG000|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
6372201|NCT00739297|7282940|FG001|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
6372202|NCT00739297|7282941|FG002|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
6372203|NCT00739297|7282942|FG003|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
6372204|NCT00739297|7282943|FG004|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
6372205|NCT00739297|7282944|FG005|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
6372206|NCT00739297|7282945|FG006|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
6372207|NCT00739297|7282939|FG000|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6372208|NCT00739297|7282940|FG001|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6372209|NCT00739297|7282941|FG002|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6372210|NCT00739297|7282942|FG003|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6372211|NCT00739297|7282943|FG004|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6372212|NCT00739297|7282944|FG005|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6372213|NCT00739297|7282945|FG006|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
6372214|NCT00739297|7282939|FG000|STARTED|Third Washout Period of 4-7 Days||16
6372215|NCT00739297|7282940|FG001|STARTED|Third Washout Period of 4-7 Days||12
6372216|NCT00739297|7282941|FG002|STARTED|Third Washout Period of 4-7 Days||6
6372217|NCT00739297|7282942|FG003|STARTED|Third Washout Period of 4-7 Days||18
6372218|NCT00739297|7282943|FG004|STARTED|Third Washout Period of 4-7 Days||6
6372219|NCT00739297|7282944|FG005|STARTED|Third Washout Period of 4-7 Days||8
6372220|NCT00739297|7282945|FG006|STARTED|Third Washout Period of 4-7 Days||66
6372221|NCT00739297|7282939|FG000|COMPLETED|Third Washout Period of 4-7 Days||16
6372222|NCT00739297|7282940|FG001|COMPLETED|Third Washout Period of 4-7 Days||12
6372223|NCT00739297|7282941|FG002|COMPLETED|Third Washout Period of 4-7 Days||6
6372224|NCT00739297|7282942|FG003|COMPLETED|Third Washout Period of 4-7 Days||18
6372225|NCT00739297|7282943|FG004|COMPLETED|Third Washout Period of 4-7 Days||6
6372226|NCT00739297|7282944|FG005|COMPLETED|Third Washout Period of 4-7 Days||8
6372227|NCT00739297|7282945|FG006|COMPLETED|Third Washout Period of 4-7 Days||66
6372228|NCT00739297|7282939|FG000|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6372229|NCT00739297|7282940|FG001|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6372230|NCT00739297|7282941|FG002|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6372231|NCT00739297|7282942|FG003|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6372232|NCT00739297|7282943|FG004|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6372233|NCT00739297|7282944|FG005|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6372234|NCT00739297|7282945|FG006|NOT COMPLETED|Third Washout Period of 4-7 Days||0
6372235|NCT00739297|7282939|FG000|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
6372236|NCT00739297|7282940|FG001|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
6372237|NCT00739297|7282941|FG002|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
6372238|NCT00739297|7282942|FG003|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
6372239|NCT00739297|7282943|FG004|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
6372240|NCT00739297|7282944|FG005|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
6372241|NCT00739297|7282945|FG006|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
6372242|NCT00739297|7282939|FG000|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
6372243|NCT00739297|7282940|FG001|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
6372244|NCT00739297|7282941|FG002|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
6372245|NCT00739297|7282942|FG003|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
6372246|NCT00739297|7282943|FG004|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
6372247|NCT00739297|7282944|FG005|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
6372248|NCT00739297|7282945|FG006|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
6372249|NCT00739297|7282939|FG000|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6372250|NCT00739297|7282940|FG001|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6372251|NCT00739297|7282941|FG002|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6778016|NCT03792672|7705980|FG002|STARTED|Treatment Period 1 (1 Day)||4
6778017|NCT03792672|7705981|FG003|STARTED|Treatment Period 1 (1 Day)||4
6778018|NCT03792672|7705982|FG004|STARTED|Treatment Period 1 (1 Day)||4
6778019|NCT03792672|7705983|FG005|STARTED|Treatment Period 1 (1 Day)||4
6778020|NCT03792672|7705978|FG000|COMPLETED|Treatment Period 1 (1 Day)||4
6778021|NCT03792672|7705979|FG001|COMPLETED|Treatment Period 1 (1 Day)||4
6778022|NCT03792672|7705980|FG002|COMPLETED|Treatment Period 1 (1 Day)||4
6778023|NCT03792672|7705981|FG003|COMPLETED|Treatment Period 1 (1 Day)||4
6778024|NCT03792672|7705982|FG004|COMPLETED|Treatment Period 1 (1 Day)||4
6778025|NCT03792672|7705983|FG005|COMPLETED|Treatment Period 1 (1 Day)||4
6778026|NCT03792672|7705978|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6778027|NCT03792672|7705979|FG001|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6778028|NCT03792672|7705980|FG002|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6778029|NCT03792672|7705981|FG003|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6778030|NCT03792672|7705982|FG004|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6778031|NCT03792672|7705983|FG005|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6778032|NCT03792672|7705978|FG000|STARTED|Washout Period 1 (10 Days)||4
6372252|NCT00739297|7282942|FG003|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6372253|NCT00739297|7282943|FG004|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
6372254|NCT00739297|7282944|FG005|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
6372255|NCT00739297|7282945|FG006|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
6372256|NCT00739310|7282961|FG000|STARTED|Overall Study||29
6372257|NCT00739310|7282961|FG000|COMPLETED|Overall Study||22
6372258|NCT00739310|7282961|FG000|NOT COMPLETED|Overall Study||7
6372259|NCT00739336|7282968|FG000|STARTED|Overall Study||21
6372260|NCT00739336|7282969|FG001|STARTED|Overall Study||24
6372261|NCT00739336|7282968|FG000|COMPLETED|Overall Study||17
6372262|NCT00739336|7282969|FG001|COMPLETED|Overall Study||24
6372263|NCT00739336|7282968|FG000|NOT COMPLETED|Overall Study||4
6372264|NCT00739336|7282969|FG001|NOT COMPLETED|Overall Study||0
6372265|NCT00739583|7282977|FG000|STARTED|Overall Study||10
6372266|NCT00739583|7282978|FG001|STARTED|Overall Study||10
6372267|NCT00739583|7282977|FG000|COMPLETED|Overall Study||10
6372268|NCT00739583|7282978|FG001|COMPLETED|Overall Study||10
6372269|NCT00739583|7282977|FG000|NOT COMPLETED|Overall Study||0
6372270|NCT00739583|7282978|FG001|NOT COMPLETED|Overall Study||0
6372271|NCT00739596|7282986|FG000|STARTED|Overall Study||166
6372272|NCT00739596|7282987|FG001|STARTED|Overall Study||166
6372273|NCT00739596|7282986|FG000|COMPLETED|Overall Study||141
6372274|NCT00739596|7282987|FG001|COMPLETED|Overall Study||149
6372275|NCT00739596|7282986|FG000|NOT COMPLETED|Overall Study||25
6372276|NCT00739596|7282987|FG001|NOT COMPLETED|Overall Study||17
6372277|NCT00739648|7282995|FG000|STARTED|Overall Study||108
6372278|NCT00739648|7282996|FG001|STARTED|Overall Study||214
6372279|NCT00739648|7282995|FG000|COMPLETED|Overall Study||82
6372280|NCT00739648|7282996|FG001|COMPLETED|Overall Study||161
6372281|NCT00739648|7282995|FG000|NOT COMPLETED|Overall Study||26
6372282|NCT00739648|7282996|FG001|NOT COMPLETED|Overall Study||53
6372283|NCT00739661|7283008|FG000|STARTED|Overall Study||52
6372284|NCT00739661|7283009|FG001|STARTED|Overall Study||52
6372285|NCT00739661|7283008|FG000|COMPLETED|Overall Study||6
6372286|NCT00739661|7283009|FG001|COMPLETED|Overall Study||10
6372287|NCT00739661|7283008|FG000|NOT COMPLETED|Overall Study||46
6372288|NCT00739661|7283009|FG001|NOT COMPLETED|Overall Study||42
6372289|NCT00739752|7283021|FG000|STARTED|Overall Study||299
6372290|NCT00739752|7283022|FG001|STARTED|Overall Study||284
6372291|NCT00739752|7283023|FG002|STARTED|Overall Study||292
6372292|NCT00739752|7283024|FG003|STARTED|Overall Study||288
6372293|NCT00739752|7283025|FG004|STARTED|Overall Study||291
6372294|NCT00739752|7283026|FG005|STARTED|Overall Study||293
6372295|NCT00739752|7283021|FG000|COMPLETED|Overall Study||299
6372296|NCT00739752|7283022|FG001|COMPLETED|Overall Study||284
6372297|NCT00739752|7283023|FG002|COMPLETED|Overall Study||292
6372298|NCT00739752|7283024|FG003|COMPLETED|Overall Study||288
6372299|NCT00739752|7283025|FG004|COMPLETED|Overall Study||291
6372300|NCT00739752|7283026|FG005|COMPLETED|Overall Study||293
6372301|NCT00739752|7283021|FG000|NOT COMPLETED|Overall Study||0
6372302|NCT00739752|7283022|FG001|NOT COMPLETED|Overall Study||0
6372303|NCT00739752|7283023|FG002|NOT COMPLETED|Overall Study||0
6372304|NCT00739752|7283024|FG003|NOT COMPLETED|Overall Study||0
6372305|NCT00739752|7283025|FG004|NOT COMPLETED|Overall Study||0
6372306|NCT00739752|7283026|FG005|NOT COMPLETED|Overall Study||0
6372307|NCT00739765|7283043|FG000|STARTED|Overall Study||40
6372308|NCT00739765|7283044|FG001|STARTED|Overall Study||38
6372309|NCT00739765|7283045|FG002|STARTED|Overall Study||32
6372310|NCT00739765|7283043|FG000|COMPLETED|Overall Study||34
6372311|NCT00739765|7283044|FG001|COMPLETED|Overall Study||27
6372312|NCT00739765|7283045|FG002|COMPLETED|Overall Study||21
6372313|NCT00739765|7283043|FG000|NOT COMPLETED|Overall Study||6
6372314|NCT00739765|7283044|FG001|NOT COMPLETED|Overall Study||11
6372315|NCT00739765|7283045|FG002|NOT COMPLETED|Overall Study||11
6372316|NCT00739908|7283055|FG000|STARTED|Overall Study||142
6372317|NCT00739908|7283056|FG001|STARTED|Overall Study||143
6561061|NCT01791205|7484001|FG000|NOT COMPLETED|Phase II||12
6561062|NCT01791205|7484002|FG001|NOT COMPLETED|Phase II||0
6372318|NCT00739908|7283055|FG000|COMPLETED|Overall Study||117
6372319|NCT00739908|7283056|FG001|COMPLETED|Overall Study||118
6372320|NCT00739908|7283055|FG000|NOT COMPLETED|Overall Study||25
6372321|NCT00739908|7283056|FG001|NOT COMPLETED|Overall Study||25
6372322|NCT00739934|7283064|FG000|STARTED|Voriconazole IV||40
6372323|NCT00739934|7283064|FG000|COMPLETED|Voriconazole IV||34
6372324|NCT00739934|7283064|FG000|NOT COMPLETED|Voriconazole IV||6
6372325|NCT00739934|7283064|FG000|STARTED|Voriconazole Oral||34
6372326|NCT00739934|7283064|FG000|COMPLETED|Voriconazole Oral||31
6372327|NCT00739934|7283064|FG000|NOT COMPLETED|Voriconazole Oral||3
6372328|NCT00739960|7283073|FG000|STARTED|Overall Study||1
6372329|NCT00739960|7283073|FG000|COMPLETED|Overall Study||1
6372330|NCT00739960|7283073|FG000|NOT COMPLETED|Overall Study||0
6372331|NCT00739973|7283086|FG000|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
6372332|NCT00739973|7283087|FG001|STARTED|Single-blind Period (2 to 4 Weeks)||0
6372333|NCT00739973|7283088|FG002|STARTED|Single-blind Period (2 to 4 Weeks)||0
6372334|NCT00739973|7283089|FG003|STARTED|Single-blind Period (2 to 4 Weeks)||0
6372335|NCT00739973|7283090|FG004|STARTED|Single-blind Period (2 to 4 Weeks)||0
6372336|NCT00739973|7283091|FG005|STARTED|Single-blind Period (2 to 4 Weeks)||0
6372337|NCT00739973|7283092|FG006|STARTED|Single-blind Period (2 to 4 Weeks)||0
6372338|NCT00739973|7283093|FG007|STARTED|Single-blind Period (2 to 4 Weeks)||0
6372339|NCT00739973|7283094|FG008|STARTED|Single-blind Period (2 to 4 Weeks)||0
6372340|NCT00739973|7283086|FG000|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
6372341|NCT00739973|7283087|FG001|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372342|NCT00739973|7283088|FG002|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372343|NCT00739973|7283089|FG003|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372344|NCT00739973|7283090|FG004|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372345|NCT00739973|7283091|FG005|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372346|NCT00739973|7283092|FG006|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372347|NCT00739973|7283093|FG007|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372348|NCT00739973|7283094|FG008|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372349|NCT00739973|7283086|FG000|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
6372350|NCT00739973|7283087|FG001|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372351|NCT00739973|7283088|FG002|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372352|NCT00739973|7283089|FG003|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372353|NCT00739973|7283090|FG004|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372354|NCT00739973|7283091|FG005|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372355|NCT00739973|7283092|FG006|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372356|NCT00739973|7283093|FG007|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372357|NCT00739973|7283094|FG008|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
6372358|NCT00739973|7283086|FG000|STARTED|Double-blind:Randomized Period (8 Weeks)||198
6372359|NCT00739973|7283087|FG001|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
6372360|NCT00739973|7283088|FG002|STARTED|Double-blind:Randomized Period (8 Weeks)||203
6372361|NCT00739973|7283089|FG003|STARTED|Double-blind:Randomized Period (8 Weeks)||185
6372362|NCT00739973|7283090|FG004|STARTED|Double-blind:Randomized Period (8 Weeks)||181
6372363|NCT00739973|7283091|FG005|STARTED|Double-blind:Randomized Period (8 Weeks)||181
6372364|NCT00739973|7283092|FG006|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
6372365|NCT00739973|7283093|FG007|STARTED|Double-blind:Randomized Period (8 Weeks)||178
6372366|NCT00739973|7283094|FG008|STARTED|Double-blind:Randomized Period (8 Weeks)||184
6372367|NCT00739973|7283086|FG000|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
6372368|NCT00739973|7283087|FG001|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
6372369|NCT00739973|7283088|FG002|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
6372370|NCT00739973|7283089|FG003|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
6372371|NCT00739973|7283090|FG004|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
6372372|NCT00739973|7283091|FG005|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
6372373|NCT00739973|7283092|FG006|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
6372374|NCT00739973|7283093|FG007|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
6372375|NCT00739973|7283094|FG008|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
6372376|NCT00739973|7283086|FG000|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
6372377|NCT00739973|7283087|FG001|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
6372378|NCT00739973|7283088|FG002|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
6372379|NCT00739973|7283089|FG003|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
6372380|NCT00739973|7283090|FG004|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
6372381|NCT00739973|7283091|FG005|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
6372382|NCT00739973|7283092|FG006|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
6372383|NCT00739973|7283093|FG007|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
6372384|NCT00739973|7283094|FG008|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
6372385|NCT00739999|7283124|FG000|STARTED|Overall Study||15
6372386|NCT00739999|7283125|FG001|STARTED|Overall Study||24
6372387|NCT00739999|7283124|FG000|COMPLETED|Overall Study||15
6372388|NCT00739999|7283125|FG001|COMPLETED|Overall Study||24
6372389|NCT00739999|7283124|FG000|NOT COMPLETED|Overall Study||0
6372390|NCT00739999|7283125|FG001|NOT COMPLETED|Overall Study||0
6372391|NCT00740051|7283138|FG000|STARTED|Overall Study||76
6372392|NCT00740051|7283139|FG001|STARTED|Overall Study||151
6372393|NCT00740051|7283138|FG000|COMPLETED|Overall Study||58
6372394|NCT00740051|7283139|FG001|COMPLETED|Overall Study||119
6372395|NCT00740051|7283138|FG000|NOT COMPLETED|Overall Study||18
6372396|NCT00740051|7283139|FG001|NOT COMPLETED|Overall Study||32
6372397|NCT00740129|7283146|FG000|STARTED|Overall Study||6
6372398|NCT00740129|7283146|FG000|COMPLETED|Overall Study||6
6372399|NCT00740129|7283146|FG000|NOT COMPLETED|Overall Study||0
6372400|NCT00740207|7283153|FG000|STARTED|Overall Study||17
6372401|NCT00740207|7283154|FG001|STARTED|Overall Study||16
6372402|NCT00740207|7283153|FG000|COMPLETED|Overall Study||17
6372403|NCT00740207|7283154|FG001|COMPLETED|Overall Study||16
6372404|NCT00740207|7283153|FG000|NOT COMPLETED|Overall Study||0
6372405|NCT00740207|7283154|FG001|NOT COMPLETED|Overall Study||0
6372406|NCT00740220|7283164|FG000|STARTED|Overall Study||97
6372407|NCT00740220|7283164|FG000|COMPLETED|Overall Study||88
6372408|NCT00740220|7283164|FG000|NOT COMPLETED|Overall Study||9
6372409|NCT00740376|7283170|FG000|STARTED|Overall Study||22
6372410|NCT00740376|7283171|FG001|STARTED|Overall Study||15
6372411|NCT00740376|7283170|FG000|COMPLETED|Overall Study||19
6372412|NCT00740376|7283171|FG001|COMPLETED|Overall Study||12
6372413|NCT00740376|7283170|FG000|NOT COMPLETED|Overall Study||3
6372414|NCT00740376|7283171|FG001|NOT COMPLETED|Overall Study||3
6377791|NCT00765206|7288462|FG001|NOT COMPLETED|First Intervention||0
6372415|NCT00740584|7283177|FG000|STARTED|Overall Study||12
6372416|NCT00740584|7283177|FG000|COMPLETED|Overall Study||11
6372417|NCT00740584|7283177|FG000|NOT COMPLETED|Overall Study||1
6372418|NCT00740636|7283184|FG000|STARTED|Overall Study||25
6372419|NCT00740636|7283185|FG001|STARTED|Overall Study||67
6372420|NCT00740636|7283184|FG000|COMPLETED|Overall Study||23
6372421|NCT00740636|7283185|FG001|COMPLETED|Overall Study||63
6372422|NCT00740636|7283184|FG000|NOT COMPLETED|Overall Study||2
6372423|NCT00740636|7283185|FG001|NOT COMPLETED|Overall Study||4
6372424|NCT00740714|7283194|FG000|STARTED|Overall Study|Randomized throughout the recruitment period|196
6372425|NCT00740714|7283195|FG001|STARTED|Overall Study|Randomized throughout the recruitment period|201
6372426|NCT00740714|7283196|FG002|STARTED|Overall Study|Randomized throughout the recruitment period|203
6372427|NCT00740714|7283194|FG000|Reaching Endpoint Before May 6, 2011|Overall Study||86
6372428|NCT00740714|7283195|FG001|Reaching Endpoint Before May 6, 2011|Overall Study||87
6372429|NCT00740714|7283196|FG002|Reaching Endpoint Before May 6, 2011|Overall Study||94
6372430|NCT00740714|7283194|FG000|Active Patients at Study Termination|Overall Study||24
6372431|NCT00740714|7283195|FG001|Active Patients at Study Termination|Overall Study||12
6372432|NCT00740714|7283196|FG002|Active Patients at Study Termination|Overall Study||33
6372433|NCT00740714|7283194|FG000|COMPLETED|Overall Study||179
6372434|NCT00740714|7283195|FG001|COMPLETED|Overall Study||182
6372435|NCT00740714|7283196|FG002|COMPLETED|Overall Study||174
6372436|NCT00740714|7283194|FG000|NOT COMPLETED|Overall Study||17
6372437|NCT00740714|7283195|FG001|NOT COMPLETED|Overall Study||19
6372438|NCT00740714|7283196|FG002|NOT COMPLETED|Overall Study||29
6372439|NCT00740779|7283207|FG000|STARTED|Overall Study||52
6372440|NCT00740779|7283208|FG001|STARTED|Overall Study||45
6372441|NCT00740779|7283209|FG002|STARTED|Overall Study||54
6372442|NCT00740779|7283207|FG000|COMPLETED|Overall Study||43
6372443|NCT00740779|7283208|FG001|COMPLETED|Overall Study||31
6372444|NCT00740779|7283209|FG002|COMPLETED|Overall Study||41
6372445|NCT00740779|7283207|FG000|NOT COMPLETED|Overall Study||9
6372446|NCT00740779|7283208|FG001|NOT COMPLETED|Overall Study||14
6372447|NCT00740779|7283209|FG002|NOT COMPLETED|Overall Study||13
6372448|NCT00740792|7283221|FG000|STARTED|Overall Study||193
6372449|NCT00740792|7283222|FG001|STARTED|Overall Study||194
6372450|NCT00740792|7283223|FG002|STARTED|Overall Study||189
6372451|NCT00740792|7283224|FG003|STARTED|Overall Study||200
6372452|NCT00740792|7283221|FG000|COMPLETED|Overall Study||183
6372453|NCT00740792|7283222|FG001|COMPLETED|Overall Study||186
6372454|NCT00740792|7283223|FG002|COMPLETED|Overall Study||180
6372455|NCT00740792|7283224|FG003|COMPLETED|Overall Study||190
6372456|NCT00740792|7283221|FG000|NOT COMPLETED|Overall Study||10
6372457|NCT00740792|7283222|FG001|NOT COMPLETED|Overall Study||8
6372458|NCT00740792|7283223|FG002|NOT COMPLETED|Overall Study||9
6372459|NCT00740792|7283224|FG003|NOT COMPLETED|Overall Study||10
6372460|NCT00740831|7283237|FG000|STARTED|Overall Study|Safety population|97
6372461|NCT00740831|7283238|FG001|STARTED|Overall Study|Safety population|103
6372462|NCT00740831|7283239|FG002|STARTED|Overall Study|Safety population|101
6372463|NCT00740831|7283237|FG000|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
6655278|NCT02452060|7585372|FG001|NOT COMPLETED|Overall Study||0
6655279|NCT02452190|7585380|FG000|STARTED|Overall Study||232
6655280|NCT02452190|7585381|FG001|STARTED|Overall Study||236
6655281|NCT02452190|7585380|FG000|Intent to Treat (ITT) Population|Overall Study||230
6655282|NCT02452190|7585381|FG001|Intent to Treat (ITT) Population|Overall Study||234
6655283|NCT02452190|7585380|FG000|Safety Population|Overall Study||231
6655284|NCT02452190|7585381|FG001|Safety Population|Overall Study||237
6778033|NCT03792672|7705979|FG001|STARTED|Washout Period 1 (10 Days)||4
6778034|NCT03792672|7705980|FG002|STARTED|Washout Period 1 (10 Days)||4
6778035|NCT03792672|7705981|FG003|STARTED|Washout Period 1 (10 Days)||4
6778036|NCT03792672|7705982|FG004|STARTED|Washout Period 1 (10 Days)||4
6778037|NCT03792672|7705983|FG005|STARTED|Washout Period 1 (10 Days)||4
6778038|NCT03792672|7705978|FG000|COMPLETED|Washout Period 1 (10 Days)||4
6778039|NCT03792672|7705979|FG001|COMPLETED|Washout Period 1 (10 Days)||4
6778040|NCT03792672|7705980|FG002|COMPLETED|Washout Period 1 (10 Days)||4
6778041|NCT03792672|7705981|FG003|COMPLETED|Washout Period 1 (10 Days)||4
6778042|NCT03792672|7705982|FG004|COMPLETED|Washout Period 1 (10 Days)||4
6778043|NCT03792672|7705983|FG005|COMPLETED|Washout Period 1 (10 Days)||4
6778044|NCT03792672|7705978|FG000|NOT COMPLETED|Washout Period 1 (10 Days)||0
6778045|NCT03792672|7705979|FG001|NOT COMPLETED|Washout Period 1 (10 Days)||0
6778046|NCT03792672|7705980|FG002|NOT COMPLETED|Washout Period 1 (10 Days)||0
6778047|NCT03792672|7705981|FG003|NOT COMPLETED|Washout Period 1 (10 Days)||0
6778048|NCT03792672|7705982|FG004|NOT COMPLETED|Washout Period 1 (10 Days)||0
6778049|NCT03792672|7705983|FG005|NOT COMPLETED|Washout Period 1 (10 Days)||0
6372464|NCT00740831|7283238|FG001|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
6655285|NCT02452190|7585380|FG000|COMPLETED|Overall Study||197
6655286|NCT02452190|7585381|FG001|COMPLETED|Overall Study||212
6655287|NCT02452190|7585380|FG000|NOT COMPLETED|Overall Study||35
6655288|NCT02452190|7585381|FG001|NOT COMPLETED|Overall Study||24
6655289|NCT02452320|7585389|FG000|STARTED|Overall Study||64
6655290|NCT02452320|7585390|FG001|STARTED|Overall Study||64
6655291|NCT02452320|7585389|FG000|COMPLETED|Overall Study||64
6655292|NCT02452320|7585390|FG001|COMPLETED|Overall Study||63
6372465|NCT00740831|7283239|FG002|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
6372466|NCT00740831|7283237|FG000|NOT COMPLETED|Overall Study||4
6372467|NCT00740831|7283238|FG001|NOT COMPLETED|Overall Study||3
6372468|NCT00740831|7283239|FG002|NOT COMPLETED|Overall Study||6
6372469|NCT00740857|7283250|FG000|STARTED|Overall Study||33
6372470|NCT00740857|7283251|FG001|STARTED|Overall Study||88
6372471|NCT00740857|7283252|FG002|STARTED|Overall Study||90
6372472|NCT00740857|7283250|FG000|COMPLETED|Overall Study||32
6372473|NCT00740857|7283251|FG001|COMPLETED|Overall Study||88
6372474|NCT00740857|7283252|FG002|COMPLETED|Overall Study||90
6372475|NCT00740857|7283250|FG000|NOT COMPLETED|Overall Study||1
6372476|NCT00740857|7283251|FG001|NOT COMPLETED|Overall Study||0
6372477|NCT00740857|7283252|FG002|NOT COMPLETED|Overall Study||0
6372478|NCT00740870|7283260|FG000|STARTED|Overall Study||171
6372479|NCT00740870|7283260|FG000|COMPLETED|Overall Study||150
6372480|NCT00740870|7283260|FG000|NOT COMPLETED|Overall Study||21
6372481|NCT00741013|7283270|FG000|STARTED|Overall Study||7
6372482|NCT00741013|7283271|FG001|STARTED|Overall Study||8
6372483|NCT00741013|7283272|FG002|STARTED|Overall Study||7
6372484|NCT00741013|7283270|FG000|COMPLETED|Overall Study||6
6372485|NCT00741013|7283271|FG001|COMPLETED|Overall Study||6
6372486|NCT00741013|7283272|FG002|COMPLETED|Overall Study||6
6372487|NCT00741013|7283270|FG000|NOT COMPLETED|Overall Study||1
6372488|NCT00741013|7283271|FG001|NOT COMPLETED|Overall Study||2
6372489|NCT00741013|7283272|FG002|NOT COMPLETED|Overall Study||1
6372490|NCT00741026|7283280|FG000|STARTED|Overall Study||15
6372491|NCT00741026|7283280|FG000|COMPLETED|Overall Study||15
6372492|NCT00741026|7283280|FG000|NOT COMPLETED|Overall Study||0
6372493|NCT00741039|7283288|FG000|STARTED|Overall Study||102
6372494|NCT00741039|7283289|FG001|STARTED|Overall Study||25
6372495|NCT00741039|7283288|FG000|COMPLETED|Overall Study||100
6372496|NCT00741039|7283289|FG001|COMPLETED|Overall Study||25
6372497|NCT00741039|7283288|FG000|NOT COMPLETED|Overall Study||2
6372498|NCT00741039|7283289|FG001|NOT COMPLETED|Overall Study||0
6372499|NCT00741091|7283295|FG000|STARTED|Overall Study||1097
6372500|NCT00741091|7283295|FG000|COMPLETED|Overall Study||1040
6372501|NCT00741091|7283295|FG000|NOT COMPLETED|Overall Study||57
6372502|NCT00741104|7283299|FG000|STARTED|Overall Study||363
6372503|NCT00741104|7283299|FG000|COMPLETED|Overall Study||363
6372504|NCT00741104|7283299|FG000|NOT COMPLETED|Overall Study||0
6372505|NCT00741156|7283303|FG000|STARTED|Overall Study||12
6372506|NCT00741156|7283303|FG000|COMPLETED|Overall Study||12
6372507|NCT00741156|7283303|FG000|NOT COMPLETED|Overall Study||0
6372508|NCT00741260|7283325|FG000|STARTED|Overall Study||6
6372509|NCT00741260|7283326|FG001|STARTED|Overall Study||8
6372510|NCT00741260|7283327|FG002|STARTED|Overall Study||4
6372511|NCT00741260|7283328|FG003|STARTED|Overall Study||6
6372512|NCT00741260|7283329|FG004|STARTED|Overall Study||9
6372513|NCT00741260|7283330|FG005|STARTED|Overall Study||65
6372514|NCT00741260|7283331|FG006|STARTED|Overall Study||7
6372515|NCT00741260|7283325|FG000|COMPLETED|Overall Study||0
6372516|NCT00741260|7283326|FG001|COMPLETED|Overall Study||0
6372517|NCT00741260|7283327|FG002|COMPLETED|Overall Study||0
6372518|NCT00741260|7283328|FG003|COMPLETED|Overall Study||0
6372519|NCT00741260|7283329|FG004|COMPLETED|Overall Study||0
6372520|NCT00741260|7283330|FG005|COMPLETED|Overall Study||20
6372521|NCT00741260|7283331|FG006|COMPLETED|Overall Study||0
6372522|NCT00741260|7283325|FG000|NOT COMPLETED|Overall Study||6
6372523|NCT00741260|7283326|FG001|NOT COMPLETED|Overall Study||8
6372524|NCT00741260|7283327|FG002|NOT COMPLETED|Overall Study||4
6372525|NCT00741260|7283328|FG003|NOT COMPLETED|Overall Study||6
6372526|NCT00741260|7283329|FG004|NOT COMPLETED|Overall Study||9
6372527|NCT00741260|7283330|FG005|NOT COMPLETED|Overall Study||45
6372528|NCT00741260|7283331|FG006|NOT COMPLETED|Overall Study||7
6372529|NCT00741273|7283354|FG000|STARTED|Overall Study||8
6372530|NCT00741273|7283355|FG001|STARTED|Overall Study||8
6372531|NCT00741273|7283354|FG000|COMPLETED|Overall Study||8
6372532|NCT00741273|7283355|FG001|COMPLETED|Overall Study||8
6372533|NCT00741273|7283354|FG000|NOT COMPLETED|Overall Study||0
6372534|NCT00741273|7283355|FG001|NOT COMPLETED|Overall Study||0
6372535|NCT00741286|7283367|FG000|STARTED|Overall Study||103
6778050|NCT03792672|7705978|FG000|STARTED|Treatment Period 2 (1 Day)||4
6778051|NCT03792672|7705979|FG001|STARTED|Treatment Period 2 (1 Day)||4
6778052|NCT03792672|7705980|FG002|STARTED|Treatment Period 2 (1 Day)||4
6778053|NCT03792672|7705981|FG003|STARTED|Treatment Period 2 (1 Day)||4
6778054|NCT03792672|7705982|FG004|STARTED|Treatment Period 2 (1 Day)||4
6778055|NCT03792672|7705983|FG005|STARTED|Treatment Period 2 (1 Day)||4
6778056|NCT03792672|7705978|FG000|COMPLETED|Treatment Period 2 (1 Day)||4
6778057|NCT03792672|7705979|FG001|COMPLETED|Treatment Period 2 (1 Day)||4
6778058|NCT03792672|7705980|FG002|COMPLETED|Treatment Period 2 (1 Day)||4
6778059|NCT03792672|7705981|FG003|COMPLETED|Treatment Period 2 (1 Day)||4
6778060|NCT03792672|7705982|FG004|COMPLETED|Treatment Period 2 (1 Day)||4
6778061|NCT03792672|7705983|FG005|COMPLETED|Treatment Period 2 (1 Day)||4
6778062|NCT03792672|7705978|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6778063|NCT03792672|7705979|FG001|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6778064|NCT03792672|7705980|FG002|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6778065|NCT03792672|7705981|FG003|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6372536|NCT00741286|7283368|FG001|STARTED|Overall Study||100
6372537|NCT00741286|7283367|FG000|COMPLETED|Overall Study||83
6778066|NCT03792672|7705982|FG004|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6372538|NCT00741286|7283368|FG001|COMPLETED|Overall Study||81
6372539|NCT00741286|7283367|FG000|NOT COMPLETED|Overall Study||20
6372540|NCT00741286|7283368|FG001|NOT COMPLETED|Overall Study||19
6372541|NCT00741338|7283376|FG000|STARTED|Overall Study||3
6372542|NCT00741338|7283377|FG001|STARTED|Overall Study||3
6372543|NCT00741338|7283376|FG000|COMPLETED|Overall Study||3
6372544|NCT00741338|7283377|FG001|COMPLETED|Overall Study||2
6372545|NCT00741338|7283376|FG000|NOT COMPLETED|Overall Study||0
6372546|NCT00741338|7283377|FG001|NOT COMPLETED|Overall Study||1
6372547|NCT00741390|7283383|FG000|STARTED|Visit 1||62
6372548|NCT00741390|7283384|FG001|STARTED|Visit 1||63
6372549|NCT00741390|7283385|FG002|STARTED|Visit 1||62
6372550|NCT00741390|7283386|FG003|STARTED|Visit 1||63
6372551|NCT00741390|7283383|FG000|COMPLETED|Visit 1||60
6372552|NCT00741390|7283384|FG001|COMPLETED|Visit 1||63
6372553|NCT00741390|7283385|FG002|COMPLETED|Visit 1||55
6372554|NCT00741390|7283386|FG003|COMPLETED|Visit 1||62
6372555|NCT00741390|7283383|FG000|NOT COMPLETED|Visit 1||2
6372556|NCT00741390|7283384|FG001|NOT COMPLETED|Visit 1||0
6372557|NCT00741390|7283385|FG002|NOT COMPLETED|Visit 1||7
6372558|NCT00741390|7283386|FG003|NOT COMPLETED|Visit 1||1
6372559|NCT00741390|7283383|FG000|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
6372560|NCT00741390|7283384|FG001|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
6372561|NCT00741390|7283385|FG002|STARTED|Visit 2||55
6372562|NCT00741390|7283386|FG003|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
6372563|NCT00741390|7283383|FG000|COMPLETED|Visit 2||59
6372564|NCT00741390|7283384|FG001|COMPLETED|Visit 2||61
6372565|NCT00741390|7283385|FG002|COMPLETED|Visit 2||54
6372566|NCT00741390|7283386|FG003|COMPLETED|Visit 2||60
6372567|NCT00741390|7283383|FG000|NOT COMPLETED|Visit 2||0
6372568|NCT00741390|7283384|FG001|NOT COMPLETED|Visit 2||0
6372569|NCT00741390|7283385|FG002|NOT COMPLETED|Visit 2||1
6372570|NCT00741390|7283386|FG003|NOT COMPLETED|Visit 2||1
6372571|NCT00741455|7283405|FG000|STARTED|Overall Study||18
6372572|NCT00741455|7283405|FG000|COMPLETED|Overall Study||17
6372573|NCT00741455|7283405|FG000|NOT COMPLETED|Overall Study||1
6372574|NCT00741468|7283409|FG000|STARTED|Overall Study||18
6372575|NCT00741468|7283409|FG000|COMPLETED|Overall Study||18
6372576|NCT00741468|7283409|FG000|NOT COMPLETED|Overall Study||0
6372577|NCT00741598|7283419|FG000|STARTED|Overall Study||33
6372578|NCT00741598|7283420|FG001|STARTED|Overall Study||39
6372579|NCT00741598|7283419|FG000|COMPLETED|Overall Study||24
6372580|NCT00741598|7283420|FG001|COMPLETED|Overall Study||30
6372581|NCT00741598|7283419|FG000|NOT COMPLETED|Overall Study||9
6372582|NCT00741598|7283420|FG001|NOT COMPLETED|Overall Study||9
6372583|NCT00741611|7283430|FG000|STARTED|Overall Study||4
6372584|NCT00741611|7283431|FG001|STARTED|Overall Study||3
6372585|NCT00741611|7283432|FG002|STARTED|Overall Study||29
6372586|NCT00741611|7283430|FG000|COMPLETED|Overall Study||4
6372587|NCT00741611|7283431|FG001|COMPLETED|Overall Study||1
6372588|NCT00741611|7283432|FG002|COMPLETED|Overall Study||26
6372589|NCT00741611|7283430|FG000|NOT COMPLETED|Overall Study||0
6372590|NCT00741611|7283431|FG001|NOT COMPLETED|Overall Study||2
6372591|NCT00741611|7283432|FG002|NOT COMPLETED|Overall Study||3
6372592|NCT00741819|7283441|FG000|STARTED|Overall Study||73
6372593|NCT00741819|7283441|FG000|COMPLETED|Overall Study||65
6372594|NCT00741819|7283441|FG000|NOT COMPLETED|Overall Study||8
6372595|NCT00741858|7283449|FG000|STARTED|Overall Study||16
6372596|NCT00741858|7283450|FG001|STARTED|Overall Study||18
6372597|NCT00741858|7283449|FG000|COMPLETED|Overall Study||16
6372598|NCT00741858|7283450|FG001|COMPLETED|Overall Study||18
6372599|NCT00741858|7283449|FG000|NOT COMPLETED|Overall Study||0
6561063|NCT01791244|7484010|FG000|STARTED|Overall Study||46
6561064|NCT01791244|7484011|FG001|STARTED|Overall Study||47
6561065|NCT01791244|7484010|FG000|Intent to Treat (ITT)|Overall Study||38
6561066|NCT01791244|7484011|FG001|Intent to Treat (ITT)|Overall Study||39
6561067|NCT01791244|7484010|FG000|COMPLETED|Overall Study||31
6561068|NCT01791244|7484011|FG001|COMPLETED|Overall Study||29
6561069|NCT01791244|7484010|FG000|NOT COMPLETED|Overall Study||15
6561070|NCT01791244|7484011|FG001|NOT COMPLETED|Overall Study||18
6561071|NCT01791413|7484021|FG000|STARTED|Overall Study||20
6561072|NCT01791413|7484022|FG001|STARTED|Overall Study||20
6561073|NCT01791413|7484021|FG000|COMPLETED|Overall Study||15
6561074|NCT01791413|7484022|FG001|COMPLETED|Overall Study||19
6561075|NCT01791413|7484021|FG000|NOT COMPLETED|Overall Study||5
6561076|NCT01791413|7484022|FG001|NOT COMPLETED|Overall Study||1
6561077|NCT01791465|7484029|FG000|STARTED|Overall Study||6
6561078|NCT01791465|7484029|FG000|COMPLETED|Overall Study||6
6561079|NCT01791465|7484029|FG000|NOT COMPLETED|Overall Study||0
6372600|NCT00741858|7283450|FG001|NOT COMPLETED|Overall Study||0
6372601|NCT00741936|7283458|FG000|STARTED|Overall Study||60
6372602|NCT00741936|7283459|FG001|STARTED|Overall Study||60
6372603|NCT00741936|7283458|FG000|COMPLETED|Overall Study||51
6561080|NCT01791491|7484034|FG000|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
6561081|NCT01791491|7484034|FG000|COMPLETED|Overall Study||9
6561082|NCT01791491|7484034|FG000|NOT COMPLETED|Overall Study||0
6372604|NCT00741936|7283459|FG001|COMPLETED|Overall Study||52
6372605|NCT00741936|7283458|FG000|NOT COMPLETED|Overall Study||9
6372606|NCT00741936|7283459|FG001|NOT COMPLETED|Overall Study||8
6372607|NCT00742001|7283468|FG000|STARTED|Overall Study||4
6372608|NCT00742001|7283469|FG001|STARTED|Overall Study||4
6372609|NCT00742001|7283470|FG002|STARTED|Overall Study||4
6372610|NCT00742001|7283468|FG000|COMPLETED|Overall Study||4
6372611|NCT00742001|7283469|FG001|COMPLETED|Overall Study||4
6372612|NCT00742001|7283470|FG002|COMPLETED|Overall Study||3
6372613|NCT00742001|7283468|FG000|NOT COMPLETED|Overall Study||0
6561083|NCT01791517|7484041|FG000|STARTED|Phase I: Period 1||19
6561084|NCT01791517|7484042|FG001|STARTED|Phase I: Period 1||20
6561085|NCT01791517|7484043|FG002|STARTED|Phase I: Period 1||20
6561086|NCT01791517|7484044|FG003|STARTED|Phase I: Period 1||19
6561087|NCT01791517|7484045|FG004|STARTED|Phase I: Period 1||20
6561088|NCT01791517|7484046|FG005|STARTED|Phase I: Period 1||20
6561089|NCT01791517|7484047|FG006|STARTED|Phase I: Period 1||20
6561090|NCT01791517|7484048|FG007|STARTED|Phase I: Period 1||20
6561091|NCT01791517|7484049|FG008|STARTED|Phase I: Period 1||20
6561092|NCT01791517|7484050|FG009|STARTED|Phase I: Period 1||20
6561093|NCT01791517|7484051|FG010|STARTED|Phase I: Period 1||18
6561094|NCT01791517|7484052|FG011|STARTED|Phase I: Period 1||20
6561095|NCT01791517|7484041|FG000|COMPLETED|Phase I: Period 1||18
6561096|NCT01791517|7484042|FG001|COMPLETED|Phase I: Period 1||18
6778067|NCT03792672|7705983|FG005|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6778068|NCT03792672|7705978|FG000|STARTED|Washout Period 2 (10 Days)||4
6372614|NCT00742001|7283469|FG001|NOT COMPLETED|Overall Study||0
6372615|NCT00742001|7283470|FG002|NOT COMPLETED|Overall Study||1
6372616|NCT00742027|7283481|FG000|STARTED|Overall Study||129
6372617|NCT00742027|7283481|FG000|COMPLETED|Overall Study||0
6372618|NCT00742027|7283481|FG000|NOT COMPLETED|Overall Study||129
6372619|NCT00742053|7283485|FG000|STARTED|Overall Study||7
6372620|NCT00742053|7283485|FG000|COMPLETED|Overall Study||7
6372621|NCT00742053|7283485|FG000|NOT COMPLETED|Overall Study||0
6372622|NCT00742079|7283491|FG000|STARTED|Overall Study||11
6778069|NCT03792672|7705979|FG001|STARTED|Washout Period 2 (10 Days)||4
6778070|NCT03792672|7705980|FG002|STARTED|Washout Period 2 (10 Days)||4
6778071|NCT03792672|7705981|FG003|STARTED|Washout Period 2 (10 Days)||4
6372623|NCT00742079|7283492|FG001|STARTED|Overall Study||10
6372624|NCT00742079|7283491|FG000|Baseline/Week 1 (Received Dose 1)|Overall Study||11
6372625|NCT00742079|7283492|FG001|Baseline/Week 1 (Received Dose 1)|Overall Study||9
6372626|NCT00742079|7283491|FG000|Week 2 (Received Dose 2)|Overall Study||11
6372627|NCT00742079|7283492|FG001|Week 2 (Received Dose 2)|Overall Study||9
6372628|NCT00742079|7283491|FG000|COMPLETED|Overall Study||11
6372629|NCT00742079|7283492|FG001|COMPLETED|Overall Study||9
6372630|NCT00742079|7283491|FG000|NOT COMPLETED|Overall Study||0
6372631|NCT00742079|7283492|FG001|NOT COMPLETED|Overall Study||1
6372632|NCT00742170|7283500|FG000|STARTED|Overall Study||26
6372633|NCT00742170|7283501|FG001|STARTED|Overall Study||29
6372634|NCT00742170|7283500|FG000|COMPLETED|Overall Study||24
6372635|NCT00742170|7283501|FG001|COMPLETED|Overall Study||24
6372636|NCT00742170|7283500|FG000|NOT COMPLETED|Overall Study||2
6372637|NCT00742170|7283501|FG001|NOT COMPLETED|Overall Study||5
6372638|NCT00742183|7283509|FG000|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
6372639|NCT00742183|7283510|FG001|STARTED|Overall Study||51
6778072|NCT03792672|7705982|FG004|STARTED|Washout Period 2 (10 Days)||4
6778073|NCT03792672|7705983|FG005|STARTED|Washout Period 2 (10 Days)||4
6778074|NCT03792672|7705978|FG000|COMPLETED|Washout Period 2 (10 Days)||4
6778075|NCT03792672|7705979|FG001|COMPLETED|Washout Period 2 (10 Days)||4
6778076|NCT03792672|7705980|FG002|COMPLETED|Washout Period 2 (10 Days)||4
6778077|NCT03792672|7705981|FG003|COMPLETED|Washout Period 2 (10 Days)||4
6778078|NCT03792672|7705982|FG004|COMPLETED|Washout Period 2 (10 Days)||4
6778079|NCT03792672|7705983|FG005|COMPLETED|Washout Period 2 (10 Days)||4
6778080|NCT03792672|7705978|FG000|NOT COMPLETED|Washout Period 2 (10 Days)||0
6778081|NCT03792672|7705979|FG001|NOT COMPLETED|Washout Period 2 (10 Days)||0
6778082|NCT03792672|7705980|FG002|NOT COMPLETED|Washout Period 2 (10 Days)||0
6778083|NCT03792672|7705981|FG003|NOT COMPLETED|Washout Period 2 (10 Days)||0
6778084|NCT03792672|7705982|FG004|NOT COMPLETED|Washout Period 2 (10 Days)||0
6778085|NCT03792672|7705983|FG005|NOT COMPLETED|Washout Period 2 (10 Days)||0
6778086|NCT03792672|7705978|FG000|STARTED|Treatment Period 3 (1 Day)||4
6778087|NCT03792672|7705979|FG001|STARTED|Treatment Period 3 (1 Day)||4
6778088|NCT03792672|7705980|FG002|STARTED|Treatment Period 3 (1 Day)||4
6778089|NCT03792672|7705981|FG003|STARTED|Treatment Period 3 (1 Day)||4
6778090|NCT03792672|7705982|FG004|STARTED|Treatment Period 3 (1 Day)||4
6778091|NCT03792672|7705983|FG005|STARTED|Treatment Period 3 (1 Day)||4
6778092|NCT03792672|7705978|FG000|COMPLETED|Treatment Period 3 (1 Day)||4
6778093|NCT03792672|7705979|FG001|COMPLETED|Treatment Period 3 (1 Day)||4
6778094|NCT03792672|7705980|FG002|COMPLETED|Treatment Period 3 (1 Day)||4
6778095|NCT03792672|7705981|FG003|COMPLETED|Treatment Period 3 (1 Day)||4
6778096|NCT03792672|7705982|FG004|COMPLETED|Treatment Period 3 (1 Day)||4
6778097|NCT03792672|7705983|FG005|COMPLETED|Treatment Period 3 (1 Day)||4
6778098|NCT03792672|7705978|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6778099|NCT03792672|7705979|FG001|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6778100|NCT03792672|7705980|FG002|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6778101|NCT03792672|7705981|FG003|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6372640|NCT00742183|7283509|FG000|COMPLETED|Overall Study||40
6372641|NCT00742183|7283510|FG001|COMPLETED|Overall Study||39
6561097|NCT01791517|7484043|FG002|COMPLETED|Phase I: Period 1||18
6561098|NCT01791517|7484044|FG003|COMPLETED|Phase I: Period 1||17
6561099|NCT01791517|7484045|FG004|COMPLETED|Phase I: Period 1||19
6561100|NCT01791517|7484046|FG005|COMPLETED|Phase I: Period 1||19
6561101|NCT01791517|7484047|FG006|COMPLETED|Phase I: Period 1||19
6778102|NCT03792672|7705982|FG004|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6778103|NCT03792672|7705983|FG005|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6778104|NCT03792672|7705978|FG000|STARTED|Washout Period 3 (10 Days)||4
6372642|NCT00742183|7283509|FG000|NOT COMPLETED|Overall Study||9
6372643|NCT00742183|7283510|FG001|NOT COMPLETED|Overall Study||12
6372644|NCT00742209|7283521|FG000|STARTED|Overall Study||129
6372645|NCT00742209|7283522|FG001|STARTED|Overall Study||67
6372646|NCT00742209|7283523|FG002|STARTED|Overall Study||134
6372647|NCT00742209|7283524|FG003|STARTED|Overall Study||134
6372648|NCT00742209|7283525|FG004|STARTED|Overall Study||62
6372649|NCT00742209|7283521|FG000|COMPLETED|Overall Study||95
6372650|NCT00742209|7283522|FG001|COMPLETED|Overall Study||49
6372651|NCT00742209|7283523|FG002|COMPLETED|Overall Study||88
6372652|NCT00742209|7283524|FG003|COMPLETED|Overall Study||97
6372653|NCT00742209|7283525|FG004|COMPLETED|Overall Study||37
6372654|NCT00742209|7283521|FG000|NOT COMPLETED|Overall Study||34
6372655|NCT00742209|7283522|FG001|NOT COMPLETED|Overall Study||18
6372656|NCT00742209|7283523|FG002|NOT COMPLETED|Overall Study||46
6372657|NCT00742209|7283524|FG003|NOT COMPLETED|Overall Study||37
6372658|NCT00742209|7283525|FG004|NOT COMPLETED|Overall Study||25
6372659|NCT00742235|7283540|FG000|STARTED|Overall Study||32
6372660|NCT00742235|7283541|FG001|STARTED|Overall Study||67
6372661|NCT00742235|7283540|FG000|COMPLETED|Overall Study||32
6372662|NCT00742235|7283541|FG001|COMPLETED|Overall Study||36
6372663|NCT00742235|7283540|FG000|NOT COMPLETED|Overall Study||0
6372664|NCT00742235|7283541|FG001|NOT COMPLETED|Overall Study||31
6372665|NCT00742274|7283549|FG000|STARTED|Overall Study||30
6372666|NCT00742274|7283550|FG001|STARTED|Overall Study||31
6372667|NCT00742274|7283549|FG000|COMPLETED|Overall Study||27
6372668|NCT00742274|7283550|FG001|COMPLETED|Overall Study||28
6372669|NCT00742274|7283549|FG000|NOT COMPLETED|Overall Study||3
6372670|NCT00742274|7283550|FG001|NOT COMPLETED|Overall Study||3
6372671|NCT00742313|7283558|FG000|STARTED|Overall Study||25
6372672|NCT00742313|7283559|FG001|STARTED|Overall Study||19
6372673|NCT00742313|7283558|FG000|COMPLETED|Overall Study||24
6372674|NCT00742313|7283559|FG001|COMPLETED|Overall Study||19
6372675|NCT00742313|7283558|FG000|NOT COMPLETED|Overall Study||1
6372676|NCT00742313|7283559|FG001|NOT COMPLETED|Overall Study||0
6372677|NCT00742326|7283567|FG000|STARTED|Overall Study||6
6372678|NCT00742326|7283568|FG001|STARTED|Overall Study||7
6372679|NCT00742326|7283567|FG000|COMPLETED|Overall Study||6
6372680|NCT00742326|7283568|FG001|COMPLETED|Overall Study||6
6372681|NCT00742326|7283567|FG000|NOT COMPLETED|Overall Study||0
6372682|NCT00742326|7283568|FG001|NOT COMPLETED|Overall Study||1
6372683|NCT00742391|7283576|FG000|STARTED|Overall Study||126
6372684|NCT00742391|7283577|FG001|STARTED|Overall Study||129
6372685|NCT00742391|7283576|FG000|COMPLETED|Overall Study||122
6372686|NCT00742391|7283577|FG001|COMPLETED|Overall Study||128
6372687|NCT00742391|7283576|FG000|NOT COMPLETED|Overall Study||4
6372688|NCT00742391|7283577|FG001|NOT COMPLETED|Overall Study||1
6372689|NCT00742417|7283585|FG000|STARTED|Randomized||21
6372690|NCT00742417|7283586|FG001|STARTED|Randomized||21
6372691|NCT00742417|7283585|FG000|COMPLETED|Randomized||19
6372692|NCT00742417|7283586|FG001|COMPLETED|Randomized||20
6372693|NCT00742417|7283585|FG000|NOT COMPLETED|Randomized||2
6372694|NCT00742417|7283586|FG001|NOT COMPLETED|Randomized||1
6372695|NCT00742417|7283585|FG000|STARTED|Intensive Period||19
6372696|NCT00742417|7283586|FG001|STARTED|Intensive Period||20
6372697|NCT00742417|7283585|FG000|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
6372698|NCT00742417|7283586|FG001|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
6372699|NCT00742417|7283585|FG000|NOT COMPLETED|Intensive Period||3
6372700|NCT00742417|7283586|FG001|NOT COMPLETED|Intensive Period||1
6372701|NCT00742417|7283585|FG000|STARTED|Maintenance I||16
6372702|NCT00742417|7283586|FG001|STARTED|Maintenance I||19
6372703|NCT00742417|7283585|FG000|COMPLETED|Maintenance I||16
6372704|NCT00742417|7283586|FG001|COMPLETED|Maintenance I||19
6372705|NCT00742417|7283585|FG000|NOT COMPLETED|Maintenance I||0
6372706|NCT00742417|7283586|FG001|NOT COMPLETED|Maintenance I||0
6372707|NCT00742417|7283585|FG000|STARTED|Maintenance II||16
6372708|NCT00742417|7283586|FG001|STARTED|Maintenance II||19
6372709|NCT00742417|7283585|FG000|COMPLETED|Maintenance II||16
6372710|NCT00742417|7283586|FG001|COMPLETED|Maintenance II||19
6372711|NCT00742417|7283585|FG000|NOT COMPLETED|Maintenance II||0
6372712|NCT00742417|7283586|FG001|NOT COMPLETED|Maintenance II||0
6372713|NCT00742469|7283596|FG000|STARTED|Overall Study||106
6372714|NCT00742469|7283597|FG001|STARTED|Overall Study||104
6372715|NCT00742469|7283596|FG000|COMPLETED|Overall Study||88
6372716|NCT00742469|7283597|FG001|COMPLETED|Overall Study||69
6372717|NCT00742469|7283596|FG000|NOT COMPLETED|Overall Study||18
6372718|NCT00742469|7283597|FG001|NOT COMPLETED|Overall Study||35
6372719|NCT00742508|7283605|FG000|STARTED|8-Week Primary Evaluation Period||22
6372720|NCT00742508|7283606|FG001|STARTED|8-Week Primary Evaluation Period||19
6372721|NCT00742508|7283605|FG000|COMPLETED|8-Week Primary Evaluation Period||11
6372722|NCT00742508|7283606|FG001|COMPLETED|8-Week Primary Evaluation Period||8
6372723|NCT00742508|7283605|FG000|NOT COMPLETED|8-Week Primary Evaluation Period||11
6372724|NCT00742508|7283606|FG001|NOT COMPLETED|8-Week Primary Evaluation Period||11
6372725|NCT00742508|7283605|FG000|STARTED|4-Week Exploratory Evaluation Period||0
6372726|NCT00742508|7283606|FG001|STARTED|4-Week Exploratory Evaluation Period||8
6372727|NCT00742508|7283605|FG000|COMPLETED|4-Week Exploratory Evaluation Period||0
6372728|NCT00742508|7283606|FG001|COMPLETED|4-Week Exploratory Evaluation Period||7
6372729|NCT00742508|7283605|FG000|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
6372730|NCT00742508|7283606|FG001|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
6372731|NCT00742560|7283617|FG000|STARTED|Overall Study||3
6372732|NCT00742560|7283618|FG001|STARTED|Overall Study||3
6372733|NCT00742560|7283619|FG002|STARTED|Overall Study||22
6372734|NCT00742560|7283620|FG003|STARTED|Overall Study||36
6372735|NCT00742560|7283621|FG004|STARTED|Overall Study||37
6372736|NCT00742560|7283617|FG000|COMPLETED|Overall Study||0
6372737|NCT00742560|7283618|FG001|COMPLETED|Overall Study||0
6372738|NCT00742560|7283619|FG002|COMPLETED|Overall Study||0
6372739|NCT00742560|7283620|FG003|COMPLETED|Overall Study||0
6372740|NCT00742560|7283621|FG004|COMPLETED|Overall Study||0
6372741|NCT00742560|7283617|FG000|NOT COMPLETED|Overall Study||3
6372742|NCT00742560|7283618|FG001|NOT COMPLETED|Overall Study||3
6372743|NCT00742560|7283619|FG002|NOT COMPLETED|Overall Study||22
6372744|NCT00742560|7283620|FG003|NOT COMPLETED|Overall Study||36
6372745|NCT00742560|7283621|FG004|NOT COMPLETED|Overall Study||37
6372746|NCT00742573|7283654|FG000|STARTED|Overall Study||83
6372747|NCT00742573|7283655|FG001|STARTED|Overall Study||87
6372748|NCT00742573|7283654|FG000|Week 12|Overall Study||46
6372749|NCT00742573|7283655|FG001|Week 12|Overall Study||51
6372750|NCT00742573|7283654|FG000|Week 24|Overall Study||39
6372751|NCT00742573|7283655|FG001|Week 24|Overall Study||37
6372752|NCT00742573|7283654|FG000|Week 52|Overall Study||26
6372753|NCT00742573|7283655|FG001|Week 52|Overall Study||25
6372754|NCT00742573|7283654|FG000|COMPLETED|Overall Study||26
6372755|NCT00742573|7283655|FG001|COMPLETED|Overall Study||25
6372756|NCT00742573|7283654|FG000|NOT COMPLETED|Overall Study||57
6372757|NCT00742573|7283655|FG001|NOT COMPLETED|Overall Study||62
6372758|NCT00742625|7283661|FG000|STARTED|Remission Induction||95
6372759|NCT00742625|7283661|FG000|COMPLETED|Remission Induction||41
6372760|NCT00742625|7283661|FG000|NOT COMPLETED|Remission Induction||54
6372761|NCT00742625|7283661|FG000|STARTED|Consolidation||41
6372762|NCT00742625|7283661|FG000|COMPLETED|Consolidation||20
6372763|NCT00742625|7283661|FG000|NOT COMPLETED|Consolidation||21
6372764|NCT00742781|7283668|FG000|STARTED|Overall Study||21
6372765|NCT00742781|7283668|FG000|COMPLETED|Overall Study||18
6372766|NCT00742781|7283668|FG000|NOT COMPLETED|Overall Study||3
6372767|NCT00742859|7283677|FG000|STARTED|Overall Study||127
6372768|NCT00742859|7283678|FG001|STARTED|Overall Study||127
6372769|NCT00742859|7283679|FG002|STARTED|Overall Study||127
6372770|NCT00742859|7283680|FG003|STARTED|Overall Study||127
6372771|NCT00742859|7283677|FG000|COMPLETED|Overall Study||116
6372772|NCT00742859|7283678|FG001|COMPLETED|Overall Study||115
6372773|NCT00742859|7283679|FG002|COMPLETED|Overall Study||116
6372774|NCT00742859|7283680|FG003|COMPLETED|Overall Study||119
6372775|NCT00742859|7283677|FG000|NOT COMPLETED|Overall Study||11
6372776|NCT00742859|7283678|FG001|NOT COMPLETED|Overall Study||12
6372777|NCT00742859|7283679|FG002|NOT COMPLETED|Overall Study||11
6372778|NCT00742859|7283680|FG003|NOT COMPLETED|Overall Study||8
6372779|NCT00742872|7283692|FG000|STARTED|Overall Study||21
6372780|NCT00742872|7283693|FG001|STARTED|Overall Study||20
6372781|NCT00742872|7283692|FG000|COMPLETED|Overall Study||9
6372782|NCT00742872|7283693|FG001|COMPLETED|Overall Study||12
6372783|NCT00742872|7283692|FG000|NOT COMPLETED|Overall Study||12
6372784|NCT00742872|7283693|FG001|NOT COMPLETED|Overall Study||8
6372785|NCT00742885|7283701|FG000|STARTED|Overall Study||50
6372786|NCT00742885|7283702|FG001|STARTED|Overall Study||50
6372787|NCT00742885|7283701|FG000|COMPLETED|Overall Study|to Day 182|49
6372788|NCT00742885|7283702|FG001|COMPLETED|Overall Study|to Day 182|50
6372789|NCT00742885|7283701|FG000|NOT COMPLETED|Overall Study||1
6372790|NCT00742885|7283702|FG001|NOT COMPLETED|Overall Study||0
6372791|NCT00742924|7283715|FG000|STARTED|Overall Study||6
6372792|NCT00742924|7283716|FG001|STARTED|Overall Study||6
6372793|NCT00742924|7283717|FG002|STARTED|Overall Study||6
6372794|NCT00742924|7283718|FG003|STARTED|Overall Study||6
6372795|NCT00742924|7283715|FG000|COMPLETED|Overall Study||1
6372796|NCT00742924|7283716|FG001|COMPLETED|Overall Study||4
6372797|NCT00742924|7283717|FG002|COMPLETED|Overall Study||2
6372798|NCT00742924|7283718|FG003|COMPLETED|Overall Study||0
6372799|NCT00742924|7283715|FG000|NOT COMPLETED|Overall Study||5
6372800|NCT00742924|7283716|FG001|NOT COMPLETED|Overall Study||2
6372801|NCT00742924|7283717|FG002|NOT COMPLETED|Overall Study||4
6372802|NCT00742924|7283718|FG003|NOT COMPLETED|Overall Study||6
6372803|NCT00742963|7283728|FG000|STARTED|Overall Study||101
6372804|NCT00742963|7283728|FG000|Completed All Treatment Cycles|Overall Study||68
6372805|NCT00742963|7283728|FG000|COMPLETED|Overall Study||68
6372806|NCT00742963|7283728|FG000|NOT COMPLETED|Overall Study||33
6372807|NCT00743093|7283734|FG000|STARTED|Base Study Period||224
6372808|NCT00743093|7283735|FG001|STARTED|Base Study Period||52
6372809|NCT00743093|7283734|FG000|COMPLETED|Base Study Period||205
6372810|NCT00743093|7283735|FG001|COMPLETED|Base Study Period||47
6372811|NCT00743093|7283734|FG000|NOT COMPLETED|Base Study Period||19
6372812|NCT00743093|7283735|FG001|NOT COMPLETED|Base Study Period||5
6372813|NCT00743093|7283734|FG000|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
6372814|NCT00743093|7283735|FG001|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
6372815|NCT00743093|7283734|FG000|COMPLETED|Extended Dosing Period||48
6372816|NCT00743093|7283735|FG001|COMPLETED|Extended Dosing Period||1
6372817|NCT00743093|7283734|FG000|NOT COMPLETED|Extended Dosing Period||3
6372818|NCT00743093|7283735|FG001|NOT COMPLETED|Extended Dosing Period||0
6372819|NCT00743106|7283743|FG000|STARTED|Overall Study||42
6372820|NCT00743106|7283744|FG001|STARTED|Overall Study||48
6372821|NCT00743106|7283743|FG000|COMPLETED|Overall Study||34
6372822|NCT00743106|7283744|FG001|COMPLETED|Overall Study||43
6372823|NCT00743106|7283743|FG000|NOT COMPLETED|Overall Study||8
6372824|NCT00743106|7283744|FG001|NOT COMPLETED|Overall Study||5
6372825|NCT00743119|7283750|FG000|STARTED|Overall Study||34
6372826|NCT00743119|7283750|FG000|COMPLETED|Overall Study||30
6372827|NCT00743119|7283750|FG000|NOT COMPLETED|Overall Study||4
6372828|NCT00743145|7283762|FG000|STARTED|Overall Study||23
6372829|NCT00743145|7283762|FG000|COMPLETED|Overall Study||19
6372830|NCT00743145|7283762|FG000|NOT COMPLETED|Overall Study||4
6372831|NCT00743249|7283778|FG000|STARTED|Overall Study||30
6372832|NCT00743249|7283779|FG001|STARTED|Overall Study||30
6372833|NCT00743249|7283778|FG000|COMPLETED|Overall Study||28
6372834|NCT00743249|7283779|FG001|COMPLETED|Overall Study||24
6372835|NCT00743249|7283778|FG000|NOT COMPLETED|Overall Study||2
6372836|NCT00743249|7283779|FG001|NOT COMPLETED|Overall Study||6
6372837|NCT00743262|7283785|FG000|STARTED|Overall Study||15
6372838|NCT00743262|7283785|FG000|COMPLETED|Overall Study||15
6372839|NCT00743262|7283785|FG000|NOT COMPLETED|Overall Study||0
6372840|NCT00743275|7283791|FG000|STARTED|Overall Study||59
6372841|NCT00743275|7283792|FG001|STARTED|Overall Study||61
6372842|NCT00743275|7283791|FG000|COMPLETED|Overall Study||59
6372843|NCT00743275|7283792|FG001|COMPLETED|Overall Study||60
6372844|NCT00743275|7283791|FG000|NOT COMPLETED|Overall Study||0
6372845|NCT00743275|7283792|FG001|NOT COMPLETED|Overall Study||1
6372846|NCT00743288|7283798|FG000|STARTED|Overall Study||3
6372847|NCT00743288|7283799|FG001|STARTED|Overall Study||3
6372848|NCT00743288|7283800|FG002|STARTED|Overall Study||6
6372849|NCT00743288|7283801|FG003|STARTED|Overall Study||7
6372850|NCT00743288|7283802|FG004|STARTED|Overall Study||6
6372851|NCT00743288|7283803|FG005|STARTED|Overall Study||6
6372852|NCT00743288|7283804|FG006|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
6372853|NCT00743288|7283798|FG000|COMPLETED|Overall Study||0
6372854|NCT00743288|7283799|FG001|COMPLETED|Overall Study||0
6372855|NCT00743288|7283800|FG002|COMPLETED|Overall Study||1
6372856|NCT00743288|7283801|FG003|COMPLETED|Overall Study||0
6372857|NCT00743288|7283802|FG004|COMPLETED|Overall Study||0
6372858|NCT00743288|7283803|FG005|COMPLETED|Overall Study||1
6372859|NCT00743288|7283804|FG006|COMPLETED|Overall Study||0
6372860|NCT00743288|7283798|FG000|NOT COMPLETED|Overall Study||3
6372861|NCT00743288|7283799|FG001|NOT COMPLETED|Overall Study||3
6372862|NCT00743288|7283800|FG002|NOT COMPLETED|Overall Study||5
6372863|NCT00743288|7283801|FG003|NOT COMPLETED|Overall Study||7
6372864|NCT00743288|7283802|FG004|NOT COMPLETED|Overall Study||6
6372865|NCT00743288|7283803|FG005|NOT COMPLETED|Overall Study||5
6372866|NCT00743288|7283804|FG006|NOT COMPLETED|Overall Study||9
6372867|NCT00743340|7283815|FG000|STARTED|Overall Study||50
6372868|NCT00743340|7283815|FG000|COMPLETED|Overall Study||9
6372869|NCT00743340|7283815|FG000|NOT COMPLETED|Overall Study||41
6372870|NCT00743366|7283819|FG000|STARTED|Intervention 1 (8 Days)||10
6372871|NCT00743366|7283820|FG001|STARTED|Intervention 1 (8 Days)||10
6372872|NCT00743366|7283819|FG000|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
6372873|NCT00743366|7283820|FG001|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
6372874|NCT00743366|7283819|FG000|NOT COMPLETED|Intervention 1 (8 Days)||3
6372875|NCT00743366|7283820|FG001|NOT COMPLETED|Intervention 1 (8 Days)||3
6372876|NCT00743366|7283819|FG000|STARTED|Intervention 2 (8 Days)||7
6372877|NCT00743366|7283820|FG001|STARTED|Intervention 2 (8 Days)||7
6372878|NCT00743366|7283819|FG000|COMPLETED|Intervention 2 (8 Days)||7
6372879|NCT00743366|7283820|FG001|COMPLETED|Intervention 2 (8 Days)||7
6372880|NCT00743366|7283819|FG000|NOT COMPLETED|Intervention 2 (8 Days)||0
6372881|NCT00743366|7283820|FG001|NOT COMPLETED|Intervention 2 (8 Days)||0
6372882|NCT00743431|7283826|FG000|STARTED|Overall Study||224
6778105|NCT03792672|7705979|FG001|STARTED|Washout Period 3 (10 Days)||4
6778106|NCT03792672|7705980|FG002|STARTED|Washout Period 3 (10 Days)||4
6778107|NCT03792672|7705981|FG003|STARTED|Washout Period 3 (10 Days)||4
6778108|NCT03792672|7705982|FG004|STARTED|Washout Period 3 (10 Days)||4
6778109|NCT03792672|7705983|FG005|STARTED|Washout Period 3 (10 Days)||4
6778110|NCT03792672|7705978|FG000|COMPLETED|Washout Period 3 (10 Days)||3
6778111|NCT03792672|7705979|FG001|COMPLETED|Washout Period 3 (10 Days)||4
6778112|NCT03792672|7705980|FG002|COMPLETED|Washout Period 3 (10 Days)||3
6778113|NCT03792672|7705981|FG003|COMPLETED|Washout Period 3 (10 Days)||2
6778114|NCT03792672|7705982|FG004|COMPLETED|Washout Period 3 (10 Days)||4
6778115|NCT03792672|7705983|FG005|COMPLETED|Washout Period 3 (10 Days)||4
6778116|NCT03792672|7705978|FG000|NOT COMPLETED|Washout Period 3 (10 Days)||1
6778117|NCT03792672|7705979|FG001|NOT COMPLETED|Washout Period 3 (10 Days)||0
6778118|NCT03792672|7705980|FG002|NOT COMPLETED|Washout Period 3 (10 Days)||1
6778119|NCT03792672|7705981|FG003|NOT COMPLETED|Washout Period 3 (10 Days)||2
6778120|NCT03792672|7705982|FG004|NOT COMPLETED|Washout Period 3 (10 Days)||0
6778121|NCT03792672|7705983|FG005|NOT COMPLETED|Washout Period 3 (10 Days)||0
6778122|NCT03792672|7705978|FG000|STARTED|Treatment Period 4 (2 Days)||3
6778123|NCT03792672|7705979|FG001|STARTED|Treatment Period 4 (2 Days)||4
6778124|NCT03792672|7705980|FG002|STARTED|Treatment Period 4 (2 Days)||3
6778125|NCT03792672|7705981|FG003|STARTED|Treatment Period 4 (2 Days)||2
6778126|NCT03792672|7705982|FG004|STARTED|Treatment Period 4 (2 Days)||4
6372883|NCT00743431|7283826|FG000|COMPLETED|Overall Study||98
6372884|NCT00743431|7283826|FG000|NOT COMPLETED|Overall Study||126
6372885|NCT00743444|7283830|FG000|STARTED|First Intervention||14
6372886|NCT00743444|7283831|FG001|STARTED|First Intervention||13
6372887|NCT00743444|7283830|FG000|COMPLETED|First Intervention||14
6372888|NCT00743444|7283831|FG001|COMPLETED|First Intervention||12
6372889|NCT00743444|7283830|FG000|NOT COMPLETED|First Intervention||0
6561102|NCT01791517|7484048|FG007|COMPLETED|Phase I: Period 1||20
6561103|NCT01791517|7484049|FG008|COMPLETED|Phase I: Period 1||19
6561104|NCT01791517|7484050|FG009|COMPLETED|Phase I: Period 1||19
6561105|NCT01791517|7484051|FG010|COMPLETED|Phase I: Period 1||18
6561106|NCT01791517|7484052|FG011|COMPLETED|Phase I: Period 1||19
6561107|NCT01791517|7484041|FG000|NOT COMPLETED|Phase I: Period 1||1
6561108|NCT01791517|7484042|FG001|NOT COMPLETED|Phase I: Period 1||2
6561109|NCT01791517|7484043|FG002|NOT COMPLETED|Phase I: Period 1||2
6372890|NCT00743444|7283831|FG001|NOT COMPLETED|First Intervention||1
6372891|NCT00743444|7283830|FG000|STARTED|Washout Period||14
6372892|NCT00743444|7283831|FG001|STARTED|Washout Period||12
6372893|NCT00743444|7283830|FG000|COMPLETED|Washout Period||14
6372894|NCT00743444|7283831|FG001|COMPLETED|Washout Period||11
6372895|NCT00743444|7283830|FG000|NOT COMPLETED|Washout Period||0
6372896|NCT00743444|7283831|FG001|NOT COMPLETED|Washout Period||1
6372897|NCT00743444|7283830|FG000|STARTED|Second Intervention||14
6372898|NCT00743444|7283831|FG001|STARTED|Second Intervention||11
6372899|NCT00743444|7283830|FG000|COMPLETED|Second Intervention||14
6372900|NCT00743444|7283831|FG001|COMPLETED|Second Intervention||11
6372901|NCT00743444|7283830|FG000|NOT COMPLETED|Second Intervention||0
6372902|NCT00743444|7283831|FG001|NOT COMPLETED|Second Intervention||0
6372903|NCT00743483|7283837|FG000|STARTED|Baseline Period||15
6372904|NCT00743483|7283837|FG000|COMPLETED|Baseline Period||14
6372905|NCT00743483|7283837|FG000|NOT COMPLETED|Baseline Period||1
6372906|NCT00743483|7283837|FG000|STARTED|Treatment Period||14
6372907|NCT00743483|7283837|FG000|COMPLETED|Treatment Period||13
6372908|NCT00743483|7283837|FG000|NOT COMPLETED|Treatment Period||1
6372909|NCT00743509|7283841|FG000|STARTED|Overall Study||49
6372910|NCT00743509|7283841|FG000|COMPLETED|Overall Study||47
6372911|NCT00743509|7283841|FG000|NOT COMPLETED|Overall Study||2
6372912|NCT00743574|7283845|FG000|STARTED|Overall Study||36
6372913|NCT00743574|7283845|FG000|Dropped Out Before Eligibility Testing|Overall Study||13
6372914|NCT00743574|7283845|FG000|Further Exclusions|Overall Study||8
6372915|NCT00743574|7283845|FG000|Dropped Out After Initiating Trial|Overall Study||3
6372916|NCT00743574|7283845|FG000|COMPLETED|Overall Study||12
6372917|NCT00743574|7283845|FG000|NOT COMPLETED|Overall Study||24
6561110|NCT01791517|7484044|FG003|NOT COMPLETED|Phase I: Period 1||2
6561111|NCT01791517|7484045|FG004|NOT COMPLETED|Phase I: Period 1||1
6561112|NCT01791517|7484046|FG005|NOT COMPLETED|Phase I: Period 1||1
6561113|NCT01791517|7484047|FG006|NOT COMPLETED|Phase I: Period 1||1
6561114|NCT01791517|7484048|FG007|NOT COMPLETED|Phase I: Period 1||0
6561115|NCT01791517|7484049|FG008|NOT COMPLETED|Phase I: Period 1||1
6561116|NCT01791517|7484050|FG009|NOT COMPLETED|Phase I: Period 1||1
6561117|NCT01791517|7484051|FG010|NOT COMPLETED|Phase I: Period 1||0
6561118|NCT01791517|7484052|FG011|NOT COMPLETED|Phase I: Period 1||1
6561119|NCT01791517|7484041|FG000|STARTED|Phase I: Period 2||18
6561120|NCT01791517|7484042|FG001|STARTED|Phase I: Period 2||18
6561121|NCT01791517|7484043|FG002|STARTED|Phase I: Period 2||18
6561122|NCT01791517|7484044|FG003|STARTED|Phase I: Period 2||17
6561123|NCT01791517|7484045|FG004|STARTED|Phase I: Period 2||19
6561124|NCT01791517|7484046|FG005|STARTED|Phase I: Period 2||19
6778127|NCT03792672|7705983|FG005|STARTED|Treatment Period 4 (2 Days)||4
6778128|NCT03792672|7705978|FG000|COMPLETED|Treatment Period 4 (2 Days)||2
6778129|NCT03792672|7705979|FG001|COMPLETED|Treatment Period 4 (2 Days)||4
6778130|NCT03792672|7705980|FG002|COMPLETED|Treatment Period 4 (2 Days)||3
6778131|NCT03792672|7705981|FG003|COMPLETED|Treatment Period 4 (2 Days)||2
6778132|NCT03792672|7705982|FG004|COMPLETED|Treatment Period 4 (2 Days)||4
6778133|NCT03792672|7705983|FG005|COMPLETED|Treatment Period 4 (2 Days)||4
6778134|NCT03792672|7705978|FG000|NOT COMPLETED|Treatment Period 4 (2 Days)||1
6778135|NCT03792672|7705979|FG001|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6778136|NCT03792672|7705980|FG002|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6778137|NCT03792672|7705981|FG003|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6778138|NCT03792672|7705982|FG004|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6778139|NCT03792672|7705983|FG005|NOT COMPLETED|Treatment Period 4 (2 Days)||0
6778140|NCT03786744|7705995|FG000|STARTED|Overall Study||10
6778141|NCT03786744|7705996|FG001|STARTED|Overall Study||10
6778142|NCT03786744|7705995|FG000|COMPLETED|Overall Study||10
6778143|NCT03786744|7705996|FG001|COMPLETED|Overall Study||10
6778144|NCT03786744|7705995|FG000|NOT COMPLETED|Overall Study||0
6778145|NCT03786744|7705996|FG001|NOT COMPLETED|Overall Study||0
6778146|NCT03782181|7706005|FG000|STARTED|Overall Study||20
6778147|NCT03782181|7706006|FG001|STARTED|Overall Study||20
6372918|NCT00743652|7283854|FG000|STARTED|Overall Study||151
6372919|NCT00743652|7283855|FG001|STARTED|Overall Study||51
6372920|NCT00743652|7283856|FG002|STARTED|Overall Study||25
6372921|NCT00743652|7283857|FG003|STARTED|Overall Study||67
6372922|NCT00743652|7283858|FG004|STARTED|Overall Study||79
6372923|NCT00743652|7283854|FG000|Vaccinated Dose 1|Overall Study||151
6561125|NCT01791517|7484047|FG006|STARTED|Phase I: Period 2||19
6561126|NCT01791517|7484048|FG007|STARTED|Phase I: Period 2||20
6561127|NCT01791517|7484049|FG008|STARTED|Phase I: Period 2||19
6561128|NCT01791517|7484050|FG009|STARTED|Phase I: Period 2||19
6561129|NCT01791517|7484051|FG010|STARTED|Phase I: Period 2||18
6778148|NCT03782181|7706005|FG000|COMPLETED|Overall Study||20
6372924|NCT00743652|7283855|FG001|Vaccinated Dose 1|Overall Study||51
6372925|NCT00743652|7283856|FG002|Vaccinated Dose 1|Overall Study||25
6372926|NCT00743652|7283857|FG003|Vaccinated Dose 1|Overall Study||66
6372927|NCT00743652|7283858|FG004|Vaccinated Dose 1|Overall Study||79
6372928|NCT00743652|7283854|FG000|Vaccinated Dose 2|Overall Study||112
6372929|NCT00743652|7283855|FG001|Vaccinated Dose 2|Overall Study||41
6372930|NCT00743652|7283856|FG002|Vaccinated Dose 2|Overall Study||0
6372931|NCT00743652|7283857|FG003|Vaccinated Dose 2|Overall Study||49
6372932|NCT00743652|7283858|FG004|Vaccinated Dose 2|Overall Study||0
6372933|NCT00743652|7283854|FG000|Vaccinated Dose 3|Overall Study||74
6372934|NCT00743652|7283855|FG001|Vaccinated Dose 3|Overall Study||0
6372935|NCT00743652|7283856|FG002|Vaccinated Dose 3|Overall Study||0
6372936|NCT00743652|7283857|FG003|Vaccinated Dose 3|Overall Study||0
6372937|NCT00743652|7283858|FG004|Vaccinated Dose 3|Overall Study||0
6372938|NCT00743652|7283854|FG000|Toddler Dose|Overall Study||15
6372939|NCT00743652|7283855|FG001|Toddler Dose|Overall Study||23
6372940|NCT00743652|7283856|FG002|Toddler Dose|Overall Study||16
6372941|NCT00743652|7283857|FG003|Toddler Dose|Overall Study||0
6372942|NCT00743652|7283858|FG004|Toddler Dose|Overall Study||0
6372943|NCT00743652|7283854|FG000|COMPLETED|Overall Study||141
6372944|NCT00743652|7283855|FG001|COMPLETED|Overall Study||48
6372945|NCT00743652|7283856|FG002|COMPLETED|Overall Study||23
6372946|NCT00743652|7283857|FG003|COMPLETED|Overall Study||63
6372947|NCT00743652|7283858|FG004|COMPLETED|Overall Study||79
6372948|NCT00743652|7283854|FG000|NOT COMPLETED|Overall Study||10
6372949|NCT00743652|7283855|FG001|NOT COMPLETED|Overall Study||3
6372950|NCT00743652|7283856|FG002|NOT COMPLETED|Overall Study||2
6372951|NCT00743652|7283857|FG003|NOT COMPLETED|Overall Study||4
6372952|NCT00743652|7283858|FG004|NOT COMPLETED|Overall Study||0
6372953|NCT00743717|7283876|FG000|STARTED|Overall Study||2
6372954|NCT00743717|7283877|FG001|STARTED|Overall Study||2
6372955|NCT00743717|7283876|FG000|COMPLETED|Overall Study||2
6372956|NCT00743717|7283877|FG001|COMPLETED|Overall Study||2
6372957|NCT00743717|7283876|FG000|NOT COMPLETED|Overall Study||0
6372958|NCT00743717|7283877|FG001|NOT COMPLETED|Overall Study||0
6372959|NCT00743730|7283886|FG000|STARTED|Overall Study||27
6372960|NCT00743730|7283887|FG001|STARTED|Overall Study||34
6372961|NCT00743730|7283888|FG002|STARTED|Overall Study||33
6372962|NCT00743730|7283886|FG000|COMPLETED|Overall Study||22
6372963|NCT00743730|7283887|FG001|COMPLETED|Overall Study||30
6372964|NCT00743730|7283888|FG002|COMPLETED|Overall Study||28
6372965|NCT00743730|7283886|FG000|NOT COMPLETED|Overall Study||5
6372966|NCT00743730|7283887|FG001|NOT COMPLETED|Overall Study||4
6372967|NCT00743730|7283888|FG002|NOT COMPLETED|Overall Study||5
6372968|NCT00744042|7283900|FG000|STARTED|Overall Study||11
6372969|NCT00744042|7283900|FG000|COMPLETED|Overall Study||10
6372970|NCT00744042|7283900|FG000|NOT COMPLETED|Overall Study||1
6372971|NCT00744055|7283912|FG000|STARTED|Overall Study||50
6372972|NCT00744055|7283913|FG001|STARTED|Overall Study||46
6372973|NCT00744055|7283912|FG000|COMPLETED|Overall Study||43
6372974|NCT00744055|7283913|FG001|COMPLETED|Overall Study||32
6372975|NCT00744055|7283912|FG000|NOT COMPLETED|Overall Study||7
6372976|NCT00744055|7283913|FG001|NOT COMPLETED|Overall Study||14
6372977|NCT00744211|7283922|FG000|STARTED|Baseline||10
6372978|NCT00744211|7283923|FG001|STARTED|Baseline||9
6372979|NCT00744211|7283924|FG002|STARTED|Baseline||10
6372980|NCT00744211|7283922|FG000|COMPLETED|Baseline||10
6372981|NCT00744211|7283923|FG001|COMPLETED|Baseline||9
6372982|NCT00744211|7283924|FG002|COMPLETED|Baseline||10
6372983|NCT00744211|7283922|FG000|NOT COMPLETED|Baseline||0
6372984|NCT00744211|7283923|FG001|NOT COMPLETED|Baseline||0
6372985|NCT00744211|7283924|FG002|NOT COMPLETED|Baseline||0
6372986|NCT00744211|7283922|FG000|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
6372987|NCT00744211|7283923|FG001|STARTED|0.5 Hours After Cardiopulmonary Bypass||9
6372988|NCT00744211|7283924|FG002|STARTED|0.5 Hours After Cardiopulmonary Bypass||10
6372989|NCT00744211|7283922|FG000|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
6372990|NCT00744211|7283923|FG001|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||9
6372991|NCT00744211|7283924|FG002|COMPLETED|0.5 Hours After Cardiopulmonary Bypass||10
6372992|NCT00744211|7283922|FG000|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
6372993|NCT00744211|7283923|FG001|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
6372994|NCT00744211|7283924|FG002|NOT COMPLETED|0.5 Hours After Cardiopulmonary Bypass||0
6372995|NCT00744211|7283922|FG000|STARTED|6 Hours After Cardiopulmonary Bypass||10
6372996|NCT00744211|7283923|FG001|STARTED|6 Hours After Cardiopulmonary Bypass||9
6372997|NCT00744211|7283924|FG002|STARTED|6 Hours After Cardiopulmonary Bypass||10
6372998|NCT00744211|7283922|FG000|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
6372999|NCT00744211|7283923|FG001|COMPLETED|6 Hours After Cardiopulmonary Bypass||9
6373000|NCT00744211|7283924|FG002|COMPLETED|6 Hours After Cardiopulmonary Bypass||10
6373001|NCT00744211|7283922|FG000|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
6373002|NCT00744211|7283923|FG001|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
6373003|NCT00744211|7283924|FG002|NOT COMPLETED|6 Hours After Cardiopulmonary Bypass||0
6373004|NCT00744211|7283922|FG000|STARTED|12 Hours After Cardiopulmonary Bypass||10
6373005|NCT00744211|7283923|FG001|STARTED|12 Hours After Cardiopulmonary Bypass||9
6373006|NCT00744211|7283924|FG002|STARTED|12 Hours After Cardiopulmonary Bypass||10
6373007|NCT00744211|7283922|FG000|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
6373008|NCT00744211|7283923|FG001|COMPLETED|12 Hours After Cardiopulmonary Bypass||9
6373009|NCT00744211|7283924|FG002|COMPLETED|12 Hours After Cardiopulmonary Bypass||10
6373010|NCT00744211|7283922|FG000|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
6373011|NCT00744211|7283923|FG001|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
6373012|NCT00744211|7283924|FG002|NOT COMPLETED|12 Hours After Cardiopulmonary Bypass||0
6373013|NCT00744211|7283922|FG000|STARTED|24 Hours After Cardiopulmonary Bypass||10
6373014|NCT00744211|7283923|FG001|STARTED|24 Hours After Cardiopulmonary Bypass||9
6373015|NCT00744211|7283924|FG002|STARTED|24 Hours After Cardiopulmonary Bypass||10
6373016|NCT00744211|7283922|FG000|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
6373017|NCT00744211|7283923|FG001|COMPLETED|24 Hours After Cardiopulmonary Bypass||9
6373018|NCT00744211|7283924|FG002|COMPLETED|24 Hours After Cardiopulmonary Bypass||10
6373019|NCT00744211|7283922|FG000|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
6373020|NCT00744211|7283923|FG001|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
6373021|NCT00744211|7283924|FG002|NOT COMPLETED|24 Hours After Cardiopulmonary Bypass||0
6373022|NCT00744237|7283938|FG000|STARTED|Overall Study||83
6373023|NCT00744237|7283939|FG001|STARTED|Overall Study||73
6373024|NCT00744237|7283940|FG002|STARTED|Overall Study||74
6373025|NCT00744237|7283938|FG000|COMPLETED|Overall Study||56
6373026|NCT00744237|7283939|FG001|COMPLETED|Overall Study||46
6373027|NCT00744237|7283940|FG002|COMPLETED|Overall Study||59
6373028|NCT00744237|7283938|FG000|NOT COMPLETED|Overall Study||27
6373029|NCT00744237|7283939|FG001|NOT COMPLETED|Overall Study||27
6373030|NCT00744237|7283940|FG002|NOT COMPLETED|Overall Study||15
6373031|NCT00744263|7283950|FG000|STARTED|Overall Study||42240
6373032|NCT00744263|7283951|FG001|STARTED|Overall Study||42256
6373033|NCT00744263|7283950|FG000|COMPLETED|Overall Study||37004
6373034|NCT00744263|7283951|FG001|COMPLETED|Overall Study||36936
6373035|NCT00744263|7283950|FG000|NOT COMPLETED|Overall Study||5236
6373036|NCT00744263|7283951|FG001|NOT COMPLETED|Overall Study||5320
6373037|NCT00744328|7283962|FG000|STARTED|Overall Study||26
6373038|NCT00744328|7283963|FG001|STARTED|Overall Study||30
6373039|NCT00744328|7283964|FG002|STARTED|Overall Study||29
6373040|NCT00744328|7283962|FG000|COMPLETED|Overall Study||19
6373041|NCT00744328|7283963|FG001|COMPLETED|Overall Study||22
6373042|NCT00744328|7283964|FG002|COMPLETED|Overall Study||21
6373043|NCT00744328|7283962|FG000|NOT COMPLETED|Overall Study||7
6778149|NCT03782181|7706006|FG001|COMPLETED|Overall Study||20
6778150|NCT03782181|7706005|FG000|NOT COMPLETED|Overall Study||0
6778151|NCT03782181|7706006|FG001|NOT COMPLETED|Overall Study||0
6778152|NCT03792191|7706015|FG000|STARTED|Overall Study||140
6778153|NCT03792191|7706016|FG001|STARTED|Overall Study||140
6778154|NCT03792191|7706015|FG000|COMPLETED|Overall Study||140
6778155|NCT03792191|7706016|FG001|COMPLETED|Overall Study||140
6778156|NCT03792191|7706015|FG000|NOT COMPLETED|Overall Study||0
6778157|NCT03792191|7706016|FG001|NOT COMPLETED|Overall Study||0
6778158|NCT03791489|7706022|FG000|STARTED|30 Days||30
6778159|NCT03791489|7706022|FG000|COMPLETED|30 Days||30
6778160|NCT03791489|7706022|FG000|NOT COMPLETED|30 Days||0
6778161|NCT03791489|7706022|FG000|STARTED|90 Days (Primary Endpoint)||30
6778162|NCT03791489|7706022|FG000|COMPLETED|90 Days (Primary Endpoint)||30
6778163|NCT03791489|7706022|FG000|NOT COMPLETED|90 Days (Primary Endpoint)||0
6778164|NCT03790865|7706029|FG000|STARTED|Overall Study||52
6778165|NCT03790865|7706030|FG001|STARTED|Overall Study||52
6778166|NCT03790865|7706031|FG002|STARTED|Overall Study||54
6778167|NCT03790865|7706029|FG000|COMPLETED|Overall Study||52
6778168|NCT03790865|7706030|FG001|COMPLETED|Overall Study||50
6778169|NCT03790865|7706031|FG002|COMPLETED|Overall Study||54
6778170|NCT03790865|7706029|FG000|NOT COMPLETED|Overall Study||0
6778171|NCT03790865|7706030|FG001|NOT COMPLETED|Overall Study||2
6778172|NCT03790865|7706031|FG002|NOT COMPLETED|Overall Study||0
6778173|NCT03784300|7706045|FG000|STARTED|Overall Study||6
6778174|NCT03784300|7706046|FG001|STARTED|Overall Study||2
6778175|NCT03784300|7706047|FG002|STARTED|Overall Study||6
6778176|NCT03784300|7706048|FG003|STARTED|Overall Study||2
6778177|NCT03784300|7706049|FG004|STARTED|Overall Study||6
6778178|NCT03784300|7706050|FG005|STARTED|Overall Study||2
6778179|NCT03784300|7706045|FG000|COMPLETED|Overall Study||6
6778180|NCT03784300|7706046|FG001|COMPLETED|Overall Study||2
6778181|NCT03784300|7706047|FG002|COMPLETED|Overall Study||6
6778182|NCT03784300|7706048|FG003|COMPLETED|Overall Study||2
6778183|NCT03784300|7706049|FG004|COMPLETED|Overall Study||6
6778184|NCT03784300|7706050|FG005|COMPLETED|Overall Study||2
6778185|NCT03784300|7706045|FG000|NOT COMPLETED|Overall Study||0
6778186|NCT03784300|7706046|FG001|NOT COMPLETED|Overall Study||0
6778187|NCT03784300|7706047|FG002|NOT COMPLETED|Overall Study||0
6778188|NCT03784300|7706048|FG003|NOT COMPLETED|Overall Study||0
6778189|NCT03784300|7706049|FG004|NOT COMPLETED|Overall Study||0
6373044|NCT00744328|7283963|FG001|NOT COMPLETED|Overall Study||8
6373045|NCT00744328|7283964|FG002|NOT COMPLETED|Overall Study||8
6373046|NCT00744380|7283974|FG000|STARTED|Overall Study||12
6373047|NCT00744380|7283975|FG001|STARTED|Overall Study||11
6373048|NCT00744380|7283974|FG000|COMPLETED|Overall Study||12
6373049|NCT00744380|7283975|FG001|COMPLETED|Overall Study||11
6373050|NCT00744380|7283974|FG000|NOT COMPLETED|Overall Study||0
6778190|NCT03784300|7706050|FG005|NOT COMPLETED|Overall Study||0
6778191|NCT03790878|7706067|FG000|STARTED|Overall Study||26
6778192|NCT03790878|7706068|FG001|STARTED|Overall Study||27
6778193|NCT03790878|7706069|FG002|STARTED|Overall Study||27
6778194|NCT03790878|7706067|FG000|COMPLETED|Overall Study||26
6778195|NCT03790878|7706068|FG001|COMPLETED|Overall Study||27
6778196|NCT03790878|7706069|FG002|COMPLETED|Overall Study||27
6778197|NCT03790878|7706067|FG000|NOT COMPLETED|Overall Study||0
6373051|NCT00744380|7283975|FG001|NOT COMPLETED|Overall Study||0
6373052|NCT00744471|7283986|FG000|STARTED|Overall Study||156
6373053|NCT00744471|7283987|FG001|STARTED|Overall Study||156
6373054|NCT00744471|7283988|FG002|STARTED|Overall Study||158
6373055|NCT00744471|7283989|FG003|STARTED|Overall Study||157
6373056|NCT00744471|7283986|FG000|Treated|Overall Study||155
6373057|NCT00744471|7283987|FG001|Treated|Overall Study||155
6373058|NCT00744471|7283988|FG002|Treated|Overall Study||154
6373059|NCT00744471|7283989|FG003|Treated|Overall Study||157
6373060|NCT00744471|7283986|FG000|COMPLETED|Overall Study||13
6373061|NCT00744471|7283987|FG001|COMPLETED|Overall Study||11
6373062|NCT00744471|7283988|FG002|COMPLETED|Overall Study||6
6373063|NCT00744471|7283989|FG003|COMPLETED|Overall Study||9
6373064|NCT00744471|7283986|FG000|NOT COMPLETED|Overall Study||143
6373065|NCT00744471|7283987|FG001|NOT COMPLETED|Overall Study||145
6373066|NCT00744471|7283988|FG002|NOT COMPLETED|Overall Study||152
6373067|NCT00744471|7283989|FG003|NOT COMPLETED|Overall Study||148
6373068|NCT00744497|7284001|FG000|STARTED|Overall Study|Randomized|760
6373069|NCT00744497|7284002|FG001|STARTED|Overall Study|Randomized|762
6373070|NCT00744497|7284001|FG000|Received Treatment|Overall Study||757
6373071|NCT00744497|7284002|FG001|Received Treatment|Overall Study||761
6373072|NCT00744497|7284001|FG000|COMPLETED|Overall Study||0
6373073|NCT00744497|7284002|FG001|COMPLETED|Overall Study||0
6373074|NCT00744497|7284001|FG000|NOT COMPLETED|Overall Study||760
6373075|NCT00744497|7284002|FG001|NOT COMPLETED|Overall Study||762
6373076|NCT00744523|7284010|FG000|STARTED|Procedure||37
6373077|NCT00744523|7284011|FG001|STARTED|Procedure||225
6373078|NCT00744523|7284010|FG000|COMPLETED|Procedure||37
6373079|NCT00744523|7284011|FG001|COMPLETED|Procedure||225
6373080|NCT00744523|7284010|FG000|NOT COMPLETED|Procedure||0
6373081|NCT00744523|7284011|FG001|NOT COMPLETED|Procedure||0
6373082|NCT00744523|7284010|FG000|STARTED|30 Days After the Procedure||37
6373083|NCT00744523|7284011|FG001|STARTED|30 Days After the Procedure||225
6373084|NCT00744523|7284010|FG000|COMPLETED|30 Days After the Procedure||37
6373085|NCT00744523|7284011|FG001|COMPLETED|30 Days After the Procedure||220
6373086|NCT00744523|7284010|FG000|NOT COMPLETED|30 Days After the Procedure||0
6373087|NCT00744523|7284011|FG001|NOT COMPLETED|30 Days After the Procedure||5
6373088|NCT00744627|7284021|FG000|STARTED|Overall Study||151
6373089|NCT00744627|7284022|FG001|STARTED|Overall Study||150
6373090|NCT00744627|7284021|FG000|Treated|Overall Study||150
6373091|NCT00744627|7284022|FG001|Treated|Overall Study||150
6373092|NCT00744627|7284021|FG000|COMPLETED|Overall Study||126
6373093|NCT00744627|7284022|FG001|COMPLETED|Overall Study||128
6373094|NCT00744627|7284021|FG000|NOT COMPLETED|Overall Study||25
6373095|NCT00744627|7284022|FG001|NOT COMPLETED|Overall Study||22
6778198|NCT03790878|7706068|FG001|NOT COMPLETED|Overall Study||0
6778199|NCT03790878|7706069|FG002|NOT COMPLETED|Overall Study||0
6778200|NCT03789474|7706079|FG000|STARTED|Overall Study||30
6778201|NCT03789474|7706080|FG001|STARTED|Overall Study||30
6778202|NCT03789474|7706079|FG000|COMPLETED|Overall Study||30
6778203|NCT03789474|7706080|FG001|COMPLETED|Overall Study||30
6778204|NCT03789474|7706079|FG000|NOT COMPLETED|Overall Study||0
6778205|NCT03789474|7706080|FG001|NOT COMPLETED|Overall Study||0
6778206|NCT03789175|7706086|FG000|STARTED|Week 0 to Week 12 of NR||1
6778207|NCT03789175|7706086|FG000|COMPLETED|Week 0 to Week 12 of NR||1
6778208|NCT03789175|7706086|FG000|NOT COMPLETED|Week 0 to Week 12 of NR||0
6778209|NCT03789175|7706086|FG000|STARTED|Week 12 to Week 24 of NR||1
6778210|NCT03789175|7706086|FG000|COMPLETED|Week 12 to Week 24 of NR|Participant did not meet primary endpoint and completed study at week 24|1
6778211|NCT03789175|7706086|FG000|NOT COMPLETED|Week 12 to Week 24 of NR||0
6778212|NCT03787615|7706092|FG000|STARTED|Overall Study||31
6778213|NCT03787615|7706092|FG000|COMPLETED|Overall Study||27
6778214|NCT03787615|7706092|FG000|NOT COMPLETED|Overall Study||4
6778215|NCT03786718|7706097|FG000|STARTED|Overall Study||67
6778216|NCT03786718|7706097|FG000|COMPLETED|Overall Study||60
6778217|NCT03786718|7706097|FG000|NOT COMPLETED|Overall Study||7
6778218|NCT03784963|7706106|FG000|STARTED|Overall Study||12
6778219|NCT03784963|7706107|FG001|STARTED|Overall Study||10
6778220|NCT03784963|7706108|FG002|STARTED|Overall Study||1
6778221|NCT03784963|7706109|FG003|STARTED|Overall Study||0
6778222|NCT03784963|7706106|FG000|COMPLETED|Overall Study||0
6778223|NCT03784963|7706107|FG001|COMPLETED|Overall Study||0
6778224|NCT03784963|7706108|FG002|COMPLETED|Overall Study||0
6778225|NCT03784963|7706109|FG003|COMPLETED|Overall Study||0
6778226|NCT03784963|7706106|FG000|NOT COMPLETED|Overall Study||12
6778227|NCT03784963|7706107|FG001|NOT COMPLETED|Overall Study||10
6373096|NCT00744653|7284028|FG000|STARTED|Overall Study||17
6373097|NCT00744653|7284028|FG000|COMPLETED|Overall Study||1
6373098|NCT00744653|7284028|FG000|NOT COMPLETED|Overall Study||16
6373099|NCT00744692|7284033|FG000|STARTED|Overall Study||22
6373100|NCT00744692|7284033|FG000|COMPLETED|Overall Study||22
6373101|NCT00744692|7284033|FG000|NOT COMPLETED|Overall Study||0
6373102|NCT00744757|7284037|FG000|STARTED|Overall Study||37
6373103|NCT00744757|7284037|FG000|COMPLETED|Overall Study||16
6778228|NCT03784963|7706108|FG002|NOT COMPLETED|Overall Study||1
6778229|NCT03784963|7706109|FG003|NOT COMPLETED|Overall Study||0
6778230|NCT03771274|7706119|FG000|STARTED|Overall Study||39
6778231|NCT03771274|7706119|FG000|COMPLETED|Overall Study||39
6778232|NCT03771274|7706119|FG000|NOT COMPLETED|Overall Study||0
6778233|NCT03787472|7706123|FG000|STARTED|Period 1||23
6778234|NCT03787472|7706124|FG001|STARTED|Period 1||22
6778235|NCT03787472|7706123|FG000|COMPLETED|Period 1||23
6373104|NCT00744757|7284037|FG000|NOT COMPLETED|Overall Study||21
6373105|NCT00744796|7284041|FG000|STARTED|Pre-operative||21
6373106|NCT00744796|7284041|FG000|COMPLETED|Pre-operative||21
6373107|NCT00744796|7284041|FG000|NOT COMPLETED|Pre-operative||0
6373108|NCT00744796|7284041|FG000|STARTED|Post-Operative Day 1||21
6373109|NCT00744796|7284041|FG000|COMPLETED|Post-Operative Day 1||21
6373110|NCT00744796|7284041|FG000|NOT COMPLETED|Post-Operative Day 1||0
6373111|NCT00744796|7284041|FG000|STARTED|Post-Operative 3-6 Months||21
6373112|NCT00744796|7284041|FG000|COMPLETED|Post-Operative 3-6 Months||21
6373113|NCT00744796|7284041|FG000|NOT COMPLETED|Post-Operative 3-6 Months||0
6373114|NCT00744796|7284041|FG000|STARTED|Post-Operative 6-9 Months||21
6373115|NCT00744796|7284041|FG000|COMPLETED|Post-Operative 6-9 Months||9
6373116|NCT00744796|7284041|FG000|NOT COMPLETED|Post-Operative 6-9 Months||12
6373117|NCT00744848|7284047|FG000|STARTED|Overall Study||103
6373118|NCT00744848|7284048|FG001|STARTED|Overall Study||101
6373119|NCT00744848|7284047|FG000|COMPLETED|Overall Study||103
6373120|NCT00744848|7284048|FG001|COMPLETED|Overall Study||101
6373121|NCT00744848|7284047|FG000|NOT COMPLETED|Overall Study||0
6373122|NCT00744848|7284048|FG001|NOT COMPLETED|Overall Study||0
6373123|NCT00744861|7284058|FG000|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|8
6373124|NCT00744861|7284059|FG001|STARTED|Feasibility Stage 1|Stage 1: Study phase to determine the feasibility of the study treatment and assessments|10
6373125|NCT00744861|7284060|FG002|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
6373126|NCT00744861|7284061|FG003|STARTED|Feasibility Stage 1|No subjects enrolled in Stage 1/Feasibility study|0
6373127|NCT00744861|7284058|FG000|COMPLETED|Feasibility Stage 1||7
6373128|NCT00744861|7284059|FG001|COMPLETED|Feasibility Stage 1||8
6373129|NCT00744861|7284060|FG002|COMPLETED|Feasibility Stage 1||0
6373130|NCT00744861|7284061|FG003|COMPLETED|Feasibility Stage 1||0
6373131|NCT00744861|7284058|FG000|NOT COMPLETED|Feasibility Stage 1||1
6373132|NCT00744861|7284059|FG001|NOT COMPLETED|Feasibility Stage 1||2
6373133|NCT00744861|7284060|FG002|NOT COMPLETED|Feasibility Stage 1||0
6373134|NCT00744861|7284061|FG003|NOT COMPLETED|Feasibility Stage 1||0
6373135|NCT00744861|7284058|FG000|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
6373136|NCT00744861|7284059|FG001|STARTED|Pivotal Stage 2|No subjects enrolled in Stage 2 pivotal study phase|0
6373137|NCT00744861|7284060|FG002|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|154
6373138|NCT00744861|7284061|FG003|STARTED|Pivotal Stage 2|Stage 2 pivotal study phase assessed safety and effectiveness of LIPUS treatment via Exospine device|156
6778236|NCT03787472|7706124|FG001|COMPLETED|Period 1||22
6778237|NCT03787472|7706123|FG000|NOT COMPLETED|Period 1||0
6778238|NCT03787472|7706124|FG001|NOT COMPLETED|Period 1||0
6778239|NCT03787472|7706123|FG000|STARTED|Period 2||23
6778240|NCT03787472|7706124|FG001|STARTED|Period 2||22
6778241|NCT03787472|7706123|FG000|COMPLETED|Period 2||23
6778242|NCT03787472|7706124|FG001|COMPLETED|Period 2||22
6778243|NCT03787472|7706123|FG000|NOT COMPLETED|Period 2||0
6778244|NCT03787472|7706124|FG001|NOT COMPLETED|Period 2||0
6778245|NCT03787212|7706130|FG000|STARTED|Period 1||2
6778246|NCT03787212|7706131|FG001|STARTED|Period 1||2
6778247|NCT03787212|7706130|FG000|COMPLETED|Period 1||2
6778248|NCT03787212|7706131|FG001|COMPLETED|Period 1||2
6778249|NCT03787212|7706130|FG000|NOT COMPLETED|Period 1||0
6778250|NCT03787212|7706131|FG001|NOT COMPLETED|Period 1||0
6778251|NCT03787212|7706130|FG000|STARTED|Period 1||2
6778252|NCT03787212|7706131|FG001|STARTED|Period 1||2
6778253|NCT03787212|7706130|FG000|COMPLETED|Period 1||0
6778254|NCT03787212|7706131|FG001|COMPLETED|Period 1||0
6778255|NCT03787212|7706130|FG000|NOT COMPLETED|Period 1||2
6778256|NCT03787212|7706131|FG001|NOT COMPLETED|Period 1||2
6778257|NCT03784001|7706140|FG000|STARTED|Overall Study||46
6778258|NCT03784001|7706141|FG001|STARTED|Overall Study||38
6778259|NCT03784001|7706142|FG002|STARTED|Overall Study||41
6778260|NCT03784001|7706140|FG000|COMPLETED|Overall Study||44
6778261|NCT03784001|7706141|FG001|COMPLETED|Overall Study||38
6778262|NCT03784001|7706142|FG002|COMPLETED|Overall Study||40
6778263|NCT03784001|7706140|FG000|NOT COMPLETED|Overall Study||2
6778264|NCT03784001|7706141|FG001|NOT COMPLETED|Overall Study||0
6778265|NCT03784001|7706142|FG002|NOT COMPLETED|Overall Study||1
6778266|NCT03783702|7706152|FG000|STARTED|Overall Study||56
6778267|NCT03783702|7706153|FG001|STARTED|Overall Study||62
6778268|NCT03783702|7706152|FG000|COMPLETED|Overall Study||49
6778269|NCT03783702|7706153|FG001|COMPLETED|Overall Study||51
6778270|NCT03783702|7706152|FG000|NOT COMPLETED|Overall Study||7
6778271|NCT03783702|7706153|FG001|NOT COMPLETED|Overall Study||11
6778272|NCT03781479|7706162|FG000|STARTED|Overall Study||6
6778273|NCT03781479|7706163|FG001|STARTED|Overall Study||6
6778274|NCT03781479|7706164|FG002|STARTED|Overall Study||1
6778275|NCT03781479|7706162|FG000|COMPLETED|Overall Study||6
6778276|NCT03781479|7706163|FG001|COMPLETED|Overall Study||6
6778277|NCT03781479|7706164|FG002|COMPLETED|Overall Study||0
6778278|NCT03781479|7706162|FG000|NOT COMPLETED|Overall Study||0
6778279|NCT03781479|7706163|FG001|NOT COMPLETED|Overall Study||0
6778280|NCT03781479|7706164|FG002|NOT COMPLETED|Overall Study||1
6778281|NCT03781037|7706170|FG000|STARTED|Overall Study||18
6778282|NCT03781037|7706170|FG000|COMPLETED|Overall Study||18
6778283|NCT03781037|7706170|FG000|NOT COMPLETED|Overall Study||0
6778284|NCT03784079|7706182|FG000|STARTED|Part 1: Up to Day 24||6
6778285|NCT03784079|7706183|FG001|STARTED|Part 1: Up to Day 24||6
6778286|NCT03784079|7706184|FG002|STARTED|Part 1: Up to Day 24||2
6373139|NCT00744861|7284058|FG000|COMPLETED|Pivotal Stage 2||0
6373140|NCT00744861|7284059|FG001|COMPLETED|Pivotal Stage 2||0
6373141|NCT00744861|7284060|FG002|COMPLETED|Pivotal Stage 2||52
6373142|NCT00744861|7284061|FG003|COMPLETED|Pivotal Stage 2||51
6373143|NCT00744861|7284058|FG000|NOT COMPLETED|Pivotal Stage 2||0
6373144|NCT00744861|7284059|FG001|NOT COMPLETED|Pivotal Stage 2||0
6373145|NCT00744861|7284060|FG002|NOT COMPLETED|Pivotal Stage 2||102
6373146|NCT00744861|7284061|FG003|NOT COMPLETED|Pivotal Stage 2||105
6373147|NCT00744874|7284069|FG000|STARTED|Overall Study||55
6373148|NCT00744874|7284069|FG000|COMPLETED|Overall Study||51
6373149|NCT00744874|7284069|FG000|NOT COMPLETED|Overall Study||4
6373150|NCT00744939|7284084|FG000|STARTED|Overall Study||168
6373151|NCT00744939|7284084|FG000|Treatment Received|Overall Study||141
6373152|NCT00744939|7284084|FG000|COMPLETED|Overall Study||77
6373153|NCT00744939|7284084|FG000|NOT COMPLETED|Overall Study||91
6373154|NCT00744965|7284098|FG000|STARTED|Overall Study||197
6373155|NCT00744965|7284099|FG001|STARTED|Overall Study||198
6373156|NCT00744965|7284098|FG000|COMPLETED|Overall Study||186
6373157|NCT00744965|7284099|FG001|COMPLETED|Overall Study||189
6373158|NCT00744965|7284098|FG000|NOT COMPLETED|Overall Study||11
6373159|NCT00744965|7284099|FG001|NOT COMPLETED|Overall Study||9
6373160|NCT00744978|7284107|FG000|STARTED|Period 1||32
6373161|NCT00744978|7284108|FG001|STARTED|Period 1||34
6373162|NCT00744978|7284107|FG000|Treated|Period 1||31
6373163|NCT00744978|7284108|FG001|Treated|Period 1||33
6373164|NCT00744978|7284107|FG000|COMPLETED|Period 1||26
6373165|NCT00744978|7284108|FG001|COMPLETED|Period 1||29
6373166|NCT00744978|7284107|FG000|NOT COMPLETED|Period 1||6
6373167|NCT00744978|7284108|FG001|NOT COMPLETED|Period 1||5
6373168|NCT00744978|7284107|FG000|STARTED|Placebo Washout||26
6373169|NCT00744978|7284108|FG001|STARTED|Placebo Washout||29
6373170|NCT00744978|7284107|FG000|COMPLETED|Placebo Washout||26
6373171|NCT00744978|7284108|FG001|COMPLETED|Placebo Washout||29
6373172|NCT00744978|7284107|FG000|NOT COMPLETED|Placebo Washout||0
6373173|NCT00744978|7284108|FG001|NOT COMPLETED|Placebo Washout||0
6373174|NCT00744978|7284107|FG000|STARTED|Period 2||26
6373175|NCT00744978|7284108|FG001|STARTED|Period 2||29
6373176|NCT00744978|7284107|FG000|COMPLETED|Period 2||26
6373177|NCT00744978|7284108|FG001|COMPLETED|Period 2||28
6373178|NCT00744978|7284107|FG000|NOT COMPLETED|Period 2||0
6373179|NCT00744978|7284108|FG001|NOT COMPLETED|Period 2||1
6561130|NCT01791517|7484052|FG011|STARTED|Phase I: Period 2||19
6561131|NCT01791517|7484041|FG000|COMPLETED|Phase I: Period 2||17
6778287|NCT03784079|7706185|FG003|STARTED|Part 1: Up to Day 24||0
6778288|NCT03784079|7706186|FG004|STARTED|Part 1: Up to Day 24||0
6778289|NCT03784079|7706187|FG005|STARTED|Part 1: Up to Day 24||0
6778290|NCT03784079|7706188|FG006|STARTED|Part 1: Up to Day 24||0
6778291|NCT03784079|7706182|FG000|COMPLETED|Part 1: Up to Day 24||6
6778292|NCT03784079|7706183|FG001|COMPLETED|Part 1: Up to Day 24||6
6778293|NCT03784079|7706184|FG002|COMPLETED|Part 1: Up to Day 24||2
6778294|NCT03784079|7706185|FG003|COMPLETED|Part 1: Up to Day 24||0
6778295|NCT03784079|7706186|FG004|COMPLETED|Part 1: Up to Day 24||0
6778296|NCT03784079|7706187|FG005|COMPLETED|Part 1: Up to Day 24||0
6778297|NCT03784079|7706188|FG006|COMPLETED|Part 1: Up to Day 24||0
6778298|NCT03784079|7706182|FG000|NOT COMPLETED|Part 1: Up to Day 24||0
6778299|NCT03784079|7706183|FG001|NOT COMPLETED|Part 1: Up to Day 24||0
6778300|NCT03784079|7706184|FG002|NOT COMPLETED|Part 1: Up to Day 24||0
6778301|NCT03784079|7706185|FG003|NOT COMPLETED|Part 1: Up to Day 24||0
6778302|NCT03784079|7706186|FG004|NOT COMPLETED|Part 1: Up to Day 24||0
6778303|NCT03784079|7706187|FG005|NOT COMPLETED|Part 1: Up to Day 24||0
6778304|NCT03784079|7706188|FG006|NOT COMPLETED|Part 1: Up to Day 24||0
6778305|NCT03784079|7706182|FG000|STARTED|Part 2: Up to Day 12||0
6778306|NCT03784079|7706183|FG001|STARTED|Part 2: Up to Day 12||0
6778307|NCT03784079|7706184|FG002|STARTED|Part 2: Up to Day 12||0
6778308|NCT03784079|7706185|FG003|STARTED|Part 2: Up to Day 12||6
6778309|NCT03784079|7706186|FG004|STARTED|Part 2: Up to Day 12||6
6778310|NCT03784079|7706187|FG005|STARTED|Part 2: Up to Day 12||6
6778311|NCT03784079|7706188|FG006|STARTED|Part 2: Up to Day 12||2
6778312|NCT03784079|7706182|FG000|COMPLETED|Part 2: Up to Day 12||0
6778313|NCT03784079|7706183|FG001|COMPLETED|Part 2: Up to Day 12||0
6778314|NCT03784079|7706184|FG002|COMPLETED|Part 2: Up to Day 12||0
6778315|NCT03784079|7706185|FG003|COMPLETED|Part 2: Up to Day 12||6
6778316|NCT03784079|7706186|FG004|COMPLETED|Part 2: Up to Day 12||6
6778317|NCT03784079|7706187|FG005|COMPLETED|Part 2: Up to Day 12||6
6778318|NCT03784079|7706188|FG006|COMPLETED|Part 2: Up to Day 12||2
6778319|NCT03784079|7706182|FG000|NOT COMPLETED|Part 2: Up to Day 12||0
6778320|NCT03784079|7706183|FG001|NOT COMPLETED|Part 2: Up to Day 12||0
6778321|NCT03784079|7706184|FG002|NOT COMPLETED|Part 2: Up to Day 12||0
6778322|NCT03784079|7706185|FG003|NOT COMPLETED|Part 2: Up to Day 12||0
6778323|NCT03784079|7706186|FG004|NOT COMPLETED|Part 2: Up to Day 12||0
6778324|NCT03784079|7706187|FG005|NOT COMPLETED|Part 2: Up to Day 12||0
6561132|NCT01791517|7484042|FG001|COMPLETED|Phase I: Period 2||15
6778325|NCT03784079|7706188|FG006|NOT COMPLETED|Part 2: Up to Day 12||0
6778326|NCT03783039|7706211|FG000|STARTED|Overall Study||119
6778327|NCT03783039|7706212|FG001|STARTED|Overall Study||115
6778328|NCT03783039|7706211|FG000|COMPLETED|Overall Study||117
6373180|NCT00744991|7284114|FG000|STARTED|Overall Study||25
6373181|NCT00744991|7284114|FG000|Received at Least 1 Dose|Overall Study||25
6373182|NCT00744991|7284114|FG000|COMPLETED|Overall Study||0
6373183|NCT00744991|7284114|FG000|NOT COMPLETED|Overall Study||25
6373184|NCT00745095|7284127|FG000|STARTED|Overall Study||15
6373185|NCT00745095|7284128|FG001|STARTED|Overall Study||15
6373186|NCT00745095|7284129|FG002|STARTED|Overall Study||15
6373187|NCT00745095|7284130|FG003|STARTED|Overall Study||15
6373188|NCT00745095|7284131|FG004|STARTED|Overall Study||150
6373189|NCT00745095|7284132|FG005|STARTED|Overall Study||150
6373190|NCT00745095|7284127|FG000|COMPLETED|Overall Study||14
6373191|NCT00745095|7284128|FG001|COMPLETED|Overall Study||13
6373192|NCT00745095|7284129|FG002|COMPLETED|Overall Study||12
6373193|NCT00745095|7284130|FG003|COMPLETED|Overall Study||12
6373194|NCT00745095|7284131|FG004|COMPLETED|Overall Study||28
6373195|NCT00745095|7284132|FG005|COMPLETED|Overall Study||27
6373196|NCT00745095|7284127|FG000|NOT COMPLETED|Overall Study||1
6373197|NCT00745095|7284128|FG001|NOT COMPLETED|Overall Study||2
6373198|NCT00745095|7284129|FG002|NOT COMPLETED|Overall Study||3
6373199|NCT00745095|7284130|FG003|NOT COMPLETED|Overall Study||3
6373200|NCT00745095|7284131|FG004|NOT COMPLETED|Overall Study||122
6373201|NCT00745095|7284132|FG005|NOT COMPLETED|Overall Study||123
6373202|NCT00745121|7284151|FG000|STARTED|Overall Study||20
6373203|NCT00745121|7284152|FG001|STARTED|Overall Study||28
6373204|NCT00745121|7284151|FG000|COMPLETED|Overall Study||11
6778329|NCT03783039|7706212|FG001|COMPLETED|Overall Study||114
6778330|NCT03783039|7706211|FG000|NOT COMPLETED|Overall Study||2
6778331|NCT03783039|7706212|FG001|NOT COMPLETED|Overall Study||1
6778332|NCT03783130|7706222|FG000|STARTED|Overall Study||3
6778333|NCT03783130|7706223|FG001|STARTED|Overall Study||3
6778334|NCT03783130|7706224|FG002|STARTED|Overall Study||5
6778335|NCT03783130|7706225|FG003|STARTED|Overall Study||5
6778336|NCT03783130|7706222|FG000|Received All Product Administrations|Overall Study||3
6778337|NCT03783130|7706223|FG001|Received All Product Administrations|Overall Study||3
6778338|NCT03783130|7706224|FG002|Received All Product Administrations|Overall Study||5
6778339|NCT03783130|7706225|FG003|Received All Product Administrations|Overall Study||5
6778340|NCT03783130|7706222|FG000|COMPLETED|Overall Study||3
6778341|NCT03783130|7706223|FG001|COMPLETED|Overall Study||3
6778342|NCT03783130|7706224|FG002|COMPLETED|Overall Study||5
6778343|NCT03783130|7706225|FG003|COMPLETED|Overall Study||5
6778344|NCT03783130|7706222|FG000|NOT COMPLETED|Overall Study||0
6778345|NCT03783130|7706223|FG001|NOT COMPLETED|Overall Study||0
6778346|NCT03783130|7706224|FG002|NOT COMPLETED|Overall Study||0
6778347|NCT03783130|7706225|FG003|NOT COMPLETED|Overall Study||0
6780897|NCT02773576|7709441|FG000|STARTED|Overall Study||0
6780898|NCT02773576|7709442|FG001|STARTED|Overall Study||0
6780899|NCT02773576|7709441|FG000|COMPLETED|Overall Study||0
6780900|NCT02773576|7709442|FG001|COMPLETED|Overall Study||0
6780901|NCT02773576|7709441|FG000|NOT COMPLETED|Overall Study||0
6780902|NCT02773576|7709442|FG001|NOT COMPLETED|Overall Study||0
6780903|NCT02730793|7709450|FG000|STARTED|Overall Study||2
6780904|NCT02730793|7709451|FG001|STARTED|Overall Study||3
6780905|NCT02730793|7709450|FG000|COMPLETED|Overall Study||2
6780906|NCT02730793|7709451|FG001|COMPLETED|Overall Study||1
6780907|NCT02730793|7709450|FG000|NOT COMPLETED|Overall Study||0
6780908|NCT02730793|7709451|FG001|NOT COMPLETED|Overall Study||2
6780909|NCT02744352|7709459|FG000|STARTED|Overall Study||4
6780910|NCT02744352|7709460|FG001|STARTED|Overall Study||4
6780911|NCT02744352|7709459|FG000|COMPLETED|Overall Study||4
6780912|NCT02744352|7709460|FG001|COMPLETED|Overall Study||4
6780913|NCT02744352|7709459|FG000|NOT COMPLETED|Overall Study||0
6780914|NCT02744352|7709460|FG001|NOT COMPLETED|Overall Study||0
6780915|NCT02760602|7709468|FG000|STARTED|Overall Study||13
6780916|NCT02760602|7709469|FG001|STARTED|Overall Study||13
6780917|NCT02760602|7709468|FG000|COMPLETED|Overall Study||0
6780918|NCT02760602|7709469|FG001|COMPLETED|Overall Study||0
6780919|NCT02760602|7709468|FG000|NOT COMPLETED|Overall Study||13
6780920|NCT02760602|7709469|FG001|NOT COMPLETED|Overall Study||13
6780921|NCT02757521|7709477|FG000|STARTED|Overall Study||1
6780922|NCT02757521|7709478|FG001|STARTED|Overall Study||0
6780923|NCT02757521|7709477|FG000|COMPLETED|Overall Study||0
6780924|NCT02757521|7709478|FG001|COMPLETED|Overall Study||0
6780925|NCT02757521|7709477|FG000|NOT COMPLETED|Overall Study||1
6780926|NCT02757521|7709478|FG001|NOT COMPLETED|Overall Study||0
6780927|NCT02758132|7709486|FG000|STARTED|Overall Study||0
6780928|NCT02758132|7709487|FG001|STARTED|Overall Study||1
6780929|NCT02758132|7709486|FG000|COMPLETED|Overall Study||0
6780930|NCT02758132|7709487|FG001|COMPLETED|Overall Study||0
6780931|NCT02758132|7709486|FG000|NOT COMPLETED|Overall Study||0
6780932|NCT02758132|7709487|FG001|NOT COMPLETED|Overall Study||1
6780933|NCT02757547|7709493|FG000|STARTED|Overall Study||2
6780934|NCT02757547|7709493|FG000|COMPLETED|Overall Study||2
6373205|NCT00745121|7284152|FG001|COMPLETED|Overall Study||26
6373206|NCT00745121|7284151|FG000|NOT COMPLETED|Overall Study||9
6373207|NCT00745121|7284152|FG001|NOT COMPLETED|Overall Study||2
6373208|NCT00745251|7284160|FG000|STARTED|Overall Study||23
6780935|NCT02757547|7709493|FG000|NOT COMPLETED|Overall Study||0
6780936|NCT02757053|7709500|FG000|STARTED|Overall Study||3
6780937|NCT02757053|7709501|FG001|STARTED|Overall Study||5
6780938|NCT02757053|7709500|FG000|COMPLETED|Overall Study||0
6780939|NCT02757053|7709501|FG001|COMPLETED|Overall Study||0
6780940|NCT02757053|7709500|FG000|NOT COMPLETED|Overall Study||3
6780941|NCT02757053|7709501|FG001|NOT COMPLETED|Overall Study||5
6373209|NCT00745251|7284161|FG001|STARTED|Overall Study||22
6373210|NCT00745251|7284160|FG000|COMPLETED|Overall Study||21
6373211|NCT00745251|7284161|FG001|COMPLETED|Overall Study||19
6780942|NCT02734940|7709509|FG000|STARTED|Overall Study||0
6373212|NCT00745251|7284160|FG000|NOT COMPLETED|Overall Study||2
6373213|NCT00745251|7284161|FG001|NOT COMPLETED|Overall Study||3
6373214|NCT00745290|7284169|FG000|STARTED|Overall Study||123
6373215|NCT00745290|7284170|FG001|STARTED|Overall Study||122
6373216|NCT00745290|7284169|FG000|COMPLETED|Overall Study||123
6373217|NCT00745290|7284170|FG001|COMPLETED|Overall Study||122
6373218|NCT00745290|7284169|FG000|NOT COMPLETED|Overall Study||0
6373219|NCT00745290|7284170|FG001|NOT COMPLETED|Overall Study||0
6373220|NCT00745368|7284176|FG000|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
6373221|NCT00745368|7284176|FG000|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
6373222|NCT00745368|7284176|FG000|NOT COMPLETED|Overall Study||3
6373223|NCT00745420|7284180|FG000|STARTED|Overall Study||30
6373224|NCT00745420|7284180|FG000|COMPLETED|Overall Study||29
6373225|NCT00745420|7284180|FG000|NOT COMPLETED|Overall Study||1
6373226|NCT00745498|7284187|FG000|STARTED|Overall Study||41
6373227|NCT00745498|7284188|FG001|STARTED|Overall Study||43
6373228|NCT00745498|7284189|FG002|STARTED|Overall Study||42
6373229|NCT00745498|7284187|FG000|COMPLETED|Overall Study||36
6373230|NCT00745498|7284188|FG001|COMPLETED|Overall Study||37
6373231|NCT00745498|7284189|FG002|COMPLETED|Overall Study||34
6373232|NCT00745498|7284187|FG000|NOT COMPLETED|Overall Study||5
6373233|NCT00745498|7284188|FG001|NOT COMPLETED|Overall Study||6
6373234|NCT00745498|7284189|FG002|NOT COMPLETED|Overall Study||8
6373235|NCT00745615|7284201|FG000|STARTED|Double-Blind Extension (36 Weeks)||80
6373236|NCT00745615|7284202|FG001|STARTED|Double-Blind Extension (36 Weeks)||94
6373237|NCT00745615|7284203|FG002|STARTED|Double-Blind Extension (36 Weeks)||39
6373238|NCT00745615|7284204|FG003|STARTED|Double-Blind Extension (36 Weeks)||44
6373239|NCT00745615|7284205|FG004|STARTED|Double-Blind Extension (36 Weeks)||0
6373240|NCT00745615|7284206|FG005|STARTED|Double-Blind Extension (36 Weeks)||0
6373241|NCT00745615|7284201|FG000|COMPLETED|Double-Blind Extension (36 Weeks)||75
6373242|NCT00745615|7284202|FG001|COMPLETED|Double-Blind Extension (36 Weeks)||87
6373243|NCT00745615|7284203|FG002|COMPLETED|Double-Blind Extension (36 Weeks)||38
6373244|NCT00745615|7284204|FG003|COMPLETED|Double-Blind Extension (36 Weeks)||39
6373245|NCT00745615|7284205|FG004|COMPLETED|Double-Blind Extension (36 Weeks)||0
6561133|NCT01791517|7484043|FG002|COMPLETED|Phase I: Period 2||16
6561134|NCT01791517|7484044|FG003|COMPLETED|Phase I: Period 2||16
6561135|NCT01791517|7484045|FG004|COMPLETED|Phase I: Period 2||19
6561136|NCT01791517|7484046|FG005|COMPLETED|Phase I: Period 2||18
6561137|NCT01791517|7484047|FG006|COMPLETED|Phase I: Period 2||19
6561138|NCT01791517|7484048|FG007|COMPLETED|Phase I: Period 2||20
6561139|NCT01791517|7484049|FG008|COMPLETED|Phase I: Period 2||19
6778348|NCT03776175|7706240|FG000|STARTED|Treatment Period (42 Days)||14
6778349|NCT03776175|7706241|FG001|STARTED|Treatment Period (42 Days)||29
6778350|NCT03776175|7706242|FG002|STARTED|Treatment Period (42 Days)||28
6778351|NCT03776175|7706243|FG003|STARTED|Treatment Period (42 Days)||28
6778352|NCT03776175|7706240|FG000|Treated|Treatment Period (42 Days)||14
6778353|NCT03776175|7706241|FG001|Treated|Treatment Period (42 Days)||29
6778354|NCT03776175|7706242|FG002|Treated|Treatment Period (42 Days)||28
6778355|NCT03776175|7706243|FG003|Treated|Treatment Period (42 Days)||28
6778356|NCT03776175|7706240|FG000|COMPLETED|Treatment Period (42 Days)||13
6778357|NCT03776175|7706241|FG001|COMPLETED|Treatment Period (42 Days)||22
6778358|NCT03776175|7706242|FG002|COMPLETED|Treatment Period (42 Days)||24
6778359|NCT03776175|7706243|FG003|COMPLETED|Treatment Period (42 Days)||26
6778360|NCT03776175|7706240|FG000|NOT COMPLETED|Treatment Period (42 Days)||1
6778361|NCT03776175|7706241|FG001|NOT COMPLETED|Treatment Period (42 Days)||7
6778362|NCT03776175|7706242|FG002|NOT COMPLETED|Treatment Period (42 Days)||4
6778363|NCT03776175|7706243|FG003|NOT COMPLETED|Treatment Period (42 Days)||2
6778364|NCT03776175|7706240|FG000|STARTED|Follow-Up Period (35 Days)||13
6778365|NCT03776175|7706241|FG001|STARTED|Follow-Up Period (35 Days)||22
6778366|NCT03776175|7706242|FG002|STARTED|Follow-Up Period (35 Days)||24
6778367|NCT03776175|7706243|FG003|STARTED|Follow-Up Period (35 Days)||26
6778368|NCT03776175|7706240|FG000|COMPLETED|Follow-Up Period (35 Days)||13
6778369|NCT03776175|7706241|FG001|COMPLETED|Follow-Up Period (35 Days)||22
6778370|NCT03776175|7706242|FG002|COMPLETED|Follow-Up Period (35 Days)||24
6778371|NCT03776175|7706243|FG003|COMPLETED|Follow-Up Period (35 Days)||24
6778372|NCT03776175|7706240|FG000|NOT COMPLETED|Follow-Up Period (35 Days)||0
6778373|NCT03776175|7706241|FG001|NOT COMPLETED|Follow-Up Period (35 Days)||0
6778374|NCT03776175|7706242|FG002|NOT COMPLETED|Follow-Up Period (35 Days)||0
6778375|NCT03776175|7706243|FG003|NOT COMPLETED|Follow-Up Period (35 Days)||2
6778376|NCT03771963|7706253|FG000|STARTED|Overall Study||200
6778377|NCT03771963|7706253|FG000|COMPLETED|Overall Study||168
6778378|NCT03771963|7706253|FG000|NOT COMPLETED|Overall Study||32
6778379|NCT03771352|7706257|FG000|STARTED|Overall Study||55
6778380|NCT03771352|7706257|FG000|COMPLETED|Overall Study|The fellow eye of one subject was not implanted per the discretion of the investigator.|51
6778381|NCT03771352|7706257|FG000|NOT COMPLETED|Overall Study||4
6778382|NCT03773796|7706261|FG000|STARTED|Overall Study||22
6373246|NCT00745615|7284206|FG005|COMPLETED|Double-Blind Extension (36 Weeks)||0
6778383|NCT03773796|7706261|FG000|COMPLETED|Overall Study||19
6778384|NCT03773796|7706261|FG000|NOT COMPLETED|Overall Study||3
6778385|NCT03782233|7706267|FG000|STARTED|Overall Study||50
6778386|NCT03782233|7706268|FG001|STARTED|Overall Study||33
6373247|NCT00745615|7284201|FG000|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
6561140|NCT01791517|7484050|FG009|COMPLETED|Phase I: Period 2||18
6373248|NCT00745615|7284202|FG001|NOT COMPLETED|Double-Blind Extension (36 Weeks)||7
6373249|NCT00745615|7284203|FG002|NOT COMPLETED|Double-Blind Extension (36 Weeks)||1
6373250|NCT00745615|7284204|FG003|NOT COMPLETED|Double-Blind Extension (36 Weeks)||5
6373251|NCT00745615|7284205|FG004|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
6373252|NCT00745615|7284206|FG005|NOT COMPLETED|Double-Blind Extension (36 Weeks)||0
6373253|NCT00745615|7284201|FG000|STARTED|Open-Label (up to Approx 10.5 Years)||0
6373254|NCT00745615|7284202|FG001|STARTED|Open-Label (up to Approx 10.5 Years)||0
6373255|NCT00745615|7284203|FG002|STARTED|Open-Label (up to Approx 10.5 Years)||0
6373256|NCT00745615|7284204|FG003|STARTED|Open-Label (up to Approx 10.5 Years)||0
6373257|NCT00745615|7284205|FG004|STARTED|Open-Label (up to Approx 10.5 Years)||96
6373258|NCT00745615|7284206|FG005|STARTED|Open-Label (up to Approx 10.5 Years)||113
6373259|NCT00745615|7284201|FG000|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6373260|NCT00745615|7284202|FG001|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6373261|NCT00745615|7284203|FG002|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6373262|NCT00745615|7284204|FG003|COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6373263|NCT00745615|7284205|FG004|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
6373264|NCT00745615|7284206|FG005|COMPLETED|Open-Label (up to Approx 10.5 Years)||5
6373265|NCT00745615|7284201|FG000|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6373266|NCT00745615|7284202|FG001|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6373267|NCT00745615|7284203|FG002|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6373268|NCT00745615|7284204|FG003|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||0
6373269|NCT00745615|7284205|FG004|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||91
6778387|NCT03782233|7706267|FG000|COMPLETED|Overall Study||46
6778388|NCT03782233|7706268|FG001|COMPLETED|Overall Study||31
6778389|NCT03782233|7706267|FG000|NOT COMPLETED|Overall Study||4
6778390|NCT03782233|7706268|FG001|NOT COMPLETED|Overall Study||2
6778391|NCT03781375|7706278|FG000|STARTED|Double-blind Phase||12
6778392|NCT03781375|7706279|FG001|STARTED|Double-blind Phase||13
6778393|NCT03781375|7706278|FG000|Received Study Drug|Double-blind Phase||12
6778394|NCT03781375|7706279|FG001|Received Study Drug|Double-blind Phase||13
6778395|NCT03781375|7706278|FG000|COMPLETED|Double-blind Phase||5
6778396|NCT03781375|7706279|FG001|COMPLETED|Double-blind Phase||7
6778397|NCT03781375|7706278|FG000|NOT COMPLETED|Double-blind Phase||7
6778398|NCT03781375|7706279|FG001|NOT COMPLETED|Double-blind Phase||6
6778399|NCT03781375|7706278|FG000|STARTED|Open-label Phase||11
6778400|NCT03781375|7706279|FG001|STARTED|Open-label Phase||9
6778401|NCT03781375|7706278|FG000|Received Study Drug|Open-label Phase||10
6778402|NCT03781375|7706279|FG001|Received Study Drug|Open-label Phase||9
6778403|NCT03781375|7706278|FG000|COMPLETED|Open-label Phase||8
6778404|NCT03781375|7706279|FG001|COMPLETED|Open-label Phase||6
6778405|NCT03781375|7706278|FG000|NOT COMPLETED|Open-label Phase||3
6778406|NCT03781375|7706279|FG001|NOT COMPLETED|Open-label Phase||3
6778407|NCT03781336|7706288|FG000|STARTED|Overall Study||45
6778408|NCT03781336|7706289|FG001|STARTED|Overall Study||37
6778409|NCT03781336|7706288|FG000|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|43
6778410|NCT03781336|7706289|FG001|COMPLETED|Overall Study|All participants were included in the analysis (Intent to treat)|35
6778411|NCT03781336|7706288|FG000|NOT COMPLETED|Overall Study||2
6778412|NCT03781336|7706289|FG001|NOT COMPLETED|Overall Study||2
6778413|NCT03780400|7706295|FG000|STARTED|Overall Study||60
6778414|NCT03780400|7706295|FG000|COMPLETED|Overall Study||53
6778415|NCT03780400|7706295|FG000|NOT COMPLETED|Overall Study||7
6778416|NCT03779997|7706301|FG000|STARTED|Overall Study||39
6778417|NCT03779997|7706302|FG001|STARTED|Overall Study||39
6778418|NCT03779997|7706301|FG000|Completed at Least One Visit|Overall Study||39
6778419|NCT03779997|7706302|FG001|Completed at Least One Visit|Overall Study||39
6778420|NCT03779997|7706301|FG000|COMPLETED|Overall Study||39
6778421|NCT03779997|7706302|FG001|COMPLETED|Overall Study||39
6778422|NCT03779997|7706301|FG000|NOT COMPLETED|Overall Study||0
6778423|NCT03779997|7706302|FG001|NOT COMPLETED|Overall Study||0
6778424|NCT03779503|7706308|FG000|STARTED|First Intervention||28
6778425|NCT03779503|7706309|FG001|STARTED|First Intervention||27
6778426|NCT03779503|7706308|FG000|COMPLETED|First Intervention||27
6778427|NCT03779503|7706309|FG001|COMPLETED|First Intervention||26
6778428|NCT03779503|7706308|FG000|NOT COMPLETED|First Intervention||1
6778429|NCT03779503|7706309|FG001|NOT COMPLETED|First Intervention||1
6778430|NCT03779503|7706308|FG000|STARTED|Second Intervention||27
6778431|NCT03779503|7706309|FG001|STARTED|Second Intervention||26
6778432|NCT03779503|7706308|FG000|COMPLETED|Second Intervention||27
6778433|NCT03779503|7706309|FG001|COMPLETED|Second Intervention||26
6778434|NCT03779503|7706308|FG000|NOT COMPLETED|Second Intervention||0
6778435|NCT03779503|7706309|FG001|NOT COMPLETED|Second Intervention||0
6778436|NCT03780010|7706317|FG000|STARTED|Overall Study||3
6778437|NCT03780010|7706318|FG001|STARTED|Overall Study||12
6778438|NCT03780010|7706317|FG000|COMPLETED|Overall Study||3
6778439|NCT03780010|7706318|FG001|COMPLETED|Overall Study||12
6778440|NCT03780010|7706317|FG000|NOT COMPLETED|Overall Study||0
6778441|NCT03780010|7706318|FG001|NOT COMPLETED|Overall Study||0
6373270|NCT00745615|7284206|FG005|NOT COMPLETED|Open-Label (up to Approx 10.5 Years)||108
6373271|NCT00745823|7284220|FG000|STARTED|Overall Study||386
6778442|NCT03778190|7706335|FG000|STARTED|Overall Study||10
6778443|NCT03778190|7706335|FG000|COMPLETED|Overall Study||10
6778444|NCT03778190|7706335|FG000|NOT COMPLETED|Overall Study||0
6778445|NCT03777059|7706343|FG000|STARTED|DB Treatment Period (Up to Week 12)||223
6373272|NCT00745823|7284221|FG001|STARTED|Overall Study||389
6373273|NCT00745823|7284220|FG000|TREATED Week 0 - 96|Overall Study||382
6373274|NCT00745823|7284221|FG001|TREATED Week 0 - 96|Overall Study||388
6778446|NCT03777059|7706344|FG001|STARTED|DB Treatment Period (Up to Week 12)||222
6778447|NCT03777059|7706345|FG002|STARTED|DB Treatment Period (Up to Week 12)||230
6778448|NCT03777059|7706346|FG003|STARTED|DB Treatment Period (Up to Week 12)||235
6778449|NCT03777059|7706343|FG000|Treated: Safety Population|DB Treatment Period (Up to Week 12)||222
6778450|NCT03777059|7706344|FG001|Treated: Safety Population|DB Treatment Period (Up to Week 12)||221
6778451|NCT03777059|7706345|FG002|Treated: Safety Population|DB Treatment Period (Up to Week 12)||228
6778452|NCT03777059|7706346|FG003|Treated: Safety Population|DB Treatment Period (Up to Week 12)||231
6778453|NCT03777059|7706343|FG000|COMPLETED|DB Treatment Period (Up to Week 12)||201
6778454|NCT03777059|7706344|FG001|COMPLETED|DB Treatment Period (Up to Week 12)||193
6778455|NCT03777059|7706345|FG002|COMPLETED|DB Treatment Period (Up to Week 12)||207
6778456|NCT03777059|7706346|FG003|COMPLETED|DB Treatment Period (Up to Week 12)||204
6778457|NCT03777059|7706343|FG000|NOT COMPLETED|DB Treatment Period (Up to Week 12)||22
6778458|NCT03777059|7706344|FG001|NOT COMPLETED|DB Treatment Period (Up to Week 12)||29
6778459|NCT03777059|7706345|FG002|NOT COMPLETED|DB Treatment Period (Up to Week 12)||23
6778460|NCT03777059|7706346|FG003|NOT COMPLETED|DB Treatment Period (Up to Week 12)||31
6778461|NCT03777059|7706343|FG000|STARTED|Follow-Up Period (Weeks 12 to 16)||46
6778462|NCT03777059|7706344|FG001|STARTED|Follow-Up Period (Weeks 12 to 16)||54
6778463|NCT03777059|7706345|FG002|STARTED|Follow-Up Period (Weeks 12 to 16)||38
6778464|NCT03777059|7706346|FG003|STARTED|Follow-Up Period (Weeks 12 to 16)||45
6778465|NCT03777059|7706343|FG000|COMPLETED|Follow-Up Period (Weeks 12 to 16)||41
6778466|NCT03777059|7706344|FG001|COMPLETED|Follow-Up Period (Weeks 12 to 16)||49
6778467|NCT03777059|7706345|FG002|COMPLETED|Follow-Up Period (Weeks 12 to 16)||32
6778468|NCT03777059|7706346|FG003|COMPLETED|Follow-Up Period (Weeks 12 to 16)||36
6778469|NCT03777059|7706343|FG000|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
6778470|NCT03777059|7706344|FG001|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||5
6778471|NCT03777059|7706345|FG002|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||6
6778472|NCT03777059|7706346|FG003|NOT COMPLETED|Follow-Up Period (Weeks 12 to 16)||9
6778473|NCT03772522|7706358|FG000|STARTED|Pre-intervention||12
6778474|NCT03772522|7706359|FG001|STARTED|Pre-intervention||15
6778475|NCT03772522|7706358|FG000|COMPLETED|Pre-intervention||9
6778476|NCT03772522|7706359|FG001|COMPLETED|Pre-intervention||11
6778477|NCT03772522|7706358|FG000|NOT COMPLETED|Pre-intervention||3
6778478|NCT03772522|7706359|FG001|NOT COMPLETED|Pre-intervention||4
6778479|NCT03772522|7706358|FG000|STARTED|Intervention||9
6778480|NCT03772522|7706359|FG001|STARTED|Intervention||11
6778481|NCT03772522|7706358|FG000|COMPLETED|Intervention||8
6778482|NCT03772522|7706359|FG001|COMPLETED|Intervention||11
6778483|NCT03772522|7706358|FG000|NOT COMPLETED|Intervention||1
6778484|NCT03772522|7706359|FG001|NOT COMPLETED|Intervention||0
6778485|NCT03772522|7706358|FG000|STARTED|Post-intervention Follow-up||8
6778486|NCT03772522|7706359|FG001|STARTED|Post-intervention Follow-up||11
6778487|NCT03772522|7706358|FG000|COMPLETED|Post-intervention Follow-up||7
6778488|NCT03772522|7706359|FG001|COMPLETED|Post-intervention Follow-up||11
6778489|NCT03772522|7706358|FG000|NOT COMPLETED|Post-intervention Follow-up||1
6778490|NCT03772522|7706359|FG001|NOT COMPLETED|Post-intervention Follow-up||0
6778491|NCT03772327|7706371|FG000|STARTED|Overall Study||30
6778492|NCT03772327|7706372|FG001|STARTED|Overall Study||33
6778493|NCT03772327|7706371|FG000|Week 0 Visit|Overall Study|2 participants were lost to follow up after randomization prior to any study interventions.|28
6778494|NCT03772327|7706372|FG001|Week 0 Visit|Overall Study||33
6778495|NCT03772327|7706371|FG000|COMPLETED|Overall Study||25
6778496|NCT03772327|7706372|FG001|COMPLETED|Overall Study||26
6778497|NCT03772327|7706371|FG000|NOT COMPLETED|Overall Study||5
6778498|NCT03772327|7706372|FG001|NOT COMPLETED|Overall Study||7
6778499|NCT03777865|7706378|FG000|STARTED|Overall Study||100
6778500|NCT03777865|7706378|FG000|COMPLETED|Overall Study||100
6778501|NCT03777865|7706378|FG000|NOT COMPLETED|Overall Study||0
6778502|NCT03774576|7706382|FG000|STARTED|Period 1||14
6778503|NCT03774576|7706382|FG000|COMPLETED|Period 1||14
6778504|NCT03774576|7706382|FG000|NOT COMPLETED|Period 1||0
6778505|NCT03774576|7706382|FG000|STARTED|Period 2||14
6778506|NCT03774576|7706382|FG000|COMPLETED|Period 2||13
6778507|NCT03774576|7706382|FG000|NOT COMPLETED|Period 2||1
6778508|NCT03776539|7706395|FG000|STARTED|Overall Study||6
6778509|NCT03776539|7706396|FG001|STARTED|Overall Study||6
6778510|NCT03776539|7706397|FG002|STARTED|Overall Study||6
6778511|NCT03776539|7706398|FG003|STARTED|Overall Study||6
6778512|NCT03776539|7706395|FG000|COMPLETED|Overall Study||6
6778513|NCT03776539|7706396|FG001|COMPLETED|Overall Study||6
6778514|NCT03776539|7706397|FG002|COMPLETED|Overall Study||6
6373275|NCT00745823|7284220|FG000|COMPLETED|Overall Study||1
6373276|NCT00745823|7284221|FG001|COMPLETED|Overall Study||3
6373277|NCT00745823|7284220|FG000|NOT COMPLETED|Overall Study||385
6373278|NCT00745823|7284221|FG001|NOT COMPLETED|Overall Study||386
6373279|NCT00745849|7284229|FG000|STARTED|First Intervention||21
6373280|NCT00745849|7284230|FG001|STARTED|First Intervention||22
6373281|NCT00745849|7284229|FG000|COMPLETED|First Intervention||20
6373282|NCT00745849|7284230|FG001|COMPLETED|First Intervention||20
6373283|NCT00745849|7284229|FG000|NOT COMPLETED|First Intervention||1
6373284|NCT00745849|7284230|FG001|NOT COMPLETED|First Intervention||2
6373285|NCT00745849|7284229|FG000|STARTED|Washout Period||20
6373286|NCT00745849|7284230|FG001|STARTED|Washout Period||20
6373287|NCT00745849|7284229|FG000|COMPLETED|Washout Period||20
6373288|NCT00745849|7284230|FG001|COMPLETED|Washout Period||20
6373289|NCT00745849|7284229|FG000|NOT COMPLETED|Washout Period||0
6373290|NCT00745849|7284230|FG001|NOT COMPLETED|Washout Period||0
6373291|NCT00745849|7284229|FG000|STARTED|Second Intervention||20
6373292|NCT00745849|7284230|FG001|STARTED|Second Intervention||20
6373293|NCT00745849|7284229|FG000|COMPLETED|Second Intervention||18
6373294|NCT00745849|7284230|FG001|COMPLETED|Second Intervention||19
6373295|NCT00745849|7284229|FG000|NOT COMPLETED|Second Intervention||2
6373296|NCT00745849|7284230|FG001|NOT COMPLETED|Second Intervention||1
6377792|NCT00765206|7288463|FG002|NOT COMPLETED|First Intervention||0
6377793|NCT00765206|7288464|FG003|NOT COMPLETED|First Intervention||0
6377794|NCT00765206|7288461|FG000|STARTED|Washout Period of 14 Days||15
6377795|NCT00765206|7288462|FG001|STARTED|Washout Period of 14 Days||15
6377796|NCT00765206|7288463|FG002|STARTED|Washout Period of 14 Days||15
6377797|NCT00765206|7288464|FG003|STARTED|Washout Period of 14 Days||15
6377798|NCT00765206|7288461|FG000|COMPLETED|Washout Period of 14 Days||15
6377799|NCT00765206|7288462|FG001|COMPLETED|Washout Period of 14 Days||15
6377800|NCT00765206|7288463|FG002|COMPLETED|Washout Period of 14 Days||15
6377801|NCT00765206|7288464|FG003|COMPLETED|Washout Period of 14 Days||15
6377802|NCT00765206|7288461|FG000|NOT COMPLETED|Washout Period of 14 Days||0
6377803|NCT00765206|7288462|FG001|NOT COMPLETED|Washout Period of 14 Days||0
6377804|NCT00765206|7288463|FG002|NOT COMPLETED|Washout Period of 14 Days||0
6377805|NCT00765206|7288464|FG003|NOT COMPLETED|Washout Period of 14 Days||0
6377806|NCT00765206|7288461|FG000|STARTED|Second Intervention||15
6377807|NCT00765206|7288462|FG001|STARTED|Second Intervention||15
6377808|NCT00765206|7288463|FG002|STARTED|Second Intervention||15
6377809|NCT00765206|7288464|FG003|STARTED|Second Intervention||15
6377810|NCT00765206|7288461|FG000|COMPLETED|Second Intervention||15
6377811|NCT00765206|7288462|FG001|COMPLETED|Second Intervention||15
6377812|NCT00765206|7288463|FG002|COMPLETED|Second Intervention||15
6377813|NCT00765206|7288464|FG003|COMPLETED|Second Intervention||15
6377814|NCT00765206|7288461|FG000|NOT COMPLETED|Second Intervention||0
6377815|NCT00765206|7288462|FG001|NOT COMPLETED|Second Intervention||0
6377816|NCT00765206|7288463|FG002|NOT COMPLETED|Second Intervention||0
6377817|NCT00765206|7288464|FG003|NOT COMPLETED|Second Intervention||0
6377818|NCT00765232|7288472|FG000|STARTED|Overall Study||57
6377819|NCT00765232|7288473|FG001|STARTED|Overall Study||54
6377820|NCT00765232|7288472|FG000|COMPLETED|Overall Study||57
6377821|NCT00765232|7288473|FG001|COMPLETED|Overall Study||54
6377822|NCT00765232|7288472|FG000|NOT COMPLETED|Overall Study||0
6377823|NCT00765232|7288473|FG001|NOT COMPLETED|Overall Study||0
6377824|NCT00765245|7288481|FG000|STARTED|Overall Study||22
6377825|NCT00765245|7288482|FG001|STARTED|Overall Study||22
6377826|NCT00765245|7288481|FG000|COMPLETED|Overall Study||9
6377827|NCT00765245|7288482|FG001|COMPLETED|Overall Study||20
6377828|NCT00765245|7288481|FG000|NOT COMPLETED|Overall Study||13
6377829|NCT00765245|7288482|FG001|NOT COMPLETED|Overall Study||2
6377958|NCT00766090|7288654|FG005|COMPLETED|Treatment Period 1 (28 Days)||23
6377959|NCT00766090|7288655|FG006|COMPLETED|Treatment Period 1 (28 Days)||6
6377960|NCT00766090|7288656|FG007|COMPLETED|Treatment Period 1 (28 Days)||8
6377961|NCT00766090|7288657|FG008|COMPLETED|Treatment Period 1 (28 Days)||6
6377962|NCT00766090|7288658|FG009|COMPLETED|Treatment Period 1 (28 Days)||8
6377963|NCT00766090|7288659|FG010|COMPLETED|Treatment Period 1 (28 Days)||7
6377964|NCT00766090|7288660|FG011|COMPLETED|Treatment Period 1 (28 Days)||7
6377965|NCT00766090|7288649|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||3
6377966|NCT00766090|7288650|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6377967|NCT00766090|7288651|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6778515|NCT03776539|7706398|FG003|COMPLETED|Overall Study||6
6778516|NCT03776539|7706395|FG000|NOT COMPLETED|Overall Study||0
6778517|NCT03776539|7706396|FG001|NOT COMPLETED|Overall Study||0
6778518|NCT03776539|7706397|FG002|NOT COMPLETED|Overall Study||0
6778519|NCT03776539|7706398|FG003|NOT COMPLETED|Overall Study||0
6778520|NCT03772041|7706410|FG000|STARTED|Overall Study||149
6778521|NCT03772041|7706411|FG001|STARTED|Overall Study||145
6778522|NCT03772041|7706410|FG000|COMPLETED|Overall Study||135
6778523|NCT03772041|7706411|FG001|COMPLETED|Overall Study||135
6778524|NCT03772041|7706410|FG000|NOT COMPLETED|Overall Study||14
6778525|NCT03772041|7706411|FG001|NOT COMPLETED|Overall Study||10
6778526|NCT03775681|7706417|FG000|STARTED|Overall Study||33
6778527|NCT03775681|7706417|FG000|COMPLETED|Overall Study||30
6778528|NCT03775681|7706417|FG000|NOT COMPLETED|Overall Study||3
6778529|NCT03774823|7706423|FG000|STARTED|Overall Study||5
6778530|NCT03774823|7706424|FG001|STARTED|Overall Study||5
6778531|NCT03774823|7706423|FG000|COMPLETED|Overall Study||4
6778532|NCT03774823|7706424|FG001|COMPLETED|Overall Study||4
6778533|NCT03774823|7706423|FG000|NOT COMPLETED|Overall Study||1
6778534|NCT03774823|7706424|FG001|NOT COMPLETED|Overall Study||1
6377968|NCT00766090|7288652|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6377969|NCT00766090|7288653|FG004|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6377970|NCT00766090|7288654|FG005|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6377971|NCT00766090|7288655|FG006|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6377972|NCT00766090|7288656|FG007|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6377973|NCT00766090|7288657|FG008|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6377974|NCT00766090|7288658|FG009|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6778535|NCT03774745|7706432|FG000|STARTED|Overall Study||6
6778536|NCT03774745|7706433|FG001|STARTED|Overall Study||6
6373297|NCT00745875|7284238|FG000|STARTED|Overall Study|Started - Number of patients randomised|36
6373298|NCT00745875|7284239|FG001|STARTED|Overall Study|Started - Number of patients randomised|30
6373299|NCT00745875|7284238|FG000|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
6373300|NCT00745875|7284239|FG001|COMPLETED|Overall Study|Completed - Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
6373301|NCT00745875|7284238|FG000|NOT COMPLETED|Overall Study||4
6373302|NCT00745875|7284239|FG001|NOT COMPLETED|Overall Study||4
6373303|NCT00745901|7284247|FG000|STARTED|Overall Study|Number of Patients Randomized|178
6373304|NCT00745901|7284248|FG001|STARTED|Overall Study|Number of Patients Randomized|177
6373305|NCT00745901|7284247|FG000|COMPLETED|Overall Study||154
6373306|NCT00745901|7284248|FG001|COMPLETED|Overall Study||156
6373307|NCT00745901|7284247|FG000|NOT COMPLETED|Overall Study||24
6373308|NCT00745901|7284248|FG001|NOT COMPLETED|Overall Study||21
6373309|NCT00745940|7284256|FG000|STARTED|Overall Study||57
6373310|NCT00745940|7284257|FG001|STARTED|Overall Study||48
6373311|NCT00745940|7284256|FG000|COMPLETED|Overall Study||38
6373312|NCT00745940|7284257|FG001|COMPLETED|Overall Study||38
6373313|NCT00745940|7284256|FG000|NOT COMPLETED|Overall Study||19
6373314|NCT00745940|7284257|FG001|NOT COMPLETED|Overall Study||10
6373315|NCT00746096|7284265|FG000|STARTED|Overall Study||58
6373316|NCT00746096|7284266|FG001|STARTED|Overall Study||57
6373317|NCT00746096|7284265|FG000|COMPLETED|Overall Study||48
6373318|NCT00746096|7284266|FG001|COMPLETED|Overall Study||54
6373319|NCT00746096|7284265|FG000|NOT COMPLETED|Overall Study||10
6373320|NCT00746096|7284266|FG001|NOT COMPLETED|Overall Study||3
6373321|NCT00746122|7284274|FG000|STARTED|Overall Study||297
6373322|NCT00746122|7284275|FG001|STARTED|Overall Study|After 600 recruitment target 13 more patients were randomised before sites could be closed down.|316
6778537|NCT03774745|7706432|FG000|Follow-Up 1|Overall Study||5
6778538|NCT03774745|7706433|FG001|Follow-Up 1|Overall Study||6
6778539|NCT03774745|7706432|FG000|Follow-up 2|Overall Study||4
6778540|NCT03774745|7706433|FG001|Follow-up 2|Overall Study||2
6778541|NCT03774745|7706432|FG000|COMPLETED|Overall Study||4
6778542|NCT03774745|7706433|FG001|COMPLETED|Overall Study||2
6778543|NCT03774745|7706432|FG000|NOT COMPLETED|Overall Study||2
6778544|NCT03774745|7706433|FG001|NOT COMPLETED|Overall Study||4
6778545|NCT03774433|7706439|FG000|STARTED|Overall Study||114
6778546|NCT03774433|7706439|FG000|COMPLETED|Overall Study|Participants who completed at least 12 EMAs for inclusion in data analysis|100
6778547|NCT03774433|7706439|FG000|NOT COMPLETED|Overall Study||14
6778548|NCT03771560|7706443|FG000|STARTED|Overall Study||18
6778549|NCT03771560|7706443|FG000|COMPLETED|Overall Study||12
6778550|NCT03771560|7706443|FG000|NOT COMPLETED|Overall Study||6
6778551|NCT03770091|7706450|FG000|STARTED|Overall Study||15
6778552|NCT03770091|7706451|FG001|STARTED|Overall Study||13
6778553|NCT03770091|7706452|FG002|STARTED|Overall Study||12
6778554|NCT03770091|7706450|FG000|COMPLETED|Overall Study||15
6778555|NCT03770091|7706451|FG001|COMPLETED|Overall Study||13
6778556|NCT03770091|7706452|FG002|COMPLETED|Overall Study||12
6778557|NCT03770091|7706450|FG000|NOT COMPLETED|Overall Study||0
6778558|NCT03770091|7706451|FG001|NOT COMPLETED|Overall Study||0
6778559|NCT03770091|7706452|FG002|NOT COMPLETED|Overall Study||0
6778560|NCT03769896|7706462|FG000|STARTED|Open-label Phase||47
6778561|NCT03769896|7706463|FG001|STARTED|Open-label Phase||0
6778562|NCT03769896|7706462|FG000|COMPLETED|Open-label Phase||38
6778563|NCT03769896|7706463|FG001|COMPLETED|Open-label Phase||0
6778564|NCT03769896|7706462|FG000|NOT COMPLETED|Open-label Phase||9
6778565|NCT03769896|7706463|FG001|NOT COMPLETED|Open-label Phase||0
6778566|NCT03769896|7706462|FG000|STARTED|Double-blind Treatment Phase||19
6778567|NCT03769896|7706463|FG001|STARTED|Double-blind Treatment Phase||19
6778568|NCT03769896|7706462|FG000|COMPLETED|Double-blind Treatment Phase||19
6778569|NCT03769896|7706463|FG001|COMPLETED|Double-blind Treatment Phase||19
6778570|NCT03769896|7706462|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
6778571|NCT03769896|7706463|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
6778572|NCT03769649|7706470|FG000|STARTED|Overall Study||15
6778573|NCT03769649|7706470|FG000|COMPLETED|Overall Study||11
6778574|NCT03769649|7706470|FG000|NOT COMPLETED|Overall Study||4
6778575|NCT03769207|7706474|FG000|STARTED|Overall Study||17
6778576|NCT03769207|7706474|FG000|Attended First Study Visit|Overall Study||11
6778577|NCT03769207|7706474|FG000|ECG Patch Shipped|Overall Study||11
6778578|NCT03769207|7706474|FG000|ECG Patch Returned and Readable|Overall Study||9
6373323|NCT00746122|7284274|FG000|COMPLETED|Overall Study||297
6778579|NCT03769207|7706474|FG000|Attended Second Study Visit|Overall Study||6
6778580|NCT03769207|7706474|FG000|COMPLETED|Overall Study||6
6778581|NCT03769207|7706474|FG000|NOT COMPLETED|Overall Study||11
6778582|NCT03768856|7706478|FG000|STARTED|Overall Study||5
6778583|NCT03768856|7706478|FG000|COMPLETED|Overall Study||5
6778584|NCT03768856|7706478|FG000|NOT COMPLETED|Overall Study||0
6778585|NCT03768726|7706484|FG000|STARTED|Treatment Phase||10
6778586|NCT03768726|7706485|FG001|STARTED|Treatment Phase||13
6778587|NCT03768726|7706484|FG000|COMPLETED|Treatment Phase||2
6373324|NCT00746122|7284275|FG001|COMPLETED|Overall Study||316
6373325|NCT00746122|7284274|FG000|NOT COMPLETED|Overall Study||0
6373326|NCT00746122|7284275|FG001|NOT COMPLETED|Overall Study||0
6778588|NCT03768726|7706485|FG001|COMPLETED|Treatment Phase||10
6778589|NCT03768726|7706484|FG000|NOT COMPLETED|Treatment Phase||8
6778590|NCT03768726|7706485|FG001|NOT COMPLETED|Treatment Phase||3
6778591|NCT03768726|7706484|FG000|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|8
6373327|NCT00746187|7284283|FG000|STARTED|Overall Study||18
6373328|NCT00746187|7284284|FG001|STARTED|Overall Study||18
6373329|NCT00746187|7284283|FG000|COMPLETED|Overall Study||15
6373330|NCT00746187|7284284|FG001|COMPLETED|Overall Study||16
6373331|NCT00746187|7284283|FG000|NOT COMPLETED|Overall Study||3
6373332|NCT00746187|7284284|FG001|NOT COMPLETED|Overall Study||2
6373333|NCT00746252|7284292|FG000|STARTED|Overall Study||1
6373334|NCT00746252|7284293|FG001|STARTED|Overall Study||2
6373335|NCT00746252|7284292|FG000|COMPLETED|Overall Study||0
6373336|NCT00746252|7284293|FG001|COMPLETED|Overall Study||0
6373337|NCT00746252|7284292|FG000|NOT COMPLETED|Overall Study||1
6373338|NCT00746252|7284293|FG001|NOT COMPLETED|Overall Study||2
6373339|NCT00746330|7284303|FG000|STARTED|Period 1||7
6373340|NCT00746330|7284304|FG001|STARTED|Period 1||9
6373341|NCT00746330|7284305|FG002|STARTED|Period 1||9
6373342|NCT00746330|7284306|FG003|STARTED|Period 1||7
6373343|NCT00746330|7284303|FG000|COMPLETED|Period 1||7
6373344|NCT00746330|7284304|FG001|COMPLETED|Period 1||9
6373345|NCT00746330|7284305|FG002|COMPLETED|Period 1||8
6373346|NCT00746330|7284306|FG003|COMPLETED|Period 1||7
6373347|NCT00746330|7284303|FG000|NOT COMPLETED|Period 1||0
6373348|NCT00746330|7284304|FG001|NOT COMPLETED|Period 1||0
6373349|NCT00746330|7284305|FG002|NOT COMPLETED|Period 1||1
6373350|NCT00746330|7284306|FG003|NOT COMPLETED|Period 1||0
6373351|NCT00746330|7284303|FG000|STARTED|Period 2||7
6373352|NCT00746330|7284304|FG001|STARTED|Period 2||9
6373353|NCT00746330|7284305|FG002|STARTED|Period 2||8
6373354|NCT00746330|7284306|FG003|STARTED|Period 2||7
6373355|NCT00746330|7284303|FG000|COMPLETED|Period 2||7
6373356|NCT00746330|7284304|FG001|COMPLETED|Period 2||9
6373357|NCT00746330|7284305|FG002|COMPLETED|Period 2||8
6373358|NCT00746330|7284306|FG003|COMPLETED|Period 2||7
6373359|NCT00746330|7284303|FG000|NOT COMPLETED|Period 2||0
6373360|NCT00746330|7284304|FG001|NOT COMPLETED|Period 2||0
6373361|NCT00746330|7284305|FG002|NOT COMPLETED|Period 2||0
6373362|NCT00746330|7284306|FG003|NOT COMPLETED|Period 2||0
6373363|NCT00746330|7284303|FG000|STARTED|Period 3||7
6373364|NCT00746330|7284304|FG001|STARTED|Period 3||9
6373365|NCT00746330|7284305|FG002|STARTED|Period 3||8
6561141|NCT01791517|7484051|FG010|COMPLETED|Phase I: Period 2||16
6561142|NCT01791517|7484052|FG011|COMPLETED|Phase I: Period 2||19
6561143|NCT01791517|7484041|FG000|NOT COMPLETED|Phase I: Period 2||1
6778592|NCT03768726|7706485|FG001|STARTED|Follow-Up|Participants were followed up after completion or discontinuation of treatment.|12
6778593|NCT03768726|7706484|FG000|Received Treatment|Follow-Up||8
6778594|NCT03768726|7706485|FG001|Received Treatment|Follow-Up||12
6373366|NCT00746330|7284306|FG003|STARTED|Period 3||7
6373367|NCT00746330|7284303|FG000|COMPLETED|Period 3||7
6373368|NCT00746330|7284304|FG001|COMPLETED|Period 3||9
6373369|NCT00746330|7284305|FG002|COMPLETED|Period 3||8
6373370|NCT00746330|7284306|FG003|COMPLETED|Period 3||7
6373371|NCT00746330|7284303|FG000|NOT COMPLETED|Period 3||0
6373372|NCT00746330|7284304|FG001|NOT COMPLETED|Period 3||0
6373373|NCT00746330|7284305|FG002|NOT COMPLETED|Period 3||0
6373374|NCT00746330|7284306|FG003|NOT COMPLETED|Period 3||0
6778595|NCT03768726|7706484|FG000|COMPLETED|Follow-Up||2
6778596|NCT03768726|7706485|FG001|COMPLETED|Follow-Up||9
6778597|NCT03768726|7706484|FG000|NOT COMPLETED|Follow-Up||6
6778598|NCT03768726|7706485|FG001|NOT COMPLETED|Follow-Up||3
6778599|NCT03768206|7706493|FG000|STARTED|Overall Study||24
6778600|NCT03768206|7706494|FG001|STARTED|Overall Study||21
6778601|NCT03768206|7706493|FG000|COMPLETED|Overall Study||22
6778602|NCT03768206|7706494|FG001|COMPLETED|Overall Study||19
6778603|NCT03768206|7706493|FG000|NOT COMPLETED|Overall Study||2
6778604|NCT03768206|7706494|FG001|NOT COMPLETED|Overall Study||2
6778605|NCT03767894|7706501|FG000|STARTED|Overall Study||12
6778606|NCT03767894|7706501|FG000|COMPLETED|Overall Study||11
6778607|NCT03767894|7706501|FG000|NOT COMPLETED|Overall Study||1
6778608|NCT03767738|7706507|FG000|STARTED|Overall Study||35
6778609|NCT03767738|7706508|FG001|STARTED|Overall Study||30
6778610|NCT03767738|7706507|FG000|COMPLETED|Overall Study||35
6778611|NCT03767738|7706508|FG001|COMPLETED|Overall Study||30
6778612|NCT03767738|7706507|FG000|NOT COMPLETED|Overall Study||0
6778613|NCT03767738|7706508|FG001|NOT COMPLETED|Overall Study||0
6373375|NCT00746330|7284303|FG000|STARTED|Period 4||7
6373376|NCT00746330|7284304|FG001|STARTED|Period 4||9
6373377|NCT00746330|7284305|FG002|STARTED|Period 4||8
6373378|NCT00746330|7284306|FG003|STARTED|Period 4||7
6373379|NCT00746330|7284303|FG000|COMPLETED|Period 4||7
6373380|NCT00746330|7284304|FG001|COMPLETED|Period 4||9
6373381|NCT00746330|7284305|FG002|COMPLETED|Period 4||8
6373382|NCT00746330|7284306|FG003|COMPLETED|Period 4||7
6373383|NCT00746330|7284303|FG000|NOT COMPLETED|Period 4||0
6373384|NCT00746330|7284304|FG001|NOT COMPLETED|Period 4||0
6373385|NCT00746330|7284305|FG002|NOT COMPLETED|Period 4||0
6778614|NCT03767153|7706516|FG000|STARTED|Overall Study||14
6373386|NCT00746330|7284306|FG003|NOT COMPLETED|Period 4||0
6373387|NCT00746356|7284317|FG000|STARTED|Overall Study||81
6373388|NCT00746356|7284318|FG001|STARTED|Overall Study||47
6373389|NCT00746356|7284317|FG000|COMPLETED|Overall Study||70
6373390|NCT00746356|7284318|FG001|COMPLETED|Overall Study||40
6373391|NCT00746356|7284317|FG000|NOT COMPLETED|Overall Study||11
6373392|NCT00746356|7284318|FG001|NOT COMPLETED|Overall Study||7
6778615|NCT03767153|7706517|FG001|STARTED|Overall Study||11
6778616|NCT03767153|7706516|FG000|COMPLETED|Overall Study||14
6778617|NCT03767153|7706517|FG001|COMPLETED|Overall Study||11
6778618|NCT03767153|7706516|FG000|NOT COMPLETED|Overall Study||0
6373393|NCT00746395|7284328|FG000|STARTED|Overall Study||20
6373394|NCT00746395|7284329|FG001|STARTED|Overall Study||20
6373395|NCT00746395|7284328|FG000|COMPLETED|Overall Study||20
6373396|NCT00746395|7284329|FG001|COMPLETED|Overall Study||20
6373397|NCT00746395|7284328|FG000|NOT COMPLETED|Overall Study||0
6373398|NCT00746395|7284329|FG001|NOT COMPLETED|Overall Study||0
6373399|NCT00746421|7284337|FG000|STARTED|Overall Study||12
6373400|NCT00746421|7284338|FG001|STARTED|Overall Study||11
6373401|NCT00746421|7284337|FG000|COMPLETED|Overall Study||5
6373402|NCT00746421|7284338|FG001|COMPLETED|Overall Study||9
6373403|NCT00746421|7284337|FG000|NOT COMPLETED|Overall Study||7
6373404|NCT00746421|7284338|FG001|NOT COMPLETED|Overall Study||2
6373405|NCT00746512|7284348|FG000|STARTED|Overall Study||8
6373406|NCT00746512|7284349|FG001|STARTED|Overall Study||10
6373407|NCT00746512|7284350|FG002|STARTED|Overall Study||18
6373408|NCT00746512|7284351|FG003|STARTED|Overall Study||9
6373409|NCT00746512|7284348|FG000|COMPLETED|Overall Study||8
6373410|NCT00746512|7284349|FG001|COMPLETED|Overall Study||10
6373411|NCT00746512|7284350|FG002|COMPLETED|Overall Study||18
6373412|NCT00746512|7284351|FG003|COMPLETED|Overall Study||9
6373413|NCT00746512|7284348|FG000|NOT COMPLETED|Overall Study||0
6373414|NCT00746512|7284349|FG001|NOT COMPLETED|Overall Study||0
6373415|NCT00746512|7284350|FG002|NOT COMPLETED|Overall Study||0
6373416|NCT00746512|7284351|FG003|NOT COMPLETED|Overall Study||0
6373417|NCT00746551|7284363|FG000|STARTED|At Gestational Age of 36 Weeks||40
6373418|NCT00746551|7284364|FG001|STARTED|At Gestational Age of 36 Weeks||40
6373419|NCT00746551|7284363|FG000|COMPLETED|At Gestational Age of 36 Weeks||38
6373420|NCT00746551|7284364|FG001|COMPLETED|At Gestational Age of 36 Weeks||36
6373421|NCT00746551|7284363|FG000|NOT COMPLETED|At Gestational Age of 36 Weeks||2
6373422|NCT00746551|7284364|FG001|NOT COMPLETED|At Gestational Age of 36 Weeks||4
6373423|NCT00746551|7284363|FG000|STARTED|At Delivery (GA of 39 Weeks)||40
6373424|NCT00746551|7284364|FG001|STARTED|At Delivery (GA of 39 Weeks)||40
6373425|NCT00746551|7284363|FG000|COMPLETED|At Delivery (GA of 39 Weeks)||25
6373426|NCT00746551|7284364|FG001|COMPLETED|At Delivery (GA of 39 Weeks)||25
6373427|NCT00746551|7284363|FG000|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
6373428|NCT00746551|7284364|FG001|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
6373429|NCT00746564|7284370|FG000|STARTED|Overall Study||75
6373430|NCT00746564|7284370|FG000|COMPLETED|Overall Study||73
6373431|NCT00746564|7284370|FG000|NOT COMPLETED|Overall Study||2
6373432|NCT00746668|7284376|FG000|STARTED|Overall Study||6
6373433|NCT00746668|7284377|FG001|STARTED|Overall Study||5
6373434|NCT00746668|7284378|FG002|STARTED|Overall Study||5
6373435|NCT00746668|7284379|FG003|STARTED|Overall Study||5
6373436|NCT00746668|7284380|FG004|STARTED|Overall Study||5
6373437|NCT00746668|7284381|FG005|STARTED|Overall Study||5
6373438|NCT00746668|7284382|FG006|STARTED|Overall Study||5
6373439|NCT00746668|7284376|FG000|COMPLETED|Overall Study||6
6373440|NCT00746668|7284377|FG001|COMPLETED|Overall Study||5
6373441|NCT00746668|7284378|FG002|COMPLETED|Overall Study||5
6373442|NCT00746668|7284379|FG003|COMPLETED|Overall Study||5
6373443|NCT00746668|7284380|FG004|COMPLETED|Overall Study||5
6373444|NCT00746668|7284381|FG005|COMPLETED|Overall Study||5
6373445|NCT00746668|7284382|FG006|COMPLETED|Overall Study||5
6373446|NCT00746668|7284376|FG000|NOT COMPLETED|Overall Study||0
6373447|NCT00746668|7284377|FG001|NOT COMPLETED|Overall Study||0
6373448|NCT00746668|7284378|FG002|NOT COMPLETED|Overall Study||0
6373449|NCT00746668|7284379|FG003|NOT COMPLETED|Overall Study||0
6373450|NCT00746668|7284380|FG004|NOT COMPLETED|Overall Study||0
6373451|NCT00746668|7284381|FG005|NOT COMPLETED|Overall Study||0
6373452|NCT00746668|7284382|FG006|NOT COMPLETED|Overall Study||0
6373453|NCT00746694|7284395|FG000|STARTED|Overall Study||154
6373454|NCT00746694|7284395|FG000|COMPLETED|Overall Study||154
6373455|NCT00746694|7284395|FG000|NOT COMPLETED|Overall Study||0
6373456|NCT00746733|7284399|FG000|STARTED|First Intervention||12
6373457|NCT00746733|7284400|FG001|STARTED|First Intervention||12
6373458|NCT00746733|7284399|FG000|COMPLETED|First Intervention||12
6373459|NCT00746733|7284400|FG001|COMPLETED|First Intervention||12
6373460|NCT00746733|7284399|FG000|NOT COMPLETED|First Intervention||0
6373461|NCT00746733|7284400|FG001|NOT COMPLETED|First Intervention||0
6373462|NCT00746733|7284399|FG000|STARTED|Second Intervention||12
6373463|NCT00746733|7284400|FG001|STARTED|Second Intervention||12
6373464|NCT00746733|7284399|FG000|COMPLETED|Second Intervention||11
6373465|NCT00746733|7284400|FG001|COMPLETED|Second Intervention||12
6373466|NCT00746733|7284399|FG000|NOT COMPLETED|Second Intervention||1
6373467|NCT00746733|7284400|FG001|NOT COMPLETED|Second Intervention||0
6373468|NCT00746733|7284399|FG000|STARTED|Third Intervention||11
6373469|NCT00746733|7284400|FG001|STARTED|Third Intervention||12
6373470|NCT00746733|7284399|FG000|COMPLETED|Third Intervention||10
6373471|NCT00746733|7284400|FG001|COMPLETED|Third Intervention||11
6373472|NCT00746733|7284399|FG000|NOT COMPLETED|Third Intervention||1
6373473|NCT00746733|7284400|FG001|NOT COMPLETED|Third Intervention||1
6373474|NCT00746733|7284399|FG000|STARTED|Fourth Intervention||10
6373475|NCT00746733|7284400|FG001|STARTED|Fourth Intervention||11
6373476|NCT00746733|7284399|FG000|COMPLETED|Fourth Intervention||10
6373477|NCT00746733|7284400|FG001|COMPLETED|Fourth Intervention||11
6373478|NCT00746733|7284399|FG000|NOT COMPLETED|Fourth Intervention||0
6373479|NCT00746733|7284400|FG001|NOT COMPLETED|Fourth Intervention||0
6373480|NCT00746785|7284416|FG000|STARTED|Overall Study||43
6373481|NCT00746785|7284417|FG001|STARTED|Overall Study||46
6373482|NCT00746785|7284418|FG002|STARTED|Overall Study||40
6373483|NCT00746785|7284416|FG000|COMPLETED|Overall Study||14
6373484|NCT00746785|7284417|FG001|COMPLETED|Overall Study||21
6373485|NCT00746785|7284418|FG002|COMPLETED|Overall Study||13
6373486|NCT00746785|7284416|FG000|NOT COMPLETED|Overall Study||29
6373487|NCT00746785|7284417|FG001|NOT COMPLETED|Overall Study||25
6373488|NCT00746785|7284418|FG002|NOT COMPLETED|Overall Study||27
6373489|NCT00746798|7284430|FG000|STARTED|Overall Study||122
6373490|NCT00746798|7284431|FG001|STARTED|Overall Study||124
6373491|NCT00746798|7284432|FG002|STARTED|Overall Study||113
6373492|NCT00746798|7284433|FG003|STARTED|Overall Study||120
6373493|NCT00746798|7284430|FG000|COMPLETED|Overall Study||121
6373494|NCT00746798|7284431|FG001|COMPLETED|Overall Study||122
6373495|NCT00746798|7284432|FG002|COMPLETED|Overall Study||110
6373496|NCT00746798|7284433|FG003|COMPLETED|Overall Study||120
6373497|NCT00746798|7284430|FG000|NOT COMPLETED|Overall Study||1
6373498|NCT00746798|7284431|FG001|NOT COMPLETED|Overall Study||2
6373499|NCT00746798|7284432|FG002|NOT COMPLETED|Overall Study||3
6373500|NCT00746798|7284433|FG003|NOT COMPLETED|Overall Study||0
6373501|NCT00746863|7284445|FG000|STARTED|Overall Study||21
6373502|NCT00746863|7284446|FG001|STARTED|Overall Study||21
6373503|NCT00746863|7284445|FG000|COMPLETED|Overall Study||21
6373504|NCT00746863|7284446|FG001|COMPLETED|Overall Study||21
6373505|NCT00746863|7284445|FG000|NOT COMPLETED|Overall Study||0
6373506|NCT00746863|7284446|FG001|NOT COMPLETED|Overall Study||0
6373507|NCT00746889|7284454|FG000|STARTED|Overall Study||40
6373508|NCT00746889|7284455|FG001|STARTED|Overall Study||39
6373509|NCT00746889|7284454|FG000|COMPLETED|Overall Study||36
6373510|NCT00746889|7284455|FG001|COMPLETED|Overall Study||35
6373511|NCT00746889|7284454|FG000|NOT COMPLETED|Overall Study||4
6373512|NCT00746889|7284455|FG001|NOT COMPLETED|Overall Study||4
6373513|NCT00746941|7284467|FG000|STARTED|Overall Study||7
6373514|NCT00746941|7284468|FG001|STARTED|Overall Study||5
6373515|NCT00746941|7284469|FG002|STARTED|Overall Study||5
6373516|NCT00746941|7284470|FG003|STARTED|Overall Study||20
6373517|NCT00746941|7284467|FG000|COMPLETED|Overall Study||0
6373518|NCT00746941|7284468|FG001|COMPLETED|Overall Study||1
6373519|NCT00746941|7284469|FG002|COMPLETED|Overall Study||3
6373520|NCT00746941|7284470|FG003|COMPLETED|Overall Study||7
6373521|NCT00746941|7284467|FG000|NOT COMPLETED|Overall Study||7
6373522|NCT00746941|7284468|FG001|NOT COMPLETED|Overall Study||4
6373523|NCT00746941|7284469|FG002|NOT COMPLETED|Overall Study||2
6373524|NCT00746941|7284470|FG003|NOT COMPLETED|Overall Study||13
6373525|NCT00746954|7284479|FG000|STARTED|Overall Study||3
6373526|NCT00746954|7284480|FG001|STARTED|Overall Study||3
6373527|NCT00746954|7284481|FG002|STARTED|Overall Study||2
6373528|NCT00746954|7284479|FG000|COMPLETED|Overall Study||3
6373529|NCT00746954|7284480|FG001|COMPLETED|Overall Study||3
6373530|NCT00746954|7284481|FG002|COMPLETED|Overall Study||2
6373531|NCT00746954|7284479|FG000|NOT COMPLETED|Overall Study||0
6373532|NCT00746954|7284480|FG001|NOT COMPLETED|Overall Study||0
6778619|NCT03767153|7706517|FG001|NOT COMPLETED|Overall Study||0
6778620|NCT03767062|7706525|FG000|STARTED|Overall Study||45
6778621|NCT03767062|7706526|FG001|STARTED|Overall Study||45
6778622|NCT03767062|7706525|FG000|COMPLETED|Overall Study||37
6778623|NCT03767062|7706526|FG001|COMPLETED|Overall Study||41
6778624|NCT03767062|7706525|FG000|NOT COMPLETED|Overall Study||8
6778625|NCT03767062|7706526|FG001|NOT COMPLETED|Overall Study||4
6778626|NCT03766646|7706534|FG000|STARTED|Overall Study||19
6778627|NCT03766646|7706535|FG001|STARTED|Overall Study||15
6778628|NCT03766646|7706534|FG000|COMPLETED|Overall Study||18
6778629|NCT03766646|7706535|FG001|COMPLETED|Overall Study||12
6778630|NCT03766646|7706534|FG000|NOT COMPLETED|Overall Study||1
6778631|NCT03766646|7706535|FG001|NOT COMPLETED|Overall Study||3
6778632|NCT03766373|7706543|FG000|STARTED|Overall Study||12
6778633|NCT03766373|7706544|FG001|STARTED|Overall Study||12
6778634|NCT03766373|7706543|FG000|COMPLETED|Overall Study||12
6778635|NCT03766373|7706544|FG001|COMPLETED|Overall Study||12
6778636|NCT03766373|7706543|FG000|NOT COMPLETED|Overall Study||0
6778637|NCT03766373|7706544|FG001|NOT COMPLETED|Overall Study||0
6778638|NCT03766165|7706552|FG000|STARTED|Overall Study||19
6778639|NCT03766165|7706553|FG001|STARTED|Overall Study||19
6778640|NCT03766165|7706552|FG000|COMPLETED|Overall Study||19
6778641|NCT03766165|7706553|FG001|COMPLETED|Overall Study||19
6373533|NCT00746954|7284481|FG002|NOT COMPLETED|Overall Study||0
6373534|NCT00747006|7284490|FG000|STARTED|Overall Study||7
6373535|NCT00747006|7284491|FG001|STARTED|Overall Study||8
6373536|NCT00747006|7284492|FG002|STARTED|Overall Study||3
6373537|NCT00747006|7284490|FG000|COMPLETED|Overall Study||4
6373538|NCT00747006|7284491|FG001|COMPLETED|Overall Study||7
6373539|NCT00747006|7284492|FG002|COMPLETED|Overall Study||2
6373540|NCT00747006|7284490|FG000|NOT COMPLETED|Overall Study||3
6373541|NCT00747006|7284491|FG001|NOT COMPLETED|Overall Study||1
6373542|NCT00747006|7284492|FG002|NOT COMPLETED|Overall Study||1
6373543|NCT00747149|7284505|FG000|STARTED|Overall Study||154
6373544|NCT00747149|7284506|FG001|STARTED|Overall Study||444
6778642|NCT03766165|7706552|FG000|NOT COMPLETED|Overall Study||0
6778643|NCT03766165|7706553|FG001|NOT COMPLETED|Overall Study||0
6778644|NCT03765996|7706562|FG000|STARTED|Overall Study||18
6778645|NCT03765996|7706563|FG001|STARTED|Overall Study||18
6778646|NCT03765996|7706562|FG000|COMPLETED|Overall Study||14
6778647|NCT03765996|7706563|FG001|COMPLETED|Overall Study||18
6778648|NCT03765996|7706562|FG000|NOT COMPLETED|Overall Study||4
6778649|NCT03765996|7706563|FG001|NOT COMPLETED|Overall Study||0
6778650|NCT03765762|7706571|FG000|STARTED|Overall Study||18
6373545|NCT00747149|7284505|FG000|COMPLETED|Overall Study||153
6373546|NCT00747149|7284506|FG001|COMPLETED|Overall Study||401
6373547|NCT00747149|7284505|FG000|NOT COMPLETED|Overall Study||1
6373548|NCT00747149|7284506|FG001|NOT COMPLETED|Overall Study||43
6373549|NCT00747214|7284520|FG000|STARTED|Overall Study||27
6373550|NCT00747214|7284521|FG001|STARTED|Overall Study||32
6373551|NCT00747214|7284520|FG000|COMPLETED|Overall Study||19
6373552|NCT00747214|7284521|FG001|COMPLETED|Overall Study||29
6373553|NCT00747214|7284520|FG000|NOT COMPLETED|Overall Study||8
6373554|NCT00747214|7284521|FG001|NOT COMPLETED|Overall Study||3
6373555|NCT00747227|7284529|FG000|STARTED|Overall Study||126
6373556|NCT00747227|7284530|FG001|STARTED|Overall Study||124
6373557|NCT00747227|7284529|FG000|COMPLETED|Overall Study||120
6373558|NCT00747227|7284530|FG001|COMPLETED|Overall Study||120
6373559|NCT00747227|7284529|FG000|NOT COMPLETED|Overall Study||6
6373560|NCT00747227|7284530|FG001|NOT COMPLETED|Overall Study||4
6373561|NCT00747344|7284538|FG000|STARTED|Controlled Period||60
6373562|NCT00747344|7284539|FG001|STARTED|Controlled Period||61
6373563|NCT00747344|7284540|FG002|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6373564|NCT00747344|7284541|FG003|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
6373565|NCT00747344|7284538|FG000|COMPLETED|Controlled Period||55
6373566|NCT00747344|7284539|FG001|COMPLETED|Controlled Period||57
6373567|NCT00747344|7284540|FG002|COMPLETED|Controlled Period||0
6373568|NCT00747344|7284541|FG003|COMPLETED|Controlled Period||0
6373569|NCT00747344|7284538|FG000|NOT COMPLETED|Controlled Period||5
6373570|NCT00747344|7284539|FG001|NOT COMPLETED|Controlled Period||4
6373571|NCT00747344|7284540|FG002|NOT COMPLETED|Controlled Period||0
6373572|NCT00747344|7284541|FG003|NOT COMPLETED|Controlled Period||0
6373573|NCT00747344|7284538|FG000|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6373574|NCT00747344|7284539|FG001|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
6373575|NCT00747344|7284540|FG002|STARTED|After Controlled Period||55
6373576|NCT00747344|7284541|FG003|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
6373577|NCT00747344|7284538|FG000|COMPLETED|After Controlled Period||0
6373578|NCT00747344|7284539|FG001|COMPLETED|After Controlled Period||0
6373579|NCT00747344|7284540|FG002|COMPLETED|After Controlled Period||55
6373580|NCT00747344|7284541|FG003|COMPLETED|After Controlled Period||56
6373581|NCT00747344|7284538|FG000|NOT COMPLETED|After Controlled Period||0
6373582|NCT00747344|7284539|FG001|NOT COMPLETED|After Controlled Period||0
6373583|NCT00747344|7284540|FG002|NOT COMPLETED|After Controlled Period||0
6373584|NCT00747344|7284541|FG003|NOT COMPLETED|After Controlled Period||1
6373585|NCT00747435|7284549|FG000|STARTED|Overall Study||73
6373586|NCT00747435|7284549|FG000|COMPLETED|Overall Study||67
6373587|NCT00747435|7284549|FG000|NOT COMPLETED|Overall Study||6
6373588|NCT00747474|7284553|FG000|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
6373589|NCT00747474|7284554|FG001|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373590|NCT00747474|7284555|FG002|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373591|NCT00747474|7284556|FG003|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373592|NCT00747474|7284557|FG004|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373593|NCT00747474|7284558|FG005|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373594|NCT00747474|7284559|FG006|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373595|NCT00747474|7284560|FG007|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373596|NCT00747474|7284561|FG008|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373597|NCT00747474|7284562|FG009|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373598|NCT00747474|7284563|FG010|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373599|NCT00747474|7284564|FG011|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
6373600|NCT00747474|7284553|FG000|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
6373601|NCT00747474|7284554|FG001|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373602|NCT00747474|7284555|FG002|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373603|NCT00747474|7284556|FG003|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373604|NCT00747474|7284557|FG004|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373605|NCT00747474|7284558|FG005|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373606|NCT00747474|7284559|FG006|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373607|NCT00747474|7284560|FG007|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373608|NCT00747474|7284561|FG008|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373609|NCT00747474|7284562|FG009|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373610|NCT00747474|7284563|FG010|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373611|NCT00747474|7284564|FG011|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373612|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373613|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373614|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373615|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373616|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373617|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373618|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373619|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373620|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373621|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373622|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373623|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
6373624|NCT00747474|7284553|FG000|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373625|NCT00747474|7284554|FG001|STARTED|Cohort 2 (3 mg/m^2) Period||4
6373626|NCT00747474|7284555|FG002|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373627|NCT00747474|7284556|FG003|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373628|NCT00747474|7284557|FG004|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373629|NCT00747474|7284558|FG005|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373630|NCT00747474|7284559|FG006|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373631|NCT00747474|7284560|FG007|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373632|NCT00747474|7284561|FG008|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373633|NCT00747474|7284562|FG009|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373634|NCT00747474|7284563|FG010|STARTED|Cohort 2 (3 mg/m^2) Period||0
6373635|NCT00747474|7284564|FG011|STARTED|Cohort 2 (3 mg/m^2) Period||0
6561144|NCT01791517|7484042|FG001|NOT COMPLETED|Phase I: Period 2||3
6561145|NCT01791517|7484043|FG002|NOT COMPLETED|Phase I: Period 2||2
6561146|NCT01791517|7484044|FG003|NOT COMPLETED|Phase I: Period 2||1
6561147|NCT01791517|7484045|FG004|NOT COMPLETED|Phase I: Period 2||0
6778651|NCT03765762|7706572|FG001|STARTED|Overall Study||8
6778652|NCT03765762|7706571|FG000|COMPLETED|Overall Study||18
6373636|NCT00747474|7284553|FG000|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373637|NCT00747474|7284554|FG001|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
6373638|NCT00747474|7284555|FG002|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373639|NCT00747474|7284556|FG003|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373640|NCT00747474|7284557|FG004|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373641|NCT00747474|7284558|FG005|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373642|NCT00747474|7284559|FG006|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373643|NCT00747474|7284560|FG007|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373644|NCT00747474|7284561|FG008|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373645|NCT00747474|7284562|FG009|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373646|NCT00747474|7284563|FG010|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373647|NCT00747474|7284564|FG011|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373648|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373649|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373650|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373651|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373652|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373653|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373654|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6778653|NCT03765762|7706572|FG001|COMPLETED|Overall Study||8
6778654|NCT03765762|7706571|FG000|NOT COMPLETED|Overall Study||0
6778655|NCT03765762|7706572|FG001|NOT COMPLETED|Overall Study||0
6778656|NCT03765502|7706581|FG000|STARTED|Simulation 1||20
6778657|NCT03765502|7706582|FG001|STARTED|Simulation 1||13
6778658|NCT03765502|7706583|FG002|STARTED|Simulation 1||33
6778659|NCT03765502|7706584|FG003|STARTED|Simulation 1||16
6778660|NCT03765502|7706585|FG004|STARTED|Simulation 1||17
6778661|NCT03765502|7706581|FG000|COMPLETED|Simulation 1||20
6778662|NCT03765502|7706582|FG001|COMPLETED|Simulation 1||13
6778663|NCT03765502|7706583|FG002|COMPLETED|Simulation 1||33
6778664|NCT03765502|7706584|FG003|COMPLETED|Simulation 1||16
6778665|NCT03765502|7706585|FG004|COMPLETED|Simulation 1||17
6778666|NCT03765502|7706581|FG000|NOT COMPLETED|Simulation 1||0
6778667|NCT03765502|7706582|FG001|NOT COMPLETED|Simulation 1||0
6778668|NCT03765502|7706583|FG002|NOT COMPLETED|Simulation 1||0
6778669|NCT03765502|7706584|FG003|NOT COMPLETED|Simulation 1||0
6778670|NCT03765502|7706585|FG004|NOT COMPLETED|Simulation 1||0
6778671|NCT03765502|7706581|FG000|STARTED|Simulation 2||20
6778672|NCT03765502|7706582|FG001|STARTED|Simulation 2|Participant completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|12
6778673|NCT03765502|7706583|FG002|STARTED|Simulation 2|PWD completed Period 1 GEK simulation but did not return for the Period 2 NG simulation.|32
6778674|NCT03765502|7706584|FG003|STARTED|Simulation 2||16
6778675|NCT03765502|7706585|FG004|STARTED|Simulation 2||17
6778676|NCT03765502|7706581|FG000|COMPLETED|Simulation 2||20
6778677|NCT03765502|7706582|FG001|COMPLETED|Simulation 2||12
6778678|NCT03765502|7706583|FG002|COMPLETED|Simulation 2||32
6778679|NCT03765502|7706584|FG003|COMPLETED|Simulation 2||16
6778680|NCT03765502|7706585|FG004|COMPLETED|Simulation 2||17
6778681|NCT03765502|7706581|FG000|NOT COMPLETED|Simulation 2||0
6778682|NCT03765502|7706582|FG001|NOT COMPLETED|Simulation 2||0
6778683|NCT03765502|7706583|FG002|NOT COMPLETED|Simulation 2||0
6778684|NCT03765502|7706584|FG003|NOT COMPLETED|Simulation 2||0
6778685|NCT03765502|7706585|FG004|NOT COMPLETED|Simulation 2||0
6778686|NCT03765164|7706607|FG000|STARTED|Pre-intervention||78
6778687|NCT03765164|7706608|FG001|STARTED|Pre-intervention||78
6778688|NCT03765164|7706607|FG000|COMPLETED|Pre-intervention||73
6778689|NCT03765164|7706608|FG001|COMPLETED|Pre-intervention||72
6778690|NCT03765164|7706607|FG000|NOT COMPLETED|Pre-intervention||5
6778691|NCT03765164|7706608|FG001|NOT COMPLETED|Pre-intervention||6
6778692|NCT03765164|7706607|FG000|STARTED|Post-intervention||73
6561148|NCT01791517|7484046|FG005|NOT COMPLETED|Phase I: Period 2||1
6778693|NCT03765164|7706608|FG001|STARTED|Post-intervention||72
6778694|NCT03765164|7706607|FG000|COMPLETED|Post-intervention||0
6778695|NCT03765164|7706608|FG001|COMPLETED|Post-intervention||0
6778696|NCT03765164|7706607|FG000|NOT COMPLETED|Post-intervention||73
6778697|NCT03765164|7706608|FG001|NOT COMPLETED|Post-intervention||72
6778698|NCT03765138|7706614|FG000|STARTED|Overall Study||1
6778699|NCT03765138|7706614|FG000|COMPLETED|Overall Study||0
6373655|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373656|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373657|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373658|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373659|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
6373660|NCT00747474|7284553|FG000|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373661|NCT00747474|7284554|FG001|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373662|NCT00747474|7284555|FG002|STARTED|Cohort 3 (6 mg/m^2) Period||3
6373663|NCT00747474|7284556|FG003|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373664|NCT00747474|7284557|FG004|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373665|NCT00747474|7284558|FG005|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373666|NCT00747474|7284559|FG006|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373667|NCT00747474|7284560|FG007|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373668|NCT00747474|7284561|FG008|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373669|NCT00747474|7284562|FG009|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373670|NCT00747474|7284563|FG010|STARTED|Cohort 3 (6 mg/m^2) Period||0
6561149|NCT01791517|7484047|FG006|NOT COMPLETED|Phase I: Period 2||0
6561150|NCT01791517|7484048|FG007|NOT COMPLETED|Phase I: Period 2||0
6561151|NCT01791517|7484049|FG008|NOT COMPLETED|Phase I: Period 2||0
6561152|NCT01791517|7484050|FG009|NOT COMPLETED|Phase I: Period 2||1
6778700|NCT03765138|7706614|FG000|NOT COMPLETED|Overall Study||1
6778701|NCT03764449|7706621|FG000|STARTED|Overall Study||8
6778702|NCT03764449|7706622|FG001|STARTED|Overall Study||8
6778703|NCT03764449|7706621|FG000|COMPLETED|Overall Study||8
6778704|NCT03764449|7706622|FG001|COMPLETED|Overall Study||8
6778705|NCT03764449|7706621|FG000|NOT COMPLETED|Overall Study||0
6778706|NCT03764449|7706622|FG001|NOT COMPLETED|Overall Study||0
6778707|NCT03763929|7706637|FG000|STARTED|Overall Study||2
6778708|NCT03763929|7706638|FG001|STARTED|Overall Study||4
6778709|NCT03763929|7706637|FG000|COMPLETED|Overall Study||2
6778710|NCT03763929|7706638|FG001|COMPLETED|Overall Study||4
6778711|NCT03763929|7706637|FG000|NOT COMPLETED|Overall Study||0
6778712|NCT03763929|7706638|FG001|NOT COMPLETED|Overall Study||0
6778713|NCT03763747|7706644|FG000|STARTED|Overall Study||200
6778714|NCT03763747|7706644|FG000|COMPLETED|Overall Study||200
6778715|NCT03763747|7706644|FG000|NOT COMPLETED|Overall Study||0
6778716|NCT03763175|7706651|FG000|STARTED|Overall Study||20
6778717|NCT03763175|7706652|FG001|STARTED|Overall Study||19
6778718|NCT03763175|7706653|FG002|STARTED|Overall Study||20
6778719|NCT03763175|7706651|FG000|COMPLETED|Overall Study||19
6778720|NCT03763175|7706652|FG001|COMPLETED|Overall Study||17
6778721|NCT03763175|7706653|FG002|COMPLETED|Overall Study||19
6778722|NCT03763175|7706651|FG000|NOT COMPLETED|Overall Study||1
6778723|NCT03763175|7706652|FG001|NOT COMPLETED|Overall Study||2
6778724|NCT03763175|7706653|FG002|NOT COMPLETED|Overall Study||1
6778725|NCT03763058|7706661|FG000|STARTED|Overall Study||20
6778726|NCT03763058|7706661|FG000|COMPLETED|Overall Study||18
6778727|NCT03763058|7706661|FG000|NOT COMPLETED|Overall Study||2
6778728|NCT03762993|7706667|FG000|STARTED|Overall Study||21
6778729|NCT03762993|7706668|FG001|STARTED|Overall Study||10
6778730|NCT03762993|7706667|FG000|COMPLETED|Overall Study||21
6778731|NCT03762993|7706668|FG001|COMPLETED|Overall Study||10
6778732|NCT03762993|7706667|FG000|NOT COMPLETED|Overall Study||0
6778733|NCT03762993|7706668|FG001|NOT COMPLETED|Overall Study||0
6778734|NCT03762681|7706682|FG000|STARTED|Part 1||8
6778735|NCT03762681|7706683|FG001|STARTED|Part 1||8
6778736|NCT03762681|7706684|FG002|STARTED|Part 1||8
6778737|NCT03762681|7706685|FG003|STARTED|Part 1||8
6778738|NCT03762681|7706686|FG004|STARTED|Part 1||8
6778739|NCT03762681|7706687|FG005|STARTED|Part 1||0
6778740|NCT03762681|7706688|FG006|STARTED|Part 1||0
6778741|NCT03762681|7706689|FG007|STARTED|Part 1||0
6778742|NCT03762681|7706682|FG000|COMPLETED|Part 1||8
6778743|NCT03762681|7706683|FG001|COMPLETED|Part 1||8
6778744|NCT03762681|7706684|FG002|COMPLETED|Part 1||8
6778745|NCT03762681|7706685|FG003|COMPLETED|Part 1||7
6778746|NCT03762681|7706686|FG004|COMPLETED|Part 1||8
6778747|NCT03762681|7706687|FG005|COMPLETED|Part 1||0
6778748|NCT03762681|7706688|FG006|COMPLETED|Part 1||0
6778749|NCT03762681|7706689|FG007|COMPLETED|Part 1||0
6778750|NCT03762681|7706682|FG000|NOT COMPLETED|Part 1||0
6778751|NCT03762681|7706683|FG001|NOT COMPLETED|Part 1||0
6778752|NCT03762681|7706684|FG002|NOT COMPLETED|Part 1||0
6778753|NCT03762681|7706685|FG003|NOT COMPLETED|Part 1||1
6778754|NCT03762681|7706686|FG004|NOT COMPLETED|Part 1||0
6778755|NCT03762681|7706687|FG005|NOT COMPLETED|Part 1||0
6778756|NCT03762681|7706688|FG006|NOT COMPLETED|Part 1||0
6778757|NCT03762681|7706689|FG007|NOT COMPLETED|Part 1||0
6778758|NCT03762681|7706682|FG000|STARTED|Part 2a||0
6778759|NCT03762681|7706683|FG001|STARTED|Part 2a||0
6778760|NCT03762681|7706684|FG002|STARTED|Part 2a||0
6778761|NCT03762681|7706685|FG003|STARTED|Part 2a||0
6561153|NCT01791517|7484051|FG010|NOT COMPLETED|Phase I: Period 2||2
6778762|NCT03762681|7706686|FG004|STARTED|Part 2a||0
6778763|NCT03762681|7706687|FG005|STARTED|Part 2a||2
6778764|NCT03762681|7706688|FG006|STARTED|Part 2a||8
6778765|NCT03762681|7706689|FG007|STARTED|Part 2a||5
6778766|NCT03762681|7706682|FG000|COMPLETED|Part 2a||0
6778767|NCT03762681|7706683|FG001|COMPLETED|Part 2a||0
6778768|NCT03762681|7706684|FG002|COMPLETED|Part 2a||0
6778769|NCT03762681|7706685|FG003|COMPLETED|Part 2a||0
6778770|NCT03762681|7706686|FG004|COMPLETED|Part 2a||0
6778771|NCT03762681|7706687|FG005|COMPLETED|Part 2a||2
6778772|NCT03762681|7706688|FG006|COMPLETED|Part 2a||8
6778773|NCT03762681|7706689|FG007|COMPLETED|Part 2a||4
6778774|NCT03762681|7706682|FG000|NOT COMPLETED|Part 2a||0
6778775|NCT03762681|7706683|FG001|NOT COMPLETED|Part 2a||0
6778776|NCT03762681|7706684|FG002|NOT COMPLETED|Part 2a||0
6373671|NCT00747474|7284564|FG011|STARTED|Cohort 3 (6 mg/m^2) Period||0
6373672|NCT00747474|7284553|FG000|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373673|NCT00747474|7284554|FG001|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373674|NCT00747474|7284555|FG002|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
6373675|NCT00747474|7284556|FG003|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373676|NCT00747474|7284557|FG004|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373677|NCT00747474|7284558|FG005|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373678|NCT00747474|7284559|FG006|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373679|NCT00747474|7284560|FG007|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373680|NCT00747474|7284561|FG008|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373681|NCT00747474|7284562|FG009|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373682|NCT00747474|7284563|FG010|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373683|NCT00747474|7284564|FG011|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6778777|NCT03762681|7706685|FG003|NOT COMPLETED|Part 2a||0
6778778|NCT03762681|7706686|FG004|NOT COMPLETED|Part 2a||0
6778779|NCT03762681|7706687|FG005|NOT COMPLETED|Part 2a||0
6778780|NCT03762681|7706688|FG006|NOT COMPLETED|Part 2a||0
6778781|NCT03762681|7706689|FG007|NOT COMPLETED|Part 2a||1
6778782|NCT03762668|7706718|FG000|STARTED|Period 1, First Week of Wear||30
6778783|NCT03762668|7706719|FG001|STARTED|Period 1, First Week of Wear||30
6778784|NCT03762668|7706718|FG000|COMPLETED|Period 1, First Week of Wear||30
6778785|NCT03762668|7706719|FG001|COMPLETED|Period 1, First Week of Wear||29
6778786|NCT03762668|7706718|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
6778787|NCT03762668|7706719|FG001|NOT COMPLETED|Period 1, First Week of Wear||1
6778788|NCT03762668|7706718|FG000|STARTED|Period 2, Second Week of Wear||30
6778789|NCT03762668|7706719|FG001|STARTED|Period 2, Second Week of Wear||29
6778790|NCT03762668|7706718|FG000|COMPLETED|Period 2, Second Week of Wear||30
6778791|NCT03762668|7706719|FG001|COMPLETED|Period 2, Second Week of Wear||29
6778792|NCT03762668|7706718|FG000|NOT COMPLETED|Period 2, Second Week of Wear||0
6778793|NCT03762668|7706719|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
6778794|NCT03762616|7706725|FG000|STARTED|Overall Study||120
6778795|NCT03762616|7706725|FG000|COMPLETED|Overall Study||118
6778796|NCT03762616|7706725|FG000|NOT COMPLETED|Overall Study||2
6778797|NCT03762213|7706733|FG000|STARTED|Overall Study||16
6778798|NCT03762213|7706734|FG001|STARTED|Overall Study||14
6778799|NCT03762213|7706733|FG000|COMPLETED|Overall Study||16
6778800|NCT03762213|7706734|FG001|COMPLETED|Overall Study||14
6778801|NCT03762213|7706733|FG000|NOT COMPLETED|Overall Study||0
6778802|NCT03762213|7706734|FG001|NOT COMPLETED|Overall Study||0
6778803|NCT03762200|7706740|FG000|STARTED|Overall Study||103
6778804|NCT03762200|7706740|FG000|COMPLETED|Overall Study||101
6778805|NCT03762200|7706740|FG000|NOT COMPLETED|Overall Study||2
6778806|NCT03761368|7706746|FG000|STARTED|Overall Study||50
6778807|NCT03761368|7706747|FG001|STARTED|Overall Study||51
6778808|NCT03761368|7706746|FG000|COMPLETED|Overall Study||50
6778809|NCT03761368|7706747|FG001|COMPLETED|Overall Study||51
6778810|NCT03761368|7706746|FG000|NOT COMPLETED|Overall Study||0
6778811|NCT03761368|7706747|FG001|NOT COMPLETED|Overall Study||0
6778812|NCT03761147|7706755|FG000|STARTED|Overall Study||32
6778813|NCT03761147|7706756|FG001|STARTED|Overall Study||32
6778814|NCT03761147|7706755|FG000|COMPLETED|Overall Study||25
6778815|NCT03761147|7706756|FG001|COMPLETED|Overall Study||28
6778816|NCT03761147|7706755|FG000|NOT COMPLETED|Overall Study||7
6778817|NCT03761147|7706756|FG001|NOT COMPLETED|Overall Study||4
6778818|NCT03760913|7706781|FG000|STARTED|Overall Study||17
6778819|NCT03760913|7706782|FG001|STARTED|Overall Study||3
6778820|NCT03760913|7706783|FG002|STARTED|Overall Study||6
6778821|NCT03760913|7706784|FG003|STARTED|Overall Study||3
6778822|NCT03760913|7706785|FG004|STARTED|Overall Study||6
6778823|NCT03760913|7706786|FG005|STARTED|Overall Study||3
6778824|NCT03760913|7706787|FG006|STARTED|Overall Study||6
6778825|NCT03760913|7706788|FG007|STARTED|Overall Study||3
6778826|NCT03760913|7706789|FG008|STARTED|Overall Study||3
6778827|NCT03760913|7706790|FG009|STARTED|Overall Study||6
6778828|NCT03760913|7706791|FG010|STARTED|Overall Study||6
6778829|NCT03760913|7706792|FG011|STARTED|Overall Study||6
6778830|NCT03760913|7706793|FG012|STARTED|Overall Study||12
6778831|NCT03760913|7706794|FG013|STARTED|Overall Study||6
6778832|NCT03760913|7706795|FG014|STARTED|Overall Study||6
6778833|NCT03760913|7706796|FG015|STARTED|Overall Study||6
6778834|NCT03760913|7706797|FG016|STARTED|Overall Study||6
6778835|NCT03760913|7706798|FG017|STARTED|Overall Study||6
6778836|NCT03760913|7706799|FG018|STARTED|Overall Study||6
6778837|NCT03760913|7706781|FG000|COMPLETED|Overall Study||17
6778838|NCT03760913|7706782|FG001|COMPLETED|Overall Study||3
6778839|NCT03760913|7706783|FG002|COMPLETED|Overall Study||6
6373684|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373685|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373686|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6778840|NCT03760913|7706784|FG003|COMPLETED|Overall Study||3
6778841|NCT03760913|7706785|FG004|COMPLETED|Overall Study||6
6778842|NCT03760913|7706786|FG005|COMPLETED|Overall Study||3
6778843|NCT03760913|7706787|FG006|COMPLETED|Overall Study||6
6778844|NCT03760913|7706788|FG007|COMPLETED|Overall Study||3
6778845|NCT03760913|7706789|FG008|COMPLETED|Overall Study||3
6778846|NCT03760913|7706790|FG009|COMPLETED|Overall Study||6
6778847|NCT03760913|7706791|FG010|COMPLETED|Overall Study||6
6373687|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6778848|NCT03760913|7706792|FG011|COMPLETED|Overall Study||6
6778849|NCT03760913|7706793|FG012|COMPLETED|Overall Study||12
6373688|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373689|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373690|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373691|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373692|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373693|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373694|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373695|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
6373696|NCT00747474|7284553|FG000|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373697|NCT00747474|7284554|FG001|STARTED|Cohort 4 (9 mg/m^2) Period||0
6778850|NCT03760913|7706794|FG013|COMPLETED|Overall Study||6
6778851|NCT03760913|7706795|FG014|COMPLETED|Overall Study||6
6778852|NCT03760913|7706796|FG015|COMPLETED|Overall Study||6
6778853|NCT03760913|7706797|FG016|COMPLETED|Overall Study||6
6778854|NCT03760913|7706798|FG017|COMPLETED|Overall Study||6
6778855|NCT03760913|7706799|FG018|COMPLETED|Overall Study||6
6778856|NCT03760913|7706781|FG000|NOT COMPLETED|Overall Study||0
6778857|NCT03760913|7706782|FG001|NOT COMPLETED|Overall Study||0
6778858|NCT03760913|7706783|FG002|NOT COMPLETED|Overall Study||0
6778859|NCT03760913|7706784|FG003|NOT COMPLETED|Overall Study||0
6778860|NCT03760913|7706785|FG004|NOT COMPLETED|Overall Study||0
6778861|NCT03760913|7706786|FG005|NOT COMPLETED|Overall Study||0
6778862|NCT03760913|7706787|FG006|NOT COMPLETED|Overall Study||0
6778863|NCT03760913|7706788|FG007|NOT COMPLETED|Overall Study||0
6778864|NCT03760913|7706789|FG008|NOT COMPLETED|Overall Study||0
6778865|NCT03760913|7706790|FG009|NOT COMPLETED|Overall Study||0
6778866|NCT03760913|7706791|FG010|NOT COMPLETED|Overall Study||0
6778867|NCT03760913|7706792|FG011|NOT COMPLETED|Overall Study||0
6778868|NCT03760913|7706793|FG012|NOT COMPLETED|Overall Study||0
6778869|NCT03760913|7706794|FG013|NOT COMPLETED|Overall Study||0
6778870|NCT03760913|7706795|FG014|NOT COMPLETED|Overall Study||0
6778871|NCT03760913|7706796|FG015|NOT COMPLETED|Overall Study||0
6778872|NCT03760913|7706797|FG016|NOT COMPLETED|Overall Study||0
6778873|NCT03760913|7706798|FG017|NOT COMPLETED|Overall Study||0
6778874|NCT03760913|7706799|FG018|NOT COMPLETED|Overall Study||0
6778875|NCT03760796|7706852|FG000|STARTED|Overall Study||200
6778876|NCT03760796|7706853|FG001|STARTED|Overall Study||864
6778877|NCT03760796|7706852|FG000|COMPLETED|Overall Study||200
6778878|NCT03760796|7706853|FG001|COMPLETED|Overall Study||864
6778879|NCT03760796|7706852|FG000|NOT COMPLETED|Overall Study||0
6778880|NCT03760796|7706853|FG001|NOT COMPLETED|Overall Study||0
6778881|NCT03760640|7706861|FG000|STARTED|Period 1||20
6778882|NCT03760640|7706862|FG001|STARTED|Period 1||22
6778883|NCT03760640|7706861|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
6778884|NCT03760640|7706862|FG001|Received at Least 1 Dose of Study Drug|Period 1||22
6778885|NCT03760640|7706861|FG000|COMPLETED|Period 1||20
6778886|NCT03760640|7706862|FG001|COMPLETED|Period 1||22
6778887|NCT03760640|7706861|FG000|NOT COMPLETED|Period 1||0
6778888|NCT03760640|7706862|FG001|NOT COMPLETED|Period 1||0
6778889|NCT03760640|7706861|FG000|STARTED|Period 2||20
6778890|NCT03760640|7706862|FG001|STARTED|Period 2||22
6778891|NCT03760640|7706861|FG000|COMPLETED|Period 2||20
6778892|NCT03760640|7706862|FG001|COMPLETED|Period 2||22
6778893|NCT03760640|7706861|FG000|NOT COMPLETED|Period 2||0
6778894|NCT03760640|7706862|FG001|NOT COMPLETED|Period 2||0
6778895|NCT03760510|7706870|FG000|STARTED|Overall Study||250
6778896|NCT03760510|7706871|FG001|STARTED|Overall Study||250
6778897|NCT03760510|7706870|FG000|COMPLETED|Overall Study||145
6778898|NCT03760510|7706871|FG001|COMPLETED|Overall Study||153
6778899|NCT03760510|7706870|FG000|NOT COMPLETED|Overall Study||105
6778900|NCT03760510|7706871|FG001|NOT COMPLETED|Overall Study||97
6778901|NCT03760250|7706877|FG000|STARTED|Overall Study||6
6778902|NCT03760250|7706877|FG000|COMPLETED|Overall Study||4
6778903|NCT03760250|7706877|FG000|NOT COMPLETED|Overall Study||2
6778904|NCT03759600|7706881|FG000|STARTED|Overall Study||20
6778905|NCT03759600|7706881|FG000|COMPLETED|Overall Study||0
6778906|NCT03759600|7706881|FG000|NOT COMPLETED|Overall Study||20
6778907|NCT03759340|7706885|FG000|STARTED|Overall Study||56
6778908|NCT03759340|7706885|FG000|COMPLETED|Overall Study||0
6778909|NCT03759340|7706885|FG000|NOT COMPLETED|Overall Study||56
6778910|NCT03758716|7706889|FG000|STARTED|Overall Study||12
6778911|NCT03758716|7706889|FG000|COMPLETED|Overall Study||12
6778912|NCT03758716|7706889|FG000|NOT COMPLETED|Overall Study||0
6778913|NCT03758365|7706893|FG000|STARTED|Overall Study||36
6778914|NCT03758365|7706893|FG000|MC2-01 Cream|Overall Study||36
6778915|NCT03758365|7706893|FG000|Clobetasol Propionate 0.05% Lotion|Overall Study||36
6778916|NCT03758365|7706893|FG000|Betamethasone Dipropionate 0.05% Cream|Overall Study||36
6778917|NCT03758365|7706893|FG000|Triamcinolone Acetonide 0,1% Cream|Overall Study||36
6778918|NCT03758365|7706893|FG000|Hydrocortisone Butyrate 0.1% Cream|Overall Study||36
6373698|NCT00747474|7284555|FG002|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373699|NCT00747474|7284556|FG003|STARTED|Cohort 4 (9 mg/m^2) Period||4
6778919|NCT03758365|7706893|FG000|Desonide 0.05% Cream|Overall Study||36
6778920|NCT03758365|7706893|FG000|Vehicle Cream|Overall Study||36
6778921|NCT03758365|7706893|FG000|COMPLETED|Overall Study||36
6778922|NCT03758365|7706893|FG000|NOT COMPLETED|Overall Study||0
6778923|NCT03758157|7706904|FG000|STARTED|Overall Study||110
6778924|NCT03758157|7706904|FG000|COMPLETED|Overall Study||110
6778925|NCT03758157|7706904|FG000|NOT COMPLETED|Overall Study||0
6778926|NCT03757988|7706908|FG000|STARTED|Overall Study||17
6778927|NCT03757988|7706908|FG000|COMPLETED|Overall Study||16
6373700|NCT00747474|7284557|FG004|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373701|NCT00747474|7284558|FG005|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373702|NCT00747474|7284559|FG006|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373703|NCT00747474|7284560|FG007|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373704|NCT00747474|7284561|FG008|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373705|NCT00747474|7284562|FG009|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373706|NCT00747474|7284563|FG010|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373707|NCT00747474|7284564|FG011|STARTED|Cohort 4 (9 mg/m^2) Period||0
6373708|NCT00747474|7284553|FG000|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373709|NCT00747474|7284554|FG001|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373710|NCT00747474|7284555|FG002|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373711|NCT00747474|7284556|FG003|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
6373712|NCT00747474|7284557|FG004|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373713|NCT00747474|7284558|FG005|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373714|NCT00747474|7284559|FG006|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373715|NCT00747474|7284560|FG007|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373716|NCT00747474|7284561|FG008|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373717|NCT00747474|7284562|FG009|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6778928|NCT03757988|7706908|FG000|NOT COMPLETED|Overall Study||1
6778929|NCT03757312|7706915|FG000|STARTED|Overall Study||5
6778930|NCT03757312|7706916|FG001|STARTED|Overall Study||9
6778931|NCT03757312|7706915|FG000|COMPLETED|Overall Study||5
6778932|NCT03757312|7706916|FG001|COMPLETED|Overall Study||9
6778933|NCT03757312|7706915|FG000|NOT COMPLETED|Overall Study||0
6778934|NCT03757312|7706916|FG001|NOT COMPLETED|Overall Study||0
6778935|NCT03757234|7706929|FG000|STARTED|Overall Study||75
6778936|NCT03757234|7706930|FG001|STARTED|Overall Study||18
6778937|NCT03757234|7706931|FG002|STARTED|Overall Study||17
6778938|NCT03757234|7706932|FG003|STARTED|Overall Study||17
6778939|NCT03757234|7706933|FG004|STARTED|Overall Study||74
6778940|NCT03757234|7706929|FG000|Completed PTE Visit|Overall Study||72
6778941|NCT03757234|7706930|FG001|Completed PTE Visit|Overall Study||16
6778942|NCT03757234|7706931|FG002|Completed PTE Visit|Overall Study||17
6778943|NCT03757234|7706932|FG003|Completed PTE Visit|Overall Study||16
6778944|NCT03757234|7706933|FG004|Completed PTE Visit|Overall Study||71
6778945|NCT03757234|7706929|FG000|COMPLETED|Overall Study||72
6778946|NCT03757234|7706930|FG001|COMPLETED|Overall Study||16
6778947|NCT03757234|7706931|FG002|COMPLETED|Overall Study||17
6778948|NCT03757234|7706932|FG003|COMPLETED|Overall Study||16
6778949|NCT03757234|7706933|FG004|COMPLETED|Overall Study||70
6778950|NCT03757234|7706929|FG000|NOT COMPLETED|Overall Study||3
6778951|NCT03757234|7706930|FG001|NOT COMPLETED|Overall Study||2
6778952|NCT03757234|7706931|FG002|NOT COMPLETED|Overall Study||0
6778953|NCT03757234|7706932|FG003|NOT COMPLETED|Overall Study||1
6778954|NCT03757234|7706933|FG004|NOT COMPLETED|Overall Study||4
6778955|NCT03757039|7706949|FG000|STARTED|Overall Study||32
6778956|NCT03757039|7706950|FG001|STARTED|Overall Study||9
6778957|NCT03757039|7706949|FG000|AOHG MF|Overall Study||11
6778958|NCT03757039|7706950|FG001|AOHG MF|Overall Study||0
6778959|NCT03757039|7706949|FG000|DT1 MF|Overall Study||11
6778960|NCT03757039|7706950|FG001|DT1 MF|Overall Study||0
6778961|NCT03757039|7706949|FG000|DACP MF|Overall Study||10
6778962|NCT03757039|7706950|FG001|DACP MF|Overall Study||0
6778963|NCT03757039|7706949|FG000|COMPLETED|Overall Study||32
6778964|NCT03757039|7706950|FG001|COMPLETED|Overall Study||9
6778965|NCT03757039|7706949|FG000|NOT COMPLETED|Overall Study||0
6778966|NCT03757039|7706950|FG001|NOT COMPLETED|Overall Study||0
6778967|NCT03756883|7706961|FG000|STARTED|Overall Study||485
6778968|NCT03756883|7706962|FG001|STARTED|Overall Study||413
6778969|NCT03756883|7706963|FG002|STARTED|Overall Study||101
6778970|NCT03756883|7706961|FG000|COMPLETED|Overall Study||472
6778971|NCT03756883|7706962|FG001|COMPLETED|Overall Study||402
6778972|NCT03756883|7706963|FG002|COMPLETED|Overall Study||94
6778973|NCT03756883|7706961|FG000|NOT COMPLETED|Overall Study||13
6778974|NCT03756883|7706962|FG001|NOT COMPLETED|Overall Study||11
6778975|NCT03756883|7706963|FG002|NOT COMPLETED|Overall Study||7
6778976|NCT03756506|7706973|FG000|STARTED|Overall Study||7
6778977|NCT03756506|7706974|FG001|STARTED|Overall Study||6
6778978|NCT03756506|7706973|FG000|COMPLETED|Overall Study||6
6778979|NCT03756506|7706974|FG001|COMPLETED|Overall Study||6
6778980|NCT03756506|7706973|FG000|NOT COMPLETED|Overall Study||1
6778981|NCT03756506|7706974|FG001|NOT COMPLETED|Overall Study||0
6778982|NCT03756285|7706982|FG000|STARTED|Overall Study||27
6778983|NCT03756285|7706983|FG001|STARTED|Overall Study||14
6778984|NCT03756285|7706982|FG000|COMPLETED|Overall Study||24
6778985|NCT03756285|7706983|FG001|COMPLETED|Overall Study||9
6778986|NCT03756285|7706982|FG000|NOT COMPLETED|Overall Study||3
6778987|NCT03756285|7706983|FG001|NOT COMPLETED|Overall Study||5
6778988|NCT03756129|7706996|FG000|STARTED|Overall Study||11
6778989|NCT03756129|7706997|FG001|STARTED|Overall Study||10
6778990|NCT03756129|7706998|FG002|STARTED|Overall Study||10
6778991|NCT03756129|7706999|FG003|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|9
6778992|NCT03756129|7707000|FG004|STARTED|Overall Study|1 participant in this group was randomized but not treated, and is not included in this data set.|10
6778993|NCT03756129|7707001|FG005|STARTED|Overall Study||20
6778994|NCT03756129|7706996|FG000|COMPLETED|Overall Study||8
6778995|NCT03756129|7706997|FG001|COMPLETED|Overall Study||8
6778996|NCT03756129|7706998|FG002|COMPLETED|Overall Study||7
6778997|NCT03756129|7706999|FG003|COMPLETED|Overall Study||6
6778998|NCT03756129|7707000|FG004|COMPLETED|Overall Study||9
6373718|NCT00747474|7284563|FG010|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373719|NCT00747474|7284564|FG011|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373720|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373721|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373722|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373723|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373724|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373725|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373726|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373727|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373728|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373729|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373730|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373731|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
6373732|NCT00747474|7284553|FG000|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373733|NCT00747474|7284554|FG001|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373734|NCT00747474|7284555|FG002|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373735|NCT00747474|7284556|FG003|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373736|NCT00747474|7284557|FG004|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
6373737|NCT00747474|7284558|FG005|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373738|NCT00747474|7284559|FG006|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373739|NCT00747474|7284560|FG007|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373740|NCT00747474|7284561|FG008|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373741|NCT00747474|7284562|FG009|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373742|NCT00747474|7284563|FG010|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373743|NCT00747474|7284564|FG011|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
6373744|NCT00747474|7284553|FG000|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373745|NCT00747474|7284554|FG001|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373746|NCT00747474|7284555|FG002|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373747|NCT00747474|7284556|FG003|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373748|NCT00747474|7284557|FG004|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
6373749|NCT00747474|7284558|FG005|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373750|NCT00747474|7284559|FG006|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373751|NCT00747474|7284560|FG007|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373752|NCT00747474|7284561|FG008|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373753|NCT00747474|7284562|FG009|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373754|NCT00747474|7284563|FG010|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6778999|NCT03756129|7707001|FG005|COMPLETED|Overall Study||15
6779000|NCT03756129|7706996|FG000|NOT COMPLETED|Overall Study||3
6779001|NCT03756129|7706997|FG001|NOT COMPLETED|Overall Study||2
6779002|NCT03756129|7706998|FG002|NOT COMPLETED|Overall Study||3
6779003|NCT03756129|7706999|FG003|NOT COMPLETED|Overall Study||3
6779004|NCT03756129|7707000|FG004|NOT COMPLETED|Overall Study||1
6779005|NCT03756129|7707001|FG005|NOT COMPLETED|Overall Study||5
6779006|NCT03756038|7707025|FG000|STARTED|Overall Study||1
6779007|NCT03756038|7707026|FG001|STARTED|Overall Study||0
6779008|NCT03756038|7707025|FG000|COMPLETED|Overall Study||1
6779009|NCT03756038|7707026|FG001|COMPLETED|Overall Study||0
6779010|NCT03756038|7707025|FG000|NOT COMPLETED|Overall Study||0
6779011|NCT03756038|7707026|FG001|NOT COMPLETED|Overall Study||0
6779012|NCT03756012|7707032|FG000|STARTED|Overall Study||15
6779013|NCT03756012|7707032|FG000|COMPLETED|Overall Study||15
6779014|NCT03756012|7707032|FG000|NOT COMPLETED|Overall Study||0
6779015|NCT03755882|7707037|FG000|STARTED|Period 1||23
6779016|NCT03755882|7707038|FG001|STARTED|Period 1||22
6779017|NCT03755882|7707037|FG000|COMPLETED|Period 1||19
6779018|NCT03755882|7707038|FG001|COMPLETED|Period 1||22
6779019|NCT03755882|7707037|FG000|NOT COMPLETED|Period 1||4
6779020|NCT03755882|7707038|FG001|NOT COMPLETED|Period 1||0
6779021|NCT03755882|7707037|FG000|STARTED|Period 2||19
6779022|NCT03755882|7707038|FG001|STARTED|Period 2||22
6779023|NCT03755882|7707037|FG000|COMPLETED|Period 2||19
6779024|NCT03755882|7707038|FG001|COMPLETED|Period 2||22
6779025|NCT03755882|7707037|FG000|NOT COMPLETED|Period 2||0
6779026|NCT03755882|7707038|FG001|NOT COMPLETED|Period 2||0
6779027|NCT03755661|7707046|FG000|STARTED|Overall Study||12
6779028|NCT03755661|7707047|FG001|STARTED|Overall Study||12
6779029|NCT03755661|7707046|FG000|COMPLETED|Overall Study||11
6779030|NCT03755661|7707047|FG001|COMPLETED|Overall Study||12
6779031|NCT03755661|7707046|FG000|NOT COMPLETED|Overall Study||1
6779032|NCT03755661|7707047|FG001|NOT COMPLETED|Overall Study||0
6779033|NCT03754582|7707053|FG000|STARTED|Pretreatment Phase||21
6779034|NCT03754582|7707054|FG001|STARTED|Pretreatment Phase||0
6779035|NCT03754582|7707055|FG002|STARTED|Pretreatment Phase||0
6779036|NCT03754582|7707053|FG000|COMPLETED|Pretreatment Phase||21
6779037|NCT03754582|7707054|FG001|COMPLETED|Pretreatment Phase||0
6779038|NCT03754582|7707055|FG002|COMPLETED|Pretreatment Phase||0
6779039|NCT03754582|7707053|FG000|NOT COMPLETED|Pretreatment Phase||0
6779040|NCT03754582|7707054|FG001|NOT COMPLETED|Pretreatment Phase||0
6779041|NCT03754582|7707055|FG002|NOT COMPLETED|Pretreatment Phase||0
6779042|NCT03754582|7707053|FG000|STARTED|Treatment Phase||0
6779043|NCT03754582|7707054|FG001|STARTED|Treatment Phase||21
6373755|NCT00747474|7284564|FG011|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373756|NCT00747474|7284553|FG000|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6779044|NCT03754582|7707055|FG002|STARTED|Treatment Phase||0
6779045|NCT03754582|7707053|FG000|COMPLETED|Treatment Phase||0
6779046|NCT03754582|7707054|FG001|COMPLETED|Treatment Phase||20
6373757|NCT00747474|7284554|FG001|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373758|NCT00747474|7284555|FG002|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373759|NCT00747474|7284556|FG003|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6561154|NCT01791517|7484052|FG011|NOT COMPLETED|Phase I: Period 2||0
6561155|NCT01791517|7484041|FG000|STARTED|Phase I: Period 3||17
6779047|NCT03754582|7707055|FG002|COMPLETED|Treatment Phase||0
6779048|NCT03754582|7707053|FG000|NOT COMPLETED|Treatment Phase||0
6779049|NCT03754582|7707054|FG001|NOT COMPLETED|Treatment Phase||1
6779050|NCT03754582|7707055|FG002|NOT COMPLETED|Treatment Phase||0
6779051|NCT03754582|7707053|FG000|STARTED|Follow-up Phase||0
6779052|NCT03754582|7707054|FG001|STARTED|Follow-up Phase||0
6779053|NCT03754582|7707055|FG002|STARTED|Follow-up Phase|1 participant who discontinued in Treatment Phase was assessed at Follow-up Visit.|21
6779054|NCT03754582|7707053|FG000|COMPLETED|Follow-up Phase||0
6779055|NCT03754582|7707054|FG001|COMPLETED|Follow-up Phase||0
6779056|NCT03754582|7707055|FG002|COMPLETED|Follow-up Phase||20
6779057|NCT03754582|7707053|FG000|NOT COMPLETED|Follow-up Phase||0
6779058|NCT03754582|7707054|FG001|NOT COMPLETED|Follow-up Phase||0
6779059|NCT03754582|7707055|FG002|NOT COMPLETED|Follow-up Phase||1
6779060|NCT03754556|7707071|FG000|STARTED|Overall Study||326658
6779061|NCT03754556|7707071|FG000|COMPLETED|Overall Study||326658
6779062|NCT03754556|7707071|FG000|NOT COMPLETED|Overall Study||0
6779063|NCT03753113|7707077|FG000|STARTED|Overall Study||12
6779064|NCT03753113|7707078|FG001|STARTED|Overall Study||12
6779065|NCT03753113|7707077|FG000|COMPLETED|Overall Study||12
6779066|NCT03753113|7707078|FG001|COMPLETED|Overall Study||12
6779067|NCT03753113|7707077|FG000|NOT COMPLETED|Overall Study||0
6779068|NCT03753113|7707078|FG001|NOT COMPLETED|Overall Study||0
6779069|NCT03752567|7707084|FG000|STARTED|Overall Study||40
6779070|NCT03752567|7707084|FG000|COMPLETED|Overall Study||40
6561156|NCT01791517|7484042|FG001|STARTED|Phase I: Period 3||15
6561157|NCT01791517|7484043|FG002|STARTED|Phase I: Period 3||16
6779071|NCT03752567|7707084|FG000|NOT COMPLETED|Overall Study||0
6779072|NCT03752528|7707088|FG000|STARTED|Part A||53
6779073|NCT03752528|7707088|FG000|COMPLETED|Part A||51
6779074|NCT03752528|7707088|FG000|NOT COMPLETED|Part A||2
6779075|NCT03752528|7707088|FG000|STARTED|Part B||24
6779076|NCT03752528|7707088|FG000|COMPLETED|Part B||20
6779077|NCT03752528|7707088|FG000|NOT COMPLETED|Part B||4
6779078|NCT03752151|7707095|FG000|STARTED|Overall Study||77
6779079|NCT03752151|7707095|FG000|COMPLETED|Overall Study||75
6779080|NCT03752151|7707095|FG000|NOT COMPLETED|Overall Study||2
6779081|NCT03751657|7707102|FG000|STARTED|Overall Study||125
6779082|NCT03751657|7707103|FG001|STARTED|Overall Study||122
6779083|NCT03751657|7707102|FG000|COMPLETED|Overall Study||122
6779084|NCT03751657|7707103|FG001|COMPLETED|Overall Study||119
6779085|NCT03751657|7707102|FG000|NOT COMPLETED|Overall Study||3
6779086|NCT03751657|7707103|FG001|NOT COMPLETED|Overall Study||3
6779087|NCT03751280|7707111|FG000|STARTED|Overall Study||56
6779088|NCT03751280|7707112|FG001|STARTED|Overall Study||56
6779089|NCT03751280|7707111|FG000|Full Analysis Set (FAS)|Overall Study||54
6779090|NCT03751280|7707112|FG001|Full Analysis Set (FAS)|Overall Study||55
6779091|NCT03751280|7707111|FG000|Safety Set (SAF)|Overall Study||55
6779092|NCT03751280|7707112|FG001|Safety Set (SAF)|Overall Study||55
6779093|NCT03751280|7707111|FG000|COMPLETED|Overall Study||48
6779094|NCT03751280|7707112|FG001|COMPLETED|Overall Study||44
6779095|NCT03751280|7707111|FG000|NOT COMPLETED|Overall Study||8
6779096|NCT03751280|7707112|FG001|NOT COMPLETED|Overall Study||12
6779097|NCT03751020|7707122|FG000|STARTED|Overall Study||36
6779098|NCT03751020|7707123|FG001|STARTED|Overall Study||36
6779099|NCT03751020|7707124|FG002|STARTED|Overall Study||36
6779100|NCT03751020|7707122|FG000|Post Intervention|Overall Study||33
6779101|NCT03751020|7707123|FG001|Post Intervention|Overall Study||33
6779102|NCT03751020|7707124|FG002|Post Intervention|Overall Study||30
6779103|NCT03751020|7707122|FG000|3 Month Follow Up|Overall Study||27
6779104|NCT03751020|7707123|FG001|3 Month Follow Up|Overall Study||32
6779105|NCT03751020|7707124|FG002|3 Month Follow Up|Overall Study||26
6779106|NCT03751020|7707122|FG000|COMPLETED|Overall Study||27
6779107|NCT03751020|7707123|FG001|COMPLETED|Overall Study||32
6779108|NCT03751020|7707124|FG002|COMPLETED|Overall Study||26
6779109|NCT03751020|7707122|FG000|NOT COMPLETED|Overall Study||9
6779110|NCT03751020|7707123|FG001|NOT COMPLETED|Overall Study||4
6779111|NCT03751020|7707124|FG002|NOT COMPLETED|Overall Study||10
6779112|NCT03750955|7707134|FG000|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
6779113|NCT03750955|7707135|FG001|STARTED|Hygiene Phase of 2 Weeks|No intervention during the hygiene phase.|16
6779114|NCT03750955|7707134|FG000|COMPLETED|Hygiene Phase of 2 Weeks||13
6779115|NCT03750955|7707135|FG001|COMPLETED|Hygiene Phase of 2 Weeks||13
6779116|NCT03750955|7707134|FG000|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
6779117|NCT03750955|7707135|FG001|NOT COMPLETED|Hygiene Phase of 2 Weeks||3
6779118|NCT03750955|7707134|FG000|STARTED|Gingivitis Induction Phase of 2 Weeks||13
6779119|NCT03750955|7707135|FG001|STARTED|Gingivitis Induction Phase of 2 Weeks||13
6779120|NCT03750955|7707134|FG000|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 participants randomized to L maxillary sextant SIBO; 7 randomized to R maxillary sextant SIBO.|13
6779121|NCT03750955|7707135|FG001|COMPLETED|Gingivitis Induction Phase of 2 Weeks|6 randomized to R max. sextant oral hygiene maintenance (OHM); 7 randomized to L max. sextant OHM.|13
6779122|NCT03750955|7707134|FG000|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
6779123|NCT03750955|7707135|FG001|NOT COMPLETED|Gingivitis Induction Phase of 2 Weeks||0
6779124|NCT03750955|7707134|FG000|STARTED|Resolution Phase of 2 Weeks|No stent in use; oral hygiene resumed.|13
6373760|NCT00747474|7284557|FG004|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373761|NCT00747474|7284558|FG005|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6561158|NCT01791517|7484044|FG003|STARTED|Phase I: Period 3||16
6779125|NCT03750955|7707135|FG001|STARTED|Resolution Phase of 2 Weeks|Oral hygiene maintenance continued.|13
6779126|NCT03750955|7707134|FG000|COMPLETED|Resolution Phase of 2 Weeks||13
6779127|NCT03750955|7707135|FG001|COMPLETED|Resolution Phase of 2 Weeks||13
6779128|NCT03750955|7707134|FG000|NOT COMPLETED|Resolution Phase of 2 Weeks||0
6779129|NCT03750955|7707135|FG001|NOT COMPLETED|Resolution Phase of 2 Weeks||0
6779130|NCT03750695|7707143|FG000|STARTED|Overall Study||8
6779131|NCT03750695|7707144|FG001|STARTED|Overall Study||8
6779132|NCT03750695|7707143|FG000|COMPLETED|Overall Study||8
6779133|NCT03750695|7707144|FG001|COMPLETED|Overall Study||7
6779134|NCT03750695|7707143|FG000|NOT COMPLETED|Overall Study||0
6779135|NCT03750695|7707144|FG001|NOT COMPLETED|Overall Study||1
6779136|NCT03748992|7707155|FG000|STARTED|Overall Study||10
6779137|NCT03748992|7707155|FG000|COMPLETED|Overall Study||10
6779138|NCT03748992|7707155|FG000|NOT COMPLETED|Overall Study||0
6779139|NCT03748979|7707170|FG000|STARTED|Overall Study||6
6779140|NCT03748979|7707171|FG001|STARTED|Overall Study||6
6779141|NCT03748979|7707172|FG002|STARTED|Overall Study||6
6779142|NCT03748979|7707173|FG003|STARTED|Overall Study||6
6779143|NCT03748979|7707174|FG004|STARTED|Overall Study||4
6779144|NCT03748979|7707175|FG005|STARTED|Overall Study||4
6779145|NCT03748979|7707176|FG006|STARTED|Overall Study||5
6779146|NCT03748979|7707177|FG007|STARTED|Overall Study||5
6779147|NCT03748979|7707178|FG008|STARTED|Overall Study||4
6779148|NCT03748979|7707179|FG009|STARTED|Overall Study||5
6779149|NCT03748979|7707180|FG010|STARTED|Overall Study||6
6779150|NCT03748979|7707170|FG000|COMPLETED|Overall Study||6
6779151|NCT03748979|7707171|FG001|COMPLETED|Overall Study||6
6779152|NCT03748979|7707172|FG002|COMPLETED|Overall Study||6
6779153|NCT03748979|7707173|FG003|COMPLETED|Overall Study||6
6779154|NCT03748979|7707174|FG004|COMPLETED|Overall Study||4
6779155|NCT03748979|7707175|FG005|COMPLETED|Overall Study||4
6779156|NCT03748979|7707176|FG006|COMPLETED|Overall Study||5
6779157|NCT03748979|7707177|FG007|COMPLETED|Overall Study||5
6779158|NCT03748979|7707178|FG008|COMPLETED|Overall Study||4
6779159|NCT03748979|7707179|FG009|COMPLETED|Overall Study||5
6779160|NCT03748979|7707180|FG010|COMPLETED|Overall Study||6
6561159|NCT01791517|7484045|FG004|STARTED|Phase I: Period 3||19
6561160|NCT01791517|7484046|FG005|STARTED|Phase I: Period 3||18
6561161|NCT01791517|7484047|FG006|STARTED|Phase I: Period 3||19
6561162|NCT01791517|7484048|FG007|STARTED|Phase I: Period 3||20
6561163|NCT01791517|7484049|FG008|STARTED|Phase I: Period 3||19
6561164|NCT01791517|7484050|FG009|STARTED|Phase I: Period 3||18
6561165|NCT01791517|7484051|FG010|STARTED|Phase I: Period 3||16
6561166|NCT01791517|7484052|FG011|STARTED|Phase I: Period 3||19
6779161|NCT03748979|7707170|FG000|NOT COMPLETED|Overall Study||0
6779162|NCT03748979|7707171|FG001|NOT COMPLETED|Overall Study||0
6779163|NCT03748979|7707172|FG002|NOT COMPLETED|Overall Study||0
6779164|NCT03748979|7707173|FG003|NOT COMPLETED|Overall Study||0
6779165|NCT03748979|7707174|FG004|NOT COMPLETED|Overall Study||0
6779166|NCT03748979|7707175|FG005|NOT COMPLETED|Overall Study||0
6779167|NCT03748979|7707176|FG006|NOT COMPLETED|Overall Study||0
6779168|NCT03748979|7707177|FG007|NOT COMPLETED|Overall Study||0
6779169|NCT03748979|7707178|FG008|NOT COMPLETED|Overall Study||0
6779170|NCT03748979|7707179|FG009|NOT COMPLETED|Overall Study||0
6779171|NCT03748979|7707180|FG010|NOT COMPLETED|Overall Study||0
6779172|NCT03748758|7707220|FG000|STARTED|Overall Study||12
6779173|NCT03748758|7707221|FG001|STARTED|Overall Study||12
6779174|NCT03748758|7707222|FG002|STARTED|Overall Study||6
6779175|NCT03748758|7707220|FG000|COMPLETED|Overall Study||12
6779176|NCT03748758|7707221|FG001|COMPLETED|Overall Study||12
6779177|NCT03748758|7707222|FG002|COMPLETED|Overall Study||5
6779178|NCT03748758|7707220|FG000|NOT COMPLETED|Overall Study||0
6779179|NCT03748758|7707221|FG001|NOT COMPLETED|Overall Study||0
6779180|NCT03748758|7707222|FG002|NOT COMPLETED|Overall Study||1
6779181|NCT03748706|7707252|FG000|STARTED|Overall Study||13
6779182|NCT03748706|7707252|FG000|COMPLETED|Overall Study||12
6779183|NCT03748706|7707252|FG000|NOT COMPLETED|Overall Study||1
6779184|NCT03748264|7707259|FG000|STARTED|Overall Study||21
6779185|NCT03748264|7707260|FG001|STARTED|Overall Study||21
6779186|NCT03748264|7707261|FG002|STARTED|Overall Study||20
6779187|NCT03748264|7707259|FG000|COMPLETED|Overall Study||21
6779188|NCT03748264|7707260|FG001|COMPLETED|Overall Study||21
6779189|NCT03748264|7707261|FG002|COMPLETED|Overall Study||20
6779190|NCT03748264|7707259|FG000|NOT COMPLETED|Overall Study||0
6561167|NCT01791517|7484041|FG000|COMPLETED|Phase I: Period 3||17
6779191|NCT03748264|7707260|FG001|NOT COMPLETED|Overall Study||0
6779192|NCT03748264|7707261|FG002|NOT COMPLETED|Overall Study||0
6779193|NCT03747497|7707271|FG000|STARTED|Overall Study||131
6779194|NCT03747497|7707272|FG001|STARTED|Overall Study||65
6779195|NCT03747497|7707271|FG000|COMPLETED|Overall Study||106
6779196|NCT03747497|7707272|FG001|COMPLETED|Overall Study||55
6779197|NCT03747497|7707271|FG000|NOT COMPLETED|Overall Study||25
6779198|NCT03747497|7707272|FG001|NOT COMPLETED|Overall Study||10
6779199|NCT03746405|7707280|FG000|STARTED|Overall Study||10
6779200|NCT03746405|7707281|FG001|STARTED|Overall Study||8
6779201|NCT03746405|7707280|FG000|COMPLETED|Overall Study||7
6779202|NCT03746405|7707281|FG001|COMPLETED|Overall Study||6
6779203|NCT03746405|7707280|FG000|NOT COMPLETED|Overall Study||3
6779204|NCT03746405|7707281|FG001|NOT COMPLETED|Overall Study||2
6373762|NCT00747474|7284559|FG006|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373763|NCT00747474|7284560|FG007|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373764|NCT00747474|7284561|FG008|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373765|NCT00747474|7284562|FG009|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373766|NCT00747474|7284563|FG010|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373767|NCT00747474|7284564|FG011|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
6373768|NCT00747474|7284553|FG000|STARTED|Cohort 6 (20 mg/m^2) Period||0
6779205|NCT03745937|7707291|FG000|STARTED|Overall Study||2
6779206|NCT03745937|7707292|FG001|STARTED|Overall Study||6
6779207|NCT03745937|7707293|FG002|STARTED|Overall Study||3
6779208|NCT03745937|7707294|FG003|STARTED|Overall Study||9
6779209|NCT03745937|7707291|FG000|COMPLETED|Overall Study||2
6779210|NCT03745937|7707292|FG001|COMPLETED|Overall Study||5
6779211|NCT03745937|7707293|FG002|COMPLETED|Overall Study||3
6779212|NCT03745937|7707294|FG003|COMPLETED|Overall Study||7
6779213|NCT03745937|7707291|FG000|NOT COMPLETED|Overall Study||0
6779214|NCT03745937|7707292|FG001|NOT COMPLETED|Overall Study||1
6779215|NCT03745937|7707293|FG002|NOT COMPLETED|Overall Study||0
6779216|NCT03745937|7707294|FG003|NOT COMPLETED|Overall Study||2
6779217|NCT03745222|7707308|FG000|STARTED|Overall Study||0
6779218|NCT03745222|7707309|FG001|STARTED|Overall Study||1
6779219|NCT03745222|7707310|FG002|STARTED|Overall Study||0
6779220|NCT03745222|7707308|FG000|COMPLETED|Overall Study||0
6779221|NCT03745222|7707309|FG001|COMPLETED|Overall Study||0
6779222|NCT03745222|7707310|FG002|COMPLETED|Overall Study||0
6779223|NCT03745222|7707308|FG000|NOT COMPLETED|Overall Study||0
6779224|NCT03745222|7707309|FG001|NOT COMPLETED|Overall Study||1
6779225|NCT03745222|7707310|FG002|NOT COMPLETED|Overall Study||0
6779226|NCT03745092|7707320|FG000|STARTED|Overall Study||26
6779227|NCT03745092|7707321|FG001|STARTED|Overall Study||23
6779228|NCT03745092|7707320|FG000|COMPLETED|Overall Study||26
6779229|NCT03745092|7707321|FG001|COMPLETED|Overall Study||23
6779230|NCT03745092|7707320|FG000|NOT COMPLETED|Overall Study||0
6779231|NCT03745092|7707321|FG001|NOT COMPLETED|Overall Study||0
6779232|NCT03744780|7707327|FG000|STARTED|Overall Study||32
6779233|NCT03744780|7707327|FG000|COMPLETED|Overall Study||32
6779234|NCT03744780|7707327|FG000|NOT COMPLETED|Overall Study||0
6780943|NCT02734940|7709510|FG001|STARTED|Overall Study||0
6780944|NCT02734940|7709509|FG000|COMPLETED|Overall Study||0
6780945|NCT02734940|7709510|FG001|COMPLETED|Overall Study||0
6780946|NCT02734940|7709509|FG000|NOT COMPLETED|Overall Study||0
6780947|NCT02734940|7709510|FG001|NOT COMPLETED|Overall Study||0
6780948|NCT02749617|7709516|FG000|STARTED|Overall Study||2
6780949|NCT02749617|7709516|FG000|COMPLETED|Overall Study||2
6780950|NCT02749617|7709516|FG000|NOT COMPLETED|Overall Study||0
6780951|NCT02749227|7709520|FG000|STARTED|Overall Study||4
6780952|NCT02749227|7709520|FG000|COMPLETED|Overall Study||4
6780953|NCT02749227|7709520|FG000|NOT COMPLETED|Overall Study||0
6780954|NCT02745210|7709526|FG000|STARTED|Overall Study||0
6780955|NCT02745210|7709527|FG001|STARTED|Overall Study||9
6780956|NCT02745210|7709526|FG000|COMPLETED|Overall Study||0
6780957|NCT02745210|7709527|FG001|COMPLETED|Overall Study||9
6780958|NCT02745210|7709526|FG000|NOT COMPLETED|Overall Study||0
6780959|NCT02745210|7709527|FG001|NOT COMPLETED|Overall Study||0
6780960|NCT02725671|7709531|FG000|STARTED|Overall Study||2
6780961|NCT02725671|7709531|FG000|COMPLETED|Overall Study||1
6780962|NCT02725671|7709531|FG000|NOT COMPLETED|Overall Study||1
6780963|NCT02746263|7709539|FG000|STARTED|Overall Study||0
6780964|NCT02746263|7709540|FG001|STARTED|Overall Study||1
6780965|NCT02746263|7709539|FG000|Per Protocol Analysis Set|Overall Study||0
6780966|NCT02746263|7709540|FG001|Per Protocol Analysis Set|Overall Study||0
6780967|NCT02746263|7709539|FG000|COMPLETED|Overall Study||0
6780968|NCT02746263|7709540|FG001|COMPLETED|Overall Study||1
6780969|NCT02746263|7709539|FG000|NOT COMPLETED|Overall Study||0
6780970|NCT02746263|7709540|FG001|NOT COMPLETED|Overall Study||0
6780971|NCT02721277|7709546|FG000|STARTED|Overall Study||2
6780972|NCT02721277|7709546|FG000|COMPLETED|Overall Study||2
6780973|NCT02721277|7709546|FG000|NOT COMPLETED|Overall Study||0
6780974|NCT02732327|7709552|FG000|STARTED|Overall Study||0
6780975|NCT02732327|7709553|FG001|STARTED|Overall Study||2
6780976|NCT02732327|7709552|FG000|COMPLETED|Overall Study||0
6780977|NCT02732327|7709553|FG001|COMPLETED|Overall Study||1
6780978|NCT02732327|7709552|FG000|NOT COMPLETED|Overall Study||0
6780979|NCT02732327|7709553|FG001|NOT COMPLETED|Overall Study||1
6780980|NCT02726399|7709559|FG000|STARTED|Overall Study||7
6780981|NCT02726399|7709559|FG000|COMPLETED|Overall Study||0
6780982|NCT02726399|7709559|FG000|NOT COMPLETED|Overall Study||7
6780983|NCT02720510|7709565|FG000|STARTED|Overall Study||3
6780984|NCT02720510|7709566|FG001|STARTED|Overall Study||3
6780985|NCT02720510|7709565|FG000|COMPLETED|Overall Study||0
6780986|NCT02720510|7709566|FG001|COMPLETED|Overall Study||0
6780987|NCT02720510|7709565|FG000|NOT COMPLETED|Overall Study||3
6780988|NCT02720510|7709566|FG001|NOT COMPLETED|Overall Study||3
6780989|NCT02715765|7709575|FG000|STARTED|Overall Study||3
6780990|NCT02715765|7709576|FG001|STARTED|Overall Study||0
6780991|NCT02715765|7709577|FG002|STARTED|Overall Study||0
6780992|NCT02715765|7709575|FG000|COMPLETED|Overall Study||0
6780993|NCT02715765|7709576|FG001|COMPLETED|Overall Study||0
6780994|NCT02715765|7709577|FG002|COMPLETED|Overall Study||0
6780995|NCT02715765|7709575|FG000|NOT COMPLETED|Overall Study||3
6780996|NCT02715765|7709576|FG001|NOT COMPLETED|Overall Study||0
6780997|NCT02715765|7709577|FG002|NOT COMPLETED|Overall Study||0
6779235|NCT03743311|7707334|FG000|STARTED|Overall Study||311
6779236|NCT03743311|7707335|FG001|STARTED|Overall Study||298
6779237|NCT03743311|7707336|FG002|STARTED|Overall Study||423
6779238|NCT03743311|7707334|FG000|COMPLETED|Overall Study||311
6779239|NCT03743311|7707335|FG001|COMPLETED|Overall Study||298
6779240|NCT03743311|7707336|FG002|COMPLETED|Overall Study||423
6779241|NCT03743311|7707334|FG000|NOT COMPLETED|Overall Study||0
6779242|NCT03743311|7707335|FG001|NOT COMPLETED|Overall Study||0
6779243|NCT03743311|7707336|FG002|NOT COMPLETED|Overall Study||0
6779244|NCT03743038|7707345|FG000|STARTED|Overall Study||12
6779245|NCT03743038|7707345|FG000|Test Article A|Overall Study||12
6779246|NCT03743038|7707345|FG000|Test Article B|Overall Study||12
6779247|NCT03743038|7707345|FG000|COMPLETED|Overall Study||11
6779248|NCT03743038|7707345|FG000|NOT COMPLETED|Overall Study||1
6779249|NCT03742973|7707353|FG000|STARTED|Overall Study||0
6779250|NCT03742973|7707354|FG001|STARTED|Overall Study||0
6779251|NCT03742973|7707353|FG000|COMPLETED|Overall Study||0
6779252|NCT03742973|7707354|FG001|COMPLETED|Overall Study||0
6779253|NCT03742973|7707353|FG000|NOT COMPLETED|Overall Study||0
6779254|NCT03742973|7707354|FG001|NOT COMPLETED|Overall Study||0
6779255|NCT03742440|7707360|FG000|STARTED|Overall Study||40
6779256|NCT03742440|7707360|FG000|COMPLETED|Overall Study||40
6779257|NCT03742440|7707360|FG000|NOT COMPLETED|Overall Study||0
6779258|NCT03742427|7707364|FG000|STARTED|Overall Study||50
6779259|NCT03742427|7707364|FG000|COMPLETED|Overall Study||50
6779260|NCT03742427|7707364|FG000|NOT COMPLETED|Overall Study||0
6779261|NCT03742271|7707368|FG000|STARTED|Overall Study||127
6779262|NCT03742271|7707368|FG000|COMPLETED|Overall Study||115
6779263|NCT03742271|7707368|FG000|NOT COMPLETED|Overall Study||12
6779264|NCT03742154|7707374|FG000|STARTED|Overall Study||50
6779265|NCT03742154|7707375|FG001|STARTED|Overall Study||49
6779266|NCT03742154|7707374|FG000|COMPLETED|Overall Study||50
6779267|NCT03742154|7707375|FG001|COMPLETED|Overall Study||49
6779268|NCT03742154|7707374|FG000|NOT COMPLETED|Overall Study||0
6779269|NCT03742154|7707375|FG001|NOT COMPLETED|Overall Study||0
6779270|NCT03741725|7707384|FG000|STARTED|Overall Study||101
6779271|NCT03741725|7707385|FG001|STARTED|Overall Study||100
6779272|NCT03741725|7707386|FG002|STARTED|Overall Study||100
6779273|NCT03741725|7707384|FG000|COMPLETED|Overall Study||101
6779274|NCT03741725|7707385|FG001|COMPLETED|Overall Study||100
6779275|NCT03741725|7707386|FG002|COMPLETED|Overall Study||100
6779276|NCT03741725|7707384|FG000|NOT COMPLETED|Overall Study||0
6779277|NCT03741725|7707385|FG001|NOT COMPLETED|Overall Study||0
6779278|NCT03741725|7707386|FG002|NOT COMPLETED|Overall Study||0
6779279|NCT03741088|7707397|FG000|STARTED|Overall Study||8
6779280|NCT03741088|7707397|FG000|COMPLETED|Overall Study||5
6779281|NCT03741088|7707397|FG000|NOT COMPLETED|Overall Study||3
6779282|NCT03741062|7707403|FG000|STARTED|Overall Study||5
6779283|NCT03741062|7707404|FG001|STARTED|Overall Study||6
6779284|NCT03741062|7707403|FG000|COMPLETED|Overall Study||4
6779285|NCT03741062|7707404|FG001|COMPLETED|Overall Study||6
6779286|NCT03741062|7707403|FG000|NOT COMPLETED|Overall Study||1
6779287|NCT03741062|7707404|FG001|NOT COMPLETED|Overall Study||0
6779288|NCT03740659|7707413|FG000|STARTED|Overall Study||42
6779289|NCT03740659|7707414|FG001|STARTED|Overall Study||42
6779290|NCT03740659|7707415|FG002|STARTED|Overall Study||41
6779291|NCT03740659|7707413|FG000|COMPLETED|Overall Study||42
6779292|NCT03740659|7707414|FG001|COMPLETED|Overall Study||42
6779293|NCT03740659|7707415|FG002|COMPLETED|Overall Study||41
6779294|NCT03740659|7707413|FG000|NOT COMPLETED|Overall Study||0
6779295|NCT03740659|7707414|FG001|NOT COMPLETED|Overall Study||0
6779296|NCT03740659|7707415|FG002|NOT COMPLETED|Overall Study||0
6779297|NCT03740152|7707423|FG000|STARTED|Overall Study||10
6779298|NCT03740152|7707423|FG000|COMPLETED|Overall Study||10
6779299|NCT03740152|7707423|FG000|NOT COMPLETED|Overall Study||0
6779300|NCT03739866|7707435|FG000|STARTED|Overall Study||6
6779301|NCT03739866|7707436|FG001|STARTED|Overall Study||6
6779302|NCT03739866|7707437|FG002|STARTED|Overall Study||7
6779303|NCT03739866|7707438|FG003|STARTED|Overall Study||6
6779304|NCT03739866|7707439|FG004|STARTED|Overall Study||6
6779305|NCT03739866|7707440|FG005|STARTED|Overall Study||10
6779306|NCT03739866|7707441|FG006|STARTED|Overall Study||7
6779307|NCT03739866|7707442|FG007|STARTED|Overall Study||5
6779308|NCT03739866|7707435|FG000|COMPLETED|Overall Study||6
6779309|NCT03739866|7707436|FG001|COMPLETED|Overall Study||6
6779310|NCT03739866|7707437|FG002|COMPLETED|Overall Study||6
6779311|NCT03739866|7707438|FG003|COMPLETED|Overall Study||5
6779312|NCT03739866|7707439|FG004|COMPLETED|Overall Study||5
6779313|NCT03739866|7707440|FG005|COMPLETED|Overall Study||10
6779314|NCT03739866|7707441|FG006|COMPLETED|Overall Study||7
6779315|NCT03739866|7707442|FG007|COMPLETED|Overall Study||5
6779316|NCT03739866|7707435|FG000|NOT COMPLETED|Overall Study||0
6779317|NCT03739866|7707436|FG001|NOT COMPLETED|Overall Study||0
6779318|NCT03739866|7707437|FG002|NOT COMPLETED|Overall Study||1
6779319|NCT03739866|7707438|FG003|NOT COMPLETED|Overall Study||1
6779320|NCT03739866|7707439|FG004|NOT COMPLETED|Overall Study||1
6779321|NCT03739866|7707440|FG005|NOT COMPLETED|Overall Study||0
6779322|NCT03739866|7707441|FG006|NOT COMPLETED|Overall Study||0
6779323|NCT03739866|7707442|FG007|NOT COMPLETED|Overall Study||0
6779324|NCT03739684|7707464|FG000|STARTED|Overall Study||208
6779325|NCT03739684|7707464|FG000|COMPLETED|Overall Study||195
6779326|NCT03739684|7707464|FG000|NOT COMPLETED|Overall Study||13
6779327|NCT03739528|7707470|FG000|STARTED|Overall Study||403
6779328|NCT03739528|7707471|FG001|STARTED|Overall Study||405
6779329|NCT03739528|7707470|FG000|Received at Least One Treatment|Overall Study||395
6779330|NCT03739528|7707471|FG001|Received at Least One Treatment|Overall Study||393
6779331|NCT03739528|7707470|FG000|COMPLETED|Overall Study||388
6779332|NCT03739528|7707471|FG001|COMPLETED|Overall Study||388
6779333|NCT03739528|7707470|FG000|NOT COMPLETED|Overall Study||15
6779334|NCT03739528|7707471|FG001|NOT COMPLETED|Overall Study||17
6779335|NCT03739242|7707482|FG000|STARTED|Overall Study||44
6779336|NCT03739242|7707483|FG001|STARTED|Overall Study||44
6779337|NCT03739242|7707482|FG000|COMPLETED|Overall Study||43
6779338|NCT03739242|7707483|FG001|COMPLETED|Overall Study||42
6779339|NCT03739242|7707482|FG000|NOT COMPLETED|Overall Study||1
6779340|NCT03739242|7707483|FG001|NOT COMPLETED|Overall Study||2
6779341|NCT03738865|7707491|FG000|STARTED|Overall Study||66
6779342|NCT03738865|7707492|FG001|STARTED|Overall Study||66
6779343|NCT03738865|7707491|FG000|COMPLETED|Overall Study||61
6779344|NCT03738865|7707492|FG001|COMPLETED|Overall Study||62
6779345|NCT03738865|7707491|FG000|NOT COMPLETED|Overall Study||5
6779346|NCT03738865|7707492|FG001|NOT COMPLETED|Overall Study||4
6779347|NCT03738826|7707500|FG000|STARTED|Overall Study||130
6779348|NCT03738826|7707501|FG001|STARTED|Overall Study||5
6779349|NCT03738826|7707500|FG000|COMPLETED|Overall Study||130
6779350|NCT03738826|7707501|FG001|COMPLETED|Overall Study||5
6779351|NCT03738826|7707500|FG000|NOT COMPLETED|Overall Study||0
6779352|NCT03738826|7707501|FG001|NOT COMPLETED|Overall Study||0
6779353|NCT03738475|7707509|FG000|STARTED|Overall Study||16
6779354|NCT03738475|7707510|FG001|STARTED|Overall Study||18
6779355|NCT03738475|7707509|FG000|COMPLETED|Overall Study||15
6779356|NCT03738475|7707510|FG001|COMPLETED|Overall Study||18
6779357|NCT03738475|7707509|FG000|NOT COMPLETED|Overall Study||1
6779358|NCT03738475|7707510|FG001|NOT COMPLETED|Overall Study||0
6779359|NCT03738241|7707526|FG000|STARTED|Overall Study||38
6779360|NCT03738241|7707527|FG001|STARTED|Overall Study||40
6779361|NCT03738241|7707528|FG002|STARTED|Overall Study||24
6779362|NCT03738241|7707529|FG003|STARTED|Overall Study||18
6779363|NCT03738241|7707530|FG004|STARTED|Overall Study||40
6779364|NCT03738241|7707531|FG005|STARTED|Overall Study||44
6779365|NCT03738241|7707532|FG006|STARTED|Overall Study||20
6779366|NCT03738241|7707533|FG007|STARTED|Overall Study||16
6779367|NCT03738241|7707534|FG008|STARTED|Overall Study||29
6779368|NCT03738241|7707535|FG009|STARTED|Overall Study||35
6779369|NCT03738241|7707526|FG000|COMPLETED|Overall Study||37
6779370|NCT03738241|7707527|FG001|COMPLETED|Overall Study||40
6779371|NCT03738241|7707528|FG002|COMPLETED|Overall Study||24
6779372|NCT03738241|7707529|FG003|COMPLETED|Overall Study||18
6779373|NCT03738241|7707530|FG004|COMPLETED|Overall Study||40
6779374|NCT03738241|7707531|FG005|COMPLETED|Overall Study||44
6779375|NCT03738241|7707532|FG006|COMPLETED|Overall Study||20
6779376|NCT03738241|7707533|FG007|COMPLETED|Overall Study||16
6779377|NCT03738241|7707534|FG008|COMPLETED|Overall Study||28
6779378|NCT03738241|7707535|FG009|COMPLETED|Overall Study||34
6779379|NCT03738241|7707526|FG000|NOT COMPLETED|Overall Study||1
6779380|NCT03738241|7707527|FG001|NOT COMPLETED|Overall Study||0
6779381|NCT03738241|7707528|FG002|NOT COMPLETED|Overall Study||0
6779382|NCT03738241|7707529|FG003|NOT COMPLETED|Overall Study||0
6779383|NCT03738241|7707530|FG004|NOT COMPLETED|Overall Study||0
6779384|NCT03738241|7707531|FG005|NOT COMPLETED|Overall Study||0
6779385|NCT03738241|7707532|FG006|NOT COMPLETED|Overall Study||0
6779386|NCT03738241|7707533|FG007|NOT COMPLETED|Overall Study||0
6779387|NCT03738241|7707534|FG008|NOT COMPLETED|Overall Study||1
6779388|NCT03738241|7707535|FG009|NOT COMPLETED|Overall Study||1
6779389|NCT03738163|7707557|FG000|STARTED|Overall Study||121
6779390|NCT03738163|7707557|FG000|COMPLETED|Overall Study||114
6779391|NCT03738163|7707557|FG000|NOT COMPLETED|Overall Study||7
6779392|NCT03738020|7707561|FG000|STARTED|Overall Study||58
6779393|NCT03738020|7707561|FG000|COMPLETED|Overall Study||57
6779394|NCT03738020|7707561|FG000|NOT COMPLETED|Overall Study||1
6779395|NCT03736928|7707573|FG000|STARTED|Overall Study||80
6779396|NCT03736928|7707574|FG001|STARTED|Overall Study||80
6779397|NCT03736928|7707575|FG002|STARTED|Overall Study||80
6779398|NCT03736928|7707576|FG003|STARTED|Overall Study||81
6779399|NCT03736928|7707577|FG004|STARTED|Overall Study||78
6779400|NCT03736928|7707573|FG000|COMPLETED|Overall Study||73
6779401|NCT03736928|7707574|FG001|COMPLETED|Overall Study||78
6779402|NCT03736928|7707575|FG002|COMPLETED|Overall Study||75
6779403|NCT03736928|7707576|FG003|COMPLETED|Overall Study||76
6779404|NCT03736928|7707577|FG004|COMPLETED|Overall Study||67
6779405|NCT03736928|7707573|FG000|NOT COMPLETED|Overall Study||7
6779406|NCT03736928|7707574|FG001|NOT COMPLETED|Overall Study||2
6779407|NCT03736928|7707575|FG002|NOT COMPLETED|Overall Study||5
6779408|NCT03736928|7707576|FG003|NOT COMPLETED|Overall Study||5
6779409|NCT03736928|7707577|FG004|NOT COMPLETED|Overall Study||11
6779410|NCT03736785|7707592|FG000|STARTED|Overall Study||135
6779411|NCT03736785|7707593|FG001|STARTED|Overall Study||132
6779412|NCT03736785|7707594|FG002|STARTED|Overall Study||132
6779413|NCT03736785|7707592|FG000|COMPLETED|Overall Study||118
6779414|NCT03736785|7707593|FG001|COMPLETED|Overall Study||115
6779415|NCT03736785|7707594|FG002|COMPLETED|Overall Study||118
6779416|NCT03736785|7707592|FG000|NOT COMPLETED|Overall Study||17
6779417|NCT03736785|7707593|FG001|NOT COMPLETED|Overall Study||17
6779418|NCT03736785|7707594|FG002|NOT COMPLETED|Overall Study||14
6779419|NCT03736031|7707605|FG000|STARTED|Overall Study||56
6779420|NCT03736031|7707606|FG001|STARTED|Overall Study||46
6779421|NCT03736031|7707605|FG000|COMPLETED|Overall Study||24
6561168|NCT01791517|7484042|FG001|COMPLETED|Phase I: Period 3||14
6561169|NCT01791517|7484043|FG002|COMPLETED|Phase I: Period 3||16
6561170|NCT01791517|7484044|FG003|COMPLETED|Phase I: Period 3||15
6561171|NCT01791517|7484045|FG004|COMPLETED|Phase I: Period 3||18
6561172|NCT01791517|7484046|FG005|COMPLETED|Phase I: Period 3||18
6561173|NCT01791517|7484047|FG006|COMPLETED|Phase I: Period 3||19
6561174|NCT01791517|7484048|FG007|COMPLETED|Phase I: Period 3||20
6561175|NCT01791517|7484049|FG008|COMPLETED|Phase I: Period 3||19
6561176|NCT01791517|7484050|FG009|COMPLETED|Phase I: Period 3||18
6561177|NCT01791517|7484051|FG010|COMPLETED|Phase I: Period 3||16
6561178|NCT01791517|7484052|FG011|COMPLETED|Phase I: Period 3||18
6561179|NCT01791517|7484041|FG000|NOT COMPLETED|Phase I: Period 3||0
6779422|NCT03736031|7707606|FG001|COMPLETED|Overall Study||40
6779423|NCT03736031|7707605|FG000|NOT COMPLETED|Overall Study||32
6779424|NCT03736031|7707606|FG001|NOT COMPLETED|Overall Study||6
6779425|NCT03735862|7707612|FG000|STARTED|Overall Study||73
6779426|NCT03735862|7707612|FG000|COMPLETED|Overall Study||73
6779427|NCT03735862|7707612|FG000|NOT COMPLETED|Overall Study||0
6779428|NCT03734991|7707618|FG000|STARTED|Overall Study||249
6779429|NCT03734991|7707619|FG001|STARTED|Overall Study||127
6779430|NCT03734991|7707618|FG000|Withdrawn Before Treatment|Overall Study||2
6779431|NCT03734991|7707619|FG001|Withdrawn Before Treatment|Overall Study||3
6779432|NCT03734991|7707618|FG000|Withdrawn Before TOC|Overall Study||59
6779433|NCT03734991|7707619|FG001|Withdrawn Before TOC|Overall Study||41
6779434|NCT03734991|7707618|FG000|Completed the TOC Visit|Overall Study||188
6779435|NCT03734991|7707619|FG001|Completed the TOC Visit|Overall Study||83
6779436|NCT03734991|7707618|FG000|Withdrawn At or After the TOC Visit|Overall Study||5
6779437|NCT03734991|7707619|FG001|Withdrawn At or After the TOC Visit|Overall Study||3
6779438|NCT03734991|7707618|FG000|COMPLETED|Overall Study||183
6779439|NCT03734991|7707619|FG001|COMPLETED|Overall Study||80
6779440|NCT03734991|7707618|FG000|NOT COMPLETED|Overall Study||66
6779441|NCT03734991|7707619|FG001|NOT COMPLETED|Overall Study||47
6779442|NCT03734822|7707625|FG000|STARTED|Overall Study||47
6779443|NCT03734822|7707625|FG000|COMPLETED|Overall Study||47
6779444|NCT03734822|7707625|FG000|NOT COMPLETED|Overall Study||0
6779445|NCT03734601|7707629|FG000|STARTED|Overall Study||22
6779446|NCT03734601|7707629|FG000|COMPLETED|Overall Study||22
6779447|NCT03734601|7707629|FG000|NOT COMPLETED|Overall Study||0
6779448|NCT03733899|7707633|FG000|STARTED|Period 1||3
6779449|NCT03733899|7707634|FG001|STARTED|Period 1||3
6779450|NCT03733899|7707635|FG002|STARTED|Period 1||3
6779451|NCT03733899|7707636|FG003|STARTED|Period 1||4
6779452|NCT03733899|7707637|FG004|STARTED|Period 1||4
6779453|NCT03733899|7707638|FG005|STARTED|Period 1||3
6779454|NCT03733899|7707633|FG000|COMPLETED|Period 1||3
6779455|NCT03733899|7707634|FG001|COMPLETED|Period 1||3
6779456|NCT03733899|7707635|FG002|COMPLETED|Period 1||3
6779457|NCT03733899|7707636|FG003|COMPLETED|Period 1||4
6779458|NCT03733899|7707637|FG004|COMPLETED|Period 1||4
6779459|NCT03733899|7707638|FG005|COMPLETED|Period 1||2
6779460|NCT03733899|7707633|FG000|NOT COMPLETED|Period 1||0
6779461|NCT03733899|7707634|FG001|NOT COMPLETED|Period 1||0
6779462|NCT03733899|7707635|FG002|NOT COMPLETED|Period 1||0
6779463|NCT03733899|7707636|FG003|NOT COMPLETED|Period 1||0
6779464|NCT03733899|7707637|FG004|NOT COMPLETED|Period 1||0
6779465|NCT03733899|7707638|FG005|NOT COMPLETED|Period 1||1
6779466|NCT03733899|7707633|FG000|STARTED|Period 2||3
6779467|NCT03733899|7707634|FG001|STARTED|Period 2||3
6779468|NCT03733899|7707635|FG002|STARTED|Period 2||3
6373769|NCT00747474|7284554|FG001|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373770|NCT00747474|7284555|FG002|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373771|NCT00747474|7284556|FG003|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373772|NCT00747474|7284557|FG004|STARTED|Cohort 6 (20 mg/m^2) Period||0
6373773|NCT00747474|7284558|FG005|STARTED|Cohort 6 (20 mg/m^2) Period||4
6561180|NCT01791517|7484042|FG001|NOT COMPLETED|Phase I: Period 3||1
6561181|NCT01791517|7484043|FG002|NOT COMPLETED|Phase I: Period 3||0
6561182|NCT01791517|7484044|FG003|NOT COMPLETED|Phase I: Period 3||1
6561183|NCT01791517|7484045|FG004|NOT COMPLETED|Phase I: Period 3||1
6561184|NCT01791517|7484046|FG005|NOT COMPLETED|Phase I: Period 3||0
6561185|NCT01791517|7484047|FG006|NOT COMPLETED|Phase I: Period 3||0
6561186|NCT01791517|7484048|FG007|NOT COMPLETED|Phase I: Period 3||0
6561187|NCT01791517|7484049|FG008|NOT COMPLETED|Phase I: Period 3||0
6561188|NCT01791517|7484050|FG009|NOT COMPLETED|Phase I: Period 3||0
6561189|NCT01791517|7484051|FG010|NOT COMPLETED|Phase I: Period 3||0
6779469|NCT03733899|7707636|FG003|STARTED|Period 2||4
6779470|NCT03733899|7707637|FG004|STARTED|Period 2||4
6779471|NCT03733899|7707638|FG005|STARTED|Period 2||2
6779472|NCT03733899|7707633|FG000|COMPLETED|Period 2||3
6779473|NCT03733899|7707634|FG001|COMPLETED|Period 2||2
6779474|NCT03733899|7707635|FG002|COMPLETED|Period 2||3
6779475|NCT03733899|7707636|FG003|COMPLETED|Period 2||4
6779476|NCT03733899|7707637|FG004|COMPLETED|Period 2||4
6779477|NCT03733899|7707638|FG005|COMPLETED|Period 2||2
6779478|NCT03733899|7707633|FG000|NOT COMPLETED|Period 2||0
6779479|NCT03733899|7707634|FG001|NOT COMPLETED|Period 2||1
6779480|NCT03733899|7707635|FG002|NOT COMPLETED|Period 2||0
6779481|NCT03733899|7707636|FG003|NOT COMPLETED|Period 2||0
6779482|NCT03733899|7707637|FG004|NOT COMPLETED|Period 2||0
6779483|NCT03733899|7707638|FG005|NOT COMPLETED|Period 2||0
6779484|NCT03733899|7707633|FG000|STARTED|Period 3||3
6779485|NCT03733899|7707634|FG001|STARTED|Period 3||2
6779486|NCT03733899|7707635|FG002|STARTED|Period 3||3
6779487|NCT03733899|7707636|FG003|STARTED|Period 3||4
6779488|NCT03733899|7707637|FG004|STARTED|Period 3||4
6779489|NCT03733899|7707638|FG005|STARTED|Period 3||2
6779490|NCT03733899|7707633|FG000|COMPLETED|Period 3||2
6779491|NCT03733899|7707634|FG001|COMPLETED|Period 3||2
6779492|NCT03733899|7707635|FG002|COMPLETED|Period 3||3
6779493|NCT03733899|7707636|FG003|COMPLETED|Period 3||4
6779494|NCT03733899|7707637|FG004|COMPLETED|Period 3||4
6779495|NCT03733899|7707638|FG005|COMPLETED|Period 3||2
6779496|NCT03733899|7707633|FG000|NOT COMPLETED|Period 3||1
6779497|NCT03733899|7707634|FG001|NOT COMPLETED|Period 3||0
6779498|NCT03733899|7707635|FG002|NOT COMPLETED|Period 3||0
6779499|NCT03733899|7707636|FG003|NOT COMPLETED|Period 3||0
6779500|NCT03733899|7707637|FG004|NOT COMPLETED|Period 3||0
6779501|NCT03733899|7707638|FG005|NOT COMPLETED|Period 3||0
6779502|NCT03733483|7707651|FG000|STARTED|Overall Study||12
6779503|NCT03733483|7707651|FG000|COMPLETED|Overall Study||12
6779504|NCT03733483|7707651|FG000|NOT COMPLETED|Overall Study||0
6779505|NCT03733470|7707657|FG000|STARTED|Overall Study||8
6779506|NCT03733470|7707658|FG001|STARTED|Overall Study||11
6779507|NCT03733470|7707657|FG000|COMPLETED|Overall Study||7
6779508|NCT03733470|7707658|FG001|COMPLETED|Overall Study||10
6779509|NCT03733470|7707657|FG000|NOT COMPLETED|Overall Study||1
6779510|NCT03733470|7707658|FG001|NOT COMPLETED|Overall Study||1
6779511|NCT03733301|7707667|FG000|STARTED|Overall Study||109
6779512|NCT03733301|7707668|FG001|STARTED|Overall Study||109
6779513|NCT03733301|7707669|FG002|STARTED|Overall Study||111
6779514|NCT03733301|7707667|FG000|Received One Dose of Study Drug|Overall Study||108
6779515|NCT03733301|7707668|FG001|Received One Dose of Study Drug|Overall Study||109
6779516|NCT03733301|7707669|FG002|Received One Dose of Study Drug|Overall Study||111
6779517|NCT03733301|7707667|FG000|COMPLETED|Overall Study||102
6779518|NCT03733301|7707668|FG001|COMPLETED|Overall Study||100
6779519|NCT03733301|7707669|FG002|COMPLETED|Overall Study||107
6779520|NCT03733301|7707667|FG000|NOT COMPLETED|Overall Study||7
6779521|NCT03733301|7707668|FG001|NOT COMPLETED|Overall Study||9
6779522|NCT03733301|7707669|FG002|NOT COMPLETED|Overall Study||4
6779523|NCT03732638|7707680|FG000|STARTED|Overall Study||370
6779524|NCT03732638|7707681|FG001|STARTED|Overall Study||371
6779525|NCT03732638|7707680|FG000|COMPLETED|Overall Study||316
6779526|NCT03732638|7707681|FG001|COMPLETED|Overall Study||310
6779527|NCT03732638|7707680|FG000|NOT COMPLETED|Overall Study||54
6779528|NCT03732638|7707681|FG001|NOT COMPLETED|Overall Study||61
6779529|NCT03732248|7707690|FG000|STARTED|Overall Study||11
6779530|NCT03732248|7707691|FG001|STARTED|Overall Study||10
6779531|NCT03732248|7707690|FG000|COMPLETED|Overall Study||10
6779532|NCT03732248|7707691|FG001|COMPLETED|Overall Study||10
6779533|NCT03732248|7707690|FG000|NOT COMPLETED|Overall Study||1
6779534|NCT03732248|7707691|FG001|NOT COMPLETED|Overall Study||0
6779535|NCT03731182|7707699|FG000|STARTED|Overall Study||70
6779536|NCT03731182|7707700|FG001|STARTED|Overall Study||34
6779537|NCT03731182|7707699|FG000|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||69
6779538|NCT03731182|7707700|FG001|V114 or Prevnar 13™ Vaccination (Day 1)|Overall Study||34
6779539|NCT03731182|7707699|FG000|COMPLETED|Overall Study||65
6779540|NCT03731182|7707700|FG001|COMPLETED|Overall Study||34
6779541|NCT03731182|7707699|FG000|NOT COMPLETED|Overall Study||5
6779542|NCT03731182|7707700|FG001|NOT COMPLETED|Overall Study||0
6779543|NCT03730961|7707709|FG000|STARTED|Overall Study||12
6779544|NCT03730961|7707710|FG001|STARTED|Overall Study||11
6779545|NCT03730961|7707709|FG000|Period 1 Completion|Overall Study||12
6779546|NCT03730961|7707710|FG001|Period 1 Completion|Overall Study||11
6779547|NCT03730961|7707709|FG000|Period 2 Completion|Overall Study|1 participant did not complete Period 2 due to hypotension but remained in the study|11
6779548|NCT03730961|7707710|FG001|Period 2 Completion|Overall Study|1 participant discontinued study due to AE|10
6779549|NCT03730961|7707709|FG000|COMPLETED|Overall Study||12
6779550|NCT03730961|7707710|FG001|COMPLETED|Overall Study||10
6779551|NCT03730961|7707709|FG000|NOT COMPLETED|Overall Study||0
6779552|NCT03730961|7707710|FG001|NOT COMPLETED|Overall Study||1
6779553|NCT03730116|7707716|FG000|STARTED|Inclusion|Planned to include 1920 pts, included 1909|1909
6779554|NCT03730116|7707716|FG000|FVFP|Inclusion||1909
6779555|NCT03730116|7707716|FG000|COMPLETED|Inclusion||1909
6779556|NCT03730116|7707716|FG000|NOT COMPLETED|Inclusion||0
6779557|NCT03730116|7707716|FG000|STARTED|1 Month After Inclusion||1909
6779558|NCT03730116|7707716|FG000|1 Month After Inclusion|1 Month After Inclusion||1909
6779559|NCT03730116|7707716|FG000|COMPLETED|1 Month After Inclusion||1909
6779560|NCT03730116|7707716|FG000|NOT COMPLETED|1 Month After Inclusion||0
6779561|NCT03730116|7707716|FG000|STARTED|3 Month After Inclusion||1909
6779562|NCT03730116|7707716|FG000|3 Month After Inclusion|3 Month After Inclusion||1909
6779563|NCT03730116|7707716|FG000|COMPLETED|3 Month After Inclusion||1892
6779564|NCT03730116|7707716|FG000|NOT COMPLETED|3 Month After Inclusion||17
6779565|NCT03730103|7707726|FG000|STARTED|Overall Study||61
6779566|NCT03730103|7707727|FG001|STARTED|Overall Study||52
6779567|NCT03730103|7707726|FG000|COMPLETED|Overall Study||61
6779568|NCT03730103|7707727|FG001|COMPLETED|Overall Study||47
6779569|NCT03730103|7707726|FG000|NOT COMPLETED|Overall Study||0
6779570|NCT03730103|7707727|FG001|NOT COMPLETED|Overall Study||5
6779571|NCT03729960|7707733|FG000|STARTED|Overall Study||20
6779572|NCT03729960|7707733|FG000|COMPLETED|Overall Study||20
6779573|NCT03729960|7707733|FG000|NOT COMPLETED|Overall Study||0
6779574|NCT03729024|7707738|FG000|STARTED|Overall Study||21
6779575|NCT03729024|7707738|FG000|COMPLETED|Overall Study||21
6779576|NCT03729024|7707738|FG000|NOT COMPLETED|Overall Study||0
6740224|NCT03301298|7669055|FG006|NOT COMPLETED|Fed Conditions||0
6740225|NCT03301623|7669074|FG000|STARTED|Overall Study||462
6740226|NCT03301623|7669075|FG001|STARTED|Overall Study||521
6740227|NCT03301623|7669074|FG000|COMPLETED|Overall Study||445
6740228|NCT03301623|7669075|FG001|COMPLETED|Overall Study||506
6740229|NCT03301623|7669074|FG000|NOT COMPLETED|Overall Study||17
6377975|NCT00766090|7288659|FG010|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6377976|NCT00766090|7288660|FG011|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6377977|NCT00766090|7288649|FG000|STARTED|Washout Period 1 (14 Days)||22
6377978|NCT00766090|7288650|FG001|STARTED|Washout Period 1 (14 Days)||27
6740230|NCT03301623|7669075|FG001|NOT COMPLETED|Overall Study||15
6740231|NCT03301649|7669084|FG000|STARTED|Overall Study||399
6740232|NCT03301649|7669085|FG001|STARTED|Overall Study||400
6740233|NCT03301649|7669086|FG002|STARTED|Overall Study||112
6740234|NCT03301649|7669084|FG000|Safety Population|Overall Study||399
6740235|NCT03301649|7669085|FG001|Safety Population|Overall Study||400
6740236|NCT03301649|7669086|FG002|Safety Population|Overall Study||112
6740237|NCT03301649|7669084|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||372
6740238|NCT03301649|7669085|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||380
6740239|NCT03301649|7669086|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||111
6740240|NCT03301649|7669084|FG000|Per-protocol (PP) Population|Overall Study||345
6740241|NCT03301649|7669085|FG001|Per-protocol (PP) Population|Overall Study||354
6740242|NCT03301649|7669086|FG002|Per-protocol (PP) Population|Overall Study||103
6740243|NCT03301649|7669084|FG000|COMPLETED|Overall Study||356
6740244|NCT03301649|7669085|FG001|COMPLETED|Overall Study||356
6740245|NCT03301649|7669086|FG002|COMPLETED|Overall Study||27
6740246|NCT03301649|7669084|FG000|NOT COMPLETED|Overall Study||43
6740247|NCT03301649|7669085|FG001|NOT COMPLETED|Overall Study||44
6740248|NCT03301649|7669086|FG002|NOT COMPLETED|Overall Study||85
6740249|NCT03301714|7669097|FG000|STARTED|Overall Study||60
6740250|NCT03301714|7669098|FG001|STARTED|Overall Study||60
6740251|NCT03301714|7669099|FG002|STARTED|Overall Study||60
6740252|NCT03301714|7669097|FG000|COMPLETED|Overall Study||50
6740253|NCT03301714|7669098|FG001|COMPLETED|Overall Study||54
6740254|NCT03301714|7669099|FG002|COMPLETED|Overall Study||53
6740255|NCT03301714|7669097|FG000|NOT COMPLETED|Overall Study||10
6740256|NCT03301714|7669098|FG001|NOT COMPLETED|Overall Study||6
6740257|NCT03301714|7669099|FG002|NOT COMPLETED|Overall Study||7
6740258|NCT03301740|7669112|FG000|STARTED|Phase 1 Intervention (3 Weeks)||18
6740259|NCT03301740|7669113|FG001|STARTED|Phase 1 Intervention (3 Weeks)||16
6740260|NCT03301740|7669112|FG000|COMPLETED|Phase 1 Intervention (3 Weeks)||18
6740261|NCT03301740|7669113|FG001|COMPLETED|Phase 1 Intervention (3 Weeks)||16
6740262|NCT03301740|7669112|FG000|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
6740263|NCT03301740|7669113|FG001|NOT COMPLETED|Phase 1 Intervention (3 Weeks)||0
6740264|NCT03301740|7669112|FG000|STARTED|First Washout (1 Week)||18
6740265|NCT03301740|7669113|FG001|STARTED|First Washout (1 Week)||16
6740266|NCT03301740|7669112|FG000|COMPLETED|First Washout (1 Week)||18
6740267|NCT03301740|7669113|FG001|COMPLETED|First Washout (1 Week)||16
6740268|NCT03301740|7669112|FG000|NOT COMPLETED|First Washout (1 Week)||0
6740269|NCT03301740|7669113|FG001|NOT COMPLETED|First Washout (1 Week)||0
6740270|NCT03301740|7669112|FG000|STARTED|Phase 2 Intervention (3 Weeks)||18
6740271|NCT03301740|7669113|FG001|STARTED|Phase 2 Intervention (3 Weeks)||16
6740272|NCT03301740|7669112|FG000|COMPLETED|Phase 2 Intervention (3 Weeks)||17
6740273|NCT03301740|7669113|FG001|COMPLETED|Phase 2 Intervention (3 Weeks)||16
6740274|NCT03301740|7669112|FG000|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||1
6740275|NCT03301740|7669113|FG001|NOT COMPLETED|Phase 2 Intervention (3 Weeks)||0
6740276|NCT03301740|7669112|FG000|STARTED|Second Washout (1 Week)||17
6740277|NCT03301740|7669113|FG001|STARTED|Second Washout (1 Week)||16
6740278|NCT03301740|7669112|FG000|COMPLETED|Second Washout (1 Week)||17
6740279|NCT03301740|7669113|FG001|COMPLETED|Second Washout (1 Week)||16
6740280|NCT03301740|7669112|FG000|NOT COMPLETED|Second Washout (1 Week)||0
6740281|NCT03301740|7669113|FG001|NOT COMPLETED|Second Washout (1 Week)||0
6740282|NCT03301740|7669112|FG000|STARTED|Phase 3 Intervention (3 Weeks)||17
6740283|NCT03301740|7669113|FG001|STARTED|Phase 3 Intervention (3 Weeks)||16
6740284|NCT03301740|7669112|FG000|COMPLETED|Phase 3 Intervention (3 Weeks)||17
6740285|NCT03301740|7669113|FG001|COMPLETED|Phase 3 Intervention (3 Weeks)||16
6740286|NCT03301740|7669112|FG000|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
6740287|NCT03301740|7669113|FG001|NOT COMPLETED|Phase 3 Intervention (3 Weeks)||0
6740288|NCT03301740|7669112|FG000|STARTED|Third Washout (1 Week)||17
6740289|NCT03301740|7669113|FG001|STARTED|Third Washout (1 Week)||16
6740290|NCT03301740|7669112|FG000|COMPLETED|Third Washout (1 Week)||17
6740291|NCT03301740|7669113|FG001|COMPLETED|Third Washout (1 Week)||16
6740292|NCT03301740|7669112|FG000|NOT COMPLETED|Third Washout (1 Week)||0
6740293|NCT03301740|7669113|FG001|NOT COMPLETED|Third Washout (1 Week)||0
6740294|NCT03301740|7669112|FG000|STARTED|Phase 4 Intervention (3 Weeks)||17
6740295|NCT03301740|7669113|FG001|STARTED|Phase 4 Intervention (3 Weeks)||16
6740296|NCT03301740|7669112|FG000|COMPLETED|Phase 4 Intervention (3 Weeks)||16
6740297|NCT03301740|7669113|FG001|COMPLETED|Phase 4 Intervention (3 Weeks)||16
6740298|NCT03301740|7669112|FG000|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||1
6740299|NCT03301740|7669113|FG001|NOT COMPLETED|Phase 4 Intervention (3 Weeks)||0
6781068|NCT02679560|7709682|FG000|NOT COMPLETED|Overall Study||0
6781069|NCT02679560|7709683|FG001|NOT COMPLETED|Overall Study||0
6781070|NCT02679066|7709691|FG000|STARTED|Overall Study||100
6781071|NCT02679066|7709692|FG001|STARTED|Overall Study||100
6781072|NCT02679066|7709691|FG000|COMPLETED|Overall Study||100
6781073|NCT02679066|7709692|FG001|COMPLETED|Overall Study||100
6781074|NCT02679066|7709691|FG000|NOT COMPLETED|Overall Study||0
6781075|NCT02679066|7709692|FG001|NOT COMPLETED|Overall Study||0
6781076|NCT02673684|7709700|FG000|STARTED|Overall Study||9
6781077|NCT02673684|7709701|FG001|STARTED|Overall Study||8
6781078|NCT02673684|7709700|FG000|COMPLETED|Overall Study||0
6781079|NCT02673684|7709701|FG001|COMPLETED|Overall Study||0
6781080|NCT02673684|7709700|FG000|NOT COMPLETED|Overall Study||9
6781081|NCT02673684|7709701|FG001|NOT COMPLETED|Overall Study||8
6781082|NCT02674204|7709711|FG000|STARTED|Overall Study||1
6781083|NCT02674204|7709712|FG001|STARTED|Overall Study||1
6781084|NCT02674204|7709711|FG000|COMPLETED|Overall Study||0
6781085|NCT02674204|7709712|FG001|COMPLETED|Overall Study||1
6781086|NCT02674204|7709711|FG000|NOT COMPLETED|Overall Study||1
6781087|NCT02674204|7709712|FG001|NOT COMPLETED|Overall Study||0
6781088|NCT02665221|7709720|FG000|STARTED|Overall Study||15
6781089|NCT02665221|7709721|FG001|STARTED|Overall Study||15
6781090|NCT02665221|7709720|FG000|COMPLETED|Overall Study||0
6781091|NCT02665221|7709721|FG001|COMPLETED|Overall Study||0
6781092|NCT02665221|7709720|FG000|NOT COMPLETED|Overall Study||15
6781093|NCT02665221|7709721|FG001|NOT COMPLETED|Overall Study||15
6781094|NCT02672033|7709727|FG000|STARTED|Overall Study||2
6781095|NCT02672033|7709727|FG000|COMPLETED|Overall Study||2
6781096|NCT02672033|7709727|FG000|NOT COMPLETED|Overall Study||0
6781097|NCT02671461|7709734|FG000|STARTED|Treatment||3
6781098|NCT02671461|7709735|FG001|STARTED|Treatment||5
6781099|NCT02671461|7709736|FG002|STARTED|Treatment||7
6781100|NCT02671461|7709734|FG000|COMPLETED|Treatment||1
6781101|NCT02671461|7709735|FG001|COMPLETED|Treatment||2
6781102|NCT02671461|7709736|FG002|COMPLETED|Treatment||2
6781103|NCT02671461|7709734|FG000|NOT COMPLETED|Treatment||2
6781104|NCT02671461|7709735|FG001|NOT COMPLETED|Treatment||3
6781105|NCT02671461|7709736|FG002|NOT COMPLETED|Treatment||5
6781106|NCT02671461|7709734|FG000|STARTED|Follow-up||2
6781107|NCT02671461|7709735|FG001|STARTED|Follow-up||5
6781108|NCT02671461|7709736|FG002|STARTED|Follow-up||7
6781109|NCT02671461|7709734|FG000|COMPLETED|Follow-up||1
6781110|NCT02671461|7709735|FG001|COMPLETED|Follow-up||4
6781111|NCT02671461|7709736|FG002|COMPLETED|Follow-up||6
6781112|NCT02671461|7709734|FG000|NOT COMPLETED|Follow-up||1
6781113|NCT02671461|7709735|FG001|NOT COMPLETED|Follow-up||1
6781114|NCT02671461|7709736|FG002|NOT COMPLETED|Follow-up||1
6781115|NCT02671136|7709746|FG000|STARTED|Overall Study||3
6781116|NCT02671136|7709747|FG001|STARTED|Overall Study||0
6781117|NCT02671136|7709746|FG000|COMPLETED|Overall Study||3
6781118|NCT02671136|7709747|FG001|COMPLETED|Overall Study||0
6781119|NCT02671136|7709746|FG000|NOT COMPLETED|Overall Study||0
6781120|NCT02671136|7709747|FG001|NOT COMPLETED|Overall Study||0
6781121|NCT02663752|7709753|FG000|STARTED|Overall Study||1
6781122|NCT02663752|7709753|FG000|COMPLETED|Overall Study||1
6781123|NCT02663752|7709753|FG000|NOT COMPLETED|Overall Study||0
6781124|NCT02658357|7709759|FG000|STARTED|Overall Study||0
6781125|NCT02658357|7709760|FG001|STARTED|Overall Study||0
6781126|NCT02658357|7709759|FG000|COMPLETED|Overall Study||0
6781127|NCT02658357|7709760|FG001|COMPLETED|Overall Study||0
6781128|NCT02658357|7709759|FG000|NOT COMPLETED|Overall Study||0
6781129|NCT02658357|7709760|FG001|NOT COMPLETED|Overall Study||0
6781130|NCT02665988|7709768|FG000|STARTED|Overall Study||2
6781131|NCT02665988|7709769|FG001|STARTED|Overall Study||2
6781132|NCT02665988|7709768|FG000|COMPLETED|Overall Study||2
6781133|NCT02665988|7709769|FG001|COMPLETED|Overall Study||2
6781134|NCT02665988|7709768|FG000|NOT COMPLETED|Overall Study||0
6781135|NCT02665988|7709769|FG001|NOT COMPLETED|Overall Study||0
6781136|NCT02660528|7709775|FG000|STARTED|Overall Study||0
6781137|NCT02660528|7709775|FG000|COMPLETED|Overall Study||0
6781138|NCT02660528|7709775|FG000|NOT COMPLETED|Overall Study||0
6781139|NCT02658877|7709781|FG000|STARTED|Overall Study||3
6781140|NCT02658877|7709782|FG001|STARTED|Overall Study||0
6781141|NCT02658877|7709781|FG000|COMPLETED|Overall Study||3
6781142|NCT02658877|7709782|FG001|COMPLETED|Overall Study||0
6781143|NCT02658877|7709781|FG000|NOT COMPLETED|Overall Study||0
6781144|NCT02658877|7709782|FG001|NOT COMPLETED|Overall Study||0
6781145|NCT02654782|7709790|FG000|STARTED|Overall Study||5
6781146|NCT02654782|7709791|FG001|STARTED|Overall Study||5
6781147|NCT02654782|7709790|FG000|COMPLETED|Overall Study||5
6781148|NCT02654782|7709791|FG001|COMPLETED|Overall Study||5
6781149|NCT02654782|7709790|FG000|NOT COMPLETED|Overall Study||0
6781150|NCT02654782|7709791|FG001|NOT COMPLETED|Overall Study||0
6781151|NCT02656199|7709797|FG000|STARTED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
6781152|NCT02656199|7709797|FG000|COMPLETED|Overall Study|0 analyzed.PI left the institution.Effort to contact PI unsuccessful.No study data available|0
6781153|NCT02656199|7709797|FG000|NOT COMPLETED|Overall Study||0
6781154|NCT02654639|7709801|FG000|STARTED|Overall Study||4
6781155|NCT02654639|7709801|FG000|COMPLETED|Overall Study||4
6781156|NCT02654639|7709801|FG000|NOT COMPLETED|Overall Study||0
6781157|NCT02653495|7709807|FG000|STARTED|Overall Study||15
6781158|NCT02653495|7709808|FG001|STARTED|Overall Study||2
6781159|NCT02653495|7709807|FG000|COMPLETED|Overall Study||3
6781160|NCT02653495|7709808|FG001|COMPLETED|Overall Study||2
6781161|NCT02653495|7709807|FG000|NOT COMPLETED|Overall Study||12
6781162|NCT02653495|7709808|FG001|NOT COMPLETED|Overall Study||0
6781163|NCT02640573|7709814|FG000|STARTED|Overall Study||1
6781164|NCT02640573|7709814|FG000|COMPLETED|Overall Study||0
6781165|NCT02640573|7709814|FG000|NOT COMPLETED|Overall Study||1
6781166|NCT02639390|7709820|FG000|STARTED|Overall Study||0
6781167|NCT02639390|7709821|FG001|STARTED|Overall Study||5
6781168|NCT02639390|7709820|FG000|COMPLETED|Overall Study||0
6781169|NCT02639390|7709821|FG001|COMPLETED|Overall Study||3
6781170|NCT02639390|7709820|FG000|NOT COMPLETED|Overall Study||0
6781171|NCT02639390|7709821|FG001|NOT COMPLETED|Overall Study||2
6781172|NCT02634606|7709827|FG000|STARTED|Overall Study||13
6781173|NCT02634606|7709827|FG000|COMPLETED|Overall Study||0
6781174|NCT02634606|7709827|FG000|NOT COMPLETED|Overall Study||13
6781175|NCT02634827|7709835|FG000|STARTED|Overall Study||1
6781176|NCT02634827|7709835|FG000|COMPLETED|Overall Study||1
6781177|NCT02634827|7709835|FG000|NOT COMPLETED|Overall Study||0
6781178|NCT02636283|7709841|FG000|STARTED|Overall Study||3
6781179|NCT02636283|7709842|FG001|STARTED|Overall Study||3
6781180|NCT02636283|7709841|FG000|COMPLETED|Overall Study||1
6781181|NCT02636283|7709842|FG001|COMPLETED|Overall Study||0
6781182|NCT02636283|7709841|FG000|NOT COMPLETED|Overall Study||2
6781183|NCT02636283|7709842|FG001|NOT COMPLETED|Overall Study||3
6781184|NCT02638129|7709850|FG000|STARTED|Overall Study||28
6781185|NCT02638129|7709851|FG001|STARTED|Overall Study||30
6781186|NCT02638129|7709850|FG000|COMPLETED|Overall Study||0
6781187|NCT02638129|7709851|FG001|COMPLETED|Overall Study||0
6781188|NCT02638129|7709850|FG000|NOT COMPLETED|Overall Study||28
6781189|NCT02638129|7709851|FG001|NOT COMPLETED|Overall Study||30
6781190|NCT02615990|7709859|FG000|STARTED|Overall Study||1
6781191|NCT02615990|7709860|FG001|STARTED|Overall Study||1
6781192|NCT02615990|7709859|FG000|COMPLETED|Overall Study||0
6781193|NCT02615990|7709860|FG001|COMPLETED|Overall Study||0
6781194|NCT02615990|7709859|FG000|NOT COMPLETED|Overall Study||1
6781195|NCT02615990|7709860|FG001|NOT COMPLETED|Overall Study||1
6781196|NCT02640677|7709866|FG000|STARTED|Overall Study||2
6781197|NCT02640677|7709866|FG000|COMPLETED|Overall Study||0
6781198|NCT02640677|7709866|FG000|NOT COMPLETED|Overall Study||2
6781199|NCT02633540|7709870|FG000|STARTED|Overall Study||2
6781200|NCT02633540|7709870|FG000|COMPLETED|Overall Study||2
6562922|NCT01803607|7485846|FG001|COMPLETED|Overall Study||0
6562923|NCT01803607|7485845|FG000|NOT COMPLETED|Overall Study||68
6562924|NCT01803607|7485846|FG001|NOT COMPLETED|Overall Study||67
6781201|NCT02633540|7709870|FG000|NOT COMPLETED|Overall Study||0
6781202|NCT02623959|7709876|FG000|STARTED|Overall Study||0
6781203|NCT02623959|7709877|FG001|STARTED|Overall Study||1
6781204|NCT02623959|7709876|FG000|COMPLETED|Overall Study||0
6781205|NCT02623959|7709877|FG001|COMPLETED|Overall Study|due to progression|0
6781206|NCT02623959|7709876|FG000|NOT COMPLETED|Overall Study||0
6623405|NCT02207556|7550533|FG000|COMPLETED|Overall Study||5
6781207|NCT02623959|7709877|FG001|NOT COMPLETED|Overall Study||1
6781208|NCT02631148|7709887|FG000|STARTED|Overall Study||12
6781209|NCT02631148|7709888|FG001|STARTED|Overall Study||0
6781210|NCT02631148|7709887|FG000|COMPLETED|Overall Study||2
6781211|NCT02631148|7709888|FG001|COMPLETED|Overall Study||0
6781212|NCT02631148|7709887|FG000|NOT COMPLETED|Overall Study||10
6781213|NCT02631148|7709888|FG001|NOT COMPLETED|Overall Study||0
6781214|NCT02630472|7709896|FG000|STARTED|Overall Study||10
6781215|NCT02630472|7709897|FG001|STARTED|Overall Study||0
6781216|NCT02630472|7709896|FG000|COMPLETED|Overall Study||0
6781217|NCT02630472|7709897|FG001|COMPLETED|Overall Study||0
6781218|NCT02630472|7709896|FG000|NOT COMPLETED|Overall Study||10
6280597|NCT00158197|7180558|FG001|COMPLETED|Overall Study||30
6623406|NCT02207556|7550534|FG001|COMPLETED|Overall Study||20
6781219|NCT02630472|7709897|FG001|NOT COMPLETED|Overall Study||0
6781220|NCT02626520|7709906|FG000|STARTED|Overall Study||1
6781221|NCT02626520|7709907|FG001|STARTED|Overall Study||10
6781222|NCT02626520|7709906|FG000|COMPLETED|Overall Study||0
6781223|NCT02626520|7709907|FG001|COMPLETED|Overall Study||0
6781224|NCT02626520|7709906|FG000|NOT COMPLETED|Overall Study||1
6781225|NCT02626520|7709907|FG001|NOT COMPLETED|Overall Study||10
6781226|NCT02614898|7709915|FG000|STARTED|Overall Study||15
6781227|NCT02614898|7709916|FG001|STARTED|Overall Study||52
6781228|NCT02614898|7709915|FG000|Safety Population|Overall Study||15
6781229|NCT02614898|7709916|FG001|Safety Population|Overall Study||52
6781230|NCT02614898|7709915|FG000|COMPLETED|Overall Study||0
6781231|NCT02614898|7709916|FG001|COMPLETED|Overall Study||1
6781232|NCT02614898|7709915|FG000|NOT COMPLETED|Overall Study||15
6781233|NCT02614898|7709916|FG001|NOT COMPLETED|Overall Study||51
6781234|NCT02622828|7709923|FG000|STARTED|Overall Study||4
6781235|NCT02622828|7709923|FG000|COMPLETED|Overall Study||1
6781236|NCT02622828|7709923|FG000|NOT COMPLETED|Overall Study||3
6781237|NCT02624739|7709929|FG000|STARTED|Overall Study||0
6781238|NCT02624739|7709930|FG001|STARTED|Overall Study||0
6781239|NCT02624739|7709929|FG000|COMPLETED|Overall Study||0
6781240|NCT02624739|7709930|FG001|COMPLETED|Overall Study||0
6781241|NCT02624739|7709929|FG000|NOT COMPLETED|Overall Study||0
6781242|NCT02624739|7709930|FG001|NOT COMPLETED|Overall Study||0
6781243|NCT02608905|7709938|FG000|STARTED|Overall Study||7
6781244|NCT02608905|7709939|FG001|STARTED|Overall Study||10
6781245|NCT02608905|7709938|FG000|COMPLETED|Overall Study||5
6781246|NCT02608905|7709939|FG001|COMPLETED|Overall Study||10
6781247|NCT02608905|7709938|FG000|NOT COMPLETED|Overall Study||2
6781248|NCT02608905|7709939|FG001|NOT COMPLETED|Overall Study||0
6781249|NCT02619812|7709949|FG000|STARTED|Overall Study||0
6781250|NCT02619812|7709950|FG001|STARTED|Overall Study||0
6781251|NCT02619812|7709951|FG002|STARTED|Overall Study||1
6781252|NCT02619812|7709952|FG003|STARTED|Overall Study||2
6781253|NCT02619812|7709949|FG000|COMPLETED|Overall Study||0
6781254|NCT02619812|7709950|FG001|COMPLETED|Overall Study||0
6781255|NCT02619812|7709951|FG002|COMPLETED|Overall Study||0
6781256|NCT02619812|7709952|FG003|COMPLETED|Overall Study||0
6781257|NCT02619812|7709949|FG000|NOT COMPLETED|Overall Study||0
6781258|NCT02619812|7709950|FG001|NOT COMPLETED|Overall Study||0
6781259|NCT02619812|7709951|FG002|NOT COMPLETED|Overall Study||1
6781260|NCT02619812|7709952|FG003|NOT COMPLETED|Overall Study||2
6781261|NCT02612285|7709962|FG000|STARTED|Overall Study||1
6781262|NCT02612285|7709962|FG000|COMPLETED|Overall Study|Subject did not complete Cycle 1; no data points recorded|0
6781263|NCT02612285|7709962|FG000|NOT COMPLETED|Overall Study||1
6781264|NCT02614586|7709966|FG000|STARTED|Overall Study||11
6781265|NCT02614586|7709966|FG000|COMPLETED|Overall Study||11
6781266|NCT02614586|7709966|FG000|NOT COMPLETED|Overall Study||0
6781267|NCT02606279|7709972|FG000|STARTED|Overall Study||0
6781268|NCT02606279|7709973|FG001|STARTED|Overall Study||1
6781269|NCT02606279|7709972|FG000|COMPLETED|Overall Study||0
6781270|NCT02606279|7709973|FG001|COMPLETED|Overall Study||0
6781271|NCT02606279|7709972|FG000|NOT COMPLETED|Overall Study||0
6781272|NCT02606279|7709973|FG001|NOT COMPLETED|Overall Study||1
6781273|NCT02605824|7709981|FG000|STARTED|Overall Study||1
6781274|NCT02605824|7709982|FG001|STARTED|Overall Study||0
6781275|NCT02605824|7709981|FG000|COMPLETED|Overall Study||0
6781276|NCT02605824|7709982|FG001|COMPLETED|Overall Study||0
6781277|NCT02605824|7709981|FG000|NOT COMPLETED|Overall Study||1
6781278|NCT02605824|7709982|FG001|NOT COMPLETED|Overall Study||0
6781279|NCT02598622|7709990|FG000|STARTED|Overall Study||8
6781280|NCT02598622|7709991|FG001|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
6781281|NCT02598622|7709990|FG000|COMPLETED|Overall Study||2
6781282|NCT02598622|7709991|FG001|COMPLETED|Overall Study||0
6781283|NCT02598622|7709990|FG000|NOT COMPLETED|Overall Study||6
6781284|NCT02598622|7709991|FG001|NOT COMPLETED|Overall Study||0
6781285|NCT02589145|7710000|FG000|STARTED|Overall Study||4
6781286|NCT02589145|7710001|FG001|STARTED|Overall Study||2
6781287|NCT02589145|7710002|FG002|STARTED|Overall Study||2
6781288|NCT02589145|7710000|FG000|COMPLETED|Overall Study||4
6781289|NCT02589145|7710001|FG001|COMPLETED|Overall Study||2
6781290|NCT02589145|7710002|FG002|COMPLETED|Overall Study||2
6781291|NCT02589145|7710000|FG000|NOT COMPLETED|Overall Study||0
6781292|NCT02589145|7710001|FG001|NOT COMPLETED|Overall Study||0
6781293|NCT02589145|7710002|FG002|NOT COMPLETED|Overall Study||0
6781294|NCT02582749|7710012|FG000|STARTED|Overall Study||5
6781295|NCT02582749|7710013|FG001|STARTED|Overall Study||11
6781296|NCT02582749|7710012|FG000|COMPLETED|Overall Study||0
6781297|NCT02582749|7710013|FG001|COMPLETED|Overall Study||0
6781298|NCT02582749|7710012|FG000|NOT COMPLETED|Overall Study||5
6781299|NCT02582749|7710013|FG001|NOT COMPLETED|Overall Study||11
6781300|NCT02590068|7710021|FG000|STARTED|Overall Study||0
6781301|NCT02590068|7710022|FG001|STARTED|Overall Study||14
6781302|NCT02590068|7710021|FG000|COMPLETED|Overall Study||0
6781303|NCT02590068|7710022|FG001|COMPLETED|Overall Study||14
6781304|NCT02590068|7710021|FG000|NOT COMPLETED|Overall Study||0
6781305|NCT02590068|7710022|FG001|NOT COMPLETED|Overall Study||0
6781306|NCT02593682|7710030|FG000|STARTED|Overall Study||0
6781307|NCT02593682|7710031|FG001|STARTED|Overall Study||0
6781308|NCT02593682|7710030|FG000|COMPLETED|Overall Study||0
6781309|NCT02593682|7710031|FG001|COMPLETED|Overall Study||0
6781310|NCT02593682|7710030|FG000|NOT COMPLETED|Overall Study||0
6781311|NCT02593682|7710031|FG001|NOT COMPLETED|Overall Study||0
6781312|NCT02587650|7710037|FG000|STARTED|Overall Study||0
6781313|NCT02587650|7710038|FG001|STARTED|Overall Study||0
6781314|NCT02587650|7710039|FG002|STARTED|Overall Study||1
6781315|NCT02587650|7710040|FG003|STARTED|Overall Study||0
6781316|NCT02587650|7710037|FG000|COMPLETED|Overall Study||0
6781317|NCT02587650|7710038|FG001|COMPLETED|Overall Study||0
6781318|NCT02587650|7710039|FG002|COMPLETED|Overall Study||1
6781319|NCT02587650|7710040|FG003|COMPLETED|Overall Study||0
6781320|NCT02587650|7710037|FG000|NOT COMPLETED|Overall Study||0
6781321|NCT02587650|7710038|FG001|NOT COMPLETED|Overall Study||0
6781322|NCT02587650|7710039|FG002|NOT COMPLETED|Overall Study||0
6781323|NCT02587650|7710040|FG003|NOT COMPLETED|Overall Study||0
6781324|NCT02569957|7710046|FG000|STARTED|Overall Study||0
6781325|NCT02569957|7710047|FG001|STARTED|Overall Study||1
6781326|NCT02569957|7710046|FG000|COMPLETED|Overall Study||0
6781327|NCT02569957|7710047|FG001|COMPLETED|Overall Study||0
6781328|NCT02569957|7710046|FG000|NOT COMPLETED|Overall Study||0
6781329|NCT02569957|7710047|FG001|NOT COMPLETED|Overall Study||1
6781330|NCT02568007|7710056|FG000|STARTED|Overall Study||2
6781331|NCT02568007|7710057|FG001|STARTED|Overall Study||2
6781332|NCT02568007|7710058|FG002|STARTED|Overall Study||0
6781333|NCT02568007|7710056|FG000|COMPLETED|Overall Study||2
6781334|NCT02568007|7710057|FG001|COMPLETED|Overall Study||2
6781335|NCT02568007|7710058|FG002|COMPLETED|Overall Study||0
6781336|NCT02568007|7710056|FG000|NOT COMPLETED|Overall Study||0
6781337|NCT02568007|7710057|FG001|NOT COMPLETED|Overall Study||0
6781338|NCT02568007|7710058|FG002|NOT COMPLETED|Overall Study||0
6781339|NCT02575365|7710066|FG000|STARTED|Overall Study||4
6781340|NCT02575365|7710066|FG000|COMPLETED|Overall Study||0
6781341|NCT02575365|7710066|FG000|NOT COMPLETED|Overall Study||4
6781342|NCT02549755|7710070|FG000|STARTED|Overall Study||1
6781343|NCT02549755|7710070|FG000|COMPLETED|Overall Study||0
6781344|NCT02549755|7710070|FG000|NOT COMPLETED|Overall Study||1
6781345|NCT02547129|7710076|FG000|STARTED|Overall Study||2
6781346|NCT02547129|7710077|FG001|STARTED|Overall Study||2
6781347|NCT02547129|7710076|FG000|COMPLETED|Overall Study||1
6781348|NCT02547129|7710077|FG001|COMPLETED|Overall Study||2
6781349|NCT02547129|7710076|FG000|NOT COMPLETED|Overall Study||1
6781350|NCT02547129|7710077|FG001|NOT COMPLETED|Overall Study||0
6781351|NCT02528097|7710085|FG000|STARTED|Overall Study||1
6781352|NCT02528097|7710086|FG001|STARTED|Overall Study||1
6781353|NCT02528097|7710085|FG000|COMPLETED|Overall Study||1
6781354|NCT02528097|7710086|FG001|COMPLETED|Overall Study||1
6781355|NCT02528097|7710085|FG000|NOT COMPLETED|Overall Study||0
6781356|NCT02528097|7710086|FG001|NOT COMPLETED|Overall Study||0
6781357|NCT02549716|7710094|FG000|STARTED|Overall Study||1
6781358|NCT02549716|7710095|FG001|STARTED|Overall Study||2
6781359|NCT02549716|7710094|FG000|COMPLETED|Overall Study||1
6781360|NCT02549716|7710095|FG001|COMPLETED|Overall Study||2
6781361|NCT02549716|7710094|FG000|NOT COMPLETED|Overall Study||0
6781362|NCT02549716|7710095|FG001|NOT COMPLETED|Overall Study||0
6781363|NCT02540434|7710103|FG000|STARTED|Overall Study||1
6781364|NCT02540434|7710104|FG001|STARTED|Overall Study||1
6781365|NCT02540434|7710103|FG000|COMPLETED|Overall Study||1
6781366|NCT02540434|7710104|FG001|COMPLETED|Overall Study||1
6781367|NCT02540434|7710103|FG000|NOT COMPLETED|Overall Study||0
6781368|NCT02540434|7710104|FG001|NOT COMPLETED|Overall Study||0
6781369|NCT02531308|7710112|FG000|STARTED|Overall Study||5
6781370|NCT02531308|7710112|FG000|COMPLETED|Overall Study||2
6781371|NCT02531308|7710112|FG000|NOT COMPLETED|Overall Study||3
6781372|NCT02533531|7710116|FG000|STARTED|Overall Study||1
6781373|NCT02533531|7710116|FG000|COMPLETED|Overall Study||0
6781374|NCT02533531|7710116|FG000|NOT COMPLETED|Overall Study||1
6781375|NCT02534038|7710122|FG000|STARTED|Period 1 (6 Weeks)||1
6781376|NCT02534038|7710123|FG001|STARTED|Period 1 (6 Weeks)||0
6502084|NCT01432444|7420720|FG001|NOT COMPLETED|Tolerability/Cross-titration Phase||0
6502085|NCT01432444|7420721|FG002|NOT COMPLETED|Tolerability/Cross-titration Phase||0
6502086|NCT01432444|7420719|FG000|STARTED|Treatment Phase||0
6502087|NCT01432444|7420720|FG001|STARTED|Treatment Phase||433
6502088|NCT01432444|7420721|FG002|STARTED|Treatment Phase||0
6502089|NCT01432444|7420719|FG000|COMPLETED|Treatment Phase||0
6781377|NCT02534038|7710122|FG000|COMPLETED|Period 1 (6 Weeks)||1
6781378|NCT02534038|7710123|FG001|COMPLETED|Period 1 (6 Weeks)||0
6781379|NCT02534038|7710122|FG000|NOT COMPLETED|Period 1 (6 Weeks)||0
6781380|NCT02534038|7710123|FG001|NOT COMPLETED|Period 1 (6 Weeks)||0
6781381|NCT02534038|7710122|FG000|STARTED|Period 2 (6 Weeks)||1
6502090|NCT01432444|7420720|FG001|COMPLETED|Treatment Phase||293
6781382|NCT02534038|7710123|FG001|STARTED|Period 2 (6 Weeks)||0
6781383|NCT02534038|7710122|FG000|COMPLETED|Period 2 (6 Weeks)||1
6781384|NCT02534038|7710123|FG001|COMPLETED|Period 2 (6 Weeks)||0
6781385|NCT02534038|7710122|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
6781386|NCT02534038|7710123|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
6781387|NCT02520726|7710132|FG000|STARTED|Overall Study||3
6502091|NCT01432444|7420721|FG002|COMPLETED|Treatment Phase||0
6502092|NCT01432444|7420719|FG000|NOT COMPLETED|Treatment Phase||0
6502093|NCT01432444|7420720|FG001|NOT COMPLETED|Treatment Phase||140
6502094|NCT01432444|7420721|FG002|NOT COMPLETED|Treatment Phase||0
6502095|NCT01432444|7420719|FG000|STARTED|Extension Phase||0
6502096|NCT01432444|7420720|FG001|STARTED|Extension Phase||0
6781388|NCT02520726|7710133|FG001|STARTED|Overall Study||2
6781389|NCT02520726|7710132|FG000|COMPLETED|Overall Study||0
6781390|NCT02520726|7710133|FG001|COMPLETED|Overall Study||0
6781391|NCT02520726|7710132|FG000|NOT COMPLETED|Overall Study||3
6781392|NCT02520726|7710133|FG001|NOT COMPLETED|Overall Study||2
6781393|NCT02520297|7710139|FG000|STARTED|Overall Study||1
6781394|NCT02520297|7710139|FG000|COMPLETED|Overall Study||1
6781395|NCT02520297|7710139|FG000|NOT COMPLETED|Overall Study||0
6781396|NCT02519712|7710143|FG000|STARTED|Overall Study||4
6781397|NCT02519712|7710143|FG000|COMPLETED|Overall Study||0
6781398|NCT02519712|7710143|FG000|NOT COMPLETED|Overall Study||4
6781399|NCT02518750|7710147|FG000|STARTED|Overall Study||3
6781400|NCT02518750|7710147|FG000|COMPLETED|Overall Study||1
6781401|NCT02518750|7710147|FG000|NOT COMPLETED|Overall Study||2
6781402|NCT02516228|7710151|FG000|STARTED|Overall Study||6
6781403|NCT02516228|7710151|FG000|COMPLETED|Overall Study||3
6781404|NCT02516228|7710151|FG000|NOT COMPLETED|Overall Study||3
6781405|NCT02515851|7710157|FG000|STARTED|Overall Study||15
6781406|NCT02515851|7710158|FG001|STARTED|Overall Study||15
6781407|NCT02515851|7710157|FG000|COMPLETED|Overall Study||15
6781408|NCT02515851|7710158|FG001|COMPLETED|Overall Study||15
6781409|NCT02515851|7710157|FG000|NOT COMPLETED|Overall Study||0
6781410|NCT02515851|7710158|FG001|NOT COMPLETED|Overall Study||0
6781411|NCT02506985|7710166|FG000|STARTED|Overall Study||4
6781412|NCT02506985|7710167|FG001|STARTED|Overall Study||6
6781413|NCT02506985|7710166|FG000|COMPLETED|Overall Study||4
6781414|NCT02506985|7710167|FG001|COMPLETED|Overall Study||6
6781415|NCT02506985|7710166|FG000|NOT COMPLETED|Overall Study||0
6781416|NCT02506985|7710167|FG001|NOT COMPLETED|Overall Study||0
6781417|NCT02514252|7710173|FG000|STARTED|Overall Study||6
6562925|NCT01803646|7485854|FG000|STARTED|Overall Study||204
6562926|NCT01803646|7485855|FG001|STARTED|Overall Study||139
6562927|NCT01803646|7485854|FG000|COMPLETED|Overall Study||187
6562928|NCT01803646|7485855|FG001|COMPLETED|Overall Study||129
6562929|NCT01803646|7485854|FG000|NOT COMPLETED|Overall Study||17
6562930|NCT01803646|7485855|FG001|NOT COMPLETED|Overall Study||10
6562931|NCT01803737|7485863|FG000|STARTED|Overall Study||13
6562932|NCT01803737|7485864|FG001|STARTED|Overall Study||13
6562933|NCT01803737|7485863|FG000|COMPLETED|Overall Study||12
6562934|NCT01803737|7485864|FG001|COMPLETED|Overall Study||10
6781418|NCT02514252|7710173|FG000|COMPLETED|Overall Study||6
6781419|NCT02514252|7710173|FG000|NOT COMPLETED|Overall Study||0
6781420|NCT02501759|7710177|FG000|STARTED|Overall Study||2
6781421|NCT02501759|7710177|FG000|COMPLETED|Overall Study||1
6781422|NCT02501759|7710177|FG000|NOT COMPLETED|Overall Study||1
6781423|NCT02487277|7710183|FG000|STARTED|Overall Study||3
6781424|NCT02487277|7710184|FG001|STARTED|Overall Study||0
6781425|NCT02487277|7710183|FG000|COMPLETED|Overall Study||3
6781426|NCT02487277|7710184|FG001|COMPLETED|Overall Study||0
6781427|NCT02487277|7710183|FG000|NOT COMPLETED|Overall Study||0
6781428|NCT02487277|7710184|FG001|NOT COMPLETED|Overall Study||0
6781429|NCT02506101|7710191|FG000|STARTED|Overall Study||2
6781430|NCT02506101|7710192|FG001|STARTED|Overall Study||0
6781431|NCT02506101|7710191|FG000|COMPLETED|Overall Study||0
6781432|NCT02506101|7710192|FG001|COMPLETED|Overall Study||0
6781433|NCT02506101|7710191|FG000|NOT COMPLETED|Overall Study||2
6781434|NCT02506101|7710192|FG001|NOT COMPLETED|Overall Study||0
6781435|NCT02499887|7710200|FG000|STARTED|Overall Study||3
6781436|NCT02499887|7710201|FG001|STARTED|Overall Study||3
6781437|NCT02499887|7710200|FG000|COMPLETED|Overall Study||3
6781438|NCT02499887|7710201|FG001|COMPLETED|Overall Study||3
6781439|NCT02499887|7710200|FG000|NOT COMPLETED|Overall Study||0
6781440|NCT02499887|7710201|FG001|NOT COMPLETED|Overall Study||0
6781441|NCT02504099|7710207|FG000|STARTED|Overall Study||3
6781442|NCT02504099|7710207|FG000|COMPLETED|Overall Study||3
6781443|NCT02504099|7710207|FG000|NOT COMPLETED|Overall Study||0
6781444|NCT02500901|7710211|FG000|STARTED|Overall Study||2
6781445|NCT02500901|7710211|FG000|COMPLETED|Overall Study||0
6781446|NCT02500901|7710211|FG000|NOT COMPLETED|Overall Study||2
6781447|NCT02483533|7710217|FG000|STARTED|Overall Study||50
6781448|NCT02483533|7710218|FG001|STARTED|Overall Study||50
6781449|NCT02483533|7710217|FG000|COMPLETED|Overall Study||0
6781450|NCT02483533|7710218|FG001|COMPLETED|Overall Study||0
6781451|NCT02483533|7710217|FG000|NOT COMPLETED|Overall Study||50
6781452|NCT02483533|7710218|FG001|NOT COMPLETED|Overall Study||50
6781453|NCT02496039|7710224|FG000|STARTED|Overall Study||5
6562935|NCT01803737|7485863|FG000|NOT COMPLETED|Overall Study||1
6562936|NCT01803737|7485864|FG001|NOT COMPLETED|Overall Study||3
6781454|NCT02496039|7710224|FG000|COMPLETED|Overall Study||1
6781455|NCT02496039|7710224|FG000|NOT COMPLETED|Overall Study||4
6781456|NCT02492295|7710228|FG000|STARTED|Overall Study||0
6781457|NCT02492295|7710228|FG000|COMPLETED|Overall Study||0
6781458|NCT02492295|7710228|FG000|NOT COMPLETED|Overall Study||0
6781459|NCT02494206|7710233|FG000|STARTED|Overall Study||9
6781460|NCT02494206|7710233|FG000|COMPLETED|Overall Study||7
6781461|NCT02494206|7710233|FG000|NOT COMPLETED|Overall Study||2
6781462|NCT02473445|7710237|FG000|STARTED|Overall Study||22
6781463|NCT02473445|7710237|FG000|COMPLETED|Overall Study||0
6781464|NCT02473445|7710237|FG000|NOT COMPLETED|Overall Study||22
6781465|NCT02491411|7710241|FG000|STARTED|Overall Study||4
6781466|NCT02491411|7710241|FG000|COMPLETED|Overall Study||0
6781467|NCT02491411|7710241|FG000|NOT COMPLETED|Overall Study||4
6781468|NCT02476994|7710247|FG000|STARTED|Overall Study||1
6781469|NCT02476994|7710248|FG001|STARTED|Overall Study||0
6781470|NCT02476994|7710247|FG000|COMPLETED|Overall Study||0
6781471|NCT02476994|7710248|FG001|COMPLETED|Overall Study||0
6781472|NCT02476994|7710247|FG000|NOT COMPLETED|Overall Study||1
6781473|NCT02476994|7710248|FG001|NOT COMPLETED|Overall Study||0
6781474|NCT02473523|7710254|FG000|STARTED|Overall Study||2
6781475|NCT02473523|7710254|FG000|COMPLETED|Overall Study||0
6781476|NCT02473523|7710254|FG000|NOT COMPLETED|Overall Study||2
6781477|NCT02468583|7710260|FG000|STARTED|Overall Study||3
6781478|NCT02468583|7710261|FG001|STARTED|Overall Study||3
6781479|NCT02468583|7710260|FG000|COMPLETED|Overall Study||3
6781480|NCT02468583|7710261|FG001|COMPLETED|Overall Study||3
6781481|NCT02468583|7710260|FG000|NOT COMPLETED|Overall Study||0
6781482|NCT02468583|7710261|FG001|NOT COMPLETED|Overall Study||0
6781483|NCT02450591|7710267|FG000|STARTED|Overall Study||4
6781484|NCT02450591|7710267|FG000|COMPLETED|Overall Study||4
6781485|NCT02450591|7710267|FG000|NOT COMPLETED|Overall Study||0
6781486|NCT02472639|7710273|FG000|STARTED|Overall Study||4
6781487|NCT02472639|7710274|FG001|STARTED|Overall Study||3
6781488|NCT02472639|7710273|FG000|COMPLETED|Overall Study||0
6781489|NCT02472639|7710274|FG001|COMPLETED|Overall Study||0
6781490|NCT02472639|7710273|FG000|NOT COMPLETED|Overall Study||4
6781491|NCT02472639|7710274|FG001|NOT COMPLETED|Overall Study||3
6781492|NCT02469415|7710280|FG000|STARTED|Overall Study||3
6781493|NCT02469415|7710280|FG000|COMPLETED|Overall Study||0
6781494|NCT02469415|7710280|FG000|NOT COMPLETED|Overall Study||3
6781495|NCT02461550|7710284|FG000|STARTED|Overall Study||2
6781496|NCT02461550|7710284|FG000|COMPLETED|Overall Study||2
6781497|NCT02461550|7710284|FG000|NOT COMPLETED|Overall Study||0
6781498|NCT02461355|7710288|FG000|STARTED|Overall Study||2
6781499|NCT02461355|7710288|FG000|COMPLETED|Overall Study||2
6781500|NCT02461355|7710288|FG000|NOT COMPLETED|Overall Study||0
6781501|NCT02452359|7710292|FG000|STARTED|Overall Study||54
6781502|NCT02452359|7710292|FG000|COMPLETED|Overall Study||33
6781503|NCT02452359|7710292|FG000|NOT COMPLETED|Overall Study||21
6781504|NCT02434146|7710296|FG000|STARTED|Overall Study||3
6781505|NCT02434146|7710296|FG000|COMPLETED|Overall Study||3
6781506|NCT02434146|7710296|FG000|NOT COMPLETED|Overall Study||0
6781507|NCT02452398|7710300|FG000|STARTED|Overall Study|Study was halted prematurely. No results analysis completed.|79
6781508|NCT02452398|7710300|FG000|COMPLETED|Overall Study|Study was halted prematurely. No results analysis completed.|38
6781509|NCT02452398|7710300|FG000|NOT COMPLETED|Overall Study||41
6781510|NCT02447887|7710304|FG000|STARTED|Overall Study||3
6781511|NCT02447887|7710304|FG000|COMPLETED|Overall Study||0
6781512|NCT02447887|7710304|FG000|NOT COMPLETED|Overall Study||3
6781513|NCT02431494|7710311|FG000|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
6781514|NCT02431494|7710312|FG001|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
6781515|NCT02431494|7710313|FG002|STARTED|Overall Study|The results cannot be evaluated because the sample size was so small. He had trouble recruiting|0
6781516|NCT02431494|7710311|FG000|COMPLETED|Overall Study||0
6781517|NCT02431494|7710312|FG001|COMPLETED|Overall Study||0
6781518|NCT02431494|7710313|FG002|COMPLETED|Overall Study||0
6781519|NCT02431494|7710311|FG000|NOT COMPLETED|Overall Study||0
6781520|NCT02431494|7710312|FG001|NOT COMPLETED|Overall Study||0
6781521|NCT02431494|7710313|FG002|NOT COMPLETED|Overall Study||0
6781522|NCT02439970|7710325|FG000|STARTED|Overall Study||2
6781523|NCT02439970|7710326|FG001|STARTED|Overall Study||3
6781524|NCT02439970|7710325|FG000|COMPLETED|Overall Study||0
6781525|NCT02439970|7710326|FG001|COMPLETED|Overall Study||0
6781526|NCT02439970|7710325|FG000|NOT COMPLETED|Overall Study||2
6781527|NCT02439970|7710326|FG001|NOT COMPLETED|Overall Study||3
6781528|NCT02439957|7710334|FG000|STARTED|Overall Study||3
6781529|NCT02439957|7710335|FG001|STARTED|Overall Study||3
6781530|NCT02439957|7710334|FG000|Blinded Treatment Period|Overall Study||1
6781531|NCT02439957|7710335|FG001|Blinded Treatment Period|Overall Study||2
6781532|NCT02439957|7710334|FG000|COMPLETED|Overall Study||0
6781533|NCT02439957|7710335|FG001|COMPLETED|Overall Study||0
6781534|NCT02439957|7710334|FG000|NOT COMPLETED|Overall Study||3
6781535|NCT02439957|7710335|FG001|NOT COMPLETED|Overall Study||3
6781536|NCT02441036|7710346|FG000|STARTED|Overall Study||3
6781537|NCT02441036|7710347|FG001|STARTED|Overall Study||5
6781538|NCT02441036|7710348|FG002|STARTED|Overall Study||3
6781539|NCT02441036|7710349|FG003|STARTED|Overall Study||4
6781540|NCT02441036|7710350|FG004|STARTED|Overall Study||1
6781541|NCT02441036|7710346|FG000|Treated|Overall Study||3
6781542|NCT02441036|7710347|FG001|Treated|Overall Study||5
6781543|NCT02441036|7710348|FG002|Treated|Overall Study||3
6781544|NCT02441036|7710349|FG003|Treated|Overall Study||4
6781545|NCT02441036|7710350|FG004|Treated|Overall Study||1
6781546|NCT02441036|7710346|FG000|Tissue Resected|Overall Study||3
6781547|NCT02441036|7710347|FG001|Tissue Resected|Overall Study||4
6781548|NCT02441036|7710348|FG002|Tissue Resected|Overall Study||3
6781549|NCT02441036|7710349|FG003|Tissue Resected|Overall Study||3
6781550|NCT02441036|7710350|FG004|Tissue Resected|Overall Study||1
6781551|NCT02441036|7710346|FG000|COMPLETED|Overall Study||3
6781552|NCT02441036|7710347|FG001|COMPLETED|Overall Study||4
6781553|NCT02441036|7710348|FG002|COMPLETED|Overall Study||3
6781554|NCT02441036|7710349|FG003|COMPLETED|Overall Study||3
6781555|NCT02441036|7710350|FG004|COMPLETED|Overall Study||1
6781556|NCT02441036|7710346|FG000|NOT COMPLETED|Overall Study||0
6781557|NCT02441036|7710347|FG001|NOT COMPLETED|Overall Study||1
6781558|NCT02441036|7710348|FG002|NOT COMPLETED|Overall Study||0
6781559|NCT02441036|7710349|FG003|NOT COMPLETED|Overall Study||1
6781560|NCT02441036|7710350|FG004|NOT COMPLETED|Overall Study||0
6781561|NCT02436265|7710365|FG000|STARTED|Overall Study||3
6781562|NCT02436265|7710366|FG001|STARTED|Overall Study||4
6781563|NCT02436265|7710365|FG000|COMPLETED|Overall Study||3
6781564|NCT02436265|7710366|FG001|COMPLETED|Overall Study||4
6781565|NCT02436265|7710365|FG000|NOT COMPLETED|Overall Study||0
6781566|NCT02436265|7710366|FG001|NOT COMPLETED|Overall Study||0
6781567|NCT02429583|7710374|FG000|STARTED|Overall Study||1
6781568|NCT02429583|7710375|FG001|STARTED|Overall Study||23
6781569|NCT02429583|7710374|FG000|COMPLETED|Overall Study||1
6781570|NCT02429583|7710375|FG001|COMPLETED|Overall Study||3
6781571|NCT02429583|7710374|FG000|NOT COMPLETED|Overall Study||0
6781572|NCT02429583|7710375|FG001|NOT COMPLETED|Overall Study||20
6781573|NCT02417870|7710381|FG000|STARTED|Overall Study||2
6781574|NCT02417870|7710381|FG000|COMPLETED|Overall Study||0
6781575|NCT02417870|7710381|FG000|NOT COMPLETED|Overall Study||2
6781576|NCT02430532|7710387|FG000|STARTED|Overall Study||30
6781577|NCT02430532|7710388|FG001|STARTED|Overall Study||28
6781578|NCT02430532|7710387|FG000|COMPLETED|Overall Study||0
6781579|NCT02430532|7710388|FG001|COMPLETED|Overall Study||0
6781580|NCT02430532|7710387|FG000|NOT COMPLETED|Overall Study||30
6781581|NCT02430532|7710388|FG001|NOT COMPLETED|Overall Study||28
6781582|NCT02428231|7710398|FG000|STARTED|Overall Study||30
6781583|NCT02428231|7710399|FG001|STARTED|Overall Study||32
6781584|NCT02428231|7710398|FG000|COMPLETED|Overall Study||17
6781585|NCT02428231|7710399|FG001|COMPLETED|Overall Study||15
6781586|NCT02428231|7710398|FG000|NOT COMPLETED|Overall Study||13
6781587|NCT02428231|7710399|FG001|NOT COMPLETED|Overall Study||17
6781588|NCT02424565|7710405|FG000|STARTED|Period 1 (D0)||8
6781589|NCT02424565|7710406|FG001|STARTED|Period 1 (D0)||7
6781590|NCT02424565|7710405|FG000|COMPLETED|Period 1 (D0)||8
6781591|NCT02424565|7710406|FG001|COMPLETED|Period 1 (D0)||6
6781592|NCT02424565|7710405|FG000|NOT COMPLETED|Period 1 (D0)||0
6781593|NCT02424565|7710406|FG001|NOT COMPLETED|Period 1 (D0)||1
6781594|NCT02424565|7710405|FG000|STARTED|Washout Period||8
6781595|NCT02424565|7710406|FG001|STARTED|Washout Period||6
6781596|NCT02424565|7710405|FG000|COMPLETED|Washout Period||8
6781597|NCT02424565|7710406|FG001|COMPLETED|Washout Period||6
6781598|NCT02424565|7710405|FG000|NOT COMPLETED|Washout Period||0
6781599|NCT02424565|7710406|FG001|NOT COMPLETED|Washout Period||0
6781600|NCT02424565|7710405|FG000|STARTED|Period 2 (D3)||8
6781601|NCT02424565|7710406|FG001|STARTED|Period 2 (D3)||6
6781602|NCT02424565|7710405|FG000|COMPLETED|Period 2 (D3)||8
6781603|NCT02424565|7710406|FG001|COMPLETED|Period 2 (D3)||6
6781604|NCT02424565|7710405|FG000|NOT COMPLETED|Period 2 (D3)||0
6781605|NCT02424565|7710406|FG001|NOT COMPLETED|Period 2 (D3)||0
6781606|NCT02413047|7710412|FG000|STARTED|Overall Study||3
6781607|NCT02413047|7710412|FG000|Participants on Infliximab|Overall Study||2
6781608|NCT02413047|7710412|FG000|Participants on Adalimumab|Overall Study||1
6781609|NCT02413047|7710412|FG000|COMPLETED|Overall Study||3
6781610|NCT02413047|7710412|FG000|NOT COMPLETED|Overall Study||0
6781611|NCT02414698|7710418|FG000|STARTED|Overall Study||3
6781612|NCT02414698|7710419|FG001|STARTED|Overall Study||1
6781613|NCT02414698|7710418|FG000|COMPLETED|Overall Study||3
6781614|NCT02414698|7710419|FG001|COMPLETED|Overall Study||1
6781615|NCT02414698|7710418|FG000|NOT COMPLETED|Overall Study||0
6781616|NCT02414698|7710419|FG001|NOT COMPLETED|Overall Study||0
6781617|NCT02422303|7710427|FG000|STARTED|Overall Study||6
6562937|NCT01803880|7485873|FG000|STARTED|Overall Study||19
6562938|NCT01803880|7485874|FG001|STARTED|Overall Study||28
6781618|NCT02422303|7710428|FG001|STARTED|Overall Study||6
6781619|NCT02422303|7710427|FG000|COMPLETED|Overall Study||5
6781620|NCT02422303|7710428|FG001|COMPLETED|Overall Study||5
6781621|NCT02422303|7710427|FG000|NOT COMPLETED|Overall Study||1
6781622|NCT02422303|7710428|FG001|NOT COMPLETED|Overall Study||1
6781623|NCT02415166|7710438|FG000|STARTED|Overall Study||6
6781624|NCT02415166|7710439|FG001|STARTED|Overall Study||0
6781625|NCT02415166|7710440|FG002|STARTED|Overall Study||0
6781626|NCT02415166|7710441|FG003|STARTED|Overall Study||0
6781627|NCT02415166|7710438|FG000|COMPLETED|Overall Study||6
6781628|NCT02415166|7710439|FG001|COMPLETED|Overall Study||0
6781629|NCT02415166|7710440|FG002|COMPLETED|Overall Study||0
6781630|NCT02415166|7710441|FG003|COMPLETED|Overall Study||0
6781631|NCT02415166|7710438|FG000|NOT COMPLETED|Overall Study||0
6781632|NCT02415166|7710439|FG001|NOT COMPLETED|Overall Study||0
6781633|NCT02415166|7710440|FG002|NOT COMPLETED|Overall Study||0
6781634|NCT02415166|7710441|FG003|NOT COMPLETED|Overall Study||0
6781635|NCT02414152|7710451|FG000|STARTED|Overall Study||2
6781636|NCT02414152|7710451|FG000|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
6781637|NCT02414152|7710451|FG000|NOT COMPLETED|Overall Study||2
6781638|NCT02410551|7710455|FG000|STARTED|Overall Study||4
6781639|NCT02410551|7710455|FG000|COMPLETED|Overall Study||0
6781640|NCT02410551|7710455|FG000|NOT COMPLETED|Overall Study||4
6781641|NCT02411643|7710460|FG000|STARTED|Overall Study||2
6781642|NCT02411643|7710460|FG000|COMPLETED|Overall Study||2
6781643|NCT02411643|7710460|FG000|NOT COMPLETED|Overall Study||0
6781644|NCT02410954|7710466|FG000|STARTED|Overall Study||14
6781645|NCT02410954|7710467|FG001|STARTED|Overall Study||0
6781646|NCT02410954|7710466|FG000|COMPLETED|Overall Study||0
6781647|NCT02410954|7710467|FG001|COMPLETED|Overall Study||0
6781648|NCT02410954|7710466|FG000|NOT COMPLETED|Overall Study||14
6781649|NCT02410954|7710467|FG001|NOT COMPLETED|Overall Study||0
6781650|NCT02410577|7710473|FG000|STARTED|Overall Study||2
6781651|NCT02410577|7710473|FG000|COMPLETED|Overall Study||2
6781652|NCT02410577|7710473|FG000|NOT COMPLETED|Overall Study||0
6781653|NCT02409355|7710479|FG000|STARTED|Overall Study||4
6781654|NCT02409355|7710480|FG001|STARTED|Overall Study||4
6781655|NCT02409355|7710479|FG000|COMPLETED|Overall Study||0
6781656|NCT02409355|7710480|FG001|COMPLETED|Overall Study||0
6781657|NCT02409355|7710479|FG000|NOT COMPLETED|Overall Study||4
6781658|NCT02409355|7710480|FG001|NOT COMPLETED|Overall Study||4
6781659|NCT02403154|7710490|FG000|STARTED|Overall Study||2
6781660|NCT02403154|7710491|FG001|STARTED|Overall Study||0
6781661|NCT02403154|7710492|FG002|STARTED|Overall Study||1
6781662|NCT02403154|7710493|FG003|STARTED|Overall Study||1
6781663|NCT02403154|7710490|FG000|COMPLETED|Overall Study||0
6781664|NCT02403154|7710491|FG001|COMPLETED|Overall Study||0
6781665|NCT02403154|7710492|FG002|COMPLETED|Overall Study||0
6781666|NCT02403154|7710493|FG003|COMPLETED|Overall Study||0
6781667|NCT02403154|7710490|FG000|NOT COMPLETED|Overall Study||2
6781668|NCT02403154|7710491|FG001|NOT COMPLETED|Overall Study||0
6781669|NCT02403154|7710492|FG002|NOT COMPLETED|Overall Study||1
6781670|NCT02403154|7710493|FG003|NOT COMPLETED|Overall Study||1
6781671|NCT02404545|7710505|FG000|STARTED|Overall Study||6
6781672|NCT02404545|7710506|FG001|STARTED|Overall Study||6
6781673|NCT02404545|7710505|FG000|COMPLETED|Overall Study||0
6781674|NCT02404545|7710506|FG001|COMPLETED|Overall Study||0
6781675|NCT02404545|7710505|FG000|NOT COMPLETED|Overall Study||6
6781676|NCT02404545|7710506|FG001|NOT COMPLETED|Overall Study||6
6781677|NCT02392377|7710515|FG000|STARTED|Overall Study||0
6781678|NCT02392377|7710516|FG001|STARTED|Overall Study||1
6781679|NCT02392377|7710515|FG000|COMPLETED|Overall Study||0
6781680|NCT02392377|7710516|FG001|COMPLETED|Overall Study||0
6781681|NCT02392377|7710515|FG000|NOT COMPLETED|Overall Study||0
6781682|NCT02392377|7710516|FG001|NOT COMPLETED|Overall Study||1
6781683|NCT02399111|7710528|FG000|STARTED|Overall Study||4
6781684|NCT02399111|7710529|FG001|STARTED|Overall Study||1
6781685|NCT02399111|7710530|FG002|STARTED|Overall Study||4
6781686|NCT02399111|7710531|FG003|STARTED|Overall Study||0
6781687|NCT02399111|7710528|FG000|COMPLETED|Overall Study||4
6781688|NCT02399111|7710529|FG001|COMPLETED|Overall Study||1
6781689|NCT02399111|7710530|FG002|COMPLETED|Overall Study||4
6781690|NCT02399111|7710531|FG003|COMPLETED|Overall Study||0
6781691|NCT02399111|7710528|FG000|NOT COMPLETED|Overall Study||0
6781692|NCT02399111|7710529|FG001|NOT COMPLETED|Overall Study||0
6781693|NCT02399111|7710530|FG002|NOT COMPLETED|Overall Study||0
6781694|NCT02399111|7710531|FG003|NOT COMPLETED|Overall Study||0
6781695|NCT02402036|7710543|FG000|STARTED|Overall Study||10
6781696|NCT02402036|7710543|FG000|COMPLETED|Overall Study||10
6781697|NCT02402036|7710543|FG000|NOT COMPLETED|Overall Study||0
6781698|NCT02394665|7710550|FG000|STARTED|Overall Study||1
6781699|NCT02394665|7710551|FG001|STARTED|Overall Study||0
6781700|NCT02394665|7710552|FG002|STARTED|Overall Study||0
6781701|NCT02394665|7710550|FG000|COMPLETED|Overall Study||0
6781702|NCT02394665|7710551|FG001|COMPLETED|Overall Study||0
6781703|NCT02394665|7710552|FG002|COMPLETED|Overall Study||0
6781704|NCT02394665|7710550|FG000|NOT COMPLETED|Overall Study||1
6781705|NCT02394665|7710551|FG001|NOT COMPLETED|Overall Study||0
6781706|NCT02394665|7710552|FG002|NOT COMPLETED|Overall Study||0
6781707|NCT02389712|7710562|FG000|STARTED|Overall Study||1
6781708|NCT02389712|7710563|FG001|STARTED|Overall Study||1
6781709|NCT02389712|7710562|FG000|COMPLETED|Overall Study||1
6781710|NCT02389712|7710563|FG001|COMPLETED|Overall Study||1
6781711|NCT02389712|7710562|FG000|NOT COMPLETED|Overall Study||0
6781712|NCT02389712|7710563|FG001|NOT COMPLETED|Overall Study||0
6781713|NCT02390362|7710571|FG000|STARTED|Overall Study|1 subject enrolled in this arm. completed 2 doses of Rituximab.|1
6781714|NCT02390362|7710572|FG001|STARTED|Overall Study||2
6781715|NCT02390362|7710571|FG000|COMPLETED|Overall Study||1
6781716|NCT02390362|7710572|FG001|COMPLETED|Overall Study||1
6781717|NCT02390362|7710571|FG000|NOT COMPLETED|Overall Study||0
6781718|NCT02390362|7710572|FG001|NOT COMPLETED|Overall Study||1
6781719|NCT02388776|7710578|FG000|STARTED|Overall Study||2
6781720|NCT02388776|7710578|FG000|COMPLETED|Overall Study||0
6781721|NCT02388776|7710578|FG000|NOT COMPLETED|Overall Study||2
6781722|NCT02383433|7710583|FG000|STARTED|Overall Study||2
6781723|NCT02383433|7710583|FG000|COMPLETED|Overall Study||0
6781724|NCT02383433|7710583|FG000|NOT COMPLETED|Overall Study||2
6781725|NCT02382588|7710589|FG000|STARTED|Overall Study||4
6781726|NCT02382588|7710590|FG001|STARTED|Overall Study||4
6781727|NCT02382588|7710589|FG000|COMPLETED|Overall Study||4
6781728|NCT02382588|7710590|FG001|COMPLETED|Overall Study||4
6781729|NCT02382588|7710589|FG000|NOT COMPLETED|Overall Study||0
6781730|NCT02382588|7710590|FG001|NOT COMPLETED|Overall Study||0
6781731|NCT02381626|7710599|FG000|STARTED|Overall Study||17
6781732|NCT02381626|7710600|FG001|STARTED|Overall Study||16
6781733|NCT02381626|7710601|FG002|STARTED|Overall Study||6
6781734|NCT02381626|7710599|FG000|COMPLETED|Overall Study||17
6781735|NCT02381626|7710600|FG001|COMPLETED|Overall Study||16
6781736|NCT02381626|7710601|FG002|COMPLETED|Overall Study||6
6781737|NCT02381626|7710599|FG000|NOT COMPLETED|Overall Study||0
6781738|NCT02381626|7710600|FG001|NOT COMPLETED|Overall Study||0
6781739|NCT02381626|7710601|FG002|NOT COMPLETED|Overall Study||0
6781740|NCT02379390|7710611|FG000|STARTED|Overall Study||4
6781741|NCT02379390|7710612|FG001|STARTED|Overall Study||4
6781742|NCT02379390|7710611|FG000|COMPLETED|Overall Study||2
6781743|NCT02379390|7710612|FG001|COMPLETED|Overall Study||2
6781744|NCT02379390|7710611|FG000|NOT COMPLETED|Overall Study||2
6781745|NCT02379390|7710612|FG001|NOT COMPLETED|Overall Study||2
6781746|NCT02373865|7710623|FG000|STARTED|Overall Study||2
6781747|NCT02373865|7710624|FG001|STARTED|Overall Study||2
6781748|NCT02373865|7710623|FG000|COMPLETED|Overall Study||2
6781749|NCT02373865|7710624|FG001|COMPLETED|Overall Study||2
6781750|NCT02373865|7710623|FG000|NOT COMPLETED|Overall Study||0
6781751|NCT02373865|7710624|FG001|NOT COMPLETED|Overall Study||0
6781752|NCT02365688|7710630|FG000|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
6781753|NCT02365688|7710630|FG000|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
6502097|NCT01432444|7420721|FG002|STARTED|Extension Phase||192
6502098|NCT01432444|7420719|FG000|COMPLETED|Extension Phase||0
6502099|NCT01432444|7420720|FG001|COMPLETED|Extension Phase||0
6502100|NCT01432444|7420721|FG002|COMPLETED|Extension Phase||0
6502101|NCT01432444|7420719|FG000|NOT COMPLETED|Extension Phase||0
6502102|NCT01432444|7420720|FG001|NOT COMPLETED|Extension Phase||0
6502103|NCT01432444|7420721|FG002|NOT COMPLETED|Extension Phase||192
6502104|NCT01432457|7420729|FG000|STARTED|Overall Study||306
6502105|NCT01432457|7420730|FG001|STARTED|Overall Study||306
6781754|NCT02365688|7710630|FG000|NOT COMPLETED|Overall Study||0
6781755|NCT02361580|7710636|FG000|STARTED|Overall Study||6
6781756|NCT02361580|7710637|FG001|STARTED|Overall Study||3
6781757|NCT02361580|7710636|FG000|COMPLETED|Overall Study||0
6781758|NCT02361580|7710637|FG001|COMPLETED|Overall Study||0
6781759|NCT02361580|7710636|FG000|NOT COMPLETED|Overall Study||6
6781760|NCT02361580|7710637|FG001|NOT COMPLETED|Overall Study||3
6781761|NCT02369744|7710645|FG000|STARTED|Overall Study||0
6781762|NCT02369744|7710646|FG001|STARTED|Overall Study||0
6781763|NCT02369744|7710645|FG000|COMPLETED|Overall Study||0
6781764|NCT02369744|7710646|FG001|COMPLETED|Overall Study||0
6781765|NCT02369744|7710645|FG000|NOT COMPLETED|Overall Study||0
6781766|NCT02369744|7710646|FG001|NOT COMPLETED|Overall Study||0
6781767|NCT02379585|7710654|FG000|STARTED|Overall Study||3
6781768|NCT02379585|7710655|FG001|STARTED|Overall Study||5
6781769|NCT02379585|7710654|FG000|COMPLETED|Overall Study||0
6781770|NCT02379585|7710655|FG001|COMPLETED|Overall Study||0
6781771|NCT02379585|7710654|FG000|NOT COMPLETED|Overall Study||3
6781772|NCT02379585|7710655|FG001|NOT COMPLETED|Overall Study||5
6781773|NCT02370888|7710668|FG000|STARTED|Overall Study||9
6781774|NCT02370888|7710668|FG000|Proceed to Treatment|Overall Study||3
6781775|NCT02370888|7710668|FG000|COMPLETED|Overall Study||1
6781776|NCT02370888|7710668|FG000|NOT COMPLETED|Overall Study||8
6781777|NCT02367170|7710678|FG000|STARTED|Overall Study||1
6781778|NCT02367170|7710679|FG001|STARTED|Overall Study||0
6781779|NCT02367170|7710678|FG000|COMPLETED|Overall Study||1
6781780|NCT02367170|7710679|FG001|COMPLETED|Overall Study||0
6781781|NCT02367170|7710678|FG000|NOT COMPLETED|Overall Study||0
6781782|NCT02367170|7710679|FG001|NOT COMPLETED|Overall Study||0
6781783|NCT02376933|7710685|FG000|STARTED|Overall Study||10
6781784|NCT02376933|7710685|FG000|COMPLETED|Overall Study||8
6781785|NCT02376933|7710685|FG000|NOT COMPLETED|Overall Study||2
6781786|NCT02365233|7710692|FG000|STARTED|Overall Study||1
6781787|NCT02365233|7710693|FG001|STARTED|Overall Study||2
6781788|NCT02365233|7710694|FG002|STARTED|Overall Study||2
6781789|NCT02365233|7710692|FG000|COMPLETED|Overall Study||0
6781790|NCT02365233|7710693|FG001|COMPLETED|Overall Study||0
6781791|NCT02365233|7710694|FG002|COMPLETED|Overall Study||0
6781792|NCT02365233|7710692|FG000|NOT COMPLETED|Overall Study||1
6781793|NCT02365233|7710693|FG001|NOT COMPLETED|Overall Study||2
6781794|NCT02365233|7710694|FG002|NOT COMPLETED|Overall Study||2
6781795|NCT02347943|7710705|FG000|STARTED|Overall Study||140
6781796|NCT02347943|7710706|FG001|STARTED|Overall Study||67
6781797|NCT02347943|7710707|FG002|STARTED|Overall Study||45
6781798|NCT02347943|7710705|FG000|COMPLETED|Overall Study||0
6781799|NCT02347943|7710706|FG001|COMPLETED|Overall Study||0
6781800|NCT02347943|7710707|FG002|COMPLETED|Overall Study||0
6781801|NCT02347943|7710705|FG000|NOT COMPLETED|Overall Study||140
6781802|NCT02347943|7710706|FG001|NOT COMPLETED|Overall Study||67
6781803|NCT02347943|7710707|FG002|NOT COMPLETED|Overall Study||45
6781804|NCT02365207|7710715|FG000|STARTED|Overall Study||6
6781805|NCT02365207|7710715|FG000|COMPLETED|Overall Study||4
6781806|NCT02365207|7710715|FG000|NOT COMPLETED|Overall Study||2
6781807|NCT02360111|7710719|FG000|STARTED|Overall Study||3
6781808|NCT02360111|7710719|FG000|COMPLETED|Overall Study||1
6781809|NCT02360111|7710719|FG000|NOT COMPLETED|Overall Study||2
6781810|NCT02353468|7710723|FG000|STARTED|Overall Study||3
6781811|NCT02353468|7710723|FG000|COMPLETED|Overall Study||0
6781812|NCT02353468|7710723|FG000|NOT COMPLETED|Overall Study||3
6781813|NCT02360059|7710729|FG000|STARTED|Overall Study||1
6781814|NCT02360059|7710730|FG001|STARTED|Overall Study||0
6781815|NCT02360059|7710729|FG000|COMPLETED|Overall Study||1
6781816|NCT02360059|7710730|FG001|COMPLETED|Overall Study||0
6781817|NCT02360059|7710729|FG000|NOT COMPLETED|Overall Study||0
6781818|NCT02360059|7710730|FG001|NOT COMPLETED|Overall Study||0
6781819|NCT02350777|7710738|FG000|STARTED|Overall Study||2
6781820|NCT02350777|7710739|FG001|STARTED|Overall Study||2
6781821|NCT02350777|7710738|FG000|COMPLETED|Overall Study||2
6781822|NCT02350777|7710739|FG001|COMPLETED|Overall Study||2
6781823|NCT02350777|7710738|FG000|NOT COMPLETED|Overall Study||0
6781824|NCT02350777|7710739|FG001|NOT COMPLETED|Overall Study||0
6781825|NCT02345460|7710745|FG000|STARTED|Overall Study||1
6781826|NCT02345460|7710745|FG000|COMPLETED|Overall Study||1
6781827|NCT02345460|7710745|FG000|NOT COMPLETED|Overall Study||0
6781828|NCT02346877|7710751|FG000|STARTED|Overall Study||19
6781829|NCT02346877|7710752|FG001|STARTED|Overall Study||0
6502106|NCT01432457|7420731|FG002|STARTED|Overall Study||312
6781830|NCT02346877|7710751|FG000|COMPLETED|Overall Study||0
6781831|NCT02346877|7710752|FG001|COMPLETED|Overall Study||0
6781832|NCT02346877|7710751|FG000|NOT COMPLETED|Overall Study||19
6781833|NCT02346877|7710752|FG001|NOT COMPLETED|Overall Study||0
6781834|NCT02351063|7710758|FG000|STARTED|Overall Study||1
6781835|NCT02351063|7710758|FG000|COMPLETED|Overall Study|Study terminated. No study data collected.|1
6781836|NCT02351063|7710758|FG000|NOT COMPLETED|Overall Study||0
6781837|NCT02345772|7710762|FG000|STARTED|Overall Study||4
6781838|NCT02345772|7710762|FG000|COMPLETED|Overall Study||0
6781839|NCT02345772|7710762|FG000|NOT COMPLETED|Overall Study||4
6781840|NCT02340728|7710768|FG000|STARTED|Overall Study||13
6781841|NCT02340728|7710769|FG001|STARTED|Overall Study||11
6781842|NCT02340728|7710768|FG000|COMPLETED|Overall Study||13
6781843|NCT02340728|7710769|FG001|COMPLETED|Overall Study||11
6781844|NCT02340728|7710768|FG000|NOT COMPLETED|Overall Study||0
6781845|NCT02340728|7710769|FG001|NOT COMPLETED|Overall Study||0
6781846|NCT02353572|7710775|FG000|STARTED|Overall Study||3
6781847|NCT02353572|7710775|FG000|COMPLETED|Overall Study||0
6781848|NCT02353572|7710775|FG000|NOT COMPLETED|Overall Study||3
6781849|NCT02345369|7710781|FG000|STARTED|Overall Study||0
6781850|NCT02345369|7710782|FG001|STARTED|Overall Study||0
6781851|NCT02345369|7710781|FG000|COMPLETED|Overall Study||0
6781852|NCT02345369|7710782|FG001|COMPLETED|Overall Study||0
6781853|NCT02345369|7710781|FG000|NOT COMPLETED|Overall Study||0
6781854|NCT02345369|7710782|FG001|NOT COMPLETED|Overall Study||0
6781855|NCT02343263|7710791|FG000|STARTED|Overall Study|Study closed due for administrative reasons|5
6781856|NCT02343263|7710792|FG001|STARTED|Overall Study||3
6781857|NCT02343263|7710793|FG002|STARTED|Overall Study||1
6781858|NCT02343263|7710791|FG000|COMPLETED|Overall Study|Study closed due for administrative reasons|0
6781859|NCT02343263|7710792|FG001|COMPLETED|Overall Study||0
6781860|NCT02343263|7710793|FG002|COMPLETED|Overall Study||0
6781861|NCT02343263|7710791|FG000|NOT COMPLETED|Overall Study||5
6781862|NCT02343263|7710792|FG001|NOT COMPLETED|Overall Study||3
6781863|NCT02343263|7710793|FG002|NOT COMPLETED|Overall Study||1
6781864|NCT02343159|7710808|FG000|STARTED|Overall Study||27
6781865|NCT02343159|7710809|FG001|STARTED|Overall Study||27
6781866|NCT02343159|7710810|FG002|STARTED|Overall Study||30
6781867|NCT02343159|7710808|FG000|COMPLETED|Overall Study||1
6781868|NCT02343159|7710809|FG001|COMPLETED|Overall Study||1
6781869|NCT02343159|7710810|FG002|COMPLETED|Overall Study||0
6781870|NCT02343159|7710808|FG000|NOT COMPLETED|Overall Study||26
6781871|NCT02343159|7710809|FG001|NOT COMPLETED|Overall Study||26
6781872|NCT02343159|7710810|FG002|NOT COMPLETED|Overall Study||30
6781873|NCT02341495|7710819|FG000|STARTED|Overall Study||4
6781874|NCT02341495|7710819|FG000|COMPLETED|Overall Study||4
6781875|NCT02341495|7710819|FG000|NOT COMPLETED|Overall Study||0
6781876|NCT02336425|7710827|FG000|STARTED|Overall Study||2
6781877|NCT02336425|7710828|FG001|STARTED|Overall Study||2
6781878|NCT02336425|7710829|FG002|STARTED|Overall Study||3
6781879|NCT02336425|7710830|FG003|STARTED|Overall Study||3
6781880|NCT02336425|7710827|FG000|COMPLETED|Overall Study||0
6781881|NCT02336425|7710828|FG001|COMPLETED|Overall Study||0
6781882|NCT02336425|7710829|FG002|COMPLETED|Overall Study||0
6781883|NCT02336425|7710830|FG003|COMPLETED|Overall Study||0
6781884|NCT02336425|7710827|FG000|NOT COMPLETED|Overall Study||2
6781885|NCT02336425|7710828|FG001|NOT COMPLETED|Overall Study||2
6781886|NCT02336425|7710829|FG002|NOT COMPLETED|Overall Study||3
6781887|NCT02336425|7710830|FG003|NOT COMPLETED|Overall Study||3
6781888|NCT02336763|7710840|FG000|STARTED|Overall Study||2
6781889|NCT02336763|7710840|FG000|COMPLETED|Overall Study||2
6781890|NCT02336763|7710840|FG000|NOT COMPLETED|Overall Study||0
6781891|NCT02320825|7710846|FG000|STARTED|Overall Study||8
6781892|NCT02320825|7710847|FG001|STARTED|Overall Study||8
6781893|NCT02320825|7710846|FG000|COMPLETED|Overall Study||8
6781894|NCT02320825|7710847|FG001|COMPLETED|Overall Study||8
6781895|NCT02320825|7710846|FG000|NOT COMPLETED|Overall Study||0
6781896|NCT02320825|7710847|FG001|NOT COMPLETED|Overall Study||0
6781897|NCT02319005|7710855|FG000|STARTED|Overall Study||140
6781898|NCT02319005|7710856|FG001|STARTED|Overall Study||66
6781899|NCT02319005|7710855|FG000|COMPLETED|Overall Study||92
6781900|NCT02319005|7710856|FG001|COMPLETED|Overall Study||51
6781901|NCT02319005|7710855|FG000|NOT COMPLETED|Overall Study||48
6781902|NCT02319005|7710856|FG001|NOT COMPLETED|Overall Study||15
6781903|NCT02318901|7710865|FG000|STARTED|Overall Study||5
6781904|NCT02318901|7710866|FG001|STARTED|Overall Study||1
6781905|NCT02318901|7710867|FG002|STARTED|Overall Study||10
6781906|NCT02318901|7710865|FG000|COMPLETED|Overall Study||0
6781907|NCT02318901|7710866|FG001|COMPLETED|Overall Study||0
6781908|NCT02318901|7710867|FG002|COMPLETED|Overall Study||0
6781909|NCT02318901|7710865|FG000|NOT COMPLETED|Overall Study||5
6781910|NCT02318901|7710866|FG001|NOT COMPLETED|Overall Study||1
6781911|NCT02318901|7710867|FG002|NOT COMPLETED|Overall Study||10
6781912|NCT02317276|7710875|FG000|STARTED|Overall Study||11
6781913|NCT02317276|7710875|FG000|COMPLETED|Overall Study||5
6781914|NCT02317276|7710875|FG000|NOT COMPLETED|Overall Study||6
6781915|NCT02307188|7710879|FG000|STARTED|Overall Study||5
6781916|NCT02307188|7710879|FG000|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
6781917|NCT02307188|7710879|FG000|NOT COMPLETED|Overall Study||4
6781918|NCT02308475|7710883|FG000|STARTED|Overall Study||2
6781919|NCT02308475|7710883|FG000|COMPLETED|Overall Study||2
6781920|NCT02308475|7710883|FG000|NOT COMPLETED|Overall Study||0
6781921|NCT02308735|7710891|FG000|STARTED|Overall Study||2
6781922|NCT02308735|7710892|FG001|STARTED|Overall Study||0
6781923|NCT02308735|7710893|FG002|STARTED|Overall Study||0
6781924|NCT02308735|7710894|FG003|STARTED|Overall Study||2
6781925|NCT02308735|7710891|FG000|COMPLETED|Overall Study||0
6781926|NCT02308735|7710892|FG001|COMPLETED|Overall Study||0
6781927|NCT02308735|7710893|FG002|COMPLETED|Overall Study||0
6781928|NCT02308735|7710894|FG003|COMPLETED|Overall Study||0
6781929|NCT02308735|7710891|FG000|NOT COMPLETED|Overall Study||2
6781930|NCT02308735|7710892|FG001|NOT COMPLETED|Overall Study||0
6781931|NCT02308735|7710893|FG002|NOT COMPLETED|Overall Study||0
6781932|NCT02308735|7710894|FG003|NOT COMPLETED|Overall Study||2
6781933|NCT02299206|7710904|FG000|STARTED|Overall Study||4
6781934|NCT02299206|7710904|FG000|COMPLETED|Overall Study||2
6781935|NCT02299206|7710904|FG000|NOT COMPLETED|Overall Study||2
6781936|NCT02302859|7710910|FG000|STARTED|Overall Study||2
6781937|NCT02302859|7710911|FG001|STARTED|Overall Study||6
6781938|NCT02302859|7710910|FG000|COMPLETED|Overall Study||1
6781939|NCT02302859|7710911|FG001|COMPLETED|Overall Study||4
6781940|NCT02302859|7710910|FG000|NOT COMPLETED|Overall Study||1
6781941|NCT02302859|7710911|FG001|NOT COMPLETED|Overall Study||2
6781942|NCT02299934|7710917|FG000|STARTED|Overall Study||13
6781943|NCT02299934|7710917|FG000|COMPLETED|Overall Study||0
6781944|NCT02299934|7710917|FG000|NOT COMPLETED|Overall Study||13
6781945|NCT02297230|7710925|FG000|STARTED|Overall Study||11
6781946|NCT02297230|7710926|FG001|STARTED|Overall Study||11
6781947|NCT02297230|7710927|FG002|STARTED|Overall Study||11
6781948|NCT02297230|7710928|FG003|STARTED|Overall Study||11
6781949|NCT02297230|7710925|FG000|COMPLETED|Overall Study||11
6781950|NCT02297230|7710926|FG001|COMPLETED|Overall Study||11
6781951|NCT02297230|7710927|FG002|COMPLETED|Overall Study||11
6781952|NCT02297230|7710928|FG003|COMPLETED|Overall Study||11
6781953|NCT02297230|7710925|FG000|NOT COMPLETED|Overall Study||0
6781954|NCT02297230|7710926|FG001|NOT COMPLETED|Overall Study||0
6781955|NCT02297230|7710927|FG002|NOT COMPLETED|Overall Study||0
6781956|NCT02297230|7710928|FG003|NOT COMPLETED|Overall Study||0
6781957|NCT02294981|7710944|FG000|STARTED|Overall Study||4
6781958|NCT02294981|7710944|FG000|COMPLETED|Overall Study||3
6781959|NCT02294981|7710944|FG000|NOT COMPLETED|Overall Study||1
6781960|NCT02284906|7710951|FG000|STARTED|Overall Study||3
6781961|NCT02284906|7710952|FG001|STARTED|Overall Study||18
6781962|NCT02284906|7710953|FG002|STARTED|Overall Study||19
6781963|NCT02284906|7710951|FG000|COMPLETED|Overall Study||0
6781964|NCT02284906|7710952|FG001|COMPLETED|Overall Study||0
6781965|NCT02284906|7710953|FG002|COMPLETED|Overall Study||0
6781966|NCT02284906|7710951|FG000|NOT COMPLETED|Overall Study||3
6781967|NCT02284906|7710952|FG001|NOT COMPLETED|Overall Study||18
6781968|NCT02284906|7710953|FG002|NOT COMPLETED|Overall Study||19
6781969|NCT02287025|7710963|FG000|STARTED|Overall Study||12
6781970|NCT02287025|7710964|FG001|STARTED|Overall Study||11
6781971|NCT02287025|7710963|FG000|COMPLETED|Overall Study||2
6781972|NCT02287025|7710964|FG001|COMPLETED|Overall Study||2
6781973|NCT02287025|7710963|FG000|NOT COMPLETED|Overall Study||10
6781974|NCT02287025|7710964|FG001|NOT COMPLETED|Overall Study||9
6781975|NCT02282332|7710968|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
6781976|NCT02282332|7710968|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
6781977|NCT02282332|7710968|FG000|NOT COMPLETED|Overall Study||0
6781978|NCT02287636|7710972|FG000|STARTED|Overall Study||13
6781979|NCT02287636|7710972|FG000|COMPLETED|Overall Study||13
6781980|NCT02287636|7710972|FG000|NOT COMPLETED|Overall Study||0
6781981|NCT02276560|7710979|FG000|STARTED|Overall Study||1
6781982|NCT02276560|7710980|FG001|STARTED|Overall Study||0
6781983|NCT02276560|7710981|FG002|STARTED|Overall Study||0
6781984|NCT02276560|7710979|FG000|COMPLETED|Overall Study||0
6781985|NCT02276560|7710980|FG001|COMPLETED|Overall Study||0
6781986|NCT02276560|7710981|FG002|COMPLETED|Overall Study||0
6781987|NCT02276560|7710979|FG000|NOT COMPLETED|Overall Study||1
6781988|NCT02276560|7710980|FG001|NOT COMPLETED|Overall Study||0
6781989|NCT02276560|7710981|FG002|NOT COMPLETED|Overall Study||0
6781990|NCT02280252|7710989|FG000|STARTED|Overall Study||0
6781991|NCT02280252|7710989|FG000|COMPLETED|Overall Study||0
6781992|NCT02280252|7710989|FG000|NOT COMPLETED|Overall Study||0
6781993|NCT02284373|7710996|FG000|STARTED|Overall Study||5
6781994|NCT02284373|7710997|FG001|STARTED|Overall Study||5
6781995|NCT02284373|7710998|FG002|STARTED|Overall Study||29
6781996|NCT02284373|7710996|FG000|COMPLETED|Overall Study||5
6781997|NCT02284373|7710997|FG001|COMPLETED|Overall Study||2
6781998|NCT02284373|7710998|FG002|COMPLETED|Overall Study||29
6781999|NCT02284373|7710996|FG000|NOT COMPLETED|Overall Study||0
6782000|NCT02284373|7710997|FG001|NOT COMPLETED|Overall Study||3
6782001|NCT02284373|7710998|FG002|NOT COMPLETED|Overall Study||0
6782002|NCT02285270|7711006|FG000|STARTED|Overall Study||10
6782003|NCT02285270|7711006|FG000|COMPLETED|Overall Study||5
6782004|NCT02285270|7711006|FG000|NOT COMPLETED|Overall Study||5
6782005|NCT02275481|7711012|FG000|STARTED|Overall Study||32
6782006|NCT02275481|7711013|FG001|STARTED|Overall Study||34
6782007|NCT02275481|7711012|FG000|COMPLETED|Overall Study||23
6782008|NCT02275481|7711013|FG001|COMPLETED|Overall Study||31
6782009|NCT02275481|7711012|FG000|NOT COMPLETED|Overall Study||9
6782010|NCT02275481|7711013|FG001|NOT COMPLETED|Overall Study||3
6782011|NCT02266914|7711019|FG000|STARTED|Overall Study||9
6782012|NCT02266914|7711019|FG000|COMPLETED|Overall Study||0
6782013|NCT02266914|7711019|FG000|NOT COMPLETED|Overall Study||9
6782014|NCT02273752|7711023|FG000|STARTED|Overall Study||2
6782015|NCT02273752|7711023|FG000|COMPLETED|Overall Study||0
6782016|NCT02273752|7711023|FG000|NOT COMPLETED|Overall Study||2
6782017|NCT02270684|7711029|FG000|STARTED|Overall Study||1
6782018|NCT02270684|7711030|FG001|STARTED|Overall Study||3
6782019|NCT02270684|7711029|FG000|COMPLETED|Overall Study||0
6782020|NCT02270684|7711030|FG001|COMPLETED|Overall Study||0
6782021|NCT02270684|7711029|FG000|NOT COMPLETED|Overall Study||1
6782022|NCT02270684|7711030|FG001|NOT COMPLETED|Overall Study||3
6782023|NCT02262000|7711038|FG000|STARTED|Overall Study||3
6782024|NCT02262000|7711039|FG001|STARTED|Overall Study||0
6782025|NCT02262000|7711038|FG000|COMPLETED|Overall Study||3
6782026|NCT02262000|7711039|FG001|COMPLETED|Overall Study||0
6782027|NCT02262000|7711038|FG000|NOT COMPLETED|Overall Study||0
6782028|NCT02262000|7711039|FG001|NOT COMPLETED|Overall Study||0
6782029|NCT02271594|7711047|FG000|STARTED|Overall Study||19
6782030|NCT02271594|7711048|FG001|STARTED|Overall Study||12
6782031|NCT02271594|7711047|FG000|COMPLETED|Overall Study|Study closed down|0
6782032|NCT02271594|7711048|FG001|COMPLETED|Overall Study|Study closed down|0
6782033|NCT02271594|7711047|FG000|NOT COMPLETED|Overall Study||19
6782034|NCT02271594|7711048|FG001|NOT COMPLETED|Overall Study||12
6782035|NCT02263365|7711058|FG000|STARTED|Overall Study||22
6782036|NCT02263365|7711059|FG001|STARTED|Overall Study||18
6782037|NCT02263365|7711058|FG000|COMPLETED|Overall Study||0
6782038|NCT02263365|7711059|FG001|COMPLETED|Overall Study||0
6782039|NCT02263365|7711058|FG000|NOT COMPLETED|Overall Study||22
6782040|NCT02263365|7711059|FG001|NOT COMPLETED|Overall Study||18
6782041|NCT02266797|7711068|FG000|STARTED|Overall Study||1
6782042|NCT02266797|7711069|FG001|STARTED|Overall Study||3
6782043|NCT02266797|7711068|FG000|COMPLETED|Overall Study||1
6782044|NCT02266797|7711069|FG001|COMPLETED|Overall Study||2
6782045|NCT02266797|7711068|FG000|NOT COMPLETED|Overall Study||0
6782046|NCT02266797|7711069|FG001|NOT COMPLETED|Overall Study||1
6782047|NCT02249377|7711077|FG000|STARTED|Overall Study||25
6782048|NCT02249377|7711078|FG001|STARTED|Overall Study||25
6782049|NCT02249377|7711077|FG000|COMPLETED|Overall Study||0
6782050|NCT02249377|7711078|FG001|COMPLETED|Overall Study||1
6782051|NCT02249377|7711077|FG000|NOT COMPLETED|Overall Study||25
6782052|NCT02249377|7711078|FG001|NOT COMPLETED|Overall Study||24
6782053|NCT02253394|7711084|FG000|STARTED|Overall Study||0
6782054|NCT02253394|7711085|FG001|STARTED|Overall Study|Ambrisentan 5 or 10 mg QD + placebo (90 d) first, then washout (21 d), then +Spiro 50 mg QD (90 d).|2
6782055|NCT02253394|7711084|FG000|COMPLETED|Overall Study||0
6782056|NCT02253394|7711085|FG001|COMPLETED|Overall Study||2
6782057|NCT02253394|7711084|FG000|NOT COMPLETED|Overall Study||0
6782058|NCT02253394|7711085|FG001|NOT COMPLETED|Overall Study||0
6782059|NCT02241551|7711093|FG000|STARTED|Overall Study||1
6782060|NCT02241551|7711094|FG001|STARTED|Overall Study||0
6782061|NCT02241551|7711093|FG000|COMPLETED|Overall Study||0
6782062|NCT02241551|7711094|FG001|COMPLETED|Overall Study||0
6782063|NCT02241551|7711093|FG000|NOT COMPLETED|Overall Study||1
6782064|NCT02241551|7711094|FG001|NOT COMPLETED|Overall Study||0
6782065|NCT02246114|7711104|FG000|STARTED|Overall Study||1
6782066|NCT02246114|7711105|FG001|STARTED|Overall Study||0
6782067|NCT02246114|7711104|FG000|COMPLETED|Overall Study||0
6782068|NCT02246114|7711105|FG001|COMPLETED|Overall Study||0
6782069|NCT02246114|7711104|FG000|NOT COMPLETED|Overall Study||1
6782070|NCT02246114|7711105|FG001|NOT COMPLETED|Overall Study||0
6782071|NCT02232880|7711111|FG000|STARTED|Overall Study||1
6782072|NCT02232880|7711111|FG000|COMPLETED|Overall Study||0
6782073|NCT02232880|7711111|FG000|NOT COMPLETED|Overall Study||1
6782074|NCT02248740|7711117|FG000|STARTED|Overall Study||18
6782075|NCT02248740|7711118|FG001|STARTED|Overall Study||18
6782076|NCT02248740|7711117|FG000|COMPLETED|Overall Study||0
6782077|NCT02248740|7711118|FG001|COMPLETED|Overall Study||0
6782078|NCT02248740|7711117|FG000|NOT COMPLETED|Overall Study||18
6782079|NCT02248740|7711118|FG001|NOT COMPLETED|Overall Study||18
6782080|NCT02239627|7711126|FG000|STARTED|Overall Study||0
6782081|NCT02239627|7711127|FG001|STARTED|Overall Study||0
6782082|NCT02239627|7711126|FG000|COMPLETED|Overall Study||0
6782083|NCT02239627|7711127|FG001|COMPLETED|Overall Study||0
6782084|NCT02239627|7711126|FG000|NOT COMPLETED|Overall Study||0
6782085|NCT02239627|7711127|FG001|NOT COMPLETED|Overall Study||0
6782086|NCT02244944|7711133|FG000|STARTED|Overall Study||2
6782087|NCT02244944|7711133|FG000|COMPLETED|Overall Study||0
6782088|NCT02244944|7711133|FG000|NOT COMPLETED|Overall Study||2
6782089|NCT02241187|7711137|FG000|STARTED|Overall Study||2
6782090|NCT02241187|7711137|FG000|COMPLETED|Overall Study||0
6782091|NCT02241187|7711137|FG000|NOT COMPLETED|Overall Study||2
6782092|NCT02239926|7711143|FG000|STARTED|Overall Study||0
6782093|NCT02239926|7711144|FG001|STARTED|Overall Study||2
6782094|NCT02239926|7711143|FG000|COMPLETED|Overall Study||0
6782095|NCT02239926|7711144|FG001|COMPLETED|Overall Study||1
6782096|NCT02239926|7711143|FG000|NOT COMPLETED|Overall Study||0
6782097|NCT02239926|7711144|FG001|NOT COMPLETED|Overall Study||1
6782098|NCT02231892|7711153|FG000|STARTED|Overall Study||17
6782099|NCT02231892|7711154|FG001|STARTED|Overall Study||17
6782100|NCT02231892|7711155|FG002|STARTED|Overall Study||70
6782101|NCT02231892|7711153|FG000|Sham|Overall Study||8
6782102|NCT02231892|7711154|FG001|Sham|Overall Study||5
6782103|NCT02231892|7711155|FG002|Sham|Overall Study||26
6782104|NCT02231892|7711153|FG000|100% MT|Overall Study||7
6782105|NCT02231892|7711154|FG001|100% MT|Overall Study||6
6782106|NCT02231892|7711155|FG002|100% MT|Overall Study||25
6782107|NCT02231892|7711153|FG000|110% MT|Overall Study||7
6782108|NCT02231892|7711154|FG001|110% MT|Overall Study||5
6782109|NCT02231892|7711155|FG002|110% MT|Overall Study||27
6782110|NCT02231892|7711153|FG000|COMPLETED|Overall Study||6
6782111|NCT02231892|7711154|FG001|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency MRI phase, but are only counted in Hi Freq MRI.|5
6782112|NCT02231892|7711155|FG002|COMPLETED|Overall Study|3 participants completed this phase and Hi Frequency Beh phase, but are only counted in Hi Freq MRI.|25
6782113|NCT02231892|7711153|FG000|NOT COMPLETED|Overall Study||11
6782114|NCT02231892|7711154|FG001|NOT COMPLETED|Overall Study||12
6782115|NCT02231892|7711155|FG002|NOT COMPLETED|Overall Study||45
6782116|NCT02241343|7711169|FG000|STARTED|Overall Study||1
6782117|NCT02241343|7711169|FG000|COMPLETED|Overall Study||0
6782118|NCT02241343|7711169|FG000|NOT COMPLETED|Overall Study||1
6782119|NCT02242578|7711176|FG000|STARTED|Overall Study||0
6782120|NCT02242578|7711177|FG001|STARTED|Overall Study||0
6782121|NCT02242578|7711176|FG000|COMPLETED|Overall Study||0
6782122|NCT02242578|7711177|FG001|COMPLETED|Overall Study||0
6782123|NCT02242578|7711176|FG000|NOT COMPLETED|Overall Study||0
6782124|NCT02242578|7711177|FG001|NOT COMPLETED|Overall Study||0
6782125|NCT02234011|7711183|FG000|STARTED|Overall Study||0
6782126|NCT02234011|7711183|FG000|COMPLETED|Overall Study||0
6782127|NCT02234011|7711183|FG000|NOT COMPLETED|Overall Study||0
6782128|NCT02236546|7711187|FG000|STARTED|Overall Study||3
6782129|NCT02236546|7711187|FG000|COMPLETED|Overall Study||3
6782130|NCT02236546|7711187|FG000|NOT COMPLETED|Overall Study||0
6782131|NCT02234687|7711194|FG000|STARTED|Overall Study|Study Terminated. No outcome measures were analyzed|6
6782132|NCT02234687|7711195|FG001|STARTED|Overall Study||4
6782133|NCT02234687|7711196|FG002|STARTED|Overall Study||4
6782134|NCT02234687|7711194|FG000|COMPLETED|Overall Study|Study Terminated. No outcome measures were analyzed|0
6782135|NCT02234687|7711195|FG001|COMPLETED|Overall Study||0
6782136|NCT02234687|7711196|FG002|COMPLETED|Overall Study||0
6782137|NCT02234687|7711194|FG000|NOT COMPLETED|Overall Study||6
6782138|NCT02234687|7711195|FG001|NOT COMPLETED|Overall Study||4
6782139|NCT02234687|7711196|FG002|NOT COMPLETED|Overall Study||4
6782140|NCT02224599|7711204|FG000|STARTED|Overall Study||3
6782141|NCT02224599|7711204|FG000|COMPLETED|Overall Study||1
6782142|NCT02224599|7711204|FG000|NOT COMPLETED|Overall Study||2
6782143|NCT02201472|7711208|FG000|STARTED|Overall Study||2
6782144|NCT02201472|7711208|FG000|COMPLETED|Overall Study||0
6782145|NCT02201472|7711208|FG000|NOT COMPLETED|Overall Study||2
6782146|NCT02202044|7711212|FG000|STARTED|Overall Study||0
6782147|NCT02202044|7711212|FG000|COMPLETED|Overall Study||0
6782148|NCT02202044|7711212|FG000|NOT COMPLETED|Overall Study||0
6562939|NCT01803880|7485875|FG002|STARTED|Overall Study||29
6562940|NCT01803880|7485873|FG000|COMPLETED|Overall Study||13
6782149|NCT02192775|7711216|FG000|STARTED|Overall Study||2
6782150|NCT02192775|7711216|FG000|COMPLETED|Overall Study||0
6782151|NCT02192775|7711216|FG000|NOT COMPLETED|Overall Study||2
6782152|NCT02200328|7711222|FG000|STARTED|Overall Study||43
6782153|NCT02200328|7711223|FG001|STARTED|Overall Study||33
6782154|NCT02200328|7711222|FG000|COMPLETED|Overall Study||0
6782155|NCT02200328|7711223|FG001|COMPLETED|Overall Study||0
6782156|NCT02200328|7711222|FG000|NOT COMPLETED|Overall Study||43
6782157|NCT02200328|7711223|FG001|NOT COMPLETED|Overall Study||33
6782158|NCT02200042|7711231|FG000|STARTED|Overall Study||0
6782159|NCT02200042|7711232|FG001|STARTED|Overall Study||1
6782160|NCT02200042|7711231|FG000|COMPLETED|Overall Study||0
6782161|NCT02200042|7711232|FG001|COMPLETED|Overall Study||0
6782162|NCT02200042|7711231|FG000|NOT COMPLETED|Overall Study||0
6782163|NCT02200042|7711232|FG001|NOT COMPLETED|Overall Study||1
6782164|NCT02181790|7711240|FG000|STARTED|Overall Study||2
6782165|NCT02181790|7711241|FG001|STARTED|Overall Study||0
6782166|NCT02181790|7711240|FG000|COMPLETED|Overall Study||0
6782167|NCT02181790|7711241|FG001|COMPLETED|Overall Study||0
6782168|NCT02181790|7711240|FG000|NOT COMPLETED|Overall Study||2
6782169|NCT02181790|7711241|FG001|NOT COMPLETED|Overall Study||0
6782170|NCT02198833|7711251|FG000|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
6782171|NCT02198833|7711252|FG001|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
6782172|NCT02198833|7711251|FG000|COMPLETED|Overall Study||1
6782173|NCT02198833|7711252|FG001|COMPLETED|Overall Study||1
6782174|NCT02198833|7711251|FG000|NOT COMPLETED|Overall Study||0
6782175|NCT02198833|7711252|FG001|NOT COMPLETED|Overall Study||0
6782176|NCT02175628|7711260|FG000|STARTED|Overall Study||6
6782177|NCT02175628|7711261|FG001|STARTED|Overall Study||17
6782178|NCT02175628|7711260|FG000|COMPLETED|Overall Study||6
6782179|NCT02175628|7711261|FG001|COMPLETED|Overall Study||17
6782180|NCT02175628|7711260|FG000|NOT COMPLETED|Overall Study||0
6782181|NCT02175628|7711261|FG001|NOT COMPLETED|Overall Study||0
6782182|NCT02177266|7711269|FG000|STARTED|Overall Study||1
6782183|NCT02177266|7711270|FG001|STARTED|Overall Study||1
6782184|NCT02177266|7711269|FG000|COMPLETED|Overall Study||0
6782185|NCT02177266|7711270|FG001|COMPLETED|Overall Study||0
6782186|NCT02177266|7711269|FG000|NOT COMPLETED|Overall Study||1
6782187|NCT02177266|7711270|FG001|NOT COMPLETED|Overall Study||1
6782188|NCT02184520|7711278|FG000|STARTED|Overall Study||0
6782189|NCT02184520|7711279|FG001|STARTED|Overall Study||0
6562941|NCT01803880|7485874|FG001|COMPLETED|Overall Study||18
6782190|NCT02184520|7711278|FG000|COMPLETED|Overall Study||0
6782191|NCT02184520|7711279|FG001|COMPLETED|Overall Study||0
6782192|NCT02184520|7711278|FG000|NOT COMPLETED|Overall Study||0
6782193|NCT02184520|7711279|FG001|NOT COMPLETED|Overall Study||0
6782194|NCT02170298|7711287|FG000|STARTED|Overall Study||1
6782195|NCT02170298|7711288|FG001|STARTED|Overall Study||5
6280598|NCT00158197|7180559|FG002|COMPLETED|Overall Study||28
6782196|NCT02170298|7711287|FG000|COMPLETED|Overall Study||0
6782197|NCT02170298|7711288|FG001|COMPLETED|Overall Study||4
6782198|NCT02170298|7711287|FG000|NOT COMPLETED|Overall Study||1
6782199|NCT02170298|7711288|FG001|NOT COMPLETED|Overall Study||1
6782200|NCT02177773|7711294|FG000|STARTED|Overall Study||300
6782201|NCT02177773|7711294|FG000|COMPLETED|Overall Study||300
6782202|NCT02177773|7711294|FG000|NOT COMPLETED|Overall Study||0
6782203|NCT02162979|7711300|FG000|STARTED|Overall Study||0
6782204|NCT02162979|7711301|FG001|STARTED|Overall Study||0
6782205|NCT02162979|7711300|FG000|COMPLETED|Overall Study||0
6782206|NCT02162979|7711301|FG001|COMPLETED|Overall Study||0
6782207|NCT02162979|7711300|FG000|NOT COMPLETED|Overall Study||0
6782208|NCT02162979|7711301|FG001|NOT COMPLETED|Overall Study||0
6782209|NCT02169830|7711310|FG000|STARTED|Diet Intervention (4 Weeks)||0
6782210|NCT02169830|7711311|FG001|STARTED|Diet Intervention (4 Weeks)||0
6782211|NCT02169830|7711312|FG002|STARTED|Diet Intervention (4 Weeks)||33
6782212|NCT02169830|7711310|FG000|COMPLETED|Diet Intervention (4 Weeks)||0
6782213|NCT02169830|7711311|FG001|COMPLETED|Diet Intervention (4 Weeks)||0
6782214|NCT02169830|7711312|FG002|COMPLETED|Diet Intervention (4 Weeks)||32
6782215|NCT02169830|7711310|FG000|NOT COMPLETED|Diet Intervention (4 Weeks)||0
6782216|NCT02169830|7711311|FG001|NOT COMPLETED|Diet Intervention (4 Weeks)||0
6782217|NCT02169830|7711312|FG002|NOT COMPLETED|Diet Intervention (4 Weeks)||1
6782218|NCT02169830|7711310|FG000|STARTED|Second Intervention (8 Weeks)||12
6782219|NCT02169830|7711311|FG001|STARTED|Second Intervention (8 Weeks)||5
6782220|NCT02169830|7711312|FG002|STARTED|Second Intervention (8 Weeks)||0
6782221|NCT02169830|7711310|FG000|COMPLETED|Second Intervention (8 Weeks)||9
6782222|NCT02169830|7711311|FG001|COMPLETED|Second Intervention (8 Weeks)||0
6782223|NCT02169830|7711312|FG002|COMPLETED|Second Intervention (8 Weeks)||0
6782224|NCT02169830|7711310|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||3
6782225|NCT02169830|7711311|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||5
6782226|NCT02169830|7711312|FG002|NOT COMPLETED|Second Intervention (8 Weeks)||0
6782227|NCT02169830|7711310|FG000|STARTED|Third Intervention (8 Weeks)||0
6782228|NCT02169830|7711311|FG001|STARTED|Third Intervention (8 Weeks)|These four subjects were randomized to Diet first Topiramate second, and Nortriptyline third. No subjects from this group were weaned and moved to Nortriptyline.|4
6782229|NCT02169830|7711312|FG002|STARTED|Third Intervention (8 Weeks)||0
6782230|NCT02169830|7711310|FG000|COMPLETED|Third Intervention (8 Weeks)||0
6782231|NCT02169830|7711311|FG001|COMPLETED|Third Intervention (8 Weeks)||2
6782232|NCT02169830|7711312|FG002|COMPLETED|Third Intervention (8 Weeks)||0
6782233|NCT02169830|7711310|FG000|NOT COMPLETED|Third Intervention (8 Weeks)||0
6782234|NCT02169830|7711311|FG001|NOT COMPLETED|Third Intervention (8 Weeks)||2
6782235|NCT02169830|7711312|FG002|NOT COMPLETED|Third Intervention (8 Weeks)||0
6782236|NCT02163187|7711322|FG000|STARTED|Overall Study||4
6782237|NCT02163187|7711323|FG001|STARTED|Overall Study||0
6782238|NCT02163187|7711322|FG000|Treatment|Overall Study||2
6782239|NCT02163187|7711323|FG001|Treatment|Overall Study||0
6782240|NCT02163187|7711322|FG000|COMPLETED|Overall Study||2
6782241|NCT02163187|7711323|FG001|COMPLETED|Overall Study||0
6562942|NCT01803880|7485875|FG002|COMPLETED|Overall Study||14
6562943|NCT01803880|7485873|FG000|NOT COMPLETED|Overall Study||6
6562944|NCT01803880|7485874|FG001|NOT COMPLETED|Overall Study||10
6562945|NCT01803880|7485875|FG002|NOT COMPLETED|Overall Study||15
6782242|NCT02163187|7711322|FG000|NOT COMPLETED|Overall Study||2
6782243|NCT02163187|7711323|FG001|NOT COMPLETED|Overall Study||0
6782244|NCT02161016|7711329|FG000|STARTED|Overall Study||1
6782245|NCT02161016|7711329|FG000|COMPLETED|Overall Study||0
6782246|NCT02161016|7711329|FG000|NOT COMPLETED|Overall Study||1
6782247|NCT02159040|7711333|FG000|STARTED|Overall Study||1
6782248|NCT02159040|7711333|FG000|COMPLETED|Overall Study||0
6782249|NCT02159040|7711333|FG000|NOT COMPLETED|Overall Study||1
6782250|NCT02168270|7711337|FG000|STARTED|Overall Study||4
6782251|NCT02168270|7711337|FG000|COMPLETED|Overall Study||0
6782252|NCT02168270|7711337|FG000|NOT COMPLETED|Overall Study||4
6782253|NCT02157116|7711341|FG000|STARTED|Overall Study|signed consent form|13
6782254|NCT02157116|7711341|FG000|COMPLETED|Overall Study||4
6782255|NCT02157116|7711341|FG000|NOT COMPLETED|Overall Study||9
6782256|NCT02154087|7711345|FG000|STARTED|Overall Study||1
6782257|NCT02154087|7711345|FG000|COMPLETED|Overall Study||0
6782258|NCT02154087|7711345|FG000|NOT COMPLETED|Overall Study||1
6782259|NCT02152670|7711349|FG000|STARTED|Overall Study||1
6782260|NCT02152670|7711349|FG000|COMPLETED|Overall Study||1
6782261|NCT02152670|7711349|FG000|NOT COMPLETED|Overall Study||0
6782262|NCT02152566|7711353|FG000|STARTED|Overall Study||6
6782263|NCT02152566|7711353|FG000|COMPLETED|Overall Study||3
6782264|NCT02152566|7711353|FG000|NOT COMPLETED|Overall Study||3
6782265|NCT02137096|7711357|FG000|STARTED|Overall Study||1
6782266|NCT02137096|7711357|FG000|COMPLETED|Overall Study||1
6782267|NCT02137096|7711357|FG000|NOT COMPLETED|Overall Study||0
6782268|NCT02147834|7711363|FG000|STARTED|Overall Study||3
6782269|NCT02147834|7711364|FG001|STARTED|Overall Study||2
6782270|NCT02147834|7711363|FG000|COMPLETED|Overall Study||3
6782271|NCT02147834|7711364|FG001|COMPLETED|Overall Study||2
6782272|NCT02147834|7711363|FG000|NOT COMPLETED|Overall Study||0
6782273|NCT02147834|7711364|FG001|NOT COMPLETED|Overall Study||0
6782274|NCT02145390|7711370|FG000|STARTED|Overall Study||1
6782275|NCT02145390|7711370|FG000|COMPLETED|Overall Study||0
6782276|NCT02145390|7711370|FG000|NOT COMPLETED|Overall Study||1
6782277|NCT02132884|7711376|FG000|STARTED|Overall Study||0
6782278|NCT02132884|7711377|FG001|STARTED|Overall Study||0
6782279|NCT02132884|7711376|FG000|COMPLETED|Overall Study||0
6782280|NCT02132884|7711377|FG001|COMPLETED|Overall Study||0
6782281|NCT02132884|7711376|FG000|NOT COMPLETED|Overall Study||0
6782282|NCT02132884|7711377|FG001|NOT COMPLETED|Overall Study||0
6782283|NCT02144155|7711383|FG000|STARTED|Overall Study||14
6782284|NCT02144155|7711383|FG000|COMPLETED|Overall Study||14
6782285|NCT02144155|7711383|FG000|NOT COMPLETED|Overall Study||0
6782286|NCT02140788|7711387|FG000|STARTED|Overall Study||0
6782287|NCT02140788|7711388|FG001|STARTED|Overall Study||0
6782288|NCT02140788|7711389|FG002|STARTED|Overall Study||0
6782289|NCT02140788|7711390|FG003|STARTED|Overall Study||0
6782290|NCT02140788|7711387|FG000|COMPLETED|Overall Study||0
6782291|NCT02140788|7711388|FG001|COMPLETED|Overall Study||0
6782292|NCT02140788|7711389|FG002|COMPLETED|Overall Study||0
6782293|NCT02140788|7711390|FG003|COMPLETED|Overall Study||0
6782294|NCT02140788|7711387|FG000|NOT COMPLETED|Overall Study||0
6782295|NCT02140788|7711388|FG001|NOT COMPLETED|Overall Study||0
6782296|NCT02140788|7711389|FG002|NOT COMPLETED|Overall Study||0
6782297|NCT02140788|7711390|FG003|NOT COMPLETED|Overall Study||0
6782298|NCT02150863|7711403|FG000|STARTED|Overall Study||0
6782299|NCT02150863|7711404|FG001|STARTED|Overall Study||1
6782300|NCT02150863|7711405|FG002|STARTED|Overall Study||0
6782301|NCT02150863|7711403|FG000|COMPLETED|Overall Study||0
6782302|NCT02150863|7711404|FG001|COMPLETED|Overall Study||0
6782303|NCT02150863|7711405|FG002|COMPLETED|Overall Study||0
6782304|NCT02150863|7711403|FG000|NOT COMPLETED|Overall Study||0
6782305|NCT02150863|7711404|FG001|NOT COMPLETED|Overall Study||1
6782306|NCT02150863|7711405|FG002|NOT COMPLETED|Overall Study||0
6782307|NCT02145169|7711413|FG000|STARTED|Overall Study||0
6782308|NCT02145169|7711413|FG000|COMPLETED|Overall Study||0
6782309|NCT02145169|7711413|FG000|NOT COMPLETED|Overall Study||0
6782310|NCT02130622|7711419|FG000|STARTED|Overall Study||2
6782311|NCT02130622|7711420|FG001|STARTED|Overall Study||1
6782312|NCT02130622|7711419|FG000|COMPLETED|Overall Study||2
6782313|NCT02130622|7711420|FG001|COMPLETED|Overall Study||1
6782314|NCT02130622|7711419|FG000|NOT COMPLETED|Overall Study||0
6782315|NCT02130622|7711420|FG001|NOT COMPLETED|Overall Study||0
6782316|NCT02133534|7711426|FG000|STARTED|Overall Study||1
6782317|NCT02133534|7711426|FG000|COMPLETED|Overall Study||1
6782318|NCT02133534|7711426|FG000|NOT COMPLETED|Overall Study||0
6782319|NCT02134912|7711432|FG000|STARTED|Overall Study||0
6782320|NCT02134912|7711433|FG001|STARTED|Overall Study||0
6782321|NCT02134912|7711432|FG000|COMPLETED|Overall Study||0
6782322|NCT02134912|7711433|FG001|COMPLETED|Overall Study||0
6782323|NCT02134912|7711432|FG000|NOT COMPLETED|Overall Study||0
6782324|NCT02134912|7711433|FG001|NOT COMPLETED|Overall Study||0
6782325|NCT02131155|7711441|FG000|STARTED|Overall Study|Started are treated patients.|25
6782326|NCT02131155|7711442|FG001|STARTED|Overall Study|Started are treated patients.|11
6782327|NCT02131155|7711441|FG000|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
6782328|NCT02131155|7711442|FG001|COMPLETED|Overall Study|Completed are patients who completed study procedures as protocol requires.|0
6782329|NCT02131155|7711441|FG000|NOT COMPLETED|Overall Study||25
6782330|NCT02131155|7711442|FG001|NOT COMPLETED|Overall Study||11
6782331|NCT02117050|7711448|FG000|STARTED|Overall Study||1
6782332|NCT02117050|7711448|FG000|COMPLETED|Overall Study||0
6782333|NCT02117050|7711448|FG000|NOT COMPLETED|Overall Study||1
6782334|NCT02110069|7711455|FG000|STARTED|Overall Study||2
6782335|NCT02110069|7711456|FG001|STARTED|Overall Study||2
6782336|NCT02110069|7711455|FG000|COMPLETED|Overall Study|subject was switched to sirolimus at maintenance course 7 for failure on Vincristine|0
6782337|NCT02110069|7711456|FG001|COMPLETED|Overall Study|1 subject was takend off protocol treatment at 10 months of maintenance for disease response.|2
6782338|NCT02110069|7711455|FG000|NOT COMPLETED|Overall Study||2
6782339|NCT02110069|7711456|FG001|NOT COMPLETED|Overall Study||0
6782340|NCT02110277|7711462|FG000|STARTED|Overall Study||2
6782341|NCT02110277|7711462|FG000|COMPLETED|Overall Study||0
6782342|NCT02110277|7711462|FG000|NOT COMPLETED|Overall Study||2
6782343|NCT02109809|7711466|FG000|STARTED|Overall Study||4
6782344|NCT02109809|7711466|FG000|COMPLETED|Overall Study||1
6782345|NCT02109809|7711466|FG000|NOT COMPLETED|Overall Study||3
6782346|NCT02105116|7711470|FG000|STARTED|Overall Study||6
6782347|NCT02105116|7711470|FG000|COMPLETED|Overall Study||0
6782348|NCT02105116|7711470|FG000|NOT COMPLETED|Overall Study||6
6782349|NCT02099318|7711476|FG000|STARTED|Overall Study||20
6782350|NCT02099318|7711477|FG001|STARTED|Overall Study||20
6782351|NCT02099318|7711476|FG000|COMPLETED|Overall Study||20
6782352|NCT02099318|7711477|FG001|COMPLETED|Overall Study||20
6782353|NCT02099318|7711476|FG000|NOT COMPLETED|Overall Study||0
6782354|NCT02099318|7711477|FG001|NOT COMPLETED|Overall Study||0
6782355|NCT02099344|7711487|FG000|STARTED|Overall Study||1
6782356|NCT02099344|7711488|FG001|STARTED|Overall Study||0
6782357|NCT02099344|7711487|FG000|COMPLETED|Overall Study||0
6782358|NCT02099344|7711488|FG001|COMPLETED|Overall Study||0
6562946|NCT01804036|7485887|FG000|STARTED|Overall Study||31
6562947|NCT01804036|7485888|FG001|STARTED|Overall Study||41
6562948|NCT01804036|7485887|FG000|COMPLETED|Overall Study||18
6562949|NCT01804036|7485888|FG001|COMPLETED|Overall Study||21
6562950|NCT01804036|7485887|FG000|NOT COMPLETED|Overall Study||13
6782359|NCT02099344|7711487|FG000|NOT COMPLETED|Overall Study||1
6782360|NCT02099344|7711488|FG001|NOT COMPLETED|Overall Study||0
6782361|NCT02094352|7711498|FG000|STARTED|Overall Study||2
6782362|NCT02094352|7711499|FG001|STARTED|Overall Study||1
6782363|NCT02094352|7711498|FG000|COMPLETED|Overall Study||2
6782364|NCT02094352|7711499|FG001|COMPLETED|Overall Study||1
6782365|NCT02094352|7711498|FG000|NOT COMPLETED|Overall Study||0
6782366|NCT02094352|7711499|FG001|NOT COMPLETED|Overall Study||0
6782367|NCT02096042|7711505|FG000|STARTED|Overall Study||1
6782368|NCT02096042|7711506|FG001|STARTED|Overall Study||0
6782369|NCT02096042|7711507|FG002|STARTED|Overall Study||0
6782370|NCT02096042|7711505|FG000|COMPLETED|Overall Study||0
6782371|NCT02096042|7711506|FG001|COMPLETED|Overall Study||0
6782372|NCT02096042|7711507|FG002|COMPLETED|Overall Study||0
6782373|NCT02096042|7711505|FG000|NOT COMPLETED|Overall Study||1
6782374|NCT02096042|7711506|FG001|NOT COMPLETED|Overall Study||0
6782375|NCT02096042|7711507|FG002|NOT COMPLETED|Overall Study||0
6782376|NCT02088957|7711514|FG000|STARTED|Overall Study||1
6782377|NCT02088957|7711515|FG001|STARTED|Overall Study||0
6782378|NCT02088957|7711514|FG000|COMPLETED|Overall Study||0
6782379|NCT02088957|7711515|FG001|COMPLETED|Overall Study||0
6782380|NCT02088957|7711514|FG000|NOT COMPLETED|Overall Study||1
6782381|NCT02088957|7711515|FG001|NOT COMPLETED|Overall Study||0
6782382|NCT02093689|7711524|FG000|STARTED|Overall Study||18
6782383|NCT02093689|7711525|FG001|STARTED|Overall Study||0
6782384|NCT02093689|7711526|FG002|STARTED|Overall Study||0
6782385|NCT02093689|7711524|FG000|COMPLETED|Overall Study||14
6782386|NCT02093689|7711525|FG001|COMPLETED|Overall Study||0
6782387|NCT02093689|7711526|FG002|COMPLETED|Overall Study||0
6782388|NCT02093689|7711524|FG000|NOT COMPLETED|Overall Study||4
6782389|NCT02093689|7711525|FG001|NOT COMPLETED|Overall Study||0
6782390|NCT02093689|7711526|FG002|NOT COMPLETED|Overall Study||0
6782391|NCT02091752|7711532|FG000|STARTED|Overall Study||3
6782392|NCT02091752|7711532|FG000|COMPLETED|Overall Study||0
6782393|NCT02091752|7711532|FG000|NOT COMPLETED|Overall Study||3
6782394|NCT02068547|7711538|FG000|STARTED|Overall Study||4
6782395|NCT02068547|7711539|FG001|STARTED|Overall Study||4
6782396|NCT02068547|7711538|FG000|COMPLETED|Overall Study||0
6782397|NCT02068547|7711539|FG001|COMPLETED|Overall Study||1
6782398|NCT02068547|7711538|FG000|NOT COMPLETED|Overall Study||4
6782399|NCT02068547|7711539|FG001|NOT COMPLETED|Overall Study||3
6782400|NCT02075411|7711549|FG000|STARTED|Overall Study||0
6782401|NCT02075411|7711550|FG001|STARTED|Overall Study||0
6782402|NCT02075411|7711551|FG002|STARTED|Overall Study||0
6782403|NCT02075411|7711552|FG003|STARTED|Overall Study||1
6782404|NCT02075411|7711549|FG000|COMPLETED|Overall Study||0
6782405|NCT02075411|7711550|FG001|COMPLETED|Overall Study||0
6782406|NCT02075411|7711551|FG002|COMPLETED|Overall Study||0
6782407|NCT02075411|7711552|FG003|COMPLETED|Overall Study||1
6782408|NCT02075411|7711549|FG000|NOT COMPLETED|Overall Study||0
6782409|NCT02075411|7711550|FG001|NOT COMPLETED|Overall Study||0
6782410|NCT02075411|7711551|FG002|NOT COMPLETED|Overall Study||0
6782411|NCT02075411|7711552|FG003|NOT COMPLETED|Overall Study||0
6782412|NCT02074904|7711564|FG000|STARTED|Overall Study||1
6782413|NCT02074904|7711565|FG001|STARTED|Overall Study||0
6782414|NCT02074904|7711564|FG000|COMPLETED|Overall Study||1
6782415|NCT02074904|7711565|FG001|COMPLETED|Overall Study||0
6782416|NCT02074904|7711564|FG000|NOT COMPLETED|Overall Study||0
6782417|NCT02074904|7711565|FG001|NOT COMPLETED|Overall Study||0
6782418|NCT02084147|7711571|FG000|STARTED|Overall Study||72
6782419|NCT02084147|7711571|FG000|COMPLETED|Overall Study||72
6782420|NCT02084147|7711571|FG000|NOT COMPLETED|Overall Study||0
6562951|NCT01804036|7485888|FG001|NOT COMPLETED|Overall Study||20
6562952|NCT01804049|7485897|FG000|STARTED|Overall Study||43
6562953|NCT01804049|7485898|FG001|STARTED|Overall Study||77
6782421|NCT02081183|7711577|FG000|STARTED|Overall Study||5
6782422|NCT02081183|7711578|FG001|STARTED|Overall Study||6
6782423|NCT02081183|7711577|FG000|COMPLETED|Overall Study||1
6782424|NCT02081183|7711578|FG001|COMPLETED|Overall Study||2
6782425|NCT02081183|7711577|FG000|NOT COMPLETED|Overall Study||4
6782426|NCT02081183|7711578|FG001|NOT COMPLETED|Overall Study||4
6782427|NCT02067611|7711584|FG000|STARTED|Overall Study||72
6782428|NCT02067611|7711585|FG001|STARTED|Overall Study||72
6782429|NCT02067611|7711586|FG002|STARTED|Overall Study||72
6782430|NCT02067611|7711584|FG000|COMPLETED|Overall Study||66
6782431|NCT02067611|7711585|FG001|COMPLETED|Overall Study||66
6782432|NCT02067611|7711586|FG002|COMPLETED|Overall Study||68
6782433|NCT02067611|7711584|FG000|NOT COMPLETED|Overall Study||6
6782434|NCT02067611|7711585|FG001|NOT COMPLETED|Overall Study||6
6782435|NCT02067611|7711586|FG002|NOT COMPLETED|Overall Study||4
6782436|NCT02067104|7711598|FG000|STARTED|Overall Study||4
6782437|NCT02067104|7711599|FG001|STARTED|Overall Study||5
6782438|NCT02067104|7711598|FG000|COMPLETED|Overall Study||0
6782439|NCT02067104|7711599|FG001|COMPLETED|Overall Study||0
6782440|NCT02067104|7711598|FG000|NOT COMPLETED|Overall Study||4
6782441|NCT02067104|7711599|FG001|NOT COMPLETED|Overall Study||5
6782442|NCT02075021|7711605|FG000|STARTED|Overall Study||3
6782443|NCT02075021|7711605|FG000|COMPLETED|Overall Study||3
6782444|NCT02075021|7711605|FG000|NOT COMPLETED|Overall Study||0
6782445|NCT02057874|7711609|FG000|STARTED|Overall Study||2
6782446|NCT02057874|7711609|FG000|COMPLETED|Overall Study||1
6782447|NCT02057874|7711609|FG000|NOT COMPLETED|Overall Study||1
6782448|NCT02057237|7711614|FG000|STARTED|Overall Study||1
6782449|NCT02057237|7711614|FG000|COMPLETED|Overall Study||1
6782450|NCT02057237|7711614|FG000|NOT COMPLETED|Overall Study||0
6782451|NCT02047747|7711619|FG000|STARTED|Overall Study||4
6782452|NCT02047747|7711619|FG000|COMPLETED|Overall Study||1
6782453|NCT02047747|7711619|FG000|NOT COMPLETED|Overall Study||3
6782454|NCT02058537|7711623|FG000|STARTED|Overall Study||3
6782455|NCT02058537|7711623|FG000|COMPLETED|Overall Study||2
6782456|NCT02058537|7711623|FG000|NOT COMPLETED|Overall Study||1
6782457|NCT02057276|7711629|FG000|STARTED|Overall Study||0
6782458|NCT02057276|7711630|FG001|STARTED|Overall Study||0
6782459|NCT02057276|7711629|FG000|COMPLETED|Overall Study||0
6782460|NCT02057276|7711630|FG001|COMPLETED|Overall Study||0
6782461|NCT02057276|7711629|FG000|NOT COMPLETED|Overall Study||0
6782462|NCT02057276|7711630|FG001|NOT COMPLETED|Overall Study||0
6782463|NCT02038153|7711636|FG000|STARTED|Overall Study||3
6782464|NCT02038153|7711636|FG000|COMPLETED|Overall Study||2
6782465|NCT02038153|7711636|FG000|NOT COMPLETED|Overall Study||1
6782466|NCT02054910|7711642|FG000|STARTED|Overall Study||4
6782467|NCT02054910|7711643|FG001|STARTED|Overall Study||1
6782468|NCT02054910|7711642|FG000|COMPLETED|Overall Study||0
6782469|NCT02054910|7711643|FG001|COMPLETED|Overall Study||0
6782470|NCT02054910|7711642|FG000|NOT COMPLETED|Overall Study||4
6782471|NCT02054910|7711643|FG001|NOT COMPLETED|Overall Study||1
6782472|NCT02044302|7711653|FG000|STARTED|Overall Study||2
6782473|NCT02044302|7711654|FG001|STARTED|Overall Study||0
6782474|NCT02044302|7711653|FG000|COMPLETED|Overall Study||0
6782475|NCT02044302|7711654|FG001|COMPLETED|Overall Study||0
6782476|NCT02044302|7711653|FG000|NOT COMPLETED|Overall Study||2
6782477|NCT02044302|7711654|FG001|NOT COMPLETED|Overall Study||0
6782478|NCT02046226|7711658|FG000|STARTED|Overall Study||7
6782479|NCT02046226|7711658|FG000|COMPLETED|Overall Study||0
6782480|NCT02046226|7711658|FG000|NOT COMPLETED|Overall Study||7
6782481|NCT02044848|7711665|FG000|STARTED|Overall Study||2
6782482|NCT02044848|7711666|FG001|STARTED|Overall Study||3
6782483|NCT02044848|7711665|FG000|COMPLETED|Overall Study||0
6782484|NCT02044848|7711666|FG001|COMPLETED|Overall Study||0
6782485|NCT02044848|7711665|FG000|NOT COMPLETED|Overall Study||2
6782486|NCT02044848|7711666|FG001|NOT COMPLETED|Overall Study||3
6782487|NCT02042950|7711672|FG000|STARTED|Overall Study||4
6782488|NCT02042950|7711672|FG000|COMPLETED|Overall Study||0
6782489|NCT02042950|7711672|FG000|NOT COMPLETED|Overall Study||4
6782490|NCT02048904|7711676|FG000|STARTED|Overall Study||142
6782491|NCT02048904|7711676|FG000|COMPLETED|Overall Study||65
6782492|NCT02048904|7711676|FG000|NOT COMPLETED|Overall Study||77
6782493|NCT02044822|7711680|FG000|STARTED|Overall Study||102
6782494|NCT02044822|7711680|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
6782495|NCT02044822|7711680|FG000|NOT COMPLETED|Overall Study||93
6782496|NCT02042924|7711684|FG000|STARTED|Overall Study||2
6782497|NCT02042924|7711684|FG000|COMPLETED|Overall Study||1
6782498|NCT02042924|7711684|FG000|NOT COMPLETED|Overall Study||1
6782499|NCT02043860|7711688|FG000|STARTED|Overall Study||2
6782500|NCT02043860|7711688|FG000|COMPLETED|Overall Study||2
6782501|NCT02043860|7711688|FG000|NOT COMPLETED|Overall Study||0
6782502|NCT02017522|7711692|FG000|STARTED|Overall Study||3
6782503|NCT02017522|7711692|FG000|Scan|Overall Study||2
6782504|NCT02017522|7711692|FG000|COMPLETED|Overall Study||2
6782505|NCT02017522|7711692|FG000|NOT COMPLETED|Overall Study||1
6782506|NCT02030015|7711697|FG000|STARTED|Overall Study||16
6782507|NCT02030015|7711697|FG000|COMPLETED|Overall Study||0
6782508|NCT02030015|7711697|FG000|NOT COMPLETED|Overall Study||16
6782509|NCT02015663|7711703|FG000|STARTED|Overall Study||16
6782510|NCT02015663|7711704|FG001|STARTED|Overall Study||16
6502107|NCT01432457|7420729|FG000|COMPLETED|Overall Study||269
6502108|NCT01432457|7420730|FG001|COMPLETED|Overall Study||258
6782511|NCT02015663|7711703|FG000|COMPLETED|Overall Study||1
6782512|NCT02015663|7711704|FG001|COMPLETED|Overall Study||4
6782513|NCT02015663|7711703|FG000|NOT COMPLETED|Overall Study||15
6782514|NCT02015663|7711704|FG001|NOT COMPLETED|Overall Study||12
6782515|NCT02029846|7711713|FG000|STARTED|Overall Study||1
6782516|NCT02029846|7711714|FG001|STARTED|Overall Study||1
6782517|NCT02029846|7711713|FG000|COMPLETED|Overall Study||0
6782518|NCT02029846|7711714|FG001|COMPLETED|Overall Study||0
6782519|NCT02029846|7711713|FG000|NOT COMPLETED|Overall Study||1
6782520|NCT02029846|7711714|FG001|NOT COMPLETED|Overall Study||1
6782521|NCT02027272|7711722|FG000|STARTED|Overall Study||0
6782522|NCT02027272|7711723|FG001|STARTED|Overall Study||1
6782523|NCT02027272|7711722|FG000|COMPLETED|Overall Study||0
6782524|NCT02027272|7711723|FG001|COMPLETED|Overall Study||0
6782525|NCT02027272|7711722|FG000|NOT COMPLETED|Overall Study||0
6782526|NCT02027272|7711723|FG001|NOT COMPLETED|Overall Study||1
6782527|NCT02012608|7711731|FG000|STARTED|Overall Study||7
6782528|NCT02012608|7711732|FG001|STARTED|Overall Study||7
6782529|NCT02012608|7711731|FG000|COMPLETED|Overall Study||4
6782530|NCT02012608|7711732|FG001|COMPLETED|Overall Study||7
6782531|NCT02012608|7711731|FG000|NOT COMPLETED|Overall Study||3
6782532|NCT02012608|7711732|FG001|NOT COMPLETED|Overall Study||0
6782533|NCT02017379|7711741|FG000|STARTED|Overall Study||0
6782534|NCT02017379|7711742|FG001|STARTED|Overall Study||0
6782535|NCT02017379|7711743|FG002|STARTED|Overall Study||0
6782536|NCT02017379|7711741|FG000|COMPLETED|Overall Study||0
6782537|NCT02017379|7711742|FG001|COMPLETED|Overall Study||0
6782538|NCT02017379|7711743|FG002|COMPLETED|Overall Study||0
6782539|NCT02017379|7711741|FG000|NOT COMPLETED|Overall Study||0
6782540|NCT02017379|7711742|FG001|NOT COMPLETED|Overall Study||0
6782541|NCT02017379|7711743|FG002|NOT COMPLETED|Overall Study||0
6782542|NCT02011542|7711751|FG000|STARTED|Overall Study||30
6782543|NCT02011542|7711751|FG000|COMPLETED|Overall Study||29
6377979|NCT00766090|7288651|FG002|STARTED|Washout Period 1 (14 Days)||23
6377980|NCT00766090|7288652|FG003|STARTED|Washout Period 1 (14 Days)||25
6377981|NCT00766090|7288653|FG004|STARTED|Washout Period 1 (14 Days)||23
6377982|NCT00766090|7288654|FG005|STARTED|Washout Period 1 (14 Days)||23
6377983|NCT00766090|7288655|FG006|STARTED|Washout Period 1 (14 Days)||6
6377984|NCT00766090|7288656|FG007|STARTED|Washout Period 1 (14 Days)||8
6377985|NCT00766090|7288657|FG008|STARTED|Washout Period 1 (14 Days)||6
6377986|NCT00766090|7288658|FG009|STARTED|Washout Period 1 (14 Days)||8
6377987|NCT00766090|7288659|FG010|STARTED|Washout Period 1 (14 Days)||7
6377988|NCT00766090|7288660|FG011|STARTED|Washout Period 1 (14 Days)||7
6377989|NCT00766090|7288649|FG000|COMPLETED|Washout Period 1 (14 Days)||22
6377990|NCT00766090|7288650|FG001|COMPLETED|Washout Period 1 (14 Days)||27
6377991|NCT00766090|7288651|FG002|COMPLETED|Washout Period 1 (14 Days)||22
6377992|NCT00766090|7288652|FG003|COMPLETED|Washout Period 1 (14 Days)||25
6377993|NCT00766090|7288653|FG004|COMPLETED|Washout Period 1 (14 Days)||23
6377994|NCT00766090|7288654|FG005|COMPLETED|Washout Period 1 (14 Days)||23
6377995|NCT00766090|7288655|FG006|COMPLETED|Washout Period 1 (14 Days)||6
6377996|NCT00766090|7288656|FG007|COMPLETED|Washout Period 1 (14 Days)||8
6377997|NCT00766090|7288657|FG008|COMPLETED|Washout Period 1 (14 Days)||6
6377998|NCT00766090|7288658|FG009|COMPLETED|Washout Period 1 (14 Days)||8
6377999|NCT00766090|7288659|FG010|COMPLETED|Washout Period 1 (14 Days)||7
6378000|NCT00766090|7288660|FG011|COMPLETED|Washout Period 1 (14 Days)||7
6378001|NCT00766090|7288649|FG000|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378002|NCT00766090|7288650|FG001|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378003|NCT00766090|7288651|FG002|NOT COMPLETED|Washout Period 1 (14 Days)||1
6378004|NCT00766090|7288652|FG003|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378005|NCT00766090|7288653|FG004|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378006|NCT00766090|7288654|FG005|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378007|NCT00766090|7288655|FG006|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378008|NCT00766090|7288656|FG007|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378009|NCT00766090|7288657|FG008|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378010|NCT00766090|7288658|FG009|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378011|NCT00766090|7288659|FG010|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378012|NCT00766090|7288660|FG011|NOT COMPLETED|Washout Period 1 (14 Days)||0
6378013|NCT00766090|7288649|FG000|STARTED|Treatment Period 2 (28 Days)||22
6378014|NCT00766090|7288650|FG001|STARTED|Treatment Period 2 (28 Days)||27
6378015|NCT00766090|7288651|FG002|STARTED|Treatment Period 2 (28 Days)||22
6378016|NCT00766090|7288652|FG003|STARTED|Treatment Period 2 (28 Days)||25
6378017|NCT00766090|7288653|FG004|STARTED|Treatment Period 2 (28 Days)||23
6378018|NCT00766090|7288654|FG005|STARTED|Treatment Period 2 (28 Days)||23
6378019|NCT00766090|7288655|FG006|STARTED|Treatment Period 2 (28 Days)||6
6378020|NCT00766090|7288656|FG007|STARTED|Treatment Period 2 (28 Days)||8
6378021|NCT00766090|7288657|FG008|STARTED|Treatment Period 2 (28 Days)||6
6378022|NCT00766090|7288658|FG009|STARTED|Treatment Period 2 (28 Days)||8
6378023|NCT00766090|7288659|FG010|STARTED|Treatment Period 2 (28 Days)||7
6378024|NCT00766090|7288660|FG011|STARTED|Treatment Period 2 (28 Days)||7
6378025|NCT00766090|7288649|FG000|COMPLETED|Treatment Period 2 (28 Days)||22
6378026|NCT00766090|7288650|FG001|COMPLETED|Treatment Period 2 (28 Days)||27
6378027|NCT00766090|7288651|FG002|COMPLETED|Treatment Period 2 (28 Days)||21
6378028|NCT00766090|7288652|FG003|COMPLETED|Treatment Period 2 (28 Days)||25
6378029|NCT00766090|7288653|FG004|COMPLETED|Treatment Period 2 (28 Days)||21
6378030|NCT00766090|7288654|FG005|COMPLETED|Treatment Period 2 (28 Days)||23
6378031|NCT00766090|7288655|FG006|COMPLETED|Treatment Period 2 (28 Days)||6
6378032|NCT00766090|7288656|FG007|COMPLETED|Treatment Period 2 (28 Days)||8
6378033|NCT00766090|7288657|FG008|COMPLETED|Treatment Period 2 (28 Days)||6
6378034|NCT00766090|7288658|FG009|COMPLETED|Treatment Period 2 (28 Days)||8
6378035|NCT00766090|7288659|FG010|COMPLETED|Treatment Period 2 (28 Days)||7
6378036|NCT00766090|7288660|FG011|COMPLETED|Treatment Period 2 (28 Days)||7
6378037|NCT00766090|7288649|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378038|NCT00766090|7288650|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378039|NCT00766090|7288651|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||1
6502109|NCT01432457|7420731|FG002|COMPLETED|Overall Study||253
6502110|NCT01432457|7420729|FG000|NOT COMPLETED|Overall Study||37
6502111|NCT01432457|7420730|FG001|NOT COMPLETED|Overall Study||48
6502112|NCT01432457|7420731|FG002|NOT COMPLETED|Overall Study||59
6502113|NCT01432535|7420742|FG000|STARTED|Overall Study||12
6562954|NCT01804049|7485897|FG000|COMPLETED|Overall Study||32
6782544|NCT02011542|7711751|FG000|NOT COMPLETED|Overall Study||1
6782545|NCT02008370|7711755|FG000|STARTED|Overall Study||7
6782546|NCT02008370|7711755|FG000|COMPLETED|Overall Study||0
6782547|NCT02008370|7711755|FG000|NOT COMPLETED|Overall Study||7
6782548|NCT02009982|7711761|FG000|STARTED|Overall Study||1
6782549|NCT02009982|7711762|FG001|STARTED|Overall Study||2
6782550|NCT02009982|7711761|FG000|COMPLETED|Overall Study||1
6782551|NCT02009982|7711762|FG001|COMPLETED|Overall Study||2
6782552|NCT02009982|7711761|FG000|NOT COMPLETED|Overall Study||0
6782553|NCT02009982|7711762|FG001|NOT COMPLETED|Overall Study||0
6782554|NCT02013414|7711768|FG000|STARTED|Overall Study||9
6782555|NCT02013414|7711768|FG000|COMPLETED|Overall Study||9
6782556|NCT02013414|7711768|FG000|NOT COMPLETED|Overall Study||0
6782557|NCT02005445|7711776|FG000|STARTED|Overall Study||2
6782558|NCT02005445|7711777|FG001|STARTED|Overall Study||2
6782559|NCT02005445|7711776|FG000|COMPLETED|Overall Study||2
6782560|NCT02005445|7711777|FG001|COMPLETED|Overall Study||1
6782561|NCT02005445|7711776|FG000|NOT COMPLETED|Overall Study||0
6782562|NCT02005445|7711777|FG001|NOT COMPLETED|Overall Study||1
6782563|NCT02020837|7711783|FG000|STARTED|Overall Study||2
6782564|NCT02020837|7711783|FG000|COMPLETED|Overall Study||2
6782565|NCT02020837|7711783|FG000|NOT COMPLETED|Overall Study||0
6782566|NCT02015910|7711789|FG000|STARTED|Overall Study||0
6378040|NCT00766090|7288652|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378041|NCT00766090|7288653|FG004|NOT COMPLETED|Treatment Period 2 (28 Days)||2
6378042|NCT00766090|7288654|FG005|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378043|NCT00766090|7288655|FG006|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378044|NCT00766090|7288656|FG007|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378045|NCT00766090|7288657|FG008|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378046|NCT00766090|7288658|FG009|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378047|NCT00766090|7288659|FG010|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6562955|NCT01804049|7485898|FG001|COMPLETED|Overall Study||45
6562956|NCT01804049|7485897|FG000|NOT COMPLETED|Overall Study||11
6562957|NCT01804049|7485898|FG001|NOT COMPLETED|Overall Study||32
6562958|NCT01804062|7485906|FG000|STARTED|Overall Study||30
6562959|NCT01804062|7485906|FG000|COMPLETED|Overall Study||30
6562960|NCT01804062|7485906|FG000|NOT COMPLETED|Overall Study||0
6562961|NCT01804075|7485912|FG000|STARTED|Overall Study||15
6378048|NCT00766090|7288660|FG011|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6378049|NCT00766090|7288649|FG000|STARTED|Washout Period 2 (14 Days)||22
6378050|NCT00766090|7288650|FG001|STARTED|Washout Period 2 (14 Days)||27
6378051|NCT00766090|7288651|FG002|STARTED|Washout Period 2 (14 Days)||21
6378052|NCT00766090|7288652|FG003|STARTED|Washout Period 2 (14 Days)||25
6378053|NCT00766090|7288653|FG004|STARTED|Washout Period 2 (14 Days)||21
6378054|NCT00766090|7288654|FG005|STARTED|Washout Period 2 (14 Days)||23
6378055|NCT00766090|7288655|FG006|STARTED|Washout Period 2 (14 Days)||6
6378056|NCT00766090|7288656|FG007|STARTED|Washout Period 2 (14 Days)||8
6378057|NCT00766090|7288657|FG008|STARTED|Washout Period 2 (14 Days)||6
6378058|NCT00766090|7288658|FG009|STARTED|Washout Period 2 (14 Days)||8
6378059|NCT00766090|7288659|FG010|STARTED|Washout Period 2 (14 Days)||7
6378060|NCT00766090|7288660|FG011|STARTED|Washout Period 2 (14 Days)||7
6378061|NCT00766090|7288649|FG000|COMPLETED|Washout Period 2 (14 Days)||22
6378062|NCT00766090|7288650|FG001|COMPLETED|Washout Period 2 (14 Days)||27
6378063|NCT00766090|7288651|FG002|COMPLETED|Washout Period 2 (14 Days)||20
6378064|NCT00766090|7288652|FG003|COMPLETED|Washout Period 2 (14 Days)||25
6378065|NCT00766090|7288653|FG004|COMPLETED|Washout Period 2 (14 Days)||21
6378066|NCT00766090|7288654|FG005|COMPLETED|Washout Period 2 (14 Days)||23
6378067|NCT00766090|7288655|FG006|COMPLETED|Washout Period 2 (14 Days)||6
6378068|NCT00766090|7288656|FG007|COMPLETED|Washout Period 2 (14 Days)||8
6378069|NCT00766090|7288657|FG008|COMPLETED|Washout Period 2 (14 Days)||6
6378070|NCT00766090|7288658|FG009|COMPLETED|Washout Period 2 (14 Days)||8
6378071|NCT00766090|7288659|FG010|COMPLETED|Washout Period 2 (14 Days)||7
6378072|NCT00766090|7288660|FG011|COMPLETED|Washout Period 2 (14 Days)||7
6378073|NCT00766090|7288649|FG000|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378074|NCT00766090|7288650|FG001|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378075|NCT00766090|7288651|FG002|NOT COMPLETED|Washout Period 2 (14 Days)||1
6378076|NCT00766090|7288652|FG003|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378077|NCT00766090|7288653|FG004|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378078|NCT00766090|7288654|FG005|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378079|NCT00766090|7288655|FG006|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378080|NCT00766090|7288656|FG007|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378081|NCT00766090|7288657|FG008|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378082|NCT00766090|7288658|FG009|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378083|NCT00766090|7288659|FG010|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378084|NCT00766090|7288660|FG011|NOT COMPLETED|Washout Period 2 (14 Days)||0
6378085|NCT00766090|7288649|FG000|STARTED|Treatment Period 3 (28 Days)||22
6378086|NCT00766090|7288650|FG001|STARTED|Treatment Period 3 (28 Days)||27
6378087|NCT00766090|7288651|FG002|STARTED|Treatment Period 3 (28 Days)||20
6378088|NCT00766090|7288652|FG003|STARTED|Treatment Period 3 (28 Days)||25
6378089|NCT00766090|7288653|FG004|STARTED|Treatment Period 3 (28 Days)||21
6378090|NCT00766090|7288654|FG005|STARTED|Treatment Period 3 (28 Days)||23
6378091|NCT00766090|7288655|FG006|STARTED|Treatment Period 3 (28 Days)||6
6378092|NCT00766090|7288656|FG007|STARTED|Treatment Period 3 (28 Days)||8
6562962|NCT01804075|7485913|FG001|STARTED|Overall Study||16
6378093|NCT00766090|7288657|FG008|STARTED|Treatment Period 3 (28 Days)||6
6782567|NCT02015910|7711790|FG001|STARTED|Overall Study||1
6782568|NCT02015910|7711789|FG000|COMPLETED|Overall Study||0
6782569|NCT02015910|7711790|FG001|COMPLETED|Overall Study||1
6782570|NCT02015910|7711789|FG000|NOT COMPLETED|Overall Study||0
6782571|NCT02015910|7711790|FG001|NOT COMPLETED|Overall Study||0
6782572|NCT02006927|7711796|FG000|STARTED|Overall Study||3
6782573|NCT02006927|7711796|FG000|COMPLETED|Overall Study||0
6782574|NCT02006927|7711796|FG000|NOT COMPLETED|Overall Study||3
6782575|NCT01996982|7711800|FG000|STARTED|Overall Study||7
6782576|NCT01996982|7711800|FG000|COMPLETED|Overall Study||0
6782577|NCT01996982|7711800|FG000|NOT COMPLETED|Overall Study||7
6782578|NCT02006407|7711804|FG000|STARTED|Overall Study||5
6782579|NCT02006407|7711804|FG000|COMPLETED|Overall Study||5
6782580|NCT02006407|7711804|FG000|NOT COMPLETED|Overall Study||0
6782581|NCT01986751|7711810|FG000|STARTED|Overall Study||10
6782582|NCT01986751|7711811|FG001|STARTED|Overall Study||4
6782583|NCT01986751|7711810|FG000|COMPLETED|Overall Study||0
6782584|NCT01986751|7711811|FG001|COMPLETED|Overall Study||2
6782585|NCT01986751|7711810|FG000|NOT COMPLETED|Overall Study||10
6782586|NCT01986751|7711811|FG001|NOT COMPLETED|Overall Study||2
6782587|NCT01996410|7711829|FG000|STARTED|Overall Study||3
6782588|NCT01996410|7711830|FG001|STARTED|Overall Study||3
6782589|NCT01996410|7711831|FG002|STARTED|Overall Study||0
6782590|NCT01996410|7711832|FG003|STARTED|Overall Study||0
6782591|NCT01996410|7711833|FG004|STARTED|Overall Study||2
6782592|NCT01996410|7711834|FG005|STARTED|Overall Study||2
6782593|NCT01996410|7711835|FG006|STARTED|Overall Study||0
6782594|NCT01996410|7711836|FG007|STARTED|Overall Study||0
6782595|NCT01996410|7711829|FG000|COMPLETED|Overall Study||3
6782596|NCT01996410|7711830|FG001|COMPLETED|Overall Study||3
6782597|NCT01996410|7711831|FG002|COMPLETED|Overall Study||0
6782598|NCT01996410|7711832|FG003|COMPLETED|Overall Study||0
6782599|NCT01996410|7711833|FG004|COMPLETED|Overall Study||2
6782600|NCT01996410|7711834|FG005|COMPLETED|Overall Study||2
6782601|NCT01996410|7711835|FG006|COMPLETED|Overall Study||0
6782602|NCT01996410|7711836|FG007|COMPLETED|Overall Study||0
6782603|NCT01996410|7711829|FG000|NOT COMPLETED|Overall Study||0
6782604|NCT01996410|7711830|FG001|NOT COMPLETED|Overall Study||0
6782605|NCT01996410|7711831|FG002|NOT COMPLETED|Overall Study||0
6782606|NCT01996410|7711832|FG003|NOT COMPLETED|Overall Study||0
6782607|NCT01996410|7711833|FG004|NOT COMPLETED|Overall Study||0
6782608|NCT01996410|7711834|FG005|NOT COMPLETED|Overall Study||0
6782609|NCT01996410|7711835|FG006|NOT COMPLETED|Overall Study||0
6782610|NCT01996410|7711836|FG007|NOT COMPLETED|Overall Study||0
6782611|NCT01996852|7711851|FG000|STARTED|Overall Study||0
6782612|NCT01996852|7711852|FG001|STARTED|Overall Study||0
6782613|NCT01996852|7711853|FG002|STARTED|Overall Study||0
6782614|NCT01996852|7711851|FG000|COMPLETED|Overall Study||0
6782615|NCT01996852|7711852|FG001|COMPLETED|Overall Study||0
6782616|NCT01996852|7711853|FG002|COMPLETED|Overall Study||0
6782617|NCT01996852|7711851|FG000|NOT COMPLETED|Overall Study||0
6782618|NCT01996852|7711852|FG001|NOT COMPLETED|Overall Study||0
6782619|NCT01996852|7711853|FG002|NOT COMPLETED|Overall Study||0
6782620|NCT01997567|7711863|FG000|STARTED|Overall Study||0
6782621|NCT01997567|7711864|FG001|STARTED|Overall Study||0
6782622|NCT01997567|7711863|FG000|COMPLETED|Overall Study||0
6782623|NCT01997567|7711864|FG001|COMPLETED|Overall Study||0
6782624|NCT01997567|7711863|FG000|NOT COMPLETED|Overall Study||0
6782625|NCT01997567|7711864|FG001|NOT COMPLETED|Overall Study||0
6782626|NCT01977729|7711870|FG000|STARTED|Overall Study||1
6782627|NCT01977729|7711870|FG000|COMPLETED|Overall Study||0
6782628|NCT01977729|7711870|FG000|NOT COMPLETED|Overall Study||1
6782629|NCT01973062|7711876|FG000|STARTED|Overall Study||1
6782630|NCT01973062|7711876|FG000|COMPLETED|Overall Study||1
6782631|NCT01973062|7711876|FG000|NOT COMPLETED|Overall Study||0
6782632|NCT01982253|7711883|FG000|STARTED|Overall Study||2
6782633|NCT01982253|7711884|FG001|STARTED|Overall Study||4
6782634|NCT01982253|7711885|FG002|STARTED|Overall Study||4
6782635|NCT01982253|7711883|FG000|COMPLETED|Overall Study||0
6782636|NCT01982253|7711884|FG001|COMPLETED|Overall Study||0
6782637|NCT01982253|7711885|FG002|COMPLETED|Overall Study||0
6782638|NCT01982253|7711883|FG000|NOT COMPLETED|Overall Study||2
6782639|NCT01982253|7711884|FG001|NOT COMPLETED|Overall Study||4
6782640|NCT01982253|7711885|FG002|NOT COMPLETED|Overall Study||4
6562963|NCT01804075|7485912|FG000|COMPLETED|Overall Study||15
6562964|NCT01804075|7485913|FG001|COMPLETED|Overall Study||16
6562965|NCT01804075|7485912|FG000|NOT COMPLETED|Overall Study||0
6562966|NCT01804075|7485913|FG001|NOT COMPLETED|Overall Study||0
6562967|NCT01804101|7485923|FG000|STARTED|Overall Study||38
6562968|NCT01804101|7485924|FG001|STARTED|Overall Study||10
6782641|NCT01984268|7711893|FG000|STARTED|Overall Study||15
6782642|NCT01984268|7711893|FG000|COMPLETED|Overall Study||0
6782643|NCT01984268|7711893|FG000|NOT COMPLETED|Overall Study||15
6782644|NCT01974284|7711897|FG000|STARTED|Overall Study||7
6782645|NCT01974284|7711897|FG000|COMPLETED|Overall Study||0
6782646|NCT01974284|7711897|FG000|NOT COMPLETED|Overall Study||7
6782647|NCT01971853|7711903|FG000|STARTED|Overall Study||0
6782648|NCT01971853|7711904|FG001|STARTED|Overall Study||0
6782649|NCT01971853|7711903|FG000|COMPLETED|Overall Study||0
6782650|NCT01971853|7711904|FG001|COMPLETED|Overall Study||0
6782651|NCT01971853|7711903|FG000|NOT COMPLETED|Overall Study||0
6782652|NCT01971853|7711904|FG001|NOT COMPLETED|Overall Study||0
6782653|NCT01980875|7711913|FG000|STARTED|Overall Study||8
6782654|NCT01980875|7711914|FG001|STARTED|Overall Study||25
6782655|NCT01980875|7711915|FG002|STARTED|Overall Study||24
6782656|NCT01980875|7711913|FG000|COMPLETED|Overall Study||0
6782657|NCT01980875|7711914|FG001|COMPLETED|Overall Study||0
6782658|NCT01980875|7711915|FG002|COMPLETED|Overall Study||0
6782659|NCT01980875|7711913|FG000|NOT COMPLETED|Overall Study||8
6782660|NCT01980875|7711914|FG001|NOT COMPLETED|Overall Study||25
6782661|NCT01980875|7711915|FG002|NOT COMPLETED|Overall Study||24
6782662|NCT01982383|7711925|FG000|STARTED|Overall Study||2
6782663|NCT01982383|7711926|FG001|STARTED|Overall Study||0
6782664|NCT01982383|7711925|FG000|COMPLETED|Overall Study||2
6782665|NCT01982383|7711926|FG001|COMPLETED|Overall Study||0
6782666|NCT01982383|7711925|FG000|NOT COMPLETED|Overall Study||0
6782667|NCT01982383|7711926|FG001|NOT COMPLETED|Overall Study||0
6782668|NCT01980342|7711932|FG000|STARTED|Overall Study||1
6782669|NCT01980342|7711932|FG000|COMPLETED|Overall Study||0
6782670|NCT01980342|7711932|FG000|NOT COMPLETED|Overall Study||1
6782671|NCT01978535|7711938|FG000|STARTED|Overall Study||1
6782672|NCT01978535|7711939|FG001|STARTED|Overall Study||2
6782673|NCT01978535|7711938|FG000|COMPLETED|Overall Study||1
6782674|NCT01978535|7711939|FG001|COMPLETED|Overall Study||2
6782675|NCT01978535|7711938|FG000|NOT COMPLETED|Overall Study||0
6782676|NCT01978535|7711939|FG001|NOT COMPLETED|Overall Study||0
6782677|NCT01974635|7711945|FG000|STARTED|Overall Study||2
6782678|NCT01974635|7711945|FG000|COMPLETED|Overall Study||2
6782679|NCT01974635|7711945|FG000|NOT COMPLETED|Overall Study||0
6782680|NCT01975467|7711952|FG000|STARTED|Overall Study|Study terminated before enrollment|0
6782681|NCT01975467|7711953|FG001|STARTED|Overall Study|Study terminated before enrollment|0
6782682|NCT01975467|7711952|FG000|COMPLETED|Overall Study||0
6782683|NCT01975467|7711953|FG001|COMPLETED|Overall Study||0
6782684|NCT01975467|7711952|FG000|NOT COMPLETED|Overall Study||0
6782685|NCT01975467|7711953|FG001|NOT COMPLETED|Overall Study||0
6782686|NCT01970462|7711961|FG000|STARTED|Overall Study||1
6562969|NCT01804101|7485923|FG000|COMPLETED|Overall Study||38
6562970|NCT01804101|7485924|FG001|COMPLETED|Overall Study||10
6562971|NCT01804101|7485923|FG000|NOT COMPLETED|Overall Study||0
6562972|NCT01804101|7485924|FG001|NOT COMPLETED|Overall Study||0
6562973|NCT01804114|7485934|FG000|STARTED|Overall Study||17
6562974|NCT01804114|7485935|FG001|STARTED|Overall Study||12
6562975|NCT01804114|7485934|FG000|COMPLETED|Overall Study||17
6782687|NCT01970462|7711962|FG001|STARTED|Overall Study||4
6782688|NCT01970462|7711961|FG000|COMPLETED|Overall Study||1
6782689|NCT01970462|7711962|FG001|COMPLETED|Overall Study||2
6782690|NCT01970462|7711961|FG000|NOT COMPLETED|Overall Study||0
6782691|NCT01970462|7711962|FG001|NOT COMPLETED|Overall Study||2
6782692|NCT01969565|7711968|FG000|STARTED|Overall Study||1
6782693|NCT01969565|7711968|FG000|COMPLETED|Overall Study||0
6782694|NCT01969565|7711968|FG000|NOT COMPLETED|Overall Study||1
6782695|NCT01968226|7711973|FG000|STARTED|Overall Study||3
6782696|NCT01968226|7711973|FG000|COMPLETED|Overall Study||1
6782697|NCT01968226|7711973|FG000|NOT COMPLETED|Overall Study||2
6782698|NCT01965782|7711977|FG000|STARTED|Overall Study||0
6782699|NCT01965782|7711977|FG000|COMPLETED|Overall Study||0
6782700|NCT01965782|7711977|FG000|NOT COMPLETED|Overall Study||0
6782701|NCT01962675|7711983|FG000|STARTED|Overall Study||7
6782702|NCT01962675|7711984|FG001|STARTED|Overall Study||7
6782703|NCT01962675|7711983|FG000|COMPLETED|Overall Study||7
6782704|NCT01962675|7711984|FG001|COMPLETED|Overall Study||7
6782705|NCT01962675|7711983|FG000|NOT COMPLETED|Overall Study||0
6782706|NCT01962675|7711984|FG001|NOT COMPLETED|Overall Study||0
6782707|NCT01962974|7711992|FG000|STARTED|Overall Study||7
6782708|NCT01962974|7711992|FG000|COMPLETED|Overall Study||0
6782709|NCT01962974|7711992|FG000|NOT COMPLETED|Overall Study||7
6782710|NCT01954160|7711998|FG000|STARTED|Overall Study||5
6782711|NCT01954160|7711999|FG001|STARTED|Overall Study|Not started|0
6782712|NCT01954160|7711998|FG000|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
6782713|NCT01954160|7711999|FG001|COMPLETED|Overall Study||0
6782714|NCT01954160|7711998|FG000|NOT COMPLETED|Overall Study||5
6782715|NCT01954160|7711999|FG001|NOT COMPLETED|Overall Study||0
6782716|NCT01951378|7712009|FG000|STARTED|Overall Study||23
6782717|NCT01951378|7712010|FG001|STARTED|Overall Study||17
6782718|NCT01951378|7712009|FG000|COMPLETED|Overall Study||0
6782719|NCT01951378|7712010|FG001|COMPLETED|Overall Study||0
6782720|NCT01951378|7712009|FG000|NOT COMPLETED|Overall Study||23
6782721|NCT01951378|7712010|FG001|NOT COMPLETED|Overall Study||17
6782722|NCT01941615|7712016|FG000|STARTED|Run in Treatment: Microgynon®||16
6782723|NCT01941615|7712016|FG000|COMPLETED|Run in Treatment: Microgynon®||16
6782724|NCT01941615|7712016|FG000|NOT COMPLETED|Run in Treatment: Microgynon®||0
6782725|NCT01941615|7712016|FG000|STARTED|Reference Treatment: Microgynon®||0
6782726|NCT01941615|7712016|FG000|COMPLETED|Reference Treatment: Microgynon®||0
6782727|NCT01941615|7712016|FG000|NOT COMPLETED|Reference Treatment: Microgynon®||0
6782728|NCT01941615|7712016|FG000|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
6782729|NCT01941615|7712016|FG000|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
6782730|NCT01941615|7712016|FG000|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
6782731|NCT01946542|7712022|FG000|STARTED|Testing Visit 1||1
6782732|NCT01946542|7712023|FG001|STARTED|Testing Visit 1||1
6782733|NCT01946542|7712022|FG000|COMPLETED|Testing Visit 1||1
6782734|NCT01946542|7712023|FG001|COMPLETED|Testing Visit 1||1
6782735|NCT01946542|7712022|FG000|NOT COMPLETED|Testing Visit 1||0
6782736|NCT01946542|7712023|FG001|NOT COMPLETED|Testing Visit 1||0
6782737|NCT01946542|7712022|FG000|STARTED|Testing Visit 2||1
6782738|NCT01946542|7712023|FG001|STARTED|Testing Visit 2||1
6782739|NCT01946542|7712022|FG000|COMPLETED|Testing Visit 2||1
6782740|NCT01946542|7712023|FG001|COMPLETED|Testing Visit 2||1
6782741|NCT01946542|7712022|FG000|NOT COMPLETED|Testing Visit 2||0
6782742|NCT01946542|7712023|FG001|NOT COMPLETED|Testing Visit 2||0
6782743|NCT01937507|7712029|FG000|STARTED|Overall Study||2
6782744|NCT01937507|7712029|FG000|COMPLETED|Overall Study||0
6782745|NCT01937507|7712029|FG000|NOT COMPLETED|Overall Study||2
6782746|NCT01944059|7712033|FG000|STARTED|Overall Study||31
6782747|NCT01944059|7712033|FG000|COMPLETED|Overall Study||24
6782748|NCT01944059|7712033|FG000|NOT COMPLETED|Overall Study||7
6782749|NCT01935947|7712041|FG000|STARTED|Overall Study||4
6782750|NCT01935947|7712042|FG001|STARTED|Overall Study||4
6782751|NCT01935947|7712043|FG002|STARTED|Overall Study||2
6782752|NCT01935947|7712041|FG000|Epigenetic Therapy|Overall Study||4
6782753|NCT01935947|7712042|FG001|Epigenetic Therapy|Overall Study||4
6782754|NCT01935947|7712043|FG002|Epigenetic Therapy|Overall Study||0
6782755|NCT01935947|7712041|FG000|Cytotoxic Therapy|Overall Study||3
6782756|NCT01935947|7712042|FG001|Cytotoxic Therapy|Overall Study||3
6782757|NCT01935947|7712043|FG002|Cytotoxic Therapy|Overall Study||2
6782758|NCT01935947|7712041|FG000|COMPLETED|Overall Study||1
6782759|NCT01935947|7712042|FG001|COMPLETED|Overall Study||0
6782760|NCT01935947|7712043|FG002|COMPLETED|Overall Study||0
6782761|NCT01935947|7712041|FG000|NOT COMPLETED|Overall Study||3
6782762|NCT01935947|7712042|FG001|NOT COMPLETED|Overall Study||4
6782763|NCT01935947|7712043|FG002|NOT COMPLETED|Overall Study||2
6782764|NCT01939223|7712056|FG000|STARTED|Overall Study||14
6782765|NCT01939223|7712057|FG001|STARTED|Overall Study||11
6782766|NCT01939223|7712056|FG000|Participants Received Treatment|Overall Study||14
6782767|NCT01939223|7712057|FG001|Participants Received Treatment|Overall Study||11
6782768|NCT01939223|7712056|FG000|COMPLETED|Overall Study||1
6782769|NCT01939223|7712057|FG001|COMPLETED|Overall Study||0
6782770|NCT01939223|7712056|FG000|NOT COMPLETED|Overall Study||13
6782771|NCT01939223|7712057|FG001|NOT COMPLETED|Overall Study||11
6782772|NCT01938716|7712063|FG000|STARTED|Overall Study||12
6782773|NCT01938716|7712063|FG000|COMPLETED|Overall Study||8
6782774|NCT01938716|7712063|FG000|NOT COMPLETED|Overall Study||4
6782775|NCT01936974|7712069|FG000|STARTED|Overall Study||2
6782776|NCT01936974|7712070|FG001|STARTED|Overall Study||5
6782777|NCT01936974|7712069|FG000|COMPLETED|Overall Study||0
6782778|NCT01936974|7712070|FG001|COMPLETED|Overall Study||0
6782779|NCT01936974|7712069|FG000|NOT COMPLETED|Overall Study||2
6782780|NCT01936974|7712070|FG001|NOT COMPLETED|Overall Study||5
6782781|NCT01938833|7712076|FG000|STARTED|Overall Study||9
6782782|NCT01938833|7712076|FG000|COMPLETED|Overall Study||9
6782783|NCT01938833|7712076|FG000|NOT COMPLETED|Overall Study||0
6378094|NCT00766090|7288658|FG009|STARTED|Treatment Period 3 (28 Days)||8
6378095|NCT00766090|7288659|FG010|STARTED|Treatment Period 3 (28 Days)||7
6378096|NCT00766090|7288660|FG011|STARTED|Treatment Period 3 (28 Days)||7
6378097|NCT00766090|7288649|FG000|COMPLETED|Treatment Period 3 (28 Days)||22
6502114|NCT01432535|7420743|FG001|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
6502115|NCT01432535|7420744|FG002|STARTED|Overall Study||6
6502116|NCT01432535|7420742|FG000|COMPLETED|Overall Study||12
6502117|NCT01432535|7420743|FG001|COMPLETED|Overall Study||7
6502118|NCT01432535|7420744|FG002|COMPLETED|Overall Study||6
6502119|NCT01432535|7420742|FG000|NOT COMPLETED|Overall Study||0
6502120|NCT01432535|7420743|FG001|NOT COMPLETED|Overall Study||0
6502121|NCT01432535|7420744|FG002|NOT COMPLETED|Overall Study||0
6502122|NCT01432561|7420752|FG000|STARTED|Overall Study||8
6502123|NCT01432561|7420752|FG000|COMPLETED|Overall Study||8
6502124|NCT01432561|7420752|FG000|NOT COMPLETED|Overall Study||0
6502125|NCT01432574|7420756|FG000|STARTED|Overall Study||150
6502126|NCT01432574|7420756|FG000|COMPLETED|Overall Study||147
6502127|NCT01432574|7420756|FG000|NOT COMPLETED|Overall Study||3
6502128|NCT01432600|7420765|FG000|STARTED|Overall Study||10
6502129|NCT01432600|7420766|FG001|STARTED|Overall Study||36
6502130|NCT01432600|7420767|FG002|STARTED|Overall Study||34
6502131|NCT01432600|7420765|FG000|COMPLETED|Overall Study||10
6502132|NCT01432600|7420766|FG001|COMPLETED|Overall Study||35
6502133|NCT01432600|7420767|FG002|COMPLETED|Overall Study||33
6502134|NCT01432600|7420765|FG000|NOT COMPLETED|Overall Study||0
6378098|NCT00766090|7288650|FG001|COMPLETED|Treatment Period 3 (28 Days)||26
6378099|NCT00766090|7288651|FG002|COMPLETED|Treatment Period 3 (28 Days)||20
6378100|NCT00766090|7288652|FG003|COMPLETED|Treatment Period 3 (28 Days)||24
6378101|NCT00766090|7288653|FG004|COMPLETED|Treatment Period 3 (28 Days)||20
6378102|NCT00766090|7288654|FG005|COMPLETED|Treatment Period 3 (28 Days)||22
6378103|NCT00766090|7288655|FG006|COMPLETED|Treatment Period 3 (28 Days)||6
6378104|NCT00766090|7288656|FG007|COMPLETED|Treatment Period 3 (28 Days)||8
6378105|NCT00766090|7288657|FG008|COMPLETED|Treatment Period 3 (28 Days)||6
6378106|NCT00766090|7288658|FG009|COMPLETED|Treatment Period 3 (28 Days)||8
6378107|NCT00766090|7288659|FG010|COMPLETED|Treatment Period 3 (28 Days)||7
6782784|NCT01934647|7712083|FG000|STARTED|Overall Study||2
6782785|NCT01934647|7712084|FG001|STARTED|Overall Study||2
6782786|NCT01934647|7712085|FG002|STARTED|Overall Study||3
6782787|NCT01934647|7712083|FG000|COMPLETED|Overall Study||2
6782788|NCT01934647|7712084|FG001|COMPLETED|Overall Study||2
6782789|NCT01934647|7712085|FG002|COMPLETED|Overall Study||3
6782790|NCT01934647|7712083|FG000|NOT COMPLETED|Overall Study||0
6782791|NCT01934647|7712084|FG001|NOT COMPLETED|Overall Study||0
6782792|NCT01934647|7712085|FG002|NOT COMPLETED|Overall Study||0
6782793|NCT01934504|7712097|FG000|STARTED|Overall Study||6
6782794|NCT01934504|7712098|FG001|STARTED|Overall Study||3
6782795|NCT01934504|7712099|FG002|STARTED|Overall Study||16
6782796|NCT01934504|7712100|FG003|STARTED|Overall Study||8
6782797|NCT01934504|7712097|FG000|COMPLETED|Overall Study||5
6782798|NCT01934504|7712098|FG001|COMPLETED|Overall Study||3
6782799|NCT01934504|7712099|FG002|COMPLETED|Overall Study||11
6782800|NCT01934504|7712100|FG003|COMPLETED|Overall Study||1
6782801|NCT01934504|7712097|FG000|NOT COMPLETED|Overall Study||1
6782802|NCT01934504|7712098|FG001|NOT COMPLETED|Overall Study||0
6782803|NCT01934504|7712099|FG002|NOT COMPLETED|Overall Study||5
6782804|NCT01934504|7712100|FG003|NOT COMPLETED|Overall Study||7
6782805|NCT01928082|7712110|FG000|STARTED|Overall Study||1
6782806|NCT01928082|7712110|FG000|COMPLETED|Overall Study||0
6782807|NCT01928082|7712110|FG000|NOT COMPLETED|Overall Study||1
6782808|NCT01928615|7712114|FG000|STARTED|Overall Study||2
6782809|NCT01928615|7712114|FG000|COMPLETED|Overall Study||0
6782810|NCT01928615|7712114|FG000|NOT COMPLETED|Overall Study||2
6782811|NCT01911793|7712121|FG000|STARTED|Overall Study||1
6782812|NCT01911793|7712122|FG001|STARTED|Overall Study||5
6782813|NCT01911793|7712121|FG000|COMPLETED|Overall Study||0
6782814|NCT01911793|7712122|FG001|COMPLETED|Overall Study||0
6782815|NCT01911793|7712121|FG000|NOT COMPLETED|Overall Study||1
6782816|NCT01911793|7712122|FG001|NOT COMPLETED|Overall Study||5
6782817|NCT01912404|7712130|FG000|STARTED|Overall Study||3
6782818|NCT01912404|7712131|FG001|STARTED|Overall Study||2
6782819|NCT01912404|7712130|FG000|COMPLETED|Overall Study||2
6782820|NCT01912404|7712131|FG001|COMPLETED|Overall Study||2
6782821|NCT01912404|7712130|FG000|NOT COMPLETED|Overall Study||1
6782822|NCT01912404|7712131|FG001|NOT COMPLETED|Overall Study||0
6782823|NCT01910389|7712139|FG000|STARTED|Overall Study||15
6782824|NCT01910389|7712140|FG001|STARTED|Overall Study||8
6782825|NCT01910389|7712139|FG000|COMPLETED|Overall Study||0
6782826|NCT01910389|7712140|FG001|COMPLETED|Overall Study||0
6782827|NCT01910389|7712139|FG000|NOT COMPLETED|Overall Study||15
6782828|NCT01910389|7712140|FG001|NOT COMPLETED|Overall Study||8
6782829|NCT01921114|7712148|FG000|STARTED|Overall Study||0
6782830|NCT01921114|7712149|FG001|STARTED|Overall Study||0
6782831|NCT01921114|7712148|FG000|COMPLETED|Overall Study||0
6782832|NCT01921114|7712149|FG001|COMPLETED|Overall Study||0
6782833|NCT01921114|7712148|FG000|NOT COMPLETED|Overall Study||0
6782834|NCT01921114|7712149|FG001|NOT COMPLETED|Overall Study||0
6782835|NCT01916590|7712157|FG000|STARTED|Overall Study||4
6782836|NCT01916590|7712158|FG001|STARTED|Overall Study||3
6782837|NCT01916590|7712157|FG000|COMPLETED|Overall Study||4
6782838|NCT01916590|7712158|FG001|COMPLETED|Overall Study||3
6782839|NCT01916590|7712157|FG000|NOT COMPLETED|Overall Study||0
6782840|NCT01916590|7712158|FG001|NOT COMPLETED|Overall Study||0
6782841|NCT01913327|7712166|FG000|STARTED|Overall Study||1
6782842|NCT01913327|7712167|FG001|STARTED|Overall Study||2
6782843|NCT01913327|7712166|FG000|COMPLETED|Overall Study||1
6782844|NCT01913327|7712167|FG001|COMPLETED|Overall Study||1
6782845|NCT01913327|7712166|FG000|NOT COMPLETED|Overall Study||0
6782846|NCT01913327|7712167|FG001|NOT COMPLETED|Overall Study||1
6782847|NCT01902888|7712173|FG000|STARTED|Overall Study||3
6782848|NCT01902888|7712173|FG000|COMPLETED|Overall Study||0
6782849|NCT01902888|7712173|FG000|NOT COMPLETED|Overall Study||3
6782850|NCT01901224|7712177|FG000|STARTED|Overall Study||2
6782851|NCT01901224|7712177|FG000|COMPLETED|Overall Study||0
6782852|NCT01901224|7712177|FG000|NOT COMPLETED|Overall Study||2
6782853|NCT01910441|7712183|FG000|STARTED|Overall Study||48
6782854|NCT01910441|7712184|FG001|STARTED|Overall Study||47
6782855|NCT01910441|7712183|FG000|COMPLETED|Overall Study||41
6782856|NCT01910441|7712184|FG001|COMPLETED|Overall Study||37
6782857|NCT01910441|7712183|FG000|NOT COMPLETED|Overall Study||7
6782858|NCT01910441|7712184|FG001|NOT COMPLETED|Overall Study||10
6782859|NCT01902966|7712190|FG000|STARTED|Overall Study||5
6782860|NCT01902966|7712190|FG000|COMPLETED|Overall Study||2
6782861|NCT01902966|7712190|FG000|NOT COMPLETED|Overall Study||3
6782862|NCT01901679|7712196|FG000|STARTED|Overall Study||5
6782863|NCT01901679|7712197|FG001|STARTED|Overall Study||5
6782864|NCT01901679|7712196|FG000|COMPLETED|Overall Study||5
6782865|NCT01901679|7712197|FG001|COMPLETED|Overall Study||5
6782866|NCT01901679|7712196|FG000|NOT COMPLETED|Overall Study||0
6782867|NCT01901679|7712197|FG001|NOT COMPLETED|Overall Study||0
6782868|NCT01900730|7712205|FG000|STARTED|Overall Study||3
6782869|NCT01900730|7712206|FG001|STARTED|Overall Study||0
6782870|NCT01900730|7712205|FG000|COMPLETED|Overall Study||1
6782871|NCT01900730|7712206|FG001|COMPLETED|Overall Study||0
6782872|NCT01900730|7712205|FG000|NOT COMPLETED|Overall Study||2
6782873|NCT01900730|7712206|FG001|NOT COMPLETED|Overall Study||0
6782874|NCT01877564|7712214|FG000|STARTED|Overall Study||6
6782875|NCT01877564|7712215|FG001|STARTED|Overall Study||4
6782876|NCT01877564|7712214|FG000|COMPLETED|Overall Study||6
6782877|NCT01877564|7712215|FG001|COMPLETED|Overall Study||4
6782878|NCT01877564|7712214|FG000|NOT COMPLETED|Overall Study||0
6782879|NCT01877564|7712215|FG001|NOT COMPLETED|Overall Study||0
6782880|NCT01890694|7712223|FG000|STARTED|Overall Study||1
6782881|NCT01890694|7712224|FG001|STARTED|Overall Study||1
6782882|NCT01890694|7712223|FG000|COMPLETED|Overall Study||0
6782883|NCT01890694|7712224|FG001|COMPLETED|Overall Study||0
6782884|NCT01890694|7712223|FG000|NOT COMPLETED|Overall Study||1
6782885|NCT01890694|7712224|FG001|NOT COMPLETED|Overall Study||1
6782886|NCT01900626|7712234|FG000|STARTED|Overall Study||1
6782887|NCT01900626|7712235|FG001|STARTED|Overall Study||1
6782888|NCT01900626|7712234|FG000|COMPLETED|Overall Study||0
6782889|NCT01900626|7712235|FG001|COMPLETED|Overall Study||0
6782890|NCT01900626|7712234|FG000|NOT COMPLETED|Overall Study||1
6782891|NCT01900626|7712235|FG001|NOT COMPLETED|Overall Study||1
6782892|NCT01890577|7712243|FG000|STARTED|Overall Study||28
6782893|NCT01890577|7712243|FG000|COMPLETED|Overall Study||0
6782894|NCT01890577|7712243|FG000|NOT COMPLETED|Overall Study||28
6782895|NCT01895959|7712247|FG000|STARTED|Overall Study||12
6782896|NCT01895959|7712247|FG000|COMPLETED|Overall Study||10
6782897|NCT01895959|7712247|FG000|NOT COMPLETED|Overall Study||2
6782898|NCT01889420|7712251|FG000|STARTED|Overall Study||1
6782899|NCT01889420|7712251|FG000|COMPLETED|Overall Study||1
6782900|NCT01889420|7712251|FG000|NOT COMPLETED|Overall Study||0
6782901|NCT01884077|7712257|FG000|STARTED|Overall Study||8
6782902|NCT01884077|7712258|FG001|STARTED|Overall Study||11
6782903|NCT01884077|7712257|FG000|COMPLETED|Overall Study||0
6782904|NCT01884077|7712258|FG001|COMPLETED|Overall Study||1
6782905|NCT01884077|7712257|FG000|NOT COMPLETED|Overall Study||8
6782906|NCT01884077|7712258|FG001|NOT COMPLETED|Overall Study||10
6782907|NCT01881984|7712264|FG000|STARTED|Overall Study||4
6782908|NCT01881984|7712264|FG000|COMPLETED|Overall Study||4
6782909|NCT01881984|7712264|FG000|NOT COMPLETED|Overall Study||0
6782910|NCT01893359|7712271|FG000|STARTED|Overall Study||0
6782911|NCT01893359|7712272|FG001|STARTED|Overall Study||2
6782912|NCT01893359|7712273|FG002|STARTED|Overall Study||0
6782913|NCT01893359|7712271|FG000|COMPLETED|Overall Study||0
6782914|NCT01893359|7712272|FG001|COMPLETED|Overall Study||2
6782915|NCT01893359|7712273|FG002|COMPLETED|Overall Study||0
6782916|NCT01893359|7712271|FG000|NOT COMPLETED|Overall Study||0
6782917|NCT01893359|7712272|FG001|NOT COMPLETED|Overall Study||0
6782918|NCT01893359|7712273|FG002|NOT COMPLETED|Overall Study||0
6782919|NCT01883908|7712283|FG000|STARTED|Overall Study||3
6782920|NCT01883908|7712284|FG001|STARTED|Overall Study||1
6782921|NCT01883908|7712283|FG000|COMPLETED|Overall Study||3
6782922|NCT01883908|7712284|FG001|COMPLETED|Overall Study||1
6782923|NCT01883908|7712283|FG000|NOT COMPLETED|Overall Study||0
6782924|NCT01883908|7712284|FG001|NOT COMPLETED|Overall Study||0
6782925|NCT01887288|7712290|FG000|STARTED|Overall Study||16
6782926|NCT01887288|7712290|FG000|COMPLETED|Overall Study||0
6782927|NCT01887288|7712290|FG000|NOT COMPLETED|Overall Study||16
6782928|NCT01881932|7712297|FG000|STARTED|Overall Study||2
6782929|NCT01881932|7712298|FG001|STARTED|Overall Study||4
6782930|NCT01881932|7712299|FG002|STARTED|Overall Study||13
6782931|NCT01881932|7712297|FG000|COMPLETED|Overall Study||2
6782932|NCT01881932|7712298|FG001|COMPLETED|Overall Study||4
6782933|NCT01881932|7712299|FG002|COMPLETED|Overall Study||13
6782934|NCT01881932|7712297|FG000|NOT COMPLETED|Overall Study||0
6782935|NCT01881932|7712298|FG001|NOT COMPLETED|Overall Study||0
6782936|NCT01881932|7712299|FG002|NOT COMPLETED|Overall Study||0
6782937|NCT01878786|7712310|FG000|STARTED|Overall Study||9
6782938|NCT01878786|7712311|FG001|STARTED|Overall Study||9
6782939|NCT01878786|7712312|FG002|STARTED|Overall Study||7
6782940|NCT01878786|7712310|FG000|COMPLETED|Overall Study|Study closed prematurely|0
6782941|NCT01878786|7712311|FG001|COMPLETED|Overall Study|Study closed prematurely|0
6782942|NCT01878786|7712312|FG002|COMPLETED|Overall Study|Study closed prematurely; 1 patient was a screen fail|0
6782943|NCT01878786|7712310|FG000|NOT COMPLETED|Overall Study||9
6782944|NCT01878786|7712311|FG001|NOT COMPLETED|Overall Study||9
6782945|NCT01878786|7712312|FG002|NOT COMPLETED|Overall Study||7
6782946|NCT01877343|7712323|FG000|STARTED|Overall Study||2
6782947|NCT01877343|7712324|FG001|STARTED|Overall Study||3
6782948|NCT01877343|7712325|FG002|STARTED|Overall Study||0
6782949|NCT01877343|7712326|FG003|STARTED|Overall Study||0
6782950|NCT01877343|7712327|FG004|STARTED|Overall Study||0
6782951|NCT01877343|7712328|FG005|STARTED|Overall Study||5
6782952|NCT01877343|7712329|FG006|STARTED|Overall Study||0
6782953|NCT01877343|7712323|FG000|COMPLETED|Overall Study||2
6782954|NCT01877343|7712324|FG001|COMPLETED|Overall Study||3
6782955|NCT01877343|7712325|FG002|COMPLETED|Overall Study||0
6782956|NCT01877343|7712326|FG003|COMPLETED|Overall Study||0
6782957|NCT01877343|7712327|FG004|COMPLETED|Overall Study||0
6782958|NCT01877343|7712328|FG005|COMPLETED|Overall Study||5
6782959|NCT01877343|7712329|FG006|COMPLETED|Overall Study||0
6782960|NCT01877343|7712323|FG000|NOT COMPLETED|Overall Study||0
6782961|NCT01877343|7712324|FG001|NOT COMPLETED|Overall Study||0
6782962|NCT01877343|7712325|FG002|NOT COMPLETED|Overall Study||0
6782963|NCT01877343|7712326|FG003|NOT COMPLETED|Overall Study||0
6782964|NCT01877343|7712327|FG004|NOT COMPLETED|Overall Study||0
6782965|NCT01877343|7712328|FG005|NOT COMPLETED|Overall Study||0
6782966|NCT01877343|7712329|FG006|NOT COMPLETED|Overall Study||0
6782967|NCT01861717|7712333|FG000|STARTED|Overall Study||4
6782968|NCT01861717|7712333|FG000|COMPLETED|Overall Study||2
6782969|NCT01861717|7712333|FG000|NOT COMPLETED|Overall Study||2
6782970|NCT01866709|7712340|FG000|STARTED|Overall Study||15
6782971|NCT01866709|7712341|FG001|STARTED|Overall Study||17
6782972|NCT01866709|7712340|FG000|COMPLETED|Overall Study||14
6782973|NCT01866709|7712341|FG001|COMPLETED|Overall Study||17
6782974|NCT01866709|7712340|FG000|NOT COMPLETED|Overall Study||1
6782975|NCT01866709|7712341|FG001|NOT COMPLETED|Overall Study||0
6782976|NCT01860040|7712349|FG000|STARTED|Overall Study|did not meet recruitment goal|1
6782977|NCT01860040|7712350|FG001|STARTED|Overall Study|did not meet recruitment goal|0
6782978|NCT01860040|7712349|FG000|COMPLETED|Overall Study|did not meet recruitment goal|0
6782979|NCT01860040|7712350|FG001|COMPLETED|Overall Study|did not meet recruitment goal|0
6782980|NCT01860040|7712349|FG000|NOT COMPLETED|Overall Study||1
6782981|NCT01860040|7712350|FG001|NOT COMPLETED|Overall Study||0
6782982|NCT01869478|7712357|FG000|STARTED|Overall Study||0
6782983|NCT01869478|7712358|FG001|STARTED|Overall Study||1
6782984|NCT01869478|7712357|FG000|COMPLETED|Overall Study||0
6782985|NCT01869478|7712358|FG001|COMPLETED|Overall Study||1
6782986|NCT01869478|7712357|FG000|NOT COMPLETED|Overall Study||0
6782987|NCT01869478|7712358|FG001|NOT COMPLETED|Overall Study||0
6782988|NCT01851174|7712364|FG000|STARTED|Overall Study||15
6782989|NCT01851174|7712364|FG000|COMPLETED|Overall Study||15
6782990|NCT01851174|7712364|FG000|NOT COMPLETED|Overall Study||0
6782991|NCT01846182|7712371|FG000|STARTED|Overall Study|Unclear due to assignment records.|0
6782992|NCT01846182|7712372|FG001|STARTED|Overall Study|Unclear due to assignment records.|0
6782993|NCT01846182|7712373|FG002|STARTED|Overall Study|Unclear due to assignment records.|0
6782994|NCT01846182|7712371|FG000|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
6782995|NCT01846182|7712372|FG001|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
6782996|NCT01846182|7712373|FG002|COMPLETED|Overall Study|The data on completion subjects is corrupted and not reliable for interpretation.|0
6782997|NCT01846182|7712371|FG000|NOT COMPLETED|Overall Study||0
6782998|NCT01846182|7712372|FG001|NOT COMPLETED|Overall Study||0
6782999|NCT01846182|7712373|FG002|NOT COMPLETED|Overall Study||0
6783000|NCT01844206|7712385|FG000|STARTED|Overall Study||2
6783001|NCT01844206|7712386|FG001|STARTED|Overall Study||3
6783002|NCT01844206|7712385|FG000|COMPLETED|Overall Study||2
6783003|NCT01844206|7712386|FG001|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
6783004|NCT01844206|7712385|FG000|NOT COMPLETED|Overall Study||0
6783005|NCT01844206|7712386|FG001|NOT COMPLETED|Overall Study||1
6783006|NCT01856322|7712395|FG000|STARTED|Overall Study||0
6783007|NCT01856322|7712396|FG001|STARTED|Overall Study||0
6783008|NCT01856322|7712397|FG002|STARTED|Overall Study||3
6783009|NCT01856322|7712395|FG000|COMPLETED|Overall Study||0
6783010|NCT01856322|7712396|FG001|COMPLETED|Overall Study||0
6783011|NCT01856322|7712397|FG002|COMPLETED|Overall Study||0
6783012|NCT01856322|7712395|FG000|NOT COMPLETED|Overall Study||0
6783013|NCT01856322|7712396|FG001|NOT COMPLETED|Overall Study||0
6783014|NCT01856322|7712397|FG002|NOT COMPLETED|Overall Study||3
6783015|NCT01853176|7712406|FG000|STARTED|Overall Study||4
6783016|NCT01853176|7712407|FG001|STARTED|Overall Study||0
6783017|NCT01853176|7712406|FG000|COMPLETED|Overall Study||0
6783018|NCT01853176|7712407|FG001|COMPLETED|Overall Study||0
6783019|NCT01853176|7712406|FG000|NOT COMPLETED|Overall Study||4
6783020|NCT01853176|7712407|FG001|NOT COMPLETED|Overall Study||0
6783021|NCT01857271|7712413|FG000|STARTED|Overall Study||3
6783022|NCT01857271|7712413|FG000|COMPLETED|Overall Study||2
6783023|NCT01857271|7712413|FG000|NOT COMPLETED|Overall Study||1
6783024|NCT01856361|7712419|FG000|STARTED|Overall Study||1
6783025|NCT01856361|7712420|FG001|STARTED|Overall Study||1
6562976|NCT01804114|7485935|FG001|COMPLETED|Overall Study||12
6562977|NCT01804114|7485934|FG000|NOT COMPLETED|Overall Study||0
6783026|NCT01856361|7712419|FG000|COMPLETED|Overall Study||1
6783027|NCT01856361|7712420|FG001|COMPLETED|Overall Study||1
6783028|NCT01856361|7712419|FG000|NOT COMPLETED|Overall Study||0
6783029|NCT01856361|7712420|FG001|NOT COMPLETED|Overall Study||0
6783030|NCT01853982|7712428|FG000|STARTED|Overall Study||2
6783031|NCT01853982|7712429|FG001|STARTED|Overall Study||2
6783032|NCT01853982|7712428|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
6783033|NCT01853982|7712429|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
6783034|NCT01853982|7712428|FG000|COMPLETED|Overall Study||0
6783035|NCT01853982|7712429|FG001|COMPLETED|Overall Study||1
6783036|NCT01853982|7712428|FG000|NOT COMPLETED|Overall Study||2
6783037|NCT01853982|7712429|FG001|NOT COMPLETED|Overall Study||1
6783038|NCT01841931|7712435|FG000|STARTED|Overall Study||4
6783039|NCT01841931|7712435|FG000|COMPLETED|Overall Study|As the PI left the institution the study was terminated|0
6783040|NCT01841931|7712435|FG000|NOT COMPLETED|Overall Study||4
6783041|NCT01836809|7712443|FG000|STARTED|Overall Study||0
6783042|NCT01836809|7712444|FG001|STARTED|Overall Study||0
6783043|NCT01836809|7712445|FG002|STARTED|Overall Study||0
6783044|NCT01836809|7712446|FG003|STARTED|Overall Study||2
6783045|NCT01836809|7712443|FG000|COMPLETED|Overall Study||0
6783046|NCT01836809|7712444|FG001|COMPLETED|Overall Study||0
6783047|NCT01836809|7712445|FG002|COMPLETED|Overall Study||0
6783048|NCT01836809|7712446|FG003|COMPLETED|Overall Study||0
6783049|NCT01836809|7712443|FG000|NOT COMPLETED|Overall Study||0
6783050|NCT01836809|7712444|FG001|NOT COMPLETED|Overall Study||0
6783051|NCT01836809|7712445|FG002|NOT COMPLETED|Overall Study||0
6783052|NCT01836809|7712446|FG003|NOT COMPLETED|Overall Study||2
6783053|NCT01831596|7712460|FG000|STARTED|Overall Study||59
6783054|NCT01831596|7712460|FG000|COMPLETED|Overall Study||51
6783055|NCT01831596|7712460|FG000|NOT COMPLETED|Overall Study||8
6783056|NCT01834144|7712466|FG000|STARTED|Overall Study||1
6783057|NCT01834144|7712467|FG001|STARTED|Overall Study||3
6783058|NCT01834144|7712466|FG000|COMPLETED|Overall Study||1
6783059|NCT01834144|7712467|FG001|COMPLETED|Overall Study||2
6783060|NCT01834144|7712466|FG000|NOT COMPLETED|Overall Study||0
6783061|NCT01834144|7712467|FG001|NOT COMPLETED|Overall Study||1
6783062|NCT01821963|7712473|FG000|STARTED|Overall Study||1
6783063|NCT01821963|7712473|FG000|COMPLETED|Overall Study||0
6783064|NCT01821963|7712473|FG000|NOT COMPLETED|Overall Study||1
6783065|NCT01821898|7712479|FG000|STARTED|Overall Study||2
6783066|NCT01821898|7712480|FG001|STARTED|Overall Study||1
6783067|NCT01821898|7712479|FG000|COMPLETED|Overall Study||0
6783068|NCT01821898|7712480|FG001|COMPLETED|Overall Study||0
6783069|NCT01821898|7712479|FG000|NOT COMPLETED|Overall Study||2
6783070|NCT01821898|7712480|FG001|NOT COMPLETED|Overall Study||1
6783071|NCT01814722|7712490|FG000|STARTED|Overall Study||36
6783072|NCT01814722|7712491|FG001|STARTED|Overall Study||21
6783073|NCT01814722|7712492|FG002|STARTED|Overall Study||6
6783074|NCT01814722|7712490|FG000|COMPLETED|Overall Study||36
6783075|NCT01814722|7712491|FG001|COMPLETED|Overall Study||21
6783076|NCT01814722|7712492|FG002|COMPLETED|Overall Study||6
6783077|NCT01814722|7712490|FG000|NOT COMPLETED|Overall Study||0
6783078|NCT01814722|7712491|FG001|NOT COMPLETED|Overall Study||0
6783079|NCT01814722|7712492|FG002|NOT COMPLETED|Overall Study||0
6783080|NCT01830790|7712502|FG000|STARTED|Overall Study||0
6783081|NCT01830790|7712503|FG001|STARTED|Overall Study||10
6783082|NCT01830790|7712502|FG000|COMPLETED|Overall Study||0
6783083|NCT01830790|7712503|FG001|COMPLETED|Overall Study||10
6783084|NCT01830790|7712502|FG000|NOT COMPLETED|Overall Study||0
6783085|NCT01830790|7712503|FG001|NOT COMPLETED|Overall Study||0
6783086|NCT01829477|7712511|FG000|STARTED|Overall Study||17
6783087|NCT01829477|7712512|FG001|STARTED|Overall Study||16
6783088|NCT01829477|7712511|FG000|COMPLETED|Overall Study||1
6783089|NCT01829477|7712512|FG001|COMPLETED|Overall Study||1
6783090|NCT01829477|7712511|FG000|NOT COMPLETED|Overall Study||16
6783091|NCT01829477|7712512|FG001|NOT COMPLETED|Overall Study||15
6783092|NCT01803711|7712520|FG000|STARTED|Overall Study||2
6783093|NCT01803711|7712521|FG001|STARTED|Overall Study||3
6783094|NCT01803711|7712520|FG000|COMPLETED|Overall Study||1
6378108|NCT00766090|7288660|FG011|COMPLETED|Treatment Period 3 (28 Days)||6
6378109|NCT00766090|7288649|FG000|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6378110|NCT00766090|7288650|FG001|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6378111|NCT00766090|7288651|FG002|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6378112|NCT00766090|7288652|FG003|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6378113|NCT00766090|7288653|FG004|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6378114|NCT00766090|7288654|FG005|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6378115|NCT00766090|7288655|FG006|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6378116|NCT00766090|7288656|FG007|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6378117|NCT00766090|7288657|FG008|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6378118|NCT00766090|7288658|FG009|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6378119|NCT00766090|7288659|FG010|NOT COMPLETED|Treatment Period 3 (28 Days)||0
6378120|NCT00766090|7288660|FG011|NOT COMPLETED|Treatment Period 3 (28 Days)||1
6378121|NCT00766116|7288674|FG000|STARTED|Overall Study||50
6378122|NCT00766116|7288674|FG000|COMPLETED|Overall Study||50
6378123|NCT00766116|7288674|FG000|NOT COMPLETED|Overall Study||0
6378124|NCT00766142|7288681|FG000|STARTED|Overall Study||18
6378125|NCT00766142|7288681|FG000|COMPLETED|Overall Study||14
6378126|NCT00766142|7288681|FG000|NOT COMPLETED|Overall Study||4
6378127|NCT00766363|7288689|FG000|STARTED|Overall Study||12
6378128|NCT00766363|7288690|FG001|STARTED|Overall Study||13
6378129|NCT00766363|7288691|FG002|STARTED|Overall Study|Number randomized.|12
6378130|NCT00766363|7288692|FG003|STARTED|Overall Study|Number randomized.|12
6378131|NCT00766363|7288689|FG000|SAFETY POPULATION|Overall Study||12
6378132|NCT00766363|7288690|FG001|SAFETY POPULATION|Overall Study||13
6378133|NCT00766363|7288691|FG002|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
6378134|NCT00766363|7288692|FG003|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
6378135|NCT00766363|7288689|FG000|PK POPULATION|Overall Study||12
6378136|NCT00766363|7288690|FG001|PK POPULATION|Overall Study||13
6378137|NCT00766363|7288691|FG002|PK POPULATION|Overall Study||10
6378138|NCT00766363|7288692|FG003|PK POPULATION|Overall Study||13
6378139|NCT00766363|7288689|FG000|COMPLETED|Overall Study||11
6378140|NCT00766363|7288690|FG001|COMPLETED|Overall Study||12
6378141|NCT00766363|7288691|FG002|COMPLETED|Overall Study||12
6378142|NCT00766363|7288692|FG003|COMPLETED|Overall Study||12
6378143|NCT00766363|7288689|FG000|NOT COMPLETED|Overall Study||1
6378144|NCT00766363|7288690|FG001|NOT COMPLETED|Overall Study||1
6783095|NCT01803711|7712521|FG001|COMPLETED|Overall Study||2
6783096|NCT01803711|7712520|FG000|NOT COMPLETED|Overall Study||1
6783097|NCT01803711|7712521|FG001|NOT COMPLETED|Overall Study||1
6783098|NCT01821859|7712529|FG000|STARTED|Overall Study||5
6783099|NCT01821859|7712529|FG000|COMPLETED|Overall Study||0
6783100|NCT01821859|7712529|FG000|NOT COMPLETED|Overall Study||5
6783101|NCT01808950|7712536|FG000|STARTED|Overall Study||1
6783102|NCT01808950|7712537|FG001|STARTED|Overall Study||3
6783103|NCT01808950|7712538|FG002|STARTED|Overall Study||0
6783104|NCT01808950|7712536|FG000|COMPLETED|Overall Study||1
6783105|NCT01808950|7712537|FG001|COMPLETED|Overall Study||3
6783106|NCT01808950|7712538|FG002|COMPLETED|Overall Study||0
6378145|NCT00766363|7288691|FG002|NOT COMPLETED|Overall Study||0
6378146|NCT00766363|7288692|FG003|NOT COMPLETED|Overall Study||0
6378147|NCT00766376|7288703|FG000|STARTED|Overall Study||151
6378148|NCT00766376|7288703|FG000|COMPLETED|Overall Study||124
6502135|NCT01432600|7420766|FG001|NOT COMPLETED|Overall Study||1
6502136|NCT01432600|7420767|FG002|NOT COMPLETED|Overall Study||1
6562978|NCT01804114|7485935|FG001|NOT COMPLETED|Overall Study||0
6783107|NCT01808950|7712536|FG000|NOT COMPLETED|Overall Study||0
6783108|NCT01808950|7712537|FG001|NOT COMPLETED|Overall Study||0
6783109|NCT01808950|7712538|FG002|NOT COMPLETED|Overall Study||0
6783110|NCT01806051|7712549|FG000|STARTED|Overall Study||6
6783111|NCT01806051|7712549|FG000|COMPLETED|Overall Study||0
6783112|NCT01806051|7712549|FG000|NOT COMPLETED|Overall Study||6
6783113|NCT01808794|7712557|FG000|STARTED|Overall Study||0
6783114|NCT01808794|7712558|FG001|STARTED|Overall Study||0
6783115|NCT01808794|7712557|FG000|COMPLETED|Overall Study||0
6783116|NCT01808794|7712558|FG001|COMPLETED|Overall Study||0
6783117|NCT01808794|7712557|FG000|NOT COMPLETED|Overall Study||0
6783118|NCT01808794|7712558|FG001|NOT COMPLETED|Overall Study||0
6783119|NCT01809899|7712566|FG000|STARTED|Overall Study||8
6783120|NCT01809899|7712567|FG001|STARTED|Overall Study||4
6783121|NCT01809899|7712566|FG000|COMPLETED|Overall Study||8
6783122|NCT01809899|7712567|FG001|COMPLETED|Overall Study||4
6783123|NCT01809899|7712566|FG000|NOT COMPLETED|Overall Study||0
6783124|NCT01809899|7712567|FG001|NOT COMPLETED|Overall Study||0
6783125|NCT01810302|7712576|FG000|STARTED|Overall Study||1
6783126|NCT01810302|7712577|FG001|STARTED|Overall Study||1
6783127|NCT01810302|7712576|FG000|COMPLETED|Overall Study||0
6783128|NCT01810302|7712577|FG001|COMPLETED|Overall Study||0
6783129|NCT01810302|7712576|FG000|NOT COMPLETED|Overall Study||1
6783130|NCT01810302|7712577|FG001|NOT COMPLETED|Overall Study||1
6783131|NCT01806961|7712583|FG000|STARTED|Overall Study||16
6783132|NCT01806961|7712583|FG000|COMPLETED|Overall Study||0
6783133|NCT01806961|7712583|FG000|NOT COMPLETED|Overall Study||16
6783134|NCT01804166|7712587|FG000|STARTED|Overall Study||1
6783135|NCT01804166|7712587|FG000|COMPLETED|Overall Study||1
6783136|NCT01804166|7712587|FG000|NOT COMPLETED|Overall Study||0
6783137|NCT01783015|7712593|FG000|STARTED|Blinded Treatment||11
6783138|NCT01783015|7712594|FG001|STARTED|Blinded Treatment||5
6783139|NCT01783015|7712595|FG002|STARTED|Blinded Treatment||0
6783140|NCT01783015|7712593|FG000|Treated|Blinded Treatment||11
6783141|NCT01783015|7712594|FG001|Treated|Blinded Treatment||5
6783142|NCT01783015|7712595|FG002|Treated|Blinded Treatment||0
6783143|NCT01783015|7712593|FG000|COMPLETED|Blinded Treatment||9
6783144|NCT01783015|7712594|FG001|COMPLETED|Blinded Treatment||2
6783145|NCT01783015|7712595|FG002|COMPLETED|Blinded Treatment||0
6783146|NCT01783015|7712593|FG000|NOT COMPLETED|Blinded Treatment||2
6783147|NCT01783015|7712594|FG001|NOT COMPLETED|Blinded Treatment||3
6783148|NCT01783015|7712595|FG002|NOT COMPLETED|Blinded Treatment||0
6783149|NCT01783015|7712593|FG000|STARTED|Open Label Treatment||0
6783150|NCT01783015|7712594|FG001|STARTED|Open Label Treatment||0
6783151|NCT01783015|7712595|FG002|STARTED|Open Label Treatment||11
6783152|NCT01783015|7712593|FG000|COMPLETED|Open Label Treatment||0
6783153|NCT01783015|7712594|FG001|COMPLETED|Open Label Treatment||0
6783154|NCT01783015|7712595|FG002|COMPLETED|Open Label Treatment||5
6783155|NCT01783015|7712593|FG000|NOT COMPLETED|Open Label Treatment||0
6783156|NCT01783015|7712594|FG001|NOT COMPLETED|Open Label Treatment||0
6783157|NCT01783015|7712595|FG002|NOT COMPLETED|Open Label Treatment||6
6783158|NCT01800162|7712606|FG000|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
6783159|NCT01800162|7712607|FG001|STARTED|Overall Study||0
6378149|NCT00766376|7288703|FG000|NOT COMPLETED|Overall Study||27
6378150|NCT00766415|7288709|FG000|STARTED|Overall Study||25
6378151|NCT00766415|7288710|FG001|STARTED|Overall Study||27
6378152|NCT00766415|7288709|FG000|COMPLETED|Overall Study||25
6378153|NCT00766415|7288710|FG001|COMPLETED|Overall Study||26
6378154|NCT00766415|7288709|FG000|NOT COMPLETED|Overall Study||0
6378155|NCT00766415|7288710|FG001|NOT COMPLETED|Overall Study||1
6378156|NCT00766467|7288718|FG000|STARTED|Overall Study||42
6378157|NCT00766467|7288719|FG001|STARTED|Overall Study||39
6783160|NCT01800162|7712608|FG002|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
6783161|NCT01800162|7712606|FG000|COMPLETED|Overall Study||1
6783162|NCT01800162|7712607|FG001|COMPLETED|Overall Study||0
6783163|NCT01800162|7712608|FG002|COMPLETED|Overall Study||1
6783164|NCT01800162|7712606|FG000|NOT COMPLETED|Overall Study||0
6783165|NCT01800162|7712607|FG001|NOT COMPLETED|Overall Study||0
6783166|NCT01800162|7712608|FG002|NOT COMPLETED|Overall Study||0
6783167|NCT01794936|7712616|FG000|STARTED|Overall Study||9
6783168|NCT01794936|7712616|FG000|COMPLETED|Overall Study||9
6378158|NCT00766467|7288718|FG000|Initiated Treatment|Overall Study||39
6378159|NCT00766467|7288719|FG001|Initiated Treatment|Overall Study||38
6378160|NCT00766467|7288718|FG000|COMPLETED|Overall Study||31
6378161|NCT00766467|7288719|FG001|COMPLETED|Overall Study||31
6378162|NCT00766467|7288718|FG000|NOT COMPLETED|Overall Study||11
6378163|NCT00766467|7288719|FG001|NOT COMPLETED|Overall Study||8
6378164|NCT00766493|7288725|FG000|STARTED|Pre-Discharge||250
6378165|NCT00766493|7288725|FG000|COMPLETED|Pre-Discharge||250
6378166|NCT00766493|7288725|FG000|NOT COMPLETED|Pre-Discharge||0
6378167|NCT00766493|7288725|FG000|STARTED|30 Days Post-Procedure||250
6378168|NCT00766493|7288725|FG000|COMPLETED|30 Days Post-Procedure||238
6378169|NCT00766493|7288725|FG000|NOT COMPLETED|30 Days Post-Procedure||12
6378170|NCT00766506|7288731|FG000|STARTED|Overall Study||58
6378171|NCT00766506|7288732|FG001|STARTED|Overall Study||50
6378172|NCT00766506|7288731|FG000|COMPLETED|Overall Study||53
6378173|NCT00766506|7288732|FG001|COMPLETED|Overall Study||48
6378174|NCT00766506|7288731|FG000|NOT COMPLETED|Overall Study||5
6378175|NCT00766506|7288732|FG001|NOT COMPLETED|Overall Study||2
6378176|NCT00766532|7288738|FG000|STARTED|Overall Study||12
6378177|NCT00766532|7288738|FG000|COMPLETED|Overall Study||10
6378178|NCT00766532|7288738|FG000|NOT COMPLETED|Overall Study||2
6378179|NCT00766597|7288742|FG000|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
6562979|NCT01804140|7485941|FG000|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
6562980|NCT01804140|7485941|FG000|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
6562981|NCT01804140|7485941|FG000|NOT COMPLETED|Overall Study||114
6562982|NCT01804257|7485945|FG000|STARTED|Overall Study||28
6562983|NCT01804257|7485945|FG000|COMPLETED|Overall Study||27
6562984|NCT01804257|7485945|FG000|NOT COMPLETED|Overall Study||1
6378180|NCT00766597|7288742|FG000|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
6378181|NCT00766597|7288742|FG000|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
6378182|NCT00766597|7288742|FG000|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
6378183|NCT00766597|7288742|FG000|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
6378184|NCT00766597|7288742|FG000|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
6378185|NCT00766597|7288742|FG000|NOT COMPLETED|Overall Study||9
6378186|NCT00766649|7288748|FG000|STARTED|Overall Study||11
6378187|NCT00766649|7288748|FG000|COMPLETED|Overall Study||1
6378188|NCT00766649|7288748|FG000|NOT COMPLETED|Overall Study||10
6378189|NCT00766675|7288752|FG000|STARTED|Overall Study||80
6378190|NCT00766675|7288752|FG000|COMPLETED|Overall Study||40
6378191|NCT00766675|7288752|FG000|NOT COMPLETED|Overall Study||40
6378192|NCT00766727|7288756|FG000|STARTED|Overall Study||12
6378193|NCT00766727|7288756|FG000|COMPLETED|Overall Study||9
6378194|NCT00766727|7288756|FG000|NOT COMPLETED|Overall Study||3
6378195|NCT00766753|7288764|FG000|STARTED|Overall Study||11
6378196|NCT00766753|7288765|FG001|STARTED|Overall Study||11
6378197|NCT00766753|7288764|FG000|Received at Least One Vaccine|Overall Study||11
6378198|NCT00766753|7288765|FG001|Received at Least One Vaccine|Overall Study||11
6378199|NCT00766753|7288764|FG000|Completed at Least Four Vaccines|Overall Study||10
6378200|NCT00766753|7288765|FG001|Completed at Least Four Vaccines|Overall Study||9
6378201|NCT00766753|7288764|FG000|COMPLETED|Overall Study||11
6378202|NCT00766753|7288765|FG001|COMPLETED|Overall Study||11
6378203|NCT00766753|7288764|FG000|NOT COMPLETED|Overall Study||0
6378204|NCT00766753|7288765|FG001|NOT COMPLETED|Overall Study||0
6378205|NCT00766831|7288772|FG000|STARTED|Overall Study||190
6378206|NCT00766831|7288772|FG000|COMPLETED|Overall Study||75
6378207|NCT00766831|7288772|FG000|NOT COMPLETED|Overall Study||115
6378208|NCT00767000|7288781|FG000|STARTED|54-week Study||119
6378209|NCT00767000|7288782|FG001|STARTED|54-week Study||117
6378210|NCT00767000|7288783|FG002|STARTED|54-week Study||117
6378211|NCT00767000|7288784|FG003|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
6378212|NCT00767000|7288785|FG004|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
6378213|NCT00767000|7288781|FG000|COMPLETED|54-week Study||11
6378214|NCT00767000|7288782|FG001|COMPLETED|54-week Study||4
6378215|NCT00767000|7288783|FG002|COMPLETED|54-week Study||8
6562985|NCT01804465|7485951|FG000|STARTED|Overall Study||24
6783169|NCT01794936|7712616|FG000|NOT COMPLETED|Overall Study||0
6783170|NCT01797380|7712622|FG000|STARTED|Overall Study|Terminated due to lack of enrollment|3
6783171|NCT01797380|7712623|FG001|STARTED|Overall Study||2
6783172|NCT01797380|7712622|FG000|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
6783173|NCT01797380|7712623|FG001|COMPLETED|Overall Study||0
6783174|NCT01797380|7712622|FG000|NOT COMPLETED|Overall Study||3
6783175|NCT01797380|7712623|FG001|NOT COMPLETED|Overall Study||2
6783176|NCT01781026|7712629|FG000|STARTED|Overall Study||2
6783177|NCT01781026|7712629|FG000|COMPLETED|Overall Study||0
6783178|NCT01781026|7712629|FG000|NOT COMPLETED|Overall Study||2
6783179|NCT01788475|7712636|FG000|STARTED|Overall Study||3
6783180|NCT01788475|7712637|FG001|STARTED|Overall Study||0
6783181|NCT01788475|7712638|FG002|STARTED|Overall Study||0
6783182|NCT01788475|7712636|FG000|COMPLETED|Overall Study||0
6783183|NCT01788475|7712637|FG001|COMPLETED|Overall Study||0
6783184|NCT01788475|7712638|FG002|COMPLETED|Overall Study||0
6783185|NCT01788475|7712636|FG000|NOT COMPLETED|Overall Study||3
6783186|NCT01788475|7712637|FG001|NOT COMPLETED|Overall Study||0
6783187|NCT01788475|7712638|FG002|NOT COMPLETED|Overall Study||0
6783188|NCT01784991|7712648|FG000|STARTED|Overall Study||0
6783189|NCT01784991|7712649|FG001|STARTED|Overall Study||0
6783190|NCT01784991|7712648|FG000|COMPLETED|Overall Study||0
6783191|NCT01784991|7712649|FG001|COMPLETED|Overall Study||0
6783192|NCT01784991|7712648|FG000|NOT COMPLETED|Overall Study||0
6783193|NCT01784991|7712649|FG001|NOT COMPLETED|Overall Study||0
6783194|NCT01777854|7712655|FG000|STARTED|Overall Study||3
6783195|NCT01777854|7712656|FG001|STARTED|Overall Study||3
6783196|NCT01777854|7712655|FG000|COMPLETED|Overall Study||0
6783197|NCT01777854|7712656|FG001|COMPLETED|Overall Study||0
6783198|NCT01777854|7712655|FG000|NOT COMPLETED|Overall Study||3
6783199|NCT01777854|7712656|FG001|NOT COMPLETED|Overall Study||3
6783200|NCT01760993|7712660|FG000|STARTED|Overall Study||0
6783201|NCT01760993|7712660|FG000|COMPLETED|Overall Study||0
6783202|NCT01760993|7712660|FG000|NOT COMPLETED|Overall Study||0
6783203|NCT01772719|7712664|FG000|STARTED|Overall Study||7
6783204|NCT01772719|7712664|FG000|COMPLETED|Overall Study||0
6783205|NCT01772719|7712664|FG000|NOT COMPLETED|Overall Study||7
6783206|NCT01764997|7712676|FG000|STARTED|Run-in Period||776
6783207|NCT01764997|7712677|FG001|STARTED|Run-in Period||0
6783208|NCT01764997|7712678|FG002|STARTED|Run-in Period||0
6783209|NCT01764997|7712679|FG003|STARTED|Run-in Period||0
6783210|NCT01764997|7712680|FG004|STARTED|Run-in Period||0
6783211|NCT01764997|7712676|FG000|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
6783212|NCT01764997|7712677|FG001|COMPLETED|Run-in Period||0
6783213|NCT01764997|7712678|FG002|COMPLETED|Run-in Period||0
6783214|NCT01764997|7712679|FG003|COMPLETED|Run-in Period||0
6783215|NCT01764997|7712680|FG004|COMPLETED|Run-in Period||0
6783216|NCT01764997|7712676|FG000|NOT COMPLETED|Run-in Period||38
6783217|NCT01764997|7712677|FG001|NOT COMPLETED|Run-in Period||0
6783218|NCT01764997|7712678|FG002|NOT COMPLETED|Run-in Period||0
6783219|NCT01764997|7712679|FG003|NOT COMPLETED|Run-in Period||0
6783220|NCT01764997|7712680|FG004|NOT COMPLETED|Run-in Period||0
6783221|NCT01764997|7712676|FG000|STARTED|Study Drug Treatment Period||0
6783222|NCT01764997|7712677|FG001|STARTED|Study Drug Treatment Period||17
6783223|NCT01764997|7712678|FG002|STARTED|Study Drug Treatment Period||13
6783224|NCT01764997|7712679|FG003|STARTED|Study Drug Treatment Period||13
6783225|NCT01764997|7712680|FG004|STARTED|Study Drug Treatment Period||322
6783226|NCT01764997|7712676|FG000|COMPLETED|Study Drug Treatment Period||0
6783227|NCT01764997|7712677|FG001|COMPLETED|Study Drug Treatment Period||16
6783228|NCT01764997|7712678|FG002|COMPLETED|Study Drug Treatment Period||13
6783229|NCT01764997|7712679|FG003|COMPLETED|Study Drug Treatment Period||13
6783230|NCT01764997|7712680|FG004|COMPLETED|Study Drug Treatment Period||286
6783231|NCT01764997|7712676|FG000|NOT COMPLETED|Study Drug Treatment Period||0
6783232|NCT01764997|7712677|FG001|NOT COMPLETED|Study Drug Treatment Period||1
6783233|NCT01764997|7712678|FG002|NOT COMPLETED|Study Drug Treatment Period||0
6783234|NCT01764997|7712679|FG003|NOT COMPLETED|Study Drug Treatment Period||0
6783235|NCT01764997|7712680|FG004|NOT COMPLETED|Study Drug Treatment Period||36
6783236|NCT01760941|7712690|FG000|STARTED|Overall Study||1
6783237|NCT01760941|7712690|FG000|COMPLETED|Overall Study||1
6783238|NCT01760941|7712690|FG000|NOT COMPLETED|Overall Study||0
6783239|NCT01769443|7712696|FG000|STARTED|Overall Study||1
6783240|NCT01769443|7712697|FG001|STARTED|Overall Study||1
6783241|NCT01769443|7712696|FG000|COMPLETED|Overall Study||0
6783242|NCT01769443|7712697|FG001|COMPLETED|Overall Study||1
6783243|NCT01769443|7712696|FG000|NOT COMPLETED|Overall Study||1
6783244|NCT01769443|7712697|FG001|NOT COMPLETED|Overall Study||0
6783245|NCT01760889|7712707|FG000|STARTED|Overall Study||0
6783246|NCT01760889|7712708|FG001|STARTED|Overall Study||0
6783247|NCT01760889|7712709|FG002|STARTED|Overall Study||0
6783248|NCT01760889|7712707|FG000|COMPLETED|Overall Study||0
6783249|NCT01760889|7712708|FG001|COMPLETED|Overall Study||0
6783250|NCT01760889|7712709|FG002|COMPLETED|Overall Study||0
6783251|NCT01760889|7712707|FG000|NOT COMPLETED|Overall Study||0
6783252|NCT01760889|7712708|FG001|NOT COMPLETED|Overall Study||0
6783253|NCT01760889|7712709|FG002|NOT COMPLETED|Overall Study||0
6783254|NCT01749826|7712719|FG000|STARTED|Overall Study||20
6783255|NCT01749826|7712720|FG001|STARTED|Overall Study||0
6783256|NCT01749826|7712719|FG000|COMPLETED|Overall Study||0
6783257|NCT01749826|7712720|FG001|COMPLETED|Overall Study||0
6783258|NCT01749826|7712719|FG000|NOT COMPLETED|Overall Study||20
6783259|NCT01749826|7712720|FG001|NOT COMPLETED|Overall Study||0
6783260|NCT01756586|7712728|FG000|STARTED|Overall Study||2
6783261|NCT01756586|7712729|FG001|STARTED|Overall Study||2
6783262|NCT01756586|7712728|FG000|COMPLETED|Overall Study||0
6783263|NCT01756586|7712729|FG001|COMPLETED|Overall Study||0
6783264|NCT01756586|7712728|FG000|NOT COMPLETED|Overall Study||2
6783265|NCT01756586|7712729|FG001|NOT COMPLETED|Overall Study||2
6783266|NCT01754987|7712737|FG000|STARTED|Overall Study||5
6783267|NCT01754987|7712738|FG001|STARTED|Overall Study||0
6783268|NCT01754987|7712737|FG000|COMPLETED|Overall Study||5
6783269|NCT01754987|7712738|FG001|COMPLETED|Overall Study||0
6783270|NCT01754987|7712737|FG000|NOT COMPLETED|Overall Study||0
6783271|NCT01754987|7712738|FG001|NOT COMPLETED|Overall Study||0
6783272|NCT01756560|7712746|FG000|STARTED|Overall Study||2
6783273|NCT01756560|7712747|FG001|STARTED|Overall Study||0
6783274|NCT01756560|7712746|FG000|COMPLETED|Overall Study||0
6783275|NCT01756560|7712747|FG001|COMPLETED|Overall Study||0
6783276|NCT01756560|7712746|FG000|NOT COMPLETED|Overall Study||2
6783277|NCT01756560|7712747|FG001|NOT COMPLETED|Overall Study||0
6783278|NCT01756573|7712756|FG000|STARTED|Overall Study||3
6783279|NCT01756573|7712757|FG001|STARTED|Overall Study||1
6783280|NCT01756573|7712758|FG002|STARTED|Overall Study||1
6783281|NCT01756573|7712756|FG000|COMPLETED|Overall Study||3
6783282|NCT01756573|7712757|FG001|COMPLETED|Overall Study||1
6783283|NCT01756573|7712758|FG002|COMPLETED|Overall Study||1
6783284|NCT01756573|7712756|FG000|NOT COMPLETED|Overall Study||0
6783285|NCT01756573|7712757|FG001|NOT COMPLETED|Overall Study||0
6783286|NCT01756573|7712758|FG002|NOT COMPLETED|Overall Study||0
6783287|NCT01745913|7712768|FG000|STARTED|Overall Study||1
6783288|NCT01745913|7712769|FG001|STARTED|Overall Study||1
6783289|NCT01745913|7712768|FG000|COMPLETED|Overall Study||0
6783290|NCT01745913|7712769|FG001|COMPLETED|Overall Study||0
6783291|NCT01745913|7712768|FG000|NOT COMPLETED|Overall Study||1
6783292|NCT01745913|7712769|FG001|NOT COMPLETED|Overall Study||1
6783293|NCT01752023|7712781|FG000|STARTED|Overall Study||2
6783294|NCT01752023|7712782|FG001|STARTED|Overall Study||1
6783295|NCT01752023|7712781|FG000|COMPLETED|Overall Study||0
6783296|NCT01752023|7712782|FG001|COMPLETED|Overall Study||0
6783297|NCT01752023|7712781|FG000|NOT COMPLETED|Overall Study||2
6783298|NCT01752023|7712782|FG001|NOT COMPLETED|Overall Study||1
6783299|NCT01740154|7712792|FG000|STARTED|Overall Study||13
6783300|NCT01740154|7712792|FG000|COMPLETED|Overall Study||12
6783301|NCT01740154|7712792|FG000|NOT COMPLETED|Overall Study||1
6783302|NCT01748890|7712796|FG000|STARTED|Overall Study||4
6783303|NCT01748890|7712796|FG000|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
6783304|NCT01748890|7712796|FG000|NOT COMPLETED|Overall Study||4
6783305|NCT01748162|7712802|FG000|STARTED|Overall Study||5
6783306|NCT01748162|7712803|FG001|STARTED|Overall Study||5
6783307|NCT01748162|7712802|FG000|Started 6 Month Initial Treatment Plan|Overall Study||2
6783308|NCT01748162|7712803|FG001|Started 6 Month Initial Treatment Plan|Overall Study||2
6783309|NCT01748162|7712802|FG000|Completed 6 Month Initial Treatment|Overall Study||0
6783310|NCT01748162|7712803|FG001|Completed 6 Month Initial Treatment|Overall Study||0
6783311|NCT01748162|7712802|FG000|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
6783312|NCT01748162|7712803|FG001|Started 6 Month Followup|Overall Study|No participants in either arm had additional croup episodes in the first 6 months; study terminated.|0
6783313|NCT01748162|7712802|FG000|COMPLETED|Overall Study||0
6783314|NCT01748162|7712803|FG001|COMPLETED|Overall Study||0
6783315|NCT01748162|7712802|FG000|NOT COMPLETED|Overall Study||5
6783316|NCT01748162|7712803|FG001|NOT COMPLETED|Overall Study||5
6783317|NCT01738698|7712813|FG000|STARTED|Overall Study||0
6783318|NCT01738698|7712814|FG001|STARTED|Overall Study||0
6783319|NCT01738698|7712815|FG002|STARTED|Overall Study||0
6783320|NCT01738698|7712816|FG003|STARTED|Overall Study||0
6783321|NCT01738698|7712813|FG000|COMPLETED|Overall Study||0
6783322|NCT01738698|7712814|FG001|COMPLETED|Overall Study||0
6783323|NCT01738698|7712815|FG002|COMPLETED|Overall Study||0
6783324|NCT01738698|7712816|FG003|COMPLETED|Overall Study||0
6783325|NCT01738698|7712813|FG000|NOT COMPLETED|Overall Study||0
6783326|NCT01738698|7712814|FG001|NOT COMPLETED|Overall Study||0
6783327|NCT01738698|7712815|FG002|NOT COMPLETED|Overall Study||0
6783328|NCT01738698|7712816|FG003|NOT COMPLETED|Overall Study||0
6783329|NCT01732926|7712828|FG000|STARTED|Overall Study||320
6783330|NCT01732926|7712829|FG001|STARTED|Overall Study||155
6783331|NCT01732926|7712828|FG000|COMPLETED|Overall Study||53
6783332|NCT01732926|7712829|FG001|COMPLETED|Overall Study||45
6783333|NCT01732926|7712828|FG000|NOT COMPLETED|Overall Study||267
6783334|NCT01732926|7712829|FG001|NOT COMPLETED|Overall Study||110
6783335|NCT01727167|7712837|FG000|STARTED|Overall Study||1
6783336|NCT01727167|7712838|FG001|STARTED|Overall Study||0
6783337|NCT01727167|7712837|FG000|COMPLETED|Overall Study||1
6783338|NCT01727167|7712838|FG001|COMPLETED|Overall Study||0
6783339|NCT01727167|7712837|FG000|NOT COMPLETED|Overall Study||0
6783340|NCT01727167|7712838|FG001|NOT COMPLETED|Overall Study||0
6783341|NCT01732913|7712846|FG000|STARTED|Overall Study||198
6783342|NCT01732913|7712847|FG001|STARTED|Overall Study||97
6783343|NCT01732913|7712846|FG000|COMPLETED|Overall Study||42
6783344|NCT01732913|7712847|FG001|COMPLETED|Overall Study||28
6783345|NCT01732913|7712846|FG000|NOT COMPLETED|Overall Study||156
6783346|NCT01732913|7712847|FG001|NOT COMPLETED|Overall Study||69
6783347|NCT01732211|7712853|FG000|STARTED|Overall Study||1
6783348|NCT01732211|7712853|FG000|COMPLETED|Overall Study||1
6783349|NCT01732211|7712853|FG000|NOT COMPLETED|Overall Study||0
6783350|NCT01716052|7712859|FG000|STARTED|Overall Study||1
6783351|NCT01716052|7712860|FG001|STARTED|Overall Study||1
6783352|NCT01716052|7712859|FG000|COMPLETED|Overall Study||0
6783353|NCT01716052|7712860|FG001|COMPLETED|Overall Study||0
6783354|NCT01716052|7712859|FG000|NOT COMPLETED|Overall Study||1
6783355|NCT01716052|7712860|FG001|NOT COMPLETED|Overall Study||1
6783356|NCT01718444|7712868|FG000|STARTED|Overall Study||0
6783357|NCT01718444|7712869|FG001|STARTED|Overall Study||0
6783358|NCT01718444|7712868|FG000|COMPLETED|Overall Study||0
6783359|NCT01718444|7712869|FG001|COMPLETED|Overall Study||0
6783360|NCT01718444|7712868|FG000|NOT COMPLETED|Overall Study||0
6783361|NCT01718444|7712869|FG001|NOT COMPLETED|Overall Study||0
6783362|NCT01712854|7712875|FG000|STARTED|Overall Study||9
6783363|NCT01712854|7712875|FG000|COMPLETED|Overall Study||8
6783364|NCT01712854|7712875|FG000|NOT COMPLETED|Overall Study||1
6783365|NCT01717482|7712881|FG000|STARTED|Overall Study||4
6783366|NCT01717482|7712882|FG001|STARTED|Overall Study||2
6783367|NCT01717482|7712881|FG000|COMPLETED|Overall Study||0
6783368|NCT01717482|7712882|FG001|COMPLETED|Overall Study||2
6783369|NCT01717482|7712881|FG000|NOT COMPLETED|Overall Study||4
6783370|NCT01717482|7712882|FG001|NOT COMPLETED|Overall Study||0
6783371|NCT01702896|7712889|FG000|STARTED|Overall Study||8
6783372|NCT01702896|7712889|FG000|COMPLETED|Overall Study||0
6783373|NCT01702896|7712889|FG000|NOT COMPLETED|Overall Study||8
6783374|NCT01709136|7712895|FG000|STARTED|Overall Study||3
6783375|NCT01709136|7712895|FG000|COMPLETED|Overall Study||3
6783376|NCT01709136|7712895|FG000|NOT COMPLETED|Overall Study||0
6783377|NCT01708057|7712902|FG000|STARTED|Overall Study||1
6783378|NCT01708057|7712903|FG001|STARTED|Overall Study||1
6783379|NCT01708057|7712904|FG002|STARTED|Overall Study||1
6783380|NCT01708057|7712902|FG000|COMPLETED|Overall Study||0
6783381|NCT01708057|7712903|FG001|COMPLETED|Overall Study||0
6783382|NCT01708057|7712904|FG002|COMPLETED|Overall Study||0
6783383|NCT01708057|7712902|FG000|NOT COMPLETED|Overall Study||1
6783384|NCT01708057|7712903|FG001|NOT COMPLETED|Overall Study||1
6783385|NCT01708057|7712904|FG002|NOT COMPLETED|Overall Study||1
6783386|NCT01697332|7712918|FG000|STARTED|Overall Study||1
6783387|NCT01697332|7712918|FG000|COMPLETED|Overall Study||1
6783388|NCT01697332|7712918|FG000|NOT COMPLETED|Overall Study||0
6783389|NCT01693367|7712924|FG000|STARTED|Overall Study||2
6783390|NCT01693367|7712925|FG001|STARTED|Overall Study||3
6783391|NCT01693367|7712924|FG000|COMPLETED|Overall Study||1
6783392|NCT01693367|7712925|FG001|COMPLETED|Overall Study||1
6783393|NCT01693367|7712924|FG000|NOT COMPLETED|Overall Study||1
6783394|NCT01693367|7712925|FG001|NOT COMPLETED|Overall Study||2
6783395|NCT01705106|7712931|FG000|STARTED|Overall Study||21
6783396|NCT01705106|7712931|FG000|COMPLETED|Overall Study||21
6783397|NCT01705106|7712931|FG000|NOT COMPLETED|Overall Study||0
6783398|NCT01702909|7712935|FG000|STARTED|Overall Study||7
6783399|NCT01702909|7712935|FG000|COMPLETED|Overall Study||7
6783400|NCT01702909|7712935|FG000|NOT COMPLETED|Overall Study||0
6378216|NCT00767000|7288784|FG003|COMPLETED|54-week Study||4
6562986|NCT01804465|7485952|FG001|STARTED|Overall Study||26
6562987|NCT01804465|7485951|FG000|COMPLETED|Overall Study||24
6562988|NCT01804465|7485952|FG001|COMPLETED|Overall Study||26
6562989|NCT01804465|7485951|FG000|NOT COMPLETED|Overall Study||0
6562990|NCT01804465|7485952|FG001|NOT COMPLETED|Overall Study||0
6656242|NCT02459262|7586363|FG005|NOT COMPLETED|Overall Study||0
6378217|NCT00767000|7288785|FG004|COMPLETED|54-week Study||7
6378218|NCT00767000|7288781|FG000|NOT COMPLETED|54-week Study||108
6378219|NCT00767000|7288782|FG001|NOT COMPLETED|54-week Study||113
6378220|NCT00767000|7288783|FG002|NOT COMPLETED|54-week Study||109
6562991|NCT01804582|7485960|FG000|STARTED|Overall Study||177
6562992|NCT01804582|7485961|FG001|STARTED|Overall Study||173
6562993|NCT01804582|7485960|FG000|COMPLETED|Overall Study||128
6562994|NCT01804582|7485961|FG001|COMPLETED|Overall Study||117
6562995|NCT01804582|7485960|FG000|NOT COMPLETED|Overall Study||49
6562996|NCT01804582|7485961|FG001|NOT COMPLETED|Overall Study||56
6562997|NCT01804673|7485968|FG000|STARTED|Overall Study||174
6783401|NCT01701622|7712939|FG000|STARTED|Overall Study||1
6783402|NCT01701622|7712939|FG000|COMPLETED|Overall Study||1
6783403|NCT01701622|7712939|FG000|NOT COMPLETED|Overall Study||0
6783404|NCT01697800|7712946|FG000|STARTED|Overall Study||15
6783405|NCT01697800|7712947|FG001|STARTED|Overall Study||25
6783406|NCT01697800|7712946|FG000|COMPLETED|Overall Study||15
6783407|NCT01697800|7712947|FG001|COMPLETED|Overall Study||24
6783408|NCT01697800|7712946|FG000|NOT COMPLETED|Overall Study||0
6783409|NCT01697800|7712947|FG001|NOT COMPLETED|Overall Study||1
6783410|NCT01700348|7712953|FG000|STARTED|Overall Study||116
6783411|NCT01700348|7712953|FG000|COMPLETED|Overall Study||93
6783412|NCT01700348|7712953|FG000|NOT COMPLETED|Overall Study||23
6783413|NCT01693484|7712959|FG000|STARTED|Overall Study||13
6783414|NCT01693484|7712959|FG000|COMPLETED|Overall Study|Study closed by PI|0
6783415|NCT01693484|7712959|FG000|NOT COMPLETED|Overall Study||13
6783416|NCT01693653|7712965|FG000|STARTED|Overall Study||1
6783417|NCT01693653|7712966|FG001|STARTED|Overall Study||0
6783418|NCT01693653|7712965|FG000|COMPLETED|Overall Study||1
6783419|NCT01693653|7712966|FG001|COMPLETED|Overall Study||0
6783420|NCT01693653|7712965|FG000|NOT COMPLETED|Overall Study||0
6783421|NCT01693653|7712966|FG001|NOT COMPLETED|Overall Study||0
6783422|NCT01692691|7712972|FG000|STARTED|Overall Study||1
6783423|NCT01692691|7712972|FG000|COMPLETED|Overall Study||1
6783424|NCT01692691|7712972|FG000|NOT COMPLETED|Overall Study||0
6783425|NCT01691079|7712980|FG000|STARTED|Overall Study||0
6783426|NCT01691079|7712981|FG001|STARTED|Overall Study||0
6783427|NCT01691079|7712980|FG000|COMPLETED|Overall Study||0
6783428|NCT01691079|7712981|FG001|COMPLETED|Overall Study||0
6783429|NCT01691079|7712980|FG000|NOT COMPLETED|Overall Study||0
6783430|NCT01691079|7712981|FG001|NOT COMPLETED|Overall Study||0
6783431|NCT01690910|7712989|FG000|STARTED|Overall Study|The study was never completed due to feasibility issues.|0
6783432|NCT01690910|7712990|FG001|STARTED|Overall Study||0
6783433|NCT01690910|7712989|FG000|COMPLETED|Overall Study||0
6783434|NCT01690910|7712990|FG001|COMPLETED|Overall Study||0
6783435|NCT01690910|7712989|FG000|NOT COMPLETED|Overall Study||0
6783436|NCT01690910|7712990|FG001|NOT COMPLETED|Overall Study||0
6783437|NCT01689974|7712998|FG000|STARTED|Overall Study||5
6783438|NCT01689974|7712999|FG001|STARTED|Overall Study||5
6783439|NCT01689974|7712998|FG000|COMPLETED|Overall Study||0
6783440|NCT01689974|7712999|FG001|COMPLETED|Overall Study||0
6783441|NCT01689974|7712998|FG000|NOT COMPLETED|Overall Study||5
6783442|NCT01689974|7712999|FG001|NOT COMPLETED|Overall Study||5
6783443|NCT01676961|7713005|FG000|STARTED|Overall Study||5
6783444|NCT01676961|7713005|FG000|COMPLETED|Overall Study||0
6783445|NCT01676961|7713005|FG000|NOT COMPLETED|Overall Study||5
6783446|NCT01681589|7713012|FG000|STARTED|Overall Study||0
6783447|NCT01681589|7713013|FG001|STARTED|Overall Study||0
6783448|NCT01681589|7713014|FG002|STARTED|Overall Study||0
6783449|NCT01681589|7713012|FG000|COMPLETED|Overall Study||0
6783450|NCT01681589|7713013|FG001|COMPLETED|Overall Study||0
6783451|NCT01681589|7713014|FG002|COMPLETED|Overall Study||0
6783452|NCT01681589|7713012|FG000|NOT COMPLETED|Overall Study||0
6783453|NCT01681589|7713013|FG001|NOT COMPLETED|Overall Study||0
6783454|NCT01681589|7713014|FG002|NOT COMPLETED|Overall Study||0
6783455|NCT01681745|7713022|FG000|STARTED|Overall Study||0
6783456|NCT01681745|7713022|FG000|COMPLETED|Overall Study||0
6783457|NCT01681745|7713022|FG000|NOT COMPLETED|Overall Study||0
6783458|NCT01682928|7713028|FG000|STARTED|Overall Study|2 subjects in this Arm|2
6783459|NCT01682928|7713029|FG001|STARTED|Overall Study|2 subjects in this Arm|2
6783460|NCT01682928|7713028|FG000|COMPLETED|Overall Study||2
6783461|NCT01682928|7713029|FG001|COMPLETED|Overall Study||2
6783462|NCT01682928|7713028|FG000|NOT COMPLETED|Overall Study||0
6783463|NCT01682928|7713029|FG001|NOT COMPLETED|Overall Study||0
6783464|NCT01668940|7713041|FG000|STARTED|Overall Study||17
6783465|NCT01668940|7713042|FG001|STARTED|Overall Study||14
6783466|NCT01668940|7713043|FG002|STARTED|Overall Study||9
6783467|NCT01668940|7713044|FG003|STARTED|Overall Study||14
6783468|NCT01668940|7713041|FG000|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|17
6783469|NCT01668940|7713042|FG001|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
6783470|NCT01668940|7713043|FG002|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|9
6783471|NCT01668940|7713044|FG003|COMPLETED|Overall Study|Data collection was completed, but data analysis did not occur due to study closure.|14
6783472|NCT01668940|7713041|FG000|NOT COMPLETED|Overall Study||0
6783473|NCT01668940|7713042|FG001|NOT COMPLETED|Overall Study||0
6783474|NCT01668940|7713043|FG002|NOT COMPLETED|Overall Study||0
6783475|NCT01668940|7713044|FG003|NOT COMPLETED|Overall Study||0
6783476|NCT01663285|7713054|FG000|STARTED|Overall Study||1
6783477|NCT01663285|7713054|FG000|COMPLETED|Overall Study||1
6783478|NCT01663285|7713054|FG000|NOT COMPLETED|Overall Study||0
6783479|NCT01683864|7713061|FG000|STARTED|Overall Study||0
6783480|NCT01683864|7713062|FG001|STARTED|Overall Study||0
6783481|NCT01683864|7713063|FG002|STARTED|Overall Study||0
6783482|NCT01683864|7713061|FG000|COMPLETED|Overall Study||0
6783483|NCT01683864|7713062|FG001|COMPLETED|Overall Study||0
6783484|NCT01683864|7713063|FG002|COMPLETED|Overall Study||0
6783485|NCT01683864|7713061|FG000|NOT COMPLETED|Overall Study||0
6783486|NCT01683864|7713062|FG001|NOT COMPLETED|Overall Study||0
6783487|NCT01683864|7713063|FG002|NOT COMPLETED|Overall Study||0
6783488|NCT01675011|7713073|FG000|STARTED|Overall Study||3
6783489|NCT01675011|7713074|FG001|STARTED|Overall Study||1
6783490|NCT01675011|7713073|FG000|COMPLETED|Overall Study||0
6783491|NCT01675011|7713074|FG001|COMPLETED|Overall Study||0
6783492|NCT01675011|7713073|FG000|NOT COMPLETED|Overall Study||3
6783493|NCT01675011|7713074|FG001|NOT COMPLETED|Overall Study||1
6783494|NCT01673425|7713080|FG000|STARTED|Overall Study||5
6783495|NCT01673425|7713080|FG000|COMPLETED|Overall Study||4
6783496|NCT01673425|7713080|FG000|NOT COMPLETED|Overall Study||1
6783497|NCT01673061|7713086|FG000|STARTED|Overall Study||0
6783498|NCT01673061|7713087|FG001|STARTED|Overall Study||0
6783499|NCT01673061|7713086|FG000|COMPLETED|Overall Study||0
6783500|NCT01673061|7713087|FG001|COMPLETED|Overall Study||0
6783501|NCT01673061|7713086|FG000|NOT COMPLETED|Overall Study||0
6783502|NCT01673061|7713087|FG001|NOT COMPLETED|Overall Study||0
6783503|NCT01675960|7713095|FG000|STARTED|Overall Study||2
6783504|NCT01675960|7713096|FG001|STARTED|Overall Study||0
6783505|NCT01675960|7713095|FG000|COMPLETED|Overall Study||2
6783506|NCT01675960|7713096|FG001|COMPLETED|Overall Study||0
6783507|NCT01675960|7713095|FG000|NOT COMPLETED|Overall Study||0
6783508|NCT01675960|7713096|FG001|NOT COMPLETED|Overall Study||0
6783509|NCT01668147|7713102|FG000|STARTED|Overall Study||13
6783510|NCT01668147|7713102|FG000|COMPLETED|Overall Study||7
6783511|NCT01668147|7713102|FG000|NOT COMPLETED|Overall Study||6
6783512|NCT01676701|7713112|FG000|STARTED|Overall Study||4
6783513|NCT01676701|7713113|FG001|STARTED|Overall Study||4
6783514|NCT01676701|7713112|FG000|Received at Least 1 Dose of Study Drug|Overall Study||4
6783515|NCT01676701|7713113|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
6783516|NCT01676701|7713112|FG000|Completed Post-Treatment Follow-Up|Overall Study||4
6783517|NCT01676701|7713113|FG001|Completed Post-Treatment Follow-Up|Overall Study||4
6783518|NCT01676701|7713112|FG000|COMPLETED|Overall Study||0
6783519|NCT01676701|7713113|FG001|COMPLETED|Overall Study||0
6783520|NCT01676701|7713112|FG000|NOT COMPLETED|Overall Study||4
6783521|NCT01676701|7713113|FG001|NOT COMPLETED|Overall Study||4
6783522|NCT01669148|7713121|FG000|STARTED|Overall Study||496
6783523|NCT01669148|7713121|FG000|COMPLETED|Overall Study||426
6783524|NCT01669148|7713121|FG000|NOT COMPLETED|Overall Study||70
6783525|NCT01662102|7713128|FG000|STARTED|Overall Study||1
6783526|NCT01662102|7713129|FG001|STARTED|Overall Study||0
6783527|NCT01662102|7713128|FG000|COMPLETED|Overall Study||0
6562998|NCT01804673|7485968|FG000|Completed Hour 24|Overall Study||170
6562999|NCT01804673|7485968|FG000|Completed Hour 48|Overall Study||79
6563000|NCT01804673|7485968|FG000|Completed Hour 72|Overall Study||36
6563001|NCT01804673|7485968|FG000|COMPLETED|Overall Study||34
6783528|NCT01662102|7713129|FG001|COMPLETED|Overall Study||0
6783529|NCT01662102|7713128|FG000|NOT COMPLETED|Overall Study||1
6783530|NCT01662102|7713129|FG001|NOT COMPLETED|Overall Study||0
6783531|NCT01659554|7713136|FG000|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
6783532|NCT01659554|7713136|FG000|COMPLETED|Overall Study||0
6783533|NCT01659554|7713136|FG000|NOT COMPLETED|Overall Study||4
6783534|NCT01658813|7713140|FG000|STARTED|Overall Study||18
6783535|NCT01658813|7713140|FG000|Eligible|Overall Study||18
6783536|NCT01658813|7713140|FG000|Treated|Overall Study||18
6783537|NCT01658813|7713140|FG000|COMPLETED|Overall Study||15
6783538|NCT01658813|7713140|FG000|NOT COMPLETED|Overall Study||3
6783539|NCT01648296|7713150|FG000|STARTED|Overall Study||11
6783540|NCT01648296|7713151|FG001|STARTED|Overall Study||17
6783541|NCT01648296|7713150|FG000|COMPLETED|Overall Study||11
6783542|NCT01648296|7713151|FG001|COMPLETED|Overall Study||17
6783543|NCT01648296|7713150|FG000|NOT COMPLETED|Overall Study||0
6783544|NCT01648296|7713151|FG001|NOT COMPLETED|Overall Study||0
6783545|NCT01649505|7713161|FG000|STARTED|Overall Study||1
6783546|NCT01649505|7713162|FG001|STARTED|Overall Study||1
6783547|NCT01649505|7713161|FG000|COMPLETED|Overall Study||0
6783548|NCT01649505|7713162|FG001|COMPLETED|Overall Study||0
6783549|NCT01649505|7713161|FG000|NOT COMPLETED|Overall Study||1
6783550|NCT01649505|7713162|FG001|NOT COMPLETED|Overall Study||1
6783551|NCT01642732|7713168|FG000|STARTED|Overall Study||1
6783552|NCT01642732|7713168|FG000|COMPLETED|Overall Study||0
6783553|NCT01642732|7713168|FG000|NOT COMPLETED|Overall Study||1
6783554|NCT01645709|7713174|FG000|STARTED|Overall Study|Study was terminated; not made unblind|0
6783555|NCT01645709|7713175|FG001|STARTED|Overall Study|Study was terminated; not made unblind|0
6783556|NCT01645709|7713174|FG000|COMPLETED|Overall Study|Study was terminated; not made unblind|0
6783557|NCT01645709|7713175|FG001|COMPLETED|Overall Study|Study was terminated; not made unblind|0
6783558|NCT01645709|7713174|FG000|NOT COMPLETED|Overall Study||0
6783559|NCT01645709|7713175|FG001|NOT COMPLETED|Overall Study||0
6783560|NCT01648270|7713181|FG000|STARTED|Intravenous Buprenorphine||25
6783561|NCT01648270|7713181|FG000|COMPLETED|Intravenous Buprenorphine||13
6783562|NCT01648270|7713181|FG000|NOT COMPLETED|Intravenous Buprenorphine||12
6783563|NCT01648270|7713181|FG000|STARTED|Sublingual Buprenorphine||13
6783564|NCT01648270|7713181|FG000|COMPLETED|Sublingual Buprenorphine||13
6783565|NCT01648270|7713181|FG000|NOT COMPLETED|Sublingual Buprenorphine||0
6783566|NCT01648270|7713181|FG000|STARTED|Cyclosporine Plus IV Buprenorphine||13
6783567|NCT01648270|7713181|FG000|COMPLETED|Cyclosporine Plus IV Buprenorphine||13
6783568|NCT01648270|7713181|FG000|NOT COMPLETED|Cyclosporine Plus IV Buprenorphine||0
6783569|NCT01648270|7713181|FG000|STARTED|Cyclosporine + Sublingual Buprenorphine||13
6783570|NCT01648270|7713181|FG000|COMPLETED|Cyclosporine + Sublingual Buprenorphine||13
6563002|NCT01804673|7485968|FG000|NOT COMPLETED|Overall Study||140
6783571|NCT01648270|7713181|FG000|NOT COMPLETED|Cyclosporine + Sublingual Buprenorphine||0
6783572|NCT01643525|7713191|FG000|STARTED|Overall Study||29
6783573|NCT01643525|7713191|FG000|COMPLETED|Overall Study||29
6783574|NCT01643525|7713191|FG000|NOT COMPLETED|Overall Study||0
6783575|NCT01641601|7713197|FG000|STARTED|Overall Study||3
6783576|NCT01641601|7713198|FG001|STARTED|Overall Study||5
6783577|NCT01641601|7713197|FG000|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
6783578|NCT01641601|7713198|FG001|COMPLETED|Overall Study|Study discontinued prior to data collection.|0
6783579|NCT01641601|7713197|FG000|NOT COMPLETED|Overall Study||3
6783580|NCT01641601|7713198|FG001|NOT COMPLETED|Overall Study||5
6783581|NCT01633814|7713204|FG000|STARTED|Overall Study||4
6783582|NCT01633814|7713204|FG000|COMPLETED|Overall Study||4
6783583|NCT01633814|7713204|FG000|NOT COMPLETED|Overall Study||0
6783584|NCT01636466|7713210|FG000|STARTED|Overall Study||1
6783585|NCT01636466|7713211|FG001|STARTED|Overall Study||0
6783586|NCT01636466|7713210|FG000|COMPLETED|Overall Study||0
6783587|NCT01636466|7713211|FG001|COMPLETED|Overall Study||0
6783588|NCT01636466|7713210|FG000|NOT COMPLETED|Overall Study||1
6783589|NCT01636466|7713211|FG001|NOT COMPLETED|Overall Study||0
6783590|NCT01629329|7713219|FG000|STARTED|Overall Study||0
6783591|NCT01629329|7713220|FG001|STARTED|Overall Study||0
6783592|NCT01629329|7713219|FG000|COMPLETED|Overall Study||0
6563003|NCT01804842|7485975|FG000|STARTED|Overall Study||9
6563004|NCT01804842|7485976|FG001|STARTED|Overall Study||8
6563005|NCT01804842|7485977|FG002|STARTED|Overall Study||9
6563006|NCT01804842|7485975|FG000|Completed Treatment A|Overall Study||9
6563007|NCT01804842|7485976|FG001|Completed Treatment A|Overall Study||6
6563008|NCT01804842|7485977|FG002|Completed Treatment A|Overall Study||8
6563009|NCT01804842|7485975|FG000|Completed Treatment B|Overall Study||8
6563010|NCT01804842|7485976|FG001|Completed Treatment B|Overall Study||8
6563011|NCT01804842|7485977|FG002|Completed Treatment B|Overall Study||8
6563012|NCT01804842|7485975|FG000|Completed Treatment C|Overall Study||7
6563013|NCT01804842|7485976|FG001|Completed Treatment C|Overall Study||7
6563014|NCT01804842|7485977|FG002|Completed Treatment C|Overall Study||9
6783593|NCT01629329|7713220|FG001|COMPLETED|Overall Study||0
6783594|NCT01629329|7713219|FG000|NOT COMPLETED|Overall Study||0
6783595|NCT01629329|7713220|FG001|NOT COMPLETED|Overall Study||0
6783596|NCT01627899|7713226|FG000|STARTED|Overall Study||5
6378221|NCT00767000|7288784|FG003|NOT COMPLETED|54-week Study||225
6378222|NCT00767000|7288785|FG004|NOT COMPLETED|54-week Study||224
6378223|NCT00767000|7288781|FG000|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
6563015|NCT01804842|7485975|FG000|COMPLETED|Overall Study||6
6563016|NCT01804842|7485976|FG001|COMPLETED|Overall Study||6
6783597|NCT01627899|7713226|FG000|COMPLETED|Overall Study||0
6783598|NCT01627899|7713226|FG000|NOT COMPLETED|Overall Study||5
6783599|NCT01632020|7713232|FG000|STARTED|Overall Study||4
6563017|NCT01804842|7485977|FG002|COMPLETED|Overall Study||8
6563018|NCT01804842|7485975|FG000|NOT COMPLETED|Overall Study||3
6563019|NCT01804842|7485976|FG001|NOT COMPLETED|Overall Study||2
6563020|NCT01804842|7485977|FG002|NOT COMPLETED|Overall Study||1
6563021|NCT01804881|7485987|FG000|STARTED|Overall Study||16
6563022|NCT01804881|7485988|FG001|STARTED|Overall Study||14
6783600|NCT01632020|7713233|FG001|STARTED|Overall Study||3
6783601|NCT01632020|7713232|FG000|COMPLETED|Overall Study||2
6783602|NCT01632020|7713233|FG001|COMPLETED|Overall Study||3
6783603|NCT01632020|7713232|FG000|NOT COMPLETED|Overall Study||2
6783604|NCT01632020|7713233|FG001|NOT COMPLETED|Overall Study||0
6783605|NCT01602471|7713239|FG000|STARTED|Overall Study||4
6783606|NCT01602471|7713239|FG000|COMPLETED|Overall Study||4
6783607|NCT01602471|7713239|FG000|NOT COMPLETED|Overall Study||0
6783608|NCT01619800|7713245|FG000|STARTED|Overall Study||2
6783609|NCT01619800|7713246|FG001|STARTED|Overall Study||0
6783610|NCT01619800|7713245|FG000|COMPLETED|Overall Study||0
6783611|NCT01619800|7713246|FG001|COMPLETED|Overall Study||0
6563023|NCT01804881|7485987|FG000|COMPLETED|Overall Study||11
6563024|NCT01804881|7485988|FG001|COMPLETED|Overall Study||10
6563025|NCT01804881|7485987|FG000|NOT COMPLETED|Overall Study||5
6783612|NCT01619800|7713245|FG000|NOT COMPLETED|Overall Study||2
6783613|NCT01619800|7713246|FG001|NOT COMPLETED|Overall Study||0
6783614|NCT01608906|7713252|FG000|STARTED|Overall Study||152
6783615|NCT01608906|7713252|FG000|COMPLETED|Overall Study||113
6563026|NCT01804881|7485988|FG001|NOT COMPLETED|Overall Study||4
6783616|NCT01608906|7713252|FG000|NOT COMPLETED|Overall Study||39
6783617|NCT01621737|7713257|FG000|STARTED|Overall Study||0
6783618|NCT01621737|7713257|FG000|COMPLETED|Overall Study||0
6783619|NCT01621737|7713257|FG000|NOT COMPLETED|Overall Study||0
6783620|NCT01614067|7713263|FG000|STARTED|Overall Study||15
6783621|NCT01614067|7713264|FG001|STARTED|Overall Study||15
6783622|NCT01614067|7713263|FG000|COMPLETED|Overall Study||0
6783623|NCT01614067|7713264|FG001|COMPLETED|Overall Study||0
6783624|NCT01614067|7713263|FG000|NOT COMPLETED|Overall Study||15
6783625|NCT01614067|7713264|FG001|NOT COMPLETED|Overall Study||15
6783626|NCT01607320|7713270|FG000|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
6783627|NCT01607320|7713271|FG001|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
6783628|NCT01607320|7713270|FG000|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
6783629|NCT01607320|7713271|FG001|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
6783630|NCT01607320|7713270|FG000|NOT COMPLETED|Overall Study||0
6783631|NCT01607320|7713271|FG001|NOT COMPLETED|Overall Study||0
6783632|NCT01605019|7713277|FG000|STARTED|Overall Study||4
6783633|NCT01605019|7713278|FG001|STARTED|Overall Study||0
6783634|NCT01605019|7713277|FG000|COMPLETED|Overall Study||1
6783635|NCT01605019|7713278|FG001|COMPLETED|Overall Study||0
6783636|NCT01605019|7713277|FG000|NOT COMPLETED|Overall Study||3
6783637|NCT01605019|7713278|FG001|NOT COMPLETED|Overall Study||0
6783638|NCT01609231|7713286|FG000|STARTED|Overall Study||6
6783639|NCT01609231|7713287|FG001|STARTED|Overall Study||5
6783640|NCT01609231|7713286|FG000|COMPLETED|Overall Study||3
6783641|NCT01609231|7713287|FG001|COMPLETED|Overall Study||2
6783642|NCT01609231|7713286|FG000|NOT COMPLETED|Overall Study||3
6783643|NCT01609231|7713287|FG001|NOT COMPLETED|Overall Study||3
6783644|NCT01602198|7713295|FG000|STARTED|Overall Study||0
6783645|NCT01602198|7713296|FG001|STARTED|Overall Study||1
6783646|NCT01602198|7713295|FG000|COMPLETED|Overall Study||0
6783647|NCT01602198|7713296|FG001|COMPLETED|Overall Study||1
6783648|NCT01602198|7713295|FG000|NOT COMPLETED|Overall Study||0
6783649|NCT01602198|7713296|FG001|NOT COMPLETED|Overall Study||0
6783650|NCT01606150|7713304|FG000|STARTED|Overall Study||0
6783651|NCT01606150|7713305|FG001|STARTED|Overall Study||0
6783652|NCT01606150|7713304|FG000|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
6783653|NCT01606150|7713305|FG001|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
6783654|NCT01606150|7713304|FG000|NOT COMPLETED|Overall Study||0
6783655|NCT01606150|7713305|FG001|NOT COMPLETED|Overall Study||0
6783656|NCT01603043|7713313|FG000|STARTED|Overall Study||7
6783657|NCT01603043|7713314|FG001|STARTED|Overall Study||3
6783658|NCT01603043|7713313|FG000|COMPLETED|Overall Study||0
6783659|NCT01603043|7713314|FG001|COMPLETED|Overall Study||0
6783660|NCT01603043|7713313|FG000|NOT COMPLETED|Overall Study||7
6783661|NCT01603043|7713314|FG001|NOT COMPLETED|Overall Study||3
6783662|NCT01605370|7713322|FG000|STARTED|Overall Study||1
6783663|NCT01605370|7713323|FG001|STARTED|Overall Study||0
6783664|NCT01605370|7713322|FG000|COMPLETED|Overall Study||0
6783665|NCT01605370|7713323|FG001|COMPLETED|Overall Study||0
6783666|NCT01605370|7713322|FG000|NOT COMPLETED|Overall Study||1
6783667|NCT01605370|7713323|FG001|NOT COMPLETED|Overall Study||0
6783668|NCT01605617|7713331|FG000|STARTED|First Intervention||2
6783669|NCT01605617|7713332|FG001|STARTED|First Intervention||2
6783670|NCT01605617|7713331|FG000|COMPLETED|First Intervention||2
6783671|NCT01605617|7713332|FG001|COMPLETED|First Intervention||1
6783672|NCT01605617|7713331|FG000|NOT COMPLETED|First Intervention||0
6783673|NCT01605617|7713332|FG001|NOT COMPLETED|First Intervention||1
6783674|NCT01605617|7713331|FG000|STARTED|Washout Period of 4 Weeks||2
6783675|NCT01605617|7713332|FG001|STARTED|Washout Period of 4 Weeks||1
6783676|NCT01605617|7713331|FG000|COMPLETED|Washout Period of 4 Weeks||0
6783677|NCT01605617|7713332|FG001|COMPLETED|Washout Period of 4 Weeks||0
6783678|NCT01605617|7713331|FG000|NOT COMPLETED|Washout Period of 4 Weeks||2
6783679|NCT01605617|7713332|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
6783680|NCT01605617|7713331|FG000|STARTED|Second Intervention||0
6783681|NCT01605617|7713332|FG001|STARTED|Second Intervention||0
6783682|NCT01605617|7713331|FG000|COMPLETED|Second Intervention||0
6783683|NCT01605617|7713332|FG001|COMPLETED|Second Intervention||0
6783684|NCT01605617|7713331|FG000|NOT COMPLETED|Second Intervention||0
6783685|NCT01605617|7713332|FG001|NOT COMPLETED|Second Intervention||0
6783686|NCT01606709|7713342|FG000|STARTED|Overall Study||4
6783687|NCT01606709|7713343|FG001|STARTED|Overall Study||3
6783688|NCT01606709|7713342|FG000|COMPLETED|Overall Study||4
6783689|NCT01606709|7713343|FG001|COMPLETED|Overall Study||3
6783690|NCT01606709|7713342|FG000|NOT COMPLETED|Overall Study||0
6783691|NCT01606709|7713343|FG001|NOT COMPLETED|Overall Study||0
6783692|NCT01603121|7713349|FG000|STARTED|First Intervention, 10 Hours||1
6783693|NCT01603121|7713350|FG001|STARTED|First Intervention, 10 Hours||0
6783694|NCT01603121|7713349|FG000|COMPLETED|First Intervention, 10 Hours||1
6783695|NCT01603121|7713350|FG001|COMPLETED|First Intervention, 10 Hours||0
6783696|NCT01603121|7713349|FG000|NOT COMPLETED|First Intervention, 10 Hours||0
6783697|NCT01603121|7713350|FG001|NOT COMPLETED|First Intervention, 10 Hours||0
6783698|NCT01603121|7713349|FG000|STARTED|Second Intervention, 10 Hours||1
6783699|NCT01603121|7713350|FG001|STARTED|Second Intervention, 10 Hours||0
6783700|NCT01603121|7713349|FG000|COMPLETED|Second Intervention, 10 Hours||0
6783701|NCT01603121|7713350|FG001|COMPLETED|Second Intervention, 10 Hours||0
6783702|NCT01603121|7713349|FG000|NOT COMPLETED|Second Intervention, 10 Hours||1
6783703|NCT01603121|7713350|FG001|NOT COMPLETED|Second Intervention, 10 Hours||0
6783704|NCT01602016|7713356|FG000|STARTED|Overall Study||0
6783705|NCT01602016|7713356|FG000|COMPLETED|Overall Study||0
6783706|NCT01602016|7713356|FG000|NOT COMPLETED|Overall Study||0
6783707|NCT01603394|7713363|FG000|STARTED|Overall Study||9
6783708|NCT01603394|7713363|FG000|COMPLETED|Overall Study||8
6783709|NCT01603394|7713363|FG000|NOT COMPLETED|Overall Study||1
6783710|NCT01592383|7713367|FG000|STARTED|Overall Study||2
6783711|NCT01592383|7713367|FG000|COMPLETED|Overall Study||1
6783712|NCT01592383|7713367|FG000|NOT COMPLETED|Overall Study||1
6783713|NCT01598025|7713374|FG000|STARTED|Overall Study||0
6783714|NCT01598025|7713375|FG001|STARTED|Overall Study||3
6783715|NCT01598025|7713374|FG000|COMPLETED|Overall Study||0
6783716|NCT01598025|7713375|FG001|COMPLETED|Overall Study||0
6783717|NCT01598025|7713374|FG000|NOT COMPLETED|Overall Study||0
6783718|NCT01598025|7713375|FG001|NOT COMPLETED|Overall Study||3
6783719|NCT01587963|7713382|FG000|STARTED|Overall Study||7
6783720|NCT01587963|7713383|FG001|STARTED|Overall Study||4
6783721|NCT01587963|7713382|FG000|COMPLETED|Overall Study||6
6783722|NCT01587963|7713383|FG001|COMPLETED|Overall Study||4
6783723|NCT01587963|7713382|FG000|NOT COMPLETED|Overall Study||1
6783724|NCT01587963|7713383|FG001|NOT COMPLETED|Overall Study||0
6783725|NCT01591096|7713389|FG000|STARTED|Overall Study||1
6783726|NCT01591096|7713389|FG000|COMPLETED|Overall Study||0
6783727|NCT01591096|7713389|FG000|NOT COMPLETED|Overall Study||1
6783728|NCT01591954|7713393|FG000|STARTED|Overall Study||1
6783729|NCT01591954|7713393|FG000|COMPLETED|Overall Study||1
6783730|NCT01591954|7713393|FG000|NOT COMPLETED|Overall Study||0
6783731|NCT01589926|7713399|FG000|STARTED|Overall Study||0
6783732|NCT01589926|7713400|FG001|STARTED|Overall Study||0
6783733|NCT01589926|7713399|FG000|COMPLETED|Overall Study||0
6378224|NCT00767000|7288782|FG001|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
6378225|NCT00767000|7288783|FG002|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
6378226|NCT00767000|7288784|FG003|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
6378227|NCT00767000|7288785|FG004|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
6378228|NCT00767000|7288781|FG000|COMPLETED|Optional 104-week Extension||0
6378229|NCT00767000|7288782|FG001|COMPLETED|Optional 104-week Extension||0
6378230|NCT00767000|7288783|FG002|COMPLETED|Optional 104-week Extension||0
6502137|NCT01432626|7420777|FG000|STARTED|Overall Study||10
6502138|NCT01432626|7420777|FG000|COMPLETED|Overall Study|Completed both images|3
6502139|NCT01432626|7420777|FG000|NOT COMPLETED|Overall Study||7
6378231|NCT00767000|7288784|FG003|COMPLETED|Optional 104-week Extension||0
6378232|NCT00767000|7288785|FG004|COMPLETED|Optional 104-week Extension||0
6378233|NCT00767000|7288781|FG000|NOT COMPLETED|Optional 104-week Extension||7
6378234|NCT00767000|7288782|FG001|NOT COMPLETED|Optional 104-week Extension||3
6378235|NCT00767000|7288783|FG002|NOT COMPLETED|Optional 104-week Extension||7
6378236|NCT00767000|7288784|FG003|NOT COMPLETED|Optional 104-week Extension||2
6378237|NCT00767000|7288785|FG004|NOT COMPLETED|Optional 104-week Extension||4
6378238|NCT00767039|7288799|FG000|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
6378239|NCT00767039|7288800|FG001|STARTED|Overall Study||25
6378240|NCT00767039|7288799|FG000|COMPLETED|Overall Study||22
6378241|NCT00767039|7288800|FG001|COMPLETED|Overall Study||23
6378242|NCT00767039|7288799|FG000|NOT COMPLETED|Overall Study||5
6378243|NCT00767039|7288800|FG001|NOT COMPLETED|Overall Study||2
6378244|NCT00767104|7288808|FG000|STARTED|Overall Study||20
6378245|NCT00767104|7288809|FG001|STARTED|Overall Study||20
6378246|NCT00767104|7288808|FG000|COMPLETED|Overall Study||19
6378247|NCT00767104|7288809|FG001|COMPLETED|Overall Study||18
6378248|NCT00767104|7288808|FG000|NOT COMPLETED|Overall Study||1
6378249|NCT00767104|7288809|FG001|NOT COMPLETED|Overall Study||2
6378250|NCT00767325|7288817|FG000|STARTED|Overall Study||104
6378251|NCT00767325|7288817|FG000|COMPLETED|Overall Study||89
6378252|NCT00767325|7288817|FG000|NOT COMPLETED|Overall Study||15
6378253|NCT00767338|7288825|FG000|STARTED|Overall Study||1
6378254|NCT00767338|7288826|FG001|STARTED|Overall Study||2
6378255|NCT00767338|7288827|FG002|STARTED|Overall Study||0
6502140|NCT01432730|7420781|FG000|STARTED|Period 1||12
6502141|NCT01432730|7420782|FG001|STARTED|Period 1||12
6502142|NCT01432730|7420781|FG000|COMPLETED|Period 1||10
6502143|NCT01432730|7420782|FG001|COMPLETED|Period 1||12
6502144|NCT01432730|7420781|FG000|NOT COMPLETED|Period 1||2
6502145|NCT01432730|7420782|FG001|NOT COMPLETED|Period 1||0
6502146|NCT01432730|7420781|FG000|STARTED|Period 2||10
6502147|NCT01432730|7420782|FG001|STARTED|Period 2||12
6502148|NCT01432730|7420781|FG000|COMPLETED|Period 2||10
6502149|NCT01432730|7420782|FG001|COMPLETED|Period 2||8
6502150|NCT01432730|7420781|FG000|NOT COMPLETED|Period 2||0
6502151|NCT01432730|7420782|FG001|NOT COMPLETED|Period 2||4
6502152|NCT01432756|7420792|FG000|STARTED|Overall Study||32
6502153|NCT01432756|7420793|FG001|STARTED|Overall Study||34
6502154|NCT01432756|7420794|FG002|STARTED|Overall Study||32
6502155|NCT01432756|7420795|FG003|STARTED|Overall Study||34
6502156|NCT01432756|7420792|FG000|COMPLETED|Overall Study||31
6783734|NCT01589926|7713400|FG001|COMPLETED|Overall Study||0
6783735|NCT01589926|7713399|FG000|NOT COMPLETED|Overall Study||0
6783736|NCT01589926|7713400|FG001|NOT COMPLETED|Overall Study||0
6783737|NCT01576575|7713406|FG000|STARTED|Buprenorphine Control||21
6783738|NCT01576575|7713406|FG000|COMPLETED|Buprenorphine Control||18
6783739|NCT01576575|7713406|FG000|NOT COMPLETED|Buprenorphine Control||3
6783740|NCT01576575|7713406|FG000|STARTED|Buprenorphine + Rifampin||18
6783741|NCT01576575|7713406|FG000|COMPLETED|Buprenorphine + Rifampin||15
6783742|NCT01576575|7713406|FG000|NOT COMPLETED|Buprenorphine + Rifampin||3
6783743|NCT01576575|7713406|FG000|STARTED|Buprenorphine + Grapefruit||15
6783744|NCT01576575|7713406|FG000|COMPLETED|Buprenorphine + Grapefruit||14
6783745|NCT01576575|7713406|FG000|NOT COMPLETED|Buprenorphine + Grapefruit||1
6783746|NCT01576575|7713406|FG000|STARTED|Buprenorphine + Ketoconazole||14
6783747|NCT01576575|7713406|FG000|COMPLETED|Buprenorphine + Ketoconazole||14
6783748|NCT01576575|7713406|FG000|NOT COMPLETED|Buprenorphine + Ketoconazole||0
6783749|NCT01590394|7713416|FG000|STARTED|Overall Study||3
6783750|NCT01590394|7713416|FG000|COMPLETED|Overall Study||3
6783751|NCT01590394|7713416|FG000|NOT COMPLETED|Overall Study||0
6783752|NCT01577628|7713422|FG000|STARTED|Overall Study||0
6783753|NCT01577628|7713423|FG001|STARTED|Overall Study||0
6783754|NCT01577628|7713424|FG002|STARTED|Overall Study||2
6783755|NCT01577628|7713422|FG000|COMPLETED|Overall Study||0
6783756|NCT01577628|7713423|FG001|COMPLETED|Overall Study||0
6783757|NCT01577628|7713424|FG002|COMPLETED|Overall Study||0
6783758|NCT01577628|7713422|FG000|NOT COMPLETED|Overall Study||0
6783759|NCT01577628|7713423|FG001|NOT COMPLETED|Overall Study||0
6783760|NCT01577628|7713424|FG002|NOT COMPLETED|Overall Study||2
6783761|NCT01582100|7713430|FG000|STARTED|Overall Study||2
6783762|NCT01582100|7713430|FG000|COMPLETED|Overall Study||0
6783763|NCT01582100|7713430|FG000|NOT COMPLETED|Overall Study||2
6783764|NCT01583647|7713434|FG000|STARTED|Overall Study||10
6783765|NCT01583647|7713435|FG001|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
6783766|NCT01583647|7713434|FG000|COMPLETED|Overall Study||10
6783767|NCT01583647|7713435|FG001|COMPLETED|Overall Study||0
6783768|NCT01583647|7713434|FG000|NOT COMPLETED|Overall Study||0
6783769|NCT01583647|7713435|FG001|NOT COMPLETED|Overall Study||0
6783770|NCT01575028|7713443|FG000|STARTED|Overall Study||2
6783771|NCT01575028|7713444|FG001|STARTED|Overall Study||1
6378256|NCT00767338|7288828|FG003|STARTED|Overall Study||0
6378257|NCT00767338|7288825|FG000|COMPLETED|Overall Study||0
6378258|NCT00767338|7288826|FG001|COMPLETED|Overall Study||0
6378259|NCT00767338|7288827|FG002|COMPLETED|Overall Study||0
6378260|NCT00767338|7288828|FG003|COMPLETED|Overall Study||0
6378261|NCT00767338|7288825|FG000|NOT COMPLETED|Overall Study||1
6378262|NCT00767338|7288826|FG001|NOT COMPLETED|Overall Study||2
6378263|NCT00767338|7288827|FG002|NOT COMPLETED|Overall Study||0
6378264|NCT00767338|7288828|FG003|NOT COMPLETED|Overall Study||0
6378265|NCT00767364|7288840|FG000|STARTED|Overall Study||5
6378266|NCT00767364|7288841|FG001|STARTED|Overall Study||3
6378267|NCT00767364|7288840|FG000|COMPLETED|Overall Study||5
6378268|NCT00767364|7288841|FG001|COMPLETED|Overall Study||3
6378269|NCT00767364|7288840|FG000|NOT COMPLETED|Overall Study||0
6783772|NCT01575028|7713443|FG000|COMPLETED|Overall Study||2
6783773|NCT01575028|7713444|FG001|COMPLETED|Overall Study||0
6783774|NCT01575028|7713443|FG000|NOT COMPLETED|Overall Study||0
6783775|NCT01575028|7713444|FG001|NOT COMPLETED|Overall Study||1
6783776|NCT01578785|7713452|FG000|STARTED|Overall Study||59
6783777|NCT01578785|7713453|FG001|STARTED|Overall Study||119
6783778|NCT01578785|7713452|FG000|COMPLETED|Overall Study||0
6783779|NCT01578785|7713453|FG001|COMPLETED|Overall Study||0
6783780|NCT01578785|7713452|FG000|NOT COMPLETED|Overall Study||59
6783781|NCT01578785|7713453|FG001|NOT COMPLETED|Overall Study||119
6783782|NCT01576549|7713459|FG000|STARTED|Overall Study||2
6783783|NCT01576549|7713459|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
6783784|NCT01576549|7713459|FG000|Completed Post-Treatment Follow-Up|Overall Study|Each participant discontinued dosing and completed the Post-Treatment Follow-Up Period.|2
6783785|NCT01576549|7713459|FG000|COMPLETED|Overall Study||0
6783786|NCT01576549|7713459|FG000|NOT COMPLETED|Overall Study||2
6783787|NCT01570634|7713464|FG000|STARTED|Overall Study||2
6783788|NCT01570634|7713464|FG000|COMPLETED|Overall Study||2
6783789|NCT01570634|7713464|FG000|NOT COMPLETED|Overall Study||0
6783790|NCT01566370|7713470|FG000|STARTED|Overall Study||2
6783791|NCT01566370|7713471|FG001|STARTED|Overall Study||1
6783792|NCT01566370|7713470|FG000|COMPLETED|Overall Study||0
6783793|NCT01566370|7713471|FG001|COMPLETED|Overall Study||0
6783794|NCT01566370|7713470|FG000|NOT COMPLETED|Overall Study||2
6783795|NCT01566370|7713471|FG001|NOT COMPLETED|Overall Study||1
6783796|NCT01561989|7713479|FG000|STARTED|Overall Study||5
6783797|NCT01561989|7713480|FG001|STARTED|Overall Study||6
6783798|NCT01561989|7713479|FG000|COMPLETED|Overall Study||0
6783799|NCT01561989|7713480|FG001|COMPLETED|Overall Study||0
6783800|NCT01561989|7713479|FG000|NOT COMPLETED|Overall Study||5
6783801|NCT01561989|7713480|FG001|NOT COMPLETED|Overall Study||6
6783802|NCT01564732|7713488|FG000|STARTED|Overall Study||6
6783803|NCT01564732|7713489|FG001|STARTED|Overall Study||5
6783804|NCT01564732|7713488|FG000|COMPLETED|Overall Study||0
6783805|NCT01564732|7713489|FG001|COMPLETED|Overall Study||0
6783806|NCT01564732|7713488|FG000|NOT COMPLETED|Overall Study||6
6783807|NCT01564732|7713489|FG001|NOT COMPLETED|Overall Study||5
6783808|NCT01560507|7713498|FG000|STARTED|Overall Study||5
6378270|NCT00767364|7288841|FG001|NOT COMPLETED|Overall Study||0
6378271|NCT00767455|7288847|FG000|STARTED|Overall Study||59
6378272|NCT00767455|7288847|FG000|COMPLETED|Overall Study||40
6378273|NCT00767455|7288847|FG000|NOT COMPLETED|Overall Study||19
6378274|NCT00767507|7288857|FG000|STARTED|Overall Study||5
6783809|NCT01560507|7713499|FG001|STARTED|Overall Study||2
6783810|NCT01560507|7713500|FG002|STARTED|Overall Study||2
6783811|NCT01560507|7713498|FG000|COMPLETED|Overall Study||1
6783812|NCT01560507|7713499|FG001|COMPLETED|Overall Study||0
6783813|NCT01560507|7713500|FG002|COMPLETED|Overall Study||0
6783814|NCT01560507|7713498|FG000|NOT COMPLETED|Overall Study||4
6783815|NCT01560507|7713499|FG001|NOT COMPLETED|Overall Study||2
6783816|NCT01560507|7713500|FG002|NOT COMPLETED|Overall Study||2
6783817|NCT01557881|7713511|FG000|STARTED|Overall Study||98
6783818|NCT01557881|7713511|FG000|COMPLETED|Overall Study||98
6783819|NCT01557881|7713511|FG000|NOT COMPLETED|Overall Study||0
6783820|NCT01555489|7713515|FG000|STARTED|Overall Study||11
6783821|NCT01555489|7713515|FG000|COMPLETED|Overall Study||11
6783822|NCT01555489|7713515|FG000|NOT COMPLETED|Overall Study||0
6783823|NCT01549977|7713521|FG000|STARTED|Overall Study||1
6783824|NCT01549977|7713522|FG001|STARTED|Overall Study||0
6783825|NCT01549977|7713521|FG000|COMPLETED|Overall Study||1
6783826|NCT01549977|7713522|FG001|COMPLETED|Overall Study||0
6783827|NCT01549977|7713521|FG000|NOT COMPLETED|Overall Study||0
6783828|NCT01549977|7713522|FG001|NOT COMPLETED|Overall Study||0
6783829|NCT01558492|7713528|FG000|STARTED|Overall Study||3
6783830|NCT01558492|7713528|FG000|COMPLETED|Overall Study||3
6783831|NCT01558492|7713528|FG000|NOT COMPLETED|Overall Study||0
6783832|NCT01550562|7713532|FG000|STARTED|First Intervention, 4 - 5 Days||1
6783833|NCT01550562|7713532|FG000|COMPLETED|First Intervention, 4 - 5 Days||1
6783834|NCT01550562|7713532|FG000|NOT COMPLETED|First Intervention, 4 - 5 Days||0
6783835|NCT01550562|7713532|FG000|STARTED|Second Intervention, 4 - 5 Days||1
6783836|NCT01550562|7713532|FG000|COMPLETED|Second Intervention, 4 - 5 Days||1
6783837|NCT01550562|7713532|FG000|NOT COMPLETED|Second Intervention, 4 - 5 Days||0
6783838|NCT01550562|7713532|FG000|STARTED|Third Intervention, 4 - 5 Days||1
6783839|NCT01550562|7713532|FG000|COMPLETED|Third Intervention, 4 - 5 Days||1
6783840|NCT01550562|7713532|FG000|NOT COMPLETED|Third Intervention, 4 - 5 Days||0
6783841|NCT01561495|7713536|FG000|STARTED|Overall Study||1
6783842|NCT01561495|7713536|FG000|COMPLETED|Overall Study||1
6783843|NCT01561495|7713536|FG000|NOT COMPLETED|Overall Study||0
6783844|NCT01555073|7713544|FG000|STARTED|Overall Study||7
6783845|NCT01555073|7713545|FG001|STARTED|Overall Study||3
6783846|NCT01555073|7713546|FG002|STARTED|Overall Study||7
6783847|NCT01555073|7713547|FG003|STARTED|Overall Study||6
6783848|NCT01555073|7713544|FG000|COMPLETED|Overall Study||6
6783849|NCT01555073|7713545|FG001|COMPLETED|Overall Study||1
6783850|NCT01555073|7713546|FG002|COMPLETED|Overall Study||7
6783851|NCT01555073|7713547|FG003|COMPLETED|Overall Study||1
6783852|NCT01555073|7713544|FG000|NOT COMPLETED|Overall Study||1
6783853|NCT01555073|7713545|FG001|NOT COMPLETED|Overall Study||2
6783854|NCT01555073|7713546|FG002|NOT COMPLETED|Overall Study||0
6783855|NCT01555073|7713547|FG003|NOT COMPLETED|Overall Study||5
6783856|NCT01551082|7713557|FG000|STARTED|Overall Study||12
6783857|NCT01551082|7713557|FG000|COMPLETED|Overall Study||12
6783858|NCT01551082|7713557|FG000|NOT COMPLETED|Overall Study||0
6783859|NCT01556009|7713563|FG000|STARTED|Overall Study||0
6783860|NCT01556009|7713564|FG001|STARTED|Overall Study||0
6783861|NCT01556009|7713563|FG000|COMPLETED|Overall Study||0
6783862|NCT01556009|7713564|FG001|COMPLETED|Overall Study||0
6783863|NCT01556009|7713563|FG000|NOT COMPLETED|Overall Study||0
6783864|NCT01556009|7713564|FG001|NOT COMPLETED|Overall Study||0
6783865|NCT01550510|7713572|FG000|STARTED|Overall Study||4
6783866|NCT01550510|7713573|FG001|STARTED|Overall Study||0
6783867|NCT01550510|7713572|FG000|COMPLETED|Overall Study||4
6783868|NCT01550510|7713573|FG001|COMPLETED|Overall Study||0
6783869|NCT01550510|7713572|FG000|NOT COMPLETED|Overall Study||0
6783870|NCT01550510|7713573|FG001|NOT COMPLETED|Overall Study||0
6783871|NCT01541397|7713582|FG000|STARTED|Overall Study||4
6783872|NCT01541397|7713583|FG001|STARTED|Overall Study||2
6378275|NCT00767507|7288858|FG001|STARTED|Overall Study||6
6378276|NCT00767507|7288859|FG002|STARTED|Overall Study||106
6783873|NCT01541397|7713582|FG000|COMPLETED|Overall Study||0
6783874|NCT01541397|7713583|FG001|COMPLETED|Overall Study||0
6783875|NCT01541397|7713582|FG000|NOT COMPLETED|Overall Study||4
6783876|NCT01541397|7713583|FG001|NOT COMPLETED|Overall Study||2
6783877|NCT01546207|7713589|FG000|STARTED|Overall Study||4
6783878|NCT01546207|7713589|FG000|COMPLETED|Overall Study||3
6783879|NCT01546207|7713589|FG000|NOT COMPLETED|Overall Study||1
6783880|NCT01553240|7713593|FG000|STARTED|Overall Study||0
6783881|NCT01553240|7713593|FG000|COMPLETED|Overall Study||0
6563027|NCT01804946|7485998|FG000|STARTED|Overall Study||81
6563028|NCT01804946|7485999|FG001|STARTED|Overall Study||80
6563029|NCT01804946|7485998|FG000|COMPLETED|Overall Study||79
6783882|NCT01553240|7713593|FG000|NOT COMPLETED|Overall Study||0
6783883|NCT01547728|7713597|FG000|STARTED|Overall Study||42
6783884|NCT01547728|7713597|FG000|COMPLETED|Overall Study||1
6783885|NCT01547728|7713597|FG000|NOT COMPLETED|Overall Study||41
6783886|NCT01548651|7713603|FG000|STARTED|Overall Study||4
6783887|NCT01548651|7713604|FG001|STARTED|Overall Study||4
6783888|NCT01548651|7713603|FG000|COMPLETED|Overall Study||3
6783889|NCT01548651|7713604|FG001|COMPLETED|Overall Study||4
6783890|NCT01548651|7713603|FG000|NOT COMPLETED|Overall Study||1
6783891|NCT01548651|7713604|FG001|NOT COMPLETED|Overall Study||0
6783892|NCT01545648|7713610|FG000|STARTED|Overall Study||4
6783893|NCT01545648|7713610|FG000|6 Months of Treatment|Overall Study||4
6783894|NCT01545648|7713610|FG000|COMPLETED|Overall Study||4
6563030|NCT01804946|7485999|FG001|COMPLETED|Overall Study||76
6563031|NCT01804946|7485998|FG000|NOT COMPLETED|Overall Study||2
6563032|NCT01804946|7485999|FG001|NOT COMPLETED|Overall Study||4
6563033|NCT01805024|7486011|FG000|STARTED|Overall Study||4
6563034|NCT01805024|7486012|FG001|STARTED|Overall Study||4
6563035|NCT01805024|7486013|FG002|STARTED|Overall Study||4
6783895|NCT01545648|7713610|FG000|NOT COMPLETED|Overall Study||0
6783896|NCT01546883|7713614|FG000|STARTED|Overall Study||14
6783897|NCT01546883|7713614|FG000|COMPLETED|Overall Study||2
6783898|NCT01546883|7713614|FG000|NOT COMPLETED|Overall Study||12
6783899|NCT01545518|7713618|FG000|STARTED|Overall Study||20
6783900|NCT01545518|7713618|FG000|COMPLETED|Overall Study||20
6783901|NCT01545518|7713618|FG000|NOT COMPLETED|Overall Study||0
6783902|NCT01536015|7713624|FG000|STARTED|Overall Study||12
6783903|NCT01536015|7713625|FG001|STARTED|Overall Study||13
6783904|NCT01536015|7713624|FG000|COMPLETED|Overall Study||4
6783905|NCT01536015|7713625|FG001|COMPLETED|Overall Study||3
6783906|NCT01536015|7713624|FG000|NOT COMPLETED|Overall Study||8
6783907|NCT01536015|7713625|FG001|NOT COMPLETED|Overall Study||10
6783908|NCT01539590|7713633|FG000|STARTED|Overall Study||3
6783909|NCT01539590|7713634|FG001|STARTED|Overall Study||2
6783910|NCT01539590|7713633|FG000|Complete Study Treatment|Overall Study||1
6783911|NCT01539590|7713634|FG001|Complete Study Treatment|Overall Study||2
6783912|NCT01539590|7713633|FG000|COMPLETED|Overall Study||0
6783913|NCT01539590|7713634|FG001|COMPLETED|Overall Study||2
6783914|NCT01539590|7713633|FG000|NOT COMPLETED|Overall Study||3
6783915|NCT01539590|7713634|FG001|NOT COMPLETED|Overall Study||0
6783916|NCT01539811|7713642|FG000|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
6783917|NCT01539811|7713643|FG001|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
6783918|NCT01539811|7713642|FG000|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
6783919|NCT01539811|7713643|FG001|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
6783920|NCT01539811|7713642|FG000|NOT COMPLETED|Overall Study||0
6783921|NCT01539811|7713643|FG001|NOT COMPLETED|Overall Study||0
6783922|NCT01534676|7713651|FG000|STARTED|Overall Study||2
6783923|NCT01534676|7713652|FG001|STARTED|Overall Study||1
6783924|NCT01534676|7713651|FG000|COMPLETED|Overall Study||0
6783925|NCT01534676|7713652|FG001|COMPLETED|Overall Study||0
6783926|NCT01534676|7713651|FG000|NOT COMPLETED|Overall Study||2
6783927|NCT01534676|7713652|FG001|NOT COMPLETED|Overall Study||1
6783928|NCT01533753|7713660|FG000|STARTED|Overall Study||2
6783929|NCT01533753|7713661|FG001|STARTED|Overall Study||3
6783930|NCT01533753|7713660|FG000|COMPLETED|Overall Study||2
6783931|NCT01533753|7713661|FG001|COMPLETED|Overall Study||3
6783932|NCT01533753|7713660|FG000|NOT COMPLETED|Overall Study||0
6783933|NCT01533753|7713661|FG001|NOT COMPLETED|Overall Study||0
6783934|NCT01534143|7713667|FG000|STARTED|Overall Study||1
6783935|NCT01534143|7713667|FG000|COMPLETED|Overall Study||1
6783936|NCT01534143|7713667|FG000|NOT COMPLETED|Overall Study||0
6783937|NCT01530880|7713671|FG000|STARTED|Overall Study||35
6783938|NCT01530880|7713671|FG000|COMPLETED|Overall Study||35
6783939|NCT01530880|7713671|FG000|NOT COMPLETED|Overall Study||0
6783940|NCT01530087|7713676|FG000|STARTED|Overall Study||3
6783941|NCT01530087|7713676|FG000|COMPLETED|Overall Study||1
6783942|NCT01530087|7713676|FG000|NOT COMPLETED|Overall Study||2
6563036|NCT01805024|7486014|FG003|STARTED|Overall Study||8
6563037|NCT01805024|7486011|FG000|COMPLETED|Overall Study||4
6563038|NCT01805024|7486012|FG001|COMPLETED|Overall Study||4
6783943|NCT01527942|7713683|FG000|STARTED|Overall Study||16
6783944|NCT01527942|7713684|FG001|STARTED|Overall Study||18
6783945|NCT01527942|7713683|FG000|COMPLETED|Overall Study||16
6783946|NCT01527942|7713684|FG001|COMPLETED|Overall Study||18
6783947|NCT01527942|7713683|FG000|NOT COMPLETED|Overall Study||0
6783948|NCT01527942|7713684|FG001|NOT COMPLETED|Overall Study||0
6783949|NCT01521143|7713694|FG000|STARTED|Overall Study||40
6783950|NCT01521143|7713695|FG001|STARTED|Overall Study||36
6783951|NCT01521143|7713696|FG002|STARTED|Overall Study||8
6783952|NCT01521143|7713697|FG003|STARTED|Overall Study||7
6783953|NCT01521143|7713694|FG000|Received Treatment|Overall Study||20
6783954|NCT01521143|7713695|FG001|Received Treatment|Overall Study||20
6783955|NCT01521143|7713696|FG002|Received Treatment|Overall Study||3
6783956|NCT01521143|7713697|FG003|Received Treatment|Overall Study||4
6783957|NCT01521143|7713694|FG000|COMPLETED|Overall Study||11
6783958|NCT01521143|7713695|FG001|COMPLETED|Overall Study||10
6783959|NCT01521143|7713696|FG002|COMPLETED|Overall Study||0
6783960|NCT01521143|7713697|FG003|COMPLETED|Overall Study||0
6783961|NCT01521143|7713694|FG000|NOT COMPLETED|Overall Study||29
6783962|NCT01521143|7713695|FG001|NOT COMPLETED|Overall Study||26
6783963|NCT01521143|7713696|FG002|NOT COMPLETED|Overall Study||8
6783964|NCT01521143|7713697|FG003|NOT COMPLETED|Overall Study||7
6783965|NCT01532635|7713707|FG000|STARTED|Overall Study||4
6783966|NCT01532635|7713707|FG000|COMPLETED|Overall Study||4
6783967|NCT01532635|7713707|FG000|NOT COMPLETED|Overall Study||0
6783968|NCT01531387|7713713|FG000|STARTED|Overall Study||11
6783969|NCT01531387|7713714|FG001|STARTED|Overall Study||11
6783970|NCT01531387|7713713|FG000|COMPLETED|Overall Study||0
6783971|NCT01531387|7713714|FG001|COMPLETED|Overall Study||0
6783972|NCT01531387|7713713|FG000|NOT COMPLETED|Overall Study||11
6783973|NCT01531387|7713714|FG001|NOT COMPLETED|Overall Study||11
6783974|NCT01532362|7713722|FG000|STARTED|Overall Study||1
6783975|NCT01532362|7713723|FG001|STARTED|Overall Study||0
6783976|NCT01532362|7713722|FG000|COMPLETED|Overall Study||1
6783977|NCT01532362|7713723|FG001|COMPLETED|Overall Study||0
6783978|NCT01532362|7713722|FG000|NOT COMPLETED|Overall Study||0
6783979|NCT01532362|7713723|FG001|NOT COMPLETED|Overall Study||0
6783980|NCT01527292|7713733|FG000|STARTED|Overall Study||0
6783981|NCT01527292|7713734|FG001|STARTED|Overall Study||3
6783982|NCT01527292|7713733|FG000|COMPLETED|Overall Study||0
6783983|NCT01527292|7713734|FG001|COMPLETED|Overall Study||0
6783984|NCT01527292|7713733|FG000|NOT COMPLETED|Overall Study||0
6783985|NCT01527292|7713734|FG001|NOT COMPLETED|Overall Study||3
6783986|NCT01525745|7713742|FG000|STARTED|Overall Study||4
6783987|NCT01525745|7713743|FG001|STARTED|Overall Study||2
6783988|NCT01525745|7713742|FG000|COMPLETED|Overall Study||3
6783989|NCT01525745|7713743|FG001|COMPLETED|Overall Study||1
6783990|NCT01525745|7713742|FG000|NOT COMPLETED|Overall Study||1
6783991|NCT01525745|7713743|FG001|NOT COMPLETED|Overall Study||1
6783992|NCT01528696|7713753|FG000|STARTED|Overall Study||18
6783993|NCT01528696|7713754|FG001|STARTED|Overall Study||19
6783994|NCT01528696|7713753|FG000|Hospital Stay (2-5 Days)|Overall Study||18
6783995|NCT01528696|7713754|FG001|Hospital Stay (2-5 Days)|Overall Study||19
6783996|NCT01528696|7713753|FG000|COMPLETED|Overall Study||0
6783997|NCT01528696|7713754|FG001|COMPLETED|Overall Study||0
6783998|NCT01528696|7713753|FG000|NOT COMPLETED|Overall Study||18
6783999|NCT01528696|7713754|FG001|NOT COMPLETED|Overall Study||19
6784000|NCT01526408|7713762|FG000|STARTED|Overall Study|early termination of study and sponsor organization closed|0
6784001|NCT01526408|7713763|FG001|STARTED|Overall Study|early termination of study and sponsor organization closed|0
6784002|NCT01526408|7713762|FG000|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
6784003|NCT01526408|7713763|FG001|COMPLETED|Overall Study|early termination of study and sponsor organization closed|0
6784004|NCT01526408|7713762|FG000|NOT COMPLETED|Overall Study||0
6784005|NCT01526408|7713763|FG001|NOT COMPLETED|Overall Study||0
6784006|NCT01528293|7713771|FG000|STARTED|Overall Study||1
6784007|NCT01528293|7713772|FG001|STARTED|Overall Study||1
6784008|NCT01528293|7713771|FG000|COMPLETED|Overall Study||0
6784009|NCT01528293|7713772|FG001|COMPLETED|Overall Study||1
6784010|NCT01528293|7713771|FG000|NOT COMPLETED|Overall Study||1
6784011|NCT01528293|7713772|FG001|NOT COMPLETED|Overall Study||0
6784012|NCT01525927|7713780|FG000|STARTED|Overall Study||0
6784013|NCT01525927|7713780|FG000|COMPLETED|Overall Study||0
6784014|NCT01525927|7713780|FG000|NOT COMPLETED|Overall Study||0
6784015|NCT01520714|7713788|FG000|STARTED|Overall Study||0
6784016|NCT01520714|7713789|FG001|STARTED|Overall Study||11
6784017|NCT01520714|7713788|FG000|COMPLETED|Overall Study||0
6784018|NCT01520714|7713789|FG001|COMPLETED|Overall Study||5
6784019|NCT01520714|7713788|FG000|NOT COMPLETED|Overall Study||0
6784020|NCT01520714|7713789|FG001|NOT COMPLETED|Overall Study||6
6784021|NCT01507233|7713797|FG000|STARTED|Overall Study||5
6784022|NCT01507233|7713798|FG001|STARTED|Overall Study||0
6784023|NCT01507233|7713797|FG000|COMPLETED|Overall Study||5
6784024|NCT01507233|7713798|FG001|COMPLETED|Overall Study||0
6784025|NCT01507233|7713797|FG000|NOT COMPLETED|Overall Study||0
6784026|NCT01507233|7713798|FG001|NOT COMPLETED|Overall Study||0
6784027|NCT01516034|7713804|FG000|STARTED|Overall Study||8
6784028|NCT01516034|7713804|FG000|COMPLETED|Overall Study||0
6784029|NCT01516034|7713804|FG000|NOT COMPLETED|Overall Study||8
6784030|NCT01500772|7713808|FG000|STARTED|Overall Study||6
6784031|NCT01500772|7713808|FG000|COMPLETED|Overall Study||0
6784032|NCT01500772|7713808|FG000|NOT COMPLETED|Overall Study||6
6784033|NCT01517763|7713815|FG000|STARTED|Overall Study||0
6784034|NCT01517763|7713816|FG001|STARTED|Overall Study||0
6784035|NCT01517763|7713817|FG002|STARTED|Overall Study||0
6784036|NCT01517763|7713815|FG000|COMPLETED|Overall Study||0
6784037|NCT01517763|7713816|FG001|COMPLETED|Overall Study||0
6784038|NCT01517763|7713817|FG002|COMPLETED|Overall Study||0
6784039|NCT01517763|7713815|FG000|NOT COMPLETED|Overall Study||0
6784040|NCT01517763|7713816|FG001|NOT COMPLETED|Overall Study||0
6784041|NCT01517763|7713817|FG002|NOT COMPLETED|Overall Study||0
6784042|NCT01507584|7713825|FG000|STARTED|Overall Study||0
6378277|NCT00767507|7288860|FG003|STARTED|Overall Study||104
6378278|NCT00767507|7288857|FG000|COMPLETED|Overall Study||5
6378279|NCT00767507|7288858|FG001|COMPLETED|Overall Study||6
6378280|NCT00767507|7288859|FG002|COMPLETED|Overall Study||106
6378281|NCT00767507|7288860|FG003|COMPLETED|Overall Study||101
6378282|NCT00767507|7288857|FG000|NOT COMPLETED|Overall Study||0
6378283|NCT00767507|7288858|FG001|NOT COMPLETED|Overall Study||0
6378284|NCT00767507|7288859|FG002|NOT COMPLETED|Overall Study||0
6378285|NCT00767507|7288860|FG003|NOT COMPLETED|Overall Study||3
6378286|NCT00767520|7288879|FG000|STARTED|Overall Study||79
6378287|NCT00767520|7288880|FG001|STARTED|Overall Study||78
6378288|NCT00767520|7288879|FG000|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
6378289|NCT00767520|7288880|FG001|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
6378290|NCT00767520|7288879|FG000|NOT COMPLETED|Overall Study||11
6378291|NCT00767520|7288880|FG001|NOT COMPLETED|Overall Study||17
6378292|NCT00767572|7288886|FG000|STARTED|First Intervention (12 Weeks)||12
6378293|NCT00767572|7288886|FG000|COMPLETED|First Intervention (12 Weeks)||12
6378294|NCT00767572|7288886|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
6378295|NCT00767572|7288886|FG000|STARTED|Washout (4 Weeks)||12
6378296|NCT00767572|7288886|FG000|COMPLETED|Washout (4 Weeks)||12
6378297|NCT00767572|7288886|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6378298|NCT00767572|7288886|FG000|STARTED|Second Intervention (12 Weeks)||12
6378299|NCT00767572|7288886|FG000|COMPLETED|Second Intervention (12 Weeks)||12
6378300|NCT00767572|7288886|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
6378301|NCT00767624|7288894|FG000|STARTED|Overall Study||75
6378302|NCT00767624|7288895|FG001|STARTED|Overall Study||75
6378303|NCT00767624|7288894|FG000|COMPLETED|Overall Study||51
6378304|NCT00767624|7288895|FG001|COMPLETED|Overall Study||58
6378305|NCT00767624|7288894|FG000|NOT COMPLETED|Overall Study||24
6378306|NCT00767624|7288895|FG001|NOT COMPLETED|Overall Study||17
6378307|NCT00767676|7288901|FG000|STARTED|Overall Study||259
6378308|NCT00767676|7288901|FG000|COMPLETED|Overall Study||205
6378309|NCT00767676|7288901|FG000|NOT COMPLETED|Overall Study||54
6378310|NCT00767767|7288910|FG000|STARTED|Overall Study||21
6378311|NCT00767767|7288911|FG001|STARTED|Overall Study||20
6378312|NCT00767767|7288912|FG002|STARTED|Overall Study||20
6378313|NCT00767767|7288913|FG003|STARTED|Overall Study||3
6378314|NCT00767767|7288914|FG004|STARTED|Overall Study||3
6378315|NCT00767767|7288910|FG000|COMPLETED|Overall Study||21
6378316|NCT00767767|7288911|FG001|COMPLETED|Overall Study||20
6378317|NCT00767767|7288912|FG002|COMPLETED|Overall Study||20
6378318|NCT00767767|7288913|FG003|COMPLETED|Overall Study||3
6378319|NCT00767767|7288914|FG004|COMPLETED|Overall Study||3
6378320|NCT00767767|7288910|FG000|NOT COMPLETED|Overall Study||0
6378321|NCT00767767|7288911|FG001|NOT COMPLETED|Overall Study||0
6378322|NCT00767767|7288912|FG002|NOT COMPLETED|Overall Study||0
6378323|NCT00767767|7288913|FG003|NOT COMPLETED|Overall Study||0
6378324|NCT00767767|7288914|FG004|NOT COMPLETED|Overall Study||0
6378325|NCT00767806|7288928|FG000|STARTED|Overall Study||198
6378326|NCT00767806|7288929|FG001|STARTED|Overall Study||203
6378327|NCT00767806|7288928|FG000|COMPLETED|Overall Study||147
6378328|NCT00767806|7288929|FG001|COMPLETED|Overall Study||156
6378329|NCT00767806|7288928|FG000|NOT COMPLETED|Overall Study||51
6378330|NCT00767806|7288929|FG001|NOT COMPLETED|Overall Study||47
6378331|NCT00767819|7288938|FG000|STARTED|Overall Study||37
6378332|NCT00767819|7288939|FG001|STARTED|Overall Study||24
6378333|NCT00767819|7288940|FG002|STARTED|Overall Study||10
6378334|NCT00767819|7288938|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||37
6378335|NCT00767819|7288939|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||24
6378336|NCT00767819|7288940|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||10
6378337|NCT00767819|7288938|FG000|Safety Analysis Set (SAF)|Overall Study||37
6378338|NCT00767819|7288939|FG001|Safety Analysis Set (SAF)|Overall Study||24
6378339|NCT00767819|7288940|FG002|Safety Analysis Set (SAF)|Overall Study||10
6378340|NCT00767819|7288938|FG000|COMPLETED|Overall Study||12
6378341|NCT00767819|7288939|FG001|COMPLETED|Overall Study||5
6378342|NCT00767819|7288940|FG002|COMPLETED|Overall Study||10
6378343|NCT00767819|7288938|FG000|NOT COMPLETED|Overall Study||25
6378344|NCT00767819|7288939|FG001|NOT COMPLETED|Overall Study||19
6378345|NCT00767819|7288940|FG002|NOT COMPLETED|Overall Study||0
6378346|NCT00768053|7288948|FG000|STARTED|Overall Study||108
6378347|NCT00768053|7288948|FG000|COMPLETED|Overall Study||97
6378348|NCT00768053|7288948|FG000|NOT COMPLETED|Overall Study||11
6378349|NCT00768066|7288955|FG000|STARTED|Overall Study||22
6378350|NCT00768066|7288956|FG001|STARTED|Overall Study||22
6378351|NCT00768066|7288957|FG002|STARTED|Overall Study||21
6378352|NCT00768066|7288955|FG000|COMPLETED|Overall Study||19
6378353|NCT00768066|7288956|FG001|COMPLETED|Overall Study||19
6784043|NCT01507584|7713825|FG000|COMPLETED|Overall Study||0
6784044|NCT01507584|7713825|FG000|NOT COMPLETED|Overall Study||0
6784045|NCT01510756|7713829|FG000|STARTED|Overall Study||4
6784046|NCT01510756|7713829|FG000|COMPLETED|Overall Study||0
6784047|NCT01510756|7713829|FG000|NOT COMPLETED|Overall Study||4
6784048|NCT01511081|7713835|FG000|STARTED|Overall Study||8
6784049|NCT01511081|7713836|FG001|STARTED|Overall Study||9
6784050|NCT01511081|7713835|FG000|COMPLETED|Overall Study||8
6784051|NCT01511081|7713836|FG001|COMPLETED|Overall Study||9
6784052|NCT01511081|7713835|FG000|NOT COMPLETED|Overall Study||0
6784053|NCT01511081|7713836|FG001|NOT COMPLETED|Overall Study||0
6784054|NCT01500109|7713845|FG000|STARTED|Overall Study||0
6784055|NCT01500109|7713846|FG001|STARTED|Overall Study||0
6784056|NCT01500109|7713847|FG002|STARTED|Overall Study||0
6784057|NCT01500109|7713845|FG000|COMPLETED|Overall Study||0
6784058|NCT01500109|7713846|FG001|COMPLETED|Overall Study||0
6784059|NCT01500109|7713847|FG002|COMPLETED|Overall Study||0
6784060|NCT01500109|7713845|FG000|NOT COMPLETED|Overall Study||0
6784061|NCT01500109|7713846|FG001|NOT COMPLETED|Overall Study||0
6784062|NCT01500109|7713847|FG002|NOT COMPLETED|Overall Study||0
6784063|NCT01509053|7713855|FG000|STARTED|Oral Aripirazole (Phase A)||19
6784064|NCT01509053|7713855|FG000|COMPLETED|Oral Aripirazole (Phase A)||8
6784065|NCT01509053|7713855|FG000|NOT COMPLETED|Oral Aripirazole (Phase A)||11
6784066|NCT01509053|7713855|FG000|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
6784067|NCT01509053|7713855|FG000|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
6784068|NCT01509053|7713855|FG000|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
6784069|NCT01509053|7713855|FG000|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
6784070|NCT01509053|7713855|FG000|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
6784071|NCT01509053|7713855|FG000|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
6784072|NCT01495988|7713867|FG000|STARTED|Vem +/- Bev (Protocol v2.0)||0
6784073|NCT01495988|7713868|FG001|STARTED|Vem +/- Bev (Protocol v2.0)||0
6784074|NCT01495988|7713869|FG002|STARTED|Vem +/- Bev (Protocol v2.0)||5
6784075|NCT01495988|7713870|FG003|STARTED|Vem +/- Bev (Protocol v2.0)||3
6784076|NCT01495988|7713867|FG000|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6784077|NCT01495988|7713868|FG001|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6784078|NCT01495988|7713869|FG002|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
6784079|NCT01495988|7713870|FG003|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
6784080|NCT01495988|7713867|FG000|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6784081|NCT01495988|7713868|FG001|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6784082|NCT01495988|7713869|FG002|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6784083|NCT01495988|7713870|FG003|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
6784084|NCT01495988|7713867|FG000|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784085|NCT01495988|7713868|FG001|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
6784086|NCT01495988|7713869|FG002|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784087|NCT01495988|7713870|FG003|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784088|NCT01495988|7713867|FG000|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784089|NCT01495988|7713868|FG001|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
6784090|NCT01495988|7713869|FG002|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784091|NCT01495988|7713870|FG003|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784092|NCT01495988|7713867|FG000|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784093|NCT01495988|7713868|FG001|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784094|NCT01495988|7713869|FG002|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784095|NCT01495988|7713870|FG003|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
6784096|NCT01498991|7713880|FG000|STARTED|Overall Study||2
6784097|NCT01498991|7713880|FG000|COMPLETED|Overall Study||2
6784098|NCT01498991|7713880|FG000|NOT COMPLETED|Overall Study||0
6784099|NCT01497171|7713886|FG000|STARTED|Overall Study||2
6784100|NCT01497171|7713887|FG001|STARTED|Overall Study||3
6784101|NCT01497171|7713886|FG000|COMPLETED|Overall Study||2
6784102|NCT01497171|7713887|FG001|COMPLETED|Overall Study||3
6784103|NCT01497171|7713886|FG000|NOT COMPLETED|Overall Study||0
6784104|NCT01497171|7713887|FG001|NOT COMPLETED|Overall Study||0
6784105|NCT01483872|7713893|FG000|STARTED|Overall Study||0
6784106|NCT01483872|7713894|FG001|STARTED|Overall Study||1
6784107|NCT01483872|7713893|FG000|COMPLETED|Overall Study||0
6784108|NCT01483872|7713894|FG001|COMPLETED|Overall Study||1
6784109|NCT01483872|7713893|FG000|NOT COMPLETED|Overall Study||0
6784110|NCT01483872|7713894|FG001|NOT COMPLETED|Overall Study||0
6784111|NCT01487499|7713898|FG000|STARTED|Overall Study||4
6784112|NCT01487499|7713898|FG000|COMPLETED|Overall Study||4
6784113|NCT01487499|7713898|FG000|NOT COMPLETED|Overall Study||0
6784114|NCT01478113|7713904|FG000|STARTED|Overall Study||2
6784115|NCT01478113|7713905|FG001|STARTED|Overall Study||2
6784116|NCT01478113|7713904|FG000|COMPLETED|Overall Study||1
6784117|NCT01478113|7713905|FG001|COMPLETED|Overall Study||1
6784118|NCT01478113|7713904|FG000|NOT COMPLETED|Overall Study||1
6784119|NCT01478113|7713905|FG001|NOT COMPLETED|Overall Study||1
6784120|NCT01483209|7713913|FG000|STARTED|Overall Study||2
6784121|NCT01483209|7713913|FG000|COMPLETED|Overall Study||1
6784122|NCT01483209|7713913|FG000|NOT COMPLETED|Overall Study||1
6784123|NCT01484314|7713917|FG000|STARTED|Overall Study||1
6784124|NCT01484314|7713917|FG000|COMPLETED|Overall Study||1
6784125|NCT01484314|7713917|FG000|NOT COMPLETED|Overall Study||0
6784126|NCT01482598|7713923|FG000|STARTED|Overall Study||66
6784127|NCT01482598|7713924|FG001|STARTED|Overall Study||73
6784128|NCT01482598|7713923|FG000|COMPLETED|Overall Study||50
6784129|NCT01482598|7713924|FG001|COMPLETED|Overall Study||51
6784130|NCT01482598|7713923|FG000|NOT COMPLETED|Overall Study||16
6784131|NCT01482598|7713924|FG001|NOT COMPLETED|Overall Study||22
6784132|NCT01479010|7713930|FG000|STARTED|Overall Study||2
6784133|NCT01479010|7713930|FG000|COMPLETED|Overall Study||1
6784134|NCT01479010|7713930|FG000|NOT COMPLETED|Overall Study||1
6784135|NCT01482325|7713934|FG000|STARTED|Overall Study||31
6784136|NCT01482325|7713934|FG000|COMPLETED|Overall Study||31
6784137|NCT01482325|7713934|FG000|NOT COMPLETED|Overall Study||0
6784138|NCT01477177|7713938|FG000|STARTED|Overall Study||4
6378354|NCT00768066|7288957|FG002|COMPLETED|Overall Study||21
6378355|NCT00768066|7288955|FG000|NOT COMPLETED|Overall Study||3
6378356|NCT00768066|7288956|FG001|NOT COMPLETED|Overall Study||3
6378357|NCT00768066|7288957|FG002|NOT COMPLETED|Overall Study||0
6378358|NCT00768079|7288968|FG000|STARTED|Overall Study||38
6378359|NCT00768079|7288969|FG001|STARTED|Overall Study||36
6378360|NCT00768079|7288970|FG002|STARTED|Overall Study||36
6378361|NCT00768079|7288968|FG000|COMPLETED|Overall Study||36
6378362|NCT00768079|7288969|FG001|COMPLETED|Overall Study||35
6378363|NCT00768079|7288970|FG002|COMPLETED|Overall Study||32
6378364|NCT00768079|7288968|FG000|NOT COMPLETED|Overall Study||2
6378365|NCT00768079|7288969|FG001|NOT COMPLETED|Overall Study||1
6378366|NCT00768079|7288970|FG002|NOT COMPLETED|Overall Study||4
6378367|NCT00768118|7288980|FG000|STARTED|Overall Study||11
6378368|NCT00768118|7288980|FG000|COMPLETED|Overall Study||11
6378369|NCT00768118|7288980|FG000|NOT COMPLETED|Overall Study||0
6378370|NCT00768144|7288984|FG000|STARTED|Overall Study||36
6378371|NCT00768144|7288984|FG000|COMPLETED|Overall Study||0
6378372|NCT00768144|7288984|FG000|NOT COMPLETED|Overall Study||36
6378373|NCT00768222|7288990|FG000|STARTED|Overall Study||50
6378374|NCT00768222|7288991|FG001|STARTED|Overall Study||51
6378375|NCT00768222|7288990|FG000|COMPLETED|Overall Study||46
6378376|NCT00768222|7288991|FG001|COMPLETED|Overall Study||47
6378377|NCT00768222|7288990|FG000|NOT COMPLETED|Overall Study||4
6378378|NCT00768222|7288991|FG001|NOT COMPLETED|Overall Study||4
6378379|NCT00768261|7289001|FG000|STARTED|Overall Study||14
6378380|NCT00768261|7289002|FG001|STARTED|Overall Study||18
6378381|NCT00768261|7289003|FG002|STARTED|Overall Study||39
6378382|NCT00768261|7289004|FG003|STARTED|Overall Study||56
6378383|NCT00768261|7289001|FG000|COMPLETED|Overall Study||14
6378384|NCT00768261|7289002|FG001|COMPLETED|Overall Study||18
6378385|NCT00768261|7289003|FG002|COMPLETED|Overall Study||14
6378386|NCT00768261|7289004|FG003|COMPLETED|Overall Study||56
6378387|NCT00768261|7289001|FG000|NOT COMPLETED|Overall Study||0
6378388|NCT00768261|7289002|FG001|NOT COMPLETED|Overall Study||0
6378389|NCT00768261|7289003|FG002|NOT COMPLETED|Overall Study||25
6378390|NCT00768261|7289004|FG003|NOT COMPLETED|Overall Study||0
6378391|NCT00768287|7289017|FG000|STARTED|Pharmacokinetic Study||16
6378392|NCT00768287|7289018|FG001|STARTED|Pharmacokinetic Study||16
6378393|NCT00768287|7289019|FG002|STARTED|Pharmacokinetic Study||0
6378394|NCT00768287|7289020|FG003|STARTED|Pharmacokinetic Study||0
6378395|NCT00768287|7289021|FG004|STARTED|Pharmacokinetic Study||0
6378396|NCT00768287|7289022|FG005|STARTED|Pharmacokinetic Study||0
6378397|NCT00768287|7289017|FG000|COMPLETED|Pharmacokinetic Study||16
6378398|NCT00768287|7289018|FG001|COMPLETED|Pharmacokinetic Study||16
6378399|NCT00768287|7289019|FG002|COMPLETED|Pharmacokinetic Study||0
6378400|NCT00768287|7289020|FG003|COMPLETED|Pharmacokinetic Study||0
6378401|NCT00768287|7289021|FG004|COMPLETED|Pharmacokinetic Study||0
6378402|NCT00768287|7289022|FG005|COMPLETED|Pharmacokinetic Study||0
6378403|NCT00768287|7289017|FG000|NOT COMPLETED|Pharmacokinetic Study||0
6378404|NCT00768287|7289018|FG001|NOT COMPLETED|Pharmacokinetic Study||0
6378405|NCT00768287|7289019|FG002|NOT COMPLETED|Pharmacokinetic Study||0
6378406|NCT00768287|7289020|FG003|NOT COMPLETED|Pharmacokinetic Study||0
6378407|NCT00768287|7289021|FG004|NOT COMPLETED|Pharmacokinetic Study||0
6378408|NCT00768287|7289022|FG005|NOT COMPLETED|Pharmacokinetic Study||0
6378409|NCT00768287|7289017|FG000|STARTED|Repeat Pharmacokinetic Study||0
6378410|NCT00768287|7289018|FG001|STARTED|Repeat Pharmacokinetic Study||0
6378411|NCT00768287|7289019|FG002|STARTED|Repeat Pharmacokinetic Study|Eight subjects were part of the IB1001 first group; 6 were from the nonacog alfa first group.|14
6378412|NCT00768287|7289020|FG003|STARTED|Repeat Pharmacokinetic Study||0
6378413|NCT00768287|7289021|FG004|STARTED|Repeat Pharmacokinetic Study||0
6378414|NCT00768287|7289022|FG005|STARTED|Repeat Pharmacokinetic Study||0
6784139|NCT01477177|7713938|FG000|COMPLETED|Overall Study||4
6784140|NCT01477177|7713938|FG000|NOT COMPLETED|Overall Study||0
6784141|NCT01473732|7713944|FG000|STARTED|Overall Study||2
6784142|NCT01473732|7713945|FG001|STARTED|Overall Study||0
6784143|NCT01473732|7713944|FG000|COMPLETED|Overall Study||0
6784144|NCT01473732|7713945|FG001|COMPLETED|Overall Study||0
6784145|NCT01473732|7713944|FG000|NOT COMPLETED|Overall Study||2
6784146|NCT01473732|7713945|FG001|NOT COMPLETED|Overall Study||0
6784147|NCT01472692|7713953|FG000|STARTED|Overall Study||0
6784148|NCT01472692|7713954|FG001|STARTED|Overall Study||0
6784149|NCT01472692|7713953|FG000|COMPLETED|Overall Study||0
6784150|NCT01472692|7713954|FG001|COMPLETED|Overall Study||0
6784151|NCT01472692|7713953|FG000|NOT COMPLETED|Overall Study||0
6784152|NCT01472692|7713954|FG001|NOT COMPLETED|Overall Study||0
6784153|NCT01465230|7713960|FG000|STARTED|Overall Study||2
6784154|NCT01465230|7713960|FG000|COMPLETED|Overall Study||0
6784155|NCT01465230|7713960|FG000|NOT COMPLETED|Overall Study||2
6784156|NCT01464723|7713964|FG000|STARTED|Overall Study||0
6784157|NCT01464723|7713964|FG000|COMPLETED|Overall Study||0
6784158|NCT01464723|7713964|FG000|NOT COMPLETED|Overall Study||0
6784159|NCT01446250|7713968|FG000|STARTED|Treatment Period 1||5
6784160|NCT01446250|7713969|FG001|STARTED|Treatment Period 1||3
6784161|NCT01446250|7713970|FG002|STARTED|Treatment Period 1||0
6784162|NCT01446250|7713971|FG003|STARTED|Treatment Period 1||0
6784163|NCT01446250|7713968|FG000|COMPLETED|Treatment Period 1||5
6784164|NCT01446250|7713969|FG001|COMPLETED|Treatment Period 1||2
6784165|NCT01446250|7713970|FG002|COMPLETED|Treatment Period 1||0
6784166|NCT01446250|7713971|FG003|COMPLETED|Treatment Period 1||0
6784167|NCT01446250|7713968|FG000|NOT COMPLETED|Treatment Period 1||0
6784168|NCT01446250|7713969|FG001|NOT COMPLETED|Treatment Period 1||1
6784169|NCT01446250|7713970|FG002|NOT COMPLETED|Treatment Period 1||0
6784170|NCT01446250|7713971|FG003|NOT COMPLETED|Treatment Period 1||0
6784171|NCT01446250|7713968|FG000|STARTED|Clinical Hold||0
6784172|NCT01446250|7713969|FG001|STARTED|Clinical Hold||2
6784173|NCT01446250|7713970|FG002|STARTED|Clinical Hold||5
6784174|NCT01446250|7713971|FG003|STARTED|Clinical Hold||0
6784175|NCT01446250|7713968|FG000|COMPLETED|Clinical Hold||0
6784176|NCT01446250|7713969|FG001|COMPLETED|Clinical Hold||2
6784177|NCT01446250|7713970|FG002|COMPLETED|Clinical Hold||5
6784178|NCT01446250|7713971|FG003|COMPLETED|Clinical Hold||0
6784179|NCT01446250|7713968|FG000|NOT COMPLETED|Clinical Hold||0
6784180|NCT01446250|7713969|FG001|NOT COMPLETED|Clinical Hold||0
6784181|NCT01446250|7713970|FG002|NOT COMPLETED|Clinical Hold||0
6784182|NCT01446250|7713971|FG003|NOT COMPLETED|Clinical Hold||0
6784183|NCT01446250|7713968|FG000|STARTED|Treatment Period 2||0
6784184|NCT01446250|7713969|FG001|STARTED|Treatment Period 2||7
6784185|NCT01446250|7713970|FG002|STARTED|Treatment Period 2||0
6784186|NCT01446250|7713971|FG003|STARTED|Treatment Period 2||0
6784187|NCT01446250|7713968|FG000|COMPLETED|Treatment Period 2||0
6784188|NCT01446250|7713969|FG001|COMPLETED|Treatment Period 2||6
6784189|NCT01446250|7713970|FG002|COMPLETED|Treatment Period 2||0
6784190|NCT01446250|7713971|FG003|COMPLETED|Treatment Period 2||0
6784191|NCT01446250|7713968|FG000|NOT COMPLETED|Treatment Period 2||0
6784192|NCT01446250|7713969|FG001|NOT COMPLETED|Treatment Period 2||1
6784193|NCT01446250|7713970|FG002|NOT COMPLETED|Treatment Period 2||0
6784194|NCT01446250|7713971|FG003|NOT COMPLETED|Treatment Period 2||0
6784195|NCT01446250|7713968|FG000|STARTED|Follow-up||0
6784196|NCT01446250|7713969|FG001|STARTED|Follow-up||0
6784197|NCT01446250|7713970|FG002|STARTED|Follow-up||0
6784198|NCT01446250|7713971|FG003|STARTED|Follow-up||6
6784199|NCT01446250|7713968|FG000|COMPLETED|Follow-up||0
6784200|NCT01446250|7713969|FG001|COMPLETED|Follow-up||0
6784201|NCT01446250|7713970|FG002|COMPLETED|Follow-up||0
6784202|NCT01446250|7713971|FG003|COMPLETED|Follow-up||0
6784203|NCT01446250|7713968|FG000|NOT COMPLETED|Follow-up||0
6784204|NCT01446250|7713969|FG001|NOT COMPLETED|Follow-up||0
6784205|NCT01446250|7713970|FG002|NOT COMPLETED|Follow-up||0
6784206|NCT01446250|7713971|FG003|NOT COMPLETED|Follow-up||6
6784207|NCT01463293|7713982|FG000|STARTED|Overall Study||74
6784208|NCT01463293|7713983|FG001|STARTED|Overall Study||79
6784209|NCT01463293|7713984|FG002|STARTED|Overall Study||71
6784210|NCT01463293|7713982|FG000|COMPLETED|Overall Study||68
6784211|NCT01463293|7713983|FG001|COMPLETED|Overall Study||63
6784212|NCT01463293|7713984|FG002|COMPLETED|Overall Study||59
6784213|NCT01463293|7713982|FG000|NOT COMPLETED|Overall Study||6
6784214|NCT01463293|7713983|FG001|NOT COMPLETED|Overall Study||16
6784215|NCT01463293|7713984|FG002|NOT COMPLETED|Overall Study||12
6784216|NCT01457053|7713992|FG000|STARTED|Overall Study||2
6784217|NCT01457053|7713993|FG001|STARTED|Overall Study||2
6784218|NCT01457053|7713992|FG000|COMPLETED|Overall Study||1
6784219|NCT01457053|7713993|FG001|COMPLETED|Overall Study||1
6784220|NCT01457053|7713992|FG000|NOT COMPLETED|Overall Study||1
6784221|NCT01457053|7713993|FG001|NOT COMPLETED|Overall Study||1
6784222|NCT01451723|7714001|FG000|STARTED|Overall Study||6
6784223|NCT01451723|7714002|FG001|STARTED|Overall Study||5
6784224|NCT01451723|7714001|FG000|COMPLETED|Overall Study||0
6784225|NCT01451723|7714002|FG001|COMPLETED|Overall Study||0
6784226|NCT01451723|7714001|FG000|NOT COMPLETED|Overall Study||6
6784227|NCT01451723|7714002|FG001|NOT COMPLETED|Overall Study||5
6784228|NCT01452854|7714008|FG000|STARTED|Overall Study||2
6784229|NCT01452854|7714008|FG000|COMPLETED|Overall Study||2
6784230|NCT01452854|7714008|FG000|NOT COMPLETED|Overall Study||0
6784231|NCT01440517|7714012|FG000|STARTED|Overall Study||5
6784232|NCT01440517|7714012|FG000|COMPLETED|Overall Study||4
6784233|NCT01440517|7714012|FG000|NOT COMPLETED|Overall Study||1
6784234|NCT01440595|7714018|FG000|STARTED|Overall Study||1
6784235|NCT01440595|7714019|FG001|STARTED|Overall Study||3
6784236|NCT01440595|7714020|FG002|STARTED|Overall Study||1
6784237|NCT01440595|7714018|FG000|COMPLETED|Overall Study||0
6784238|NCT01440595|7714019|FG001|COMPLETED|Overall Study||0
6784239|NCT01440595|7714020|FG002|COMPLETED|Overall Study||0
6784240|NCT01440595|7714018|FG000|NOT COMPLETED|Overall Study||1
6784241|NCT01440595|7714019|FG001|NOT COMPLETED|Overall Study||3
6784242|NCT01440595|7714020|FG002|NOT COMPLETED|Overall Study||1
6784243|NCT01446796|7714026|FG000|STARTED|Overall Study||3
6784244|NCT01446796|7714027|FG001|STARTED|Overall Study||0
6784245|NCT01446796|7714026|FG000|COMPLETED|Overall Study|"Study terminated early~One subject of three withdrew prior to randomization and did not start"|2
6784246|NCT01446796|7714027|FG001|COMPLETED|Overall Study|Study terminated early|0
6784247|NCT01446796|7714026|FG000|NOT COMPLETED|Overall Study||1
6784248|NCT01446796|7714027|FG001|NOT COMPLETED|Overall Study||0
6784249|NCT01443923|7714037|FG000|STARTED|Overall Study||3
6784250|NCT01443923|7714038|FG001|STARTED|Overall Study||1
6784251|NCT01443923|7714037|FG000|COMPLETED|Overall Study||2
6784252|NCT01443923|7714038|FG001|COMPLETED|Overall Study||1
6784253|NCT01443923|7714037|FG000|NOT COMPLETED|Overall Study||1
6784254|NCT01443923|7714038|FG001|NOT COMPLETED|Overall Study||0
6784255|NCT01439347|7714046|FG000|STARTED|Overall Study||13
6784256|NCT01439347|7714047|FG001|STARTED|Overall Study||13
6784257|NCT01439347|7714046|FG000|COMPLETED|Overall Study||0
6784258|NCT01439347|7714047|FG001|COMPLETED|Overall Study||0
6784259|NCT01439347|7714046|FG000|NOT COMPLETED|Overall Study||13
6784260|NCT01439347|7714047|FG001|NOT COMPLETED|Overall Study||13
6784261|NCT01440452|7714057|FG000|STARTED|Overall Study||6
6784262|NCT01440452|7714058|FG001|STARTED|Overall Study||7
6784263|NCT01440452|7714059|FG002|STARTED|Overall Study||8
6784264|NCT01440452|7714060|FG003|STARTED|Overall Study||4
6784265|NCT01440452|7714057|FG000|COMPLETED|Overall Study||6
6784266|NCT01440452|7714058|FG001|COMPLETED|Overall Study||7
6784267|NCT01440452|7714059|FG002|COMPLETED|Overall Study||8
6784268|NCT01440452|7714060|FG003|COMPLETED|Overall Study||4
6784269|NCT01440452|7714057|FG000|NOT COMPLETED|Overall Study||0
6784270|NCT01440452|7714058|FG001|NOT COMPLETED|Overall Study||0
6784271|NCT01440452|7714059|FG002|NOT COMPLETED|Overall Study||0
6784272|NCT01440452|7714060|FG003|NOT COMPLETED|Overall Study||0
6784273|NCT01433471|7714072|FG000|STARTED|Overall Study||2
6784274|NCT01433471|7714073|FG001|STARTED|Overall Study||2
6784275|NCT01433471|7714072|FG000|COMPLETED|Overall Study||2
6784276|NCT01433471|7714073|FG001|COMPLETED|Overall Study||1
6784277|NCT01433471|7714072|FG000|NOT COMPLETED|Overall Study||0
6784278|NCT01433471|7714073|FG001|NOT COMPLETED|Overall Study||1
6784279|NCT01436084|7714081|FG000|STARTED|Overall Study||4
6784280|NCT01436084|7714081|FG000|COMPLETED|Overall Study||0
6784281|NCT01436084|7714081|FG000|NOT COMPLETED|Overall Study||4
6784282|NCT01434511|7714085|FG000|STARTED|Overall Study||1
6784283|NCT01434511|7714085|FG000|COMPLETED|Overall Study||1
6784284|NCT01434511|7714085|FG000|NOT COMPLETED|Overall Study||0
6784285|NCT01426555|7714091|FG000|STARTED|Overall Study||35
6784286|NCT01426555|7714092|FG001|STARTED|Overall Study||35
6784287|NCT01426555|7714091|FG000|COMPLETED|Overall Study||17
6784288|NCT01426555|7714092|FG001|COMPLETED|Overall Study||20
6784289|NCT01426555|7714091|FG000|NOT COMPLETED|Overall Study||18
6784290|NCT01426555|7714092|FG001|NOT COMPLETED|Overall Study||15
6784291|NCT01434745|7714102|FG000|STARTED|Overall Study||0
6784292|NCT01434745|7714103|FG001|STARTED|Overall Study||0
6784293|NCT01434745|7714102|FG000|COMPLETED|Overall Study||0
6784294|NCT01434745|7714103|FG001|COMPLETED|Overall Study||0
6784295|NCT01434745|7714102|FG000|NOT COMPLETED|Overall Study||0
6784296|NCT01434745|7714103|FG001|NOT COMPLETED|Overall Study||0
6784297|NCT01415986|7714109|FG000|STARTED|Overall Study||1
6784298|NCT01415986|7714109|FG000|COMPLETED|Overall Study|Study terminated|0
6784299|NCT01415986|7714109|FG000|NOT COMPLETED|Overall Study||1
6784300|NCT01410799|7714114|FG000|STARTED|Overall Study||13
6784301|NCT01410799|7714114|FG000|COMPLETED|Overall Study||0
6784302|NCT01410799|7714114|FG000|NOT COMPLETED|Overall Study||13
6784303|NCT01426113|7714120|FG000|STARTED|Overall Study||3
6784304|NCT01426113|7714121|FG001|STARTED|Overall Study||3
6784305|NCT01426113|7714120|FG000|COMPLETED|Overall Study||2
6784306|NCT01426113|7714121|FG001|COMPLETED|Overall Study||1
6784307|NCT01426113|7714120|FG000|NOT COMPLETED|Overall Study||1
6784308|NCT01426113|7714121|FG001|NOT COMPLETED|Overall Study||2
6784309|NCT01426516|7714129|FG000|STARTED|Overall Study||12
6784310|NCT01426516|7714130|FG001|STARTED|Overall Study||17
6784311|NCT01426516|7714129|FG000|COMPLETED|Overall Study||12
6784312|NCT01426516|7714130|FG001|COMPLETED|Overall Study||17
6784313|NCT01426516|7714129|FG000|NOT COMPLETED|Overall Study||0
6784314|NCT01426516|7714130|FG001|NOT COMPLETED|Overall Study||0
6784315|NCT01420965|7714139|FG000|STARTED|Overall Study||2
6784316|NCT01420965|7714140|FG001|STARTED|Overall Study||2
6784317|NCT01420965|7714141|FG002|STARTED|Overall Study||3
6784318|NCT01420965|7714139|FG000|COMPLETED|Overall Study||1
6784319|NCT01420965|7714140|FG001|COMPLETED|Overall Study||1
6784320|NCT01420965|7714141|FG002|COMPLETED|Overall Study||3
6784321|NCT01420965|7714139|FG000|NOT COMPLETED|Overall Study||1
6784322|NCT01420965|7714140|FG001|NOT COMPLETED|Overall Study||1
6784323|NCT01420965|7714141|FG002|NOT COMPLETED|Overall Study||0
6784324|NCT01417377|7714149|FG000|STARTED|Overall Study||22
6784325|NCT01417377|7714149|FG000|Treated|Overall Study||21
6784326|NCT01417377|7714149|FG000|COMPLETED|Overall Study||9
6784327|NCT01417377|7714149|FG000|NOT COMPLETED|Overall Study||13
6784328|NCT01416272|7714153|FG000|STARTED|Overall Study||12
6784329|NCT01416272|7714153|FG000|COMPLETED|Overall Study||8
6784330|NCT01416272|7714153|FG000|NOT COMPLETED|Overall Study||4
6784331|NCT01414166|7714159|FG000|STARTED|Overall Study||122
6784332|NCT01414166|7714160|FG001|STARTED|Overall Study||122
6784333|NCT01414166|7714159|FG000|Treated|Overall Study||120
6563039|NCT01805024|7486013|FG002|COMPLETED|Overall Study||4
6563040|NCT01805024|7486014|FG003|COMPLETED|Overall Study||8
6563041|NCT01805024|7486011|FG000|NOT COMPLETED|Overall Study||0
6563042|NCT01805024|7486012|FG001|NOT COMPLETED|Overall Study||0
6784334|NCT01414166|7714160|FG001|Treated|Overall Study||121
6784335|NCT01414166|7714159|FG000|COMPLETED|Overall Study||31
6784336|NCT01414166|7714160|FG001|COMPLETED|Overall Study||39
6784337|NCT01414166|7714159|FG000|NOT COMPLETED|Overall Study||91
6784338|NCT01414166|7714160|FG001|NOT COMPLETED|Overall Study||83
6784339|NCT01406860|7714168|FG000|STARTED|Overall Study||11
6784340|NCT01406860|7714169|FG001|STARTED|Overall Study||8
6784341|NCT01406860|7714168|FG000|COMPLETED|Overall Study||11
6784342|NCT01406860|7714169|FG001|COMPLETED|Overall Study||8
6784343|NCT01406860|7714168|FG000|NOT COMPLETED|Overall Study||0
6784344|NCT01406860|7714169|FG001|NOT COMPLETED|Overall Study||0
6784345|NCT01401049|7714178|FG000|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
6784346|NCT01401049|7714179|FG001|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
6378415|NCT00768287|7289017|FG000|COMPLETED|Repeat Pharmacokinetic Study||0
6378416|NCT00768287|7289018|FG001|COMPLETED|Repeat Pharmacokinetic Study||0
6378417|NCT00768287|7289019|FG002|COMPLETED|Repeat Pharmacokinetic Study||14
6784347|NCT01401049|7714178|FG000|COMPLETED|Overall Study||0
6784348|NCT01401049|7714179|FG001|COMPLETED|Overall Study||0
6784349|NCT01401049|7714178|FG000|NOT COMPLETED|Overall Study||0
6784350|NCT01401049|7714179|FG001|NOT COMPLETED|Overall Study||0
6784351|NCT01409031|7714187|FG000|STARTED|Overall Study||1
6784352|NCT01409031|7714188|FG001|STARTED|Overall Study||2
6784353|NCT01409031|7714187|FG000|COMPLETED|Overall Study||0
6784354|NCT01409031|7714188|FG001|COMPLETED|Overall Study||2
6784355|NCT01409031|7714187|FG000|NOT COMPLETED|Overall Study||1
6784356|NCT01409031|7714188|FG001|NOT COMPLETED|Overall Study||0
6784357|NCT01402531|7714194|FG000|STARTED|Overall Study||0
6784358|NCT01402531|7714194|FG000|COMPLETED|Overall Study||0
6784359|NCT01402531|7714194|FG000|NOT COMPLETED|Overall Study||0
6784360|NCT01394926|7714198|FG000|STARTED|Overall Study||21
6784361|NCT01394926|7714198|FG000|COMPLETED|Overall Study||21
6784362|NCT01394926|7714198|FG000|NOT COMPLETED|Overall Study||0
6784363|NCT01383681|7714207|FG000|STARTED|Overall Study||235
6784364|NCT01383681|7714207|FG000|COMPLETED|Overall Study||189
6784365|NCT01383681|7714207|FG000|NOT COMPLETED|Overall Study||46
6784366|NCT01403194|7714211|FG000|STARTED|Overall Study||11
6784367|NCT01403194|7714211|FG000|COMPLETED|Overall Study||1
6784368|NCT01403194|7714211|FG000|NOT COMPLETED|Overall Study||10
6784369|NCT01397552|7714217|FG000|STARTED|Overall Study||4
6784370|NCT01397552|7714218|FG001|STARTED|Overall Study||4
6784371|NCT01397552|7714217|FG000|COMPLETED|Overall Study||1
6784372|NCT01397552|7714218|FG001|COMPLETED|Overall Study||3
6784373|NCT01397552|7714217|FG000|NOT COMPLETED|Overall Study||3
6784374|NCT01397552|7714218|FG001|NOT COMPLETED|Overall Study||1
6784375|NCT01392170|7714224|FG000|STARTED|Overall Study||2
6784376|NCT01392170|7714224|FG000|COMPLETED|Overall Study||0
6784377|NCT01392170|7714224|FG000|NOT COMPLETED|Overall Study||2
6784378|NCT01389817|7714230|FG000|STARTED|Overall Study||4
6784379|NCT01389817|7714231|FG001|STARTED|Overall Study||0
6784380|NCT01389817|7714230|FG000|COMPLETED|Overall Study||0
6784381|NCT01389817|7714231|FG001|COMPLETED|Overall Study||0
6784382|NCT01389817|7714230|FG000|NOT COMPLETED|Overall Study||4
6784383|NCT01389817|7714231|FG001|NOT COMPLETED|Overall Study||0
6784384|NCT01397695|7714237|FG000|STARTED|Overall Study||0
6784385|NCT01397695|7714237|FG000|COMPLETED|Overall Study||0
6784386|NCT01397695|7714237|FG000|NOT COMPLETED|Overall Study||0
6784387|NCT01390181|7714241|FG000|STARTED|Overall Study||4
6784388|NCT01390181|7714241|FG000|COMPLETED|Overall Study||0
6784389|NCT01390181|7714241|FG000|NOT COMPLETED|Overall Study||4
6784390|NCT01385033|7714247|FG000|STARTED|Part I|These subjects did not participate in Part II or III|6
6784391|NCT01385033|7714248|FG001|STARTED|Part I|These subjects did not participate in Part II or III|14
6784392|NCT01385033|7714249|FG002|STARTED|Part I||0
6784393|NCT01385033|7714250|FG003|STARTED|Part I||0
6784394|NCT01385033|7714251|FG004|STARTED|Part I||0
6784395|NCT01385033|7714252|FG005|STARTED|Part I||0
6378418|NCT00768287|7289020|FG003|COMPLETED|Repeat Pharmacokinetic Study||0
6563043|NCT01805024|7486013|FG002|NOT COMPLETED|Overall Study||0
6784396|NCT01385033|7714247|FG000|COMPLETED|Part I||6
6784397|NCT01385033|7714248|FG001|COMPLETED|Part I||14
6784398|NCT01385033|7714249|FG002|COMPLETED|Part I||0
6784399|NCT01385033|7714250|FG003|COMPLETED|Part I||0
6784400|NCT01385033|7714251|FG004|COMPLETED|Part I||0
6784401|NCT01385033|7714252|FG005|COMPLETED|Part I||0
6784402|NCT01385033|7714247|FG000|NOT COMPLETED|Part I||0
6784403|NCT01385033|7714248|FG001|NOT COMPLETED|Part I||0
6784404|NCT01385033|7714249|FG002|NOT COMPLETED|Part I||0
6784405|NCT01385033|7714250|FG003|NOT COMPLETED|Part I||0
6784406|NCT01385033|7714251|FG004|NOT COMPLETED|Part I||0
6784407|NCT01385033|7714252|FG005|NOT COMPLETED|Part I||0
6784408|NCT01385033|7714247|FG000|STARTED|Part II||0
6784409|NCT01385033|7714248|FG001|STARTED|Part II||0
6784410|NCT01385033|7714249|FG002|STARTED|Part II||0
6784411|NCT01385033|7714250|FG003|STARTED|Part II||0
6784412|NCT01385033|7714251|FG004|STARTED|Part II||0
6784413|NCT01385033|7714252|FG005|STARTED|Part II||0
6784414|NCT01385033|7714247|FG000|COMPLETED|Part II||0
6784415|NCT01385033|7714248|FG001|COMPLETED|Part II||0
6784416|NCT01385033|7714249|FG002|COMPLETED|Part II||0
6784417|NCT01385033|7714250|FG003|COMPLETED|Part II||0
6784418|NCT01385033|7714251|FG004|COMPLETED|Part II||0
6784419|NCT01385033|7714252|FG005|COMPLETED|Part II||0
6784420|NCT01385033|7714247|FG000|NOT COMPLETED|Part II||0
6784421|NCT01385033|7714248|FG001|NOT COMPLETED|Part II||0
6784422|NCT01385033|7714249|FG002|NOT COMPLETED|Part II||0
6784423|NCT01385033|7714250|FG003|NOT COMPLETED|Part II||0
6784424|NCT01385033|7714251|FG004|NOT COMPLETED|Part II||0
6784425|NCT01385033|7714252|FG005|NOT COMPLETED|Part II||0
6784426|NCT01385033|7714247|FG000|STARTED|Part III||0
6784427|NCT01385033|7714248|FG001|STARTED|Part III||0
6784428|NCT01385033|7714249|FG002|STARTED|Part III||0
6784429|NCT01385033|7714250|FG003|STARTED|Part III||0
6784430|NCT01385033|7714251|FG004|STARTED|Part III||0
6784431|NCT01385033|7714252|FG005|STARTED|Part III||0
6784432|NCT01385033|7714247|FG000|COMPLETED|Part III||0
6784433|NCT01385033|7714248|FG001|COMPLETED|Part III||0
6784434|NCT01385033|7714249|FG002|COMPLETED|Part III||0
6784435|NCT01385033|7714250|FG003|COMPLETED|Part III||0
6784436|NCT01385033|7714251|FG004|COMPLETED|Part III||0
6784437|NCT01385033|7714252|FG005|COMPLETED|Part III||0
6784438|NCT01385033|7714247|FG000|NOT COMPLETED|Part III||0
6784439|NCT01385033|7714248|FG001|NOT COMPLETED|Part III||0
6784440|NCT01385033|7714249|FG002|NOT COMPLETED|Part III||0
6784441|NCT01385033|7714250|FG003|NOT COMPLETED|Part III||0
6784442|NCT01385033|7714251|FG004|NOT COMPLETED|Part III||0
6784443|NCT01385033|7714252|FG005|NOT COMPLETED|Part III||0
6784444|NCT01394211|7714259|FG000|STARTED|Overall Study||2
6784445|NCT01394211|7714259|FG000|COMPLETED|Overall Study||0
6784446|NCT01394211|7714259|FG000|NOT COMPLETED|Overall Study||2
6784447|NCT01377441|7714265|FG000|STARTED|Overall Study||0
6784448|NCT01377441|7714266|FG001|STARTED|Overall Study||0
6784449|NCT01377441|7714265|FG000|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
6784450|NCT01377441|7714266|FG001|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
6784451|NCT01377441|7714265|FG000|NOT COMPLETED|Overall Study||0
6784452|NCT01377441|7714266|FG001|NOT COMPLETED|Overall Study||0
6784453|NCT01383447|7714272|FG000|STARTED|Overall Study||2
6784454|NCT01383447|7714272|FG000|COMPLETED|Overall Study||0
6784455|NCT01383447|7714272|FG000|NOT COMPLETED|Overall Study||2
6784456|NCT01372618|7714276|FG000|STARTED|Overall Study||9
6784457|NCT01372618|7714276|FG000|COMPLETED|Overall Study||0
6784458|NCT01372618|7714276|FG000|NOT COMPLETED|Overall Study||9
6784459|NCT01385280|7714280|FG000|STARTED|Overall Study||13
6784460|NCT01385280|7714280|FG000|COMPLETED|Overall Study||13
6784461|NCT01385280|7714280|FG000|NOT COMPLETED|Overall Study||0
6784462|NCT01379274|7714284|FG000|STARTED|Overall Study||2
6784463|NCT01379274|7714284|FG000|COMPLETED|Overall Study||1
6784464|NCT01379274|7714284|FG000|NOT COMPLETED|Overall Study||1
6784465|NCT01379469|7714290|FG000|STARTED|Overall Study||13
6784466|NCT01379469|7714291|FG001|STARTED|Overall Study||7
6784467|NCT01379469|7714290|FG000|COMPLETED|Overall Study||1
6784468|NCT01379469|7714291|FG001|COMPLETED|Overall Study||3
6784469|NCT01379469|7714290|FG000|NOT COMPLETED|Overall Study||12
6784470|NCT01379469|7714291|FG001|NOT COMPLETED|Overall Study||4
6784471|NCT01369641|7714297|FG000|STARTED|Overall Study||1
6784472|NCT01369641|7714297|FG000|COMPLETED|Overall Study||0
6784473|NCT01369641|7714297|FG000|NOT COMPLETED|Overall Study||1
6784474|NCT01365156|7714303|FG000|STARTED|Overall Study||14
6784475|NCT01365156|7714304|FG001|STARTED|Overall Study||14
6784476|NCT01365156|7714303|FG000|COMPLETED|Overall Study||14
6784477|NCT01365156|7714304|FG001|COMPLETED|Overall Study||14
6784478|NCT01365156|7714303|FG000|NOT COMPLETED|Overall Study||0
6784479|NCT01365156|7714304|FG001|NOT COMPLETED|Overall Study||0
6784480|NCT01359254|7714312|FG000|STARTED|Overall Study||1
6784481|NCT01359254|7714313|FG001|STARTED|Overall Study||0
6784482|NCT01359254|7714312|FG000|COMPLETED|Overall Study||0
6784483|NCT01359254|7714313|FG001|COMPLETED|Overall Study||0
6784484|NCT01359254|7714312|FG000|NOT COMPLETED|Overall Study||1
6784485|NCT01359254|7714313|FG001|NOT COMPLETED|Overall Study||0
6784486|NCT01347632|7714319|FG000|STARTED|Overall Study||35
6784487|NCT01347632|7714319|FG000|COMPLETED|Overall Study||33
6784488|NCT01347632|7714319|FG000|NOT COMPLETED|Overall Study||2
6784489|NCT01356667|7714325|FG000|STARTED|Overall Study||4
6784490|NCT01356667|7714326|FG001|STARTED|Overall Study||6
6784491|NCT01356667|7714325|FG000|COMPLETED|Overall Study||0
6784492|NCT01356667|7714326|FG001|COMPLETED|Overall Study||0
6784493|NCT01356667|7714325|FG000|NOT COMPLETED|Overall Study||4
6784494|NCT01356667|7714326|FG001|NOT COMPLETED|Overall Study||6
6784495|NCT01354951|7714334|FG000|STARTED|Overall Study||3
6784496|NCT01354951|7714334|FG000|COMPLETED|Overall Study||1
6784497|NCT01354951|7714334|FG000|NOT COMPLETED|Overall Study||2
6784498|NCT01350232|7714338|FG000|STARTED|Overall Study||2
6784499|NCT01350232|7714338|FG000|COMPLETED|Overall Study||2
6784500|NCT01350232|7714338|FG000|NOT COMPLETED|Overall Study||0
6784501|NCT01350583|7714342|FG000|STARTED|Overall Study||2
6784502|NCT01350583|7714342|FG000|COMPLETED|Overall Study||2
6784503|NCT01350583|7714342|FG000|NOT COMPLETED|Overall Study||0
6784504|NCT01352416|7714350|FG000|STARTED|Overall Study||4
6784505|NCT01352416|7714351|FG001|STARTED|Overall Study||7
6784506|NCT01352416|7714352|FG002|STARTED|Overall Study||2
6784507|NCT01352416|7714353|FG003|STARTED|Overall Study||2
6784508|NCT01352416|7714350|FG000|COMPLETED|Overall Study||3
6784509|NCT01352416|7714351|FG001|COMPLETED|Overall Study||5
6784510|NCT01352416|7714352|FG002|COMPLETED|Overall Study||0
6784511|NCT01352416|7714353|FG003|COMPLETED|Overall Study||1
6784512|NCT01352416|7714350|FG000|NOT COMPLETED|Overall Study||1
6784513|NCT01352416|7714351|FG001|NOT COMPLETED|Overall Study||2
6784514|NCT01352416|7714352|FG002|NOT COMPLETED|Overall Study||2
6784515|NCT01352416|7714353|FG003|NOT COMPLETED|Overall Study||1
6784516|NCT01350258|7714363|FG000|STARTED|Overall Study||8
6784517|NCT01350258|7714363|FG000|COMPLETED|Overall Study||8
6784518|NCT01350258|7714363|FG000|NOT COMPLETED|Overall Study||0
6784519|NCT01349595|7714369|FG000|STARTED|Overall Study||2
6784520|NCT01349595|7714370|FG001|STARTED|Overall Study||2
6784521|NCT01349595|7714369|FG000|COMPLETED|Overall Study||0
6784522|NCT01349595|7714370|FG001|COMPLETED|Overall Study||0
6784523|NCT01349595|7714369|FG000|NOT COMPLETED|Overall Study||2
6784524|NCT01349595|7714370|FG001|NOT COMPLETED|Overall Study||2
6784525|NCT01337609|7714379|FG000|STARTED|Overall Study||1
6784526|NCT01337609|7714380|FG001|STARTED|Overall Study||2
6784527|NCT01337609|7714381|FG002|STARTED|Overall Study||2
6784528|NCT01337609|7714379|FG000|COMPLETED|Overall Study||0
6784529|NCT01337609|7714380|FG001|COMPLETED|Overall Study||2
6784530|NCT01337609|7714381|FG002|COMPLETED|Overall Study||2
6784531|NCT01337609|7714379|FG000|NOT COMPLETED|Overall Study||1
6784532|NCT01337609|7714380|FG001|NOT COMPLETED|Overall Study||0
6784533|NCT01337609|7714381|FG002|NOT COMPLETED|Overall Study||0
6784534|NCT01347840|7714389|FG000|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
6784535|NCT01347840|7714389|FG000|COMPLETED|Overall Study||0
6784536|NCT01347840|7714389|FG000|NOT COMPLETED|Overall Study||1
6784537|NCT01340573|7714393|FG000|STARTED|Overall Study||3
6784538|NCT01340573|7714393|FG000|COMPLETED|Overall Study||0
6784539|NCT01340573|7714393|FG000|NOT COMPLETED|Overall Study||3
6784540|NCT01335997|7714400|FG000|STARTED|Period I and II||577
6784541|NCT01335997|7714401|FG001|STARTED|Period I and II||562
6784542|NCT01335997|7714400|FG000|COMPLETED|Period I and II||84
6784543|NCT01335997|7714401|FG001|COMPLETED|Period I and II||83
6784544|NCT01335997|7714400|FG000|NOT COMPLETED|Period I and II||493
6784545|NCT01335997|7714401|FG001|NOT COMPLETED|Period I and II||479
6784546|NCT01335997|7714400|FG000|STARTED|Period III||84
6784547|NCT01335997|7714401|FG001|STARTED|Period III||83
6784548|NCT01335997|7714400|FG000|COMPLETED|Period III||6
6784549|NCT01335997|7714401|FG001|COMPLETED|Period III||4
6784550|NCT01335997|7714400|FG000|NOT COMPLETED|Period III||78
6784551|NCT01335997|7714401|FG001|NOT COMPLETED|Period III||79
6784552|NCT01340885|7714412|FG000|STARTED|Overall Study||0
6784553|NCT01340885|7714413|FG001|STARTED|Overall Study||0
6784554|NCT01340885|7714414|FG002|STARTED|Overall Study||0
6784555|NCT01340885|7714412|FG000|COMPLETED|Overall Study||0
6784556|NCT01340885|7714413|FG001|COMPLETED|Overall Study||0
6784557|NCT01340885|7714414|FG002|COMPLETED|Overall Study||0
6784558|NCT01340885|7714412|FG000|NOT COMPLETED|Overall Study||0
6784559|NCT01340885|7714413|FG001|NOT COMPLETED|Overall Study||0
6784560|NCT01340885|7714414|FG002|NOT COMPLETED|Overall Study||0
6784561|NCT01341587|7714424|FG000|STARTED|Overall Study||4
6784562|NCT01341587|7714425|FG001|STARTED|Overall Study||10
6784563|NCT01341587|7714424|FG000|COMPLETED|Overall Study||0
6784564|NCT01341587|7714425|FG001|COMPLETED|Overall Study||0
6784565|NCT01341587|7714424|FG000|NOT COMPLETED|Overall Study||4
6784566|NCT01341587|7714425|FG001|NOT COMPLETED|Overall Study||10
6784567|NCT01326923|7714431|FG000|STARTED|Overall Study||7
6784568|NCT01326923|7714431|FG000|COMPLETED|Overall Study||7
6784569|NCT01326923|7714431|FG000|NOT COMPLETED|Overall Study||0
6784570|NCT01332799|7714437|FG000|STARTED|Overall Study||10
6784571|NCT01332799|7714438|FG001|STARTED|Overall Study||10
6784572|NCT01332799|7714437|FG000|COMPLETED|Overall Study||0
6784573|NCT01332799|7714438|FG001|COMPLETED|Overall Study||0
6784574|NCT01332799|7714437|FG000|NOT COMPLETED|Overall Study||10
6784575|NCT01332799|7714438|FG001|NOT COMPLETED|Overall Study||10
6563044|NCT01805024|7486014|FG003|NOT COMPLETED|Overall Study||0
6563045|NCT01805037|7486024|FG000|STARTED|Induction (4 Weeks)||0
6563046|NCT01805037|7486025|FG001|STARTED|Induction (4 Weeks)||20
6563047|NCT01805037|7486024|FG000|Received Dose of Study Drug|Induction (4 Weeks)||0
6784576|NCT01329549|7714444|FG000|STARTED|Overall Study||2
6784577|NCT01329549|7714444|FG000|COMPLETED|Overall Study||0
6784578|NCT01329549|7714444|FG000|NOT COMPLETED|Overall Study||2
6563048|NCT01805037|7486025|FG001|Received Dose of Study Drug|Induction (4 Weeks)||20
6563049|NCT01805037|7486024|FG000|COMPLETED|Induction (4 Weeks)||0
6563050|NCT01805037|7486025|FG001|COMPLETED|Induction (4 Weeks)||20
6563051|NCT01805037|7486024|FG000|NOT COMPLETED|Induction (4 Weeks)||0
6563052|NCT01805037|7486025|FG001|NOT COMPLETED|Induction (4 Weeks)||0
6563053|NCT01805037|7486024|FG000|STARTED|Consolidation (Optional, 4 Weeks)||0
6784579|NCT01326845|7714450|FG000|STARTED|Overall Study||7
6784580|NCT01326845|7714451|FG001|STARTED|Overall Study||5
6784581|NCT01326845|7714450|FG000|COMPLETED|Overall Study|Study terminated early|0
6784582|NCT01326845|7714451|FG001|COMPLETED|Overall Study|Study terminated early|0
6784583|NCT01326845|7714450|FG000|NOT COMPLETED|Overall Study||7
6784584|NCT01326845|7714451|FG001|NOT COMPLETED|Overall Study||5
6784585|NCT01329341|7714457|FG000|STARTED|Overall Study||60
6784586|NCT01329341|7714457|FG000|COMPLETED|Overall Study||16
6784587|NCT01329341|7714457|FG000|NOT COMPLETED|Overall Study||44
6784588|NCT01319760|7714463|FG000|STARTED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
6784589|NCT01319760|7714464|FG001|STARTED|Overall Study||5
6784590|NCT01319760|7714463|FG000|COMPLETED|Overall Study|The study experienced a very low enrollment rate. the sponsor decided to stop the study.|0
6784591|NCT01319760|7714464|FG001|COMPLETED|Overall Study||5
6784592|NCT01319760|7714463|FG000|NOT COMPLETED|Overall Study||0
6784593|NCT01319760|7714464|FG001|NOT COMPLETED|Overall Study||0
6784594|NCT01320683|7714470|FG000|STARTED|Overall Study||1
6784595|NCT01320683|7714470|FG000|COMPLETED|Overall Study||0
6784596|NCT01320683|7714470|FG000|NOT COMPLETED|Overall Study||1
6784597|NCT01313273|7714476|FG000|STARTED|Overall Study||2
6784598|NCT01313273|7714477|FG001|STARTED|Overall Study||1
6784599|NCT01313273|7714476|FG000|COMPLETED|Overall Study||0
6784600|NCT01313273|7714477|FG001|COMPLETED|Overall Study||0
6784601|NCT01313273|7714476|FG000|NOT COMPLETED|Overall Study||2
6784602|NCT01313273|7714477|FG001|NOT COMPLETED|Overall Study||1
6784603|NCT01321008|7714483|FG000|STARTED|Overall Study||1
6784604|NCT01321008|7714483|FG000|COMPLETED|Overall Study||0
6784605|NCT01321008|7714483|FG000|NOT COMPLETED|Overall Study||1
6784606|NCT01310803|7714489|FG000|STARTED|Overall Study||1
6784607|NCT01310803|7714490|FG001|STARTED|Overall Study||0
6784608|NCT01310803|7714489|FG000|COMPLETED|Overall Study||0
6563054|NCT01805037|7486025|FG001|STARTED|Consolidation (Optional, 4 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction.|6
6784609|NCT01310803|7714490|FG001|COMPLETED|Overall Study||0
6784610|NCT01310803|7714489|FG000|NOT COMPLETED|Overall Study||1
6784611|NCT01310803|7714490|FG001|NOT COMPLETED|Overall Study||0
6784612|NCT01309581|7714498|FG000|STARTED|Overall Study||2
6784613|NCT01309581|7714499|FG001|STARTED|Overall Study||1
6784614|NCT01309581|7714498|FG000|COMPLETED|Overall Study||2
6784615|NCT01309581|7714499|FG001|COMPLETED|Overall Study||1
6784616|NCT01309581|7714498|FG000|NOT COMPLETED|Overall Study||0
6784617|NCT01309581|7714499|FG001|NOT COMPLETED|Overall Study||0
6784618|NCT01315873|7714505|FG000|STARTED|Overall Study||24
6784619|NCT01315873|7714505|FG000|COMPLETED|Overall Study||24
6784620|NCT01315873|7714505|FG000|NOT COMPLETED|Overall Study||0
6784621|NCT01313923|7714509|FG000|STARTED|Overall Study||3
6784622|NCT01313923|7714509|FG000|COMPLETED|Overall Study||0
6784623|NCT01313923|7714509|FG000|NOT COMPLETED|Overall Study||3
6784624|NCT01321697|7714513|FG000|STARTED|Overall Study||7
6784625|NCT01321697|7714513|FG000|COMPLETED|Overall Study||0
6784626|NCT01321697|7714513|FG000|NOT COMPLETED|Overall Study||7
6784627|NCT01312428|7714519|FG000|STARTED|Overall Study||3
6784628|NCT01312428|7714520|FG001|STARTED|Overall Study||4
6784629|NCT01312428|7714519|FG000|COMPLETED|Overall Study||0
6784630|NCT01312428|7714520|FG001|COMPLETED|Overall Study||0
6784631|NCT01312428|7714519|FG000|NOT COMPLETED|Overall Study||3
6784632|NCT01312428|7714520|FG001|NOT COMPLETED|Overall Study||4
6784633|NCT01313416|7714528|FG000|STARTED|Overall Study||2
6784634|NCT01313416|7714528|FG000|COMPLETED|Overall Study||2
6784635|NCT01313416|7714528|FG000|NOT COMPLETED|Overall Study||0
6784636|NCT01303003|7714534|FG000|STARTED|Overall Study||0
6784637|NCT01303003|7714535|FG001|STARTED|Overall Study||0
6784638|NCT01303003|7714534|FG000|COMPLETED|Overall Study||0
6784639|NCT01303003|7714535|FG001|COMPLETED|Overall Study||0
6784640|NCT01303003|7714534|FG000|NOT COMPLETED|Overall Study||0
6784641|NCT01303003|7714535|FG001|NOT COMPLETED|Overall Study||0
6784642|NCT01302444|7714543|FG000|STARTED|Overall Study||1
6784643|NCT01302444|7714544|FG001|STARTED|Overall Study||0
6784644|NCT01302444|7714543|FG000|COMPLETED|Overall Study||1
6784645|NCT01302444|7714544|FG001|COMPLETED|Overall Study||0
6784646|NCT01302444|7714543|FG000|NOT COMPLETED|Overall Study||0
6784647|NCT01302444|7714544|FG001|NOT COMPLETED|Overall Study||0
6563055|NCT01805037|7486024|FG000|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||0
6784648|NCT01301963|7714552|FG000|STARTED|Overall Study||5
6784649|NCT01301963|7714553|FG001|STARTED|Overall Study||4
6784650|NCT01301963|7714552|FG000|COMPLETED|Overall Study||5
6784651|NCT01301963|7714553|FG001|COMPLETED|Overall Study||4
6784652|NCT01301963|7714552|FG000|NOT COMPLETED|Overall Study||0
6784653|NCT01301963|7714553|FG001|NOT COMPLETED|Overall Study||0
6784654|NCT01298921|7714561|FG000|STARTED|Overall Study||0
6784655|NCT01298921|7714562|FG001|STARTED|Overall Study||0
6784656|NCT01298921|7714561|FG000|COMPLETED|Overall Study||0
6784657|NCT01298921|7714562|FG001|COMPLETED|Overall Study||0
6784658|NCT01298921|7714561|FG000|NOT COMPLETED|Overall Study||0
6784659|NCT01298921|7714562|FG001|NOT COMPLETED|Overall Study||0
6784660|NCT01292070|7714570|FG000|STARTED|Overall Study||4
6784661|NCT01292070|7714570|FG000|COMPLETED|Overall Study||4
6784662|NCT01292070|7714570|FG000|NOT COMPLETED|Overall Study||0
6784663|NCT01292265|7714574|FG000|STARTED|Overall Study||3
6784664|NCT01292265|7714574|FG000|COMPLETED|Overall Study||3
6784665|NCT01292265|7714574|FG000|NOT COMPLETED|Overall Study||0
6784666|NCT01290822|7714578|FG000|STARTED|Overall Study||12
6563056|NCT01805037|7486025|FG001|Received Dose of Study Drug|Consolidation (Optional, 4 Weeks)||6
6563057|NCT01805037|7486024|FG000|COMPLETED|Consolidation (Optional, 4 Weeks)||0
6563058|NCT01805037|7486025|FG001|COMPLETED|Consolidation (Optional, 4 Weeks)||6
6563059|NCT01805037|7486024|FG000|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
6563060|NCT01805037|7486025|FG001|NOT COMPLETED|Consolidation (Optional, 4 Weeks)||0
6563061|NCT01805037|7486024|FG000|STARTED|1st Cycle of Maintenance (3 Weeks)||0
6563062|NCT01805037|7486025|FG001|STARTED|1st Cycle of Maintenance (3 Weeks)|Consolidation is optional for patients who have a partial or complete response during induction|20
6563063|NCT01805037|7486024|FG000|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||0
6563064|NCT01805037|7486025|FG001|Received Dose of Study Drug|1st Cycle of Maintenance (3 Weeks)||14
6563065|NCT01805037|7486024|FG000|COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
6563066|NCT01805037|7486025|FG001|COMPLETED|1st Cycle of Maintenance (3 Weeks)||14
6563067|NCT01805037|7486024|FG000|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||0
6563068|NCT01805037|7486025|FG001|NOT COMPLETED|1st Cycle of Maintenance (3 Weeks)||6
6563069|NCT01805037|7486024|FG000|STARTED|2nd Cycle of Maintenance and Beyond||0
6563070|NCT01805037|7486025|FG001|STARTED|2nd Cycle of Maintenance and Beyond||14
6563071|NCT01805037|7486024|FG000|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||0
6563072|NCT01805037|7486025|FG001|Received Dose of Study Drug|2nd Cycle of Maintenance and Beyond||14
6563073|NCT01805037|7486024|FG000|COMPLETED|2nd Cycle of Maintenance and Beyond||0
6563074|NCT01805037|7486025|FG001|COMPLETED|2nd Cycle of Maintenance and Beyond||2
6502157|NCT01432756|7420793|FG001|COMPLETED|Overall Study||34
6502158|NCT01432756|7420794|FG002|COMPLETED|Overall Study||30
6502159|NCT01432756|7420795|FG003|COMPLETED|Overall Study||33
6502160|NCT01432756|7420792|FG000|NOT COMPLETED|Overall Study||1
6502161|NCT01432756|7420793|FG001|NOT COMPLETED|Overall Study||0
6502162|NCT01432756|7420794|FG002|NOT COMPLETED|Overall Study||2
6502163|NCT01432756|7420795|FG003|NOT COMPLETED|Overall Study||1
6502164|NCT01432886|7420805|FG000|STARTED|Overall Study||6
6502165|NCT01432886|7420806|FG001|STARTED|Overall Study||6
6502166|NCT01432886|7420805|FG000|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
6502167|NCT01432886|7420806|FG001|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
6502168|NCT01432886|7420805|FG000|NOT COMPLETED|Overall Study||0
6784667|NCT01290822|7714578|FG000|COMPLETED|Overall Study||1
6784668|NCT01290822|7714578|FG000|NOT COMPLETED|Overall Study||11
6784669|NCT01290718|7714582|FG000|STARTED|Overall Study||4
6784670|NCT01290718|7714582|FG000|COMPLETED|Overall Study||0
6784671|NCT01290718|7714582|FG000|NOT COMPLETED|Overall Study||4
6784672|NCT01293123|7714588|FG000|STARTED|Overall Study||1
6784673|NCT01293123|7714589|FG001|STARTED|Overall Study||1
6784674|NCT01293123|7714588|FG000|COMPLETED|Overall Study||1
6784675|NCT01293123|7714589|FG001|COMPLETED|Overall Study||0
6784676|NCT01293123|7714588|FG000|NOT COMPLETED|Overall Study||0
6784677|NCT01293123|7714589|FG001|NOT COMPLETED|Overall Study||1
6784678|NCT01294046|7714595|FG000|STARTED|Overall Study||3
6784679|NCT01294046|7714595|FG000|COMPLETED|Overall Study||0
6784680|NCT01294046|7714595|FG000|NOT COMPLETED|Overall Study||3
6784681|NCT01280643|7714611|FG000|STARTED|Overall Study||0
6784682|NCT01280643|7714612|FG001|STARTED|Overall Study||1
6784683|NCT01280643|7714613|FG002|STARTED|Overall Study||1
6784684|NCT01280643|7714614|FG003|STARTED|Overall Study||1
6784685|NCT01280643|7714615|FG004|STARTED|Overall Study||0
6784686|NCT01280643|7714616|FG005|STARTED|Overall Study||0
6784687|NCT01280643|7714617|FG006|STARTED|Overall Study||0
6784688|NCT01280643|7714618|FG007|STARTED|Overall Study||0
6784689|NCT01280643|7714619|FG008|STARTED|Overall Study||0
6784690|NCT01280643|7714611|FG000|COMPLETED|Overall Study||0
6784691|NCT01280643|7714612|FG001|COMPLETED|Overall Study||0
6784692|NCT01280643|7714613|FG002|COMPLETED|Overall Study||1
6784693|NCT01280643|7714614|FG003|COMPLETED|Overall Study||1
6784694|NCT01280643|7714615|FG004|COMPLETED|Overall Study||0
6784695|NCT01280643|7714616|FG005|COMPLETED|Overall Study||0
6784696|NCT01280643|7714617|FG006|COMPLETED|Overall Study||0
6784697|NCT01280643|7714618|FG007|COMPLETED|Overall Study||0
6784698|NCT01280643|7714619|FG008|COMPLETED|Overall Study||0
6784699|NCT01280643|7714611|FG000|NOT COMPLETED|Overall Study||0
6784700|NCT01280643|7714612|FG001|NOT COMPLETED|Overall Study||1
6784701|NCT01280643|7714613|FG002|NOT COMPLETED|Overall Study||0
6784702|NCT01280643|7714614|FG003|NOT COMPLETED|Overall Study||0
6784703|NCT01280643|7714615|FG004|NOT COMPLETED|Overall Study||0
6784704|NCT01280643|7714616|FG005|NOT COMPLETED|Overall Study||0
6784705|NCT01280643|7714617|FG006|NOT COMPLETED|Overall Study||0
6784706|NCT01280643|7714618|FG007|NOT COMPLETED|Overall Study||0
6784707|NCT01280643|7714619|FG008|NOT COMPLETED|Overall Study||0
6784708|NCT01281124|7714639|FG000|STARTED|Overall Study||1
6784709|NCT01281124|7714639|FG000|COMPLETED|Overall Study||0
6784710|NCT01281124|7714639|FG000|NOT COMPLETED|Overall Study||1
6784711|NCT01272141|7714645|FG000|STARTED|Overall Study||5
6784712|NCT01272141|7714645|FG000|COMPLETED|Overall Study||5
6784713|NCT01272141|7714645|FG000|NOT COMPLETED|Overall Study||0
6784714|NCT01282216|7714651|FG000|STARTED|Overall Study||18
6784715|NCT01282216|7714652|FG001|STARTED|Overall Study||26
6784716|NCT01282216|7714653|FG002|STARTED|Overall Study||52
6784717|NCT01282216|7714654|FG003|STARTED|Overall Study||8
6784718|NCT01282216|7714651|FG000|COMPLETED|Overall Study||18
6784719|NCT01282216|7714652|FG001|COMPLETED|Overall Study||26
6784720|NCT01282216|7714653|FG002|COMPLETED|Overall Study||19
6784721|NCT01282216|7714654|FG003|COMPLETED|Overall Study||0
6784722|NCT01282216|7714651|FG000|NOT COMPLETED|Overall Study||0
6784723|NCT01282216|7714652|FG001|NOT COMPLETED|Overall Study||0
6784724|NCT01282216|7714653|FG002|NOT COMPLETED|Overall Study||33
6784725|NCT01282216|7714654|FG003|NOT COMPLETED|Overall Study||8
6784726|NCT01284491|7714660|FG000|STARTED|Overall Study||13
6784727|NCT01284491|7714660|FG000|COMPLETED|Overall Study||0
6784728|NCT01284491|7714660|FG000|NOT COMPLETED|Overall Study||13
6784729|NCT01284504|7714668|FG000|STARTED|Overall Study||0
6784730|NCT01284504|7714669|FG001|STARTED|Overall Study||0
6784731|NCT01284504|7714668|FG000|COMPLETED|Overall Study||0
6784732|NCT01284504|7714669|FG001|COMPLETED|Overall Study||0
6784733|NCT01284504|7714668|FG000|NOT COMPLETED|Overall Study||0
6784734|NCT01284504|7714669|FG001|NOT COMPLETED|Overall Study||0
6784735|NCT01269034|7714679|FG000|STARTED|Overall Study||1
6784736|NCT01269034|7714680|FG001|STARTED|Overall Study||2
6784737|NCT01269034|7714681|FG002|STARTED|Overall Study||1
6784738|NCT01269034|7714682|FG003|STARTED|Overall Study||9
6784739|NCT01269034|7714679|FG000|COMPLETED|Overall Study||0
6784740|NCT01269034|7714680|FG001|COMPLETED|Overall Study||2
6784741|NCT01269034|7714681|FG002|COMPLETED|Overall Study||1
6784742|NCT01269034|7714682|FG003|COMPLETED|Overall Study||9
6784743|NCT01269034|7714679|FG000|NOT COMPLETED|Overall Study||1
6784744|NCT01269034|7714680|FG001|NOT COMPLETED|Overall Study||0
6784745|NCT01269034|7714681|FG002|NOT COMPLETED|Overall Study||0
6784746|NCT01269034|7714682|FG003|NOT COMPLETED|Overall Study||0
6784747|NCT01274533|7714692|FG000|STARTED|Overall Study||4
6784748|NCT01274533|7714692|FG000|COMPLETED|Overall Study||0
6784749|NCT01274533|7714692|FG000|NOT COMPLETED|Overall Study||4
6784750|NCT01279616|7714696|FG000|STARTED|Overall Study||8
6784751|NCT01279616|7714696|FG000|COMPLETED|Overall Study||1
6784752|NCT01279616|7714696|FG000|NOT COMPLETED|Overall Study||7
6784753|NCT01276054|7714702|FG000|STARTED|Overall Study||2
6784754|NCT01276054|7714703|FG001|STARTED|Overall Study||2
6784755|NCT01276054|7714702|FG000|COMPLETED|Overall Study||0
6784756|NCT01276054|7714703|FG001|COMPLETED|Overall Study||0
6784757|NCT01276054|7714702|FG000|NOT COMPLETED|Overall Study||2
6784758|NCT01276054|7714703|FG001|NOT COMPLETED|Overall Study||2
6784759|NCT01264965|7714709|FG000|STARTED|Overall Study||25
6784760|NCT01264965|7714709|FG000|COMPLETED|Overall Study||15
6784761|NCT01264965|7714709|FG000|NOT COMPLETED|Overall Study||10
6784762|NCT01266824|7714715|FG000|STARTED|Overall Study||2
6784763|NCT01266824|7714716|FG001|STARTED|Overall Study||3
6784764|NCT01266824|7714715|FG000|COMPLETED|Overall Study||0
6784765|NCT01266824|7714716|FG001|COMPLETED|Overall Study||0
6784766|NCT01266824|7714715|FG000|NOT COMPLETED|Overall Study||2
6784767|NCT01266824|7714716|FG001|NOT COMPLETED|Overall Study||3
6784768|NCT01264835|7714722|FG000|STARTED|Overall Study||2
6784769|NCT01264835|7714722|FG000|COMPLETED|Overall Study||1
6784770|NCT01264835|7714722|FG000|NOT COMPLETED|Overall Study||1
6784771|NCT01274429|7714726|FG000|STARTED|Overall Study||5
6784772|NCT01274429|7714726|FG000|COMPLETED|Overall Study||0
6784773|NCT01274429|7714726|FG000|NOT COMPLETED|Overall Study||5
6784774|NCT01273064|7714735|FG000|STARTED|Overall Study||23
6784775|NCT01273064|7714736|FG001|STARTED|Overall Study||30
6784776|NCT01273064|7714737|FG002|STARTED|Overall Study||31
6784777|NCT01273064|7714738|FG003|STARTED|Overall Study||20
6784778|NCT01273064|7714739|FG004|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
6784779|NCT01273064|7714735|FG000|COMPLETED|Overall Study||0
6784780|NCT01273064|7714736|FG001|COMPLETED|Overall Study||0
6784781|NCT01273064|7714737|FG002|COMPLETED|Overall Study||0
6784782|NCT01273064|7714738|FG003|COMPLETED|Overall Study||0
6378419|NCT00768287|7289021|FG004|COMPLETED|Repeat Pharmacokinetic Study||0
6378420|NCT00768287|7289022|FG005|COMPLETED|Repeat Pharmacokinetic Study||0
6378421|NCT00768287|7289017|FG000|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6378422|NCT00768287|7289018|FG001|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6378423|NCT00768287|7289019|FG002|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6378424|NCT00768287|7289020|FG003|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6378425|NCT00768287|7289021|FG004|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6378426|NCT00768287|7289022|FG005|NOT COMPLETED|Repeat Pharmacokinetic Study||0
6378427|NCT00768287|7289017|FG000|STARTED|Treatment Study||0
6378428|NCT00768287|7289018|FG001|STARTED|Treatment Study||0
6378429|NCT00768287|7289019|FG002|STARTED|Treatment Study||0
6378430|NCT00768287|7289020|FG003|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|58
6378431|NCT00768287|7289021|FG004|STARTED|Treatment Study|1 subject was not assigned a regimen at the start of the study.|9
6378432|NCT00768287|7289022|FG005|STARTED|Treatment Study||0
6378433|NCT00768287|7289017|FG000|Treated|Treatment Study||0
6378434|NCT00768287|7289018|FG001|Treated|Treatment Study||0
6378435|NCT00768287|7289019|FG002|Treated|Treatment Study||0
6378436|NCT00768287|7289020|FG003|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from On Demand to Prophylaxis.|61
6378437|NCT00768287|7289021|FG004|Treated|Treatment Study|Subjects could switch treatment regimens. 3 subjects switched from Prophylaxis to On Demand.|12
6378438|NCT00768287|7289022|FG005|Treated|Treatment Study||0
6378439|NCT00768287|7289017|FG000|COMPLETED|Treatment Study||0
6378440|NCT00768287|7289018|FG001|COMPLETED|Treatment Study||0
6378441|NCT00768287|7289019|FG002|COMPLETED|Treatment Study||0
6378442|NCT00768287|7289020|FG003|COMPLETED|Treatment Study||58
6378443|NCT00768287|7289021|FG004|COMPLETED|Treatment Study||9
6378444|NCT00768287|7289022|FG005|COMPLETED|Treatment Study||0
6378445|NCT00768287|7289017|FG000|NOT COMPLETED|Treatment Study||0
6378446|NCT00768287|7289018|FG001|NOT COMPLETED|Treatment Study||0
6378447|NCT00768287|7289019|FG002|NOT COMPLETED|Treatment Study||0
6378448|NCT00768287|7289020|FG003|NOT COMPLETED|Treatment Study||0
6502169|NCT01432886|7420806|FG001|NOT COMPLETED|Overall Study||0
6502170|NCT01432938|7420813|FG000|STARTED|First Intervention||14
6502171|NCT01432938|7420814|FG001|STARTED|First Intervention||14
6502172|NCT01432938|7420813|FG000|Received at Least 1 Dose of Study Drug|First Intervention||14
6502173|NCT01432938|7420814|FG001|Received at Least 1 Dose of Study Drug|First Intervention||14
6502174|NCT01432938|7420813|FG000|COMPLETED|First Intervention||12
6502175|NCT01432938|7420814|FG001|COMPLETED|First Intervention||14
6502176|NCT01432938|7420813|FG000|NOT COMPLETED|First Intervention||2
6502177|NCT01432938|7420814|FG001|NOT COMPLETED|First Intervention||0
6502178|NCT01432938|7420813|FG000|STARTED|Washout Period of at Least 24 Days||12
6502179|NCT01432938|7420814|FG001|STARTED|Washout Period of at Least 24 Days||14
6502180|NCT01432938|7420813|FG000|COMPLETED|Washout Period of at Least 24 Days||12
6502181|NCT01432938|7420814|FG001|COMPLETED|Washout Period of at Least 24 Days||14
6502182|NCT01432938|7420813|FG000|NOT COMPLETED|Washout Period of at Least 24 Days||0
6502183|NCT01432938|7420814|FG001|NOT COMPLETED|Washout Period of at Least 24 Days||0
6502184|NCT01432938|7420813|FG000|STARTED|Second Intervention||12
6502185|NCT01432938|7420814|FG001|STARTED|Second Intervention||14
6502186|NCT01432938|7420813|FG000|COMPLETED|Second Intervention||11
6502187|NCT01432938|7420814|FG001|COMPLETED|Second Intervention||14
6502188|NCT01432938|7420813|FG000|NOT COMPLETED|Second Intervention||1
6502189|NCT01432938|7420814|FG001|NOT COMPLETED|Second Intervention||0
6502190|NCT01432951|7420821|FG000|STARTED|Treatment Phase (Day 1 to 30)||26
6502191|NCT01432951|7420821|FG000|Received at Least One Dose of Study Drug|Treatment Phase (Day 1 to 30)||25
6502192|NCT01432951|7420821|FG000|PK Sampling (no Dosing) Days 15-17|Treatment Phase (Day 1 to 30)||23
6784783|NCT01273064|7714739|FG004|COMPLETED|Overall Study||0
6784784|NCT01273064|7714735|FG000|NOT COMPLETED|Overall Study||23
6784785|NCT01273064|7714736|FG001|NOT COMPLETED|Overall Study||30
6784786|NCT01273064|7714737|FG002|NOT COMPLETED|Overall Study||31
6784787|NCT01273064|7714738|FG003|NOT COMPLETED|Overall Study||20
6784788|NCT01273064|7714739|FG004|NOT COMPLETED|Overall Study||10
6784789|NCT01274559|7714753|FG000|STARTED|Overall Study||587
6784790|NCT01274559|7714754|FG001|STARTED|Overall Study||586
6784791|NCT01274559|7714753|FG000|Treated|Overall Study||572
6784792|NCT01274559|7714754|FG001|Treated|Overall Study||572
6784793|NCT01274559|7714753|FG000|COMPLETED|Overall Study||390
6784794|NCT01274559|7714754|FG001|COMPLETED|Overall Study||441
6784795|NCT01274559|7714753|FG000|NOT COMPLETED|Overall Study||197
6784796|NCT01274559|7714754|FG001|NOT COMPLETED|Overall Study||145
6784797|NCT01270581|7714762|FG000|STARTED|Overall Study||4
6784798|NCT01270581|7714763|FG001|STARTED|Overall Study||3
6784799|NCT01270581|7714762|FG000|COMPLETED|Overall Study||3
6784800|NCT01270581|7714763|FG001|COMPLETED|Overall Study||3
6784801|NCT01270581|7714762|FG000|NOT COMPLETED|Overall Study||1
6784802|NCT01270581|7714763|FG001|NOT COMPLETED|Overall Study||0
6784803|NCT01269749|7714771|FG000|STARTED|Overall Study||16
6784804|NCT01269749|7714772|FG001|STARTED|Overall Study||3
6784805|NCT01269749|7714771|FG000|COMPLETED|Overall Study||16
6784806|NCT01269749|7714772|FG001|COMPLETED|Overall Study||3
6784807|NCT01269749|7714771|FG000|NOT COMPLETED|Overall Study||0
6784808|NCT01269749|7714772|FG001|NOT COMPLETED|Overall Study||0
6784809|NCT01270919|7714778|FG000|STARTED|Overall Study|One participant was enrolled but was censored.|0
6784810|NCT01270919|7714778|FG000|COMPLETED|Overall Study||0
6784811|NCT01270919|7714778|FG000|NOT COMPLETED|Overall Study||0
6784812|NCT01262339|7714782|FG000|STARTED|Overall Study||2
6784813|NCT01262339|7714782|FG000|COMPLETED|Overall Study||2
6784814|NCT01262339|7714782|FG000|NOT COMPLETED|Overall Study||0
6784815|NCT01267825|7714788|FG000|STARTED|Overall Study||1
6784816|NCT01267825|7714789|FG001|STARTED|Overall Study||0
6784817|NCT01267825|7714788|FG000|COMPLETED|Overall Study||0
6784818|NCT01267825|7714789|FG001|COMPLETED|Overall Study||0
6784819|NCT01267825|7714788|FG000|NOT COMPLETED|Overall Study||1
6784820|NCT01267825|7714789|FG001|NOT COMPLETED|Overall Study||0
6784825|NCT01259284|7714803|FG000|STARTED|Overall Study||2
6784826|NCT01259284|7714804|FG001|STARTED|Overall Study||0
6784827|NCT01259284|7714805|FG002|STARTED|Overall Study||0
6784828|NCT01259284|7714803|FG000|COMPLETED|Overall Study||0
6784829|NCT01259284|7714804|FG001|COMPLETED|Overall Study||0
6784830|NCT01259284|7714805|FG002|COMPLETED|Overall Study||0
6784831|NCT01259284|7714803|FG000|NOT COMPLETED|Overall Study||2
6784832|NCT01259284|7714804|FG001|NOT COMPLETED|Overall Study||0
6784833|NCT01259284|7714805|FG002|NOT COMPLETED|Overall Study||0
6784834|NCT01249157|7714813|FG000|STARTED|Overall Study||1
6784835|NCT01249157|7714813|FG000|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
6784836|NCT01249157|7714813|FG000|NOT COMPLETED|Overall Study||1
6784837|NCT01263028|7714817|FG000|STARTED|Overall Study||6
6784838|NCT01263028|7714817|FG000|COMPLETED|Overall Study||0
6784839|NCT01263028|7714817|FG000|NOT COMPLETED|Overall Study||6
6784840|NCT01256281|7714821|FG000|STARTED|Overall Study||2
6784841|NCT01256281|7714821|FG000|COMPLETED|Overall Study||2
6784842|NCT01256281|7714821|FG000|NOT COMPLETED|Overall Study||0
6784843|NCT01253668|7714825|FG000|STARTED|Overall Study||0
6784844|NCT01253668|7714825|FG000|COMPLETED|Overall Study||0
6784845|NCT01253668|7714825|FG000|NOT COMPLETED|Overall Study||0
6784846|NCT01259024|7714829|FG000|STARTED|Overall Study||1
6784847|NCT01259024|7714829|FG000|COMPLETED|Overall Study||0
6784848|NCT01259024|7714829|FG000|NOT COMPLETED|Overall Study||1
6784849|NCT01251952|7714833|FG000|STARTED|Overall Study||2
6784850|NCT01251952|7714833|FG000|COMPLETED|Overall Study||1
6784851|NCT01251952|7714833|FG000|NOT COMPLETED|Overall Study||1
6784852|NCT01251120|7714839|FG000|STARTED|Overall Study||1
6784853|NCT01251120|7714840|FG001|STARTED|Overall Study||1
6784854|NCT01251120|7714839|FG000|COMPLETED|Overall Study||1
6784855|NCT01251120|7714840|FG001|COMPLETED|Overall Study||0
6784856|NCT01251120|7714839|FG000|NOT COMPLETED|Overall Study||0
6784857|NCT01251120|7714840|FG001|NOT COMPLETED|Overall Study||1
6784858|NCT01248130|7714848|FG000|STARTED|Overall Study||3
6784859|NCT01248130|7714849|FG001|STARTED|Overall Study||4
6784860|NCT01248130|7714848|FG000|COMPLETED|Overall Study||1
6784861|NCT01248130|7714849|FG001|COMPLETED|Overall Study||4
6784862|NCT01248130|7714848|FG000|NOT COMPLETED|Overall Study||2
6784863|NCT01248130|7714849|FG001|NOT COMPLETED|Overall Study||0
6784864|NCT01243892|7714857|FG000|STARTED|Overall Study||15
6784865|NCT01243892|7714858|FG001|STARTED|Overall Study||3
6784866|NCT01243892|7714857|FG000|COMPLETED|Overall Study||13
6784867|NCT01243892|7714858|FG001|COMPLETED|Overall Study||3
6784868|NCT01243892|7714857|FG000|NOT COMPLETED|Overall Study||2
6784869|NCT01243892|7714858|FG001|NOT COMPLETED|Overall Study||0
6784870|NCT01246011|7714867|FG000|STARTED|Overall Study||0
6784871|NCT01246011|7714868|FG001|STARTED|Overall Study||0
6784872|NCT01246011|7714869|FG002|STARTED|Overall Study||9
6784873|NCT01246011|7714867|FG000|COMPLETED|Overall Study||0
6784874|NCT01246011|7714868|FG001|COMPLETED|Overall Study||0
6784875|NCT01246011|7714869|FG002|COMPLETED|Overall Study||5
6784876|NCT01246011|7714867|FG000|NOT COMPLETED|Overall Study||0
6784877|NCT01246011|7714868|FG001|NOT COMPLETED|Overall Study||0
6784878|NCT01246011|7714869|FG002|NOT COMPLETED|Overall Study||4
6784879|NCT01242020|7714880|FG000|STARTED|Overall Study||6
6784880|NCT01242020|7714881|FG001|STARTED|Overall Study||0
6784881|NCT01242020|7714880|FG000|COMPLETED|Overall Study||3
6784882|NCT01242020|7714881|FG001|COMPLETED|Overall Study||0
6784883|NCT01242020|7714880|FG000|NOT COMPLETED|Overall Study||3
6784884|NCT01242020|7714881|FG001|NOT COMPLETED|Overall Study||0
6784885|NCT01244620|7714887|FG000|STARTED|Overall Study||4
6784886|NCT01244620|7714888|FG001|STARTED|Overall Study||4
6784887|NCT01244620|7714889|FG002|STARTED|Overall Study||4
6784888|NCT01244620|7714890|FG003|STARTED|Overall Study||4
6784889|NCT01244620|7714887|FG000|COMPLETED|Overall Study||0
6784890|NCT01244620|7714888|FG001|COMPLETED|Overall Study||0
6784891|NCT01244620|7714889|FG002|COMPLETED|Overall Study||0
6784892|NCT01244620|7714890|FG003|COMPLETED|Overall Study||0
6784893|NCT01244620|7714887|FG000|NOT COMPLETED|Overall Study||4
6784894|NCT01244620|7714888|FG001|NOT COMPLETED|Overall Study||4
6784895|NCT01244620|7714889|FG002|NOT COMPLETED|Overall Study||4
6784896|NCT01244620|7714890|FG003|NOT COMPLETED|Overall Study||4
6784897|NCT01240304|7714900|FG000|STARTED|Overall Study||10
6784898|NCT01240304|7714900|FG000|COMPLETED|Overall Study||0
6784899|NCT01240304|7714900|FG000|NOT COMPLETED|Overall Study||10
6784900|NCT01241279|7714906|FG000|STARTED|Overall Study||4
6784901|NCT01241279|7714907|FG001|STARTED|Overall Study||2
6784902|NCT01241279|7714906|FG000|COMPLETED|Overall Study||4
6784903|NCT01241279|7714907|FG001|COMPLETED|Overall Study||1
6784904|NCT01241279|7714906|FG000|NOT COMPLETED|Overall Study||0
6784905|NCT01241279|7714907|FG001|NOT COMPLETED|Overall Study||1
6784906|NCT01230788|7714913|FG000|STARTED|Overall Study||1
6784907|NCT01230788|7714913|FG000|COMPLETED|Overall Study||0
6784908|NCT01230788|7714913|FG000|NOT COMPLETED|Overall Study||1
6784909|NCT01239680|7714919|FG000|STARTED|Overall Study||3
6784910|NCT01239680|7714920|FG001|STARTED|Overall Study||2
6784911|NCT01239680|7714919|FG000|COMPLETED|Overall Study||1
6784912|NCT01239680|7714920|FG001|COMPLETED|Overall Study||2
6784913|NCT01239680|7714919|FG000|NOT COMPLETED|Overall Study||2
6784914|NCT01239680|7714920|FG001|NOT COMPLETED|Overall Study||0
6784915|NCT01237613|7714926|FG000|STARTED|Overall Study||4
6502193|NCT01432951|7420821|FG000|Progressive Disease|Treatment Phase (Day 1 to 30)||10
6502194|NCT01432951|7420821|FG000|COMPLETED|Treatment Phase (Day 1 to 30)||25
6502195|NCT01432951|7420821|FG000|NOT COMPLETED|Treatment Phase (Day 1 to 30)||1
6502196|NCT01432951|7420821|FG000|STARTED|Safety Extension Day 30 to End of Study|Participants had the option to continue on to safety extension period.|15
6502197|NCT01432951|7420821|FG000|COMPLETED|Safety Extension Day 30 to End of Study||15
6502198|NCT01432951|7420821|FG000|NOT COMPLETED|Safety Extension Day 30 to End of Study||0
6502199|NCT01433016|7420826|FG000|STARTED|Overall Study||20
6502200|NCT01433016|7420826|FG000|COMPLETED|Overall Study||20
6502201|NCT01433016|7420826|FG000|NOT COMPLETED|Overall Study||0
6502202|NCT01433042|7420830|FG000|STARTED|Overall Study||225
6502203|NCT01433042|7420830|FG000|COMPLETED|Overall Study||224
6502204|NCT01433042|7420830|FG000|NOT COMPLETED|Overall Study||1
6502205|NCT01433055|7420836|FG000|STARTED|Overall Study||29
6502206|NCT01433055|7420837|FG001|STARTED|Overall Study||23
6502207|NCT01433055|7420836|FG000|COMPLETED|Overall Study||27
6502208|NCT01433055|7420837|FG001|COMPLETED|Overall Study||23
6502209|NCT01433055|7420836|FG000|NOT COMPLETED|Overall Study||2
6502210|NCT01433055|7420837|FG001|NOT COMPLETED|Overall Study||0
6502211|NCT01433081|7420845|FG000|STARTED|Overall Study||25
6502212|NCT01433081|7420846|FG001|STARTED|Overall Study||25
6502213|NCT01433081|7420845|FG000|COMPLETED|Overall Study||23
6502214|NCT01433081|7420846|FG001|COMPLETED|Overall Study||23
6502215|NCT01433081|7420845|FG000|NOT COMPLETED|Overall Study||2
6502216|NCT01433081|7420846|FG001|NOT COMPLETED|Overall Study||2
6502217|NCT01433107|7420855|FG000|STARTED|Overall Study||145
6502218|NCT01433107|7420856|FG001|STARTED|Overall Study||145
6502219|NCT01433107|7420855|FG000|COMPLETED|Overall Study||118
6502220|NCT01433107|7420856|FG001|COMPLETED|Overall Study||128
6784916|NCT01237613|7714926|FG000|COMPLETED|Overall Study||4
6784917|NCT01237613|7714926|FG000|NOT COMPLETED|Overall Study||0
6784918|NCT01234103|7714933|FG000|STARTED|Overall Study||542
6784919|NCT01234103|7714934|FG001|STARTED|Overall Study||391
6784920|NCT01234103|7714933|FG000|COMPLETED|Overall Study||542
6784921|NCT01234103|7714934|FG001|COMPLETED|Overall Study||391
6784922|NCT01234103|7714933|FG000|NOT COMPLETED|Overall Study||0
6784923|NCT01234103|7714934|FG001|NOT COMPLETED|Overall Study||0
6784924|NCT01231750|7714942|FG000|STARTED|Overall Study||3
6784925|NCT01231750|7714943|FG001|STARTED|Overall Study||4
6784926|NCT01231750|7714942|FG000|COMPLETED|Overall Study||3
6784927|NCT01231750|7714943|FG001|COMPLETED|Overall Study||4
6784928|NCT01231750|7714942|FG000|NOT COMPLETED|Overall Study||0
6784929|NCT01231750|7714943|FG001|NOT COMPLETED|Overall Study||0
6784930|NCT01230307|7714951|FG000|STARTED|Overall Study||6
6784931|NCT01230307|7714952|FG001|STARTED|Overall Study||6
6784932|NCT01230307|7714951|FG000|COMPLETED|Overall Study||6
6784933|NCT01230307|7714952|FG001|COMPLETED|Overall Study||4
6784934|NCT01230307|7714951|FG000|NOT COMPLETED|Overall Study||0
6784935|NCT01230307|7714952|FG001|NOT COMPLETED|Overall Study||2
6784936|NCT01230489|7714958|FG000|STARTED|Overall Study||13
6502221|NCT01433107|7420855|FG000|NOT COMPLETED|Overall Study||27
6502222|NCT01433107|7420856|FG001|NOT COMPLETED|Overall Study||17
6502223|NCT01433159|7420864|FG000|STARTED|Overall Study||9
6502224|NCT01433159|7420865|FG001|STARTED|Overall Study||10
6502225|NCT01433159|7420864|FG000|COMPLETED|Overall Study||7
6784937|NCT01230489|7714958|FG000|COMPLETED|Overall Study||8
6784938|NCT01230489|7714958|FG000|NOT COMPLETED|Overall Study||5
6784939|NCT01222871|7714964|FG000|STARTED|Overall Study||0
6784940|NCT01222871|7714965|FG001|STARTED|Overall Study||0
6784941|NCT01222871|7714964|FG000|COMPLETED|Overall Study||0
6784942|NCT01222871|7714965|FG001|COMPLETED|Overall Study||0
6784943|NCT01222871|7714964|FG000|NOT COMPLETED|Overall Study||0
6784944|NCT01222871|7714965|FG001|NOT COMPLETED|Overall Study||0
6784945|NCT01219673|7714980|FG000|STARTED|Overall Study||0
6784946|NCT01219673|7714981|FG001|STARTED|Overall Study||0
6784947|NCT01219673|7714982|FG002|STARTED|Overall Study||1
6784948|NCT01219673|7714983|FG003|STARTED|Overall Study||0
6784949|NCT01219673|7714984|FG004|STARTED|Overall Study||0
6784950|NCT01219673|7714985|FG005|STARTED|Overall Study||0
6784951|NCT01219673|7714986|FG006|STARTED|Overall Study||0
6784952|NCT01219673|7714987|FG007|STARTED|Overall Study||0
6784953|NCT01219673|7714980|FG000|COMPLETED|Overall Study||0
6784954|NCT01219673|7714981|FG001|COMPLETED|Overall Study||0
6784955|NCT01219673|7714982|FG002|COMPLETED|Overall Study||1
6784956|NCT01219673|7714983|FG003|COMPLETED|Overall Study||0
6784957|NCT01219673|7714984|FG004|COMPLETED|Overall Study||0
6784958|NCT01219673|7714985|FG005|COMPLETED|Overall Study||0
6784959|NCT01219673|7714986|FG006|COMPLETED|Overall Study||0
6784960|NCT01219673|7714987|FG007|COMPLETED|Overall Study||0
6784961|NCT01219673|7714980|FG000|NOT COMPLETED|Overall Study||0
6784962|NCT01219673|7714981|FG001|NOT COMPLETED|Overall Study||0
6784963|NCT01219673|7714982|FG002|NOT COMPLETED|Overall Study||0
6784964|NCT01219673|7714983|FG003|NOT COMPLETED|Overall Study||0
6784965|NCT01219673|7714984|FG004|NOT COMPLETED|Overall Study||0
6784966|NCT01219673|7714985|FG005|NOT COMPLETED|Overall Study||0
6784967|NCT01219673|7714986|FG006|NOT COMPLETED|Overall Study||0
6784968|NCT01219673|7714987|FG007|NOT COMPLETED|Overall Study||0
6784969|NCT01223001|7715007|FG000|STARTED|Overall Study||4
6784970|NCT01223001|7715008|FG001|STARTED|Overall Study||4
6784971|NCT01223001|7715007|FG000|COMPLETED|Overall Study||0
6784972|NCT01223001|7715008|FG001|COMPLETED|Overall Study||0
6784973|NCT01223001|7715007|FG000|NOT COMPLETED|Overall Study||4
6784974|NCT01223001|7715008|FG001|NOT COMPLETED|Overall Study||4
6784975|NCT01217060|7715014|FG000|STARTED|Overall Study||4
6784976|NCT01217060|7715014|FG000|COMPLETED|Overall Study||3
6784977|NCT01217060|7715014|FG000|NOT COMPLETED|Overall Study||1
6784978|NCT01217047|7715022|FG000|STARTED|Overall Study||3
6784979|NCT01217047|7715023|FG001|STARTED|Overall Study||4
6784980|NCT01217047|7715024|FG002|STARTED|Overall Study||3
6784981|NCT01217047|7715022|FG000|COMPLETED|Overall Study||3
6784982|NCT01217047|7715023|FG001|COMPLETED|Overall Study||3
6784983|NCT01217047|7715024|FG002|COMPLETED|Overall Study||3
6784984|NCT01217047|7715022|FG000|NOT COMPLETED|Overall Study||0
6784985|NCT01217047|7715023|FG001|NOT COMPLETED|Overall Study||1
6784986|NCT01217047|7715024|FG002|NOT COMPLETED|Overall Study||0
6784987|NCT01206101|7715035|FG000|STARTED|Overall Study||2
6784988|NCT01206101|7715036|FG001|STARTED|Overall Study||1
6784989|NCT01206101|7715035|FG000|COMPLETED|Overall Study||0
6784990|NCT01206101|7715036|FG001|COMPLETED|Overall Study||0
6784991|NCT01206101|7715035|FG000|NOT COMPLETED|Overall Study||2
6784992|NCT01206101|7715036|FG001|NOT COMPLETED|Overall Study||1
6784993|NCT01216631|7715045|FG000|STARTED|Overall Study||0
6784994|NCT01216631|7715046|FG001|STARTED|Overall Study||0
6784995|NCT01216631|7715047|FG002|STARTED|Overall Study||1
6784996|NCT01216631|7715045|FG000|COMPLETED|Overall Study||0
6784997|NCT01216631|7715046|FG001|COMPLETED|Overall Study||0
6784998|NCT01216631|7715047|FG002|COMPLETED|Overall Study||1
6784999|NCT01216631|7715045|FG000|NOT COMPLETED|Overall Study||0
6785000|NCT01216631|7715046|FG001|NOT COMPLETED|Overall Study||0
6785001|NCT01216631|7715047|FG002|NOT COMPLETED|Overall Study||0
6785002|NCT01211756|7715055|FG000|STARTED|Overall Study||1
6785003|NCT01211756|7715055|FG000|COMPLETED|Overall Study||1
6785004|NCT01211756|7715055|FG000|NOT COMPLETED|Overall Study||0
6785005|NCT01209520|7715059|FG000|STARTED|Overall Study||6
6785006|NCT01209520|7715059|FG000|COMPLETED|Overall Study||3
6502226|NCT01433159|7420865|FG001|COMPLETED|Overall Study||9
6785007|NCT01209520|7715059|FG000|NOT COMPLETED|Overall Study||3
6785008|NCT01207726|7715065|FG000|STARTED|Overall Study||7
6502227|NCT01433159|7420864|FG000|NOT COMPLETED|Overall Study||2
6785009|NCT01207726|7715066|FG001|STARTED|Overall Study||6
6785010|NCT01207726|7715065|FG000|COMPLETED|Overall Study||7
6502228|NCT01433159|7420865|FG001|NOT COMPLETED|Overall Study||1
6656243|NCT02459262|7586364|FG006|NOT COMPLETED|Overall Study||0
6656244|NCT02459262|7586365|FG007|NOT COMPLETED|Overall Study||0
6656245|NCT02459262|7586366|FG008|NOT COMPLETED|Overall Study||0
6656246|NCT02459262|7586367|FG009|NOT COMPLETED|Overall Study||1
6656247|NCT02459262|7586368|FG010|NOT COMPLETED|Overall Study||0
6656248|NCT02459275|7586394|FG000|STARTED|Overall Study||19
6785011|NCT01207726|7715066|FG001|COMPLETED|Overall Study||6
6785012|NCT01207726|7715065|FG000|NOT COMPLETED|Overall Study||0
6785013|NCT01207726|7715066|FG001|NOT COMPLETED|Overall Study||0
6785014|NCT01206296|7715076|FG000|STARTED|Overall Study||0
6785015|NCT01206296|7715076|FG000|COMPLETED|Overall Study||0
6785016|NCT01206296|7715076|FG000|NOT COMPLETED|Overall Study||0
6656249|NCT02459275|7586395|FG001|STARTED|Overall Study||17
6656250|NCT02459275|7586394|FG000|COMPLETED|Overall Study||19
6785017|NCT01207102|7715080|FG000|STARTED|Overall Study||10
6785018|NCT01207102|7715080|FG000|COMPLETED|Overall Study||0
6785019|NCT01207102|7715080|FG000|NOT COMPLETED|Overall Study||10
6785020|NCT01213329|7715086|FG000|STARTED|Screening||25
6785021|NCT01213329|7715087|FG001|STARTED|Screening||25
6378449|NCT00768287|7289021|FG004|NOT COMPLETED|Treatment Study||0
6378450|NCT00768287|7289022|FG005|NOT COMPLETED|Treatment Study||0
6378451|NCT00768287|7289017|FG000|STARTED|Surgical Sub-study||0
6378452|NCT00768287|7289018|FG001|STARTED|Surgical Sub-study||0
6378453|NCT00768287|7289019|FG002|STARTED|Surgical Sub-study||0
6785022|NCT01213329|7715086|FG000|COMPLETED|Screening||25
6785023|NCT01213329|7715087|FG001|COMPLETED|Screening||25
6785024|NCT01213329|7715086|FG000|NOT COMPLETED|Screening||0
6785025|NCT01213329|7715087|FG001|NOT COMPLETED|Screening||0
6785026|NCT01213329|7715086|FG000|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
6785027|NCT01213329|7715087|FG001|STARTED|Phase 2|No subjects continued into phase 2.This is due to a loss of samples from a processing inconsistency.|0
6785028|NCT01213329|7715086|FG000|COMPLETED|Phase 2||0
6785029|NCT01213329|7715087|FG001|COMPLETED|Phase 2||0
6785030|NCT01213329|7715086|FG000|NOT COMPLETED|Phase 2||0
6785031|NCT01213329|7715087|FG001|NOT COMPLETED|Phase 2||0
6785032|NCT01202110|7715093|FG000|STARTED|Overall Study||10
6785033|NCT01202110|7715094|FG001|STARTED|Overall Study||0
6785034|NCT01202110|7715093|FG000|COMPLETED|Overall Study||10
6785035|NCT01202110|7715094|FG001|COMPLETED|Overall Study||0
6785036|NCT01202110|7715093|FG000|NOT COMPLETED|Overall Study||0
6785037|NCT01202110|7715094|FG001|NOT COMPLETED|Overall Study||0
6785038|NCT01206439|7715098|FG000|STARTED|Overall Study||2
6785039|NCT01206439|7715098|FG000|COMPLETED|Overall Study||1
6785040|NCT01206439|7715098|FG000|NOT COMPLETED|Overall Study||1
6785041|NCT01204788|7715104|FG000|STARTED|Overall Study||1
6785042|NCT01204788|7715105|FG001|STARTED|Overall Study||3
6785043|NCT01204788|7715104|FG000|COMPLETED|Overall Study||0
6785044|NCT01204788|7715105|FG001|COMPLETED|Overall Study||0
6785045|NCT01204788|7715104|FG000|NOT COMPLETED|Overall Study||1
6785046|NCT01204788|7715105|FG001|NOT COMPLETED|Overall Study||3
6785047|NCT01200602|7715113|FG000|STARTED|Overall Study||0
6785048|NCT01200602|7715114|FG001|STARTED|Overall Study||0
6785049|NCT01200602|7715113|FG000|COMPLETED|Overall Study||0
6785050|NCT01200602|7715114|FG001|COMPLETED|Overall Study||0
6785051|NCT01200602|7715113|FG000|NOT COMPLETED|Overall Study||0
6785052|NCT01200602|7715114|FG001|NOT COMPLETED|Overall Study||0
6785053|NCT01198548|7715120|FG000|STARTED|Overall Study||10
6785054|NCT01198548|7715120|FG000|COMPLETED|Overall Study||0
6785055|NCT01198548|7715120|FG000|NOT COMPLETED|Overall Study||10
6785056|NCT01194908|7715124|FG000|STARTED|Overall Study||5
6785057|NCT01194908|7715124|FG000|COMPLETED|Overall Study||5
6785058|NCT01194908|7715124|FG000|NOT COMPLETED|Overall Study||0
6785059|NCT01194856|7715130|FG000|STARTED|Overall Study||1
6785060|NCT01194856|7715131|FG001|STARTED|Overall Study||0
6785061|NCT01194856|7715130|FG000|COMPLETED|Overall Study||0
6785062|NCT01194856|7715131|FG001|COMPLETED|Overall Study||0
6785063|NCT01194856|7715130|FG000|NOT COMPLETED|Overall Study||1
6785064|NCT01194856|7715131|FG001|NOT COMPLETED|Overall Study||0
6785065|NCT01194427|7715137|FG000|STARTED|Overall Study||2
6785066|NCT01194427|7715137|FG000|COMPLETED|Overall Study||2
6785067|NCT01194427|7715137|FG000|NOT COMPLETED|Overall Study||0
6785068|NCT01193556|7715143|FG000|STARTED|Overall Study||26
6785069|NCT01193556|7715144|FG001|STARTED|Overall Study||25
6785070|NCT01193556|7715143|FG000|COMPLETED|Overall Study||0
6785071|NCT01193556|7715144|FG001|COMPLETED|Overall Study||0
6785072|NCT01193556|7715143|FG000|NOT COMPLETED|Overall Study||26
6785073|NCT01193556|7715144|FG001|NOT COMPLETED|Overall Study||25
6785074|NCT01189435|7715150|FG000|STARTED|Overall Study||2
6785075|NCT01189435|7715150|FG000|COMPLETED|Overall Study||0
6785076|NCT01189435|7715150|FG000|NOT COMPLETED|Overall Study||2
6785077|NCT01193530|7715156|FG000|STARTED|Overall Study||4
6785078|NCT01193530|7715157|FG001|STARTED|Overall Study||8
6785079|NCT01193530|7715156|FG000|COMPLETED|Overall Study||1
6785080|NCT01193530|7715157|FG001|COMPLETED|Overall Study||3
6785081|NCT01193530|7715156|FG000|NOT COMPLETED|Overall Study||3
6785082|NCT01193530|7715157|FG001|NOT COMPLETED|Overall Study||5
6785083|NCT01182610|7715163|FG000|STARTED|Overall Study||1
6785084|NCT01182610|7715163|FG000|COMPLETED|Overall Study||1
6785085|NCT01182610|7715163|FG000|NOT COMPLETED|Overall Study||0
6785086|NCT01189071|7715169|FG000|STARTED|Overall Study||0
6785087|NCT01189071|7715170|FG001|STARTED|Overall Study||0
6785088|NCT01189071|7715169|FG000|COMPLETED|Overall Study||0
6785089|NCT01189071|7715170|FG001|COMPLETED|Overall Study||0
6785090|NCT01189071|7715169|FG000|NOT COMPLETED|Overall Study||0
6785091|NCT01189071|7715170|FG001|NOT COMPLETED|Overall Study||0
6785092|NCT01183416|7715176|FG000|STARTED|Overall Study||4
6785093|NCT01183416|7715176|FG000|COMPLETED|Overall Study||4
6785094|NCT01183416|7715176|FG000|NOT COMPLETED|Overall Study||0
6785095|NCT01184456|7715182|FG000|STARTED|Overall Study||0
6785096|NCT01184456|7715183|FG001|STARTED|Overall Study||0
6785097|NCT01184456|7715182|FG000|COMPLETED|Overall Study||0
6378454|NCT00768287|7289020|FG003|STARTED|Surgical Sub-study||0
6378455|NCT00768287|7289021|FG004|STARTED|Surgical Sub-study||0
6785098|NCT01184456|7715183|FG001|COMPLETED|Overall Study||0
6785099|NCT01184456|7715182|FG000|NOT COMPLETED|Overall Study||0
6785100|NCT01184456|7715183|FG001|NOT COMPLETED|Overall Study||0
6785101|NCT01183221|7715191|FG000|STARTED|First Dose||15
6785102|NCT01183221|7715192|FG001|STARTED|First Dose||15
6785103|NCT01183221|7715191|FG000|COMPLETED|First Dose||15
6785104|NCT01183221|7715192|FG001|COMPLETED|First Dose||15
6785105|NCT01183221|7715191|FG000|NOT COMPLETED|First Dose||0
6785106|NCT01183221|7715192|FG001|NOT COMPLETED|First Dose||0
6785107|NCT01183221|7715191|FG000|STARTED|3 Weeks Wash Out||15
6785108|NCT01183221|7715192|FG001|STARTED|3 Weeks Wash Out||15
6785109|NCT01183221|7715191|FG000|COMPLETED|3 Weeks Wash Out||14
6785110|NCT01183221|7715192|FG001|COMPLETED|3 Weeks Wash Out||14
6785111|NCT01183221|7715191|FG000|NOT COMPLETED|3 Weeks Wash Out||1
6785112|NCT01183221|7715192|FG001|NOT COMPLETED|3 Weeks Wash Out||1
6785113|NCT01183221|7715191|FG000|STARTED|Second Dose||14
6785114|NCT01183221|7715192|FG001|STARTED|Second Dose||14
6785115|NCT01183221|7715191|FG000|COMPLETED|Second Dose||14
6785116|NCT01183221|7715192|FG001|COMPLETED|Second Dose||14
6785117|NCT01183221|7715191|FG000|NOT COMPLETED|Second Dose||0
6785118|NCT01183221|7715192|FG001|NOT COMPLETED|Second Dose||0
6785119|NCT01189227|7715200|FG000|STARTED|Overall Study||6
6785120|NCT01189227|7715201|FG001|STARTED|Overall Study||3
6785121|NCT01189227|7715200|FG000|COMPLETED|Overall Study||0
6785122|NCT01189227|7715201|FG001|COMPLETED|Overall Study||0
6785123|NCT01189227|7715200|FG000|NOT COMPLETED|Overall Study||6
6785124|NCT01189227|7715201|FG001|NOT COMPLETED|Overall Study||3
6785125|NCT01190306|7715209|FG000|STARTED|Overall Study||61
6785126|NCT01190306|7715210|FG001|STARTED|Overall Study||66
6785127|NCT01190306|7715209|FG000|COMPLETED|Overall Study||61
6785128|NCT01190306|7715210|FG001|COMPLETED|Overall Study||66
6785129|NCT01190306|7715209|FG000|NOT COMPLETED|Overall Study||0
6785130|NCT01190306|7715210|FG001|NOT COMPLETED|Overall Study||0
6785131|NCT01179737|7715220|FG000|STARTED|Cohort 1 & Cohort 2||12
6785132|NCT01179737|7715221|FG001|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
6785133|NCT01179737|7715222|FG002|STARTED|Cohort 1 & Cohort 2||4
6785134|NCT01179737|7715223|FG003|STARTED|Cohort 1 & Cohort 2||4
6785135|NCT01179737|7715220|FG000|COMPLETED|Cohort 1 & Cohort 2||7
6785136|NCT01179737|7715221|FG001|COMPLETED|Cohort 1 & Cohort 2||1
6785137|NCT01179737|7715222|FG002|COMPLETED|Cohort 1 & Cohort 2||0
6785138|NCT01179737|7715223|FG003|COMPLETED|Cohort 1 & Cohort 2||0
6785139|NCT01179737|7715220|FG000|NOT COMPLETED|Cohort 1 & Cohort 2||5
6785140|NCT01179737|7715221|FG001|NOT COMPLETED|Cohort 1 & Cohort 2||2
6785141|NCT01179737|7715222|FG002|NOT COMPLETED|Cohort 1 & Cohort 2||4
6785142|NCT01179737|7715223|FG003|NOT COMPLETED|Cohort 1 & Cohort 2||4
6785143|NCT01179737|7715220|FG000|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
6785144|NCT01179737|7715221|FG001|STARTED|Cohort 1 & Cohort 2 Expansion||1
6785145|NCT01179737|7715222|FG002|STARTED|Cohort 1 & Cohort 2 Expansion||0
6785146|NCT01179737|7715223|FG003|STARTED|Cohort 1 & Cohort 2 Expansion||0
6785147|NCT01179737|7715220|FG000|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
6785148|NCT01179737|7715221|FG001|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
6785149|NCT01179737|7715222|FG002|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6785150|NCT01179737|7715223|FG003|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6785151|NCT01179737|7715220|FG000|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
6785152|NCT01179737|7715221|FG001|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6785153|NCT01179737|7715222|FG002|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6785154|NCT01179737|7715223|FG003|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
6785155|NCT01179737|7715220|FG000|STARTED|Extension|Two patients did not enrol in the extension|3
6785156|NCT01179737|7715221|FG001|STARTED|Extension|One patient did not enrol in the extension|0
6785157|NCT01179737|7715222|FG002|STARTED|Extension||0
6785158|NCT01179737|7715223|FG003|STARTED|Extension||0
6785159|NCT01179737|7715220|FG000|COMPLETED|Extension||0
6785160|NCT01179737|7715221|FG001|COMPLETED|Extension||0
6785161|NCT01179737|7715222|FG002|COMPLETED|Extension||0
6785162|NCT01179737|7715223|FG003|COMPLETED|Extension||0
6785163|NCT01179737|7715220|FG000|NOT COMPLETED|Extension||3
6785164|NCT01179737|7715221|FG001|NOT COMPLETED|Extension||0
6785165|NCT01179737|7715222|FG002|NOT COMPLETED|Extension||0
6785166|NCT01179737|7715223|FG003|NOT COMPLETED|Extension||0
6785167|NCT01183468|7715236|FG000|STARTED|Overall Study||8
6785168|NCT01183468|7715237|FG001|STARTED|Overall Study||9
6785169|NCT01183468|7715238|FG002|STARTED|Overall Study||0
6785170|NCT01183468|7715239|FG003|STARTED|Overall Study||0
6785171|NCT01183468|7715236|FG000|COMPLETED|Overall Study||5
6785172|NCT01183468|7715237|FG001|COMPLETED|Overall Study||7
6785173|NCT01183468|7715238|FG002|COMPLETED|Overall Study||0
6785174|NCT01183468|7715239|FG003|COMPLETED|Overall Study||0
6785175|NCT01183468|7715236|FG000|NOT COMPLETED|Overall Study||3
6785176|NCT01183468|7715237|FG001|NOT COMPLETED|Overall Study||2
6785177|NCT01183468|7715238|FG002|NOT COMPLETED|Overall Study||0
6785178|NCT01183468|7715239|FG003|NOT COMPLETED|Overall Study||0
6785179|NCT01181921|7715247|FG000|STARTED|Overall Study||1
6785180|NCT01181921|7715247|FG000|COMPLETED|Overall Study||0
6785181|NCT01181921|7715247|FG000|NOT COMPLETED|Overall Study||1
6785182|NCT01188798|7715253|FG000|STARTED|Overall Study||2
6785183|NCT01188798|7715254|FG001|STARTED|Overall Study||4
6785184|NCT01188798|7715253|FG000|COMPLETED|Overall Study||0
6785185|NCT01188798|7715254|FG001|COMPLETED|Overall Study||1
6785186|NCT01188798|7715253|FG000|NOT COMPLETED|Overall Study||2
6785187|NCT01188798|7715254|FG001|NOT COMPLETED|Overall Study||3
6656251|NCT02459275|7586395|FG001|COMPLETED|Overall Study||17
6656252|NCT02459275|7586394|FG000|NOT COMPLETED|Overall Study||0
6656253|NCT02459275|7586395|FG001|NOT COMPLETED|Overall Study||0
6656254|NCT02459418|7586403|FG000|STARTED|Overall Study||21
6656255|NCT02459418|7586404|FG001|STARTED|Overall Study||21
6656256|NCT02459418|7586403|FG000|Received First Treatment|Overall Study||21
6785188|NCT01174368|7715261|FG000|STARTED|Overall Study||1
6785189|NCT01174368|7715261|FG000|COMPLETED|Overall Study||0
6785190|NCT01174368|7715261|FG000|NOT COMPLETED|Overall Study||1
6785191|NCT01183897|7715265|FG000|STARTED|Overall Study||31
6785192|NCT01183897|7715265|FG000|COMPLETED|Overall Study||31
6785193|NCT01183897|7715265|FG000|NOT COMPLETED|Overall Study||0
6785194|NCT01183884|7715269|FG000|STARTED|Overall Study||46
6785195|NCT01183884|7715269|FG000|COMPLETED|Overall Study||8
6785196|NCT01183884|7715269|FG000|NOT COMPLETED|Overall Study||38
6785197|NCT01183429|7715273|FG000|STARTED|Overall Study||39
6785198|NCT01183429|7715273|FG000|COMPLETED|Overall Study||39
6785199|NCT01183429|7715273|FG000|NOT COMPLETED|Overall Study||0
6785200|NCT01166178|7715279|FG000|STARTED|Overall Study||21
6785201|NCT01166178|7715280|FG001|STARTED|Overall Study||8
6785202|NCT01166178|7715279|FG000|COMPLETED|Overall Study||0
6785203|NCT01166178|7715280|FG001|COMPLETED|Overall Study||0
6785204|NCT01166178|7715279|FG000|NOT COMPLETED|Overall Study||21
6785205|NCT01166178|7715280|FG001|NOT COMPLETED|Overall Study||8
6785206|NCT01176513|7715286|FG000|STARTED|Overall Study||25
6785207|NCT01176513|7715286|FG000|COMPLETED|Overall Study||22
6785208|NCT01176513|7715286|FG000|NOT COMPLETED|Overall Study||3
6785209|NCT01165450|7715290|FG000|STARTED|Overall Study||2
6785210|NCT01165450|7715290|FG000|COMPLETED|Overall Study||2
6785211|NCT01165450|7715290|FG000|NOT COMPLETED|Overall Study||0
6785212|NCT01179399|7715294|FG000|STARTED|Overall Study||32
6785213|NCT01179399|7715294|FG000|COMPLETED|Overall Study||0
6785214|NCT01179399|7715294|FG000|NOT COMPLETED|Overall Study||32
6785215|NCT01169753|7715300|FG000|STARTED|Overall Study||0
6785216|NCT01169753|7715301|FG001|STARTED|Overall Study||1
6785217|NCT01169753|7715300|FG000|COMPLETED|Overall Study||0
6785218|NCT01169753|7715301|FG001|COMPLETED|Overall Study||0
6785219|NCT01169753|7715300|FG000|NOT COMPLETED|Overall Study||0
6785220|NCT01169753|7715301|FG001|NOT COMPLETED|Overall Study||1
6785221|NCT01171534|7715309|FG000|STARTED|Overall Study|retrospective arm never performed on study|0
6785222|NCT01171534|7715310|FG001|STARTED|Overall Study||7
6563075|NCT01805037|7486024|FG000|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||0
6785223|NCT01171534|7715309|FG000|COMPLETED|Overall Study||0
6785224|NCT01171534|7715310|FG001|COMPLETED|Overall Study||4
6785225|NCT01171534|7715309|FG000|NOT COMPLETED|Overall Study||0
6785226|NCT01171534|7715310|FG001|NOT COMPLETED|Overall Study||3
6785227|NCT01169610|7715316|FG000|STARTED|Overall Study||1
6785228|NCT01169610|7715316|FG000|COMPLETED|Overall Study||1
6785229|NCT01169610|7715316|FG000|NOT COMPLETED|Overall Study||0
6563076|NCT01805037|7486025|FG001|NOT COMPLETED|2nd Cycle of Maintenance and Beyond||12
6785238|NCT01163084|7715332|FG000|STARTED|Overall Study||4
6785239|NCT01163084|7715333|FG001|STARTED|Overall Study||5
6785240|NCT01163084|7715332|FG000|COMPLETED|Overall Study||4
6785241|NCT01163084|7715333|FG001|COMPLETED|Overall Study||5
6785242|NCT01163084|7715332|FG000|NOT COMPLETED|Overall Study||0
6785243|NCT01163084|7715333|FG001|NOT COMPLETED|Overall Study||0
6785244|NCT01166724|7715341|FG000|STARTED|Overall Study||7
6785245|NCT01166724|7715342|FG001|STARTED|Overall Study||5
6563077|NCT01805037|7486024|FG000|STARTED|Follow Up (up to 3 Years)||0
6563078|NCT01805037|7486025|FG001|STARTED|Follow Up (up to 3 Years)|Patients who received at least one dose of study treatment go into follow-up.|20
6563079|NCT01805037|7486024|FG000|COMPLETED|Follow Up (up to 3 Years)||0
6785246|NCT01166724|7715341|FG000|COMPLETED|Overall Study||0
6785247|NCT01166724|7715342|FG001|COMPLETED|Overall Study||0
6785248|NCT01166724|7715341|FG000|NOT COMPLETED|Overall Study||7
6785249|NCT01166724|7715342|FG001|NOT COMPLETED|Overall Study||5
6785250|NCT01162382|7715348|FG000|STARTED|Overall Study||0
6785251|NCT01162382|7715348|FG000|COMPLETED|Overall Study||0
6785252|NCT01162382|7715348|FG000|NOT COMPLETED|Overall Study||0
6785253|NCT01157533|7715352|FG000|STARTED|Overall Study||1
6785254|NCT01157533|7715352|FG000|COMPLETED|Overall Study||1
6785255|NCT01157533|7715352|FG000|NOT COMPLETED|Overall Study||0
6785256|NCT01162304|7715356|FG000|STARTED|Overall Study||18
6785257|NCT01162304|7715356|FG000|COMPLETED|Overall Study||7
6785258|NCT01162304|7715356|FG000|NOT COMPLETED|Overall Study||11
6785259|NCT01151904|7715362|FG000|STARTED|Overall Study||17
6785260|NCT01151904|7715362|FG000|COMPLETED|Overall Study||17
6785261|NCT01151904|7715362|FG000|NOT COMPLETED|Overall Study||0
6785262|NCT01155518|7715372|FG000|STARTED|Overall Study||1
6785263|NCT01155518|7715373|FG001|STARTED|Overall Study||1
6785264|NCT01155518|7715374|FG002|STARTED|Overall Study||0
6785265|NCT01155518|7715375|FG003|STARTED|Overall Study||0
6785266|NCT01155518|7715376|FG004|STARTED|Overall Study||1
6785267|NCT01155518|7715377|FG005|STARTED|Overall Study||2
6785268|NCT01155518|7715372|FG000|COMPLETED|Overall Study||1
6785269|NCT01155518|7715373|FG001|COMPLETED|Overall Study|never started the study|0
6785270|NCT01155518|7715374|FG002|COMPLETED|Overall Study||0
6785271|NCT01155518|7715375|FG003|COMPLETED|Overall Study||0
6785272|NCT01155518|7715376|FG004|COMPLETED|Overall Study||1
6785273|NCT01155518|7715377|FG005|COMPLETED|Overall Study||2
6785274|NCT01155518|7715372|FG000|NOT COMPLETED|Overall Study||0
6785275|NCT01155518|7715373|FG001|NOT COMPLETED|Overall Study||1
6785276|NCT01155518|7715374|FG002|NOT COMPLETED|Overall Study||0
6785277|NCT01155518|7715375|FG003|NOT COMPLETED|Overall Study||0
6785278|NCT01155518|7715376|FG004|NOT COMPLETED|Overall Study||0
6785279|NCT01155518|7715377|FG005|NOT COMPLETED|Overall Study||0
6785280|NCT01150409|7715393|FG000|STARTED|Overall Study||11
6785281|NCT01150409|7715394|FG001|STARTED|Overall Study||0
6785282|NCT01150409|7715393|FG000|COMPLETED|Overall Study||11
6785283|NCT01150409|7715394|FG001|COMPLETED|Overall Study||0
6785284|NCT01150409|7715393|FG000|NOT COMPLETED|Overall Study||0
6785285|NCT01150409|7715394|FG001|NOT COMPLETED|Overall Study||0
6785286|NCT01151553|7715400|FG000|STARTED|Overall Study||5
6785287|NCT01151553|7715400|FG000|COMPLETED|Overall Study||5
6785288|NCT01151553|7715400|FG000|NOT COMPLETED|Overall Study||0
6785289|NCT01148056|7715404|FG000|STARTED|Overall Study||2
6785290|NCT01148056|7715404|FG000|COMPLETED|Overall Study||2
6785291|NCT01148056|7715404|FG000|NOT COMPLETED|Overall Study||0
6785292|NCT01147393|7715408|FG000|STARTED|Dose Level 1||3
6785293|NCT01147393|7715408|FG000|COMPLETED|Dose Level 1||1
6785294|NCT01147393|7715408|FG000|NOT COMPLETED|Dose Level 1||2
6785295|NCT01147393|7715408|FG000|STARTED|Dose Level -1||1
6785296|NCT01147393|7715408|FG000|COMPLETED|Dose Level -1||0
6785297|NCT01147393|7715408|FG000|NOT COMPLETED|Dose Level -1||1
6785298|NCT01147042|7715415|FG000|STARTED|Overall Study||2
6785299|NCT01147042|7715416|FG001|STARTED|Overall Study||0
6785300|NCT01147042|7715415|FG000|COMPLETED|Overall Study||2
6785301|NCT01147042|7715416|FG001|COMPLETED|Overall Study||0
6785302|NCT01147042|7715415|FG000|NOT COMPLETED|Overall Study||0
6785303|NCT01147042|7715416|FG001|NOT COMPLETED|Overall Study||0
6785304|NCT01147536|7715421|FG000|STARTED|Overall Study||12
6785305|NCT01147536|7715421|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
6785306|NCT01147536|7715421|FG000|COMPLETED|Overall Study||9
6785307|NCT01147536|7715421|FG000|NOT COMPLETED|Overall Study||3
6785308|NCT01139996|7715427|FG000|STARTED|Overall Study||11
6785309|NCT01139996|7715428|FG001|STARTED|Overall Study||11
6785310|NCT01139996|7715427|FG000|COMPLETED|Overall Study||11
6785311|NCT01139996|7715428|FG001|COMPLETED|Overall Study||11
6785312|NCT01139996|7715427|FG000|NOT COMPLETED|Overall Study||0
6785313|NCT01139996|7715428|FG001|NOT COMPLETED|Overall Study||0
6785314|NCT01133288|7715434|FG000|STARTED|Eligibility Assessment||7
6785315|NCT01133288|7715434|FG000|COMPLETED|Eligibility Assessment||2
6785316|NCT01133288|7715434|FG000|NOT COMPLETED|Eligibility Assessment||5
6785317|NCT01133288|7715434|FG000|STARTED|Intervention Allocation||2
6785318|NCT01133288|7715434|FG000|COMPLETED|Intervention Allocation||0
6785319|NCT01133288|7715434|FG000|NOT COMPLETED|Intervention Allocation||2
6785320|NCT01142128|7715442|FG000|STARTED|Overall Study||8
6785321|NCT01142128|7715442|FG000|Nexium Alone|Overall Study||3
6785322|NCT01142128|7715442|FG000|Placebo to Nexium, Alone|Overall Study||3
6785323|NCT01142128|7715442|FG000|Viokase 16 Plus Nexium|Overall Study||2
6785324|NCT01142128|7715442|FG000|Viokase 16 Plus Placebo to Nexium|Overall Study||0
6785325|NCT01142128|7715442|FG000|COMPLETED|Overall Study||4
6785326|NCT01142128|7715442|FG000|NOT COMPLETED|Overall Study||4
6785327|NCT01131884|7715454|FG000|STARTED|Overall Study||1
6785328|NCT01131884|7715455|FG001|STARTED|Overall Study||0
6785329|NCT01131884|7715454|FG000|COMPLETED|Overall Study||1
6785330|NCT01131884|7715455|FG001|COMPLETED|Overall Study||0
6785331|NCT01131884|7715454|FG000|NOT COMPLETED|Overall Study||0
6785332|NCT01131884|7715455|FG001|NOT COMPLETED|Overall Study||0
6785333|NCT01128114|7715461|FG000|STARTED|Overall Study||32
6785334|NCT01128114|7715461|FG000|COMPLETED|Overall Study||24
6785335|NCT01128114|7715461|FG000|NOT COMPLETED|Overall Study||8
6785336|NCT01126879|7715467|FG000|STARTED|Overall Study||8
6785337|NCT01126879|7715468|FG001|STARTED|Overall Study||4
6785338|NCT01126879|7715467|FG000|Started 3 Months of Genistein/Placebo|Overall Study||8
6785339|NCT01126879|7715468|FG001|Started 3 Months of Genistein/Placebo|Overall Study||4
6785340|NCT01126879|7715467|FG000|Prostatectomy or Radiation|Overall Study||8
6785341|NCT01126879|7715468|FG001|Prostatectomy or Radiation|Overall Study||4
6785342|NCT01126879|7715467|FG000|Completed 3 Months Genistein/Placebo|Overall Study||4
6785343|NCT01126879|7715468|FG001|Completed 3 Months Genistein/Placebo|Overall Study||2
6785344|NCT01126879|7715467|FG000|COMPLETED|Overall Study||3
6785345|NCT01126879|7715468|FG001|COMPLETED|Overall Study||2
6785346|NCT01126879|7715467|FG000|NOT COMPLETED|Overall Study||5
6785347|NCT01126879|7715468|FG001|NOT COMPLETED|Overall Study||2
6785348|NCT01136811|7715474|FG000|STARTED|Overall Study||11
6785349|NCT01136811|7715474|FG000|COMPLETED|Overall Study||0
6785350|NCT01136811|7715474|FG000|NOT COMPLETED|Overall Study||11
6785351|NCT01139294|7715480|FG000|STARTED|Overall Study||0
6785352|NCT01139294|7715481|FG001|STARTED|Overall Study||0
6785353|NCT01139294|7715480|FG000|COMPLETED|Overall Study||0
6785354|NCT01139294|7715481|FG001|COMPLETED|Overall Study||0
6785355|NCT01139294|7715480|FG000|NOT COMPLETED|Overall Study||0
6785356|NCT01139294|7715481|FG001|NOT COMPLETED|Overall Study||0
6785357|NCT01139125|7715487|FG000|STARTED|Overall Study||3
6785358|NCT01139125|7715487|FG000|COMPLETED|Overall Study||2
6785359|NCT01139125|7715487|FG000|NOT COMPLETED|Overall Study||1
6785360|NCT01136668|7715493|FG000|STARTED|Overall Study||7
6785361|NCT01136668|7715494|FG001|STARTED|Overall Study||6
6785362|NCT01136668|7715493|FG000|COMPLETED|Overall Study||7
6785363|NCT01136668|7715494|FG001|COMPLETED|Overall Study||6
6785364|NCT01136668|7715493|FG000|NOT COMPLETED|Overall Study||0
6785365|NCT01136668|7715494|FG001|NOT COMPLETED|Overall Study||0
6785366|NCT01133639|7715502|FG000|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
6785367|NCT01133639|7715503|FG001|STARTED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
6785368|NCT01133639|7715502|FG000|COMPLETED|Overall Study|18 total subjects were enrolled, study was terminated prematurely and data was not analyzed|0
6785369|NCT01133639|7715503|FG001|COMPLETED|Overall Study|18 total subjects were enrolled,study was terminated prematurely and data was not analyzed|0
6785370|NCT01133639|7715502|FG000|NOT COMPLETED|Overall Study||0
6785371|NCT01133639|7715503|FG001|NOT COMPLETED|Overall Study||0
6785372|NCT01131455|7715511|FG000|STARTED|Overall Study||6
6785373|NCT01131455|7715512|FG001|STARTED|Overall Study||4
6785374|NCT01131455|7715513|FG002|STARTED|Overall Study||0
6785375|NCT01131455|7715511|FG000|COMPLETED|Overall Study||0
6785376|NCT01131455|7715512|FG001|COMPLETED|Overall Study||0
6785377|NCT01131455|7715513|FG002|COMPLETED|Overall Study||0
6785378|NCT01131455|7715511|FG000|NOT COMPLETED|Overall Study||6
6785379|NCT01131455|7715512|FG001|NOT COMPLETED|Overall Study||4
6785380|NCT01131455|7715513|FG002|NOT COMPLETED|Overall Study||0
6785381|NCT01126801|7715523|FG000|STARTED|Overall Study||1
6785382|NCT01126801|7715524|FG001|STARTED|Overall Study||1
6785383|NCT01126801|7715523|FG000|COMPLETED|Overall Study||1
6785384|NCT01126801|7715524|FG001|COMPLETED|Overall Study||1
6785385|NCT01126801|7715523|FG000|NOT COMPLETED|Overall Study||0
6785386|NCT01126801|7715524|FG001|NOT COMPLETED|Overall Study||0
6785387|NCT01123850|7715530|FG000|STARTED|Overall Study||45
6785388|NCT01123850|7715530|FG000|COMPLETED|Overall Study||0
6785389|NCT01123850|7715530|FG000|NOT COMPLETED|Overall Study||45
6785390|NCT01126957|7715534|FG000|STARTED|Overall Study||103
6785391|NCT01126957|7715534|FG000|COMPLETED|Overall Study||103
6785392|NCT01126957|7715534|FG000|NOT COMPLETED|Overall Study||0
6785393|NCT01127503|7715541|FG000|STARTED|Overall Study||1
6785394|NCT01127503|7715542|FG001|STARTED|Overall Study||1
6785395|NCT01127503|7715541|FG000|COMPLETED|Overall Study||1
6785396|NCT01127503|7715542|FG001|COMPLETED|Overall Study||1
6785397|NCT01127503|7715541|FG000|NOT COMPLETED|Overall Study||0
6785398|NCT01127503|7715542|FG001|NOT COMPLETED|Overall Study||0
6785399|NCT01122511|7715550|FG000|STARTED|Overall Study||2
6785400|NCT01122511|7715551|FG001|STARTED|Overall Study||2
6785401|NCT01122511|7715550|FG000|COMPLETED|Overall Study||0
6785402|NCT01122511|7715551|FG001|COMPLETED|Overall Study||0
6785403|NCT01122511|7715550|FG000|NOT COMPLETED|Overall Study||2
6785404|NCT01122511|7715551|FG001|NOT COMPLETED|Overall Study||2
6563080|NCT01805037|7486025|FG001|COMPLETED|Follow Up (up to 3 Years)||14
6563081|NCT01805037|7486024|FG000|NOT COMPLETED|Follow Up (up to 3 Years)||0
6785405|NCT01118013|7715557|FG000|STARTED|Overall Study||6
6785406|NCT01118013|7715557|FG000|COMPLETED|Overall Study||6
6785407|NCT01118013|7715557|FG000|NOT COMPLETED|Overall Study||0
6785408|NCT01122381|7715563|FG000|STARTED|Overall Study||1
6785409|NCT01122381|7715564|FG001|STARTED|Overall Study||1
6785410|NCT01122381|7715563|FG000|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
6785411|NCT01122381|7715564|FG001|COMPLETED|Overall Study||0
6785412|NCT01122381|7715563|FG000|NOT COMPLETED|Overall Study||0
6785413|NCT01122381|7715564|FG001|NOT COMPLETED|Overall Study||1
6785414|NCT01116232|7715570|FG000|STARTED|Overall Study||4
6563082|NCT01805037|7486025|FG001|NOT COMPLETED|Follow Up (up to 3 Years)||6
6785415|NCT01116232|7715570|FG000|COMPLETED|Overall Study||0
6785416|NCT01116232|7715570|FG000|NOT COMPLETED|Overall Study||4
6785417|NCT01110174|7715577|FG000|STARTED|Overall Study||8
6785418|NCT01110174|7715577|FG000|COMPLETED|Overall Study||8
6785419|NCT01110174|7715577|FG000|NOT COMPLETED|Overall Study||0
6785420|NCT01115699|7715581|FG000|STARTED|Overall Study||2
6785421|NCT01115699|7715581|FG000|COMPLETED|Overall Study||2
6785422|NCT01115699|7715581|FG000|NOT COMPLETED|Overall Study||0
6785423|NCT01108666|7715585|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
6785424|NCT01108666|7715585|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study, data per dose-level are not available to be reported|7
6785425|NCT01108666|7715585|FG000|NOT COMPLETED|Overall Study||0
6785426|NCT01115244|7715591|FG000|STARTED|Overall Study||0
6785427|NCT01115244|7715592|FG001|STARTED|Overall Study||0
6785428|NCT01115244|7715591|FG000|COMPLETED|Overall Study||0
6785429|NCT01115244|7715592|FG001|COMPLETED|Overall Study||0
6785430|NCT01115244|7715591|FG000|NOT COMPLETED|Overall Study||0
6785431|NCT01115244|7715592|FG001|NOT COMPLETED|Overall Study||0
6785432|NCT01108523|7715598|FG000|STARTED|Overall Study||7
6785433|NCT01108523|7715598|FG000|COMPLETED|Overall Study||3
6785434|NCT01108523|7715598|FG000|NOT COMPLETED|Overall Study||4
6785435|NCT01107795|7715602|FG000|STARTED|Overall Study||41
6785436|NCT01107795|7715602|FG000|COMPLETED|Overall Study||41
6785437|NCT01107795|7715602|FG000|NOT COMPLETED|Overall Study||0
6785438|NCT01106534|7715606|FG000|STARTED|Overall Study||2997
6785439|NCT01106534|7715606|FG000|COMPLETED|Overall Study||2960
6656257|NCT02459418|7586404|FG001|Received First Treatment|Overall Study||21
6656258|NCT02459418|7586403|FG000|Received Second Treatment|Overall Study||13
6656259|NCT02459418|7586404|FG001|Received Second Treatment|Overall Study||15
6656260|NCT02459418|7586403|FG000|COMPLETED|Overall Study||13
6656261|NCT02459418|7586404|FG001|COMPLETED|Overall Study||15
6656262|NCT02459418|7586403|FG000|NOT COMPLETED|Overall Study||8
6656263|NCT02459418|7586404|FG001|NOT COMPLETED|Overall Study||6
6656264|NCT02459587|7586415|FG000|STARTED|3-Month Follow-up Assessment||157
6785440|NCT01106534|7715606|FG000|NOT COMPLETED|Overall Study||37
6785441|NCT01104116|7715611|FG000|STARTED|Overall Study||1
6785442|NCT01104116|7715611|FG000|COMPLETED|Overall Study||1
6785443|NCT01104116|7715611|FG000|NOT COMPLETED|Overall Study||0
6785444|NCT01100658|7715615|FG000|STARTED|Overall Study||1
6785445|NCT01100658|7715615|FG000|COMPLETED|Overall Study||0
6785446|NCT01100658|7715615|FG000|NOT COMPLETED|Overall Study||1
6785447|NCT01103180|7715621|FG000|STARTED|Overall Study||35
6785448|NCT01103180|7715622|FG001|STARTED|Overall Study||35
6785449|NCT01103180|7715621|FG000|COMPLETED|Overall Study||13
6785450|NCT01103180|7715622|FG001|COMPLETED|Overall Study||14
6785451|NCT01103180|7715621|FG000|NOT COMPLETED|Overall Study||22
6785452|NCT01103180|7715622|FG001|NOT COMPLETED|Overall Study||21
6785453|NCT01090141|7715630|FG000|STARTED|Overall Study||0
6785454|NCT01090141|7715631|FG001|STARTED|Overall Study||0
6378456|NCT00768287|7289022|FG005|STARTED|Surgical Sub-study|1 female subject was excluded from the efficacy analysis. She was included in the safety population.|17
6378457|NCT00768287|7289017|FG000|COMPLETED|Surgical Sub-study||0
6378458|NCT00768287|7289018|FG001|COMPLETED|Surgical Sub-study||0
6378459|NCT00768287|7289019|FG002|COMPLETED|Surgical Sub-study||0
6378460|NCT00768287|7289020|FG003|COMPLETED|Surgical Sub-study||0
6378461|NCT00768287|7289021|FG004|COMPLETED|Surgical Sub-study||0
6378462|NCT00768287|7289022|FG005|COMPLETED|Surgical Sub-study||17
6378463|NCT00768287|7289017|FG000|NOT COMPLETED|Surgical Sub-study||0
6378464|NCT00768287|7289018|FG001|NOT COMPLETED|Surgical Sub-study||0
6378465|NCT00768287|7289019|FG002|NOT COMPLETED|Surgical Sub-study||0
6656265|NCT02459587|7586416|FG001|STARTED|3-Month Follow-up Assessment||150
6656266|NCT02459587|7586415|FG000|COMPLETED|3-Month Follow-up Assessment||125
6785455|NCT01090141|7715630|FG000|COMPLETED|Overall Study||0
6378466|NCT00768287|7289020|FG003|NOT COMPLETED|Surgical Sub-study||0
6378467|NCT00768287|7289021|FG004|NOT COMPLETED|Surgical Sub-study||0
6378468|NCT00768287|7289022|FG005|NOT COMPLETED|Surgical Sub-study||0
6785456|NCT01090141|7715631|FG001|COMPLETED|Overall Study||0
6785457|NCT01090141|7715630|FG000|NOT COMPLETED|Overall Study||0
6785458|NCT01090141|7715631|FG001|NOT COMPLETED|Overall Study||0
6785459|NCT01102140|7715639|FG000|STARTED|Overall Study||13
6785460|NCT01102140|7715640|FG001|STARTED|Overall Study||7
6785461|NCT01102140|7715639|FG000|COMPLETED|Overall Study||10
6785462|NCT01102140|7715640|FG001|COMPLETED|Overall Study||5
6785463|NCT01102140|7715639|FG000|NOT COMPLETED|Overall Study||3
6785464|NCT01102140|7715640|FG001|NOT COMPLETED|Overall Study||2
6785465|NCT01095250|7715652|FG000|STARTED|Overall Study||8
6785466|NCT01095250|7715653|FG001|STARTED|Overall Study||10
6785467|NCT01095250|7715654|FG002|STARTED|Overall Study||8
6785468|NCT01095250|7715655|FG003|STARTED|Overall Study||5
6785469|NCT01095250|7715652|FG000|COMPLETED|Overall Study||0
6785470|NCT01095250|7715653|FG001|COMPLETED|Overall Study||0
6785471|NCT01095250|7715654|FG002|COMPLETED|Overall Study||0
6785472|NCT01095250|7715655|FG003|COMPLETED|Overall Study||0
6785473|NCT01095250|7715652|FG000|NOT COMPLETED|Overall Study||8
6785474|NCT01095250|7715653|FG001|NOT COMPLETED|Overall Study||10
6785475|NCT01095250|7715654|FG002|NOT COMPLETED|Overall Study||8
6785476|NCT01095250|7715655|FG003|NOT COMPLETED|Overall Study||5
6785477|NCT01094561|7715665|FG000|STARTED|Overall Study||23
6785478|NCT01094561|7715665|FG000|COMPLETED|Overall Study||17
6785479|NCT01094561|7715665|FG000|NOT COMPLETED|Overall Study||6
6656267|NCT02459587|7586416|FG001|COMPLETED|3-Month Follow-up Assessment||119
6656268|NCT02459587|7586415|FG000|NOT COMPLETED|3-Month Follow-up Assessment||32
6656269|NCT02459587|7586416|FG001|NOT COMPLETED|3-Month Follow-up Assessment||31
6656270|NCT02459587|7586415|FG000|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|152
6656271|NCT02459587|7586416|FG001|STARTED|6-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|141
6378469|NCT00768300|7289036|FG000|STARTED|Overall Study||330
6378470|NCT00768300|7289037|FG001|STARTED|Overall Study||164
6378471|NCT00768300|7289036|FG000|Randomized and Treated|Overall Study||329
6378472|NCT00768300|7289037|FG001|Randomized and Treated|Overall Study||163
6378473|NCT00768300|7289036|FG000|COMPLETED|Overall Study||1
6378474|NCT00768300|7289037|FG001|COMPLETED|Overall Study||1
6378475|NCT00768300|7289036|FG000|NOT COMPLETED|Overall Study||329
6378476|NCT00768300|7289037|FG001|NOT COMPLETED|Overall Study||163
6378477|NCT00768430|7289045|FG000|STARTED|24 Hour Endpoint||48
6378478|NCT00768430|7289046|FG001|STARTED|24 Hour Endpoint||25
6378479|NCT00768430|7289045|FG000|COMPLETED|24 Hour Endpoint||47
6378480|NCT00768430|7289046|FG001|COMPLETED|24 Hour Endpoint||25
6785480|NCT01093846|7715672|FG000|STARTED|Overall Study||19
6785481|NCT01093846|7715673|FG001|STARTED|Overall Study||18
6785482|NCT01093846|7715674|FG002|STARTED|Overall Study||22
6785483|NCT01093846|7715672|FG000|COMPLETED|Overall Study||0
6785484|NCT01093846|7715673|FG001|COMPLETED|Overall Study||0
6785485|NCT01093846|7715674|FG002|COMPLETED|Overall Study||1
6785486|NCT01093846|7715672|FG000|NOT COMPLETED|Overall Study||19
6785487|NCT01093846|7715673|FG001|NOT COMPLETED|Overall Study||18
6785488|NCT01093846|7715674|FG002|NOT COMPLETED|Overall Study||21
6785489|NCT01078844|7715680|FG000|STARTED|Overall Study||4
6785490|NCT01078844|7715680|FG000|COMPLETED|Overall Study||0
6785491|NCT01078844|7715680|FG000|NOT COMPLETED|Overall Study||4
6785492|NCT01081886|7715687|FG000|STARTED|Overall Study||11
6785493|NCT01081886|7715688|FG001|STARTED|Overall Study||13
6785494|NCT01081886|7715687|FG000|COMPLETED|Overall Study||0
6785495|NCT01081886|7715688|FG001|COMPLETED|Overall Study||0
6785496|NCT01081886|7715687|FG000|NOT COMPLETED|Overall Study||11
6785497|NCT01081886|7715688|FG001|NOT COMPLETED|Overall Study||13
6785498|NCT01085643|7715694|FG000|STARTED|Overall Study||4
6785499|NCT01085643|7715694|FG000|COMPLETED|Overall Study||4
6785500|NCT01085643|7715694|FG000|NOT COMPLETED|Overall Study||0
6785501|NCT01083472|7715700|FG000|STARTED|Overall Study||18
6785502|NCT01083472|7715701|FG001|STARTED|Overall Study||19
6785503|NCT01083472|7715700|FG000|COMPLETED|Overall Study||18
6785504|NCT01083472|7715701|FG001|COMPLETED|Overall Study||19
6785505|NCT01083472|7715700|FG000|NOT COMPLETED|Overall Study||0
6785506|NCT01083472|7715701|FG001|NOT COMPLETED|Overall Study||0
6785507|NCT01080768|7715709|FG000|STARTED|Overall Study||14
6785508|NCT01080768|7715710|FG001|STARTED|Overall Study||17
6785509|NCT01080768|7715709|FG000|COMPLETED|Overall Study||12
6378481|NCT00768430|7289045|FG000|NOT COMPLETED|24 Hour Endpoint||1
6378482|NCT00768430|7289046|FG001|NOT COMPLETED|24 Hour Endpoint||0
6785510|NCT01080768|7715710|FG001|COMPLETED|Overall Study||16
6785511|NCT01080768|7715709|FG000|NOT COMPLETED|Overall Study||2
6785512|NCT01080768|7715710|FG001|NOT COMPLETED|Overall Study||1
6785513|NCT01079598|7715716|FG000|STARTED|Overall Study||8
6785514|NCT01079598|7715716|FG000|COMPLETED|Overall Study||8
6785515|NCT01079598|7715716|FG000|NOT COMPLETED|Overall Study||0
6785516|NCT01074502|7715720|FG000|STARTED|Overall Study||3
6785517|NCT01074502|7715720|FG000|COMPLETED|Overall Study||2
6785518|NCT01074502|7715720|FG000|NOT COMPLETED|Overall Study||1
6785519|NCT01074437|7715726|FG000|STARTED|Overall Study||4
6785520|NCT01074437|7715727|FG001|STARTED|Overall Study||5
6785521|NCT01074437|7715726|FG000|COMPLETED|Overall Study||4
6785522|NCT01074437|7715727|FG001|COMPLETED|Overall Study||5
6785523|NCT01074437|7715726|FG000|NOT COMPLETED|Overall Study||0
6785524|NCT01074437|7715727|FG001|NOT COMPLETED|Overall Study||0
6563083|NCT01805089|7486031|FG000|STARTED|Overall Study||48
6563084|NCT01805089|7486032|FG001|STARTED|Overall Study||47
6785525|NCT01069861|7715733|FG000|STARTED|Overall Study||4
6785526|NCT01069861|7715733|FG000|COMPLETED|Overall Study||1
6785527|NCT01069861|7715733|FG000|NOT COMPLETED|Overall Study||3
6785528|NCT01072526|7715737|FG000|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
6785529|NCT01072526|7715738|FG001|STARTED|Overall Study||0
6785530|NCT01072526|7715737|FG000|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
6785531|NCT01072526|7715738|FG001|COMPLETED|Overall Study||0
6785532|NCT01072526|7715737|FG000|NOT COMPLETED|Overall Study||0
6656272|NCT02459587|7586415|FG000|COMPLETED|6-month Follow-up Assessment||128
6656273|NCT02459587|7586416|FG001|COMPLETED|6-month Follow-up Assessment||116
6656274|NCT02459587|7586415|FG000|NOT COMPLETED|6-month Follow-up Assessment||24
6656275|NCT02459587|7586416|FG001|NOT COMPLETED|6-month Follow-up Assessment||25
6656276|NCT02459587|7586415|FG000|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|149
6656277|NCT02459587|7586416|FG001|STARTED|12-month Follow-up Assessment|Total excludes participants who withdrew participation or were deceased prior to follow-up.|138
6785533|NCT01072526|7715738|FG001|NOT COMPLETED|Overall Study||0
6785534|NCT01071993|7715748|FG000|STARTED|Overall Study||0
6785535|NCT01071993|7715749|FG001|STARTED|Overall Study||0
6785536|NCT01071993|7715748|FG000|COMPLETED|Overall Study||0
6785537|NCT01071993|7715749|FG001|COMPLETED|Overall Study||0
6785538|NCT01071993|7715748|FG000|NOT COMPLETED|Overall Study||0
6785539|NCT01071993|7715749|FG001|NOT COMPLETED|Overall Study||0
6785540|NCT01065051|7715757|FG000|STARTED|Overall Study||1
6785541|NCT01065051|7715758|FG001|STARTED|Overall Study||0
6785542|NCT01065051|7715757|FG000|COMPLETED|Overall Study||1
6785543|NCT01065051|7715758|FG001|COMPLETED|Overall Study||0
6785544|NCT01065051|7715757|FG000|NOT COMPLETED|Overall Study||0
6785545|NCT01065051|7715758|FG001|NOT COMPLETED|Overall Study||0
6785546|NCT01069120|7715766|FG000|STARTED|Overall Study||27
6785547|NCT01069120|7715766|FG000|COMPLETED|Overall Study||0
6785548|NCT01069120|7715766|FG000|NOT COMPLETED|Overall Study||27
6785549|NCT01066637|7715774|FG000|STARTED|Overall Study||16
6785550|NCT01066637|7715775|FG001|STARTED|Overall Study||10
6785551|NCT01066637|7715774|FG000|COMPLETED|Overall Study||16
6785552|NCT01066637|7715775|FG001|COMPLETED|Overall Study||10
6785553|NCT01066637|7715774|FG000|NOT COMPLETED|Overall Study||0
6785554|NCT01066637|7715775|FG001|NOT COMPLETED|Overall Study||0
6785555|NCT01058642|7715785|FG000|STARTED|Treatment Period 1||9
6785556|NCT01058642|7715786|FG001|STARTED|Treatment Period 1||12
6785557|NCT01058642|7715787|FG002|STARTED|Treatment Period 1||11
6785558|NCT01058642|7715788|FG003|STARTED|Treatment Period 1||9
6785559|NCT01058642|7715785|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
6563085|NCT01805089|7486031|FG000|COMPLETED|Overall Study||43
6563086|NCT01805089|7486032|FG001|COMPLETED|Overall Study||43
6563087|NCT01805089|7486031|FG000|NOT COMPLETED|Overall Study||5
6563088|NCT01805089|7486032|FG001|NOT COMPLETED|Overall Study||4
6563089|NCT01805154|7486038|FG000|STARTED|Overall Study||1529
6563090|NCT01805154|7486038|FG000|COMPLETED|Overall Study||1175
6563091|NCT01805154|7486038|FG000|NOT COMPLETED|Overall Study||354
6563092|NCT01805180|7486047|FG000|STARTED|Lead-in Donor Phase||7
6563093|NCT01805180|7486048|FG001|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
6563094|NCT01805180|7486049|FG002|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
6563095|NCT01805180|7486047|FG000|COMPLETED|Lead-in Donor Phase||6
6563096|NCT01805180|7486048|FG001|COMPLETED|Lead-in Donor Phase||0
6563097|NCT01805180|7486049|FG002|COMPLETED|Lead-in Donor Phase||0
6563098|NCT01805180|7486047|FG000|NOT COMPLETED|Lead-in Donor Phase||1
6563099|NCT01805180|7486048|FG001|NOT COMPLETED|Lead-in Donor Phase||0
6563100|NCT01805180|7486049|FG002|NOT COMPLETED|Lead-in Donor Phase||0
6563101|NCT01805180|7486047|FG000|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
6563102|NCT01805180|7486048|FG001|STARTED|Pivotal Randomization Through Study Exit||22
6563103|NCT01805180|7486049|FG002|STARTED|Pivotal Randomization Through Study Exit||20
6563104|NCT01805180|7486047|FG000|COMPLETED|Pivotal Randomization Through Study Exit||0
6563105|NCT01805180|7486048|FG001|COMPLETED|Pivotal Randomization Through Study Exit||17
6563106|NCT01805180|7486049|FG002|COMPLETED|Pivotal Randomization Through Study Exit||15
6563107|NCT01805180|7486047|FG000|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
6563108|NCT01805180|7486048|FG001|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
6563109|NCT01805180|7486049|FG002|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
6563110|NCT01805297|7486059|FG000|STARTED|Overall Study||6
6563111|NCT01805297|7486060|FG001|STARTED|Overall Study||6
6656278|NCT02459587|7586415|FG000|COMPLETED|12-month Follow-up Assessment||127
6785560|NCT01058642|7715786|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
6785561|NCT01058642|7715787|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
6785562|NCT01058642|7715788|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
6785563|NCT01058642|7715785|FG000|COMPLETED|Treatment Period 1||7
6785564|NCT01058642|7715786|FG001|COMPLETED|Treatment Period 1||11
6785565|NCT01058642|7715787|FG002|COMPLETED|Treatment Period 1||9
6785566|NCT01058642|7715788|FG003|COMPLETED|Treatment Period 1||7
6785567|NCT01058642|7715785|FG000|NOT COMPLETED|Treatment Period 1||2
6785568|NCT01058642|7715786|FG001|NOT COMPLETED|Treatment Period 1||1
6785569|NCT01058642|7715787|FG002|NOT COMPLETED|Treatment Period 1||2
6785570|NCT01058642|7715788|FG003|NOT COMPLETED|Treatment Period 1||2
6785571|NCT01058642|7715785|FG000|STARTED|Washout Period||7
6785572|NCT01058642|7715786|FG001|STARTED|Washout Period||11
6785573|NCT01058642|7715787|FG002|STARTED|Washout Period||9
6785574|NCT01058642|7715788|FG003|STARTED|Washout Period||7
6785575|NCT01058642|7715785|FG000|COMPLETED|Washout Period||7
6785576|NCT01058642|7715786|FG001|COMPLETED|Washout Period||11
6785577|NCT01058642|7715787|FG002|COMPLETED|Washout Period||9
6785578|NCT01058642|7715788|FG003|COMPLETED|Washout Period||7
6785579|NCT01058642|7715785|FG000|NOT COMPLETED|Washout Period||0
6785580|NCT01058642|7715786|FG001|NOT COMPLETED|Washout Period||0
6785581|NCT01058642|7715787|FG002|NOT COMPLETED|Washout Period||0
6785582|NCT01058642|7715788|FG003|NOT COMPLETED|Washout Period||0
6785583|NCT01058642|7715785|FG000|STARTED|Treatment Period 2||7
6785584|NCT01058642|7715786|FG001|STARTED|Treatment Period 2||11
6785585|NCT01058642|7715787|FG002|STARTED|Treatment Period 2||9
6785586|NCT01058642|7715788|FG003|STARTED|Treatment Period 2||7
6785587|NCT01058642|7715785|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
6785588|NCT01058642|7715786|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
6785589|NCT01058642|7715787|FG002|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
6785590|NCT01058642|7715788|FG003|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
6785591|NCT01058642|7715785|FG000|COMPLETED|Treatment Period 2||7
6785592|NCT01058642|7715786|FG001|COMPLETED|Treatment Period 2||11
6785593|NCT01058642|7715787|FG002|COMPLETED|Treatment Period 2||9
6785594|NCT01058642|7715788|FG003|COMPLETED|Treatment Period 2||7
6785595|NCT01058642|7715785|FG000|NOT COMPLETED|Treatment Period 2||0
6785596|NCT01058642|7715786|FG001|NOT COMPLETED|Treatment Period 2||0
6785597|NCT01058642|7715787|FG002|NOT COMPLETED|Treatment Period 2||0
6785598|NCT01058642|7715788|FG003|NOT COMPLETED|Treatment Period 2||0
6785599|NCT01065818|7715796|FG000|STARTED|Overall Study||6
6785600|NCT01065818|7715796|FG000|COMPLETED|Overall Study||4
6785601|NCT01065818|7715796|FG000|NOT COMPLETED|Overall Study||2
6785602|NCT01051921|7715800|FG000|STARTED|Overall Study||67
6785603|NCT01051921|7715800|FG000|COMPLETED|Overall Study||37
6785604|NCT01051921|7715800|FG000|NOT COMPLETED|Overall Study||30
6785605|NCT01048125|7715806|FG000|STARTED|Overall Study||0
6785606|NCT01048125|7715807|FG001|STARTED|Overall Study||0
6785607|NCT01048125|7715806|FG000|COMPLETED|Overall Study||0
6785608|NCT01048125|7715807|FG001|COMPLETED|Overall Study||0
6785609|NCT01048125|7715806|FG000|NOT COMPLETED|Overall Study||0
6785610|NCT01048125|7715807|FG001|NOT COMPLETED|Overall Study||0
6785611|NCT01056315|7715815|FG000|STARTED|Overall Study||27
6785612|NCT01056315|7715816|FG001|STARTED|Overall Study||23
6785613|NCT01056315|7715815|FG000|COMPLETED|Overall Study||13
6785614|NCT01056315|7715816|FG001|COMPLETED|Overall Study||12
6785615|NCT01056315|7715815|FG000|NOT COMPLETED|Overall Study||14
6785616|NCT01056315|7715816|FG001|NOT COMPLETED|Overall Study||11
6785617|NCT01058369|7715822|FG000|STARTED|Overall Study||2
6785618|NCT01058369|7715822|FG000|COMPLETED|Overall Study||0
6785619|NCT01058369|7715822|FG000|NOT COMPLETED|Overall Study||2
6785620|NCT01048723|7715826|FG000|STARTED|Overall Study||2
6785621|NCT01048723|7715826|FG000|COMPLETED|Overall Study||2
6785622|NCT01048723|7715826|FG000|NOT COMPLETED|Overall Study||0
6785623|NCT01053221|7715832|FG000|STARTED|Overall Study||5
6785624|NCT01053221|7715833|FG001|STARTED|Overall Study||9
6785625|NCT01053221|7715832|FG000|COMPLETED|Overall Study||0
6785626|NCT01053221|7715833|FG001|COMPLETED|Overall Study||0
6785627|NCT01053221|7715832|FG000|NOT COMPLETED|Overall Study||5
6785628|NCT01053221|7715833|FG001|NOT COMPLETED|Overall Study||9
6785629|NCT01038752|7715841|FG000|STARTED|Overall Study||8
6785630|NCT01038752|7715842|FG001|STARTED|Overall Study||6
6785631|NCT01038752|7715841|FG000|COMPLETED|Overall Study||3
6785632|NCT01038752|7715842|FG001|COMPLETED|Overall Study||1
6785633|NCT01038752|7715841|FG000|NOT COMPLETED|Overall Study||5
6785634|NCT01038752|7715842|FG001|NOT COMPLETED|Overall Study||5
6785635|NCT01050218|7715848|FG000|STARTED|Overall Study||237
6785636|NCT01050218|7715848|FG000|COMPLETED|Overall Study||142
6785637|NCT01050218|7715848|FG000|NOT COMPLETED|Overall Study||95
6785638|NCT01045694|7715852|FG000|STARTED|Overall Study||8
6785639|NCT01045694|7715852|FG000|COMPLETED|Overall Study||6
6785640|NCT01045694|7715852|FG000|NOT COMPLETED|Overall Study||2
6785641|NCT01035944|7715860|FG000|STARTED|Overall Study||14
6785642|NCT01035944|7715861|FG001|STARTED|Overall Study||14
6785643|NCT01035944|7715862|FG002|STARTED|Overall Study||5
6785644|NCT01035944|7715863|FG003|STARTED|Overall Study||4
6785645|NCT01035944|7715860|FG000|COMPLETED|Overall Study||11
6785646|NCT01035944|7715861|FG001|COMPLETED|Overall Study||13
6785647|NCT01035944|7715862|FG002|COMPLETED|Overall Study||4
6785648|NCT01035944|7715863|FG003|COMPLETED|Overall Study||4
6785649|NCT01035944|7715860|FG000|NOT COMPLETED|Overall Study||3
6785650|NCT01035944|7715861|FG001|NOT COMPLETED|Overall Study||1
6785651|NCT01035944|7715862|FG002|NOT COMPLETED|Overall Study||1
6785652|NCT01035944|7715863|FG003|NOT COMPLETED|Overall Study||0
6785653|NCT01031628|7715877|FG000|STARTED|Overall Study||0
6785654|NCT01031628|7715878|FG001|STARTED|Overall Study||1
6785655|NCT01031628|7715879|FG002|STARTED|Overall Study||3
6785656|NCT01031628|7715880|FG003|STARTED|Overall Study||0
6785657|NCT01031628|7715877|FG000|COMPLETED|Overall Study||0
6785658|NCT01031628|7715878|FG001|COMPLETED|Overall Study||0
6785659|NCT01031628|7715879|FG002|COMPLETED|Overall Study||0
6785660|NCT01031628|7715880|FG003|COMPLETED|Overall Study||0
6785661|NCT01031628|7715877|FG000|NOT COMPLETED|Overall Study||0
6785662|NCT01031628|7715878|FG001|NOT COMPLETED|Overall Study||1
6785663|NCT01031628|7715879|FG002|NOT COMPLETED|Overall Study||3
6785664|NCT01031628|7715880|FG003|NOT COMPLETED|Overall Study||0
6785665|NCT01030757|7715890|FG000|STARTED|Overall Study||2
6785666|NCT01030757|7715890|FG000|COMPLETED|Overall Study||2
6785667|NCT01030757|7715890|FG000|NOT COMPLETED|Overall Study||0
6785668|NCT01035073|7715894|FG000|STARTED|Overall Study||0
6785669|NCT01035073|7715894|FG000|COMPLETED|Overall Study||0
6785670|NCT01035073|7715894|FG000|NOT COMPLETED|Overall Study||0
6785671|NCT01031550|7715900|FG000|STARTED|Overall Study||5
6785672|NCT01031550|7715901|FG001|STARTED|Overall Study||3
6785673|NCT01031550|7715900|FG000|COMPLETED|Overall Study||5
6785674|NCT01031550|7715901|FG001|COMPLETED|Overall Study||3
6785675|NCT01031550|7715900|FG000|NOT COMPLETED|Overall Study||0
6785676|NCT01031550|7715901|FG001|NOT COMPLETED|Overall Study||0
6785677|NCT01030198|7715911|FG000|STARTED|Overall Study|None recruited|0
6785678|NCT01030198|7715912|FG001|STARTED|Overall Study||7
6785679|NCT01030198|7715911|FG000|COMPLETED|Overall Study|None recruited|0
6785680|NCT01030198|7715912|FG001|COMPLETED|Overall Study|Study terminated due to poor results and lack of enrollment|0
6785681|NCT01030198|7715911|FG000|NOT COMPLETED|Overall Study||0
6785682|NCT01030198|7715912|FG001|NOT COMPLETED|Overall Study||7
6785683|NCT01028300|7715918|FG000|STARTED|Overall Study||4
6785684|NCT01028300|7715918|FG000|COMPLETED|Overall Study||0
6785685|NCT01028300|7715918|FG000|NOT COMPLETED|Overall Study||4
6785686|NCT01025271|7715922|FG000|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
6785687|NCT01025271|7715922|FG000|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
6785688|NCT01025271|7715922|FG000|NOT COMPLETED|Overall Study||0
6785689|NCT01022398|7715929|FG000|STARTED|Overall Study||2
6785690|NCT01022398|7715930|FG001|STARTED|Overall Study||2
6785691|NCT01022398|7715929|FG000|COMPLETED|Overall Study||0
6785692|NCT01022398|7715930|FG001|COMPLETED|Overall Study||0
6785693|NCT01022398|7715929|FG000|NOT COMPLETED|Overall Study||2
6785694|NCT01022398|7715930|FG001|NOT COMPLETED|Overall Study||2
6785695|NCT01019980|7715937|FG000|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
6785696|NCT01019980|7715938|FG001|STARTED|Overall Study||0
6785697|NCT01019980|7715937|FG000|Discontinued|Overall Study||2
6785698|NCT01019980|7715938|FG001|Discontinued|Overall Study||0
6785699|NCT01019980|7715937|FG000|COMPLETED|Overall Study||0
6785700|NCT01019980|7715938|FG001|COMPLETED|Overall Study||0
6785701|NCT01019980|7715937|FG000|NOT COMPLETED|Overall Study||2
6785702|NCT01019980|7715938|FG001|NOT COMPLETED|Overall Study||0
6785703|NCT01025492|7715944|FG000|STARTED|Overall Study||24
6785704|NCT01025492|7715944|FG000|COMPLETED|Overall Study||24
6785705|NCT01025492|7715944|FG000|NOT COMPLETED|Overall Study||0
6785706|NCT01017263|7715948|FG000|STARTED|Overall Study||14
6785707|NCT01017263|7715948|FG000|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
6785708|NCT01017263|7715948|FG000|NOT COMPLETED|Overall Study||12
6563112|NCT01805297|7486059|FG000|COMPLETED|Overall Study||4
6563113|NCT01805297|7486060|FG001|COMPLETED|Overall Study||3
6563114|NCT01805297|7486059|FG000|NOT COMPLETED|Overall Study||2
6563115|NCT01805297|7486060|FG001|NOT COMPLETED|Overall Study||3
6785709|NCT01020903|7715954|FG000|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
6785710|NCT01020903|7715955|FG001|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
6785711|NCT01020903|7715954|FG000|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
6785712|NCT01020903|7715955|FG001|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
6785713|NCT01020903|7715954|FG000|NOT COMPLETED|Overall Study||0
6785714|NCT01020903|7715955|FG001|NOT COMPLETED|Overall Study||0
6785715|NCT01023620|7715963|FG000|STARTED|Overall Study||0
6785716|NCT01023620|7715964|FG001|STARTED|Overall Study||0
6785717|NCT01023620|7715963|FG000|COMPLETED|Overall Study||0
6785718|NCT01023620|7715964|FG001|COMPLETED|Overall Study||0
6785719|NCT01023620|7715963|FG000|NOT COMPLETED|Overall Study||0
6785720|NCT01023620|7715964|FG001|NOT COMPLETED|Overall Study||0
6785721|NCT01018810|7715975|FG000|STARTED|Overall Study||4
6785722|NCT01018810|7715976|FG001|STARTED|Overall Study||1
6785723|NCT01018810|7715977|FG002|STARTED|Overall Study||1
6785724|NCT01018810|7715978|FG003|STARTED|Overall Study||1
6785725|NCT01018810|7715979|FG004|STARTED|Overall Study||1
6785726|NCT01018810|7715975|FG000|COMPLETED|Overall Study||2
6785727|NCT01018810|7715976|FG001|COMPLETED|Overall Study||0
6785728|NCT01018810|7715977|FG002|COMPLETED|Overall Study||0
6785729|NCT01018810|7715978|FG003|COMPLETED|Overall Study||0
6785730|NCT01018810|7715979|FG004|COMPLETED|Overall Study||0
6785731|NCT01018810|7715975|FG000|NOT COMPLETED|Overall Study||2
6785732|NCT01018810|7715976|FG001|NOT COMPLETED|Overall Study||1
6785733|NCT01018810|7715977|FG002|NOT COMPLETED|Overall Study||1
6785734|NCT01018810|7715978|FG003|NOT COMPLETED|Overall Study||1
6785735|NCT01018810|7715979|FG004|NOT COMPLETED|Overall Study||1
6785736|NCT01016561|7715991|FG000|STARTED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
6785737|NCT01016561|7715991|FG000|COMPLETED|Overall Study|Despite all possible efforts to contact the PI/study team, no data are available to be reported|0
6785738|NCT01016561|7715991|FG000|NOT COMPLETED|Overall Study||0
6785739|NCT01016847|7715997|FG000|STARTED|Overall Study||1
6785740|NCT01016847|7715998|FG001|STARTED|Overall Study||2
6785741|NCT01016847|7715997|FG000|COMPLETED|Overall Study||1
6785742|NCT01016847|7715998|FG001|COMPLETED|Overall Study||2
6785743|NCT01016847|7715997|FG000|NOT COMPLETED|Overall Study||0
6785744|NCT01016847|7715998|FG001|NOT COMPLETED|Overall Study||0
6785745|NCT01014767|7716008|FG000|STARTED|Overall Study||12
6785746|NCT01014767|7716009|FG001|STARTED|Overall Study||1
6785747|NCT01014767|7716010|FG002|STARTED|Overall Study||4
6785748|NCT01014767|7716011|FG003|STARTED|Overall Study||1
6785749|NCT01014767|7716008|FG000|COMPLETED|Overall Study||0
6785750|NCT01014767|7716009|FG001|COMPLETED|Overall Study||0
6785751|NCT01014767|7716010|FG002|COMPLETED|Overall Study||0
6785752|NCT01014767|7716011|FG003|COMPLETED|Overall Study||0
6785753|NCT01014767|7716008|FG000|NOT COMPLETED|Overall Study||12
6785754|NCT01014767|7716009|FG001|NOT COMPLETED|Overall Study||1
6785755|NCT01014767|7716010|FG002|NOT COMPLETED|Overall Study||4
6785756|NCT01014767|7716011|FG003|NOT COMPLETED|Overall Study||1
6785757|NCT01013701|7716021|FG000|STARTED|Overall Study||7
6785758|NCT01013701|7716021|FG000|COMPLETED|Overall Study||0
6785759|NCT01013701|7716021|FG000|NOT COMPLETED|Overall Study||7
6785760|NCT01012414|7716026|FG000|STARTED|Overall Study||10
6785761|NCT01012414|7716026|FG000|COMPLETED|Overall Study|No subjects completed the study.|0
6785762|NCT01012414|7716026|FG000|NOT COMPLETED|Overall Study||10
6785763|NCT01011634|7716034|FG000|STARTED|Overall Study||9
6785764|NCT01011634|7716035|FG001|STARTED|Overall Study||9
6785765|NCT01011634|7716034|FG000|COMPLETED|Overall Study||9
6785766|NCT01011634|7716035|FG001|COMPLETED|Overall Study||8
6785767|NCT01011634|7716034|FG000|NOT COMPLETED|Overall Study||0
6785768|NCT01011634|7716035|FG001|NOT COMPLETED|Overall Study||1
6785769|NCT01009931|7716041|FG000|STARTED|Overall Study||1
6785770|NCT01009931|7716041|FG000|COMPLETED|Overall Study||0
6785771|NCT01009931|7716041|FG000|NOT COMPLETED|Overall Study||1
6785772|NCT01001390|7716045|FG000|STARTED|Overall Study||2
6785773|NCT01001390|7716046|FG001|STARTED|Overall Study||0
6785774|NCT01001390|7716045|FG000|COMPLETED|Overall Study||0
6785775|NCT01001390|7716046|FG001|COMPLETED|Overall Study||0
6785776|NCT01001390|7716045|FG000|NOT COMPLETED|Overall Study||2
6785777|NCT01001390|7716046|FG001|NOT COMPLETED|Overall Study||0
6785778|NCT01006018|7716054|FG000|STARTED|Overall Study||0
6785779|NCT01006018|7716055|FG001|STARTED|Overall Study||0
6785780|NCT01006018|7716056|FG002|STARTED|Overall Study||0
6785781|NCT01006018|7716054|FG000|COMPLETED|Overall Study||0
6785782|NCT01006018|7716055|FG001|COMPLETED|Overall Study||0
6785783|NCT01006018|7716056|FG002|COMPLETED|Overall Study||0
6785784|NCT01006018|7716054|FG000|NOT COMPLETED|Overall Study||0
6785785|NCT01006018|7716055|FG001|NOT COMPLETED|Overall Study||0
6785786|NCT01006018|7716056|FG002|NOT COMPLETED|Overall Study||0
6785787|NCT01004510|7716064|FG000|STARTED|Overall Study||3
6785788|NCT01004510|7716064|FG000|COMPLETED|Overall Study||2
6785789|NCT01004510|7716064|FG000|NOT COMPLETED|Overall Study||1
6785790|NCT01005914|7716068|FG000|STARTED|Overall Study||11
6785791|NCT01005914|7716068|FG000|COMPLETED|Overall Study||1
6785792|NCT01005914|7716068|FG000|NOT COMPLETED|Overall Study||10
6785793|NCT00996333|7716072|FG000|STARTED|Overall Study||46
6785794|NCT00996333|7716072|FG000|COMPLETED|Overall Study||33
6785795|NCT00996333|7716072|FG000|NOT COMPLETED|Overall Study||13
6785796|NCT00998738|7716076|FG000|STARTED|Overall Study||1
6785797|NCT00998738|7716076|FG000|COMPLETED|Overall Study||0
6785798|NCT00998738|7716076|FG000|NOT COMPLETED|Overall Study||1
6785799|NCT00996502|7716080|FG000|STARTED|Overall Study||4
6785800|NCT00996502|7716080|FG000|COMPLETED|Overall Study||4
6785801|NCT00996502|7716080|FG000|NOT COMPLETED|Overall Study||0
6785802|NCT00997386|7716084|FG000|STARTED|Overall Study||16
6785803|NCT00997386|7716084|FG000|COMPLETED|Overall Study||9
6785804|NCT00997386|7716084|FG000|NOT COMPLETED|Overall Study||7
6785805|NCT00985738|7716090|FG000|STARTED|Overall Study||8
6785806|NCT00985738|7716091|FG001|STARTED|Overall Study||8
6785807|NCT00985738|7716090|FG000|COMPLETED|Overall Study||0
6785808|NCT00985738|7716091|FG001|COMPLETED|Overall Study||0
6785809|NCT00985738|7716090|FG000|NOT COMPLETED|Overall Study||8
6785810|NCT00985738|7716091|FG001|NOT COMPLETED|Overall Study||8
6785811|NCT00986999|7716097|FG000|STARTED|Overall Study||7
6785812|NCT00986999|7716097|FG000|COMPLETED|Overall Study||6
6785813|NCT00986999|7716097|FG000|NOT COMPLETED|Overall Study||1
6785814|NCT00989937|7716101|FG000|STARTED|Overall Study||0
6785815|NCT00989937|7716101|FG000|COMPLETED|Overall Study||0
6785816|NCT00989937|7716101|FG000|NOT COMPLETED|Overall Study||0
6785817|NCT00986947|7716105|FG000|STARTED|Overall Study||20
6785818|NCT00986947|7716105|FG000|COMPLETED|Overall Study||0
6785819|NCT00986947|7716105|FG000|NOT COMPLETED|Overall Study||20
6785820|NCT00982995|7716109|FG000|STARTED|Overall Study||3
6785821|NCT00982995|7716109|FG000|COMPLETED|Overall Study||3
6785822|NCT00982995|7716109|FG000|NOT COMPLETED|Overall Study||0
6785823|NCT00984490|7716113|FG000|STARTED|Overall Study||5
6785824|NCT00984490|7716113|FG000|COMPLETED|Overall Study||5
6785825|NCT00984490|7716113|FG000|NOT COMPLETED|Overall Study||0
6785826|NCT00986310|7716120|FG000|STARTED|Overall Study||0
6785827|NCT00986310|7716121|FG001|STARTED|Overall Study||0
6785828|NCT00986310|7716120|FG000|COMPLETED|Overall Study||0
6785829|NCT00986310|7716121|FG001|COMPLETED|Overall Study||0
6785830|NCT00986310|7716120|FG000|NOT COMPLETED|Overall Study||0
6785831|NCT00986310|7716121|FG001|NOT COMPLETED|Overall Study||0
6785832|NCT00978874|7716127|FG000|STARTED|Overall Study|The study was terminated and no data are available to be reported|0
6785833|NCT00978874|7716127|FG000|COMPLETED|Overall Study|The study was terminated and no data are available to be reported|0
6785834|NCT00978874|7716127|FG000|NOT COMPLETED|Overall Study||0
6785835|NCT00983645|7716133|FG000|STARTED|Overall Study||8
6785836|NCT00983645|7716134|FG001|STARTED|Overall Study||7
6785837|NCT00983645|7716133|FG000|COMPLETED|Overall Study||8
6785838|NCT00983645|7716134|FG001|COMPLETED|Overall Study||7
6785839|NCT00983645|7716133|FG000|NOT COMPLETED|Overall Study||0
6785840|NCT00983645|7716134|FG001|NOT COMPLETED|Overall Study||0
6785841|NCT00979147|7716142|FG000|STARTED|Overall Study||0
6785842|NCT00979147|7716143|FG001|STARTED|Overall Study||0
6785843|NCT00979147|7716142|FG000|COMPLETED|Overall Study||0
6785844|NCT00979147|7716143|FG001|COMPLETED|Overall Study||0
6785845|NCT00979147|7716142|FG000|NOT COMPLETED|Overall Study||0
6785846|NCT00979147|7716143|FG001|NOT COMPLETED|Overall Study||0
6785847|NCT00967447|7716149|FG000|STARTED|Overall Study|there are no collected data in CRF|2
6785848|NCT00967447|7716149|FG000|COMPLETED|Overall Study|there are no collected data in CRF|2
6785849|NCT00967447|7716149|FG000|NOT COMPLETED|Overall Study||0
6785850|NCT00970606|7716155|FG000|STARTED|Overall Study||4
6785851|NCT00970606|7716156|FG001|STARTED|Overall Study||3
6785852|NCT00970606|7716155|FG000|COMPLETED|Overall Study||4
6785853|NCT00970606|7716156|FG001|COMPLETED|Overall Study||3
6785854|NCT00970606|7716155|FG000|NOT COMPLETED|Overall Study||0
6785855|NCT00970606|7716156|FG001|NOT COMPLETED|Overall Study||0
6785856|NCT00979550|7716164|FG000|STARTED|Overall Study||4
6563116|NCT01805323|7486067|FG000|STARTED|Overall Study||101
6785857|NCT00979550|7716165|FG001|STARTED|Overall Study||3
6785858|NCT00979550|7716164|FG000|COMPLETED|Overall Study||4
6785859|NCT00979550|7716165|FG001|COMPLETED|Overall Study||3
6785860|NCT00979550|7716164|FG000|NOT COMPLETED|Overall Study||0
6785861|NCT00979550|7716165|FG001|NOT COMPLETED|Overall Study||0
6785862|NCT00966992|7716173|FG000|STARTED|Overall Study||3
6785863|NCT00966992|7716174|FG001|STARTED|Overall Study||0
6785864|NCT00966992|7716173|FG000|COMPLETED|Overall Study||3
6785865|NCT00966992|7716174|FG001|COMPLETED|Overall Study||0
6785866|NCT00966992|7716173|FG000|NOT COMPLETED|Overall Study||0
6785867|NCT00966992|7716174|FG001|NOT COMPLETED|Overall Study||0
6785868|NCT00981370|7716180|FG000|STARTED|Overall Study||0
6378483|NCT00768430|7289045|FG000|STARTED|7 Day Endpoint||47
6378484|NCT00768430|7289046|FG001|STARTED|7 Day Endpoint||25
6785869|NCT00981370|7716180|FG000|COMPLETED|Overall Study||0
6785870|NCT00981370|7716180|FG000|NOT COMPLETED|Overall Study||0
6785871|NCT00975611|7716184|FG000|STARTED|Overall Study||22
6785872|NCT00975611|7716184|FG000|COMPLETED|Overall Study||5
6785873|NCT00975611|7716184|FG000|NOT COMPLETED|Overall Study||17
6785874|NCT00978419|7716190|FG000|STARTED|Overall Study||0
6785875|NCT00978419|7716191|FG001|STARTED|Overall Study||0
6785876|NCT00978419|7716190|FG000|COMPLETED|Overall Study||0
6785877|NCT00978419|7716191|FG001|COMPLETED|Overall Study||0
6785878|NCT00978419|7716190|FG000|NOT COMPLETED|Overall Study||0
6785879|NCT00978419|7716191|FG001|NOT COMPLETED|Overall Study||0
6785880|NCT00973856|7716199|FG000|STARTED|Overall Study||3
6785881|NCT00973856|7716200|FG001|STARTED|Overall Study||2
6785882|NCT00973856|7716199|FG000|COMPLETED|Overall Study||3
6785883|NCT00973856|7716200|FG001|COMPLETED|Overall Study||2
6785884|NCT00973856|7716199|FG000|NOT COMPLETED|Overall Study||0
6563117|NCT01805323|7486067|FG000|COMPLETED|Overall Study||101
6563118|NCT01805323|7486067|FG000|NOT COMPLETED|Overall Study||0
6563119|NCT01805440|7486074|FG000|STARTED|Overall Study||19
6563120|NCT01805440|7486075|FG001|STARTED|Overall Study||17
6785885|NCT00973856|7716200|FG001|NOT COMPLETED|Overall Study||0
6785886|NCT00979810|7716205|FG000|STARTED|Overall Study||11
6785887|NCT00979810|7716205|FG000|COMPLETED|Overall Study||11
6785888|NCT00979810|7716205|FG000|NOT COMPLETED|Overall Study||0
6785889|NCT00974922|7716209|FG000|STARTED|Overall Study||40
6785890|NCT00974922|7716209|FG000|COMPLETED|Overall Study||16
6785891|NCT00974922|7716209|FG000|NOT COMPLETED|Overall Study||24
6785892|NCT00976339|7716215|FG000|STARTED|Overall Study||10
6785893|NCT00976339|7716216|FG001|STARTED|Overall Study||10
6785894|NCT00976339|7716215|FG000|COMPLETED|Overall Study||10
6785895|NCT00976339|7716216|FG001|COMPLETED|Overall Study||10
6785896|NCT00976339|7716215|FG000|NOT COMPLETED|Overall Study||0
6785897|NCT00976339|7716216|FG001|NOT COMPLETED|Overall Study||0
6785898|NCT00965146|7716224|FG000|STARTED|Overall Study||210
6785899|NCT00965146|7716224|FG000|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
6785900|NCT00965146|7716224|FG000|NOT COMPLETED|Overall Study||210
6785901|NCT00972023|7716228|FG000|STARTED|Overall Study||1
6785902|NCT00972023|7716228|FG000|COMPLETED|Overall Study||0
6785903|NCT00972023|7716228|FG000|NOT COMPLETED|Overall Study||1
6785904|NCT00970736|7716234|FG000|STARTED|Overall Study||20
6785905|NCT00970736|7716234|FG000|COMPLETED|Overall Study||18
6785906|NCT00970736|7716234|FG000|NOT COMPLETED|Overall Study||2
6785907|NCT00957827|7716240|FG000|STARTED|Overall Study||2
6785908|NCT00957827|7716241|FG001|STARTED|Overall Study||2
6785909|NCT00957827|7716240|FG000|COMPLETED|Overall Study||2
6785910|NCT00957827|7716241|FG001|COMPLETED|Overall Study||2
6785911|NCT00957827|7716240|FG000|NOT COMPLETED|Overall Study||0
6785912|NCT00957827|7716241|FG001|NOT COMPLETED|Overall Study||0
6785913|NCT00953329|7716247|FG000|STARTED|Overall Study||1
6785914|NCT00953329|7716247|FG000|COMPLETED|Overall Study||0
6785915|NCT00953329|7716247|FG000|NOT COMPLETED|Overall Study||1
6785916|NCT00965055|7716251|FG000|STARTED|Overall Study||2
6785917|NCT00965055|7716251|FG000|COMPLETED|Overall Study||2
6785918|NCT00965055|7716251|FG000|NOT COMPLETED|Overall Study||0
6785919|NCT00962429|7716257|FG000|STARTED|Overall Study||0
6785920|NCT00962429|7716258|FG001|STARTED|Overall Study||0
6785921|NCT00962429|7716257|FG000|COMPLETED|Overall Study||0
6785922|NCT00962429|7716258|FG001|COMPLETED|Overall Study||0
6785923|NCT00962429|7716257|FG000|NOT COMPLETED|Overall Study||0
6785924|NCT00962429|7716258|FG001|NOT COMPLETED|Overall Study||0
6785925|NCT00958893|7716264|FG000|STARTED|Overall Study||4
6785926|NCT00958893|7716264|FG000|COMPLETED|Overall Study||0
6785927|NCT00958893|7716264|FG000|NOT COMPLETED|Overall Study||4
6785928|NCT00966654|7716268|FG000|STARTED|Overall Study||12
6785929|NCT00966654|7716268|FG000|COMPLETED|Overall Study||0
6785930|NCT00966654|7716268|FG000|NOT COMPLETED|Overall Study||12
6785931|NCT00960154|7716276|FG000|STARTED|Overall Study||25
6785932|NCT00960154|7716277|FG001|STARTED|Overall Study||25
6785933|NCT00960154|7716276|FG000|COMPLETED|Overall Study||0
6785934|NCT00960154|7716277|FG001|COMPLETED|Overall Study||0
6785935|NCT00960154|7716276|FG000|NOT COMPLETED|Overall Study||25
6785936|NCT00960154|7716277|FG001|NOT COMPLETED|Overall Study||25
6785937|NCT00960752|7716286|FG000|STARTED|Overall Study||13
6785938|NCT00960752|7716287|FG001|STARTED|Overall Study||13
6785939|NCT00960752|7716288|FG002|STARTED|Overall Study||19
6785940|NCT00960752|7716286|FG000|COMPLETED|Overall Study||13
6785941|NCT00960752|7716287|FG001|COMPLETED|Overall Study||13
6785942|NCT00960752|7716288|FG002|COMPLETED|Overall Study||17
6785943|NCT00960752|7716286|FG000|NOT COMPLETED|Overall Study||0
6785944|NCT00960752|7716287|FG001|NOT COMPLETED|Overall Study||0
6785945|NCT00960752|7716288|FG002|NOT COMPLETED|Overall Study||2
6785946|NCT00958347|7716296|FG000|STARTED|Overall Study||226
6785947|NCT00958347|7716296|FG000|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
6785948|NCT00958347|7716296|FG000|NOT COMPLETED|Overall Study||226
6785949|NCT00954187|7716302|FG000|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
6785950|NCT00954187|7716303|FG001|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
6785951|NCT00954187|7716302|FG000|COMPLETED|Overall Study||0
6785952|NCT00954187|7716303|FG001|COMPLETED|Overall Study||0
6785953|NCT00954187|7716302|FG000|NOT COMPLETED|Overall Study||0
6785954|NCT00954187|7716303|FG001|NOT COMPLETED|Overall Study||0
6785955|NCT00953615|7716309|FG000|STARTED|Overall Study||1
6785956|NCT00953615|7716309|FG000|COMPLETED|Overall Study||0
6785957|NCT00953615|7716309|FG000|NOT COMPLETED|Overall Study||1
6563121|NCT01805440|7486076|FG002|STARTED|Overall Study||26
6785958|NCT00947284|7716313|FG000|STARTED|Overall Study||0
6785959|NCT00947284|7716314|FG001|STARTED|Overall Study||3
6785960|NCT00947284|7716313|FG000|COMPLETED|Overall Study||0
6785961|NCT00947284|7716314|FG001|COMPLETED|Overall Study||0
6785962|NCT00947284|7716313|FG000|NOT COMPLETED|Overall Study||0
6785963|NCT00947284|7716314|FG001|NOT COMPLETED|Overall Study||3
6785964|NCT00957034|7716321|FG000|STARTED|Overall Study||6
6268858|NCT00068692|7167972|FG007|Had Sphincter Preservation|Step 2: Randomization||30
6785965|NCT00957034|7716322|FG001|STARTED|Overall Study||4
6785966|NCT00957034|7716323|FG002|STARTED|Overall Study||7
6785967|NCT00957034|7716321|FG000|COMPLETED|Overall Study||0
6785968|NCT00957034|7716322|FG001|COMPLETED|Overall Study||0
6785969|NCT00957034|7716323|FG002|COMPLETED|Overall Study||1
6785970|NCT00957034|7716321|FG000|NOT COMPLETED|Overall Study||6
6785971|NCT00957034|7716322|FG001|NOT COMPLETED|Overall Study||4
6785972|NCT00957034|7716323|FG002|NOT COMPLETED|Overall Study||6
6785973|NCT00949988|7716331|FG000|STARTED|Overall Study||3
6785974|NCT00949988|7716331|FG000|COMPLETED|Overall Study||0
6785975|NCT00949988|7716331|FG000|NOT COMPLETED|Overall Study||3
6785976|NCT00948194|7716337|FG000|STARTED|Overall Study||6
6785977|NCT00948194|7716338|FG001|STARTED|Overall Study||7
6785978|NCT00948194|7716337|FG000|COMPLETED|Overall Study||5
6785979|NCT00948194|7716338|FG001|COMPLETED|Overall Study||7
6785980|NCT00948194|7716337|FG000|NOT COMPLETED|Overall Study||1
6785981|NCT00948194|7716338|FG001|NOT COMPLETED|Overall Study||0
6785982|NCT00946985|7716344|FG000|STARTED|Stabilization Phase (25 Weeks)||162
6785983|NCT00946985|7716344|FG000|COMPLETED|Stabilization Phase (25 Weeks)||2
6785984|NCT00946985|7716344|FG000|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
6785985|NCT00946985|7716344|FG000|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
6785986|NCT00946985|7716344|FG000|COMPLETED|Relapse Prevention Phase (24 Months)||0
6785987|NCT00946985|7716344|FG000|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
6785988|NCT00950183|7716348|FG000|STARTED|Overall Study||36
6785989|NCT00950183|7716348|FG000|COMPLETED|Overall Study||0
6785990|NCT00950183|7716348|FG000|NOT COMPLETED|Overall Study||36
6785991|NCT00950690|7716352|FG000|STARTED|Overall Study||1349
6785992|NCT00950690|7716352|FG000|COMPLETED|Overall Study||1105
6563122|NCT01805440|7486074|FG000|COMPLETED|Overall Study||18
6563123|NCT01805440|7486075|FG001|COMPLETED|Overall Study||17
6563124|NCT01805440|7486076|FG002|COMPLETED|Overall Study||26
6563125|NCT01805440|7486074|FG000|NOT COMPLETED|Overall Study||1
6563126|NCT01805440|7486075|FG001|NOT COMPLETED|Overall Study||0
6563127|NCT01805440|7486076|FG002|NOT COMPLETED|Overall Study||0
6785993|NCT00950690|7716352|FG000|NOT COMPLETED|Overall Study||244
6785994|NCT00944229|7716356|FG000|STARTED|Overall Study||58
6785995|NCT00944229|7716356|FG000|COMPLETED|Overall Study||33
6563128|NCT01805687|7486083|FG000|STARTED|Overall Study||25
6563129|NCT01805687|7486083|FG000|COMPLETED|Overall Study||25
6563130|NCT01805687|7486083|FG000|NOT COMPLETED|Overall Study||0
6563131|NCT01805791|7486090|FG000|STARTED|Overall Study||66
6563132|NCT01805791|7486091|FG001|STARTED|Overall Study||67
6563133|NCT01805791|7486092|FG002|STARTED|Overall Study||68
6656279|NCT02459587|7586416|FG001|COMPLETED|12-month Follow-up Assessment||111
6785996|NCT00944229|7716356|FG000|NOT COMPLETED|Overall Study||25
6785997|NCT00941928|7716360|FG000|STARTED|Overall Study||2
6785998|NCT00941928|7716360|FG000|COMPLETED|Overall Study||0
6785999|NCT00941928|7716360|FG000|NOT COMPLETED|Overall Study||2
6786000|NCT00949403|7716364|FG000|STARTED|Overall Study||9
6786001|NCT00949403|7716364|FG000|COMPLETED|Overall Study||9
6786002|NCT00949403|7716364|FG000|NOT COMPLETED|Overall Study||0
6786003|NCT00947791|7716370|FG000|STARTED|Overall Study||0
6786004|NCT00947791|7716371|FG001|STARTED|Overall Study||1
6786005|NCT00947791|7716370|FG000|COMPLETED|Overall Study||0
6786006|NCT00947791|7716371|FG001|COMPLETED|Overall Study||1
6786007|NCT00947791|7716370|FG000|NOT COMPLETED|Overall Study||0
6786008|NCT00947791|7716371|FG001|NOT COMPLETED|Overall Study||0
6786009|NCT00947011|7716377|FG000|STARTED|Overall Study||12
6786010|NCT00947011|7716377|FG000|COMPLETED|Overall Study||0
6786011|NCT00947011|7716377|FG000|NOT COMPLETED|Overall Study||12
6786012|NCT00943605|7716385|FG000|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
6786013|NCT00943605|7716386|FG001|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
6786014|NCT00943605|7716385|FG000|COMPLETED|Overall Study||0
6786015|NCT00943605|7716386|FG001|COMPLETED|Overall Study||0
6786016|NCT00943605|7716385|FG000|NOT COMPLETED|Overall Study||30
6786017|NCT00943605|7716386|FG001|NOT COMPLETED|Overall Study||30
6786018|NCT00942409|7716392|FG000|STARTED|Overall Study||5
6786019|NCT00942409|7716392|FG000|COMPLETED|Overall Study||2
6786020|NCT00942409|7716392|FG000|NOT COMPLETED|Overall Study||3
6786021|NCT00936585|7716396|FG000|STARTED|Overall Study||2
6786022|NCT00936585|7716396|FG000|COMPLETED|Overall Study||2
6786023|NCT00936585|7716396|FG000|NOT COMPLETED|Overall Study||0
6786024|NCT00936598|7716402|FG000|STARTED|Overall Study||4
6786025|NCT00936598|7716403|FG001|STARTED|Overall Study||1
6786026|NCT00936598|7716402|FG000|COMPLETED|Overall Study||2
6786027|NCT00936598|7716403|FG001|COMPLETED|Overall Study||1
6786028|NCT00936598|7716402|FG000|NOT COMPLETED|Overall Study||2
6786029|NCT00936598|7716403|FG001|NOT COMPLETED|Overall Study||0
6786030|NCT00920309|7716411|FG000|STARTED|Overall Study||14
6786031|NCT00920309|7716412|FG001|STARTED|Overall Study||7
6563134|NCT01805791|7486090|FG000|COMPLETED|Overall Study||44
6563135|NCT01805791|7486091|FG001|COMPLETED|Overall Study||50
6563136|NCT01805791|7486092|FG002|COMPLETED|Overall Study||48
6563137|NCT01805791|7486090|FG000|NOT COMPLETED|Overall Study||22
6563138|NCT01805791|7486091|FG001|NOT COMPLETED|Overall Study||17
6563139|NCT01805791|7486092|FG002|NOT COMPLETED|Overall Study||20
6563140|NCT01805882|7486109|FG000|STARTED|Overall Study||20
6563141|NCT01805882|7486110|FG001|STARTED|Overall Study||20
6563142|NCT01805882|7486111|FG002|STARTED|Overall Study||20
6563143|NCT01805882|7486112|FG003|STARTED|Overall Study||34
6786032|NCT00920309|7716411|FG000|COMPLETED|Overall Study||14
6786033|NCT00920309|7716412|FG001|COMPLETED|Overall Study||7
6786034|NCT00920309|7716411|FG000|NOT COMPLETED|Overall Study||0
6786035|NCT00920309|7716412|FG001|NOT COMPLETED|Overall Study||0
6786036|NCT00935649|7716419|FG000|STARTED|Overall Study||139
6786037|NCT00935649|7716419|FG000|COMPLETED|Overall Study||134
6786038|NCT00935649|7716419|FG000|NOT COMPLETED|Overall Study||5
6786039|NCT00934791|7716427|FG000|STARTED|Overall Study||1
6786040|NCT00934791|7716428|FG001|STARTED|Overall Study||0
6786041|NCT00934791|7716427|FG000|COMPLETED|Overall Study||0
6786042|NCT00934791|7716428|FG001|COMPLETED|Overall Study||0
6786043|NCT00934791|7716427|FG000|NOT COMPLETED|Overall Study||1
6786044|NCT00934791|7716428|FG001|NOT COMPLETED|Overall Study||0
6786045|NCT00932152|7716436|FG000|STARTED|Overall Study||1
6786046|NCT00932152|7716437|FG001|STARTED|Overall Study||2
6786047|NCT00932152|7716436|FG000|COMPLETED|Overall Study||0
6786048|NCT00932152|7716437|FG001|COMPLETED|Overall Study||0
6786049|NCT00932152|7716436|FG000|NOT COMPLETED|Overall Study||1
6786050|NCT00932152|7716437|FG001|NOT COMPLETED|Overall Study||2
6786051|NCT00928499|7716445|FG000|STARTED|Overall Study||18
6786052|NCT00928499|7716446|FG001|STARTED|Overall Study||14
6786053|NCT00928499|7716445|FG000|COMPLETED|Overall Study||18
6786054|NCT00928499|7716446|FG001|COMPLETED|Overall Study||14
6786055|NCT00928499|7716445|FG000|NOT COMPLETED|Overall Study||0
6786056|NCT00928499|7716446|FG001|NOT COMPLETED|Overall Study||0
6786057|NCT00924807|7716452|FG000|STARTED|Overall Study||4
6563144|NCT01805882|7486113|FG004|STARTED|Overall Study||14
6737460|NCT03266172|7666732|FG000|STARTED|Part C Washout Period (7 Days)||0
6786058|NCT00924807|7716452|FG000|COMPLETED|Overall Study||4
6786059|NCT00924807|7716452|FG000|NOT COMPLETED|Overall Study||0
6786060|NCT00930787|7716458|FG000|STARTED|Overall Study||14
6786061|NCT00930787|7716459|FG001|STARTED|Overall Study||9
6786062|NCT00930787|7716458|FG000|COMPLETED|Overall Study||14
6786063|NCT00930787|7716459|FG001|COMPLETED|Overall Study||9
6786064|NCT00930787|7716458|FG000|NOT COMPLETED|Overall Study||0
6786065|NCT00930787|7716459|FG001|NOT COMPLETED|Overall Study||0
6786066|NCT00929474|7716467|FG000|STARTED|Overall Study||8
6786067|NCT00929474|7716468|FG001|STARTED|Overall Study||9
6786068|NCT00929474|7716467|FG000|COMPLETED|Overall Study||0
6786069|NCT00929474|7716468|FG001|COMPLETED|Overall Study||0
6786070|NCT00929474|7716467|FG000|NOT COMPLETED|Overall Study||8
6786071|NCT00929474|7716468|FG001|NOT COMPLETED|Overall Study||9
6786072|NCT00925548|7716476|FG000|STARTED|Overall Study||11
6786073|NCT00925548|7716477|FG001|STARTED|Overall Study||5
6786074|NCT00925548|7716476|FG000|COMPLETED|Overall Study||1
6786075|NCT00925548|7716477|FG001|COMPLETED|Overall Study||0
6786076|NCT00925548|7716476|FG000|NOT COMPLETED|Overall Study||10
6786077|NCT00925548|7716477|FG001|NOT COMPLETED|Overall Study||5
6786078|NCT00926575|7716486|FG000|STARTED|Overall Study||70
6786079|NCT00926575|7716487|FG001|STARTED|Overall Study||70
6786080|NCT00926575|7716486|FG000|COMPLETED|Overall Study||54
6786081|NCT00926575|7716487|FG001|COMPLETED|Overall Study||53
6786082|NCT00926575|7716486|FG000|NOT COMPLETED|Overall Study||16
6786083|NCT00926575|7716487|FG001|NOT COMPLETED|Overall Study||17
6786084|NCT00911053|7716498|FG000|STARTED|Overall Study||0
6786085|NCT00911053|7716499|FG001|STARTED|Overall Study||0
6786086|NCT00911053|7716500|FG002|STARTED|Overall Study||0
6786087|NCT00911053|7716501|FG003|STARTED|Overall Study||0
6786088|NCT00911053|7716502|FG004|STARTED|Overall Study||0
6786089|NCT00911053|7716498|FG000|COMPLETED|Overall Study||0
6786090|NCT00911053|7716499|FG001|COMPLETED|Overall Study||0
6786091|NCT00911053|7716500|FG002|COMPLETED|Overall Study||0
6786092|NCT00911053|7716501|FG003|COMPLETED|Overall Study||0
6786093|NCT00911053|7716502|FG004|COMPLETED|Overall Study||0
6786094|NCT00911053|7716498|FG000|NOT COMPLETED|Overall Study||0
6786095|NCT00911053|7716499|FG001|NOT COMPLETED|Overall Study||0
6786096|NCT00911053|7716500|FG002|NOT COMPLETED|Overall Study||0
6786097|NCT00911053|7716501|FG003|NOT COMPLETED|Overall Study||0
6786098|NCT00911053|7716502|FG004|NOT COMPLETED|Overall Study||0
6786099|NCT00918463|7716514|FG000|STARTED|Overall Study||2
6786100|NCT00918463|7716514|FG000|COMPLETED|Overall Study||0
6786101|NCT00918463|7716514|FG000|NOT COMPLETED|Overall Study||2
6786102|NCT00913692|7716518|FG000|STARTED|Screening (4 Months)||11
6786103|NCT00913692|7716518|FG000|COMPLETED|Screening (4 Months)||2
6786104|NCT00913692|7716518|FG000|NOT COMPLETED|Screening (4 Months)||9
6563145|NCT01805882|7486114|FG005|STARTED|Overall Study||21
6563146|NCT01805882|7486115|FG006|STARTED|Overall Study||50
6737461|NCT03266172|7666733|FG001|STARTED|Part C Washout Period (7 Days)||0
6737462|NCT03266172|7666734|FG002|STARTED|Part C Washout Period (7 Days)||16
6737463|NCT03266172|7666732|FG000|COMPLETED|Part C Washout Period (7 Days)||0
6737464|NCT03266172|7666733|FG001|COMPLETED|Part C Washout Period (7 Days)||0
6737465|NCT03266172|7666734|FG002|COMPLETED|Part C Washout Period (7 Days)||15
6737466|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737467|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737468|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
6737469|NCT03266172|7666732|FG000|STARTED|Part C Period 5(2 Days)||0
6737470|NCT03266172|7666733|FG001|STARTED|Part C Period 5(2 Days)||0
6737471|NCT03266172|7666734|FG002|STARTED|Part C Period 5(2 Days)||15
6737472|NCT03266172|7666732|FG000|COMPLETED|Part C Period 5(2 Days)||0
6737473|NCT03266172|7666733|FG001|COMPLETED|Part C Period 5(2 Days)||0
6737474|NCT03266172|7666734|FG002|COMPLETED|Part C Period 5(2 Days)||15
6737475|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Period 5(2 Days)||0
6786105|NCT00913692|7716518|FG000|STARTED|Treatment Phase 1 (5 Months)||2
6786106|NCT00913692|7716518|FG000|COMPLETED|Treatment Phase 1 (5 Months)||1
6786107|NCT00913692|7716518|FG000|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
6786108|NCT00913692|7716518|FG000|STARTED|Washout (2 Weeks)||1
6786109|NCT00913692|7716518|FG000|COMPLETED|Washout (2 Weeks)||1
6786110|NCT00913692|7716518|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6786111|NCT00913692|7716518|FG000|STARTED|Treatment Phase 2 (5 Months)||1
6786112|NCT00913692|7716518|FG000|COMPLETED|Treatment Phase 2 (5 Months)||1
6786113|NCT00913692|7716518|FG000|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
6786114|NCT00918645|7716525|FG000|STARTED|Overall Study||13
6786115|NCT00918645|7716525|FG000|COMPLETED|Overall Study||12
6786116|NCT00918645|7716525|FG000|NOT COMPLETED|Overall Study||1
6786117|NCT00907218|7716529|FG000|STARTED|Overall Study||2
6786118|NCT00907218|7716529|FG000|COMPLETED|Overall Study||2
6786119|NCT00907218|7716529|FG000|NOT COMPLETED|Overall Study||0
6786120|NCT00895284|7716535|FG000|STARTED|Overall Study||3
6786121|NCT00895284|7716536|FG001|STARTED|Overall Study||0
6786122|NCT00895284|7716535|FG000|COMPLETED|Overall Study||3
6786123|NCT00895284|7716536|FG001|COMPLETED|Overall Study||0
6786124|NCT00895284|7716535|FG000|NOT COMPLETED|Overall Study||0
6786125|NCT00895284|7716536|FG001|NOT COMPLETED|Overall Study||0
6786126|NCT00897910|7716542|FG000|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
6786127|NCT00897910|7716542|FG000|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
6786128|NCT00897910|7716542|FG000|NOT COMPLETED|Overall Study||0
6786129|NCT00901303|7716548|FG000|STARTED|Overall Study||5
6786130|NCT00901303|7716549|FG001|STARTED|Overall Study||1
6786131|NCT00901303|7716548|FG000|COMPLETED|Overall Study||5
6786132|NCT00901303|7716549|FG001|COMPLETED|Overall Study||1
6786133|NCT00901303|7716548|FG000|NOT COMPLETED|Overall Study||0
6786134|NCT00901303|7716549|FG001|NOT COMPLETED|Overall Study||0
6786135|NCT00906035|7716558|FG000|STARTED|Overall Study||8
6786136|NCT00906035|7716559|FG001|STARTED|Overall Study||9
6786137|NCT00906035|7716560|FG002|STARTED|Overall Study||8
6786138|NCT00906035|7716558|FG000|COMPLETED|Overall Study|One Drop-Out; SAE day before Visit 1 and One subject Withrew prior to visit 1|6
6786139|NCT00906035|7716559|FG001|COMPLETED|Overall Study|2 subjects Withdrew after Visit 1 and 1 subject Withdrew shortly after Visit 1due to an AE|6
6786140|NCT00906035|7716560|FG002|COMPLETED|Overall Study||8
6786141|NCT00906035|7716558|FG000|NOT COMPLETED|Overall Study||2
6786142|NCT00906035|7716559|FG001|NOT COMPLETED|Overall Study||3
6786143|NCT00906035|7716560|FG002|NOT COMPLETED|Overall Study||0
6786144|NCT00904423|7716568|FG000|STARTED|Overall Study||8
6786145|NCT00904423|7716568|FG000|COMPLETED|Overall Study||8
6786146|NCT00904423|7716568|FG000|NOT COMPLETED|Overall Study||0
6786147|NCT00903396|7716576|FG000|STARTED|Overall Study||2
6786148|NCT00903396|7716577|FG001|STARTED|Overall Study||1
6786149|NCT00903396|7716578|FG002|STARTED|Overall Study||3
6786150|NCT00903396|7716579|FG003|STARTED|Overall Study||1
6786151|NCT00903396|7716576|FG000|COMPLETED|Overall Study||2
6786152|NCT00903396|7716577|FG001|COMPLETED|Overall Study||1
6786153|NCT00903396|7716578|FG002|COMPLETED|Overall Study||3
6786154|NCT00903396|7716579|FG003|COMPLETED|Overall Study||1
6786155|NCT00903396|7716576|FG000|NOT COMPLETED|Overall Study||0
6786156|NCT00903396|7716577|FG001|NOT COMPLETED|Overall Study||0
6786157|NCT00903396|7716578|FG002|NOT COMPLETED|Overall Study||0
6786158|NCT00903396|7716579|FG003|NOT COMPLETED|Overall Study||0
6786159|NCT00894790|7716591|FG000|STARTED|Overall Study||4
6786160|NCT00894790|7716592|FG001|STARTED|Overall Study||4
6786161|NCT00894790|7716591|FG000|COMPLETED|Overall Study||3
6786162|NCT00894790|7716592|FG001|COMPLETED|Overall Study||2
6786163|NCT00894790|7716591|FG000|NOT COMPLETED|Overall Study||1
6786164|NCT00894790|7716592|FG001|NOT COMPLETED|Overall Study||2
6786165|NCT00902668|7716598|FG000|STARTED|Overall Study||3
6786166|NCT00902668|7716598|FG000|COMPLETED|Overall Study||0
6786167|NCT00902668|7716598|FG000|NOT COMPLETED|Overall Study||3
6786168|NCT00881205|7716604|FG000|STARTED|Overall Study||45
6786169|NCT00881205|7716605|FG001|STARTED|Overall Study||41
6786170|NCT00881205|7716604|FG000|COMPLETED|Overall Study||34
6786171|NCT00881205|7716605|FG001|COMPLETED|Overall Study||34
6786172|NCT00881205|7716604|FG000|NOT COMPLETED|Overall Study||11
6786173|NCT00881205|7716605|FG001|NOT COMPLETED|Overall Study||7
6786174|NCT00896025|7716612|FG000|STARTED|Overall Study||8
6786175|NCT00896025|7716612|FG000|COMPLETED|Overall Study||8
6786176|NCT00896025|7716612|FG000|NOT COMPLETED|Overall Study||0
6786177|NCT00903006|7716622|FG000|STARTED|Overall Study||2
6786178|NCT00903006|7716623|FG001|STARTED|Overall Study||3
6786179|NCT00903006|7716624|FG002|STARTED|Overall Study||1
6786180|NCT00903006|7716625|FG003|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
6786181|NCT00903006|7716622|FG000|COMPLETED|Overall Study||0
6786182|NCT00903006|7716623|FG001|COMPLETED|Overall Study||0
6786183|NCT00903006|7716624|FG002|COMPLETED|Overall Study||0
6786184|NCT00903006|7716625|FG003|COMPLETED|Overall Study||0
6786185|NCT00903006|7716622|FG000|NOT COMPLETED|Overall Study||2
6786186|NCT00903006|7716623|FG001|NOT COMPLETED|Overall Study||3
6786187|NCT00903006|7716624|FG002|NOT COMPLETED|Overall Study||1
6786188|NCT00903006|7716625|FG003|NOT COMPLETED|Overall Study||0
6786189|NCT00904189|7716635|FG000|STARTED|Overall Study||2
6786190|NCT00904189|7716635|FG000|COMPLETED|Overall Study||2
6786191|NCT00904189|7716635|FG000|NOT COMPLETED|Overall Study||0
6786192|NCT00887315|7716642|FG000|STARTED|Overall Study||7
6786193|NCT00887315|7716643|FG001|STARTED|Overall Study||4
6786194|NCT00887315|7716642|FG000|COMPLETED|Overall Study||0
6786195|NCT00887315|7716643|FG001|COMPLETED|Overall Study||0
6786196|NCT00887315|7716642|FG000|NOT COMPLETED|Overall Study||7
6786197|NCT00887315|7716643|FG001|NOT COMPLETED|Overall Study||4
6786198|NCT00891904|7716649|FG000|STARTED|Overall Study||2
6786199|NCT00891904|7716649|FG000|COMPLETED|Overall Study||0
6786200|NCT00891904|7716649|FG000|NOT COMPLETED|Overall Study||2
6786201|NCT00881608|7716658|FG000|STARTED|Overall Study||11
6786202|NCT00881608|7716658|FG000|COMPLETED|Overall Study||0
6786203|NCT00881608|7716658|FG000|NOT COMPLETED|Overall Study||11
6786204|NCT00889421|7716670|FG000|STARTED|Overall Study||3
6786205|NCT00889421|7716670|FG000|COMPLETED|Overall Study||0
6786206|NCT00889421|7716670|FG000|NOT COMPLETED|Overall Study||3
6786207|NCT00875394|7716677|FG000|STARTED|Overall Study||36
6786208|NCT00875394|7716678|FG001|STARTED|Overall Study||23
6786209|NCT00875394|7716679|FG002|STARTED|Overall Study||9
6786210|NCT00875394|7716677|FG000|COMPLETED|Overall Study||36
6786211|NCT00875394|7716678|FG001|COMPLETED|Overall Study||23
6786212|NCT00875394|7716679|FG002|COMPLETED|Overall Study||9
6786213|NCT00875394|7716677|FG000|NOT COMPLETED|Overall Study||0
6786214|NCT00875394|7716678|FG001|NOT COMPLETED|Overall Study||0
6786215|NCT00875394|7716679|FG002|NOT COMPLETED|Overall Study||0
6786216|NCT00882310|7716687|FG000|STARTED|Overall Study||37
6563147|NCT01805882|7486116|FG007|STARTED|Overall Study||25
6563148|NCT01805882|7486117|FG008|STARTED|Overall Study||25
6563149|NCT01805882|7486109|FG000|COMPLETED|Overall Study||20
6563150|NCT01805882|7486110|FG001|COMPLETED|Overall Study||20
6563151|NCT01805882|7486111|FG002|COMPLETED|Overall Study||19
6563152|NCT01805882|7486112|FG003|COMPLETED|Overall Study||32
6563153|NCT01805882|7486113|FG004|COMPLETED|Overall Study||14
6563154|NCT01805882|7486114|FG005|COMPLETED|Overall Study||20
6563155|NCT01805882|7486115|FG006|COMPLETED|Overall Study||48
6656280|NCT02459587|7586415|FG000|NOT COMPLETED|12-month Follow-up Assessment||22
6786217|NCT00882310|7716687|FG000|COMPLETED|Overall Study||15
6656281|NCT02459587|7586416|FG001|NOT COMPLETED|12-month Follow-up Assessment||27
6786218|NCT00882310|7716687|FG000|NOT COMPLETED|Overall Study||22
6786219|NCT00880542|7716691|FG000|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
6786220|NCT00880542|7716691|FG000|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
6786221|NCT00880542|7716691|FG000|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
6786222|NCT00880542|7716691|FG000|STARTED|Response Evaluation Period(REP): PET/CT||4
6786223|NCT00880542|7716691|FG000|COMPLETED|Response Evaluation Period(REP): PET/CT||4
6786224|NCT00880542|7716691|FG000|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
6786225|NCT00880542|7716691|FG000|STARTED|REP: Surgical Resection||4
6786226|NCT00880542|7716691|FG000|COMPLETED|REP: Surgical Resection||3
6786227|NCT00880542|7716691|FG000|NOT COMPLETED|REP: Surgical Resection||1
6786228|NCT00880542|7716691|FG000|STARTED|Post Surgical Evaluation||3
6786229|NCT00880542|7716691|FG000|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
6786230|NCT00880542|7716691|FG000|NOT COMPLETED|Post Surgical Evaluation||0
6786231|NCT00880542|7716691|FG000|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
6786232|NCT00880542|7716691|FG000|COMPLETED|Continued Treatment Period||0
6786233|NCT00880542|7716691|FG000|NOT COMPLETED|Continued Treatment Period||0
6786234|NCT00880542|7716691|FG000|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
6786235|NCT00880542|7716691|FG000|COMPLETED|Follow-up Period||7
6786236|NCT00880542|7716691|FG000|NOT COMPLETED|Follow-up Period||0
6786237|NCT00879619|7716695|FG000|STARTED|Overall Study||4
6786238|NCT00879619|7716695|FG000|COMPLETED|Overall Study||4
6786239|NCT00879619|7716695|FG000|NOT COMPLETED|Overall Study||0
6786240|NCT00874939|7716699|FG000|STARTED|Overall Study||4
6786241|NCT00874939|7716699|FG000|Treated|Overall Study||0
6786242|NCT00874939|7716699|FG000|COMPLETED|Overall Study||0
6786243|NCT00874939|7716699|FG000|NOT COMPLETED|Overall Study||4
6786244|NCT00878605|7716713|FG000|STARTED|Overall Study||10
6786245|NCT00878605|7716714|FG001|STARTED|Overall Study||10
6786246|NCT00878605|7716715|FG002|STARTED|Overall Study||9
6786247|NCT00878605|7716716|FG003|STARTED|Overall Study||9
6786248|NCT00878605|7716713|FG000|COMPLETED|Overall Study||7
6786249|NCT00878605|7716714|FG001|COMPLETED|Overall Study||7
6786250|NCT00878605|7716715|FG002|COMPLETED|Overall Study||8
6786251|NCT00878605|7716716|FG003|COMPLETED|Overall Study||6
6786252|NCT00878605|7716713|FG000|NOT COMPLETED|Overall Study||3
6786253|NCT00878605|7716714|FG001|NOT COMPLETED|Overall Study||3
6786254|NCT00878605|7716715|FG002|NOT COMPLETED|Overall Study||1
6786255|NCT00878605|7716716|FG003|NOT COMPLETED|Overall Study||3
6786256|NCT00877071|7716726|FG000|STARTED|Overall Study||2
6786257|NCT00877071|7716726|FG000|COMPLETED|Overall Study||0
6786258|NCT00877071|7716726|FG000|NOT COMPLETED|Overall Study||2
6656282|NCT02459665|7586427|FG000|STARTED|Overall Study||17
6656283|NCT02459665|7586428|FG001|STARTED|Overall Study||17
6656284|NCT02459665|7586429|FG002|STARTED|Overall Study||17
6656285|NCT02459665|7586430|FG003|STARTED|Overall Study||17
6656286|NCT02459665|7586427|FG000|Day 7 Visit|Overall Study||17
6656287|NCT02459665|7586428|FG001|Day 7 Visit|Overall Study||17
6656288|NCT02459665|7586429|FG002|Day 7 Visit|Overall Study||17
6656289|NCT02459665|7586430|FG003|Day 7 Visit|Overall Study||16
6656290|NCT02459665|7586427|FG000|Month 1 Visit|Overall Study||17
6786259|NCT00878969|7716733|FG000|STARTED|Overall Study||25
6786260|NCT00878969|7716734|FG001|STARTED|Overall Study||27
6786261|NCT00878969|7716735|FG002|STARTED|Overall Study||26
6786262|NCT00878969|7716733|FG000|COMPLETED|Overall Study||10
6786263|NCT00878969|7716734|FG001|COMPLETED|Overall Study||12
6786264|NCT00878969|7716735|FG002|COMPLETED|Overall Study||15
6786265|NCT00878969|7716733|FG000|NOT COMPLETED|Overall Study||15
6786266|NCT00878969|7716734|FG001|NOT COMPLETED|Overall Study||15
6786267|NCT00878969|7716735|FG002|NOT COMPLETED|Overall Study||11
6786268|NCT00865514|7716743|FG000|STARTED|Overall Study||2
6563156|NCT01805882|7486116|FG007|COMPLETED|Overall Study||25
6563157|NCT01805882|7486117|FG008|COMPLETED|Overall Study||24
6656291|NCT02459665|7586428|FG001|Month 1 Visit|Overall Study||17
6656292|NCT02459665|7586429|FG002|Month 1 Visit|Overall Study||17
6786269|NCT00865514|7716743|FG000|COMPLETED|Overall Study||0
6786270|NCT00865514|7716743|FG000|NOT COMPLETED|Overall Study||2
6786271|NCT00869414|7716748|FG000|STARTED|Overall Study||0
6786272|NCT00869414|7716749|FG001|STARTED|Overall Study||0
6786273|NCT00869414|7716750|FG002|STARTED|Overall Study||0
6786274|NCT00869414|7716748|FG000|COMPLETED|Overall Study||0
6786275|NCT00869414|7716749|FG001|COMPLETED|Overall Study||0
6378485|NCT00768430|7289045|FG000|COMPLETED|7 Day Endpoint||45
6378486|NCT00768430|7289046|FG001|COMPLETED|7 Day Endpoint||22
6378487|NCT00768430|7289045|FG000|NOT COMPLETED|7 Day Endpoint||2
6378488|NCT00768430|7289046|FG001|NOT COMPLETED|7 Day Endpoint||3
6378489|NCT00768469|7289054|FG000|STARTED|Overall Study||3
6378490|NCT00768469|7289055|FG001|STARTED|Overall Study||7
6378491|NCT00768469|7289054|FG000|COMPLETED|Overall Study||0
6378492|NCT00768469|7289055|FG001|COMPLETED|Overall Study||0
6378493|NCT00768469|7289054|FG000|NOT COMPLETED|Overall Study||3
6378494|NCT00768469|7289055|FG001|NOT COMPLETED|Overall Study||7
6378495|NCT00768521|7289062|FG000|STARTED|Period 1||9
6378496|NCT00768521|7289063|FG001|STARTED|Period 1||11
6378497|NCT00768521|7289062|FG000|COMPLETED|Period 1||9
6378498|NCT00768521|7289063|FG001|COMPLETED|Period 1||11
6378499|NCT00768521|7289062|FG000|NOT COMPLETED|Period 1||0
6378500|NCT00768521|7289063|FG001|NOT COMPLETED|Period 1||0
6378501|NCT00768521|7289062|FG000|STARTED|Period 2||9
6378502|NCT00768521|7289063|FG001|STARTED|Period 2||11
6378503|NCT00768521|7289062|FG000|COMPLETED|Period 2||9
6378504|NCT00768521|7289063|FG001|COMPLETED|Period 2||11
6378505|NCT00768521|7289062|FG000|NOT COMPLETED|Period 2||0
6378506|NCT00768521|7289063|FG001|NOT COMPLETED|Period 2||0
6378507|NCT00768560|7289075|FG000|STARTED|Intervention Set 1|3-period/treatment crossover|5
6378508|NCT00768560|7289076|FG001|STARTED|Intervention Set 1|3-period/treatment crossover|6
6378509|NCT00768560|7289077|FG002|STARTED|Intervention Set 1|3-period/treatment crossover|6
6378510|NCT00768560|7289078|FG003|STARTED|Intervention Set 1|3-period/treatment crossover|6
6378511|NCT00768560|7289079|FG004|STARTED|Intervention Set 1|3-period/treatment crossover|6
6378512|NCT00768560|7289080|FG005|STARTED|Intervention Set 1|3-period/treatment crossover|6
6378513|NCT00768560|7289075|FG000|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
6378514|NCT00768560|7289076|FG001|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
6395530|NCT00858845|7308099|FG001|COMPLETED|Overall Study||5
6786276|NCT00869414|7716750|FG002|COMPLETED|Overall Study||0
6786277|NCT00869414|7716748|FG000|NOT COMPLETED|Overall Study||0
6786278|NCT00869414|7716749|FG001|NOT COMPLETED|Overall Study||0
6786279|NCT00869414|7716750|FG002|NOT COMPLETED|Overall Study||0
6786280|NCT00863512|7716760|FG000|STARTED|Overall Study||17
6786281|NCT00863512|7716761|FG001|STARTED|Overall Study||17
6786282|NCT00863512|7716760|FG000|COMPLETED|Overall Study||3
6786283|NCT00863512|7716761|FG001|COMPLETED|Overall Study||17
6786284|NCT00863512|7716760|FG000|NOT COMPLETED|Overall Study||14
6786285|NCT00863512|7716761|FG001|NOT COMPLETED|Overall Study||0
6786286|NCT00868998|7716767|FG000|STARTED|Overall Study||5
6786287|NCT00868998|7716767|FG000|COMPLETED|Overall Study||0
6786288|NCT00868998|7716767|FG000|NOT COMPLETED|Overall Study||5
6786289|NCT00869258|7716771|FG000|STARTED|Overall Study||32
6786290|NCT00869258|7716771|FG000|COMPLETED|Overall Study||31
6786291|NCT00869258|7716771|FG000|NOT COMPLETED|Overall Study||1
6786292|NCT00863330|7716775|FG000|STARTED|Overall Study||6
6786293|NCT00863330|7716775|FG000|COMPLETED|Overall Study||0
6786294|NCT00863330|7716775|FG000|NOT COMPLETED|Overall Study||6
6786295|NCT00853229|7716781|FG000|STARTED|Phase 1: Initial Intervention||8
6786296|NCT00853229|7716782|FG001|STARTED|Phase 1: Initial Intervention||8
6786297|NCT00853229|7716781|FG000|COMPLETED|Phase 1: Initial Intervention||0
6786298|NCT00853229|7716782|FG001|COMPLETED|Phase 1: Initial Intervention||0
6786299|NCT00853229|7716781|FG000|NOT COMPLETED|Phase 1: Initial Intervention||8
6786300|NCT00853229|7716782|FG001|NOT COMPLETED|Phase 1: Initial Intervention||8
6786301|NCT00853229|7716781|FG000|STARTED|Phase 2: Cross Over||0
6786302|NCT00853229|7716782|FG001|STARTED|Phase 2: Cross Over||0
6786303|NCT00853229|7716781|FG000|COMPLETED|Phase 2: Cross Over||0
6786304|NCT00853229|7716782|FG001|COMPLETED|Phase 2: Cross Over||0
6786305|NCT00853229|7716781|FG000|NOT COMPLETED|Phase 2: Cross Over||0
6786306|NCT00853229|7716782|FG001|NOT COMPLETED|Phase 2: Cross Over||0
6786307|NCT00860249|7716793|FG000|STARTED|Overall Study||21
6786308|NCT00860249|7716794|FG001|STARTED|Overall Study||18
6786309|NCT00860249|7716795|FG002|STARTED|Overall Study||21
6786310|NCT00860249|7716793|FG000|COMPLETED|Overall Study||0
6786311|NCT00860249|7716794|FG001|COMPLETED|Overall Study||0
6786312|NCT00860249|7716795|FG002|COMPLETED|Overall Study||0
6786313|NCT00860249|7716793|FG000|NOT COMPLETED|Overall Study||21
6786314|NCT00860249|7716794|FG001|NOT COMPLETED|Overall Study||18
6786315|NCT00860249|7716795|FG002|NOT COMPLETED|Overall Study||21
6786316|NCT00860158|7716803|FG000|STARTED|Overall Study||1
6786317|NCT00860158|7716803|FG000|COMPLETED|Overall Study||0
6786318|NCT00860158|7716803|FG000|NOT COMPLETED|Overall Study||1
6786319|NCT00853567|7716810|FG000|STARTED|Overall Study||71
6786320|NCT00853567|7716810|FG000|COMPLETED|Overall Study||0
6786321|NCT00853567|7716810|FG000|NOT COMPLETED|Overall Study||71
6786322|NCT00849524|7716818|FG000|STARTED|Overall Study||6
6786323|NCT00849524|7716818|FG000|COMPLETED|Overall Study||3
6786324|NCT00849524|7716818|FG000|NOT COMPLETED|Overall Study||3
6786325|NCT00843986|7716824|FG000|STARTED|Overall Study||3
6786326|NCT00843986|7716825|FG001|STARTED|Overall Study||6
6786327|NCT00843986|7716824|FG000|Completed Treatment (Infusion)|Overall Study||2
6786328|NCT00843986|7716825|FG001|Completed Treatment (Infusion)|Overall Study||6
6786329|NCT00843986|7716824|FG000|COMPLETED|Overall Study||2
6786330|NCT00843986|7716825|FG001|COMPLETED|Overall Study||5
6786331|NCT00843986|7716824|FG000|NOT COMPLETED|Overall Study||1
6786332|NCT00843986|7716825|FG001|NOT COMPLETED|Overall Study||1
6786333|NCT00851682|7716833|FG000|STARTED|Overall Study||60
6786334|NCT00851682|7716834|FG001|STARTED|Overall Study||5
6786335|NCT00851682|7716833|FG000|COMPLETED|Overall Study||55
6786336|NCT00851682|7716834|FG001|COMPLETED|Overall Study||5
6786337|NCT00851682|7716833|FG000|NOT COMPLETED|Overall Study||5
6786338|NCT00851682|7716834|FG001|NOT COMPLETED|Overall Study||0
6786339|NCT00852124|7716842|FG000|STARTED|Overall Study||3
6786340|NCT00852124|7716843|FG001|STARTED|Overall Study||0
6786341|NCT00852124|7716842|FG000|COMPLETED|Overall Study||3
6786342|NCT00852124|7716843|FG001|COMPLETED|Overall Study||0
6786343|NCT00852124|7716842|FG000|NOT COMPLETED|Overall Study||0
6786344|NCT00852124|7716843|FG001|NOT COMPLETED|Overall Study||0
6786345|NCT00850421|7716848|FG000|STARTED|Overall Study||35
6786346|NCT00850421|7716848|FG000|COMPLETED|Overall Study||18
6786347|NCT00850421|7716848|FG000|NOT COMPLETED|Overall Study||17
6786348|NCT00851747|7716856|FG000|STARTED|Overall Study||6
6786349|NCT00851747|7716857|FG001|STARTED|Overall Study||6
6786350|NCT00851747|7716858|FG002|STARTED|Overall Study||6
6786351|NCT00851747|7716856|FG000|COMPLETED|Overall Study||0
6786352|NCT00851747|7716857|FG001|COMPLETED|Overall Study||0
6786353|NCT00851747|7716858|FG002|COMPLETED|Overall Study||0
6786354|NCT00851747|7716856|FG000|NOT COMPLETED|Overall Study||6
6786355|NCT00851747|7716857|FG001|NOT COMPLETED|Overall Study||6
6786356|NCT00851747|7716858|FG002|NOT COMPLETED|Overall Study||6
6786357|NCT00852241|7716865|FG000|STARTED|Overall Study||18
6786358|NCT00852241|7716865|FG000|COMPLETED|Overall Study||0
6786359|NCT00852241|7716865|FG000|NOT COMPLETED|Overall Study||18
6786360|NCT00851552|7716869|FG000|STARTED|Overall Study||9
6786361|NCT00851552|7716869|FG000|COMPLETED|Overall Study||2
6786362|NCT00851552|7716869|FG000|NOT COMPLETED|Overall Study||7
6786363|NCT00850720|7716873|FG000|STARTED|Overall Study||0
6786364|NCT00850720|7716873|FG000|COMPLETED|Overall Study||0
6786365|NCT00850720|7716873|FG000|NOT COMPLETED|Overall Study||0
6786366|NCT00845845|7716879|FG000|STARTED|Overall Study||3
6786367|NCT00845845|7716880|FG001|STARTED|Overall Study||6
6786368|NCT00845845|7716879|FG000|COMPLETED|Overall Study||3
6786369|NCT00845845|7716880|FG001|COMPLETED|Overall Study||2
6786370|NCT00845845|7716879|FG000|NOT COMPLETED|Overall Study||0
6786371|NCT00845845|7716880|FG001|NOT COMPLETED|Overall Study||4
6786372|NCT00851591|7716888|FG000|STARTED|Overall Study|These 2 participants did not receive treatment.|2
6786373|NCT00851591|7716889|FG001|STARTED|Overall Study|One received treatment.|1
6786374|NCT00851591|7716888|FG000|COMPLETED|Overall Study||0
6786375|NCT00851591|7716889|FG001|COMPLETED|Overall Study||1
6786376|NCT00851591|7716888|FG000|NOT COMPLETED|Overall Study||2
6786377|NCT00851591|7716889|FG001|NOT COMPLETED|Overall Study||0
6786378|NCT00847509|7716895|FG000|STARTED|Overall Study||49
6786379|NCT00847509|7716895|FG000|COMPLETED|Overall Study||38
6786380|NCT00847509|7716895|FG000|NOT COMPLETED|Overall Study||11
6786381|NCT00843310|7716899|FG000|STARTED|Overall Study||8
6786382|NCT00843310|7716899|FG000|COMPLETED|Overall Study||1
6786383|NCT00843310|7716899|FG000|NOT COMPLETED|Overall Study||7
6786384|NCT00847002|7716905|FG000|STARTED|Overall Study||4
6786385|NCT00847002|7716906|FG001|STARTED|Overall Study||4
6786386|NCT00847002|7716905|FG000|COMPLETED|Overall Study||4
6786387|NCT00847002|7716906|FG001|COMPLETED|Overall Study||4
6786388|NCT00847002|7716905|FG000|NOT COMPLETED|Overall Study||0
6786389|NCT00847002|7716906|FG001|NOT COMPLETED|Overall Study||0
6786390|NCT00845702|7716912|FG000|STARTED|TOF MRA||33
6786391|NCT00845702|7716912|FG000|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
6786392|NCT00845702|7716912|FG000|NOT COMPLETED|TOF MRA||1
6786393|NCT00845702|7716912|FG000|STARTED|Dotarem MRA||32
6786394|NCT00845702|7716912|FG000|COMPLETED|Dotarem MRA||32
6786395|NCT00845702|7716912|FG000|NOT COMPLETED|Dotarem MRA||0
6786396|NCT00843830|7716918|FG000|STARTED|Overall Study||4
6786397|NCT00843830|7716918|FG000|COMPLETED|Overall Study||4
6786398|NCT00843830|7716918|FG000|NOT COMPLETED|Overall Study||0
6786399|NCT00835679|7716926|FG000|STARTED|Overall Study||9
6786400|NCT00835679|7716927|FG001|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
6786401|NCT00835679|7716928|FG002|STARTED|Overall Study||0
6786402|NCT00835679|7716929|FG003|STARTED|Overall Study||0
6786403|NCT00835679|7716926|FG000|COMPLETED|Overall Study||8
6786404|NCT00835679|7716927|FG001|COMPLETED|Overall Study||0
6786405|NCT00835679|7716928|FG002|COMPLETED|Overall Study||0
6786406|NCT00835679|7716929|FG003|COMPLETED|Overall Study||0
6786407|NCT00835679|7716926|FG000|NOT COMPLETED|Overall Study||1
6786408|NCT00835679|7716927|FG001|NOT COMPLETED|Overall Study||0
6786409|NCT00835679|7716928|FG002|NOT COMPLETED|Overall Study||0
6786410|NCT00835679|7716929|FG003|NOT COMPLETED|Overall Study||0
6786411|NCT00841035|7716943|FG000|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
6786412|NCT00841035|7716943|FG000|COMPLETED|Phase 1 Overall Study||6
6378515|NCT00768560|7289077|FG002|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
6378516|NCT00768560|7289078|FG003|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
6378517|NCT00768560|7289079|FG004|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
6378518|NCT00768560|7289080|FG005|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
6378519|NCT00768560|7289075|FG000|COMPLETED|Intervention Set 1||5
6378520|NCT00768560|7289076|FG001|COMPLETED|Intervention Set 1||5
6378521|NCT00768560|7289077|FG002|COMPLETED|Intervention Set 1||6
6378522|NCT00768560|7289078|FG003|COMPLETED|Intervention Set 1||6
6378523|NCT00768560|7289079|FG004|COMPLETED|Intervention Set 1||6
6378524|NCT00768560|7289080|FG005|COMPLETED|Intervention Set 1||6
6378525|NCT00768560|7289075|FG000|NOT COMPLETED|Intervention Set 1||0
6378526|NCT00768560|7289076|FG001|NOT COMPLETED|Intervention Set 1||1
6378527|NCT00768560|7289077|FG002|NOT COMPLETED|Intervention Set 1||0
6378528|NCT00768560|7289078|FG003|NOT COMPLETED|Intervention Set 1||0
6378529|NCT00768560|7289079|FG004|NOT COMPLETED|Intervention Set 1||0
6378530|NCT00768560|7289080|FG005|NOT COMPLETED|Intervention Set 1||0
6378531|NCT00768560|7289075|FG000|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
6656293|NCT02459665|7586430|FG003|Month 1 Visit|Overall Study||16
6656294|NCT02459665|7586427|FG000|Month 2 Visit|Overall Study||17
6656295|NCT02459665|7586428|FG001|Month 2 Visit|Overall Study||16
6656296|NCT02459665|7586429|FG002|Month 2 Visit|Overall Study||17
6656297|NCT02459665|7586430|FG003|Month 2 Visit|Overall Study||16
6656298|NCT02459665|7586427|FG000|Month 6 Visit|Overall Study||17
6656299|NCT02459665|7586428|FG001|Month 6 Visit|Overall Study||16
6656300|NCT02459665|7586429|FG002|Month 6 Visit|Overall Study||16
6656301|NCT02459665|7586430|FG003|Month 6 Visit|Overall Study||15
6656302|NCT02459665|7586427|FG000|COMPLETED|Overall Study||17
6656303|NCT02459665|7586428|FG001|COMPLETED|Overall Study||16
6656304|NCT02459665|7586429|FG002|COMPLETED|Overall Study||16
6378532|NCT00768560|7289076|FG001|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
6786413|NCT00841035|7716943|FG000|NOT COMPLETED|Phase 1 Overall Study||13
6786414|NCT00841035|7716943|FG000|STARTED|Phase 2 of Overall Study||6
6786415|NCT00841035|7716943|FG000|COMPLETED|Phase 2 of Overall Study||6
6786416|NCT00841035|7716943|FG000|NOT COMPLETED|Phase 2 of Overall Study||0
6786417|NCT00832520|7716948|FG000|STARTED|Overall Study||13
6786418|NCT00832520|7716948|FG000|COMPLETED|Overall Study||13
6378533|NCT00768560|7289077|FG002|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
6378534|NCT00768560|7289078|FG003|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
6378535|NCT00768560|7289079|FG004|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
6378536|NCT00768560|7289080|FG005|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
6786419|NCT00832520|7716948|FG000|NOT COMPLETED|Overall Study||0
6786420|NCT00833859|7716952|FG000|STARTED|Overall Study||2
6786421|NCT00833859|7716952|FG000|COMPLETED|Overall Study||2
6786422|NCT00833859|7716952|FG000|NOT COMPLETED|Overall Study||0
6786423|NCT00843050|7716956|FG000|STARTED|Overall Study||13
6786424|NCT00843050|7716956|FG000|COMPLETED|Overall Study||0
6786425|NCT00843050|7716956|FG000|NOT COMPLETED|Overall Study||13
6786426|NCT00840827|7716961|FG000|STARTED|Overall Study||6
6786427|NCT00840827|7716961|FG000|COMPLETED|Overall Study||0
6786428|NCT00840827|7716961|FG000|NOT COMPLETED|Overall Study||6
6786429|NCT00835328|7716969|FG000|STARTED|Cohort 1: Dose Level 1||5
6786430|NCT00835328|7716970|FG001|STARTED|Cohort 1: Dose Level 1||0
6786431|NCT00835328|7716971|FG002|STARTED|Cohort 1: Dose Level 1||0
6786432|NCT00835328|7716972|FG003|STARTED|Cohort 1: Dose Level 1||0
6786433|NCT00835328|7716969|FG000|COMPLETED|Cohort 1: Dose Level 1||5
6786434|NCT00835328|7716970|FG001|COMPLETED|Cohort 1: Dose Level 1||0
6786435|NCT00835328|7716971|FG002|COMPLETED|Cohort 1: Dose Level 1||0
6786436|NCT00835328|7716972|FG003|COMPLETED|Cohort 1: Dose Level 1||0
6786437|NCT00835328|7716969|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||0
6786438|NCT00835328|7716970|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
6786439|NCT00835328|7716971|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
6786440|NCT00835328|7716972|FG003|NOT COMPLETED|Cohort 1: Dose Level 1||0
6786441|NCT00835328|7716969|FG000|STARTED|Cohort 2: Dose Level 2||0
6786442|NCT00835328|7716970|FG001|STARTED|Cohort 2: Dose Level 2||2
6786443|NCT00835328|7716971|FG002|STARTED|Cohort 2: Dose Level 2||0
6786444|NCT00835328|7716972|FG003|STARTED|Cohort 2: Dose Level 2||0
6786445|NCT00835328|7716969|FG000|COMPLETED|Cohort 2: Dose Level 2||0
6786446|NCT00835328|7716970|FG001|COMPLETED|Cohort 2: Dose Level 2||2
6786447|NCT00835328|7716971|FG002|COMPLETED|Cohort 2: Dose Level 2||0
6786448|NCT00835328|7716972|FG003|COMPLETED|Cohort 2: Dose Level 2||0
6786449|NCT00835328|7716969|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
6786450|NCT00835328|7716970|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||0
6786451|NCT00835328|7716971|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
6786452|NCT00835328|7716972|FG003|NOT COMPLETED|Cohort 2: Dose Level 2||0
6786453|NCT00835328|7716969|FG000|STARTED|Cohort 3: Dose Level 3||0
6786454|NCT00835328|7716970|FG001|STARTED|Cohort 3: Dose Level 3||0
6786455|NCT00835328|7716971|FG002|STARTED|Cohort 3: Dose Level 3||2
6786456|NCT00835328|7716972|FG003|STARTED|Cohort 3: Dose Level 3||0
6786457|NCT00835328|7716969|FG000|COMPLETED|Cohort 3: Dose Level 3||0
6786458|NCT00835328|7716970|FG001|COMPLETED|Cohort 3: Dose Level 3||0
6786459|NCT00835328|7716971|FG002|COMPLETED|Cohort 3: Dose Level 3||2
6786460|NCT00835328|7716972|FG003|COMPLETED|Cohort 3: Dose Level 3||0
6786461|NCT00835328|7716969|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
6786462|NCT00835328|7716970|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
6786463|NCT00835328|7716971|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||0
6786464|NCT00835328|7716972|FG003|NOT COMPLETED|Cohort 3: Dose Level 3||0
6786465|NCT00835328|7716969|FG000|STARTED|Cohort 4: Dose Level 4|Cohort#4 enrolled 4 subsequent subjects|0
6786466|NCT00835328|7716970|FG001|STARTED|Cohort 4: Dose Level 4||0
6786467|NCT00835328|7716971|FG002|STARTED|Cohort 4: Dose Level 4||0
6786468|NCT00835328|7716972|FG003|STARTED|Cohort 4: Dose Level 4||4
6786469|NCT00835328|7716969|FG000|COMPLETED|Cohort 4: Dose Level 4||0
6786470|NCT00835328|7716970|FG001|COMPLETED|Cohort 4: Dose Level 4||0
6786471|NCT00835328|7716971|FG002|COMPLETED|Cohort 4: Dose Level 4||0
6786472|NCT00835328|7716972|FG003|COMPLETED|Cohort 4: Dose Level 4||4
6786473|NCT00835328|7716969|FG000|NOT COMPLETED|Cohort 4: Dose Level 4||0
6786474|NCT00835328|7716970|FG001|NOT COMPLETED|Cohort 4: Dose Level 4||0
6786475|NCT00835328|7716971|FG002|NOT COMPLETED|Cohort 4: Dose Level 4||0
6786476|NCT00835328|7716972|FG003|NOT COMPLETED|Cohort 4: Dose Level 4||0
6786477|NCT00832572|7716986|FG000|STARTED|Period 1||3
6786478|NCT00832572|7716987|FG001|STARTED|Period 1||2
6786479|NCT00832572|7716986|FG000|COMPLETED|Period 1||3
6786480|NCT00832572|7716987|FG001|COMPLETED|Period 1||2
6786481|NCT00832572|7716986|FG000|NOT COMPLETED|Period 1||0
6786482|NCT00832572|7716987|FG001|NOT COMPLETED|Period 1||0
6786483|NCT00832572|7716986|FG000|STARTED|Period 2||3
6786484|NCT00832572|7716987|FG001|STARTED|Period 2||2
6786485|NCT00832572|7716986|FG000|COMPLETED|Period 2||3
6786486|NCT00832572|7716987|FG001|COMPLETED|Period 2||2
6786487|NCT00832572|7716986|FG000|NOT COMPLETED|Period 2||0
6786488|NCT00832572|7716987|FG001|NOT COMPLETED|Period 2||0
6786489|NCT00832624|7716995|FG000|STARTED|Overall Study||10
6786490|NCT00832624|7716995|FG000|COMPLETED|Overall Study||0
6786491|NCT00832624|7716995|FG000|NOT COMPLETED|Overall Study||10
6786492|NCT00832299|7716999|FG000|STARTED|Overall Study||2
6786493|NCT00832299|7716999|FG000|COMPLETED|Overall Study||2
6786494|NCT00832299|7716999|FG000|NOT COMPLETED|Overall Study||0
6786495|NCT00836355|7717007|FG000|STARTED|Overall Study||0
6786496|NCT00836355|7717008|FG001|STARTED|Overall Study||4
6786497|NCT00836355|7717009|FG002|STARTED|Overall Study||0
6786498|NCT00836355|7717010|FG003|STARTED|Overall Study||2
6786499|NCT00836355|7717007|FG000|COMPLETED|Overall Study||0
6786500|NCT00836355|7717008|FG001|COMPLETED|Overall Study||4
6786501|NCT00836355|7717009|FG002|COMPLETED|Overall Study||0
6786502|NCT00836355|7717010|FG003|COMPLETED|Overall Study||2
6786503|NCT00836355|7717007|FG000|NOT COMPLETED|Overall Study||0
6786504|NCT00836355|7717008|FG001|NOT COMPLETED|Overall Study||0
6786505|NCT00836355|7717009|FG002|NOT COMPLETED|Overall Study||0
6786506|NCT00836355|7717010|FG003|NOT COMPLETED|Overall Study||0
6786507|NCT00832598|7717020|FG000|STARTED|Overall Study||13
6786508|NCT00832598|7717020|FG000|COMPLETED|Overall Study||13
6786509|NCT00832598|7717020|FG000|NOT COMPLETED|Overall Study||0
6786510|NCT00816777|7717026|FG000|STARTED|Overall Study||2
6786511|NCT00816777|7717027|FG001|STARTED|Overall Study||2
6786512|NCT00816777|7717026|FG000|COMPLETED|Overall Study||2
6786513|NCT00816777|7717027|FG001|COMPLETED|Overall Study||2
6786514|NCT00816777|7717026|FG000|NOT COMPLETED|Overall Study||0
6786515|NCT00816777|7717027|FG001|NOT COMPLETED|Overall Study||0
6786516|NCT00823095|7717033|FG000|STARTED|Overall Study||7
6786517|NCT00823095|7717033|FG000|COMPLETED|Overall Study||7
6786518|NCT00823095|7717033|FG000|NOT COMPLETED|Overall Study||0
6786519|NCT00827567|7717038|FG000|STARTED|Overall Study||4
6786520|NCT00827567|7717038|FG000|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
6786521|NCT00827567|7717038|FG000|NOT COMPLETED|Overall Study||4
6786522|NCT00815633|7717042|FG000|STARTED|Overall Study||1
6786523|NCT00815633|7717042|FG000|COMPLETED|Overall Study||0
6786524|NCT00815633|7717042|FG000|NOT COMPLETED|Overall Study||1
6786525|NCT00814983|7717048|FG000|STARTED|Overall Study||15
6786526|NCT00814983|7717049|FG001|STARTED|Overall Study||0
6786527|NCT00814983|7717048|FG000|COMPLETED|Overall Study||12
6786528|NCT00814983|7717049|FG001|COMPLETED|Overall Study||0
6786529|NCT00814983|7717048|FG000|NOT COMPLETED|Overall Study||3
6786530|NCT00814983|7717049|FG001|NOT COMPLETED|Overall Study||0
6786531|NCT00825227|7717057|FG000|STARTED|Overall Study||6
6786532|NCT00825227|7717058|FG001|STARTED|Overall Study||4
6786533|NCT00825227|7717057|FG000|COMPLETED|Overall Study||6
6786534|NCT00825227|7717058|FG001|COMPLETED|Overall Study||4
6786535|NCT00825227|7717057|FG000|NOT COMPLETED|Overall Study||0
6786536|NCT00825227|7717058|FG001|NOT COMPLETED|Overall Study||0
6786537|NCT00819832|7717072|FG000|STARTED|Overall Study|No patient data analysis.|3
6786538|NCT00819832|7717073|FG001|STARTED|Overall Study||0
6786539|NCT00819832|7717074|FG002|STARTED|Overall Study||0
6786540|NCT00819832|7717075|FG003|STARTED|Overall Study||0
6786541|NCT00819832|7717076|FG004|STARTED|Overall Study||0
6786542|NCT00819832|7717077|FG005|STARTED|Overall Study||0
6786543|NCT00819832|7717072|FG000|COMPLETED|Overall Study||0
6786544|NCT00819832|7717073|FG001|COMPLETED|Overall Study||0
6786545|NCT00819832|7717074|FG002|COMPLETED|Overall Study||0
6786546|NCT00819832|7717075|FG003|COMPLETED|Overall Study||0
6786547|NCT00819832|7717076|FG004|COMPLETED|Overall Study||0
6786548|NCT00819832|7717077|FG005|COMPLETED|Overall Study||0
6786549|NCT00819832|7717072|FG000|NOT COMPLETED|Overall Study||3
6786550|NCT00819832|7717073|FG001|NOT COMPLETED|Overall Study||0
6786551|NCT00819832|7717074|FG002|NOT COMPLETED|Overall Study||0
6786552|NCT00819832|7717075|FG003|NOT COMPLETED|Overall Study||0
6786553|NCT00819832|7717076|FG004|NOT COMPLETED|Overall Study||0
6786554|NCT00819832|7717077|FG005|NOT COMPLETED|Overall Study||0
6786555|NCT00822679|7717093|FG000|STARTED|Overall Study||0
6786556|NCT00822679|7717094|FG001|STARTED|Overall Study||0
6786557|NCT00822679|7717093|FG000|COMPLETED|Overall Study||0
6786558|NCT00822679|7717094|FG001|COMPLETED|Overall Study||0
6786559|NCT00822679|7717093|FG000|NOT COMPLETED|Overall Study||0
6786560|NCT00822679|7717094|FG001|NOT COMPLETED|Overall Study||0
6786561|NCT00814892|7717100|FG000|STARTED|Overall Study||2
6786562|NCT00814892|7717100|FG000|COMPLETED|Overall Study||0
6786563|NCT00814892|7717100|FG000|NOT COMPLETED|Overall Study||2
6786564|NCT00809458|7717106|FG000|STARTED|Overall Study||9
6786565|NCT00809458|7717107|FG001|STARTED|Overall Study||6
6786566|NCT00809458|7717106|FG000|COMPLETED|Overall Study||8
6786567|NCT00809458|7717107|FG001|COMPLETED|Overall Study||5
6786568|NCT00809458|7717106|FG000|NOT COMPLETED|Overall Study||1
6786569|NCT00809458|7717107|FG001|NOT COMPLETED|Overall Study||1
6786570|NCT00802659|7717117|FG000|STARTED|Overall Study||0
6786571|NCT00802659|7717118|FG001|STARTED|Overall Study||2
6786572|NCT00802659|7717119|FG002|STARTED|Overall Study||0
6786573|NCT00802659|7717120|FG003|STARTED|Overall Study||0
6786574|NCT00802659|7717117|FG000|COMPLETED|Overall Study||0
6786575|NCT00802659|7717118|FG001|COMPLETED|Overall Study||1
6786576|NCT00802659|7717119|FG002|COMPLETED|Overall Study||0
6786577|NCT00802659|7717120|FG003|COMPLETED|Overall Study||0
6786578|NCT00802659|7717117|FG000|NOT COMPLETED|Overall Study||0
6786579|NCT00802659|7717118|FG001|NOT COMPLETED|Overall Study||1
6786580|NCT00802659|7717119|FG002|NOT COMPLETED|Overall Study||0
6786581|NCT00802659|7717120|FG003|NOT COMPLETED|Overall Study||0
6786582|NCT00807365|7717130|FG000|STARTED|Overall Study||5
6786583|NCT00807365|7717130|FG000|COMPLETED|Overall Study||0
6786584|NCT00807365|7717130|FG000|NOT COMPLETED|Overall Study||5
6786585|NCT00814333|7717136|FG000|STARTED|Enrollment||1
6786586|NCT00814333|7717137|FG001|STARTED|Enrollment||0
6786587|NCT00814333|7717136|FG000|COMPLETED|Enrollment||0
6786588|NCT00814333|7717137|FG001|COMPLETED|Enrollment||0
6786589|NCT00814333|7717136|FG000|NOT COMPLETED|Enrollment||1
6786590|NCT00814333|7717137|FG001|NOT COMPLETED|Enrollment||0
6786591|NCT00814333|7717136|FG000|STARTED|Treatment Period||0
6786592|NCT00814333|7717137|FG001|STARTED|Treatment Period||0
6786593|NCT00814333|7717136|FG000|COMPLETED|Treatment Period||0
6786594|NCT00814333|7717137|FG001|COMPLETED|Treatment Period||0
6786595|NCT00814333|7717136|FG000|NOT COMPLETED|Treatment Period||0
6786596|NCT00814333|7717137|FG001|NOT COMPLETED|Treatment Period||0
6786597|NCT00808080|7717143|FG000|STARTED|Overall Study||6
6786598|NCT00808080|7717143|FG000|COMPLETED|Overall Study||0
6786599|NCT00808080|7717143|FG000|NOT COMPLETED|Overall Study||6
6786600|NCT00802893|7717148|FG000|STARTED|Overall Study||3
6786601|NCT00802893|7717148|FG000|COMPLETED|Overall Study||0
6786602|NCT00802893|7717148|FG000|NOT COMPLETED|Overall Study||3
6786603|NCT00809341|7717154|FG000|STARTED|Overall Study||20
6786604|NCT00809341|7717155|FG001|STARTED|Overall Study||5
6786605|NCT00809341|7717154|FG000|COMPLETED|Overall Study||20
6786606|NCT00809341|7717155|FG001|COMPLETED|Overall Study||4
6786607|NCT00809341|7717154|FG000|NOT COMPLETED|Overall Study||0
6786608|NCT00809341|7717155|FG001|NOT COMPLETED|Overall Study||1
6786609|NCT00804349|7717163|FG000|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available.|0
6786610|NCT00804349|7717164|FG001|STARTED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
6786611|NCT00804349|7717163|FG000|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
6786612|NCT00804349|7717164|FG001|COMPLETED|Overall Study|0 analyzed PI no longer at institution;PI contacted, information not added; No data available|0
6786613|NCT00804349|7717163|FG000|NOT COMPLETED|Overall Study||0
6786614|NCT00804349|7717164|FG001|NOT COMPLETED|Overall Study||0
6786615|NCT00803283|7717172|FG000|STARTED|Overall Study||1
6786616|NCT00803283|7717173|FG001|STARTED|Overall Study||1
6786617|NCT00803283|7717172|FG000|COMPLETED|Overall Study||1
6786618|NCT00803283|7717173|FG001|COMPLETED|Overall Study||1
6786619|NCT00803283|7717172|FG000|NOT COMPLETED|Overall Study||0
6786620|NCT00803283|7717173|FG001|NOT COMPLETED|Overall Study||0
6786621|NCT00811590|7717179|FG000|STARTED|Overall Study||3
6786622|NCT00811590|7717179|FG000|COMPLETED|Overall Study||3
6786623|NCT00811590|7717179|FG000|NOT COMPLETED|Overall Study||0
6786624|NCT00808899|7717183|FG000|STARTED|Overall Study||4
6786625|NCT00808899|7717183|FG000|COMPLETED|Overall Study||0
6786626|NCT00808899|7717183|FG000|NOT COMPLETED|Overall Study||4
6786627|NCT00808769|7717187|FG000|STARTED|First Intervention||15
6786628|NCT00808769|7717188|FG001|STARTED|First Intervention||15
6786629|NCT00808769|7717187|FG000|COMPLETED|First Intervention||15
6786630|NCT00808769|7717188|FG001|COMPLETED|First Intervention||15
6786631|NCT00808769|7717187|FG000|NOT COMPLETED|First Intervention||0
6786632|NCT00808769|7717188|FG001|NOT COMPLETED|First Intervention||0
6786633|NCT00808769|7717187|FG000|STARTED|Second Intervention||15
6786634|NCT00808769|7717188|FG001|STARTED|Second Intervention||15
6786635|NCT00808769|7717187|FG000|COMPLETED|Second Intervention||15
6786636|NCT00808769|7717188|FG001|COMPLETED|Second Intervention||15
6786637|NCT00808769|7717187|FG000|NOT COMPLETED|Second Intervention||0
6786638|NCT00808769|7717188|FG001|NOT COMPLETED|Second Intervention||0
6786639|NCT00803179|7717194|FG000|STARTED|Overall Study||5
6786640|NCT00803179|7717194|FG000|COMPLETED|Overall Study||2
6786641|NCT00803179|7717194|FG000|NOT COMPLETED|Overall Study||3
6786642|NCT00801931|7717198|FG000|STARTED|Overall Study||1
6786643|NCT00801931|7717198|FG000|COMPLETED|Overall Study||1
6786644|NCT00801931|7717198|FG000|NOT COMPLETED|Overall Study||0
6786645|NCT00793520|7717204|FG000|STARTED|Milnacipran Crossover to Placebo||1
6786646|NCT00793520|7717205|FG001|STARTED|Milnacipran Crossover to Placebo||0
6786647|NCT00793520|7717204|FG000|COMPLETED|Milnacipran Crossover to Placebo||0
6786648|NCT00793520|7717205|FG001|COMPLETED|Milnacipran Crossover to Placebo||0
6786649|NCT00793520|7717204|FG000|NOT COMPLETED|Milnacipran Crossover to Placebo||1
6786650|NCT00793520|7717205|FG001|NOT COMPLETED|Milnacipran Crossover to Placebo||0
6786651|NCT00793520|7717204|FG000|STARTED|Placebo Crossover to Milnacipran||0
6786652|NCT00793520|7717205|FG001|STARTED|Placebo Crossover to Milnacipran||1
6786653|NCT00793520|7717204|FG000|COMPLETED|Placebo Crossover to Milnacipran||0
6786654|NCT00793520|7717205|FG001|COMPLETED|Placebo Crossover to Milnacipran||0
6786655|NCT00793520|7717204|FG000|NOT COMPLETED|Placebo Crossover to Milnacipran||0
6786656|NCT00793520|7717205|FG001|NOT COMPLETED|Placebo Crossover to Milnacipran||1
6786657|NCT00795236|7717213|FG000|STARTED|Overall Study||0
6786658|NCT00795236|7717214|FG001|STARTED|Overall Study||0
6786659|NCT00795236|7717213|FG000|COMPLETED|Overall Study|Unable to consistently obtain saliva DLMO in subjects and thus couldn't measure circadian period|0
6786660|NCT00795236|7717214|FG001|COMPLETED|Overall Study||0
6786661|NCT00795236|7717213|FG000|NOT COMPLETED|Overall Study||0
6786662|NCT00795236|7717214|FG001|NOT COMPLETED|Overall Study||0
6786663|NCT00799773|7717224|FG000|STARTED|Overall Study||2
6786664|NCT00799773|7717225|FG001|STARTED|Overall Study||1
6786665|NCT00799773|7717224|FG000|COMPLETED|Overall Study||2
6786666|NCT00799773|7717225|FG001|COMPLETED|Overall Study||1
6786667|NCT00799773|7717224|FG000|NOT COMPLETED|Overall Study||0
6786668|NCT00799773|7717225|FG001|NOT COMPLETED|Overall Study||0
6786669|NCT00790452|7717233|FG000|STARTED|Overall Study||1
6786670|NCT00790452|7717234|FG001|STARTED|Overall Study||0
6786671|NCT00790452|7717233|FG000|COMPLETED|Overall Study||0
6786672|NCT00790452|7717234|FG001|COMPLETED|Overall Study||0
6786673|NCT00790452|7717233|FG000|NOT COMPLETED|Overall Study||1
6786674|NCT00790452|7717234|FG001|NOT COMPLETED|Overall Study||0
6786675|NCT00795665|7717240|FG000|STARTED|Overall Study||7
6786676|NCT00795665|7717240|FG000|COMPLETED|Overall Study||7
6786677|NCT00795665|7717240|FG000|NOT COMPLETED|Overall Study||0
6786678|NCT00787917|7717246|FG000|STARTED|Blinded Treatment||9
6786679|NCT00787917|7717247|FG001|STARTED|Blinded Treatment||5
6786680|NCT00787917|7717246|FG000|COMPLETED|Blinded Treatment||4
6786681|NCT00787917|7717247|FG001|COMPLETED|Blinded Treatment||3
6786682|NCT00787917|7717246|FG000|NOT COMPLETED|Blinded Treatment||5
6786683|NCT00787917|7717247|FG001|NOT COMPLETED|Blinded Treatment||2
6786684|NCT00787917|7717246|FG000|STARTED|Open Label||7
6786685|NCT00787917|7717247|FG001|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
6786686|NCT00787917|7717246|FG000|COMPLETED|Open Label||3
6786687|NCT00787917|7717247|FG001|COMPLETED|Open Label||0
6786688|NCT00787917|7717246|FG000|NOT COMPLETED|Open Label||4
6786689|NCT00787917|7717247|FG001|NOT COMPLETED|Open Label||0
6786690|NCT00798590|7717257|FG000|STARTED|Overall Study||11
6786691|NCT00798590|7717258|FG001|STARTED|Overall Study||8
6786692|NCT00798590|7717257|FG000|COMPLETED|Overall Study||0
6786693|NCT00798590|7717258|FG001|COMPLETED|Overall Study||0
6786694|NCT00798590|7717257|FG000|NOT COMPLETED|Overall Study||11
6786695|NCT00798590|7717258|FG001|NOT COMPLETED|Overall Study||8
6786696|NCT00796510|7717266|FG000|STARTED|Overall Study||3
6786697|NCT00796510|7717267|FG001|STARTED|Overall Study||0
6786698|NCT00796510|7717266|FG000|COMPLETED|Overall Study||0
6786699|NCT00796510|7717267|FG001|COMPLETED|Overall Study||0
6786700|NCT00796510|7717266|FG000|NOT COMPLETED|Overall Study||3
6786701|NCT00796510|7717267|FG001|NOT COMPLETED|Overall Study||0
6786702|NCT00796861|7717273|FG000|STARTED|Overall Study||4
6786703|NCT00796861|7717273|FG000|COMPLETED|Overall Study||0
6786704|NCT00796861|7717273|FG000|NOT COMPLETED|Overall Study||4
6786705|NCT00791076|7717277|FG000|STARTED|Overall Study||8
6786706|NCT00791076|7717277|FG000|COMPLETED|Overall Study||0
6786707|NCT00791076|7717277|FG000|NOT COMPLETED|Overall Study||8
6786708|NCT00790478|7717285|FG000|STARTED|Overall Study||0
6786709|NCT00790478|7717286|FG001|STARTED|Overall Study||0
6786710|NCT00790478|7717285|FG000|COMPLETED|Overall Study||0
6786711|NCT00790478|7717286|FG001|COMPLETED|Overall Study||0
6786712|NCT00790478|7717285|FG000|NOT COMPLETED|Overall Study||0
6563158|NCT01805882|7486109|FG000|NOT COMPLETED|Overall Study||0
6563159|NCT01805882|7486110|FG001|NOT COMPLETED|Overall Study||0
6563160|NCT01805882|7486111|FG002|NOT COMPLETED|Overall Study||1
6786713|NCT00790478|7717286|FG001|NOT COMPLETED|Overall Study||0
6563161|NCT01805882|7486112|FG003|NOT COMPLETED|Overall Study||2
6786714|NCT00796107|7717292|FG000|STARTED|Overall Study||6
6786715|NCT00796107|7717292|FG000|COMPLETED|Overall Study||0
6786716|NCT00796107|7717292|FG000|NOT COMPLETED|Overall Study||6
6786717|NCT00791336|7717296|FG000|STARTED|Overall Study||1
6786718|NCT00791336|7717296|FG000|COMPLETED|Overall Study||1
6786719|NCT00791336|7717296|FG000|NOT COMPLETED|Overall Study||0
6786720|NCT00786682|7717300|FG000|STARTED|Overall Study||11
6786721|NCT00786682|7717300|FG000|COMPLETED|Overall Study||11
6786722|NCT00786682|7717300|FG000|NOT COMPLETED|Overall Study||0
6786723|NCT00787124|7717306|FG000|STARTED|Overall Study||4
6786724|NCT00787124|7717307|FG001|STARTED|Overall Study||4
6563162|NCT01805882|7486113|FG004|NOT COMPLETED|Overall Study||0
6786725|NCT00787124|7717306|FG000|COMPLETED|Overall Study||4
6786726|NCT00787124|7717307|FG001|COMPLETED|Overall Study||4
6786727|NCT00787124|7717306|FG000|NOT COMPLETED|Overall Study||0
6786728|NCT00787124|7717307|FG001|NOT COMPLETED|Overall Study||0
6786729|NCT00785356|7717316|FG000|STARTED|Overall Study||8
6786730|NCT00785356|7717316|FG000|COMPLETED|Overall Study||0
6786731|NCT00785356|7717316|FG000|NOT COMPLETED|Overall Study||8
6786732|NCT00782483|7717324|FG000|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
6786733|NCT00782483|7717324|FG000|COMPLETED|Overall Study||0
6786734|NCT00782483|7717324|FG000|NOT COMPLETED|Overall Study||6
6786735|NCT00791843|7717328|FG000|STARTED|Overall Study|Data unavailable for the study|0
6786736|NCT00791843|7717328|FG000|COMPLETED|Overall Study|Data unavailable for the study|0
6786737|NCT00791843|7717328|FG000|NOT COMPLETED|Overall Study||0
6786738|NCT00784043|7717334|FG000|STARTED|Overall Study||31
6786739|NCT00784043|7717335|FG001|STARTED|Overall Study||6
6786740|NCT00784043|7717334|FG000|COMPLETED|Overall Study||0
6786741|NCT00784043|7717335|FG001|COMPLETED|Overall Study||0
6786742|NCT00784043|7717334|FG000|NOT COMPLETED|Overall Study||31
6786743|NCT00784043|7717335|FG001|NOT COMPLETED|Overall Study||6
6786744|NCT00787618|7717344|FG000|STARTED|Overall Study||3
6786745|NCT00787618|7717345|FG001|STARTED|Overall Study||0
6786746|NCT00787618|7717346|FG002|STARTED|Overall Study||3
6786747|NCT00787618|7717344|FG000|COMPLETED|Overall Study||3
6786748|NCT00787618|7717345|FG001|COMPLETED|Overall Study||0
6786749|NCT00787618|7717346|FG002|COMPLETED|Overall Study||3
6786750|NCT00787618|7717344|FG000|NOT COMPLETED|Overall Study||0
6786751|NCT00787618|7717345|FG001|NOT COMPLETED|Overall Study||0
6786752|NCT00787618|7717346|FG002|NOT COMPLETED|Overall Study||0
6786753|NCT00774306|7717358|FG000|STARTED|Overall Study||24
6786754|NCT00774306|7717359|FG001|STARTED|Overall Study||5
6786755|NCT00774306|7717360|FG002|STARTED|Overall Study||16
6786756|NCT00774306|7717361|FG003|STARTED|Overall Study||7
6786757|NCT00774306|7717358|FG000|COMPLETED|Overall Study||6
6786758|NCT00774306|7717359|FG001|COMPLETED|Overall Study||3
6786759|NCT00774306|7717360|FG002|COMPLETED|Overall Study||8
6786760|NCT00774306|7717361|FG003|COMPLETED|Overall Study||2
6786761|NCT00774306|7717358|FG000|NOT COMPLETED|Overall Study||18
6786762|NCT00774306|7717359|FG001|NOT COMPLETED|Overall Study||2
6786763|NCT00774306|7717360|FG002|NOT COMPLETED|Overall Study||8
6786764|NCT00774306|7717361|FG003|NOT COMPLETED|Overall Study||5
6786765|NCT00771602|7717374|FG000|STARTED|Overall Study||1
6786766|NCT00771602|7717375|FG001|STARTED|Overall Study||0
6786767|NCT00771602|7717376|FG002|STARTED|Overall Study||0
6786768|NCT00771602|7717374|FG000|COMPLETED|Overall Study||1
6786769|NCT00771602|7717375|FG001|COMPLETED|Overall Study||0
6786770|NCT00771602|7717376|FG002|COMPLETED|Overall Study||0
6786771|NCT00771602|7717374|FG000|NOT COMPLETED|Overall Study||0
6786772|NCT00771602|7717375|FG001|NOT COMPLETED|Overall Study||0
6786773|NCT00771602|7717376|FG002|NOT COMPLETED|Overall Study||0
6786774|NCT00779038|7717384|FG000|STARTED|Overall Study||13
6786775|NCT00779038|7717384|FG000|COMPLETED|Overall Study||0
6786776|NCT00779038|7717384|FG000|NOT COMPLETED|Overall Study||13
6786777|NCT00780455|7717390|FG000|STARTED|Overall Study||2
6786778|NCT00780455|7717391|FG001|STARTED|Overall Study||2
6786779|NCT00780455|7717390|FG000|COMPLETED|Overall Study||2
6786780|NCT00780455|7717391|FG001|COMPLETED|Overall Study||2
6786781|NCT00780455|7717390|FG000|NOT COMPLETED|Overall Study||0
6786782|NCT00780455|7717391|FG001|NOT COMPLETED|Overall Study||0
6786783|NCT00776100|7717399|FG000|STARTED|Overall Study||1
6786784|NCT00776100|7717400|FG001|STARTED|Overall Study||1
6786785|NCT00776100|7717399|FG000|COMPLETED|Overall Study||0
6786786|NCT00776100|7717400|FG001|COMPLETED|Overall Study||1
6786787|NCT00776100|7717399|FG000|NOT COMPLETED|Overall Study||1
6786788|NCT00776100|7717400|FG001|NOT COMPLETED|Overall Study||0
6786789|NCT00771316|7717408|FG000|STARTED|Overall Study||4
6786790|NCT00771316|7717409|FG001|STARTED|Overall Study||2
6786791|NCT00771316|7717408|FG000|COMPLETED|Overall Study||2
6786792|NCT00771316|7717409|FG001|COMPLETED|Overall Study||1
6786793|NCT00771316|7717408|FG000|NOT COMPLETED|Overall Study||2
6786794|NCT00771316|7717409|FG001|NOT COMPLETED|Overall Study||1
6786795|NCT00780481|7717415|FG000|STARTED|Overall Study||13
6786796|NCT00780481|7717415|FG000|COMPLETED|Overall Study||13
6786797|NCT00780481|7717415|FG000|NOT COMPLETED|Overall Study||0
6786798|NCT00769652|7717421|FG000|STARTED|Overall Study||6
6786799|NCT00769652|7717422|FG001|STARTED|Overall Study||1
6786800|NCT00769652|7717421|FG000|COMPLETED|Overall Study||6
6786801|NCT00769652|7717422|FG001|COMPLETED|Overall Study||1
6786802|NCT00769652|7717421|FG000|NOT COMPLETED|Overall Study||0
6786803|NCT00769652|7717422|FG001|NOT COMPLETED|Overall Study||0
6786804|NCT00768040|7717430|FG000|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
6786805|NCT00768040|7717431|FG001|STARTED|Overall Study||19
6786806|NCT00768040|7717430|FG000|COMPLETED|Overall Study||16
6786807|NCT00768040|7717431|FG001|COMPLETED|Overall Study||16
6786808|NCT00768040|7717430|FG000|NOT COMPLETED|Overall Study||4
6786809|NCT00768040|7717431|FG001|NOT COMPLETED|Overall Study||3
6786810|NCT00776555|7717439|FG000|STARTED|Overall Study||3
6786811|NCT00776555|7717440|FG001|STARTED|Overall Study||0
6786812|NCT00776555|7717439|FG000|COMPLETED|Overall Study||0
6786813|NCT00776555|7717440|FG001|COMPLETED|Overall Study||0
6786814|NCT00776555|7717439|FG000|NOT COMPLETED|Overall Study||3
6786815|NCT00776555|7717440|FG001|NOT COMPLETED|Overall Study||0
6786816|NCT00775190|7717448|FG000|STARTED|Overall Study||7
6786817|NCT00775190|7717449|FG001|STARTED|Overall Study||5
6786818|NCT00775190|7717448|FG000|COMPLETED|Overall Study||3
6786819|NCT00775190|7717449|FG001|COMPLETED|Overall Study||0
6786820|NCT00775190|7717448|FG000|NOT COMPLETED|Overall Study||4
6786821|NCT00775190|7717449|FG001|NOT COMPLETED|Overall Study||5
6378537|NCT00768560|7289075|FG000|COMPLETED|Intervention Set 2||5
6378538|NCT00768560|7289076|FG001|COMPLETED|Intervention Set 2||5
6378539|NCT00768560|7289077|FG002|COMPLETED|Intervention Set 2||6
6378540|NCT00768560|7289078|FG003|COMPLETED|Intervention Set 2||6
6378541|NCT00768560|7289079|FG004|COMPLETED|Intervention Set 2||6
6378542|NCT00768560|7289080|FG005|COMPLETED|Intervention Set 2||6
6378543|NCT00768560|7289075|FG000|NOT COMPLETED|Intervention Set 2||0
6378544|NCT00768560|7289076|FG001|NOT COMPLETED|Intervention Set 2||0
6563163|NCT01805882|7486114|FG005|NOT COMPLETED|Overall Study||1
6563164|NCT01805882|7486115|FG006|NOT COMPLETED|Overall Study||2
6378545|NCT00768560|7289077|FG002|NOT COMPLETED|Intervention Set 2||0
6378546|NCT00768560|7289078|FG003|NOT COMPLETED|Intervention Set 2||0
6378547|NCT00768560|7289079|FG004|NOT COMPLETED|Intervention Set 2||0
6378548|NCT00768560|7289080|FG005|NOT COMPLETED|Intervention Set 2||0
6378549|NCT00768560|7289075|FG000|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
6378550|NCT00768560|7289076|FG001|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
6378551|NCT00768560|7289077|FG002|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
6378552|NCT00768560|7289078|FG003|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
6378553|NCT00768560|7289079|FG004|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
6378554|NCT00768560|7289080|FG005|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
6378555|NCT00768560|7289075|FG000|COMPLETED|Intervention Set 3||5
6378556|NCT00768560|7289076|FG001|COMPLETED|Intervention Set 3||5
6378557|NCT00768560|7289077|FG002|COMPLETED|Intervention Set 3||6
6378558|NCT00768560|7289078|FG003|COMPLETED|Intervention Set 3||6
6378559|NCT00768560|7289079|FG004|COMPLETED|Intervention Set 3||6
6378560|NCT00768560|7289080|FG005|COMPLETED|Intervention Set 3||6
6378561|NCT00768560|7289075|FG000|NOT COMPLETED|Intervention Set 3||0
6378562|NCT00768560|7289076|FG001|NOT COMPLETED|Intervention Set 3||0
6378563|NCT00768560|7289077|FG002|NOT COMPLETED|Intervention Set 3||0
6378564|NCT00768560|7289078|FG003|NOT COMPLETED|Intervention Set 3||0
6378565|NCT00768560|7289079|FG004|NOT COMPLETED|Intervention Set 3||0
6378566|NCT00768560|7289080|FG005|NOT COMPLETED|Intervention Set 3||0
6378567|NCT00768599|7289091|FG000|STARTED|Overall Study||45
6378568|NCT00768599|7289092|FG001|STARTED|Overall Study||43
6378569|NCT00768599|7289093|FG002|STARTED|Overall Study||47
6378570|NCT00768599|7289091|FG000|COMPLETED|Overall Study||34
6378571|NCT00768599|7289092|FG001|COMPLETED|Overall Study||27
6378572|NCT00768599|7289093|FG002|COMPLETED|Overall Study||35
6378573|NCT00768599|7289091|FG000|NOT COMPLETED|Overall Study||11
6378574|NCT00768599|7289092|FG001|NOT COMPLETED|Overall Study||16
6378575|NCT00768599|7289093|FG002|NOT COMPLETED|Overall Study||12
6378576|NCT00768651|7289101|FG000|STARTED|Overall Study||8
6378577|NCT00768651|7289101|FG000|COMPLETED|Overall Study||7
6378578|NCT00768651|7289101|FG000|NOT COMPLETED|Overall Study||1
6378579|NCT00768664|7289106|FG000|STARTED|Overall Study||69
6378580|NCT00768664|7289106|FG000|COMPLETED|Overall Study||0
6378581|NCT00768664|7289106|FG000|NOT COMPLETED|Overall Study||69
6378582|NCT00768716|7289112|FG000|STARTED|Overall Study||54
6378583|NCT00768716|7289113|FG001|STARTED|Overall Study||41
6378584|NCT00768716|7289112|FG000|COMPLETED|Overall Study||54
6378585|NCT00768716|7289113|FG001|COMPLETED|Overall Study||41
6378586|NCT00768716|7289112|FG000|NOT COMPLETED|Overall Study||0
6378587|NCT00768716|7289113|FG001|NOT COMPLETED|Overall Study||0
6378588|NCT00768755|7289126|FG000|STARTED|Phase 1||10
6786822|NCT00755261|7717455|FG000|STARTED|Overall Study||6
6786823|NCT00755261|7717455|FG000|COMPLETED|Overall Study||4
6786824|NCT00755261|7717455|FG000|NOT COMPLETED|Overall Study||2
6786825|NCT00762723|7717462|FG000|STARTED|Overall Study||5
6786826|NCT00762723|7717463|FG001|STARTED|Overall Study||11
6786827|NCT00762723|7717464|FG002|STARTED|Overall Study||3
6786828|NCT00762723|7717462|FG000|COMPLETED|Overall Study||0
6786829|NCT00762723|7717463|FG001|COMPLETED|Overall Study||6
6786830|NCT00762723|7717464|FG002|COMPLETED|Overall Study||0
6786831|NCT00762723|7717462|FG000|NOT COMPLETED|Overall Study||5
6786832|NCT00762723|7717463|FG001|NOT COMPLETED|Overall Study||5
6786833|NCT00762723|7717464|FG002|NOT COMPLETED|Overall Study||3
6786834|NCT00770965|7717476|FG000|STARTED|Safety Set||2
6786835|NCT00770965|7717477|FG001|STARTED|Safety Set||4
6786836|NCT00770965|7717478|FG002|STARTED|Safety Set||4
6786837|NCT00770965|7717479|FG003|STARTED|Safety Set||5
6786838|NCT00770965|7717476|FG000|COMPLETED|Safety Set||2
6786839|NCT00770965|7717477|FG001|COMPLETED|Safety Set||4
6786840|NCT00770965|7717478|FG002|COMPLETED|Safety Set||3
6786841|NCT00770965|7717479|FG003|COMPLETED|Safety Set||4
6786842|NCT00770965|7717476|FG000|NOT COMPLETED|Safety Set||0
6786843|NCT00770965|7717477|FG001|NOT COMPLETED|Safety Set||0
6786844|NCT00770965|7717478|FG002|NOT COMPLETED|Safety Set||1
6786845|NCT00770965|7717479|FG003|NOT COMPLETED|Safety Set||1
6786846|NCT00770965|7717476|FG000|STARTED|Excluded Set||18
6786847|NCT00770965|7717477|FG001|STARTED|Excluded Set||16
6786848|NCT00770965|7717478|FG002|STARTED|Excluded Set||16
6786849|NCT00770965|7717479|FG003|STARTED|Excluded Set||15
6786850|NCT00770965|7717476|FG000|COMPLETED|Excluded Set||3
6786851|NCT00770965|7717477|FG001|COMPLETED|Excluded Set||3
6786852|NCT00770965|7717478|FG002|COMPLETED|Excluded Set||2
6786853|NCT00770965|7717479|FG003|COMPLETED|Excluded Set||2
6786854|NCT00770965|7717476|FG000|NOT COMPLETED|Excluded Set||15
6786855|NCT00770965|7717477|FG001|NOT COMPLETED|Excluded Set||13
6786856|NCT00770965|7717478|FG002|NOT COMPLETED|Excluded Set||14
6786857|NCT00770965|7717479|FG003|NOT COMPLETED|Excluded Set||13
6786858|NCT00769002|7717493|FG000|STARTED|Overall Study||9
6786859|NCT00769002|7717494|FG001|STARTED|Overall Study||9
6786860|NCT00769002|7717493|FG000|COMPLETED|Overall Study||0
6786861|NCT00769002|7717494|FG001|COMPLETED|Overall Study||0
6786862|NCT00769002|7717493|FG000|NOT COMPLETED|Overall Study||9
6786863|NCT00769002|7717494|FG001|NOT COMPLETED|Overall Study||9
6786864|NCT00766636|7717501|FG000|STARTED|Overall Study||3
6786865|NCT00766636|7717502|FG001|STARTED|Overall Study||2
6786866|NCT00766636|7717501|FG000|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
6786867|NCT00766636|7717502|FG001|COMPLETED|Overall Study||0
6786868|NCT00766636|7717501|FG000|NOT COMPLETED|Overall Study||3
6786869|NCT00766636|7717502|FG001|NOT COMPLETED|Overall Study||2
6786870|NCT00768248|7717510|FG000|STARTED|Overall Study||1
6786871|NCT00768248|7717511|FG001|STARTED|Overall Study||1
6786872|NCT00768248|7717510|FG000|COMPLETED|Overall Study||0
6786873|NCT00768248|7717511|FG001|COMPLETED|Overall Study||0
6786874|NCT00768248|7717510|FG000|NOT COMPLETED|Overall Study||1
6786875|NCT00768248|7717511|FG001|NOT COMPLETED|Overall Study||1
6786876|NCT00765765|7717517|FG000|STARTED|Overall Study||6
6786877|NCT00765765|7717517|FG000|COMPLETED|Overall Study||6
6786878|NCT00765765|7717517|FG000|NOT COMPLETED|Overall Study||0
6786879|NCT00764699|7717521|FG000|STARTED|Overall Study||3
6786880|NCT00764699|7717521|FG000|COMPLETED|Overall Study||0
6786881|NCT00764699|7717521|FG000|NOT COMPLETED|Overall Study||3
6786882|NCT00759577|7717525|FG000|STARTED|Overall Study||36
6786883|NCT00759577|7717525|FG000|COMPLETED|Overall Study||36
6786884|NCT00759577|7717525|FG000|NOT COMPLETED|Overall Study||0
6786885|NCT00763009|7717529|FG000|STARTED|Overall Study||8
6786886|NCT00763009|7717529|FG000|COMPLETED|Overall Study||7
6786887|NCT00763009|7717529|FG000|NOT COMPLETED|Overall Study||1
6786888|NCT00761176|7717536|FG000|STARTED|Overall Study||4
6786889|NCT00761176|7717537|FG001|STARTED|Overall Study||4
6786890|NCT00761176|7717536|FG000|COMPLETED|Overall Study||2
6786891|NCT00761176|7717537|FG001|COMPLETED|Overall Study||3
6786892|NCT00761176|7717536|FG000|NOT COMPLETED|Overall Study||2
6786893|NCT00761176|7717537|FG001|NOT COMPLETED|Overall Study||1
6786894|NCT00749476|7717543|FG000|STARTED|Overall Study||1
6786895|NCT00749476|7717543|FG000|COMPLETED|Overall Study||1
6786896|NCT00749476|7717543|FG000|NOT COMPLETED|Overall Study||0
6786897|NCT00760461|7717547|FG000|STARTED|Overall Study||44
6786898|NCT00760461|7717547|FG000|COMPLETED|Overall Study||0
6786899|NCT00760461|7717547|FG000|NOT COMPLETED|Overall Study||44
6786900|NCT00749658|7717553|FG000|STARTED|Overall Study||60
6786901|NCT00749658|7717554|FG001|STARTED|Overall Study||61
6786902|NCT00749658|7717553|FG000|COMPLETED|Overall Study||60
6786903|NCT00749658|7717554|FG001|COMPLETED|Overall Study||61
6786904|NCT00749658|7717553|FG000|NOT COMPLETED|Overall Study||0
6786905|NCT00749658|7717554|FG001|NOT COMPLETED|Overall Study||0
6786906|NCT00754793|7717562|FG000|STARTED|Overall Study||1
6786907|NCT00754793|7717563|FG001|STARTED|Overall Study||2
6786908|NCT00754793|7717562|FG000|COMPLETED|Overall Study||1
6786909|NCT00754793|7717563|FG001|COMPLETED|Overall Study||1
6786910|NCT00754793|7717562|FG000|NOT COMPLETED|Overall Study||0
6786911|NCT00754793|7717563|FG001|NOT COMPLETED|Overall Study||1
6786912|NCT00754052|7717571|FG000|STARTED|Overall Study||5
6786913|NCT00754052|7717572|FG001|STARTED|Overall Study||3
6786914|NCT00754052|7717571|FG000|COMPLETED|Overall Study||0
6786915|NCT00754052|7717572|FG001|COMPLETED|Overall Study||0
6786916|NCT00754052|7717571|FG000|NOT COMPLETED|Overall Study||5
6786917|NCT00754052|7717572|FG001|NOT COMPLETED|Overall Study||3
6786918|NCT00750555|7717578|FG000|STARTED|Overall Study||0
6786919|NCT00750555|7717578|FG000|COMPLETED|Overall Study||0
6786920|NCT00750555|7717578|FG000|NOT COMPLETED|Overall Study||0
6786921|NCT00754767|7717585|FG000|STARTED|Overall Study||2
6786922|NCT00754767|7717586|FG001|STARTED|Overall Study||0
6786923|NCT00754767|7717585|FG000|COMPLETED|Overall Study||2
6786924|NCT00754767|7717586|FG001|COMPLETED|Overall Study||0
6786925|NCT00754767|7717585|FG000|NOT COMPLETED|Overall Study||0
6786926|NCT00754767|7717586|FG001|NOT COMPLETED|Overall Study||0
6786927|NCT00750204|7717594|FG000|STARTED|Overall Study||1
6786928|NCT00750204|7717595|FG001|STARTED|Overall Study||1
6786929|NCT00750204|7717594|FG000|COMPLETED|Overall Study||0
6786930|NCT00750204|7717595|FG001|COMPLETED|Overall Study||0
6786931|NCT00750204|7717594|FG000|NOT COMPLETED|Overall Study||1
6786932|NCT00750204|7717595|FG001|NOT COMPLETED|Overall Study||1
6786933|NCT00748579|7717603|FG000|STARTED|Overall Study||2
6786934|NCT00748579|7717604|FG001|STARTED|Overall Study||0
6786935|NCT00748579|7717603|FG000|COMPLETED|Overall Study||2
6786936|NCT00748579|7717604|FG001|COMPLETED|Overall Study||0
6786937|NCT00748579|7717603|FG000|NOT COMPLETED|Overall Study||0
6786938|NCT00748579|7717604|FG001|NOT COMPLETED|Overall Study||0
6786939|NCT00748085|7717610|FG000|STARTED|Overall Study||5
6786940|NCT00748085|7717610|FG000|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
6786941|NCT00748085|7717610|FG000|NOT COMPLETED|Overall Study||0
6786942|NCT00752986|7717617|FG000|STARTED|Overall Study||16
6786943|NCT00752986|7717618|FG001|STARTED|Overall Study||12
6786944|NCT00752986|7717619|FG002|STARTED|Overall Study||11
6786945|NCT00752986|7717617|FG000|COMPLETED|Overall Study||11
6786946|NCT00752986|7717618|FG001|COMPLETED|Overall Study||11
6786947|NCT00752986|7717619|FG002|COMPLETED|Overall Study||9
6786948|NCT00752986|7717617|FG000|NOT COMPLETED|Overall Study||5
6786949|NCT00752986|7717618|FG001|NOT COMPLETED|Overall Study||1
6786950|NCT00752986|7717619|FG002|NOT COMPLETED|Overall Study||2
6786951|NCT00751335|7717629|FG000|STARTED|Overall Study||0
6786952|NCT00751335|7717630|FG001|STARTED|Overall Study||0
6786953|NCT00751335|7717629|FG000|COMPLETED|Overall Study||0
6786954|NCT00751335|7717630|FG001|COMPLETED|Overall Study||0
6563165|NCT01805882|7486116|FG007|NOT COMPLETED|Overall Study||0
6563166|NCT01805882|7486117|FG008|NOT COMPLETED|Overall Study||1
6563167|NCT01805895|7486139|FG000|STARTED|Overall Study||8
6563168|NCT01805895|7486140|FG001|STARTED|Overall Study||8
6378589|NCT00768755|7289127|FG001|STARTED|Phase 1||0
6378590|NCT00768755|7289128|FG002|STARTED|Phase 1||0
6786955|NCT00751335|7717629|FG000|NOT COMPLETED|Overall Study||0
6378591|NCT00768755|7289129|FG003|STARTED|Phase 1||0
6378592|NCT00768755|7289126|FG000|COMPLETED|Phase 1||0
6378593|NCT00768755|7289127|FG001|COMPLETED|Phase 1||0
6378594|NCT00768755|7289128|FG002|COMPLETED|Phase 1||0
6378595|NCT00768755|7289129|FG003|COMPLETED|Phase 1||0
6378596|NCT00768755|7289126|FG000|NOT COMPLETED|Phase 1||10
6378597|NCT00768755|7289127|FG001|NOT COMPLETED|Phase 1||0
6378598|NCT00768755|7289128|FG002|NOT COMPLETED|Phase 1||0
6378599|NCT00768755|7289129|FG003|NOT COMPLETED|Phase 1||0
6378600|NCT00768755|7289126|FG000|STARTED|Phase 2||0
6378601|NCT00768755|7289127|FG001|STARTED|Phase 2||55
6378602|NCT00768755|7289128|FG002|STARTED|Phase 2||58
6378603|NCT00768755|7289129|FG003|STARTED|Phase 2||57
6378604|NCT00768755|7289126|FG000|Treated|Phase 2||0
6378605|NCT00768755|7289127|FG001|Treated|Phase 2||55
6378606|NCT00768755|7289128|FG002|Treated|Phase 2||58
6378607|NCT00768755|7289129|FG003|Treated|Phase 2||55
6378608|NCT00768755|7289126|FG000|COMPLETED|Phase 2||0
6378609|NCT00768755|7289127|FG001|COMPLETED|Phase 2||0
6378610|NCT00768755|7289128|FG002|COMPLETED|Phase 2||0
6378611|NCT00768755|7289129|FG003|COMPLETED|Phase 2||0
6378612|NCT00768755|7289126|FG000|NOT COMPLETED|Phase 2||0
6378613|NCT00768755|7289127|FG001|NOT COMPLETED|Phase 2||55
6378614|NCT00768755|7289128|FG002|NOT COMPLETED|Phase 2||58
6378615|NCT00768755|7289129|FG003|NOT COMPLETED|Phase 2||57
6378616|NCT00768898|7289138|FG000|STARTED|Overall Study||30
6378617|NCT00768898|7289138|FG000|COMPLETED|Overall Study||28
6378618|NCT00768898|7289138|FG000|NOT COMPLETED|Overall Study||2
6378619|NCT00768989|7289149|FG000|STARTED|Prior to Week 24||63
6378620|NCT00768989|7289150|FG001|STARTED|Prior to Week 24||30
6378621|NCT00768989|7289149|FG000|COMPLETED|Prior to Week 24||59
6378622|NCT00768989|7289150|FG001|COMPLETED|Prior to Week 24||27
6378623|NCT00768989|7289149|FG000|NOT COMPLETED|Prior to Week 24||4
6378624|NCT00768989|7289150|FG001|NOT COMPLETED|Prior to Week 24||3
6786956|NCT00751335|7717630|FG001|NOT COMPLETED|Overall Study||0
6786957|NCT00746239|7717636|FG000|STARTED|Overall Study||11
6786958|NCT00746239|7717636|FG000|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
6786959|NCT00746239|7717636|FG000|NOT COMPLETED|Overall Study||6
6378625|NCT00768989|7289149|FG000|STARTED|Week 24 to Prior to Week 36||59
6378626|NCT00768989|7289150|FG001|STARTED|Week 24 to Prior to Week 36||27
6378627|NCT00768989|7289149|FG000|COMPLETED|Week 24 to Prior to Week 36||51
6378628|NCT00768989|7289150|FG001|COMPLETED|Week 24 to Prior to Week 36||27
6378629|NCT00768989|7289149|FG000|NOT COMPLETED|Week 24 to Prior to Week 36||8
6378630|NCT00768989|7289150|FG001|NOT COMPLETED|Week 24 to Prior to Week 36||0
6563169|NCT01805895|7486139|FG000|COMPLETED|Overall Study||8
6786960|NCT00754013|7717642|FG000|STARTED|Overall Study||4
6786961|NCT00754013|7717643|FG001|STARTED|Overall Study||5
6786962|NCT00754013|7717642|FG000|COMPLETED|Overall Study||0
6786963|NCT00754013|7717643|FG001|COMPLETED|Overall Study||0
6786964|NCT00754013|7717642|FG000|NOT COMPLETED|Overall Study||4
6786965|NCT00754013|7717643|FG001|NOT COMPLETED|Overall Study||5
6786966|NCT00735553|7717652|FG000|STARTED|Overall Study||77
6786967|NCT00735553|7717652|FG000|COMPLETED|Overall Study||0
6786968|NCT00735553|7717652|FG000|NOT COMPLETED|Overall Study||77
6786969|NCT00751933|7717660|FG000|STARTED|Overall Study||0
6786970|NCT00751933|7717661|FG001|STARTED|Overall Study||1
6786971|NCT00751933|7717662|FG002|STARTED|Overall Study||1
6786972|NCT00751933|7717663|FG003|STARTED|Overall Study||1
6786973|NCT00751933|7717660|FG000|COMPLETED|Overall Study||0
6786974|NCT00751933|7717661|FG001|COMPLETED|Overall Study||0
6786975|NCT00751933|7717662|FG002|COMPLETED|Overall Study||0
6786976|NCT00751933|7717663|FG003|COMPLETED|Overall Study||0
6786977|NCT00751933|7717660|FG000|NOT COMPLETED|Overall Study||0
6786978|NCT00751933|7717661|FG001|NOT COMPLETED|Overall Study||1
6786979|NCT00751933|7717662|FG002|NOT COMPLETED|Overall Study||1
6786980|NCT00751933|7717663|FG003|NOT COMPLETED|Overall Study||1
6786981|NCT00747916|7717667|FG000|STARTED|Overall Study||3
6786982|NCT00747916|7717667|FG000|COMPLETED|Overall Study||3
6786983|NCT00747916|7717667|FG000|NOT COMPLETED|Overall Study||0
6786984|NCT00745030|7717673|FG000|STARTED|Overall Study||1
6786985|NCT00745030|7717674|FG001|STARTED|Overall Study||2
6786986|NCT00745030|7717673|FG000|COMPLETED|Overall Study||1
6786987|NCT00745030|7717674|FG001|COMPLETED|Overall Study||2
6786988|NCT00745030|7717673|FG000|NOT COMPLETED|Overall Study||0
6786989|NCT00745030|7717674|FG001|NOT COMPLETED|Overall Study||0
6786990|NCT00747461|7717680|FG000|STARTED|Overall Study||5
6786991|NCT00747461|7717680|FG000|COMPLETED|Overall Study||0
6786992|NCT00747461|7717680|FG000|NOT COMPLETED|Overall Study||5
6786993|NCT00746018|7717685|FG000|STARTED|Overall Study||39
6786994|NCT00746018|7717685|FG000|COMPLETED|Overall Study||39
6786995|NCT00746018|7717685|FG000|NOT COMPLETED|Overall Study||0
6786996|NCT00746603|7717689|FG000|STARTED|Overall Study||3
6786997|NCT00746603|7717689|FG000|COMPLETED|Overall Study||3
6786998|NCT00746603|7717689|FG000|NOT COMPLETED|Overall Study||0
6786999|NCT00736385|7717695|FG000|STARTED|Overall Study||4
6787000|NCT00736385|7717696|FG001|STARTED|Overall Study||5
6787001|NCT00736385|7717695|FG000|COMPLETED|Overall Study||2
6787002|NCT00736385|7717696|FG001|COMPLETED|Overall Study||2
6787003|NCT00736385|7717695|FG000|NOT COMPLETED|Overall Study||2
6787004|NCT00736385|7717696|FG001|NOT COMPLETED|Overall Study||3
6787005|NCT00738972|7717706|FG000|STARTED|Overall Study||3
6787006|NCT00738972|7717707|FG001|STARTED|Overall Study||3
6787007|NCT00738972|7717708|FG002|STARTED|Overall Study||3
6787008|NCT00738972|7717709|FG003|STARTED|Overall Study||3
6787009|NCT00738972|7717706|FG000|COMPLETED|Overall Study||3
6787010|NCT00738972|7717707|FG001|COMPLETED|Overall Study||3
6787011|NCT00738972|7717708|FG002|COMPLETED|Overall Study||3
6787012|NCT00738972|7717709|FG003|COMPLETED|Overall Study||2
6563170|NCT01805895|7486140|FG001|COMPLETED|Overall Study||8
6563171|NCT01805895|7486139|FG000|NOT COMPLETED|Overall Study||0
6563172|NCT01805895|7486140|FG001|NOT COMPLETED|Overall Study||0
6787013|NCT00738972|7717706|FG000|NOT COMPLETED|Overall Study||0
6787014|NCT00738972|7717707|FG001|NOT COMPLETED|Overall Study||0
6787015|NCT00738972|7717708|FG002|NOT COMPLETED|Overall Study||0
6787016|NCT00738972|7717709|FG003|NOT COMPLETED|Overall Study||1
6787017|NCT00739063|7717719|FG000|STARTED|Overall Study||11
6787018|NCT00739063|7717719|FG000|COMPLETED|Overall Study||3
6787019|NCT00739063|7717719|FG000|NOT COMPLETED|Overall Study||8
6787020|NCT00740597|7717723|FG000|STARTED|Overall Study||1
6787021|NCT00740597|7717723|FG000|COMPLETED|Overall Study||0
6787022|NCT00740597|7717723|FG000|NOT COMPLETED|Overall Study||1
6787023|NCT00737594|7717730|FG000|STARTED|Overall Study||0
6787024|NCT00737594|7717731|FG001|STARTED|Overall Study||0
6787025|NCT00737594|7717732|FG002|STARTED|Overall Study||0
6787026|NCT00737594|7717730|FG000|COMPLETED|Overall Study||0
6787027|NCT00737594|7717731|FG001|COMPLETED|Overall Study||0
6787028|NCT00737594|7717732|FG002|COMPLETED|Overall Study||0
6787029|NCT00737594|7717730|FG000|NOT COMPLETED|Overall Study||0
6787030|NCT00737594|7717731|FG001|NOT COMPLETED|Overall Study||0
6787031|NCT00737594|7717732|FG002|NOT COMPLETED|Overall Study||0
6787032|NCT00737282|7717742|FG000|STARTED|Overall Study||175
6787033|NCT00737282|7717742|FG000|COMPLETED|Overall Study||0
6787034|NCT00737282|7717742|FG000|NOT COMPLETED|Overall Study||175
6787035|NCT00739882|7717750|FG000|STARTED|Double-blind Period||51
6787036|NCT00739882|7717751|FG001|STARTED|Double-blind Period||25
6787037|NCT00739882|7717750|FG000|COMPLETED|Double-blind Period||32
6787038|NCT00739882|7717751|FG001|COMPLETED|Double-blind Period||14
6787039|NCT00739882|7717750|FG000|NOT COMPLETED|Double-blind Period||19
6787040|NCT00739882|7717751|FG001|NOT COMPLETED|Double-blind Period||11
6787041|NCT00739882|7717750|FG000|STARTED|Open-label Period||17
6787042|NCT00739882|7717751|FG001|STARTED|Open-label Period||14
6787043|NCT00739882|7717750|FG000|COMPLETED|Open-label Period||7
6787044|NCT00739882|7717751|FG001|COMPLETED|Open-label Period||9
6787045|NCT00739882|7717750|FG000|NOT COMPLETED|Open-label Period||10
6787046|NCT00739882|7717751|FG001|NOT COMPLETED|Open-label Period||5
6787047|NCT00739024|7717761|FG000|STARTED|Overall Study||7
6787048|NCT00739024|7717762|FG001|STARTED|Overall Study||6
6787049|NCT00739024|7717761|FG000|COMPLETED|Overall Study||7
6787050|NCT00739024|7717762|FG001|COMPLETED|Overall Study||6
6787051|NCT00739024|7717761|FG000|NOT COMPLETED|Overall Study||0
6787052|NCT00739024|7717762|FG001|NOT COMPLETED|Overall Study||0
6787053|NCT00731770|7717770|FG000|STARTED|Overall Study||5
6787054|NCT00731770|7717771|FG001|STARTED|Overall Study||5
6787055|NCT00731770|7717770|FG000|COMPLETED|Overall Study||5
6787056|NCT00731770|7717771|FG001|COMPLETED|Overall Study||5
6787057|NCT00731770|7717770|FG000|NOT COMPLETED|Overall Study||0
6787058|NCT00731770|7717771|FG001|NOT COMPLETED|Overall Study||0
6787059|NCT00735254|7717783|FG000|STARTED|Overall Study||1
6787060|NCT00735254|7717784|FG001|STARTED|Overall Study||1
6787061|NCT00735254|7717785|FG002|STARTED|Overall Study||1
6787062|NCT00735254|7717786|FG003|STARTED|Overall Study||0
6787063|NCT00735254|7717783|FG000|COMPLETED|Overall Study||0
6787064|NCT00735254|7717784|FG001|COMPLETED|Overall Study||0
6787065|NCT00735254|7717785|FG002|COMPLETED|Overall Study||0
6787066|NCT00735254|7717786|FG003|COMPLETED|Overall Study||0
6787067|NCT00735254|7717783|FG000|NOT COMPLETED|Overall Study||1
6787068|NCT00735254|7717784|FG001|NOT COMPLETED|Overall Study||1
6787069|NCT00735254|7717785|FG002|NOT COMPLETED|Overall Study||1
6787070|NCT00735254|7717786|FG003|NOT COMPLETED|Overall Study||0
6787071|NCT00729365|7717799|FG000|STARTED|Overall Study||33
6787072|NCT00729365|7717800|FG001|STARTED|Overall Study||6
6787073|NCT00729365|7717801|FG002|STARTED|Overall Study||7
6787074|NCT00729365|7717799|FG000|COMPLETED|Overall Study|Study terminated|0
6787075|NCT00729365|7717800|FG001|COMPLETED|Overall Study|Study Terminated|0
6787076|NCT00729365|7717801|FG002|COMPLETED|Overall Study|Study terminated|0
6787077|NCT00729365|7717799|FG000|NOT COMPLETED|Overall Study||33
6787078|NCT00729365|7717800|FG001|NOT COMPLETED|Overall Study||6
6787079|NCT00729365|7717801|FG002|NOT COMPLETED|Overall Study||7
6787080|NCT00732680|7717811|FG000|STARTED|Overall Study||9
6787081|NCT00732680|7717811|FG000|COMPLETED|Overall Study||9
6787082|NCT00732680|7717811|FG000|NOT COMPLETED|Overall Study||0
6787083|NCT00726180|7717815|FG000|STARTED|Overall Study||1
6787084|NCT00726180|7717815|FG000|COMPLETED|Overall Study||1
6787085|NCT00726180|7717815|FG000|NOT COMPLETED|Overall Study||0
6787086|NCT00724282|7717819|FG000|STARTED|Overall Study||20
6787087|NCT00724282|7717819|FG000|COMPLETED|Overall Study||16
6787088|NCT00724282|7717819|FG000|NOT COMPLETED|Overall Study||4
6787089|NCT00730886|7717825|FG000|STARTED|Overall Study||2
6787090|NCT00730886|7717826|FG001|STARTED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
6787091|NCT00730886|7717825|FG000|COMPLETED|Overall Study||0
6787092|NCT00730886|7717826|FG001|COMPLETED|Overall Study|no subjects enrolled in this arm. Study enrollment terminated early.|0
6787093|NCT00730886|7717825|FG000|NOT COMPLETED|Overall Study||2
6787094|NCT00730886|7717826|FG001|NOT COMPLETED|Overall Study||0
6787095|NCT00728845|7717834|FG000|STARTED|Overall Study||8
6787096|NCT00728845|7717835|FG001|STARTED|Overall Study||0
6787097|NCT00728845|7717834|FG000|COMPLETED|Overall Study||8
6787098|NCT00728845|7717835|FG001|COMPLETED|Overall Study||0
6787099|NCT00728845|7717834|FG000|NOT COMPLETED|Overall Study||0
6787100|NCT00728845|7717835|FG001|NOT COMPLETED|Overall Study||0
6787101|NCT00726830|7717843|FG000|STARTED|Overall Study||1
6787102|NCT00726830|7717844|FG001|STARTED|Overall Study||0
6787103|NCT00726830|7717843|FG000|COMPLETED|Overall Study||1
6787104|NCT00726830|7717844|FG001|COMPLETED|Overall Study||0
6787105|NCT00726830|7717843|FG000|NOT COMPLETED|Overall Study||0
6787106|NCT00726830|7717844|FG001|NOT COMPLETED|Overall Study||0
6787107|NCT00726037|7717850|FG000|STARTED|Overall Study||7
6787108|NCT00726037|7717850|FG000|COMPLETED|Overall Study||7
6787109|NCT00726037|7717850|FG000|NOT COMPLETED|Overall Study||0
6787110|NCT00729560|7717854|FG000|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
6787111|NCT00729560|7717854|FG000|COMPLETED|Overall Study||5
6787112|NCT00729560|7717854|FG000|NOT COMPLETED|Overall Study||3
6787113|NCT00716807|7717862|FG000|STARTED|Overall Study||8
6787114|NCT00716807|7717863|FG001|STARTED|Overall Study||5
6787115|NCT00716807|7717864|FG002|STARTED|Overall Study||18
6787116|NCT00716807|7717865|FG003|STARTED|Overall Study||15
6787117|NCT00716807|7717862|FG000|COMPLETED|Overall Study||8
6787118|NCT00716807|7717863|FG001|COMPLETED|Overall Study||5
6787119|NCT00716807|7717864|FG002|COMPLETED|Overall Study||18
6787120|NCT00716807|7717865|FG003|COMPLETED|Overall Study||15
6787121|NCT00716807|7717862|FG000|NOT COMPLETED|Overall Study||0
6787122|NCT00716807|7717863|FG001|NOT COMPLETED|Overall Study||0
6787123|NCT00716807|7717864|FG002|NOT COMPLETED|Overall Study||0
6787124|NCT00716807|7717865|FG003|NOT COMPLETED|Overall Study||0
6787125|NCT00714948|7717875|FG000|STARTED|Overall Study||2
6787126|NCT00714948|7717875|FG000|COMPLETED|Overall Study||0
6787127|NCT00714948|7717875|FG000|NOT COMPLETED|Overall Study||2
6787128|NCT00720343|7717879|FG000|STARTED|Overall Study||54
6787129|NCT00720343|7717879|FG000|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
6787130|NCT00720343|7717879|FG000|NOT COMPLETED|Overall Study||6
6787131|NCT00719914|7717887|FG000|STARTED|Overall Study||10
6787132|NCT00719914|7717888|FG001|STARTED|Overall Study||7
6787133|NCT00719914|7717887|FG000|COMPLETED|Overall Study||10
6787134|NCT00719914|7717888|FG001|COMPLETED|Overall Study||7
6787135|NCT00719914|7717887|FG000|NOT COMPLETED|Overall Study||0
6787136|NCT00719914|7717888|FG001|NOT COMPLETED|Overall Study||0
6787137|NCT00718640|7717894|FG000|STARTED|Overall Study||10
6787138|NCT00718640|7717894|FG000|COMPLETED|Overall Study||3
6787139|NCT00718640|7717894|FG000|NOT COMPLETED|Overall Study||7
6787140|NCT00720083|7717900|FG000|STARTED|Overall Study||17
6787141|NCT00720083|7717901|FG001|STARTED|Overall Study||15
6787142|NCT00720083|7717900|FG000|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
6787143|NCT00720083|7717901|FG001|COMPLETED|Overall Study||13
6787144|NCT00720083|7717900|FG000|NOT COMPLETED|Overall Study||1
6787145|NCT00720083|7717901|FG001|NOT COMPLETED|Overall Study||2
6787146|NCT00717275|7717907|FG000|STARTED|Overall Study||3
6787147|NCT00717275|7717907|FG000|COMPLETED|Overall Study||0
6787148|NCT00717275|7717907|FG000|NOT COMPLETED|Overall Study||3
6787149|NCT00708734|7717911|FG000|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
6787150|NCT00708734|7717911|FG000|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
6787151|NCT00708734|7717911|FG000|NOT COMPLETED|Overall Study||7
6787152|NCT00711087|7717917|FG000|STARTED|Overall Study||1
6787153|NCT00711087|7717918|FG001|STARTED|Overall Study||0
6787154|NCT00711087|7717917|FG000|COMPLETED|Overall Study||0
6787155|NCT00711087|7717918|FG001|COMPLETED|Overall Study||0
6787156|NCT00711087|7717917|FG000|NOT COMPLETED|Overall Study||1
6787157|NCT00711087|7717918|FG001|NOT COMPLETED|Overall Study||0
6787158|NCT00706797|7717926|FG000|STARTED|Overall Study||70
6787159|NCT00706797|7717927|FG001|STARTED|Overall Study||71
6787160|NCT00706797|7717926|FG000|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
6787161|NCT00706797|7717927|FG001|Safety Population|Overall Study||71
6787162|NCT00706797|7717926|FG000|COMPLETED|Overall Study||1
6787163|NCT00706797|7717927|FG001|COMPLETED|Overall Study||0
6787164|NCT00706797|7717926|FG000|NOT COMPLETED|Overall Study||69
6787165|NCT00706797|7717927|FG001|NOT COMPLETED|Overall Study||71
6787166|NCT00713596|7717936|FG000|STARTED|Overall Study||9
6787167|NCT00713596|7717937|FG001|STARTED|Overall Study||8
6787168|NCT00713596|7717938|FG002|STARTED|Overall Study||8
6787169|NCT00713596|7717936|FG000|COMPLETED|Overall Study||7
6787170|NCT00713596|7717937|FG001|COMPLETED|Overall Study||5
6787171|NCT00713596|7717938|FG002|COMPLETED|Overall Study||6
6787172|NCT00713596|7717936|FG000|NOT COMPLETED|Overall Study||2
6787173|NCT00713596|7717937|FG001|NOT COMPLETED|Overall Study||3
6787174|NCT00713596|7717938|FG002|NOT COMPLETED|Overall Study||2
6787175|NCT00703885|7717946|FG000|STARTED|Overall Study||16
6787176|NCT00703885|7717946|FG000|COMPLETED|Overall Study||16
6787177|NCT00703885|7717946|FG000|NOT COMPLETED|Overall Study||0
6787178|NCT00703092|7717951|FG000|STARTED|Overall Study||2
6787179|NCT00703092|7717951|FG000|COMPLETED|Overall Study||0
6787180|NCT00703092|7717951|FG000|NOT COMPLETED|Overall Study||2
6787181|NCT00713258|7717957|FG000|STARTED|Overall Study||41
6787182|NCT00713258|7717958|FG001|STARTED|Overall Study||34
6787183|NCT00713258|7717957|FG000|COMPLETED|Overall Study||36
6787184|NCT00713258|7717958|FG001|COMPLETED|Overall Study||28
6787185|NCT00713258|7717957|FG000|NOT COMPLETED|Overall Study||5
6787186|NCT00713258|7717958|FG001|NOT COMPLETED|Overall Study||6
6787187|NCT00706329|7717964|FG000|STARTED|Overall Study||25
6787188|NCT00706329|7717964|FG000|COMPLETED|Overall Study||25
6787189|NCT00706329|7717964|FG000|NOT COMPLETED|Overall Study||0
6787190|NCT00707434|7717968|FG000|STARTED|Overall Study||6
6787191|NCT00707434|7717968|FG000|COMPLETED|Overall Study||5
6787192|NCT00707434|7717968|FG000|NOT COMPLETED|Overall Study||1
6787193|NCT00707161|7717972|FG000|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
6787194|NCT00707161|7717972|FG000|COMPLETED|Overall Study||0
6787195|NCT00707161|7717972|FG000|NOT COMPLETED|Overall Study||6
6787196|NCT00704496|7717978|FG000|STARTED|Overall Study||0
6787197|NCT00704496|7717979|FG001|STARTED|Overall Study||0
6787198|NCT00704496|7717978|FG000|COMPLETED|Overall Study||0
6787199|NCT00704496|7717979|FG001|COMPLETED|Overall Study||0
6787200|NCT00704496|7717978|FG000|NOT COMPLETED|Overall Study||0
6787201|NCT00704496|7717979|FG001|NOT COMPLETED|Overall Study||0
6787202|NCT00708916|7717985|FG000|STARTED|Overall Study||12
6787203|NCT00708916|7717985|FG000|COMPLETED|Overall Study||8
6787204|NCT00708916|7717985|FG000|NOT COMPLETED|Overall Study||4
6787205|NCT00700778|7717990|FG000|STARTED|Overall Study||2
6787206|NCT00700778|7717990|FG000|COMPLETED|Overall Study||0
6787207|NCT00700778|7717990|FG000|NOT COMPLETED|Overall Study||2
6787208|NCT00699842|7717997|FG000|STARTED|Overall Study||3
6787209|NCT00699842|7717998|FG001|STARTED|Overall Study||5
6787210|NCT00699842|7717999|FG002|STARTED|Overall Study||0
6787211|NCT00699842|7717997|FG000|COMPLETED|Overall Study||3
6787212|NCT00699842|7717998|FG001|COMPLETED|Overall Study||4
6787213|NCT00699842|7717999|FG002|COMPLETED|Overall Study||0
6787214|NCT00699842|7717997|FG000|NOT COMPLETED|Overall Study||0
6787215|NCT00699842|7717998|FG001|NOT COMPLETED|Overall Study||1
6787216|NCT00699842|7717999|FG002|NOT COMPLETED|Overall Study||0
6787217|NCT00702962|7718009|FG000|STARTED|Overall Study|One initiated treatment. Milestones not achieved due to premature closing due to low accrual.|1
6787218|NCT00702962|7718010|FG001|STARTED|Overall Study|Three treated. Milestone not met as Phase I closed prematurely as NCI research established the MTD.|3
6787219|NCT00702962|7718009|FG000|COMPLETED|Overall Study|The one participant off treatment after 2 doses due to concurrent health disorder.|0
6787220|NCT00702962|7718010|FG001|COMPLETED|Overall Study|Two completed all required cycles. One experienced progressive disease after 2 cycles|2
6787221|NCT00702962|7718009|FG000|NOT COMPLETED|Overall Study||1
6787222|NCT00702962|7718010|FG001|NOT COMPLETED|Overall Study||1
6787223|NCT00703534|7718020|FG000|STARTED|Overall Study||235
6787224|NCT00703534|7718021|FG001|STARTED|Overall Study||243
6787225|NCT00703534|7718020|FG000|COMPLETED|Overall Study||205
6787226|NCT00703534|7718021|FG001|COMPLETED|Overall Study||218
6787227|NCT00703534|7718020|FG000|NOT COMPLETED|Overall Study||30
6787228|NCT00703534|7718021|FG001|NOT COMPLETED|Overall Study||25
6787229|NCT00698009|7718027|FG000|STARTED|Overall Study||1
6787230|NCT00698009|7718027|FG000|COMPLETED|Overall Study||0
6787231|NCT00698009|7718027|FG000|NOT COMPLETED|Overall Study||1
6787232|NCT00703339|7718031|FG000|STARTED|Overall Study||1
6787233|NCT00703339|7718031|FG000|COMPLETED|Overall Study||1
6787234|NCT00703339|7718031|FG000|NOT COMPLETED|Overall Study||0
6787235|NCT00691444|7718038|FG000|STARTED|Overall Study||0
6787236|NCT00691444|7718039|FG001|STARTED|Overall Study||0
6787237|NCT00691444|7718040|FG002|STARTED|Overall Study||0
6787238|NCT00691444|7718038|FG000|COMPLETED|Overall Study||0
6787239|NCT00691444|7718039|FG001|COMPLETED|Overall Study||0
6787240|NCT00691444|7718040|FG002|COMPLETED|Overall Study||0
6787241|NCT00691444|7718038|FG000|NOT COMPLETED|Overall Study||0
6787242|NCT00691444|7718039|FG001|NOT COMPLETED|Overall Study||0
6787243|NCT00691444|7718040|FG002|NOT COMPLETED|Overall Study||0
6656305|NCT02459665|7586430|FG003|COMPLETED|Overall Study||15
6656306|NCT02459665|7586427|FG000|NOT COMPLETED|Overall Study||0
6787244|NCT00702702|7718051|FG000|STARTED|Overall Study||56
6787245|NCT00702702|7718051|FG000|COMPLETED|Overall Study||0
6787246|NCT00702702|7718051|FG000|NOT COMPLETED|Overall Study||56
6787247|NCT00693628|7718061|FG000|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
6787248|NCT00693628|7718062|FG001|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
6787249|NCT00693628|7718061|FG000|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
6787250|NCT00693628|7718062|FG001|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
6787251|NCT00693628|7718061|FG000|NOT COMPLETED|Overall Study||0
6787252|NCT00693628|7718062|FG001|NOT COMPLETED|Overall Study||0
6787253|NCT00699413|7718070|FG000|STARTED|Overall Study||4
6787254|NCT00699413|7718071|FG001|STARTED|Overall Study||4
6787255|NCT00699413|7718070|FG000|COMPLETED|Overall Study||0
6787256|NCT00699413|7718071|FG001|COMPLETED|Overall Study||0
6787257|NCT00699413|7718070|FG000|NOT COMPLETED|Overall Study||4
6656307|NCT02459665|7586428|FG001|NOT COMPLETED|Overall Study||1
6656308|NCT02459665|7586429|FG002|NOT COMPLETED|Overall Study||1
6656309|NCT02459665|7586430|FG003|NOT COMPLETED|Overall Study||2
6656310|NCT02459795|7586450|FG000|STARTED|Overall Study||187
6656311|NCT02459795|7586451|FG001|STARTED|Overall Study||189
6656312|NCT02459795|7586452|FG002|STARTED|Overall Study||93
6656313|NCT02459795|7586450|FG000|COMPLETED|Overall Study||181
6656314|NCT02459795|7586451|FG001|COMPLETED|Overall Study||186
6656315|NCT02459795|7586452|FG002|COMPLETED|Overall Study||92
6656316|NCT02459795|7586450|FG000|NOT COMPLETED|Overall Study||6
6656317|NCT02459795|7586451|FG001|NOT COMPLETED|Overall Study||3
6656318|NCT02459795|7586452|FG002|NOT COMPLETED|Overall Study||1
6656319|NCT02459899|7586464|FG000|STARTED|Overall Study||36
6656320|NCT02459899|7586465|FG001|STARTED|Overall Study||35
6656321|NCT02459899|7586466|FG002|STARTED|Overall Study||35
6656322|NCT02459899|7586467|FG003|STARTED|Overall Study||35
6656323|NCT02459899|7586464|FG000|COMPLETED|Overall Study||33
6656324|NCT02459899|7586465|FG001|COMPLETED|Overall Study||29
6656325|NCT02459899|7586466|FG002|COMPLETED|Overall Study||35
6787258|NCT00699413|7718071|FG001|NOT COMPLETED|Overall Study||4
6787259|NCT00691652|7718077|FG000|STARTED|Overall Study||2
6787260|NCT00691652|7718077|FG000|COMPLETED|Overall Study||1
6787261|NCT00691652|7718077|FG000|NOT COMPLETED|Overall Study||1
6787262|NCT00686972|7718081|FG000|STARTED|Overall Study||51
6787263|NCT00686972|7718081|FG000|COMPLETED|Overall Study||0
6787264|NCT00686972|7718081|FG000|NOT COMPLETED|Overall Study||51
6787265|NCT00693017|7718087|FG000|STARTED|Overall Study||2
6787266|NCT00693017|7718088|FG001|STARTED|Overall Study||2
6787267|NCT00693017|7718087|FG000|COMPLETED|Overall Study||0
6787268|NCT00693017|7718088|FG001|COMPLETED|Overall Study||0
6787269|NCT00693017|7718087|FG000|NOT COMPLETED|Overall Study||2
6787270|NCT00693017|7718088|FG001|NOT COMPLETED|Overall Study||2
6787271|NCT00691574|7718096|FG000|STARTED|Overall Study||0
6787272|NCT00691574|7718097|FG001|STARTED|Overall Study||0
6787273|NCT00691574|7718096|FG000|COMPLETED|Overall Study||0
6787274|NCT00691574|7718097|FG001|COMPLETED|Overall Study||0
6787275|NCT00691574|7718096|FG000|NOT COMPLETED|Overall Study||0
6787276|NCT00691574|7718097|FG001|NOT COMPLETED|Overall Study||0
6787277|NCT00692094|7718107|FG000|STARTED|Overall Study||0
6787278|NCT00692094|7718108|FG001|STARTED|Overall Study||0
6787279|NCT00692094|7718109|FG002|STARTED|Overall Study||0
6787280|NCT00692094|7718110|FG003|STARTED|Overall Study||0
6787281|NCT00692094|7718107|FG000|COMPLETED|Overall Study||0
6787282|NCT00692094|7718108|FG001|COMPLETED|Overall Study||0
6787283|NCT00692094|7718109|FG002|COMPLETED|Overall Study||0
6787284|NCT00692094|7718110|FG003|COMPLETED|Overall Study||0
6787285|NCT00692094|7718107|FG000|NOT COMPLETED|Overall Study||0
6787286|NCT00692094|7718108|FG001|NOT COMPLETED|Overall Study||0
6787287|NCT00692094|7718109|FG002|NOT COMPLETED|Overall Study||0
6787288|NCT00692094|7718110|FG003|NOT COMPLETED|Overall Study||0
6787289|NCT00689884|7718120|FG000|STARTED|Overall Study||7
6787290|NCT00689884|7718120|FG000|COMPLETED|Overall Study||7
6787291|NCT00689884|7718120|FG000|NOT COMPLETED|Overall Study||0
6787292|NCT00692003|7718127|FG000|STARTED|Overall Study||5
6787293|NCT00692003|7718128|FG001|STARTED|Overall Study||1
6787294|NCT00692003|7718127|FG000|COMPLETED|Overall Study||0
6787295|NCT00692003|7718128|FG001|COMPLETED|Overall Study||0
6787296|NCT00692003|7718127|FG000|NOT COMPLETED|Overall Study||5
6787297|NCT00692003|7718128|FG001|NOT COMPLETED|Overall Study||1
6787298|NCT00678288|7718136|FG000|STARTED|Overall Study||10
6787299|NCT00678288|7718137|FG001|STARTED|Overall Study||6
6787300|NCT00678288|7718136|FG000|COMPLETED|Overall Study||0
6787301|NCT00678288|7718137|FG001|COMPLETED|Overall Study||0
6787302|NCT00678288|7718136|FG000|NOT COMPLETED|Overall Study||10
6787303|NCT00678288|7718137|FG001|NOT COMPLETED|Overall Study||6
6787304|NCT00676026|7718143|FG000|STARTED|Overall Study||8
6787305|NCT00676026|7718143|FG000|COMPLETED|Overall Study||8
6787306|NCT00676026|7718143|FG000|NOT COMPLETED|Overall Study||0
6787307|NCT00689052|7718149|FG000|STARTED|Overall Study||31
6787308|NCT00689052|7718150|FG001|STARTED|Overall Study||30
6787309|NCT00689052|7718149|FG000|COMPLETED|Overall Study||0
6787310|NCT00689052|7718150|FG001|COMPLETED|Overall Study||0
6787311|NCT00689052|7718149|FG000|NOT COMPLETED|Overall Study||31
6787312|NCT00689052|7718150|FG001|NOT COMPLETED|Overall Study||30
6787313|NCT00678574|7718160|FG000|STARTED|Overall Study||18
6787314|NCT00678574|7718161|FG001|STARTED|Overall Study||27
6787315|NCT00678574|7718160|FG000|COMPLETED|Overall Study||18
6787316|NCT00678574|7718161|FG001|COMPLETED|Overall Study||27
6787317|NCT00678574|7718160|FG000|NOT COMPLETED|Overall Study||0
6787318|NCT00678574|7718161|FG001|NOT COMPLETED|Overall Study||0
6378631|NCT00768989|7289149|FG000|STARTED|On or After Week 36||51
6378632|NCT00768989|7289150|FG001|STARTED|On or After Week 36||27
6378633|NCT00768989|7289149|FG000|COMPLETED|On or After Week 36||0
6378634|NCT00768989|7289150|FG001|COMPLETED|On or After Week 36||0
6502229|NCT01433172|7420874|FG000|STARTED|Overall Study||3
6656326|NCT02459899|7586467|FG003|COMPLETED|Overall Study||33
6656327|NCT02459899|7586464|FG000|NOT COMPLETED|Overall Study||3
6656328|NCT02459899|7586465|FG001|NOT COMPLETED|Overall Study||6
6656329|NCT02459899|7586466|FG002|NOT COMPLETED|Overall Study||0
6656330|NCT02459899|7586467|FG003|NOT COMPLETED|Overall Study||2
6656331|NCT02459951|7586477|FG000|STARTED|Overall Study||10
6656332|NCT02459951|7586477|FG000|COMPLETED|Overall Study||9
6787319|NCT00683917|7718170|FG000|STARTED|Overall Study||10
6787320|NCT00683917|7718170|FG000|COMPLETED|Overall Study||0
6787321|NCT00683917|7718170|FG000|NOT COMPLETED|Overall Study||10
6787322|NCT00688935|7718178|FG000|STARTED|Overall Study||0
6787323|NCT00688935|7718178|FG000|COMPLETED|Overall Study||0
6787324|NCT00688935|7718178|FG000|NOT COMPLETED|Overall Study||0
6787325|NCT00685880|7718184|FG000|STARTED|Overall Study||0
6787326|NCT00685880|7718185|FG001|STARTED|Overall Study||2
6787327|NCT00685880|7718184|FG000|COMPLETED|Overall Study||0
6787328|NCT00685880|7718185|FG001|COMPLETED|Overall Study||2
6787329|NCT00685880|7718184|FG000|NOT COMPLETED|Overall Study||0
6787330|NCT00685880|7718185|FG001|NOT COMPLETED|Overall Study||0
6787331|NCT00686036|7718193|FG000|STARTED|Overall Study||9
6787332|NCT00686036|7718194|FG001|STARTED|Overall Study||8
6787333|NCT00686036|7718193|FG000|COMPLETED|Overall Study||0
6787334|NCT00686036|7718194|FG001|COMPLETED|Overall Study||2
6787335|NCT00686036|7718193|FG000|NOT COMPLETED|Overall Study||9
6787336|NCT00686036|7718194|FG001|NOT COMPLETED|Overall Study||6
6787337|NCT00681044|7718200|FG000|STARTED|Overall Study||4
6787338|NCT00681044|7718200|FG000|COMPLETED|Overall Study||4
6787339|NCT00681044|7718200|FG000|NOT COMPLETED|Overall Study||0
6787340|NCT00676455|7718204|FG000|STARTED|Overall Study||14
6787341|NCT00676455|7718204|FG000|COMPLETED|Overall Study||14
6787342|NCT00676455|7718204|FG000|NOT COMPLETED|Overall Study||0
6787343|NCT00684255|7718208|FG000|STARTED|Overall Study||1
6787344|NCT00684255|7718208|FG000|COMPLETED|Overall Study||1
6787345|NCT00684255|7718208|FG000|NOT COMPLETED|Overall Study||0
6787346|NCT00683787|7718216|FG000|STARTED|Overall Study||3
6787347|NCT00683787|7718217|FG001|STARTED|Overall Study||3
6787348|NCT00683787|7718218|FG002|STARTED|Overall Study||2
6787349|NCT00683787|7718216|FG000|COMPLETED|Overall Study||0
6787350|NCT00683787|7718217|FG001|COMPLETED|Overall Study||0
6787351|NCT00683787|7718218|FG002|COMPLETED|Overall Study||0
6787352|NCT00683787|7718216|FG000|NOT COMPLETED|Overall Study||3
6787353|NCT00683787|7718217|FG001|NOT COMPLETED|Overall Study||3
6502230|NCT01433172|7420875|FG001|STARTED|Overall Study||37
6502231|NCT01433172|7420876|FG002|STARTED|Overall Study||33
6502232|NCT01433172|7420874|FG000|COMPLETED|Overall Study||3
6502233|NCT01433172|7420875|FG001|COMPLETED|Overall Study||34
6502234|NCT01433172|7420876|FG002|COMPLETED|Overall Study||32
6502235|NCT01433172|7420874|FG000|NOT COMPLETED|Overall Study||0
6502236|NCT01433172|7420875|FG001|NOT COMPLETED|Overall Study||3
6502237|NCT01433172|7420876|FG002|NOT COMPLETED|Overall Study||1
6502238|NCT01433250|7420886|FG000|STARTED|Overall Study||22
6502239|NCT01433250|7420887|FG001|STARTED|Overall Study||17
6502240|NCT01433250|7420886|FG000|COMPLETED|Overall Study||19
6502241|NCT01433250|7420887|FG001|COMPLETED|Overall Study||14
6502242|NCT01433250|7420886|FG000|NOT COMPLETED|Overall Study||3
6563173|NCT01806064|7486151|FG000|STARTED|Overall Study||3
6787354|NCT00683787|7718218|FG002|NOT COMPLETED|Overall Study||2
6787355|NCT00679926|7718226|FG000|STARTED|Overall Study||15
6787356|NCT00679926|7718226|FG000|COMPLETED|Overall Study||2
6787357|NCT00679926|7718226|FG000|NOT COMPLETED|Overall Study||13
6563174|NCT01806064|7486152|FG001|STARTED|Overall Study||15
6563175|NCT01806064|7486153|FG002|STARTED|Overall Study||5
6563176|NCT01806064|7486154|FG003|STARTED|Overall Study||75
6563177|NCT01806064|7486155|FG004|STARTED|Overall Study||75
6563178|NCT01806064|7486151|FG000|COMPLETED|Overall Study||3
6563179|NCT01806064|7486152|FG001|COMPLETED|Overall Study||15
6563180|NCT01806064|7486153|FG002|COMPLETED|Overall Study||5
6563181|NCT01806064|7486154|FG003|COMPLETED|Overall Study||74
6563182|NCT01806064|7486155|FG004|COMPLETED|Overall Study||73
6563183|NCT01806064|7486151|FG000|NOT COMPLETED|Overall Study||0
6563184|NCT01806064|7486152|FG001|NOT COMPLETED|Overall Study||0
6563185|NCT01806064|7486153|FG002|NOT COMPLETED|Overall Study||0
6563186|NCT01806064|7486154|FG003|NOT COMPLETED|Overall Study||1
6563187|NCT01806064|7486155|FG004|NOT COMPLETED|Overall Study||2
6563188|NCT01806168|7486174|FG000|STARTED|Overall Study||11
6563189|NCT01806168|7486175|FG001|STARTED|Overall Study||10
6563190|NCT01806168|7486176|FG002|STARTED|Overall Study||10
6563191|NCT01806168|7486174|FG000|Received Allocated Intervention|Overall Study||11
6656333|NCT02459951|7586477|FG000|NOT COMPLETED|Overall Study||1
6656334|NCT02459964|7586485|FG000|STARTED|Overall Study||42
6656335|NCT02459964|7586486|FG001|STARTED|Overall Study||40
6656336|NCT02459964|7586487|FG002|STARTED|Overall Study||2
6656337|NCT02459964|7586485|FG000|COMPLETED|Overall Study||42
6656338|NCT02459964|7586486|FG001|COMPLETED|Overall Study||40
6656339|NCT02459964|7586487|FG002|COMPLETED|Overall Study||0
6656340|NCT02459964|7586485|FG000|NOT COMPLETED|Overall Study||0
6656341|NCT02459964|7586486|FG001|NOT COMPLETED|Overall Study||0
6656342|NCT02459964|7586487|FG002|NOT COMPLETED|Overall Study||2
6656343|NCT02460172|7586494|FG000|STARTED|Overall Study||25
6656344|NCT02460172|7586494|FG000|COMPLETED|Overall Study||25
6502243|NCT01433250|7420887|FG001|NOT COMPLETED|Overall Study||3
6502244|NCT01433263|7420895|FG000|STARTED|Overall Study||29
6502245|NCT01433263|7420896|FG001|STARTED|Overall Study||28
6656345|NCT02460172|7586494|FG000|NOT COMPLETED|Overall Study||0
6656346|NCT02460263|7586500|FG000|STARTED|In-Center Period||30
6656347|NCT02460263|7586500|FG000|COMPLETED|In-Center Period||30
6787358|NCT00678041|7718233|FG000|STARTED|Overall Study||5
6787359|NCT00678041|7718234|FG001|STARTED|Overall Study||5
6787360|NCT00678041|7718233|FG000|COMPLETED|Overall Study||0
6787361|NCT00678041|7718234|FG001|COMPLETED|Overall Study||0
6787362|NCT00678041|7718233|FG000|NOT COMPLETED|Overall Study||5
6787363|NCT00678041|7718234|FG001|NOT COMPLETED|Overall Study||5
6787364|NCT00680316|7718243|FG000|STARTED|Overall Study||1
6787365|NCT00680316|7718244|FG001|STARTED|Overall Study||2
6787366|NCT00680316|7718243|FG000|COMPLETED|Overall Study||1
6787367|NCT00680316|7718244|FG001|COMPLETED|Overall Study||2
6787368|NCT00680316|7718243|FG000|NOT COMPLETED|Overall Study||0
6787369|NCT00680316|7718244|FG001|NOT COMPLETED|Overall Study||0
6787370|NCT00681629|7718252|FG000|STARTED|Overall Study|It was planned to recruit 100 patient|5
6787371|NCT00681629|7718253|FG001|STARTED|Overall Study|It was planned to recruit 100 patient|2
6787372|NCT00681629|7718252|FG000|COMPLETED|Overall Study||0
6787373|NCT00681629|7718253|FG001|COMPLETED|Overall Study||0
6787374|NCT00681629|7718252|FG000|NOT COMPLETED|Overall Study||5
6787375|NCT00681629|7718253|FG001|NOT COMPLETED|Overall Study||2
6787376|NCT00669461|7718259|FG000|STARTED|Overall Study||1
6787377|NCT00669461|7718259|FG000|COMPLETED|Overall Study||1
6787378|NCT00669461|7718259|FG000|NOT COMPLETED|Overall Study||0
6787379|NCT00671606|7718264|FG000|STARTED|Overall Study||5
6787380|NCT00671606|7718264|FG000|COMPLETED|Overall Study||5
6787381|NCT00671606|7718264|FG000|NOT COMPLETED|Overall Study||0
6787382|NCT00673309|7718278|FG000|STARTED|Overall Study||64
6787383|NCT00673309|7718279|FG001|STARTED|Overall Study||14
6787384|NCT00673309|7718280|FG002|STARTED|Overall Study||14
6787385|NCT00673309|7718281|FG003|STARTED|Overall Study||25
6787386|NCT00673309|7718282|FG004|STARTED|Overall Study||18
6787387|NCT00673309|7718283|FG005|STARTED|Overall Study||35
6787388|NCT00673309|7718284|FG006|STARTED|Overall Study||14
6787389|NCT00673309|7718285|FG007|STARTED|Overall Study||13
6787390|NCT00673309|7718286|FG008|STARTED|Overall Study||17
6787391|NCT00673309|7718287|FG009|STARTED|Overall Study||30
6787392|NCT00673309|7718278|FG000|COMPLETED|Overall Study||64
6787393|NCT00673309|7718279|FG001|COMPLETED|Overall Study||14
6787394|NCT00673309|7718280|FG002|COMPLETED|Overall Study||14
6787395|NCT00673309|7718281|FG003|COMPLETED|Overall Study||25
6787396|NCT00673309|7718282|FG004|COMPLETED|Overall Study||18
6787397|NCT00673309|7718283|FG005|COMPLETED|Overall Study||35
6787398|NCT00673309|7718284|FG006|COMPLETED|Overall Study||14
6787399|NCT00673309|7718285|FG007|COMPLETED|Overall Study||13
6787400|NCT00673309|7718286|FG008|COMPLETED|Overall Study||17
6787401|NCT00673309|7718287|FG009|COMPLETED|Overall Study||30
6787402|NCT00673309|7718278|FG000|NOT COMPLETED|Overall Study||0
6787403|NCT00673309|7718279|FG001|NOT COMPLETED|Overall Study||0
6787404|NCT00673309|7718280|FG002|NOT COMPLETED|Overall Study||0
6787405|NCT00673309|7718281|FG003|NOT COMPLETED|Overall Study||0
6787406|NCT00673309|7718282|FG004|NOT COMPLETED|Overall Study||0
6787407|NCT00673309|7718283|FG005|NOT COMPLETED|Overall Study||0
6787408|NCT00673309|7718284|FG006|NOT COMPLETED|Overall Study||0
6656348|NCT02460263|7586500|FG000|NOT COMPLETED|In-Center Period||0
6656349|NCT02460263|7586500|FG000|STARTED|Transition Period||30
6656350|NCT02460263|7586500|FG000|COMPLETED|Transition Period||28
6656351|NCT02460263|7586500|FG000|NOT COMPLETED|Transition Period||2
6656352|NCT02460263|7586500|FG000|STARTED|In-Home Period||28
6656353|NCT02460263|7586500|FG000|COMPLETED|In-Home Period||28
6787409|NCT00673309|7718285|FG007|NOT COMPLETED|Overall Study||0
6787410|NCT00673309|7718286|FG008|NOT COMPLETED|Overall Study||0
6787411|NCT00673309|7718287|FG009|NOT COMPLETED|Overall Study||0
6787412|NCT00672178|7718300|FG000|STARTED|Overall Study||1
6787413|NCT00672178|7718300|FG000|COMPLETED|Overall Study||1
6787414|NCT00672178|7718300|FG000|NOT COMPLETED|Overall Study||0
6787415|NCT00673595|7718306|FG000|STARTED|Overall Study||8
6656354|NCT02460263|7586500|FG000|NOT COMPLETED|In-Home Period||0
6656355|NCT02460380|7586510|FG000|STARTED|Overall Study||45
6656356|NCT02460380|7586511|FG001|STARTED|Overall Study||23
6656357|NCT02460380|7586510|FG000|COMPLETED|Overall Study||35
6656358|NCT02460380|7586511|FG001|COMPLETED|Overall Study||18
6656359|NCT02460380|7586510|FG000|NOT COMPLETED|Overall Study||10
6656360|NCT02460380|7586511|FG001|NOT COMPLETED|Overall Study||5
6656361|NCT02460562|7586520|FG000|STARTED|Overall Study||74
6656362|NCT02460562|7586521|FG001|STARTED|Overall Study||76
6656363|NCT02460562|7586520|FG000|COMPLETED|Overall Study||59
6787416|NCT00673595|7718307|FG001|STARTED|Overall Study||11
6787417|NCT00673595|7718306|FG000|COMPLETED|Overall Study||8
6787418|NCT00673595|7718307|FG001|COMPLETED|Overall Study||11
6787419|NCT00673595|7718306|FG000|NOT COMPLETED|Overall Study||0
6787420|NCT00673595|7718307|FG001|NOT COMPLETED|Overall Study||0
6787421|NCT00673361|7718313|FG000|STARTED|Overall Study||9
6787422|NCT00673361|7718313|FG000|COMPLETED|Overall Study||7
6787423|NCT00673361|7718313|FG000|NOT COMPLETED|Overall Study||2
6787424|NCT00670631|7718317|FG000|STARTED|Overall Study||0
6787425|NCT00670631|7718317|FG000|COMPLETED|Overall Study||0
6787426|NCT00670631|7718317|FG000|NOT COMPLETED|Overall Study||0
6787427|NCT00668785|7718322|FG000|STARTED|Overall Study||6
6787428|NCT00668785|7718322|FG000|COMPLETED|Overall Study||6
6656364|NCT02460562|7586521|FG001|COMPLETED|Overall Study||60
6656365|NCT02460562|7586520|FG000|NOT COMPLETED|Overall Study||15
6656366|NCT02460562|7586521|FG001|NOT COMPLETED|Overall Study||16
6656367|NCT02460575|7586529|FG000|STARTED|Overall Study||40
6656368|NCT02460575|7586530|FG001|STARTED|Overall Study||20
6787429|NCT00668785|7718322|FG000|NOT COMPLETED|Overall Study||0
6656369|NCT02460575|7586529|FG000|COMPLETED|Overall Study||39
6787430|NCT00673179|7718330|FG000|STARTED|Overall Study||7
6787431|NCT00673179|7718331|FG001|STARTED|Overall Study||0
6787432|NCT00673179|7718330|FG000|COMPLETED|Overall Study||4
6787433|NCT00673179|7718331|FG001|COMPLETED|Overall Study||0
6787434|NCT00673179|7718330|FG000|NOT COMPLETED|Overall Study||3
6787435|NCT00673179|7718331|FG001|NOT COMPLETED|Overall Study||0
6787436|NCT00668265|7718339|FG000|STARTED|Overall Study||9
6787437|NCT00668265|7718340|FG001|STARTED|Overall Study||5
6787438|NCT00668265|7718339|FG000|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
6787439|NCT00668265|7718340|FG001|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
6787440|NCT00668265|7718339|FG000|NOT COMPLETED|Overall Study||9
6787441|NCT00668265|7718340|FG001|NOT COMPLETED|Overall Study||5
6787442|NCT00660348|7718350|FG000|STARTED|Overall Study||1
6787443|NCT00660348|7718351|FG001|STARTED|Overall Study||0
6787444|NCT00660348|7718350|FG000|COMPLETED|Overall Study||0
6787445|NCT00660348|7718351|FG001|COMPLETED|Overall Study||0
6787446|NCT00660348|7718350|FG000|NOT COMPLETED|Overall Study||1
6787447|NCT00660348|7718351|FG001|NOT COMPLETED|Overall Study||0
6787448|NCT00664066|7718357|FG000|STARTED|Overall Study||3
6787449|NCT00664066|7718357|FG000|COMPLETED|Overall Study||0
6787450|NCT00664066|7718357|FG000|NOT COMPLETED|Overall Study||3
6787451|NCT00667017|7718361|FG000|STARTED|Overall Study||1
6787452|NCT00667017|7718361|FG000|COMPLETED|Overall Study||0
6787453|NCT00667017|7718361|FG000|NOT COMPLETED|Overall Study||1
6787454|NCT00665444|7718365|FG000|STARTED|Overall Study||3
6787455|NCT00665444|7718365|FG000|COMPLETED|Overall Study||1
6787456|NCT00665444|7718365|FG000|NOT COMPLETED|Overall Study||2
6787457|NCT00656916|7718371|FG000|STARTED|Overall Study||1
6787458|NCT00656916|7718372|FG001|STARTED|Overall Study||0
6787459|NCT00656916|7718371|FG000|COMPLETED|Overall Study||1
6787460|NCT00656916|7718372|FG001|COMPLETED|Overall Study||0
6787461|NCT00656916|7718371|FG000|NOT COMPLETED|Overall Study||0
6787462|NCT00656916|7718372|FG001|NOT COMPLETED|Overall Study||0
6787463|NCT00660595|7718380|FG000|STARTED|Overall Study||19
6787464|NCT00660595|7718381|FG001|STARTED|Overall Study||10
6787465|NCT00660595|7718380|FG000|COMPLETED|Overall Study||1
6787466|NCT00660595|7718381|FG001|COMPLETED|Overall Study|One of the two was lost to follow-up|1
6787467|NCT00660595|7718380|FG000|NOT COMPLETED|Overall Study||18
6787468|NCT00660595|7718381|FG001|NOT COMPLETED|Overall Study||9
6787469|NCT00661466|7718389|FG000|STARTED|Overall Study|Participants|4
6787470|NCT00661466|7718390|FG001|STARTED|Overall Study|Participants|3
6787471|NCT00661466|7718389|FG000|COMPLETED|Overall Study|Participants|4
6787472|NCT00661466|7718390|FG001|COMPLETED|Overall Study|Participants|3
6787473|NCT00661466|7718389|FG000|NOT COMPLETED|Overall Study||0
6787474|NCT00661466|7718390|FG001|NOT COMPLETED|Overall Study||0
6787475|NCT00646282|7718398|FG000|STARTED|Overall Study||4
6787476|NCT00646282|7718399|FG001|STARTED|Overall Study||4
6787477|NCT00646282|7718398|FG000|COMPLETED|Overall Study||0
6787478|NCT00646282|7718399|FG001|COMPLETED|Overall Study||0
6787479|NCT00646282|7718398|FG000|NOT COMPLETED|Overall Study||4
6787480|NCT00646282|7718399|FG001|NOT COMPLETED|Overall Study||4
6787481|NCT00657553|7718407|FG000|STARTED|Overall Study||5
6787482|NCT00657553|7718408|FG001|STARTED|Overall Study||5
6787483|NCT00657553|7718407|FG000|COMPLETED|Overall Study||0
6787484|NCT00657553|7718408|FG001|COMPLETED|Overall Study||0
6787485|NCT00657553|7718407|FG000|NOT COMPLETED|Overall Study||5
6787486|NCT00657553|7718408|FG001|NOT COMPLETED|Overall Study||5
6787487|NCT00655057|7718417|FG000|STARTED|Overall Study||0
6787488|NCT00655057|7718418|FG001|STARTED|Overall Study||0
6787489|NCT00655057|7718419|FG002|STARTED|Overall Study||0
6787490|NCT00655057|7718417|FG000|COMPLETED|Overall Study||0
6787491|NCT00655057|7718418|FG001|COMPLETED|Overall Study||0
6787492|NCT00655057|7718419|FG002|COMPLETED|Overall Study||0
6787493|NCT00655057|7718417|FG000|NOT COMPLETED|Overall Study||0
6787494|NCT00655057|7718418|FG001|NOT COMPLETED|Overall Study||0
6787495|NCT00655057|7718419|FG002|NOT COMPLETED|Overall Study||0
6787496|NCT00648895|7718429|FG000|STARTED|Overall Study||6
6787497|NCT00648895|7718430|FG001|STARTED|Overall Study||6
6787498|NCT00648895|7718429|FG000|COMPLETED|Overall Study||6
6787499|NCT00648895|7718430|FG001|COMPLETED|Overall Study||5
6787500|NCT00648895|7718429|FG000|NOT COMPLETED|Overall Study||0
6787501|NCT00648895|7718430|FG001|NOT COMPLETED|Overall Study||1
6787502|NCT00647426|7718436|FG000|STARTED|Overall Study||7
6787503|NCT00647426|7718436|FG000|COMPLETED|Overall Study||5
6656370|NCT02460575|7586530|FG001|COMPLETED|Overall Study||20
6656371|NCT02460575|7586529|FG000|NOT COMPLETED|Overall Study||1
6656372|NCT02460575|7586530|FG001|NOT COMPLETED|Overall Study||0
6656373|NCT02460666|7586538|FG000|STARTED|Overall Study||89
6656374|NCT02460666|7586539|FG001|STARTED|Overall Study||89
6656375|NCT02460666|7586538|FG000|COMPLETED|Overall Study||62
6656376|NCT02460666|7586539|FG001|COMPLETED|Overall Study||63
6656377|NCT02460666|7586538|FG000|NOT COMPLETED|Overall Study||27
6656378|NCT02460666|7586539|FG001|NOT COMPLETED|Overall Study||26
6787504|NCT00647426|7718436|FG000|NOT COMPLETED|Overall Study||2
6787505|NCT00645567|7718441|FG000|STARTED|Overall Study||5
6787506|NCT00645567|7718441|FG000|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
6787507|NCT00645567|7718441|FG000|NOT COMPLETED|Overall Study||1
6656379|NCT02460679|7586545|FG000|STARTED|Overall Study||19
6787508|NCT00637806|7718452|FG000|STARTED|Double-blind Phase||2
6787509|NCT00637806|7718453|FG001|STARTED|Double-blind Phase||0
6787510|NCT00637806|7718454|FG002|STARTED|Double-blind Phase||2
6787511|NCT00637806|7718455|FG003|STARTED|Double-blind Phase||0
6787512|NCT00637806|7718452|FG000|COMPLETED|Double-blind Phase||0
6787513|NCT00637806|7718453|FG001|COMPLETED|Double-blind Phase||0
6787514|NCT00637806|7718454|FG002|COMPLETED|Double-blind Phase||1
6787515|NCT00637806|7718455|FG003|COMPLETED|Double-blind Phase||0
6787516|NCT00637806|7718452|FG000|NOT COMPLETED|Double-blind Phase||2
6787517|NCT00637806|7718453|FG001|NOT COMPLETED|Double-blind Phase||0
6787518|NCT00637806|7718454|FG002|NOT COMPLETED|Double-blind Phase||1
6787519|NCT00637806|7718455|FG003|NOT COMPLETED|Double-blind Phase||0
6787520|NCT00637806|7718452|FG000|STARTED|Extension Phase||0
6787521|NCT00637806|7718453|FG001|STARTED|Extension Phase||0
6787522|NCT00637806|7718454|FG002|STARTED|Extension Phase||0
6787523|NCT00637806|7718455|FG003|STARTED|Extension Phase||1
6787524|NCT00637806|7718452|FG000|COMPLETED|Extension Phase||0
6787525|NCT00637806|7718453|FG001|COMPLETED|Extension Phase||0
6787526|NCT00637806|7718454|FG002|COMPLETED|Extension Phase||0
6787527|NCT00637806|7718455|FG003|COMPLETED|Extension Phase||0
6787528|NCT00637806|7718452|FG000|NOT COMPLETED|Extension Phase||0
6787529|NCT00637806|7718453|FG001|NOT COMPLETED|Extension Phase||0
6787530|NCT00637806|7718454|FG002|NOT COMPLETED|Extension Phase||0
6787531|NCT00637806|7718455|FG003|NOT COMPLETED|Extension Phase||1
6787532|NCT00652457|7718464|FG000|STARTED|Overall Study||23
6787533|NCT00652457|7718465|FG001|STARTED|Overall Study||27
6787534|NCT00652457|7718464|FG000|COMPLETED|Overall Study||23
6787535|NCT00652457|7718465|FG001|COMPLETED|Overall Study||27
6787536|NCT00652457|7718464|FG000|NOT COMPLETED|Overall Study||0
6787537|NCT00652457|7718465|FG001|NOT COMPLETED|Overall Study||0
6787538|NCT00642603|7718473|FG000|STARTED|Overall Study||21
6787539|NCT00642603|7718474|FG001|STARTED|Overall Study||20
6787540|NCT00642603|7718473|FG000|Safety Population|Overall Study||19
6787541|NCT00642603|7718474|FG001|Safety Population|Overall Study||20
6656380|NCT02460679|7586545|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
6656381|NCT02460679|7586545|FG000|COMPLETED|Overall Study||14
6656382|NCT02460679|7586545|FG000|NOT COMPLETED|Overall Study||5
6787542|NCT00642603|7718473|FG000|COMPLETED|Overall Study||0
6787543|NCT00642603|7718474|FG001|COMPLETED|Overall Study||2
6787544|NCT00642603|7718473|FG000|NOT COMPLETED|Overall Study||21
6787545|NCT00642603|7718474|FG001|NOT COMPLETED|Overall Study||18
6787546|NCT00629798|7718480|FG000|STARTED|Overall Study||64
6787547|NCT00629798|7718480|FG000|COMPLETED|Overall Study||60
6787548|NCT00629798|7718480|FG000|NOT COMPLETED|Overall Study||4
6787549|NCT00645359|7718484|FG000|STARTED|Overall Study||9
6787550|NCT00645359|7718484|FG000|COMPLETED|Overall Study||9
6787551|NCT00645359|7718484|FG000|NOT COMPLETED|Overall Study||0
6787552|NCT00637728|7718490|FG000|STARTED|Double-blind Phase||4
6787553|NCT00637728|7718491|FG001|STARTED|Double-blind Phase||1
6787554|NCT00637728|7718492|FG002|STARTED|Double-blind Phase||0
6787555|NCT00637728|7718490|FG000|COMPLETED|Double-blind Phase||0
6787556|NCT00637728|7718491|FG001|COMPLETED|Double-blind Phase||0
6787557|NCT00637728|7718492|FG002|COMPLETED|Double-blind Phase||0
6787558|NCT00637728|7718490|FG000|NOT COMPLETED|Double-blind Phase||4
6787559|NCT00637728|7718491|FG001|NOT COMPLETED|Double-blind Phase||1
6787560|NCT00637728|7718492|FG002|NOT COMPLETED|Double-blind Phase||0
6787561|NCT00637728|7718490|FG000|STARTED|Extension Phase||0
6787562|NCT00637728|7718491|FG001|STARTED|Extension Phase||0
6787563|NCT00637728|7718492|FG002|STARTED|Extension Phase||0
6787564|NCT00637728|7718490|FG000|COMPLETED|Extension Phase||0
6787565|NCT00637728|7718491|FG001|COMPLETED|Extension Phase||0
6787566|NCT00637728|7718492|FG002|COMPLETED|Extension Phase||0
6787567|NCT00637728|7718490|FG000|NOT COMPLETED|Extension Phase||0
6787568|NCT00637728|7718491|FG001|NOT COMPLETED|Extension Phase||0
6787569|NCT00637728|7718492|FG002|NOT COMPLETED|Extension Phase||0
6787570|NCT00639626|7718499|FG000|STARTED|Overall Study||0
6787571|NCT00639626|7718499|FG000|COMPLETED|Overall Study||0
6787572|NCT00639626|7718499|FG000|NOT COMPLETED|Overall Study||0
6787573|NCT00634582|7718503|FG000|STARTED|Overall Study||2
6787574|NCT00634582|7718503|FG000|COMPLETED|Overall Study||2
6787575|NCT00634582|7718503|FG000|NOT COMPLETED|Overall Study||0
6787576|NCT00641108|7718509|FG000|STARTED|Overall Study||0
6787577|NCT00641108|7718510|FG001|STARTED|Overall Study||0
6787578|NCT00641108|7718509|FG000|COMPLETED|Overall Study||0
6787579|NCT00641108|7718510|FG001|COMPLETED|Overall Study||0
6787580|NCT00641108|7718509|FG000|NOT COMPLETED|Overall Study||0
6378635|NCT00768989|7289149|FG000|NOT COMPLETED|On or After Week 36||51
6378636|NCT00768989|7289150|FG001|NOT COMPLETED|On or After Week 36||27
6656383|NCT02460822|7586549|FG000|STARTED|Overall Study||16
6656384|NCT02460822|7586549|FG000|COMPLETED|Overall Study||15
6656385|NCT02460822|7586549|FG000|NOT COMPLETED|Overall Study||1
6656386|NCT02460978|7586556|FG000|STARTED|Overall Study||271
6656387|NCT02460978|7586557|FG001|STARTED|Overall Study||270
6656388|NCT02460978|7586558|FG002|STARTED|Overall Study||272
6656389|NCT02460978|7586556|FG000|COMPLETED|Overall Study||244
6787581|NCT00641108|7718510|FG001|NOT COMPLETED|Overall Study||0
6787582|NCT00642382|7718518|FG000|STARTED|Overall Study||0
6787583|NCT00642382|7718519|FG001|STARTED|Overall Study||0
6268859|NCT00068692|7167965|FG000|Reported AE Data|Step 2: Randomization||0
6268860|NCT00068692|7167966|FG001|Reported AE Data|Step 2: Randomization||0
6268861|NCT00068692|7167967|FG002|Reported AE Data|Step 2: Randomization||27
6787584|NCT00642382|7718518|FG000|COMPLETED|Overall Study||0
6787585|NCT00642382|7718519|FG001|COMPLETED|Overall Study||0
6787586|NCT00642382|7718518|FG000|NOT COMPLETED|Overall Study||0
6787587|NCT00642382|7718519|FG001|NOT COMPLETED|Overall Study||0
6787588|NCT00637416|7718527|FG000|STARTED|Overall Study||4
6787589|NCT00637416|7718528|FG001|STARTED|Overall Study||5
6787590|NCT00637416|7718527|FG000|COMPLETED|Overall Study||3
6787591|NCT00637416|7718528|FG001|COMPLETED|Overall Study||3
6787592|NCT00637416|7718527|FG000|NOT COMPLETED|Overall Study||1
6787593|NCT00637416|7718528|FG001|NOT COMPLETED|Overall Study||2
6787594|NCT00635167|7718534|FG000|STARTED|Overall Study||1
6787595|NCT00635167|7718534|FG000|COMPLETED|Overall Study||1
6787596|NCT00635167|7718534|FG000|NOT COMPLETED|Overall Study||0
6378637|NCT00769015|7289160|FG000|STARTED|Overall Study||96
6378638|NCT00769015|7289161|FG001|STARTED|Overall Study||92
6378639|NCT00769015|7289160|FG000|COMPLETED|Overall Study||87
6378640|NCT00769015|7289161|FG001|COMPLETED|Overall Study||76
6378641|NCT00769015|7289160|FG000|NOT COMPLETED|Overall Study||9
6378642|NCT00769015|7289161|FG001|NOT COMPLETED|Overall Study||16
6378643|NCT00769067|7289169|FG000|STARTED|Overall Study||94
6378644|NCT00769067|7289170|FG001|STARTED|Overall Study||94
6378645|NCT00769067|7289169|FG000|Treated|Overall Study||94
6378646|NCT00769067|7289170|FG001|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
6378647|NCT00769067|7289169|FG000|COMPLETED|Overall Study||0
6378648|NCT00769067|7289170|FG001|COMPLETED|Overall Study||0
6378649|NCT00769067|7289169|FG000|NOT COMPLETED|Overall Study||94
6378650|NCT00769067|7289170|FG001|NOT COMPLETED|Overall Study||94
6378651|NCT00769119|7289179|FG000|STARTED|Overall Study||22
6378652|NCT00769119|7289180|FG001|STARTED|Overall Study||16
6378653|NCT00769119|7289179|FG000|COMPLETED|Overall Study||20
6378654|NCT00769119|7289180|FG001|COMPLETED|Overall Study||13
6378655|NCT00769119|7289179|FG000|NOT COMPLETED|Overall Study||2
6378656|NCT00769119|7289180|FG001|NOT COMPLETED|Overall Study||3
6378657|NCT00769132|7289186|FG000|STARTED|Period 1||7
6378658|NCT00769132|7289187|FG001|STARTED|Period 1||6
6378659|NCT00769132|7289188|FG002|STARTED|Period 1||6
6378660|NCT00769132|7289189|FG003|STARTED|Period 1||7
6378661|NCT00769132|7289186|FG000|COMPLETED|Period 1||6
6378662|NCT00769132|7289187|FG001|COMPLETED|Period 1||6
6378663|NCT00769132|7289188|FG002|COMPLETED|Period 1||6
6378664|NCT00769132|7289189|FG003|COMPLETED|Period 1||6
6378665|NCT00769132|7289186|FG000|NOT COMPLETED|Period 1||1
6378666|NCT00769132|7289187|FG001|NOT COMPLETED|Period 1||0
6378667|NCT00769132|7289188|FG002|NOT COMPLETED|Period 1||0
6378668|NCT00769132|7289189|FG003|NOT COMPLETED|Period 1||1
6378669|NCT00769132|7289186|FG000|STARTED|Period 2||6
6378670|NCT00769132|7289187|FG001|STARTED|Period 2||6
6378671|NCT00769132|7289188|FG002|STARTED|Period 2||6
6378672|NCT00769132|7289189|FG003|STARTED|Period 2||6
6378673|NCT00769132|7289186|FG000|COMPLETED|Period 2||6
6378674|NCT00769132|7289187|FG001|COMPLETED|Period 2||6
6378675|NCT00769132|7289188|FG002|COMPLETED|Period 2||6
6378676|NCT00769132|7289189|FG003|COMPLETED|Period 2||5
6378677|NCT00769132|7289186|FG000|NOT COMPLETED|Period 2||0
6378678|NCT00769132|7289187|FG001|NOT COMPLETED|Period 2||0
6378679|NCT00769132|7289188|FG002|NOT COMPLETED|Period 2||0
6378680|NCT00769132|7289189|FG003|NOT COMPLETED|Period 2||1
6378681|NCT00769132|7289186|FG000|STARTED|Period 3||6
6378682|NCT00769132|7289187|FG001|STARTED|Period 3||6
6378683|NCT00769132|7289188|FG002|STARTED|Period 3||6
6378684|NCT00769132|7289189|FG003|STARTED|Period 3||5
6378685|NCT00769132|7289186|FG000|COMPLETED|Period 3||5
6378686|NCT00769132|7289187|FG001|COMPLETED|Period 3||6
6378687|NCT00769132|7289188|FG002|COMPLETED|Period 3||6
6378688|NCT00769132|7289189|FG003|COMPLETED|Period 3||5
6378689|NCT00769132|7289186|FG000|NOT COMPLETED|Period 3||1
6378690|NCT00769132|7289187|FG001|NOT COMPLETED|Period 3||0
6378691|NCT00769132|7289188|FG002|NOT COMPLETED|Period 3||0
6378692|NCT00769132|7289189|FG003|NOT COMPLETED|Period 3||0
6378693|NCT00769132|7289186|FG000|STARTED|Period 4||5
6378694|NCT00769132|7289187|FG001|STARTED|Period 4||6
6787597|NCT00637312|7718540|FG000|STARTED|Overall Study||72
6787598|NCT00637312|7718541|FG001|STARTED|Overall Study||36
6787599|NCT00637312|7718540|FG000|COMPLETED|Overall Study||30
6787600|NCT00637312|7718541|FG001|COMPLETED|Overall Study||19
6787601|NCT00637312|7718540|FG000|NOT COMPLETED|Overall Study||42
6787602|NCT00637312|7718541|FG001|NOT COMPLETED|Overall Study||17
6787603|NCT00638222|7718550|FG000|STARTED|Overall Study||0
6787604|NCT00638222|7718551|FG001|STARTED|Overall Study||0
6787605|NCT00638222|7718552|FG002|STARTED|Overall Study||6
6787606|NCT00638222|7718550|FG000|COMPLETED|Overall Study||0
6378695|NCT00769132|7289188|FG002|STARTED|Period 4||6
6378696|NCT00769132|7289189|FG003|STARTED|Period 4||5
6378697|NCT00769132|7289186|FG000|COMPLETED|Period 4||5
6378698|NCT00769132|7289187|FG001|COMPLETED|Period 4||5
6378699|NCT00769132|7289188|FG002|COMPLETED|Period 4||6
6378700|NCT00769132|7289189|FG003|COMPLETED|Period 4||5
6378701|NCT00769132|7289186|FG000|NOT COMPLETED|Period 4||0
6378702|NCT00769132|7289187|FG001|NOT COMPLETED|Period 4||1
6378703|NCT00769132|7289188|FG002|NOT COMPLETED|Period 4||0
6378704|NCT00769132|7289189|FG003|NOT COMPLETED|Period 4||0
6378705|NCT00769184|7289199|FG000|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
6378706|NCT00769184|7289200|FG001|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
6378707|NCT00769184|7289199|FG000|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
6395531|NCT00858845|7308098|FG000|NOT COMPLETED|Overall Study||0
6787607|NCT00638222|7718551|FG001|COMPLETED|Overall Study||0
6787608|NCT00638222|7718552|FG002|COMPLETED|Overall Study||6
6787609|NCT00638222|7718550|FG000|NOT COMPLETED|Overall Study||0
6787610|NCT00638222|7718551|FG001|NOT COMPLETED|Overall Study||0
6787611|NCT00638222|7718552|FG002|NOT COMPLETED|Overall Study||0
6787612|NCT00634322|7718562|FG000|STARTED|Overall Study||1
6787613|NCT00634322|7718563|FG001|STARTED|Overall Study||1
6787614|NCT00634322|7718564|FG002|STARTED|Overall Study||5
6787615|NCT00634322|7718562|FG000|COMPLETED|Overall Study||1
6787616|NCT00634322|7718563|FG001|COMPLETED|Overall Study||1
6787617|NCT00634322|7718564|FG002|COMPLETED|Overall Study||5
6787618|NCT00634322|7718562|FG000|NOT COMPLETED|Overall Study||0
6787619|NCT00634322|7718563|FG001|NOT COMPLETED|Overall Study||0
6787620|NCT00634322|7718564|FG002|NOT COMPLETED|Overall Study||0
6787621|NCT00633087|7718572|FG000|STARTED|Overall Study||12
6787622|NCT00633087|7718572|FG000|COMPLETED|Overall Study||12
6787623|NCT00633087|7718572|FG000|NOT COMPLETED|Overall Study||0
6787624|NCT00631137|7718578|FG000|STARTED|Overall Study||1
6787625|NCT00631137|7718579|FG001|STARTED|Overall Study||0
6787626|NCT00631137|7718578|FG000|COMPLETED|Overall Study||0
6787627|NCT00631137|7718579|FG001|COMPLETED|Overall Study||0
6787628|NCT00631137|7718578|FG000|NOT COMPLETED|Overall Study||1
6787629|NCT00631137|7718579|FG001|NOT COMPLETED|Overall Study||0
6787630|NCT00634972|7718587|FG000|STARTED|Overall Study||40
6787631|NCT00634972|7718588|FG001|STARTED|Overall Study||43
6787632|NCT00634972|7718587|FG000|COMPLETED|Overall Study||40
6787633|NCT00634972|7718588|FG001|COMPLETED|Overall Study||43
6787634|NCT00634972|7718587|FG000|NOT COMPLETED|Overall Study||0
6787635|NCT00634972|7718588|FG001|NOT COMPLETED|Overall Study||0
6787636|NCT00633061|7718596|FG000|STARTED|Overall Study|Study was on hold for 2 months for continuing review|136
6787637|NCT00633061|7718597|FG001|STARTED|Overall Study||0
6787638|NCT00633061|7718596|FG000|Met Criteria for Imaging|Overall Study||25
6787639|NCT00633061|7718597|FG001|Met Criteria for Imaging|Overall Study||0
6787640|NCT00633061|7718596|FG000|Had Prior Thrombosis Identified|Overall Study||25
6787641|NCT00633061|7718597|FG001|Had Prior Thrombosis Identified|Overall Study||0
6787642|NCT00633061|7718596|FG000|COMPLETED|Overall Study||50
6787643|NCT00633061|7718597|FG001|COMPLETED|Overall Study||0
6787644|NCT00633061|7718596|FG000|NOT COMPLETED|Overall Study||86
6787645|NCT00633061|7718597|FG001|NOT COMPLETED|Overall Study||0
6787646|NCT00626444|7718605|FG000|STARTED|Overall Study||2
6787647|NCT00626444|7718605|FG000|COMPLETED|Overall Study||2
6787648|NCT00626444|7718605|FG000|NOT COMPLETED|Overall Study||0
6787649|NCT00630292|7718609|FG000|STARTED|Overall Study||6
6787650|NCT00630292|7718609|FG000|COMPLETED|Overall Study||5
6787651|NCT00630292|7718609|FG000|NOT COMPLETED|Overall Study||1
6787652|NCT00634010|7718615|FG000|STARTED|Overall Study||18
6787653|NCT00634010|7718616|FG001|STARTED|Overall Study||18
6787654|NCT00634010|7718615|FG000|COMPLETED|Overall Study||8
6787655|NCT00634010|7718616|FG001|COMPLETED|Overall Study||4
6787656|NCT00634010|7718615|FG000|NOT COMPLETED|Overall Study||10
6787657|NCT00634010|7718616|FG001|NOT COMPLETED|Overall Study||14
6787658|NCT00630487|7718624|FG000|STARTED|Overall Study||0
6787659|NCT00630487|7718625|FG001|STARTED|Overall Study||0
6787660|NCT00630487|7718624|FG000|COMPLETED|Overall Study||0
6787661|NCT00630487|7718625|FG001|COMPLETED|Overall Study||0
6787662|NCT00630487|7718624|FG000|NOT COMPLETED|Overall Study||0
6787663|NCT00630487|7718625|FG001|NOT COMPLETED|Overall Study||0
6787664|NCT00629850|7718633|FG000|STARTED|Overall Study||1
6787665|NCT00629850|7718634|FG001|STARTED|Overall Study||0
6787666|NCT00629850|7718633|FG000|COMPLETED|Overall Study||1
6787667|NCT00629850|7718634|FG001|COMPLETED|Overall Study||0
6787668|NCT00629850|7718633|FG000|NOT COMPLETED|Overall Study||0
6787669|NCT00629850|7718634|FG001|NOT COMPLETED|Overall Study||0
6787670|NCT00623974|7718644|FG000|STARTED|Overall Study||0
6787671|NCT00623974|7718645|FG001|STARTED|Overall Study||0
6787672|NCT00623974|7718646|FG002|STARTED|Overall Study||0
6787673|NCT00623974|7718647|FG003|STARTED|Overall Study||0
6787674|NCT00623974|7718644|FG000|COMPLETED|Overall Study||0
6787675|NCT00623974|7718645|FG001|COMPLETED|Overall Study||0
6787676|NCT00623974|7718646|FG002|COMPLETED|Overall Study||0
6787677|NCT00623974|7718647|FG003|COMPLETED|Overall Study||0
6787678|NCT00623974|7718644|FG000|NOT COMPLETED|Overall Study||0
6787679|NCT00623974|7718645|FG001|NOT COMPLETED|Overall Study||0
6787680|NCT00623974|7718646|FG002|NOT COMPLETED|Overall Study||0
6787681|NCT00623974|7718647|FG003|NOT COMPLETED|Overall Study||0
6787682|NCT00624650|7718659|FG000|STARTED|Overall Study||17
6787683|NCT00624650|7718660|FG001|STARTED|Overall Study||16
6787684|NCT00624650|7718659|FG000|COMPLETED|Overall Study||16
6787685|NCT00624650|7718660|FG001|COMPLETED|Overall Study||15
6787686|NCT00624650|7718659|FG000|NOT COMPLETED|Overall Study||1
6787687|NCT00624650|7718660|FG001|NOT COMPLETED|Overall Study||1
6787688|NCT00626561|7718666|FG000|STARTED|Overall Study||4
6787689|NCT00626561|7718666|FG000|COMPLETED|Overall Study||0
6787690|NCT00626561|7718666|FG000|NOT COMPLETED|Overall Study||4
6787691|NCT00613730|7718670|FG000|STARTED|Overall Study||3
6787692|NCT00613730|7718670|FG000|COMPLETED|Overall Study||0
6787693|NCT00613730|7718670|FG000|NOT COMPLETED|Overall Study||3
6787694|NCT00625586|7718674|FG000|STARTED|Overall Study||2
6787695|NCT00625586|7718674|FG000|COMPLETED|Overall Study||1
6787696|NCT00625586|7718674|FG000|NOT COMPLETED|Overall Study||1
6787697|NCT00625703|7718678|FG000|STARTED|Overall Study||0
6787698|NCT00625703|7718678|FG000|COMPLETED|Overall Study||0
6787699|NCT00625703|7718678|FG000|NOT COMPLETED|Overall Study||0
6787700|NCT00625742|7718682|FG000|STARTED|Overall Study||15
6787701|NCT00625742|7718682|FG000|COMPLETED|Overall Study||3
6787702|NCT00625742|7718682|FG000|NOT COMPLETED|Overall Study||12
6787703|NCT00619242|7718686|FG000|STARTED|Overall Study||3
6787704|NCT00619242|7718686|FG000|COMPLETED|Overall Study||3
6787705|NCT00619242|7718686|FG000|NOT COMPLETED|Overall Study||0
6787706|NCT00619151|7718692|FG000|STARTED|Overall Study||2
6787707|NCT00619151|7718693|FG001|STARTED|Overall Study||0
6787708|NCT00619151|7718692|FG000|COMPLETED|Overall Study||1
6787709|NCT00619151|7718693|FG001|COMPLETED|Overall Study||0
6787710|NCT00619151|7718692|FG000|NOT COMPLETED|Overall Study||1
6787711|NCT00619151|7718693|FG001|NOT COMPLETED|Overall Study||0
6787712|NCT00622167|7718699|FG000|STARTED|Overall Study||24
6787713|NCT00622167|7718699|FG000|COMPLETED|Overall Study||4
6787714|NCT00622167|7718699|FG000|NOT COMPLETED|Overall Study||20
6787715|NCT00616577|7718706|FG000|STARTED|Overall Study||6
6787716|NCT00616577|7718707|FG001|STARTED|Overall Study||9
6787717|NCT00616577|7718708|FG002|STARTED|Overall Study||7
6787718|NCT00616577|7718706|FG000|COMPLETED|Overall Study||6
6787719|NCT00616577|7718707|FG001|COMPLETED|Overall Study||9
6787720|NCT00616577|7718708|FG002|COMPLETED|Overall Study||7
6787721|NCT00616577|7718706|FG000|NOT COMPLETED|Overall Study||0
6787722|NCT00616577|7718707|FG001|NOT COMPLETED|Overall Study||0
6787723|NCT00616577|7718708|FG002|NOT COMPLETED|Overall Study||0
6787724|NCT00616759|7718718|FG000|STARTED|Overall Study||10
6787725|NCT00616759|7718719|FG001|STARTED|Overall Study||10
6787726|NCT00616759|7718718|FG000|COMPLETED|Overall Study||7
6787727|NCT00616759|7718719|FG001|COMPLETED|Overall Study||8
6787728|NCT00616759|7718718|FG000|NOT COMPLETED|Overall Study||3
6787729|NCT00616759|7718719|FG001|NOT COMPLETED|Overall Study||2
6787730|NCT00616642|7718727|FG000|STARTED|Overall Study||0
6787731|NCT00616642|7718728|FG001|STARTED|Overall Study||1
6787732|NCT00616642|7718727|FG000|COMPLETED|Overall Study||0
6787733|NCT00616642|7718728|FG001|COMPLETED|Overall Study||0
6787734|NCT00616642|7718727|FG000|NOT COMPLETED|Overall Study||0
6787735|NCT00616642|7718728|FG001|NOT COMPLETED|Overall Study||1
6787736|NCT00619515|7718734|FG000|STARTED|Overall Study||73
6787737|NCT00619515|7718734|FG000|COMPLETED|Overall Study||0
6787738|NCT00619515|7718734|FG000|NOT COMPLETED|Overall Study||73
6787739|NCT00616343|7718738|FG000|STARTED|Overall Study||9
6787740|NCT00616343|7718738|FG000|COMPLETED|Overall Study||9
6787741|NCT00616343|7718738|FG000|NOT COMPLETED|Overall Study||0
6787742|NCT00612677|7718742|FG000|STARTED|Overall Study||1
6787743|NCT00612677|7718742|FG000|COMPLETED|Overall Study||0
6787744|NCT00612677|7718742|FG000|NOT COMPLETED|Overall Study||1
6787745|NCT00616603|7718749|FG000|STARTED|Overall Study||14
6787746|NCT00616603|7718750|FG001|STARTED|Overall Study||14
6787747|NCT00616603|7718751|FG002|STARTED|Overall Study||15
6787748|NCT00616603|7718749|FG000|COMPLETED|Overall Study||12
6787749|NCT00616603|7718750|FG001|COMPLETED|Overall Study||14
6787750|NCT00616603|7718751|FG002|COMPLETED|Overall Study||13
6787751|NCT00616603|7718749|FG000|NOT COMPLETED|Overall Study||2
6787752|NCT00616603|7718750|FG001|NOT COMPLETED|Overall Study||0
6787753|NCT00616603|7718751|FG002|NOT COMPLETED|Overall Study||2
6787754|NCT00613886|7718759|FG000|STARTED|Overall Study||24
6787755|NCT00613886|7718759|FG000|COMPLETED|Overall Study||0
6787756|NCT00613886|7718759|FG000|NOT COMPLETED|Overall Study||24
6787757|NCT00610467|7718766|FG000|STARTED|Overall Study||1
6787758|NCT00610467|7718767|FG001|STARTED|Overall Study||1
6787759|NCT00610467|7718766|FG000|COMPLETED|Overall Study||1
6787760|NCT00610467|7718767|FG001|COMPLETED|Overall Study||1
6787761|NCT00610467|7718766|FG000|NOT COMPLETED|Overall Study||0
6787762|NCT00610467|7718767|FG001|NOT COMPLETED|Overall Study||0
6787763|NCT00610558|7718776|FG000|STARTED|Overall Study||20
6787764|NCT00610558|7718777|FG001|STARTED|Overall Study||20
6787765|NCT00610558|7718778|FG002|STARTED|Overall Study||20
6787766|NCT00610558|7718776|FG000|COMPLETED|Overall Study||15
6787767|NCT00610558|7718777|FG001|COMPLETED|Overall Study||14
6787768|NCT00610558|7718778|FG002|COMPLETED|Overall Study||14
6787769|NCT00610558|7718776|FG000|NOT COMPLETED|Overall Study||5
6787770|NCT00610558|7718777|FG001|NOT COMPLETED|Overall Study||6
6787771|NCT00610558|7718778|FG002|NOT COMPLETED|Overall Study||6
6787772|NCT00610532|7718786|FG000|STARTED|Intravenous Phenytoin Alone||8
6787773|NCT00610532|7718786|FG000|COMPLETED|Intravenous Phenytoin Alone||8
6787774|NCT00610532|7718786|FG000|NOT COMPLETED|Intravenous Phenytoin Alone||0
6787775|NCT00610532|7718786|FG000|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
6787776|NCT00610532|7718786|FG000|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
6787777|NCT00610532|7718786|FG000|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
6787778|NCT00609765|7718792|FG000|STARTED|Overall Study||1
6787779|NCT00609765|7718792|FG000|COMPLETED|Overall Study||0
6787780|NCT00609765|7718792|FG000|NOT COMPLETED|Overall Study||1
6787781|NCT00608465|7718796|FG000|STARTED|Overall Study||4
6787782|NCT00608465|7718796|FG000|COMPLETED|Overall Study||4
6787783|NCT00608465|7718796|FG000|NOT COMPLETED|Overall Study||0
6787784|NCT00608777|7718800|FG000|STARTED|Overall Study||6
6787785|NCT00608777|7718800|FG000|COMPLETED|Overall Study||6
6787786|NCT00608777|7718800|FG000|NOT COMPLETED|Overall Study||0
6787787|NCT00601848|7718804|FG000|STARTED|Overall Study||9
6787788|NCT00601848|7718804|FG000|COMPLETED|Overall Study||0
6787789|NCT00601848|7718804|FG000|NOT COMPLETED|Overall Study||9
6787790|NCT00607477|7718810|FG000|STARTED|Overall Study||0
6787791|NCT00607477|7718811|FG001|STARTED|Overall Study||2
6787792|NCT00607477|7718810|FG000|COMPLETED|Overall Study||0
6787793|NCT00607477|7718811|FG001|COMPLETED|Overall Study||2
6787794|NCT00607477|7718810|FG000|NOT COMPLETED|Overall Study||0
6787795|NCT00607477|7718811|FG001|NOT COMPLETED|Overall Study||0
6787796|NCT00595920|7718817|FG000|STARTED|Overall Study||116
6787797|NCT00595920|7718817|FG000|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
6787798|NCT00595920|7718817|FG000|COMPLETED|Overall Study||0
6787799|NCT00595920|7718817|FG000|NOT COMPLETED|Overall Study||116
6787800|NCT00596947|7718823|FG000|STARTED|Overall Study||9
6787801|NCT00596947|7718824|FG001|STARTED|Overall Study||9
6787802|NCT00596947|7718823|FG000|COMPLETED|Overall Study||3
6787803|NCT00596947|7718824|FG001|COMPLETED|Overall Study||6
6787804|NCT00596947|7718823|FG000|NOT COMPLETED|Overall Study||6
6787805|NCT00596947|7718824|FG001|NOT COMPLETED|Overall Study||3
6787806|NCT00584012|7718830|FG000|STARTED|Overall Study||9
6787807|NCT00584012|7718830|FG000|COMPLETED|Overall Study||8
6787808|NCT00584012|7718830|FG000|NOT COMPLETED|Overall Study||1
6787809|NCT00599131|7718834|FG000|STARTED|Overall Study||4
6787810|NCT00599131|7718834|FG000|COMPLETED|Overall Study||4
6787811|NCT00599131|7718834|FG000|NOT COMPLETED|Overall Study||0
6787812|NCT00597909|7718841|FG000|STARTED|Overall Study||0
6787813|NCT00597909|7718842|FG001|STARTED|Overall Study||0
6787814|NCT00597909|7718843|FG002|STARTED|Overall Study||0
6787815|NCT00597909|7718841|FG000|COMPLETED|Overall Study||0
6787816|NCT00597909|7718842|FG001|COMPLETED|Overall Study||0
6787817|NCT00597909|7718843|FG002|COMPLETED|Overall Study||0
6787818|NCT00597909|7718841|FG000|NOT COMPLETED|Overall Study||0
6787819|NCT00597909|7718842|FG001|NOT COMPLETED|Overall Study||0
6787820|NCT00597909|7718843|FG002|NOT COMPLETED|Overall Study||0
6787821|NCT00593320|7718853|FG000|STARTED|Overall Study||1
6787822|NCT00593320|7718854|FG001|STARTED|Overall Study||1
6787823|NCT00593320|7718853|FG000|COMPLETED|Overall Study||1
6787824|NCT00593320|7718854|FG001|COMPLETED|Overall Study||1
6787825|NCT00593320|7718853|FG000|NOT COMPLETED|Overall Study||0
6787826|NCT00593320|7718854|FG001|NOT COMPLETED|Overall Study||0
6787827|NCT00589550|7718860|FG000|STARTED|Overall Study||1
6787828|NCT00589550|7718860|FG000|Withdrew From Study|Overall Study||1
6787829|NCT00589550|7718860|FG000|COMPLETED|Overall Study||0
6787830|NCT00589550|7718860|FG000|NOT COMPLETED|Overall Study||1
6787831|NCT00577772|7718866|FG000|STARTED|Overall Study||10
6787832|NCT00577772|7718867|FG001|STARTED|Overall Study||7
6787833|NCT00577772|7718866|FG000|COMPLETED|Overall Study||10
6787834|NCT00577772|7718867|FG001|COMPLETED|Overall Study||6
6787835|NCT00577772|7718866|FG000|NOT COMPLETED|Overall Study||0
6787836|NCT00577772|7718867|FG001|NOT COMPLETED|Overall Study||1
6787837|NCT00592007|7718873|FG000|STARTED|Overall Study||7
6787838|NCT00592007|7718873|FG000|COMPLETED|Overall Study||5
6787839|NCT00592007|7718873|FG000|NOT COMPLETED|Overall Study||2
6787840|NCT00595582|7718877|FG000|STARTED|Overall Study||10
6787841|NCT00595582|7718877|FG000|COMPLETED|Overall Study||0
6787842|NCT00595582|7718877|FG000|NOT COMPLETED|Overall Study||10
6787843|NCT00588146|7718881|FG000|STARTED|First Intervention (Baseline to 6 mo)||5
6787844|NCT00588146|7718882|FG001|STARTED|First Intervention (Baseline to 6 mo)||5
6787845|NCT00588146|7718881|FG000|COMPLETED|First Intervention (Baseline to 6 mo)||1
6787846|NCT00588146|7718882|FG001|COMPLETED|First Intervention (Baseline to 6 mo)||2
6787847|NCT00588146|7718881|FG000|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
6787848|NCT00588146|7718882|FG001|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
6787849|NCT00588146|7718881|FG000|STARTED|Second Intervention (6 Months to 1 Year)||1
6787850|NCT00588146|7718882|FG001|STARTED|Second Intervention (6 Months to 1 Year)||2
6787851|NCT00588146|7718881|FG000|COMPLETED|Second Intervention (6 Months to 1 Year)||1
6787852|NCT00588146|7718882|FG001|COMPLETED|Second Intervention (6 Months to 1 Year)||2
6787853|NCT00588146|7718881|FG000|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
6787854|NCT00588146|7718882|FG001|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
6787855|NCT00586209|7718890|FG000|STARTED|Overall Study||5
6787856|NCT00586209|7718891|FG001|STARTED|Overall Study||10
6787857|NCT00586209|7718890|FG000|COMPLETED|Overall Study||5
6563192|NCT01806168|7486175|FG001|Received Allocated Intervention|Overall Study||9
6563193|NCT01806168|7486176|FG002|Received Allocated Intervention|Overall Study||9
6563194|NCT01806168|7486174|FG000|COMPLETED|Overall Study||10
6563195|NCT01806168|7486175|FG001|COMPLETED|Overall Study||9
6563196|NCT01806168|7486176|FG002|COMPLETED|Overall Study||7
6563197|NCT01806168|7486174|FG000|NOT COMPLETED|Overall Study||1
6787858|NCT00586209|7718891|FG001|COMPLETED|Overall Study||10
6787859|NCT00586209|7718890|FG000|NOT COMPLETED|Overall Study||0
6787860|NCT00586209|7718891|FG001|NOT COMPLETED|Overall Study||0
6787861|NCT00590538|7718897|FG000|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
6787862|NCT00590538|7718897|FG000|COMPLETED|Overall Study||7
6787863|NCT00590538|7718897|FG000|NOT COMPLETED|Overall Study||2
6787864|NCT00583115|7718901|FG000|STARTED|Overall Study||1
6787865|NCT00583115|7718901|FG000|COMPLETED|Overall Study||0
6787866|NCT00583115|7718901|FG000|NOT COMPLETED|Overall Study||1
6787867|NCT00582712|7718905|FG000|STARTED|Overall Study||5
6787868|NCT00582712|7718905|FG000|COMPLETED|Overall Study||1
6787869|NCT00582712|7718905|FG000|NOT COMPLETED|Overall Study||4
6787870|NCT00586716|7718911|FG000|STARTED|Overall Study||14
6787871|NCT00586716|7718912|FG001|STARTED|Overall Study||8
6787872|NCT00586716|7718911|FG000|COMPLETED|Overall Study||14
6787873|NCT00586716|7718912|FG001|COMPLETED|Overall Study||8
6787874|NCT00586716|7718911|FG000|NOT COMPLETED|Overall Study||0
6787875|NCT00586716|7718912|FG001|NOT COMPLETED|Overall Study||0
6787876|NCT00583466|7718919|FG000|STARTED|Overall Study||18
6787877|NCT00583466|7718919|FG000|COMPLETED|Overall Study||18
6787878|NCT00583466|7718919|FG000|NOT COMPLETED|Overall Study||0
6787879|NCT00588471|7718927|FG000|STARTED|Overall Study||28
6787880|NCT00588471|7718928|FG001|STARTED|Overall Study||29
6787881|NCT00588471|7718927|FG000|COMPLETED|Overall Study||28
6787882|NCT00588471|7718928|FG001|COMPLETED|Overall Study||29
6787883|NCT00588471|7718927|FG000|NOT COMPLETED|Overall Study||0
6787884|NCT00588471|7718928|FG001|NOT COMPLETED|Overall Study||0
6787885|NCT00587795|7718936|FG000|STARTED|Overall Study||1
6787886|NCT00587795|7718937|FG001|STARTED|Overall Study||0
6787887|NCT00587795|7718936|FG000|COMPLETED|Overall Study||0
6787888|NCT00587795|7718937|FG001|COMPLETED|Overall Study||0
6787889|NCT00587795|7718936|FG000|NOT COMPLETED|Overall Study||1
6787890|NCT00587795|7718937|FG001|NOT COMPLETED|Overall Study||0
6787891|NCT00590135|7718943|FG000|STARTED|Overall Study||59
6787892|NCT00590135|7718943|FG000|COMPLETED|Overall Study||0
6787893|NCT00590135|7718943|FG000|NOT COMPLETED|Overall Study||59
6787894|NCT00582036|7718950|FG000|STARTED|Overall Study||5
6787895|NCT00582036|7718951|FG001|STARTED|Overall Study||6
6787896|NCT00582036|7718950|FG000|COMPLETED|Overall Study||5
6787897|NCT00582036|7718951|FG001|COMPLETED|Overall Study|One patient withdrew consent|5
6787898|NCT00582036|7718950|FG000|NOT COMPLETED|Overall Study||0
6787899|NCT00582036|7718951|FG001|NOT COMPLETED|Overall Study||1
6787900|NCT00585585|7718957|FG000|STARTED|Overall Study||1
6787901|NCT00585585|7718957|FG000|Patients Receiving Drug|Overall Study||1
6787902|NCT00585585|7718957|FG000|COMPLETED|Overall Study||0
6787903|NCT00585585|7718957|FG000|NOT COMPLETED|Overall Study||1
6787904|NCT00585221|7718961|FG000|STARTED|Overall Study||8
6787905|NCT00585221|7718961|FG000|COMPLETED|Overall Study||0
6787906|NCT00585221|7718961|FG000|NOT COMPLETED|Overall Study||8
6787907|NCT00581113|7718967|FG000|STARTED|Overall Study||4
6787908|NCT00581113|7718968|FG001|STARTED|Overall Study||4
6787909|NCT00581113|7718967|FG000|COMPLETED|Overall Study||4
6787910|NCT00581113|7718968|FG001|COMPLETED|Overall Study||3
6787911|NCT00581113|7718967|FG000|NOT COMPLETED|Overall Study||0
6787912|NCT00581113|7718968|FG001|NOT COMPLETED|Overall Study||1
6787913|NCT00579254|7718974|FG000|STARTED|Overall Study||112
6787914|NCT00579254|7718974|FG000|COMPLETED|Overall Study||0
6787915|NCT00579254|7718974|FG000|NOT COMPLETED|Overall Study||112
6787916|NCT00587223|7718978|FG000|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
6787917|NCT00587223|7718978|FG000|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
6787918|NCT00587223|7718978|FG000|NOT COMPLETED|Overall Study||1
6787919|NCT00585611|7718987|FG000|STARTED|Overall Study||0
6787920|NCT00585611|7718988|FG001|STARTED|Overall Study||0
6787921|NCT00585611|7718987|FG000|COMPLETED|Overall Study||0
6787922|NCT00585611|7718988|FG001|COMPLETED|Overall Study||0
6787923|NCT00585611|7718987|FG000|NOT COMPLETED|Overall Study||0
6787924|NCT00585611|7718988|FG001|NOT COMPLETED|Overall Study||0
6787925|NCT00572260|7718994|FG000|STARTED|Overall Study||11
6787926|NCT00572260|7718994|FG000|COMPLETED|Overall Study||11
6787927|NCT00572260|7718994|FG000|NOT COMPLETED|Overall Study||0
6787928|NCT00571194|7718998|FG000|STARTED|Overall Study||7
6787929|NCT00571194|7718998|FG000|COMPLETED|Overall Study||7
6787930|NCT00571194|7718998|FG000|NOT COMPLETED|Overall Study||0
6787931|NCT00584935|7719002|FG000|STARTED|Overall Study||3
6787932|NCT00584935|7719002|FG000|COMPLETED|Overall Study||3
6787933|NCT00584935|7719002|FG000|NOT COMPLETED|Overall Study||0
6787934|NCT00577395|7719009|FG000|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
6787935|NCT00577395|7719010|FG001|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
6787936|NCT00577395|7719009|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
6787937|NCT00577395|7719010|FG001|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
6787938|NCT00577395|7719009|FG000|NOT COMPLETED|Overall Study||7
6787939|NCT00577395|7719010|FG001|NOT COMPLETED|Overall Study||6
6787940|NCT00573391|7719018|FG000|STARTED|Overall Study||3
6787941|NCT00573391|7719019|FG001|STARTED|Overall Study||2
6787942|NCT00573391|7719018|FG000|COMPLETED|Overall Study||0
6787943|NCT00573391|7719019|FG001|COMPLETED|Overall Study||0
6787944|NCT00573391|7719018|FG000|NOT COMPLETED|Overall Study||3
6787945|NCT00573391|7719019|FG001|NOT COMPLETED|Overall Study||2
6787946|NCT00570258|7719027|FG000|STARTED|Overall Study||12
6787947|NCT00570258|7719028|FG001|STARTED|Overall Study||15
6787948|NCT00570258|7719027|FG000|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
6787949|NCT00570258|7719028|FG001|COMPLETED|Overall Study|Early termination due to a change in drug FDA approval.|0
6787950|NCT00570258|7719027|FG000|NOT COMPLETED|Overall Study||12
6787951|NCT00570258|7719028|FG001|NOT COMPLETED|Overall Study||15
6787952|NCT00568802|7719036|FG000|STARTED|Overall Study||27
6787953|NCT00568802|7719036|FG000|COMPLETED|Overall Study||24
6787954|NCT00568802|7719036|FG000|NOT COMPLETED|Overall Study||3
6787955|NCT00576524|7719044|FG000|STARTED|Overall Study||2
6787956|NCT00576524|7719045|FG001|STARTED|Overall Study||0
6787957|NCT00576524|7719044|FG000|COMPLETED|Overall Study||2
6787958|NCT00576524|7719045|FG001|COMPLETED|Overall Study||0
6787959|NCT00576524|7719044|FG000|NOT COMPLETED|Overall Study||0
6787960|NCT00576524|7719045|FG001|NOT COMPLETED|Overall Study||0
6787961|NCT00568698|7719055|FG000|STARTED|Overall Study||29
6787962|NCT00568698|7719055|FG000|COMPLETED|Overall Study||18
6787963|NCT00568698|7719055|FG000|NOT COMPLETED|Overall Study||11
6787964|NCT00574080|7719063|FG000|STARTED|Overall Study||10
6787965|NCT00574080|7719064|FG001|STARTED|Overall Study||10
6787966|NCT00574080|7719063|FG000|COMPLETED|Overall Study||0
6787967|NCT00574080|7719064|FG001|COMPLETED|Overall Study||0
6787968|NCT00574080|7719063|FG000|NOT COMPLETED|Overall Study||10
6787969|NCT00574080|7719064|FG001|NOT COMPLETED|Overall Study||10
6787970|NCT00558558|7719070|FG000|STARTED|Overall Study||6
6787971|NCT00558558|7719070|FG000|COMPLETED|Overall Study||0
6787972|NCT00558558|7719070|FG000|NOT COMPLETED|Overall Study||6
6787973|NCT00577356|7719074|FG000|STARTED|Overall Study||6
6787974|NCT00577356|7719074|FG000|COMPLETED|Overall Study||6
6787975|NCT00577356|7719074|FG000|NOT COMPLETED|Overall Study||0
6787976|NCT00573937|7719080|FG000|STARTED|Overall Study||0
6787977|NCT00573937|7719081|FG001|STARTED|Overall Study||1
6787978|NCT00573937|7719080|FG000|COMPLETED|Overall Study||0
6787979|NCT00573937|7719081|FG001|COMPLETED|Overall Study||0
6787980|NCT00573937|7719080|FG000|NOT COMPLETED|Overall Study||0
6787981|NCT00573937|7719081|FG001|NOT COMPLETED|Overall Study||1
6787982|NCT00577317|7719089|FG000|STARTED|Overall Study||0
6787983|NCT00577317|7719090|FG001|STARTED|Overall Study||2
6787984|NCT00577317|7719089|FG000|COMPLETED|Overall Study||0
6787985|NCT00577317|7719090|FG001|COMPLETED|Overall Study||0
6787986|NCT00577317|7719089|FG000|NOT COMPLETED|Overall Study||0
6787987|NCT00577317|7719090|FG001|NOT COMPLETED|Overall Study||2
6787988|NCT00571922|7719098|FG000|STARTED|Overall Study||36
6787989|NCT00571922|7719099|FG001|STARTED|Overall Study||36
6787990|NCT00571922|7719098|FG000|COMPLETED|Overall Study||0
6787991|NCT00571922|7719099|FG001|COMPLETED|Overall Study||0
6787992|NCT00571922|7719098|FG000|NOT COMPLETED|Overall Study||36
6787993|NCT00571922|7719099|FG001|NOT COMPLETED|Overall Study||36
6787994|NCT00569868|7719105|FG000|STARTED|Overall Study||11
6787995|NCT00569868|7719105|FG000|COMPLETED|Overall Study||11
6787996|NCT00569868|7719105|FG000|NOT COMPLETED|Overall Study||0
6787997|NCT00573157|7719111|FG000|STARTED|Overall Study||4
6787998|NCT00573157|7719112|FG001|STARTED|Overall Study||2
6787999|NCT00573157|7719111|FG000|COMPLETED|Overall Study||0
6788000|NCT00573157|7719112|FG001|COMPLETED|Overall Study||0
6788001|NCT00573157|7719111|FG000|NOT COMPLETED|Overall Study||4
6788002|NCT00573157|7719112|FG001|NOT COMPLETED|Overall Study||2
6788003|NCT00570531|7719118|FG000|STARTED|Overall Study||6
6788004|NCT00570531|7719118|FG000|COMPLETED|Overall Study||6
6788005|NCT00570531|7719118|FG000|NOT COMPLETED|Overall Study||0
6788006|NCT00566462|7719124|FG000|STARTED|Overall Study||1
6788007|NCT00566462|7719125|FG001|STARTED|Overall Study||0
6788008|NCT00566462|7719124|FG000|COMPLETED|Overall Study||1
6788009|NCT00566462|7719125|FG001|COMPLETED|Overall Study||0
6788010|NCT00566462|7719124|FG000|NOT COMPLETED|Overall Study||0
6788011|NCT00566462|7719125|FG001|NOT COMPLETED|Overall Study||0
6788012|NCT00561912|7719131|FG000|STARTED|Overall Study||2
6788013|NCT00561912|7719131|FG000|COMPLETED|Overall Study||1
6788014|NCT00561912|7719131|FG000|NOT COMPLETED|Overall Study||1
6788015|NCT00561795|7719137|FG000|STARTED|Overall Study||6
6788016|NCT00561795|7719138|FG001|STARTED|Overall Study||6
6788017|NCT00561795|7719139|FG002|STARTED|Overall Study||0
6788018|NCT00561795|7719140|FG003|STARTED|Overall Study||0
6788019|NCT00561795|7719137|FG000|COMPLETED|Overall Study||2
6788020|NCT00561795|7719138|FG001|COMPLETED|Overall Study||0
6788021|NCT00561795|7719139|FG002|COMPLETED|Overall Study||0
6788022|NCT00561795|7719140|FG003|COMPLETED|Overall Study||0
6788023|NCT00561795|7719137|FG000|NOT COMPLETED|Overall Study||4
6788024|NCT00561795|7719138|FG001|NOT COMPLETED|Overall Study||6
6788025|NCT00561795|7719139|FG002|NOT COMPLETED|Overall Study||0
6788026|NCT00561795|7719140|FG003|NOT COMPLETED|Overall Study||0
6788027|NCT00564876|7719148|FG000|STARTED|Overall Study||2
6788028|NCT00564876|7719148|FG000|COMPLETED|Overall Study||2
6788029|NCT00564876|7719148|FG000|NOT COMPLETED|Overall Study||0
6788030|NCT00558870|7719154|FG000|STARTED|Overall Study||2
6788031|NCT00558870|7719155|FG001|STARTED|Overall Study||2
6788032|NCT00558870|7719154|FG000|COMPLETED|Overall Study||2
6788033|NCT00558870|7719155|FG001|COMPLETED|Overall Study||2
6788034|NCT00558870|7719154|FG000|NOT COMPLETED|Overall Study||0
6788035|NCT00558870|7719155|FG001|NOT COMPLETED|Overall Study||0
6788036|NCT00559897|7719161|FG000|STARTED|Overall Study||6
6788037|NCT00559897|7719161|FG000|COMPLETED|Overall Study||6
6788038|NCT00559897|7719161|FG000|NOT COMPLETED|Overall Study||0
6788039|NCT00556400|7719167|FG000|STARTED|Overall Study||1
6788040|NCT00556400|7719168|FG001|STARTED|Overall Study||0
6788041|NCT00556400|7719167|FG000|COMPLETED|Overall Study||1
6788042|NCT00556400|7719168|FG001|COMPLETED|Overall Study||0
6788043|NCT00556400|7719167|FG000|NOT COMPLETED|Overall Study||0
6788044|NCT00556400|7719168|FG001|NOT COMPLETED|Overall Study||0
6788045|NCT00556075|7719176|FG000|STARTED|Overall Study||22
6788046|NCT00556075|7719177|FG001|STARTED|Overall Study||22
6788047|NCT00556075|7719178|FG002|STARTED|Overall Study||23
6788048|NCT00556075|7719176|FG000|COMPLETED|Overall Study||9
6788049|NCT00556075|7719177|FG001|COMPLETED|Overall Study||13
6788050|NCT00556075|7719178|FG002|COMPLETED|Overall Study||15
6788051|NCT00556075|7719176|FG000|NOT COMPLETED|Overall Study||13
6788052|NCT00556075|7719177|FG001|NOT COMPLETED|Overall Study||9
6788053|NCT00556075|7719178|FG002|NOT COMPLETED|Overall Study||8
6788054|NCT00556166|7719190|FG000|STARTED|Overall Study||4
6788055|NCT00556166|7719190|FG000|COMPLETED|Overall Study||3
6788056|NCT00556166|7719190|FG000|NOT COMPLETED|Overall Study||1
6788057|NCT00521924|7719196|FG000|STARTED|Overall Study|Subjects randomized|4
6788058|NCT00521924|7719197|FG001|STARTED|Overall Study|Subjects randomized|4
6788059|NCT00521924|7719196|FG000|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
6788060|NCT00521924|7719197|FG001|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
6788061|NCT00521924|7719196|FG000|NOT COMPLETED|Overall Study||4
6788062|NCT00521924|7719197|FG001|NOT COMPLETED|Overall Study||4
6788063|NCT00548886|7719203|FG000|STARTED|Overall Study||7
6788064|NCT00548886|7719203|FG000|COMPLETED|Overall Study||7
6788065|NCT00548886|7719203|FG000|NOT COMPLETED|Overall Study||0
6788066|NCT00547456|7719207|FG000|STARTED|Overall Study||20
6788067|NCT00547456|7719207|FG000|COMPLETED|Overall Study||20
6788068|NCT00547456|7719207|FG000|NOT COMPLETED|Overall Study||0
6788069|NCT00539838|7719214|FG000|STARTED|Overall Study||12
6788070|NCT00539838|7719215|FG001|STARTED|Overall Study||11
6788071|NCT00539838|7719216|FG002|STARTED|Overall Study||10
6788072|NCT00539838|7719214|FG000|COMPLETED|Overall Study||5
6788073|NCT00539838|7719215|FG001|COMPLETED|Overall Study||5
6788074|NCT00539838|7719216|FG002|COMPLETED|Overall Study||1
6788075|NCT00539838|7719214|FG000|NOT COMPLETED|Overall Study||7
6788076|NCT00539838|7719215|FG001|NOT COMPLETED|Overall Study||6
6788077|NCT00539838|7719216|FG002|NOT COMPLETED|Overall Study||9
6788078|NCT00549328|7719226|FG000|STARTED|Overall Study||14
6788079|NCT00549328|7719226|FG000|COMPLETED|Overall Study||0
6788080|NCT00549328|7719226|FG000|NOT COMPLETED|Overall Study||14
6788081|NCT00548327|7719232|FG000|STARTED|Overall Study||6
6788082|NCT00548327|7719233|FG001|STARTED|Overall Study||5
6788083|NCT00548327|7719232|FG000|COMPLETED|Overall Study||6
6788084|NCT00548327|7719233|FG001|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
6788085|NCT00548327|7719232|FG000|NOT COMPLETED|Overall Study||0
6788086|NCT00548327|7719233|FG001|NOT COMPLETED|Overall Study||1
6788087|NCT00542542|7719246|FG000|STARTED|Overall Study||44
6788088|NCT00542542|7719247|FG001|STARTED|Overall Study||44
6788089|NCT00542542|7719246|FG000|COMPLETED|Overall Study||44
6788090|NCT00542542|7719247|FG001|COMPLETED|Overall Study||44
6788091|NCT00542542|7719246|FG000|NOT COMPLETED|Overall Study||0
6788092|NCT00542542|7719247|FG001|NOT COMPLETED|Overall Study||0
6788093|NCT00545506|7719255|FG000|STARTED|Overall Study||3
6788094|NCT00545506|7719256|FG001|STARTED|Overall Study||3
6788095|NCT00545506|7719255|FG000|COMPLETED|Overall Study||3
6788096|NCT00545506|7719256|FG001|COMPLETED|Overall Study||3
6788097|NCT00545506|7719255|FG000|NOT COMPLETED|Overall Study||0
6788098|NCT00545506|7719256|FG001|NOT COMPLETED|Overall Study||0
6788099|NCT00547300|7719264|FG000|STARTED|Overall Study||25
6788100|NCT00547300|7719265|FG001|STARTED|Overall Study|Two (2) patients were randomized in error, but no study medication taken.|26
6788101|NCT00547300|7719264|FG000|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
6788102|NCT00547300|7719265|FG001|COMPLETED|Overall Study|No patients completed because the study was administratively terminated.|0
6788103|NCT00547300|7719264|FG000|NOT COMPLETED|Overall Study||25
6788104|NCT00547300|7719265|FG001|NOT COMPLETED|Overall Study||26
6788105|NCT00539617|7719271|FG000|STARTED|Pre-screening Period||7
6788106|NCT00539617|7719271|FG000|COMPLETED|Pre-screening Period||4
6788107|NCT00539617|7719271|FG000|NOT COMPLETED|Pre-screening Period||3
6788108|NCT00539617|7719271|FG000|STARTED|Run-In Period||4
6788109|NCT00539617|7719271|FG000|COMPLETED|Run-In Period||3
6788110|NCT00539617|7719271|FG000|NOT COMPLETED|Run-In Period||1
6788111|NCT00539617|7719271|FG000|STARTED|Treatment Period||3
6788112|NCT00539617|7719271|FG000|COMPLETED|Treatment Period||3
6788113|NCT00539617|7719271|FG000|NOT COMPLETED|Treatment Period||0
6788114|NCT00546455|7719277|FG000|STARTED|Overall Study||0
6788115|NCT00546455|7719278|FG001|STARTED|Overall Study||0
6788116|NCT00546455|7719277|FG000|COMPLETED|Overall Study||0
6788117|NCT00546455|7719278|FG001|COMPLETED|Overall Study||0
6788118|NCT00546455|7719277|FG000|NOT COMPLETED|Overall Study||0
6788119|NCT00546455|7719278|FG001|NOT COMPLETED|Overall Study||0
6788120|NCT00538980|7719284|FG000|STARTED|Overall Study||10
6788121|NCT00538980|7719284|FG000|COMPLETED|Overall Study||0
6788122|NCT00538980|7719284|FG000|NOT COMPLETED|Overall Study||10
6788123|NCT00540969|7719290|FG000|STARTED|Overall Study||2
6788124|NCT00540969|7719291|FG001|STARTED|Overall Study||1
6788125|NCT00540969|7719290|FG000|COMPLETED|Overall Study||2
6788126|NCT00540969|7719291|FG001|COMPLETED|Overall Study||1
6788127|NCT00540969|7719290|FG000|NOT COMPLETED|Overall Study||0
6788128|NCT00540969|7719291|FG001|NOT COMPLETED|Overall Study||0
6788129|NCT00535262|7719297|FG000|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
6788130|NCT00535262|7719297|FG000|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
6788131|NCT00535262|7719297|FG000|NOT COMPLETED|Overall Study||3
6788132|NCT00529464|7719304|FG000|STARTED|Overall Study||0
6788133|NCT00529464|7719305|FG001|STARTED|Overall Study||0
6788134|NCT00529464|7719306|FG002|STARTED|Overall Study||0
6788135|NCT00529464|7719304|FG000|COMPLETED|Overall Study||0
6788136|NCT00529464|7719305|FG001|COMPLETED|Overall Study||0
6788137|NCT00529464|7719306|FG002|COMPLETED|Overall Study||0
6788138|NCT00529464|7719304|FG000|NOT COMPLETED|Overall Study||0
6788139|NCT00529464|7719305|FG001|NOT COMPLETED|Overall Study||0
6788140|NCT00529464|7719306|FG002|NOT COMPLETED|Overall Study||0
6788141|NCT00537199|7719314|FG000|STARTED|Overall Study||1
6788142|NCT00537199|7719314|FG000|COMPLETED|Overall Study||0
6788143|NCT00537199|7719314|FG000|NOT COMPLETED|Overall Study||1
6788144|NCT00537446|7719318|FG000|STARTED|Overall Study||8
6788145|NCT00537446|7719318|FG000|COMPLETED|Overall Study||8
6788146|NCT00537446|7719318|FG000|NOT COMPLETED|Overall Study||0
6788147|NCT00536978|7719324|FG000|STARTED|Overall Study||22
6788148|NCT00536978|7719324|FG000|COMPLETED|Overall Study||0
6788149|NCT00536978|7719324|FG000|NOT COMPLETED|Overall Study||22
6788150|NCT00524485|7719328|FG000|STARTED|Overall Study||12
6788151|NCT00524485|7719328|FG000|COMPLETED|Overall Study||7
6788152|NCT00524485|7719328|FG000|NOT COMPLETED|Overall Study||5
6788153|NCT00533351|7719334|FG000|STARTED|Period 1||7
6788154|NCT00533351|7719335|FG001|STARTED|Period 1||2
6788155|NCT00533351|7719334|FG000|COMPLETED|Period 1||5
6788156|NCT00533351|7719335|FG001|COMPLETED|Period 1||1
6788157|NCT00533351|7719334|FG000|NOT COMPLETED|Period 1||2
6788158|NCT00533351|7719335|FG001|NOT COMPLETED|Period 1||1
6788159|NCT00533351|7719334|FG000|STARTED|Period 2||5
6788160|NCT00533351|7719335|FG001|STARTED|Period 2||1
6788161|NCT00533351|7719334|FG000|COMPLETED|Period 2||5
6788162|NCT00533351|7719335|FG001|COMPLETED|Period 2||1
6788163|NCT00533351|7719334|FG000|NOT COMPLETED|Period 2||0
6788164|NCT00533351|7719335|FG001|NOT COMPLETED|Period 2||0
6788165|NCT00533351|7719334|FG000|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
6788166|NCT00533351|7719335|FG001|STARTED|Period 3|No patients continued to Period 3|0
6788167|NCT00533351|7719334|FG000|COMPLETED|Period 3||3
6788168|NCT00533351|7719335|FG001|COMPLETED|Period 3||0
6788169|NCT00533351|7719334|FG000|NOT COMPLETED|Period 3||0
6788170|NCT00533351|7719335|FG001|NOT COMPLETED|Period 3||0
6788171|NCT00529282|7719343|FG000|STARTED|Overall Study||0
6788172|NCT00529282|7719344|FG001|STARTED|Overall Study||2
6788173|NCT00529282|7719343|FG000|COMPLETED|Overall Study||0
6788174|NCT00529282|7719344|FG001|COMPLETED|Overall Study||2
6788175|NCT00529282|7719343|FG000|NOT COMPLETED|Overall Study||0
6788176|NCT00529282|7719344|FG001|NOT COMPLETED|Overall Study||0
6788177|NCT00524134|7719350|FG000|STARTED|Overall Study||6
6788178|NCT00524134|7719350|FG000|COMPLETED|Overall Study||4
6788179|NCT00524134|7719350|FG000|NOT COMPLETED|Overall Study||2
6788180|NCT00527748|7719354|FG000|STARTED|Overall Study||26
6788181|NCT00527748|7719354|FG000|COMPLETED|Overall Study||23
6788182|NCT00527748|7719354|FG000|NOT COMPLETED|Overall Study||3
6788183|NCT00517699|7719358|FG000|STARTED|Overall Study||5
6788184|NCT00517699|7719358|FG000|COMPLETED|Overall Study||0
6788185|NCT00517699|7719358|FG000|NOT COMPLETED|Overall Study||5
6788186|NCT00528775|7719362|FG000|STARTED|Overall Study||6
6788187|NCT00528775|7719362|FG000|COMPLETED|Overall Study||5
6788188|NCT00528775|7719362|FG000|NOT COMPLETED|Overall Study||1
6788189|NCT00528437|7719366|FG000|STARTED|Overall Study||46
6788190|NCT00528437|7719366|FG000|COMPLETED|Overall Study||46
6788191|NCT00528437|7719366|FG000|NOT COMPLETED|Overall Study||0
6788192|NCT00524511|7719372|FG000|STARTED|Overall Study||68
6788193|NCT00524511|7719373|FG001|STARTED|Overall Study||68
6788194|NCT00524511|7719372|FG000|COMPLETED|Overall Study||64
6788195|NCT00524511|7719373|FG001|COMPLETED|Overall Study||61
6788196|NCT00524511|7719372|FG000|NOT COMPLETED|Overall Study||4
6788197|NCT00524511|7719373|FG001|NOT COMPLETED|Overall Study||7
6788198|NCT00517075|7719383|FG000|STARTED|Overall Study||0
6788199|NCT00517075|7719384|FG001|STARTED|Overall Study||0
6788200|NCT00517075|7719385|FG002|STARTED|Overall Study||0
6788201|NCT00517075|7719386|FG003|STARTED|Overall Study||0
6788202|NCT00517075|7719383|FG000|COMPLETED|Overall Study||0
6788203|NCT00517075|7719384|FG001|COMPLETED|Overall Study||0
6788204|NCT00517075|7719385|FG002|COMPLETED|Overall Study||0
6788205|NCT00517075|7719386|FG003|COMPLETED|Overall Study||0
6788206|NCT00517075|7719383|FG000|NOT COMPLETED|Overall Study||0
6788207|NCT00517075|7719384|FG001|NOT COMPLETED|Overall Study||0
6788208|NCT00517075|7719385|FG002|NOT COMPLETED|Overall Study||0
6788209|NCT00517075|7719386|FG003|NOT COMPLETED|Overall Study||0
6563198|NCT01806168|7486175|FG001|NOT COMPLETED|Overall Study||1
6563199|NCT01806168|7486176|FG002|NOT COMPLETED|Overall Study||3
6563200|NCT01806259|7486189|FG000|STARTED|Overall Study||96
6563201|NCT01806259|7486190|FG001|STARTED|Overall Study||107
6563202|NCT01806259|7486189|FG000|COMPLETED|Overall Study||96
6563203|NCT01806259|7486190|FG001|COMPLETED|Overall Study||107
6563204|NCT01806259|7486189|FG000|NOT COMPLETED|Overall Study||0
6563205|NCT01806259|7486190|FG001|NOT COMPLETED|Overall Study||0
6563206|NCT01806298|7486197|FG000|STARTED|Overall Study||78
6563207|NCT01806298|7486197|FG000|COMPLETED|Overall Study||68
6563208|NCT01806298|7486197|FG000|NOT COMPLETED|Overall Study||10
6563209|NCT01806389|7486201|FG000|STARTED|Overall Study||14
6563210|NCT01806389|7486201|FG000|COMPLETED|Overall Study||10
6563211|NCT01806389|7486201|FG000|NOT COMPLETED|Overall Study||4
6563212|NCT01806506|7486217|FG000|STARTED|Overall Study||36
6563213|NCT01806506|7486218|FG001|STARTED|Overall Study||36
6563214|NCT01806506|7486217|FG000|1 Month|Overall Study||36
6563215|NCT01806506|7486218|FG001|1 Month|Overall Study||36
6563216|NCT01806506|7486217|FG000|3 Months|Overall Study|1 patient (reason - lost contact)|35
6563217|NCT01806506|7486218|FG001|3 Months|Overall Study||36
6563218|NCT01806506|7486217|FG000|6 Months|Overall Study|1 patient (reason - lost contact)|34
6563219|NCT01806506|7486218|FG001|6 Months|Overall Study||36
6563220|NCT01806506|7486217|FG000|9 Months|Overall Study||34
6563221|NCT01806506|7486218|FG001|9 Months|Overall Study|1 patient (reason - lost contact)|35
6563222|NCT01806506|7486217|FG000|COMPLETED|Overall Study||34
6563223|NCT01806506|7486218|FG001|COMPLETED|Overall Study||35
6563224|NCT01806506|7486217|FG000|NOT COMPLETED|Overall Study||2
6563225|NCT01806506|7486218|FG001|NOT COMPLETED|Overall Study||1
6563226|NCT01806545|7486226|FG000|STARTED|Overall Study||29
6563227|NCT01806545|7486227|FG001|STARTED|Overall Study||35
6563228|NCT01806545|7486226|FG000|COMPLETED|Overall Study||23
6563229|NCT01806545|7486227|FG001|COMPLETED|Overall Study||30
6563230|NCT01806545|7486226|FG000|NOT COMPLETED|Overall Study||6
6563231|NCT01806545|7486227|FG001|NOT COMPLETED|Overall Study||5
6563232|NCT01806571|7486233|FG000|STARTED|Overall Study||34
6563233|NCT01806571|7486233|FG000|COMPLETED|Overall Study||34
6563234|NCT01806571|7486233|FG000|NOT COMPLETED|Overall Study||0
6563235|NCT01806584|7486239|FG000|STARTED|Overall Study||14
6563236|NCT01806584|7486240|FG001|STARTED|Overall Study||18
6563237|NCT01806584|7486239|FG000|COMPLETED|Overall Study||0
6788210|NCT00527982|7719398|FG000|STARTED|Overall Study||1
6788211|NCT00527982|7719399|FG001|STARTED|Overall Study||0
6788212|NCT00527982|7719398|FG000|COMPLETED|Overall Study||0
6788213|NCT00527982|7719399|FG001|COMPLETED|Overall Study||0
6788214|NCT00527982|7719398|FG000|NOT COMPLETED|Overall Study||1
6788215|NCT00527982|7719399|FG001|NOT COMPLETED|Overall Study||0
6788216|NCT00524459|7719405|FG000|STARTED|Overall Study||6
6788217|NCT00524459|7719405|FG000|COMPLETED|Overall Study||4
6788218|NCT00524459|7719405|FG000|NOT COMPLETED|Overall Study||2
6788219|NCT00517361|7719409|FG000|STARTED|Overall Study||11
6788220|NCT00517361|7719409|FG000|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
6788221|NCT00517361|7719409|FG000|NOT COMPLETED|Overall Study||11
6788222|NCT00523939|7719415|FG000|STARTED|Overall Study||2
6788223|NCT00523939|7719416|FG001|STARTED|Overall Study||2
6788224|NCT00523939|7719415|FG000|COMPLETED|Overall Study||2
6788225|NCT00523939|7719416|FG001|COMPLETED|Overall Study||2
6788226|NCT00523939|7719415|FG000|NOT COMPLETED|Overall Study||0
6788227|NCT00523939|7719416|FG001|NOT COMPLETED|Overall Study||0
6788228|NCT00522457|7719421|FG000|STARTED|Overall Study||19
6788229|NCT00522457|7719421|FG000|COMPLETED|Overall Study||1
6788230|NCT00522457|7719421|FG000|NOT COMPLETED|Overall Study||18
6788231|NCT00526331|7719425|FG000|STARTED|Overall Study||55
6788232|NCT00526331|7719425|FG000|COMPLETED|Overall Study||0
6788233|NCT00526331|7719425|FG000|NOT COMPLETED|Overall Study||55
6788234|NCT00519090|7719431|FG000|STARTED|Overall Study||2
6788235|NCT00519090|7719432|FG001|STARTED|Overall Study||4
6788236|NCT00519090|7719431|FG000|COMPLETED|Overall Study||2
6788237|NCT00519090|7719432|FG001|COMPLETED|Overall Study||4
6788238|NCT00519090|7719431|FG000|NOT COMPLETED|Overall Study||0
6788239|NCT00519090|7719432|FG001|NOT COMPLETED|Overall Study||0
6788240|NCT00524394|7719438|FG000|STARTED|Overall Study||2
6788241|NCT00524394|7719438|FG000|COMPLETED|Overall Study||1
6788242|NCT00524394|7719438|FG000|NOT COMPLETED|Overall Study||1
6788243|NCT00523809|7719442|FG000|STARTED|Overall Study||5
6788244|NCT00523809|7719442|FG000|COMPLETED|Overall Study||5
6788245|NCT00523809|7719442|FG000|NOT COMPLETED|Overall Study||0
6788246|NCT00522301|7719446|FG000|STARTED|Overall Study||6
6788247|NCT00522301|7719446|FG000|COMPLETED|Overall Study||0
6788248|NCT00522301|7719446|FG000|NOT COMPLETED|Overall Study||6
6788249|NCT00517192|7719452|FG000|STARTED|Overall Study||19
6788250|NCT00517192|7719453|FG001|STARTED|Overall Study||20
6788251|NCT00517192|7719452|FG000|COMPLETED|Overall Study||0
6788252|NCT00517192|7719453|FG001|COMPLETED|Overall Study||0
6788253|NCT00517192|7719452|FG000|NOT COMPLETED|Overall Study||19
6788254|NCT00517192|7719453|FG001|NOT COMPLETED|Overall Study||20
6788255|NCT00504985|7719459|FG000|STARTED|Overall Study||14
6788256|NCT00504985|7719459|FG000|COMPLETED|Overall Study||14
6788257|NCT00504985|7719459|FG000|NOT COMPLETED|Overall Study||0
6788258|NCT00503581|7719466|FG000|STARTED|Overall Study||3
6788259|NCT00503581|7719467|FG001|STARTED|Overall Study||4
6788260|NCT00503581|7719468|FG002|STARTED|Overall Study||2
6788261|NCT00503581|7719466|FG000|COMPLETED|Overall Study||0
6788262|NCT00503581|7719467|FG001|COMPLETED|Overall Study||0
6788263|NCT00503581|7719468|FG002|COMPLETED|Overall Study||0
6788264|NCT00503581|7719466|FG000|NOT COMPLETED|Overall Study||3
6788265|NCT00503581|7719467|FG001|NOT COMPLETED|Overall Study||4
6788266|NCT00503581|7719468|FG002|NOT COMPLETED|Overall Study||2
6788267|NCT00509600|7719476|FG000|STARTED|Overall Study||1
6788268|NCT00509600|7719476|FG000|COMPLETED|Overall Study||0
6788269|NCT00509600|7719476|FG000|NOT COMPLETED|Overall Study||1
6788270|NCT00515112|7719482|FG000|STARTED|Overall Study||3
6788271|NCT00515112|7719483|FG001|STARTED|Overall Study||3
6788272|NCT00515112|7719482|FG000|COMPLETED|Overall Study||0
6788273|NCT00515112|7719483|FG001|COMPLETED|Overall Study||0
6788274|NCT00515112|7719482|FG000|NOT COMPLETED|Overall Study||3
6563238|NCT01806584|7486240|FG001|COMPLETED|Overall Study||0
6563239|NCT01806584|7486239|FG000|NOT COMPLETED|Overall Study||14
6563240|NCT01806584|7486240|FG001|NOT COMPLETED|Overall Study||18
6563241|NCT01806597|7486249|FG000|STARTED|Period 1 (Baseline to Week 16)||68
6788275|NCT00515112|7719483|FG001|NOT COMPLETED|Overall Study||3
6788276|NCT00508872|7719489|FG000|STARTED|Overall Study||2
6788277|NCT00508872|7719489|FG000|COMPLETED|Overall Study||0
6788278|NCT00508872|7719489|FG000|NOT COMPLETED|Overall Study||2
6788279|NCT00514813|7719497|FG000|STARTED|Overall Study||15
6788280|NCT00514813|7719498|FG001|STARTED|Overall Study||86
6788281|NCT00514813|7719499|FG002|STARTED|Overall Study||47
6788282|NCT00514813|7719500|FG003|STARTED|Overall Study||4
6788283|NCT00514813|7719497|FG000|COMPLETED|Overall Study||0
6788284|NCT00514813|7719498|FG001|COMPLETED|Overall Study||0
6788285|NCT00514813|7719499|FG002|COMPLETED|Overall Study||0
6788286|NCT00514813|7719500|FG003|COMPLETED|Overall Study||0
6788287|NCT00514813|7719497|FG000|NOT COMPLETED|Overall Study||15
6788288|NCT00514813|7719498|FG001|NOT COMPLETED|Overall Study||86
6788289|NCT00514813|7719499|FG002|NOT COMPLETED|Overall Study||47
6788290|NCT00514813|7719500|FG003|NOT COMPLETED|Overall Study||4
6788291|NCT00506064|7719512|FG000|STARTED|Overall Study||1
6788292|NCT00506064|7719513|FG001|STARTED|Overall Study||0
6788293|NCT00506064|7719512|FG000|COMPLETED|Overall Study||1
6788294|NCT00506064|7719513|FG001|COMPLETED|Overall Study||0
6788295|NCT00506064|7719512|FG000|NOT COMPLETED|Overall Study||0
6788296|NCT00506064|7719513|FG001|NOT COMPLETED|Overall Study||0
6563242|NCT01806597|7486250|FG001|STARTED|Period 1 (Baseline to Week 16)||69
6788297|NCT00503880|7719519|FG000|STARTED|Overall Study||2
6788298|NCT00503880|7719520|FG001|STARTED|Overall Study||0
6788299|NCT00503880|7719521|FG002|STARTED|Overall Study||0
6788300|NCT00503880|7719522|FG003|STARTED|Overall Study||0
6788301|NCT00503880|7719523|FG004|STARTED|Overall Study||0
6788302|NCT00503880|7719519|FG000|COMPLETED|Overall Study||0
6788303|NCT00503880|7719520|FG001|COMPLETED|Overall Study||0
6788304|NCT00503880|7719521|FG002|COMPLETED|Overall Study||0
6788305|NCT00503880|7719522|FG003|COMPLETED|Overall Study||0
6788306|NCT00503880|7719523|FG004|COMPLETED|Overall Study||0
6788307|NCT00503880|7719519|FG000|NOT COMPLETED|Overall Study||2
6788308|NCT00503880|7719520|FG001|NOT COMPLETED|Overall Study||0
6788309|NCT00503880|7719521|FG002|NOT COMPLETED|Overall Study||0
6788310|NCT00503880|7719522|FG003|NOT COMPLETED|Overall Study||0
6788311|NCT00503880|7719523|FG004|NOT COMPLETED|Overall Study||0
6788312|NCT00511329|7719529|FG000|STARTED|Overall Study||0
6788313|NCT00511329|7719529|FG000|COMPLETED|Overall Study||0
6788314|NCT00511329|7719529|FG000|NOT COMPLETED|Overall Study||0
6788315|NCT00501228|7719533|FG000|STARTED|Overall Study||2
6788316|NCT00501228|7719533|FG000|COMPLETED|Overall Study||1
6788317|NCT00501228|7719533|FG000|NOT COMPLETED|Overall Study||1
6788318|NCT00496782|7719539|FG000|STARTED|Overall Study||9
6788319|NCT00496782|7719540|FG001|STARTED|Overall Study||7
6788320|NCT00496782|7719539|FG000|COMPLETED|Overall Study||8
6788321|NCT00496782|7719540|FG001|COMPLETED|Overall Study||5
6788322|NCT00496782|7719539|FG000|NOT COMPLETED|Overall Study||1
6788323|NCT00496782|7719540|FG001|NOT COMPLETED|Overall Study||2
6788324|NCT00506909|7719546|FG000|STARTED|Overall Study||0
6788325|NCT00506909|7719546|FG000|COMPLETED|Overall Study||0
6788326|NCT00506909|7719546|FG000|NOT COMPLETED|Overall Study||0
6788327|NCT00487578|7719552|FG000|STARTED|Overall Study||3
6788328|NCT00487578|7719553|FG001|STARTED|Overall Study||9
6788329|NCT00487578|7719552|FG000|COMPLETED|Overall Study||2
6788330|NCT00487578|7719553|FG001|COMPLETED|Overall Study||5
6788331|NCT00487578|7719552|FG000|NOT COMPLETED|Overall Study||1
6788332|NCT00487578|7719553|FG001|NOT COMPLETED|Overall Study||4
6788333|NCT00503009|7719562|FG000|STARTED|Overall Study||5
6788334|NCT00503009|7719563|FG001|STARTED|Overall Study||5
6788335|NCT00503009|7719564|FG002|STARTED|Overall Study||6
6788336|NCT00503009|7719562|FG000|COMPLETED|Overall Study||4
6788337|NCT00503009|7719563|FG001|COMPLETED|Overall Study||3
6788338|NCT00503009|7719564|FG002|COMPLETED|Overall Study||3
6788339|NCT00503009|7719562|FG000|NOT COMPLETED|Overall Study||1
6788340|NCT00503009|7719563|FG001|NOT COMPLETED|Overall Study||2
6788341|NCT00503009|7719564|FG002|NOT COMPLETED|Overall Study||3
6788342|NCT00500045|7719572|FG000|STARTED|Overall Study||0
6788343|NCT00500045|7719572|FG000|COMPLETED|Overall Study||0
6378708|NCT00769184|7289200|FG001|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
6378709|NCT00769184|7289199|FG000|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
6378710|NCT00769184|7289200|FG001|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
6378711|NCT00769184|7289199|FG000|STARTED|+LCD / +Placebo Only (4 Weeks)||6
6563243|NCT01806597|7486251|FG002|STARTED|Period 1 (Baseline to Week 16)||0
6563244|NCT01806597|7486252|FG003|STARTED|Period 1 (Baseline to Week 16)||0
6563245|NCT01806597|7486253|FG004|STARTED|Period 1 (Baseline to Week 16)||68
6563246|NCT01806597|7486254|FG005|STARTED|Period 1 (Baseline to Week 16)||0
6563247|NCT01806597|7486249|FG000|COMPLETED|Period 1 (Baseline to Week 16)||63
6563248|NCT01806597|7486250|FG001|COMPLETED|Period 1 (Baseline to Week 16)||64
6378712|NCT00769184|7289200|FG001|STARTED|+LCD / +Placebo Only (4 Weeks)||7
6378713|NCT00769184|7289199|FG000|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
6378714|NCT00769184|7289200|FG001|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
6378715|NCT00769184|7289199|FG000|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
6378716|NCT00769184|7289200|FG001|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
6378717|NCT00769184|7289199|FG000|STARTED|No Treatment (6 Weeks)||6
6378718|NCT00769184|7289200|FG001|STARTED|No Treatment (6 Weeks)||7
6378719|NCT00769184|7289199|FG000|COMPLETED|No Treatment (6 Weeks)||5
6378720|NCT00769184|7289200|FG001|COMPLETED|No Treatment (6 Weeks)||6
6378721|NCT00769184|7289199|FG000|NOT COMPLETED|No Treatment (6 Weeks)||1
6378722|NCT00769184|7289200|FG001|NOT COMPLETED|No Treatment (6 Weeks)||1
6378723|NCT00769314|7289210|FG000|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
6502246|NCT01433263|7420895|FG000|COMPLETED|Overall Study||10
6502247|NCT01433263|7420896|FG001|COMPLETED|Overall Study||16
6502248|NCT01433263|7420895|FG000|NOT COMPLETED|Overall Study||19
6502249|NCT01433263|7420896|FG001|NOT COMPLETED|Overall Study||12
6563249|NCT01806597|7486251|FG002|COMPLETED|Period 1 (Baseline to Week 16)||0
6563250|NCT01806597|7486252|FG003|COMPLETED|Period 1 (Baseline to Week 16)||0
6563251|NCT01806597|7486253|FG004|COMPLETED|Period 1 (Baseline to Week 16)||63
6788344|NCT00500045|7719572|FG000|NOT COMPLETED|Overall Study||0
6788345|NCT00499590|7719579|FG000|STARTED|Overall Study||113
6788346|NCT00499590|7719580|FG001|STARTED|Overall Study||112
6788347|NCT00499590|7719581|FG002|STARTED|Overall Study||113
6378724|NCT00769314|7289211|FG001|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
6378725|NCT00769314|7289210|FG000|COMPLETED|Overall Study||361
6378726|NCT00769314|7289211|FG001|COMPLETED|Overall Study||384
6378727|NCT00769314|7289210|FG000|NOT COMPLETED|Overall Study||17
6378728|NCT00769314|7289211|FG001|NOT COMPLETED|Overall Study||13
6378729|NCT00769392|7289217|FG000|STARTED|Overall Study||28
6378730|NCT00769392|7289217|FG000|COMPLETED|Overall Study||24
6788348|NCT00499590|7719579|FG000|COMPLETED|Overall Study||0
6788349|NCT00499590|7719580|FG001|COMPLETED|Overall Study||0
6788350|NCT00499590|7719581|FG002|COMPLETED|Overall Study||0
6788351|NCT00499590|7719579|FG000|NOT COMPLETED|Overall Study||113
6788352|NCT00499590|7719580|FG001|NOT COMPLETED|Overall Study||112
6788353|NCT00499590|7719581|FG002|NOT COMPLETED|Overall Study||113
6788354|NCT00501345|7719590|FG000|STARTED|Overall Study||5
6788355|NCT00501345|7719590|FG000|COMPLETED|Overall Study||5
6788356|NCT00501345|7719590|FG000|NOT COMPLETED|Overall Study||0
6788357|NCT00496756|7719594|FG000|STARTED|Overall Study||14
6788358|NCT00496756|7719594|FG000|COMPLETED|Overall Study||11
6788359|NCT00496756|7719594|FG000|NOT COMPLETED|Overall Study||3
6788360|NCT00495716|7719600|FG000|STARTED|Overall Study||35
6788361|NCT00495716|7719601|FG001|STARTED|Overall Study||37
6788362|NCT00495716|7719600|FG000|COMPLETED|Overall Study||20
6788363|NCT00495716|7719601|FG001|COMPLETED|Overall Study||24
6788364|NCT00495716|7719600|FG000|NOT COMPLETED|Overall Study||15
6788365|NCT00495716|7719601|FG001|NOT COMPLETED|Overall Study||13
6788366|NCT00500890|7719609|FG000|STARTED|Overall Study||1
6788367|NCT00500890|7719610|FG001|STARTED|Overall Study||1
6788368|NCT00500890|7719609|FG000|COMPLETED|Overall Study||1
6788369|NCT00500890|7719610|FG001|COMPLETED|Overall Study||1
6788370|NCT00500890|7719609|FG000|NOT COMPLETED|Overall Study||0
6788371|NCT00500890|7719610|FG001|NOT COMPLETED|Overall Study||0
6788372|NCT00503841|7719616|FG000|STARTED|Overall Study||44
6788373|NCT00503841|7719616|FG000|COMPLETED|Overall Study||0
6788374|NCT00503841|7719616|FG000|NOT COMPLETED|Overall Study||44
6788375|NCT00493025|7719622|FG000|STARTED|Overall Study||19
6788376|NCT00493025|7719622|FG000|COMPLETED|Overall Study|Trial stopped due to early stopping rule|0
6788377|NCT00493025|7719622|FG000|NOT COMPLETED|Overall Study||19
6788378|NCT00491400|7719629|FG000|STARTED|Overall Study||15
6788379|NCT00491400|7719630|FG001|STARTED|Overall Study||13
6788380|NCT00491400|7719629|FG000|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
6788381|NCT00491400|7719630|FG001|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
6788382|NCT00491400|7719629|FG000|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
6788383|NCT00491400|7719630|FG001|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
6788384|NCT00491400|7719629|FG000|Started Second Treatment|Overall Study|2 withdrew during washout period|12
6788385|NCT00491400|7719630|FG001|Started Second Treatment|Overall Study|None withdrew during the washout period|9
6788386|NCT00491400|7719629|FG000|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
6788387|NCT00491400|7719630|FG001|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
6788388|NCT00491400|7719629|FG000|COMPLETED|Overall Study||10
6788389|NCT00491400|7719630|FG001|COMPLETED|Overall Study||9
6788390|NCT00491400|7719629|FG000|NOT COMPLETED|Overall Study||5
6788391|NCT00491400|7719630|FG001|NOT COMPLETED|Overall Study||4
6788392|NCT00490776|7719638|FG000|STARTED|Overall Study||9
6788393|NCT00490776|7719638|FG000|COMPLETED|Overall Study||0
6788394|NCT00490776|7719638|FG000|NOT COMPLETED|Overall Study||9
6788395|NCT00487162|7719644|FG000|STARTED|Overall Study||30
6788396|NCT00487162|7719645|FG001|STARTED|Overall Study||26
6788397|NCT00487162|7719644|FG000|COMPLETED|Overall Study||28
6788398|NCT00487162|7719645|FG001|COMPLETED|Overall Study||21
6788399|NCT00487162|7719644|FG000|NOT COMPLETED|Overall Study||2
6788400|NCT00487162|7719645|FG001|NOT COMPLETED|Overall Study||5
6788401|NCT00487981|7719651|FG000|STARTED|Overall Study||1
6788402|NCT00487981|7719651|FG000|COMPLETED|Overall Study||0
6788403|NCT00487981|7719651|FG000|NOT COMPLETED|Overall Study||1
6788404|NCT00491387|7719655|FG000|STARTED|Overall Study||24
6788405|NCT00491387|7719655|FG000|Study Enrollment|Overall Study||24
6788406|NCT00491387|7719655|FG000|COMPLETED|Overall Study||4
6788407|NCT00491387|7719655|FG000|NOT COMPLETED|Overall Study||20
6788408|NCT00475332|7719659|FG000|STARTED|Overall Study||2
6788409|NCT00475332|7719659|FG000|COMPLETED|Overall Study||2
6788410|NCT00475332|7719659|FG000|NOT COMPLETED|Overall Study||0
6788411|NCT00483119|7719666|FG000|STARTED|Overall Study||5
6788412|NCT00483119|7719667|FG001|STARTED|Overall Study||4
6788413|NCT00483119|7719666|FG000|COMPLETED|Overall Study||4
6788414|NCT00483119|7719667|FG001|COMPLETED|Overall Study||3
6788415|NCT00483119|7719666|FG000|NOT COMPLETED|Overall Study||1
6788416|NCT00483119|7719667|FG001|NOT COMPLETED|Overall Study||1
6788417|NCT00487461|7719676|FG000|STARTED|Overall Study||2
6788418|NCT00487461|7719677|FG001|STARTED|Overall Study||12
6788419|NCT00487461|7719678|FG002|STARTED|Overall Study||11
6788420|NCT00487461|7719676|FG000|COMPLETED|Overall Study||2
6788421|NCT00487461|7719677|FG001|COMPLETED|Overall Study||10
6788422|NCT00487461|7719678|FG002|COMPLETED|Overall Study||7
6378731|NCT00769392|7289217|FG000|NOT COMPLETED|Overall Study||4
6563252|NCT01806597|7486254|FG005|COMPLETED|Period 1 (Baseline to Week 16)||0
6623407|NCT02207556|7550533|FG000|NOT COMPLETED|Overall Study||2
6788423|NCT00487461|7719676|FG000|NOT COMPLETED|Overall Study||0
6788424|NCT00487461|7719677|FG001|NOT COMPLETED|Overall Study||2
6788425|NCT00487461|7719678|FG002|NOT COMPLETED|Overall Study||4
6788426|NCT00484718|7719686|FG000|STARTED|Treatment Period 1 (2 Weeks)||1
6788427|NCT00484718|7719687|FG001|STARTED|Treatment Period 1 (2 Weeks)||1
6788428|NCT00484718|7719688|FG002|STARTED|Treatment Period 1 (2 Weeks)||1
6788429|NCT00484718|7719689|FG003|STARTED|Treatment Period 1 (2 Weeks)||1
6788430|NCT00484718|7719690|FG004|STARTED|Treatment Period 1 (2 Weeks)||1
6788431|NCT00484718|7719691|FG005|STARTED|Treatment Period 1 (2 Weeks)||1
6788432|NCT00484718|7719686|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||1
6788433|NCT00484718|7719687|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||1
6788434|NCT00484718|7719688|FG002|COMPLETED|Treatment Period 1 (2 Weeks)||1
6788435|NCT00484718|7719689|FG003|COMPLETED|Treatment Period 1 (2 Weeks)||1
6788436|NCT00484718|7719690|FG004|COMPLETED|Treatment Period 1 (2 Weeks)||1
6788437|NCT00484718|7719691|FG005|COMPLETED|Treatment Period 1 (2 Weeks)||1
6788438|NCT00484718|7719686|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6788439|NCT00484718|7719687|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6788440|NCT00484718|7719688|FG002|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6788441|NCT00484718|7719689|FG003|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6788442|NCT00484718|7719690|FG004|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6788443|NCT00484718|7719691|FG005|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6788444|NCT00484718|7719686|FG000|STARTED|Washout Period (2 Weeks)||1
6788445|NCT00484718|7719687|FG001|STARTED|Washout Period (2 Weeks)||1
6788446|NCT00484718|7719688|FG002|STARTED|Washout Period (2 Weeks)||1
6788447|NCT00484718|7719689|FG003|STARTED|Washout Period (2 Weeks)||1
6788448|NCT00484718|7719690|FG004|STARTED|Washout Period (2 Weeks)||1
6788449|NCT00484718|7719691|FG005|STARTED|Washout Period (2 Weeks)||1
6788450|NCT00484718|7719686|FG000|COMPLETED|Washout Period (2 Weeks)||1
6788451|NCT00484718|7719687|FG001|COMPLETED|Washout Period (2 Weeks)||1
6788452|NCT00484718|7719688|FG002|COMPLETED|Washout Period (2 Weeks)||1
6788453|NCT00484718|7719689|FG003|COMPLETED|Washout Period (2 Weeks)||1
6788454|NCT00484718|7719690|FG004|COMPLETED|Washout Period (2 Weeks)||1
6788455|NCT00484718|7719691|FG005|COMPLETED|Washout Period (2 Weeks)||1
6788456|NCT00484718|7719686|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
6788457|NCT00484718|7719687|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
6788458|NCT00484718|7719688|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
6788459|NCT00484718|7719689|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
6788460|NCT00484718|7719690|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
6788461|NCT00484718|7719691|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
6788462|NCT00484718|7719686|FG000|STARTED|Treatment Period 2 (2 Weeks)||1
6788463|NCT00484718|7719687|FG001|STARTED|Treatment Period 2 (2 Weeks)||1
6788464|NCT00484718|7719688|FG002|STARTED|Treatment Period 2 (2 Weeks)||1
6788465|NCT00484718|7719689|FG003|STARTED|Treatment Period 2 (2 Weeks)||1
6788466|NCT00484718|7719690|FG004|STARTED|Treatment Period 2 (2 Weeks)||1
6563253|NCT01806597|7486249|FG000|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
6563254|NCT01806597|7486250|FG001|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
6563255|NCT01806597|7486251|FG002|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
6563256|NCT01806597|7486252|FG003|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
6563257|NCT01806597|7486253|FG004|NOT COMPLETED|Period 1 (Baseline to Week 16)||5
6563258|NCT01806597|7486254|FG005|NOT COMPLETED|Period 1 (Baseline to Week 16)||0
6563259|NCT01806597|7486249|FG000|STARTED|Treatment Period 2 (Week 16 to Week 132)||63
6788467|NCT00484718|7719691|FG005|STARTED|Treatment Period 2 (2 Weeks)||1
6788468|NCT00484718|7719686|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||1
6788469|NCT00484718|7719687|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||1
6788470|NCT00484718|7719688|FG002|COMPLETED|Treatment Period 2 (2 Weeks)||1
6788471|NCT00484718|7719689|FG003|COMPLETED|Treatment Period 2 (2 Weeks)||1
6788472|NCT00484718|7719690|FG004|COMPLETED|Treatment Period 2 (2 Weeks)||1
6788473|NCT00484718|7719691|FG005|COMPLETED|Treatment Period 2 (2 Weeks)||1
6788474|NCT00484718|7719686|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6788475|NCT00484718|7719687|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6788476|NCT00484718|7719688|FG002|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6788477|NCT00484718|7719689|FG003|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6788478|NCT00484718|7719690|FG004|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6788479|NCT00484718|7719691|FG005|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6788480|NCT00484718|7719686|FG000|STARTED|Washout Period (2 Weeks)||1
6788481|NCT00484718|7719687|FG001|STARTED|Washout Period (2 Weeks)||1
6788482|NCT00484718|7719688|FG002|STARTED|Washout Period (2 Weeks)||1
6788483|NCT00484718|7719689|FG003|STARTED|Washout Period (2 Weeks)||1
6788484|NCT00484718|7719690|FG004|STARTED|Washout Period (2 Weeks)||1
6788485|NCT00484718|7719691|FG005|STARTED|Washout Period (2 Weeks)||1
6788486|NCT00484718|7719686|FG000|COMPLETED|Washout Period (2 Weeks)||1
6788487|NCT00484718|7719687|FG001|COMPLETED|Washout Period (2 Weeks)||1
6788488|NCT00484718|7719688|FG002|COMPLETED|Washout Period (2 Weeks)||1
6788489|NCT00484718|7719689|FG003|COMPLETED|Washout Period (2 Weeks)||1
6788490|NCT00484718|7719690|FG004|COMPLETED|Washout Period (2 Weeks)||1
6788491|NCT00484718|7719691|FG005|COMPLETED|Washout Period (2 Weeks)||1
6788492|NCT00484718|7719686|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
6788493|NCT00484718|7719687|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
6788494|NCT00484718|7719688|FG002|NOT COMPLETED|Washout Period (2 Weeks)||0
6788495|NCT00484718|7719689|FG003|NOT COMPLETED|Washout Period (2 Weeks)||0
6788496|NCT00484718|7719690|FG004|NOT COMPLETED|Washout Period (2 Weeks)||0
6788497|NCT00484718|7719691|FG005|NOT COMPLETED|Washout Period (2 Weeks)||0
6788498|NCT00484718|7719686|FG000|STARTED|Treatment Period 3 (2 Weeks)||1
6788499|NCT00484718|7719687|FG001|STARTED|Treatment Period 3 (2 Weeks)||1
6788500|NCT00484718|7719688|FG002|STARTED|Treatment Period 3 (2 Weeks)||1
6788501|NCT00484718|7719689|FG003|STARTED|Treatment Period 3 (2 Weeks)||1
6788502|NCT00484718|7719690|FG004|STARTED|Treatment Period 3 (2 Weeks)||1
6788503|NCT00484718|7719691|FG005|STARTED|Treatment Period 3 (2 Weeks)||1
6788504|NCT00484718|7719686|FG000|COMPLETED|Treatment Period 3 (2 Weeks)||1
6788505|NCT00484718|7719687|FG001|COMPLETED|Treatment Period 3 (2 Weeks)||1
6788506|NCT00484718|7719688|FG002|COMPLETED|Treatment Period 3 (2 Weeks)||1
6788507|NCT00484718|7719689|FG003|COMPLETED|Treatment Period 3 (2 Weeks)||1
6788508|NCT00484718|7719690|FG004|COMPLETED|Treatment Period 3 (2 Weeks)||1
6788509|NCT00484718|7719691|FG005|COMPLETED|Treatment Period 3 (2 Weeks)||1
6788510|NCT00484718|7719686|FG000|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
6788511|NCT00484718|7719687|FG001|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
6788512|NCT00484718|7719688|FG002|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
6788513|NCT00484718|7719689|FG003|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
6788514|NCT00484718|7719690|FG004|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
6788515|NCT00484718|7719691|FG005|NOT COMPLETED|Treatment Period 3 (2 Weeks)||0
6502250|NCT01433354|7420905|FG000|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
6788516|NCT00477230|7719701|FG000|STARTED|Overall Study||32
6788517|NCT00477230|7719702|FG001|STARTED|Overall Study||32
6788518|NCT00477230|7719701|FG000|COMPLETED|Overall Study||12
6788519|NCT00477230|7719702|FG001|COMPLETED|Overall Study||1
6788520|NCT00477230|7719701|FG000|NOT COMPLETED|Overall Study||20
6788521|NCT00477230|7719702|FG001|NOT COMPLETED|Overall Study||31
6788522|NCT00470067|7719708|FG000|STARTED|Overall Study||9
6788523|NCT00470067|7719708|FG000|COMPLETED|Overall Study||2
6788524|NCT00470067|7719708|FG000|NOT COMPLETED|Overall Study||7
6788525|NCT00476827|7719718|FG000|STARTED|Overall Study||3
6788526|NCT00476827|7719719|FG001|STARTED|Overall Study||0
6788527|NCT00476827|7719720|FG002|STARTED|Overall Study||1
6788528|NCT00476827|7719721|FG003|STARTED|Overall Study||0
6788529|NCT00476827|7719722|FG004|STARTED|Overall Study||2
6788530|NCT00476827|7719723|FG005|STARTED|Overall Study||2
6788531|NCT00476827|7719718|FG000|COMPLETED|Overall Study||3
6788532|NCT00476827|7719719|FG001|COMPLETED|Overall Study||0
6788533|NCT00476827|7719720|FG002|COMPLETED|Overall Study||1
6788534|NCT00476827|7719721|FG003|COMPLETED|Overall Study||0
6788535|NCT00476827|7719722|FG004|COMPLETED|Overall Study||2
6788536|NCT00476827|7719723|FG005|COMPLETED|Overall Study||2
6788537|NCT00476827|7719718|FG000|NOT COMPLETED|Overall Study||0
6788538|NCT00476827|7719719|FG001|NOT COMPLETED|Overall Study||0
6788539|NCT00476827|7719720|FG002|NOT COMPLETED|Overall Study||0
6788540|NCT00476827|7719721|FG003|NOT COMPLETED|Overall Study||0
6788541|NCT00476827|7719722|FG004|NOT COMPLETED|Overall Study||0
6788542|NCT00476827|7719723|FG005|NOT COMPLETED|Overall Study||0
6788543|NCT00475657|7719735|FG000|STARTED|Overall Study||5
6788544|NCT00475657|7719735|FG000|COMPLETED|Overall Study||1
6788545|NCT00475657|7719735|FG000|NOT COMPLETED|Overall Study||4
6788546|NCT00472082|7719739|FG000|STARTED|Overall Study||5
6788547|NCT00472082|7719739|FG000|COMPLETED|Overall Study||0
6788548|NCT00472082|7719739|FG000|NOT COMPLETED|Overall Study||5
6788549|NCT00478062|7719743|FG000|STARTED|Overall Study||1
6788550|NCT00478062|7719743|FG000|COMPLETED|Overall Study||1
6788551|NCT00478062|7719743|FG000|NOT COMPLETED|Overall Study||0
6788552|NCT00470574|7719747|FG000|STARTED|Overall Study||7
6788553|NCT00470574|7719747|FG000|COMPLETED|Overall Study||7
6788554|NCT00470574|7719747|FG000|NOT COMPLETED|Overall Study||0
6788555|NCT00467753|7719753|FG000|STARTED|Overall Study||3
6788556|NCT00467753|7719754|FG001|STARTED|Overall Study||2
6788557|NCT00467753|7719753|FG000|COMPLETED|Overall Study||0
6788558|NCT00467753|7719754|FG001|COMPLETED|Overall Study||0
6788559|NCT00467753|7719753|FG000|NOT COMPLETED|Overall Study||3
6788560|NCT00467753|7719754|FG001|NOT COMPLETED|Overall Study||2
6788561|NCT00456612|7719764|FG000|STARTED|Overall Study||4
6788562|NCT00456612|7719764|FG000|COMPLETED|Overall Study||1
6788563|NCT00456612|7719764|FG000|NOT COMPLETED|Overall Study||3
6788564|NCT00469612|7719771|FG000|STARTED|Overall Study||2
6788565|NCT00469612|7719772|FG001|STARTED|Overall Study||0
6788566|NCT00469612|7719771|FG000|COMPLETED|Overall Study|Subjects enrolled, but no data collected. Study terminated before data collection.|0
6788567|NCT00469612|7719772|FG001|COMPLETED|Overall Study||0
6788568|NCT00469612|7719771|FG000|NOT COMPLETED|Overall Study||2
6788569|NCT00469612|7719772|FG001|NOT COMPLETED|Overall Study||0
6788570|NCT00461812|7719778|FG000|STARTED|Overall Study||10
6788571|NCT00461812|7719778|FG000|COMPLETED|Overall Study||0
6788572|NCT00461812|7719778|FG000|NOT COMPLETED|Overall Study||10
6788573|NCT00459121|7719783|FG000|STARTED|Overall Study||2
6788574|NCT00459121|7719783|FG000|COMPLETED|Overall Study||2
6788575|NCT00459121|7719783|FG000|NOT COMPLETED|Overall Study||0
6788576|NCT00461682|7719788|FG000|STARTED|Overall Study||1
6788577|NCT00461682|7719788|FG000|COMPLETED|Overall Study||0
6788578|NCT00461682|7719788|FG000|NOT COMPLETED|Overall Study||1
6788579|NCT00462904|7719794|FG000|STARTED|Overall Study||4
6788580|NCT00462904|7719794|FG000|COMPLETED|Overall Study||3
6788581|NCT00462904|7719794|FG000|NOT COMPLETED|Overall Study||1
6788582|NCT00450333|7719802|FG000|STARTED|Overall Study||98
6788583|NCT00450333|7719803|FG001|STARTED|Overall Study||107
6788584|NCT00450333|7719804|FG002|STARTED|Overall Study||100
6788585|NCT00450333|7719805|FG003|STARTED|Overall Study||102
6788586|NCT00450333|7719802|FG000|COMPLETED|Overall Study||44
6788587|NCT00450333|7719803|FG001|COMPLETED|Overall Study||44
6788588|NCT00450333|7719804|FG002|COMPLETED|Overall Study||75
6788589|NCT00450333|7719805|FG003|COMPLETED|Overall Study||74
6788590|NCT00450333|7719802|FG000|NOT COMPLETED|Overall Study||54
6788591|NCT00450333|7719803|FG001|NOT COMPLETED|Overall Study||63
6788592|NCT00450333|7719804|FG002|NOT COMPLETED|Overall Study||25
6788593|NCT00450333|7719805|FG003|NOT COMPLETED|Overall Study||28
6788594|NCT00455143|7719815|FG000|STARTED|Overall Study||27
6788595|NCT00455143|7719815|FG000|COMPLETED|Overall Study||21
6788596|NCT00455143|7719815|FG000|NOT COMPLETED|Overall Study||6
6788597|NCT00456989|7719820|FG000|STARTED|Overall Study||39
6788598|NCT00456989|7719820|FG000|COMPLETED|Overall Study||39
6788599|NCT00456989|7719820|FG000|NOT COMPLETED|Overall Study||0
6788600|NCT00448682|7719825|FG000|STARTED|Overall Study||25
6788601|NCT00448682|7719825|FG000|COMPLETED|Overall Study||25
6788602|NCT00448682|7719825|FG000|NOT COMPLETED|Overall Study||0
6788603|NCT00454571|7719831|FG000|STARTED|Overall Study||18
6788604|NCT00454571|7719832|FG001|STARTED|Overall Study||19
6788605|NCT00454571|7719831|FG000|COMPLETED|Overall Study||5
6788606|NCT00454571|7719832|FG001|COMPLETED|Overall Study||13
6788607|NCT00454571|7719831|FG000|NOT COMPLETED|Overall Study||13
6788608|NCT00454571|7719832|FG001|NOT COMPLETED|Overall Study||6
6788609|NCT00452361|7719840|FG000|STARTED|Overall Study||21
6788610|NCT00452361|7719841|FG001|STARTED|Overall Study||10
6788611|NCT00452361|7719840|FG000|COMPLETED|Overall Study||0
6788612|NCT00452361|7719841|FG001|COMPLETED|Overall Study||0
6788613|NCT00452361|7719840|FG000|NOT COMPLETED|Overall Study||21
6788614|NCT00452361|7719841|FG001|NOT COMPLETED|Overall Study||10
6788615|NCT00443040|7719850|FG000|STARTED|Overall Study||14
6788616|NCT00443040|7719851|FG001|STARTED|Overall Study||11
6788617|NCT00443040|7719852|FG002|STARTED|Overall Study||10
6788618|NCT00443040|7719850|FG000|COMPLETED|Overall Study||10
6788619|NCT00443040|7719851|FG001|COMPLETED|Overall Study||11
6788620|NCT00443040|7719852|FG002|COMPLETED|Overall Study||9
6788621|NCT00443040|7719850|FG000|NOT COMPLETED|Overall Study||4
6788622|NCT00443040|7719851|FG001|NOT COMPLETED|Overall Study||0
6788623|NCT00443040|7719852|FG002|NOT COMPLETED|Overall Study||1
6788624|NCT00447421|7719860|FG000|STARTED|Overall Study||9
6788625|NCT00447421|7719860|FG000|COMPLETED|Overall Study||3
6788626|NCT00447421|7719860|FG000|NOT COMPLETED|Overall Study||6
6788627|NCT00441272|7719866|FG000|STARTED|Overall Study||25
6788628|NCT00441272|7719867|FG001|STARTED|Overall Study||25
6788629|NCT00441272|7719866|FG000|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
6788630|NCT00441272|7719867|FG001|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
6788631|NCT00441272|7719866|FG000|NOT COMPLETED|Overall Study||25
6788632|NCT00441272|7719867|FG001|NOT COMPLETED|Overall Study||25
6788633|NCT00437398|7719873|FG000|STARTED|Overall Study||2
6788634|NCT00437398|7719873|FG000|COMPLETED|Overall Study||2
6788635|NCT00437398|7719873|FG000|NOT COMPLETED|Overall Study||0
6788636|NCT00440271|7719879|FG000|STARTED|Overall Study||15
6788637|NCT00440271|7719880|FG001|STARTED|Overall Study||18
6788638|NCT00440271|7719879|FG000|COMPLETED|Overall Study||3
6788639|NCT00440271|7719880|FG001|COMPLETED|Overall Study||3
6788640|NCT00440271|7719879|FG000|NOT COMPLETED|Overall Study||12
6788641|NCT00440271|7719880|FG001|NOT COMPLETED|Overall Study||15
6788642|NCT00442260|7719886|FG000|STARTED|Overall Study||2
6788643|NCT00442260|7719886|FG000|COMPLETED|Overall Study||2
6788644|NCT00442260|7719886|FG000|NOT COMPLETED|Overall Study||0
6788645|NCT00429026|7719890|FG000|STARTED|Overall Study||40
6788646|NCT00429026|7719890|FG000|COMPLETED|Overall Study||0
6788647|NCT00429026|7719890|FG000|NOT COMPLETED|Overall Study||40
6788648|NCT00428207|7719894|FG000|STARTED|Overall Study||2
6788649|NCT00428207|7719895|FG001|STARTED|Overall Study||2
6788650|NCT00428207|7719894|FG000|COMPLETED|Overall Study||2
6788651|NCT00428207|7719895|FG001|COMPLETED|Overall Study||2
6788652|NCT00428207|7719894|FG000|NOT COMPLETED|Overall Study||0
6788653|NCT00428207|7719895|FG001|NOT COMPLETED|Overall Study||0
6788654|NCT00439569|7719901|FG000|STARTED|Cohort 1 (500 mg/kg/Day)||7
6788655|NCT00439569|7719901|FG000|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
6788656|NCT00439569|7719901|FG000|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
6788657|NCT00439569|7719901|FG000|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
6788658|NCT00439569|7719901|FG000|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
6788659|NCT00439569|7719901|FG000|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
6788660|NCT00422669|7719908|FG000|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
6788661|NCT00422669|7719909|FG001|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
6788662|NCT00422669|7719910|FG002|STARTED|Overall Study||7
6788663|NCT00422669|7719908|FG000|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
6788664|NCT00422669|7719909|FG001|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
6788665|NCT00422669|7719910|FG002|COMPLETED|Overall Study||0
6788666|NCT00422669|7719908|FG000|NOT COMPLETED|Overall Study||98
6788667|NCT00422669|7719909|FG001|NOT COMPLETED|Overall Study||100
6788668|NCT00422669|7719910|FG002|NOT COMPLETED|Overall Study||7
6788669|NCT00432445|7719916|FG000|STARTED|Overall Study||2
6788670|NCT00432445|7719916|FG000|COMPLETED|Overall Study||2
6788671|NCT00432445|7719916|FG000|NOT COMPLETED|Overall Study||0
6788672|NCT00434590|7719922|FG000|STARTED|Overall Study||5
6788673|NCT00434590|7719923|FG001|STARTED|Overall Study||5
6788674|NCT00434590|7719922|FG000|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
6788675|NCT00434590|7719923|FG001|COMPLETED|Overall Study||0
6788676|NCT00434590|7719922|FG000|NOT COMPLETED|Overall Study||5
6788677|NCT00434590|7719923|FG001|NOT COMPLETED|Overall Study||5
6788678|NCT00424645|7719931|FG000|STARTED|Overall Study||3
6788679|NCT00424645|7719932|FG001|STARTED|Overall Study||0
6788680|NCT00424645|7719931|FG000|COMPLETED|Overall Study||2
6788681|NCT00424645|7719932|FG001|COMPLETED|Overall Study||0
6788682|NCT00424645|7719931|FG000|NOT COMPLETED|Overall Study||1
6788683|NCT00424645|7719932|FG001|NOT COMPLETED|Overall Study||0
6788684|NCT00430027|7719938|FG000|STARTED|Overall Study||8
6788685|NCT00430027|7719938|FG000|COMPLETED|Overall Study||0
6788686|NCT00430027|7719938|FG000|NOT COMPLETED|Overall Study||8
6788687|NCT00429858|7719942|FG000|STARTED|Overall Study||21
6788688|NCT00429858|7719942|FG000|COMPLETED|Overall Study||19
6788689|NCT00429858|7719942|FG000|NOT COMPLETED|Overall Study||2
6788690|NCT00425438|7719949|FG000|STARTED|Overall Study||25
6788691|NCT00425438|7719950|FG001|STARTED|Overall Study||27
6788692|NCT00425438|7719949|FG000|COMPLETED|Overall Study||0
6788693|NCT00425438|7719950|FG001|COMPLETED|Overall Study||0
6788694|NCT00425438|7719949|FG000|NOT COMPLETED|Overall Study||25
6788695|NCT00425438|7719950|FG001|NOT COMPLETED|Overall Study||27
6788696|NCT00421954|7719956|FG000|STARTED|Overall Study||0
6788697|NCT00421954|7719956|FG000|COMPLETED|Overall Study||0
6788698|NCT00421954|7719956|FG000|NOT COMPLETED|Overall Study||0
6788699|NCT00422942|7719960|FG000|STARTED|Overall Study||3
6788700|NCT00422942|7719960|FG000|COMPLETED|Overall Study||0
6788701|NCT00422942|7719960|FG000|NOT COMPLETED|Overall Study||3
6788702|NCT00409344|7719966|FG000|STARTED|Overall Study|No participants enrolled|0
6788703|NCT00409344|7719967|FG001|STARTED|Overall Study|No participants enrolled|0
6788704|NCT00409344|7719966|FG000|COMPLETED|Overall Study|No participants were enrolled to completion|0
6788705|NCT00409344|7719967|FG001|COMPLETED|Overall Study|No participants were enrolled to completion|0
6788706|NCT00409344|7719966|FG000|NOT COMPLETED|Overall Study||0
6788707|NCT00409344|7719967|FG001|NOT COMPLETED|Overall Study||0
6788708|NCT00414453|7719973|FG000|STARTED|Overall Study||19
6788709|NCT00414453|7719973|FG000|COMPLETED|Overall Study||3
6788710|NCT00414453|7719973|FG000|NOT COMPLETED|Overall Study||16
6788711|NCT00417248|7719983|FG000|STARTED|Overall Study||8
6788712|NCT00417248|7719983|FG000|COMPLETED|Overall Study||0
6788713|NCT00417248|7719983|FG000|NOT COMPLETED|Overall Study||8
6788714|NCT00418145|7719988|FG000|STARTED|Overall Study||16
6788715|NCT00418145|7719988|FG000|COMPLETED|Overall Study||10
6788716|NCT00418145|7719988|FG000|NOT COMPLETED|Overall Study||6
6788717|NCT00409331|7719994|FG000|STARTED|Overall Study||1
6788718|NCT00409331|7719994|FG000|COMPLETED|Overall Study||0
6788719|NCT00409331|7719994|FG000|NOT COMPLETED|Overall Study||1
6788720|NCT00392860|7720000|FG000|STARTED|Overall Study||3
6788721|NCT00392860|7720001|FG001|STARTED|Overall Study||0
6788722|NCT00392860|7720002|FG002|STARTED|Overall Study||1
6788723|NCT00392860|7720000|FG000|COMPLETED|Overall Study||3
6788724|NCT00392860|7720001|FG001|COMPLETED|Overall Study||0
6788725|NCT00392860|7720002|FG002|COMPLETED|Overall Study||1
6788726|NCT00392860|7720000|FG000|NOT COMPLETED|Overall Study||0
6788727|NCT00392860|7720001|FG001|NOT COMPLETED|Overall Study||0
6788728|NCT00392860|7720002|FG002|NOT COMPLETED|Overall Study||0
6788729|NCT00391430|7720011|FG000|STARTED|Overall Study||8
6788730|NCT00391430|7720012|FG001|STARTED|Overall Study||0
6788731|NCT00391430|7720013|FG002|STARTED|Overall Study||31
6788732|NCT00391430|7720011|FG000|COMPLETED|Overall Study||5
6788733|NCT00391430|7720012|FG001|COMPLETED|Overall Study||0
6788734|NCT00391430|7720013|FG002|COMPLETED|Overall Study||19
6788735|NCT00391430|7720011|FG000|NOT COMPLETED|Overall Study||3
6788736|NCT00391430|7720012|FG001|NOT COMPLETED|Overall Study||0
6788737|NCT00391430|7720013|FG002|NOT COMPLETED|Overall Study||12
6788738|NCT00399841|7720021|FG000|STARTED|Overall Study||13
6788739|NCT00399841|7720022|FG001|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
6788740|NCT00399841|7720023|FG002|STARTED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
6788741|NCT00399841|7720021|FG000|Permanent Implant|Overall Study||6
6788742|NCT00399841|7720022|FG001|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
6788743|NCT00399841|7720023|FG002|Permanent Implant|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
6788744|NCT00399841|7720021|FG000|12-week|Overall Study||2
6788745|NCT00399841|7720022|FG001|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
6788746|NCT00399841|7720023|FG002|12-week|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
6788747|NCT00399841|7720021|FG000|COMPLETED|Overall Study||1
6788748|NCT00399841|7720022|FG001|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
6788749|NCT00399841|7720023|FG002|COMPLETED|Overall Study|# of participants unknown. Efforts were made to locate data. No data are available|0
6788750|NCT00399841|7720021|FG000|NOT COMPLETED|Overall Study||12
6788751|NCT00399841|7720022|FG001|NOT COMPLETED|Overall Study||0
6788752|NCT00399841|7720023|FG002|NOT COMPLETED|Overall Study||0
6788753|NCT00387673|7720028|FG000|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6788754|NCT00387673|7720029|FG001|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6788755|NCT00387673|7720030|FG002|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6788756|NCT00387673|7720028|FG000|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6788757|NCT00387673|7720029|FG001|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6788758|NCT00387673|7720030|FG002|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
6788759|NCT00387673|7720028|FG000|NOT COMPLETED|Overall Study||0
6788760|NCT00387673|7720029|FG001|NOT COMPLETED|Overall Study||0
6788761|NCT00387673|7720030|FG002|NOT COMPLETED|Overall Study||0
6788762|NCT00386724|7720036|FG000|STARTED|Overall Study||8
6788763|NCT00386724|7720036|FG000|3 Months Post-activation|Overall Study||4
6788764|NCT00386724|7720036|FG000|COMPLETED|Overall Study||3
6788765|NCT00386724|7720036|FG000|NOT COMPLETED|Overall Study||5
6788766|NCT00387244|7720040|FG000|STARTED|Overall Study||7
6788767|NCT00387244|7720040|FG000|End of Trial|Overall Study||0
6788768|NCT00387244|7720040|FG000|COMPLETED|Overall Study||0
6788769|NCT00387244|7720040|FG000|NOT COMPLETED|Overall Study||7
6788770|NCT00384293|7720046|FG000|STARTED|MK0524A Active Run-In, Pre-randomization||937
6788771|NCT00384293|7720047|FG001|STARTED|MK0524A Active Run-In, Pre-randomization||0
6788772|NCT00384293|7720048|FG002|STARTED|MK0524A Active Run-In, Pre-randomization||0
6788773|NCT00384293|7720046|FG000|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
6788774|NCT00384293|7720047|FG001|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
6788775|NCT00384293|7720048|FG002|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
6788776|NCT00384293|7720046|FG000|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
6788777|NCT00384293|7720047|FG001|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
6788778|NCT00384293|7720048|FG002|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
6788779|NCT00384293|7720046|FG000|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
6788780|NCT00384293|7720047|FG001|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
6788781|NCT00384293|7720048|FG002|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
6788782|NCT00384293|7720046|FG000|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
6788783|NCT00384293|7720047|FG001|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
6788784|NCT00384293|7720048|FG002|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
6788785|NCT00384293|7720046|FG000|STARTED|Post-randomization Period||0
6788786|NCT00384293|7720047|FG001|STARTED|Post-randomization Period||214
6788787|NCT00384293|7720048|FG002|STARTED|Post-randomization Period||219
6788788|NCT00384293|7720046|FG000|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
6788789|NCT00384293|7720047|FG001|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
6788790|NCT00384293|7720048|FG002|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
6788791|NCT00384293|7720046|FG000|COMPLETED|Post-randomization Period||0
6788792|NCT00384293|7720047|FG001|COMPLETED|Post-randomization Period||0
6788793|NCT00384293|7720048|FG002|COMPLETED|Post-randomization Period||0
6788794|NCT00384293|7720046|FG000|NOT COMPLETED|Post-randomization Period||0
6788795|NCT00384293|7720047|FG001|NOT COMPLETED|Post-randomization Period||214
6788796|NCT00384293|7720048|FG002|NOT COMPLETED|Post-randomization Period||219
6788797|NCT00383630|7720056|FG000|STARTED|Overall Study||1
6788798|NCT00383630|7720056|FG000|COMPLETED|Overall Study||1
6788799|NCT00383630|7720056|FG000|NOT COMPLETED|Overall Study||0
6788800|NCT00374543|7720062|FG000|STARTED|Overall Study||2
6788801|NCT00374543|7720063|FG001|STARTED|Overall Study||1
6788802|NCT00374543|7720062|FG000|COMPLETED|Overall Study||2
6788803|NCT00374543|7720063|FG001|COMPLETED|Overall Study||1
6788804|NCT00374543|7720062|FG000|NOT COMPLETED|Overall Study||0
6788805|NCT00374543|7720063|FG001|NOT COMPLETED|Overall Study||0
6788806|NCT00377455|7720069|FG000|STARTED|Overall Study||5
6788807|NCT00377455|7720069|FG000|COMPLETED|Overall Study||4
6788808|NCT00377455|7720069|FG000|NOT COMPLETED|Overall Study||1
6788809|NCT00371462|7720075|FG000|STARTED|Overall Study||35
6788810|NCT00371462|7720076|FG001|STARTED|Overall Study||35
6788811|NCT00371462|7720075|FG000|COMPLETED|Overall Study||27
6788812|NCT00371462|7720076|FG001|COMPLETED|Overall Study||27
6788813|NCT00371462|7720075|FG000|NOT COMPLETED|Overall Study||8
6788814|NCT00371462|7720076|FG001|NOT COMPLETED|Overall Study||8
6788815|NCT00369265|7720084|FG000|STARTED|Overall Study||4
6788816|NCT00369265|7720085|FG001|STARTED|Overall Study||7
6788817|NCT00369265|7720084|FG000|COMPLETED|Overall Study||0
6788818|NCT00369265|7720085|FG001|COMPLETED|Overall Study||0
6788819|NCT00369265|7720084|FG000|NOT COMPLETED|Overall Study||4
6788820|NCT00369265|7720085|FG001|NOT COMPLETED|Overall Study||7
6788821|NCT00370695|7720091|FG000|STARTED|Overall Study||15
6788822|NCT00370695|7720091|FG000|12 Weeks Post-activation|Overall Study||2
6788823|NCT00370695|7720091|FG000|COMPLETED|Overall Study||0
6788824|NCT00370695|7720091|FG000|NOT COMPLETED|Overall Study||15
6788825|NCT00364689|7720098|FG000|STARTED|Overall Study||13
6788826|NCT00364689|7720098|FG000|COMPLETED|Overall Study||12
6788827|NCT00364689|7720098|FG000|NOT COMPLETED|Overall Study||1
6788828|NCT00352118|7720104|FG000|STARTED|Overall Study||4
6788829|NCT00352118|7720104|FG000|COMPLETED|Overall Study||0
6788830|NCT00352118|7720104|FG000|NOT COMPLETED|Overall Study||4
6788831|NCT00368654|7720112|FG000|STARTED|Overall Study||3
6788832|NCT00368654|7720113|FG001|STARTED|Overall Study||3
6788833|NCT00368654|7720114|FG002|STARTED|Overall Study||3
6788834|NCT00368654|7720115|FG003|STARTED|Overall Study||3
6788835|NCT00368654|7720112|FG000|COMPLETED|Overall Study||0
6788836|NCT00368654|7720113|FG001|COMPLETED|Overall Study||0
6788837|NCT00368654|7720114|FG002|COMPLETED|Overall Study||0
6788838|NCT00368654|7720115|FG003|COMPLETED|Overall Study||0
6788839|NCT00368654|7720112|FG000|NOT COMPLETED|Overall Study||3
6788840|NCT00368654|7720113|FG001|NOT COMPLETED|Overall Study||3
6788841|NCT00368654|7720114|FG002|NOT COMPLETED|Overall Study||3
6788842|NCT00368654|7720115|FG003|NOT COMPLETED|Overall Study||3
6788843|NCT00356421|7720127|FG000|STARTED|Overall Study||38
6788844|NCT00356421|7720128|FG001|STARTED|Overall Study||20
6788845|NCT00356421|7720127|FG000|COMPLETED|Overall Study||6
6788846|NCT00356421|7720128|FG001|COMPLETED|Overall Study||3
6788847|NCT00356421|7720127|FG000|NOT COMPLETED|Overall Study||32
6788848|NCT00356421|7720128|FG001|NOT COMPLETED|Overall Study||17
6788849|NCT00350623|7720137|FG000|STARTED|Overall Study||71
6788850|NCT00350623|7720138|FG001|STARTED|Overall Study||71
6788851|NCT00350623|7720139|FG002|STARTED|Overall Study||68
6788852|NCT00350623|7720137|FG000|COMPLETED|Overall Study||63
6788853|NCT00350623|7720138|FG001|COMPLETED|Overall Study||67
6788854|NCT00350623|7720139|FG002|COMPLETED|Overall Study||62
6788855|NCT00350623|7720137|FG000|NOT COMPLETED|Overall Study||8
6788856|NCT00350623|7720138|FG001|NOT COMPLETED|Overall Study||4
6788857|NCT00350623|7720139|FG002|NOT COMPLETED|Overall Study||6
6788858|NCT00356187|7720149|FG000|STARTED|Overall Study||0
6788859|NCT00356187|7720150|FG001|STARTED|Overall Study||0
6788860|NCT00356187|7720149|FG000|COMPLETED|Overall Study||0
6788861|NCT00356187|7720150|FG001|COMPLETED|Overall Study||0
6788862|NCT00356187|7720149|FG000|NOT COMPLETED|Overall Study||0
6788863|NCT00356187|7720150|FG001|NOT COMPLETED|Overall Study||0
6788864|NCT00353275|7720160|FG000|STARTED|Overall Study||2
6788865|NCT00353275|7720161|FG001|STARTED|Overall Study||3
6788866|NCT00353275|7720160|FG000|COMPLETED|Overall Study||2
6788867|NCT00353275|7720161|FG001|COMPLETED|Overall Study||3
6788868|NCT00353275|7720160|FG000|NOT COMPLETED|Overall Study||0
6788869|NCT00353275|7720161|FG001|NOT COMPLETED|Overall Study||0
6788870|NCT00350844|7720167|FG000|STARTED|Overall Study||6
6788871|NCT00350844|7720167|FG000|COMPLETED|Overall Study||5
6788872|NCT00350844|7720167|FG000|NOT COMPLETED|Overall Study||1
6788873|NCT00348556|7720171|FG000|STARTED|Overall Study||4
6788874|NCT00348556|7720171|FG000|COMPLETED|Overall Study||3
6788875|NCT00348556|7720171|FG000|NOT COMPLETED|Overall Study||1
6788876|NCT00319839|7720175|FG000|STARTED|Overall Study||7
6788877|NCT00319839|7720175|FG000|COMPLETED|Overall Study||1
6788878|NCT00319839|7720175|FG000|NOT COMPLETED|Overall Study||6
6788879|NCT00344019|7720182|FG000|STARTED|Overall Study||12
6788880|NCT00344019|7720183|FG001|STARTED|Overall Study||11
6788881|NCT00344019|7720184|FG002|STARTED|Overall Study||74
6788882|NCT00344019|7720182|FG000|COMPLETED|Overall Study||12
6788883|NCT00344019|7720183|FG001|COMPLETED|Overall Study||11
6788884|NCT00344019|7720184|FG002|COMPLETED|Overall Study||0
6788885|NCT00344019|7720182|FG000|NOT COMPLETED|Overall Study||0
6788886|NCT00344019|7720183|FG001|NOT COMPLETED|Overall Study||0
6788887|NCT00344019|7720184|FG002|NOT COMPLETED|Overall Study||74
6788888|NCT00338455|7720197|FG000|STARTED|Overall Study||9
6788889|NCT00338455|7720198|FG001|STARTED|Overall Study||7
6788890|NCT00338455|7720197|FG000|Administered Study Drug|Overall Study||8
6788891|NCT00338455|7720198|FG001|Administered Study Drug|Overall Study||7
6788892|NCT00338455|7720197|FG000|COMPLETED|Overall Study||6
6788893|NCT00338455|7720198|FG001|COMPLETED|Overall Study||6
6788894|NCT00338455|7720197|FG000|NOT COMPLETED|Overall Study||3
6788895|NCT00338455|7720198|FG001|NOT COMPLETED|Overall Study||1
6788896|NCT00329108|7720206|FG000|STARTED|Overall Study|study terminated due to poor recruitment|15
6788897|NCT00329108|7720207|FG001|STARTED|Overall Study|study terminated due to poor recruitment|14
6788898|NCT00329108|7720206|FG000|COMPLETED|Overall Study||5
6788899|NCT00329108|7720207|FG001|COMPLETED|Overall Study||2
6788900|NCT00329108|7720206|FG000|NOT COMPLETED|Overall Study||10
6788901|NCT00329108|7720207|FG001|NOT COMPLETED|Overall Study||12
6788902|NCT00325572|7720215|FG000|STARTED|PHASE I||45
6788903|NCT00325572|7720216|FG001|STARTED|PHASE I||44
6788904|NCT00325572|7720215|FG000|COMPLETED|PHASE I||45
6788905|NCT00325572|7720216|FG001|COMPLETED|PHASE I||44
6788906|NCT00325572|7720215|FG000|NOT COMPLETED|PHASE I||0
6788907|NCT00325572|7720216|FG001|NOT COMPLETED|PHASE I||0
6788908|NCT00325572|7720215|FG000|STARTED|PHASE ii||0
6788909|NCT00325572|7720216|FG001|STARTED|PHASE ii||0
6788910|NCT00325572|7720215|FG000|COMPLETED|PHASE ii||0
6788911|NCT00325572|7720216|FG001|COMPLETED|PHASE ii||0
6788912|NCT00325572|7720215|FG000|NOT COMPLETED|PHASE ii||0
6788913|NCT00325572|7720216|FG001|NOT COMPLETED|PHASE ii||0
6788914|NCT00333762|7720222|FG000|STARTED|Overall Study||4
6788915|NCT00333762|7720222|FG000|COMPLETED|Overall Study||0
6788916|NCT00333762|7720222|FG000|NOT COMPLETED|Overall Study||4
6788917|NCT00333229|7720228|FG000|STARTED|Overall Study||6
6788918|NCT00333229|7720229|FG001|STARTED|Overall Study||5
6788919|NCT00333229|7720228|FG000|COMPLETED|Overall Study||6
6788920|NCT00333229|7720229|FG001|COMPLETED|Overall Study||4
6788921|NCT00333229|7720228|FG000|NOT COMPLETED|Overall Study||0
6788922|NCT00333229|7720229|FG001|NOT COMPLETED|Overall Study||1
6788923|NCT00322855|7720235|FG000|STARTED|Overall Study||1
6788924|NCT00322855|7720235|FG000|COMPLETED|Overall Study||1
6788925|NCT00322855|7720235|FG000|NOT COMPLETED|Overall Study||0
6788926|NCT00323635|7720241|FG000|STARTED|Overall Study||10
6788927|NCT00323635|7720242|FG001|STARTED|Overall Study||9
6788928|NCT00323635|7720241|FG000|COMPLETED|Overall Study||10
6788929|NCT00323635|7720242|FG001|COMPLETED|Overall Study||9
6788930|NCT00323635|7720241|FG000|NOT COMPLETED|Overall Study||0
6788931|NCT00323635|7720242|FG001|NOT COMPLETED|Overall Study||0
6788932|NCT00329732|7720252|FG000|STARTED|Overall Study||2
6788933|NCT00329732|7720253|FG001|STARTED|Overall Study||0
6788934|NCT00329732|7720252|FG000|COMPLETED|Overall Study||2
6788935|NCT00329732|7720253|FG001|COMPLETED|Overall Study||0
6788936|NCT00329732|7720252|FG000|NOT COMPLETED|Overall Study||0
6788937|NCT00329732|7720253|FG001|NOT COMPLETED|Overall Study||0
6788938|NCT00320931|7720258|FG000|STARTED|Overall Study||30
6788939|NCT00320931|7720258|FG000|COMPLETED|Overall Study||30
6378732|NCT00769483|7289227|FG000|STARTED|Overall Study||9
6378733|NCT00769483|7289228|FG001|STARTED|Overall Study||13
6378734|NCT00769483|7289229|FG002|STARTED|Overall Study||15
6788940|NCT00320931|7720258|FG000|NOT COMPLETED|Overall Study||0
6788941|NCT00314353|7720264|FG000|STARTED|Protocol Therapy (8 Cycles)||4
6788942|NCT00314353|7720265|FG001|STARTED|Protocol Therapy (8 Cycles)||3
6788943|NCT00314353|7720264|FG000|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
6788944|NCT00314353|7720265|FG001|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
6788945|NCT00314353|7720264|FG000|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
6788946|NCT00314353|7720265|FG001|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
6788947|NCT00314353|7720264|FG000|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
6788948|NCT00314353|7720265|FG001|STARTED|Follow-up||0
6788949|NCT00314353|7720264|FG000|COMPLETED|Follow-up||3
6788950|NCT00314353|7720265|FG001|COMPLETED|Follow-up||0
6788951|NCT00314353|7720264|FG000|NOT COMPLETED|Follow-up||0
6788952|NCT00314353|7720265|FG001|NOT COMPLETED|Follow-up||0
6788953|NCT00314093|7720271|FG000|STARTED|Overall Study||0
6788954|NCT00314093|7720271|FG000|COMPLETED|Overall Study||0
6788955|NCT00314093|7720271|FG000|NOT COMPLETED|Overall Study||0
6788956|NCT00314327|7720275|FG000|STARTED|Overall Study||1
6788957|NCT00314327|7720275|FG000|COMPLETED|Overall Study||0
6788958|NCT00314327|7720275|FG000|NOT COMPLETED|Overall Study||1
6788959|NCT00308113|7720283|FG000|STARTED|Overall Study||0
6788960|NCT00308113|7720284|FG001|STARTED|Overall Study||0
6788961|NCT00308113|7720285|FG002|STARTED|Overall Study||1
6788962|NCT00308113|7720286|FG003|STARTED|Overall Study||2
6788963|NCT00308113|7720283|FG000|COMPLETED|Overall Study||0
6788964|NCT00308113|7720284|FG001|COMPLETED|Overall Study||0
6788965|NCT00308113|7720285|FG002|COMPLETED|Overall Study||1
6788966|NCT00308113|7720286|FG003|COMPLETED|Overall Study||1
6788967|NCT00308113|7720283|FG000|NOT COMPLETED|Overall Study||0
6788968|NCT00308113|7720284|FG001|NOT COMPLETED|Overall Study||0
6788969|NCT00308113|7720285|FG002|NOT COMPLETED|Overall Study||0
6788970|NCT00308113|7720286|FG003|NOT COMPLETED|Overall Study||1
6788971|NCT00305643|7720298|FG000|STARTED|Overall Study||6
6378735|NCT00769483|7289230|FG003|STARTED|Overall Study||15
6378736|NCT00769483|7289231|FG004|STARTED|Overall Study||16
6502251|NCT01433354|7420905|FG000|COMPLETED|Overall Study||0
6502252|NCT01433354|7420905|FG000|NOT COMPLETED|Overall Study||119
6502253|NCT01433549|7420919|FG000|STARTED|Phase 1: First Study Product||12
6502254|NCT01433549|7420920|FG001|STARTED|Phase 1: First Study Product||13
6502255|NCT01433549|7420919|FG000|COMPLETED|Phase 1: First Study Product||12
6788972|NCT00305643|7720299|FG001|STARTED|Overall Study||5
6788973|NCT00305643|7720298|FG000|COMPLETED|Overall Study||6
6788974|NCT00305643|7720299|FG001|COMPLETED|Overall Study||5
6788975|NCT00305643|7720298|FG000|NOT COMPLETED|Overall Study||0
6788976|NCT00305643|7720299|FG001|NOT COMPLETED|Overall Study||0
6788977|NCT00298740|7720306|FG000|STARTED|Overall Study||12
6788978|NCT00298740|7720306|FG000|COMPLETED|Overall Study||3
6788979|NCT00298740|7720306|FG000|NOT COMPLETED|Overall Study||9
6788980|NCT00301080|7720310|FG000|STARTED|Original Version (2 Arms & 4 Weeks)||4
6788981|NCT00301080|7720311|FG001|STARTED|Original Version (2 Arms & 4 Weeks)||3
6788982|NCT00301080|7720312|FG002|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
6788983|NCT00301080|7720313|FG003|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
6788984|NCT00301080|7720314|FG004|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
6788985|NCT00301080|7720310|FG000|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
6788986|NCT00301080|7720311|FG001|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
6788987|NCT00301080|7720312|FG002|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
6788988|NCT00301080|7720313|FG003|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
6788989|NCT00301080|7720314|FG004|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
6788990|NCT00301080|7720310|FG000|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
6788991|NCT00301080|7720311|FG001|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
6788992|NCT00301080|7720312|FG002|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
6788993|NCT00301080|7720313|FG003|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
6788994|NCT00301080|7720314|FG004|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
6788995|NCT00301080|7720310|FG000|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
6788996|NCT00301080|7720311|FG001|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
6788997|NCT00301080|7720312|FG002|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6788998|NCT00301080|7720313|FG003|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6788999|NCT00301080|7720314|FG004|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6789000|NCT00301080|7720310|FG000|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
6789001|NCT00301080|7720311|FG001|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6789002|NCT00301080|7720312|FG002|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6789003|NCT00301080|7720313|FG003|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6789004|NCT00301080|7720314|FG004|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
6789005|NCT00301080|7720310|FG000|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
6789006|NCT00301080|7720311|FG001|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
6789007|NCT00301080|7720312|FG002|STARTED|Revised Version (3 Arms & 12 Weeks)||0
6789008|NCT00301080|7720313|FG003|STARTED|Revised Version (3 Arms & 12 Weeks)||0
6789009|NCT00301080|7720314|FG004|STARTED|Revised Version (3 Arms & 12 Weeks)||0
6789010|NCT00301080|7720310|FG000|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789011|NCT00301080|7720311|FG001|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789012|NCT00301080|7720312|FG002|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789013|NCT00301080|7720313|FG003|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789014|NCT00301080|7720314|FG004|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789015|NCT00301080|7720310|FG000|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789016|NCT00301080|7720311|FG001|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789017|NCT00301080|7720312|FG002|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789018|NCT00301080|7720313|FG003|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789019|NCT00301080|7720314|FG004|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
6789020|NCT00299195|7720325|FG000|STARTED|Overall Study||30
6789021|NCT00299195|7720326|FG001|STARTED|Overall Study||33
6789022|NCT00299195|7720325|FG000|COMPLETED|Overall Study||30
6789023|NCT00299195|7720326|FG001|COMPLETED|Overall Study||33
6789024|NCT00299195|7720325|FG000|NOT COMPLETED|Overall Study||0
6789025|NCT00299195|7720326|FG001|NOT COMPLETED|Overall Study||0
6789026|NCT00290407|7720332|FG000|STARTED|Overall Study||2
6789027|NCT00290407|7720332|FG000|COMPLETED|Overall Study||0
6789028|NCT00290407|7720332|FG000|NOT COMPLETED|Overall Study||2
6789029|NCT00295490|7720340|FG000|STARTED|Overall Study||15
6789030|NCT00295490|7720341|FG001|STARTED|Overall Study||19
6789031|NCT00295490|7720342|FG002|STARTED|Overall Study||16
6789032|NCT00295490|7720343|FG003|STARTED|Overall Study||17
6789033|NCT00295490|7720340|FG000|COMPLETED|Overall Study||14
6789034|NCT00295490|7720341|FG001|COMPLETED|Overall Study||15
6789035|NCT00295490|7720342|FG002|COMPLETED|Overall Study||12
6789036|NCT00295490|7720343|FG003|COMPLETED|Overall Study||12
6789037|NCT00295490|7720340|FG000|NOT COMPLETED|Overall Study||1
6789038|NCT00295490|7720341|FG001|NOT COMPLETED|Overall Study||4
6789039|NCT00295490|7720342|FG002|NOT COMPLETED|Overall Study||4
6789040|NCT00295490|7720343|FG003|NOT COMPLETED|Overall Study||5
6789041|NCT00268463|7720355|FG000|STARTED|Overall Study||10
6789042|NCT00268463|7720356|FG001|STARTED|Overall Study||12
6789043|NCT00268463|7720355|FG000|COMPLETED|Overall Study||0
6789044|NCT00268463|7720356|FG001|COMPLETED|Overall Study||0
6789045|NCT00268463|7720355|FG000|NOT COMPLETED|Overall Study||10
6789046|NCT00268463|7720356|FG001|NOT COMPLETED|Overall Study||12
6789047|NCT00271102|7720364|FG000|STARTED|Overall Study||35
6789048|NCT00271102|7720365|FG001|STARTED|Overall Study||35
6789049|NCT00271102|7720364|FG000|COMPLETED|Overall Study||30
6789050|NCT00271102|7720365|FG001|COMPLETED|Overall Study||30
6789051|NCT00271102|7720364|FG000|NOT COMPLETED|Overall Study||5
6789052|NCT00271102|7720365|FG001|NOT COMPLETED|Overall Study||5
6789053|NCT00276419|7720373|FG000|STARTED|First Intervention||8
6789054|NCT00276419|7720374|FG001|STARTED|First Intervention||10
6789055|NCT00276419|7720373|FG000|COMPLETED|First Intervention||7
6789056|NCT00276419|7720374|FG001|COMPLETED|First Intervention||8
6789057|NCT00276419|7720373|FG000|NOT COMPLETED|First Intervention||1
6789058|NCT00276419|7720374|FG001|NOT COMPLETED|First Intervention||2
6789059|NCT00276419|7720373|FG000|STARTED|Wash-out Phase||7
6789060|NCT00276419|7720374|FG001|STARTED|Wash-out Phase||8
6789061|NCT00276419|7720373|FG000|COMPLETED|Wash-out Phase||7
6789062|NCT00276419|7720374|FG001|COMPLETED|Wash-out Phase||8
6789063|NCT00276419|7720373|FG000|NOT COMPLETED|Wash-out Phase||0
6789064|NCT00276419|7720374|FG001|NOT COMPLETED|Wash-out Phase||0
6789065|NCT00276419|7720373|FG000|STARTED|Second Intervention||7
6789066|NCT00276419|7720374|FG001|STARTED|Second Intervention||8
6789067|NCT00276419|7720373|FG000|COMPLETED|Second Intervention||7
6789068|NCT00276419|7720374|FG001|COMPLETED|Second Intervention||8
6789069|NCT00276419|7720373|FG000|NOT COMPLETED|Second Intervention||0
6789070|NCT00276419|7720374|FG001|NOT COMPLETED|Second Intervention||0
6789071|NCT00279409|7720382|FG000|STARTED|Overall Study||0
6789072|NCT00279409|7720383|FG001|STARTED|Overall Study||0
6789073|NCT00279409|7720382|FG000|COMPLETED|Overall Study||0
6789074|NCT00279409|7720383|FG001|COMPLETED|Overall Study||0
6789075|NCT00279409|7720382|FG000|NOT COMPLETED|Overall Study||0
6789076|NCT00279409|7720383|FG001|NOT COMPLETED|Overall Study||0
6789077|NCT00281879|7720397|FG000|STARTED|Overall Study||128
6789078|NCT00281879|7720398|FG001|STARTED|Overall Study||36
6789079|NCT00281879|7720399|FG002|STARTED|Overall Study||20
6789080|NCT00281879|7720400|FG003|STARTED|Overall Study||0
6789081|NCT00281879|7720401|FG004|STARTED|Overall Study||6
6789082|NCT00281879|7720402|FG005|STARTED|Overall Study||9
6789083|NCT00281879|7720403|FG006|STARTED|Overall Study||0
6789084|NCT00281879|7720404|FG007|STARTED|Overall Study||1
6789085|NCT00281879|7720397|FG000|COMPLETED|Overall Study||0
6789086|NCT00281879|7720398|FG001|COMPLETED|Overall Study||0
6789087|NCT00281879|7720399|FG002|COMPLETED|Overall Study||0
6563260|NCT01806597|7486250|FG001|STARTED|Treatment Period 2 (Week 16 to Week 132)||64
6563261|NCT01806597|7486251|FG002|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
6563262|NCT01806597|7486252|FG003|STARTED|Treatment Period 2 (Week 16 to Week 132)||31
6563263|NCT01806597|7486253|FG004|STARTED|Treatment Period 2 (Week 16 to Week 132)||1
6563264|NCT01806597|7486254|FG005|STARTED|Treatment Period 2 (Week 16 to Week 132)||0
6789088|NCT00281879|7720400|FG003|COMPLETED|Overall Study||0
6789089|NCT00281879|7720401|FG004|COMPLETED|Overall Study||0
6789090|NCT00281879|7720402|FG005|COMPLETED|Overall Study||0
6789091|NCT00281879|7720403|FG006|COMPLETED|Overall Study||0
6789092|NCT00281879|7720404|FG007|COMPLETED|Overall Study||0
6789093|NCT00281879|7720397|FG000|NOT COMPLETED|Overall Study||128
6789094|NCT00281879|7720398|FG001|NOT COMPLETED|Overall Study||36
6789095|NCT00281879|7720399|FG002|NOT COMPLETED|Overall Study||20
6789096|NCT00281879|7720400|FG003|NOT COMPLETED|Overall Study||0
6789097|NCT00281879|7720401|FG004|NOT COMPLETED|Overall Study||6
6789098|NCT00281879|7720402|FG005|NOT COMPLETED|Overall Study||9
6789099|NCT00281879|7720403|FG006|NOT COMPLETED|Overall Study||0
6789100|NCT00281879|7720404|FG007|NOT COMPLETED|Overall Study||1
6789101|NCT00271947|7720422|FG000|STARTED|Overall Study||1
6789102|NCT00271947|7720422|FG000|COMPLETED|Overall Study||0
6789103|NCT00271947|7720422|FG000|NOT COMPLETED|Overall Study||1
6789104|NCT00271011|7720426|FG000|STARTED|Overall Study||13
6789105|NCT00271011|7720426|FG000|COMPLETED|Overall Study||13
6789106|NCT00271011|7720426|FG000|NOT COMPLETED|Overall Study||0
6789107|NCT00253981|7720432|FG000|STARTED|Overall Study||16
6789108|NCT00253981|7720433|FG001|STARTED|Overall Study||14
6789109|NCT00253981|7720432|FG000|COMPLETED|Overall Study||16
6789110|NCT00253981|7720433|FG001|COMPLETED|Overall Study||14
6789111|NCT00253981|7720432|FG000|NOT COMPLETED|Overall Study||0
6789112|NCT00253981|7720433|FG001|NOT COMPLETED|Overall Study||0
6789113|NCT00252174|7720442|FG000|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
6789114|NCT00252174|7720443|FG001|STARTED|Overall Study|2 subjects entered the control arm in total|2
6789115|NCT00252174|7720444|FG002|STARTED|Overall Study|No subjects entered Stage 2|0
6789116|NCT00252174|7720442|FG000|COMPLETED|Overall Study||0
6789117|NCT00252174|7720443|FG001|COMPLETED|Overall Study||1
6789118|NCT00252174|7720444|FG002|COMPLETED|Overall Study||0
6789119|NCT00252174|7720442|FG000|NOT COMPLETED|Overall Study||0
6789120|NCT00252174|7720443|FG001|NOT COMPLETED|Overall Study||1
6789121|NCT00252174|7720444|FG002|NOT COMPLETED|Overall Study||0
6789122|NCT00256295|7720452|FG000|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
6789123|NCT00256295|7720452|FG000|COMPLETED|Overall Study||3
6789124|NCT00256295|7720452|FG000|NOT COMPLETED|Overall Study||4
6789125|NCT00245128|7720456|FG000|STARTED|Overall Study||10
6789126|NCT00245128|7720456|FG000|COMPLETED|Overall Study||0
6563265|NCT01806597|7486249|FG000|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||24
6563266|NCT01806597|7486250|FG001|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||44
6563267|NCT01806597|7486251|FG002|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||17
6789127|NCT00245128|7720456|FG000|NOT COMPLETED|Overall Study||10
6789128|NCT00268450|7720460|FG000|STARTED|Overall Study||21
6789129|NCT00268450|7720460|FG000|COMPLETED|Overall Study||21
6789130|NCT00268450|7720460|FG000|NOT COMPLETED|Overall Study||0
6789131|NCT00239720|7720466|FG000|STARTED|Overall Study||3
6789132|NCT00239720|7720467|FG001|STARTED|Overall Study||1
6789133|NCT00239720|7720466|FG000|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
6789134|NCT00239720|7720467|FG001|COMPLETED|Overall Study|One participant lost to follow-up|0
6789135|NCT00239720|7720466|FG000|NOT COMPLETED|Overall Study||1
6789136|NCT00239720|7720467|FG001|NOT COMPLETED|Overall Study||1
6789137|NCT00250718|7720473|FG000|STARTED|Overall Study||17
6789138|NCT00250718|7720473|FG000|Received Treatment|Overall Study||16
6789139|NCT00250718|7720473|FG000|COMPLETED|Overall Study||14
6789140|NCT00250718|7720473|FG000|NOT COMPLETED|Overall Study||3
6378737|NCT00769483|7289232|FG005|STARTED|Overall Study||9
6378738|NCT00769483|7289227|FG000|COMPLETED|Overall Study||9
6378739|NCT00769483|7289228|FG001|COMPLETED|Overall Study||12
6378740|NCT00769483|7289229|FG002|COMPLETED|Overall Study||15
6378741|NCT00769483|7289230|FG003|COMPLETED|Overall Study||15
6378742|NCT00769483|7289231|FG004|COMPLETED|Overall Study||15
6378743|NCT00769483|7289232|FG005|COMPLETED|Overall Study||9
6378744|NCT00769483|7289227|FG000|NOT COMPLETED|Overall Study||0
6378745|NCT00769483|7289228|FG001|NOT COMPLETED|Overall Study||1
6378746|NCT00769483|7289229|FG002|NOT COMPLETED|Overall Study||0
6378747|NCT00769483|7289230|FG003|NOT COMPLETED|Overall Study||0
6378748|NCT00769483|7289231|FG004|NOT COMPLETED|Overall Study||1
6378749|NCT00769483|7289232|FG005|NOT COMPLETED|Overall Study||0
6378750|NCT00769561|7289250|FG000|STARTED|Overall Study||29
6378751|NCT00769561|7289251|FG001|STARTED|Overall Study||29
6378752|NCT00769561|7289250|FG000|COMPLETED|Overall Study||26
6378753|NCT00769561|7289251|FG001|COMPLETED|Overall Study||24
6378754|NCT00769561|7289250|FG000|NOT COMPLETED|Overall Study||3
6378755|NCT00769561|7289251|FG001|NOT COMPLETED|Overall Study||5
6378756|NCT00769600|7289259|FG000|STARTED|Overall Study||15
6378757|NCT00769600|7289260|FG001|STARTED|Overall Study||8
6378758|NCT00769600|7289259|FG000|COMPLETED|Overall Study||15
6378759|NCT00769600|7289260|FG001|COMPLETED|Overall Study||8
6378760|NCT00769600|7289259|FG000|NOT COMPLETED|Overall Study||0
6378761|NCT00769600|7289260|FG001|NOT COMPLETED|Overall Study||0
6378762|NCT00769704|7289271|FG000|STARTED|Overall Study||141
6378763|NCT00769704|7289272|FG001|STARTED|Overall Study||296
6378764|NCT00769704|7289271|FG000|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
6378765|NCT00769704|7289272|FG001|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
6378766|NCT00769704|7289271|FG000|Received Treatment|Overall Study||127
6378767|NCT00769704|7289272|FG001|Received Treatment|Overall Study||292
6378768|NCT00769704|7289271|FG000|COMPLETED|Overall Study||30
6378769|NCT00769704|7289272|FG001|COMPLETED|Overall Study||97
6378770|NCT00769704|7289271|FG000|NOT COMPLETED|Overall Study||111
6378771|NCT00769704|7289272|FG001|NOT COMPLETED|Overall Study||199
6378772|NCT00769808|7289279|FG000|STARTED|Overall Study||72
6378773|NCT00769808|7289279|FG000|COMPLETED|Overall Study||64
6378774|NCT00769808|7289279|FG000|NOT COMPLETED|Overall Study||8
6378775|NCT00769860|7289285|FG000|STARTED|Overall Study||16
6378776|NCT00769860|7289286|FG001|STARTED|Overall Study||8
6378777|NCT00769860|7289285|FG000|Month 4|Overall Study||16
6378778|NCT00769860|7289286|FG001|Month 4|Overall Study||8
6378779|NCT00769860|7289285|FG000|Month 8|Overall Study||14
6378780|NCT00769860|7289286|FG001|Month 8|Overall Study||8
6378781|NCT00769860|7289285|FG000|COMPLETED|Overall Study||14
6378782|NCT00769860|7289286|FG001|COMPLETED|Overall Study||8
6378783|NCT00769860|7289285|FG000|NOT COMPLETED|Overall Study||2
6378784|NCT00769860|7289286|FG001|NOT COMPLETED|Overall Study||0
6563268|NCT01806597|7486252|FG003|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
6563269|NCT01806597|7486253|FG004|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
6563270|NCT01806597|7486254|FG005|COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
6563271|NCT01806597|7486249|FG000|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||39
6378785|NCT00769886|7289296|FG000|STARTED|Overall Study||36
6378786|NCT00769886|7289297|FG001|STARTED|Overall Study||36
6378787|NCT00769886|7289298|FG002|STARTED|Overall Study||35
6378788|NCT00769886|7289299|FG003|STARTED|Overall Study||37
6378789|NCT00769886|7289296|FG000|COMPLETED|Overall Study||31
6378790|NCT00769886|7289297|FG001|COMPLETED|Overall Study||32
6378791|NCT00769886|7289298|FG002|COMPLETED|Overall Study||34
6378792|NCT00769886|7289299|FG003|COMPLETED|Overall Study||35
6789141|NCT00244010|7720479|FG000|STARTED|Overall Study||2
6789142|NCT00244010|7720480|FG001|STARTED|Overall Study||2
6789143|NCT00244010|7720479|FG000|COMPLETED|Overall Study||2
6789144|NCT00244010|7720480|FG001|COMPLETED|Overall Study||2
6789145|NCT00244010|7720479|FG000|NOT COMPLETED|Overall Study||0
6789146|NCT00244010|7720480|FG001|NOT COMPLETED|Overall Study||0
6789147|NCT00218036|7720491|FG000|STARTED|Overall Study||11
6789148|NCT00218036|7720492|FG001|STARTED|Overall Study||6
6789149|NCT00218036|7720493|FG002|STARTED|Overall Study||13
6789150|NCT00218036|7720494|FG003|STARTED|Overall Study||12
6789151|NCT00218036|7720495|FG004|STARTED|Overall Study||9
6789152|NCT00218036|7720491|FG000|COMPLETED|Overall Study||6
6789153|NCT00218036|7720492|FG001|COMPLETED|Overall Study||3
6789154|NCT00218036|7720493|FG002|COMPLETED|Overall Study||5
6789155|NCT00218036|7720494|FG003|COMPLETED|Overall Study||6
6789156|NCT00218036|7720495|FG004|COMPLETED|Overall Study||3
6789157|NCT00218036|7720491|FG000|NOT COMPLETED|Overall Study||5
6789158|NCT00218036|7720492|FG001|NOT COMPLETED|Overall Study||3
6789159|NCT00218036|7720493|FG002|NOT COMPLETED|Overall Study||8
6789160|NCT00218036|7720494|FG003|NOT COMPLETED|Overall Study||6
6789161|NCT00218036|7720495|FG004|NOT COMPLETED|Overall Study||6
6789162|NCT00240227|7720507|FG000|STARTED|Overall Study||8
6789163|NCT00240227|7720507|FG000|COMPLETED|Overall Study||8
6789164|NCT00240227|7720507|FG000|NOT COMPLETED|Overall Study||0
6789165|NCT00205868|7720514|FG000|STARTED|Overall Study||304
6789166|NCT00205868|7720514|FG000|COMPLETED|Overall Study||304
6789167|NCT00205868|7720514|FG000|NOT COMPLETED|Overall Study||0
6789168|NCT00206375|7720521|FG000|STARTED|Overall Study||6
6789169|NCT00206375|7720522|FG001|STARTED|Overall Study||3
6789170|NCT00206375|7720523|FG002|STARTED|Overall Study||7
6789171|NCT00206375|7720521|FG000|COMPLETED|Overall Study||3
6789172|NCT00206375|7720522|FG001|COMPLETED|Overall Study||1
6789173|NCT00206375|7720523|FG002|COMPLETED|Overall Study||3
6789174|NCT00206375|7720521|FG000|NOT COMPLETED|Overall Study||3
6789175|NCT00206375|7720522|FG001|NOT COMPLETED|Overall Study||2
6789176|NCT00206375|7720523|FG002|NOT COMPLETED|Overall Study||4
6789177|NCT00229931|7720533|FG000|STARTED|Overall Study||6
6789178|NCT00229931|7720534|FG001|STARTED|Overall Study||5
6789179|NCT00229931|7720533|FG000|COMPLETED|Overall Study||2
6789180|NCT00229931|7720534|FG001|COMPLETED|Overall Study||3
6789181|NCT00229931|7720533|FG000|NOT COMPLETED|Overall Study||4
6789182|NCT00229931|7720534|FG001|NOT COMPLETED|Overall Study||2
6789183|NCT00209131|7720542|FG000|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
6789184|NCT00209131|7720543|FG001|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
6789185|NCT00209131|7720542|FG000|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
6789186|NCT00209131|7720543|FG001|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
6789187|NCT00209131|7720542|FG000|NOT COMPLETED|Overall Study||15
6789188|NCT00209131|7720543|FG001|NOT COMPLETED|Overall Study||11
6789189|NCT00233090|7720551|FG000|STARTED|Overall Study||12
6789190|NCT00233090|7720552|FG001|STARTED|Overall Study||9
6789191|NCT00233090|7720551|FG000|COMPLETED|Overall Study||12
6789192|NCT00233090|7720552|FG001|COMPLETED|Overall Study||9
6789193|NCT00233090|7720551|FG000|NOT COMPLETED|Overall Study||0
6789194|NCT00233090|7720552|FG001|NOT COMPLETED|Overall Study||0
6789195|NCT00214149|7720558|FG000|STARTED|Overall Study||127
6789196|NCT00214149|7720558|FG000|COMPLETED|Overall Study|No data are available; study was terminated and PI has left the institution.|0
6789197|NCT00214149|7720558|FG000|NOT COMPLETED|Overall Study||127
6789198|NCT00205049|7720564|FG000|STARTED|Overall Study||0
6789199|NCT00205049|7720565|FG001|STARTED|Overall Study||0
6789200|NCT00205049|7720564|FG000|COMPLETED|Overall Study||0
6789201|NCT00205049|7720565|FG001|COMPLETED|Overall Study||0
6789202|NCT00205049|7720564|FG000|NOT COMPLETED|Overall Study||0
6789203|NCT00205049|7720565|FG001|NOT COMPLETED|Overall Study||0
6789204|NCT00209027|7720573|FG000|STARTED|Overall Study||10
6789205|NCT00209027|7720574|FG001|STARTED|Overall Study||10
6789206|NCT00209027|7720573|FG000|COMPLETED|Overall Study||0
6789207|NCT00209027|7720574|FG001|COMPLETED|Overall Study||10
6789208|NCT00209027|7720573|FG000|NOT COMPLETED|Overall Study||10
6789209|NCT00209027|7720574|FG001|NOT COMPLETED|Overall Study||0
6789210|NCT00182637|7720580|FG000|STARTED|Overall Study|active/on treatment date|5
6789211|NCT00182637|7720580|FG000|COMPLETED|Overall Study|off study date|2
6789212|NCT00182637|7720580|FG000|NOT COMPLETED|Overall Study||3
6789213|NCT00176488|7720585|FG000|STARTED|Overall Study||31
6378793|NCT00769886|7289296|FG000|NOT COMPLETED|Overall Study||5
6378794|NCT00769886|7289297|FG001|NOT COMPLETED|Overall Study||4
6378795|NCT00769886|7289298|FG002|NOT COMPLETED|Overall Study||1
6378796|NCT00769886|7289299|FG003|NOT COMPLETED|Overall Study||2
6378797|NCT00770029|7289311|FG000|STARTED|Overall Study||184
6789214|NCT00176488|7720585|FG000|COMPLETED|Overall Study||30
6789215|NCT00176488|7720585|FG000|NOT COMPLETED|Overall Study||1
6789216|NCT00179127|7720591|FG000|STARTED|Overall Study||0
6378798|NCT00770029|7289312|FG001|STARTED|Overall Study||92
6378799|NCT00770029|7289311|FG000|COMPLETED|Overall Study||178
6378800|NCT00770029|7289312|FG001|COMPLETED|Overall Study||89
6789217|NCT00179127|7720592|FG001|STARTED|Overall Study||0
6789218|NCT00179127|7720591|FG000|COMPLETED|Overall Study||0
6789219|NCT00179127|7720592|FG001|COMPLETED|Overall Study||0
6789220|NCT00179127|7720591|FG000|NOT COMPLETED|Overall Study||0
6789221|NCT00179127|7720592|FG001|NOT COMPLETED|Overall Study||0
6789222|NCT00183963|7720602|FG000|STARTED|Overall Study||1
6789223|NCT00183963|7720603|FG001|STARTED|Overall Study||1
6789224|NCT00183963|7720604|FG002|STARTED|Overall Study||1
6789225|NCT00183963|7720605|FG003|STARTED|Overall Study||1
6789226|NCT00183963|7720602|FG000|COMPLETED|Overall Study||0
6789227|NCT00183963|7720603|FG001|COMPLETED|Overall Study||0
6789228|NCT00183963|7720604|FG002|COMPLETED|Overall Study||0
6789229|NCT00183963|7720605|FG003|COMPLETED|Overall Study||0
6789230|NCT00183963|7720602|FG000|NOT COMPLETED|Overall Study||1
6789231|NCT00183963|7720603|FG001|NOT COMPLETED|Overall Study||1
6789232|NCT00183963|7720604|FG002|NOT COMPLETED|Overall Study||1
6789233|NCT00183963|7720605|FG003|NOT COMPLETED|Overall Study||1
6789234|NCT00178477|7720618|FG000|STARTED|Overall Study||10
6789235|NCT00178477|7720618|FG000|COMPLETED|Overall Study||5
6789236|NCT00178477|7720618|FG000|NOT COMPLETED|Overall Study||5
6789237|NCT00162773|7720622|FG000|STARTED|Overall Study||29
6789238|NCT00162773|7720622|FG000|COMPLETED|Overall Study||7
6789239|NCT00162773|7720622|FG000|NOT COMPLETED|Overall Study||22
6789240|NCT00176631|7720626|FG000|STARTED|Overall Study||10
6789241|NCT00176631|7720626|FG000|COMPLETED|Overall Study||10
6789242|NCT00176631|7720626|FG000|NOT COMPLETED|Overall Study||0
6789243|NCT00176501|7720630|FG000|STARTED|Overall Study||3
6789244|NCT00176501|7720630|FG000|COMPLETED|Overall Study||3
6789245|NCT00176501|7720630|FG000|NOT COMPLETED|Overall Study||0
6789246|NCT00177970|7720636|FG000|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
6789247|NCT00177970|7720637|FG001|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
6789248|NCT00177970|7720636|FG000|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
6789249|NCT00177970|7720637|FG001|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
6789250|NCT00177970|7720636|FG000|NOT COMPLETED|Overall Study||0
6789251|NCT00177970|7720637|FG001|NOT COMPLETED|Overall Study||0
6789252|NCT00177866|7720645|FG000|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
6789253|NCT00177866|7720646|FG001|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
6789254|NCT00177866|7720645|FG000|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
6789255|NCT00177866|7720646|FG001|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
6789256|NCT00177866|7720645|FG000|NOT COMPLETED|Overall Study||0
6789257|NCT00177866|7720646|FG001|NOT COMPLETED|Overall Study||0
6789258|NCT00147238|7720652|FG000|STARTED|Overall Study||10
6789259|NCT00147238|7720652|FG000|COMPLETED|Overall Study||2
6789260|NCT00147238|7720652|FG000|NOT COMPLETED|Overall Study||8
6789261|NCT00165503|7720656|FG000|STARTED|Overall Study||16
6789262|NCT00165503|7720656|FG000|COMPLETED|Overall Study||0
6789263|NCT00165503|7720656|FG000|NOT COMPLETED|Overall Study||16
6789264|NCT00160563|7720663|FG000|STARTED|Overall Study||59
6789265|NCT00160563|7720664|FG001|STARTED|Overall Study||47
6789266|NCT00160563|7720665|FG002|STARTED|Overall Study||101
6789267|NCT00160563|7720663|FG000|COMPLETED|Overall Study||8
6789268|NCT00160563|7720664|FG001|COMPLETED|Overall Study||2
6563272|NCT01806597|7486250|FG001|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||20
6789269|NCT00160563|7720665|FG002|COMPLETED|Overall Study||11
6789270|NCT00160563|7720663|FG000|NOT COMPLETED|Overall Study||51
6789271|NCT00160563|7720664|FG001|NOT COMPLETED|Overall Study||45
6789272|NCT00160563|7720665|FG002|NOT COMPLETED|Overall Study||90
6789273|NCT00142519|7720676|FG000|STARTED|Overall Study||25
6789274|NCT00142519|7720677|FG001|STARTED|Overall Study||25
6789275|NCT00142519|7720676|FG000|COMPLETED|Overall Study||7
6789276|NCT00142519|7720677|FG001|COMPLETED|Overall Study||9
6789277|NCT00142519|7720676|FG000|NOT COMPLETED|Overall Study||18
6789278|NCT00142519|7720677|FG001|NOT COMPLETED|Overall Study||16
6789279|NCT00145704|7720685|FG000|STARTED|Overall Study||3
6789280|NCT00145704|7720686|FG001|STARTED|Overall Study||3
6789281|NCT00145704|7720685|FG000|COMPLETED|Overall Study||0
6789282|NCT00145704|7720686|FG001|COMPLETED|Overall Study||0
6789283|NCT00145704|7720685|FG000|NOT COMPLETED|Overall Study||3
6789284|NCT00145704|7720686|FG001|NOT COMPLETED|Overall Study||3
6789285|NCT00138073|7720692|FG000|STARTED|Overall Study||55
6789286|NCT00138073|7720692|FG000|Pre-intervention Testing|Overall Study||55
6789287|NCT00138073|7720692|FG000|COMPLETED|Overall Study||0
6789288|NCT00138073|7720692|FG000|NOT COMPLETED|Overall Study||55
6789289|NCT00113386|7720698|FG000|STARTED|Overall Study||10
6789290|NCT00113386|7720699|FG001|STARTED|Overall Study||9
6789291|NCT00113386|7720698|FG000|COMPLETED|Overall Study||3
6789292|NCT00113386|7720699|FG001|COMPLETED|Overall Study||5
6789293|NCT00113386|7720698|FG000|NOT COMPLETED|Overall Study||7
6789294|NCT00113386|7720699|FG001|NOT COMPLETED|Overall Study||4
6789295|NCT00138151|7720705|FG000|STARTED|Overall Study||33
6789296|NCT00138151|7720705|FG000|COMPLETED|Overall Study||29
6789297|NCT00138151|7720705|FG000|NOT COMPLETED|Overall Study||4
6789298|NCT00129974|7720709|FG000|STARTED|Overall Study||1
6789299|NCT00129974|7720709|FG000|COMPLETED|Overall Study||0
6789300|NCT00129974|7720709|FG000|NOT COMPLETED|Overall Study||1
6789301|NCT00126659|7720716|FG000|STARTED|Overall Study||3
6789302|NCT00126659|7720717|FG001|STARTED|Overall Study||3
6789303|NCT00126659|7720718|FG002|STARTED|Overall Study||4
6789304|NCT00126659|7720716|FG000|COMPLETED|Overall Study||3
6789305|NCT00126659|7720717|FG001|COMPLETED|Overall Study||3
6789306|NCT00126659|7720718|FG002|COMPLETED|Overall Study||2
6789307|NCT00126659|7720716|FG000|NOT COMPLETED|Overall Study||0
6789308|NCT00126659|7720717|FG001|NOT COMPLETED|Overall Study||0
6789309|NCT00126659|7720718|FG002|NOT COMPLETED|Overall Study||2
6789310|NCT00133679|7720726|FG000|STARTED|Overall Study||0
6789311|NCT00133679|7720727|FG001|STARTED|Overall Study||0
6789312|NCT00133679|7720726|FG000|COMPLETED|Overall Study||0
6789313|NCT00133679|7720727|FG001|COMPLETED|Overall Study||0
6789314|NCT00133679|7720726|FG000|NOT COMPLETED|Overall Study||0
6789315|NCT00133679|7720727|FG001|NOT COMPLETED|Overall Study||0
6789316|NCT00125268|7720735|FG000|STARTED|Overall Study||16
6789317|NCT00125268|7720736|FG001|STARTED|Overall Study||14
6789318|NCT00125268|7720735|FG000|COMPLETED|Overall Study||15
6789319|NCT00125268|7720736|FG001|COMPLETED|Overall Study||13
6789320|NCT00125268|7720735|FG000|NOT COMPLETED|Overall Study||1
6789321|NCT00125268|7720736|FG001|NOT COMPLETED|Overall Study||1
6789322|NCT00113399|7720744|FG000|STARTED|Overall Study||7
6789323|NCT00113399|7720745|FG001|STARTED|Overall Study||8
6789324|NCT00113399|7720744|FG000|COMPLETED|Overall Study||5
6789325|NCT00113399|7720745|FG001|COMPLETED|Overall Study||3
6789326|NCT00113399|7720744|FG000|NOT COMPLETED|Overall Study||2
6789327|NCT00113399|7720745|FG001|NOT COMPLETED|Overall Study||5
6789328|NCT00118053|7720751|FG000|STARTED|Overall Study||5
6789329|NCT00118053|7720751|FG000|COMPLETED|Overall Study||5
6789330|NCT00118053|7720751|FG000|NOT COMPLETED|Overall Study||0
6789331|NCT00107614|7720755|FG000|STARTED|Overall Study||12
6789332|NCT00107614|7720755|FG000|COMPLETED|Overall Study||0
6789333|NCT00107614|7720755|FG000|NOT COMPLETED|Overall Study||12
6789334|NCT00107315|7720759|FG000|STARTED|Overall Study||16
6789335|NCT00107315|7720759|FG000|COMPLETED|Overall Study||1
6789336|NCT00107315|7720759|FG000|NOT COMPLETED|Overall Study||15
6789337|NCT00108433|7720765|FG000|STARTED|Overall Study||30
6789338|NCT00108433|7720766|FG001|STARTED|Overall Study||31
6789339|NCT00108433|7720765|FG000|COMPLETED|Overall Study||9
6563273|NCT01806597|7486251|FG002|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||14
6563274|NCT01806597|7486252|FG003|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||11
6563275|NCT01806597|7486253|FG004|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||1
6563276|NCT01806597|7486254|FG005|NOT COMPLETED|Treatment Period 2 (Week 16 to Week 132)||0
6563277|NCT01806597|7486249|FG000|STARTED|Follow-up Period (Week 132 to Week 140)||0
6563278|NCT01806597|7486250|FG001|STARTED|Follow-up Period (Week 132 to Week 140)||0
6789340|NCT00108433|7720766|FG001|COMPLETED|Overall Study||14
6789341|NCT00108433|7720765|FG000|NOT COMPLETED|Overall Study||21
6789342|NCT00108433|7720766|FG001|NOT COMPLETED|Overall Study||17
6789343|NCT00113919|7720772|FG000|STARTED|Overall Study||14
6789344|NCT00113919|7720772|FG000|COMPLETED|Overall Study||0
6789345|NCT00113919|7720772|FG000|NOT COMPLETED|Overall Study||14
6789346|NCT00108342|7720778|FG000|STARTED|Overall Study||8
6789347|NCT00108342|7720779|FG001|STARTED|Overall Study||9
6789348|NCT00108342|7720778|FG000|COMPLETED|Overall Study||7
6789349|NCT00108342|7720779|FG001|COMPLETED|Overall Study||9
6789350|NCT00108342|7720778|FG000|NOT COMPLETED|Overall Study||1
6789351|NCT00108342|7720779|FG001|NOT COMPLETED|Overall Study||0
6789352|NCT00100828|7720785|FG000|STARTED|Overall Study||6
6789353|NCT00100828|7720785|FG000|COMPLETED|Overall Study||0
6789354|NCT00100828|7720785|FG000|NOT COMPLETED|Overall Study||6
6789355|NCT00104728|7720789|FG000|STARTED|Overall Study|42 consented on study|42
6789356|NCT00104728|7720789|FG000|COMPLETED|Overall Study||23
6789357|NCT00104728|7720789|FG000|NOT COMPLETED|Overall Study||19
6789358|NCT00089414|7720796|FG000|STARTED|Overall Study||2
6789359|NCT00089414|7720797|FG001|STARTED|Overall Study||1
6789360|NCT00089414|7720798|FG002|STARTED|Overall Study||2
6789361|NCT00089414|7720796|FG000|COMPLETED|Overall Study||2
6789362|NCT00089414|7720797|FG001|COMPLETED|Overall Study||1
6789363|NCT00089414|7720798|FG002|COMPLETED|Overall Study||2
6789364|NCT00089414|7720796|FG000|NOT COMPLETED|Overall Study||0
6789365|NCT00089414|7720797|FG001|NOT COMPLETED|Overall Study||0
6789366|NCT00089414|7720798|FG002|NOT COMPLETED|Overall Study||0
6789367|NCT00083915|7720808|FG000|STARTED|Overall Study||52
6789368|NCT00083915|7720809|FG001|STARTED|Overall Study||45
6789369|NCT00083915|7720808|FG000|COMPLETED|Overall Study||2
6789370|NCT00083915|7720809|FG001|COMPLETED|Overall Study||8
6789371|NCT00083915|7720808|FG000|NOT COMPLETED|Overall Study||50
6789372|NCT00083915|7720809|FG001|NOT COMPLETED|Overall Study||37
6789373|NCT00090870|7720815|FG000|STARTED|Overall Study||10
6789374|NCT00090870|7720815|FG000|COMPLETED|Overall Study||10
6789375|NCT00090870|7720815|FG000|NOT COMPLETED|Overall Study||0
6789376|NCT00088972|7720821|FG000|STARTED|Overall Study||3
6789377|NCT00088972|7720822|FG001|STARTED|Overall Study||5
6789378|NCT00088972|7720821|FG000|COMPLETED|Overall Study||1
6789379|NCT00088972|7720822|FG001|COMPLETED|Overall Study||1
6789380|NCT00088972|7720821|FG000|NOT COMPLETED|Overall Study||2
6789381|NCT00088972|7720822|FG001|NOT COMPLETED|Overall Study||4
6789382|NCT00088829|7720828|FG000|STARTED|Overall Study||22
6789383|NCT00088829|7720828|FG000|COMPLETED|Overall Study||0
6789384|NCT00088829|7720828|FG000|NOT COMPLETED|Overall Study||22
6789385|NCT00089128|7720832|FG000|STARTED|Overall Study||16
6789386|NCT00089128|7720832|FG000|COMPLETED|Overall Study||16
6789387|NCT00089128|7720832|FG000|NOT COMPLETED|Overall Study||0
6789388|NCT00075608|7720836|FG000|STARTED|Overall Study||12
6789389|NCT00075608|7720836|FG000|COMPLETED|Overall Study||12
6789390|NCT00075608|7720836|FG000|NOT COMPLETED|Overall Study||0
6789391|NCT00074724|7720844|FG000|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
6789392|NCT00074724|7720845|FG001|STARTED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
6789393|NCT00074724|7720844|FG000|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
6789394|NCT00074724|7720845|FG001|COMPLETED|Overall Study|The PI has left the institution and no results data is available. Efforts were made to contact the PI/study team members, as well as to review data on shared drives, IRB historical records and published resources, but were unsuccessful. No study data are available|0
6789395|NCT00074724|7720844|FG000|NOT COMPLETED|Overall Study||0
6789396|NCT00074724|7720845|FG001|NOT COMPLETED|Overall Study||0
6789397|NCT00085631|7720851|FG000|STARTED|Overall Study||13
6789398|NCT00085631|7720852|FG001|STARTED|Overall Study||49
6789399|NCT00085631|7720853|FG002|STARTED|Overall Study||39
6789400|NCT00085631|7720851|FG000|COMPLETED|Overall Study||9
6789401|NCT00085631|7720852|FG001|COMPLETED|Overall Study||38
6789402|NCT00085631|7720853|FG002|COMPLETED|Overall Study||32
6789403|NCT00085631|7720851|FG000|NOT COMPLETED|Overall Study||4
6789404|NCT00085631|7720852|FG001|NOT COMPLETED|Overall Study||11
6789405|NCT00085631|7720853|FG002|NOT COMPLETED|Overall Study||7
6789406|NCT00062751|7720865|FG000|STARTED|Overall Study||33
6789407|NCT00062751|7720866|FG001|STARTED|Overall Study||30
6789408|NCT00062751|7720867|FG002|STARTED|Overall Study||33
6789409|NCT00062751|7720868|FG003|STARTED|Overall Study||6
6789410|NCT00062751|7720869|FG004|STARTED|Overall Study||6
6789411|NCT00062751|7720865|FG000|COMPLETED|Overall Study||0
6789412|NCT00062751|7720866|FG001|COMPLETED|Overall Study||0
6789413|NCT00062751|7720867|FG002|COMPLETED|Overall Study||3
6789414|NCT00062751|7720868|FG003|COMPLETED|Overall Study||1
6378801|NCT00770029|7289311|FG000|NOT COMPLETED|Overall Study||6
6789415|NCT00062751|7720869|FG004|COMPLETED|Overall Study||0
6789416|NCT00062751|7720865|FG000|NOT COMPLETED|Overall Study||33
6789417|NCT00062751|7720866|FG001|NOT COMPLETED|Overall Study||30
6789418|NCT00062751|7720867|FG002|NOT COMPLETED|Overall Study||30
6789419|NCT00062751|7720868|FG003|NOT COMPLETED|Overall Study||5
6789420|NCT00062751|7720869|FG004|NOT COMPLETED|Overall Study||6
6789421|NCT00066807|7720884|FG000|STARTED|Overall Study||14
6789422|NCT00066807|7720885|FG001|STARTED|Overall Study||15
6789423|NCT00066807|7720884|FG000|COMPLETED|Overall Study||0
6789424|NCT00066807|7720885|FG001|COMPLETED|Overall Study||0
6789425|NCT00066807|7720884|FG000|NOT COMPLETED|Overall Study||14
6789426|NCT00066807|7720885|FG001|NOT COMPLETED|Overall Study||15
6789427|NCT00058188|7720893|FG000|STARTED|Overall Study||0
6789428|NCT00058188|7720894|FG001|STARTED|Overall Study||0
6789429|NCT00058188|7720893|FG000|COMPLETED|Overall Study||0
6789430|NCT00058188|7720894|FG001|COMPLETED|Overall Study||0
6789431|NCT00058188|7720893|FG000|NOT COMPLETED|Overall Study||0
6789432|NCT00058188|7720894|FG001|NOT COMPLETED|Overall Study||0
6789433|NCT00014560|7720900|FG000|STARTED|Overall Study||3
6789434|NCT00014560|7720900|FG000|COMPLETED|Overall Study||0
6789435|NCT00014560|7720900|FG000|NOT COMPLETED|Overall Study||3
6789436|NCT00038142|7720906|FG000|STARTED|Overall Study||32
6789437|NCT00038142|7720907|FG001|STARTED|Overall Study||14
6789438|NCT00038142|7720906|FG000|COMPLETED|Overall Study||10
6789439|NCT00038142|7720907|FG001|COMPLETED|Overall Study||7
6789440|NCT00038142|7720906|FG000|NOT COMPLETED|Overall Study||22
6789441|NCT00038142|7720907|FG001|NOT COMPLETED|Overall Study||7
6789442|NCT00020722|7720913|FG000|STARTED|Overall Study||7
6789443|NCT00020722|7720913|FG000|COMPLETED|Overall Study||7
6789444|NCT00020722|7720913|FG000|NOT COMPLETED|Overall Study||0
6789445|NCT00002975|7720918|FG000|STARTED|Overall Study||180
6789446|NCT00002975|7720918|FG000|Treated With Study Therapy|Overall Study||175
6789447|NCT00002975|7720918|FG000|COMPLETED|Overall Study||175
6789448|NCT00002975|7720918|FG000|NOT COMPLETED|Overall Study||5
6789449|NCT00006478|7720922|FG000|STARTED|Overall Study||19
6789450|NCT00006478|7720922|FG000|COMPLETED|Overall Study||12
6789451|NCT00006478|7720922|FG000|NOT COMPLETED|Overall Study||7
6789452|NCT00019747|7720928|FG000|STARTED|Overall Study||23
6789453|NCT00019747|7720929|FG001|STARTED|Overall Study||16
6789454|NCT00019747|7720928|FG000|COMPLETED|Overall Study||23
6789455|NCT00019747|7720929|FG001|COMPLETED|Overall Study||16
6789456|NCT00019747|7720928|FG000|NOT COMPLETED|Overall Study||0
6789457|NCT00019747|7720929|FG001|NOT COMPLETED|Overall Study||0
6789458|NCT00006916|7720935|FG000|STARTED|Overall Study||19
6789459|NCT00006916|7720935|FG000|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
6789460|NCT00006916|7720935|FG000|NOT COMPLETED|Overall Study||5
6789461|NCT00003726|7720939|FG000|STARTED|Overall Study||1
6789462|NCT00003726|7720939|FG000|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
6789463|NCT00003726|7720939|FG000|NOT COMPLETED|Overall Study||1
6789464|NCT04051996|7720945|FG000|STARTED|Overall Study||1
6789465|NCT04051996|7720946|FG001|STARTED|Overall Study||0
6789466|NCT04051996|7720945|FG000|COMPLETED|Overall Study||1
6789467|NCT04051996|7720946|FG001|COMPLETED|Overall Study||0
6789468|NCT04051996|7720945|FG000|NOT COMPLETED|Overall Study||0
6789469|NCT04051996|7720946|FG001|NOT COMPLETED|Overall Study||0
6789470|NCT02970799|7720954|FG000|STARTED|Overall Study||0
6789471|NCT02970799|7720955|FG001|STARTED|Overall Study||0
6789472|NCT02970799|7720954|FG000|COMPLETED|Overall Study||0
6789473|NCT02970799|7720955|FG001|COMPLETED|Overall Study||0
6789474|NCT02970799|7720954|FG000|NOT COMPLETED|Overall Study||0
6789475|NCT02970799|7720955|FG001|NOT COMPLETED|Overall Study||0
6789476|NCT02385292|7720963|FG000|STARTED|Overall Study||0
6789477|NCT02385292|7720964|FG001|STARTED|Overall Study||0
6789478|NCT02385292|7720963|FG000|COMPLETED|Overall Study||0
6789479|NCT02385292|7720964|FG001|COMPLETED|Overall Study||0
6789480|NCT02385292|7720963|FG000|NOT COMPLETED|Overall Study||0
6789481|NCT02385292|7720964|FG001|NOT COMPLETED|Overall Study||0
6789482|NCT02126878|7720973|FG000|STARTED|Overall Study||0
6789483|NCT02126878|7720974|FG001|STARTED|Overall Study||0
6789484|NCT02126878|7720975|FG002|STARTED|Overall Study||0
6789485|NCT02126878|7720973|FG000|COMPLETED|Overall Study||0
6789486|NCT02126878|7720974|FG001|COMPLETED|Overall Study||0
6789487|NCT02126878|7720975|FG002|COMPLETED|Overall Study||0
6789488|NCT02126878|7720973|FG000|NOT COMPLETED|Overall Study||0
6789489|NCT02126878|7720974|FG001|NOT COMPLETED|Overall Study||0
6789490|NCT02126878|7720975|FG002|NOT COMPLETED|Overall Study||0
6789491|NCT02221817|7720985|FG000|STARTED|Overall Study||0
6789492|NCT02221817|7720986|FG001|STARTED|Overall Study||0
6789493|NCT02221817|7720985|FG000|COMPLETED|Overall Study||0
6789494|NCT02221817|7720986|FG001|COMPLETED|Overall Study||0
6789495|NCT02221817|7720985|FG000|NOT COMPLETED|Overall Study||0
6789496|NCT02221817|7720986|FG001|NOT COMPLETED|Overall Study||0
6789497|NCT02595996|7720992|FG000|STARTED|Overall Study||1
6789498|NCT02595996|7720992|FG000|COMPLETED|Overall Study||1
6789499|NCT02595996|7720992|FG000|NOT COMPLETED|Overall Study||0
6789500|NCT03879044|7720996|FG000|STARTED|Overall Study||30
6789501|NCT03879044|7720996|FG000|COMPLETED|Overall Study||26
6789502|NCT03879044|7720996|FG000|NOT COMPLETED|Overall Study||4
6789503|NCT03198156|7721002|FG000|STARTED|Overall Study||19
6789504|NCT03198156|7721003|FG001|STARTED|Overall Study||19
6789505|NCT03198156|7721002|FG000|COMPLETED|Overall Study||19
6789506|NCT03198156|7721003|FG001|COMPLETED|Overall Study||19
6789507|NCT03198156|7721002|FG000|NOT COMPLETED|Overall Study||0
6789508|NCT03198156|7721003|FG001|NOT COMPLETED|Overall Study||0
6789509|NCT02009384|7721009|FG000|STARTED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|2
6789510|NCT02009384|7721009|FG000|COMPLETED|Overall Study|Study was Terminated due to low subject enrollment Data was not analyzed|0
6789511|NCT02009384|7721009|FG000|NOT COMPLETED|Overall Study||2
6789512|NCT04558125|7721013|FG000|STARTED|Overall Study||2
6789513|NCT04558125|7721013|FG000|COMPLETED|Overall Study||1
6789514|NCT04558125|7721013|FG000|NOT COMPLETED|Overall Study||1
6789515|NCT02401308|7721019|FG000|STARTED|Overall Study||0
6789516|NCT02401308|7721020|FG001|STARTED|Overall Study||1
6789517|NCT02401308|7721019|FG000|COMPLETED|Overall Study||0
6789518|NCT02401308|7721020|FG001|COMPLETED|Overall Study||0
6789519|NCT02401308|7721019|FG000|NOT COMPLETED|Overall Study||0
6789520|NCT02401308|7721020|FG001|NOT COMPLETED|Overall Study||1
6789521|NCT04381988|7721028|FG000|STARTED|Overall Study||4
6789522|NCT04381988|7721029|FG001|STARTED|Overall Study||0
6789523|NCT04381988|7721028|FG000|COMPLETED|Overall Study||0
6789524|NCT04381988|7721029|FG001|COMPLETED|Overall Study||0
6789525|NCT04381988|7721028|FG000|NOT COMPLETED|Overall Study||4
6789526|NCT04381988|7721029|FG001|NOT COMPLETED|Overall Study||0
6789527|NCT00521885|7721037|FG000|STARTED|Overall Study||0
6789528|NCT00521885|7721038|FG001|STARTED|Overall Study||0
6789529|NCT00521885|7721037|FG000|COMPLETED|Overall Study||0
6789530|NCT00521885|7721038|FG001|COMPLETED|Overall Study||0
6789531|NCT00521885|7721037|FG000|NOT COMPLETED|Overall Study||0
6789532|NCT00521885|7721038|FG001|NOT COMPLETED|Overall Study||0
6789533|NCT02376946|7721046|FG000|STARTED|Overall Study|study terminated prior to being conducted|0
6789534|NCT02376946|7721047|FG001|STARTED|Overall Study|study terminated prior to being conducted|0
6789535|NCT02376946|7721046|FG000|COMPLETED|Overall Study|study terminated prior to being conducted|0
6789536|NCT02376946|7721047|FG001|COMPLETED|Overall Study|study terminated prior to being conducted|0
6789537|NCT02376946|7721046|FG000|NOT COMPLETED|Overall Study||0
6789538|NCT02376946|7721047|FG001|NOT COMPLETED|Overall Study||0
6789539|NCT01780636|7721053|FG000|STARTED|Overall Study||7
6789540|NCT01780636|7721053|FG000|COMPLETED|Overall Study||7
6789541|NCT01780636|7721053|FG000|NOT COMPLETED|Overall Study||0
6789542|NCT00479167|7721057|FG000|STARTED|Overall Study||1
6789543|NCT00479167|7721057|FG000|COMPLETED|Overall Study||0
6789544|NCT00479167|7721057|FG000|NOT COMPLETED|Overall Study||1
6789545|NCT03998189|7721064|FG000|STARTED|Overall Study||0
6789546|NCT03998189|7721065|FG001|STARTED|Overall Study||1
6789547|NCT03998189|7721064|FG000|COMPLETED|Overall Study||0
6789548|NCT03998189|7721065|FG001|COMPLETED|Overall Study|Samples were collected but were not analyzed as the analysis would have been done once a proper batch of samples were collected. This did not occur as the study was found to no longer be feasible and was terminated.|0
6789549|NCT03998189|7721064|FG000|NOT COMPLETED|Overall Study||0
6789550|NCT03998189|7721065|FG001|NOT COMPLETED|Overall Study||1
6789551|NCT02212574|7721071|FG000|STARTED|Overall Study||6
6789552|NCT02212574|7721071|FG000|COMPLETED|Overall Study||6
6789553|NCT02212574|7721071|FG000|NOT COMPLETED|Overall Study||0
6789554|NCT04422210|7721084|FG000|STARTED|Overall Study||0
6789555|NCT04422210|7721085|FG001|STARTED|Overall Study||0
6378802|NCT00770029|7289312|FG001|NOT COMPLETED|Overall Study||3
6378803|NCT00770120|7289318|FG000|STARTED|Overall Study||61
6378804|NCT00770120|7289318|FG000|Eligible|Overall Study||60
6378805|NCT00770120|7289318|FG000|Not Analyzable|Overall Study||1
6378806|NCT00770120|7289318|FG000|COMPLETED|Overall Study||0
6378807|NCT00770120|7289318|FG000|NOT COMPLETED|Overall Study||61
6378808|NCT00770133|7289327|FG000|STARTED|Overall Study||35
6378809|NCT00770133|7289328|FG001|STARTED|Overall Study||36
6378810|NCT00770133|7289329|FG002|STARTED|Overall Study||35
6378811|NCT00770133|7289330|FG003|STARTED|Overall Study||35
6378812|NCT00770133|7289327|FG000|COMPLETED|Overall Study||32
6378813|NCT00770133|7289328|FG001|COMPLETED|Overall Study||35
6378814|NCT00770133|7289329|FG002|COMPLETED|Overall Study||32
6378815|NCT00770133|7289330|FG003|COMPLETED|Overall Study||32
6378816|NCT00770133|7289327|FG000|NOT COMPLETED|Overall Study||3
6378817|NCT00770133|7289328|FG001|NOT COMPLETED|Overall Study||1
6378818|NCT00770133|7289329|FG002|NOT COMPLETED|Overall Study||3
6378819|NCT00770133|7289330|FG003|NOT COMPLETED|Overall Study||3
6378820|NCT00770146|7289342|FG000|STARTED|Treatment Period||53
6378821|NCT00770146|7289343|FG001|STARTED|Treatment Period||105
6378822|NCT00770146|7289342|FG000|Treated|Treatment Period||52
6378823|NCT00770146|7289343|FG001|Treated|Treatment Period||105
6378824|NCT00770146|7289342|FG000|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
6378825|NCT00770146|7289343|FG001|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
6378826|NCT00770146|7289342|FG000|COMPLETED|Treatment Period||44
6378827|NCT00770146|7289343|FG001|COMPLETED|Treatment Period||60
6378828|NCT00770146|7289342|FG000|NOT COMPLETED|Treatment Period||9
6502256|NCT01433549|7420920|FG001|COMPLETED|Phase 1: First Study Product||13
6502257|NCT01433549|7420919|FG000|NOT COMPLETED|Phase 1: First Study Product||0
6502258|NCT01433549|7420920|FG001|NOT COMPLETED|Phase 1: First Study Product||0
6502259|NCT01433549|7420919|FG000|STARTED|Phase 2: Second Study Product||12
6502260|NCT01433549|7420920|FG001|STARTED|Phase 2: Second Study Product||13
6563279|NCT01806597|7486251|FG002|STARTED|Follow-up Period (Week 132 to Week 140)||0
6378829|NCT00770146|7289343|FG001|NOT COMPLETED|Treatment Period||45
6378830|NCT00770146|7289342|FG000|STARTED|Follow-up Period||53
6378831|NCT00770146|7289343|FG001|STARTED|Follow-up Period||105
6378832|NCT00770146|7289342|FG000|COMPLETED|Follow-up Period||42
6378833|NCT00770146|7289343|FG001|COMPLETED|Follow-up Period||85
6789556|NCT04422210|7721086|FG002|STARTED|Overall Study||0
6789557|NCT04422210|7721087|FG003|STARTED|Overall Study||0
6789558|NCT04422210|7721088|FG004|STARTED|Overall Study||0
6789559|NCT04422210|7721089|FG005|STARTED|Overall Study||0
6789560|NCT04422210|7721090|FG006|STARTED|Overall Study||0
6789561|NCT04422210|7721091|FG007|STARTED|Overall Study||0
6789562|NCT04422210|7721084|FG000|COMPLETED|Overall Study||0
6789563|NCT04422210|7721085|FG001|COMPLETED|Overall Study||0
6789564|NCT04422210|7721086|FG002|COMPLETED|Overall Study||0
6789565|NCT04422210|7721087|FG003|COMPLETED|Overall Study||0
6789566|NCT04422210|7721088|FG004|COMPLETED|Overall Study||0
6789567|NCT04422210|7721089|FG005|COMPLETED|Overall Study||0
6789568|NCT04422210|7721090|FG006|COMPLETED|Overall Study||0
6789569|NCT04422210|7721091|FG007|COMPLETED|Overall Study||0
6789570|NCT04422210|7721084|FG000|NOT COMPLETED|Overall Study||0
6789571|NCT04422210|7721085|FG001|NOT COMPLETED|Overall Study||0
6789572|NCT04422210|7721086|FG002|NOT COMPLETED|Overall Study||0
6789573|NCT04422210|7721087|FG003|NOT COMPLETED|Overall Study||0
6789574|NCT04422210|7721088|FG004|NOT COMPLETED|Overall Study||0
6789575|NCT04422210|7721089|FG005|NOT COMPLETED|Overall Study||0
6789576|NCT04422210|7721090|FG006|NOT COMPLETED|Overall Study||0
6378834|NCT00770146|7289342|FG000|NOT COMPLETED|Follow-up Period||11
6378835|NCT00770146|7289343|FG001|NOT COMPLETED|Follow-up Period||20
6378836|NCT00770211|7289351|FG000|STARTED|Overall Study||182
6378837|NCT00770211|7289352|FG001|STARTED|Overall Study||89
6378838|NCT00770211|7289351|FG000|COMPLETED|Overall Study||181
6378839|NCT00770211|7289352|FG001|COMPLETED|Overall Study||87
6378840|NCT00770211|7289351|FG000|NOT COMPLETED|Overall Study||1
6378841|NCT00770211|7289352|FG001|NOT COMPLETED|Overall Study||2
6378842|NCT00770224|7289358|FG000|STARTED|Step 1: Induction||87
6378843|NCT00770224|7289359|FG001|STARTED|Step 1: Induction||0
6378844|NCT00770224|7289358|FG000|Eligible and Evaluable|Step 1: Induction||84
6378845|NCT00770224|7289359|FG001|Eligible and Evaluable|Step 1: Induction||0
6378846|NCT00770224|7289358|FG000|COMPLETED|Step 1: Induction||73
6378847|NCT00770224|7289359|FG001|COMPLETED|Step 1: Induction||0
6378848|NCT00770224|7289358|FG000|NOT COMPLETED|Step 1: Induction||14
6378849|NCT00770224|7289359|FG001|NOT COMPLETED|Step 1: Induction||0
6378850|NCT00770224|7289358|FG000|STARTED|Step 2: Maintenance||0
6378851|NCT00770224|7289359|FG001|STARTED|Step 2: Maintenance||71
6378852|NCT00770224|7289358|FG000|Eligible and Evaluable|Step 2: Maintenance||0
6378853|NCT00770224|7289359|FG001|Eligible and Evaluable|Step 2: Maintenance||69
6378854|NCT00770224|7289358|FG000|COMPLETED|Step 2: Maintenance||0
6378855|NCT00770224|7289359|FG001|COMPLETED|Step 2: Maintenance||41
6789577|NCT04422210|7721091|FG007|NOT COMPLETED|Overall Study||0
6789578|NCT04298918|7721114|FG000|STARTED|Overall Study||0
6789579|NCT04298918|7721115|FG001|STARTED|Overall Study||0
6789580|NCT04298918|7721116|FG002|STARTED|Overall Study||0
6789581|NCT04298918|7721117|FG003|STARTED|Overall Study||0
6789582|NCT04298918|7721114|FG000|COMPLETED|Overall Study||0
6789583|NCT04298918|7721115|FG001|COMPLETED|Overall Study||0
6789584|NCT04298918|7721116|FG002|COMPLETED|Overall Study||0
6789585|NCT04298918|7721117|FG003|COMPLETED|Overall Study||0
6789586|NCT04298918|7721114|FG000|NOT COMPLETED|Overall Study||0
6789587|NCT04298918|7721115|FG001|NOT COMPLETED|Overall Study||0
6789588|NCT04298918|7721116|FG002|NOT COMPLETED|Overall Study||0
6789589|NCT04298918|7721117|FG003|NOT COMPLETED|Overall Study||0
6789590|NCT01996371|7721135|FG000|STARTED|Overall Study||5
6789591|NCT01996371|7721136|FG001|STARTED|Overall Study||4
6789592|NCT01996371|7721137|FG002|STARTED|Overall Study||6
6789593|NCT01996371|7721135|FG000|COMPLETED|Overall Study||5
6789594|NCT01996371|7721136|FG001|COMPLETED|Overall Study||4
6789595|NCT01996371|7721137|FG002|COMPLETED|Overall Study||6
6789596|NCT01996371|7721135|FG000|NOT COMPLETED|Overall Study||0
6789597|NCT01996371|7721136|FG001|NOT COMPLETED|Overall Study||0
6789598|NCT01996371|7721137|FG002|NOT COMPLETED|Overall Study||0
6789599|NCT01561378|7721150|FG000|STARTED|Overall Study||11
6789600|NCT01561378|7721151|FG001|STARTED|Overall Study||11
6789601|NCT01561378|7721150|FG000|COMPLETED|Overall Study||11
6789602|NCT01561378|7721151|FG001|COMPLETED|Overall Study||11
6789603|NCT01561378|7721150|FG000|NOT COMPLETED|Overall Study||0
6789604|NCT01561378|7721151|FG001|NOT COMPLETED|Overall Study||0
6789605|NCT00955929|7721160|FG000|STARTED|Overall Study||13
6789606|NCT00955929|7721161|FG001|STARTED|Overall Study||30
6789607|NCT00955929|7721162|FG002|STARTED|Overall Study||33
6789608|NCT00955929|7721160|FG000|COMPLETED|Overall Study||13
6789609|NCT00955929|7721161|FG001|COMPLETED|Overall Study||30
6789610|NCT00955929|7721162|FG002|COMPLETED|Overall Study||33
6789611|NCT00955929|7721160|FG000|NOT COMPLETED|Overall Study||0
6789612|NCT00955929|7721161|FG001|NOT COMPLETED|Overall Study||0
6789613|NCT00955929|7721162|FG002|NOT COMPLETED|Overall Study||0
6789614|NCT00402883|7721170|FG000|STARTED|Induction Therapy||5
6789615|NCT00402883|7721170|FG000|COMPLETED|Induction Therapy||5
6789616|NCT00402883|7721170|FG000|NOT COMPLETED|Induction Therapy||0
6789617|NCT00402883|7721170|FG000|STARTED|Consolidation Therapy||5
6789618|NCT00402883|7721170|FG000|COMPLETED|Consolidation Therapy||5
6789619|NCT00402883|7721170|FG000|NOT COMPLETED|Consolidation Therapy||0
6789620|NCT00402883|7721170|FG000|STARTED|Maintenance Therapy||5
6789621|NCT00402883|7721170|FG000|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
6789622|NCT00402883|7721170|FG000|NOT COMPLETED|Maintenance Therapy||0
6789623|NCT03482505|7721175|FG000|STARTED|Overall Study||10
6789624|NCT03482505|7721175|FG000|COMPLETED|Overall Study||10
6789625|NCT03482505|7721175|FG000|NOT COMPLETED|Overall Study||0
6789626|NCT02934503|7721179|FG000|STARTED|Overall Study||5
6789627|NCT02934503|7721179|FG000|COMPLETED|Overall Study||1
6789628|NCT02934503|7721179|FG000|NOT COMPLETED|Overall Study||4
6789629|NCT02137252|7721185|FG000|STARTED|Overall Study||2
6789630|NCT02137252|7721186|FG001|STARTED|Overall Study||1
6789631|NCT02137252|7721185|FG000|COMPLETED|Overall Study||0
6789632|NCT02137252|7721186|FG001|COMPLETED|Overall Study||0
6789633|NCT02137252|7721185|FG000|NOT COMPLETED|Overall Study||2
6789634|NCT02137252|7721186|FG001|NOT COMPLETED|Overall Study||1
6789635|NCT03863522|7721192|FG000|STARTED|Overall Study||116
6789636|NCT03863522|7721192|FG000|COMPLETED|Overall Study||116
6789637|NCT03863522|7721192|FG000|NOT COMPLETED|Overall Study||0
6789638|NCT01294670|7721201|FG000|STARTED|Overall Study||7
6789639|NCT01294670|7721202|FG001|STARTED|Overall Study||3
6789640|NCT01294670|7721203|FG002|STARTED|Overall Study||3
6789641|NCT01294670|7721204|FG003|STARTED|Overall Study||9
6789642|NCT01294670|7721205|FG004|STARTED|Overall Study||5
6789643|NCT01294670|7721201|FG000|COMPLETED|Overall Study||6
6789644|NCT01294670|7721202|FG001|COMPLETED|Overall Study||3
6789645|NCT01294670|7721203|FG002|COMPLETED|Overall Study||3
6789646|NCT01294670|7721204|FG003|COMPLETED|Overall Study||9
6789647|NCT01294670|7721205|FG004|COMPLETED|Overall Study||5
6789648|NCT01294670|7721201|FG000|NOT COMPLETED|Overall Study||1
6789649|NCT01294670|7721202|FG001|NOT COMPLETED|Overall Study||0
6789650|NCT01294670|7721203|FG002|NOT COMPLETED|Overall Study||0
6789651|NCT01294670|7721204|FG003|NOT COMPLETED|Overall Study||0
6789652|NCT01294670|7721205|FG004|NOT COMPLETED|Overall Study||0
6789653|NCT03095287|7721217|FG000|STARTED|Overall Study||2
6789654|NCT03095287|7721217|FG000|COMPLETED|Overall Study||0
6789655|NCT03095287|7721217|FG000|NOT COMPLETED|Overall Study||2
6789656|NCT03236662|7721221|FG000|STARTED|Overall Study||2
6789657|NCT03236662|7721221|FG000|COMPLETED|Overall Study||2
6789658|NCT03236662|7721221|FG000|NOT COMPLETED|Overall Study||0
6789659|NCT02930122|7721227|FG000|STARTED|Overall Study||3
6789660|NCT02930122|7721228|FG001|STARTED|Overall Study||3
6789661|NCT02930122|7721227|FG000|COMPLETED|Overall Study||0
6789662|NCT02930122|7721228|FG001|COMPLETED|Overall Study||0
6789663|NCT02930122|7721227|FG000|NOT COMPLETED|Overall Study||3
6789664|NCT02930122|7721228|FG001|NOT COMPLETED|Overall Study||3
6789665|NCT01444209|7721235|FG000|STARTED|Overall Study||2
6789666|NCT01444209|7721235|FG000|COMPLETED|Overall Study||2
6789667|NCT01444209|7721235|FG000|NOT COMPLETED|Overall Study||0
6789668|NCT04267380|7721241|FG000|STARTED|Overall Study||149
6789669|NCT04267380|7721242|FG001|STARTED|Overall Study||149
6789670|NCT04267380|7721241|FG000|COMPLETED|Overall Study||149
6789671|NCT04267380|7721242|FG001|COMPLETED|Overall Study||149
6789672|NCT04267380|7721241|FG000|NOT COMPLETED|Overall Study||0
6789673|NCT04267380|7721242|FG001|NOT COMPLETED|Overall Study||0
6789674|NCT04144166|7721248|FG000|STARTED|Overall Study||60
6789675|NCT04144166|7721248|FG000|COMPLETED|Overall Study||57
6789676|NCT04144166|7721248|FG000|NOT COMPLETED|Overall Study||3
6789677|NCT04090164|7721259|FG000|STARTED|Overall Study|Number of patients retrivied from the hospital files.|650
6789678|NCT04090164|7721260|FG001|STARTED|Overall Study||145
6789679|NCT04090164|7721259|FG000|COMPLETED|Overall Study|Number of patients analyzed.|405
6789680|NCT04090164|7721260|FG001|COMPLETED|Overall Study||145
6789681|NCT04090164|7721259|FG000|NOT COMPLETED|Overall Study||245
6789682|NCT04090164|7721260|FG001|NOT COMPLETED|Overall Study||0
6789683|NCT04047121|7721273|FG000|STARTED|Overall Study||310
6789684|NCT04047121|7721274|FG001|STARTED|Overall Study||299
6789685|NCT04047121|7721275|FG002|STARTED|Overall Study||79
6789686|NCT04047121|7721276|FG003|STARTED|Overall Study||287
6789687|NCT04047121|7721277|FG004|STARTED|Overall Study||112
6789688|NCT04047121|7721278|FG005|STARTED|Overall Study||262
6789689|NCT04047121|7721273|FG000|COMPLETED|Overall Study||310
6789690|NCT04047121|7721274|FG001|COMPLETED|Overall Study||299
6789691|NCT04047121|7721275|FG002|COMPLETED|Overall Study||79
6789692|NCT04047121|7721276|FG003|COMPLETED|Overall Study||287
6789693|NCT04047121|7721277|FG004|COMPLETED|Overall Study||112
6789694|NCT04047121|7721278|FG005|COMPLETED|Overall Study||262
6789695|NCT04047121|7721273|FG000|NOT COMPLETED|Overall Study||0
6789696|NCT04047121|7721274|FG001|NOT COMPLETED|Overall Study||0
6789697|NCT04047121|7721275|FG002|NOT COMPLETED|Overall Study||0
6789698|NCT04047121|7721276|FG003|NOT COMPLETED|Overall Study||0
6789699|NCT04047121|7721277|FG004|NOT COMPLETED|Overall Study||0
6789700|NCT04047121|7721278|FG005|NOT COMPLETED|Overall Study||0
6789701|NCT04036799|7721292|FG000|STARTED|Overall Study||572
6789702|NCT04036799|7721292|FG000|COMPLETED|Overall Study||572
6789703|NCT04036799|7721292|FG000|NOT COMPLETED|Overall Study||0
6789704|NCT04018001|7721298|FG000|STARTED|Overall Study||678
6789705|NCT04018001|7721299|FG001|STARTED|Overall Study||379
6789706|NCT04018001|7721298|FG000|COMPLETED|Overall Study||678
6789707|NCT04018001|7721299|FG001|COMPLETED|Overall Study||379
6789708|NCT04018001|7721298|FG000|NOT COMPLETED|Overall Study||0
6789709|NCT04018001|7721299|FG001|NOT COMPLETED|Overall Study||0
6789710|NCT04017754|7721305|FG000|STARTED|Overall Study||267
6789711|NCT04017754|7721306|FG001|STARTED|Overall Study||185
6789712|NCT04017754|7721305|FG000|COMPLETED|Overall Study||267
6789713|NCT04017754|7721306|FG001|COMPLETED|Overall Study||185
6789714|NCT04017754|7721305|FG000|NOT COMPLETED|Overall Study||0
6789715|NCT04017754|7721306|FG001|NOT COMPLETED|Overall Study||0
6789716|NCT04010370|7721349|FG000|STARTED|Overall Study||25
6789717|NCT04010370|7721349|FG000|COMPLETED|Overall Study||25
6789718|NCT04010370|7721349|FG000|NOT COMPLETED|Overall Study||0
6789719|NCT03997825|7721353|FG000|STARTED|Overall Study||117
6789720|NCT03997825|7721353|FG000|COMPLETED|Overall Study||100
6789721|NCT03997825|7721353|FG000|NOT COMPLETED|Overall Study||17
6789722|NCT03975790|7721360|FG000|STARTED|Overall Study||337
6789723|NCT03975790|7721361|FG001|STARTED|Overall Study||94
6789724|NCT03975790|7721362|FG002|STARTED|Overall Study||48
6789725|NCT03975790|7721360|FG000|COMPLETED|Overall Study||337
6789726|NCT03975790|7721361|FG001|COMPLETED|Overall Study||94
6789727|NCT03975790|7721362|FG002|COMPLETED|Overall Study||48
6789728|NCT03975790|7721360|FG000|NOT COMPLETED|Overall Study||0
6789729|NCT03975790|7721361|FG001|NOT COMPLETED|Overall Study||0
6789730|NCT03975790|7721362|FG002|NOT COMPLETED|Overall Study||0
6789731|NCT03979079|7721370|FG000|STARTED|Overall Study||2384
6789732|NCT03979079|7721370|FG000|COMPLETED|Overall Study||2384
6789733|NCT03979079|7721370|FG000|NOT COMPLETED|Overall Study||0
6789734|NCT03895632|7721375|FG000|STARTED|Overall Study||25
6789735|NCT03895632|7721375|FG000|COMPLETED|Overall Study||25
6789736|NCT03895632|7721375|FG000|NOT COMPLETED|Overall Study||0
6789737|NCT03859622|7721379|FG000|STARTED|Overall Study||289
6789738|NCT03859622|7721379|FG000|COMPLETED|Overall Study||289
6789739|NCT03859622|7721379|FG000|NOT COMPLETED|Overall Study||0
6789740|NCT03764813|7721390|FG000|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving no transfusions before the age of 32 weeks|14
6789741|NCT03764813|7721391|FG001|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only cord-RBC transfusions before the age of 32 weeks|3
6789742|NCT03764813|7721392|FG002|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving only adult-RBC transfusions before the age of 32 weeks|4
6789743|NCT03764813|7721393|FG003|STARTED|From Enrollment to the Age of 32 Weeks|Patients receiving both adult-RBC and cord-RBCs before the age of 32 weeks|4
6789744|NCT03764813|7721390|FG000|COMPLETED|From Enrollment to the Age of 32 Weeks||14
6789745|NCT03764813|7721391|FG001|COMPLETED|From Enrollment to the Age of 32 Weeks||2
6789746|NCT03764813|7721392|FG002|COMPLETED|From Enrollment to the Age of 32 Weeks||3
6789747|NCT03764813|7721393|FG003|COMPLETED|From Enrollment to the Age of 32 Weeks||4
6789748|NCT03764813|7721390|FG000|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
6789749|NCT03764813|7721391|FG001|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
6789750|NCT03764813|7721392|FG002|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||1
6789751|NCT03764813|7721393|FG003|NOT COMPLETED|From Enrollment to the Age of 32 Weeks||0
6789752|NCT03764813|7721390|FG000|STARTED|From Enrollment to the Last HbF Test|Patients receiving no transfusions before last HbF test (occurring at 36 weeks,discharge or death)|13
6789753|NCT03764813|7721391|FG001|STARTED|From Enrollment to the Last HbF Test|Patients receiving only cord-RBCs before last HbF test (occurring at 36 wks,discharge or death)|3
6789754|NCT03764813|7721392|FG002|STARTED|From Enrollment to the Last HbF Test|Patients receiving only adult-RBC before last HbF test (occurring at 36 wks,discharge or death)|4
6789755|NCT03764813|7721393|FG003|STARTED|From Enrollment to the Last HbF Test|Patients receiving both cord and adult-RBCs before the last HbFtest(age of 36 wk,discharge or death)|5
6789756|NCT03764813|7721390|FG000|COMPLETED|From Enrollment to the Last HbF Test||13
6789757|NCT03764813|7721391|FG001|COMPLETED|From Enrollment to the Last HbF Test||3
6789758|NCT03764813|7721392|FG002|COMPLETED|From Enrollment to the Last HbF Test||4
6789759|NCT03764813|7721393|FG003|COMPLETED|From Enrollment to the Last HbF Test||5
6789760|NCT03764813|7721390|FG000|NOT COMPLETED|From Enrollment to the Last HbF Test||0
6789761|NCT03764813|7721391|FG001|NOT COMPLETED|From Enrollment to the Last HbF Test||0
6789762|NCT03764813|7721392|FG002|NOT COMPLETED|From Enrollment to the Last HbF Test||0
6789763|NCT03764813|7721393|FG003|NOT COMPLETED|From Enrollment to the Last HbF Test||0
6789764|NCT00078806|7721409|FG000|STARTED|Part 1A||19
6789765|NCT00078806|7721410|FG001|STARTED|Part 1A||0
6789766|NCT00078806|7721411|FG002|STARTED|Part 1A||0
6789767|NCT00078806|7721412|FG003|STARTED|Part 1A||0
6789768|NCT00078806|7721409|FG000|COMPLETED|Part 1A||9
6789769|NCT00078806|7721410|FG001|COMPLETED|Part 1A||0
6789770|NCT00078806|7721411|FG002|COMPLETED|Part 1A||0
6789771|NCT00078806|7721412|FG003|COMPLETED|Part 1A||0
6789772|NCT00078806|7721409|FG000|NOT COMPLETED|Part 1A||10
6789773|NCT00078806|7721410|FG001|NOT COMPLETED|Part 1A||0
6789774|NCT00078806|7721411|FG002|NOT COMPLETED|Part 1A||0
6789775|NCT00078806|7721412|FG003|NOT COMPLETED|Part 1A||0
6789776|NCT00078806|7721409|FG000|STARTED|Part 1B||10
6789777|NCT00078806|7721410|FG001|STARTED|Part 1B||0
6789778|NCT00078806|7721411|FG002|STARTED|Part 1B||0
6789779|NCT00078806|7721412|FG003|STARTED|Part 1B||0
6789780|NCT00078806|7721409|FG000|COMPLETED|Part 1B||2
6789781|NCT00078806|7721410|FG001|COMPLETED|Part 1B||0
6789782|NCT00078806|7721411|FG002|COMPLETED|Part 1B||0
6789783|NCT00078806|7721412|FG003|COMPLETED|Part 1B||0
6789784|NCT00078806|7721409|FG000|NOT COMPLETED|Part 1B||8
6789785|NCT00078806|7721410|FG001|NOT COMPLETED|Part 1B||0
6789786|NCT00078806|7721411|FG002|NOT COMPLETED|Part 1B||0
6789787|NCT00078806|7721412|FG003|NOT COMPLETED|Part 1B||0
6789788|NCT00078806|7721409|FG000|STARTED|Part 2||0
6789789|NCT00078806|7721410|FG001|STARTED|Part 2||6
6789790|NCT00078806|7721411|FG002|STARTED|Part 2||4
6789791|NCT00078806|7721412|FG003|STARTED|Part 2||0
6789792|NCT00078806|7721409|FG000|Received Study Drug|Part 2||0
6789793|NCT00078806|7721410|FG001|Received Study Drug|Part 2||5
6789794|NCT00078806|7721411|FG002|Received Study Drug|Part 2||4
6789795|NCT00078806|7721412|FG003|Received Study Drug|Part 2||0
6789796|NCT00078806|7721409|FG000|COMPLETED|Part 2||0
6789797|NCT00078806|7721410|FG001|COMPLETED|Part 2||5
6789798|NCT00078806|7721411|FG002|COMPLETED|Part 2||4
6789799|NCT00078806|7721412|FG003|COMPLETED|Part 2||0
6789800|NCT00078806|7721409|FG000|NOT COMPLETED|Part 2||0
6789801|NCT00078806|7721410|FG001|NOT COMPLETED|Part 2||1
6789802|NCT00078806|7721411|FG002|NOT COMPLETED|Part 2||0
6789803|NCT00078806|7721412|FG003|NOT COMPLETED|Part 2||0
6789804|NCT00078806|7721409|FG000|STARTED|Part 3||0
6789805|NCT00078806|7721410|FG001|STARTED|Part 3||0
6789806|NCT00078806|7721411|FG002|STARTED|Part 3||0
6789807|NCT00078806|7721412|FG003|STARTED|Part 3||9
6789808|NCT00078806|7721409|FG000|COMPLETED|Part 3||0
6789809|NCT00078806|7721410|FG001|COMPLETED|Part 3||0
6789810|NCT00078806|7721411|FG002|COMPLETED|Part 3||0
6789811|NCT00078806|7721412|FG003|COMPLETED|Part 3||9
6789812|NCT00078806|7721409|FG000|NOT COMPLETED|Part 3||0
6789813|NCT00078806|7721410|FG001|NOT COMPLETED|Part 3||0
6789814|NCT00078806|7721411|FG002|NOT COMPLETED|Part 3||0
6789815|NCT00078806|7721412|FG003|NOT COMPLETED|Part 3||0
6789816|NCT00162370|7721427|FG000|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
6789817|NCT00162370|7721427|FG000|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
6789818|NCT00162370|7721427|FG000|NOT COMPLETED|Completed Echocardiography Imaging||0
6789819|NCT00162370|7721427|FG000|STARTED|Efficacy Population||366
6789820|NCT00162370|7721427|FG000|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
6789821|NCT00162370|7721427|FG000|NOT COMPLETED|Efficacy Population||51
6789822|NCT00204737|7721436|FG000|STARTED|Overall Study||6
6789823|NCT00204737|7721437|FG001|STARTED|Overall Study||6
6789824|NCT00204737|7721436|FG000|COMPLETED|Overall Study||6
6789825|NCT00204737|7721437|FG001|COMPLETED|Overall Study||6
6789826|NCT00204737|7721436|FG000|NOT COMPLETED|Overall Study||0
6789827|NCT00204737|7721437|FG001|NOT COMPLETED|Overall Study||0
6789828|NCT00214500|7721443|FG000|STARTED|Treatment Period|All eligible-enrolled participants who received at least 1 dose of study drug|9
6789829|NCT00214500|7721443|FG000|Safety Population|Treatment Period||9
6789830|NCT00214500|7721443|FG000|Pharmacokinetic (PK) Population|Treatment Period||9
6789831|NCT00214500|7721443|FG000|Pharmacodynamic (PD) Population|Treatment Period||9
6789832|NCT00214500|7721443|FG000|COMPLETED|Treatment Period||8
6789833|NCT00214500|7721443|FG000|NOT COMPLETED|Treatment Period||1
6789834|NCT00214500|7721443|FG000|STARTED|Extension Period||8
6789835|NCT00214500|7721443|FG000|COMPLETED|Extension Period||6
6789836|NCT00214500|7721443|FG000|NOT COMPLETED|Extension Period||2
6789837|NCT00278343|7721450|FG000|STARTED|Overall Study||74
6789838|NCT00278343|7721450|FG000|COMPLETED|Overall Study||74
6789839|NCT00278343|7721450|FG000|NOT COMPLETED|Overall Study||0
6789840|NCT00283959|7721455|FG000|STARTED|Treatment Period||4
6789841|NCT00283959|7721455|FG000|Safety Population|Treatment Period||4
6789842|NCT00283959|7721455|FG000|Pharmacodynamics (PD) Population|Treatment Period||4
6789843|NCT00283959|7721455|FG000|COMPLETED|Treatment Period||4
6789844|NCT00283959|7721455|FG000|NOT COMPLETED|Treatment Period||0
6789845|NCT00283959|7721455|FG000|STARTED|Extension Period||4
6789846|NCT00283959|7721455|FG000|COMPLETED|Extension Period||3
6789847|NCT00283959|7721455|FG000|NOT COMPLETED|Extension Period||1
6789848|NCT00290758|7721461|FG000|STARTED|Pre-Intervention rFNA Through Follow-Up||62
6789849|NCT00290758|7721462|FG001|STARTED|Pre-Intervention rFNA Through Follow-Up||64
6789850|NCT00290758|7721461|FG000|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
6789851|NCT00290758|7721462|FG001|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
6789852|NCT00290758|7721461|FG000|Randomization|Pre-Intervention rFNA Through Follow-Up||62
6789853|NCT00290758|7721462|FG001|Randomization|Pre-Intervention rFNA Through Follow-Up||62
6789854|NCT00290758|7721461|FG000|Treatment|Pre-Intervention rFNA Through Follow-Up||61
6789855|NCT00290758|7721462|FG001|Treatment|Pre-Intervention rFNA Through Follow-Up||64
6789856|NCT00290758|7721461|FG000|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
6789857|NCT00290758|7721462|FG001|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
6789858|NCT00290758|7721461|FG000|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
6789859|NCT00290758|7721462|FG001|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
6789860|NCT00290758|7721461|FG000|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
6789861|NCT00290758|7721462|FG001|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
6789862|NCT00290758|7721461|FG000|STARTED|Post Intervention rFNA||55
6789863|NCT00290758|7721462|FG001|STARTED|Post Intervention rFNA||54
6789864|NCT00290758|7721461|FG000|COMPLETED|Post Intervention rFNA||49
6789865|NCT00290758|7721462|FG001|COMPLETED|Post Intervention rFNA||49
6789866|NCT00290758|7721461|FG000|NOT COMPLETED|Post Intervention rFNA||6
6789867|NCT00290758|7721462|FG001|NOT COMPLETED|Post Intervention rFNA||5
6789868|NCT00310388|7721472|FG000|STARTED|Primary Reporting Phase||376
6789869|NCT00310388|7721473|FG001|STARTED|Primary Reporting Phase||0
6789870|NCT00310388|7721472|FG000|COMPLETED|Primary Reporting Phase||30
6789871|NCT00310388|7721473|FG001|COMPLETED|Primary Reporting Phase||0
6789872|NCT00310388|7721472|FG000|NOT COMPLETED|Primary Reporting Phase||346
6563280|NCT01806597|7486252|FG003|STARTED|Follow-up Period (Week 132 to Week 140)||0
6563281|NCT01806597|7486253|FG004|STARTED|Follow-up Period (Week 132 to Week 140)||3
6563282|NCT01806597|7486254|FG005|STARTED|Follow-up Period (Week 132 to Week 140)||161
6563283|NCT01806597|7486249|FG000|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6563284|NCT01806597|7486250|FG001|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6563285|NCT01806597|7486251|FG002|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6563286|NCT01806597|7486252|FG003|COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6563287|NCT01806597|7486253|FG004|COMPLETED|Follow-up Period (Week 132 to Week 140)||3
6563288|NCT01806597|7486254|FG005|COMPLETED|Follow-up Period (Week 132 to Week 140)||149
6563289|NCT01806597|7486249|FG000|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6563290|NCT01806597|7486250|FG001|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6789873|NCT00310388|7721473|FG001|NOT COMPLETED|Primary Reporting Phase||0
6789874|NCT00310388|7721472|FG000|STARTED|Safety Follow-up Continuation Phase||0
6789875|NCT00310388|7721473|FG001|STARTED|Safety Follow-up Continuation Phase||26
6789876|NCT00310388|7721472|FG000|COMPLETED|Safety Follow-up Continuation Phase||0
6789877|NCT00310388|7721473|FG001|COMPLETED|Safety Follow-up Continuation Phase||13
6789878|NCT00310388|7721472|FG000|NOT COMPLETED|Safety Follow-up Continuation Phase||0
6789879|NCT00310388|7721473|FG001|NOT COMPLETED|Safety Follow-up Continuation Phase||13
6789880|NCT00345358|7721482|FG000|STARTED|Primary Vaccination Phase||150
6789881|NCT00345358|7721483|FG001|STARTED|Primary Vaccination Phase||150
6789882|NCT00345358|7721484|FG002|STARTED|Primary Vaccination Phase||150
6789883|NCT00345358|7721485|FG003|STARTED|Primary Vaccination Phase||150
6789884|NCT00345358|7721482|FG000|COMPLETED|Primary Vaccination Phase||145
6789885|NCT00345358|7721483|FG001|COMPLETED|Primary Vaccination Phase||146
6789886|NCT00345358|7721484|FG002|COMPLETED|Primary Vaccination Phase||142
6789887|NCT00345358|7721485|FG003|COMPLETED|Primary Vaccination Phase||148
6789888|NCT00345358|7721482|FG000|NOT COMPLETED|Primary Vaccination Phase||5
6789889|NCT00345358|7721483|FG001|NOT COMPLETED|Primary Vaccination Phase||4
6789890|NCT00345358|7721484|FG002|NOT COMPLETED|Primary Vaccination Phase||8
6789891|NCT00345358|7721485|FG003|NOT COMPLETED|Primary Vaccination Phase||2
6789892|NCT00345358|7721482|FG000|STARTED|Booster Vaccination Phase||145
6789893|NCT00345358|7721483|FG001|STARTED|Booster Vaccination Phase||145
6789894|NCT00345358|7721484|FG002|STARTED|Booster Vaccination Phase||0
6789895|NCT00345358|7721485|FG003|STARTED|Booster Vaccination Phase||0
6789896|NCT00345358|7721482|FG000|COMPLETED|Booster Vaccination Phase||141
6789897|NCT00345358|7721483|FG001|COMPLETED|Booster Vaccination Phase||145
6789898|NCT00345358|7721484|FG002|COMPLETED|Booster Vaccination Phase||0
6789899|NCT00345358|7721485|FG003|COMPLETED|Booster Vaccination Phase||0
6789900|NCT00345358|7721482|FG000|NOT COMPLETED|Booster Vaccination Phase||4
6789901|NCT00345358|7721483|FG001|NOT COMPLETED|Booster Vaccination Phase||0
6789902|NCT00345358|7721484|FG002|NOT COMPLETED|Booster Vaccination Phase||0
6789903|NCT00345358|7721485|FG003|NOT COMPLETED|Booster Vaccination Phase||0
6789904|NCT00345800|7721495|FG000|STARTED|Overall Study||25
6789905|NCT00345800|7721495|FG000|COMPLETED|Overall Study||25
6789906|NCT00345800|7721495|FG000|NOT COMPLETED|Overall Study||0
6789907|NCT00372229|7721501|FG000|STARTED|Study Phase||148
6789908|NCT00372229|7721502|FG001|STARTED|Study Phase||151
6789909|NCT00372229|7721501|FG000|COMPLETED|Study Phase||117
6789910|NCT00372229|7721502|FG001|COMPLETED|Study Phase||122
6789911|NCT00372229|7721501|FG000|NOT COMPLETED|Study Phase||31
6789912|NCT00372229|7721502|FG001|NOT COMPLETED|Study Phase||29
6789913|NCT00372229|7721501|FG000|STARTED|Follow-Up Phase||117
6789914|NCT00372229|7721502|FG001|STARTED|Follow-Up Phase||122
6789915|NCT00372229|7721501|FG000|COMPLETED|Follow-Up Phase||71
6789916|NCT00372229|7721502|FG001|COMPLETED|Follow-Up Phase||70
6789917|NCT00372229|7721501|FG000|NOT COMPLETED|Follow-Up Phase||46
6789918|NCT00372229|7721502|FG001|NOT COMPLETED|Follow-Up Phase||52
6789919|NCT00383708|7721512|FG000|STARTED|Enrolment Through Start Treatment||125
6789920|NCT00383708|7721512|FG000|COMPLETED|Enrolment Through Start Treatment||92
6789921|NCT00383708|7721512|FG000|NOT COMPLETED|Enrolment Through Start Treatment||33
6789922|NCT00383708|7721512|FG000|STARTED|Run-in Period||92
6789923|NCT00383708|7721512|FG000|COMPLETED|Run-in Period||85
6789924|NCT00383708|7721512|FG000|NOT COMPLETED|Run-in Period||7
6789925|NCT00383708|7721512|FG000|STARTED|Co-administration Period||57
6789926|NCT00383708|7721512|FG000|COMPLETED|Co-administration Period||52
6789927|NCT00383708|7721512|FG000|NOT COMPLETED|Co-administration Period||5
6789928|NCT00413699|7721519|FG000|STARTED|Initial Period||1123
6789929|NCT00413699|7721520|FG001|STARTED|Initial Period||3358
6789930|NCT00413699|7721521|FG002|STARTED|Initial Period||0
6789931|NCT00413699|7721519|FG000|COMPLETED|Initial Period||484
6789932|NCT00413699|7721520|FG001|COMPLETED|Initial Period||1653
6789933|NCT00413699|7721521|FG002|COMPLETED|Initial Period||0
6789934|NCT00413699|7721519|FG000|NOT COMPLETED|Initial Period||639
6789935|NCT00413699|7721520|FG001|NOT COMPLETED|Initial Period||1705
6789936|NCT00413699|7721521|FG002|NOT COMPLETED|Initial Period||0
6789937|NCT00413699|7721519|FG000|STARTED|Extension Period||0
6789938|NCT00413699|7721520|FG001|STARTED|Extension Period||0
6789939|NCT00413699|7721521|FG002|STARTED|Extension Period||48
6563291|NCT01806597|7486251|FG002|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6789940|NCT00413699|7721519|FG000|COMPLETED|Extension Period||0
6789941|NCT00413699|7721520|FG001|COMPLETED|Extension Period||0
6789942|NCT00413699|7721521|FG002|COMPLETED|Extension Period||43
6789943|NCT00413699|7721519|FG000|NOT COMPLETED|Extension Period||0
6789944|NCT00413699|7721520|FG001|NOT COMPLETED|Extension Period||0
6789945|NCT00413699|7721521|FG002|NOT COMPLETED|Extension Period||5
6378856|NCT00770224|7289358|FG000|NOT COMPLETED|Step 2: Maintenance||0
6378857|NCT00770224|7289359|FG001|NOT COMPLETED|Step 2: Maintenance||30
6378858|NCT00770289|7289366|FG000|STARTED|Overall Study||851
6378859|NCT00770289|7289366|FG000|COMPLETED|Overall Study||845
6378860|NCT00770289|7289366|FG000|NOT COMPLETED|Overall Study||6
6378861|NCT00770315|7289379|FG000|STARTED|Overall Study||197
6378862|NCT00770315|7289380|FG001|STARTED|Overall Study||195
6378863|NCT00770315|7289381|FG002|STARTED|Overall Study||194
6378864|NCT00770315|7289382|FG003|STARTED|Overall Study||198
6378865|NCT00770315|7289379|FG000|COMPLETED|Overall Study||157
6378866|NCT00770315|7289380|FG001|COMPLETED|Overall Study||152
6378867|NCT00770315|7289381|FG002|COMPLETED|Overall Study||137
6378868|NCT00770315|7289382|FG003|COMPLETED|Overall Study||160
6378869|NCT00770315|7289379|FG000|NOT COMPLETED|Overall Study||40
6378870|NCT00770315|7289380|FG001|NOT COMPLETED|Overall Study||43
6378871|NCT00770315|7289381|FG002|NOT COMPLETED|Overall Study||57
6378872|NCT00770315|7289382|FG003|NOT COMPLETED|Overall Study||38
6378873|NCT00770328|7289394|FG000|STARTED|Overall Study||22
6378874|NCT00770328|7289395|FG001|STARTED|Overall Study||15
6378875|NCT00770328|7289394|FG000|COMPLETED|Overall Study||9
6378876|NCT00770328|7289395|FG001|COMPLETED|Overall Study||11
6378877|NCT00770328|7289394|FG000|NOT COMPLETED|Overall Study||13
6378878|NCT00770328|7289395|FG001|NOT COMPLETED|Overall Study||4
6378879|NCT00770341|7289404|FG000|STARTED|Overall Study|Number randomized|89
6378880|NCT00770341|7289405|FG001|STARTED|Overall Study|Number randomized|22
6378881|NCT00770341|7289406|FG002|STARTED|Overall Study|Number randomized|11
6378882|NCT00770341|7289404|FG000|COMPLETED|Overall Study||77
6378883|NCT00770341|7289405|FG001|COMPLETED|Overall Study||17
6378884|NCT00770341|7289406|FG002|COMPLETED|Overall Study||8
6378885|NCT00770341|7289404|FG000|NOT COMPLETED|Overall Study||12
6378886|NCT00770341|7289405|FG001|NOT COMPLETED|Overall Study||5
6378887|NCT00770341|7289406|FG002|NOT COMPLETED|Overall Study||3
6378888|NCT00770367|7289417|FG000|STARTED|First Intervention||18
6378889|NCT00770367|7289418|FG001|STARTED|First Intervention||18
6378890|NCT00770367|7289417|FG000|COMPLETED|First Intervention||18
6378891|NCT00770367|7289418|FG001|COMPLETED|First Intervention||16
6378892|NCT00770367|7289417|FG000|NOT COMPLETED|First Intervention||0
6378893|NCT00770367|7289418|FG001|NOT COMPLETED|First Intervention||2
6378894|NCT00770367|7289417|FG000|STARTED|Washout Period of 4 Weeks||18
6378895|NCT00770367|7289418|FG001|STARTED|Washout Period of 4 Weeks||16
6378896|NCT00770367|7289417|FG000|COMPLETED|Washout Period of 4 Weeks||18
6378897|NCT00770367|7289418|FG001|COMPLETED|Washout Period of 4 Weeks||15
6378898|NCT00770367|7289417|FG000|NOT COMPLETED|Washout Period of 4 Weeks||0
6378899|NCT00770367|7289418|FG001|NOT COMPLETED|Washout Period of 4 Weeks||1
6378900|NCT00770367|7289417|FG000|STARTED|Second Intervention||18
6378901|NCT00770367|7289418|FG001|STARTED|Second Intervention||15
6378902|NCT00770367|7289417|FG000|COMPLETED|Second Intervention||16
6378903|NCT00770367|7289418|FG001|COMPLETED|Second Intervention||15
6378904|NCT00770367|7289417|FG000|NOT COMPLETED|Second Intervention||2
6378905|NCT00770367|7289418|FG001|NOT COMPLETED|Second Intervention||0
6789946|NCT00435227|7721549|FG000|STARTED|Overall Study||5
6789947|NCT00435227|7721550|FG001|STARTED|Overall Study||7
6789948|NCT00435227|7721549|FG000|COMPLETED|Overall Study||5
6789949|NCT00435227|7721550|FG001|COMPLETED|Overall Study||7
6789950|NCT00435227|7721549|FG000|NOT COMPLETED|Overall Study||0
6789951|NCT00435227|7721550|FG001|NOT COMPLETED|Overall Study||0
6790006|NCT00442546|7721583|FG000|STARTED|Overall Study||103
6790007|NCT00442546|7721584|FG001|STARTED|Overall Study||100
6790008|NCT00442546|7721585|FG002|STARTED|Overall Study||104
6790009|NCT00442546|7721583|FG000|Received Treatment|Overall Study||98
6790010|NCT00442546|7721584|FG001|Received Treatment|Overall Study||96
6790011|NCT00442546|7721585|FG002|Received Treatment|Overall Study||98
6790012|NCT00442546|7721583|FG000|COMPLETED|Overall Study||77
6790013|NCT00442546|7721584|FG001|COMPLETED|Overall Study||63
6790014|NCT00442546|7721585|FG002|COMPLETED|Overall Study||71
6790015|NCT00442546|7721583|FG000|NOT COMPLETED|Overall Study||26
6790016|NCT00442546|7721584|FG001|NOT COMPLETED|Overall Study||37
6790017|NCT00442546|7721585|FG002|NOT COMPLETED|Overall Study||33
6790018|NCT04715932|7721597|FG000|STARTED|Overall Study||107
6790019|NCT04715932|7721598|FG001|STARTED|Overall Study||109
6790020|NCT04715932|7721597|FG000|COMPLETED|Overall Study||106
6790021|NCT04715932|7721598|FG001|COMPLETED|Overall Study||109
6790022|NCT04715932|7721597|FG000|NOT COMPLETED|Overall Study||1
6790023|NCT04715932|7721598|FG001|NOT COMPLETED|Overall Study||0
6790024|NCT04666441|7721612|FG000|STARTED|Overall Study||82
6790025|NCT04666441|7721613|FG001|STARTED|Overall Study||165
6790026|NCT04666441|7721614|FG002|STARTED|Overall Study||162
6790027|NCT04666441|7721615|FG003|STARTED|Overall Study||165
6790028|NCT04666441|7721616|FG004|STARTED|Overall Study||166
6790029|NCT04666441|7721617|FG005|STARTED|Overall Study||82
6790030|NCT04666441|7721618|FG006|STARTED|Overall Study||163
6790031|NCT04666441|7721619|FG007|STARTED|Overall Study||164
6790032|NCT04666441|7721612|FG000|COMPLETED|Overall Study||80
6790033|NCT04666441|7721613|FG001|COMPLETED|Overall Study||160
6790034|NCT04666441|7721614|FG002|COMPLETED|Overall Study||158
6790035|NCT04666441|7721615|FG003|COMPLETED|Overall Study||161
6790036|NCT04666441|7721616|FG004|COMPLETED|Overall Study||166
6790037|NCT04666441|7721617|FG005|COMPLETED|Overall Study||79
6790038|NCT04666441|7721618|FG006|COMPLETED|Overall Study||158
6790039|NCT04666441|7721619|FG007|COMPLETED|Overall Study||160
6790040|NCT04666441|7721612|FG000|NOT COMPLETED|Overall Study||2
6790041|NCT04666441|7721613|FG001|NOT COMPLETED|Overall Study||5
6790042|NCT04666441|7721614|FG002|NOT COMPLETED|Overall Study||4
6790043|NCT04666441|7721615|FG003|NOT COMPLETED|Overall Study||4
6790044|NCT04666441|7721616|FG004|NOT COMPLETED|Overall Study||0
6790045|NCT04666441|7721617|FG005|NOT COMPLETED|Overall Study||3
6790046|NCT04666441|7721618|FG006|NOT COMPLETED|Overall Study||5
6790047|NCT04666441|7721619|FG007|NOT COMPLETED|Overall Study||4
6790074|NCT04259346|7721685|FG001|COMPLETED|Overall Study||115
6790075|NCT04259346|7721684|FG000|NOT COMPLETED|Overall Study||4
6790076|NCT04259346|7721685|FG001|NOT COMPLETED|Overall Study||4
6378906|NCT00770432|7289428|FG000|STARTED|Overall Study||102
6378907|NCT00770432|7289429|FG001|STARTED|Overall Study||101
6378908|NCT00770432|7289428|FG000|COMPLETED|Overall Study||98
6378909|NCT00770432|7289429|FG001|COMPLETED|Overall Study||94
6378910|NCT00770432|7289428|FG000|NOT COMPLETED|Overall Study||4
6378911|NCT00770432|7289429|FG001|NOT COMPLETED|Overall Study||7
6378912|NCT00770484|7289437|FG000|STARTED|Overall Study||8
6378913|NCT00770484|7289438|FG001|STARTED|Overall Study||4
6378914|NCT00770484|7289437|FG000|COMPLETED|Overall Study||7
6378915|NCT00770484|7289438|FG001|COMPLETED|Overall Study||4
6378916|NCT00770484|7289437|FG000|NOT COMPLETED|Overall Study||1
6378917|NCT00770484|7289438|FG001|NOT COMPLETED|Overall Study||0
6378918|NCT00770510|7289444|FG000|STARTED|Overall Study||72
6378919|NCT00770510|7289444|FG000|COMPLETED|Overall Study||67
6378920|NCT00770510|7289444|FG000|NOT COMPLETED|Overall Study||5
6378921|NCT00770562|7289458|FG000|STARTED|Overall Study||53
6378922|NCT00770562|7289459|FG001|STARTED|Overall Study||50
6789952|NCT00436826|7721559|FG000|STARTED|Double Blind Period (DBP)||124
6789953|NCT00436826|7721560|FG001|STARTED|Double Blind Period (DBP)||48
6789954|NCT00436826|7721561|FG002|STARTED|Double Blind Period (DBP)||0
6789955|NCT00436826|7721562|FG003|STARTED|Double Blind Period (DBP)||0
6789956|NCT00436826|7721563|FG004|STARTED|Double Blind Period (DBP)||0
6789957|NCT00436826|7721564|FG005|STARTED|Double Blind Period (DBP)||0
6789958|NCT00436826|7721559|FG000|COMPLETED|Double Blind Period (DBP)||111
6789959|NCT00436826|7721560|FG001|COMPLETED|Double Blind Period (DBP)||37
6789960|NCT00436826|7721561|FG002|COMPLETED|Double Blind Period (DBP)||0
6789961|NCT00436826|7721562|FG003|COMPLETED|Double Blind Period (DBP)||0
6789962|NCT00436826|7721563|FG004|COMPLETED|Double Blind Period (DBP)||0
6789963|NCT00436826|7721564|FG005|COMPLETED|Double Blind Period (DBP)||0
6789964|NCT00436826|7721559|FG000|NOT COMPLETED|Double Blind Period (DBP)||13
6789965|NCT00436826|7721560|FG001|NOT COMPLETED|Double Blind Period (DBP)||11
6789966|NCT00436826|7721561|FG002|NOT COMPLETED|Double Blind Period (DBP)||0
6789967|NCT00436826|7721562|FG003|NOT COMPLETED|Double Blind Period (DBP)||0
6789968|NCT00436826|7721563|FG004|NOT COMPLETED|Double Blind Period (DBP)||0
6789969|NCT00436826|7721564|FG005|NOT COMPLETED|Double Blind Period (DBP)||0
6789970|NCT00436826|7721559|FG000|STARTED|Ext. Period (With Cladribine Treatment)||0
6789971|NCT00436826|7721560|FG001|STARTED|Ext. Period (With Cladribine Treatment)||0
6789972|NCT00436826|7721561|FG002|STARTED|Ext. Period (With Cladribine Treatment)||47
6789973|NCT00436826|7721562|FG003|STARTED|Ext. Period (With Cladribine Treatment)||28
6789974|NCT00436826|7721563|FG004|STARTED|Ext. Period (With Cladribine Treatment)||0
6789975|NCT00436826|7721564|FG005|STARTED|Ext. Period (With Cladribine Treatment)||0
6789976|NCT00436826|7721559|FG000|COMPLETED|Ext. Period (With Cladribine Treatment)||0
6789977|NCT00436826|7721560|FG001|COMPLETED|Ext. Period (With Cladribine Treatment)||0
6789978|NCT00436826|7721561|FG002|COMPLETED|Ext. Period (With Cladribine Treatment)||1
6789979|NCT00436826|7721562|FG003|COMPLETED|Ext. Period (With Cladribine Treatment)||2
6789980|NCT00436826|7721563|FG004|COMPLETED|Ext. Period (With Cladribine Treatment)||0
6789981|NCT00436826|7721564|FG005|COMPLETED|Ext. Period (With Cladribine Treatment)||0
6789982|NCT00436826|7721559|FG000|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
6789983|NCT00436826|7721560|FG001|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
6789984|NCT00436826|7721561|FG002|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||46
6789985|NCT00436826|7721562|FG003|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||26
6789986|NCT00436826|7721563|FG004|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
6789987|NCT00436826|7721564|FG005|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
6789988|NCT00436826|7721559|FG000|STARTED|Ext. Period (No Cladribine Treatment)||0
6789989|NCT00436826|7721560|FG001|STARTED|Ext. Period (No Cladribine Treatment)||0
6789990|NCT00436826|7721561|FG002|STARTED|Ext. Period (No Cladribine Treatment)||0
6789991|NCT00436826|7721562|FG003|STARTED|Ext. Period (No Cladribine Treatment)||0
6789992|NCT00436826|7721563|FG004|STARTED|Ext. Period (No Cladribine Treatment)||52
6789993|NCT00436826|7721564|FG005|STARTED|Ext. Period (No Cladribine Treatment)||7
6789994|NCT00436826|7721559|FG000|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6789995|NCT00436826|7721560|FG001|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6789996|NCT00436826|7721561|FG002|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6789997|NCT00436826|7721562|FG003|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6789998|NCT00436826|7721563|FG004|COMPLETED|Ext. Period (No Cladribine Treatment)||1
6789999|NCT00436826|7721564|FG005|COMPLETED|Ext. Period (No Cladribine Treatment)||0
6790000|NCT00436826|7721559|FG000|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
6790001|NCT00436826|7721560|FG001|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
6790002|NCT00436826|7721561|FG002|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
6790003|NCT00436826|7721562|FG003|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
6790004|NCT00436826|7721563|FG004|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
6790005|NCT00436826|7721564|FG005|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
6790048|NCT04593641|7721650|FG000|STARTED|Overall Study||5
6790049|NCT04593641|7721651|FG001|STARTED|Overall Study||5
6790050|NCT04593641|7721652|FG002|STARTED|Overall Study||5
6790051|NCT04593641|7721653|FG003|STARTED|Overall Study||3
6790052|NCT04593641|7721650|FG000|COMPLETED|Overall Study||4
6790053|NCT04593641|7721651|FG001|COMPLETED|Overall Study||5
6790054|NCT04593641|7721652|FG002|COMPLETED|Overall Study||5
6790055|NCT04593641|7721653|FG003|COMPLETED|Overall Study||3
6790056|NCT04593641|7721650|FG000|NOT COMPLETED|Overall Study||1
6790057|NCT04593641|7721651|FG001|NOT COMPLETED|Overall Study||0
6790058|NCT04593641|7721652|FG002|NOT COMPLETED|Overall Study||0
6790059|NCT04593641|7721653|FG003|NOT COMPLETED|Overall Study||0
6790060|NCT04381052|7721665|FG000|STARTED|Overall Study||1
6790061|NCT04381052|7721665|FG000|COMPLETED|Overall Study||1
6790062|NCT04381052|7721665|FG000|NOT COMPLETED|Overall Study||0
6790063|NCT04274192|7721673|FG000|STARTED|Overall Study||1
6790064|NCT04274192|7721674|FG001|STARTED|Overall Study||0
6790065|NCT04274192|7721673|FG000|COMPLETED|Overall Study||0
6790066|NCT04274192|7721674|FG001|COMPLETED|Overall Study||0
6790067|NCT04274192|7721673|FG000|NOT COMPLETED|Overall Study||1
6790068|NCT04274192|7721674|FG001|NOT COMPLETED|Overall Study||0
6790069|NCT04259346|7721684|FG000|STARTED|Overall Study||126
6790070|NCT04259346|7721685|FG001|STARTED|Overall Study||119
6790071|NCT04259346|7721684|FG000|Received at Least One Dose of Study Drug|Overall Study||126
6790072|NCT04259346|7721685|FG001|Received at Least One Dose of Study Drug|Overall Study||119
6790073|NCT04259346|7721684|FG000|COMPLETED|Overall Study||122
6790077|NCT03959423|7721693|FG000|STARTED|Overall Study||160
6790078|NCT03959423|7721694|FG001|STARTED|Overall Study||128
6790079|NCT03959423|7721693|FG000|COMPLETED|Overall Study||151
6790080|NCT03959423|7721694|FG001|COMPLETED|Overall Study||124
6790081|NCT03959423|7721693|FG000|NOT COMPLETED|Overall Study||9
6790082|NCT03959423|7721694|FG001|NOT COMPLETED|Overall Study||4
6790154|NCT03077412|7721750|FG000|STARTED|Overall Study||17
6790155|NCT03077412|7721751|FG001|STARTED|Overall Study||25
6790156|NCT03077412|7721752|FG002|STARTED|Overall Study||15
6790157|NCT03077412|7721750|FG000|COMPLETED|Overall Study||14
6790158|NCT03077412|7721751|FG001|COMPLETED|Overall Study||12
6790159|NCT03077412|7721752|FG002|COMPLETED|Overall Study||6
6790160|NCT03077412|7721750|FG000|NOT COMPLETED|Overall Study||3
6790161|NCT03077412|7721751|FG001|NOT COMPLETED|Overall Study||13
6790162|NCT03077412|7721752|FG002|NOT COMPLETED|Overall Study||9
6790163|NCT03026504|7721760|FG000|STARTED|Overall Study||15
6790164|NCT03026504|7721760|FG000|COMPLETED|Overall Study||14
6790165|NCT03026504|7721760|FG000|NOT COMPLETED|Overall Study||1
6790166|NCT02971956|7721764|FG000|STARTED|Overall Study||49
6790167|NCT02971956|7721764|FG000|COMPLETED|Overall Study||49
6790168|NCT02971956|7721764|FG000|NOT COMPLETED|Overall Study||0
6790169|NCT02915367|7721770|FG000|STARTED|Overall Study||173
6790170|NCT02915367|7721771|FG001|STARTED|Overall Study||175
6790171|NCT02915367|7721770|FG000|COMPLETED|Overall Study||136
6790172|NCT02915367|7721771|FG001|COMPLETED|Overall Study||144
6790173|NCT02915367|7721770|FG000|NOT COMPLETED|Overall Study||37
6790174|NCT02915367|7721771|FG001|NOT COMPLETED|Overall Study||31
6790175|NCT02886572|7721777|FG000|STARTED|Survival Analysis and Distant Recurrence||40
6790176|NCT02886572|7721777|FG000|COMPLETED|Survival Analysis and Distant Recurrence||40
6790083|NCT03713320|7721702|FG000|STARTED|Randomized Period||19
6790084|NCT03713320|7721703|FG001|STARTED|Randomized Period||18
6790085|NCT03713320|7721704|FG002|STARTED|Randomized Period||0
6790086|NCT03713320|7721702|FG000|COMPLETED|Randomized Period||4
6790087|NCT03713320|7721703|FG001|COMPLETED|Randomized Period||8
6790088|NCT03713320|7721704|FG002|COMPLETED|Randomized Period||0
6790089|NCT03713320|7721702|FG000|NOT COMPLETED|Randomized Period||15
6790090|NCT03713320|7721703|FG001|NOT COMPLETED|Randomized Period||10
6790091|NCT03713320|7721704|FG002|NOT COMPLETED|Randomized Period||0
6790092|NCT03713320|7721702|FG000|STARTED|Cobomarsen Crossover Period||0
6790093|NCT03713320|7721703|FG001|STARTED|Cobomarsen Crossover Period||0
6790094|NCT03713320|7721704|FG002|STARTED|Cobomarsen Crossover Period||7
6790095|NCT03713320|7721702|FG000|COMPLETED|Cobomarsen Crossover Period||0
6790096|NCT03713320|7721703|FG001|COMPLETED|Cobomarsen Crossover Period||0
6790097|NCT03713320|7721704|FG002|COMPLETED|Cobomarsen Crossover Period||0
6790098|NCT03713320|7721702|FG000|NOT COMPLETED|Cobomarsen Crossover Period||0
6790099|NCT03713320|7721703|FG001|NOT COMPLETED|Cobomarsen Crossover Period||0
6790100|NCT03713320|7721704|FG002|NOT COMPLETED|Cobomarsen Crossover Period||7
6378923|NCT00770562|7289458|FG000|COMPLETED|Overall Study||52
6378924|NCT00770562|7289459|FG001|COMPLETED|Overall Study||49
6378925|NCT00770562|7289458|FG000|NOT COMPLETED|Overall Study||1
6563292|NCT01806597|7486252|FG003|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6563293|NCT01806597|7486253|FG004|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||0
6378926|NCT00770562|7289459|FG001|NOT COMPLETED|Overall Study||1
6378927|NCT00770588|7289468|FG000|STARTED|Overall Study||148
6378928|NCT00770588|7289469|FG001|STARTED|Overall Study||148
6378929|NCT00770588|7289468|FG000|COMPLETED|Overall Study||67
6378930|NCT00770588|7289469|FG001|COMPLETED|Overall Study||53
6378931|NCT00770588|7289468|FG000|NOT COMPLETED|Overall Study||81
6378932|NCT00770588|7289469|FG001|NOT COMPLETED|Overall Study||95
6378933|NCT00770601|7289476|FG000|STARTED|Overall Study||7
6378934|NCT00770601|7289476|FG000|COMPLETED|Overall Study||6
6790101|NCT03429049|7721713|FG000|STARTED|Overall Study||138
6790102|NCT03429049|7721714|FG001|STARTED|Overall Study||194
6790103|NCT03429049|7721713|FG000|Treated|Overall Study||136
6790104|NCT03429049|7721714|FG001|Treated|Overall Study||189
6790105|NCT03429049|7721713|FG000|COMPLETED|Overall Study||110
6790106|NCT03429049|7721714|FG001|COMPLETED|Overall Study||152
6790107|NCT03429049|7721713|FG000|NOT COMPLETED|Overall Study||28
6790108|NCT03429049|7721714|FG001|NOT COMPLETED|Overall Study||42
6790109|NCT03409731|7721720|FG000|STARTED|Overall Study||135
6790110|NCT03409731|7721720|FG000|COMPLETED|Overall Study||132
6790111|NCT03409731|7721720|FG000|NOT COMPLETED|Overall Study||3
6790148|NCT03283566|7721740|FG000|STARTED|Overall Study||4
6790149|NCT03283566|7721741|FG001|STARTED|Overall Study||5
6790150|NCT03283566|7721740|FG000|COMPLETED|Overall Study||3
6790151|NCT03283566|7721741|FG001|COMPLETED|Overall Study||3
6790152|NCT03283566|7721740|FG000|NOT COMPLETED|Overall Study||1
6790153|NCT03283566|7721741|FG001|NOT COMPLETED|Overall Study||2
6790177|NCT02886572|7721777|FG000|NOT COMPLETED|Survival Analysis and Distant Recurrence||0
6790178|NCT02886572|7721777|FG000|STARTED|Baseline Through Follow up MRI||40
6790179|NCT02886572|7721777|FG000|COMPLETED|Baseline Through Follow up MRI||32
6790180|NCT02886572|7721777|FG000|NOT COMPLETED|Baseline Through Follow up MRI||8
6790181|NCT02665143|7721781|FG000|STARTED|Phase 1||6
6790182|NCT02665143|7721781|FG000|COMPLETED|Phase 1||6
6790183|NCT02665143|7721781|FG000|NOT COMPLETED|Phase 1||0
6790184|NCT02665143|7721781|FG000|STARTED|Phase 2|19 Participants were enrolled in Phase 2.|19
6790185|NCT02665143|7721781|FG000|Completed 0 Cycles|Phase 2||1
6790186|NCT02665143|7721781|FG000|Completed 1 Cycle|Phase 2||12
6790187|NCT02665143|7721781|FG000|Completed 2 Cycles|Phase 2||3
6790188|NCT02665143|7721781|FG000|Completed 3 Cycles|Phase 2||3
6790189|NCT02665143|7721781|FG000|COMPLETED|Phase 2||19
6790190|NCT02665143|7721781|FG000|NOT COMPLETED|Phase 2||0
6790191|NCT02625766|7721788|FG000|STARTED|Overall Study||47
6790192|NCT02625766|7721789|FG001|STARTED|Overall Study||48
6790193|NCT02625766|7721788|FG000|COMPLETED|Overall Study||47
6790194|NCT02625766|7721789|FG001|COMPLETED|Overall Study||48
6790195|NCT02625766|7721788|FG000|NOT COMPLETED|Overall Study||0
6790196|NCT02625766|7721789|FG001|NOT COMPLETED|Overall Study||0
6790197|NCT02550470|7721798|FG000|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
6790198|NCT02550470|7721799|FG001|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
6790199|NCT02550470|7721800|FG002|STARTED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
6790200|NCT02550470|7721798|FG000|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
6790201|NCT02550470|7721799|FG001|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
6790202|NCT02550470|7721800|FG002|COMPLETED|Overall Study|"time to reach FiO2 of 4 mm Hg was recorded for each absorbent in the anesthesia circuit~Absorbent units other than participants were assigned to Arms/Groups"|
6790203|NCT02550470|7721798|FG000|NOT COMPLETED|Overall Study||
6790204|NCT02550470|7721799|FG001|NOT COMPLETED|Overall Study||
6790205|NCT02550470|7721800|FG002|NOT COMPLETED|Overall Study||
6790206|NCT02384850|7721810|FG000|STARTED|Overall Study||4
6790207|NCT02384850|7721811|FG001|STARTED|Overall Study||6
6790208|NCT02384850|7721810|FG000|COMPLETED|Overall Study||2
6790209|NCT02384850|7721811|FG001|COMPLETED|Overall Study||4
6790210|NCT02384850|7721810|FG000|NOT COMPLETED|Overall Study||2
6790211|NCT02384850|7721811|FG001|NOT COMPLETED|Overall Study||2
6790212|NCT02352090|7721820|FG000|STARTED|Overall Study||20
6790213|NCT02352090|7721821|FG001|STARTED|Overall Study||20
6790214|NCT02352090|7721822|FG002|STARTED|Overall Study||19
6790215|NCT02352090|7721820|FG000|COMPLETED|Overall Study||19
6790216|NCT02352090|7721821|FG001|COMPLETED|Overall Study||20
6790217|NCT02352090|7721822|FG002|COMPLETED|Overall Study||17
6790218|NCT02352090|7721820|FG000|NOT COMPLETED|Overall Study||1
6790219|NCT02352090|7721821|FG001|NOT COMPLETED|Overall Study||0
6790220|NCT02352090|7721822|FG002|NOT COMPLETED|Overall Study||2
6790221|NCT01976091|7721833|FG000|STARTED|Overall Study||1
6790222|NCT01976091|7721834|FG001|STARTED|Overall Study||3
6790223|NCT01976091|7721835|FG002|STARTED|Overall Study||2
6790224|NCT01976091|7721833|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1
6790225|NCT01976091|7721834|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6790226|NCT01976091|7721835|FG002|Received at Least 1 Dose of Study Drug|Overall Study||2
6790227|NCT01976091|7721833|FG000|COMPLETED|Overall Study||1
6790228|NCT01976091|7721834|FG001|COMPLETED|Overall Study||3
6790229|NCT01976091|7721835|FG002|COMPLETED|Overall Study||2
6790230|NCT01976091|7721833|FG000|NOT COMPLETED|Overall Study||0
6790231|NCT01976091|7721834|FG001|NOT COMPLETED|Overall Study||0
6790232|NCT01976091|7721835|FG002|NOT COMPLETED|Overall Study||0
6790233|NCT01145209|7721845|FG000|STARTED|Overall Study||13
6790234|NCT01145209|7721846|FG001|STARTED|Overall Study||19
6790235|NCT01145209|7721845|FG000|COMPLETED|Overall Study||10
6790236|NCT01145209|7721846|FG001|COMPLETED|Overall Study||18
6790237|NCT01145209|7721845|FG000|NOT COMPLETED|Overall Study||3
6790238|NCT01145209|7721846|FG001|NOT COMPLETED|Overall Study||1
6790239|NCT01078662|7721857|FG000|STARTED|Overall Study||62
6790240|NCT01078662|7721858|FG001|STARTED|Overall Study||193
6790241|NCT01078662|7721859|FG002|STARTED|Overall Study||23
6790242|NCT01078662|7721860|FG003|STARTED|Overall Study||8
6790243|NCT01078662|7721861|FG004|STARTED|Overall Study||12
6790244|NCT01078662|7721857|FG000|COMPLETED|Overall Study||4
6790245|NCT01078662|7721858|FG001|COMPLETED|Overall Study||25
6790246|NCT01078662|7721859|FG002|COMPLETED|Overall Study||2
6790247|NCT01078662|7721860|FG003|COMPLETED|Overall Study||1
6790248|NCT01078662|7721861|FG004|COMPLETED|Overall Study||1
6790249|NCT01078662|7721857|FG000|NOT COMPLETED|Overall Study||58
6790250|NCT01078662|7721858|FG001|NOT COMPLETED|Overall Study||168
6790251|NCT01078662|7721859|FG002|NOT COMPLETED|Overall Study||21
6790252|NCT01078662|7721860|FG003|NOT COMPLETED|Overall Study||7
6790253|NCT01078662|7721861|FG004|NOT COMPLETED|Overall Study||11
6790254|NCT00971867|7721870|FG000|STARTED|Overall Study||11
6790255|NCT00971867|7721870|FG000|COMPLETED|Overall Study||0
6790256|NCT00971867|7721870|FG000|NOT COMPLETED|Overall Study||11
6790257|NCT00853307|7721876|FG000|STARTED|Overall Study||6
6790258|NCT00853307|7721877|FG001|STARTED|Overall Study||25
6790259|NCT00853307|7721876|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment.|4
6790260|NCT00853307|7721877|FG001|COMPLETED|Overall Study||20
6790261|NCT00853307|7721876|FG000|NOT COMPLETED|Overall Study||2
6790262|NCT00853307|7721877|FG001|NOT COMPLETED|Overall Study||5
6790263|NCT00583804|7721883|FG000|STARTED|Overall Study||10
6790264|NCT00583804|7721883|FG000|COMPLETED|Overall Study|Subjects were considered enrolled when they underwent implantation of the device. All completed.|10
6790265|NCT00583804|7721883|FG000|NOT COMPLETED|Overall Study||0
6790266|NCT00545129|7721891|FG000|STARTED|Overall Study||29
6790267|NCT00545129|7721892|FG001|STARTED|Overall Study||30
6790268|NCT00545129|7721891|FG000|COMPLETED|Overall Study||12
6790269|NCT00545129|7721892|FG001|COMPLETED|Overall Study||6
6790270|NCT00545129|7721891|FG000|NOT COMPLETED|Overall Study||17
6790271|NCT00545129|7721892|FG001|NOT COMPLETED|Overall Study||24
6790278|NCT00554606|7721910|FG000|STARTED|Overall Study||115
6790279|NCT00554606|7721910|FG000|COMPLETED|Overall Study||30
6790280|NCT00554606|7721910|FG000|NOT COMPLETED|Overall Study||85
6790287|NCT00565461|7721929|FG000|STARTED|Overall Study||40
6790288|NCT00565461|7721930|FG001|STARTED|Overall Study||40
6790289|NCT00565461|7721931|FG002|STARTED|Overall Study||40
6790290|NCT00565461|7721932|FG003|STARTED|Overall Study||40
6790291|NCT00565461|7721929|FG000|COMPLETED|Overall Study||40
6790292|NCT00565461|7721930|FG001|COMPLETED|Overall Study||39
6790293|NCT00565461|7721931|FG002|COMPLETED|Overall Study||39
6790294|NCT00565461|7721932|FG003|COMPLETED|Overall Study||37
6790295|NCT00565461|7721929|FG000|NOT COMPLETED|Overall Study||0
6790296|NCT00565461|7721930|FG001|NOT COMPLETED|Overall Study||1
6790297|NCT00565461|7721931|FG002|NOT COMPLETED|Overall Study||1
6790298|NCT00565461|7721932|FG003|NOT COMPLETED|Overall Study||3
6790302|NCT00586924|7721958|FG000|STARTED|Overall Study||3
6790303|NCT00586924|7721959|FG001|STARTED|Overall Study||3
6790304|NCT00586924|7721960|FG002|STARTED|Overall Study||3
6790305|NCT00586924|7721961|FG003|STARTED|Overall Study||3
6790306|NCT00586924|7721962|FG004|STARTED|Overall Study||4
6790307|NCT00586924|7721963|FG005|STARTED|Overall Study||33
6790308|NCT00586924|7721958|FG000|COMPLETED|Overall Study||0
6790309|NCT00586924|7721959|FG001|COMPLETED|Overall Study||0
6790310|NCT00586924|7721960|FG002|COMPLETED|Overall Study||0
6563294|NCT01806597|7486254|FG005|NOT COMPLETED|Follow-up Period (Week 132 to Week 140)||12
6563295|NCT01806623|7486268|FG000|STARTED|Overall Study||157
6563296|NCT01806623|7486268|FG000|COMPLETED|Overall Study||99
6563297|NCT01806623|7486268|FG000|NOT COMPLETED|Overall Study||58
6563298|NCT01806662|7486272|FG000|STARTED|First Intervention (Weeks 0-16)||16
6563299|NCT01806662|7486273|FG001|STARTED|First Intervention (Weeks 0-16)||16
6563300|NCT01806662|7486272|FG000|Received Intervention|First Intervention (Weeks 0-16)||12
6563301|NCT01806662|7486273|FG001|Received Intervention|First Intervention (Weeks 0-16)||15
6563302|NCT01806662|7486272|FG000|COMPLETED|First Intervention (Weeks 0-16)||12
6563303|NCT01806662|7486273|FG001|COMPLETED|First Intervention (Weeks 0-16)||15
6563304|NCT01806662|7486272|FG000|NOT COMPLETED|First Intervention (Weeks 0-16)||4
6563305|NCT01806662|7486273|FG001|NOT COMPLETED|First Intervention (Weeks 0-16)||1
6563306|NCT01806662|7486272|FG000|STARTED|Second Intervention (Weeks 16-32)||12
6563307|NCT01806662|7486273|FG001|STARTED|Second Intervention (Weeks 16-32)||15
6563308|NCT01806662|7486272|FG000|COMPLETED|Second Intervention (Weeks 16-32)||10
6563309|NCT01806662|7486273|FG001|COMPLETED|Second Intervention (Weeks 16-32)||11
6563310|NCT01806662|7486272|FG000|NOT COMPLETED|Second Intervention (Weeks 16-32)||2
6790311|NCT00586924|7721961|FG003|COMPLETED|Overall Study||0
6790312|NCT00586924|7721962|FG004|COMPLETED|Overall Study||0
6790313|NCT00586924|7721963|FG005|COMPLETED|Overall Study||0
6790272|NCT00548093|7721900|FG000|STARTED|Overall Study||50
6790273|NCT00548093|7721901|FG001|STARTED|Overall Study||16
6790274|NCT00548093|7721900|FG000|COMPLETED|Overall Study||0
6790275|NCT00548093|7721901|FG001|COMPLETED|Overall Study||0
6790276|NCT00548093|7721900|FG000|NOT COMPLETED|Overall Study||50
6790277|NCT00548093|7721901|FG001|NOT COMPLETED|Overall Study||16
6790281|NCT00555009|7721918|FG000|STARTED|Overall Study||4
6790282|NCT00555009|7721919|FG001|STARTED|Overall Study||6
6790283|NCT00555009|7721918|FG000|COMPLETED|Overall Study||2
6790284|NCT00555009|7721919|FG001|COMPLETED|Overall Study||0
6790285|NCT00555009|7721918|FG000|NOT COMPLETED|Overall Study||2
6790286|NCT00555009|7721919|FG001|NOT COMPLETED|Overall Study||6
6790299|NCT00566995|7721948|FG000|STARTED|Overall Study||37
6790300|NCT00566995|7721948|FG000|COMPLETED|Overall Study||30
6790301|NCT00566995|7721948|FG000|NOT COMPLETED|Overall Study||7
6790314|NCT00586924|7721958|FG000|NOT COMPLETED|Overall Study||3
6790315|NCT00586924|7721959|FG001|NOT COMPLETED|Overall Study||3
6790316|NCT00586924|7721960|FG002|NOT COMPLETED|Overall Study||3
6790317|NCT00586924|7721961|FG003|NOT COMPLETED|Overall Study||3
6790318|NCT00586924|7721962|FG004|NOT COMPLETED|Overall Study||4
6790319|NCT00586924|7721963|FG005|NOT COMPLETED|Overall Study||33
6563311|NCT01806662|7486273|FG001|NOT COMPLETED|Second Intervention (Weeks 16-32)||4
6563312|NCT01806675|7486282|FG000|STARTED|Overall Study||11
6563313|NCT01806675|7486283|FG001|STARTED|Overall Study||6
6563314|NCT01806675|7486284|FG002|STARTED|Overall Study||8
6563315|NCT01806675|7486282|FG000|COMPLETED|Overall Study||11
6563316|NCT01806675|7486283|FG001|COMPLETED|Overall Study||6
6563317|NCT01806675|7486284|FG002|COMPLETED|Overall Study||8
6563318|NCT01806675|7486282|FG000|NOT COMPLETED|Overall Study||0
6563319|NCT01806675|7486283|FG001|NOT COMPLETED|Overall Study||0
6563320|NCT01806675|7486284|FG002|NOT COMPLETED|Overall Study||0
6563321|NCT01806688|7486294|FG000|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
6563322|NCT01806688|7486295|FG001|STARTED|First Intervention Seed Study|"Participants received one of the following:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
6563323|NCT01806688|7486294|FG000|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|13
6790320|NCT00588861|7721979|FG000|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
6790321|NCT00588861|7721980|FG001|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
6790322|NCT00588861|7721979|FG000|COMPLETED|Pre-Operative||107
6790323|NCT00588861|7721980|FG001|COMPLETED|Pre-Operative||114
6790324|NCT00588861|7721979|FG000|NOT COMPLETED|Pre-Operative||95
6790325|NCT00588861|7721980|FG001|NOT COMPLETED|Pre-Operative||86
6790326|NCT00588861|7721979|FG000|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
6790327|NCT00588861|7721980|FG001|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
6790328|NCT00588861|7721979|FG000|COMPLETED|6 Months||9
6790329|NCT00588861|7721980|FG001|COMPLETED|6 Months||41
6790330|NCT00588861|7721979|FG000|NOT COMPLETED|6 Months||98
6790331|NCT00588861|7721980|FG001|NOT COMPLETED|6 Months||73
6790332|NCT00588861|7721979|FG000|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
6790333|NCT00588861|7721980|FG001|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
6790334|NCT00588861|7721979|FG000|COMPLETED|1 Year||18
6790335|NCT00588861|7721980|FG001|COMPLETED|1 Year||32
6790336|NCT00588861|7721979|FG000|NOT COMPLETED|1 Year||89
6790337|NCT00588861|7721980|FG001|NOT COMPLETED|1 Year||82
6790338|NCT00588861|7721979|FG000|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
6790339|NCT00588861|7721980|FG001|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
6790340|NCT00588861|7721979|FG000|COMPLETED|2 Years||15
6790341|NCT00588861|7721980|FG001|COMPLETED|2 Years||27
6790342|NCT00588861|7721979|FG000|NOT COMPLETED|2 Years||92
6790343|NCT00588861|7721980|FG001|NOT COMPLETED|2 Years||87
6790344|NCT00588861|7721979|FG000|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
6790345|NCT00588861|7721980|FG001|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
6790346|NCT00588861|7721979|FG000|COMPLETED|4 Years||16
6790347|NCT00588861|7721980|FG001|COMPLETED|4 Years||11
6790348|NCT00588861|7721979|FG000|NOT COMPLETED|4 Years||91
6790349|NCT00588861|7721980|FG001|NOT COMPLETED|4 Years||103
6790350|NCT00588861|7721979|FG000|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
6790351|NCT00588861|7721980|FG001|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
6790352|NCT00588861|7721979|FG000|COMPLETED|6 Years||3
6790353|NCT00588861|7721980|FG001|COMPLETED|6 Years||5
6790354|NCT00588861|7721979|FG000|NOT COMPLETED|6 Years||104
6790355|NCT00588861|7721980|FG001|NOT COMPLETED|6 Years||109
6790356|NCT00588861|7721979|FG000|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
6790357|NCT00588861|7721980|FG001|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
6790358|NCT00588861|7721979|FG000|COMPLETED|8 Years||2
6790359|NCT00588861|7721980|FG001|COMPLETED|8 Years||0
6790360|NCT00588861|7721979|FG000|NOT COMPLETED|8 Years||105
6790361|NCT00588861|7721980|FG001|NOT COMPLETED|8 Years||114
6790362|NCT00588861|7721979|FG000|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
6790363|NCT00588861|7721980|FG001|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
6790364|NCT00588861|7721979|FG000|COMPLETED|10 Years||0
6790365|NCT00588861|7721980|FG001|COMPLETED|10 Years||0
6790366|NCT00588861|7721979|FG000|NOT COMPLETED|10 Years||107
6790367|NCT00588861|7721980|FG001|NOT COMPLETED|10 Years||114
6790368|NCT04505722|7721988|FG000|STARTED|Overall Study||22174
6790369|NCT04505722|7721989|FG001|STARTED|Overall Study||22150
6790370|NCT04505722|7721988|FG000|Vaccinated|Overall Study||21898
6790371|NCT04505722|7721989|FG001|Vaccinated|Overall Study||21890
6790372|NCT04505722|7721988|FG000|Participants in Entire Double Blind Phase|Overall Study||21894
6790373|NCT04505722|7721989|FG001|Participants in Entire Double Blind Phase|Overall Study||21882
6790374|NCT04505722|7721988|FG000|COMPLETED|Overall Study||0
6790375|NCT04505722|7721989|FG001|COMPLETED|Overall Study||0
6790376|NCT04505722|7721988|FG000|NOT COMPLETED|Overall Study||22174
6790377|NCT04505722|7721989|FG001|NOT COMPLETED|Overall Study||22150
6790378|NCT03400943|7721999|FG000|STARTED|Treatment Period 1||23
6790379|NCT03400943|7722000|FG001|STARTED|Treatment Period 1||23
6790380|NCT03400943|7722001|FG002|STARTED|Treatment Period 1||24
6790381|NCT03400943|7722002|FG003|STARTED|Treatment Period 1||23
6790382|NCT03400943|7721999|FG000|Treated|Treatment Period 1||18
6790383|NCT03400943|7722000|FG001|Treated|Treatment Period 1||21
6790384|NCT03400943|7722001|FG002|Treated|Treatment Period 1||20
6790385|NCT03400943|7722002|FG003|Treated|Treatment Period 1||20
6790386|NCT03400943|7721999|FG000|COMPLETED|Treatment Period 1||18
6790387|NCT03400943|7722000|FG001|COMPLETED|Treatment Period 1||21
6790388|NCT03400943|7722001|FG002|COMPLETED|Treatment Period 1||18
6790389|NCT03400943|7722002|FG003|COMPLETED|Treatment Period 1||18
6790390|NCT03400943|7721999|FG000|NOT COMPLETED|Treatment Period 1||5
6790391|NCT03400943|7722000|FG001|NOT COMPLETED|Treatment Period 1||2
6790392|NCT03400943|7722001|FG002|NOT COMPLETED|Treatment Period 1||6
6790393|NCT03400943|7722002|FG003|NOT COMPLETED|Treatment Period 1||5
6790394|NCT03400943|7721999|FG000|STARTED|Post-treatment Period 1||18
6790395|NCT03400943|7722000|FG001|STARTED|Post-treatment Period 1||0
6790396|NCT03400943|7722001|FG002|STARTED|Post-treatment Period 1||18
6790397|NCT03400943|7722002|FG003|STARTED|Post-treatment Period 1||18
6790398|NCT03400943|7721999|FG000|COMPLETED|Post-treatment Period 1||7
6790399|NCT03400943|7722000|FG001|COMPLETED|Post-treatment Period 1||0
6790400|NCT03400943|7722001|FG002|COMPLETED|Post-treatment Period 1||7
6790401|NCT03400943|7722002|FG003|COMPLETED|Post-treatment Period 1||5
6790402|NCT03400943|7721999|FG000|NOT COMPLETED|Post-treatment Period 1||11
6790403|NCT03400943|7722000|FG001|NOT COMPLETED|Post-treatment Period 1||0
6790404|NCT03400943|7722001|FG002|NOT COMPLETED|Post-treatment Period 1||11
6563324|NCT01806688|7486295|FG001|Experimental Snack #1|First Intervention Seed Study|Received experimental snack #1 at the first visit, a 30g serving of buckwheat groats|0
6563325|NCT01806688|7486294|FG000|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|13
6563326|NCT01806688|7486295|FG001|Placebo Comparator Reference Product #1|First Intervention Seed Study|Received the placebo comparator reference product #1 at the first visit, a 32g serving of corn nuts|0
6563327|NCT01806688|7486294|FG000|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|12
6790405|NCT03400943|7722002|FG003|NOT COMPLETED|Post-treatment Period 1||13
6790406|NCT03400943|7721999|FG000|STARTED|Treatment Period 2||7
6790407|NCT03400943|7722000|FG001|STARTED|Treatment Period 2||21
6790408|NCT03400943|7722001|FG002|STARTED|Treatment Period 2||7
6790409|NCT03400943|7722002|FG003|STARTED|Treatment Period 2||5
6790410|NCT03400943|7721999|FG000|COMPLETED|Treatment Period 2||6
6790411|NCT03400943|7722000|FG001|COMPLETED|Treatment Period 2||13
6790412|NCT03400943|7722001|FG002|COMPLETED|Treatment Period 2||7
6790413|NCT03400943|7722002|FG003|COMPLETED|Treatment Period 2||5
6790414|NCT03400943|7721999|FG000|NOT COMPLETED|Treatment Period 2||1
6790415|NCT03400943|7722000|FG001|NOT COMPLETED|Treatment Period 2||8
6790416|NCT03400943|7722001|FG002|NOT COMPLETED|Treatment Period 2||0
6790417|NCT03400943|7722002|FG003|NOT COMPLETED|Treatment Period 2||0
6790418|NCT03400943|7721999|FG000|STARTED|Follow-up Period||7
6790419|NCT03400943|7722000|FG001|STARTED|Follow-up Period||15
6790420|NCT03400943|7722001|FG002|STARTED|Follow-up Period||7
6790421|NCT03400943|7722002|FG003|STARTED|Follow-up Period||5
6790422|NCT03400943|7721999|FG000|COMPLETED|Follow-up Period||6
6790423|NCT03400943|7722000|FG001|COMPLETED|Follow-up Period||15
6790424|NCT03400943|7722001|FG002|COMPLETED|Follow-up Period||7
6790425|NCT03400943|7722002|FG003|COMPLETED|Follow-up Period||5
6790426|NCT03400943|7721999|FG000|NOT COMPLETED|Follow-up Period||1
6790427|NCT03400943|7722000|FG001|NOT COMPLETED|Follow-up Period||0
6790428|NCT03400943|7722001|FG002|NOT COMPLETED|Follow-up Period||0
6790429|NCT03400943|7722002|FG003|NOT COMPLETED|Follow-up Period||0
6790430|NCT03288142|7722016|FG000|STARTED|Overall Study||166
6563328|NCT01806688|7486295|FG001|Placebo Comparator Non-caloric Control #1|First Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at the first visit|0
6790431|NCT03288142|7722017|FG001|STARTED|Overall Study||167
6790432|NCT03288142|7722016|FG000|COMPLETED|Overall Study||144
6790433|NCT03288142|7722017|FG001|COMPLETED|Overall Study||152
6790434|NCT03288142|7722016|FG000|NOT COMPLETED|Overall Study||22
6790435|NCT03288142|7722017|FG001|NOT COMPLETED|Overall Study||15
6790436|NCT03112603|7722027|FG000|STARTED|End of Randomization Period||165
6790437|NCT03112603|7722028|FG001|STARTED|End of Randomization Period||164
6790438|NCT03112603|7722029|FG002|STARTED|End of Randomization Period||0
6790439|NCT03112603|7722027|FG000|COMPLETED|End of Randomization Period||0
6790440|NCT03112603|7722028|FG001|COMPLETED|End of Randomization Period||0
6790441|NCT03112603|7722029|FG002|COMPLETED|End of Randomization Period||0
6790442|NCT03112603|7722027|FG000|NOT COMPLETED|End of Randomization Period||165
6790443|NCT03112603|7722028|FG001|NOT COMPLETED|End of Randomization Period||164
6790444|NCT03112603|7722029|FG002|NOT COMPLETED|End of Randomization Period||0
6790445|NCT03112603|7722027|FG000|STARTED|End of Cross Over Period||0
6790446|NCT03112603|7722028|FG001|STARTED|End of Cross Over Period||0
6790447|NCT03112603|7722029|FG002|STARTED|End of Cross Over Period||61
6790448|NCT03112603|7722027|FG000|COMPLETED|End of Cross Over Period||0
6790449|NCT03112603|7722028|FG001|COMPLETED|End of Cross Over Period||0
6790450|NCT03112603|7722029|FG002|COMPLETED|End of Cross Over Period||0
6790451|NCT03112603|7722027|FG000|NOT COMPLETED|End of Cross Over Period||0
6790452|NCT03112603|7722028|FG001|NOT COMPLETED|End of Cross Over Period||0
6790453|NCT03112603|7722029|FG002|NOT COMPLETED|End of Cross Over Period||61
6790454|NCT02949934|7722041|FG000|STARTED|Natural Drinking Period||16
6790455|NCT02949934|7722042|FG001|STARTED|Natural Drinking Period||12
6790456|NCT02949934|7722043|FG002|STARTED|Natural Drinking Period||17
6790457|NCT02949934|7722044|FG003|STARTED|Natural Drinking Period||16
6790458|NCT02949934|7722045|FG004|STARTED|Natural Drinking Period||15
6790459|NCT02949934|7722046|FG005|STARTED|Natural Drinking Period||14
6790460|NCT02949934|7722041|FG000|COMPLETED|Natural Drinking Period||15
6790461|NCT02949934|7722042|FG001|COMPLETED|Natural Drinking Period||12
6790462|NCT02949934|7722043|FG002|COMPLETED|Natural Drinking Period||17
6790463|NCT02949934|7722044|FG003|COMPLETED|Natural Drinking Period||15
6790464|NCT02949934|7722045|FG004|COMPLETED|Natural Drinking Period||14
6790465|NCT02949934|7722046|FG005|COMPLETED|Natural Drinking Period||14
6790466|NCT02949934|7722041|FG000|NOT COMPLETED|Natural Drinking Period||1
6790467|NCT02949934|7722042|FG001|NOT COMPLETED|Natural Drinking Period||0
6790468|NCT02949934|7722043|FG002|NOT COMPLETED|Natural Drinking Period||0
6790469|NCT02949934|7722044|FG003|NOT COMPLETED|Natural Drinking Period||1
6790470|NCT02949934|7722045|FG004|NOT COMPLETED|Natural Drinking Period||1
6790471|NCT02949934|7722046|FG005|NOT COMPLETED|Natural Drinking Period||0
6790472|NCT02949934|7722041|FG000|STARTED|Neuroimaging||15
6790473|NCT02949934|7722042|FG001|STARTED|Neuroimaging||12
6790474|NCT02949934|7722043|FG002|STARTED|Neuroimaging||17
6790475|NCT02949934|7722044|FG003|STARTED|Neuroimaging||15
6790476|NCT02949934|7722045|FG004|STARTED|Neuroimaging||14
6790477|NCT02949934|7722046|FG005|STARTED|Neuroimaging||14
6790478|NCT02949934|7722041|FG000|COMPLETED|Neuroimaging||12
6790479|NCT02949934|7722042|FG001|COMPLETED|Neuroimaging||12
6790480|NCT02949934|7722043|FG002|COMPLETED|Neuroimaging||15
6790481|NCT02949934|7722044|FG003|COMPLETED|Neuroimaging||15
6790482|NCT02949934|7722045|FG004|COMPLETED|Neuroimaging||12
6790483|NCT02949934|7722046|FG005|COMPLETED|Neuroimaging||12
6790484|NCT02949934|7722041|FG000|NOT COMPLETED|Neuroimaging||3
6790485|NCT02949934|7722042|FG001|NOT COMPLETED|Neuroimaging||0
6790486|NCT02949934|7722043|FG002|NOT COMPLETED|Neuroimaging||2
6790487|NCT02949934|7722044|FG003|NOT COMPLETED|Neuroimaging||0
6790488|NCT02949934|7722045|FG004|NOT COMPLETED|Neuroimaging||2
6790489|NCT02949934|7722046|FG005|NOT COMPLETED|Neuroimaging||2
6790490|NCT02949934|7722041|FG000|STARTED|Bar Laboratory||15
6790491|NCT02949934|7722042|FG001|STARTED|Bar Laboratory||12
6790492|NCT02949934|7722043|FG002|STARTED|Bar Laboratory||17
6790493|NCT02949934|7722044|FG003|STARTED|Bar Laboratory||15
6790494|NCT02949934|7722045|FG004|STARTED|Bar Laboratory||14
6790495|NCT02949934|7722046|FG005|STARTED|Bar Laboratory||14
6790496|NCT02949934|7722041|FG000|COMPLETED|Bar Laboratory||14
6790497|NCT02949934|7722042|FG001|COMPLETED|Bar Laboratory||7
6790498|NCT02949934|7722043|FG002|COMPLETED|Bar Laboratory||10
6790499|NCT02949934|7722044|FG003|COMPLETED|Bar Laboratory||11
6790500|NCT02949934|7722045|FG004|COMPLETED|Bar Laboratory||8
6790501|NCT02949934|7722046|FG005|COMPLETED|Bar Laboratory||13
6790502|NCT02949934|7722041|FG000|NOT COMPLETED|Bar Laboratory||1
6790503|NCT02949934|7722042|FG001|NOT COMPLETED|Bar Laboratory||5
6790504|NCT02949934|7722043|FG002|NOT COMPLETED|Bar Laboratory||7
6790505|NCT02949934|7722044|FG003|NOT COMPLETED|Bar Laboratory||4
6790506|NCT02949934|7722045|FG004|NOT COMPLETED|Bar Laboratory||6
6790507|NCT02949934|7722046|FG005|NOT COMPLETED|Bar Laboratory||1
6790508|NCT02908672|7722062|FG000|STARTED|Overall Study||258
6790509|NCT02908672|7722063|FG001|STARTED|Overall Study||256
6790510|NCT02908672|7722062|FG000|COMPLETED|Overall Study||0
6790511|NCT02908672|7722063|FG001|COMPLETED|Overall Study||0
6790512|NCT02908672|7722062|FG000|NOT COMPLETED|Overall Study||258
6790513|NCT02908672|7722063|FG001|NOT COMPLETED|Overall Study||256
6790514|NCT02767570|7722071|FG000|STARTED|Overall Study||34
6790515|NCT02767570|7722072|FG001|STARTED|Overall Study||34
6790516|NCT02767570|7722071|FG000|Per Protocol Week 6|Overall Study||31
6790517|NCT02767570|7722072|FG001|Per Protocol Week 6|Overall Study||33
6790518|NCT02767570|7722071|FG000|COMPLETED|Overall Study||25
6790519|NCT02767570|7722072|FG001|COMPLETED|Overall Study||24
6790520|NCT02767570|7722071|FG000|NOT COMPLETED|Overall Study||9
6790521|NCT02767570|7722072|FG001|NOT COMPLETED|Overall Study||10
6790522|NCT02743494|7722080|FG000|STARTED|Pre-treatment Period||532
6790523|NCT02743494|7722081|FG001|STARTED|Pre-treatment Period||262
6790524|NCT02743494|7722080|FG000|COMPLETED|Pre-treatment Period||532
6790525|NCT02743494|7722081|FG001|COMPLETED|Pre-treatment Period||260
6790526|NCT02743494|7722080|FG000|NOT COMPLETED|Pre-treatment Period||0
6790527|NCT02743494|7722081|FG001|NOT COMPLETED|Pre-treatment Period||2
6790528|NCT02743494|7722080|FG000|STARTED|Treatment Period||532
6790529|NCT02743494|7722081|FG001|STARTED|Treatment Period||260
6790530|NCT02743494|7722080|FG000|COMPLETED|Treatment Period||31
6790531|NCT02743494|7722081|FG001|COMPLETED|Treatment Period||19
6790532|NCT02743494|7722080|FG000|NOT COMPLETED|Treatment Period||501
6790533|NCT02743494|7722081|FG001|NOT COMPLETED|Treatment Period||241
6790534|NCT02702180|7722090|FG000|STARTED|Double-blind Treatment Period||46
6790535|NCT02702180|7722091|FG001|STARTED|Double-blind Treatment Period||45
6790536|NCT02702180|7722092|FG002|STARTED|Double-blind Treatment Period||47
6790537|NCT02702180|7722090|FG000|COMPLETED|Double-blind Treatment Period||45
6790538|NCT02702180|7722091|FG001|COMPLETED|Double-blind Treatment Period||44
6790539|NCT02702180|7722092|FG002|COMPLETED|Double-blind Treatment Period||43
6790540|NCT02702180|7722090|FG000|NOT COMPLETED|Double-blind Treatment Period||1
6790541|NCT02702180|7722091|FG001|NOT COMPLETED|Double-blind Treatment Period||1
6790542|NCT02702180|7722092|FG002|NOT COMPLETED|Double-blind Treatment Period||4
6563329|NCT01806688|7486294|FG000|COMPLETED|First Intervention Seed Study||38
6563330|NCT01806688|7486295|FG001|COMPLETED|First Intervention Seed Study||0
6563331|NCT01806688|7486294|FG000|NOT COMPLETED|First Intervention Seed Study||0
6790543|NCT02702180|7722090|FG000|STARTED|Open-label Treatment Period||45
6790544|NCT02702180|7722091|FG001|STARTED|Open-label Treatment Period||43
6790545|NCT02702180|7722092|FG002|STARTED|Open-label Treatment Period||43
6790546|NCT02702180|7722090|FG000|COMPLETED|Open-label Treatment Period||45
6790547|NCT02702180|7722091|FG001|COMPLETED|Open-label Treatment Period||42
6790548|NCT02702180|7722092|FG002|COMPLETED|Open-label Treatment Period||41
6790549|NCT02702180|7722090|FG000|NOT COMPLETED|Open-label Treatment Period||0
6790550|NCT02702180|7722091|FG001|NOT COMPLETED|Open-label Treatment Period||1
6790551|NCT02702180|7722092|FG002|NOT COMPLETED|Open-label Treatment Period||2
6790552|NCT02545049|7722103|FG000|STARTED|Overall Study||3723
6790553|NCT02545049|7722104|FG001|STARTED|Overall Study||3714
6790554|NCT02545049|7722103|FG000|Treated|Overall Study||3683
6790555|NCT02545049|7722104|FG001|Treated|Overall Study||3658
6790556|NCT02545049|7722103|FG000|Included in FAS|Overall Study||3686
6790557|NCT02545049|7722104|FG001|Included in FAS|Overall Study||3666
6790558|NCT02545049|7722103|FG000|COMPLETED|Overall Study||3681
6790559|NCT02545049|7722104|FG001|COMPLETED|Overall Study||3653
6790560|NCT02545049|7722103|FG000|NOT COMPLETED|Overall Study||42
6790561|NCT02545049|7722104|FG001|NOT COMPLETED|Overall Study||61
6563332|NCT01806688|7486295|FG001|NOT COMPLETED|First Intervention Seed Study||0
6563333|NCT01806688|7486294|FG000|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|38
6623408|NCT02207556|7550534|FG001|NOT COMPLETED|Overall Study||5
6656390|NCT02460978|7586557|FG001|COMPLETED|Overall Study||245
6656391|NCT02460978|7586558|FG002|COMPLETED|Overall Study||239
6790562|NCT02488759|7722116|FG000|STARTED|Overall Study||113
6790563|NCT02488759|7722117|FG001|STARTED|Overall Study||195
6790564|NCT02488759|7722118|FG002|STARTED|Overall Study||133
6790565|NCT02488759|7722119|FG003|STARTED|Overall Study||8
6790566|NCT02488759|7722120|FG004|STARTED|Overall Study||6
6790567|NCT02488759|7722121|FG005|STARTED|Overall Study||123
6790568|NCT02488759|7722116|FG000|COMPLETED|Overall Study||2
6790569|NCT02488759|7722117|FG001|COMPLETED|Overall Study||0
6790570|NCT02488759|7722118|FG002|COMPLETED|Overall Study||2
6790571|NCT02488759|7722119|FG003|COMPLETED|Overall Study||0
6790572|NCT02488759|7722120|FG004|COMPLETED|Overall Study||0
6790573|NCT02488759|7722121|FG005|COMPLETED|Overall Study||0
6790574|NCT02488759|7722116|FG000|NOT COMPLETED|Overall Study||111
6790575|NCT02488759|7722117|FG001|NOT COMPLETED|Overall Study||195
6790576|NCT02488759|7722118|FG002|NOT COMPLETED|Overall Study||131
6790577|NCT02488759|7722119|FG003|NOT COMPLETED|Overall Study||8
6790578|NCT02488759|7722120|FG004|NOT COMPLETED|Overall Study||6
6790579|NCT02488759|7722121|FG005|NOT COMPLETED|Overall Study||123
6563334|NCT01806688|7486295|FG001|STARTED|Second Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product #1, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control #1, water"|0
6563335|NCT01806688|7486294|FG000|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|13
6563336|NCT01806688|7486295|FG001|Experimental Snack #1|Second Intervention Seed Study|Received the experimental snack #1, a 30g serving of buckwheat groats at visit 2|0
6563337|NCT01806688|7486294|FG000|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|13
6790580|NCT02448381|7722137|FG000|STARTED|Overall Study||118
6790581|NCT02448381|7722138|FG001|STARTED|Overall Study||51
6790582|NCT02448381|7722137|FG000|Randomized, Not Treated|Overall Study||2
6790583|NCT02448381|7722138|FG001|Randomized, Not Treated|Overall Study||1
6790584|NCT02448381|7722137|FG000|Cycle 1|Overall Study||116
6790585|NCT02448381|7722138|FG001|Cycle 1|Overall Study||50
6790586|NCT02448381|7722137|FG000|Cycle 2|Overall Study||110
6790587|NCT02448381|7722138|FG001|Cycle 2|Overall Study||45
6790588|NCT02448381|7722137|FG000|Cycle 3|Overall Study||78
6790589|NCT02448381|7722138|FG001|Cycle 3|Overall Study||32
6790590|NCT02448381|7722137|FG000|Follow-up Period|Overall Study||98
6790591|NCT02448381|7722138|FG001|Follow-up Period|Overall Study||39
6790592|NCT02448381|7722137|FG000|COMPLETED|Overall Study||83
6790593|NCT02448381|7722138|FG001|COMPLETED|Overall Study||32
6790594|NCT02448381|7722137|FG000|NOT COMPLETED|Overall Study||35
6790595|NCT02448381|7722138|FG001|NOT COMPLETED|Overall Study||19
6790596|NCT02151981|7722152|FG000|STARTED|Overall Study||279
6790597|NCT02151981|7722153|FG001|STARTED|Overall Study||140
6790598|NCT02151981|7722152|FG000|Received Randomised Treatment Only|Overall Study||279
6790599|NCT02151981|7722153|FG001|Received Randomised Treatment Only|Overall Study||136
6790600|NCT02151981|7722152|FG000|Did Not Receive Treatment|Overall Study||0
6790601|NCT02151981|7722153|FG001|Did Not Receive Treatment|Overall Study||4
6790602|NCT02151981|7722152|FG000|Crossed Over Osimertinib|Overall Study||0
6790603|NCT02151981|7722153|FG001|Crossed Over Osimertinib|Overall Study|Patients randomised to chemotherapy were allowed to crossover to Osimertinib after progression|99
6790604|NCT02151981|7722152|FG000|COMPLETED|Overall Study||0
6790605|NCT02151981|7722153|FG001|COMPLETED|Overall Study||0
6790606|NCT02151981|7722152|FG000|NOT COMPLETED|Overall Study||279
6790607|NCT02151981|7722153|FG001|NOT COMPLETED|Overall Study||140
6790608|NCT01972217|7722163|FG000|STARTED|Part A: Open-label Safety Run-in Period||3
6790609|NCT01972217|7722164|FG001|STARTED|Part A: Open-label Safety Run-in Period||13
6790610|NCT01972217|7722165|FG002|STARTED|Part A: Open-label Safety Run-in Period||0
6790611|NCT01972217|7722166|FG003|STARTED|Part A: Open-label Safety Run-in Period||0
6790612|NCT01972217|7722163|FG000|COMPLETED|Part A: Open-label Safety Run-in Period||2
6790613|NCT01972217|7722164|FG001|COMPLETED|Part A: Open-label Safety Run-in Period||1
6790614|NCT01972217|7722165|FG002|COMPLETED|Part A: Open-label Safety Run-in Period||0
6790615|NCT01972217|7722166|FG003|COMPLETED|Part A: Open-label Safety Run-in Period||0
6790616|NCT01972217|7722163|FG000|NOT COMPLETED|Part A: Open-label Safety Run-in Period||1
6790617|NCT01972217|7722164|FG001|NOT COMPLETED|Part A: Open-label Safety Run-in Period||12
6790618|NCT01972217|7722165|FG002|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
6790619|NCT01972217|7722166|FG003|NOT COMPLETED|Part A: Open-label Safety Run-in Period||0
6790620|NCT01972217|7722163|FG000|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
6790621|NCT01972217|7722164|FG001|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part A did not participate in Part B.|0
6790622|NCT01972217|7722165|FG002|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
6790623|NCT01972217|7722166|FG003|STARTED|Part B Double-blind, Randomised Period|Patients recruited to Part B did not participate in Part A.|71
6790624|NCT01972217|7722163|FG000|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
6790625|NCT01972217|7722164|FG001|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||0
6790626|NCT01972217|7722165|FG002|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
6790627|NCT01972217|7722166|FG003|Received Olaparib/Placebo|Part B Double-blind, Randomised Period||71
6790628|NCT01972217|7722163|FG000|Received Abiraterone|Part B Double-blind, Randomised Period||0
6563338|NCT01806688|7486295|FG001|Placebo Comparator Reference Product #1|Second Intervention Seed Study|Received the Placebo comparator reference product #1, a 32g serving of corn nuts at visit 2|0
6563339|NCT01806688|7486294|FG000|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|12
6563340|NCT01806688|7486295|FG001|Placebo Comparator Non-caloric Control #1|Second Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 2|0
6563341|NCT01806688|7486294|FG000|COMPLETED|Second Intervention Seed Study||38
6563342|NCT01806688|7486295|FG001|COMPLETED|Second Intervention Seed Study||0
6563343|NCT01806688|7486294|FG000|NOT COMPLETED|Second Intervention Seed Study||0
6563344|NCT01806688|7486295|FG001|NOT COMPLETED|Second Intervention Seed Study||0
6563345|NCT01806688|7486294|FG000|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|38
6563346|NCT01806688|7486295|FG001|STARTED|Third Intervention Seed Study|"Participants received one of the following they hadn't previously received at visit 1 or visit 2:~experimental snack #1 gluten-free high protein snack a 30 g serving of buckwheat groats~placebo comparator reference product, a gluten-free snack with similar energy density but 1/2 the protein as the experimental snack, a 32g serving of corn nuts~placebo comparator non-caloric control water"|0
6563347|NCT01806688|7486294|FG000|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|12
6563348|NCT01806688|7486295|FG001|Experimental Snack #1|Third Intervention Seed Study|Received the Experimental snack #1, a 30g serving of buckwheat groats at visit 3|0
6563349|NCT01806688|7486294|FG000|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|12
6563350|NCT01806688|7486295|FG001|Placebo Comparator Reference Product #1|Third Intervention Seed Study|Received the placebo comparator reference product #1, a 32g serving of corn nuts at visit 3|0
6563351|NCT01806688|7486294|FG000|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|14
6563352|NCT01806688|7486295|FG001|Placebo Comparator Non-caloric Control #1|Third Intervention Seed Study|Received water, the placebo comparator non-caloric control #1 at visit 3|0
6563353|NCT01806688|7486294|FG000|COMPLETED|Third Intervention Seed Study||38
6563354|NCT01806688|7486295|FG001|COMPLETED|Third Intervention Seed Study||0
6563355|NCT01806688|7486294|FG000|NOT COMPLETED|Third Intervention Seed Study||0
6563356|NCT01806688|7486295|FG001|NOT COMPLETED|Third Intervention Seed Study||0
6563357|NCT01806688|7486294|FG000|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
6563358|NCT01806688|7486295|FG001|STARTED|First Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
6563359|NCT01806688|7486294|FG000|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|0
6563360|NCT01806688|7486295|FG001|Experimental Snack #2|First Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the first visit|14
6656392|NCT02460978|7586556|FG000|NOT COMPLETED|Overall Study||27
6656393|NCT02460978|7586557|FG001|NOT COMPLETED|Overall Study||25
6790629|NCT01972217|7722164|FG001|Received Abiraterone|Part B Double-blind, Randomised Period||0
6790630|NCT01972217|7722165|FG002|Received Abiraterone|Part B Double-blind, Randomised Period||71
6790631|NCT01972217|7722166|FG003|Received Abiraterone|Part B Double-blind, Randomised Period||71
6790632|NCT01972217|7722163|FG000|COMPLETED|Part B Double-blind, Randomised Period||0
6790633|NCT01972217|7722164|FG001|COMPLETED|Part B Double-blind, Randomised Period||0
6790634|NCT01972217|7722165|FG002|COMPLETED|Part B Double-blind, Randomised Period||25
6790635|NCT01972217|7722166|FG003|COMPLETED|Part B Double-blind, Randomised Period||24
6790636|NCT01972217|7722163|FG000|NOT COMPLETED|Part B Double-blind, Randomised Period||0
6790637|NCT01972217|7722164|FG001|NOT COMPLETED|Part B Double-blind, Randomised Period||0
6790638|NCT01972217|7722165|FG002|NOT COMPLETED|Part B Double-blind, Randomised Period||46
6790639|NCT01972217|7722166|FG003|NOT COMPLETED|Part B Double-blind, Randomised Period||47
6790640|NCT01849874|7722180|FG000|STARTED|Overall Study||201
6790641|NCT01849874|7722181|FG001|STARTED|Overall Study||102
6790642|NCT01849874|7722180|FG000|Treated|Overall Study||200
6790643|NCT01849874|7722181|FG001|Treated|Overall Study||94
6790644|NCT01849874|7722180|FG000|COMPLETED|Overall Study||0
6790645|NCT01849874|7722181|FG001|COMPLETED|Overall Study||0
6790646|NCT01849874|7722180|FG000|NOT COMPLETED|Overall Study||201
6790647|NCT01849874|7722181|FG001|NOT COMPLETED|Overall Study||102
6790648|NCT01724866|7722191|FG000|STARTED|Overall Study||39
6790649|NCT01724866|7722192|FG001|STARTED|Overall Study||37
6790650|NCT01724866|7722193|FG002|STARTED|Overall Study||36
6790651|NCT01724866|7722194|FG003|STARTED|Overall Study||36
6790652|NCT01724866|7722191|FG000|Evaluable Population|Overall Study||39
6790653|NCT01724866|7722192|FG001|Evaluable Population|Overall Study||36
6790654|NCT01724866|7722193|FG002|Evaluable Population|Overall Study||36
6790655|NCT01724866|7722194|FG003|Evaluable Population|Overall Study||36
6790656|NCT01724866|7722191|FG000|COMPLETED|Overall Study||38
6790657|NCT01724866|7722192|FG001|COMPLETED|Overall Study||32
6790658|NCT01724866|7722193|FG002|COMPLETED|Overall Study||33
6790659|NCT01724866|7722194|FG003|COMPLETED|Overall Study||35
6790660|NCT01724866|7722191|FG000|NOT COMPLETED|Overall Study||1
6790661|NCT01724866|7722192|FG001|NOT COMPLETED|Overall Study||5
6790662|NCT01724866|7722193|FG002|NOT COMPLETED|Overall Study||3
6790663|NCT01724866|7722194|FG003|NOT COMPLETED|Overall Study||1
6790664|NCT01670877|7722208|FG000|STARTED|Part I and Part 2||16
6790665|NCT01670877|7722209|FG001|STARTED|Part I and Part 2||5
6790666|NCT01670877|7722210|FG002|STARTED|Part I and Part 2||11
6790667|NCT01670877|7722211|FG003|STARTED|Part I and Part 2||24
6790668|NCT01670877|7722212|FG004|STARTED|Part I and Part 2||0
6790669|NCT01670877|7722213|FG005|STARTED|Part I and Part 2||0
6790670|NCT01670877|7722208|FG000|COMPLETED|Part I and Part 2||16
6790671|NCT01670877|7722209|FG001|COMPLETED|Part I and Part 2||4
6790672|NCT01670877|7722210|FG002|COMPLETED|Part I and Part 2||10
6790673|NCT01670877|7722211|FG003|COMPLETED|Part I and Part 2||21
6790674|NCT01670877|7722212|FG004|COMPLETED|Part I and Part 2||0
6790675|NCT01670877|7722213|FG005|COMPLETED|Part I and Part 2||0
6790676|NCT01670877|7722208|FG000|NOT COMPLETED|Part I and Part 2||0
6790677|NCT01670877|7722209|FG001|NOT COMPLETED|Part I and Part 2||1
6790678|NCT01670877|7722210|FG002|NOT COMPLETED|Part I and Part 2||1
6790679|NCT01670877|7722211|FG003|NOT COMPLETED|Part I and Part 2||3
6790680|NCT01670877|7722212|FG004|NOT COMPLETED|Part I and Part 2||0
6790681|NCT01670877|7722213|FG005|NOT COMPLETED|Part I and Part 2||0
6790682|NCT01670877|7722208|FG000|STARTED|Crossover||0
6790683|NCT01670877|7722209|FG001|STARTED|Crossover||0
6790684|NCT01670877|7722210|FG002|STARTED|Crossover||0
6790685|NCT01670877|7722211|FG003|STARTED|Crossover||0
6790686|NCT01670877|7722212|FG004|STARTED|Crossover||3
6790687|NCT01670877|7722213|FG005|STARTED|Crossover||5
6790688|NCT01670877|7722208|FG000|COMPLETED|Crossover||0
6790689|NCT01670877|7722209|FG001|COMPLETED|Crossover||0
6790690|NCT01670877|7722210|FG002|COMPLETED|Crossover||0
6790691|NCT01670877|7722211|FG003|COMPLETED|Crossover||0
6790692|NCT01670877|7722212|FG004|COMPLETED|Crossover||3
6790693|NCT01670877|7722213|FG005|COMPLETED|Crossover||5
6790694|NCT01670877|7722208|FG000|NOT COMPLETED|Crossover||0
6790695|NCT01670877|7722209|FG001|NOT COMPLETED|Crossover||0
6790696|NCT01670877|7722210|FG002|NOT COMPLETED|Crossover||0
6790697|NCT01670877|7722211|FG003|NOT COMPLETED|Crossover||0
6790698|NCT01670877|7722212|FG004|NOT COMPLETED|Crossover||0
6790699|NCT01670877|7722213|FG005|NOT COMPLETED|Crossover||0
6790700|NCT01602380|7722229|FG000|STARTED|Overall Study||230
6790701|NCT01602380|7722230|FG001|STARTED|Overall Study||232
6790702|NCT01602380|7722229|FG000|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
6790703|NCT01602380|7722230|FG001|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
6790704|NCT01602380|7722229|FG000|NOT COMPLETED|Overall Study||93
6790705|NCT01602380|7722230|FG001|NOT COMPLETED|Overall Study||101
6790706|NCT01412333|7722238|FG000|STARTED|Overall Study||418
6790707|NCT01412333|7722239|FG001|STARTED|Overall Study||417
6790708|NCT01412333|7722238|FG000|COMPLETED|Overall Study||320
6790709|NCT01412333|7722239|FG001|COMPLETED|Overall Study||360
6790710|NCT01412333|7722238|FG000|NOT COMPLETED|Overall Study||98
6790711|NCT01412333|7722239|FG001|NOT COMPLETED|Overall Study||57
6790712|NCT01247324|7722248|FG000|STARTED|Overall Study||411
6790713|NCT01247324|7722249|FG001|STARTED|Overall Study||410
6790714|NCT01247324|7722248|FG000|COMPLETED|Overall Study||340
6790715|NCT01247324|7722249|FG001|COMPLETED|Overall Study||366
6790716|NCT01247324|7722248|FG000|NOT COMPLETED|Overall Study||71
6790717|NCT01247324|7722249|FG001|NOT COMPLETED|Overall Study||44
6790718|NCT00667628|7722258|FG000|STARTED|Overall Study||25
6790719|NCT00667628|7722259|FG001|STARTED|Overall Study||27
6790720|NCT00667628|7722258|FG000|COMPLETED|Overall Study||0
6790721|NCT00667628|7722259|FG001|COMPLETED|Overall Study||0
6790722|NCT00667628|7722258|FG000|NOT COMPLETED|Overall Study||25
6790723|NCT00667628|7722259|FG001|NOT COMPLETED|Overall Study||27
6790724|NCT04286529|7722269|FG000|STARTED|Overall Study||4
6790725|NCT04286529|7722270|FG001|STARTED|Overall Study||4
6790726|NCT04286529|7722271|FG002|STARTED|Overall Study||5
6790727|NCT04286529|7722272|FG003|STARTED|Overall Study||4
6790728|NCT04286529|7722269|FG000|COMPLETED|Overall Study||3
6790729|NCT04286529|7722270|FG001|COMPLETED|Overall Study||1
6790730|NCT04286529|7722271|FG002|COMPLETED|Overall Study||3
6790731|NCT04286529|7722272|FG003|COMPLETED|Overall Study||1
6790732|NCT04286529|7722269|FG000|NOT COMPLETED|Overall Study||1
6790733|NCT04286529|7722270|FG001|NOT COMPLETED|Overall Study||3
6790734|NCT04286529|7722271|FG002|NOT COMPLETED|Overall Study||2
6790735|NCT04286529|7722272|FG003|NOT COMPLETED|Overall Study||3
6790736|NCT03581786|7722284|FG000|STARTED|Overall Study||143
6790737|NCT03581786|7722285|FG001|STARTED|Overall Study||146
6790738|NCT03581786|7722284|FG000|COMPLETED|Overall Study||0
6790739|NCT03581786|7722285|FG001|COMPLETED|Overall Study||0
6790740|NCT03581786|7722284|FG000|NOT COMPLETED|Overall Study||143
6790741|NCT03581786|7722285|FG001|NOT COMPLETED|Overall Study||146
6790742|NCT03573518|7722295|FG000|STARTED|Overall Study||92
6790743|NCT03573518|7722296|FG001|STARTED|Overall Study||92
6790744|NCT03573518|7722297|FG002|STARTED|Overall Study||92
6790745|NCT03573518|7722298|FG003|STARTED|Overall Study||92
6790746|NCT03573518|7722295|FG000|COMPLETED|Overall Study||69
6790747|NCT03573518|7722296|FG001|COMPLETED|Overall Study||77
6790748|NCT03573518|7722297|FG002|COMPLETED|Overall Study||70
6790749|NCT03573518|7722298|FG003|COMPLETED|Overall Study||81
6790750|NCT03573518|7722295|FG000|NOT COMPLETED|Overall Study||23
6790751|NCT03573518|7722296|FG001|NOT COMPLETED|Overall Study||15
6790752|NCT03573518|7722297|FG002|NOT COMPLETED|Overall Study||22
6790753|NCT03573518|7722298|FG003|NOT COMPLETED|Overall Study||11
6790754|NCT03486314|7722308|FG000|STARTED|Part A||20
6790755|NCT03486314|7722309|FG001|STARTED|Part A||0
6790756|NCT03486314|7722310|FG002|STARTED|Part A||0
6790757|NCT03486314|7722308|FG000|COMPLETED|Part A||17
6790758|NCT03486314|7722309|FG001|COMPLETED|Part A||0
6790759|NCT03486314|7722310|FG002|COMPLETED|Part A||0
6790760|NCT03486314|7722308|FG000|NOT COMPLETED|Part A||3
6790761|NCT03486314|7722309|FG001|NOT COMPLETED|Part A||0
6790762|NCT03486314|7722310|FG002|NOT COMPLETED|Part A||0
6790763|NCT03486314|7722308|FG000|STARTED|Part B||0
6790764|NCT03486314|7722309|FG001|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|9
6790765|NCT03486314|7722310|FG002|STARTED|Part B|These are the participants who completed Part A, met eligibility criteria, and provided consent for Part B.|8
6790766|NCT03486314|7722308|FG000|COMPLETED|Part B||0
6790767|NCT03486314|7722309|FG001|COMPLETED|Part B||9
6790768|NCT03486314|7722310|FG002|COMPLETED|Part B||8
6790769|NCT03486314|7722308|FG000|NOT COMPLETED|Part B||0
6790770|NCT03486314|7722309|FG001|NOT COMPLETED|Part B||0
6790771|NCT03486314|7722310|FG002|NOT COMPLETED|Part B||0
6790772|NCT02988713|7722318|FG000|STARTED|Overall Study||35
6790773|NCT02988713|7722318|FG000|COMPLETED|Overall Study||32
6790774|NCT02988713|7722318|FG000|NOT COMPLETED|Overall Study||3
6790775|NCT02879448|7722324|FG000|STARTED|Overall Study||934
6790776|NCT02879448|7722325|FG001|STARTED|Overall Study||944
6790777|NCT02879448|7722324|FG000|COMPLETED|Overall Study||796
6790778|NCT02879448|7722325|FG001|COMPLETED|Overall Study||742
6790779|NCT02879448|7722324|FG000|NOT COMPLETED|Overall Study||138
6790780|NCT02879448|7722325|FG001|NOT COMPLETED|Overall Study||202
6790781|NCT02845453|7722333|FG000|STARTED|Overall Study||13
6790782|NCT02845453|7722334|FG001|STARTED|Overall Study||11
6790783|NCT02845453|7722333|FG000|Took One Dose of Study Medication|Overall Study||11
6790784|NCT02845453|7722334|FG001|Took One Dose of Study Medication|Overall Study||10
6790785|NCT02845453|7722333|FG000|Took One Week of Study Medication|Overall Study||10
6790786|NCT02845453|7722334|FG001|Took One Week of Study Medication|Overall Study||9
6790787|NCT02845453|7722333|FG000|COMPLETED|Overall Study||7
6790788|NCT02845453|7722334|FG001|COMPLETED|Overall Study||6
6790789|NCT02845453|7722333|FG000|NOT COMPLETED|Overall Study||6
6790790|NCT02845453|7722334|FG001|NOT COMPLETED|Overall Study||5
6790791|NCT02794883|7722343|FG000|STARTED|Pre-Surgical Treatment||12
6790792|NCT02794883|7722344|FG001|STARTED|Pre-Surgical Treatment||12
6790793|NCT02794883|7722345|FG002|STARTED|Pre-Surgical Treatment||12
6790794|NCT02794883|7722343|FG000|Registered for Study|Pre-Surgical Treatment||12
6790795|NCT02794883|7722344|FG001|Registered for Study|Pre-Surgical Treatment||12
6790796|NCT02794883|7722345|FG002|Registered for Study|Pre-Surgical Treatment||12
6790797|NCT02794883|7722343|FG000|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||12
6790798|NCT02794883|7722344|FG001|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
6790799|NCT02794883|7722345|FG002|Received First Dose (Pre-surgical Dose) of Study Drug|Pre-Surgical Treatment||11
6790800|NCT02794883|7722343|FG000|COMPLETED|Pre-Surgical Treatment||12
6790801|NCT02794883|7722344|FG001|COMPLETED|Pre-Surgical Treatment||11
6790802|NCT02794883|7722345|FG002|COMPLETED|Pre-Surgical Treatment||11
6790803|NCT02794883|7722343|FG000|NOT COMPLETED|Pre-Surgical Treatment||0
6790804|NCT02794883|7722344|FG001|NOT COMPLETED|Pre-Surgical Treatment||1
6790805|NCT02794883|7722345|FG002|NOT COMPLETED|Pre-Surgical Treatment||1
6790806|NCT02794883|7722343|FG000|STARTED|Post-Surgery Treatment (Adjuvant)||12
6790807|NCT02794883|7722344|FG001|STARTED|Post-Surgery Treatment (Adjuvant)||11
6790808|NCT02794883|7722345|FG002|STARTED|Post-Surgery Treatment (Adjuvant)||11
6790809|NCT02794883|7722343|FG000|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
6790810|NCT02794883|7722344|FG001|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||8
6790811|NCT02794883|7722345|FG002|Started Cycle 1|Post-Surgery Treatment (Adjuvant)||11
6790812|NCT02794883|7722343|FG000|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||7
6790813|NCT02794883|7722344|FG001|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||8
6790814|NCT02794883|7722345|FG002|Started Cycle 2|Post-Surgery Treatment (Adjuvant)||11
6790815|NCT02794883|7722343|FG000|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||3
6790816|NCT02794883|7722344|FG001|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||7
6790817|NCT02794883|7722345|FG002|Started Cycle 3|Post-Surgery Treatment (Adjuvant)||4
6790818|NCT02794883|7722343|FG000|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
6790819|NCT02794883|7722344|FG001|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||5
6790820|NCT02794883|7722345|FG002|Started Cycle 4|Post-Surgery Treatment (Adjuvant)||2
6790821|NCT02794883|7722343|FG000|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
6790822|NCT02794883|7722344|FG001|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||3
6790823|NCT02794883|7722345|FG002|Started Cycle 5|Post-Surgery Treatment (Adjuvant)||2
6790824|NCT02794883|7722343|FG000|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||0
6790825|NCT02794883|7722344|FG001|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||3
6790826|NCT02794883|7722345|FG002|Started Cycle 6|Post-Surgery Treatment (Adjuvant)||2
6790827|NCT02794883|7722343|FG000|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||0
6790828|NCT02794883|7722344|FG001|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||3
6790829|NCT02794883|7722345|FG002|Started Cycle 7|Post-Surgery Treatment (Adjuvant)||1
6378935|NCT00770601|7289476|FG000|NOT COMPLETED|Overall Study||1
6395532|NCT00858845|7308099|FG001|NOT COMPLETED|Overall Study||1
6395533|NCT00858858|7308105|FG000|STARTED|Overall Study||60
6395534|NCT00858858|7308105|FG000|COMPLETED|Overall Study||42
6395535|NCT00858858|7308105|FG000|NOT COMPLETED|Overall Study||18
6395536|NCT00858962|7308109|FG000|STARTED|Overall Study||12
6395537|NCT00858962|7308109|FG000|COMPLETED|Overall Study||12
6395538|NCT00858962|7308109|FG000|NOT COMPLETED|Overall Study||0
6395539|NCT00858988|7308115|FG000|STARTED|Randomized and Allocation||74
6395540|NCT00858988|7308116|FG001|STARTED|Randomized and Allocation||73
6395541|NCT00858988|7308115|FG000|COMPLETED|Randomized and Allocation||74
6395542|NCT00858988|7308116|FG001|COMPLETED|Randomized and Allocation||73
6395543|NCT00858988|7308115|FG000|NOT COMPLETED|Randomized and Allocation||0
6395544|NCT00858988|7308116|FG001|NOT COMPLETED|Randomized and Allocation||0
6395545|NCT00858988|7308115|FG000|STARTED|Analysis||74
6395546|NCT00858988|7308116|FG001|STARTED|Analysis||73
6395547|NCT00858988|7308115|FG000|COMPLETED|Analysis||72
6395548|NCT00858988|7308116|FG001|COMPLETED|Analysis||72
6395549|NCT00858988|7308115|FG000|NOT COMPLETED|Analysis||2
6790830|NCT02794883|7722343|FG000|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||0
6790831|NCT02794883|7722344|FG001|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||3
6790832|NCT02794883|7722345|FG002|Started Cycle 8|Post-Surgery Treatment (Adjuvant)||1
6790833|NCT02794883|7722343|FG000|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||0
6790834|NCT02794883|7722344|FG001|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||3
6790835|NCT02794883|7722345|FG002|Started Cycle 9|Post-Surgery Treatment (Adjuvant)||1
6790836|NCT02794883|7722343|FG000|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||0
6790837|NCT02794883|7722344|FG001|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||2
6790838|NCT02794883|7722345|FG002|Started Cycle 10|Post-Surgery Treatment (Adjuvant)||1
6790839|NCT02794883|7722343|FG000|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||0
6790840|NCT02794883|7722344|FG001|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||2
6790841|NCT02794883|7722345|FG002|Started Cycle 11|Post-Surgery Treatment (Adjuvant)||1
6790842|NCT02794883|7722343|FG000|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||0
6790843|NCT02794883|7722344|FG001|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
6790844|NCT02794883|7722345|FG002|Started Cycle 12|Post-Surgery Treatment (Adjuvant)||1
6790845|NCT02794883|7722343|FG000|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||0
6790846|NCT02794883|7722344|FG001|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
6790847|NCT02794883|7722345|FG002|Started Cycle 13|Post-Surgery Treatment (Adjuvant)||1
6395550|NCT00858988|7308116|FG001|NOT COMPLETED|Analysis||1
6395551|NCT00859014|7308122|FG000|STARTED|Overall Study||25
6395552|NCT00859014|7308122|FG000|COMPLETED|Overall Study||20
6395553|NCT00859014|7308122|FG000|NOT COMPLETED|Overall Study||5
6395554|NCT00859027|7308128|FG000|STARTED|Overall Study||25
6395555|NCT00859027|7308129|FG001|STARTED|Overall Study||25
6395556|NCT00859027|7308128|FG000|COMPLETED|Overall Study||20
6395557|NCT00859027|7308129|FG001|COMPLETED|Overall Study||20
6395558|NCT00859027|7308128|FG000|NOT COMPLETED|Overall Study||5
6395559|NCT00859027|7308129|FG001|NOT COMPLETED|Overall Study||5
6395560|NCT00859040|7308137|FG000|STARTED|Overall Study||18
6395561|NCT00859040|7308138|FG001|STARTED|Overall Study||16
6395562|NCT00859040|7308137|FG000|COMPLETED|Overall Study||18
6395563|NCT00859040|7308138|FG001|COMPLETED|Overall Study||16
6395564|NCT00859040|7308137|FG000|NOT COMPLETED|Overall Study||0
6395565|NCT00859040|7308138|FG001|NOT COMPLETED|Overall Study||0
6395566|NCT00859053|7308148|FG000|STARTED|Overall Study||6
6395567|NCT00859053|7308149|FG001|STARTED|Overall Study||6
6395568|NCT00859053|7308150|FG002|STARTED|Overall Study||6
6395569|NCT00859053|7308151|FG003|STARTED|Overall Study||12
6395570|NCT00859053|7308148|FG000|COMPLETED|Overall Study||6
6395571|NCT00859053|7308149|FG001|COMPLETED|Overall Study||6
6395572|NCT00859053|7308150|FG002|COMPLETED|Overall Study||6
6395573|NCT00859053|7308151|FG003|COMPLETED|Overall Study||12
6790848|NCT02794883|7722343|FG000|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||0
6790849|NCT02794883|7722344|FG001|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
6790850|NCT02794883|7722345|FG002|Started Cycle 14|Post-Surgery Treatment (Adjuvant)||1
6790851|NCT02794883|7722343|FG000|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
6790852|NCT02794883|7722344|FG001|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||0
6790853|NCT02794883|7722345|FG002|Started Cycle 15|Post-Surgery Treatment (Adjuvant)||1
6790854|NCT02794883|7722343|FG000|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
6790855|NCT02794883|7722344|FG001|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||0
6790856|NCT02794883|7722345|FG002|Started Cycle 16|Post-Surgery Treatment (Adjuvant)||1
6790857|NCT02794883|7722343|FG000|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
6378936|NCT00770653|7289482|FG000|STARTED|Overall Study||155
6790858|NCT02794883|7722344|FG001|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
6790859|NCT02794883|7722345|FG002|Started Cycle 17|Post-Surgery Treatment (Adjuvant)||0
6790860|NCT02794883|7722343|FG000|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
6790861|NCT02794883|7722344|FG001|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
6790862|NCT02794883|7722345|FG002|COMPLETED|Post-Surgery Treatment (Adjuvant)||0
6790863|NCT02794883|7722343|FG000|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||12
6790864|NCT02794883|7722344|FG001|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
6790865|NCT02794883|7722345|FG002|NOT COMPLETED|Post-Surgery Treatment (Adjuvant)||11
6790866|NCT02794883|7722343|FG000|STARTED|Follow-up Period (up to 2 Years)||12
6790867|NCT02794883|7722344|FG001|STARTED|Follow-up Period (up to 2 Years)||11
6790868|NCT02794883|7722345|FG002|STARTED|Follow-up Period (up to 2 Years)||11
6790869|NCT02794883|7722343|FG000|COMPLETED|Follow-up Period (up to 2 Years)||0
6790870|NCT02794883|7722344|FG001|COMPLETED|Follow-up Period (up to 2 Years)||1
6790871|NCT02794883|7722345|FG002|COMPLETED|Follow-up Period (up to 2 Years)||1
6790872|NCT02794883|7722343|FG000|NOT COMPLETED|Follow-up Period (up to 2 Years)||12
6790873|NCT02794883|7722344|FG001|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
6790874|NCT02794883|7722345|FG002|NOT COMPLETED|Follow-up Period (up to 2 Years)||10
6790875|NCT02677987|7722355|FG000|STARTED|Overall Study||23
6790876|NCT02677987|7722356|FG001|STARTED|Overall Study||24
6790877|NCT02677987|7722355|FG000|COMPLETED|Overall Study||19
6790878|NCT02677987|7722356|FG001|COMPLETED|Overall Study||24
6790879|NCT02677987|7722355|FG000|NOT COMPLETED|Overall Study||4
6790880|NCT02677987|7722356|FG001|NOT COMPLETED|Overall Study||0
6790881|NCT02659059|7722368|FG000|STARTED|Overall Study||288
6790882|NCT02659059|7722369|FG001|STARTED|Overall Study||36
6790883|NCT02659059|7722368|FG000|COMPLETED|Overall Study||88
6790884|NCT02659059|7722369|FG001|COMPLETED|Overall Study||4
6790885|NCT02659059|7722368|FG000|NOT COMPLETED|Overall Study||200
6790886|NCT02659059|7722369|FG001|NOT COMPLETED|Overall Study||32
6790887|NCT02337829|7722380|FG000|STARTED|Overall Study||18
6790888|NCT02337829|7722381|FG001|STARTED|Overall Study||14
6790889|NCT02337829|7722382|FG002|STARTED|Overall Study||6
6790890|NCT02337829|7722383|FG003|STARTED|Overall Study||10
6790891|NCT02337829|7722380|FG000|COMPLETED|Overall Study||0
6790892|NCT02337829|7722381|FG001|COMPLETED|Overall Study||0
6790893|NCT02337829|7722382|FG002|COMPLETED|Overall Study||0
6790894|NCT02337829|7722383|FG003|COMPLETED|Overall Study||0
6790895|NCT02337829|7722380|FG000|NOT COMPLETED|Overall Study||18
6790896|NCT02337829|7722381|FG001|NOT COMPLETED|Overall Study||14
6790897|NCT02337829|7722382|FG002|NOT COMPLETED|Overall Study||6
6790898|NCT02337829|7722383|FG003|NOT COMPLETED|Overall Study||10
6790899|NCT02258451|7722397|FG000|STARTED|Overall Study||142
6790900|NCT02258451|7722398|FG001|STARTED|Overall Study||141
6790901|NCT02258451|7722397|FG000|COMPLETED|Overall Study||0
6790902|NCT02258451|7722398|FG001|COMPLETED|Overall Study||0
6790903|NCT02258451|7722397|FG000|NOT COMPLETED|Overall Study||142
6790904|NCT02258451|7722398|FG001|NOT COMPLETED|Overall Study||141
6790905|NCT01928394|7722429|FG000|STARTED|Treatment Period||18
6790906|NCT01928394|7722430|FG001|STARTED|Treatment Period||3
6790907|NCT01928394|7722431|FG002|STARTED|Treatment Period||18
6790908|NCT01928394|7722432|FG003|STARTED|Treatment Period||59
6790909|NCT01928394|7722433|FG004|STARTED|Treatment Period||3
6790910|NCT01928394|7722434|FG005|STARTED|Treatment Period||49
6790911|NCT01928394|7722435|FG006|STARTED|Treatment Period||52
6790912|NCT01928394|7722436|FG007|STARTED|Treatment Period||18
6790913|NCT01928394|7722437|FG008|STARTED|Treatment Period||3
6790914|NCT01928394|7722438|FG009|STARTED|Treatment Period||18
6790915|NCT01928394|7722439|FG010|STARTED|Treatment Period||30
6790916|NCT01928394|7722440|FG011|STARTED|Treatment Period||98
6790917|NCT01928394|7722441|FG012|STARTED|Treatment Period||61
6790918|NCT01928394|7722442|FG013|STARTED|Treatment Period||147
6790919|NCT01928394|7722443|FG014|STARTED|Treatment Period||96
6790920|NCT01928394|7722444|FG015|STARTED|Treatment Period||3
6790921|NCT01928394|7722445|FG016|STARTED|Treatment Period||55
6790922|NCT01928394|7722446|FG017|STARTED|Treatment Period||78
6790923|NCT01928394|7722447|FG018|STARTED|Treatment Period||92
6790924|NCT01928394|7722448|FG019|STARTED|Treatment Period||104
6790925|NCT01928394|7722449|FG020|STARTED|Treatment Period||41
6790926|NCT01928394|7722450|FG021|STARTED|Treatment Period||43
6790927|NCT01928394|7722451|FG022|STARTED|Treatment Period||42
6790928|NCT01928394|7722429|FG000|Transition|Treatment Period||3
6790929|NCT01928394|7722430|FG001|Transition|Treatment Period||0
6790930|NCT01928394|7722431|FG002|Transition|Treatment Period||0
6790931|NCT01928394|7722432|FG003|Transition|Treatment Period||9
6378937|NCT00770653|7289483|FG001|STARTED|Overall Study||150
6790932|NCT01928394|7722433|FG004|Transition|Treatment Period||0
6790933|NCT01928394|7722434|FG005|Transition|Treatment Period||0
6790934|NCT01928394|7722435|FG006|Transition|Treatment Period||0
6790935|NCT01928394|7722436|FG007|Transition|Treatment Period||2
6790936|NCT01928394|7722437|FG008|Transition|Treatment Period||0
6790937|NCT01928394|7722438|FG009|Transition|Treatment Period||0
6790938|NCT01928394|7722439|FG010|Transition|Treatment Period||0
6563361|NCT01806688|7486294|FG000|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|0
6563362|NCT01806688|7486295|FG001|Placebo Comparator Reference Product #2|First Intervention Pita Study|Received the placebo comparator reference product #2 at the first visit, a 50g serving of rice bread|12
6563363|NCT01806688|7486294|FG000|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|0
6563364|NCT01806688|7486295|FG001|Placebo Comparator Non-caloric Control #2|First Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the first visit|12
6563365|NCT01806688|7486294|FG000|COMPLETED|First Intervention Pita Study||0
6563366|NCT01806688|7486295|FG001|COMPLETED|First Intervention Pita Study||38
6563367|NCT01806688|7486294|FG000|NOT COMPLETED|First Intervention Pita Study||0
6563368|NCT01806688|7486295|FG001|NOT COMPLETED|First Intervention Pita Study||0
6563369|NCT01806688|7486294|FG000|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|0
6563370|NCT01806688|7486295|FG001|STARTED|Second Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread~placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread~placebo comparator non-caloric control water"|38
6563371|NCT01806688|7486294|FG000|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|0
6563372|NCT01806688|7486295|FG001|Experimental Snack #2|Second Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the second visit|12
6790939|NCT01928394|7722440|FG011|Transition|Treatment Period||17
6790940|NCT01928394|7722441|FG012|Transition|Treatment Period||0
6790941|NCT01928394|7722442|FG013|Transition|Treatment Period||2
6790942|NCT01928394|7722443|FG014|Transition|Treatment Period||0
6790943|NCT01928394|7722444|FG015|Transition|Treatment Period||0
6790944|NCT01928394|7722445|FG016|Transition|Treatment Period||0
6563373|NCT01806688|7486294|FG000|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|0
6563374|NCT01806688|7486295|FG001|Placebo Comparator Reference Product #2|Second Intervention Pita Study|Received the placebo comparator reference product #2 at the second visit, a 50g serving of rice bread|13
6563375|NCT01806688|7486294|FG000|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|0
6563376|NCT01806688|7486295|FG001|Placebo Comparator Non-caloric Control #2|Second Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the second visit|13
6563377|NCT01806688|7486294|FG000|COMPLETED|Second Intervention Pita Study||0
6563378|NCT01806688|7486295|FG001|COMPLETED|Second Intervention Pita Study||38
6790945|NCT01928394|7722446|FG017|Transition|Treatment Period||20
6790946|NCT01928394|7722447|FG018|Transition|Treatment Period||0
6790947|NCT01928394|7722448|FG019|Transition|Treatment Period||0
6790948|NCT01928394|7722449|FG020|Transition|Treatment Period||0
6790949|NCT01928394|7722450|FG021|Transition|Treatment Period||0
6790950|NCT01928394|7722451|FG022|Transition|Treatment Period||0
6790951|NCT01928394|7722429|FG000|Transition- Continued|Treatment Period||0
6790952|NCT01928394|7722430|FG001|Transition- Continued|Treatment Period||0
6790953|NCT01928394|7722431|FG002|Transition- Continued|Treatment Period||3
6790954|NCT01928394|7722432|FG003|Transition- Continued|Treatment Period||0
6790955|NCT01928394|7722433|FG004|Transition- Continued|Treatment Period||0
6790956|NCT01928394|7722434|FG005|Transition- Continued|Treatment Period||3
6790957|NCT01928394|7722435|FG006|Transition- Continued|Treatment Period||6
6790958|NCT01928394|7722436|FG007|Transition- Continued|Treatment Period||0
6790959|NCT01928394|7722437|FG008|Transition- Continued|Treatment Period||1
6563379|NCT01806688|7486294|FG000|NOT COMPLETED|Second Intervention Pita Study||0
6790960|NCT01928394|7722438|FG009|Transition- Continued|Treatment Period||1
6790961|NCT01928394|7722439|FG010|Transition- Continued|Treatment Period||0
6790962|NCT01928394|7722440|FG011|Transition- Continued|Treatment Period||0
6790963|NCT01928394|7722441|FG012|Transition- Continued|Treatment Period||17
6790964|NCT01928394|7722442|FG013|Transition- Continued|Treatment Period||0
6790965|NCT01928394|7722443|FG014|Transition- Continued|Treatment Period||2
6790966|NCT01928394|7722444|FG015|Transition- Continued|Treatment Period||0
6790967|NCT01928394|7722445|FG016|Transition- Continued|Treatment Period||0
6790968|NCT01928394|7722446|FG017|Transition- Continued|Treatment Period||0
6790969|NCT01928394|7722447|FG018|Transition- Continued|Treatment Period||1
6790970|NCT01928394|7722448|FG019|Transition- Continued|Treatment Period||19
6790971|NCT01928394|7722449|FG020|Transition- Continued|Treatment Period||0
6790972|NCT01928394|7722450|FG021|Transition- Continued|Treatment Period||0
6790973|NCT01928394|7722451|FG022|Transition- Continued|Treatment Period||0
6790974|NCT01928394|7722429|FG000|COMPLETED|Treatment Period||0
6790975|NCT01928394|7722430|FG001|COMPLETED|Treatment Period||0
6790976|NCT01928394|7722431|FG002|COMPLETED|Treatment Period||0
6790977|NCT01928394|7722432|FG003|COMPLETED|Treatment Period||3
6790978|NCT01928394|7722433|FG004|COMPLETED|Treatment Period||0
6790979|NCT01928394|7722434|FG005|COMPLETED|Treatment Period||6
6790980|NCT01928394|7722435|FG006|COMPLETED|Treatment Period||3
6790981|NCT01928394|7722436|FG007|COMPLETED|Treatment Period||0
6790982|NCT01928394|7722437|FG008|COMPLETED|Treatment Period||0
6378938|NCT00770653|7289482|FG000|COMPLETED|Overall Study||123
6378939|NCT00770653|7289483|FG001|COMPLETED|Overall Study||121
6378940|NCT00770653|7289482|FG000|NOT COMPLETED|Overall Study||32
6378941|NCT00770653|7289483|FG001|NOT COMPLETED|Overall Study||29
6378942|NCT00770679|7289489|FG000|STARTED|Overall Study||16
6502261|NCT01433549|7420919|FG000|COMPLETED|Phase 2: Second Study Product||12
6790983|NCT01928394|7722438|FG009|COMPLETED|Treatment Period||0
6790984|NCT01928394|7722439|FG010|COMPLETED|Treatment Period||0
6790985|NCT01928394|7722440|FG011|COMPLETED|Treatment Period||5
6790986|NCT01928394|7722441|FG012|COMPLETED|Treatment Period||6
6790987|NCT01928394|7722442|FG013|COMPLETED|Treatment Period||8
6790988|NCT01928394|7722443|FG014|COMPLETED|Treatment Period||8
6790989|NCT01928394|7722444|FG015|COMPLETED|Treatment Period||1
6790990|NCT01928394|7722445|FG016|COMPLETED|Treatment Period||5
6790991|NCT01928394|7722446|FG017|COMPLETED|Treatment Period||7
6790992|NCT01928394|7722447|FG018|COMPLETED|Treatment Period||22
6790993|NCT01928394|7722448|FG019|COMPLETED|Treatment Period||8
6790994|NCT01928394|7722449|FG020|COMPLETED|Treatment Period||1
6790995|NCT01928394|7722450|FG021|COMPLETED|Treatment Period||1
6790996|NCT01928394|7722451|FG022|COMPLETED|Treatment Period||3
6790997|NCT01928394|7722429|FG000|NOT COMPLETED|Treatment Period||18
6790998|NCT01928394|7722430|FG001|NOT COMPLETED|Treatment Period||3
6790999|NCT01928394|7722431|FG002|NOT COMPLETED|Treatment Period||18
6791000|NCT01928394|7722432|FG003|NOT COMPLETED|Treatment Period||56
6791001|NCT01928394|7722433|FG004|NOT COMPLETED|Treatment Period||3
6791002|NCT01928394|7722434|FG005|NOT COMPLETED|Treatment Period||43
6791003|NCT01928394|7722435|FG006|NOT COMPLETED|Treatment Period||49
6791004|NCT01928394|7722436|FG007|NOT COMPLETED|Treatment Period||18
6791005|NCT01928394|7722437|FG008|NOT COMPLETED|Treatment Period||3
6791006|NCT01928394|7722438|FG009|NOT COMPLETED|Treatment Period||18
6791007|NCT01928394|7722439|FG010|NOT COMPLETED|Treatment Period||30
6791008|NCT01928394|7722440|FG011|NOT COMPLETED|Treatment Period||93
6791009|NCT01928394|7722441|FG012|NOT COMPLETED|Treatment Period||55
6791010|NCT01928394|7722442|FG013|NOT COMPLETED|Treatment Period||139
6791011|NCT01928394|7722443|FG014|NOT COMPLETED|Treatment Period||88
6791012|NCT01928394|7722444|FG015|NOT COMPLETED|Treatment Period||2
6791013|NCT01928394|7722445|FG016|NOT COMPLETED|Treatment Period||50
6791014|NCT01928394|7722446|FG017|NOT COMPLETED|Treatment Period||71
6791015|NCT01928394|7722447|FG018|NOT COMPLETED|Treatment Period||70
6791016|NCT01928394|7722448|FG019|NOT COMPLETED|Treatment Period||96
6791017|NCT01928394|7722449|FG020|NOT COMPLETED|Treatment Period||40
6791018|NCT01928394|7722450|FG021|NOT COMPLETED|Treatment Period||42
6791019|NCT01928394|7722451|FG022|NOT COMPLETED|Treatment Period||39
6791020|NCT01928394|7722429|FG000|STARTED|Follow-up Period||15
6791021|NCT01928394|7722430|FG001|STARTED|Follow-up Period||3
6791022|NCT01928394|7722431|FG002|STARTED|Follow-up Period||18
6791023|NCT01928394|7722432|FG003|STARTED|Follow-up Period||50
6791024|NCT01928394|7722433|FG004|STARTED|Follow-up Period||3
6791025|NCT01928394|7722434|FG005|STARTED|Follow-up Period||49
6791026|NCT01928394|7722435|FG006|STARTED|Follow-up Period||52
6791027|NCT01928394|7722436|FG007|STARTED|Follow-up Period||16
6791028|NCT01928394|7722437|FG008|STARTED|Follow-up Period||3
6791029|NCT01928394|7722438|FG009|STARTED|Follow-up Period||18
6791030|NCT01928394|7722439|FG010|STARTED|Follow-up Period||30
6791031|NCT01928394|7722440|FG011|STARTED|Follow-up Period||81
6791032|NCT01928394|7722441|FG012|STARTED|Follow-up Period||61
6791033|NCT01928394|7722442|FG013|STARTED|Follow-up Period||145
6791034|NCT01928394|7722443|FG014|STARTED|Follow-up Period||96
6791035|NCT01928394|7722444|FG015|STARTED|Follow-up Period||3
6791036|NCT01928394|7722445|FG016|STARTED|Follow-up Period||55
6791037|NCT01928394|7722446|FG017|STARTED|Follow-up Period||58
6791038|NCT01928394|7722447|FG018|STARTED|Follow-up Period||92
6791039|NCT01928394|7722448|FG019|STARTED|Follow-up Period||104
6791040|NCT01928394|7722449|FG020|STARTED|Follow-up Period||41
6791041|NCT01928394|7722450|FG021|STARTED|Follow-up Period||43
6791042|NCT01928394|7722451|FG022|STARTED|Follow-up Period||42
6791043|NCT01928394|7722429|FG000|COMPLETED|Follow-up Period||12
6791044|NCT01928394|7722430|FG001|COMPLETED|Follow-up Period||3
6791045|NCT01928394|7722431|FG002|COMPLETED|Follow-up Period||15
6791046|NCT01928394|7722432|FG003|COMPLETED|Follow-up Period||40
6791047|NCT01928394|7722433|FG004|COMPLETED|Follow-up Period||3
6791048|NCT01928394|7722434|FG005|COMPLETED|Follow-up Period||41
6378943|NCT00770679|7289489|FG000|COMPLETED|Overall Study||10
6791049|NCT01928394|7722435|FG006|COMPLETED|Follow-up Period||40
6791050|NCT01928394|7722436|FG007|COMPLETED|Follow-up Period||10
6791051|NCT01928394|7722437|FG008|COMPLETED|Follow-up Period||2
6791052|NCT01928394|7722438|FG009|COMPLETED|Follow-up Period||16
6791053|NCT01928394|7722439|FG010|COMPLETED|Follow-up Period||19
6791054|NCT01928394|7722440|FG011|COMPLETED|Follow-up Period||59
6791055|NCT01928394|7722441|FG012|COMPLETED|Follow-up Period||47
6791056|NCT01928394|7722442|FG013|COMPLETED|Follow-up Period||107
6791057|NCT01928394|7722443|FG014|COMPLETED|Follow-up Period||66
6791058|NCT01928394|7722444|FG015|COMPLETED|Follow-up Period||3
6791059|NCT01928394|7722445|FG016|COMPLETED|Follow-up Period||41
6791060|NCT01928394|7722446|FG017|COMPLETED|Follow-up Period||50
6791061|NCT01928394|7722447|FG018|COMPLETED|Follow-up Period||76
6791062|NCT01928394|7722448|FG019|COMPLETED|Follow-up Period||83
6791063|NCT01928394|7722449|FG020|COMPLETED|Follow-up Period||32
6791064|NCT01928394|7722450|FG021|COMPLETED|Follow-up Period||34
6791065|NCT01928394|7722451|FG022|COMPLETED|Follow-up Period||36
6791066|NCT01928394|7722429|FG000|NOT COMPLETED|Follow-up Period||3
6791067|NCT01928394|7722430|FG001|NOT COMPLETED|Follow-up Period||0
6791068|NCT01928394|7722431|FG002|NOT COMPLETED|Follow-up Period||3
6791069|NCT01928394|7722432|FG003|NOT COMPLETED|Follow-up Period||10
6791070|NCT01928394|7722433|FG004|NOT COMPLETED|Follow-up Period||0
6791071|NCT01928394|7722434|FG005|NOT COMPLETED|Follow-up Period||8
6791072|NCT01928394|7722435|FG006|NOT COMPLETED|Follow-up Period||12
6791073|NCT01928394|7722436|FG007|NOT COMPLETED|Follow-up Period||6
6791074|NCT01928394|7722437|FG008|NOT COMPLETED|Follow-up Period||1
6791075|NCT01928394|7722438|FG009|NOT COMPLETED|Follow-up Period||2
6791076|NCT01928394|7722439|FG010|NOT COMPLETED|Follow-up Period||11
6791077|NCT01928394|7722440|FG011|NOT COMPLETED|Follow-up Period||22
6791078|NCT01928394|7722441|FG012|NOT COMPLETED|Follow-up Period||14
6791079|NCT01928394|7722442|FG013|NOT COMPLETED|Follow-up Period||38
6791080|NCT01928394|7722443|FG014|NOT COMPLETED|Follow-up Period||30
6791081|NCT01928394|7722444|FG015|NOT COMPLETED|Follow-up Period||0
6791082|NCT01928394|7722445|FG016|NOT COMPLETED|Follow-up Period||14
6791083|NCT01928394|7722446|FG017|NOT COMPLETED|Follow-up Period||8
6791084|NCT01928394|7722447|FG018|NOT COMPLETED|Follow-up Period||16
6791085|NCT01928394|7722448|FG019|NOT COMPLETED|Follow-up Period||21
6791086|NCT01928394|7722449|FG020|NOT COMPLETED|Follow-up Period||9
6791087|NCT01928394|7722450|FG021|NOT COMPLETED|Follow-up Period||9
6791088|NCT01928394|7722451|FG022|NOT COMPLETED|Follow-up Period||6
6791089|NCT01657500|7722501|FG000|STARTED|Overall Study||32
6791090|NCT01657500|7722502|FG001|STARTED|Overall Study||32
6791091|NCT01657500|7722501|FG000|COMPLETED|Overall Study||27
6791092|NCT01657500|7722502|FG001|COMPLETED|Overall Study||27
6791093|NCT01657500|7722501|FG000|NOT COMPLETED|Overall Study||5
6791094|NCT01657500|7722502|FG001|NOT COMPLETED|Overall Study||5
6791095|NCT04810221|7722508|FG000|STARTED|Overall Study||16
6791096|NCT04810221|7722508|FG000|COMPLETED|Overall Study|"Included in the 13 subjects which completed the study, it is necessary to consider the case 0, a pilot test for the verification of study procedures. Data from this subject were not used in the statistical evaluation, which therefore included data from 12 eligible subjects that completed the study."|13
6791097|NCT04810221|7722508|FG000|NOT COMPLETED|Overall Study||3
6791098|NCT04575038|7722514|FG000|STARTED|Overall Study||56
6791099|NCT04575038|7722515|FG001|STARTED|Overall Study||59
6791100|NCT04575038|7722514|FG000|COMPLETED|Overall Study||55
6791101|NCT04575038|7722515|FG001|COMPLETED|Overall Study||58
6563380|NCT01806688|7486295|FG001|NOT COMPLETED|Second Intervention Pita Study||0
6563381|NCT01806688|7486294|FG000|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|0
6623409|NCT02207569|7550543|FG000|STARTED|Enrolled to Implant|241 Attempted Implant|241
6623410|NCT02207569|7550543|FG000|COMPLETED|Enrolled to Implant|237 Implanted|237
6623411|NCT02207569|7550543|FG000|NOT COMPLETED|Enrolled to Implant||4
6791102|NCT04575038|7722514|FG000|NOT COMPLETED|Overall Study||1
6791103|NCT04575038|7722515|FG001|NOT COMPLETED|Overall Study||1
6791137|NCT04350593|7722569|FG000|STARTED|Overall Study||625
6791138|NCT04350593|7722570|FG001|STARTED|Overall Study||625
6791139|NCT04350593|7722569|FG000|COMPLETED|Overall Study||617
6791140|NCT04350593|7722570|FG001|COMPLETED|Overall Study||620
6791141|NCT04350593|7722569|FG000|NOT COMPLETED|Overall Study||8
6791142|NCT04350593|7722570|FG001|NOT COMPLETED|Overall Study||5
6791143|NCT04329832|7722578|FG000|STARTED|Overall Study||42
6791144|NCT04329832|7722579|FG001|STARTED|Overall Study||43
6791145|NCT04329832|7722578|FG000|COMPLETED|Overall Study||42
6791146|NCT04329832|7722579|FG001|COMPLETED|Overall Study||43
6791147|NCT04329832|7722578|FG000|NOT COMPLETED|Overall Study||0
6791148|NCT04329832|7722579|FG001|NOT COMPLETED|Overall Study||0
6791149|NCT04112303|7722593|FG000|STARTED|Overall Study||37
6791150|NCT04112303|7722593|FG000|COMPLETED|Overall Study||36
6791151|NCT04112303|7722593|FG000|NOT COMPLETED|Overall Study||1
6791152|NCT03896477|7722600|FG000|STARTED|Overall Study||220
6791153|NCT03896477|7722601|FG001|STARTED|Overall Study||220
6791154|NCT03896477|7722602|FG002|STARTED|Overall Study||220
6791155|NCT03896477|7722600|FG000|Received First Vaccination|Overall Study||220
6791156|NCT03896477|7722601|FG001|Received First Vaccination|Overall Study||220
6791157|NCT03896477|7722602|FG002|Received First Vaccination|Overall Study||220
6791158|NCT03896477|7722600|FG000|Received Second Vaccination|Overall Study||217
6791159|NCT03896477|7722601|FG001|Received Second Vaccination|Overall Study||213
6791160|NCT03896477|7722602|FG002|Received Second Vaccination|Overall Study||213
6791161|NCT03896477|7722600|FG000|Received Booster Vaccination|Overall Study||208
6791162|NCT03896477|7722601|FG001|Received Booster Vaccination|Overall Study||206
6791163|NCT03896477|7722602|FG002|Received Booster Vaccination|Overall Study||206
6791164|NCT03896477|7722600|FG000|COMPLETED|Overall Study||203
6791165|NCT03896477|7722601|FG001|COMPLETED|Overall Study||200
6791166|NCT03896477|7722602|FG002|COMPLETED|Overall Study||200
6791167|NCT03896477|7722600|FG000|NOT COMPLETED|Overall Study||17
6791168|NCT03896477|7722601|FG001|NOT COMPLETED|Overall Study||20
6791169|NCT03896477|7722602|FG002|NOT COMPLETED|Overall Study||20
6791170|NCT03760185|7722613|FG000|STARTED|Overall Study||13
6791171|NCT03760185|7722614|FG001|STARTED|Overall Study||13
6791172|NCT03760185|7722613|FG000|COMPLETED|Overall Study||12
6791173|NCT03760185|7722614|FG001|COMPLETED|Overall Study||12
6791174|NCT03760185|7722613|FG000|NOT COMPLETED|Overall Study||1
6791175|NCT03760185|7722614|FG001|NOT COMPLETED|Overall Study||1
6791176|NCT03732534|7722622|FG000|STARTED|Overall Study||6
6791177|NCT03732534|7722622|FG000|COMPLETED|Overall Study||0
6791178|NCT03732534|7722622|FG000|NOT COMPLETED|Overall Study||6
6791179|NCT03721705|7722628|FG000|STARTED|Overall Study||95
6791180|NCT03721705|7722629|FG001|STARTED|Overall Study||95
6791181|NCT03721705|7722628|FG000|COMPLETED|Overall Study||85
6791182|NCT03721705|7722629|FG001|COMPLETED|Overall Study||77
6791183|NCT03721705|7722628|FG000|NOT COMPLETED|Overall Study||10
6791184|NCT03721705|7722629|FG001|NOT COMPLETED|Overall Study||18
6791185|NCT03692910|7722635|FG000|STARTED|Overall Study||35
6791186|NCT03692910|7722636|FG001|STARTED|Overall Study||0
6791187|NCT03692910|7722637|FG002|STARTED|Overall Study||0
6791188|NCT03692910|7722635|FG000|COMPLETED|Overall Study||29
6791189|NCT03692910|7722636|FG001|COMPLETED|Overall Study||0
6791190|NCT03692910|7722637|FG002|COMPLETED|Overall Study||0
6791191|NCT03692910|7722635|FG000|NOT COMPLETED|Overall Study||6
6791192|NCT03692910|7722636|FG001|NOT COMPLETED|Overall Study||0
6791193|NCT03692910|7722637|FG002|NOT COMPLETED|Overall Study||0
6791194|NCT03673956|7722647|FG000|STARTED|Overall Study||12
6791195|NCT03673956|7722648|FG001|STARTED|Overall Study||1
6791196|NCT03673956|7722649|FG002|STARTED|Overall Study||5
6791197|NCT03673956|7722650|FG003|STARTED|Overall Study||1
6791198|NCT03673956|7722647|FG000|COMPLETED|Overall Study||10
6791199|NCT03673956|7722648|FG001|COMPLETED|Overall Study||1
6791200|NCT03673956|7722649|FG002|COMPLETED|Overall Study||5
6791201|NCT03673956|7722650|FG003|COMPLETED|Overall Study||1
6791202|NCT03673956|7722647|FG000|NOT COMPLETED|Overall Study||2
6791203|NCT03673956|7722648|FG001|NOT COMPLETED|Overall Study||0
6791204|NCT03673956|7722649|FG002|NOT COMPLETED|Overall Study||0
6791205|NCT03673956|7722650|FG003|NOT COMPLETED|Overall Study||0
6791104|NCT04545567|7722523|FG000|STARTED|Overall Study||10
6791105|NCT04545567|7722524|FG001|STARTED|Overall Study||11
6791106|NCT04545567|7722523|FG000|COMPLETED|Overall Study||9
6791107|NCT04545567|7722524|FG001|COMPLETED|Overall Study||9
6791108|NCT04545567|7722523|FG000|NOT COMPLETED|Overall Study||1
6791109|NCT04545567|7722524|FG001|NOT COMPLETED|Overall Study||2
6791110|NCT04425538|7722530|FG000|STARTED|Overall Study||17
6791111|NCT04425538|7722530|FG000|COMPLETED|Overall Study||17
6791112|NCT04425538|7722530|FG000|NOT COMPLETED|Overall Study||0
6791113|NCT04397757|7722536|FG000|STARTED|Overall Study||41
6791114|NCT04397757|7722537|FG001|STARTED|Overall Study||39
6791115|NCT04397757|7722536|FG000|Treated|Overall Study||39
6791116|NCT04397757|7722537|FG001|Treated|Overall Study||39
6791117|NCT04397757|7722536|FG000|COMPLETED|Overall Study||32
6791118|NCT04397757|7722537|FG001|COMPLETED|Overall Study||25
6791119|NCT04397757|7722536|FG000|NOT COMPLETED|Overall Study||9
6791120|NCT04397757|7722537|FG001|NOT COMPLETED|Overall Study||14
6791121|NCT04388683|7722550|FG000|STARTED|Overall Study||6
6791122|NCT04388683|7722551|FG001|STARTED|Overall Study||3
6791123|NCT04388683|7722550|FG000|COMPLETED|Overall Study||5
6791124|NCT04388683|7722551|FG001|COMPLETED|Overall Study||3
6791125|NCT04388683|7722550|FG000|NOT COMPLETED|Overall Study||1
6791126|NCT04388683|7722551|FG001|NOT COMPLETED|Overall Study||0
6791127|NCT04382651|7722559|FG000|STARTED|Overall Study||69
6791128|NCT04382651|7722560|FG001|STARTED|Overall Study||71
6791129|NCT04382651|7722559|FG000|Safety Analysis Set|Overall Study||68
6791130|NCT04382651|7722560|FG001|Safety Analysis Set|Overall Study||70
6791131|NCT04382651|7722559|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||63
6791132|NCT04382651|7722560|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||0
6791133|NCT04382651|7722559|FG000|COMPLETED|Overall Study||38
6791134|NCT04382651|7722560|FG001|COMPLETED|Overall Study||43
6791135|NCT04382651|7722559|FG000|NOT COMPLETED|Overall Study||31
6791136|NCT04382651|7722560|FG001|NOT COMPLETED|Overall Study||28
6791206|NCT03649347|7722664|FG000|STARTED|Overall Study||13
6791207|NCT03649347|7722665|FG001|STARTED|Overall Study||12
6791208|NCT03649347|7722666|FG002|STARTED|Overall Study||0
6791209|NCT03649347|7722667|FG003|STARTED|Overall Study||0
6791210|NCT03649347|7722664|FG000|COMPLETED|Overall Study||13
6791211|NCT03649347|7722665|FG001|COMPLETED|Overall Study||12
6791212|NCT03649347|7722666|FG002|COMPLETED|Overall Study||0
6791213|NCT03649347|7722667|FG003|COMPLETED|Overall Study||0
6791214|NCT03649347|7722664|FG000|NOT COMPLETED|Overall Study||0
6791215|NCT03649347|7722665|FG001|NOT COMPLETED|Overall Study||0
6791216|NCT03649347|7722666|FG002|NOT COMPLETED|Overall Study||0
6791217|NCT03649347|7722667|FG003|NOT COMPLETED|Overall Study||0
6791218|NCT03641326|7722677|FG000|STARTED|Overall Study||2
6791219|NCT03641326|7722678|FG001|STARTED|Overall Study||3
6791220|NCT03641326|7722677|FG000|COMPLETED|Overall Study||2
6791221|NCT03641326|7722678|FG001|COMPLETED|Overall Study||3
6791222|NCT03641326|7722677|FG000|NOT COMPLETED|Overall Study||0
6791223|NCT03641326|7722678|FG001|NOT COMPLETED|Overall Study||0
6791224|NCT03618420|7722689|FG000|STARTED|Overall Study||50
6791225|NCT03618420|7722689|FG000|COMPLETED|Overall Study||50
6791226|NCT03618420|7722689|FG000|NOT COMPLETED|Overall Study||0
6791227|NCT03586050|7722693|FG000|STARTED|Overall Study||33
6791228|NCT03586050|7722693|FG000|COMPLETED|Overall Study||33
6791229|NCT03586050|7722693|FG000|NOT COMPLETED|Overall Study||0
6502262|NCT01433549|7420920|FG001|COMPLETED|Phase 2: Second Study Product||12
6791230|NCT03474107|7722699|FG000|STARTED|Overall Study||301
6791231|NCT03474107|7722700|FG001|STARTED|Overall Study||307
6791232|NCT03474107|7722699|FG000|Treated|Overall Study||296
6791233|NCT03474107|7722700|FG001|Treated|Overall Study||291
6791234|NCT03474107|7722699|FG000|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|56
6791235|NCT03474107|7722700|FG001|COMPLETED|Overall Study|Participants still on treatment as of data cut-off date 15-Jul-2020|22
6791236|NCT03474107|7722699|FG000|NOT COMPLETED|Overall Study||245
6791237|NCT03474107|7722700|FG001|NOT COMPLETED|Overall Study||285
6791238|NCT03463993|7722708|FG000|STARTED|Overall Study||253
6791239|NCT03463993|7722709|FG001|STARTED|Overall Study||253
6791240|NCT03463993|7722708|FG000|COMPLETED|Overall Study||224
6791241|NCT03463993|7722709|FG001|COMPLETED|Overall Study||227
6791242|NCT03463993|7722708|FG000|NOT COMPLETED|Overall Study||29
6791243|NCT03463993|7722709|FG001|NOT COMPLETED|Overall Study||26
6791244|NCT03411031|7722717|FG000|STARTED|Overall Study||9
6791245|NCT03411031|7722718|FG001|STARTED|Overall Study||9
6791246|NCT03411031|7722717|FG000|COMPLETED|Overall Study||9
6791247|NCT03411031|7722718|FG001|COMPLETED|Overall Study||9
6791248|NCT03411031|7722717|FG000|NOT COMPLETED|Overall Study||0
6791249|NCT03411031|7722718|FG001|NOT COMPLETED|Overall Study||0
6791250|NCT03365752|7722727|FG000|STARTED|Overall Study||13
6791251|NCT03365752|7722728|FG001|STARTED|Overall Study||13
6791252|NCT03365752|7722729|FG002|STARTED|Overall Study||13
6791253|NCT03365752|7722727|FG000|COMPLETED|Overall Study||13
6791254|NCT03365752|7722728|FG001|COMPLETED|Overall Study||13
6791255|NCT03365752|7722729|FG002|COMPLETED|Overall Study||13
6378944|NCT00770679|7289489|FG000|NOT COMPLETED|Overall Study||6
6378945|NCT00770692|7289497|FG000|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
6378946|NCT00770692|7289498|FG001|STARTED|Overall Study||83
6378947|NCT00770692|7289499|FG002|STARTED|Overall Study||84
6378948|NCT00770692|7289500|FG003|STARTED|Overall Study||77
6378949|NCT00770692|7289497|FG000|COMPLETED|Overall Study||69
6378950|NCT00770692|7289498|FG001|COMPLETED|Overall Study||74
6378951|NCT00770692|7289499|FG002|COMPLETED|Overall Study||70
6378952|NCT00770692|7289500|FG003|COMPLETED|Overall Study||66
6378953|NCT00770692|7289497|FG000|NOT COMPLETED|Overall Study||12
6378954|NCT00770692|7289498|FG001|NOT COMPLETED|Overall Study||9
6378955|NCT00770692|7289499|FG002|NOT COMPLETED|Overall Study||14
6378956|NCT00770692|7289500|FG003|NOT COMPLETED|Overall Study||11
6378957|NCT00770757|7289510|FG000|STARTED|Overall Study||13
6378958|NCT00770757|7289510|FG000|COMPLETED|Overall Study||13
6378959|NCT00770757|7289510|FG000|NOT COMPLETED|Overall Study||0
6378960|NCT00770770|7289516|FG000|STARTED|Overall Study||14
6378961|NCT00770770|7289517|FG001|STARTED|Overall Study||6
6378962|NCT00770770|7289516|FG000|COMPLETED|Overall Study||4
6378963|NCT00770770|7289517|FG001|COMPLETED|Overall Study||5
6378964|NCT00770770|7289516|FG000|NOT COMPLETED|Overall Study||10
6378965|NCT00770770|7289517|FG001|NOT COMPLETED|Overall Study||1
6378966|NCT00770861|7289525|FG000|STARTED|Overall Study||141
6378967|NCT00770861|7289526|FG001|STARTED|Overall Study||136
6378968|NCT00770861|7289525|FG000|COMPLETED|Overall Study||131
6378969|NCT00770861|7289526|FG001|COMPLETED|Overall Study||120
6378970|NCT00770861|7289525|FG000|NOT COMPLETED|Overall Study||10
6378971|NCT00770861|7289526|FG001|NOT COMPLETED|Overall Study||16
6378972|NCT00770874|7289534|FG000|STARTED|Overall Study||188
6378973|NCT00770874|7289535|FG001|STARTED|Overall Study||176
6378974|NCT00770874|7289534|FG000|COMPLETED|Overall Study||188
6378975|NCT00770874|7289535|FG001|COMPLETED|Overall Study||176
6378976|NCT00770874|7289534|FG000|NOT COMPLETED|Overall Study||0
6378977|NCT00770874|7289535|FG001|NOT COMPLETED|Overall Study||0
6378978|NCT00770913|7289544|FG000|STARTED|Overall Study||113
6378979|NCT00770913|7289545|FG001|STARTED|Overall Study||111
6378980|NCT00770913|7289546|FG002|STARTED|Overall Study||113
6378981|NCT00770913|7289544|FG000|COMPLETED|Overall Study||102
6378982|NCT00770913|7289545|FG001|COMPLETED|Overall Study||103
6378983|NCT00770913|7289546|FG002|COMPLETED|Overall Study||100
6378984|NCT00770913|7289544|FG000|NOT COMPLETED|Overall Study||11
6378985|NCT00770913|7289545|FG001|NOT COMPLETED|Overall Study||8
6378986|NCT00770913|7289546|FG002|NOT COMPLETED|Overall Study||13
6791256|NCT03365752|7722727|FG000|NOT COMPLETED|Overall Study||0
6791257|NCT03365752|7722728|FG001|NOT COMPLETED|Overall Study||0
6791258|NCT03365752|7722729|FG002|NOT COMPLETED|Overall Study||0
6791259|NCT03364036|7722737|FG000|STARTED|Overall Study||270
6791260|NCT03364036|7722737|FG000|Full Analysis Set (FAS)|Overall Study||270
6791261|NCT03364036|7722737|FG000|COMPLETED|Overall Study||264
6791262|NCT03364036|7722737|FG000|NOT COMPLETED|Overall Study||6
6791263|NCT03205163|7722743|FG000|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||7
6791264|NCT03205163|7722744|FG001|STARTED|ATP (LDC: 3 Days; HDC: 4 Days)||9
6791265|NCT03205163|7722743|FG000|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||7
6791266|NCT03205163|7722744|FG001|Safety Population|ATP (LDC: 3 Days; HDC: 4 Days)||9
6791267|NCT03205163|7722743|FG000|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||6
6791268|NCT03205163|7722744|FG001|COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||9
6791269|NCT03205163|7722743|FG000|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||1
6791270|NCT03205163|7722744|FG001|NOT COMPLETED|ATP (LDC: 3 Days; HDC: 4 Days)||0
6791271|NCT03205163|7722743|FG000|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||6
6791272|NCT03205163|7722744|FG001|STARTED|BTP (LDC: 28 Days; HDC: 28 Days)||9
6791273|NCT03205163|7722743|FG000|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||6
6791274|NCT03205163|7722744|FG001|Safety Population|BTP (LDC: 28 Days; HDC: 28 Days)||9
6791275|NCT03205163|7722743|FG000|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||6
6791276|NCT03205163|7722744|FG001|COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||9
6791277|NCT03205163|7722743|FG000|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
6563382|NCT01806688|7486295|FG001|STARTED|Third Intervention Pita Study|"Participants received one of the following:~experimental snack #2 gluten-free high protein and high fibre snack a 50 g serving of buckwheat and pinto bean flour pita bread placebo comparator reference product, a gluten-free snack with similar energy density but less protein and fibre as the experimental snack, a 50g serving of rice bread placebo comparator non-caloric control water"|38
6563383|NCT01806688|7486294|FG000|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|0
6563384|NCT01806688|7486295|FG001|Experimental Snack #2|Third Intervention Pita Study|Received the Experimental snack #2, a 50 g serving of buckwheat and pinto bean flour pita bread at the third visit|12
6563385|NCT01806688|7486294|FG000|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|0
6563386|NCT01806688|7486295|FG001|Placebo Comparator Reference Product #2|Third Intervention Pita Study|Received the placebo comparator reference product #2 at the third visit, a 50g serving of rice bread|13
6563387|NCT01806688|7486294|FG000|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|0
6563388|NCT01806688|7486295|FG001|Placebo Comparator Non-caloric Control #2|Third Intervention Pita Study|Received water, the placebo comparator non-caloric control #2 at the third visit|13
6791278|NCT03205163|7722744|FG001|NOT COMPLETED|BTP (LDC: 28 Days; HDC: 28 Days)||0
6791279|NCT03178045|7722761|FG000|STARTED|Overall Study||1396
6791280|NCT03178045|7722762|FG001|STARTED|Overall Study||1397
6791281|NCT03178045|7722761|FG000|COMPLETED|Overall Study||1310
6791282|NCT03178045|7722762|FG001|COMPLETED|Overall Study||1314
6791283|NCT03178045|7722761|FG000|NOT COMPLETED|Overall Study||86
6791284|NCT03178045|7722762|FG001|NOT COMPLETED|Overall Study||83
6791285|NCT03145766|7722774|FG000|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
6563389|NCT01806688|7486294|FG000|COMPLETED|Third Intervention Pita Study||0
6563390|NCT01806688|7486295|FG001|COMPLETED|Third Intervention Pita Study||38
6563391|NCT01806688|7486294|FG000|NOT COMPLETED|Third Intervention Pita Study||0
6656394|NCT02460978|7586558|FG002|NOT COMPLETED|Overall Study||33
6656395|NCT02460991|7586568|FG000|STARTED|Overall Study||0
6656396|NCT02460991|7586569|FG001|STARTED|Overall Study||2
6656397|NCT02460991|7586568|FG000|COMPLETED|Overall Study||0
6656398|NCT02460991|7586569|FG001|COMPLETED|Overall Study||0
6656399|NCT02460991|7586568|FG000|NOT COMPLETED|Overall Study||0
6656400|NCT02460991|7586569|FG001|NOT COMPLETED|Overall Study||2
6656401|NCT02461134|7586580|FG000|STARTED|Overall Study||1
6791286|NCT03145766|7722775|FG001|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
6791287|NCT03145766|7722776|FG002|STARTED|Active Vaccination Phase (Day 0-Day 56)||80
6791288|NCT03145766|7722777|FG003|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
6791289|NCT03145766|7722778|FG004|STARTED|Active Vaccination Phase (Day 0-Day 56)||40
6791290|NCT03145766|7722774|FG000|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
6656402|NCT02461134|7586580|FG000|COMPLETED|Overall Study||0
6656403|NCT02461134|7586580|FG000|NOT COMPLETED|Overall Study||1
6656404|NCT02461160|7586597|FG000|STARTED|Overall Study||8
6656405|NCT02461160|7586598|FG001|STARTED|Overall Study||6
6656406|NCT02461160|7586599|FG002|STARTED|Overall Study||6
6656407|NCT02461160|7586600|FG003|STARTED|Overall Study||12
6656408|NCT02461160|7586601|FG004|STARTED|Overall Study||6
6656409|NCT02461160|7586602|FG005|STARTED|Overall Study||6
6656410|NCT02461160|7586603|FG006|STARTED|Overall Study||6
6656411|NCT02461160|7586604|FG007|STARTED|Overall Study||6
6656412|NCT02461160|7586605|FG008|STARTED|Overall Study||12
6656413|NCT02461160|7586606|FG009|STARTED|Overall Study||4
6656414|NCT02461160|7586607|FG010|STARTED|Overall Study||4
6656415|NCT02461160|7586608|FG011|STARTED|Overall Study||4
6656416|NCT02461160|7586609|FG012|STARTED|Overall Study||8
6656417|NCT02461160|7586597|FG000|COMPLETED|Overall Study||8
6656418|NCT02461160|7586598|FG001|COMPLETED|Overall Study||6
6656419|NCT02461160|7586599|FG002|COMPLETED|Overall Study||6
6791291|NCT03145766|7722775|FG001|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
6791292|NCT03145766|7722776|FG002|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)||80
6791293|NCT03145766|7722777|FG003|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of this arm received Imovax Rabies, and counted in Group 5 for safety analysis.|39
6791294|NCT03145766|7722778|FG004|Vaccination 1|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 4 received Imovax Rabies, and counted in Group 5 for safety analysis.|41
6791295|NCT03145766|7722774|FG000|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety analysis.|77
6791296|NCT03145766|7722775|FG001|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)|1 participant of Group 1 received Group 2 vaccine: counted in Group 2 for post-vaccination 2 safety.|81
6791297|NCT03145766|7722776|FG002|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||80
6791298|NCT03145766|7722777|FG003|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
6791299|NCT03145766|7722778|FG004|Vaccination 2|Active Vaccination Phase (Day 0-Day 56)||39
6791300|NCT03145766|7722774|FG000|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||78
6791301|NCT03145766|7722775|FG001|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||79
6791302|NCT03145766|7722776|FG002|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||80
6791303|NCT03145766|7722777|FG003|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||39
6791304|NCT03145766|7722778|FG004|Vaccination 3|Active Vaccination Phase (Day 0-Day 56)||38
6791305|NCT03145766|7722774|FG000|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||78
6791306|NCT03145766|7722775|FG001|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||79
6791307|NCT03145766|7722776|FG002|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||80
6791308|NCT03145766|7722777|FG003|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
6791309|NCT03145766|7722778|FG004|Vaccination 4|Active Vaccination Phase (Day 0-Day 56)||38
6791310|NCT03145766|7722774|FG000|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||75
6791311|NCT03145766|7722775|FG001|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||78
6791312|NCT03145766|7722776|FG002|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||79
6791313|NCT03145766|7722777|FG003|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||34
6791314|NCT03145766|7722778|FG004|Vaccination 5|Active Vaccination Phase (Day 0-Day 56)||37
6791315|NCT03145766|7722774|FG000|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||74
6791316|NCT03145766|7722775|FG001|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||77
6791317|NCT03145766|7722776|FG002|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||78
6791318|NCT03145766|7722777|FG003|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||33
6791319|NCT03145766|7722778|FG004|COMPLETED|Active Vaccination Phase (Day 0-Day 56)||37
6791320|NCT03145766|7722774|FG000|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||6
6791321|NCT03145766|7722775|FG001|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
6791322|NCT03145766|7722776|FG002|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||2
6791323|NCT03145766|7722777|FG003|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||7
6791324|NCT03145766|7722778|FG004|NOT COMPLETED|Active Vaccination Phase (Day 0-Day 56)||3
6791325|NCT03145766|7722774|FG000|STARTED|Follow-up Phase (Day 56 Till Month 7)||74
6791326|NCT03145766|7722775|FG001|STARTED|Follow-up Phase (Day 56 Till Month 7)||77
6791327|NCT03145766|7722776|FG002|STARTED|Follow-up Phase (Day 56 Till Month 7)||78
6791328|NCT03145766|7722777|FG003|STARTED|Follow-up Phase (Day 56 Till Month 7)||33
6791329|NCT03145766|7722778|FG004|STARTED|Follow-up Phase (Day 56 Till Month 7)||37
6791330|NCT03145766|7722774|FG000|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||67
6791331|NCT03145766|7722775|FG001|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||75
6791332|NCT03145766|7722776|FG002|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||73
6791333|NCT03145766|7722777|FG003|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||30
6791334|NCT03145766|7722778|FG004|COMPLETED|Follow-up Phase (Day 56 Till Month 7)||34
6791335|NCT03145766|7722774|FG000|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||7
6791336|NCT03145766|7722775|FG001|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||2
6791337|NCT03145766|7722776|FG002|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||5
6791338|NCT03145766|7722777|FG003|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
6791339|NCT03145766|7722778|FG004|NOT COMPLETED|Follow-up Phase (Day 56 Till Month 7)||3
6791340|NCT03106987|7722795|FG000|STARTED|Overall Study||74
6791341|NCT03106987|7722796|FG001|STARTED|Overall Study||38
6791342|NCT03106987|7722797|FG002|STARTED|Overall Study||72
6791343|NCT03106987|7722798|FG003|STARTED|Overall Study||36
6791344|NCT03106987|7722795|FG000|COMPLETED|Overall Study||30
6791345|NCT03106987|7722796|FG001|COMPLETED|Overall Study||15
6791346|NCT03106987|7722797|FG002|COMPLETED|Overall Study||54
6791347|NCT03106987|7722798|FG003|COMPLETED|Overall Study||25
6791348|NCT03106987|7722795|FG000|NOT COMPLETED|Overall Study||44
6791349|NCT03106987|7722796|FG001|NOT COMPLETED|Overall Study||23
6791350|NCT03106987|7722797|FG002|NOT COMPLETED|Overall Study||18
6791351|NCT03106987|7722798|FG003|NOT COMPLETED|Overall Study||11
6791352|NCT03103087|7722811|FG000|STARTED|Overall Study||126
6791353|NCT03103087|7722812|FG001|STARTED|Overall Study||127
6791354|NCT03103087|7722813|FG002|STARTED|Overall Study||129
6791355|NCT03103087|7722811|FG000|COMPLETED|Overall Study||102
6791356|NCT03103087|7722812|FG001|COMPLETED|Overall Study||98
6791357|NCT03103087|7722813|FG002|COMPLETED|Overall Study||102
6791358|NCT03103087|7722811|FG000|NOT COMPLETED|Overall Study||24
6791359|NCT03103087|7722812|FG001|NOT COMPLETED|Overall Study||29
6791360|NCT03103087|7722813|FG002|NOT COMPLETED|Overall Study||27
6791361|NCT03073980|7722826|FG000|STARTED|Overall Study||53
6791362|NCT03073980|7722827|FG001|STARTED|Overall Study||54
6791363|NCT03073980|7722828|FG002|STARTED|Overall Study||54
6791364|NCT03073980|7722826|FG000|COMPLETED|Overall Study||43
6791365|NCT03073980|7722827|FG001|COMPLETED|Overall Study||52
6791366|NCT03073980|7722828|FG002|COMPLETED|Overall Study||43
6791367|NCT03073980|7722826|FG000|NOT COMPLETED|Overall Study||10
6791368|NCT03073980|7722827|FG001|NOT COMPLETED|Overall Study||2
6791369|NCT03073980|7722828|FG002|NOT COMPLETED|Overall Study||11
6791370|NCT03049735|7722843|FG000|STARTED|Overall Study||128
6791371|NCT03049735|7722844|FG001|STARTED|Overall Study||132
6791372|NCT03049735|7722845|FG002|STARTED|Overall Study||128
6791373|NCT03049735|7722843|FG000|Received at Least 1 Dose of Study Drug|Overall Study||128
6791374|NCT03049735|7722844|FG001|Received at Least 1 Dose of Study Drug|Overall Study||132
6791375|NCT03049735|7722845|FG002|Received at Least 1 Dose of Study Drug|Overall Study||127
6791376|NCT03049735|7722843|FG000|COMPLETED|Overall Study||100
6791377|NCT03049735|7722844|FG001|COMPLETED|Overall Study||103
6791378|NCT03049735|7722845|FG002|COMPLETED|Overall Study||105
6791379|NCT03049735|7722843|FG000|NOT COMPLETED|Overall Study||28
6791380|NCT03049735|7722844|FG001|NOT COMPLETED|Overall Study||29
6791381|NCT03049735|7722845|FG002|NOT COMPLETED|Overall Study||23
6791382|NCT03021551|7722853|FG000|STARTED|Overall Study||80
6791383|NCT03021551|7722853|FG000|COMPLETED|Overall Study||77
6791384|NCT03021551|7722853|FG000|NOT COMPLETED|Overall Study||3
6791385|NCT02990338|7722859|FG000|STARTED|Overall Study||153
6791386|NCT02990338|7722860|FG001|STARTED|Overall Study||154
6791387|NCT02990338|7722859|FG000|Treated|Overall Study||149
6791388|NCT02990338|7722860|FG001|Treated|Overall Study||152
6791389|NCT02990338|7722859|FG000|Ongoing|Overall Study||35
6791390|NCT02990338|7722860|FG001|Ongoing|Overall Study||65
6791391|NCT02990338|7722859|FG000|COMPLETED|Overall Study||35
6791392|NCT02990338|7722860|FG001|COMPLETED|Overall Study||65
6791393|NCT02990338|7722859|FG000|NOT COMPLETED|Overall Study||118
6791394|NCT02990338|7722860|FG001|NOT COMPLETED|Overall Study||89
6791395|NCT02972996|7722869|FG000|STARTED|Overall Study||27
6791396|NCT02972996|7722870|FG001|STARTED|Overall Study||28
6791397|NCT02972996|7722869|FG000|COMPLETED|Overall Study||26
6791398|NCT02972996|7722870|FG001|COMPLETED|Overall Study||26
6791399|NCT02972996|7722869|FG000|NOT COMPLETED|Overall Study||1
6791400|NCT02972996|7722870|FG001|NOT COMPLETED|Overall Study||2
6791401|NCT02932332|7722880|FG000|STARTED|Overall Study||5
6791402|NCT02932332|7722881|FG001|STARTED|Overall Study||4
6791403|NCT02932332|7722882|FG002|STARTED|Overall Study||5
6791404|NCT02932332|7722883|FG003|STARTED|Overall Study||5
6791405|NCT02932332|7722880|FG000|Intervention 1|Overall Study||4
6791406|NCT02932332|7722881|FG001|Intervention 1|Overall Study||4
6791407|NCT02932332|7722882|FG002|Intervention 1|Overall Study||5
6791408|NCT02932332|7722883|FG003|Intervention 1|Overall Study||4
6791409|NCT02932332|7722880|FG000|Intervention 2|Overall Study||4
6791410|NCT02932332|7722881|FG001|Intervention 2|Overall Study||3
6791411|NCT02932332|7722882|FG002|Intervention 2|Overall Study||4
6791412|NCT02932332|7722883|FG003|Intervention 2|Overall Study||4
6791413|NCT02932332|7722880|FG000|Intervention 3|Overall Study||3
6791414|NCT02932332|7722881|FG001|Intervention 3|Overall Study||2
6791415|NCT02932332|7722882|FG002|Intervention 3|Overall Study||4
6791416|NCT02932332|7722883|FG003|Intervention 3|Overall Study||3
6791417|NCT02932332|7722880|FG000|Intervention 4|Overall Study||3
6791418|NCT02932332|7722881|FG001|Intervention 4|Overall Study||1
6791419|NCT02932332|7722882|FG002|Intervention 4|Overall Study||4
6791420|NCT02932332|7722883|FG003|Intervention 4|Overall Study||3
6791421|NCT02932332|7722880|FG000|COMPLETED|Overall Study||3
6791422|NCT02932332|7722881|FG001|COMPLETED|Overall Study||1
6791423|NCT02932332|7722882|FG002|COMPLETED|Overall Study||4
6791424|NCT02932332|7722883|FG003|COMPLETED|Overall Study||3
6791425|NCT02932332|7722880|FG000|NOT COMPLETED|Overall Study||2
6791426|NCT02932332|7722881|FG001|NOT COMPLETED|Overall Study||3
6791427|NCT02932332|7722882|FG002|NOT COMPLETED|Overall Study||1
6791428|NCT02932332|7722883|FG003|NOT COMPLETED|Overall Study||2
6791429|NCT02845440|7722898|FG000|STARTED|Overall Study||333
6791430|NCT02845440|7722899|FG001|STARTED|Overall Study||336
6791431|NCT02845440|7722900|FG002|STARTED|Overall Study||341
6791432|NCT02845440|7722901|FG003|STARTED|Overall Study||78
6791433|NCT02845440|7722902|FG004|STARTED|Overall Study||77
6791434|NCT02845440|7722898|FG000|COMPLETED|Overall Study||201
6791435|NCT02845440|7722899|FG001|COMPLETED|Overall Study||203
6791436|NCT02845440|7722900|FG002|COMPLETED|Overall Study||204
6791437|NCT02845440|7722901|FG003|COMPLETED|Overall Study||49
6791438|NCT02845440|7722902|FG004|COMPLETED|Overall Study||39
6791439|NCT02845440|7722898|FG000|NOT COMPLETED|Overall Study||132
6791440|NCT02845440|7722899|FG001|NOT COMPLETED|Overall Study||133
6791441|NCT02845440|7722900|FG002|NOT COMPLETED|Overall Study||137
6791442|NCT02845440|7722901|FG003|NOT COMPLETED|Overall Study||29
6791443|NCT02845440|7722902|FG004|NOT COMPLETED|Overall Study||38
6791444|NCT02786394|7722919|FG000|STARTED|Overall Study||11
6791445|NCT02786394|7722919|FG000|COMPLETED|Overall Study||10
6791446|NCT02786394|7722919|FG000|NOT COMPLETED|Overall Study||1
6791447|NCT02588248|7722926|FG000|STARTED|Overall Study||42
6791448|NCT02588248|7722927|FG001|STARTED|Overall Study||40
6791449|NCT02588248|7722926|FG000|COMPLETED|Overall Study||38
6791450|NCT02588248|7722927|FG001|COMPLETED|Overall Study||37
6791451|NCT02588248|7722926|FG000|NOT COMPLETED|Overall Study||4
6791452|NCT02588248|7722927|FG001|NOT COMPLETED|Overall Study||3
6791453|NCT02535065|7722938|FG000|STARTED|Overall Study||62
6791454|NCT02535065|7722938|FG000|1-Month Follow-up|Overall Study||62
6791455|NCT02535065|7722938|FG000|12-Month Follow-up|Overall Study||61
6791456|NCT02535065|7722938|FG000|COMPLETED|Overall Study||42
6791457|NCT02535065|7722938|FG000|NOT COMPLETED|Overall Study||20
6791458|NCT02510885|7722942|FG000|STARTED|Overall Study||39
6791459|NCT02510885|7722942|FG000|COMPLETED|Overall Study||39
6791460|NCT02510885|7722942|FG000|NOT COMPLETED|Overall Study||0
6791461|NCT02451358|7722950|FG000|STARTED|Overall Study||100
6791462|NCT02451358|7722951|FG001|STARTED|Overall Study||100
6791463|NCT02451358|7722952|FG002|STARTED|Overall Study||100
6791464|NCT02451358|7722953|FG003|STARTED|Overall Study||100
6791465|NCT02451358|7722950|FG000|Vaccinated at Day 0|Overall Study||100
6791466|NCT02451358|7722951|FG001|Vaccinated at Day 0|Overall Study||100
6791467|NCT02451358|7722952|FG002|Vaccinated at Day 0|Overall Study||100
6791468|NCT02451358|7722953|FG003|Vaccinated at Day 0|Overall Study||100
6791469|NCT02451358|7722950|FG000|Vaccinated at Day 28|Overall Study||99
6791470|NCT02451358|7722951|FG001|Vaccinated at Day 28|Overall Study||98
6791471|NCT02451358|7722952|FG002|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
6791472|NCT02451358|7722953|FG003|Vaccinated at Day 28|Overall Study|Participants aged 9 years and older received only 1 dose of Quadrivalent Influenza Vaccine.|0
6791473|NCT02451358|7722950|FG000|COMPLETED|Overall Study||99
6791474|NCT02451358|7722951|FG001|COMPLETED|Overall Study||98
6791475|NCT02451358|7722952|FG002|COMPLETED|Overall Study||99
6791476|NCT02451358|7722953|FG003|COMPLETED|Overall Study||100
6791477|NCT02451358|7722950|FG000|NOT COMPLETED|Overall Study||1
6791478|NCT02451358|7722951|FG001|NOT COMPLETED|Overall Study||2
6791479|NCT02451358|7722952|FG002|NOT COMPLETED|Overall Study||1
6791480|NCT02451358|7722953|FG003|NOT COMPLETED|Overall Study||0
6791481|NCT02268175|7722965|FG000|STARTED|Overall Study||50
6791482|NCT02268175|7722966|FG001|STARTED|Overall Study||25
6791483|NCT02268175|7722965|FG000|COMPLETED|Overall Study||50
6791484|NCT02268175|7722966|FG001|COMPLETED|Overall Study||25
6791485|NCT02268175|7722965|FG000|NOT COMPLETED|Overall Study||0
6791486|NCT02268175|7722966|FG001|NOT COMPLETED|Overall Study||0
6791487|NCT02178709|7722972|FG000|STARTED|Overall Study||48
6791488|NCT02178709|7722972|FG000|COMPLETED|Overall Study||32
6791489|NCT02178709|7722972|FG000|NOT COMPLETED|Overall Study||16
6791490|NCT02163681|7722976|FG000|STARTED|Overall Study||45
6791491|NCT02163681|7722976|FG000|COMPLETED|Overall Study||44
6791492|NCT02163681|7722976|FG000|NOT COMPLETED|Overall Study||1
6791493|NCT01980017|7722982|FG000|STARTED|Overall Study||114
6791494|NCT01980017|7722983|FG001|STARTED|Overall Study||199
6791495|NCT01980017|7722982|FG000|COMPLETED|Overall Study||84
6791496|NCT01980017|7722983|FG001|COMPLETED|Overall Study||177
6791497|NCT01980017|7722982|FG000|NOT COMPLETED|Overall Study||30
6791498|NCT01980017|7722983|FG001|NOT COMPLETED|Overall Study||22
6791499|NCT01890759|7722994|FG000|STARTED|Overall Study||100
6791500|NCT01890759|7722995|FG001|STARTED|Overall Study||200
6791501|NCT01890759|7722994|FG000|COMPLETED|Overall Study||98
6791502|NCT01890759|7722995|FG001|COMPLETED|Overall Study||188
6791503|NCT01890759|7722994|FG000|NOT COMPLETED|Overall Study||2
6791504|NCT01890759|7722995|FG001|NOT COMPLETED|Overall Study||12
6563392|NCT01806688|7486295|FG001|NOT COMPLETED|Third Intervention Pita Study||0
6791505|NCT01855867|7723001|FG000|STARTED|Overall Study||100
6791506|NCT01855867|7723001|FG000|COMPLETED|Overall Study||100
6791507|NCT01855867|7723001|FG000|NOT COMPLETED|Overall Study||0
6791508|NCT01721746|7723008|FG000|STARTED|Pre-Treatment||272
6791509|NCT01721746|7723009|FG001|STARTED|Pre-Treatment||133
6791510|NCT01721746|7723008|FG000|COMPLETED|Pre-Treatment||268
6791511|NCT01721746|7723009|FG001|COMPLETED|Pre-Treatment||102
6791512|NCT01721746|7723008|FG000|NOT COMPLETED|Pre-Treatment||4
6791513|NCT01721746|7723009|FG001|NOT COMPLETED|Pre-Treatment||31
6791514|NCT01721746|7723008|FG000|STARTED|Treatment||268
6791515|NCT01721746|7723009|FG001|STARTED|Treatment||102
6791516|NCT01721746|7723008|FG000|COMPLETED|Treatment||0
6791517|NCT01721746|7723009|FG001|COMPLETED|Treatment||0
6791518|NCT01721746|7723008|FG000|NOT COMPLETED|Treatment||268
6791519|NCT01721746|7723009|FG001|NOT COMPLETED|Treatment||102
6791520|NCT01705977|7723018|FG000|STARTED|Overall Study||2002
6791521|NCT01705977|7723019|FG001|STARTED|Overall Study||2001
6791522|NCT01705977|7723018|FG000|COMPLETED|Overall Study||1729
6791523|NCT01705977|7723019|FG001|COMPLETED|Overall Study||1741
6791524|NCT01705977|7723018|FG000|NOT COMPLETED|Overall Study||273
6791525|NCT01705977|7723019|FG001|NOT COMPLETED|Overall Study||260
6791526|NCT01587040|7723029|FG000|STARTED|Overall Study||17
6791527|NCT01587040|7723030|FG001|STARTED|Overall Study||3
6791528|NCT01587040|7723031|FG002|STARTED|Overall Study||37
6791529|NCT01587040|7723032|FG003|STARTED|Overall Study||4
6791530|NCT01587040|7723029|FG000|COMPLETED|Overall Study||0
6791531|NCT01587040|7723030|FG001|COMPLETED|Overall Study||0
6791532|NCT01587040|7723031|FG002|COMPLETED|Overall Study||0
6791533|NCT01587040|7723032|FG003|COMPLETED|Overall Study||0
6791534|NCT01587040|7723029|FG000|NOT COMPLETED|Overall Study||17
6791535|NCT01587040|7723030|FG001|NOT COMPLETED|Overall Study||3
6791536|NCT01587040|7723031|FG002|NOT COMPLETED|Overall Study||37
6791537|NCT01587040|7723032|FG003|NOT COMPLETED|Overall Study||4
6791538|NCT01293682|7723042|FG000|STARTED|Overall Study||12
6791539|NCT01293682|7723042|FG000|COMPLETED|Overall Study||12
6791540|NCT01293682|7723042|FG000|NOT COMPLETED|Overall Study||0
6791541|NCT01254409|7723050|FG000|STARTED|Overall Study||6
6791542|NCT01254409|7723051|FG001|STARTED|Overall Study||6
6791543|NCT01254409|7723052|FG002|STARTED|Overall Study||5
6791544|NCT01254409|7723053|FG003|STARTED|Overall Study||4
6791545|NCT01254409|7723050|FG000|COMPLETED|Overall Study||6
6791546|NCT01254409|7723051|FG001|COMPLETED|Overall Study||5
6791547|NCT01254409|7723052|FG002|COMPLETED|Overall Study||5
6791548|NCT01254409|7723053|FG003|COMPLETED|Overall Study||4
6791549|NCT01254409|7723050|FG000|NOT COMPLETED|Overall Study||0
6791550|NCT01254409|7723051|FG001|NOT COMPLETED|Overall Study||1
6791551|NCT01254409|7723052|FG002|NOT COMPLETED|Overall Study||0
6791552|NCT01254409|7723053|FG003|NOT COMPLETED|Overall Study||0
6791553|NCT01253161|7723066|FG000|STARTED|Overall Study||29
6791554|NCT01253161|7723066|FG000|COMPLETED|Overall Study||28
6791555|NCT01253161|7723066|FG000|NOT COMPLETED|Overall Study||1
6791556|NCT01084252|7723084|FG000|STARTED|Phase 1 (120 Weeks)||16
6563393|NCT01806714|7486306|FG000|STARTED|Overall Study||2093
6791557|NCT01084252|7723085|FG001|STARTED|Phase 1 (120 Weeks)||6
6791558|NCT01084252|7723086|FG002|STARTED|Phase 1 (120 Weeks)||3
6791559|NCT01084252|7723087|FG003|STARTED|Phase 1 (120 Weeks)||26
6791560|NCT01084252|7723088|FG004|STARTED|Phase 1 (120 Weeks)||18
6791561|NCT01084252|7723089|FG005|STARTED|Phase 1 (120 Weeks)||6
6791562|NCT01084252|7723090|FG006|STARTED|Phase 1 (120 Weeks)||7
6791563|NCT01084252|7723091|FG007|STARTED|Phase 1 (120 Weeks)||7
6791564|NCT01084252|7723092|FG008|STARTED|Phase 1 (120 Weeks)||0
6791565|NCT01084252|7723093|FG009|STARTED|Phase 1 (120 Weeks)||0
6791566|NCT01084252|7723094|FG010|STARTED|Phase 1 (120 Weeks)||0
6791567|NCT01084252|7723095|FG011|STARTED|Phase 1 (120 Weeks)||0
6791568|NCT01084252|7723096|FG012|STARTED|Phase 1 (120 Weeks)||0
6791569|NCT01084252|7723097|FG013|STARTED|Phase 1 (120 Weeks)||0
6791570|NCT01084252|7723084|FG000|All Treated (AT) Population|Phase 1 (120 Weeks)||16
6791571|NCT01084252|7723085|FG001|All Treated (AT) Population|Phase 1 (120 Weeks)||6
6791572|NCT01084252|7723086|FG002|All Treated (AT) Population|Phase 1 (120 Weeks)||3
6791573|NCT01084252|7723087|FG003|All Treated (AT) Population|Phase 1 (120 Weeks)||26
6791574|NCT01084252|7723088|FG004|All Treated (AT) Population|Phase 1 (120 Weeks)||18
6791575|NCT01084252|7723089|FG005|All Treated (AT) Population|Phase 1 (120 Weeks)||6
6791576|NCT01084252|7723090|FG006|All Treated (AT) Population|Phase 1 (120 Weeks)||7
6791577|NCT01084252|7723091|FG007|All Treated (AT) Population|Phase 1 (120 Weeks)||7
6791578|NCT01084252|7723092|FG008|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6791579|NCT01084252|7723093|FG009|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6791580|NCT01084252|7723094|FG010|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6791581|NCT01084252|7723095|FG011|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6791582|NCT01084252|7723096|FG012|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6791583|NCT01084252|7723097|FG013|All Treated (AT) Population|Phase 1 (120 Weeks)||0
6791584|NCT01084252|7723084|FG000|COMPLETED|Phase 1 (120 Weeks)||0
6791585|NCT01084252|7723085|FG001|COMPLETED|Phase 1 (120 Weeks)||0
6791586|NCT01084252|7723086|FG002|COMPLETED|Phase 1 (120 Weeks)||0
6791587|NCT01084252|7723087|FG003|COMPLETED|Phase 1 (120 Weeks)||0
6791588|NCT01084252|7723088|FG004|COMPLETED|Phase 1 (120 Weeks)||0
6791589|NCT01084252|7723089|FG005|COMPLETED|Phase 1 (120 Weeks)||0
6791590|NCT01084252|7723090|FG006|COMPLETED|Phase 1 (120 Weeks)||0
6791591|NCT01084252|7723091|FG007|COMPLETED|Phase 1 (120 Weeks)||0
6791592|NCT01084252|7723092|FG008|COMPLETED|Phase 1 (120 Weeks)||0
6791593|NCT01084252|7723093|FG009|COMPLETED|Phase 1 (120 Weeks)||0
6791594|NCT01084252|7723094|FG010|COMPLETED|Phase 1 (120 Weeks)||0
6791595|NCT01084252|7723095|FG011|COMPLETED|Phase 1 (120 Weeks)||0
6791596|NCT01084252|7723096|FG012|COMPLETED|Phase 1 (120 Weeks)||0
6791597|NCT01084252|7723097|FG013|COMPLETED|Phase 1 (120 Weeks)||0
6791598|NCT01084252|7723084|FG000|NOT COMPLETED|Phase 1 (120 Weeks)||16
6791599|NCT01084252|7723085|FG001|NOT COMPLETED|Phase 1 (120 Weeks)||6
6791600|NCT01084252|7723086|FG002|NOT COMPLETED|Phase 1 (120 Weeks)||3
6791601|NCT01084252|7723087|FG003|NOT COMPLETED|Phase 1 (120 Weeks)||26
6378987|NCT00770991|7289556|FG000|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
6378988|NCT00770991|7289557|FG001|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
6378989|NCT00770991|7289556|FG000|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
6378990|NCT00770991|7289557|FG001|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
6502263|NCT01433549|7420919|FG000|NOT COMPLETED|Phase 2: Second Study Product||0
6502264|NCT01433549|7420920|FG001|NOT COMPLETED|Phase 2: Second Study Product||1
6502265|NCT01433731|7420930|FG000|STARTED|Overall Study||3
6502266|NCT01433731|7420931|FG001|STARTED|Overall Study||5
6502267|NCT01433731|7420932|FG002|STARTED|Overall Study||5
6791602|NCT01084252|7723088|FG004|NOT COMPLETED|Phase 1 (120 Weeks)||18
6791603|NCT01084252|7723089|FG005|NOT COMPLETED|Phase 1 (120 Weeks)||6
6791604|NCT01084252|7723090|FG006|NOT COMPLETED|Phase 1 (120 Weeks)||7
6791605|NCT01084252|7723091|FG007|NOT COMPLETED|Phase 1 (120 Weeks)||7
6791606|NCT01084252|7723092|FG008|NOT COMPLETED|Phase 1 (120 Weeks)||0
6791607|NCT01084252|7723093|FG009|NOT COMPLETED|Phase 1 (120 Weeks)||0
6791608|NCT01084252|7723094|FG010|NOT COMPLETED|Phase 1 (120 Weeks)||0
6791609|NCT01084252|7723095|FG011|NOT COMPLETED|Phase 1 (120 Weeks)||0
6791610|NCT01084252|7723096|FG012|NOT COMPLETED|Phase 1 (120 Weeks)||0
6791611|NCT01084252|7723097|FG013|NOT COMPLETED|Phase 1 (120 Weeks)||0
6791612|NCT01084252|7723084|FG000|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791613|NCT01084252|7723085|FG001|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791614|NCT01084252|7723086|FG002|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791615|NCT01084252|7723087|FG003|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791616|NCT01084252|7723088|FG004|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791617|NCT01084252|7723089|FG005|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791618|NCT01084252|7723090|FG006|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791619|NCT01084252|7723091|FG007|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791620|NCT01084252|7723092|FG008|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|23
6791621|NCT01084252|7723093|FG009|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|24
6791622|NCT01084252|7723094|FG010|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
6791623|NCT01084252|7723095|FG011|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|25
6791624|NCT01084252|7723096|FG012|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791625|NCT01084252|7723097|FG013|STARTED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791626|NCT01084252|7723084|FG000|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791627|NCT01084252|7723085|FG001|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791628|NCT01084252|7723086|FG002|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791629|NCT01084252|7723087|FG003|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791630|NCT01084252|7723088|FG004|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791631|NCT01084252|7723089|FG005|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791632|NCT01084252|7723090|FG006|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6502268|NCT01433731|7420933|FG003|STARTED|Overall Study||5
6502269|NCT01433731|7420930|FG000|COMPLETED|Overall Study||3
6502270|NCT01433731|7420931|FG001|COMPLETED|Overall Study||5
6502271|NCT01433731|7420932|FG002|COMPLETED|Overall Study||5
6791633|NCT01084252|7723091|FG007|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791634|NCT01084252|7723092|FG008|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
6791635|NCT01084252|7723093|FG009|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
6791636|NCT01084252|7723094|FG010|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
6791637|NCT01084252|7723095|FG011|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
6791638|NCT01084252|7723096|FG012|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791639|NCT01084252|7723097|FG013|AT Population|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791640|NCT01084252|7723084|FG000|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791641|NCT01084252|7723085|FG001|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791642|NCT01084252|7723086|FG002|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791643|NCT01084252|7723087|FG003|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791644|NCT01084252|7723088|FG004|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791645|NCT01084252|7723089|FG005|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791646|NCT01084252|7723090|FG006|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791647|NCT01084252|7723091|FG007|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791648|NCT01084252|7723092|FG008|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791649|NCT01084252|7723093|FG009|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791650|NCT01084252|7723094|FG010|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791651|NCT01084252|7723095|FG011|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791652|NCT01084252|7723096|FG012|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791653|NCT01084252|7723097|FG013|COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791654|NCT01084252|7723084|FG000|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791655|NCT01084252|7723085|FG001|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791656|NCT01084252|7723086|FG002|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791657|NCT01084252|7723087|FG003|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791658|NCT01084252|7723088|FG004|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791659|NCT01084252|7723089|FG005|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791660|NCT01084252|7723090|FG006|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791661|NCT01084252|7723091|FG007|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791662|NCT01084252|7723092|FG008|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||23
6791663|NCT01084252|7723093|FG009|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||24
6791664|NCT01084252|7723094|FG010|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
6791665|NCT01084252|7723095|FG011|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||25
6791666|NCT01084252|7723096|FG012|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791667|NCT01084252|7723097|FG013|NOT COMPLETED|Phase 2 Stage 1(1a-77 Weeks;1b-53 Weeks)||0
6791668|NCT01084252|7723084|FG000|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791669|NCT01084252|7723085|FG001|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791670|NCT01084252|7723086|FG002|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791671|NCT01084252|7723087|FG003|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791672|NCT01084252|7723088|FG004|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791673|NCT01084252|7723089|FG005|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791674|NCT01084252|7723090|FG006|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791675|NCT01084252|7723091|FG007|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791676|NCT01084252|7723092|FG008|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791677|NCT01084252|7723093|FG009|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791678|NCT01084252|7723094|FG010|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791679|NCT01084252|7723095|FG011|STARTED|Phase 2 Stage 2 (97 Weeks)||0
6791680|NCT01084252|7723096|FG012|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|110
6791681|NCT01084252|7723097|FG013|STARTED|Phase 2 Stage 2 (97 Weeks)|Phase 1, Phase 2 Stage 1 and Phase 2 Stage 2 were separate populations.|55
6791682|NCT01084252|7723084|FG000|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791683|NCT01084252|7723085|FG001|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791684|NCT01084252|7723086|FG002|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791685|NCT01084252|7723087|FG003|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791686|NCT01084252|7723088|FG004|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791687|NCT01084252|7723089|FG005|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791688|NCT01084252|7723090|FG006|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791689|NCT01084252|7723091|FG007|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791690|NCT01084252|7723092|FG008|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791691|NCT01084252|7723093|FG009|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791692|NCT01084252|7723094|FG010|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791693|NCT01084252|7723095|FG011|AT Population|Phase 2 Stage 2 (97 Weeks)||0
6791694|NCT01084252|7723096|FG012|AT Population|Phase 2 Stage 2 (97 Weeks)||109
6791695|NCT01084252|7723097|FG013|AT Population|Phase 2 Stage 2 (97 Weeks)||55
6791696|NCT01084252|7723084|FG000|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791697|NCT01084252|7723085|FG001|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791698|NCT01084252|7723086|FG002|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791699|NCT01084252|7723087|FG003|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791700|NCT01084252|7723088|FG004|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791701|NCT01084252|7723089|FG005|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791702|NCT01084252|7723090|FG006|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791703|NCT01084252|7723091|FG007|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791704|NCT01084252|7723092|FG008|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791705|NCT01084252|7723093|FG009|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791706|NCT01084252|7723094|FG010|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791707|NCT01084252|7723095|FG011|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791708|NCT01084252|7723096|FG012|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791709|NCT01084252|7723097|FG013|COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791710|NCT01084252|7723084|FG000|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791711|NCT01084252|7723085|FG001|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791712|NCT01084252|7723086|FG002|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791713|NCT01084252|7723087|FG003|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791714|NCT01084252|7723088|FG004|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791715|NCT01084252|7723089|FG005|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791716|NCT01084252|7723090|FG006|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791717|NCT01084252|7723091|FG007|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791718|NCT01084252|7723092|FG008|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791719|NCT01084252|7723093|FG009|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791720|NCT01084252|7723094|FG010|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791721|NCT01084252|7723095|FG011|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||0
6791722|NCT01084252|7723096|FG012|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||110
6791723|NCT01084252|7723097|FG013|NOT COMPLETED|Phase 2 Stage 2 (97 Weeks)||55
6791724|NCT00867321|7723164|FG000|STARTED|Overall Study||4
6791725|NCT00867321|7723165|FG001|STARTED|Overall Study||3
6791726|NCT00867321|7723166|FG002|STARTED|Overall Study||3
6791727|NCT00867321|7723167|FG003|STARTED|Overall Study||6
6791728|NCT00867321|7723168|FG004|STARTED|Overall Study||5
6791729|NCT00867321|7723169|FG005|STARTED|Overall Study||3
6791730|NCT00867321|7723164|FG000|COMPLETED|Overall Study||4
6791731|NCT00867321|7723165|FG001|COMPLETED|Overall Study||2
6791732|NCT00867321|7723166|FG002|COMPLETED|Overall Study||3
6791733|NCT00867321|7723167|FG003|COMPLETED|Overall Study||6
6791734|NCT00867321|7723168|FG004|COMPLETED|Overall Study||5
6791735|NCT00867321|7723169|FG005|COMPLETED|Overall Study||3
6791736|NCT00867321|7723164|FG000|NOT COMPLETED|Overall Study||0
6791737|NCT00867321|7723165|FG001|NOT COMPLETED|Overall Study||1
6791738|NCT00867321|7723166|FG002|NOT COMPLETED|Overall Study||0
6791739|NCT00867321|7723167|FG003|NOT COMPLETED|Overall Study||0
6791740|NCT00867321|7723168|FG004|NOT COMPLETED|Overall Study||0
6791741|NCT00867321|7723169|FG005|NOT COMPLETED|Overall Study||0
6791742|NCT00728962|7723184|FG000|STARTED|Implant Placement Surgery||75
6791743|NCT00728962|7723184|FG000|COMPLETED|Implant Placement Surgery||65
6791744|NCT00728962|7723184|FG000|NOT COMPLETED|Implant Placement Surgery||10
6791745|NCT00728962|7723184|FG000|STARTED|Permanent Prosthesis Placement||65
6791746|NCT00728962|7723184|FG000|COMPLETED|Permanent Prosthesis Placement||62
6791747|NCT00728962|7723184|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
6791748|NCT00728962|7723184|FG000|STARTED|One Year Post Placement Follow-up||62
6791749|NCT00728962|7723184|FG000|COMPLETED|One Year Post Placement Follow-up||62
6791750|NCT00728962|7723184|FG000|NOT COMPLETED|One Year Post Placement Follow-up||0
6791751|NCT00728962|7723184|FG000|STARTED|Two Year Post Placement Follow-up||62
6791752|NCT00728962|7723184|FG000|COMPLETED|Two Year Post Placement Follow-up||59
6791753|NCT00728962|7723184|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||3
6791754|NCT00728754|7723190|FG000|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
6791755|NCT00728754|7723191|FG001|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
6791756|NCT00728754|7723190|FG000|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
6791757|NCT00728754|7723191|FG001|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
6791758|NCT00728754|7723190|FG000|NOT COMPLETED|Implant Placement Surgery||0
6791759|NCT00728754|7723191|FG001|NOT COMPLETED|Implant Placement Surgery||0
6791760|NCT00728754|7723190|FG000|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
6791761|NCT00728754|7723191|FG001|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
6791762|NCT00728754|7723190|FG000|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
6791763|NCT00728754|7723191|FG001|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
6791764|NCT00728754|7723190|FG000|NOT COMPLETED|Permanent Prosthesis Placement||4
6791765|NCT00728754|7723191|FG001|NOT COMPLETED|Permanent Prosthesis Placement||4
6791766|NCT00728754|7723190|FG000|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
6791767|NCT00728754|7723191|FG001|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
6791768|NCT00728754|7723190|FG000|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
6791769|NCT00728754|7723191|FG001|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
6791770|NCT00728754|7723190|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
6791771|NCT00728754|7723191|FG001|NOT COMPLETED|One Year Post Placement Follow-up||0
6791772|NCT00728754|7723190|FG000|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
6791773|NCT00728754|7723191|FG001|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
6791774|NCT00728754|7723190|FG000|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
6791775|NCT00728754|7723191|FG001|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
6378991|NCT00770991|7289556|FG000|NOT COMPLETED|Overall Study||5
6378992|NCT00770991|7289557|FG001|NOT COMPLETED|Overall Study||5
6378993|NCT00771030|7289575|FG000|STARTED|Overall Study||6
6378994|NCT00771030|7289576|FG001|STARTED|Overall Study||4
6378995|NCT00771030|7289577|FG002|STARTED|Overall Study||6
6378996|NCT00771030|7289578|FG003|STARTED|Overall Study||6
6791776|NCT00728754|7723190|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
6791777|NCT00728754|7723191|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
6791778|NCT00723944|7723199|FG000|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
6791779|NCT00723944|7723200|FG001|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
6791780|NCT00723944|7723199|FG000|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
6791781|NCT00723944|7723200|FG001|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
6791782|NCT00723944|7723199|FG000|NOT COMPLETED|Implant Placement Surgery||0
6791783|NCT00723944|7723200|FG001|NOT COMPLETED|Implant Placement Surgery||0
6791784|NCT00723944|7723199|FG000|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
6791785|NCT00723944|7723200|FG001|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
6791786|NCT00723944|7723199|FG000|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
6563394|NCT01806714|7486307|FG001|STARTED|Overall Study||2089
6563395|NCT01806714|7486306|FG000|COMPLETED|Overall Study||1893
6563396|NCT01806714|7486307|FG001|COMPLETED|Overall Study||1919
6563397|NCT01806714|7486306|FG000|NOT COMPLETED|Overall Study||200
6563398|NCT01806714|7486307|FG001|NOT COMPLETED|Overall Study||170
6563399|NCT01806740|7486313|FG000|STARTED|Overall Study||37
6791787|NCT00723944|7723200|FG001|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
6791788|NCT00723944|7723199|FG000|NOT COMPLETED|Permanent Prosthesis Placement||3
6791789|NCT00723944|7723200|FG001|NOT COMPLETED|Permanent Prosthesis Placement||9
6791790|NCT00723944|7723199|FG000|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
6791791|NCT00723944|7723200|FG001|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
6791792|NCT00723944|7723199|FG000|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
6791793|NCT00723944|7723200|FG001|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
6791794|NCT00723944|7723199|FG000|NOT COMPLETED|One Year Post Placement Follow-up||1
6791795|NCT00723944|7723200|FG001|NOT COMPLETED|One Year Post Placement Follow-up||4
6563400|NCT01806740|7486313|FG000|COMPLETED|Overall Study||31
6791796|NCT00723944|7723199|FG000|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
6791797|NCT00723944|7723200|FG001|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
6791798|NCT00723944|7723199|FG000|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
6791799|NCT00723944|7723200|FG001|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
6791800|NCT00723944|7723199|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
6791801|NCT00723944|7723200|FG001|NOT COMPLETED|Two Year Post Placement Follow-up||0
6791802|NCT00565851|7723214|FG000|STARTED|Surgical Assignment||316
6791803|NCT00565851|7723215|FG001|STARTED|Surgical Assignment||456
6791804|NCT00565851|7723216|FG002|STARTED|Surgical Assignment||33
6791805|NCT00565851|7723217|FG003|STARTED|Surgical Assignment||165
6791806|NCT00565851|7723218|FG004|STARTED|Surgical Assignment||6
6791807|NCT00565851|7723219|FG005|STARTED|Surgical Assignment||34
6791808|NCT00565851|7723220|FG006|STARTED|Surgical Assignment||5
6563401|NCT01806740|7486313|FG000|NOT COMPLETED|Overall Study||6
6563402|NCT01806779|7486322|FG000|STARTED|Overall Study||90
6563403|NCT01806779|7486323|FG001|STARTED|Overall Study||84
6563404|NCT01806779|7486324|FG002|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
6563405|NCT01806779|7486322|FG000|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
6563406|NCT01806779|7486323|FG001|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
6563407|NCT01806779|7486324|FG002|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
6563408|NCT01806779|7486322|FG000|Randomized at Visit 2|Overall Study||90
6563409|NCT01806779|7486323|FG001|Randomized at Visit 2|Overall Study||84
6791809|NCT00565851|7723221|FG007|STARTED|Surgical Assignment||37
6563410|NCT01806779|7486324|FG002|Randomized at Visit 2|Overall Study||0
6563411|NCT01806779|7486322|FG000|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
6563412|NCT01806779|7486323|FG001|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
6563413|NCT01806779|7486324|FG002|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
6563414|NCT01806779|7486322|FG000|COMPLETED|Overall Study||48
6563415|NCT01806779|7486323|FG001|COMPLETED|Overall Study||40
6563416|NCT01806779|7486324|FG002|COMPLETED|Overall Study||0
6563417|NCT01806779|7486322|FG000|NOT COMPLETED|Overall Study||42
6563418|NCT01806779|7486323|FG001|NOT COMPLETED|Overall Study||44
6563419|NCT01806779|7486324|FG002|NOT COMPLETED|Overall Study||23
6563420|NCT01806857|7486331|FG000|STARTED|Overall Study||31
6563421|NCT01806857|7486332|FG001|STARTED|Overall Study||29
6563422|NCT01806857|7486331|FG000|COMPLETED|Overall Study||30
6563423|NCT01806857|7486332|FG001|COMPLETED|Overall Study||29
6563424|NCT01806857|7486331|FG000|NOT COMPLETED|Overall Study||1
6563425|NCT01806857|7486332|FG001|NOT COMPLETED|Overall Study||0
6563426|NCT01806896|7486341|FG000|STARTED|Overall Study||20
6563427|NCT01806896|7486342|FG001|STARTED|Overall Study||17
6563428|NCT01806896|7486341|FG000|Received Treatment|Overall Study||19
6563429|NCT01806896|7486342|FG001|Received Treatment|Overall Study||17
6791810|NCT00565851|7723214|FG000|Randomized - Yes Surgery|Surgical Assignment||0
6791811|NCT00565851|7723215|FG001|Randomized - Yes Surgery|Surgical Assignment||0
6791812|NCT00565851|7723216|FG002|Randomized - Yes Surgery|Surgical Assignment||33
6791813|NCT00565851|7723217|FG003|Randomized - Yes Surgery|Surgical Assignment||165
6791814|NCT00565851|7723218|FG004|Randomized - Yes Surgery|Surgical Assignment||0
6791815|NCT00565851|7723219|FG005|Randomized - Yes Surgery|Surgical Assignment||0
6791816|NCT00565851|7723220|FG006|Randomized - Yes Surgery|Surgical Assignment||5
6791817|NCT00565851|7723221|FG007|Randomized - Yes Surgery|Surgical Assignment||37
6791818|NCT00565851|7723214|FG000|Randomized - no Surgery|Surgical Assignment||33
6791819|NCT00565851|7723215|FG001|Randomized - no Surgery|Surgical Assignment||172
6791820|NCT00565851|7723216|FG002|Randomized - no Surgery|Surgical Assignment||0
6563430|NCT01806896|7486341|FG000|COMPLETED|Overall Study||17
6563431|NCT01806896|7486342|FG001|COMPLETED|Overall Study||17
6563432|NCT01806896|7486341|FG000|NOT COMPLETED|Overall Study||3
6563433|NCT01806896|7486342|FG001|NOT COMPLETED|Overall Study||0
6563434|NCT01807000|7486348|FG000|STARTED|Overall Study||6
6563435|NCT01807000|7486348|FG000|COMPLETED|Overall Study||6
6563436|NCT01807000|7486348|FG000|NOT COMPLETED|Overall Study||0
6563437|NCT01807026|7486358|FG000|STARTED|Overall Study||10
6563438|NCT01807026|7486359|FG001|STARTED|Overall Study||2
6563439|NCT01807026|7486360|FG002|STARTED|Overall Study||10
6563440|NCT01807026|7486361|FG003|STARTED|Overall Study||2
6563441|NCT01807026|7486362|FG004|STARTED|Overall Study||9
6563442|NCT01807026|7486363|FG005|STARTED|Overall Study||3
6563443|NCT01807026|7486358|FG000|Received at Least One Dose of Study Drug|Overall Study||10
6563444|NCT01807026|7486359|FG001|Received at Least One Dose of Study Drug|Overall Study||2
6563445|NCT01807026|7486360|FG002|Received at Least One Dose of Study Drug|Overall Study||10
6563446|NCT01807026|7486361|FG003|Received at Least One Dose of Study Drug|Overall Study||2
6563447|NCT01807026|7486362|FG004|Received at Least One Dose of Study Drug|Overall Study||9
6791821|NCT00565851|7723217|FG003|Randomized - no Surgery|Surgical Assignment||0
6791822|NCT00565851|7723218|FG004|Randomized - no Surgery|Surgical Assignment||6
6791823|NCT00565851|7723219|FG005|Randomized - no Surgery|Surgical Assignment||34
6791824|NCT00565851|7723220|FG006|Randomized - no Surgery|Surgical Assignment||0
6791825|NCT00565851|7723221|FG007|Randomized - no Surgery|Surgical Assignment||0
6791826|NCT00565851|7723214|FG000|Not Surgical Candidate|Surgical Assignment||283
6791827|NCT00565851|7723215|FG001|Not Surgical Candidate|Surgical Assignment||284
6791828|NCT00565851|7723216|FG002|Not Surgical Candidate|Surgical Assignment||0
6791829|NCT00565851|7723217|FG003|Not Surgical Candidate|Surgical Assignment||0
6791830|NCT00565851|7723218|FG004|Not Surgical Candidate|Surgical Assignment||0
6563448|NCT01807026|7486363|FG005|Received at Least One Dose of Study Drug|Overall Study||3
6563449|NCT01807026|7486358|FG000|COMPLETED|Overall Study||10
6563450|NCT01807026|7486359|FG001|COMPLETED|Overall Study||2
6563451|NCT01807026|7486360|FG002|COMPLETED|Overall Study||10
6563452|NCT01807026|7486361|FG003|COMPLETED|Overall Study||2
6563453|NCT01807026|7486362|FG004|COMPLETED|Overall Study||9
6563454|NCT01807026|7486363|FG005|COMPLETED|Overall Study||3
6563455|NCT01807026|7486358|FG000|NOT COMPLETED|Overall Study||0
6563456|NCT01807026|7486359|FG001|NOT COMPLETED|Overall Study||0
6563457|NCT01807026|7486360|FG002|NOT COMPLETED|Overall Study||0
6563458|NCT01807026|7486361|FG003|NOT COMPLETED|Overall Study||0
6563459|NCT01807026|7486362|FG004|NOT COMPLETED|Overall Study||0
6563460|NCT01807026|7486363|FG005|NOT COMPLETED|Overall Study||0
6563461|NCT01807065|7486384|FG000|STARTED|Overall Study||25
6656420|NCT02461160|7586600|FG003|COMPLETED|Overall Study||12
6656421|NCT02461160|7586601|FG004|COMPLETED|Overall Study||6
6656422|NCT02461160|7586602|FG005|COMPLETED|Overall Study||6
6656423|NCT02461160|7586603|FG006|COMPLETED|Overall Study||6
6656424|NCT02461160|7586604|FG007|COMPLETED|Overall Study||5
6656425|NCT02461160|7586605|FG008|COMPLETED|Overall Study||12
6656426|NCT02461160|7586606|FG009|COMPLETED|Overall Study||4
6656427|NCT02461160|7586607|FG010|COMPLETED|Overall Study||4
6656428|NCT02461160|7586608|FG011|COMPLETED|Overall Study||4
6656429|NCT02461160|7586609|FG012|COMPLETED|Overall Study||8
6656430|NCT02461160|7586597|FG000|NOT COMPLETED|Overall Study||0
6656431|NCT02461160|7586598|FG001|NOT COMPLETED|Overall Study||0
6656432|NCT02461160|7586599|FG002|NOT COMPLETED|Overall Study||0
6656433|NCT02461160|7586600|FG003|NOT COMPLETED|Overall Study||0
6656434|NCT02461160|7586601|FG004|NOT COMPLETED|Overall Study||0
6656435|NCT02461160|7586602|FG005|NOT COMPLETED|Overall Study||0
6656436|NCT02461160|7586603|FG006|NOT COMPLETED|Overall Study||0
6656437|NCT02461160|7586604|FG007|NOT COMPLETED|Overall Study||1
6656438|NCT02461160|7586605|FG008|NOT COMPLETED|Overall Study||0
6656439|NCT02461160|7586606|FG009|NOT COMPLETED|Overall Study||0
6563462|NCT01807065|7486385|FG001|STARTED|Overall Study||26
6563463|NCT01807065|7486384|FG000|COMPLETED|Overall Study||24
6563464|NCT01807065|7486385|FG001|COMPLETED|Overall Study||25
6563465|NCT01807065|7486384|FG000|NOT COMPLETED|Overall Study||1
6563466|NCT01807065|7486385|FG001|NOT COMPLETED|Overall Study||1
6563467|NCT01807091|7486391|FG000|STARTED|Overall Study||17
6563468|NCT01807091|7486391|FG000|COMPLETED|Overall Study||17
6656440|NCT02461160|7586607|FG010|NOT COMPLETED|Overall Study||0
6656441|NCT02461160|7586608|FG011|NOT COMPLETED|Overall Study||0
6656442|NCT02461160|7586609|FG012|NOT COMPLETED|Overall Study||0
6791831|NCT00565851|7723219|FG005|Not Surgical Candidate|Surgical Assignment||0
6791832|NCT00565851|7723220|FG006|Not Surgical Candidate|Surgical Assignment||0
6791833|NCT00565851|7723221|FG007|Not Surgical Candidate|Surgical Assignment||0
6791834|NCT00565851|7723214|FG000|COMPLETED|Surgical Assignment||313
6791835|NCT00565851|7723215|FG001|COMPLETED|Surgical Assignment||454
6791836|NCT00565851|7723216|FG002|COMPLETED|Surgical Assignment||31
6791837|NCT00565851|7723217|FG003|COMPLETED|Surgical Assignment||154
6791838|NCT00565851|7723218|FG004|COMPLETED|Surgical Assignment||6
6791839|NCT00565851|7723219|FG005|COMPLETED|Surgical Assignment||34
6791840|NCT00565851|7723220|FG006|COMPLETED|Surgical Assignment||5
6791841|NCT00565851|7723221|FG007|COMPLETED|Surgical Assignment||35
6791842|NCT00565851|7723214|FG000|NOT COMPLETED|Surgical Assignment||3
6791843|NCT00565851|7723215|FG001|NOT COMPLETED|Surgical Assignment||2
6791844|NCT00565851|7723216|FG002|NOT COMPLETED|Surgical Assignment||2
6791845|NCT00565851|7723217|FG003|NOT COMPLETED|Surgical Assignment||11
6791846|NCT00565851|7723218|FG004|NOT COMPLETED|Surgical Assignment||0
6791847|NCT00565851|7723219|FG005|NOT COMPLETED|Surgical Assignment||0
6791848|NCT00565851|7723220|FG006|NOT COMPLETED|Surgical Assignment||0
6791849|NCT00565851|7723221|FG007|NOT COMPLETED|Surgical Assignment||2
6791850|NCT00565851|7723214|FG000|STARTED|Chemotherapy Assignment||316
6791851|NCT00565851|7723215|FG001|STARTED|Chemotherapy Assignment||456
6791852|NCT00565851|7723216|FG002|STARTED|Chemotherapy Assignment||33
6791853|NCT00565851|7723217|FG003|STARTED|Chemotherapy Assignment||165
6791854|NCT00565851|7723218|FG004|STARTED|Chemotherapy Assignment||6
6791855|NCT00565851|7723219|FG005|STARTED|Chemotherapy Assignment||34
6791856|NCT00565851|7723220|FG006|STARTED|Chemotherapy Assignment||5
6791857|NCT00565851|7723221|FG007|STARTED|Chemotherapy Assignment||37
6791858|NCT00565851|7723214|FG000|Randomized to Chemo|Chemotherapy Assignment||310
6791859|NCT00565851|7723215|FG001|Randomized to Chemo|Chemotherapy Assignment||311
6791860|NCT00565851|7723216|FG002|Randomized to Chemo|Chemotherapy Assignment||27
6791861|NCT00565851|7723217|FG003|Randomized to Chemo|Chemotherapy Assignment||26
6791862|NCT00565851|7723218|FG004|Randomized to Chemo|Chemotherapy Assignment||0
6791863|NCT00565851|7723219|FG005|Randomized to Chemo|Chemotherapy Assignment||0
6791864|NCT00565851|7723220|FG006|Randomized to Chemo|Chemotherapy Assignment||0
6791865|NCT00565851|7723221|FG007|Randomized to Chemo|Chemotherapy Assignment||0
6791866|NCT00565851|7723214|FG000|Pre-specified Chemo|Chemotherapy Assignment||6
6791867|NCT00565851|7723215|FG001|Pre-specified Chemo|Chemotherapy Assignment||145
6791868|NCT00565851|7723216|FG002|Pre-specified Chemo|Chemotherapy Assignment||6
6791869|NCT00565851|7723217|FG003|Pre-specified Chemo|Chemotherapy Assignment||139
6791870|NCT00565851|7723218|FG004|Pre-specified Chemo|Chemotherapy Assignment||6
6791871|NCT00565851|7723219|FG005|Pre-specified Chemo|Chemotherapy Assignment||34
6791872|NCT00565851|7723220|FG006|Pre-specified Chemo|Chemotherapy Assignment||5
6791873|NCT00565851|7723221|FG007|Pre-specified Chemo|Chemotherapy Assignment||37
6791874|NCT00565851|7723214|FG000|COMPLETED|Chemotherapy Assignment||307
6791875|NCT00565851|7723215|FG001|COMPLETED|Chemotherapy Assignment||433
6791876|NCT00565851|7723216|FG002|COMPLETED|Chemotherapy Assignment||30
6791877|NCT00565851|7723217|FG003|COMPLETED|Chemotherapy Assignment||129
6791878|NCT00565851|7723218|FG004|COMPLETED|Chemotherapy Assignment||6
6791879|NCT00565851|7723219|FG005|COMPLETED|Chemotherapy Assignment||31
6791880|NCT00565851|7723220|FG006|COMPLETED|Chemotherapy Assignment||5
6791881|NCT00565851|7723221|FG007|COMPLETED|Chemotherapy Assignment||34
6791882|NCT00565851|7723214|FG000|NOT COMPLETED|Chemotherapy Assignment||9
6791883|NCT00565851|7723215|FG001|NOT COMPLETED|Chemotherapy Assignment||23
6791884|NCT00565851|7723216|FG002|NOT COMPLETED|Chemotherapy Assignment||3
6791885|NCT00565851|7723217|FG003|NOT COMPLETED|Chemotherapy Assignment||36
6791886|NCT00565851|7723218|FG004|NOT COMPLETED|Chemotherapy Assignment||0
6791887|NCT00565851|7723219|FG005|NOT COMPLETED|Chemotherapy Assignment||3
6791888|NCT00565851|7723220|FG006|NOT COMPLETED|Chemotherapy Assignment||0
6791889|NCT00565851|7723221|FG007|NOT COMPLETED|Chemotherapy Assignment||3
6791890|NCT00467142|7723243|FG000|STARTED|Overall Study||62
6791891|NCT00467142|7723243|FG000|COMPLETED|Overall Study||59
6791892|NCT00467142|7723243|FG000|NOT COMPLETED|Overall Study||3
6791893|NCT04878172|7723251|FG000|STARTED|Overall Study||2
6791894|NCT04878172|7723252|FG001|STARTED|Overall Study||2
6791895|NCT04878172|7723253|FG002|STARTED|Overall Study||2
6791896|NCT04878172|7723254|FG003|STARTED|Overall Study||3
6791897|NCT04878172|7723251|FG000|COMPLETED|Overall Study||2
6791898|NCT04878172|7723252|FG001|COMPLETED|Overall Study||2
6791899|NCT04878172|7723253|FG002|COMPLETED|Overall Study||2
6791900|NCT04878172|7723254|FG003|COMPLETED|Overall Study||3
6791901|NCT04878172|7723251|FG000|NOT COMPLETED|Overall Study||0
6791902|NCT04878172|7723252|FG001|NOT COMPLETED|Overall Study||0
6791903|NCT04878172|7723253|FG002|NOT COMPLETED|Overall Study||0
6791904|NCT04878172|7723254|FG003|NOT COMPLETED|Overall Study||0
6791905|NCT04671017|7723267|FG000|STARTED|Overall Study||51
6791906|NCT04671017|7723268|FG001|STARTED|Overall Study||51
6791907|NCT04671017|7723269|FG002|STARTED|Overall Study||51
6791908|NCT04671017|7723267|FG000|COMPLETED|Overall Study||51
6791909|NCT04671017|7723268|FG001|COMPLETED|Overall Study||51
6791910|NCT04671017|7723269|FG002|COMPLETED|Overall Study||51
6791911|NCT04671017|7723267|FG000|NOT COMPLETED|Overall Study||0
6791912|NCT04671017|7723268|FG001|NOT COMPLETED|Overall Study||0
6791913|NCT04671017|7723269|FG002|NOT COMPLETED|Overall Study||0
6791914|NCT04557371|7723280|FG000|STARTED|Overall Study||50
6791915|NCT04557371|7723281|FG001|STARTED|Overall Study||49
6791916|NCT04557371|7723282|FG002|STARTED|Overall Study||51
6791917|NCT04557371|7723280|FG000|COMPLETED|Overall Study||49
6791918|NCT04557371|7723281|FG001|COMPLETED|Overall Study||47
6791919|NCT04557371|7723282|FG002|COMPLETED|Overall Study||51
6791920|NCT04557371|7723280|FG000|NOT COMPLETED|Overall Study||1
6791921|NCT04557371|7723281|FG001|NOT COMPLETED|Overall Study||2
6791922|NCT04557371|7723282|FG002|NOT COMPLETED|Overall Study||0
6791923|NCT04540952|7723292|FG000|STARTED|Overall Study||34
6791924|NCT04540952|7723293|FG001|STARTED|Overall Study||34
6791925|NCT04540952|7723292|FG000|COMPLETED|Overall Study||34
6791926|NCT04540952|7723293|FG001|COMPLETED|Overall Study||34
6791927|NCT04540952|7723292|FG000|NOT COMPLETED|Overall Study||0
6791928|NCT04540952|7723293|FG001|NOT COMPLETED|Overall Study||0
6791929|NCT04369742|7723303|FG000|STARTED|Overall Study||67
6791930|NCT04369742|7723304|FG001|STARTED|Overall Study||61
6791931|NCT04369742|7723303|FG000|COMPLETED|Overall Study||53
6791932|NCT04369742|7723304|FG001|COMPLETED|Overall Study||50
6791933|NCT04369742|7723303|FG000|NOT COMPLETED|Overall Study||14
6791934|NCT04369742|7723304|FG001|NOT COMPLETED|Overall Study||11
6791935|NCT04346628|7723312|FG000|STARTED|Overall Study||74
6791936|NCT04346628|7723313|FG001|STARTED|Overall Study||75
6791937|NCT04346628|7723312|FG000|Intention-to-treat (ITT) Analysis Set|Overall Study||74
6791938|NCT04346628|7723313|FG001|Intention-to-treat (ITT) Analysis Set|Overall Study||75
6791939|NCT04346628|7723312|FG000|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||70
6791940|NCT04346628|7723313|FG001|Symptomatic Modified ITT (smITT) Analysis Set|Overall Study||65
6791941|NCT04346628|7723312|FG000|Modified ITT (mITT) Analysis|Overall Study||57
6791942|NCT04346628|7723313|FG001|Modified ITT (mITT) Analysis|Overall Study||59
6791943|NCT04346628|7723312|FG000|COMPLETED|Overall Study||68
6791944|NCT04346628|7723313|FG001|COMPLETED|Overall Study||62
6791945|NCT04346628|7723312|FG000|NOT COMPLETED|Overall Study||6
6791946|NCT04346628|7723313|FG001|NOT COMPLETED|Overall Study||13
6791947|NCT04115644|7723322|FG000|STARTED|Overall Study||26
6791948|NCT04115644|7723323|FG001|STARTED|Overall Study||30
6791949|NCT04115644|7723324|FG002|STARTED|Overall Study||26
6791950|NCT04115644|7723322|FG000|COMPLETED|Overall Study||26
6791951|NCT04115644|7723323|FG001|COMPLETED|Overall Study||30
6791952|NCT04115644|7723324|FG002|COMPLETED|Overall Study||25
6791953|NCT04115644|7723322|FG000|NOT COMPLETED|Overall Study||0
6791954|NCT04115644|7723323|FG001|NOT COMPLETED|Overall Study||0
6791955|NCT04115644|7723324|FG002|NOT COMPLETED|Overall Study||1
6791980|NCT03875664|7723371|FG000|STARTED|Overall Study||37
6791981|NCT03875664|7723372|FG001|STARTED|Overall Study||35
6791982|NCT03875664|7723371|FG000|COMPLETED|Overall Study|vaginal surgery n=18; vaginal + abdominal surgery n=19|37
6791983|NCT03875664|7723372|FG001|COMPLETED|Overall Study|Vaginal surgery n=18; vaginal + abdominal surgery n=17|35
6791984|NCT03875664|7723371|FG000|NOT COMPLETED|Overall Study||0
6791985|NCT03875664|7723372|FG001|NOT COMPLETED|Overall Study||0
6791986|NCT03812588|7723382|FG000|STARTED|Overall Study||5
6791987|NCT03812588|7723383|FG001|STARTED|Overall Study||7
6791988|NCT03812588|7723384|FG002|STARTED|Overall Study||5
6791989|NCT03812588|7723385|FG003|STARTED|Overall Study||8
6791990|NCT03812588|7723382|FG000|COMPLETED|Overall Study||3
6791991|NCT03812588|7723383|FG001|COMPLETED|Overall Study||5
6791992|NCT03812588|7723384|FG002|COMPLETED|Overall Study||3
6791993|NCT03812588|7723385|FG003|COMPLETED|Overall Study||8
6791994|NCT03812588|7723382|FG000|NOT COMPLETED|Overall Study||2
6791995|NCT03812588|7723383|FG001|NOT COMPLETED|Overall Study||2
6791996|NCT03812588|7723384|FG002|NOT COMPLETED|Overall Study||2
6791997|NCT03812588|7723385|FG003|NOT COMPLETED|Overall Study||0
6791998|NCT03690674|7723395|FG000|STARTED|Overall Study||35
6791999|NCT03690674|7723396|FG001|STARTED|Overall Study||35
6792000|NCT03690674|7723395|FG000|COMPLETED|Overall Study||32
6792001|NCT03690674|7723396|FG001|COMPLETED|Overall Study||32
6792002|NCT03690674|7723395|FG000|NOT COMPLETED|Overall Study||3
6792003|NCT03690674|7723396|FG001|NOT COMPLETED|Overall Study||3
6791956|NCT04005859|7723334|FG000|STARTED|Overall Study||32
6791957|NCT04005859|7723335|FG001|STARTED|Overall Study||29
6791958|NCT04005859|7723334|FG000|COMPLETED|Overall Study||28
6378997|NCT00771030|7289579|FG004|STARTED|Overall Study||6
6378998|NCT00771030|7289580|FG005|STARTED|Overall Study||6
6791959|NCT04005859|7723335|FG001|COMPLETED|Overall Study||25
6791960|NCT04005859|7723334|FG000|NOT COMPLETED|Overall Study||4
6791961|NCT04005859|7723335|FG001|NOT COMPLETED|Overall Study||4
6791962|NCT04003623|7723343|FG000|STARTED|Overall Study||1
6791963|NCT04003623|7723344|FG001|STARTED|Overall Study||0
6791964|NCT04003623|7723343|FG000|COMPLETED|Overall Study||0
6791965|NCT04003623|7723344|FG001|COMPLETED|Overall Study||0
6791966|NCT04003623|7723343|FG000|NOT COMPLETED|Overall Study||1
6791967|NCT04003623|7723344|FG001|NOT COMPLETED|Overall Study||0
6791968|NCT03969589|7723352|FG000|STARTED|Overall Study||20
6791969|NCT03969589|7723353|FG001|STARTED|Overall Study||20
6791970|NCT03969589|7723352|FG000|COMPLETED|Overall Study||17
6791971|NCT03969589|7723353|FG001|COMPLETED|Overall Study||17
6791972|NCT03969589|7723352|FG000|NOT COMPLETED|Overall Study||3
6791973|NCT03969589|7723353|FG001|NOT COMPLETED|Overall Study||3
6791974|NCT03917472|7723361|FG000|STARTED|Overall Study||346
6791975|NCT03917472|7723362|FG001|STARTED|Overall Study||171
6791976|NCT03917472|7723361|FG000|COMPLETED|Overall Study||311
6791977|NCT03917472|7723362|FG001|COMPLETED|Overall Study||156
6791978|NCT03917472|7723361|FG000|NOT COMPLETED|Overall Study||35
6791979|NCT03917472|7723362|FG001|NOT COMPLETED|Overall Study||15
6792004|NCT03655691|7723406|FG000|STARTED|Overall Study||26
6792005|NCT03655691|7723407|FG001|STARTED|Overall Study||26
6792006|NCT03655691|7723408|FG002|STARTED|Overall Study||27
6792007|NCT03655691|7723406|FG000|COMPLETED|Overall Study||24
6792008|NCT03655691|7723407|FG001|COMPLETED|Overall Study||23
6792009|NCT03655691|7723408|FG002|COMPLETED|Overall Study||24
6792010|NCT03655691|7723406|FG000|NOT COMPLETED|Overall Study||2
6792011|NCT03655691|7723407|FG001|NOT COMPLETED|Overall Study||3
6792012|NCT03655691|7723408|FG002|NOT COMPLETED|Overall Study||3
6792013|NCT03608670|7723416|FG000|STARTED|Overall Study||26
6792014|NCT03608670|7723416|FG000|Implant Attempted|Overall Study||21
6792015|NCT03608670|7723416|FG000|Successfully Implanted|Overall Study||17
6792016|NCT03608670|7723416|FG000|2-week Follow-up|Overall Study||17
6792017|NCT03608670|7723416|FG000|4-6 Weeks Follow-up|Overall Study||17
6792018|NCT03608670|7723416|FG000|COMPLETED|Overall Study||16
6792019|NCT03608670|7723416|FG000|NOT COMPLETED|Overall Study||10
6792020|NCT03462719|7723422|FG000|STARTED|Overall Study||106
6792021|NCT03462719|7723423|FG001|STARTED|Overall Study||105
6792022|NCT03462719|7723422|FG000|COMPLETED|Overall Study||11
6792023|NCT03462719|7723423|FG001|COMPLETED|Overall Study||11
6792024|NCT03462719|7723422|FG000|NOT COMPLETED|Overall Study||95
6792025|NCT03462719|7723423|FG001|NOT COMPLETED|Overall Study||94
6792026|NCT03412565|7723433|FG000|STARTED|Overall Study||67
6792027|NCT03412565|7723434|FG001|STARTED|Overall Study||67
6792028|NCT03412565|7723435|FG002|STARTED|Overall Study||65
6792029|NCT03412565|7723436|FG003|STARTED|Overall Study||66
6792030|NCT03412565|7723433|FG000|COMPLETED|Overall Study||66
6792031|NCT03412565|7723434|FG001|COMPLETED|Overall Study||2
6792032|NCT03412565|7723435|FG002|COMPLETED|Overall Study||3
6792033|NCT03412565|7723436|FG003|COMPLETED|Overall Study||12
6792034|NCT03412565|7723433|FG000|NOT COMPLETED|Overall Study||1
6792035|NCT03412565|7723434|FG001|NOT COMPLETED|Overall Study||65
6792036|NCT03412565|7723435|FG002|NOT COMPLETED|Overall Study||62
6792037|NCT03412565|7723436|FG003|NOT COMPLETED|Overall Study||54
6792038|NCT03364686|7723451|FG000|STARTED|Overall Study||6
6792039|NCT03364686|7723451|FG000|COMPLETED|Overall Study||4
6792040|NCT03364686|7723451|FG000|NOT COMPLETED|Overall Study||2
6792041|NCT03345771|7723457|FG000|STARTED|Overall Study||115
6792042|NCT03345771|7723458|FG001|STARTED|Overall Study||115
6792043|NCT03345771|7723457|FG000|COMPLETED|Overall Study||115
6792044|NCT03345771|7723458|FG001|COMPLETED|Overall Study||115
6792045|NCT03345771|7723457|FG000|NOT COMPLETED|Overall Study||0
6792046|NCT03345771|7723458|FG001|NOT COMPLETED|Overall Study||0
6792047|NCT03326856|7723469|FG000|STARTED|Overall Study||13
6792048|NCT03326856|7723470|FG001|STARTED|Overall Study||9
6792049|NCT03326856|7723471|FG002|STARTED|Overall Study||9
6792050|NCT03326856|7723472|FG003|STARTED|Overall Study||9
6792051|NCT03326856|7723473|FG004|STARTED|Overall Study||8
6792052|NCT03326856|7723469|FG000|COMPLETED|Overall Study||12
6792053|NCT03326856|7723470|FG001|COMPLETED|Overall Study||8
6792054|NCT03326856|7723471|FG002|COMPLETED|Overall Study||9
6792055|NCT03326856|7723472|FG003|COMPLETED|Overall Study||9
6792056|NCT03326856|7723473|FG004|COMPLETED|Overall Study||8
6792057|NCT03326856|7723469|FG000|NOT COMPLETED|Overall Study||1
6792058|NCT03326856|7723470|FG001|NOT COMPLETED|Overall Study||1
6792059|NCT03326856|7723471|FG002|NOT COMPLETED|Overall Study||0
6792060|NCT03326856|7723472|FG003|NOT COMPLETED|Overall Study||0
6792061|NCT03326856|7723473|FG004|NOT COMPLETED|Overall Study||0
6792062|NCT03287947|7723485|FG000|STARTED|Overall Study|Five subjects were enrolled to the study.|5
6792063|NCT03287947|7723485|FG000|COMPLETED|Overall Study|All subjects enrolled discontinued treatment and are now off study.|5
6792064|NCT03287947|7723485|FG000|NOT COMPLETED|Overall Study||0
6792065|NCT03287089|7723491|FG000|STARTED|Overall Study||82
6792066|NCT03287089|7723492|FG001|STARTED|Overall Study||82
6792067|NCT03287089|7723491|FG000|COMPLETED|Overall Study||82
6792068|NCT03287089|7723492|FG001|COMPLETED|Overall Study||76
6792069|NCT03287089|7723491|FG000|NOT COMPLETED|Overall Study||0
6792070|NCT03287089|7723492|FG001|NOT COMPLETED|Overall Study||6
6792071|NCT03277105|7723500|FG000|STARTED|Overall Study||259
6792072|NCT03277105|7723501|FG001|STARTED|Overall Study||263
6792073|NCT03277105|7723500|FG000|Safety Analysis Set|Overall Study||258
6792074|NCT03277105|7723501|FG001|Safety Analysis Set|Overall Study||260
6792075|NCT03277105|7723500|FG000|COMPLETED|Overall Study||0
6792076|NCT03277105|7723501|FG001|COMPLETED|Overall Study||0
6792077|NCT03277105|7723500|FG000|NOT COMPLETED|Overall Study||259
6792078|NCT03277105|7723501|FG001|NOT COMPLETED|Overall Study||263
6792079|NCT03240692|7723507|FG000|STARTED|Overall Study||23
6792080|NCT03240692|7723507|FG000|COMPLETED|Overall Study||21
6792081|NCT03240692|7723507|FG000|NOT COMPLETED|Overall Study||2
6792082|NCT03227029|7723514|FG000|STARTED|Overall Study||26
6792083|NCT03227029|7723515|FG001|STARTED|Overall Study||26
6792084|NCT03227029|7723516|FG002|STARTED|Overall Study||13
6792085|NCT03227029|7723514|FG000|Received Inoculation|Overall Study||26
6792086|NCT03227029|7723515|FG001|Received Inoculation|Overall Study||25
6792087|NCT03227029|7723516|FG002|Received Inoculation|Overall Study||12
6792088|NCT03227029|7723514|FG000|COMPLETED|Overall Study||22
6792089|NCT03227029|7723515|FG001|COMPLETED|Overall Study||22
6792090|NCT03227029|7723516|FG002|COMPLETED|Overall Study||9
6792091|NCT03227029|7723514|FG000|NOT COMPLETED|Overall Study||4
6792092|NCT03227029|7723515|FG001|NOT COMPLETED|Overall Study||4
6792093|NCT03227029|7723516|FG002|NOT COMPLETED|Overall Study||4
6792094|NCT03207776|7723526|FG000|STARTED|Overall Study||2479
6792095|NCT03207776|7723527|FG001|STARTED|Overall Study||2353
6792096|NCT03207776|7723526|FG000|COMPLETED|Overall Study||2479
6792097|NCT03207776|7723527|FG001|COMPLETED|Overall Study||2353
6792098|NCT03207776|7723526|FG000|NOT COMPLETED|Overall Study||0
6792099|NCT03207776|7723527|FG001|NOT COMPLETED|Overall Study||0
6792100|NCT03204643|7723535|FG000|STARTED|Overall Study||323
6792101|NCT03204643|7723536|FG001|STARTED|Overall Study||314
6792102|NCT03204643|7723535|FG000|COMPLETED|Overall Study||323
6792103|NCT03204643|7723536|FG001|COMPLETED|Overall Study||314
6792104|NCT03204643|7723535|FG000|NOT COMPLETED|Overall Study||0
6792105|NCT03204643|7723536|FG001|NOT COMPLETED|Overall Study||0
6792106|NCT03201965|7723545|FG000|STARTED|Overall Study||28
6792107|NCT03201965|7723546|FG001|STARTED|Overall Study||193
6792108|NCT03201965|7723547|FG002|STARTED|Overall Study||195
6792109|NCT03201965|7723545|FG000|Treated|Overall Study||28
6792110|NCT03201965|7723546|FG001|Treated|Overall Study||188
6792111|NCT03201965|7723547|FG002|Treated|Overall Study||193
6792112|NCT03201965|7723545|FG000|COMPLETED|Overall Study||0
6792113|NCT03201965|7723546|FG001|COMPLETED|Overall Study||0
6792114|NCT03201965|7723547|FG002|COMPLETED|Overall Study||0
6792115|NCT03201965|7723545|FG000|NOT COMPLETED|Overall Study||28
6792116|NCT03201965|7723546|FG001|NOT COMPLETED|Overall Study||193
6792117|NCT03201965|7723547|FG002|NOT COMPLETED|Overall Study||195
6792118|NCT03182829|7723556|FG000|STARTED|Overall Study||467
6792119|NCT03182829|7723557|FG001|STARTED|Overall Study||444
6792120|NCT03182829|7723556|FG000|COMPLETED|Overall Study||451
6792121|NCT03182829|7723557|FG001|COMPLETED|Overall Study||429
6792122|NCT03182829|7723556|FG000|NOT COMPLETED|Overall Study||16
6792123|NCT03182829|7723557|FG001|NOT COMPLETED|Overall Study||15
6792124|NCT03181789|7723567|FG000|STARTED|Overall Study||25
6792125|NCT03181789|7723568|FG001|STARTED|Overall Study||25
6792126|NCT03181789|7723569|FG002|STARTED|Overall Study||3
6792127|NCT03181789|7723570|FG003|STARTED|Overall Study||3
6792128|NCT03181789|7723567|FG000|Safety Population|Overall Study||25
6792129|NCT03181789|7723568|FG001|Safety Population|Overall Study||25
6792130|NCT03181789|7723569|FG002|Safety Population|Overall Study||3
6792131|NCT03181789|7723570|FG003|Safety Population|Overall Study||3
6792132|NCT03181789|7723567|FG000|COMPLETED|Overall Study||18
6792133|NCT03181789|7723568|FG001|COMPLETED|Overall Study||22
6792134|NCT03181789|7723569|FG002|COMPLETED|Overall Study||2
6792135|NCT03181789|7723570|FG003|COMPLETED|Overall Study||3
6792136|NCT03181789|7723567|FG000|NOT COMPLETED|Overall Study||7
6792137|NCT03181789|7723568|FG001|NOT COMPLETED|Overall Study||3
6792138|NCT03181789|7723569|FG002|NOT COMPLETED|Overall Study||1
6792139|NCT03181789|7723570|FG003|NOT COMPLETED|Overall Study||0
6792140|NCT03164356|7723585|FG000|STARTED|Overall Study||19
6792141|NCT03164356|7723586|FG001|STARTED|Overall Study||15
6792142|NCT03164356|7723587|FG002|STARTED|Overall Study||17
6792143|NCT03164356|7723588|FG003|STARTED|Overall Study||17
6792144|NCT03164356|7723585|FG000|COMPLETED|Overall Study||14
6792145|NCT03164356|7723586|FG001|COMPLETED|Overall Study||10
6792146|NCT03164356|7723587|FG002|COMPLETED|Overall Study||11
6792147|NCT03164356|7723588|FG003|COMPLETED|Overall Study||15
6792148|NCT03164356|7723585|FG000|NOT COMPLETED|Overall Study||5
6792149|NCT03164356|7723586|FG001|NOT COMPLETED|Overall Study||5
6792150|NCT03164356|7723587|FG002|NOT COMPLETED|Overall Study||6
6792151|NCT03164356|7723588|FG003|NOT COMPLETED|Overall Study||2
6792152|NCT02975700|7723608|FG000|STARTED|Overall Study||6
6792153|NCT02975700|7723608|FG000|COMPLETED|Overall Study||0
6792154|NCT02975700|7723608|FG000|NOT COMPLETED|Overall Study||6
6792155|NCT02941549|7723615|FG000|STARTED|Overall Study||31
6792156|NCT02941549|7723616|FG001|STARTED|Overall Study||32
6792157|NCT02941549|7723617|FG002|STARTED|Overall Study||33
6792158|NCT02941549|7723615|FG000|COMPLETED|Overall Study||28
6792159|NCT02941549|7723616|FG001|COMPLETED|Overall Study||31
6792160|NCT02941549|7723617|FG002|COMPLETED|Overall Study||31
6792161|NCT02941549|7723615|FG000|NOT COMPLETED|Overall Study||3
6792162|NCT02941549|7723616|FG001|NOT COMPLETED|Overall Study||1
6792163|NCT02941549|7723617|FG002|NOT COMPLETED|Overall Study||2
6792164|NCT02937766|7723630|FG000|STARTED|Overall Study||30
6792165|NCT02937766|7723631|FG001|STARTED|Overall Study||30
6792166|NCT02937766|7723630|FG000|COMPLETED|Overall Study||23
6792167|NCT02937766|7723631|FG001|COMPLETED|Overall Study||30
6792168|NCT02937766|7723630|FG000|NOT COMPLETED|Overall Study||7
6792169|NCT02937766|7723631|FG001|NOT COMPLETED|Overall Study||0
6792170|NCT02927938|7723641|FG000|STARTED|Overall Study||1
6792171|NCT02927938|7723642|FG001|STARTED|Overall Study||6
6792172|NCT02927938|7723643|FG002|STARTED|Overall Study||4
6792173|NCT02927938|7723644|FG003|STARTED|Overall Study||7
6792174|NCT02927938|7723641|FG000|COMPLETED|Overall Study||0
6792175|NCT02927938|7723642|FG001|COMPLETED|Overall Study||0
6792176|NCT02927938|7723643|FG002|COMPLETED|Overall Study||0
6792177|NCT02927938|7723644|FG003|COMPLETED|Overall Study||0
6792178|NCT02927938|7723641|FG000|NOT COMPLETED|Overall Study||1
6792179|NCT02927938|7723642|FG001|NOT COMPLETED|Overall Study||6
6792180|NCT02927938|7723643|FG002|NOT COMPLETED|Overall Study||4
6792181|NCT02927938|7723644|FG003|NOT COMPLETED|Overall Study||7
6792182|NCT02913131|7723654|FG000|STARTED|Overall Study||18
6792183|NCT02913131|7723655|FG001|STARTED|Overall Study|Two of the five participants enrolled in Part B were previously enrolled in Part A.|5
6792184|NCT02913131|7723654|FG000|COMPLETED|Overall Study||18
6792185|NCT02913131|7723655|FG001|COMPLETED|Overall Study||5
6792186|NCT02913131|7723654|FG000|NOT COMPLETED|Overall Study||0
6792187|NCT02913131|7723655|FG001|NOT COMPLETED|Overall Study||0
6792188|NCT02883400|7723664|FG000|STARTED|Overall Study||22
6792189|NCT02883400|7723665|FG001|STARTED|Overall Study||8
6792190|NCT02883400|7723664|FG000|COMPLETED|Overall Study||22
6792191|NCT02883400|7723665|FG001|COMPLETED|Overall Study||8
6792192|NCT02883400|7723664|FG000|NOT COMPLETED|Overall Study||0
6792193|NCT02883400|7723665|FG001|NOT COMPLETED|Overall Study||0
6792194|NCT02855060|7723673|FG000|STARTED|Overall Study||22
6792195|NCT02855060|7723674|FG001|STARTED|Overall Study||28
6792196|NCT02855060|7723673|FG000|COMPLETED|Overall Study||20
6792197|NCT02855060|7723674|FG001|COMPLETED|Overall Study||23
6792198|NCT02855060|7723673|FG000|NOT COMPLETED|Overall Study||2
6792199|NCT02855060|7723674|FG001|NOT COMPLETED|Overall Study||5
6792200|NCT02823574|7723684|FG000|STARTED|Pre-Treatment Period||159
6792201|NCT02823574|7723685|FG001|STARTED|Pre-Treatment Period||82
6792202|NCT02823574|7723686|FG002|STARTED|Pre-Treatment Period||123
6792203|NCT02823574|7723687|FG003|STARTED|Pre-Treatment Period||61
6792204|NCT02823574|7723684|FG000|COMPLETED|Pre-Treatment Period||158
6792205|NCT02823574|7723685|FG001|COMPLETED|Pre-Treatment Period||82
6792206|NCT02823574|7723686|FG002|COMPLETED|Pre-Treatment Period||122
6792207|NCT02823574|7723687|FG003|COMPLETED|Pre-Treatment Period||61
6792208|NCT02823574|7723684|FG000|NOT COMPLETED|Pre-Treatment Period||1
6792209|NCT02823574|7723685|FG001|NOT COMPLETED|Pre-Treatment Period||0
6792210|NCT02823574|7723686|FG002|NOT COMPLETED|Pre-Treatment Period||1
6792211|NCT02823574|7723687|FG003|NOT COMPLETED|Pre-Treatment Period||0
6792212|NCT02823574|7723684|FG000|STARTED|Treatment Period||158
6792213|NCT02823574|7723685|FG001|STARTED|Treatment Period||82
6792214|NCT02823574|7723686|FG002|STARTED|Treatment Period||122
6792215|NCT02823574|7723687|FG003|STARTED|Treatment Period||61
6792216|NCT02823574|7723684|FG000|COMPLETED|Treatment Period||19
6792217|NCT02823574|7723685|FG001|COMPLETED|Treatment Period||16
6792218|NCT02823574|7723686|FG002|COMPLETED|Treatment Period||14
6792219|NCT02823574|7723687|FG003|COMPLETED|Treatment Period||10
6792220|NCT02823574|7723684|FG000|NOT COMPLETED|Treatment Period||139
6792221|NCT02823574|7723685|FG001|NOT COMPLETED|Treatment Period||66
6792222|NCT02823574|7723686|FG002|NOT COMPLETED|Treatment Period||108
6792223|NCT02823574|7723687|FG003|NOT COMPLETED|Treatment Period||51
6792224|NCT02771990|7723702|FG000|STARTED|Overall Study||11
6792225|NCT02771990|7723703|FG001|STARTED|Overall Study||10
6792226|NCT02771990|7723702|FG000|COMPLETED|Overall Study||11
6792227|NCT02771990|7723703|FG001|COMPLETED|Overall Study||10
6792228|NCT02771990|7723702|FG000|NOT COMPLETED|Overall Study||0
6792229|NCT02771990|7723703|FG001|NOT COMPLETED|Overall Study||0
6792230|NCT02743819|7723709|FG000|STARTED|Overall Study||70
6792231|NCT02743819|7723709|FG000|COMPLETED|Overall Study||62
6792232|NCT02743819|7723709|FG000|NOT COMPLETED|Overall Study||8
6792233|NCT02729753|7723715|FG000|STARTED|Overall Study|First patient enrolled April 2016|3
6792234|NCT02729753|7723716|FG001|STARTED|Overall Study|First patient enrolled April 2016|7
6792235|NCT02729753|7723715|FG000|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|3
6792236|NCT02729753|7723716|FG001|COMPLETED|Overall Study|Study Complete on 30 Oct 2016|6
6792237|NCT02729753|7723715|FG000|NOT COMPLETED|Overall Study||0
6792238|NCT02729753|7723716|FG001|NOT COMPLETED|Overall Study||1
6792239|NCT02704130|7723727|FG000|STARTED|Overall Study||5
6792240|NCT02704130|7723728|FG001|STARTED|Overall Study||3
6792241|NCT02704130|7723727|FG000|COMPLETED|Overall Study||0
6792242|NCT02704130|7723728|FG001|COMPLETED|Overall Study||0
6792243|NCT02704130|7723727|FG000|NOT COMPLETED|Overall Study||5
6792244|NCT02704130|7723728|FG001|NOT COMPLETED|Overall Study||3
6792245|NCT02701192|7723734|FG000|STARTED|Overall Study||100
6792246|NCT02701192|7723734|FG000|COMPLETED|Overall Study||94
6792247|NCT02701192|7723734|FG000|NOT COMPLETED|Overall Study||6
6792248|NCT02685709|7723742|FG000|STARTED|Run-in Phase||146
6792249|NCT02685709|7723743|FG001|STARTED|Run-in Phase||0
6792250|NCT02685709|7723744|FG002|STARTED|Run-in Phase||0
6792251|NCT02685709|7723745|FG003|STARTED|Run-in Phase||0
6792252|NCT02685709|7723742|FG000|COMPLETED|Run-in Phase|30 patients early terminated the Run-in phase and 24 patient were not randomized to RCT|116
6792253|NCT02685709|7723743|FG001|COMPLETED|Run-in Phase||0
6792254|NCT02685709|7723744|FG002|COMPLETED|Run-in Phase||0
6792255|NCT02685709|7723745|FG003|COMPLETED|Run-in Phase||0
6792256|NCT02685709|7723742|FG000|NOT COMPLETED|Run-in Phase||30
6792257|NCT02685709|7723743|FG001|NOT COMPLETED|Run-in Phase||0
6792258|NCT02685709|7723744|FG002|NOT COMPLETED|Run-in Phase||0
6792259|NCT02685709|7723745|FG003|NOT COMPLETED|Run-in Phase||0
6792260|NCT02685709|7723742|FG000|STARTED|RCT Phase|116 patients completed the Run-in phase, out of which 92 were randomized to the RCT phase, and 24 were not randomized to the RCT phase. Out of these 24, 11 patients eneterd the combination phase.|0
6792261|NCT02685709|7723743|FG001|STARTED|RCT Phase||55
6792262|NCT02685709|7723744|FG002|STARTED|RCT Phase||37
6792263|NCT02685709|7723745|FG003|STARTED|RCT Phase||0
6792264|NCT02685709|7723742|FG000|COMPLETED|RCT Phase||0
6792265|NCT02685709|7723743|FG001|COMPLETED|RCT Phase||54
6792266|NCT02685709|7723744|FG002|COMPLETED|RCT Phase||35
6792267|NCT02685709|7723745|FG003|COMPLETED|RCT Phase||0
6792268|NCT02685709|7723742|FG000|NOT COMPLETED|RCT Phase||0
6792269|NCT02685709|7723743|FG001|NOT COMPLETED|RCT Phase||1
6792270|NCT02685709|7723744|FG002|NOT COMPLETED|RCT Phase||2
6792271|NCT02685709|7723745|FG003|NOT COMPLETED|RCT Phase||0
6792272|NCT02685709|7723742|FG000|STARTED|Combination Phase||0
6792273|NCT02685709|7723743|FG001|STARTED|Combination Phase||0
6792274|NCT02685709|7723744|FG002|STARTED|Combination Phase||0
6792275|NCT02685709|7723745|FG003|STARTED|Combination Phase|14 patients entered the combination phase (3 patients early discontinued the Run-in phase, and 11 patients completed Run-in and were not eligible to RCT phase).|14
6792276|NCT02685709|7723742|FG000|COMPLETED|Combination Phase||0
6792277|NCT02685709|7723743|FG001|COMPLETED|Combination Phase||0
6792278|NCT02685709|7723744|FG002|COMPLETED|Combination Phase||0
6792279|NCT02685709|7723745|FG003|COMPLETED|Combination Phase||8
6792280|NCT02685709|7723742|FG000|NOT COMPLETED|Combination Phase||0
6792281|NCT02685709|7723743|FG001|NOT COMPLETED|Combination Phase||0
6792282|NCT02685709|7723744|FG002|NOT COMPLETED|Combination Phase||0
6792283|NCT02685709|7723745|FG003|NOT COMPLETED|Combination Phase||6
6792284|NCT02684851|7723757|FG000|STARTED|Overall Study||42
6792285|NCT02684851|7723758|FG001|STARTED|Overall Study||45
6792286|NCT02684851|7723757|FG000|COMPLETED|Overall Study||42
6792287|NCT02684851|7723758|FG001|COMPLETED|Overall Study||45
6792288|NCT02684851|7723757|FG000|NOT COMPLETED|Overall Study||0
6792289|NCT02684851|7723758|FG001|NOT COMPLETED|Overall Study||0
6792290|NCT02653482|7723768|FG000|STARTED|Overall Study||131
6792291|NCT02653482|7723769|FG001|STARTED|Overall Study||132
6792292|NCT02653482|7723768|FG000|COMPLETED|Overall Study||130
6792293|NCT02653482|7723769|FG001|COMPLETED|Overall Study||131
6792294|NCT02653482|7723768|FG000|NOT COMPLETED|Overall Study||1
6378999|NCT00771030|7289581|FG006|STARTED|Overall Study||6
6379000|NCT00771030|7289575|FG000|Received Study Drug|Overall Study||6
6379001|NCT00771030|7289576|FG001|Received Study Drug|Overall Study||4
6379002|NCT00771030|7289577|FG002|Received Study Drug|Overall Study||6
6379003|NCT00771030|7289578|FG003|Received Study Drug|Overall Study||6
6379004|NCT00771030|7289579|FG004|Received Study Drug|Overall Study||6
6792295|NCT02653482|7723769|FG001|NOT COMPLETED|Overall Study||1
6792296|NCT02632409|7723777|FG000|STARTED|Randomized||356
6792297|NCT02632409|7723778|FG001|STARTED|Randomized||353
6792298|NCT02632409|7723777|FG000|COMPLETED|Randomized||348
6792299|NCT02632409|7723778|FG001|COMPLETED|Randomized||351
6792300|NCT02632409|7723777|FG000|NOT COMPLETED|Randomized||8
6792301|NCT02632409|7723778|FG001|NOT COMPLETED|Randomized||2
6792302|NCT02632409|7723777|FG000|STARTED|Treatment Period||348
6792303|NCT02632409|7723778|FG001|STARTED|Treatment Period||351
6792304|NCT02632409|7723777|FG000|COMPLETED|Treatment Period||132
6792305|NCT02632409|7723778|FG001|COMPLETED|Treatment Period||143
6792306|NCT02632409|7723777|FG000|NOT COMPLETED|Treatment Period||216
6792307|NCT02632409|7723778|FG001|NOT COMPLETED|Treatment Period||208
6792308|NCT02612194|7723787|FG000|STARTED|Overall Study||6
6792309|NCT02612194|7723788|FG001|STARTED|Overall Study||0
6792310|NCT02612194|7723789|FG002|STARTED|Overall Study||2
6792311|NCT02612194|7723787|FG000|COMPLETED|Overall Study||0
6792312|NCT02612194|7723788|FG001|COMPLETED|Overall Study||0
6792313|NCT02612194|7723789|FG002|COMPLETED|Overall Study||0
6792314|NCT02612194|7723787|FG000|NOT COMPLETED|Overall Study||6
6792315|NCT02612194|7723788|FG001|NOT COMPLETED|Overall Study||0
6792316|NCT02612194|7723789|FG002|NOT COMPLETED|Overall Study||2
6792317|NCT02586207|7723796|FG000|STARTED|Overall Study||59
6792318|NCT02586207|7723796|FG000|COMPLETED|Overall Study||57
6792319|NCT02586207|7723796|FG000|NOT COMPLETED|Overall Study||2
6656443|NCT02461290|7586658|FG000|STARTED|Overall Study||99
6656444|NCT02461290|7586658|FG000|COMPLETED|Overall Study||89
6656445|NCT02461290|7586658|FG000|NOT COMPLETED|Overall Study||10
6656446|NCT02461433|7586664|FG000|STARTED|Overall Study||1
6656447|NCT02461433|7586665|FG001|STARTED|Overall Study||1
6656448|NCT02461433|7586664|FG000|COMPLETED|Overall Study||1
6656449|NCT02461433|7586665|FG001|COMPLETED|Overall Study||1
6656450|NCT02461433|7586664|FG000|NOT COMPLETED|Overall Study||0
6656451|NCT02461433|7586665|FG001|NOT COMPLETED|Overall Study||0
6656452|NCT02461563|7586675|FG000|STARTED|Overall Study||3
6656453|NCT02461563|7586676|FG001|STARTED|Overall Study||3
6656454|NCT02461563|7586677|FG002|STARTED|Overall Study||3
6656455|NCT02461563|7586678|FG003|STARTED|Overall Study||3
6656456|NCT02461563|7586675|FG000|COMPLETED|Overall Study||3
6656457|NCT02461563|7586676|FG001|COMPLETED|Overall Study||3
6656458|NCT02461563|7586677|FG002|COMPLETED|Overall Study||3
6656459|NCT02461563|7586678|FG003|COMPLETED|Overall Study||3
6656460|NCT02461563|7586675|FG000|NOT COMPLETED|Overall Study||0
6656461|NCT02461563|7586676|FG001|NOT COMPLETED|Overall Study||0
6656462|NCT02461563|7586677|FG002|NOT COMPLETED|Overall Study||0
6656463|NCT02461563|7586678|FG003|NOT COMPLETED|Overall Study||0
6656464|NCT02461589|7586704|FG000|STARTED|Overall Study||64
6656465|NCT02461589|7586705|FG001|STARTED|Overall Study||63
6656466|NCT02461589|7586706|FG002|STARTED|Overall Study||65
6656467|NCT02461589|7586707|FG003|STARTED|Overall Study||63
6656468|NCT02461589|7586708|FG004|STARTED|Overall Study||64
6656469|NCT02461589|7586709|FG005|STARTED|Overall Study||64
6656470|NCT02461589|7586710|FG006|STARTED|Overall Study||64
6656471|NCT02461589|7586711|FG007|STARTED|Overall Study||65
6656472|NCT02461589|7586712|FG008|STARTED|Overall Study||129
6656473|NCT02461589|7586713|FG009|STARTED|Overall Study||65
6656474|NCT02461589|7586704|FG000|Exposed|Overall Study||64
6656475|NCT02461589|7586705|FG001|Exposed|Overall Study||63
6656476|NCT02461589|7586706|FG002|Exposed|Overall Study||65
6656477|NCT02461589|7586707|FG003|Exposed|Overall Study||63
6656478|NCT02461589|7586708|FG004|Exposed|Overall Study||64
6656479|NCT02461589|7586709|FG005|Exposed|Overall Study||64
6656480|NCT02461589|7586710|FG006|Exposed|Overall Study||64
6656481|NCT02461589|7586711|FG007|Exposed|Overall Study||65
6656482|NCT02461589|7586712|FG008|Exposed|Overall Study||129
6656483|NCT02461589|7586713|FG009|Exposed|Overall Study||64
6656484|NCT02461589|7586704|FG000|COMPLETED|Overall Study||58
6656485|NCT02461589|7586705|FG001|COMPLETED|Overall Study||61
6656486|NCT02461589|7586706|FG002|COMPLETED|Overall Study||60
6656487|NCT02461589|7586707|FG003|COMPLETED|Overall Study||58
6656488|NCT02461589|7586708|FG004|COMPLETED|Overall Study||62
6656489|NCT02461589|7586709|FG005|COMPLETED|Overall Study||61
6656490|NCT02461589|7586710|FG006|COMPLETED|Overall Study||58
6792320|NCT02542397|7723800|FG000|STARTED|Overall Study|75 subjects were enrolled to the study (i.e., submitted buccal swab).|75
6379005|NCT00771030|7289580|FG005|Received Study Drug|Overall Study||6
6656491|NCT02461589|7586711|FG007|COMPLETED|Overall Study||60
6656492|NCT02461589|7586712|FG008|COMPLETED|Overall Study||123
6656493|NCT02461589|7586713|FG009|COMPLETED|Overall Study||60
6656494|NCT02461589|7586704|FG000|NOT COMPLETED|Overall Study||6
6656495|NCT02461589|7586705|FG001|NOT COMPLETED|Overall Study||2
6792321|NCT02542397|7723800|FG000|COMPLETED|Overall Study|54 enrolled subjects provided pain scores at baseline and final assessments within 30 +/- 7 days.|59
6656496|NCT02461589|7586706|FG002|NOT COMPLETED|Overall Study||5
6656497|NCT02461589|7586707|FG003|NOT COMPLETED|Overall Study||5
6656498|NCT02461589|7586708|FG004|NOT COMPLETED|Overall Study||2
6656499|NCT02461589|7586709|FG005|NOT COMPLETED|Overall Study||3
6656500|NCT02461589|7586710|FG006|NOT COMPLETED|Overall Study||6
6656501|NCT02461589|7586711|FG007|NOT COMPLETED|Overall Study||5
6656502|NCT02461589|7586712|FG008|NOT COMPLETED|Overall Study||6
6379006|NCT00771030|7289581|FG006|Received Study Drug|Overall Study||6
6379007|NCT00771030|7289575|FG000|COMPLETED|Overall Study||6
6379008|NCT00771030|7289576|FG001|COMPLETED|Overall Study||3
6379009|NCT00771030|7289577|FG002|COMPLETED|Overall Study||6
6379010|NCT00771030|7289578|FG003|COMPLETED|Overall Study||6
6379011|NCT00771030|7289579|FG004|COMPLETED|Overall Study||6
6379012|NCT00771030|7289580|FG005|COMPLETED|Overall Study||6
6379013|NCT00771030|7289581|FG006|COMPLETED|Overall Study||6
6379014|NCT00771030|7289575|FG000|NOT COMPLETED|Overall Study||0
6379015|NCT00771030|7289576|FG001|NOT COMPLETED|Overall Study||1
6379016|NCT00771030|7289577|FG002|NOT COMPLETED|Overall Study||0
6379017|NCT00771030|7289578|FG003|NOT COMPLETED|Overall Study||0
6379018|NCT00771030|7289579|FG004|NOT COMPLETED|Overall Study||0
6379019|NCT00771030|7289580|FG005|NOT COMPLETED|Overall Study||0
6379020|NCT00771030|7289581|FG006|NOT COMPLETED|Overall Study||0
6379021|NCT00771056|7289602|FG000|STARTED|Overall Study||23
6379022|NCT00771056|7289602|FG000|COMPLETED|Overall Study||18
6379023|NCT00771056|7289602|FG000|NOT COMPLETED|Overall Study||5
6379024|NCT00771173|7289608|FG000|STARTED|Overall Study||129
6379025|NCT00771173|7289609|FG001|STARTED|Overall Study||129
6379026|NCT00771173|7289608|FG000|COMPLETED|Overall Study||107
6379027|NCT00771173|7289609|FG001|COMPLETED|Overall Study||112
6379028|NCT00771173|7289608|FG000|NOT COMPLETED|Overall Study||22
6379029|NCT00771173|7289609|FG001|NOT COMPLETED|Overall Study||17
6379030|NCT00771238|7289617|FG000|STARTED|Overall Study||31
6379031|NCT00771238|7289618|FG001|STARTED|Overall Study||21
6379032|NCT00771238|7289617|FG000|COMPLETED|Overall Study||31
6379033|NCT00771238|7289618|FG001|COMPLETED|Overall Study||21
6379034|NCT00771238|7289617|FG000|NOT COMPLETED|Overall Study||0
6379035|NCT00771238|7289618|FG001|NOT COMPLETED|Overall Study||0
6379036|NCT00771264|7289626|FG000|STARTED|Overall Study||110
6379037|NCT00771264|7289627|FG001|STARTED|Overall Study||110
6379038|NCT00771264|7289626|FG000|COMPLETED|Overall Study||103
6379039|NCT00771264|7289627|FG001|COMPLETED|Overall Study||105
6379040|NCT00771264|7289626|FG000|NOT COMPLETED|Overall Study||7
6379041|NCT00771264|7289627|FG001|NOT COMPLETED|Overall Study||5
6379042|NCT00771277|7289633|FG000|STARTED|Overall Study||6
6379043|NCT00771277|7289633|FG000|COMPLETED|Overall Study||6
6379044|NCT00771277|7289633|FG000|NOT COMPLETED|Overall Study||0
6379045|NCT00771407|7289639|FG000|STARTED|Overall Study||60
6379046|NCT00771407|7289640|FG001|STARTED|Overall Study||60
6379047|NCT00771407|7289639|FG000|COMPLETED|Overall Study||40
6379048|NCT00771407|7289640|FG001|COMPLETED|Overall Study||35
6379049|NCT00771407|7289639|FG000|NOT COMPLETED|Overall Study||20
6379050|NCT00771407|7289640|FG001|NOT COMPLETED|Overall Study||25
6379051|NCT00771472|7289646|FG000|STARTED|Overall Study||6
6563469|NCT01807091|7486391|FG000|NOT COMPLETED|Overall Study||0
6563470|NCT01807104|7486397|FG000|STARTED|Overall Study||43
6379052|NCT00771472|7289647|FG001|STARTED|Overall Study||4
6379053|NCT00771472|7289646|FG000|COMPLETED|Overall Study||0
6379054|NCT00771472|7289647|FG001|COMPLETED|Overall Study||0
6379055|NCT00771472|7289646|FG000|NOT COMPLETED|Overall Study||6
6379056|NCT00771472|7289647|FG001|NOT COMPLETED|Overall Study||4
6379057|NCT00771537|7289668|FG000|STARTED|Overall Study||135
6379058|NCT00771537|7289669|FG001|STARTED|Overall Study||124
6379059|NCT00771537|7289670|FG002|STARTED|Overall Study||151
6379060|NCT00771537|7289671|FG003|STARTED|Overall Study||114
6379061|NCT00771537|7289672|FG004|STARTED|Overall Study||127
6379062|NCT00771537|7289673|FG005|STARTED|Overall Study||118
6379063|NCT00771537|7289674|FG006|STARTED|Overall Study||128
6379064|NCT00771537|7289675|FG007|STARTED|Overall Study||132
6563471|NCT01807104|7486398|FG001|STARTED|Overall Study||44
6379065|NCT00771537|7289676|FG008|STARTED|Overall Study||115
6379066|NCT00771537|7289677|FG009|STARTED|Overall Study||119
6379067|NCT00771537|7289678|FG010|STARTED|Overall Study||133
6379068|NCT00771537|7289679|FG011|STARTED|Overall Study||137
6379069|NCT00771537|7289680|FG012|STARTED|Overall Study||128
6379070|NCT00771537|7289681|FG013|STARTED|Overall Study||124
6379071|NCT00771537|7289682|FG014|STARTED|Overall Study||124
6379072|NCT00771537|7289683|FG015|STARTED|Overall Study||122
6379073|NCT00771537|7289668|FG000|COMPLETED|Overall Study||135
6379074|NCT00771537|7289669|FG001|COMPLETED|Overall Study||124
6379075|NCT00771537|7289670|FG002|COMPLETED|Overall Study||151
6563472|NCT01807104|7486397|FG000|COMPLETED|Overall Study||39
6563473|NCT01807104|7486398|FG001|COMPLETED|Overall Study||40
6563474|NCT01807104|7486397|FG000|NOT COMPLETED|Overall Study||4
6656503|NCT02461589|7586713|FG009|NOT COMPLETED|Overall Study||5
6656504|NCT02461628|7586737|FG000|STARTED|Overall Study||3733
6656505|NCT02461628|7586738|FG001|STARTED|Overall Study||3632
6656506|NCT02461628|7586737|FG000|Baseline Survey|Overall Study||1038
6656507|NCT02461628|7586738|FG001|Baseline Survey|Overall Study||974
6656508|NCT02461628|7586737|FG000|6 Month Survey|Overall Study||814
6656509|NCT02461628|7586738|FG001|6 Month Survey|Overall Study||832
6656510|NCT02461628|7586737|FG000|12 Month Survey|Overall Study||882
6656511|NCT02461628|7586738|FG001|12 Month Survey|Overall Study||914
6656512|NCT02461628|7586737|FG000|18 Month Survey|Overall Study||995
6656513|NCT02461628|7586738|FG001|18 Month Survey|Overall Study||905
6656514|NCT02461628|7586737|FG000|COMPLETED|Overall Study||3729
6656515|NCT02461628|7586738|FG001|COMPLETED|Overall Study||3625
6656516|NCT02461628|7586737|FG000|NOT COMPLETED|Overall Study||4
6656517|NCT02461628|7586738|FG001|NOT COMPLETED|Overall Study||7
6656518|NCT02461693|7586746|FG000|STARTED|Overall Study||103
6656519|NCT02461693|7586747|FG001|STARTED|Overall Study||102
6656520|NCT02461693|7586746|FG000|COMPLETED|Overall Study||103
6656521|NCT02461693|7586747|FG001|COMPLETED|Overall Study||102
6656522|NCT02461693|7586746|FG000|NOT COMPLETED|Overall Study||0
6656523|NCT02461693|7586747|FG001|NOT COMPLETED|Overall Study||0
6656524|NCT02461745|7586755|FG000|STARTED|Overall Study||130
6656525|NCT02461745|7586756|FG001|STARTED|Overall Study||70
6656526|NCT02461745|7586755|FG000|COMPLETED|Overall Study||116
6656527|NCT02461745|7586756|FG001|COMPLETED|Overall Study||66
6656528|NCT02461745|7586755|FG000|NOT COMPLETED|Overall Study||14
6656529|NCT02461745|7586756|FG001|NOT COMPLETED|Overall Study||4
6656530|NCT02461758|7586768|FG000|STARTED|Overall Study||20
6656531|NCT02461758|7586769|FG001|STARTED|Overall Study||20
6656532|NCT02461758|7586770|FG002|STARTED|Overall Study||26
6656533|NCT02461758|7586771|FG003|STARTED|Overall Study||15
6656534|NCT02461758|7586768|FG000|COMPLETED|Overall Study||20
6656535|NCT02461758|7586769|FG001|COMPLETED|Overall Study||19
6656536|NCT02461758|7586770|FG002|COMPLETED|Overall Study||25
6656537|NCT02461758|7586771|FG003|COMPLETED|Overall Study||15
6656538|NCT02461758|7586768|FG000|NOT COMPLETED|Overall Study||0
6656539|NCT02461758|7586769|FG001|NOT COMPLETED|Overall Study||1
6656540|NCT02461758|7586770|FG002|NOT COMPLETED|Overall Study||1
6656541|NCT02461758|7586771|FG003|NOT COMPLETED|Overall Study||0
6656542|NCT02461771|7586787|FG000|STARTED|Overall Study||3
6656543|NCT02461771|7586788|FG001|STARTED|Overall Study||3
6656544|NCT02461771|7586789|FG002|STARTED|Overall Study||7
6656545|NCT02461771|7586787|FG000|COMPLETED|Overall Study||3
6656546|NCT02461771|7586788|FG001|COMPLETED|Overall Study||3
6656547|NCT02461771|7586789|FG002|COMPLETED|Overall Study||7
6379076|NCT00771537|7289671|FG003|COMPLETED|Overall Study||114
6379077|NCT00771537|7289672|FG004|COMPLETED|Overall Study||127
6379078|NCT00771537|7289673|FG005|COMPLETED|Overall Study||118
6379079|NCT00771537|7289674|FG006|COMPLETED|Overall Study||128
6379080|NCT00771537|7289675|FG007|COMPLETED|Overall Study||132
6379081|NCT00771537|7289676|FG008|COMPLETED|Overall Study||115
6379082|NCT00771537|7289677|FG009|COMPLETED|Overall Study||119
6379083|NCT00771537|7289678|FG010|COMPLETED|Overall Study||133
6379084|NCT00771537|7289679|FG011|COMPLETED|Overall Study||137
6379085|NCT00771537|7289680|FG012|COMPLETED|Overall Study||128
6379086|NCT00771537|7289681|FG013|COMPLETED|Overall Study||124
6379087|NCT00771537|7289682|FG014|COMPLETED|Overall Study||124
6379088|NCT00771537|7289683|FG015|COMPLETED|Overall Study||122
6379089|NCT00771537|7289668|FG000|NOT COMPLETED|Overall Study||0
6379090|NCT00771537|7289669|FG001|NOT COMPLETED|Overall Study||0
6379091|NCT00771537|7289670|FG002|NOT COMPLETED|Overall Study||0
6379092|NCT00771537|7289671|FG003|NOT COMPLETED|Overall Study||0
6563475|NCT01807104|7486398|FG001|NOT COMPLETED|Overall Study||4
6563476|NCT01807156|7486404|FG000|STARTED|Overall Study||7
6563477|NCT01807156|7486404|FG000|COMPLETED|Overall Study||6
6563478|NCT01807156|7486404|FG000|NOT COMPLETED|Overall Study||1
6563479|NCT01807221|7486414|FG000|STARTED|Overall Study||224
6563480|NCT01807221|7486415|FG001|STARTED|Overall Study||173
6563481|NCT01807221|7486416|FG002|STARTED|Overall Study||165
6563482|NCT01807221|7486417|FG003|STARTED|Overall Study||169
6656548|NCT02461771|7586787|FG000|NOT COMPLETED|Overall Study||0
6563483|NCT01807221|7486418|FG004|STARTED|Overall Study||170
6563484|NCT01807221|7486419|FG005|STARTED|Overall Study||165
6563485|NCT01807221|7486414|FG000|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||221
6563486|NCT01807221|7486415|FG001|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||172
6563487|NCT01807221|7486416|FG002|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
6656549|NCT02461771|7586788|FG001|NOT COMPLETED|Overall Study||0
6656550|NCT02461771|7586789|FG002|NOT COMPLETED|Overall Study||0
6656551|NCT02461966|7586800|FG000|STARTED|Overall Study||160
6656552|NCT02461966|7586801|FG001|STARTED|Overall Study||80
6656553|NCT02461966|7586802|FG002|STARTED|Overall Study||60
6379093|NCT00771537|7289672|FG004|NOT COMPLETED|Overall Study||0
6379094|NCT00771537|7289673|FG005|NOT COMPLETED|Overall Study||0
6379095|NCT00771537|7289674|FG006|NOT COMPLETED|Overall Study||0
6379096|NCT00771537|7289675|FG007|NOT COMPLETED|Overall Study||0
6379097|NCT00771537|7289676|FG008|NOT COMPLETED|Overall Study||0
6379098|NCT00771537|7289677|FG009|NOT COMPLETED|Overall Study||0
6379099|NCT00771537|7289678|FG010|NOT COMPLETED|Overall Study||0
6379100|NCT00771537|7289679|FG011|NOT COMPLETED|Overall Study||0
6379101|NCT00771537|7289680|FG012|NOT COMPLETED|Overall Study||0
6656554|NCT02461966|7586800|FG000|COMPLETED|Overall Study||160
6656555|NCT02461966|7586801|FG001|COMPLETED|Overall Study||80
6656556|NCT02461966|7586802|FG002|COMPLETED|Overall Study||60
6656557|NCT02461966|7586800|FG000|NOT COMPLETED|Overall Study||0
6656558|NCT02461966|7586801|FG001|NOT COMPLETED|Overall Study||0
6656559|NCT02461966|7586802|FG002|NOT COMPLETED|Overall Study||0
6656560|NCT02461992|7586810|FG000|STARTED|Overall Study||13
6563488|NCT01807221|7486417|FG003|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||167
6563489|NCT01807221|7486418|FG004|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||169
6563490|NCT01807221|7486419|FG005|Participants Received Study Treatment and Valid for Safety Analysis Set|Overall Study||163
6563491|NCT01807221|7486414|FG000|COMPLETED|Overall Study||144
6563492|NCT01807221|7486415|FG001|COMPLETED|Overall Study||121
6656561|NCT02461992|7586810|FG000|COMPLETED|Overall Study||13
6656562|NCT02461992|7586810|FG000|NOT COMPLETED|Overall Study||0
6656563|NCT02462057|7586819|FG000|STARTED|Overall Study||791
6792322|NCT02542397|7723800|FG000|NOT COMPLETED|Overall Study||16
6792323|NCT02536794|7723805|FG000|STARTED|Reached 1st Response Assessment||30
6792324|NCT02536794|7723805|FG000|Started Treatment|Reached 1st Response Assessment||30
6792325|NCT02536794|7723805|FG000|Attempted First Cycle|Reached 1st Response Assessment||30
6792326|NCT02536794|7723805|FG000|Attempted Second Cycle|Reached 1st Response Assessment||24
6792327|NCT02536794|7723805|FG000|Reached First Response|Reached 1st Response Assessment||24
6792328|NCT02536794|7723805|FG000|COMPLETED|Reached 1st Response Assessment||24
6792329|NCT02536794|7723805|FG000|NOT COMPLETED|Reached 1st Response Assessment||6
6792330|NCT02536794|7723805|FG000|STARTED|Continued Treatment After 1st Response||24
6792331|NCT02536794|7723805|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||16
6792332|NCT02536794|7723805|FG000|COMPLETED|Continued Treatment After 1st Response||16
6792333|NCT02536794|7723805|FG000|NOT COMPLETED|Continued Treatment After 1st Response||8
6792334|NCT02536794|7723805|FG000|STARTED|Follow up for 3 Years or Death|one patient did not go into follow up as treatment was discontinued due to a protocol violation|29
6792335|NCT02536794|7723805|FG000|COMPLETED|Follow up for 3 Years or Death||29
6792336|NCT02536794|7723805|FG000|NOT COMPLETED|Follow up for 3 Years or Death||0
6792337|NCT02519777|7723812|FG000|STARTED|Overall Study||63
6792338|NCT02519777|7723813|FG001|STARTED|Overall Study||67
6792339|NCT02519777|7723814|FG002|STARTED|Overall Study||61
6792340|NCT02519777|7723812|FG000|COMPLETED|Overall Study||57
6792341|NCT02519777|7723813|FG001|COMPLETED|Overall Study||59
6792342|NCT02519777|7723814|FG002|COMPLETED|Overall Study||57
6792343|NCT02519777|7723812|FG000|NOT COMPLETED|Overall Study||6
6792344|NCT02519777|7723813|FG001|NOT COMPLETED|Overall Study||8
6792345|NCT02519777|7723814|FG002|NOT COMPLETED|Overall Study||4
6792346|NCT02489318|7723824|FG000|STARTED|Randomized||527
6792347|NCT02489318|7723825|FG001|STARTED|Randomized||525
6792348|NCT02489318|7723824|FG000|COMPLETED|Randomized||527
6792349|NCT02489318|7723825|FG001|COMPLETED|Randomized||524
6379102|NCT00771537|7289681|FG013|NOT COMPLETED|Overall Study||0
6379103|NCT00771537|7289682|FG014|NOT COMPLETED|Overall Study||0
6379104|NCT00771537|7289683|FG015|NOT COMPLETED|Overall Study||0
6379105|NCT00771615|7289718|FG000|STARTED|Overall Study||49
6379106|NCT00771615|7289719|FG001|STARTED|Overall Study||72
6379107|NCT00771615|7289720|FG002|STARTED|Overall Study||41
6379108|NCT00771615|7289721|FG003|STARTED|Overall Study||60
6379109|NCT00771615|7289722|FG004|STARTED|Overall Study||40
6379110|NCT00771615|7289723|FG005|STARTED|Overall Study||61
6792350|NCT02489318|7723824|FG000|NOT COMPLETED|Randomized||0
6792351|NCT02489318|7723825|FG001|NOT COMPLETED|Randomized||1
6792352|NCT02489318|7723824|FG000|STARTED|Treated||527
6792353|NCT02489318|7723825|FG001|STARTED|Treated||524
6792354|NCT02489318|7723824|FG000|COMPLETED|Treated|Participants crossed over from placebo to apalutamide after positive results at interim analysis.|208
6792355|NCT02489318|7723825|FG001|COMPLETED|Treated||0
6792356|NCT02489318|7723824|FG000|NOT COMPLETED|Treated||319
6792357|NCT02489318|7723825|FG001|NOT COMPLETED|Treated||524
6792358|NCT02484443|7723832|FG000|STARTED|Overall Study||41
6792359|NCT02484443|7723832|FG000|COMPLETED|Overall Study||9
6792360|NCT02484443|7723832|FG000|NOT COMPLETED|Overall Study||32
6792361|NCT02395666|7723838|FG000|STARTED|Overall Study||101
6792362|NCT02395666|7723839|FG001|STARTED|Overall Study||39
6792363|NCT02395666|7723838|FG000|COMPLETED|Overall Study||95
6792364|NCT02395666|7723839|FG001|COMPLETED|Overall Study||38
6792365|NCT02395666|7723838|FG000|NOT COMPLETED|Overall Study||6
6792366|NCT02395666|7723839|FG001|NOT COMPLETED|Overall Study||1
6792367|NCT02357810|7723849|FG000|STARTED|Registered and Started Treatment||178
6792368|NCT02357810|7723849|FG000|Signed Consent|Registered and Started Treatment||178
6792369|NCT02357810|7723849|FG000|Registered to Study|Registered and Started Treatment||152
6792370|NCT02357810|7723849|FG000|Initiated Treatment on Study|Registered and Started Treatment||151
6792371|NCT02357810|7723849|FG000|COMPLETED|Registered and Started Treatment||151
6792372|NCT02357810|7723849|FG000|NOT COMPLETED|Registered and Started Treatment||27
6792373|NCT02357810|7723849|FG000|STARTED|Reached 12 Weeks Response||151
6792374|NCT02357810|7723849|FG000|Completed 4 Weeks/1 Cycle|Reached 12 Weeks Response||151
6792375|NCT02357810|7723849|FG000|Reached 6 Week Response|Reached 12 Weeks Response||129
6792376|NCT02357810|7723849|FG000|Reached 12 Weeks/3 Cycles|Reached 12 Weeks Response||95
6563493|NCT01807221|7486416|FG002|COMPLETED|Overall Study||122
6563494|NCT01807221|7486417|FG003|COMPLETED|Overall Study||123
6563495|NCT01807221|7486418|FG004|COMPLETED|Overall Study||134
6563496|NCT01807221|7486419|FG005|COMPLETED|Overall Study||124
6563497|NCT01807221|7486414|FG000|NOT COMPLETED|Overall Study||80
6792377|NCT02357810|7723849|FG000|COMPLETED|Reached 12 Weeks Response||95
6792378|NCT02357810|7723849|FG000|NOT COMPLETED|Reached 12 Weeks Response||56
6792379|NCT02357810|7723849|FG000|STARTED|12 Week Response and Further Treatment||95
6792380|NCT02357810|7723849|FG000|Assessed for 12 Week Response|12 Week Response and Further Treatment||95
6792381|NCT02357810|7723849|FG000|Went on to be Treated After Response|12 Week Response and Further Treatment||73
6792382|NCT02357810|7723849|FG000|COMPLETED|12 Week Response and Further Treatment||73
6792383|NCT02357810|7723849|FG000|NOT COMPLETED|12 Week Response and Further Treatment||22
6792384|NCT02357810|7723849|FG000|STARTED|Follow-up at Treatment Discontinuation|All patients that receive at least one dose of study treatment go into follow up phase of the study.|151
6792385|NCT02357810|7723849|FG000|COMPLETED|Follow-up at Treatment Discontinuation||144
6792386|NCT02357810|7723849|FG000|NOT COMPLETED|Follow-up at Treatment Discontinuation||7
6792387|NCT02343549|7723853|FG000|STARTED|Overall Study||13
6792388|NCT02343549|7723853|FG000|COMPLETED|Overall Study||0
6792389|NCT02343549|7723853|FG000|NOT COMPLETED|Overall Study||13
6792390|NCT02339233|7723857|FG000|STARTED|Overall Study||8
6792391|NCT02339233|7723857|FG000|COMPLETED|Overall Study||8
6792392|NCT02339233|7723857|FG000|NOT COMPLETED|Overall Study||0
6792393|NCT02328105|7723861|FG000|STARTED|Overall Study||11
6792394|NCT02328105|7723861|FG000|COMPLETED|Overall Study||0
6792395|NCT02328105|7723861|FG000|NOT COMPLETED|Overall Study||11
6792396|NCT02327195|7723867|FG000|STARTED|Overall Study||27
6792397|NCT02327195|7723868|FG001|STARTED|Overall Study||27
6792398|NCT02327195|7723867|FG000|COMPLETED|Overall Study||27
6792399|NCT02327195|7723868|FG001|COMPLETED|Overall Study||27
6792400|NCT02327195|7723867|FG000|NOT COMPLETED|Overall Study||0
6792401|NCT02327195|7723868|FG001|NOT COMPLETED|Overall Study||0
6792402|NCT02315066|7723888|FG000|STARTED|Overall Study||2
6792403|NCT02315066|7723889|FG001|STARTED|Overall Study||10
6792404|NCT02315066|7723890|FG002|STARTED|Overall Study||11
6792405|NCT02315066|7723891|FG003|STARTED|Overall Study||12
6792406|NCT02315066|7723892|FG004|STARTED|Overall Study||13
6792407|NCT02315066|7723893|FG005|STARTED|Overall Study||4
6792408|NCT02315066|7723894|FG006|STARTED|Overall Study||16
6792409|NCT02315066|7723895|FG007|STARTED|Overall Study||19
6792410|NCT02315066|7723896|FG008|STARTED|Overall Study||11
6792411|NCT02315066|7723897|FG009|STARTED|Overall Study||12
6792412|NCT02315066|7723898|FG010|STARTED|Overall Study||12
6792413|NCT02315066|7723899|FG011|STARTED|Overall Study||11
6792414|NCT02315066|7723900|FG012|STARTED|Overall Study||11
6792415|NCT02315066|7723901|FG013|STARTED|Overall Study||30
6792416|NCT02315066|7723888|FG000|COMPLETED|Overall Study||0
6792417|NCT02315066|7723889|FG001|COMPLETED|Overall Study||0
6792418|NCT02315066|7723890|FG002|COMPLETED|Overall Study||2
6792419|NCT02315066|7723891|FG003|COMPLETED|Overall Study||1
6792420|NCT02315066|7723892|FG004|COMPLETED|Overall Study||2
6792421|NCT02315066|7723893|FG005|COMPLETED|Overall Study||1
6792422|NCT02315066|7723894|FG006|COMPLETED|Overall Study||3
6792423|NCT02315066|7723895|FG007|COMPLETED|Overall Study||5
6792424|NCT02315066|7723896|FG008|COMPLETED|Overall Study||0
6792425|NCT02315066|7723897|FG009|COMPLETED|Overall Study||1
6792426|NCT02315066|7723898|FG010|COMPLETED|Overall Study||0
6792427|NCT02315066|7723899|FG011|COMPLETED|Overall Study||0
6792428|NCT02315066|7723900|FG012|COMPLETED|Overall Study||1
6792429|NCT02315066|7723901|FG013|COMPLETED|Overall Study||0
6792430|NCT02315066|7723888|FG000|NOT COMPLETED|Overall Study||2
6792431|NCT02315066|7723889|FG001|NOT COMPLETED|Overall Study||10
6792432|NCT02315066|7723890|FG002|NOT COMPLETED|Overall Study||9
6792433|NCT02315066|7723891|FG003|NOT COMPLETED|Overall Study||11
6792434|NCT02315066|7723892|FG004|NOT COMPLETED|Overall Study||11
6792435|NCT02315066|7723893|FG005|NOT COMPLETED|Overall Study||3
6792436|NCT02315066|7723894|FG006|NOT COMPLETED|Overall Study||13
6792437|NCT02315066|7723895|FG007|NOT COMPLETED|Overall Study||14
6792438|NCT02315066|7723896|FG008|NOT COMPLETED|Overall Study||11
6792439|NCT02315066|7723897|FG009|NOT COMPLETED|Overall Study||11
6563498|NCT01807221|7486415|FG001|NOT COMPLETED|Overall Study||52
6792440|NCT02315066|7723898|FG010|NOT COMPLETED|Overall Study||12
6792441|NCT02315066|7723899|FG011|NOT COMPLETED|Overall Study||11
6792442|NCT02315066|7723900|FG012|NOT COMPLETED|Overall Study||10
6792443|NCT02315066|7723901|FG013|NOT COMPLETED|Overall Study||30
6792444|NCT02277444|7723931|FG000|STARTED|Overall Study||130
6792445|NCT02277444|7723931|FG000|Treated|Overall Study||127
6792446|NCT02277444|7723931|FG000|COMPLETED|Overall Study||0
6792447|NCT02277444|7723931|FG000|NOT COMPLETED|Overall Study||130
6792448|NCT02265367|7723937|FG000|STARTED|Overall Study||28
6792449|NCT02265367|7723938|FG001|STARTED|Overall Study||28
6792450|NCT02265367|7723937|FG000|Completed First 3-week Period|Overall Study||24
6792451|NCT02265367|7723938|FG001|Completed First 3-week Period|Overall Study||26
6792452|NCT02265367|7723937|FG000|COMPLETED|Overall Study||18
6792453|NCT02265367|7723938|FG001|COMPLETED|Overall Study||22
6792454|NCT02265367|7723937|FG000|NOT COMPLETED|Overall Study||10
6792455|NCT02265367|7723938|FG001|NOT COMPLETED|Overall Study||6
6792456|NCT02257736|7723946|FG000|STARTED|Overall Study||490
6792457|NCT02257736|7723947|FG001|STARTED|Overall Study||492
6792458|NCT02257736|7723946|FG000|COMPLETED|Overall Study||39
6792459|NCT02257736|7723947|FG001|COMPLETED|Overall Study||45
6792460|NCT02257736|7723946|FG000|NOT COMPLETED|Overall Study||451
6792461|NCT02257736|7723947|FG001|NOT COMPLETED|Overall Study||447
6792462|NCT02256631|7723960|FG000|STARTED|Overall Study||13
6792463|NCT02256631|7723961|FG001|STARTED|Overall Study||14
6792464|NCT02256631|7723962|FG002|STARTED|Overall Study||13
6792465|NCT02256631|7723963|FG003|STARTED|Overall Study||10
6792466|NCT02256631|7723964|FG004|STARTED|Overall Study||11
6792467|NCT02256631|7723965|FG005|STARTED|Overall Study||11
6792468|NCT02256631|7723966|FG006|STARTED|Overall Study||11
6792469|NCT02256631|7723960|FG000|COMPLETED|Overall Study||12
6792470|NCT02256631|7723961|FG001|COMPLETED|Overall Study||11
6792471|NCT02256631|7723962|FG002|COMPLETED|Overall Study||13
6792472|NCT02256631|7723963|FG003|COMPLETED|Overall Study||6
6792473|NCT02256631|7723964|FG004|COMPLETED|Overall Study||10
6792474|NCT02256631|7723965|FG005|COMPLETED|Overall Study||9
6792475|NCT02256631|7723966|FG006|COMPLETED|Overall Study||7
6792476|NCT02256631|7723960|FG000|NOT COMPLETED|Overall Study||1
6792477|NCT02256631|7723961|FG001|NOT COMPLETED|Overall Study||3
6792478|NCT02256631|7723962|FG002|NOT COMPLETED|Overall Study||0
6792479|NCT02256631|7723963|FG003|NOT COMPLETED|Overall Study||4
6792480|NCT02256631|7723964|FG004|NOT COMPLETED|Overall Study||1
6792481|NCT02256631|7723965|FG005|NOT COMPLETED|Overall Study||2
6792482|NCT02256631|7723966|FG006|NOT COMPLETED|Overall Study||4
6792483|NCT02252172|7723984|FG000|STARTED|Overall Study||369
6792484|NCT02252172|7723985|FG001|STARTED|Overall Study||368
6792485|NCT02252172|7723984|FG000|Treated|Overall Study||365
6792486|NCT02252172|7723985|FG001|Treated|Overall Study||364
6792487|NCT02252172|7723984|FG000|COMPLETED|Overall Study||90
6792488|NCT02252172|7723985|FG001|COMPLETED|Overall Study||69
6792489|NCT02252172|7723984|FG000|NOT COMPLETED|Overall Study||279
6792490|NCT02252172|7723985|FG001|NOT COMPLETED|Overall Study||299
6792491|NCT02195479|7723993|FG000|STARTED|Overall Study||356
6792492|NCT02195479|7723994|FG001|STARTED|Overall Study||350
6792493|NCT02195479|7723993|FG000|Treated|Overall Study||354
6792494|NCT02195479|7723994|FG001|Treated|Overall Study||346
6792495|NCT02195479|7723993|FG000|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
6792496|NCT02195479|7723994|FG001|COMPLETED|Overall Study|None of the participants completed the study as the study is still on-going.|0
6792497|NCT02195479|7723993|FG000|NOT COMPLETED|Overall Study||356
6792498|NCT02195479|7723994|FG001|NOT COMPLETED|Overall Study||350
6792499|NCT02173379|7724002|FG000|STARTED|Overall Study||1296
6792500|NCT02173379|7724003|FG001|STARTED|Overall Study||1308
6792501|NCT02173379|7724002|FG000|COMPLETED|Overall Study||1205
6792502|NCT02173379|7724003|FG001|COMPLETED|Overall Study||1231
6792503|NCT02173379|7724002|FG000|NOT COMPLETED|Overall Study||91
6792504|NCT02173379|7724003|FG001|NOT COMPLETED|Overall Study||77
6792505|NCT02136134|7724012|FG000|STARTED|Overall Study||247
6792506|NCT02136134|7724013|FG001|STARTED|Overall Study||251
6792507|NCT02136134|7724012|FG000|Treated|Overall Study||237
6792508|NCT02136134|7724013|FG001|Treated|Overall Study||243
6792509|NCT02136134|7724012|FG000|COMPLETED|Overall Study||0
6792510|NCT02136134|7724013|FG001|COMPLETED|Overall Study||0
6792511|NCT02136134|7724012|FG000|NOT COMPLETED|Overall Study||247
6792512|NCT02136134|7724013|FG001|NOT COMPLETED|Overall Study||251
6792513|NCT02129348|7724021|FG000|STARTED|Overall Study||38
6792514|NCT02129348|7724022|FG001|STARTED|Overall Study||39
6792515|NCT02129348|7724021|FG000|COMPLETED|Overall Study||29
6792516|NCT02129348|7724022|FG001|COMPLETED|Overall Study||29
6792517|NCT02129348|7724021|FG000|NOT COMPLETED|Overall Study||9
6792518|NCT02129348|7724022|FG001|NOT COMPLETED|Overall Study||10
6792519|NCT02080260|7724028|FG000|STARTED|Overall Study||20
6792520|NCT02080260|7724028|FG000|COMPLETED|Overall Study|Defined as still alive in follow-up when the study was terminated and the database was locked.|1
6792521|NCT02080260|7724028|FG000|NOT COMPLETED|Overall Study||19
6792522|NCT02076009|7724034|FG000|STARTED|Overall Study||283
6792523|NCT02076009|7724035|FG001|STARTED|Overall Study||286
6792524|NCT02076009|7724034|FG000|Treated|Overall Study||281
6792525|NCT02076009|7724035|FG001|Treated|Overall Study||283
6792526|NCT02076009|7724034|FG000|COMPLETED|Overall Study||0
6792527|NCT02076009|7724035|FG001|COMPLETED|Overall Study||0
6792528|NCT02076009|7724034|FG000|NOT COMPLETED|Overall Study||283
6792529|NCT02076009|7724035|FG001|NOT COMPLETED|Overall Study||286
6792530|NCT02051933|7724043|FG000|STARTED|Overall Study||5
6792531|NCT02051933|7724044|FG001|STARTED|Overall Study||5
6792532|NCT02051933|7724043|FG000|COMPLETED|Overall Study||5
6792533|NCT02051933|7724044|FG001|COMPLETED|Overall Study||4
6792534|NCT02051933|7724043|FG000|NOT COMPLETED|Overall Study||0
6792535|NCT02051933|7724044|FG001|NOT COMPLETED|Overall Study||1
6792536|NCT02047929|7724058|FG000|STARTED|Overall Study||1503
6792537|NCT02047929|7724059|FG001|STARTED|Overall Study||2523
6792538|NCT02047929|7724060|FG002|STARTED|Overall Study||2248
6792539|NCT02047929|7724058|FG000|Practice Rollout|Overall Study||1503
6792540|NCT02047929|7724059|FG001|Practice Rollout|Overall Study||2523
6792541|NCT02047929|7724060|FG002|Practice Rollout|Overall Study|Per protocol, practice did not receive any intervention from practice facilitator|0
6792542|NCT02047929|7724058|FG000|Practice Refresher|Overall Study||1503
6792543|NCT02047929|7724059|FG001|Practice Refresher|Overall Study||2523
6792544|NCT02047929|7724060|FG002|Practice Refresher|Overall Study|Per protocol, practices did not receive any interaction from practice facilitator|0
6792545|NCT02047929|7724058|FG000|Surveys Collected|Overall Study||1503
6792546|NCT02047929|7724059|FG001|Surveys Collected|Overall Study||2523
6792547|NCT02047929|7724060|FG002|Surveys Collected|Overall Study|Per protocol, practice did not receive any interaction from practice facilitator|0
6792548|NCT02047929|7724058|FG000|COMPLETED|Overall Study||1503
6792549|NCT02047929|7724059|FG001|COMPLETED|Overall Study||2523
6792550|NCT02047929|7724060|FG002|COMPLETED|Overall Study||2248
6792551|NCT02047929|7724058|FG000|NOT COMPLETED|Overall Study||0
6792552|NCT02047929|7724059|FG001|NOT COMPLETED|Overall Study||0
6792553|NCT02047929|7724060|FG002|NOT COMPLETED|Overall Study||0
6792554|NCT01999569|7724071|FG000|STARTED|Control Cycle|First cycle no meds|10
6792555|NCT01999569|7724071|FG000|COMPLETED|Control Cycle||10
6792556|NCT01999569|7724071|FG000|NOT COMPLETED|Control Cycle||0
6792557|NCT01999569|7724071|FG000|STARTED|Letrozole Treatment Cycle||10
6792558|NCT01999569|7724071|FG000|COMPLETED|Letrozole Treatment Cycle||10
6792559|NCT01999569|7724071|FG000|NOT COMPLETED|Letrozole Treatment Cycle||0
6792560|NCT01969812|7724080|FG000|STARTED|Overall Study||12
6792561|NCT01969812|7724081|FG001|STARTED|Overall Study||10
6792562|NCT01969812|7724080|FG000|COMPLETED|Overall Study||12
6792563|NCT01969812|7724081|FG001|COMPLETED|Overall Study||10
6792564|NCT01969812|7724080|FG000|NOT COMPLETED|Overall Study||0
6792565|NCT01969812|7724081|FG001|NOT COMPLETED|Overall Study||0
6792566|NCT01959464|7724089|FG000|STARTED|Overall Study||10
6792567|NCT01959464|7724090|FG001|STARTED|Overall Study||10
6792568|NCT01959464|7724089|FG000|COMPLETED|Overall Study||9
6792569|NCT01959464|7724090|FG001|COMPLETED|Overall Study||10
6792570|NCT01959464|7724089|FG000|NOT COMPLETED|Overall Study||1
6379111|NCT00771615|7289724|FG006|STARTED|Overall Study||46
6379112|NCT00771615|7289725|FG007|STARTED|Overall Study||59
6792571|NCT01959464|7724090|FG001|NOT COMPLETED|Overall Study||0
6792572|NCT01946204|7724098|FG000|STARTED|Overall Study||401
6792573|NCT01946204|7724099|FG001|STARTED|Overall Study||806
6792574|NCT01946204|7724098|FG000|Treated|Overall Study||398
6792575|NCT01946204|7724099|FG001|Treated|Overall Study||803
6792576|NCT01946204|7724098|FG000|COMPLETED|Overall Study||0
6792577|NCT01946204|7724099|FG001|COMPLETED|Overall Study||0
6792578|NCT01946204|7724098|FG000|NOT COMPLETED|Overall Study||401
6792579|NCT01946204|7724099|FG001|NOT COMPLETED|Overall Study||806
6792580|NCT01921166|7724107|FG000|STARTED|Overall Study||8
6792581|NCT01921166|7724108|FG001|STARTED|Overall Study||15
6792582|NCT01921166|7724107|FG000|COMPLETED|Overall Study||8
6792583|NCT01921166|7724108|FG001|COMPLETED|Overall Study||15
6792584|NCT01921166|7724107|FG000|NOT COMPLETED|Overall Study||0
6792585|NCT01921166|7724108|FG001|NOT COMPLETED|Overall Study||0
6792586|NCT01886963|7724116|FG000|STARTED|Overall Study||57
6792587|NCT01886963|7724117|FG001|STARTED|Overall Study||58
6792588|NCT01886963|7724116|FG000|2 Week Follow Up|Overall Study||55
6792589|NCT01886963|7724117|FG001|2 Week Follow Up|Overall Study||55
6792590|NCT01886963|7724116|FG000|4 Week Follow Up|Overall Study||50
6792591|NCT01886963|7724117|FG001|4 Week Follow Up|Overall Study||51
6792592|NCT01886963|7724116|FG000|12 Week Follow Up|Overall Study||46
6792593|NCT01886963|7724117|FG001|12 Week Follow Up|Overall Study||49
6792594|NCT01886963|7724116|FG000|COMPLETED|Overall Study||46
6792595|NCT01886963|7724117|FG001|COMPLETED|Overall Study||49
6792596|NCT01886963|7724116|FG000|NOT COMPLETED|Overall Study||11
6792597|NCT01886963|7724117|FG001|NOT COMPLETED|Overall Study||9
6792598|NCT01802281|7724125|FG000|STARTED|Overall Study||93
6792599|NCT01802281|7724126|FG001|STARTED|Overall Study||90
6792600|NCT01802281|7724125|FG000|Eligible and Received Randomized Treatment|Overall Study||88
6792601|NCT01802281|7724126|FG001|Eligible and Received Randomized Treatment|Overall Study||87
6792602|NCT01802281|7724125|FG000|Completed Year 1 Follow-up|Overall Study||88
6792603|NCT01802281|7724126|FG001|Completed Year 1 Follow-up|Overall Study||86
6792604|NCT01802281|7724125|FG000|Completed Year 2 Follow-up|Overall Study||87
6563499|NCT01807221|7486416|FG002|NOT COMPLETED|Overall Study||43
6563500|NCT01807221|7486417|FG003|NOT COMPLETED|Overall Study||46
6563501|NCT01807221|7486418|FG004|NOT COMPLETED|Overall Study||36
6563502|NCT01807221|7486419|FG005|NOT COMPLETED|Overall Study||41
6563503|NCT01807234|7486439|FG000|STARTED|Overall Study||12
6563504|NCT01807234|7486440|FG001|STARTED|Overall Study||12
6563505|NCT01807234|7486441|FG002|STARTED|Overall Study||12
6792605|NCT01802281|7724126|FG001|Completed Year 2 Follow-up|Overall Study||84
6792606|NCT01802281|7724125|FG000|COMPLETED|Overall Study||85
6792607|NCT01802281|7724126|FG001|COMPLETED|Overall Study||84
6792608|NCT01802281|7724125|FG000|NOT COMPLETED|Overall Study||8
6792609|NCT01802281|7724126|FG001|NOT COMPLETED|Overall Study||6
6792610|NCT01774253|7724132|FG000|STARTED|Overall Study||9
6792611|NCT01774253|7724132|FG000|COMPLETED|Overall Study||0
6792612|NCT01774253|7724132|FG000|NOT COMPLETED|Overall Study||9
6379113|NCT00771615|7289726|FG008|STARTED|Overall Study||41
6379114|NCT00771615|7289718|FG000|COMPLETED|Overall Study|Up to Day 364|48
6379115|NCT00771615|7289719|FG001|COMPLETED|Overall Study|Up to Day 364|70
6379116|NCT00771615|7289720|FG002|COMPLETED|Overall Study|Up to Day 364|40
6379117|NCT00771615|7289721|FG003|COMPLETED|Overall Study|Up to Day 364|59
6379118|NCT00771615|7289722|FG004|COMPLETED|Overall Study|Up to Day 364|40
6379119|NCT00771615|7289723|FG005|COMPLETED|Overall Study|Up to Day 364|60
6563506|NCT01807234|7486442|FG003|STARTED|Overall Study||12
6379120|NCT00771615|7289724|FG006|COMPLETED|Overall Study|Up to Day 364|45
6379121|NCT00771615|7289725|FG007|COMPLETED|Overall Study|Up to Day 364|58
6379122|NCT00771615|7289726|FG008|COMPLETED|Overall Study|Up to Day 364|41
6792640|NCT01666145|7724150|FG000|STARTED|Overall Study||14
6792641|NCT01666145|7724150|FG000|COMPLETED|Overall Study||14
6792642|NCT01666145|7724150|FG000|NOT COMPLETED|Overall Study||0
6792643|NCT01615029|7724159|FG000|STARTED|Overall Study||3
6792644|NCT01615029|7724160|FG001|STARTED|Overall Study||3
6792645|NCT01615029|7724161|FG002|STARTED|Overall Study||4
6792646|NCT01615029|7724162|FG003|STARTED|Overall Study||3
6792647|NCT01615029|7724163|FG004|STARTED|Overall Study||32
6792648|NCT01615029|7724159|FG000|COMPLETED|Overall Study||0
6792649|NCT01615029|7724160|FG001|COMPLETED|Overall Study||0
6792650|NCT01615029|7724161|FG002|COMPLETED|Overall Study||0
6792651|NCT01615029|7724162|FG003|COMPLETED|Overall Study||0
6792652|NCT01615029|7724163|FG004|COMPLETED|Overall Study||0
6792653|NCT01615029|7724159|FG000|NOT COMPLETED|Overall Study||3
6792654|NCT01615029|7724160|FG001|NOT COMPLETED|Overall Study||3
6792655|NCT01615029|7724161|FG002|NOT COMPLETED|Overall Study||4
6792656|NCT01615029|7724162|FG003|NOT COMPLETED|Overall Study||3
6792657|NCT01615029|7724163|FG004|NOT COMPLETED|Overall Study||32
6792658|NCT01505608|7724177|FG000|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
6792659|NCT01505608|7724178|FG001|STARTED|Phase I||8
6792660|NCT01505608|7724177|FG000|COMPLETED|Phase I||0
6792661|NCT01505608|7724178|FG001|COMPLETED|Phase I||2
6792662|NCT01505608|7724177|FG000|NOT COMPLETED|Phase I||0
6792663|NCT01505608|7724178|FG001|NOT COMPLETED|Phase I||6
6792664|NCT01505608|7724177|FG000|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
6792665|NCT01505608|7724178|FG001|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
6792666|NCT01505608|7724177|FG000|COMPLETED|Phase II||0
6792667|NCT01505608|7724178|FG001|COMPLETED|Phase II||2
6792668|NCT01505608|7724177|FG000|NOT COMPLETED|Phase II||2
6792669|NCT01505608|7724178|FG001|NOT COMPLETED|Phase II||2
6792670|NCT01483820|7724187|FG000|STARTED|Overall Study||8
6792671|NCT01483820|7724187|FG000|COMPLETED|Overall Study||0
6792672|NCT01483820|7724187|FG000|NOT COMPLETED|Overall Study||8
6792673|NCT01355679|7724191|FG000|STARTED|Overall Study||16
6792674|NCT01355679|7724191|FG000|COMPLETED|Overall Study||14
6563507|NCT01807234|7486443|FG004|STARTED|Overall Study||12
6563508|NCT01807234|7486444|FG005|STARTED|Overall Study||12
6563509|NCT01807234|7486439|FG000|Randomized, But Did Not Take Drug|Overall Study||3
6563510|NCT01807234|7486440|FG001|Randomized, But Did Not Take Drug|Overall Study||5
6563511|NCT01807234|7486441|FG002|Randomized, But Did Not Take Drug|Overall Study||2
6563512|NCT01807234|7486442|FG003|Randomized, But Did Not Take Drug|Overall Study||1
6563513|NCT01807234|7486443|FG004|Randomized, But Did Not Take Drug|Overall Study||4
6563514|NCT01807234|7486444|FG005|Randomized, But Did Not Take Drug|Overall Study||3
6563515|NCT01807234|7486439|FG000|Completed Only 1 Attack|Overall Study||2
6563516|NCT01807234|7486440|FG001|Completed Only 1 Attack|Overall Study||1
6563517|NCT01807234|7486441|FG002|Completed Only 1 Attack|Overall Study||0
6563518|NCT01807234|7486442|FG003|Completed Only 1 Attack|Overall Study||1
6792675|NCT01355679|7724191|FG000|NOT COMPLETED|Overall Study||2
6792676|NCT01314118|7724196|FG000|STARTED|Overall Study||131
6792677|NCT01314118|7724196|FG000|COMPLETED|Overall Study||0
6792678|NCT01314118|7724196|FG000|NOT COMPLETED|Overall Study||131
6563519|NCT01807234|7486443|FG004|Completed Only 1 Attack|Overall Study||0
6563520|NCT01807234|7486444|FG005|Completed Only 1 Attack|Overall Study||1
6563521|NCT01807234|7486439|FG000|COMPLETED|Overall Study||7
6563522|NCT01807234|7486440|FG001|COMPLETED|Overall Study||6
6563523|NCT01807234|7486441|FG002|COMPLETED|Overall Study||10
6563524|NCT01807234|7486442|FG003|COMPLETED|Overall Study||10
6563525|NCT01807234|7486443|FG004|COMPLETED|Overall Study||8
6563526|NCT01807234|7486444|FG005|COMPLETED|Overall Study||8
6563527|NCT01807234|7486439|FG000|NOT COMPLETED|Overall Study||5
6563528|NCT01807234|7486440|FG001|NOT COMPLETED|Overall Study||6
6563529|NCT01807234|7486441|FG002|NOT COMPLETED|Overall Study||2
6563530|NCT01807234|7486442|FG003|NOT COMPLETED|Overall Study||2
6563531|NCT01807234|7486443|FG004|NOT COMPLETED|Overall Study||4
6792709|NCT01227616|7724224|FG000|STARTED|Overall Study||196
6792710|NCT01227616|7724225|FG001|STARTED|Overall Study||97
6792711|NCT01227616|7724224|FG000|COMPLETED|Overall Study||142
6792712|NCT01227616|7724225|FG001|COMPLETED|Overall Study||74
6792713|NCT01227616|7724224|FG000|NOT COMPLETED|Overall Study||54
6792714|NCT01227616|7724225|FG001|NOT COMPLETED|Overall Study||23
6792715|NCT01192698|7724233|FG000|STARTED|Overall Study||10
6792716|NCT01192698|7724234|FG001|STARTED|Overall Study||5
6792717|NCT01192698|7724233|FG000|COMPLETED|Overall Study||10
6792718|NCT01192698|7724234|FG001|COMPLETED|Overall Study||5
6792719|NCT01192698|7724233|FG000|NOT COMPLETED|Overall Study||0
6792720|NCT01192698|7724234|FG001|NOT COMPLETED|Overall Study||0
6792721|NCT01171898|7724244|FG000|STARTED|Overall Study||30
6792722|NCT01171898|7724245|FG001|STARTED|Overall Study||51
6792723|NCT01171898|7724246|FG002|STARTED|Overall Study||25
6792724|NCT01171898|7724247|FG003|STARTED|Overall Study||21
6792725|NCT01171898|7724244|FG000|COMPLETED|Overall Study||26
6792726|NCT01171898|7724245|FG001|COMPLETED|Overall Study||32
6792727|NCT01171898|7724246|FG002|COMPLETED|Overall Study||13
6792728|NCT01171898|7724247|FG003|COMPLETED|Overall Study||15
6792729|NCT01171898|7724244|FG000|NOT COMPLETED|Overall Study||4
6792730|NCT01171898|7724245|FG001|NOT COMPLETED|Overall Study||19
6792731|NCT01171898|7724246|FG002|NOT COMPLETED|Overall Study||12
6792732|NCT01171898|7724247|FG003|NOT COMPLETED|Overall Study||6
6792733|NCT01166386|7724262|FG000|STARTED|Overall Study||82
6792734|NCT01166386|7724263|FG001|STARTED|Overall Study||83
6792735|NCT01166386|7724262|FG000|COMPLETED|Overall Study||79
6792736|NCT01166386|7724263|FG001|COMPLETED|Overall Study||78
6792737|NCT01166386|7724262|FG000|NOT COMPLETED|Overall Study||3
6792738|NCT01166386|7724263|FG001|NOT COMPLETED|Overall Study||5
6502272|NCT01433731|7420933|FG003|COMPLETED|Overall Study||5
6563532|NCT01807234|7486444|FG005|NOT COMPLETED|Overall Study||4
6563533|NCT01807299|7486458|FG000|STARTED|Overall Study||14
6563534|NCT01807299|7486459|FG001|STARTED|Overall Study||14
6792749|NCT01114217|7724280|FG000|STARTED|Overall Study||337
6792750|NCT01114217|7724281|FG001|STARTED|Overall Study||297
6792751|NCT01114217|7724280|FG000|Received at Least 1 Dose of Ferumoxytol|Overall Study||337
6792752|NCT01114217|7724281|FG001|Received at Least 1 Dose of Ferumoxytol|Overall Study||0
6792753|NCT01114217|7724280|FG000|COMPLETED|Overall Study|Two participants lacked study completion data: one site stopped communicating during the study.|262
6792754|NCT01114217|7724281|FG001|COMPLETED|Overall Study||199
6792755|NCT01114217|7724280|FG000|NOT COMPLETED|Overall Study||75
6792756|NCT01114217|7724281|FG001|NOT COMPLETED|Overall Study||98
6792757|NCT01114204|7724287|FG000|STARTED|Overall Study||406
6792758|NCT01114204|7724288|FG001|STARTED|Overall Study||199
6792759|NCT01114204|7724287|FG000|Received at Least 1 Dose of Study Drug|Overall Study||406
6792760|NCT01114204|7724288|FG001|Received at Least 1 Dose of Study Drug|Overall Study||199
6792761|NCT01114204|7724287|FG000|COMPLETED|Overall Study||385
6792762|NCT01114204|7724288|FG001|COMPLETED|Overall Study||191
6792763|NCT01114204|7724287|FG000|NOT COMPLETED|Overall Study||21
6792764|NCT01114204|7724288|FG001|NOT COMPLETED|Overall Study||8
6792765|NCT01114139|7724296|FG000|STARTED|Overall Study||609
6792766|NCT01114139|7724297|FG001|STARTED|Overall Study||203
6792767|NCT01114139|7724296|FG000|Received at Least 1 Dose of Study Drug|Overall Study||608
6792768|NCT01114139|7724297|FG001|Received at Least 1 Dose of Study Drug|Overall Study||200
6792769|NCT01114139|7724296|FG000|COMPLETED|Overall Study||569
6792770|NCT01114139|7724297|FG001|COMPLETED|Overall Study||187
6792771|NCT01114139|7724296|FG000|NOT COMPLETED|Overall Study||40
6792772|NCT01114139|7724297|FG001|NOT COMPLETED|Overall Study||16
6792773|NCT01059071|7724303|FG000|STARTED|Overall Study||4
6792774|NCT01059071|7724304|FG001|STARTED|Overall Study||5
6792775|NCT01059071|7724305|FG002|STARTED|Overall Study||3
6792776|NCT01059071|7724306|FG003|STARTED|Overall Study||9
6792777|NCT01059071|7724303|FG000|COMPLETED|Overall Study||2
6792778|NCT01059071|7724304|FG001|COMPLETED|Overall Study||1
6792779|NCT01059071|7724305|FG002|COMPLETED|Overall Study||1
6792780|NCT01059071|7724306|FG003|COMPLETED|Overall Study||3
6792781|NCT01059071|7724303|FG000|NOT COMPLETED|Overall Study||2
6792782|NCT01059071|7724304|FG001|NOT COMPLETED|Overall Study||4
6792783|NCT01059071|7724305|FG002|NOT COMPLETED|Overall Study||2
6792784|NCT01059071|7724306|FG003|NOT COMPLETED|Overall Study||6
6792785|NCT01027702|7724314|FG000|STARTED|Overall Study||4
6792786|NCT01027702|7724315|FG001|STARTED|Overall Study||4
6792787|NCT01027702|7724316|FG002|STARTED|Overall Study||3
6792788|NCT01027702|7724317|FG003|STARTED|Overall Study||14
6792789|NCT01027702|7724318|FG004|STARTED|Overall Study||10
6792790|NCT01027702|7724319|FG005|STARTED|Overall Study||1
6792791|NCT01027702|7724320|FG006|STARTED|Overall Study||2
6792792|NCT01027702|7724314|FG000|COMPLETED|Overall Study||3
6792793|NCT01027702|7724315|FG001|COMPLETED|Overall Study||2
6792794|NCT01027702|7724316|FG002|COMPLETED|Overall Study||2
6792795|NCT01027702|7724317|FG003|COMPLETED|Overall Study||10
6792796|NCT01027702|7724318|FG004|COMPLETED|Overall Study||9
6792797|NCT01027702|7724319|FG005|COMPLETED|Overall Study||1
6792798|NCT01027702|7724320|FG006|COMPLETED|Overall Study||1
6792799|NCT01027702|7724314|FG000|NOT COMPLETED|Overall Study||1
6792800|NCT01027702|7724315|FG001|NOT COMPLETED|Overall Study||2
6792801|NCT01027702|7724316|FG002|NOT COMPLETED|Overall Study||1
6792802|NCT01027702|7724317|FG003|NOT COMPLETED|Overall Study||4
6792803|NCT01027702|7724318|FG004|NOT COMPLETED|Overall Study||1
6792804|NCT01027702|7724319|FG005|NOT COMPLETED|Overall Study||0
6792805|NCT01027702|7724320|FG006|NOT COMPLETED|Overall Study||1
6792806|NCT00991887|7724333|FG000|STARTED|Overall Study||26
6792807|NCT00991887|7724334|FG001|STARTED|Overall Study||22
6792808|NCT00991887|7724333|FG000|COMPLETED|Overall Study||24
6792809|NCT00991887|7724334|FG001|COMPLETED|Overall Study||21
6792810|NCT00991887|7724333|FG000|NOT COMPLETED|Overall Study||2
6792811|NCT00991887|7724334|FG001|NOT COMPLETED|Overall Study||1
6379123|NCT00771615|7289718|FG000|NOT COMPLETED|Overall Study||1
6792812|NCT00968864|7724340|FG000|STARTED|Overall Study|One patient, FDA and IRB approved to enroll as an exception, was not evaluable for study endpoints.|53
6792813|NCT00968864|7724340|FG000|COMPLETED|Overall Study||52
6792814|NCT00968864|7724340|FG000|NOT COMPLETED|Overall Study||1
6792815|NCT00934700|7724351|FG000|STARTED|Overall Study||46
6792816|NCT00934700|7724352|FG001|STARTED|Overall Study||46
6792817|NCT00934700|7724351|FG000|COMPLETED|Overall Study||33
6792818|NCT00934700|7724352|FG001|COMPLETED|Overall Study||34
6792819|NCT00934700|7724351|FG000|NOT COMPLETED|Overall Study||13
6792820|NCT00934700|7724352|FG001|NOT COMPLETED|Overall Study||12
6792821|NCT00867568|7724359|FG000|STARTED|Overall Study||18
6792822|NCT00867568|7724359|FG000|COMPLETED|Overall Study||3
6792823|NCT00867568|7724359|FG000|NOT COMPLETED|Overall Study||15
6792824|NCT00785291|7724366|FG000|STARTED|Overall Study||283
6792825|NCT00785291|7724367|FG001|STARTED|Overall Study||271
6792826|NCT00785291|7724368|FG002|STARTED|Overall Study||245
6792827|NCT00785291|7724366|FG000|COMPLETED|Overall Study||147
6792828|NCT00785291|7724367|FG001|COMPLETED|Overall Study||122
6792829|NCT00785291|7724368|FG002|COMPLETED|Overall Study||139
6792830|NCT00785291|7724366|FG000|NOT COMPLETED|Overall Study||136
6792831|NCT00785291|7724367|FG001|NOT COMPLETED|Overall Study||149
6792832|NCT00785291|7724368|FG002|NOT COMPLETED|Overall Study||106
6792833|NCT00782288|7724379|FG000|STARTED|Overall Study||8
6792834|NCT00782288|7724380|FG001|STARTED|Overall Study||8
6792835|NCT00782288|7724381|FG002|STARTED|Overall Study||8
6792836|NCT00782288|7724379|FG000|COMPLETED|Overall Study||8
6792837|NCT00782288|7724380|FG001|COMPLETED|Overall Study||8
6792838|NCT00782288|7724381|FG002|COMPLETED|Overall Study||8
6792839|NCT00782288|7724379|FG000|NOT COMPLETED|Overall Study||0
6792840|NCT00782288|7724380|FG001|NOT COMPLETED|Overall Study||0
6792841|NCT00782288|7724381|FG002|NOT COMPLETED|Overall Study||0
6792842|NCT00777036|7724394|FG000|STARTED|On Treatment||29
6792843|NCT00777036|7724395|FG001|STARTED|On Treatment||17
6792844|NCT00777036|7724396|FG002|STARTED|On Treatment||84
6792845|NCT00777036|7724394|FG000|COMPLETED|On Treatment|Completed = Still on treatment|14
6792846|NCT00777036|7724395|FG001|COMPLETED|On Treatment|Completed = Still on treatment|1
6792847|NCT00777036|7724396|FG002|COMPLETED|On Treatment|Completed = Still on treatment|61
6792848|NCT00777036|7724394|FG000|NOT COMPLETED|On Treatment||15
6792849|NCT00777036|7724395|FG001|NOT COMPLETED|On Treatment||16
6792850|NCT00777036|7724396|FG002|NOT COMPLETED|On Treatment||23
6792851|NCT00777036|7724394|FG000|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|14
6792852|NCT00777036|7724395|FG001|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|13
6792853|NCT00777036|7724396|FG002|STARTED|Follow-Up|Not all participants who discontinued treatment entered the follow-up period|23
6792854|NCT00777036|7724394|FG000|COMPLETED|Follow-Up|Completed = Still in Follow-up|9
6792855|NCT00777036|7724395|FG001|COMPLETED|Follow-Up|Completed = Still in Follow-up|5
6792856|NCT00777036|7724396|FG002|COMPLETED|Follow-Up|Completed = Still in Follow-up|19
6792857|NCT00777036|7724394|FG000|NOT COMPLETED|Follow-Up||5
6792858|NCT00777036|7724395|FG001|NOT COMPLETED|Follow-Up||8
6792859|NCT00777036|7724396|FG002|NOT COMPLETED|Follow-Up||4
6792860|NCT00770809|7724414|FG000|STARTED|Overall Study||118
6792861|NCT00770809|7724415|FG001|STARTED|Overall Study||120
6792862|NCT00770809|7724416|FG002|STARTED|Overall Study||67
6792863|NCT00770809|7724414|FG000|COMPLETED|Overall Study||101
6792864|NCT00770809|7724415|FG001|COMPLETED|Overall Study||110
6792865|NCT00770809|7724416|FG002|COMPLETED|Overall Study||44
6792866|NCT00770809|7724414|FG000|NOT COMPLETED|Overall Study||17
6792867|NCT00770809|7724415|FG001|NOT COMPLETED|Overall Study||10
6792868|NCT00770809|7724416|FG002|NOT COMPLETED|Overall Study||23
6792869|NCT00643864|7724424|FG000|STARTED|Pre-test Assessment||3
6792870|NCT00643864|7724424|FG000|COMPLETED|Pre-test Assessment||3
6792871|NCT00643864|7724424|FG000|NOT COMPLETED|Pre-test Assessment||0
6792872|NCT00643864|7724424|FG000|STARTED|Post-test Assessment||3
6563535|NCT01807299|7486460|FG002|STARTED|Overall Study||12
6563536|NCT01807299|7486461|FG003|STARTED|Overall Study||13
6563537|NCT01807299|7486458|FG000|COMPLETED|Overall Study||11
6563538|NCT01807299|7486459|FG001|COMPLETED|Overall Study||13
6563539|NCT01807299|7486460|FG002|COMPLETED|Overall Study||12
6792873|NCT00643864|7724424|FG000|COMPLETED|Post-test Assessment||3
6792874|NCT00643864|7724424|FG000|NOT COMPLETED|Post-test Assessment||0
6792875|NCT00628446|7724429|FG000|STARTED|Overall Study||45
6792876|NCT00628446|7724429|FG000|COMPLETED|Overall Study||38
6792877|NCT00628446|7724429|FG000|NOT COMPLETED|Overall Study||7
6792878|NCT00621751|7724436|FG000|STARTED|Overall Study||35
6792879|NCT00621751|7724437|FG001|STARTED|Overall Study||35
6792880|NCT00621751|7724436|FG000|COMPLETED|Overall Study||35
6792881|NCT00621751|7724437|FG001|COMPLETED|Overall Study||34
6792882|NCT00621751|7724436|FG000|NOT COMPLETED|Overall Study||0
6792883|NCT00621751|7724437|FG001|NOT COMPLETED|Overall Study||1
6792884|NCT00605215|7724446|FG000|STARTED|Overall Study||450
6792885|NCT00605215|7724447|FG001|STARTED|Overall Study||434
6792886|NCT00605215|7724448|FG002|STARTED|Overall Study||447
6792887|NCT00605215|7724446|FG000|Received at Least 1 Dose of Study Drug|Overall Study||449
6792888|NCT00605215|7724447|FG001|Received at Least 1 Dose of Study Drug|Overall Study||433
6792889|NCT00605215|7724448|FG002|Received at Least 1 Dose of Study Drug|Overall Study||442
6792890|NCT00605215|7724446|FG000|COMPLETED|Overall Study||359
6792891|NCT00605215|7724447|FG001|COMPLETED|Overall Study||353
6792892|NCT00605215|7724448|FG002|COMPLETED|Overall Study||378
6792893|NCT00605215|7724446|FG000|NOT COMPLETED|Overall Study||91
6792894|NCT00605215|7724447|FG001|NOT COMPLETED|Overall Study||81
6563540|NCT01807299|7486461|FG003|COMPLETED|Overall Study||11
6792895|NCT00605215|7724448|FG002|NOT COMPLETED|Overall Study||69
6792896|NCT00605150|7724456|FG000|STARTED|Overall Study|11 started|11
6792897|NCT00605150|7724456|FG000|COMPLETED|Overall Study||10
6792898|NCT00605150|7724456|FG000|NOT COMPLETED|Overall Study||1
6792899|NCT00552513|7724462|FG000|STARTED|Overall Study||1593
6792900|NCT00552513|7724463|FG001|STARTED|Overall Study||1438
6792901|NCT00552513|7724462|FG000|COMPLETED|Overall Study||1588
6792902|NCT00552513|7724463|FG001|COMPLETED|Overall Study||1437
6792903|NCT00552513|7724462|FG000|NOT COMPLETED|Overall Study||5
6792904|NCT00552513|7724463|FG001|NOT COMPLETED|Overall Study||1
6792905|NCT00368836|7724473|FG000|STARTED|Phase II||350
6792906|NCT00368836|7724473|FG000|COMPLETED|Phase II||329
6792907|NCT00368836|7724473|FG000|NOT COMPLETED|Phase II||21
6792908|NCT00368836|7724473|FG000|STARTED|Phase I Pre-op/Post-op|The phases consisted of unique subjects. Those enrolled in Phase I did not carry over to Phase II.|125
6792909|NCT00368836|7724473|FG000|COMPLETED|Phase I Pre-op/Post-op||104
6792910|NCT00368836|7724473|FG000|NOT COMPLETED|Phase I Pre-op/Post-op||21
6792911|NCT00290511|7724480|FG000|STARTED|Overall Study||49
6792912|NCT00290511|7724480|FG000|No Treatment Per Protocol|Overall Study||2
6792913|NCT00290511|7724480|FG000|Toxicity Assessment|Overall Study||47
6792914|NCT00290511|7724480|FG000|Response Assessment|Overall Study||45
6792915|NCT00290511|7724480|FG000|COMPLETED|Overall Study||45
6792916|NCT00290511|7724480|FG000|NOT COMPLETED|Overall Study||4
6792917|NCT00265798|7724484|FG000|STARTED|Overall Study||38
6792918|NCT00265798|7724484|FG000|COMPLETED|Overall Study||38
6792919|NCT00265798|7724484|FG000|NOT COMPLETED|Overall Study||0
6792920|NCT00641537|7724493|FG000|STARTED|96-week Period||98
6792921|NCT00641537|7724494|FG001|STARTED|96-week Period||92
6792922|NCT00641537|7724495|FG002|STARTED|96-week Period||186
6792923|NCT00641537|7724496|FG003|STARTED|96-week Period||186
6792924|NCT00641537|7724497|FG004|STARTED|96-week Period||244
6792925|NCT00641537|7724498|FG005|STARTED|96-week Period||22
6792926|NCT00641537|7724499|FG006|STARTED|96-week Period||17
6792927|NCT00641537|7724500|FG007|STARTED|96-week Period||22
6792928|NCT00641537|7724493|FG000|COMPLETED|96-week Period||89
6792929|NCT00641537|7724494|FG001|COMPLETED|96-week Period||82
6792930|NCT00641537|7724495|FG002|COMPLETED|96-week Period||166
6792931|NCT00641537|7724496|FG003|COMPLETED|96-week Period||174
6792932|NCT00641537|7724497|FG004|COMPLETED|96-week Period||227
6792933|NCT00641537|7724498|FG005|COMPLETED|96-week Period||15
6792934|NCT00641537|7724499|FG006|COMPLETED|96-week Period||12
6379124|NCT00771615|7289719|FG001|NOT COMPLETED|Overall Study||2
6379125|NCT00771615|7289720|FG002|NOT COMPLETED|Overall Study||1
6379126|NCT00771615|7289721|FG003|NOT COMPLETED|Overall Study||1
6379127|NCT00771615|7289722|FG004|NOT COMPLETED|Overall Study||0
6379128|NCT00771615|7289723|FG005|NOT COMPLETED|Overall Study||1
6379129|NCT00771615|7289724|FG006|NOT COMPLETED|Overall Study||1
6379130|NCT00771615|7289725|FG007|NOT COMPLETED|Overall Study||1
6379131|NCT00771615|7289726|FG008|NOT COMPLETED|Overall Study||0
6379132|NCT00771667|7289759|FG000|STARTED|Induction Phase||132
6379133|NCT00771667|7289760|FG001|STARTED|Induction Phase||131
6379134|NCT00771667|7289761|FG002|STARTED|Induction Phase||132
6379135|NCT00771667|7289762|FG003|STARTED|Induction Phase||131
6379136|NCT00771667|7289763|FG004|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6379137|NCT00771667|7289764|FG005|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6379138|NCT00771667|7289765|FG006|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6379139|NCT00771667|7289766|FG007|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6379140|NCT00771667|7289767|FG008|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6379141|NCT00771667|7289768|FG009|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
6379142|NCT00771667|7289759|FG000|COMPLETED|Induction Phase||113
6379143|NCT00771667|7289760|FG001|COMPLETED|Induction Phase||121
6379144|NCT00771667|7289761|FG002|COMPLETED|Induction Phase||120
6379145|NCT00771667|7289762|FG003|COMPLETED|Induction Phase||123
6379146|NCT00771667|7289763|FG004|COMPLETED|Induction Phase||0
6379147|NCT00771667|7289764|FG005|COMPLETED|Induction Phase||0
6379148|NCT00771667|7289765|FG006|COMPLETED|Induction Phase||0
6379149|NCT00771667|7289766|FG007|COMPLETED|Induction Phase||0
6379150|NCT00771667|7289767|FG008|COMPLETED|Induction Phase||0
6379151|NCT00771667|7289768|FG009|COMPLETED|Induction Phase||0
6379152|NCT00771667|7289759|FG000|NOT COMPLETED|Induction Phase||19
6379153|NCT00771667|7289760|FG001|NOT COMPLETED|Induction Phase||10
6379154|NCT00771667|7289761|FG002|NOT COMPLETED|Induction Phase||12
6379155|NCT00771667|7289762|FG003|NOT COMPLETED|Induction Phase||8
6379156|NCT00771667|7289763|FG004|NOT COMPLETED|Induction Phase||0
6379157|NCT00771667|7289764|FG005|NOT COMPLETED|Induction Phase||0
6379158|NCT00771667|7289765|FG006|NOT COMPLETED|Induction Phase||0
6379159|NCT00771667|7289766|FG007|NOT COMPLETED|Induction Phase||0
6379160|NCT00771667|7289767|FG008|NOT COMPLETED|Induction Phase||0
6379161|NCT00771667|7289768|FG009|NOT COMPLETED|Induction Phase||0
6379162|NCT00771667|7289759|FG000|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
6379163|NCT00771667|7289760|FG001|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
6379164|NCT00771667|7289761|FG002|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
6379165|NCT00771667|7289762|FG003|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
6792935|NCT00641537|7724500|FG007|COMPLETED|96-week Period||16
6792936|NCT00641537|7724493|FG000|NOT COMPLETED|96-week Period||9
6792937|NCT00641537|7724494|FG001|NOT COMPLETED|96-week Period||10
6792938|NCT00641537|7724495|FG002|NOT COMPLETED|96-week Period||20
6792939|NCT00641537|7724496|FG003|NOT COMPLETED|96-week Period||12
6792940|NCT00641537|7724497|FG004|NOT COMPLETED|96-week Period||17
6563541|NCT01807299|7486458|FG000|NOT COMPLETED|Overall Study||3
6563542|NCT01807299|7486459|FG001|NOT COMPLETED|Overall Study||1
6563543|NCT01807299|7486460|FG002|NOT COMPLETED|Overall Study||0
6563544|NCT01807299|7486461|FG003|NOT COMPLETED|Overall Study||2
6563545|NCT01807455|7486471|FG000|STARTED|Overall Study||12
6563546|NCT01807455|7486471|FG000|COMPLETED|Overall Study||12
6563547|NCT01807455|7486471|FG000|NOT COMPLETED|Overall Study||0
6563548|NCT01807520|7486478|FG000|STARTED|Treatment Period 1 (0-16 Weeks)||67
6563549|NCT01807520|7486479|FG001|STARTED|Treatment Period 1 (0-16 Weeks)||66
6563550|NCT01807520|7486480|FG002|STARTED|Treatment Period 1 (0-16 Weeks)||65
6563551|NCT01807520|7486481|FG003|STARTED|Treatment Period 1 (0-16 Weeks)||0
6563552|NCT01807520|7486482|FG004|STARTED|Treatment Period 1 (0-16 Weeks)||0
6563553|NCT01807520|7486483|FG005|STARTED|Treatment Period 1 (0-16 Weeks)||0
6563554|NCT01807520|7486484|FG006|STARTED|Treatment Period 1 (0-16 Weeks)||0
6563555|NCT01807520|7486478|FG000|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||67
6563556|NCT01807520|7486479|FG001|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||66
6563557|NCT01807520|7486480|FG002|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||65
6656564|NCT02462057|7586820|FG001|STARTED|Overall Study||793
6563558|NCT01807520|7486481|FG003|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
6792941|NCT00641537|7724498|FG005|NOT COMPLETED|96-week Period||7
6792942|NCT00641537|7724499|FG006|NOT COMPLETED|96-week Period||5
6792943|NCT00641537|7724500|FG007|NOT COMPLETED|96-week Period||6
6792944|NCT00641537|7724493|FG000|STARTED|24-Week Supplemental Follow-up Period||75
6792945|NCT00641537|7724494|FG001|STARTED|24-Week Supplemental Follow-up Period||69
6792946|NCT00641537|7724495|FG002|STARTED|24-Week Supplemental Follow-up Period||143
6792947|NCT00641537|7724496|FG003|STARTED|24-Week Supplemental Follow-up Period||151
6792948|NCT00641537|7724497|FG004|STARTED|24-Week Supplemental Follow-up Period||198
6792949|NCT00641537|7724498|FG005|STARTED|24-Week Supplemental Follow-up Period||15
6792950|NCT00641537|7724499|FG006|STARTED|24-Week Supplemental Follow-up Period||9
6792951|NCT00641537|7724500|FG007|STARTED|24-Week Supplemental Follow-up Period||11
6792952|NCT00641537|7724493|FG000|COMPLETED|24-Week Supplemental Follow-up Period||75
6792953|NCT00641537|7724494|FG001|COMPLETED|24-Week Supplemental Follow-up Period||66
6792954|NCT00641537|7724495|FG002|COMPLETED|24-Week Supplemental Follow-up Period||140
6792955|NCT00641537|7724496|FG003|COMPLETED|24-Week Supplemental Follow-up Period||147
6792956|NCT00641537|7724497|FG004|COMPLETED|24-Week Supplemental Follow-up Period||193
6792957|NCT00641537|7724498|FG005|COMPLETED|24-Week Supplemental Follow-up Period||14
6792958|NCT00641537|7724499|FG006|COMPLETED|24-Week Supplemental Follow-up Period||8
6792959|NCT00641537|7724500|FG007|COMPLETED|24-Week Supplemental Follow-up Period||10
6792960|NCT00641537|7724493|FG000|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
6792961|NCT00641537|7724494|FG001|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
6792962|NCT00641537|7724495|FG002|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
6792963|NCT00641537|7724496|FG003|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
6792964|NCT00641537|7724497|FG004|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
6792965|NCT00641537|7724498|FG005|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
6792966|NCT00641537|7724499|FG006|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
6792967|NCT00641537|7724500|FG007|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
6792968|NCT00655824|7724518|FG000|STARTED|Overall Study||92
6792969|NCT00655824|7724518|FG000|COMPLETED|Overall Study||8
6792970|NCT00655824|7724518|FG000|NOT COMPLETED|Overall Study||84
6792971|NCT00663052|7724524|FG000|STARTED|Overall Study||136
6792972|NCT00663052|7724525|FG001|STARTED|Overall Study||137
6792973|NCT00663052|7724524|FG000|COMPLETED|Overall Study||124
6792974|NCT00663052|7724525|FG001|COMPLETED|Overall Study||127
6792975|NCT00663052|7724524|FG000|NOT COMPLETED|Overall Study||12
6792976|NCT00663052|7724525|FG001|NOT COMPLETED|Overall Study||10
6792977|NCT00686374|7724531|FG000|STARTED|Overall Study||100
6792978|NCT00686374|7724531|FG000|COMPLETED|Overall Study||39
6792979|NCT00686374|7724531|FG000|NOT COMPLETED|Overall Study||61
6792980|NCT00698828|7724538|FG000|STARTED|Overall Study||76
6792981|NCT00698828|7724539|FG001|STARTED|Overall Study||75
6792982|NCT00698828|7724540|FG002|STARTED|Overall Study||76
6792983|NCT00698828|7724538|FG000|COMPLETED|Overall Study||67
6792984|NCT00698828|7724539|FG001|COMPLETED|Overall Study||60
6792985|NCT00698828|7724540|FG002|COMPLETED|Overall Study||65
6379166|NCT00771667|7289763|FG004|STARTED|Maintenance Phase||28
6379167|NCT00771667|7289764|FG005|STARTED|Maintenance Phase||85
6379168|NCT00771667|7289765|FG006|STARTED|Maintenance Phase||73
6379169|NCT00771667|7289766|FG007|STARTED|Maintenance Phase||72
6379170|NCT00771667|7289767|FG008|STARTED|Maintenance Phase||110
6379171|NCT00771667|7289768|FG009|STARTED|Maintenance Phase||109
6379172|NCT00771667|7289759|FG000|COMPLETED|Maintenance Phase||0
6379173|NCT00771667|7289760|FG001|COMPLETED|Maintenance Phase||0
6379174|NCT00771667|7289761|FG002|COMPLETED|Maintenance Phase||0
6792986|NCT00698828|7724538|FG000|NOT COMPLETED|Overall Study||9
6792987|NCT00698828|7724539|FG001|NOT COMPLETED|Overall Study||15
6792988|NCT00698828|7724540|FG002|NOT COMPLETED|Overall Study||11
6792989|NCT00712933|7724548|FG000|STARTED|Overall Study||735
6792990|NCT00712933|7724548|FG000|COMPLETED|Overall Study||368
6792991|NCT00712933|7724548|FG000|NOT COMPLETED|Overall Study||367
6792992|NCT00725985|7724559|FG000|STARTED|ITP- Treatment Disposition||205
6792993|NCT00725985|7724560|FG001|STARTED|ITP- Treatment Disposition||206
6792994|NCT00725985|7724561|FG002|STARTED|ITP- Treatment Disposition||206
6792995|NCT00725985|7724562|FG003|STARTED|ITP- Treatment Disposition||0
6792996|NCT00725985|7724563|FG004|STARTED|ITP- Treatment Disposition||0
6792997|NCT00725985|7724564|FG005|STARTED|ITP- Treatment Disposition||0
6792998|NCT00725985|7724565|FG006|STARTED|ITP- Treatment Disposition||0
6792999|NCT00725985|7724566|FG007|STARTED|ITP- Treatment Disposition||0
6793000|NCT00725985|7724567|FG008|STARTED|ITP- Treatment Disposition||0
6793001|NCT00725985|7724568|FG009|STARTED|ITP- Treatment Disposition||0
6793002|NCT00725985|7724569|FG010|STARTED|ITP- Treatment Disposition||0
6379175|NCT00771667|7289762|FG003|COMPLETED|Maintenance Phase||0
6379176|NCT00771667|7289763|FG004|COMPLETED|Maintenance Phase||26
6793003|NCT00725985|7724570|FG011|STARTED|ITP- Treatment Disposition||0
6793004|NCT00725985|7724559|FG000|Treated|ITP- Treatment Disposition||204
6793005|NCT00725985|7724560|FG001|Treated|ITP- Treatment Disposition||206
6793006|NCT00725985|7724561|FG002|Treated|ITP- Treatment Disposition||206
6793007|NCT00725985|7724562|FG003|Treated|ITP- Treatment Disposition||0
6793008|NCT00725985|7724563|FG004|Treated|ITP- Treatment Disposition||0
6793009|NCT00725985|7724564|FG005|Treated|ITP- Treatment Disposition||0
6793010|NCT00725985|7724565|FG006|Treated|ITP- Treatment Disposition||0
6793011|NCT00725985|7724566|FG007|Treated|ITP- Treatment Disposition||0
6793012|NCT00725985|7724567|FG008|Treated|ITP- Treatment Disposition||0
6793013|NCT00725985|7724568|FG009|Treated|ITP- Treatment Disposition||0
6793014|NCT00725985|7724569|FG010|Treated|ITP- Treatment Disposition||0
6793015|NCT00725985|7724570|FG011|Treated|ITP- Treatment Disposition||0
6793016|NCT00725985|7724559|FG000|COMPLETED|ITP- Treatment Disposition||104
6793017|NCT00725985|7724560|FG001|COMPLETED|ITP- Treatment Disposition||131
6793018|NCT00725985|7724561|FG002|COMPLETED|ITP- Treatment Disposition||104
6793019|NCT00725985|7724562|FG003|COMPLETED|ITP- Treatment Disposition||0
6793020|NCT00725985|7724563|FG004|COMPLETED|ITP- Treatment Disposition||0
6793021|NCT00725985|7724564|FG005|COMPLETED|ITP- Treatment Disposition||0
6793022|NCT00725985|7724565|FG006|COMPLETED|ITP- Treatment Disposition||0
6793023|NCT00725985|7724566|FG007|COMPLETED|ITP- Treatment Disposition||0
6793024|NCT00725985|7724567|FG008|COMPLETED|ITP- Treatment Disposition||0
6793025|NCT00725985|7724568|FG009|COMPLETED|ITP- Treatment Disposition||0
6793026|NCT00725985|7724569|FG010|COMPLETED|ITP- Treatment Disposition||0
6793027|NCT00725985|7724570|FG011|COMPLETED|ITP- Treatment Disposition||0
6793028|NCT00725985|7724559|FG000|NOT COMPLETED|ITP- Treatment Disposition||101
6793029|NCT00725985|7724560|FG001|NOT COMPLETED|ITP- Treatment Disposition||75
6793030|NCT00725985|7724561|FG002|NOT COMPLETED|ITP- Treatment Disposition||102
6793031|NCT00725985|7724562|FG003|NOT COMPLETED|ITP- Treatment Disposition||0
6793032|NCT00725985|7724563|FG004|NOT COMPLETED|ITP- Treatment Disposition||0
6793033|NCT00725985|7724564|FG005|NOT COMPLETED|ITP- Treatment Disposition||0
6379177|NCT00771667|7289764|FG005|COMPLETED|Maintenance Phase||78
6379178|NCT00771667|7289765|FG006|COMPLETED|Maintenance Phase||63
6379179|NCT00771667|7289766|FG007|COMPLETED|Maintenance Phase||67
6379180|NCT00771667|7289767|FG008|COMPLETED|Maintenance Phase||88
6379181|NCT00771667|7289768|FG009|COMPLETED|Maintenance Phase||92
6379182|NCT00771667|7289759|FG000|NOT COMPLETED|Maintenance Phase||0
6379183|NCT00771667|7289760|FG001|NOT COMPLETED|Maintenance Phase||0
6379184|NCT00771667|7289761|FG002|NOT COMPLETED|Maintenance Phase||0
6379185|NCT00771667|7289762|FG003|NOT COMPLETED|Maintenance Phase||0
6379186|NCT00771667|7289763|FG004|NOT COMPLETED|Maintenance Phase||2
6379187|NCT00771667|7289764|FG005|NOT COMPLETED|Maintenance Phase||7
6379188|NCT00771667|7289765|FG006|NOT COMPLETED|Maintenance Phase||10
6379189|NCT00771667|7289766|FG007|NOT COMPLETED|Maintenance Phase||5
6379190|NCT00771667|7289767|FG008|NOT COMPLETED|Maintenance Phase||22
6379191|NCT00771667|7289768|FG009|NOT COMPLETED|Maintenance Phase||17
6379192|NCT00771745|7289788|FG000|STARTED|Overall Study||6
6379193|NCT00771745|7289789|FG001|STARTED|Overall Study||5
6379194|NCT00771745|7289788|FG000|COMPLETED|Overall Study||6
6502273|NCT01433731|7420930|FG000|NOT COMPLETED|Overall Study||0
6502274|NCT01433731|7420931|FG001|NOT COMPLETED|Overall Study||0
6502275|NCT01433731|7420932|FG002|NOT COMPLETED|Overall Study||0
6502276|NCT01433731|7420933|FG003|NOT COMPLETED|Overall Study||0
6502277|NCT01433913|7420943|FG000|STARTED|Overall Study||10
6502278|NCT01433913|7420944|FG001|STARTED|Overall Study||10
6502279|NCT01433913|7420943|FG000|COMPLETED|Overall Study||9
6502280|NCT01433913|7420944|FG001|COMPLETED|Overall Study||10
6502281|NCT01433913|7420943|FG000|NOT COMPLETED|Overall Study||1
6502282|NCT01433913|7420944|FG001|NOT COMPLETED|Overall Study||0
6502283|NCT01433978|7420953|FG000|STARTED|Core Study||11
6502284|NCT01433978|7420954|FG001|STARTED|Core Study||12
6502285|NCT01433978|7420955|FG002|STARTED|Core Study||0
6502286|NCT01433978|7420953|FG000|COMPLETED|Core Study||0
6502287|NCT01433978|7420954|FG001|COMPLETED|Core Study||1
6502288|NCT01433978|7420955|FG002|COMPLETED|Core Study||0
6502289|NCT01433978|7420953|FG000|NOT COMPLETED|Core Study||11
6502290|NCT01433978|7420954|FG001|NOT COMPLETED|Core Study||11
6502291|NCT01433978|7420955|FG002|NOT COMPLETED|Core Study||0
6502292|NCT01433978|7420953|FG000|STARTED|Extension Phase||0
6502293|NCT01433978|7420954|FG001|STARTED|Extension Phase||0
6502294|NCT01433978|7420955|FG002|STARTED|Extension Phase||6
6502295|NCT01433978|7420953|FG000|COMPLETED|Extension Phase||0
6563559|NCT01807520|7486482|FG004|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
6793034|NCT00725985|7724565|FG006|NOT COMPLETED|ITP- Treatment Disposition||0
6502296|NCT01433978|7420954|FG001|COMPLETED|Extension Phase||0
6502297|NCT01433978|7420955|FG002|COMPLETED|Extension Phase||0
6502298|NCT01433978|7420953|FG000|NOT COMPLETED|Extension Phase||0
6502299|NCT01433978|7420954|FG001|NOT COMPLETED|Extension Phase||0
6502300|NCT01433978|7420955|FG002|NOT COMPLETED|Extension Phase||6
6379195|NCT00771745|7289789|FG001|COMPLETED|Overall Study||5
6379196|NCT00771745|7289788|FG000|NOT COMPLETED|Overall Study||0
6563560|NCT01807520|7486483|FG005|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
6793035|NCT00725985|7724566|FG007|NOT COMPLETED|ITP- Treatment Disposition||0
6379197|NCT00771745|7289789|FG001|NOT COMPLETED|Overall Study||0
6379198|NCT00771758|7289798|FG000|STARTED|Overall Study||44
6379199|NCT00771758|7289799|FG001|STARTED|Overall Study||43
6502301|NCT01433991|7420966|FG000|STARTED|Pretreatment Phase (Single Agent Run-in)||5
6563561|NCT01807520|7486484|FG006|Full Analysis Set|Treatment Period 1 (0-16 Weeks)||0
6563562|NCT01807520|7486478|FG000|Safety Set|Treatment Period 1 (0-16 Weeks)||67
6563563|NCT01807520|7486479|FG001|Safety Set|Treatment Period 1 (0-16 Weeks)||65
6563564|NCT01807520|7486480|FG002|Safety Set|Treatment Period 1 (0-16 Weeks)||65
6563565|NCT01807520|7486481|FG003|Safety Set|Treatment Period 1 (0-16 Weeks)||0
6563566|NCT01807520|7486482|FG004|Safety Set|Treatment Period 1 (0-16 Weeks)||0
6793036|NCT00725985|7724567|FG008|NOT COMPLETED|ITP- Treatment Disposition||0
6793037|NCT00725985|7724568|FG009|NOT COMPLETED|ITP- Treatment Disposition||0
6793038|NCT00725985|7724569|FG010|NOT COMPLETED|ITP- Treatment Disposition||0
6793039|NCT00725985|7724570|FG011|NOT COMPLETED|ITP- Treatment Disposition||0
6793040|NCT00725985|7724559|FG000|STARTED|OLMP (Up to 96 Weeks)||0
6793041|NCT00725985|7724560|FG001|STARTED|OLMP (Up to 96 Weeks)||0
6656565|NCT02462057|7586821|FG002|STARTED|Overall Study||812
6656566|NCT02462057|7586822|FG003|STARTED|Overall Study||752
6793042|NCT00725985|7724561|FG002|STARTED|OLMP (Up to 96 Weeks)||0
6793043|NCT00725985|7724562|FG003|STARTED|OLMP (Up to 96 Weeks)||24
6793044|NCT00725985|7724563|FG004|STARTED|OLMP (Up to 96 Weeks)||25
6793045|NCT00725985|7724564|FG005|STARTED|OLMP (Up to 96 Weeks)||60
6793046|NCT00725985|7724565|FG006|STARTED|OLMP (Up to 96 Weeks)||0
6793047|NCT00725985|7724566|FG007|STARTED|OLMP (Up to 96 Weeks)||0
6793048|NCT00725985|7724567|FG008|STARTED|OLMP (Up to 96 Weeks)||0
6793049|NCT00725985|7724568|FG009|STARTED|OLMP (Up to 96 Weeks)||0
6793050|NCT00725985|7724569|FG010|STARTED|OLMP (Up to 96 Weeks)||0
6793051|NCT00725985|7724570|FG011|STARTED|OLMP (Up to 96 Weeks)||0
6793052|NCT00725985|7724559|FG000|COMPLETED|OLMP (Up to 96 Weeks)||0
6502302|NCT01433991|7420967|FG001|STARTED|Pretreatment Phase (Single Agent Run-in)||3
6563567|NCT01807520|7486483|FG005|Safety Set|Treatment Period 1 (0-16 Weeks)||0
6656567|NCT02462057|7586823|FG004|STARTED|Overall Study||758
6656568|NCT02462057|7586819|FG000|COMPLETED|Overall Study||737
6656569|NCT02462057|7586820|FG001|COMPLETED|Overall Study||753
6656570|NCT02462057|7586821|FG002|COMPLETED|Overall Study||766
6656571|NCT02462057|7586822|FG003|COMPLETED|Overall Study||701
6656572|NCT02462057|7586823|FG004|COMPLETED|Overall Study||708
6656573|NCT02462057|7586819|FG000|NOT COMPLETED|Overall Study||54
6656574|NCT02462057|7586820|FG001|NOT COMPLETED|Overall Study||40
6656575|NCT02462057|7586821|FG002|NOT COMPLETED|Overall Study||46
6793053|NCT00725985|7724560|FG001|COMPLETED|OLMP (Up to 96 Weeks)||0
6793054|NCT00725985|7724561|FG002|COMPLETED|OLMP (Up to 96 Weeks)||0
6793055|NCT00725985|7724562|FG003|COMPLETED|OLMP (Up to 96 Weeks)||6
6793056|NCT00725985|7724563|FG004|COMPLETED|OLMP (Up to 96 Weeks)||2
6793057|NCT00725985|7724564|FG005|COMPLETED|OLMP (Up to 96 Weeks)||7
6793058|NCT00725985|7724565|FG006|COMPLETED|OLMP (Up to 96 Weeks)||0
6793059|NCT00725985|7724566|FG007|COMPLETED|OLMP (Up to 96 Weeks)||0
6793060|NCT00725985|7724567|FG008|COMPLETED|OLMP (Up to 96 Weeks)||0
6793061|NCT00725985|7724568|FG009|COMPLETED|OLMP (Up to 96 Weeks)||0
6793062|NCT00725985|7724569|FG010|COMPLETED|OLMP (Up to 96 Weeks)||0
6793063|NCT00725985|7724570|FG011|COMPLETED|OLMP (Up to 96 Weeks)||0
6793064|NCT00725985|7724559|FG000|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793065|NCT00725985|7724560|FG001|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793066|NCT00725985|7724561|FG002|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793067|NCT00725985|7724562|FG003|NOT COMPLETED|OLMP (Up to 96 Weeks)||18
6793068|NCT00725985|7724563|FG004|NOT COMPLETED|OLMP (Up to 96 Weeks)||23
6793069|NCT00725985|7724564|FG005|NOT COMPLETED|OLMP (Up to 96 Weeks)||53
6793070|NCT00725985|7724565|FG006|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793071|NCT00725985|7724566|FG007|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793072|NCT00725985|7724567|FG008|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793073|NCT00725985|7724568|FG009|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793074|NCT00725985|7724569|FG010|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793075|NCT00725985|7724570|FG011|NOT COMPLETED|OLMP (Up to 96 Weeks)||0
6793076|NCT00725985|7724559|FG000|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793077|NCT00725985|7724560|FG001|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793078|NCT00725985|7724561|FG002|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793079|NCT00725985|7724562|FG003|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793080|NCT00725985|7724563|FG004|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793081|NCT00725985|7724564|FG005|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793082|NCT00725985|7724565|FG006|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
6793083|NCT00725985|7724566|FG007|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||9
6793084|NCT00725985|7724567|FG008|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||17
6793085|NCT00725985|7724568|FG009|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793086|NCT00725985|7724569|FG010|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793087|NCT00725985|7724570|FG011|STARTED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793088|NCT00725985|7724559|FG000|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793089|NCT00725985|7724560|FG001|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793090|NCT00725985|7724561|FG002|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793091|NCT00725985|7724562|FG003|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793092|NCT00725985|7724563|FG004|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793093|NCT00725985|7724564|FG005|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793094|NCT00725985|7724565|FG006|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793095|NCT00725985|7724566|FG007|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793096|NCT00725985|7724567|FG008|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793097|NCT00725985|7724568|FG009|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793098|NCT00725985|7724569|FG010|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793099|NCT00725985|7724570|FG011|COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793100|NCT00725985|7724559|FG000|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793101|NCT00725985|7724560|FG001|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793102|NCT00725985|7724561|FG002|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793103|NCT00725985|7724562|FG003|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793104|NCT00725985|7724563|FG004|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793105|NCT00725985|7724564|FG005|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793106|NCT00725985|7724565|FG006|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
6793107|NCT00725985|7724566|FG007|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||9
6793108|NCT00725985|7724567|FG008|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||17
6793109|NCT00725985|7724568|FG009|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793110|NCT00725985|7724569|FG010|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793111|NCT00725985|7724570|FG011|NOT COMPLETED|LTFU (Cladribine Treatment) (48 Weeks)||0
6793112|NCT00725985|7724559|FG000|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793113|NCT00725985|7724560|FG001|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793114|NCT00725985|7724561|FG002|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793115|NCT00725985|7724562|FG003|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793116|NCT00725985|7724563|FG004|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793117|NCT00725985|7724564|FG005|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793118|NCT00725985|7724565|FG006|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793119|NCT00725985|7724566|FG007|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793120|NCT00725985|7724567|FG008|STARTED|LTFU (No Cladribine) (48 Weeks)||0
6793121|NCT00725985|7724568|FG009|STARTED|LTFU (No Cladribine) (48 Weeks)||34
6379200|NCT00771758|7289800|FG002|STARTED|Overall Study||21
6379201|NCT00771758|7289798|FG000|COMPLETED|Overall Study||36
6379202|NCT00771758|7289799|FG001|COMPLETED|Overall Study||31
6379203|NCT00771758|7289800|FG002|COMPLETED|Overall Study||19
6793122|NCT00725985|7724569|FG010|STARTED|LTFU (No Cladribine) (48 Weeks)||36
6793123|NCT00725985|7724570|FG011|STARTED|LTFU (No Cladribine) (48 Weeks)||14
6793124|NCT00725985|7724559|FG000|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793125|NCT00725985|7724560|FG001|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6379204|NCT00771758|7289798|FG000|NOT COMPLETED|Overall Study||8
6379205|NCT00771758|7289799|FG001|NOT COMPLETED|Overall Study||12
6379206|NCT00771758|7289800|FG002|NOT COMPLETED|Overall Study||2
6379207|NCT00771810|7289828|FG000|STARTED|Overall Study||10
6793126|NCT00725985|7724561|FG002|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793127|NCT00725985|7724562|FG003|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793128|NCT00725985|7724563|FG004|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793129|NCT00725985|7724564|FG005|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793130|NCT00725985|7724565|FG006|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793131|NCT00725985|7724566|FG007|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793132|NCT00725985|7724567|FG008|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793133|NCT00725985|7724568|FG009|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6563568|NCT01807520|7486484|FG006|Safety Set|Treatment Period 1 (0-16 Weeks)||0
6563569|NCT01807520|7486478|FG000|COMPLETED|Treatment Period 1 (0-16 Weeks)||63
6563570|NCT01807520|7486479|FG001|COMPLETED|Treatment Period 1 (0-16 Weeks)||65
6563571|NCT01807520|7486480|FG002|COMPLETED|Treatment Period 1 (0-16 Weeks)||58
6563572|NCT01807520|7486481|FG003|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6563573|NCT01807520|7486482|FG004|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6563574|NCT01807520|7486483|FG005|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6563575|NCT01807520|7486484|FG006|COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6793134|NCT00725985|7724569|FG010|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793135|NCT00725985|7724570|FG011|COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793136|NCT00725985|7724559|FG000|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793137|NCT00725985|7724560|FG001|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793138|NCT00725985|7724561|FG002|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793139|NCT00725985|7724562|FG003|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793140|NCT00725985|7724563|FG004|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793141|NCT00725985|7724564|FG005|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793142|NCT00725985|7724565|FG006|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6379208|NCT00771810|7289829|FG001|STARTED|Overall Study||11
6379209|NCT00771810|7289830|FG002|STARTED|Overall Study||13
6379210|NCT00771810|7289828|FG000|COMPLETED|Overall Study||5
6379211|NCT00771810|7289829|FG001|COMPLETED|Overall Study||6
6379212|NCT00771810|7289830|FG002|COMPLETED|Overall Study||6
6379213|NCT00771810|7289828|FG000|NOT COMPLETED|Overall Study||5
6379214|NCT00771810|7289829|FG001|NOT COMPLETED|Overall Study||5
6379215|NCT00771810|7289830|FG002|NOT COMPLETED|Overall Study||7
6379216|NCT00771849|7289841|FG000|STARTED|Overall Study||52
6379217|NCT00771849|7289842|FG001|STARTED|Overall Study|One subject was not vaccinated|51
6379218|NCT00771849|7289841|FG000|COMPLETED|Overall Study||50
6379219|NCT00771849|7289842|FG001|COMPLETED|Overall Study||47
6379220|NCT00771849|7289841|FG000|NOT COMPLETED|Overall Study||2
6379221|NCT00771849|7289842|FG001|NOT COMPLETED|Overall Study||4
6379222|NCT00771875|7289851|FG000|STARTED|Overall Study||10
6379223|NCT00771875|7289852|FG001|STARTED|Overall Study||10
6379224|NCT00771875|7289853|FG002|STARTED|Overall Study||10
6379225|NCT00771875|7289851|FG000|COMPLETED|Overall Study||10
6379226|NCT00771875|7289852|FG001|COMPLETED|Overall Study||9
6379227|NCT00771875|7289853|FG002|COMPLETED|Overall Study||10
6379228|NCT00771875|7289851|FG000|NOT COMPLETED|Overall Study||0
6502303|NCT01433991|7420968|FG002|STARTED|Pretreatment Phase (Single Agent Run-in)||14
6502304|NCT01433991|7420969|FG003|STARTED|Pretreatment Phase (Single Agent Run-in)||8
6502305|NCT01433991|7420966|FG000|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
6502306|NCT01433991|7420967|FG001|COMPLETED|Pretreatment Phase (Single Agent Run-in)||3
6502307|NCT01433991|7420968|FG002|COMPLETED|Pretreatment Phase (Single Agent Run-in)||14
6502308|NCT01433991|7420969|FG003|COMPLETED|Pretreatment Phase (Single Agent Run-in)||8
6502309|NCT01433991|7420966|FG000|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||2
6502310|NCT01433991|7420967|FG001|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
6502311|NCT01433991|7420968|FG002|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
6502312|NCT01433991|7420969|FG003|NOT COMPLETED|Pretreatment Phase (Single Agent Run-in)||0
6563576|NCT01807520|7486478|FG000|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||4
6563577|NCT01807520|7486479|FG001|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||1
6563578|NCT01807520|7486480|FG002|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||7
6656576|NCT02462057|7586822|FG003|NOT COMPLETED|Overall Study||51
6379229|NCT00771875|7289852|FG001|NOT COMPLETED|Overall Study||1
6379230|NCT00771875|7289853|FG002|NOT COMPLETED|Overall Study||0
6379231|NCT00771901|7289864|FG000|STARTED|Overall Study||10
6379232|NCT00771901|7289865|FG001|STARTED|Overall Study||10
6379233|NCT00771901|7289866|FG002|STARTED|Overall Study||10
6379234|NCT00771901|7289864|FG000|COMPLETED|Overall Study||10
6379235|NCT00771901|7289865|FG001|COMPLETED|Overall Study||10
6379236|NCT00771901|7289866|FG002|COMPLETED|Overall Study||6
6379237|NCT00771901|7289864|FG000|NOT COMPLETED|Overall Study||0
6502313|NCT01433991|7420966|FG000|STARTED|Treatment Phase (Combination Agent)||3
6502314|NCT01433991|7420967|FG001|STARTED|Treatment Phase (Combination Agent)||3
6502315|NCT01433991|7420968|FG002|STARTED|Treatment Phase (Combination Agent)||14
6793143|NCT00725985|7724566|FG007|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793144|NCT00725985|7724567|FG008|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||0
6793145|NCT00725985|7724568|FG009|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||34
6793146|NCT00725985|7724569|FG010|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||36
6793147|NCT00725985|7724570|FG011|NOT COMPLETED|LTFU (No Cladribine) (48 Weeks)||14
6563579|NCT01807520|7486481|FG003|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6563580|NCT01807520|7486482|FG004|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6563581|NCT01807520|7486483|FG005|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6563582|NCT01807520|7486484|FG006|NOT COMPLETED|Treatment Period 1 (0-16 Weeks)||0
6563583|NCT01807520|7486478|FG000|STARTED|Treatment Period 2 (16-132 Weeks)||63
6563584|NCT01807520|7486479|FG001|STARTED|Treatment Period 2 (16-132 Weeks)||65
6793148|NCT00788671|7724596|FG000|STARTED|Overall Study||57
6793149|NCT00788671|7724596|FG000|COMPLETED|Overall Study||47
6793150|NCT00788671|7724596|FG000|NOT COMPLETED|Overall Study||10
6793151|NCT00799266|7724602|FG000|STARTED|Overall Study||18
6793152|NCT00799266|7724603|FG001|STARTED|Overall Study||16
6793153|NCT00799266|7724602|FG000|Modified Intention-to-treat (MITT)|Overall Study||17
6793154|NCT00799266|7724603|FG001|Modified Intention-to-treat (MITT)|Overall Study||16
6793155|NCT00799266|7724602|FG000|Safety Set|Overall Study||18
6793156|NCT00799266|7724603|FG001|Safety Set|Overall Study||16
6793157|NCT00799266|7724602|FG000|COMPLETED|Overall Study||15
6793158|NCT00799266|7724603|FG001|COMPLETED|Overall Study||15
6793159|NCT00799266|7724602|FG000|NOT COMPLETED|Overall Study||3
6793160|NCT00799266|7724603|FG001|NOT COMPLETED|Overall Study||1
6793161|NCT00810446|7724609|FG000|STARTED|Overall Study||72
6793162|NCT00810446|7724609|FG000|COMPLETED|Overall Study||72
6793163|NCT00810446|7724609|FG000|NOT COMPLETED|Overall Study||0
6793164|NCT00844480|7724615|FG000|STARTED|Overall Study||8
6793165|NCT00844480|7724616|FG001|STARTED|Overall Study||9
6793166|NCT00844480|7724615|FG000|COMPLETED|Overall Study||6
6793167|NCT00844480|7724616|FG001|COMPLETED|Overall Study||6
6793168|NCT00844480|7724615|FG000|NOT COMPLETED|Overall Study||2
6793169|NCT00844480|7724616|FG001|NOT COMPLETED|Overall Study||3
6563585|NCT01807520|7486480|FG002|STARTED|Treatment Period 2 (16-132 Weeks)||0
6563586|NCT01807520|7486481|FG003|STARTED|Treatment Period 2 (16-132 Weeks)||29
6563587|NCT01807520|7486482|FG004|STARTED|Treatment Period 2 (16-132 Weeks)||29
6793170|NCT00864474|7724622|FG000|STARTED|Overall Study||68
6793171|NCT00864474|7724622|FG000|COMPLETED|Overall Study||68
6793172|NCT00864474|7724622|FG000|NOT COMPLETED|Overall Study||0
6793173|NCT00873366|7724626|FG000|STARTED|Overall Study||77
6563588|NCT01807520|7486483|FG005|STARTED|Treatment Period 2 (16-132 Weeks)||0
6563589|NCT01807520|7486484|FG006|STARTED|Treatment Period 2 (16-132 Weeks)||0
6563590|NCT01807520|7486478|FG000|Safety Set|Treatment Period 2 (16-132 Weeks)||63
6793174|NCT00873366|7724626|FG000|COMPLETED|Overall Study||71
6793175|NCT00873366|7724626|FG000|NOT COMPLETED|Overall Study||6
6793176|NCT00923247|7724632|FG000|STARTED|Overall Study||21
6793177|NCT00923247|7724633|FG001|STARTED|Overall Study||1
6793178|NCT00923247|7724632|FG000|COMPLETED|Overall Study||21
6793179|NCT00923247|7724633|FG001|COMPLETED|Overall Study||1
6793180|NCT00923247|7724632|FG000|NOT COMPLETED|Overall Study||0
6793181|NCT00923247|7724633|FG001|NOT COMPLETED|Overall Study||0
6793182|NCT00928226|7724649|FG000|STARTED|Overall Study||20
6793183|NCT00928226|7724650|FG001|STARTED|Overall Study||12
6793184|NCT00928226|7724651|FG002|STARTED|Overall Study||12
6793185|NCT00928226|7724652|FG003|STARTED|Overall Study||12
6793186|NCT00928226|7724649|FG000|Strata A: Small Tumor, Resected|Overall Study||6
6793187|NCT00928226|7724650|FG001|Strata A: Small Tumor, Resected|Overall Study||6
6793188|NCT00928226|7724651|FG002|Strata A: Small Tumor, Resected|Overall Study||6
6793189|NCT00928226|7724652|FG003|Strata A: Small Tumor, Resected|Overall Study||6
6793190|NCT00928226|7724649|FG000|Strata B: Small Tumor, Not Resected|Overall Study||5
6793191|NCT00928226|7724650|FG001|Strata B: Small Tumor, Not Resected|Overall Study||0
6793192|NCT00928226|7724651|FG002|Strata B: Small Tumor, Not Resected|Overall Study||0
6793193|NCT00928226|7724652|FG003|Strata B: Small Tumor, Not Resected|Overall Study||0
6793194|NCT00928226|7724649|FG000|Strata C: Large Tumor, Resected|Overall Study||8
6793195|NCT00928226|7724650|FG001|Strata C: Large Tumor, Resected|Overall Study||6
6793196|NCT00928226|7724651|FG002|Strata C: Large Tumor, Resected|Overall Study||6
6793197|NCT00928226|7724652|FG003|Strata C: Large Tumor, Resected|Overall Study||6
6793198|NCT00928226|7724649|FG000|Strata D: Large Tumor, Not Resected|Overall Study||1
6793199|NCT00928226|7724650|FG001|Strata D: Large Tumor, Not Resected|Overall Study||0
6793200|NCT00928226|7724651|FG002|Strata D: Large Tumor, Not Resected|Overall Study||0
6793201|NCT00928226|7724652|FG003|Strata D: Large Tumor, Not Resected|Overall Study||0
6793202|NCT00928226|7724649|FG000|COMPLETED|Overall Study||20
6793203|NCT00928226|7724650|FG001|COMPLETED|Overall Study||12
6793204|NCT00928226|7724651|FG002|COMPLETED|Overall Study||12
6793205|NCT00928226|7724652|FG003|COMPLETED|Overall Study||12
6793206|NCT00928226|7724649|FG000|NOT COMPLETED|Overall Study||0
6793207|NCT00928226|7724650|FG001|NOT COMPLETED|Overall Study||0
6793208|NCT00928226|7724651|FG002|NOT COMPLETED|Overall Study||0
6563591|NCT01807520|7486479|FG001|Safety Set|Treatment Period 2 (16-132 Weeks)||65
6793209|NCT00928226|7724652|FG003|NOT COMPLETED|Overall Study||0
6793213|NCT00940498|7724674|FG000|STARTED|Overall Study||4
6793214|NCT00940498|7724675|FG001|STARTED|Overall Study||4
6793215|NCT00940498|7724676|FG002|STARTED|Overall Study||4
6793216|NCT00940498|7724677|FG003|STARTED|Overall Study||4
6793217|NCT00940498|7724678|FG004|STARTED|Overall Study||43
6793218|NCT00940498|7724679|FG005|STARTED|Overall Study||7
6793219|NCT00940498|7724680|FG006|STARTED|Overall Study||8
6793220|NCT00940498|7724681|FG007|STARTED|Overall Study||4
6793221|NCT00940498|7724674|FG000|COMPLETED|Overall Study||1
6793222|NCT00940498|7724675|FG001|COMPLETED|Overall Study||3
6793223|NCT00940498|7724676|FG002|COMPLETED|Overall Study||1
6793210|NCT00930722|7724662|FG000|STARTED|Overall Study||329
6793211|NCT00930722|7724662|FG000|COMPLETED|Overall Study||302
6793212|NCT00930722|7724662|FG000|NOT COMPLETED|Overall Study||27
6793224|NCT00940498|7724677|FG003|COMPLETED|Overall Study||2
6793225|NCT00940498|7724678|FG004|COMPLETED|Overall Study||34
6793226|NCT00940498|7724679|FG005|COMPLETED|Overall Study||6
6793227|NCT00940498|7724680|FG006|COMPLETED|Overall Study||7
6793228|NCT00940498|7724681|FG007|COMPLETED|Overall Study||3
6793229|NCT00940498|7724674|FG000|NOT COMPLETED|Overall Study||3
6793230|NCT00940498|7724675|FG001|NOT COMPLETED|Overall Study||1
6793231|NCT00940498|7724676|FG002|NOT COMPLETED|Overall Study||3
6793232|NCT00940498|7724677|FG003|NOT COMPLETED|Overall Study||2
6793233|NCT00940498|7724678|FG004|NOT COMPLETED|Overall Study||9
6793234|NCT00940498|7724679|FG005|NOT COMPLETED|Overall Study||1
6793235|NCT00940498|7724680|FG006|NOT COMPLETED|Overall Study||1
6793236|NCT00940498|7724681|FG007|NOT COMPLETED|Overall Study||1
6379238|NCT00771901|7289865|FG001|NOT COMPLETED|Overall Study||0
6379239|NCT00771901|7289866|FG002|NOT COMPLETED|Overall Study||4
6379240|NCT00771914|7289878|FG000|STARTED|Overall Study||7
6379241|NCT00771914|7289879|FG001|STARTED|Overall Study||6
6379242|NCT00771914|7289880|FG002|STARTED|Overall Study||6
6379243|NCT00771914|7289881|FG003|STARTED|Overall Study||8
6379244|NCT00771914|7289878|FG000|COMPLETED|Overall Study||7
6379245|NCT00771914|7289879|FG001|COMPLETED|Overall Study||6
6379246|NCT00771914|7289880|FG002|COMPLETED|Overall Study||6
6379247|NCT00771914|7289881|FG003|COMPLETED|Overall Study||6
6379248|NCT00771914|7289878|FG000|NOT COMPLETED|Overall Study||0
6379249|NCT00771914|7289879|FG001|NOT COMPLETED|Overall Study||0
6379250|NCT00771914|7289880|FG002|NOT COMPLETED|Overall Study||0
6379251|NCT00771914|7289881|FG003|NOT COMPLETED|Overall Study||2
6379252|NCT00771927|7289893|FG000|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
6379253|NCT00771927|7289894|FG001|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
6379254|NCT00771927|7289893|FG000|COMPLETED|Overall Study||256
6379255|NCT00771927|7289894|FG001|COMPLETED|Overall Study||256
6379256|NCT00771927|7289893|FG000|NOT COMPLETED|Overall Study||255
6379257|NCT00771927|7289894|FG001|NOT COMPLETED|Overall Study||237
6379258|NCT00771953|7289902|FG000|STARTED|Overall Study||36
6379259|NCT00771953|7289903|FG001|STARTED|Overall Study||36
6379260|NCT00771953|7289902|FG000|COMPLETED|Overall Study||26
6379261|NCT00771953|7289903|FG001|COMPLETED|Overall Study||26
6379262|NCT00771953|7289902|FG000|NOT COMPLETED|Overall Study||10
6379263|NCT00771953|7289903|FG001|NOT COMPLETED|Overall Study||10
6379264|NCT00772005|7289915|FG000|STARTED|Overall Study||71
6379265|NCT00772005|7289916|FG001|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
6379266|NCT00772005|7289917|FG002|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
6379267|NCT00772005|7289918|FG003|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
6379268|NCT00772005|7289915|FG000|COMPLETED|Overall Study||46
6379269|NCT00772005|7289916|FG001|COMPLETED|Overall Study||40
6379270|NCT00772005|7289917|FG002|COMPLETED|Overall Study||44
6379271|NCT00772005|7289918|FG003|COMPLETED|Overall Study||46
6379272|NCT00772005|7289915|FG000|NOT COMPLETED|Overall Study||25
6379273|NCT00772005|7289916|FG001|NOT COMPLETED|Overall Study||30
6379274|NCT00772005|7289917|FG002|NOT COMPLETED|Overall Study||28
6379275|NCT00772005|7289918|FG003|NOT COMPLETED|Overall Study||26
6379276|NCT00772031|7289930|FG000|STARTED|Overall Study||96
6379277|NCT00772031|7289931|FG001|STARTED|Overall Study||95
6379278|NCT00772031|7289930|FG000|COMPLETED|Overall Study||64
6379279|NCT00772031|7289931|FG001|COMPLETED|Overall Study||52
6793237|NCT04720547|7724707|FG000|STARTED|Overall Study||6
6793238|NCT04720547|7724708|FG001|STARTED|Overall Study||8
6793239|NCT04720547|7724707|FG000|COMPLETED|Overall Study||6
6793240|NCT04720547|7724708|FG001|COMPLETED|Overall Study||5
6793241|NCT04720547|7724707|FG000|NOT COMPLETED|Overall Study||0
6793242|NCT04720547|7724708|FG001|NOT COMPLETED|Overall Study||3
6793243|NCT04553913|7724714|FG000|STARTED|Overall Study||15
6793244|NCT04553913|7724714|FG000|COMPLETED|Overall Study||9
6793245|NCT04553913|7724714|FG000|NOT COMPLETED|Overall Study||6
6793246|NCT04079452|7724719|FG000|STARTED|Overall Study||15
6793247|NCT04079452|7724719|FG000|COMPLETED|Overall Study||15
6793248|NCT04079452|7724719|FG000|NOT COMPLETED|Overall Study||0
6793249|NCT04009824|7724729|FG000|STARTED|Overall Study||10
6793250|NCT04009824|7724730|FG001|STARTED|Overall Study||10
6793251|NCT04009824|7724731|FG002|STARTED|Overall Study||11
6793252|NCT04009824|7724732|FG003|STARTED|Overall Study||10
6793253|NCT04009824|7724733|FG004|STARTED|Overall Study||10
6793254|NCT04009824|7724729|FG000|COMPLETED|Overall Study||8
6793255|NCT04009824|7724730|FG001|COMPLETED|Overall Study||7
6793256|NCT04009824|7724731|FG002|COMPLETED|Overall Study||6
6793257|NCT04009824|7724732|FG003|COMPLETED|Overall Study||8
6793258|NCT04009824|7724733|FG004|COMPLETED|Overall Study||7
6793259|NCT04009824|7724729|FG000|NOT COMPLETED|Overall Study||2
6793260|NCT04009824|7724730|FG001|NOT COMPLETED|Overall Study||3
6793261|NCT04009824|7724731|FG002|NOT COMPLETED|Overall Study||5
6793262|NCT04009824|7724732|FG003|NOT COMPLETED|Overall Study||2
6793263|NCT04009824|7724733|FG004|NOT COMPLETED|Overall Study||3
6793264|NCT03867383|7724747|FG000|STARTED|Overall Study||20
6793265|NCT03867383|7724748|FG001|STARTED|Overall Study||20
6793266|NCT03867383|7724747|FG000|COMPLETED|Overall Study||20
6793267|NCT03867383|7724748|FG001|COMPLETED|Overall Study||20
6793268|NCT03867383|7724747|FG000|NOT COMPLETED|Overall Study||0
6793269|NCT03867383|7724748|FG001|NOT COMPLETED|Overall Study||0
6793270|NCT03449758|7724755|FG000|STARTED|Overall Study||84
6793271|NCT03449758|7724755|FG000|COMPLETED|Overall Study||65
6793272|NCT03449758|7724755|FG000|NOT COMPLETED|Overall Study||19
6793273|NCT03222973|7724762|FG000|STARTED|Part 1 (Week 0 to Week 72)||131
6793274|NCT03222973|7724763|FG001|STARTED|Part 1 (Week 0 to Week 72)||132
6793275|NCT03222973|7724764|FG002|STARTED|Part 1 (Week 0 to Week 72)||0
6502316|NCT01433991|7420969|FG003|STARTED|Treatment Phase (Combination Agent)||8
6502317|NCT01433991|7420966|FG000|COMPLETED|Treatment Phase (Combination Agent)||1
6793276|NCT03222973|7724765|FG003|STARTED|Part 1 (Week 0 to Week 72)||0
6793277|NCT03222973|7724762|FG000|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||131
6793278|NCT03222973|7724763|FG001|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||132
6793279|NCT03222973|7724764|FG002|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
6793280|NCT03222973|7724765|FG003|Intent-to-treat (ITT) Population|Part 1 (Week 0 to Week 72)||0
6793281|NCT03222973|7724762|FG000|Safety Population|Part 1 (Week 0 to Week 72)||131
6793282|NCT03222973|7724763|FG001|Safety Population|Part 1 (Week 0 to Week 72)||132
6793283|NCT03222973|7724764|FG002|Safety Population|Part 1 (Week 0 to Week 72)||0
6793284|NCT03222973|7724765|FG003|Safety Population|Part 1 (Week 0 to Week 72)||0
6502318|NCT01433991|7420967|FG001|COMPLETED|Treatment Phase (Combination Agent)||2
6793285|NCT03222973|7724762|FG000|COMPLETED|Part 1 (Week 0 to Week 72)||107
6793286|NCT03222973|7724763|FG001|COMPLETED|Part 1 (Week 0 to Week 72)||118
6793287|NCT03222973|7724764|FG002|COMPLETED|Part 1 (Week 0 to Week 72)||0
6793288|NCT03222973|7724765|FG003|COMPLETED|Part 1 (Week 0 to Week 72)||0
6793289|NCT03222973|7724762|FG000|NOT COMPLETED|Part 1 (Week 0 to Week 72)||24
6793290|NCT03222973|7724763|FG001|NOT COMPLETED|Part 1 (Week 0 to Week 72)||14
6793291|NCT03222973|7724764|FG002|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
6793292|NCT03222973|7724765|FG003|NOT COMPLETED|Part 1 (Week 0 to Week 72)||0
6793293|NCT03222973|7724762|FG000|STARTED|Part 2 (Week 73 to Week 168)||0
6793294|NCT03222973|7724763|FG001|STARTED|Part 2 (Week 73 to Week 168)||0
6793295|NCT03222973|7724764|FG002|STARTED|Part 2 (Week 73 to Week 168)|6 participants who completed Part 1 did not enter Part 2.|101
6793296|NCT03222973|7724765|FG003|STARTED|Part 2 (Week 73 to Week 168)|5 participants who completed Part 1 did not enter Part 2.|113
6793297|NCT03222973|7724762|FG000|ITT Population|Part 2 (Week 73 to Week 168)||0
6793298|NCT03222973|7724763|FG001|ITT Population|Part 2 (Week 73 to Week 168)||0
6793299|NCT03222973|7724764|FG002|ITT Population|Part 2 (Week 73 to Week 168)||100
6793300|NCT03222973|7724765|FG003|ITT Population|Part 2 (Week 73 to Week 168)||113
6793301|NCT03222973|7724762|FG000|Safety Population|Part 2 (Week 73 to Week 168)||0
6793302|NCT03222973|7724763|FG001|Safety Population|Part 2 (Week 73 to Week 168)||0
6793303|NCT03222973|7724764|FG002|Safety Population|Part 2 (Week 73 to Week 168)||100
6793304|NCT03222973|7724765|FG003|Safety Population|Part 2 (Week 73 to Week 168)||113
6793305|NCT03222973|7724762|FG000|COMPLETED|Part 2 (Week 73 to Week 168)||0
6793306|NCT03222973|7724763|FG001|COMPLETED|Part 2 (Week 73 to Week 168)||0
6793307|NCT03222973|7724764|FG002|COMPLETED|Part 2 (Week 73 to Week 168)||0
6793308|NCT03222973|7724765|FG003|COMPLETED|Part 2 (Week 73 to Week 168)||0
6793309|NCT03222973|7724762|FG000|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
6793310|NCT03222973|7724763|FG001|NOT COMPLETED|Part 2 (Week 73 to Week 168)||0
6793311|NCT03222973|7724764|FG002|NOT COMPLETED|Part 2 (Week 73 to Week 168)||101
6793312|NCT03222973|7724765|FG003|NOT COMPLETED|Part 2 (Week 73 to Week 168)||113
6793313|NCT03187262|7724775|FG000|STARTED|Induction||13
6793314|NCT03187262|7724775|FG000|COMPLETED|Induction||7
6793315|NCT03187262|7724775|FG000|NOT COMPLETED|Induction||6
6793316|NCT03187262|7724775|FG000|STARTED|Consolidation||7
6793317|NCT03187262|7724775|FG000|COMPLETED|Consolidation||2
6793318|NCT03187262|7724775|FG000|NOT COMPLETED|Consolidation||5
6793319|NCT03187262|7724775|FG000|STARTED|Maintenance||2
6793320|NCT03187262|7724775|FG000|COMPLETED|Maintenance||2
6793321|NCT03187262|7724775|FG000|NOT COMPLETED|Maintenance||0
6793322|NCT03137693|7724779|FG000|STARTED|Overall Study||20
6793323|NCT03137693|7724779|FG000|COMPLETED|Overall Study||20
6793324|NCT03137693|7724779|FG000|NOT COMPLETED|Overall Study||0
6793325|NCT02987959|7724783|FG000|STARTED|Overall Study||6
6793326|NCT02987959|7724783|FG000|COMPLETED|Overall Study||0
6793327|NCT02987959|7724783|FG000|NOT COMPLETED|Overall Study||6
6793328|NCT02985541|7724787|FG000|STARTED|Overall Study||364
6379280|NCT00772031|7289930|FG000|NOT COMPLETED|Overall Study||32
6379281|NCT00772031|7289931|FG001|NOT COMPLETED|Overall Study||43
6379282|NCT00772070|7289945|FG000|STARTED|Overall Study||102
6379283|NCT00772070|7289946|FG001|STARTED|Overall Study||71
6379284|NCT00772070|7289945|FG000|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
6379285|NCT00772070|7289946|FG001|COMPLETED|Overall Study||61
6379286|NCT00772070|7289945|FG000|NOT COMPLETED|Overall Study||2
6379287|NCT00772070|7289946|FG001|NOT COMPLETED|Overall Study||10
6379288|NCT00772109|7289956|FG000|STARTED|Overall Study||956
6379289|NCT00772109|7289957|FG001|STARTED|Overall Study||953
6379290|NCT00772109|7289958|FG002|STARTED|Overall Study||955
6379291|NCT00772109|7289959|FG003|STARTED|Overall Study||1428
6379292|NCT00772109|7289956|FG000|COMPLETED|Overall Study||935
6379293|NCT00772109|7289957|FG001|COMPLETED|Overall Study||934
6379294|NCT00772109|7289958|FG002|COMPLETED|Overall Study||936
6379295|NCT00772109|7289959|FG003|COMPLETED|Overall Study||1397
6379296|NCT00772109|7289956|FG000|NOT COMPLETED|Overall Study||21
6379297|NCT00772109|7289957|FG001|NOT COMPLETED|Overall Study||19
6379298|NCT00772109|7289958|FG002|NOT COMPLETED|Overall Study||19
6379299|NCT00772109|7289959|FG003|NOT COMPLETED|Overall Study||31
6379300|NCT00772148|7289971|FG000|STARTED|Pharmacokinetic Phase (14 Days)||29
6379301|NCT00772148|7289972|FG001|STARTED|Pharmacokinetic Phase (14 Days)||29
6379302|NCT00772148|7289971|FG000|COMPLETED|Pharmacokinetic Phase (14 Days)||21
6379303|NCT00772148|7289972|FG001|COMPLETED|Pharmacokinetic Phase (14 Days)||23
6379304|NCT00772148|7289971|FG000|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
6379305|NCT00772148|7289972|FG001|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
6379306|NCT00772148|7289971|FG000|STARTED|Maintenance Phase (Week 52)||21
6379307|NCT00772148|7289972|FG001|STARTED|Maintenance Phase (Week 52)||23
6379308|NCT00772148|7289971|FG000|COMPLETED|Maintenance Phase (Week 52)||17
6379309|NCT00772148|7289972|FG001|COMPLETED|Maintenance Phase (Week 52)||18
6379310|NCT00772148|7289971|FG000|NOT COMPLETED|Maintenance Phase (Week 52)||4
6379311|NCT00772148|7289972|FG001|NOT COMPLETED|Maintenance Phase (Week 52)||5
6379312|NCT00772304|7289978|FG000|STARTED|Overall Study||102
6379313|NCT00772304|7289978|FG000|COMPLETED|Overall Study||102
6793329|NCT02985541|7724787|FG000|Valid for FAS|Overall Study||362
6379314|NCT00772304|7289978|FG000|NOT COMPLETED|Overall Study||0
6379315|NCT00772330|7289982|FG000|STARTED|Overall Study||23
6379316|NCT00772330|7289982|FG000|COMPLETED|Overall Study||20
6379317|NCT00772330|7289982|FG000|NOT COMPLETED|Overall Study||3
6379318|NCT00772369|7289989|FG000|STARTED|Overall Study||3214
6793330|NCT02985541|7724787|FG000|Continued Into Year 7 of Mirena Use|Overall Study||305
6793331|NCT02985541|7724787|FG000|Continued Into Year 8 of Mirena Use|Overall Study||243
6793332|NCT02985541|7724787|FG000|COMPLETED|Overall Study||223
6793333|NCT02985541|7724787|FG000|NOT COMPLETED|Overall Study||141
6793334|NCT02960893|7724793|FG000|STARTED|Randomization Phase (8-week)||71
6793335|NCT02960893|7724794|FG001|STARTED|Randomization Phase (8-week)||70
6793336|NCT02960893|7724793|FG000|COMPLETED|Randomization Phase (8-week)||64
6793337|NCT02960893|7724794|FG001|COMPLETED|Randomization Phase (8-week)||68
6793338|NCT02960893|7724793|FG000|NOT COMPLETED|Randomization Phase (8-week)||7
6793339|NCT02960893|7724794|FG001|NOT COMPLETED|Randomization Phase (8-week)||2
6793340|NCT02960893|7724793|FG000|STARTED|Extension Phase (48-week)||64
6793341|NCT02960893|7724794|FG001|STARTED|Extension Phase (48-week)|One participant in placebo arm who completed Randomization Phase did not continue to Extension Phase|67
6793342|NCT02960893|7724793|FG000|COMPLETED|Extension Phase (48-week)||50
6793343|NCT02960893|7724794|FG001|COMPLETED|Extension Phase (48-week)||54
6793344|NCT02960893|7724793|FG000|NOT COMPLETED|Extension Phase (48-week)||14
6793345|NCT02960893|7724794|FG001|NOT COMPLETED|Extension Phase (48-week)||13
6793346|NCT02940522|7724809|FG000|STARTED|Overall Study||59
6793347|NCT02940522|7724810|FG001|STARTED|Overall Study||61
6793348|NCT02940522|7724809|FG000|COMPLETED|Overall Study||57
6793349|NCT02940522|7724810|FG001|COMPLETED|Overall Study||59
6793350|NCT02940522|7724809|FG000|NOT COMPLETED|Overall Study||2
6793351|NCT02940522|7724810|FG001|NOT COMPLETED|Overall Study||2
6793352|NCT02789657|7724820|FG000|STARTED|Overall Study||27
6793353|NCT02789657|7724821|FG001|STARTED|Overall Study||3
6793354|NCT02789657|7724822|FG002|STARTED|Overall Study||0
6793355|NCT02789657|7724823|FG003|STARTED|Overall Study||2
6793356|NCT02789657|7724820|FG000|COMPLETED|Overall Study||25
6793357|NCT02789657|7724821|FG001|COMPLETED|Overall Study||3
6793358|NCT02789657|7724822|FG002|COMPLETED|Overall Study||0
6793359|NCT02789657|7724823|FG003|COMPLETED|Overall Study||2
6793360|NCT02789657|7724820|FG000|NOT COMPLETED|Overall Study||2
6793361|NCT02789657|7724821|FG001|NOT COMPLETED|Overall Study||0
6793362|NCT02789657|7724822|FG002|NOT COMPLETED|Overall Study||0
6793363|NCT02789657|7724823|FG003|NOT COMPLETED|Overall Study||0
6793364|NCT02711137|7724847|FG000|STARTED|Overall Study||4
6793365|NCT02711137|7724848|FG001|STARTED|Overall Study||5
6793366|NCT02711137|7724849|FG002|STARTED|Overall Study||8
6793367|NCT02711137|7724850|FG003|STARTED|Overall Study||7
6793368|NCT02711137|7724851|FG004|STARTED|Overall Study||5
6793369|NCT02711137|7724852|FG005|STARTED|Overall Study||1
6793370|NCT02711137|7724853|FG006|STARTED|Overall Study||86
6793371|NCT02711137|7724854|FG007|STARTED|Overall Study||5
6793372|NCT02711137|7724855|FG008|STARTED|Overall Study||1
6793373|NCT02711137|7724856|FG009|STARTED|Overall Study||2
6793374|NCT02711137|7724857|FG010|STARTED|Overall Study||4
6793375|NCT02711137|7724858|FG011|STARTED|Overall Study||3
6793376|NCT02711137|7724859|FG012|STARTED|Overall Study||1
6793377|NCT02711137|7724860|FG013|STARTED|Overall Study||2
6793378|NCT02711137|7724861|FG014|STARTED|Overall Study||3
6793379|NCT02711137|7724847|FG000|COMPLETED|Overall Study||0
6793380|NCT02711137|7724848|FG001|COMPLETED|Overall Study||0
6793381|NCT02711137|7724849|FG002|COMPLETED|Overall Study||0
6793382|NCT02711137|7724850|FG003|COMPLETED|Overall Study||0
6793383|NCT02711137|7724851|FG004|COMPLETED|Overall Study||0
6793384|NCT02711137|7724852|FG005|COMPLETED|Overall Study||0
6793385|NCT02711137|7724853|FG006|COMPLETED|Overall Study||0
6793386|NCT02711137|7724854|FG007|COMPLETED|Overall Study||0
6793387|NCT02711137|7724855|FG008|COMPLETED|Overall Study||0
6379319|NCT00772369|7289989|FG000|COMPLETED|Overall Study||3213
6379320|NCT00772369|7289989|FG000|NOT COMPLETED|Overall Study||1
6379321|NCT00772382|7289993|FG000|STARTED|Overall Study||116
6379322|NCT00772382|7289993|FG000|COMPLETED|Overall Study||61
6379323|NCT00772382|7289993|FG000|NOT COMPLETED|Overall Study||55
6379324|NCT00772447|7289999|FG000|STARTED|Overall Study||131
6379325|NCT00772447|7290000|FG001|STARTED|Overall Study||134
6379326|NCT00772447|7289999|FG000|COMPLETED|Overall Study||111
6379327|NCT00772447|7290000|FG001|COMPLETED|Overall Study||110
6379328|NCT00772447|7289999|FG000|NOT COMPLETED|Overall Study||20
6379329|NCT00772447|7290000|FG001|NOT COMPLETED|Overall Study||24
6379330|NCT00772538|7290009|FG000|STARTED|Overall Study||222
6379331|NCT00772538|7290010|FG001|STARTED|Overall Study||237
6379332|NCT00772538|7290009|FG000|COMPLETED|Overall Study||202
6379333|NCT00772538|7290010|FG001|COMPLETED|Overall Study||211
6379334|NCT00772538|7290009|FG000|NOT COMPLETED|Overall Study||20
6379335|NCT00772538|7290010|FG001|NOT COMPLETED|Overall Study||26
6379336|NCT00772577|7290018|FG000|STARTED|Overall Study||193
6379337|NCT00772577|7290019|FG001|STARTED|Overall Study||193
6379338|NCT00772577|7290018|FG000|COMPLETED|Overall Study||170
6379339|NCT00772577|7290019|FG001|COMPLETED|Overall Study||170
6379340|NCT00772577|7290018|FG000|NOT COMPLETED|Overall Study||23
6379341|NCT00772577|7290019|FG001|NOT COMPLETED|Overall Study||23
6379342|NCT00772590|7290029|FG000|STARTED|Overall Study||19
6379343|NCT00772590|7290030|FG001|STARTED|Overall Study||19
6793388|NCT02711137|7724856|FG009|COMPLETED|Overall Study||0
6793389|NCT02711137|7724857|FG010|COMPLETED|Overall Study||0
6268862|NCT00068692|7167968|FG003|Reported AE Data|Step 2: Randomization||22
6793390|NCT02711137|7724858|FG011|COMPLETED|Overall Study||0
6793391|NCT02711137|7724859|FG012|COMPLETED|Overall Study||0
6793392|NCT02711137|7724860|FG013|COMPLETED|Overall Study||0
6793393|NCT02711137|7724861|FG014|COMPLETED|Overall Study||0
6793394|NCT02711137|7724847|FG000|NOT COMPLETED|Overall Study||4
6793395|NCT02711137|7724848|FG001|NOT COMPLETED|Overall Study||5
6793396|NCT02711137|7724849|FG002|NOT COMPLETED|Overall Study||8
6793397|NCT02711137|7724850|FG003|NOT COMPLETED|Overall Study||7
6793398|NCT02711137|7724851|FG004|NOT COMPLETED|Overall Study||5
6793399|NCT02711137|7724852|FG005|NOT COMPLETED|Overall Study||1
6793400|NCT02711137|7724853|FG006|NOT COMPLETED|Overall Study||86
6793401|NCT02711137|7724854|FG007|NOT COMPLETED|Overall Study||5
6793402|NCT02711137|7724855|FG008|NOT COMPLETED|Overall Study||1
6793403|NCT02711137|7724856|FG009|NOT COMPLETED|Overall Study||2
6793404|NCT02711137|7724857|FG010|NOT COMPLETED|Overall Study||4
6793405|NCT02711137|7724858|FG011|NOT COMPLETED|Overall Study||3
6793406|NCT02711137|7724859|FG012|NOT COMPLETED|Overall Study||1
6793407|NCT02711137|7724860|FG013|NOT COMPLETED|Overall Study||2
6793408|NCT02711137|7724861|FG014|NOT COMPLETED|Overall Study||3
6793409|NCT02630459|7724902|FG000|STARTED|Double-Blind Treatment Phase (DBTP)||136
6793410|NCT02630459|7724903|FG001|STARTED|Double-Blind Treatment Phase (DBTP)||67
6793411|NCT02630459|7724904|FG002|STARTED|Double-Blind Treatment Phase (DBTP)||135
6793412|NCT02630459|7724905|FG003|STARTED|Double-Blind Treatment Phase (DBTP)||137
6793413|NCT02630459|7724906|FG004|STARTED|Double-Blind Treatment Phase (DBTP)||0
6793414|NCT02630459|7724907|FG005|STARTED|Double-Blind Treatment Phase (DBTP)||0
6793415|NCT02630459|7724908|FG006|STARTED|Double-Blind Treatment Phase (DBTP)||0
6793416|NCT02630459|7724909|FG007|STARTED|Double-Blind Treatment Phase (DBTP)||0
6793417|NCT02630459|7724902|FG000|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||136
6793418|NCT02630459|7724903|FG001|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||66
6793419|NCT02630459|7724904|FG002|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||135
6793420|NCT02630459|7724905|FG003|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||137
6793421|NCT02630459|7724906|FG004|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
6793422|NCT02630459|7724907|FG005|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
6793423|NCT02630459|7724908|FG006|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
6793424|NCT02630459|7724909|FG007|Received Investigational Product (IP)|Double-Blind Treatment Phase (DBTP)||0
6793425|NCT02630459|7724902|FG000|COMPLETED|Double-Blind Treatment Phase (DBTP)||133
6793426|NCT02630459|7724903|FG001|COMPLETED|Double-Blind Treatment Phase (DBTP)||65
6793427|NCT02630459|7724904|FG002|COMPLETED|Double-Blind Treatment Phase (DBTP)||130
6793428|NCT02630459|7724905|FG003|COMPLETED|Double-Blind Treatment Phase (DBTP)||134
6793429|NCT02630459|7724906|FG004|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
6793430|NCT02630459|7724907|FG005|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
6793431|NCT02630459|7724908|FG006|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
6793432|NCT02630459|7724909|FG007|COMPLETED|Double-Blind Treatment Phase (DBTP)||0
6793433|NCT02630459|7724902|FG000|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
6793434|NCT02630459|7724903|FG001|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||2
6793435|NCT02630459|7724904|FG002|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||5
6793436|NCT02630459|7724905|FG003|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||3
6793437|NCT02630459|7724906|FG004|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
6793438|NCT02630459|7724907|FG005|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
6793439|NCT02630459|7724908|FG006|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
6793440|NCT02630459|7724909|FG007|NOT COMPLETED|Double-Blind Treatment Phase (DBTP)||0
6793441|NCT02630459|7724902|FG000|STARTED|Open-Label Treatment Phase (OLTP)||0
6793442|NCT02630459|7724903|FG001|STARTED|Open-Label Treatment Phase (OLTP)||0
6793443|NCT02630459|7724904|FG002|STARTED|Open-Label Treatment Phase (OLTP)||0
6793444|NCT02630459|7724905|FG003|STARTED|Open-Label Treatment Phase (OLTP)||0
6793445|NCT02630459|7724906|FG004|STARTED|Open-Label Treatment Phase (OLTP)||386
6793446|NCT02630459|7724907|FG005|STARTED|Open-Label Treatment Phase (OLTP)||73
6793447|NCT02630459|7724908|FG006|STARTED|Open-Label Treatment Phase (OLTP)||0
6793448|NCT02630459|7724909|FG007|STARTED|Open-Label Treatment Phase (OLTP)||0
6793449|NCT02630459|7724902|FG000|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793450|NCT02630459|7724903|FG001|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793451|NCT02630459|7724904|FG002|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793452|NCT02630459|7724905|FG003|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793453|NCT02630459|7724906|FG004|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||270
6793454|NCT02630459|7724907|FG005|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793455|NCT02630459|7724908|FG006|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793456|NCT02630459|7724909|FG007|Received Only 70 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793457|NCT02630459|7724902|FG000|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793458|NCT02630459|7724903|FG001|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793459|NCT02630459|7724904|FG002|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793460|NCT02630459|7724905|FG003|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793461|NCT02630459|7724906|FG004|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793462|NCT02630459|7724907|FG005|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||73
6793463|NCT02630459|7724908|FG006|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793464|NCT02630459|7724909|FG007|Received Only 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793465|NCT02630459|7724902|FG000|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793466|NCT02630459|7724903|FG001|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793467|NCT02630459|7724904|FG002|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793468|NCT02630459|7724905|FG003|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793469|NCT02630459|7724906|FG004|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||116
6793470|NCT02630459|7724907|FG005|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793471|NCT02630459|7724908|FG006|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793472|NCT02630459|7724909|FG007|Received Both 70 mg and 140 mg in OLTP|Open-Label Treatment Phase (OLTP)||0
6793473|NCT02630459|7724902|FG000|COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793474|NCT02630459|7724903|FG001|COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793475|NCT02630459|7724904|FG002|COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793476|NCT02630459|7724905|FG003|COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793477|NCT02630459|7724906|FG004|COMPLETED|Open-Label Treatment Phase (OLTP)||357
6793478|NCT02630459|7724907|FG005|COMPLETED|Open-Label Treatment Phase (OLTP)||69
6793479|NCT02630459|7724908|FG006|COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793480|NCT02630459|7724909|FG007|COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793481|NCT02630459|7724902|FG000|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793482|NCT02630459|7724903|FG001|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793483|NCT02630459|7724904|FG002|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793484|NCT02630459|7724905|FG003|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793485|NCT02630459|7724906|FG004|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||29
6793486|NCT02630459|7724907|FG005|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||4
6793487|NCT02630459|7724908|FG006|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793488|NCT02630459|7724909|FG007|NOT COMPLETED|Open-Label Treatment Phase (OLTP)||0
6793489|NCT02630459|7724902|FG000|STARTED|Optional CHU Sub-Study (During OLTP)||0
6793490|NCT02630459|7724903|FG001|STARTED|Optional CHU Sub-Study (During OLTP)||0
6793491|NCT02630459|7724904|FG002|STARTED|Optional CHU Sub-Study (During OLTP)||0
6793492|NCT02630459|7724905|FG003|STARTED|Optional CHU Sub-Study (During OLTP)||0
6793493|NCT02630459|7724906|FG004|STARTED|Optional CHU Sub-Study (During OLTP)||0
6793494|NCT02630459|7724907|FG005|STARTED|Optional CHU Sub-Study (During OLTP)||0
6793495|NCT02630459|7724908|FG006|STARTED|Optional CHU Sub-Study (During OLTP)||24
6793496|NCT02630459|7724909|FG007|STARTED|Optional CHU Sub-Study (During OLTP)||25
6793497|NCT02630459|7724902|FG000|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793498|NCT02630459|7724903|FG001|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793499|NCT02630459|7724904|FG002|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793500|NCT02630459|7724905|FG003|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793501|NCT02630459|7724906|FG004|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793502|NCT02630459|7724907|FG005|COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793503|NCT02630459|7724908|FG006|COMPLETED|Optional CHU Sub-Study (During OLTP)||24
6793504|NCT02630459|7724909|FG007|COMPLETED|Optional CHU Sub-Study (During OLTP)||25
6793505|NCT02630459|7724902|FG000|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793506|NCT02630459|7724903|FG001|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793507|NCT02630459|7724904|FG002|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793508|NCT02630459|7724905|FG003|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793509|NCT02630459|7724906|FG004|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793510|NCT02630459|7724907|FG005|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793511|NCT02630459|7724908|FG006|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793512|NCT02630459|7724909|FG007|NOT COMPLETED|Optional CHU Sub-Study (During OLTP)||0
6793513|NCT02586857|7724936|FG000|STARTED|Overall Study||15
6793514|NCT02586857|7724937|FG001|STARTED|Overall Study||9
6793515|NCT02586857|7724936|FG000|Enrolled|Overall Study||15
6793516|NCT02586857|7724937|FG001|Enrolled|Overall Study||9
6793517|NCT02586857|7724936|FG000|Received Study Medication|Overall Study||15
6793518|NCT02586857|7724937|FG001|Received Study Medication|Overall Study||9
6793519|NCT02586857|7724936|FG000|Discontinued Study|Overall Study||14
6793520|NCT02586857|7724937|FG001|Discontinued Study|Overall Study||9
6793521|NCT02586857|7724936|FG000|COMPLETED|Overall Study||14
6793522|NCT02586857|7724937|FG001|COMPLETED|Overall Study||9
6793523|NCT02586857|7724936|FG000|NOT COMPLETED|Overall Study||1
6793524|NCT02586857|7724937|FG001|NOT COMPLETED|Overall Study||0
6793525|NCT02575976|7724946|FG000|STARTED|Overall Study||37
6793526|NCT02575976|7724947|FG001|STARTED|Overall Study||39
6793527|NCT02575976|7724948|FG002|STARTED|Overall Study||39
6793528|NCT02575976|7724946|FG000|COMPLETED|Overall Study||32
6793529|NCT02575976|7724947|FG001|COMPLETED|Overall Study||31
6793530|NCT02575976|7724948|FG002|COMPLETED|Overall Study||30
6793531|NCT02575976|7724946|FG000|NOT COMPLETED|Overall Study||5
6793532|NCT02575976|7724947|FG001|NOT COMPLETED|Overall Study||8
6793533|NCT02575976|7724948|FG002|NOT COMPLETED|Overall Study||9
6793534|NCT02545868|7724959|FG000|STARTED|Immunization Study Period (ISP)||33
6793535|NCT02545868|7724960|FG001|STARTED|Immunization Study Period (ISP)||35
6793536|NCT02545868|7724961|FG002|STARTED|Immunization Study Period (ISP)||34
6793537|NCT02545868|7724959|FG000|COMPLETED|Immunization Study Period (ISP)||33
6793538|NCT02545868|7724960|FG001|COMPLETED|Immunization Study Period (ISP)||35
6793539|NCT02545868|7724961|FG002|COMPLETED|Immunization Study Period (ISP)||34
6793540|NCT02545868|7724959|FG000|NOT COMPLETED|Immunization Study Period (ISP)||0
6793541|NCT02545868|7724960|FG001|NOT COMPLETED|Immunization Study Period (ISP)||0
6793542|NCT02545868|7724961|FG002|NOT COMPLETED|Immunization Study Period (ISP)||0
6793543|NCT02545868|7724959|FG000|STARTED|Optional Ocrelizumab Ext (OOE) Period||33
6793544|NCT02545868|7724960|FG001|STARTED|Optional Ocrelizumab Ext (OOE) Period||35
6793545|NCT02545868|7724961|FG002|STARTED|Optional Ocrelizumab Ext (OOE) Period||34
6793546|NCT02545868|7724959|FG000|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
6793547|NCT02545868|7724960|FG001|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
6793548|NCT02545868|7724961|FG002|COMPLETED|Optional Ocrelizumab Ext (OOE) Period||0
6793549|NCT02545868|7724959|FG000|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||33
6793550|NCT02545868|7724960|FG001|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||35
6793551|NCT02545868|7724961|FG002|NOT COMPLETED|Optional Ocrelizumab Ext (OOE) Period||34
6793552|NCT02470091|7724976|FG000|STARTED|Overall Study||16
6793553|NCT02470091|7724977|FG001|STARTED|Overall Study||40
6793554|NCT02470091|7724976|FG000|Follow-up Report|Overall Study||1
6793555|NCT02470091|7724977|FG001|Follow-up Report|Overall Study||10
6793556|NCT02470091|7724976|FG000|COMPLETED|Overall Study||15
6793557|NCT02470091|7724977|FG001|COMPLETED|Overall Study||38
6793558|NCT02470091|7724976|FG000|NOT COMPLETED|Overall Study||1
6793559|NCT02470091|7724977|FG001|NOT COMPLETED|Overall Study||2
6793560|NCT02440425|7724985|FG000|STARTED|Overall Study||42
6793561|NCT02440425|7724985|FG000|COMPLETED|Overall Study||37
6793562|NCT02440425|7724985|FG000|NOT COMPLETED|Overall Study||5
6793563|NCT02343120|7724994|FG000|STARTED|Part 1: Dose Escalation||3
6793564|NCT02343120|7724995|FG001|STARTED|Part 1: Dose Escalation||4
6793565|NCT02343120|7724996|FG002|STARTED|Part 1: Dose Escalation||5
6793566|NCT02343120|7724997|FG003|STARTED|Part 1: Dose Escalation||4
6793567|NCT02343120|7724998|FG004|STARTED|Part 1: Dose Escalation||1
6793568|NCT02343120|7724994|FG000|COMPLETED|Part 1: Dose Escalation||0
6793569|NCT02343120|7724995|FG001|COMPLETED|Part 1: Dose Escalation||0
6793570|NCT02343120|7724996|FG002|COMPLETED|Part 1: Dose Escalation||0
6793571|NCT02343120|7724997|FG003|COMPLETED|Part 1: Dose Escalation||0
6793572|NCT02343120|7724998|FG004|COMPLETED|Part 1: Dose Escalation||0
6793573|NCT02343120|7724994|FG000|NOT COMPLETED|Part 1: Dose Escalation||3
6793574|NCT02343120|7724995|FG001|NOT COMPLETED|Part 1: Dose Escalation||4
6793575|NCT02343120|7724996|FG002|NOT COMPLETED|Part 1: Dose Escalation||5
6793576|NCT02343120|7724997|FG003|NOT COMPLETED|Part 1: Dose Escalation||4
6793577|NCT02343120|7724998|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
6793578|NCT02343120|7724994|FG000|STARTED|Part 2: Expansion||0
6793579|NCT02343120|7724995|FG001|STARTED|Part 2: Expansion||0
6793580|NCT02343120|7724996|FG002|STARTED|Part 2: Expansion||0
6793581|NCT02343120|7724997|FG003|STARTED|Part 2: Expansion||274
6793582|NCT02343120|7724998|FG004|STARTED|Part 2: Expansion||94
6793583|NCT02343120|7724994|FG000|COMPLETED|Part 2: Expansion||0
6793584|NCT02343120|7724995|FG001|COMPLETED|Part 2: Expansion||0
6793585|NCT02343120|7724996|FG002|COMPLETED|Part 2: Expansion||0
6793586|NCT02343120|7724997|FG003|COMPLETED|Part 2: Expansion||0
6793587|NCT02343120|7724998|FG004|COMPLETED|Part 2: Expansion||0
6793588|NCT02343120|7724994|FG000|NOT COMPLETED|Part 2: Expansion||0
6793589|NCT02343120|7724995|FG001|NOT COMPLETED|Part 2: Expansion||0
6793590|NCT02343120|7724996|FG002|NOT COMPLETED|Part 2: Expansion||0
6793591|NCT02343120|7724997|FG003|NOT COMPLETED|Part 2: Expansion||274
6793592|NCT02343120|7724998|FG004|NOT COMPLETED|Part 2: Expansion||94
6793593|NCT02066415|7725020|FG000|STARTED|Overall Study||286
6793594|NCT02066415|7725021|FG001|STARTED|Overall Study||191
6793595|NCT02066415|7725022|FG002|STARTED|Overall Study||190
6793596|NCT02066415|7725020|FG000|Received Study Drug|Overall Study||282
6793597|NCT02066415|7725021|FG001|Received Study Drug|Overall Study||190
6793598|NCT02066415|7725022|FG002|Received Study Drug|Overall Study||188
6793599|NCT02066415|7725020|FG000|COMPLETED|Overall Study||265
6793600|NCT02066415|7725021|FG001|COMPLETED|Overall Study||184
6793601|NCT02066415|7725022|FG002|COMPLETED|Overall Study||182
6793602|NCT02066415|7725020|FG000|NOT COMPLETED|Overall Study||21
6793603|NCT02066415|7725021|FG001|NOT COMPLETED|Overall Study||7
6793604|NCT02066415|7725022|FG002|NOT COMPLETED|Overall Study||8
6793605|NCT01952574|7725034|FG000|STARTED|Double-blind Treatment Phase||160
6793606|NCT01952574|7725035|FG001|STARTED|Double-blind Treatment Phase||108
6793607|NCT01952574|7725036|FG002|STARTED|Double-blind Treatment Phase||108
6793608|NCT01952574|7725037|FG003|STARTED|Double-blind Treatment Phase||107
6793609|NCT01952574|7725038|FG004|STARTED|Double-blind Treatment Phase||0
6793610|NCT01952574|7725039|FG005|STARTED|Double-blind Treatment Phase||0
6793611|NCT01952574|7725040|FG006|STARTED|Double-blind Treatment Phase||0
6379344|NCT00772590|7290031|FG002|STARTED|Overall Study||18
6379345|NCT00772590|7290032|FG003|STARTED|Overall Study||17
6379346|NCT00772590|7290029|FG000|COMPLETED|Overall Study||19
6379347|NCT00772590|7290030|FG001|COMPLETED|Overall Study||19
6379348|NCT00772590|7290031|FG002|COMPLETED|Overall Study||18
6379349|NCT00772590|7290032|FG003|COMPLETED|Overall Study||17
6379350|NCT00772590|7290029|FG000|NOT COMPLETED|Overall Study||0
6379351|NCT00772590|7290030|FG001|NOT COMPLETED|Overall Study||0
6379352|NCT00772590|7290031|FG002|NOT COMPLETED|Overall Study||0
6379353|NCT00772590|7290032|FG003|NOT COMPLETED|Overall Study||0
6379354|NCT00772603|7290045|FG000|STARTED|Overall Study||123
6379355|NCT00772603|7290046|FG001|STARTED|Overall Study||122
6379356|NCT00772603|7290047|FG002|STARTED|Overall Study||121
6379357|NCT00772603|7290045|FG000|COMPLETED|Overall Study||71
6379358|NCT00772603|7290046|FG001|COMPLETED|Overall Study||82
6379359|NCT00772603|7290047|FG002|COMPLETED|Overall Study||95
6379360|NCT00772603|7290045|FG000|NOT COMPLETED|Overall Study||52
6379361|NCT00772603|7290046|FG001|NOT COMPLETED|Overall Study||40
6379362|NCT00772603|7290047|FG002|NOT COMPLETED|Overall Study||26
6379363|NCT00772629|7290060|FG000|STARTED|Overall Study||17
6379364|NCT00772629|7290061|FG001|STARTED|Overall Study||1
6379365|NCT00772629|7290060|FG000|COMPLETED|Overall Study||16
6379366|NCT00772629|7290061|FG001|COMPLETED|Overall Study||1
6379367|NCT00772629|7290060|FG000|NOT COMPLETED|Overall Study||1
6379368|NCT00772629|7290061|FG001|NOT COMPLETED|Overall Study||0
6379369|NCT00772668|7290067|FG000|STARTED|Overall Study||3
6379370|NCT00772668|7290067|FG000|COMPLETED|Overall Study||0
6379371|NCT00772668|7290067|FG000|NOT COMPLETED|Overall Study||3
6793612|NCT01952574|7725034|FG000|Received Study Drug|Double-blind Treatment Phase||153
6793613|NCT01952574|7725035|FG001|Received Study Drug|Double-blind Treatment Phase||108
6793614|NCT01952574|7725036|FG002|Received Study Drug|Double-blind Treatment Phase||105
6379372|NCT00772707|7290072|FG000|STARTED|Overall Study||114
6379373|NCT00772707|7290072|FG000|COMPLETED|Overall Study||111
6379374|NCT00772707|7290072|FG000|NOT COMPLETED|Overall Study||3
6379375|NCT00772772|7290076|FG000|STARTED|Overall Study||12
6379376|NCT00772772|7290076|FG000|COMPLETED|Overall Study||12
6379377|NCT00772772|7290076|FG000|NOT COMPLETED|Overall Study||0
6793615|NCT01952574|7725037|FG003|Received Study Drug|Double-blind Treatment Phase||106
6793616|NCT01952574|7725038|FG004|Received Study Drug|Double-blind Treatment Phase||0
6793617|NCT01952574|7725039|FG005|Received Study Drug|Double-blind Treatment Phase||0
6793618|NCT01952574|7725040|FG006|Received Study Drug|Double-blind Treatment Phase||0
6793619|NCT01952574|7725034|FG000|COMPLETED|Double-blind Treatment Phase||143
6793620|NCT01952574|7725035|FG001|COMPLETED|Double-blind Treatment Phase||105
6793621|NCT01952574|7725036|FG002|COMPLETED|Double-blind Treatment Phase||99
6793622|NCT01952574|7725037|FG003|COMPLETED|Double-blind Treatment Phase||101
6793623|NCT01952574|7725038|FG004|COMPLETED|Double-blind Treatment Phase||0
6793624|NCT01952574|7725039|FG005|COMPLETED|Double-blind Treatment Phase||0
6793625|NCT01952574|7725040|FG006|COMPLETED|Double-blind Treatment Phase||0
6793626|NCT01952574|7725034|FG000|NOT COMPLETED|Double-blind Treatment Phase||17
6793627|NCT01952574|7725035|FG001|NOT COMPLETED|Double-blind Treatment Phase||3
6793628|NCT01952574|7725036|FG002|NOT COMPLETED|Double-blind Treatment Phase||9
6793629|NCT01952574|7725037|FG003|NOT COMPLETED|Double-blind Treatment Phase||6
6793630|NCT01952574|7725038|FG004|NOT COMPLETED|Double-blind Treatment Phase||0
6793631|NCT01952574|7725039|FG005|NOT COMPLETED|Double-blind Treatment Phase||0
6793632|NCT01952574|7725040|FG006|NOT COMPLETED|Double-blind Treatment Phase||0
6793633|NCT01952574|7725034|FG000|STARTED|Open-label Treatment Phase||0
6793634|NCT01952574|7725035|FG001|STARTED|Open-label Treatment Phase||0
6793635|NCT01952574|7725036|FG002|STARTED|Open-label Treatment Phase||0
6793636|NCT01952574|7725037|FG003|STARTED|Open-label Treatment Phase||0
6793637|NCT01952574|7725038|FG004|STARTED|Open-label Treatment Phase||383
6793638|NCT01952574|7725039|FG005|STARTED|Open-label Treatment Phase||0
6793639|NCT01952574|7725040|FG006|STARTED|Open-label Treatment Phase||0
6793640|NCT01952574|7725034|FG000|Received 70 mg Erenumab|Open-label Treatment Phase||0
6793641|NCT01952574|7725035|FG001|Received 70 mg Erenumab|Open-label Treatment Phase||0
6793642|NCT01952574|7725036|FG002|Received 70 mg Erenumab|Open-label Treatment Phase||0
6793643|NCT01952574|7725037|FG003|Received 70 mg Erenumab|Open-label Treatment Phase||0
6793644|NCT01952574|7725038|FG004|Received 70 mg Erenumab|Open-label Treatment Phase||383
6268863|NCT00068692|7167969|FG004|Reported AE Data|Step 2: Randomization||28
6268864|NCT00068692|7167970|FG005|Reported AE Data|Step 2: Randomization||31
6268865|NCT00068692|7167971|FG006|Reported AE Data|Step 2: Randomization||33
6268866|NCT00068692|7167972|FG007|Reported AE Data|Step 2: Randomization||32
6268867|NCT00068692|7167965|FG000|COMPLETED|Step 2: Randomization||0
6268868|NCT00068692|7167966|FG001|COMPLETED|Step 2: Randomization||0
6268869|NCT00068692|7167967|FG002|COMPLETED|Step 2: Randomization||18
6268870|NCT00068692|7167968|FG003|COMPLETED|Step 2: Randomization||13
6268871|NCT00068692|7167969|FG004|COMPLETED|Step 2: Randomization||21
6268872|NCT00068692|7167970|FG005|COMPLETED|Step 2: Randomization||25
6268873|NCT00068692|7167971|FG006|COMPLETED|Step 2: Randomization||29
6268874|NCT00068692|7167972|FG007|COMPLETED|Step 2: Randomization||24
6268875|NCT00068692|7167965|FG000|NOT COMPLETED|Step 2: Randomization||0
6268876|NCT00068692|7167966|FG001|NOT COMPLETED|Step 2: Randomization||0
6563592|NCT01807520|7486480|FG002|Safety Set|Treatment Period 2 (16-132 Weeks)||0
6563593|NCT01807520|7486481|FG003|Safety Set|Treatment Period 2 (16-132 Weeks)||29
6563594|NCT01807520|7486482|FG004|Safety Set|Treatment Period 2 (16-132 Weeks)||29
6563595|NCT01807520|7486483|FG005|Safety Set|Treatment Period 2 (16-132 Weeks)||0
6563596|NCT01807520|7486484|FG006|Safety Set|Treatment Period 2 (16-132 Weeks)||0
6268877|NCT00068692|7167967|FG002|NOT COMPLETED|Step 2: Randomization||10
6268878|NCT00068692|7167968|FG003|NOT COMPLETED|Step 2: Randomization||12
6268879|NCT00068692|7167969|FG004|NOT COMPLETED|Step 2: Randomization||9
6268880|NCT00068692|7167970|FG005|NOT COMPLETED|Step 2: Randomization||6
6268881|NCT00068692|7167971|FG006|NOT COMPLETED|Step 2: Randomization||4
6563597|NCT01807520|7486478|FG000|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||67
6793645|NCT01952574|7725039|FG005|Received 70 mg Erenumab|Open-label Treatment Phase||0
6793646|NCT01952574|7725040|FG006|Received 70 mg Erenumab|Open-label Treatment Phase||0
6793647|NCT01952574|7725034|FG000|Received 140 mg Erenumab|Open-label Treatment Phase||0
6793648|NCT01952574|7725035|FG001|Received 140 mg Erenumab|Open-label Treatment Phase||0
6793649|NCT01952574|7725036|FG002|Received 140 mg Erenumab|Open-label Treatment Phase||0
6793650|NCT01952574|7725037|FG003|Received 140 mg Erenumab|Open-label Treatment Phase||0
6793651|NCT01952574|7725038|FG004|Received 140 mg Erenumab|Open-label Treatment Phase||250
6793652|NCT01952574|7725039|FG005|Received 140 mg Erenumab|Open-label Treatment Phase||0
6563598|NCT01807520|7486479|FG001|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||66
6563599|NCT01807520|7486480|FG002|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
6563600|NCT01807520|7486481|FG003|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
6563601|NCT01807520|7486482|FG004|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||29
6563602|NCT01807520|7486483|FG005|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
6656577|NCT02462057|7586823|FG004|NOT COMPLETED|Overall Study||50
6793653|NCT01952574|7725040|FG006|Received 140 mg Erenumab|Open-label Treatment Phase||0
6793654|NCT01952574|7725034|FG000|COMPLETED|Open-label Treatment Phase||0
6793655|NCT01952574|7725035|FG001|COMPLETED|Open-label Treatment Phase||0
6793656|NCT01952574|7725036|FG002|COMPLETED|Open-label Treatment Phase||0
6793657|NCT01952574|7725037|FG003|COMPLETED|Open-label Treatment Phase||0
6793658|NCT01952574|7725038|FG004|COMPLETED|Open-label Treatment Phase||221
6793659|NCT01952574|7725039|FG005|COMPLETED|Open-label Treatment Phase||0
6793660|NCT01952574|7725040|FG006|COMPLETED|Open-label Treatment Phase||0
6793661|NCT01952574|7725034|FG000|NOT COMPLETED|Open-label Treatment Phase||0
6793662|NCT01952574|7725035|FG001|NOT COMPLETED|Open-label Treatment Phase||0
6793663|NCT01952574|7725036|FG002|NOT COMPLETED|Open-label Treatment Phase||0
6793664|NCT01952574|7725037|FG003|NOT COMPLETED|Open-label Treatment Phase||0
6793665|NCT01952574|7725038|FG004|NOT COMPLETED|Open-label Treatment Phase||162
6793666|NCT01952574|7725039|FG005|NOT COMPLETED|Open-label Treatment Phase||0
6793667|NCT01952574|7725040|FG006|NOT COMPLETED|Open-label Treatment Phase||0
6793668|NCT01952574|7725034|FG000|STARTED|Clinical Home Use Substudy||0
6793669|NCT01952574|7725035|FG001|STARTED|Clinical Home Use Substudy||0
6793670|NCT01952574|7725036|FG002|STARTED|Clinical Home Use Substudy||0
6793671|NCT01952574|7725037|FG003|STARTED|Clinical Home Use Substudy||0
6793672|NCT01952574|7725038|FG004|STARTED|Clinical Home Use Substudy||0
6793673|NCT01952574|7725039|FG005|STARTED|Clinical Home Use Substudy||42
6793674|NCT01952574|7725040|FG006|STARTED|Clinical Home Use Substudy||41
6793675|NCT01952574|7725034|FG000|COMPLETED|Clinical Home Use Substudy||0
6793676|NCT01952574|7725035|FG001|COMPLETED|Clinical Home Use Substudy||0
6793677|NCT01952574|7725036|FG002|COMPLETED|Clinical Home Use Substudy||0
6793678|NCT01952574|7725037|FG003|COMPLETED|Clinical Home Use Substudy||0
6793679|NCT01952574|7725038|FG004|COMPLETED|Clinical Home Use Substudy||0
6793680|NCT01952574|7725039|FG005|COMPLETED|Clinical Home Use Substudy||39
6793681|NCT01952574|7725040|FG006|COMPLETED|Clinical Home Use Substudy||40
6793682|NCT01952574|7725034|FG000|NOT COMPLETED|Clinical Home Use Substudy||0
6793683|NCT01952574|7725035|FG001|NOT COMPLETED|Clinical Home Use Substudy||0
6793684|NCT01952574|7725036|FG002|NOT COMPLETED|Clinical Home Use Substudy||0
6793685|NCT01952574|7725037|FG003|NOT COMPLETED|Clinical Home Use Substudy||0
6793686|NCT01952574|7725038|FG004|NOT COMPLETED|Clinical Home Use Substudy||0
6793687|NCT01952574|7725039|FG005|NOT COMPLETED|Clinical Home Use Substudy||3
6793688|NCT01952574|7725040|FG006|NOT COMPLETED|Clinical Home Use Substudy||1
6793689|NCT01660451|7725068|FG000|STARTED|Overall Study||33
6793690|NCT01660451|7725069|FG001|STARTED|Overall Study||51
6793691|NCT01660451|7725070|FG002|STARTED|Overall Study||142
6793692|NCT01660451|7725068|FG000|COMPLETED|Overall Study||16
6793693|NCT01660451|7725069|FG001|COMPLETED|Overall Study||34
6793694|NCT01660451|7725070|FG002|COMPLETED|Overall Study||37
6793695|NCT01660451|7725068|FG000|NOT COMPLETED|Overall Study||17
6793696|NCT01660451|7725069|FG001|NOT COMPLETED|Overall Study||17
6793697|NCT01660451|7725070|FG002|NOT COMPLETED|Overall Study||105
6793698|NCT01659151|7725079|FG000|STARTED|Overall Study||17
6793699|NCT01659151|7725079|FG000|COMPLETED|Overall Study||16
6793700|NCT01659151|7725079|FG000|NOT COMPLETED|Overall Study||1
6793701|NCT01634048|7725085|FG000|STARTED|Overall Study||21
6793702|NCT01634048|7725086|FG001|STARTED|Overall Study||18
6793703|NCT01634048|7725085|FG000|COMPLETED|Overall Study||15
6793704|NCT01634048|7725086|FG001|COMPLETED|Overall Study||15
6793705|NCT01634048|7725085|FG000|NOT COMPLETED|Overall Study||6
6793706|NCT01634048|7725086|FG001|NOT COMPLETED|Overall Study||3
6793707|NCT01539863|7725094|FG000|STARTED|Overall Study||166
6793708|NCT01539863|7725095|FG001|STARTED|Overall Study||162
6793709|NCT01539863|7725094|FG000|COMPLETED|Overall Study||161
6793710|NCT01539863|7725095|FG001|COMPLETED|Overall Study||158
6793711|NCT01539863|7725094|FG000|NOT COMPLETED|Overall Study||5
6793712|NCT01539863|7725095|FG001|NOT COMPLETED|Overall Study||4
6793713|NCT01505062|7725104|FG000|STARTED|Overall Study||3
6793714|NCT01505062|7725105|FG001|STARTED|Overall Study||3
6793715|NCT01505062|7725106|FG002|STARTED|Overall Study||3
6793716|NCT01505062|7725104|FG000|COMPLETED|Overall Study||3
6793717|NCT01505062|7725105|FG001|COMPLETED|Overall Study||3
6793718|NCT01505062|7725106|FG002|COMPLETED|Overall Study||3
6793719|NCT01505062|7725104|FG000|NOT COMPLETED|Overall Study||0
6793720|NCT01505062|7725105|FG001|NOT COMPLETED|Overall Study||0
6793721|NCT01505062|7725106|FG002|NOT COMPLETED|Overall Study||0
6793722|NCT01439165|7725116|FG000|STARTED|Overall Study||1002
6793723|NCT01439165|7725117|FG001|STARTED|Overall Study||328
6793724|NCT01439165|7725116|FG000|COMPLETED|Overall Study||981
6793725|NCT01439165|7725117|FG001|COMPLETED|Overall Study||326
6793726|NCT01439165|7725116|FG000|NOT COMPLETED|Overall Study||21
6793727|NCT01439165|7725117|FG001|NOT COMPLETED|Overall Study||2
6793728|NCT01264679|7725123|FG000|STARTED|Overall Study||8
6793729|NCT01264679|7725123|FG000|Received at Least 1 Dose of Study Drug|Overall Study||7
6793730|NCT01264679|7725123|FG000|COMPLETED|Overall Study||3
6793731|NCT01264679|7725123|FG000|NOT COMPLETED|Overall Study||5
6793732|NCT01155388|7725130|FG000|STARTED|Overall Study||8
6793733|NCT01155388|7725131|FG001|STARTED|Overall Study||6
6793734|NCT01155388|7725130|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6793735|NCT01155388|7725131|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6793736|NCT01155388|7725130|FG000|COMPLETED|Overall Study||7
6793737|NCT01155388|7725131|FG001|COMPLETED|Overall Study||6
6793738|NCT01155388|7725130|FG000|NOT COMPLETED|Overall Study||1
6793739|NCT01155388|7725131|FG001|NOT COMPLETED|Overall Study||0
6793740|NCT01137435|7725138|FG000|STARTED|Overall Study||687
6793741|NCT01137435|7725138|FG000|COMPLETED|Overall Study||659
6793742|NCT01137435|7725138|FG000|NOT COMPLETED|Overall Study||28
6793743|NCT01095003|7725144|FG000|STARTED|Overall Study||384
6793744|NCT01095003|7725145|FG001|STARTED|Overall Study||386
6793745|NCT01095003|7725144|FG000|COMPLETED|Overall Study||0
6793746|NCT01095003|7725145|FG001|COMPLETED|Overall Study||0
6793747|NCT01095003|7725144|FG000|NOT COMPLETED|Overall Study||384
6793748|NCT01095003|7725145|FG001|NOT COMPLETED|Overall Study||386
6793749|NCT01064817|7725155|FG000|STARTED|All Study Treatment Days 1-9||62
6793750|NCT01064817|7725156|FG001|STARTED|All Study Treatment Days 1-9||62
6793751|NCT01064817|7725155|FG000|COMPLETED|All Study Treatment Days 1-9||62
6793752|NCT01064817|7725156|FG001|COMPLETED|All Study Treatment Days 1-9||62
6793753|NCT01064817|7725155|FG000|NOT COMPLETED|All Study Treatment Days 1-9||0
6793754|NCT01064817|7725156|FG001|NOT COMPLETED|All Study Treatment Days 1-9||0
6793755|NCT01064817|7725155|FG000|STARTED|Study Completion||62
6793756|NCT01064817|7725156|FG001|STARTED|Study Completion||62
6793757|NCT01064817|7725155|FG000|COMPLETED|Study Completion||60
6793758|NCT01064817|7725156|FG001|COMPLETED|Study Completion||62
6793759|NCT01064817|7725155|FG000|NOT COMPLETED|Study Completion||2
6793760|NCT01064817|7725156|FG001|NOT COMPLETED|Study Completion||0
6793761|NCT01026220|7725162|FG000|STARTED|Induction||166
6793762|NCT01026220|7725163|FG001|STARTED|Induction||0
6793763|NCT01026220|7725164|FG002|STARTED|Induction||0
6793764|NCT01026220|7725162|FG000|COMPLETED|Induction||141
6793765|NCT01026220|7725163|FG001|COMPLETED|Induction||0
6793766|NCT01026220|7725164|FG002|COMPLETED|Induction||0
6793767|NCT01026220|7725162|FG000|NOT COMPLETED|Induction||25
6793768|NCT01026220|7725163|FG001|NOT COMPLETED|Induction||0
6793769|NCT01026220|7725164|FG002|NOT COMPLETED|Induction||0
6793770|NCT01026220|7725162|FG000|STARTED|Consolidation Maintenance||0
6793771|NCT01026220|7725163|FG001|STARTED|Consolidation Maintenance||81
6793772|NCT01026220|7725164|FG002|STARTED|Consolidation Maintenance||80
6793773|NCT01026220|7725162|FG000|COMPLETED|Consolidation Maintenance||0
6793774|NCT01026220|7725163|FG001|COMPLETED|Consolidation Maintenance||75
6793775|NCT01026220|7725164|FG002|COMPLETED|Consolidation Maintenance||66
6793776|NCT01026220|7725162|FG000|NOT COMPLETED|Consolidation Maintenance||0
6793777|NCT01026220|7725163|FG001|NOT COMPLETED|Consolidation Maintenance||6
6793778|NCT01026220|7725164|FG002|NOT COMPLETED|Consolidation Maintenance||14
6793779|NCT00961714|7725179|FG000|STARTED|Overall Study||15
6793780|NCT00961714|7725179|FG000|COMPLETED|Overall Study||13
6793781|NCT00961714|7725179|FG000|NOT COMPLETED|Overall Study||2
6793782|NCT00567567|7725186|FG000|STARTED|Overall Study||210
6793783|NCT00567567|7725187|FG001|STARTED|Overall Study||176
6793784|NCT00567567|7725188|FG002|STARTED|Overall Study||279
6793785|NCT00567567|7725186|FG000|COMPLETED|Overall Study||58
6793786|NCT00567567|7725187|FG001|COMPLETED|Overall Study||42
6793787|NCT00567567|7725188|FG002|COMPLETED|Overall Study||1
6793788|NCT00567567|7725186|FG000|NOT COMPLETED|Overall Study||152
6793789|NCT00567567|7725187|FG001|NOT COMPLETED|Overall Study||134
6793790|NCT00567567|7725188|FG002|NOT COMPLETED|Overall Study||278
6793791|NCT00450450|7725200|FG000|STARTED|Overall Study||13
6793792|NCT00450450|7725201|FG001|STARTED|Overall Study||14
6793793|NCT00450450|7725200|FG000|COMPLETED|Overall Study||8
6793794|NCT00450450|7725201|FG001|COMPLETED|Overall Study||11
6793795|NCT00450450|7725200|FG000|NOT COMPLETED|Overall Study||5
6793796|NCT00450450|7725201|FG001|NOT COMPLETED|Overall Study||3
6793797|NCT00392821|7725210|FG000|STARTED|Overall Study||3
6793798|NCT00392821|7725211|FG001|STARTED|Overall Study||6
6793799|NCT00392821|7725212|FG002|STARTED|Overall Study||69
6793800|NCT00392821|7725210|FG000|COMPLETED|Overall Study||0
6793801|NCT00392821|7725211|FG001|COMPLETED|Overall Study||0
6793802|NCT00392821|7725212|FG002|COMPLETED|Overall Study||0
6793803|NCT00392821|7725210|FG000|NOT COMPLETED|Overall Study||3
6793804|NCT00392821|7725211|FG001|NOT COMPLETED|Overall Study||6
6793805|NCT00392821|7725212|FG002|NOT COMPLETED|Overall Study||69
6793806|NCT00346164|7725222|FG000|STARTED|Overall Study||222
6793807|NCT00346164|7725223|FG001|STARTED|Overall Study||21
6793808|NCT00346164|7725224|FG002|STARTED|Overall Study||122
6793809|NCT00346164|7725225|FG003|STARTED|Overall Study||223
6793810|NCT00346164|7725222|FG000|COMPLETED|Overall Study||205
6793811|NCT00346164|7725223|FG001|COMPLETED|Overall Study||14
6793812|NCT00346164|7725224|FG002|COMPLETED|Overall Study||96
6793813|NCT00346164|7725225|FG003|COMPLETED|Overall Study||117
6793814|NCT00346164|7725222|FG000|NOT COMPLETED|Overall Study||17
6793815|NCT00346164|7725223|FG001|NOT COMPLETED|Overall Study||7
6793816|NCT00346164|7725224|FG002|NOT COMPLETED|Overall Study||26
6793817|NCT00346164|7725225|FG003|NOT COMPLETED|Overall Study||106
6793818|NCT01009294|7725251|FG000|STARTED|Overall Study||6
6793819|NCT01009294|7725251|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6793820|NCT01009294|7725251|FG000|COMPLETED|Overall Study||0
6793821|NCT01009294|7725251|FG000|NOT COMPLETED|Overall Study||6
6793822|NCT01053637|7725257|FG000|STARTED|Overall Study||43
6793823|NCT01053637|7725258|FG001|STARTED|Overall Study||42
6793824|NCT01053637|7725257|FG000|COMPLETED|Overall Study|2 with incomplete pain scores|43
6793825|NCT01053637|7725258|FG001|COMPLETED|Overall Study|4 incomplete pain scores 4 proceeded to procedural sedation|42
6793826|NCT01053637|7725257|FG000|NOT COMPLETED|Overall Study||0
6793827|NCT01053637|7725258|FG001|NOT COMPLETED|Overall Study||0
6793828|NCT01072175|7725276|FG000|STARTED|Part A (Drug-Drug Interaction)||8
6793829|NCT01072175|7725277|FG001|STARTED|Part A (Drug-Drug Interaction)||0
6793830|NCT01072175|7725278|FG002|STARTED|Part A (Drug-Drug Interaction)||0
6793831|NCT01072175|7725279|FG003|STARTED|Part A (Drug-Drug Interaction)||0
6793832|NCT01072175|7725280|FG004|STARTED|Part A (Drug-Drug Interaction)||0
6793833|NCT01072175|7725281|FG005|STARTED|Part A (Drug-Drug Interaction)||0
6793834|NCT01072175|7725282|FG006|STARTED|Part A (Drug-Drug Interaction)||0
6793835|NCT01072175|7725283|FG007|STARTED|Part A (Drug-Drug Interaction)||0
6793836|NCT01072175|7725284|FG008|STARTED|Part A (Drug-Drug Interaction)||0
6793837|NCT01072175|7725285|FG009|STARTED|Part A (Drug-Drug Interaction)||0
6793838|NCT01072175|7725286|FG010|STARTED|Part A (Drug-Drug Interaction)||0
6793839|NCT01072175|7725287|FG011|STARTED|Part A (Drug-Drug Interaction)||0
6793840|NCT01072175|7725288|FG012|STARTED|Part A (Drug-Drug Interaction)||0
6793841|NCT01072175|7725276|FG000|COMPLETED|Part A (Drug-Drug Interaction)||0
6793842|NCT01072175|7725277|FG001|COMPLETED|Part A (Drug-Drug Interaction)||0
6793843|NCT01072175|7725278|FG002|COMPLETED|Part A (Drug-Drug Interaction)||0
6793844|NCT01072175|7725279|FG003|COMPLETED|Part A (Drug-Drug Interaction)||0
6793845|NCT01072175|7725280|FG004|COMPLETED|Part A (Drug-Drug Interaction)||0
6793846|NCT01072175|7725281|FG005|COMPLETED|Part A (Drug-Drug Interaction)||0
6793847|NCT01072175|7725282|FG006|COMPLETED|Part A (Drug-Drug Interaction)||0
6793848|NCT01072175|7725283|FG007|COMPLETED|Part A (Drug-Drug Interaction)||0
6793849|NCT01072175|7725284|FG008|COMPLETED|Part A (Drug-Drug Interaction)||0
6793850|NCT01072175|7725285|FG009|COMPLETED|Part A (Drug-Drug Interaction)||0
6793851|NCT01072175|7725286|FG010|COMPLETED|Part A (Drug-Drug Interaction)||0
6793852|NCT01072175|7725287|FG011|COMPLETED|Part A (Drug-Drug Interaction)||0
6793853|NCT01072175|7725288|FG012|COMPLETED|Part A (Drug-Drug Interaction)||0
6793854|NCT01072175|7725276|FG000|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
6793855|NCT01072175|7725277|FG001|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793856|NCT01072175|7725278|FG002|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793857|NCT01072175|7725279|FG003|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793858|NCT01072175|7725280|FG004|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793859|NCT01072175|7725281|FG005|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793860|NCT01072175|7725282|FG006|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793861|NCT01072175|7725283|FG007|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793862|NCT01072175|7725284|FG008|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793863|NCT01072175|7725285|FG009|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793864|NCT01072175|7725286|FG010|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793865|NCT01072175|7725287|FG011|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793866|NCT01072175|7725288|FG012|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
6793867|NCT01072175|7725276|FG000|STARTED|Part B (Dose Escalation and Expansion)||0
6793868|NCT01072175|7725277|FG001|STARTED|Part B (Dose Escalation and Expansion)||6
6793869|NCT01072175|7725278|FG002|STARTED|Part B (Dose Escalation and Expansion)||23
6793870|NCT01072175|7725279|FG003|STARTED|Part B (Dose Escalation and Expansion)||27
6793871|NCT01072175|7725280|FG004|STARTED|Part B (Dose Escalation and Expansion)||94
6793872|NCT01072175|7725281|FG005|STARTED|Part B (Dose Escalation and Expansion)||0
6793873|NCT01072175|7725282|FG006|STARTED|Part B (Dose Escalation and Expansion)||0
6793874|NCT01072175|7725283|FG007|STARTED|Part B (Dose Escalation and Expansion)||0
6793875|NCT01072175|7725284|FG008|STARTED|Part B (Dose Escalation and Expansion)||0
6793876|NCT01072175|7725285|FG009|STARTED|Part B (Dose Escalation and Expansion)||0
6793877|NCT01072175|7725286|FG010|STARTED|Part B (Dose Escalation and Expansion)||0
6793878|NCT01072175|7725287|FG011|STARTED|Part B (Dose Escalation and Expansion)||0
6793879|NCT01072175|7725288|FG012|STARTED|Part B (Dose Escalation and Expansion)||0
6793880|NCT01072175|7725276|FG000|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793881|NCT01072175|7725277|FG001|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793882|NCT01072175|7725278|FG002|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793883|NCT01072175|7725279|FG003|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793884|NCT01072175|7725280|FG004|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793885|NCT01072175|7725281|FG005|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793886|NCT01072175|7725282|FG006|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793887|NCT01072175|7725283|FG007|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793888|NCT01072175|7725284|FG008|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793889|NCT01072175|7725285|FG009|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793890|NCT01072175|7725286|FG010|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793891|NCT01072175|7725287|FG011|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793892|NCT01072175|7725288|FG012|COMPLETED|Part B (Dose Escalation and Expansion)||0
6793893|NCT01072175|7725276|FG000|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793894|NCT01072175|7725277|FG001|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
6793895|NCT01072175|7725278|FG002|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
6793896|NCT01072175|7725279|FG003|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
6793897|NCT01072175|7725280|FG004|NOT COMPLETED|Part B (Dose Escalation and Expansion)||94
6793898|NCT01072175|7725281|FG005|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793899|NCT01072175|7725282|FG006|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793900|NCT01072175|7725283|FG007|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793901|NCT01072175|7725284|FG008|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793902|NCT01072175|7725285|FG009|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793903|NCT01072175|7725286|FG010|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793904|NCT01072175|7725287|FG011|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793905|NCT01072175|7725288|FG012|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
6793906|NCT01072175|7725276|FG000|STARTED|Part C (Phase II: Randomized Phase)||0
6793907|NCT01072175|7725277|FG001|STARTED|Part C (Phase II: Randomized Phase)||0
6793908|NCT01072175|7725278|FG002|STARTED|Part C (Phase II: Randomized Phase)||0
6793909|NCT01072175|7725279|FG003|STARTED|Part C (Phase II: Randomized Phase)||0
6793910|NCT01072175|7725280|FG004|STARTED|Part C (Phase II: Randomized Phase)||0
6793911|NCT01072175|7725281|FG005|STARTED|Part C (Phase II: Randomized Phase)||54
6793912|NCT01072175|7725282|FG006|STARTED|Part C (Phase II: Randomized Phase)||54
6793913|NCT01072175|7725283|FG007|STARTED|Part C (Phase II: Randomized Phase)||54
6793914|NCT01072175|7725284|FG008|STARTED|Part C (Phase II: Randomized Phase)||0
6793915|NCT01072175|7725285|FG009|STARTED|Part C (Phase II: Randomized Phase)||0
6793916|NCT01072175|7725286|FG010|STARTED|Part C (Phase II: Randomized Phase)||0
6793917|NCT01072175|7725287|FG011|STARTED|Part C (Phase II: Randomized Phase)||0
6793918|NCT01072175|7725288|FG012|STARTED|Part C (Phase II: Randomized Phase)||0
6793919|NCT01072175|7725276|FG000|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793920|NCT01072175|7725277|FG001|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793921|NCT01072175|7725278|FG002|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793922|NCT01072175|7725279|FG003|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793923|NCT01072175|7725280|FG004|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793924|NCT01072175|7725281|FG005|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793925|NCT01072175|7725282|FG006|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793926|NCT01072175|7725283|FG007|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793927|NCT01072175|7725284|FG008|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793928|NCT01072175|7725285|FG009|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793929|NCT01072175|7725286|FG010|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793930|NCT01072175|7725287|FG011|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793931|NCT01072175|7725288|FG012|COMPLETED|Part C (Phase II: Randomized Phase)||0
6793932|NCT01072175|7725276|FG000|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793933|NCT01072175|7725277|FG001|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793934|NCT01072175|7725278|FG002|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793935|NCT01072175|7725279|FG003|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793936|NCT01072175|7725280|FG004|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793937|NCT01072175|7725281|FG005|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
6793938|NCT01072175|7725282|FG006|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
6793939|NCT01072175|7725283|FG007|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
6793940|NCT01072175|7725284|FG008|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793941|NCT01072175|7725285|FG009|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793942|NCT01072175|7725286|FG010|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793943|NCT01072175|7725287|FG011|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6379378|NCT00772889|7290084|FG000|STARTED|Overall Study||375
6379379|NCT00772889|7290085|FG001|STARTED|Overall Study||393
6379380|NCT00772889|7290086|FG002|STARTED|Overall Study||203
6793944|NCT01072175|7725288|FG012|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
6793945|NCT01072175|7725276|FG000|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793946|NCT01072175|7725277|FG001|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793947|NCT01072175|7725278|FG002|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793948|NCT01072175|7725279|FG003|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793949|NCT01072175|7725280|FG004|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793950|NCT01072175|7725281|FG005|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793951|NCT01072175|7725282|FG006|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793952|NCT01072175|7725283|FG007|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793953|NCT01072175|7725284|FG008|STARTED|Part C (Phase II: Crossover Phase [CP])||45
6793954|NCT01072175|7725285|FG009|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793955|NCT01072175|7725286|FG010|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793956|NCT01072175|7725287|FG011|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793957|NCT01072175|7725288|FG012|STARTED|Part C (Phase II: Crossover Phase [CP])||0
6793958|NCT01072175|7725276|FG000|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793959|NCT01072175|7725277|FG001|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793960|NCT01072175|7725278|FG002|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793961|NCT01072175|7725279|FG003|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793962|NCT01072175|7725280|FG004|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793963|NCT01072175|7725281|FG005|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793964|NCT01072175|7725282|FG006|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793965|NCT01072175|7725283|FG007|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793966|NCT01072175|7725284|FG008|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793967|NCT01072175|7725285|FG009|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793968|NCT01072175|7725286|FG010|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793969|NCT01072175|7725287|FG011|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793970|NCT01072175|7725288|FG012|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793971|NCT01072175|7725276|FG000|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793972|NCT01072175|7725277|FG001|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793973|NCT01072175|7725278|FG002|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793974|NCT01072175|7725279|FG003|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793975|NCT01072175|7725280|FG004|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793976|NCT01072175|7725281|FG005|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793977|NCT01072175|7725282|FG006|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793978|NCT01072175|7725283|FG007|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793979|NCT01072175|7725284|FG008|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||45
6793980|NCT01072175|7725285|FG009|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793981|NCT01072175|7725286|FG010|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793982|NCT01072175|7725287|FG011|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793983|NCT01072175|7725288|FG012|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
6793984|NCT01072175|7725276|FG000|STARTED|Part D (HPMC Capsules)||0
6793985|NCT01072175|7725277|FG001|STARTED|Part D (HPMC Capsules)||0
6793986|NCT01072175|7725278|FG002|STARTED|Part D (HPMC Capsules)||0
6379381|NCT00772889|7290084|FG000|Completed at Day 21|Overall Study||374
6379382|NCT00772889|7290085|FG001|Completed at Day 21|Overall Study||390
6379383|NCT00772889|7290086|FG002|Completed at Day 21|Overall Study||203
6379384|NCT00772889|7290084|FG000|COMPLETED|Overall Study||353
6656578|NCT02462070|7586837|FG000|STARTED|Overall Study||135
6793987|NCT01072175|7725279|FG003|STARTED|Part D (HPMC Capsules)||0
6793988|NCT01072175|7725280|FG004|STARTED|Part D (HPMC Capsules)||0
6793989|NCT01072175|7725281|FG005|STARTED|Part D (HPMC Capsules)||0
6793990|NCT01072175|7725282|FG006|STARTED|Part D (HPMC Capsules)||0
6793991|NCT01072175|7725283|FG007|STARTED|Part D (HPMC Capsules)||0
6793992|NCT01072175|7725284|FG008|STARTED|Part D (HPMC Capsules)||0
6793993|NCT01072175|7725285|FG009|STARTED|Part D (HPMC Capsules)||12
6793994|NCT01072175|7725286|FG010|STARTED|Part D (HPMC Capsules)||16
6793995|NCT01072175|7725287|FG011|STARTED|Part D (HPMC Capsules)||43
6793996|NCT01072175|7725288|FG012|STARTED|Part D (HPMC Capsules)||39
6793997|NCT01072175|7725276|FG000|COMPLETED|Part D (HPMC Capsules)||0
6793998|NCT01072175|7725277|FG001|COMPLETED|Part D (HPMC Capsules)||0
6793999|NCT01072175|7725278|FG002|COMPLETED|Part D (HPMC Capsules)||0
6794000|NCT01072175|7725279|FG003|COMPLETED|Part D (HPMC Capsules)||0
6794001|NCT01072175|7725280|FG004|COMPLETED|Part D (HPMC Capsules)||0
6794002|NCT01072175|7725281|FG005|COMPLETED|Part D (HPMC Capsules)||0
6794003|NCT01072175|7725282|FG006|COMPLETED|Part D (HPMC Capsules)||0
6794004|NCT01072175|7725283|FG007|COMPLETED|Part D (HPMC Capsules)||0
6794005|NCT01072175|7725284|FG008|COMPLETED|Part D (HPMC Capsules)||0
6794006|NCT01072175|7725285|FG009|COMPLETED|Part D (HPMC Capsules)||0
6794007|NCT01072175|7725286|FG010|COMPLETED|Part D (HPMC Capsules)||0
6794008|NCT01072175|7725287|FG011|COMPLETED|Part D (HPMC Capsules)||0
6794009|NCT01072175|7725288|FG012|COMPLETED|Part D (HPMC Capsules)||0
6794010|NCT01072175|7725276|FG000|NOT COMPLETED|Part D (HPMC Capsules)||0
6794011|NCT01072175|7725277|FG001|NOT COMPLETED|Part D (HPMC Capsules)||0
6794012|NCT01072175|7725278|FG002|NOT COMPLETED|Part D (HPMC Capsules)||0
6794013|NCT01072175|7725279|FG003|NOT COMPLETED|Part D (HPMC Capsules)||0
6794014|NCT01072175|7725280|FG004|NOT COMPLETED|Part D (HPMC Capsules)||0
6794015|NCT01072175|7725281|FG005|NOT COMPLETED|Part D (HPMC Capsules)||0
6794016|NCT01072175|7725282|FG006|NOT COMPLETED|Part D (HPMC Capsules)||0
6794017|NCT01072175|7725283|FG007|NOT COMPLETED|Part D (HPMC Capsules)||0
6794018|NCT01072175|7725284|FG008|NOT COMPLETED|Part D (HPMC Capsules)||0
6794019|NCT01072175|7725285|FG009|NOT COMPLETED|Part D (HPMC Capsules)||12
6794020|NCT01072175|7725286|FG010|NOT COMPLETED|Part D (HPMC Capsules)||16
6794021|NCT01072175|7725287|FG011|NOT COMPLETED|Part D (HPMC Capsules)||43
6794022|NCT01072175|7725288|FG012|NOT COMPLETED|Part D (HPMC Capsules)||39
6794023|NCT01087203|7725322|FG000|STARTED|Overall Study||35
6794024|NCT01087203|7725323|FG001|STARTED|Overall Study||38
6794025|NCT01087203|7725322|FG000|COMPLETED|Overall Study||3
6794026|NCT01087203|7725323|FG001|COMPLETED|Overall Study||3
6794027|NCT01087203|7725322|FG000|NOT COMPLETED|Overall Study||32
6794028|NCT01087203|7725323|FG001|NOT COMPLETED|Overall Study||35
6794032|NCT01108055|7725334|FG000|STARTED|Overall Study||43
6794033|NCT01108055|7725334|FG000|Eligible and Started Treatment|Overall Study||32
6794034|NCT01108055|7725334|FG000|COMPLETED|Overall Study||28
6794035|NCT01108055|7725334|FG000|NOT COMPLETED|Overall Study||15
6794036|NCT01111019|7725338|FG000|STARTED|Overall Study||19
6794037|NCT01111019|7725338|FG000|COMPLETED|Overall Study||16
6794038|NCT01111019|7725338|FG000|NOT COMPLETED|Overall Study||3
6794039|NCT01136967|7725344|FG000|STARTED|Overall Study||93
6794040|NCT01136967|7725345|FG001|STARTED|Overall Study||89
6794041|NCT01136967|7725344|FG000|Disease Progression|Overall Study||55
6794042|NCT01136967|7725345|FG001|Disease Progression|Overall Study||56
6794043|NCT01136967|7725344|FG000|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
6794044|NCT01136967|7725345|FG001|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
6794045|NCT01136967|7725344|FG000|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
6794046|NCT01136967|7725345|FG001|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
6794047|NCT01136967|7725344|FG000|NOT COMPLETED|Overall Study||24
6794048|NCT01136967|7725345|FG001|NOT COMPLETED|Overall Study||27
6794049|NCT01136980|7725353|FG000|STARTED|Overall Study||42
6794050|NCT01136980|7725354|FG001|STARTED|Overall Study||87
6794051|NCT01136980|7725353|FG000|COMPLETED|Overall Study||28
6794052|NCT01136980|7725354|FG001|COMPLETED|Overall Study||76
6794053|NCT01136980|7725353|FG000|NOT COMPLETED|Overall Study||14
6794054|NCT01136980|7725354|FG001|NOT COMPLETED|Overall Study||11
6794055|NCT01140451|7725362|FG000|STARTED|Overall Study||95
6794056|NCT01140451|7725363|FG001|STARTED|Overall Study||96
6794057|NCT01140451|7725362|FG000|Completed 24 Weeks|Overall Study||89
6794058|NCT01140451|7725363|FG001|Completed 24 Weeks|Overall Study||86
6794059|NCT01140451|7725362|FG000|Completed 48 Weeks|Overall Study||78
6794060|NCT01140451|7725363|FG001|Completed 48 Weeks|Overall Study||70
6794061|NCT01140451|7725362|FG000|Completed 72 Weeks|Overall Study||63
6794062|NCT01140451|7725363|FG001|Completed 72 Weeks|Overall Study||62
6794063|NCT01140451|7725362|FG000|Completed 96 Weeks|Overall Study||57
6794064|NCT01140451|7725363|FG001|Completed 96 Weeks|Overall Study||54
6794065|NCT01140451|7725362|FG000|As-Treated Population|Overall Study||95
6794066|NCT01140451|7725363|FG001|As-Treated Population|Overall Study||96
6794067|NCT01140451|7725362|FG000|96-Week Completer Population|Overall Study||78
6794068|NCT01140451|7725363|FG001|96-Week Completer Population|Overall Study||70
6794069|NCT01140451|7725362|FG000|144-Week Completer Population|Overall Study||57
6794070|NCT01140451|7725363|FG001|144-Week Completer Population|Overall Study||54
6794071|NCT01140451|7725362|FG000|COMPLETED|Overall Study||57
6794072|NCT01140451|7725363|FG001|COMPLETED|Overall Study||54
6794073|NCT01140451|7725362|FG000|NOT COMPLETED|Overall Study||38
6794074|NCT01140451|7725363|FG001|NOT COMPLETED|Overall Study||42
6794075|NCT01174563|7725370|FG000|STARTED|Overall Study||60
6794076|NCT01174563|7725370|FG000|Efficacy Set|Overall Study||59
6794077|NCT01174563|7725370|FG000|Safety Set|Overall Study||59
6794078|NCT01174563|7725370|FG000|COMPLETED|Overall Study||0
6794079|NCT01174563|7725370|FG000|NOT COMPLETED|Overall Study||60
6794080|NCT01190202|7725378|FG000|STARTED|Overall Study||6404
6794081|NCT01190202|7725379|FG001|STARTED|Overall Study||6414
6794082|NCT01190202|7725380|FG002|STARTED|Overall Study||6400
6794083|NCT01190202|7725381|FG003|STARTED|Overall Study||2400
6794084|NCT01190202|7725378|FG000|COMPLETED|Overall Study||6404
6794085|NCT01190202|7725379|FG001|COMPLETED|Overall Study||6414
6563603|NCT01807520|7486484|FG006|Full Analysis Set|Treatment Period 2 (16-132 Weeks)||0
6794086|NCT01190202|7725380|FG002|COMPLETED|Overall Study||6400
6794087|NCT01190202|7725381|FG003|COMPLETED|Overall Study||2400
6794088|NCT01190202|7725378|FG000|NOT COMPLETED|Overall Study||0
6794089|NCT01190202|7725379|FG001|NOT COMPLETED|Overall Study||0
6794090|NCT01190202|7725380|FG002|NOT COMPLETED|Overall Study||0
6794091|NCT01190202|7725381|FG003|NOT COMPLETED|Overall Study||0
6794092|NCT01200862|7725426|FG000|STARTED|Part 1||14
6794093|NCT01200862|7725427|FG001|STARTED|Part 1||0
6794094|NCT01200862|7725428|FG002|STARTED|Part 1||0
6794095|NCT01200862|7725426|FG000|COMPLETED|Part 1||13
6794096|NCT01200862|7725427|FG001|COMPLETED|Part 1||0
6794097|NCT01200862|7725428|FG002|COMPLETED|Part 1||0
6794098|NCT01200862|7725426|FG000|NOT COMPLETED|Part 1||1
6794099|NCT01200862|7725427|FG001|NOT COMPLETED|Part 1||0
6794100|NCT01200862|7725428|FG002|NOT COMPLETED|Part 1||0
6794101|NCT01200862|7725426|FG000|STARTED|Part 2||0
6794102|NCT01200862|7725427|FG001|STARTED|Part 2||7
6794103|NCT01200862|7725428|FG002|STARTED|Part 2||8
6794104|NCT01200862|7725426|FG000|COMPLETED|Part 2||0
6794105|NCT01200862|7725427|FG001|COMPLETED|Part 2||6
6794106|NCT01200862|7725428|FG002|COMPLETED|Part 2||8
6794107|NCT01200862|7725426|FG000|NOT COMPLETED|Part 2||0
6794108|NCT01200862|7725427|FG001|NOT COMPLETED|Part 2||1
6794109|NCT01200862|7725428|FG002|NOT COMPLETED|Part 2||0
6794110|NCT01225341|7725439|FG000|STARTED|Overall Study||0
6794111|NCT01225341|7725440|FG001|STARTED|Overall Study||0
6794112|NCT01225341|7725439|FG000|COMPLETED|Overall Study||0
6794029|NCT01088815|7725330|FG000|STARTED|Overall Study||72
6794030|NCT01088815|7725330|FG000|COMPLETED|Overall Study||72
6794031|NCT01088815|7725330|FG000|NOT COMPLETED|Overall Study||0
6794113|NCT01225341|7725440|FG001|COMPLETED|Overall Study||0
6794114|NCT01225341|7725439|FG000|NOT COMPLETED|Overall Study||0
6794115|NCT01225341|7725440|FG001|NOT COMPLETED|Overall Study||0
6794116|NCT01235962|7725450|FG000|STARTED|Overall Study||198
6794117|NCT01235962|7725451|FG001|STARTED|Overall Study||205
6794118|NCT01235962|7725452|FG002|STARTED|Overall Study||571
6794119|NCT01235962|7725453|FG003|STARTED|Overall Study||564
6794120|NCT01235962|7725450|FG000|Prem. Withdrawn = Did Not Complete Study|Overall Study||46
6794121|NCT01235962|7725451|FG001|Prem. Withdrawn = Did Not Complete Study|Overall Study||35
6794122|NCT01235962|7725452|FG002|Prem. Withdrawn = Did Not Complete Study|Overall Study||118
6794123|NCT01235962|7725453|FG003|Prem. Withdrawn = Did Not Complete Study|Overall Study||86
6794124|NCT01235962|7725450|FG000|All Deaths|Overall Study||43
6794125|NCT01235962|7725451|FG001|All Deaths|Overall Study||46
6794126|NCT01235962|7725452|FG002|All Deaths|Overall Study||102
6794127|NCT01235962|7725453|FG003|All Deaths|Overall Study||104
6794128|NCT01235962|7725450|FG000|COMPLETED|Overall Study||152
6794129|NCT01235962|7725451|FG001|COMPLETED|Overall Study||170
6794130|NCT01235962|7725452|FG002|COMPLETED|Overall Study||453
6794131|NCT01235962|7725453|FG003|COMPLETED|Overall Study||478
6794132|NCT01235962|7725450|FG000|NOT COMPLETED|Overall Study||46
6794133|NCT01235962|7725451|FG001|NOT COMPLETED|Overall Study||35
6794134|NCT01235962|7725452|FG002|NOT COMPLETED|Overall Study||118
6794135|NCT01235962|7725453|FG003|NOT COMPLETED|Overall Study||86
6794136|NCT01239368|7725481|FG000|STARTED|Overall Study||2
6794137|NCT01239368|7725482|FG001|STARTED|Overall Study||1
6794138|NCT01239368|7725483|FG002|STARTED|Overall Study||1
6794139|NCT01239368|7725484|FG003|STARTED|Overall Study||2
6794140|NCT01239368|7725485|FG004|STARTED|Overall Study||7
6794141|NCT01239368|7725486|FG005|STARTED|Overall Study||5
6794142|NCT01239368|7725487|FG006|STARTED|Overall Study||7
6794143|NCT01239368|7725488|FG007|STARTED|Overall Study||0
6794144|NCT01239368|7725489|FG008|STARTED|Overall Study||1
6794145|NCT01239368|7725490|FG009|STARTED|Overall Study||5
6794146|NCT01239368|7725481|FG000|COMPLETED|Overall Study||0
6794147|NCT01239368|7725482|FG001|COMPLETED|Overall Study||0
6794148|NCT01239368|7725483|FG002|COMPLETED|Overall Study||0
6794149|NCT01239368|7725484|FG003|COMPLETED|Overall Study||1
6794150|NCT01239368|7725485|FG004|COMPLETED|Overall Study||2
6794151|NCT01239368|7725486|FG005|COMPLETED|Overall Study||1
6794152|NCT01239368|7725487|FG006|COMPLETED|Overall Study||1
6794153|NCT01239368|7725488|FG007|COMPLETED|Overall Study||0
6794154|NCT01239368|7725489|FG008|COMPLETED|Overall Study||1
6794155|NCT01239368|7725490|FG009|COMPLETED|Overall Study||1
6794156|NCT01239368|7725481|FG000|NOT COMPLETED|Overall Study||2
6794157|NCT01239368|7725482|FG001|NOT COMPLETED|Overall Study||1
6794158|NCT01239368|7725483|FG002|NOT COMPLETED|Overall Study||1
6794159|NCT01239368|7725484|FG003|NOT COMPLETED|Overall Study||1
6794160|NCT01239368|7725485|FG004|NOT COMPLETED|Overall Study||5
6794161|NCT01239368|7725486|FG005|NOT COMPLETED|Overall Study||4
6794162|NCT01239368|7725487|FG006|NOT COMPLETED|Overall Study||6
6794163|NCT01239368|7725488|FG007|NOT COMPLETED|Overall Study||0
6794164|NCT01239368|7725489|FG008|NOT COMPLETED|Overall Study||0
6794165|NCT01239368|7725490|FG009|NOT COMPLETED|Overall Study||4
6794166|NCT01266031|7725526|FG000|STARTED|Overall Study||6
6794167|NCT01266031|7725527|FG001|STARTED|Overall Study||41
6794168|NCT01266031|7725528|FG002|STARTED|Overall Study||49
6794169|NCT01266031|7725526|FG000|COMPLETED|Overall Study||6
6794170|NCT01266031|7725527|FG001|COMPLETED|Overall Study||38
6794171|NCT01266031|7725528|FG002|COMPLETED|Overall Study||47
6794172|NCT01266031|7725526|FG000|NOT COMPLETED|Overall Study||0
6794173|NCT01266031|7725527|FG001|NOT COMPLETED|Overall Study||3
6794174|NCT01266031|7725528|FG002|NOT COMPLETED|Overall Study||2
6794175|NCT01287741|7725549|FG000|STARTED|Overall Study||712
6794176|NCT01287741|7725550|FG001|STARTED|Overall Study||706
6794177|NCT01287741|7725549|FG000|COMPLETED|Overall Study||86
6794178|NCT01287741|7725550|FG001|COMPLETED|Overall Study||91
6794179|NCT01287741|7725549|FG000|NOT COMPLETED|Overall Study||626
6794180|NCT01287741|7725550|FG001|NOT COMPLETED|Overall Study||615
6794181|NCT01304316|7725557|FG000|STARTED|Overall Study||12
6794182|NCT01304316|7725557|FG000|COMPLETED|Overall Study||12
6794183|NCT01304316|7725557|FG000|NOT COMPLETED|Overall Study||0
6794184|NCT01313689|7725567|FG000|STARTED|24-Week Randomization 1||79
6794185|NCT01313689|7725568|FG001|STARTED|24-Week Randomization 1|Of the 43 participants in the PC arm, 22 entered the OFA Salvage arm.|43
6794186|NCT01313689|7725569|FG002|STARTED|24-Week Randomization 1||0
6794187|NCT01313689|7725570|FG003|STARTED|24-Week Randomization 1||0
6794188|NCT01313689|7725571|FG004|STARTED|24-Week Randomization 1||0
6794189|NCT01313689|7725567|FG000|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
6794190|NCT01313689|7725568|FG001|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
6794191|NCT01313689|7725569|FG002|COMPLETED|24-Week Randomization 1||0
6794192|NCT01313689|7725570|FG003|COMPLETED|24-Week Randomization 1||0
6794193|NCT01313689|7725571|FG004|COMPLETED|24-Week Randomization 1||0
6794194|NCT01313689|7725567|FG000|NOT COMPLETED|24-Week Randomization 1||19
6794195|NCT01313689|7725568|FG001|NOT COMPLETED|24-Week Randomization 1||10
6794196|NCT01313689|7725569|FG002|NOT COMPLETED|24-Week Randomization 1||0
6794197|NCT01313689|7725570|FG003|NOT COMPLETED|24-Week Randomization 1||0
6794198|NCT01313689|7725571|FG004|NOT COMPLETED|24-Week Randomization 1||0
6794199|NCT01313689|7725567|FG000|STARTED|24-Week Randomization 2||0
6794200|NCT01313689|7725568|FG001|STARTED|24-Week Randomization 2||0
6794201|NCT01313689|7725569|FG002|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
6794202|NCT01313689|7725570|FG003|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
6794203|NCT01313689|7725571|FG004|STARTED|24-Week Randomization 2|OFA Participants who did not enter Randomization 2.|42
6794204|NCT01313689|7725567|FG000|COMPLETED|24-Week Randomization 2||0
6794205|NCT01313689|7725568|FG001|COMPLETED|24-Week Randomization 2||0
6794206|NCT01313689|7725569|FG002|COMPLETED|24-Week Randomization 2||21
6794207|NCT01313689|7725570|FG003|COMPLETED|24-Week Randomization 2||12
6794208|NCT01313689|7725571|FG004|COMPLETED|24-Week Randomization 2||27
6794209|NCT01313689|7725567|FG000|NOT COMPLETED|24-Week Randomization 2||0
6794210|NCT01313689|7725568|FG001|NOT COMPLETED|24-Week Randomization 2||0
6794211|NCT01313689|7725569|FG002|NOT COMPLETED|24-Week Randomization 2||3
6794212|NCT01313689|7725570|FG003|NOT COMPLETED|24-Week Randomization 2||1
6794213|NCT01313689|7725571|FG004|NOT COMPLETED|24-Week Randomization 2||15
6794214|NCT01315353|7725593|FG000|STARTED|Overall Study||145
6794215|NCT01315353|7725594|FG001|STARTED|Overall Study||143
6794216|NCT01315353|7725595|FG002|STARTED|Overall Study||179
6794217|NCT01315353|7725593|FG000|COMPLETED|Overall Study||116
6794218|NCT01315353|7725594|FG001|COMPLETED|Overall Study||120
6794219|NCT01315353|7725595|FG002|COMPLETED|Overall Study||166
6794220|NCT01315353|7725593|FG000|NOT COMPLETED|Overall Study||29
6794221|NCT01315353|7725594|FG001|NOT COMPLETED|Overall Study||23
6794222|NCT01315353|7725595|FG002|NOT COMPLETED|Overall Study||13
6794223|NCT01318993|7725603|FG000|STARTED|Overall Study||398
6794224|NCT01318993|7725603|FG000|COMPLETED|Overall Study||0
6794225|NCT01318993|7725603|FG000|NOT COMPLETED|Overall Study||398
6794226|NCT01335685|7725611|FG000|STARTED|Overall Study||7
6794227|NCT01335685|7725612|FG001|STARTED|Overall Study||4
6794228|NCT01335685|7725613|FG002|STARTED|Overall Study||3
6794229|NCT01335685|7725614|FG003|STARTED|Overall Study||26
6794230|NCT01335685|7725615|FG004|STARTED|Overall Study||5
6794231|NCT01335685|7725616|FG005|STARTED|Overall Study||6
6794232|NCT01335685|7725617|FG006|STARTED|Overall Study||4
6794233|NCT01335685|7725618|FG007|STARTED|Overall Study||6
6794234|NCT01335685|7725611|FG000|COMPLETED|Overall Study||4
6794235|NCT01335685|7725612|FG001|COMPLETED|Overall Study||3
6794236|NCT01335685|7725613|FG002|COMPLETED|Overall Study||1
6794237|NCT01335685|7725614|FG003|COMPLETED|Overall Study||15
6794238|NCT01335685|7725615|FG004|COMPLETED|Overall Study||5
6794239|NCT01335685|7725616|FG005|COMPLETED|Overall Study||1
6794240|NCT01335685|7725617|FG006|COMPLETED|Overall Study||2
6794241|NCT01335685|7725618|FG007|COMPLETED|Overall Study||3
6794242|NCT01335685|7725611|FG000|NOT COMPLETED|Overall Study||3
6794243|NCT01335685|7725612|FG001|NOT COMPLETED|Overall Study||1
6794244|NCT01335685|7725613|FG002|NOT COMPLETED|Overall Study||2
6794245|NCT01335685|7725614|FG003|NOT COMPLETED|Overall Study||11
6794246|NCT01335685|7725615|FG004|NOT COMPLETED|Overall Study||0
6794247|NCT01335685|7725616|FG005|NOT COMPLETED|Overall Study||5
6794248|NCT01335685|7725617|FG006|NOT COMPLETED|Overall Study||2
6794249|NCT01335685|7725618|FG007|NOT COMPLETED|Overall Study||3
6794256|NCT04391036|7725650|FG000|STARTED|Overall Study||15
6794257|NCT04391036|7725651|FG001|STARTED|Overall Study||15
6794258|NCT04391036|7725650|FG000|COMPLETED|Overall Study||15
6794259|NCT04391036|7725651|FG001|COMPLETED|Overall Study||15
6794260|NCT04391036|7725650|FG000|NOT COMPLETED|Overall Study||0
6794261|NCT04391036|7725651|FG001|NOT COMPLETED|Overall Study||0
6794262|NCT04170296|7725661|FG000|STARTED|Overall Study||81
6794263|NCT04170296|7725662|FG001|STARTED|Overall Study||72
6794264|NCT04170296|7725661|FG000|COMPLETED|Overall Study||73
6794265|NCT04170296|7725662|FG001|COMPLETED|Overall Study||68
6794266|NCT04170296|7725661|FG000|NOT COMPLETED|Overall Study||8
6794267|NCT04170296|7725662|FG001|NOT COMPLETED|Overall Study||4
6794268|NCT04039217|7725674|FG000|STARTED|Overall Study||20
6794269|NCT04039217|7725674|FG000|Started Study Arm A.1|Overall Study||4
6794270|NCT04039217|7725674|FG000|Completed Study Arm A.1|Overall Study||4
6794271|NCT04039217|7725674|FG000|Started Study Arm A.2|Overall Study||4
6794272|NCT04039217|7725674|FG000|Completed Study Arm A.2|Overall Study||4
6794273|NCT04039217|7725674|FG000|Started Study Arm A.3|Overall Study||4
6794274|NCT04039217|7725674|FG000|Completed Study Arm A.3|Overall Study||4
6794275|NCT04039217|7725674|FG000|Started Study Arm B.1|Overall Study||4
6794276|NCT04039217|7725674|FG000|Completed Study Arm B.1|Overall Study||4
6794277|NCT04039217|7725674|FG000|Started Study Arm B.2|Overall Study||4
6794278|NCT04039217|7725674|FG000|Completed Study Arm B.2|Overall Study||4
6794279|NCT04039217|7725674|FG000|Started Study Arm C.1|Overall Study||5
6794280|NCT04039217|7725674|FG000|Completed Study Arm C.1|Overall Study||4
6794281|NCT04039217|7725674|FG000|Started Study Arm C.2|Overall Study||0
6794282|NCT04039217|7725674|FG000|Completed Study Arm C.2|Overall Study||0
6794283|NCT04039217|7725674|FG000|COMPLETED|Overall Study||19
6794284|NCT04039217|7725674|FG000|NOT COMPLETED|Overall Study||1
6794285|NCT03998046|7725684|FG000|STARTED|Overall Study||38
6794286|NCT03998046|7725685|FG001|STARTED|Overall Study||42
6794287|NCT03998046|7725684|FG000|COMPLETED|Overall Study||38
6794288|NCT03998046|7725685|FG001|COMPLETED|Overall Study||42
6794289|NCT03998046|7725684|FG000|NOT COMPLETED|Overall Study||0
6794290|NCT03998046|7725685|FG001|NOT COMPLETED|Overall Study||0
6794291|NCT03160521|7725695|FG000|STARTED|Overall Study|From 145 randomized patients in the 75 mg dose arm, one of them withdrew consent before receiving the study treatment. Due to, only 144 patients received allocated intervention.|144
6794292|NCT03160521|7725696|FG001|STARTED|Overall Study||146
6794293|NCT03160521|7725697|FG002|STARTED|Overall Study||147
6794294|NCT03160521|7725695|FG000|COMPLETED|Overall Study||107
6794295|NCT03160521|7725696|FG001|COMPLETED|Overall Study||95
6794296|NCT03160521|7725697|FG002|COMPLETED|Overall Study||88
6794297|NCT03160521|7725695|FG000|NOT COMPLETED|Overall Study||37
6794298|NCT03160521|7725696|FG001|NOT COMPLETED|Overall Study||51
6794299|NCT03160521|7725697|FG002|NOT COMPLETED|Overall Study||59
6794300|NCT03143816|7725713|FG000|STARTED|Overall Study||26
6794301|NCT03143816|7725714|FG001|STARTED|Overall Study||34
6794302|NCT03143816|7725713|FG000|COMPLETED|Overall Study||22
6794303|NCT03143816|7725714|FG001|COMPLETED|Overall Study||34
6794304|NCT03143816|7725713|FG000|NOT COMPLETED|Overall Study||4
6794305|NCT03143816|7725714|FG001|NOT COMPLETED|Overall Study||0
6794306|NCT03078192|7725728|FG000|STARTED|Overall Study||30
6794307|NCT03078192|7725729|FG001|STARTED|Overall Study||32
6794308|NCT03078192|7725728|FG000|COMPLETED|Overall Study||28
6794309|NCT03078192|7725729|FG001|COMPLETED|Overall Study||28
6794310|NCT03078192|7725728|FG000|NOT COMPLETED|Overall Study||2
6794311|NCT03078192|7725729|FG001|NOT COMPLETED|Overall Study||4
6794312|NCT02959944|7725737|FG000|STARTED|Overall Study||95
6794313|NCT02959944|7725738|FG001|STARTED|Overall Study||98
6794314|NCT02959944|7725737|FG000|Received at Least 1 Dose of Study Drug|Overall Study||94
6794315|NCT02959944|7725738|FG001|Received at Least 1 Dose of Study Drug|Overall Study||96
6794316|NCT02959944|7725737|FG000|COMPLETED|Overall Study||95
6794317|NCT02959944|7725738|FG001|COMPLETED|Overall Study||98
6794250|NCT01336621|7725641|FG000|STARTED|Primary Reporting Phase (Upto 5.8 Years)||98
6794251|NCT01336621|7725641|FG000|COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||0
6794252|NCT01336621|7725641|FG000|NOT COMPLETED|Primary Reporting Phase (Upto 5.8 Years)||98
6794253|NCT01336621|7725641|FG000|STARTED|SFUCP (up to 2.6 Years)||9
6794254|NCT01336621|7725641|FG000|COMPLETED|SFUCP (up to 2.6 Years)||0
6794255|NCT01336621|7725641|FG000|NOT COMPLETED|SFUCP (up to 2.6 Years)||9
6794318|NCT02959944|7725737|FG000|NOT COMPLETED|Overall Study||0
6794319|NCT02959944|7725738|FG001|NOT COMPLETED|Overall Study||0
6794320|NCT02903823|7725744|FG000|STARTED|Overall Study|First subject enrollment|27
6794321|NCT02903823|7725744|FG000|COMPLETED|Overall Study||20
6794322|NCT02903823|7725744|FG000|NOT COMPLETED|Overall Study||7
6794323|NCT02666183|7725752|FG000|STARTED|Overall Study||137
6794324|NCT02666183|7725753|FG001|STARTED|Overall Study||141
6379385|NCT00772889|7290085|FG001|COMPLETED|Overall Study||375
6379386|NCT00772889|7290086|FG002|COMPLETED|Overall Study||187
6379387|NCT00772889|7290084|FG000|NOT COMPLETED|Overall Study||22
6379388|NCT00772889|7290085|FG001|NOT COMPLETED|Overall Study||18
6379389|NCT00772889|7290086|FG002|NOT COMPLETED|Overall Study||16
6379390|NCT00772915|7290094|FG000|STARTED|Overall Study||38
6379391|NCT00772915|7290094|FG000|COMPLETED|Overall Study||23
6379392|NCT00772915|7290094|FG000|NOT COMPLETED|Overall Study||15
6379393|NCT00772928|7290100|FG000|STARTED|Overall Study||587
6379394|NCT00772928|7290101|FG001|STARTED|Overall Study||579
6379395|NCT00772928|7290100|FG000|COMPLETED|Overall Study||543
6379396|NCT00772928|7290101|FG001|COMPLETED|Overall Study||538
6379397|NCT00772928|7290100|FG000|NOT COMPLETED|Overall Study||44
6379398|NCT00772928|7290101|FG001|NOT COMPLETED|Overall Study||41
6379399|NCT00772941|7290107|FG000|STARTED|Overall Study||3939
6379400|NCT00772941|7290107|FG000|COMPLETED|Overall Study||3257
6379401|NCT00772941|7290107|FG000|NOT COMPLETED|Overall Study||682
6379402|NCT00772954|7290137|FG000|STARTED|Overall Study||12
6379403|NCT00772954|7290138|FG001|STARTED|Overall Study||12
6379404|NCT00772954|7290139|FG002|STARTED|Overall Study||12
6379405|NCT00772954|7290137|FG000|COMPLETED|Overall Study||12
6379406|NCT00772954|7290138|FG001|COMPLETED|Overall Study||12
6379407|NCT00772954|7290139|FG002|COMPLETED|Overall Study||11
6379408|NCT00772954|7290137|FG000|NOT COMPLETED|Overall Study||0
6379409|NCT00772954|7290138|FG001|NOT COMPLETED|Overall Study||0
6379410|NCT00772954|7290139|FG002|NOT COMPLETED|Overall Study||1
6379411|NCT00772967|7290147|FG000|STARTED|Crossover Treatment 1||3
6379412|NCT00772967|7290148|FG001|STARTED|Crossover Treatment 1||5
6379413|NCT00772967|7290149|FG002|STARTED|Crossover Treatment 1||3
6379414|NCT00772967|7290150|FG003|STARTED|Crossover Treatment 1||4
6379415|NCT00772967|7290151|FG004|STARTED|Crossover Treatment 1||4
6379416|NCT00772967|7290152|FG005|STARTED|Crossover Treatment 1||3
6379417|NCT00772967|7290147|FG000|COMPLETED|Crossover Treatment 1||3
6379418|NCT00772967|7290148|FG001|COMPLETED|Crossover Treatment 1||5
6379419|NCT00772967|7290149|FG002|COMPLETED|Crossover Treatment 1||3
6379420|NCT00772967|7290150|FG003|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
6379421|NCT00772967|7290151|FG004|COMPLETED|Crossover Treatment 1||4
6379422|NCT00772967|7290152|FG005|COMPLETED|Crossover Treatment 1||3
6379423|NCT00772967|7290147|FG000|NOT COMPLETED|Crossover Treatment 1||0
6379424|NCT00772967|7290148|FG001|NOT COMPLETED|Crossover Treatment 1||0
6379425|NCT00772967|7290149|FG002|NOT COMPLETED|Crossover Treatment 1||0
6794325|NCT02666183|7725754|FG002|STARTED|Overall Study||119
6794326|NCT02666183|7725752|FG000|COMPLETED|Overall Study||103
6794327|NCT02666183|7725753|FG001|COMPLETED|Overall Study||106
6794328|NCT02666183|7725754|FG002|COMPLETED|Overall Study||93
6794329|NCT02666183|7725752|FG000|NOT COMPLETED|Overall Study||34
6794330|NCT02666183|7725753|FG001|NOT COMPLETED|Overall Study||35
6794331|NCT02666183|7725754|FG002|NOT COMPLETED|Overall Study||26
6379426|NCT00772967|7290150|FG003|NOT COMPLETED|Crossover Treatment 1||1
6379427|NCT00772967|7290151|FG004|NOT COMPLETED|Crossover Treatment 1||0
6379428|NCT00772967|7290152|FG005|NOT COMPLETED|Crossover Treatment 1||0
6379429|NCT00772967|7290147|FG000|STARTED|Break 1 (4-7 Days)||3
6379430|NCT00772967|7290148|FG001|STARTED|Break 1 (4-7 Days)||5
6379431|NCT00772967|7290149|FG002|STARTED|Break 1 (4-7 Days)||3
6379432|NCT00772967|7290150|FG003|STARTED|Break 1 (4-7 Days)||3
6563604|NCT01807520|7486478|FG000|COMPLETED|Treatment Period 2 (16-132 Weeks)||38
6563605|NCT01807520|7486479|FG001|COMPLETED|Treatment Period 2 (16-132 Weeks)||47
6563606|NCT01807520|7486480|FG002|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6794332|NCT01547117|7725766|FG000|STARTED|Overall Study||12
6794333|NCT01547117|7725767|FG001|STARTED|Overall Study||5
6794334|NCT01547117|7725768|FG002|STARTED|Overall Study||10
6794335|NCT01547117|7725769|FG003|STARTED|Overall Study||11
6794336|NCT01547117|7725766|FG000|Phase 1 Baseline Labs|Overall Study||12
6794337|NCT01547117|7725767|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
6794338|NCT01547117|7725768|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
6794339|NCT01547117|7725769|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
6794340|NCT01547117|7725766|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
6794341|NCT01547117|7725767|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
6794342|NCT01547117|7725768|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
6794343|NCT01547117|7725769|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
6794344|NCT01547117|7725766|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
6794345|NCT01547117|7725767|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
6794346|NCT01547117|7725768|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
6794347|NCT01547117|7725769|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
6794348|NCT01547117|7725766|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
6794349|NCT01547117|7725767|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators..|2
6794350|NCT01547117|7725768|FG002|Phase 1-finish|Overall Study||8
6794351|NCT01547117|7725769|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
6794352|NCT01547117|7725766|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
6794353|NCT01547117|7725767|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
6794354|NCT01547117|7725768|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
6794355|NCT01547117|7725769|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
6794356|NCT01547117|7725766|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
6794357|NCT01547117|7725767|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
6794358|NCT01547117|7725768|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
6794359|NCT01547117|7725769|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
6794360|NCT01547117|7725766|FG000|Phase 2-finish|Overall Study||11
6794361|NCT01547117|7725767|FG001|Phase 2-finish|Overall Study||2
6794362|NCT01547117|7725768|FG002|Phase 2-finish|Overall Study||8
6794363|NCT01547117|7725769|FG003|Phase 2-finish|Overall Study||6
6794364|NCT01547117|7725766|FG000|COMPLETED|Overall Study||11
6563607|NCT01807520|7486481|FG003|COMPLETED|Treatment Period 2 (16-132 Weeks)||22
6794365|NCT01547117|7725767|FG001|COMPLETED|Overall Study||2
6794366|NCT01547117|7725768|FG002|COMPLETED|Overall Study||8
6794367|NCT01547117|7725769|FG003|COMPLETED|Overall Study||6
6794368|NCT01547117|7725766|FG000|NOT COMPLETED|Overall Study||1
6563608|NCT01807520|7486482|FG004|COMPLETED|Treatment Period 2 (16-132 Weeks)||24
6794369|NCT01547117|7725767|FG001|NOT COMPLETED|Overall Study||3
6794370|NCT01547117|7725768|FG002|NOT COMPLETED|Overall Study||2
6794371|NCT01547117|7725769|FG003|NOT COMPLETED|Overall Study||5
6794372|NCT01431508|7725795|FG000|STARTED|Overall Study||15
6794373|NCT01431508|7725795|FG000|COMPLETED|Overall Study||13
6794374|NCT01431508|7725795|FG000|NOT COMPLETED|Overall Study||2
6794375|NCT00871351|7725802|FG000|STARTED|Overall Study||47
6794376|NCT00871351|7725803|FG001|STARTED|Overall Study||46
6794377|NCT00871351|7725804|FG002|STARTED|Overall Study||32
6794378|NCT00871351|7725802|FG000|COMPLETED|Overall Study||43
6794379|NCT00871351|7725803|FG001|COMPLETED|Overall Study||45
6794380|NCT00871351|7725804|FG002|COMPLETED|Overall Study||32
6794381|NCT00871351|7725802|FG000|NOT COMPLETED|Overall Study||4
6794382|NCT00871351|7725803|FG001|NOT COMPLETED|Overall Study||1
6379433|NCT00772967|7290151|FG004|STARTED|Break 1 (4-7 Days)||4
6379434|NCT00772967|7290152|FG005|STARTED|Break 1 (4-7 Days)||3
6379435|NCT00772967|7290147|FG000|COMPLETED|Break 1 (4-7 Days)||3
6379436|NCT00772967|7290148|FG001|COMPLETED|Break 1 (4-7 Days)||4
6379437|NCT00772967|7290149|FG002|COMPLETED|Break 1 (4-7 Days)||3
6379438|NCT00772967|7290150|FG003|COMPLETED|Break 1 (4-7 Days)||3
6379439|NCT00772967|7290151|FG004|COMPLETED|Break 1 (4-7 Days)||4
6379440|NCT00772967|7290152|FG005|COMPLETED|Break 1 (4-7 Days)||3
6379441|NCT00772967|7290147|FG000|NOT COMPLETED|Break 1 (4-7 Days)||0
6379442|NCT00772967|7290148|FG001|NOT COMPLETED|Break 1 (4-7 Days)||1
6379443|NCT00772967|7290149|FG002|NOT COMPLETED|Break 1 (4-7 Days)||0
6379444|NCT00772967|7290150|FG003|NOT COMPLETED|Break 1 (4-7 Days)||0
6379445|NCT00772967|7290151|FG004|NOT COMPLETED|Break 1 (4-7 Days)||0
6379446|NCT00772967|7290152|FG005|NOT COMPLETED|Break 1 (4-7 Days)||0
6379447|NCT00772967|7290147|FG000|STARTED|Crossover Treatment 2||3
6379448|NCT00772967|7290148|FG001|STARTED|Crossover Treatment 2||4
6379449|NCT00772967|7290149|FG002|STARTED|Crossover Treatment 2||3
6379450|NCT00772967|7290150|FG003|STARTED|Crossover Treatment 2||3
6794383|NCT00871351|7725804|FG002|NOT COMPLETED|Overall Study||0
6794384|NCT00832455|7725812|FG000|STARTED|Overall Study|445 - number of patients that signed the informed consent form (Safety population)|445
6794385|NCT00832455|7725812|FG000|Baseline|Overall Study|420 -patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
6794386|NCT00832455|7725812|FG000|Week 4|Overall Study||411
6794387|NCT00832455|7725812|FG000|Week 8 (Optional)|Overall Study||247
6794388|NCT00832455|7725812|FG000|Week 12|Overall Study||373
6794389|NCT00832455|7725812|FG000|COMPLETED|Overall Study||373
6379451|NCT00772967|7290151|FG004|STARTED|Crossover Treatment 2||4
6379452|NCT00772967|7290152|FG005|STARTED|Crossover Treatment 2||3
6379453|NCT00772967|7290147|FG000|COMPLETED|Crossover Treatment 2||3
6794390|NCT00832455|7725812|FG000|NOT COMPLETED|Overall Study||72
6794391|NCT00812006|7725828|FG000|STARTED|Overall Study||36
6563609|NCT01807520|7486483|FG005|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6563610|NCT01807520|7486484|FG006|COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6563611|NCT01807520|7486478|FG000|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||25
6563612|NCT01807520|7486479|FG001|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||18
6794392|NCT00812006|7725829|FG001|STARTED|Overall Study||36
6794393|NCT00812006|7725830|FG002|STARTED|Overall Study||36
6794394|NCT00812006|7725828|FG000|COMPLETED|Overall Study||30
6794395|NCT00812006|7725829|FG001|COMPLETED|Overall Study||33
6794396|NCT00812006|7725830|FG002|COMPLETED|Overall Study||30
6794397|NCT00812006|7725828|FG000|NOT COMPLETED|Overall Study||6
6794398|NCT00812006|7725829|FG001|NOT COMPLETED|Overall Study||3
6794399|NCT00812006|7725830|FG002|NOT COMPLETED|Overall Study||6
6794400|NCT00739050|7725836|FG000|STARTED|Overall Study||4
6794401|NCT00739050|7725837|FG001|STARTED|Overall Study||0
6794402|NCT00739050|7725836|FG000|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
6794403|NCT00739050|7725837|FG001|COMPLETED|Overall Study||0
6794404|NCT00739050|7725836|FG000|NOT COMPLETED|Overall Study||1
6794405|NCT00739050|7725837|FG001|NOT COMPLETED|Overall Study||0
6794406|NCT00687531|7725843|FG000|STARTED|Overall Study|Completed screening procedures|385
6794407|NCT00687531|7725843|FG000|RECEIVED TREATMENT|Overall Study||281
6794408|NCT00687531|7725843|FG000|COMPLETED|Overall Study||250
6794409|NCT00687531|7725843|FG000|NOT COMPLETED|Overall Study||135
6794410|NCT00654628|7725847|FG000|STARTED|6-week Active Treatment Period||173
6794411|NCT00654628|7725847|FG000|COMPLETED|6-week Active Treatment Period||152
6794412|NCT00654628|7725847|FG000|NOT COMPLETED|6-week Active Treatment Period||21
6794413|NCT00654628|7725847|FG000|STARTED|6 -Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
6794414|NCT00654628|7725847|FG000|COMPLETED|6 -Week Extension Period (Single Site)||55
6794415|NCT00654628|7725847|FG000|NOT COMPLETED|6 -Week Extension Period (Single Site)||5
6794416|NCT00604812|7725854|FG000|STARTED|Overall Study||9
6794417|NCT00604812|7725855|FG001|STARTED|Overall Study||3
6794418|NCT00604812|7725856|FG002|STARTED|Overall Study||10
6794419|NCT00604812|7725857|FG003|STARTED|Overall Study||3
6794420|NCT00604812|7725858|FG004|STARTED|Overall Study||5
6794421|NCT00604812|7725859|FG005|STARTED|Overall Study||1
6794422|NCT00604812|7725854|FG000|COMPLETED|Overall Study||9
6794423|NCT00604812|7725855|FG001|COMPLETED|Overall Study||3
6794424|NCT00604812|7725856|FG002|COMPLETED|Overall Study||10
6794425|NCT00604812|7725857|FG003|COMPLETED|Overall Study||3
6794426|NCT00604812|7725858|FG004|COMPLETED|Overall Study||5
6794427|NCT00604812|7725859|FG005|COMPLETED|Overall Study||1
6794428|NCT00604812|7725854|FG000|NOT COMPLETED|Overall Study||0
6794429|NCT00604812|7725855|FG001|NOT COMPLETED|Overall Study||0
6794430|NCT00604812|7725856|FG002|NOT COMPLETED|Overall Study||0
6794431|NCT00604812|7725857|FG003|NOT COMPLETED|Overall Study||0
6794432|NCT00604812|7725858|FG004|NOT COMPLETED|Overall Study||0
6794433|NCT00604812|7725859|FG005|NOT COMPLETED|Overall Study||0
6794434|NCT00536380|7725873|FG000|STARTED|Overall Study||106
6794435|NCT00536380|7725874|FG001|STARTED|Overall Study||104
6794436|NCT00536380|7725875|FG002|STARTED|Overall Study||104
6794437|NCT00536380|7725873|FG000|COMPLETED|Overall Study||94
6794438|NCT00536380|7725874|FG001|COMPLETED|Overall Study||95
6794439|NCT00536380|7725875|FG002|COMPLETED|Overall Study||94
6794440|NCT00536380|7725873|FG000|NOT COMPLETED|Overall Study||12
6794441|NCT00536380|7725874|FG001|NOT COMPLETED|Overall Study||9
6794442|NCT00536380|7725875|FG002|NOT COMPLETED|Overall Study||10
6794443|NCT00521599|7725886|FG000|STARTED|Overall Study||268
6794444|NCT00521599|7725887|FG001|STARTED|Overall Study||268
6794445|NCT00521599|7725888|FG002|STARTED|Overall Study||136
6794446|NCT00521599|7725886|FG000|COMPLETED|Overall Study||243
6794447|NCT00521599|7725887|FG001|COMPLETED|Overall Study||239
6794448|NCT00521599|7725888|FG002|COMPLETED|Overall Study||100
6794449|NCT00521599|7725886|FG000|NOT COMPLETED|Overall Study||25
6794450|NCT00521599|7725887|FG001|NOT COMPLETED|Overall Study||29
6794451|NCT00521599|7725888|FG002|NOT COMPLETED|Overall Study||36
6794452|NCT00496834|7725899|FG000|STARTED|Overall Study||101
6794453|NCT00496834|7725900|FG001|STARTED|Overall Study||100
6794454|NCT00496834|7725899|FG000|COMPLETED|Overall Study||83
6794455|NCT00496834|7725900|FG001|COMPLETED|Overall Study||87
6794456|NCT00496834|7725899|FG000|NOT COMPLETED|Overall Study||18
6794457|NCT00496834|7725900|FG001|NOT COMPLETED|Overall Study||13
6794458|NCT00442897|7725910|FG000|STARTED|Base Study (12 Week Follow-up)||118
6794459|NCT00442897|7725911|FG001|STARTED|Base Study (12 Week Follow-up)||111
6794460|NCT00442897|7725910|FG000|COMPLETED|Base Study (12 Week Follow-up)||101
6794461|NCT00442897|7725911|FG001|COMPLETED|Base Study (12 Week Follow-up)||99
6794462|NCT00442897|7725910|FG000|NOT COMPLETED|Base Study (12 Week Follow-up)||17
6794463|NCT00442897|7725911|FG001|NOT COMPLETED|Base Study (12 Week Follow-up)||12
6794464|NCT00442897|7725910|FG000|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
6794465|NCT00442897|7725911|FG001|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
6794466|NCT00442897|7725910|FG000|COMPLETED|24 Weeks Follow-up (3 Centers)||29
6794467|NCT00442897|7725911|FG001|COMPLETED|24 Weeks Follow-up (3 Centers)||28
6794468|NCT00442897|7725910|FG000|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
6794469|NCT00442897|7725911|FG001|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
6794470|NCT00423579|7725919|FG000|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
6794471|NCT00423579|7725920|FG001|STARTED|Overall Study||60
6794472|NCT00423579|7725919|FG000|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
6794473|NCT00423579|7725920|FG001|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
6794474|NCT00423579|7725919|FG000|NOT COMPLETED|Overall Study||4
6794475|NCT00423579|7725920|FG001|NOT COMPLETED|Overall Study||4
6794476|NCT00394355|7725930|FG000|STARTED|Overall Study||140
6794477|NCT00394355|7725931|FG001|STARTED|Overall Study||137
6794478|NCT00394355|7725932|FG002|STARTED|Overall Study||147
6794479|NCT00394355|7725933|FG003|STARTED|Overall Study||142
6794480|NCT00394355|7725930|FG000|COMPLETED|Overall Study||105
6794481|NCT00394355|7725931|FG001|COMPLETED|Overall Study||103
6794482|NCT00394355|7725932|FG002|COMPLETED|Overall Study||109
6794483|NCT00394355|7725933|FG003|COMPLETED|Overall Study||111
6794484|NCT00394355|7725930|FG000|NOT COMPLETED|Overall Study||35
6794485|NCT00394355|7725931|FG001|NOT COMPLETED|Overall Study||34
6794486|NCT00394355|7725932|FG002|NOT COMPLETED|Overall Study||38
6794487|NCT00394355|7725933|FG003|NOT COMPLETED|Overall Study||31
6794488|NCT00359216|7725945|FG000|STARTED|Overall Study||20
6794489|NCT00359216|7725946|FG001|STARTED|Overall Study||10
6794490|NCT00359216|7725945|FG000|COMPLETED|Overall Study||20
6794491|NCT00359216|7725946|FG001|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
6794492|NCT00359216|7725945|FG000|NOT COMPLETED|Overall Study||0
6794493|NCT00359216|7725946|FG001|NOT COMPLETED|Overall Study||1
6794494|NCT00166504|7725954|FG000|STARTED|Overall Study||108
6794495|NCT00166504|7725955|FG001|STARTED|Overall Study||95
6794496|NCT00166504|7725954|FG000|COMPLETED|Overall Study||103
6794497|NCT00166504|7725955|FG001|COMPLETED|Overall Study||91
6794498|NCT00166504|7725954|FG000|NOT COMPLETED|Overall Study||5
6794499|NCT00166504|7725955|FG001|NOT COMPLETED|Overall Study||4
6379454|NCT00772967|7290148|FG001|COMPLETED|Crossover Treatment 2||4
6379455|NCT00772967|7290149|FG002|COMPLETED|Crossover Treatment 2||3
6379456|NCT00772967|7290150|FG003|COMPLETED|Crossover Treatment 2||3
6379457|NCT00772967|7290151|FG004|COMPLETED|Crossover Treatment 2||4
6379458|NCT00772967|7290152|FG005|COMPLETED|Crossover Treatment 2||3
6379459|NCT00772967|7290147|FG000|NOT COMPLETED|Crossover Treatment 2||0
6502319|NCT01433991|7420968|FG002|COMPLETED|Treatment Phase (Combination Agent)||8
6502320|NCT01433991|7420969|FG003|COMPLETED|Treatment Phase (Combination Agent)||2
6502321|NCT01433991|7420966|FG000|NOT COMPLETED|Treatment Phase (Combination Agent)||2
6379460|NCT00772967|7290148|FG001|NOT COMPLETED|Crossover Treatment 2||0
6794500|NCT01345240|7725966|FG000|STARTED|Overall Study||142
6794501|NCT01345240|7725967|FG001|STARTED|Overall Study||142
6794502|NCT01345240|7725968|FG002|STARTED|Overall Study||141
6794503|NCT01345240|7725969|FG003|STARTED|Overall Study||141
6794504|NCT01345240|7725970|FG004|STARTED|Overall Study||139
6794505|NCT01345240|7725966|FG000|COMPLETED|Overall Study||131
6794506|NCT01345240|7725967|FG001|COMPLETED|Overall Study||128
6794507|NCT01345240|7725968|FG002|COMPLETED|Overall Study||123
6794508|NCT01345240|7725969|FG003|COMPLETED|Overall Study||132
6794509|NCT01345240|7725970|FG004|COMPLETED|Overall Study||129
6794510|NCT01345240|7725966|FG000|NOT COMPLETED|Overall Study||11
6794511|NCT01345240|7725967|FG001|NOT COMPLETED|Overall Study||14
6563613|NCT01807520|7486480|FG002|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6563614|NCT01807520|7486481|FG003|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||7
6563615|NCT01807520|7486482|FG004|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||5
6794512|NCT01345240|7725968|FG002|NOT COMPLETED|Overall Study||18
6794513|NCT01345240|7725969|FG003|NOT COMPLETED|Overall Study||9
6794514|NCT01345240|7725970|FG004|NOT COMPLETED|Overall Study||10
6379461|NCT00772967|7290149|FG002|NOT COMPLETED|Crossover Treatment 2||0
6379462|NCT00772967|7290150|FG003|NOT COMPLETED|Crossover Treatment 2||0
6379463|NCT00772967|7290151|FG004|NOT COMPLETED|Crossover Treatment 2||0
6379464|NCT00772967|7290152|FG005|NOT COMPLETED|Crossover Treatment 2||0
6379465|NCT00772967|7290147|FG000|STARTED|Break 2 (4-7 Days)||3
6379466|NCT00772967|7290148|FG001|STARTED|Break 2 (4-7 Days)||4
6379467|NCT00772967|7290149|FG002|STARTED|Break 2 (4-7 Days)||3
6379468|NCT00772967|7290150|FG003|STARTED|Break 2 (4-7 Days)||3
6379469|NCT00772967|7290151|FG004|STARTED|Break 2 (4-7 Days)||4
6379470|NCT00772967|7290152|FG005|STARTED|Break 2 (4-7 Days)||3
6379471|NCT00772967|7290147|FG000|COMPLETED|Break 2 (4-7 Days)||3
6379472|NCT00772967|7290148|FG001|COMPLETED|Break 2 (4-7 Days)||4
6379473|NCT00772967|7290149|FG002|COMPLETED|Break 2 (4-7 Days)||3
6379474|NCT00772967|7290150|FG003|COMPLETED|Break 2 (4-7 Days)||3
6379475|NCT00772967|7290151|FG004|COMPLETED|Break 2 (4-7 Days)||4
6379476|NCT00772967|7290152|FG005|COMPLETED|Break 2 (4-7 Days)||3
6379477|NCT00772967|7290147|FG000|NOT COMPLETED|Break 2 (4-7 Days)||0
6379478|NCT00772967|7290148|FG001|NOT COMPLETED|Break 2 (4-7 Days)||0
6379479|NCT00772967|7290149|FG002|NOT COMPLETED|Break 2 (4-7 Days)||0
6379480|NCT00772967|7290150|FG003|NOT COMPLETED|Break 2 (4-7 Days)||0
6379481|NCT00772967|7290151|FG004|NOT COMPLETED|Break 2 (4-7 Days)||0
6379482|NCT00772967|7290152|FG005|NOT COMPLETED|Break 2 (4-7 Days)||0
6379483|NCT00772967|7290147|FG000|STARTED|Crossover Treatment 3||3
6379484|NCT00772967|7290148|FG001|STARTED|Crossover Treatment 3||4
6379485|NCT00772967|7290149|FG002|STARTED|Crossover Treatment 3||3
6379486|NCT00772967|7290150|FG003|STARTED|Crossover Treatment 3||3
6379487|NCT00772967|7290151|FG004|STARTED|Crossover Treatment 3||4
6379488|NCT00772967|7290152|FG005|STARTED|Crossover Treatment 3||3
6379489|NCT00772967|7290147|FG000|COMPLETED|Crossover Treatment 3||3
6379490|NCT00772967|7290148|FG001|COMPLETED|Crossover Treatment 3||4
6379491|NCT00772967|7290149|FG002|COMPLETED|Crossover Treatment 3||3
6379492|NCT00772967|7290150|FG003|COMPLETED|Crossover Treatment 3||3
6379493|NCT00772967|7290151|FG004|COMPLETED|Crossover Treatment 3||3
6379494|NCT00772967|7290152|FG005|COMPLETED|Crossover Treatment 3||3
6379495|NCT00772967|7290147|FG000|NOT COMPLETED|Crossover Treatment 3||0
6379496|NCT00772967|7290148|FG001|NOT COMPLETED|Crossover Treatment 3||0
6379497|NCT00772967|7290149|FG002|NOT COMPLETED|Crossover Treatment 3||0
6379498|NCT00772967|7290150|FG003|NOT COMPLETED|Crossover Treatment 3||0
6379499|NCT00772967|7290151|FG004|NOT COMPLETED|Crossover Treatment 3||1
6379500|NCT00772967|7290152|FG005|NOT COMPLETED|Crossover Treatment 3||0
6379501|NCT00773097|7290160|FG000|STARTED|Overall Study||46
6379502|NCT00773097|7290160|FG000|COMPLETED|Overall Study||39
6379503|NCT00773097|7290160|FG000|NOT COMPLETED|Overall Study||7
6379504|NCT00773136|7290164|FG000|STARTED|Overall Study||21
6379505|NCT00773136|7290164|FG000|COMPLETED|Overall Study||19
6379506|NCT00773136|7290164|FG000|NOT COMPLETED|Overall Study||2
6794515|NCT01371305|7725997|FG000|STARTED|Overall Study||6
6794516|NCT01371305|7725998|FG001|STARTED|Overall Study||6
6794517|NCT01371305|7725999|FG002|STARTED|Overall Study||6
6794518|NCT01371305|7726000|FG003|STARTED|Overall Study||7
6794519|NCT01371305|7726001|FG004|STARTED|Overall Study||6
6794520|NCT01371305|7726002|FG005|STARTED|Overall Study||10
6794521|NCT01371305|7725997|FG000|COMPLETED|Overall Study||6
6794522|NCT01371305|7725998|FG001|COMPLETED|Overall Study||6
6794523|NCT01371305|7725999|FG002|COMPLETED|Overall Study||6
6794524|NCT01371305|7726000|FG003|COMPLETED|Overall Study||5
6794525|NCT01371305|7726001|FG004|COMPLETED|Overall Study||2
6794526|NCT01371305|7726002|FG005|COMPLETED|Overall Study||8
6794527|NCT01371305|7725997|FG000|NOT COMPLETED|Overall Study||0
6794528|NCT01371305|7725998|FG001|NOT COMPLETED|Overall Study||0
6794529|NCT01371305|7725999|FG002|NOT COMPLETED|Overall Study||0
6794530|NCT01371305|7726000|FG003|NOT COMPLETED|Overall Study||2
6794531|NCT01371305|7726001|FG004|NOT COMPLETED|Overall Study||4
6794532|NCT01371305|7726002|FG005|NOT COMPLETED|Overall Study||2
6794533|NCT01376323|7726022|FG000|STARTED|Overall Study||20
6794534|NCT01376323|7726023|FG001|STARTED|Overall Study||18
6794535|NCT01376323|7726024|FG002|STARTED|Overall Study||19
6794536|NCT01376323|7726025|FG003|STARTED|Overall Study||19
6794537|NCT01376323|7726026|FG004|STARTED|Overall Study||18
6794538|NCT01376323|7726022|FG000|COMPLETED|Overall Study||18
6794539|NCT01376323|7726023|FG001|COMPLETED|Overall Study||17
6794540|NCT01376323|7726024|FG002|COMPLETED|Overall Study||16
6794541|NCT01376323|7726025|FG003|COMPLETED|Overall Study||14
6794542|NCT01376323|7726026|FG004|COMPLETED|Overall Study||17
6794543|NCT01376323|7726022|FG000|NOT COMPLETED|Overall Study||2
6794544|NCT01376323|7726023|FG001|NOT COMPLETED|Overall Study||1
6794545|NCT01376323|7726024|FG002|NOT COMPLETED|Overall Study||3
6794546|NCT01376323|7726025|FG003|NOT COMPLETED|Overall Study||5
6794547|NCT01376323|7726026|FG004|NOT COMPLETED|Overall Study||1
6794548|NCT01386658|7726050|FG000|STARTED|Initial Icatibant Exposure||11
6794549|NCT01386658|7726051|FG001|STARTED|Initial Icatibant Exposure||21
6794550|NCT01386658|7726050|FG000|COMPLETED|Initial Icatibant Exposure||11
6794551|NCT01386658|7726051|FG001|COMPLETED|Initial Icatibant Exposure||9
6794552|NCT01386658|7726050|FG000|NOT COMPLETED|Initial Icatibant Exposure||0
6794553|NCT01386658|7726051|FG001|NOT COMPLETED|Initial Icatibant Exposure||12
6794554|NCT01386658|7726050|FG000|STARTED|Icatibant Exposure 2||0
6794555|NCT01386658|7726051|FG001|STARTED|Icatibant Exposure 2||9
6794556|NCT01386658|7726050|FG000|COMPLETED|Icatibant Exposure 2||0
6794557|NCT01386658|7726051|FG001|COMPLETED|Icatibant Exposure 2||9
6794558|NCT01386658|7726050|FG000|NOT COMPLETED|Icatibant Exposure 2||0
6794559|NCT01386658|7726051|FG001|NOT COMPLETED|Icatibant Exposure 2||0
6794560|NCT01386658|7726050|FG000|STARTED|Icatibant Exposure 3||0
6794561|NCT01386658|7726051|FG001|STARTED|Icatibant Exposure 3||9
6794562|NCT01386658|7726050|FG000|COMPLETED|Icatibant Exposure 3||0
6794563|NCT01386658|7726051|FG001|COMPLETED|Icatibant Exposure 3||9
6794564|NCT01386658|7726050|FG000|NOT COMPLETED|Icatibant Exposure 3||0
6794565|NCT01386658|7726051|FG001|NOT COMPLETED|Icatibant Exposure 3||0
6794566|NCT01386684|7726061|FG000|STARTED|Overall Study||552
6794567|NCT01386684|7726061|FG000|COMPLETED|Overall Study||259
6794568|NCT01386684|7726061|FG000|NOT COMPLETED|Overall Study||293
6794569|NCT04980014|7726065|FG000|STARTED|Overall Study||730
6794570|NCT04980014|7726065|FG000|Safety Analysis Set|Overall Study||655
6794571|NCT04980014|7726065|FG000|Effectiveness Analysis Set|Overall Study||482
6794572|NCT04980014|7726065|FG000|COMPLETED|Overall Study||655
6794573|NCT04980014|7726065|FG000|NOT COMPLETED|Overall Study||75
6794574|NCT04503603|7726071|FG000|STARTED|Overall Study||9
6794575|NCT04503603|7726072|FG001|STARTED|Overall Study||3
6794576|NCT04503603|7726071|FG000|COMPLETED|Overall Study||9
6794577|NCT04503603|7726072|FG001|COMPLETED|Overall Study||3
6794578|NCT04503603|7726071|FG000|NOT COMPLETED|Overall Study||0
6794579|NCT04503603|7726072|FG001|NOT COMPLETED|Overall Study||0
6794580|NCT04454918|7726078|FG000|STARTED|Treatment Period 1 (Day 1)||6
6794581|NCT04454918|7726078|FG000|COMPLETED|Treatment Period 1 (Day 1)||6
6794582|NCT04454918|7726078|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6794583|NCT04454918|7726078|FG000|STARTED|Washout Period (Day 2 to 8)||6
6794584|NCT04454918|7726078|FG000|COMPLETED|Washout Period (Day 2 to 8)||6
6794585|NCT04454918|7726078|FG000|NOT COMPLETED|Washout Period (Day 2 to 8)||0
6794586|NCT04454918|7726078|FG000|STARTED|Treatment Period 2(Day9[Day1of Period2])||6
6794587|NCT04454918|7726078|FG000|COMPLETED|Treatment Period 2(Day9[Day1of Period2])||6
6794588|NCT04454918|7726078|FG000|NOT COMPLETED|Treatment Period 2(Day9[Day1of Period2])||0
6794589|NCT04427501|7726096|FG000|STARTED|Overall Study||156
6794590|NCT04427501|7726097|FG001|STARTED|Overall Study||101
6794591|NCT04427501|7726098|FG002|STARTED|Overall Study||107
6379507|NCT00773175|7290171|FG000|STARTED|Overall Study||73
6379508|NCT00773175|7290172|FG001|STARTED|Overall Study||75
6794592|NCT04427501|7726099|FG003|STARTED|Overall Study||101
6794593|NCT04427501|7726100|FG004|STARTED|Overall Study||112
6794594|NCT04427501|7726101|FG005|STARTED|Overall Study|Participants in Placebo for Phase 3: 2800 mg Bamlanivimab + 2800 mg Etesevimab and Phase 3: 700 mg Bamlanivimab + 1400 mg Etesevimab were combined to avoid double counting.|776
6794595|NCT04427501|7726102|FG006|STARTED|Overall Study||518
6794596|NCT04427501|7726103|FG007|STARTED|Overall Study||513
6794597|NCT04427501|7726104|FG008|STARTED|Overall Study||141
6794598|NCT04427501|7726105|FG009|STARTED|Overall Study||213
6794599|NCT04427501|7726096|FG000|Received at Least One Dose of Study Drug|Overall Study||156
6794600|NCT04427501|7726097|FG001|Received at Least One Dose of Study Drug|Overall Study||101
6794601|NCT04427501|7726098|FG002|Received at Least One Dose of Study Drug|Overall Study||107
6794602|NCT04427501|7726099|FG003|Received at Least One Dose of Study Drug|Overall Study||101
6794603|NCT04427501|7726100|FG004|Received at Least One Dose of Study Drug|Overall Study||112
6794604|NCT04427501|7726101|FG005|Received at Least One Dose of Study Drug|Overall Study||776
6794605|NCT04427501|7726102|FG006|Received at Least One Dose of Study Drug|Overall Study||518
6794606|NCT04427501|7726103|FG007|Received at Least One Dose of Study Drug|Overall Study||513
6794607|NCT04427501|7726104|FG008|Received at Least One Dose of Study Drug|Overall Study||141
6794608|NCT04427501|7726105|FG009|Received at Least One Dose of Study Drug|Overall Study||213
6794609|NCT04427501|7726096|FG000|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794610|NCT04427501|7726097|FG001|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794611|NCT04427501|7726098|FG002|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794612|NCT04427501|7726099|FG003|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794613|NCT04427501|7726100|FG004|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794614|NCT04427501|7726101|FG005|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||517
6794615|NCT04427501|7726102|FG006|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794616|NCT04427501|7726103|FG007|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794617|NCT04427501|7726104|FG008|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794618|NCT04427501|7726105|FG009|Phase 3: Placebo For 2800 mg Bamlanivimab + 2800 mg Etesevimab|Overall Study||0
6794619|NCT04427501|7726096|FG000|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794620|NCT04427501|7726097|FG001|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794621|NCT04427501|7726098|FG002|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794622|NCT04427501|7726099|FG003|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794623|NCT04427501|7726100|FG004|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794624|NCT04427501|7726101|FG005|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||776
6794625|NCT04427501|7726102|FG006|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794626|NCT04427501|7726103|FG007|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794627|NCT04427501|7726104|FG008|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794628|NCT04427501|7726105|FG009|Phase 3: Placebo For 700 mg Bamlanivimab + 1400 mg Etesevimab|Overall Study||0
6794629|NCT04427501|7726096|FG000|COMPLETED|Overall Study||141
6794630|NCT04427501|7726097|FG001|COMPLETED|Overall Study||95
6794631|NCT04427501|7726098|FG002|COMPLETED|Overall Study||103
6794632|NCT04427501|7726099|FG003|COMPLETED|Overall Study||98
6794633|NCT04427501|7726100|FG004|COMPLETED|Overall Study||103
6794634|NCT04427501|7726101|FG005|COMPLETED|Overall Study||719
6794635|NCT04427501|7726102|FG006|COMPLETED|Overall Study||485
6794636|NCT04427501|7726103|FG007|COMPLETED|Overall Study||496
6794637|NCT04427501|7726104|FG008|COMPLETED|Overall Study||135
6794638|NCT04427501|7726105|FG009|COMPLETED|Overall Study||207
6794639|NCT04427501|7726096|FG000|NOT COMPLETED|Overall Study||15
6794640|NCT04427501|7726097|FG001|NOT COMPLETED|Overall Study||6
6794641|NCT04427501|7726098|FG002|NOT COMPLETED|Overall Study||4
6794642|NCT04427501|7726099|FG003|NOT COMPLETED|Overall Study||3
6794643|NCT04427501|7726100|FG004|NOT COMPLETED|Overall Study||9
6794644|NCT04427501|7726101|FG005|NOT COMPLETED|Overall Study||57
6794645|NCT04427501|7726102|FG006|NOT COMPLETED|Overall Study||33
6794646|NCT04427501|7726103|FG007|NOT COMPLETED|Overall Study||17
6794647|NCT04427501|7726104|FG008|NOT COMPLETED|Overall Study||6
6794648|NCT04427501|7726105|FG009|NOT COMPLETED|Overall Study||6
6563616|NCT01807520|7486483|FG005|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6563617|NCT01807520|7486484|FG006|NOT COMPLETED|Treatment Period 2 (16-132 Weeks)||0
6794649|NCT03735849|7726141|FG000|STARTED|Overall Study||11
6794650|NCT03735849|7726142|FG001|STARTED|Overall Study||13
6794651|NCT03735849|7726143|FG002|STARTED|Overall Study||4
6794652|NCT03735849|7726141|FG000|Safety Population|Overall Study||11
6794653|NCT03735849|7726142|FG001|Safety Population|Overall Study||13
6794654|NCT03735849|7726143|FG002|Safety Population|Overall Study||4
6794655|NCT03735849|7726141|FG000|COMPLETED|Overall Study||9
6794656|NCT03735849|7726142|FG001|COMPLETED|Overall Study||13
6794657|NCT03735849|7726143|FG002|COMPLETED|Overall Study||0
6794658|NCT03735849|7726141|FG000|NOT COMPLETED|Overall Study||2
6794659|NCT03735849|7726142|FG001|NOT COMPLETED|Overall Study||0
6794660|NCT03735849|7726143|FG002|NOT COMPLETED|Overall Study||4
6794661|NCT03552822|7726152|FG000|STARTED|Overall Study||112
6794662|NCT03552822|7726153|FG001|STARTED|Overall Study||429
6794663|NCT03552822|7726152|FG000|COMPLETED|Overall Study||112
6794664|NCT03552822|7726153|FG001|COMPLETED|Overall Study||429
6794665|NCT03552822|7726152|FG000|NOT COMPLETED|Overall Study||0
6794666|NCT03552822|7726153|FG001|NOT COMPLETED|Overall Study||0
6794667|NCT03552393|7726159|FG000|STARTED|Core Period||40
6794668|NCT03552393|7726159|FG000|COMPLETED|Core Period||38
6794669|NCT03552393|7726159|FG000|NOT COMPLETED|Core Period||2
6794670|NCT03552393|7726159|FG000|STARTED|Safety Extension Period||25
6794671|NCT03552393|7726159|FG000|COMPLETED|Safety Extension Period||21
6794672|NCT03552393|7726159|FG000|NOT COMPLETED|Safety Extension Period||4
6794673|NCT03412747|7726166|FG000|STARTED|Initial Treatment Period: Wk0-Wk16||161
6794674|NCT03412747|7726167|FG001|STARTED|Initial Treatment Period: Wk0-Wk16||158
6794675|NCT03412747|7726168|FG002|STARTED|Initial Treatment Period: Wk0-Wk16||159
6794676|NCT03412747|7726166|FG000|COMPLETED|Initial Treatment Period: Wk0-Wk16||154
6794677|NCT03412747|7726167|FG001|COMPLETED|Initial Treatment Period: Wk0-Wk16||153
6794678|NCT03412747|7726168|FG002|COMPLETED|Initial Treatment Period: Wk0-Wk16||150
6794679|NCT03412747|7726166|FG000|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||7
6794680|NCT03412747|7726167|FG001|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||5
6794681|NCT03412747|7726168|FG002|NOT COMPLETED|Initial Treatment Period: Wk0-Wk16||9
6794682|NCT03412747|7726166|FG000|STARTED|Maintenance Treatment Period: Wk16-Wk24||154
6794683|NCT03412747|7726167|FG001|STARTED|Maintenance Treatment Period: Wk16-Wk24||153
6794684|NCT03412747|7726168|FG002|STARTED|Maintenance Treatment Period: Wk16-Wk24||150
6794685|NCT03412747|7726166|FG000|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
6794686|NCT03412747|7726167|FG001|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||152
6794687|NCT03412747|7726168|FG002|COMPLETED|Maintenance Treatment Period: Wk16-Wk24||149
6794688|NCT03412747|7726166|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||5
6794689|NCT03412747|7726167|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
6794690|NCT03412747|7726168|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk16-Wk24||1
6794691|NCT03412747|7726166|FG000|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
6794692|NCT03412747|7726167|FG001|STARTED|Maintenance Treatment Period: Wk24-Wk56||152
6794693|NCT03412747|7726168|FG002|STARTED|Maintenance Treatment Period: Wk24-Wk56||149
6794694|NCT03412747|7726166|FG000|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
6794695|NCT03412747|7726167|FG001|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||143
6794696|NCT03412747|7726168|FG002|COMPLETED|Maintenance Treatment Period: Wk24-Wk56||133
6794697|NCT03412747|7726166|FG000|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||6
6794698|NCT03412747|7726167|FG001|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||9
6794699|NCT03412747|7726168|FG002|NOT COMPLETED|Maintenance Treatment Period: Wk24-Wk56||16
6794700|NCT03333382|7726188|FG000|STARTED|Overall Study||1
6794701|NCT03333382|7726189|FG001|STARTED|Overall Study||0
6563618|NCT01807520|7486478|FG000|STARTED|Follow-up Period (132-140 Weeks)||0
6563619|NCT01807520|7486479|FG001|STARTED|Follow-up Period (132-140 Weeks)||0
6794702|NCT03333382|7726188|FG000|COMPLETED|Overall Study||0
6794703|NCT03333382|7726189|FG001|COMPLETED|Overall Study||0
6794704|NCT03333382|7726188|FG000|NOT COMPLETED|Overall Study||1
6794705|NCT03333382|7726189|FG001|NOT COMPLETED|Overall Study||0
6794706|NCT03129321|7726198|FG000|STARTED|Overall Study||351
6794707|NCT03129321|7726199|FG001|STARTED|Overall Study||350
6794708|NCT03129321|7726200|FG002|STARTED|Overall Study||175
6794709|NCT03129321|7726198|FG000|COMPLETED|Overall Study||253
6794710|NCT03129321|7726199|FG001|COMPLETED|Overall Study||241
6794711|NCT03129321|7726200|FG002|COMPLETED|Overall Study||120
6794712|NCT03129321|7726198|FG000|NOT COMPLETED|Overall Study||98
6794713|NCT03129321|7726199|FG001|NOT COMPLETED|Overall Study||109
6794714|NCT03129321|7726200|FG002|NOT COMPLETED|Overall Study||55
6794715|NCT03107611|7726213|FG000|STARTED|Overall Study||217
6794716|NCT03107611|7726214|FG001|STARTED|Overall Study||216
6794717|NCT03107611|7726215|FG002|STARTED|Overall Study||221
6794718|NCT03107611|7726213|FG000|Dosed|Overall Study||215
6794719|NCT03107611|7726214|FG001|Dosed|Overall Study||214
6563620|NCT01807520|7486480|FG002|STARTED|Follow-up Period (132-140 Weeks)|These participants discontinued from Treatment Period 1.|2
6794720|NCT03107611|7726215|FG002|Dosed|Overall Study||220
6794721|NCT03107611|7726213|FG000|COMPLETED|Overall Study||210
6794722|NCT03107611|7726214|FG001|COMPLETED|Overall Study||212
6794723|NCT03107611|7726215|FG002|COMPLETED|Overall Study||212
6794724|NCT03107611|7726213|FG000|NOT COMPLETED|Overall Study||7
6794725|NCT03107611|7726214|FG001|NOT COMPLETED|Overall Study||4
6794726|NCT03107611|7726215|FG002|NOT COMPLETED|Overall Study||9
6794727|NCT02720016|7726226|FG000|STARTED|Overall Study||92
6794728|NCT02720016|7726227|FG001|STARTED|Overall Study||92
6794729|NCT02720016|7726228|FG002|STARTED|Overall Study||90
6563621|NCT01807520|7486481|FG003|STARTED|Follow-up Period (132-140 Weeks)||0
6794730|NCT02720016|7726226|FG000|Y1|Overall Study||26
6794731|NCT02720016|7726227|FG001|Y1|Overall Study||26
6794732|NCT02720016|7726228|FG002|Y1|Overall Study||28
6794733|NCT02720016|7726226|FG000|Y2|Overall Study||34
6794734|NCT02720016|7726227|FG001|Y2|Overall Study||32
6794735|NCT02720016|7726228|FG002|Y2|Overall Study||34
6794736|NCT02720016|7726226|FG000|Y3|Overall Study||28
6794737|NCT02720016|7726227|FG001|Y3|Overall Study||30
6794738|NCT02720016|7726228|FG002|Y3|Overall Study||24
6794739|NCT02720016|7726226|FG000|Y4|Overall Study||4
6794740|NCT02720016|7726227|FG001|Y4|Overall Study||4
6794741|NCT02720016|7726228|FG002|Y4|Overall Study||4
6794742|NCT02720016|7726226|FG000|Veteran Total|Overall Study||46
6794743|NCT02720016|7726227|FG001|Veteran Total|Overall Study||46
6794744|NCT02720016|7726228|FG002|Veteran Total|Overall Study||45
6794745|NCT02720016|7726226|FG000|Intimate Partner Total|Overall Study||46
6794746|NCT02720016|7726227|FG001|Intimate Partner Total|Overall Study||46
6794747|NCT02720016|7726228|FG002|Intimate Partner Total|Overall Study||45
6794748|NCT02720016|7726226|FG000|COMPLETED|Overall Study||72
6794749|NCT02720016|7726227|FG001|COMPLETED|Overall Study||72
6794750|NCT02720016|7726228|FG002|COMPLETED|Overall Study||70
6794751|NCT02720016|7726226|FG000|NOT COMPLETED|Overall Study||20
6794752|NCT02720016|7726227|FG001|NOT COMPLETED|Overall Study||20
6794753|NCT02720016|7726228|FG002|NOT COMPLETED|Overall Study||20
6794754|NCT02607956|7726239|FG000|STARTED|Double-Blinded Phase||327
6794755|NCT02607956|7726240|FG001|STARTED|Double-Blinded Phase||330
6794756|NCT02607956|7726241|FG002|STARTED|Double-Blinded Phase||0
6794757|NCT02607956|7726242|FG003|STARTED|Double-Blinded Phase||0
6794758|NCT02607956|7726239|FG000|COMPLETED|Double-Blinded Phase||266
6794759|NCT02607956|7726240|FG001|COMPLETED|Double-Blinded Phase||277
6794760|NCT02607956|7726241|FG002|COMPLETED|Double-Blinded Phase||0
6794761|NCT02607956|7726242|FG003|COMPLETED|Double-Blinded Phase||0
6794762|NCT02607956|7726239|FG000|NOT COMPLETED|Double-Blinded Phase||61
6794763|NCT02607956|7726240|FG001|NOT COMPLETED|Double-Blinded Phase||53
6794764|NCT02607956|7726241|FG002|NOT COMPLETED|Double-Blinded Phase||0
6794765|NCT02607956|7726242|FG003|NOT COMPLETED|Double-Blinded Phase||0
6794766|NCT02607956|7726239|FG000|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
6794767|NCT02607956|7726240|FG001|STARTED|Open-Label Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
6794768|NCT02607956|7726241|FG002|STARTED|Open-Label Extension Phase|66 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|254
6794769|NCT02607956|7726242|FG003|STARTED|Open-Label Extension Phase|60 participants from the Double-Blinded Phase did not enter the Open-Label Extension Phase.|265
6794770|NCT02607956|7726239|FG000|COMPLETED|Open-Label Extension Phase||0
6794771|NCT02607956|7726240|FG001|COMPLETED|Open-Label Extension Phase||0
6794772|NCT02607956|7726241|FG002|COMPLETED|Open-Label Extension Phase||225
6794773|NCT02607956|7726242|FG003|COMPLETED|Open-Label Extension Phase||235
6794774|NCT02607956|7726239|FG000|NOT COMPLETED|Open-Label Extension Phase||0
6794775|NCT02607956|7726240|FG001|NOT COMPLETED|Open-Label Extension Phase||0
6794776|NCT02607956|7726241|FG002|NOT COMPLETED|Open-Label Extension Phase||29
6794777|NCT02607956|7726242|FG003|NOT COMPLETED|Open-Label Extension Phase||30
6794778|NCT02564523|7726272|FG000|STARTED|Overall Study||225
6794779|NCT02564523|7726273|FG001|STARTED|Overall Study||43
6794780|NCT02564523|7726274|FG002|STARTED|Overall Study||224
6794781|NCT02564523|7726275|FG003|STARTED|Overall Study||44
6794782|NCT02564523|7726276|FG004|STARTED|Overall Study||110
6794783|NCT02564523|7726277|FG005|STARTED|Overall Study||22
6794784|NCT02564523|7726278|FG006|STARTED|Overall Study||59
6794785|NCT02564523|7726279|FG007|STARTED|Overall Study||12
6794786|NCT02564523|7726280|FG008|STARTED|Overall Study||59
6794787|NCT02564523|7726281|FG009|STARTED|Overall Study||12
6794788|NCT02564523|7726282|FG010|STARTED|Overall Study||55
6794789|NCT02564523|7726283|FG011|STARTED|Overall Study||11
6794790|NCT02564523|7726284|FG012|STARTED|Overall Study||55
6794791|NCT02564523|7726285|FG013|STARTED|Overall Study||10
6794792|NCT02564523|7726286|FG014|STARTED|Overall Study||54
6794793|NCT02564523|7726287|FG015|STARTED|Overall Study||12
6794794|NCT02564523|7726288|FG016|STARTED|Overall Study||54
6794795|NCT02564523|7726289|FG017|STARTED|Overall Study||12
6794796|NCT02564523|7726272|FG000|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||34
6794797|NCT02564523|7726273|FG001|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||8
6794798|NCT02564523|7726274|FG002|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||39
6794799|NCT02564523|7726275|FG003|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||9
6794800|NCT02564523|7726276|FG004|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794801|NCT02564523|7726277|FG005|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794802|NCT02564523|7726278|FG006|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794803|NCT02564523|7726279|FG007|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794804|NCT02564523|7726280|FG008|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794805|NCT02564523|7726281|FG009|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794806|NCT02564523|7726282|FG010|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794807|NCT02564523|7726283|FG011|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794808|NCT02564523|7726284|FG012|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794809|NCT02564523|7726285|FG013|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794810|NCT02564523|7726286|FG014|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794811|NCT02564523|7726287|FG015|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794812|NCT02564523|7726288|FG016|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794813|NCT02564523|7726289|FG017|Participants Who Received Booster Dose at 1 Year Post Dose 1 (on Day 365)|Overall Study||0
6794814|NCT02564523|7726272|FG000|COMPLETED|Overall Study||215
6794815|NCT02564523|7726273|FG001|COMPLETED|Overall Study||40
6794816|NCT02564523|7726274|FG002|COMPLETED|Overall Study||214
6794817|NCT02564523|7726275|FG003|COMPLETED|Overall Study||43
6794818|NCT02564523|7726276|FG004|COMPLETED|Overall Study||106
6794819|NCT02564523|7726277|FG005|COMPLETED|Overall Study||22
6794820|NCT02564523|7726278|FG006|COMPLETED|Overall Study||56
6794821|NCT02564523|7726279|FG007|COMPLETED|Overall Study||12
6794822|NCT02564523|7726280|FG008|COMPLETED|Overall Study||59
6563622|NCT01807520|7486482|FG004|STARTED|Follow-up Period (132-140 Weeks)||0
6563623|NCT01807520|7486483|FG005|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457150mg during treatment period 1 and/or treatment period 2.|81
6794823|NCT02564523|7726281|FG009|COMPLETED|Overall Study||12
6794824|NCT02564523|7726282|FG010|COMPLETED|Overall Study||52
6656579|NCT02462070|7586838|FG001|STARTED|Overall Study||68
6794825|NCT02564523|7726283|FG011|COMPLETED|Overall Study||10
6794826|NCT02564523|7726284|FG012|COMPLETED|Overall Study||53
6794827|NCT02564523|7726285|FG013|COMPLETED|Overall Study||10
6794828|NCT02564523|7726286|FG014|COMPLETED|Overall Study||54
6794829|NCT02564523|7726287|FG015|COMPLETED|Overall Study||12
6794830|NCT02564523|7726288|FG016|COMPLETED|Overall Study||54
6794831|NCT02564523|7726289|FG017|COMPLETED|Overall Study||11
6794832|NCT02564523|7726272|FG000|NOT COMPLETED|Overall Study||10
6794833|NCT02564523|7726273|FG001|NOT COMPLETED|Overall Study||3
6794834|NCT02564523|7726274|FG002|NOT COMPLETED|Overall Study||10
6794835|NCT02564523|7726275|FG003|NOT COMPLETED|Overall Study||1
6794836|NCT02564523|7726276|FG004|NOT COMPLETED|Overall Study||4
6794837|NCT02564523|7726277|FG005|NOT COMPLETED|Overall Study||0
6794838|NCT02564523|7726278|FG006|NOT COMPLETED|Overall Study||3
6794839|NCT02564523|7726279|FG007|NOT COMPLETED|Overall Study||0
6379509|NCT00773175|7290171|FG000|Initial Fluids Via Randomized Route|Overall Study||73
6379510|NCT00773175|7290172|FG001|Initial Fluids Via Randomized Route|Overall Study||59
6379511|NCT00773175|7290171|FG000|Initial Fluids Via Subcutaneous Rescue|Overall Study||0
6379512|NCT00773175|7290172|FG001|Initial Fluids Via Subcutaneous Rescue|Overall Study||15
6502322|NCT01433991|7420967|FG001|NOT COMPLETED|Treatment Phase (Combination Agent)||1
6502323|NCT01433991|7420968|FG002|NOT COMPLETED|Treatment Phase (Combination Agent)||6
6502324|NCT01433991|7420969|FG003|NOT COMPLETED|Treatment Phase (Combination Agent)||6
6502325|NCT01434030|7420985|FG000|STARTED|Overall Study||57
6502326|NCT01434030|7420985|FG000|COMPLETED|Overall Study||56
6502327|NCT01434030|7420985|FG000|NOT COMPLETED|Overall Study||1
6502328|NCT01434121|7420993|FG000|STARTED|Overall Study||8
6502329|NCT01434121|7420994|FG001|STARTED|Overall Study||8
6502330|NCT01434121|7420995|FG002|STARTED|Overall Study||8
6502331|NCT01434121|7420993|FG000|COMPLETED|Overall Study||8
6502332|NCT01434121|7420994|FG001|COMPLETED|Overall Study||8
6502333|NCT01434121|7420995|FG002|COMPLETED|Overall Study||8
6502334|NCT01434121|7420993|FG000|NOT COMPLETED|Overall Study||0
6502335|NCT01434121|7420994|FG001|NOT COMPLETED|Overall Study||0
6502336|NCT01434121|7420995|FG002|NOT COMPLETED|Overall Study||0
6502337|NCT01434186|7421008|FG000|STARTED|Overall Study||2
6502338|NCT01434186|7421009|FG001|STARTED|Overall Study||4
6502339|NCT01434186|7421008|FG000|COMPLETED|Overall Study||2
6502340|NCT01434186|7421009|FG001|COMPLETED|Overall Study||4
6502341|NCT01434186|7421008|FG000|NOT COMPLETED|Overall Study||0
6502342|NCT01434186|7421009|FG001|NOT COMPLETED|Overall Study||0
6502343|NCT01434290|7421017|FG000|STARTED|Overall Study||127
6502344|NCT01434290|7421018|FG001|STARTED|Overall Study||128
6794840|NCT02564523|7726280|FG008|NOT COMPLETED|Overall Study||0
6794841|NCT02564523|7726281|FG009|NOT COMPLETED|Overall Study||0
6794842|NCT02564523|7726282|FG010|NOT COMPLETED|Overall Study||3
6379513|NCT00773175|7290171|FG000|No Fluids Received|Overall Study||0
6379514|NCT00773175|7290172|FG001|No Fluids Received|Overall Study||1
6379515|NCT00773175|7290171|FG000|COMPLETED|Overall Study||71
6794843|NCT02564523|7726283|FG011|NOT COMPLETED|Overall Study||1
6794844|NCT02564523|7726284|FG012|NOT COMPLETED|Overall Study||2
6794845|NCT02564523|7726285|FG013|NOT COMPLETED|Overall Study||0
6794846|NCT02564523|7726286|FG014|NOT COMPLETED|Overall Study||0
6794847|NCT02564523|7726287|FG015|NOT COMPLETED|Overall Study||0
6794848|NCT02564523|7726288|FG016|NOT COMPLETED|Overall Study||0
6794849|NCT02564523|7726289|FG017|NOT COMPLETED|Overall Study||1
6794850|NCT02094716|7726346|FG000|STARTED|Overall Study||43
6794851|NCT02094716|7726347|FG001|STARTED|Overall Study||43
6794852|NCT02094716|7726348|FG002|STARTED|Overall Study||44
6794853|NCT02094716|7726346|FG000|Received Second Dose at Day 14|Overall Study||15
6794854|NCT02094716|7726347|FG001|Received Second Dose at Day 14|Overall Study||10
6794855|NCT02094716|7726348|FG002|Received Second Dose at Day 14|Overall Study||17
6794856|NCT02094716|7726346|FG000|COMPLETED|Overall Study||41
6794857|NCT02094716|7726347|FG001|COMPLETED|Overall Study||36
6794858|NCT02094716|7726348|FG002|COMPLETED|Overall Study||40
6794859|NCT02094716|7726346|FG000|NOT COMPLETED|Overall Study||2
6794860|NCT02094716|7726347|FG001|NOT COMPLETED|Overall Study||7
6794861|NCT02094716|7726348|FG002|NOT COMPLETED|Overall Study||4
6794862|NCT02094261|7726368|FG000|STARTED|Overall Study||210
6794863|NCT02094261|7726368|FG000|COMPLETED|Overall Study||0
6794864|NCT02094261|7726368|FG000|NOT COMPLETED|Overall Study||210
6794865|NCT01988493|7726377|FG000|STARTED|Overall Study||7
6794866|NCT01988493|7726378|FG001|STARTED|Overall Study||14
6794867|NCT01988493|7726379|FG002|STARTED|Overall Study||6
6794868|NCT01988493|7726380|FG003|STARTED|Overall Study||45
6794869|NCT01988493|7726381|FG004|STARTED|Overall Study||45
6794870|NCT01988493|7726377|FG000|Treated|Overall Study||7
6794871|NCT01988493|7726378|FG001|Treated|Overall Study||14
6794872|NCT01988493|7726379|FG002|Treated|Overall Study||6
6794873|NCT01988493|7726380|FG003|Treated|Overall Study||45
6794874|NCT01988493|7726381|FG004|Treated|Overall Study||44
6794875|NCT01988493|7726377|FG000|Safety Population|Overall Study||7
6794876|NCT01988493|7726378|FG001|Safety Population|Overall Study||14
6794877|NCT01988493|7726379|FG002|Safety Population|Overall Study||6
6794878|NCT01988493|7726380|FG003|Safety Population|Overall Study||45
6794879|NCT01988493|7726381|FG004|Safety Population|Overall Study||44
6794880|NCT01988493|7726377|FG000|COMPLETED|Overall Study||7
6794881|NCT01988493|7726378|FG001|COMPLETED|Overall Study||14
6794882|NCT01988493|7726379|FG002|COMPLETED|Overall Study||6
6794883|NCT01988493|7726380|FG003|COMPLETED|Overall Study||45
6794884|NCT01988493|7726381|FG004|COMPLETED|Overall Study||44
6794885|NCT01988493|7726377|FG000|NOT COMPLETED|Overall Study||0
6794886|NCT01988493|7726378|FG001|NOT COMPLETED|Overall Study||0
6794887|NCT01988493|7726379|FG002|NOT COMPLETED|Overall Study||0
6794888|NCT01988493|7726380|FG003|NOT COMPLETED|Overall Study||0
6794889|NCT01988493|7726381|FG004|NOT COMPLETED|Overall Study||1
6794890|NCT01868139|7726393|FG000|STARTED|Overall Study||1
6794891|NCT01868139|7726393|FG000|COMPLETED|Overall Study||0
6794892|NCT01868139|7726393|FG000|NOT COMPLETED|Overall Study||1
6794893|NCT01798004|7726398|FG000|STARTED|Overall Study||150
6794894|NCT01798004|7726398|FG000|COMPLETED|Overall Study||63
6794895|NCT01798004|7726398|FG000|NOT COMPLETED|Overall Study||87
6794896|NCT01751906|7726404|FG000|STARTED|Overall Study||1322
6794897|NCT01751906|7726405|FG001|STARTED|Overall Study||686
6794898|NCT01751906|7726404|FG000|COMPLETED|Overall Study||1059
6563624|NCT01807520|7486484|FG006|STARTED|Follow-up Period (132-140 Weeks)|These participants received AIN457 300mg during treatment period 1 and/or treatment period 2.|76
6563625|NCT01807520|7486478|FG000|COMPLETED|Follow-up Period (132-140 Weeks)||0
6563626|NCT01807520|7486479|FG001|COMPLETED|Follow-up Period (132-140 Weeks)||0
6794899|NCT01751906|7726405|FG001|COMPLETED|Overall Study||555
6794900|NCT01751906|7726404|FG000|NOT COMPLETED|Overall Study||263
6794901|NCT01751906|7726405|FG001|NOT COMPLETED|Overall Study||131
6379516|NCT00773175|7290172|FG001|COMPLETED|Overall Study||73
6379517|NCT00773175|7290171|FG000|NOT COMPLETED|Overall Study||2
6379518|NCT00773175|7290172|FG001|NOT COMPLETED|Overall Study||2
6379519|NCT00773253|7290185|FG000|STARTED|First Intervention (Week 0-24)||5
6379520|NCT00773253|7290186|FG001|STARTED|First Intervention (Week 0-24)||5
6379521|NCT00773253|7290185|FG000|COMPLETED|First Intervention (Week 0-24)||5
6379522|NCT00773253|7290186|FG001|COMPLETED|First Intervention (Week 0-24)||4
6379523|NCT00773253|7290185|FG000|NOT COMPLETED|First Intervention (Week 0-24)||0
6379524|NCT00773253|7290186|FG001|NOT COMPLETED|First Intervention (Week 0-24)||1
6379525|NCT00773253|7290185|FG000|STARTED|Second Intervention (Week 24-48)||5
6379526|NCT00773253|7290186|FG001|STARTED|Second Intervention (Week 24-48)||4
6379527|NCT00773253|7290185|FG000|COMPLETED|Second Intervention (Week 24-48)||5
6563627|NCT01807520|7486480|FG002|COMPLETED|Follow-up Period (132-140 Weeks)||2
6563628|NCT01807520|7486481|FG003|COMPLETED|Follow-up Period (132-140 Weeks)||0
6794902|NCT01620658|7726414|FG000|STARTED|Overall Study||59
6379528|NCT00773253|7290186|FG001|COMPLETED|Second Intervention (Week 24-48)||4
6379529|NCT00773253|7290185|FG000|NOT COMPLETED|Second Intervention (Week 24-48)||0
6379530|NCT00773253|7290186|FG001|NOT COMPLETED|Second Intervention (Week 24-48)||0
6379531|NCT00773279|7290194|FG000|STARTED|Period 1||121
6379532|NCT00773279|7290195|FG001|STARTED|Period 1||121
6379533|NCT00773279|7290194|FG000|COMPLETED|Period 1||114
6379534|NCT00773279|7290195|FG001|COMPLETED|Period 1||117
6379535|NCT00773279|7290194|FG000|NOT COMPLETED|Period 1||7
6379536|NCT00773279|7290195|FG001|NOT COMPLETED|Period 1||4
6379537|NCT00773279|7290194|FG000|STARTED|Period 2||114
6379538|NCT00773279|7290195|FG001|STARTED|Period 2||117
6379539|NCT00773279|7290194|FG000|COMPLETED|Period 2||111
6379540|NCT00773279|7290195|FG001|COMPLETED|Period 2||111
6794903|NCT01620658|7726415|FG001|STARTED|Overall Study||74
6379541|NCT00773279|7290194|FG000|NOT COMPLETED|Period 2||3
6379542|NCT00773279|7290195|FG001|NOT COMPLETED|Period 2||6
6379543|NCT00773292|7290202|FG000|STARTED|Pre-treatment 4 Weeks||7
6379544|NCT00773292|7290202|FG000|COMPLETED|Pre-treatment 4 Weeks||7
6379545|NCT00773292|7290202|FG000|NOT COMPLETED|Pre-treatment 4 Weeks||0
6794904|NCT01620658|7726416|FG002|STARTED|Overall Study||64
6794905|NCT01620658|7726414|FG000|COMPLETED|Overall Study||35
6794906|NCT01620658|7726415|FG001|COMPLETED|Overall Study||45
6794907|NCT01620658|7726416|FG002|COMPLETED|Overall Study||44
6794908|NCT01620658|7726414|FG000|NOT COMPLETED|Overall Study||24
6794909|NCT01620658|7726415|FG001|NOT COMPLETED|Overall Study||29
6794910|NCT01620658|7726416|FG002|NOT COMPLETED|Overall Study||20
6794911|NCT01447628|7726434|FG000|STARTED|Week 0 to Week 12 (1st Intervention)||19
6794912|NCT01447628|7726435|FG001|STARTED|Week 0 to Week 12 (1st Intervention)||20
6794913|NCT01447628|7726436|FG002|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|12
6794914|NCT01447628|7726437|FG003|STARTED|Week 0 to Week 12 (1st Intervention)|Randomisation error meant the arms were not balanced- refer to protocol description for full details|5
6794915|NCT01447628|7726434|FG000|COMPLETED|Week 0 to Week 12 (1st Intervention)||19
6794916|NCT01447628|7726435|FG001|COMPLETED|Week 0 to Week 12 (1st Intervention)||20
6794917|NCT01447628|7726436|FG002|COMPLETED|Week 0 to Week 12 (1st Intervention)||12
6794918|NCT01447628|7726437|FG003|COMPLETED|Week 0 to Week 12 (1st Intervention)||4
6794919|NCT01447628|7726434|FG000|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
6794920|NCT01447628|7726435|FG001|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
6794921|NCT01447628|7726436|FG002|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||0
6794922|NCT01447628|7726437|FG003|NOT COMPLETED|Week 0 to Week 12 (1st Intervention)||1
6794923|NCT01447628|7726434|FG000|STARTED|Week 12 to Week 24 (2nd Intervention)||19
6794924|NCT01447628|7726435|FG001|STARTED|Week 12 to Week 24 (2nd Intervention)||20
6794925|NCT01447628|7726436|FG002|STARTED|Week 12 to Week 24 (2nd Intervention)||12
6794926|NCT01447628|7726437|FG003|STARTED|Week 12 to Week 24 (2nd Intervention)||4
6794927|NCT01447628|7726434|FG000|COMPLETED|Week 12 to Week 24 (2nd Intervention)||19
6794928|NCT01447628|7726435|FG001|COMPLETED|Week 12 to Week 24 (2nd Intervention)||20
6794929|NCT01447628|7726436|FG002|COMPLETED|Week 12 to Week 24 (2nd Intervention)||12
6794930|NCT01447628|7726437|FG003|COMPLETED|Week 12 to Week 24 (2nd Intervention)||4
6794931|NCT01447628|7726434|FG000|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
6794932|NCT01447628|7726435|FG001|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
6794933|NCT01447628|7726436|FG002|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
6794934|NCT01447628|7726437|FG003|NOT COMPLETED|Week 12 to Week 24 (2nd Intervention)||0
6794935|NCT01175356|7726457|FG000|STARTED|Overall Study||99
6794936|NCT01175356|7726457|FG000|COMPLETED|Overall Study||18
6794937|NCT01175356|7726457|FG000|NOT COMPLETED|Overall Study||81
6794938|NCT00515853|7726463|FG000|STARTED|Overall Study||61
6794939|NCT00515853|7726464|FG001|STARTED|Overall Study||60
6794940|NCT00515853|7726463|FG000|COMPLETED|Overall Study||46
6794941|NCT00515853|7726464|FG001|COMPLETED|Overall Study||43
6794942|NCT00515853|7726463|FG000|NOT COMPLETED|Overall Study||15
6794943|NCT00515853|7726464|FG001|NOT COMPLETED|Overall Study||17
6794944|NCT00003458|7726470|FG000|STARTED|Overall Study||34
6794945|NCT00003458|7726470|FG000|COMPLETED|Overall Study||30
6794946|NCT00003458|7726470|FG000|NOT COMPLETED|Overall Study||4
6379546|NCT00773292|7290202|FG000|STARTED|Treatment 48 Weeks||7
6379547|NCT00773292|7290202|FG000|COMPLETED|Treatment 48 Weeks|Two patients discontinued the treatment but remained on the study|5
6379548|NCT00773292|7290202|FG000|NOT COMPLETED|Treatment 48 Weeks||2
6379549|NCT00773292|7290202|FG000|STARTED|Post Treatment 24 Weeks||7
6379550|NCT00773292|7290202|FG000|COMPLETED|Post Treatment 24 Weeks||7
6794947|NCT04871815|7726475|FG000|STARTED|Baseline Day 1-7||22
6794948|NCT04871815|7726475|FG000|COMPLETED|Baseline Day 1-7||22
6794949|NCT04871815|7726475|FG000|NOT COMPLETED|Baseline Day 1-7||0
6794950|NCT04871815|7726475|FG000|STARTED|N115 Treatment Day 8-14||22
6794951|NCT04871815|7726475|FG000|COMPLETED|N115 Treatment Day 8-14||22
6794952|NCT04871815|7726475|FG000|NOT COMPLETED|N115 Treatment Day 8-14||0
6794953|NCT04772560|7726487|FG000|STARTED|Overall Study||11
6794954|NCT04772560|7726488|FG001|STARTED|Overall Study||12
6794955|NCT04772560|7726487|FG000|COMPLETED|Overall Study||11
6794956|NCT04772560|7726488|FG001|COMPLETED|Overall Study||12
6794957|NCT04772560|7726487|FG000|NOT COMPLETED|Overall Study||0
6794958|NCT04772560|7726488|FG001|NOT COMPLETED|Overall Study||0
6794959|NCT04613739|7726495|FG000|STARTED|Overall Study||19
6794960|NCT04613739|7726496|FG001|STARTED|Overall Study||37
6794961|NCT04613739|7726495|FG000|COMPLETED|Overall Study||12
6794962|NCT04613739|7726496|FG001|COMPLETED|Overall Study||25
6794963|NCT04613739|7726495|FG000|NOT COMPLETED|Overall Study||7
6794964|NCT04613739|7726496|FG001|NOT COMPLETED|Overall Study||12
6794965|NCT04573972|7726504|FG000|STARTED|Overall Study||88
6794966|NCT04573972|7726505|FG001|STARTED|Overall Study||84
6794967|NCT04573972|7726504|FG000|COMPLETED|Overall Study||56
6794968|NCT04573972|7726505|FG001|COMPLETED|Overall Study||70
6794969|NCT04573972|7726504|FG000|NOT COMPLETED|Overall Study||32
6794970|NCT04573972|7726505|FG001|NOT COMPLETED|Overall Study||14
6794971|NCT04432272|7726513|FG000|STARTED|Overall Study||43
6794972|NCT04432272|7726514|FG001|STARTED|Overall Study||28
6794973|NCT04432272|7726513|FG000|COMPLETED|Overall Study||43
6794974|NCT04432272|7726514|FG001|COMPLETED|Overall Study||28
6794975|NCT04432272|7726513|FG000|NOT COMPLETED|Overall Study||0
6794976|NCT04432272|7726514|FG001|NOT COMPLETED|Overall Study||0
6794992|NCT04209621|7726546|FG000|STARTED|Overall Study||3
6794993|NCT04209621|7726546|FG000|Dose Level 1|Overall Study||3
6794994|NCT04209621|7726546|FG000|COMPLETED|Overall Study||0
6794995|NCT04209621|7726546|FG000|NOT COMPLETED|Overall Study||3
6794996|NCT04186663|7726551|FG000|STARTED|Overall Study||59
6794997|NCT04186663|7726551|FG000|COMPLETED|Overall Study||55
6794998|NCT04186663|7726551|FG000|NOT COMPLETED|Overall Study||4
6794999|NCT04158219|7726555|FG000|STARTED|Overall Study||8
6795000|NCT04158219|7726555|FG000|COMPLETED|Overall Study||7
6795001|NCT04158219|7726555|FG000|NOT COMPLETED|Overall Study||1
6795002|NCT04131959|7726559|FG000|STARTED|Overall Study||5
6795003|NCT04131959|7726559|FG000|COMPLETED|Overall Study||5
6795004|NCT04131959|7726559|FG000|NOT COMPLETED|Overall Study||0
6795005|NCT04084990|7726566|FG000|STARTED|Overall Study||2
6795006|NCT04084990|7726567|FG001|STARTED|Overall Study||1
6795007|NCT04084990|7726566|FG000|COMPLETED|Overall Study||2
6795008|NCT04084990|7726567|FG001|COMPLETED|Overall Study||1
6795009|NCT04084990|7726566|FG000|NOT COMPLETED|Overall Study||0
6795010|NCT04084990|7726567|FG001|NOT COMPLETED|Overall Study||0
6795011|NCT04056299|7726575|FG000|STARTED|Overall Study||9
6795012|NCT04056299|7726576|FG001|STARTED|Overall Study||6
6795013|NCT04056299|7726575|FG000|COMPLETED|Overall Study||6
6795014|NCT04056299|7726576|FG001|COMPLETED|Overall Study||3
6795015|NCT04056299|7726575|FG000|NOT COMPLETED|Overall Study||3
6795016|NCT04056299|7726576|FG001|NOT COMPLETED|Overall Study||3
6795017|NCT04020718|7726584|FG000|STARTED|Pre-assessment and Adaptation||16
6795018|NCT04020718|7726585|FG001|STARTED|Pre-assessment and Adaptation||19
6795019|NCT04020718|7726586|FG002|STARTED|Pre-assessment and Adaptation||0
6795020|NCT04020718|7726587|FG003|STARTED|Pre-assessment and Adaptation||0
6795021|NCT04020718|7726588|FG004|STARTED|Pre-assessment and Adaptation||0
6795022|NCT04020718|7726589|FG005|STARTED|Pre-assessment and Adaptation||0
6795023|NCT04020718|7726590|FG006|STARTED|Pre-assessment and Adaptation||0
6795024|NCT04020718|7726591|FG007|STARTED|Pre-assessment and Adaptation||0
6795025|NCT04020718|7726584|FG000|COMPLETED|Pre-assessment and Adaptation||16
6795026|NCT04020718|7726585|FG001|COMPLETED|Pre-assessment and Adaptation||15
6795027|NCT04020718|7726586|FG002|COMPLETED|Pre-assessment and Adaptation||0
6795028|NCT04020718|7726587|FG003|COMPLETED|Pre-assessment and Adaptation||0
6795029|NCT04020718|7726588|FG004|COMPLETED|Pre-assessment and Adaptation||0
6379551|NCT00773292|7290202|FG000|NOT COMPLETED|Post Treatment 24 Weeks||0
6379552|NCT00773370|7290208|FG000|STARTED|Overall Study||43
6379553|NCT00773370|7290209|FG001|STARTED|Overall Study||33
6379554|NCT00773370|7290208|FG000|COMPLETED|Overall Study||25
6379555|NCT00773370|7290209|FG001|COMPLETED|Overall Study||23
6379556|NCT00773370|7290208|FG000|NOT COMPLETED|Overall Study||18
6379557|NCT00773370|7290209|FG001|NOT COMPLETED|Overall Study||10
6379558|NCT00773383|7290215|FG000|STARTED|Overall Study||35
6379559|NCT00773383|7290215|FG000|Received Study Drug|Overall Study||34
6379560|NCT00773383|7290215|FG000|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
6379561|NCT00773383|7290215|FG000|NOT COMPLETED|Overall Study||31
6379562|NCT00773422|7290226|FG000|STARTED|Overall Study||11
6379563|NCT00773422|7290227|FG001|STARTED|Overall Study||9
6379564|NCT00773422|7290228|FG002|STARTED|Overall Study||10
6379565|NCT00773422|7290226|FG000|COMPLETED|Overall Study||11
6795030|NCT04020718|7726589|FG005|COMPLETED|Pre-assessment and Adaptation||0
6795031|NCT04020718|7726590|FG006|COMPLETED|Pre-assessment and Adaptation||0
6795032|NCT04020718|7726591|FG007|COMPLETED|Pre-assessment and Adaptation||0
6795033|NCT04020718|7726584|FG000|NOT COMPLETED|Pre-assessment and Adaptation||0
6795034|NCT04020718|7726585|FG001|NOT COMPLETED|Pre-assessment and Adaptation||4
6795035|NCT04020718|7726586|FG002|NOT COMPLETED|Pre-assessment and Adaptation||0
6563629|NCT01807520|7486482|FG004|COMPLETED|Follow-up Period (132-140 Weeks)||0
6794977|NCT04407806|7726523|FG000|STARTED|Overall Study||3
6794978|NCT04407806|7726524|FG001|STARTED|Overall Study||3
6794979|NCT04407806|7726523|FG000|COMPLETED|Overall Study||2
6794980|NCT04407806|7726524|FG001|COMPLETED|Overall Study||1
6794981|NCT04407806|7726523|FG000|NOT COMPLETED|Overall Study||1
6794982|NCT04407806|7726524|FG001|NOT COMPLETED|Overall Study||2
6794983|NCT04324021|7726533|FG000|STARTED|Overall Study||5
6794984|NCT04324021|7726534|FG001|STARTED|Overall Study||5
6794985|NCT04324021|7726535|FG002|STARTED|Overall Study||6
6794986|NCT04324021|7726533|FG000|COMPLETED|Overall Study||3
6794987|NCT04324021|7726534|FG001|COMPLETED|Overall Study||4
6794988|NCT04324021|7726535|FG002|COMPLETED|Overall Study||5
6794989|NCT04324021|7726533|FG000|NOT COMPLETED|Overall Study||2
6794990|NCT04324021|7726534|FG001|NOT COMPLETED|Overall Study||1
6794991|NCT04324021|7726535|FG002|NOT COMPLETED|Overall Study||1
6795036|NCT04020718|7726587|FG003|NOT COMPLETED|Pre-assessment and Adaptation||0
6795037|NCT04020718|7726588|FG004|NOT COMPLETED|Pre-assessment and Adaptation||0
6795038|NCT04020718|7726589|FG005|NOT COMPLETED|Pre-assessment and Adaptation||0
6795039|NCT04020718|7726590|FG006|NOT COMPLETED|Pre-assessment and Adaptation||0
6795040|NCT04020718|7726591|FG007|NOT COMPLETED|Pre-assessment and Adaptation||0
6795041|NCT04020718|7726584|FG000|STARTED|Post-assessment and Adaptation||0
6795042|NCT04020718|7726585|FG001|STARTED|Post-assessment and Adaptation||0
6795043|NCT04020718|7726586|FG002|STARTED|Post-assessment and Adaptation||8
6795044|NCT04020718|7726587|FG003|STARTED|Post-assessment and Adaptation||6
6795045|NCT04020718|7726588|FG004|STARTED|Post-assessment and Adaptation||8
6795046|NCT04020718|7726589|FG005|STARTED|Post-assessment and Adaptation||7
6795047|NCT04020718|7726590|FG006|STARTED|Post-assessment and Adaptation||2
6795048|NCT04020718|7726591|FG007|STARTED|Post-assessment and Adaptation||0
6795049|NCT04020718|7726584|FG000|COMPLETED|Post-assessment and Adaptation||0
6795050|NCT04020718|7726585|FG001|COMPLETED|Post-assessment and Adaptation||0
6795051|NCT04020718|7726586|FG002|COMPLETED|Post-assessment and Adaptation||8
6795052|NCT04020718|7726587|FG003|COMPLETED|Post-assessment and Adaptation||5
6795053|NCT04020718|7726588|FG004|COMPLETED|Post-assessment and Adaptation||8
6795054|NCT04020718|7726589|FG005|COMPLETED|Post-assessment and Adaptation||7
6795055|NCT04020718|7726590|FG006|COMPLETED|Post-assessment and Adaptation||2
6795056|NCT04020718|7726591|FG007|COMPLETED|Post-assessment and Adaptation||0
6795057|NCT04020718|7726584|FG000|NOT COMPLETED|Post-assessment and Adaptation||0
6795058|NCT04020718|7726585|FG001|NOT COMPLETED|Post-assessment and Adaptation||0
6563630|NCT01807520|7486483|FG005|COMPLETED|Follow-up Period (132-140 Weeks)||77
6563631|NCT01807520|7486484|FG006|COMPLETED|Follow-up Period (132-140 Weeks)||75
6563632|NCT01807520|7486478|FG000|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6563633|NCT01807520|7486479|FG001|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6563634|NCT01807520|7486480|FG002|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6563635|NCT01807520|7486481|FG003|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6563636|NCT01807520|7486482|FG004|NOT COMPLETED|Follow-up Period (132-140 Weeks)||0
6563637|NCT01807520|7486483|FG005|NOT COMPLETED|Follow-up Period (132-140 Weeks)||4
6563638|NCT01807520|7486484|FG006|NOT COMPLETED|Follow-up Period (132-140 Weeks)||1
6563639|NCT01807585|7486498|FG000|STARTED|Overall Study||20
6563640|NCT01807585|7486499|FG001|STARTED|Overall Study||108
6563641|NCT01807585|7486500|FG002|STARTED|Overall Study||114
6563642|NCT01807585|7486498|FG000|3 Mos|Overall Study||20
6563643|NCT01807585|7486499|FG001|3 Mos|Overall Study||108
6563644|NCT01807585|7486500|FG002|3 Mos|Overall Study||113
6563645|NCT01807585|7486498|FG000|COMPLETED|Overall Study||19
6563646|NCT01807585|7486499|FG001|COMPLETED|Overall Study||104
6563647|NCT01807585|7486500|FG002|COMPLETED|Overall Study||108
6563648|NCT01807585|7486498|FG000|NOT COMPLETED|Overall Study||1
6563649|NCT01807585|7486499|FG001|NOT COMPLETED|Overall Study||4
6656580|NCT02462070|7586837|FG000|COMPLETED|Overall Study||112
6656581|NCT02462070|7586838|FG001|COMPLETED|Overall Study||57
6656582|NCT02462070|7586837|FG000|NOT COMPLETED|Overall Study||23
6656583|NCT02462070|7586838|FG001|NOT COMPLETED|Overall Study||11
6656584|NCT02462083|7586844|FG000|STARTED|Overall Study||555
6656585|NCT02462083|7586844|FG000|Safety Population|Overall Study||550
6656586|NCT02462083|7586844|FG000|COMPLETED|Overall Study||136
6656587|NCT02462083|7586844|FG000|NOT COMPLETED|Overall Study||419
6656588|NCT02462122|7586850|FG000|STARTED|Overall Study||141
6656589|NCT02462122|7586851|FG001|STARTED|Overall Study||74
6795059|NCT04020718|7726586|FG002|NOT COMPLETED|Post-assessment and Adaptation||0
6795060|NCT04020718|7726587|FG003|NOT COMPLETED|Post-assessment and Adaptation||1
6795061|NCT04020718|7726588|FG004|NOT COMPLETED|Post-assessment and Adaptation||0
6795062|NCT04020718|7726589|FG005|NOT COMPLETED|Post-assessment and Adaptation||0
6795063|NCT04020718|7726590|FG006|NOT COMPLETED|Post-assessment and Adaptation||0
6795064|NCT04020718|7726591|FG007|NOT COMPLETED|Post-assessment and Adaptation||0
6795065|NCT03970109|7726612|FG000|STARTED|Overall Study||15
6795066|NCT03970109|7726613|FG001|STARTED|Overall Study||13
6795067|NCT03970109|7726614|FG002|STARTED|Overall Study||15
6795068|NCT03970109|7726612|FG000|COMPLETED|Overall Study||14
6795069|NCT03970109|7726613|FG001|COMPLETED|Overall Study||10
6795070|NCT03970109|7726614|FG002|COMPLETED|Overall Study||15
6795071|NCT03970109|7726612|FG000|NOT COMPLETED|Overall Study||1
6563650|NCT01807585|7486500|FG002|NOT COMPLETED|Overall Study||6
6656590|NCT02462122|7586850|FG000|COMPLETED|Overall Study||120
6656591|NCT02462122|7586851|FG001|COMPLETED|Overall Study||61
6795072|NCT03970109|7726613|FG001|NOT COMPLETED|Overall Study||3
6795073|NCT03970109|7726614|FG002|NOT COMPLETED|Overall Study||0
6795074|NCT03954743|7726624|FG000|STARTED|Overall Study||677
6795075|NCT03954743|7726625|FG001|STARTED|Overall Study||674
6795076|NCT03954743|7726624|FG000|COMPLETED|Overall Study||653
6795077|NCT03954743|7726625|FG001|COMPLETED|Overall Study||657
6795078|NCT03954743|7726624|FG000|NOT COMPLETED|Overall Study||24
6795079|NCT03954743|7726625|FG001|NOT COMPLETED|Overall Study||17
6379566|NCT00773422|7290227|FG001|COMPLETED|Overall Study||9
6379567|NCT00773422|7290228|FG002|COMPLETED|Overall Study||10
6379568|NCT00773422|7290226|FG000|NOT COMPLETED|Overall Study||0
6379569|NCT00773422|7290227|FG001|NOT COMPLETED|Overall Study||0
6379570|NCT00773422|7290228|FG002|NOT COMPLETED|Overall Study||0
6379571|NCT00773461|7290238|FG000|STARTED|Overall Study||70
6379572|NCT00773461|7290239|FG001|STARTED|Overall Study||139
6379573|NCT00773461|7290238|FG000|COMPLETED|Overall Study||65
6379574|NCT00773461|7290239|FG001|COMPLETED|Overall Study||135
6379575|NCT00773461|7290238|FG000|NOT COMPLETED|Overall Study||5
6379576|NCT00773461|7290239|FG001|NOT COMPLETED|Overall Study||4
6379577|NCT00773474|7290246|FG000|STARTED|Overall Study||29
6379578|NCT00773474|7290246|FG000|COMPLETED|Overall Study||29
6379579|NCT00773474|7290246|FG000|NOT COMPLETED|Overall Study||0
6379580|NCT00773513|7290252|FG000|STARTED|Overall Study||1413
6379581|NCT00773513|7290253|FG001|STARTED|Overall Study||1412
6379582|NCT00773513|7290252|FG000|Received Study Treatment|Overall Study||1409
6379583|NCT00773513|7290253|FG001|Received Study Treatment|Overall Study||1409
6379584|NCT00773513|7290252|FG000|COMPLETED|Overall Study||312
6379585|NCT00773513|7290253|FG001|COMPLETED|Overall Study||303
6379586|NCT00773513|7290252|FG000|NOT COMPLETED|Overall Study||1101
6379587|NCT00773513|7290253|FG001|NOT COMPLETED|Overall Study||1109
6379588|NCT00773604|7290259|FG000|STARTED|Overall Study||9
6379589|NCT00773604|7290259|FG000|COMPLETED|Overall Study||9
6379590|NCT00773604|7290259|FG000|NOT COMPLETED|Overall Study||0
6379591|NCT00773734|7290267|FG000|STARTED|Core: Placebo Controlled Phase Week 0-16||88
6379592|NCT00773734|7290268|FG001|STARTED|Core: Placebo Controlled Phase Week 0-16||89
6379593|NCT00773734|7290269|FG002|STARTED|Core: Placebo Controlled Phase Week 0-16||87
6379594|NCT00773734|7290270|FG003|STARTED|Core: Placebo Controlled Phase Week 0-16||88
6379595|NCT00773734|7290271|FG004|STARTED|Core: Placebo Controlled Phase Week 0-16||0
6379596|NCT00773734|7290272|FG005|STARTED|Core: Placebo Controlled Phase Week 0-16||0
6379597|NCT00773734|7290267|FG000|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
6379598|NCT00773734|7290268|FG001|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
6379599|NCT00773734|7290269|FG002|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
6379600|NCT00773734|7290270|FG003|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
6379601|NCT00773734|7290271|FG004|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
6379602|NCT00773734|7290272|FG005|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
6379603|NCT00773734|7290267|FG000|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
6379604|NCT00773734|7290268|FG001|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
6379605|NCT00773734|7290269|FG002|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
6379606|NCT00773734|7290270|FG003|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
6379607|NCT00773734|7290271|FG004|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
6379608|NCT00773734|7290272|FG005|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
6379609|NCT00773734|7290267|FG000|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
6379610|NCT00773734|7290268|FG001|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
6379611|NCT00773734|7290269|FG002|STARTED|Core: Active Treatment Phase Week 16-24||66
6379612|NCT00773734|7290270|FG003|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
6379613|NCT00773734|7290271|FG004|STARTED|Core: Active Treatment Phase Week 16-24||34
6379614|NCT00773734|7290272|FG005|STARTED|Core: Active Treatment Phase Week 16-24||36
6379615|NCT00773734|7290267|FG000|COMPLETED|Core: Active Treatment Phase Week 16-24||0
6379616|NCT00773734|7290268|FG001|COMPLETED|Core: Active Treatment Phase Week 16-24||65
6379617|NCT00773734|7290269|FG002|COMPLETED|Core: Active Treatment Phase Week 16-24||59
6379618|NCT00773734|7290270|FG003|COMPLETED|Core: Active Treatment Phase Week 16-24||65
6379619|NCT00773734|7290271|FG004|COMPLETED|Core: Active Treatment Phase Week 16-24||33
6379620|NCT00773734|7290272|FG005|COMPLETED|Core: Active Treatment Phase Week 16-24||31
6379621|NCT00773734|7290267|FG000|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
6379622|NCT00773734|7290268|FG001|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
6379623|NCT00773734|7290269|FG002|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
6379624|NCT00773734|7290270|FG003|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
6379625|NCT00773734|7290271|FG004|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
6379626|NCT00773734|7290272|FG005|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
6563651|NCT01807598|7486511|FG000|STARTED|Overall Study||10
6563652|NCT01807598|7486511|FG000|COMPLETED|Overall Study||4
6563653|NCT01807598|7486511|FG000|NOT COMPLETED|Overall Study||6
6563654|NCT01807624|7486515|FG000|STARTED|Overall Study||24
6795080|NCT03880565|7726633|FG000|STARTED|Overall Study||15
6795081|NCT03880565|7726634|FG001|STARTED|Overall Study||15
6795082|NCT03880565|7726633|FG000|COMPLETED|Overall Study||14
6795083|NCT03880565|7726634|FG001|COMPLETED|Overall Study||15
6795084|NCT03880565|7726633|FG000|NOT COMPLETED|Overall Study||1
6795085|NCT03880565|7726634|FG001|NOT COMPLETED|Overall Study||0
6795086|NCT03833661|7726640|FG000|STARTED|Overall Study||159
6795087|NCT03833661|7726640|FG000|COMPLETED|Overall Study||150
6795088|NCT03833661|7726640|FG000|NOT COMPLETED|Overall Study||9
6795089|NCT03809663|7726648|FG000|STARTED|Overall Study||63
6795090|NCT03809663|7726649|FG001|STARTED|Overall Study||62
6795091|NCT03809663|7726650|FG002|STARTED|Overall Study||63
6795092|NCT03809663|7726651|FG003|STARTED|Overall Study||63
6795093|NCT03809663|7726652|FG004|STARTED|Overall Study||0
6795094|NCT03809663|7726653|FG005|STARTED|Overall Study||0
6795095|NCT03809663|7726648|FG000|Participants Who Received Investigational Product|Overall Study||63
6795096|NCT03809663|7726649|FG001|Participants Who Received Investigational Product|Overall Study||61
6795097|NCT03809663|7726650|FG002|Participants Who Received Investigational Product|Overall Study||63
6795098|NCT03809663|7726651|FG003|Participants Who Received Investigational Product|Overall Study||63
6795099|NCT03809663|7726652|FG004|Participants Who Received Investigational Product|Overall Study||0
6795100|NCT03809663|7726653|FG005|Participants Who Received Investigational Product|Overall Study||0
6795101|NCT03809663|7726648|FG000|EASI 50 Non-responder at Week 16|Overall Study||40
6795102|NCT03809663|7726649|FG001|EASI 50 Non-responder at Week 16|Overall Study||26
6795103|NCT03809663|7726650|FG002|EASI 50 Non-responder at Week 16|Overall Study||30
6795104|NCT03809663|7726651|FG003|EASI 50 Non-responder at Week 16|Overall Study||38
6795105|NCT03809663|7726652|FG004|EASI 50 Non-responder at Week 16|Overall Study||0
6795106|NCT03809663|7726653|FG005|EASI 50 Non-responder at Week 16|Overall Study||0
6795107|NCT03809663|7726648|FG000|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||39
6795108|NCT03809663|7726649|FG001|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||24
6795109|NCT03809663|7726650|FG002|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||30
6795110|NCT03809663|7726651|FG003|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||38
6795111|NCT03809663|7726652|FG004|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
6795112|NCT03809663|7726653|FG005|Switched to Tezepelumab 420 mg Q2W After Week 16|Overall Study||0
6795113|NCT03809663|7726648|FG000|COMPLETED|Overall Study||12
6795114|NCT03809663|7726649|FG001|COMPLETED|Overall Study||18
6795115|NCT03809663|7726650|FG002|COMPLETED|Overall Study||15
6795116|NCT03809663|7726651|FG003|COMPLETED|Overall Study||16
6795117|NCT03809663|7726652|FG004|COMPLETED|Overall Study||0
6795118|NCT03809663|7726653|FG005|COMPLETED|Overall Study||0
6795119|NCT03809663|7726648|FG000|NOT COMPLETED|Overall Study||51
6795120|NCT03809663|7726649|FG001|NOT COMPLETED|Overall Study||44
6795121|NCT03809663|7726650|FG002|NOT COMPLETED|Overall Study||48
6795122|NCT03809663|7726651|FG003|NOT COMPLETED|Overall Study||47
6795123|NCT03809663|7726652|FG004|NOT COMPLETED|Overall Study||0
6795124|NCT03809663|7726653|FG005|NOT COMPLETED|Overall Study||0
6795125|NCT03782792|7726680|FG000|STARTED|Overall Study||18
6795126|NCT03782792|7726681|FG001|STARTED|Overall Study||35
6795127|NCT03782792|7726680|FG000|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||15
6795128|NCT03782792|7726681|FG001|Received Open Label Treatment With Spesolimab at Wk1/D8|Overall Study||12
6795129|NCT03782792|7726680|FG000|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||2
6795130|NCT03782792|7726681|FG001|Received Rescue Treatment With Spesolimab After Wk1|Overall Study||4
6795131|NCT03782792|7726680|FG000|COMPLETED|Overall Study||17
6795132|NCT03782792|7726681|FG001|COMPLETED|Overall Study||32
6795133|NCT03782792|7726680|FG000|NOT COMPLETED|Overall Study||1
6795134|NCT03782792|7726681|FG001|NOT COMPLETED|Overall Study||3
6795135|NCT03750461|7726691|FG000|STARTED|Overall Study||20
6795136|NCT03750461|7726692|FG001|STARTED|Overall Study||92
6795137|NCT03750461|7726691|FG000|Primary Endpoint|Overall Study||20
6795138|NCT03750461|7726692|FG001|Primary Endpoint|Overall Study|Considered study completion for the Historical Controls.|92
6795139|NCT03750461|7726691|FG000|Secondary Endpoint|Overall Study||19
6795140|NCT03750461|7726692|FG001|Secondary Endpoint|Overall Study|Not applicable for the historical controls.|0
6795141|NCT03750461|7726691|FG000|COMPLETED|Overall Study||19
6795142|NCT03750461|7726692|FG001|COMPLETED|Overall Study|Not applicable for the historical controls; no follow-up data was collected.|0
6795143|NCT03750461|7726691|FG000|NOT COMPLETED|Overall Study||1
6795144|NCT03750461|7726692|FG001|NOT COMPLETED|Overall Study||92
6795145|NCT03733119|7726700|FG000|STARTED|Overall Study||2
6795146|NCT03733119|7726701|FG001|STARTED|Overall Study||2
6795147|NCT03733119|7726700|FG000|Treated|Overall Study||2
6795148|NCT03733119|7726701|FG001|Treated|Overall Study||1
6795149|NCT03733119|7726700|FG000|Stopped Treatment After 1 Dose|Overall Study||1
6795150|NCT03733119|7726701|FG001|Stopped Treatment After 1 Dose|Overall Study||0
6795151|NCT03733119|7726700|FG000|Stopped Treatment After 3 Cycles|Overall Study||1
6795152|NCT03733119|7726701|FG001|Stopped Treatment After 3 Cycles|Overall Study||1
6795153|NCT03733119|7726700|FG000|COMPLETED|Overall Study||0
6795154|NCT03733119|7726701|FG001|COMPLETED|Overall Study||0
6795155|NCT03733119|7726700|FG000|NOT COMPLETED|Overall Study||2
6795156|NCT03733119|7726701|FG001|NOT COMPLETED|Overall Study||2
6795157|NCT03661996|7726712|FG000|STARTED|Overall Study||162
6795158|NCT03661996|7726713|FG001|STARTED|Overall Study||180
6795159|NCT03661996|7726714|FG002|STARTED|Overall Study||176
6795160|NCT03661996|7726715|FG003|STARTED|Overall Study||163
6795161|NCT03661996|7726716|FG004|STARTED|Overall Study||173
6795162|NCT03661996|7726712|FG000|Treated|Overall Study||162
6795163|NCT03661996|7726713|FG001|Treated|Overall Study||179
6795164|NCT03661996|7726714|FG002|Treated|Overall Study||175
6795165|NCT03661996|7726715|FG003|Treated|Overall Study||160
6795166|NCT03661996|7726716|FG004|Treated|Overall Study||172
6795167|NCT03661996|7726712|FG000|COMPLETED|Overall Study||150
6795168|NCT03661996|7726713|FG001|COMPLETED|Overall Study||172
6795169|NCT03661996|7726714|FG002|COMPLETED|Overall Study||170
6795170|NCT03661996|7726715|FG003|COMPLETED|Overall Study||150
6795171|NCT03661996|7726716|FG004|COMPLETED|Overall Study||159
6795172|NCT03661996|7726712|FG000|NOT COMPLETED|Overall Study||12
6795173|NCT03661996|7726713|FG001|NOT COMPLETED|Overall Study||8
6795174|NCT03661996|7726714|FG002|NOT COMPLETED|Overall Study||6
6795175|NCT03661996|7726715|FG003|NOT COMPLETED|Overall Study||13
6795176|NCT03661996|7726716|FG004|NOT COMPLETED|Overall Study||14
6795177|NCT03633461|7726733|FG000|STARTED|Overall Study||34
6795178|NCT03633461|7726734|FG001|STARTED|Overall Study||19
6795179|NCT03633461|7726733|FG000|COMPLETED|Overall Study||34
6795180|NCT03633461|7726734|FG001|COMPLETED|Overall Study||18
6795181|NCT03633461|7726733|FG000|NOT COMPLETED|Overall Study||0
6795182|NCT03633461|7726734|FG001|NOT COMPLETED|Overall Study||1
6795183|NCT03622658|7726742|FG000|STARTED|Overall Study||6
6795184|NCT03622658|7726743|FG001|STARTED|Overall Study||36
6795185|NCT03622658|7726742|FG000|COMPLETED|Overall Study||3
6795186|NCT03622658|7726743|FG001|COMPLETED|Overall Study||32
6795187|NCT03622658|7726742|FG000|NOT COMPLETED|Overall Study||3
6795188|NCT03622658|7726743|FG001|NOT COMPLETED|Overall Study||4
6795189|NCT03600142|7726751|FG000|STARTED|Overall Study||777
6795190|NCT03600142|7726752|FG001|STARTED|Overall Study||762
6795191|NCT03600142|7726751|FG000|COMPLETED|Overall Study||773
6795192|NCT03600142|7726752|FG001|COMPLETED|Overall Study||758
6795193|NCT03600142|7726751|FG000|NOT COMPLETED|Overall Study||4
6795194|NCT03600142|7726752|FG001|NOT COMPLETED|Overall Study||4
6795195|NCT03517722|7726762|FG000|STARTED|Double Blind Period: Week 0-52||208
6795196|NCT03517722|7726763|FG001|STARTED|Double Blind Period: Week 0-52||308
6795197|NCT03517722|7726762|FG000|Treated|Double Blind Period: Week 0-52||208
6795198|NCT03517722|7726763|FG001|Treated|Double Blind Period: Week 0-52||307
6795199|NCT03517722|7726762|FG000|COMPLETED|Double Blind Period: Week 0-52||105
6795200|NCT03517722|7726763|FG001|COMPLETED|Double Blind Period: Week 0-52||153
6795201|NCT03517722|7726762|FG000|NOT COMPLETED|Double Blind Period: Week 0-52||103
6795202|NCT03517722|7726763|FG001|NOT COMPLETED|Double Blind Period: Week 0-52||155
6795203|NCT03517722|7726762|FG000|STARTED|Open-label Extension Period: Week 52-113||88
6795204|NCT03517722|7726763|FG001|STARTED|Open-label Extension Period: Week 52-113||137
6795205|NCT03517722|7726762|FG000|COMPLETED|Open-label Extension Period: Week 52-113||0
6795206|NCT03517722|7726763|FG001|COMPLETED|Open-label Extension Period: Week 52-113||0
6795207|NCT03517722|7726762|FG000|NOT COMPLETED|Open-label Extension Period: Week 52-113||88
6795208|NCT03517722|7726763|FG001|NOT COMPLETED|Open-label Extension Period: Week 52-113||137
6795209|NCT03499314|7726772|FG000|STARTED|Overall Study||33
6795210|NCT03499314|7726773|FG001|STARTED|Overall Study||32
6795211|NCT03499314|7726772|FG000|COMPLETED|Overall Study||31
6795212|NCT03499314|7726773|FG001|COMPLETED|Overall Study||29
6795213|NCT03499314|7726772|FG000|NOT COMPLETED|Overall Study||2
6795214|NCT03499314|7726773|FG001|NOT COMPLETED|Overall Study||3
6795215|NCT03439124|7726781|FG000|STARTED|Overall Study||94
6795216|NCT03439124|7726782|FG001|STARTED|Overall Study||44
6795217|NCT03439124|7726781|FG000|COMPLETED|Overall Study||90
6795218|NCT03439124|7726782|FG001|COMPLETED|Overall Study||44
6563655|NCT01807624|7486515|FG000|COMPLETED|Overall Study||24
6563656|NCT01807624|7486515|FG000|NOT COMPLETED|Overall Study||0
6563657|NCT01807637|7486521|FG000|STARTED|Baseline||4
6563658|NCT01807637|7486522|FG001|STARTED|Baseline||2
6563659|NCT01807637|7486521|FG000|COMPLETED|Baseline||4
6563660|NCT01807637|7486522|FG001|COMPLETED|Baseline||2
6268882|NCT00068692|7167972|FG007|NOT COMPLETED|Step 2: Randomization||8
6795219|NCT03439124|7726781|FG000|NOT COMPLETED|Overall Study||4
6795220|NCT03439124|7726782|FG001|NOT COMPLETED|Overall Study||0
6795221|NCT03369431|7726790|FG000|STARTED|Overall Study||35
6795222|NCT03369431|7726791|FG001|STARTED|Overall Study||34
6795223|NCT03369431|7726790|FG000|Taste Test (1 Week)|Overall Study||35
6795224|NCT03369431|7726791|FG001|Taste Test (1 Week)|Overall Study||34
6795225|NCT03369431|7726790|FG000|Part 1 Treatment (12 Weeks)|Overall Study||34
6795226|NCT03369431|7726791|FG001|Part 1 Treatment (12 Weeks)|Overall Study||34
6795227|NCT03369431|7726790|FG000|Washout (4 Weeks)|Overall Study||34
6795228|NCT03369431|7726791|FG001|Washout (4 Weeks)|Overall Study||32
6795229|NCT03369431|7726790|FG000|Part 2 Treatment (12 Weeks)|Overall Study||34
6795230|NCT03369431|7726791|FG001|Part 2 Treatment (12 Weeks)|Overall Study||32
6795231|NCT03369431|7726790|FG000|COMPLETED|Overall Study||31
6795232|NCT03369431|7726791|FG001|COMPLETED|Overall Study||27
6795233|NCT03369431|7726790|FG000|NOT COMPLETED|Overall Study||4
6795234|NCT03369431|7726791|FG001|NOT COMPLETED|Overall Study||7
6795235|NCT03343054|7726800|FG000|STARTED|Dose Escalation Period (Up to 286 Days)||3
6795236|NCT03343054|7726801|FG001|STARTED|Dose Escalation Period (Up to 286 Days)||6
6795237|NCT03343054|7726802|FG002|STARTED|Dose Escalation Period (Up to 286 Days)|Dose escalation and Dose expansion were separate populations.|0
6795238|NCT03343054|7726800|FG000|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
6795239|NCT03343054|7726801|FG001|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
6795240|NCT03343054|7726802|FG002|COMPLETED|Dose Escalation Period (Up to 286 Days)||0
6795241|NCT03343054|7726800|FG000|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||3
6795242|NCT03343054|7726801|FG001|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||6
6795243|NCT03343054|7726802|FG002|NOT COMPLETED|Dose Escalation Period (Up to 286 Days)||0
6795244|NCT03343054|7726800|FG000|STARTED|Dose Expansion Period (Up to 502 Days)||0
6795245|NCT03343054|7726801|FG001|STARTED|Dose Expansion Period (Up to 502 Days)||0
6795246|NCT03343054|7726802|FG002|STARTED|Dose Expansion Period (Up to 502 Days)|Dose escalation and Dose expansion were separate populations.|19
6795247|NCT03343054|7726800|FG000|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
6795248|NCT03343054|7726801|FG001|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
6795249|NCT03343054|7726802|FG002|COMPLETED|Dose Expansion Period (Up to 502 Days)||0
6795250|NCT03343054|7726800|FG000|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
6795251|NCT03343054|7726801|FG001|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||0
6795252|NCT03343054|7726802|FG002|NOT COMPLETED|Dose Expansion Period (Up to 502 Days)||19
6795253|NCT03336866|7726814|FG000|STARTED|Overall Study||20
6795254|NCT03336866|7726815|FG001|STARTED|Overall Study||18
6795255|NCT03336866|7726816|FG002|STARTED|Overall Study||18
6795256|NCT03336866|7726814|FG000|COMPLETED|Overall Study||17
6795257|NCT03336866|7726815|FG001|COMPLETED|Overall Study||17
6795258|NCT03336866|7726816|FG002|COMPLETED|Overall Study||14
6795259|NCT03336866|7726814|FG000|NOT COMPLETED|Overall Study||3
6795260|NCT03336866|7726815|FG001|NOT COMPLETED|Overall Study||1
6795261|NCT03336866|7726816|FG002|NOT COMPLETED|Overall Study||4
6795262|NCT03332173|7726829|FG000|STARTED|Overall Study||44
6563661|NCT01807637|7486521|FG000|NOT COMPLETED|Baseline||0
6563662|NCT01807637|7486522|FG001|NOT COMPLETED|Baseline||0
6563663|NCT01807637|7486521|FG000|STARTED|One Week||4
6563664|NCT01807637|7486522|FG001|STARTED|One Week||2
6563665|NCT01807637|7486521|FG000|COMPLETED|One Week||4
6563666|NCT01807637|7486522|FG001|COMPLETED|One Week||2
6563667|NCT01807637|7486521|FG000|NOT COMPLETED|One Week||0
6563668|NCT01807637|7486522|FG001|NOT COMPLETED|One Week||0
6563669|NCT01807637|7486521|FG000|STARTED|One Month||4
6563670|NCT01807637|7486522|FG001|STARTED|One Month||2
6563671|NCT01807637|7486521|FG000|COMPLETED|One Month||4
6563672|NCT01807637|7486522|FG001|COMPLETED|One Month||2
6563673|NCT01807637|7486521|FG000|NOT COMPLETED|One Month||0
6563674|NCT01807637|7486522|FG001|NOT COMPLETED|One Month||0
6563675|NCT01807650|7486530|FG000|STARTED|Overall Study||112
6563676|NCT01807650|7486530|FG000|COMPLETED|Overall Study||92
6563677|NCT01807650|7486530|FG000|NOT COMPLETED|Overall Study||20
6563678|NCT01807871|7486573|FG000|STARTED|Overall Study||356
6563679|NCT01807871|7486574|FG001|STARTED|Overall Study||345
6563680|NCT01807871|7486573|FG000|COMPLETED|Overall Study||178
6563681|NCT01807871|7486574|FG001|COMPLETED|Overall Study||127
6563682|NCT01807871|7486573|FG000|NOT COMPLETED|Overall Study||178
6563683|NCT01807871|7486574|FG001|NOT COMPLETED|Overall Study||218
6563684|NCT01807923|7486583|FG000|STARTED|Overall Study||187
6563685|NCT01807923|7486584|FG001|STARTED|Overall Study||185
6563686|NCT01807923|7486585|FG002|STARTED|Overall Study||187
6563687|NCT01807923|7486583|FG000|COMPLETED|Overall Study||182
6563688|NCT01807923|7486584|FG001|COMPLETED|Overall Study||179
6563689|NCT01807923|7486585|FG002|COMPLETED|Overall Study||176
6563690|NCT01807923|7486583|FG000|NOT COMPLETED|Overall Study||5
6795263|NCT03332173|7726829|FG000|COMPLETED|Overall Study||0
6795264|NCT03332173|7726829|FG000|NOT COMPLETED|Overall Study||44
6795265|NCT03322293|7726836|FG000|STARTED|Overall Study||8
6795266|NCT03322293|7726837|FG001|STARTED|Overall Study||8
6795267|NCT03322293|7726838|FG002|STARTED|Overall Study||8
6795268|NCT03322293|7726836|FG000|COMPLETED|Overall Study||8
6795269|NCT03322293|7726837|FG001|COMPLETED|Overall Study||8
6795270|NCT03322293|7726838|FG002|COMPLETED|Overall Study||7
6795271|NCT03322293|7726836|FG000|NOT COMPLETED|Overall Study||0
6795272|NCT03322293|7726837|FG001|NOT COMPLETED|Overall Study||0
6795273|NCT03322293|7726838|FG002|NOT COMPLETED|Overall Study||1
6795274|NCT03315039|7726848|FG000|STARTED|Overall Study||4
6563691|NCT01807923|7486584|FG001|NOT COMPLETED|Overall Study||6
6563692|NCT01807923|7486585|FG002|NOT COMPLETED|Overall Study||11
6795275|NCT03315039|7726849|FG001|STARTED|Overall Study||3
6795276|NCT03315039|7726848|FG000|COMPLETED|Overall Study||4
6795277|NCT03315039|7726849|FG001|COMPLETED|Overall Study||3
6795278|NCT03315039|7726848|FG000|NOT COMPLETED|Overall Study||0
6795279|NCT03315039|7726849|FG001|NOT COMPLETED|Overall Study||0
6795280|NCT03254394|7726860|FG000|STARTED|Overall Study||12
6795281|NCT03254394|7726861|FG001|STARTED|Overall Study||14
6795282|NCT03254394|7726860|FG000|COMPLETED|Overall Study||12
6795283|NCT03254394|7726861|FG001|COMPLETED|Overall Study||12
6795284|NCT03254394|7726860|FG000|NOT COMPLETED|Overall Study||0
6795285|NCT03254394|7726861|FG001|NOT COMPLETED|Overall Study||2
6795286|NCT03253809|7726867|FG000|STARTED|Overall Study||14
6795287|NCT03253809|7726867|FG000|COMPLETED|Overall Study||0
6795288|NCT03253809|7726867|FG000|NOT COMPLETED|Overall Study||14
6795289|NCT03180294|7726874|FG000|STARTED|Overall Study||79
6795290|NCT03180294|7726875|FG001|STARTED|Overall Study||74
6795291|NCT03180294|7726876|FG002|STARTED|Overall Study||77
6795292|NCT03180294|7726874|FG000|Eligible Population|Overall Study||79
6795293|NCT03180294|7726875|FG001|Eligible Population|Overall Study||74
6795294|NCT03180294|7726876|FG002|Eligible Population|Overall Study||77
6795295|NCT03180294|7726874|FG000|Adverse Event Population|Overall Study||77
6795296|NCT03180294|7726875|FG001|Adverse Event Population|Overall Study||73
6795297|NCT03180294|7726876|FG002|Adverse Event Population|Overall Study||76
6795298|NCT03180294|7726874|FG000|COMPLETED|Overall Study||79
6795299|NCT03180294|7726875|FG001|COMPLETED|Overall Study||74
6795300|NCT03180294|7726876|FG002|COMPLETED|Overall Study||77
6795301|NCT03180294|7726874|FG000|NOT COMPLETED|Overall Study||0
6795302|NCT03180294|7726875|FG001|NOT COMPLETED|Overall Study||0
6795303|NCT03180294|7726876|FG002|NOT COMPLETED|Overall Study||0
6795304|NCT03151408|7726887|FG000|STARTED|Overall Study|Screened patients|203
6795305|NCT03151408|7726888|FG001|STARTED|Overall Study|Screened patients|203
6795306|NCT03151408|7726887|FG000|Treated|Overall Study||201
6795307|NCT03151408|7726888|FG001|Treated|Overall Study||201
6795308|NCT03151408|7726887|FG000|COMPLETED|Overall Study||0
6795309|NCT03151408|7726888|FG001|COMPLETED|Overall Study||0
6795310|NCT03151408|7726887|FG000|NOT COMPLETED|Overall Study||203
6795311|NCT03151408|7726888|FG001|NOT COMPLETED|Overall Study||203
6795312|NCT03137173|7726896|FG000|STARTED|Overall Study||335
6795313|NCT03137173|7726897|FG001|STARTED|Overall Study||344
6795314|NCT03137173|7726896|FG000|COMPLETED|Overall Study||309
6795315|NCT03137173|7726897|FG001|COMPLETED|Overall Study||308
6795316|NCT03137173|7726896|FG000|NOT COMPLETED|Overall Study||26
6795317|NCT03137173|7726897|FG001|NOT COMPLETED|Overall Study||36
6795318|NCT03111030|7726906|FG000|STARTED|Overall Study||14
6795319|NCT03111030|7726907|FG001|STARTED|Overall Study||14
6795320|NCT03111030|7726906|FG000|COMPLETED|Overall Study||14
6795321|NCT03111030|7726907|FG001|COMPLETED|Overall Study||14
6795322|NCT03111030|7726906|FG000|NOT COMPLETED|Overall Study||0
6795323|NCT03111030|7726907|FG001|NOT COMPLETED|Overall Study||0
6795324|NCT03100149|7726916|FG000|STARTED|Overall Study||105
6795325|NCT03100149|7726917|FG001|STARTED|Overall Study||105
6795326|NCT03100149|7726918|FG002|STARTED|Overall Study||106
6795327|NCT03100149|7726916|FG000|COMPLETED|Overall Study||105
6795328|NCT03100149|7726917|FG001|COMPLETED|Overall Study||101
6795329|NCT03100149|7726918|FG002|COMPLETED|Overall Study||104
6795330|NCT03100149|7726916|FG000|NOT COMPLETED|Overall Study||0
6795331|NCT03100149|7726917|FG001|NOT COMPLETED|Overall Study||4
6795332|NCT03100149|7726918|FG002|NOT COMPLETED|Overall Study||2
6795333|NCT03081052|7726930|FG000|STARTED|Overall Study||98
6268883|NCT00068718|7167985|FG000|STARTED|Overall Study||35
6795334|NCT03081052|7726931|FG001|STARTED|Overall Study||103
6795335|NCT03081052|7726932|FG002|STARTED|Overall Study||111
6795336|NCT03081052|7726933|FG003|STARTED|Overall Study||120
6795337|NCT03081052|7726930|FG000|COMPLETED|Overall Study||98
6795338|NCT03081052|7726931|FG001|COMPLETED|Overall Study||103
6795339|NCT03081052|7726932|FG002|COMPLETED|Overall Study||111
6795340|NCT03081052|7726933|FG003|COMPLETED|Overall Study||120
6795341|NCT03081052|7726930|FG000|NOT COMPLETED|Overall Study||0
6795342|NCT03081052|7726931|FG001|NOT COMPLETED|Overall Study||0
6795343|NCT03081052|7726932|FG002|NOT COMPLETED|Overall Study||0
6795344|NCT03081052|7726933|FG003|NOT COMPLETED|Overall Study||0
6795345|NCT03028740|7726949|FG000|STARTED|Overall Study||593
6795346|NCT03028740|7726950|FG001|STARTED|Overall Study||1185
6795347|NCT03028740|7726949|FG000|Full Study Cohort: Received Study Drug|Overall Study||589
6795348|NCT03028740|7726950|FG001|Full Study Cohort: Received Study Drug|Overall Study||1180
6795349|NCT03028740|7726949|FG000|Participated in Part 1|Overall Study||432
6795350|NCT03028740|7726950|FG001|Participated in Part 1|Overall Study||861
6795351|NCT03028740|7726949|FG000|Part 1: Received Study Drug|Overall Study||429
6795352|NCT03028740|7726950|FG001|Part 1: Received Study Drug|Overall Study||859
6795353|NCT03028740|7726949|FG000|COMPLETED|Overall Study||0
6795354|NCT03028740|7726950|FG001|COMPLETED|Overall Study||0
6795355|NCT03028740|7726949|FG000|NOT COMPLETED|Overall Study||593
6795356|NCT03028740|7726950|FG001|NOT COMPLETED|Overall Study||1185
6795357|NCT03015142|7726959|FG000|STARTED|Overall Study||21
6795358|NCT03015142|7726959|FG000|COMPLETED|Overall Study||20
6795359|NCT03015142|7726959|FG000|NOT COMPLETED|Overall Study||1
6795360|NCT03012672|7726967|FG000|STARTED|Overall Study||20
6795361|NCT03012672|7726968|FG001|STARTED|Overall Study||30
6795362|NCT03012672|7726967|FG000|COMPLETED|Overall Study||20
6795363|NCT03012672|7726968|FG001|COMPLETED|Overall Study||30
6795364|NCT03012672|7726967|FG000|NOT COMPLETED|Overall Study||0
6795365|NCT03012672|7726968|FG001|NOT COMPLETED|Overall Study||0
6795366|NCT03011775|7726975|FG000|STARTED|Overall Study||20
6795367|NCT03011775|7726976|FG001|STARTED|Overall Study||23
6795368|NCT03011775|7726975|FG000|COMPLETED|Overall Study||20
6795369|NCT03011775|7726976|FG001|COMPLETED|Overall Study||23
6795370|NCT03011775|7726975|FG000|NOT COMPLETED|Overall Study||0
6795371|NCT03011775|7726976|FG001|NOT COMPLETED|Overall Study||0
6795372|NCT03007485|7726988|FG000|STARTED|Overall Study||98
6795373|NCT03007485|7726989|FG001|STARTED|Overall Study||111
6795374|NCT03007485|7726988|FG000|COMPLETED|Overall Study||28
6795375|NCT03007485|7726989|FG001|COMPLETED|Overall Study||57
6795376|NCT03007485|7726988|FG000|NOT COMPLETED|Overall Study||70
6795377|NCT03007485|7726989|FG001|NOT COMPLETED|Overall Study||54
6795378|NCT02998476|7727002|FG000|STARTED|Overall Study||55
6795379|NCT02998476|7727003|FG001|STARTED|Overall Study||5
6795380|NCT02998476|7727002|FG000|COMPLETED|Overall Study||0
6795381|NCT02998476|7727003|FG001|COMPLETED|Overall Study||0
6795382|NCT02998476|7727002|FG000|NOT COMPLETED|Overall Study||55
6795383|NCT02998476|7727003|FG001|NOT COMPLETED|Overall Study||5
6795384|NCT02960997|7727012|FG000|STARTED|First Intervention, 12 Weeks||4
6795385|NCT02960997|7727013|FG001|STARTED|First Intervention, 12 Weeks||4
6795386|NCT02960997|7727012|FG000|COMPLETED|First Intervention, 12 Weeks||4
6795387|NCT02960997|7727013|FG001|COMPLETED|First Intervention, 12 Weeks||4
6795388|NCT02960997|7727012|FG000|NOT COMPLETED|First Intervention, 12 Weeks||0
6795389|NCT02960997|7727013|FG001|NOT COMPLETED|First Intervention, 12 Weeks||0
6795390|NCT02960997|7727012|FG000|STARTED|Washout Period, 4 Weeks||4
6795391|NCT02960997|7727013|FG001|STARTED|Washout Period, 4 Weeks||4
6795392|NCT02960997|7727012|FG000|COMPLETED|Washout Period, 4 Weeks||4
6795393|NCT02960997|7727013|FG001|COMPLETED|Washout Period, 4 Weeks||4
6795394|NCT02960997|7727012|FG000|NOT COMPLETED|Washout Period, 4 Weeks||0
6795395|NCT02960997|7727013|FG001|NOT COMPLETED|Washout Period, 4 Weeks||0
6795396|NCT02960997|7727012|FG000|STARTED|Second Treatment, 12 Weeks||4
6795397|NCT02960997|7727013|FG001|STARTED|Second Treatment, 12 Weeks||4
6795398|NCT02960997|7727012|FG000|COMPLETED|Second Treatment, 12 Weeks||4
6795399|NCT02960997|7727013|FG001|COMPLETED|Second Treatment, 12 Weeks||4
6795400|NCT02960997|7727012|FG000|NOT COMPLETED|Second Treatment, 12 Weeks||0
6795401|NCT02960997|7727013|FG001|NOT COMPLETED|Second Treatment, 12 Weeks||0
6795402|NCT02960997|7727012|FG000|STARTED|Follow-up Period, 4 Weeks||4
6795403|NCT02960997|7727013|FG001|STARTED|Follow-up Period, 4 Weeks||4
6795404|NCT02960997|7727012|FG000|COMPLETED|Follow-up Period, 4 Weeks||4
6795405|NCT02960997|7727013|FG001|COMPLETED|Follow-up Period, 4 Weeks||4
6795406|NCT02960997|7727012|FG000|NOT COMPLETED|Follow-up Period, 4 Weeks||0
6795407|NCT02960997|7727013|FG001|NOT COMPLETED|Follow-up Period, 4 Weeks||0
6795408|NCT02949128|7727019|FG000|STARTED|Initial Evaluation Period||58
6795409|NCT02949128|7727019|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||58
6795410|NCT02949128|7727019|FG000|COMPLETED|Initial Evaluation Period||49
6795411|NCT02949128|7727019|FG000|NOT COMPLETED|Initial Evaluation Period||9
6795412|NCT02949128|7727019|FG000|STARTED|Extension Period||49
6795413|NCT02949128|7727019|FG000|Received At Least 1 Dose of Study Drug|Extension Period||47
6795414|NCT02949128|7727019|FG000|COMPLETED|Extension Period||47
6795415|NCT02949128|7727019|FG000|NOT COMPLETED|Extension Period||2
6795416|NCT02944071|7727023|FG000|STARTED|Overall Study||123
6795417|NCT02944071|7727023|FG000|COMPLETED|Overall Study||113
6563693|NCT01807949|7486598|FG000|STARTED|Overall Study||187
6563694|NCT01807949|7486599|FG001|STARTED|Overall Study||187
6563695|NCT01807949|7486600|FG002|STARTED|Overall Study||189
6563696|NCT01807949|7486598|FG000|COMPLETED|Overall Study||185
6563697|NCT01807949|7486599|FG001|COMPLETED|Overall Study||180
6563698|NCT01807949|7486600|FG002|COMPLETED|Overall Study||180
6563699|NCT01807949|7486598|FG000|NOT COMPLETED|Overall Study||2
6563700|NCT01807949|7486599|FG001|NOT COMPLETED|Overall Study||7
6563701|NCT01807949|7486600|FG002|NOT COMPLETED|Overall Study||9
6563702|NCT01808066|7486610|FG000|STARTED|Overall Study||21
6563703|NCT01808066|7486610|FG000|COMPLETED|Overall Study||6
6563704|NCT01808066|7486610|FG000|NOT COMPLETED|Overall Study||15
6795418|NCT02944071|7727023|FG000|NOT COMPLETED|Overall Study||10
6795419|NCT02924064|7727029|FG000|STARTED|Overall Study||123
6795420|NCT02924064|7727030|FG001|STARTED|Overall Study||124
6795421|NCT02924064|7727029|FG000|FAS|Overall Study||122
6795422|NCT02924064|7727030|FG001|FAS|Overall Study||124
6795423|NCT02924064|7727029|FG000|COMPLETED|Overall Study||99
6795424|NCT02924064|7727030|FG001|COMPLETED|Overall Study||81
6795425|NCT02924064|7727029|FG000|NOT COMPLETED|Overall Study||24
6795426|NCT02924064|7727030|FG001|NOT COMPLETED|Overall Study||43
6795427|NCT02916706|7727038|FG000|STARTED|Overall Study||127
6795428|NCT02916706|7727039|FG001|STARTED|Overall Study||127
6795429|NCT02916706|7727038|FG000|FAS|Overall Study||125
6795430|NCT02916706|7727039|FG001|FAS|Overall Study||126
6795431|NCT02916706|7727038|FG000|COMPLETED|Overall Study||112
6795432|NCT02916706|7727039|FG001|COMPLETED|Overall Study||96
6795433|NCT02916706|7727038|FG000|NOT COMPLETED|Overall Study||15
6795434|NCT02916706|7727039|FG001|NOT COMPLETED|Overall Study||31
6795435|NCT02889900|7727045|FG000|STARTED|Overall Study||62
6795436|NCT02889900|7727045|FG000|Received Treatment|Overall Study||60
6795437|NCT02889900|7727045|FG000|COMPLETED|Overall Study|Patients ongoing in study at primary analysis data cut off (DCO)|5
6795438|NCT02889900|7727045|FG000|NOT COMPLETED|Overall Study||57
6795439|NCT02866695|7727049|FG000|STARTED|Overall Study||20
6795440|NCT02866695|7727049|FG000|COMPLETED|Overall Study||18
6795441|NCT02866695|7727049|FG000|NOT COMPLETED|Overall Study||2
6795442|NCT02854436|7727053|FG000|STARTED|Overall Study||289
6795443|NCT02854436|7727053|FG000|Intent to Treat Participants (Breast Cancer Gene [BRCA] and Non-BRCA Participants)|Overall Study|There were 142 BRCA participants and 81 non-BRCA participants.|223
6795444|NCT02854436|7727053|FG000|COMPLETED|Overall Study||0
6795445|NCT02854436|7727053|FG000|NOT COMPLETED|Overall Study||289
6795446|NCT02834793|7727059|FG000|STARTED|Core Study (Up to 18 Weeks)||36
6795447|NCT02834793|7727060|FG001|STARTED|Core Study (Up to 18 Weeks)||34
6795448|NCT02834793|7727061|FG002|STARTED|Core Study (Up to 18 Weeks)||0
6795449|NCT02834793|7727062|FG003|STARTED|Core Study (Up to 18 Weeks)||0
6795450|NCT02834793|7727059|FG000|COMPLETED|Core Study (Up to 18 Weeks)||32
6795451|NCT02834793|7727060|FG001|COMPLETED|Core Study (Up to 18 Weeks)||29
6795452|NCT02834793|7727061|FG002|COMPLETED|Core Study (Up to 18 Weeks)||0
6795453|NCT02834793|7727062|FG003|COMPLETED|Core Study (Up to 18 Weeks)||0
6563705|NCT01808092|7486617|FG000|STARTED|Overall Study||409
6563706|NCT01808092|7486618|FG001|STARTED|Overall Study||408
6563707|NCT01808092|7486617|FG000|COMPLETED|Overall Study||355
6563708|NCT01808092|7486618|FG001|COMPLETED|Overall Study||363
6795454|NCT02834793|7727059|FG000|NOT COMPLETED|Core Study (Up to 18 Weeks)||4
6795455|NCT02834793|7727060|FG001|NOT COMPLETED|Core Study (Up to 18 Weeks)||5
6795456|NCT02834793|7727061|FG002|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
6795457|NCT02834793|7727062|FG003|NOT COMPLETED|Core Study (Up to 18 Weeks)||0
6795458|NCT02834793|7727059|FG000|STARTED|Extension Phase A (up to 52 Weeks)||0
6795459|NCT02834793|7727060|FG001|STARTED|Extension Phase A (up to 52 Weeks)||0
6795460|NCT02834793|7727061|FG002|STARTED|Extension Phase A (up to 52 Weeks)|Only eligible participants who completed Core Study entered into Extension Phase A.|58
6795461|NCT02834793|7727062|FG003|STARTED|Extension Phase A (up to 52 Weeks)||0
6795462|NCT02834793|7727059|FG000|COMPLETED|Extension Phase A (up to 52 Weeks)||0
6795463|NCT02834793|7727060|FG001|COMPLETED|Extension Phase A (up to 52 Weeks)||0
6795464|NCT02834793|7727061|FG002|COMPLETED|Extension Phase A (up to 52 Weeks)||32
6795465|NCT02834793|7727062|FG003|COMPLETED|Extension Phase A (up to 52 Weeks)||0
6795466|NCT02834793|7727059|FG000|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
6795467|NCT02834793|7727060|FG001|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
6795468|NCT02834793|7727061|FG002|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||26
6795469|NCT02834793|7727062|FG003|NOT COMPLETED|Extension Phase A (up to 52 Weeks)||0
6795470|NCT02834793|7727059|FG000|STARTED|Extension Phase B (up to 188 Weeks)||0
6795471|NCT02834793|7727060|FG001|STARTED|Extension Phase B (up to 188 Weeks)||0
6795472|NCT02834793|7727061|FG002|STARTED|Extension Phase B (up to 188 Weeks)||0
6795473|NCT02834793|7727062|FG003|STARTED|Extension Phase B (up to 188 Weeks)|Only eligible participants who completed Extension Phase A entered into Extension Phase B.|13
6795474|NCT02834793|7727059|FG000|COMPLETED|Extension Phase B (up to 188 Weeks)||0
6795475|NCT02834793|7727060|FG001|COMPLETED|Extension Phase B (up to 188 Weeks)||0
6795476|NCT02834793|7727061|FG002|COMPLETED|Extension Phase B (up to 188 Weeks)||0
6795477|NCT02834793|7727062|FG003|COMPLETED|Extension Phase B (up to 188 Weeks)||1
6795478|NCT02834793|7727059|FG000|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
6795479|NCT02834793|7727060|FG001|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
6795480|NCT02834793|7727061|FG002|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||0
6795481|NCT02834793|7727062|FG003|NOT COMPLETED|Extension Phase B (up to 188 Weeks)||12
6795482|NCT02810457|7727072|FG000|STARTED|Overall Study|362 patients received study treatment|364
6795483|NCT02810457|7727073|FG001|STARTED|Overall Study|366 patients received study treatment|367
6795484|NCT02810457|7727072|FG000|COMPLETED|Overall Study||37
6795485|NCT02810457|7727073|FG001|COMPLETED|Overall Study||38
6795486|NCT02810457|7727072|FG000|NOT COMPLETED|Overall Study||327
6795487|NCT02810457|7727073|FG001|NOT COMPLETED|Overall Study||329
6795488|NCT02797964|7727085|FG000|STARTED|Overall Study||32
6795489|NCT02797964|7727086|FG001|STARTED|Overall Study||37
6795490|NCT02797964|7727087|FG002|STARTED|Overall Study||10
6795491|NCT02797964|7727088|FG003|STARTED|Overall Study||16
6795492|NCT02797964|7727089|FG004|STARTED|Overall Study||4
6795493|NCT02797964|7727090|FG005|STARTED|Overall Study||8
6795494|NCT02797964|7727085|FG000|COMPLETED|Overall Study||32
6795495|NCT02797964|7727086|FG001|COMPLETED|Overall Study||37
6795496|NCT02797964|7727087|FG002|COMPLETED|Overall Study||10
6795497|NCT02797964|7727088|FG003|COMPLETED|Overall Study||16
6795498|NCT02797964|7727089|FG004|COMPLETED|Overall Study||4
6795499|NCT02797964|7727090|FG005|COMPLETED|Overall Study||8
6795500|NCT02797964|7727085|FG000|NOT COMPLETED|Overall Study||0
6795501|NCT02797964|7727086|FG001|NOT COMPLETED|Overall Study||0
6795502|NCT02797964|7727087|FG002|NOT COMPLETED|Overall Study||0
6795503|NCT02797964|7727088|FG003|NOT COMPLETED|Overall Study||0
6795504|NCT02797964|7727089|FG004|NOT COMPLETED|Overall Study||0
6795505|NCT02797964|7727090|FG005|NOT COMPLETED|Overall Study||0
6795506|NCT02746809|7727103|FG000|STARTED|Baseline- 30 Days||60
6795507|NCT02746809|7727103|FG000|COMPLETED|Baseline- 30 Days||59
6795508|NCT02746809|7727103|FG000|NOT COMPLETED|Baseline- 30 Days||1
6795509|NCT02746809|7727103|FG000|STARTED|Baseline-6 Months||59
6795510|NCT02746809|7727103|FG000|COMPLETED|Baseline-6 Months||54
6795511|NCT02746809|7727103|FG000|NOT COMPLETED|Baseline-6 Months||5
6795512|NCT02745535|7727109|FG000|STARTED|Overall Study||77
6795513|NCT02745535|7727109|FG000|Sustained Virologic Repsonse|Overall Study|Sustained Virologic response measured 24 weeks after completing study medication|70
6795514|NCT02745535|7727109|FG000|COMPLETED|Overall Study|Completed 12 weeks of study medication per protocol|71
6795515|NCT02745535|7727109|FG000|NOT COMPLETED|Overall Study||6
6795516|NCT02738853|7727113|FG000|STARTED|Baseline -30 Days||60
6795517|NCT02738853|7727113|FG000|COMPLETED|Baseline -30 Days||59
6795518|NCT02738853|7727113|FG000|NOT COMPLETED|Baseline -30 Days||1
6795519|NCT02738853|7727113|FG000|STARTED|30 Days- 6 Months||59
6795520|NCT02738853|7727113|FG000|COMPLETED|30 Days- 6 Months||57
6795521|NCT02738853|7727113|FG000|NOT COMPLETED|30 Days- 6 Months||2
6795522|NCT02729701|7727117|FG000|STARTED|Overall Study||28
6795523|NCT02729701|7727117|FG000|COMPLETED|Overall Study||28
6795524|NCT02729701|7727117|FG000|NOT COMPLETED|Overall Study||0
6795525|NCT02684253|7727123|FG000|STARTED|Overall Study||32
6795526|NCT02684253|7727124|FG001|STARTED|Overall Study||33
6795527|NCT02684253|7727123|FG000|COMPLETED|Overall Study||32
6795528|NCT02684253|7727124|FG001|COMPLETED|Overall Study||33
6795529|NCT02684253|7727123|FG000|NOT COMPLETED|Overall Study||0
6795530|NCT02684253|7727124|FG001|NOT COMPLETED|Overall Study||0
6795531|NCT02681406|7727134|FG000|STARTED|Overall Study||65
6795532|NCT02681406|7727135|FG001|STARTED|Overall Study||59
6795533|NCT02681406|7727136|FG002|STARTED|Overall Study||68
6795534|NCT02681406|7727137|FG003|STARTED|Overall Study||70
6795535|NCT02681406|7727134|FG000|COMPLETED|Overall Study||49
6795536|NCT02681406|7727135|FG001|COMPLETED|Overall Study||35
6795537|NCT02681406|7727136|FG002|COMPLETED|Overall Study||42
6795538|NCT02681406|7727137|FG003|COMPLETED|Overall Study||58
6795539|NCT02681406|7727134|FG000|NOT COMPLETED|Overall Study||16
6795540|NCT02681406|7727135|FG001|NOT COMPLETED|Overall Study||24
6795541|NCT02681406|7727136|FG002|NOT COMPLETED|Overall Study||26
6795542|NCT02681406|7727137|FG003|NOT COMPLETED|Overall Study||12
6795543|NCT02625090|7727147|FG000|STARTED|Overall Study||42
6795544|NCT02625090|7727147|FG000|COMPLETED|Overall Study||0
6795545|NCT02625090|7727147|FG000|NOT COMPLETED|Overall Study||42
6563709|NCT01808092|7486617|FG000|NOT COMPLETED|Overall Study||54
6563710|NCT01808092|7486618|FG001|NOT COMPLETED|Overall Study||45
6563711|NCT01808118|7486624|FG000|STARTED|Period 1||673
6563712|NCT01808118|7486625|FG001|STARTED|Period 1||0
6563713|NCT01808118|7486626|FG002|STARTED|Period 1||0
6563714|NCT01808118|7486624|FG000|COMPLETED|Period 1||305
6563715|NCT01808118|7486625|FG001|COMPLETED|Period 1||0
6563716|NCT01808118|7486626|FG002|COMPLETED|Period 1||0
6563717|NCT01808118|7486624|FG000|NOT COMPLETED|Period 1||368
6563718|NCT01808118|7486625|FG001|NOT COMPLETED|Period 1||0
6563719|NCT01808118|7486626|FG002|NOT COMPLETED|Period 1||0
6563720|NCT01808118|7486624|FG000|STARTED|Period 2||0
6563721|NCT01808118|7486625|FG001|STARTED|Period 2||153
6563722|NCT01808118|7486626|FG002|STARTED|Period 2||152
6563723|NCT01808118|7486624|FG000|COMPLETED|Period 2||0
6563724|NCT01808118|7486625|FG001|COMPLETED|Period 2||140
6563725|NCT01808118|7486626|FG002|COMPLETED|Period 2||144
6563726|NCT01808118|7486624|FG000|NOT COMPLETED|Period 2||0
6563727|NCT01808118|7486625|FG001|NOT COMPLETED|Period 2||13
6563728|NCT01808118|7486626|FG002|NOT COMPLETED|Period 2||8
6795546|NCT02539225|7727154|FG000|STARTED|Part A||97
6795547|NCT02539225|7727155|FG001|STARTED|Part A||94
6795548|NCT02539225|7727154|FG000|Received Any Quantity of Study Drug|Part A||96
6795549|NCT02539225|7727155|FG001|Received Any Quantity of Study Drug|Part A||93
6795550|NCT02539225|7727154|FG000|COMPLETED|Part A||77
6795551|NCT02539225|7727155|FG001|COMPLETED|Part A||78
6795552|NCT02539225|7727154|FG000|NOT COMPLETED|Part A||20
6795553|NCT02539225|7727155|FG001|NOT COMPLETED|Part A||16
6795554|NCT02539225|7727154|FG000|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|63
6795555|NCT02539225|7727155|FG001|STARTED|Pre Treatment for Part B|Participants who met initiation criteria of Part B were allowed to pretreatment for part B.|66
6795556|NCT02539225|7727154|FG000|COMPLETED|Pre Treatment for Part B||58
6795557|NCT02539225|7727155|FG001|COMPLETED|Pre Treatment for Part B||64
6795558|NCT02539225|7727154|FG000|NOT COMPLETED|Pre Treatment for Part B||5
6795559|NCT02539225|7727155|FG001|NOT COMPLETED|Pre Treatment for Part B||2
6795560|NCT02539225|7727154|FG000|STARTED|Part B||58
6795561|NCT02539225|7727155|FG001|STARTED|Part B||64
6795562|NCT02539225|7727154|FG000|COMPLETED|Part B||54
6795563|NCT02539225|7727155|FG001|COMPLETED|Part B||48
6795564|NCT02539225|7727154|FG000|NOT COMPLETED|Part B||4
6795565|NCT02539225|7727155|FG001|NOT COMPLETED|Part B||16
6795566|NCT02528500|7727166|FG000|STARTED|Overall Study||10
6795567|NCT02528500|7727166|FG000|COMPLETED|Overall Study||10
6795568|NCT02528500|7727166|FG000|NOT COMPLETED|Overall Study||0
6795569|NCT02527681|7727170|FG000|STARTED|Overall Study||15
6795570|NCT02527681|7727170|FG000|COMPLETED|Overall Study||15
6795571|NCT02527681|7727170|FG000|NOT COMPLETED|Overall Study||0
6795572|NCT02526017|7727183|FG000|STARTED|Overall Study||3
6795573|NCT02526017|7727184|FG001|STARTED|Overall Study||10
6795574|NCT02526017|7727185|FG002|STARTED|Overall Study||11
6795575|NCT02526017|7727186|FG003|STARTED|Overall Study||4
6795576|NCT02526017|7727187|FG004|STARTED|Overall Study||4
6795577|NCT02526017|7727188|FG005|STARTED|Overall Study||3
6795578|NCT02526017|7727189|FG006|STARTED|Overall Study||6
6795579|NCT02526017|7727190|FG007|STARTED|Overall Study||10
6795580|NCT02526017|7727191|FG008|STARTED|Overall Study||262
6795581|NCT02526017|7727183|FG000|Received Study Treatment|Overall Study||3
6795582|NCT02526017|7727184|FG001|Received Study Treatment|Overall Study||10
6795583|NCT02526017|7727185|FG002|Received Study Treatment|Overall Study||11
6795584|NCT02526017|7727186|FG003|Received Study Treatment|Overall Study||4
6795585|NCT02526017|7727187|FG004|Received Study Treatment|Overall Study||3
6795586|NCT02526017|7727188|FG005|Received Study Treatment|Overall Study||3
6795587|NCT02526017|7727189|FG006|Received Study Treatment|Overall Study||6
6795588|NCT02526017|7727190|FG007|Received Study Treatment|Overall Study||10
6795589|NCT02526017|7727191|FG008|Received Study Treatment|Overall Study||262
6795590|NCT02526017|7727183|FG000|COMPLETED|Overall Study||3
6795591|NCT02526017|7727184|FG001|COMPLETED|Overall Study||10
6795592|NCT02526017|7727185|FG002|COMPLETED|Overall Study||11
6379627|NCT00773734|7290267|FG000|STARTED|Extension: Active Treatment Week 24-52||0
6379628|NCT00773734|7290268|FG001|STARTED|Extension: Active Treatment Week 24-52||47
6379629|NCT00773734|7290269|FG002|STARTED|Extension: Active Treatment Week 24-52||50
6379630|NCT00773734|7290270|FG003|STARTED|Extension: Active Treatment Week 24-52||58
6379631|NCT00773734|7290271|FG004|STARTED|Extension: Active Treatment Week 24-52||27
6379632|NCT00773734|7290272|FG005|STARTED|Extension: Active Treatment Week 24-52||27
6379633|NCT00773734|7290267|FG000|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
6379634|NCT00773734|7290268|FG001|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
6563729|NCT01808144|7486642|FG000|STARTED|Overall Study||97
6795593|NCT02526017|7727186|FG003|COMPLETED|Overall Study||4
6795594|NCT02526017|7727187|FG004|COMPLETED|Overall Study||3
6795595|NCT02526017|7727188|FG005|COMPLETED|Overall Study||3
6795596|NCT02526017|7727189|FG006|COMPLETED|Overall Study||6
6795597|NCT02526017|7727190|FG007|COMPLETED|Overall Study||10
6795598|NCT02526017|7727191|FG008|COMPLETED|Overall Study||262
6795599|NCT02526017|7727183|FG000|NOT COMPLETED|Overall Study||0
6795600|NCT02526017|7727184|FG001|NOT COMPLETED|Overall Study||0
6795601|NCT02526017|7727185|FG002|NOT COMPLETED|Overall Study||0
6795602|NCT02526017|7727186|FG003|NOT COMPLETED|Overall Study||0
6795603|NCT02526017|7727187|FG004|NOT COMPLETED|Overall Study||1
6795604|NCT02526017|7727188|FG005|NOT COMPLETED|Overall Study||0
6795605|NCT02526017|7727189|FG006|NOT COMPLETED|Overall Study||0
6795606|NCT02526017|7727190|FG007|NOT COMPLETED|Overall Study||0
6795607|NCT02526017|7727191|FG008|NOT COMPLETED|Overall Study||0
6795608|NCT02482233|7727253|FG000|STARTED|Overall Study||10
6795609|NCT02482233|7727254|FG001|STARTED|Overall Study||20
6795610|NCT02482233|7727253|FG000|COMPLETED|Overall Study||9
6795611|NCT02482233|7727254|FG001|COMPLETED|Overall Study||19
6795612|NCT02482233|7727253|FG000|NOT COMPLETED|Overall Study||1
6795613|NCT02482233|7727254|FG001|NOT COMPLETED|Overall Study||1
6795614|NCT02476916|7727264|FG000|STARTED|Core Period||27
6795615|NCT02476916|7727265|FG001|STARTED|Core Period||25
6795616|NCT02476916|7727264|FG000|COMPLETED|Core Period||21
6795617|NCT02476916|7727265|FG001|COMPLETED|Core Period||22
6795618|NCT02476916|7727264|FG000|NOT COMPLETED|Core Period||6
6795619|NCT02476916|7727265|FG001|NOT COMPLETED|Core Period||3
6795620|NCT02476916|7727264|FG000|STARTED|Extension Period||18
6795621|NCT02476916|7727265|FG001|STARTED|Extension Period||18
6795622|NCT02476916|7727264|FG000|COMPLETED|Extension Period||0
6795623|NCT02476916|7727265|FG001|COMPLETED|Extension Period||0
6795624|NCT02476916|7727264|FG000|NOT COMPLETED|Extension Period||18
6795625|NCT02476916|7727265|FG001|NOT COMPLETED|Extension Period||18
6795626|NCT02450331|7727274|FG000|STARTED|Overall Study||403
6795627|NCT02450331|7727275|FG001|STARTED|Overall Study||406
6795628|NCT02450331|7727274|FG000|COMPLETED|Overall Study||0
6795629|NCT02450331|7727275|FG001|COMPLETED|Overall Study||0
6795630|NCT02450331|7727274|FG000|NOT COMPLETED|Overall Study||403
6795631|NCT02450331|7727275|FG001|NOT COMPLETED|Overall Study||406
6795632|NCT02417415|7727282|FG000|STARTED|Overall Study||13
6795633|NCT02417415|7727283|FG001|STARTED|Overall Study||9
6795634|NCT02417415|7727282|FG000|COMPLETED|Overall Study||13
6795635|NCT02417415|7727283|FG001|COMPLETED|Overall Study||9
6795636|NCT02417415|7727282|FG000|NOT COMPLETED|Overall Study||0
6795637|NCT02417415|7727283|FG001|NOT COMPLETED|Overall Study||0
6795638|NCT02400736|7727291|FG000|STARTED|Overall Study||58
6795639|NCT02400736|7727292|FG001|STARTED|Overall Study||61
6795640|NCT02400736|7727291|FG000|COMPLETED|Overall Study||47
6795641|NCT02400736|7727292|FG001|COMPLETED|Overall Study||53
6795642|NCT02400736|7727291|FG000|NOT COMPLETED|Overall Study||11
6795643|NCT02400736|7727292|FG001|NOT COMPLETED|Overall Study||8
6795644|NCT02369653|7727304|FG000|STARTED|Overall Study||256
6795645|NCT02369653|7727305|FG001|STARTED|Overall Study||256
6795646|NCT02369653|7727304|FG000|Adverse Event Analysis Population|Overall Study|Out of the 256 participants randomized to Apixaban only 250 participants received an apixaban dose.|250
6795647|NCT02369653|7727305|FG001|Adverse Event Analysis Population|Overall Study|The 6 subjects who were randomized to apixaban but received no dose were analyzed in Standard of Care.|262
6795648|NCT02369653|7727304|FG000|COMPLETED|Overall Study||242
6563730|NCT01808144|7486643|FG001|STARTED|Overall Study||99
6563731|NCT01808144|7486642|FG000|COMPLETED|Overall Study||57
6795649|NCT02369653|7727305|FG001|COMPLETED|Overall Study||249
6795650|NCT02369653|7727304|FG000|NOT COMPLETED|Overall Study||14
6795651|NCT02369653|7727305|FG001|NOT COMPLETED|Overall Study||7
6795652|NCT02335424|7727315|FG000|STARTED|Overall Study||374
6795653|NCT02335424|7727315|FG000|Treated|Overall Study||370
6795654|NCT02335424|7727315|FG000|COMPLETED|Overall Study||0
6795655|NCT02335424|7727315|FG000|NOT COMPLETED|Overall Study||374
6795656|NCT02326974|7727319|FG000|STARTED|Overall Study||164
6795657|NCT02326974|7727319|FG000|Treated|Overall Study||163
6795658|NCT02326974|7727319|FG000|COMPLETED|Overall Study||157
6795659|NCT02326974|7727319|FG000|NOT COMPLETED|Overall Study||7
6379635|NCT00773734|7290269|FG002|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
6379636|NCT00773734|7290270|FG003|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
6379637|NCT00773734|7290271|FG004|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
6379638|NCT00773734|7290272|FG005|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
6379639|NCT00773734|7290267|FG000|COMPLETED|Extension: Active Treatment Week 24-52||0
6379640|NCT00773734|7290268|FG001|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
6379641|NCT00773734|7290269|FG002|COMPLETED|Extension: Active Treatment Week 24-52||33
6379642|NCT00773734|7290270|FG003|COMPLETED|Extension: Active Treatment Week 24-52||48
6379643|NCT00773734|7290271|FG004|COMPLETED|Extension: Active Treatment Week 24-52||22
6379644|NCT00773734|7290272|FG005|COMPLETED|Extension: Active Treatment Week 24-52||19
6379645|NCT00773734|7290267|FG000|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
6379646|NCT00773734|7290268|FG001|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
6379647|NCT00773734|7290269|FG002|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
6379648|NCT00773734|7290270|FG003|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
6379649|NCT00773734|7290271|FG004|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
6379650|NCT00773734|7290272|FG005|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
6379651|NCT00773734|7290267|FG000|STARTED|LTE Period: Week 52 to 6 Years||0
6379652|NCT00773734|7290268|FG001|STARTED|LTE Period: Week 52 to 6 Years||0
6379653|NCT00773734|7290269|FG002|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
6379654|NCT00773734|7290270|FG003|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
6379655|NCT00773734|7290271|FG004|STARTED|LTE Period: Week 52 to 6 Years||0
6379656|NCT00773734|7290272|FG005|STARTED|LTE Period: Week 52 to 6 Years||0
6379657|NCT00773734|7290267|FG000|COMPLETED|LTE Period: Week 52 to 6 Years||0
6379658|NCT00773734|7290268|FG001|COMPLETED|LTE Period: Week 52 to 6 Years||0
6379659|NCT00773734|7290269|FG002|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
6379660|NCT00773734|7290270|FG003|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
6379661|NCT00773734|7290271|FG004|COMPLETED|LTE Period: Week 52 to 6 Years||0
6379662|NCT00773734|7290272|FG005|COMPLETED|LTE Period: Week 52 to 6 Years||0
6379663|NCT00773734|7290267|FG000|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
6379664|NCT00773734|7290268|FG001|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
6379665|NCT00773734|7290269|FG002|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
6379666|NCT00773734|7290270|FG003|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
6379667|NCT00773734|7290271|FG004|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
6379668|NCT00773734|7290272|FG005|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
6379669|NCT00773747|7290331|FG000|STARTED|Overall Study||317
6379670|NCT00773747|7290332|FG001|STARTED|Overall Study||320
6795660|NCT02284568|7727330|FG000|STARTED|Overall Study|Intent to treat (ITT) population|140
6795661|NCT02284568|7727331|FG001|STARTED|Overall Study|Intent to treat (ITT) population|139
6795662|NCT02284568|7727332|FG002|STARTED|Overall Study|Intent to treat (ITT) population|95
6795663|NCT02284568|7727330|FG000|Safety Population|Overall Study||140
6795664|NCT02284568|7727331|FG001|Safety Population|Overall Study||138
6795665|NCT02284568|7727332|FG002|Safety Population|Overall Study||95
6795666|NCT02284568|7727330|FG000|Completed Week 48 MRI - on Treatment|Overall Study||113
6795667|NCT02284568|7727331|FG001|Completed Week 48 MRI - on Treatment|Overall Study||107
6795668|NCT02284568|7727332|FG002|Completed Week 48 MRI - on Treatment|Overall Study||0
6795669|NCT02284568|7727330|FG000|COMPLETED|Overall Study||109
6795670|NCT02284568|7727331|FG001|COMPLETED|Overall Study||93
6795671|NCT02284568|7727332|FG002|COMPLETED|Overall Study||0
6795672|NCT02284568|7727330|FG000|NOT COMPLETED|Overall Study||31
6795673|NCT02284568|7727331|FG001|NOT COMPLETED|Overall Study||46
6795674|NCT02284568|7727332|FG002|NOT COMPLETED|Overall Study||95
6795675|NCT02228525|7727340|FG000|STARTED|Overall Study||25
6795676|NCT02228525|7727340|FG000|COMPLETED|Overall Study||25
6795677|NCT02228525|7727340|FG000|NOT COMPLETED|Overall Study||0
6795678|NCT02227238|7727346|FG000|STARTED|Overall Study||312
6795679|NCT02227238|7727347|FG001|STARTED|Overall Study||312
6795680|NCT02227238|7727346|FG000|COMPLETED|Overall Study||275
6795681|NCT02227238|7727347|FG001|COMPLETED|Overall Study||245
6795682|NCT02227238|7727346|FG000|NOT COMPLETED|Overall Study||37
6795683|NCT02227238|7727347|FG001|NOT COMPLETED|Overall Study||67
6795684|NCT02195986|7727356|FG000|STARTED|Overall Study||146
6795685|NCT02195986|7727357|FG001|STARTED|Overall Study||147
6795686|NCT02195986|7727358|FG002|STARTED|Overall Study||73
6795687|NCT02195986|7727356|FG000|COMPLETED|Overall Study||143
6795688|NCT02195986|7727357|FG001|COMPLETED|Overall Study||142
6795689|NCT02195986|7727358|FG002|COMPLETED|Overall Study||71
6795690|NCT02195986|7727356|FG000|NOT COMPLETED|Overall Study||3
6795691|NCT02195986|7727357|FG001|NOT COMPLETED|Overall Study||5
6795692|NCT02195986|7727358|FG002|NOT COMPLETED|Overall Study||2
6795693|NCT02128958|7727368|FG000|STARTED|Overall Study||50
6795694|NCT02128958|7727369|FG001|STARTED|Overall Study||28
6795695|NCT02128958|7727368|FG000|COMPLETED|Overall Study||29
6795696|NCT02128958|7727369|FG001|COMPLETED|Overall Study||18
6795697|NCT02128958|7727368|FG000|NOT COMPLETED|Overall Study||21
6795698|NCT02128958|7727369|FG001|NOT COMPLETED|Overall Study||10
6795699|NCT02087423|7727378|FG000|STARTED|Overall Study|Treated|111
6795700|NCT02087423|7727379|FG001|STARTED|Overall Study|Treated|265
6795701|NCT02087423|7727380|FG002|STARTED|Overall Study|Treated|68
6795702|NCT02087423|7727378|FG000|Completed 12 Months of Treatment|Overall Study||18
6795703|NCT02087423|7727379|FG001|Completed 12 Months of Treatment|Overall Study||60
6795704|NCT02087423|7727380|FG002|Completed 12 Months of Treatment|Overall Study||26
6795705|NCT02087423|7727378|FG000|COMPLETED|Overall Study||0
6795706|NCT02087423|7727379|FG001|COMPLETED|Overall Study||0
6795707|NCT02087423|7727380|FG002|COMPLETED|Overall Study||0
6795708|NCT02087423|7727378|FG000|NOT COMPLETED|Overall Study||111
6795709|NCT02087423|7727379|FG001|NOT COMPLETED|Overall Study||265
6795710|NCT02087423|7727380|FG002|NOT COMPLETED|Overall Study||68
6795711|NCT02086448|7727394|FG000|STARTED|Overall Study||25
6795712|NCT02086448|7727395|FG001|STARTED|Overall Study||26
6795713|NCT02086448|7727396|FG002|STARTED|Overall Study||20
6795714|NCT02086448|7727397|FG003|STARTED|Overall Study||18
6795715|NCT02086448|7727394|FG000|COMPLETED|Overall Study||24
6795716|NCT02086448|7727395|FG001|COMPLETED|Overall Study||26
6795717|NCT02086448|7727396|FG002|COMPLETED|Overall Study||20
6795718|NCT02086448|7727397|FG003|COMPLETED|Overall Study||16
6795719|NCT02086448|7727394|FG000|NOT COMPLETED|Overall Study||1
6795720|NCT02086448|7727395|FG001|NOT COMPLETED|Overall Study||0
6795721|NCT02086448|7727396|FG002|NOT COMPLETED|Overall Study||0
6563732|NCT01808144|7486643|FG001|COMPLETED|Overall Study||51
6656592|NCT02462122|7586850|FG000|NOT COMPLETED|Overall Study||21
6795722|NCT02086448|7727397|FG003|NOT COMPLETED|Overall Study||2
6795723|NCT01982630|7727415|FG000|STARTED|Overall Study||10
6795724|NCT01982630|7727416|FG001|STARTED|Overall Study||8
6795725|NCT01982630|7727417|FG002|STARTED|Overall Study||13
6795726|NCT01982630|7727418|FG003|STARTED|Overall Study||9
6795727|NCT01982630|7727419|FG004|STARTED|Overall Study||19
6795728|NCT01982630|7727420|FG005|STARTED|Overall Study||14
6795729|NCT01982630|7727421|FG006|STARTED|Overall Study||6
6795730|NCT01982630|7727422|FG007|STARTED|Overall Study||8
6795731|NCT01982630|7727415|FG000|Treated|Overall Study||9
6795732|NCT01982630|7727416|FG001|Treated|Overall Study||8
6795733|NCT01982630|7727417|FG002|Treated|Overall Study||11
6795734|NCT01982630|7727418|FG003|Treated|Overall Study||9
6795735|NCT01982630|7727419|FG004|Treated|Overall Study||18
6795736|NCT01982630|7727420|FG005|Treated|Overall Study||14
6795737|NCT01982630|7727421|FG006|Treated|Overall Study||6
6795738|NCT01982630|7727422|FG007|Treated|Overall Study||8
6795739|NCT01982630|7727415|FG000|COMPLETED|Overall Study||7
6795740|NCT01982630|7727416|FG001|COMPLETED|Overall Study||8
6795741|NCT01982630|7727417|FG002|COMPLETED|Overall Study||8
6795742|NCT01982630|7727418|FG003|COMPLETED|Overall Study||8
6795743|NCT01982630|7727419|FG004|COMPLETED|Overall Study||16
6795744|NCT01982630|7727420|FG005|COMPLETED|Overall Study||11
6795745|NCT01982630|7727421|FG006|COMPLETED|Overall Study||5
6795746|NCT01982630|7727422|FG007|COMPLETED|Overall Study||8
6795747|NCT01982630|7727415|FG000|NOT COMPLETED|Overall Study||3
6795748|NCT01982630|7727416|FG001|NOT COMPLETED|Overall Study||0
6795749|NCT01982630|7727417|FG002|NOT COMPLETED|Overall Study||5
6795750|NCT01982630|7727418|FG003|NOT COMPLETED|Overall Study||1
6795751|NCT01982630|7727419|FG004|NOT COMPLETED|Overall Study||3
6795752|NCT01982630|7727420|FG005|NOT COMPLETED|Overall Study||3
6795753|NCT01982630|7727421|FG006|NOT COMPLETED|Overall Study||1
6795754|NCT01982630|7727422|FG007|NOT COMPLETED|Overall Study||0
6795755|NCT01982448|7727477|FG000|STARTED|Preoperative Chemotherapy||75
6795756|NCT01982448|7727478|FG001|STARTED|Preoperative Chemotherapy||72
6795757|NCT01982448|7727477|FG000|Eligible & Treated|Preoperative Chemotherapy||72
6795758|NCT01982448|7727478|FG001|Eligible & Treated|Preoperative Chemotherapy||70
6795759|NCT01982448|7727477|FG000|Evaluable for Safety|Preoperative Chemotherapy||72
6795760|NCT01982448|7727478|FG001|Evaluable for Safety|Preoperative Chemotherapy||68
6795761|NCT01982448|7727477|FG000|COMPLETED|Preoperative Chemotherapy||72
6795762|NCT01982448|7727478|FG001|COMPLETED|Preoperative Chemotherapy||67
6795763|NCT01982448|7727477|FG000|NOT COMPLETED|Preoperative Chemotherapy||3
6795764|NCT01982448|7727478|FG001|NOT COMPLETED|Preoperative Chemotherapy||5
6795765|NCT01982448|7727477|FG000|STARTED|Definitive Breast Surgery||72
6795766|NCT01982448|7727478|FG001|STARTED|Definitive Breast Surgery||67
6795767|NCT01982448|7727477|FG000|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||56
6795768|NCT01982448|7727478|FG001|Evaluable for Response by Homologous Recombination Deficiency (HRD)|Definitive Breast Surgery||48
6795769|NCT01982448|7727477|FG000|COMPLETED|Definitive Breast Surgery||72
6795770|NCT01982448|7727478|FG001|COMPLETED|Definitive Breast Surgery||67
6795771|NCT01982448|7727477|FG000|NOT COMPLETED|Definitive Breast Surgery||0
6795772|NCT01982448|7727478|FG001|NOT COMPLETED|Definitive Breast Surgery||0
6795773|NCT01879228|7727490|FG000|STARTED|Overall Study||13
6795774|NCT01879228|7727491|FG001|STARTED|Overall Study||13
6795775|NCT01879228|7727490|FG000|COMPLETED|Overall Study||12
6795776|NCT01879228|7727491|FG001|COMPLETED|Overall Study||12
6795777|NCT01879228|7727490|FG000|NOT COMPLETED|Overall Study||1
6795778|NCT01879228|7727491|FG001|NOT COMPLETED|Overall Study||1
6795779|NCT01783041|7727499|FG000|STARTED|First 2 Weeks of Life||72
6795780|NCT01783041|7727500|FG001|STARTED|First 2 Weeks of Life||72
6795781|NCT01783041|7727499|FG000|COMPLETED|First 2 Weeks of Life||69
6795782|NCT01783041|7727500|FG001|COMPLETED|First 2 Weeks of Life||71
6795783|NCT01783041|7727499|FG000|NOT COMPLETED|First 2 Weeks of Life||3
6795784|NCT01783041|7727500|FG001|NOT COMPLETED|First 2 Weeks of Life||1
6795785|NCT01783041|7727499|FG000|STARTED|NNNS Examination at Term Equivalent Age||69
6795786|NCT01783041|7727500|FG001|STARTED|NNNS Examination at Term Equivalent Age||71
6795787|NCT01783041|7727499|FG000|COMPLETED|NNNS Examination at Term Equivalent Age||60
6795788|NCT01783041|7727500|FG001|COMPLETED|NNNS Examination at Term Equivalent Age||59
6795789|NCT01783041|7727499|FG000|NOT COMPLETED|NNNS Examination at Term Equivalent Age||9
6795790|NCT01783041|7727500|FG001|NOT COMPLETED|NNNS Examination at Term Equivalent Age||12
6795791|NCT01752920|7727510|FG000|STARTED|Overall Study||29
6795792|NCT01752920|7727511|FG001|STARTED|Overall Study||13
6795793|NCT01752920|7727512|FG002|STARTED|Overall Study||19
6795794|NCT01752920|7727513|FG003|STARTED|Overall Study||58
6795795|NCT01752920|7727510|FG000|COMPLETED|Overall Study||0
6795796|NCT01752920|7727511|FG001|COMPLETED|Overall Study||0
6795797|NCT01752920|7727512|FG002|COMPLETED|Overall Study||0
6795798|NCT01752920|7727513|FG003|COMPLETED|Overall Study||0
6795799|NCT01752920|7727510|FG000|NOT COMPLETED|Overall Study||29
6795800|NCT01752920|7727511|FG001|NOT COMPLETED|Overall Study||13
6795801|NCT01752920|7727512|FG002|NOT COMPLETED|Overall Study||19
6795802|NCT01752920|7727513|FG003|NOT COMPLETED|Overall Study||58
6795803|NCT01744093|7727527|FG000|STARTED|Overall Study||18
6795804|NCT01744093|7727528|FG001|STARTED|Overall Study||9
6795805|NCT01744093|7727527|FG000|COMPLETED|Overall Study||12
6795806|NCT01744093|7727528|FG001|COMPLETED|Overall Study||8
6795807|NCT01744093|7727527|FG000|NOT COMPLETED|Overall Study||6
6795808|NCT01744093|7727528|FG001|NOT COMPLETED|Overall Study||1
6795809|NCT01740297|7727545|FG000|STARTED|Overall Study||19
6795810|NCT01740297|7727546|FG001|STARTED|Overall Study||100
6795811|NCT01740297|7727547|FG002|STARTED|Overall Study||98
6795812|NCT01740297|7727545|FG000|Received Talimogene Laherparepvec|Overall Study||19
6795813|NCT01740297|7727546|FG001|Received Talimogene Laherparepvec|Overall Study||0
6795814|NCT01740297|7727547|FG002|Received Talimogene Laherparepvec|Overall Study||95
6379671|NCT00773747|7290331|FG000|Treated|Overall Study||315
6379672|NCT00773747|7290332|FG001|Treated|Overall Study||320
6379673|NCT00773747|7290331|FG000|COMPLETED|Overall Study||20
6379674|NCT00773747|7290332|FG001|COMPLETED|Overall Study||24
6379675|NCT00773747|7290331|FG000|NOT COMPLETED|Overall Study||297
6379676|NCT00773747|7290332|FG001|NOT COMPLETED|Overall Study||296
6795815|NCT01740297|7727545|FG000|Received Ipilimumab|Overall Study||18
6795816|NCT01740297|7727546|FG001|Received Ipilimumab|Overall Study||95
6795817|NCT01740297|7727547|FG002|Received Ipilimumab|Overall Study||92
6795818|NCT01740297|7727545|FG000|COMPLETED|Overall Study||6
6795819|NCT01740297|7727546|FG001|COMPLETED|Overall Study||36
6795820|NCT01740297|7727547|FG002|COMPLETED|Overall Study||37
6795821|NCT01740297|7727545|FG000|NOT COMPLETED|Overall Study||13
6795822|NCT01740297|7727546|FG001|NOT COMPLETED|Overall Study||64
6795823|NCT01740297|7727547|FG002|NOT COMPLETED|Overall Study||61
6795824|NCT01729754|7727561|FG000|STARTED|Part 1||20
6795825|NCT01729754|7727562|FG001|STARTED|Part 1||184
6795826|NCT01729754|7727563|FG002|STARTED|Part 1||110
6795827|NCT01729754|7727564|FG003|STARTED|Part 1||18
6795828|NCT01729754|7727565|FG004|STARTED|Part 1||21
6795829|NCT01729754|7727566|FG005|STARTED|Part 1||268
6795830|NCT01729754|7727567|FG006|STARTED|Part 1||14
6795831|NCT01729754|7727568|FG007|STARTED|Part 1||72
6795832|NCT01729754|7727569|FG008|STARTED|Part 1||70
6795833|NCT01729754|7727570|FG009|STARTED|Part 1||313
6795834|NCT01729754|7727561|FG000|COMPLETED|Part 1||6
6795835|NCT01729754|7727562|FG001|COMPLETED|Part 1||184
6795836|NCT01729754|7727563|FG002|COMPLETED|Part 1||110
6795837|NCT01729754|7727564|FG003|COMPLETED|Part 1||6
6795838|NCT01729754|7727565|FG004|COMPLETED|Part 1||21
6795839|NCT01729754|7727566|FG005|COMPLETED|Part 1||268
6795840|NCT01729754|7727567|FG006|COMPLETED|Part 1||0
6795841|NCT01729754|7727568|FG007|COMPLETED|Part 1||72
6795842|NCT01729754|7727569|FG008|COMPLETED|Part 1||70
6795843|NCT01729754|7727570|FG009|COMPLETED|Part 1||289
6795844|NCT01729754|7727561|FG000|NOT COMPLETED|Part 1||14
6379677|NCT00773786|7290338|FG000|STARTED|First Intervention (1 Week)||10
6379678|NCT00773786|7290339|FG001|STARTED|First Intervention (1 Week)||10
6379679|NCT00773786|7290338|FG000|COMPLETED|First Intervention (1 Week)||10
6379680|NCT00773786|7290339|FG001|COMPLETED|First Intervention (1 Week)||10
6379681|NCT00773786|7290338|FG000|NOT COMPLETED|First Intervention (1 Week)||0
6379682|NCT00773786|7290339|FG001|NOT COMPLETED|First Intervention (1 Week)||0
6379683|NCT00773786|7290338|FG000|STARTED|Washout (1 Week)||10
6379684|NCT00773786|7290339|FG001|STARTED|Washout (1 Week)||10
6379685|NCT00773786|7290338|FG000|COMPLETED|Washout (1 Week)||10
6379686|NCT00773786|7290339|FG001|COMPLETED|Washout (1 Week)||10
6379687|NCT00773786|7290338|FG000|NOT COMPLETED|Washout (1 Week)||0
6379688|NCT00773786|7290339|FG001|NOT COMPLETED|Washout (1 Week)||0
6379689|NCT00773786|7290338|FG000|STARTED|Second Intervention (1 Week)||10
6379690|NCT00773786|7290339|FG001|STARTED|Second Intervention (1 Week)||10
6379691|NCT00773786|7290338|FG000|COMPLETED|Second Intervention (1 Week)||10
6379692|NCT00773786|7290339|FG001|COMPLETED|Second Intervention (1 Week)||10
6379693|NCT00773786|7290338|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6379694|NCT00773786|7290339|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6379695|NCT00773838|7290346|FG000|STARTED|Overall Study||143
6795845|NCT01729754|7727562|FG001|NOT COMPLETED|Part 1||0
6795846|NCT01729754|7727563|FG002|NOT COMPLETED|Part 1||0
6795847|NCT01729754|7727564|FG003|NOT COMPLETED|Part 1||12
6795848|NCT01729754|7727565|FG004|NOT COMPLETED|Part 1||0
6795849|NCT01729754|7727566|FG005|NOT COMPLETED|Part 1||0
6795850|NCT01729754|7727567|FG006|NOT COMPLETED|Part 1||14
6795851|NCT01729754|7727568|FG007|NOT COMPLETED|Part 1||0
6795852|NCT01729754|7727569|FG008|NOT COMPLETED|Part 1||0
6795853|NCT01729754|7727570|FG009|NOT COMPLETED|Part 1||24
6379696|NCT00773838|7290346|FG000|COMPLETED|Overall Study||0
6379697|NCT00773838|7290346|FG000|NOT COMPLETED|Overall Study||143
6795854|NCT01729754|7727561|FG000|STARTED|Part 2||6
6795855|NCT01729754|7727562|FG001|STARTED|Part 2||184
6795856|NCT01729754|7727563|FG002|STARTED|Part 2||110
6379698|NCT00773955|7290350|FG000|STARTED|Overall Study||15
6379699|NCT00773955|7290350|FG000|COMPLETED|Overall Study||15
6379700|NCT00773955|7290350|FG000|NOT COMPLETED|Overall Study||0
6379701|NCT00773968|7290354|FG000|STARTED|Overall Study||140
6379702|NCT00773968|7290354|FG000|Treated|Overall Study||111
6379703|NCT00773968|7290354|FG000|COMPLETED|Overall Study||95
6379704|NCT00773968|7290354|FG000|NOT COMPLETED|Overall Study||45
6379705|NCT00774046|7290358|FG000|STARTED|Screening||116
6379706|NCT00774046|7290358|FG000|COMPLETED|Screening||60
6379707|NCT00774046|7290358|FG000|NOT COMPLETED|Screening||56
6795857|NCT01729754|7727564|FG003|STARTED|Part 2|1 participant completed Part 1 but did not enter Part 2|5
6795858|NCT01729754|7727565|FG004|STARTED|Part 2||21
6795859|NCT01729754|7727566|FG005|STARTED|Part 2||268
6795860|NCT01729754|7727567|FG006|STARTED|Part 2||0
6795861|NCT01729754|7727568|FG007|STARTED|Part 2||72
6795862|NCT01729754|7727569|FG008|STARTED|Part 2||70
6795863|NCT01729754|7727570|FG009|STARTED|Part 2||289
6795864|NCT01729754|7727561|FG000|COMPLETED|Part 2||0
6795865|NCT01729754|7727562|FG001|COMPLETED|Part 2||184
6795866|NCT01729754|7727563|FG002|COMPLETED|Part 2||110
6379708|NCT00774046|7290358|FG000|STARTED|Enrollment||60
6379709|NCT00774046|7290358|FG000|COMPLETED|Enrollment||32
6379710|NCT00774046|7290358|FG000|NOT COMPLETED|Enrollment||28
6379711|NCT00774046|7290358|FG000|STARTED|Induction Therapy||32
6379712|NCT00774046|7290358|FG000|COMPLETED|Induction Therapy||32
6379713|NCT00774046|7290358|FG000|NOT COMPLETED|Induction Therapy||0
6379714|NCT00774046|7290358|FG000|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
6379715|NCT00774046|7290358|FG000|COMPLETED|Stem Cell Mobilization||7
6379716|NCT00774046|7290358|FG000|NOT COMPLETED|Stem Cell Mobilization||3
6379717|NCT00774046|7290358|FG000|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
6379718|NCT00774046|7290358|FG000|COMPLETED|Autologous Transplant||4
6379719|NCT00774046|7290358|FG000|NOT COMPLETED|Autologous Transplant||0
6379720|NCT00774163|7290364|FG000|STARTED|Overall Study||30
6379721|NCT00774163|7290365|FG001|STARTED|Overall Study||15
6379722|NCT00774163|7290364|FG000|COMPLETED|Overall Study||30
6379723|NCT00774163|7290365|FG001|COMPLETED|Overall Study||15
6379724|NCT00774163|7290364|FG000|NOT COMPLETED|Overall Study||0
6379725|NCT00774163|7290365|FG001|NOT COMPLETED|Overall Study||0
6379726|NCT00774202|7290373|FG000|STARTED|Overall Study||9
6379727|NCT00774202|7290374|FG001|STARTED|Overall Study||8
6379728|NCT00774202|7290373|FG000|COMPLETED|Overall Study||9
6379729|NCT00774202|7290374|FG001|COMPLETED|Overall Study||8
6379730|NCT00774202|7290373|FG000|NOT COMPLETED|Overall Study||0
6379731|NCT00774202|7290374|FG001|NOT COMPLETED|Overall Study||0
6379732|NCT00774267|7290388|FG000|STARTED|Overall Study||132
6379733|NCT00774267|7290389|FG001|STARTED|Overall Study||111
6379734|NCT00774267|7290390|FG002|STARTED|Overall Study||129
6379735|NCT00774267|7290391|FG003|STARTED|Overall Study||135
6379736|NCT00774267|7290388|FG000|COMPLETED|Overall Study||132
6379737|NCT00774267|7290389|FG001|COMPLETED|Overall Study||111
6379738|NCT00774267|7290390|FG002|COMPLETED|Overall Study||129
6379739|NCT00774267|7290391|FG003|COMPLETED|Overall Study||135
6379740|NCT00774267|7290388|FG000|NOT COMPLETED|Overall Study||0
6379741|NCT00774267|7290389|FG001|NOT COMPLETED|Overall Study||0
6379742|NCT00774267|7290390|FG002|NOT COMPLETED|Overall Study||0
6379743|NCT00774267|7290391|FG003|NOT COMPLETED|Overall Study||0
6379744|NCT00774397|7290408|FG000|STARTED|Overall Study||71
6379745|NCT00774397|7290409|FG001|STARTED|Overall Study||69
6379746|NCT00774397|7290410|FG002|STARTED|Overall Study||143
6379747|NCT00774397|7290411|FG003|STARTED|Overall Study||146
6379748|NCT00774397|7290412|FG004|STARTED|Overall Study||143
6379749|NCT00774397|7290413|FG005|STARTED|Overall Study||76
6379750|NCT00774397|7290414|FG006|STARTED|Overall Study||71
6379751|NCT00774397|7290408|FG000|COMPLETED|Overall Study||57
6379752|NCT00774397|7290409|FG001|COMPLETED|Overall Study||56
6379753|NCT00774397|7290410|FG002|COMPLETED|Overall Study||113
6379754|NCT00774397|7290411|FG003|COMPLETED|Overall Study||129
6379755|NCT00774397|7290412|FG004|COMPLETED|Overall Study||97
6379756|NCT00774397|7290413|FG005|COMPLETED|Overall Study||54
6379757|NCT00774397|7290414|FG006|COMPLETED|Overall Study||41
6379758|NCT00774397|7290408|FG000|NOT COMPLETED|Overall Study||14
6379759|NCT00774397|7290409|FG001|NOT COMPLETED|Overall Study||13
6379760|NCT00774397|7290410|FG002|NOT COMPLETED|Overall Study||30
6379761|NCT00774397|7290411|FG003|NOT COMPLETED|Overall Study||17
6379762|NCT00774397|7290412|FG004|NOT COMPLETED|Overall Study||46
6379763|NCT00774397|7290413|FG005|NOT COMPLETED|Overall Study||22
6379764|NCT00774397|7290414|FG006|NOT COMPLETED|Overall Study||30
6379765|NCT00774566|7290439|FG000|STARTED|Overall Study||159
6379766|NCT00774566|7290440|FG001|STARTED|Overall Study||156
6379767|NCT00774566|7290439|FG000|6 Month Follow up|Overall Study||154
6379768|NCT00774566|7290440|FG001|6 Month Follow up|Overall Study||150
6379769|NCT00774566|7290439|FG000|12 Month Follow up|Overall Study||141
6379770|NCT00774566|7290440|FG001|12 Month Follow up|Overall Study||141
6379771|NCT00774566|7290439|FG000|COMPLETED|Overall Study||141
6379772|NCT00774566|7290440|FG001|COMPLETED|Overall Study||141
6379773|NCT00774566|7290439|FG000|NOT COMPLETED|Overall Study||18
6379774|NCT00774566|7290440|FG001|NOT COMPLETED|Overall Study||15
6795867|NCT01729754|7727564|FG003|COMPLETED|Part 2||0
6379775|NCT00774579|7290448|FG000|STARTED|Overall Study||9
6379776|NCT00774579|7290449|FG001|STARTED|Overall Study||9
6379777|NCT00774579|7290448|FG000|COMPLETED|Overall Study||9
6795868|NCT01729754|7727565|FG004|COMPLETED|Part 2||21
6795869|NCT01729754|7727566|FG005|COMPLETED|Part 2||268
6795870|NCT01729754|7727567|FG006|COMPLETED|Part 2||0
6795871|NCT01729754|7727568|FG007|COMPLETED|Part 2||69
6795872|NCT01729754|7727569|FG008|COMPLETED|Part 2||66
6795873|NCT01729754|7727570|FG009|COMPLETED|Part 2||277
6795874|NCT01729754|7727561|FG000|NOT COMPLETED|Part 2||6
6795875|NCT01729754|7727562|FG001|NOT COMPLETED|Part 2||0
6795876|NCT01729754|7727563|FG002|NOT COMPLETED|Part 2||0
6795877|NCT01729754|7727564|FG003|NOT COMPLETED|Part 2||5
6795878|NCT01729754|7727565|FG004|NOT COMPLETED|Part 2||0
6795879|NCT01729754|7727566|FG005|NOT COMPLETED|Part 2||0
6795880|NCT01729754|7727567|FG006|NOT COMPLETED|Part 2||0
6795881|NCT01729754|7727568|FG007|NOT COMPLETED|Part 2||3
6795882|NCT01729754|7727569|FG008|NOT COMPLETED|Part 2||4
6795883|NCT01729754|7727570|FG009|NOT COMPLETED|Part 2||12
6795884|NCT01729754|7727561|FG000|STARTED|Part 3||0
6795885|NCT01729754|7727562|FG001|STARTED|Part 3|14 participants completed Part 2 but did not enter Part 3|170
6795886|NCT01729754|7727563|FG002|STARTED|Part 3||110
6795887|NCT01729754|7727564|FG003|STARTED|Part 3||0
6795888|NCT01729754|7727565|FG004|STARTED|Part 3||21
6795889|NCT01729754|7727566|FG005|STARTED|Part 3|31 participants completed Part 2 but did not enter Part 3|237
6795890|NCT01729754|7727567|FG006|STARTED|Part 3||0
6795891|NCT01729754|7727568|FG007|STARTED|Part 3||69
6795892|NCT01729754|7727569|FG008|STARTED|Part 3||66
6795893|NCT01729754|7727570|FG009|STARTED|Part 3|156 participants completed Part 2 but did not enter Part 3|121
6795894|NCT01729754|7727561|FG000|COMPLETED|Part 3||0
6795895|NCT01729754|7727562|FG001|COMPLETED|Part 3||165
6795896|NCT01729754|7727563|FG002|COMPLETED|Part 3||105
6795897|NCT01729754|7727564|FG003|COMPLETED|Part 3||0
6795898|NCT01729754|7727565|FG004|COMPLETED|Part 3||17
6795899|NCT01729754|7727566|FG005|COMPLETED|Part 3||224
6795900|NCT01729754|7727567|FG006|COMPLETED|Part 3||0
6795901|NCT01729754|7727568|FG007|COMPLETED|Part 3||66
6379778|NCT00774579|7290449|FG001|COMPLETED|Overall Study||9
6379779|NCT00774579|7290448|FG000|NOT COMPLETED|Overall Study||0
6379780|NCT00774579|7290449|FG001|NOT COMPLETED|Overall Study||0
6379781|NCT00774748|7290455|FG000|STARTED|Overall Study||21
6379782|NCT00774748|7290455|FG000|COMPLETED|Overall Study||18
6795902|NCT01729754|7727569|FG008|COMPLETED|Part 3||65
6795903|NCT01729754|7727570|FG009|COMPLETED|Part 3||114
6379783|NCT00774748|7290455|FG000|NOT COMPLETED|Overall Study||3
6379784|NCT00774787|7290463|FG000|STARTED|Overall Study||27
6379785|NCT00774787|7290463|FG000|COMPLETED|Overall Study||26
6379786|NCT00774787|7290463|FG000|NOT COMPLETED|Overall Study||1
6795904|NCT01729754|7727561|FG000|NOT COMPLETED|Part 3||0
6795905|NCT01729754|7727562|FG001|NOT COMPLETED|Part 3||5
6795906|NCT01729754|7727563|FG002|NOT COMPLETED|Part 3||5
6795907|NCT01729754|7727564|FG003|NOT COMPLETED|Part 3||0
6795908|NCT01729754|7727565|FG004|NOT COMPLETED|Part 3||4
6795909|NCT01729754|7727566|FG005|NOT COMPLETED|Part 3||13
6795910|NCT01729754|7727567|FG006|NOT COMPLETED|Part 3||0
6795911|NCT01729754|7727568|FG007|NOT COMPLETED|Part 3||3
6795912|NCT01729754|7727569|FG008|NOT COMPLETED|Part 3||1
6795913|NCT01729754|7727570|FG009|NOT COMPLETED|Part 3||7
6795914|NCT01684826|7727600|FG000|STARTED|Overall Study||49
6795915|NCT01684826|7727600|FG000|Collected Dose and Image Information|Overall Study||39
6795916|NCT01684826|7727600|FG000|COMPLETED|Overall Study||39
6795917|NCT01684826|7727600|FG000|NOT COMPLETED|Overall Study||10
6795918|NCT01672242|7727604|FG000|STARTED|Period 1||4
6795919|NCT01672242|7727605|FG001|STARTED|Period 1||2
6795920|NCT01672242|7727604|FG000|COMPLETED|Period 1||4
6795921|NCT01672242|7727605|FG001|COMPLETED|Period 1||2
6795922|NCT01672242|7727604|FG000|NOT COMPLETED|Period 1||0
6795923|NCT01672242|7727605|FG001|NOT COMPLETED|Period 1||0
6795924|NCT01672242|7727604|FG000|STARTED|Period 2||4
6795925|NCT01672242|7727605|FG001|STARTED|Period 2||2
6795926|NCT01672242|7727604|FG000|COMPLETED|Period 2||4
6795927|NCT01672242|7727605|FG001|COMPLETED|Period 2||2
6795928|NCT01672242|7727604|FG000|NOT COMPLETED|Period 2||0
6795929|NCT01672242|7727605|FG001|NOT COMPLETED|Period 2||0
6795930|NCT01668784|7727613|FG000|STARTED|Randomized (Pre-treatment)||410
6795931|NCT01668784|7727614|FG001|STARTED|Randomized (Pre-treatment)||411
6795932|NCT01668784|7727613|FG000|COMPLETED|Randomized (Pre-treatment)||406
6795933|NCT01668784|7727614|FG001|COMPLETED|Randomized (Pre-treatment)||397
6795934|NCT01668784|7727613|FG000|NOT COMPLETED|Randomized (Pre-treatment)||4
6795935|NCT01668784|7727614|FG001|NOT COMPLETED|Randomized (Pre-treatment)||14
6795936|NCT01668784|7727613|FG000|STARTED|Treated (Overall)||406
6795937|NCT01668784|7727614|FG001|STARTED|Treated (Overall)||397
6795938|NCT01668784|7727613|FG000|COMPLETED|Treated (Overall)||67
6795939|NCT01668784|7727614|FG001|COMPLETED|Treated (Overall)||28
6795940|NCT01668784|7727613|FG000|NOT COMPLETED|Treated (Overall)||339
6795941|NCT01668784|7727614|FG001|NOT COMPLETED|Treated (Overall)||369
6795942|NCT01599741|7727620|FG000|STARTED|Overall Study||51
6795943|NCT01599741|7727620|FG000|Collected Dose and Image Information|Overall Study||48
6795944|NCT01599741|7727620|FG000|COMPLETED|Overall Study||48
6795945|NCT01599741|7727620|FG000|NOT COMPLETED|Overall Study||3
6795946|NCT01593852|7727626|FG000|STARTED|Overall Study||68
6795947|NCT01593852|7727627|FG001|STARTED|Overall Study||68
6795948|NCT01593852|7727626|FG000|COMPLETED|Overall Study||68
6795949|NCT01593852|7727627|FG001|COMPLETED|Overall Study||68
6795950|NCT01593852|7727626|FG000|NOT COMPLETED|Overall Study||0
6795951|NCT01593852|7727627|FG001|NOT COMPLETED|Overall Study||0
6795952|NCT01564537|7727635|FG000|STARTED|Overall Study||360
6795953|NCT01564537|7727636|FG001|STARTED|Overall Study||362
6795954|NCT01564537|7727635|FG000|Safety Population: Received Study Drug|Overall Study||360
6795955|NCT01564537|7727636|FG001|Safety Population: Received Study Drug|Overall Study||360
6795956|NCT01564537|7727635|FG000|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
6795957|NCT01564537|7727636|FG001|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
6795958|NCT01564537|7727635|FG000|NOT COMPLETED|Overall Study||6
6795959|NCT01564537|7727636|FG001|NOT COMPLETED|Overall Study||6
6795960|NCT01515306|7727645|FG000|STARTED|Overall Study||24
6795961|NCT01515306|7727646|FG001|STARTED|Overall Study||16
6795962|NCT01515306|7727645|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
6795963|NCT01515306|7727646|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
6795964|NCT01515306|7727645|FG000|Cycle 1|Overall Study||24
6795965|NCT01515306|7727646|FG001|Cycle 1|Overall Study||16
6795966|NCT01515306|7727645|FG000|Cycle 2|Overall Study||21
6795967|NCT01515306|7727646|FG001|Cycle 2|Overall Study||15
6795968|NCT01515306|7727645|FG000|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
6795969|NCT01515306|7727646|FG001|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
6795970|NCT01515306|7727645|FG000|COMPLETED|Overall Study||0
6795971|NCT01515306|7727646|FG001|COMPLETED|Overall Study||2
6795972|NCT01515306|7727645|FG000|NOT COMPLETED|Overall Study||24
6795973|NCT01515306|7727646|FG001|NOT COMPLETED|Overall Study||14
6795974|NCT01423851|7727667|FG000|STARTED|Whole Study||3
6795975|NCT01423851|7727668|FG001|STARTED|Whole Study||3
6795976|NCT01423851|7727669|FG002|STARTED|Whole Study||3
6795977|NCT01423851|7727670|FG003|STARTED|Whole Study||6
6795978|NCT01423851|7727671|FG004|STARTED|Whole Study||3
6795979|NCT01423851|7727672|FG005|STARTED|Whole Study||3
6795980|NCT01423851|7727673|FG006|STARTED|Whole Study||3
6795981|NCT01423851|7727674|FG007|STARTED|Whole Study||8
6795982|NCT01423851|7727675|FG008|STARTED|Whole Study||8
6795983|NCT01423851|7727676|FG009|STARTED|Whole Study||8
6795984|NCT01423851|7727677|FG010|STARTED|Whole Study||29
6795985|NCT01423851|7727667|FG000|COMPLETED|Whole Study||0
6795986|NCT01423851|7727668|FG001|COMPLETED|Whole Study||0
6795987|NCT01423851|7727669|FG002|COMPLETED|Whole Study||0
6795988|NCT01423851|7727670|FG003|COMPLETED|Whole Study||0
6795989|NCT01423851|7727671|FG004|COMPLETED|Whole Study||0
6795990|NCT01423851|7727672|FG005|COMPLETED|Whole Study||0
6795991|NCT01423851|7727673|FG006|COMPLETED|Whole Study||0
6795992|NCT01423851|7727674|FG007|COMPLETED|Whole Study||0
6795993|NCT01423851|7727675|FG008|COMPLETED|Whole Study||0
6795994|NCT01423851|7727676|FG009|COMPLETED|Whole Study||0
6795995|NCT01423851|7727677|FG010|COMPLETED|Whole Study||0
6795996|NCT01423851|7727667|FG000|NOT COMPLETED|Whole Study||3
6795997|NCT01423851|7727668|FG001|NOT COMPLETED|Whole Study||3
6795998|NCT01423851|7727669|FG002|NOT COMPLETED|Whole Study||3
6795999|NCT01423851|7727670|FG003|NOT COMPLETED|Whole Study||6
6796000|NCT01423851|7727671|FG004|NOT COMPLETED|Whole Study||3
6796001|NCT01423851|7727672|FG005|NOT COMPLETED|Whole Study||3
6796002|NCT01423851|7727673|FG006|NOT COMPLETED|Whole Study||3
6796003|NCT01423851|7727674|FG007|NOT COMPLETED|Whole Study||8
6796004|NCT01423851|7727675|FG008|NOT COMPLETED|Whole Study||8
6796005|NCT01423851|7727676|FG009|NOT COMPLETED|Whole Study||8
6796006|NCT01423851|7727677|FG010|NOT COMPLETED|Whole Study||29
6796007|NCT01423851|7727667|FG000|STARTED|Dose Finding Period - Escalation||0
6796008|NCT01423851|7727668|FG001|STARTED|Dose Finding Period - Escalation||1
6796009|NCT01423851|7727669|FG002|STARTED|Dose Finding Period - Escalation||4
6796010|NCT01423851|7727670|FG003|STARTED|Dose Finding Period - Escalation||4
6796011|NCT01423851|7727671|FG004|STARTED|Dose Finding Period - Escalation||0
6796012|NCT01423851|7727672|FG005|STARTED|Dose Finding Period - Escalation||0
6796013|NCT01423851|7727673|FG006|STARTED|Dose Finding Period - Escalation||2
6796014|NCT01423851|7727674|FG007|STARTED|Dose Finding Period - Escalation||0
6796015|NCT01423851|7727675|FG008|STARTED|Dose Finding Period - Escalation||1
6796016|NCT01423851|7727676|FG009|STARTED|Dose Finding Period - Escalation||0
6796017|NCT01423851|7727677|FG010|STARTED|Dose Finding Period - Escalation||0
6796018|NCT01423851|7727667|FG000|COMPLETED|Dose Finding Period - Escalation||0
6796019|NCT01423851|7727668|FG001|COMPLETED|Dose Finding Period - Escalation||0
6796020|NCT01423851|7727669|FG002|COMPLETED|Dose Finding Period - Escalation||0
6796021|NCT01423851|7727670|FG003|COMPLETED|Dose Finding Period - Escalation||0
6796022|NCT01423851|7727671|FG004|COMPLETED|Dose Finding Period - Escalation||0
6796023|NCT01423851|7727672|FG005|COMPLETED|Dose Finding Period - Escalation||0
6796024|NCT01423851|7727673|FG006|COMPLETED|Dose Finding Period - Escalation||0
6796025|NCT01423851|7727674|FG007|COMPLETED|Dose Finding Period - Escalation||0
6796026|NCT01423851|7727675|FG008|COMPLETED|Dose Finding Period - Escalation||0
6563733|NCT01808144|7486642|FG000|NOT COMPLETED|Overall Study||40
6563734|NCT01808144|7486643|FG001|NOT COMPLETED|Overall Study||48
6563735|NCT01808196|7486649|FG000|STARTED|Overall Study||6
6563736|NCT01808196|7486649|FG000|COMPLETED|Overall Study||5
6563737|NCT01808196|7486649|FG000|NOT COMPLETED|Overall Study||1
6563738|NCT01808209|7486655|FG000|STARTED|Overall Study||33
6796027|NCT01423851|7727676|FG009|COMPLETED|Dose Finding Period - Escalation||0
6796028|NCT01423851|7727677|FG010|COMPLETED|Dose Finding Period - Escalation||0
6796029|NCT01423851|7727667|FG000|NOT COMPLETED|Dose Finding Period - Escalation||0
6796030|NCT01423851|7727668|FG001|NOT COMPLETED|Dose Finding Period - Escalation||1
6796031|NCT01423851|7727669|FG002|NOT COMPLETED|Dose Finding Period - Escalation||4
6796032|NCT01423851|7727670|FG003|NOT COMPLETED|Dose Finding Period - Escalation||4
6563739|NCT01808209|7486656|FG001|STARTED|Overall Study||27
6563740|NCT01808209|7486655|FG000|COMPLETED|Overall Study||33
6563741|NCT01808209|7486656|FG001|COMPLETED|Overall Study||26
6563742|NCT01808209|7486655|FG000|NOT COMPLETED|Overall Study||0
6563743|NCT01808209|7486656|FG001|NOT COMPLETED|Overall Study||1
6563744|NCT01808222|7486666|FG000|STARTED|Overall Study||25
6563745|NCT01808222|7486666|FG000|Completed Fluciclovine PET-CT Scan|Overall Study||25
6563746|NCT01808222|7486666|FG000|Completed mpMR Scan|Overall Study||24
6563747|NCT01808222|7486666|FG000|COMPLETED|Overall Study||24
6563748|NCT01808222|7486666|FG000|NOT COMPLETED|Overall Study||1
6563749|NCT01808248|7486672|FG000|STARTED|Overall Study||47
6563750|NCT01808248|7486672|FG000|Completed Posttreatment Week 12 Visit|Overall Study||45
6563751|NCT01808248|7486672|FG000|COMPLETED|Overall Study||42
6563752|NCT01808248|7486672|FG000|NOT COMPLETED|Overall Study||5
6563753|NCT01808313|7486678|FG000|STARTED|Overall Study||133
6563754|NCT01808313|7486678|FG000|COMPLETED|Overall Study||123
6563755|NCT01808313|7486678|FG000|NOT COMPLETED|Overall Study||10
6563756|NCT01808326|7486682|FG000|STARTED|Overall Study||5
6563757|NCT01808326|7486682|FG000|COMPLETED|Overall Study||5
6563758|NCT01808326|7486682|FG000|NOT COMPLETED|Overall Study||0
6563759|NCT01808339|7486686|FG000|STARTED|Treatment Period 1 (14 Days)||4
6796033|NCT01423851|7727671|FG004|NOT COMPLETED|Dose Finding Period - Escalation||0
6796034|NCT01423851|7727672|FG005|NOT COMPLETED|Dose Finding Period - Escalation||0
6796035|NCT01423851|7727673|FG006|NOT COMPLETED|Dose Finding Period - Escalation||2
6796036|NCT01423851|7727674|FG007|NOT COMPLETED|Dose Finding Period - Escalation||0
6796037|NCT01423851|7727675|FG008|NOT COMPLETED|Dose Finding Period - Escalation||1
6796038|NCT01423851|7727676|FG009|NOT COMPLETED|Dose Finding Period - Escalation||0
6796039|NCT01423851|7727677|FG010|NOT COMPLETED|Dose Finding Period - Escalation||0
6796040|NCT01423851|7727667|FG000|STARTED|Dose Finding Period - Reduction||0
6796041|NCT01423851|7727668|FG001|STARTED|Dose Finding Period - Reduction||0
6796042|NCT01423851|7727669|FG002|STARTED|Dose Finding Period - Reduction||3
6796043|NCT01423851|7727670|FG003|STARTED|Dose Finding Period - Reduction||5
6796044|NCT01423851|7727671|FG004|STARTED|Dose Finding Period - Reduction||1
6796045|NCT01423851|7727672|FG005|STARTED|Dose Finding Period - Reduction||2
6796046|NCT01423851|7727673|FG006|STARTED|Dose Finding Period - Reduction||8
6796047|NCT01423851|7727674|FG007|STARTED|Dose Finding Period - Reduction||0
6796048|NCT01423851|7727675|FG008|STARTED|Dose Finding Period - Reduction||3
6796049|NCT01423851|7727676|FG009|STARTED|Dose Finding Period - Reduction||0
6796050|NCT01423851|7727677|FG010|STARTED|Dose Finding Period - Reduction||0
6796051|NCT01423851|7727667|FG000|COMPLETED|Dose Finding Period - Reduction||0
6796052|NCT01423851|7727668|FG001|COMPLETED|Dose Finding Period - Reduction||0
6796053|NCT01423851|7727669|FG002|COMPLETED|Dose Finding Period - Reduction||0
6796054|NCT01423851|7727670|FG003|COMPLETED|Dose Finding Period - Reduction||0
6796055|NCT01423851|7727671|FG004|COMPLETED|Dose Finding Period - Reduction||0
6796056|NCT01423851|7727672|FG005|COMPLETED|Dose Finding Period - Reduction||0
6796057|NCT01423851|7727673|FG006|COMPLETED|Dose Finding Period - Reduction||0
6796058|NCT01423851|7727674|FG007|COMPLETED|Dose Finding Period - Reduction||0
6796059|NCT01423851|7727675|FG008|COMPLETED|Dose Finding Period - Reduction||0
6796060|NCT01423851|7727676|FG009|COMPLETED|Dose Finding Period - Reduction||0
6796061|NCT01423851|7727677|FG010|COMPLETED|Dose Finding Period - Reduction||0
6796062|NCT01423851|7727667|FG000|NOT COMPLETED|Dose Finding Period - Reduction||0
6796063|NCT01423851|7727668|FG001|NOT COMPLETED|Dose Finding Period - Reduction||0
6796064|NCT01423851|7727669|FG002|NOT COMPLETED|Dose Finding Period - Reduction||3
6796065|NCT01423851|7727670|FG003|NOT COMPLETED|Dose Finding Period - Reduction||5
6796066|NCT01423851|7727671|FG004|NOT COMPLETED|Dose Finding Period - Reduction||1
6796067|NCT01423851|7727672|FG005|NOT COMPLETED|Dose Finding Period - Reduction||2
6796068|NCT01423851|7727673|FG006|NOT COMPLETED|Dose Finding Period - Reduction||8
6796069|NCT01423851|7727674|FG007|NOT COMPLETED|Dose Finding Period - Reduction||0
6796070|NCT01423851|7727675|FG008|NOT COMPLETED|Dose Finding Period - Reduction||3
6796071|NCT01423851|7727676|FG009|NOT COMPLETED|Dose Finding Period - Reduction||0
6796072|NCT01423851|7727677|FG010|NOT COMPLETED|Dose Finding Period - Reduction||0
6796073|NCT01385176|7727708|FG000|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|63
6796074|NCT01385176|7727709|FG001|STARTED|Randomization Phase|The randomization phase of the study started after implant of the investigational device system.|32
6796075|NCT01385176|7727708|FG000|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|62
6796076|NCT01385176|7727709|FG001|COMPLETED|Randomization Phase|The study randomization phase ended after all patients have had their 6 month follow-up visit.|30
6796077|NCT01385176|7727708|FG000|NOT COMPLETED|Randomization Phase||1
6796078|NCT01385176|7727709|FG001|NOT COMPLETED|Randomization Phase||2
6796079|NCT01385176|7727708|FG000|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|62
6796080|NCT01385176|7727709|FG001|STARTED|6-18 Month All VNS Active|Primary Study Phase ended with completion of the 18 months follow-up visit for the last patient|30
6796081|NCT01385176|7727708|FG000|COMPLETED|6-18 Month All VNS Active||58
6796082|NCT01385176|7727709|FG001|COMPLETED|6-18 Month All VNS Active||27
6796083|NCT01385176|7727708|FG000|NOT COMPLETED|6-18 Month All VNS Active||4
6796084|NCT01385176|7727709|FG001|NOT COMPLETED|6-18 Month All VNS Active||3
6796085|NCT01360593|7727720|FG000|STARTED|Overall Study||35
6796086|NCT01360593|7727720|FG000|COMPLETED|Overall Study||35
6796087|NCT01360593|7727720|FG000|NOT COMPLETED|Overall Study||0
6796088|NCT01354977|7727726|FG000|STARTED|Overall Study||12
6796089|NCT01354977|7727727|FG001|STARTED|Overall Study||8
6796090|NCT01354977|7727726|FG000|COMPLETED|Overall Study||12
6796091|NCT01354977|7727727|FG001|COMPLETED|Overall Study||8
6796092|NCT01354977|7727726|FG000|NOT COMPLETED|Overall Study||0
6796093|NCT01354977|7727727|FG001|NOT COMPLETED|Overall Study||0
6796094|NCT01354431|7727736|FG000|STARTED|Randomized to Enter Treatment Period||60
6563760|NCT01808339|7486687|FG001|STARTED|Treatment Period 1 (14 Days)||4
6563761|NCT01808339|7486688|FG002|STARTED|Treatment Period 1 (14 Days)||4
6563762|NCT01808339|7486689|FG003|STARTED|Treatment Period 1 (14 Days)||4
6563763|NCT01808339|7486690|FG004|STARTED|Treatment Period 1 (14 Days)||6
6563764|NCT01808339|7486691|FG005|STARTED|Treatment Period 1 (14 Days)||6
6563765|NCT01808339|7486686|FG000|COMPLETED|Treatment Period 1 (14 Days)||4
6563766|NCT01808339|7486687|FG001|COMPLETED|Treatment Period 1 (14 Days)||3
6563767|NCT01808339|7486688|FG002|COMPLETED|Treatment Period 1 (14 Days)||4
6563768|NCT01808339|7486689|FG003|COMPLETED|Treatment Period 1 (14 Days)||2
6563769|NCT01808339|7486690|FG004|COMPLETED|Treatment Period 1 (14 Days)||4
6563770|NCT01808339|7486691|FG005|COMPLETED|Treatment Period 1 (14 Days)||5
6563771|NCT01808339|7486686|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6563772|NCT01808339|7486687|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6563773|NCT01808339|7486688|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6563774|NCT01808339|7486689|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6796095|NCT01354431|7727737|FG001|STARTED|Randomized to Enter Treatment Period||54
6379787|NCT00774800|7290467|FG000|STARTED|Intervention 1||22
6379788|NCT00774800|7290467|FG000|Received at Least One Dose of Study Drug|Intervention 1||22
6379789|NCT00774800|7290467|FG000|COMPLETED|Intervention 1||22
6379790|NCT00774800|7290467|FG000|NOT COMPLETED|Intervention 1||0
6379791|NCT00774800|7290467|FG000|STARTED|Washout (3 to 10 Days)||22
6796096|NCT01354431|7727738|FG002|STARTED|Randomized to Enter Treatment Period||54
6796097|NCT01354431|7727736|FG000|COMPLETED|Randomized to Enter Treatment Period||59
6796098|NCT01354431|7727737|FG001|COMPLETED|Randomized to Enter Treatment Period||54
6796099|NCT01354431|7727738|FG002|COMPLETED|Randomized to Enter Treatment Period||54
6796100|NCT01354431|7727736|FG000|NOT COMPLETED|Randomized to Enter Treatment Period||1
6796101|NCT01354431|7727737|FG001|NOT COMPLETED|Randomized to Enter Treatment Period||0
6796102|NCT01354431|7727738|FG002|NOT COMPLETED|Randomized to Enter Treatment Period||0
6796103|NCT01354431|7727736|FG000|STARTED|Participants Treated||59
6796104|NCT01354431|7727737|FG001|STARTED|Participants Treated||54
6796105|NCT01354431|7727738|FG002|STARTED|Participants Treated||54
6796106|NCT01354431|7727736|FG000|COMPLETED|Participants Treated||0
6796107|NCT01354431|7727737|FG001|COMPLETED|Participants Treated||0
6796108|NCT01354431|7727738|FG002|COMPLETED|Participants Treated||0
6796109|NCT01354431|7727736|FG000|NOT COMPLETED|Participants Treated||59
6796110|NCT01354431|7727737|FG001|NOT COMPLETED|Participants Treated||54
6796111|NCT01354431|7727738|FG002|NOT COMPLETED|Participants Treated||54
6796112|NCT01334606|7727750|FG000|STARTED|Overall Study||21
6796113|NCT01334606|7727750|FG000|COMPLETED|Overall Study||3
6796114|NCT01334606|7727750|FG000|NOT COMPLETED|Overall Study||18
6796115|NCT01317875|7727766|FG000|STARTED|Overall Study||5
6796116|NCT01317875|7727767|FG001|STARTED|Overall Study||3
6796117|NCT01317875|7727768|FG002|STARTED|Overall Study||20
6796118|NCT01317875|7727769|FG003|STARTED|Overall Study||4
6796119|NCT01317875|7727770|FG004|STARTED|Overall Study||12
6796120|NCT01317875|7727771|FG005|STARTED|Overall Study||3
6796121|NCT01317875|7727772|FG006|STARTED|Overall Study||4
6796122|NCT01317875|7727773|FG007|STARTED|Overall Study||18
6796123|NCT01317875|7727774|FG008|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 4|0
6796124|NCT01317875|7727775|FG009|STARTED|Overall Study|No participants enrolled in Stratum 2 : Cohort 5|0
6796125|NCT01317875|7727766|FG000|COMPLETED|Overall Study||2
6796126|NCT01317875|7727767|FG001|COMPLETED|Overall Study||1
6796127|NCT01317875|7727768|FG002|COMPLETED|Overall Study||11
6796128|NCT01317875|7727769|FG003|COMPLETED|Overall Study||2
6796129|NCT01317875|7727770|FG004|COMPLETED|Overall Study||3
6796130|NCT01317875|7727771|FG005|COMPLETED|Overall Study||1
6796131|NCT01317875|7727772|FG006|COMPLETED|Overall Study||2
6796132|NCT01317875|7727773|FG007|COMPLETED|Overall Study||3
6796133|NCT01317875|7727774|FG008|COMPLETED|Overall Study||0
6796134|NCT01317875|7727775|FG009|COMPLETED|Overall Study||0
6796135|NCT01317875|7727766|FG000|NOT COMPLETED|Overall Study||3
6796136|NCT01317875|7727767|FG001|NOT COMPLETED|Overall Study||2
6796137|NCT01317875|7727768|FG002|NOT COMPLETED|Overall Study||9
6796138|NCT01317875|7727769|FG003|NOT COMPLETED|Overall Study||2
6796139|NCT01317875|7727770|FG004|NOT COMPLETED|Overall Study||9
6796140|NCT01317875|7727771|FG005|NOT COMPLETED|Overall Study||2
6796141|NCT01317875|7727772|FG006|NOT COMPLETED|Overall Study||2
6796142|NCT01317875|7727773|FG007|NOT COMPLETED|Overall Study||15
6796143|NCT01317875|7727774|FG008|NOT COMPLETED|Overall Study||0
6796144|NCT01317875|7727775|FG009|NOT COMPLETED|Overall Study||0
6796145|NCT01226732|7727811|FG000|STARTED|Overall Study||3
6796146|NCT01226732|7727812|FG001|STARTED|Overall Study||3
6796147|NCT01226732|7727813|FG002|STARTED|Overall Study||3
6796148|NCT01226732|7727814|FG003|STARTED|Overall Study||5
6796149|NCT01226732|7727815|FG004|STARTED|Overall Study||3
6796150|NCT01226732|7727816|FG005|STARTED|Overall Study||6
6796151|NCT01226732|7727811|FG000|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6796152|NCT01226732|7727812|FG001|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6796153|NCT01226732|7727813|FG002|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6796154|NCT01226732|7727814|FG003|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6796155|NCT01226732|7727815|FG004|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6796156|NCT01226732|7727816|FG005|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
6796157|NCT01226732|7727811|FG000|NOT COMPLETED|Overall Study||3
6796158|NCT01226732|7727812|FG001|NOT COMPLETED|Overall Study||3
6796159|NCT01226732|7727813|FG002|NOT COMPLETED|Overall Study||3
6796160|NCT01226732|7727814|FG003|NOT COMPLETED|Overall Study||5
6796161|NCT01226732|7727815|FG004|NOT COMPLETED|Overall Study||3
6796162|NCT01226732|7727816|FG005|NOT COMPLETED|Overall Study||6
6796163|NCT01216683|7727840|FG000|STARTED|Induction||65
6796164|NCT01216683|7727841|FG001|STARTED|Induction||99
6796165|NCT01216683|7727842|FG002|STARTED|Induction||125
6796166|NCT01216683|7727840|FG000|Received Treatment and Assessed for Toxicities|Induction||65
6796167|NCT01216683|7727841|FG001|Received Treatment and Assessed for Toxicities|Induction||93
6796168|NCT01216683|7727842|FG002|Received Treatment and Assessed for Toxicities|Induction||122
6796169|NCT01216683|7727840|FG000|Eligible and Treated|Induction||59
6796170|NCT01216683|7727841|FG001|Eligible and Treated|Induction||85
6796171|NCT01216683|7727842|FG002|Eligible and Treated|Induction||114
6796172|NCT01216683|7727840|FG000|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||48
6796173|NCT01216683|7727841|FG001|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||85
6796174|NCT01216683|7727842|FG002|Included in the Primary Analysis of Complete Remission Rate During Induction Treatment|Induction||89
6796175|NCT01216683|7727840|FG000|COMPLETED|Induction||61
6796176|NCT01216683|7727841|FG001|COMPLETED|Induction||80
6796177|NCT01216683|7727842|FG002|COMPLETED|Induction||104
6796178|NCT01216683|7727840|FG000|NOT COMPLETED|Induction||4
6796179|NCT01216683|7727841|FG001|NOT COMPLETED|Induction||19
6796180|NCT01216683|7727842|FG002|NOT COMPLETED|Induction||21
6796181|NCT01216683|7727840|FG000|STARTED|Continuation||59
6796182|NCT01216683|7727841|FG001|STARTED|Continuation||71
6796183|NCT01216683|7727842|FG002|STARTED|Continuation||94
6796184|NCT01216683|7727840|FG000|Received Continuation Treatment|Continuation||59
6796185|NCT01216683|7727841|FG001|Received Continuation Treatment|Continuation||70
6796186|NCT01216683|7727842|FG002|Received Continuation Treatment|Continuation||89
6796187|NCT01216683|7727840|FG000|COMPLETED|Continuation||44
6796188|NCT01216683|7727841|FG001|COMPLETED|Continuation||56
6796189|NCT01216683|7727842|FG002|COMPLETED|Continuation||51
6796190|NCT01216683|7727840|FG000|NOT COMPLETED|Continuation||15
6796191|NCT01216683|7727841|FG001|NOT COMPLETED|Continuation||15
6796192|NCT01216683|7727842|FG002|NOT COMPLETED|Continuation||43
6796193|NCT01085097|7727866|FG000|STARTED|Overall Study||15
6796194|NCT01085097|7727867|FG001|STARTED|Overall Study||16
6796195|NCT01085097|7727868|FG002|STARTED|Overall Study||15
6796196|NCT01085097|7727866|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
6796197|NCT01085097|7727867|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
6796198|NCT01085097|7727868|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
6796199|NCT01085097|7727866|FG000|COMPLETED|Overall Study||13
6796200|NCT01085097|7727867|FG001|COMPLETED|Overall Study||16
6796201|NCT01085097|7727868|FG002|COMPLETED|Overall Study||13
6796202|NCT01085097|7727866|FG000|NOT COMPLETED|Overall Study||2
6796203|NCT01085097|7727867|FG001|NOT COMPLETED|Overall Study||0
6796204|NCT01085097|7727868|FG002|NOT COMPLETED|Overall Study||2
6796205|NCT00920621|7727880|FG000|STARTED|Overall Study||440
6796206|NCT00920621|7727881|FG001|STARTED|Overall Study||436
6796207|NCT00920621|7727882|FG002|STARTED|Overall Study||440
6796208|NCT00920621|7727883|FG003|STARTED|Overall Study||436
6796209|NCT00920621|7727880|FG000|COMPLETED|Overall Study||386
6796210|NCT00920621|7727881|FG001|COMPLETED|Overall Study||391
6796211|NCT00920621|7727882|FG002|COMPLETED|Overall Study||405
6796212|NCT00920621|7727883|FG003|COMPLETED|Overall Study||401
6796213|NCT00920621|7727880|FG000|NOT COMPLETED|Overall Study||54
6796214|NCT00920621|7727881|FG001|NOT COMPLETED|Overall Study||45
6796215|NCT00920621|7727882|FG002|NOT COMPLETED|Overall Study||35
6796216|NCT00920621|7727883|FG003|NOT COMPLETED|Overall Study||35
6796217|NCT00828308|7727894|FG000|STARTED|Overall Study||16
6796218|NCT00828308|7727894|FG000|COMPLETED|Overall Study||16
6796219|NCT00828308|7727894|FG000|NOT COMPLETED|Overall Study||0
6796220|NCT00680901|7727900|FG000|STARTED|Overall Study||272
6796221|NCT00680901|7727901|FG001|STARTED|Overall Study||273
6796222|NCT00680901|7727900|FG000|Ongoing: On Study Treatment|Overall Study||16
6796223|NCT00680901|7727901|FG001|Ongoing: On Study Treatment|Overall Study||13
6796224|NCT00680901|7727900|FG000|Ongoing: In Follow Up|Overall Study||45
6796225|NCT00680901|7727901|FG001|Ongoing: In Follow Up|Overall Study||41
6796226|NCT00680901|7727900|FG000|COMPLETED|Overall Study||199
6796227|NCT00680901|7727901|FG001|COMPLETED|Overall Study||197
6796228|NCT00680901|7727900|FG000|NOT COMPLETED|Overall Study||73
6796229|NCT00680901|7727901|FG001|NOT COMPLETED|Overall Study||76
6796230|NCT00667251|7727909|FG000|STARTED|Overall Study||326
6796231|NCT00667251|7727910|FG001|STARTED|Overall Study||326
6796232|NCT00667251|7727909|FG000|Combination Rx|Overall Study||322
6796233|NCT00667251|7727910|FG001|Combination Rx|Overall Study||325
6796234|NCT00667251|7727909|FG000|Monotherapy|Overall Study||225
6796235|NCT00667251|7727910|FG001|Monotherapy|Overall Study||232
6796236|NCT00667251|7727909|FG000|Not Started|Overall Study||4
6796237|NCT00667251|7727910|FG001|Not Started|Overall Study||1
6796238|NCT00667251|7727909|FG000|COMPLETED|Overall Study||256
6796239|NCT00667251|7727910|FG001|COMPLETED|Overall Study||231
6796240|NCT00667251|7727909|FG000|NOT COMPLETED|Overall Study||70
6796241|NCT00667251|7727910|FG001|NOT COMPLETED|Overall Study||95
6796242|NCT00602459|7727920|FG000|STARTED|Initial Registration/Randomization||138
6796243|NCT00602459|7727921|FG001|STARTED|Initial Registration/Randomization||140
6796244|NCT00602459|7727922|FG002|STARTED|Initial Registration/Randomization||140
6796245|NCT00602459|7727923|FG003|STARTED|Initial Registration/Randomization||0
6796246|NCT00602459|7727920|FG000|COMPLETED|Initial Registration/Randomization||133
6796247|NCT00602459|7727921|FG001|COMPLETED|Initial Registration/Randomization||130
6796248|NCT00602459|7727922|FG002|COMPLETED|Initial Registration/Randomization||137
6796249|NCT00602459|7727923|FG003|COMPLETED|Initial Registration/Randomization||0
6796250|NCT00602459|7727920|FG000|NOT COMPLETED|Initial Registration/Randomization||5
6796251|NCT00602459|7727921|FG001|NOT COMPLETED|Initial Registration/Randomization||10
6796252|NCT00602459|7727922|FG002|NOT COMPLETED|Initial Registration/Randomization||3
6796253|NCT00602459|7727923|FG003|NOT COMPLETED|Initial Registration/Randomization||0
6796254|NCT00602459|7727920|FG000|STARTED|Re-assignment After Del(11q22.3) Testing||123
6796255|NCT00602459|7727921|FG001|STARTED|Re-assignment After Del(11q22.3) Testing||109
6796256|NCT00602459|7727922|FG002|STARTED|Re-assignment After Del(11q22.3) Testing||137
6796257|NCT00602459|7727923|FG003|STARTED|Re-assignment After Del(11q22.3) Testing||31
6796258|NCT00602459|7727920|FG000|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
6796259|NCT00602459|7727921|FG001|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
6796260|NCT00602459|7727922|FG002|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
6796261|NCT00602459|7727923|FG003|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
6796262|NCT00602459|7727920|FG000|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
6796263|NCT00602459|7727921|FG001|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
6796264|NCT00602459|7727922|FG002|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
6796265|NCT00602459|7727923|FG003|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
6796266|NCT00600015|7727941|FG000|STARTED|Overall Study||111
6796267|NCT00600015|7727942|FG001|STARTED|Overall Study||55
6796268|NCT00600015|7727941|FG000|COMPLETED|Overall Study|Completed >=2 cycles|51
6796269|NCT00600015|7727942|FG001|COMPLETED|Overall Study|Completed >=2 cycles|20
6796270|NCT00600015|7727941|FG000|NOT COMPLETED|Overall Study||60
6796271|NCT00600015|7727942|FG001|NOT COMPLETED|Overall Study||35
6796272|NCT00500071|7727949|FG000|STARTED|Screening and Washout Phase||318
6796273|NCT00500071|7727949|FG000|COMPLETED|Screening and Washout Phase||317
6796274|NCT00500071|7727949|FG000|NOT COMPLETED|Screening and Washout Phase||1
6796275|NCT00500071|7727949|FG000|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
6796276|NCT00500071|7727949|FG000|COMPLETED|Dose-optimization and Maintenance Phase||295
6796277|NCT00500071|7727949|FG000|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
6796278|NCT00500071|7727949|FG000|STARTED|30-day Safety Follow-up||295
6796279|NCT00500071|7727949|FG000|COMPLETED|30-day Safety Follow-up||278
6796280|NCT00500071|7727949|FG000|NOT COMPLETED|30-day Safety Follow-up||17
6796281|NCT00447122|7727957|FG000|STARTED|Overall Study||3
6796282|NCT00447122|7727958|FG001|STARTED|Overall Study||11
6796283|NCT00447122|7727959|FG002|STARTED|Overall Study||6
6796284|NCT00447122|7727960|FG003|STARTED|Overall Study||5
6796285|NCT00447122|7727957|FG000|COMPLETED|Overall Study||3
6796286|NCT00447122|7727958|FG001|COMPLETED|Overall Study||10
6796287|NCT00447122|7727959|FG002|COMPLETED|Overall Study||6
6796288|NCT00447122|7727960|FG003|COMPLETED|Overall Study||5
6796289|NCT00447122|7727957|FG000|NOT COMPLETED|Overall Study||0
6796290|NCT00447122|7727958|FG001|NOT COMPLETED|Overall Study||1
6796291|NCT00447122|7727959|FG002|NOT COMPLETED|Overall Study||0
6796292|NCT00447122|7727960|FG003|NOT COMPLETED|Overall Study||0
6796293|NCT00382252|7727970|FG000|STARTED|Overall Study||89
6796294|NCT00382252|7727970|FG000|COMPLETED|Overall Study||76
6796295|NCT00382252|7727970|FG000|NOT COMPLETED|Overall Study||13
6796296|NCT00324805|7727976|FG000|STARTED|Overall Study||749
6796297|NCT00324805|7727977|FG001|STARTED|Overall Study||752
6796298|NCT00324805|7727976|FG000|Started Assigned Therapy|Overall Study||737
6796299|NCT00324805|7727977|FG001|Started Assigned Therapy|Overall Study||735
6796300|NCT00324805|7727976|FG000|COMPLETED|Overall Study||599
6796301|NCT00324805|7727977|FG001|COMPLETED|Overall Study||269
6796302|NCT00324805|7727976|FG000|NOT COMPLETED|Overall Study||150
6796303|NCT00324805|7727977|FG001|NOT COMPLETED|Overall Study||483
6796304|NCT00310180|7727987|FG000|STARTED|Overall Study||1629
6796305|NCT00310180|7727988|FG001|STARTED|Overall Study||3458
6796306|NCT00310180|7727989|FG002|STARTED|Overall Study||3449
6796307|NCT00310180|7727990|FG003|STARTED|Overall Study||1737
6796308|NCT00310180|7727987|FG000|No On-study Data|Overall Study||0
6796309|NCT00310180|7727988|FG001|No On-study Data|Overall Study||2
6796310|NCT00310180|7727989|FG002|No On-study Data|Overall Study||10
6796311|NCT00310180|7727990|FG003|No On-study Data|Overall Study||172
6796312|NCT00310180|7727987|FG000|Ineligible|Overall Study||3
6796313|NCT00310180|7727988|FG001|Ineligible|Overall Study||4
6796314|NCT00310180|7727989|FG002|Ineligible|Overall Study||6
6796315|NCT00310180|7727990|FG003|Ineligible|Overall Study||7
6796316|NCT00310180|7727987|FG000|No Follow-up Data|Overall Study||7
6796317|NCT00310180|7727988|FG001|No Follow-up Data|Overall Study||55
6796318|NCT00310180|7727989|FG002|No Follow-up Data|Overall Study||131
6796319|NCT00310180|7727990|FG003|No Follow-up Data|Overall Study||245
6796320|NCT00310180|7727987|FG000|COMPLETED|Overall Study||1619
6563775|NCT01808339|7486690|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6563776|NCT01808339|7486691|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6268884|NCT00068718|7167985|FG000|COMPLETED|Overall Study||35
6563777|NCT01808339|7486686|FG000|STARTED|Washout Period 1 (14-21 Days)||4
6796321|NCT00310180|7727988|FG001|COMPLETED|Overall Study||3399
6796322|NCT00310180|7727989|FG002|COMPLETED|Overall Study||3312
6796323|NCT00310180|7727990|FG003|COMPLETED|Overall Study||1389
6796324|NCT00310180|7727987|FG000|NOT COMPLETED|Overall Study||10
6796325|NCT00310180|7727988|FG001|NOT COMPLETED|Overall Study||59
6796326|NCT00310180|7727989|FG002|NOT COMPLETED|Overall Study||137
6796327|NCT00310180|7727990|FG003|NOT COMPLETED|Overall Study||348
6796328|NCT00309985|7728002|FG000|STARTED|Overall Study||397
6796329|NCT00309985|7728003|FG001|STARTED|Overall Study||393
6796330|NCT00309985|7728002|FG000|Toxicity Analysis|Overall Study||390
6796331|NCT00309985|7728003|FG001|Toxicity Analysis|Overall Study||392
6796332|NCT00309985|7728002|FG000|Both Baseline and 3-month FACT-P Evals|Overall Study||334
6796333|NCT00309985|7728003|FG001|Both Baseline and 3-month FACT-P Evals|Overall Study||299
6796334|NCT00309985|7728002|FG000|COMPLETED|Overall Study||335
6796335|NCT00309985|7728003|FG001|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
6796336|NCT00309985|7728002|FG000|NOT COMPLETED|Overall Study||62
6796337|NCT00309985|7728003|FG001|NOT COMPLETED|Overall Study||1
6796338|NCT00290251|7728012|FG000|STARTED|Baseline (Month 1)||14
6796339|NCT00290251|7728013|FG001|STARTED|Baseline (Month 1)||14
6796340|NCT00290251|7728014|FG002|STARTED|Baseline (Month 1)||14
6796341|NCT00290251|7728015|FG003|STARTED|Baseline (Month 1)||0
6796342|NCT00290251|7728016|FG004|STARTED|Baseline (Month 1)||0
6796343|NCT00290251|7728017|FG005|STARTED|Baseline (Month 1)||0
6796344|NCT00290251|7728012|FG000|COMPLETED|Baseline (Month 1)||14
6796345|NCT00290251|7728013|FG001|COMPLETED|Baseline (Month 1)||14
6796346|NCT00290251|7728014|FG002|COMPLETED|Baseline (Month 1)||14
6796347|NCT00290251|7728015|FG003|COMPLETED|Baseline (Month 1)||0
6796348|NCT00290251|7728016|FG004|COMPLETED|Baseline (Month 1)||0
6796349|NCT00290251|7728017|FG005|COMPLETED|Baseline (Month 1)||0
6796350|NCT00290251|7728012|FG000|NOT COMPLETED|Baseline (Month 1)||0
6796351|NCT00290251|7728013|FG001|NOT COMPLETED|Baseline (Month 1)||0
6796352|NCT00290251|7728014|FG002|NOT COMPLETED|Baseline (Month 1)||0
6796353|NCT00290251|7728015|FG003|NOT COMPLETED|Baseline (Month 1)||0
6796354|NCT00290251|7728016|FG004|NOT COMPLETED|Baseline (Month 1)||0
6796355|NCT00290251|7728017|FG005|NOT COMPLETED|Baseline (Month 1)||0
6796356|NCT00290251|7728012|FG000|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
6796357|NCT00290251|7728013|FG001|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
6796358|NCT00290251|7728014|FG002|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|0
6796359|NCT00290251|7728015|FG003|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
6796360|NCT00290251|7728016|FG004|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
6796361|NCT00290251|7728017|FG005|STARTED|Treatment 1 (Months 2-4)|Subjects crossed over from no intervention baseline to treatment assignment|14
6796362|NCT00290251|7728012|FG000|COMPLETED|Treatment 1 (Months 2-4)||0
6796363|NCT00290251|7728013|FG001|COMPLETED|Treatment 1 (Months 2-4)||0
6796364|NCT00290251|7728014|FG002|COMPLETED|Treatment 1 (Months 2-4)||0
6796365|NCT00290251|7728015|FG003|COMPLETED|Treatment 1 (Months 2-4)||13
6796366|NCT00290251|7728016|FG004|COMPLETED|Treatment 1 (Months 2-4)||13
6796367|NCT00290251|7728017|FG005|COMPLETED|Treatment 1 (Months 2-4)||12
6796368|NCT00290251|7728012|FG000|NOT COMPLETED|Treatment 1 (Months 2-4)||0
6796369|NCT00290251|7728013|FG001|NOT COMPLETED|Treatment 1 (Months 2-4)||0
6796370|NCT00290251|7728014|FG002|NOT COMPLETED|Treatment 1 (Months 2-4)||0
6796371|NCT00290251|7728015|FG003|NOT COMPLETED|Treatment 1 (Months 2-4)||1
6796372|NCT00290251|7728016|FG004|NOT COMPLETED|Treatment 1 (Months 2-4)||1
6796373|NCT00290251|7728017|FG005|NOT COMPLETED|Treatment 1 (Months 2-4)||2
6796374|NCT00066963|7728033|FG000|STARTED|Overall Study||126
6796375|NCT00066963|7728034|FG001|STARTED|Overall Study||124
6796376|NCT00066963|7728035|FG002|STARTED|Overall Study||126
6796377|NCT00066963|7728033|FG000|COMPLETED|Overall Study|any follow-up|100
6796378|NCT00066963|7728034|FG001|COMPLETED|Overall Study||93
6796379|NCT00066963|7728035|FG002|COMPLETED|Overall Study||87
6796380|NCT00066963|7728033|FG000|NOT COMPLETED|Overall Study||26
6796381|NCT00066963|7728034|FG001|NOT COMPLETED|Overall Study||31
6796382|NCT00066963|7728035|FG002|NOT COMPLETED|Overall Study||39
6379792|NCT00774800|7290467|FG000|COMPLETED|Washout (3 to 10 Days)||22
6379793|NCT00774800|7290467|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
6379794|NCT00774800|7290467|FG000|STARTED|Intervention 2||22
6379795|NCT00774800|7290467|FG000|Received at Least One Dose of Study Drug|Intervention 2||22
6379796|NCT00774800|7290467|FG000|COMPLETED|Intervention 2||22
6379797|NCT00774800|7290467|FG000|NOT COMPLETED|Intervention 2||0
6796383|NCT01403948|7728053|FG000|STARTED|Overall Study||1
6796384|NCT01403948|7728054|FG001|STARTED|Overall Study||4
6796385|NCT01403948|7728055|FG002|STARTED|Overall Study||3
6796386|NCT01403948|7728056|FG003|STARTED|Overall Study||4
6796387|NCT01403948|7728057|FG004|STARTED|Overall Study||6
6796388|NCT01403948|7728058|FG005|STARTED|Overall Study||7
6796389|NCT01403948|7728059|FG006|STARTED|Overall Study||6
6796390|NCT01403948|7728060|FG007|STARTED|Overall Study||4
6796391|NCT01403948|7728061|FG008|STARTED|Overall Study||6
6796392|NCT01403948|7728062|FG009|STARTED|Overall Study||7
6796393|NCT01403948|7728053|FG000|COMPLETED|Overall Study||0
6796394|NCT01403948|7728054|FG001|COMPLETED|Overall Study||0
6796395|NCT01403948|7728055|FG002|COMPLETED|Overall Study||0
6796396|NCT01403948|7728056|FG003|COMPLETED|Overall Study||0
6796397|NCT01403948|7728057|FG004|COMPLETED|Overall Study||0
6796398|NCT01403948|7728058|FG005|COMPLETED|Overall Study||0
6796399|NCT01403948|7728059|FG006|COMPLETED|Overall Study||0
6796400|NCT01403948|7728060|FG007|COMPLETED|Overall Study||0
6796401|NCT01403948|7728061|FG008|COMPLETED|Overall Study||0
6796402|NCT01403948|7728062|FG009|COMPLETED|Overall Study||0
6796403|NCT01403948|7728053|FG000|NOT COMPLETED|Overall Study||1
6796404|NCT01403948|7728054|FG001|NOT COMPLETED|Overall Study||4
6796405|NCT01403948|7728055|FG002|NOT COMPLETED|Overall Study||3
6796406|NCT01403948|7728056|FG003|NOT COMPLETED|Overall Study||4
6796407|NCT01403948|7728057|FG004|NOT COMPLETED|Overall Study||6
6796408|NCT01403948|7728058|FG005|NOT COMPLETED|Overall Study||7
6796409|NCT01403948|7728059|FG006|NOT COMPLETED|Overall Study||6
6796410|NCT01403948|7728060|FG007|NOT COMPLETED|Overall Study||4
6796411|NCT01403948|7728061|FG008|NOT COMPLETED|Overall Study||6
6796412|NCT01403948|7728062|FG009|NOT COMPLETED|Overall Study||7
6796413|NCT01404312|7728090|FG000|STARTED|Overall Study||1496
6796414|NCT01404312|7728091|FG001|STARTED|Overall Study||1504
6796415|NCT01404312|7728090|FG000|COMPLETED|Overall Study||1198
6796416|NCT01404312|7728091|FG001|COMPLETED|Overall Study||1193
6796417|NCT01404312|7728090|FG000|NOT COMPLETED|Overall Study||298
6796418|NCT01404312|7728091|FG001|NOT COMPLETED|Overall Study||311
6379798|NCT00774800|7290467|FG000|STARTED|Washout (3 to 10 Days)||22
6379799|NCT00774800|7290467|FG000|COMPLETED|Washout (3 to 10 Days)||22
6379800|NCT00774800|7290467|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
6379801|NCT00774800|7290467|FG000|STARTED|Intervention 3||22
6379802|NCT00774800|7290467|FG000|Received at Least One Dose of Study Drug|Intervention 3||22
6379803|NCT00774800|7290467|FG000|COMPLETED|Intervention 3||22
6379804|NCT00774800|7290467|FG000|NOT COMPLETED|Intervention 3||0
6379805|NCT00774800|7290467|FG000|STARTED|Washout (3 to 10 Days)||22
6379806|NCT00774800|7290467|FG000|COMPLETED|Washout (3 to 10 Days)||22
6379807|NCT00774800|7290467|FG000|NOT COMPLETED|Washout (3 to 10 Days)||0
6379808|NCT00774800|7290467|FG000|STARTED|Intervention 4||22
6379809|NCT00774800|7290467|FG000|Received at Least One Dose of Study Drug|Intervention 4||21
6379810|NCT00774800|7290467|FG000|COMPLETED|Intervention 4||21
6379811|NCT00774800|7290467|FG000|NOT COMPLETED|Intervention 4||1
6379812|NCT00774852|7290479|FG000|STARTED|Overall Study||69
6379813|NCT00774852|7290480|FG001|STARTED|Overall Study||68
6379814|NCT00774852|7290479|FG000|COMPLETED|Overall Study||24
6379815|NCT00774852|7290480|FG001|COMPLETED|Overall Study||27
6379816|NCT00774852|7290479|FG000|NOT COMPLETED|Overall Study||45
6379817|NCT00774852|7290480|FG001|NOT COMPLETED|Overall Study||41
6796419|NCT01425008|7728117|FG000|STARTED|Dose Escalation Phase||4
6796420|NCT01425008|7728118|FG001|STARTED|Dose Escalation Phase||3
6796421|NCT01425008|7728119|FG002|STARTED|Dose Escalation Phase||3
6796422|NCT01425008|7728120|FG003|STARTED|Dose Escalation Phase||3
6796423|NCT01425008|7728121|FG004|STARTED|Dose Escalation Phase||7
6796424|NCT01425008|7728122|FG005|STARTED|Dose Escalation Phase||7
6796425|NCT01425008|7728123|FG006|STARTED|Dose Escalation Phase||3
6796426|NCT01425008|7728124|FG007|STARTED|Dose Escalation Phase||3
6796427|NCT01425008|7728125|FG008|STARTED|Dose Escalation Phase||13
6796428|NCT01425008|7728126|FG009|STARTED|Dose Escalation Phase||4
6796429|NCT01425008|7728127|FG010|STARTED|Dose Escalation Phase||0
6796430|NCT01425008|7728128|FG011|STARTED|Dose Escalation Phase||0
6796431|NCT01425008|7728129|FG012|STARTED|Dose Escalation Phase||0
6796432|NCT01425008|7728130|FG013|STARTED|Dose Escalation Phase||0
6796433|NCT01425008|7728131|FG014|STARTED|Dose Escalation Phase||0
6796434|NCT01425008|7728132|FG015|STARTED|Dose Escalation Phase||0
6796435|NCT01425008|7728133|FG016|STARTED|Dose Escalation Phase||0
6796436|NCT01425008|7728134|FG017|STARTED|Dose Escalation Phase||0
6796437|NCT01425008|7728135|FG018|STARTED|Dose Escalation Phase||0
6796438|NCT01425008|7728117|FG000|COMPLETED|Dose Escalation Phase||0
6796439|NCT01425008|7728118|FG001|COMPLETED|Dose Escalation Phase||0
6796440|NCT01425008|7728119|FG002|COMPLETED|Dose Escalation Phase||0
6796441|NCT01425008|7728120|FG003|COMPLETED|Dose Escalation Phase||0
6796442|NCT01425008|7728121|FG004|COMPLETED|Dose Escalation Phase||0
6796443|NCT01425008|7728122|FG005|COMPLETED|Dose Escalation Phase||0
6796444|NCT01425008|7728123|FG006|COMPLETED|Dose Escalation Phase||0
6796445|NCT01425008|7728124|FG007|COMPLETED|Dose Escalation Phase||0
6796446|NCT01425008|7728125|FG008|COMPLETED|Dose Escalation Phase||0
6796447|NCT01425008|7728126|FG009|COMPLETED|Dose Escalation Phase||0
6796448|NCT01425008|7728127|FG010|COMPLETED|Dose Escalation Phase||0
6796449|NCT01425008|7728128|FG011|COMPLETED|Dose Escalation Phase||0
6796450|NCT01425008|7728129|FG012|COMPLETED|Dose Escalation Phase||0
6796451|NCT01425008|7728130|FG013|COMPLETED|Dose Escalation Phase||0
6796452|NCT01425008|7728131|FG014|COMPLETED|Dose Escalation Phase||0
6796453|NCT01425008|7728132|FG015|COMPLETED|Dose Escalation Phase||0
6796454|NCT01425008|7728133|FG016|COMPLETED|Dose Escalation Phase||0
6796455|NCT01425008|7728134|FG017|COMPLETED|Dose Escalation Phase||0
6796456|NCT01425008|7728135|FG018|COMPLETED|Dose Escalation Phase||0
6796457|NCT01425008|7728117|FG000|NOT COMPLETED|Dose Escalation Phase||4
6796458|NCT01425008|7728118|FG001|NOT COMPLETED|Dose Escalation Phase||3
6796459|NCT01425008|7728119|FG002|NOT COMPLETED|Dose Escalation Phase||3
6796460|NCT01425008|7728120|FG003|NOT COMPLETED|Dose Escalation Phase||3
6796461|NCT01425008|7728121|FG004|NOT COMPLETED|Dose Escalation Phase||7
6796462|NCT01425008|7728122|FG005|NOT COMPLETED|Dose Escalation Phase||7
6796463|NCT01425008|7728123|FG006|NOT COMPLETED|Dose Escalation Phase||3
6796464|NCT01425008|7728124|FG007|NOT COMPLETED|Dose Escalation Phase||3
6796465|NCT01425008|7728125|FG008|NOT COMPLETED|Dose Escalation Phase||13
6796466|NCT01425008|7728126|FG009|NOT COMPLETED|Dose Escalation Phase||4
6796467|NCT01425008|7728127|FG010|NOT COMPLETED|Dose Escalation Phase||0
6796468|NCT01425008|7728128|FG011|NOT COMPLETED|Dose Escalation Phase||0
6796469|NCT01425008|7728129|FG012|NOT COMPLETED|Dose Escalation Phase||0
6796470|NCT01425008|7728130|FG013|NOT COMPLETED|Dose Escalation Phase||0
6796471|NCT01425008|7728131|FG014|NOT COMPLETED|Dose Escalation Phase||0
6796472|NCT01425008|7728132|FG015|NOT COMPLETED|Dose Escalation Phase||0
6796473|NCT01425008|7728133|FG016|NOT COMPLETED|Dose Escalation Phase||0
6796474|NCT01425008|7728134|FG017|NOT COMPLETED|Dose Escalation Phase||0
6796475|NCT01425008|7728135|FG018|NOT COMPLETED|Dose Escalation Phase||0
6796476|NCT01425008|7728117|FG000|STARTED|Dose Expansion Phase||0
6796477|NCT01425008|7728118|FG001|STARTED|Dose Expansion Phase||0
6796478|NCT01425008|7728119|FG002|STARTED|Dose Expansion Phase||0
6796479|NCT01425008|7728120|FG003|STARTED|Dose Expansion Phase||0
6796480|NCT01425008|7728121|FG004|STARTED|Dose Expansion Phase||0
6796481|NCT01425008|7728122|FG005|STARTED|Dose Expansion Phase||0
6796482|NCT01425008|7728123|FG006|STARTED|Dose Expansion Phase||0
6796483|NCT01425008|7728124|FG007|STARTED|Dose Expansion Phase||0
6796484|NCT01425008|7728125|FG008|STARTED|Dose Expansion Phase||0
6796485|NCT01425008|7728126|FG009|STARTED|Dose Expansion Phase||0
6796486|NCT01425008|7728127|FG010|STARTED|Dose Expansion Phase||16
6796487|NCT01425008|7728128|FG011|STARTED|Dose Expansion Phase||8
6796488|NCT01425008|7728129|FG012|STARTED|Dose Expansion Phase||16
6796489|NCT01425008|7728130|FG013|STARTED|Dose Expansion Phase||1
6796490|NCT01425008|7728131|FG014|STARTED|Dose Expansion Phase||6
6796491|NCT01425008|7728132|FG015|STARTED|Dose Expansion Phase||11
6796492|NCT01425008|7728133|FG016|STARTED|Dose Expansion Phase||20
6796493|NCT01425008|7728134|FG017|STARTED|Dose Expansion Phase||2
6796494|NCT01425008|7728135|FG018|STARTED|Dose Expansion Phase||19
6796495|NCT01425008|7728117|FG000|COMPLETED|Dose Expansion Phase||0
6796496|NCT01425008|7728118|FG001|COMPLETED|Dose Expansion Phase||0
6796497|NCT01425008|7728119|FG002|COMPLETED|Dose Expansion Phase||0
6796498|NCT01425008|7728120|FG003|COMPLETED|Dose Expansion Phase||0
6796499|NCT01425008|7728121|FG004|COMPLETED|Dose Expansion Phase||0
6796500|NCT01425008|7728122|FG005|COMPLETED|Dose Expansion Phase||0
6796501|NCT01425008|7728123|FG006|COMPLETED|Dose Expansion Phase||0
6796502|NCT01425008|7728124|FG007|COMPLETED|Dose Expansion Phase||0
6796503|NCT01425008|7728125|FG008|COMPLETED|Dose Expansion Phase||0
6796504|NCT01425008|7728126|FG009|COMPLETED|Dose Expansion Phase||0
6796505|NCT01425008|7728127|FG010|COMPLETED|Dose Expansion Phase||1
6796506|NCT01425008|7728128|FG011|COMPLETED|Dose Expansion Phase||0
6796507|NCT01425008|7728129|FG012|COMPLETED|Dose Expansion Phase||0
6796508|NCT01425008|7728130|FG013|COMPLETED|Dose Expansion Phase||0
6796509|NCT01425008|7728131|FG014|COMPLETED|Dose Expansion Phase||0
6796510|NCT01425008|7728132|FG015|COMPLETED|Dose Expansion Phase||0
6796511|NCT01425008|7728133|FG016|COMPLETED|Dose Expansion Phase||0
6796512|NCT01425008|7728134|FG017|COMPLETED|Dose Expansion Phase||0
6796513|NCT01425008|7728135|FG018|COMPLETED|Dose Expansion Phase||0
6796514|NCT01425008|7728117|FG000|NOT COMPLETED|Dose Expansion Phase||0
6796515|NCT01425008|7728118|FG001|NOT COMPLETED|Dose Expansion Phase||0
6796516|NCT01425008|7728119|FG002|NOT COMPLETED|Dose Expansion Phase||0
6796517|NCT01425008|7728120|FG003|NOT COMPLETED|Dose Expansion Phase||0
6796518|NCT01425008|7728121|FG004|NOT COMPLETED|Dose Expansion Phase||0
6796519|NCT01425008|7728122|FG005|NOT COMPLETED|Dose Expansion Phase||0
6796520|NCT01425008|7728123|FG006|NOT COMPLETED|Dose Expansion Phase||0
6796521|NCT01425008|7728124|FG007|NOT COMPLETED|Dose Expansion Phase||0
6796522|NCT01425008|7728125|FG008|NOT COMPLETED|Dose Expansion Phase||0
6796523|NCT01425008|7728126|FG009|NOT COMPLETED|Dose Expansion Phase||0
6796524|NCT01425008|7728127|FG010|NOT COMPLETED|Dose Expansion Phase||15
6796525|NCT01425008|7728128|FG011|NOT COMPLETED|Dose Expansion Phase||8
6796526|NCT01425008|7728129|FG012|NOT COMPLETED|Dose Expansion Phase||16
6796527|NCT01425008|7728130|FG013|NOT COMPLETED|Dose Expansion Phase||1
6796528|NCT01425008|7728131|FG014|NOT COMPLETED|Dose Expansion Phase||6
6796529|NCT01425008|7728132|FG015|NOT COMPLETED|Dose Expansion Phase||11
6796530|NCT01425008|7728133|FG016|NOT COMPLETED|Dose Expansion Phase||20
6796531|NCT01425008|7728134|FG017|NOT COMPLETED|Dose Expansion Phase||2
6796532|NCT01425008|7728135|FG018|NOT COMPLETED|Dose Expansion Phase||19
6563778|NCT01808339|7486687|FG001|STARTED|Washout Period 1 (14-21 Days)||3
6563779|NCT01808339|7486688|FG002|STARTED|Washout Period 1 (14-21 Days)||4
6563780|NCT01808339|7486689|FG003|STARTED|Washout Period 1 (14-21 Days)||2
6563781|NCT01808339|7486690|FG004|STARTED|Washout Period 1 (14-21 Days)||4
6563782|NCT01808339|7486691|FG005|STARTED|Washout Period 1 (14-21 Days)||5
6563783|NCT01808339|7486686|FG000|COMPLETED|Washout Period 1 (14-21 Days)||4
6563784|NCT01808339|7486687|FG001|COMPLETED|Washout Period 1 (14-21 Days)||3
6563785|NCT01808339|7486688|FG002|COMPLETED|Washout Period 1 (14-21 Days)||4
6563786|NCT01808339|7486689|FG003|COMPLETED|Washout Period 1 (14-21 Days)||2
6563787|NCT01808339|7486690|FG004|COMPLETED|Washout Period 1 (14-21 Days)||4
6796533|NCT01470326|7728188|FG000|STARTED|Overall Study||3187
6796534|NCT01470326|7728188|FG000|COMPLETED|Overall Study||3034
6796535|NCT01470326|7728188|FG000|NOT COMPLETED|Overall Study||153
6796536|NCT01480180|7728194|FG000|STARTED|Main Phase||174
6796537|NCT01480180|7728195|FG001|STARTED|Main Phase||12
6796538|NCT01480180|7728196|FG002|STARTED|Main Phase|Not applicable for this phase|0
6796539|NCT01480180|7728197|FG003|STARTED|Main Phase|Not applicable for this phase|0
6796540|NCT01480180|7728198|FG004|STARTED|Main Phase|Not applicable for this phase|0
6796541|NCT01480180|7728199|FG005|STARTED|Main Phase|Not applicable for this phase|0
6796542|NCT01480180|7728194|FG000|Max. Participants After Switching|Main Phase||175
6796543|NCT01480180|7728195|FG001|Max. Participants After Switching|Main Phase||11
6796544|NCT01480180|7728196|FG002|Max. Participants After Switching|Main Phase||0
6796545|NCT01480180|7728197|FG003|Max. Participants After Switching|Main Phase||0
6796546|NCT01480180|7728198|FG004|Max. Participants After Switching|Main Phase||0
6796547|NCT01480180|7728199|FG005|Max. Participants After Switching|Main Phase||0
6796548|NCT01480180|7728194|FG000|COMPLETED|Main Phase||155
6796549|NCT01480180|7728195|FG001|COMPLETED|Main Phase||11
6796550|NCT01480180|7728196|FG002|COMPLETED|Main Phase|Not applicable for this phase|0
6796551|NCT01480180|7728197|FG003|COMPLETED|Main Phase|Not applicable for this phase|0
6796552|NCT01480180|7728198|FG004|COMPLETED|Main Phase|Not applicable for this phase|0
6796553|NCT01480180|7728199|FG005|COMPLETED|Main Phase|Not applicable for this phase|0
6796554|NCT01480180|7728194|FG000|NOT COMPLETED|Main Phase||19
6796555|NCT01480180|7728195|FG001|NOT COMPLETED|Main Phase||1
6796556|NCT01480180|7728196|FG002|NOT COMPLETED|Main Phase||0
6796557|NCT01480180|7728197|FG003|NOT COMPLETED|Main Phase||0
6796558|NCT01480180|7728198|FG004|NOT COMPLETED|Main Phase||0
6796559|NCT01480180|7728199|FG005|NOT COMPLETED|Main Phase||0
6796560|NCT01480180|7728194|FG000|STARTED|Extension Phase, Part 1||0
6796561|NCT01480180|7728195|FG001|STARTED|Extension Phase, Part 1||0
6796562|NCT01480180|7728196|FG002|STARTED|Extension Phase, Part 1||105
6796563|NCT01480180|7728197|FG003|STARTED|Extension Phase, Part 1||38
6796564|NCT01480180|7728198|FG004|STARTED|Extension Phase, Part 1||7
6796565|NCT01480180|7728199|FG005|STARTED|Extension Phase, Part 1||0
6796566|NCT01480180|7728194|FG000|COMPLETED|Extension Phase, Part 1||0
6796567|NCT01480180|7728195|FG001|COMPLETED|Extension Phase, Part 1||0
6796568|NCT01480180|7728196|FG002|COMPLETED|Extension Phase, Part 1||95
6796569|NCT01480180|7728197|FG003|COMPLETED|Extension Phase, Part 1||28
6796570|NCT01480180|7728198|FG004|COMPLETED|Extension Phase, Part 1||7
6796571|NCT01480180|7728199|FG005|COMPLETED|Extension Phase, Part 1||0
6796572|NCT01480180|7728194|FG000|NOT COMPLETED|Extension Phase, Part 1||0
6796573|NCT01480180|7728195|FG001|NOT COMPLETED|Extension Phase, Part 1||0
6796574|NCT01480180|7728196|FG002|NOT COMPLETED|Extension Phase, Part 1||10
6796575|NCT01480180|7728197|FG003|NOT COMPLETED|Extension Phase, Part 1||10
6796576|NCT01480180|7728198|FG004|NOT COMPLETED|Extension Phase, Part 1||0
6796577|NCT01480180|7728199|FG005|NOT COMPLETED|Extension Phase, Part 1||0
6796578|NCT01480180|7728194|FG000|STARTED|Extension Phase, Part 2||0
6796579|NCT01480180|7728195|FG001|STARTED|Extension Phase, Part 2||0
6796580|NCT01480180|7728196|FG002|STARTED|Extension Phase, Part 2||94
6796581|NCT01480180|7728197|FG003|STARTED|Extension Phase, Part 2||40
6796582|NCT01480180|7728198|FG004|STARTED|Extension Phase, Part 2||5
6796583|NCT01480180|7728199|FG005|STARTED|Extension Phase, Part 2||0
6796584|NCT01480180|7728194|FG000|COMPLETED|Extension Phase, Part 2||0
6796585|NCT01480180|7728195|FG001|COMPLETED|Extension Phase, Part 2||0
6796586|NCT01480180|7728196|FG002|COMPLETED|Extension Phase, Part 2||77
6796587|NCT01480180|7728197|FG003|COMPLETED|Extension Phase, Part 2||33
6796588|NCT01480180|7728198|FG004|COMPLETED|Extension Phase, Part 2||3
6796589|NCT01480180|7728199|FG005|COMPLETED|Extension Phase, Part 2||0
6796590|NCT01480180|7728194|FG000|NOT COMPLETED|Extension Phase, Part 2||0
6796591|NCT01480180|7728195|FG001|NOT COMPLETED|Extension Phase, Part 2||0
6796592|NCT01480180|7728196|FG002|NOT COMPLETED|Extension Phase, Part 2||17
6796593|NCT01480180|7728197|FG003|NOT COMPLETED|Extension Phase, Part 2||7
6796594|NCT01480180|7728198|FG004|NOT COMPLETED|Extension Phase, Part 2||2
6796595|NCT01480180|7728199|FG005|NOT COMPLETED|Extension Phase, Part 2||0
6796596|NCT01504438|7728222|FG000|STARTED|Overall Study||48
6796597|NCT01504438|7728223|FG001|STARTED|Overall Study||50
6796598|NCT01504438|7728222|FG000|COMPLETED|Overall Study||22
6796599|NCT01504438|7728223|FG001|COMPLETED|Overall Study||25
6796600|NCT01504438|7728222|FG000|NOT COMPLETED|Overall Study||26
6796601|NCT01504438|7728223|FG001|NOT COMPLETED|Overall Study||25
6796602|NCT01545050|7728235|FG000|STARTED|Overall Study||18
6796603|NCT01545050|7728236|FG001|STARTED|Overall Study||9
6796604|NCT01545050|7728237|FG002|STARTED|Overall Study||9
6796605|NCT01545050|7728238|FG003|STARTED|Overall Study||18
6796606|NCT01545050|7728239|FG004|STARTED|Overall Study||18
6796607|NCT01545050|7728235|FG000|COMPLETED|Overall Study||11
6796608|NCT01545050|7728236|FG001|COMPLETED|Overall Study||4
6796609|NCT01545050|7728237|FG002|COMPLETED|Overall Study||4
6796610|NCT01545050|7728238|FG003|COMPLETED|Overall Study||6
6796611|NCT01545050|7728239|FG004|COMPLETED|Overall Study||9
6796612|NCT01545050|7728235|FG000|NOT COMPLETED|Overall Study||7
6796613|NCT01545050|7728236|FG001|NOT COMPLETED|Overall Study||5
6796614|NCT01545050|7728237|FG002|NOT COMPLETED|Overall Study||5
6796615|NCT01545050|7728238|FG003|NOT COMPLETED|Overall Study||12
6796616|NCT01545050|7728239|FG004|NOT COMPLETED|Overall Study||9
6796617|NCT01550302|7728257|FG000|STARTED|Overall Study||5
6796618|NCT01550302|7728258|FG001|STARTED|Overall Study||5
6796619|NCT01550302|7728257|FG000|COMPLETED|Overall Study||5
6796620|NCT01550302|7728258|FG001|COMPLETED|Overall Study||5
6796621|NCT01550302|7728257|FG000|NOT COMPLETED|Overall Study||0
6796622|NCT01550302|7728258|FG001|NOT COMPLETED|Overall Study||0
6563788|NCT01808339|7486691|FG005|COMPLETED|Washout Period 1 (14-21 Days)||5
6656593|NCT02462122|7586851|FG001|NOT COMPLETED|Overall Study||13
6656594|NCT02462148|7586860|FG000|STARTED|Overall Study||37
6656595|NCT02462148|7586861|FG001|STARTED|Overall Study||36
6656596|NCT02462148|7586862|FG002|STARTED|Overall Study||12
6656597|NCT02462148|7586860|FG000|COMPLETED|Overall Study||36
6656598|NCT02462148|7586861|FG001|COMPLETED|Overall Study||36
6656599|NCT02462148|7586862|FG002|COMPLETED|Overall Study||12
6656600|NCT02462148|7586860|FG000|NOT COMPLETED|Overall Study||1
6656601|NCT02462148|7586861|FG001|NOT COMPLETED|Overall Study||0
6656602|NCT02462148|7586862|FG002|NOT COMPLETED|Overall Study||0
6656603|NCT02462291|7586875|FG000|STARTED|Overall Study||82
6656604|NCT02462291|7586876|FG001|STARTED|Overall Study||81
6656605|NCT02462291|7586875|FG000|COMPLETED|Overall Study||77
6656606|NCT02462291|7586876|FG001|COMPLETED|Overall Study||75
6656607|NCT02462291|7586875|FG000|NOT COMPLETED|Overall Study||5
6656608|NCT02462291|7586876|FG001|NOT COMPLETED|Overall Study||6
6656609|NCT02462382|7586886|FG000|STARTED|Overall Study||24
6656610|NCT02462382|7586887|FG001|STARTED|Overall Study||27
6656611|NCT02462382|7586886|FG000|COMPLETED|Overall Study||24
6656612|NCT02462382|7586887|FG001|COMPLETED|Overall Study||27
6656613|NCT02462382|7586886|FG000|NOT COMPLETED|Overall Study||0
6656614|NCT02462382|7586887|FG001|NOT COMPLETED|Overall Study||0
6656615|NCT02462473|7586893|FG000|STARTED|Overall Study||9
6656616|NCT02462473|7586893|FG000|COMPLETED|Overall Study||5
6656617|NCT02462473|7586893|FG000|NOT COMPLETED|Overall Study||4
6656618|NCT02462486|7586900|FG000|STARTED|Overall Study||316
6656619|NCT02462486|7586901|FG001|STARTED|Overall Study||315
6656620|NCT02462486|7586902|FG002|STARTED|Overall Study||318
6656621|NCT02462486|7586900|FG000|COMPLETED|Overall Study||222
6656622|NCT02462486|7586901|FG001|COMPLETED|Overall Study||223
6656623|NCT02462486|7586902|FG002|COMPLETED|Overall Study||266
6656624|NCT02462486|7586900|FG000|NOT COMPLETED|Overall Study||94
6656625|NCT02462486|7586901|FG001|NOT COMPLETED|Overall Study||92
6656626|NCT02462486|7586902|FG002|NOT COMPLETED|Overall Study||52
6656627|NCT02462720|7586910|FG000|STARTED|Part 1||18
6656628|NCT02462720|7586911|FG001|STARTED|Part 1||17
6656629|NCT02462720|7586910|FG000|COMPLETED|Part 1||18
6656630|NCT02462720|7586911|FG001|COMPLETED|Part 1||17
6656631|NCT02462720|7586910|FG000|NOT COMPLETED|Part 1||0
6656632|NCT02462720|7586911|FG001|NOT COMPLETED|Part 1||0
6656633|NCT02462720|7586910|FG000|STARTED|Part 2||18
6656634|NCT02462720|7586911|FG001|STARTED|Part 2||17
6656635|NCT02462720|7586910|FG000|COMPLETED|Part 2||17
6656636|NCT02462720|7586911|FG001|COMPLETED|Part 2||16
6656637|NCT02462720|7586910|FG000|NOT COMPLETED|Part 2||1
6656638|NCT02462720|7586911|FG001|NOT COMPLETED|Part 2||1
6656639|NCT02462759|7586921|FG000|STARTED|Part 1: Double Blind||7
6656640|NCT02462759|7586922|FG001|STARTED|Part 1: Double Blind||14
6656641|NCT02462759|7586923|FG002|STARTED|Part 1: Double Blind||0
6656642|NCT02462759|7586921|FG000|COMPLETED|Part 1: Double Blind||6
6656643|NCT02462759|7586922|FG001|COMPLETED|Part 1: Double Blind||14
6656644|NCT02462759|7586923|FG002|COMPLETED|Part 1: Double Blind||0
6563789|NCT01808339|7486686|FG000|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6563790|NCT01808339|7486687|FG001|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6563791|NCT01808339|7486688|FG002|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6563792|NCT01808339|7486689|FG003|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6563793|NCT01808339|7486690|FG004|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6563794|NCT01808339|7486691|FG005|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
6563795|NCT01808339|7486686|FG000|STARTED|Treatment Period 2 (14 Days)||4
6563796|NCT01808339|7486687|FG001|STARTED|Treatment Period 2 (14 Days)||3
6563797|NCT01808339|7486688|FG002|STARTED|Treatment Period 2 (14 Days)||4
6563798|NCT01808339|7486689|FG003|STARTED|Treatment Period 2 (14 Days)||2
6656645|NCT02462759|7586921|FG000|NOT COMPLETED|Part 1: Double Blind||1
6656646|NCT02462759|7586922|FG001|NOT COMPLETED|Part 1: Double Blind||0
6796623|NCT01555021|7728266|FG000|STARTED|Overall Study||2
6796624|NCT01555021|7728267|FG001|STARTED|Overall Study||2
6796625|NCT01555021|7728266|FG000|COMPLETED|Overall Study|One treatment as usual subject completed 1 month, 3 month, and 6 month follow up visits|1
6796626|NCT01555021|7728267|FG001|COMPLETED|Overall Study|None of the AGT subjects competed month 1, month 3, or month 6 follow up visits.|0
6796627|NCT01555021|7728266|FG000|NOT COMPLETED|Overall Study||1
6796628|NCT01555021|7728267|FG001|NOT COMPLETED|Overall Study||2
6796629|NCT01561430|7728283|FG000|STARTED|Overall Study||9
6796630|NCT01561430|7728284|FG001|STARTED|Overall Study||23
6796631|NCT01561430|7728285|FG002|STARTED|Overall Study||18
6796632|NCT01561430|7728286|FG003|STARTED|Overall Study||20
6796633|NCT01561430|7728283|FG000|Received at Least One Dose of Study Drug|Overall Study||9
6796634|NCT01561430|7728284|FG001|Received at Least One Dose of Study Drug|Overall Study||23
6796635|NCT01561430|7728285|FG002|Received at Least One Dose of Study Drug|Overall Study||18
6796636|NCT01561430|7728286|FG003|Received at Least One Dose of Study Drug|Overall Study||20
6796637|NCT01561430|7728283|FG000|COMPLETED|Overall Study||8
6796638|NCT01561430|7728284|FG001|COMPLETED|Overall Study||8
6796639|NCT01561430|7728285|FG002|COMPLETED|Overall Study||1
6796640|NCT01561430|7728286|FG003|COMPLETED|Overall Study||7
6796641|NCT01561430|7728283|FG000|NOT COMPLETED|Overall Study||1
6796642|NCT01561430|7728284|FG001|NOT COMPLETED|Overall Study||15
6796643|NCT01561430|7728285|FG002|NOT COMPLETED|Overall Study||17
6796644|NCT01561430|7728286|FG003|NOT COMPLETED|Overall Study||13
6796645|NCT01580813|7728297|FG000|STARTED|Overall Study||4
6796646|NCT01580813|7728298|FG001|STARTED|Overall Study||3
6796647|NCT01580813|7728297|FG000|Completed First Intervention|Overall Study||4
6796648|NCT01580813|7728298|FG001|Completed First Intervention|Overall Study||3
6796649|NCT01580813|7728297|FG000|Completed 1 Week Washout|Overall Study||4
6796650|NCT01580813|7728298|FG001|Completed 1 Week Washout|Overall Study||3
6796651|NCT01580813|7728297|FG000|Started Second Intervention|Overall Study||4
6796652|NCT01580813|7728298|FG001|Started Second Intervention|Overall Study||3
6796653|NCT01580813|7728297|FG000|COMPLETED|Overall Study||4
6796654|NCT01580813|7728298|FG001|COMPLETED|Overall Study||3
6563799|NCT01808339|7486690|FG004|STARTED|Treatment Period 2 (14 Days)||4
6796655|NCT01580813|7728297|FG000|NOT COMPLETED|Overall Study||0
6796656|NCT01580813|7728298|FG001|NOT COMPLETED|Overall Study||0
6796657|NCT01595009|7728306|FG000|STARTED|Core||126
6796658|NCT01595009|7728307|FG001|STARTED|Core||120
6796659|NCT01595009|7728308|FG002|STARTED|Core||0
6796660|NCT01595009|7728309|FG003|STARTED|Core||0
6796661|NCT01595009|7728306|FG000|COMPLETED|Core||0
6796662|NCT01595009|7728307|FG001|COMPLETED|Core||0
6796663|NCT01595009|7728308|FG002|COMPLETED|Core||0
6796664|NCT01595009|7728309|FG003|COMPLETED|Core||0
6796665|NCT01595009|7728306|FG000|NOT COMPLETED|Core||126
6796666|NCT01595009|7728307|FG001|NOT COMPLETED|Core||120
6796667|NCT01595009|7728308|FG002|NOT COMPLETED|Core||0
6796668|NCT01595009|7728309|FG003|NOT COMPLETED|Core||0
6796669|NCT01595009|7728306|FG000|STARTED|Extension||0
6796670|NCT01595009|7728307|FG001|STARTED|Extension||0
6796671|NCT01595009|7728308|FG002|STARTED|Extension||4
6796672|NCT01595009|7728309|FG003|STARTED|Extension||11
6796673|NCT01595009|7728306|FG000|COMPLETED|Extension||0
6796674|NCT01595009|7728307|FG001|COMPLETED|Extension||0
6796675|NCT01595009|7728308|FG002|COMPLETED|Extension||0
6796676|NCT01595009|7728309|FG003|COMPLETED|Extension||0
6796677|NCT01595009|7728306|FG000|NOT COMPLETED|Extension||0
6796678|NCT01595009|7728307|FG001|NOT COMPLETED|Extension||0
6796679|NCT01595009|7728308|FG002|NOT COMPLETED|Extension||4
6796680|NCT01595009|7728309|FG003|NOT COMPLETED|Extension||11
6268885|NCT00068718|7167985|FG000|NOT COMPLETED|Overall Study||0
6268886|NCT00068770|7167991|FG000|STARTED|Overall Study||13
6268887|NCT00068770|7167992|FG001|STARTED|Overall Study||22
6563800|NCT01808339|7486691|FG005|STARTED|Treatment Period 2 (14 Days)||5
6563801|NCT01808339|7486686|FG000|COMPLETED|Treatment Period 2 (14 Days)||4
6563802|NCT01808339|7486687|FG001|COMPLETED|Treatment Period 2 (14 Days)||3
6796681|NCT01620944|7728326|FG000|STARTED|Overall Study||2
6796682|NCT01620944|7728327|FG001|STARTED|Overall Study||1
6796683|NCT01620944|7728326|FG000|COMPLETED|Overall Study||0
6796684|NCT01620944|7728327|FG001|COMPLETED|Overall Study||0
6796685|NCT01620944|7728326|FG000|NOT COMPLETED|Overall Study||2
6796686|NCT01620944|7728327|FG001|NOT COMPLETED|Overall Study||1
6796687|NCT01627561|7728335|FG000|STARTED|Overall Study||74
6796688|NCT01627561|7728336|FG001|STARTED|Overall Study||74
6796689|NCT01627561|7728335|FG000|COMPLETED|Overall Study||73
6796690|NCT01627561|7728336|FG001|COMPLETED|Overall Study||71
6796691|NCT01627561|7728335|FG000|NOT COMPLETED|Overall Study||1
6796692|NCT01627561|7728336|FG001|NOT COMPLETED|Overall Study||3
6796705|NCT01652534|7728361|FG000|STARTED|Overall Study||2
6796706|NCT01652534|7728362|FG001|STARTED|Overall Study||1
6796707|NCT01652534|7728361|FG000|COMPLETED|Overall Study||1
6796708|NCT01652534|7728362|FG001|COMPLETED|Overall Study||1
6796709|NCT01652534|7728361|FG000|NOT COMPLETED|Overall Study||1
6796710|NCT01652534|7728362|FG001|NOT COMPLETED|Overall Study||0
6796711|NCT04871425|7728370|FG000|STARTED|Overall Study||57
6796712|NCT04871425|7728371|FG001|STARTED|Overall Study||53
6796713|NCT04871425|7728370|FG000|COMPLETED|Overall Study||42
6796714|NCT04871425|7728371|FG001|COMPLETED|Overall Study||45
6796715|NCT04871425|7728370|FG000|NOT COMPLETED|Overall Study||15
6796716|NCT04871425|7728371|FG001|NOT COMPLETED|Overall Study||8
6796717|NCT04799405|7728377|FG000|STARTED|Phase 1 - Acute Stimulation, Daily tDCS||5
6379818|NCT00774930|7290498|FG000|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
6379819|NCT00774930|7290499|FG001|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
6379820|NCT00774930|7290498|FG000|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
6395574|NCT00859053|7308148|FG000|NOT COMPLETED|Overall Study||0
6796693|NCT01629511|7728346|FG000|STARTED|Overall Study||4
6796694|NCT01629511|7728347|FG001|STARTED|Overall Study||0
6796695|NCT01629511|7728348|FG002|STARTED|Overall Study||8
6796696|NCT01629511|7728349|FG003|STARTED|Overall Study||3
6796697|NCT01629511|7728346|FG000|COMPLETED|Overall Study||4
6796698|NCT01629511|7728347|FG001|COMPLETED|Overall Study||0
6796699|NCT01629511|7728348|FG002|COMPLETED|Overall Study||8
6796700|NCT01629511|7728349|FG003|COMPLETED|Overall Study||3
6796701|NCT01629511|7728346|FG000|NOT COMPLETED|Overall Study||0
6796702|NCT01629511|7728347|FG001|NOT COMPLETED|Overall Study||0
6796703|NCT01629511|7728348|FG002|NOT COMPLETED|Overall Study||0
6796704|NCT01629511|7728349|FG003|NOT COMPLETED|Overall Study||0
6796718|NCT04799405|7728377|FG000|COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||3
6796719|NCT04799405|7728377|FG000|NOT COMPLETED|Phase 1 - Acute Stimulation, Daily tDCS||2
6796720|NCT04799405|7728377|FG000|STARTED|Phase 2 - Tapered Stimulation Schedule||3
6796721|NCT04799405|7728377|FG000|COMPLETED|Phase 2 - Tapered Stimulation Schedule||3
6796722|NCT04799405|7728377|FG000|NOT COMPLETED|Phase 2 - Tapered Stimulation Schedule||0
6796723|NCT04799405|7728377|FG000|STARTED|Phase 3 - Follow up Phase||3
6796724|NCT04799405|7728377|FG000|COMPLETED|Phase 3 - Follow up Phase||3
6796725|NCT04799405|7728377|FG000|NOT COMPLETED|Phase 3 - Follow up Phase||0
6379821|NCT00774930|7290499|FG001|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
6379822|NCT00774930|7290498|FG000|NOT COMPLETED|DB Phase||14
6379823|NCT00774930|7290499|FG001|NOT COMPLETED|DB Phase||22
6379824|NCT00774930|7290498|FG000|STARTED|IOL Phase||56
6379825|NCT00774930|7290499|FG001|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
6379826|NCT00774930|7290498|FG000|COMPLETED|IOL Phase||43
6502345|NCT01434290|7421017|FG000|COMPLETED|Overall Study|Eligible subjects included in analysis|119
6796726|NCT04748458|7728381|FG000|STARTED|Overall Study||85
6796727|NCT04748458|7728381|FG000|COMPLETED|Overall Study||85
6796728|NCT04748458|7728381|FG000|NOT COMPLETED|Overall Study||0
6796729|NCT04537949|7728393|FG000|STARTED|Overall Study||12
6796730|NCT04537949|7728394|FG001|STARTED|Overall Study||12
6796731|NCT04537949|7728395|FG002|STARTED|Overall Study||12
6796732|NCT04537949|7728396|FG003|STARTED|Overall Study||12
6796733|NCT04537949|7728397|FG004|STARTED|Overall Study||12
6796734|NCT04537949|7728398|FG005|STARTED|Overall Study||12
6796735|NCT04537949|7728399|FG006|STARTED|Overall Study||12
6796736|NCT04537949|7728400|FG007|STARTED|Overall Study||12
6796737|NCT04537949|7728393|FG000|COMPLETED|Overall Study||11
6796738|NCT04537949|7728394|FG001|COMPLETED|Overall Study||12
6796739|NCT04537949|7728395|FG002|COMPLETED|Overall Study||12
6796740|NCT04537949|7728396|FG003|COMPLETED|Overall Study||12
6796741|NCT04537949|7728397|FG004|COMPLETED|Overall Study||12
6796742|NCT04537949|7728398|FG005|COMPLETED|Overall Study||12
6563803|NCT01808339|7486688|FG002|COMPLETED|Treatment Period 2 (14 Days)||4
6563804|NCT01808339|7486689|FG003|COMPLETED|Treatment Period 2 (14 Days)||2
6563805|NCT01808339|7486690|FG004|COMPLETED|Treatment Period 2 (14 Days)||4
6796743|NCT04537949|7728399|FG006|COMPLETED|Overall Study||12
6796744|NCT04537949|7728400|FG007|COMPLETED|Overall Study||12
6796745|NCT04537949|7728393|FG000|NOT COMPLETED|Overall Study||1
6796746|NCT04537949|7728394|FG001|NOT COMPLETED|Overall Study||0
6796747|NCT04537949|7728395|FG002|NOT COMPLETED|Overall Study||0
6796748|NCT04537949|7728396|FG003|NOT COMPLETED|Overall Study||0
6796749|NCT04537949|7728397|FG004|NOT COMPLETED|Overall Study||0
6796750|NCT04537949|7728398|FG005|NOT COMPLETED|Overall Study||0
6796751|NCT04537949|7728399|FG006|NOT COMPLETED|Overall Study||0
6563806|NCT01808339|7486691|FG005|COMPLETED|Treatment Period 2 (14 Days)||5
6563807|NCT01808339|7486686|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6563808|NCT01808339|7486687|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6563809|NCT01808339|7486688|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6563810|NCT01808339|7486689|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6563811|NCT01808339|7486690|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6563812|NCT01808339|7486691|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6563813|NCT01808339|7486686|FG000|STARTED|Washout Period 2 (14-21 Days)||4
6563814|NCT01808339|7486687|FG001|STARTED|Washout Period 2 (14-21 Days)||3
6563815|NCT01808339|7486688|FG002|STARTED|Washout Period 2 (14-21 Days)||4
6563816|NCT01808339|7486689|FG003|STARTED|Washout Period 2 (14-21 Days)||2
6563817|NCT01808339|7486690|FG004|STARTED|Washout Period 2 (14-21 Days)||4
6796752|NCT04537949|7728400|FG007|NOT COMPLETED|Overall Study||0
6563818|NCT01808339|7486691|FG005|STARTED|Washout Period 2 (14-21 Days)||5
6563819|NCT01808339|7486686|FG000|COMPLETED|Washout Period 2 (14-21 Days)||4
6563820|NCT01808339|7486687|FG001|COMPLETED|Washout Period 2 (14-21 Days)||3
6563821|NCT01808339|7486688|FG002|COMPLETED|Washout Period 2 (14-21 Days)||4
6796753|NCT04529499|7728420|FG000|STARTED|Overall Study||175
6796754|NCT04529499|7728421|FG001|STARTED|Overall Study||178
6796755|NCT04529499|7728420|FG000|Discharged From Hospital Before Day 28|Overall Study||136
6796756|NCT04529499|7728421|FG001|Discharged From Hospital Before Day 28|Overall Study||136
6796757|NCT04529499|7728420|FG000|Completed 10-day Treatment Course of IMP|Overall Study||150
6796758|NCT04529499|7728421|FG001|Completed 10-day Treatment Course of IMP|Overall Study||147
6796759|NCT04529499|7728420|FG000|Completed Day 14 Telephonic Visit|Overall Study||107
6796760|NCT04529499|7728421|FG001|Completed Day 14 Telephonic Visit|Overall Study||102
6796761|NCT04529499|7728420|FG000|Completed Day 21 Telephonic Visit|Overall Study||119
6796762|NCT04529499|7728421|FG001|Completed Day 21 Telephonic Visit|Overall Study||120
6796763|NCT04529499|7728420|FG000|Completed Day 28 Telephonic Visit|Overall Study||134
6796764|NCT04529499|7728421|FG001|Completed Day 28 Telephonic Visit|Overall Study||131
6563822|NCT01808339|7486689|FG003|COMPLETED|Washout Period 2 (14-21 Days)||2
6563823|NCT01808339|7486690|FG004|COMPLETED|Washout Period 2 (14-21 Days)||4
6563824|NCT01808339|7486691|FG005|COMPLETED|Washout Period 2 (14-21 Days)||5
6563825|NCT01808339|7486686|FG000|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6563826|NCT01808339|7486687|FG001|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6563827|NCT01808339|7486688|FG002|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6563828|NCT01808339|7486689|FG003|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6563829|NCT01808339|7486690|FG004|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6563830|NCT01808339|7486691|FG005|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
6563831|NCT01808339|7486686|FG000|STARTED|Treatment Period 3 (14 Days)||4
6563832|NCT01808339|7486687|FG001|STARTED|Treatment Period 3 (14 Days)||3
6563833|NCT01808339|7486688|FG002|STARTED|Treatment Period 3 (14 Days)||4
6563834|NCT01808339|7486689|FG003|STARTED|Treatment Period 3 (14 Days)||2
6563835|NCT01808339|7486690|FG004|STARTED|Treatment Period 3 (14 Days)||4
6563836|NCT01808339|7486691|FG005|STARTED|Treatment Period 3 (14 Days)||5
6563837|NCT01808339|7486686|FG000|COMPLETED|Treatment Period 3 (14 Days)||4
6563838|NCT01808339|7486687|FG001|COMPLETED|Treatment Period 3 (14 Days)||3
6563839|NCT01808339|7486688|FG002|COMPLETED|Treatment Period 3 (14 Days)||3
6563840|NCT01808339|7486689|FG003|COMPLETED|Treatment Period 3 (14 Days)||2
6563841|NCT01808339|7486690|FG004|COMPLETED|Treatment Period 3 (14 Days)||4
6563842|NCT01808339|7486691|FG005|COMPLETED|Treatment Period 3 (14 Days)||5
6563843|NCT01808339|7486686|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6563844|NCT01808339|7486687|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6563845|NCT01808339|7486688|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6563846|NCT01808339|7486689|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6563847|NCT01808339|7486690|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6563848|NCT01808339|7486691|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6563849|NCT01808508|7486702|FG000|STARTED|Overall Study||11
6563850|NCT01808508|7486703|FG001|STARTED|Overall Study||9
6563851|NCT01808508|7486704|FG002|STARTED|Overall Study||3
6563852|NCT01808508|7486702|FG000|COMPLETED|Overall Study||10
6563853|NCT01808508|7486703|FG001|COMPLETED|Overall Study||9
6563854|NCT01808508|7486704|FG002|COMPLETED|Overall Study||3
6563855|NCT01808508|7486702|FG000|NOT COMPLETED|Overall Study||1
6563856|NCT01808508|7486703|FG001|NOT COMPLETED|Overall Study||0
6563857|NCT01808508|7486704|FG002|NOT COMPLETED|Overall Study||0
6563858|NCT01808534|7486712|FG000|STARTED|Overall Study||5
6563859|NCT01808534|7486712|FG000|COMPLETED|Overall Study||1
6563860|NCT01808534|7486712|FG000|NOT COMPLETED|Overall Study||4
6563861|NCT01808547|7486718|FG000|STARTED|Overall Study||174
6563862|NCT01808547|7486719|FG001|STARTED|Overall Study||94
6563863|NCT01808547|7486718|FG000|Safety Population|Overall Study||170
6563864|NCT01808547|7486719|FG001|Safety Population|Overall Study||85
6563865|NCT01808547|7486718|FG000|mITT Population|Overall Study||168
6563866|NCT01808547|7486719|FG001|mITT Population|Overall Study||85
6563867|NCT01808547|7486718|FG000|COMPLETED|Overall Study||137
6563868|NCT01808547|7486719|FG001|COMPLETED|Overall Study||48
6563869|NCT01808547|7486718|FG000|NOT COMPLETED|Overall Study||37
6563870|NCT01808547|7486719|FG001|NOT COMPLETED|Overall Study||46
6563871|NCT01808560|7486728|FG000|STARTED|Randomization and Treatment Allocation||18
6563872|NCT01808560|7486729|FG001|STARTED|Randomization and Treatment Allocation||16
6563873|NCT01808560|7486730|FG002|STARTED|Randomization and Treatment Allocation||0
6563874|NCT01808560|7486728|FG000|COMPLETED|Randomization and Treatment Allocation||18
6563875|NCT01808560|7486729|FG001|COMPLETED|Randomization and Treatment Allocation||16
6563876|NCT01808560|7486730|FG002|COMPLETED|Randomization and Treatment Allocation||0
6563877|NCT01808560|7486728|FG000|NOT COMPLETED|Randomization and Treatment Allocation||0
6563878|NCT01808560|7486729|FG001|NOT COMPLETED|Randomization and Treatment Allocation||0
6563879|NCT01808560|7486730|FG002|NOT COMPLETED|Randomization and Treatment Allocation||0
6563880|NCT01808560|7486728|FG000|STARTED|1-Month After Cataract Surgery|ITT: 2 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|16
6563881|NCT01808560|7486729|FG001|STARTED|1-Month After Cataract Surgery|ITT: 3 subjects withdrew b/c they were unable to complete cataract surgery scheduled for both eyes|13
6563882|NCT01808560|7486730|FG002|STARTED|1-Month After Cataract Surgery||0
6563883|NCT01808560|7486728|FG000|COMPLETED|1-Month After Cataract Surgery||16
6563884|NCT01808560|7486729|FG001|COMPLETED|1-Month After Cataract Surgery||13
6563885|NCT01808560|7486730|FG002|COMPLETED|1-Month After Cataract Surgery||0
6563886|NCT01808560|7486728|FG000|NOT COMPLETED|1-Month After Cataract Surgery||0
6563887|NCT01808560|7486729|FG001|NOT COMPLETED|1-Month After Cataract Surgery||0
6563888|NCT01808560|7486730|FG002|NOT COMPLETED|1-Month After Cataract Surgery||0
6563889|NCT01808560|7486728|FG000|STARTED|3-Month After Cataract Surgery||17
6563890|NCT01808560|7486729|FG001|STARTED|3-Month After Cataract Surgery||13
6563891|NCT01808560|7486730|FG002|STARTED|3-Month After Cataract Surgery||0
6563892|NCT01808560|7486728|FG000|COMPLETED|3-Month After Cataract Surgery||17
6563893|NCT01808560|7486729|FG001|COMPLETED|3-Month After Cataract Surgery||13
6563894|NCT01808560|7486730|FG002|COMPLETED|3-Month After Cataract Surgery||0
6563895|NCT01808560|7486728|FG000|NOT COMPLETED|3-Month After Cataract Surgery||0
6563896|NCT01808560|7486729|FG001|NOT COMPLETED|3-Month After Cataract Surgery||0
6563897|NCT01808560|7486730|FG002|NOT COMPLETED|3-Month After Cataract Surgery||0
6563898|NCT01808560|7486728|FG000|STARTED|Crossover Treatment||0
6563899|NCT01808560|7486729|FG001|STARTED|Crossover Treatment||0
6563900|NCT01808560|7486730|FG002|STARTED|Crossover Treatment|Post-Treatment Group Received Crossover LipiFlow treatment 3 Months after cataract surgery|13
6563901|NCT01808560|7486728|FG000|COMPLETED|Crossover Treatment||0
6563902|NCT01808560|7486729|FG001|COMPLETED|Crossover Treatment||0
6563903|NCT01808560|7486730|FG002|COMPLETED|Crossover Treatment||13
6796765|NCT04529499|7728420|FG000|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||98
6796766|NCT04529499|7728421|FG001|Completed Days 14, 21 and 28 Telephonic Visits in Stage I|Overall Study||94
6796767|NCT04529499|7728420|FG000|Continue to be in Hospital as of Day 28|Overall Study||6
6796768|NCT04529499|7728421|FG001|Continue to be in Hospital as of Day 28|Overall Study||4
6796769|NCT04529499|7728420|FG000|Completed Day 42 Telephonic Visit|Overall Study||136
6796770|NCT04529499|7728421|FG001|Completed Day 42 Telephonic Visit|Overall Study||135
6796771|NCT04529499|7728420|FG000|Completed Day 60 Telephonic Visit|Overall Study||129
6796772|NCT04529499|7728421|FG001|Completed Day 60 Telephonic Visit|Overall Study||132
6796773|NCT04529499|7728420|FG000|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||126
6796774|NCT04529499|7728421|FG001|Completed Days 42 and 60 Telephonic Visits in Stage II|Overall Study||130
6563904|NCT01808560|7486728|FG000|NOT COMPLETED|Crossover Treatment||0
6563905|NCT01808560|7486729|FG001|NOT COMPLETED|Crossover Treatment||0
6563906|NCT01808560|7486730|FG002|NOT COMPLETED|Crossover Treatment||0
6563907|NCT01808560|7486728|FG000|STARTED|4-Month After Cataract Surgery||0
6563908|NCT01808560|7486729|FG001|STARTED|4-Month After Cataract Surgery||0
6563909|NCT01808560|7486730|FG002|STARTED|4-Month After Cataract Surgery||13
6563910|NCT01808560|7486728|FG000|COMPLETED|4-Month After Cataract Surgery||0
6563911|NCT01808560|7486729|FG001|COMPLETED|4-Month After Cataract Surgery||0
6563912|NCT01808560|7486730|FG002|COMPLETED|4-Month After Cataract Surgery||13
6563913|NCT01808560|7486728|FG000|NOT COMPLETED|4-Month After Cataract Surgery||0
6563914|NCT01808560|7486729|FG001|NOT COMPLETED|4-Month After Cataract Surgery||0
6563915|NCT01808560|7486730|FG002|NOT COMPLETED|4-Month After Cataract Surgery||0
6563916|NCT01808573|7486740|FG000|STARTED|Overall Study||307
6563917|NCT01808573|7486741|FG001|STARTED|Overall Study||314
6563918|NCT01808573|7486740|FG000|Received Treatment|Overall Study||303
6563919|NCT01808573|7486741|FG001|Received Treatment|Overall Study||311
6563920|NCT01808573|7486740|FG000|COMPLETED|Overall Study||0
6563921|NCT01808573|7486741|FG001|COMPLETED|Overall Study||0
6563922|NCT01808573|7486740|FG000|NOT COMPLETED|Overall Study||307
6563923|NCT01808573|7486741|FG001|NOT COMPLETED|Overall Study||314
6563924|NCT01808612|7486750|FG000|STARTED|Treatment Period||169
6563925|NCT01808612|7486751|FG001|STARTED|Treatment Period||84
6563926|NCT01808612|7486752|FG002|STARTED|Treatment Period||260
6563927|NCT01808612|7486750|FG000|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
6563928|NCT01808612|7486751|FG001|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
6563929|NCT01808612|7486752|FG002|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
6563930|NCT01808612|7486750|FG000|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
6563931|NCT01808612|7486751|FG001|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
6563932|NCT01808612|7486752|FG002|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
6563933|NCT01808612|7486750|FG000|NOT COMPLETED|Treatment Period||15
6563934|NCT01808612|7486751|FG001|NOT COMPLETED|Treatment Period||7
6563935|NCT01808612|7486752|FG002|NOT COMPLETED|Treatment Period||14
6563936|NCT01808612|7486750|FG000|STARTED|Discontinuation Period||87
6563937|NCT01808612|7486751|FG001|STARTED|Discontinuation Period||38
6563938|NCT01808612|7486752|FG002|STARTED|Discontinuation Period||145
6563939|NCT01808612|7486750|FG000|COMPLETED|Discontinuation Period||85
6563940|NCT01808612|7486751|FG001|COMPLETED|Discontinuation Period||37
6563941|NCT01808612|7486752|FG002|COMPLETED|Discontinuation Period||145
6563942|NCT01808612|7486750|FG000|NOT COMPLETED|Discontinuation Period||2
6563943|NCT01808612|7486751|FG001|NOT COMPLETED|Discontinuation Period||1
6563944|NCT01808612|7486752|FG002|NOT COMPLETED|Discontinuation Period||0
6563945|NCT01808651|7486766|FG000|STARTED|Study Period 1||99
6563946|NCT01808651|7486767|FG001|STARTED|Study Period 1||65
6563947|NCT01808651|7486768|FG002|STARTED|Study Period 1||36
6563948|NCT01808651|7486766|FG000|Received at Least One Dose of Study Drug|Study Period 1||98
6563949|NCT01808651|7486767|FG001|Received at Least One Dose of Study Drug|Study Period 1||65
6563950|NCT01808651|7486768|FG002|Received at Least One Dose of Study Drug|Study Period 1||36
6563951|NCT01808651|7486766|FG000|COMPLETED|Study Period 1||73
6563952|NCT01808651|7486767|FG001|COMPLETED|Study Period 1||48
6563953|NCT01808651|7486768|FG002|COMPLETED|Study Period 1||31
6563954|NCT01808651|7486766|FG000|NOT COMPLETED|Study Period 1||26
6563955|NCT01808651|7486767|FG001|NOT COMPLETED|Study Period 1||17
6563956|NCT01808651|7486768|FG002|NOT COMPLETED|Study Period 1||5
6563957|NCT01808651|7486766|FG000|STARTED|Study Period 2||77
6563958|NCT01808651|7486767|FG001|STARTED|Study Period 2||52
6563959|NCT01808651|7486768|FG002|STARTED|Study Period 2||33
6563960|NCT01808651|7486766|FG000|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
6563961|NCT01808651|7486767|FG001|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
6563962|NCT01808651|7486768|FG002|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
6563963|NCT01808651|7486766|FG000|NOT COMPLETED|Study Period 2||0
6563964|NCT01808651|7486767|FG001|NOT COMPLETED|Study Period 2||0
6563965|NCT01808651|7486768|FG002|NOT COMPLETED|Study Period 2||0
6563966|NCT01808690|7486781|FG000|STARTED|Overall Study||25
6563967|NCT01808690|7486782|FG001|STARTED|Overall Study||23
6563968|NCT01808690|7486781|FG000|COMPLETED|Overall Study||24
6563969|NCT01808690|7486782|FG001|COMPLETED|Overall Study||21
6563970|NCT01808690|7486781|FG000|NOT COMPLETED|Overall Study||1
6563971|NCT01808690|7486782|FG001|NOT COMPLETED|Overall Study||2
6563972|NCT01808755|7486788|FG000|STARTED|Overall Study||30
6563973|NCT01808755|7486789|FG001|STARTED|Overall Study||30
6563974|NCT01808755|7486788|FG000|COMPLETED|Overall Study||30
6563975|NCT01808755|7486789|FG001|COMPLETED|Overall Study||30
6563976|NCT01808755|7486788|FG000|NOT COMPLETED|Overall Study||0
6563977|NCT01808755|7486789|FG001|NOT COMPLETED|Overall Study||0
6563978|NCT01808963|7486794|FG000|STARTED|Overall Study||13
6563979|NCT01808963|7486794|FG000|COMPLETED|Overall Study||13
6563980|NCT01808963|7486794|FG000|NOT COMPLETED|Overall Study||0
6563981|NCT01809054|7486800|FG000|STARTED|Overall Study||27
6563982|NCT01809054|7486801|FG001|STARTED|Overall Study||22
6563983|NCT01809054|7486800|FG000|COMPLETED|Overall Study||27
6563984|NCT01809054|7486801|FG001|COMPLETED|Overall Study||22
6563985|NCT01809054|7486800|FG000|NOT COMPLETED|Overall Study||0
6563986|NCT01809054|7486801|FG001|NOT COMPLETED|Overall Study||0
6563987|NCT01809106|7486811|FG000|STARTED|Overall Study||130
6563988|NCT01809106|7486812|FG001|STARTED|Overall Study||130
6563989|NCT01809106|7486813|FG002|STARTED|Overall Study||130
6563990|NCT01809106|7486814|FG003|STARTED|Overall Study||128
6563991|NCT01809106|7486811|FG000|COMPLETED|Overall Study||122
6563992|NCT01809106|7486812|FG001|COMPLETED|Overall Study||125
6563993|NCT01809106|7486813|FG002|COMPLETED|Overall Study||127
6563994|NCT01809106|7486814|FG003|COMPLETED|Overall Study||124
6563995|NCT01809106|7486811|FG000|NOT COMPLETED|Overall Study||8
6563996|NCT01809106|7486812|FG001|NOT COMPLETED|Overall Study||5
6563997|NCT01809106|7486813|FG002|NOT COMPLETED|Overall Study||3
6563998|NCT01809106|7486814|FG003|NOT COMPLETED|Overall Study||4
6563999|NCT01809132|7486827|FG000|STARTED|Overall Study||53
6564000|NCT01809132|7486828|FG001|STARTED|Overall Study||50
6564001|NCT01809132|7486829|FG002|STARTED|Overall Study|Subject was consented but withdrew prior to randomization and initiation of treatment.|1
6564002|NCT01809132|7486827|FG000|COMPLETED|Overall Study||53
6564003|NCT01809132|7486828|FG001|COMPLETED|Overall Study||50
6564004|NCT01809132|7486829|FG002|COMPLETED|Overall Study||0
6564005|NCT01809132|7486827|FG000|NOT COMPLETED|Overall Study||0
6564006|NCT01809132|7486828|FG001|NOT COMPLETED|Overall Study||0
6564007|NCT01809132|7486829|FG002|NOT COMPLETED|Overall Study||1
6564008|NCT01809197|7486839|FG000|STARTED|Overall Study||187
6564009|NCT01809197|7486840|FG001|STARTED|Overall Study||185
6564010|NCT01809197|7486839|FG000|COMPLETED|Overall Study||177
6564011|NCT01809197|7486840|FG001|COMPLETED|Overall Study||177
6564012|NCT01809197|7486839|FG000|NOT COMPLETED|Overall Study||10
6564013|NCT01809197|7486840|FG001|NOT COMPLETED|Overall Study||8
6564014|NCT01809210|7486853|FG000|STARTED|Overall Study||3
6564015|NCT01809210|7486854|FG001|STARTED|Overall Study||9
6564016|NCT01809210|7486855|FG002|STARTED|Overall Study||7
6564017|NCT01809210|7486856|FG003|STARTED|Overall Study||3
6564018|NCT01809210|7486857|FG004|STARTED|Overall Study||6
6564019|NCT01809210|7486858|FG005|STARTED|Overall Study||15
6564020|NCT01809210|7486859|FG006|STARTED|Overall Study||12
6564021|NCT01809210|7486853|FG000|COMPLETED|Overall Study||2
6564022|NCT01809210|7486854|FG001|COMPLETED|Overall Study||8
6796775|NCT04529499|7728420|FG000|Continued to be in Hospital When Study Was Terminated|Overall Study||11
6796776|NCT04529499|7728421|FG001|Continued to be in Hospital When Study Was Terminated|Overall Study||17
6796777|NCT04529499|7728420|FG000|COMPLETED|Overall Study||139
6796778|NCT04529499|7728421|FG001|COMPLETED|Overall Study||138
6796779|NCT04529499|7728420|FG000|NOT COMPLETED|Overall Study||36
6796780|NCT04529499|7728421|FG001|NOT COMPLETED|Overall Study||40
6796781|NCT04501094|7728429|FG000|STARTED|Overall Study||1
6796782|NCT04501094|7728430|FG001|STARTED|Overall Study||1
6796783|NCT04501094|7728429|FG000|COMPLETED|Overall Study||0
6796784|NCT04501094|7728430|FG001|COMPLETED|Overall Study||1
6796785|NCT04501094|7728429|FG000|NOT COMPLETED|Overall Study||1
6796786|NCT04501094|7728430|FG001|NOT COMPLETED|Overall Study||0
6564023|NCT01809210|7486855|FG002|COMPLETED|Overall Study||4
6564024|NCT01809210|7486856|FG003|COMPLETED|Overall Study||2
6564025|NCT01809210|7486857|FG004|COMPLETED|Overall Study||4
6564026|NCT01809210|7486858|FG005|COMPLETED|Overall Study||12
6564027|NCT01809210|7486859|FG006|COMPLETED|Overall Study||7
6564028|NCT01809210|7486853|FG000|NOT COMPLETED|Overall Study||1
6564029|NCT01809210|7486854|FG001|NOT COMPLETED|Overall Study||1
6564030|NCT01809210|7486855|FG002|NOT COMPLETED|Overall Study||3
6564031|NCT01809210|7486856|FG003|NOT COMPLETED|Overall Study||1
6564032|NCT01809210|7486857|FG004|NOT COMPLETED|Overall Study||2
6564033|NCT01809210|7486858|FG005|NOT COMPLETED|Overall Study||3
6564034|NCT01809210|7486859|FG006|NOT COMPLETED|Overall Study||5
6564035|NCT01809262|7486875|FG000|STARTED|Period 1 (First Dose + Washout)||4
6796787|NCT04421027|7728438|FG000|STARTED|Overall Study||761
6564036|NCT01809262|7486876|FG001|STARTED|Period 1 (First Dose + Washout)||4
6564037|NCT01809262|7486877|FG002|STARTED|Period 1 (First Dose + Washout)||4
6564038|NCT01809262|7486878|FG003|STARTED|Period 1 (First Dose + Washout)||3
6564039|NCT01809262|7486879|FG004|STARTED|Period 1 (First Dose + Washout)||4
6564040|NCT01809262|7486880|FG005|STARTED|Period 1 (First Dose + Washout)||3
6564041|NCT01809262|7486881|FG006|STARTED|Period 1 (First Dose + Washout)||3
6564042|NCT01809262|7486882|FG007|STARTED|Period 1 (First Dose + Washout)||4
6564043|NCT01809262|7486883|FG008|STARTED|Period 1 (First Dose + Washout)||3
6564044|NCT01809262|7486884|FG009|STARTED|Period 1 (First Dose + Washout)||4
6564045|NCT01809262|7486875|FG000|COMPLETED|Period 1 (First Dose + Washout)||4
6564046|NCT01809262|7486876|FG001|COMPLETED|Period 1 (First Dose + Washout)||4
6564047|NCT01809262|7486877|FG002|COMPLETED|Period 1 (First Dose + Washout)||4
6564048|NCT01809262|7486878|FG003|COMPLETED|Period 1 (First Dose + Washout)||3
6564049|NCT01809262|7486879|FG004|COMPLETED|Period 1 (First Dose + Washout)||3
6656647|NCT02462759|7586923|FG002|NOT COMPLETED|Part 1: Double Blind||0
6656648|NCT02462759|7586921|FG000|STARTED|Part 2: Open-Label Phase||0
6796788|NCT04421027|7728439|FG001|STARTED|Overall Study||764
6796789|NCT04421027|7728438|FG000|Received at Least One Dose of Study Drug|Overall Study||752
6796790|NCT04421027|7728439|FG001|Received at Least One Dose of Study Drug|Overall Study||750
6796791|NCT04421027|7728438|FG000|COMPLETED|Overall Study||604
6796792|NCT04421027|7728439|FG001|COMPLETED|Overall Study||644
6796793|NCT04421027|7728438|FG000|NOT COMPLETED|Overall Study||157
6796794|NCT04421027|7728439|FG001|NOT COMPLETED|Overall Study||120
6796795|NCT04414618|7728449|FG000|STARTED|Overall Study||23
6796796|NCT04414618|7728450|FG001|STARTED|Overall Study||19
6796797|NCT04414618|7728449|FG000|COMPLETED|Overall Study||15
6796798|NCT04414618|7728450|FG001|COMPLETED|Overall Study||12
6796799|NCT04414618|7728449|FG000|NOT COMPLETED|Overall Study||8
6796800|NCT04414618|7728450|FG001|NOT COMPLETED|Overall Study||7
6796801|NCT04412057|7728459|FG000|STARTED|Overall Study||41
6796802|NCT04412057|7728460|FG001|STARTED|Overall Study||42
6796803|NCT04412057|7728459|FG000|Randomized Analysis Set|Overall Study||41
6796804|NCT04412057|7728460|FG001|Randomized Analysis Set|Overall Study||42
6796805|NCT04412057|7728459|FG000|Safety Analysis Set|Overall Study||40
6796806|NCT04412057|7728460|FG001|Safety Analysis Set|Overall Study||42
6796807|NCT04412057|7728459|FG000|Full Analysis Set|Overall Study||40
6796808|NCT04412057|7728460|FG001|Full Analysis Set|Overall Study||42
6796809|NCT04412057|7728459|FG000|Primary Analysis Set|Overall Study||31
6796810|NCT04412057|7728460|FG001|Primary Analysis Set|Overall Study||31
6796811|NCT04412057|7728459|FG000|COMPLETED|Overall Study||37
6796812|NCT04412057|7728460|FG001|COMPLETED|Overall Study||35
6796813|NCT04412057|7728459|FG000|NOT COMPLETED|Overall Study||4
6796814|NCT04412057|7728460|FG001|NOT COMPLETED|Overall Study||7
6796815|NCT04402060|7728469|FG000|STARTED|Overall Study||6
6796816|NCT04402060|7728470|FG001|STARTED|Overall Study||34
6796817|NCT04402060|7728471|FG002|STARTED|Overall Study||32
6796818|NCT04402060|7728469|FG000|Received Treatment|Overall Study||6
6796819|NCT04402060|7728470|FG001|Received Treatment|Overall Study||33
6796820|NCT04402060|7728471|FG002|Received Treatment|Overall Study||32
6796821|NCT04402060|7728469|FG000|COMPLETED|Overall Study||5
6796822|NCT04402060|7728470|FG001|COMPLETED|Overall Study||18
6796823|NCT04402060|7728471|FG002|COMPLETED|Overall Study||21
6796824|NCT04402060|7728469|FG000|NOT COMPLETED|Overall Study||1
6796825|NCT04402060|7728470|FG001|NOT COMPLETED|Overall Study||16
6796826|NCT04402060|7728471|FG002|NOT COMPLETED|Overall Study||11
6796827|NCT04396626|7728484|FG000|STARTED|Overall Study||975
6796828|NCT04396626|7728484|FG000|COMPLETED|Overall Study||0
6796829|NCT04396626|7728484|FG000|NOT COMPLETED|Overall Study||975
6796830|NCT04391179|7728490|FG000|STARTED|Overall Study||49
6796831|NCT04391179|7728491|FG001|STARTED|Overall Study||50
6796832|NCT04391179|7728490|FG000|COMPLETED|Overall Study||34
6796833|NCT04391179|7728491|FG001|COMPLETED|Overall Study||34
6796834|NCT04391179|7728490|FG000|NOT COMPLETED|Overall Study||15
6796835|NCT04391179|7728491|FG001|NOT COMPLETED|Overall Study||16
6796836|NCT04386096|7728499|FG000|STARTED|Overall Study||20
6796837|NCT04386096|7728500|FG001|STARTED|Overall Study||20
6796838|NCT04386096|7728499|FG000|COMPLETED|Overall Study||20
6796839|NCT04386096|7728500|FG001|COMPLETED|Overall Study||20
6796840|NCT04386096|7728499|FG000|NOT COMPLETED|Overall Study||0
6796841|NCT04386096|7728500|FG001|NOT COMPLETED|Overall Study||0
6796842|NCT04376684|7728510|FG000|STARTED|Part 1 (Up to Day 60)||403
6796843|NCT04376684|7728511|FG001|STARTED|Part 1 (Up to Day 60)||403
6796844|NCT04376684|7728512|FG002|STARTED|Part 1 (Up to Day 60)||0
6564050|NCT01809262|7486880|FG005|COMPLETED|Period 1 (First Dose + Washout)||3
6564051|NCT01809262|7486881|FG006|COMPLETED|Period 1 (First Dose + Washout)||3
6564052|NCT01809262|7486882|FG007|COMPLETED|Period 1 (First Dose + Washout)||4
6796845|NCT04376684|7728513|FG003|STARTED|Part 1 (Up to Day 60)||0
6796846|NCT04376684|7728510|FG000|COMPLETED|Part 1 (Up to Day 60)||388
6796847|NCT04376684|7728511|FG001|COMPLETED|Part 1 (Up to Day 60)||379
6796848|NCT04376684|7728512|FG002|COMPLETED|Part 1 (Up to Day 60)||0
6796849|NCT04376684|7728513|FG003|COMPLETED|Part 1 (Up to Day 60)||0
6796850|NCT04376684|7728510|FG000|NOT COMPLETED|Part 1 (Up to Day 60)||15
6796851|NCT04376684|7728511|FG001|NOT COMPLETED|Part 1 (Up to Day 60)||24
6796852|NCT04376684|7728512|FG002|NOT COMPLETED|Part 1 (Up to Day 60)||0
6796853|NCT04376684|7728513|FG003|NOT COMPLETED|Part 1 (Up to Day 60)||0
6796854|NCT04376684|7728510|FG000|STARTED|Part 2 (Up to Day 60)||0
6796855|NCT04376684|7728511|FG001|STARTED|Part 2 (Up to Day 60)||0
6796856|NCT04376684|7728512|FG002|STARTED|Part 2 (Up to Day 60)||175
6796857|NCT04376684|7728513|FG003|STARTED|Part 2 (Up to Day 60)||175
6796858|NCT04376684|7728510|FG000|COMPLETED|Part 2 (Up to Day 60)||0
6796859|NCT04376684|7728511|FG001|COMPLETED|Part 2 (Up to Day 60)||0
6796860|NCT04376684|7728512|FG002|COMPLETED|Part 2 (Up to Day 60)||170
6796861|NCT04376684|7728513|FG003|COMPLETED|Part 2 (Up to Day 60)||171
6796862|NCT04376684|7728510|FG000|NOT COMPLETED|Part 2 (Up to Day 60)||0
6796863|NCT04376684|7728511|FG001|NOT COMPLETED|Part 2 (Up to Day 60)||0
6796864|NCT04376684|7728512|FG002|NOT COMPLETED|Part 2 (Up to Day 60)||5
6796865|NCT04376684|7728513|FG003|NOT COMPLETED|Part 2 (Up to Day 60)||4
6796866|NCT04353284|7728525|FG000|STARTED|Overall Study||35
6796867|NCT04353284|7728526|FG001|STARTED|Overall Study||35
6796868|NCT04353284|7728525|FG000|COMPLETED|Overall Study||33
6796869|NCT04353284|7728526|FG001|COMPLETED|Overall Study||34
6796870|NCT04353284|7728525|FG000|NOT COMPLETED|Overall Study||2
6796871|NCT04353284|7728526|FG001|NOT COMPLETED|Overall Study||1
6796872|NCT04294147|7728534|FG000|STARTED|Overall Study||32
6796873|NCT04294147|7728535|FG001|STARTED|Overall Study||33
6796874|NCT04294147|7728534|FG000|Received at Least One Dose of Study Drug|Overall Study||32
6796875|NCT04294147|7728535|FG001|Received at Least One Dose of Study Drug|Overall Study||33
6796876|NCT04294147|7728534|FG000|COMPLETED|Overall Study||30
6796877|NCT04294147|7728535|FG001|COMPLETED|Overall Study||33
6796878|NCT04294147|7728534|FG000|NOT COMPLETED|Overall Study||2
6796879|NCT04294147|7728535|FG001|NOT COMPLETED|Overall Study||0
6796880|NCT04269707|7728541|FG000|STARTED|Overall Study||7
6796881|NCT04269707|7728541|FG000|COMPLETED|Overall Study||7
6796882|NCT04269707|7728541|FG000|NOT COMPLETED|Overall Study||0
6796883|NCT04231825|7728547|FG000|STARTED|Overall Study||23
6796884|NCT04231825|7728548|FG001|STARTED|Overall Study||24
6796885|NCT04231825|7728547|FG000|COMPLETED|Overall Study||20
6796886|NCT04231825|7728548|FG001|COMPLETED|Overall Study||20
6796887|NCT04231825|7728547|FG000|NOT COMPLETED|Overall Study||3
6796888|NCT04231825|7728548|FG001|NOT COMPLETED|Overall Study||4
6796889|NCT04196686|7728554|FG000|STARTED|First Treatment (4 Minutes)||78
6796890|NCT04196686|7728555|FG001|STARTED|First Treatment (4 Minutes)||78
6796891|NCT04196686|7728554|FG000|COMPLETED|First Treatment (4 Minutes)||78
6796892|NCT04196686|7728555|FG001|COMPLETED|First Treatment (4 Minutes)||75
6796893|NCT04196686|7728554|FG000|NOT COMPLETED|First Treatment (4 Minutes)||0
6796894|NCT04196686|7728555|FG001|NOT COMPLETED|First Treatment (4 Minutes)||3
6796895|NCT04196686|7728554|FG000|STARTED|Second Treatment (4 Minutes)||78
6796896|NCT04196686|7728555|FG001|STARTED|Second Treatment (4 Minutes)||75
6796897|NCT04196686|7728554|FG000|COMPLETED|Second Treatment (4 Minutes)||78
6564053|NCT01809262|7486883|FG008|COMPLETED|Period 1 (First Dose + Washout)||3
6564054|NCT01809262|7486884|FG009|COMPLETED|Period 1 (First Dose + Washout)||4
6564055|NCT01809262|7486875|FG000|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564056|NCT01809262|7486876|FG001|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564057|NCT01809262|7486877|FG002|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564058|NCT01809262|7486878|FG003|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564059|NCT01809262|7486879|FG004|NOT COMPLETED|Period 1 (First Dose + Washout)||1
6564060|NCT01809262|7486880|FG005|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564061|NCT01809262|7486881|FG006|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564062|NCT01809262|7486882|FG007|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564063|NCT01809262|7486883|FG008|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564064|NCT01809262|7486884|FG009|NOT COMPLETED|Period 1 (First Dose + Washout)||0
6564065|NCT01809262|7486875|FG000|STARTED|Period 2 (Second Dose + Washout)||4
6564066|NCT01809262|7486876|FG001|STARTED|Period 2 (Second Dose + Washout)||4
6796898|NCT04196686|7728555|FG001|COMPLETED|Second Treatment (4 Minutes)||75
6796899|NCT04196686|7728554|FG000|NOT COMPLETED|Second Treatment (4 Minutes)||0
6796900|NCT04196686|7728555|FG001|NOT COMPLETED|Second Treatment (4 Minutes)||0
6796901|NCT04178772|7728561|FG000|STARTED|Overall Study||27
6796902|NCT04178772|7728561|FG000|COMPLETED|Overall Study||19
6796903|NCT04178772|7728561|FG000|NOT COMPLETED|Overall Study||8
6796904|NCT04148651|7728565|FG000|STARTED|Overall Study||12
6796905|NCT04148651|7728565|FG000|COMPLETED|Overall Study|2 subjects did not complete the final follow-up due to COVID-19 pandemic|10
6796906|NCT04148651|7728565|FG000|NOT COMPLETED|Overall Study||2
6796907|NCT04113304|7728570|FG000|STARTED|Overall Study||6
6796908|NCT04113304|7728570|FG000|COMPLETED|Overall Study||6
6796909|NCT04113304|7728570|FG000|NOT COMPLETED|Overall Study||0
6796910|NCT03929588|7728574|FG000|STARTED|Overall Study||230
6796911|NCT03929588|7728574|FG000|COMPLETED|Overall Study||143
6796912|NCT03929588|7728574|FG000|NOT COMPLETED|Overall Study||87
6796991|NCT03811574|7728702|FG001|STARTED|Overall Study||199
6796992|NCT03811574|7728703|FG002|STARTED|Overall Study||101
6796993|NCT03811574|7728701|FG000|Full Analysis Set (FAS)|Overall Study||101
6796994|NCT03811574|7728702|FG001|Full Analysis Set (FAS)|Overall Study||199
6796995|NCT03811574|7728703|FG002|Full Analysis Set (FAS)|Overall Study||101
6796996|NCT03811574|7728701|FG000|Safety Analysis Set (SAS)|Overall Study||100
6796997|NCT03811574|7728702|FG001|Safety Analysis Set (SAS)|Overall Study||199
6796998|NCT03811574|7728703|FG002|Safety Analysis Set (SAS)|Overall Study||101
6796999|NCT03811574|7728701|FG000|Treated|Overall Study||100
6797000|NCT03811574|7728702|FG001|Treated|Overall Study||199
6797001|NCT03811574|7728703|FG002|Treated|Overall Study||101
6797002|NCT03811574|7728701|FG000|COMPLETED|Overall Study||99
6797003|NCT03811574|7728702|FG001|COMPLETED|Overall Study||195
6797004|NCT03811574|7728703|FG002|COMPLETED|Overall Study||101
6797005|NCT03811574|7728701|FG000|NOT COMPLETED|Overall Study||2
6797006|NCT03811574|7728702|FG001|NOT COMPLETED|Overall Study||4
6797007|NCT03811574|7728703|FG002|NOT COMPLETED|Overall Study||0
6797008|NCT03800420|7728713|FG000|STARTED|Overall Study||12
6797009|NCT03800420|7728714|FG001|STARTED|Overall Study||4
6797010|NCT03800420|7728713|FG000|COMPLETED|Overall Study||10
6797011|NCT03800420|7728714|FG001|COMPLETED|Overall Study||3
6797012|NCT03800420|7728713|FG000|NOT COMPLETED|Overall Study||2
6797013|NCT03800420|7728714|FG001|NOT COMPLETED|Overall Study||1
6379827|NCT00774930|7290499|FG001|COMPLETED|IOL Phase||37
6379828|NCT00774930|7290498|FG000|NOT COMPLETED|IOL Phase||13
6379829|NCT00774930|7290499|FG001|NOT COMPLETED|IOL Phase||9
6379830|NCT00774930|7290498|FG000|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
6379831|NCT00774930|7290499|FG001|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
6379832|NCT00774930|7290498|FG000|COMPLETED|LTOLE Phase||17
6379833|NCT00774930|7290499|FG001|COMPLETED|LTOLE Phase||8
6379834|NCT00774930|7290498|FG000|NOT COMPLETED|LTOLE Phase||15
6379835|NCT00774930|7290499|FG001|NOT COMPLETED|LTOLE Phase||17
6379836|NCT00774995|7290511|FG000|STARTED|Overall Study||9
6379837|NCT00774995|7290512|FG001|STARTED|Overall Study||16
6379838|NCT00774995|7290513|FG002|STARTED|Overall Study||8
6379839|NCT00774995|7290514|FG003|STARTED|Overall Study||16
6379840|NCT00774995|7290511|FG000|COMPLETED|Overall Study||9
6379841|NCT00774995|7290512|FG001|COMPLETED|Overall Study||16
6379842|NCT00774995|7290513|FG002|COMPLETED|Overall Study||7
6379843|NCT00774995|7290514|FG003|COMPLETED|Overall Study||16
6379844|NCT00774995|7290511|FG000|NOT COMPLETED|Overall Study||0
6379845|NCT00774995|7290512|FG001|NOT COMPLETED|Overall Study||0
6379846|NCT00774995|7290513|FG002|NOT COMPLETED|Overall Study||1
6564067|NCT01809262|7486877|FG002|STARTED|Period 2 (Second Dose + Washout)||4
6564068|NCT01809262|7486878|FG003|STARTED|Period 2 (Second Dose + Washout)||3
6564069|NCT01809262|7486879|FG004|STARTED|Period 2 (Second Dose + Washout)||3
6564070|NCT01809262|7486880|FG005|STARTED|Period 2 (Second Dose + Washout)||3
6564071|NCT01809262|7486881|FG006|STARTED|Period 2 (Second Dose + Washout)||3
6564072|NCT01809262|7486882|FG007|STARTED|Period 2 (Second Dose + Washout)||4
6564073|NCT01809262|7486883|FG008|STARTED|Period 2 (Second Dose + Washout)||3
6564074|NCT01809262|7486884|FG009|STARTED|Period 2 (Second Dose + Washout)||4
6564075|NCT01809262|7486875|FG000|COMPLETED|Period 2 (Second Dose + Washout)||4
6564076|NCT01809262|7486876|FG001|COMPLETED|Period 2 (Second Dose + Washout)||4
6564077|NCT01809262|7486877|FG002|COMPLETED|Period 2 (Second Dose + Washout)||4
6796913|NCT03893448|7728580|FG000|STARTED|Overall Study||860
6796914|NCT03893448|7728581|FG001|STARTED|Overall Study||860
6796915|NCT03893448|7728580|FG000|Treated|Overall Study||858
6796916|NCT03893448|7728581|FG001|Treated|Overall Study||856
6796917|NCT03893448|7728580|FG000|COMPLETED|Overall Study||758
6796918|NCT03893448|7728581|FG001|COMPLETED|Overall Study||734
6796919|NCT03893448|7728580|FG000|NOT COMPLETED|Overall Study||102
6796920|NCT03893448|7728581|FG001|NOT COMPLETED|Overall Study||126
6796921|NCT03870880|7728594|FG000|STARTED|Overall Study||27
6796922|NCT03870880|7728595|FG001|STARTED|Overall Study||58
6796923|NCT03870880|7728596|FG002|STARTED|Overall Study||31
6796924|NCT03870880|7728597|FG003|STARTED|Overall Study||28
6796925|NCT03870880|7728598|FG004|STARTED|Overall Study||61
6796926|NCT03870880|7728599|FG005|STARTED|Overall Study||10
6796927|NCT03870880|7728594|FG000|COMPLETED|Overall Study||21
6796928|NCT03870880|7728595|FG001|COMPLETED|Overall Study||43
6796929|NCT03870880|7728596|FG002|COMPLETED|Overall Study||26
6796930|NCT03870880|7728597|FG003|COMPLETED|Overall Study||20
6796931|NCT03870880|7728598|FG004|COMPLETED|Overall Study||44
6796932|NCT03870880|7728599|FG005|COMPLETED|Overall Study||7
6796933|NCT03870880|7728594|FG000|NOT COMPLETED|Overall Study||6
6796934|NCT03870880|7728595|FG001|NOT COMPLETED|Overall Study||15
6796935|NCT03870880|7728596|FG002|NOT COMPLETED|Overall Study||5
6796936|NCT03870880|7728597|FG003|NOT COMPLETED|Overall Study||8
6796937|NCT03870880|7728598|FG004|NOT COMPLETED|Overall Study||17
6796938|NCT03870880|7728599|FG005|NOT COMPLETED|Overall Study||3
6796939|NCT03850444|7728620|FG000|STARTED|Overall Study||128
6796940|NCT03850444|7728621|FG001|STARTED|Overall Study||134
6796941|NCT03850444|7728620|FG000|COMPLETED|Overall Study||0
6796942|NCT03850444|7728621|FG001|COMPLETED|Overall Study||0
6796943|NCT03850444|7728620|FG000|NOT COMPLETED|Overall Study||128
6796944|NCT03850444|7728621|FG001|NOT COMPLETED|Overall Study||134
6796945|NCT03831347|7728627|FG000|STARTED|Overall Study||11
6796946|NCT03831347|7728627|FG000|COMPLETED|Overall Study||9
6796947|NCT03831347|7728627|FG000|NOT COMPLETED|Overall Study||2
6796948|NCT03814590|7728645|FG000|STARTED|Overall Study||12
6796949|NCT03814590|7728646|FG001|STARTED|Overall Study||12
6796950|NCT03814590|7728647|FG002|STARTED|Overall Study||12
6796951|NCT03814590|7728648|FG003|STARTED|Overall Study||12
6796952|NCT03814590|7728649|FG004|STARTED|Overall Study||101
6796953|NCT03814590|7728650|FG005|STARTED|Overall Study||97
6796954|NCT03814590|7728651|FG006|STARTED|Overall Study||100
6796955|NCT03814590|7728652|FG007|STARTED|Overall Study||101
6796956|NCT03814590|7728653|FG008|STARTED|Overall Study||101
6796957|NCT03814590|7728654|FG009|STARTED|Overall Study||100
6796958|NCT03814590|7728655|FG010|STARTED|Overall Study||103
6796959|NCT03814590|7728656|FG011|STARTED|Overall Study||100
6796960|NCT03814590|7728657|FG012|STARTED|Overall Study||101
6796961|NCT03814590|7728658|FG013|STARTED|Overall Study||101
6796962|NCT03814590|7728645|FG000|COMPLETED|Overall Study||12
6796963|NCT03814590|7728646|FG001|COMPLETED|Overall Study||10
6796964|NCT03814590|7728647|FG002|COMPLETED|Overall Study||11
6796965|NCT03814590|7728648|FG003|COMPLETED|Overall Study||12
6796966|NCT03814590|7728649|FG004|COMPLETED|Overall Study||100
6796967|NCT03814590|7728650|FG005|COMPLETED|Overall Study||92
6796968|NCT03814590|7728651|FG006|COMPLETED|Overall Study||97
6564078|NCT01809262|7486878|FG003|COMPLETED|Period 2 (Second Dose + Washout)||3
6564079|NCT01809262|7486879|FG004|COMPLETED|Period 2 (Second Dose + Washout)||3
6796969|NCT03814590|7728652|FG007|COMPLETED|Overall Study||95
6796970|NCT03814590|7728653|FG008|COMPLETED|Overall Study||101
6796971|NCT03814590|7728654|FG009|COMPLETED|Overall Study||95
6796972|NCT03814590|7728655|FG010|COMPLETED|Overall Study||100
6796973|NCT03814590|7728656|FG011|COMPLETED|Overall Study||100
6796974|NCT03814590|7728657|FG012|COMPLETED|Overall Study||97
6796975|NCT03814590|7728658|FG013|COMPLETED|Overall Study||98
6796976|NCT03814590|7728645|FG000|NOT COMPLETED|Overall Study||0
6796977|NCT03814590|7728646|FG001|NOT COMPLETED|Overall Study||2
6796978|NCT03814590|7728647|FG002|NOT COMPLETED|Overall Study||1
6796979|NCT03814590|7728648|FG003|NOT COMPLETED|Overall Study||0
6796980|NCT03814590|7728649|FG004|NOT COMPLETED|Overall Study||1
6796981|NCT03814590|7728650|FG005|NOT COMPLETED|Overall Study||5
6796982|NCT03814590|7728651|FG006|NOT COMPLETED|Overall Study||3
6796983|NCT03814590|7728652|FG007|NOT COMPLETED|Overall Study||6
6796984|NCT03814590|7728653|FG008|NOT COMPLETED|Overall Study||0
6796985|NCT03814590|7728654|FG009|NOT COMPLETED|Overall Study||5
6796986|NCT03814590|7728655|FG010|NOT COMPLETED|Overall Study||3
6796987|NCT03814590|7728656|FG011|NOT COMPLETED|Overall Study||0
6796988|NCT03814590|7728657|FG012|NOT COMPLETED|Overall Study||4
6796989|NCT03814590|7728658|FG013|NOT COMPLETED|Overall Study||3
6796990|NCT03811574|7728701|FG000|STARTED|Overall Study||101
6797014|NCT03759184|7728724|FG000|STARTED|Overall Study||1
6797015|NCT03759184|7728724|FG000|COMPLETED|Overall Study||1
6797016|NCT03759184|7728724|FG000|NOT COMPLETED|Overall Study||0
6797017|NCT03747640|7728730|FG000|STARTED|Overall Study||15
6797018|NCT03747640|7728731|FG001|STARTED|Overall Study||15
6797019|NCT03747640|7728730|FG000|COMPLETED|Overall Study||15
6797020|NCT03747640|7728731|FG001|COMPLETED|Overall Study||15
6797021|NCT03747640|7728730|FG000|NOT COMPLETED|Overall Study||0
6797022|NCT03747640|7728731|FG001|NOT COMPLETED|Overall Study||0
6797023|NCT03727750|7728739|FG000|STARTED|Overall Study||51
6797024|NCT03727750|7728739|FG000|Safety Set|Overall Study||50
6797025|NCT03727750|7728739|FG000|COMPLETED|Overall Study||2
6797026|NCT03727750|7728739|FG000|NOT COMPLETED|Overall Study||49
6797027|NCT03726879|7728745|FG000|STARTED|Overall Study||226
6797028|NCT03726879|7728746|FG001|STARTED|Overall Study||228
6797029|NCT03726879|7728745|FG000|COMPLETED|Overall Study||0
6797030|NCT03726879|7728746|FG001|COMPLETED|Overall Study||0
6797031|NCT03726879|7728745|FG000|NOT COMPLETED|Overall Study||226
6797032|NCT03726879|7728746|FG001|NOT COMPLETED|Overall Study||228
6797033|NCT03715829|7728758|FG000|STARTED|Dose Ranging Period||65
6797034|NCT03715829|7728759|FG001|STARTED|Dose Ranging Period||67
6797035|NCT03715829|7728760|FG002|STARTED|Dose Ranging Period||67
6797036|NCT03715829|7728761|FG003|STARTED|Dose Ranging Period||50
6797037|NCT03715829|7728762|FG004|STARTED|Dose Ranging Period||49
6797038|NCT03715829|7728763|FG005|STARTED|Dose Ranging Period||66
6797039|NCT03715829|7728764|FG006|STARTED|Dose Ranging Period||0
6797040|NCT03715829|7728765|FG007|STARTED|Dose Ranging Period||0
6797041|NCT03715829|7728766|FG008|STARTED|Dose Ranging Period||0
6797042|NCT03715829|7728767|FG009|STARTED|Dose Ranging Period||0
6797043|NCT03715829|7728768|FG010|STARTED|Dose Ranging Period||0
6797044|NCT03715829|7728758|FG000|COMPLETED|Dose Ranging Period||53
6797045|NCT03715829|7728759|FG001|COMPLETED|Dose Ranging Period||58
6797046|NCT03715829|7728760|FG002|COMPLETED|Dose Ranging Period||54
6797047|NCT03715829|7728761|FG003|COMPLETED|Dose Ranging Period||36
6797048|NCT03715829|7728762|FG004|COMPLETED|Dose Ranging Period||42
6797049|NCT03715829|7728763|FG005|COMPLETED|Dose Ranging Period||55
6797050|NCT03715829|7728764|FG006|COMPLETED|Dose Ranging Period||0
6797051|NCT03715829|7728765|FG007|COMPLETED|Dose Ranging Period||0
6797052|NCT03715829|7728766|FG008|COMPLETED|Dose Ranging Period||0
6797053|NCT03715829|7728767|FG009|COMPLETED|Dose Ranging Period||0
6797054|NCT03715829|7728768|FG010|COMPLETED|Dose Ranging Period||0
6797055|NCT03715829|7728758|FG000|NOT COMPLETED|Dose Ranging Period||12
6797056|NCT03715829|7728759|FG001|NOT COMPLETED|Dose Ranging Period||9
6797057|NCT03715829|7728760|FG002|NOT COMPLETED|Dose Ranging Period||13
6797058|NCT03715829|7728761|FG003|NOT COMPLETED|Dose Ranging Period||14
6797059|NCT03715829|7728762|FG004|NOT COMPLETED|Dose Ranging Period||7
6797060|NCT03715829|7728763|FG005|NOT COMPLETED|Dose Ranging Period||11
6797061|NCT03715829|7728764|FG006|NOT COMPLETED|Dose Ranging Period||0
6797062|NCT03715829|7728765|FG007|NOT COMPLETED|Dose Ranging Period||0
6797063|NCT03715829|7728766|FG008|NOT COMPLETED|Dose Ranging Period||0
6797064|NCT03715829|7728767|FG009|NOT COMPLETED|Dose Ranging Period||0
6797065|NCT03715829|7728768|FG010|NOT COMPLETED|Dose Ranging Period||0
6797066|NCT03715829|7728758|FG000|STARTED|Extension Period||0
6797067|NCT03715829|7728759|FG001|STARTED|Extension Period||0
6797068|NCT03715829|7728760|FG002|STARTED|Extension Period||0
6797069|NCT03715829|7728761|FG003|STARTED|Extension Period||0
6797070|NCT03715829|7728762|FG004|STARTED|Extension Period||0
6797071|NCT03715829|7728763|FG005|STARTED|Extension Period||0
6797072|NCT03715829|7728764|FG006|STARTED|Extension Period||55
6797073|NCT03715829|7728765|FG007|STARTED|Extension Period||43
6797074|NCT03715829|7728766|FG008|STARTED|Extension Period||187
6797075|NCT03715829|7728767|FG009|STARTED|Extension Period||6
6797076|NCT03715829|7728768|FG010|STARTED|Extension Period||2
6797077|NCT03715829|7728758|FG000|COMPLETED|Extension Period||0
6797078|NCT03715829|7728759|FG001|COMPLETED|Extension Period||0
6797079|NCT03715829|7728760|FG002|COMPLETED|Extension Period||0
6797080|NCT03715829|7728761|FG003|COMPLETED|Extension Period||0
6797081|NCT03715829|7728762|FG004|COMPLETED|Extension Period||0
6797082|NCT03715829|7728763|FG005|COMPLETED|Extension Period||0
6797083|NCT03715829|7728764|FG006|COMPLETED|Extension Period||47
6797084|NCT03715829|7728765|FG007|COMPLETED|Extension Period||27
6797085|NCT03715829|7728766|FG008|COMPLETED|Extension Period||158
6797086|NCT03715829|7728767|FG009|COMPLETED|Extension Period||3
6797087|NCT03715829|7728768|FG010|COMPLETED|Extension Period||2
6797088|NCT03715829|7728758|FG000|NOT COMPLETED|Extension Period||0
6797089|NCT03715829|7728759|FG001|NOT COMPLETED|Extension Period||0
6797090|NCT03715829|7728760|FG002|NOT COMPLETED|Extension Period||0
6797091|NCT03715829|7728761|FG003|NOT COMPLETED|Extension Period||0
6797092|NCT03715829|7728762|FG004|NOT COMPLETED|Extension Period||0
6797093|NCT03715829|7728763|FG005|NOT COMPLETED|Extension Period||0
6797094|NCT03715829|7728764|FG006|NOT COMPLETED|Extension Period||8
6797095|NCT03715829|7728765|FG007|NOT COMPLETED|Extension Period||16
6797096|NCT03715829|7728766|FG008|NOT COMPLETED|Extension Period||29
6797097|NCT03715829|7728767|FG009|NOT COMPLETED|Extension Period||3
6797098|NCT03715829|7728768|FG010|NOT COMPLETED|Extension Period||0
6797099|NCT03693430|7728796|FG000|STARTED|Overall Study||152
6797100|NCT03693430|7728797|FG001|STARTED|Overall Study||152
6797101|NCT03693430|7728796|FG000|Full Analysis Set (FAS)|Overall Study||152
6797102|NCT03693430|7728797|FG001|Full Analysis Set (FAS)|Overall Study||152
6797103|NCT03693430|7728796|FG000|Safety Analysis Set (SAS)|Overall Study||152
6797104|NCT03693430|7728797|FG001|Safety Analysis Set (SAS)|Overall Study||152
6797105|NCT03693430|7728796|FG000|COMPLETED|Overall Study||148
6797106|NCT03693430|7728797|FG001|COMPLETED|Overall Study||134
6797107|NCT03693430|7728796|FG000|NOT COMPLETED|Overall Study||4
6797108|NCT03693430|7728797|FG001|NOT COMPLETED|Overall Study||18
6797109|NCT03677934|7728805|FG000|STARTED|Overall Study||248
6797110|NCT03677934|7728806|FG001|STARTED|Overall Study||167
6797111|NCT03677934|7728805|FG000|COMPLETED|Overall Study||0
6797112|NCT03677934|7728806|FG001|COMPLETED|Overall Study||0
6797113|NCT03677934|7728805|FG000|NOT COMPLETED|Overall Study||248
6797114|NCT03677934|7728806|FG001|NOT COMPLETED|Overall Study||167
6797115|NCT03660839|7728816|FG000|STARTED|Overall Study||35
6797116|NCT03660839|7728817|FG001|STARTED|Overall Study||36
6797117|NCT03660839|7728818|FG002|STARTED|Overall Study||36
6797118|NCT03660839|7728819|FG003|STARTED|Overall Study||33
6797119|NCT03660839|7728816|FG000|COMPLETED|Overall Study||35
6797120|NCT03660839|7728817|FG001|COMPLETED|Overall Study||36
6797121|NCT03660839|7728818|FG002|COMPLETED|Overall Study||36
6797122|NCT03660839|7728819|FG003|COMPLETED|Overall Study||33
6797123|NCT03660839|7728816|FG000|NOT COMPLETED|Overall Study||0
6797124|NCT03660839|7728817|FG001|NOT COMPLETED|Overall Study||0
6797125|NCT03660839|7728818|FG002|NOT COMPLETED|Overall Study||0
6797126|NCT03660839|7728819|FG003|NOT COMPLETED|Overall Study||0
6797127|NCT03660241|7728835|FG000|STARTED|Overall Study||8
6797128|NCT03660241|7728836|FG001|STARTED|Overall Study||7
6797129|NCT03660241|7728837|FG002|STARTED|Overall Study||8
6797130|NCT03660241|7728835|FG000|COMPLETED|Overall Study||8
6797131|NCT03660241|7728836|FG001|COMPLETED|Overall Study||7
6797132|NCT03660241|7728837|FG002|COMPLETED|Overall Study||8
6797133|NCT03660241|7728835|FG000|NOT COMPLETED|Overall Study||0
6797134|NCT03660241|7728836|FG001|NOT COMPLETED|Overall Study||0
6797135|NCT03660241|7728837|FG002|NOT COMPLETED|Overall Study||0
6797136|NCT03575104|7728848|FG000|STARTED|Overall Study||307
6797137|NCT03575104|7728849|FG001|STARTED|Overall Study||309
6797138|NCT03575104|7728850|FG002|STARTED|Overall Study||308
6797139|NCT03575104|7728848|FG000|COMPLETED|Overall Study||283
6797140|NCT03575104|7728849|FG001|COMPLETED|Overall Study||280
6797141|NCT03575104|7728850|FG002|COMPLETED|Overall Study||286
6797142|NCT03575104|7728848|FG000|NOT COMPLETED|Overall Study||24
6797143|NCT03575104|7728849|FG001|NOT COMPLETED|Overall Study||29
6797144|NCT03575104|7728850|FG002|NOT COMPLETED|Overall Study||22
6797145|NCT03569475|7728861|FG000|STARTED|Double-blind Treatment Period (8 Weeks)||164
6797146|NCT03569475|7728862|FG001|STARTED|Double-blind Treatment Period (8 Weeks)||169
6797147|NCT03569475|7728863|FG002|STARTED|Double-blind Treatment Period (8 Weeks)||168
6797148|NCT03569475|7728861|FG000|Safety Population|Double-blind Treatment Period (8 Weeks)||160
6797149|NCT03569475|7728862|FG001|Safety Population|Double-blind Treatment Period (8 Weeks)||166
6797150|NCT03569475|7728863|FG002|Safety Population|Double-blind Treatment Period (8 Weeks)||166
6797151|NCT03569475|7728861|FG000|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
6797152|NCT03569475|7728862|FG001|COMPLETED|Double-blind Treatment Period (8 Weeks)||146
6797153|NCT03569475|7728863|FG002|COMPLETED|Double-blind Treatment Period (8 Weeks)||144
6797154|NCT03569475|7728861|FG000|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||18
6797155|NCT03569475|7728862|FG001|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||23
6797156|NCT03569475|7728863|FG002|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||24
6797157|NCT03569475|7728861|FG000|STARTED|Double-blind Down-taper Period (1 Week)||140
6797158|NCT03569475|7728862|FG001|STARTED|Double-blind Down-taper Period (1 Week)||141
6797159|NCT03569475|7728863|FG002|STARTED|Double-blind Down-taper Period (1 Week)||140
6797160|NCT03569475|7728861|FG000|COMPLETED|Double-blind Down-taper Period (1 Week)||140
6797161|NCT03569475|7728862|FG001|COMPLETED|Double-blind Down-taper Period (1 Week)||139
6797162|NCT03569475|7728863|FG002|COMPLETED|Double-blind Down-taper Period (1 Week)||138
6797163|NCT03569475|7728861|FG000|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||0
6797164|NCT03569475|7728862|FG001|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
6564080|NCT01809262|7486880|FG005|COMPLETED|Period 2 (Second Dose + Washout)||3
6564081|NCT01809262|7486881|FG006|COMPLETED|Period 2 (Second Dose + Washout)||3
6797165|NCT03569475|7728863|FG002|NOT COMPLETED|Double-blind Down-taper Period (1 Week)||2
6797166|NCT03554798|7728883|FG000|STARTED|Overall Study||50
6797167|NCT03554798|7728884|FG001|STARTED|Overall Study||50
6797168|NCT03554798|7728885|FG002|STARTED|Overall Study||51
6797169|NCT03554798|7728886|FG003|STARTED|Overall Study||156
6797170|NCT03554798|7728887|FG004|STARTED|Overall Study||144
6797171|NCT03554798|7728888|FG005|STARTED|Overall Study||138
6797172|NCT03554798|7728889|FG006|STARTED|Overall Study||150
6797173|NCT03554798|7728890|FG007|STARTED|Overall Study||135
6797174|NCT03554798|7728891|FG008|STARTED|Overall Study||151
6797175|NCT03554798|7728883|FG000|COMPLETED|Overall Study||45
6797176|NCT03554798|7728884|FG001|COMPLETED|Overall Study||47
6797177|NCT03554798|7728885|FG002|COMPLETED|Overall Study||48
6797178|NCT03554798|7728886|FG003|COMPLETED|Overall Study||154
6797179|NCT03554798|7728887|FG004|COMPLETED|Overall Study||141
6797180|NCT03554798|7728888|FG005|COMPLETED|Overall Study||137
6797181|NCT03554798|7728889|FG006|COMPLETED|Overall Study||149
6797182|NCT03554798|7728890|FG007|COMPLETED|Overall Study||133
6797183|NCT03554798|7728891|FG008|COMPLETED|Overall Study||149
6797184|NCT03554798|7728883|FG000|NOT COMPLETED|Overall Study||5
6797185|NCT03554798|7728884|FG001|NOT COMPLETED|Overall Study||3
6564082|NCT01809262|7486882|FG007|COMPLETED|Period 2 (Second Dose + Washout)||4
6797186|NCT03554798|7728885|FG002|NOT COMPLETED|Overall Study||3
6797187|NCT03554798|7728886|FG003|NOT COMPLETED|Overall Study||2
6797188|NCT03554798|7728887|FG004|NOT COMPLETED|Overall Study||3
6797189|NCT03554798|7728888|FG005|NOT COMPLETED|Overall Study||1
6797190|NCT03554798|7728889|FG006|NOT COMPLETED|Overall Study||1
6797191|NCT03554798|7728890|FG007|NOT COMPLETED|Overall Study||2
6797192|NCT03554798|7728891|FG008|NOT COMPLETED|Overall Study||2
6797193|NCT03545191|7728917|FG000|STARTED|Overall Study||310
6797194|NCT03545191|7728918|FG001|STARTED|Overall Study||310
6797195|NCT03545191|7728919|FG002|STARTED|Overall Study||310
6797196|NCT03545191|7728917|FG000|COMPLETED|Overall Study||288
6797197|NCT03545191|7728918|FG001|COMPLETED|Overall Study||285
6797198|NCT03545191|7728919|FG002|COMPLETED|Overall Study||280
6797199|NCT03545191|7728917|FG000|NOT COMPLETED|Overall Study||22
6797200|NCT03545191|7728918|FG001|NOT COMPLETED|Overall Study||25
6797201|NCT03545191|7728919|FG002|NOT COMPLETED|Overall Study||30
6797202|NCT03500549|7728929|FG000|STARTED|Run-in Period (Day -28 to ≤Day 1)||41
6797203|NCT03500549|7728930|FG001|STARTED|Run-in Period (Day -28 to ≤Day 1)||39
6797204|NCT03500549|7728929|FG000|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||41
6797205|NCT03500549|7728930|FG001|COMPLETED|Run-in Period (Day -28 to ≤Day 1)||39
6797206|NCT03500549|7728929|FG000|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
6797207|NCT03500549|7728930|FG001|NOT COMPLETED|Run-in Period (Day -28 to ≤Day 1)||0
6797208|NCT03500549|7728929|FG000|STARTED|RCP (Day 1 - Week 16)||41
6797209|NCT03500549|7728930|FG001|STARTED|RCP (Day 1 - Week 16)||39
6797210|NCT03500549|7728929|FG000|COMPLETED|RCP (Day 1 - Week 16)||38
6797211|NCT03500549|7728930|FG001|COMPLETED|RCP (Day 1 - Week 16)||39
6797212|NCT03500549|7728929|FG000|NOT COMPLETED|RCP (Day 1 - Week 16)||3
6797213|NCT03500549|7728930|FG001|NOT COMPLETED|RCP (Day 1 - Week 16)||0
6797214|NCT03500549|7728929|FG000|STARTED|Open-label Period (Week 17 to Week 48)||38
6797215|NCT03500549|7728930|FG001|STARTED|Open-label Period (Week 17 to Week 48)||39
6797216|NCT03500549|7728929|FG000|COMPLETED|Open-label Period (Week 17 to Week 48)||35
6797217|NCT03500549|7728930|FG001|COMPLETED|Open-label Period (Week 17 to Week 48)||32
6797218|NCT03500549|7728929|FG000|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||3
6797219|NCT03500549|7728930|FG001|NOT COMPLETED|Open-label Period (Week 17 to Week 48)||7
6379847|NCT00774995|7290514|FG003|NOT COMPLETED|Overall Study||0
6379848|NCT00775021|7290524|FG000|STARTED|First Intervention||63
6379849|NCT00775021|7290525|FG001|STARTED|First Intervention||60
6379850|NCT00775021|7290524|FG000|COMPLETED|First Intervention||62
6379851|NCT00775021|7290525|FG001|COMPLETED|First Intervention||60
6379852|NCT00775021|7290524|FG000|NOT COMPLETED|First Intervention||1
6379853|NCT00775021|7290525|FG001|NOT COMPLETED|First Intervention||0
6379854|NCT00775021|7290524|FG000|STARTED|Second Intervention||62
6379855|NCT00775021|7290525|FG001|STARTED|Second Intervention||60
6379856|NCT00775021|7290524|FG000|COMPLETED|Second Intervention||62
6379857|NCT00775021|7290525|FG001|COMPLETED|Second Intervention||59
6379858|NCT00775021|7290524|FG000|NOT COMPLETED|Second Intervention||0
6379859|NCT00775021|7290525|FG001|NOT COMPLETED|Second Intervention||1
6379860|NCT00775138|7290535|FG000|STARTED|Overall Study||24
6379861|NCT00775138|7290536|FG001|STARTED|Overall Study||10
6379862|NCT00775138|7290537|FG002|STARTED|Overall Study||20
6379863|NCT00775138|7290538|FG003|STARTED|Overall Study||10
6379864|NCT00775138|7290535|FG000|COMPLETED|Overall Study||24
6379865|NCT00775138|7290536|FG001|COMPLETED|Overall Study||10
6379866|NCT00775138|7290537|FG002|COMPLETED|Overall Study||17
6379867|NCT00775138|7290538|FG003|COMPLETED|Overall Study||8
6379868|NCT00775138|7290535|FG000|NOT COMPLETED|Overall Study||0
6379869|NCT00775138|7290536|FG001|NOT COMPLETED|Overall Study||0
6379870|NCT00775138|7290537|FG002|NOT COMPLETED|Overall Study||3
6379871|NCT00775138|7290538|FG003|NOT COMPLETED|Overall Study||2
6379872|NCT00775203|7290552|FG000|STARTED|Overall Study||206
6379873|NCT00775203|7290553|FG001|STARTED|Overall Study||206
6379874|NCT00775203|7290552|FG000|Received Study Medication|Overall Study||202
6379875|NCT00775203|7290553|FG001|Received Study Medication|Overall Study||204
6379876|NCT00775203|7290552|FG000|COMPLETED|Overall Study||144
6379877|NCT00775203|7290553|FG001|COMPLETED|Overall Study||163
6379878|NCT00775203|7290552|FG000|NOT COMPLETED|Overall Study||62
6379879|NCT00775203|7290553|FG001|NOT COMPLETED|Overall Study||43
6379880|NCT00775229|7290561|FG000|STARTED|Overall Study||25
6379881|NCT00775229|7290562|FG001|STARTED|Overall Study||26
6379882|NCT00775229|7290561|FG000|COMPLETED|Overall Study||20
6379883|NCT00775229|7290562|FG001|COMPLETED|Overall Study||24
6379884|NCT00775229|7290561|FG000|NOT COMPLETED|Overall Study||5
6379885|NCT00775229|7290562|FG001|NOT COMPLETED|Overall Study||2
6379886|NCT00775268|7290570|FG000|STARTED|Baseline||9
6379887|NCT00775268|7290571|FG001|STARTED|Baseline||22
6379888|NCT00775268|7290570|FG000|COMPLETED|Baseline||8
6379889|NCT00775268|7290571|FG001|COMPLETED|Baseline||21
6379890|NCT00775268|7290570|FG000|NOT COMPLETED|Baseline||1
6379891|NCT00775268|7290571|FG001|NOT COMPLETED|Baseline||1
6379892|NCT00775268|7290570|FG000|STARTED|After 2 Cycles||8
6379893|NCT00775268|7290571|FG001|STARTED|After 2 Cycles|These 21 patients were not scanned after 2-cycles in this Arm. They were only scanned at baseline.|0
6379894|NCT00775268|7290570|FG000|COMPLETED|After 2 Cycles||7
6379895|NCT00775268|7290571|FG001|COMPLETED|After 2 Cycles||0
6379896|NCT00775268|7290570|FG000|NOT COMPLETED|After 2 Cycles||1
6379897|NCT00775268|7290571|FG001|NOT COMPLETED|After 2 Cycles||0
6797220|NCT03456700|7728941|FG000|STARTED|Overall Study||22
6797221|NCT03456700|7728941|FG000|COMPLETED|Overall Study||21
6797222|NCT03456700|7728941|FG000|NOT COMPLETED|Overall Study||1
6797223|NCT03435185|7728947|FG000|STARTED|Overall Study||44
6797224|NCT03435185|7728948|FG001|STARTED|Overall Study||43
6797225|NCT03435185|7728947|FG000|COMPLETED|Overall Study||43
6797226|NCT03435185|7728948|FG001|COMPLETED|Overall Study||28
6797227|NCT03435185|7728947|FG000|NOT COMPLETED|Overall Study||1
6797228|NCT03435185|7728948|FG001|NOT COMPLETED|Overall Study||15
6797229|NCT03427411|7728956|FG000|STARTED|Overall Study||30
6797230|NCT03427411|7728957|FG001|STARTED|Overall Study||27
6797231|NCT03427411|7728956|FG000|COMPLETED|Overall Study||30
6797232|NCT03427411|7728957|FG001|COMPLETED|Overall Study||26
6797233|NCT03427411|7728956|FG000|NOT COMPLETED|Overall Study||0
6797234|NCT03427411|7728957|FG001|NOT COMPLETED|Overall Study||1
6797235|NCT03387150|7728970|FG000|STARTED|Overall Study||19
6797236|NCT03387150|7728971|FG001|STARTED|Overall Study||19
6797237|NCT03387150|7728972|FG002|STARTED|Overall Study||21
6797238|NCT03387150|7728973|FG003|STARTED|Overall Study||21
6797239|NCT03387150|7728974|FG004|STARTED|Overall Study||20
6797240|NCT03387150|7728975|FG005|STARTED|Overall Study||21
6797241|NCT03387150|7728976|FG006|STARTED|Overall Study||3
6797242|NCT03387150|7728970|FG000|Safety Population|Overall Study||19
6797243|NCT03387150|7728971|FG001|Safety Population|Overall Study||19
6797244|NCT03387150|7728972|FG002|Safety Population|Overall Study||21
6797245|NCT03387150|7728973|FG003|Safety Population|Overall Study||21
6797246|NCT03387150|7728974|FG004|Safety Population|Overall Study||20
6797247|NCT03387150|7728975|FG005|Safety Population|Overall Study||21
6797248|NCT03387150|7728976|FG006|Safety Population|Overall Study||3
6797249|NCT03387150|7728970|FG000|COMPLETED|Overall Study||13
6797250|NCT03387150|7728971|FG001|COMPLETED|Overall Study||16
6797251|NCT03387150|7728972|FG002|COMPLETED|Overall Study||16
6797252|NCT03387150|7728973|FG003|COMPLETED|Overall Study||14
6797253|NCT03387150|7728974|FG004|COMPLETED|Overall Study||14
6797254|NCT03387150|7728975|FG005|COMPLETED|Overall Study||14
6797255|NCT03387150|7728976|FG006|COMPLETED|Overall Study||3
6797256|NCT03387150|7728970|FG000|NOT COMPLETED|Overall Study||6
6797257|NCT03387150|7728971|FG001|NOT COMPLETED|Overall Study||3
6797258|NCT03387150|7728972|FG002|NOT COMPLETED|Overall Study||5
6797259|NCT03387150|7728973|FG003|NOT COMPLETED|Overall Study||7
6797260|NCT03387150|7728974|FG004|NOT COMPLETED|Overall Study||6
6797261|NCT03387150|7728975|FG005|NOT COMPLETED|Overall Study||7
6797262|NCT03387150|7728976|FG006|NOT COMPLETED|Overall Study||0
6797263|NCT03370133|7728995|FG000|STARTED|Initial Treatment Period (WK 16)||83
6797264|NCT03370133|7728996|FG001|STARTED|Initial Treatment Period (WK 16)||321
6797265|NCT03370133|7728997|FG002|STARTED|Initial Treatment Period (WK 16)||163
6797266|NCT03370133|7728998|FG003|STARTED|Initial Treatment Period (WK 16)||0
6797267|NCT03370133|7728999|FG004|STARTED|Initial Treatment Period (WK 16)||0
6797268|NCT03370133|7729000|FG005|STARTED|Initial Treatment Period (WK 16)||0
6797269|NCT03370133|7728995|FG000|COMPLETED|Initial Treatment Period (WK 16)||74
6797270|NCT03370133|7728996|FG001|COMPLETED|Initial Treatment Period (WK 16)||306
6797271|NCT03370133|7728997|FG002|COMPLETED|Initial Treatment Period (WK 16)||157
6797272|NCT03370133|7728998|FG003|COMPLETED|Initial Treatment Period (WK 16)||0
6797273|NCT03370133|7728999|FG004|COMPLETED|Initial Treatment Period (WK 16)||0
6797274|NCT03370133|7729000|FG005|COMPLETED|Initial Treatment Period (WK 16)||0
6797275|NCT03370133|7728995|FG000|NOT COMPLETED|Initial Treatment Period (WK 16)||9
6797276|NCT03370133|7728996|FG001|NOT COMPLETED|Initial Treatment Period (WK 16)||15
6797277|NCT03370133|7728997|FG002|NOT COMPLETED|Initial Treatment Period (WK 16)||6
6797278|NCT03370133|7728998|FG003|NOT COMPLETED|Initial Treatment Period (WK 16)||0
6797279|NCT03370133|7728999|FG004|NOT COMPLETED|Initial Treatment Period (WK 16)||0
6797280|NCT03370133|7729000|FG005|NOT COMPLETED|Initial Treatment Period (WK 16)||0
6797281|NCT03370133|7728995|FG000|STARTED|Maintenance Treatment Period (WK 52)||0
6797282|NCT03370133|7728996|FG001|STARTED|Maintenance Treatment Period (WK 52)||0
6797283|NCT03370133|7728997|FG002|STARTED|Maintenance Treatment Period (WK 52)||0
6797284|NCT03370133|7728998|FG003|STARTED|Maintenance Treatment Period (WK 52)||74
6797285|NCT03370133|7728999|FG004|STARTED|Maintenance Treatment Period (WK 52)||306
6379898|NCT00775268|7290570|FG000|STARTED|After Completion||7
6379899|NCT00775268|7290571|FG001|STARTED|After Completion||0
6379900|NCT00775268|7290570|FG000|COMPLETED|After Completion||6
6379901|NCT00775268|7290571|FG001|COMPLETED|After Completion||0
6379902|NCT00775268|7290570|FG000|NOT COMPLETED|After Completion||1
6379903|NCT00775268|7290571|FG001|NOT COMPLETED|After Completion||0
6379904|NCT00775346|7290588|FG000|STARTED|Overall Study||92
6379905|NCT00775346|7290588|FG000|COMPLETED|Overall Study||92
6379906|NCT00775346|7290588|FG000|NOT COMPLETED|Overall Study||0
6379907|NCT00775411|7290592|FG000|STARTED|Overall Study||44
6379908|NCT00775411|7290592|FG000|COMPLETED|Overall Study||43
6379909|NCT00775411|7290592|FG000|NOT COMPLETED|Overall Study||1
6379910|NCT00775437|7290596|FG000|STARTED|Overall Study||32
6379911|NCT00775437|7290596|FG000|COMPLETED|Overall Study||26
6379912|NCT00775437|7290596|FG000|NOT COMPLETED|Overall Study||6
6379913|NCT00775450|7290605|FG000|STARTED|Overall Study||295
6379914|NCT00775450|7290606|FG001|STARTED|Overall Study||98
6379915|NCT00775450|7290607|FG002|STARTED|Overall Study||105
6379916|NCT00775450|7290608|FG003|STARTED|Overall Study||108
6379917|NCT00775450|7290609|FG004|STARTED|Overall Study||201
6379918|NCT00775450|7290605|FG000|COMPLETED|Overall Study||292
6379919|NCT00775450|7290606|FG001|COMPLETED|Overall Study||98
6379920|NCT00775450|7290607|FG002|COMPLETED|Overall Study||105
6379921|NCT00775450|7290608|FG003|COMPLETED|Overall Study||108
6379922|NCT00775450|7290609|FG004|COMPLETED|Overall Study||199
6379923|NCT00775450|7290605|FG000|NOT COMPLETED|Overall Study||3
6379924|NCT00775450|7290606|FG001|NOT COMPLETED|Overall Study||0
6379925|NCT00775450|7290607|FG002|NOT COMPLETED|Overall Study||0
6379926|NCT00775450|7290608|FG003|NOT COMPLETED|Overall Study||0
6379927|NCT00775450|7290609|FG004|NOT COMPLETED|Overall Study||2
6379928|NCT00775463|7290623|FG000|STARTED|Overall Study||76
6379929|NCT00775463|7290624|FG001|STARTED|Overall Study||72
6379930|NCT00775463|7290623|FG000|COMPLETED|Overall Study||65
6379931|NCT00775463|7290624|FG001|COMPLETED|Overall Study||59
6379932|NCT00775463|7290623|FG000|NOT COMPLETED|Overall Study||11
6379933|NCT00775463|7290624|FG001|NOT COMPLETED|Overall Study||13
6379934|NCT00775528|7290637|FG000|STARTED|Overall Study|Started means number of patients who consented|19
6379935|NCT00775528|7290637|FG000|COMPLETED|Overall Study||18
6379936|NCT00775528|7290637|FG000|NOT COMPLETED|Overall Study||1
6379937|NCT00775593|7290641|FG000|STARTED|Overall Study||60
6379938|NCT00775593|7290641|FG000|COMPLETED|Overall Study||53
6379939|NCT00775593|7290641|FG000|NOT COMPLETED|Overall Study||7
6379940|NCT00775606|7290647|FG000|STARTED|Overall Study||8
6379941|NCT00775606|7290648|FG001|STARTED|Overall Study||5
6379942|NCT00775606|7290647|FG000|COMPLETED|Overall Study||5
6379943|NCT00775606|7290648|FG001|COMPLETED|Overall Study||5
6379944|NCT00775606|7290647|FG000|NOT COMPLETED|Overall Study||3
6379945|NCT00775606|7290648|FG001|NOT COMPLETED|Overall Study||0
6379946|NCT00775645|7290658|FG000|STARTED|Overall Study||208
6797286|NCT03370133|7729000|FG005|STARTED|Maintenance Treatment Period (WK 52)||157
6797287|NCT03370133|7728995|FG000|COMPLETED|Maintenance Treatment Period (WK 52)||0
6797288|NCT03370133|7728996|FG001|COMPLETED|Maintenance Treatment Period (WK 52)||0
6797289|NCT03370133|7728997|FG002|COMPLETED|Maintenance Treatment Period (WK 52)||0
6797290|NCT03370133|7728998|FG003|COMPLETED|Maintenance Treatment Period (WK 52)||69
6379947|NCT00775645|7290659|FG001|STARTED|Overall Study||201
6379948|NCT00775645|7290658|FG000|COMPLETED|Overall Study||191
6379949|NCT00775645|7290659|FG001|COMPLETED|Overall Study||181
6379950|NCT00775645|7290658|FG000|NOT COMPLETED|Overall Study||17
6379951|NCT00775645|7290659|FG001|NOT COMPLETED|Overall Study||20
6379952|NCT00775658|7290665|FG000|STARTED|First Intervention||10
6379953|NCT00775658|7290666|FG001|STARTED|First Intervention||11
6379954|NCT00775658|7290665|FG000|COMPLETED|First Intervention||10
6379955|NCT00775658|7290666|FG001|COMPLETED|First Intervention||11
6379956|NCT00775658|7290665|FG000|NOT COMPLETED|First Intervention||0
6379957|NCT00775658|7290666|FG001|NOT COMPLETED|First Intervention||0
6564083|NCT01809262|7486883|FG008|COMPLETED|Period 2 (Second Dose + Washout)||3
6564084|NCT01809262|7486884|FG009|COMPLETED|Period 2 (Second Dose + Washout)||4
6564085|NCT01809262|7486875|FG000|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6564086|NCT01809262|7486876|FG001|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6797291|NCT03370133|7728999|FG004|COMPLETED|Maintenance Treatment Period (WK 52)||283
6797292|NCT03370133|7729000|FG005|COMPLETED|Maintenance Treatment Period (WK 52)||141
6656649|NCT02462759|7586922|FG001|STARTED|Part 2: Open-Label Phase||0
6656650|NCT02462759|7586923|FG002|STARTED|Part 2: Open-Label Phase||20
6656651|NCT02462759|7586921|FG000|COMPLETED|Part 2: Open-Label Phase||0
6656652|NCT02462759|7586922|FG001|COMPLETED|Part 2: Open-Label Phase||0
6797293|NCT03370133|7728995|FG000|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
6797294|NCT03370133|7728996|FG001|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
6797295|NCT03370133|7728997|FG002|NOT COMPLETED|Maintenance Treatment Period (WK 52)||0
6797296|NCT03370133|7728998|FG003|NOT COMPLETED|Maintenance Treatment Period (WK 52)||5
6797297|NCT03370133|7728999|FG004|NOT COMPLETED|Maintenance Treatment Period (WK 52)||23
6797298|NCT03370133|7729000|FG005|NOT COMPLETED|Maintenance Treatment Period (WK 52)||16
6797299|NCT03366792|7729018|FG000|STARTED|Overall Study||46
6797300|NCT03366792|7729018|FG000|COMPLETED|Overall Study||31
6797301|NCT03366792|7729018|FG000|NOT COMPLETED|Overall Study||15
6797302|NCT03366337|7729026|FG000|STARTED|Overall Study||31
6797303|NCT03366337|7729027|FG001|STARTED|Overall Study||26
6797304|NCT03366337|7729028|FG002|STARTED|Overall Study||28
6797305|NCT03366337|7729029|FG003|STARTED|Overall Study||18
6797306|NCT03366337|7729026|FG000|COMPLETED|Overall Study||28
6797307|NCT03366337|7729027|FG001|COMPLETED|Overall Study||26
6797308|NCT03366337|7729028|FG002|COMPLETED|Overall Study||26
6797309|NCT03366337|7729029|FG003|COMPLETED|Overall Study||17
6797310|NCT03366337|7729026|FG000|NOT COMPLETED|Overall Study||3
6797311|NCT03366337|7729027|FG001|NOT COMPLETED|Overall Study||0
6797312|NCT03366337|7729028|FG002|NOT COMPLETED|Overall Study||2
6797313|NCT03366337|7729029|FG003|NOT COMPLETED|Overall Study||1
6797314|NCT03342053|7729041|FG000|STARTED|Overall Study||23
6797315|NCT03342053|7729042|FG001|STARTED|Overall Study||23
6797316|NCT03342053|7729041|FG000|COMPLETED|Overall Study||21
6797317|NCT03342053|7729042|FG001|COMPLETED|Overall Study||22
6797318|NCT03342053|7729041|FG000|NOT COMPLETED|Overall Study||2
6797319|NCT03342053|7729042|FG001|NOT COMPLETED|Overall Study||1
6797320|NCT03330847|7729051|FG000|STARTED|Overall Study||114
6797321|NCT03330847|7729052|FG001|STARTED|Overall Study||112
6797322|NCT03330847|7729053|FG002|STARTED|Overall Study||47
6797323|NCT03330847|7729051|FG000|COMPLETED|Overall Study||52
6797324|NCT03330847|7729052|FG001|COMPLETED|Overall Study||47
6797325|NCT03330847|7729053|FG002|COMPLETED|Overall Study||32
6797326|NCT03330847|7729051|FG000|NOT COMPLETED|Overall Study||62
6797327|NCT03330847|7729052|FG001|NOT COMPLETED|Overall Study||65
6797328|NCT03330847|7729053|FG002|NOT COMPLETED|Overall Study||15
6656653|NCT02462759|7586923|FG002|COMPLETED|Part 2: Open-Label Phase||20
6797329|NCT03283241|7729065|FG000|STARTED|Overall Study||32
6797330|NCT03283241|7729066|FG001|STARTED|Overall Study||30
6797331|NCT03283241|7729065|FG000|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
6797332|NCT03283241|7729066|FG001|Completed 12 Weeks|Overall Study|Completed 12 weeks|29
6797333|NCT03283241|7729065|FG000|COMPLETED|Overall Study|Completed 24 month|28
6797334|NCT03283241|7729066|FG001|COMPLETED|Overall Study|Completed 24 month|27
6797335|NCT03283241|7729065|FG000|NOT COMPLETED|Overall Study||4
6797336|NCT03283241|7729066|FG001|NOT COMPLETED|Overall Study||3
6797337|NCT03242772|7729074|FG000|STARTED|Overall Study||9
6797338|NCT03242772|7729075|FG001|STARTED|Overall Study||9
6797339|NCT03242772|7729074|FG000|COMPLETED|Overall Study||6
6797340|NCT03242772|7729075|FG001|COMPLETED|Overall Study||8
6797341|NCT03242772|7729074|FG000|NOT COMPLETED|Overall Study||3
6797342|NCT03242772|7729075|FG001|NOT COMPLETED|Overall Study||1
6797343|NCT03236311|7729083|FG000|STARTED|Overall Study||5
6797344|NCT03236311|7729084|FG001|STARTED|Overall Study||5
6797345|NCT03236311|7729083|FG000|COMPLETED|Overall Study||5
6797346|NCT03236311|7729084|FG001|COMPLETED|Overall Study||2
6797347|NCT03236311|7729083|FG000|NOT COMPLETED|Overall Study||0
6797348|NCT03236311|7729084|FG001|NOT COMPLETED|Overall Study||3
6564087|NCT01809262|7486877|FG002|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6564088|NCT01809262|7486878|FG003|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6564089|NCT01809262|7486879|FG004|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6564090|NCT01809262|7486880|FG005|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6564091|NCT01809262|7486881|FG006|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6797349|NCT03206476|7729092|FG000|STARTED|Overall Study||54
6797350|NCT03206476|7729093|FG001|STARTED|Overall Study||53
6797351|NCT03206476|7729092|FG000|COMPLETED|Overall Study||48
6797352|NCT03206476|7729093|FG001|COMPLETED|Overall Study||40
6797353|NCT03206476|7729092|FG000|NOT COMPLETED|Overall Study||6
6797354|NCT03206476|7729093|FG001|NOT COMPLETED|Overall Study||13
6797355|NCT03192046|7729101|FG000|STARTED|Overall Study||5
6797356|NCT03192046|7729102|FG001|STARTED|Overall Study||4
6797357|NCT03192046|7729101|FG000|COMPLETED|Overall Study||4
6797358|NCT03192046|7729102|FG001|COMPLETED|Overall Study||3
6797359|NCT03192046|7729101|FG000|NOT COMPLETED|Overall Study||1
6797360|NCT03192046|7729102|FG001|NOT COMPLETED|Overall Study||1
6797361|NCT03190369|7729110|FG000|STARTED|Overall Study||220
6797362|NCT03190369|7729111|FG001|STARTED|Overall Study||220
6797363|NCT03190369|7729110|FG000|Treated|Overall Study||220
6797364|NCT03190369|7729111|FG001|Treated|Overall Study||218
6797365|NCT03190369|7729110|FG000|COMPLETED|Overall Study||219
6797366|NCT03190369|7729111|FG001|COMPLETED|Overall Study||212
6797367|NCT03190369|7729110|FG000|NOT COMPLETED|Overall Study||1
6797368|NCT03190369|7729111|FG001|NOT COMPLETED|Overall Study||8
6797369|NCT03178487|7729119|FG000|STARTED|Overall Study||94
6797370|NCT03178487|7729120|FG001|STARTED|Overall Study||93
6797371|NCT03178487|7729119|FG000|Received Treatment|Overall Study||94
6797372|NCT03178487|7729120|FG001|Received Treatment|Overall Study||93
6797373|NCT03178487|7729119|FG000|COMPLETED|Overall Study||90
6797374|NCT03178487|7729120|FG001|COMPLETED|Overall Study||89
6797375|NCT03178487|7729119|FG000|NOT COMPLETED|Overall Study||4
6797376|NCT03178487|7729120|FG001|NOT COMPLETED|Overall Study||4
6797377|NCT03155932|7729126|FG000|STARTED|Overall Study||2
6797378|NCT03155932|7729126|FG000|Participants Escalated to 2 mg Dose of APD334 at Week 12 to Week 24|Overall Study||2
6797379|NCT03155932|7729126|FG000|COMPLETED|Overall Study||2
6797380|NCT03155932|7729126|FG000|NOT COMPLETED|Overall Study||0
6797381|NCT03106779|7729133|FG000|STARTED|Overall Study||157
6797382|NCT03106779|7729134|FG001|STARTED|Overall Study||76
6797383|NCT03106779|7729133|FG000|Treated|Overall Study||156
6797384|NCT03106779|7729134|FG001|Treated|Overall Study||0
6797385|NCT03106779|7729133|FG000|Not Treated|Overall Study||1
6797386|NCT03106779|7729134|FG001|Not Treated|Overall Study||0
6797387|NCT03106779|7729133|FG000|COMPLETED|Overall Study||97
6797388|NCT03106779|7729134|FG001|COMPLETED|Overall Study||22
6797389|NCT03106779|7729133|FG000|NOT COMPLETED|Overall Study||60
6797390|NCT03106779|7729134|FG001|NOT COMPLETED|Overall Study||54
6797391|NCT03096834|7729142|FG000|STARTED|Double-Blind Treatment Epoch||121
6797392|NCT03096834|7729143|FG001|STARTED|Double-Blind Treatment Epoch||125
6797393|NCT03096834|7729144|FG002|STARTED|Double-Blind Treatment Epoch||0
6797394|NCT03096834|7729145|FG003|STARTED|Double-Blind Treatment Epoch||0
6797395|NCT03096834|7729142|FG000|COMPLETED|Double-Blind Treatment Epoch||118
6797396|NCT03096834|7729143|FG001|COMPLETED|Double-Blind Treatment Epoch||122
6797397|NCT03096834|7729144|FG002|COMPLETED|Double-Blind Treatment Epoch||0
6797398|NCT03096834|7729145|FG003|COMPLETED|Double-Blind Treatment Epoch||0
6797399|NCT03096834|7729142|FG000|NOT COMPLETED|Double-Blind Treatment Epoch||3
6797400|NCT03096834|7729143|FG001|NOT COMPLETED|Double-Blind Treatment Epoch||3
6797401|NCT03096834|7729144|FG002|NOT COMPLETED|Double-Blind Treatment Epoch||0
6797402|NCT03096834|7729145|FG003|NOT COMPLETED|Double-Blind Treatment Epoch||0
6797403|NCT03096834|7729142|FG000|STARTED|Open-Label Treatment Epoch||0
6797404|NCT03096834|7729143|FG001|STARTED|Open-Label Treatment Epoch||0
6797405|NCT03096834|7729144|FG002|STARTED|Open-Label Treatment Epoch||118
6797406|NCT03096834|7729145|FG003|STARTED|Open-Label Treatment Epoch||122
6797407|NCT03096834|7729142|FG000|COMPLETED|Open-Label Treatment Epoch||0
6797408|NCT03096834|7729143|FG001|COMPLETED|Open-Label Treatment Epoch||0
6797409|NCT03096834|7729144|FG002|COMPLETED|Open-Label Treatment Epoch||86
6797410|NCT03096834|7729145|FG003|COMPLETED|Open-Label Treatment Epoch||83
6797411|NCT03096834|7729142|FG000|NOT COMPLETED|Open-Label Treatment Epoch||0
6797412|NCT03096834|7729143|FG001|NOT COMPLETED|Open-Label Treatment Epoch||0
6797413|NCT03096834|7729144|FG002|NOT COMPLETED|Open-Label Treatment Epoch||32
6797414|NCT03096834|7729145|FG003|NOT COMPLETED|Open-Label Treatment Epoch||39
6797415|NCT03096834|7729142|FG000|STARTED|Safety Follow-Up Epoch||0
6797416|NCT03096834|7729143|FG001|STARTED|Safety Follow-Up Epoch||0
6797417|NCT03096834|7729144|FG002|STARTED|Safety Follow-Up Epoch||66
6797418|NCT03096834|7729145|FG003|STARTED|Safety Follow-Up Epoch||61
6797419|NCT03096834|7729142|FG000|COMPLETED|Safety Follow-Up Epoch||0
6797420|NCT03096834|7729143|FG001|COMPLETED|Safety Follow-Up Epoch||0
6797421|NCT03096834|7729144|FG002|COMPLETED|Safety Follow-Up Epoch||65
6797422|NCT03096834|7729145|FG003|COMPLETED|Safety Follow-Up Epoch||59
6797423|NCT03096834|7729142|FG000|NOT COMPLETED|Safety Follow-Up Epoch||0
6797424|NCT03096834|7729143|FG001|NOT COMPLETED|Safety Follow-Up Epoch||0
6797425|NCT03096834|7729144|FG002|NOT COMPLETED|Safety Follow-Up Epoch||1
6797426|NCT03096834|7729145|FG003|NOT COMPLETED|Safety Follow-Up Epoch||2
6797427|NCT03096834|7729142|FG000|STARTED|Post-Trial Access Epoch||0
6797428|NCT03096834|7729143|FG001|STARTED|Post-Trial Access Epoch||0
6797429|NCT03096834|7729144|FG002|STARTED|Post-Trial Access Epoch||21
6797430|NCT03096834|7729145|FG003|STARTED|Post-Trial Access Epoch||15
6797431|NCT03096834|7729142|FG000|COMPLETED|Post-Trial Access Epoch||0
6797432|NCT03096834|7729143|FG001|COMPLETED|Post-Trial Access Epoch||0
6797433|NCT03096834|7729144|FG002|COMPLETED|Post-Trial Access Epoch||21
6797434|NCT03096834|7729145|FG003|COMPLETED|Post-Trial Access Epoch||15
6797435|NCT03096834|7729142|FG000|NOT COMPLETED|Post-Trial Access Epoch||0
6797436|NCT03096834|7729143|FG001|NOT COMPLETED|Post-Trial Access Epoch||0
6797437|NCT03096834|7729144|FG002|NOT COMPLETED|Post-Trial Access Epoch||0
6797438|NCT03096834|7729145|FG003|NOT COMPLETED|Post-Trial Access Epoch||0
6797439|NCT03089853|7729156|FG000|STARTED|Overall Study||4
6797440|NCT03089853|7729157|FG001|STARTED|Overall Study||3
6797441|NCT03089853|7729156|FG000|COMPLETED|Overall Study||2
6797442|NCT03089853|7729157|FG001|COMPLETED|Overall Study||2
6797443|NCT03089853|7729156|FG000|NOT COMPLETED|Overall Study||2
6797444|NCT03089853|7729157|FG001|NOT COMPLETED|Overall Study||1
6797445|NCT03070392|7729165|FG000|STARTED|Overall Study||252
6797446|NCT03070392|7729166|FG001|STARTED|Overall Study||7
6797447|NCT03070392|7729167|FG002|STARTED|Overall Study||16
6797448|NCT03070392|7729168|FG003|STARTED|Overall Study||103
6797449|NCT03070392|7729165|FG000|COMPLETED|Overall Study||0
6797450|NCT03070392|7729166|FG001|COMPLETED|Overall Study||0
6797451|NCT03070392|7729167|FG002|COMPLETED|Overall Study||10
6797452|NCT03070392|7729168|FG003|COMPLETED|Overall Study||0
6797453|NCT03070392|7729165|FG000|NOT COMPLETED|Overall Study||252
6797454|NCT03070392|7729166|FG001|NOT COMPLETED|Overall Study||7
6797455|NCT03070392|7729167|FG002|NOT COMPLETED|Overall Study||6
6797456|NCT03070392|7729168|FG003|NOT COMPLETED|Overall Study||103
6797457|NCT03048578|7729176|FG000|STARTED|Overall Study||89
6797458|NCT03048578|7729177|FG001|STARTED|Overall Study||43
6797459|NCT03048578|7729176|FG000|COMPLETED|Overall Study||58
6797460|NCT03048578|7729177|FG001|COMPLETED|Overall Study||23
6797461|NCT03048578|7729176|FG000|NOT COMPLETED|Overall Study||31
6797462|NCT03048578|7729177|FG001|NOT COMPLETED|Overall Study||20
6797463|NCT03015194|7729183|FG000|STARTED|Overall Study||30
6797464|NCT03015194|7729183|FG000|COMPLETED|Overall Study||18
6797465|NCT03015194|7729183|FG000|NOT COMPLETED|Overall Study||12
6797466|NCT03012815|7729190|FG000|STARTED|Overall Study||46
6797467|NCT03012815|7729191|FG001|STARTED|Overall Study||42
6797468|NCT03012815|7729190|FG000|COMPLETED|Overall Study||41
6797469|NCT03012815|7729191|FG001|COMPLETED|Overall Study||40
6797470|NCT03012815|7729190|FG000|NOT COMPLETED|Overall Study||5
6797471|NCT03012815|7729191|FG001|NOT COMPLETED|Overall Study||2
6797472|NCT03001011|7729200|FG000|STARTED|Overall Study||101
6797473|NCT03001011|7729201|FG001|STARTED|Overall Study||101
6797474|NCT03001011|7729200|FG000|COMPLETED|Overall Study||74
6797475|NCT03001011|7729201|FG001|COMPLETED|Overall Study||80
6797476|NCT03001011|7729200|FG000|NOT COMPLETED|Overall Study||27
6797477|NCT03001011|7729201|FG001|NOT COMPLETED|Overall Study||21
6797478|NCT02999633|7729208|FG000|STARTED|Overall Study||14
6797479|NCT02999633|7729208|FG000|COMPLETED|Overall Study||0
6797480|NCT02999633|7729208|FG000|NOT COMPLETED|Overall Study||14
6797481|NCT02993757|7729214|FG000|STARTED|Overall Study||266
6797482|NCT02993757|7729215|FG001|STARTED|Overall Study||262
6797483|NCT02993757|7729214|FG000|Safety Analysis Set (SafAS)|Overall Study||263
6797484|NCT02993757|7729215|FG001|Safety Analysis Set (SafAS)|Overall Study||260
6379958|NCT00775658|7290665|FG000|STARTED|Second Intervention||10
6379959|NCT00775658|7290666|FG001|STARTED|Second Intervention||11
6379960|NCT00775658|7290665|FG000|COMPLETED|Second Intervention||10
6379961|NCT00775658|7290666|FG001|COMPLETED|Second Intervention||11
6379962|NCT00775658|7290665|FG000|NOT COMPLETED|Second Intervention||0
6379963|NCT00775658|7290666|FG001|NOT COMPLETED|Second Intervention||0
6395575|NCT00859053|7308149|FG001|NOT COMPLETED|Overall Study||0
6395576|NCT00859053|7308150|FG002|NOT COMPLETED|Overall Study||0
6395577|NCT00859053|7308151|FG003|NOT COMPLETED|Overall Study||0
6395578|NCT00859131|7308163|FG000|STARTED|Overall Study||102
6395579|NCT00859131|7308164|FG001|STARTED|Overall Study||98
6395580|NCT00859131|7308163|FG000|COMPLETED|Overall Study||102
6395581|NCT00859131|7308164|FG001|COMPLETED|Overall Study||98
6395582|NCT00859131|7308163|FG000|NOT COMPLETED|Overall Study||0
6395583|NCT00859131|7308164|FG001|NOT COMPLETED|Overall Study||0
6395584|NCT00859222|7308173|FG000|STARTED|Overall Study||3
6797485|NCT02993757|7729214|FG000|COMPLETED|Overall Study||102
6797486|NCT02993757|7729215|FG001|COMPLETED|Overall Study||84
6797487|NCT02993757|7729214|FG000|NOT COMPLETED|Overall Study||164
6797488|NCT02993757|7729215|FG001|NOT COMPLETED|Overall Study||178
6797489|NCT02992418|7729223|FG000|STARTED|Overall Study||346
6797490|NCT02992418|7729224|FG001|STARTED|Overall Study||342
6797491|NCT02992418|7729223|FG000|Safety Analysis Set (SafAS)|Overall Study||338
6797492|NCT02992418|7729224|FG001|Safety Analysis Set (SafAS)|Overall Study||342
6797493|NCT02992418|7729223|FG000|COMPLETED|Overall Study||0
6797494|NCT02992418|7729224|FG001|COMPLETED|Overall Study||0
6797495|NCT02992418|7729223|FG000|NOT COMPLETED|Overall Study||346
6797496|NCT02992418|7729224|FG001|NOT COMPLETED|Overall Study||342
6797497|NCT02979535|7729232|FG000|STARTED|Overall Study||239
6797498|NCT02979535|7729233|FG001|STARTED|Overall Study||241
6797499|NCT02979535|7729232|FG000|Safety Analysis Set|Overall Study||237
6797500|NCT02979535|7729233|FG001|Safety Analysis Set|Overall Study||241
6797501|NCT02979535|7729232|FG000|COMPLETED|Overall Study||144
6797502|NCT02979535|7729233|FG001|COMPLETED|Overall Study||140
6797503|NCT02979535|7729232|FG000|NOT COMPLETED|Overall Study||95
6797504|NCT02979535|7729233|FG001|NOT COMPLETED|Overall Study||101
6797505|NCT02978716|7729242|FG000|STARTED|Overall Study||34
6797506|NCT02978716|7729243|FG001|STARTED|Overall Study||33
6797507|NCT02978716|7729244|FG002|STARTED|Overall Study||35
6797508|NCT02978716|7729242|FG000|ITT Population|Overall Study||34
6797509|NCT02978716|7729243|FG001|ITT Population|Overall Study||33
6797510|NCT02978716|7729244|FG002|ITT Population|Overall Study||35
6797511|NCT02978716|7729242|FG000|Safety Analysis Set|Overall Study||30
6797512|NCT02978716|7729243|FG001|Safety Analysis Set|Overall Study||33
6797513|NCT02978716|7729244|FG002|Safety Analysis Set|Overall Study||35
6797514|NCT02978716|7729242|FG000|Treated|Overall Study||30
6797515|NCT02978716|7729243|FG001|Treated|Overall Study||33
6797516|NCT02978716|7729244|FG002|Treated|Overall Study||35
6797517|NCT02978716|7729242|FG000|COMPLETED|Overall Study||0
6797518|NCT02978716|7729243|FG001|COMPLETED|Overall Study||0
6797519|NCT02978716|7729244|FG002|COMPLETED|Overall Study||0
6797520|NCT02978716|7729242|FG000|NOT COMPLETED|Overall Study||34
6797521|NCT02978716|7729243|FG001|NOT COMPLETED|Overall Study||33
6797522|NCT02978716|7729244|FG002|NOT COMPLETED|Overall Study||35
6797523|NCT02973321|7729259|FG000|STARTED|Overall Study||33
6797524|NCT02973321|7729260|FG001|STARTED|Overall Study||66
6797525|NCT02973321|7729261|FG002|STARTED|Overall Study||66
6797526|NCT02973321|7729262|FG003|STARTED|Overall Study||64
6797527|NCT02973321|7729263|FG004|STARTED|Overall Study||67
6797528|NCT02973321|7729259|FG000|COMPLETED|Overall Study||32
6797529|NCT02973321|7729260|FG001|COMPLETED|Overall Study||51
6797530|NCT02973321|7729261|FG002|COMPLETED|Overall Study||52
6797531|NCT02973321|7729262|FG003|COMPLETED|Overall Study||48
6797532|NCT02973321|7729263|FG004|COMPLETED|Overall Study||62
6797533|NCT02973321|7729259|FG000|NOT COMPLETED|Overall Study||1
6797534|NCT02973321|7729260|FG001|NOT COMPLETED|Overall Study||15
6797535|NCT02973321|7729261|FG002|NOT COMPLETED|Overall Study||14
6797536|NCT02973321|7729262|FG003|NOT COMPLETED|Overall Study||16
6797537|NCT02973321|7729263|FG004|NOT COMPLETED|Overall Study||5
6797538|NCT02943785|7729278|FG000|STARTED|Overall Study||713
6797539|NCT02943785|7729279|FG001|STARTED|Overall Study||713
6797540|NCT02943785|7729278|FG000|COMPLETED|Overall Study||431
6797541|NCT02943785|7729279|FG001|COMPLETED|Overall Study||350
6797542|NCT02943785|7729278|FG000|NOT COMPLETED|Overall Study||282
6797543|NCT02943785|7729279|FG001|NOT COMPLETED|Overall Study||363
6797544|NCT02937818|7729289|FG000|STARTED|Overall Study||21
6797545|NCT02937818|7729290|FG001|STARTED|Overall Study||20
6797546|NCT02937818|7729291|FG002|STARTED|Overall Study||10
6797547|NCT02937818|7729292|FG003|STARTED|Overall Study||21
6797548|NCT02937818|7729289|FG000|COMPLETED|Overall Study||0
6797549|NCT02937818|7729290|FG001|COMPLETED|Overall Study||0
6797550|NCT02937818|7729291|FG002|COMPLETED|Overall Study||0
6797551|NCT02937818|7729292|FG003|COMPLETED|Overall Study||0
6797552|NCT02937818|7729289|FG000|NOT COMPLETED|Overall Study||21
6797553|NCT02937818|7729290|FG001|NOT COMPLETED|Overall Study||20
6797554|NCT02937818|7729291|FG002|NOT COMPLETED|Overall Study||10
6797555|NCT02937818|7729292|FG003|NOT COMPLETED|Overall Study||21
6797556|NCT02923674|7729308|FG000|STARTED|Overall Study||60
6797557|NCT02923674|7729309|FG001|STARTED|Overall Study||60
6797558|NCT02923674|7729310|FG002|STARTED|Overall Study||63
6797559|NCT02923674|7729308|FG000|COMPLETED|Overall Study||32
6797560|NCT02923674|7729309|FG001|COMPLETED|Overall Study||32
6797561|NCT02923674|7729310|FG002|COMPLETED|Overall Study||38
6797562|NCT02923674|7729308|FG000|NOT COMPLETED|Overall Study||28
6797563|NCT02923674|7729309|FG001|NOT COMPLETED|Overall Study||28
6797564|NCT02923674|7729310|FG002|NOT COMPLETED|Overall Study||25
6797565|NCT02921971|7729320|FG000|STARTED|Overall Study||49
6797566|NCT02921971|7729321|FG001|STARTED|Overall Study||48
6797567|NCT02921971|7729320|FG000|COMPLETED|Overall Study||43
6797568|NCT02921971|7729321|FG001|COMPLETED|Overall Study||44
6797569|NCT02921971|7729320|FG000|NOT COMPLETED|Overall Study||6
6797570|NCT02921971|7729321|FG001|NOT COMPLETED|Overall Study||4
6797571|NCT02908685|7729339|FG000|STARTED|Part 1 Exploratory||7
6797572|NCT02908685|7729340|FG001|STARTED|Part 1 Exploratory||7
6797573|NCT02908685|7729341|FG002|STARTED|Part 1 Exploratory||3
6797574|NCT02908685|7729342|FG003|STARTED|Part 1 Exploratory||3
6797575|NCT02908685|7729343|FG004|STARTED|Part 1 Exploratory||7
6797576|NCT02908685|7729344|FG005|STARTED|Part 1 Exploratory||7
6797577|NCT02908685|7729345|FG006|STARTED|Part 1 Exploratory||7
6797578|NCT02908685|7729346|FG007|STARTED|Part 1 Exploratory||3
6797579|NCT02908685|7729347|FG008|STARTED|Part 1 Exploratory||4
6797580|NCT02908685|7729348|FG009|STARTED|Part 1 Exploratory||3
6797581|NCT02908685|7729349|FG010|STARTED|Part 1 Exploratory||0
6797582|NCT02908685|7729350|FG011|STARTED|Part 1 Exploratory||0
6797583|NCT02908685|7729339|FG000|COMPLETED|Part 1 Exploratory||7
6797584|NCT02908685|7729340|FG001|COMPLETED|Part 1 Exploratory||6
6797585|NCT02908685|7729341|FG002|COMPLETED|Part 1 Exploratory||3
6797586|NCT02908685|7729342|FG003|COMPLETED|Part 1 Exploratory||3
6797587|NCT02908685|7729343|FG004|COMPLETED|Part 1 Exploratory||7
6797588|NCT02908685|7729344|FG005|COMPLETED|Part 1 Exploratory||7
6797589|NCT02908685|7729345|FG006|COMPLETED|Part 1 Exploratory||7
6797590|NCT02908685|7729346|FG007|COMPLETED|Part 1 Exploratory||3
6797591|NCT02908685|7729347|FG008|COMPLETED|Part 1 Exploratory||4
6797592|NCT02908685|7729348|FG009|COMPLETED|Part 1 Exploratory||3
6797593|NCT02908685|7729349|FG010|COMPLETED|Part 1 Exploratory||0
6797594|NCT02908685|7729350|FG011|COMPLETED|Part 1 Exploratory||0
6797595|NCT02908685|7729339|FG000|NOT COMPLETED|Part 1 Exploratory||0
6797596|NCT02908685|7729340|FG001|NOT COMPLETED|Part 1 Exploratory||1
6797597|NCT02908685|7729341|FG002|NOT COMPLETED|Part 1 Exploratory||0
6797598|NCT02908685|7729342|FG003|NOT COMPLETED|Part 1 Exploratory||0
6797599|NCT02908685|7729343|FG004|NOT COMPLETED|Part 1 Exploratory||0
6797600|NCT02908685|7729344|FG005|NOT COMPLETED|Part 1 Exploratory||0
6797601|NCT02908685|7729345|FG006|NOT COMPLETED|Part 1 Exploratory||0
6797602|NCT02908685|7729346|FG007|NOT COMPLETED|Part 1 Exploratory||0
6797603|NCT02908685|7729347|FG008|NOT COMPLETED|Part 1 Exploratory||0
6797604|NCT02908685|7729348|FG009|NOT COMPLETED|Part 1 Exploratory||0
6797605|NCT02908685|7729349|FG010|NOT COMPLETED|Part 1 Exploratory||0
6797606|NCT02908685|7729350|FG011|NOT COMPLETED|Part 1 Exploratory||0
6797607|NCT02908685|7729339|FG000|STARTED|Part 2 Confirmatory||0
6797608|NCT02908685|7729340|FG001|STARTED|Part 2 Confirmatory||0
6797609|NCT02908685|7729341|FG002|STARTED|Part 2 Confirmatory||0
6797610|NCT02908685|7729342|FG003|STARTED|Part 2 Confirmatory||0
6797611|NCT02908685|7729343|FG004|STARTED|Part 2 Confirmatory||0
6797612|NCT02908685|7729344|FG005|STARTED|Part 2 Confirmatory||0
6797613|NCT02908685|7729345|FG006|STARTED|Part 2 Confirmatory||0
6797614|NCT02908685|7729346|FG007|STARTED|Part 2 Confirmatory||0
6797615|NCT02908685|7729347|FG008|STARTED|Part 2 Confirmatory||0
6797616|NCT02908685|7729348|FG009|STARTED|Part 2 Confirmatory||0
6797617|NCT02908685|7729349|FG010|STARTED|Part 2 Confirmatory||120
6797618|NCT02908685|7729350|FG011|STARTED|Part 2 Confirmatory||60
6797619|NCT02908685|7729339|FG000|COMPLETED|Part 2 Confirmatory||0
6797620|NCT02908685|7729340|FG001|COMPLETED|Part 2 Confirmatory||0
6797621|NCT02908685|7729341|FG002|COMPLETED|Part 2 Confirmatory||0
6797622|NCT02908685|7729342|FG003|COMPLETED|Part 2 Confirmatory||0
6797623|NCT02908685|7729343|FG004|COMPLETED|Part 2 Confirmatory||0
6797624|NCT02908685|7729344|FG005|COMPLETED|Part 2 Confirmatory||0
6797625|NCT02908685|7729345|FG006|COMPLETED|Part 2 Confirmatory||0
6797626|NCT02908685|7729346|FG007|COMPLETED|Part 2 Confirmatory||0
6797627|NCT02908685|7729347|FG008|COMPLETED|Part 2 Confirmatory||0
6797628|NCT02908685|7729348|FG009|COMPLETED|Part 2 Confirmatory||0
6797629|NCT02908685|7729349|FG010|COMPLETED|Part 2 Confirmatory||117
6797630|NCT02908685|7729350|FG011|COMPLETED|Part 2 Confirmatory||59
6797631|NCT02908685|7729339|FG000|NOT COMPLETED|Part 2 Confirmatory||0
6797632|NCT02908685|7729340|FG001|NOT COMPLETED|Part 2 Confirmatory||0
6797633|NCT02908685|7729341|FG002|NOT COMPLETED|Part 2 Confirmatory||0
6797634|NCT02908685|7729342|FG003|NOT COMPLETED|Part 2 Confirmatory||0
6797635|NCT02908685|7729343|FG004|NOT COMPLETED|Part 2 Confirmatory||0
6797636|NCT02908685|7729344|FG005|NOT COMPLETED|Part 2 Confirmatory||0
6797637|NCT02908685|7729345|FG006|NOT COMPLETED|Part 2 Confirmatory||0
6797638|NCT02908685|7729346|FG007|NOT COMPLETED|Part 2 Confirmatory||0
6797639|NCT02908685|7729347|FG008|NOT COMPLETED|Part 2 Confirmatory||0
6797640|NCT02908685|7729348|FG009|NOT COMPLETED|Part 2 Confirmatory||0
6797641|NCT02908685|7729349|FG010|NOT COMPLETED|Part 2 Confirmatory||3
6797642|NCT02908685|7729350|FG011|NOT COMPLETED|Part 2 Confirmatory||1
6797643|NCT02903914|7729375|FG000|STARTED|Overall Study||8
6797644|NCT02903914|7729376|FG001|STARTED|Overall Study||7
6797645|NCT02903914|7729377|FG002|STARTED|Overall Study||85
6797646|NCT02903914|7729378|FG003|STARTED|Overall Study||7
6797647|NCT02903914|7729379|FG004|STARTED|Overall Study||10
6797648|NCT02903914|7729380|FG005|STARTED|Overall Study||14
6797649|NCT02903914|7729381|FG006|STARTED|Overall Study||123
6797650|NCT02903914|7729382|FG007|STARTED|Overall Study||6
6797651|NCT02903914|7729375|FG000|COMPLETED|Overall Study||0
6797652|NCT02903914|7729376|FG001|COMPLETED|Overall Study||0
6797653|NCT02903914|7729377|FG002|COMPLETED|Overall Study||0
6797654|NCT02903914|7729378|FG003|COMPLETED|Overall Study||0
6797655|NCT02903914|7729379|FG004|COMPLETED|Overall Study||0
6797656|NCT02903914|7729380|FG005|COMPLETED|Overall Study||0
6797657|NCT02903914|7729381|FG006|COMPLETED|Overall Study||6
6797658|NCT02903914|7729382|FG007|COMPLETED|Overall Study||1
6797659|NCT02903914|7729375|FG000|NOT COMPLETED|Overall Study||8
6797660|NCT02903914|7729376|FG001|NOT COMPLETED|Overall Study||7
6797661|NCT02903914|7729377|FG002|NOT COMPLETED|Overall Study||85
6797662|NCT02903914|7729378|FG003|NOT COMPLETED|Overall Study||7
6797663|NCT02903914|7729379|FG004|NOT COMPLETED|Overall Study||10
6797664|NCT02903914|7729380|FG005|NOT COMPLETED|Overall Study||14
6797665|NCT02903914|7729381|FG006|NOT COMPLETED|Overall Study||117
6797666|NCT02903914|7729382|FG007|NOT COMPLETED|Overall Study||5
6797667|NCT02890355|7729404|FG000|STARTED|Overall Study||59
6797668|NCT02890355|7729405|FG001|STARTED|Overall Study||58
6797669|NCT02890355|7729404|FG000|Treated & Assessed for AEs|Overall Study||56
6797670|NCT02890355|7729405|FG001|Treated & Assessed for AEs|Overall Study||50
6797671|NCT02890355|7729404|FG000|COMPLETED|Overall Study||0
6797672|NCT02890355|7729405|FG001|COMPLETED|Overall Study||0
6797673|NCT02890355|7729404|FG000|NOT COMPLETED|Overall Study||59
6797674|NCT02890355|7729405|FG001|NOT COMPLETED|Overall Study||58
6797675|NCT02886286|7729415|FG000|STARTED|Overall Study||8
6797676|NCT02886286|7729416|FG001|STARTED|Overall Study||9
6797677|NCT02886286|7729415|FG000|COMPLETED|Overall Study||8
6797678|NCT02886286|7729416|FG001|COMPLETED|Overall Study||8
6797679|NCT02886286|7729415|FG000|NOT COMPLETED|Overall Study||0
6797680|NCT02886286|7729416|FG001|NOT COMPLETED|Overall Study||1
6797681|NCT02874742|7729425|FG000|STARTED|Overall Study||103
6797682|NCT02874742|7729426|FG001|STARTED|Overall Study||104
6797683|NCT02874742|7729427|FG002|STARTED|Overall Study||16
6797684|NCT02874742|7729425|FG000|Safety|Overall Study||102
6797685|NCT02874742|7729426|FG001|Safety|Overall Study||99
6797686|NCT02874742|7729427|FG002|Safety|Overall Study||16
6797687|NCT02874742|7729425|FG000|COMPLETED|Overall Study||0
6797688|NCT02874742|7729426|FG001|COMPLETED|Overall Study||0
6797689|NCT02874742|7729427|FG002|COMPLETED|Overall Study||0
6797690|NCT02874742|7729425|FG000|NOT COMPLETED|Overall Study||103
6797691|NCT02874742|7729426|FG001|NOT COMPLETED|Overall Study||104
6797692|NCT02874742|7729427|FG002|NOT COMPLETED|Overall Study||16
6797693|NCT02865187|7729437|FG000|STARTED|Overall Study||33
6797694|NCT02865187|7729438|FG001|STARTED|Overall Study||14
6797695|NCT02865187|7729437|FG000|Visit 2 - at 3 Months|Overall Study||23
6797696|NCT02865187|7729438|FG001|Visit 2 - at 3 Months|Overall Study||7
6797697|NCT02865187|7729437|FG000|COMPLETED|Overall Study||20
6797698|NCT02865187|7729438|FG001|COMPLETED|Overall Study||7
6797699|NCT02865187|7729437|FG000|NOT COMPLETED|Overall Study||13
6797700|NCT02865187|7729438|FG001|NOT COMPLETED|Overall Study||7
6797701|NCT02836249|7729446|FG000|STARTED|Overall Study||123
6797702|NCT02836249|7729447|FG001|STARTED|Overall Study||58
6797703|NCT02836249|7729446|FG000|COMPLETED|Overall Study||0
6797704|NCT02836249|7729447|FG001|COMPLETED|Overall Study||0
6797705|NCT02836249|7729446|FG000|NOT COMPLETED|Overall Study||123
6797706|NCT02836249|7729447|FG001|NOT COMPLETED|Overall Study||58
6797707|NCT02832167|7729453|FG000|STARTED|Treatment Period 1||239
6797708|NCT02832167|7729453|FG000|COMPLETED|Treatment Period 1||110
6797709|NCT02832167|7729453|FG000|NOT COMPLETED|Treatment Period 1||129
6797710|NCT02832167|7729453|FG000|STARTED|Transition From Period 1 to Period 2||110
6797711|NCT02832167|7729453|FG000|COMPLETED|Transition From Period 1 to Period 2||103
6797712|NCT02832167|7729453|FG000|NOT COMPLETED|Transition From Period 1 to Period 2||7
6797713|NCT02832167|7729453|FG000|STARTED|Treatment Period 2||103
6797714|NCT02832167|7729453|FG000|COMPLETED|Treatment Period 2||20
6797715|NCT02832167|7729453|FG000|NOT COMPLETED|Treatment Period 2||83
6797716|NCT02829918|7729457|FG000|STARTED|Overall Study||54
6797717|NCT02829918|7729457|FG000|COMPLETED|Overall Study||46
6797718|NCT02829918|7729457|FG000|NOT COMPLETED|Overall Study||8
6797719|NCT02824198|7729463|FG000|STARTED|Overall Study||89
6797720|NCT02824198|7729464|FG001|STARTED|Overall Study||29
6797721|NCT02824198|7729463|FG000|COMPLETED|Overall Study||74
6797722|NCT02824198|7729464|FG001|COMPLETED|Overall Study||26
6797723|NCT02824198|7729463|FG000|NOT COMPLETED|Overall Study||15
6797724|NCT02824198|7729464|FG001|NOT COMPLETED|Overall Study||3
6797725|NCT02821754|7729475|FG000|STARTED|Overall Study||36
6797726|NCT02821754|7729476|FG001|STARTED|Overall Study||16
6797727|NCT02821754|7729477|FG002|STARTED|Overall Study|No results data were collected for these participants.|2
6797728|NCT02821754|7729475|FG000|COMPLETED|Overall Study||20
6797729|NCT02821754|7729476|FG001|COMPLETED|Overall Study||4
6797730|NCT02821754|7729477|FG002|COMPLETED|Overall Study||0
6797731|NCT02821754|7729475|FG000|NOT COMPLETED|Overall Study||16
6797732|NCT02821754|7729476|FG001|NOT COMPLETED|Overall Study||12
6797733|NCT02821754|7729477|FG002|NOT COMPLETED|Overall Study||2
6797734|NCT02787551|7729485|FG000|STARTED|Core Period: 26 Weeks||257
6797735|NCT02787551|7729486|FG001|STARTED|Core Period: 26 Weeks||257
6797736|NCT02787551|7729485|FG000|Treated|Core Period: 26 Weeks||255
6797737|NCT02787551|7729486|FG001|Treated|Core Period: 26 Weeks||256
6797738|NCT02787551|7729485|FG000|COMPLETED|Core Period: 26 Weeks|Out of 230 participants, 206 participants entered in single arm extension period.|230
6797739|NCT02787551|7729486|FG001|COMPLETED|Core Period: 26 Weeks||246
6797740|NCT02787551|7729485|FG000|NOT COMPLETED|Core Period: 26 Weeks||27
6797741|NCT02787551|7729486|FG001|NOT COMPLETED|Core Period: 26 Weeks||11
6797742|NCT02787551|7729485|FG000|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)|Participants who completed core period and met eligibility criteria for extension period.|206
6797743|NCT02787551|7729486|FG001|STARTED|Extension Period:26 Weeks(Upto 52 Weeks)||0
6797744|NCT02787551|7729485|FG000|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||197
6797745|NCT02787551|7729486|FG001|COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
6797746|NCT02787551|7729485|FG000|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||9
6797747|NCT02787551|7729486|FG001|NOT COMPLETED|Extension Period:26 Weeks(Upto 52 Weeks)||0
6797748|NCT02747121|7729497|FG000|STARTED|Overall Study||3594
6797749|NCT02747121|7729498|FG001|STARTED|Overall Study||3813
6797750|NCT02747121|7729497|FG000|COMPLETED|Overall Study||3594
6797751|NCT02747121|7729498|FG001|COMPLETED|Overall Study||3813
6797752|NCT02747121|7729497|FG000|NOT COMPLETED|Overall Study||0
6797753|NCT02747121|7729498|FG001|NOT COMPLETED|Overall Study||0
6797754|NCT02735044|7729506|FG000|STARTED|Overall Study||233
6797755|NCT02735044|7729507|FG001|STARTED|Overall Study||230
6797756|NCT02735044|7729506|FG000|Treated|Overall Study||233
6797757|NCT02735044|7729507|FG001|Treated|Overall Study||228
6797758|NCT02735044|7729506|FG000|COMPLETED|Overall Study||217
6797759|NCT02735044|7729507|FG001|COMPLETED|Overall Study||207
6797760|NCT02735044|7729506|FG000|NOT COMPLETED|Overall Study||16
6797761|NCT02735044|7729507|FG001|NOT COMPLETED|Overall Study||23
6797762|NCT02724410|7729515|FG000|STARTED|Overall Study||44
6797763|NCT02724410|7729516|FG001|STARTED|Overall Study||38
6797764|NCT02724410|7729515|FG000|COMPLETED|Overall Study||44
6797765|NCT02724410|7729516|FG001|COMPLETED|Overall Study||38
6797766|NCT02724410|7729515|FG000|NOT COMPLETED|Overall Study||0
6797767|NCT02724410|7729516|FG001|NOT COMPLETED|Overall Study||0
6797768|NCT02720744|7729524|FG000|STARTED|Overall Study||107
6797769|NCT02720744|7729525|FG001|STARTED|Overall Study||105
6797770|NCT02720744|7729524|FG000|COMPLETED|Overall Study||69
6797771|NCT02720744|7729525|FG001|COMPLETED|Overall Study||79
6797772|NCT02720744|7729524|FG000|NOT COMPLETED|Overall Study||38
6797773|NCT02720744|7729525|FG001|NOT COMPLETED|Overall Study||26
6797774|NCT02713867|7729533|FG000|STARTED|Randomization||180
6797775|NCT02713867|7729534|FG001|STARTED|Randomization||183
6797776|NCT02713867|7729533|FG000|COMPLETED|Randomization||178
6797777|NCT02713867|7729534|FG001|COMPLETED|Randomization||180
6797778|NCT02713867|7729533|FG000|NOT COMPLETED|Randomization||2
6797779|NCT02713867|7729534|FG001|NOT COMPLETED|Randomization||3
6797780|NCT02713867|7729533|FG000|STARTED|Treatment Period||178
6797781|NCT02713867|7729534|FG001|STARTED|Treatment Period||180
6797782|NCT02713867|7729533|FG000|COMPLETED|Treatment Period||31
6797783|NCT02713867|7729534|FG001|COMPLETED|Treatment Period||30
6797784|NCT02713867|7729533|FG000|NOT COMPLETED|Treatment Period||147
6797785|NCT02713867|7729534|FG001|NOT COMPLETED|Treatment Period||150
6797786|NCT02704403|7729542|FG000|STARTED|Overall Study||1437
6797787|NCT02704403|7729543|FG001|STARTED|Overall Study||720
6797788|NCT02704403|7729542|FG000|Full Intent-to-Treat Population|Overall Study||1437
6797789|NCT02704403|7729543|FG001|Full Intent-to-Treat Population|Overall Study||720
6797790|NCT02704403|7729542|FG000|Full Safety Population|Overall Study||1433
6797791|NCT02704403|7729543|FG001|Full Safety Population|Overall Study||717
6797792|NCT02704403|7729542|FG000|COMPLETED|Overall Study||0
6797793|NCT02704403|7729543|FG001|COMPLETED|Overall Study||0
6797794|NCT02704403|7729542|FG000|NOT COMPLETED|Overall Study||1437
6797795|NCT02704403|7729543|FG001|NOT COMPLETED|Overall Study||720
6797796|NCT02694185|7729551|FG000|STARTED|Overall Study||476
6797797|NCT02694185|7729552|FG001|STARTED|Overall Study||4793
6797798|NCT02694185|7729551|FG000|COMPLETED|Overall Study||431
6797799|NCT02694185|7729552|FG001|COMPLETED|Overall Study||4793
6797800|NCT02694185|7729551|FG000|NOT COMPLETED|Overall Study||45
6797801|NCT02694185|7729552|FG001|NOT COMPLETED|Overall Study||0
6797802|NCT02692651|7729560|FG000|STARTED|Study Treatment||70
6797803|NCT02692651|7729561|FG001|STARTED|Study Treatment||74
6797804|NCT02692651|7729560|FG000|COMPLETED|Study Treatment||54
6797805|NCT02692651|7729561|FG001|COMPLETED|Study Treatment||64
6797806|NCT02692651|7729560|FG000|NOT COMPLETED|Study Treatment||16
6797807|NCT02692651|7729561|FG001|NOT COMPLETED|Study Treatment||10
6797808|NCT02692651|7729560|FG000|STARTED|Post Study Treatment Follow-up||54
6797809|NCT02692651|7729561|FG001|STARTED|Post Study Treatment Follow-up||64
6797810|NCT02692651|7729560|FG000|COMPLETED|Post Study Treatment Follow-up||50
6797811|NCT02692651|7729561|FG001|COMPLETED|Post Study Treatment Follow-up||60
6379964|NCT00775671|7290674|FG000|STARTED|Overall Study||23
6379965|NCT00775671|7290675|FG001|STARTED|Overall Study||23
6379966|NCT00775671|7290674|FG000|COMPLETED|Overall Study||23
6379967|NCT00775671|7290675|FG001|COMPLETED|Overall Study||23
6379968|NCT00775671|7290674|FG000|NOT COMPLETED|Overall Study||0
6379969|NCT00775671|7290675|FG001|NOT COMPLETED|Overall Study||0
6379970|NCT00775684|7290684|FG000|STARTED|Overall Study||17
6379971|NCT00775684|7290685|FG001|STARTED|Overall Study||13
6379972|NCT00775684|7290686|FG002|STARTED|Overall Study||17
6379973|NCT00775684|7290684|FG000|COMPLETED|Overall Study||14
6379974|NCT00775684|7290685|FG001|COMPLETED|Overall Study||12
6379975|NCT00775684|7290686|FG002|COMPLETED|Overall Study||14
6379976|NCT00775684|7290684|FG000|NOT COMPLETED|Overall Study||3
6379977|NCT00775684|7290685|FG001|NOT COMPLETED|Overall Study||1
6379978|NCT00775684|7290686|FG002|NOT COMPLETED|Overall Study||3
6379979|NCT00775931|7290705|FG000|STARTED|Overall Study||6
6379980|NCT00775931|7290706|FG001|STARTED|Overall Study||1
6379981|NCT00775931|7290705|FG000|COMPLETED|Overall Study||6
6379982|NCT00775931|7290706|FG001|COMPLETED|Overall Study||1
6379983|NCT00775931|7290705|FG000|NOT COMPLETED|Overall Study||0
6379984|NCT00775931|7290706|FG001|NOT COMPLETED|Overall Study||0
6379985|NCT00775944|7290716|FG000|STARTED|Overall Study||648
6502346|NCT01434290|7421018|FG001|COMPLETED|Overall Study|Eligible subjects included in analysis|121
6502347|NCT01434290|7421017|FG000|NOT COMPLETED|Overall Study||8
6502348|NCT01434290|7421018|FG001|NOT COMPLETED|Overall Study||7
6502349|NCT01434342|7421027|FG000|STARTED|Overall Study||98
6502350|NCT01434342|7421028|FG001|STARTED|Overall Study||48
6502351|NCT01434342|7421027|FG000|COMPLETED|Overall Study||50
6502352|NCT01434342|7421028|FG001|COMPLETED|Overall Study||31
6502353|NCT01434342|7421027|FG000|NOT COMPLETED|Overall Study||48
6502354|NCT01434342|7421028|FG001|NOT COMPLETED|Overall Study||17
6502355|NCT01434472|7421034|FG000|STARTED|Overall Study||20
6502356|NCT01434472|7421034|FG000|COMPLETED|Overall Study||20
6502357|NCT01434472|7421034|FG000|NOT COMPLETED|Overall Study||0
6502358|NCT01434641|7421038|FG000|STARTED|Overall Study||102
6502359|NCT01434641|7421038|FG000|COMPLETED|Overall Study||102
6502360|NCT01434641|7421038|FG000|NOT COMPLETED|Overall Study||0
6502361|NCT01434654|7421044|FG000|STARTED|Overall Study||7
6502362|NCT01434654|7421045|FG001|STARTED|Overall Study||12
6502363|NCT01434654|7421044|FG000|COMPLETED|Overall Study||5
6502364|NCT01434654|7421045|FG001|COMPLETED|Overall Study||12
6502365|NCT01434654|7421044|FG000|NOT COMPLETED|Overall Study||2
6502366|NCT01434654|7421045|FG001|NOT COMPLETED|Overall Study||0
6502367|NCT01434667|7421055|FG000|STARTED|Overall Study||39
6502368|NCT01434667|7421056|FG001|STARTED|Overall Study||75
6502369|NCT01434667|7421055|FG000|COMPLETED|Overall Study||34
6502370|NCT01434667|7421056|FG001|COMPLETED|Overall Study||65
6502371|NCT01434667|7421055|FG000|NOT COMPLETED|Overall Study||5
6502372|NCT01434667|7421056|FG001|NOT COMPLETED|Overall Study||10
6502373|NCT01434680|7421066|FG000|STARTED|Overall Study||299
6502374|NCT01434680|7421067|FG001|STARTED|Overall Study||268
6502375|NCT01434680|7421068|FG002|STARTED|Overall Study||306
6502376|NCT01434680|7421069|FG003|STARTED|Overall Study||119
6502377|NCT01434680|7421066|FG000|COMPLETED|Overall Study||296
6502378|NCT01434680|7421067|FG001|COMPLETED|Overall Study||266
6502379|NCT01434680|7421068|FG002|COMPLETED|Overall Study||304
6502380|NCT01434680|7421069|FG003|COMPLETED|Overall Study||119
6502381|NCT01434680|7421066|FG000|NOT COMPLETED|Overall Study||3
6502382|NCT01434680|7421067|FG001|NOT COMPLETED|Overall Study||2
6502383|NCT01434680|7421068|FG002|NOT COMPLETED|Overall Study||2
6502384|NCT01434680|7421069|FG003|NOT COMPLETED|Overall Study||0
6502385|NCT01434693|7421083|FG000|STARTED|Overall Study||9
6502386|NCT01434693|7421084|FG001|STARTED|Overall Study||9
6502387|NCT01434693|7421085|FG002|STARTED|Overall Study||9
6502388|NCT01434693|7421086|FG003|STARTED|Overall Study||9
6502389|NCT01434693|7421083|FG000|COMPLETED|Overall Study||6
6502390|NCT01434693|7421084|FG001|COMPLETED|Overall Study||9
6502391|NCT01434693|7421085|FG002|COMPLETED|Overall Study||8
6502392|NCT01434693|7421086|FG003|COMPLETED|Overall Study||8
6502393|NCT01434693|7421083|FG000|NOT COMPLETED|Overall Study||3
6502394|NCT01434693|7421084|FG001|NOT COMPLETED|Overall Study||0
6502395|NCT01434693|7421085|FG002|NOT COMPLETED|Overall Study||1
6502396|NCT01434693|7421086|FG003|NOT COMPLETED|Overall Study||1
6502397|NCT01434810|7421098|FG000|STARTED|Overall Study||224
6379986|NCT00775944|7290717|FG001|STARTED|Overall Study||647
6379987|NCT00775944|7290718|FG002|STARTED|Overall Study||648
6379988|NCT00775944|7290719|FG003|STARTED|Overall Study||648
6502398|NCT01434810|7421099|FG001|STARTED|Overall Study||223
6502399|NCT01434810|7421098|FG000|COMPLETED|Overall Study||201
6502400|NCT01434810|7421099|FG001|COMPLETED|Overall Study||213
6797812|NCT02692651|7729560|FG000|NOT COMPLETED|Post Study Treatment Follow-up||4
6797813|NCT02692651|7729561|FG001|NOT COMPLETED|Post Study Treatment Follow-up||4
6797814|NCT02674061|7729569|FG000|STARTED|Overall Study||285
6797815|NCT02674061|7729570|FG001|STARTED|Overall Study||91
6797816|NCT02674061|7729569|FG000|COMPLETED|Overall Study||0
6797817|NCT02674061|7729570|FG001|COMPLETED|Overall Study||0
6797818|NCT02674061|7729569|FG000|NOT COMPLETED|Overall Study||285
6797819|NCT02674061|7729570|FG001|NOT COMPLETED|Overall Study||91
6797820|NCT02656706|7729578|FG000|STARTED|Overall Study||22
6797821|NCT02656706|7729578|FG000|COMPLETED|Overall Study||21
6797822|NCT02656706|7729578|FG000|NOT COMPLETED|Overall Study||1
6797823|NCT02654314|7729584|FG000|STARTED|Overall Study||136
6797824|NCT02654314|7729585|FG001|STARTED|Overall Study||141
6797825|NCT02654314|7729584|FG000|COMPLETED|Overall Study||136
6797826|NCT02654314|7729585|FG001|COMPLETED|Overall Study||141
6797827|NCT02654314|7729584|FG000|NOT COMPLETED|Overall Study||0
6797828|NCT02654314|7729585|FG001|NOT COMPLETED|Overall Study||0
6797829|NCT02642042|7729591|FG000|STARTED|Overall Study||54
6797830|NCT02642042|7729591|FG000|COMPLETED|Overall Study||0
6797831|NCT02642042|7729591|FG000|NOT COMPLETED|Overall Study||54
6797832|NCT02628444|7729598|FG000|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||350
6797833|NCT02628444|7729599|FG001|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||348
6797834|NCT02628444|7729600|FG002|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||352
6797835|NCT02628444|7729601|FG003|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797836|NCT02628444|7729602|FG004|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797837|NCT02628444|7729603|FG005|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797838|NCT02628444|7729604|FG006|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797839|NCT02628444|7729605|FG007|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797840|NCT02628444|7729606|FG008|STARTED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797841|NCT02628444|7729598|FG000|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
6797842|NCT02628444|7729599|FG001|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||348
6797843|NCT02628444|7729600|FG002|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||352
6395585|NCT00859222|7308174|FG001|STARTED|Overall Study||3
6797844|NCT02628444|7729601|FG003|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797845|NCT02628444|7729602|FG004|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797846|NCT02628444|7729603|FG005|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797847|NCT02628444|7729604|FG006|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797848|NCT02628444|7729605|FG007|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797849|NCT02628444|7729606|FG008|Vaccinated|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797850|NCT02628444|7729598|FG000|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||333
6797851|NCT02628444|7729599|FG001|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||328
6797852|NCT02628444|7729600|FG002|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||332
6564092|NCT01809262|7486882|FG007|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6564093|NCT01809262|7486883|FG008|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6564094|NCT01809262|7486884|FG009|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
6564095|NCT01809262|7486875|FG000|STARTED|Period 3 (Third Dose + Washout)||4
6797853|NCT02628444|7729601|FG003|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797854|NCT02628444|7729602|FG004|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797855|NCT02628444|7729603|FG005|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797856|NCT02628444|7729604|FG006|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797857|NCT02628444|7729605|FG007|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797858|NCT02628444|7729606|FG008|Full Analysis Set (FAS)|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797859|NCT02628444|7729598|FG000|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||314
6797860|NCT02628444|7729599|FG001|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||309
6797861|NCT02628444|7729600|FG002|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||310
6797862|NCT02628444|7729601|FG003|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797863|NCT02628444|7729602|FG004|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797864|NCT02628444|7729603|FG005|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797865|NCT02628444|7729604|FG006|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797866|NCT02628444|7729605|FG007|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797867|NCT02628444|7729606|FG008|COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6379989|NCT00775944|7290716|FG000|COMPLETED|Overall Study|15 participants withdrew consent|633
6379990|NCT00775944|7290717|FG001|COMPLETED|Overall Study|9 participants withdrew consent|638
6379991|NCT00775944|7290718|FG002|COMPLETED|Overall Study|16 participants withdrew consent|632
6797868|NCT02628444|7729598|FG000|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||36
6797869|NCT02628444|7729599|FG001|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||39
6797870|NCT02628444|7729600|FG002|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||42
6797871|NCT02628444|7729601|FG003|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797872|NCT02628444|7729602|FG004|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797873|NCT02628444|7729603|FG005|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6379992|NCT00775944|7290719|FG003|COMPLETED|Overall Study|16 participants withdrew consent|632
6379993|NCT00775944|7290716|FG000|NOT COMPLETED|Overall Study||15
6379994|NCT00775944|7290717|FG001|NOT COMPLETED|Overall Study||9
6379995|NCT00775944|7290718|FG002|NOT COMPLETED|Overall Study||16
6379996|NCT00775944|7290719|FG003|NOT COMPLETED|Overall Study||16
6379997|NCT00775983|7290731|FG000|STARTED|Overall Study||36
6797874|NCT02628444|7729604|FG006|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797875|NCT02628444|7729605|FG007|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797876|NCT02628444|7729606|FG008|NOT COMPLETED|Stage-I(24M:12M Treatment+12M Follow-up)||0
6797877|NCT02628444|7729598|FG000|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797878|NCT02628444|7729599|FG001|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797879|NCT02628444|7729600|FG002|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797880|NCT02628444|7729601|FG003|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||145
6797881|NCT02628444|7729602|FG004|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
6797882|NCT02628444|7729603|FG005|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||157
6379998|NCT00775983|7290732|FG001|STARTED|Overall Study||36
6379999|NCT00775983|7290731|FG000|COMPLETED|Overall Study||35
6380000|NCT00775983|7290732|FG001|COMPLETED|Overall Study||34
6380001|NCT00775983|7290731|FG000|NOT COMPLETED|Overall Study||1
6502401|NCT01434810|7421098|FG000|NOT COMPLETED|Overall Study||23
6502402|NCT01434810|7421099|FG001|NOT COMPLETED|Overall Study||10
6502403|NCT01434823|7421107|FG000|STARTED|Overall Study||824
6502404|NCT01434823|7421108|FG001|STARTED|Overall Study||785
6502405|NCT01434823|7421107|FG000|COMPLETED|Overall Study||820
6502406|NCT01434823|7421108|FG001|COMPLETED|Overall Study||778
6502407|NCT01434823|7421107|FG000|NOT COMPLETED|Overall Study||4
6502408|NCT01434823|7421108|FG001|NOT COMPLETED|Overall Study||7
6502409|NCT01435018|7421118|FG000|STARTED|Overall Study||135
6502410|NCT01435018|7421119|FG001|STARTED|Overall Study||60
6502411|NCT01435018|7421120|FG002|STARTED|Overall Study||139
6502412|NCT01435018|7421118|FG000|COMPLETED|Overall Study||88
6502413|NCT01435018|7421119|FG001|COMPLETED|Overall Study||26
6502414|NCT01435018|7421120|FG002|COMPLETED|Overall Study||98
6797883|NCT02628444|7729604|FG006|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||149
6797884|NCT02628444|7729605|FG007|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||152
6797885|NCT02628444|7729606|FG008|STARTED|STAGE-II(18M:12M Treatment+6M Follow-up)||151
6797886|NCT02628444|7729598|FG000|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797887|NCT02628444|7729599|FG001|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797888|NCT02628444|7729600|FG002|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797889|NCT02628444|7729601|FG003|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||55
6797890|NCT02628444|7729602|FG004|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||59
6797891|NCT02628444|7729603|FG005|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||62
6797892|NCT02628444|7729604|FG006|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
6797893|NCT02628444|7729605|FG007|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||56
6797894|NCT02628444|7729606|FG008|Vaccinated|STAGE-II(18M:12M Treatment+6M Follow-up)||53
6502415|NCT01435018|7421118|FG000|NOT COMPLETED|Overall Study||47
6502416|NCT01435018|7421119|FG001|NOT COMPLETED|Overall Study||34
6502417|NCT01435018|7421120|FG002|NOT COMPLETED|Overall Study||41
6502418|NCT01435031|7421130|FG000|STARTED|ITT at 1 Month|ITT population|222
6502419|NCT01435031|7421130|FG000|COMPLETED|ITT at 1 Month||216
6502420|NCT01435031|7421130|FG000|NOT COMPLETED|ITT at 1 Month||6
6502421|NCT01435031|7421130|FG000|STARTED|ITT at 6 Months||216
6502422|NCT01435031|7421130|FG000|COMPLETED|ITT at 6 Months||211
6797895|NCT02628444|7729598|FG000|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797896|NCT02628444|7729599|FG001|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797897|NCT02628444|7729600|FG002|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797898|NCT02628444|7729601|FG003|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||55
6797899|NCT02628444|7729602|FG004|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||59
6797900|NCT02628444|7729603|FG005|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||62
6797901|NCT02628444|7729604|FG006|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||53
6797902|NCT02628444|7729605|FG007|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||54
6797903|NCT02628444|7729606|FG008|COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||52
6797904|NCT02628444|7729598|FG000|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797905|NCT02628444|7729599|FG001|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797906|NCT02628444|7729600|FG002|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||0
6797907|NCT02628444|7729601|FG003|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||90
6797908|NCT02628444|7729602|FG004|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||93
6797909|NCT02628444|7729603|FG005|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||95
6797910|NCT02628444|7729604|FG006|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||96
6797911|NCT02628444|7729605|FG007|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||98
6797912|NCT02628444|7729606|FG008|NOT COMPLETED|STAGE-II(18M:12M Treatment+6M Follow-up)||99
6380002|NCT00775983|7290732|FG001|NOT COMPLETED|Overall Study||2
6380003|NCT00776009|7290744|FG000|STARTED|Period 1: First Intervention||26
6380004|NCT00776009|7290745|FG001|STARTED|Period 1: First Intervention||28
6380005|NCT00776009|7290746|FG002|STARTED|Period 1: First Intervention||29
6564096|NCT01809262|7486876|FG001|STARTED|Period 3 (Third Dose + Washout)||4
6564097|NCT01809262|7486877|FG002|STARTED|Period 3 (Third Dose + Washout)||4
6564098|NCT01809262|7486878|FG003|STARTED|Period 3 (Third Dose + Washout)||3
6564099|NCT01809262|7486879|FG004|STARTED|Period 3 (Third Dose + Washout)||3
6797913|NCT02623998|7729633|FG000|STARTED|Overall Study||50
6380006|NCT00776009|7290747|FG003|STARTED|Period 1: First Intervention||27
6380007|NCT00776009|7290748|FG004|STARTED|Period 1: First Intervention||28
6380008|NCT00776009|7290749|FG005|STARTED|Period 1: First Intervention||27
6380009|NCT00776009|7290744|FG000|COMPLETED|Period 1: First Intervention||26
6380010|NCT00776009|7290745|FG001|COMPLETED|Period 1: First Intervention||27
6380011|NCT00776009|7290746|FG002|COMPLETED|Period 1: First Intervention||28
6380012|NCT00776009|7290747|FG003|COMPLETED|Period 1: First Intervention||27
6380013|NCT00776009|7290748|FG004|COMPLETED|Period 1: First Intervention||26
6380014|NCT00776009|7290749|FG005|COMPLETED|Period 1: First Intervention||27
6380015|NCT00776009|7290744|FG000|NOT COMPLETED|Period 1: First Intervention||0
6380016|NCT00776009|7290745|FG001|NOT COMPLETED|Period 1: First Intervention||1
6380017|NCT00776009|7290746|FG002|NOT COMPLETED|Period 1: First Intervention||1
6380018|NCT00776009|7290747|FG003|NOT COMPLETED|Period 1: First Intervention||0
6380019|NCT00776009|7290748|FG004|NOT COMPLETED|Period 1: First Intervention||2
6380020|NCT00776009|7290749|FG005|NOT COMPLETED|Period 1: First Intervention||0
6380021|NCT00776009|7290744|FG000|STARTED|Period 2: Second Intervention||26
6380022|NCT00776009|7290745|FG001|STARTED|Period 2: Second Intervention||27
6380023|NCT00776009|7290746|FG002|STARTED|Period 2: Second Intervention||28
6380024|NCT00776009|7290747|FG003|STARTED|Period 2: Second Intervention||27
6380025|NCT00776009|7290748|FG004|STARTED|Period 2: Second Intervention||26
6380026|NCT00776009|7290749|FG005|STARTED|Period 2: Second Intervention||27
6380027|NCT00776009|7290744|FG000|COMPLETED|Period 2: Second Intervention||25
6380028|NCT00776009|7290745|FG001|COMPLETED|Period 2: Second Intervention||27
6380029|NCT00776009|7290746|FG002|COMPLETED|Period 2: Second Intervention||27
6380030|NCT00776009|7290747|FG003|COMPLETED|Period 2: Second Intervention||27
6380031|NCT00776009|7290748|FG004|COMPLETED|Period 2: Second Intervention||26
6380032|NCT00776009|7290749|FG005|COMPLETED|Period 2: Second Intervention||26
6380033|NCT00776009|7290744|FG000|NOT COMPLETED|Period 2: Second Intervention||1
6380034|NCT00776009|7290745|FG001|NOT COMPLETED|Period 2: Second Intervention||0
6380035|NCT00776009|7290746|FG002|NOT COMPLETED|Period 2: Second Intervention||1
6380036|NCT00776009|7290747|FG003|NOT COMPLETED|Period 2: Second Intervention||0
6380037|NCT00776009|7290748|FG004|NOT COMPLETED|Period 2: Second Intervention||0
6380038|NCT00776009|7290749|FG005|NOT COMPLETED|Period 2: Second Intervention||1
6380039|NCT00776009|7290744|FG000|STARTED|Period 3: Third Intervention||25
6380040|NCT00776009|7290745|FG001|STARTED|Period 3: Third Intervention||27
6380041|NCT00776009|7290746|FG002|STARTED|Period 3: Third Intervention||27
6380042|NCT00776009|7290747|FG003|STARTED|Period 3: Third Intervention||27
6380043|NCT00776009|7290748|FG004|STARTED|Period 3: Third Intervention||26
6797914|NCT02623998|7729634|FG001|STARTED|Overall Study||52
6797915|NCT02623998|7729633|FG000|COMPLETED|Overall Study||48
6797916|NCT02623998|7729634|FG001|COMPLETED|Overall Study||51
6797917|NCT02623998|7729633|FG000|NOT COMPLETED|Overall Study||2
6797918|NCT02623998|7729634|FG001|NOT COMPLETED|Overall Study||1
6797919|NCT02623725|7729642|FG000|STARTED|Overall Study||187
6797920|NCT02623725|7729643|FG001|STARTED|Overall Study||64
6797921|NCT02623725|7729642|FG000|COMPLETED|Overall Study||171
6797922|NCT02623725|7729643|FG001|COMPLETED|Overall Study||58
6797923|NCT02623725|7729642|FG000|NOT COMPLETED|Overall Study||16
6797924|NCT02623725|7729643|FG001|NOT COMPLETED|Overall Study||6
6797925|NCT02608684|7729651|FG000|STARTED|Overall Study||21
6797926|NCT02608684|7729651|FG000|COMPLETED|Overall Study||18
6797927|NCT02608684|7729651|FG000|NOT COMPLETED|Overall Study||3
6380044|NCT00776009|7290749|FG005|STARTED|Period 3: Third Intervention||26
6380045|NCT00776009|7290744|FG000|COMPLETED|Period 3: Third Intervention||24
6380046|NCT00776009|7290745|FG001|COMPLETED|Period 3: Third Intervention||27
6380047|NCT00776009|7290746|FG002|COMPLETED|Period 3: Third Intervention||27
6380048|NCT00776009|7290747|FG003|COMPLETED|Period 3: Third Intervention||27
6380049|NCT00776009|7290748|FG004|COMPLETED|Period 3: Third Intervention||26
6380050|NCT00776009|7290749|FG005|COMPLETED|Period 3: Third Intervention||26
6380051|NCT00776009|7290744|FG000|NOT COMPLETED|Period 3: Third Intervention||1
6380052|NCT00776009|7290745|FG001|NOT COMPLETED|Period 3: Third Intervention||0
6380053|NCT00776009|7290746|FG002|NOT COMPLETED|Period 3: Third Intervention||0
6380054|NCT00776009|7290747|FG003|NOT COMPLETED|Period 3: Third Intervention||0
6380055|NCT00776009|7290748|FG004|NOT COMPLETED|Period 3: Third Intervention||0
6380056|NCT00776009|7290749|FG005|NOT COMPLETED|Period 3: Third Intervention||0
6380057|NCT00776230|7290760|FG000|STARTED|Overall Study||99
6380058|NCT00776230|7290761|FG001|STARTED|Overall Study||103
6380059|NCT00776230|7290762|FG002|STARTED|Overall Study||102
6380060|NCT00776230|7290760|FG000|Enrolled and Vaccinated at Day 0|Overall Study||98
6380061|NCT00776230|7290761|FG001|Enrolled and Vaccinated at Day 0|Overall Study||103
6380062|NCT00776230|7290762|FG002|Enrolled and Vaccinated at Day 0|Overall Study||102
6380063|NCT00776230|7290760|FG000|COMPLETED|Overall Study||96
6380064|NCT00776230|7290761|FG001|COMPLETED|Overall Study||100
6380065|NCT00776230|7290762|FG002|COMPLETED|Overall Study||97
6380066|NCT00776230|7290760|FG000|NOT COMPLETED|Overall Study||3
6380067|NCT00776230|7290761|FG001|NOT COMPLETED|Overall Study||3
6380068|NCT00776230|7290762|FG002|NOT COMPLETED|Overall Study||5
6380069|NCT00776295|7290770|FG000|STARTED|Overall Study||2
6380070|NCT00776295|7290770|FG000|COMPLETED|Overall Study||2
6380071|NCT00776295|7290770|FG000|NOT COMPLETED|Overall Study||0
6380072|NCT00776594|7290776|FG000|STARTED|Overall Study||66
6380073|NCT00776594|7290777|FG001|STARTED|Overall Study||36
6380074|NCT00776594|7290776|FG000|COMPLETED|Overall Study||62
6380075|NCT00776594|7290777|FG001|COMPLETED|Overall Study||34
6380076|NCT00776594|7290776|FG000|NOT COMPLETED|Overall Study||4
6380077|NCT00776594|7290777|FG001|NOT COMPLETED|Overall Study||2
6380078|NCT00776659|7290785|FG000|STARTED|Overall Study||39
6380079|NCT00776659|7290785|FG000|COMPLETED|Overall Study||13
6380080|NCT00776659|7290785|FG000|NOT COMPLETED|Overall Study||26
6380081|NCT00776789|7290791|FG000|STARTED|Overall Study||20
6380082|NCT00776789|7290792|FG001|STARTED|Overall Study||21
6380083|NCT00776789|7290791|FG000|COMPLETED|Overall Study||17
6380084|NCT00776789|7290792|FG001|COMPLETED|Overall Study||18
6380085|NCT00776789|7290791|FG000|NOT COMPLETED|Overall Study||3
6797928|NCT02603887|7729655|FG000|STARTED|Stage 1||12
6797929|NCT02603887|7729655|FG000|Cycle 1|Stage 1||12
6797930|NCT02603887|7729655|FG000|Cycle 8|Stage 1||7
6797931|NCT02603887|7729655|FG000|COMPLETED|Stage 1||7
6797932|NCT02603887|7729655|FG000|NOT COMPLETED|Stage 1||5
6380086|NCT00776789|7290792|FG001|NOT COMPLETED|Overall Study||3
6380087|NCT00776919|7290804|FG000|STARTED|Overall Study||327
6380088|NCT00776919|7290805|FG001|STARTED|Overall Study||328
6380089|NCT00776919|7290806|FG002|STARTED|Overall Study||328
6380090|NCT00776919|7290807|FG003|STARTED|Overall Study||332
6380091|NCT00776919|7290804|FG000|COMPLETED|Overall Study||300
6380092|NCT00776919|7290805|FG001|COMPLETED|Overall Study||295
6380093|NCT00776919|7290806|FG002|COMPLETED|Overall Study||296
6380094|NCT00776919|7290807|FG003|COMPLETED|Overall Study||293
6380095|NCT00776919|7290804|FG000|NOT COMPLETED|Overall Study||27
6380096|NCT00776919|7290805|FG001|NOT COMPLETED|Overall Study||33
6380097|NCT00776919|7290806|FG002|NOT COMPLETED|Overall Study||32
6380098|NCT00776919|7290807|FG003|NOT COMPLETED|Overall Study||39
6564100|NCT01809262|7486880|FG005|STARTED|Period 3 (Third Dose + Washout)||3
6564101|NCT01809262|7486881|FG006|STARTED|Period 3 (Third Dose + Washout)||3
6564102|NCT01809262|7486882|FG007|STARTED|Period 3 (Third Dose + Washout)||4
6564103|NCT01809262|7486883|FG008|STARTED|Period 3 (Third Dose + Washout)||3
6564104|NCT01809262|7486884|FG009|STARTED|Period 3 (Third Dose + Washout)||4
6380099|NCT00776984|7290819|FG000|STARTED|Overall Study||234
6380100|NCT00776984|7290820|FG001|STARTED|Overall Study||219
6380101|NCT00776984|7290819|FG000|COMPLETED|Overall Study||203
6380102|NCT00776984|7290820|FG001|COMPLETED|Overall Study||198
6380103|NCT00776984|7290819|FG000|NOT COMPLETED|Overall Study||31
6380104|NCT00776984|7290820|FG001|NOT COMPLETED|Overall Study||21
6380105|NCT00776997|7290826|FG000|STARTED|Overall Study||100
6380106|NCT00776997|7290826|FG000|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
6380107|NCT00776997|7290826|FG000|NOT COMPLETED|Overall Study||2
6380108|NCT00777023|7290833|FG000|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
6380109|NCT00777023|7290834|FG001|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
6380110|NCT00777023|7290835|FG002|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
6380111|NCT00777023|7290833|FG000|COMPLETED|Overall Study||151
6564105|NCT01809262|7486875|FG000|COMPLETED|Period 3 (Third Dose + Washout)||4
6797933|NCT02603887|7729655|FG000|STARTED|Stage 2||1
6380112|NCT00777023|7290834|FG001|COMPLETED|Overall Study||149
6380113|NCT00777023|7290835|FG002|COMPLETED|Overall Study||146
6380114|NCT00777023|7290833|FG000|NOT COMPLETED|Overall Study||35
6380115|NCT00777023|7290834|FG001|NOT COMPLETED|Overall Study||41
6380116|NCT00777023|7290835|FG002|NOT COMPLETED|Overall Study||37
6380117|NCT00777049|7290845|FG000|STARTED|Overall Study||33
6380118|NCT00777049|7290846|FG001|STARTED|Overall Study||21
6380119|NCT00777049|7290845|FG000|COMPLETED|Overall Study||32
6797934|NCT02603887|7729655|FG000|Cycle 1|Stage 2||1
6797935|NCT02603887|7729655|FG000|Cycle 8|Stage 2||0
6797936|NCT02603887|7729655|FG000|COMPLETED|Stage 2||0
6797937|NCT02603887|7729655|FG000|NOT COMPLETED|Stage 2||1
6797938|NCT02601209|7729666|FG000|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
6797939|NCT02601209|7729667|FG001|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
6797940|NCT02601209|7729668|FG002|STARTED|Initial Treatment (Up to 4 Months)|Pre-registered|4
6797941|NCT02601209|7729669|FG003|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
6797942|NCT02601209|7729670|FG004|STARTED|Initial Treatment (Up to 4 Months)|Randomized|13
6797943|NCT02601209|7729671|FG005|STARTED|Initial Treatment (Up to 4 Months)|Randomized|15
6797944|NCT02601209|7729672|FG006|STARTED|Initial Treatment (Up to 4 Months)|Randomized|56
6797945|NCT02601209|7729673|FG007|STARTED|Initial Treatment (Up to 4 Months)|Randomized|6
6797946|NCT02601209|7729674|FG008|STARTED|Initial Treatment (Up to 4 Months)|Randomized|43
6797947|NCT02601209|7729666|FG000|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
6797948|NCT02601209|7729667|FG001|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
6797949|NCT02601209|7729668|FG002|COMPLETED|Initial Treatment (Up to 4 Months)|Registered|3
6380120|NCT00777049|7290846|FG001|COMPLETED|Overall Study||20
6380121|NCT00777049|7290845|FG000|NOT COMPLETED|Overall Study||1
6380122|NCT00777049|7290846|FG001|NOT COMPLETED|Overall Study||1
6797950|NCT02601209|7729669|FG003|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
6797951|NCT02601209|7729670|FG004|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|12
6797952|NCT02601209|7729671|FG005|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|13
6797953|NCT02601209|7729672|FG006|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|55
6797954|NCT02601209|7729673|FG007|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|6
6797955|NCT02601209|7729674|FG008|COMPLETED|Initial Treatment (Up to 4 Months)|Received treatment; included in safety analysis|43
6797956|NCT02601209|7729666|FG000|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6797957|NCT02601209|7729667|FG001|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6797958|NCT02601209|7729668|FG002|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6797959|NCT02601209|7729669|FG003|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
6797960|NCT02601209|7729670|FG004|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6797961|NCT02601209|7729671|FG005|NOT COMPLETED|Initial Treatment (Up to 4 Months)||2
6797962|NCT02601209|7729672|FG006|NOT COMPLETED|Initial Treatment (Up to 4 Months)||1
6797963|NCT02601209|7729673|FG007|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
6797964|NCT02601209|7729674|FG008|NOT COMPLETED|Initial Treatment (Up to 4 Months)||0
6797965|NCT02601209|7729666|FG000|STARTED|Optional Crossover (Up to 2 Months)||0
6797966|NCT02601209|7729667|FG001|STARTED|Optional Crossover (Up to 2 Months)||0
6797967|NCT02601209|7729668|FG002|STARTED|Optional Crossover (Up to 2 Months)||0
6797968|NCT02601209|7729669|FG003|STARTED|Optional Crossover (Up to 2 Months)||0
6797969|NCT02601209|7729670|FG004|STARTED|Optional Crossover (Up to 2 Months)||0
6797970|NCT02601209|7729671|FG005|STARTED|Optional Crossover (Up to 2 Months)||0
6797971|NCT02601209|7729672|FG006|STARTED|Optional Crossover (Up to 2 Months)||0
6797972|NCT02601209|7729673|FG007|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|6
6797973|NCT02601209|7729674|FG008|STARTED|Optional Crossover (Up to 2 Months)|PD on pazopanib|43
6797974|NCT02601209|7729666|FG000|COMPLETED|Optional Crossover (Up to 2 Months)||0
6797975|NCT02601209|7729667|FG001|COMPLETED|Optional Crossover (Up to 2 Months)||0
6797976|NCT02601209|7729668|FG002|COMPLETED|Optional Crossover (Up to 2 Months)||0
6797977|NCT02601209|7729669|FG003|COMPLETED|Optional Crossover (Up to 2 Months)||0
6797978|NCT02601209|7729670|FG004|COMPLETED|Optional Crossover (Up to 2 Months)||0
6797979|NCT02601209|7729671|FG005|COMPLETED|Optional Crossover (Up to 2 Months)||0
6797980|NCT02601209|7729672|FG006|COMPLETED|Optional Crossover (Up to 2 Months)||0
6797981|NCT02601209|7729673|FG007|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|4
6380123|NCT00777062|7290854|FG000|STARTED|Overall Study||39
6380124|NCT00777062|7290855|FG001|STARTED|Overall Study||41
6380125|NCT00777062|7290854|FG000|COMPLETED|Overall Study||36
6380126|NCT00777062|7290855|FG001|COMPLETED|Overall Study||36
6380127|NCT00777062|7290854|FG000|NOT COMPLETED|Overall Study||3
6380128|NCT00777062|7290855|FG001|NOT COMPLETED|Overall Study||5
6380129|NCT00777088|7290861|FG000|STARTED|Overall Study||108
6380130|NCT00777088|7290861|FG000|COMPLETED|Overall Study||107
6380131|NCT00777088|7290861|FG000|NOT COMPLETED|Overall Study||1
6380132|NCT00777101|7290868|FG000|STARTED|Overall Study||117
6380133|NCT00777101|7290869|FG001|STARTED|Overall Study||116
6380134|NCT00777101|7290868|FG000|Treated|Overall Study||116
6380135|NCT00777101|7290869|FG001|Treated|Overall Study||115
6380136|NCT00777101|7290868|FG000|COMPLETED|Overall Study||55
6380137|NCT00777101|7290869|FG001|COMPLETED|Overall Study||65
6380138|NCT00777101|7290868|FG000|NOT COMPLETED|Overall Study||62
6380139|NCT00777101|7290869|FG001|NOT COMPLETED|Overall Study||51
6380140|NCT00777153|7290879|FG000|STARTED|Overall Study||131
6502423|NCT01435031|7421130|FG000|NOT COMPLETED|ITT at 6 Months||5
6380141|NCT00777153|7290880|FG001|STARTED|Overall Study||129
6380142|NCT00777153|7290881|FG002|STARTED|Overall Study||65
6380143|NCT00777153|7290879|FG000|COMPLETED|Overall Study||41
6380144|NCT00777153|7290880|FG001|COMPLETED|Overall Study||46
6380145|NCT00777153|7290881|FG002|COMPLETED|Overall Study||28
6380146|NCT00777153|7290879|FG000|NOT COMPLETED|Overall Study||90
6380147|NCT00777153|7290880|FG001|NOT COMPLETED|Overall Study||83
6380148|NCT00777153|7290881|FG002|NOT COMPLETED|Overall Study||37
6380149|NCT00777179|7290895|FG000|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
6380150|NCT00777179|7290896|FG001|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
6380151|NCT00777179|7290895|FG000|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
6380152|NCT00777179|7290896|FG001|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
6380153|NCT00777179|7290895|FG000|NOT COMPLETED|Overall Study||0
6380154|NCT00777179|7290896|FG001|NOT COMPLETED|Overall Study||0
6380155|NCT00777205|7290904|FG000|STARTED|Overall Study||243
6380156|NCT00777205|7290905|FG001|STARTED|Overall Study||200
6380157|NCT00777205|7290904|FG000|Intervention Interruption|Overall Study||0
6380158|NCT00777205|7290905|FG001|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
6380159|NCT00777205|7290904|FG000|COMPLETED|Overall Study||212
6380160|NCT00777205|7290905|FG001|COMPLETED|Overall Study||129
6380161|NCT00777205|7290904|FG000|NOT COMPLETED|Overall Study||31
6380162|NCT00777205|7290905|FG001|NOT COMPLETED|Overall Study||71
6380163|NCT00777257|7290916|FG000|STARTED|Overall Study||444
6380164|NCT00777257|7290917|FG001|STARTED|Overall Study||450
6380165|NCT00777257|7290918|FG002|STARTED|Overall Study||451
6380166|NCT00777257|7290916|FG000|COMPLETED|Overall Study||433
6380167|NCT00777257|7290917|FG001|COMPLETED|Overall Study||438
6380168|NCT00777257|7290918|FG002|COMPLETED|Overall Study||442
6380169|NCT00777257|7290916|FG000|NOT COMPLETED|Overall Study||11
6380170|NCT00777257|7290917|FG001|NOT COMPLETED|Overall Study||12
6380171|NCT00777257|7290918|FG002|NOT COMPLETED|Overall Study||9
6380172|NCT00777296|7290930|FG000|STARTED|Overall Study||21
6380173|NCT00777296|7290931|FG001|STARTED|Overall Study||11
6380174|NCT00777296|7290932|FG002|STARTED|Overall Study||23
6380175|NCT00777296|7290933|FG003|STARTED|Overall Study||11
6380176|NCT00777296|7290930|FG000|COMPLETED|Overall Study||20
6380177|NCT00777296|7290931|FG001|COMPLETED|Overall Study||10
6380178|NCT00777296|7290932|FG002|COMPLETED|Overall Study||21
6380179|NCT00777296|7290933|FG003|COMPLETED|Overall Study||10
6380180|NCT00777296|7290930|FG000|NOT COMPLETED|Overall Study||1
6797982|NCT02601209|7729674|FG008|COMPLETED|Optional Crossover (Up to 2 Months)|Initiated crossover to MLN0128 following PD on pazopanib|26
6797983|NCT02601209|7729666|FG000|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6797984|NCT02601209|7729667|FG001|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6797985|NCT02601209|7729668|FG002|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6797986|NCT02601209|7729669|FG003|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6797987|NCT02601209|7729670|FG004|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6797988|NCT02601209|7729671|FG005|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6797989|NCT02601209|7729672|FG006|NOT COMPLETED|Optional Crossover (Up to 2 Months)||0
6797990|NCT02601209|7729673|FG007|NOT COMPLETED|Optional Crossover (Up to 2 Months)||2
6797991|NCT02601209|7729674|FG008|NOT COMPLETED|Optional Crossover (Up to 2 Months)||17
6797992|NCT02587520|7729706|FG000|STARTED|Overall Study||80
6797993|NCT02587520|7729707|FG001|STARTED|Overall Study||71
6797994|NCT02587520|7729708|FG002|STARTED|Overall Study||78
6797995|NCT02587520|7729709|FG003|STARTED|Overall Study||79
6797996|NCT02587520|7729710|FG004|STARTED|Overall Study||75
6797997|NCT02587520|7729711|FG005|STARTED|Overall Study||75
6797998|NCT02587520|7729712|FG006|STARTED|Overall Study||76
6797999|NCT02587520|7729713|FG007|STARTED|Overall Study||73
6798000|NCT02587520|7729714|FG008|STARTED|Overall Study||76
6380181|NCT00777296|7290931|FG001|NOT COMPLETED|Overall Study||1
6380182|NCT00777296|7290932|FG002|NOT COMPLETED|Overall Study||2
6380183|NCT00777296|7290933|FG003|NOT COMPLETED|Overall Study||1
6380184|NCT00777335|7290957|FG000|STARTED|Overall Study||2
6380185|NCT00777335|7290958|FG001|STARTED|Overall Study||2
6380186|NCT00777335|7290957|FG000|COMPLETED|Overall Study||2
6380187|NCT00777335|7290958|FG001|COMPLETED|Overall Study||2
6380188|NCT00777335|7290957|FG000|NOT COMPLETED|Overall Study||0
6380189|NCT00777335|7290958|FG001|NOT COMPLETED|Overall Study||0
6380190|NCT00777491|7290966|FG000|STARTED|Overall Study||35
6380191|NCT00777491|7290967|FG001|STARTED|Overall Study||35
6380192|NCT00777491|7290966|FG000|Eligible|Overall Study||33
6380193|NCT00777491|7290967|FG001|Eligible|Overall Study||33
6380194|NCT00777491|7290966|FG000|Has 3-year Efficacy Data|Overall Study||27
6380195|NCT00777491|7290967|FG001|Has 3-year Efficacy Data|Overall Study||25
6380196|NCT00777491|7290966|FG000|Started Induction Therapy|Overall Study||33
6380197|NCT00777491|7290967|FG001|Started Induction Therapy|Overall Study||33
6380198|NCT00777491|7290966|FG000|Started Consolidation Therapy|Overall Study||29
6380199|NCT00777491|7290967|FG001|Started Consolidation Therapy|Overall Study||25
6380200|NCT00777491|7290966|FG000|Started Adjuvant Therapy|Overall Study||32
6380201|NCT00777491|7290967|FG001|Started Adjuvant Therapy|Overall Study||31
6380202|NCT00777491|7290966|FG000|Has Adverse Event Data (Treatment)|Overall Study||33
6798001|NCT02587520|7729715|FG009|STARTED|Overall Study||76
6798002|NCT02587520|7729716|FG010|STARTED|Overall Study||76
6798003|NCT02587520|7729717|FG011|STARTED|Overall Study||73
6798004|NCT02587520|7729718|FG012|STARTED|Overall Study||77
6798005|NCT02587520|7729719|FG013|STARTED|Overall Study||74
6380203|NCT00777491|7290967|FG001|Has Adverse Event Data (Treatment)|Overall Study||33
6380204|NCT00777491|7290966|FG000|Has Adverse Event Data (Late)|Overall Study||32
6380205|NCT00777491|7290967|FG001|Has Adverse Event Data (Late)|Overall Study||31
6380206|NCT00777491|7290966|FG000|Has 3 Year AUASI Data|Overall Study||6
6380207|NCT00777491|7290967|FG001|Has 3 Year AUASI Data|Overall Study||6
6380208|NCT00777491|7290966|FG000|COMPLETED|Overall Study||33
6380209|NCT00777491|7290967|FG001|COMPLETED|Overall Study||33
6380210|NCT00777491|7290966|FG000|NOT COMPLETED|Overall Study||2
6380211|NCT00777491|7290967|FG001|NOT COMPLETED|Overall Study||2
6380212|NCT00777556|7290973|FG000|STARTED|Overall Study|Enrolled; signed informed consent|343
6380213|NCT00777556|7290973|FG000|Dispensed Product|Overall Study||307
6380214|NCT00777556|7290973|FG000|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
6380215|NCT00777556|7290973|FG000|Used Product|Overall Study||297
6380216|NCT00777556|7290973|FG000|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
6380217|NCT00777556|7290973|FG000|NOT COMPLETED|Overall Study||66
6380218|NCT00777608|7290979|FG000|STARTED|Overall Study||53
6380219|NCT00777608|7290980|FG001|STARTED|Overall Study||53
6380220|NCT00777608|7290979|FG000|COMPLETED|Overall Study||49
6380221|NCT00777608|7290980|FG001|COMPLETED|Overall Study||47
6380222|NCT00777608|7290979|FG000|NOT COMPLETED|Overall Study||4
6380223|NCT00777608|7290980|FG001|NOT COMPLETED|Overall Study||6
6380224|NCT00777634|7290988|FG000|STARTED|Overall Study||134
6380225|NCT00777634|7290989|FG001|STARTED|Overall Study||134
6380226|NCT00777634|7290988|FG000|COMPLETED|Overall Study||129
6380227|NCT00777634|7290989|FG001|COMPLETED|Overall Study||133
6798006|NCT02587520|7729720|FG014|STARTED|Overall Study||78
6798007|NCT02587520|7729721|FG015|STARTED|Overall Study||72
6798008|NCT02587520|7729722|FG016|STARTED|Overall Study||76
6798009|NCT02587520|7729723|FG017|STARTED|Overall Study||78
6798010|NCT02587520|7729706|FG000|Safety Analysis Set (SafAS)|Overall Study||79
6798011|NCT02587520|7729707|FG001|Safety Analysis Set (SafAS)|Overall Study||71
6798012|NCT02587520|7729708|FG002|Safety Analysis Set (SafAS)|Overall Study||77
6798013|NCT02587520|7729709|FG003|Safety Analysis Set (SafAS)|Overall Study||77
6798014|NCT02587520|7729710|FG004|Safety Analysis Set (SafAS)|Overall Study||75
6798015|NCT02587520|7729711|FG005|Safety Analysis Set (SafAS)|Overall Study||75
6798016|NCT02587520|7729712|FG006|Safety Analysis Set (SafAS)|Overall Study||76
6798017|NCT02587520|7729713|FG007|Safety Analysis Set (SafAS)|Overall Study||73
6798018|NCT02587520|7729714|FG008|Safety Analysis Set (SafAS)|Overall Study||76
6798019|NCT02587520|7729715|FG009|Safety Analysis Set (SafAS)|Overall Study||76
6798020|NCT02587520|7729716|FG010|Safety Analysis Set (SafAS)|Overall Study||76
6798021|NCT02587520|7729717|FG011|Safety Analysis Set (SafAS)|Overall Study||72
6798022|NCT02587520|7729718|FG012|Safety Analysis Set (SafAS)|Overall Study||77
6798023|NCT02587520|7729719|FG013|Safety Analysis Set (SafAS)|Overall Study||73
6798024|NCT02587520|7729720|FG014|Safety Analysis Set (SafAS)|Overall Study||78
6798025|NCT02587520|7729721|FG015|Safety Analysis Set (SafAS)|Overall Study||72
6798026|NCT02587520|7729722|FG016|Safety Analysis Set (SafAS)|Overall Study||76
6798027|NCT02587520|7729723|FG017|Safety Analysis Set (SafAS)|Overall Study||78
6380228|NCT00777634|7290988|FG000|NOT COMPLETED|Overall Study||5
6380229|NCT00777634|7290989|FG001|NOT COMPLETED|Overall Study||1
6380230|NCT00777764|7290997|FG000|STARTED|Overall Study||30
6380231|NCT00777764|7290998|FG001|STARTED|Overall Study||30
6380232|NCT00777764|7290997|FG000|COMPLETED|Overall Study||30
6380233|NCT00777764|7290998|FG001|COMPLETED|Overall Study||29
6380234|NCT00777764|7290997|FG000|NOT COMPLETED|Overall Study||0
6380235|NCT00777764|7290998|FG001|NOT COMPLETED|Overall Study||1
6380236|NCT00777790|7291009|FG000|STARTED|Overall Study||76
6380237|NCT00777790|7291010|FG001|STARTED|Overall Study||77
6380238|NCT00777790|7291011|FG002|STARTED|Overall Study||88
6380239|NCT00777790|7291009|FG000|COMPLETED|Overall Study||76
6380240|NCT00777790|7291010|FG001|COMPLETED|Overall Study||77
6380241|NCT00777790|7291011|FG002|COMPLETED|Overall Study||88
6380242|NCT00777790|7291009|FG000|NOT COMPLETED|Overall Study||0
6380243|NCT00777790|7291010|FG001|NOT COMPLETED|Overall Study||0
6380244|NCT00777790|7291011|FG002|NOT COMPLETED|Overall Study||0
6380245|NCT00777803|7291021|FG000|STARTED|Overall Study||284
6380246|NCT00777803|7291022|FG001|STARTED|Overall Study||97
6380247|NCT00777803|7291021|FG000|COMPLETED|Overall Study||269
6380248|NCT00777803|7291022|FG001|COMPLETED|Overall Study||90
6380249|NCT00777803|7291021|FG000|NOT COMPLETED|Overall Study||15
6380250|NCT00777803|7291022|FG001|NOT COMPLETED|Overall Study||7
6380251|NCT00777829|7291028|FG000|STARTED|Overall Study||15
6380252|NCT00777829|7291029|FG001|STARTED|Overall Study||15
6380253|NCT00777829|7291028|FG000|Study Orientation|Overall Study||15
6380254|NCT00777829|7291029|FG001|Study Orientation|Overall Study||13
6380255|NCT00777829|7291028|FG000|COMPLETED|Overall Study||15
6380256|NCT00777829|7291029|FG001|COMPLETED|Overall Study||13
6380257|NCT00777829|7291028|FG000|NOT COMPLETED|Overall Study||0
6380258|NCT00777829|7291029|FG001|NOT COMPLETED|Overall Study||2
6380259|NCT00777855|7291037|FG000|STARTED|First Intervention||5
6380260|NCT00777855|7291038|FG001|STARTED|First Intervention||5
6380261|NCT00777855|7291037|FG000|COMPLETED|First Intervention||5
6380262|NCT00777855|7291038|FG001|COMPLETED|First Intervention||5
6380263|NCT00777855|7291037|FG000|NOT COMPLETED|First Intervention||0
6380264|NCT00777855|7291038|FG001|NOT COMPLETED|First Intervention||0
6380265|NCT00777855|7291037|FG000|STARTED|Washout Period (>= 14 Days)||5
6380266|NCT00777855|7291038|FG001|STARTED|Washout Period (>= 14 Days)||5
6380267|NCT00777855|7291037|FG000|COMPLETED|Washout Period (>= 14 Days)||5
6380268|NCT00777855|7291038|FG001|COMPLETED|Washout Period (>= 14 Days)||5
6380269|NCT00777855|7291037|FG000|NOT COMPLETED|Washout Period (>= 14 Days)||0
6380270|NCT00777855|7291038|FG001|NOT COMPLETED|Washout Period (>= 14 Days)||0
6380271|NCT00777855|7291037|FG000|STARTED|Second Intervention||5
6380272|NCT00777855|7291038|FG001|STARTED|Second Intervention||5
6380273|NCT00777855|7291037|FG000|COMPLETED|Second Intervention||5
6380274|NCT00777855|7291038|FG001|COMPLETED|Second Intervention||5
6380275|NCT00777855|7291037|FG000|NOT COMPLETED|Second Intervention||0
6380276|NCT00777855|7291038|FG001|NOT COMPLETED|Second Intervention||0
6380277|NCT00777920|7291043|FG000|STARTED|Overall Study||140
6380278|NCT00777920|7291043|FG000|COMPLETED|Overall Study||90
6380279|NCT00777920|7291043|FG000|NOT COMPLETED|Overall Study||50
6380280|NCT00777946|7291050|FG000|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
6380281|NCT00777946|7291051|FG001|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
6380282|NCT00777946|7291052|FG002|STARTED|Overall Study||260
6380283|NCT00777946|7291050|FG000|Safety & Full Analysis Sets|Overall Study||282
6380284|NCT00777946|7291051|FG001|Safety & Full Analysis Sets|Overall Study||276
6380285|NCT00777946|7291052|FG002|Safety & Full Analysis Sets|Overall Study||260
6380286|NCT00777946|7291050|FG000|COMPLETED|Overall Study||262
6380287|NCT00777946|7291051|FG001|COMPLETED|Overall Study||271
6380288|NCT00777946|7291052|FG002|COMPLETED|Overall Study||244
6380289|NCT00777946|7291050|FG000|NOT COMPLETED|Overall Study||21
6380290|NCT00777946|7291051|FG001|NOT COMPLETED|Overall Study||6
6380291|NCT00777946|7291052|FG002|NOT COMPLETED|Overall Study||16
6380292|NCT00778102|7291062|FG000|STARTED|Overall Study||39
6380293|NCT00778102|7291063|FG001|STARTED|Overall Study||41
6380294|NCT00778102|7291062|FG000|COMPLETED|Overall Study||18
6380295|NCT00778102|7291063|FG001|COMPLETED|Overall Study||19
6380296|NCT00778102|7291062|FG000|NOT COMPLETED|Overall Study||21
6380297|NCT00778102|7291063|FG001|NOT COMPLETED|Overall Study||22
6380298|NCT00778167|7291072|FG000|STARTED|Overall Study||6
6380299|NCT00778167|7291073|FG001|STARTED|Overall Study||8
6380300|NCT00778167|7291074|FG002|STARTED|Overall Study||4
6380301|NCT00778167|7291072|FG000|COMPLETED|Overall Study||6
6380302|NCT00778167|7291073|FG001|COMPLETED|Overall Study||8
6380303|NCT00778167|7291074|FG002|COMPLETED|Overall Study||4
6798028|NCT02587520|7729706|FG000|COMPLETED|Overall Study||78
6798029|NCT02587520|7729707|FG001|COMPLETED|Overall Study||69
6798030|NCT02587520|7729708|FG002|COMPLETED|Overall Study||77
6798031|NCT02587520|7729709|FG003|COMPLETED|Overall Study||74
6798032|NCT02587520|7729710|FG004|COMPLETED|Overall Study||75
6798033|NCT02587520|7729711|FG005|COMPLETED|Overall Study||72
6798034|NCT02587520|7729712|FG006|COMPLETED|Overall Study||73
6798035|NCT02587520|7729713|FG007|COMPLETED|Overall Study||71
6798036|NCT02587520|7729714|FG008|COMPLETED|Overall Study||73
6798037|NCT02587520|7729715|FG009|COMPLETED|Overall Study||71
6798038|NCT02587520|7729716|FG010|COMPLETED|Overall Study||73
6798039|NCT02587520|7729717|FG011|COMPLETED|Overall Study||69
6798040|NCT02587520|7729718|FG012|COMPLETED|Overall Study||77
6798041|NCT02587520|7729719|FG013|COMPLETED|Overall Study||73
6798042|NCT02587520|7729720|FG014|COMPLETED|Overall Study||78
6380304|NCT00778167|7291072|FG000|NOT COMPLETED|Overall Study||0
6380305|NCT00778167|7291073|FG001|NOT COMPLETED|Overall Study||0
6380306|NCT00778167|7291074|FG002|NOT COMPLETED|Overall Study||0
6380307|NCT00778258|7291091|FG000|STARTED|Overall Study||16
6380308|NCT00778258|7291092|FG001|STARTED|Overall Study||5
6380309|NCT00778258|7291093|FG002|STARTED|Overall Study||20
6380310|NCT00778258|7291094|FG003|STARTED|Overall Study||15
6380311|NCT00778258|7291095|FG004|STARTED|Overall Study||6
6380312|NCT00778258|7291096|FG005|STARTED|Overall Study||23
6380313|NCT00778258|7291097|FG006|STARTED|Overall Study||34
6380314|NCT00778258|7291098|FG007|STARTED|Overall Study||41
6798043|NCT02587520|7729721|FG015|COMPLETED|Overall Study||72
6380315|NCT00778258|7291099|FG008|STARTED|Overall Study||10
6380316|NCT00778258|7291091|FG000|COMPLETED|Overall Study||9
6380317|NCT00778258|7291092|FG001|COMPLETED|Overall Study||3
6380318|NCT00778258|7291093|FG002|COMPLETED|Overall Study||10
6380319|NCT00778258|7291094|FG003|COMPLETED|Overall Study||12
6380320|NCT00778258|7291095|FG004|COMPLETED|Overall Study||6
6380321|NCT00778258|7291096|FG005|COMPLETED|Overall Study||13
6380322|NCT00778258|7291097|FG006|COMPLETED|Overall Study||19
6380323|NCT00778258|7291098|FG007|COMPLETED|Overall Study||26
6380324|NCT00778258|7291099|FG008|COMPLETED|Overall Study||6
6380325|NCT00778258|7291091|FG000|NOT COMPLETED|Overall Study||7
6380326|NCT00778258|7291092|FG001|NOT COMPLETED|Overall Study||2
6380327|NCT00778258|7291093|FG002|NOT COMPLETED|Overall Study||10
6380328|NCT00778258|7291094|FG003|NOT COMPLETED|Overall Study||3
6380329|NCT00778258|7291095|FG004|NOT COMPLETED|Overall Study||0
6798044|NCT02587520|7729722|FG016|COMPLETED|Overall Study||76
6798045|NCT02587520|7729723|FG017|COMPLETED|Overall Study||78
6798046|NCT02587520|7729706|FG000|NOT COMPLETED|Overall Study||2
6798047|NCT02587520|7729707|FG001|NOT COMPLETED|Overall Study||2
6798048|NCT02587520|7729708|FG002|NOT COMPLETED|Overall Study||1
6798049|NCT02587520|7729709|FG003|NOT COMPLETED|Overall Study||5
6380330|NCT00778258|7291096|FG005|NOT COMPLETED|Overall Study||10
6380331|NCT00778258|7291097|FG006|NOT COMPLETED|Overall Study||15
6380332|NCT00778258|7291098|FG007|NOT COMPLETED|Overall Study||15
6380333|NCT00778258|7291099|FG008|NOT COMPLETED|Overall Study||4
6380334|NCT00778310|7291127|FG000|STARTED|Overall Study||17
6380335|NCT00778310|7291128|FG001|STARTED|Overall Study||26
6380336|NCT00778310|7291127|FG000|Usable Data|Overall Study||14
6380337|NCT00778310|7291128|FG001|Usable Data|Overall Study||21
6380338|NCT00778310|7291127|FG000|COMPLETED|Overall Study||17
6798050|NCT02587520|7729710|FG004|NOT COMPLETED|Overall Study||0
6798051|NCT02587520|7729711|FG005|NOT COMPLETED|Overall Study||3
6798052|NCT02587520|7729712|FG006|NOT COMPLETED|Overall Study||3
6798053|NCT02587520|7729713|FG007|NOT COMPLETED|Overall Study||2
6798054|NCT02587520|7729714|FG008|NOT COMPLETED|Overall Study||3
6798055|NCT02587520|7729715|FG009|NOT COMPLETED|Overall Study||5
6798056|NCT02587520|7729716|FG010|NOT COMPLETED|Overall Study||3
6798057|NCT02587520|7729717|FG011|NOT COMPLETED|Overall Study||4
6798058|NCT02587520|7729718|FG012|NOT COMPLETED|Overall Study||0
6380339|NCT00778310|7291128|FG001|COMPLETED|Overall Study||26
6380340|NCT00778310|7291127|FG000|NOT COMPLETED|Overall Study||0
6380341|NCT00778310|7291128|FG001|NOT COMPLETED|Overall Study||0
6380342|NCT00778336|7291140|FG000|STARTED|Index Procedure-Discharge||198
6380343|NCT00778336|7291141|FG001|STARTED|Index Procedure-Discharge||170
6798059|NCT02587520|7729719|FG013|NOT COMPLETED|Overall Study||1
6798060|NCT02587520|7729720|FG014|NOT COMPLETED|Overall Study||0
6798061|NCT02587520|7729721|FG015|NOT COMPLETED|Overall Study||0
6798062|NCT02587520|7729722|FG016|NOT COMPLETED|Overall Study||0
6380344|NCT00778336|7291142|FG002|STARTED|Index Procedure-Discharge||72
6380345|NCT00778336|7291143|FG003|STARTED|Index Procedure-Discharge||12
6380346|NCT00778336|7291140|FG000|COMPLETED|Index Procedure-Discharge||192
6380347|NCT00778336|7291141|FG001|COMPLETED|Index Procedure-Discharge||167
6380348|NCT00778336|7291142|FG002|COMPLETED|Index Procedure-Discharge||70
6380349|NCT00778336|7291143|FG003|COMPLETED|Index Procedure-Discharge||12
6380350|NCT00778336|7291140|FG000|NOT COMPLETED|Index Procedure-Discharge||6
6380351|NCT00778336|7291141|FG001|NOT COMPLETED|Index Procedure-Discharge||3
6380352|NCT00778336|7291142|FG002|NOT COMPLETED|Index Procedure-Discharge||2
6380353|NCT00778336|7291143|FG003|NOT COMPLETED|Index Procedure-Discharge||0
6380354|NCT00778336|7291140|FG000|STARTED|3 Month Follow Up||192
6380355|NCT00778336|7291141|FG001|STARTED|3 Month Follow Up||167
6380356|NCT00778336|7291142|FG002|STARTED|3 Month Follow Up||70
6380357|NCT00778336|7291143|FG003|STARTED|3 Month Follow Up||12
6380358|NCT00778336|7291140|FG000|COMPLETED|3 Month Follow Up||169
6380359|NCT00778336|7291141|FG001|COMPLETED|3 Month Follow Up||144
6380360|NCT00778336|7291142|FG002|COMPLETED|3 Month Follow Up||65
6380361|NCT00778336|7291143|FG003|COMPLETED|3 Month Follow Up||12
6380362|NCT00778336|7291140|FG000|NOT COMPLETED|3 Month Follow Up||23
6380363|NCT00778336|7291141|FG001|NOT COMPLETED|3 Month Follow Up||23
6380364|NCT00778336|7291142|FG002|NOT COMPLETED|3 Month Follow Up||5
6380365|NCT00778336|7291143|FG003|NOT COMPLETED|3 Month Follow Up||0
6380366|NCT00778375|7291153|FG000|STARTED|Overall Study||122
6380367|NCT00778375|7291153|FG000|COMPLETED|Overall Study||119
6380368|NCT00778375|7291153|FG000|NOT COMPLETED|Overall Study||3
6380369|NCT00778622|7291162|FG000|STARTED|Overall Study||125
6380370|NCT00778622|7291163|FG001|STARTED|Overall Study||122
6380371|NCT00778622|7291164|FG002|STARTED|Overall Study||124
6502424|NCT01435031|7421130|FG000|STARTED|ITT at 1 Year||211
6502425|NCT01435031|7421130|FG000|COMPLETED|ITT at 1 Year||202
6502426|NCT01435031|7421130|FG000|NOT COMPLETED|ITT at 1 Year||9
6502427|NCT01435031|7421130|FG000|STARTED|ITT at 2 Years||202
6502428|NCT01435031|7421130|FG000|COMPLETED|ITT at 2 Years||189
6502429|NCT01435031|7421130|FG000|NOT COMPLETED|ITT at 2 Years||13
6798063|NCT02587520|7729723|FG017|NOT COMPLETED|Overall Study||0
6798064|NCT02584829|7729763|FG000|STARTED|Overall Study||1
6798065|NCT02584829|7729764|FG001|STARTED|Overall Study||7
6380372|NCT00778622|7291162|FG000|COMPLETED|Overall Study||109
6380373|NCT00778622|7291163|FG001|COMPLETED|Overall Study||107
6380374|NCT00778622|7291164|FG002|COMPLETED|Overall Study||109
6380375|NCT00778622|7291162|FG000|NOT COMPLETED|Overall Study||16
6380376|NCT00778622|7291163|FG001|NOT COMPLETED|Overall Study||15
6798066|NCT02584829|7729763|FG000|COMPLETED|Overall Study||0
6798067|NCT02584829|7729764|FG001|COMPLETED|Overall Study||3
6798068|NCT02584829|7729763|FG000|NOT COMPLETED|Overall Study||1
6798069|NCT02584829|7729764|FG001|NOT COMPLETED|Overall Study||4
6798070|NCT02570308|7729777|FG000|STARTED|Overall Study||3
6798071|NCT02570308|7729778|FG001|STARTED|Overall Study||6
6798072|NCT02570308|7729779|FG002|STARTED|Overall Study||4
6798073|NCT02570308|7729780|FG003|STARTED|Overall Study||6
6798074|NCT02570308|7729781|FG004|STARTED|Overall Study||127
6798075|NCT02570308|7729777|FG000|COMPLETED|Overall Study||2
6798076|NCT02570308|7729778|FG001|COMPLETED|Overall Study||1
6798077|NCT02570308|7729779|FG002|COMPLETED|Overall Study||0
6798078|NCT02570308|7729780|FG003|COMPLETED|Overall Study||2
6798079|NCT02570308|7729781|FG004|COMPLETED|Overall Study||53
6798080|NCT02570308|7729777|FG000|NOT COMPLETED|Overall Study||1
6798081|NCT02570308|7729778|FG001|NOT COMPLETED|Overall Study||5
6798082|NCT02570308|7729779|FG002|NOT COMPLETED|Overall Study||4
6798083|NCT02570308|7729780|FG003|NOT COMPLETED|Overall Study||4
6798084|NCT02570308|7729781|FG004|NOT COMPLETED|Overall Study||74
6380377|NCT00778622|7291164|FG002|NOT COMPLETED|Overall Study||15
6380378|NCT00778648|7291178|FG000|STARTED|Overall Study||272
6380379|NCT00778648|7291179|FG001|STARTED|Overall Study||271
6380380|NCT00778648|7291178|FG000|COMPLETED|Overall Study||263
6380381|NCT00778648|7291179|FG001|COMPLETED|Overall Study||266
6380382|NCT00778648|7291178|FG000|NOT COMPLETED|Overall Study||9
6380383|NCT00778648|7291179|FG001|NOT COMPLETED|Overall Study||5
6380384|NCT00778817|7291185|FG000|STARTED|Overall Study||20
6380385|NCT00778817|7291185|FG000|COMPLETED|Overall Study||16
6380386|NCT00778817|7291185|FG000|NOT COMPLETED|Overall Study||4
6380387|NCT00778830|7291191|FG000|STARTED|Overall Study||101
6380388|NCT00778830|7291192|FG001|STARTED|Overall Study||188
6380389|NCT00778830|7291191|FG000|COMPLETED|Overall Study||101
6380390|NCT00778830|7291192|FG001|COMPLETED|Overall Study||187
6380391|NCT00778830|7291191|FG000|NOT COMPLETED|Overall Study||0
6380392|NCT00778830|7291192|FG001|NOT COMPLETED|Overall Study||1
6502430|NCT01435031|7421130|FG000|STARTED|ITT at 3 Years||189
6502431|NCT01435031|7421130|FG000|COMPLETED|ITT at 3 Years||178
6502432|NCT01435031|7421130|FG000|NOT COMPLETED|ITT at 3 Years||11
6502433|NCT01435031|7421130|FG000|STARTED|ITT at 4 Years||178
6502434|NCT01435031|7421130|FG000|COMPLETED|ITT at 4 Years||171
6502435|NCT01435031|7421130|FG000|NOT COMPLETED|ITT at 4 Years||7
6502436|NCT01435122|7421134|FG000|STARTED|Overall Study||30
6502437|NCT01435122|7421134|FG000|COMPLETED|Overall Study||22
6502438|NCT01435122|7421134|FG000|NOT COMPLETED|Overall Study||8
6502439|NCT01435174|7421138|FG000|STARTED|Overall Study||17
6502440|NCT01435174|7421138|FG000|COMPLETED|Overall Study||8
6502441|NCT01435174|7421138|FG000|NOT COMPLETED|Overall Study||9
6502442|NCT01435265|7421144|FG000|STARTED|Overall Study||3
6502443|NCT01435265|7421145|FG001|STARTED|Overall Study||4
6502444|NCT01435265|7421144|FG000|COMPLETED|Overall Study||3
6502445|NCT01435265|7421145|FG001|COMPLETED|Overall Study||3
6502446|NCT01435265|7421144|FG000|NOT COMPLETED|Overall Study||0
6502447|NCT01435265|7421145|FG001|NOT COMPLETED|Overall Study||1
6502448|NCT01435304|7421153|FG000|STARTED|Overall Study||50
6502449|NCT01435304|7421154|FG001|STARTED|Overall Study||50
6502450|NCT01435304|7421153|FG000|COMPLETED|Overall Study||50
6502451|NCT01435304|7421154|FG001|COMPLETED|Overall Study||50
6502452|NCT01435304|7421153|FG000|NOT COMPLETED|Overall Study||0
6502453|NCT01435304|7421154|FG001|NOT COMPLETED|Overall Study||0
6502454|NCT01435356|7421162|FG000|STARTED|Overall Study||48
6502455|NCT01435356|7421163|FG001|STARTED|Overall Study||29
6502456|NCT01435356|7421162|FG000|COMPLETED|Overall Study||16
6502457|NCT01435356|7421163|FG001|COMPLETED|Overall Study||5
6502458|NCT01435356|7421162|FG000|NOT COMPLETED|Overall Study||32
6502459|NCT01435356|7421163|FG001|NOT COMPLETED|Overall Study||24
6502460|NCT01435382|7421173|FG000|STARTED|Overall Study||12
6502461|NCT01435382|7421174|FG001|STARTED|Overall Study||13
6502462|NCT01435382|7421175|FG002|STARTED|Overall Study||13
6502463|NCT01435382|7421176|FG003|STARTED|Overall Study||11
6502464|NCT01435382|7421173|FG000|COMPLETED|Overall Study||11
6380393|NCT00778869|7291198|FG000|STARTED|Overall Study||10
6502465|NCT01435382|7421174|FG001|COMPLETED|Overall Study||11
6502466|NCT01435382|7421175|FG002|COMPLETED|Overall Study||12
6502467|NCT01435382|7421176|FG003|COMPLETED|Overall Study||10
6502468|NCT01435382|7421173|FG000|NOT COMPLETED|Overall Study||1
6502469|NCT01435382|7421174|FG001|NOT COMPLETED|Overall Study||2
6502470|NCT01435382|7421175|FG002|NOT COMPLETED|Overall Study||1
6798085|NCT02516241|7729802|FG000|STARTED|Overall Study||342
6798086|NCT02516241|7729803|FG001|STARTED|Overall Study||346
6798087|NCT02516241|7729804|FG002|STARTED|Overall Study||344
6798088|NCT02516241|7729802|FG000|Received Treatment|Overall Study||340
6798089|NCT02516241|7729803|FG001|Received Treatment|Overall Study||345
6798090|NCT02516241|7729804|FG002|Received Treatment|Overall Study||313
6798091|NCT02516241|7729802|FG000|COMPLETED|Overall Study||0
6798092|NCT02516241|7729803|FG001|COMPLETED|Overall Study||0
6798093|NCT02516241|7729804|FG002|COMPLETED|Overall Study||0
6798094|NCT02516241|7729802|FG000|NOT COMPLETED|Overall Study||342
6798095|NCT02516241|7729803|FG001|NOT COMPLETED|Overall Study||346
6798096|NCT02516241|7729804|FG002|NOT COMPLETED|Overall Study||344
6798097|NCT02514083|7729817|FG000|STARTED|Overall Study||29
6798098|NCT02514083|7729817|FG000|COMPLETED|Overall Study||28
6798099|NCT02514083|7729817|FG000|NOT COMPLETED|Overall Study||1
6798100|NCT02500797|7729829|FG000|STARTED|Overall Study||43
6798101|NCT02500797|7729830|FG001|STARTED|Overall Study||42
6798102|NCT02500797|7729831|FG002|STARTED|Overall Study||15
6798103|NCT02500797|7729832|FG003|STARTED|Overall Study||14
6798104|NCT02500797|7729833|FG004|STARTED|Overall Study||14
6798105|NCT02500797|7729834|FG005|STARTED|Overall Study||15
6798106|NCT02500797|7729835|FG006|STARTED|Overall Study||10
6798107|NCT02500797|7729836|FG007|STARTED|Overall Study||11
6798108|NCT02500797|7729829|FG000|Arm I Crossover|Overall Study||4
6798109|NCT02500797|7729830|FG001|Arm I Crossover|Overall Study||0
6798110|NCT02500797|7729831|FG002|Arm I Crossover|Overall Study||6
6798111|NCT02500797|7729832|FG003|Arm I Crossover|Overall Study||0
6798112|NCT02500797|7729833|FG004|Arm I Crossover|Overall Study||1
6380394|NCT00778869|7291198|FG000|COMPLETED|Overall Study||10
6380395|NCT00778869|7291198|FG000|NOT COMPLETED|Overall Study||0
6502471|NCT01435382|7421176|FG003|NOT COMPLETED|Overall Study||1
6502472|NCT01435460|7421194|FG000|STARTED|Overall Study||151
6502473|NCT01435460|7421195|FG001|STARTED|Overall Study||149
6502474|NCT01435460|7421194|FG000|COMPLETED|Overall Study||140
6502475|NCT01435460|7421195|FG001|COMPLETED|Overall Study||143
6502476|NCT01435460|7421194|FG000|NOT COMPLETED|Overall Study||11
6502477|NCT01435460|7421195|FG001|NOT COMPLETED|Overall Study||6
6502478|NCT01435512|7421203|FG000|STARTED|Overall Study||67
6502479|NCT01435512|7421204|FG001|STARTED|Overall Study||68
6502480|NCT01435512|7421203|FG000|COMPLETED|Overall Study||67
6502481|NCT01435512|7421204|FG001|COMPLETED|Overall Study||68
6502482|NCT01435512|7421203|FG000|NOT COMPLETED|Overall Study||0
6502483|NCT01435512|7421204|FG001|NOT COMPLETED|Overall Study||0
6502484|NCT01435577|7421212|FG000|STARTED|Overall Study||64
6502485|NCT01435577|7421213|FG001|STARTED|Overall Study||65
6502486|NCT01435577|7421212|FG000|COMPLETED|Overall Study||47
6502487|NCT01435577|7421213|FG001|COMPLETED|Overall Study||13
6502488|NCT01435577|7421212|FG000|NOT COMPLETED|Overall Study||17
6502489|NCT01435577|7421213|FG001|NOT COMPLETED|Overall Study||52
6502490|NCT01435603|7421225|FG000|STARTED|Overall Study||167
6502491|NCT01435603|7421226|FG001|STARTED|Overall Study||164
6502492|NCT01435603|7421225|FG000|COMPLETED|Overall Study||128
6798113|NCT02500797|7729834|FG005|Arm I Crossover|Overall Study||0
6798114|NCT02500797|7729835|FG006|Arm I Crossover|Overall Study||2
6798115|NCT02500797|7729836|FG007|Arm I Crossover|Overall Study||0
6502493|NCT01435603|7421226|FG001|COMPLETED|Overall Study||129
6502494|NCT01435603|7421225|FG000|NOT COMPLETED|Overall Study||39
6502495|NCT01435603|7421226|FG001|NOT COMPLETED|Overall Study||35
6502496|NCT01435616|7421234|FG000|STARTED|Overall Study||1003
6502497|NCT01435616|7421235|FG001|STARTED|Overall Study||535
6502498|NCT01435616|7421234|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1003
6502499|NCT01435616|7421235|FG001|Received at Least 1 Dose of Study Drug|Overall Study||535
6502500|NCT01435616|7421234|FG000|COMPLETED|Overall Study||832
6502501|NCT01435616|7421235|FG001|COMPLETED|Overall Study||455
6502502|NCT01435616|7421234|FG000|NOT COMPLETED|Overall Study||171
6502503|NCT01435616|7421235|FG001|NOT COMPLETED|Overall Study||80
6502504|NCT01435655|7421243|FG000|STARTED|Overall Study||10
6502505|NCT01435655|7421243|FG000|COMPLETED|Overall Study||7
6502506|NCT01435655|7421243|FG000|NOT COMPLETED|Overall Study||3
6502507|NCT01435759|7421252|FG000|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
6502508|NCT01435759|7421253|FG001|STARTED|Antidepressant Lead-in Phase||0
6502509|NCT01435759|7421254|FG002|STARTED|Antidepressant Lead-in Phase||0
6798116|NCT02500797|7729829|FG000|COMPLETED|Overall Study||42
6798117|NCT02500797|7729830|FG001|COMPLETED|Overall Study||42
6798118|NCT02500797|7729831|FG002|COMPLETED|Overall Study||15
6798119|NCT02500797|7729832|FG003|COMPLETED|Overall Study||14
6798120|NCT02500797|7729833|FG004|COMPLETED|Overall Study||13
6798121|NCT02500797|7729834|FG005|COMPLETED|Overall Study||14
6798122|NCT02500797|7729835|FG006|COMPLETED|Overall Study||10
6502510|NCT01435759|7421255|FG003|STARTED|Antidepressant Lead-in Phase||0
6798123|NCT02500797|7729836|FG007|COMPLETED|Overall Study||11
6798124|NCT02500797|7729829|FG000|NOT COMPLETED|Overall Study||1
6798125|NCT02500797|7729830|FG001|NOT COMPLETED|Overall Study||0
6380396|NCT00778895|7291205|FG000|STARTED|Active Phase||164
6380397|NCT00778895|7291206|FG001|STARTED|Active Phase||167
6798126|NCT02500797|7729831|FG002|NOT COMPLETED|Overall Study||0
6798127|NCT02500797|7729832|FG003|NOT COMPLETED|Overall Study||0
6798128|NCT02500797|7729833|FG004|NOT COMPLETED|Overall Study||1
6380398|NCT00778895|7291207|FG002|STARTED|Active Phase||43
6380399|NCT00778895|7291205|FG000|COMPLETED|Active Phase||157
6380400|NCT00778895|7291206|FG001|COMPLETED|Active Phase||161
6380401|NCT00778895|7291207|FG002|COMPLETED|Active Phase||43
6380402|NCT00778895|7291205|FG000|NOT COMPLETED|Active Phase||7
6380403|NCT00778895|7291206|FG001|NOT COMPLETED|Active Phase||6
6798129|NCT02500797|7729834|FG005|NOT COMPLETED|Overall Study||1
6380404|NCT00778895|7291207|FG002|NOT COMPLETED|Active Phase||0
6380405|NCT00778895|7291205|FG000|STARTED|ESFU Phase||164
6380406|NCT00778895|7291206|FG001|STARTED|ESFU Phase||167
6502511|NCT01435759|7421256|FG004|STARTED|Antidepressant Lead-in Phase||0
6502512|NCT01435759|7421257|FG005|STARTED|Antidepressant Lead-in Phase||0
6502513|NCT01435759|7421252|FG000|COMPLETED|Antidepressant Lead-in Phase||855
6502514|NCT01435759|7421253|FG001|COMPLETED|Antidepressant Lead-in Phase||0
6502515|NCT01435759|7421254|FG002|COMPLETED|Antidepressant Lead-in Phase||0
6502516|NCT01435759|7421255|FG003|COMPLETED|Antidepressant Lead-in Phase||0
6502517|NCT01435759|7421256|FG004|COMPLETED|Antidepressant Lead-in Phase||0
6502518|NCT01435759|7421257|FG005|COMPLETED|Antidepressant Lead-in Phase||0
6502519|NCT01435759|7421252|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||342
6502520|NCT01435759|7421253|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
6502521|NCT01435759|7421254|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
6502522|NCT01435759|7421255|FG003|NOT COMPLETED|Antidepressant Lead-in Phase||0
6502523|NCT01435759|7421256|FG004|NOT COMPLETED|Antidepressant Lead-in Phase||0
6502524|NCT01435759|7421257|FG005|NOT COMPLETED|Antidepressant Lead-in Phase||0
6502525|NCT01435759|7421252|FG000|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
6502526|NCT01435759|7421253|FG001|STARTED|Double-blind Phase||78
6564106|NCT01809262|7486876|FG001|COMPLETED|Period 3 (Third Dose + Washout)||3
6798130|NCT02500797|7729835|FG006|NOT COMPLETED|Overall Study||0
6798131|NCT02500797|7729836|FG007|NOT COMPLETED|Overall Study||0
6798132|NCT02497612|7729865|FG000|STARTED|Overall Study||93
6798133|NCT02497612|7729866|FG001|STARTED|Overall Study||94
6798134|NCT02497612|7729867|FG002|STARTED|Overall Study||97
6798135|NCT02497612|7729868|FG003|STARTED|Overall Study||93
6798136|NCT02497612|7729865|FG000|Treated|Overall Study||92
6798137|NCT02497612|7729866|FG001|Treated|Overall Study||94
6798138|NCT02497612|7729867|FG002|Treated|Overall Study||96
6798139|NCT02497612|7729868|FG003|Treated|Overall Study||91
6798140|NCT02497612|7729865|FG000|Cohort 1: >14 Years to <70 Years|Overall Study||14
6798141|NCT02497612|7729866|FG001|Cohort 1: >14 Years to <70 Years|Overall Study||15
6798142|NCT02497612|7729867|FG002|Cohort 1: >14 Years to <70 Years|Overall Study||18
6798143|NCT02497612|7729868|FG003|Cohort 1: >14 Years to <70 Years|Overall Study||16
6798144|NCT02497612|7729865|FG000|Cohort 2: >5 Years to <=14 Years|Overall Study||6
6798145|NCT02497612|7729866|FG001|Cohort 2: >5 Years to <=14 Years|Overall Study||5
6798146|NCT02497612|7729867|FG002|Cohort 2: >5 Years to <=14 Years|Overall Study||6
6798147|NCT02497612|7729868|FG003|Cohort 2: >5 Years to <=14 Years|Overall Study||5
6798148|NCT02497612|7729865|FG000|Cohort 3: >2 Years to <=5 Years|Overall Study||66
6798149|NCT02497612|7729866|FG001|Cohort 3: >2 Years to <=5 Years|Overall Study||66
6798150|NCT02497612|7729867|FG002|Cohort 3: >2 Years to <=5 Years|Overall Study||67
6798151|NCT02497612|7729868|FG003|Cohort 3: >2 Years to <=5 Years|Overall Study||65
6798152|NCT02497612|7729865|FG000|Cohort 4: >6 Months to <=2 Years|Overall Study||7
6798153|NCT02497612|7729866|FG001|Cohort 4: >6 Months to <=2 Years|Overall Study||8
6798154|NCT02497612|7729867|FG002|Cohort 4: >6 Months to <=2 Years|Overall Study||6
6798155|NCT02497612|7729868|FG003|Cohort 4: >6 Months to <=2 Years|Overall Study||7
6798156|NCT02497612|7729865|FG000|COMPLETED|Overall Study||27
6798157|NCT02497612|7729866|FG001|COMPLETED|Overall Study||37
6798158|NCT02497612|7729867|FG002|COMPLETED|Overall Study||48
6798159|NCT02497612|7729868|FG003|COMPLETED|Overall Study||46
6798160|NCT02497612|7729865|FG000|NOT COMPLETED|Overall Study||66
6798161|NCT02497612|7729866|FG001|NOT COMPLETED|Overall Study||57
6798162|NCT02497612|7729867|FG002|NOT COMPLETED|Overall Study||49
6798163|NCT02497612|7729868|FG003|NOT COMPLETED|Overall Study||47
6798164|NCT02460458|7729878|FG000|STARTED|Retrospective Phase||265
6798165|NCT02460458|7729878|FG000|COMPLETED|Retrospective Phase||265
6798166|NCT02460458|7729878|FG000|NOT COMPLETED|Retrospective Phase||0
6798167|NCT02460458|7729878|FG000|STARTED|Confirmatory Phase||265
6798168|NCT02460458|7729878|FG000|COMPLETED|Confirmatory Phase||177
6798169|NCT02460458|7729878|FG000|NOT COMPLETED|Confirmatory Phase||88
6798170|NCT02460458|7729878|FG000|STARTED|First Prospective Phase||177
6798171|NCT02460458|7729878|FG000|COMPLETED|First Prospective Phase||161
6798172|NCT02460458|7729878|FG000|NOT COMPLETED|First Prospective Phase||16
6798173|NCT02460458|7729878|FG000|STARTED|Confirmation of Clinical Phase Data||161
6798174|NCT02460458|7729878|FG000|COMPLETED|Confirmation of Clinical Phase Data||152
6798175|NCT02460458|7729878|FG000|NOT COMPLETED|Confirmation of Clinical Phase Data||9
6798176|NCT02460458|7729878|FG000|STARTED|Second Prospective Phase||152
6380407|NCT00778895|7291207|FG002|STARTED|ESFU Phase||43
6380408|NCT00778895|7291205|FG000|COMPLETED|ESFU Phase||153
6380409|NCT00778895|7291206|FG001|COMPLETED|ESFU Phase||155
6380410|NCT00778895|7291207|FG002|COMPLETED|ESFU Phase||41
6380411|NCT00778895|7291205|FG000|NOT COMPLETED|ESFU Phase||11
6380412|NCT00778895|7291206|FG001|NOT COMPLETED|ESFU Phase||12
6564107|NCT01809262|7486877|FG002|COMPLETED|Period 3 (Third Dose + Washout)||4
6564108|NCT01809262|7486878|FG003|COMPLETED|Period 3 (Third Dose + Washout)||3
6564109|NCT01809262|7486879|FG004|COMPLETED|Period 3 (Third Dose + Washout)||3
6564110|NCT01809262|7486880|FG005|COMPLETED|Period 3 (Third Dose + Washout)||3
6564111|NCT01809262|7486881|FG006|COMPLETED|Period 3 (Third Dose + Washout)||3
6564112|NCT01809262|7486882|FG007|COMPLETED|Period 3 (Third Dose + Washout)||4
6564113|NCT01809262|7486883|FG008|COMPLETED|Period 3 (Third Dose + Washout)||3
6564114|NCT01809262|7486884|FG009|COMPLETED|Period 3 (Third Dose + Washout)||4
6564115|NCT01809262|7486875|FG000|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564116|NCT01809262|7486876|FG001|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
6564117|NCT01809262|7486877|FG002|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564118|NCT01809262|7486878|FG003|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564119|NCT01809262|7486879|FG004|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564120|NCT01809262|7486880|FG005|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564121|NCT01809262|7486881|FG006|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564122|NCT01809262|7486882|FG007|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564123|NCT01809262|7486883|FG008|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564124|NCT01809262|7486884|FG009|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
6564125|NCT01809262|7486875|FG000|STARTED|Period 4 (Fourth Dose + Washout)||4
6564126|NCT01809262|7486876|FG001|STARTED|Period 4 (Fourth Dose + Washout)||3
6798177|NCT02460458|7729878|FG000|COMPLETED|Second Prospective Phase|Information not available yet, anticipated date is december 2022|0
6798178|NCT02460458|7729878|FG000|NOT COMPLETED|Second Prospective Phase||152
6798179|NCT02457559|7729893|FG000|STARTED|Overall Study||2
6798180|NCT02457559|7729894|FG001|STARTED|Overall Study||3
6798181|NCT02457559|7729895|FG002|STARTED|Overall Study||7
6798182|NCT02457559|7729896|FG003|STARTED|Overall Study||2
6798183|NCT02457559|7729897|FG004|STARTED|Overall Study||1
6798184|NCT02457559|7729898|FG005|STARTED|Overall Study||2
6798185|NCT02457559|7729899|FG006|STARTED|Overall Study||2
6798186|NCT02457559|7729900|FG007|STARTED|Overall Study||1
6798187|NCT02457559|7729901|FG008|STARTED|Overall Study||3
6798188|NCT02457559|7729902|FG009|STARTED|Overall Study||4
6798189|NCT02457559|7729903|FG010|STARTED|Overall Study||2
6798190|NCT02457559|7729893|FG000|COMPLETED|Overall Study||0
6798191|NCT02457559|7729894|FG001|COMPLETED|Overall Study||0
6798192|NCT02457559|7729895|FG002|COMPLETED|Overall Study||0
6798193|NCT02457559|7729896|FG003|COMPLETED|Overall Study||2
6798194|NCT02457559|7729897|FG004|COMPLETED|Overall Study||0
6798195|NCT02457559|7729898|FG005|COMPLETED|Overall Study||0
6798196|NCT02457559|7729899|FG006|COMPLETED|Overall Study||0
6798197|NCT02457559|7729900|FG007|COMPLETED|Overall Study||1
6798198|NCT02457559|7729901|FG008|COMPLETED|Overall Study||0
6798199|NCT02457559|7729902|FG009|COMPLETED|Overall Study||0
6798200|NCT02457559|7729903|FG010|COMPLETED|Overall Study||0
6798201|NCT02457559|7729893|FG000|NOT COMPLETED|Overall Study||2
6798202|NCT02457559|7729894|FG001|NOT COMPLETED|Overall Study||3
6798203|NCT02457559|7729895|FG002|NOT COMPLETED|Overall Study||7
6798204|NCT02457559|7729896|FG003|NOT COMPLETED|Overall Study||0
6798205|NCT02457559|7729897|FG004|NOT COMPLETED|Overall Study||1
6798206|NCT02457559|7729898|FG005|NOT COMPLETED|Overall Study||2
6798207|NCT02457559|7729899|FG006|NOT COMPLETED|Overall Study||2
6798208|NCT02457559|7729900|FG007|NOT COMPLETED|Overall Study||0
6798209|NCT02457559|7729901|FG008|NOT COMPLETED|Overall Study||3
6798210|NCT02457559|7729902|FG009|NOT COMPLETED|Overall Study||4
6798211|NCT02457559|7729903|FG010|NOT COMPLETED|Overall Study||2
6798212|NCT02442349|7729941|FG000|STARTED|Overall Study||171
6798213|NCT02442349|7729941|FG000|COMPLETED|Overall Study||0
6798214|NCT02442349|7729941|FG000|NOT COMPLETED|Overall Study||171
6798215|NCT02434354|7729945|FG000|STARTED|Overall Study|Consented|33
6798216|NCT02434354|7729945|FG000|Post Consent Screening|Overall Study||30
6798217|NCT02434354|7729945|FG000|COMPLETED|Overall Study||30
6798218|NCT02434354|7729945|FG000|NOT COMPLETED|Overall Study||3
6798219|NCT02417974|7729951|FG000|STARTED|Overall Study||15
6798220|NCT02417974|7729952|FG001|STARTED|Overall Study||9
6564127|NCT01809262|7486877|FG002|STARTED|Period 4 (Fourth Dose + Washout)||4
6656654|NCT02462759|7586921|FG000|NOT COMPLETED|Part 2: Open-Label Phase||0
6564128|NCT01809262|7486878|FG003|STARTED|Period 4 (Fourth Dose + Washout)||3
6798221|NCT02417974|7729951|FG000|COMPLETED|Overall Study||15
6798222|NCT02417974|7729952|FG001|COMPLETED|Overall Study||9
6798223|NCT02417974|7729951|FG000|NOT COMPLETED|Overall Study||0
6798224|NCT02417974|7729952|FG001|NOT COMPLETED|Overall Study||0
6798225|NCT02381652|7729961|FG000|STARTED|Overall Study|Cingal injection in 13-01 study; receiving a 2nd Cingal injection in 13-02|94
6798226|NCT02381652|7729962|FG001|STARTED|Overall Study|Monovisc injection in 13-01 study; receiving a Cingal injection in 13-02|98
6798227|NCT02381652|7729963|FG002|STARTED|Overall Study|Saline injection in 13-01 study; receiving a Cingal injection in 13-02|50
6564129|NCT01809262|7486879|FG004|STARTED|Period 4 (Fourth Dose + Washout)||3
6564130|NCT01809262|7486880|FG005|STARTED|Period 4 (Fourth Dose + Washout)||3
6564131|NCT01809262|7486881|FG006|STARTED|Period 4 (Fourth Dose + Washout)||3
6564132|NCT01809262|7486882|FG007|STARTED|Period 4 (Fourth Dose + Washout)||4
6564133|NCT01809262|7486883|FG008|STARTED|Period 4 (Fourth Dose + Washout)||3
6798228|NCT02381652|7729961|FG000|COMPLETED|Overall Study||94
6798229|NCT02381652|7729962|FG001|COMPLETED|Overall Study||98
6798230|NCT02381652|7729963|FG002|COMPLETED|Overall Study||49
6798231|NCT02381652|7729961|FG000|NOT COMPLETED|Overall Study||0
6798232|NCT02381652|7729962|FG001|NOT COMPLETED|Overall Study||0
6798233|NCT02381652|7729963|FG002|NOT COMPLETED|Overall Study||1
6798234|NCT02367794|7729972|FG000|STARTED|Overall Study||340
6798235|NCT02367794|7729973|FG001|STARTED|Overall Study||343
6798236|NCT02367794|7729974|FG002|STARTED|Overall Study||338
6798237|NCT02367794|7729972|FG000|COMPLETED|Overall Study||0
6798238|NCT02367794|7729973|FG001|COMPLETED|Overall Study||0
6798239|NCT02367794|7729974|FG002|COMPLETED|Overall Study||0
6798240|NCT02367794|7729972|FG000|NOT COMPLETED|Overall Study||340
6798241|NCT02367794|7729973|FG001|NOT COMPLETED|Overall Study||343
6798242|NCT02367794|7729974|FG002|NOT COMPLETED|Overall Study||338
6798243|NCT02367456|7729990|FG000|STARTED|Overall Study||12
6798244|NCT02367456|7729991|FG001|STARTED|Overall Study||30
6798245|NCT02367456|7729992|FG002|STARTED|Overall Study||30
6798246|NCT02367456|7729990|FG000|COMPLETED|Overall Study||0
6798247|NCT02367456|7729991|FG001|COMPLETED|Overall Study||0
6798248|NCT02367456|7729992|FG002|COMPLETED|Overall Study||0
6798249|NCT02367456|7729990|FG000|NOT COMPLETED|Overall Study||12
6798250|NCT02367456|7729991|FG001|NOT COMPLETED|Overall Study||30
6798251|NCT02367456|7729992|FG002|NOT COMPLETED|Overall Study||30
6798252|NCT02363998|7730005|FG000|STARTED|Overall Study||286
6798253|NCT02363998|7730005|FG000|COMPLETED|Overall Study|A subject was defined as completed if at least one dose was taken on Day 7.|168
6798254|NCT02363998|7730005|FG000|NOT COMPLETED|Overall Study||118
6798255|NCT02358031|7730028|FG000|STARTED|Overall Study||301
6798256|NCT02358031|7730029|FG001|STARTED|Overall Study||281
6798257|NCT02358031|7730030|FG002|STARTED|Overall Study||300
6798258|NCT02358031|7730028|FG000|Treated|Overall Study||300
6798259|NCT02358031|7730029|FG001|Treated|Overall Study||276
6798260|NCT02358031|7730030|FG002|Treated|Overall Study||287
6798261|NCT02358031|7730028|FG000|Pembro Mono v Control Efficacy Analyses|Overall Study||301
6798262|NCT02358031|7730029|FG001|Pembro Mono v Control Efficacy Analyses|Overall Study||0
6798263|NCT02358031|7730030|FG002|Pembro Mono v Control Efficacy Analyses|Overall Study||300
6798264|NCT02358031|7730028|FG000|Pembro Combo v Control Efficacy Analyses|Overall Study||0
6798265|NCT02358031|7730029|FG001|Pembro Combo v Control Efficacy Analyses|Overall Study||281
6798266|NCT02358031|7730030|FG002|Pembro Combo v Control Efficacy Analyses|Overall Study||278
6798267|NCT02358031|7730028|FG000|COMPLETED|Overall Study||0
6798268|NCT02358031|7730029|FG001|COMPLETED|Overall Study||0
6798269|NCT02358031|7730030|FG002|COMPLETED|Overall Study||0
6798270|NCT02358031|7730028|FG000|NOT COMPLETED|Overall Study||301
6798271|NCT02358031|7730029|FG001|NOT COMPLETED|Overall Study||281
6798272|NCT02358031|7730030|FG002|NOT COMPLETED|Overall Study||300
6798273|NCT02353832|7730038|FG000|STARTED|Overall Study||44
6798274|NCT02353832|7730038|FG000|COMPLETED|Overall Study||42
6798275|NCT02353832|7730038|FG000|NOT COMPLETED|Overall Study||2
6798276|NCT02353728|7730042|FG000|STARTED|Overall Study||16
6798277|NCT02353728|7730042|FG000|COMPLETED|Overall Study||15
6798278|NCT02353728|7730042|FG000|NOT COMPLETED|Overall Study||1
6798279|NCT02345070|7730049|FG000|STARTED|Overall Study||110
6798280|NCT02345070|7730050|FG001|STARTED|Overall Study||109
6798281|NCT02345070|7730051|FG002|STARTED|Overall Study||108
6798282|NCT02345070|7730049|FG000|Treated|Overall Study||109
6798283|NCT02345070|7730050|FG001|Treated|Overall Study||108
6798284|NCT02345070|7730051|FG002|Treated|Overall Study||108
6798285|NCT02345070|7730049|FG000|COMPLETED|Overall Study||90
6798286|NCT02345070|7730050|FG001|COMPLETED|Overall Study||98
6798287|NCT02345070|7730051|FG002|COMPLETED|Overall Study||85
6798288|NCT02345070|7730049|FG000|NOT COMPLETED|Overall Study||20
6798289|NCT02345070|7730050|FG001|NOT COMPLETED|Overall Study||11
6798290|NCT02345070|7730051|FG002|NOT COMPLETED|Overall Study||23
6798291|NCT02325466|7730059|FG000|STARTED|Period 1 Timeframe - Baseline to Week 4||23
6798292|NCT02325466|7730060|FG001|STARTED|Period 1 Timeframe - Baseline to Week 4||23
6798293|NCT02325466|7730061|FG002|STARTED|Period 1 Timeframe - Baseline to Week 4||24
6798294|NCT02325466|7730059|FG000|COMPLETED|Period 1 Timeframe - Baseline to Week 4||22
6798295|NCT02325466|7730060|FG001|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
6798296|NCT02325466|7730061|FG002|COMPLETED|Period 1 Timeframe - Baseline to Week 4||21
6798297|NCT02325466|7730059|FG000|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||1
6798298|NCT02325466|7730060|FG001|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||2
6798299|NCT02325466|7730061|FG002|NOT COMPLETED|Period 1 Timeframe - Baseline to Week 4||3
6798300|NCT02325466|7730059|FG000|STARTED|Period 2 - Timeframe Week 4 to Week 10||22
6798301|NCT02325466|7730060|FG001|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
6564134|NCT01809262|7486884|FG009|STARTED|Period 4 (Fourth Dose + Washout)||4
6798302|NCT02325466|7730061|FG002|STARTED|Period 2 - Timeframe Week 4 to Week 10||21
6798303|NCT02325466|7730059|FG000|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||19
6798304|NCT02325466|7730060|FG001|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||20
6798305|NCT02325466|7730061|FG002|COMPLETED|Period 2 - Timeframe Week 4 to Week 10||21
6798306|NCT02325466|7730059|FG000|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||3
6798307|NCT02325466|7730060|FG001|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||1
6798308|NCT02325466|7730061|FG002|NOT COMPLETED|Period 2 - Timeframe Week 4 to Week 10||0
6798309|NCT02325466|7730059|FG000|STARTED|3rd Crossover - Week 10 to Week 16||19
6798310|NCT02325466|7730060|FG001|STARTED|3rd Crossover - Week 10 to Week 16||20
6798311|NCT02325466|7730061|FG002|STARTED|3rd Crossover - Week 10 to Week 16||21
6798312|NCT02325466|7730059|FG000|COMPLETED|3rd Crossover - Week 10 to Week 16||18
6798313|NCT02325466|7730060|FG001|COMPLETED|3rd Crossover - Week 10 to Week 16||18
6798314|NCT02325466|7730061|FG002|COMPLETED|3rd Crossover - Week 10 to Week 16||21
6798315|NCT02325466|7730059|FG000|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||1
6798316|NCT02325466|7730060|FG001|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||2
6798317|NCT02325466|7730061|FG002|NOT COMPLETED|3rd Crossover - Week 10 to Week 16||0
6798318|NCT02322710|7730072|FG000|STARTED|Overall Study||105
6798319|NCT02322710|7730073|FG001|STARTED|Overall Study||99
6798320|NCT02322710|7730072|FG000|Safety Population|Overall Study||105
6798321|NCT02322710|7730073|FG001|Safety Population|Overall Study||99
6798322|NCT02322710|7730072|FG000|Full Analysis Population|Overall Study||105
6798323|NCT02322710|7730073|FG001|Full Analysis Population|Overall Study||98
6798324|NCT02322710|7730072|FG000|COMPLETED|Overall Study||85
6798325|NCT02322710|7730073|FG001|COMPLETED|Overall Study||73
6798326|NCT02322710|7730072|FG000|NOT COMPLETED|Overall Study||20
6798327|NCT02322710|7730073|FG001|NOT COMPLETED|Overall Study||26
6798328|NCT02303548|7730081|FG000|STARTED|Overall Study||25
6798329|NCT02303548|7730082|FG001|STARTED|Overall Study||25
6798330|NCT02303548|7730081|FG000|COMPLETED|Overall Study||25
6798331|NCT02303548|7730082|FG001|COMPLETED|Overall Study||25
6798332|NCT02303548|7730081|FG000|NOT COMPLETED|Overall Study||0
6798333|NCT02303548|7730082|FG001|NOT COMPLETED|Overall Study||0
6798334|NCT02292654|7730091|FG000|STARTED|Overall Study||4
6798335|NCT02292654|7730092|FG001|STARTED|Overall Study||9
6798336|NCT02292654|7730093|FG002|STARTED|Overall Study||7
6798337|NCT02292654|7730091|FG000|COMPLETED|Overall Study||4
6798338|NCT02292654|7730092|FG001|COMPLETED|Overall Study||9
6798339|NCT02292654|7730093|FG002|COMPLETED|Overall Study||7
6798340|NCT02292654|7730091|FG000|NOT COMPLETED|Overall Study||0
6798341|NCT02292654|7730092|FG001|NOT COMPLETED|Overall Study||0
6798342|NCT02292654|7730093|FG002|NOT COMPLETED|Overall Study||0
6798343|NCT02251548|7730107|FG000|STARTED|Overall Study||85
6798344|NCT02251548|7730107|FG000|COMPLETED|Overall Study||0
6798345|NCT02251548|7730107|FG000|NOT COMPLETED|Overall Study||85
6798346|NCT02239354|7730114|FG000|STARTED|Overall Study||19
6798347|NCT02239354|7730115|FG001|STARTED|Overall Study||0
6798348|NCT02239354|7730114|FG000|COMPLETED|Overall Study||9
6798349|NCT02239354|7730115|FG001|COMPLETED|Overall Study||0
6798350|NCT02239354|7730114|FG000|NOT COMPLETED|Overall Study||10
6798351|NCT02239354|7730115|FG001|NOT COMPLETED|Overall Study||0
6798352|NCT02234310|7730121|FG000|STARTED|Overall Study||33
6798353|NCT02234310|7730121|FG000|Episodic Treatment Regimen|Overall Study|Participants were treated in more than one regimen and counted in all categories wherever applicable|22
6798354|NCT02234310|7730121|FG000|Prophylactic Treatment Regimen|Overall Study|17 participants among the 22 who started in episodic regimen, switched to the prophylactic regimen.|28
6798355|NCT02234310|7730121|FG000|COMPLETED|Overall Study||27
6798356|NCT02234310|7730121|FG000|NOT COMPLETED|Overall Study||6
6798357|NCT02212015|7730125|FG000|STARTED|Overall Study||26
6798358|NCT02212015|7730125|FG000|COMPLETED|Overall Study||25
6380413|NCT00778895|7291207|FG002|NOT COMPLETED|ESFU Phase||2
6380414|NCT00778921|7291219|FG000|STARTED|Overall Study||279
6380415|NCT00778921|7291220|FG001|STARTED|Overall Study||285
6502527|NCT01435759|7421254|FG002|STARTED|Double-blind Phase|One subject was not dosed.|78
6502528|NCT01435759|7421255|FG003|STARTED|Double-blind Phase|Two subjects were not dosed.|78
6798359|NCT02212015|7730125|FG000|NOT COMPLETED|Overall Study||1
6798360|NCT02158091|7730135|FG000|STARTED|Overall Study||6
6798361|NCT02158091|7730136|FG001|STARTED|Overall Study||6
6798362|NCT02158091|7730137|FG002|STARTED|Overall Study||20
6798363|NCT02158091|7730135|FG000|COMPLETED|Overall Study||4
6798364|NCT02158091|7730136|FG001|COMPLETED|Overall Study||5
6798365|NCT02158091|7730137|FG002|COMPLETED|Overall Study||20
6798366|NCT02158091|7730135|FG000|NOT COMPLETED|Overall Study||2
6798367|NCT02158091|7730136|FG001|NOT COMPLETED|Overall Study||1
6798368|NCT02158091|7730137|FG002|NOT COMPLETED|Overall Study||0
6798369|NCT02139436|7730148|FG000|STARTED|Overall Study||41
6798370|NCT02139436|7730149|FG001|STARTED|Overall Study||14
6380416|NCT00778921|7291221|FG002|STARTED|Overall Study||283
6380417|NCT00778921|7291219|FG000|COMPLETED|Overall Study||261
6380418|NCT00778921|7291220|FG001|COMPLETED|Overall Study||266
6380419|NCT00778921|7291221|FG002|COMPLETED|Overall Study||255
6380420|NCT00778921|7291219|FG000|NOT COMPLETED|Overall Study||18
6380421|NCT00778921|7291220|FG001|NOT COMPLETED|Overall Study||19
6380422|NCT00778921|7291221|FG002|NOT COMPLETED|Overall Study||28
6380423|NCT00779025|7291229|FG000|STARTED|Overall Study||82
6502529|NCT01435759|7421256|FG004|STARTED|Double-blind Phase||78
6502530|NCT01435759|7421257|FG005|STARTED|Double-blind Phase||80
6380424|NCT00779025|7291229|FG000|COMPLETED|Overall Study||81
6798371|NCT02139436|7730150|FG002|STARTED|Overall Study||13
6798372|NCT02139436|7730148|FG000|COMPLETED|Overall Study||41
6798373|NCT02139436|7730149|FG001|COMPLETED|Overall Study||14
6798374|NCT02139436|7730150|FG002|COMPLETED|Overall Study||13
6798375|NCT02139436|7730148|FG000|NOT COMPLETED|Overall Study||0
6798376|NCT02139436|7730149|FG001|NOT COMPLETED|Overall Study||0
6798377|NCT02139436|7730150|FG002|NOT COMPLETED|Overall Study||0
6798378|NCT02120079|7730166|FG000|STARTED|Baseline||17
6798379|NCT02120079|7730167|FG001|STARTED|Baseline||20
6798380|NCT02120079|7730166|FG000|COMPLETED|Baseline||17
6798381|NCT02120079|7730167|FG001|COMPLETED|Baseline||20
6798382|NCT02120079|7730166|FG000|NOT COMPLETED|Baseline||0
6798383|NCT02120079|7730167|FG001|NOT COMPLETED|Baseline||0
6798384|NCT02120079|7730166|FG000|STARTED|2 Weeks||17
6798385|NCT02120079|7730167|FG001|STARTED|2 Weeks||20
6798386|NCT02120079|7730166|FG000|COMPLETED|2 Weeks||17
6798387|NCT02120079|7730167|FG001|COMPLETED|2 Weeks||20
6798388|NCT02120079|7730166|FG000|NOT COMPLETED|2 Weeks||0
6798389|NCT02120079|7730167|FG001|NOT COMPLETED|2 Weeks||0
6798390|NCT02120079|7730166|FG000|STARTED|6 Weeks||17
6798391|NCT02120079|7730167|FG001|STARTED|6 Weeks||20
6798392|NCT02120079|7730166|FG000|COMPLETED|6 Weeks||17
6798393|NCT02120079|7730167|FG001|COMPLETED|6 Weeks||20
6798394|NCT02120079|7730166|FG000|NOT COMPLETED|6 Weeks||0
6798395|NCT02120079|7730167|FG001|NOT COMPLETED|6 Weeks||0
6798396|NCT02112526|7730176|FG000|STARTED|Overall Study||11
6798397|NCT02112526|7730177|FG001|STARTED|Overall Study||10
6798398|NCT02112526|7730176|FG000|Enrolled|Overall Study||11
6380425|NCT00779025|7291229|FG000|NOT COMPLETED|Overall Study||1
6380426|NCT00779103|7291234|FG000|STARTED|Overall Study|Initial Phase (First Implant) - 36 Completed|36
6380427|NCT00779103|7291234|FG000|Second & Third Implant|Overall Study|Initial Extension Phase/Extended Access Phase (Second and Third Implant) - 22 Completed|31
6380428|NCT00779103|7291234|FG000|Fourth Implant|Overall Study|Second Extension Phase (4th Implant with Yearly Implantations till no longer required): 11 Completed|13
6380429|NCT00779103|7291234|FG000|No Treatment|Overall Study|Optional Long Term Follow-up Phase (No Treatment)|9
6380430|NCT00779103|7291234|FG000|COMPLETED|Overall Study|Initial Phase (First Implant)|36
6380431|NCT00779103|7291234|FG000|NOT COMPLETED|Overall Study||0
6380432|NCT00779142|7291242|FG000|STARTED|Overall Study|5 patients signed consent and were screened.|5
6380433|NCT00779142|7291242|FG000|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
6380434|NCT00779142|7291242|FG000|NOT COMPLETED|Overall Study||3
6380435|NCT00779155|7291249|FG000|STARTED|Overall Study||6
6380436|NCT00779155|7291250|FG001|STARTED|Overall Study||6
6380437|NCT00779155|7291249|FG000|COMPLETED|Overall Study||6
6380438|NCT00779155|7291250|FG001|COMPLETED|Overall Study||6
6380439|NCT00779155|7291249|FG000|NOT COMPLETED|Overall Study||0
6380440|NCT00779155|7291250|FG001|NOT COMPLETED|Overall Study||0
6380441|NCT00779246|7291258|FG000|STARTED|Overall Study||750
6380442|NCT00779246|7291259|FG001|STARTED|Overall Study||768
6380443|NCT00779246|7291258|FG000|COMPLETED|Overall Study||717
6380444|NCT00779246|7291259|FG001|COMPLETED|Overall Study||715
6380445|NCT00779246|7291258|FG000|NOT COMPLETED|Overall Study||33
6380446|NCT00779246|7291259|FG001|NOT COMPLETED|Overall Study||53
6380447|NCT00779259|7291265|FG000|STARTED|Theophylline Alone||24
6380448|NCT00779259|7291265|FG000|COMPLETED|Theophylline Alone||24
6380449|NCT00779259|7291265|FG000|NOT COMPLETED|Theophylline Alone||0
6380450|NCT00779259|7291265|FG000|STARTED|4 Day Washout Period||24
6380451|NCT00779259|7291265|FG000|COMPLETED|4 Day Washout Period||24
6380452|NCT00779259|7291265|FG000|NOT COMPLETED|4 Day Washout Period||0
6380453|NCT00779259|7291265|FG000|STARTED|Quinine Alone||24
6380454|NCT00779259|7291265|FG000|COMPLETED|Quinine Alone||22
6380455|NCT00779259|7291265|FG000|NOT COMPLETED|Quinine Alone||2
6380456|NCT00779259|7291265|FG000|STARTED|Theophylline With Quinine||22
6380457|NCT00779259|7291265|FG000|COMPLETED|Theophylline With Quinine||22
6380458|NCT00779259|7291265|FG000|NOT COMPLETED|Theophylline With Quinine||0
6380459|NCT00779285|7291283|FG000|STARTED|Overall Study||1
6380460|NCT00779285|7291283|FG000|COMPLETED|Overall Study||1
6380461|NCT00779285|7291283|FG000|NOT COMPLETED|Overall Study||0
6380462|NCT00779311|7291292|FG000|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
6380463|NCT00779311|7291293|FG001|STARTED|Overall Study||0
6380464|NCT00779311|7291294|FG002|STARTED|Overall Study||0
6380465|NCT00779311|7291295|FG003|STARTED|Overall Study||0
6380466|NCT00779311|7291296|FG004|STARTED|Overall Study||0
6380467|NCT00779311|7291292|FG000|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
6380468|NCT00779311|7291293|FG001|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
6380469|NCT00779311|7291294|FG002|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
6380470|NCT00779311|7291295|FG003|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
6380471|NCT00779311|7291296|FG004|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
6380472|NCT00779311|7291292|FG000|COMPLETED|Overall Study||8
6380473|NCT00779311|7291293|FG001|COMPLETED|Overall Study||0
6380474|NCT00779311|7291294|FG002|COMPLETED|Overall Study||0
6380475|NCT00779311|7291295|FG003|COMPLETED|Overall Study||0
6502531|NCT01435759|7421252|FG000|COMPLETED|Double-blind Phase||397
6502532|NCT01435759|7421253|FG001|COMPLETED|Double-blind Phase||71
6502533|NCT01435759|7421254|FG002|COMPLETED|Double-blind Phase||71
6798399|NCT02112526|7730177|FG001|Enrolled|Overall Study||10
6798400|NCT02112526|7730176|FG000|Received Study Medication|Overall Study||11
6798401|NCT02112526|7730177|FG001|Received Study Medication|Overall Study||10
6798402|NCT02112526|7730176|FG000|Discontinued Study|Overall Study||11
6798403|NCT02112526|7730177|FG001|Discontinued Study|Overall Study||9
6798404|NCT02112526|7730176|FG000|Subjects Continuing Study Medication|Overall Study||0
6798405|NCT02112526|7730177|FG001|Subjects Continuing Study Medication|Overall Study||1
6798406|NCT02112526|7730176|FG000|COMPLETED|Overall Study||0
6798407|NCT02112526|7730177|FG001|COMPLETED|Overall Study||1
6798408|NCT02112526|7730176|FG000|NOT COMPLETED|Overall Study||11
6798409|NCT02112526|7730177|FG001|NOT COMPLETED|Overall Study||9
6798410|NCT02106195|7730183|FG000|STARTED|Overall Study||8
6798411|NCT02106195|7730183|FG000|COMPLETED|Overall Study|Includes all 3 periods of study: Screening, Treatment, Post-treatment|5
6798412|NCT02106195|7730183|FG000|NOT COMPLETED|Overall Study||3
6798413|NCT02104180|7730195|FG000|STARTED|Overall Study||31
6798414|NCT02104180|7730196|FG001|STARTED|Overall Study||31
6798415|NCT02104180|7730195|FG000|COMPLETED|Overall Study||30
6798416|NCT02104180|7730196|FG001|COMPLETED|Overall Study||31
6798417|NCT02104180|7730195|FG000|NOT COMPLETED|Overall Study||1
6798418|NCT02104180|7730196|FG001|NOT COMPLETED|Overall Study||0
6798419|NCT02075840|7730204|FG000|STARTED|Overall Study||152
6798420|NCT02075840|7730205|FG001|STARTED|Overall Study||151
6798421|NCT02075840|7730204|FG000|COMPLETED|Overall Study||0
6798422|NCT02075840|7730205|FG001|COMPLETED|Overall Study||0
6798423|NCT02075840|7730204|FG000|NOT COMPLETED|Overall Study||152
6798424|NCT02075840|7730205|FG001|NOT COMPLETED|Overall Study||151
6798425|NCT02066181|7730213|FG000|STARTED|Overall Study||50
6798426|NCT02066181|7730214|FG001|STARTED|Overall Study||37
6798427|NCT02066181|7730213|FG000|Crossed Over|Overall Study||0
6798428|NCT02066181|7730214|FG001|Crossed Over|Overall Study||28
6798429|NCT02066181|7730213|FG000|COMPLETED|Overall Study||49
6798430|NCT02066181|7730214|FG001|COMPLETED|Overall Study||36
6798431|NCT02066181|7730213|FG000|NOT COMPLETED|Overall Study||1
6798432|NCT02066181|7730214|FG001|NOT COMPLETED|Overall Study||1
6798433|NCT02050919|7730223|FG000|STARTED|Overall Study||20
6798434|NCT02050919|7730223|FG000|COMPLETED|Overall Study||20
6798435|NCT02050919|7730223|FG000|NOT COMPLETED|Overall Study||0
6798436|NCT02040857|7730227|FG000|STARTED|Overall Study||162
6798437|NCT02040857|7730227|FG000|Treatment Discontinuation Evaluable|Overall Study|Evaluable population excludes participants who discontinue early for reasons unrelated to treatment.|152
6798438|NCT02040857|7730227|FG000|COMPLETED|Overall Study||102
6798439|NCT02040857|7730227|FG000|NOT COMPLETED|Overall Study||60
6798440|NCT01997463|7730236|FG000|STARTED|Overall Study||192
6798441|NCT01997463|7730237|FG001|STARTED|Overall Study||250
6798442|NCT01997463|7730236|FG000|COMPLETED|Overall Study||107
6798443|NCT01997463|7730237|FG001|COMPLETED|Overall Study||147
6798444|NCT01997463|7730236|FG000|NOT COMPLETED|Overall Study||85
6798445|NCT01997463|7730237|FG001|NOT COMPLETED|Overall Study||103
6798446|NCT01943825|7730247|FG000|STARTED|Overall Study||25
6798447|NCT01943825|7730248|FG001|STARTED|Overall Study||15
6798448|NCT01943825|7730249|FG002|STARTED|Overall Study||25
6798449|NCT01943825|7730250|FG003|STARTED|Overall Study||25
6798450|NCT01943825|7730247|FG000|COMPLETED|Overall Study||15
6798451|NCT01943825|7730248|FG001|COMPLETED|Overall Study||11
6798452|NCT01943825|7730249|FG002|COMPLETED|Overall Study||10
6798453|NCT01943825|7730250|FG003|COMPLETED|Overall Study||14
6798454|NCT01943825|7730247|FG000|NOT COMPLETED|Overall Study||10
6798455|NCT01943825|7730248|FG001|NOT COMPLETED|Overall Study||4
6798456|NCT01943825|7730249|FG002|NOT COMPLETED|Overall Study||15
6798457|NCT01943825|7730250|FG003|NOT COMPLETED|Overall Study||11
6798458|NCT01940471|7730266|FG000|STARTED|Double-Blind Phase||582
6798459|NCT01940471|7730267|FG001|STARTED|Double-Blind Phase||293
6798460|NCT01940471|7730266|FG000|COMPLETED|Double-Blind Phase||14
6798461|NCT01940471|7730267|FG001|COMPLETED|Double-Blind Phase||8
6798462|NCT01940471|7730266|FG000|NOT COMPLETED|Double-Blind Phase||568
6798463|NCT01940471|7730267|FG001|NOT COMPLETED|Double-Blind Phase||285
6798464|NCT01940471|7730266|FG000|STARTED|Open-Label Extension||14
6798465|NCT01940471|7730267|FG001|STARTED|Open-Label Extension||8
6798466|NCT01940471|7730266|FG000|COMPLETED|Open-Label Extension||0
6798467|NCT01940471|7730267|FG001|COMPLETED|Open-Label Extension||0
6798468|NCT01940471|7730266|FG000|NOT COMPLETED|Open-Label Extension||14
6798469|NCT01940471|7730267|FG001|NOT COMPLETED|Open-Label Extension||8
6798470|NCT01909453|7730279|FG000|STARTED|Overall Study||192
6798471|NCT01909453|7730280|FG001|STARTED|Overall Study||194
6798472|NCT01909453|7730281|FG002|STARTED|Overall Study||191
6798473|NCT01909453|7730282|FG003|STARTED|Overall Study||258
6798474|NCT01909453|7730283|FG004|STARTED|Overall Study||86
6798475|NCT01909453|7730279|FG000|COMPLETED|Overall Study||0
6798476|NCT01909453|7730280|FG001|COMPLETED|Overall Study||0
6798477|NCT01909453|7730281|FG002|COMPLETED|Overall Study||0
6798478|NCT01909453|7730282|FG003|COMPLETED|Overall Study||0
6798479|NCT01909453|7730283|FG004|COMPLETED|Overall Study||0
6798480|NCT01909453|7730279|FG000|NOT COMPLETED|Overall Study||192
6798481|NCT01909453|7730280|FG001|NOT COMPLETED|Overall Study||194
6798482|NCT01909453|7730281|FG002|NOT COMPLETED|Overall Study||191
6798483|NCT01909453|7730282|FG003|NOT COMPLETED|Overall Study||258
6798484|NCT01909453|7730283|FG004|NOT COMPLETED|Overall Study||86
6798485|NCT01874353|7730303|FG000|STARTED|Overall Study||196
6798486|NCT01874353|7730304|FG001|STARTED|Overall Study||99
6798487|NCT01874353|7730305|FG002|STARTED|Overall Study||22
6798488|NCT01874353|7730306|FG003|STARTED|Overall Study||10
6798489|NCT01874353|7730303|FG000|COMPLETED|Overall Study||69
6798490|NCT01874353|7730304|FG001|COMPLETED|Overall Study||26
6798491|NCT01874353|7730305|FG002|COMPLETED|Overall Study||7
6798492|NCT01874353|7730306|FG003|COMPLETED|Overall Study||3
6798493|NCT01874353|7730303|FG000|NOT COMPLETED|Overall Study||127
6798494|NCT01874353|7730304|FG001|NOT COMPLETED|Overall Study||73
6798495|NCT01874353|7730305|FG002|NOT COMPLETED|Overall Study||15
6798496|NCT01874353|7730306|FG003|NOT COMPLETED|Overall Study||7
6798497|NCT01863186|7730321|FG000|STARTED|Double-blind Phase|Original number of 230. One participant was randomly assigned into the study, but not dosed.|229
6798498|NCT01863186|7730322|FG001|STARTED|Double-blind Phase||222
6798499|NCT01863186|7730323|FG002|STARTED|Double-blind Phase||151
6798500|NCT01863186|7730324|FG003|STARTED|Double-blind Phase||0
6798501|NCT01863186|7730321|FG000|COMPLETED|Double-blind Phase||95
6798502|NCT01863186|7730322|FG001|COMPLETED|Double-blind Phase||88
6798503|NCT01863186|7730323|FG002|COMPLETED|Double-blind Phase||42
6798504|NCT01863186|7730324|FG003|COMPLETED|Double-blind Phase||0
6798505|NCT01863186|7730321|FG000|NOT COMPLETED|Double-blind Phase||134
6798506|NCT01863186|7730322|FG001|NOT COMPLETED|Double-blind Phase||134
6798507|NCT01863186|7730323|FG002|NOT COMPLETED|Double-blind Phase||109
6798508|NCT01863186|7730324|FG003|NOT COMPLETED|Double-blind Phase||0
6798509|NCT01863186|7730321|FG000|STARTED|Open-label Phase||0
6798510|NCT01863186|7730322|FG001|STARTED|Open-label Phase||0
6798511|NCT01863186|7730323|FG002|STARTED|Open-label Phase|No placebo group in the Open-label Phase.|0
6798512|NCT01863186|7730324|FG003|STARTED|Open-label Phase|36 from 2.4 mg group, 28 from 3.2mg group, and 19 from Placebo continued to the Open-label phase.|83
6798513|NCT01863186|7730321|FG000|COMPLETED|Open-label Phase||0
6798514|NCT01863186|7730322|FG001|COMPLETED|Open-label Phase||0
6798515|NCT01863186|7730323|FG002|COMPLETED|Open-label Phase||0
6798516|NCT01863186|7730324|FG003|COMPLETED|Open-label Phase||70
6798517|NCT01863186|7730321|FG000|NOT COMPLETED|Open-label Phase||0
6798518|NCT01863186|7730322|FG001|NOT COMPLETED|Open-label Phase||0
6798519|NCT01863186|7730323|FG002|NOT COMPLETED|Open-label Phase||0
6798520|NCT01863186|7730324|FG003|NOT COMPLETED|Open-label Phase||13
6798521|NCT01856192|7730335|FG000|STARTED|Overall Study||173
6798522|NCT01856192|7730336|FG001|STARTED|Overall Study||176
6798523|NCT01856192|7730335|FG000|Treated Patients|Overall Study||166
6798524|NCT01856192|7730336|FG001|Treated Patients|Overall Study||171
6798525|NCT01856192|7730335|FG000|Evaluable Patients (Eligible and Treated)|Overall Study||145
6798526|NCT01856192|7730336|FG001|Evaluable Patients (Eligible and Treated)|Overall Study||135
6798527|NCT01856192|7730335|FG000|COMPLETED|Overall Study||124
6798528|NCT01856192|7730336|FG001|COMPLETED|Overall Study||116
6502534|NCT01435759|7421255|FG003|COMPLETED|Double-blind Phase||69
6502535|NCT01435759|7421256|FG004|COMPLETED|Double-blind Phase||69
6502536|NCT01435759|7421257|FG005|COMPLETED|Double-blind Phase||71
6798529|NCT01856192|7730335|FG000|NOT COMPLETED|Overall Study||49
6798530|NCT01856192|7730336|FG001|NOT COMPLETED|Overall Study||60
6798531|NCT01853748|7730344|FG000|STARTED|Allocation||384
6798532|NCT01853748|7730345|FG001|STARTED|Allocation||128
6798533|NCT01853748|7730344|FG000|COMPLETED|Allocation||383
6798534|NCT01853748|7730345|FG001|COMPLETED|Allocation||114
6798535|NCT01853748|7730344|FG000|NOT COMPLETED|Allocation||1
6798536|NCT01853748|7730345|FG001|NOT COMPLETED|Allocation||14
6798537|NCT01853748|7730344|FG000|STARTED|Follow-Up||383
6798538|NCT01853748|7730345|FG001|STARTED|Follow-Up||114
6798539|NCT01853748|7730344|FG000|COMPLETED|Follow-Up||293
6798540|NCT01853748|7730345|FG001|COMPLETED|Follow-Up||97
6798541|NCT01853748|7730344|FG000|NOT COMPLETED|Follow-Up||90
6798542|NCT01853748|7730345|FG001|NOT COMPLETED|Follow-Up||17
6798543|NCT01843374|7730362|FG000|STARTED|Overall Study||189
6798544|NCT01843374|7730363|FG001|STARTED|Overall Study||382
6798545|NCT01843374|7730362|FG000|RANDOMIZED|Overall Study||189
6798546|NCT01843374|7730363|FG001|RANDOMIZED|Overall Study||382
6798547|NCT01843374|7730362|FG000|COMPLETED|Overall Study||0
6798548|NCT01843374|7730363|FG001|COMPLETED|Overall Study||3
6798549|NCT01843374|7730362|FG000|NOT COMPLETED|Overall Study||189
6798550|NCT01843374|7730363|FG001|NOT COMPLETED|Overall Study||379
6798551|NCT01841736|7730374|FG000|STARTED|Overall Study||97
6798552|NCT01841736|7730375|FG001|STARTED|Overall Study||74
6798553|NCT01841736|7730374|FG000|Crossover|Overall Study||0
6798554|NCT01841736|7730375|FG001|Crossover|Overall Study||49
6798555|NCT01841736|7730374|FG000|COMPLETED|Overall Study||97
6798556|NCT01841736|7730375|FG001|COMPLETED|Overall Study||74
6798557|NCT01841736|7730374|FG000|NOT COMPLETED|Overall Study||0
6798558|NCT01841736|7730375|FG001|NOT COMPLETED|Overall Study||0
6798559|NCT01817751|7730382|FG000|STARTED|Overall Study||47
6798560|NCT01817751|7730382|FG000|COMPLETED|Overall Study||46
6798561|NCT01817751|7730382|FG000|NOT COMPLETED|Overall Study||1
6798562|NCT01722331|7730389|FG000|STARTED|Part 1||308
6798563|NCT01722331|7730390|FG001|STARTED|Part 1||249
6798564|NCT01722331|7730391|FG002|STARTED|Part 1||41
6798565|NCT01722331|7730392|FG003|STARTED|Part 1||19
6798566|NCT01722331|7730393|FG004|STARTED|Part 1||9
6798567|NCT01722331|7730394|FG005|STARTED|Part 1||72
6798568|NCT01722331|7730395|FG006|STARTED|Part 1||74
6798569|NCT01722331|7730389|FG000|COMPLETED|Part 1||298
6798570|NCT01722331|7730390|FG001|COMPLETED|Part 1||249
6798571|NCT01722331|7730391|FG002|COMPLETED|Part 1||32
6798572|NCT01722331|7730392|FG003|COMPLETED|Part 1||19
6798573|NCT01722331|7730393|FG004|COMPLETED|Part 1||0
6798574|NCT01722331|7730394|FG005|COMPLETED|Part 1||72
6798575|NCT01722331|7730395|FG006|COMPLETED|Part 1||74
6798576|NCT01722331|7730389|FG000|NOT COMPLETED|Part 1||10
6798577|NCT01722331|7730390|FG001|NOT COMPLETED|Part 1||0
6798578|NCT01722331|7730391|FG002|NOT COMPLETED|Part 1||9
6798579|NCT01722331|7730392|FG003|NOT COMPLETED|Part 1||0
6798580|NCT01722331|7730393|FG004|NOT COMPLETED|Part 1||9
6798581|NCT01722331|7730394|FG005|NOT COMPLETED|Part 1||0
6798582|NCT01722331|7730395|FG006|NOT COMPLETED|Part 1||0
6798583|NCT01722331|7730389|FG000|STARTED|Part 2||298
6798584|NCT01722331|7730390|FG001|STARTED|Part 2||249
6798585|NCT01722331|7730391|FG002|STARTED|Part 2|1 participant who completed Part 1 did not enter Part 2|31
6798586|NCT01722331|7730392|FG003|STARTED|Part 2||19
6798587|NCT01722331|7730393|FG004|STARTED|Part 2||0
6798588|NCT01722331|7730394|FG005|STARTED|Part 2||72
6798589|NCT01722331|7730395|FG006|STARTED|Part 2||74
6798590|NCT01722331|7730389|FG000|COMPLETED|Part 2||279
6798591|NCT01722331|7730390|FG001|COMPLETED|Part 2||249
6798592|NCT01722331|7730391|FG002|COMPLETED|Part 2||0
6798593|NCT01722331|7730392|FG003|COMPLETED|Part 2||19
6798594|NCT01722331|7730393|FG004|COMPLETED|Part 2||0
6798595|NCT01722331|7730394|FG005|COMPLETED|Part 2||62
6798596|NCT01722331|7730395|FG006|COMPLETED|Part 2||67
6798597|NCT01722331|7730389|FG000|NOT COMPLETED|Part 2||19
6798598|NCT01722331|7730390|FG001|NOT COMPLETED|Part 2||0
6798599|NCT01722331|7730391|FG002|NOT COMPLETED|Part 2||31
6798600|NCT01722331|7730392|FG003|NOT COMPLETED|Part 2||0
6798601|NCT01722331|7730393|FG004|NOT COMPLETED|Part 2||0
6798602|NCT01722331|7730394|FG005|NOT COMPLETED|Part 2||10
6798603|NCT01722331|7730395|FG006|NOT COMPLETED|Part 2||7
6798604|NCT01722331|7730389|FG000|STARTED|Part 3||279
6798605|NCT01722331|7730390|FG001|STARTED|Part 3||249
6798606|NCT01722331|7730391|FG002|STARTED|Part 3||0
6798607|NCT01722331|7730392|FG003|STARTED|Part 3||19
6798608|NCT01722331|7730393|FG004|STARTED|Part 3||0
6798609|NCT01722331|7730394|FG005|STARTED|Part 3||62
6798610|NCT01722331|7730395|FG006|STARTED|Part 3||67
6798611|NCT01722331|7730389|FG000|COMPLETED|Part 3||264
6798612|NCT01722331|7730390|FG001|COMPLETED|Part 3||232
6798613|NCT01722331|7730391|FG002|COMPLETED|Part 3||0
6798614|NCT01722331|7730392|FG003|COMPLETED|Part 3||18
6798615|NCT01722331|7730393|FG004|COMPLETED|Part 3||0
6798616|NCT01722331|7730394|FG005|COMPLETED|Part 3||59
6798617|NCT01722331|7730395|FG006|COMPLETED|Part 3||65
6798618|NCT01722331|7730389|FG000|NOT COMPLETED|Part 3||15
6798619|NCT01722331|7730390|FG001|NOT COMPLETED|Part 3||17
6798620|NCT01722331|7730391|FG002|NOT COMPLETED|Part 3||0
6798621|NCT01722331|7730392|FG003|NOT COMPLETED|Part 3||1
6798622|NCT01722331|7730393|FG004|NOT COMPLETED|Part 3||0
6798623|NCT01722331|7730394|FG005|NOT COMPLETED|Part 3||3
6798624|NCT01722331|7730395|FG006|NOT COMPLETED|Part 3||2
6798625|NCT01716117|7730409|FG000|STARTED|Overall Study||180
6798626|NCT01716117|7730410|FG001|STARTED|Overall Study||33
6798627|NCT01716117|7730409|FG000|Discharge|Overall Study||177
6798628|NCT01716117|7730410|FG001|Discharge|Overall Study||33
6798629|NCT01716117|7730409|FG000|1-Month Visit|Overall Study||176
6798630|NCT01716117|7730410|FG001|1-Month Visit|Overall Study||33
6798631|NCT01716117|7730409|FG000|6-Month Visit|Overall Study||174
6798632|NCT01716117|7730410|FG001|6-Month Visit|Overall Study||32
6798633|NCT01716117|7730409|FG000|COMPLETED|Overall Study||173
6798634|NCT01716117|7730410|FG001|COMPLETED|Overall Study||31
6798635|NCT01716117|7730409|FG000|NOT COMPLETED|Overall Study||7
6798636|NCT01716117|7730410|FG001|NOT COMPLETED|Overall Study||2
6798637|NCT01698905|7730424|FG000|STARTED|Overall Study||163
6798638|NCT01698905|7730424|FG000|Still on Study Phase|Overall Study||0
6798639|NCT01698905|7730424|FG000|TFR Phase|Overall Study||126
6798640|NCT01698905|7730424|FG000|NTRI Phase|Overall Study||51
6798641|NCT01698905|7730424|FG000|NTCT Phase|Overall Study||26
6798642|NCT01698905|7730424|FG000|TFR-2 Phase|Overall Study||2
6798643|NCT01698905|7730424|FG000|NTRI-2 Phase|Overall Study||1
6798644|NCT01698905|7730424|FG000|NTCT-P Phase Phase|Overall Study||6
6798645|NCT01698905|7730424|FG000|COMPLETED|Overall Study||152
6798646|NCT01698905|7730424|FG000|NOT COMPLETED|Overall Study||11
6798647|NCT01676350|7730437|FG000|STARTED|Overall Study||11
6798648|NCT01676350|7730438|FG001|STARTED|Overall Study||11
6798649|NCT01676350|7730437|FG000|COMPLETED|Overall Study||11
6798650|NCT01676350|7730438|FG001|COMPLETED|Overall Study||11
6798651|NCT01676350|7730437|FG000|NOT COMPLETED|Overall Study||0
6798652|NCT01676350|7730438|FG001|NOT COMPLETED|Overall Study||0
6798653|NCT01670500|7730447|FG000|STARTED|Overall Study||58
6798654|NCT01670500|7730448|FG001|STARTED|Overall Study||60
6798655|NCT01670500|7730447|FG000|COMPLETED|Overall Study|1 patient withdrew after 3 cycles; 5 patients received additional non-protocol chemo before surgery|57
6798656|NCT01670500|7730448|FG001|COMPLETED|Overall Study|4 pts received <4 cycles of assigned chemo; 2 pts received add'l non-protocol chemo before surgery|60
6798657|NCT01670500|7730447|FG000|NOT COMPLETED|Overall Study||1
6502537|NCT01435759|7421252|FG000|NOT COMPLETED|Double-blind Phase||66
6502538|NCT01435759|7421253|FG001|NOT COMPLETED|Double-blind Phase||7
6798658|NCT01670500|7730448|FG001|NOT COMPLETED|Overall Study||0
6798659|NCT01630590|7730454|FG000|STARTED|Overall Study||62
6502539|NCT01435759|7421254|FG002|NOT COMPLETED|Double-blind Phase||7
6502540|NCT01435759|7421255|FG003|NOT COMPLETED|Double-blind Phase||9
6798660|NCT01630590|7730454|FG000|COMPLETED|Overall Study||5
6798661|NCT01630590|7730454|FG000|NOT COMPLETED|Overall Study||57
6798662|NCT01619085|7730458|FG000|STARTED|Overall Study||752
6798663|NCT01619085|7730458|FG000|Treated|Overall Study||751
6798664|NCT01619085|7730458|FG000|COMPLETED|Overall Study||227
6798665|NCT01619085|7730458|FG000|NOT COMPLETED|Overall Study||525
6798666|NCT01499095|7730471|FG000|STARTED|Overall Study||404
6798667|NCT01499095|7730472|FG001|STARTED|Overall Study||407
6798668|NCT01499095|7730471|FG000|Treated|Overall Study||403
6798669|NCT01499095|7730472|FG001|Treated|Overall Study||406
6798670|NCT01499095|7730471|FG000|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
6798671|NCT01499095|7730472|FG001|Participated in Substudy|Overall Study||0
6798672|NCT01499095|7730471|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
6798673|NCT01499095|7730472|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
6798674|NCT01499095|7730471|FG000|COMPLETED|Overall Study||315
6798675|NCT01499095|7730472|FG001|COMPLETED|Overall Study||314
6798676|NCT01499095|7730471|FG000|NOT COMPLETED|Overall Study||89
6798677|NCT01499095|7730472|FG001|NOT COMPLETED|Overall Study||93
6798678|NCT01499082|7730483|FG000|STARTED|Overall Study||404
6798679|NCT01499082|7730484|FG001|STARTED|Overall Study||403
6798680|NCT01499082|7730483|FG000|Treated|Overall Study||404
6798681|NCT01499082|7730484|FG001|Treated|Overall Study||402
6798682|NCT01499082|7730483|FG000|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
6798683|NCT01499082|7730484|FG001|Participated in Substudy|Overall Study||0
6798684|NCT01499082|7730483|FG000|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
6798685|NCT01499082|7730484|FG001|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
6798686|NCT01499082|7730483|FG000|COMPLETED|Overall Study||359
6798687|NCT01499082|7730484|FG001|COMPLETED|Overall Study||355
6798688|NCT01499082|7730483|FG000|NOT COMPLETED|Overall Study||45
6798689|NCT01499082|7730484|FG001|NOT COMPLETED|Overall Study||48
6798690|NCT01496976|7730492|FG000|STARTED|Overall Study||45
6798691|NCT01496976|7730492|FG000|COMPLETED|Overall Study||44
6798692|NCT01496976|7730492|FG000|NOT COMPLETED|Overall Study||1
6798693|NCT01488890|7730500|FG000|STARTED|Overall Study||120
6798694|NCT01488890|7730501|FG001|STARTED|Overall Study||120
6798695|NCT01488890|7730502|FG002|STARTED|Overall Study||120
6798696|NCT01488890|7730503|FG003|STARTED|Overall Study||30
6798697|NCT01488890|7730500|FG000|Treated|Overall Study||120
6798698|NCT01488890|7730501|FG001|Treated|Overall Study||120
6798699|NCT01488890|7730502|FG002|Treated|Overall Study||119
6798700|NCT01488890|7730503|FG003|Treated|Overall Study||30
6798701|NCT01488890|7730500|FG000|COMPLETED|Overall Study||88
6798702|NCT01488890|7730501|FG001|COMPLETED|Overall Study||100
6798703|NCT01488890|7730502|FG002|COMPLETED|Overall Study||85
6798704|NCT01488890|7730503|FG003|COMPLETED|Overall Study||25
6798705|NCT01488890|7730500|FG000|NOT COMPLETED|Overall Study||32
6798706|NCT01488890|7730501|FG001|NOT COMPLETED|Overall Study||20
6798707|NCT01488890|7730502|FG002|NOT COMPLETED|Overall Study||35
6798708|NCT01488890|7730503|FG003|NOT COMPLETED|Overall Study||5
6798709|NCT01436396|7730519|FG000|STARTED|Overall Study||396
6798710|NCT01436396|7730520|FG001|STARTED|Overall Study||396
6798711|NCT01436396|7730519|FG000|Vaccinated|Overall Study||394
6798712|NCT01436396|7730520|FG001|Vaccinated|Overall Study||393
6798713|NCT01436396|7730519|FG000|COMPLETED|Overall Study||364
6798714|NCT01436396|7730520|FG001|COMPLETED|Overall Study||354
6798715|NCT01436396|7730519|FG000|NOT COMPLETED|Overall Study||32
6798716|NCT01436396|7730520|FG001|NOT COMPLETED|Overall Study||42
6798717|NCT01411241|7730528|FG000|STARTED|Overall Study||309
6798718|NCT01411241|7730529|FG001|STARTED|Overall Study||315
6798719|NCT01411241|7730528|FG000|COMPLETED|Overall Study||298
6798720|NCT01411241|7730529|FG001|COMPLETED|Overall Study||293
6798721|NCT01411241|7730528|FG000|NOT COMPLETED|Overall Study||11
6798722|NCT01411241|7730529|FG001|NOT COMPLETED|Overall Study||22
6798723|NCT01374516|7730537|FG000|STARTED|Vaccination Phase (Up to 25 Months)||13920
6798724|NCT01374516|7730538|FG001|STARTED|Vaccination Phase (Up to 25 Months)||6949
6798725|NCT01374516|7730537|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||13281
6798726|NCT01374516|7730538|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||6640
6798727|NCT01374516|7730537|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||639
6798728|NCT01374516|7730538|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||309
6798729|NCT01374516|7730537|FG000|STARTED|Surveillance Expansion Period||13281
6798730|NCT01374516|7730538|FG001|STARTED|Surveillance Expansion Period||6640
6798731|NCT01374516|7730537|FG000|COMPLETED|Surveillance Expansion Period||10932
6798732|NCT01374516|7730538|FG001|COMPLETED|Surveillance Expansion Period||5387
6798733|NCT01374516|7730537|FG000|NOT COMPLETED|Surveillance Expansion Period||2349
6798734|NCT01374516|7730538|FG001|NOT COMPLETED|Surveillance Expansion Period||1253
6798735|NCT01373281|7730553|FG000|STARTED|Vaccination Phase (Up to 25 Months)||6851
6798736|NCT01373281|7730554|FG001|STARTED|Vaccination Phase (Up to 25 Months)||3424
6798737|NCT01373281|7730553|FG000|COMPLETED|Vaccination Phase (Up to 25 Months)||6797
6798738|NCT01373281|7730554|FG001|COMPLETED|Vaccination Phase (Up to 25 Months)||3397
6798739|NCT01373281|7730553|FG000|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||54
6798740|NCT01373281|7730554|FG001|NOT COMPLETED|Vaccination Phase (Up to 25 Months)||27
6798741|NCT01373281|7730553|FG000|STARTED|Surveillance Expansion Period||6797
6798742|NCT01373281|7730554|FG001|STARTED|Surveillance Expansion Period||3397
6798743|NCT01373281|7730553|FG000|COMPLETED|Surveillance Expansion Period||6595
6798744|NCT01373281|7730554|FG001|COMPLETED|Surveillance Expansion Period||3279
6798745|NCT01373281|7730553|FG000|NOT COMPLETED|Surveillance Expansion Period||202
6798746|NCT01373281|7730554|FG001|NOT COMPLETED|Surveillance Expansion Period||118
6798747|NCT01302847|7730575|FG000|STARTED|Overall Study||23
6798748|NCT01302847|7730576|FG001|STARTED|Overall Study||23
6798749|NCT01302847|7730577|FG002|STARTED|Overall Study||17
6798750|NCT01302847|7730578|FG003|STARTED|Overall Study||15
6798751|NCT01302847|7730579|FG004|STARTED|Overall Study||7
6798752|NCT01302847|7730580|FG005|STARTED|Overall Study||36
6798753|NCT01302847|7730581|FG006|STARTED|Overall Study||35
6798754|NCT01302847|7730582|FG007|STARTED|Overall Study||25
6798755|NCT01302847|7730575|FG000|COMPLETED|Overall Study||10
6798756|NCT01302847|7730576|FG001|COMPLETED|Overall Study||16
6798757|NCT01302847|7730577|FG002|COMPLETED|Overall Study||15
6798758|NCT01302847|7730578|FG003|COMPLETED|Overall Study||14
6798759|NCT01302847|7730579|FG004|COMPLETED|Overall Study||5
6798760|NCT01302847|7730580|FG005|COMPLETED|Overall Study||6
6798761|NCT01302847|7730581|FG006|COMPLETED|Overall Study||9
6798762|NCT01302847|7730582|FG007|COMPLETED|Overall Study||3
6798763|NCT01302847|7730575|FG000|NOT COMPLETED|Overall Study||13
6798764|NCT01302847|7730576|FG001|NOT COMPLETED|Overall Study||7
6798765|NCT01302847|7730577|FG002|NOT COMPLETED|Overall Study||2
6798766|NCT01302847|7730578|FG003|NOT COMPLETED|Overall Study||1
6798767|NCT01302847|7730579|FG004|NOT COMPLETED|Overall Study||2
6798768|NCT01302847|7730580|FG005|NOT COMPLETED|Overall Study||30
6798769|NCT01302847|7730581|FG006|NOT COMPLETED|Overall Study||26
6798770|NCT01302847|7730582|FG007|NOT COMPLETED|Overall Study||22
6798771|NCT01287611|7730611|FG000|STARTED|Overall Study||84
6798772|NCT01287611|7730612|FG001|STARTED|Overall Study||84
6798773|NCT01287611|7730611|FG000|The Number of Patients Who Underwent C/S|Overall Study||84
6798774|NCT01287611|7730612|FG001|The Number of Patients Who Underwent C/S|Overall Study||84
6798775|NCT01287611|7730611|FG000|COMPLETED|Overall Study||51
6798776|NCT01287611|7730612|FG001|COMPLETED|Overall Study||65
6798777|NCT01287611|7730611|FG000|NOT COMPLETED|Overall Study||33
6798778|NCT01287611|7730612|FG001|NOT COMPLETED|Overall Study||19
6798779|NCT01275677|7730622|FG000|STARTED|Overall Study||1630
6798780|NCT01275677|7730623|FG001|STARTED|Overall Study||1640
6798781|NCT01275677|7730622|FG000|COMPLETED|Overall Study||1602
6798782|NCT01275677|7730623|FG001|COMPLETED|Overall Study||1598
6798783|NCT01275677|7730622|FG000|NOT COMPLETED|Overall Study||28
6798784|NCT01275677|7730623|FG001|NOT COMPLETED|Overall Study||42
6798785|NCT01254422|7730631|FG000|STARTED|Overall Study||199
6798786|NCT01254422|7730632|FG001|STARTED|Overall Study||51
6798787|NCT01254422|7730631|FG000|COMPLETED|Overall Study||196
6798788|NCT01254422|7730632|FG001|COMPLETED|Overall Study||50
6798789|NCT01254422|7730631|FG000|NOT COMPLETED|Overall Study||3
6798790|NCT01254422|7730632|FG001|NOT COMPLETED|Overall Study||1
6798791|NCT01196390|7730640|FG000|STARTED|Overall Study||102
6798792|NCT01196390|7730641|FG001|STARTED|Overall Study||101
6798793|NCT01196390|7730640|FG000|Eligible|Overall Study||98
6798794|NCT01196390|7730641|FG001|Eligible|Overall Study||96
6798795|NCT01196390|7730640|FG000|Eligible and Started Study Treatment|Overall Study||95
6798796|NCT01196390|7730641|FG001|Eligible and Started Study Treatment|Overall Study||96
6798797|NCT01196390|7730640|FG000|Eligible and Had Surgery|Overall Study||82
6798798|NCT01196390|7730641|FG001|Eligible and Had Surgery|Overall Study||78
6798799|NCT01196390|7730640|FG000|COMPLETED|Overall Study||98
6798800|NCT01196390|7730641|FG001|COMPLETED|Overall Study||96
6798801|NCT01196390|7730640|FG000|NOT COMPLETED|Overall Study||4
6798802|NCT01196390|7730641|FG001|NOT COMPLETED|Overall Study||5
6798803|NCT01194570|7730651|FG000|STARTED|Overall Study||244
6798804|NCT01194570|7730652|FG001|STARTED|Overall Study||488
6798805|NCT01194570|7730651|FG000|COMPLETED|Overall Study|"Reason for discontinuation were provided for Core Treatment Completion."|0
6798806|NCT01194570|7730652|FG001|COMPLETED|Overall Study||0
6798807|NCT01194570|7730651|FG000|NOT COMPLETED|Overall Study||244
6798808|NCT01194570|7730652|FG001|NOT COMPLETED|Overall Study||488
6798809|NCT01187433|7730660|FG000|STARTED|Overall Study||100
6798810|NCT01187433|7730661|FG001|STARTED|Overall Study||50
6798811|NCT01187433|7730660|FG000|COMPLETED|Overall Study||89
6798812|NCT01187433|7730661|FG001|COMPLETED|Overall Study||46
6798813|NCT01187433|7730660|FG000|NOT COMPLETED|Overall Study||11
6798814|NCT01187433|7730661|FG001|NOT COMPLETED|Overall Study||4
6798815|NCT01150045|7730671|FG000|STARTED|Overall Study||615
6798816|NCT01150045|7730672|FG001|STARTED|Overall Study||647
6798817|NCT01150045|7730673|FG002|STARTED|Overall Study||646
6798818|NCT01150045|7730674|FG003|STARTED|Overall Study||618
6798819|NCT01150045|7730671|FG000|COMPLETED|Overall Study||615
6798820|NCT01150045|7730672|FG001|COMPLETED|Overall Study||646
6798821|NCT01150045|7730673|FG002|COMPLETED|Overall Study||646
6798822|NCT01150045|7730674|FG003|COMPLETED|Overall Study||617
6798823|NCT01150045|7730671|FG000|NOT COMPLETED|Overall Study||0
6798824|NCT01150045|7730672|FG001|NOT COMPLETED|Overall Study||1
6798825|NCT01150045|7730673|FG002|NOT COMPLETED|Overall Study||0
6798826|NCT01150045|7730674|FG003|NOT COMPLETED|Overall Study||1
6798827|NCT01098032|7730684|FG000|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
6380476|NCT00779311|7291296|FG004|COMPLETED|Overall Study||0
6380477|NCT00779311|7291292|FG000|NOT COMPLETED|Overall Study||0
6380478|NCT00779311|7291293|FG001|NOT COMPLETED|Overall Study||0
6380479|NCT00779311|7291294|FG002|NOT COMPLETED|Overall Study||0
6380480|NCT00779311|7291295|FG003|NOT COMPLETED|Overall Study||0
6380481|NCT00779311|7291296|FG004|NOT COMPLETED|Overall Study||0
6380482|NCT00779324|7291310|FG000|STARTED|Overall Study||82
6380483|NCT00779324|7291311|FG001|STARTED|Overall Study||86
6380484|NCT00779324|7291310|FG000|Completed 28-day Mid-point|Overall Study||80
6380485|NCT00779324|7291311|FG001|Completed 28-day Mid-point|Overall Study||81
6380486|NCT00779324|7291310|FG000|COMPLETED|Overall Study||75
6380487|NCT00779324|7291311|FG001|COMPLETED|Overall Study||82
6380488|NCT00779324|7291310|FG000|NOT COMPLETED|Overall Study||7
6380489|NCT00779324|7291311|FG001|NOT COMPLETED|Overall Study||4
6380490|NCT00779402|7291319|FG000|STARTED|Treatment Phase 1||117
6380491|NCT00779402|7291320|FG001|STARTED|Treatment Phase 1||59
6380492|NCT00779402|7291319|FG000|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||116
6798828|NCT01098032|7730685|FG001|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
6798829|NCT01098032|7730684|FG000|COMPLETED|Overall Study||146
6798830|NCT01098032|7730685|FG001|COMPLETED|Overall Study||146
6798831|NCT01098032|7730684|FG000|NOT COMPLETED|Overall Study||1
6798832|NCT01098032|7730685|FG001|NOT COMPLETED|Overall Study||1
6798833|NCT01034306|7730693|FG000|STARTED|Overall Study||42
6798834|NCT01034306|7730694|FG001|STARTED|Overall Study||37
6798835|NCT01034306|7730693|FG000|COMPLETED|Overall Study||37
6798836|NCT01034306|7730694|FG001|COMPLETED|Overall Study||34
6798837|NCT01034306|7730693|FG000|NOT COMPLETED|Overall Study||5
6798838|NCT01034306|7730694|FG001|NOT COMPLETED|Overall Study||3
6798839|NCT01015833|7730702|FG000|STARTED|Overall Study||180
6798840|NCT01015833|7730703|FG001|STARTED|Overall Study||176
6798841|NCT01015833|7730702|FG000|COMPLETED|Overall Study||167
6798842|NCT01015833|7730703|FG001|COMPLETED|Overall Study||171
6798843|NCT01015833|7730702|FG000|NOT COMPLETED|Overall Study||13
6798844|NCT01015833|7730703|FG001|NOT COMPLETED|Overall Study||5
6798845|NCT01005745|7730709|FG000|STARTED|Overall Study||19
6798846|NCT01005745|7730709|FG000|COMPLETED|Overall Study||13
6798847|NCT01005745|7730709|FG000|NOT COMPLETED|Overall Study||6
6798848|NCT00993447|7730715|FG000|STARTED|Overall Study||401
6798849|NCT00993447|7730716|FG001|STARTED|Overall Study||199
6798850|NCT00993447|7730715|FG000|COMPLETED|Overall Study||364
6798851|NCT00993447|7730716|FG001|COMPLETED|Overall Study||180
6798852|NCT00993447|7730715|FG000|NOT COMPLETED|Overall Study||37
6798853|NCT00993447|7730716|FG001|NOT COMPLETED|Overall Study||19
6798854|NCT00945009|7730725|FG000|STARTED|Overall Study||201
6798855|NCT00945009|7730726|FG001|STARTED|Overall Study||39
6798856|NCT00945009|7730727|FG002|STARTED|Overall Study||9
6798857|NCT00945009|7730725|FG000|COMPLETED|Overall Study||156
6798858|NCT00945009|7730726|FG001|COMPLETED|Overall Study||32
6798859|NCT00945009|7730727|FG002|COMPLETED|Overall Study||6
6798860|NCT00945009|7730725|FG000|NOT COMPLETED|Overall Study||45
6798861|NCT00945009|7730726|FG001|NOT COMPLETED|Overall Study||7
6798862|NCT00945009|7730727|FG002|NOT COMPLETED|Overall Study||3
6798863|NCT00942877|7730737|FG000|STARTED|Overall Study||46
6798864|NCT00942877|7730738|FG001|STARTED|Overall Study||7
6798865|NCT00942877|7730737|FG000|COMPLETED|Overall Study||1
6798866|NCT00942877|7730738|FG001|COMPLETED|Overall Study||3
6798867|NCT00942877|7730737|FG000|NOT COMPLETED|Overall Study||45
6798868|NCT00942877|7730738|FG001|NOT COMPLETED|Overall Study||4
6798869|NCT00942331|7730747|FG000|STARTED|Overall Study||252
6798870|NCT00942331|7730748|FG001|STARTED|Overall Study||254
6798871|NCT00942331|7730747|FG000|COMPLETED|Overall Study||237
6798872|NCT00942331|7730748|FG001|COMPLETED|Overall Study||232
6798873|NCT00942331|7730747|FG000|NOT COMPLETED|Overall Study||15
6798874|NCT00942331|7730748|FG001|NOT COMPLETED|Overall Study||22
6798875|NCT00896389|7730754|FG000|STARTED|Salt Loading||124
6798876|NCT00896389|7730754|FG000|COMPLETED|Salt Loading||124
6798877|NCT00896389|7730754|FG000|NOT COMPLETED|Salt Loading||0
6798878|NCT00896389|7730754|FG000|STARTED|HCTZ Low Dose|Only subjects with SBP > 120 mmHg and agreeable to the HCTZ protocol continued to the next period.|28
6798879|NCT00896389|7730754|FG000|COMPLETED|HCTZ Low Dose||28
6798880|NCT00896389|7730754|FG000|NOT COMPLETED|HCTZ Low Dose||0
6798881|NCT00896389|7730754|FG000|STARTED|HCTZ High Dose||25
6798882|NCT00896389|7730754|FG000|COMPLETED|HCTZ High Dose||25
6798883|NCT00896389|7730754|FG000|NOT COMPLETED|HCTZ High Dose||0
6798884|NCT00880893|7730762|FG000|STARTED|Overall Study||898
6798885|NCT00880893|7730763|FG001|STARTED|Overall Study||300
6798886|NCT00880893|7730762|FG000|COMPLETED|Overall Study||791
6798887|NCT00880893|7730763|FG001|COMPLETED|Overall Study||255
6798888|NCT00880893|7730762|FG000|NOT COMPLETED|Overall Study||107
6798889|NCT00880893|7730763|FG001|NOT COMPLETED|Overall Study||45
6798890|NCT00866918|7730771|FG000|STARTED|Overall Study||69
6798891|NCT00866918|7730772|FG001|STARTED|Overall Study||39
6798892|NCT00866918|7730771|FG000|COMPLETED|Overall Study||53
6798893|NCT00866918|7730772|FG001|COMPLETED|Overall Study||27
6798894|NCT00866918|7730771|FG000|NOT COMPLETED|Overall Study||16
6798895|NCT00866918|7730772|FG001|NOT COMPLETED|Overall Study||12
6798896|NCT00769379|7730780|FG000|STARTED|Overall Study||1008
6798897|NCT00769379|7730781|FG001|STARTED|Overall Study||1006
6798898|NCT00769379|7730780|FG000|COMPLETED|Overall Study||1005
6798899|NCT00769379|7730781|FG001|COMPLETED|Overall Study||993
6798900|NCT00769379|7730780|FG000|NOT COMPLETED|Overall Study||3
6798901|NCT00769379|7730781|FG001|NOT COMPLETED|Overall Study||13
6798902|NCT00753545|7730789|FG000|STARTED|Overall Study|Patients randomized|136
6798903|NCT00753545|7730790|FG001|STARTED|Overall Study|Patients randomized|129
6798904|NCT00753545|7730789|FG000|COMPLETED|Overall Study|Patients completing the Study|28
6798905|NCT00753545|7730790|FG001|COMPLETED|Overall Study|Patients completing the Study|11
6798906|NCT00753545|7730789|FG000|NOT COMPLETED|Overall Study||108
6798907|NCT00753545|7730790|FG001|NOT COMPLETED|Overall Study||118
6798908|NCT00588770|7730798|FG000|STARTED|Overall Study||200
6798909|NCT00588770|7730799|FG001|STARTED|Overall Study||203
6798910|NCT00588770|7730798|FG000|Eligible|Overall Study||188
6798911|NCT00588770|7730799|FG001|Eligible|Overall Study||183
6798912|NCT00588770|7730798|FG000|Start Protocol Therapy|Overall Study||200
6798913|NCT00588770|7730799|FG001|Start Protocol Therapy|Overall Study||194
6798914|NCT00588770|7730798|FG000|COMPLETED|Overall Study||41
6798915|NCT00588770|7730799|FG001|COMPLETED|Overall Study||3
6798916|NCT00588770|7730798|FG000|NOT COMPLETED|Overall Study||159
6798917|NCT00588770|7730799|FG001|NOT COMPLETED|Overall Study||200
6798918|NCT00587301|7730805|FG000|STARTED|Overall Study||119
6798919|NCT00587301|7730805|FG000|COMPLETED|Overall Study||74
6798920|NCT00587301|7730805|FG000|NOT COMPLETED|Overall Study||45
6798921|NCT00579527|7730809|FG000|STARTED|Overall Study||14
6798922|NCT00579527|7730809|FG000|COMPLETED|Overall Study||10
6798923|NCT00579527|7730809|FG000|NOT COMPLETED|Overall Study||4
6798924|NCT00576836|7730814|FG000|STARTED|Overall Study||0
6798925|NCT00576836|7730815|FG001|STARTED|Overall Study||7
6798926|NCT00576836|7730814|FG000|COMPLETED|Overall Study||0
6798927|NCT00576836|7730815|FG001|COMPLETED|Overall Study||5
6798928|NCT00576836|7730814|FG000|NOT COMPLETED|Overall Study||0
6798929|NCT00576836|7730815|FG001|NOT COMPLETED|Overall Study||2
6798930|NCT00576407|7730819|FG000|STARTED|Overall Study||26
6798931|NCT00576407|7730819|FG000|COMPLETED|Overall Study||18
6798932|NCT00576407|7730819|FG000|NOT COMPLETED|Overall Study||8
6798933|NCT00557193|7730824|FG000|STARTED|Induction||218
6798934|NCT00557193|7730825|FG001|STARTED|Induction||0
6798935|NCT00557193|7730826|FG002|STARTED|Induction||0
6798936|NCT00557193|7730827|FG003|STARTED|Induction||0
6798937|NCT00557193|7730828|FG004|STARTED|Induction||0
6798938|NCT00557193|7730829|FG005|STARTED|Induction||0
6798939|NCT00557193|7730824|FG000|COMPLETED|Induction||192
6798940|NCT00557193|7730825|FG001|COMPLETED|Induction||0
6798941|NCT00557193|7730826|FG002|COMPLETED|Induction||0
6798942|NCT00557193|7730827|FG003|COMPLETED|Induction||0
6798943|NCT00557193|7730828|FG004|COMPLETED|Induction||0
6798944|NCT00557193|7730829|FG005|COMPLETED|Induction||0
6798945|NCT00557193|7730824|FG000|NOT COMPLETED|Induction||26
6798946|NCT00557193|7730825|FG001|NOT COMPLETED|Induction||0
6798947|NCT00557193|7730826|FG002|NOT COMPLETED|Induction||0
6798948|NCT00557193|7730827|FG003|NOT COMPLETED|Induction||0
6798949|NCT00557193|7730828|FG004|NOT COMPLETED|Induction||0
6798950|NCT00557193|7730829|FG005|NOT COMPLETED|Induction||0
6798951|NCT00557193|7730824|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
6798952|NCT00557193|7730825|FG001|STARTED|Post Induction Therapy by Tx Assignment||60
6798953|NCT00557193|7730826|FG002|STARTED|Post Induction Therapy by Tx Assignment||54
6798954|NCT00557193|7730827|FG003|STARTED|Post Induction Therapy by Tx Assignment||11
6798955|NCT00557193|7730828|FG004|STARTED|Post Induction Therapy by Tx Assignment||11
6798956|NCT00557193|7730829|FG005|STARTED|Post Induction Therapy by Tx Assignment||56
6564135|NCT01809262|7486875|FG000|COMPLETED|Period 4 (Fourth Dose + Washout)||4
6564136|NCT01809262|7486876|FG001|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6564137|NCT01809262|7486877|FG002|COMPLETED|Period 4 (Fourth Dose + Washout)||4
6564138|NCT01809262|7486878|FG003|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6564139|NCT01809262|7486879|FG004|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6564140|NCT01809262|7486880|FG005|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6564141|NCT01809262|7486881|FG006|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6798957|NCT00557193|7730824|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
6798958|NCT00557193|7730825|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||50
6798959|NCT00557193|7730826|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||22
6798960|NCT00557193|7730827|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||4
6798961|NCT00557193|7730828|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||4
6798962|NCT00557193|7730829|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||19
6798963|NCT00557193|7730824|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
6798964|NCT00557193|7730825|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||10
6798965|NCT00557193|7730826|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||32
6798966|NCT00557193|7730827|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
6798967|NCT00557193|7730828|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||7
6798968|NCT00557193|7730829|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||37
6798969|NCT00547339|7730858|FG000|STARTED|Overall Study||15
6798970|NCT00547339|7730859|FG001|STARTED|Overall Study||15
6798971|NCT00547339|7730860|FG002|STARTED|Overall Study||15
6798972|NCT00547339|7730861|FG003|STARTED|Overall Study||47
6798973|NCT00547339|7730858|FG000|COMPLETED|Overall Study||15
6798974|NCT00547339|7730859|FG001|COMPLETED|Overall Study||15
6798975|NCT00547339|7730860|FG002|COMPLETED|Overall Study||14
6798976|NCT00547339|7730861|FG003|COMPLETED|Overall Study||47
6798977|NCT00547339|7730858|FG000|NOT COMPLETED|Overall Study||0
6798978|NCT00547339|7730859|FG001|NOT COMPLETED|Overall Study||0
6798979|NCT00547339|7730860|FG002|NOT COMPLETED|Overall Study||1
6798980|NCT00547339|7730861|FG003|NOT COMPLETED|Overall Study||0
6798981|NCT00531232|7730883|FG000|STARTED|Overall Study||4
6798982|NCT00531232|7730884|FG001|STARTED|Overall Study||9
6798983|NCT00531232|7730885|FG002|STARTED|Overall Study||25
6798984|NCT00531232|7730883|FG000|Treated|Overall Study||4
6798985|NCT00531232|7730884|FG001|Treated|Overall Study||8
6798986|NCT00531232|7730885|FG002|Treated|Overall Study||24
6798987|NCT00531232|7730883|FG000|COMPLETED|Overall Study||0
6798988|NCT00531232|7730884|FG001|COMPLETED|Overall Study||0
6798989|NCT00531232|7730885|FG002|COMPLETED|Overall Study||0
6798990|NCT00531232|7730883|FG000|NOT COMPLETED|Overall Study||4
6798991|NCT00531232|7730884|FG001|NOT COMPLETED|Overall Study||9
6798992|NCT00531232|7730885|FG002|NOT COMPLETED|Overall Study||25
6798993|NCT00379340|7730901|FG000|STARTED|Overall Study||120
6798994|NCT00379340|7730902|FG001|STARTED|Overall Study||135
6798995|NCT00379340|7730903|FG002|STARTED|Overall Study||52
6798996|NCT00379340|7730904|FG003|STARTED|Overall Study||50
6798997|NCT00379340|7730905|FG004|STARTED|Overall Study||23
6798998|NCT00379340|7730901|FG000|COMPLETED|Overall Study||107
6798999|NCT00379340|7730902|FG001|COMPLETED|Overall Study||132
6799000|NCT00379340|7730903|FG002|COMPLETED|Overall Study||50
6799001|NCT00379340|7730904|FG003|COMPLETED|Overall Study||37
6799002|NCT00379340|7730905|FG004|COMPLETED|Overall Study||9
6799003|NCT00379340|7730901|FG000|NOT COMPLETED|Overall Study||13
6799004|NCT00379340|7730902|FG001|NOT COMPLETED|Overall Study||3
6799005|NCT00379340|7730903|FG002|NOT COMPLETED|Overall Study||2
6799006|NCT00379340|7730904|FG003|NOT COMPLETED|Overall Study||13
6799007|NCT00379340|7730905|FG004|NOT COMPLETED|Overall Study||14
6799008|NCT00304070|7730921|FG000|STARTED|Overall Study||24
6799009|NCT00304070|7730922|FG001|STARTED|Overall Study||15
6799010|NCT00304070|7730923|FG002|STARTED|Overall Study||39
6799011|NCT00304070|7730921|FG000|COMPLETED|Overall Study||21
6799012|NCT00304070|7730922|FG001|COMPLETED|Overall Study||8
6799013|NCT00304070|7730923|FG002|COMPLETED|Overall Study||27
6799014|NCT00304070|7730921|FG000|NOT COMPLETED|Overall Study||3
6799015|NCT00304070|7730922|FG001|NOT COMPLETED|Overall Study||7
6799016|NCT00304070|7730923|FG002|NOT COMPLETED|Overall Study||12
6799017|NCT00001322|7730935|FG000|STARTED|Phase 1 - Lupron Only||92
6799018|NCT00001322|7730936|FG001|STARTED|Phase 1 - Lupron Only||0
6799019|NCT00001322|7730937|FG002|STARTED|Phase 1 - Lupron Only||0
6799020|NCT00001322|7730935|FG000|COMPLETED|Phase 1 - Lupron Only||92
6799021|NCT00001322|7730936|FG001|COMPLETED|Phase 1 - Lupron Only||0
6799022|NCT00001322|7730937|FG002|COMPLETED|Phase 1 - Lupron Only||0
6799023|NCT00001322|7730935|FG000|NOT COMPLETED|Phase 1 - Lupron Only||0
6799024|NCT00001322|7730936|FG001|NOT COMPLETED|Phase 1 - Lupron Only||0
6799025|NCT00001322|7730937|FG002|NOT COMPLETED|Phase 1 - Lupron Only||0
6799026|NCT00001322|7730935|FG000|STARTED|Phase 2, Period 1 - Crossover Phase||0
6799027|NCT00001322|7730936|FG001|STARTED|Phase 2, Period 1 - Crossover Phase||42
6799028|NCT00001322|7730937|FG002|STARTED|Phase 2, Period 1 - Crossover Phase||40
6799029|NCT00001322|7730935|FG000|COMPLETED|Phase 2, Period 1 - Crossover Phase||0
6799030|NCT00001322|7730936|FG001|COMPLETED|Phase 2, Period 1 - Crossover Phase||42
6799031|NCT00001322|7730937|FG002|COMPLETED|Phase 2, Period 1 - Crossover Phase||40
6799032|NCT00001322|7730935|FG000|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
6799033|NCT00001322|7730936|FG001|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
6799034|NCT00001322|7730937|FG002|NOT COMPLETED|Phase 2, Period 1 - Crossover Phase||0
6799035|NCT00001322|7730935|FG000|STARTED|Phase 2, Period 2 - Crossover Phase||0
6799036|NCT00001322|7730936|FG001|STARTED|Phase 2, Period 2 - Crossover Phase||42
6799037|NCT00001322|7730937|FG002|STARTED|Phase 2, Period 2 - Crossover Phase||40
6502541|NCT01435759|7421256|FG004|NOT COMPLETED|Double-blind Phase||9
6502542|NCT01435759|7421257|FG005|NOT COMPLETED|Double-blind Phase||9
6799038|NCT00001322|7730935|FG000|COMPLETED|Phase 2, Period 2 - Crossover Phase||0
6799039|NCT00001322|7730936|FG001|COMPLETED|Phase 2, Period 2 - Crossover Phase||42
6799040|NCT00001322|7730937|FG002|COMPLETED|Phase 2, Period 2 - Crossover Phase||40
6799041|NCT00001322|7730935|FG000|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
6799042|NCT00001322|7730936|FG001|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
6799043|NCT00001322|7730937|FG002|NOT COMPLETED|Phase 2, Period 2 - Crossover Phase||0
6799044|NCT01701583|7730947|FG000|STARTED|Overall Study||7
6799045|NCT01701583|7730948|FG001|STARTED|Overall Study||3
6799046|NCT01701583|7730947|FG000|COMPLETED|Overall Study||5
6799047|NCT01701583|7730948|FG001|COMPLETED|Overall Study||3
6799048|NCT01701583|7730947|FG000|NOT COMPLETED|Overall Study||2
6799049|NCT01701583|7730948|FG001|NOT COMPLETED|Overall Study||0
6799050|NCT01714817|7730957|FG000|STARTED|Year 1 Period||203
6799051|NCT01714817|7730958|FG001|STARTED|Year 1 Period||203
6799052|NCT01714817|7730957|FG000|Treated|Year 1 Period||202
6799053|NCT01714817|7730958|FG001|Treated|Year 1 Period||203
6799054|NCT01714817|7730957|FG000|COMPLETED|Year 1 Period|Completed = continued study through Year 1|155
6799055|NCT01714817|7730958|FG001|COMPLETED|Year 1 Period|Completed = continued study through Year 1|161
6799056|NCT01714817|7730957|FG000|NOT COMPLETED|Year 1 Period||48
6799057|NCT01714817|7730958|FG001|NOT COMPLETED|Year 1 Period||42
6799058|NCT01714817|7730957|FG000|STARTED|Year 2 Period|Started = Completed Year 1|155
6799059|NCT01714817|7730958|FG001|STARTED|Year 2 Period|Started = Completed Year 1|161
6799060|NCT01714817|7730957|FG000|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|129
6799061|NCT01714817|7730958|FG001|COMPLETED|Year 2 Period|Completed = Continued study through Year 2|123
6799062|NCT01714817|7730957|FG000|NOT COMPLETED|Year 2 Period||26
6799063|NCT01714817|7730958|FG001|NOT COMPLETED|Year 2 Period||38
6799064|NCT01714817|7730957|FG000|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|129
6799065|NCT01714817|7730958|FG001|STARTED|Long-Term Extension (LTE) Period|Started = Completed Year 2|123
6799066|NCT01714817|7730957|FG000|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|62
6564142|NCT01809262|7486882|FG007|COMPLETED|Period 4 (Fourth Dose + Washout)||4
6799067|NCT01714817|7730958|FG001|COMPLETED|Long-Term Extension (LTE) Period|Completed = Continued study through LTE|53
6799068|NCT01714817|7730957|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||67
6799069|NCT01714817|7730958|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||70
6799070|NCT01755689|7730971|FG000|STARTED|Overall Study||259
6799071|NCT01755689|7730972|FG001|STARTED|Overall Study||259
6799072|NCT01755689|7730973|FG002|STARTED|Overall Study||261
6799073|NCT01755689|7730974|FG003|STARTED|Overall Study||260
6799074|NCT01755689|7730975|FG004|STARTED|Overall Study||261
6799075|NCT01755689|7730971|FG000|COMPLETED|Overall Study||256
6799076|NCT01755689|7730972|FG001|COMPLETED|Overall Study||254
6799077|NCT01755689|7730973|FG002|COMPLETED|Overall Study||255
6799078|NCT01755689|7730974|FG003|COMPLETED|Overall Study||254
6799079|NCT01755689|7730975|FG004|COMPLETED|Overall Study||255
6799080|NCT01755689|7730971|FG000|NOT COMPLETED|Overall Study||3
6799081|NCT01755689|7730972|FG001|NOT COMPLETED|Overall Study||5
6799082|NCT01755689|7730973|FG002|NOT COMPLETED|Overall Study||6
6799083|NCT01755689|7730974|FG003|NOT COMPLETED|Overall Study||6
6799084|NCT01755689|7730975|FG004|NOT COMPLETED|Overall Study||6
6799085|NCT01762761|7730997|FG000|STARTED|Overall Study||51
6799086|NCT01762761|7730998|FG001|STARTED|Overall Study||104
6799087|NCT01762761|7730997|FG000|COMPLETED|Overall Study||12
6799088|NCT01762761|7730998|FG001|COMPLETED|Overall Study||39
6799089|NCT01762761|7730997|FG000|NOT COMPLETED|Overall Study||39
6799090|NCT01762761|7730998|FG001|NOT COMPLETED|Overall Study||65
6799107|NCT01774370|7731022|FG000|STARTED|Overall Study||3182
6799108|NCT01774370|7731022|FG000|COMPLETED|Overall Study||3053
6799109|NCT01774370|7731022|FG000|NOT COMPLETED|Overall Study||129
6799110|NCT01777295|7731028|FG000|STARTED|Overall Study||40
6799111|NCT01777295|7731029|FG001|STARTED|Overall Study||41
6799112|NCT01777295|7731028|FG000|COMPLETED|Overall Study||36
6799113|NCT01777295|7731029|FG001|COMPLETED|Overall Study||38
6799114|NCT01777295|7731028|FG000|NOT COMPLETED|Overall Study||4
6799115|NCT01777295|7731029|FG001|NOT COMPLETED|Overall Study||3
6799116|NCT01787552|7731049|FG000|STARTED|Overall Study||8
6799117|NCT01787552|7731050|FG001|STARTED|Overall Study||10
6799118|NCT01787552|7731051|FG002|STARTED|Overall Study||5
6799119|NCT01787552|7731052|FG003|STARTED|Overall Study||27
6799120|NCT01787552|7731049|FG000|COMPLETED|Overall Study||0
6799121|NCT01787552|7731050|FG001|COMPLETED|Overall Study||1
6799122|NCT01787552|7731051|FG002|COMPLETED|Overall Study||0
6799123|NCT01787552|7731052|FG003|COMPLETED|Overall Study||0
6799124|NCT01787552|7731049|FG000|NOT COMPLETED|Overall Study||8
6799125|NCT01787552|7731050|FG001|NOT COMPLETED|Overall Study||9
6799126|NCT01787552|7731051|FG002|NOT COMPLETED|Overall Study||5
6799127|NCT01787552|7731052|FG003|NOT COMPLETED|Overall Study||27
6799128|NCT01807117|7731067|FG000|STARTED|Overall Study||15
6799129|NCT01807117|7731067|FG000|COMPLETED|Overall Study||12
6799130|NCT01807117|7731067|FG000|NOT COMPLETED|Overall Study||3
6799137|NCT01814826|7731095|FG000|STARTED|Overall Study|6 participants were enrolled into the dose escalation phase and 26 in the MTD expansion phase.|32
6799138|NCT01814826|7731096|FG001|STARTED|Overall Study|29 participants were enrolled into the MTD expansion phase.|29
6799139|NCT01814826|7731097|FG002|STARTED|Overall Study|3 participants were enrolled into the dose escalation phase.|3
6799140|NCT01814826|7731095|FG000|COMPLETED|Overall Study||0
6799141|NCT01814826|7731096|FG001|COMPLETED|Overall Study||0
6799142|NCT01814826|7731097|FG002|COMPLETED|Overall Study||0
6799143|NCT01814826|7731095|FG000|NOT COMPLETED|Overall Study||32
6799144|NCT01814826|7731096|FG001|NOT COMPLETED|Overall Study||29
6799145|NCT01814826|7731097|FG002|NOT COMPLETED|Overall Study||3
6799146|NCT01829711|7731106|FG000|STARTED|Overall Study||80
6799147|NCT01829711|7731106|FG000|COMPLETED|Overall Study||37
6799148|NCT01829711|7731106|FG000|NOT COMPLETED|Overall Study||43
6799149|NCT01846273|7731113|FG000|STARTED|Overall Study||168
6799091|NCT01763788|7731009|FG000|STARTED|Overall Study||3
6799092|NCT01763788|7731010|FG001|STARTED|Overall Study||6
6799093|NCT01763788|7731011|FG002|STARTED|Overall Study||91
6799094|NCT01763788|7731012|FG003|STARTED|Overall Study||92
6799095|NCT01763788|7731009|FG000|Received at Least 1dose of Study Drug|Overall Study||3
6799096|NCT01763788|7731010|FG001|Received at Least 1dose of Study Drug|Overall Study||6
6799097|NCT01763788|7731011|FG002|Received at Least 1dose of Study Drug|Overall Study||90
6799098|NCT01763788|7731012|FG003|Received at Least 1dose of Study Drug|Overall Study||91
6799099|NCT01763788|7731009|FG000|COMPLETED|Overall Study||3
6799100|NCT01763788|7731010|FG001|COMPLETED|Overall Study||6
6799101|NCT01763788|7731011|FG002|COMPLETED|Overall Study||90
6799102|NCT01763788|7731012|FG003|COMPLETED|Overall Study||92
6799103|NCT01763788|7731009|FG000|NOT COMPLETED|Overall Study||0
6799104|NCT01763788|7731010|FG001|NOT COMPLETED|Overall Study||0
6799105|NCT01763788|7731011|FG002|NOT COMPLETED|Overall Study||1
6799106|NCT01763788|7731012|FG003|NOT COMPLETED|Overall Study||0
6799131|NCT01808261|7731075|FG000|STARTED|Overall Study||68
6799132|NCT01808261|7731076|FG001|STARTED|Overall Study||65
6799133|NCT01808261|7731075|FG000|COMPLETED|Overall Study||32
6799134|NCT01808261|7731076|FG001|COMPLETED|Overall Study||32
6799135|NCT01808261|7731075|FG000|NOT COMPLETED|Overall Study||36
6564143|NCT01809262|7486883|FG008|COMPLETED|Period 4 (Fourth Dose + Washout)||3
6564144|NCT01809262|7486884|FG009|COMPLETED|Period 4 (Fourth Dose + Washout)||4
6564145|NCT01809262|7486875|FG000|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564146|NCT01809262|7486876|FG001|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564147|NCT01809262|7486877|FG002|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564148|NCT01809262|7486878|FG003|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6799136|NCT01808261|7731076|FG001|NOT COMPLETED|Overall Study||33
6799150|NCT01846273|7731114|FG001|STARTED|Overall Study||113
6799151|NCT01846273|7731115|FG002|STARTED|Overall Study||41
6799152|NCT01846273|7731113|FG000|Safety Analysis Set|Overall Study||172
6799153|NCT01846273|7731114|FG001|Safety Analysis Set|Overall Study||135
6799154|NCT01846273|7731115|FG002|Safety Analysis Set|Overall Study||14
6799155|NCT01846273|7731113|FG000|COMPLETED|Overall Study||146
6799156|NCT01846273|7731114|FG001|COMPLETED|Overall Study||87
6799157|NCT01846273|7731115|FG002|COMPLETED|Overall Study||41
6799158|NCT01846273|7731113|FG000|NOT COMPLETED|Overall Study||22
6799159|NCT01846273|7731114|FG001|NOT COMPLETED|Overall Study||26
6799160|NCT01846273|7731115|FG002|NOT COMPLETED|Overall Study||0
6564149|NCT01809262|7486879|FG004|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564150|NCT01809262|7486880|FG005|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564151|NCT01809262|7486881|FG006|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564152|NCT01809262|7486882|FG007|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564153|NCT01809262|7486883|FG008|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564154|NCT01809262|7486884|FG009|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
6564155|NCT01809262|7486875|FG000|STARTED|Period 5 (Fifth Dose + Washout)||4
6564156|NCT01809262|7486876|FG001|STARTED|Period 5 (Fifth Dose + Washout)||3
6564157|NCT01809262|7486877|FG002|STARTED|Period 5 (Fifth Dose + Washout)||4
6564158|NCT01809262|7486878|FG003|STARTED|Period 5 (Fifth Dose + Washout)||3
6564159|NCT01809262|7486879|FG004|STARTED|Period 5 (Fifth Dose + Washout)||3
6564160|NCT01809262|7486880|FG005|STARTED|Period 5 (Fifth Dose + Washout)||3
6564161|NCT01809262|7486881|FG006|STARTED|Period 5 (Fifth Dose + Washout)||3
6564162|NCT01809262|7486882|FG007|STARTED|Period 5 (Fifth Dose + Washout)||4
6564163|NCT01809262|7486883|FG008|STARTED|Period 5 (Fifth Dose + Washout)||3
6564164|NCT01809262|7486884|FG009|STARTED|Period 5 (Fifth Dose + Washout)||4
6564165|NCT01809262|7486875|FG000|COMPLETED|Period 5 (Fifth Dose + Washout)||4
6564166|NCT01809262|7486876|FG001|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6564167|NCT01809262|7486877|FG002|COMPLETED|Period 5 (Fifth Dose + Washout)||4
6564168|NCT01809262|7486878|FG003|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6564169|NCT01809262|7486879|FG004|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6564170|NCT01809262|7486880|FG005|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6564171|NCT01809262|7486881|FG006|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6564172|NCT01809262|7486882|FG007|COMPLETED|Period 5 (Fifth Dose + Washout)||4
6564173|NCT01809262|7486883|FG008|COMPLETED|Period 5 (Fifth Dose + Washout)||3
6564174|NCT01809262|7486884|FG009|COMPLETED|Period 5 (Fifth Dose + Washout)||4
6564175|NCT01809262|7486875|FG000|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564176|NCT01809262|7486876|FG001|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564177|NCT01809262|7486877|FG002|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564178|NCT01809262|7486878|FG003|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564179|NCT01809262|7486879|FG004|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564180|NCT01809262|7486880|FG005|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564181|NCT01809262|7486881|FG006|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564182|NCT01809262|7486882|FG007|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564183|NCT01809262|7486883|FG008|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6799161|NCT01875185|7731125|FG000|STARTED|Overall Study||52
6799162|NCT01875185|7731126|FG001|STARTED|Overall Study||48
6799163|NCT01875185|7731125|FG000|COMPLETED|Overall Study||0
6799164|NCT01875185|7731126|FG001|COMPLETED|Overall Study||0
6799165|NCT01875185|7731125|FG000|NOT COMPLETED|Overall Study||52
6799166|NCT01875185|7731126|FG001|NOT COMPLETED|Overall Study||48
6799167|NCT01887743|7731139|FG000|STARTED|Overall Study||20
6799168|NCT01887743|7731140|FG001|STARTED|Overall Study||19
6799169|NCT01887743|7731141|FG002|STARTED|Overall Study||32
6799170|NCT01887743|7731139|FG000|COMPLETED|Overall Study||19
6799171|NCT01887743|7731140|FG001|COMPLETED|Overall Study||17
6799172|NCT01887743|7731141|FG002|COMPLETED|Overall Study||29
6799173|NCT01887743|7731139|FG000|NOT COMPLETED|Overall Study||1
6799174|NCT01887743|7731140|FG001|NOT COMPLETED|Overall Study||2
6799175|NCT01887743|7731141|FG002|NOT COMPLETED|Overall Study||3
6799176|NCT01891643|7731152|FG000|STARTED|Overall Study||13
6799177|NCT01891643|7731153|FG001|STARTED|Overall Study||10
6799178|NCT01891643|7731152|FG000|COMPLETED|Overall Study||3
6799179|NCT01891643|7731153|FG001|COMPLETED|Overall Study||0
6799180|NCT01891643|7731152|FG000|NOT COMPLETED|Overall Study||10
6799181|NCT01891643|7731153|FG001|NOT COMPLETED|Overall Study||10
6799182|NCT01900691|7731159|FG000|STARTED|Overall Study||130
6799183|NCT01900691|7731159|FG000|COMPLETED|Overall Study||111
6799184|NCT01900691|7731159|FG000|NOT COMPLETED|Overall Study||19
6799211|NCT01915498|7731220|FG000|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6799212|NCT01915498|7731221|FG001|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6799213|NCT01915498|7731222|FG002|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6799214|NCT01915498|7731223|FG003|STARTED|Main Analysis (Sept 2013 - Sept 2017)||8
6799215|NCT01915498|7731224|FG004|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
6799216|NCT01915498|7731225|FG005|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
6799217|NCT01915498|7731226|FG006|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6799218|NCT01915498|7731227|FG007|STARTED|Main Analysis (Sept 2013 - Sept 2017)||22
6799219|NCT01915498|7731228|FG008|STARTED|Main Analysis (Sept 2013 - Sept 2017)||6
6799220|NCT01915498|7731229|FG009|STARTED|Main Analysis (Sept 2013 - Sept 2017)||14
6799221|NCT01915498|7731230|FG010|STARTED|Main Analysis (Sept 2013 - Sept 2017)||9
6799222|NCT01915498|7731231|FG011|STARTED|Main Analysis (Sept 2013 - Sept 2017)||5
6799223|NCT01915498|7731232|FG012|STARTED|Main Analysis (Sept 2013 - Sept 2017)||7
6799224|NCT01915498|7731233|FG013|STARTED|Main Analysis (Sept 2013 - Sept 2017)||49
6799225|NCT01915498|7731234|FG014|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
6799226|NCT01915498|7731235|FG015|STARTED|Main Analysis (Sept 2013 - Sept 2017)||25
6799227|NCT01915498|7731236|FG016|STARTED|Main Analysis (Sept 2013 - Sept 2017)||27
6799228|NCT01915498|7731237|FG017|STARTED|Main Analysis (Sept 2013 - Sept 2017)||106
6799229|NCT01915498|7731238|FG018|STARTED|Main Analysis (Sept 2013 - Sept 2017)||0
6799230|NCT01915498|7731220|FG000|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799231|NCT01915498|7731221|FG001|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799232|NCT01915498|7731222|FG002|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799233|NCT01915498|7731223|FG003|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799234|NCT01915498|7731224|FG004|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799235|NCT01915498|7731225|FG005|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799236|NCT01915498|7731226|FG006|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799237|NCT01915498|7731227|FG007|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
6799238|NCT01915498|7731228|FG008|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799239|NCT01915498|7731229|FG009|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799240|NCT01915498|7731230|FG010|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799241|NCT01915498|7731231|FG011|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||1
6799242|NCT01915498|7731232|FG012|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799243|NCT01915498|7731233|FG013|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
6799244|NCT01915498|7731234|FG014|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799245|NCT01915498|7731235|FG015|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||2
6799246|NCT01915498|7731236|FG016|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||3
6799247|NCT01915498|7731237|FG017|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
6799248|NCT01915498|7731238|FG018|COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799249|NCT01915498|7731220|FG000|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6799250|NCT01915498|7731221|FG001|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6799251|NCT01915498|7731222|FG002|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6799252|NCT01915498|7731223|FG003|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||8
6799253|NCT01915498|7731224|FG004|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||5
6799254|NCT01915498|7731225|FG005|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
6799255|NCT01915498|7731226|FG006|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6799256|NCT01915498|7731227|FG007|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||21
6799257|NCT01915498|7731228|FG008|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||6
6799258|NCT01915498|7731229|FG009|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||14
6799259|NCT01915498|7731230|FG010|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||9
6799260|NCT01915498|7731231|FG011|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||4
6799261|NCT01915498|7731232|FG012|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||7
6799262|NCT01915498|7731233|FG013|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||46
6799263|NCT01915498|7731234|FG014|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||25
6799185|NCT01901432|7731169|FG000|STARTED|Overall Study||3
6799186|NCT01901432|7731170|FG001|STARTED|Overall Study||3
6799187|NCT01901432|7731171|FG002|STARTED|Overall Study||3
6799188|NCT01901432|7731172|FG003|STARTED|Overall Study||3
6799189|NCT01901432|7731173|FG004|STARTED|Overall Study||36
6799190|NCT01901432|7731169|FG000|Received Study Drug|Overall Study||3
6799191|NCT01901432|7731170|FG001|Received Study Drug|Overall Study||3
6799192|NCT01901432|7731171|FG002|Received Study Drug|Overall Study||3
6799193|NCT01901432|7731172|FG003|Received Study Drug|Overall Study||3
6799194|NCT01901432|7731173|FG004|Received Study Drug|Overall Study||35
6799195|NCT01901432|7731169|FG000|COMPLETED|Overall Study||3
6799196|NCT01901432|7731170|FG001|COMPLETED|Overall Study||2
6799197|NCT01901432|7731171|FG002|COMPLETED|Overall Study||1
6799198|NCT01901432|7731172|FG003|COMPLETED|Overall Study||3
6799199|NCT01901432|7731173|FG004|COMPLETED|Overall Study||27
6799200|NCT01901432|7731169|FG000|NOT COMPLETED|Overall Study||0
6799201|NCT01901432|7731170|FG001|NOT COMPLETED|Overall Study||1
6799202|NCT01901432|7731171|FG002|NOT COMPLETED|Overall Study||2
6799203|NCT01901432|7731172|FG003|NOT COMPLETED|Overall Study||0
6799204|NCT01901432|7731173|FG004|NOT COMPLETED|Overall Study||9
6799264|NCT01915498|7731235|FG015|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||23
6799265|NCT01915498|7731236|FG016|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||24
6799266|NCT01915498|7731237|FG017|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||100
6799267|NCT01915498|7731238|FG018|NOT COMPLETED|Main Analysis (Sept 2013 - Sept 2017)||0
6799268|NCT01915498|7731220|FG000|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799269|NCT01915498|7731221|FG001|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799270|NCT01915498|7731222|FG002|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799271|NCT01915498|7731223|FG003|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799272|NCT01915498|7731224|FG004|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799273|NCT01915498|7731225|FG005|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799274|NCT01915498|7731226|FG006|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799275|NCT01915498|7731227|FG007|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799276|NCT01915498|7731228|FG008|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799277|NCT01915498|7731229|FG009|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799278|NCT01915498|7731230|FG010|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799279|NCT01915498|7731231|FG011|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799280|NCT01915498|7731232|FG012|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799281|NCT01915498|7731233|FG013|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799282|NCT01915498|7731234|FG014|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799283|NCT01915498|7731235|FG015|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799284|NCT01915498|7731236|FG016|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799285|NCT01915498|7731237|FG017|STARTED|Safety Follow-up (Sept 2017 to July 2019||0
6799286|NCT01915498|7731238|FG018|STARTED|Safety Follow-up (Sept 2017 to July 2019||16
6799287|NCT01915498|7731220|FG000|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799288|NCT01915498|7731221|FG001|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799289|NCT01915498|7731222|FG002|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799290|NCT01915498|7731223|FG003|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799291|NCT01915498|7731224|FG004|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799292|NCT01915498|7731225|FG005|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799293|NCT01915498|7731226|FG006|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799294|NCT01915498|7731227|FG007|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799295|NCT01915498|7731228|FG008|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799296|NCT01915498|7731229|FG009|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6564184|NCT01809262|7486884|FG009|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
6564185|NCT01809314|7486896|FG000|STARTED|Overall Study||1167
6564186|NCT01809314|7486896|FG000|COMPLETED|Overall Study||422
6564187|NCT01809314|7486896|FG000|NOT COMPLETED|Overall Study||745
6799297|NCT01915498|7731230|FG010|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799298|NCT01915498|7731231|FG011|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799299|NCT01915498|7731232|FG012|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799300|NCT01915498|7731233|FG013|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799301|NCT01915498|7731234|FG014|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799302|NCT01915498|7731235|FG015|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799303|NCT01915498|7731236|FG016|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799304|NCT01915498|7731237|FG017|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799305|NCT01915498|7731238|FG018|COMPLETED|Safety Follow-up (Sept 2017 to July 2019||14
6799306|NCT01915498|7731220|FG000|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799307|NCT01915498|7731221|FG001|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799308|NCT01915498|7731222|FG002|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799309|NCT01915498|7731223|FG003|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799310|NCT01915498|7731224|FG004|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799311|NCT01915498|7731225|FG005|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799312|NCT01915498|7731226|FG006|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799313|NCT01915498|7731227|FG007|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799314|NCT01915498|7731228|FG008|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6564188|NCT01809327|7486905|FG000|STARTED|Overall Study||237
6564189|NCT01809327|7486906|FG001|STARTED|Overall Study||237
6799205|NCT01904279|7731194|FG000|STARTED|Overall Study||27
6799206|NCT01904279|7731195|FG001|STARTED|Overall Study||25
6799207|NCT01904279|7731194|FG000|COMPLETED|Overall Study||24
6799208|NCT01904279|7731195|FG001|COMPLETED|Overall Study||22
6799209|NCT01904279|7731194|FG000|NOT COMPLETED|Overall Study||3
6799210|NCT01904279|7731195|FG001|NOT COMPLETED|Overall Study||3
6799315|NCT01915498|7731229|FG009|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799316|NCT01915498|7731230|FG010|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799317|NCT01915498|7731231|FG011|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799318|NCT01915498|7731232|FG012|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799319|NCT01915498|7731233|FG013|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799320|NCT01915498|7731234|FG014|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799321|NCT01915498|7731235|FG015|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799322|NCT01915498|7731236|FG016|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799323|NCT01915498|7731237|FG017|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||0
6799324|NCT01915498|7731238|FG018|NOT COMPLETED|Safety Follow-up (Sept 2017 to July 2019||2
6380493|NCT00779402|7291320|FG001|Received ≥1 Leukapherisis (Safety Set)|Treatment Phase 1||59
6380494|NCT00779402|7291319|FG000|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||113
6380495|NCT00779402|7291320|FG001|Received ≥1 Study Product (Exposure Set)|Treatment Phase 1||59
6380496|NCT00779402|7291319|FG000|Received Booster Infusion|Treatment Phase 1||50
6380497|NCT00779402|7291320|FG001|Received Booster Infusion|Treatment Phase 1||30
6380498|NCT00779402|7291319|FG000|COMPLETED|Treatment Phase 1||84
6799325|NCT01917318|7731328|FG000|STARTED|First Treatment||0
6799326|NCT01917318|7731329|FG001|STARTED|First Treatment||1
6799327|NCT01917318|7731328|FG000|COMPLETED|First Treatment||0
6799328|NCT01917318|7731329|FG001|COMPLETED|First Treatment||0
6799329|NCT01917318|7731328|FG000|NOT COMPLETED|First Treatment||0
6799330|NCT01917318|7731329|FG001|NOT COMPLETED|First Treatment||1
6799331|NCT01917318|7731328|FG000|STARTED|Second Treatment||0
6799332|NCT01917318|7731329|FG001|STARTED|Second Treatment||0
6799333|NCT01917318|7731328|FG000|COMPLETED|Second Treatment||0
6799334|NCT01917318|7731329|FG001|COMPLETED|Second Treatment||0
6799335|NCT01917318|7731328|FG000|NOT COMPLETED|Second Treatment||0
6799336|NCT01917318|7731329|FG001|NOT COMPLETED|Second Treatment||0
6799388|NCT01931098|7731379|FG000|STARTED|Overall Study||9
6799389|NCT01931098|7731380|FG001|STARTED|Overall Study||26
6799390|NCT01931098|7731379|FG000|COMPLETED|Overall Study||9
6799391|NCT01931098|7731380|FG001|COMPLETED|Overall Study||22
6799392|NCT01931098|7731379|FG000|NOT COMPLETED|Overall Study||0
6799393|NCT01931098|7731380|FG001|NOT COMPLETED|Overall Study||4
6799394|NCT01945021|7731388|FG000|STARTED|Overall Study||127
6799395|NCT01945021|7731388|FG000|Safety Population|Overall Study|Received at least 1 dose of study medication.|127
6799396|NCT01945021|7731388|FG000|Response Evaluable Population|Overall Study|Received at least 1 dose of study drug and an adequate baseline tumor assessment.|127
6799397|NCT01945021|7731388|FG000|Patient Reported Outcome Evaluable|Overall Study|Received at least 1 dose of study drug, completed baseline with at least 1 post-baseline assessment.|123
6799398|NCT01945021|7731388|FG000|COMPLETED|Overall Study||44
6799399|NCT01945021|7731388|FG000|NOT COMPLETED|Overall Study||83
6799400|NCT01956669|7731399|FG000|STARTED|Overall Study||12
6799401|NCT01956669|7731400|FG001|STARTED|Overall Study||11
6799402|NCT01956669|7731401|FG002|STARTED|Overall Study||10
6799403|NCT01956669|7731402|FG003|STARTED|Overall Study||10
6799404|NCT01956669|7731403|FG004|STARTED|Overall Study||4
6799405|NCT01956669|7731404|FG005|STARTED|Overall Study||4
6799406|NCT01956669|7731405|FG006|STARTED|Overall Study||6
6799407|NCT01956669|7731399|FG000|PK Set|Overall Study||11
6799408|NCT01956669|7731400|FG001|PK Set|Overall Study||11
6799409|NCT01956669|7731401|FG002|PK Set|Overall Study||10
6799410|NCT01956669|7731402|FG003|PK Set|Overall Study||10
6799411|NCT01956669|7731403|FG004|PK Set|Overall Study||4
6799412|NCT01956669|7731404|FG005|PK Set|Overall Study||4
6799413|NCT01956669|7731405|FG006|PK Set|Overall Study||6
6799414|NCT01956669|7731399|FG000|PKES Set|Overall Study||4
6799415|NCT01956669|7731400|FG001|PKES Set|Overall Study||0
6564190|NCT01809327|7486907|FG002|STARTED|Overall Study||238
6564191|NCT01809327|7486908|FG003|STARTED|Overall Study||237
6564192|NCT01809327|7486909|FG004|STARTED|Overall Study||237
6564193|NCT01809327|7486905|FG000|COMPLETED|Overall Study||205
6564194|NCT01809327|7486906|FG001|COMPLETED|Overall Study||211
6799416|NCT01956669|7731401|FG002|PKES Set|Overall Study||3
6799417|NCT01956669|7731402|FG003|PKES Set|Overall Study||0
6799418|NCT01956669|7731403|FG004|PKES Set|Overall Study||1
6799419|NCT01956669|7731404|FG005|PKES Set|Overall Study||1
6799420|NCT01956669|7731405|FG006|PKES Set|Overall Study||5
6799421|NCT01956669|7731399|FG000|Biomarker Set|Overall Study||12
6799422|NCT01956669|7731400|FG001|Biomarker Set|Overall Study||11
6799423|NCT01956669|7731401|FG002|Biomarker Set|Overall Study||9
6799424|NCT01956669|7731402|FG003|Biomarker Set|Overall Study||9
6799425|NCT01956669|7731403|FG004|Biomarker Set|Overall Study||3
6799426|NCT01956669|7731404|FG005|Biomarker Set|Overall Study||4
6799427|NCT01956669|7731405|FG006|Biomarker Set|Overall Study||3
6799428|NCT01956669|7731399|FG000|Per Protocol Set (PP Set)|Overall Study||9
6799429|NCT01956669|7731400|FG001|Per Protocol Set (PP Set)|Overall Study||10
6799430|NCT01956669|7731401|FG002|Per Protocol Set (PP Set)|Overall Study||6
6799431|NCT01956669|7731402|FG003|Per Protocol Set (PP Set)|Overall Study||9
6799432|NCT01956669|7731403|FG004|Per Protocol Set (PP Set)|Overall Study||4
6799433|NCT01956669|7731404|FG005|Per Protocol Set (PP Set)|Overall Study||4
6799434|NCT01956669|7731405|FG006|Per Protocol Set (PP Set)|Overall Study||5
6799435|NCT01956669|7731399|FG000|COMPLETED|Overall Study||0
6799436|NCT01956669|7731400|FG001|COMPLETED|Overall Study||0
6799437|NCT01956669|7731401|FG002|COMPLETED|Overall Study||0
6799438|NCT01956669|7731402|FG003|COMPLETED|Overall Study||0
6799439|NCT01956669|7731403|FG004|COMPLETED|Overall Study||0
6799440|NCT01956669|7731404|FG005|COMPLETED|Overall Study||0
6799441|NCT01956669|7731405|FG006|COMPLETED|Overall Study||0
6799442|NCT01956669|7731399|FG000|NOT COMPLETED|Overall Study||12
6799443|NCT01956669|7731400|FG001|NOT COMPLETED|Overall Study||11
6799444|NCT01956669|7731401|FG002|NOT COMPLETED|Overall Study||10
6799445|NCT01956669|7731402|FG003|NOT COMPLETED|Overall Study||10
6799446|NCT01956669|7731403|FG004|NOT COMPLETED|Overall Study||4
6799447|NCT01956669|7731404|FG005|NOT COMPLETED|Overall Study||4
6564195|NCT01809327|7486907|FG002|COMPLETED|Overall Study||216
6564196|NCT01809327|7486908|FG003|COMPLETED|Overall Study||225
6564197|NCT01809327|7486909|FG004|COMPLETED|Overall Study||212
6799448|NCT01956669|7731405|FG006|NOT COMPLETED|Overall Study||6
6799449|NCT01967823|7731430|FG000|STARTED|Overall Study||11
6799450|NCT01967823|7731430|FG000|COMPLETED|Overall Study||10
6799451|NCT01967823|7731430|FG000|NOT COMPLETED|Overall Study||1
6799452|NCT01989676|7731440|FG000|STARTED|Overall Study||352
6799453|NCT01989676|7731441|FG001|STARTED|Overall Study||355
6799454|NCT01989676|7731440|FG000|Treated|Overall Study||349
6799455|NCT01989676|7731441|FG001|Treated|Overall Study||353
6799456|NCT01989676|7731440|FG000|COMPLETED|Overall Study||234
6799337|NCT01921218|7731337|FG000|STARTED|Overall Study||6
6799338|NCT01921218|7731338|FG001|STARTED|Overall Study||7
6799339|NCT01921218|7731337|FG000|COMPLETED|Overall Study||3
6799340|NCT01921218|7731338|FG001|COMPLETED|Overall Study||3
6799341|NCT01921218|7731337|FG000|NOT COMPLETED|Overall Study||3
6799342|NCT01921218|7731338|FG001|NOT COMPLETED|Overall Study||4
6799457|NCT01989676|7731441|FG001|COMPLETED|Overall Study||217
6799458|NCT01989676|7731440|FG000|NOT COMPLETED|Overall Study||118
6799459|NCT01989676|7731441|FG001|NOT COMPLETED|Overall Study||138
6380499|NCT00779402|7291320|FG001|COMPLETED|Treatment Phase 1||44
6380500|NCT00779402|7291319|FG000|NOT COMPLETED|Treatment Phase 1||33
6380501|NCT00779402|7291320|FG001|NOT COMPLETED|Treatment Phase 1||15
6380502|NCT00779402|7291319|FG000|STARTED|Surveillance Phase||84
6380503|NCT00779402|7291320|FG001|STARTED|Surveillance Phase||44
6380504|NCT00779402|7291319|FG000|COMPLETED|Surveillance Phase||41
6380505|NCT00779402|7291320|FG001|COMPLETED|Surveillance Phase||13
6380506|NCT00779402|7291319|FG000|NOT COMPLETED|Surveillance Phase||43
6380507|NCT00779402|7291320|FG001|NOT COMPLETED|Surveillance Phase||31
6380508|NCT00779402|7291319|FG000|STARTED|Long-term Follow-up||41
6380509|NCT00779402|7291320|FG001|STARTED|Long-term Follow-up||13
6380510|NCT00779402|7291319|FG000|COMPLETED|Long-term Follow-up||20
6380511|NCT00779402|7291320|FG001|COMPLETED|Long-term Follow-up||7
6380512|NCT00779402|7291319|FG000|NOT COMPLETED|Long-term Follow-up||21
6380513|NCT00779402|7291320|FG001|NOT COMPLETED|Long-term Follow-up||6
6380514|NCT00779467|7291330|FG000|STARTED|Overall Study||53
6380515|NCT00779467|7291331|FG001|STARTED|Overall Study||45
6380516|NCT00779467|7291332|FG002|STARTED|Overall Study||48
6380517|NCT00779467|7291333|FG003|STARTED|Overall Study||54
6380518|NCT00779467|7291330|FG000|COMPLETED|Overall Study||38
6380519|NCT00779467|7291331|FG001|COMPLETED|Overall Study||40
6380520|NCT00779467|7291332|FG002|COMPLETED|Overall Study||38
6380521|NCT00779467|7291333|FG003|COMPLETED|Overall Study||35
6380522|NCT00779467|7291330|FG000|NOT COMPLETED|Overall Study||15
6380523|NCT00779467|7291331|FG001|NOT COMPLETED|Overall Study||5
6380524|NCT00779467|7291332|FG002|NOT COMPLETED|Overall Study||10
6380525|NCT00779467|7291333|FG003|NOT COMPLETED|Overall Study||19
6380526|NCT00779506|7291343|FG000|STARTED|Overall Study||96
6380527|NCT00779506|7291343|FG000|Enrolled|Overall Study||96
6380528|NCT00779506|7291343|FG000|Screen Failed|Overall Study||2
6380529|NCT00779506|7291343|FG000|Assigned|Overall Study||94
6380530|NCT00779506|7291343|FG000|MITT|Overall Study||89
6380531|NCT00779506|7291343|FG000|Treatment Complete|Overall Study||67
6380532|NCT00779506|7291343|FG000|Withdrawal Treatment|Overall Study||27
6380533|NCT00779506|7291343|FG000|COMPLETED|Overall Study||67
6380534|NCT00779506|7291343|FG000|NOT COMPLETED|Overall Study||29
6380535|NCT00779558|7291349|FG000|STARTED|Overall Study||57
6380536|NCT00779558|7291350|FG001|STARTED|Overall Study||44
6380537|NCT00779558|7291349|FG000|COMPLETED|Overall Study||53
6380538|NCT00779558|7291350|FG001|COMPLETED|Overall Study||37
6380539|NCT00779558|7291349|FG000|NOT COMPLETED|Overall Study||4
6380540|NCT00779558|7291350|FG001|NOT COMPLETED|Overall Study||7
6380541|NCT00779584|7291365|FG000|STARTED|Overall Study||3
6380542|NCT00779584|7291366|FG001|STARTED|Overall Study||3
6380543|NCT00779584|7291367|FG002|STARTED|Overall Study||7
6380544|NCT00779584|7291368|FG003|STARTED|Overall Study||6
6799343|NCT01923168|7731347|FG000|STARTED|Overall Study||131
6799344|NCT01923168|7731348|FG001|STARTED|Overall Study||83
6799345|NCT01923168|7731349|FG002|STARTED|Overall Study||126
6799346|NCT01923168|7731347|FG000|COMPLETED|Overall Study||94
6799347|NCT01923168|7731348|FG001|COMPLETED|Overall Study||44
6799348|NCT01923168|7731349|FG002|COMPLETED|Overall Study||109
6799349|NCT01923168|7731347|FG000|NOT COMPLETED|Overall Study||37
6799350|NCT01923168|7731348|FG001|NOT COMPLETED|Overall Study||39
6799351|NCT01923168|7731349|FG002|NOT COMPLETED|Overall Study||17
6799352|NCT01923480|7731360|FG000|STARTED|Period 1 (Hours 1-7)||1
6799353|NCT01923480|7731361|FG001|STARTED|Period 1 (Hours 1-7)||2
6799354|NCT01923480|7731362|FG002|STARTED|Period 1 (Hours 1-7)||2
6799355|NCT01923480|7731363|FG003|STARTED|Period 1 (Hours 1-7)||2
6799356|NCT01923480|7731364|FG004|STARTED|Period 1 (Hours 1-7)||2
6799357|NCT01923480|7731365|FG005|STARTED|Period 1 (Hours 1-7)||2
6799358|NCT01923480|7731360|FG000|COMPLETED|Period 1 (Hours 1-7)||1
6799359|NCT01923480|7731361|FG001|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
6799360|NCT01923480|7731362|FG002|COMPLETED|Period 1 (Hours 1-7)||2
6799361|NCT01923480|7731363|FG003|COMPLETED|Period 1 (Hours 1-7)||2
6799362|NCT01923480|7731364|FG004|COMPLETED|Period 1 (Hours 1-7)||2
6799363|NCT01923480|7731365|FG005|COMPLETED|Period 1 (Hours 1-7)||2
6799364|NCT01923480|7731360|FG000|NOT COMPLETED|Period 1 (Hours 1-7)||0
6799365|NCT01923480|7731361|FG001|NOT COMPLETED|Period 1 (Hours 1-7)||0
6799366|NCT01923480|7731362|FG002|NOT COMPLETED|Period 1 (Hours 1-7)||0
6799367|NCT01923480|7731363|FG003|NOT COMPLETED|Period 1 (Hours 1-7)||0
6799368|NCT01923480|7731364|FG004|NOT COMPLETED|Period 1 (Hours 1-7)||0
6799369|NCT01923480|7731365|FG005|NOT COMPLETED|Period 1 (Hours 1-7)||0
6799370|NCT01923480|7731360|FG000|STARTED|Period 2 (Hours 1-7)||1
6799371|NCT01923480|7731361|FG001|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
6799372|NCT01923480|7731362|FG002|STARTED|Period 2 (Hours 1-7)||2
6799373|NCT01923480|7731363|FG003|STARTED|Period 2 (Hours 1-7)||2
6799374|NCT01923480|7731364|FG004|STARTED|Period 2 (Hours 1-7)||2
6799375|NCT01923480|7731365|FG005|STARTED|Period 2 (Hours 1-7)||2
6799376|NCT01923480|7731360|FG000|COMPLETED|Period 2 (Hours 1-7)||1
6799377|NCT01923480|7731361|FG001|COMPLETED|Period 2 (Hours 1-7)||1
6799378|NCT01923480|7731362|FG002|COMPLETED|Period 2 (Hours 1-7)||2
6799379|NCT01923480|7731363|FG003|COMPLETED|Period 2 (Hours 1-7)||2
6799380|NCT01923480|7731364|FG004|COMPLETED|Period 2 (Hours 1-7)||2
6799381|NCT01923480|7731365|FG005|COMPLETED|Period 2 (Hours 1-7)||2
6799382|NCT01923480|7731360|FG000|NOT COMPLETED|Period 2 (Hours 1-7)||0
6799383|NCT01923480|7731361|FG001|NOT COMPLETED|Period 2 (Hours 1-7)||0
6799384|NCT01923480|7731362|FG002|NOT COMPLETED|Period 2 (Hours 1-7)||0
6799385|NCT01923480|7731363|FG003|NOT COMPLETED|Period 2 (Hours 1-7)||0
6799386|NCT01923480|7731364|FG004|NOT COMPLETED|Period 2 (Hours 1-7)||0
6799387|NCT01923480|7731365|FG005|NOT COMPLETED|Period 2 (Hours 1-7)||0
6799460|NCT01992653|7731456|FG000|STARTED|Overall Study||3
6799461|NCT01992653|7731457|FG001|STARTED|Overall Study||3
6799462|NCT01992653|7731458|FG002|STARTED|Overall Study||6
6799463|NCT01992653|7731459|FG003|STARTED|Overall Study||1
6799464|NCT01992653|7731460|FG004|STARTED|Overall Study||6
6799465|NCT01992653|7731461|FG005|STARTED|Overall Study||6
6799466|NCT01992653|7731462|FG006|STARTED|Overall Study||40
6799467|NCT01992653|7731463|FG007|STARTED|Overall Study||17
6799468|NCT01992653|7731456|FG000|COMPLETED|Overall Study||3
6799469|NCT01992653|7731457|FG001|COMPLETED|Overall Study||3
6799470|NCT01992653|7731458|FG002|COMPLETED|Overall Study||5
6799471|NCT01992653|7731459|FG003|COMPLETED|Overall Study||1
6799472|NCT01992653|7731460|FG004|COMPLETED|Overall Study||5
6799473|NCT01992653|7731461|FG005|COMPLETED|Overall Study||6
6799474|NCT01992653|7731462|FG006|COMPLETED|Overall Study||32
6799475|NCT01992653|7731463|FG007|COMPLETED|Overall Study||13
6799476|NCT01992653|7731456|FG000|NOT COMPLETED|Overall Study||0
6799477|NCT01992653|7731457|FG001|NOT COMPLETED|Overall Study||0
6799478|NCT01992653|7731458|FG002|NOT COMPLETED|Overall Study||1
6799479|NCT01992653|7731459|FG003|NOT COMPLETED|Overall Study||0
6799480|NCT01992653|7731460|FG004|NOT COMPLETED|Overall Study||1
6799481|NCT01992653|7731461|FG005|NOT COMPLETED|Overall Study||0
6799482|NCT01992653|7731462|FG006|NOT COMPLETED|Overall Study||8
6799483|NCT01992653|7731463|FG007|NOT COMPLETED|Overall Study||4
6799484|NCT02001974|7731484|FG000|STARTED|Run-in Period||4
6799485|NCT02001974|7731485|FG001|STARTED|Run-in Period||3
6799486|NCT02001974|7731486|FG002|STARTED|Run-in Period||26
6799487|NCT02001974|7731484|FG000|COMPLETED|Run-in Period||4
6799488|NCT02001974|7731485|FG001|COMPLETED|Run-in Period||3
6799489|NCT02001974|7731486|FG002|COMPLETED|Run-in Period||26
6799490|NCT02001974|7731484|FG000|NOT COMPLETED|Run-in Period||0
6799491|NCT02001974|7731485|FG001|NOT COMPLETED|Run-in Period||0
6799492|NCT02001974|7731486|FG002|NOT COMPLETED|Run-in Period||0
6799493|NCT02001974|7731484|FG000|STARTED|Reparixin + Paclitaxel (28-day Cycles)||4
6799494|NCT02001974|7731485|FG001|STARTED|Reparixin + Paclitaxel (28-day Cycles)||3
6799495|NCT02001974|7731486|FG002|STARTED|Reparixin + Paclitaxel (28-day Cycles)||26
6799496|NCT02001974|7731484|FG000|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
6799497|NCT02001974|7731485|FG001|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
6799498|NCT02001974|7731486|FG002|COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||0
6799499|NCT02001974|7731484|FG000|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||4
6799500|NCT02001974|7731485|FG001|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||3
6799501|NCT02001974|7731486|FG002|NOT COMPLETED|Reparixin + Paclitaxel (28-day Cycles)||26
6799502|NCT02014558|7731507|FG000|STARTED|Overall Study||5
6799503|NCT02014558|7731508|FG001|STARTED|Overall Study||3
6799504|NCT02014558|7731509|FG002|STARTED|Overall Study||3
6799505|NCT02014558|7731510|FG003|STARTED|Overall Study||3
6799506|NCT02014558|7731511|FG004|STARTED|Overall Study||4
6799507|NCT02014558|7731512|FG005|STARTED|Overall Study||3
6564198|NCT01809327|7486905|FG000|NOT COMPLETED|Overall Study||32
6564199|NCT01809327|7486906|FG001|NOT COMPLETED|Overall Study||26
6564200|NCT01809327|7486907|FG002|NOT COMPLETED|Overall Study||22
6564201|NCT01809327|7486908|FG003|NOT COMPLETED|Overall Study||12
6564202|NCT01809327|7486909|FG004|NOT COMPLETED|Overall Study||25
6564203|NCT01809639|7486923|FG000|STARTED|Overall Study||18
6564204|NCT01809639|7486924|FG001|STARTED|Overall Study||7
6564205|NCT01809639|7486923|FG000|COMPLETED|Overall Study||18
6564206|NCT01809639|7486924|FG001|COMPLETED|Overall Study||7
6564207|NCT01809639|7486923|FG000|NOT COMPLETED|Overall Study||0
6799508|NCT02014558|7731513|FG006|STARTED|Overall Study||4
6799509|NCT02014558|7731514|FG007|STARTED|Overall Study||11
6799510|NCT02014558|7731515|FG008|STARTED|Overall Study||15
6799511|NCT02014558|7731516|FG009|STARTED|Overall Study||21
6799512|NCT02014558|7731517|FG010|STARTED|Overall Study||69
6799513|NCT02014558|7731518|FG011|STARTED|Overall Study||102
6799514|NCT02014558|7731519|FG012|STARTED|Overall Study||17
6799515|NCT02014558|7731507|FG000|Treated|Overall Study||5
6799516|NCT02014558|7731508|FG001|Treated|Overall Study||3
6799517|NCT02014558|7731509|FG002|Treated|Overall Study||3
6799518|NCT02014558|7731510|FG003|Treated|Overall Study||3
6799519|NCT02014558|7731511|FG004|Treated|Overall Study||3
6799520|NCT02014558|7731512|FG005|Treated|Overall Study||3
6799521|NCT02014558|7731513|FG006|Treated|Overall Study||3
6799522|NCT02014558|7731514|FG007|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|12
6799523|NCT02014558|7731515|FG008|Treated|Overall Study||13
6799524|NCT02014558|7731516|FG009|Treated|Overall Study||21
6799525|NCT02014558|7731517|FG010|Treated|Overall Study|A participant randomized to the 120 mg was treated with an initial dose of 20 mg by mistake.|66
6799526|NCT02014558|7731518|FG011|Treated|Overall Study||100
6799527|NCT02014558|7731519|FG012|Treated|Overall Study||17
6799528|NCT02014558|7731507|FG000|COMPLETED|Overall Study||0
6799529|NCT02014558|7731508|FG001|COMPLETED|Overall Study||0
6799530|NCT02014558|7731509|FG002|COMPLETED|Overall Study||0
6799531|NCT02014558|7731510|FG003|COMPLETED|Overall Study||0
6799532|NCT02014558|7731511|FG004|COMPLETED|Overall Study||0
6799533|NCT02014558|7731512|FG005|COMPLETED|Overall Study||0
6799534|NCT02014558|7731513|FG006|COMPLETED|Overall Study||0
6799535|NCT02014558|7731514|FG007|COMPLETED|Overall Study||0
6799536|NCT02014558|7731515|FG008|COMPLETED|Overall Study||0
6799537|NCT02014558|7731516|FG009|COMPLETED|Overall Study||0
6799538|NCT02014558|7731517|FG010|COMPLETED|Overall Study||0
6799539|NCT02014558|7731518|FG011|COMPLETED|Overall Study||0
6799540|NCT02014558|7731519|FG012|COMPLETED|Overall Study||0
6799541|NCT02014558|7731507|FG000|NOT COMPLETED|Overall Study||5
6799542|NCT02014558|7731508|FG001|NOT COMPLETED|Overall Study||3
6799543|NCT02014558|7731509|FG002|NOT COMPLETED|Overall Study||3
6799544|NCT02014558|7731510|FG003|NOT COMPLETED|Overall Study||3
6799545|NCT02014558|7731511|FG004|NOT COMPLETED|Overall Study||4
6799546|NCT02014558|7731512|FG005|NOT COMPLETED|Overall Study||3
6799547|NCT02014558|7731513|FG006|NOT COMPLETED|Overall Study||4
6799548|NCT02014558|7731514|FG007|NOT COMPLETED|Overall Study||11
6799549|NCT02014558|7731515|FG008|NOT COMPLETED|Overall Study||15
6799550|NCT02014558|7731516|FG009|NOT COMPLETED|Overall Study||21
6799551|NCT02014558|7731517|FG010|NOT COMPLETED|Overall Study||69
6799552|NCT02014558|7731518|FG011|NOT COMPLETED|Overall Study||102
6799553|NCT02014558|7731519|FG012|NOT COMPLETED|Overall Study||17
6799554|NCT02015455|7731563|FG000|STARTED|Step 0 - Oct 2013 to Mar 2014||48233
6799555|NCT02015455|7731564|FG001|STARTED|Step 0 - Oct 2013 to Mar 2014||0
6799556|NCT02015455|7731563|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||135
6799557|NCT02015455|7731564|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 0 - Oct 2013 to Mar 2014||0
6799558|NCT02015455|7731563|FG000|COMPLETED|Step 0 - Oct 2013 to Mar 2014||48233
6799559|NCT02015455|7731564|FG001|COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
6799560|NCT02015455|7731563|FG000|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
6799561|NCT02015455|7731564|FG001|NOT COMPLETED|Step 0 - Oct 2013 to Mar 2014||0
6564208|NCT01809639|7486924|FG001|NOT COMPLETED|Overall Study||0
6799562|NCT02015455|7731563|FG000|STARTED|Step 1 - Apr 2014 to Sep 2014||24074
6799563|NCT02015455|7731564|FG001|STARTED|Step 1 - Apr 2014 to Sep 2014||6455
6799564|NCT02015455|7731563|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||390
6799565|NCT02015455|7731564|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 1 - Apr 2014 to Sep 2014||2208
6799566|NCT02015455|7731563|FG000|COMPLETED|Step 1 - Apr 2014 to Sep 2014||24074
6564209|NCT01809834|7486930|FG000|STARTED|Overall Study||44
6799567|NCT02015455|7731564|FG001|COMPLETED|Step 1 - Apr 2014 to Sep 2014||6455
6799568|NCT02015455|7731563|FG000|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
6799569|NCT02015455|7731564|FG001|NOT COMPLETED|Step 1 - Apr 2014 to Sep 2014||0
6799570|NCT02015455|7731563|FG000|STARTED|Step 2 - Oct 2014 to Mar 2015||23139
6799571|NCT02015455|7731564|FG001|STARTED|Step 2 - Oct 2014 to Mar 2015||16285
6799572|NCT02015455|7731563|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||98
6799573|NCT02015455|7731564|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 2 - Oct 2014 to Mar 2015||1511
6799574|NCT02015455|7731563|FG000|COMPLETED|Step 2 - Oct 2014 to Mar 2015||23139
6799575|NCT02015455|7731564|FG001|COMPLETED|Step 2 - Oct 2014 to Mar 2015||16285
6799576|NCT02015455|7731563|FG000|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
6799577|NCT02015455|7731564|FG001|NOT COMPLETED|Step 2 - Oct 2014 to Mar 2015||0
6799578|NCT02015455|7731563|FG000|STARTED|Step 3 - Apr 2015 to Sep 2015||14135
6799579|NCT02015455|7731564|FG001|STARTED|Step 3 - Apr 2015 to Sep 2015||27661
6799580|NCT02015455|7731563|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||72
6799581|NCT02015455|7731564|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 3 - Apr 2015 to Sep 2015||4915
6799582|NCT02015455|7731563|FG000|COMPLETED|Step 3 - Apr 2015 to Sep 2015||14135
6799583|NCT02015455|7731564|FG001|COMPLETED|Step 3 - Apr 2015 to Sep 2015||27661
6799584|NCT02015455|7731563|FG000|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
6799585|NCT02015455|7731564|FG001|NOT COMPLETED|Step 3 - Apr 2015 to Sep 2015||0
6799586|NCT02015455|7731563|FG000|STARTED|Step 4 - Oct 2015 to Mar 2016||7874
6799587|NCT02015455|7731564|FG001|STARTED|Step 4 - Oct 2015 to Mar 2016||31316
6799588|NCT02015455|7731563|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||76
6799589|NCT02015455|7731564|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 4 - Oct 2015 to Mar 2016||3742
6799590|NCT02015455|7731563|FG000|COMPLETED|Step 4 - Oct 2015 to Mar 2016||7874
6799591|NCT02015455|7731564|FG001|COMPLETED|Step 4 - Oct 2015 to Mar 2016||31316
6799592|NCT02015455|7731563|FG000|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
6799593|NCT02015455|7731564|FG001|NOT COMPLETED|Step 4 - Oct 2015 to Mar 2016||0
6799594|NCT02015455|7731563|FG000|STARTED|Step 5 - Apr 2016 to Sep 2016||0
6799595|NCT02015455|7731564|FG001|STARTED|Step 5 - Apr 2016 to Sep 2016||39714
6799596|NCT02015455|7731563|FG000|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||0
6799597|NCT02015455|7731564|FG001|Did Not Receive Intended Inclusion/Exclusion of Intervention Report Text|Step 5 - Apr 2016 to Sep 2016||3512
6799598|NCT02015455|7731563|FG000|COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
6799599|NCT02015455|7731564|FG001|COMPLETED|Step 5 - Apr 2016 to Sep 2016||39714
6799600|NCT02015455|7731563|FG000|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
6799601|NCT02015455|7731564|FG001|NOT COMPLETED|Step 5 - Apr 2016 to Sep 2016||0
6799602|NCT02024555|7731574|FG000|STARTED|Overall Study||49
6799603|NCT02024555|7731575|FG001|STARTED|Overall Study||48
6799604|NCT02024555|7731574|FG000|COMPLETED|Overall Study||43
6799605|NCT02024555|7731575|FG001|COMPLETED|Overall Study||46
6799606|NCT02024555|7731574|FG000|NOT COMPLETED|Overall Study||6
6799607|NCT02024555|7731575|FG001|NOT COMPLETED|Overall Study||2
6799608|NCT02034123|7731599|FG000|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
6799609|NCT02034123|7731600|FG001|STARTED|Part1(Median of 7.286 Weeks of Exposure)||1
6799610|NCT02034123|7731601|FG002|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
6799611|NCT02034123|7731602|FG003|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
6799612|NCT02034123|7731603|FG004|STARTED|Part1(Median of 7.286 Weeks of Exposure)||7
6799613|NCT02034123|7731604|FG005|STARTED|Part1(Median of 7.286 Weeks of Exposure)||3
6799614|NCT02034123|7731605|FG006|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
6799615|NCT02034123|7731606|FG007|STARTED|Part1(Median of 7.286 Weeks of Exposure)||5
6799616|NCT02034123|7731607|FG008|STARTED|Part1(Median of 7.286 Weeks of Exposure)||2
6799617|NCT02034123|7731608|FG009|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799618|NCT02034123|7731609|FG010|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799619|NCT02034123|7731610|FG011|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799620|NCT02034123|7731611|FG012|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799621|NCT02034123|7731612|FG013|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799622|NCT02034123|7731613|FG014|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799623|NCT02034123|7731614|FG015|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799624|NCT02034123|7731615|FG016|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799625|NCT02034123|7731616|FG017|STARTED|Part1(Median of 7.286 Weeks of Exposure)||0
6799626|NCT02034123|7731599|FG000|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
6799627|NCT02034123|7731600|FG001|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
6799628|NCT02034123|7731601|FG002|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
6799629|NCT02034123|7731602|FG003|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
6799630|NCT02034123|7731603|FG004|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||5
6799631|NCT02034123|7731604|FG005|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||3
6799632|NCT02034123|7731605|FG006|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
6799633|NCT02034123|7731606|FG007|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||4
6799634|NCT02034123|7731607|FG008|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799635|NCT02034123|7731608|FG009|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799636|NCT02034123|7731609|FG010|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799637|NCT02034123|7731610|FG011|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799638|NCT02034123|7731611|FG012|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799639|NCT02034123|7731612|FG013|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799640|NCT02034123|7731613|FG014|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799641|NCT02034123|7731614|FG015|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799642|NCT02034123|7731615|FG016|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799643|NCT02034123|7731616|FG017|COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799644|NCT02034123|7731599|FG000|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799645|NCT02034123|7731600|FG001|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799646|NCT02034123|7731601|FG002|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799647|NCT02034123|7731602|FG003|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
6799648|NCT02034123|7731603|FG004|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
6799649|NCT02034123|7731604|FG005|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799650|NCT02034123|7731605|FG006|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799651|NCT02034123|7731606|FG007|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||1
6799652|NCT02034123|7731607|FG008|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||2
6799653|NCT02034123|7731608|FG009|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799654|NCT02034123|7731609|FG010|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799655|NCT02034123|7731610|FG011|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799656|NCT02034123|7731611|FG012|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799657|NCT02034123|7731612|FG013|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799658|NCT02034123|7731613|FG014|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799659|NCT02034123|7731614|FG015|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799660|NCT02034123|7731615|FG016|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799661|NCT02034123|7731616|FG017|NOT COMPLETED|Part1(Median of 7.286 Weeks of Exposure)||0
6799662|NCT02034123|7731599|FG000|STARTED|Part2(Up to 2 Years)||0
6799663|NCT02034123|7731600|FG001|STARTED|Part2(Up to 2 Years)||0
6799664|NCT02034123|7731601|FG002|STARTED|Part2(Up to 2 Years)||0
6799665|NCT02034123|7731602|FG003|STARTED|Part2(Up to 2 Years)||0
6799666|NCT02034123|7731603|FG004|STARTED|Part2(Up to 2 Years)||0
6799667|NCT02034123|7731604|FG005|STARTED|Part2(Up to 2 Years)||0
6799668|NCT02034123|7731605|FG006|STARTED|Part2(Up to 2 Years)||0
6799669|NCT02034123|7731606|FG007|STARTED|Part2(Up to 2 Years)||0
6799670|NCT02034123|7731607|FG008|STARTED|Part2(Up to 2 Years)||0
6799671|NCT02034123|7731608|FG009|STARTED|Part2(Up to 2 Years)||0
6799672|NCT02034123|7731609|FG010|STARTED|Part2(Up to 2 Years)||0
6799673|NCT02034123|7731610|FG011|STARTED|Part2(Up to 2 Years)||0
6799674|NCT02034123|7731611|FG012|STARTED|Part2(Up to 2 Years)||0
6799675|NCT02034123|7731612|FG013|STARTED|Part2(Up to 2 Years)||0
6799676|NCT02034123|7731613|FG014|STARTED|Part2(Up to 2 Years)||0
6799677|NCT02034123|7731614|FG015|STARTED|Part2(Up to 2 Years)||0
6799678|NCT02034123|7731615|FG016|STARTED|Part2(Up to 2 Years)||0
6799679|NCT02034123|7731616|FG017|STARTED|Part2(Up to 2 Years)||0
6799680|NCT02034123|7731599|FG000|COMPLETED|Part2(Up to 2 Years)||0
6799681|NCT02034123|7731600|FG001|COMPLETED|Part2(Up to 2 Years)||0
6799682|NCT02034123|7731601|FG002|COMPLETED|Part2(Up to 2 Years)||0
6799683|NCT02034123|7731602|FG003|COMPLETED|Part2(Up to 2 Years)||0
6799684|NCT02034123|7731603|FG004|COMPLETED|Part2(Up to 2 Years)||0
6799685|NCT02034123|7731604|FG005|COMPLETED|Part2(Up to 2 Years)||0
6799686|NCT02034123|7731605|FG006|COMPLETED|Part2(Up to 2 Years)||0
6799687|NCT02034123|7731606|FG007|COMPLETED|Part2(Up to 2 Years)||0
6799688|NCT02034123|7731607|FG008|COMPLETED|Part2(Up to 2 Years)||0
6799689|NCT02034123|7731608|FG009|COMPLETED|Part2(Up to 2 Years)||0
6799690|NCT02034123|7731609|FG010|COMPLETED|Part2(Up to 2 Years)||0
6799691|NCT02034123|7731610|FG011|COMPLETED|Part2(Up to 2 Years)||0
6799692|NCT02034123|7731611|FG012|COMPLETED|Part2(Up to 2 Years)||0
6799693|NCT02034123|7731612|FG013|COMPLETED|Part2(Up to 2 Years)||0
6799694|NCT02034123|7731613|FG014|COMPLETED|Part2(Up to 2 Years)||0
6799695|NCT02034123|7731614|FG015|COMPLETED|Part2(Up to 2 Years)||0
6799696|NCT02034123|7731615|FG016|COMPLETED|Part2(Up to 2 Years)||0
6799697|NCT02034123|7731616|FG017|COMPLETED|Part2(Up to 2 Years)||0
6799698|NCT02034123|7731599|FG000|NOT COMPLETED|Part2(Up to 2 Years)||0
6799699|NCT02034123|7731600|FG001|NOT COMPLETED|Part2(Up to 2 Years)||0
6799700|NCT02034123|7731601|FG002|NOT COMPLETED|Part2(Up to 2 Years)||0
6799701|NCT02034123|7731602|FG003|NOT COMPLETED|Part2(Up to 2 Years)||0
6799702|NCT02034123|7731603|FG004|NOT COMPLETED|Part2(Up to 2 Years)||0
6799703|NCT02034123|7731604|FG005|NOT COMPLETED|Part2(Up to 2 Years)||0
6799704|NCT02034123|7731605|FG006|NOT COMPLETED|Part2(Up to 2 Years)||0
6799705|NCT02034123|7731606|FG007|NOT COMPLETED|Part2(Up to 2 Years)||0
6799706|NCT02034123|7731607|FG008|NOT COMPLETED|Part2(Up to 2 Years)||0
6799707|NCT02034123|7731608|FG009|NOT COMPLETED|Part2(Up to 2 Years)||0
6799708|NCT02034123|7731609|FG010|NOT COMPLETED|Part2(Up to 2 Years)||0
6799709|NCT02034123|7731610|FG011|NOT COMPLETED|Part2(Up to 2 Years)||0
6799710|NCT02034123|7731611|FG012|NOT COMPLETED|Part2(Up to 2 Years)||0
6799711|NCT02034123|7731612|FG013|NOT COMPLETED|Part2(Up to 2 Years)||0
6799712|NCT02034123|7731613|FG014|NOT COMPLETED|Part2(Up to 2 Years)||0
6799713|NCT02034123|7731614|FG015|NOT COMPLETED|Part2(Up to 2 Years)||0
6799714|NCT02034123|7731615|FG016|NOT COMPLETED|Part2(Up to 2 Years)||0
6799715|NCT02034123|7731616|FG017|NOT COMPLETED|Part2(Up to 2 Years)||0
6799716|NCT02040584|7731661|FG000|STARTED|Overall Study||105
6799717|NCT02040584|7731662|FG001|STARTED|Overall Study||106
6799718|NCT02040584|7731661|FG000|COMPLETED|Overall Study||70
6799719|NCT02040584|7731662|FG001|COMPLETED|Overall Study||74
6799720|NCT02040584|7731661|FG000|NOT COMPLETED|Overall Study||35
6799721|NCT02040584|7731662|FG001|NOT COMPLETED|Overall Study||32
6799722|NCT02045797|7731681|FG000|STARTED|Overall Study||58
6799723|NCT02045797|7731682|FG001|STARTED|Overall Study||39
6799724|NCT02045797|7731683|FG002|STARTED|Overall Study||25
6799725|NCT02045797|7731681|FG000|COMPLETED|Overall Study||51
6799726|NCT02045797|7731682|FG001|COMPLETED|Overall Study||32
6799727|NCT02045797|7731683|FG002|COMPLETED|Overall Study||24
6799728|NCT02045797|7731681|FG000|NOT COMPLETED|Overall Study||7
6799729|NCT02045797|7731682|FG001|NOT COMPLETED|Overall Study||7
6799730|NCT02045797|7731683|FG002|NOT COMPLETED|Overall Study||1
6799731|NCT02049710|7731693|FG000|STARTED|Overall Study||653
6799732|NCT02049710|7731694|FG001|STARTED|Overall Study||664
6799733|NCT02049710|7731693|FG000|COMPLETED|Overall Study||334
6799734|NCT02049710|7731694|FG001|COMPLETED|Overall Study||340
6799735|NCT02049710|7731693|FG000|NOT COMPLETED|Overall Study||319
6799736|NCT02049710|7731694|FG001|NOT COMPLETED|Overall Study||324
6799737|NCT02055547|7731700|FG000|STARTED|Overall Study||2
6799738|NCT02055547|7731701|FG001|STARTED|Overall Study||2
6799739|NCT02055547|7731702|FG002|STARTED|Overall Study||5
6799740|NCT02055547|7731703|FG003|STARTED|Overall Study||2
6799741|NCT02055547|7731704|FG004|STARTED|Overall Study||2
6799742|NCT02055547|7731705|FG005|STARTED|Overall Study||2
6799743|NCT02055547|7731706|FG006|STARTED|Overall Study||2
6799744|NCT02055547|7731707|FG007|STARTED|Overall Study||6
6799745|NCT02055547|7731708|FG008|STARTED|Overall Study||6
6799746|NCT02055547|7731709|FG009|STARTED|Overall Study||6
6799747|NCT02055547|7731710|FG010|STARTED|Overall Study||6
6799748|NCT02055547|7731711|FG011|STARTED|Overall Study||6
6799749|NCT02055547|7731712|FG012|STARTED|Overall Study||2
6799750|NCT02055547|7731713|FG013|STARTED|Overall Study||2
6799751|NCT02055547|7731714|FG014|STARTED|Overall Study||2
6799752|NCT02055547|7731715|FG015|STARTED|Overall Study||2
6799753|NCT02055547|7731716|FG016|STARTED|Overall Study||2
6799754|NCT02055547|7731717|FG017|STARTED|Overall Study||2
6799755|NCT02055547|7731718|FG018|STARTED|Overall Study||2
6799756|NCT02055547|7731700|FG000|COMPLETED|Overall Study||2
6799757|NCT02055547|7731701|FG001|COMPLETED|Overall Study||1
6799758|NCT02055547|7731702|FG002|COMPLETED|Overall Study||2
6799759|NCT02055547|7731703|FG003|COMPLETED|Overall Study||2
6799760|NCT02055547|7731704|FG004|COMPLETED|Overall Study||1
6799761|NCT02055547|7731705|FG005|COMPLETED|Overall Study||1
6799762|NCT02055547|7731706|FG006|COMPLETED|Overall Study||0
6799763|NCT02055547|7731707|FG007|COMPLETED|Overall Study||6
6799764|NCT02055547|7731708|FG008|COMPLETED|Overall Study||4
6799765|NCT02055547|7731709|FG009|COMPLETED|Overall Study||5
6799766|NCT02055547|7731710|FG010|COMPLETED|Overall Study||5
6799767|NCT02055547|7731711|FG011|COMPLETED|Overall Study||6
6799768|NCT02055547|7731712|FG012|COMPLETED|Overall Study||2
6799769|NCT02055547|7731713|FG013|COMPLETED|Overall Study||1
6799770|NCT02055547|7731714|FG014|COMPLETED|Overall Study||2
6799771|NCT02055547|7731715|FG015|COMPLETED|Overall Study||1
6799772|NCT02055547|7731716|FG016|COMPLETED|Overall Study||2
6799773|NCT02055547|7731717|FG017|COMPLETED|Overall Study||2
6799774|NCT02055547|7731718|FG018|COMPLETED|Overall Study||2
6799775|NCT02055547|7731700|FG000|NOT COMPLETED|Overall Study||0
6799776|NCT02055547|7731701|FG001|NOT COMPLETED|Overall Study||1
6799777|NCT02055547|7731702|FG002|NOT COMPLETED|Overall Study||3
6799778|NCT02055547|7731703|FG003|NOT COMPLETED|Overall Study||0
6799779|NCT02055547|7731704|FG004|NOT COMPLETED|Overall Study||1
6799780|NCT02055547|7731705|FG005|NOT COMPLETED|Overall Study||1
6799781|NCT02055547|7731706|FG006|NOT COMPLETED|Overall Study||2
6799782|NCT02055547|7731707|FG007|NOT COMPLETED|Overall Study||0
6799783|NCT02055547|7731708|FG008|NOT COMPLETED|Overall Study||2
6799784|NCT02055547|7731709|FG009|NOT COMPLETED|Overall Study||1
6799785|NCT02055547|7731710|FG010|NOT COMPLETED|Overall Study||1
6799786|NCT02055547|7731711|FG011|NOT COMPLETED|Overall Study||0
6799787|NCT02055547|7731712|FG012|NOT COMPLETED|Overall Study||0
6799788|NCT02055547|7731713|FG013|NOT COMPLETED|Overall Study||1
6799789|NCT02055547|7731714|FG014|NOT COMPLETED|Overall Study||0
6799790|NCT02055547|7731715|FG015|NOT COMPLETED|Overall Study||1
6799791|NCT02055547|7731716|FG016|NOT COMPLETED|Overall Study||0
6799792|NCT02055547|7731717|FG017|NOT COMPLETED|Overall Study||0
6799793|NCT02055547|7731718|FG018|NOT COMPLETED|Overall Study||0
6799794|NCT02064387|7731764|FG000|STARTED|Part 1 Max 23.5 Months Followup Duration||1
6799795|NCT02064387|7731765|FG001|STARTED|Part 1 Max 23.5 Months Followup Duration||1
6799796|NCT02064387|7731766|FG002|STARTED|Part 1 Max 23.5 Months Followup Duration||4
6799797|NCT02064387|7731767|FG003|STARTED|Part 1 Max 23.5 Months Followup Duration||4
6799798|NCT02064387|7731768|FG004|STARTED|Part 1 Max 23.5 Months Followup Duration||4
6799799|NCT02064387|7731769|FG005|STARTED|Part 1 Max 23.5 Months Followup Duration||3
6799800|NCT02064387|7731770|FG006|STARTED|Part 1 Max 23.5 Months Followup Duration||4
6799801|NCT02064387|7731771|FG007|STARTED|Part 1 Max 23.5 Months Followup Duration||8
6799802|NCT02064387|7731772|FG008|STARTED|Part 1 Max 23.5 Months Followup Duration||3
6799803|NCT02064387|7731773|FG009|STARTED|Part 1 Max 23.5 Months Followup Duration||6
6799804|NCT02064387|7731774|FG010|STARTED|Part 1 Max 23.5 Months Followup Duration||0
6799805|NCT02064387|7731775|FG011|STARTED|Part 1 Max 23.5 Months Followup Duration||0
6799806|NCT02064387|7731764|FG000|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
6799807|NCT02064387|7731765|FG001|COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
6799808|NCT02064387|7731766|FG002|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
6799809|NCT02064387|7731767|FG003|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
6799810|NCT02064387|7731768|FG004|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
6799811|NCT02064387|7731769|FG005|COMPLETED|Part 1 Max 23.5 Months Followup Duration||3
6799812|NCT02064387|7731770|FG006|COMPLETED|Part 1 Max 23.5 Months Followup Duration||4
6799813|NCT02064387|7731771|FG007|COMPLETED|Part 1 Max 23.5 Months Followup Duration||6
6799814|NCT02064387|7731772|FG008|COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
6799815|NCT02064387|7731773|FG009|COMPLETED|Part 1 Max 23.5 Months Followup Duration||5
6799816|NCT02064387|7731774|FG010|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799817|NCT02064387|7731775|FG011|COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799818|NCT02064387|7731764|FG000|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799819|NCT02064387|7731765|FG001|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799820|NCT02064387|7731766|FG002|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799821|NCT02064387|7731767|FG003|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799822|NCT02064387|7731768|FG004|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799823|NCT02064387|7731769|FG005|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799824|NCT02064387|7731770|FG006|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799825|NCT02064387|7731771|FG007|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||2
6799826|NCT02064387|7731772|FG008|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
6799827|NCT02064387|7731773|FG009|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||1
6799828|NCT02064387|7731774|FG010|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799829|NCT02064387|7731775|FG011|NOT COMPLETED|Part 1 Max 23.5 Months Followup Duration||0
6799830|NCT02064387|7731764|FG000|STARTED|Part 2 Max 35 Months Followup Duration||0
6799831|NCT02064387|7731765|FG001|STARTED|Part 2 Max 35 Months Followup Duration||0
6799832|NCT02064387|7731766|FG002|STARTED|Part 2 Max 35 Months Followup Duration||0
6799833|NCT02064387|7731767|FG003|STARTED|Part 2 Max 35 Months Followup Duration||0
6799834|NCT02064387|7731768|FG004|STARTED|Part 2 Max 35 Months Followup Duration||0
6799835|NCT02064387|7731769|FG005|STARTED|Part 2 Max 35 Months Followup Duration||0
6799836|NCT02064387|7731770|FG006|STARTED|Part 2 Max 35 Months Followup Duration||0
6799837|NCT02064387|7731771|FG007|STARTED|Part 2 Max 35 Months Followup Duration||0
6799838|NCT02064387|7731772|FG008|STARTED|Part 2 Max 35 Months Followup Duration||0
6799839|NCT02064387|7731773|FG009|STARTED|Part 2 Max 35 Months Followup Duration||0
6799840|NCT02064387|7731774|FG010|STARTED|Part 2 Max 35 Months Followup Duration||35
6799841|NCT02064387|7731775|FG011|STARTED|Part 2 Max 35 Months Followup Duration||6
6799842|NCT02064387|7731764|FG000|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799843|NCT02064387|7731765|FG001|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799844|NCT02064387|7731766|FG002|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799845|NCT02064387|7731767|FG003|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799846|NCT02064387|7731768|FG004|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799847|NCT02064387|7731769|FG005|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799848|NCT02064387|7731770|FG006|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799849|NCT02064387|7731771|FG007|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799850|NCT02064387|7731772|FG008|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799851|NCT02064387|7731773|FG009|COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799852|NCT02064387|7731774|FG010|COMPLETED|Part 2 Max 35 Months Followup Duration||29
6799853|NCT02064387|7731775|FG011|COMPLETED|Part 2 Max 35 Months Followup Duration||3
6799854|NCT02064387|7731764|FG000|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799855|NCT02064387|7731765|FG001|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799856|NCT02064387|7731766|FG002|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799857|NCT02064387|7731767|FG003|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799858|NCT02064387|7731768|FG004|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799859|NCT02064387|7731769|FG005|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799860|NCT02064387|7731770|FG006|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799861|NCT02064387|7731771|FG007|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799862|NCT02064387|7731772|FG008|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799863|NCT02064387|7731773|FG009|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||0
6799864|NCT02064387|7731774|FG010|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||6
6799865|NCT02064387|7731775|FG011|NOT COMPLETED|Part 2 Max 35 Months Followup Duration||3
6380545|NCT00779584|7291369|FG004|STARTED|Overall Study||7
6799866|NCT02076178|7731816|FG000|STARTED|Oral Phase||21
6799867|NCT02076178|7731817|FG001|STARTED|Oral Phase||106
6564210|NCT01809834|7486930|FG000|COMPLETED|Overall Study||44
6564211|NCT01809834|7486930|FG000|NOT COMPLETED|Overall Study||0
6799868|NCT02076178|7731816|FG000|COMPLETED|Oral Phase||21
6799869|NCT02076178|7731817|FG001|COMPLETED|Oral Phase||94
6799870|NCT02076178|7731816|FG000|NOT COMPLETED|Oral Phase||0
6799871|NCT02076178|7731817|FG001|NOT COMPLETED|Oral Phase||12
6799872|NCT02076178|7731816|FG000|STARTED|Injection Phase||21
6799873|NCT02076178|7731817|FG001|STARTED|Injection Phase||94
6799874|NCT02076178|7731816|FG000|COMPLETED|Injection Phase||20
6799875|NCT02076178|7731817|FG001|COMPLETED|Injection Phase||87
6799876|NCT02076178|7731816|FG000|NOT COMPLETED|Injection Phase||1
6799877|NCT02076178|7731817|FG001|NOT COMPLETED|Injection Phase||7
6799878|NCT02079766|7731827|FG000|STARTED|Overall Study||30
6799879|NCT02079766|7731828|FG001|STARTED|Overall Study||11
6799880|NCT02079766|7731827|FG000|COMPLETED|Overall Study||28
6799881|NCT02079766|7731828|FG001|COMPLETED|Overall Study||11
6799882|NCT02079766|7731827|FG000|NOT COMPLETED|Overall Study||2
6799883|NCT02079766|7731828|FG001|NOT COMPLETED|Overall Study||0
6799908|NCT02087189|7731861|FG000|STARTED|Overall Study||30
6799909|NCT02087189|7731861|FG000|COMPLETED|Overall Study||28
6799910|NCT02087189|7731861|FG000|NOT COMPLETED|Overall Study||2
6799911|NCT02112916|7731869|FG000|STARTED|Overall Study||312
6799912|NCT02112916|7731870|FG001|STARTED|Overall Study||315
6799913|NCT02112916|7731871|FG002|STARTED|Overall Study||111
6799914|NCT02112916|7731872|FG003|STARTED|Overall Study||109
6799915|NCT02112916|7731869|FG000|COMPLETED|Overall Study||108
6799916|NCT02112916|7731870|FG001|COMPLETED|Overall Study||123
6799917|NCT02112916|7731871|FG002|COMPLETED|Overall Study||52
6799918|NCT02112916|7731872|FG003|COMPLETED|Overall Study||62
6799919|NCT02112916|7731869|FG000|NOT COMPLETED|Overall Study||204
6799920|NCT02112916|7731870|FG001|NOT COMPLETED|Overall Study||192
6799921|NCT02112916|7731871|FG002|NOT COMPLETED|Overall Study||59
6799922|NCT02112916|7731872|FG003|NOT COMPLETED|Overall Study||47
6799931|NCT02134717|7731896|FG000|STARTED|Overall Study||3
6799932|NCT02134717|7731896|FG000|COMPLETED|Overall Study||3
6799933|NCT02134717|7731896|FG000|NOT COMPLETED|Overall Study||0
6799934|NCT02135029|7731903|FG000|STARTED|Overall Study||73
6799935|NCT02135029|7731904|FG001|STARTED|Overall Study||74
6799936|NCT02135029|7731905|FG002|STARTED|Overall Study||37
6799937|NCT02135029|7731903|FG000|Treated|Overall Study||73
6799938|NCT02135029|7731904|FG001|Treated|Overall Study||74
6799939|NCT02135029|7731905|FG002|Treated|Overall Study||36
6799940|NCT02135029|7731903|FG000|COMPLETED|Overall Study||69
6799941|NCT02135029|7731904|FG001|COMPLETED|Overall Study||69
6799942|NCT02135029|7731905|FG002|COMPLETED|Overall Study||34
6799943|NCT02135029|7731903|FG000|NOT COMPLETED|Overall Study||4
6799944|NCT02135029|7731904|FG001|NOT COMPLETED|Overall Study||5
6799945|NCT02135029|7731905|FG002|NOT COMPLETED|Overall Study||3
6799952|NCT02148133|7731923|FG000|STARTED|Overall Study||21
6799953|NCT02148133|7731923|FG000|Safety Set (SS)|Overall Study||21
6799954|NCT02148133|7731923|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||21
6799955|NCT02148133|7731923|FG000|COMPLETED|Overall Study||16
6799956|NCT02148133|7731923|FG000|NOT COMPLETED|Overall Study||5
6799957|NCT02151383|7731930|FG000|STARTED|Overall Study||8
6799958|NCT02151383|7731931|FG001|STARTED|Overall Study||3
6380546|NCT00779584|7291370|FG005|STARTED|Overall Study||6
6380547|NCT00779584|7291371|FG006|STARTED|Overall Study||8
6380548|NCT00779584|7291372|FG007|STARTED|Overall Study||3
6380549|NCT00779584|7291373|FG008|STARTED|Overall Study||2
6380550|NCT00779584|7291365|FG000|Treated|Overall Study||3
6380551|NCT00779584|7291366|FG001|Treated|Overall Study||3
6380552|NCT00779584|7291367|FG002|Treated|Overall Study||7
6380553|NCT00779584|7291368|FG003|Treated|Overall Study||6
6380554|NCT00779584|7291369|FG004|Treated|Overall Study||7
6380555|NCT00779584|7291370|FG005|Treated|Overall Study||4
6380556|NCT00779584|7291371|FG006|Treated|Overall Study||8
6380557|NCT00779584|7291372|FG007|Treated|Overall Study||3
6380558|NCT00779584|7291373|FG008|Treated|Overall Study||2
6380559|NCT00779584|7291365|FG000|COMPLETED|Overall Study||0
6380560|NCT00779584|7291366|FG001|COMPLETED|Overall Study||0
6380561|NCT00779584|7291367|FG002|COMPLETED|Overall Study||0
6380562|NCT00779584|7291368|FG003|COMPLETED|Overall Study||0
6380563|NCT00779584|7291369|FG004|COMPLETED|Overall Study||0
6380564|NCT00779584|7291370|FG005|COMPLETED|Overall Study||0
6380565|NCT00779584|7291371|FG006|COMPLETED|Overall Study||0
6380566|NCT00779584|7291372|FG007|COMPLETED|Overall Study||0
6564212|NCT01809938|7486936|FG000|STARTED|First Intervention (170 Minutes)||5
6656655|NCT02462759|7586922|FG001|NOT COMPLETED|Part 2: Open-Label Phase||0
6799959|NCT02151383|7731932|FG002|STARTED|Overall Study||1
6799960|NCT02151383|7731930|FG000|Low-dose|Overall Study||2
6799961|NCT02151383|7731931|FG001|Low-dose|Overall Study||3
6799962|NCT02151383|7731932|FG002|Low-dose|Overall Study||1
6799963|NCT02151383|7731930|FG000|High-dose|Overall Study||6
6799964|NCT02151383|7731931|FG001|High-dose|Overall Study||0
6799965|NCT02151383|7731932|FG002|High-dose|Overall Study||0
6799966|NCT02151383|7731930|FG000|COMPLETED|Overall Study||8
6799967|NCT02151383|7731931|FG001|COMPLETED|Overall Study||3
6799968|NCT02151383|7731932|FG002|COMPLETED|Overall Study||1
6799969|NCT02151383|7731930|FG000|NOT COMPLETED|Overall Study||0
6799970|NCT02151383|7731931|FG001|NOT COMPLETED|Overall Study||0
6799971|NCT02151383|7731932|FG002|NOT COMPLETED|Overall Study||0
6799972|NCT02165215|7731943|FG000|STARTED|Induction Phase||359
6799884|NCT02081391|7731838|FG000|STARTED|12-hour Treatment||108
6799885|NCT02081391|7731839|FG001|STARTED|12-hour Treatment||52
6799886|NCT02081391|7731840|FG002|STARTED|12-hour Treatment||11
6799887|NCT02081391|7731841|FG003|STARTED|12-hour Treatment||4
6799888|NCT02081391|7731838|FG000|COMPLETED|12-hour Treatment||90
6799889|NCT02081391|7731839|FG001|COMPLETED|12-hour Treatment||46
6799890|NCT02081391|7731840|FG002|COMPLETED|12-hour Treatment||10
6799891|NCT02081391|7731841|FG003|COMPLETED|12-hour Treatment||4
6799892|NCT02081391|7731838|FG000|NOT COMPLETED|12-hour Treatment||18
6799893|NCT02081391|7731839|FG001|NOT COMPLETED|12-hour Treatment||6
6799894|NCT02081391|7731840|FG002|NOT COMPLETED|12-hour Treatment||1
6799895|NCT02081391|7731841|FG003|NOT COMPLETED|12-hour Treatment||0
6799896|NCT02081391|7731838|FG000|STARTED|24-hour Treatment and Trial Completion||90
6799897|NCT02081391|7731839|FG001|STARTED|24-hour Treatment and Trial Completion||46
6799898|NCT02081391|7731840|FG002|STARTED|24-hour Treatment and Trial Completion||10
6799899|NCT02081391|7731841|FG003|STARTED|24-hour Treatment and Trial Completion||4
6799900|NCT02081391|7731838|FG000|COMPLETED|24-hour Treatment and Trial Completion||63
6799901|NCT02081391|7731839|FG001|COMPLETED|24-hour Treatment and Trial Completion||28
6799902|NCT02081391|7731840|FG002|COMPLETED|24-hour Treatment and Trial Completion||9
6799903|NCT02081391|7731841|FG003|COMPLETED|24-hour Treatment and Trial Completion||4
6799904|NCT02081391|7731838|FG000|NOT COMPLETED|24-hour Treatment and Trial Completion||27
6799905|NCT02081391|7731839|FG001|NOT COMPLETED|24-hour Treatment and Trial Completion||18
6799906|NCT02081391|7731840|FG002|NOT COMPLETED|24-hour Treatment and Trial Completion||1
6799907|NCT02081391|7731841|FG003|NOT COMPLETED|24-hour Treatment and Trial Completion||0
6799923|NCT02114697|7731889|FG000|STARTED|Overall Study||5
6799924|NCT02114697|7731890|FG001|STARTED|Overall Study||4
6799925|NCT02114697|7731889|FG000|Completed Month 18 Visit|Overall Study||0
6799926|NCT02114697|7731890|FG001|Completed Month 18 Visit|Overall Study||1
6799927|NCT02114697|7731889|FG000|COMPLETED|Overall Study||0
6799928|NCT02114697|7731890|FG001|COMPLETED|Overall Study||0
6799929|NCT02114697|7731889|FG000|NOT COMPLETED|Overall Study||5
6799930|NCT02114697|7731890|FG001|NOT COMPLETED|Overall Study||4
6799946|NCT02137239|7731916|FG000|STARTED|Overall Study||26
6799947|NCT02137239|7731917|FG001|STARTED|Overall Study||32
6799948|NCT02137239|7731916|FG000|COMPLETED|Overall Study||23
6799949|NCT02137239|7731917|FG001|COMPLETED|Overall Study||26
6799950|NCT02137239|7731916|FG000|NOT COMPLETED|Overall Study||3
6799951|NCT02137239|7731917|FG001|NOT COMPLETED|Overall Study||6
6799973|NCT02165215|7731944|FG001|STARTED|Induction Phase||0
6799974|NCT02165215|7731945|FG002|STARTED|Induction Phase||0
6799975|NCT02165215|7731943|FG000|Dosed|Induction Phase||358
6799976|NCT02165215|7731944|FG001|Dosed|Induction Phase||0
6799977|NCT02165215|7731945|FG002|Dosed|Induction Phase||0
6799978|NCT02165215|7731943|FG000|COMPLETED|Induction Phase||336
6799979|NCT02165215|7731944|FG001|COMPLETED|Induction Phase||0
6799980|NCT02165215|7731945|FG002|COMPLETED|Induction Phase||0
6799981|NCT02165215|7731943|FG000|NOT COMPLETED|Induction Phase||23
6799982|NCT02165215|7731944|FG001|NOT COMPLETED|Induction Phase||0
6799983|NCT02165215|7731945|FG002|NOT COMPLETED|Induction Phase||0
6799984|NCT02165215|7731943|FG000|STARTED|Maintenance Phase||0
6799985|NCT02165215|7731944|FG001|STARTED|Maintenance Phase||108
6799986|NCT02165215|7731945|FG002|STARTED|Maintenance Phase||106
6799987|NCT02165215|7731943|FG000|Dosed|Maintenance Phase||0
6799988|NCT02165215|7731944|FG001|Dosed|Maintenance Phase||108
6799989|NCT02165215|7731945|FG002|Dosed|Maintenance Phase||102
6799990|NCT02165215|7731943|FG000|COMPLETED|Maintenance Phase||0
6799991|NCT02165215|7731944|FG001|COMPLETED|Maintenance Phase||96
6799992|NCT02165215|7731945|FG002|COMPLETED|Maintenance Phase||101
6799993|NCT02165215|7731943|FG000|NOT COMPLETED|Maintenance Phase||0
6799994|NCT02165215|7731944|FG001|NOT COMPLETED|Maintenance Phase||12
6799995|NCT02165215|7731945|FG002|NOT COMPLETED|Maintenance Phase||5
6799996|NCT02180217|7731959|FG000|STARTED|Overall Study||36
6799997|NCT02180217|7731960|FG001|STARTED|Overall Study||35
6799998|NCT02180217|7731961|FG002|STARTED|Overall Study||66
6799999|NCT02180217|7731959|FG000|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
6800000|NCT02180217|7731960|FG001|Discontinued at/Prior to Week 12 (W12)|Overall Study||0
6800001|NCT02180217|7731961|FG002|Discontinued at/Prior to Week 12 (W12)|Overall Study||7
6800002|NCT02180217|7731959|FG000|Discont. at/Prior to W26 But After W12|Overall Study||0
6800003|NCT02180217|7731960|FG001|Discont. at/Prior to W26 But After W12|Overall Study||0
6800004|NCT02180217|7731961|FG002|Discont. at/Prior to W26 But After W12|Overall Study||12
6800005|NCT02180217|7731959|FG000|Discontinued Prior to W48 But After W26|Overall Study||0
6800006|NCT02180217|7731960|FG001|Discontinued Prior to W48 But After W26|Overall Study||2
6800007|NCT02180217|7731961|FG002|Discontinued Prior to W48 But After W26|Overall Study||3
6800008|NCT02180217|7731959|FG000|Completed Week 48 (Core Phase)|Overall Study||36
6800009|NCT02180217|7731960|FG001|Completed Week 48 (Core Phase)|Overall Study||33
6800010|NCT02180217|7731961|FG002|Completed Week 48 (Core Phase)|Overall Study||44
6800011|NCT02180217|7731959|FG000|Completed W48, Did Not Enter Ext. Phase|Overall Study||1
6800012|NCT02180217|7731960|FG001|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
6800013|NCT02180217|7731961|FG002|Completed W48, Did Not Enter Ext. Phase|Overall Study||3
6800014|NCT02180217|7731959|FG000|Completed W48, Entered Ext. Phase|Overall Study||35
6800015|NCT02180217|7731960|FG001|Completed W48, Entered Ext. Phase|Overall Study||30
6800016|NCT02180217|7731961|FG002|Completed W48, Entered Ext. Phase|Overall Study||41
6800017|NCT02180217|7731959|FG000|Discontinued Extension Phase|Overall Study||12
6800018|NCT02180217|7731960|FG001|Discontinued Extension Phase|Overall Study||6
6800019|NCT02180217|7731961|FG002|Discontinued Extension Phase|Overall Study||16
6800020|NCT02180217|7731959|FG000|Completed Ext. Phase|Overall Study||23
6800021|NCT02180217|7731960|FG001|Completed Ext. Phase|Overall Study||24
6800022|NCT02180217|7731961|FG002|Completed Ext. Phase|Overall Study||25
6800023|NCT02180217|7731959|FG000|COMPLETED|Overall Study||24
6800024|NCT02180217|7731960|FG001|COMPLETED|Overall Study||27
6800025|NCT02180217|7731961|FG002|COMPLETED|Overall Study||28
6800026|NCT02180217|7731959|FG000|NOT COMPLETED|Overall Study||12
6800027|NCT02180217|7731960|FG001|NOT COMPLETED|Overall Study||8
6800028|NCT02180217|7731961|FG002|NOT COMPLETED|Overall Study||38
6800029|NCT02186457|7731978|FG000|STARTED|Overall Study||95
6800030|NCT02186457|7731979|FG001|STARTED|Overall Study||95
6800031|NCT02186457|7731978|FG000|COMPLETED|Overall Study||95
6800032|NCT02186457|7731979|FG001|COMPLETED|Overall Study||95
6564213|NCT01809938|7486937|FG001|STARTED|First Intervention (170 Minutes)||5
6564214|NCT01809938|7486936|FG000|COMPLETED|First Intervention (170 Minutes)||5
6800033|NCT02186457|7731978|FG000|NOT COMPLETED|Overall Study||0
6800034|NCT02186457|7731979|FG001|NOT COMPLETED|Overall Study||0
6800035|NCT02193867|7731985|FG000|STARTED|Overall Study||10
6800036|NCT02193867|7731985|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||10
6800037|NCT02193867|7731985|FG000|Completed 18 Months Of Treatment|Overall Study||8
6800038|NCT02193867|7731985|FG000|COMPLETED|Overall Study||6
6800039|NCT02193867|7731985|FG000|NOT COMPLETED|Overall Study||4
6800040|NCT02215096|7731992|FG000|STARTED|Run-In Period (Up to Week 2)||37
6800041|NCT02215096|7731993|FG001|STARTED|Run-In Period (Up to Week 2)||0
6800042|NCT02215096|7731994|FG002|STARTED|Run-In Period (Up to Week 2)||0
6800043|NCT02215096|7731995|FG003|STARTED|Run-In Period (Up to Week 2)||0
6800044|NCT02215096|7731996|FG004|STARTED|Run-In Period (Up to Week 2)||0
6800045|NCT02215096|7731992|FG000|COMPLETED|Run-In Period (Up to Week 2)||36
6800046|NCT02215096|7731993|FG001|COMPLETED|Run-In Period (Up to Week 2)||0
6800047|NCT02215096|7731994|FG002|COMPLETED|Run-In Period (Up to Week 2)||0
6800048|NCT02215096|7731995|FG003|COMPLETED|Run-In Period (Up to Week 2)||0
6800049|NCT02215096|7731996|FG004|COMPLETED|Run-In Period (Up to Week 2)||0
6800050|NCT02215096|7731992|FG000|NOT COMPLETED|Run-In Period (Up to Week 2)||1
6800051|NCT02215096|7731993|FG001|NOT COMPLETED|Run-In Period (Up to Week 2)||0
6800052|NCT02215096|7731994|FG002|NOT COMPLETED|Run-In Period (Up to Week 2)||0
6800053|NCT02215096|7731995|FG003|NOT COMPLETED|Run-In Period (Up to Week 2)||0
6800054|NCT02215096|7731996|FG004|NOT COMPLETED|Run-In Period (Up to Week 2)||0
6800055|NCT02215096|7731992|FG000|STARTED|Combination TP (Up to Maximum 654 Days)||0
6800056|NCT02215096|7731993|FG001|STARTED|Combination TP (Up to Maximum 654 Days)||11
6800057|NCT02215096|7731994|FG002|STARTED|Combination TP (Up to Maximum 654 Days)||11
6800058|NCT02215096|7731995|FG003|STARTED|Combination TP (Up to Maximum 654 Days)||12
6800059|NCT02215096|7731996|FG004|STARTED|Combination TP (Up to Maximum 654 Days)||2
6800060|NCT02215096|7731992|FG000|COMPLETED|Combination TP (Up to Maximum 654 Days)||0
6800061|NCT02215096|7731993|FG001|COMPLETED|Combination TP (Up to Maximum 654 Days)||9
6800062|NCT02215096|7731994|FG002|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
6800063|NCT02215096|7731995|FG003|COMPLETED|Combination TP (Up to Maximum 654 Days)||10
6800064|NCT02215096|7731996|FG004|COMPLETED|Combination TP (Up to Maximum 654 Days)||1
6800065|NCT02215096|7731992|FG000|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||0
6564215|NCT01809938|7486937|FG001|COMPLETED|First Intervention (170 Minutes)||5
6656656|NCT02462759|7586923|FG002|NOT COMPLETED|Part 2: Open-Label Phase||0
6800066|NCT02215096|7731993|FG001|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
6800067|NCT02215096|7731994|FG002|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
6800068|NCT02215096|7731995|FG003|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||2
6800069|NCT02215096|7731996|FG004|NOT COMPLETED|Combination TP (Up to Maximum 654 Days)||1
6502543|NCT01435772|7421272|FG000|STARTED|Overall Study||3
6502544|NCT01435772|7421273|FG001|STARTED|Overall Study||3
6502545|NCT01435772|7421274|FG002|STARTED|Overall Study||15
6502546|NCT01435772|7421272|FG000|COMPLETED|Overall Study||0
6502547|NCT01435772|7421273|FG001|COMPLETED|Overall Study||0
6502548|NCT01435772|7421274|FG002|COMPLETED|Overall Study||0
6502549|NCT01435772|7421272|FG000|NOT COMPLETED|Overall Study||3
6502550|NCT01435772|7421273|FG001|NOT COMPLETED|Overall Study||3
6502551|NCT01435772|7421274|FG002|NOT COMPLETED|Overall Study||15
6502552|NCT01435798|7421283|FG000|STARTED|Overall Study|Crossover design|26
6502553|NCT01435798|7421283|FG000|0% MTD|Overall Study||25
6502554|NCT01435798|7421283|FG000|25% MTD|Overall Study||26
6502555|NCT01435798|7421283|FG000|50% MTD|Overall Study||25
6800070|NCT02218697|7732014|FG000|STARTED|Overall Study||179
6800071|NCT02218697|7732015|FG001|STARTED|Overall Study||177
6800072|NCT02218697|7732014|FG000|COMPLETED|Overall Study||177
6800073|NCT02218697|7732015|FG001|COMPLETED|Overall Study||171
6800074|NCT02218697|7732014|FG000|NOT COMPLETED|Overall Study||2
6800075|NCT02218697|7732015|FG001|NOT COMPLETED|Overall Study||6
6800076|NCT02221037|7732025|FG000|STARTED|Overall Study||5
6800077|NCT02221037|7732026|FG001|STARTED|Overall Study||11
6800078|NCT02221037|7732027|FG002|STARTED|Overall Study||8
6800079|NCT02221037|7732028|FG003|STARTED|Overall Study||9
6800080|NCT02221037|7732025|FG000|COMPLETED|Overall Study||5
6800081|NCT02221037|7732026|FG001|COMPLETED|Overall Study||11
6800082|NCT02221037|7732027|FG002|COMPLETED|Overall Study||7
6800083|NCT02221037|7732028|FG003|COMPLETED|Overall Study||9
6800084|NCT02221037|7732025|FG000|NOT COMPLETED|Overall Study||0
6800085|NCT02221037|7732026|FG001|NOT COMPLETED|Overall Study||0
6800086|NCT02221037|7732027|FG002|NOT COMPLETED|Overall Study||1
6800087|NCT02221037|7732028|FG003|NOT COMPLETED|Overall Study||0
6800091|NCT02231762|7732046|FG000|STARTED|Combination Phase||57
6800092|NCT02231762|7732047|FG001|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
6800093|NCT02231762|7732048|FG002|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
6800094|NCT02231762|7732049|FG003|STARTED|Combination Phase|This arm was not included in period 1 (combination phase).|0
6800095|NCT02231762|7732046|FG000|COMPLETED|Combination Phase||37
6800096|NCT02231762|7732047|FG001|COMPLETED|Combination Phase||0
6800097|NCT02231762|7732048|FG002|COMPLETED|Combination Phase||0
6800098|NCT02231762|7732049|FG003|COMPLETED|Combination Phase||0
6800099|NCT02231762|7732046|FG000|NOT COMPLETED|Combination Phase||20
6800100|NCT02231762|7732047|FG001|NOT COMPLETED|Combination Phase||0
6800101|NCT02231762|7732048|FG002|NOT COMPLETED|Combination Phase||0
6800102|NCT02231762|7732049|FG003|NOT COMPLETED|Combination Phase||0
6800103|NCT02231762|7732046|FG000|STARTED|Maintenance Phase|This arm was not included in period 2 (maintenance phase).|0
6800104|NCT02231762|7732047|FG001|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|11
6800105|NCT02231762|7732048|FG002|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|14
6800106|NCT02231762|7732049|FG003|STARTED|Maintenance Phase|The 37 subjects completing period 1 were split between the 3 arms in period 2.|12
6800107|NCT02231762|7732046|FG000|COMPLETED|Maintenance Phase||0
6800108|NCT02231762|7732047|FG001|COMPLETED|Maintenance Phase||8
6800109|NCT02231762|7732048|FG002|COMPLETED|Maintenance Phase||9
6800110|NCT02231762|7732049|FG003|COMPLETED|Maintenance Phase||7
6800111|NCT02231762|7732046|FG000|NOT COMPLETED|Maintenance Phase||0
6800112|NCT02231762|7732047|FG001|NOT COMPLETED|Maintenance Phase||3
6800113|NCT02231762|7732048|FG002|NOT COMPLETED|Maintenance Phase||5
6800114|NCT02231762|7732049|FG003|NOT COMPLETED|Maintenance Phase||5
6800115|NCT02234843|7732073|FG000|STARTED|Overall Study||184
6800116|NCT02234843|7732074|FG001|STARTED|Overall Study||67
6800117|NCT02234843|7732075|FG002|STARTED|Overall Study||47
6800118|NCT02234843|7732076|FG003|STARTED|Overall Study||21
6800119|NCT02234843|7732077|FG004|STARTED|Overall Study||16
6800120|NCT02234843|7732078|FG005|STARTED|Overall Study||92
6800121|NCT02234843|7732079|FG006|STARTED|Overall Study||34
6800122|NCT02234843|7732080|FG007|STARTED|Overall Study||22
6800123|NCT02234843|7732081|FG008|STARTED|Overall Study||9
6800124|NCT02234843|7732082|FG009|STARTED|Overall Study||8
6800125|NCT02234843|7732073|FG000|COMPLETED|Overall Study||162
6800126|NCT02234843|7732074|FG001|COMPLETED|Overall Study||61
6800127|NCT02234843|7732075|FG002|COMPLETED|Overall Study||44
6800128|NCT02234843|7732076|FG003|COMPLETED|Overall Study||16
6800129|NCT02234843|7732077|FG004|COMPLETED|Overall Study||14
6800130|NCT02234843|7732078|FG005|COMPLETED|Overall Study||79
6800131|NCT02234843|7732079|FG006|COMPLETED|Overall Study||32
6800132|NCT02234843|7732080|FG007|COMPLETED|Overall Study||20
6800133|NCT02234843|7732081|FG008|COMPLETED|Overall Study||8
6800134|NCT02234843|7732082|FG009|COMPLETED|Overall Study||8
6800135|NCT02234843|7732073|FG000|NOT COMPLETED|Overall Study||22
6800136|NCT02234843|7732074|FG001|NOT COMPLETED|Overall Study||6
6800137|NCT02234843|7732075|FG002|NOT COMPLETED|Overall Study||3
6800138|NCT02234843|7732076|FG003|NOT COMPLETED|Overall Study||5
6800139|NCT02234843|7732077|FG004|NOT COMPLETED|Overall Study||2
6800140|NCT02234843|7732078|FG005|NOT COMPLETED|Overall Study||13
6800141|NCT02234843|7732079|FG006|NOT COMPLETED|Overall Study||2
6800142|NCT02234843|7732080|FG007|NOT COMPLETED|Overall Study||2
6800143|NCT02234843|7732081|FG008|NOT COMPLETED|Overall Study||1
6800144|NCT02234843|7732082|FG009|NOT COMPLETED|Overall Study||0
6800145|NCT02243306|7732117|FG000|STARTED|Overall Study||1
6800146|NCT02243306|7732118|FG001|STARTED|Overall Study||7
6800147|NCT02243306|7732117|FG000|COMPLETED|Overall Study||1
6800148|NCT02243306|7732118|FG001|COMPLETED|Overall Study||4
6564216|NCT01809938|7486936|FG000|NOT COMPLETED|First Intervention (170 Minutes)||0
6564217|NCT01809938|7486937|FG001|NOT COMPLETED|First Intervention (170 Minutes)||0
6564218|NCT01809938|7486936|FG000|STARTED|Washout (Not Less Than 24 Hours)||5
6800149|NCT02243306|7732117|FG000|NOT COMPLETED|Overall Study||0
6800150|NCT02243306|7732118|FG001|NOT COMPLETED|Overall Study||3
6800151|NCT02246621|7732127|FG000|STARTED|Overall Study||328
6656657|NCT02462928|7586937|FG000|STARTED|Overall Study||314
6800152|NCT02246621|7732128|FG001|STARTED|Overall Study||165
6800153|NCT02246621|7732127|FG000|Received At Least One Dose of Study Drug|Overall Study||327
6800154|NCT02246621|7732128|FG001|Received At Least One Dose of Study Drug|Overall Study||161
6800088|NCT02224456|7732042|FG000|STARTED|Overall Study||197
6800089|NCT02224456|7732042|FG000|COMPLETED|Overall Study||161
6800090|NCT02224456|7732042|FG000|NOT COMPLETED|Overall Study||36
6800155|NCT02246621|7732127|FG000|COMPLETED|Overall Study||63
6800156|NCT02246621|7732128|FG001|COMPLETED|Overall Study||30
6800157|NCT02246621|7732127|FG000|NOT COMPLETED|Overall Study||265
6800158|NCT02246621|7732128|FG001|NOT COMPLETED|Overall Study||135
6564219|NCT01809938|7486937|FG001|STARTED|Washout (Not Less Than 24 Hours)||5
6380567|NCT00779584|7291373|FG008|COMPLETED|Overall Study||0
6380568|NCT00779584|7291365|FG000|NOT COMPLETED|Overall Study||3
6380569|NCT00779584|7291366|FG001|NOT COMPLETED|Overall Study||3
6380570|NCT00779584|7291367|FG002|NOT COMPLETED|Overall Study||7
6380571|NCT00779584|7291368|FG003|NOT COMPLETED|Overall Study||6
6380572|NCT00779584|7291369|FG004|NOT COMPLETED|Overall Study||7
6380573|NCT00779584|7291370|FG005|NOT COMPLETED|Overall Study||6
6380574|NCT00779584|7291371|FG006|NOT COMPLETED|Overall Study||8
6380575|NCT00779584|7291372|FG007|NOT COMPLETED|Overall Study||3
6380576|NCT00779584|7291373|FG008|NOT COMPLETED|Overall Study||2
6380577|NCT00779675|7291393|FG000|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
6656658|NCT02462928|7586938|FG001|STARTED|Overall Study||313
6380578|NCT00779675|7291393|FG000|COMPLETED|Treatment Period||328
6380579|NCT00779675|7291393|FG000|NOT COMPLETED|Treatment Period||332
6380580|NCT00779675|7291393|FG000|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
6380581|NCT00779675|7291393|FG000|COMPLETED|Extended Treatment Period||147
6380582|NCT00779675|7291393|FG000|NOT COMPLETED|Extended Treatment Period||46
6380583|NCT00779701|7291401|FG000|STARTED|Overall Study||27
6800159|NCT04435795|7732136|FG000|STARTED|Overall Study||108
6800160|NCT04435795|7732137|FG001|STARTED|Overall Study||107
6800161|NCT04435795|7732136|FG000|COMPLETED|Overall Study||105
6800162|NCT04435795|7732137|FG001|COMPLETED|Overall Study||98
6800163|NCT04435795|7732136|FG000|NOT COMPLETED|Overall Study||3
6800164|NCT04435795|7732137|FG001|NOT COMPLETED|Overall Study||9
6380584|NCT00779701|7291401|FG000|COMPLETED|Overall Study||27
6380585|NCT00779701|7291401|FG000|NOT COMPLETED|Overall Study||0
6380586|NCT00779766|7291407|FG000|STARTED|Month 24||3026
6800165|NCT04093843|7732143|FG000|STARTED|Overall Study||6
6800166|NCT04093843|7732143|FG000|COMPLETED|Overall Study||6
6800167|NCT04093843|7732143|FG000|NOT COMPLETED|Overall Study||0
6800168|NCT03926611|7732154|FG000|STARTED|Overall Study||44
6800169|NCT03926611|7732155|FG001|STARTED|Overall Study||44
6800170|NCT03926611|7732156|FG002|STARTED|Overall Study||47
6800171|NCT03926611|7732157|FG003|STARTED|Overall Study||44
6800172|NCT03926611|7732158|FG004|STARTED|Overall Study||44
6800173|NCT03926611|7732159|FG005|STARTED|Overall Study||45
6800174|NCT03926611|7732160|FG006|STARTED|Overall Study||43
6800175|NCT03926611|7732154|FG000|Randomized Set (RAN)|Overall Study||44
6800176|NCT03926611|7732155|FG001|Randomized Set (RAN)|Overall Study||44
6800177|NCT03926611|7732156|FG002|Randomized Set (RAN)|Overall Study||47
6800178|NCT03926611|7732157|FG003|Randomized Set (RAN)|Overall Study||44
6800179|NCT03926611|7732158|FG004|Randomized Set (RAN)|Overall Study||44
6800180|NCT03926611|7732159|FG005|Randomized Set (RAN)|Overall Study||45
6800181|NCT03926611|7732160|FG006|Randomized Set (RAN)|Overall Study||43
6800182|NCT03926611|7732154|FG000|Full Analysis Set (FAS)|Overall Study||44
6800183|NCT03926611|7732155|FG001|Full Analysis Set (FAS)|Overall Study||44
6800184|NCT03926611|7732156|FG002|Full Analysis Set (FAS)|Overall Study||47
6800185|NCT03926611|7732157|FG003|Full Analysis Set (FAS)|Overall Study||44
6800186|NCT03926611|7732158|FG004|Full Analysis Set (FAS)|Overall Study||43
6800187|NCT03926611|7732159|FG005|Full Analysis Set (FAS)|Overall Study||45
6800188|NCT03926611|7732160|FG006|Full Analysis Set (FAS)|Overall Study||42
6800189|NCT03926611|7732154|FG000|Safety Set (SAF)|Overall Study||44
6800190|NCT03926611|7732155|FG001|Safety Set (SAF)|Overall Study||44
6800191|NCT03926611|7732156|FG002|Safety Set (SAF)|Overall Study||47
6800192|NCT03926611|7732157|FG003|Safety Set (SAF)|Overall Study||44
6800193|NCT03926611|7732158|FG004|Safety Set (SAF)|Overall Study||43
6800194|NCT03926611|7732159|FG005|Safety Set (SAF)|Overall Study||45
6800195|NCT03926611|7732160|FG006|Safety Set (SAF)|Overall Study||42
6800196|NCT03926611|7732154|FG000|COMPLETED|Overall Study||41
6800197|NCT03926611|7732155|FG001|COMPLETED|Overall Study||41
6800198|NCT03926611|7732156|FG002|COMPLETED|Overall Study||45
6800199|NCT03926611|7732157|FG003|COMPLETED|Overall Study||40
6800200|NCT03926611|7732158|FG004|COMPLETED|Overall Study||40
6800201|NCT03926611|7732159|FG005|COMPLETED|Overall Study||36
6800202|NCT03926611|7732160|FG006|COMPLETED|Overall Study||38
6800203|NCT03926611|7732154|FG000|NOT COMPLETED|Overall Study||3
6800204|NCT03926611|7732155|FG001|NOT COMPLETED|Overall Study||3
6800205|NCT03926611|7732156|FG002|NOT COMPLETED|Overall Study||2
6800206|NCT03926611|7732157|FG003|NOT COMPLETED|Overall Study||4
6800207|NCT03926611|7732158|FG004|NOT COMPLETED|Overall Study||4
6800208|NCT03926611|7732159|FG005|NOT COMPLETED|Overall Study||9
6800209|NCT03926611|7732160|FG006|NOT COMPLETED|Overall Study||5
6800210|NCT03838484|7732184|FG000|STARTED|Overall Study||5
6800211|NCT03838484|7732185|FG001|STARTED|Overall Study||5
6800212|NCT03838484|7732186|FG002|STARTED|Overall Study||4
6800213|NCT03838484|7732187|FG003|STARTED|Overall Study||4
6800214|NCT03838484|7732184|FG000|COMPLETED|Overall Study||5
6800215|NCT03838484|7732185|FG001|COMPLETED|Overall Study||4
6800216|NCT03838484|7732186|FG002|COMPLETED|Overall Study||4
6800217|NCT03838484|7732187|FG003|COMPLETED|Overall Study||4
6800218|NCT03838484|7732184|FG000|NOT COMPLETED|Overall Study||0
6800219|NCT03838484|7732185|FG001|NOT COMPLETED|Overall Study||1
6800220|NCT03838484|7732186|FG002|NOT COMPLETED|Overall Study||0
6800221|NCT03838484|7732187|FG003|NOT COMPLETED|Overall Study||0
6800222|NCT03814720|7732208|FG000|STARTED|Overall Study||5
6800223|NCT03814720|7732209|FG001|STARTED|Overall Study||12
6800224|NCT03814720|7732210|FG002|STARTED|Overall Study||12
6800225|NCT03814720|7732211|FG003|STARTED|Overall Study||12
6800226|NCT03814720|7732212|FG004|STARTED|Overall Study||11
6800227|NCT03814720|7732208|FG000|Received First Product Administration|Overall Study||5
6800228|NCT03814720|7732209|FG001|Received First Product Administration|Overall Study||12
6800229|NCT03814720|7732210|FG002|Received First Product Administration|Overall Study||12
6800230|NCT03814720|7732211|FG003|Received First Product Administration|Overall Study||12
6800231|NCT03814720|7732212|FG004|Received First Product Administration|Overall Study||11
6800232|NCT03814720|7732208|FG000|Received All Product Administrations|Overall Study||5
6800233|NCT03814720|7732209|FG001|Received All Product Administrations|Overall Study||12
6800234|NCT03814720|7732210|FG002|Received All Product Administrations|Overall Study|One participant did not receive the second dose due to moving out of area and 4 participants did not receive the second dose due to the COVID-19 pandemic|7
6800235|NCT03814720|7732211|FG003|Received All Product Administrations|Overall Study|Three (3) participants did not receive the second dose due to the COVID-19 pandemic|9
6800236|NCT03814720|7732212|FG004|Received All Product Administrations|Overall Study|Four (4) participants did not receive the second dose due to the COVID-19 pandemic|7
6800237|NCT03814720|7732208|FG000|COMPLETED|Overall Study||5
6800238|NCT03814720|7732209|FG001|COMPLETED|Overall Study||11
6800239|NCT03814720|7732210|FG002|COMPLETED|Overall Study||12
6800240|NCT03814720|7732211|FG003|COMPLETED|Overall Study||12
6800241|NCT03814720|7732212|FG004|COMPLETED|Overall Study||11
6800242|NCT03814720|7732208|FG000|NOT COMPLETED|Overall Study||0
6800243|NCT03814720|7732209|FG001|NOT COMPLETED|Overall Study||1
6800244|NCT03814720|7732210|FG002|NOT COMPLETED|Overall Study||0
6800245|NCT03814720|7732211|FG003|NOT COMPLETED|Overall Study||0
6800246|NCT03814720|7732212|FG004|NOT COMPLETED|Overall Study||0
6800247|NCT03635424|7732226|FG000|STARTED|Overall Study||150
6380587|NCT00779766|7291408|FG001|STARTED|Month 24||3025
6380588|NCT00779766|7291407|FG000|COMPLETED|Month 24||2694
6380589|NCT00779766|7291408|FG001|COMPLETED|Month 24||2693
6380590|NCT00779766|7291407|FG000|NOT COMPLETED|Month 24||332
6380591|NCT00779766|7291408|FG001|NOT COMPLETED|Month 24||332
6380592|NCT00779766|7291407|FG000|STARTED|Month 48||2703
6380593|NCT00779766|7291408|FG001|STARTED|Month 48||2727
6380594|NCT00779766|7291407|FG000|COMPLETED|Month 48||2529
6380595|NCT00779766|7291408|FG001|COMPLETED|Month 48||2559
6380596|NCT00779766|7291407|FG000|NOT COMPLETED|Month 48||174
6380597|NCT00779766|7291408|FG001|NOT COMPLETED|Month 48||168
6380598|NCT00779766|7291407|FG000|STARTED|Month 72||2319
6380599|NCT00779766|7291408|FG001|STARTED|Month 72||2347
6380600|NCT00779766|7291407|FG000|COMPLETED|Month 72||2134
6380601|NCT00779766|7291408|FG001|COMPLETED|Month 72||2158
6380602|NCT00779766|7291407|FG000|NOT COMPLETED|Month 72||185
6380603|NCT00779766|7291408|FG001|NOT COMPLETED|Month 72||189
6380604|NCT00779779|7291415|FG000|STARTED|Overall Study||522
6380605|NCT00779779|7291415|FG000|COMPLETED|Overall Study||498
6380606|NCT00779779|7291415|FG000|NOT COMPLETED|Overall Study||24
6380607|NCT00779857|7291419|FG000|STARTED|Overall Study|70 patients treated|70
6380608|NCT00779857|7291419|FG000|30 Day Post Procedure|Overall Study|2 missed Visit|68
6380609|NCT00779857|7291419|FG000|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
6380610|NCT00779857|7291419|FG000|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
6380611|NCT00779857|7291419|FG000|NOT COMPLETED|Overall Study||6
6380612|NCT00779870|7291426|FG000|STARTED|Overall Study||5
6380613|NCT00779870|7291427|FG001|STARTED|Overall Study||6
6380614|NCT00779870|7291428|FG002|STARTED|Overall Study||7
6380615|NCT00779870|7291426|FG000|COMPLETED|Overall Study||5
6380616|NCT00779870|7291427|FG001|COMPLETED|Overall Study||6
6380617|NCT00779870|7291428|FG002|COMPLETED|Overall Study||7
6380618|NCT00779870|7291426|FG000|NOT COMPLETED|Overall Study||0
6380619|NCT00779870|7291427|FG001|NOT COMPLETED|Overall Study||0
6380620|NCT00779870|7291428|FG002|NOT COMPLETED|Overall Study||0
6380621|NCT00779909|7291440|FG000|STARTED|Overall Study||10
6380622|NCT00779909|7291441|FG001|STARTED|Overall Study||9
6380623|NCT00779909|7291442|FG002|STARTED|Overall Study||8
6380624|NCT00779909|7291443|FG003|STARTED|Overall Study||8
6380625|NCT00779909|7291440|FG000|COMPLETED|Overall Study||9
6380626|NCT00779909|7291441|FG001|COMPLETED|Overall Study||8
6380627|NCT00779909|7291442|FG002|COMPLETED|Overall Study||8
6380628|NCT00779909|7291443|FG003|COMPLETED|Overall Study||7
6380629|NCT00779909|7291440|FG000|NOT COMPLETED|Overall Study||1
6380630|NCT00779909|7291441|FG001|NOT COMPLETED|Overall Study||1
6380631|NCT00779909|7291442|FG002|NOT COMPLETED|Overall Study||0
6380632|NCT00779909|7291443|FG003|NOT COMPLETED|Overall Study||1
6380633|NCT00780026|7291462|FG000|STARTED|Overall Study||50
6380634|NCT00780026|7291463|FG001|STARTED|Overall Study||50
6380635|NCT00780026|7291462|FG000|COMPLETED|Overall Study||50
6380636|NCT00780026|7291463|FG001|COMPLETED|Overall Study||50
6380637|NCT00780026|7291462|FG000|NOT COMPLETED|Overall Study||0
6380638|NCT00780026|7291463|FG001|NOT COMPLETED|Overall Study||0
6380639|NCT00780143|7291469|FG000|STARTED|Overall Study||3
6380640|NCT00780143|7291469|FG000|COMPLETED|Overall Study||0
6380641|NCT00780143|7291469|FG000|NOT COMPLETED|Overall Study||3
6380642|NCT00780208|7291473|FG000|STARTED|Overall Study||14
6380643|NCT00780208|7291473|FG000|COMPLETED|Overall Study||8
6380644|NCT00780208|7291473|FG000|NOT COMPLETED|Overall Study||6
6380645|NCT00780234|7291479|FG000|STARTED|Overall Study||47
6380646|NCT00780234|7291480|FG001|STARTED|Overall Study||45
6380647|NCT00780234|7291479|FG000|COMPLETED|Overall Study||39
6380648|NCT00780234|7291480|FG001|COMPLETED|Overall Study||37
6380649|NCT00780234|7291479|FG000|NOT COMPLETED|Overall Study||8
6380650|NCT00780234|7291480|FG001|NOT COMPLETED|Overall Study||8
6380651|NCT00780273|7291486|FG000|STARTED|Overall Study||19
6380652|NCT00780273|7291486|FG000|COMPLETED|Overall Study||17
6380653|NCT00780273|7291486|FG000|NOT COMPLETED|Overall Study||2
6380654|NCT00780338|7291493|FG000|STARTED|Baseline to Mid (1 Year)||174
6380655|NCT00780338|7291494|FG001|STARTED|Baseline to Mid (1 Year)||202
6380656|NCT00780338|7291493|FG000|COMPLETED|Baseline to Mid (1 Year)||169
6380657|NCT00780338|7291494|FG001|COMPLETED|Baseline to Mid (1 Year)||164
6380658|NCT00780338|7291493|FG000|NOT COMPLETED|Baseline to Mid (1 Year)||5
6380659|NCT00780338|7291494|FG001|NOT COMPLETED|Baseline to Mid (1 Year)||38
6268888|NCT00068770|7167991|FG000|COMPLETED|Overall Study||13
6268889|NCT00068770|7167992|FG001|COMPLETED|Overall Study||22
6268890|NCT00068770|7167991|FG000|NOT COMPLETED|Overall Study||0
6268891|NCT00068770|7167992|FG001|NOT COMPLETED|Overall Study||0
6268892|NCT00068822|7168002|FG000|STARTED|First Randomized Intervention||68
6268893|NCT00068822|7168003|FG001|STARTED|First Randomized Intervention||63
6268894|NCT00068822|7168002|FG000|COMPLETED|First Randomized Intervention||67
6268895|NCT00068822|7168003|FG001|COMPLETED|First Randomized Intervention||61
6268896|NCT00068822|7168002|FG000|NOT COMPLETED|First Randomized Intervention||1
6268897|NCT00068822|7168003|FG001|NOT COMPLETED|First Randomized Intervention||2
6268898|NCT00068822|7168002|FG000|STARTED|Optional Crossover Intervention||9
6800248|NCT03635424|7732226|FG000|COMPLETED|Overall Study||147
6800249|NCT03635424|7732226|FG000|NOT COMPLETED|Overall Study||3
6800250|NCT03529110|7732232|FG000|STARTED|Overall Study||261
6800251|NCT03529110|7732233|FG001|STARTED|Overall Study||263
6800252|NCT03529110|7732232|FG000|COMPLETED|Overall Study||136
6800253|NCT03529110|7732233|FG001|COMPLETED|Overall Study||49
6800254|NCT03529110|7732232|FG000|NOT COMPLETED|Overall Study||125
6564220|NCT01809938|7486936|FG000|COMPLETED|Washout (Not Less Than 24 Hours)||5
6564221|NCT01809938|7486937|FG001|COMPLETED|Washout (Not Less Than 24 Hours)||5
6564222|NCT01809938|7486936|FG000|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
6564223|NCT01809938|7486937|FG001|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
6564224|NCT01809938|7486936|FG000|STARTED|Second Intervention (170 Minutes)||5
6564225|NCT01809938|7486937|FG001|STARTED|Second Intervention (170 Minutes)||5
6564226|NCT01809938|7486936|FG000|COMPLETED|Second Intervention (170 Minutes)||5
6564227|NCT01809938|7486937|FG001|COMPLETED|Second Intervention (170 Minutes)||5
6564228|NCT01809938|7486936|FG000|NOT COMPLETED|Second Intervention (170 Minutes)||0
6800255|NCT03529110|7732233|FG001|NOT COMPLETED|Overall Study||214
6800256|NCT03517540|7732243|FG000|STARTED|Overall Study||50
6800257|NCT03517540|7732244|FG001|STARTED|Overall Study||48
6800258|NCT03517540|7732245|FG002|STARTED|Overall Study||47
6800259|NCT03517540|7732246|FG003|STARTED|Overall Study||48
6800260|NCT03517540|7732243|FG000|COMPLETED|Overall Study||36
6800261|NCT03517540|7732244|FG001|COMPLETED|Overall Study||41
6800262|NCT03517540|7732245|FG002|COMPLETED|Overall Study||38
6800263|NCT03517540|7732246|FG003|COMPLETED|Overall Study||43
6800264|NCT03517540|7732243|FG000|NOT COMPLETED|Overall Study||14
6800265|NCT03517540|7732244|FG001|NOT COMPLETED|Overall Study||7
6800266|NCT03517540|7732245|FG002|NOT COMPLETED|Overall Study||9
6800267|NCT03517540|7732246|FG003|NOT COMPLETED|Overall Study||5
6800268|NCT03443635|7732258|FG000|STARTED|Overall Study||2616
6800269|NCT03443635|7732259|FG001|STARTED|Overall Study||4576
6800270|NCT03443635|7732258|FG000|COMPLETED|Overall Study||2127
6800271|NCT03443635|7732259|FG001|COMPLETED|Overall Study||3720
6800272|NCT03443635|7732258|FG000|NOT COMPLETED|Overall Study||489
6800273|NCT03443635|7732259|FG001|NOT COMPLETED|Overall Study||856
6800274|NCT03437278|7732268|FG000|STARTED|Overall Study||24
6800275|NCT03437278|7732269|FG001|STARTED|Overall Study||13
6800276|NCT03437278|7732270|FG002|STARTED|Overall Study||12
6800277|NCT03437278|7732268|FG000|COMPLETED|Overall Study||22
6800278|NCT03437278|7732269|FG001|COMPLETED|Overall Study||13
6800279|NCT03437278|7732270|FG002|COMPLETED|Overall Study||10
6800280|NCT03437278|7732268|FG000|NOT COMPLETED|Overall Study||2
6800281|NCT03437278|7732269|FG001|NOT COMPLETED|Overall Study||0
6800282|NCT03437278|7732270|FG002|NOT COMPLETED|Overall Study||2
6800283|NCT03350815|7732280|FG000|STARTED|Period 1||322
6800284|NCT03350815|7732281|FG001|STARTED|Period 1||0
6800285|NCT03350815|7732282|FG002|STARTED|Period 1||0
6800286|NCT03350815|7732283|FG003|STARTED|Period 1||0
6800287|NCT03350815|7732280|FG000|Non-responders|Period 1||50
6800288|NCT03350815|7732281|FG001|Non-responders|Period 1||0
6800289|NCT03350815|7732282|FG002|Non-responders|Period 1||0
6800290|NCT03350815|7732283|FG003|Non-responders|Period 1||0
6800291|NCT03350815|7732280|FG000|Inadequate Responders|Period 1||207
6800292|NCT03350815|7732281|FG001|Inadequate Responders|Period 1||0
6800293|NCT03350815|7732282|FG002|Inadequate Responders|Period 1||0
6800294|NCT03350815|7732283|FG003|Inadequate Responders|Period 1||0
6800295|NCT03350815|7732280|FG000|Responders|Period 1||22
6800296|NCT03350815|7732281|FG001|Responders|Period 1||0
6800297|NCT03350815|7732282|FG002|Responders|Period 1||0
6800298|NCT03350815|7732283|FG003|Responders|Period 1||0
6800299|NCT03350815|7732280|FG000|COMPLETED|Period 1||279
6800300|NCT03350815|7732281|FG001|COMPLETED|Period 1||0
6800301|NCT03350815|7732282|FG002|COMPLETED|Period 1||0
6800302|NCT03350815|7732283|FG003|COMPLETED|Period 1||0
6800303|NCT03350815|7732280|FG000|NOT COMPLETED|Period 1||43
6800304|NCT03350815|7732281|FG001|NOT COMPLETED|Period 1||0
6800305|NCT03350815|7732282|FG002|NOT COMPLETED|Period 1||0
6800306|NCT03350815|7732283|FG003|NOT COMPLETED|Period 1||0
6800307|NCT03350815|7732280|FG000|STARTED|Period 2||0
6800308|NCT03350815|7732281|FG001|STARTED|Period 2||102
6800309|NCT03350815|7732282|FG002|STARTED|Period 2||105
6800310|NCT03350815|7732283|FG003|STARTED|Period 2||22
6800311|NCT03350815|7732280|FG000|COMPLETED|Period 2||0
6800312|NCT03350815|7732281|FG001|COMPLETED|Period 2||86
6800313|NCT03350815|7732282|FG002|COMPLETED|Period 2||88
6800314|NCT03350815|7732283|FG003|COMPLETED|Period 2||22
6800315|NCT03350815|7732280|FG000|NOT COMPLETED|Period 2||0
6800316|NCT03350815|7732281|FG001|NOT COMPLETED|Period 2||16
6800317|NCT03350815|7732282|FG002|NOT COMPLETED|Period 2||17
6800318|NCT03350815|7732283|FG003|NOT COMPLETED|Period 2||0
6800319|NCT03249714|7732296|FG000|STARTED|Double-blind Treatment (Core Part)||43
6800320|NCT03249714|7732297|FG001|STARTED|Double-blind Treatment (Core Part)||21
6800321|NCT03249714|7732296|FG000|COMPLETED|Double-blind Treatment (Core Part)||40
6800322|NCT03249714|7732297|FG001|COMPLETED|Double-blind Treatment (Core Part)||19
6800323|NCT03249714|7732296|FG000|NOT COMPLETED|Double-blind Treatment (Core Part)||3
6800324|NCT03249714|7732297|FG001|NOT COMPLETED|Double-blind Treatment (Core Part)||2
6800325|NCT03249714|7732296|FG000|STARTED|Open-label Treatment (Extension Part)||40
6800326|NCT03249714|7732297|FG001|STARTED|Open-label Treatment (Extension Part)||19
6564229|NCT01809938|7486937|FG001|NOT COMPLETED|Second Intervention (170 Minutes)||0
6564230|NCT01810016|7486945|FG000|STARTED|Overall Study||5
6564231|NCT01810016|7486946|FG001|STARTED|Overall Study||2
6564232|NCT01810016|7486947|FG002|STARTED|Overall Study||1
6564233|NCT01810016|7486945|FG000|COMPLETED|Overall Study||4
6800327|NCT03249714|7732296|FG000|COMPLETED|Open-label Treatment (Extension Part)||38
6800328|NCT03249714|7732297|FG001|COMPLETED|Open-label Treatment (Extension Part)||19
6800329|NCT03249714|7732296|FG000|NOT COMPLETED|Open-label Treatment (Extension Part)||2
6800330|NCT03249714|7732297|FG001|NOT COMPLETED|Open-label Treatment (Extension Part)||0
6800331|NCT03219333|7732321|FG000|STARTED|Overall Study||128
6800332|NCT03219333|7732322|FG001|STARTED|Overall Study||91
6564234|NCT01810016|7486946|FG001|COMPLETED|Overall Study||1
6564235|NCT01810016|7486947|FG002|COMPLETED|Overall Study||0
6564236|NCT01810016|7486945|FG000|NOT COMPLETED|Overall Study||1
6564237|NCT01810016|7486946|FG001|NOT COMPLETED|Overall Study||1
6564238|NCT01810016|7486947|FG002|NOT COMPLETED|Overall Study||1
6623412|NCT02207569|7550543|FG000|STARTED|Implant to 1-Month|241 Attempted Implant|241
6623413|NCT02207569|7550543|FG000|COMPLETED|Implant to 1-Month||232
6623414|NCT02207569|7550543|FG000|NOT COMPLETED|Implant to 1-Month||9
6623415|NCT02207569|7550543|FG000|STARTED|1-Month to 6-Month||232
6623416|NCT02207569|7550543|FG000|COMPLETED|1-Month to 6-Month||222
6623417|NCT02207569|7550543|FG000|NOT COMPLETED|1-Month to 6-Month||10
6623418|NCT02207569|7550543|FG000|STARTED|12-Month||222
6623419|NCT02207569|7550543|FG000|COMPLETED|12-Month||213
6623420|NCT02207569|7550543|FG000|NOT COMPLETED|12-Month||9
6623421|NCT02207569|7550543|FG000|STARTED|6-Month to 12-Month||213
6623422|NCT02207569|7550543|FG000|COMPLETED|6-Month to 12-Month||197
6623423|NCT02207569|7550543|FG000|NOT COMPLETED|6-Month to 12-Month||16
6623424|NCT02207569|7550543|FG000|STARTED|12-Month to 24 Month||197
6623425|NCT02207569|7550543|FG000|COMPLETED|12-Month to 24 Month||171
6623426|NCT02207569|7550543|FG000|NOT COMPLETED|12-Month to 24 Month||26
6623427|NCT02207569|7550543|FG000|STARTED|24-Month to 36-Month||171
6623428|NCT02207569|7550543|FG000|COMPLETED|24-Month to 36-Month||144
6623429|NCT02207569|7550543|FG000|NOT COMPLETED|24-Month to 36-Month||27
6623430|NCT02207569|7550543|FG000|STARTED|36-Month to 48-Month||144
6623431|NCT02207569|7550543|FG000|COMPLETED|36-Month to 48-Month||113
6623432|NCT02207569|7550543|FG000|NOT COMPLETED|36-Month to 48-Month||31
6623433|NCT02207569|7550543|FG000|STARTED|48-Month to 60-Month||113
6623434|NCT02207569|7550543|FG000|COMPLETED|48-Month to 60-Month||109
6623435|NCT02207569|7550543|FG000|NOT COMPLETED|48-Month to 60-Month||4
6623436|NCT02207608|7550549|FG000|STARTED|Overall Study||15
6623437|NCT02207608|7550550|FG001|STARTED|Overall Study||15
6623438|NCT02207608|7550549|FG000|COMPLETED|Overall Study||14
6623439|NCT02207608|7550550|FG001|COMPLETED|Overall Study||15
6623440|NCT02207608|7550549|FG000|NOT COMPLETED|Overall Study||1
6623441|NCT02207608|7550550|FG001|NOT COMPLETED|Overall Study||0
6623442|NCT02207621|7550559|FG000|STARTED|Overall Study||251
6623443|NCT02207621|7550560|FG001|STARTED|Overall Study||251
6623444|NCT02207621|7550561|FG002|STARTED|Overall Study||254
6623445|NCT02207621|7550559|FG000|COMPLETED|Overall Study||146
6623446|NCT02207621|7550560|FG001|COMPLETED|Overall Study||204
6623447|NCT02207621|7550561|FG002|COMPLETED|Overall Study||86
6623448|NCT02207621|7550559|FG000|NOT COMPLETED|Overall Study||105
6623449|NCT02207621|7550560|FG001|NOT COMPLETED|Overall Study||47
6623450|NCT02207621|7550561|FG002|NOT COMPLETED|Overall Study||168
6623451|NCT02207634|7550572|FG000|STARTED|Overall Study||990
6623452|NCT02207634|7550573|FG001|STARTED|Overall Study||984
6623453|NCT02207634|7550572|FG000|Received Treatment|Overall Study||990
6623454|NCT02207634|7550573|FG001|Received Treatment|Overall Study||983
6623455|NCT02207634|7550572|FG000|COMPLETED|Overall Study||968
6623456|NCT02207634|7550573|FG001|COMPLETED|Overall Study||953
6623457|NCT02207634|7550572|FG000|NOT COMPLETED|Overall Study||22
6623458|NCT02207634|7550573|FG001|NOT COMPLETED|Overall Study||31
6623459|NCT02207725|7550583|FG000|STARTED|Overall Study||9
6623460|NCT02207725|7550584|FG001|STARTED|Overall Study||25
6623461|NCT02207725|7550585|FG002|STARTED|Overall Study||9
6623462|NCT02207725|7550586|FG003|STARTED|Overall Study||25
6623463|NCT02207725|7550583|FG000|COMPLETED|Overall Study||9
6623464|NCT02207725|7550584|FG001|COMPLETED|Overall Study||24
6623465|NCT02207725|7550585|FG002|COMPLETED|Overall Study||8
6623466|NCT02207725|7550586|FG003|COMPLETED|Overall Study||24
6623467|NCT02207725|7550583|FG000|NOT COMPLETED|Overall Study||0
6623468|NCT02207725|7550584|FG001|NOT COMPLETED|Overall Study||1
6623469|NCT02207725|7550585|FG002|NOT COMPLETED|Overall Study||1
6623470|NCT02207725|7550586|FG003|NOT COMPLETED|Overall Study||1
6623471|NCT02207803|7550600|FG000|STARTED|Overall Study||125
6623472|NCT02207803|7550601|FG001|STARTED|Overall Study||125
6623473|NCT02207803|7550600|FG000|COMPLETED|Overall Study||110
6623474|NCT02207803|7550601|FG001|COMPLETED|Overall Study||108
6623475|NCT02207803|7550600|FG000|NOT COMPLETED|Overall Study||15
6623476|NCT02207803|7550601|FG001|NOT COMPLETED|Overall Study||17
6623477|NCT02207816|7550610|FG000|STARTED|Overall Study||1046
6623478|NCT02207816|7550611|FG001|STARTED|Overall Study||1010
6623479|NCT02207816|7550612|FG002|STARTED|Overall Study||1028
6800333|NCT03219333|7732321|FG000|Treated|Overall Study||125
6800334|NCT03219333|7732322|FG001|Treated|Overall Study||89
6623480|NCT02207816|7550610|FG000|COMPLETED|Overall Study||995
6623481|NCT02207816|7550611|FG001|COMPLETED|Overall Study||924
6623482|NCT02207816|7550612|FG002|COMPLETED|Overall Study||961
6623483|NCT02207816|7550610|FG000|NOT COMPLETED|Overall Study||51
6623484|NCT02207816|7550611|FG001|NOT COMPLETED|Overall Study||86
6564239|NCT01810042|7486955|FG000|STARTED|Overall Study||49
6564240|NCT01810042|7486955|FG000|COMPLETED|Overall Study||39
6564241|NCT01810042|7486955|FG000|NOT COMPLETED|Overall Study||10
6564242|NCT01810263|7486961|FG000|STARTED|Overall Study||16
6564243|NCT01810263|7486962|FG001|STARTED|Overall Study||18
6564244|NCT01810263|7486961|FG000|COMPLETED|Overall Study|2014 July|8
6564245|NCT01810263|7486962|FG001|COMPLETED|Overall Study||11
6656659|NCT02462928|7586939|FG002|STARTED|Overall Study||312
6656660|NCT02462928|7586937|FG000|COMPLETED|Overall Study||224
6656661|NCT02462928|7586938|FG001|COMPLETED|Overall Study||221
6656662|NCT02462928|7586939|FG002|COMPLETED|Overall Study||255
6656663|NCT02462928|7586937|FG000|NOT COMPLETED|Overall Study||90
6656664|NCT02462928|7586938|FG001|NOT COMPLETED|Overall Study||92
6656665|NCT02462928|7586939|FG002|NOT COMPLETED|Overall Study||57
6656666|NCT02462967|7586950|FG000|STARTED|Overall Study||54
6656667|NCT02462967|7586951|FG001|STARTED|Overall Study||54
6656668|NCT02462967|7586952|FG002|STARTED|Overall Study||54
6656669|NCT02462967|7586950|FG000|COMPLETED|Overall Study||52
6656670|NCT02462967|7586951|FG001|COMPLETED|Overall Study||48
6656671|NCT02462967|7586952|FG002|COMPLETED|Overall Study||51
6656672|NCT02462967|7586950|FG000|NOT COMPLETED|Overall Study||2
6656673|NCT02462967|7586951|FG001|NOT COMPLETED|Overall Study||6
6656674|NCT02462967|7586952|FG002|NOT COMPLETED|Overall Study||3
6656675|NCT02463032|7586962|FG000|STARTED|Overall Study||72
6656676|NCT02463032|7586963|FG001|STARTED|Overall Study||64
6656677|NCT02463032|7586962|FG000|COMPLETED|Overall Study||1
6656678|NCT02463032|7586963|FG001|COMPLETED|Overall Study||0
6656679|NCT02463032|7586962|FG000|NOT COMPLETED|Overall Study||71
6656680|NCT02463032|7586963|FG001|NOT COMPLETED|Overall Study||64
6656681|NCT02463071|7586972|FG000|STARTED|Overall Study||152
6656682|NCT02463071|7586973|FG001|STARTED|Overall Study||154
6656683|NCT02463071|7586974|FG002|STARTED|Overall Study||77
6656684|NCT02463071|7586972|FG000|COMPLETED|Overall Study||140
6656685|NCT02463071|7586973|FG001|COMPLETED|Overall Study||138
6656686|NCT02463071|7586974|FG002|COMPLETED|Overall Study||71
6656687|NCT02463071|7586972|FG000|NOT COMPLETED|Overall Study||12
6800335|NCT03219333|7732321|FG000|COMPLETED|Overall Study|Cohort 1 Completed includes 4 participants on treatment and 19 participants in follow-up.|23
6800336|NCT03219333|7732322|FG001|COMPLETED|Overall Study|Cohort 2 Completed includes 16 participants on treatment and 26 participants in follow-up.|42
6800337|NCT03219333|7732321|FG000|NOT COMPLETED|Overall Study||105
6564246|NCT01810263|7486961|FG000|NOT COMPLETED|Overall Study||8
6564247|NCT01810263|7486962|FG001|NOT COMPLETED|Overall Study||7
6564248|NCT01810289|7486970|FG000|STARTED|Overall Study||7277
6656688|NCT02463071|7586973|FG001|NOT COMPLETED|Overall Study||16
6656689|NCT02463071|7586974|FG002|NOT COMPLETED|Overall Study||6
6800338|NCT03219333|7732322|FG001|NOT COMPLETED|Overall Study||49
6800339|NCT03170882|7732330|FG000|STARTED|Overall Study||49
6800340|NCT03170882|7732331|FG001|STARTED|Overall Study||73
6800341|NCT03170882|7732330|FG000|Treated: Safety Population|Overall Study||47
6800342|NCT03170882|7732331|FG001|Treated: Safety Population|Overall Study||72
6800343|NCT03170882|7732330|FG000|ITT PRO Population|Overall Study||45
6800344|NCT03170882|7732331|FG001|ITT PRO Population|Overall Study||70
6800345|NCT03170882|7732330|FG000|COMPLETED|Overall Study||20
6800346|NCT03170882|7732331|FG001|COMPLETED|Overall Study||22
6800347|NCT03170882|7732330|FG000|NOT COMPLETED|Overall Study||29
6800348|NCT03170882|7732331|FG001|NOT COMPLETED|Overall Study||51
6800349|NCT03074318|7732341|FG000|STARTED|Overall Study||6
6800350|NCT03074318|7732342|FG001|STARTED|Overall Study||7
6800351|NCT03074318|7732343|FG002|STARTED|Overall Study||6
6800352|NCT03074318|7732344|FG003|STARTED|Overall Study||16
6800353|NCT03074318|7732341|FG000|COMPLETED|Overall Study||2
6800354|NCT03074318|7732342|FG001|COMPLETED|Overall Study||2
6800355|NCT03074318|7732343|FG002|COMPLETED|Overall Study||0
6800356|NCT03074318|7732344|FG003|COMPLETED|Overall Study||0
6800357|NCT03074318|7732341|FG000|NOT COMPLETED|Overall Study||4
6800358|NCT03074318|7732342|FG001|NOT COMPLETED|Overall Study||5
6800359|NCT03074318|7732343|FG002|NOT COMPLETED|Overall Study||6
6800360|NCT03074318|7732344|FG003|NOT COMPLETED|Overall Study||16
6800361|NCT03052608|7732365|FG000|STARTED|Treatment Phase||149
6800362|NCT03052608|7732366|FG001|STARTED|Treatment Phase||147
6800363|NCT03052608|7732365|FG000|COMPLETED|Treatment Phase||26
6800364|NCT03052608|7732366|FG001|COMPLETED|Treatment Phase||83
6800365|NCT03052608|7732365|FG000|NOT COMPLETED|Treatment Phase||123
6800366|NCT03052608|7732366|FG001|NOT COMPLETED|Treatment Phase||64
6800367|NCT03052608|7732365|FG000|STARTED|Long-Term Follow-up Phase||149
6800368|NCT03052608|7732366|FG001|STARTED|Long-Term Follow-up Phase||147
6800369|NCT03052608|7732365|FG000|COMPLETED|Long-Term Follow-up Phase||0
6800370|NCT03052608|7732366|FG001|COMPLETED|Long-Term Follow-up Phase||0
6800371|NCT03052608|7732365|FG000|NOT COMPLETED|Long-Term Follow-up Phase||149
6800372|NCT03052608|7732366|FG001|NOT COMPLETED|Long-Term Follow-up Phase||147
6800373|NCT03010319|7732374|FG000|STARTED|Overall Study||110
6800374|NCT03010319|7732375|FG001|STARTED|Overall Study||116
6800375|NCT03010319|7732374|FG000|COMPLETED|Overall Study||84
6800376|NCT03010319|7732375|FG001|COMPLETED|Overall Study||87
6800377|NCT03010319|7732374|FG000|NOT COMPLETED|Overall Study||26
6800378|NCT03010319|7732375|FG001|NOT COMPLETED|Overall Study||29
6800379|NCT02915016|7732389|FG000|STARTED|Overall Study||30
6800380|NCT02915016|7732390|FG001|STARTED|Overall Study||50
6656690|NCT02463097|7586982|FG000|STARTED|Overall Study||124
6656691|NCT02463097|7586982|FG000|COMPLETED|Overall Study||123
6800381|NCT02915016|7732391|FG002|STARTED|Overall Study||50
6800382|NCT02915016|7732392|FG003|STARTED|Overall Study||30
6800383|NCT02915016|7732393|FG004|STARTED|Overall Study||50
6800384|NCT02915016|7732394|FG005|STARTED|Overall Study||50
6800385|NCT02915016|7732395|FG006|STARTED|Overall Study||50
6800386|NCT02915016|7732396|FG007|STARTED|Overall Study||24
6800387|NCT02915016|7732389|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||23
6800388|NCT02915016|7732390|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||49
6800389|NCT02915016|7732391|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||46
6800390|NCT02915016|7732392|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||26
6800391|NCT02915016|7732393|FG004|Month 6.5 Immunogenicity Timepoint|Overall Study||43
6800392|NCT02915016|7732394|FG005|Month 6.5 Immunogenicity Timepoint|Overall Study||42
6800393|NCT02915016|7732395|FG006|Month 6.5 Immunogenicity Timepoint|Overall Study||42
6800394|NCT02915016|7732396|FG007|Month 6.5 Immunogenicity Timepoint|Overall Study||21
6800395|NCT02915016|7732389|FG000|COMPLETED|Overall Study||23
6800396|NCT02915016|7732390|FG001|COMPLETED|Overall Study||47
6800397|NCT02915016|7732391|FG002|COMPLETED|Overall Study||42
6800398|NCT02915016|7732392|FG003|COMPLETED|Overall Study||26
6800399|NCT02915016|7732393|FG004|COMPLETED|Overall Study||43
6800400|NCT02915016|7732394|FG005|COMPLETED|Overall Study||44
6800401|NCT02915016|7732395|FG006|COMPLETED|Overall Study||38
6800402|NCT02915016|7732396|FG007|COMPLETED|Overall Study||20
6800403|NCT02915016|7732389|FG000|NOT COMPLETED|Overall Study||7
6800404|NCT02915016|7732390|FG001|NOT COMPLETED|Overall Study||3
6800405|NCT02915016|7732391|FG002|NOT COMPLETED|Overall Study||8
6800406|NCT02915016|7732392|FG003|NOT COMPLETED|Overall Study||4
6800407|NCT02915016|7732393|FG004|NOT COMPLETED|Overall Study||7
6800408|NCT02915016|7732394|FG005|NOT COMPLETED|Overall Study||6
6800409|NCT02915016|7732395|FG006|NOT COMPLETED|Overall Study||12
6800410|NCT02915016|7732396|FG007|NOT COMPLETED|Overall Study||4
6800411|NCT02871401|7732416|FG000|STARTED|Overall Study||20
6800412|NCT02871401|7732417|FG001|STARTED|Overall Study||11
6800413|NCT02871401|7732416|FG000|COMPLETED|Overall Study||19
6800414|NCT02871401|7732417|FG001|COMPLETED|Overall Study||11
6800415|NCT02871401|7732416|FG000|NOT COMPLETED|Overall Study||1
6800416|NCT02871401|7732417|FG001|NOT COMPLETED|Overall Study||0
6800417|NCT02811913|7732423|FG000|STARTED|Overall Study||20
6800418|NCT02811913|7732423|FG000|COMPLETED|Overall Study||16
6800419|NCT02811913|7732423|FG000|NOT COMPLETED|Overall Study||4
6800420|NCT02701283|7732435|FG000|STARTED|Overall Study||737
6800421|NCT02701283|7732436|FG001|STARTED|Overall Study||741
6800422|NCT02701283|7732437|FG002|STARTED|Overall Study||745
6800423|NCT02701283|7732435|FG000|As Treated (Attempted Implant)|Overall Study||730
6800424|NCT02701283|7732436|FG001|As Treated (Attempted Implant)|Overall Study||684
6800425|NCT02701283|7732437|FG002|As Treated (Attempted Implant)|Overall Study||745
6800426|NCT02701283|7732435|FG000|Implanted|Overall Study||727
6800427|NCT02701283|7732436|FG001|Implanted|Overall Study||686
6800428|NCT02701283|7732437|FG002|Implanted|Overall Study||745
6800429|NCT02701283|7732435|FG000|COMPLETED|Overall Study||668
6800430|NCT02701283|7732436|FG001|COMPLETED|Overall Study||579
6800431|NCT02701283|7732437|FG002|COMPLETED|Overall Study||724
6380660|NCT00780338|7291493|FG000|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
6268899|NCT00068822|7168003|FG001|STARTED|Optional Crossover Intervention||29
6800432|NCT02701283|7732435|FG000|NOT COMPLETED|Overall Study||69
6800433|NCT02701283|7732436|FG001|NOT COMPLETED|Overall Study||162
6800434|NCT02701283|7732437|FG002|NOT COMPLETED|Overall Study||21
6800435|NCT02696031|7732451|FG000|STARTED|Up to Week 24||185
6800436|NCT02696031|7732452|FG001|STARTED|Up to Week 24||184
6800437|NCT02696031|7732453|FG002|STARTED|Up to Week 24||186
6800438|NCT02696031|7732454|FG003|STARTED|Up to Week 24||0
6800439|NCT02696031|7732455|FG004|STARTED|Up to Week 24||0
6800440|NCT02696031|7732456|FG005|STARTED|Up to Week 24||0
6800441|NCT02696031|7732451|FG000|COMPLETED|Up to Week 24||175
6800442|NCT02696031|7732452|FG001|COMPLETED|Up to Week 24||177
6800443|NCT02696031|7732453|FG002|COMPLETED|Up to Week 24||175
6800444|NCT02696031|7732454|FG003|COMPLETED|Up to Week 24||0
6800445|NCT02696031|7732455|FG004|COMPLETED|Up to Week 24||0
6800446|NCT02696031|7732456|FG005|COMPLETED|Up to Week 24||0
6800447|NCT02696031|7732451|FG000|NOT COMPLETED|Up to Week 24||10
6800448|NCT02696031|7732452|FG001|NOT COMPLETED|Up to Week 24||7
6800449|NCT02696031|7732453|FG002|NOT COMPLETED|Up to Week 24||11
6800450|NCT02696031|7732454|FG003|NOT COMPLETED|Up to Week 24||0
6800451|NCT02696031|7732455|FG004|NOT COMPLETED|Up to Week 24||0
6800452|NCT02696031|7732456|FG005|NOT COMPLETED|Up to Week 24||0
6800453|NCT02696031|7732451|FG000|STARTED|Up to Week 52||185
6800454|NCT02696031|7732452|FG001|STARTED|Up to Week 52||184
6800455|NCT02696031|7732453|FG002|STARTED|Up to Week 52||186
6800456|NCT02696031|7732454|FG003|STARTED|Up to Week 52||0
6800457|NCT02696031|7732455|FG004|STARTED|Up to Week 52||0
6800458|NCT02696031|7732456|FG005|STARTED|Up to Week 52||0
6800459|NCT02696031|7732451|FG000|COMPLETED|Up to Week 52||156
6800460|NCT02696031|7732452|FG001|COMPLETED|Up to Week 52||165
6800461|NCT02696031|7732453|FG002|COMPLETED|Up to Week 52||160
6800462|NCT02696031|7732454|FG003|COMPLETED|Up to Week 52||0
6800463|NCT02696031|7732455|FG004|COMPLETED|Up to Week 52||0
6800464|NCT02696031|7732456|FG005|COMPLETED|Up to Week 52||0
6800465|NCT02696031|7732451|FG000|NOT COMPLETED|Up to Week 52||29
6800466|NCT02696031|7732452|FG001|NOT COMPLETED|Up to Week 52||19
6800467|NCT02696031|7732453|FG002|NOT COMPLETED|Up to Week 52||26
6800468|NCT02696031|7732454|FG003|NOT COMPLETED|Up to Week 52||0
6800469|NCT02696031|7732455|FG004|NOT COMPLETED|Up to Week 52||0
6800470|NCT02696031|7732456|FG005|NOT COMPLETED|Up to Week 52||0
6800471|NCT02696031|7732451|FG000|STARTED|Up to Week 104||185
6800472|NCT02696031|7732452|FG001|STARTED|Up to Week 104||184
6800473|NCT02696031|7732453|FG002|STARTED|Up to Week 104||186
6800474|NCT02696031|7732454|FG003|STARTED|Up to Week 104||0
6800475|NCT02696031|7732455|FG004|STARTED|Up to Week 104||0
6800476|NCT02696031|7732456|FG005|STARTED|Up to Week 104||0
6800477|NCT02696031|7732451|FG000|COMPLETED|Up to Week 104||146
6800478|NCT02696031|7732452|FG001|COMPLETED|Up to Week 104||143
6800479|NCT02696031|7732453|FG002|COMPLETED|Up to Week 104||149
6800480|NCT02696031|7732454|FG003|COMPLETED|Up to Week 104||0
6800481|NCT02696031|7732455|FG004|COMPLETED|Up to Week 104||0
6800482|NCT02696031|7732456|FG005|COMPLETED|Up to Week 104||0
6800483|NCT02696031|7732451|FG000|NOT COMPLETED|Up to Week 104||39
6800484|NCT02696031|7732452|FG001|NOT COMPLETED|Up to Week 104||41
6800485|NCT02696031|7732453|FG002|NOT COMPLETED|Up to Week 104||37
6800486|NCT02696031|7732454|FG003|NOT COMPLETED|Up to Week 104||0
6800487|NCT02696031|7732455|FG004|NOT COMPLETED|Up to Week 104||0
6800488|NCT02696031|7732456|FG005|NOT COMPLETED|Up to Week 104||0
6800489|NCT02696031|7732451|FG000|STARTED|Extension Phase From wk 104 to wk 208||0
6800490|NCT02696031|7732452|FG001|STARTED|Extension Phase From wk 104 to wk 208||0
6800491|NCT02696031|7732453|FG002|STARTED|Extension Phase From wk 104 to wk 208||0
6800492|NCT02696031|7732454|FG003|STARTED|Extension Phase From wk 104 to wk 208||147
6800493|NCT02696031|7732455|FG004|STARTED|Extension Phase From wk 104 to wk 208||147
6800494|NCT02696031|7732456|FG005|STARTED|Extension Phase From wk 104 to wk 208||78
6800495|NCT02696031|7732451|FG000|COMPLETED|Extension Phase From wk 104 to wk 208||0
6800496|NCT02696031|7732452|FG001|COMPLETED|Extension Phase From wk 104 to wk 208||0
6800497|NCT02696031|7732453|FG002|COMPLETED|Extension Phase From wk 104 to wk 208||0
6800498|NCT02696031|7732454|FG003|COMPLETED|Extension Phase From wk 104 to wk 208||137
6800499|NCT02696031|7732455|FG004|COMPLETED|Extension Phase From wk 104 to wk 208||132
6800500|NCT02696031|7732456|FG005|COMPLETED|Extension Phase From wk 104 to wk 208||72
6800501|NCT02696031|7732451|FG000|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
6800502|NCT02696031|7732452|FG001|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
6800503|NCT02696031|7732453|FG002|NOT COMPLETED|Extension Phase From wk 104 to wk 208||0
6800504|NCT02696031|7732454|FG003|NOT COMPLETED|Extension Phase From wk 104 to wk 208||10
6800505|NCT02696031|7732455|FG004|NOT COMPLETED|Extension Phase From wk 104 to wk 208||15
6800506|NCT02696031|7732456|FG005|NOT COMPLETED|Extension Phase From wk 104 to wk 208||6
6800507|NCT02689453|7732468|FG000|STARTED|Overall Study||3
6800508|NCT02689453|7732469|FG001|STARTED|Overall Study||4
6800509|NCT02689453|7732470|FG002|STARTED|Overall Study||4
6800510|NCT02689453|7732468|FG000|COMPLETED|Overall Study||3
6800511|NCT02689453|7732469|FG001|COMPLETED|Overall Study||3
6800512|NCT02689453|7732470|FG002|COMPLETED|Overall Study||3
6800513|NCT02689453|7732468|FG000|NOT COMPLETED|Overall Study||0
6800514|NCT02689453|7732469|FG001|NOT COMPLETED|Overall Study||1
6800515|NCT02689453|7732470|FG002|NOT COMPLETED|Overall Study||1
6800516|NCT02476851|7732482|FG000|STARTED|Overall Study||31
6800517|NCT02476851|7732483|FG001|STARTED|Overall Study||31
6800518|NCT02476851|7732482|FG000|COMPLETED|Overall Study||30
6800519|NCT02476851|7732483|FG001|COMPLETED|Overall Study||30
6800520|NCT02476851|7732482|FG000|NOT COMPLETED|Overall Study||1
6800521|NCT02476851|7732483|FG001|NOT COMPLETED|Overall Study||1
6800522|NCT02446600|7732493|FG000|STARTED|Overall Study||187
6800523|NCT02446600|7732494|FG001|STARTED|Overall Study|Duplicate enrollment patient has been excluded from all analyses.|190
6800524|NCT02446600|7732495|FG002|STARTED|Overall Study||189
6800525|NCT02446600|7732496|FG003|STARTED|Overall Study||13
6800526|NCT02446600|7732493|FG000|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|147
6800527|NCT02446600|7732494|FG001|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|178
6800528|NCT02446600|7732495|FG002|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|162
6800529|NCT02446600|7732496|FG003|COMPLETED|Overall Study|Completed status includes all clinical reasons for suspending treatment, including disease progression, death and adverse events.|12
6800530|NCT02446600|7732493|FG000|NOT COMPLETED|Overall Study||40
6800531|NCT02446600|7732494|FG001|NOT COMPLETED|Overall Study||12
6800532|NCT02446600|7732495|FG002|NOT COMPLETED|Overall Study||27
6800533|NCT02446600|7732496|FG003|NOT COMPLETED|Overall Study||1
6800534|NCT02389946|7732508|FG000|STARTED|Overall Study||884
6800535|NCT02389946|7732509|FG001|STARTED|Overall Study||450
6800536|NCT02389946|7732508|FG000|COMPLETED|Overall Study||860
6800537|NCT02389946|7732509|FG001|COMPLETED|Overall Study||435
6800538|NCT02389946|7732508|FG000|NOT COMPLETED|Overall Study||24
6800539|NCT02389946|7732509|FG001|NOT COMPLETED|Overall Study||15
6800540|NCT02310919|7732517|FG000|STARTED|Overall Study||54
6800541|NCT02310919|7732518|FG001|STARTED|Overall Study||51
6800542|NCT02310919|7732517|FG000|COMPLETED|Overall Study|Four participants receiving the study trigger deviated from protocol. One patient was randomized before her E2 resulted >5,000 pg/ml. Another elected to convert to intrauterine insemination while another underwent oocyte cryopreservation as their male partner was unable to produce a fresh sperm sample for fertilization. The 4th patient inadvertently spilled a portion of the trigger prior to injection. Since her post-trigger hCG was <18 IU/L, she was unblinded and re-triggered with 10,000 IU hCG.|54
6800543|NCT02310919|7732518|FG001|COMPLETED|Overall Study|Two participants that received the standard trigger requested exclusionary embryo co-culture to be added post-trigger.|51
6800544|NCT02310919|7732517|FG000|NOT COMPLETED|Overall Study||0
6800545|NCT02310919|7732518|FG001|NOT COMPLETED|Overall Study||0
6800546|NCT02208024|7732525|FG000|STARTED|Overall Study||18
6800547|NCT02208024|7732525|FG000|COMPLETED|Overall Study||17
6800548|NCT02208024|7732525|FG000|NOT COMPLETED|Overall Study||1
6800549|NCT02180867|7732536|FG000|STARTED|Overall Study||10
6800550|NCT02180867|7732537|FG001|STARTED|Overall Study||11
6800551|NCT02180867|7732538|FG002|STARTED|Overall Study||10
6800552|NCT02180867|7732539|FG003|STARTED|Overall Study||49
6800553|NCT02180867|7732540|FG004|STARTED|Overall Study||48
6800554|NCT02180867|7732541|FG005|STARTED|Overall Study||6
6800555|NCT02180867|7732542|FG006|STARTED|Overall Study||6
6800556|NCT02180867|7732536|FG000|Pediatric Patients|Overall Study||6
6800557|NCT02180867|7732537|FG001|Pediatric Patients|Overall Study||4
6800558|NCT02180867|7732538|FG002|Pediatric Patients|Overall Study||3
6800559|NCT02180867|7732539|FG003|Pediatric Patients|Overall Study||18
6800560|NCT02180867|7732540|FG004|Pediatric Patients|Overall Study||19
6800561|NCT02180867|7732541|FG005|Pediatric Patients|Overall Study||1
6800562|NCT02180867|7732542|FG006|Pediatric Patients|Overall Study||0
6800563|NCT02180867|7732536|FG000|Adult Patients|Overall Study||4
6502556|NCT01435798|7421283|FG000|100% MTD|Overall Study||25
6502557|NCT01435798|7421283|FG000|COMPLETED|Overall Study|Crossover design|25
6564249|NCT01810289|7486971|FG001|STARTED|Overall Study||4747
6800564|NCT02180867|7732537|FG001|Adult Patients|Overall Study||7
6800565|NCT02180867|7732538|FG002|Adult Patients|Overall Study||7
6800566|NCT02180867|7732539|FG003|Adult Patients|Overall Study||31
6800567|NCT02180867|7732540|FG004|Adult Patients|Overall Study||29
6800568|NCT02180867|7732541|FG005|Adult Patients|Overall Study||5
6800569|NCT02180867|7732542|FG006|Adult Patients|Overall Study||6
6800570|NCT02180867|7732536|FG000|COMPLETED|Overall Study||4
6800571|NCT02180867|7732537|FG001|COMPLETED|Overall Study||0
6800572|NCT02180867|7732538|FG002|COMPLETED|Overall Study||6
6800573|NCT02180867|7732539|FG003|COMPLETED|Overall Study||23
6800574|NCT02180867|7732540|FG004|COMPLETED|Overall Study||21
6800575|NCT02180867|7732541|FG005|COMPLETED|Overall Study||3
6800576|NCT02180867|7732542|FG006|COMPLETED|Overall Study||1
6800577|NCT02180867|7732536|FG000|NOT COMPLETED|Overall Study||6
6800578|NCT02180867|7732537|FG001|NOT COMPLETED|Overall Study||11
6800579|NCT02180867|7732538|FG002|NOT COMPLETED|Overall Study||4
6800580|NCT02180867|7732539|FG003|NOT COMPLETED|Overall Study||26
6800581|NCT02180867|7732540|FG004|NOT COMPLETED|Overall Study||27
6800582|NCT02180867|7732541|FG005|NOT COMPLETED|Overall Study||3
6800583|NCT02180867|7732542|FG006|NOT COMPLETED|Overall Study||5
6800584|NCT01866111|7732574|FG000|STARTED|Double-blind Period of Study YKP3089C017||108
6800585|NCT01866111|7732575|FG001|STARTED|Double-blind Period of Study YKP3089C017||108
6800586|NCT01866111|7732576|FG002|STARTED|Double-blind Period of Study YKP3089C017||110
6800587|NCT01866111|7732577|FG003|STARTED|Double-blind Period of Study YKP3089C017||111
6800588|NCT01866111|7732574|FG000|COMPLETED|Double-blind Period of Study YKP3089C017||94
6800589|NCT01866111|7732575|FG001|COMPLETED|Double-blind Period of Study YKP3089C017||95
6800590|NCT01866111|7732576|FG002|COMPLETED|Double-blind Period of Study YKP3089C017||90
6800591|NCT01866111|7732577|FG003|COMPLETED|Double-blind Period of Study YKP3089C017||81
6800592|NCT01866111|7732574|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C017||14
6800593|NCT01866111|7732575|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C017||13
6800594|NCT01866111|7732576|FG002|NOT COMPLETED|Double-blind Period of Study YKP3089C017||20
6800595|NCT01866111|7732577|FG003|NOT COMPLETED|Double-blind Period of Study YKP3089C017||30
6800596|NCT01866111|7732574|FG000|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|91
6800597|NCT01866111|7732575|FG001|STARTED|Open-label Extension Study YKP3089C017||95
6800598|NCT01866111|7732576|FG002|STARTED|Open-label Extension Study YKP3089C017||90
6800599|NCT01866111|7732577|FG003|STARTED|Open-label Extension Study YKP3089C017|Not all patients from double-blind rolled over to open-label|80
6800600|NCT01866111|7732574|FG000|COMPLETED|Open-label Extension Study YKP3089C017||26
6800601|NCT01866111|7732575|FG001|COMPLETED|Open-label Extension Study YKP3089C017||28
6800602|NCT01866111|7732576|FG002|COMPLETED|Open-label Extension Study YKP3089C017||27
6800603|NCT01866111|7732577|FG003|COMPLETED|Open-label Extension Study YKP3089C017||28
6800604|NCT01866111|7732574|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C017||65
6800605|NCT01866111|7732575|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C017||67
6800606|NCT01866111|7732576|FG002|NOT COMPLETED|Open-label Extension Study YKP3089C017||63
6800607|NCT01866111|7732577|FG003|NOT COMPLETED|Open-label Extension Study YKP3089C017||52
6800608|NCT01767194|7732589|FG000|STARTED|Overall Study||19
6800609|NCT01767194|7732590|FG001|STARTED|Overall Study||54
6800610|NCT01767194|7732589|FG000|COMPLETED|Overall Study||1
6800611|NCT01767194|7732590|FG001|COMPLETED|Overall Study||11
6800612|NCT01767194|7732589|FG000|NOT COMPLETED|Overall Study||18
6800613|NCT01767194|7732590|FG001|NOT COMPLETED|Overall Study||43
6564250|NCT01810289|7486970|FG000|COMPLETED|Overall Study||7277
6564251|NCT01810289|7486971|FG001|COMPLETED|Overall Study||4747
6800614|NCT01767129|7732597|FG000|STARTED|Treatment Period 1 (14 Days)||7
6800615|NCT01767129|7732598|FG001|STARTED|Treatment Period 1 (14 Days)||7
6800616|NCT01767129|7732597|FG000|COMPLETED|Treatment Period 1 (14 Days)||6
6800617|NCT01767129|7732598|FG001|COMPLETED|Treatment Period 1 (14 Days)||7
6564252|NCT01810289|7486970|FG000|NOT COMPLETED|Overall Study||0
6564253|NCT01810289|7486971|FG001|NOT COMPLETED|Overall Study||0
6564254|NCT01810380|7486980|FG000|STARTED|Overall Study||163
6800618|NCT01767129|7732597|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6800619|NCT01767129|7732598|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6800620|NCT01767129|7732597|FG000|STARTED|Treatment Period 2 (14 Days)||6
6800621|NCT01767129|7732598|FG001|STARTED|Treatment Period 2 (14 Days)||7
6800622|NCT01767129|7732597|FG000|COMPLETED|Treatment Period 2 (14 Days)||6
6800623|NCT01767129|7732598|FG001|COMPLETED|Treatment Period 2 (14 Days)||7
6800624|NCT01767129|7732597|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6800625|NCT01767129|7732598|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6800626|NCT01708954|7732608|FG000|STARTED|Step 1||42
6800627|NCT01708954|7732609|FG001|STARTED|Step 1||40
6800628|NCT01708954|7732610|FG002|STARTED|Step 1||43
6800629|NCT01708954|7732608|FG000|Started Protocol Therapy|Step 1||40
6800630|NCT01708954|7732609|FG001|Started Protocol Therapy|Step 1||40
6800631|NCT01708954|7732610|FG002|Started Protocol Therapy|Step 1||39
6800632|NCT01708954|7732608|FG000|Eligible and Treated|Step 1||38
6800633|NCT01708954|7732609|FG001|Eligible and Treated|Step 1||38
6800634|NCT01708954|7732610|FG002|Eligible and Treated|Step 1||35
6800635|NCT01708954|7732608|FG000|Patients With MET Status Data Available|Step 1||30
6800636|NCT01708954|7732609|FG001|Patients With MET Status Data Available|Step 1||32
6800637|NCT01708954|7732610|FG002|Patients With MET Status Data Available|Step 1||24
6800638|NCT01708954|7732608|FG000|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
6800639|NCT01708954|7732609|FG001|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
6800640|NCT01708954|7732610|FG002|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
6800641|NCT01708954|7732608|FG000|NOT COMPLETED|Step 1||42
6800642|NCT01708954|7732609|FG001|NOT COMPLETED|Step 1||40
6800643|NCT01708954|7732610|FG002|NOT COMPLETED|Step 1||43
6800644|NCT01708954|7732608|FG000|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
6800645|NCT01708954|7732609|FG001|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
6800646|NCT01708954|7732610|FG002|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
6800647|NCT01708954|7732608|FG000|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
6800648|NCT01708954|7732609|FG001|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
6800649|NCT01708954|7732610|FG002|COMPLETED|Step 2||0
6800650|NCT01708954|7732608|FG000|NOT COMPLETED|Step 2||13
6800651|NCT01708954|7732609|FG001|NOT COMPLETED|Step 2||7
6800652|NCT01708954|7732610|FG002|NOT COMPLETED|Step 2||0
6800653|NCT01708941|7732623|FG000|STARTED|Overall Study||21
6800654|NCT01708941|7732624|FG001|STARTED|Overall Study||23
6800655|NCT01708941|7732625|FG002|STARTED|Overall Study||22
6800656|NCT01708941|7732626|FG003|STARTED|Overall Study||22
6800657|NCT01708941|7732623|FG000|Eligible and Started Treatment|Overall Study||18
6800658|NCT01708941|7732624|FG001|Eligible and Started Treatment|Overall Study||22
6800659|NCT01708941|7732625|FG002|Eligible and Started Treatment|Overall Study||19
6800660|NCT01708941|7732626|FG003|Eligible and Started Treatment|Overall Study||22
6800661|NCT01708941|7732623|FG000|COMPLETED|Overall Study||3
6800662|NCT01708941|7732624|FG001|COMPLETED|Overall Study||5
6800663|NCT01708941|7732625|FG002|COMPLETED|Overall Study||3
6800664|NCT01708941|7732626|FG003|COMPLETED|Overall Study||4
6800665|NCT01708941|7732623|FG000|NOT COMPLETED|Overall Study||18
6800666|NCT01708941|7732624|FG001|NOT COMPLETED|Overall Study||18
6800667|NCT01708941|7732625|FG002|NOT COMPLETED|Overall Study||19
6800668|NCT01708941|7732626|FG003|NOT COMPLETED|Overall Study||18
6800669|NCT01622868|7732638|FG000|STARTED|Overall Study||72
6800670|NCT01622868|7732639|FG001|STARTED|Overall Study||71
6800671|NCT01622868|7732638|FG000|Eligible|Overall Study||65
6800672|NCT01622868|7732639|FG001|Eligible|Overall Study||71
6800673|NCT01622868|7732638|FG000|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||63
6800674|NCT01622868|7732639|FG001|Eligible, Started Study Treatment, Has Adverse Event Data|Overall Study||71
6800675|NCT01622868|7732638|FG000|COMPLETED|Overall Study||65
6800676|NCT01622868|7732639|FG001|COMPLETED|Overall Study||71
6800677|NCT01622868|7732638|FG000|NOT COMPLETED|Overall Study||7
6800678|NCT01622868|7732639|FG001|NOT COMPLETED|Overall Study||0
6800679|NCT01609790|7732648|FG000|STARTED|Overall Study||7
6800680|NCT01609790|7732649|FG001|STARTED|Overall Study||65
6800681|NCT01609790|7732650|FG002|STARTED|Overall Study||65
6800682|NCT01609790|7732648|FG000|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
6800683|NCT01609790|7732649|FG001|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
6800684|NCT01609790|7732650|FG002|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
6800685|NCT01609790|7732648|FG000|NOT COMPLETED|Overall Study||1
6800686|NCT01609790|7732649|FG001|NOT COMPLETED|Overall Study||7
6800687|NCT01609790|7732650|FG002|NOT COMPLETED|Overall Study||8
6800688|NCT01586910|7732660|FG000|STARTED|Overall Study||879
6800689|NCT01586910|7732661|FG001|STARTED|Overall Study||867
6800690|NCT01586910|7732660|FG000|COMPLETED|Overall Study||864
6800691|NCT01586910|7732661|FG001|COMPLETED|Overall Study||796
6800692|NCT01586910|7732660|FG000|NOT COMPLETED|Overall Study||15
6800693|NCT01586910|7732661|FG001|NOT COMPLETED|Overall Study||71
6800694|NCT01553149|7732671|FG000|STARTED|Overall Study||37
6800695|NCT01553149|7732672|FG001|STARTED|Overall Study||38
6800696|NCT01553149|7732671|FG000|COMPLETED|Overall Study||32
6800697|NCT01553149|7732672|FG001|COMPLETED|Overall Study||18
6800698|NCT01553149|7732671|FG000|NOT COMPLETED|Overall Study||5
6800699|NCT01553149|7732672|FG001|NOT COMPLETED|Overall Study||20
6800700|NCT01531374|7732681|FG000|STARTED|Overall Study||1285
6800701|NCT01531374|7732682|FG001|STARTED|Overall Study||373
6800702|NCT01531374|7732683|FG002|STARTED|Overall Study||1119
6800703|NCT01531374|7732681|FG000|COMPLETED|Overall Study||921
6800704|NCT01531374|7732682|FG001|COMPLETED|Overall Study||231
6800705|NCT01531374|7732683|FG002|COMPLETED|Overall Study||836
6800706|NCT01531374|7732681|FG000|NOT COMPLETED|Overall Study||364
6800707|NCT01531374|7732682|FG001|NOT COMPLETED|Overall Study||142
6800708|NCT01531374|7732683|FG002|NOT COMPLETED|Overall Study||283
6800709|NCT01371981|7732699|FG000|STARTED|Overall Study||580
6800710|NCT01371981|7732700|FG001|STARTED|Overall Study||591
6800711|NCT01371981|7732701|FG002|STARTED|Overall Study||12
6800712|NCT01371981|7732702|FG003|STARTED|Overall Study||33
6800713|NCT01371981|7732703|FG004|STARTED|Overall Study||47
6800714|NCT01371981|7732704|FG005|STARTED|Overall Study||382
6800715|NCT01371981|7732699|FG000|COMPLETED|Overall Study||396
6800716|NCT01371981|7732700|FG001|COMPLETED|Overall Study||399
6800717|NCT01371981|7732701|FG002|COMPLETED|Overall Study||6
6800718|NCT01371981|7732702|FG003|COMPLETED|Overall Study||12
6800719|NCT01371981|7732703|FG004|COMPLETED|Overall Study||15
6800720|NCT01371981|7732704|FG005|COMPLETED|Overall Study||368
6800721|NCT01371981|7732699|FG000|NOT COMPLETED|Overall Study||184
6800722|NCT01371981|7732700|FG001|NOT COMPLETED|Overall Study||192
6800723|NCT01371981|7732701|FG002|NOT COMPLETED|Overall Study||6
6800724|NCT01371981|7732702|FG003|NOT COMPLETED|Overall Study||21
6800725|NCT01371981|7732703|FG004|NOT COMPLETED|Overall Study||32
6800726|NCT01371981|7732704|FG005|NOT COMPLETED|Overall Study||14
6800727|NCT01240902|7732727|FG000|STARTED|Overall Study||500
6800728|NCT01240902|7732728|FG001|STARTED|Overall Study||156
6800729|NCT01240902|7732729|FG002|STARTED|Overall Study||395
6800730|NCT01240902|7732730|FG003|STARTED|Overall Study||402
6800731|NCT01240902|7732727|FG000|COMPLETED|Overall Study||289
6800732|NCT01240902|7732728|FG001|COMPLETED|Overall Study||77
6800733|NCT01240902|7732729|FG002|COMPLETED|Overall Study||295
6800734|NCT01240902|7732730|FG003|COMPLETED|Overall Study||237
6800735|NCT01240902|7732727|FG000|NOT COMPLETED|Overall Study||211
6268900|NCT00068822|7168002|FG000|Crossover at Month 1|Optional Crossover Intervention||1
6380661|NCT00780338|7291494|FG001|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
6380662|NCT00780338|7291493|FG000|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
6380663|NCT00780338|7291494|FG001|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
6380664|NCT00780338|7291493|FG000|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
6380665|NCT00780338|7291494|FG001|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
6380666|NCT00780416|7291506|FG000|STARTED|Overall Study||126
6380667|NCT00780416|7291507|FG001|STARTED|Overall Study||63
6380668|NCT00780416|7291506|FG000|COMPLETED|Overall Study||114
6380669|NCT00780416|7291507|FG001|COMPLETED|Overall Study||54
6380670|NCT00780416|7291506|FG000|NOT COMPLETED|Overall Study||12
6380671|NCT00780416|7291507|FG001|NOT COMPLETED|Overall Study||9
6380672|NCT00780442|7291515|FG000|STARTED|Overall Study||12
6380673|NCT00780442|7291516|FG001|STARTED|Overall Study||15
6380674|NCT00780442|7291515|FG000|COMPLETED|Overall Study||12
6380675|NCT00780442|7291516|FG001|COMPLETED|Overall Study||15
6380676|NCT00780442|7291515|FG000|NOT COMPLETED|Overall Study||0
6380677|NCT00780442|7291516|FG001|NOT COMPLETED|Overall Study||0
6380678|NCT00780494|7291522|FG000|STARTED|Overall Study||35
6380679|NCT00780494|7291522|FG000|COMPLETED|Overall Study||35
6380680|NCT00780494|7291522|FG000|NOT COMPLETED|Overall Study||0
6380681|NCT00780559|7291528|FG000|STARTED|Overall Study||32
6564255|NCT01810380|7486981|FG001|STARTED|Overall Study||151
6800736|NCT01240902|7732728|FG001|NOT COMPLETED|Overall Study||79
6800737|NCT01240902|7732729|FG002|NOT COMPLETED|Overall Study||100
6800738|NCT01240902|7732730|FG003|NOT COMPLETED|Overall Study||165
6800739|NCT01236560|7732746|FG000|STARTED|Overall Study||6
6800740|NCT01236560|7732747|FG001|STARTED|Overall Study||32
6800741|NCT01236560|7732748|FG002|STARTED|Overall Study||31
6800742|NCT01236560|7732749|FG003|STARTED|Overall Study||32
6800743|NCT01236560|7732750|FG004|STARTED|Overall Study||0
6800744|NCT01236560|7732751|FG005|STARTED|Overall Study||0
6800745|NCT01236560|7732746|FG000|COMPLETED|Overall Study||1
6800746|NCT01236560|7732747|FG001|COMPLETED|Overall Study||8
6800747|NCT01236560|7732748|FG002|COMPLETED|Overall Study||11
6800748|NCT01236560|7732749|FG003|COMPLETED|Overall Study||10
6800749|NCT01236560|7732750|FG004|COMPLETED|Overall Study||0
6800750|NCT01236560|7732751|FG005|COMPLETED|Overall Study||0
6800751|NCT01236560|7732746|FG000|NOT COMPLETED|Overall Study||5
6800752|NCT01236560|7732747|FG001|NOT COMPLETED|Overall Study||24
6800753|NCT01236560|7732748|FG002|NOT COMPLETED|Overall Study||20
6800754|NCT01236560|7732749|FG003|NOT COMPLETED|Overall Study||22
6800755|NCT01236560|7732750|FG004|NOT COMPLETED|Overall Study||0
6800756|NCT01236560|7732751|FG005|NOT COMPLETED|Overall Study||0
6800757|NCT01236547|7732766|FG000|STARTED|Overall Study||11
6800758|NCT01236547|7732767|FG001|STARTED|Overall Study||11
6800759|NCT01236547|7732768|FG002|STARTED|Overall Study||12
6800760|NCT01236547|7732769|FG003|STARTED|Overall Study||42
6800761|NCT01236547|7732770|FG004|STARTED|Overall Study||47
6800762|NCT01236547|7732766|FG000|Eligible|Overall Study||11
6800763|NCT01236547|7732767|FG001|Eligible|Overall Study||10
6800764|NCT01236547|7732768|FG002|Eligible|Overall Study||11
6800765|NCT01236547|7732769|FG003|Eligible|Overall Study||36
6800766|NCT01236547|7732770|FG004|Eligible|Overall Study||35
6800767|NCT01236547|7732766|FG000|Eligible and Started Study Treatment|Overall Study||11
6800768|NCT01236547|7732767|FG001|Eligible and Started Study Treatment|Overall Study||10
6800769|NCT01236547|7732768|FG002|Eligible and Started Study Treatment|Overall Study||11
6800770|NCT01236547|7732769|FG003|Eligible and Started Study Treatment|Overall Study||36
6800771|NCT01236547|7732770|FG004|Eligible and Started Study Treatment|Overall Study||34
6800772|NCT01236547|7732766|FG000|Eligible and Response Assessed|Overall Study||0
6800773|NCT01236547|7732767|FG001|Eligible and Response Assessed|Overall Study||0
6800774|NCT01236547|7732768|FG002|Eligible and Response Assessed|Overall Study||0
6800775|NCT01236547|7732769|FG003|Eligible and Response Assessed|Overall Study||23
6800776|NCT01236547|7732770|FG004|Eligible and Response Assessed|Overall Study||27
6800777|NCT01236547|7732766|FG000|COMPLETED|Overall Study||11
6800778|NCT01236547|7732767|FG001|COMPLETED|Overall Study||10
6800779|NCT01236547|7732768|FG002|COMPLETED|Overall Study||11
6800780|NCT01236547|7732769|FG003|COMPLETED|Overall Study||36
6800781|NCT01236547|7732770|FG004|COMPLETED|Overall Study||35
6800782|NCT01236547|7732766|FG000|NOT COMPLETED|Overall Study||0
6800783|NCT01236547|7732767|FG001|NOT COMPLETED|Overall Study||1
6800784|NCT01236547|7732768|FG002|NOT COMPLETED|Overall Study||1
6800785|NCT01236547|7732769|FG003|NOT COMPLETED|Overall Study||6
6800786|NCT01236547|7732770|FG004|NOT COMPLETED|Overall Study||12
6800787|NCT01142388|7732785|FG000|STARTED|Overall Study||47
6800788|NCT01142388|7732786|FG001|STARTED|Overall Study||47
6800789|NCT01142388|7732785|FG000|Eligible|Overall Study||43
6800790|NCT01142388|7732786|FG001|Eligible|Overall Study||44
6800791|NCT01142388|7732785|FG000|Treated|Overall Study||40
6800792|NCT01142388|7732786|FG001|Treated|Overall Study||44
6800793|NCT01142388|7732785|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
6800794|NCT01142388|7732786|FG001|COMPLETED|Overall Study||0
6800795|NCT01142388|7732785|FG000|NOT COMPLETED|Overall Study||47
6800796|NCT01142388|7732786|FG001|NOT COMPLETED|Overall Study||47
6800797|NCT01134614|7732794|FG000|STARTED|Overall Study||123
6800798|NCT01134614|7732795|FG001|STARTED|Overall Study||122
6800799|NCT01134614|7732794|FG000|Treated|Overall Study||119
6800800|NCT01134614|7732795|FG001|Treated|Overall Study||121
6800801|NCT01134614|7732794|FG000|Treated and Toxicity Assessed|Overall Study||118
6800802|NCT01134614|7732795|FG001|Treated and Toxicity Assessed|Overall Study||120
6800803|NCT01134614|7732794|FG000|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
6800804|NCT01134614|7732795|FG001|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
6800805|NCT01134614|7732794|FG000|NOT COMPLETED|Overall Study||123
6800806|NCT01134614|7732795|FG001|NOT COMPLETED|Overall Study||122
6800807|NCT01062425|7732803|FG000|STARTED|Overall Study||55
6800808|NCT01062425|7732804|FG001|STARTED|Overall Study||103
6800809|NCT01062425|7732803|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
6800810|NCT01062425|7732804|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
6800811|NCT01062425|7732803|FG000|NOT COMPLETED|Overall Study||3
6800812|NCT01062425|7732804|FG001|NOT COMPLETED|Overall Study||6
6800813|NCT00980460|7732815|FG000|STARTED|Overall Study||8
6800814|NCT00980460|7732816|FG001|STARTED|Overall Study||51
6800815|NCT00980460|7732817|FG002|STARTED|Overall Study||105
6800816|NCT00980460|7732818|FG003|STARTED|Overall Study||32
6800817|NCT00980460|7732819|FG004|STARTED|Overall Study||40
6800818|NCT00980460|7732815|FG000|COMPLETED|Overall Study||8
6800819|NCT00980460|7732816|FG001|COMPLETED|Overall Study||47
6800820|NCT00980460|7732817|FG002|COMPLETED|Overall Study||70
6800821|NCT00980460|7732818|FG003|COMPLETED|Overall Study||14
6800822|NCT00980460|7732819|FG004|COMPLETED|Overall Study||24
6800823|NCT00980460|7732815|FG000|NOT COMPLETED|Overall Study||0
6800824|NCT00980460|7732816|FG001|NOT COMPLETED|Overall Study||4
6800825|NCT00980460|7732817|FG002|NOT COMPLETED|Overall Study||35
6800826|NCT00980460|7732818|FG003|NOT COMPLETED|Overall Study||18
6800827|NCT00980460|7732819|FG004|NOT COMPLETED|Overall Study||16
6800828|NCT00977574|7732841|FG000|STARTED|Overall Study||116
6800829|NCT00977574|7732842|FG001|STARTED|Overall Study||115
6800830|NCT00977574|7732843|FG002|STARTED|Overall Study||118
6800831|NCT00977574|7732841|FG000|COMPLETED|Overall Study||112
6800832|NCT00977574|7732842|FG001|COMPLETED|Overall Study||113
6800833|NCT00977574|7732843|FG002|COMPLETED|Overall Study||114
6800834|NCT00977574|7732841|FG000|NOT COMPLETED|Overall Study||4
6800835|NCT00977574|7732842|FG001|NOT COMPLETED|Overall Study||2
6800836|NCT00977574|7732843|FG002|NOT COMPLETED|Overall Study||4
6800837|NCT00843882|7732854|FG000|STARTED|Step 1||38
6800838|NCT00843882|7732855|FG001|STARTED|Step 1||103
6800839|NCT00843882|7732856|FG002|STARTED|Step 1||106
6800840|NCT00843882|7732854|FG000|Treated Patients|Step 1||36
6800841|NCT00843882|7732855|FG001|Treated Patients|Step 1||103
6800842|NCT00843882|7732856|FG002|Treated Patients|Step 1||106
6800843|NCT00843882|7732854|FG000|Evaluable Patients Included in Primary Analysis|Step 1||0
6800844|NCT00843882|7732855|FG001|Evaluable Patients Included in Primary Analysis|Step 1||96
6800845|NCT00843882|7732856|FG002|Evaluable Patients Included in Primary Analysis|Step 1||99
6800846|NCT00843882|7732854|FG000|Patients With Cytogenetic Response Data Available|Step 1||0
6800847|NCT00843882|7732855|FG001|Patients With Cytogenetic Response Data Available|Step 1||55
6800848|NCT00843882|7732856|FG002|Patients With Cytogenetic Response Data Available|Step 1||51
6800849|NCT00843882|7732854|FG000|COMPLETED|Step 1||6
6800850|NCT00843882|7732855|FG001|COMPLETED|Step 1||48
6800851|NCT00843882|7732856|FG002|COMPLETED|Step 1||41
6800852|NCT00843882|7732854|FG000|NOT COMPLETED|Step 1||32
6800853|NCT00843882|7732855|FG001|NOT COMPLETED|Step 1||55
6800854|NCT00843882|7732856|FG002|NOT COMPLETED|Step 1||65
6800855|NCT00843882|7732854|FG000|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|7
6800856|NCT00843882|7732855|FG001|STARTED|Step 2 (Cross-over to Arm B)|All patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|46
6800857|NCT00843882|7732856|FG002|STARTED|Step 2 (Cross-over to Arm B)|Only patients in Arm A that did not achieve major erythroid response (MER) were offered to receive combined treatment in Step 2.|0
6800858|NCT00843882|7732854|FG000|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||7
6800859|NCT00843882|7732855|FG001|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||37
6800860|NCT00843882|7732856|FG002|Evaluable Patients Included in Primary Analysis|Step 2 (Cross-over to Arm B)||0
6800861|NCT00843882|7732854|FG000|COMPLETED|Step 2 (Cross-over to Arm B)||3
6800862|NCT00843882|7732855|FG001|COMPLETED|Step 2 (Cross-over to Arm B)||20
6800863|NCT00843882|7732856|FG002|COMPLETED|Step 2 (Cross-over to Arm B)||0
6800864|NCT00843882|7732854|FG000|NOT COMPLETED|Step 2 (Cross-over to Arm B)||4
6800865|NCT00843882|7732855|FG001|NOT COMPLETED|Step 2 (Cross-over to Arm B)||26
6800866|NCT00843882|7732856|FG002|NOT COMPLETED|Step 2 (Cross-over to Arm B)||0
6800867|NCT00644228|7732871|FG000|STARTED|Randomization & Eligibility||261
6800868|NCT00644228|7732872|FG001|STARTED|Randomization & Eligibility||264
6800869|NCT00644228|7732871|FG000|Eligible and Analyzable|Randomization & Eligibility||229
6800870|NCT00644228|7732872|FG001|Eligible and Analyzable|Randomization & Eligibility||242
6800871|NCT00644228|7732871|FG000|COMPLETED|Randomization & Eligibility||229
6800872|NCT00644228|7732872|FG001|COMPLETED|Randomization & Eligibility||242
6800873|NCT00644228|7732871|FG000|NOT COMPLETED|Randomization & Eligibility||32
6800874|NCT00644228|7732872|FG001|NOT COMPLETED|Randomization & Eligibility||22
6800875|NCT00644228|7732871|FG000|STARTED|Induction Therapy||229
6800876|NCT00644228|7732872|FG001|STARTED|Induction Therapy||242
6800877|NCT00644228|7732871|FG000|COMPLETED|Induction Therapy||146
6800878|NCT00644228|7732872|FG001|COMPLETED|Induction Therapy||137
6800879|NCT00644228|7732871|FG000|NOT COMPLETED|Induction Therapy||83
6800880|NCT00644228|7732872|FG001|NOT COMPLETED|Induction Therapy||105
6800881|NCT00644228|7732871|FG000|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
6800882|NCT00644228|7732872|FG001|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
6800883|NCT00644228|7732871|FG000|COMPLETED|Maintenance||0
6800884|NCT00644228|7732872|FG001|COMPLETED|Maintenance||0
6800885|NCT00644228|7732871|FG000|NOT COMPLETED|Maintenance||143
6800886|NCT00644228|7732872|FG001|NOT COMPLETED|Maintenance||135
6800887|NCT00602641|7732880|FG000|STARTED|Overall Study||154
6800888|NCT00602641|7732881|FG001|STARTED|Overall Study||152
6800889|NCT00602641|7732880|FG000|Started Protocol Therapy|Overall Study||148
6800890|NCT00602641|7732881|FG001|Started Protocol Therapy|Overall Study||150
6800891|NCT00602641|7732880|FG000|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
6800892|NCT00602641|7732881|FG001|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
6800893|NCT00602641|7732880|FG000|NOT COMPLETED|Overall Study||154
6800894|NCT00602641|7732881|FG001|NOT COMPLETED|Overall Study||152
6800895|NCT00559936|7732887|FG000|STARTED|Overall Study||24
6800896|NCT00559936|7732887|FG000|COMPLETED|Overall Study||20
6800897|NCT00559936|7732887|FG000|NOT COMPLETED|Overall Study||4
6800898|NCT00504582|7732894|FG000|STARTED|Overall Study||47
6800899|NCT00504582|7732895|FG001|STARTED|Overall Study||45
6800900|NCT00504582|7732896|FG002|STARTED|Overall Study||20
6800901|NCT00504582|7732894|FG000|COMPLETED|Overall Study||46
6800902|NCT00504582|7732895|FG001|COMPLETED|Overall Study||45
6800903|NCT00504582|7732896|FG002|COMPLETED|Overall Study||20
6800904|NCT00504582|7732894|FG000|NOT COMPLETED|Overall Study||1
6800905|NCT00504582|7732895|FG001|NOT COMPLETED|Overall Study||0
6800906|NCT00504582|7732896|FG002|NOT COMPLETED|Overall Study||0
6800907|NCT00433511|7732907|FG000|STARTED|Step 1||1000
6800908|NCT00433511|7732908|FG001|STARTED|Step 1||1986
6800909|NCT00433511|7732909|FG002|STARTED|Step 1||2008
6800910|NCT00433511|7732907|FG000|Patients Who Received Treatment|Step 1||972
6800911|NCT00433511|7732908|FG001|Patients Who Received Treatment|Step 1||1922
6800912|NCT00433511|7732909|FG002|Patients Who Received Treatment|Step 1||1942
6800913|NCT00433511|7732907|FG000|Patients in Genetic Ancestry Analysis|Step 1||575
6800914|NCT00433511|7732908|FG001|Patients in Genetic Ancestry Analysis|Step 1||1126
6800915|NCT00433511|7732909|FG002|Patients in Genetic Ancestry Analysis|Step 1||1158
6800916|NCT00433511|7732907|FG000|COMPLETED|Step 1||864
6800917|NCT00433511|7732908|FG001|COMPLETED|Step 1||1601
6800918|NCT00433511|7732909|FG002|COMPLETED|Step 1||1618
6800919|NCT00433511|7732907|FG000|NOT COMPLETED|Step 1||136
6800920|NCT00433511|7732908|FG001|NOT COMPLETED|Step 1||385
6800921|NCT00433511|7732909|FG002|NOT COMPLETED|Step 1||390
6800922|NCT00433511|7732907|FG000|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
6800923|NCT00433511|7732908|FG001|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|0
6800924|NCT00433511|7732909|FG002|STARTED|Step 2 (Arm D)|Only Arm C patients at Step 1 who did not end protocol therapy early were eligible for Step 2, Arm D|1316
6800925|NCT00433511|7732907|FG000|Patients Who Received Treatment|Step 2 (Arm D)||0
6800926|NCT00433511|7732908|FG001|Patients Who Received Treatment|Step 2 (Arm D)||0
6800927|NCT00433511|7732909|FG002|Patients Who Received Treatment|Step 2 (Arm D)||1168
6800928|NCT00433511|7732907|FG000|COMPLETED|Step 2 (Arm D)||0
6800929|NCT00433511|7732908|FG001|COMPLETED|Step 2 (Arm D)||0
6800930|NCT00433511|7732909|FG002|COMPLETED|Step 2 (Arm D)||825
6800931|NCT00433511|7732907|FG000|NOT COMPLETED|Step 2 (Arm D)||0
6800932|NCT00433511|7732908|FG001|NOT COMPLETED|Step 2 (Arm D)||0
6800933|NCT00433511|7732909|FG002|NOT COMPLETED|Step 2 (Arm D)||491
6800934|NCT00408005|7732922|FG000|STARTED|Induction||1596
6800935|NCT00408005|7732923|FG001|STARTED|Induction||299
6800936|NCT00408005|7732924|FG002|STARTED|Induction||0
6800937|NCT00408005|7732925|FG003|STARTED|Induction||0
6800938|NCT00408005|7732926|FG004|STARTED|Induction||0
6800939|NCT00408005|7732927|FG005|STARTED|Induction||0
6800940|NCT00408005|7732928|FG006|STARTED|Induction||0
6800941|NCT00408005|7732929|FG007|STARTED|Induction||0
6800942|NCT00408005|7732922|FG000|COMPLETED|Induction||1189
6800943|NCT00408005|7732923|FG001|COMPLETED|Induction||205
6800944|NCT00408005|7732924|FG002|COMPLETED|Induction||0
6800945|NCT00408005|7732925|FG003|COMPLETED|Induction||0
6800946|NCT00408005|7732926|FG004|COMPLETED|Induction||0
6800947|NCT00408005|7732927|FG005|COMPLETED|Induction||0
6800948|NCT00408005|7732928|FG006|COMPLETED|Induction||0
6800949|NCT00408005|7732929|FG007|COMPLETED|Induction||0
6800950|NCT00408005|7732922|FG000|NOT COMPLETED|Induction||407
6800951|NCT00408005|7732923|FG001|NOT COMPLETED|Induction||94
6800952|NCT00408005|7732924|FG002|NOT COMPLETED|Induction||0
6800953|NCT00408005|7732925|FG003|NOT COMPLETED|Induction||0
6800954|NCT00408005|7732926|FG004|NOT COMPLETED|Induction||0
6800955|NCT00408005|7732927|FG005|NOT COMPLETED|Induction||0
6800956|NCT00408005|7732928|FG006|NOT COMPLETED|Induction||0
6800957|NCT00408005|7732929|FG007|NOT COMPLETED|Induction||0
6800958|NCT00408005|7732922|FG000|STARTED|Post Induction Therapy by Tx Assignment||0
6800959|NCT00408005|7732923|FG001|STARTED|Post Induction Therapy by Tx Assignment||0
6800960|NCT00408005|7732924|FG002|STARTED|Post Induction Therapy by Tx Assignment||372
6800961|NCT00408005|7732925|FG003|STARTED|Post Induction Therapy by Tx Assignment||147
6800962|NCT00408005|7732926|FG004|STARTED|Post Induction Therapy by Tx Assignment||451
6800963|NCT00408005|7732927|FG005|STARTED|Post Induction Therapy by Tx Assignment||219
6800964|NCT00408005|7732928|FG006|STARTED|Post Induction Therapy by Tx Assignment||143
6800965|NCT00408005|7732929|FG007|STARTED|Post Induction Therapy by Tx Assignment||62
6800966|NCT00408005|7732922|FG000|Low Risk|Post Induction Therapy by Tx Assignment||0
6800967|NCT00408005|7732923|FG001|Low Risk|Post Induction Therapy by Tx Assignment||0
6800968|NCT00408005|7732924|FG002|Low Risk|Post Induction Therapy by Tx Assignment||217
6800969|NCT00408005|7732925|FG003|Low Risk|Post Induction Therapy by Tx Assignment||0
6800970|NCT00408005|7732926|FG004|Low Risk|Post Induction Therapy by Tx Assignment||55
6800971|NCT00408005|7732927|FG005|Low Risk|Post Induction Therapy by Tx Assignment||0
6800972|NCT00408005|7732928|FG006|Low Risk|Post Induction Therapy by Tx Assignment||0
6800973|NCT00408005|7732929|FG007|Low Risk|Post Induction Therapy by Tx Assignment||0
6800974|NCT00408005|7732922|FG000|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
6800975|NCT00408005|7732923|FG001|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
6800976|NCT00408005|7732924|FG002|Intermediate Risk|Post Induction Therapy by Tx Assignment||99
6800977|NCT00408005|7732925|FG003|Intermediate Risk|Post Induction Therapy by Tx Assignment||95
6800978|NCT00408005|7732926|FG004|Intermediate Risk|Post Induction Therapy by Tx Assignment||257
6800979|NCT00408005|7732927|FG005|Intermediate Risk|Post Induction Therapy by Tx Assignment||93
6800980|NCT00408005|7732928|FG006|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
6800981|NCT00408005|7732929|FG007|Intermediate Risk|Post Induction Therapy by Tx Assignment||0
6800982|NCT00408005|7732922|FG000|High Risk|Post Induction Therapy by Tx Assignment||0
6564256|NCT01810380|7486982|FG002|STARTED|Overall Study||154
6564257|NCT01810380|7486980|FG000|Treated|Overall Study||161
6564258|NCT01810380|7486981|FG001|Treated|Overall Study||150
6800983|NCT00408005|7732923|FG001|High Risk|Post Induction Therapy by Tx Assignment||0
6800984|NCT00408005|7732924|FG002|High Risk|Post Induction Therapy by Tx Assignment||56
6800985|NCT00408005|7732925|FG003|High Risk|Post Induction Therapy by Tx Assignment||52
6800986|NCT00408005|7732926|FG004|High Risk|Post Induction Therapy by Tx Assignment||55
6800987|NCT00408005|7732927|FG005|High Risk|Post Induction Therapy by Tx Assignment||52
6800988|NCT00408005|7732928|FG006|High Risk|Post Induction Therapy by Tx Assignment||0
6800989|NCT00408005|7732929|FG007|High Risk|Post Induction Therapy by Tx Assignment||0
6800990|NCT00408005|7732922|FG000|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6800991|NCT00408005|7732923|FG001|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6800992|NCT00408005|7732924|FG002|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6800993|NCT00408005|7732925|FG003|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6800994|NCT00408005|7732926|FG004|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||84
6800995|NCT00408005|7732927|FG005|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||31
6800996|NCT00408005|7732928|FG006|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6800997|NCT00408005|7732929|FG007|CNS 3 and/or Testicular Disease|Post Induction Therapy by Tx Assignment||0
6800998|NCT00408005|7732922|FG000|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6800999|NCT00408005|7732923|FG001|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6801000|NCT00408005|7732924|FG002|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6801001|NCT00408005|7732925|FG003|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6801002|NCT00408005|7732926|FG004|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6801003|NCT00408005|7732927|FG005|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||43
6801004|NCT00408005|7732928|FG006|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6801005|NCT00408005|7732929|FG007|T-ALL M3 Marrow End of Induction|Post Induction Therapy by Tx Assignment||0
6801006|NCT00408005|7732922|FG000|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6801007|NCT00408005|7732923|FG001|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6801008|NCT00408005|7732924|FG002|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6801009|NCT00408005|7732925|FG003|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6801010|NCT00408005|7732926|FG004|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6801011|NCT00408005|7732927|FG005|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6801012|NCT00408005|7732928|FG006|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||82
6801013|NCT00408005|7732929|FG007|T-LLy Standard Risk|Post Induction Therapy by Tx Assignment||0
6801014|NCT00408005|7732922|FG000|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6801015|NCT00408005|7732923|FG001|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6801016|NCT00408005|7732924|FG002|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6801017|NCT00408005|7732925|FG003|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6564259|NCT01810380|7486982|FG002|Treated|Overall Study||153
6564260|NCT01810380|7486980|FG000|COMPLETED|Overall Study||108
6801018|NCT00408005|7732926|FG004|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6801019|NCT00408005|7732927|FG005|T-LLy High Risk|Post Induction Therapy by Tx Assignment||0
6801020|NCT00408005|7732928|FG006|T-LLy High Risk|Post Induction Therapy by Tx Assignment||61
6801021|NCT00408005|7732929|FG007|T-LLy High Risk|Post Induction Therapy by Tx Assignment||60
6801022|NCT00408005|7732922|FG000|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6801023|NCT00408005|7732923|FG001|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6801024|NCT00408005|7732924|FG002|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6801025|NCT00408005|7732925|FG003|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6801026|NCT00408005|7732926|FG004|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6801027|NCT00408005|7732927|FG005|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6801028|NCT00408005|7732928|FG006|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||0
6380682|NCT00780559|7291529|FG001|STARTED|Overall Study||40
6380683|NCT00780559|7291528|FG000|COMPLETED|Overall Study||29
6380684|NCT00780559|7291529|FG001|COMPLETED|Overall Study||33
6380685|NCT00780559|7291528|FG000|NOT COMPLETED|Overall Study||3
6380686|NCT00780559|7291529|FG001|NOT COMPLETED|Overall Study||7
6380687|NCT00780572|7291539|FG000|STARTED|Overall Study||297
6380688|NCT00780572|7291540|FG001|STARTED|Overall Study||298
6380689|NCT00780572|7291539|FG000|COMPLETED|Overall Study||297
6380690|NCT00780572|7291540|FG001|COMPLETED|Overall Study||298
6380691|NCT00780572|7291539|FG000|NOT COMPLETED|Overall Study||0
6380692|NCT00780572|7291540|FG001|NOT COMPLETED|Overall Study||0
6380693|NCT00780676|7291551|FG000|STARTED|Overall Study||9
6380694|NCT00780676|7291552|FG001|STARTED|Overall Study||8
6380695|NCT00780676|7291553|FG002|STARTED|Overall Study||13
6380696|NCT00780676|7291554|FG003|STARTED|Overall Study||0
6380697|NCT00780676|7291555|FG004|STARTED|Overall Study||0
6380698|NCT00780676|7291551|FG000|COMPLETED|Overall Study||9
6380699|NCT00780676|7291552|FG001|COMPLETED|Overall Study||8
6380700|NCT00780676|7291553|FG002|COMPLETED|Overall Study||13
6380701|NCT00780676|7291554|FG003|COMPLETED|Overall Study||0
6380702|NCT00780676|7291555|FG004|COMPLETED|Overall Study||0
6380703|NCT00780676|7291551|FG000|NOT COMPLETED|Overall Study||0
6502558|NCT01435798|7421283|FG000|NOT COMPLETED|Overall Study||1
6502559|NCT01435824|7421293|FG000|STARTED|First Intervention||8
6502560|NCT01435824|7421294|FG001|STARTED|First Intervention||8
6502561|NCT01435824|7421293|FG000|COMPLETED|First Intervention||8
6502562|NCT01435824|7421294|FG001|COMPLETED|First Intervention||8
6502563|NCT01435824|7421293|FG000|NOT COMPLETED|First Intervention||0
6502564|NCT01435824|7421294|FG001|NOT COMPLETED|First Intervention||0
6502565|NCT01435824|7421293|FG000|STARTED|Washout of 1-2 Weeks||8
6380704|NCT00780676|7291552|FG001|NOT COMPLETED|Overall Study||0
6380705|NCT00780676|7291553|FG002|NOT COMPLETED|Overall Study||0
6380706|NCT00780676|7291554|FG003|NOT COMPLETED|Overall Study||0
6380707|NCT00780676|7291555|FG004|NOT COMPLETED|Overall Study||0
6380708|NCT00780715|7291565|FG000|STARTED|Overall Study||6
6380709|NCT00780715|7291566|FG001|STARTED|Overall Study||6
6502566|NCT01435824|7421294|FG001|STARTED|Washout of 1-2 Weeks||8
6502567|NCT01435824|7421293|FG000|COMPLETED|Washout of 1-2 Weeks||8
6502568|NCT01435824|7421294|FG001|COMPLETED|Washout of 1-2 Weeks||8
6801029|NCT00408005|7732929|FG007|T-LLy Induction Failure|Post Induction Therapy by Tx Assignment||2
6801030|NCT00408005|7732922|FG000|COMPLETED|Post Induction Therapy by Tx Assignment||0
6801031|NCT00408005|7732923|FG001|COMPLETED|Post Induction Therapy by Tx Assignment||0
6801032|NCT00408005|7732924|FG002|COMPLETED|Post Induction Therapy by Tx Assignment||287
6801033|NCT00408005|7732925|FG003|COMPLETED|Post Induction Therapy by Tx Assignment||103
6801034|NCT00408005|7732926|FG004|COMPLETED|Post Induction Therapy by Tx Assignment||319
6801035|NCT00408005|7732927|FG005|COMPLETED|Post Induction Therapy by Tx Assignment||118
6801036|NCT00408005|7732928|FG006|COMPLETED|Post Induction Therapy by Tx Assignment||115
6801037|NCT00408005|7732929|FG007|COMPLETED|Post Induction Therapy by Tx Assignment||48
6801038|NCT00408005|7732922|FG000|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
6801039|NCT00408005|7732923|FG001|NOT COMPLETED|Post Induction Therapy by Tx Assignment||0
6801040|NCT00408005|7732924|FG002|NOT COMPLETED|Post Induction Therapy by Tx Assignment||85
6801041|NCT00408005|7732925|FG003|NOT COMPLETED|Post Induction Therapy by Tx Assignment||44
6801042|NCT00408005|7732926|FG004|NOT COMPLETED|Post Induction Therapy by Tx Assignment||132
6801043|NCT00408005|7732927|FG005|NOT COMPLETED|Post Induction Therapy by Tx Assignment||101
6801044|NCT00408005|7732928|FG006|NOT COMPLETED|Post Induction Therapy by Tx Assignment||28
6801045|NCT00408005|7732929|FG007|NOT COMPLETED|Post Induction Therapy by Tx Assignment||14
6801046|NCT00098475|7732951|FG000|STARTED|Step 1||223
6801047|NCT00098475|7732952|FG001|STARTED|Step 1||222
6801048|NCT00098475|7732953|FG002|STARTED|Step 1||4
6801049|NCT00098475|7732954|FG003|STARTED|Step 1||3
6801050|NCT00098475|7732951|FG000|Treated|Step 1||223
6801051|NCT00098475|7732952|FG001|Treated|Step 1||220
6801052|NCT00098475|7732953|FG002|Treated|Step 1||4
6801053|NCT00098475|7732954|FG003|Treated|Step 1||3
6801054|NCT00098475|7732951|FG000|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
6801055|NCT00098475|7732952|FG001|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
6801056|NCT00098475|7732953|FG002|Eligible|Step 1||4
6801057|NCT00098475|7732954|FG003|Eligible|Step 1||3
6801058|NCT00098475|7732951|FG000|COMPLETED|Step 1||52
6801059|NCT00098475|7732952|FG001|COMPLETED|Step 1||49
6801060|NCT00098475|7732953|FG002|COMPLETED|Step 1||0
6801061|NCT00098475|7732954|FG003|COMPLETED|Step 1||0
6801062|NCT00098475|7732951|FG000|NOT COMPLETED|Step 1||171
6801063|NCT00098475|7732952|FG001|NOT COMPLETED|Step 1||173
6801064|NCT00098475|7732953|FG002|NOT COMPLETED|Step 1||4
6801065|NCT00098475|7732954|FG003|NOT COMPLETED|Step 1||3
6801066|NCT00098475|7732951|FG000|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
6801067|NCT00098475|7732952|FG001|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
6801068|NCT00098475|7732953|FG002|STARTED|Step 2||0
6801069|NCT00098475|7732954|FG003|STARTED|Step 2||0
6801070|NCT00098475|7732951|FG000|Treated|Step 2||4
6801071|NCT00098475|7732952|FG001|Treated|Step 2||14
6801072|NCT00098475|7732953|FG002|Treated|Step 2||0
6801073|NCT00098475|7732954|FG003|Treated|Step 2||0
6801074|NCT00098475|7732951|FG000|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
6801075|NCT00098475|7732952|FG001|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
6801076|NCT00098475|7732953|FG002|Eligible|Step 2||0
6801077|NCT00098475|7732954|FG003|Eligible|Step 2||0
6801078|NCT00098475|7732951|FG000|COMPLETED|Step 2||0
6801079|NCT00098475|7732952|FG001|COMPLETED|Step 2||5
6801080|NCT00098475|7732953|FG002|COMPLETED|Step 2||0
6801081|NCT00098475|7732954|FG003|COMPLETED|Step 2||0
6801082|NCT00098475|7732951|FG000|NOT COMPLETED|Step 2||5
6801083|NCT00098475|7732952|FG001|NOT COMPLETED|Step 2||10
6801084|NCT00098475|7732953|FG002|NOT COMPLETED|Step 2||0
6801085|NCT00098475|7732954|FG003|NOT COMPLETED|Step 2||0
6801086|NCT00026312|7732966|FG000|STARTED|Overall Study||116
6801087|NCT00026312|7732967|FG001|STARTED|Overall Study||1333
6801088|NCT00026312|7732966|FG000|COMPLETED|Overall Study||82
6801089|NCT00026312|7732967|FG001|COMPLETED|Overall Study||1064
6801090|NCT00026312|7732966|FG000|NOT COMPLETED|Overall Study||34
6801091|NCT00026312|7732967|FG001|NOT COMPLETED|Overall Study||269
6801092|NCT02257918|7732980|FG000|STARTED|Overall Study||72
6801093|NCT02257918|7732981|FG001|STARTED|Overall Study||67
6801094|NCT02257918|7732982|FG002|STARTED|Overall Study||41
6801095|NCT02257918|7732980|FG000|Test of Cure Visit|Overall Study||72
6801096|NCT02257918|7732981|FG001|Test of Cure Visit|Overall Study||67
6801097|NCT02257918|7732982|FG002|Test of Cure Visit|Overall Study||40
6801098|NCT02257918|7732980|FG000|COMPLETED|Overall Study||68
6801099|NCT02257918|7732981|FG001|COMPLETED|Overall Study||66
6801100|NCT02257918|7732982|FG002|COMPLETED|Overall Study||39
6801101|NCT02257918|7732980|FG000|NOT COMPLETED|Overall Study||4
6801102|NCT02257918|7732981|FG001|NOT COMPLETED|Overall Study||1
6801103|NCT02257918|7732982|FG002|NOT COMPLETED|Overall Study||2
6801104|NCT02258542|7732994|FG000|STARTED|Overall Study||953
6801105|NCT02258542|7732995|FG001|STARTED|Overall Study||973
6801106|NCT02258542|7732996|FG002|STARTED|Overall Study||100
6801107|NCT02258542|7732997|FG003|STARTED|Overall Study||97
6801108|NCT02258542|7732994|FG000|Treated|Overall Study||953
6801109|NCT02258542|7732995|FG001|Treated|Overall Study||971
6801110|NCT02258542|7732996|FG002|Treated|Overall Study||100
6801111|NCT02258542|7732997|FG003|Treated|Overall Study||97
6801112|NCT02258542|7732994|FG000|Adolescents Only|Overall Study||25
6801113|NCT02258542|7732995|FG001|Adolescents Only|Overall Study||61
6801114|NCT02258542|7732996|FG002|Adolescents Only|Overall Study||0
6801115|NCT02258542|7732997|FG003|Adolescents Only|Overall Study||0
6801116|NCT02258542|7732994|FG000|COMPLETED|Overall Study|170 enrolled into study MELTEMI|911
6801117|NCT02258542|7732995|FG001|COMPLETED|Overall Study|178 enrolled into study MELTEMI|924
6801118|NCT02258542|7732996|FG002|COMPLETED|Overall Study|51 enrolled into study MELTEMI|92
6801119|NCT02258542|7732997|FG003|COMPLETED|Overall Study|48 enrolled into study MELTEMI|92
6801120|NCT02258542|7732994|FG000|NOT COMPLETED|Overall Study||42
6801121|NCT02258542|7732995|FG001|NOT COMPLETED|Overall Study||49
6801122|NCT02258542|7732996|FG002|NOT COMPLETED|Overall Study||8
6801123|NCT02258542|7732997|FG003|NOT COMPLETED|Overall Study||5
6801124|NCT02290431|7733025|FG000|STARTED|Overall Study||31
6801125|NCT02290431|7733025|FG000|Subjects. Discont. Prematurely|Overall Study||27
6801126|NCT02290431|7733025|FG000|Subjects Completed Study Per Protocol|Overall Study||8
6801127|NCT02290431|7733025|FG000|Subjs. Ntered Post-treatment Eval. Phase|Overall Study||31
6801128|NCT02290431|7733025|FG000|Subjects Entered Survival f/u Phase|Overall Study||24
6801129|NCT02290431|7733025|FG000|Entered Treatment Phase 2|Overall Study||17
6801130|NCT02290431|7733025|FG000|COMPLETED|Overall Study||4
6801131|NCT02290431|7733025|FG000|NOT COMPLETED|Overall Study||27
6801132|NCT02314923|7733039|FG000|STARTED|Overall Study||64
6801133|NCT02314923|7733040|FG001|STARTED|Overall Study||64
6801134|NCT02314923|7733041|FG002|STARTED|Overall Study||64
6801135|NCT02314923|7733042|FG003|STARTED|Overall Study||64
6801136|NCT02314923|7733043|FG004|STARTED|Overall Study||74
6801137|NCT02314923|7733044|FG005|STARTED|Overall Study||20
6801138|NCT02314923|7733045|FG006|STARTED|Overall Study||48
6801139|NCT02314923|7733046|FG007|STARTED|Overall Study||47
6801140|NCT02314923|7733047|FG008|STARTED|Overall Study||48
6801141|NCT02314923|7733048|FG009|STARTED|Overall Study||20
6801142|NCT02314923|7733039|FG000|Treated|Overall Study||64
6801143|NCT02314923|7733040|FG001|Treated|Overall Study||64
6801144|NCT02314923|7733041|FG002|Treated|Overall Study||64
6801145|NCT02314923|7733042|FG003|Treated|Overall Study||64
6801146|NCT02314923|7733043|FG004|Treated|Overall Study||74
6801147|NCT02314923|7733044|FG005|Treated|Overall Study||20
6801148|NCT02314923|7733045|FG006|Treated|Overall Study|One participant did not receive vaccination due to missing blood sample at randomization.|47
6801149|NCT02314923|7733046|FG007|Treated|Overall Study||47
6801150|NCT02314923|7733047|FG008|Treated|Overall Study||48
6801151|NCT02314923|7733048|FG009|Treated|Overall Study||20
6801152|NCT02314923|7733039|FG000|COMPLETED|Overall Study||61
6801153|NCT02314923|7733040|FG001|COMPLETED|Overall Study||60
6801154|NCT02314923|7733041|FG002|COMPLETED|Overall Study||62
6801155|NCT02314923|7733042|FG003|COMPLETED|Overall Study||63
6801156|NCT02314923|7733043|FG004|COMPLETED|Overall Study||73
6801157|NCT02314923|7733044|FG005|COMPLETED|Overall Study||19
6801158|NCT02314923|7733045|FG006|COMPLETED|Overall Study||43
6801159|NCT02314923|7733046|FG007|COMPLETED|Overall Study||42
6801160|NCT02314923|7733047|FG008|COMPLETED|Overall Study||46
6801161|NCT02314923|7733048|FG009|COMPLETED|Overall Study||20
6801162|NCT02314923|7733039|FG000|NOT COMPLETED|Overall Study||3
6801163|NCT02314923|7733040|FG001|NOT COMPLETED|Overall Study||4
6801164|NCT02314923|7733041|FG002|NOT COMPLETED|Overall Study||2
6801165|NCT02314923|7733042|FG003|NOT COMPLETED|Overall Study||1
6801166|NCT02314923|7733043|FG004|NOT COMPLETED|Overall Study||1
6801167|NCT02314923|7733044|FG005|NOT COMPLETED|Overall Study||1
6801168|NCT02314923|7733045|FG006|NOT COMPLETED|Overall Study||5
6801169|NCT02314923|7733046|FG007|NOT COMPLETED|Overall Study||5
6801170|NCT02314923|7733047|FG008|NOT COMPLETED|Overall Study||2
6801171|NCT02314923|7733048|FG009|NOT COMPLETED|Overall Study||0
6801172|NCT04821362|7733074|FG000|STARTED|Overall Study||90
6801173|NCT04821362|7733075|FG001|STARTED|Overall Study||90
6801174|NCT04821362|7733076|FG002|STARTED|Overall Study||90
6801175|NCT04821362|7733074|FG000|COMPLETED|Overall Study||90
6801176|NCT04821362|7733075|FG001|COMPLETED|Overall Study||90
6801177|NCT04821362|7733076|FG002|COMPLETED|Overall Study||90
6801178|NCT04821362|7733074|FG000|NOT COMPLETED|Overall Study||0
6801179|NCT04821362|7733075|FG001|NOT COMPLETED|Overall Study||0
6801180|NCT04821362|7733076|FG002|NOT COMPLETED|Overall Study||0
6380710|NCT00780715|7291567|FG002|STARTED|Overall Study||6
6380711|NCT00780715|7291568|FG003|STARTED|Overall Study||11
6801181|NCT04524507|7733089|FG000|STARTED|Overall Study||15
6801182|NCT04524507|7733090|FG001|STARTED|Overall Study||41
6801183|NCT04524507|7733089|FG000|Received Intervention|Overall Study||14
6801184|NCT04524507|7733090|FG001|Received Intervention|Overall Study||41
6801185|NCT04524507|7733089|FG000|Hospital Discharge|Overall Study||13
6380712|NCT00780715|7291565|FG000|COMPLETED|Overall Study||6
6380713|NCT00780715|7291566|FG001|COMPLETED|Overall Study||6
6380714|NCT00780715|7291567|FG002|COMPLETED|Overall Study||6
6801186|NCT04524507|7733090|FG001|Hospital Discharge|Overall Study||27
6801187|NCT04524507|7733089|FG000|COMPLETED|Overall Study||9
6801188|NCT04524507|7733090|FG001|COMPLETED|Overall Study||18
6801189|NCT04524507|7733089|FG000|NOT COMPLETED|Overall Study||6
6801190|NCT04524507|7733090|FG001|NOT COMPLETED|Overall Study||23
6801191|NCT04382924|7733099|FG000|STARTED|Overall Study||52
6801192|NCT04382924|7733100|FG001|STARTED|Overall Study||56
6801193|NCT04382924|7733101|FG002|STARTED|Overall Study||60
6801194|NCT04382924|7733099|FG000|COMPLETED|Overall Study||44
6801195|NCT04382924|7733100|FG001|COMPLETED|Overall Study||46
6801196|NCT04382924|7733101|FG002|COMPLETED|Overall Study||48
6801197|NCT04382924|7733099|FG000|NOT COMPLETED|Overall Study||8
6801198|NCT04382924|7733100|FG001|NOT COMPLETED|Overall Study||10
6801199|NCT04382924|7733101|FG002|NOT COMPLETED|Overall Study||12
6801200|NCT04166214|7733111|FG000|STARTED|Overall Study||12
6801201|NCT04166214|7733112|FG001|STARTED|Overall Study||39
6801202|NCT04166214|7733111|FG000|COMPLETED|Overall Study||12
6801203|NCT04166214|7733112|FG001|COMPLETED|Overall Study||39
6801204|NCT04166214|7733111|FG000|NOT COMPLETED|Overall Study||0
6801205|NCT04166214|7733112|FG001|NOT COMPLETED|Overall Study||0
6801206|NCT03947788|7733120|FG000|STARTED|Overall Study||69
6801207|NCT03947788|7733121|FG001|STARTED|Overall Study||74
6502569|NCT01435824|7421293|FG000|NOT COMPLETED|Washout of 1-2 Weeks||0
6502570|NCT01435824|7421294|FG001|NOT COMPLETED|Washout of 1-2 Weeks||0
6502571|NCT01435824|7421293|FG000|STARTED|Second Intervention||8
6502572|NCT01435824|7421294|FG001|STARTED|Second Intervention||8
6564261|NCT01810380|7486981|FG001|COMPLETED|Overall Study||113
6801208|NCT03947788|7733120|FG000|COMPLETED|Overall Study||69
6801209|NCT03947788|7733121|FG001|COMPLETED|Overall Study||74
6801210|NCT03947788|7733120|FG000|NOT COMPLETED|Overall Study||0
6801211|NCT03947788|7733121|FG001|NOT COMPLETED|Overall Study||0
6801212|NCT03842436|7733132|FG000|STARTED|Overall Study||16
6801213|NCT03842436|7733132|FG000|COMPLETED|Overall Study||15
6801214|NCT03842436|7733132|FG000|NOT COMPLETED|Overall Study||1
6502573|NCT01435824|7421293|FG000|COMPLETED|Second Intervention||8
6502574|NCT01435824|7421294|FG001|COMPLETED|Second Intervention||8
6502575|NCT01435824|7421293|FG000|NOT COMPLETED|Second Intervention||0
6801215|NCT03646162|7733139|FG000|STARTED|Overall Study||31
6801216|NCT03646162|7733140|FG001|STARTED|Overall Study||31
6801217|NCT03646162|7733141|FG002|STARTED|Overall Study||31
6801218|NCT03646162|7733139|FG000|COMPLETED|Overall Study||26
6801219|NCT03646162|7733140|FG001|COMPLETED|Overall Study||27
6801220|NCT03646162|7733141|FG002|COMPLETED|Overall Study||30
6801221|NCT03646162|7733139|FG000|NOT COMPLETED|Overall Study||5
6801222|NCT03646162|7733140|FG001|NOT COMPLETED|Overall Study||4
6801223|NCT03646162|7733141|FG002|NOT COMPLETED|Overall Study||1
6801224|NCT03462030|7733153|FG000|STARTED|Overall Study||15
6801225|NCT03462030|7733154|FG001|STARTED|Overall Study||15
6801226|NCT03462030|7733153|FG000|End of Build-up|Overall Study||14
6801227|NCT03462030|7733154|FG001|End of Build-up|Overall Study||14
6801228|NCT03462030|7733153|FG000|Month 12 Food Challenge|Overall Study||14
6801229|NCT03462030|7733154|FG001|Month 12 Food Challenge|Overall Study||14
6801230|NCT03462030|7733153|FG000|COMPLETED|Overall Study||14
6801231|NCT03462030|7733154|FG001|COMPLETED|Overall Study||14
6801232|NCT03462030|7733153|FG000|NOT COMPLETED|Overall Study||1
6801233|NCT03462030|7733154|FG001|NOT COMPLETED|Overall Study||1
6801234|NCT03446768|7733162|FG000|STARTED|Overall Study||141
6801235|NCT03446768|7733163|FG001|STARTED|Overall Study||153
6801236|NCT03446768|7733162|FG000|COMPLETED|Overall Study||141
6801237|NCT03446768|7733163|FG001|COMPLETED|Overall Study||152
6801238|NCT03446768|7733162|FG000|NOT COMPLETED|Overall Study||0
6801239|NCT03446768|7733163|FG001|NOT COMPLETED|Overall Study||1
6801240|NCT03405714|7733173|FG000|STARTED|Overall Study||12
6801241|NCT03405714|7733174|FG001|STARTED|Overall Study||12
6801242|NCT03405714|7733175|FG002|STARTED|Overall Study||13
6801243|NCT03405714|7733176|FG003|STARTED|Overall Study||13
6801244|NCT03405714|7733173|FG000|COMPLETED|Overall Study||12
6801245|NCT03405714|7733174|FG001|COMPLETED|Overall Study||12
6801246|NCT03405714|7733175|FG002|COMPLETED|Overall Study||13
6801247|NCT03405714|7733176|FG003|COMPLETED|Overall Study||13
6801248|NCT03405714|7733173|FG000|NOT COMPLETED|Overall Study||0
6801249|NCT03405714|7733174|FG001|NOT COMPLETED|Overall Study||0
6801250|NCT03405714|7733175|FG002|NOT COMPLETED|Overall Study||0
6801251|NCT03405714|7733176|FG003|NOT COMPLETED|Overall Study||0
6801252|NCT03348514|7733200|FG000|STARTED|Overall Study||1
6801253|NCT03348514|7733201|FG001|STARTED|Overall Study||1
6801254|NCT03348514|7733202|FG002|STARTED|Overall Study||1
6801255|NCT03348514|7733203|FG003|STARTED|Overall Study||1
6801256|NCT03348514|7733204|FG004|STARTED|Overall Study||3
6801257|NCT03348514|7733205|FG005|STARTED|Overall Study||4
6801258|NCT03348514|7733206|FG006|STARTED|Overall Study||6
6801259|NCT03348514|7733207|FG007|STARTED|Overall Study||2
6801260|NCT03348514|7733200|FG000|COMPLETED|Overall Study||1
6801261|NCT03348514|7733201|FG001|COMPLETED|Overall Study||1
6801262|NCT03348514|7733202|FG002|COMPLETED|Overall Study||1
6801263|NCT03348514|7733203|FG003|COMPLETED|Overall Study||1
6801264|NCT03348514|7733204|FG004|COMPLETED|Overall Study||3
6801265|NCT03348514|7733205|FG005|COMPLETED|Overall Study||4
6801266|NCT03348514|7733206|FG006|COMPLETED|Overall Study||6
6380715|NCT00780715|7291568|FG003|COMPLETED|Overall Study||11
6380716|NCT00780715|7291565|FG000|NOT COMPLETED|Overall Study||0
6380717|NCT00780715|7291566|FG001|NOT COMPLETED|Overall Study||0
6380718|NCT00780715|7291567|FG002|NOT COMPLETED|Overall Study||0
6380719|NCT00780715|7291568|FG003|NOT COMPLETED|Overall Study||0
6380720|NCT00780741|7291580|FG000|STARTED|Overall Study|randomized|82
6380721|NCT00780741|7291581|FG001|STARTED|Overall Study|randomized|81
6380722|NCT00780741|7291580|FG000|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
6380723|NCT00780741|7291581|FG001|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
6380724|NCT00780741|7291580|FG000|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
6380725|NCT00780741|7291581|FG001|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
6380726|NCT00780741|7291580|FG000|NOT COMPLETED|Overall Study||7
6380727|NCT00780741|7291581|FG001|NOT COMPLETED|Overall Study||10
6380728|NCT00780910|7291588|FG000|STARTED|Overall Study||109
6380729|NCT00780910|7291588|FG000|COMPLETED|Overall Study||107
6380730|NCT00780910|7291588|FG000|NOT COMPLETED|Overall Study||2
6380731|NCT00780962|7291594|FG000|STARTED|Overall Study||200
6380732|NCT00780962|7291595|FG001|STARTED|Overall Study||199
6502576|NCT01435824|7421294|FG001|NOT COMPLETED|Second Intervention||0
6502577|NCT01435928|7421302|FG000|STARTED|Open Label Phase - up to 24 Weeks||676
6801267|NCT03348514|7733207|FG007|COMPLETED|Overall Study||2
6801268|NCT03348514|7733200|FG000|NOT COMPLETED|Overall Study||0
6801269|NCT03348514|7733201|FG001|NOT COMPLETED|Overall Study||0
6801270|NCT03348514|7733202|FG002|NOT COMPLETED|Overall Study||0
6801271|NCT03348514|7733203|FG003|NOT COMPLETED|Overall Study||0
6280599|NCT00158197|7180560|FG003|COMPLETED|Overall Study||29
6280600|NCT00158197|7180557|FG000|NOT COMPLETED|Overall Study||0
6280601|NCT00158197|7180558|FG001|NOT COMPLETED|Overall Study||0
6280602|NCT00158197|7180559|FG002|NOT COMPLETED|Overall Study||0
6280603|NCT00158197|7180560|FG003|NOT COMPLETED|Overall Study||0
6280604|NCT00158223|7180572|FG000|STARTED|Overall Study||28
6280605|NCT00158223|7180573|FG001|STARTED|Overall Study||25
6280606|NCT00158223|7180572|FG000|COMPLETED|Overall Study||23
6280607|NCT00158223|7180573|FG001|COMPLETED|Overall Study||22
6280608|NCT00158223|7180572|FG000|NOT COMPLETED|Overall Study||5
6280609|NCT00158223|7180573|FG001|NOT COMPLETED|Overall Study||3
6280610|NCT00158249|7180581|FG000|STARTED|Overall Study||11
6280611|NCT00158249|7180582|FG001|STARTED|Overall Study||10
6280612|NCT00158249|7180581|FG000|COMPLETED|Overall Study||9
6801272|NCT03348514|7733204|FG004|NOT COMPLETED|Overall Study||0
6801273|NCT03348514|7733205|FG005|NOT COMPLETED|Overall Study||0
6801274|NCT03348514|7733206|FG006|NOT COMPLETED|Overall Study||0
6801275|NCT03348514|7733207|FG007|NOT COMPLETED|Overall Study||0
6801276|NCT03253393|7733231|FG000|STARTED|First Intervention||12
6801277|NCT03253393|7733232|FG001|STARTED|First Intervention||13
6801278|NCT03253393|7733233|FG002|STARTED|First Intervention||0
6801279|NCT03253393|7733231|FG000|COMPLETED|First Intervention||12
6801280|NCT03253393|7733232|FG001|COMPLETED|First Intervention||13
6801281|NCT03253393|7733233|FG002|COMPLETED|First Intervention||0
6801282|NCT03253393|7733231|FG000|NOT COMPLETED|First Intervention||0
6801283|NCT03253393|7733232|FG001|NOT COMPLETED|First Intervention||0
6801284|NCT03253393|7733233|FG002|NOT COMPLETED|First Intervention||0
6801285|NCT03253393|7733231|FG000|STARTED|Washout (Minimum 48 Hours)||12
6801286|NCT03253393|7733232|FG001|STARTED|Washout (Minimum 48 Hours)||13
6801287|NCT03253393|7733233|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
6801288|NCT03253393|7733231|FG000|COMPLETED|Washout (Minimum 48 Hours)||12
6801289|NCT03253393|7733232|FG001|COMPLETED|Washout (Minimum 48 Hours)||13
6801290|NCT03253393|7733233|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
6801291|NCT03253393|7733231|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||0
6801292|NCT03253393|7733232|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||0
6801293|NCT03253393|7733233|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
6801294|NCT03253393|7733231|FG000|STARTED|Second Intervention||12
6801295|NCT03253393|7733232|FG001|STARTED|Second Intervention||13
6801296|NCT03253393|7733233|FG002|STARTED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
6801297|NCT03253393|7733231|FG000|COMPLETED|Second Intervention||12
6801298|NCT03253393|7733232|FG001|COMPLETED|Second Intervention||13
6801299|NCT03253393|7733233|FG002|COMPLETED|Second Intervention|Participants in this group were only assigned to one visit/intervention|0
6801300|NCT03253393|7733231|FG000|NOT COMPLETED|Second Intervention||0
6801301|NCT03253393|7733232|FG001|NOT COMPLETED|Second Intervention||0
6801302|NCT03253393|7733233|FG002|NOT COMPLETED|Second Intervention||0
6801303|NCT03253393|7733231|FG000|STARTED|Washout (Minimum 48 Hours)||12
6801304|NCT03253393|7733232|FG001|STARTED|Washout (Minimum 48 Hours)||13
6801305|NCT03253393|7733233|FG002|STARTED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
6801306|NCT03253393|7733231|FG000|COMPLETED|Washout (Minimum 48 Hours)||6
6801307|NCT03253393|7733232|FG001|COMPLETED|Washout (Minimum 48 Hours)||6
6801308|NCT03253393|7733233|FG002|COMPLETED|Washout (Minimum 48 Hours)|Participants in this group were only assigned to one visit/intervention|0
6801309|NCT03253393|7733231|FG000|NOT COMPLETED|Washout (Minimum 48 Hours)||6
6801310|NCT03253393|7733232|FG001|NOT COMPLETED|Washout (Minimum 48 Hours)||7
6801311|NCT03253393|7733233|FG002|NOT COMPLETED|Washout (Minimum 48 Hours)||0
6801312|NCT03253393|7733231|FG000|STARTED|Third Intervention||6
6801313|NCT03253393|7733232|FG001|STARTED|Third Intervention||6
6801314|NCT03253393|7733233|FG002|STARTED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
6801315|NCT03253393|7733231|FG000|COMPLETED|Third Intervention||6
6801316|NCT03253393|7733232|FG001|COMPLETED|Third Intervention||6
6801317|NCT03253393|7733233|FG002|COMPLETED|Third Intervention|Participants in this group were only assigned to one visit/intervention|13
6801318|NCT03253393|7733231|FG000|NOT COMPLETED|Third Intervention||0
6801319|NCT03253393|7733232|FG001|NOT COMPLETED|Third Intervention||0
6801320|NCT03253393|7733233|FG002|NOT COMPLETED|Third Intervention||0
6801321|NCT03188822|7733247|FG000|STARTED|Overall Study||9
6801322|NCT03188822|7733247|FG000|COMPLETED|Overall Study||2
6801323|NCT03188822|7733247|FG000|NOT COMPLETED|Overall Study||7
6801324|NCT03128671|7733253|FG000|STARTED|Enrollment||89
6801325|NCT03128671|7733254|FG001|STARTED|Enrollment||89
6801326|NCT03128671|7733253|FG000|COMPLETED|Enrollment||89
6801327|NCT03128671|7733254|FG001|COMPLETED|Enrollment||89
6801328|NCT03128671|7733253|FG000|NOT COMPLETED|Enrollment||0
6801329|NCT03128671|7733254|FG001|NOT COMPLETED|Enrollment||0
6801330|NCT03128671|7733253|FG000|STARTED|Allocation||89
6801331|NCT03128671|7733254|FG001|STARTED|Allocation||89
6801332|NCT03128671|7733253|FG000|COMPLETED|Allocation||80
6801333|NCT03128671|7733254|FG001|COMPLETED|Allocation||89
6801334|NCT03128671|7733253|FG000|NOT COMPLETED|Allocation||9
6801335|NCT03128671|7733254|FG001|NOT COMPLETED|Allocation||0
6801336|NCT03128671|7733253|FG000|STARTED|Intervention||80
6801337|NCT03128671|7733254|FG001|STARTED|Intervention||89
6801338|NCT03128671|7733253|FG000|COMPLETED|Intervention||44
6801339|NCT03128671|7733254|FG001|COMPLETED|Intervention||55
6801340|NCT03128671|7733253|FG000|NOT COMPLETED|Intervention||36
6801341|NCT03128671|7733254|FG001|NOT COMPLETED|Intervention||34
6801342|NCT03111732|7733260|FG000|STARTED|Overall Study||11
6801343|NCT03111732|7733260|FG000|COMPLETED|Overall Study||6
6801344|NCT03111732|7733260|FG000|NOT COMPLETED|Overall Study||5
6801345|NCT03065244|7733271|FG000|STARTED|Overall Study||50
6801346|NCT03065244|7733272|FG001|STARTED|Overall Study||55
6801347|NCT03065244|7733271|FG000|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||22
6801348|NCT03065244|7733272|FG001|Participants Who Failed 1st Treatment and Crossed Over to Receive Other Treatment|Overall Study||9
6801349|NCT03065244|7733271|FG000|COMPLETED|Overall Study||47
6801350|NCT03065244|7733272|FG001|COMPLETED|Overall Study||51
6801351|NCT03065244|7733271|FG000|NOT COMPLETED|Overall Study||3
6801352|NCT03065244|7733272|FG001|NOT COMPLETED|Overall Study||4
6801353|NCT02879305|7733280|FG000|STARTED|Overall Study||1487
6801354|NCT02879305|7733281|FG001|STARTED|Overall Study||1477
6801355|NCT02879305|7733280|FG000|COMPLETED|Overall Study||1370
6801356|NCT02879305|7733281|FG001|COMPLETED|Overall Study||1366
6801357|NCT02879305|7733280|FG000|NOT COMPLETED|Overall Study||117
6801358|NCT02879305|7733281|FG001|NOT COMPLETED|Overall Study||111
6801359|NCT02816736|7733289|FG000|STARTED|Overall Study||179
6801360|NCT02816736|7733290|FG001|STARTED|Overall Study||186
6801361|NCT02816736|7733289|FG000|COMPLETED|Overall Study||164
6801362|NCT02816736|7733290|FG001|COMPLETED|Overall Study||166
6801363|NCT02816736|7733289|FG000|NOT COMPLETED|Overall Study||15
6801364|NCT02816736|7733290|FG001|NOT COMPLETED|Overall Study||20
6801365|NCT02787850|7733298|FG000|STARTED|Overall Study||10
6801366|NCT02787850|7733299|FG001|STARTED|Overall Study||10
6801367|NCT02787850|7733298|FG000|COMPLETED|Overall Study||10
6801368|NCT02787850|7733299|FG001|COMPLETED|Overall Study||9
6801369|NCT02787850|7733298|FG000|NOT COMPLETED|Overall Study||0
6801370|NCT02787850|7733299|FG001|NOT COMPLETED|Overall Study||1
6801371|NCT02713373|7733314|FG000|STARTED|Overall Study||44
6801372|NCT02713373|7733314|FG000|COMPLETED|Overall Study||44
6801373|NCT02713373|7733314|FG000|NOT COMPLETED|Overall Study||0
6801374|NCT02676284|7733318|FG000|STARTED|Overall Study||36
6801375|NCT02676284|7733318|FG000|COMPLETED|Overall Study||35
6801376|NCT02676284|7733318|FG000|NOT COMPLETED|Overall Study||1
6801377|NCT02431702|7733322|FG000|STARTED|Part 1: 2-Month Oral Run-in Phase||273
6801378|NCT02431702|7733323|FG001|STARTED|Part 1: 2-Month Oral Run-in Phase||0
6801379|NCT02431702|7733324|FG002|STARTED|Part 1: 2-Month Oral Run-in Phase||0
6801380|NCT02431702|7733325|FG003|STARTED|Part 1: 2-Month Oral Run-in Phase||0
6801381|NCT02431702|7733326|FG004|STARTED|Part 1: 2-Month Oral Run-in Phase||0
6801382|NCT02431702|7733327|FG005|STARTED|Part 1: 2-Month Oral Run-in Phase||0
6801383|NCT02431702|7733328|FG006|STARTED|Part 1: 2-Month Oral Run-in Phase||64
6801384|NCT02431702|7733322|FG000|COMPLETED|Part 1: 2-Month Oral Run-in Phase||239
6801385|NCT02431702|7733323|FG001|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801386|NCT02431702|7733324|FG002|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801387|NCT02431702|7733325|FG003|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801388|NCT02431702|7733326|FG004|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801389|NCT02431702|7733327|FG005|COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801390|NCT02431702|7733328|FG006|COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
6801391|NCT02431702|7733322|FG000|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||34
6801392|NCT02431702|7733323|FG001|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801393|NCT02431702|7733324|FG002|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801394|NCT02431702|7733325|FG003|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801395|NCT02431702|7733326|FG004|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801396|NCT02431702|7733327|FG005|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||0
6801397|NCT02431702|7733328|FG006|NOT COMPLETED|Part 1: 2-Month Oral Run-in Phase||32
6801398|NCT02431702|7733322|FG000|STARTED|Part 2: 9Month Disease Progression Phase||0
6801399|NCT02431702|7733323|FG001|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|78
6801400|NCT02431702|7733324|FG002|STARTED|Part 2: 9Month Disease Progression Phase|Participants who completed Part 1 and were eligible to be randomized in this group.|157
6801401|NCT02431702|7733325|FG003|STARTED|Part 2: 9Month Disease Progression Phase||0
6801402|NCT02431702|7733326|FG004|STARTED|Part 2: 9Month Disease Progression Phase||0
6801403|NCT02431702|7733327|FG005|STARTED|Part 2: 9Month Disease Progression Phase||0
6801404|NCT02431702|7733328|FG006|STARTED|Part 2: 9Month Disease Progression Phase||0
6801405|NCT02431702|7733322|FG000|COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801406|NCT02431702|7733323|FG001|COMPLETED|Part 2: 9Month Disease Progression Phase||52
6801407|NCT02431702|7733324|FG002|COMPLETED|Part 2: 9Month Disease Progression Phase||128
6801408|NCT02431702|7733325|FG003|COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801409|NCT02431702|7733326|FG004|COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801410|NCT02431702|7733327|FG005|COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801411|NCT02431702|7733328|FG006|COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801412|NCT02431702|7733322|FG000|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801413|NCT02431702|7733323|FG001|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||26
6801414|NCT02431702|7733324|FG002|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||29
6801415|NCT02431702|7733325|FG003|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801416|NCT02431702|7733326|FG004|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801417|NCT02431702|7733327|FG005|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801418|NCT02431702|7733328|FG006|NOT COMPLETED|Part 2: 9Month Disease Progression Phase||0
6801419|NCT02431702|7733322|FG000|STARTED|Part 3: 9 Month of Additional Treatment||0
6801420|NCT02431702|7733323|FG001|STARTED|Part 3: 9 Month of Additional Treatment||0
6801421|NCT02431702|7733324|FG002|STARTED|Part 3: 9 Month of Additional Treatment||0
6801422|NCT02431702|7733325|FG003|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to continue treatment in this group.|49
6801423|NCT02431702|7733326|FG004|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|57
6801424|NCT02431702|7733327|FG005|STARTED|Part 3: 9 Month of Additional Treatment|Participants who completed Part 2 and were eligible to be re-randomized in this group.|63
6801425|NCT02431702|7733328|FG006|STARTED|Part 3: 9 Month of Additional Treatment||0
6801426|NCT02431702|7733322|FG000|COMPLETED|Part 3: 9 Month of Additional Treatment||0
6801427|NCT02431702|7733323|FG001|COMPLETED|Part 3: 9 Month of Additional Treatment||0
6801428|NCT02431702|7733324|FG002|COMPLETED|Part 3: 9 Month of Additional Treatment||0
6801429|NCT02431702|7733325|FG003|COMPLETED|Part 3: 9 Month of Additional Treatment||40
6801430|NCT02431702|7733326|FG004|COMPLETED|Part 3: 9 Month of Additional Treatment||47
6801431|NCT02431702|7733327|FG005|COMPLETED|Part 3: 9 Month of Additional Treatment||46
6801432|NCT02431702|7733328|FG006|COMPLETED|Part 3: 9 Month of Additional Treatment||0
6801433|NCT02431702|7733322|FG000|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
6801434|NCT02431702|7733323|FG001|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
6801435|NCT02431702|7733324|FG002|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
6801436|NCT02431702|7733325|FG003|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||9
6801437|NCT02431702|7733326|FG004|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||10
6801438|NCT02431702|7733327|FG005|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||17
6801439|NCT02431702|7733328|FG006|NOT COMPLETED|Part 3: 9 Month of Additional Treatment||0
6801440|NCT02368002|7733348|FG000|STARTED|Stage 1 Intervention (Up to 20 Weeks)||233
6801441|NCT02368002|7733349|FG001|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
6801442|NCT02368002|7733350|FG002|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
6801443|NCT02368002|7733351|FG003|STARTED|Stage 1 Intervention (Up to 20 Weeks)||235
6801444|NCT02368002|7733352|FG004|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
6801445|NCT02368002|7733353|FG005|STARTED|Stage 1 Intervention (Up to 20 Weeks)||0
6801446|NCT02368002|7733348|FG000|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||228
6801447|NCT02368002|7733349|FG001|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
6801448|NCT02368002|7733350|FG002|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
6801449|NCT02368002|7733351|FG003|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||214
6801450|NCT02368002|7733352|FG004|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
6801451|NCT02368002|7733353|FG005|COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
6801452|NCT02368002|7733348|FG000|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||5
6801453|NCT02368002|7733349|FG001|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
6801454|NCT02368002|7733350|FG002|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
6801455|NCT02368002|7733351|FG003|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||21
6801456|NCT02368002|7733352|FG004|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
6801457|NCT02368002|7733353|FG005|NOT COMPLETED|Stage 1 Intervention (Up to 20 Weeks)||0
6801458|NCT02368002|7733348|FG000|STARTED|Stage 2 Intervention (Up to 17 Weeks)||88
6801459|NCT02368002|7733349|FG001|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
6801460|NCT02368002|7733350|FG002|STARTED|Stage 2 Intervention (Up to 17 Weeks)||70
6801461|NCT02368002|7733351|FG003|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
6801462|NCT02368002|7733352|FG004|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
6801463|NCT02368002|7733353|FG005|STARTED|Stage 2 Intervention (Up to 17 Weeks)||0
6801464|NCT02368002|7733348|FG000|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||86
6801465|NCT02368002|7733349|FG001|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||60
6801466|NCT02368002|7733350|FG002|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||64
6801467|NCT02368002|7733351|FG003|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
6801468|NCT02368002|7733352|FG004|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
6801469|NCT02368002|7733353|FG005|COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
6801470|NCT02368002|7733348|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||2
6801471|NCT02368002|7733349|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||10
6801472|NCT02368002|7733350|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||6
6801473|NCT02368002|7733351|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
6801474|NCT02368002|7733352|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
6801475|NCT02368002|7733353|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 17 Weeks)||0
6801476|NCT02368002|7733348|FG000|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
6801477|NCT02368002|7733349|FG001|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
6801478|NCT02368002|7733350|FG002|STARTED|Stage 2 Intervention (Up to 13 Weeks)||0
6801479|NCT02368002|7733351|FG003|STARTED|Stage 2 Intervention (Up to 13 Weeks)||95
6801480|NCT02368002|7733352|FG004|STARTED|Stage 2 Intervention (Up to 13 Weeks)||57
6801481|NCT02368002|7733353|FG005|STARTED|Stage 2 Intervention (Up to 13 Weeks)||62
6801482|NCT02368002|7733348|FG000|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
6801483|NCT02368002|7733349|FG001|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
6801484|NCT02368002|7733350|FG002|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
6801485|NCT02368002|7733351|FG003|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||94
6801486|NCT02368002|7733352|FG004|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||53
6801487|NCT02368002|7733353|FG005|COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||59
6801488|NCT02368002|7733348|FG000|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
6801489|NCT02368002|7733349|FG001|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
6801490|NCT02368002|7733350|FG002|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||0
6801491|NCT02368002|7733351|FG003|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||1
6801492|NCT02368002|7733352|FG004|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||4
6801493|NCT02368002|7733353|FG005|NOT COMPLETED|Stage 2 Intervention (Up to 13 Weeks)||3
6801494|NCT02200770|7733365|FG000|STARTED|Randomized-controlled Period (RCP)||56
6801495|NCT02200770|7733366|FG001|STARTED|Randomized-controlled Period (RCP)||175
6801496|NCT02200770|7733365|FG000|Treated|Randomized-controlled Period (RCP)||56
6801497|NCT02200770|7733366|FG001|Treated|Randomized-controlled Period (RCP)||174
6801498|NCT02200770|7733365|FG000|COMPLETED|Randomized-controlled Period (RCP)||54
6801499|NCT02200770|7733366|FG001|COMPLETED|Randomized-controlled Period (RCP)||169
6801500|NCT02200770|7733365|FG000|NOT COMPLETED|Randomized-controlled Period (RCP)||2
6801501|NCT02200770|7733366|FG001|NOT COMPLETED|Randomized-controlled Period (RCP)||6
6801502|NCT02200770|7733365|FG000|STARTED|Open-label Period (OLP)|3 participants completed RCP but did not roll over to OLP.|51
6801503|NCT02200770|7733366|FG001|STARTED|Open-label Period (OLP)|4 participants completed RCP but did not roll over to OLP.|165
6801504|NCT02200770|7733365|FG000|COMPLETED|Open-label Period (OLP)||43
6801505|NCT02200770|7733366|FG001|COMPLETED|Open-label Period (OLP)||131
6801506|NCT02200770|7733365|FG000|NOT COMPLETED|Open-label Period (OLP)||8
6801507|NCT02200770|7733366|FG001|NOT COMPLETED|Open-label Period (OLP)||34
6801508|NCT02136069|7733376|FG000|STARTED|Overall Study||199
6801509|NCT02136069|7733377|FG001|STARTED|Overall Study||198
6801510|NCT02136069|7733376|FG000|COMPLETED|Overall Study||165
6801511|NCT02136069|7733377|FG001|COMPLETED|Overall Study||170
6801512|NCT02136069|7733376|FG000|NOT COMPLETED|Overall Study||34
6801513|NCT02136069|7733377|FG001|NOT COMPLETED|Overall Study||28
6801514|NCT02086552|7733383|FG000|STARTED|Overall Study||28
6801515|NCT02086552|7733383|FG000|COMPLETED|Overall Study||27
6801516|NCT02086552|7733383|FG000|NOT COMPLETED|Overall Study||1
6801517|NCT01517659|7733387|FG000|STARTED|Overall Study||45
6801518|NCT01517659|7733387|FG000|COMPLETED|Overall Study||45
6801519|NCT01517659|7733387|FG000|NOT COMPLETED|Overall Study||0
6801520|NCT01209767|7733392|FG000|STARTED|Overall Study||22
6801521|NCT01209767|7733392|FG000|COMPLETED|Overall Study||18
6801522|NCT01209767|7733392|FG000|NOT COMPLETED|Overall Study||4
6801523|NCT01186848|7733400|FG000|STARTED|Overall Study||30
6801524|NCT01186848|7733400|FG000|COMPLETED|Overall Study||22
6801525|NCT01186848|7733400|FG000|NOT COMPLETED|Overall Study||8
6801526|NCT01040624|7733408|FG000|STARTED|Overall Study||58
6801527|NCT01040624|7733409|FG001|STARTED|Overall Study||19
6801528|NCT01040624|7733408|FG000|COMPLETED|Overall Study||58
6801529|NCT01040624|7733409|FG001|COMPLETED|Overall Study||19
6801530|NCT01040624|7733408|FG000|NOT COMPLETED|Overall Study||0
6801531|NCT01040624|7733409|FG001|NOT COMPLETED|Overall Study||0
6801532|NCT01024608|7733417|FG000|STARTED|Overall Study||169
6801533|NCT01024608|7733418|FG001|STARTED|Overall Study||171
6801534|NCT01024608|7733417|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
6801535|NCT01024608|7733418|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
6801536|NCT01024608|7733417|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
6801537|NCT01024608|7733418|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
6801538|NCT01024608|7733417|FG000|COMPLETED|Overall Study||165
6801539|NCT01024608|7733418|FG001|COMPLETED|Overall Study||167
6801540|NCT01024608|7733417|FG000|NOT COMPLETED|Overall Study||4
6801541|NCT01024608|7733418|FG001|NOT COMPLETED|Overall Study||4
6801542|NCT00988247|7733426|FG000|STARTED|Overall Study||418
6801543|NCT00988247|7733427|FG001|STARTED|Overall Study||111
6801544|NCT00988247|7733426|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
6801545|NCT00988247|7733427|FG001|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
6801546|NCT00988247|7733426|FG000|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
6801547|NCT00988247|7733427|FG001|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
6801548|NCT00988247|7733426|FG000|COMPLETED|Overall Study||335
6801549|NCT00988247|7733427|FG001|COMPLETED|Overall Study||85
6801550|NCT00988247|7733426|FG000|NOT COMPLETED|Overall Study||83
6801551|NCT00988247|7733427|FG001|NOT COMPLETED|Overall Study||26
6801552|NCT00838981|7733437|FG000|STARTED|Week 1 Days 1-3||26
6801553|NCT00838981|7733438|FG001|STARTED|Week 1 Days 1-3||19
6801554|NCT00838981|7733439|FG002|STARTED|Week 1 Days 1-3||27
6801555|NCT00838981|7733440|FG003|STARTED|Week 1 Days 1-3||19
6801556|NCT00838981|7733437|FG000|COMPLETED|Week 1 Days 1-3||26
6801557|NCT00838981|7733438|FG001|COMPLETED|Week 1 Days 1-3||19
6801558|NCT00838981|7733439|FG002|COMPLETED|Week 1 Days 1-3||27
6801559|NCT00838981|7733440|FG003|COMPLETED|Week 1 Days 1-3||19
6801560|NCT00838981|7733437|FG000|NOT COMPLETED|Week 1 Days 1-3||0
6801561|NCT00838981|7733438|FG001|NOT COMPLETED|Week 1 Days 1-3||0
6801562|NCT00838981|7733439|FG002|NOT COMPLETED|Week 1 Days 1-3||0
6801563|NCT00838981|7733440|FG003|NOT COMPLETED|Week 1 Days 1-3||0
6801564|NCT00838981|7733437|FG000|STARTED|Day 4 to Week 11||26
6801565|NCT00838981|7733438|FG001|STARTED|Day 4 to Week 11||19
6801566|NCT00838981|7733439|FG002|STARTED|Day 4 to Week 11||27
6801567|NCT00838981|7733440|FG003|STARTED|Day 4 to Week 11||19
6801568|NCT00838981|7733437|FG000|Completed Main Treatment on 400mg|Day 4 to Week 11||22
6801569|NCT00838981|7733438|FG001|Completed Main Treatment on 400mg|Day 4 to Week 11||13
6801570|NCT00838981|7733439|FG002|Completed Main Treatment on 400mg|Day 4 to Week 11||17
6801571|NCT00838981|7733440|FG003|Completed Main Treatment on 400mg|Day 4 to Week 11||14
6801572|NCT00838981|7733437|FG000|COMPLETED|Day 4 to Week 11||19
6801573|NCT00838981|7733438|FG001|COMPLETED|Day 4 to Week 11||11
6801574|NCT00838981|7733439|FG002|COMPLETED|Day 4 to Week 11||16
6801575|NCT00838981|7733440|FG003|COMPLETED|Day 4 to Week 11||12
6801576|NCT00838981|7733437|FG000|NOT COMPLETED|Day 4 to Week 11||7
6801577|NCT00838981|7733438|FG001|NOT COMPLETED|Day 4 to Week 11||8
6380733|NCT00780962|7291594|FG000|Second Blood Draw (Outcome Measurement)|Overall Study||185
6380734|NCT00780962|7291595|FG001|Second Blood Draw (Outcome Measurement)|Overall Study||172
6380735|NCT00780962|7291594|FG000|COMPLETED|Overall Study||185
6380736|NCT00780962|7291595|FG001|COMPLETED|Overall Study||172
6380737|NCT00780962|7291594|FG000|NOT COMPLETED|Overall Study||15
6380738|NCT00780962|7291595|FG001|NOT COMPLETED|Overall Study||27
6380739|NCT00780975|7291601|FG000|STARTED|Overall Study||8
6380740|NCT00780975|7291601|FG000|COMPLETED|Overall Study||0
6380741|NCT00780975|7291601|FG000|NOT COMPLETED|Overall Study||8
6801578|NCT00838981|7733439|FG002|NOT COMPLETED|Day 4 to Week 11||11
6801579|NCT00838981|7733440|FG003|NOT COMPLETED|Day 4 to Week 11||7
6801580|NCT00730639|7733459|FG000|STARTED|Overall Study||17
6801581|NCT00730639|7733460|FG001|STARTED|Overall Study||18
6801582|NCT00730639|7733461|FG002|STARTED|Overall Study||86
6801583|NCT00730639|7733462|FG003|STARTED|Overall Study||54
6801584|NCT00730639|7733463|FG004|STARTED|Overall Study||131
6801585|NCT00730639|7733459|FG000|COMPLETED|Overall Study||0
6801586|NCT00730639|7733460|FG001|COMPLETED|Overall Study||0
6801587|NCT00730639|7733461|FG002|COMPLETED|Overall Study||0
6801588|NCT00730639|7733462|FG003|COMPLETED|Overall Study||0
6801589|NCT00730639|7733463|FG004|COMPLETED|Overall Study||0
6801590|NCT00730639|7733459|FG000|NOT COMPLETED|Overall Study||17
6801591|NCT00730639|7733460|FG001|NOT COMPLETED|Overall Study||18
6801592|NCT00730639|7733461|FG002|NOT COMPLETED|Overall Study||86
6801593|NCT00730639|7733462|FG003|NOT COMPLETED|Overall Study||54
6801594|NCT00730639|7733463|FG004|NOT COMPLETED|Overall Study||131
6801595|NCT00693238|7733488|FG000|STARTED|Overall Study||122
6801596|NCT00693238|7733489|FG001|STARTED|Overall Study||106
6801597|NCT00693238|7733488|FG000|COMPLETED|Overall Study||122
6801598|NCT00693238|7733489|FG001|COMPLETED|Overall Study||106
6801599|NCT00693238|7733488|FG000|NOT COMPLETED|Overall Study||0
6801600|NCT00693238|7733489|FG001|NOT COMPLETED|Overall Study||0
6801601|NCT00363038|7733495|FG000|STARTED|Overall Study||16
6801602|NCT00363038|7733495|FG000|COMPLETED|Overall Study||16
6801603|NCT00363038|7733495|FG000|NOT COMPLETED|Overall Study||0
6801604|NCT04834362|7733501|FG000|STARTED|Overall Study||53
6801605|NCT04834362|7733502|FG001|STARTED|Overall Study||52
6801606|NCT04834362|7733501|FG000|COMPLETED|Overall Study||52
6801607|NCT04834362|7733502|FG001|COMPLETED|Overall Study||50
6801608|NCT04834362|7733501|FG000|NOT COMPLETED|Overall Study||1
6801609|NCT04834362|7733502|FG001|NOT COMPLETED|Overall Study||2
6380742|NCT00781079|7291607|FG000|STARTED|Overall Study||149
6380743|NCT00781079|7291608|FG001|STARTED|Overall Study||133
6380744|NCT00781079|7291607|FG000|COMPLETED|Overall Study||122
6380745|NCT00781079|7291608|FG001|COMPLETED|Overall Study||116
6380746|NCT00781079|7291607|FG000|NOT COMPLETED|Overall Study||27
6380747|NCT00781079|7291608|FG001|NOT COMPLETED|Overall Study||17
6380748|NCT00781274|7291614|FG000|STARTED|Overall Study||32
6380749|NCT00781274|7291614|FG000|COMPLETED|Overall Study||30
6380750|NCT00781274|7291614|FG000|NOT COMPLETED|Overall Study||2
6801610|NCT04681482|7733512|FG000|STARTED|Overall Study||35051
6801611|NCT04681482|7733513|FG001|STARTED|Overall Study||38756
6801612|NCT04681482|7733514|FG002|STARTED|Overall Study||12148
6801613|NCT04681482|7733515|FG003|STARTED|Overall Study||21428
6801614|NCT04681482|7733512|FG000|COMPLETED|Overall Study||35051
6801615|NCT04681482|7733513|FG001|COMPLETED|Overall Study||38756
6801616|NCT04681482|7733514|FG002|COMPLETED|Overall Study||12148
6801617|NCT04681482|7733515|FG003|COMPLETED|Overall Study||21428
6801618|NCT04681482|7733512|FG000|NOT COMPLETED|Overall Study||0
6801619|NCT04681482|7733513|FG001|NOT COMPLETED|Overall Study||0
6801620|NCT04681482|7733514|FG002|NOT COMPLETED|Overall Study||0
6801621|NCT04681482|7733515|FG003|NOT COMPLETED|Overall Study||0
6801622|NCT04611789|7733528|FG000|STARTED|Overall Study||4
6801623|NCT04611789|7733529|FG001|STARTED|Overall Study||7
6801624|NCT04611789|7733530|FG002|STARTED|Overall Study||7
6801625|NCT04611789|7733528|FG000|COMPLETED|Overall Study||3
6801626|NCT04611789|7733529|FG001|COMPLETED|Overall Study||7
6801627|NCT04611789|7733530|FG002|COMPLETED|Overall Study||7
6801628|NCT04611789|7733528|FG000|NOT COMPLETED|Overall Study||1
6801629|NCT04611789|7733529|FG001|NOT COMPLETED|Overall Study||0
6801630|NCT04611789|7733530|FG002|NOT COMPLETED|Overall Study||0
6801631|NCT04537910|7733541|FG000|STARTED|Overall Study||6
6801632|NCT04537910|7733542|FG001|STARTED|Overall Study||5
6801633|NCT04537910|7733543|FG002|STARTED|Overall Study||7
6801634|NCT04537910|7733544|FG003|STARTED|Overall Study||7
6801635|NCT04537910|7733541|FG000|Received at Least One Dose of Study Drug|Overall Study||6
6801636|NCT04537910|7733542|FG001|Received at Least One Dose of Study Drug|Overall Study||5
6801637|NCT04537910|7733543|FG002|Received at Least One Dose of Study Drug|Overall Study||7
6801638|NCT04537910|7733544|FG003|Received at Least One Dose of Study Drug|Overall Study||7
6801639|NCT04537910|7733541|FG000|COMPLETED|Overall Study||6
6801640|NCT04537910|7733542|FG001|COMPLETED|Overall Study||5
6801641|NCT04537910|7733543|FG002|COMPLETED|Overall Study||7
6801642|NCT04537910|7733544|FG003|COMPLETED|Overall Study||7
6801643|NCT04537910|7733541|FG000|NOT COMPLETED|Overall Study||0
6564262|NCT01810380|7486982|FG002|COMPLETED|Overall Study||122
6564263|NCT01810380|7486980|FG000|NOT COMPLETED|Overall Study||55
6801644|NCT04537910|7733542|FG001|NOT COMPLETED|Overall Study||0
6801645|NCT04537910|7733543|FG002|NOT COMPLETED|Overall Study||0
6801646|NCT04537910|7733544|FG003|NOT COMPLETED|Overall Study||0
6801647|NCT04441931|7733557|FG000|STARTED|Overall Study||6
6801648|NCT04441931|7733558|FG001|STARTED|Overall Study||7
6801649|NCT04441931|7733559|FG002|STARTED|Overall Study||7
6801650|NCT04441931|7733560|FG003|STARTED|Overall Study||6
6801651|NCT04441931|7733557|FG000|Received at Least One Dose of Study Drug|Overall Study||6
6801652|NCT04441931|7733558|FG001|Received at Least One Dose of Study Drug|Overall Study||7
6801653|NCT04441931|7733559|FG002|Received at Least One Dose of Study Drug|Overall Study||7
6801654|NCT04441931|7733560|FG003|Received at Least One Dose of Study Drug|Overall Study||6
6801655|NCT04441931|7733557|FG000|COMPLETED|Overall Study||6
6801656|NCT04441931|7733558|FG001|COMPLETED|Overall Study||7
6801657|NCT04441931|7733559|FG002|COMPLETED|Overall Study||7
6801658|NCT04441931|7733560|FG003|COMPLETED|Overall Study||6
6801659|NCT04441931|7733557|FG000|NOT COMPLETED|Overall Study||0
6801660|NCT04441931|7733558|FG001|NOT COMPLETED|Overall Study||0
6801661|NCT04441931|7733559|FG002|NOT COMPLETED|Overall Study||0
6801662|NCT04441931|7733560|FG003|NOT COMPLETED|Overall Study||0
6801663|NCT04355728|7733575|FG000|STARTED|Overall Study||12
6801664|NCT04355728|7733576|FG001|STARTED|Overall Study||12
6801665|NCT04355728|7733575|FG000|COMPLETED|Overall Study||12
6801666|NCT04355728|7733576|FG001|COMPLETED|Overall Study||12
6801667|NCT04355728|7733575|FG000|NOT COMPLETED|Overall Study||0
6801668|NCT04355728|7733576|FG001|NOT COMPLETED|Overall Study||0
6801669|NCT04344535|7733584|FG000|STARTED|Overall Study||59
6801670|NCT04344535|7733585|FG001|STARTED|Overall Study||15
6801671|NCT04344535|7733584|FG000|COMPLETED|Overall Study||59
6801672|NCT04344535|7733585|FG001|COMPLETED|Overall Study||15
6801673|NCT04344535|7733584|FG000|NOT COMPLETED|Overall Study||0
6801674|NCT04344535|7733585|FG001|NOT COMPLETED|Overall Study||0
6801675|NCT04254809|7733593|FG000|STARTED|Overall Study||48
6801676|NCT04254809|7733594|FG001|STARTED|Overall Study||48
6801677|NCT04254809|7733593|FG000|COMPLETED|Overall Study||43
6801678|NCT04254809|7733594|FG001|COMPLETED|Overall Study||38
6801679|NCT04254809|7733593|FG000|NOT COMPLETED|Overall Study||5
6801680|NCT04254809|7733594|FG001|NOT COMPLETED|Overall Study||10
6801681|NCT04230122|7733602|FG000|STARTED|Overall Study||3
6801682|NCT04230122|7733603|FG001|STARTED|Overall Study||1
6801683|NCT04230122|7733602|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6801684|NCT04230122|7733603|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1
6801685|NCT04230122|7733602|FG000|COMPLETED|Overall Study||2
6801686|NCT04230122|7733603|FG001|COMPLETED|Overall Study||1
6801687|NCT04230122|7733602|FG000|NOT COMPLETED|Overall Study||1
6801688|NCT04230122|7733603|FG001|NOT COMPLETED|Overall Study||0
6801689|NCT04110366|7733611|FG000|STARTED|Overall Study||40
6801690|NCT04110366|7733612|FG001|STARTED|Overall Study||8
6801691|NCT04110366|7733611|FG000|COMPLETED|Overall Study||40
6801692|NCT04110366|7733612|FG001|COMPLETED|Overall Study||8
6801693|NCT04110366|7733611|FG000|NOT COMPLETED|Overall Study||0
6801694|NCT04110366|7733612|FG001|NOT COMPLETED|Overall Study||0
6801695|NCT04086693|7733621|FG000|STARTED|Overall Study||175
6801696|NCT04086693|7733622|FG001|STARTED|Overall Study||175
6801697|NCT04086693|7733621|FG000|COMPLETED|Overall Study||174
6801698|NCT04086693|7733622|FG001|COMPLETED|Overall Study||171
6801699|NCT04086693|7733621|FG000|NOT COMPLETED|Overall Study||1
6801700|NCT04086693|7733622|FG001|NOT COMPLETED|Overall Study||4
6801701|NCT04033068|7733632|FG000|STARTED|Overall Study||14
6801702|NCT04033068|7733633|FG001|STARTED|Overall Study||14
6801703|NCT04033068|7733634|FG002|STARTED|Overall Study||12
6801704|NCT04033068|7733635|FG003|STARTED|Overall Study||8
6801705|NCT04033068|7733632|FG000|First Dose|Overall Study||14
6801706|NCT04033068|7733633|FG001|First Dose|Overall Study||14
6801707|NCT04033068|7733634|FG002|First Dose|Overall Study||12
6801708|NCT04033068|7733635|FG003|First Dose|Overall Study||8
6801709|NCT04033068|7733632|FG000|Second Dose|Overall Study||14
6801710|NCT04033068|7733633|FG001|Second Dose|Overall Study||14
6801711|NCT04033068|7733634|FG002|Second Dose|Overall Study||11
6801712|NCT04033068|7733635|FG003|Second Dose|Overall Study||7
6801713|NCT04033068|7733632|FG000|COMPLETED|Overall Study||14
6801714|NCT04033068|7733633|FG001|COMPLETED|Overall Study||13
6801715|NCT04033068|7733634|FG002|COMPLETED|Overall Study||11
6801716|NCT04033068|7733635|FG003|COMPLETED|Overall Study||7
6801717|NCT04033068|7733632|FG000|NOT COMPLETED|Overall Study||0
6801718|NCT04033068|7733633|FG001|NOT COMPLETED|Overall Study||1
6801719|NCT04033068|7733634|FG002|NOT COMPLETED|Overall Study||1
6801720|NCT04033068|7733635|FG003|NOT COMPLETED|Overall Study||1
6801721|NCT03561597|7733645|FG000|STARTED|Overall Study|Recruited|40
6564264|NCT01810380|7486981|FG001|NOT COMPLETED|Overall Study||38
6564265|NCT01810380|7486982|FG002|NOT COMPLETED|Overall Study||32
6564266|NCT01810432|7486990|FG000|STARTED|Period 1||20
6801722|NCT03561597|7733645|FG000|3 Month Follow up|Overall Study|Attended 3 month follow up|21
6801723|NCT03561597|7733645|FG000|COMPLETED|Overall Study|Attend month 6 follow up|20
6801724|NCT03561597|7733645|FG000|NOT COMPLETED|Overall Study||20
6801725|NCT03402607|7733651|FG000|STARTED|Overall Study||6
6801726|NCT03402607|7733652|FG001|STARTED|Overall Study||6
6801727|NCT03402607|7733651|FG000|COMPLETED|Overall Study||6
6801728|NCT03402607|7733652|FG001|COMPLETED|Overall Study||6
6801729|NCT03402607|7733651|FG000|NOT COMPLETED|Overall Study||0
6801730|NCT03402607|7733652|FG001|NOT COMPLETED|Overall Study||0
6801731|NCT03350984|7733660|FG000|STARTED|Overall Study||39
6801732|NCT03350984|7733661|FG001|STARTED|Overall Study||36
6801733|NCT03350984|7733660|FG000|COMPLETED|Overall Study||31
6801734|NCT03350984|7733661|FG001|COMPLETED|Overall Study||28
6801735|NCT03350984|7733660|FG000|NOT COMPLETED|Overall Study||8
6801736|NCT03350984|7733661|FG001|NOT COMPLETED|Overall Study||8
6801737|NCT03277261|7733669|FG000|STARTED|Overall Study||274
6801738|NCT03277261|7733670|FG001|STARTED|Overall Study||275
6801739|NCT03277261|7733669|FG000|COMPLETED|Overall Study||240
6801740|NCT03277261|7733670|FG001|COMPLETED|Overall Study||252
6801741|NCT03277261|7733669|FG000|NOT COMPLETED|Overall Study||34
6801742|NCT03277261|7733670|FG001|NOT COMPLETED|Overall Study||23
6801743|NCT03277248|7733679|FG000|STARTED|Overall Study||272
6801744|NCT03277248|7733680|FG001|STARTED|Overall Study||273
6801745|NCT03277248|7733679|FG000|COMPLETED|Overall Study||254
6801746|NCT03277248|7733680|FG001|COMPLETED|Overall Study||239
6801747|NCT03277248|7733679|FG000|NOT COMPLETED|Overall Study||18
6801748|NCT03277248|7733680|FG001|NOT COMPLETED|Overall Study||34
6564267|NCT01810432|7486991|FG001|STARTED|Period 1||20
6564268|NCT01810432|7486990|FG000|Received at Least 1 Dose of Study Drug|Period 1||20
6564269|NCT01810432|7486991|FG001|Received at Least 1 Dose of Study Drug|Period 1||20
6564270|NCT01810432|7486990|FG000|COMPLETED|Period 1||20
6564271|NCT01810432|7486991|FG001|COMPLETED|Period 1||20
6564272|NCT01810432|7486990|FG000|NOT COMPLETED|Period 1||0
6564273|NCT01810432|7486991|FG001|NOT COMPLETED|Period 1||0
6801749|NCT03179462|7733689|FG000|STARTED|Overall Study||9
6801750|NCT03179462|7733690|FG001|STARTED|Overall Study||10
6801751|NCT03179462|7733691|FG002|STARTED|Overall Study||8
6801752|NCT03179462|7733689|FG000|COMPLETED|Overall Study||8
6801753|NCT03179462|7733690|FG001|COMPLETED|Overall Study||8
6801754|NCT03179462|7733691|FG002|COMPLETED|Overall Study||8
6801755|NCT03179462|7733689|FG000|NOT COMPLETED|Overall Study||1
6801756|NCT03179462|7733690|FG001|NOT COMPLETED|Overall Study||2
6801757|NCT03179462|7733691|FG002|NOT COMPLETED|Overall Study||0
6801758|NCT03099707|7733701|FG000|STARTED|Overall Study||43
6801759|NCT03099707|7733702|FG001|STARTED|Overall Study||41
6801760|NCT03099707|7733701|FG000|COMPLETED|Overall Study||43
6801761|NCT03099707|7733702|FG001|COMPLETED|Overall Study||37
6801762|NCT03099707|7733701|FG000|NOT COMPLETED|Overall Study||0
6801763|NCT03099707|7733702|FG001|NOT COMPLETED|Overall Study||4
6801764|NCT03064763|7733708|FG000|STARTED|Overall Study||18
6801765|NCT03064763|7733708|FG000|Received Treatment|Overall Study||18
6801766|NCT03064763|7733708|FG000|COMPLETED|Overall Study||0
6801767|NCT03064763|7733708|FG000|NOT COMPLETED|Overall Study||18
6801768|NCT03036267|7733712|FG000|STARTED|Overall Study||46
6801769|NCT03036267|7733712|FG000|COMPLETED|Overall Study||46
6801770|NCT03036267|7733712|FG000|NOT COMPLETED|Overall Study||0
6801771|NCT02941146|7733716|FG000|STARTED|Overall Study||15
6801772|NCT02941146|7733716|FG000|COMPLETED|Overall Study||15
6801773|NCT02941146|7733716|FG000|NOT COMPLETED|Overall Study||0
6801774|NCT02922985|7733722|FG000|STARTED|Overall Study||60
6801775|NCT02922985|7733723|FG001|STARTED|Overall Study||60
6801776|NCT02922985|7733722|FG000|COMPLETED|Overall Study||60
6801777|NCT02922985|7733723|FG001|COMPLETED|Overall Study||60
6801778|NCT02922985|7733722|FG000|NOT COMPLETED|Overall Study||0
6801779|NCT02922985|7733723|FG001|NOT COMPLETED|Overall Study||0
6801780|NCT02906033|7733733|FG000|STARTED|Baseline||231
6801781|NCT02906033|7733734|FG001|STARTED|Baseline||222
6801782|NCT02906033|7733733|FG000|15 D at Baseline|Baseline||211
6801783|NCT02906033|7733734|FG001|15 D at Baseline|Baseline||189
6801784|NCT02906033|7733733|FG000|STATE at Baseline|Baseline||199
6801785|NCT02906033|7733734|FG001|STATE at Baseline|Baseline||190
6801786|NCT02906033|7733733|FG000|TRAIT at Baseline|Baseline||194
6801787|NCT02906033|7733734|FG001|TRAIT at Baseline|Baseline||189
6801788|NCT02906033|7733733|FG000|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety|194
6801789|NCT02906033|7733734|FG001|COMPLETED|Baseline|Analyzed at baseline for 15 D and STATE anxiety and TRAIT anxiety.|189
6801790|NCT02906033|7733733|FG000|NOT COMPLETED|Baseline||37
6801791|NCT02906033|7733734|FG001|NOT COMPLETED|Baseline||33
6801792|NCT02906033|7733733|FG000|STARTED|Follow-up||194
6801793|NCT02906033|7733734|FG001|STARTED|Follow-up||189
6801794|NCT02906033|7733733|FG000|15 D at Follow-up|Follow-up||151
6801795|NCT02906033|7733734|FG001|15 D at Follow-up|Follow-up||135
6801796|NCT02906033|7733733|FG000|STATE at Follow-up|Follow-up||154
6801797|NCT02906033|7733734|FG001|STATE at Follow-up|Follow-up||135
6801798|NCT02906033|7733733|FG000|TRAIT at Follow-up|Follow-up||148
6801799|NCT02906033|7733734|FG001|TRAIT at Follow-up|Follow-up||127
6801800|NCT02906033|7733733|FG000|COMPLETED|Follow-up|Analyzed for 15 D and STATE anxiety and TRAIT anxiety at follow-up|148
6801801|NCT02906033|7733734|FG001|COMPLETED|Follow-up|Analyzed at follow-up 15 D and STATE anxiety and TRAIT anxiety.|127
6801802|NCT02906033|7733733|FG000|NOT COMPLETED|Follow-up||46
6801803|NCT02906033|7733734|FG001|NOT COMPLETED|Follow-up||62
6801804|NCT02837783|7733742|FG000|STARTED|Overall Study||9
6801805|NCT02837783|7733743|FG001|STARTED|Overall Study||11
6801806|NCT02837783|7733742|FG000|Received >= 1 Dose of Study Drug|Overall Study||9
6801807|NCT02837783|7733743|FG001|Received >= 1 Dose of Study Drug|Overall Study||10
6801808|NCT02837783|7733742|FG000|COMPLETED|Overall Study||7
6801809|NCT02837783|7733743|FG001|COMPLETED|Overall Study||9
6801810|NCT02837783|7733742|FG000|NOT COMPLETED|Overall Study||2
6801811|NCT02837783|7733743|FG001|NOT COMPLETED|Overall Study||2
6801812|NCT02786537|7733755|FG000|STARTED|As Randomized||56
6801813|NCT02786537|7733756|FG001|STARTED|As Randomized||644
6801814|NCT02786537|7733757|FG002|STARTED|As Randomized||15
6801815|NCT02786537|7733758|FG003|STARTED|As Randomized||413
6801816|NCT02786537|7733759|FG004|STARTED|As Randomized||99
6801817|NCT02786537|7733760|FG005|STARTED|As Randomized||48
6801818|NCT02786537|7733755|FG000|COMPLETED|As Randomized||50
6801819|NCT02786537|7733756|FG001|COMPLETED|As Randomized||582
6801820|NCT02786537|7733757|FG002|COMPLETED|As Randomized||15
6801821|NCT02786537|7733758|FG003|COMPLETED|As Randomized||378
6801822|NCT02786537|7733759|FG004|COMPLETED|As Randomized||87
6801823|NCT02786537|7733760|FG005|COMPLETED|As Randomized||41
6801824|NCT02786537|7733755|FG000|NOT COMPLETED|As Randomized||6
6801825|NCT02786537|7733756|FG001|NOT COMPLETED|As Randomized||62
6801826|NCT02786537|7733757|FG002|NOT COMPLETED|As Randomized||0
6801827|NCT02786537|7733758|FG003|NOT COMPLETED|As Randomized||35
6801828|NCT02786537|7733759|FG004|NOT COMPLETED|As Randomized||12
6801829|NCT02786537|7733760|FG005|NOT COMPLETED|As Randomized||7
6801830|NCT02786537|7733755|FG000|STARTED|As Treated||56
6801831|NCT02786537|7733756|FG001|STARTED|As Treated||664
6801832|NCT02786537|7733757|FG002|STARTED|As Treated||15
6801833|NCT02786537|7733758|FG003|STARTED|As Treated||394
6801834|NCT02786537|7733759|FG004|STARTED|As Treated||99
6801835|NCT02786537|7733760|FG005|STARTED|As Treated||47
6801836|NCT02786537|7733755|FG000|COMPLETED|As Treated||50
6801837|NCT02786537|7733756|FG001|COMPLETED|As Treated||602
6801838|NCT02786537|7733757|FG002|COMPLETED|As Treated||15
6801839|NCT02786537|7733758|FG003|COMPLETED|As Treated||359
6801840|NCT02786537|7733759|FG004|COMPLETED|As Treated||87
6801841|NCT02786537|7733760|FG005|COMPLETED|As Treated||40
6801842|NCT02786537|7733755|FG000|NOT COMPLETED|As Treated||6
6801843|NCT02786537|7733756|FG001|NOT COMPLETED|As Treated||62
6801844|NCT02786537|7733757|FG002|NOT COMPLETED|As Treated||0
6801845|NCT02786537|7733758|FG003|NOT COMPLETED|As Treated||35
6801846|NCT02786537|7733759|FG004|NOT COMPLETED|As Treated||12
6801847|NCT02786537|7733760|FG005|NOT COMPLETED|As Treated||7
6801848|NCT02740231|7733870|FG000|STARTED|Overall Study||41
6801849|NCT02740231|7733871|FG001|STARTED|Overall Study||41
6801850|NCT02740231|7733872|FG002|STARTED|Overall Study||41
6801851|NCT02740231|7733873|FG003|STARTED|Overall Study||41
6801852|NCT02740231|7733870|FG000|COMPLETED|Overall Study||39
6801853|NCT02740231|7733871|FG001|COMPLETED|Overall Study||35
6801854|NCT02740231|7733872|FG002|COMPLETED|Overall Study||40
6801855|NCT02740231|7733873|FG003|COMPLETED|Overall Study||33
6801856|NCT02740231|7733870|FG000|NOT COMPLETED|Overall Study||2
6801857|NCT02740231|7733871|FG001|NOT COMPLETED|Overall Study||6
6801858|NCT02740231|7733872|FG002|NOT COMPLETED|Overall Study||1
6801859|NCT02740231|7733873|FG003|NOT COMPLETED|Overall Study||8
6801860|NCT02710084|7733885|FG000|STARTED|First Phase - 12 Weeks||10
6801861|NCT02710084|7733886|FG001|STARTED|First Phase - 12 Weeks||8
6801862|NCT02710084|7733885|FG000|COMPLETED|First Phase - 12 Weeks||7
6801863|NCT02710084|7733886|FG001|COMPLETED|First Phase - 12 Weeks||7
6801864|NCT02710084|7733885|FG000|NOT COMPLETED|First Phase - 12 Weeks||3
6801865|NCT02710084|7733886|FG001|NOT COMPLETED|First Phase - 12 Weeks||1
6801866|NCT02710084|7733885|FG000|STARTED|Open Label Phase: Week 12 to 24||7
6801867|NCT02710084|7733886|FG001|STARTED|Open Label Phase: Week 12 to 24||7
6801868|NCT02710084|7733885|FG000|COMPLETED|Open Label Phase: Week 12 to 24||7
6801869|NCT02710084|7733886|FG001|COMPLETED|Open Label Phase: Week 12 to 24||7
6801870|NCT02710084|7733885|FG000|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
6801871|NCT02710084|7733886|FG001|NOT COMPLETED|Open Label Phase: Week 12 to 24||0
6801872|NCT02660034|7733907|FG000|STARTED|Overall Study||12
6801873|NCT02660034|7733908|FG001|STARTED|Overall Study||12
6801874|NCT02660034|7733909|FG002|STARTED|Overall Study||6
6801875|NCT02660034|7733910|FG003|STARTED|Overall Study||13
6801876|NCT02660034|7733911|FG004|STARTED|Overall Study||6
6801877|NCT02660034|7733912|FG005|STARTED|Overall Study||23
6801878|NCT02660034|7733913|FG006|STARTED|Overall Study||23
6801879|NCT02660034|7733914|FG007|STARTED|Overall Study||19
6801880|NCT02660034|7733915|FG008|STARTED|Overall Study||20
6801881|NCT02660034|7733916|FG009|STARTED|Overall Study||23
6801882|NCT02660034|7733917|FG010|STARTED|Overall Study||20
6801883|NCT02660034|7733918|FG011|STARTED|Overall Study||21
6801884|NCT02660034|7733919|FG012|STARTED|Overall Study||21
6801885|NCT02660034|7733920|FG013|STARTED|Overall Study||10
6801886|NCT02660034|7733907|FG000|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
6801887|NCT02660034|7733908|FG001|Received At Least 1 Dose of Study Drug(s)|Overall Study||12
6801888|NCT02660034|7733909|FG002|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
6801889|NCT02660034|7733910|FG003|Received At Least 1 Dose of Study Drug(s)|Overall Study||13
6801890|NCT02660034|7733911|FG004|Received At Least 1 Dose of Study Drug(s)|Overall Study||6
6502578|NCT01435928|7421303|FG001|STARTED|Open Label Phase - up to 24 Weeks||0
6801891|NCT02660034|7733912|FG005|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
6801892|NCT02660034|7733913|FG006|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
6801893|NCT02660034|7733914|FG007|Received At Least 1 Dose of Study Drug(s)|Overall Study||19
6801894|NCT02660034|7733915|FG008|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
6801895|NCT02660034|7733916|FG009|Received At Least 1 Dose of Study Drug(s)|Overall Study||23
6801896|NCT02660034|7733917|FG010|Received At Least 1 Dose of Study Drug(s)|Overall Study||20
6801897|NCT02660034|7733918|FG011|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
6801898|NCT02660034|7733919|FG012|Received At Least 1 Dose of Study Drug(s)|Overall Study||21
6801899|NCT02660034|7733920|FG013|Received At Least 1 Dose of Study Drug(s)|Overall Study||10
6801900|NCT02660034|7733907|FG000|COMPLETED|Overall Study||0
6801901|NCT02660034|7733908|FG001|COMPLETED|Overall Study||0
6801902|NCT02660034|7733909|FG002|COMPLETED|Overall Study||0
6801903|NCT02660034|7733910|FG003|COMPLETED|Overall Study||0
6801904|NCT02660034|7733911|FG004|COMPLETED|Overall Study||0
6801905|NCT02660034|7733912|FG005|COMPLETED|Overall Study||0
6801906|NCT02660034|7733913|FG006|COMPLETED|Overall Study||0
6801907|NCT02660034|7733914|FG007|COMPLETED|Overall Study||0
6801908|NCT02660034|7733915|FG008|COMPLETED|Overall Study||0
6801909|NCT02660034|7733916|FG009|COMPLETED|Overall Study||0
6801910|NCT02660034|7733917|FG010|COMPLETED|Overall Study||0
6801911|NCT02660034|7733918|FG011|COMPLETED|Overall Study||0
6801912|NCT02660034|7733919|FG012|COMPLETED|Overall Study||0
6801913|NCT02660034|7733920|FG013|COMPLETED|Overall Study||0
6801914|NCT02660034|7733907|FG000|NOT COMPLETED|Overall Study||12
6801915|NCT02660034|7733908|FG001|NOT COMPLETED|Overall Study||12
6801916|NCT02660034|7733909|FG002|NOT COMPLETED|Overall Study||6
6801917|NCT02660034|7733910|FG003|NOT COMPLETED|Overall Study||13
6801918|NCT02660034|7733911|FG004|NOT COMPLETED|Overall Study||6
6801919|NCT02660034|7733912|FG005|NOT COMPLETED|Overall Study||23
6801920|NCT02660034|7733913|FG006|NOT COMPLETED|Overall Study||23
6801921|NCT02660034|7733914|FG007|NOT COMPLETED|Overall Study||19
6801922|NCT02660034|7733915|FG008|NOT COMPLETED|Overall Study||20
6801923|NCT02660034|7733916|FG009|NOT COMPLETED|Overall Study||23
6801924|NCT02660034|7733917|FG010|NOT COMPLETED|Overall Study||20
6801925|NCT02660034|7733918|FG011|NOT COMPLETED|Overall Study||21
6801926|NCT02660034|7733919|FG012|NOT COMPLETED|Overall Study||21
6801927|NCT02660034|7733920|FG013|NOT COMPLETED|Overall Study||10
6801928|NCT02640625|7733954|FG000|STARTED|Overall Study||20
6801929|NCT02640625|7733954|FG000|COMPLETED|Overall Study||19
6801930|NCT02640625|7733954|FG000|NOT COMPLETED|Overall Study||1
6801931|NCT02561962|7733968|FG000|STARTED|Overall Study||3
6801932|NCT02561962|7733969|FG001|STARTED|Overall Study||3
6801933|NCT02561962|7733970|FG002|STARTED|Overall Study||3
6801934|NCT02561962|7733971|FG003|STARTED|Overall Study||3
6801935|NCT02561962|7733972|FG004|STARTED|Overall Study||6
6801936|NCT02561962|7733973|FG005|STARTED|Overall Study||6
6801937|NCT02561962|7733974|FG006|STARTED|Overall Study||5
6801938|NCT02561962|7733975|FG007|STARTED|Overall Study||11
6801939|NCT02561962|7733976|FG008|STARTED|Overall Study||2
6801940|NCT02561962|7733968|FG000|Received Treatment|Overall Study||3
6801941|NCT02561962|7733969|FG001|Received Treatment|Overall Study||3
6801942|NCT02561962|7733970|FG002|Received Treatment|Overall Study||3
6801943|NCT02561962|7733971|FG003|Received Treatment|Overall Study||3
6801944|NCT02561962|7733972|FG004|Received Treatment|Overall Study||6
6801945|NCT02561962|7733973|FG005|Received Treatment|Overall Study||6
6801946|NCT02561962|7733974|FG006|Received Treatment|Overall Study||5
6801947|NCT02561962|7733975|FG007|Received Treatment|Overall Study||9
6801948|NCT02561962|7733976|FG008|Received Treatment|Overall Study||2
6801949|NCT02561962|7733968|FG000|COMPLETED|Overall Study||1
6801950|NCT02561962|7733969|FG001|COMPLETED|Overall Study||3
6801951|NCT02561962|7733970|FG002|COMPLETED|Overall Study||3
6801952|NCT02561962|7733971|FG003|COMPLETED|Overall Study||2
6801953|NCT02561962|7733972|FG004|COMPLETED|Overall Study||4
6801954|NCT02561962|7733973|FG005|COMPLETED|Overall Study||2
6801955|NCT02561962|7733974|FG006|COMPLETED|Overall Study||3
6801956|NCT02561962|7733975|FG007|COMPLETED|Overall Study||3
6801957|NCT02561962|7733976|FG008|COMPLETED|Overall Study||1
6801958|NCT02561962|7733968|FG000|NOT COMPLETED|Overall Study||2
6801959|NCT02561962|7733969|FG001|NOT COMPLETED|Overall Study||0
6801960|NCT02561962|7733970|FG002|NOT COMPLETED|Overall Study||0
6801961|NCT02561962|7733971|FG003|NOT COMPLETED|Overall Study||1
6801962|NCT02561962|7733972|FG004|NOT COMPLETED|Overall Study||2
6801963|NCT02561962|7733973|FG005|NOT COMPLETED|Overall Study||4
6801964|NCT02561962|7733974|FG006|NOT COMPLETED|Overall Study||2
6801965|NCT02561962|7733975|FG007|NOT COMPLETED|Overall Study||8
6801966|NCT02561962|7733976|FG008|NOT COMPLETED|Overall Study||1
6801967|NCT02500589|7733998|FG000|STARTED|Overall Study||175
6801968|NCT02500589|7733999|FG001|STARTED|Overall Study||175
6801969|NCT02500589|7733998|FG000|COMPLETED|Overall Study||147
6380751|NCT00781326|7291618|FG000|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
6380752|NCT00781326|7291618|FG000|COMPLETED|Phase I||2
6380753|NCT00781326|7291618|FG000|NOT COMPLETED|Phase I||4
6380754|NCT00781326|7291618|FG000|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
6380755|NCT00781326|7291618|FG000|COMPLETED|Phase 2||0
6380756|NCT00781326|7291618|FG000|NOT COMPLETED|Phase 2||0
6380757|NCT00781365|7291624|FG000|STARTED|Overall Study||228
6380758|NCT00781365|7291625|FG001|STARTED|Overall Study||222
6502579|NCT01435928|7421304|FG002|STARTED|Open Label Phase - up to 24 Weeks||0
6801970|NCT02500589|7733999|FG001|COMPLETED|Overall Study||143
6801971|NCT02500589|7733998|FG000|NOT COMPLETED|Overall Study||28
6801972|NCT02500589|7733999|FG001|NOT COMPLETED|Overall Study||32
6801973|NCT02474329|7734009|FG000|STARTED|Overall Study|Participants (People with Parkinson's Disease) who signed a consent form.|304
6380759|NCT00781365|7291624|FG000|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
6801974|NCT02474329|7734009|FG000|COMPLETED|Overall Study|Participants (People with Parkinson's Disease) who contributed data for 13 weeks.|291
6801975|NCT02474329|7734009|FG000|NOT COMPLETED|Overall Study||13
6801976|NCT02471339|7734016|FG000|STARTED|Overall Study||32
6801977|NCT02471339|7734017|FG001|STARTED|Overall Study||34
6801978|NCT02471339|7734016|FG000|COMPLETED|Overall Study||30
6801979|NCT02471339|7734017|FG001|COMPLETED|Overall Study||34
6801980|NCT02471339|7734016|FG000|NOT COMPLETED|Overall Study||2
6801981|NCT02471339|7734017|FG001|NOT COMPLETED|Overall Study||0
6801982|NCT01976273|7734025|FG000|STARTED|Overall Study||10
6801983|NCT01976273|7734026|FG001|STARTED|Overall Study||10
6801984|NCT01976273|7734025|FG000|COMPLETED|Overall Study||9
6801985|NCT01976273|7734026|FG001|COMPLETED|Overall Study||9
6801986|NCT01976273|7734025|FG000|NOT COMPLETED|Overall Study||1
6801987|NCT01976273|7734026|FG001|NOT COMPLETED|Overall Study||1
6801988|NCT01722929|7734032|FG000|STARTED|Overall Study||4
6801989|NCT01722929|7734032|FG000|COMPLETED|Overall Study||4
6801990|NCT01722929|7734032|FG000|NOT COMPLETED|Overall Study||0
6801991|NCT01500733|7734039|FG000|STARTED|Overall Study||35
6801992|NCT01500733|7734040|FG001|STARTED|Overall Study||51
6801993|NCT01500733|7734039|FG000|COMPLETED|Overall Study||33
6801994|NCT01500733|7734040|FG001|COMPLETED|Overall Study||48
6801995|NCT01500733|7734039|FG000|NOT COMPLETED|Overall Study||2
6801996|NCT01500733|7734040|FG001|NOT COMPLETED|Overall Study||3
6801997|NCT01388491|7734048|FG000|STARTED|Overall Study|number randomized|150
6801998|NCT01388491|7734049|FG001|STARTED|Overall Study||143
6801999|NCT01388491|7734048|FG000|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
6802000|NCT01388491|7734049|FG001|Safety Population|Overall Study||142
6802001|NCT01388491|7734048|FG000|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
6802002|NCT01388491|7734049|FG001|Intent-to-Treat (ITT) Population|Overall Study||136
6802003|NCT01388491|7734048|FG000|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
6802004|NCT01388491|7734049|FG001|Per Protocol (PP) Population|Overall Study||121
6802005|NCT01388491|7734048|FG000|COMPLETED|Overall Study||116
6802006|NCT01388491|7734049|FG001|COMPLETED|Overall Study||114
6802007|NCT01388491|7734048|FG000|NOT COMPLETED|Overall Study||34
6802008|NCT01388491|7734049|FG001|NOT COMPLETED|Overall Study||29
6802009|NCT01373151|7734062|FG000|STARTED|Period 1||61
6802010|NCT01373151|7734063|FG001|STARTED|Period 1||59
6802011|NCT01373151|7734064|FG002|STARTED|Period 1||60
6802012|NCT01373151|7734065|FG003|STARTED|Period 1||60
6802013|NCT01373151|7734066|FG004|STARTED|Period 1||59
6802014|NCT01373151|7734067|FG005|STARTED|Period 1||60
6802015|NCT01373151|7734068|FG006|STARTED|Period 1||59
6802016|NCT01373151|7734062|FG000|COMPLETED|Period 1||56
6802017|NCT01373151|7734063|FG001|COMPLETED|Period 1||59
6802018|NCT01373151|7734064|FG002|COMPLETED|Period 1||56
6802019|NCT01373151|7734065|FG003|COMPLETED|Period 1||59
6802020|NCT01373151|7734066|FG004|COMPLETED|Period 1||54
6802021|NCT01373151|7734067|FG005|COMPLETED|Period 1||56
6802022|NCT01373151|7734068|FG006|COMPLETED|Period 1||59
6802023|NCT01373151|7734062|FG000|NOT COMPLETED|Period 1||5
6802024|NCT01373151|7734063|FG001|NOT COMPLETED|Period 1||0
6802025|NCT01373151|7734064|FG002|NOT COMPLETED|Period 1||4
6802026|NCT01373151|7734065|FG003|NOT COMPLETED|Period 1||1
6802027|NCT01373151|7734066|FG004|NOT COMPLETED|Period 1||5
6802028|NCT01373151|7734067|FG005|NOT COMPLETED|Period 1||4
6802029|NCT01373151|7734068|FG006|NOT COMPLETED|Period 1||0
6802030|NCT01373151|7734062|FG000|STARTED|Period 2||56
6802031|NCT01373151|7734063|FG001|STARTED|Period 2||58
6802032|NCT01373151|7734064|FG002|STARTED|Period 2||56
6802033|NCT01373151|7734065|FG003|STARTED|Period 2||59
6802034|NCT01373151|7734066|FG004|STARTED|Period 2||54
6802035|NCT01373151|7734067|FG005|STARTED|Period 2||55
6802036|NCT01373151|7734068|FG006|STARTED|Period 2||59
6802037|NCT01373151|7734062|FG000|COMPLETED|Period 2||47
6802038|NCT01373151|7734063|FG001|COMPLETED|Period 2||57
6802039|NCT01373151|7734064|FG002|COMPLETED|Period 2||52
6802040|NCT01373151|7734065|FG003|COMPLETED|Period 2||54
6802041|NCT01373151|7734066|FG004|COMPLETED|Period 2||52
6802042|NCT01373151|7734067|FG005|COMPLETED|Period 2||55
6802043|NCT01373151|7734068|FG006|COMPLETED|Period 2||54
6802044|NCT01373151|7734062|FG000|NOT COMPLETED|Period 2||9
6802045|NCT01373151|7734063|FG001|NOT COMPLETED|Period 2||1
6802046|NCT01373151|7734064|FG002|NOT COMPLETED|Period 2||4
6802047|NCT01373151|7734065|FG003|NOT COMPLETED|Period 2||5
6802048|NCT01373151|7734066|FG004|NOT COMPLETED|Period 2||2
6802049|NCT01373151|7734067|FG005|NOT COMPLETED|Period 2||0
6802050|NCT01373151|7734068|FG006|NOT COMPLETED|Period 2||5
6802051|NCT01328587|7734084|FG000|STARTED|Overall Study||34
6802052|NCT01328587|7734084|FG000|COMPLETED|Overall Study||34
6802053|NCT01328587|7734084|FG000|NOT COMPLETED|Overall Study||0
6802054|NCT01285947|7734090|FG000|STARTED|Overall Study||10
6802055|NCT01285947|7734091|FG001|STARTED|Overall Study||10
6802056|NCT01285947|7734090|FG000|COMPLETED|Overall Study||10
6802057|NCT01285947|7734091|FG001|COMPLETED|Overall Study||10
6802058|NCT01285947|7734090|FG000|NOT COMPLETED|Overall Study||0
6802059|NCT01285947|7734091|FG001|NOT COMPLETED|Overall Study||0
6802060|NCT01281644|7734097|FG000|STARTED|Overall Study||23
6802061|NCT01281644|7734097|FG000|COMPLETED|Overall Study||18
6802062|NCT01281644|7734097|FG000|NOT COMPLETED|Overall Study||5
6802063|NCT01274611|7734103|FG000|STARTED|Overall Study||20
6802064|NCT01274611|7734103|FG000|COMPLETED|Overall Study||20
6802065|NCT01274611|7734103|FG000|NOT COMPLETED|Overall Study||0
6802066|NCT00960297|7734109|FG000|STARTED|Overall Study||4
6802067|NCT00960297|7734109|FG000|COMPLETED|Overall Study||1
6802068|NCT00960297|7734109|FG000|NOT COMPLETED|Overall Study||3
6802069|NCT00910650|7734113|FG000|STARTED|Overall Study||14
6802070|NCT00910650|7734113|FG000|COMPLETED|Overall Study||12
6802071|NCT00910650|7734113|FG000|NOT COMPLETED|Overall Study||2
6802072|NCT00793169|7734117|FG000|STARTED|Overall Study||19
6802073|NCT00793169|7734117|FG000|COMPLETED|Overall Study||19
6802074|NCT00793169|7734117|FG000|NOT COMPLETED|Overall Study||0
6802075|NCT00703326|7734123|FG000|STARTED|Overall Study||759
6802076|NCT00703326|7734124|FG001|STARTED|Overall Study||385
6802077|NCT00703326|7734123|FG000|Received at Least 1 Dose of Study Drug|Overall Study||752
6802078|NCT00703326|7734124|FG001|Received at Least 1 Dose of Study Drug|Overall Study||382
6802079|NCT00703326|7734123|FG000|COMPLETED|Overall Study||657
6802080|NCT00703326|7734124|FG001|COMPLETED|Overall Study||347
6802081|NCT00703326|7734123|FG000|NOT COMPLETED|Overall Study||102
6802082|NCT00703326|7734124|FG001|NOT COMPLETED|Overall Study||38
6802083|NCT00602667|7734134|FG000|STARTED|Overall Study||57
6802084|NCT00602667|7734135|FG001|STARTED|Overall Study||156
6802085|NCT00602667|7734136|FG002|STARTED|Overall Study||77
6802086|NCT00602667|7734134|FG000|COMPLETED|Overall Study||38
6802087|NCT00602667|7734135|FG001|COMPLETED|Overall Study||75
6802088|NCT00602667|7734136|FG002|COMPLETED|Overall Study||14
6802089|NCT00602667|7734134|FG000|NOT COMPLETED|Overall Study||19
6802090|NCT00602667|7734135|FG001|NOT COMPLETED|Overall Study||81
6802091|NCT00602667|7734136|FG002|NOT COMPLETED|Overall Study||63
6802092|NCT00535990|7734171|FG000|STARTED|Overall Study||250
6802093|NCT00535990|7734171|FG000|COMPLETED|Overall Study||250
6802094|NCT00535990|7734171|FG000|NOT COMPLETED|Overall Study||0
6802095|NCT00472186|7734177|FG000|STARTED|Overall Study||2
6802096|NCT00472186|7734178|FG001|STARTED|Overall Study||0
6802097|NCT00472186|7734177|FG000|COMPLETED|Overall Study||1
6802098|NCT00472186|7734178|FG001|COMPLETED|Overall Study||0
6802099|NCT00472186|7734177|FG000|NOT COMPLETED|Overall Study||1
6802100|NCT00472186|7734178|FG001|NOT COMPLETED|Overall Study||0
6802101|NCT03996876|7734188|FG000|STARTED|Overall Study||14
6802102|NCT03996876|7734189|FG001|STARTED|Overall Study||14
6802103|NCT03996876|7734188|FG000|COMPLETED|Overall Study||12
6802104|NCT03996876|7734189|FG001|COMPLETED|Overall Study||10
6802105|NCT03996876|7734188|FG000|NOT COMPLETED|Overall Study||2
6802106|NCT03996876|7734189|FG001|NOT COMPLETED|Overall Study||4
6802107|NCT03589976|7734198|FG000|STARTED|Overall Study||35
6802108|NCT03589976|7734199|FG001|STARTED|Overall Study||12
6802109|NCT03589976|7734198|FG000|COMPLETED|Overall Study||16
6802110|NCT03589976|7734199|FG001|COMPLETED|Overall Study||6
6802111|NCT03589976|7734198|FG000|NOT COMPLETED|Overall Study||19
6802112|NCT03589976|7734199|FG001|NOT COMPLETED|Overall Study||6
6802113|NCT03490227|7734205|FG000|STARTED|Overall Study||10
6802114|NCT03490227|7734205|FG000|COMPLETED|Overall Study||10
6802115|NCT03490227|7734205|FG000|NOT COMPLETED|Overall Study||0
6802116|NCT03401190|7734214|FG000|STARTED|Overall Study||8
6802117|NCT03401190|7734215|FG001|STARTED|Overall Study||6
6802118|NCT03401190|7734216|FG002|STARTED|Overall Study||7
6802119|NCT03401190|7734214|FG000|COMPLETED|Overall Study||8
6802120|NCT03401190|7734215|FG001|COMPLETED|Overall Study||4
6802121|NCT03401190|7734216|FG002|COMPLETED|Overall Study||7
6802122|NCT03401190|7734214|FG000|NOT COMPLETED|Overall Study||0
6802123|NCT03401190|7734215|FG001|NOT COMPLETED|Overall Study||2
6802124|NCT03401190|7734216|FG002|NOT COMPLETED|Overall Study||0
6802125|NCT03392753|7734230|FG000|STARTED|Overall Study||83
6802126|NCT03392753|7734231|FG001|STARTED|Overall Study||84
6802127|NCT03392753|7734230|FG000|COMPLETED|Overall Study||47
6802128|NCT03392753|7734231|FG001|COMPLETED|Overall Study||50
6802129|NCT03392753|7734230|FG000|NOT COMPLETED|Overall Study||36
6802130|NCT03392753|7734231|FG001|NOT COMPLETED|Overall Study||34
6802131|NCT03212963|7734237|FG000|STARTED|Overall Study||16
6802132|NCT03212963|7734237|FG000|COMPLETED|Overall Study||16
6802133|NCT03212963|7734237|FG000|NOT COMPLETED|Overall Study||0
6802134|NCT03135262|7734246|FG000|STARTED|Overall Study||9
6802135|NCT03135262|7734247|FG001|STARTED|Overall Study||6
6802136|NCT03135262|7734248|FG002|STARTED|Overall Study||7
6802137|NCT03135262|7734249|FG003|STARTED|Overall Study||6
6802138|NCT03135262|7734250|FG004|STARTED|Overall Study||1
6802139|NCT03135262|7734246|FG000|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
6802140|NCT03135262|7734247|FG001|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
6802141|NCT03135262|7734248|FG002|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
6802142|NCT03135262|7734249|FG003|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
6802143|NCT03135262|7734250|FG004|COMPLETED|Overall Study|The study was terminated after escalation phase. The planned expansion phase did not take place due to the early termination.|0
6802144|NCT03135262|7734246|FG000|NOT COMPLETED|Overall Study||9
6802145|NCT03135262|7734247|FG001|NOT COMPLETED|Overall Study||6
6802146|NCT03135262|7734248|FG002|NOT COMPLETED|Overall Study||7
6802147|NCT03135262|7734249|FG003|NOT COMPLETED|Overall Study||6
6802148|NCT03135262|7734250|FG004|NOT COMPLETED|Overall Study||1
6802149|NCT03104075|7734282|FG000|STARTED|Overall Study||20
6802150|NCT03104075|7734283|FG001|STARTED|Overall Study||20
6802151|NCT03104075|7734282|FG000|COMPLETED|Overall Study||19
6802152|NCT03104075|7734283|FG001|COMPLETED|Overall Study||20
6802153|NCT03104075|7734282|FG000|NOT COMPLETED|Overall Study||1
6802154|NCT03104075|7734283|FG001|NOT COMPLETED|Overall Study||0
6802155|NCT03038087|7734290|FG000|STARTED|Overall Study||10
6802156|NCT03038087|7734290|FG000|COMPLETED|Overall Study||9
6802157|NCT03038087|7734290|FG000|NOT COMPLETED|Overall Study||1
6802158|NCT02880540|7734298|FG000|STARTED|Overall Study||13
6802159|NCT02880540|7734299|FG001|STARTED|Overall Study||13
6802160|NCT02880540|7734298|FG000|COMPLETED|Overall Study||13
6802161|NCT02880540|7734299|FG001|COMPLETED|Overall Study||13
6802162|NCT02880540|7734298|FG000|NOT COMPLETED|Overall Study||0
6802163|NCT02880540|7734299|FG001|NOT COMPLETED|Overall Study||0
6802164|NCT02740972|7734307|FG000|STARTED|4-week Double-blinded Placebo-controlled||5
6802165|NCT02740972|7734308|FG001|STARTED|4-week Double-blinded Placebo-controlled||6
6802166|NCT02740972|7734309|FG002|STARTED|4-week Double-blinded Placebo-controlled||5
6802167|NCT02740972|7734310|FG003|STARTED|4-week Double-blinded Placebo-controlled||0
6802168|NCT02740972|7734311|FG004|STARTED|4-week Double-blinded Placebo-controlled||0
6802169|NCT02740972|7734307|FG000|COMPLETED|4-week Double-blinded Placebo-controlled||5
6802170|NCT02740972|7734308|FG001|COMPLETED|4-week Double-blinded Placebo-controlled||6
6802171|NCT02740972|7734309|FG002|COMPLETED|4-week Double-blinded Placebo-controlled||5
6802172|NCT02740972|7734310|FG003|COMPLETED|4-week Double-blinded Placebo-controlled||0
6802173|NCT02740972|7734311|FG004|COMPLETED|4-week Double-blinded Placebo-controlled||0
6802174|NCT02740972|7734307|FG000|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
6802175|NCT02740972|7734308|FG001|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
6802176|NCT02740972|7734309|FG002|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
6802177|NCT02740972|7734310|FG003|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
6802178|NCT02740972|7734311|FG004|NOT COMPLETED|4-week Double-blinded Placebo-controlled||0
6802179|NCT02740972|7734307|FG000|STARTED|20-week Open Label Treatment Period||0
6802180|NCT02740972|7734308|FG001|STARTED|20-week Open Label Treatment Period||0
6802181|NCT02740972|7734309|FG002|STARTED|20-week Open Label Treatment Period||0
6802182|NCT02740972|7734310|FG003|STARTED|20-week Open Label Treatment Period||8
6802183|NCT02740972|7734311|FG004|STARTED|20-week Open Label Treatment Period||8
6802184|NCT02740972|7734307|FG000|COMPLETED|20-week Open Label Treatment Period||0
6802185|NCT02740972|7734308|FG001|COMPLETED|20-week Open Label Treatment Period||0
6802186|NCT02740972|7734309|FG002|COMPLETED|20-week Open Label Treatment Period||0
6802187|NCT02740972|7734310|FG003|COMPLETED|20-week Open Label Treatment Period||8
6802188|NCT02740972|7734311|FG004|COMPLETED|20-week Open Label Treatment Period||8
6802189|NCT02740972|7734307|FG000|NOT COMPLETED|20-week Open Label Treatment Period||0
6802190|NCT02740972|7734308|FG001|NOT COMPLETED|20-week Open Label Treatment Period||0
6802191|NCT02740972|7734309|FG002|NOT COMPLETED|20-week Open Label Treatment Period||0
6802192|NCT02740972|7734310|FG003|NOT COMPLETED|20-week Open Label Treatment Period||0
6802193|NCT02740972|7734311|FG004|NOT COMPLETED|20-week Open Label Treatment Period||0
6802194|NCT02662985|7734330|FG000|STARTED|Treatment Period 1||83
6802195|NCT02662985|7734331|FG001|STARTED|Treatment Period 1||83
6802196|NCT02662985|7734330|FG000|COMPLETED|Treatment Period 1||82
6802197|NCT02662985|7734331|FG001|COMPLETED|Treatment Period 1||79
6802198|NCT02662985|7734330|FG000|NOT COMPLETED|Treatment Period 1||1
6802199|NCT02662985|7734331|FG001|NOT COMPLETED|Treatment Period 1||4
6802200|NCT02662985|7734330|FG000|STARTED|Treatment Period 2||82
6802201|NCT02662985|7734331|FG001|STARTED|Treatment Period 2||79
6802202|NCT02662985|7734330|FG000|COMPLETED|Treatment Period 2||81
6802203|NCT02662985|7734331|FG001|COMPLETED|Treatment Period 2||78
6802204|NCT02662985|7734330|FG000|NOT COMPLETED|Treatment Period 2||1
6802205|NCT02662985|7734331|FG001|NOT COMPLETED|Treatment Period 2||1
6802206|NCT02662985|7734330|FG000|STARTED|Treatment Period 3 (Extension Period)||81
6802207|NCT02662985|7734331|FG001|STARTED|Treatment Period 3 (Extension Period)||78
6802208|NCT02662985|7734330|FG000|COMPLETED|Treatment Period 3 (Extension Period)||75
6802209|NCT02662985|7734331|FG001|COMPLETED|Treatment Period 3 (Extension Period)||69
6802210|NCT02662985|7734330|FG000|NOT COMPLETED|Treatment Period 3 (Extension Period)||6
6802211|NCT02662985|7734331|FG001|NOT COMPLETED|Treatment Period 3 (Extension Period)||9
6802212|NCT02606461|7734341|FG000|STARTED|Overall Study||27
6802213|NCT02606461|7734342|FG001|STARTED|Overall Study||30
6802214|NCT02606461|7734343|FG002|STARTED|Overall Study||188
6802215|NCT02606461|7734344|FG003|STARTED|Overall Study||97
6802216|NCT02606461|7734341|FG000|Treated|Overall Study||27
6802217|NCT02606461|7734342|FG001|Treated|Overall Study||30
6802218|NCT02606461|7734343|FG002|Treated|Overall Study||187
6802219|NCT02606461|7734344|FG003|Treated|Overall Study||97
6802220|NCT02606461|7734341|FG000|Open Label|Overall Study||0
6802221|NCT02606461|7734342|FG001|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 2 double-blinded treatment, switched to open-label selinexor.|24
6802222|NCT02606461|7734343|FG002|Open Label|Overall Study||0
6802223|NCT02606461|7734344|FG003|Open Label|Overall Study|Participants in the placebo group who had PD during the Phase 3 double-blinded treatment, switched to open-label selinexor.|57
6802224|NCT02606461|7734341|FG000|COMPLETED|Overall Study||0
6802225|NCT02606461|7734342|FG001|COMPLETED|Overall Study||0
6802226|NCT02606461|7734343|FG002|COMPLETED|Overall Study||0
6802227|NCT02606461|7734344|FG003|COMPLETED|Overall Study||0
6802228|NCT02606461|7734341|FG000|NOT COMPLETED|Overall Study||27
6802229|NCT02606461|7734342|FG001|NOT COMPLETED|Overall Study||30
6802230|NCT02606461|7734343|FG002|NOT COMPLETED|Overall Study||188
6802231|NCT02606461|7734344|FG003|NOT COMPLETED|Overall Study||97
6802232|NCT02536339|7734357|FG000|STARTED|Overall Study||40
6802233|NCT02536339|7734357|FG000|Received at Least One Dose of Study Drug|Overall Study||39
6802234|NCT02536339|7734357|FG000|Efficacy-Evaluable Population|Overall Study|2 participants did not have post-baseline assessments and were not evaluable for efficacy.|37
6802235|NCT02536339|7734357|FG000|COMPLETED|Overall Study||12
6802236|NCT02536339|7734357|FG000|NOT COMPLETED|Overall Study||28
6802237|NCT02323295|7734363|FG000|STARTED|Overall Study||2
6802238|NCT02323295|7734364|FG001|STARTED|Overall Study||10
6802239|NCT02323295|7734363|FG000|COMPLETED|Overall Study||2
6802240|NCT02323295|7734364|FG001|COMPLETED|Overall Study||7
6802241|NCT02323295|7734363|FG000|NOT COMPLETED|Overall Study||0
6802242|NCT02323295|7734364|FG001|NOT COMPLETED|Overall Study||3
6802243|NCT02050308|7734372|FG000|STARTED|Overall Study||127
6802244|NCT02050308|7734373|FG001|STARTED|Overall Study||124
6802245|NCT02050308|7734372|FG000|COMPLETED|Overall Study||28
6802246|NCT02050308|7734373|FG001|COMPLETED|Overall Study||22
6802247|NCT02050308|7734372|FG000|NOT COMPLETED|Overall Study||99
6802248|NCT02050308|7734373|FG001|NOT COMPLETED|Overall Study||102
6802249|NCT02036970|7734394|FG000|STARTED|Part 1: Day 1 Through Week 16||6
6802250|NCT02036970|7734395|FG001|STARTED|Part 1: Day 1 Through Week 16||12
6802251|NCT02036970|7734396|FG002|STARTED|Part 1: Day 1 Through Week 16||11
6802252|NCT02036970|7734397|FG003|STARTED|Part 1: Day 1 Through Week 16||12
6802253|NCT02036970|7734398|FG004|STARTED|Part 1: Day 1 Through Week 16||2
6802254|NCT02036970|7734399|FG005|STARTED|Part 1: Day 1 Through Week 16||4
6802255|NCT02036970|7734400|FG006|STARTED|Part 1: Day 1 Through Week 16||3
6802256|NCT02036970|7734401|FG007|STARTED|Part 1: Day 1 Through Week 16||4
6802257|NCT02036970|7734402|FG008|STARTED|Part 1: Day 1 Through Week 16||74
6802258|NCT02036970|7734403|FG009|STARTED|Part 1: Day 1 Through Week 16||38
6802259|NCT02036970|7734394|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
6802260|NCT02036970|7734395|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
6802261|NCT02036970|7734396|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||11
6802262|NCT02036970|7734397|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||6
6802263|NCT02036970|7734398|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
6802264|NCT02036970|7734399|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
6802265|NCT02036970|7734400|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||3
6802266|NCT02036970|7734401|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||2
6802267|NCT02036970|7734402|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
6802268|NCT02036970|7734403|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 1: Day 1 Through Week 16||0
6802269|NCT02036970|7734394|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
6802270|NCT02036970|7734395|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
6802271|NCT02036970|7734396|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
6802272|NCT02036970|7734397|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||6
6802273|NCT02036970|7734398|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
6802274|NCT02036970|7734399|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
6802275|NCT02036970|7734400|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
6802276|NCT02036970|7734401|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||2
6802277|NCT02036970|7734402|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
6802278|NCT02036970|7734403|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 1: Day 1 Through Week 16||0
6802279|NCT02036970|7734394|FG000|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
6802280|NCT02036970|7734395|FG001|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
6802281|NCT02036970|7734396|FG002|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
6802282|NCT02036970|7734397|FG003|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
6802283|NCT02036970|7734398|FG004|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
6802284|NCT02036970|7734399|FG005|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
6802285|NCT02036970|7734400|FG006|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
6802286|NCT02036970|7734401|FG007|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||0
6802287|NCT02036970|7734402|FG008|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||14
6802288|NCT02036970|7734403|FG009|Cohort 3a: PAH CTD|Part 1: Day 1 Through Week 16||8
6802289|NCT02036970|7734394|FG000|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
6802290|NCT02036970|7734395|FG001|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
6802291|NCT02036970|7734396|FG002|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
6802292|NCT02036970|7734397|FG003|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
6802293|NCT02036970|7734398|FG004|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
6802294|NCT02036970|7734399|FG005|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
6802295|NCT02036970|7734400|FG006|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
6802296|NCT02036970|7734401|FG007|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||0
6802297|NCT02036970|7734402|FG008|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||16
6802298|NCT02036970|7734403|FG009|Cohort 3b: PAH Non-CTD|Part 1: Day 1 Through Week 16||9
6802299|NCT02036970|7734394|FG000|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
6802300|NCT02036970|7734395|FG001|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
6802301|NCT02036970|7734396|FG002|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
6802302|NCT02036970|7734397|FG003|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
6802303|NCT02036970|7734398|FG004|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
6802304|NCT02036970|7734399|FG005|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
6802305|NCT02036970|7734400|FG006|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
6802306|NCT02036970|7734401|FG007|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||0
6802307|NCT02036970|7734402|FG008|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||17
6802308|NCT02036970|7734403|FG009|Cohort 4a: PH CTD-ILD|Part 1: Day 1 Through Week 16||8
6802309|NCT02036970|7734394|FG000|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
6802310|NCT02036970|7734395|FG001|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
6802311|NCT02036970|7734396|FG002|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
6802312|NCT02036970|7734397|FG003|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
6802313|NCT02036970|7734398|FG004|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
6802314|NCT02036970|7734399|FG005|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
6802315|NCT02036970|7734400|FG006|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
6802316|NCT02036970|7734401|FG007|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||0
6802317|NCT02036970|7734402|FG008|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||6
6802318|NCT02036970|7734403|FG009|Cohort 4b: PH CTD-IPF|Part 1: Day 1 Through Week 16||2
6802319|NCT02036970|7734394|FG000|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
6802320|NCT02036970|7734395|FG001|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
6802321|NCT02036970|7734396|FG002|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
6802322|NCT02036970|7734397|FG003|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
6802323|NCT02036970|7734398|FG004|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
6802324|NCT02036970|7734399|FG005|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
6802325|NCT02036970|7734400|FG006|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
6802326|NCT02036970|7734401|FG007|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||0
6802327|NCT02036970|7734402|FG008|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||4
6802328|NCT02036970|7734403|FG009|Cohort 4c: PH CTD-IIP|Part 1: Day 1 Through Week 16||1
6802329|NCT02036970|7734394|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
6802330|NCT02036970|7734395|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
6802331|NCT02036970|7734396|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
6802332|NCT02036970|7734397|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
6802333|NCT02036970|7734398|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
6802334|NCT02036970|7734399|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
6802335|NCT02036970|7734400|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
6802336|NCT02036970|7734401|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||0
6802337|NCT02036970|7734402|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||17
6802338|NCT02036970|7734403|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 1: Day 1 Through Week 16||1
6802339|NCT02036970|7734394|FG000|COMPLETED|Part 1: Day 1 Through Week 16||5
6802340|NCT02036970|7734395|FG001|COMPLETED|Part 1: Day 1 Through Week 16||12
6802341|NCT02036970|7734396|FG002|COMPLETED|Part 1: Day 1 Through Week 16||7
6802342|NCT02036970|7734397|FG003|COMPLETED|Part 1: Day 1 Through Week 16||9
6802343|NCT02036970|7734398|FG004|COMPLETED|Part 1: Day 1 Through Week 16||1
6802344|NCT02036970|7734399|FG005|COMPLETED|Part 1: Day 1 Through Week 16||3
6802345|NCT02036970|7734400|FG006|COMPLETED|Part 1: Day 1 Through Week 16||3
6802346|NCT02036970|7734401|FG007|COMPLETED|Part 1: Day 1 Through Week 16||3
6802347|NCT02036970|7734402|FG008|COMPLETED|Part 1: Day 1 Through Week 16||66
6802348|NCT02036970|7734403|FG009|COMPLETED|Part 1: Day 1 Through Week 16||33
6802349|NCT02036970|7734394|FG000|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
6802350|NCT02036970|7734395|FG001|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
6802351|NCT02036970|7734396|FG002|NOT COMPLETED|Part 1: Day 1 Through Week 16||4
6802352|NCT02036970|7734397|FG003|NOT COMPLETED|Part 1: Day 1 Through Week 16||3
6802353|NCT02036970|7734398|FG004|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
6802354|NCT02036970|7734399|FG005|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
6802355|NCT02036970|7734400|FG006|NOT COMPLETED|Part 1: Day 1 Through Week 16||0
6802356|NCT02036970|7734401|FG007|NOT COMPLETED|Part 1: Day 1 Through Week 16||1
6802357|NCT02036970|7734402|FG008|NOT COMPLETED|Part 1: Day 1 Through Week 16||8
6802358|NCT02036970|7734403|FG009|NOT COMPLETED|Part 1: Day 1 Through Week 16||5
6802359|NCT02036970|7734394|FG000|STARTED|Part 2: Week 16 Onwards||5
6802360|NCT02036970|7734395|FG001|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|11
6802361|NCT02036970|7734396|FG002|STARTED|Part 2: Week 16 Onwards|One patient who completed Part 1 elected not to continue to Part 2.|6
6802362|NCT02036970|7734397|FG003|STARTED|Part 2: Week 16 Onwards||9
6802363|NCT02036970|7734398|FG004|STARTED|Part 2: Week 16 Onwards||1
6802364|NCT02036970|7734399|FG005|STARTED|Part 2: Week 16 Onwards||3
6802365|NCT02036970|7734400|FG006|STARTED|Part 2: Week 16 Onwards||3
6802366|NCT02036970|7734401|FG007|STARTED|Part 2: Week 16 Onwards||3
6802367|NCT02036970|7734402|FG008|STARTED|Part 2: Week 16 Onwards|Three patients who completed Part 1 elected not to continue to Part 2.|63
6802368|NCT02036970|7734403|FG009|STARTED|Part 2: Week 16 Onwards||33
6802369|NCT02036970|7734394|FG000|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
6802370|NCT02036970|7734395|FG001|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
6802371|NCT02036970|7734396|FG002|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||6
6802372|NCT02036970|7734397|FG003|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||5
6802373|NCT02036970|7734398|FG004|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
6802374|NCT02036970|7734399|FG005|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||1
6802375|NCT02036970|7734400|FG006|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||3
6802376|NCT02036970|7734401|FG007|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||2
6802377|NCT02036970|7734402|FG008|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
6802378|NCT02036970|7734403|FG009|Cohort 1: PAH (BL 6MWD <= 450 Meters)|Part 2: Week 16 Onwards||0
6802379|NCT02036970|7734394|FG000|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
6802380|NCT02036970|7734395|FG001|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||6
6802381|NCT02036970|7734396|FG002|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
6802382|NCT02036970|7734397|FG003|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||4
6802383|NCT02036970|7734398|FG004|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
6802384|NCT02036970|7734399|FG005|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||2
6802385|NCT02036970|7734400|FG006|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
6802386|NCT02036970|7734401|FG007|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||1
6802387|NCT02036970|7734402|FG008|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
6802388|NCT02036970|7734403|FG009|Cohort 2: PAH (BL 6MWD > 450 Meters)|Part 2: Week 16 Onwards||0
6802389|NCT02036970|7734394|FG000|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
6802390|NCT02036970|7734395|FG001|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
6802391|NCT02036970|7734396|FG002|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
6802392|NCT02036970|7734397|FG003|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
6802393|NCT02036970|7734398|FG004|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
6802394|NCT02036970|7734399|FG005|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
6802395|NCT02036970|7734400|FG006|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
6802396|NCT02036970|7734401|FG007|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||0
6802397|NCT02036970|7734402|FG008|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||12
6802398|NCT02036970|7734403|FG009|Cohort 3a: PAH CTD|Part 2: Week 16 Onwards||8
6802399|NCT02036970|7734394|FG000|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
6802400|NCT02036970|7734395|FG001|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
6802401|NCT02036970|7734396|FG002|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
6802402|NCT02036970|7734397|FG003|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
6802403|NCT02036970|7734398|FG004|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
6802404|NCT02036970|7734399|FG005|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
6802405|NCT02036970|7734400|FG006|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
6802406|NCT02036970|7734401|FG007|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||0
6802407|NCT02036970|7734402|FG008|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||12
6802408|NCT02036970|7734403|FG009|Cohort 3b: PAH Non-CTD|Part 2: Week 16 Onwards||7
6802409|NCT02036970|7734394|FG000|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
6802410|NCT02036970|7734395|FG001|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
6802411|NCT02036970|7734396|FG002|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
6802412|NCT02036970|7734397|FG003|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
6802413|NCT02036970|7734398|FG004|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
6802414|NCT02036970|7734399|FG005|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
6802415|NCT02036970|7734400|FG006|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
6802416|NCT02036970|7734401|FG007|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||0
6802417|NCT02036970|7734402|FG008|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||16
6802418|NCT02036970|7734403|FG009|Cohort 4a: PH CTD-ILD|Part 2: Week 16 Onwards||7
6802419|NCT02036970|7734394|FG000|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
6802420|NCT02036970|7734395|FG001|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
6802421|NCT02036970|7734396|FG002|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
6802422|NCT02036970|7734397|FG003|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
6802423|NCT02036970|7734398|FG004|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
6802424|NCT02036970|7734399|FG005|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
6802425|NCT02036970|7734400|FG006|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
6802426|NCT02036970|7734401|FG007|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||0
6802427|NCT02036970|7734402|FG008|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||5
6802428|NCT02036970|7734403|FG009|Cohort 4b: PH CTD-IPF|Part 2: Week 16 Onwards||2
6802429|NCT02036970|7734394|FG000|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
6564274|NCT01810432|7486990|FG000|STARTED|Washout||20
6564275|NCT01810432|7486991|FG001|STARTED|Washout||20
6802430|NCT02036970|7734395|FG001|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
6802431|NCT02036970|7734396|FG002|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
6802432|NCT02036970|7734397|FG003|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
6802433|NCT02036970|7734398|FG004|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
6802434|NCT02036970|7734399|FG005|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
6802435|NCT02036970|7734400|FG006|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
6802436|NCT02036970|7734401|FG007|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||0
6802437|NCT02036970|7734402|FG008|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||3
6802438|NCT02036970|7734403|FG009|Cohort 4c: PH CTD-IIP|Part 2: Week 16 Onwards||1
6802439|NCT02036970|7734394|FG000|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
6802440|NCT02036970|7734395|FG001|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
6802441|NCT02036970|7734396|FG002|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
6802442|NCT02036970|7734397|FG003|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
6802443|NCT02036970|7734398|FG004|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
6802444|NCT02036970|7734399|FG005|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
6802445|NCT02036970|7734400|FG006|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
6802446|NCT02036970|7734401|FG007|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||0
6802447|NCT02036970|7734402|FG008|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||15
6802448|NCT02036970|7734403|FG009|Cohort 4d: PH CTD-Sarcoidosis|Part 2: Week 16 Onwards||8
6564276|NCT01810432|7486990|FG000|COMPLETED|Washout||19
6564277|NCT01810432|7486991|FG001|COMPLETED|Washout||19
6564278|NCT01810432|7486990|FG000|NOT COMPLETED|Washout||1
6802449|NCT02036970|7734394|FG000|COMPLETED|Part 2: Week 16 Onwards||5
6802450|NCT02036970|7734395|FG001|COMPLETED|Part 2: Week 16 Onwards||6
6802451|NCT02036970|7734396|FG002|COMPLETED|Part 2: Week 16 Onwards||3
6802452|NCT02036970|7734397|FG003|COMPLETED|Part 2: Week 16 Onwards||7
6802453|NCT02036970|7734398|FG004|COMPLETED|Part 2: Week 16 Onwards||0
6802454|NCT02036970|7734399|FG005|COMPLETED|Part 2: Week 16 Onwards||3
6802455|NCT02036970|7734400|FG006|COMPLETED|Part 2: Week 16 Onwards||2
6802456|NCT02036970|7734401|FG007|COMPLETED|Part 2: Week 16 Onwards||2
6802457|NCT02036970|7734402|FG008|COMPLETED|Part 2: Week 16 Onwards||54
6802458|NCT02036970|7734403|FG009|COMPLETED|Part 2: Week 16 Onwards||28
6802459|NCT02036970|7734394|FG000|NOT COMPLETED|Part 2: Week 16 Onwards||0
6802460|NCT02036970|7734395|FG001|NOT COMPLETED|Part 2: Week 16 Onwards||5
6802461|NCT02036970|7734396|FG002|NOT COMPLETED|Part 2: Week 16 Onwards||3
6802462|NCT02036970|7734397|FG003|NOT COMPLETED|Part 2: Week 16 Onwards||2
6802463|NCT02036970|7734398|FG004|NOT COMPLETED|Part 2: Week 16 Onwards||1
6802464|NCT02036970|7734399|FG005|NOT COMPLETED|Part 2: Week 16 Onwards||0
6802465|NCT02036970|7734400|FG006|NOT COMPLETED|Part 2: Week 16 Onwards||1
6802466|NCT02036970|7734401|FG007|NOT COMPLETED|Part 2: Week 16 Onwards||1
6802467|NCT02036970|7734402|FG008|NOT COMPLETED|Part 2: Week 16 Onwards||9
6802468|NCT02036970|7734403|FG009|NOT COMPLETED|Part 2: Week 16 Onwards||5
6802469|NCT01958021|7734437|FG000|STARTED|Overall Study||334
6802470|NCT01958021|7734438|FG001|STARTED|Overall Study||334
6802471|NCT01958021|7734437|FG000|Patients Untreated|Overall Study||0
6802472|NCT01958021|7734438|FG001|Patients Untreated|Overall Study||4
6802473|NCT01958021|7734437|FG000|Patients Treated|Overall Study||334
6802474|NCT01958021|7734438|FG001|Patients Treated|Overall Study||330
6802475|NCT01958021|7734437|FG000|COMPLETED|Overall Study|Completed = Treatment ongoing|195
6802476|NCT01958021|7734438|FG001|COMPLETED|Overall Study|Completed = Treatment ongoing|154
6802477|NCT01958021|7734437|FG000|NOT COMPLETED|Overall Study||139
6802478|NCT01958021|7734438|FG001|NOT COMPLETED|Overall Study||180
6802479|NCT01941719|7734446|FG000|STARTED|Overall Study||48
6802480|NCT01941719|7734447|FG001|STARTED|Overall Study||51
6802481|NCT01941719|7734446|FG000|Month 1|Overall Study||43
6802482|NCT01941719|7734447|FG001|Month 1|Overall Study||48
6802483|NCT01941719|7734446|FG000|Month 3|Overall Study||38
6802484|NCT01941719|7734447|FG001|Month 3|Overall Study||44
6802485|NCT01941719|7734446|FG000|Month 6|Overall Study||34
6802486|NCT01941719|7734447|FG001|Month 6|Overall Study||42
6802487|NCT01941719|7734446|FG000|Month 9|Overall Study||29
6802488|NCT01941719|7734447|FG001|Month 9|Overall Study||37
6802489|NCT01941719|7734446|FG000|Month 12|Overall Study||28
6802490|NCT01941719|7734447|FG001|Month 12|Overall Study||32
6802491|NCT01941719|7734446|FG000|COMPLETED|Overall Study||28
6802492|NCT01941719|7734447|FG001|COMPLETED|Overall Study||32
6802493|NCT01941719|7734446|FG000|NOT COMPLETED|Overall Study||20
6802494|NCT01941719|7734447|FG001|NOT COMPLETED|Overall Study||19
6802495|NCT01828099|7734456|FG000|STARTED|Overall Study||189
6802496|NCT01828099|7734457|FG001|STARTED|Overall Study||187
6802497|NCT01828099|7734456|FG000|Untreated Patients|Overall Study||0
6802498|NCT01828099|7734457|FG001|Untreated Patients|Overall Study||12
6802499|NCT01828099|7734456|FG000|Treated|Overall Study|discontinued from treatment phase = Not completed|189
6802500|NCT01828099|7734457|FG001|Treated|Overall Study||175
6802501|NCT01828099|7734456|FG000|Discontinued From Treatment Phase|Overall Study||94
6802502|NCT01828099|7734457|FG001|Discontinued From Treatment Phase|Overall Study||157
6802503|NCT01828099|7734456|FG000|Entered Extension-treatment Phase|Overall Study||0
6802504|NCT01828099|7734457|FG001|Entered Extension-treatment Phase|Overall Study||81
6802505|NCT01828099|7734456|FG000|Entered Post-treatment Follow-up Phase|Overall Study||10
6802506|NCT01828099|7734457|FG001|Entered Post-treatment Follow-up Phase|Overall Study||16
6802507|NCT01828099|7734456|FG000|Entered Survival Follow-up Phase|Overall Study||64
6802508|NCT01828099|7734457|FG001|Entered Survival Follow-up Phase|Overall Study||31
6802509|NCT01828099|7734456|FG000|Discontinued From Study|Overall Study||20
6802510|NCT01828099|7734457|FG001|Discontinued From Study|Overall Study||29
6802511|NCT01828099|7734456|FG000|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|95
6802512|NCT01828099|7734457|FG001|COMPLETED|Overall Study|Completed = Patients ongoing at the time of data cut-off of 24-Jun-2016|30
6802513|NCT01828099|7734456|FG000|NOT COMPLETED|Overall Study||94
6802514|NCT01828099|7734457|FG001|NOT COMPLETED|Overall Study||157
6802515|NCT01593254|7734465|FG000|STARTED|Treatment Period||86
6802516|NCT01593254|7734466|FG001|STARTED|Treatment Period||174
6802517|NCT01593254|7734465|FG000|Crossed Over to Dasatinib|Treatment Period||42
6802518|NCT01593254|7734466|FG001|Crossed Over to Dasatinib|Treatment Period||0
6802519|NCT01593254|7734465|FG000|COMPLETED|Treatment Period||72
6802520|NCT01593254|7734466|FG001|COMPLETED|Treatment Period||143
6802521|NCT01593254|7734465|FG000|NOT COMPLETED|Treatment Period||14
6802522|NCT01593254|7734466|FG001|NOT COMPLETED|Treatment Period||31
6802523|NCT01593254|7734465|FG000|STARTED|Follow-Up Period||14
6802524|NCT01593254|7734466|FG001|STARTED|Follow-Up Period||28
6802525|NCT01593254|7734465|FG000|COMPLETED|Follow-Up Period||11
6802526|NCT01593254|7734466|FG001|COMPLETED|Follow-Up Period||17
6802527|NCT01593254|7734465|FG000|NOT COMPLETED|Follow-Up Period||3
6802528|NCT01593254|7734466|FG001|NOT COMPLETED|Follow-Up Period||11
6802529|NCT01578967|7734473|FG000|STARTED|Overall Study||41
6802530|NCT01578967|7734473|FG000|COMPLETED|Overall Study||41
6802531|NCT01578967|7734473|FG000|NOT COMPLETED|Overall Study||0
6802532|NCT01186003|7734482|FG000|STARTED|Overall Study||14
6802533|NCT01186003|7734483|FG001|STARTED|Overall Study||16
6802534|NCT01186003|7734482|FG000|COMPLETED|Overall Study||14
6802535|NCT01186003|7734483|FG001|COMPLETED|Overall Study||16
6802536|NCT01186003|7734482|FG000|NOT COMPLETED|Overall Study||0
6802537|NCT01186003|7734483|FG001|NOT COMPLETED|Overall Study||0
6802538|NCT00943618|7734492|FG000|STARTED|Overall Study||163
6802539|NCT00943618|7734493|FG001|STARTED|Overall Study||166
6802540|NCT00943618|7734494|FG002|STARTED|Overall Study||56
6802541|NCT00943618|7734492|FG000|COMPLETED|Overall Study||108
6802542|NCT00943618|7734493|FG001|COMPLETED|Overall Study||89
6802543|NCT00943618|7734494|FG002|COMPLETED|Overall Study||25
6802544|NCT00943618|7734492|FG000|NOT COMPLETED|Overall Study||55
6802545|NCT00943618|7734493|FG001|NOT COMPLETED|Overall Study||77
6802546|NCT00943618|7734494|FG002|NOT COMPLETED|Overall Study||31
6802547|NCT00529763|7734505|FG000|STARTED|Overall Study||25
6802548|NCT00529763|7734506|FG001|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
6802549|NCT00529763|7734507|FG002|STARTED|Overall Study||59
6802550|NCT00529763|7734505|FG000|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
6802551|NCT00529763|7734506|FG001|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
6802552|NCT00529763|7734507|FG002|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
6802553|NCT00529763|7734505|FG000|NOT COMPLETED|Overall Study||10
6802554|NCT00529763|7734506|FG001|NOT COMPLETED|Overall Study||33
6802555|NCT00529763|7734507|FG002|NOT COMPLETED|Overall Study||7
6802556|NCT03938272|7734524|FG000|STARTED|Overall Study||11
6802557|NCT03938272|7734525|FG001|STARTED|Overall Study||11
6802558|NCT03938272|7734524|FG000|COMPLETED|Overall Study||0
6802559|NCT03938272|7734525|FG001|COMPLETED|Overall Study||1
6802560|NCT03938272|7734524|FG000|NOT COMPLETED|Overall Study||11
6802561|NCT03938272|7734525|FG001|NOT COMPLETED|Overall Study||10
6802562|NCT03641339|7734537|FG000|STARTED|Overall Study||16
6802563|NCT03641339|7734538|FG001|STARTED|Overall Study||17
6802564|NCT03641339|7734539|FG002|STARTED|Overall Study||15
6802565|NCT03641339|7734540|FG003|STARTED|Overall Study||16
6802566|NCT03641339|7734541|FG004|STARTED|Overall Study||15
6802567|NCT03641339|7734542|FG005|STARTED|Overall Study||16
6802568|NCT03641339|7734537|FG000|COMPLETED|Overall Study||15
6802569|NCT03641339|7734538|FG001|COMPLETED|Overall Study||15
6802570|NCT03641339|7734539|FG002|COMPLETED|Overall Study||15
6380760|NCT00781365|7291625|FG001|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
6380761|NCT00781365|7291624|FG000|NOT COMPLETED|Overall Study||34
6380762|NCT00781365|7291625|FG001|NOT COMPLETED|Overall Study||36
6380763|NCT00781391|7291634|FG000|STARTED|Overall Study||7036
6380764|NCT00781391|7291635|FG001|STARTED|Overall Study||7035
6380765|NCT00781391|7291636|FG002|STARTED|Overall Study||7034
6380766|NCT00781391|7291634|FG000|Safety Analysis Set (Received Drug)|Overall Study||7012
6380767|NCT00781391|7291635|FG001|Safety Analysis Set (Received Drug)|Overall Study||7012
6380768|NCT00781391|7291636|FG002|Safety Analysis Set (Received Drug)|Overall Study||7002
6380769|NCT00781391|7291634|FG000|mITT Analysis Set (Received Drug)|Overall Study||7012
6380770|NCT00781391|7291635|FG001|mITT Analysis Set (Received Drug)|Overall Study||7012
6380771|NCT00781391|7291636|FG002|mITT Analysis Set (Received Drug)|Overall Study||7002
6380772|NCT00781391|7291634|FG000|Per Protocol Analysis Set|Overall Study||6993
6380773|NCT00781391|7291635|FG001|Per Protocol Analysis Set|Overall Study||6995
6380774|NCT00781391|7291636|FG002|Per Protocol Analysis Set|Overall Study||6982
6380775|NCT00781391|7291634|FG000|COMPLETED|Overall Study||6157
6380776|NCT00781391|7291635|FG001|COMPLETED|Overall Study||6228
6380777|NCT00781391|7291636|FG002|COMPLETED|Overall Study||6250
6380778|NCT00781391|7291634|FG000|NOT COMPLETED|Overall Study||879
6380779|NCT00781391|7291635|FG001|NOT COMPLETED|Overall Study||807
6380780|NCT00781391|7291636|FG002|NOT COMPLETED|Overall Study||784
6380781|NCT00781456|7291646|FG000|STARTED|Overall Study||58
6380782|NCT00781456|7291647|FG001|STARTED|Overall Study||51
6380783|NCT00781456|7291646|FG000|Received Study Drug|Overall Study||57
6380784|NCT00781456|7291647|FG001|Received Study Drug|Overall Study||49
6380785|NCT00781456|7291646|FG000|COMPLETED|Overall Study||37
6380786|NCT00781456|7291647|FG001|COMPLETED|Overall Study||35
6380787|NCT00781456|7291646|FG000|NOT COMPLETED|Overall Study||21
6380788|NCT00781456|7291647|FG001|NOT COMPLETED|Overall Study||16
6380789|NCT00781508|7291655|FG000|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
6380790|NCT00781508|7291656|FG001|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
6380791|NCT00781508|7291655|FG000|COMPLETED|Overall Study||5
6380792|NCT00781508|7291656|FG001|COMPLETED|Overall Study||5
6380793|NCT00781508|7291655|FG000|NOT COMPLETED|Overall Study||0
6380794|NCT00781508|7291656|FG001|NOT COMPLETED|Overall Study||0
6380795|NCT00781599|7291666|FG000|STARTED|Overall Study||36
6380796|NCT00781599|7291667|FG001|STARTED|Overall Study||36
6380797|NCT00781599|7291666|FG000|COMPLETED|Overall Study||29
6380798|NCT00781599|7291667|FG001|COMPLETED|Overall Study||32
6380799|NCT00781599|7291666|FG000|NOT COMPLETED|Overall Study||7
6380800|NCT00781599|7291667|FG001|NOT COMPLETED|Overall Study||4
6502580|NCT01435928|7421302|FG000|COMPLETED|Open Label Phase - up to 24 Weeks||287
6502581|NCT01435928|7421303|FG001|COMPLETED|Open Label Phase - up to 24 Weeks||0
6502582|NCT01435928|7421304|FG002|COMPLETED|Open Label Phase - up to 24 Weeks||0
6502583|NCT01435928|7421302|FG000|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
6502584|NCT01435928|7421303|FG001|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
6502585|NCT01435928|7421304|FG002|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
6502586|NCT01435928|7421302|FG000|STARTED|Double Blind Phase - 28 Weeks||0
6502587|NCT01435928|7421303|FG001|STARTED|Double Blind Phase - 28 Weeks||144
6502588|NCT01435928|7421304|FG002|STARTED|Double Blind Phase - 28 Weeks||141
6502589|NCT01435928|7421302|FG000|COMPLETED|Double Blind Phase - 28 Weeks||0
6502590|NCT01435928|7421303|FG001|COMPLETED|Double Blind Phase - 28 Weeks||28
6502591|NCT01435928|7421304|FG002|COMPLETED|Double Blind Phase - 28 Weeks||20
6502592|NCT01435928|7421302|FG000|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
6502593|NCT01435928|7421303|FG001|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
6502594|NCT01435928|7421304|FG002|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
6502595|NCT01436006|7421311|FG000|STARTED|Overall Study||6700
6502596|NCT01436006|7421311|FG000|COMPLETED|Overall Study||6663
6502597|NCT01436006|7421311|FG000|NOT COMPLETED|Overall Study||37
6502598|NCT01436045|7421323|FG000|STARTED|Overall Study||6
6502599|NCT01436045|7421324|FG001|STARTED|Overall Study||6
6502600|NCT01436045|7421323|FG000|COMPLETED|Overall Study||6
6502601|NCT01436045|7421324|FG001|COMPLETED|Overall Study||6
6502602|NCT01436045|7421323|FG000|NOT COMPLETED|Overall Study||0
6502603|NCT01436045|7421324|FG001|NOT COMPLETED|Overall Study||0
6802571|NCT03641339|7734540|FG003|COMPLETED|Overall Study||14
6802572|NCT03641339|7734541|FG004|COMPLETED|Overall Study||15
6380801|NCT00781768|7291675|FG000|STARTED|Overall Study||89
6380802|NCT00781768|7291676|FG001|STARTED|Overall Study||92
6380803|NCT00781768|7291675|FG000|COMPLETED|Overall Study||89
6380804|NCT00781768|7291676|FG001|COMPLETED|Overall Study||90
6802573|NCT03641339|7734542|FG005|COMPLETED|Overall Study||15
6802574|NCT03641339|7734537|FG000|NOT COMPLETED|Overall Study||1
6802575|NCT03641339|7734538|FG001|NOT COMPLETED|Overall Study||2
6802576|NCT03641339|7734539|FG002|NOT COMPLETED|Overall Study||0
6802577|NCT03641339|7734540|FG003|NOT COMPLETED|Overall Study||2
6802578|NCT03641339|7734541|FG004|NOT COMPLETED|Overall Study||0
6802579|NCT03641339|7734542|FG005|NOT COMPLETED|Overall Study||1
6802580|NCT03625466|7734558|FG000|STARTED|Overall Study||16
6802581|NCT03625466|7734559|FG001|STARTED|Overall Study||35
6802582|NCT03625466|7734558|FG000|COMPLETED|Overall Study||16
6802583|NCT03625466|7734559|FG001|COMPLETED|Overall Study||33
6802584|NCT03625466|7734558|FG000|NOT COMPLETED|Overall Study||0
6802585|NCT03625466|7734559|FG001|NOT COMPLETED|Overall Study||2
6802586|NCT03476239|7734565|FG000|STARTED|Overall Study||106
6802587|NCT03476239|7734565|FG000|Enrolled Before 21 February 2019|Overall Study||91
6802588|NCT03476239|7734565|FG000|Interim Analysis Set|Overall Study||90
6802589|NCT03476239|7734565|FG000|COMPLETED|Overall Study||0
6802590|NCT03476239|7734565|FG000|NOT COMPLETED|Overall Study||106
6802591|NCT03317795|7734571|FG000|STARTED|Overall Study||9
6802592|NCT03317795|7734572|FG001|STARTED|Overall Study||9
6802593|NCT03317795|7734571|FG000|COMPLETED|Overall Study||7
6802594|NCT03317795|7734572|FG001|COMPLETED|Overall Study||2
6802595|NCT03317795|7734571|FG000|NOT COMPLETED|Overall Study||2
6802596|NCT03317795|7734572|FG001|NOT COMPLETED|Overall Study||7
6802597|NCT03287245|7734582|FG000|STARTED|Overall Study||15
6802598|NCT03287245|7734583|FG001|STARTED|Overall Study||5
6802599|NCT03287245|7734584|FG002|STARTED|Overall Study||6
6802600|NCT03287245|7734585|FG003|STARTED|Overall Study||1
6802601|NCT03287245|7734582|FG000|COMPLETED|Overall Study||0
6802602|NCT03287245|7734583|FG001|COMPLETED|Overall Study||0
6802603|NCT03287245|7734584|FG002|COMPLETED|Overall Study||0
6802604|NCT03287245|7734585|FG003|COMPLETED|Overall Study||0
6802605|NCT03287245|7734582|FG000|NOT COMPLETED|Overall Study||15
6564279|NCT01810432|7486991|FG001|NOT COMPLETED|Washout||1
6564280|NCT01810432|7486990|FG000|STARTED|Period 2||19
6564281|NCT01810432|7486991|FG001|STARTED|Period 2||19
6380805|NCT00781768|7291675|FG000|NOT COMPLETED|Overall Study||0
6380806|NCT00781768|7291676|FG001|NOT COMPLETED|Overall Study||2
6380807|NCT00781859|7291684|FG000|STARTED|Overall Study||219
6380808|NCT00781859|7291685|FG001|STARTED|Overall Study||107
6380809|NCT00781859|7291684|FG000|COMPLETED|Overall Study||200
6380810|NCT00781859|7291685|FG001|COMPLETED|Overall Study||98
6380811|NCT00781859|7291684|FG000|NOT COMPLETED|Overall Study||19
6380812|NCT00781859|7291685|FG001|NOT COMPLETED|Overall Study||9
6380813|NCT00781885|7291691|FG000|STARTED|Overall Study||19
6380814|NCT00781885|7291691|FG000|Received at Least 1 Dose of Study Drug|Overall Study||19
6380815|NCT00781885|7291691|FG000|COMPLETED|Overall Study||18
6380816|NCT00781885|7291691|FG000|NOT COMPLETED|Overall Study||1
6380817|NCT00781898|7291697|FG000|STARTED|Overall Study||153
6380818|NCT00781898|7291698|FG001|STARTED|Overall Study||155
6380819|NCT00781898|7291697|FG000|COMPLETED|Overall Study||119
6380820|NCT00781898|7291698|FG001|COMPLETED|Overall Study||126
6380821|NCT00781898|7291697|FG000|NOT COMPLETED|Overall Study||34
6380822|NCT00781898|7291698|FG001|NOT COMPLETED|Overall Study||29
6380823|NCT00781911|7291706|FG000|STARTED|Overall Study||31
6380824|NCT00781911|7291707|FG001|STARTED|Overall Study||12
6380825|NCT00781911|7291706|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
6380826|NCT00781911|7291707|FG001|Received at Least 1 Dose of Study Drug|Overall Study||12
6380827|NCT00781911|7291706|FG000|COMPLETED|Overall Study||25
6380828|NCT00781911|7291707|FG001|COMPLETED|Overall Study||4
6380829|NCT00781911|7291706|FG000|NOT COMPLETED|Overall Study||6
6380830|NCT00781911|7291707|FG001|NOT COMPLETED|Overall Study||8
6395586|NCT00859222|7308175|FG002|STARTED|Overall Study||6
6395587|NCT00859222|7308176|FG003|STARTED|Overall Study||24
6395588|NCT00859222|7308177|FG004|STARTED|Overall Study||15
6395589|NCT00859222|7308173|FG000|COMPLETED|Overall Study||0
6395590|NCT00859222|7308174|FG001|COMPLETED|Overall Study||0
6395591|NCT00859222|7308175|FG002|COMPLETED|Overall Study||0
6802606|NCT03287245|7734583|FG001|NOT COMPLETED|Overall Study||5
6802607|NCT03287245|7734584|FG002|NOT COMPLETED|Overall Study||6
6395592|NCT00859222|7308176|FG003|COMPLETED|Overall Study||0
6395593|NCT00859222|7308177|FG004|COMPLETED|Overall Study||0
6564282|NCT01810432|7486990|FG000|Received at Least 1 Dose of Study Drug|Period 2||19
6802608|NCT03287245|7734585|FG003|NOT COMPLETED|Overall Study||1
6802609|NCT03165916|7734617|FG000|STARTED|Overall Study||58
6802610|NCT03165916|7734618|FG001|STARTED|Overall Study||57
6802611|NCT03165916|7734617|FG000|Reconstruction Interventions|Overall Study||59
6802612|NCT03165916|7734618|FG001|Reconstruction Interventions|Overall Study||57
6802613|NCT03165916|7734617|FG000|COMPLETED|Overall Study||58
6802614|NCT03165916|7734618|FG001|COMPLETED|Overall Study||57
6395594|NCT00859222|7308173|FG000|NOT COMPLETED|Overall Study||3
6395595|NCT00859222|7308174|FG001|NOT COMPLETED|Overall Study||3
6395596|NCT00859222|7308175|FG002|NOT COMPLETED|Overall Study||6
6802615|NCT03165916|7734617|FG000|NOT COMPLETED|Overall Study||0
6802616|NCT03165916|7734618|FG001|NOT COMPLETED|Overall Study||0
6802617|NCT03092219|7734626|FG000|STARTED|Overall Study||150
6802618|NCT03092219|7734627|FG001|STARTED|Overall Study||52
6802619|NCT03092219|7734626|FG000|Baseline / ITT Population|Overall Study||150
6802620|NCT03092219|7734627|FG001|Baseline / ITT Population|Overall Study|Subject randomized to No Treatment group but received treatment at Visit 1.|51
6802621|NCT03092219|7734626|FG000|Primary Analysis Endpoint|Overall Study||150
6802622|NCT03092219|7734627|FG001|Primary Analysis Endpoint|Overall Study||51
6802623|NCT03092219|7734626|FG000|Pooled SAFT Population|Overall Study||150
6802624|NCT03092219|7734627|FG001|Pooled SAFT Population|Overall Study|2 subjects did not receive treatment at Visit 1b.|50
6802625|NCT03092219|7734626|FG000|COMPLETED|Overall Study||143
6802626|NCT03092219|7734627|FG001|COMPLETED|Overall Study||48
6802627|NCT03092219|7734626|FG000|NOT COMPLETED|Overall Study||7
6802628|NCT03092219|7734627|FG001|NOT COMPLETED|Overall Study||4
6802629|NCT03033069|7734640|FG000|STARTED|Overall Study||82
6802630|NCT03033069|7734641|FG001|STARTED|Overall Study||75
6802631|NCT03033069|7734642|FG002|STARTED|Overall Study||81
6802632|NCT03033069|7734643|FG003|STARTED|Overall Study||83
6802633|NCT03033069|7734640|FG000|Safety Sample|Overall Study||80
6802634|NCT03033069|7734641|FG001|Safety Sample|Overall Study||75
6802635|NCT03033069|7734642|FG002|Safety Sample|Overall Study||79
6802636|NCT03033069|7734643|FG003|Safety Sample|Overall Study||82
6802637|NCT03033069|7734640|FG000|Intent to Treat (ITT) Sample|Overall Study||79
6802638|NCT03033069|7734641|FG001|Intent to Treat (ITT) Sample|Overall Study||72
6802639|NCT03033069|7734642|FG002|Intent to Treat (ITT) Sample|Overall Study||77
6802640|NCT03033069|7734643|FG003|Intent to Treat (ITT) Sample|Overall Study||80
6802641|NCT03033069|7734640|FG000|COMPLETED|Overall Study||58
6802642|NCT03033069|7734641|FG001|COMPLETED|Overall Study||50
6802643|NCT03033069|7734642|FG002|COMPLETED|Overall Study||59
6802644|NCT03033069|7734643|FG003|COMPLETED|Overall Study||64
6802645|NCT03033069|7734640|FG000|NOT COMPLETED|Overall Study||24
6802646|NCT03033069|7734641|FG001|NOT COMPLETED|Overall Study||25
6802647|NCT03033069|7734642|FG002|NOT COMPLETED|Overall Study||22
6802648|NCT03033069|7734643|FG003|NOT COMPLETED|Overall Study||19
6802649|NCT02956434|7734657|FG000|STARTED|Overall Study||10
6380831|NCT00781937|7291717|FG000|STARTED|Main Trial Period Through Week 56||212
6380832|NCT00781937|7291718|FG001|STARTED|Main Trial Period Through Week 56||210
6380833|NCT00781937|7291717|FG000|COMPLETED|Main Trial Period Through Week 56||159
6502604|NCT01436071|7421332|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|124
6502605|NCT01436071|7421333|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|124
6502606|NCT01436071|7421332|FG000|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
6502607|NCT01436071|7421333|FG001|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
6502608|NCT01436071|7421332|FG000|COMPLETED|Overall Study||98
6502609|NCT01436071|7421333|FG001|COMPLETED|Overall Study||110
6502610|NCT01436071|7421332|FG000|NOT COMPLETED|Overall Study||26
6502611|NCT01436071|7421333|FG001|NOT COMPLETED|Overall Study||14
6502612|NCT01436110|7421342|FG000|STARTED|Overall Study|These participants were randomized to trial medication.|116
6502613|NCT01436110|7421343|FG001|STARTED|Overall Study|These participants were randomized to trial medication.|117
6502614|NCT01436110|7421344|FG002|STARTED|Overall Study|These participants were randomized to trial medication.|118
6502615|NCT01436110|7421342|FG000|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
6502616|NCT01436110|7421343|FG001|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
6502617|NCT01436110|7421344|FG002|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
6502618|NCT01436110|7421342|FG000|COMPLETED|Overall Study||77
6502619|NCT01436110|7421343|FG001|COMPLETED|Overall Study||91
6502620|NCT01436110|7421344|FG002|COMPLETED|Overall Study||95
6502621|NCT01436110|7421342|FG000|NOT COMPLETED|Overall Study||39
6502622|NCT01436110|7421343|FG001|NOT COMPLETED|Overall Study||26
6502623|NCT01436110|7421344|FG002|NOT COMPLETED|Overall Study||23
6502624|NCT01436149|7421354|FG000|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
6502625|NCT01436149|7421355|FG001|STARTED|Antidepressant Lead-in Phase||0
6502626|NCT01436149|7421356|FG002|STARTED|Antidepressant Lead-in Phase||0
6502627|NCT01436149|7421354|FG000|COMPLETED|Antidepressant Lead-in Phase||896
6502628|NCT01436149|7421355|FG001|COMPLETED|Antidepressant Lead-in Phase||0
6502629|NCT01436149|7421356|FG002|COMPLETED|Antidepressant Lead-in Phase||0
6502630|NCT01436149|7421354|FG000|NOT COMPLETED|Antidepressant Lead-in Phase||366
6502631|NCT01436149|7421355|FG001|NOT COMPLETED|Antidepressant Lead-in Phase||0
6502632|NCT01436149|7421356|FG002|NOT COMPLETED|Antidepressant Lead-in Phase||0
6502633|NCT01436149|7421354|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
6802650|NCT02956434|7734658|FG001|STARTED|Overall Study||10
6802651|NCT02956434|7734659|FG002|STARTED|Overall Study||10
6802652|NCT02956434|7734660|FG003|STARTED|Overall Study||10
6380834|NCT00781937|7291718|FG001|COMPLETED|Main Trial Period Through Week 56||146
6802653|NCT02956434|7734657|FG000|COMPLETED|Overall Study||10
6802654|NCT02956434|7734658|FG001|COMPLETED|Overall Study||10
6802655|NCT02956434|7734659|FG002|COMPLETED|Overall Study||10
6802656|NCT02956434|7734660|FG003|COMPLETED|Overall Study||10
6802657|NCT02956434|7734657|FG000|NOT COMPLETED|Overall Study||0
6802658|NCT02956434|7734658|FG001|NOT COMPLETED|Overall Study||0
6802659|NCT02956434|7734659|FG002|NOT COMPLETED|Overall Study||0
6802660|NCT02956434|7734660|FG003|NOT COMPLETED|Overall Study||0
6802661|NCT02663622|7734672|FG000|STARTED|Overall Study||6
6802662|NCT02663622|7734673|FG001|STARTED|Overall Study||6
6802663|NCT02663622|7734674|FG002|STARTED|Overall Study||6
6802664|NCT02663622|7734675|FG003|STARTED|Overall Study||26
6802665|NCT02663622|7734672|FG000|COMPLETED|Overall Study||3
6802666|NCT02663622|7734673|FG001|COMPLETED|Overall Study||5
6802667|NCT02663622|7734674|FG002|COMPLETED|Overall Study||5
6802668|NCT02663622|7734675|FG003|COMPLETED|Overall Study||11
6802669|NCT02663622|7734672|FG000|NOT COMPLETED|Overall Study||3
6802670|NCT02663622|7734673|FG001|NOT COMPLETED|Overall Study||1
6802671|NCT02663622|7734674|FG002|NOT COMPLETED|Overall Study||1
6802672|NCT02663622|7734675|FG003|NOT COMPLETED|Overall Study||15
6802673|NCT02609503|7734686|FG000|STARTED|Overall Study||29
6802674|NCT02609503|7734686|FG000|COMPLETED|Overall Study||25
6802675|NCT02609503|7734686|FG000|NOT COMPLETED|Overall Study||4
6802676|NCT02587598|7734704|FG000|STARTED|Overall Study||4
6802677|NCT02587598|7734705|FG001|STARTED|Overall Study||11
6802678|NCT02587598|7734706|FG002|STARTED|Overall Study||4
6802679|NCT02587598|7734707|FG003|STARTED|Overall Study||21
6802680|NCT02587598|7734708|FG004|STARTED|Overall Study||12
6802681|NCT02587598|7734709|FG005|STARTED|Overall Study||6
6802682|NCT02587598|7734710|FG006|STARTED|Overall Study||6
6802683|NCT02587598|7734711|FG007|STARTED|Overall Study||7
6802684|NCT02587598|7734712|FG008|STARTED|Overall Study||9
6802685|NCT02587598|7734713|FG009|STARTED|Overall Study||3
6802686|NCT02587598|7734714|FG010|STARTED|Overall Study||14
6802687|NCT02587598|7734704|FG000|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802688|NCT02587598|7734705|FG001|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802689|NCT02587598|7734706|FG002|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802690|NCT02587598|7734707|FG003|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802691|NCT02587598|7734708|FG004|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802692|NCT02587598|7734709|FG005|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802693|NCT02587598|7734710|FG006|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802694|NCT02587598|7734711|FG007|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802695|NCT02587598|7734712|FG008|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802696|NCT02587598|7734713|FG009|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802697|NCT02587598|7734714|FG010|COMPLETED|Overall Study|All participants discontinued study treatment and withdrew from the study.|0
6802698|NCT02587598|7734704|FG000|NOT COMPLETED|Overall Study||4
6802699|NCT02587598|7734705|FG001|NOT COMPLETED|Overall Study||11
6802700|NCT02587598|7734706|FG002|NOT COMPLETED|Overall Study||4
6802701|NCT02587598|7734707|FG003|NOT COMPLETED|Overall Study||21
6802702|NCT02587598|7734708|FG004|NOT COMPLETED|Overall Study||12
6802703|NCT02587598|7734709|FG005|NOT COMPLETED|Overall Study||6
6802704|NCT02587598|7734710|FG006|NOT COMPLETED|Overall Study||6
6802705|NCT02587598|7734711|FG007|NOT COMPLETED|Overall Study||7
6802706|NCT02587598|7734712|FG008|NOT COMPLETED|Overall Study||9
6802707|NCT02587598|7734713|FG009|NOT COMPLETED|Overall Study||3
6802708|NCT02587598|7734714|FG010|NOT COMPLETED|Overall Study||14
6802709|NCT02485574|7734750|FG000|STARTED|Overall Study||69
6802710|NCT02485574|7734750|FG000|COMPLETED|Overall Study||65
6802711|NCT02485574|7734750|FG000|NOT COMPLETED|Overall Study||4
6802712|NCT02214160|7734762|FG000|STARTED|Overall Study||24
6802713|NCT02214160|7734763|FG001|STARTED|Overall Study||37
6802714|NCT02214160|7734764|FG002|STARTED|Overall Study||33
6802715|NCT02214160|7734762|FG000|COMPLETED|Overall Study||20
6802716|NCT02214160|7734763|FG001|COMPLETED|Overall Study||29
6802717|NCT02214160|7734764|FG002|COMPLETED|Overall Study||23
6802718|NCT02214160|7734762|FG000|NOT COMPLETED|Overall Study||4
6802719|NCT02214160|7734763|FG001|NOT COMPLETED|Overall Study||8
6802720|NCT02214160|7734764|FG002|NOT COMPLETED|Overall Study||10
6802721|NCT01899261|7734776|FG000|STARTED|Overall Study||20
6802722|NCT01899261|7734776|FG000|COMPLETED|Overall Study||20
6802723|NCT01899261|7734776|FG000|NOT COMPLETED|Overall Study||0
6802724|NCT01612351|7734780|FG000|STARTED|Chemotherapy||40
6802725|NCT01612351|7734780|FG000|COMPLETED|Chemotherapy||40
6802726|NCT01612351|7734780|FG000|NOT COMPLETED|Chemotherapy||0
6802727|NCT01612351|7734780|FG000|STARTED|Transoral Surgery|One patient completed chemotherapy then withdrew before surgery.|39
6802728|NCT01612351|7734780|FG000|COMPLETED|Transoral Surgery||39
6802729|NCT01612351|7734780|FG000|NOT COMPLETED|Transoral Surgery||0
6802730|NCT01612351|7734780|FG000|STARTED|Post-Operative Treatment||39
6802731|NCT01612351|7734780|FG000|COMPLETED|Post-Operative Treatment|One patient completed chemotherapy then withdrew before surgery.|39
6802732|NCT01612351|7734780|FG000|NOT COMPLETED|Post-Operative Treatment||0
6802733|NCT01595503|7734787|FG000|STARTED|Overall Study||5
6802734|NCT01595503|7734787|FG000|COMPLETED|Overall Study||5
6802735|NCT01595503|7734787|FG000|NOT COMPLETED|Overall Study||0
6802736|NCT01460160|7734791|FG000|STARTED|Treatment Phase||106
6802737|NCT01460160|7734791|FG000|COMPLETED|Treatment Phase||78
6802738|NCT01460160|7734791|FG000|NOT COMPLETED|Treatment Phase||28
6802739|NCT01460160|7734791|FG000|STARTED|Follow-up Phase|Some of the participants who did not completed the Treatment Phase were still moved to the Follow-up Phase|100
6802740|NCT01460160|7734791|FG000|COMPLETED|Follow-up Phase||0
6802741|NCT01460160|7734791|FG000|NOT COMPLETED|Follow-up Phase||100
6802742|NCT01413399|7734797|FG000|STARTED|Overall Study||208
6802743|NCT01413399|7734798|FG001|STARTED|Overall Study||334
6802744|NCT01413399|7734797|FG000|COMPLETED|Overall Study||208
6802745|NCT01413399|7734798|FG001|COMPLETED|Overall Study||334
6802746|NCT01413399|7734797|FG000|NOT COMPLETED|Overall Study||0
6802747|NCT01413399|7734798|FG001|NOT COMPLETED|Overall Study||0
6802748|NCT01170702|7734808|FG000|STARTED|Overall Study||34
6802749|NCT01170702|7734809|FG001|STARTED|Overall Study||32
6802750|NCT01170702|7734810|FG002|STARTED|Overall Study||25
6802751|NCT01170702|7734811|FG003|STARTED|Overall Study||29
6802752|NCT01170702|7734808|FG000|COMPLETED|Overall Study||33
6802753|NCT01170702|7734809|FG001|COMPLETED|Overall Study||30
6802754|NCT01170702|7734810|FG002|COMPLETED|Overall Study||25
6802755|NCT01170702|7734811|FG003|COMPLETED|Overall Study||27
6802756|NCT01170702|7734808|FG000|NOT COMPLETED|Overall Study||1
6802757|NCT01170702|7734809|FG001|NOT COMPLETED|Overall Study||2
6802758|NCT01170702|7734810|FG002|NOT COMPLETED|Overall Study||0
6802759|NCT01170702|7734811|FG003|NOT COMPLETED|Overall Study||2
6802760|NCT01018563|7734821|FG000|STARTED|Overall Study||2
6802761|NCT01018563|7734822|FG001|STARTED|Overall Study||1
6802762|NCT01018563|7734821|FG000|COMPLETED|Overall Study||0
6802763|NCT01018563|7734822|FG001|COMPLETED|Overall Study||0
6802764|NCT01018563|7734821|FG000|NOT COMPLETED|Overall Study||2
6802765|NCT01018563|7734822|FG001|NOT COMPLETED|Overall Study||1
6802766|NCT00805961|7734832|FG000|STARTED|Modality Therapy||68
6802767|NCT00805961|7734832|FG000|COMPLETED|Modality Therapy||64
6802768|NCT00805961|7734832|FG000|NOT COMPLETED|Modality Therapy||4
6802769|NCT00805961|7734832|FG000|STARTED|Treatment-Free Interval||64
6802770|NCT00805961|7734832|FG000|COMPLETED|Treatment-Free Interval||57
6802771|NCT00805961|7734832|FG000|NOT COMPLETED|Treatment-Free Interval||7
6802772|NCT00805961|7734832|FG000|STARTED|Maintenance Treatment||57
6802773|NCT00805961|7734832|FG000|COMPLETED|Maintenance Treatment||23
6802774|NCT00805961|7734832|FG000|NOT COMPLETED|Maintenance Treatment||34
6802775|NCT04056182|7734836|FG000|STARTED|Overall Study||20
6802776|NCT04056182|7734836|FG000|COMPLETED|Overall Study||3
6802777|NCT04056182|7734836|FG000|NOT COMPLETED|Overall Study||17
6802778|NCT03954106|7734842|FG000|STARTED|Part 1: Safety Lead In Phase||4
6802779|NCT03954106|7734843|FG001|STARTED|Part 1: Safety Lead In Phase||0
6802780|NCT03954106|7734842|FG000|COMPLETED|Part 1: Safety Lead In Phase||4
6802781|NCT03954106|7734843|FG001|COMPLETED|Part 1: Safety Lead In Phase||0
6802782|NCT03954106|7734842|FG000|NOT COMPLETED|Part 1: Safety Lead In Phase||0
6802783|NCT03954106|7734843|FG001|NOT COMPLETED|Part 1: Safety Lead In Phase||0
6802784|NCT03954106|7734842|FG000|STARTED|Phase 2: Treatment at RP2D||0
6802785|NCT03954106|7734843|FG001|STARTED|Phase 2: Treatment at RP2D||21
6802786|NCT03954106|7734842|FG000|COMPLETED|Phase 2: Treatment at RP2D||0
6802787|NCT03954106|7734843|FG001|COMPLETED|Phase 2: Treatment at RP2D||21
6802788|NCT03954106|7734842|FG000|NOT COMPLETED|Phase 2: Treatment at RP2D||0
6802789|NCT03954106|7734843|FG001|NOT COMPLETED|Phase 2: Treatment at RP2D||0
6802790|NCT03921424|7734853|FG000|STARTED|Overall Study||203
6802791|NCT03921424|7734854|FG001|STARTED|Overall Study||204
6802792|NCT03921424|7734853|FG000|Vaccination 1 - (Day 1)|Overall Study||203
6802793|NCT03921424|7734854|FG001|Vaccination 1 - (Day 1)|Overall Study||204
6802794|NCT03921424|7734853|FG000|Vaccination 2 - (Week 8)|Overall Study||203
6802795|NCT03921424|7734854|FG001|Vaccination 2 - (Week 8)|Overall Study|Two participants did not receive Vaccination 2.|202
6802796|NCT03921424|7734853|FG000|COMPLETED|Overall Study||203
6802797|NCT03921424|7734854|FG001|COMPLETED|Overall Study||201
6802798|NCT03921424|7734853|FG000|NOT COMPLETED|Overall Study||0
6802799|NCT03921424|7734854|FG001|NOT COMPLETED|Overall Study||3
6802800|NCT03598777|7734867|FG000|STARTED|Overall Study||13
6802801|NCT03598777|7734868|FG001|STARTED|Overall Study||8
6802802|NCT03598777|7734869|FG002|STARTED|Overall Study||8
6802803|NCT03598777|7734870|FG003|STARTED|Overall Study||14
6802804|NCT03598777|7734871|FG004|STARTED|Overall Study||17
6802805|NCT03598777|7734867|FG000|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||13
6802806|NCT03598777|7734868|FG001|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
6802807|NCT03598777|7734869|FG002|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||8
6802808|NCT03598777|7734870|FG003|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||14
6802809|NCT03598777|7734871|FG004|Received Treatment in Cycle 1 DB Treatment Period|Overall Study||17
6802810|NCT03598777|7734867|FG000|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
6802811|NCT03598777|7734868|FG001|Retreated in Cycle 2 OL Treatment Period|Overall Study||7
6802812|NCT03598777|7734869|FG002|Retreated in Cycle 2 OL Treatment Period|Overall Study||8
6802813|NCT03598777|7734870|FG003|Retreated in Cycle 2 OL Treatment Period|Overall Study||13
6802814|NCT03598777|7734871|FG004|Retreated in Cycle 2 OL Treatment Period|Overall Study||11
6802815|NCT03598777|7734867|FG000|Retreated in Cycle 3 OL Treatment Period|Overall Study||8
6802816|NCT03598777|7734868|FG001|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
6802817|NCT03598777|7734869|FG002|Retreated in Cycle 3 OL Treatment Period|Overall Study||6
6802818|NCT03598777|7734870|FG003|Retreated in Cycle 3 OL Treatment Period|Overall Study||12
6802819|NCT03598777|7734871|FG004|Retreated in Cycle 3 OL Treatment Period|Overall Study||2
6802820|NCT03598777|7734867|FG000|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
6802821|NCT03598777|7734868|FG001|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
6802822|NCT03598777|7734869|FG002|Retreated in Cycle 4 OL Treatment Period|Overall Study||1
6802823|NCT03598777|7734870|FG003|Retreated in Cycle 4 OL Treatment Period|Overall Study||3
6802824|NCT03598777|7734871|FG004|Retreated in Cycle 4 OL Treatment Period|Overall Study||0
6802825|NCT03598777|7734867|FG000|COMPLETED|Overall Study||7
6564283|NCT01810432|7486991|FG001|Received at Least 1 Dose of Study Drug|Period 2||19
6564284|NCT01810432|7486990|FG000|COMPLETED|Period 2||15
6564285|NCT01810432|7486991|FG001|COMPLETED|Period 2||17
6564286|NCT01810432|7486990|FG000|NOT COMPLETED|Period 2||4
6564287|NCT01810432|7486991|FG001|NOT COMPLETED|Period 2||2
6564288|NCT01810666|7486997|FG000|STARTED|Overall Study||30
6564289|NCT01810666|7486997|FG000|COMPLETED|Overall Study||30
6564290|NCT01810666|7486997|FG000|NOT COMPLETED|Overall Study||0
6564291|NCT01810692|7487003|FG000|STARTED|Overall Study||77
6564292|NCT01810692|7487004|FG001|STARTED|Overall Study||77
6802826|NCT03598777|7734868|FG001|COMPLETED|Overall Study||7
6802827|NCT03598777|7734869|FG002|COMPLETED|Overall Study||8
6802828|NCT03598777|7734870|FG003|COMPLETED|Overall Study||14
6802829|NCT03598777|7734871|FG004|COMPLETED|Overall Study||2
6802830|NCT03598777|7734867|FG000|NOT COMPLETED|Overall Study||6
6802831|NCT03598777|7734868|FG001|NOT COMPLETED|Overall Study||1
6802832|NCT03598777|7734869|FG002|NOT COMPLETED|Overall Study||0
6802833|NCT03598777|7734870|FG003|NOT COMPLETED|Overall Study||0
6802834|NCT03598777|7734871|FG004|NOT COMPLETED|Overall Study||15
6802835|NCT03406078|7734888|FG000|STARTED|Overall Study||74
6802836|NCT03406078|7734889|FG001|STARTED|Overall Study||76
6802837|NCT03406078|7734888|FG000|COMPLETED|Overall Study||68
6802838|NCT03406078|7734889|FG001|COMPLETED|Overall Study||73
6380835|NCT00781937|7291717|FG000|NOT COMPLETED|Main Trial Period Through Week 56||53
6380836|NCT00781937|7291718|FG001|NOT COMPLETED|Main Trial Period Through Week 56||64
6380837|NCT00781937|7291717|FG000|STARTED|Follow up Period (Week 56-68)||159
6380838|NCT00781937|7291718|FG001|STARTED|Follow up Period (Week 56-68)||146
6380839|NCT00781937|7291717|FG000|COMPLETED|Follow up Period (Week 56-68)||153
6380840|NCT00781937|7291718|FG001|COMPLETED|Follow up Period (Week 56-68)||141
6380841|NCT00781937|7291717|FG000|NOT COMPLETED|Follow up Period (Week 56-68)||6
6380842|NCT00781937|7291718|FG001|NOT COMPLETED|Follow up Period (Week 56-68)||5
6380843|NCT00781950|7291726|FG000|STARTED|Overall Study||52
6380844|NCT00781950|7291727|FG001|STARTED|Overall Study||58
6380845|NCT00781950|7291726|FG000|COMPLETED|Overall Study||41
6380846|NCT00781950|7291727|FG001|COMPLETED|Overall Study||45
6380847|NCT00781950|7291726|FG000|NOT COMPLETED|Overall Study||11
6380848|NCT00781950|7291727|FG001|NOT COMPLETED|Overall Study||13
6380849|NCT00781963|7291736|FG000|STARTED|Overall Study||106
6380850|NCT00781963|7291737|FG001|STARTED|Overall Study||53
6380851|NCT00781963|7291736|FG000|COMPLETED|Overall Study||89
6380852|NCT00781963|7291737|FG001|COMPLETED|Overall Study||51
6380853|NCT00781963|7291736|FG000|NOT COMPLETED|Overall Study||17
6380854|NCT00781963|7291737|FG001|NOT COMPLETED|Overall Study||2
6380855|NCT00782067|7291743|FG000|STARTED|Overall Study||116
6380856|NCT00782067|7291743|FG000|Safety Set (SS)|Overall Study||116
6380857|NCT00782067|7291743|FG000|Primary Efficacy Population (PEP)|Overall Study||89
6380858|NCT00782067|7291743|FG000|COMPLETED|Overall Study||0
6380859|NCT00782067|7291743|FG000|NOT COMPLETED|Overall Study||116
6380860|NCT00782171|7291749|FG000|STARTED|Overall Study||146
6380861|NCT00782171|7291750|FG001|STARTED|Overall Study||134
6380862|NCT00782171|7291749|FG000|20-23 Weeks|Overall Study||135
6380863|NCT00782171|7291750|FG001|20-23 Weeks|Overall Study||124
6380864|NCT00782171|7291749|FG000|1 Year|Overall Study||131
6380865|NCT00782171|7291750|FG001|1 Year|Overall Study||120
6380866|NCT00782171|7291749|FG000|Surgery (Baseline)|Overall Study||138
6380867|NCT00782171|7291750|FG001|Surgery (Baseline)|Overall Study||128
6380868|NCT00782171|7291749|FG000|COMPLETED|Overall Study||124
6380869|NCT00782171|7291750|FG001|COMPLETED|Overall Study||115
6380870|NCT00782171|7291749|FG000|NOT COMPLETED|Overall Study||22
6380871|NCT00782171|7291750|FG001|NOT COMPLETED|Overall Study||19
6380872|NCT00782210|7291759|FG000|STARTED|Overall Study||209
6380873|NCT00782210|7291760|FG001|STARTED|Overall Study||208
6380874|NCT00782210|7291761|FG002|STARTED|Overall Study||207
6380875|NCT00782210|7291759|FG000|COMPLETED|Overall Study||159
6380876|NCT00782210|7291760|FG001|COMPLETED|Overall Study||173
6380877|NCT00782210|7291761|FG002|COMPLETED|Overall Study||172
6380878|NCT00782210|7291759|FG000|NOT COMPLETED|Overall Study||50
6564293|NCT01810692|7487003|FG000|COMPLETED|Overall Study||77
6564294|NCT01810692|7487004|FG001|COMPLETED|Overall Study||77
6564295|NCT01810692|7487003|FG000|NOT COMPLETED|Overall Study||0
6564296|NCT01810692|7487004|FG001|NOT COMPLETED|Overall Study||0
6380879|NCT00782210|7291760|FG001|NOT COMPLETED|Overall Study||35
6380880|NCT00782210|7291761|FG002|NOT COMPLETED|Overall Study||35
6380881|NCT00782275|7291778|FG000|STARTED|Overall Study||41
6380882|NCT00782275|7291778|FG000|Treated|Overall Study||40
6380883|NCT00782275|7291778|FG000|Prior VEGFR Response Evaluable|Overall Study|One patient was unevaluable and therefore excluded from related subgroup analyses.|39
6380884|NCT00782275|7291778|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6380885|NCT00782275|7291778|FG000|NOT COMPLETED|Overall Study||41
6380886|NCT00782340|7291785|FG000|STARTED|Open Label Titration||263
6380887|NCT00782340|7291786|FG001|STARTED|Open Label Titration||0
6380888|NCT00782340|7291787|FG002|STARTED|Open Label Titration||0
6380889|NCT00782340|7291785|FG000|COMPLETED|Open Label Titration||162
6380890|NCT00782340|7291786|FG001|COMPLETED|Open Label Titration||0
6380891|NCT00782340|7291787|FG002|COMPLETED|Open Label Titration||0
6380892|NCT00782340|7291785|FG000|NOT COMPLETED|Open Label Titration||101
6380893|NCT00782340|7291786|FG001|NOT COMPLETED|Open Label Titration||0
6380894|NCT00782340|7291787|FG002|NOT COMPLETED|Open Label Titration||0
6380895|NCT00782340|7291785|FG000|STARTED|Randomized Double Blind||0
6380896|NCT00782340|7291786|FG001|STARTED|Randomized Double Blind||82
6380897|NCT00782340|7291787|FG002|STARTED|Randomized Double Blind||80
6380898|NCT00782340|7291785|FG000|COMPLETED|Randomized Double Blind||0
6380899|NCT00782340|7291786|FG001|COMPLETED|Randomized Double Blind||82
6380900|NCT00782340|7291787|FG002|COMPLETED|Randomized Double Blind||80
6380901|NCT00782340|7291785|FG000|NOT COMPLETED|Randomized Double Blind||0
6380902|NCT00782340|7291786|FG001|NOT COMPLETED|Randomized Double Blind||0
6380903|NCT00782340|7291787|FG002|NOT COMPLETED|Randomized Double Blind||0
6380904|NCT00782379|7291794|FG000|STARTED|Overall Study||20
6380905|NCT00782379|7291794|FG000|COMPLETED|Overall Study||20
6380906|NCT00782379|7291794|FG000|NOT COMPLETED|Overall Study||0
6380907|NCT00782418|7291798|FG000|STARTED|Period 1 Procedure/Treatment Groups||3
6380908|NCT00782418|7291799|FG001|STARTED|Period 1 Procedure/Treatment Groups||4
6380909|NCT00782418|7291800|FG002|STARTED|Period 1 Procedure/Treatment Groups||4
6380910|NCT00782418|7291801|FG003|STARTED|Period 1 Procedure/Treatment Groups||2
6380911|NCT00782418|7291802|FG004|STARTED|Period 1 Procedure/Treatment Groups||5
6380912|NCT00782418|7291803|FG005|STARTED|Period 1 Procedure/Treatment Groups||5
6380913|NCT00782418|7291804|FG006|STARTED|Period 1 Procedure/Treatment Groups||4
6380914|NCT00782418|7291798|FG000|COMPLETED|Period 1 Procedure/Treatment Groups||1
6380915|NCT00782418|7291799|FG001|COMPLETED|Period 1 Procedure/Treatment Groups||4
6380916|NCT00782418|7291800|FG002|COMPLETED|Period 1 Procedure/Treatment Groups||4
6380917|NCT00782418|7291801|FG003|COMPLETED|Period 1 Procedure/Treatment Groups||2
6380918|NCT00782418|7291802|FG004|COMPLETED|Period 1 Procedure/Treatment Groups||4
6380919|NCT00782418|7291803|FG005|COMPLETED|Period 1 Procedure/Treatment Groups||4
6380920|NCT00782418|7291804|FG006|COMPLETED|Period 1 Procedure/Treatment Groups||4
6380921|NCT00782418|7291798|FG000|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
6380922|NCT00782418|7291799|FG001|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
6380923|NCT00782418|7291800|FG002|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
6380924|NCT00782418|7291801|FG003|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
6380925|NCT00782418|7291802|FG004|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
6380926|NCT00782418|7291803|FG005|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
6380927|NCT00782418|7291804|FG006|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
6380928|NCT00782418|7291798|FG000|STARTED|Period 2 Procedure/Treatment Groups||3
6380929|NCT00782418|7291799|FG001|STARTED|Period 2 Procedure/Treatment Groups||4
6380930|NCT00782418|7291800|FG002|STARTED|Period 2 Procedure/Treatment Groups||4
6380931|NCT00782418|7291801|FG003|STARTED|Period 2 Procedure/Treatment Groups||1
6380932|NCT00782418|7291802|FG004|STARTED|Period 2 Procedure/Treatment Groups||3
6380933|NCT00782418|7291803|FG005|STARTED|Period 2 Procedure/Treatment Groups||4
6380934|NCT00782418|7291804|FG006|STARTED|Period 2 Procedure/Treatment Groups||4
6380935|NCT00782418|7291798|FG000|COMPLETED|Period 2 Procedure/Treatment Groups||3
6380936|NCT00782418|7291799|FG001|COMPLETED|Period 2 Procedure/Treatment Groups||4
6380937|NCT00782418|7291800|FG002|COMPLETED|Period 2 Procedure/Treatment Groups||4
6380938|NCT00782418|7291801|FG003|COMPLETED|Period 2 Procedure/Treatment Groups||1
6380939|NCT00782418|7291802|FG004|COMPLETED|Period 2 Procedure/Treatment Groups||3
6380940|NCT00782418|7291803|FG005|COMPLETED|Period 2 Procedure/Treatment Groups||4
6380941|NCT00782418|7291804|FG006|COMPLETED|Period 2 Procedure/Treatment Groups||4
6380942|NCT00782418|7291798|FG000|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6380943|NCT00782418|7291799|FG001|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6380944|NCT00782418|7291800|FG002|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6380945|NCT00782418|7291801|FG003|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6380946|NCT00782418|7291802|FG004|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6380947|NCT00782418|7291803|FG005|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6380948|NCT00782418|7291804|FG006|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
6380949|NCT00782496|7291820|FG000|STARTED|Overall Study||106
6380950|NCT00782496|7291821|FG001|STARTED|Overall Study||105
6564297|NCT01810783|7487010|FG000|STARTED|Overall Study||210
6564298|NCT01810783|7487010|FG000|COMPLETED|Overall Study||101
6268901|NCT00068822|7168003|FG001|Crossover at Month 1|Optional Crossover Intervention||2
6268902|NCT00068822|7168002|FG000|Crossover at Month 3|Optional Crossover Intervention||8
6268903|NCT00068822|7168003|FG001|Crossover at Month 3|Optional Crossover Intervention||27
6268904|NCT00068822|7168002|FG000|COMPLETED|Optional Crossover Intervention||9
6268905|NCT00068822|7168003|FG001|COMPLETED|Optional Crossover Intervention||29
6268906|NCT00068822|7168002|FG000|NOT COMPLETED|Optional Crossover Intervention||0
6268907|NCT00068822|7168003|FG001|NOT COMPLETED|Optional Crossover Intervention||0
6268908|NCT00069095|7168015|FG000|STARTED|Primary Treatment Phase||317
6268909|NCT00069095|7168016|FG001|STARTED|Primary Treatment Phase||317
6268910|NCT00069095|7168017|FG002|STARTED|Primary Treatment Phase||350
6268911|NCT00069095|7168018|FG003|STARTED|Primary Treatment Phase||351
6268912|NCT00069095|7168019|FG004|STARTED|Primary Treatment Phase||350
6268913|NCT00069095|7168020|FG005|STARTED|Primary Treatment Phase||349
6380951|NCT00782496|7291820|FG000|COMPLETED|Overall Study||92
6380952|NCT00782496|7291821|FG001|COMPLETED|Overall Study||90
6380953|NCT00782496|7291820|FG000|NOT COMPLETED|Overall Study||14
6380954|NCT00782496|7291821|FG001|NOT COMPLETED|Overall Study||15
6380955|NCT00782509|7291831|FG000|STARTED|Overall Study||216
6380956|NCT00782509|7291832|FG001|STARTED|Overall Study||209
6380957|NCT00782509|7291833|FG002|STARTED|Overall Study||217
6380958|NCT00782509|7291831|FG000|COMPLETED|Overall Study||175
6380959|NCT00782509|7291832|FG001|COMPLETED|Overall Study||185
6380960|NCT00782509|7291833|FG002|COMPLETED|Overall Study||181
6380961|NCT00782509|7291831|FG000|NOT COMPLETED|Overall Study||41
6380962|NCT00782509|7291832|FG001|NOT COMPLETED|Overall Study||24
6380963|NCT00782509|7291833|FG002|NOT COMPLETED|Overall Study||36
6380964|NCT00782626|7291848|FG000|STARTED|Overall Study||23
6380965|NCT00782626|7291848|FG000|COMPLETED|Overall Study||16
6380966|NCT00782626|7291848|FG000|NOT COMPLETED|Overall Study||7
6380967|NCT00782639|7291854|FG000|STARTED|Overall Study||12
6380968|NCT00782639|7291855|FG001|STARTED|Overall Study||11
6380969|NCT00782639|7291854|FG000|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
6380970|NCT00782639|7291855|FG001|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
6380971|NCT00782639|7291854|FG000|NOT COMPLETED|Overall Study||0
6564299|NCT01810783|7487010|FG000|NOT COMPLETED|Overall Study||109
6564300|NCT01810939|7487014|FG000|STARTED|Part A Treatment Period||243
6564301|NCT01810939|7487015|FG001|STARTED|Part A Treatment Period||0
6564302|NCT01810939|7487016|FG002|STARTED|Part A Treatment Period||0
6802839|NCT03406078|7734888|FG000|NOT COMPLETED|Overall Study||6
6802840|NCT03406078|7734889|FG001|NOT COMPLETED|Overall Study||3
6802841|NCT03397589|7734897|FG000|STARTED|Overall Study||211
6802842|NCT03397589|7734898|FG001|STARTED|Overall Study||209
6802843|NCT03397589|7734897|FG000|COMPLETED|Overall Study||175
6802844|NCT03397589|7734898|FG001|COMPLETED|Overall Study||187
6802845|NCT03397589|7734897|FG000|NOT COMPLETED|Overall Study||36
6802846|NCT03397589|7734898|FG001|NOT COMPLETED|Overall Study||22
6802847|NCT03368066|7734904|FG000|STARTED|Overall Study||58
6380972|NCT00782639|7291855|FG001|NOT COMPLETED|Overall Study||0
6380973|NCT00782717|7291865|FG000|STARTED|Overall Study||133
6802848|NCT03368066|7734905|FG001|STARTED|Overall Study||37
6802849|NCT03368066|7734904|FG000|COMPLETED|Overall Study||58
6380974|NCT00782717|7291866|FG001|STARTED|Overall Study||130
6380975|NCT00782717|7291865|FG000|COMPLETED|Overall Study||118
6380976|NCT00782717|7291866|FG001|COMPLETED|Overall Study||102
6380977|NCT00782717|7291865|FG000|NOT COMPLETED|Overall Study||15
6380978|NCT00782717|7291866|FG001|NOT COMPLETED|Overall Study||28
6380979|NCT00782756|7291872|FG000|STARTED|Overall Study||40
6380980|NCT00782756|7291872|FG000|COMPLETED|Overall Study||40
6380981|NCT00782756|7291872|FG000|NOT COMPLETED|Overall Study||0
6380982|NCT00782795|7291878|FG000|STARTED|Overall Study||17
6380983|NCT00782795|7291879|FG001|STARTED|Overall Study||8
6380984|NCT00782795|7291878|FG000|6 Weeks (1st Apptment)|Overall Study||16
6380985|NCT00782795|7291879|FG001|6 Weeks (1st Apptment)|Overall Study||7
6380986|NCT00782795|7291878|FG000|24 Week Appointment|Overall Study||16
6380987|NCT00782795|7291879|FG001|24 Week Appointment|Overall Study||7
6380988|NCT00782795|7291878|FG000|COMPLETED|Overall Study||16
6380989|NCT00782795|7291879|FG001|COMPLETED|Overall Study||6
6380990|NCT00782795|7291878|FG000|NOT COMPLETED|Overall Study||1
6380991|NCT00782795|7291879|FG001|NOT COMPLETED|Overall Study||2
6380992|NCT00782821|7291889|FG000|STARTED|Overall Study||10
6380993|NCT00782821|7291890|FG001|STARTED|Overall Study||10
6380994|NCT00782821|7291891|FG002|STARTED|Overall Study||10
6380995|NCT00782821|7291892|FG003|STARTED|Overall Study||10
6380996|NCT00782821|7291889|FG000|COMPLETED|Overall Study||10
6380997|NCT00782821|7291890|FG001|COMPLETED|Overall Study||10
6380998|NCT00782821|7291891|FG002|COMPLETED|Overall Study||9
6380999|NCT00782821|7291892|FG003|COMPLETED|Overall Study||8
6381000|NCT00782821|7291889|FG000|NOT COMPLETED|Overall Study||0
6381001|NCT00782821|7291890|FG001|NOT COMPLETED|Overall Study||0
6381002|NCT00782821|7291891|FG002|NOT COMPLETED|Overall Study||1
6381003|NCT00782821|7291892|FG003|NOT COMPLETED|Overall Study||2
6381004|NCT00782834|7291909|FG000|STARTED|Screened Patients||15
6381005|NCT00782834|7291909|FG000|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
6381006|NCT00782834|7291909|FG000|NOT COMPLETED|Screened Patients||1
6381007|NCT00782834|7291909|FG000|STARTED|Treatment Phase||14
6381008|NCT00782834|7291909|FG000|COMPLETED|Treatment Phase||13
6381009|NCT00782834|7291909|FG000|NOT COMPLETED|Treatment Phase||1
6381010|NCT00783094|7291916|FG000|STARTED|Randomized Double-Blind Treatment Period||142
6381011|NCT00783094|7291917|FG001|STARTED|Randomized Double-Blind Treatment Period||140
6381012|NCT00783094|7291918|FG002|STARTED|Randomized Double-Blind Treatment Period||140
6381013|NCT00783094|7291916|FG000|COMPLETED|Randomized Double-Blind Treatment Period||135
6381014|NCT00783094|7291917|FG001|COMPLETED|Randomized Double-Blind Treatment Period||128
6381015|NCT00783094|7291918|FG002|COMPLETED|Randomized Double-Blind Treatment Period||131
6381016|NCT00783094|7291916|FG000|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
6381017|NCT00783094|7291917|FG001|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
6564303|NCT01810939|7487014|FG000|COMPLETED|Part A Treatment Period||219
6564304|NCT01810939|7487015|FG001|COMPLETED|Part A Treatment Period||0
6564305|NCT01810939|7487016|FG002|COMPLETED|Part A Treatment Period||0
6564306|NCT01810939|7487014|FG000|NOT COMPLETED|Part A Treatment Period||24
6381018|NCT00783094|7291918|FG002|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
6381019|NCT00783094|7291916|FG000|STARTED|Open-Label Extension Period||135
6381020|NCT00783094|7291917|FG001|STARTED|Open-Label Extension Period||128
6381021|NCT00783094|7291918|FG002|STARTED|Open-Label Extension Period||131
6381022|NCT00783094|7291916|FG000|COMPLETED|Open-Label Extension Period||113
6381023|NCT00783094|7291917|FG001|COMPLETED|Open-Label Extension Period||109
6381024|NCT00783094|7291918|FG002|COMPLETED|Open-Label Extension Period||101
6381025|NCT00783094|7291916|FG000|NOT COMPLETED|Open-Label Extension Period||22
6502634|NCT01436149|7421355|FG001|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
6502635|NCT01436149|7421356|FG002|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
6502636|NCT01436149|7421354|FG000|COMPLETED|Randomized Phase||415
6502637|NCT01436149|7421355|FG001|COMPLETED|Randomized Phase||164
6502638|NCT01436149|7421356|FG002|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
6502639|NCT01436149|7421354|FG000|NOT COMPLETED|Randomized Phase||77
6502640|NCT01436149|7421355|FG001|NOT COMPLETED|Randomized Phase||38
6502641|NCT01436149|7421356|FG002|NOT COMPLETED|Randomized Phase||42
6502642|NCT01436162|7421364|FG000|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
6502643|NCT01436162|7421365|FG001|STARTED|Single-blind Lead-in Phase||0
6502644|NCT01436162|7421366|FG002|STARTED|Single-blind Lead-in Phase||0
6564307|NCT01810939|7487015|FG001|NOT COMPLETED|Part A Treatment Period||0
6564308|NCT01810939|7487016|FG002|NOT COMPLETED|Part A Treatment Period||0
6564309|NCT01810939|7487014|FG000|STARTED|Part B Placebo-Controlled Withdrawal||0
6623485|NCT02207816|7550612|FG002|NOT COMPLETED|Overall Study||67
6623486|NCT02207829|7550625|FG000|STARTED|Overall Study||509
6381026|NCT00783094|7291917|FG001|NOT COMPLETED|Open-Label Extension Period||19
6381027|NCT00783094|7291918|FG002|NOT COMPLETED|Open-Label Extension Period||30
6381028|NCT00783198|7291932|FG000|STARTED|Overall Study||190
6381029|NCT00783198|7291933|FG001|STARTED|Overall Study||187
6381030|NCT00783198|7291934|FG002|STARTED|Overall Study||188
6381031|NCT00783198|7291932|FG000|COMPLETED|Overall Study||133
6381032|NCT00783198|7291933|FG001|COMPLETED|Overall Study||144
6381033|NCT00783198|7291934|FG002|COMPLETED|Overall Study||146
6381034|NCT00783198|7291932|FG000|NOT COMPLETED|Overall Study||57
6381035|NCT00783198|7291933|FG001|NOT COMPLETED|Overall Study||43
6381036|NCT00783198|7291934|FG002|NOT COMPLETED|Overall Study||42
6381037|NCT00783289|7291946|FG000|STARTED|Overall Study||6
6381038|NCT00783289|7291947|FG001|STARTED|Overall Study||7
6381039|NCT00783289|7291948|FG002|STARTED|Overall Study||6
6381040|NCT00783289|7291949|FG003|STARTED|Overall Study||6
6381041|NCT00783289|7291946|FG000|COMPLETED|Overall Study||6
6381042|NCT00783289|7291947|FG001|COMPLETED|Overall Study||6
6381043|NCT00783289|7291948|FG002|COMPLETED|Overall Study||6
6381044|NCT00783289|7291949|FG003|COMPLETED|Overall Study||6
6381045|NCT00783289|7291946|FG000|NOT COMPLETED|Overall Study||0
6381046|NCT00783289|7291947|FG001|NOT COMPLETED|Overall Study||1
6381047|NCT00783289|7291948|FG002|NOT COMPLETED|Overall Study||0
6381048|NCT00783289|7291949|FG003|NOT COMPLETED|Overall Study||0
6381049|NCT00783302|7291962|FG000|STARTED|Overall Study||885
6381050|NCT00783302|7291962|FG000|COMPLETED|Overall Study||850
6381051|NCT00783302|7291962|FG000|NOT COMPLETED|Overall Study||35
6381052|NCT00783367|7291982|FG000|STARTED|Overall Study||27
6381053|NCT00783367|7291983|FG001|STARTED|Overall Study||23
6381054|NCT00783367|7291982|FG000|COMPLETED|Overall Study||27
6381055|NCT00783367|7291983|FG001|COMPLETED|Overall Study||23
6381056|NCT00783367|7291982|FG000|NOT COMPLETED|Overall Study||0
6381057|NCT00783367|7291983|FG001|NOT COMPLETED|Overall Study||0
6381058|NCT00783432|7291991|FG000|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
6381059|NCT00783432|7291992|FG001|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
6381060|NCT00783432|7291991|FG000|COMPLETED|Overall Study||345
6381061|NCT00783432|7291992|FG001|COMPLETED|Overall Study||354
6381062|NCT00783432|7291991|FG000|NOT COMPLETED|Overall Study||85
6381063|NCT00783432|7291992|FG001|NOT COMPLETED|Overall Study||78
6381064|NCT00783614|7292002|FG000|STARTED|Overall Study||6
6381065|NCT00783614|7292003|FG001|STARTED|Overall Study||6
6381066|NCT00783614|7292004|FG002|STARTED|Overall Study||5
6381067|NCT00783614|7292005|FG003|STARTED|Overall Study||5
6381068|NCT00783614|7292002|FG000|COMPLETED|Overall Study||6
6381069|NCT00783614|7292003|FG001|COMPLETED|Overall Study||6
6381070|NCT00783614|7292004|FG002|COMPLETED|Overall Study||5
6381071|NCT00783614|7292005|FG003|COMPLETED|Overall Study||5
6381072|NCT00783614|7292002|FG000|NOT COMPLETED|Overall Study||0
6381073|NCT00783614|7292003|FG001|NOT COMPLETED|Overall Study||0
6381074|NCT00783614|7292004|FG002|NOT COMPLETED|Overall Study||0
6381075|NCT00783614|7292005|FG003|NOT COMPLETED|Overall Study||0
6381076|NCT00783692|7292018|FG000|STARTED|Induction Phase||148
6381077|NCT00783692|7292019|FG001|STARTED|Induction Phase||220
6381078|NCT00783692|7292020|FG002|STARTED|Induction Phase||748
6381079|NCT00783692|7292021|FG003|STARTED|Induction Phase||0
6381080|NCT00783692|7292022|FG004|STARTED|Induction Phase||0
6381081|NCT00783692|7292023|FG005|STARTED|Induction Phase||0
6381082|NCT00783692|7292024|FG006|STARTED|Induction Phase||0
6268914|NCT00069095|7168015|FG000|COMPLETED|Primary Treatment Phase||22
6564310|NCT01810939|7487015|FG001|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
6564311|NCT01810939|7487016|FG002|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
6564312|NCT01810939|7487014|FG000|COMPLETED|Part B Placebo-Controlled Withdrawal||0
6656692|NCT02463097|7586982|FG000|NOT COMPLETED|Overall Study||1
6802850|NCT03368066|7734905|FG001|COMPLETED|Overall Study||37
6802851|NCT03368066|7734904|FG000|NOT COMPLETED|Overall Study||0
6802852|NCT03368066|7734905|FG001|NOT COMPLETED|Overall Study||0
6802853|NCT03345342|7734911|FG000|STARTED|Open-Label Phase||838
6802854|NCT03345342|7734912|FG001|STARTED|Open-Label Phase||0
6802855|NCT03345342|7734913|FG002|STARTED|Open-Label Phase||0
6381083|NCT00783692|7292018|FG000|Treated|Induction Phase||148
6381084|NCT00783692|7292019|FG001|Treated|Induction Phase||220
6381085|NCT00783692|7292020|FG002|Treated|Induction Phase||747
6381086|NCT00783692|7292021|FG003|Treated|Induction Phase||0
6381087|NCT00783692|7292022|FG004|Treated|Induction Phase||0
6381088|NCT00783692|7292023|FG005|Treated|Induction Phase||0
6564313|NCT01810939|7487015|FG001|COMPLETED|Part B Placebo-Controlled Withdrawal||45
6564314|NCT01810939|7487016|FG002|COMPLETED|Part B Placebo-Controlled Withdrawal||30
6564315|NCT01810939|7487014|FG000|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
6564316|NCT01810939|7487015|FG001|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
6564317|NCT01810939|7487016|FG002|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
6564318|NCT01810952|7487027|FG000|STARTED|Overall Study||20
6564319|NCT01810952|7487028|FG001|STARTED|Overall Study||17
6564320|NCT01810952|7487027|FG000|COMPLETED|Overall Study||20
6564321|NCT01810952|7487028|FG001|COMPLETED|Overall Study||17
6564322|NCT01810952|7487027|FG000|NOT COMPLETED|Overall Study||0
6564323|NCT01810952|7487028|FG001|NOT COMPLETED|Overall Study||0
6564324|NCT01810991|7487040|FG000|STARTED|Overall Study||19
6564325|NCT01810991|7487040|FG000|COMPLETED|Overall Study||17
6802856|NCT03345342|7734914|FG003|STARTED|Open-Label Phase||0
6802857|NCT03345342|7734915|FG004|STARTED|Open-Label Phase||0
6802858|NCT03345342|7734911|FG000|COMPLETED|Open-Label Phase||702
6802859|NCT03345342|7734912|FG001|COMPLETED|Open-Label Phase||0
6802860|NCT03345342|7734913|FG002|COMPLETED|Open-Label Phase||0
6381089|NCT00783692|7292024|FG006|Treated|Induction Phase||0
6381090|NCT00783692|7292018|FG000|COMPLETED|Induction Phase||137
6381091|NCT00783692|7292019|FG001|COMPLETED|Induction Phase||199
6381092|NCT00783692|7292020|FG002|COMPLETED|Induction Phase||674
6381093|NCT00783692|7292021|FG003|COMPLETED|Induction Phase||0
6381094|NCT00783692|7292022|FG004|COMPLETED|Induction Phase||0
6381095|NCT00783692|7292023|FG005|COMPLETED|Induction Phase||0
6381096|NCT00783692|7292024|FG006|COMPLETED|Induction Phase||0
6381097|NCT00783692|7292018|FG000|NOT COMPLETED|Induction Phase||11
6381098|NCT00783692|7292019|FG001|NOT COMPLETED|Induction Phase||21
6381099|NCT00783692|7292020|FG002|NOT COMPLETED|Induction Phase||74
6381100|NCT00783692|7292021|FG003|NOT COMPLETED|Induction Phase||0
6381101|NCT00783692|7292022|FG004|NOT COMPLETED|Induction Phase||0
6381102|NCT00783692|7292023|FG005|NOT COMPLETED|Induction Phase||0
6381103|NCT00783692|7292024|FG006|NOT COMPLETED|Induction Phase||0
6381104|NCT00783692|7292018|FG000|STARTED|Maintenance Phase||137
6381105|NCT00783692|7292019|FG001|STARTED|Maintenance Phase||0
6381106|NCT00783692|7292020|FG002|STARTED|Maintenance Phase||0
6381107|NCT00783692|7292021|FG003|STARTED|Maintenance Phase||153
6381108|NCT00783692|7292022|FG004|STARTED|Maintenance Phase||154
6381109|NCT00783692|7292023|FG005|STARTED|Maintenance Phase||154
6381110|NCT00783692|7292024|FG006|STARTED|Maintenance Phase||412
6381111|NCT00783692|7292018|FG000|COMPLETED|Maintenance Phase||42
6381112|NCT00783692|7292019|FG001|COMPLETED|Maintenance Phase||0
6381113|NCT00783692|7292020|FG002|COMPLETED|Maintenance Phase||0
6381114|NCT00783692|7292021|FG003|COMPLETED|Maintenance Phase||64
6381115|NCT00783692|7292022|FG004|COMPLETED|Maintenance Phase||73
6381116|NCT00783692|7292023|FG005|COMPLETED|Maintenance Phase||82
6381117|NCT00783692|7292024|FG006|COMPLETED|Maintenance Phase||163
6381118|NCT00783692|7292018|FG000|NOT COMPLETED|Maintenance Phase||95
6381119|NCT00783692|7292019|FG001|NOT COMPLETED|Maintenance Phase||0
6381120|NCT00783692|7292020|FG002|NOT COMPLETED|Maintenance Phase||0
6381121|NCT00783692|7292021|FG003|NOT COMPLETED|Maintenance Phase||89
6381122|NCT00783692|7292022|FG004|NOT COMPLETED|Maintenance Phase||81
6381123|NCT00783692|7292023|FG005|NOT COMPLETED|Maintenance Phase||72
6381124|NCT00783692|7292024|FG006|NOT COMPLETED|Maintenance Phase||249
6381125|NCT00783705|7292039|FG000|STARTED|Overall Study||44
6381126|NCT00783705|7292040|FG001|STARTED|Overall Study||41
6564326|NCT01810991|7487040|FG000|NOT COMPLETED|Overall Study||2
6564327|NCT01811004|7487046|FG000|STARTED|Overall Study||9
6381127|NCT00783705|7292039|FG000|COMPLETED|Overall Study||38
6381128|NCT00783705|7292040|FG001|COMPLETED|Overall Study||36
6381129|NCT00783705|7292039|FG000|NOT COMPLETED|Overall Study||6
6381130|NCT00783705|7292040|FG001|NOT COMPLETED|Overall Study||5
6381131|NCT00783718|7292049|FG000|STARTED|Induction Phase||149
6381132|NCT00783718|7292050|FG001|STARTED|Induction Phase||225
6381133|NCT00783718|7292051|FG002|STARTED|Induction Phase||521
6381134|NCT00783718|7292052|FG003|STARTED|Induction Phase||0
6564328|NCT01811004|7487047|FG001|STARTED|Overall Study||8
6381135|NCT00783718|7292053|FG004|STARTED|Induction Phase||0
6381136|NCT00783718|7292054|FG005|STARTED|Induction Phase||0
6381137|NCT00783718|7292055|FG006|STARTED|Induction Phase||0
6381138|NCT00783718|7292049|FG000|COMPLETED|Induction Phase||135
6381139|NCT00783718|7292050|FG001|COMPLETED|Induction Phase||218
6564329|NCT01811004|7487046|FG000|COMPLETED|Overall Study||8
6564330|NCT01811004|7487047|FG001|COMPLETED|Overall Study||5
6564331|NCT01811004|7487046|FG000|NOT COMPLETED|Overall Study||1
6564332|NCT01811004|7487047|FG001|NOT COMPLETED|Overall Study||3
6564333|NCT01811030|7487055|FG000|STARTED|Overall Study||33
6381140|NCT00783718|7292051|FG002|COMPLETED|Induction Phase||485
6381141|NCT00783718|7292052|FG003|COMPLETED|Induction Phase||0
6381142|NCT00783718|7292053|FG004|COMPLETED|Induction Phase||0
6381143|NCT00783718|7292054|FG005|COMPLETED|Induction Phase||0
6381144|NCT00783718|7292055|FG006|COMPLETED|Induction Phase||0
6564334|NCT01811030|7487055|FG000|COMPLETED|Overall Study||20
6381145|NCT00783718|7292049|FG000|NOT COMPLETED|Induction Phase||14
6656693|NCT02463227|7586986|FG000|STARTED|Overall Study||14
6656694|NCT02463227|7586986|FG000|COMPLETED|Overall Study||14
6656695|NCT02463227|7586986|FG000|NOT COMPLETED|Overall Study||0
6656696|NCT02463331|7586992|FG000|STARTED|Overall Study||26
6656697|NCT02463331|7586993|FG001|STARTED|Overall Study||31
6656698|NCT02463331|7586992|FG000|COMPLETED|Overall Study||10
6656699|NCT02463331|7586993|FG001|COMPLETED|Overall Study||25
6656700|NCT02463331|7586992|FG000|NOT COMPLETED|Overall Study||16
6656701|NCT02463331|7586993|FG001|NOT COMPLETED|Overall Study||6
6268915|NCT00069095|7168016|FG001|COMPLETED|Primary Treatment Phase||15
6268916|NCT00069095|7168017|FG002|COMPLETED|Primary Treatment Phase||36
6268917|NCT00069095|7168018|FG003|COMPLETED|Primary Treatment Phase||31
6268918|NCT00069095|7168019|FG004|COMPLETED|Primary Treatment Phase||48
6268919|NCT00069095|7168020|FG005|COMPLETED|Primary Treatment Phase||48
6268920|NCT00069095|7168015|FG000|NOT COMPLETED|Primary Treatment Phase||295
6268921|NCT00069095|7168016|FG001|NOT COMPLETED|Primary Treatment Phase||302
6268922|NCT00069095|7168017|FG002|NOT COMPLETED|Primary Treatment Phase||314
6268923|NCT00069095|7168018|FG003|NOT COMPLETED|Primary Treatment Phase||320
6268924|NCT00069095|7168019|FG004|NOT COMPLETED|Primary Treatment Phase||302
6268925|NCT00069095|7168020|FG005|NOT COMPLETED|Primary Treatment Phase||301
6268926|NCT00069095|7168015|FG000|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
6268927|NCT00069095|7168016|FG001|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
6268928|NCT00069095|7168017|FG002|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
6268929|NCT00069095|7168018|FG003|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
6268930|NCT00069095|7168019|FG004|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
6268931|NCT00069095|7168020|FG005|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
6268932|NCT00069095|7168015|FG000|COMPLETED|Post-study Treatment Phase||0
6268933|NCT00069095|7168016|FG001|COMPLETED|Post-study Treatment Phase||0
6268934|NCT00069095|7168017|FG002|COMPLETED|Post-study Treatment Phase||0
6268935|NCT00069095|7168018|FG003|COMPLETED|Post-study Treatment Phase||0
6268936|NCT00069095|7168019|FG004|COMPLETED|Post-study Treatment Phase||0
6268937|NCT00069095|7168020|FG005|COMPLETED|Post-study Treatment Phase||0
6268938|NCT00069095|7168015|FG000|NOT COMPLETED|Post-study Treatment Phase||8
6268939|NCT00069095|7168016|FG001|NOT COMPLETED|Post-study Treatment Phase||13
6268940|NCT00069095|7168017|FG002|NOT COMPLETED|Post-study Treatment Phase||21
6268941|NCT00069095|7168018|FG003|NOT COMPLETED|Post-study Treatment Phase||17
6268942|NCT00069095|7168019|FG004|NOT COMPLETED|Post-study Treatment Phase||36
6268943|NCT00069095|7168020|FG005|NOT COMPLETED|Post-study Treatment Phase||29
6268944|NCT00069095|7168015|FG000|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
6268945|NCT00069095|7168016|FG001|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
6268946|NCT00069095|7168017|FG002|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
6268947|NCT00069095|7168018|FG003|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
6268948|NCT00069095|7168019|FG004|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
6268949|NCT00069095|7168020|FG005|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
6268950|NCT00069095|7168015|FG000|COMPLETED|Follow-up Phase||110
6268951|NCT00069095|7168016|FG001|COMPLETED|Follow-up Phase||93
6737476|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Period 5(2 Days)||0
6381146|NCT00783718|7292050|FG001|NOT COMPLETED|Induction Phase||7
6381147|NCT00783718|7292051|FG002|NOT COMPLETED|Induction Phase||36
6381148|NCT00783718|7292052|FG003|NOT COMPLETED|Induction Phase||0
6381149|NCT00783718|7292053|FG004|NOT COMPLETED|Induction Phase||0
6381150|NCT00783718|7292054|FG005|NOT COMPLETED|Induction Phase||0
6381151|NCT00783718|7292055|FG006|NOT COMPLETED|Induction Phase||0
6381152|NCT00783718|7292049|FG000|STARTED|Maintenance Phase||135
6381153|NCT00783718|7292050|FG001|STARTED|Maintenance Phase||0
6381154|NCT00783718|7292051|FG002|STARTED|Maintenance Phase||0
6381155|NCT00783718|7292052|FG003|STARTED|Maintenance Phase||126
6381156|NCT00783718|7292053|FG004|STARTED|Maintenance Phase||122
6381157|NCT00783718|7292054|FG005|STARTED|Maintenance Phase||125
6381158|NCT00783718|7292055|FG006|STARTED|Maintenance Phase||330
6381159|NCT00783718|7292049|FG000|COMPLETED|Maintenance Phase||30
6381160|NCT00783718|7292050|FG001|COMPLETED|Maintenance Phase||0
6381161|NCT00783718|7292051|FG002|COMPLETED|Maintenance Phase||0
6381162|NCT00783718|7292052|FG003|COMPLETED|Maintenance Phase||48
6381163|NCT00783718|7292053|FG004|COMPLETED|Maintenance Phase||77
6381164|NCT00783718|7292054|FG005|COMPLETED|Maintenance Phase||84
6381165|NCT00783718|7292055|FG006|COMPLETED|Maintenance Phase||135
6381166|NCT00783718|7292049|FG000|NOT COMPLETED|Maintenance Phase||105
6381167|NCT00783718|7292050|FG001|NOT COMPLETED|Maintenance Phase||0
6502645|NCT01436162|7421364|FG000|COMPLETED|Single-blind Lead-in Phase||823
6502646|NCT01436162|7421365|FG001|COMPLETED|Single-blind Lead-in Phase||0
6502647|NCT01436162|7421366|FG002|COMPLETED|Single-blind Lead-in Phase||0
6502648|NCT01436162|7421364|FG000|NOT COMPLETED|Single-blind Lead-in Phase||282
6381168|NCT00783718|7292051|FG002|NOT COMPLETED|Maintenance Phase||0
6381169|NCT00783718|7292052|FG003|NOT COMPLETED|Maintenance Phase||78
6381170|NCT00783718|7292053|FG004|NOT COMPLETED|Maintenance Phase||45
6381171|NCT00783718|7292054|FG005|NOT COMPLETED|Maintenance Phase||41
6502649|NCT01436162|7421365|FG001|NOT COMPLETED|Single-blind Lead-in Phase||0
6502650|NCT01436162|7421366|FG002|NOT COMPLETED|Single-blind Lead-in Phase||0
6381172|NCT00783718|7292055|FG006|NOT COMPLETED|Maintenance Phase||195
6381173|NCT00783796|7292065|FG000|STARTED|Overall Study||150
6381174|NCT00783796|7292065|FG000|COMPLETED|Overall Study||144
6381175|NCT00783796|7292065|FG000|NOT COMPLETED|Overall Study||6
6381176|NCT00783835|7292071|FG000|STARTED|Overall Study||60
6381177|NCT00783835|7292071|FG000|COMPLETED|Overall Study||50
6381178|NCT00783835|7292071|FG000|NOT COMPLETED|Overall Study||10
6381179|NCT00783952|7292075|FG000|STARTED|Overall Study||8
6381180|NCT00783952|7292075|FG000|COMPLETED|Overall Study||8
6381181|NCT00783952|7292075|FG000|NOT COMPLETED|Overall Study||0
6381182|NCT00783965|7292082|FG000|STARTED|First Intervention (12 Months)||5
6381183|NCT00783965|7292083|FG001|STARTED|First Intervention (12 Months)||29
6381184|NCT00783965|7292082|FG000|COMPLETED|First Intervention (12 Months)||2
6381185|NCT00783965|7292083|FG001|COMPLETED|First Intervention (12 Months)||25
6381186|NCT00783965|7292082|FG000|NOT COMPLETED|First Intervention (12 Months)||3
6502651|NCT01436162|7421364|FG000|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
6564335|NCT01811030|7487055|FG000|NOT COMPLETED|Overall Study||13
6381187|NCT00783965|7292083|FG001|NOT COMPLETED|First Intervention (12 Months)||4
6381188|NCT00783965|7292082|FG000|STARTED|Second Intervention (24 Months)||2
6381189|NCT00783965|7292083|FG001|STARTED|Second Intervention (24 Months)||25
6381190|NCT00783965|7292082|FG000|COMPLETED|Second Intervention (24 Months)||2
6381191|NCT00783965|7292083|FG001|COMPLETED|Second Intervention (24 Months)||16
6381192|NCT00783965|7292082|FG000|NOT COMPLETED|Second Intervention (24 Months)||0
6381193|NCT00783965|7292083|FG001|NOT COMPLETED|Second Intervention (24 Months)||9
6381194|NCT00784030|7292091|FG000|STARTED|Overall Study||13
6381195|NCT00784030|7292092|FG001|STARTED|Overall Study||10
6381196|NCT00784030|7292091|FG000|COMPLETED|Overall Study||13
6381197|NCT00784030|7292092|FG001|COMPLETED|Overall Study||10
6381198|NCT00784030|7292091|FG000|NOT COMPLETED|Overall Study||0
6381199|NCT00784030|7292092|FG001|NOT COMPLETED|Overall Study||0
6381200|NCT00784095|7292101|FG000|STARTED|Overall Study||12
6381201|NCT00784095|7292102|FG001|STARTED|Overall Study||12
6381202|NCT00784095|7292103|FG002|STARTED|Overall Study||12
6381203|NCT00784095|7292101|FG000|COMPLETED|Overall Study||12
6381204|NCT00784095|7292102|FG001|COMPLETED|Overall Study||11
6381205|NCT00784095|7292103|FG002|COMPLETED|Overall Study||11
6381206|NCT00784095|7292101|FG000|NOT COMPLETED|Overall Study||0
6381207|NCT00784095|7292102|FG001|NOT COMPLETED|Overall Study||1
6381208|NCT00784095|7292103|FG002|NOT COMPLETED|Overall Study||1
6381209|NCT00784134|7292116|FG000|STARTED|Overall Study||249
6381210|NCT00784134|7292117|FG001|STARTED|Overall Study||251
6381211|NCT00784134|7292116|FG000|COMPLETED|Overall Study||246
6381212|NCT00784134|7292117|FG001|COMPLETED|Overall Study||245
6381213|NCT00784134|7292116|FG000|NOT COMPLETED|Overall Study||3
6381214|NCT00784134|7292117|FG001|NOT COMPLETED|Overall Study||6
6381215|NCT00784147|7292125|FG000|STARTED|Overall Study||59
6381216|NCT00784147|7292126|FG001|STARTED|Overall Study||54
6381217|NCT00784147|7292125|FG000|COMPLETED|Overall Study||51
6381218|NCT00784147|7292126|FG001|COMPLETED|Overall Study||45
6381219|NCT00784147|7292125|FG000|NOT COMPLETED|Overall Study||8
6381220|NCT00784147|7292126|FG001|NOT COMPLETED|Overall Study||9
6381221|NCT00784225|7292136|FG000|STARTED|Overall Study||3375
6381222|NCT00784225|7292137|FG001|STARTED|Overall Study||3357
6381223|NCT00784225|7292138|FG002|STARTED|Overall Study||3369
6381224|NCT00784225|7292139|FG003|STARTED|Overall Study||3374
6381225|NCT00784225|7292136|FG000|COMPLETED|Overall Study||3375
6381226|NCT00784225|7292137|FG001|COMPLETED|Overall Study||3357
6381227|NCT00784225|7292138|FG002|COMPLETED|Overall Study||3369
6381228|NCT00784225|7292139|FG003|COMPLETED|Overall Study||3374
6381229|NCT00784225|7292136|FG000|NOT COMPLETED|Overall Study||0
6381230|NCT00784225|7292137|FG001|NOT COMPLETED|Overall Study||0
6381231|NCT00784225|7292138|FG002|NOT COMPLETED|Overall Study||0
6381232|NCT00784225|7292139|FG003|NOT COMPLETED|Overall Study||0
6381233|NCT00784238|7292153|FG000|STARTED|Overall Study||289
6381234|NCT00784238|7292153|FG000|COMPLETED|Overall Study||170
6381235|NCT00784238|7292153|FG000|NOT COMPLETED|Overall Study||119
6381236|NCT00784277|7292164|FG000|STARTED|IR Treatment||148
6381237|NCT00784277|7292165|FG001|STARTED|IR Treatment||151
6381238|NCT00784277|7292166|FG002|STARTED|IR Treatment||154
6381239|NCT00784277|7292167|FG003|STARTED|IR Treatment||143
6381240|NCT00784277|7292168|FG004|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
6381241|NCT00784277|7292169|FG005|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
6381242|NCT00784277|7292170|FG006|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
6381243|NCT00784277|7292164|FG000|COMPLETED|IR Treatment||132
6381244|NCT00784277|7292165|FG001|COMPLETED|IR Treatment||134
6381245|NCT00784277|7292166|FG002|COMPLETED|IR Treatment||126
6381246|NCT00784277|7292167|FG003|COMPLETED|IR Treatment||100
6381247|NCT00784277|7292168|FG004|COMPLETED|IR Treatment||0
6381248|NCT00784277|7292169|FG005|COMPLETED|IR Treatment||0
6381249|NCT00784277|7292170|FG006|COMPLETED|IR Treatment||0
6381250|NCT00784277|7292164|FG000|NOT COMPLETED|IR Treatment||16
6381251|NCT00784277|7292165|FG001|NOT COMPLETED|IR Treatment||17
6381252|NCT00784277|7292166|FG002|NOT COMPLETED|IR Treatment||28
6381253|NCT00784277|7292167|FG003|NOT COMPLETED|IR Treatment||43
6564336|NCT01811147|7487063|FG000|STARTED|Overall Study||51
6564337|NCT01811147|7487064|FG001|STARTED|Overall Study||56
6564338|NCT01811147|7487065|FG002|STARTED|Overall Study||49
6564339|NCT01811147|7487066|FG003|STARTED|Overall Study||33
6564340|NCT01811147|7487063|FG000|COMPLETED|Overall Study||15
6564341|NCT01811147|7487064|FG001|COMPLETED|Overall Study||11
6381254|NCT00784277|7292168|FG004|NOT COMPLETED|IR Treatment||0
6381255|NCT00784277|7292169|FG005|NOT COMPLETED|IR Treatment||0
6381256|NCT00784277|7292170|FG006|NOT COMPLETED|IR Treatment||0
6381257|NCT00784277|7292164|FG000|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
6381258|NCT00784277|7292165|FG001|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
6381259|NCT00784277|7292166|FG002|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
6381260|NCT00784277|7292167|FG003|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
6381261|NCT00784277|7292168|FG004|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
6381262|NCT00784277|7292169|FG005|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
6381263|NCT00784277|7292170|FG006|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
6381264|NCT00784277|7292164|FG000|COMPLETED|ER Treatment||0
6381265|NCT00784277|7292165|FG001|COMPLETED|ER Treatment||0
6381266|NCT00784277|7292166|FG002|COMPLETED|ER Treatment||0
6381267|NCT00784277|7292167|FG003|COMPLETED|ER Treatment||0
6381268|NCT00784277|7292168|FG004|COMPLETED|ER Treatment||113
6381269|NCT00784277|7292169|FG005|COMPLETED|ER Treatment||226
6381270|NCT00784277|7292170|FG006|COMPLETED|ER Treatment||76
6381271|NCT00784277|7292164|FG000|NOT COMPLETED|ER Treatment||0
6381272|NCT00784277|7292165|FG001|NOT COMPLETED|ER Treatment||0
6381273|NCT00784277|7292166|FG002|NOT COMPLETED|ER Treatment||0
6381274|NCT00784277|7292167|FG003|NOT COMPLETED|ER Treatment||0
6381275|NCT00784277|7292168|FG004|NOT COMPLETED|ER Treatment||9
6381276|NCT00784277|7292169|FG005|NOT COMPLETED|ER Treatment||24
6381277|NCT00784277|7292170|FG006|NOT COMPLETED|ER Treatment||15
6381278|NCT00784303|7292185|FG000|STARTED|Overall Study||58
6381279|NCT00784303|7292186|FG001|STARTED|Overall Study||59
6381280|NCT00784303|7292185|FG000|COMPLETED|Overall Study||58
6564342|NCT01811147|7487065|FG002|COMPLETED|Overall Study||6
6564343|NCT01811147|7487066|FG003|COMPLETED|Overall Study||4
6564344|NCT01811147|7487063|FG000|NOT COMPLETED|Overall Study||36
6564345|NCT01811147|7487064|FG001|NOT COMPLETED|Overall Study||45
6564346|NCT01811147|7487065|FG002|NOT COMPLETED|Overall Study||43
6564347|NCT01811147|7487066|FG003|NOT COMPLETED|Overall Study||29
6564348|NCT01811186|7487078|FG000|STARTED|Overall Study||132
6381281|NCT00784303|7292186|FG001|COMPLETED|Overall Study||59
6381282|NCT00784303|7292185|FG000|NOT COMPLETED|Overall Study||0
6381283|NCT00784303|7292186|FG001|NOT COMPLETED|Overall Study||0
6381284|NCT00784368|7292196|FG000|STARTED|Overall Study||16
6381285|NCT00784368|7292197|FG001|STARTED|Overall Study||16
6381286|NCT00784368|7292198|FG002|STARTED|Overall Study||23
6381287|NCT00784368|7292196|FG000|COMPLETED|Overall Study||8
6564349|NCT01811186|7487079|FG001|STARTED|Overall Study||126
6564350|NCT01811186|7487078|FG000|COMPLETED|Overall Study||61
6564351|NCT01811186|7487079|FG001|COMPLETED|Overall Study||64
6564352|NCT01811186|7487078|FG000|NOT COMPLETED|Overall Study||71
6564353|NCT01811186|7487079|FG001|NOT COMPLETED|Overall Study||62
6564354|NCT01811212|7487089|FG000|STARTED|Overall Study||25
6564355|NCT01811212|7487089|FG000|COMPLETED|Overall Study||25
6564356|NCT01811212|7487089|FG000|NOT COMPLETED|Overall Study||0
6564357|NCT01811225|7487093|FG000|STARTED|Treatment Period 1||49
6564358|NCT01811225|7487094|FG001|STARTED|Treatment Period 1||46
6564359|NCT01811225|7487093|FG000|COMPLETED|Treatment Period 1|53 completed one arm of the cross-over and 43 completed two arms of the cross-over|24
6564360|NCT01811225|7487094|FG001|COMPLETED|Treatment Period 1||29
6564361|NCT01811225|7487093|FG000|NOT COMPLETED|Treatment Period 1||25
6564362|NCT01811225|7487094|FG001|NOT COMPLETED|Treatment Period 1||17
6564363|NCT01811225|7487093|FG000|STARTED|Treatment Period 2||24
6802861|NCT03345342|7734914|FG003|COMPLETED|Open-Label Phase||0
6802862|NCT03345342|7734915|FG004|COMPLETED|Open-Label Phase||0
6802863|NCT03345342|7734911|FG000|NOT COMPLETED|Open-Label Phase||136
6802864|NCT03345342|7734912|FG001|NOT COMPLETED|Open-Label Phase||0
6802865|NCT03345342|7734913|FG002|NOT COMPLETED|Open-Label Phase||0
6802866|NCT03345342|7734914|FG003|NOT COMPLETED|Open-Label Phase||0
6802867|NCT03345342|7734915|FG004|NOT COMPLETED|Open-Label Phase||0
6802868|NCT03345342|7734911|FG000|STARTED|Double-Blind Phase||0
6802869|NCT03345342|7734912|FG001|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|224
6802870|NCT03345342|7734913|FG002|STARTED|Double-Blind Phase|Participants from the OL phase have continued in the DB phase.|478
6802871|NCT03345342|7734914|FG003|STARTED|Double-Blind Phase||0
6802872|NCT03345342|7734915|FG004|STARTED|Double-Blind Phase||0
6802873|NCT03345342|7734911|FG000|COMPLETED|Double-Blind Phase||0
6802874|NCT03345342|7734912|FG001|COMPLETED|Double-Blind Phase||202
6802875|NCT03345342|7734913|FG002|COMPLETED|Double-Blind Phase||416
6802876|NCT03345342|7734914|FG003|COMPLETED|Double-Blind Phase||0
6802877|NCT03345342|7734915|FG004|COMPLETED|Double-Blind Phase||0
6802878|NCT03345342|7734911|FG000|NOT COMPLETED|Double-Blind Phase||0
6802879|NCT03345342|7734912|FG001|NOT COMPLETED|Double-Blind Phase||22
6802880|NCT03345342|7734913|FG002|NOT COMPLETED|Double-Blind Phase||62
6802881|NCT03345342|7734914|FG003|NOT COMPLETED|Double-Blind Phase||0
6802882|NCT03345342|7734915|FG004|NOT COMPLETED|Double-Blind Phase||0
6564364|NCT01811225|7487094|FG001|STARTED|Treatment Period 2||29
6564365|NCT01811225|7487093|FG000|COMPLETED|Treatment Period 2||20
6564366|NCT01811225|7487094|FG001|COMPLETED|Treatment Period 2||23
6381288|NCT00784368|7292197|FG001|COMPLETED|Overall Study||5
6381289|NCT00784368|7292198|FG002|COMPLETED|Overall Study||12
6564367|NCT01811225|7487093|FG000|NOT COMPLETED|Treatment Period 2||4
6564368|NCT01811225|7487094|FG001|NOT COMPLETED|Treatment Period 2||6
6656702|NCT02463357|7587004|FG000|STARTED|Overall Study||20
6656703|NCT02463357|7587005|FG001|STARTED|Overall Study||20
6656704|NCT02463357|7587006|FG002|STARTED|Overall Study||20
6656705|NCT02463357|7587007|FG003|STARTED|Overall Study||19
6802883|NCT03345342|7734911|FG000|STARTED|Follow-Up Phase||0
6802884|NCT03345342|7734912|FG001|STARTED|Follow-Up Phase||0
6802885|NCT03345342|7734913|FG002|STARTED|Follow-Up Phase||0
6802886|NCT03345342|7734914|FG003|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|42
6802887|NCT03345342|7734915|FG004|STARTED|Follow-Up Phase|Participants from the DB phase have continued in the FU phase.|109
6802888|NCT03345342|7734911|FG000|COMPLETED|Follow-Up Phase||0
6802889|NCT03345342|7734912|FG001|COMPLETED|Follow-Up Phase||0
6802890|NCT03345342|7734913|FG002|COMPLETED|Follow-Up Phase||0
6802891|NCT03345342|7734914|FG003|COMPLETED|Follow-Up Phase||34
6802892|NCT03345342|7734915|FG004|COMPLETED|Follow-Up Phase||78
6802893|NCT03345342|7734911|FG000|NOT COMPLETED|Follow-Up Phase||0
6802894|NCT03345342|7734912|FG001|NOT COMPLETED|Follow-Up Phase||0
6802895|NCT03345342|7734913|FG002|NOT COMPLETED|Follow-Up Phase||0
6802896|NCT03345342|7734914|FG003|NOT COMPLETED|Follow-Up Phase||8
6802897|NCT03345342|7734915|FG004|NOT COMPLETED|Follow-Up Phase||31
6802898|NCT03265145|7734929|FG000|STARTED|Overall Study||356
6802899|NCT03265145|7734930|FG001|STARTED|Overall Study||358
6802900|NCT03265145|7734929|FG000|COMPLETED|Overall Study||285
6802901|NCT03265145|7734930|FG001|COMPLETED|Overall Study||302
6802902|NCT03265145|7734929|FG000|NOT COMPLETED|Overall Study||71
6802903|NCT03265145|7734930|FG001|NOT COMPLETED|Overall Study||56
6802904|NCT03218995|7734937|FG000|STARTED|Overall Study||15
6802905|NCT03218995|7734937|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
6802906|NCT03218995|7734937|FG000|COMPLETED|Overall Study||15
6802907|NCT03218995|7734937|FG000|NOT COMPLETED|Overall Study||0
6802908|NCT03030222|7734945|FG000|STARTED|Overall Study||33
6802909|NCT03030222|7734946|FG001|STARTED|Overall Study||32
6802910|NCT03030222|7734945|FG000|COMPLETED|Overall Study||33
6802911|NCT03030222|7734946|FG001|COMPLETED|Overall Study||32
6802912|NCT03030222|7734945|FG000|NOT COMPLETED|Overall Study||0
6656706|NCT02463357|7587008|FG004|STARTED|Overall Study||20
6656707|NCT02463357|7587004|FG000|COMPLETED|Overall Study||19
6656708|NCT02463357|7587005|FG001|COMPLETED|Overall Study||20
6656709|NCT02463357|7587006|FG002|COMPLETED|Overall Study||20
6656710|NCT02463357|7587007|FG003|COMPLETED|Overall Study||19
6656711|NCT02463357|7587008|FG004|COMPLETED|Overall Study||19
6656712|NCT02463357|7587004|FG000|NOT COMPLETED|Overall Study||1
6656713|NCT02463357|7587005|FG001|NOT COMPLETED|Overall Study||0
6656714|NCT02463357|7587006|FG002|NOT COMPLETED|Overall Study||0
6656715|NCT02463357|7587007|FG003|NOT COMPLETED|Overall Study||0
6656716|NCT02463357|7587008|FG004|NOT COMPLETED|Overall Study||1
6802913|NCT03030222|7734946|FG001|NOT COMPLETED|Overall Study||0
6802914|NCT02880241|7734958|FG000|STARTED|Overall Study|Study terminated|8
6802915|NCT02880241|7734959|FG001|STARTED|Overall Study|Study terminated|0
6802916|NCT02880241|7734960|FG002|STARTED|Overall Study|Study terminated|0
6802917|NCT02880241|7734961|FG003|STARTED|Overall Study|Study terminated|0
6802918|NCT02880241|7734962|FG004|STARTED|Overall Study|Study terminated|0
6802919|NCT02880241|7734963|FG005|STARTED|Overall Study|Study terminated|0
6802920|NCT02880241|7734958|FG000|COMPLETED|Overall Study|Study terminated|7
6656717|NCT02463409|7587020|FG000|STARTED|Overall Study||6
6802921|NCT02880241|7734959|FG001|COMPLETED|Overall Study|Study terminated|0
6802922|NCT02880241|7734960|FG002|COMPLETED|Overall Study|Study terminated|0
6802923|NCT02880241|7734961|FG003|COMPLETED|Overall Study|Study terminated|0
6802924|NCT02880241|7734962|FG004|COMPLETED|Overall Study|Study terminated|0
6802925|NCT02880241|7734963|FG005|COMPLETED|Overall Study|Study terminated|0
6802926|NCT02880241|7734958|FG000|NOT COMPLETED|Overall Study||1
6802927|NCT02880241|7734959|FG001|NOT COMPLETED|Overall Study||0
6802928|NCT02880241|7734960|FG002|NOT COMPLETED|Overall Study||0
6802929|NCT02880241|7734961|FG003|NOT COMPLETED|Overall Study||0
6802930|NCT02880241|7734962|FG004|NOT COMPLETED|Overall Study||0
6802931|NCT02880241|7734963|FG005|NOT COMPLETED|Overall Study||0
6802932|NCT02832687|7734981|FG000|STARTED|Overall Study||41
6381290|NCT00784368|7292196|FG000|NOT COMPLETED|Overall Study||8
6381291|NCT00784368|7292197|FG001|NOT COMPLETED|Overall Study||11
6381292|NCT00784368|7292198|FG002|NOT COMPLETED|Overall Study||11
6381293|NCT00784459|7292211|FG000|STARTED|Overall Study||11
6381294|NCT00784459|7292212|FG001|STARTED|Overall Study||13
6381295|NCT00784459|7292211|FG000|COMPLETED|Overall Study||11
6381296|NCT00784459|7292212|FG001|COMPLETED|Overall Study||11
6381297|NCT00784459|7292211|FG000|NOT COMPLETED|Overall Study||0
6381298|NCT00784459|7292212|FG001|NOT COMPLETED|Overall Study||2
6381299|NCT00784524|7292218|FG000|STARTED|Overall Study||14
6381300|NCT00784524|7292218|FG000|COMPLETED|Overall Study||14
6381301|NCT00784524|7292218|FG000|NOT COMPLETED|Overall Study||0
6381302|NCT00784550|7292224|FG000|STARTED|Overall Study||173
6381303|NCT00784550|7292225|FG001|STARTED|Overall Study||169
6381304|NCT00784550|7292224|FG000|COMPLETED|Overall Study||137
6381305|NCT00784550|7292225|FG001|COMPLETED|Overall Study||127
6381306|NCT00784550|7292224|FG000|NOT COMPLETED|Overall Study||36
6381307|NCT00784550|7292225|FG001|NOT COMPLETED|Overall Study||42
6381308|NCT00784563|7292234|FG000|STARTED|Years 1 & 2||21
6381309|NCT00784563|7292235|FG001|STARTED|Years 1 & 2||22
6381310|NCT00784563|7292236|FG002|STARTED|Years 1 & 2||0
6381311|NCT00784563|7292234|FG000|COMPLETED|Years 1 & 2||18
6381312|NCT00784563|7292235|FG001|COMPLETED|Years 1 & 2||17
6381313|NCT00784563|7292236|FG002|COMPLETED|Years 1 & 2||0
6381314|NCT00784563|7292234|FG000|NOT COMPLETED|Years 1 & 2||3
6381315|NCT00784563|7292235|FG001|NOT COMPLETED|Years 1 & 2||5
6381316|NCT00784563|7292236|FG002|NOT COMPLETED|Years 1 & 2||0
6381317|NCT00784563|7292234|FG000|STARTED|Year 3||0
6381318|NCT00784563|7292235|FG001|STARTED|Year 3||0
6381319|NCT00784563|7292236|FG002|STARTED|Year 3||17
6381320|NCT00784563|7292234|FG000|COMPLETED|Year 3||0
6381321|NCT00784563|7292235|FG001|COMPLETED|Year 3||0
6381322|NCT00784563|7292236|FG002|COMPLETED|Year 3||14
6381323|NCT00784563|7292234|FG000|NOT COMPLETED|Year 3||0
6381324|NCT00784563|7292235|FG001|NOT COMPLETED|Year 3||0
6381325|NCT00784563|7292236|FG002|NOT COMPLETED|Year 3||3
6802933|NCT02832687|7734982|FG001|STARTED|Overall Study||47
6802934|NCT02832687|7734981|FG000|Participants Who Were Included in the Analysis|Overall Study||31
6381326|NCT00784641|7292245|FG000|STARTED|Overall Study||189
6381327|NCT00784641|7292246|FG001|STARTED|Overall Study||189
6381328|NCT00784641|7292247|FG002|STARTED|Overall Study||189
6381329|NCT00784641|7292245|FG000|COMPLETED|Overall Study||183
6381330|NCT00784641|7292246|FG001|COMPLETED|Overall Study||186
6381331|NCT00784641|7292247|FG002|COMPLETED|Overall Study||187
6381332|NCT00784641|7292245|FG000|NOT COMPLETED|Overall Study||6
6381333|NCT00784641|7292246|FG001|NOT COMPLETED|Overall Study||3
6381334|NCT00784641|7292247|FG002|NOT COMPLETED|Overall Study||2
6381335|NCT00784654|7292255|FG000|STARTED|Open-Label Period (Non-Randomized)||276
6381336|NCT00784654|7292256|FG001|STARTED|Open-Label Period (Non-Randomized)||0
6381337|NCT00784654|7292257|FG002|STARTED|Open-Label Period (Non-Randomized)||0
6381338|NCT00784654|7292255|FG000|COMPLETED|Open-Label Period (Non-Randomized)||165
6381339|NCT00784654|7292256|FG001|COMPLETED|Open-Label Period (Non-Randomized)||0
6381340|NCT00784654|7292257|FG002|COMPLETED|Open-Label Period (Non-Randomized)||0
6381341|NCT00784654|7292255|FG000|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
6381342|NCT00784654|7292256|FG001|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
6381343|NCT00784654|7292257|FG002|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
6381344|NCT00784654|7292255|FG000|STARTED|Randomized Withdrawal Period||0
6381345|NCT00784654|7292256|FG001|STARTED|Randomized Withdrawal Period||78
6381346|NCT00784654|7292257|FG002|STARTED|Randomized Withdrawal Period||79
6502652|NCT01436162|7421365|FG001|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
6502653|NCT01436162|7421366|FG002|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
6502654|NCT01436162|7421364|FG000|COMPLETED|Randomized Phase||353
6502655|NCT01436162|7421365|FG001|COMPLETED|Randomized Phase||181
6502656|NCT01436162|7421366|FG002|COMPLETED|Randomized Phase||189
6502657|NCT01436162|7421364|FG000|NOT COMPLETED|Randomized Phase||44
6502658|NCT01436162|7421365|FG001|NOT COMPLETED|Randomized Phase||31
6502659|NCT01436162|7421366|FG002|NOT COMPLETED|Randomized Phase||25
6502660|NCT01436175|7421374|FG000|STARTED|Overall Study||1570
6502661|NCT01436175|7421374|FG000|COMPLETED|Overall Study||300
6502662|NCT01436175|7421374|FG000|NOT COMPLETED|Overall Study||1270
6502663|NCT01436201|7421379|FG000|STARTED|Overall Study||24
6502664|NCT01436201|7421379|FG000|Received at Least 1 Dose of Study Drug|Overall Study||24
6502665|NCT01436201|7421379|FG000|COMPLETED|Overall Study||20
6502666|NCT01436201|7421379|FG000|NOT COMPLETED|Overall Study||4
6502667|NCT01436266|7421387|FG000|STARTED|Overall Study||1
6502668|NCT01436266|7421388|FG001|STARTED|Overall Study||1
6502669|NCT01436266|7421387|FG000|COMPLETED|Overall Study||1
6502670|NCT01436266|7421388|FG001|COMPLETED|Overall Study||1
6802935|NCT02832687|7734982|FG001|Participants Who Were Included in the Analysis|Overall Study||34
6802936|NCT02832687|7734981|FG000|COMPLETED|Overall Study||41
6802937|NCT02832687|7734982|FG001|COMPLETED|Overall Study||45
6802938|NCT02832687|7734981|FG000|NOT COMPLETED|Overall Study||0
6802939|NCT02832687|7734982|FG001|NOT COMPLETED|Overall Study||2
6802940|NCT02568449|7734988|FG000|STARTED|Overall Study||20
6802941|NCT02568449|7734988|FG000|COMPLETED|Overall Study||20
6802942|NCT02568449|7734988|FG000|NOT COMPLETED|Overall Study||0
6802943|NCT02499900|7734994|FG000|STARTED|Core Study Period||430
6802944|NCT02499900|7734995|FG001|STARTED|Core Study Period||431
6802945|NCT02499900|7734994|FG000|Safety Analysis Set|Core Study Period||427
6802946|NCT02499900|7734995|FG001|Safety Analysis Set|Core Study Period||430
6802947|NCT02499900|7734994|FG000|COMPLETED|Core Study Period||395
6802948|NCT02499900|7734995|FG001|COMPLETED|Core Study Period||399
6802949|NCT02499900|7734994|FG000|NOT COMPLETED|Core Study Period||35
6802950|NCT02499900|7734995|FG001|NOT COMPLETED|Core Study Period||32
6802951|NCT02499900|7734994|FG000|STARTED|Completed Core, Continued Into Extension||395
6502671|NCT01436266|7421387|FG000|NOT COMPLETED|Overall Study||0
6502672|NCT01436266|7421388|FG001|NOT COMPLETED|Overall Study||0
6502673|NCT01436279|7421396|FG000|STARTED|Overall Study||30
6502674|NCT01436279|7421397|FG001|STARTED|Overall Study||20
6502675|NCT01436279|7421396|FG000|COMPLETED|Overall Study||30
6502676|NCT01436279|7421397|FG001|COMPLETED|Overall Study||20
6502677|NCT01436279|7421396|FG000|NOT COMPLETED|Overall Study||0
6502678|NCT01436279|7421397|FG001|NOT COMPLETED|Overall Study||0
6502679|NCT01436305|7421408|FG000|STARTED|Overall Study||6
6502680|NCT01436305|7421409|FG001|STARTED|Overall Study||6
6502681|NCT01436305|7421410|FG002|STARTED|Overall Study||7
6502682|NCT01436305|7421408|FG000|COMPLETED|Overall Study||4
6802952|NCT02499900|7734995|FG001|STARTED|Completed Core, Continued Into Extension||399
6381347|NCT00784654|7292255|FG000|COMPLETED|Randomized Withdrawal Period||0
6381348|NCT00784654|7292256|FG001|COMPLETED|Randomized Withdrawal Period||60
6381349|NCT00784654|7292257|FG002|COMPLETED|Randomized Withdrawal Period||16
6381350|NCT00784654|7292255|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
6381351|NCT00784654|7292256|FG001|NOT COMPLETED|Randomized Withdrawal Period||18
6381352|NCT00784654|7292257|FG002|NOT COMPLETED|Randomized Withdrawal Period||63
6381353|NCT00784693|7292270|FG000|STARTED|Overall Study||23
6381354|NCT00784693|7292271|FG001|STARTED|Overall Study||25
6502683|NCT01436305|7421409|FG001|COMPLETED|Overall Study||2
6502684|NCT01436305|7421410|FG002|COMPLETED|Overall Study||7
6502685|NCT01436305|7421408|FG000|NOT COMPLETED|Overall Study||2
6502686|NCT01436305|7421409|FG001|NOT COMPLETED|Overall Study||4
6502687|NCT01436305|7421410|FG002|NOT COMPLETED|Overall Study||0
6502688|NCT01436357|7421420|FG000|STARTED|Overall Study||274
6502689|NCT01436357|7421421|FG001|STARTED|Overall Study||274
6502690|NCT01436357|7421420|FG000|Stage 1|Overall Study||49
6502691|NCT01436357|7421421|FG001|Stage 1|Overall Study||48
6502692|NCT01436357|7421420|FG000|Stage 2|Overall Study||225
6502693|NCT01436357|7421421|FG001|Stage 2|Overall Study||226
6502694|NCT01436357|7421420|FG000|COMPLETED|Overall Study||152
6502695|NCT01436357|7421421|FG001|COMPLETED|Overall Study||146
6502696|NCT01436357|7421420|FG000|NOT COMPLETED|Overall Study||122
6502697|NCT01436357|7421421|FG001|NOT COMPLETED|Overall Study||128
6502698|NCT01436370|7421435|FG000|STARTED|Overall Study||6
6502699|NCT01436370|7421436|FG001|STARTED|Overall Study||6
6502700|NCT01436370|7421437|FG002|STARTED|Overall Study||10
6502701|NCT01436370|7421438|FG003|STARTED|Overall Study||10
6502702|NCT01436370|7421439|FG004|STARTED|Overall Study||19
6502703|NCT01436370|7421440|FG005|STARTED|Overall Study||19
6502704|NCT01436370|7421441|FG006|STARTED|Overall Study||16
6502705|NCT01436370|7421442|FG007|STARTED|Overall Study||16
6502706|NCT01436370|7421435|FG000|COMPLETED|Overall Study||6
6502707|NCT01436370|7421436|FG001|COMPLETED|Overall Study||6
6502708|NCT01436370|7421437|FG002|COMPLETED|Overall Study||10
6502709|NCT01436370|7421438|FG003|COMPLETED|Overall Study||10
6502710|NCT01436370|7421439|FG004|COMPLETED|Overall Study||18
6502711|NCT01436370|7421440|FG005|COMPLETED|Overall Study||19
6502712|NCT01436370|7421441|FG006|COMPLETED|Overall Study||16
6502713|NCT01436370|7421442|FG007|COMPLETED|Overall Study||16
6502714|NCT01436370|7421435|FG000|NOT COMPLETED|Overall Study||0
6502715|NCT01436370|7421436|FG001|NOT COMPLETED|Overall Study||0
6502716|NCT01436370|7421437|FG002|NOT COMPLETED|Overall Study||0
6502717|NCT01436370|7421438|FG003|NOT COMPLETED|Overall Study||0
6502718|NCT01436370|7421439|FG004|NOT COMPLETED|Overall Study||1
6502719|NCT01436370|7421440|FG005|NOT COMPLETED|Overall Study||0
6502720|NCT01436370|7421441|FG006|NOT COMPLETED|Overall Study||0
6502721|NCT01436370|7421442|FG007|NOT COMPLETED|Overall Study||0
6502722|NCT01436435|7421468|FG000|STARTED|Overall Study||241
6502723|NCT01436435|7421468|FG000|COMPLETED|Overall Study||177
6502724|NCT01436435|7421468|FG000|NOT COMPLETED|Overall Study||64
6502725|NCT01436500|7421474|FG000|STARTED|Overall Study||12
6502726|NCT01436500|7421475|FG001|STARTED|Overall Study||12
6502727|NCT01436500|7421476|FG002|STARTED|Overall Study||12
6502728|NCT01436500|7421477|FG003|STARTED|Overall Study||6
6502729|NCT01436500|7421478|FG004|STARTED|Overall Study||13
6502730|NCT01436500|7421474|FG000|COMPLETED|Overall Study||9
6502731|NCT01436500|7421475|FG001|COMPLETED|Overall Study||9
6502732|NCT01436500|7421476|FG002|COMPLETED|Overall Study||7
6502733|NCT01436500|7421477|FG003|COMPLETED|Overall Study||5
6502734|NCT01436500|7421478|FG004|COMPLETED|Overall Study||9
6502735|NCT01436500|7421474|FG000|NOT COMPLETED|Overall Study||3
6502736|NCT01436500|7421475|FG001|NOT COMPLETED|Overall Study||3
6502737|NCT01436500|7421476|FG002|NOT COMPLETED|Overall Study||5
6502738|NCT01436500|7421477|FG003|NOT COMPLETED|Overall Study||1
6502739|NCT01436500|7421478|FG004|NOT COMPLETED|Overall Study||4
6502740|NCT01436526|7421493|FG000|STARTED|Period 1||14
6502741|NCT01436526|7421494|FG001|STARTED|Period 1||14
6381355|NCT00784693|7292270|FG000|Treated|Overall Study||22
6381356|NCT00784693|7292271|FG001|Treated|Overall Study||25
6381357|NCT00784693|7292270|FG000|COMPLETED|Overall Study||20
6381358|NCT00784693|7292271|FG001|COMPLETED|Overall Study||19
6381359|NCT00784693|7292270|FG000|NOT COMPLETED|Overall Study||3
6381360|NCT00784693|7292271|FG001|NOT COMPLETED|Overall Study||6
6381361|NCT00784719|7292284|FG000|STARTED|Overall Study||47
6381362|NCT00784719|7292285|FG001|STARTED|Overall Study||46
6381363|NCT00784719|7292286|FG002|STARTED|Overall Study||47
6381364|NCT00784719|7292287|FG003|STARTED|Overall Study||48
6381365|NCT00784719|7292288|FG004|STARTED|Overall Study||48
6381366|NCT00784719|7292289|FG005|STARTED|Overall Study||44
6381367|NCT00784719|7292290|FG006|STARTED|Overall Study||47
6381368|NCT00784719|7292284|FG000|COMPLETED|Overall Study||44
6268952|NCT00069095|7168017|FG002|COMPLETED|Follow-up Phase||178
6268953|NCT00069095|7168018|FG003|COMPLETED|Follow-up Phase||187
6268954|NCT00069095|7168019|FG004|COMPLETED|Follow-up Phase||186
6268955|NCT00069095|7168020|FG005|COMPLETED|Follow-up Phase||171
6268956|NCT00069095|7168015|FG000|NOT COMPLETED|Follow-up Phase||174
6268957|NCT00069095|7168016|FG001|NOT COMPLETED|Follow-up Phase||206
6268958|NCT00069095|7168017|FG002|NOT COMPLETED|Follow-up Phase||120
6268959|NCT00069095|7168018|FG003|NOT COMPLETED|Follow-up Phase||112
6268960|NCT00069095|7168019|FG004|NOT COMPLETED|Follow-up Phase||92
6268961|NCT00069095|7168020|FG005|NOT COMPLETED|Follow-up Phase||101
6268962|NCT00069108|7168034|FG000|STARTED|Overall Study||313
6268963|NCT00069108|7168035|FG001|STARTED|Overall Study||314
6268964|NCT00069108|7168034|FG000|COMPLETED|Overall Study||100
6268965|NCT00069108|7168035|FG001|COMPLETED|Overall Study||95
6268966|NCT00069108|7168034|FG000|NOT COMPLETED|Overall Study||213
6268967|NCT00069108|7168035|FG001|NOT COMPLETED|Overall Study||219
6268968|NCT00069121|7168044|FG000|STARTED|Overall Study||942
6268969|NCT00069121|7168045|FG001|STARTED|Overall Study||944
6268970|NCT00069121|7168044|FG000|Received Treatment|Overall Study|Safety Population|926
6268971|NCT00069121|7168045|FG001|Received Treatment|Overall Study|Safety Population|938
6268972|NCT00069121|7168044|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|575
6268973|NCT00069121|7168045|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|619
6268974|NCT00069121|7168044|FG000|NOT COMPLETED|Overall Study||367
6268975|NCT00069121|7168045|FG001|NOT COMPLETED|Overall Study||325
6268976|NCT00069160|7168057|FG000|STARTED|Overall Study||23
6268977|NCT00069160|7168058|FG001|STARTED|Overall Study||25
6268978|NCT00069160|7168057|FG000|COMPLETED|Overall Study||23
6268979|NCT00069160|7168058|FG001|COMPLETED|Overall Study||25
6268980|NCT00069160|7168057|FG000|NOT COMPLETED|Overall Study||0
6268981|NCT00069160|7168058|FG001|NOT COMPLETED|Overall Study||0
6268982|NCT00069264|7168067|FG000|STARTED|Overall Study||32
6268983|NCT00069264|7168067|FG000|COMPLETED|Overall Study||0
6268984|NCT00069264|7168067|FG000|NOT COMPLETED|Overall Study||32
6268985|NCT00069277|7168071|FG000|STARTED|Overall Study||21
6268986|NCT00069277|7168071|FG000|COMPLETED|Overall Study||0
6268987|NCT00069277|7168071|FG000|NOT COMPLETED|Overall Study||21
6268988|NCT00069329|7168075|FG000|STARTED|Overall Study||43
6268989|NCT00069329|7168075|FG000|COMPLETED|Overall Study||41
6268990|NCT00069329|7168075|FG000|NOT COMPLETED|Overall Study||2
6268991|NCT00069576|7168081|FG000|STARTED|Original Trial||485
6268992|NCT00069576|7168082|FG001|STARTED|Original Trial||473
6268993|NCT00069576|7168081|FG000|COMPLETED|Original Trial||460
6268994|NCT00069576|7168082|FG001|COMPLETED|Original Trial||440
6268995|NCT00069576|7168081|FG000|NOT COMPLETED|Original Trial||25
6268996|NCT00069576|7168082|FG001|NOT COMPLETED|Original Trial||33
6268997|NCT00069576|7168081|FG000|STARTED|Follow-up Study at 5-10 Years||460
6268998|NCT00069576|7168082|FG001|STARTED|Follow-up Study at 5-10 Years||440
6268999|NCT00069576|7168081|FG000|COMPLETED|Follow-up Study at 5-10 Years||264
6269000|NCT00069576|7168082|FG001|COMPLETED|Follow-up Study at 5-10 Years||236
6269001|NCT00069576|7168081|FG000|NOT COMPLETED|Follow-up Study at 5-10 Years||196
6269002|NCT00069576|7168082|FG001|NOT COMPLETED|Follow-up Study at 5-10 Years||204
6269003|NCT00069641|7168091|FG000|STARTED|Overall Study||32
6269004|NCT00069641|7168092|FG001|STARTED|Overall Study||32
6269005|NCT00069641|7168093|FG002|STARTED|Overall Study||32
6269006|NCT00069641|7168091|FG000|COMPLETED|Overall Study||31
6269007|NCT00069641|7168092|FG001|COMPLETED|Overall Study||32
6269008|NCT00069641|7168093|FG002|COMPLETED|Overall Study||31
6269009|NCT00069641|7168091|FG000|NOT COMPLETED|Overall Study||1
6269010|NCT00069641|7168092|FG001|NOT COMPLETED|Overall Study||0
6269011|NCT00069641|7168093|FG002|NOT COMPLETED|Overall Study||1
6269012|NCT00069784|7168104|FG000|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
6269013|NCT00069784|7168105|FG001|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
6269014|NCT00069784|7168104|FG000|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
6269015|NCT00069784|7168105|FG001|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
6381369|NCT00784719|7292285|FG001|COMPLETED|Overall Study||43
6269016|NCT00069784|7168104|FG000|COMPLETED|Overall Study|completed study treatment|5052
6269017|NCT00069784|7168105|FG001|COMPLETED|Overall Study|not applicable (no treatment)|6273
6269018|NCT00069784|7168104|FG000|NOT COMPLETED|Overall Study||1212
6269019|NCT00069784|7168105|FG001|NOT COMPLETED|Overall Study||0
6269020|NCT00069823|7168113|FG000|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
6269021|NCT00069823|7168114|FG001|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
6269022|NCT00069823|7168113|FG000|COMPLETED|Overall Study||193
6269023|NCT00069823|7168114|FG001|COMPLETED|Overall Study||200
6269024|NCT00069823|7168113|FG000|NOT COMPLETED|Overall Study||6
6269025|NCT00069823|7168114|FG001|NOT COMPLETED|Overall Study||3
6269026|NCT00069953|7168120|FG000|STARTED|Overall Study||43
6269027|NCT00069953|7168120|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
6269028|NCT00069953|7168120|FG000|NOT COMPLETED|Overall Study||2
6802953|NCT02499900|7734994|FG000|COMPLETED|Completed Core, Continued Into Extension||392
6802954|NCT02499900|7734995|FG001|COMPLETED|Completed Core, Continued Into Extension||397
6802955|NCT02499900|7734994|FG000|NOT COMPLETED|Completed Core, Continued Into Extension||3
6802956|NCT02499900|7734995|FG001|NOT COMPLETED|Completed Core, Continued Into Extension||2
6802957|NCT02499900|7734994|FG000|STARTED|Extension Study Period||392
6802958|NCT02499900|7734995|FG001|STARTED|Extension Study Period||397
6802959|NCT02499900|7734994|FG000|Safety Analysis Set|Extension Study Period||392
6802960|NCT02499900|7734995|FG001|Safety Analysis Set|Extension Study Period|One participant was not treated in the Extension Study Period|396
6802961|NCT02499900|7734994|FG000|COMPLETED|Extension Study Period||380
6381370|NCT00784719|7292286|FG002|COMPLETED|Overall Study||46
6381371|NCT00784719|7292287|FG003|COMPLETED|Overall Study||48
6381372|NCT00784719|7292288|FG004|COMPLETED|Overall Study||42
6381373|NCT00784719|7292289|FG005|COMPLETED|Overall Study||41
6381374|NCT00784719|7292290|FG006|COMPLETED|Overall Study||42
6381375|NCT00784719|7292284|FG000|NOT COMPLETED|Overall Study||3
6381376|NCT00784719|7292285|FG001|NOT COMPLETED|Overall Study||3
6381377|NCT00784719|7292286|FG002|NOT COMPLETED|Overall Study||1
6381378|NCT00784719|7292287|FG003|NOT COMPLETED|Overall Study||0
6381379|NCT00784719|7292288|FG004|NOT COMPLETED|Overall Study||6
6381380|NCT00784719|7292289|FG005|NOT COMPLETED|Overall Study||3
6381381|NCT00784719|7292290|FG006|NOT COMPLETED|Overall Study||5
6381382|NCT00784758|7292308|FG000|STARTED|Overall Study||42
6381383|NCT00784758|7292309|FG001|STARTED|Overall Study||39
6381384|NCT00784758|7292308|FG000|Began Treatment|Overall Study||41
6381385|NCT00784758|7292309|FG001|Began Treatment|Overall Study||39
6381386|NCT00784758|7292308|FG000|Completed Treatment|Overall Study||40
6381387|NCT00784758|7292309|FG001|Completed Treatment|Overall Study||39
6381388|NCT00784758|7292308|FG000|COMPLETED|Overall Study||38
6381389|NCT00784758|7292309|FG001|COMPLETED|Overall Study||39
6381390|NCT00784758|7292308|FG000|NOT COMPLETED|Overall Study||4
6381391|NCT00784758|7292309|FG001|NOT COMPLETED|Overall Study||0
6381392|NCT00784784|7292319|FG000|STARTED|Overall Study||22
6381393|NCT00784784|7292320|FG001|STARTED|Overall Study||42
6381394|NCT00784784|7292319|FG000|COMPLETED|Overall Study||20
6381395|NCT00784784|7292320|FG001|COMPLETED|Overall Study||40
6381396|NCT00784784|7292319|FG000|NOT COMPLETED|Overall Study||2
6381397|NCT00784784|7292320|FG001|NOT COMPLETED|Overall Study||2
6381398|NCT00784810|7292328|FG000|STARTED|Overall Study||124
6381399|NCT00784810|7292329|FG001|STARTED|Overall Study||123
6381400|NCT00784810|7292328|FG000|COMPLETED|Overall Study||61
6381401|NCT00784810|7292329|FG001|COMPLETED|Overall Study||74
6381402|NCT00784810|7292328|FG000|NOT COMPLETED|Overall Study||63
6381403|NCT00784810|7292329|FG001|NOT COMPLETED|Overall Study||49
6381404|NCT00784836|7292335|FG000|STARTED|Overall Study||3
6381405|NCT00784836|7292335|FG000|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
6381406|NCT00784836|7292335|FG000|NOT COMPLETED|Overall Study||3
6381407|NCT00784849|7292339|FG000|STARTED|Overall Study||62
6381408|NCT00784849|7292339|FG000|COMPLETED|Overall Study||62
6381409|NCT00784849|7292339|FG000|NOT COMPLETED|Overall Study||0
6381410|NCT00784875|7292347|FG000|STARTED|Period A - Baseline||0
6381411|NCT00784875|7292348|FG001|STARTED|Period A - Baseline||0
6381412|NCT00784875|7292349|FG002|STARTED|Period A - Baseline||0
6381413|NCT00784875|7292350|FG003|STARTED|Period A - Baseline||643
6381414|NCT00784875|7292347|FG000|COMPLETED|Period A - Baseline||0
6381415|NCT00784875|7292348|FG001|COMPLETED|Period A - Baseline||0
6381416|NCT00784875|7292349|FG002|COMPLETED|Period A - Baseline||0
6381417|NCT00784875|7292350|FG003|COMPLETED|Period A - Baseline||461
6381418|NCT00784875|7292347|FG000|NOT COMPLETED|Period A - Baseline||0
6381419|NCT00784875|7292348|FG001|NOT COMPLETED|Period A - Baseline||0
6381420|NCT00784875|7292349|FG002|NOT COMPLETED|Period A - Baseline||0
6381421|NCT00784875|7292350|FG003|NOT COMPLETED|Period A - Baseline||182
6381422|NCT00784875|7292347|FG000|STARTED|Period B - Efficacy Endpoint||114
6381423|NCT00784875|7292348|FG001|STARTED|Period B - Efficacy Endpoint||113
6381424|NCT00784875|7292349|FG002|STARTED|Period B - Efficacy Endpoint||117
6381425|NCT00784875|7292350|FG003|STARTED|Period B - Efficacy Endpoint||117
6381426|NCT00784875|7292347|FG000|Cohort 2|Period B - Efficacy Endpoint||102
6381427|NCT00784875|7292348|FG001|Cohort 2|Period B - Efficacy Endpoint||102
6381428|NCT00784875|7292349|FG002|Cohort 2|Period B - Efficacy Endpoint||102
6381429|NCT00784875|7292350|FG003|Cohort 2|Period B - Efficacy Endpoint||101
6381430|NCT00784875|7292347|FG000|COMPLETED|Period B - Efficacy Endpoint||100
6381431|NCT00784875|7292348|FG001|COMPLETED|Period B - Efficacy Endpoint||101
6381432|NCT00784875|7292349|FG002|COMPLETED|Period B - Efficacy Endpoint||96
6381433|NCT00784875|7292350|FG003|COMPLETED|Period B - Efficacy Endpoint||98
6381434|NCT00784875|7292347|FG000|NOT COMPLETED|Period B - Efficacy Endpoint||14
6381435|NCT00784875|7292348|FG001|NOT COMPLETED|Period B - Efficacy Endpoint||12
6381436|NCT00784875|7292349|FG002|NOT COMPLETED|Period B - Efficacy Endpoint||21
6381437|NCT00784875|7292350|FG003|NOT COMPLETED|Period B - Efficacy Endpoint||19
6381438|NCT00784875|7292347|FG000|STARTED|Period C||103
6381439|NCT00784875|7292348|FG001|STARTED|Period C||97
6381440|NCT00784875|7292349|FG002|STARTED|Period C||97
6381441|NCT00784875|7292350|FG003|STARTED|Period C||98
6381442|NCT00784875|7292347|FG000|COMPLETED|Period C||96
6381443|NCT00784875|7292348|FG001|COMPLETED|Period C||91
6381444|NCT00784875|7292349|FG002|COMPLETED|Period C||84
6381445|NCT00784875|7292350|FG003|COMPLETED|Period C||91
6381446|NCT00784875|7292347|FG000|NOT COMPLETED|Period C||7
6381447|NCT00784875|7292348|FG001|NOT COMPLETED|Period C||6
6381448|NCT00784875|7292349|FG002|NOT COMPLETED|Period C||13
6381449|NCT00784875|7292350|FG003|NOT COMPLETED|Period C||7
6381450|NCT00784875|7292347|FG000|STARTED|Period D||91
6381451|NCT00784875|7292348|FG001|STARTED|Period D||89
6381452|NCT00784875|7292349|FG002|STARTED|Period D||94
6381453|NCT00784875|7292350|FG003|STARTED|Period D||88
6381454|NCT00784875|7292347|FG000|COMPLETED|Period D||86
6381455|NCT00784875|7292348|FG001|COMPLETED|Period D||85
6381456|NCT00784875|7292349|FG002|COMPLETED|Period D||88
6381457|NCT00784875|7292350|FG003|COMPLETED|Period D||87
6381458|NCT00784875|7292347|FG000|NOT COMPLETED|Period D||5
6381459|NCT00784875|7292348|FG001|NOT COMPLETED|Period D||4
6381460|NCT00784875|7292349|FG002|NOT COMPLETED|Period D||6
6381461|NCT00784875|7292350|FG003|NOT COMPLETED|Period D||1
6381462|NCT00784927|7292373|FG000|STARTED|Overall Study||36
6381463|NCT00784927|7292373|FG000|COMPLETED|Overall Study||33
6381464|NCT00784927|7292373|FG000|NOT COMPLETED|Overall Study||3
6381465|NCT00784979|7292378|FG000|STARTED|Overall Study||26
6381466|NCT00784979|7292378|FG000|COMPLETED|Overall Study||20
6381467|NCT00784979|7292378|FG000|NOT COMPLETED|Overall Study||6
6381468|NCT00785044|7292382|FG000|STARTED|Overall Study|Eligible to participate in MBG313|964
6381469|NCT00785044|7292382|FG000|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
6381470|NCT00785044|7292382|FG000|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
6381471|NCT00785044|7292382|FG000|NOT COMPLETED|Overall Study||496
6381472|NCT00785213|7292387|FG000|STARTED|Rosiglitazone Alone||23
6381473|NCT00785213|7292387|FG000|COMPLETED|Rosiglitazone Alone||23
6381474|NCT00785213|7292387|FG000|NOT COMPLETED|Rosiglitazone Alone||0
6381475|NCT00785213|7292387|FG000|STARTED|2 Day Washout Period||23
6381476|NCT00785213|7292387|FG000|COMPLETED|2 Day Washout Period||23
6381477|NCT00785213|7292387|FG000|NOT COMPLETED|2 Day Washout Period||0
6381478|NCT00785213|7292387|FG000|STARTED|Quinine Sulfate Alone||23
6381479|NCT00785213|7292387|FG000|COMPLETED|Quinine Sulfate Alone||19
6381480|NCT00785213|7292387|FG000|NOT COMPLETED|Quinine Sulfate Alone||4
6381481|NCT00785213|7292387|FG000|STARTED|Rosiglitazone With Quinine Sulfate||19
6381482|NCT00785213|7292387|FG000|COMPLETED|Rosiglitazone With Quinine Sulfate||18
6381483|NCT00785213|7292387|FG000|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
6381484|NCT00785486|7292394|FG000|STARTED|Midazolam Alone||24
6381485|NCT00785486|7292394|FG000|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
6381486|NCT00785486|7292394|FG000|NOT COMPLETED|Midazolam Alone||1
6381487|NCT00785486|7292394|FG000|STARTED|3 Day Washout||23
6381488|NCT00785486|7292394|FG000|COMPLETED|3 Day Washout||23
6381489|NCT00785486|7292394|FG000|NOT COMPLETED|3 Day Washout||0
6381490|NCT00785486|7292394|FG000|STARTED|Qualaquin Alone at Steady State||23
6381491|NCT00785486|7292394|FG000|COMPLETED|Qualaquin Alone at Steady State||23
6381492|NCT00785486|7292394|FG000|NOT COMPLETED|Qualaquin Alone at Steady State||0
6381493|NCT00785486|7292394|FG000|STARTED|Midazolam With Qualaquin at Steady State||23
6381494|NCT00785486|7292394|FG000|COMPLETED|Midazolam With Qualaquin at Steady State||23
6381495|NCT00785486|7292394|FG000|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
6381496|NCT00785512|7292417|FG000|STARTED|Overall Study||102
6381497|NCT00785512|7292418|FG001|STARTED|Overall Study||105
6381498|NCT00785512|7292417|FG000|COMPLETED|Overall Study||99
6381499|NCT00785512|7292418|FG001|COMPLETED|Overall Study||101
6381500|NCT00785512|7292417|FG000|NOT COMPLETED|Overall Study||3
6381501|NCT00785512|7292418|FG001|NOT COMPLETED|Overall Study||4
6381502|NCT00785538|7292429|FG000|STARTED|PK Period||7
6381503|NCT00785538|7292430|FG001|STARTED|PK Period||1
6381504|NCT00785538|7292431|FG002|STARTED|PK Period||1
6381505|NCT00785538|7292432|FG003|STARTED|PK Period||0
6381506|NCT00785538|7292429|FG000|COMPLETED|PK Period||7
6381507|NCT00785538|7292430|FG001|COMPLETED|PK Period||1
6381508|NCT00785538|7292431|FG002|COMPLETED|PK Period||1
6381509|NCT00785538|7292432|FG003|COMPLETED|PK Period||0
6381510|NCT00785538|7292429|FG000|NOT COMPLETED|PK Period||0
6381511|NCT00785538|7292430|FG001|NOT COMPLETED|PK Period||0
6381512|NCT00785538|7292431|FG002|NOT COMPLETED|PK Period||0
6381513|NCT00785538|7292432|FG003|NOT COMPLETED|PK Period||0
6381514|NCT00785538|7292429|FG000|STARTED|Treatment Period||7
6381515|NCT00785538|7292430|FG001|STARTED|Treatment Period||9
6381516|NCT00785538|7292431|FG002|STARTED|Treatment Period||6
6381517|NCT00785538|7292432|FG003|STARTED|Treatment Period||2
6381518|NCT00785538|7292429|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||7
6381519|NCT00785538|7292430|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||9
6381520|NCT00785538|7292431|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||6
6381521|NCT00785538|7292432|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||2
6381522|NCT00785538|7292429|FG000|COMPLETED|Treatment Period||6
6381523|NCT00785538|7292430|FG001|COMPLETED|Treatment Period||7
6381524|NCT00785538|7292431|FG002|COMPLETED|Treatment Period||4
6381525|NCT00785538|7292432|FG003|COMPLETED|Treatment Period||1
6656718|NCT02463409|7587020|FG000|COMPLETED|Overall Study||4
6656719|NCT02463409|7587020|FG000|NOT COMPLETED|Overall Study||2
6656720|NCT02463487|7587026|FG000|STARTED|Overall Study||75
6656721|NCT02463487|7587027|FG001|STARTED|Overall Study||75
6656722|NCT02463487|7587026|FG000|COMPLETED|Overall Study||65
6656723|NCT02463487|7587027|FG001|COMPLETED|Overall Study||65
6656724|NCT02463487|7587026|FG000|NOT COMPLETED|Overall Study||10
6381526|NCT00785538|7292429|FG000|NOT COMPLETED|Treatment Period||1
6656725|NCT02463487|7587027|FG001|NOT COMPLETED|Overall Study||10
6656726|NCT02463799|7587035|FG000|STARTED|Overall Study||16
6656727|NCT02463799|7587036|FG001|STARTED|Overall Study||16
6656728|NCT02463799|7587035|FG000|COMPLETED|Overall Study||16
6564369|NCT01811238|7487100|FG000|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
6564370|NCT01811238|7487100|FG000|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
6564371|NCT01811238|7487100|FG000|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
6564372|NCT01811238|7487100|FG000|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
6564373|NCT01811238|7487100|FG000|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
6381527|NCT00785538|7292430|FG001|NOT COMPLETED|Treatment Period||2
6381528|NCT00785538|7292431|FG002|NOT COMPLETED|Treatment Period||2
6381529|NCT00785538|7292432|FG003|NOT COMPLETED|Treatment Period||1
6381530|NCT00785577|7292448|FG000|STARTED|Study Period 2: Therapy Phase||89
6381531|NCT00785577|7292449|FG001|STARTED|Study Period 2: Therapy Phase||45
6381532|NCT00785577|7292450|FG002|STARTED|Study Period 2: Therapy Phase||43
6381533|NCT00785577|7292451|FG003|STARTED|Study Period 2: Therapy Phase||49
6381534|NCT00785577|7292452|FG004|STARTED|Study Period 2: Therapy Phase||47
6381535|NCT00785577|7292448|FG000|COMPLETED|Study Period 2: Therapy Phase||78
6381536|NCT00785577|7292449|FG001|COMPLETED|Study Period 2: Therapy Phase||36
6381537|NCT00785577|7292450|FG002|COMPLETED|Study Period 2: Therapy Phase||25
6381538|NCT00785577|7292451|FG003|COMPLETED|Study Period 2: Therapy Phase||36
6381539|NCT00785577|7292452|FG004|COMPLETED|Study Period 2: Therapy Phase||27
6381540|NCT00785577|7292448|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||11
6381541|NCT00785577|7292449|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||9
6381542|NCT00785577|7292450|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||18
6381543|NCT00785577|7292451|FG003|NOT COMPLETED|Study Period 2: Therapy Phase||13
6381544|NCT00785577|7292452|FG004|NOT COMPLETED|Study Period 2: Therapy Phase||20
6381545|NCT00785577|7292448|FG000|STARTED|Study Period 3: 1-Week Washout Phase||78
6381546|NCT00785577|7292449|FG001|STARTED|Study Period 3: 1-Week Washout Phase||36
6381547|NCT00785577|7292450|FG002|STARTED|Study Period 3: 1-Week Washout Phase||25
6381548|NCT00785577|7292451|FG003|STARTED|Study Period 3: 1-Week Washout Phase||36
6381549|NCT00785577|7292452|FG004|STARTED|Study Period 3: 1-Week Washout Phase||27
6381550|NCT00785577|7292448|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||78
6381551|NCT00785577|7292449|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||36
6381552|NCT00785577|7292450|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||25
6381553|NCT00785577|7292451|FG003|COMPLETED|Study Period 3: 1-Week Washout Phase||35
6381554|NCT00785577|7292452|FG004|COMPLETED|Study Period 3: 1-Week Washout Phase||26
6381555|NCT00785577|7292448|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
6381556|NCT00785577|7292449|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
6381557|NCT00785577|7292450|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
6381558|NCT00785577|7292451|FG003|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
6381559|NCT00785577|7292452|FG004|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
6381560|NCT00785629|7292478|FG000|STARTED|Overall Study||30
6564374|NCT01811238|7487100|FG000|NOT COMPLETED|Overall Study||81
6381561|NCT00785629|7292479|FG001|STARTED|Overall Study||30
6381562|NCT00785629|7292480|FG002|STARTED|Overall Study||28
6381563|NCT00785629|7292481|FG003|STARTED|Overall Study||57
6381564|NCT00785629|7292478|FG000|COMPLETED|Overall Study|8 not completed|22
6381565|NCT00785629|7292479|FG001|COMPLETED|Overall Study|5 not completed|25
6381566|NCT00785629|7292480|FG002|COMPLETED|Overall Study|10 not completed|18
6381567|NCT00785629|7292481|FG003|COMPLETED|Overall Study|16 not completed|41
6381568|NCT00785629|7292478|FG000|NOT COMPLETED|Overall Study||8
6381569|NCT00785629|7292479|FG001|NOT COMPLETED|Overall Study||5
6381570|NCT00785629|7292480|FG002|NOT COMPLETED|Overall Study||10
6381571|NCT00785629|7292481|FG003|NOT COMPLETED|Overall Study||16
6381572|NCT00785707|7292489|FG000|STARTED|Overall Study||31
6381573|NCT00785707|7292489|FG000|COMPLETED|Overall Study||24
6381574|NCT00785707|7292489|FG000|NOT COMPLETED|Overall Study||7
6381575|NCT00785772|7292493|FG000|STARTED|Overall Study||1
6381576|NCT00785772|7292493|FG000|COMPLETED|Overall Study||1
6381577|NCT00785772|7292493|FG000|NOT COMPLETED|Overall Study||0
6381578|NCT00785785|7292499|FG000|STARTED|Core Phase up to 36 Months||324
6381579|NCT00785785|7292500|FG001|STARTED|Core Phase up to 36 Months||320
6502742|NCT01436526|7421493|FG000|Participants Received Treatment|Period 1||14
6502743|NCT01436526|7421494|FG001|Participants Received Treatment|Period 1||14
6564375|NCT01811303|7487105|FG000|STARTED|First Intervention (1 Day)||4
6564376|NCT01811303|7487106|FG001|STARTED|First Intervention (1 Day)||4
6564377|NCT01811303|7487107|FG002|STARTED|First Intervention (1 Day)||4
6564378|NCT01811303|7487108|FG003|STARTED|First Intervention (1 Day)||2
6564379|NCT01811303|7487105|FG000|COMPLETED|First Intervention (1 Day)||4
6564380|NCT01811303|7487106|FG001|COMPLETED|First Intervention (1 Day)||4
6269029|NCT00070070|7168128|FG000|STARTED|Overall Study||1
6381580|NCT00785785|7292499|FG000|COMPLETED|Core Phase up to 36 Months||0
6381581|NCT00785785|7292500|FG001|COMPLETED|Core Phase up to 36 Months||0
6564381|NCT01811303|7487107|FG002|COMPLETED|First Intervention (1 Day)||4
6381582|NCT00785785|7292499|FG000|NOT COMPLETED|Core Phase up to 36 Months||324
6381583|NCT00785785|7292500|FG001|NOT COMPLETED|Core Phase up to 36 Months||320
6564382|NCT01811303|7487108|FG003|COMPLETED|First Intervention (1 Day)||2
6381584|NCT00785785|7292499|FG000|STARTED|Optional Extension Phase|crossover extension phase was optional|39
6381585|NCT00785785|7292500|FG001|STARTED|Optional Extension Phase|crossover extension phase was optional|125
6381586|NCT00785785|7292499|FG000|COMPLETED|Optional Extension Phase||0
6564383|NCT01811303|7487105|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6564384|NCT01811303|7487106|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6564385|NCT01811303|7487107|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6564386|NCT01811303|7487108|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6564387|NCT01811303|7487105|FG000|STARTED|Washout (2 Days or More)||4
6381587|NCT00785785|7292500|FG001|COMPLETED|Optional Extension Phase||0
6381588|NCT00785785|7292499|FG000|NOT COMPLETED|Optional Extension Phase||39
6381589|NCT00785785|7292500|FG001|NOT COMPLETED|Optional Extension Phase||125
6381590|NCT00785928|7292515|FG000|STARTED|Treatment Phase||36
6381591|NCT00785928|7292516|FG001|STARTED|Treatment Phase||30
6381592|NCT00785928|7292517|FG002|STARTED|Treatment Phase||20
6381593|NCT00785928|7292518|FG003|STARTED|Treatment Phase||15
6381594|NCT00785928|7292519|FG004|STARTED|Treatment Phase||18
6381595|NCT00785928|7292520|FG005|STARTED|Treatment Phase||13
6381596|NCT00785928|7292521|FG006|STARTED|Treatment Phase||26
6381597|NCT00785928|7292515|FG000|COMPLETED|Treatment Phase||33
6381598|NCT00785928|7292516|FG001|COMPLETED|Treatment Phase||25
6381599|NCT00785928|7292517|FG002|COMPLETED|Treatment Phase||17
6381600|NCT00785928|7292518|FG003|COMPLETED|Treatment Phase||15
6381601|NCT00785928|7292519|FG004|COMPLETED|Treatment Phase||16
6381602|NCT00785928|7292520|FG005|COMPLETED|Treatment Phase||13
6381603|NCT00785928|7292521|FG006|COMPLETED|Treatment Phase||23
6381604|NCT00785928|7292515|FG000|NOT COMPLETED|Treatment Phase||3
6381605|NCT00785928|7292516|FG001|NOT COMPLETED|Treatment Phase||5
6381606|NCT00785928|7292517|FG002|NOT COMPLETED|Treatment Phase||3
6381607|NCT00785928|7292518|FG003|NOT COMPLETED|Treatment Phase||0
6381608|NCT00785928|7292519|FG004|NOT COMPLETED|Treatment Phase||2
6381609|NCT00785928|7292520|FG005|NOT COMPLETED|Treatment Phase||0
6381610|NCT00785928|7292521|FG006|NOT COMPLETED|Treatment Phase||3
6381611|NCT00785928|7292515|FG000|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
6395597|NCT00859222|7308176|FG003|NOT COMPLETED|Overall Study||24
6802962|NCT02499900|7734995|FG001|COMPLETED|Extension Study Period||377
6802963|NCT02499900|7734994|FG000|NOT COMPLETED|Extension Study Period||12
6802964|NCT02499900|7734995|FG001|NOT COMPLETED|Extension Study Period||20
6802965|NCT02481986|7735009|FG000|STARTED|Overall Study||108
6802966|NCT02481986|7735010|FG001|STARTED|Overall Study||115
6802967|NCT02481986|7735009|FG000|COMPLETED|Overall Study||103
6802968|NCT02481986|7735010|FG001|COMPLETED|Overall Study||106
6802969|NCT02481986|7735009|FG000|NOT COMPLETED|Overall Study||5
6802970|NCT02481986|7735010|FG001|NOT COMPLETED|Overall Study||9
6802971|NCT02394548|7735016|FG000|STARTED|Overall Study||26
6802972|NCT02394548|7735016|FG000|COMPLETED|Overall Study||25
6802973|NCT02394548|7735016|FG000|NOT COMPLETED|Overall Study||1
6564388|NCT01811303|7487106|FG001|STARTED|Washout (2 Days or More)||4
6564389|NCT01811303|7487107|FG002|STARTED|Washout (2 Days or More)||4
6564390|NCT01811303|7487108|FG003|STARTED|Washout (2 Days or More)||2
6269030|NCT00070070|7168129|FG001|STARTED|Overall Study||0
6269031|NCT00070070|7168130|FG002|STARTED|Overall Study||0
6269032|NCT00070070|7168131|FG003|STARTED|Overall Study||5
6269033|NCT00070070|7168128|FG000|COMPLETED|Overall Study||1
6269034|NCT00070070|7168129|FG001|COMPLETED|Overall Study||0
6269035|NCT00070070|7168130|FG002|COMPLETED|Overall Study||0
6269036|NCT00070070|7168131|FG003|COMPLETED|Overall Study||5
6269037|NCT00070070|7168128|FG000|NOT COMPLETED|Overall Study||0
6269038|NCT00070070|7168129|FG001|NOT COMPLETED|Overall Study||0
6269039|NCT00070070|7168130|FG002|NOT COMPLETED|Overall Study||0
6269040|NCT00070070|7168131|FG003|NOT COMPLETED|Overall Study||0
6269041|NCT00070109|7168146|FG000|STARTED|Overall Study||8
6269042|NCT00070109|7168147|FG001|STARTED|Overall Study||6
6269043|NCT00070109|7168148|FG002|STARTED|Overall Study||8
6269044|NCT00070109|7168149|FG003|STARTED|Overall Study||20
6269045|NCT00070109|7168150|FG004|STARTED|Overall Study||8
6269046|NCT00070109|7168146|FG000|COMPLETED|Overall Study||0
6269047|NCT00070109|7168147|FG001|COMPLETED|Overall Study||0
6269048|NCT00070109|7168148|FG002|COMPLETED|Overall Study||0
6269049|NCT00070109|7168149|FG003|COMPLETED|Overall Study||0
6269050|NCT00070109|7168150|FG004|COMPLETED|Overall Study||0
6269051|NCT00070109|7168146|FG000|NOT COMPLETED|Overall Study||8
6269052|NCT00070109|7168147|FG001|NOT COMPLETED|Overall Study||6
6269053|NCT00070109|7168148|FG002|NOT COMPLETED|Overall Study||8
6269054|NCT00070109|7168149|FG003|NOT COMPLETED|Overall Study||20
6269055|NCT00070109|7168150|FG004|NOT COMPLETED|Overall Study||8
6269056|NCT00070135|7168169|FG000|STARTED|Overall Study||114
6269057|NCT00070135|7168169|FG000|COMPLETED|Overall Study||114
6269058|NCT00070135|7168169|FG000|NOT COMPLETED|Overall Study||0
6269059|NCT00070291|7168173|FG000|STARTED|Step 1||4
6269060|NCT00070291|7168173|FG000|Treated|Step 1||3
6269061|NCT00070291|7168173|FG000|COMPLETED|Step 1||2
6269062|NCT00070291|7168173|FG000|NOT COMPLETED|Step 1||2
6269063|NCT00070291|7168173|FG000|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
6269064|NCT00070291|7168173|FG000|COMPLETED|Step 2||0
6269065|NCT00070291|7168173|FG000|NOT COMPLETED|Step 2||1
6269066|NCT00070317|7168177|FG000|STARTED|Overall Study||102
6269067|NCT00070317|7168177|FG000|COMPLETED|Overall Study||89
6269068|NCT00070317|7168177|FG000|NOT COMPLETED|Overall Study||13
6269069|NCT00070941|7168184|FG000|STARTED|Overall Study||12
6269070|NCT00070941|7168185|FG001|STARTED|Overall Study||11
6269071|NCT00070941|7168186|FG002|STARTED|Overall Study||6
6269072|NCT00070941|7168184|FG000|COMPLETED|Overall Study||2
6269073|NCT00070941|7168185|FG001|COMPLETED|Overall Study||3
6269074|NCT00070941|7168186|FG002|COMPLETED|Overall Study||2
6269075|NCT00070941|7168184|FG000|NOT COMPLETED|Overall Study||10
6269076|NCT00070941|7168185|FG001|NOT COMPLETED|Overall Study||8
6269077|NCT00070941|7168186|FG002|NOT COMPLETED|Overall Study||4
6269078|NCT00071006|7168194|FG000|STARTED|Overall Study||12
6269079|NCT00071006|7168194|FG000|COMPLETED|Overall Study||0
6269080|NCT00071006|7168194|FG000|NOT COMPLETED|Overall Study||12
6269081|NCT00071032|7168200|FG000|STARTED|Overall Study||1007
6269082|NCT00071032|7168201|FG001|STARTED|Overall Study||1009
6269083|NCT00071032|7168200|FG000|COMPLETED|Overall Study||998
6269084|NCT00071032|7168201|FG001|COMPLETED|Overall Study||1001
6564391|NCT01811303|7487105|FG000|COMPLETED|Washout (2 Days or More)||4
6381612|NCT00785928|7292516|FG001|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|8
6381613|NCT00785928|7292517|FG002|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
6381614|NCT00785928|7292518|FG003|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|4
6381615|NCT00785928|7292519|FG004|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|6
6381616|NCT00785928|7292520|FG005|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|0
6381617|NCT00785928|7292521|FG006|STARTED|Follow-up Phases (Weeks 24-72)|Participants enrolling in an open-label extension study were not required to be in Follow-up Phase.|14
6381618|NCT00785928|7292515|FG000|COMPLETED|Follow-up Phases (Weeks 24-72)||7
6381619|NCT00785928|7292516|FG001|COMPLETED|Follow-up Phases (Weeks 24-72)||5
6381620|NCT00785928|7292517|FG002|COMPLETED|Follow-up Phases (Weeks 24-72)||4
6381621|NCT00785928|7292518|FG003|COMPLETED|Follow-up Phases (Weeks 24-72)||4
6502744|NCT01436526|7421493|FG000|COMPLETED|Period 1||14
6502745|NCT01436526|7421494|FG001|COMPLETED|Period 1||14
6502746|NCT01436526|7421493|FG000|NOT COMPLETED|Period 1||0
6502747|NCT01436526|7421494|FG001|NOT COMPLETED|Period 1||0
6502748|NCT01436526|7421493|FG000|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
6502749|NCT01436526|7421494|FG001|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
6502750|NCT01436526|7421493|FG000|Participants Received Treatment|Period 2||13
6502751|NCT01436526|7421494|FG001|Participants Received Treatment|Period 2||13
6502752|NCT01436526|7421493|FG000|COMPLETED|Period 2||13
6502753|NCT01436526|7421494|FG001|COMPLETED|Period 2||13
6502754|NCT01436526|7421493|FG000|NOT COMPLETED|Period 2||0
6502755|NCT01436526|7421494|FG001|NOT COMPLETED|Period 2||0
6564392|NCT01811303|7487106|FG001|COMPLETED|Washout (2 Days or More)||4
6802974|NCT02269917|7735022|FG000|STARTED|BL to EOE-Test and BL to Switch-Control||766
6802975|NCT02269917|7735023|FG001|STARTED|BL to EOE-Test and BL to Switch-Control||383
6802976|NCT02269917|7735024|FG002|STARTED|BL to EOE-Test and BL to Switch-Control||0
6802977|NCT02269917|7735022|FG000|Treated|BL to EOE-Test and BL to Switch-Control||763
6802978|NCT02269917|7735023|FG001|Treated|BL to EOE-Test and BL to Switch-Control||378
6802979|NCT02269917|7735024|FG002|Treated|BL to EOE-Test and BL to Switch-Control||0
6802980|NCT02269917|7735022|FG000|COMPLETED|BL to EOE-Test and BL to Switch-Control||649
6802981|NCT02269917|7735023|FG001|COMPLETED|BL to EOE-Test and BL to Switch-Control||352
6802982|NCT02269917|7735024|FG002|COMPLETED|BL to EOE-Test and BL to Switch-Control||0
6269085|NCT00071032|7168200|FG000|NOT COMPLETED|Overall Study||9
6269086|NCT00071032|7168201|FG001|NOT COMPLETED|Overall Study||8
6269087|NCT00071058|7168208|FG000|STARTED|Overall Study||50
6381622|NCT00785928|7292519|FG004|COMPLETED|Follow-up Phases (Weeks 24-72)||4
6381623|NCT00785928|7292520|FG005|COMPLETED|Follow-up Phases (Weeks 24-72)||0
6381624|NCT00785928|7292521|FG006|COMPLETED|Follow-up Phases (Weeks 24-72)||9
6381625|NCT00785928|7292515|FG000|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||1
6381626|NCT00785928|7292516|FG001|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||3
6381627|NCT00785928|7292517|FG002|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
6381628|NCT00785928|7292518|FG003|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
6381629|NCT00785928|7292519|FG004|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||2
6381630|NCT00785928|7292520|FG005|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||0
6381631|NCT00785928|7292521|FG006|NOT COMPLETED|Follow-up Phases (Weeks 24-72)||5
6381632|NCT00785980|7292559|FG000|STARTED|Quinine Sulfate Alone||24
6381633|NCT00785980|7292559|FG000|COMPLETED|Quinine Sulfate Alone||24
6381634|NCT00785980|7292559|FG000|NOT COMPLETED|Quinine Sulfate Alone||0
6381635|NCT00785980|7292559|FG000|STARTED|7 Day Washout Period||24
6381636|NCT00785980|7292559|FG000|COMPLETED|7 Day Washout Period||21
6381637|NCT00785980|7292559|FG000|NOT COMPLETED|7 Day Washout Period||3
6381638|NCT00785980|7292559|FG000|STARTED|Ciprofloxacin Alone||21
6381639|NCT00785980|7292559|FG000|COMPLETED|Ciprofloxacin Alone||21
6381640|NCT00785980|7292559|FG000|NOT COMPLETED|Ciprofloxacin Alone||0
6381641|NCT00785980|7292559|FG000|STARTED|Quinine Sulfate With Ciprofloxacin||21
6381642|NCT00785980|7292559|FG000|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
6381643|NCT00785980|7292559|FG000|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
6381644|NCT00786019|7292568|FG000|STARTED|Overall Study||20
6381645|NCT00786019|7292569|FG001|STARTED|Overall Study||27
6381646|NCT00786019|7292568|FG000|COMPLETED|Overall Study||15
6381647|NCT00786019|7292569|FG001|COMPLETED|Overall Study||17
6381648|NCT00786019|7292568|FG000|NOT COMPLETED|Overall Study||5
6381649|NCT00786019|7292569|FG001|NOT COMPLETED|Overall Study||10
6381650|NCT00786032|7292577|FG000|STARTED|Overall Study||27
6381651|NCT00786032|7292577|FG000|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
6381652|NCT00786032|7292577|FG000|COMPLETED|Overall Study||3
6381653|NCT00786032|7292577|FG000|NOT COMPLETED|Overall Study||24
6381654|NCT00786188|7292585|FG000|STARTED|Overall Study||50
6381655|NCT00786188|7292586|FG001|STARTED|Overall Study||52
6381656|NCT00786188|7292585|FG000|COMPLETED|Overall Study||45
6381657|NCT00786188|7292586|FG001|COMPLETED|Overall Study||51
6381658|NCT00786188|7292585|FG000|NOT COMPLETED|Overall Study||5
6381659|NCT00786188|7292586|FG001|NOT COMPLETED|Overall Study||1
6381660|NCT00786409|7292594|FG000|STARTED|Overall Study||27
6381661|NCT00786409|7292594|FG000|COMPLETED|Overall Study||20
6381662|NCT00786409|7292594|FG000|NOT COMPLETED|Overall Study||7
6381663|NCT00786422|7292598|FG000|STARTED|Rivaroxaban Treatment||25
6381664|NCT00786422|7292598|FG000|COMPLETED|Rivaroxaban Treatment||14
6269088|NCT00071058|7168208|FG000|COMPLETED|Overall Study||49
6564393|NCT01811303|7487107|FG002|COMPLETED|Washout (2 Days or More)||4
6564394|NCT01811303|7487108|FG003|COMPLETED|Washout (2 Days or More)||2
6564395|NCT01811303|7487105|FG000|NOT COMPLETED|Washout (2 Days or More)||0
6564396|NCT01811303|7487106|FG001|NOT COMPLETED|Washout (2 Days or More)||0
6564397|NCT01811303|7487107|FG002|NOT COMPLETED|Washout (2 Days or More)||0
6564398|NCT01811303|7487108|FG003|NOT COMPLETED|Washout (2 Days or More)||0
6564399|NCT01811303|7487105|FG000|STARTED|Second Intervention (1 Day)||4
6564400|NCT01811303|7487106|FG001|STARTED|Second Intervention (1 Day)||4
6564401|NCT01811303|7487107|FG002|STARTED|Second Intervention (1 Day)||4
6564402|NCT01811303|7487108|FG003|STARTED|Second Intervention (1 Day)||2
6564403|NCT01811303|7487105|FG000|COMPLETED|Second Intervention (1 Day)||4
6564404|NCT01811303|7487106|FG001|COMPLETED|Second Intervention (1 Day)||4
6564405|NCT01811303|7487107|FG002|COMPLETED|Second Intervention (1 Day)||4
6564406|NCT01811303|7487108|FG003|COMPLETED|Second Intervention (1 Day)||2
6381665|NCT00786422|7292598|FG000|NOT COMPLETED|Rivaroxaban Treatment||11
6381666|NCT00786422|7292598|FG000|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
6381667|NCT00786422|7292598|FG000|COMPLETED|Follow-up Period||17
6381668|NCT00786422|7292598|FG000|NOT COMPLETED|Follow-up Period||3
6381669|NCT00786474|7292606|FG000|STARTED|Overall Study||950
6381670|NCT00786474|7292607|FG001|STARTED|Overall Study||934
6381671|NCT00786474|7292606|FG000|COMPLETED|Overall Study||913
6381672|NCT00786474|7292607|FG001|COMPLETED|Overall Study||891
6381673|NCT00786474|7292606|FG000|NOT COMPLETED|Overall Study||37
6381674|NCT00786474|7292607|FG001|NOT COMPLETED|Overall Study||43
6381675|NCT00786487|7292617|FG000|STARTED|Overall Study||10
6381676|NCT00786487|7292618|FG001|STARTED|Overall Study||7
6381677|NCT00786487|7292619|FG002|STARTED|Overall Study||9
6381678|NCT00786487|7292620|FG003|STARTED|Overall Study||7
6381679|NCT00786487|7292617|FG000|COMPLETED|Overall Study||10
6381680|NCT00786487|7292618|FG001|COMPLETED|Overall Study||7
6381681|NCT00786487|7292619|FG002|COMPLETED|Overall Study||9
6381682|NCT00786487|7292620|FG003|COMPLETED|Overall Study||7
6381683|NCT00786487|7292617|FG000|NOT COMPLETED|Overall Study||0
6381684|NCT00786487|7292618|FG001|NOT COMPLETED|Overall Study||0
6381685|NCT00786487|7292619|FG002|NOT COMPLETED|Overall Study||0
6381686|NCT00786487|7292620|FG003|NOT COMPLETED|Overall Study||0
6381687|NCT00786565|7292630|FG000|STARTED|Enrollment Prior to Surgery||75
6381688|NCT00786565|7292630|FG000|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
6381689|NCT00786565|7292630|FG000|NOT COMPLETED|Enrollment Prior to Surgery||6
6381690|NCT00786565|7292630|FG000|STARTED|Post Surgery||69
6381691|NCT00786565|7292630|FG000|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
6381692|NCT00786565|7292630|FG000|NOT COMPLETED|Post Surgery||2
6381693|NCT00786643|7292638|FG000|STARTED|Overall Study||20
6381694|NCT00786643|7292639|FG001|STARTED|Overall Study||28
6381695|NCT00786643|7292638|FG000|COMPLETED|Overall Study||20
6381696|NCT00786643|7292639|FG001|COMPLETED|Overall Study||28
6381697|NCT00786643|7292638|FG000|NOT COMPLETED|Overall Study||0
6381698|NCT00786643|7292639|FG001|NOT COMPLETED|Overall Study||0
6381699|NCT00786799|7292647|FG000|STARTED|Overall Study||14
6381700|NCT00786799|7292648|FG001|STARTED|Overall Study||13
6381701|NCT00786799|7292647|FG000|COMPLETED|Overall Study||13
6381702|NCT00786799|7292648|FG001|COMPLETED|Overall Study||12
6381703|NCT00786799|7292647|FG000|NOT COMPLETED|Overall Study||1
6381704|NCT00786799|7292648|FG001|NOT COMPLETED|Overall Study||1
6381705|NCT00786825|7292661|FG000|STARTED|Overall Study||5
6381706|NCT00786825|7292662|FG001|STARTED|Overall Study||5
6381707|NCT00786825|7292661|FG000|COMPLETED|Overall Study||5
6381708|NCT00786825|7292662|FG001|COMPLETED|Overall Study||5
6381709|NCT00786825|7292661|FG000|NOT COMPLETED|Overall Study||0
6381710|NCT00786825|7292662|FG001|NOT COMPLETED|Overall Study||0
6381711|NCT00786838|7292668|FG000|STARTED|Overall Study||75
6381712|NCT00786838|7292668|FG000|COMPLETED|Overall Study||26
6381713|NCT00786838|7292668|FG000|NOT COMPLETED|Overall Study||49
6381714|NCT00786864|7292679|FG000|STARTED|Overall Study||39
6381715|NCT00786864|7292680|FG001|STARTED|Overall Study||33
6381716|NCT00786864|7292679|FG000|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
6381717|NCT00786864|7292680|FG001|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
6381718|NCT00786864|7292679|FG000|NOT COMPLETED|Overall Study||1
6381719|NCT00786864|7292680|FG001|NOT COMPLETED|Overall Study||1
6564407|NCT01811303|7487105|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6564408|NCT01811303|7487106|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6381720|NCT00786916|7292689|FG000|STARTED|Overall Study||39
6381721|NCT00786916|7292690|FG001|STARTED|Overall Study||36
6381722|NCT00786916|7292691|FG002|STARTED|Overall Study||34
6381723|NCT00786916|7292689|FG000|COMPLETED|Overall Study||39
6381724|NCT00786916|7292690|FG001|COMPLETED|Overall Study||36
6381725|NCT00786916|7292691|FG002|COMPLETED|Overall Study||34
6381726|NCT00786916|7292689|FG000|NOT COMPLETED|Overall Study||0
6381727|NCT00786916|7292690|FG001|NOT COMPLETED|Overall Study||0
6381728|NCT00786916|7292691|FG002|NOT COMPLETED|Overall Study||0
6381729|NCT00786994|7292703|FG000|STARTED|Overall Study||57
6381730|NCT00786994|7292704|FG001|STARTED|Overall Study||54
6381731|NCT00786994|7292705|FG002|STARTED|Overall Study||26
6381732|NCT00786994|7292706|FG003|STARTED|Overall Study||28
6381733|NCT00786994|7292703|FG000|ITT|Overall Study||53
6502756|NCT01436643|7421503|FG000|STARTED|2-week Pre-treatment||0
6381734|NCT00786994|7292704|FG001|ITT|Overall Study||51
6802983|NCT02269917|7735022|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||117
6802984|NCT02269917|7735023|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||31
6802985|NCT02269917|7735024|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch-Control||0
6802986|NCT02269917|7735022|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
6802987|NCT02269917|7735023|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)||0
6802988|NCT02269917|7735024|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)||352
6802989|NCT02269917|7735022|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
6381735|NCT00786994|7292705|FG002|ITT|Overall Study||25
6381736|NCT00786994|7292706|FG003|ITT|Overall Study||28
6381737|NCT00786994|7292703|FG000|COMPLETED|Overall Study||47
6381738|NCT00786994|7292704|FG001|COMPLETED|Overall Study||39
6381739|NCT00786994|7292705|FG002|COMPLETED|Overall Study||24
6381740|NCT00786994|7292706|FG003|COMPLETED|Overall Study||22
6381741|NCT00786994|7292703|FG000|NOT COMPLETED|Overall Study||10
6381742|NCT00786994|7292704|FG001|NOT COMPLETED|Overall Study||15
6381743|NCT00786994|7292705|FG002|NOT COMPLETED|Overall Study||2
6381744|NCT00786994|7292706|FG003|NOT COMPLETED|Overall Study||6
6381745|NCT00787020|7292717|FG000|STARTED|Overall Study||24
6381746|NCT00787020|7292718|FG001|STARTED|Overall Study||13
6381747|NCT00787020|7292717|FG000|COMPLETED|Overall Study||24
6381748|NCT00787020|7292718|FG001|COMPLETED|Overall Study||13
6381749|NCT00787020|7292717|FG000|NOT COMPLETED|Overall Study||0
6381750|NCT00787020|7292718|FG001|NOT COMPLETED|Overall Study||0
6381751|NCT00787137|7292727|FG000|STARTED|Overall Study||6
6381752|NCT00787137|7292728|FG001|STARTED|Overall Study||6
6381753|NCT00787137|7292729|FG002|STARTED|Overall Study||5
6381754|NCT00787137|7292727|FG000|COMPLETED|Overall Study||6
6381755|NCT00787137|7292728|FG001|COMPLETED|Overall Study||6
6381756|NCT00787137|7292729|FG002|COMPLETED|Overall Study||4
6381757|NCT00787137|7292727|FG000|NOT COMPLETED|Overall Study||0
6381758|NCT00787137|7292728|FG001|NOT COMPLETED|Overall Study||0
6381759|NCT00787137|7292729|FG002|NOT COMPLETED|Overall Study||1
6381760|NCT00787150|7292740|FG000|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
6381761|NCT00787150|7292741|FG001|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
6381762|NCT00787150|7292742|FG002|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
6802990|NCT02269917|7735023|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
6381763|NCT00787150|7292740|FG000|COMPLETED|Overall Study||66
6381764|NCT00787150|7292741|FG001|COMPLETED|Overall Study||65
6381765|NCT00787150|7292742|FG002|COMPLETED|Overall Study||66
6381766|NCT00787150|7292740|FG000|NOT COMPLETED|Overall Study||9
6381767|NCT00787150|7292741|FG001|NOT COMPLETED|Overall Study||7
6381768|NCT00787150|7292742|FG002|NOT COMPLETED|Overall Study||5
6381769|NCT00787189|7292754|FG000|STARTED|Overall Study||32
6381770|NCT00787189|7292755|FG001|STARTED|Overall Study||32
6381771|NCT00787189|7292754|FG000|COMPLETED|Overall Study|To study end point.|30
6381772|NCT00787189|7292755|FG001|COMPLETED|Overall Study|To study end point.|30
6381773|NCT00787189|7292754|FG000|NOT COMPLETED|Overall Study||2
6381774|NCT00787189|7292755|FG001|NOT COMPLETED|Overall Study||2
6381775|NCT00787202|7292766|FG000|STARTED|Overall Study||49
6381776|NCT00787202|7292767|FG001|STARTED|Overall Study||31
6381777|NCT00787202|7292768|FG002|STARTED|Overall Study||33
6381778|NCT00787202|7292769|FG003|STARTED|Overall Study||33
6381779|NCT00787202|7292770|FG004|STARTED|Overall Study||49
6381780|NCT00787202|7292766|FG000|Treated|Overall Study||48
6381781|NCT00787202|7292767|FG001|Treated|Overall Study||31
6381782|NCT00787202|7292768|FG002|Treated|Overall Study||33
6381783|NCT00787202|7292769|FG003|Treated|Overall Study||33
6381784|NCT00787202|7292770|FG004|Treated|Overall Study||49
6381785|NCT00787202|7292766|FG000|COMPLETED|Overall Study||35
6381786|NCT00787202|7292767|FG001|COMPLETED|Overall Study||20
6381787|NCT00787202|7292768|FG002|COMPLETED|Overall Study||26
6381788|NCT00787202|7292769|FG003|COMPLETED|Overall Study||31
6381789|NCT00787202|7292770|FG004|COMPLETED|Overall Study||45
6381790|NCT00787202|7292766|FG000|NOT COMPLETED|Overall Study||14
6381791|NCT00787202|7292767|FG001|NOT COMPLETED|Overall Study||11
6381792|NCT00787202|7292768|FG002|NOT COMPLETED|Overall Study||7
6381793|NCT00787202|7292769|FG003|NOT COMPLETED|Overall Study||2
6381794|NCT00787202|7292770|FG004|NOT COMPLETED|Overall Study||4
6381795|NCT00787241|7292789|FG000|STARTED|Overall Study||261
6381796|NCT00787241|7292790|FG001|STARTED|Overall Study||143
6381797|NCT00787241|7292791|FG002|STARTED|Overall Study||41
6381798|NCT00787241|7292789|FG000|COMPLETED|Overall Study||261
6381799|NCT00787241|7292790|FG001|COMPLETED|Overall Study||143
6381800|NCT00787241|7292791|FG002|COMPLETED|Overall Study||41
6381801|NCT00787241|7292789|FG000|NOT COMPLETED|Overall Study||0
6381802|NCT00787241|7292790|FG001|NOT COMPLETED|Overall Study||0
6381803|NCT00787241|7292791|FG002|NOT COMPLETED|Overall Study||0
6502757|NCT01436643|7421504|FG001|STARTED|2-week Pre-treatment||0
6502758|NCT01436643|7421505|FG002|STARTED|2-week Pre-treatment||0
6502759|NCT01436643|7421506|FG003|STARTED|2-week Pre-treatment||54
6502760|NCT01436643|7421503|FG000|COMPLETED|2-week Pre-treatment||0
6502761|NCT01436643|7421504|FG001|COMPLETED|2-week Pre-treatment||0
6502762|NCT01436643|7421505|FG002|COMPLETED|2-week Pre-treatment||0
6502763|NCT01436643|7421506|FG003|COMPLETED|2-week Pre-treatment||44
6502764|NCT01436643|7421503|FG000|NOT COMPLETED|2-week Pre-treatment||0
6502765|NCT01436643|7421504|FG001|NOT COMPLETED|2-week Pre-treatment||0
6502766|NCT01436643|7421505|FG002|NOT COMPLETED|2-week Pre-treatment||0
6502767|NCT01436643|7421506|FG003|NOT COMPLETED|2-week Pre-treatment||10
6502768|NCT01436643|7421503|FG000|STARTED|Core Phase (16 Weeks)||17
6502769|NCT01436643|7421504|FG001|STARTED|Core Phase (16 Weeks)||15
6502770|NCT01436643|7421505|FG002|STARTED|Core Phase (16 Weeks)||20
6502771|NCT01436643|7421506|FG003|STARTED|Core Phase (16 Weeks)||0
6502772|NCT01436643|7421503|FG000|COMPLETED|Core Phase (16 Weeks)||16
6502773|NCT01436643|7421504|FG001|COMPLETED|Core Phase (16 Weeks)||11
6502774|NCT01436643|7421505|FG002|COMPLETED|Core Phase (16 Weeks)||17
6502775|NCT01436643|7421506|FG003|COMPLETED|Core Phase (16 Weeks)||0
6502776|NCT01436643|7421503|FG000|NOT COMPLETED|Core Phase (16 Weeks)||1
6502777|NCT01436643|7421504|FG001|NOT COMPLETED|Core Phase (16 Weeks)||4
6502778|NCT01436643|7421505|FG002|NOT COMPLETED|Core Phase (16 Weeks)||3
6502779|NCT01436643|7421506|FG003|NOT COMPLETED|Core Phase (16 Weeks)||0
6502780|NCT01436799|7421518|FG000|STARTED|Overall Study||20
6502781|NCT01436799|7421519|FG001|STARTED|Overall Study||20
6502782|NCT01436799|7421518|FG000|COMPLETED|Overall Study||20
6502783|NCT01436799|7421519|FG001|COMPLETED|Overall Study||20
6502784|NCT01436799|7421518|FG000|NOT COMPLETED|Overall Study||0
6502785|NCT01436799|7421519|FG001|NOT COMPLETED|Overall Study||0
6381804|NCT00787254|7292801|FG000|STARTED|Overall Study||185
6381805|NCT00787254|7292802|FG001|STARTED|Overall Study||181
6381806|NCT00787254|7292801|FG000|COMPLETED|Overall Study||109
6381807|NCT00787254|7292802|FG001|COMPLETED|Overall Study||99
6381808|NCT00787254|7292801|FG000|NOT COMPLETED|Overall Study||76
6269089|NCT00071058|7168208|FG000|NOT COMPLETED|Overall Study||1
6269090|NCT00071110|7168215|FG000|STARTED|Overall Study||28
6269091|NCT00071110|7168216|FG001|STARTED|Overall Study||29
6802991|NCT02269917|7735024|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||314
6802992|NCT02269917|7735022|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
6802993|NCT02269917|7735023|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
6802994|NCT02269917|7735024|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||38
6269092|NCT00071110|7168215|FG000|COMPLETED|Overall Study||28
6269093|NCT00071110|7168216|FG001|COMPLETED|Overall Study||25
6269094|NCT00071110|7168215|FG000|NOT COMPLETED|Overall Study||0
6269095|NCT00071110|7168216|FG001|NOT COMPLETED|Overall Study||4
6280613|NCT00158249|7180582|FG001|COMPLETED|Overall Study||10
6280614|NCT00158249|7180581|FG000|NOT COMPLETED|Overall Study||2
6280615|NCT00158249|7180582|FG001|NOT COMPLETED|Overall Study||0
6280616|NCT00158262|7180590|FG000|STARTED|Overall Study||21
6280617|NCT00158262|7180591|FG001|STARTED|Overall Study||22
6280618|NCT00158262|7180590|FG000|COMPLETED|Overall Study||20
6280619|NCT00158262|7180591|FG001|COMPLETED|Overall Study||21
6280620|NCT00158262|7180590|FG000|NOT COMPLETED|Overall Study||1
6280621|NCT00158262|7180591|FG001|NOT COMPLETED|Overall Study||1
6280622|NCT00158379|7180597|FG000|STARTED|Overall Study||105
6280623|NCT00158379|7180597|FG000|COMPLETED|Overall Study||105
6280624|NCT00158379|7180597|FG000|NOT COMPLETED|Overall Study||0
6280625|NCT00158600|7180603|FG000|STARTED|Overall Study||60
6280626|NCT00158600|7180604|FG001|STARTED|Overall Study||30
6280627|NCT00158600|7180603|FG000|COMPLETED|Overall Study||55
6280628|NCT00158600|7180604|FG001|COMPLETED|Overall Study||26
6280629|NCT00158600|7180603|FG000|NOT COMPLETED|Overall Study||5
6280630|NCT00158600|7180604|FG001|NOT COMPLETED|Overall Study||4
6280631|NCT00158743|7180613|FG000|STARTED|Overall Study||24
6280632|NCT00158743|7180614|FG001|STARTED|Overall Study||27
6280633|NCT00158743|7180613|FG000|COMPLETED|Overall Study||15
6280634|NCT00158743|7180614|FG001|COMPLETED|Overall Study||20
6280635|NCT00158743|7180613|FG000|NOT COMPLETED|Overall Study||9
6280636|NCT00158743|7180614|FG001|NOT COMPLETED|Overall Study||7
6280637|NCT00158756|7180625|FG000|STARTED|Overall Study||80
6280638|NCT00158756|7180626|FG001|STARTED|Overall Study||25
6280639|NCT00158756|7180627|FG002|STARTED|Overall Study||81
6280640|NCT00158756|7180628|FG003|STARTED|Overall Study||23
6280641|NCT00158756|7180629|FG004|STARTED|Overall Study||99
6280642|NCT00158756|7180625|FG000|COMPLETED|Overall Study||75
6280643|NCT00158756|7180626|FG001|COMPLETED|Overall Study||25
6564409|NCT01811303|7487107|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6564410|NCT01811303|7487108|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6564411|NCT01811303|7487105|FG000|STARTED|Washout (2 Days or More)||4
6564412|NCT01811303|7487106|FG001|STARTED|Washout (2 Days or More)||4
6564413|NCT01811303|7487107|FG002|STARTED|Washout (2 Days or More)||4
6564414|NCT01811303|7487108|FG003|STARTED|Washout (2 Days or More)||2
6564415|NCT01811303|7487105|FG000|COMPLETED|Washout (2 Days or More)||4
6564416|NCT01811303|7487106|FG001|COMPLETED|Washout (2 Days or More)||4
6564417|NCT01811303|7487107|FG002|COMPLETED|Washout (2 Days or More)||4
6802995|NCT02225366|7735035|FG000|STARTED|Overall Study||2
6802996|NCT02225366|7735036|FG001|STARTED|Overall Study||1
6802997|NCT02225366|7735035|FG000|COMPLETED|Overall Study||1
6802998|NCT02225366|7735036|FG001|COMPLETED|Overall Study||1
6802999|NCT02225366|7735035|FG000|NOT COMPLETED|Overall Study||1
6803000|NCT02225366|7735036|FG001|NOT COMPLETED|Overall Study||0
6803001|NCT02021773|7735045|FG000|STARTED|Overall Study||89
6803002|NCT02021773|7735046|FG001|STARTED|Overall Study||88
6803003|NCT02021773|7735047|FG002|STARTED|Overall Study||87
6803004|NCT02021773|7735045|FG000|Safety Analysis Set|Overall Study||89
6803005|NCT02021773|7735046|FG001|Safety Analysis Set|Overall Study||88
6803006|NCT02021773|7735047|FG002|Safety Analysis Set|Overall Study||86
6803007|NCT02021773|7735045|FG000|Intent-to-treat (ITT)|Overall Study||89
6803008|NCT02021773|7735046|FG001|Intent-to-treat (ITT)|Overall Study||87
6803009|NCT02021773|7735047|FG002|Intent-to-treat (ITT)|Overall Study||85
6803010|NCT02021773|7735045|FG000|COMPLETED|Overall Study||77
6803011|NCT02021773|7735046|FG001|COMPLETED|Overall Study||72
6803012|NCT02021773|7735047|FG002|COMPLETED|Overall Study||76
6803013|NCT02021773|7735045|FG000|NOT COMPLETED|Overall Study||12
6803014|NCT02021773|7735046|FG001|NOT COMPLETED|Overall Study||16
6803015|NCT02021773|7735047|FG002|NOT COMPLETED|Overall Study||11
6803016|NCT01530997|7735055|FG000|STARTED|Overall Study||45
6803017|NCT01530997|7735055|FG000|COMPLETED|Overall Study||43
6803018|NCT01530997|7735055|FG000|NOT COMPLETED|Overall Study||2
6803019|NCT01109004|7735069|FG000|STARTED|Overall Study||247
6803020|NCT01109004|7735070|FG001|STARTED|Overall Study||254
6803021|NCT01109004|7735071|FG002|STARTED|Overall Study||257
6803022|NCT01109004|7735069|FG000|COMPLETED|Overall Study||247
6803023|NCT01109004|7735070|FG001|COMPLETED|Overall Study||254
6803024|NCT01109004|7735071|FG002|COMPLETED|Overall Study||257
6803025|NCT01109004|7735069|FG000|NOT COMPLETED|Overall Study||0
6803026|NCT01109004|7735070|FG001|NOT COMPLETED|Overall Study||0
6803027|NCT01109004|7735071|FG002|NOT COMPLETED|Overall Study||0
6803028|NCT01067521|7735081|FG000|STARTED|Double-Blind Placebo-Controlled Period||943
6803029|NCT01067521|7735082|FG001|STARTED|Double-Blind Placebo-Controlled Period||461
6803030|NCT01067521|7735081|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||859
6803031|NCT01067521|7735082|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||430
6803032|NCT01067521|7735081|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||84
6803033|NCT01067521|7735082|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||31
6803034|NCT01067521|7735081|FG000|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|834
6803035|NCT01067521|7735082|FG001|STARTED|Open-Label Period|Some participants did not continue into the open-label period.|419
6803036|NCT01067521|7735081|FG000|COMPLETED|Open-Label Period||580
6803037|NCT01067521|7735082|FG001|COMPLETED|Open-Label Period||261
6803038|NCT01067521|7735081|FG000|NOT COMPLETED|Open-Label Period||254
6803039|NCT01067521|7735082|FG001|NOT COMPLETED|Open-Label Period||158
6381809|NCT00787254|7292802|FG001|NOT COMPLETED|Overall Study||82
6381810|NCT00787267|7292808|FG000|STARTED|Overall Study|Signed a consent form|37
6803040|NCT01047319|7735096|FG000|STARTED|Overall Study||345
6803041|NCT01047319|7735097|FG001|STARTED|Overall Study||350
6803042|NCT01047319|7735098|FG002|STARTED|Overall Study||352
6803043|NCT01047319|7735096|FG000|COMPLETED|Overall Study||0
6803044|NCT01047319|7735097|FG001|COMPLETED|Overall Study||0
6803045|NCT01047319|7735098|FG002|COMPLETED|Overall Study||0
6803046|NCT01047319|7735096|FG000|NOT COMPLETED|Overall Study||345
6803047|NCT01047319|7735097|FG001|NOT COMPLETED|Overall Study||350
6381811|NCT00787267|7292808|FG000|COMPLETED|Overall Study|Received at least one dose of study drug|25
6564418|NCT01811303|7487108|FG003|COMPLETED|Washout (2 Days or More)||2
6564419|NCT01811303|7487105|FG000|NOT COMPLETED|Washout (2 Days or More)||0
6564420|NCT01811303|7487106|FG001|NOT COMPLETED|Washout (2 Days or More)||0
6564421|NCT01811303|7487107|FG002|NOT COMPLETED|Washout (2 Days or More)||0
6803048|NCT01047319|7735098|FG002|NOT COMPLETED|Overall Study||352
6803049|NCT00988052|7735108|FG000|STARTED|Overall Study||423
6381812|NCT00787267|7292808|FG000|NOT COMPLETED|Overall Study||12
6381813|NCT00787319|7292812|FG000|STARTED|Overall Study||108
6381814|NCT00787319|7292812|FG000|COMPLETED|Overall Study||45
6381815|NCT00787319|7292812|FG000|NOT COMPLETED|Overall Study||63
6381816|NCT00787332|7292818|FG000|STARTED|Overall Study||8
6381817|NCT00787332|7292819|FG001|STARTED|Overall Study||8
6381818|NCT00787332|7292818|FG000|COMPLETED|Overall Study||8
6381819|NCT00787332|7292819|FG001|COMPLETED|Overall Study||8
6381820|NCT00787332|7292818|FG000|NOT COMPLETED|Overall Study||0
6381821|NCT00787332|7292819|FG001|NOT COMPLETED|Overall Study||0
6502786|NCT01437098|7421525|FG000|STARTED|Overall Study||55
6502787|NCT01437098|7421525|FG000|30 Days|Overall Study||51
6502788|NCT01437098|7421525|FG000|6 Months|Overall Study||47
6502789|NCT01437098|7421525|FG000|12 Months|Overall Study||45
6803050|NCT00988052|7735109|FG001|STARTED|Overall Study||416
6803051|NCT00988052|7735108|FG000|COMPLETED|Overall Study||0
6803052|NCT00988052|7735109|FG001|COMPLETED|Overall Study||0
6803053|NCT00988052|7735108|FG000|NOT COMPLETED|Overall Study||423
6502790|NCT01437098|7421525|FG000|24 Months|Overall Study||42
6502791|NCT01437098|7421525|FG000|36 Months|Overall Study||36
6502792|NCT01437098|7421525|FG000|COMPLETED|Overall Study||42
6502793|NCT01437098|7421525|FG000|NOT COMPLETED|Overall Study||13
6502794|NCT01437124|7421537|FG000|STARTED|Overall Study||83
6502795|NCT01437124|7421537|FG000|COMPLETED|Overall Study||83
6564422|NCT01811303|7487108|FG003|NOT COMPLETED|Washout (2 Days or More)||0
6803054|NCT00988052|7735109|FG001|NOT COMPLETED|Overall Study||416
6502796|NCT01437124|7421537|FG000|NOT COMPLETED|Overall Study||0
6564423|NCT01811303|7487105|FG000|STARTED|Third Intervention (1 Day)||4
6564424|NCT01811303|7487106|FG001|STARTED|Third Intervention (1 Day)||4
6564425|NCT01811303|7487107|FG002|STARTED|Third Intervention (1 Day)||4
6564426|NCT01811303|7487108|FG003|STARTED|Third Intervention (1 Day)||2
6564427|NCT01811303|7487105|FG000|COMPLETED|Third Intervention (1 Day)||4
6564428|NCT01811303|7487106|FG001|COMPLETED|Third Intervention (1 Day)||4
6381822|NCT00787527|7292825|FG000|STARTED|Overall Study||14
6381823|NCT00787527|7292825|FG000|COMPLETED|Overall Study||11
6381824|NCT00787527|7292825|FG000|NOT COMPLETED|Overall Study||3
6381825|NCT00787566|7292836|FG000|STARTED|Overall Study||21
6381826|NCT00787566|7292837|FG001|STARTED|Overall Study||25
6381827|NCT00787566|7292838|FG002|STARTED|Overall Study||22
6381828|NCT00787566|7292836|FG000|COMPLETED|Overall Study||21
6381829|NCT00787566|7292837|FG001|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
6381830|NCT00787566|7292838|FG002|COMPLETED|Overall Study||22
6381831|NCT00787566|7292836|FG000|NOT COMPLETED|Overall Study||0
6381832|NCT00787566|7292837|FG001|NOT COMPLETED|Overall Study||1
6381833|NCT00787566|7292838|FG002|NOT COMPLETED|Overall Study||0
6381834|NCT00787605|7292848|FG000|STARTED|Overall Study||428
6381835|NCT00787605|7292849|FG001|STARTED|Overall Study||432
6381836|NCT00787605|7292848|FG000|COMPLETED|Overall Study||382
6381837|NCT00787605|7292849|FG001|COMPLETED|Overall Study||376
6381838|NCT00787605|7292848|FG000|NOT COMPLETED|Overall Study||46
6381839|NCT00787605|7292849|FG001|NOT COMPLETED|Overall Study||56
6381840|NCT00787644|7292857|FG000|STARTED|Overall Study||12
6381841|NCT00787644|7292858|FG001|STARTED|Overall Study||11
6381842|NCT00787644|7292857|FG000|COMPLETED|Overall Study||10
6381843|NCT00787644|7292858|FG001|COMPLETED|Overall Study||9
6381844|NCT00787644|7292857|FG000|NOT COMPLETED|Overall Study||2
6381845|NCT00787644|7292858|FG001|NOT COMPLETED|Overall Study||2
6381846|NCT00787722|7292864|FG000|STARTED|Overall Study||13
6381847|NCT00787722|7292864|FG000|COMPLETED|Overall Study||12
6381848|NCT00787722|7292864|FG000|NOT COMPLETED|Overall Study||1
6395598|NCT00859222|7308177|FG004|NOT COMPLETED|Overall Study||15
6395599|NCT00859313|7308192|FG000|STARTED|Overall Study||30
6395600|NCT00859313|7308192|FG000|COMPLETED|Overall Study||26
6395601|NCT00859313|7308192|FG000|NOT COMPLETED|Overall Study||4
6395602|NCT00859339|7308196|FG000|STARTED|Overall Study||9
6395603|NCT00859339|7308196|FG000|COMPLETED|Overall Study||9
6395604|NCT00859339|7308196|FG000|NOT COMPLETED|Overall Study||0
6395605|NCT00859456|7308200|FG000|STARTED|Overall Study||9
6395606|NCT00859456|7308200|FG000|COMPLETED|Overall Study||1
6395607|NCT00859456|7308200|FG000|NOT COMPLETED|Overall Study||8
6395608|NCT00859469|7308204|FG000|STARTED|Overall Study||29
6395609|NCT00859469|7308204|FG000|6 Cycles|Overall Study||16
6395610|NCT00859469|7308204|FG000|COMPLETED|Overall Study||1
6395611|NCT00859469|7308204|FG000|NOT COMPLETED|Overall Study||28
6395612|NCT00859495|7308208|FG000|STARTED|Overall Study||9
6395613|NCT00859495|7308208|FG000|COMPLETED|Overall Study||9
6395614|NCT00859495|7308208|FG000|NOT COMPLETED|Overall Study||0
6395615|NCT00859508|7308214|FG000|STARTED|Overall Study||68
6395616|NCT00859508|7308215|FG001|STARTED|Overall Study||37
6395617|NCT00859508|7308214|FG000|COMPLETED|Overall Study||62
6395618|NCT00859508|7308215|FG001|COMPLETED|Overall Study||37
6395619|NCT00859508|7308214|FG000|NOT COMPLETED|Overall Study||6
6395620|NCT00859508|7308215|FG001|NOT COMPLETED|Overall Study||0
6395621|NCT00859547|7308221|FG000|STARTED|Overall Study||30
6564429|NCT01811303|7487107|FG002|COMPLETED|Third Intervention (1 Day)||4
6395622|NCT00859547|7308221|FG000|COMPLETED|Overall Study||28
6395623|NCT00859547|7308221|FG000|NOT COMPLETED|Overall Study||2
6395624|NCT00859573|7308227|FG000|STARTED|Overall Study||6
6395625|NCT00859573|7308228|FG001|STARTED|Overall Study||3
6395626|NCT00859573|7308227|FG000|COMPLETED|Overall Study||1
6395627|NCT00859573|7308228|FG001|COMPLETED|Overall Study||1
6395628|NCT00859573|7308227|FG000|NOT COMPLETED|Overall Study||5
6395629|NCT00859573|7308228|FG001|NOT COMPLETED|Overall Study||2
6395630|NCT00859586|7308234|FG000|STARTED|Overall Study||8
6395631|NCT00859586|7308234|FG000|COMPLETED|Overall Study||4
6395632|NCT00859586|7308234|FG000|NOT COMPLETED|Overall Study||4
6381849|NCT00787761|7292869|FG000|STARTED|Overall Study||24
6381850|NCT00787761|7292869|FG000|COMPLETED|Overall Study||24
6381851|NCT00787761|7292869|FG000|NOT COMPLETED|Overall Study||0
6381852|NCT00787787|7292875|FG000|STARTED|Overall Study||7
6381853|NCT00787787|7292875|FG000|COMPLETED|Overall Study||0
6381854|NCT00787787|7292875|FG000|NOT COMPLETED|Overall Study||7
6381855|NCT00787800|7292881|FG000|STARTED|Overall Study||50
6381856|NCT00787800|7292882|FG001|STARTED|Overall Study||50
6381857|NCT00787800|7292881|FG000|COMPLETED|Overall Study||47
6381858|NCT00787800|7292882|FG001|COMPLETED|Overall Study||43
6381859|NCT00787800|7292881|FG000|NOT COMPLETED|Overall Study||3
6381860|NCT00787800|7292882|FG001|NOT COMPLETED|Overall Study||7
6381861|NCT00787839|7292889|FG000|STARTED|Overall Study||1939
6381862|NCT00787839|7292889|FG000|Consented|Overall Study|consented|1939
6381863|NCT00787839|7292889|FG000|Completed GCT Screening|Overall Study||1876
6381864|NCT00787839|7292889|FG000|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
6381865|NCT00787839|7292889|FG000|COMPLETED|Overall Study||1535
6381866|NCT00787839|7292889|FG000|NOT COMPLETED|Overall Study||404
6381867|NCT00787852|7292912|FG000|STARTED|Overall Study||6
6381868|NCT00787852|7292913|FG001|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
6381869|NCT00787852|7292912|FG000|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
6564430|NCT01811303|7487108|FG003|COMPLETED|Third Intervention (1 Day)||2
6381870|NCT00787852|7292913|FG001|COMPLETED|Overall Study||5
6381871|NCT00787852|7292912|FG000|NOT COMPLETED|Overall Study||1
6381872|NCT00787852|7292913|FG001|NOT COMPLETED|Overall Study||0
6381873|NCT00787891|7292921|FG000|STARTED|Short-term Double-blind Phase (Part 1)||65
6381874|NCT00787891|7292922|FG001|STARTED|Short-term Double-blind Phase (Part 1)||62
6381875|NCT00787891|7292921|FG000|COMPLETED|Short-term Double-blind Phase (Part 1)||55
6381876|NCT00787891|7292922|FG001|COMPLETED|Short-term Double-blind Phase (Part 1)||53
6381877|NCT00787891|7292921|FG000|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
6381878|NCT00787891|7292922|FG001|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
6381879|NCT00787891|7292921|FG000|STARTED|Maintenance Double-blind Phase (Part 2)||33
6381880|NCT00787891|7292922|FG001|STARTED|Maintenance Double-blind Phase (Part 2)||31
6564431|NCT01811303|7487105|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6564432|NCT01811303|7487106|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6564433|NCT01811303|7487107|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6381881|NCT00787891|7292921|FG000|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
6381882|NCT00787891|7292922|FG001|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
6381883|NCT00787891|7292921|FG000|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
6381884|NCT00787891|7292922|FG001|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
6381885|NCT00787904|7292932|FG000|STARTED|Overall Study||6
6381886|NCT00787904|7292933|FG001|STARTED|Overall Study||13
6381887|NCT00787904|7292932|FG000|COMPLETED|Overall Study||6
6381888|NCT00787904|7292933|FG001|COMPLETED|Overall Study||13
6381889|NCT00787904|7292932|FG000|NOT COMPLETED|Overall Study||0
6381890|NCT00787904|7292933|FG001|NOT COMPLETED|Overall Study||0
6381891|NCT00787930|7292939|FG000|STARTED|Acute Treatment -- 3 Weeks||19
6381892|NCT00787930|7292939|FG000|COMPLETED|Acute Treatment -- 3 Weeks||19
6381893|NCT00787930|7292939|FG000|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
6381894|NCT00787930|7292939|FG000|STARTED|Continuation Treatment -- up to 12 Month||19
6381895|NCT00787930|7292939|FG000|COMPLETED|Continuation Treatment -- up to 12 Month||16
6381896|NCT00787930|7292939|FG000|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
6381897|NCT00787943|7292949|FG000|STARTED|Overall Study||10
6381898|NCT00787943|7292949|FG000|COMPLETED|Overall Study||10
6381899|NCT00787943|7292949|FG000|NOT COMPLETED|Overall Study||0
6381900|NCT00788008|7292959|FG000|STARTED|Overall Study||98
6564434|NCT01811303|7487108|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6381901|NCT00788008|7292960|FG001|STARTED|Overall Study||101
6381902|NCT00788008|7292959|FG000|COMPLETED|Overall Study||98
6381903|NCT00788008|7292960|FG001|COMPLETED|Overall Study||101
6381904|NCT00788008|7292959|FG000|NOT COMPLETED|Overall Study||0
6381905|NCT00788008|7292960|FG001|NOT COMPLETED|Overall Study||0
6381906|NCT00788073|7292968|FG000|STARTED|STX209 Then Placebo||30
6381907|NCT00788073|7292969|FG001|STARTED|STX209 Then Placebo||33
6381908|NCT00788073|7292968|FG000|COMPLETED|STX209 Then Placebo||29
6381909|NCT00788073|7292969|FG001|COMPLETED|STX209 Then Placebo||30
6381910|NCT00788073|7292968|FG000|NOT COMPLETED|STX209 Then Placebo||1
6381911|NCT00788073|7292969|FG001|NOT COMPLETED|STX209 Then Placebo||3
6381912|NCT00788073|7292968|FG000|STARTED|Placebo Then STX209||29
6381913|NCT00788073|7292969|FG001|STARTED|Placebo Then STX209||30
6381914|NCT00788073|7292968|FG000|COMPLETED|Placebo Then STX209||27
6381915|NCT00788073|7292969|FG001|COMPLETED|Placebo Then STX209||29
6381916|NCT00788073|7292968|FG000|NOT COMPLETED|Placebo Then STX209||2
6381917|NCT00788073|7292969|FG001|NOT COMPLETED|Placebo Then STX209||1
6381918|NCT00788255|7292975|FG000|STARTED|Overall Study||25
6381919|NCT00788255|7292975|FG000|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
6381920|NCT00788255|7292975|FG000|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
6381921|NCT00788255|7292975|FG000|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
6381922|NCT00788255|7292975|FG000|Oxytocin: 0 μU/mL|Overall Study||25
6381923|NCT00788255|7292975|FG000|COMPLETED|Overall Study||25
6381924|NCT00788255|7292975|FG000|NOT COMPLETED|Overall Study||0
6381925|NCT00788372|7292982|FG000|STARTED|Period 1 (up to 4 Weeks)||142
6381926|NCT00788372|7292982|FG000|COMPLETED|Period 1 (up to 4 Weeks)||111
6381927|NCT00788372|7292982|FG000|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
6381928|NCT00788372|7292982|FG000|STARTED|Period 2 (Week 4 to Week 52)||111
6381929|NCT00788372|7292982|FG000|COMPLETED|Period 2 (Week 4 to Week 52)||79
6381930|NCT00788372|7292982|FG000|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
6381931|NCT00788593|7292986|FG000|STARTED|Placebo Run-in Phase||82
6381932|NCT00788593|7292987|FG001|STARTED|Placebo Run-in Phase||0
6381933|NCT00788593|7292988|FG002|STARTED|Placebo Run-in Phase||0
6381934|NCT00788593|7292986|FG000|COMPLETED|Placebo Run-in Phase||76
6381935|NCT00788593|7292987|FG001|COMPLETED|Placebo Run-in Phase||0
6381936|NCT00788593|7292988|FG002|COMPLETED|Placebo Run-in Phase||0
6381937|NCT00788593|7292986|FG000|NOT COMPLETED|Placebo Run-in Phase||6
6381938|NCT00788593|7292987|FG001|NOT COMPLETED|Placebo Run-in Phase||0
6381939|NCT00788593|7292988|FG002|NOT COMPLETED|Placebo Run-in Phase||0
6381940|NCT00788593|7292986|FG000|STARTED|First Intervention Period||0
6381941|NCT00788593|7292987|FG001|STARTED|First Intervention Period||39
6381942|NCT00788593|7292988|FG002|STARTED|First Intervention Period||37
6381943|NCT00788593|7292986|FG000|COMPLETED|First Intervention Period||0
6381944|NCT00788593|7292987|FG001|COMPLETED|First Intervention Period||38
6381945|NCT00788593|7292988|FG002|COMPLETED|First Intervention Period||37
6381946|NCT00788593|7292986|FG000|NOT COMPLETED|First Intervention Period||0
6381947|NCT00788593|7292987|FG001|NOT COMPLETED|First Intervention Period||1
6381948|NCT00788593|7292988|FG002|NOT COMPLETED|First Intervention Period||0
6381949|NCT00788593|7292986|FG000|STARTED|Second Intervention Period||0
6564435|NCT01811303|7487105|FG000|STARTED|Washout (2 Days or More)||4
6564436|NCT01811303|7487106|FG001|STARTED|Washout (2 Days or More)||4
6381950|NCT00788593|7292987|FG001|STARTED|Second Intervention Period||38
6381951|NCT00788593|7292988|FG002|STARTED|Second Intervention Period||37
6381952|NCT00788593|7292986|FG000|COMPLETED|Second Intervention Period||0
6381953|NCT00788593|7292987|FG001|COMPLETED|Second Intervention Period||37
6381954|NCT00788593|7292988|FG002|COMPLETED|Second Intervention Period||36
6381955|NCT00788593|7292986|FG000|NOT COMPLETED|Second Intervention Period||0
6381956|NCT00788593|7292987|FG001|NOT COMPLETED|Second Intervention Period||1
6381957|NCT00788593|7292988|FG002|NOT COMPLETED|Second Intervention Period||1
6381958|NCT00788697|7292998|FG000|STARTED|Overall Study||349
6381959|NCT00788697|7292998|FG000|COMPLETED|Overall Study||240
6381960|NCT00788697|7292998|FG000|NOT COMPLETED|Overall Study||109
6381961|NCT00788775|7293012|FG000|STARTED|Overall Study||11
6381962|NCT00788775|7293013|FG001|STARTED|Overall Study||9
6381963|NCT00788775|7293012|FG000|Treated|Overall Study||11
6381964|NCT00788775|7293013|FG001|Treated|Overall Study||8
6381965|NCT00788775|7293012|FG000|COMPLETED|Overall Study||1
6381966|NCT00788775|7293013|FG001|COMPLETED|Overall Study||1
6381967|NCT00788775|7293012|FG000|NOT COMPLETED|Overall Study||10
6381968|NCT00788775|7293013|FG001|NOT COMPLETED|Overall Study||8
6381969|NCT00788827|7293019|FG000|STARTED|Overall Study||7
6381970|NCT00788827|7293019|FG000|COMPLETED|Overall Study||5
6381971|NCT00788827|7293019|FG000|NOT COMPLETED|Overall Study||2
6381972|NCT00788892|7293027|FG000|STARTED|Overall Study||85
6381973|NCT00788892|7293028|FG001|STARTED|Overall Study||41
6381974|NCT00788892|7293027|FG000|COMPLETED|Overall Study||36
6502797|NCT01437267|7421547|FG000|STARTED|Overall Study||20
6381975|NCT00788892|7293028|FG001|COMPLETED|Overall Study||18
6381976|NCT00788892|7293027|FG000|NOT COMPLETED|Overall Study||49
6381977|NCT00788892|7293028|FG001|NOT COMPLETED|Overall Study||23
6381978|NCT00788957|7293038|FG000|STARTED|Part 1||11
6381979|NCT00788957|7293039|FG001|STARTED|Part 1||0
6381980|NCT00788957|7293040|FG002|STARTED|Part 1||0
6381981|NCT00788957|7293041|FG003|STARTED|Part 1||0
6381982|NCT00788957|7293042|FG004|STARTED|Part 1||0
6381983|NCT00788957|7293043|FG005|STARTED|Part 1||0
6502798|NCT01437267|7421548|FG001|STARTED|Overall Study||20
6269096|NCT00071396|7168222|FG000|STARTED|Overall Study||44
6269097|NCT00071396|7168222|FG000|COMPLETED|Overall Study|Evaluable for response.|41
6269098|NCT00071396|7168222|FG000|NOT COMPLETED|Overall Study||3
6269099|NCT00071487|7168230|FG000|STARTED|52-Week Double-Blind Period||113
6269100|NCT00071487|7168231|FG001|STARTED|52-Week Double-Blind Period||114
6269101|NCT00071487|7168232|FG002|STARTED|52-Week Double-Blind Period||111
6269102|NCT00071487|7168233|FG003|STARTED|52-Week Double-Blind Period||111
6269103|NCT00071487|7168230|FG000|COMPLETED|52-Week Double-Blind Period||93
6269104|NCT00071487|7168231|FG001|COMPLETED|52-Week Double-Blind Period||87
6269105|NCT00071487|7168232|FG002|COMPLETED|52-Week Double-Blind Period||94
6269106|NCT00071487|7168233|FG003|COMPLETED|52-Week Double-Blind Period||90
6269107|NCT00071487|7168230|FG000|NOT COMPLETED|52-Week Double-Blind Period||20
6269108|NCT00071487|7168231|FG001|NOT COMPLETED|52-Week Double-Blind Period||27
6269109|NCT00071487|7168232|FG002|NOT COMPLETED|52-Week Double-Blind Period||17
6269110|NCT00071487|7168233|FG003|NOT COMPLETED|52-Week Double-Blind Period||21
6269111|NCT00071487|7168230|FG000|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
6269112|NCT00071487|7168231|FG001|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
6269113|NCT00071487|7168232|FG002|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
6269114|NCT00071487|7168233|FG003|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
6269115|NCT00071487|7168230|FG000|COMPLETED|24-Week Open-Label Extension Period||0
6269116|NCT00071487|7168231|FG001|COMPLETED|24-Week Open-Label Extension Period||19
6269117|NCT00071487|7168232|FG002|COMPLETED|24-Week Open-Label Extension Period||23
6269118|NCT00071487|7168233|FG003|COMPLETED|24-Week Open-Label Extension Period||279
6269119|NCT00071487|7168230|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
6269120|NCT00071487|7168231|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
6269121|NCT00071487|7168232|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
6269122|NCT00071487|7168233|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||23
6269123|NCT00071513|7168247|FG000|STARTED|Intervention Component||241
6269124|NCT00071513|7168248|FG001|STARTED|Intervention Component||256
6269125|NCT00071513|7168247|FG000|COMPLETED|Intervention Component||239
6269126|NCT00071513|7168248|FG001|COMPLETED|Intervention Component||253
6269127|NCT00071513|7168247|FG000|NOT COMPLETED|Intervention Component||2
6269128|NCT00071513|7168248|FG001|NOT COMPLETED|Intervention Component||3
6269129|NCT00071513|7168247|FG000|STARTED|Follow-up Assessment||239
6269130|NCT00071513|7168248|FG001|STARTED|Follow-up Assessment||253
6269131|NCT00071513|7168247|FG000|COMPLETED|Follow-up Assessment||233
6269132|NCT00071513|7168248|FG001|COMPLETED|Follow-up Assessment||247
6269133|NCT00071513|7168247|FG000|NOT COMPLETED|Follow-up Assessment||6
6269134|NCT00071513|7168248|FG001|NOT COMPLETED|Follow-up Assessment||6
6269135|NCT00071721|7168258|FG000|STARTED|Overall Study||153
6269136|NCT00071721|7168259|FG001|STARTED|Overall Study||160
6269137|NCT00071721|7168258|FG000|COMPLETED|Overall Study||81
6269138|NCT00071721|7168259|FG001|COMPLETED|Overall Study||69
6269139|NCT00071721|7168258|FG000|NOT COMPLETED|Overall Study||72
6269140|NCT00071721|7168259|FG001|NOT COMPLETED|Overall Study||91
6269141|NCT00071760|7168265|FG000|STARTED|Overall Study||54
6269142|NCT00071760|7168265|FG000|Ongoing|Overall Study||25
6269143|NCT00071760|7168265|FG000|COMPLETED|Overall Study||0
6269144|NCT00071760|7168265|FG000|NOT COMPLETED|Overall Study||54
6269145|NCT00071799|7168277|FG000|STARTED|Overall Study||179
6269146|NCT00071799|7168278|FG001|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
6280644|NCT00158756|7180627|FG002|COMPLETED|Overall Study||73
6564437|NCT01811303|7487107|FG002|STARTED|Washout (2 Days or More)||4
6564438|NCT01811303|7487108|FG003|STARTED|Washout (2 Days or More)||2
6564439|NCT01811303|7487105|FG000|COMPLETED|Washout (2 Days or More)||4
6656729|NCT02463799|7587036|FG001|COMPLETED|Overall Study||16
6502799|NCT01437267|7421549|FG002|STARTED|Overall Study||20
6803055|NCT04689932|7735115|FG000|STARTED|Overall Study||12
6803056|NCT04689932|7735115|FG000|COMPLETED|Overall Study||12
6803057|NCT04689932|7735115|FG000|NOT COMPLETED|Overall Study||0
6803058|NCT04635579|7735122|FG000|STARTED|Overall Study||20
6803059|NCT04635579|7735123|FG001|STARTED|Overall Study||20
6803060|NCT04635579|7735122|FG000|COMPLETED|Overall Study||20
6803061|NCT04635579|7735123|FG001|COMPLETED|Overall Study||20
6803062|NCT04635579|7735122|FG000|NOT COMPLETED|Overall Study||0
6803063|NCT04635579|7735123|FG001|NOT COMPLETED|Overall Study||0
6803073|NCT03739593|7735146|FG000|STARTED|Overall Study||5
6803074|NCT03739593|7735147|FG001|STARTED|Overall Study||22
6803075|NCT03739593|7735148|FG002|STARTED|Overall Study||22
6803076|NCT03739593|7735146|FG000|COMPLETED|Overall Study||2
6803077|NCT03739593|7735147|FG001|COMPLETED|Overall Study||16
6803078|NCT03739593|7735148|FG002|COMPLETED|Overall Study||14
6803079|NCT03739593|7735146|FG000|NOT COMPLETED|Overall Study||3
6803080|NCT03739593|7735147|FG001|NOT COMPLETED|Overall Study||6
6803081|NCT03739593|7735148|FG002|NOT COMPLETED|Overall Study||8
6803082|NCT03739138|7735159|FG000|STARTED|Overall Study||0
6803083|NCT03739138|7735160|FG001|STARTED|Overall Study||7
6803084|NCT03739138|7735161|FG002|STARTED|Overall Study||5
6803085|NCT03739138|7735162|FG003|STARTED|Overall Study||18
6803086|NCT03739138|7735163|FG004|STARTED|Overall Study||0
6803087|NCT03739138|7735159|FG000|COMPLETED|Overall Study||0
6803088|NCT03739138|7735160|FG001|COMPLETED|Overall Study||0
6803089|NCT03739138|7735161|FG002|COMPLETED|Overall Study||0
6803090|NCT03739138|7735162|FG003|COMPLETED|Overall Study||0
6803091|NCT03739138|7735163|FG004|COMPLETED|Overall Study||0
6803092|NCT03739138|7735159|FG000|NOT COMPLETED|Overall Study||0
6803093|NCT03739138|7735160|FG001|NOT COMPLETED|Overall Study||7
6803094|NCT03739138|7735161|FG002|NOT COMPLETED|Overall Study||5
6803095|NCT03739138|7735162|FG003|NOT COMPLETED|Overall Study||18
6803096|NCT03739138|7735163|FG004|NOT COMPLETED|Overall Study||0
6803097|NCT03518086|7735173|FG000|STARTED|Overall Study||322
6803098|NCT03518086|7735174|FG001|STARTED|Overall Study||959
6803099|NCT03518086|7735175|FG002|STARTED|Overall Study||0
6381984|NCT00788957|7293038|FG000|COMPLETED|Part 1|Completed the safety follow-up visit|2
6381985|NCT00788957|7293039|FG001|COMPLETED|Part 1||0
6381986|NCT00788957|7293040|FG002|COMPLETED|Part 1||0
6381987|NCT00788957|7293041|FG003|COMPLETED|Part 1||0
6381988|NCT00788957|7293042|FG004|COMPLETED|Part 1||0
6381989|NCT00788957|7293043|FG005|COMPLETED|Part 1||0
6381990|NCT00788957|7293038|FG000|NOT COMPLETED|Part 1||9
6381991|NCT00788957|7293039|FG001|NOT COMPLETED|Part 1||0
6502800|NCT01437267|7421550|FG003|STARTED|Overall Study||20
6502801|NCT01437267|7421551|FG004|STARTED|Overall Study||20
6502802|NCT01437267|7421552|FG005|STARTED|Overall Study||20
6502803|NCT01437267|7421547|FG000|COMPLETED|Overall Study||20
6502804|NCT01437267|7421548|FG001|COMPLETED|Overall Study||19
6502805|NCT01437267|7421549|FG002|COMPLETED|Overall Study||20
6502806|NCT01437267|7421550|FG003|COMPLETED|Overall Study||19
6502807|NCT01437267|7421551|FG004|COMPLETED|Overall Study||20
6502808|NCT01437267|7421552|FG005|COMPLETED|Overall Study||20
6502809|NCT01437267|7421547|FG000|NOT COMPLETED|Overall Study||0
6502810|NCT01437267|7421548|FG001|NOT COMPLETED|Overall Study||1
6502811|NCT01437267|7421549|FG002|NOT COMPLETED|Overall Study||0
6502812|NCT01437267|7421550|FG003|NOT COMPLETED|Overall Study||1
6502813|NCT01437267|7421551|FG004|NOT COMPLETED|Overall Study||0
6502814|NCT01437267|7421552|FG005|NOT COMPLETED|Overall Study||0
6502815|NCT01437319|7421566|FG000|STARTED|Phase I||282
6502816|NCT01437319|7421567|FG001|STARTED|Phase I||0
6502817|NCT01437319|7421568|FG002|STARTED|Phase I||0
6502818|NCT01437319|7421566|FG000|COMPLETED|Phase I||227
6502819|NCT01437319|7421567|FG001|COMPLETED|Phase I||0
6502820|NCT01437319|7421568|FG002|COMPLETED|Phase I||0
6502821|NCT01437319|7421566|FG000|NOT COMPLETED|Phase I||55
6502822|NCT01437319|7421567|FG001|NOT COMPLETED|Phase I||0
6502823|NCT01437319|7421568|FG002|NOT COMPLETED|Phase I||0
6502824|NCT01437319|7421566|FG000|STARTED|Phase II||0
6502825|NCT01437319|7421567|FG001|STARTED|Phase II||115
6502826|NCT01437319|7421568|FG002|STARTED|Phase II||112
6502827|NCT01437319|7421566|FG000|COMPLETED|Phase II||0
6502828|NCT01437319|7421567|FG001|COMPLETED|Phase II||71
6502829|NCT01437319|7421568|FG002|COMPLETED|Phase II||75
6502830|NCT01437319|7421566|FG000|NOT COMPLETED|Phase II||0
6502831|NCT01437319|7421567|FG001|NOT COMPLETED|Phase II||44
6502832|NCT01437319|7421568|FG002|NOT COMPLETED|Phase II||37
6502833|NCT01437397|7421582|FG000|STARTED|Overall Study||338
6502834|NCT01437397|7421583|FG001|STARTED|Overall Study||338
6502835|NCT01437397|7421584|FG002|STARTED|Overall Study||340
6502836|NCT01437397|7421585|FG003|STARTED|Overall Study||339
6502837|NCT01437397|7421586|FG004|STARTED|Overall Study||337
6502838|NCT01437397|7421582|FG000|COMPLETED|Overall Study||272
6502839|NCT01437397|7421583|FG001|COMPLETED|Overall Study||276
6502840|NCT01437397|7421584|FG002|COMPLETED|Overall Study||268
6502841|NCT01437397|7421585|FG003|COMPLETED|Overall Study||270
6502842|NCT01437397|7421586|FG004|COMPLETED|Overall Study||236
6502843|NCT01437397|7421582|FG000|NOT COMPLETED|Overall Study||66
6502844|NCT01437397|7421583|FG001|NOT COMPLETED|Overall Study||62
6502845|NCT01437397|7421584|FG002|NOT COMPLETED|Overall Study||72
6502846|NCT01437397|7421585|FG003|NOT COMPLETED|Overall Study||69
6502847|NCT01437397|7421586|FG004|NOT COMPLETED|Overall Study||101
6502848|NCT01437449|7421598|FG000|STARTED|Overall Study||27
6502849|NCT01437449|7421598|FG000|COMPLETED|Overall Study||27
6502850|NCT01437449|7421598|FG000|NOT COMPLETED|Overall Study||0
6502851|NCT01437488|7421602|FG000|STARTED|Overall Study||14
6502852|NCT01437488|7421602|FG000|COMPLETED|Overall Study||14
6502853|NCT01437488|7421602|FG000|NOT COMPLETED|Overall Study||0
6564440|NCT01811303|7487106|FG001|COMPLETED|Washout (2 Days or More)||4
6564441|NCT01811303|7487107|FG002|COMPLETED|Washout (2 Days or More)||4
6564442|NCT01811303|7487108|FG003|COMPLETED|Washout (2 Days or More)||2
6564443|NCT01811303|7487105|FG000|NOT COMPLETED|Washout (2 Days or More)||0
6564444|NCT01811303|7487106|FG001|NOT COMPLETED|Washout (2 Days or More)||0
6564445|NCT01811303|7487107|FG002|NOT COMPLETED|Washout (2 Days or More)||0
6564446|NCT01811303|7487108|FG003|NOT COMPLETED|Washout (2 Days or More)||0
6564447|NCT01811303|7487105|FG000|STARTED|Fourth Intervention (1 Day)||4
6564448|NCT01811303|7487106|FG001|STARTED|Fourth Intervention (1 Day)||4
6564449|NCT01811303|7487107|FG002|STARTED|Fourth Intervention (1 Day)||4
6564450|NCT01811303|7487108|FG003|STARTED|Fourth Intervention (1 Day)||2
6564451|NCT01811303|7487105|FG000|COMPLETED|Fourth Intervention (1 Day)||4
6564452|NCT01811303|7487106|FG001|COMPLETED|Fourth Intervention (1 Day)||4
6564453|NCT01811303|7487107|FG002|COMPLETED|Fourth Intervention (1 Day)||4
6564454|NCT01811303|7487108|FG003|COMPLETED|Fourth Intervention (1 Day)||2
6381992|NCT00788957|7293040|FG002|NOT COMPLETED|Part 1||0
6381993|NCT00788957|7293041|FG003|NOT COMPLETED|Part 1||0
6381994|NCT00788957|7293042|FG004|NOT COMPLETED|Part 1||0
6381995|NCT00788957|7293043|FG005|NOT COMPLETED|Part 1||0
6502854|NCT01437501|7421611|FG000|STARTED|Overall Study||148
6502855|NCT01437501|7421612|FG001|STARTED|Overall Study||143
6502856|NCT01437501|7421611|FG000|COMPLETED|Overall Study||135
6564455|NCT01811303|7487105|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
6564456|NCT01811303|7487106|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
6564457|NCT01811303|7487107|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
6564458|NCT01811303|7487108|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
6564459|NCT01811316|7487119|FG000|STARTED|Overall Study||21
6381996|NCT00788957|7293038|FG000|STARTED|Part 2||0
6381997|NCT00788957|7293039|FG001|STARTED|Part 2||48
6381998|NCT00788957|7293040|FG002|STARTED|Part 2||48
6564460|NCT01811316|7487120|FG001|STARTED|Overall Study||22
6564461|NCT01811316|7487121|FG002|STARTED|Overall Study||19
6564462|NCT01811316|7487119|FG000|Visit 4 Weeks|Overall Study||19
6564463|NCT01811316|7487120|FG001|Visit 4 Weeks|Overall Study||22
6564464|NCT01811316|7487121|FG002|Visit 4 Weeks|Overall Study||19
6564465|NCT01811316|7487119|FG000|Visit 12 Weeks|Overall Study||18
6381999|NCT00788957|7293041|FG003|STARTED|Part 2||46
6382000|NCT00788957|7293042|FG004|STARTED|Part 2||0
6382001|NCT00788957|7293043|FG005|STARTED|Part 2||0
6382002|NCT00788957|7293038|FG000|COMPLETED|Part 2||0
6382003|NCT00788957|7293039|FG001|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
6382004|NCT00788957|7293040|FG002|COMPLETED|Part 2|Completed the safety follow-up visit|4
6382005|NCT00788957|7293041|FG003|COMPLETED|Part 2|Completed the safety follow-up visit|5
6382006|NCT00788957|7293042|FG004|COMPLETED|Part 2||0
6382007|NCT00788957|7293043|FG005|COMPLETED|Part 2||0
6382008|NCT00788957|7293038|FG000|NOT COMPLETED|Part 2||0
6382009|NCT00788957|7293039|FG001|NOT COMPLETED|Part 2||42
6382010|NCT00788957|7293040|FG002|NOT COMPLETED|Part 2||44
6382011|NCT00788957|7293041|FG003|NOT COMPLETED|Part 2||41
6382012|NCT00788957|7293042|FG004|NOT COMPLETED|Part 2||0
6382013|NCT00788957|7293043|FG005|NOT COMPLETED|Part 2||0
6382014|NCT00788957|7293038|FG000|STARTED|Part 3||0
6382015|NCT00788957|7293039|FG001|STARTED|Part 3||0
6564466|NCT01811316|7487120|FG001|Visit 12 Weeks|Overall Study||22
6564467|NCT01811316|7487121|FG002|Visit 12 Weeks|Overall Study||19
6564468|NCT01811316|7487119|FG000|COMPLETED|Overall Study||18
6564469|NCT01811316|7487120|FG001|COMPLETED|Overall Study||22
6564470|NCT01811316|7487121|FG002|COMPLETED|Overall Study||19
6564471|NCT01811316|7487119|FG000|NOT COMPLETED|Overall Study||3
6564472|NCT01811316|7487120|FG001|NOT COMPLETED|Overall Study||0
6564473|NCT01811316|7487121|FG002|NOT COMPLETED|Overall Study||0
6564474|NCT01811355|7487129|FG000|STARTED|First Dose||11
6564475|NCT01811355|7487130|FG001|STARTED|First Dose||12
6564476|NCT01811355|7487129|FG000|COMPLETED|First Dose||9
6564477|NCT01811355|7487130|FG001|COMPLETED|First Dose||12
6564478|NCT01811355|7487129|FG000|NOT COMPLETED|First Dose||2
6564479|NCT01811355|7487130|FG001|NOT COMPLETED|First Dose||0
6564480|NCT01811355|7487129|FG000|STARTED|Washout||9
6564481|NCT01811355|7487130|FG001|STARTED|Washout||12
6564482|NCT01811355|7487129|FG000|COMPLETED|Washout||9
6382016|NCT00788957|7293040|FG002|STARTED|Part 3||0
6382017|NCT00788957|7293041|FG003|STARTED|Part 3||0
6382018|NCT00788957|7293042|FG004|STARTED|Part 3||13
6382019|NCT00788957|7293043|FG005|STARTED|Part 3||12
6382020|NCT00788957|7293038|FG000|COMPLETED|Part 3||0
6382021|NCT00788957|7293039|FG001|COMPLETED|Part 3||0
6382022|NCT00788957|7293040|FG002|COMPLETED|Part 3||0
6382023|NCT00788957|7293041|FG003|COMPLETED|Part 3||0
6564483|NCT01811355|7487130|FG001|COMPLETED|Washout||12
6564484|NCT01811355|7487129|FG000|NOT COMPLETED|Washout||0
6564485|NCT01811355|7487130|FG001|NOT COMPLETED|Washout||0
6564486|NCT01811355|7487129|FG000|STARTED|Second Dose||9
6564487|NCT01811355|7487130|FG001|STARTED|Second Dose||12
6564488|NCT01811355|7487129|FG000|COMPLETED|Second Dose||9
6564489|NCT01811355|7487130|FG001|COMPLETED|Second Dose||12
6564490|NCT01811355|7487129|FG000|NOT COMPLETED|Second Dose||0
6564491|NCT01811355|7487130|FG001|NOT COMPLETED|Second Dose||0
6564492|NCT01811472|7487141|FG000|STARTED|Overall Study||20
6564493|NCT01811472|7487142|FG001|STARTED|Overall Study||11
6564494|NCT01811472|7487143|FG002|STARTED|Overall Study||21
6564495|NCT01811472|7487141|FG000|COMPLETED|Overall Study||18
6564496|NCT01811472|7487142|FG001|COMPLETED|Overall Study||11
6564497|NCT01811472|7487143|FG002|COMPLETED|Overall Study||16
6564498|NCT01811472|7487141|FG000|NOT COMPLETED|Overall Study||2
6564499|NCT01811472|7487142|FG001|NOT COMPLETED|Overall Study||0
6564500|NCT01811472|7487143|FG002|NOT COMPLETED|Overall Study||5
6382024|NCT00788957|7293042|FG004|COMPLETED|Part 3|Completed the safety follow-up visit|4
6382025|NCT00788957|7293043|FG005|COMPLETED|Part 3|Completed the safety follow-up visit|1
6382026|NCT00788957|7293038|FG000|NOT COMPLETED|Part 3||0
6382027|NCT00788957|7293039|FG001|NOT COMPLETED|Part 3||0
6382028|NCT00788957|7293040|FG002|NOT COMPLETED|Part 3||0
6382029|NCT00788957|7293041|FG003|NOT COMPLETED|Part 3||0
6382030|NCT00788957|7293042|FG004|NOT COMPLETED|Part 3||9
6382031|NCT00788957|7293043|FG005|NOT COMPLETED|Part 3||11
6382032|NCT00789035|7293065|FG000|STARTED|Overall Study||82
6382033|NCT00789035|7293066|FG001|STARTED|Overall Study||81
6382034|NCT00789035|7293067|FG002|STARTED|Overall Study||81
6382035|NCT00789035|7293068|FG003|STARTED|Overall Study||82
6382036|NCT00789035|7293069|FG004|STARTED|Overall Study||80
6382037|NCT00789035|7293065|FG000|COMPLETED|Overall Study||76
6382038|NCT00789035|7293066|FG001|COMPLETED|Overall Study||74
6382039|NCT00789035|7293067|FG002|COMPLETED|Overall Study||80
6382040|NCT00789035|7293068|FG003|COMPLETED|Overall Study||81
6382041|NCT00789035|7293069|FG004|COMPLETED|Overall Study||74
6382042|NCT00789035|7293065|FG000|NOT COMPLETED|Overall Study||6
6382043|NCT00789035|7293066|FG001|NOT COMPLETED|Overall Study||7
6382044|NCT00789035|7293067|FG002|NOT COMPLETED|Overall Study||1
6382045|NCT00789035|7293068|FG003|NOT COMPLETED|Overall Study||1
6382046|NCT00789035|7293069|FG004|NOT COMPLETED|Overall Study||6
6382047|NCT00789074|7293086|FG000|STARTED|Overall Study||53
6382048|NCT00789074|7293087|FG001|STARTED|Overall Study||48
6382049|NCT00789074|7293086|FG000|COMPLETED|Overall Study||42
6382050|NCT00789074|7293087|FG001|COMPLETED|Overall Study||35
6382051|NCT00789074|7293086|FG000|NOT COMPLETED|Overall Study||11
6382052|NCT00789074|7293087|FG001|NOT COMPLETED|Overall Study||13
6382053|NCT00789113|7293096|FG000|STARTED|Overall Study||12
6382054|NCT00789113|7293096|FG000|COMPLETED|Overall Study||12
6382055|NCT00789113|7293096|FG000|NOT COMPLETED|Overall Study||0
6382056|NCT00789191|7293103|FG000|STARTED|Overall Study||111
6382057|NCT00789191|7293104|FG001|STARTED|Overall Study||111
6382058|NCT00789191|7293103|FG000|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
6382059|NCT00789191|7293104|FG001|Exposed|Overall Study|1 non-compliance|110
6382060|NCT00789191|7293103|FG000|COMPLETED|Overall Study||97
6382061|NCT00789191|7293104|FG001|COMPLETED|Overall Study||92
6382062|NCT00789191|7293103|FG000|NOT COMPLETED|Overall Study||14
6382063|NCT00789191|7293104|FG001|NOT COMPLETED|Overall Study||19
6382064|NCT00789256|7293112|FG000|STARTED|Overall Study||14
6382065|NCT00789256|7293113|FG001|STARTED|Overall Study||12
6382066|NCT00789256|7293112|FG000|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
6382067|NCT00789256|7293113|FG001|COMPLETED|Overall Study||12
6382068|NCT00789256|7293112|FG000|NOT COMPLETED|Overall Study||0
6382069|NCT00789256|7293113|FG001|NOT COMPLETED|Overall Study||0
6382070|NCT00789321|7293124|FG000|STARTED|Overall Study||24
6382071|NCT00789321|7293125|FG001|STARTED|Overall Study||23
6382072|NCT00789321|7293124|FG000|COMPLETED|Overall Study||24
6382073|NCT00789321|7293125|FG001|COMPLETED|Overall Study||22
6382074|NCT00789321|7293124|FG000|NOT COMPLETED|Overall Study||0
6382075|NCT00789321|7293125|FG001|NOT COMPLETED|Overall Study||1
6382076|NCT00789360|7293133|FG000|STARTED|Overall Study||15
6382077|NCT00789360|7293134|FG001|STARTED|Overall Study||15
6382078|NCT00789360|7293133|FG000|COMPLETED|Overall Study||12
6382079|NCT00789360|7293134|FG001|COMPLETED|Overall Study||14
6382080|NCT00789360|7293133|FG000|NOT COMPLETED|Overall Study||3
6382081|NCT00789360|7293134|FG001|NOT COMPLETED|Overall Study||1
6382082|NCT00789373|7293141|FG000|STARTED|Induction||939
6382083|NCT00789373|7293142|FG001|STARTED|Induction||0
6382084|NCT00789373|7293143|FG002|STARTED|Induction||0
6382085|NCT00789373|7293141|FG000|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
6382086|NCT00789373|7293142|FG001|COMPLETED|Induction||0
6382087|NCT00789373|7293143|FG002|COMPLETED|Induction||0
6382088|NCT00789373|7293141|FG000|NOT COMPLETED|Induction||399
6382089|NCT00789373|7293142|FG001|NOT COMPLETED|Induction||0
6382090|NCT00789373|7293143|FG002|NOT COMPLETED|Induction||0
6382091|NCT00789373|7293141|FG000|STARTED|Maintenance||0
6382092|NCT00789373|7293142|FG001|STARTED|Maintenance||359
6382093|NCT00789373|7293143|FG002|STARTED|Maintenance||180
6382094|NCT00789373|7293141|FG000|COMPLETED|Maintenance||0
6382095|NCT00789373|7293142|FG001|COMPLETED|Maintenance||0
6382096|NCT00789373|7293143|FG002|COMPLETED|Maintenance||0
6382097|NCT00789373|7293141|FG000|NOT COMPLETED|Maintenance||0
6382098|NCT00789373|7293142|FG001|NOT COMPLETED|Maintenance||359
6382099|NCT00789373|7293143|FG002|NOT COMPLETED|Maintenance||180
6382100|NCT00789438|7293157|FG000|STARTED|Overall Study||21
6382101|NCT00789438|7293158|FG001|STARTED|Overall Study||20
6382102|NCT00789438|7293159|FG002|STARTED|Overall Study||28
6382103|NCT00789438|7293157|FG000|COMPLETED|Overall Study||21
6382104|NCT00789438|7293158|FG001|COMPLETED|Overall Study||20
6382105|NCT00789438|7293159|FG002|COMPLETED|Overall Study||28
6382106|NCT00789438|7293157|FG000|NOT COMPLETED|Overall Study||0
6382107|NCT00789438|7293158|FG001|NOT COMPLETED|Overall Study||0
6382108|NCT00789438|7293159|FG002|NOT COMPLETED|Overall Study||0
6382109|NCT00789477|7293172|FG000|STARTED|Overall Study|randomized|44
6382110|NCT00789477|7293173|FG001|STARTED|Overall Study|randomized|44
6382111|NCT00789477|7293174|FG002|STARTED|Overall Study|randomized|44
6382112|NCT00789477|7293175|FG003|STARTED|Overall Study|randomized|44
6382113|NCT00789477|7293176|FG004|STARTED|Overall Study|randomized|45
6382114|NCT00789477|7293172|FG000|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
6382115|NCT00789477|7293173|FG001|Participants Received Treatment|Overall Study|SAF|44
6382116|NCT00789477|7293174|FG002|Participants Received Treatment|Overall Study|SAF|44
6382117|NCT00789477|7293175|FG003|Participants Received Treatment|Overall Study|SAF|42
6382118|NCT00789477|7293176|FG004|Participants Received Treatment|Overall Study|SAF|45
6382119|NCT00789477|7293172|FG000|COMPLETED|Overall Study||33
6382120|NCT00789477|7293173|FG001|COMPLETED|Overall Study||38
6382121|NCT00789477|7293174|FG002|COMPLETED|Overall Study||33
6382122|NCT00789477|7293175|FG003|COMPLETED|Overall Study||34
6382123|NCT00789477|7293176|FG004|COMPLETED|Overall Study||38
6382124|NCT00789477|7293172|FG000|NOT COMPLETED|Overall Study||11
6382125|NCT00789477|7293173|FG001|NOT COMPLETED|Overall Study||6
6382126|NCT00789477|7293174|FG002|NOT COMPLETED|Overall Study||11
6382127|NCT00789477|7293175|FG003|NOT COMPLETED|Overall Study||10
6382128|NCT00789477|7293176|FG004|NOT COMPLETED|Overall Study||7
6382129|NCT00789529|7293192|FG000|STARTED|Overall Study||16
6382130|NCT00789529|7293193|FG001|STARTED|Overall Study||16
6382131|NCT00789529|7293192|FG000|COMPLETED|Overall Study||15
6382132|NCT00789529|7293193|FG001|COMPLETED|Overall Study||15
6382133|NCT00789529|7293192|FG000|NOT COMPLETED|Overall Study||1
6382134|NCT00789529|7293193|FG001|NOT COMPLETED|Overall Study||1
6382135|NCT00789555|7293202|FG000|STARTED|Overall Study||421
6382136|NCT00789555|7293203|FG001|STARTED|Overall Study||417
6382137|NCT00789555|7293204|FG002|STARTED|Overall Study||422
6382138|NCT00789555|7293202|FG000|COMPLETED|Overall Study||262
6382139|NCT00789555|7293203|FG001|COMPLETED|Overall Study||278
6382140|NCT00789555|7293204|FG002|COMPLETED|Overall Study||263
6382141|NCT00789555|7293202|FG000|NOT COMPLETED|Overall Study||159
6382142|NCT00789555|7293203|FG001|NOT COMPLETED|Overall Study||139
6382143|NCT00789555|7293204|FG002|NOT COMPLETED|Overall Study||159
6382144|NCT00789581|7293214|FG000|STARTED|AC Therapy||306
6382145|NCT00789581|7293215|FG001|STARTED|AC Therapy||308
6382146|NCT00789581|7293214|FG000|COMPLETED|AC Therapy||295
6382147|NCT00789581|7293215|FG001|COMPLETED|AC Therapy||291
6382148|NCT00789581|7293214|FG000|NOT COMPLETED|AC Therapy||11
6382149|NCT00789581|7293215|FG001|NOT COMPLETED|AC Therapy||17
6382150|NCT00789581|7293214|FG000|STARTED|Adjuvant Therapy||295
6382151|NCT00789581|7293215|FG001|STARTED|Adjuvant Therapy||291
6382152|NCT00789581|7293214|FG000|COMPLETED|Adjuvant Therapy||255
6382153|NCT00789581|7293215|FG001|COMPLETED|Adjuvant Therapy||234
6382154|NCT00789581|7293214|FG000|NOT COMPLETED|Adjuvant Therapy||40
6382155|NCT00789581|7293215|FG001|NOT COMPLETED|Adjuvant Therapy||57
6382156|NCT00789672|7293224|FG000|STARTED|Overall Study||16
6382157|NCT00789672|7293225|FG001|STARTED|Overall Study||17
6382158|NCT00789672|7293224|FG000|COMPLETED|Overall Study||16
6382159|NCT00789672|7293225|FG001|COMPLETED|Overall Study||17
6382160|NCT00789672|7293224|FG000|NOT COMPLETED|Overall Study||0
6382161|NCT00789672|7293225|FG001|NOT COMPLETED|Overall Study||0
6382162|NCT00789685|7293231|FG000|STARTED|Overall Study||37
6382163|NCT00789685|7293231|FG000|COMPLETED|Overall Study|Completed the study to Day 28|25
6382164|NCT00789685|7293231|FG000|NOT COMPLETED|Overall Study||12
6382165|NCT00789698|7293239|FG000|STARTED|Overall Study||72
6382166|NCT00789698|7293240|FG001|STARTED|Overall Study||79
6382167|NCT00789698|7293241|FG002|STARTED|Overall Study||56
6382168|NCT00789698|7293242|FG003|STARTED|Overall Study||85
6382169|NCT00789698|7293239|FG000|COMPLETED|Overall Study||32
6382170|NCT00789698|7293240|FG001|COMPLETED|Overall Study||46
6382171|NCT00789698|7293241|FG002|COMPLETED|Overall Study||29
6382172|NCT00789698|7293242|FG003|COMPLETED|Overall Study||33
6382173|NCT00789698|7293239|FG000|NOT COMPLETED|Overall Study||40
6382174|NCT00789698|7293240|FG001|NOT COMPLETED|Overall Study||33
6382175|NCT00789698|7293241|FG002|NOT COMPLETED|Overall Study||27
6382176|NCT00789698|7293242|FG003|NOT COMPLETED|Overall Study||52
6382177|NCT00789724|7293253|FG000|STARTED|Overall Study||5
6382178|NCT00789724|7293254|FG001|STARTED|Overall Study||5
6382179|NCT00789724|7293253|FG000|COMPLETED|Overall Study||5
6269147|NCT00071799|7168277|FG000|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
6269148|NCT00071799|7168278|FG001|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
6269149|NCT00071799|7168277|FG000|NOT COMPLETED|Overall Study||70
6269150|NCT00071799|7168278|FG001|NOT COMPLETED|Overall Study||98
6269151|NCT00071812|7168294|FG000|STARTED|24-Week Double-Blind Period||69
6269152|NCT00071812|7168295|FG001|STARTED|24-Week Double-Blind Period||72
6269153|NCT00071812|7168296|FG002|STARTED|24-Week Double-Blind Period||71
6269154|NCT00071812|7168297|FG003|STARTED|24-Week Double-Blind Period||71
6269155|NCT00071812|7168294|FG000|COMPLETED|24-Week Double-Blind Period||59
6269156|NCT00071812|7168295|FG001|COMPLETED|24-Week Double-Blind Period||66
6269157|NCT00071812|7168296|FG002|COMPLETED|24-Week Double-Blind Period||63
6269158|NCT00071812|7168297|FG003|COMPLETED|24-Week Double-Blind Period||60
6269159|NCT00071812|7168294|FG000|NOT COMPLETED|24-Week Double-Blind Period||10
6269160|NCT00071812|7168295|FG001|NOT COMPLETED|24-Week Double-Blind Period||6
6269161|NCT00071812|7168296|FG002|NOT COMPLETED|24-Week Double-Blind Period||8
6269162|NCT00071812|7168297|FG003|NOT COMPLETED|24-Week Double-Blind Period||11
6269163|NCT00071812|7168294|FG000|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
6269164|NCT00071812|7168295|FG001|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
6269165|NCT00071812|7168296|FG002|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
6269166|NCT00071812|7168297|FG003|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
6269167|NCT00071812|7168294|FG000|COMPLETED|24-Week Open-Label Extension Period||0
6269168|NCT00071812|7168295|FG001|COMPLETED|24-Week Open-Label Extension Period||11
6269169|NCT00071812|7168296|FG002|COMPLETED|24-Week Open-Label Extension Period||7
6269170|NCT00071812|7168297|FG003|COMPLETED|24-Week Open-Label Extension Period||178
6269171|NCT00071812|7168294|FG000|NOT COMPLETED|24-Week Open-Label Extension Period||0
6269172|NCT00071812|7168295|FG001|NOT COMPLETED|24-Week Open-Label Extension Period||0
6269173|NCT00071812|7168296|FG002|NOT COMPLETED|24-Week Open-Label Extension Period||1
6269174|NCT00071812|7168297|FG003|NOT COMPLETED|24-Week Open-Label Extension Period||40
6269175|NCT00071890|7168311|FG000|STARTED|Overall Study|3 patients did not received Interleukin-2|81
6269176|NCT00071890|7168312|FG001|STARTED|Overall Study|1 patients stopped HAART at week 0|67
6269177|NCT00071890|7168311|FG000|COMPLETED|Overall Study|"1 withdrawal~1 death 81 patients analysed"|81
6269178|NCT00071890|7168312|FG001|COMPLETED|Overall Study|"1 withdrawal~1 lost of follow-up~1 death 67 patients analysed"|67
6269179|NCT00071890|7168311|FG000|NOT COMPLETED|Overall Study||0
6269180|NCT00071890|7168312|FG001|NOT COMPLETED|Overall Study||0
6269181|NCT00071981|7168322|FG000|STARTED|Overall Study||47
6564501|NCT01811485|7487155|FG000|STARTED|Overall Study|"Started indicates randomized patients"|56
6564502|NCT01811485|7487156|FG001|STARTED|Overall Study||59
6803064|NCT04553406|7735131|FG000|STARTED|Overall Study||1
6803065|NCT04553406|7735132|FG001|STARTED|Overall Study||1
6803066|NCT04553406|7735131|FG000|COMPLETED|Overall Study||1
6803067|NCT04553406|7735132|FG001|COMPLETED|Overall Study||0
6803068|NCT04553406|7735131|FG000|NOT COMPLETED|Overall Study||0
6803069|NCT04553406|7735132|FG001|NOT COMPLETED|Overall Study||1
6803070|NCT03792750|7735138|FG000|STARTED|Overall Study||12
6803071|NCT03792750|7735138|FG000|COMPLETED|Overall Study||9
6803072|NCT03792750|7735138|FG000|NOT COMPLETED|Overall Study||3
6803100|NCT03518086|7735176|FG003|STARTED|Overall Study||0
6803101|NCT03518086|7735173|FG000|Received at Least One Dose of Study Drug|Overall Study||321
6803102|NCT03518086|7735174|FG001|Received at Least One Dose of Study Drug|Overall Study||958
6803103|NCT03518086|7735175|FG002|Received at Least One Dose of Study Drug|Overall Study||0
6803104|NCT03518086|7735176|FG003|Received at Least One Dose of Study Drug|Overall Study||0
6803105|NCT03518086|7735173|FG000|COMPLETED|Overall Study||285
6803106|NCT03518086|7735174|FG001|COMPLETED|Overall Study||920
6803107|NCT03518086|7735175|FG002|COMPLETED|Overall Study||0
6803108|NCT03518086|7735176|FG003|COMPLETED|Overall Study||0
6803109|NCT03518086|7735173|FG000|NOT COMPLETED|Overall Study||37
6803110|NCT03518086|7735174|FG001|NOT COMPLETED|Overall Study||39
6803111|NCT03518086|7735175|FG002|NOT COMPLETED|Overall Study||0
6803112|NCT03518086|7735176|FG003|NOT COMPLETED|Overall Study||0
6803113|NCT03468309|7735183|FG000|STARTED|Overall Study||53
6803114|NCT03468309|7735183|FG000|COMPLETED|Overall Study||47
6803115|NCT03468309|7735183|FG000|NOT COMPLETED|Overall Study||6
6803116|NCT03347123|7735189|FG000|STARTED|Overall Study||5
6803117|NCT03347123|7735190|FG001|STARTED|Overall Study||6
6803118|NCT03347123|7735191|FG002|STARTED|Overall Study||0
6803119|NCT03347123|7735192|FG003|STARTED|Overall Study||0
6803120|NCT03347123|7735193|FG004|STARTED|Overall Study||0
6803121|NCT03347123|7735194|FG005|STARTED|Overall Study||0
6803122|NCT03347123|7735195|FG006|STARTED|Overall Study||0
6803123|NCT03347123|7735189|FG000|COMPLETED|Overall Study||0
6803124|NCT03347123|7735190|FG001|COMPLETED|Overall Study||0
6803125|NCT03347123|7735191|FG002|COMPLETED|Overall Study||0
6803126|NCT03347123|7735192|FG003|COMPLETED|Overall Study||0
6803127|NCT03347123|7735193|FG004|COMPLETED|Overall Study||0
6803128|NCT03347123|7735194|FG005|COMPLETED|Overall Study||0
6803129|NCT03347123|7735195|FG006|COMPLETED|Overall Study||0
6803130|NCT03347123|7735189|FG000|NOT COMPLETED|Overall Study||5
6803131|NCT03347123|7735190|FG001|NOT COMPLETED|Overall Study||6
6803132|NCT03347123|7735191|FG002|NOT COMPLETED|Overall Study||0
6803133|NCT03347123|7735192|FG003|NOT COMPLETED|Overall Study||0
6803134|NCT03347123|7735193|FG004|NOT COMPLETED|Overall Study||0
6803135|NCT03347123|7735194|FG005|NOT COMPLETED|Overall Study||0
6803136|NCT03347123|7735195|FG006|NOT COMPLETED|Overall Study||0
6803137|NCT03318523|7735210|FG000|STARTED|PC Period: Up to Year 1||100
6803138|NCT03318523|7735211|FG001|STARTED|PC Period: Up to Year 1||55
6803139|NCT03318523|7735212|FG002|STARTED|PC Period: Up to Year 1||102
6803140|NCT03318523|7735213|FG003|STARTED|PC Period: Up to Year 1||100
6803141|NCT03318523|7735214|FG004|STARTED|PC Period: Up to Year 1||0
6803142|NCT03318523|7735215|FG005|STARTED|PC Period: Up to Year 1||0
6803143|NCT03318523|7735216|FG006|STARTED|PC Period: Up to Year 1||0
6803144|NCT03318523|7735217|FG007|STARTED|PC Period: Up to Year 1||0
6803145|NCT03318523|7735218|FG008|STARTED|PC Period: Up to Year 1||0
6803146|NCT03318523|7735219|FG009|STARTED|PC Period: Up to Year 1||0
6803147|NCT03318523|7735210|FG000|COMPLETED|PC Period: Up to Year 1||96
6803148|NCT03318523|7735211|FG001|COMPLETED|PC Period: Up to Year 1||53
6803149|NCT03318523|7735212|FG002|COMPLETED|PC Period: Up to Year 1||100
6803150|NCT03318523|7735213|FG003|COMPLETED|PC Period: Up to Year 1||96
6803151|NCT03318523|7735214|FG004|COMPLETED|PC Period: Up to Year 1||0
6803152|NCT03318523|7735215|FG005|COMPLETED|PC Period: Up to Year 1||0
6803153|NCT03318523|7735216|FG006|COMPLETED|PC Period: Up to Year 1||0
6803154|NCT03318523|7735217|FG007|COMPLETED|PC Period: Up to Year 1||0
6803155|NCT03318523|7735218|FG008|COMPLETED|PC Period: Up to Year 1||0
6803156|NCT03318523|7735219|FG009|COMPLETED|PC Period: Up to Year 1||0
6803157|NCT03318523|7735210|FG000|NOT COMPLETED|PC Period: Up to Year 1||4
6803158|NCT03318523|7735211|FG001|NOT COMPLETED|PC Period: Up to Year 1||2
6803159|NCT03318523|7735212|FG002|NOT COMPLETED|PC Period: Up to Year 1||2
6803160|NCT03318523|7735213|FG003|NOT COMPLETED|PC Period: Up to Year 1||4
6803161|NCT03318523|7735214|FG004|NOT COMPLETED|PC Period: Up to Year 1||0
6803162|NCT03318523|7735215|FG005|NOT COMPLETED|PC Period: Up to Year 1||0
6803163|NCT03318523|7735216|FG006|NOT COMPLETED|PC Period: Up to Year 1||0
6803164|NCT03318523|7735217|FG007|NOT COMPLETED|PC Period: Up to Year 1||0
6803165|NCT03318523|7735218|FG008|NOT COMPLETED|PC Period: Up to Year 1||0
6803166|NCT03318523|7735219|FG009|NOT COMPLETED|PC Period: Up to Year 1||0
6382180|NCT00789724|7293254|FG001|COMPLETED|Overall Study||5
6382181|NCT00789724|7293253|FG000|NOT COMPLETED|Overall Study||0
6382182|NCT00789724|7293254|FG001|NOT COMPLETED|Overall Study||0
6382183|NCT00789737|7293262|FG000|STARTED|Overall Study||176
6382184|NCT00789737|7293263|FG001|STARTED|Overall Study||181
6382185|NCT00789737|7293262|FG000|COMPLETED|Overall Study||128
6382186|NCT00789737|7293263|FG001|COMPLETED|Overall Study||126
6382187|NCT00789737|7293262|FG000|NOT COMPLETED|Overall Study||48
6382188|NCT00789737|7293263|FG001|NOT COMPLETED|Overall Study||55
6382189|NCT00789750|7293271|FG000|STARTED|Overall Study||280
6382190|NCT00789750|7293272|FG001|STARTED|Overall Study||282
6382191|NCT00789750|7293271|FG000|Dropped During run-in Period|Overall Study||6
6382192|NCT00789750|7293272|FG001|Dropped During run-in Period|Overall Study||5
6382193|NCT00789750|7293271|FG000|Safety Set|Overall Study||274
6382194|NCT00789750|7293272|FG001|Safety Set|Overall Study||277
6564503|NCT01811485|7487157|FG002|STARTED|Overall Study||56
6564504|NCT01811485|7487155|FG000|COMPLETED|Overall Study||54
6564505|NCT01811485|7487156|FG001|COMPLETED|Overall Study||55
6564506|NCT01811485|7487157|FG002|COMPLETED|Overall Study||51
6564507|NCT01811485|7487155|FG000|NOT COMPLETED|Overall Study||2
6803167|NCT03318523|7735210|FG000|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803168|NCT03318523|7735211|FG001|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803169|NCT03318523|7735212|FG002|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803170|NCT03318523|7735213|FG003|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6564508|NCT01811485|7487156|FG001|NOT COMPLETED|Overall Study||4
6564509|NCT01811485|7487157|FG002|NOT COMPLETED|Overall Study||5
6564510|NCT01811563|7487170|FG000|STARTED|Overall Study||25
6564511|NCT01811563|7487171|FG001|STARTED|Overall Study||23
6564512|NCT01811563|7487170|FG000|COMPLETED|Overall Study||20
6564513|NCT01811563|7487171|FG001|COMPLETED|Overall Study||20
6564514|NCT01811563|7487170|FG000|NOT COMPLETED|Overall Study||5
6564515|NCT01811563|7487171|FG001|NOT COMPLETED|Overall Study||3
6564516|NCT01811654|7487179|FG000|STARTED|Overall Study||14
6803171|NCT03318523|7735214|FG004|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
6803172|NCT03318523|7735215|FG005|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
6803173|NCT03318523|7735216|FG006|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
6803174|NCT03318523|7735217|FG007|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
6803175|NCT03318523|7735218|FG008|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
6803176|NCT03318523|7735219|FG009|STARTED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
6803177|NCT03318523|7735210|FG000|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803178|NCT03318523|7735211|FG001|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803179|NCT03318523|7735212|FG002|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803180|NCT03318523|7735213|FG003|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803181|NCT03318523|7735214|FG004|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||20
6803182|NCT03318523|7735215|FG005|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||37
6803183|NCT03318523|7735216|FG006|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||39
6803184|NCT03318523|7735217|FG007|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||52
6803185|NCT03318523|7735218|FG008|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||100
6564517|NCT01811654|7487180|FG001|STARTED|Overall Study||16
6564518|NCT01811654|7487179|FG000|COMPLETED|Overall Study||14
6564519|NCT01811654|7487180|FG001|COMPLETED|Overall Study||16
6564520|NCT01811654|7487179|FG000|NOT COMPLETED|Overall Study||0
6564521|NCT01811654|7487180|FG001|NOT COMPLETED|Overall Study||0
6564522|NCT01811680|7487186|FG000|STARTED|Overall Study||10
6564523|NCT01811680|7487186|FG000|COMPLETED|Overall Study||10
6564524|NCT01811680|7487186|FG000|NOT COMPLETED|Overall Study||0
6564525|NCT01811693|7487194|FG000|STARTED|Overall Study||4
6564526|NCT01811693|7487195|FG001|STARTED|Overall Study||0
6564527|NCT01811693|7487196|FG002|STARTED|Overall Study||0
6564528|NCT01811693|7487194|FG000|COMPLETED|Overall Study||4
6564529|NCT01811693|7487195|FG001|COMPLETED|Overall Study||0
6564530|NCT01811693|7487196|FG002|COMPLETED|Overall Study||0
6564531|NCT01811693|7487194|FG000|NOT COMPLETED|Overall Study||0
6564532|NCT01811693|7487195|FG001|NOT COMPLETED|Overall Study||0
6564533|NCT01811693|7487196|FG002|NOT COMPLETED|Overall Study||0
6564534|NCT01811706|7487200|FG000|STARTED|First Intervention ( 4 Weeks)||10
6564535|NCT01811706|7487201|FG001|STARTED|First Intervention ( 4 Weeks)||10
6564536|NCT01811706|7487200|FG000|COMPLETED|First Intervention ( 4 Weeks)||9
6564537|NCT01811706|7487201|FG001|COMPLETED|First Intervention ( 4 Weeks)||10
6564538|NCT01811706|7487200|FG000|NOT COMPLETED|First Intervention ( 4 Weeks)||1
6564539|NCT01811706|7487201|FG001|NOT COMPLETED|First Intervention ( 4 Weeks)||0
6564540|NCT01811706|7487200|FG000|STARTED|Washout ( 2 Weeks)||9
6564541|NCT01811706|7487201|FG001|STARTED|Washout ( 2 Weeks)||10
6564542|NCT01811706|7487200|FG000|COMPLETED|Washout ( 2 Weeks)||9
6564543|NCT01811706|7487201|FG001|COMPLETED|Washout ( 2 Weeks)||10
6564544|NCT01811706|7487200|FG000|NOT COMPLETED|Washout ( 2 Weeks)||0
6564545|NCT01811706|7487201|FG001|NOT COMPLETED|Washout ( 2 Weeks)||0
6564546|NCT01811706|7487200|FG000|STARTED|Second Intervention (4 Weeks)||9
6382195|NCT00789750|7293271|FG000|Intent to Treat Set|Overall Study||271
6382196|NCT00789750|7293272|FG001|Intent to Treat Set|Overall Study||276
6382197|NCT00789750|7293271|FG000|COMPLETED|Overall Study||221
6382198|NCT00789750|7293272|FG001|COMPLETED|Overall Study||222
6382199|NCT00789750|7293271|FG000|NOT COMPLETED|Overall Study||59
6382200|NCT00789750|7293272|FG001|NOT COMPLETED|Overall Study||60
6382201|NCT00789776|7293280|FG000|STARTED|Overall Study||5
6382202|NCT00789776|7293281|FG001|STARTED|Overall Study||36
6382203|NCT00789776|7293280|FG000|COMPLETED|Overall Study||5
6382204|NCT00789776|7293281|FG001|COMPLETED|Overall Study||35
6382205|NCT00789776|7293280|FG000|NOT COMPLETED|Overall Study||0
6382206|NCT00789776|7293281|FG001|NOT COMPLETED|Overall Study||1
6382207|NCT00789802|7293290|FG000|STARTED|Overall Study||44
6382208|NCT00789802|7293291|FG001|STARTED|Overall Study||42
6382209|NCT00789802|7293292|FG002|STARTED|Overall Study||43
6382210|NCT00789802|7293290|FG000|COMPLETED|Overall Study||34
6382211|NCT00789802|7293291|FG001|COMPLETED|Overall Study||35
6382212|NCT00789802|7293292|FG002|COMPLETED|Overall Study||37
6382213|NCT00789802|7293290|FG000|NOT COMPLETED|Overall Study||10
6564547|NCT01811706|7487201|FG001|STARTED|Second Intervention (4 Weeks)||10
6564548|NCT01811706|7487200|FG000|COMPLETED|Second Intervention (4 Weeks)||9
6382214|NCT00789802|7293291|FG001|NOT COMPLETED|Overall Study||7
6382215|NCT00789802|7293292|FG002|NOT COMPLETED|Overall Study||6
6382216|NCT00789815|7293305|FG000|STARTED|Overall Study||250
6382217|NCT00789815|7293306|FG001|STARTED|Overall Study||250
6382218|NCT00789815|7293305|FG000|COMPLETED|Overall Study||243
6382219|NCT00789815|7293306|FG001|COMPLETED|Overall Study||249
6382220|NCT00789815|7293305|FG000|NOT COMPLETED|Overall Study||7
6382221|NCT00789815|7293306|FG001|NOT COMPLETED|Overall Study||1
6382222|NCT00789828|7293314|FG000|STARTED|Core Period (48 Weeks)||78
6382223|NCT00789828|7293315|FG001|STARTED|Core Period (48 Weeks)||39
6382224|NCT00789828|7293314|FG000|COMPLETED|Core Period (48 Weeks)||78
6382225|NCT00789828|7293315|FG001|COMPLETED|Core Period (48 Weeks)||33
6382226|NCT00789828|7293314|FG000|NOT COMPLETED|Core Period (48 Weeks)||0
6382227|NCT00789828|7293315|FG001|NOT COMPLETED|Core Period (48 Weeks)||6
6382228|NCT00789828|7293314|FG000|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
6382229|NCT00789828|7293315|FG001|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
6382230|NCT00789828|7293314|FG000|COMPLETED|Open-label Extension Period (4 Years)||82
6382231|NCT00789828|7293315|FG001|COMPLETED|Open-label Extension Period (4 Years)||0
6502857|NCT01437501|7421612|FG001|COMPLETED|Overall Study||132
6502858|NCT01437501|7421611|FG000|NOT COMPLETED|Overall Study||13
6502859|NCT01437501|7421612|FG001|NOT COMPLETED|Overall Study||11
6502860|NCT01437540|7421622|FG000|STARTED|Overall Study||392
6502861|NCT01437540|7421623|FG001|STARTED|Overall Study||198
6564549|NCT01811706|7487201|FG001|COMPLETED|Second Intervention (4 Weeks)||10
6564550|NCT01811706|7487200|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6564551|NCT01811706|7487201|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
6564552|NCT01811732|7487211|FG000|STARTED|Overall Study||331
6564553|NCT01811732|7487212|FG001|STARTED|Overall Study||329
6564554|NCT01811732|7487211|FG000|COMPLETED|Overall Study||276
6502862|NCT01437540|7421622|FG000|COMPLETED|Overall Study||265
6502863|NCT01437540|7421623|FG001|COMPLETED|Overall Study||133
6502864|NCT01437540|7421622|FG000|NOT COMPLETED|Overall Study||127
6502865|NCT01437540|7421623|FG001|NOT COMPLETED|Overall Study||65
6502866|NCT01437605|7421631|FG000|STARTED|Overall Study||9
6502867|NCT01437605|7421632|FG001|STARTED|Overall Study||5
6502868|NCT01437605|7421631|FG000|COMPLETED|Overall Study||9
6502869|NCT01437605|7421632|FG001|COMPLETED|Overall Study||5
6502870|NCT01437605|7421631|FG000|NOT COMPLETED|Overall Study||0
6502871|NCT01437605|7421632|FG001|NOT COMPLETED|Overall Study||0
6502872|NCT01437852|7421638|FG000|STARTED|Overall Study||30
6502873|NCT01437852|7421638|FG000|Received StrataGraft Skin Tissue|Overall Study||30
6502874|NCT01437852|7421638|FG000|Received Autograft|Overall Study||30
6502875|NCT01437852|7421638|FG000|COMPLETED|Overall Study||30
6502876|NCT01437852|7421638|FG000|NOT COMPLETED|Overall Study||0
6502877|NCT01437878|7421645|FG000|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
6502878|NCT01437878|7421646|FG001|STARTED|Overall Study||1
6502879|NCT01437878|7421645|FG000|COMPLETED|Overall Study||0
6502880|NCT01437878|7421646|FG001|COMPLETED|Overall Study||1
6502881|NCT01437878|7421645|FG000|NOT COMPLETED|Overall Study||1
6502882|NCT01437878|7421646|FG001|NOT COMPLETED|Overall Study||0
6502883|NCT01437943|7421654|FG000|STARTED|Overall Study||7
6502884|NCT01437943|7421655|FG001|STARTED|Overall Study||3
6502885|NCT01437943|7421654|FG000|COMPLETED|Overall Study||0
6502886|NCT01437943|7421655|FG001|COMPLETED|Overall Study||1
6502887|NCT01437943|7421654|FG000|NOT COMPLETED|Overall Study||7
6502888|NCT01437943|7421655|FG001|NOT COMPLETED|Overall Study||2
6502889|NCT01437995|7421664|FG000|STARTED|Overall Study||151
6502890|NCT01437995|7421665|FG001|STARTED|Overall Study||149
6502891|NCT01437995|7421666|FG002|STARTED|Overall Study||155
6564555|NCT01811732|7487212|FG001|COMPLETED|Overall Study||271
6564556|NCT01811732|7487211|FG000|NOT COMPLETED|Overall Study||55
6564557|NCT01811732|7487212|FG001|NOT COMPLETED|Overall Study||58
6564558|NCT01811875|7487219|FG000|STARTED|Overall Study||7
6564559|NCT01811875|7487219|FG000|COMPLETED|Overall Study||5
6382232|NCT00789828|7293314|FG000|NOT COMPLETED|Open-label Extension Period (4 Years)||29
6382233|NCT00789828|7293315|FG001|NOT COMPLETED|Open-label Extension Period (4 Years)||0
6502892|NCT01437995|7421664|FG000|Included in Treatment Failure Analysis|Overall Study||150
6502893|NCT01437995|7421665|FG001|Included in Treatment Failure Analysis|Overall Study||146
6502894|NCT01437995|7421666|FG002|Included in Treatment Failure Analysis|Overall Study||151
6502895|NCT01437995|7421664|FG000|COMPLETED|Overall Study||140
6502896|NCT01437995|7421665|FG001|COMPLETED|Overall Study||131
6502897|NCT01437995|7421666|FG002|COMPLETED|Overall Study||135
6502898|NCT01437995|7421664|FG000|NOT COMPLETED|Overall Study||11
6803186|NCT03318523|7735219|FG009|Number of Participants Dosed|DBE Period:Year 2 to EOS (Up to 3 Years)||94
6803187|NCT03318523|7735210|FG000|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803188|NCT03318523|7735211|FG001|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803189|NCT03318523|7735212|FG002|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803190|NCT03318523|7735213|FG003|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6382234|NCT00789854|7293327|FG000|STARTED|Overall Study||228
6382235|NCT00789854|7293328|FG001|STARTED|Overall Study||231
6382236|NCT00789854|7293329|FG002|STARTED|Overall Study||229
6382237|NCT00789854|7293327|FG000|COMPLETED|Overall Study||179
6382238|NCT00789854|7293328|FG001|COMPLETED|Overall Study||196
6382239|NCT00789854|7293329|FG002|COMPLETED|Overall Study||182
6382240|NCT00789854|7293327|FG000|NOT COMPLETED|Overall Study||49
6382241|NCT00789854|7293328|FG001|NOT COMPLETED|Overall Study||35
6382242|NCT00789854|7293329|FG002|NOT COMPLETED|Overall Study||47
6382243|NCT00789867|7293340|FG000|STARTED|Overall Study||17
6382244|NCT00789867|7293341|FG001|STARTED|Overall Study||10
6382245|NCT00789867|7293342|FG002|STARTED|Overall Study||8
6382246|NCT00789867|7293340|FG000|COMPLETED|Overall Study||17
6382247|NCT00789867|7293341|FG001|COMPLETED|Overall Study||10
6382248|NCT00789867|7293342|FG002|COMPLETED|Overall Study||8
6382249|NCT00789867|7293340|FG000|NOT COMPLETED|Overall Study||0
6382250|NCT00789867|7293341|FG001|NOT COMPLETED|Overall Study||0
6382251|NCT00789867|7293342|FG002|NOT COMPLETED|Overall Study||0
6382252|NCT00789880|7293357|FG000|STARTED|Overall Study||16
6382253|NCT00789880|7293358|FG001|STARTED|Overall Study||16
6382254|NCT00789880|7293359|FG002|STARTED|Overall Study||8
6382255|NCT00789880|7293360|FG003|STARTED|Overall Study||16
6382256|NCT00789880|7293361|FG004|STARTED|Overall Study||18
6382257|NCT00789880|7293362|FG005|STARTED|Overall Study||8
6382258|NCT00789880|7293357|FG000|COMPLETED|Overall Study||15
6502899|NCT01437995|7421665|FG001|NOT COMPLETED|Overall Study||18
6502900|NCT01437995|7421666|FG002|NOT COMPLETED|Overall Study||20
6502901|NCT01438008|7421676|FG000|STARTED|Overall Study||4
6502902|NCT01438008|7421677|FG001|STARTED|Overall Study||5
6502903|NCT01438008|7421676|FG000|COMPLETED|Overall Study||4
6502904|NCT01438008|7421677|FG001|COMPLETED|Overall Study||5
6502905|NCT01438008|7421676|FG000|NOT COMPLETED|Overall Study||0
6502906|NCT01438008|7421677|FG001|NOT COMPLETED|Overall Study||0
6502907|NCT01438060|7421685|FG000|STARTED|Acute Phase: Double-blind, 10 Weeks||102
6502908|NCT01438060|7421686|FG001|STARTED|Acute Phase: Double-blind, 10 Weeks||106
6803191|NCT03318523|7735214|FG004|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803192|NCT03318523|7735215|FG005|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6382259|NCT00789880|7293358|FG001|COMPLETED|Overall Study||15
6382260|NCT00789880|7293359|FG002|COMPLETED|Overall Study||8
6382261|NCT00789880|7293360|FG003|COMPLETED|Overall Study||15
6382262|NCT00789880|7293361|FG004|COMPLETED|Overall Study||15
6382263|NCT00789880|7293362|FG005|COMPLETED|Overall Study||8
6502909|NCT01438060|7421685|FG000|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
6382264|NCT00789880|7293357|FG000|NOT COMPLETED|Overall Study||1
6382265|NCT00789880|7293358|FG001|NOT COMPLETED|Overall Study||1
6382266|NCT00789880|7293359|FG002|NOT COMPLETED|Overall Study||0
6382267|NCT00789880|7293360|FG003|NOT COMPLETED|Overall Study||1
6382268|NCT00789880|7293361|FG004|NOT COMPLETED|Overall Study||3
6382269|NCT00789880|7293362|FG005|NOT COMPLETED|Overall Study||0
6382270|NCT00789958|7293376|FG000|STARTED|Overall Study||105
6382271|NCT00789958|7293376|FG000|Eligible and Analyzable|Overall Study||79
6382272|NCT00789958|7293376|FG000|COMPLETED|Overall Study||68
6382273|NCT00789958|7293376|FG000|NOT COMPLETED|Overall Study||37
6382274|NCT00789997|7293384|FG000|STARTED|Overall Study||41
6382275|NCT00789997|7293385|FG001|STARTED|Overall Study||40
6382276|NCT00789997|7293384|FG000|COMPLETED|Overall Study||40
6382277|NCT00789997|7293385|FG001|COMPLETED|Overall Study||38
6382278|NCT00789997|7293384|FG000|NOT COMPLETED|Overall Study||1
6382279|NCT00789997|7293385|FG001|NOT COMPLETED|Overall Study||2
6382280|NCT00790023|7293394|FG000|STARTED|Overall Study||237
6382281|NCT00790023|7293395|FG001|STARTED|Overall Study||235
6382282|NCT00790023|7293396|FG002|STARTED|Overall Study||235
6382283|NCT00790023|7293394|FG000|COMPLETED|Overall Study||226
6382284|NCT00790023|7293395|FG001|COMPLETED|Overall Study||225
6382285|NCT00790023|7293396|FG002|COMPLETED|Overall Study||214
6382286|NCT00790023|7293394|FG000|NOT COMPLETED|Overall Study||11
6382287|NCT00790023|7293395|FG001|NOT COMPLETED|Overall Study||10
6382288|NCT00790023|7293396|FG002|NOT COMPLETED|Overall Study||21
6382289|NCT00790036|7293407|FG000|STARTED|Overall Study||372
6382290|NCT00790036|7293408|FG001|STARTED|Overall Study||370
6382291|NCT00790036|7293407|FG000|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
6382292|NCT00790036|7293408|FG001|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
6382293|NCT00790036|7293407|FG000|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
6382294|NCT00790036|7293408|FG001|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
6382295|NCT00790036|7293407|FG000|NOT COMPLETED|Overall Study||195
6382296|NCT00790036|7293408|FG001|NOT COMPLETED|Overall Study||121
6382297|NCT00790062|7293418|FG000|STARTED|Overall Study||659
6382298|NCT00790062|7293419|FG001|STARTED|Overall Study||481
6382299|NCT00790062|7293420|FG002|STARTED|Overall Study||658
6382300|NCT00790062|7293418|FG000|COMPLETED|Overall Study||659
6382301|NCT00790062|7293419|FG001|COMPLETED|Overall Study||481
6382302|NCT00790062|7293420|FG002|COMPLETED|Overall Study||658
6382303|NCT00790062|7293418|FG000|NOT COMPLETED|Overall Study||0
6382304|NCT00790062|7293419|FG001|NOT COMPLETED|Overall Study||0
6382305|NCT00790062|7293420|FG002|NOT COMPLETED|Overall Study||0
6382306|NCT00790088|7293437|FG000|STARTED|Overall Study||274
6382307|NCT00790088|7293437|FG000|Eligible for Data Analysis|Overall Study|Number of participants minus 11 protocol violation|263
6382308|NCT00790088|7293437|FG000|COMPLETED|Overall Study||235
6382309|NCT00790088|7293437|FG000|NOT COMPLETED|Overall Study||39
6382310|NCT00790192|7293447|FG000|STARTED|Overall Study||125
6382311|NCT00790192|7293448|FG001|STARTED|Overall Study||121
6382312|NCT00790192|7293449|FG002|STARTED|Overall Study||120
6382313|NCT00790192|7293450|FG003|STARTED|Overall Study||122
6382314|NCT00790192|7293447|FG000|COMPLETED|Overall Study||89
6382315|NCT00790192|7293448|FG001|COMPLETED|Overall Study||93
6382316|NCT00790192|7293449|FG002|COMPLETED|Overall Study||97
6382317|NCT00790192|7293450|FG003|COMPLETED|Overall Study||74
6382318|NCT00790192|7293447|FG000|NOT COMPLETED|Overall Study||36
6382319|NCT00790192|7293448|FG001|NOT COMPLETED|Overall Study||28
6382320|NCT00790192|7293449|FG002|NOT COMPLETED|Overall Study||23
6382321|NCT00790192|7293450|FG003|NOT COMPLETED|Overall Study||48
6382322|NCT00790205|7293462|FG000|STARTED|Overall Study||7332
6382323|NCT00790205|7293463|FG001|STARTED|Overall Study||7339
6382324|NCT00790205|7293462|FG000|Treated|Overall Study||7266
6382325|NCT00790205|7293463|FG001|Treated|Overall Study||7274
6382326|NCT00790205|7293462|FG000|COMPLETED|Overall Study||6972
6382327|NCT00790205|7293463|FG001|COMPLETED|Overall Study||6905
6382328|NCT00790205|7293462|FG000|NOT COMPLETED|Overall Study||360
6382329|NCT00790205|7293463|FG001|NOT COMPLETED|Overall Study||434
6382330|NCT00790218|7293469|FG000|STARTED|Overall Study||6
6382331|NCT00790218|7293470|FG001|STARTED|Overall Study||6
6382332|NCT00790218|7293471|FG002|STARTED|Overall Study||7
6382333|NCT00790218|7293469|FG000|COMPLETED|Overall Study||5
6382334|NCT00790218|7293470|FG001|COMPLETED|Overall Study||6
6382335|NCT00790218|7293471|FG002|COMPLETED|Overall Study||7
6382336|NCT00790218|7293469|FG000|NOT COMPLETED|Overall Study||1
6382337|NCT00790218|7293470|FG001|NOT COMPLETED|Overall Study||0
6382338|NCT00790218|7293471|FG002|NOT COMPLETED|Overall Study||0
6382339|NCT00790270|7293482|FG000|STARTED|Overall Study||21
6564560|NCT01811875|7487219|FG000|NOT COMPLETED|Overall Study||2
6564561|NCT01811940|7487225|FG000|STARTED|Overall Study||64
6564562|NCT01811940|7487226|FG001|STARTED|Overall Study||63
6564563|NCT01811940|7487225|FG000|COMPLETED|Overall Study||42
6564564|NCT01811940|7487226|FG001|COMPLETED|Overall Study||37
6564565|NCT01811940|7487225|FG000|NOT COMPLETED|Overall Study||22
6564566|NCT01811940|7487226|FG001|NOT COMPLETED|Overall Study||26
6564567|NCT01811953|7487238|FG000|STARTED|Overall Study||6
6564568|NCT01811953|7487239|FG001|STARTED|Overall Study||6
6564569|NCT01811953|7487240|FG002|STARTED|Overall Study||6
6382340|NCT00790270|7293483|FG001|STARTED|Overall Study||20
6502910|NCT01438060|7421686|FG001|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
6502911|NCT01438060|7421685|FG000|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
6502912|NCT01438060|7421686|FG001|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
6564570|NCT01811953|7487241|FG003|STARTED|Overall Study||6
6564571|NCT01811953|7487242|FG004|STARTED|Overall Study||12
6382341|NCT00790270|7293484|FG002|STARTED|Overall Study||20
6382342|NCT00790270|7293482|FG000|COMPLETED|Overall Study||21
6382343|NCT00790270|7293483|FG001|COMPLETED|Overall Study||20
6382344|NCT00790270|7293484|FG002|COMPLETED|Overall Study||20
6382345|NCT00790270|7293482|FG000|NOT COMPLETED|Overall Study||0
6382346|NCT00790270|7293483|FG001|NOT COMPLETED|Overall Study||0
6382347|NCT00790270|7293484|FG002|NOT COMPLETED|Overall Study||0
6382348|NCT00790296|7293494|FG000|STARTED|Overall Study||5
6382349|NCT00790296|7293495|FG001|STARTED|Overall Study||6
6382350|NCT00790296|7293494|FG000|COMPLETED|Overall Study||4
6382351|NCT00790296|7293495|FG001|COMPLETED|Overall Study||4
6382352|NCT00790296|7293494|FG000|NOT COMPLETED|Overall Study||1
6382353|NCT00790296|7293495|FG001|NOT COMPLETED|Overall Study||2
6382354|NCT00790335|7293503|FG000|STARTED|Overall Study||337
6382355|NCT00790335|7293504|FG001|STARTED|Overall Study||355
6382356|NCT00790335|7293503|FG000|COMPLETED|Overall Study||257
6382357|NCT00790335|7293504|FG001|COMPLETED|Overall Study||243
6382358|NCT00790335|7293503|FG000|NOT COMPLETED|Overall Study||80
6382359|NCT00790335|7293504|FG001|NOT COMPLETED|Overall Study||112
6382360|NCT00790400|7293512|FG000|STARTED|Double-blind Period (Core Phase)||79
6382361|NCT00790400|7293513|FG001|STARTED|Double-blind Period (Core Phase)||39
6382362|NCT00790400|7293512|FG000|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
6382363|NCT00790400|7293513|FG001|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
6382364|NCT00790400|7293512|FG000|NOT COMPLETED|Double-blind Period (Core Phase)||7
6382365|NCT00790400|7293513|FG001|NOT COMPLETED|Double-blind Period (Core Phase)||13
6382366|NCT00790400|7293512|FG000|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
6382367|NCT00790400|7293513|FG001|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
6382368|NCT00790400|7293512|FG000|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
6382369|NCT00790400|7293513|FG001|COMPLETED|Everolimus Period (Core or Extension)||0
6382370|NCT00790400|7293512|FG000|NOT COMPLETED|Everolimus Period (Core or Extension)||29
6382371|NCT00790400|7293513|FG001|NOT COMPLETED|Everolimus Period (Core or Extension)||0
6382372|NCT00790556|7293522|FG000|STARTED|Treatment Period 1||8
6382373|NCT00790556|7293523|FG001|STARTED|Treatment Period 1||6
6382374|NCT00790556|7293522|FG000|COMPLETED|Treatment Period 1||6
6382375|NCT00790556|7293523|FG001|COMPLETED|Treatment Period 1||6
6382376|NCT00790556|7293522|FG000|NOT COMPLETED|Treatment Period 1||2
6382377|NCT00790556|7293523|FG001|NOT COMPLETED|Treatment Period 1||0
6382378|NCT00790556|7293522|FG000|STARTED|Washout After Period 1||6
6382379|NCT00790556|7293523|FG001|STARTED|Washout After Period 1||6
6382380|NCT00790556|7293522|FG000|COMPLETED|Washout After Period 1||6
6382381|NCT00790556|7293523|FG001|COMPLETED|Washout After Period 1||6
6382382|NCT00790556|7293522|FG000|NOT COMPLETED|Washout After Period 1||0
6564572|NCT01811953|7487243|FG005|STARTED|Overall Study||12
6564573|NCT01811953|7487238|FG000|COMPLETED|Overall Study||6
6564574|NCT01811953|7487239|FG001|COMPLETED|Overall Study||6
6564575|NCT01811953|7487240|FG002|COMPLETED|Overall Study||6
6564576|NCT01811953|7487241|FG003|COMPLETED|Overall Study||5
6564577|NCT01811953|7487242|FG004|COMPLETED|Overall Study||11
6564578|NCT01811953|7487243|FG005|COMPLETED|Overall Study||11
6564579|NCT01811953|7487238|FG000|NOT COMPLETED|Overall Study||0
6564580|NCT01811953|7487239|FG001|NOT COMPLETED|Overall Study||0
6564581|NCT01811953|7487240|FG002|NOT COMPLETED|Overall Study||0
6564582|NCT01811953|7487241|FG003|NOT COMPLETED|Overall Study||1
6564583|NCT01811953|7487242|FG004|NOT COMPLETED|Overall Study||1
6269182|NCT00071981|7168323|FG001|STARTED|Overall Study||43
6269183|NCT00071981|7168324|FG002|STARTED|Overall Study||37
6269184|NCT00071981|7168325|FG003|STARTED|Overall Study||48
6269185|NCT00071981|7168322|FG000|Eligible|Overall Study||43
6269186|NCT00071981|7168323|FG001|Eligible|Overall Study||36
6269187|NCT00071981|7168324|FG002|Eligible|Overall Study||33
6269188|NCT00071981|7168325|FG003|Eligible|Overall Study||42
6269189|NCT00071981|7168322|FG000|Treated|Overall Study||45
6269190|NCT00071981|7168323|FG001|Treated|Overall Study||38
6269191|NCT00071981|7168324|FG002|Treated|Overall Study||36
6269192|NCT00071981|7168325|FG003|Treated|Overall Study||48
6269193|NCT00071981|7168322|FG000|Eligible and Treated|Overall Study||41
6269194|NCT00071981|7168323|FG001|Eligible and Treated|Overall Study||33
6269195|NCT00071981|7168324|FG002|Eligible and Treated|Overall Study||32
6269196|NCT00071981|7168325|FG003|Eligible and Treated|Overall Study||42
6269197|NCT00071981|7168322|FG000|Have CTL Response Data|Overall Study||40
6269198|NCT00071981|7168323|FG001|Have CTL Response Data|Overall Study||30
6269199|NCT00071981|7168324|FG002|Have CTL Response Data|Overall Study||29
6269200|NCT00071981|7168325|FG003|Have CTL Response Data|Overall Study||41
6269201|NCT00071981|7168322|FG000|Have Helper T Cell Response Data|Overall Study||37
6269202|NCT00071981|7168323|FG001|Have Helper T Cell Response Data|Overall Study||27
6269203|NCT00071981|7168324|FG002|Have Helper T Cell Response Data|Overall Study||25
6269204|NCT00071981|7168325|FG003|Have Helper T Cell Response Data|Overall Study||39
6269205|NCT00071981|7168322|FG000|COMPLETED|Overall Study||1
6269206|NCT00071981|7168323|FG001|COMPLETED|Overall Study||2
6269207|NCT00071981|7168324|FG002|COMPLETED|Overall Study||0
6269208|NCT00071981|7168325|FG003|COMPLETED|Overall Study||3
6269209|NCT00071981|7168322|FG000|NOT COMPLETED|Overall Study||46
6269210|NCT00071981|7168323|FG001|NOT COMPLETED|Overall Study||41
6269211|NCT00071981|7168324|FG002|NOT COMPLETED|Overall Study||37
6564584|NCT01811953|7487243|FG005|NOT COMPLETED|Overall Study||1
6656730|NCT02463799|7587035|FG000|NOT COMPLETED|Overall Study||0
6656731|NCT02463799|7587036|FG001|NOT COMPLETED|Overall Study||0
6269212|NCT00071981|7168325|FG003|NOT COMPLETED|Overall Study||45
6564585|NCT01812005|7487259|FG000|STARTED|Overall Study||1
6564586|NCT01812005|7487260|FG001|STARTED|Overall Study||13
6269213|NCT00072176|7168337|FG000|STARTED|Overall Study||34
6269214|NCT00072176|7168338|FG001|STARTED|Overall Study||28
6269215|NCT00072176|7168337|FG000|COMPLETED|Overall Study||33
6269216|NCT00072176|7168338|FG001|COMPLETED|Overall Study||27
6269217|NCT00072176|7168337|FG000|NOT COMPLETED|Overall Study||1
6269218|NCT00072176|7168338|FG001|NOT COMPLETED|Overall Study||1
6269219|NCT00072189|7168344|FG000|STARTED|Overall Study||17
6269220|NCT00072189|7168344|FG000|COMPLETED|Overall Study||16
6269221|NCT00072189|7168344|FG000|NOT COMPLETED|Overall Study||1
6269222|NCT00072280|7168350|FG000|STARTED|Treatment||3
6269223|NCT00072280|7168351|FG001|STARTED|Treatment||4
6269224|NCT00072280|7168350|FG000|COMPLETED|Treatment||2
6269225|NCT00072280|7168351|FG001|COMPLETED|Treatment||2
6269226|NCT00072280|7168350|FG000|NOT COMPLETED|Treatment||1
6269227|NCT00072280|7168351|FG001|NOT COMPLETED|Treatment||2
6269228|NCT00072280|7168350|FG000|STARTED|Follow-up||2
6269229|NCT00072280|7168351|FG001|STARTED|Follow-up||2
6269230|NCT00072280|7168350|FG000|COMPLETED|Follow-up||0
6269231|NCT00072280|7168351|FG001|COMPLETED|Follow-up||0
6269232|NCT00072280|7168350|FG000|NOT COMPLETED|Follow-up||2
6269233|NCT00072280|7168351|FG001|NOT COMPLETED|Follow-up||2
6269234|NCT00072293|7168358|FG000|STARTED|Overall Study||465
6269235|NCT00072293|7168359|FG001|STARTED|Overall Study||469
6269236|NCT00072293|7168358|FG000|COMPLETED|Overall Study||464
6269237|NCT00072293|7168359|FG001|COMPLETED|Overall Study||467
6269238|NCT00072293|7168358|FG000|NOT COMPLETED|Overall Study||1
6269239|NCT00072293|7168359|FG001|NOT COMPLETED|Overall Study||2
6269240|NCT00072384|7168365|FG000|STARTED|Overall Study||30
6269241|NCT00072384|7168365|FG000|COMPLETED|Overall Study||21
6269242|NCT00072384|7168365|FG000|NOT COMPLETED|Overall Study||9
6269243|NCT00072449|7168371|FG000|STARTED|Overall Study||12
6269244|NCT00072449|7168371|FG000|COMPLETED|Overall Study||12
6269245|NCT00072449|7168371|FG000|NOT COMPLETED|Overall Study||0
6269246|NCT00072475|7168375|FG000|STARTED|Overall Study||142
6269247|NCT00072475|7168375|FG000|COMPLETED|Overall Study||45
6269248|NCT00072475|7168375|FG000|NOT COMPLETED|Overall Study||97
6656732|NCT02464033|7587042|FG000|STARTED|Overall Study||20
6269249|NCT00072514|7168379|FG000|STARTED|Overall Study||55
6269250|NCT00072514|7168379|FG000|COMPLETED|Overall Study||51
6269251|NCT00072514|7168379|FG000|NOT COMPLETED|Overall Study||4
6382383|NCT00790556|7293523|FG001|NOT COMPLETED|Washout After Period 1||0
6382384|NCT00790556|7293522|FG000|STARTED|Treatment Period 2||6
6382385|NCT00790556|7293523|FG001|STARTED|Treatment Period 2||6
6382386|NCT00790556|7293522|FG000|COMPLETED|Treatment Period 2||6
6382387|NCT00790556|7293523|FG001|COMPLETED|Treatment Period 2||6
6382388|NCT00790556|7293522|FG000|NOT COMPLETED|Treatment Period 2||0
6382389|NCT00790556|7293523|FG001|NOT COMPLETED|Treatment Period 2||0
6382390|NCT00790569|7293532|FG000|STARTED|End of Treatment (6 Month Interview)||137
6382391|NCT00790569|7293533|FG001|STARTED|End of Treatment (6 Month Interview)||45
6382392|NCT00790569|7293534|FG002|STARTED|End of Treatment (6 Month Interview)||133
6382393|NCT00790569|7293532|FG000|COMPLETED|End of Treatment (6 Month Interview)||115
6382394|NCT00790569|7293533|FG001|COMPLETED|End of Treatment (6 Month Interview)||35
6382395|NCT00790569|7293534|FG002|COMPLETED|End of Treatment (6 Month Interview)||107
6382396|NCT00790569|7293532|FG000|NOT COMPLETED|End of Treatment (6 Month Interview)||22
6382397|NCT00790569|7293533|FG001|NOT COMPLETED|End of Treatment (6 Month Interview)||10
6382398|NCT00790569|7293534|FG002|NOT COMPLETED|End of Treatment (6 Month Interview)||26
6382399|NCT00790569|7293532|FG000|STARTED|End of Study (12 Month Interview)||137
6382400|NCT00790569|7293533|FG001|STARTED|End of Study (12 Month Interview)||45
6502913|NCT01438060|7421685|FG000|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
6502914|NCT01438060|7421686|FG001|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
6502915|NCT01438060|7421685|FG000|COMPLETED|Extension Phase: Week 10 to Week 130||22
6502916|NCT01438060|7421686|FG001|COMPLETED|Extension Phase: Week 10 to Week 130||25
6502917|NCT01438060|7421685|FG000|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
6502918|NCT01438060|7421686|FG001|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
6502919|NCT01438060|7421685|FG000|STARTED|On Study Beyond Week 140||0
6502920|NCT01438060|7421686|FG001|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
6502921|NCT01438060|7421685|FG000|COMPLETED|On Study Beyond Week 140||0
6502922|NCT01438060|7421686|FG001|COMPLETED|On Study Beyond Week 140||1
6382401|NCT00790569|7293534|FG002|STARTED|End of Study (12 Month Interview)||133
6382402|NCT00790569|7293532|FG000|COMPLETED|End of Study (12 Month Interview)||71
6382403|NCT00790569|7293533|FG001|COMPLETED|End of Study (12 Month Interview)||26
6382404|NCT00790569|7293534|FG002|COMPLETED|End of Study (12 Month Interview)||83
6382405|NCT00790569|7293532|FG000|NOT COMPLETED|End of Study (12 Month Interview)||66
6382406|NCT00790569|7293533|FG001|NOT COMPLETED|End of Study (12 Month Interview)||19
6382407|NCT00790569|7293534|FG002|NOT COMPLETED|End of Study (12 Month Interview)||50
6382408|NCT00790582|7293544|FG000|STARTED|Overall Study||109
6382409|NCT00790582|7293545|FG001|STARTED|Overall Study||249
6382410|NCT00790582|7293544|FG000|COMPLETED|Overall Study||78
6382411|NCT00790582|7293545|FG001|COMPLETED|Overall Study||162
6382412|NCT00790582|7293544|FG000|NOT COMPLETED|Overall Study||31
6382413|NCT00790582|7293545|FG001|NOT COMPLETED|Overall Study||87
6382414|NCT00790647|7293553|FG000|STARTED|Overall Study||10
6382415|NCT00790647|7293553|FG000|COMPLETED|Overall Study||9
6382416|NCT00790647|7293553|FG000|NOT COMPLETED|Overall Study||1
6382417|NCT00790673|7293563|FG000|STARTED|Overall Study||6
6382418|NCT00790673|7293564|FG001|STARTED|Overall Study||6
6382419|NCT00790673|7293565|FG002|STARTED|Overall Study||12
6382420|NCT00790673|7293566|FG003|STARTED|Overall Study||8
6382421|NCT00790673|7293563|FG000|COMPLETED|Overall Study||6
6382422|NCT00790673|7293564|FG001|COMPLETED|Overall Study||6
6564587|NCT01812005|7487259|FG000|COMPLETED|Overall Study||1
6564588|NCT01812005|7487260|FG001|COMPLETED|Overall Study||13
6564589|NCT01812005|7487259|FG000|NOT COMPLETED|Overall Study||0
6564590|NCT01812005|7487260|FG001|NOT COMPLETED|Overall Study||0
6564591|NCT01812044|7487269|FG000|STARTED|Overall Study||17
6564592|NCT01812044|7487270|FG001|STARTED|Overall Study||17
6382423|NCT00790673|7293565|FG002|COMPLETED|Overall Study||12
6382424|NCT00790673|7293566|FG003|COMPLETED|Overall Study||8
6382425|NCT00790673|7293563|FG000|NOT COMPLETED|Overall Study||0
6382426|NCT00790673|7293564|FG001|NOT COMPLETED|Overall Study||0
6382427|NCT00790673|7293565|FG002|NOT COMPLETED|Overall Study||0
6382428|NCT00790673|7293566|FG003|NOT COMPLETED|Overall Study||0
6382429|NCT00790699|7293578|FG000|STARTED|Overall Study||17
6382430|NCT00790699|7293579|FG001|STARTED|Overall Study||14
6382431|NCT00790699|7293578|FG000|COMPLETED|Overall Study||16
6382432|NCT00790699|7293579|FG001|COMPLETED|Overall Study||14
6382433|NCT00790699|7293578|FG000|NOT COMPLETED|Overall Study||1
6382434|NCT00790699|7293579|FG001|NOT COMPLETED|Overall Study||0
6382435|NCT00790738|7293589|FG000|STARTED|Overall Study||5
6564593|NCT01812044|7487271|FG002|STARTED|Overall Study||16
6564594|NCT01812044|7487269|FG000|COMPLETED|Overall Study||17
6564595|NCT01812044|7487270|FG001|COMPLETED|Overall Study||17
6564596|NCT01812044|7487271|FG002|COMPLETED|Overall Study||16
6656733|NCT02464033|7587042|FG000|COMPLETED|Overall Study||20
6803193|NCT03318523|7735216|FG006|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6382436|NCT00790738|7293590|FG001|STARTED|Overall Study||6
6382437|NCT00790738|7293589|FG000|COMPLETED|Overall Study||3
6382438|NCT00790738|7293590|FG001|COMPLETED|Overall Study||3
6382439|NCT00790738|7293589|FG000|NOT COMPLETED|Overall Study||2
6382440|NCT00790738|7293590|FG001|NOT COMPLETED|Overall Study||3
6382441|NCT00790751|7293600|FG000|STARTED|Overall Study||162
6382442|NCT00790751|7293601|FG001|STARTED|Overall Study||161
6382443|NCT00790751|7293602|FG002|STARTED|Overall Study||161
6382444|NCT00790751|7293603|FG003|STARTED|Overall Study||162
6382445|NCT00790751|7293600|FG000|COMPLETED|Overall Study||137
6382446|NCT00790751|7293601|FG001|COMPLETED|Overall Study||131
6382447|NCT00790751|7293602|FG002|COMPLETED|Overall Study||141
6382448|NCT00790751|7293603|FG003|COMPLETED|Overall Study||141
6382449|NCT00790751|7293600|FG000|NOT COMPLETED|Overall Study||25
6382450|NCT00790751|7293601|FG001|NOT COMPLETED|Overall Study||30
6382451|NCT00790751|7293602|FG002|NOT COMPLETED|Overall Study||20
6382452|NCT00790751|7293603|FG003|NOT COMPLETED|Overall Study||21
6382453|NCT00790790|7293616|FG000|STARTED|Study Period 2: Therapy Phase||49
6382454|NCT00790790|7293617|FG001|STARTED|Study Period 2: Therapy Phase||50
6382455|NCT00790790|7293618|FG002|STARTED|Study Period 2: Therapy Phase||48
6382456|NCT00790790|7293616|FG000|COMPLETED|Study Period 2: Therapy Phase||37
6382457|NCT00790790|7293617|FG001|COMPLETED|Study Period 2: Therapy Phase||32
6382458|NCT00790790|7293618|FG002|COMPLETED|Study Period 2: Therapy Phase||27
6382459|NCT00790790|7293616|FG000|NOT COMPLETED|Study Period 2: Therapy Phase||12
6382460|NCT00790790|7293617|FG001|NOT COMPLETED|Study Period 2: Therapy Phase||18
6382461|NCT00790790|7293618|FG002|NOT COMPLETED|Study Period 2: Therapy Phase||21
6382462|NCT00790790|7293616|FG000|STARTED|Study Period 3: 1-Week Washout Phase||37
6382463|NCT00790790|7293617|FG001|STARTED|Study Period 3: 1-Week Washout Phase||32
6382464|NCT00790790|7293618|FG002|STARTED|Study Period 3: 1-Week Washout Phase||27
6382465|NCT00790790|7293616|FG000|COMPLETED|Study Period 3: 1-Week Washout Phase||37
6382466|NCT00790790|7293617|FG001|COMPLETED|Study Period 3: 1-Week Washout Phase||31
6382467|NCT00790790|7293618|FG002|COMPLETED|Study Period 3: 1-Week Washout Phase||26
6382468|NCT00790790|7293616|FG000|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
6382469|NCT00790790|7293617|FG001|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
6803194|NCT03318523|7735217|FG007|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803195|NCT03318523|7735218|FG008|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803196|NCT03318523|7735219|FG009|COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803197|NCT03318523|7735210|FG000|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803198|NCT03318523|7735211|FG001|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803199|NCT03318523|7735212|FG002|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803200|NCT03318523|7735213|FG003|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||0
6803201|NCT03318523|7735214|FG004|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||20
6803202|NCT03318523|7735215|FG005|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||37
6803203|NCT03318523|7735216|FG006|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||39
6803204|NCT03318523|7735217|FG007|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||52
6803205|NCT03318523|7735218|FG008|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||100
6803206|NCT03318523|7735219|FG009|NOT COMPLETED|DBE Period:Year 2 to EOS (Up to 3 Years)||96
6803207|NCT03260894|7735245|FG000|STARTED|Overall Study||64
6803208|NCT03260894|7735246|FG001|STARTED|Overall Study||65
6803209|NCT03260894|7735245|FG000|Intention-to-Treat (ITT)|Overall Study||64
6803210|NCT03260894|7735246|FG001|Intention-to-Treat (ITT)|Overall Study||65
6803211|NCT03260894|7735245|FG000|All Subjects as Treated (ASaT)|Overall Study||64
6803212|NCT03260894|7735246|FG001|All Subjects as Treated (ASaT)|Overall Study||63
6803213|NCT03260894|7735245|FG000|COMPLETED|Overall Study||18
6803214|NCT03260894|7735246|FG001|COMPLETED|Overall Study||15
6803215|NCT03260894|7735245|FG000|NOT COMPLETED|Overall Study||46
6803216|NCT03260894|7735246|FG001|NOT COMPLETED|Overall Study||50
6803217|NCT03125902|7735254|FG000|STARTED|Overall Study||220
6803218|NCT03125902|7735255|FG001|STARTED|Overall Study||431
6803219|NCT03125902|7735254|FG000|COMPLETED|Overall Study||0
6803220|NCT03125902|7735255|FG001|COMPLETED|Overall Study||0
6803221|NCT03125902|7735254|FG000|NOT COMPLETED|Overall Study||220
6803222|NCT03125902|7735255|FG001|NOT COMPLETED|Overall Study||431
6502923|NCT01438060|7421685|FG000|NOT COMPLETED|On Study Beyond Week 140||0
6502924|NCT01438060|7421686|FG001|NOT COMPLETED|On Study Beyond Week 140||8
6502925|NCT01438151|7421697|FG000|STARTED|Overall Study||11
6502926|NCT01438151|7421697|FG000|COMPLETED|Overall Study||3
6502927|NCT01438151|7421697|FG000|NOT COMPLETED|Overall Study||8
6502928|NCT01438177|7421701|FG000|STARTED|Overall Study||11
6803223|NCT02906020|7735272|FG000|STARTED|Part 1: Dose Escalation Period||4
6803224|NCT02906020|7735273|FG001|STARTED|Part 1: Dose Escalation Period||4
6803225|NCT02906020|7735274|FG002|STARTED|Part 1: Dose Escalation Period||5
6803226|NCT02906020|7735275|FG003|STARTED|Part 1: Dose Escalation Period||4
6803227|NCT02906020|7735276|FG004|STARTED|Part 1: Dose Escalation Period||3
6803228|NCT02906020|7735277|FG005|STARTED|Part 1: Dose Escalation Period||3
6803229|NCT02906020|7735278|FG006|STARTED|Part 1: Dose Escalation Period||3
6803230|NCT02906020|7735279|FG007|STARTED|Part 1: Dose Escalation Period||3
6803231|NCT02906020|7735280|FG008|STARTED|Part 1: Dose Escalation Period||0
6803232|NCT02906020|7735281|FG009|STARTED|Part 1: Dose Escalation Period||0
6803233|NCT02906020|7735282|FG010|STARTED|Part 1: Dose Escalation Period||0
6803234|NCT02906020|7735283|FG011|STARTED|Part 1: Dose Escalation Period||0
6803235|NCT02906020|7735284|FG012|STARTED|Part 1: Dose Escalation Period||0
6803236|NCT02906020|7735285|FG013|STARTED|Part 1: Dose Escalation Period||0
6803237|NCT02906020|7735286|FG014|STARTED|Part 1: Dose Escalation Period||0
6803238|NCT02906020|7735287|FG015|STARTED|Part 1: Dose Escalation Period||0
6803239|NCT02906020|7735272|FG000|Treated|Part 1: Dose Escalation Period||4
6803240|NCT02906020|7735273|FG001|Treated|Part 1: Dose Escalation Period||4
6803241|NCT02906020|7735274|FG002|Treated|Part 1: Dose Escalation Period||5
6803242|NCT02906020|7735275|FG003|Treated|Part 1: Dose Escalation Period||4
6803243|NCT02906020|7735276|FG004|Treated|Part 1: Dose Escalation Period||3
6803244|NCT02906020|7735277|FG005|Treated|Part 1: Dose Escalation Period||3
6803245|NCT02906020|7735278|FG006|Treated|Part 1: Dose Escalation Period||3
6803246|NCT02906020|7735279|FG007|Treated|Part 1: Dose Escalation Period||3
6803247|NCT02906020|7735280|FG008|Treated|Part 1: Dose Escalation Period||0
6803248|NCT02906020|7735281|FG009|Treated|Part 1: Dose Escalation Period||0
6803249|NCT02906020|7735282|FG010|Treated|Part 1: Dose Escalation Period||0
6803250|NCT02906020|7735283|FG011|Treated|Part 1: Dose Escalation Period||0
6803251|NCT02906020|7735284|FG012|Treated|Part 1: Dose Escalation Period||0
6803252|NCT02906020|7735285|FG013|Treated|Part 1: Dose Escalation Period||0
6803253|NCT02906020|7735286|FG014|Treated|Part 1: Dose Escalation Period||0
6803254|NCT02906020|7735287|FG015|Treated|Part 1: Dose Escalation Period||0
6803255|NCT02906020|7735272|FG000|COMPLETED|Part 1: Dose Escalation Period||4
6803256|NCT02906020|7735273|FG001|COMPLETED|Part 1: Dose Escalation Period||3
6803257|NCT02906020|7735274|FG002|COMPLETED|Part 1: Dose Escalation Period||5
6803258|NCT02906020|7735275|FG003|COMPLETED|Part 1: Dose Escalation Period||3
6803259|NCT02906020|7735276|FG004|COMPLETED|Part 1: Dose Escalation Period||3
6803260|NCT02906020|7735277|FG005|COMPLETED|Part 1: Dose Escalation Period||3
6656734|NCT02464033|7587042|FG000|NOT COMPLETED|Overall Study||0
6656735|NCT02464059|7587047|FG000|STARTED|Overall Study||23
6382470|NCT00790790|7293618|FG002|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
6382471|NCT00790842|7293634|FG000|STARTED|Dose Level 1||6
6382472|NCT00790842|7293635|FG001|STARTED|Dose Level 1||0
6382473|NCT00790842|7293636|FG002|STARTED|Dose Level 1||0
6382474|NCT00790842|7293637|FG003|STARTED|Dose Level 1||3
6382475|NCT00790842|7293638|FG004|STARTED|Dose Level 1||0
6382476|NCT00790842|7293639|FG005|STARTED|Dose Level 1||0
6382477|NCT00790842|7293640|FG006|STARTED|Dose Level 1||0
6382478|NCT00790842|7293641|FG007|STARTED|Dose Level 1||3
6382479|NCT00790842|7293642|FG008|STARTED|Dose Level 1||0
6382480|NCT00790842|7293643|FG009|STARTED|Dose Level 1||0
6382481|NCT00790842|7293644|FG010|STARTED|Dose Level 1||0
6382482|NCT00790842|7293634|FG000|Began Treatment|Dose Level 1||6
6382483|NCT00790842|7293635|FG001|Began Treatment|Dose Level 1||0
6382484|NCT00790842|7293636|FG002|Began Treatment|Dose Level 1||0
6382485|NCT00790842|7293637|FG003|Began Treatment|Dose Level 1||3
6382486|NCT00790842|7293638|FG004|Began Treatment|Dose Level 1||0
6382487|NCT00790842|7293639|FG005|Began Treatment|Dose Level 1||0
6382488|NCT00790842|7293640|FG006|Began Treatment|Dose Level 1||0
6382489|NCT00790842|7293641|FG007|Began Treatment|Dose Level 1||3
6382490|NCT00790842|7293642|FG008|Began Treatment|Dose Level 1||0
6382491|NCT00790842|7293643|FG009|Began Treatment|Dose Level 1||0
6382492|NCT00790842|7293644|FG010|Began Treatment|Dose Level 1||0
6382493|NCT00790842|7293634|FG000|COMPLETED|Dose Level 1||3
6382494|NCT00790842|7293635|FG001|COMPLETED|Dose Level 1||0
6382495|NCT00790842|7293636|FG002|COMPLETED|Dose Level 1||0
6382496|NCT00790842|7293637|FG003|COMPLETED|Dose Level 1||1
6382497|NCT00790842|7293638|FG004|COMPLETED|Dose Level 1||0
6382498|NCT00790842|7293639|FG005|COMPLETED|Dose Level 1||0
6382499|NCT00790842|7293640|FG006|COMPLETED|Dose Level 1||0
6382500|NCT00790842|7293641|FG007|COMPLETED|Dose Level 1||1
6382501|NCT00790842|7293642|FG008|COMPLETED|Dose Level 1||0
6382502|NCT00790842|7293643|FG009|COMPLETED|Dose Level 1||0
6382503|NCT00790842|7293644|FG010|COMPLETED|Dose Level 1||0
6382504|NCT00790842|7293634|FG000|NOT COMPLETED|Dose Level 1||3
6382505|NCT00790842|7293635|FG001|NOT COMPLETED|Dose Level 1||0
6382506|NCT00790842|7293636|FG002|NOT COMPLETED|Dose Level 1||0
6382507|NCT00790842|7293637|FG003|NOT COMPLETED|Dose Level 1||2
6382508|NCT00790842|7293638|FG004|NOT COMPLETED|Dose Level 1||0
6382509|NCT00790842|7293639|FG005|NOT COMPLETED|Dose Level 1||0
6382510|NCT00790842|7293640|FG006|NOT COMPLETED|Dose Level 1||0
6382511|NCT00790842|7293641|FG007|NOT COMPLETED|Dose Level 1||2
6382512|NCT00790842|7293642|FG008|NOT COMPLETED|Dose Level 1||0
6382513|NCT00790842|7293643|FG009|NOT COMPLETED|Dose Level 1||0
6382514|NCT00790842|7293644|FG010|NOT COMPLETED|Dose Level 1||0
6382515|NCT00790842|7293634|FG000|STARTED|Dose Level 2||0
6382516|NCT00790842|7293635|FG001|STARTED|Dose Level 2||3
6382517|NCT00790842|7293636|FG002|STARTED|Dose Level 2||0
6382518|NCT00790842|7293637|FG003|STARTED|Dose Level 2||0
6382519|NCT00790842|7293638|FG004|STARTED|Dose Level 2||3
6382520|NCT00790842|7293639|FG005|STARTED|Dose Level 2||0
6382521|NCT00790842|7293640|FG006|STARTED|Dose Level 2||0
6382522|NCT00790842|7293641|FG007|STARTED|Dose Level 2||0
6382523|NCT00790842|7293642|FG008|STARTED|Dose Level 2||3
6382524|NCT00790842|7293643|FG009|STARTED|Dose Level 2||0
6382525|NCT00790842|7293644|FG010|STARTED|Dose Level 2||0
6382526|NCT00790842|7293634|FG000|Began Treatment|Dose Level 2||0
6382527|NCT00790842|7293635|FG001|Began Treatment|Dose Level 2||3
6382528|NCT00790842|7293636|FG002|Began Treatment|Dose Level 2||0
6382529|NCT00790842|7293637|FG003|Began Treatment|Dose Level 2||0
6382530|NCT00790842|7293638|FG004|Began Treatment|Dose Level 2||3
6382531|NCT00790842|7293639|FG005|Began Treatment|Dose Level 2||0
6382532|NCT00790842|7293640|FG006|Began Treatment|Dose Level 2||0
6382533|NCT00790842|7293641|FG007|Began Treatment|Dose Level 2||0
6382534|NCT00790842|7293642|FG008|Began Treatment|Dose Level 2||3
6382535|NCT00790842|7293643|FG009|Began Treatment|Dose Level 2||0
6382536|NCT00790842|7293644|FG010|Began Treatment|Dose Level 2||0
6382537|NCT00790842|7293634|FG000|COMPLETED|Dose Level 2||0
6382538|NCT00790842|7293635|FG001|COMPLETED|Dose Level 2||0
6382539|NCT00790842|7293636|FG002|COMPLETED|Dose Level 2||0
6382540|NCT00790842|7293637|FG003|COMPLETED|Dose Level 2||0
6382541|NCT00790842|7293638|FG004|COMPLETED|Dose Level 2||2
6382542|NCT00790842|7293639|FG005|COMPLETED|Dose Level 2||0
6382543|NCT00790842|7293640|FG006|COMPLETED|Dose Level 2||0
6382544|NCT00790842|7293641|FG007|COMPLETED|Dose Level 2||0
6382545|NCT00790842|7293642|FG008|COMPLETED|Dose Level 2||1
6382546|NCT00790842|7293643|FG009|COMPLETED|Dose Level 2||0
6382547|NCT00790842|7293644|FG010|COMPLETED|Dose Level 2||0
6382548|NCT00790842|7293634|FG000|NOT COMPLETED|Dose Level 2||0
6382549|NCT00790842|7293635|FG001|NOT COMPLETED|Dose Level 2||3
6382550|NCT00790842|7293636|FG002|NOT COMPLETED|Dose Level 2||0
6382551|NCT00790842|7293637|FG003|NOT COMPLETED|Dose Level 2||0
6382552|NCT00790842|7293638|FG004|NOT COMPLETED|Dose Level 2||1
6382553|NCT00790842|7293639|FG005|NOT COMPLETED|Dose Level 2||0
6382554|NCT00790842|7293640|FG006|NOT COMPLETED|Dose Level 2||0
6382555|NCT00790842|7293641|FG007|NOT COMPLETED|Dose Level 2||0
6564597|NCT01812044|7487269|FG000|NOT COMPLETED|Overall Study||0
6564598|NCT01812044|7487270|FG001|NOT COMPLETED|Overall Study||0
6382556|NCT00790842|7293642|FG008|NOT COMPLETED|Dose Level 2||2
6382557|NCT00790842|7293643|FG009|NOT COMPLETED|Dose Level 2||0
6382558|NCT00790842|7293644|FG010|NOT COMPLETED|Dose Level 2||0
6382559|NCT00790842|7293634|FG000|STARTED|Dose Level 3||0
6382560|NCT00790842|7293635|FG001|STARTED|Dose Level 3||0
6382561|NCT00790842|7293636|FG002|STARTED|Dose Level 3||7
6564599|NCT01812044|7487271|FG002|NOT COMPLETED|Overall Study||0
6269252|NCT00072566|7168383|FG000|STARTED|Overall Study||70
6269253|NCT00072566|7168383|FG000|COMPLETED|Overall Study||70
6269254|NCT00072566|7168383|FG000|NOT COMPLETED|Overall Study||0
6269255|NCT00072761|7168389|FG000|STARTED|Overall Study||99
6269256|NCT00072761|7168390|FG001|STARTED|Overall Study||97
6269257|NCT00072761|7168389|FG000|COMPLETED|Overall Study||90
6269258|NCT00072761|7168390|FG001|COMPLETED|Overall Study||95
6269259|NCT00072761|7168389|FG000|NOT COMPLETED|Overall Study||9
6269260|NCT00072761|7168390|FG001|NOT COMPLETED|Overall Study||2
6269261|NCT00073008|7168398|FG000|STARTED|Overall Study||65
6269262|NCT00073008|7168399|FG001|STARTED|Overall Study||66
6269263|NCT00073008|7168398|FG000|COMPLETED|Overall Study||3
6269264|NCT00073008|7168399|FG001|COMPLETED|Overall Study||3
6269265|NCT00073008|7168398|FG000|NOT COMPLETED|Overall Study||62
6269266|NCT00073008|7168399|FG001|NOT COMPLETED|Overall Study||63
6269267|NCT00073021|7168407|FG000|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
6269268|NCT00073021|7168408|FG001|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
6269269|NCT00073021|7168407|FG000|COMPLETED|Overall Study||113
6269270|NCT00073021|7168408|FG001|COMPLETED|Overall Study||113
6269271|NCT00073021|7168407|FG000|NOT COMPLETED|Overall Study||26
6269272|NCT00073021|7168408|FG001|NOT COMPLETED|Overall Study||16
6269273|NCT00073073|7168414|FG000|STARTED|Overall Study||46
6269274|NCT00073073|7168414|FG000|COMPLETED|Overall Study||42
6269275|NCT00073073|7168414|FG000|NOT COMPLETED|Overall Study||4
6269276|NCT00073307|7168420|FG000|STARTED|Double-Blind (DB, as of ~31May2005)||451
6269277|NCT00073307|7168421|FG001|STARTED|Double-Blind (DB, as of ~31May2005)||452
6269278|NCT00073307|7168422|FG002|STARTED|Double-Blind (DB, as of ~31May2005)||0
6269279|NCT00073307|7168420|FG000|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
6269280|NCT00073307|7168421|FG001|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
6269281|NCT00073307|7168422|FG002|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
6269282|NCT00073307|7168420|FG000|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
6269283|NCT00073307|7168421|FG001|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
6269284|NCT00073307|7168422|FG002|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
6269285|NCT00073307|7168420|FG000|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
6269286|NCT00073307|7168421|FG001|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
6269287|NCT00073307|7168422|FG002|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
6269288|NCT00073307|7168420|FG000|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
6269289|NCT00073307|7168421|FG001|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
6269290|NCT00073307|7168422|FG002|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
6269291|NCT00073307|7168420|FG000|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
6269292|NCT00073307|7168421|FG001|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
6269293|NCT00073307|7168422|FG002|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
6269294|NCT00073307|7168420|FG000|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
6269295|NCT00073307|7168421|FG001|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
6269296|NCT00073307|7168422|FG002|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
6269297|NCT00073307|7168420|FG000|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
6269298|NCT00073307|7168421|FG001|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
6269299|NCT00073307|7168422|FG002|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
6269300|NCT00073333|7168434|FG000|STARTED|Overall Study||46
6269301|NCT00073333|7168435|FG001|STARTED|Overall Study||41
6269302|NCT00073333|7168436|FG002|STARTED|Overall Study||19
6269303|NCT00073333|7168434|FG000|COMPLETED|Overall Study||32
6269304|NCT00073333|7168435|FG001|COMPLETED|Overall Study||27
6269305|NCT00073333|7168436|FG002|COMPLETED|Overall Study||19
6269306|NCT00073333|7168434|FG000|NOT COMPLETED|Overall Study||14
6382562|NCT00790842|7293637|FG003|STARTED|Dose Level 3||0
6382563|NCT00790842|7293638|FG004|STARTED|Dose Level 3||0
6269307|NCT00073333|7168435|FG001|NOT COMPLETED|Overall Study||14
6269308|NCT00073333|7168436|FG002|NOT COMPLETED|Overall Study||0
6269309|NCT00073528|7168446|FG000|STARTED|Overall Study||644
6269310|NCT00073528|7168447|FG001|STARTED|Overall Study||642
6269311|NCT00073528|7168446|FG000|COMPLETED|Overall Study||14
6269312|NCT00073528|7168447|FG001|COMPLETED|Overall Study||14
6269313|NCT00073528|7168446|FG000|NOT COMPLETED|Overall Study||630
6269314|NCT00073528|7168447|FG001|NOT COMPLETED|Overall Study||628
6269315|NCT00073749|7168460|FG000|STARTED|Overall Study||2
6269316|NCT00073749|7168461|FG001|STARTED|Overall Study||5
6269317|NCT00073749|7168462|FG002|STARTED|Overall Study||11
6269318|NCT00073749|7168463|FG003|STARTED|Overall Study||6
6269319|NCT00073749|7168464|FG004|STARTED|Overall Study||6
6564600|NCT01812057|7487281|FG000|STARTED|Overall Study||25
6564601|NCT01812057|7487282|FG001|STARTED|Overall Study||24
6564602|NCT01812057|7487281|FG000|COMPLETED|Overall Study||23
6382564|NCT00790842|7293639|FG005|STARTED|Dose Level 3||3
6564603|NCT01812057|7487282|FG001|COMPLETED|Overall Study||24
6803261|NCT02906020|7735278|FG006|COMPLETED|Part 1: Dose Escalation Period||3
6803262|NCT02906020|7735279|FG007|COMPLETED|Part 1: Dose Escalation Period||3
6803263|NCT02906020|7735280|FG008|COMPLETED|Part 1: Dose Escalation Period||0
6803264|NCT02906020|7735281|FG009|COMPLETED|Part 1: Dose Escalation Period||0
6803265|NCT02906020|7735282|FG010|COMPLETED|Part 1: Dose Escalation Period||0
6803266|NCT02906020|7735283|FG011|COMPLETED|Part 1: Dose Escalation Period||0
6803267|NCT02906020|7735284|FG012|COMPLETED|Part 1: Dose Escalation Period||0
6803268|NCT02906020|7735285|FG013|COMPLETED|Part 1: Dose Escalation Period||0
6803269|NCT02906020|7735286|FG014|COMPLETED|Part 1: Dose Escalation Period||0
6803270|NCT02906020|7735287|FG015|COMPLETED|Part 1: Dose Escalation Period||0
6803271|NCT02906020|7735272|FG000|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803272|NCT02906020|7735273|FG001|NOT COMPLETED|Part 1: Dose Escalation Period||1
6803273|NCT02906020|7735274|FG002|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803274|NCT02906020|7735275|FG003|NOT COMPLETED|Part 1: Dose Escalation Period||1
6803275|NCT02906020|7735276|FG004|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803276|NCT02906020|7735277|FG005|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803277|NCT02906020|7735278|FG006|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803278|NCT02906020|7735279|FG007|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803279|NCT02906020|7735280|FG008|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803280|NCT02906020|7735281|FG009|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803281|NCT02906020|7735282|FG010|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803282|NCT02906020|7735283|FG011|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803283|NCT02906020|7735284|FG012|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803284|NCT02906020|7735285|FG013|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803285|NCT02906020|7735286|FG014|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803286|NCT02906020|7735287|FG015|NOT COMPLETED|Part 1: Dose Escalation Period||0
6803287|NCT02906020|7735272|FG000|STARTED|Part 2: Double-blind Treatment Period||0
6803288|NCT02906020|7735273|FG001|STARTED|Part 2: Double-blind Treatment Period||0
6803289|NCT02906020|7735274|FG002|STARTED|Part 2: Double-blind Treatment Period||0
6803290|NCT02906020|7735275|FG003|STARTED|Part 2: Double-blind Treatment Period||0
6803291|NCT02906020|7735276|FG004|STARTED|Part 2: Double-blind Treatment Period||0
6564604|NCT01812057|7487281|FG000|NOT COMPLETED|Overall Study||2
6803292|NCT02906020|7735277|FG005|STARTED|Part 2: Double-blind Treatment Period||0
6803293|NCT02906020|7735278|FG006|STARTED|Part 2: Double-blind Treatment Period||0
6803294|NCT02906020|7735279|FG007|STARTED|Part 2: Double-blind Treatment Period||0
6803295|NCT02906020|7735280|FG008|STARTED|Part 2: Double-blind Treatment Period||111
6803296|NCT02906020|7735281|FG009|STARTED|Part 2: Double-blind Treatment Period||110
6803297|NCT02906020|7735282|FG010|STARTED|Part 2: Double-blind Treatment Period||10
6803298|NCT02906020|7735283|FG011|STARTED|Part 2: Double-blind Treatment Period||13
6803299|NCT02906020|7735284|FG012|STARTED|Part 2: Double-blind Treatment Period||0
6803300|NCT02906020|7735285|FG013|STARTED|Part 2: Double-blind Treatment Period||0
6564605|NCT01812057|7487282|FG001|NOT COMPLETED|Overall Study||0
6564606|NCT01812109|7487292|FG000|STARTED|Overall Study||154
6564607|NCT01812109|7487292|FG000|With Torsion|Overall Study||36
6803301|NCT02906020|7735286|FG014|STARTED|Part 2: Double-blind Treatment Period||0
6803302|NCT02906020|7735287|FG015|STARTED|Part 2: Double-blind Treatment Period||0
6803303|NCT02906020|7735272|FG000|Treated|Part 2: Double-blind Treatment Period||0
6564608|NCT01812109|7487292|FG000|Without Torsion|Overall Study||85
6803304|NCT02906020|7735273|FG001|Treated|Part 2: Double-blind Treatment Period||0
6803305|NCT02906020|7735274|FG002|Treated|Part 2: Double-blind Treatment Period||0
6803306|NCT02906020|7735275|FG003|Treated|Part 2: Double-blind Treatment Period||0
6803307|NCT02906020|7735276|FG004|Treated|Part 2: Double-blind Treatment Period||0
6803308|NCT02906020|7735277|FG005|Treated|Part 2: Double-blind Treatment Period||0
6803309|NCT02906020|7735278|FG006|Treated|Part 2: Double-blind Treatment Period||0
6803310|NCT02906020|7735279|FG007|Treated|Part 2: Double-blind Treatment Period||0
6803311|NCT02906020|7735280|FG008|Treated|Part 2: Double-blind Treatment Period||111
6803312|NCT02906020|7735281|FG009|Treated|Part 2: Double-blind Treatment Period||110
6803313|NCT02906020|7735282|FG010|Treated|Part 2: Double-blind Treatment Period||10
6382565|NCT00790842|7293640|FG006|STARTED|Dose Level 3||0
6382566|NCT00790842|7293641|FG007|STARTED|Dose Level 3||0
6382567|NCT00790842|7293642|FG008|STARTED|Dose Level 3||0
6382568|NCT00790842|7293643|FG009|STARTED|Dose Level 3||3
6382569|NCT00790842|7293644|FG010|STARTED|Dose Level 3||0
6382570|NCT00790842|7293634|FG000|Began Treatment|Dose Level 3||0
6382571|NCT00790842|7293635|FG001|Began Treatment|Dose Level 3||0
6382572|NCT00790842|7293636|FG002|Began Treatment|Dose Level 3||6
6382573|NCT00790842|7293637|FG003|Began Treatment|Dose Level 3||0
6564609|NCT01812109|7487292|FG000|COMPLETED|Overall Study||121
6564610|NCT01812109|7487292|FG000|NOT COMPLETED|Overall Study||33
6564611|NCT01812473|7487298|FG000|STARTED|Overall Study||22
6564612|NCT01812473|7487299|FG001|STARTED|Overall Study||13
6803314|NCT02906020|7735283|FG011|Treated|Part 2: Double-blind Treatment Period||13
6803315|NCT02906020|7735284|FG012|Treated|Part 2: Double-blind Treatment Period||0
6382574|NCT00790842|7293638|FG004|Began Treatment|Dose Level 3||0
6382575|NCT00790842|7293639|FG005|Began Treatment|Dose Level 3||3
6382576|NCT00790842|7293640|FG006|Began Treatment|Dose Level 3||0
6382577|NCT00790842|7293641|FG007|Began Treatment|Dose Level 3||0
6382578|NCT00790842|7293642|FG008|Began Treatment|Dose Level 3||0
6382579|NCT00790842|7293643|FG009|Began Treatment|Dose Level 3||3
6382580|NCT00790842|7293644|FG010|Began Treatment|Dose Level 3||0
6382581|NCT00790842|7293634|FG000|COMPLETED|Dose Level 3||0
6382582|NCT00790842|7293635|FG001|COMPLETED|Dose Level 3||0
6382583|NCT00790842|7293636|FG002|COMPLETED|Dose Level 3||2
6382584|NCT00790842|7293637|FG003|COMPLETED|Dose Level 3||0
6382585|NCT00790842|7293638|FG004|COMPLETED|Dose Level 3||0
6382586|NCT00790842|7293639|FG005|COMPLETED|Dose Level 3||2
6382587|NCT00790842|7293640|FG006|COMPLETED|Dose Level 3||0
6382588|NCT00790842|7293641|FG007|COMPLETED|Dose Level 3||0
6382589|NCT00790842|7293642|FG008|COMPLETED|Dose Level 3||0
6382590|NCT00790842|7293643|FG009|COMPLETED|Dose Level 3||1
6382591|NCT00790842|7293644|FG010|COMPLETED|Dose Level 3||0
6382592|NCT00790842|7293634|FG000|NOT COMPLETED|Dose Level 3||0
6382593|NCT00790842|7293635|FG001|NOT COMPLETED|Dose Level 3||0
6382594|NCT00790842|7293636|FG002|NOT COMPLETED|Dose Level 3||5
6803316|NCT02906020|7735285|FG013|Treated|Part 2: Double-blind Treatment Period||0
6382595|NCT00790842|7293637|FG003|NOT COMPLETED|Dose Level 3||0
6382596|NCT00790842|7293638|FG004|NOT COMPLETED|Dose Level 3||0
6382597|NCT00790842|7293639|FG005|NOT COMPLETED|Dose Level 3||1
6382598|NCT00790842|7293640|FG006|NOT COMPLETED|Dose Level 3||0
6382599|NCT00790842|7293641|FG007|NOT COMPLETED|Dose Level 3||0
6382600|NCT00790842|7293642|FG008|NOT COMPLETED|Dose Level 3||0
6382601|NCT00790842|7293643|FG009|NOT COMPLETED|Dose Level 3||2
6382602|NCT00790842|7293644|FG010|NOT COMPLETED|Dose Level 3||0
6382603|NCT00790842|7293634|FG000|STARTED|Dose Level 4||0
6382604|NCT00790842|7293635|FG001|STARTED|Dose Level 4||0
6382605|NCT00790842|7293636|FG002|STARTED|Dose Level 4||0
6382606|NCT00790842|7293637|FG003|STARTED|Dose Level 4||0
6382607|NCT00790842|7293638|FG004|STARTED|Dose Level 4||0
6382608|NCT00790842|7293639|FG005|STARTED|Dose Level 4||0
6382609|NCT00790842|7293640|FG006|STARTED|Dose Level 4||8
6382610|NCT00790842|7293641|FG007|STARTED|Dose Level 4||0
6382611|NCT00790842|7293642|FG008|STARTED|Dose Level 4||0
6564613|NCT01812473|7487298|FG000|COMPLETED|Overall Study||22
6564614|NCT01812473|7487299|FG001|COMPLETED|Overall Study||13
6803317|NCT02906020|7735286|FG014|Treated|Part 2: Double-blind Treatment Period||0
6803318|NCT02906020|7735287|FG015|Treated|Part 2: Double-blind Treatment Period||0
6803319|NCT02906020|7735272|FG000|COMPLETED|Part 2: Double-blind Treatment Period||0
6803320|NCT02906020|7735273|FG001|COMPLETED|Part 2: Double-blind Treatment Period||0
6803321|NCT02906020|7735274|FG002|COMPLETED|Part 2: Double-blind Treatment Period||0
6803322|NCT02906020|7735275|FG003|COMPLETED|Part 2: Double-blind Treatment Period||0
6803323|NCT02906020|7735276|FG004|COMPLETED|Part 2: Double-blind Treatment Period||0
6803324|NCT02906020|7735277|FG005|COMPLETED|Part 2: Double-blind Treatment Period||0
6803325|NCT02906020|7735278|FG006|COMPLETED|Part 2: Double-blind Treatment Period||0
6803326|NCT02906020|7735279|FG007|COMPLETED|Part 2: Double-blind Treatment Period||0
6803327|NCT02906020|7735280|FG008|COMPLETED|Part 2: Double-blind Treatment Period||99
6803328|NCT02906020|7735281|FG009|COMPLETED|Part 2: Double-blind Treatment Period||85
6803329|NCT02906020|7735282|FG010|COMPLETED|Part 2: Double-blind Treatment Period||10
6803330|NCT02906020|7735283|FG011|COMPLETED|Part 2: Double-blind Treatment Period||13
6803331|NCT02906020|7735284|FG012|COMPLETED|Part 2: Double-blind Treatment Period||0
6803332|NCT02906020|7735285|FG013|COMPLETED|Part 2: Double-blind Treatment Period||0
6803333|NCT02906020|7735286|FG014|COMPLETED|Part 2: Double-blind Treatment Period||0
6803334|NCT02906020|7735287|FG015|COMPLETED|Part 2: Double-blind Treatment Period||0
6803335|NCT02906020|7735272|FG000|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803336|NCT02906020|7735273|FG001|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6382612|NCT00790842|7293643|FG009|STARTED|Dose Level 4||0
6382613|NCT00790842|7293644|FG010|STARTED|Dose Level 4||5
6382614|NCT00790842|7293634|FG000|Began Treatment|Dose Level 4||0
6382615|NCT00790842|7293635|FG001|Began Treatment|Dose Level 4||0
6382616|NCT00790842|7293636|FG002|Began Treatment|Dose Level 4||0
6803337|NCT02906020|7735274|FG002|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803338|NCT02906020|7735275|FG003|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803339|NCT02906020|7735276|FG004|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803340|NCT02906020|7735277|FG005|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6502929|NCT01438177|7421701|FG000|COMPLETED|Overall Study|Patients who were off due to disease progression|9
6502930|NCT01438177|7421701|FG000|NOT COMPLETED|Overall Study||2
6564615|NCT01812473|7487298|FG000|NOT COMPLETED|Overall Study||0
6564616|NCT01812473|7487299|FG001|NOT COMPLETED|Overall Study||0
6564617|NCT01812655|7487308|FG000|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
6564618|NCT01812655|7487309|FG001|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
6564619|NCT01812655|7487310|FG002|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
6564620|NCT01812655|7487308|FG000|COMPLETED|Overall Study||8
6564621|NCT01812655|7487309|FG001|COMPLETED|Overall Study||10
6564622|NCT01812655|7487310|FG002|COMPLETED|Overall Study||10
6564623|NCT01812655|7487308|FG000|NOT COMPLETED|Overall Study||1
6564624|NCT01812655|7487309|FG001|NOT COMPLETED|Overall Study||1
6564625|NCT01812655|7487310|FG002|NOT COMPLETED|Overall Study||0
6564626|NCT01812668|7487321|FG000|STARTED|Overall Study||20
6564627|NCT01812668|7487321|FG000|COMPLETED|Overall Study||20
6564628|NCT01812668|7487321|FG000|NOT COMPLETED|Overall Study||0
6564629|NCT01812681|7487327|FG000|STARTED|Overall Study||60
6564630|NCT01812681|7487328|FG001|STARTED|Overall Study||24
6564631|NCT01812681|7487327|FG000|COMPLETED|Overall Study||57
6564632|NCT01812681|7487328|FG001|COMPLETED|Overall Study||24
6564633|NCT01812681|7487327|FG000|NOT COMPLETED|Overall Study||3
6564634|NCT01812681|7487328|FG001|NOT COMPLETED|Overall Study||0
6803341|NCT02906020|7735278|FG006|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803342|NCT02906020|7735279|FG007|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803343|NCT02906020|7735280|FG008|NOT COMPLETED|Part 2: Double-blind Treatment Period||12
6803344|NCT02906020|7735281|FG009|NOT COMPLETED|Part 2: Double-blind Treatment Period||25
6803345|NCT02906020|7735282|FG010|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803346|NCT02906020|7735283|FG011|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803347|NCT02906020|7735284|FG012|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803348|NCT02906020|7735285|FG013|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6382617|NCT00790842|7293637|FG003|Began Treatment|Dose Level 4||0
6502931|NCT01438229|7421705|FG000|STARTED|Overall Study||47
6502932|NCT01438229|7421705|FG000|Excluded Due to Renal Artery Anatomy|Overall Study||1
6502933|NCT01438229|7421705|FG000|Underwent Procedure|Overall Study||46
6502934|NCT01438229|7421705|FG000|COMPLETED|Overall Study||44
6502935|NCT01438229|7421705|FG000|NOT COMPLETED|Overall Study||3
6502936|NCT01438294|7421711|FG000|STARTED|Overall Study||16
6502937|NCT01438294|7421712|FG001|STARTED|Overall Study||20
6502938|NCT01438294|7421711|FG000|COMPLETED|Overall Study||13
6502939|NCT01438294|7421712|FG001|COMPLETED|Overall Study||13
6502940|NCT01438294|7421711|FG000|NOT COMPLETED|Overall Study||3
6502941|NCT01438294|7421712|FG001|NOT COMPLETED|Overall Study||7
6502942|NCT01438307|7421720|FG000|STARTED|Overall Study||14
6502943|NCT01438307|7421721|FG001|STARTED|Overall Study||14
6502944|NCT01438307|7421720|FG000|COMPLETED|Overall Study||13
6502945|NCT01438307|7421721|FG001|COMPLETED|Overall Study||13
6502946|NCT01438307|7421720|FG000|NOT COMPLETED|Overall Study||1
6502947|NCT01438307|7421721|FG001|NOT COMPLETED|Overall Study||1
6502948|NCT01438411|7421727|FG000|STARTED|Overall Study||53
6502949|NCT01438411|7421727|FG000|COMPLETED|Overall Study||40
6502950|NCT01438411|7421727|FG000|NOT COMPLETED|Overall Study||13
6502951|NCT01438424|7421731|FG000|STARTED|Overall Study|Received treatment|1051
6502952|NCT01438424|7421731|FG000|COMPLETED|Overall Study|Completed treatment|634
6502953|NCT01438424|7421731|FG000|NOT COMPLETED|Overall Study||417
6502954|NCT01438476|7421747|FG000|STARTED|Overall Study||116
6502955|NCT01438476|7421748|FG001|STARTED|Overall Study||45
6502956|NCT01438476|7421747|FG000|COMPLETED|Overall Study||106
6502957|NCT01438476|7421748|FG001|COMPLETED|Overall Study||34
6502958|NCT01438476|7421747|FG000|NOT COMPLETED|Overall Study||10
6502959|NCT01438476|7421748|FG001|NOT COMPLETED|Overall Study||11
6502960|NCT01438489|7421757|FG000|STARTED|Overall Study||103
6502961|NCT01438489|7421758|FG001|STARTED|Overall Study||100
6502962|NCT01438489|7421759|FG002|STARTED|Overall Study||104
6502963|NCT01438489|7421757|FG000|COMPLETED|Overall Study||77
6502964|NCT01438489|7421758|FG001|COMPLETED|Overall Study||84
6502965|NCT01438489|7421759|FG002|COMPLETED|Overall Study||85
6502966|NCT01438489|7421757|FG000|NOT COMPLETED|Overall Study||26
6502967|NCT01438489|7421758|FG001|NOT COMPLETED|Overall Study||16
6502968|NCT01438489|7421759|FG002|NOT COMPLETED|Overall Study||19
6502969|NCT01438541|7421769|FG000|STARTED|Overall Study||29
6502970|NCT01438541|7421769|FG000|COMPLETED|Overall Study||22
6502971|NCT01438541|7421769|FG000|NOT COMPLETED|Overall Study||7
6502972|NCT01438710|7421773|FG000|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
6502973|NCT01438710|7421774|FG001|STARTED|First Week of Treatment||44
6502974|NCT01438710|7421773|FG000|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
6502975|NCT01438710|7421774|FG001|COMPLETED|First Week of Treatment||41
6502976|NCT01438710|7421773|FG000|NOT COMPLETED|First Week of Treatment||0
6502977|NCT01438710|7421774|FG001|NOT COMPLETED|First Week of Treatment||3
6502978|NCT01438710|7421773|FG000|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
6502979|NCT01438710|7421774|FG001|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
6502980|NCT01438710|7421773|FG000|COMPLETED|Second Week of Treatment||40
6502981|NCT01438710|7421774|FG001|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
6502982|NCT01438710|7421773|FG000|NOT COMPLETED|Second Week of Treatment||1
6502983|NCT01438710|7421774|FG001|NOT COMPLETED|Second Week of Treatment||0
6502984|NCT01438814|7421781|FG000|STARTED|Overall Study||344
6502985|NCT01438814|7421782|FG001|STARTED|Overall Study||345
6502986|NCT01438814|7421781|FG000|COMPLETED|Overall Study||330
6502987|NCT01438814|7421782|FG001|COMPLETED|Overall Study||331
6502988|NCT01438814|7421781|FG000|NOT COMPLETED|Overall Study||14
6502989|NCT01438814|7421782|FG001|NOT COMPLETED|Overall Study||14
6502990|NCT01438840|7421790|FG000|STARTED|Core Study||17
6502991|NCT01438840|7421791|FG001|STARTED|Core Study||32
6502992|NCT01438840|7421792|FG002|STARTED|Core Study||0
6502993|NCT01438840|7421790|FG000|COMPLETED|Core Study||1
6502994|NCT01438840|7421791|FG001|COMPLETED|Core Study||22
6502995|NCT01438840|7421792|FG002|COMPLETED|Core Study||0
6502996|NCT01438840|7421790|FG000|NOT COMPLETED|Core Study||16
6502997|NCT01438840|7421791|FG001|NOT COMPLETED|Core Study||10
6502998|NCT01438840|7421792|FG002|NOT COMPLETED|Core Study||0
6502999|NCT01438840|7421790|FG000|STARTED|Extension Phase||0
6503000|NCT01438840|7421791|FG001|STARTED|Extension Phase||0
6503001|NCT01438840|7421792|FG002|STARTED|Extension Phase|39 participants met eligibility criteria for the Extension Phase.|39
6503002|NCT01438840|7421790|FG000|COMPLETED|Extension Phase||0
6503003|NCT01438840|7421791|FG001|COMPLETED|Extension Phase||0
6503004|NCT01438840|7421792|FG002|COMPLETED|Extension Phase||29
6564635|NCT01812707|7487338|FG000|STARTED|Overall Study||25
6382618|NCT00790842|7293638|FG004|Began Treatment|Dose Level 4||0
6382619|NCT00790842|7293639|FG005|Began Treatment|Dose Level 4||0
6382620|NCT00790842|7293640|FG006|Began Treatment|Dose Level 4||8
6382621|NCT00790842|7293641|FG007|Began Treatment|Dose Level 4||0
6382622|NCT00790842|7293642|FG008|Began Treatment|Dose Level 4||0
6382623|NCT00790842|7293643|FG009|Began Treatment|Dose Level 4||0
6382624|NCT00790842|7293644|FG010|Began Treatment|Dose Level 4||5
6382625|NCT00790842|7293634|FG000|COMPLETED|Dose Level 4||0
6382626|NCT00790842|7293635|FG001|COMPLETED|Dose Level 4||0
6382627|NCT00790842|7293636|FG002|COMPLETED|Dose Level 4||0
6382628|NCT00790842|7293637|FG003|COMPLETED|Dose Level 4||0
6382629|NCT00790842|7293638|FG004|COMPLETED|Dose Level 4||0
6382630|NCT00790842|7293639|FG005|COMPLETED|Dose Level 4||0
6382631|NCT00790842|7293640|FG006|COMPLETED|Dose Level 4||6
6382632|NCT00790842|7293641|FG007|COMPLETED|Dose Level 4||0
6382633|NCT00790842|7293642|FG008|COMPLETED|Dose Level 4||0
6382634|NCT00790842|7293643|FG009|COMPLETED|Dose Level 4||0
6382635|NCT00790842|7293644|FG010|COMPLETED|Dose Level 4||3
6382636|NCT00790842|7293634|FG000|NOT COMPLETED|Dose Level 4||0
6382637|NCT00790842|7293635|FG001|NOT COMPLETED|Dose Level 4||0
6382638|NCT00790842|7293636|FG002|NOT COMPLETED|Dose Level 4||0
6382639|NCT00790842|7293637|FG003|NOT COMPLETED|Dose Level 4||0
6382640|NCT00790842|7293638|FG004|NOT COMPLETED|Dose Level 4||0
6382641|NCT00790842|7293639|FG005|NOT COMPLETED|Dose Level 4||0
6382642|NCT00790842|7293640|FG006|NOT COMPLETED|Dose Level 4||2
6382643|NCT00790842|7293641|FG007|NOT COMPLETED|Dose Level 4||0
6382644|NCT00790842|7293642|FG008|NOT COMPLETED|Dose Level 4||0
6382645|NCT00790842|7293643|FG009|NOT COMPLETED|Dose Level 4||0
6382646|NCT00790842|7293644|FG010|NOT COMPLETED|Dose Level 4||2
6382647|NCT00790842|7293634|FG000|STARTED|Expansion Cohort||0
6382648|NCT00790842|7293635|FG001|STARTED|Expansion Cohort||0
6382649|NCT00790842|7293636|FG002|STARTED|Expansion Cohort||14
6382650|NCT00790842|7293637|FG003|STARTED|Expansion Cohort||0
6382651|NCT00790842|7293638|FG004|STARTED|Expansion Cohort||0
6382652|NCT00790842|7293639|FG005|STARTED|Expansion Cohort||0
6382653|NCT00790842|7293640|FG006|STARTED|Expansion Cohort||2
6382654|NCT00790842|7293641|FG007|STARTED|Expansion Cohort||0
6382655|NCT00790842|7293642|FG008|STARTED|Expansion Cohort||0
6382656|NCT00790842|7293643|FG009|STARTED|Expansion Cohort||0
6382657|NCT00790842|7293644|FG010|STARTED|Expansion Cohort||0
6382658|NCT00790842|7293634|FG000|Began Treatment|Expansion Cohort||0
6382659|NCT00790842|7293635|FG001|Began Treatment|Expansion Cohort||0
6564636|NCT01812707|7487339|FG001|STARTED|Overall Study||25
6564637|NCT01812707|7487340|FG002|STARTED|Overall Study||25
6564638|NCT01812707|7487341|FG003|STARTED|Overall Study||25
6564639|NCT01812707|7487338|FG000|Treated|Overall Study||25
6564640|NCT01812707|7487339|FG001|Treated|Overall Study||25
6382660|NCT00790842|7293636|FG002|Began Treatment|Expansion Cohort||14
6382661|NCT00790842|7293637|FG003|Began Treatment|Expansion Cohort||0
6564641|NCT01812707|7487340|FG002|Treated|Overall Study||25
6382662|NCT00790842|7293638|FG004|Began Treatment|Expansion Cohort||0
6382663|NCT00790842|7293639|FG005|Began Treatment|Expansion Cohort||0
6564642|NCT01812707|7487341|FG003|Treated|Overall Study||25
6382664|NCT00790842|7293640|FG006|Began Treatment|Expansion Cohort||2
6382665|NCT00790842|7293641|FG007|Began Treatment|Expansion Cohort||0
6382666|NCT00790842|7293642|FG008|Began Treatment|Expansion Cohort||0
6503005|NCT01438840|7421790|FG000|NOT COMPLETED|Extension Phase||0
6503006|NCT01438840|7421791|FG001|NOT COMPLETED|Extension Phase||0
6503007|NCT01438840|7421792|FG002|NOT COMPLETED|Extension Phase||10
6503008|NCT01438957|7421804|FG000|STARTED|Overall Study||22
6503009|NCT01438957|7421805|FG001|STARTED|Overall Study||23
6503010|NCT01438957|7421806|FG002|STARTED|Overall Study||24
6503011|NCT01438957|7421807|FG003|STARTED|Overall Study||25
6503012|NCT01438957|7421808|FG004|STARTED|Overall Study||25
6503013|NCT01438957|7421804|FG000|COMPLETED|Overall Study||21
6503014|NCT01438957|7421805|FG001|COMPLETED|Overall Study||22
6503015|NCT01438957|7421806|FG002|COMPLETED|Overall Study||24
6503016|NCT01438957|7421807|FG003|COMPLETED|Overall Study||24
6503017|NCT01438957|7421808|FG004|COMPLETED|Overall Study||25
6503018|NCT01438957|7421804|FG000|NOT COMPLETED|Overall Study||1
6382667|NCT00790842|7293643|FG009|Began Treatment|Expansion Cohort||0
6503019|NCT01438957|7421805|FG001|NOT COMPLETED|Overall Study||1
6564643|NCT01812707|7487338|FG000|COMPLETED|Overall Study||23
6564644|NCT01812707|7487339|FG001|COMPLETED|Overall Study||25
6564645|NCT01812707|7487340|FG002|COMPLETED|Overall Study||25
6564646|NCT01812707|7487341|FG003|COMPLETED|Overall Study||23
6564647|NCT01812707|7487338|FG000|NOT COMPLETED|Overall Study||2
6564648|NCT01812707|7487339|FG001|NOT COMPLETED|Overall Study||0
6564649|NCT01812707|7487340|FG002|NOT COMPLETED|Overall Study||0
6564650|NCT01812707|7487341|FG003|NOT COMPLETED|Overall Study||2
6803349|NCT02906020|7735286|FG014|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803350|NCT02906020|7735287|FG015|NOT COMPLETED|Part 2: Double-blind Treatment Period||0
6803351|NCT02906020|7735272|FG000|STARTED|Part 2: Long-term Follow-up Period||0
6803352|NCT02906020|7735273|FG001|STARTED|Part 2: Long-term Follow-up Period||0
6564651|NCT01812759|7487355|FG000|STARTED|Overall Study||1
6564652|NCT01812759|7487356|FG001|STARTED|Overall Study||1
6803353|NCT02906020|7735274|FG002|STARTED|Part 2: Long-term Follow-up Period||0
6803354|NCT02906020|7735275|FG003|STARTED|Part 2: Long-term Follow-up Period||0
6803355|NCT02906020|7735276|FG004|STARTED|Part 2: Long-term Follow-up Period||0
6803356|NCT02906020|7735277|FG005|STARTED|Part 2: Long-term Follow-up Period||0
6803357|NCT02906020|7735278|FG006|STARTED|Part 2: Long-term Follow-up Period||0
6803358|NCT02906020|7735279|FG007|STARTED|Part 2: Long-term Follow-up Period||0
6803359|NCT02906020|7735280|FG008|STARTED|Part 2: Long-term Follow-up Period||0
6803360|NCT02906020|7735281|FG009|STARTED|Part 2: Long-term Follow-up Period||0
6564653|NCT01812759|7487357|FG002|STARTED|Overall Study||1
6803361|NCT02906020|7735282|FG010|STARTED|Part 2: Long-term Follow-up Period||0
6803362|NCT02906020|7735283|FG011|STARTED|Part 2: Long-term Follow-up Period||0
6803363|NCT02906020|7735284|FG012|STARTED|Part 2: Long-term Follow-up Period||99
6803364|NCT02906020|7735285|FG013|STARTED|Part 2: Long-term Follow-up Period||85
6803365|NCT02906020|7735286|FG014|STARTED|Part 2: Long-term Follow-up Period||10
6803366|NCT02906020|7735287|FG015|STARTED|Part 2: Long-term Follow-up Period|Out of 13 completed participants in the previous part 2 DB period-arm, 2 didn't enter LTFU period.|11
6803367|NCT02906020|7735272|FG000|Treated|Part 2: Long-term Follow-up Period||0
6803368|NCT02906020|7735273|FG001|Treated|Part 2: Long-term Follow-up Period||0
6803369|NCT02906020|7735274|FG002|Treated|Part 2: Long-term Follow-up Period||0
6803370|NCT02906020|7735275|FG003|Treated|Part 2: Long-term Follow-up Period||0
6803371|NCT02906020|7735276|FG004|Treated|Part 2: Long-term Follow-up Period||0
6803372|NCT02906020|7735277|FG005|Treated|Part 2: Long-term Follow-up Period||0
6803373|NCT02906020|7735278|FG006|Treated|Part 2: Long-term Follow-up Period||0
6803374|NCT02906020|7735279|FG007|Treated|Part 2: Long-term Follow-up Period||0
6803375|NCT02906020|7735280|FG008|Treated|Part 2: Long-term Follow-up Period||0
6803376|NCT02906020|7735281|FG009|Treated|Part 2: Long-term Follow-up Period||0
6803377|NCT02906020|7735282|FG010|Treated|Part 2: Long-term Follow-up Period||0
6803378|NCT02906020|7735283|FG011|Treated|Part 2: Long-term Follow-up Period||0
6803379|NCT02906020|7735284|FG012|Treated|Part 2: Long-term Follow-up Period||87
6803380|NCT02906020|7735285|FG013|Treated|Part 2: Long-term Follow-up Period||75
6656736|NCT02464059|7587047|FG000|COMPLETED|Overall Study||17
6656737|NCT02464059|7587047|FG000|NOT COMPLETED|Overall Study||6
6656738|NCT02464163|7587055|FG000|STARTED|Overall Study||102
6656739|NCT02464163|7587056|FG001|STARTED|Overall Study||102
6656740|NCT02464163|7587057|FG002|STARTED|Overall Study||102
6656741|NCT02464163|7587058|FG003|STARTED|Overall Study||101
6382668|NCT00790842|7293644|FG010|Began Treatment|Expansion Cohort||0
6382669|NCT00790842|7293634|FG000|COMPLETED|Expansion Cohort||0
6382670|NCT00790842|7293635|FG001|COMPLETED|Expansion Cohort||0
6382671|NCT00790842|7293636|FG002|COMPLETED|Expansion Cohort||7
6382672|NCT00790842|7293637|FG003|COMPLETED|Expansion Cohort||0
6382673|NCT00790842|7293638|FG004|COMPLETED|Expansion Cohort||0
6382674|NCT00790842|7293639|FG005|COMPLETED|Expansion Cohort||0
6382675|NCT00790842|7293640|FG006|COMPLETED|Expansion Cohort||1
6382676|NCT00790842|7293641|FG007|COMPLETED|Expansion Cohort||0
6382677|NCT00790842|7293642|FG008|COMPLETED|Expansion Cohort||0
6382678|NCT00790842|7293643|FG009|COMPLETED|Expansion Cohort||0
6382679|NCT00790842|7293644|FG010|COMPLETED|Expansion Cohort||0
6382680|NCT00790842|7293634|FG000|NOT COMPLETED|Expansion Cohort||0
6382681|NCT00790842|7293635|FG001|NOT COMPLETED|Expansion Cohort||0
6382682|NCT00790842|7293636|FG002|NOT COMPLETED|Expansion Cohort||7
6382683|NCT00790842|7293637|FG003|NOT COMPLETED|Expansion Cohort||0
6382684|NCT00790842|7293638|FG004|NOT COMPLETED|Expansion Cohort||0
6382685|NCT00790842|7293639|FG005|NOT COMPLETED|Expansion Cohort||0
6382686|NCT00790842|7293640|FG006|NOT COMPLETED|Expansion Cohort||1
6382687|NCT00790842|7293641|FG007|NOT COMPLETED|Expansion Cohort||0
6382688|NCT00790842|7293642|FG008|NOT COMPLETED|Expansion Cohort||0
6382689|NCT00790842|7293643|FG009|NOT COMPLETED|Expansion Cohort||0
6382690|NCT00790842|7293644|FG010|NOT COMPLETED|Expansion Cohort||0
6382691|NCT00790855|7293692|FG000|STARTED|Overall Study||25
6382692|NCT00790855|7293692|FG000|COMPLETED|Overall Study||25
6382693|NCT00790855|7293692|FG000|NOT COMPLETED|Overall Study||0
6382694|NCT00790868|7293699|FG000|STARTED|Overall Study||88
6382695|NCT00790868|7293700|FG001|STARTED|Overall Study||92
6564654|NCT01812759|7487355|FG000|COMPLETED|Overall Study||1
6564655|NCT01812759|7487356|FG001|COMPLETED|Overall Study||1
6564656|NCT01812759|7487357|FG002|COMPLETED|Overall Study||0
6564657|NCT01812759|7487355|FG000|NOT COMPLETED|Overall Study||0
6564658|NCT01812759|7487356|FG001|NOT COMPLETED|Overall Study||0
6564659|NCT01812759|7487357|FG002|NOT COMPLETED|Overall Study||1
6564660|NCT01812837|7487368|FG000|STARTED|Overall Study||17
6564661|NCT01812837|7487369|FG001|STARTED|Overall Study||17
6564662|NCT01812837|7487370|FG002|STARTED|Overall Study||17
6382696|NCT00790868|7293699|FG000|COMPLETED|Overall Study||82
6382697|NCT00790868|7293700|FG001|COMPLETED|Overall Study||75
6382698|NCT00790868|7293699|FG000|NOT COMPLETED|Overall Study||6
6382699|NCT00790868|7293700|FG001|NOT COMPLETED|Overall Study||17
6382700|NCT00790907|7293711|FG000|STARTED|Overall Study||1209
6382701|NCT00790907|7293712|FG001|STARTED|Overall Study||1024
6382702|NCT00790907|7293713|FG002|STARTED|Overall Study||1002
6382703|NCT00790907|7293711|FG000|COMPLETED|Overall Study||754
6564663|NCT01812837|7487368|FG000|COMPLETED|Overall Study||15
6803381|NCT02906020|7735286|FG014|Treated|Part 2: Long-term Follow-up Period||10
6803382|NCT02906020|7735287|FG015|Treated|Part 2: Long-term Follow-up Period||11
6803383|NCT02906020|7735272|FG000|COMPLETED|Part 2: Long-term Follow-up Period||0
6803384|NCT02906020|7735273|FG001|COMPLETED|Part 2: Long-term Follow-up Period||0
6803385|NCT02906020|7735274|FG002|COMPLETED|Part 2: Long-term Follow-up Period||0
6803386|NCT02906020|7735275|FG003|COMPLETED|Part 2: Long-term Follow-up Period||0
6803387|NCT02906020|7735276|FG004|COMPLETED|Part 2: Long-term Follow-up Period||0
6803388|NCT02906020|7735277|FG005|COMPLETED|Part 2: Long-term Follow-up Period||0
6803389|NCT02906020|7735278|FG006|COMPLETED|Part 2: Long-term Follow-up Period||0
6803390|NCT02906020|7735279|FG007|COMPLETED|Part 2: Long-term Follow-up Period||0
6803391|NCT02906020|7735280|FG008|COMPLETED|Part 2: Long-term Follow-up Period||0
6803392|NCT02906020|7735281|FG009|COMPLETED|Part 2: Long-term Follow-up Period||0
6803393|NCT02906020|7735282|FG010|COMPLETED|Part 2: Long-term Follow-up Period||0
6803394|NCT02906020|7735283|FG011|COMPLETED|Part 2: Long-term Follow-up Period||0
6803395|NCT02906020|7735284|FG012|COMPLETED|Part 2: Long-term Follow-up Period||0
6803396|NCT02906020|7735285|FG013|COMPLETED|Part 2: Long-term Follow-up Period||0
6803397|NCT02906020|7735286|FG014|COMPLETED|Part 2: Long-term Follow-up Period||0
6803398|NCT02906020|7735287|FG015|COMPLETED|Part 2: Long-term Follow-up Period||0
6803399|NCT02906020|7735272|FG000|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803400|NCT02906020|7735273|FG001|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803401|NCT02906020|7735274|FG002|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803402|NCT02906020|7735275|FG003|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803403|NCT02906020|7735276|FG004|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803404|NCT02906020|7735277|FG005|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803405|NCT02906020|7735278|FG006|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803406|NCT02906020|7735279|FG007|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803407|NCT02906020|7735280|FG008|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803408|NCT02906020|7735281|FG009|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6382704|NCT00790907|7293712|FG001|COMPLETED|Overall Study||684
6382705|NCT00790907|7293713|FG002|COMPLETED|Overall Study||663
6803409|NCT02906020|7735282|FG010|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803410|NCT02906020|7735283|FG011|NOT COMPLETED|Part 2: Long-term Follow-up Period||0
6803411|NCT02906020|7735284|FG012|NOT COMPLETED|Part 2: Long-term Follow-up Period||99
6803412|NCT02906020|7735285|FG013|NOT COMPLETED|Part 2: Long-term Follow-up Period||85
6656742|NCT02464163|7587055|FG000|COMPLETED|Overall Study||99
6803413|NCT02906020|7735286|FG014|NOT COMPLETED|Part 2: Long-term Follow-up Period||10
6803414|NCT02906020|7735287|FG015|NOT COMPLETED|Part 2: Long-term Follow-up Period||11
6803415|NCT02899299|7735317|FG000|STARTED|Pre-treatment||303
6803416|NCT02899299|7735318|FG001|STARTED|Pre-treatment||302
6803417|NCT02899299|7735317|FG000|COMPLETED|Pre-treatment||300
6803418|NCT02899299|7735318|FG001|COMPLETED|Pre-treatment||284
6803419|NCT02899299|7735317|FG000|NOT COMPLETED|Pre-treatment||3
6803420|NCT02899299|7735318|FG001|NOT COMPLETED|Pre-treatment||18
6803421|NCT02899299|7735317|FG000|STARTED|Treatment||300
6803422|NCT02899299|7735318|FG001|STARTED|Treatment||284
6803423|NCT02899299|7735317|FG000|COMPLETED|Treatment||5
6803424|NCT02899299|7735318|FG001|COMPLETED|Treatment||0
6803425|NCT02899299|7735317|FG000|NOT COMPLETED|Treatment||295
6803426|NCT02899299|7735318|FG001|NOT COMPLETED|Treatment||284
6803427|NCT02891226|7735328|FG000|STARTED|Period 1 (Weeks 0 to 12)||64
6803428|NCT02891226|7735329|FG001|STARTED|Period 1 (Weeks 0 to 12)||31
6803429|NCT02891226|7735330|FG002|STARTED|Period 1 (Weeks 0 to 12)||32
6803430|NCT02891226|7735331|FG003|STARTED|Period 1 (Weeks 0 to 12)||64
6803431|NCT02891226|7735332|FG004|STARTED|Period 1 (Weeks 0 to 12)||0
6803432|NCT02891226|7735333|FG005|STARTED|Period 1 (Weeks 0 to 12)||0
6803433|NCT02891226|7735334|FG006|STARTED|Period 1 (Weeks 0 to 12)||0
6803434|NCT02891226|7735335|FG007|STARTED|Period 1 (Weeks 0 to 12)||0
6803435|NCT02891226|7735336|FG008|STARTED|Period 1 (Weeks 0 to 12)||0
6803436|NCT02891226|7735337|FG009|STARTED|Period 1 (Weeks 0 to 12)||0
6803437|NCT02891226|7735338|FG010|STARTED|Period 1 (Weeks 0 to 12)||0
6803438|NCT02891226|7735339|FG011|STARTED|Period 1 (Weeks 0 to 12)||0
6803439|NCT02891226|7735340|FG012|STARTED|Period 1 (Weeks 0 to 12)||0
6803440|NCT02891226|7735341|FG013|STARTED|Period 1 (Weeks 0 to 12)||0
6803441|NCT02891226|7735342|FG014|STARTED|Period 1 (Weeks 0 to 12)||0
6803442|NCT02891226|7735343|FG015|STARTED|Period 1 (Weeks 0 to 12)||0
6803443|NCT02891226|7735328|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
6803444|NCT02891226|7735329|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||31
6803445|NCT02891226|7735330|FG002|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||32
6803446|NCT02891226|7735331|FG003|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||64
6803447|NCT02891226|7735332|FG004|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803448|NCT02891226|7735333|FG005|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803449|NCT02891226|7735334|FG006|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803450|NCT02891226|7735335|FG007|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803451|NCT02891226|7735336|FG008|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803452|NCT02891226|7735337|FG009|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803453|NCT02891226|7735338|FG010|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803454|NCT02891226|7735339|FG011|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803455|NCT02891226|7735340|FG012|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803456|NCT02891226|7735341|FG013|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803457|NCT02891226|7735342|FG014|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803458|NCT02891226|7735343|FG015|Received at Least 1 Dose of Study Drug|Period 1 (Weeks 0 to 12)||0
6803459|NCT02891226|7735328|FG000|COMPLETED|Period 1 (Weeks 0 to 12)||59
6803460|NCT02891226|7735329|FG001|COMPLETED|Period 1 (Weeks 0 to 12)||29
6803461|NCT02891226|7735330|FG002|COMPLETED|Period 1 (Weeks 0 to 12)||28
6803462|NCT02891226|7735331|FG003|COMPLETED|Period 1 (Weeks 0 to 12)||60
6803463|NCT02891226|7735332|FG004|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803464|NCT02891226|7735333|FG005|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803465|NCT02891226|7735334|FG006|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803466|NCT02891226|7735335|FG007|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803467|NCT02891226|7735336|FG008|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803468|NCT02891226|7735337|FG009|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803469|NCT02891226|7735338|FG010|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803470|NCT02891226|7735339|FG011|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803471|NCT02891226|7735340|FG012|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803472|NCT02891226|7735341|FG013|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803473|NCT02891226|7735342|FG014|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803474|NCT02891226|7735343|FG015|COMPLETED|Period 1 (Weeks 0 to 12)||0
6803475|NCT02891226|7735328|FG000|NOT COMPLETED|Period 1 (Weeks 0 to 12)||5
6803476|NCT02891226|7735329|FG001|NOT COMPLETED|Period 1 (Weeks 0 to 12)||2
6803477|NCT02891226|7735330|FG002|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
6803478|NCT02891226|7735331|FG003|NOT COMPLETED|Period 1 (Weeks 0 to 12)||4
6803479|NCT02891226|7735332|FG004|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803480|NCT02891226|7735333|FG005|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803481|NCT02891226|7735334|FG006|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803482|NCT02891226|7735335|FG007|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803483|NCT02891226|7735336|FG008|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803484|NCT02891226|7735337|FG009|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803485|NCT02891226|7735338|FG010|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803486|NCT02891226|7735339|FG011|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803487|NCT02891226|7735340|FG012|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803488|NCT02891226|7735341|FG013|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803489|NCT02891226|7735342|FG014|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803490|NCT02891226|7735343|FG015|NOT COMPLETED|Period 1 (Weeks 0 to 12)||0
6803491|NCT02891226|7735328|FG000|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
6803492|NCT02891226|7735329|FG001|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
6803493|NCT02891226|7735330|FG002|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
6803494|NCT02891226|7735331|FG003|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 1.|0
6803495|NCT02891226|7735332|FG004|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
6803496|NCT02891226|7735333|FG005|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|9
6803497|NCT02891226|7735334|FG006|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|23
6803498|NCT02891226|7735335|FG007|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|46
6803499|NCT02891226|7735336|FG008|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|30
6803500|NCT02891226|7735337|FG009|STARTED|Period 2 (Weeks 12 to 52)|Participants were assigned to this arm during period 2.|59
6803501|NCT02891226|7735338|FG010|STARTED|Period 2 (Weeks 12 to 52)||0
6803502|NCT02891226|7735339|FG011|STARTED|Period 2 (Weeks 12 to 52)||0
6803503|NCT02891226|7735340|FG012|STARTED|Period 2 (Weeks 12 to 52)||0
6803504|NCT02891226|7735341|FG013|STARTED|Period 2 (Weeks 12 to 52)||0
6803505|NCT02891226|7735342|FG014|STARTED|Period 2 (Weeks 12 to 52)||0
6803506|NCT02891226|7735343|FG015|STARTED|Period 2 (Weeks 12 to 52)||0
6803507|NCT02891226|7735328|FG000|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803508|NCT02891226|7735329|FG001|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803509|NCT02891226|7735330|FG002|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803510|NCT02891226|7735331|FG003|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803511|NCT02891226|7735332|FG004|COMPLETED|Period 2 (Weeks 12 to 52)||8
6803512|NCT02891226|7735333|FG005|COMPLETED|Period 2 (Weeks 12 to 52)||8
6803513|NCT02891226|7735334|FG006|COMPLETED|Period 2 (Weeks 12 to 52)||20
6803514|NCT02891226|7735335|FG007|COMPLETED|Period 2 (Weeks 12 to 52)||41
6803515|NCT02891226|7735336|FG008|COMPLETED|Period 2 (Weeks 12 to 52)||24
6803516|NCT02891226|7735337|FG009|COMPLETED|Period 2 (Weeks 12 to 52)||42
6803517|NCT02891226|7735338|FG010|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803518|NCT02891226|7735339|FG011|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803519|NCT02891226|7735340|FG012|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803520|NCT02891226|7735341|FG013|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803521|NCT02891226|7735342|FG014|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803522|NCT02891226|7735343|FG015|COMPLETED|Period 2 (Weeks 12 to 52)||0
6803523|NCT02891226|7735328|FG000|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803524|NCT02891226|7735329|FG001|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803525|NCT02891226|7735330|FG002|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803526|NCT02891226|7735331|FG003|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6564664|NCT01812837|7487369|FG001|COMPLETED|Overall Study||16
6656743|NCT02464163|7587056|FG001|COMPLETED|Overall Study||94
6803527|NCT02891226|7735332|FG004|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
6803528|NCT02891226|7735333|FG005|NOT COMPLETED|Period 2 (Weeks 12 to 52)||1
6803529|NCT02891226|7735334|FG006|NOT COMPLETED|Period 2 (Weeks 12 to 52)||3
6803530|NCT02891226|7735335|FG007|NOT COMPLETED|Period 2 (Weeks 12 to 52)||5
6803531|NCT02891226|7735336|FG008|NOT COMPLETED|Period 2 (Weeks 12 to 52)||6
6803532|NCT02891226|7735337|FG009|NOT COMPLETED|Period 2 (Weeks 12 to 52)||17
6803533|NCT02891226|7735338|FG010|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803534|NCT02891226|7735339|FG011|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803535|NCT02891226|7735340|FG012|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803536|NCT02891226|7735341|FG013|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803537|NCT02891226|7735342|FG014|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803538|NCT02891226|7735343|FG015|NOT COMPLETED|Period 2 (Weeks 12 to 52)||0
6803539|NCT02891226|7735328|FG000|STARTED|Period 3 (Weeks 52 to 208)||0
6803540|NCT02891226|7735329|FG001|STARTED|Period 3 (Weeks 52 to 208)||0
6803541|NCT02891226|7735330|FG002|STARTED|Period 3 (Weeks 52 to 208)||0
6803542|NCT02891226|7735331|FG003|STARTED|Period 3 (Weeks 52 to 208)||0
6803543|NCT02891226|7735332|FG004|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
6803544|NCT02891226|7735333|FG005|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
6564665|NCT01812837|7487370|FG002|COMPLETED|Overall Study||17
6564666|NCT01812837|7487368|FG000|NOT COMPLETED|Overall Study||2
6803545|NCT02891226|7735334|FG006|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
6803546|NCT02891226|7735335|FG007|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
6803547|NCT02891226|7735336|FG008|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
6803548|NCT02891226|7735337|FG009|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 2.|0
6803549|NCT02891226|7735338|FG010|STARTED|Period 3 (Weeks 52 to 208)|Participants were assigned to this arm during period 3.|137
6803550|NCT02891226|7735339|FG011|STARTED|Period 3 (Weeks 52 to 208)||0
6803551|NCT02891226|7735340|FG012|STARTED|Period 3 (Weeks 52 to 208)||0
6803552|NCT02891226|7735341|FG013|STARTED|Period 3 (Weeks 52 to 208)||0
6803553|NCT02891226|7735342|FG014|STARTED|Period 3 (Weeks 52 to 208)||0
6803554|NCT02891226|7735343|FG015|STARTED|Period 3 (Weeks 52 to 208)||0
6803555|NCT02891226|7735328|FG000|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803556|NCT02891226|7735329|FG001|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803557|NCT02891226|7735330|FG002|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803558|NCT02891226|7735331|FG003|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803559|NCT02891226|7735332|FG004|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803560|NCT02891226|7735333|FG005|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803561|NCT02891226|7735334|FG006|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803562|NCT02891226|7735335|FG007|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803563|NCT02891226|7735336|FG008|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803564|NCT02891226|7735337|FG009|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803565|NCT02891226|7735338|FG010|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803566|NCT02891226|7735339|FG011|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803567|NCT02891226|7735340|FG012|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803568|NCT02891226|7735341|FG013|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803569|NCT02891226|7735342|FG014|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803570|NCT02891226|7735343|FG015|COMPLETED|Period 3 (Weeks 52 to 208)||0
6803571|NCT02891226|7735328|FG000|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803572|NCT02891226|7735329|FG001|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803573|NCT02891226|7735330|FG002|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803574|NCT02891226|7735331|FG003|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803575|NCT02891226|7735332|FG004|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803576|NCT02891226|7735333|FG005|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803577|NCT02891226|7735334|FG006|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803578|NCT02891226|7735335|FG007|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803579|NCT02891226|7735336|FG008|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803580|NCT02891226|7735337|FG009|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803581|NCT02891226|7735338|FG010|NOT COMPLETED|Period 3 (Weeks 52 to 208)||137
6803582|NCT02891226|7735339|FG011|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803583|NCT02891226|7735340|FG012|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803584|NCT02891226|7735341|FG013|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803585|NCT02891226|7735342|FG014|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803586|NCT02891226|7735343|FG015|NOT COMPLETED|Period 3 (Weeks 52 to 208)||0
6803587|NCT02891226|7735328|FG000|STARTED|Follow-up Period||0
6803588|NCT02891226|7735329|FG001|STARTED|Follow-up Period||0
6803589|NCT02891226|7735330|FG002|STARTED|Follow-up Period||0
6803590|NCT02891226|7735331|FG003|STARTED|Follow-up Period||0
6803591|NCT02891226|7735332|FG004|STARTED|Follow-up Period||0
6803592|NCT02891226|7735333|FG005|STARTED|Follow-up Period||0
6803593|NCT02891226|7735334|FG006|STARTED|Follow-up Period||0
6803594|NCT02891226|7735335|FG007|STARTED|Follow-up Period||0
6803595|NCT02891226|7735336|FG008|STARTED|Follow-up Period||0
6803596|NCT02891226|7735337|FG009|STARTED|Follow-up Period||0
6803597|NCT02891226|7735338|FG010|STARTED|Follow-up Period||0
6803598|NCT02891226|7735339|FG011|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
6803599|NCT02891226|7735340|FG012|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|2
6803600|NCT02891226|7735341|FG013|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
6803601|NCT02891226|7735342|FG014|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|1
6382706|NCT00790907|7293711|FG000|NOT COMPLETED|Overall Study||455
6382707|NCT00790907|7293712|FG001|NOT COMPLETED|Overall Study||340
6382708|NCT00790907|7293713|FG002|NOT COMPLETED|Overall Study||339
6382709|NCT00790933|7293725|FG000|STARTED|Overall Study||675
6382710|NCT00790933|7293726|FG001|STARTED|Overall Study||726
6382711|NCT00790933|7293727|FG002|STARTED|Overall Study||384
6382712|NCT00790933|7293728|FG003|STARTED|Overall Study||37
6382713|NCT00790933|7293729|FG004|STARTED|Overall Study||421
6382714|NCT00790933|7293725|FG000|COMPLETED|Overall Study||237
6382715|NCT00790933|7293726|FG001|COMPLETED|Overall Study||246
6382716|NCT00790933|7293727|FG002|COMPLETED|Overall Study||115
6382717|NCT00790933|7293728|FG003|COMPLETED|Overall Study||23
6803602|NCT02891226|7735343|FG015|STARTED|Follow-up Period|Participants were assigned to this arm during follow-up period.|3
6803603|NCT02891226|7735328|FG000|COMPLETED|Follow-up Period||0
6803604|NCT02891226|7735329|FG001|COMPLETED|Follow-up Period||0
6803605|NCT02891226|7735330|FG002|COMPLETED|Follow-up Period||0
6803606|NCT02891226|7735331|FG003|COMPLETED|Follow-up Period||0
6803607|NCT02891226|7735332|FG004|COMPLETED|Follow-up Period||0
6803608|NCT02891226|7735333|FG005|COMPLETED|Follow-up Period||0
6803609|NCT02891226|7735334|FG006|COMPLETED|Follow-up Period||0
6803610|NCT02891226|7735335|FG007|COMPLETED|Follow-up Period||0
6803611|NCT02891226|7735336|FG008|COMPLETED|Follow-up Period||0
6803612|NCT02891226|7735337|FG009|COMPLETED|Follow-up Period||0
6803613|NCT02891226|7735338|FG010|COMPLETED|Follow-up Period||0
6803614|NCT02891226|7735339|FG011|COMPLETED|Follow-up Period||0
6803615|NCT02891226|7735340|FG012|COMPLETED|Follow-up Period||2
6803616|NCT02891226|7735341|FG013|COMPLETED|Follow-up Period||1
6803617|NCT02891226|7735342|FG014|COMPLETED|Follow-up Period||0
6803618|NCT02891226|7735343|FG015|COMPLETED|Follow-up Period||2
6803619|NCT02891226|7735328|FG000|NOT COMPLETED|Follow-up Period||0
6803620|NCT02891226|7735329|FG001|NOT COMPLETED|Follow-up Period||0
6803621|NCT02891226|7735330|FG002|NOT COMPLETED|Follow-up Period||0
6803622|NCT02891226|7735331|FG003|NOT COMPLETED|Follow-up Period||0
6803623|NCT02891226|7735332|FG004|NOT COMPLETED|Follow-up Period||0
6803624|NCT02891226|7735333|FG005|NOT COMPLETED|Follow-up Period||0
6803625|NCT02891226|7735334|FG006|NOT COMPLETED|Follow-up Period||0
6803626|NCT02891226|7735335|FG007|NOT COMPLETED|Follow-up Period||0
6803627|NCT02891226|7735336|FG008|NOT COMPLETED|Follow-up Period||0
6803628|NCT02891226|7735337|FG009|NOT COMPLETED|Follow-up Period||0
6803629|NCT02891226|7735338|FG010|NOT COMPLETED|Follow-up Period||0
6803630|NCT02891226|7735339|FG011|NOT COMPLETED|Follow-up Period||1
6803631|NCT02891226|7735340|FG012|NOT COMPLETED|Follow-up Period||0
6803632|NCT02891226|7735341|FG013|NOT COMPLETED|Follow-up Period||0
6803633|NCT02891226|7735342|FG014|NOT COMPLETED|Follow-up Period||1
6803634|NCT02891226|7735343|FG015|NOT COMPLETED|Follow-up Period||1
6803635|NCT02703480|7735367|FG000|STARTED|Overall Study||11
6803636|NCT02703480|7735368|FG001|STARTED|Overall Study||11
6803637|NCT02703480|7735367|FG000|COMPLETED|Overall Study||10
6803638|NCT02703480|7735368|FG001|COMPLETED|Overall Study||10
6803639|NCT02703480|7735367|FG000|NOT COMPLETED|Overall Study||1
6803640|NCT02703480|7735368|FG001|NOT COMPLETED|Overall Study||1
6382718|NCT00790933|7293729|FG004|COMPLETED|Overall Study||145
6382719|NCT00790933|7293725|FG000|NOT COMPLETED|Overall Study||438
6382720|NCT00790933|7293726|FG001|NOT COMPLETED|Overall Study||480
6803641|NCT02549092|7735376|FG000|STARTED|Treatment Period||44
6803642|NCT02549092|7735377|FG001|STARTED|Treatment Period||45
6803643|NCT02549092|7735376|FG000|COMPLETED|Treatment Period||41
6803644|NCT02549092|7735377|FG001|COMPLETED|Treatment Period||38
6803645|NCT02549092|7735376|FG000|NOT COMPLETED|Treatment Period||3
6803646|NCT02549092|7735377|FG001|NOT COMPLETED|Treatment Period||7
6803647|NCT02549092|7735376|FG000|STARTED|Extension/Transition Period||10
6803648|NCT02549092|7735377|FG001|STARTED|Extension/Transition Period||14
6803649|NCT02549092|7735376|FG000|COMPLETED|Extension/Transition Period||5
6803650|NCT02549092|7735377|FG001|COMPLETED|Extension/Transition Period||5
6803651|NCT02549092|7735376|FG000|NOT COMPLETED|Extension/Transition Period||5
6803652|NCT02549092|7735377|FG001|NOT COMPLETED|Extension/Transition Period||9
6803653|NCT02506465|7735388|FG000|STARTED|Overall Study||128
6803654|NCT02506465|7735389|FG001|STARTED|Overall Study||57
6803655|NCT02506465|7735388|FG000|COMPLETED|Overall Study|78 patients reached 12 months FU visit.|78
6803656|NCT02506465|7735389|FG001|COMPLETED|Overall Study|The Sham arm was analyzed up to 3 months FU visit as primary endpoint timeframe in accordance with the FDA guideline for BPH treatments, published in 2010, the most recent guidance available at the time of the study.|57
6803657|NCT02506465|7735388|FG000|NOT COMPLETED|Overall Study||50
6803658|NCT02506465|7735389|FG001|NOT COMPLETED|Overall Study||0
6803659|NCT02323126|7735398|FG000|STARTED|Overall Study||18
6803660|NCT02323126|7735399|FG001|STARTED|Overall Study||16
6382721|NCT00790933|7293727|FG002|NOT COMPLETED|Overall Study||269
6382722|NCT00790933|7293728|FG003|NOT COMPLETED|Overall Study||14
6503020|NCT01438957|7421806|FG002|NOT COMPLETED|Overall Study||0
6503021|NCT01438957|7421807|FG003|NOT COMPLETED|Overall Study||1
6503022|NCT01438957|7421808|FG004|NOT COMPLETED|Overall Study||0
6503023|NCT01438996|7421823|FG000|STARTED|Overall Study||18
6503024|NCT01438996|7421824|FG001|STARTED|Overall Study||13
6503025|NCT01438996|7421825|FG002|STARTED|Overall Study||20
6656744|NCT02464163|7587057|FG002|COMPLETED|Overall Study||97
6656745|NCT02464163|7587058|FG003|COMPLETED|Overall Study||96
6656746|NCT02464163|7587055|FG000|NOT COMPLETED|Overall Study||3
6803661|NCT02323126|7735400|FG002|STARTED|Overall Study||30
6803662|NCT02323126|7735398|FG000|COMPLETED|Overall Study||0
6803663|NCT02323126|7735399|FG001|COMPLETED|Overall Study||0
6803664|NCT02323126|7735400|FG002|COMPLETED|Overall Study||0
6803665|NCT02323126|7735398|FG000|NOT COMPLETED|Overall Study||18
6803666|NCT02323126|7735399|FG001|NOT COMPLETED|Overall Study||16
6803667|NCT02323126|7735400|FG002|NOT COMPLETED|Overall Study||30
6803668|NCT01902290|7735413|FG000|STARTED|Overall Study||210
6803669|NCT01902290|7735414|FG001|STARTED|Overall Study||211
6803670|NCT01902290|7735413|FG000|Received Study Drug|Overall Study||207
6803671|NCT01902290|7735414|FG001|Received Study Drug|Overall Study||208
6803672|NCT01902290|7735413|FG000|COMPLETED|Overall Study||162
6803673|NCT01902290|7735414|FG001|COMPLETED|Overall Study||158
6803674|NCT01902290|7735413|FG000|NOT COMPLETED|Overall Study||48
6803675|NCT01902290|7735414|FG001|NOT COMPLETED|Overall Study||53
6803676|NCT01126749|7735425|FG000|STARTED|Phase 1b||3
6803677|NCT01126749|7735426|FG001|STARTED|Phase 1b||6
6803678|NCT01126749|7735427|FG002|STARTED|Phase 1b||0
6803679|NCT01126749|7735428|FG003|STARTED|Phase 1b||0
6803680|NCT01126749|7735425|FG000|COMPLETED|Phase 1b||0
6803681|NCT01126749|7735426|FG001|COMPLETED|Phase 1b||0
6803682|NCT01126749|7735427|FG002|COMPLETED|Phase 1b||0
6803683|NCT01126749|7735428|FG003|COMPLETED|Phase 1b||0
6803684|NCT01126749|7735425|FG000|NOT COMPLETED|Phase 1b||3
6803685|NCT01126749|7735426|FG001|NOT COMPLETED|Phase 1b||6
6803686|NCT01126749|7735427|FG002|NOT COMPLETED|Phase 1b||0
6803687|NCT01126749|7735428|FG003|NOT COMPLETED|Phase 1b||0
6803688|NCT01126749|7735425|FG000|STARTED|Phase 2||0
6803689|NCT01126749|7735426|FG001|STARTED|Phase 2||0
6803690|NCT01126749|7735427|FG002|STARTED|Phase 2||42
6803691|NCT01126749|7735428|FG003|STARTED|Phase 2||41
6803692|NCT01126749|7735425|FG000|Safety Analysis Set (SAS)/Treated|Phase 2||0
6803693|NCT01126749|7735426|FG001|Safety Analysis Set (SAS)/Treated|Phase 2||0
6803694|NCT01126749|7735427|FG002|Safety Analysis Set (SAS)/Treated|Phase 2||41
6803695|NCT01126749|7735428|FG003|Safety Analysis Set (SAS)/Treated|Phase 2||39
6803696|NCT01126749|7735425|FG000|Modified-intent-to-treat (MITT)|Phase 2||0
6803697|NCT01126749|7735426|FG001|Modified-intent-to-treat (MITT)|Phase 2||0
6803698|NCT01126749|7735427|FG002|Modified-intent-to-treat (MITT)|Phase 2||40
6803699|NCT01126749|7735428|FG003|Modified-intent-to-treat (MITT)|Phase 2||39
6803700|NCT01126749|7735425|FG000|COMPLETED|Phase 2||0
6803701|NCT01126749|7735426|FG001|COMPLETED|Phase 2||0
6656747|NCT02464163|7587056|FG001|NOT COMPLETED|Overall Study||8
6656748|NCT02464163|7587057|FG002|NOT COMPLETED|Overall Study||5
6656749|NCT02464163|7587058|FG003|NOT COMPLETED|Overall Study||5
6656750|NCT02464176|7587071|FG000|STARTED|Overall Study||50
6656751|NCT02464176|7587072|FG001|STARTED|Overall Study||50
6803702|NCT01126749|7735427|FG002|COMPLETED|Phase 2||0
6803703|NCT01126749|7735428|FG003|COMPLETED|Phase 2||0
6803704|NCT01126749|7735425|FG000|NOT COMPLETED|Phase 2||0
6803705|NCT01126749|7735426|FG001|NOT COMPLETED|Phase 2||0
6803706|NCT01126749|7735427|FG002|NOT COMPLETED|Phase 2||42
6803707|NCT01126749|7735428|FG003|NOT COMPLETED|Phase 2||41
6803708|NCT01111110|7735440|FG000|STARTED|Overall Study||3
6803709|NCT01111110|7735441|FG001|STARTED|Overall Study||4
6803710|NCT01111110|7735440|FG000|COMPLETED|Overall Study||3
6269320|NCT00073749|7168465|FG005|STARTED|Overall Study||6
6269321|NCT00073749|7168466|FG006|STARTED|Overall Study||43
6269322|NCT00073749|7168460|FG000|COMPLETED|Overall Study||0
6269323|NCT00073749|7168461|FG001|COMPLETED|Overall Study||0
6269324|NCT00073749|7168462|FG002|COMPLETED|Overall Study||0
6269325|NCT00073749|7168463|FG003|COMPLETED|Overall Study||0
6269326|NCT00073749|7168464|FG004|COMPLETED|Overall Study||0
6269327|NCT00073749|7168465|FG005|COMPLETED|Overall Study||0
6269328|NCT00073749|7168466|FG006|COMPLETED|Overall Study||3
6269329|NCT00073749|7168460|FG000|NOT COMPLETED|Overall Study||2
6269330|NCT00073749|7168461|FG001|NOT COMPLETED|Overall Study||5
6269331|NCT00073749|7168462|FG002|NOT COMPLETED|Overall Study||11
6269332|NCT00073749|7168463|FG003|NOT COMPLETED|Overall Study||6
6269333|NCT00073749|7168464|FG004|NOT COMPLETED|Overall Study||6
6269334|NCT00073749|7168465|FG005|NOT COMPLETED|Overall Study||6
6269335|NCT00073749|7168466|FG006|NOT COMPLETED|Overall Study||40
6269336|NCT00073918|7168485|FG000|STARTED|Overall Study||111
6269337|NCT00073918|7168485|FG000|COMPLETED|Overall Study||107
6269338|NCT00073918|7168485|FG000|NOT COMPLETED|Overall Study||4
6269339|NCT00073957|7168489|FG000|STARTED|Overall Study||25
6269340|NCT00073957|7168489|FG000|COMPLETED|Overall Study||25
6269341|NCT00073957|7168489|FG000|NOT COMPLETED|Overall Study||0
6269342|NCT00073983|7168495|FG000|STARTED|Overall Study||54
6269343|NCT00073983|7168495|FG000|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
6269344|NCT00073983|7168495|FG000|NOT COMPLETED|Overall Study||1
6269345|NCT00074035|7168501|FG000|STARTED|Overall Study||38
6269346|NCT00074035|7168501|FG000|COMPLETED|Overall Study||38
6269347|NCT00074035|7168501|FG000|NOT COMPLETED|Overall Study||0
6269348|NCT00074152|7168507|FG000|STARTED|Overall Study||77
6269349|NCT00074152|7168508|FG001|STARTED|Overall Study||85
6269350|NCT00074152|7168507|FG000|COMPLETED|Overall Study||22
6269351|NCT00074152|7168508|FG001|COMPLETED|Overall Study||52
6269352|NCT00074152|7168507|FG000|NOT COMPLETED|Overall Study||55
6269353|NCT00074152|7168508|FG001|NOT COMPLETED|Overall Study||33
6269354|NCT00074165|7168515|FG000|STARTED|Overall Study||17
6269355|NCT00074165|7168515|FG000|COMPLETED|Overall Study||17
6269356|NCT00074165|7168515|FG000|NOT COMPLETED|Overall Study||0
6269357|NCT00074269|7168519|FG000|STARTED|Overall Study||5
6269358|NCT00074269|7168519|FG000|COMPLETED|Overall Study||5
6269359|NCT00074269|7168519|FG000|NOT COMPLETED|Overall Study||0
6269360|NCT00074282|7168527|FG000|STARTED|Step 1||102
6269361|NCT00074282|7168528|FG001|STARTED|Step 1||0
6269362|NCT00074282|7168529|FG002|STARTED|Step 1||0
6269363|NCT00074282|7168527|FG000|Eligible|Step 1||98
6269364|NCT00074282|7168528|FG001|Eligible|Step 1||0
6269365|NCT00074282|7168529|FG002|Eligible|Step 1||0
6269366|NCT00074282|7168527|FG000|Started Treatment|Step 1||96
6269367|NCT00074282|7168528|FG001|Started Treatment|Step 1||0
6269368|NCT00074282|7168529|FG002|Started Treatment|Step 1||0
6269369|NCT00074282|7168527|FG000|COMPLETED|Step 1||44
6269370|NCT00074282|7168528|FG001|COMPLETED|Step 1||0
6269371|NCT00074282|7168529|FG002|COMPLETED|Step 1||0
6269372|NCT00074282|7168527|FG000|NOT COMPLETED|Step 1||58
6269373|NCT00074282|7168528|FG001|NOT COMPLETED|Step 1||0
6269374|NCT00074282|7168529|FG002|NOT COMPLETED|Step 1||0
6269375|NCT00074282|7168527|FG000|STARTED|Step 2||0
6269376|NCT00074282|7168528|FG001|STARTED|Step 2||9
6269377|NCT00074282|7168529|FG002|STARTED|Step 2||31
6269378|NCT00074282|7168527|FG000|COMPLETED|Step 2||0
6269379|NCT00074282|7168528|FG001|COMPLETED|Step 2||7
6269380|NCT00074282|7168529|FG002|COMPLETED|Step 2||7
6269381|NCT00074282|7168527|FG000|NOT COMPLETED|Step 2||0
6269382|NCT00074282|7168528|FG001|NOT COMPLETED|Step 2||2
6269383|NCT00074282|7168529|FG002|NOT COMPLETED|Step 2||24
6269384|NCT00074308|7168539|FG000|STARTED|Overall Study||3
6269385|NCT00074308|7168540|FG001|STARTED|Overall Study||3
6269386|NCT00074308|7168541|FG002|STARTED|Overall Study||3
6269387|NCT00074308|7168542|FG003|STARTED|Overall Study||8
6269388|NCT00074308|7168543|FG004|STARTED|Overall Study||23
6269389|NCT00074308|7168539|FG000|COMPLETED|Overall Study||3
6269390|NCT00074308|7168540|FG001|COMPLETED|Overall Study||3
6269391|NCT00074308|7168541|FG002|COMPLETED|Overall Study||3
6382723|NCT00790933|7293729|FG004|NOT COMPLETED|Overall Study||276
6382724|NCT00791037|7293745|FG000|STARTED|Overall Study||23
6382725|NCT00791037|7293745|FG000|Primary Outcome|Overall Study||19
6382726|NCT00791037|7293745|FG000|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
6382727|NCT00791037|7293745|FG000|COMPLETED|Overall Study||23
6382728|NCT00791037|7293745|FG000|NOT COMPLETED|Overall Study||0
6382729|NCT00791089|7293753|FG000|STARTED|Overall Study||6
6564667|NCT01812837|7487369|FG001|NOT COMPLETED|Overall Study||1
6564668|NCT01812837|7487370|FG002|NOT COMPLETED|Overall Study||0
6803711|NCT01111110|7735441|FG001|COMPLETED|Overall Study||4
6803712|NCT01111110|7735440|FG000|NOT COMPLETED|Overall Study||0
6803713|NCT01111110|7735441|FG001|NOT COMPLETED|Overall Study||0
6803714|NCT01059448|7735451|FG000|STARTED|Overall Study||49
6803715|NCT01059448|7735452|FG001|STARTED|Overall Study||55
6803716|NCT01059448|7735453|FG002|STARTED|Overall Study||53
6803717|NCT01059448|7735454|FG003|STARTED|Overall Study||54
6803718|NCT01059448|7735451|FG000|COMPLETED|Overall Study||0
6803719|NCT01059448|7735452|FG001|COMPLETED|Overall Study||0
6803720|NCT01059448|7735453|FG002|COMPLETED|Overall Study||0
6803721|NCT01059448|7735454|FG003|COMPLETED|Overall Study||0
6803722|NCT01059448|7735451|FG000|NOT COMPLETED|Overall Study||49
6803723|NCT01059448|7735452|FG001|NOT COMPLETED|Overall Study||55
6803724|NCT01059448|7735453|FG002|NOT COMPLETED|Overall Study||53
6803725|NCT01059448|7735454|FG003|NOT COMPLETED|Overall Study||54
6803726|NCT01032603|7735466|FG000|STARTED|Overall Study||101
6803727|NCT01032603|7735467|FG001|STARTED|Overall Study||96
6803728|NCT01032603|7735466|FG000|COMPLETED|Overall Study||86
6803729|NCT01032603|7735467|FG001|COMPLETED|Overall Study||77
6803730|NCT01032603|7735466|FG000|NOT COMPLETED|Overall Study||15
6803731|NCT01032603|7735467|FG001|NOT COMPLETED|Overall Study||19
6803732|NCT00821587|7735475|FG000|STARTED|Overall Study||20
6803733|NCT00821587|7735476|FG001|STARTED|Overall Study||19
6803734|NCT00821587|7735475|FG000|COMPLETED|Overall Study||20
6803735|NCT00821587|7735476|FG001|COMPLETED|Overall Study||18
6803736|NCT00821587|7735475|FG000|NOT COMPLETED|Overall Study||0
6803737|NCT00821587|7735476|FG001|NOT COMPLETED|Overall Study||1
6803738|NCT00585195|7735503|FG000|STARTED|Overall Study||3
6803739|NCT00585195|7735504|FG001|STARTED|Overall Study||4
6803740|NCT00585195|7735505|FG002|STARTED|Overall Study||9
6803741|NCT00585195|7735506|FG003|STARTED|Overall Study||7
6803742|NCT00585195|7735507|FG004|STARTED|Overall Study||9
6803743|NCT00585195|7735508|FG005|STARTED|Overall Study||6
6803744|NCT00585195|7735509|FG006|STARTED|Overall Study||7
6803745|NCT00585195|7735510|FG007|STARTED|Overall Study||5
6803746|NCT00585195|7735511|FG008|STARTED|Overall Study||3
6803747|NCT00585195|7735512|FG009|STARTED|Overall Study||6
6803748|NCT00585195|7735513|FG010|STARTED|Overall Study||11
6803749|NCT00585195|7735514|FG011|STARTED|Overall Study||53
6803750|NCT00585195|7735515|FG012|STARTED|Overall Study||85
6803751|NCT00585195|7735516|FG013|STARTED|Overall Study||41
6803752|NCT00585195|7735517|FG014|STARTED|Overall Study||48
6564669|NCT01813019|7487380|FG000|STARTED|Overall Study||24
6564670|NCT01813019|7487381|FG001|STARTED|Overall Study||26
6564671|NCT01813019|7487380|FG000|COMPLETED|Overall Study||17
6803753|NCT00585195|7735518|FG015|STARTED|Overall Study||19
6803754|NCT00585195|7735519|FG016|STARTED|Overall Study||154
6803755|NCT00585195|7735520|FG017|STARTED|Overall Study||67
6803756|NCT00585195|7735521|FG018|STARTED|Overall Study||21
6803757|NCT00585195|7735522|FG019|STARTED|Overall Study||18
6803758|NCT00585195|7735523|FG020|STARTED|Overall Study||14
6803759|NCT00585195|7735503|FG000|Treated|Overall Study||3
6803760|NCT00585195|7735504|FG001|Treated|Overall Study||4
6803761|NCT00585195|7735505|FG002|Treated|Overall Study||8
6803762|NCT00585195|7735506|FG003|Treated|Overall Study||7
6564672|NCT01813019|7487381|FG001|COMPLETED|Overall Study||20
6564673|NCT01813019|7487380|FG000|NOT COMPLETED|Overall Study||7
6564674|NCT01813019|7487381|FG001|NOT COMPLETED|Overall Study||6
6803763|NCT00585195|7735507|FG004|Treated|Overall Study||8
6803764|NCT00585195|7735508|FG005|Treated|Overall Study||6
6803765|NCT00585195|7735509|FG006|Treated|Overall Study||6
6803766|NCT00585195|7735510|FG007|Treated|Overall Study||5
6803767|NCT00585195|7735511|FG008|Treated|Overall Study||3
6803768|NCT00585195|7735512|FG009|Treated|Overall Study||6
6803769|NCT00585195|7735513|FG010|Treated|Overall Study||9
6803770|NCT00585195|7735514|FG011|Treated|Overall Study||53
6803771|NCT00585195|7735515|FG012|Treated|Overall Study||85
6803772|NCT00585195|7735516|FG013|Treated|Overall Study||41
6803773|NCT00585195|7735517|FG014|Treated|Overall Study||48
6803774|NCT00585195|7735518|FG015|Treated|Overall Study||18
6803775|NCT00585195|7735519|FG016|Treated|Overall Study||154
6803776|NCT00585195|7735520|FG017|Treated|Overall Study||66
6803777|NCT00585195|7735521|FG018|Treated|Overall Study||18
6803778|NCT00585195|7735522|FG019|Treated|Overall Study||18
6803779|NCT00585195|7735523|FG020|Treated|Overall Study||12
6803780|NCT00585195|7735503|FG000|COMPLETED|Overall Study||0
6803781|NCT00585195|7735504|FG001|COMPLETED|Overall Study||0
6803782|NCT00585195|7735505|FG002|COMPLETED|Overall Study||0
6803783|NCT00585195|7735506|FG003|COMPLETED|Overall Study||0
6803784|NCT00585195|7735507|FG004|COMPLETED|Overall Study||0
6803785|NCT00585195|7735508|FG005|COMPLETED|Overall Study||0
6803786|NCT00585195|7735509|FG006|COMPLETED|Overall Study||0
6803787|NCT00585195|7735510|FG007|COMPLETED|Overall Study||0
6803788|NCT00585195|7735511|FG008|COMPLETED|Overall Study||0
6803789|NCT00585195|7735512|FG009|COMPLETED|Overall Study||0
6803790|NCT00585195|7735513|FG010|COMPLETED|Overall Study||0
6803791|NCT00585195|7735514|FG011|COMPLETED|Overall Study||0
6803792|NCT00585195|7735515|FG012|COMPLETED|Overall Study||0
6803793|NCT00585195|7735516|FG013|COMPLETED|Overall Study||0
6803794|NCT00585195|7735517|FG014|COMPLETED|Overall Study||0
6803795|NCT00585195|7735518|FG015|COMPLETED|Overall Study||0
6803796|NCT00585195|7735519|FG016|COMPLETED|Overall Study||0
6803797|NCT00585195|7735520|FG017|COMPLETED|Overall Study||0
6803798|NCT00585195|7735521|FG018|COMPLETED|Overall Study||0
6803799|NCT00585195|7735522|FG019|COMPLETED|Overall Study||0
6803800|NCT00585195|7735523|FG020|COMPLETED|Overall Study||0
6803801|NCT00585195|7735503|FG000|NOT COMPLETED|Overall Study||3
6803802|NCT00585195|7735504|FG001|NOT COMPLETED|Overall Study||4
6803803|NCT00585195|7735505|FG002|NOT COMPLETED|Overall Study||9
6803804|NCT00585195|7735506|FG003|NOT COMPLETED|Overall Study||7
6803805|NCT00585195|7735507|FG004|NOT COMPLETED|Overall Study||9
6803806|NCT00585195|7735508|FG005|NOT COMPLETED|Overall Study||6
6803807|NCT00585195|7735509|FG006|NOT COMPLETED|Overall Study||7
6803808|NCT00585195|7735510|FG007|NOT COMPLETED|Overall Study||5
6803809|NCT00585195|7735511|FG008|NOT COMPLETED|Overall Study||3
6803810|NCT00585195|7735512|FG009|NOT COMPLETED|Overall Study||6
6803811|NCT00585195|7735513|FG010|NOT COMPLETED|Overall Study||11
6803812|NCT00585195|7735514|FG011|NOT COMPLETED|Overall Study||53
6803813|NCT00585195|7735515|FG012|NOT COMPLETED|Overall Study||85
6803814|NCT00585195|7735516|FG013|NOT COMPLETED|Overall Study||41
6803815|NCT00585195|7735517|FG014|NOT COMPLETED|Overall Study||48
6803816|NCT00585195|7735518|FG015|NOT COMPLETED|Overall Study||19
6803817|NCT00585195|7735519|FG016|NOT COMPLETED|Overall Study||154
6803818|NCT00585195|7735520|FG017|NOT COMPLETED|Overall Study||67
6803819|NCT00585195|7735521|FG018|NOT COMPLETED|Overall Study||21
6803820|NCT00585195|7735522|FG019|NOT COMPLETED|Overall Study||18
6803821|NCT00585195|7735523|FG020|NOT COMPLETED|Overall Study||14
6803822|NCT00278915|7735606|FG000|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
6803823|NCT00278915|7735606|FG000|COMPLETED|Overall Study||29
6803824|NCT00278915|7735606|FG000|NOT COMPLETED|Overall Study||1
6803825|NCT04446429|7735612|FG000|STARTED|Overall Study||134
6564675|NCT01813058|7487389|FG000|STARTED|Overall Study||60
6564676|NCT01813058|7487390|FG001|STARTED|Overall Study||60
6564677|NCT01813058|7487389|FG000|COMPLETED|Overall Study||55
6382730|NCT00791089|7293754|FG001|STARTED|Overall Study||6
6382731|NCT00791089|7293753|FG000|Began Actually Taking Fish Oil or Placeb|Overall Study||6
6382732|NCT00791089|7293754|FG001|Began Actually Taking Fish Oil or Placeb|Overall Study||5
6382733|NCT00791089|7293753|FG000|Six-month Data Collected|Overall Study||6
6382734|NCT00791089|7293754|FG001|Six-month Data Collected|Overall Study||5
6503026|NCT01438996|7421823|FG000|COMPLETED|Overall Study||14
6503027|NCT01438996|7421824|FG001|COMPLETED|Overall Study||12
6503028|NCT01438996|7421825|FG002|COMPLETED|Overall Study||20
6503029|NCT01438996|7421823|FG000|NOT COMPLETED|Overall Study||4
6503030|NCT01438996|7421824|FG001|NOT COMPLETED|Overall Study||1
6503031|NCT01438996|7421825|FG002|NOT COMPLETED|Overall Study||0
6803826|NCT04446429|7735613|FG001|STARTED|Overall Study||134
6803827|NCT04446429|7735612|FG000|COMPLETED|Overall Study|In placebo group, 6 patients were lost to follow-up but were included in intention-to-treat analysis.|128
6803828|NCT04446429|7735613|FG001|COMPLETED|Overall Study||134
6803829|NCT04446429|7735612|FG000|NOT COMPLETED|Overall Study||6
6803830|NCT04446429|7735613|FG001|NOT COMPLETED|Overall Study||0
6803831|NCT04372017|7735623|FG000|STARTED|Overall Study||1
6803832|NCT04372017|7735624|FG001|STARTED|Overall Study||0
6803833|NCT04372017|7735625|FG002|STARTED|Overall Study||0
6803834|NCT04372017|7735626|FG003|STARTED|Overall Study||0
6803835|NCT04372017|7735623|FG000|COMPLETED|Overall Study||1
6803836|NCT04372017|7735624|FG001|COMPLETED|Overall Study||0
6803837|NCT04372017|7735625|FG002|COMPLETED|Overall Study||0
6803838|NCT04372017|7735626|FG003|COMPLETED|Overall Study||0
6803839|NCT04372017|7735623|FG000|NOT COMPLETED|Overall Study||0
6803840|NCT04372017|7735624|FG001|NOT COMPLETED|Overall Study||0
6803841|NCT04372017|7735625|FG002|NOT COMPLETED|Overall Study||0
6803842|NCT04372017|7735626|FG003|NOT COMPLETED|Overall Study||0
6803843|NCT04194528|7735636|FG000|STARTED|Overall Study||2
6803844|NCT04194528|7735636|FG000|COMPLETED|Overall Study||1
6803845|NCT04194528|7735636|FG000|NOT COMPLETED|Overall Study||1
6382735|NCT00791089|7293753|FG000|COMPLETED|Overall Study||0
6382736|NCT00791089|7293754|FG001|COMPLETED|Overall Study||0
6382737|NCT00791089|7293753|FG000|NOT COMPLETED|Overall Study||6
6382738|NCT00791089|7293754|FG001|NOT COMPLETED|Overall Study||6
6382739|NCT00791102|7293760|FG000|STARTED|Period 1||10
6382740|NCT00791102|7293761|FG001|STARTED|Period 1||10
6382741|NCT00791102|7293760|FG000|COMPLETED|Period 1||10
6382742|NCT00791102|7293761|FG001|COMPLETED|Period 1||10
6503032|NCT01439009|7421835|FG000|STARTED|Overall Study||50
6503033|NCT01439009|7421836|FG001|STARTED|Overall Study||50
6503034|NCT01439009|7421835|FG000|COMPLETED|Overall Study||42
6803846|NCT04147650|7735644|FG000|STARTED|Overall Study||127
6803847|NCT04147650|7735645|FG001|STARTED|Overall Study||126
6803848|NCT04147650|7735646|FG002|STARTED|Overall Study||128
6803849|NCT04147650|7735647|FG003|STARTED|Overall Study||127
6803850|NCT04147650|7735644|FG000|Modified Intent to Treat (mITT)|Overall Study||120
6803851|NCT04147650|7735645|FG001|Modified Intent to Treat (mITT)|Overall Study||119
6803852|NCT04147650|7735646|FG002|Modified Intent to Treat (mITT)|Overall Study||122
6803853|NCT04147650|7735647|FG003|Modified Intent to Treat (mITT)|Overall Study||121
6803854|NCT04147650|7735644|FG000|COMPLETED|Overall Study||116
6803855|NCT04147650|7735645|FG001|COMPLETED|Overall Study||107
6803856|NCT04147650|7735646|FG002|COMPLETED|Overall Study||121
6803857|NCT04147650|7735647|FG003|COMPLETED|Overall Study||120
6803858|NCT04147650|7735644|FG000|NOT COMPLETED|Overall Study||11
6803859|NCT04147650|7735645|FG001|NOT COMPLETED|Overall Study||19
6803860|NCT04147650|7735646|FG002|NOT COMPLETED|Overall Study||7
6803861|NCT04147650|7735647|FG003|NOT COMPLETED|Overall Study||7
6803862|NCT03907540|7735657|FG000|STARTED|Overall Study||5
6803863|NCT03907540|7735657|FG000|Completed Part 1|Overall Study||5
6803864|NCT03907540|7735657|FG000|Completed Part 2|Overall Study||5
6803865|NCT03907540|7735657|FG000|COMPLETED|Overall Study||5
6803866|NCT03907540|7735657|FG000|NOT COMPLETED|Overall Study||0
6803867|NCT03527238|7735672|FG000|STARTED|Overall Study||31
6803868|NCT03527238|7735673|FG001|STARTED|Overall Study||31
6803869|NCT03527238|7735672|FG000|COMPLETED|Overall Study||29
6803870|NCT03527238|7735673|FG001|COMPLETED|Overall Study||27
6803871|NCT03527238|7735672|FG000|NOT COMPLETED|Overall Study||2
6803872|NCT03527238|7735673|FG001|NOT COMPLETED|Overall Study||4
6803873|NCT03116685|7735681|FG000|STARTED|Overall Study||13
6803874|NCT03116685|7735682|FG001|STARTED|Overall Study||12
6803875|NCT03116685|7735681|FG000|COMPLETED|Overall Study||13
6803876|NCT03116685|7735682|FG001|COMPLETED|Overall Study||11
6803877|NCT03116685|7735681|FG000|NOT COMPLETED|Overall Study||0
6803878|NCT03116685|7735682|FG001|NOT COMPLETED|Overall Study||1
6803879|NCT03099304|7735693|FG000|STARTED|DB Period Day 1 to Week 24||32
6803880|NCT03099304|7735694|FG001|STARTED|DB Period Day 1 to Week 24||31
6803881|NCT03099304|7735695|FG002|STARTED|DB Period Day 1 to Week 24||31
6803882|NCT03099304|7735696|FG003|STARTED|DB Period Day 1 to Week 24||30
6803883|NCT03099304|7735697|FG004|STARTED|DB Period Day 1 to Week 24||33
6803884|NCT03099304|7735693|FG000|COMPLETED|DB Period Day 1 to Week 24||27
6803885|NCT03099304|7735694|FG001|COMPLETED|DB Period Day 1 to Week 24||26
6803886|NCT03099304|7735695|FG002|COMPLETED|DB Period Day 1 to Week 24||30
6803887|NCT03099304|7735696|FG003|COMPLETED|DB Period Day 1 to Week 24||26
6803888|NCT03099304|7735697|FG004|COMPLETED|DB Period Day 1 to Week 24||30
6803889|NCT03099304|7735693|FG000|NOT COMPLETED|DB Period Day 1 to Week 24||5
6803890|NCT03099304|7735694|FG001|NOT COMPLETED|DB Period Day 1 to Week 24||5
6803891|NCT03099304|7735695|FG002|NOT COMPLETED|DB Period Day 1 to Week 24||1
6803892|NCT03099304|7735696|FG003|NOT COMPLETED|DB Period Day 1 to Week 24||4
6803893|NCT03099304|7735697|FG004|NOT COMPLETED|DB Period Day 1 to Week 24||3
6803894|NCT03099304|7735693|FG000|STARTED|DB Period Weeks 24 to 52|Vehicle cream was not used after Week 24. After DB 24 week period, participants who met criteria were rerandomized to 1 of the 3 higher active blinded treatment groups.|0
6803895|NCT03099304|7735694|FG001|STARTED|DB Period Weeks 24 to 52|These subjects continued on the initial .15% QD treatment.|11
6803896|NCT03099304|7735695|FG002|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 0.5% QD and those re-randomized from vehicle cream and .15% QD to 0.5% QD.|45
6803897|NCT03099304|7735696|FG003|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% QD and those re-randomized from vehicle cream and .15% QD to 1.5% QD.|44
6803898|NCT03099304|7735697|FG004|STARTED|DB Period Weeks 24 to 52|Total participants include those initially randomized to 1.5% BID and those re-randomized from vehicle cream and .15% QD to 1.5% BID|47
6803899|NCT03099304|7735693|FG000|COMPLETED|DB Period Weeks 24 to 52||0
6803900|NCT03099304|7735694|FG001|COMPLETED|DB Period Weeks 24 to 52||10
6803901|NCT03099304|7735695|FG002|COMPLETED|DB Period Weeks 24 to 52||43
6803902|NCT03099304|7735696|FG003|COMPLETED|DB Period Weeks 24 to 52||37
6803903|NCT03099304|7735697|FG004|COMPLETED|DB Period Weeks 24 to 52||45
6803904|NCT03099304|7735693|FG000|NOT COMPLETED|DB Period Weeks 24 to 52||0
6803905|NCT03099304|7735694|FG001|NOT COMPLETED|DB Period Weeks 24 to 52||1
6803906|NCT03099304|7735695|FG002|NOT COMPLETED|DB Period Weeks 24 to 52||2
6803907|NCT03099304|7735696|FG003|NOT COMPLETED|DB Period Weeks 24 to 52||7
6803908|NCT03099304|7735697|FG004|NOT COMPLETED|DB Period Weeks 24 to 52||2
6803909|NCT03034863|7735718|FG000|STARTED|Overall Study||38
6803910|NCT03034863|7735719|FG001|STARTED|Overall Study||40
6803911|NCT03034863|7735718|FG000|Veterans|Overall Study||19
6803912|NCT03034863|7735719|FG001|Veterans|Overall Study||20
6803913|NCT03034863|7735718|FG000|Supporting Partners|Overall Study||19
6803914|NCT03034863|7735719|FG001|Supporting Partners|Overall Study||20
6803915|NCT03034863|7735718|FG000|COMPLETED|Overall Study||28
6803916|NCT03034863|7735719|FG001|COMPLETED|Overall Study||28
6803917|NCT03034863|7735718|FG000|NOT COMPLETED|Overall Study||10
6803918|NCT03034863|7735719|FG001|NOT COMPLETED|Overall Study||12
6803919|NCT02819050|7735732|FG000|STARTED|Overall Study||40
6803920|NCT02819050|7735733|FG001|STARTED|Overall Study||40
6803921|NCT02819050|7735732|FG000|COMPLETED|Overall Study||40
6803922|NCT02819050|7735733|FG001|COMPLETED|Overall Study||40
6803923|NCT02819050|7735732|FG000|NOT COMPLETED|Overall Study||0
6803924|NCT02819050|7735733|FG001|NOT COMPLETED|Overall Study||0
6803925|NCT02682901|7735743|FG000|STARTED|Overall Study||43
6803926|NCT02682901|7735744|FG001|STARTED|Overall Study||41
6803927|NCT02682901|7735743|FG000|Completed 4 Weeks|Overall Study||38
6803928|NCT02682901|7735744|FG001|Completed 4 Weeks|Overall Study||39
6803929|NCT02682901|7735743|FG000|Completed 12 Weeks|Overall Study||36
6382743|NCT00791102|7293760|FG000|NOT COMPLETED|Period 1||0
6382744|NCT00791102|7293761|FG001|NOT COMPLETED|Period 1||0
6382745|NCT00791102|7293760|FG000|STARTED|Washout Period of 2 Weeks||10
6382746|NCT00791102|7293761|FG001|STARTED|Washout Period of 2 Weeks||10
6382747|NCT00791102|7293760|FG000|COMPLETED|Washout Period of 2 Weeks||10
6382748|NCT00791102|7293761|FG001|COMPLETED|Washout Period of 2 Weeks||10
6382749|NCT00791102|7293760|FG000|NOT COMPLETED|Washout Period of 2 Weeks||0
6382750|NCT00791102|7293761|FG001|NOT COMPLETED|Washout Period of 2 Weeks||0
6269392|NCT00074308|7168542|FG003|COMPLETED|Overall Study||8
6382751|NCT00791102|7293760|FG000|STARTED|Period 2||10
6382752|NCT00791102|7293761|FG001|STARTED|Period 2||10
6382753|NCT00791102|7293760|FG000|COMPLETED|Period 2||10
6382754|NCT00791102|7293761|FG001|COMPLETED|Period 2||10
6382755|NCT00791102|7293760|FG000|NOT COMPLETED|Period 2||0
6382756|NCT00791102|7293761|FG001|NOT COMPLETED|Period 2||0
6382757|NCT00791128|7293767|FG000|STARTED|Overall Study||22
6382758|NCT00791128|7293767|FG000|COMPLETED|Overall Study||13
6382759|NCT00791128|7293767|FG000|NOT COMPLETED|Overall Study||9
6382760|NCT00791219|7293774|FG000|STARTED|Overall Study||24
6382761|NCT00791219|7293775|FG001|STARTED|Overall Study||76
6382762|NCT00791219|7293776|FG002|STARTED|Overall Study||75
6382763|NCT00791219|7293774|FG000|COMPLETED|Overall Study||19
6382764|NCT00791219|7293775|FG001|COMPLETED|Overall Study||60
6382765|NCT00791219|7293776|FG002|COMPLETED|Overall Study||61
6382766|NCT00791219|7293774|FG000|NOT COMPLETED|Overall Study||5
6382767|NCT00791219|7293775|FG001|NOT COMPLETED|Overall Study||16
6382768|NCT00791219|7293776|FG002|NOT COMPLETED|Overall Study||14
6803930|NCT02682901|7735744|FG001|Completed 12 Weeks|Overall Study||37
6803931|NCT02682901|7735743|FG000|COMPLETED|Overall Study||33
6803932|NCT02682901|7735744|FG001|COMPLETED|Overall Study||37
6803933|NCT02682901|7735743|FG000|NOT COMPLETED|Overall Study||10
6803934|NCT02682901|7735744|FG001|NOT COMPLETED|Overall Study||4
6803935|NCT02567825|7735752|FG000|STARTED|Overall Study||129
6803936|NCT02567825|7735753|FG001|STARTED|Overall Study||121
6803937|NCT02567825|7735752|FG000|COMPLETED|Overall Study||108
6803938|NCT02567825|7735753|FG001|COMPLETED|Overall Study||100
6803939|NCT02567825|7735752|FG000|NOT COMPLETED|Overall Study||21
6803940|NCT02567825|7735753|FG001|NOT COMPLETED|Overall Study||21
6803941|NCT02555657|7735761|FG000|STARTED|Overall Study||312
6803942|NCT02555657|7735762|FG001|STARTED|Overall Study||310
6803943|NCT02555657|7735761|FG000|Treated|Overall Study||309
6803944|NCT02555657|7735762|FG001|Treated|Overall Study||292
6803945|NCT02555657|7735761|FG000|COMPLETED|Overall Study||0
6803946|NCT02555657|7735762|FG001|COMPLETED|Overall Study||0
6803947|NCT02555657|7735761|FG000|NOT COMPLETED|Overall Study||312
6803948|NCT02555657|7735762|FG001|NOT COMPLETED|Overall Study||310
6803949|NCT02190721|7735772|FG000|STARTED|Overall Study||2
6803950|NCT02190721|7735773|FG001|STARTED|Overall Study||30
6803951|NCT02190721|7735774|FG002|STARTED|Overall Study||18
6803952|NCT02190721|7735772|FG000|Completed Treatment|Overall Study||2
6803953|NCT02190721|7735773|FG001|Completed Treatment|Overall Study||30
6803954|NCT02190721|7735774|FG002|Completed Treatment|Overall Study||18
6803955|NCT02190721|7735772|FG000|Completed 30 Day Follow-up|Overall Study||2
6803956|NCT02190721|7735773|FG001|Completed 30 Day Follow-up|Overall Study||29
6803957|NCT02190721|7735774|FG002|Completed 30 Day Follow-up|Overall Study||18
6803958|NCT02190721|7735772|FG000|Completed 90 Day Follow-up|Overall Study||2
6803959|NCT02190721|7735773|FG001|Completed 90 Day Follow-up|Overall Study||29
6803960|NCT02190721|7735774|FG002|Completed 90 Day Follow-up|Overall Study||18
6803961|NCT02190721|7735772|FG000|COMPLETED|Overall Study||2
6803962|NCT02190721|7735773|FG001|COMPLETED|Overall Study||29
6803963|NCT02190721|7735774|FG002|COMPLETED|Overall Study||18
6803964|NCT02190721|7735772|FG000|NOT COMPLETED|Overall Study||0
6803965|NCT02190721|7735773|FG001|NOT COMPLETED|Overall Study||1
6803966|NCT02190721|7735774|FG002|NOT COMPLETED|Overall Study||0
6803967|NCT00908687|7735788|FG000|STARTED|Overall Study||50
6803968|NCT00908687|7735789|FG001|STARTED|Overall Study||100
6803969|NCT00908687|7735790|FG002|STARTED|Overall Study||102
6803970|NCT00908687|7735791|FG003|STARTED|Overall Study||50
6803971|NCT00908687|7735792|FG004|STARTED|Overall Study||98
6803972|NCT00908687|7735793|FG005|STARTED|Overall Study||100
6803973|NCT00908687|7735788|FG000|COMPLETED|Overall Study||49
6803974|NCT00908687|7735789|FG001|COMPLETED|Overall Study||99
6803975|NCT00908687|7735790|FG002|COMPLETED|Overall Study||99
6803976|NCT00908687|7735791|FG003|COMPLETED|Overall Study||47
6803977|NCT00908687|7735792|FG004|COMPLETED|Overall Study||94
6803978|NCT00908687|7735793|FG005|COMPLETED|Overall Study||94
6803979|NCT00908687|7735788|FG000|NOT COMPLETED|Overall Study||1
6803980|NCT00908687|7735789|FG001|NOT COMPLETED|Overall Study||1
6803981|NCT00908687|7735790|FG002|NOT COMPLETED|Overall Study||3
6803982|NCT00908687|7735791|FG003|NOT COMPLETED|Overall Study||3
6803983|NCT00908687|7735792|FG004|NOT COMPLETED|Overall Study||4
6803984|NCT00908687|7735793|FG005|NOT COMPLETED|Overall Study||6
6803985|NCT00739401|7735807|FG000|STARTED|Overall Study||44
6803986|NCT00739401|7735807|FG000|COMPLETED|Overall Study||3
6803987|NCT00739401|7735807|FG000|NOT COMPLETED|Overall Study||41
6803988|NCT00651742|7735811|FG000|STARTED|Overall Study||28
6803989|NCT00651742|7735811|FG000|Treated|Overall Study||27
6803990|NCT00651742|7735811|FG000|Efficacy Analysis Per Investigator|Overall Study||21
6382769|NCT00791258|7293784|FG000|STARTED|Overall Study||999
6803991|NCT00651742|7735811|FG000|Efficacy Analysis Per Independent Reader|Overall Study||25
6803992|NCT00651742|7735811|FG000|COMPLETED|Overall Study||0
6803993|NCT00651742|7735811|FG000|NOT COMPLETED|Overall Study||28
6803994|NCT00308516|7735817|FG000|STARTED|Overall Study||35
6803995|NCT00308516|7735818|FG001|STARTED|Overall Study||31
6382770|NCT00791258|7293784|FG000|COMPLETED|Overall Study||736
6382771|NCT00791258|7293784|FG000|NOT COMPLETED|Overall Study||263
6382772|NCT00791323|7293790|FG000|STARTED|Overall Study||6
6382773|NCT00791323|7293791|FG001|STARTED|Overall Study||3
6382774|NCT00791323|7293790|FG000|COMPLETED|Overall Study||6
6803996|NCT00308516|7735817|FG000|COMPLETED|Overall Study||6
6803997|NCT00308516|7735818|FG001|COMPLETED|Overall Study||10
6803998|NCT00308516|7735817|FG000|NOT COMPLETED|Overall Study||29
6803999|NCT00308516|7735818|FG001|NOT COMPLETED|Overall Study||21
6804000|NCT04331366|7735824|FG000|STARTED|Overall Study||2
6804001|NCT04331366|7735824|FG000|COMPLETED|Overall Study||2
6804002|NCT04331366|7735824|FG000|NOT COMPLETED|Overall Study||0
6804003|NCT04930263|7735830|FG000|STARTED|Overall Study||33
6804004|NCT04930263|7735831|FG001|STARTED|Overall Study||33
6804005|NCT04930263|7735830|FG000|COMPLETED|Overall Study||30
6804006|NCT04930263|7735831|FG001|COMPLETED|Overall Study||28
6804007|NCT04930263|7735830|FG000|NOT COMPLETED|Overall Study||3
6804008|NCT04930263|7735831|FG001|NOT COMPLETED|Overall Study||5
6804009|NCT04321252|7735846|FG000|STARTED|Overall Study||6
6804010|NCT04321252|7735847|FG001|STARTED|Overall Study||6
6804011|NCT04321252|7735848|FG002|STARTED|Overall Study||6
6804012|NCT04321252|7735849|FG003|STARTED|Overall Study||6
6804013|NCT04321252|7735850|FG004|STARTED|Overall Study||6
6804014|NCT04321252|7735851|FG005|STARTED|Overall Study||9
6804015|NCT04321252|7735852|FG006|STARTED|Overall Study||6
6804016|NCT04321252|7735853|FG007|STARTED|Overall Study||6
6804017|NCT04321252|7735854|FG008|STARTED|Overall Study||6
6804018|NCT04321252|7735846|FG000|PK Analysis Set|Overall Study||6
6804019|NCT04321252|7735847|FG001|PK Analysis Set|Overall Study||6
6804020|NCT04321252|7735848|FG002|PK Analysis Set|Overall Study||6
6804021|NCT04321252|7735849|FG003|PK Analysis Set|Overall Study||6
6804022|NCT04321252|7735850|FG004|PK Analysis Set|Overall Study||6
6804023|NCT04321252|7735851|FG005|PK Analysis Set|Overall Study||0
6804024|NCT04321252|7735852|FG006|PK Analysis Set|Overall Study||6
6804025|NCT04321252|7735853|FG007|PK Analysis Set|Overall Study||6
6804026|NCT04321252|7735854|FG008|PK Analysis Set|Overall Study||0
6804027|NCT04321252|7735846|FG000|COMPLETED|Overall Study||6
6804028|NCT04321252|7735847|FG001|COMPLETED|Overall Study||6
6804029|NCT04321252|7735848|FG002|COMPLETED|Overall Study||6
6804030|NCT04321252|7735849|FG003|COMPLETED|Overall Study||6
6804031|NCT04321252|7735850|FG004|COMPLETED|Overall Study||6
6804032|NCT04321252|7735851|FG005|COMPLETED|Overall Study||8
6804033|NCT04321252|7735852|FG006|COMPLETED|Overall Study||6
6804034|NCT04321252|7735853|FG007|COMPLETED|Overall Study||6
6804035|NCT04321252|7735854|FG008|COMPLETED|Overall Study||6
6804036|NCT04321252|7735846|FG000|NOT COMPLETED|Overall Study||0
6804037|NCT04321252|7735847|FG001|NOT COMPLETED|Overall Study||0
6804038|NCT04321252|7735848|FG002|NOT COMPLETED|Overall Study||0
6804039|NCT04321252|7735849|FG003|NOT COMPLETED|Overall Study||0
6804040|NCT04321252|7735850|FG004|NOT COMPLETED|Overall Study||0
6804041|NCT04321252|7735851|FG005|NOT COMPLETED|Overall Study||1
6804042|NCT04321252|7735852|FG006|NOT COMPLETED|Overall Study||0
6804043|NCT04321252|7735853|FG007|NOT COMPLETED|Overall Study||0
6804044|NCT04321252|7735854|FG008|NOT COMPLETED|Overall Study||0
6804045|NCT04285684|7735880|FG000|STARTED|Overall Study||4
6804046|NCT04285684|7735880|FG000|COMPLETED|Overall Study||4
6804047|NCT04285684|7735880|FG000|NOT COMPLETED|Overall Study||0
6804048|NCT04176445|7735884|FG000|STARTED|Overall Study||12
6804049|NCT04176445|7735885|FG001|STARTED|Overall Study||7
6804050|NCT04176445|7735884|FG000|COMPLETED|Overall Study||12
6804051|NCT04176445|7735885|FG001|COMPLETED|Overall Study||5
6804052|NCT04176445|7735884|FG000|NOT COMPLETED|Overall Study||0
6804053|NCT04176445|7735885|FG001|NOT COMPLETED|Overall Study||2
6804054|NCT04126213|7735897|FG000|STARTED|Overall Study||70
6804055|NCT04126213|7735898|FG001|STARTED|Overall Study||75
6269393|NCT00074308|7168543|FG004|COMPLETED|Overall Study||23
6564678|NCT01813058|7487390|FG001|COMPLETED|Overall Study||56
6564679|NCT01813058|7487389|FG000|NOT COMPLETED|Overall Study||5
6564680|NCT01813058|7487390|FG001|NOT COMPLETED|Overall Study||4
6804056|NCT04126213|7735899|FG002|STARTED|Overall Study||68
6804057|NCT04126213|7735900|FG003|STARTED|Overall Study||67
6804058|NCT04126213|7735901|FG004|STARTED|Overall Study||73
6804059|NCT04126213|7735902|FG005|STARTED|Overall Study||66
6804060|NCT04126213|7735897|FG000|COMPLETED|Overall Study||58
6804061|NCT04126213|7735898|FG001|COMPLETED|Overall Study||70
6804062|NCT04126213|7735899|FG002|COMPLETED|Overall Study||59
6804063|NCT04126213|7735900|FG003|COMPLETED|Overall Study||54
6804064|NCT04126213|7735901|FG004|COMPLETED|Overall Study||67
6804065|NCT04126213|7735902|FG005|COMPLETED|Overall Study||55
6804066|NCT04126213|7735897|FG000|NOT COMPLETED|Overall Study||12
6804067|NCT04126213|7735898|FG001|NOT COMPLETED|Overall Study||5
6804068|NCT04126213|7735899|FG002|NOT COMPLETED|Overall Study||9
6804069|NCT04126213|7735900|FG003|NOT COMPLETED|Overall Study||13
6804070|NCT04126213|7735901|FG004|NOT COMPLETED|Overall Study||6
6804071|NCT04126213|7735902|FG005|NOT COMPLETED|Overall Study||11
6804072|NCT03916458|7735919|FG000|STARTED|Overall Study||62
6804073|NCT03916458|7735919|FG000|COMPLETED|Overall Study|Out of these 62 participants, 2 participants died. But data available before censoring date for these 2 participants were observed and included in results.|62
6804074|NCT03916458|7735919|FG000|NOT COMPLETED|Overall Study||0
6804075|NCT03672188|7735938|FG000|STARTED|Overall Study||6
6804076|NCT03672188|7735939|FG001|STARTED|Overall Study||6
6804077|NCT03672188|7735940|FG002|STARTED|Overall Study||6
6804078|NCT03672188|7735941|FG003|STARTED|Overall Study||8
6804079|NCT03672188|7735942|FG004|STARTED|Overall Study||6
6804080|NCT03672188|7735943|FG005|STARTED|Overall Study||6
6804081|NCT03672188|7735944|FG006|STARTED|Overall Study||12
6804082|NCT03672188|7735945|FG007|STARTED|Overall Study||3
6804083|NCT03672188|7735946|FG008|STARTED|Overall Study||6
6804084|NCT03672188|7735947|FG009|STARTED|Overall Study||6
6804085|NCT03672188|7735948|FG010|STARTED|Overall Study||3
6804086|NCT03672188|7735949|FG011|STARTED|Overall Study||3
6804087|NCT03672188|7735950|FG012|STARTED|Overall Study||3
6804088|NCT03672188|7735951|FG013|STARTED|Overall Study||6
6804089|NCT03672188|7735952|FG014|STARTED|Overall Study||2
6804090|NCT03672188|7735938|FG000|Dosed|Overall Study||6
6804091|NCT03672188|7735939|FG001|Dosed|Overall Study||6
6804092|NCT03672188|7735940|FG002|Dosed|Overall Study||6
6804093|NCT03672188|7735941|FG003|Dosed|Overall Study|1 subject was not dosed and therefore not included in any analyses.|7
6804094|NCT03672188|7735942|FG004|Dosed|Overall Study||6
6804095|NCT03672188|7735943|FG005|Dosed|Overall Study||6
6804096|NCT03672188|7735944|FG006|Dosed|Overall Study||12
6804097|NCT03672188|7735945|FG007|Dosed|Overall Study||3
6804098|NCT03672188|7735946|FG008|Dosed|Overall Study||6
6804099|NCT03672188|7735947|FG009|Dosed|Overall Study||6
6804100|NCT03672188|7735948|FG010|Dosed|Overall Study||3
6804101|NCT03672188|7735949|FG011|Dosed|Overall Study||3
6804102|NCT03672188|7735950|FG012|Dosed|Overall Study||3
6804103|NCT03672188|7735951|FG013|Dosed|Overall Study||6
6804104|NCT03672188|7735952|FG014|Dosed|Overall Study||2
6804105|NCT03672188|7735938|FG000|COMPLETED|Overall Study||6
6804106|NCT03672188|7735939|FG001|COMPLETED|Overall Study||6
6804107|NCT03672188|7735940|FG002|COMPLETED|Overall Study|1 Subject could not attend last follow up (Week 12 visit)|5
6804108|NCT03672188|7735941|FG003|COMPLETED|Overall Study||5
6804109|NCT03672188|7735942|FG004|COMPLETED|Overall Study||6
6804110|NCT03672188|7735943|FG005|COMPLETED|Overall Study||6
6804111|NCT03672188|7735944|FG006|COMPLETED|Overall Study||12
6804112|NCT03672188|7735945|FG007|COMPLETED|Overall Study||3
6804113|NCT03672188|7735946|FG008|COMPLETED|Overall Study||6
6804114|NCT03672188|7735947|FG009|COMPLETED|Overall Study||6
6804115|NCT03672188|7735948|FG010|COMPLETED|Overall Study||3
6804116|NCT03672188|7735949|FG011|COMPLETED|Overall Study||3
6269394|NCT00074308|7168539|FG000|NOT COMPLETED|Overall Study||0
6269395|NCT00074308|7168540|FG001|NOT COMPLETED|Overall Study||0
6382775|NCT00791323|7293791|FG001|COMPLETED|Overall Study||3
6382776|NCT00791323|7293790|FG000|NOT COMPLETED|Overall Study||0
6382777|NCT00791323|7293791|FG001|NOT COMPLETED|Overall Study||0
6382778|NCT00791388|7293802|FG000|STARTED|Period 1 - 50 mg Dose Group||3
6382779|NCT00791388|7293803|FG001|STARTED|Period 1 - 50 mg Dose Group||8
6382780|NCT00791388|7293804|FG002|STARTED|Period 1 - 50 mg Dose Group||0
6382781|NCT00791388|7293805|FG003|STARTED|Period 1 - 50 mg Dose Group||0
6382782|NCT00791388|7293806|FG004|STARTED|Period 1 - 50 mg Dose Group||0
6382783|NCT00791388|7293802|FG000|COMPLETED|Period 1 - 50 mg Dose Group||3
6382784|NCT00791388|7293803|FG001|COMPLETED|Period 1 - 50 mg Dose Group||7
6382785|NCT00791388|7293804|FG002|COMPLETED|Period 1 - 50 mg Dose Group||0
6382786|NCT00791388|7293805|FG003|COMPLETED|Period 1 - 50 mg Dose Group||0
6382787|NCT00791388|7293806|FG004|COMPLETED|Period 1 - 50 mg Dose Group||0
6382788|NCT00791388|7293802|FG000|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
6382789|NCT00791388|7293803|FG001|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
6382790|NCT00791388|7293804|FG002|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
6382791|NCT00791388|7293805|FG003|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
6382792|NCT00791388|7293806|FG004|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
6382793|NCT00791388|7293802|FG000|STARTED|Period 2 - 100 mg Dose Group||3
6382794|NCT00791388|7293803|FG001|STARTED|Period 2 - 100 mg Dose Group||0
6382795|NCT00791388|7293804|FG002|STARTED|Period 2 - 100 mg Dose Group||8
6382796|NCT00791388|7293805|FG003|STARTED|Period 2 - 100 mg Dose Group||0
6382797|NCT00791388|7293806|FG004|STARTED|Period 2 - 100 mg Dose Group||0
6382798|NCT00791388|7293802|FG000|COMPLETED|Period 2 - 100 mg Dose Group||2
6382799|NCT00791388|7293803|FG001|COMPLETED|Period 2 - 100 mg Dose Group||0
6382800|NCT00791388|7293804|FG002|COMPLETED|Period 2 - 100 mg Dose Group||8
6382801|NCT00791388|7293805|FG003|COMPLETED|Period 2 - 100 mg Dose Group||0
6382802|NCT00791388|7293806|FG004|COMPLETED|Period 2 - 100 mg Dose Group||0
6382803|NCT00791388|7293802|FG000|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
6382804|NCT00791388|7293803|FG001|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
6382805|NCT00791388|7293804|FG002|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
6382806|NCT00791388|7293805|FG003|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
6382807|NCT00791388|7293806|FG004|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
6382808|NCT00791388|7293802|FG000|STARTED|Period 3 - 200 mg Dose Group||3
6382809|NCT00791388|7293803|FG001|STARTED|Period 3 - 200 mg Dose Group||0
6382810|NCT00791388|7293804|FG002|STARTED|Period 3 - 200 mg Dose Group||0
6382811|NCT00791388|7293805|FG003|STARTED|Period 3 - 200 mg Dose Group||8
6382812|NCT00791388|7293806|FG004|STARTED|Period 3 - 200 mg Dose Group||0
6382813|NCT00791388|7293802|FG000|COMPLETED|Period 3 - 200 mg Dose Group||3
6382814|NCT00791388|7293803|FG001|COMPLETED|Period 3 - 200 mg Dose Group||0
6382815|NCT00791388|7293804|FG002|COMPLETED|Period 3 - 200 mg Dose Group||0
6382816|NCT00791388|7293805|FG003|COMPLETED|Period 3 - 200 mg Dose Group||8
6382817|NCT00791388|7293806|FG004|COMPLETED|Period 3 - 200 mg Dose Group||0
6564681|NCT01813071|7487405|FG000|STARTED|Overall Study||10
6804117|NCT03672188|7735950|FG012|COMPLETED|Overall Study|1 non-treatment related SAE of suicide during follow up period|2
6804118|NCT03672188|7735951|FG013|COMPLETED|Overall Study||6
6804119|NCT03672188|7735952|FG014|COMPLETED|Overall Study||2
6804120|NCT03672188|7735938|FG000|NOT COMPLETED|Overall Study||0
6804121|NCT03672188|7735939|FG001|NOT COMPLETED|Overall Study||0
6804122|NCT03672188|7735940|FG002|NOT COMPLETED|Overall Study||1
6804123|NCT03672188|7735941|FG003|NOT COMPLETED|Overall Study||3
6804124|NCT03672188|7735942|FG004|NOT COMPLETED|Overall Study||0
6804125|NCT03672188|7735943|FG005|NOT COMPLETED|Overall Study||0
6804126|NCT03672188|7735944|FG006|NOT COMPLETED|Overall Study||0
6804127|NCT03672188|7735945|FG007|NOT COMPLETED|Overall Study||0
6804128|NCT03672188|7735946|FG008|NOT COMPLETED|Overall Study||0
6804129|NCT03672188|7735947|FG009|NOT COMPLETED|Overall Study||0
6804130|NCT03672188|7735948|FG010|NOT COMPLETED|Overall Study||0
6804131|NCT03672188|7735949|FG011|NOT COMPLETED|Overall Study||0
6804132|NCT03672188|7735950|FG012|NOT COMPLETED|Overall Study||1
6804133|NCT03672188|7735951|FG013|NOT COMPLETED|Overall Study||0
6804134|NCT03672188|7735952|FG014|NOT COMPLETED|Overall Study||0
6804135|NCT03637959|7736018|FG000|STARTED|Overall Study||270
6804136|NCT03637959|7736018|FG000|COMPLETED|Overall Study||270
6804137|NCT03637959|7736018|FG000|NOT COMPLETED|Overall Study||0
6804138|NCT03573336|7736025|FG000|STARTED|Overall Study||2
6804139|NCT03573336|7736026|FG001|STARTED|Overall Study||4
6382818|NCT00791388|7293802|FG000|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6804140|NCT03573336|7736027|FG002|STARTED|Overall Study||2
6804141|NCT03573336|7736025|FG000|Treated|Overall Study||2
6804142|NCT03573336|7736026|FG001|Treated|Overall Study||4
6382819|NCT00791388|7293803|FG001|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6382820|NCT00791388|7293804|FG002|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6804143|NCT03573336|7736027|FG002|Treated|Overall Study||2
6804144|NCT03573336|7736025|FG000|COMPLETED|Overall Study||0
6804145|NCT03573336|7736026|FG001|COMPLETED|Overall Study||0
6804146|NCT03573336|7736027|FG002|COMPLETED|Overall Study||0
6804147|NCT03573336|7736025|FG000|NOT COMPLETED|Overall Study||2
6804148|NCT03573336|7736026|FG001|NOT COMPLETED|Overall Study||4
6804149|NCT03573336|7736027|FG002|NOT COMPLETED|Overall Study||2
6804150|NCT03230916|7736046|FG000|STARTED|Overall Study||7
6804151|NCT03230916|7736047|FG001|STARTED|Overall Study||6
6804152|NCT03230916|7736048|FG002|STARTED|Overall Study||6
6804153|NCT03230916|7736049|FG003|STARTED|Overall Study||4
6804154|NCT03230916|7736050|FG004|STARTED|Overall Study||4
6804155|NCT03230916|7736051|FG005|STARTED|Overall Study||6
6804156|NCT03230916|7736052|FG006|STARTED|Overall Study||3
6804157|NCT03230916|7736053|FG007|STARTED|Overall Study||2
6804158|NCT03230916|7736054|FG008|STARTED|Overall Study||2
6804159|NCT03230916|7736055|FG009|STARTED|Overall Study||3
6804160|NCT03230916|7736056|FG010|STARTED|Overall Study||4
6804161|NCT03230916|7736046|FG000|Treated|Overall Study||7
6804162|NCT03230916|7736047|FG001|Treated|Overall Study||6
6804163|NCT03230916|7736048|FG002|Treated|Overall Study||6
6804164|NCT03230916|7736049|FG003|Treated|Overall Study||4
6804165|NCT03230916|7736050|FG004|Treated|Overall Study||4
6804166|NCT03230916|7736051|FG005|Treated|Overall Study||5
6804167|NCT03230916|7736052|FG006|Treated|Overall Study||3
6804168|NCT03230916|7736053|FG007|Treated|Overall Study||2
6804169|NCT03230916|7736054|FG008|Treated|Overall Study||2
6804170|NCT03230916|7736055|FG009|Treated|Overall Study||3
6804171|NCT03230916|7736056|FG010|Treated|Overall Study||4
6804172|NCT03230916|7736046|FG000|COMPLETED|Overall Study||7
6804173|NCT03230916|7736047|FG001|COMPLETED|Overall Study||6
6804174|NCT03230916|7736048|FG002|COMPLETED|Overall Study||6
6804175|NCT03230916|7736049|FG003|COMPLETED|Overall Study||4
6804176|NCT03230916|7736050|FG004|COMPLETED|Overall Study||4
6804177|NCT03230916|7736051|FG005|COMPLETED|Overall Study||5
6804178|NCT03230916|7736052|FG006|COMPLETED|Overall Study||3
6804179|NCT03230916|7736053|FG007|COMPLETED|Overall Study||2
6804180|NCT03230916|7736054|FG008|COMPLETED|Overall Study||2
6804181|NCT03230916|7736055|FG009|COMPLETED|Overall Study||3
6804182|NCT03230916|7736056|FG010|COMPLETED|Overall Study||4
6804183|NCT03230916|7736046|FG000|NOT COMPLETED|Overall Study||0
6804184|NCT03230916|7736047|FG001|NOT COMPLETED|Overall Study||0
6804185|NCT03230916|7736048|FG002|NOT COMPLETED|Overall Study||0
6804186|NCT03230916|7736049|FG003|NOT COMPLETED|Overall Study||0
6804187|NCT03230916|7736050|FG004|NOT COMPLETED|Overall Study||0
6804188|NCT03230916|7736051|FG005|NOT COMPLETED|Overall Study||1
6804189|NCT03230916|7736052|FG006|NOT COMPLETED|Overall Study||0
6804190|NCT03230916|7736053|FG007|NOT COMPLETED|Overall Study||0
6804191|NCT03230916|7736054|FG008|NOT COMPLETED|Overall Study||0
6804192|NCT03230916|7736055|FG009|NOT COMPLETED|Overall Study||0
6804193|NCT03230916|7736056|FG010|NOT COMPLETED|Overall Study||0
6804194|NCT03195894|7736099|FG000|STARTED|Overall Study||59
6804195|NCT03195894|7736100|FG001|STARTED|Overall Study||56
6804196|NCT03195894|7736099|FG000|COMPLETED|Overall Study||26
6804197|NCT03195894|7736100|FG001|COMPLETED|Overall Study||28
6804198|NCT03195894|7736099|FG000|NOT COMPLETED|Overall Study||33
6804199|NCT03195894|7736100|FG001|NOT COMPLETED|Overall Study||28
6804200|NCT03032705|7736111|FG000|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
6804201|NCT03032705|7736112|FG001|STARTED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|51
6804202|NCT03032705|7736111|FG000|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
6382821|NCT00791388|7293805|FG003|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6382822|NCT00791388|7293806|FG004|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
6382823|NCT00791388|7293802|FG000|STARTED|Period 4 - 400 mg Dose Group||4
6382824|NCT00791388|7293803|FG001|STARTED|Period 4 - 400 mg Dose Group||0
6382825|NCT00791388|7293804|FG002|STARTED|Period 4 - 400 mg Dose Group||0
6382826|NCT00791388|7293805|FG003|STARTED|Period 4 - 400 mg Dose Group||0
6382827|NCT00791388|7293806|FG004|STARTED|Period 4 - 400 mg Dose Group||8
6382828|NCT00791388|7293802|FG000|COMPLETED|Period 4 - 400 mg Dose Group||4
6382829|NCT00791388|7293803|FG001|COMPLETED|Period 4 - 400 mg Dose Group||0
6503035|NCT01439009|7421836|FG001|COMPLETED|Overall Study||47
6503036|NCT01439009|7421835|FG000|NOT COMPLETED|Overall Study||8
6564682|NCT01813071|7487406|FG001|STARTED|Overall Study||10
6382830|NCT00791388|7293804|FG002|COMPLETED|Period 4 - 400 mg Dose Group||0
6382831|NCT00791388|7293805|FG003|COMPLETED|Period 4 - 400 mg Dose Group||0
6382832|NCT00791388|7293806|FG004|COMPLETED|Period 4 - 400 mg Dose Group||4
6503037|NCT01439009|7421836|FG001|NOT COMPLETED|Overall Study||3
6382833|NCT00791388|7293802|FG000|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
6804203|NCT03032705|7736112|FG001|Completion of Restorations (V2)|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|45
6804204|NCT03032705|7736111|FG000|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|29
6804205|NCT03032705|7736112|FG001|COMPLETED|Overall Study|"Number of participants are same (repeated) for both groups~unit = teeth"|28
6804206|NCT03032705|7736111|FG000|NOT COMPLETED|Overall Study||22
6804207|NCT03032705|7736112|FG001|NOT COMPLETED|Overall Study||23
6804208|NCT02573259|7736125|FG000|STARTED|Overall Study||2
6804209|NCT02573259|7736126|FG001|STARTED|Overall Study||8
6804210|NCT02573259|7736127|FG002|STARTED|Overall Study||8
6804211|NCT02573259|7736128|FG003|STARTED|Overall Study||7
6804212|NCT02573259|7736129|FG004|STARTED|Overall Study||15
6804213|NCT02573259|7736130|FG005|STARTED|Overall Study||68
6804214|NCT02573259|7736131|FG006|STARTED|Overall Study||39
6804215|NCT02573259|7736125|FG000|Treated|Overall Study||2
6804216|NCT02573259|7736126|FG001|Treated|Overall Study||8
6804217|NCT02573259|7736127|FG002|Treated|Overall Study||8
6804218|NCT02573259|7736128|FG003|Treated|Overall Study||7
6804219|NCT02573259|7736129|FG004|Treated|Overall Study||15
6804220|NCT02573259|7736130|FG005|Treated|Overall Study||68
6804221|NCT02573259|7736131|FG006|Treated|Overall Study||38
6804222|NCT02573259|7736125|FG000|COMPLETED|Overall Study||1
6804223|NCT02573259|7736126|FG001|COMPLETED|Overall Study||0
6804224|NCT02573259|7736127|FG002|COMPLETED|Overall Study||2
6804225|NCT02573259|7736128|FG003|COMPLETED|Overall Study||1
6804226|NCT02573259|7736129|FG004|COMPLETED|Overall Study||2
6804227|NCT02573259|7736130|FG005|COMPLETED|Overall Study||10
6804228|NCT02573259|7736131|FG006|COMPLETED|Overall Study||5
6804229|NCT02573259|7736125|FG000|NOT COMPLETED|Overall Study||1
6804230|NCT02573259|7736126|FG001|NOT COMPLETED|Overall Study||8
6804231|NCT02573259|7736127|FG002|NOT COMPLETED|Overall Study||6
6804232|NCT02573259|7736128|FG003|NOT COMPLETED|Overall Study||6
6804233|NCT02573259|7736129|FG004|NOT COMPLETED|Overall Study||13
6804234|NCT02573259|7736130|FG005|NOT COMPLETED|Overall Study||58
6804235|NCT02573259|7736131|FG006|NOT COMPLETED|Overall Study||34
6804236|NCT02318329|7736173|FG000|STARTED|Overall Study||3
6804237|NCT02318329|7736174|FG001|STARTED|Overall Study||4
6804238|NCT02318329|7736175|FG002|STARTED|Overall Study||3
6804239|NCT02318329|7736176|FG003|STARTED|Overall Study||3
6804240|NCT02318329|7736177|FG004|STARTED|Overall Study||3
6804241|NCT02318329|7736178|FG005|STARTED|Overall Study||3
6804242|NCT02318329|7736179|FG006|STARTED|Overall Study||1
6804243|NCT02318329|7736180|FG007|STARTED|Overall Study||1
6804244|NCT02318329|7736181|FG008|STARTED|Overall Study||6
6804245|NCT02318329|7736182|FG009|STARTED|Overall Study||52
6804246|NCT02318329|7736173|FG000|COMPLETED|Overall Study||0
6804247|NCT02318329|7736174|FG001|COMPLETED|Overall Study||0
6804248|NCT02318329|7736175|FG002|COMPLETED|Overall Study||0
6804249|NCT02318329|7736176|FG003|COMPLETED|Overall Study||0
6804250|NCT02318329|7736177|FG004|COMPLETED|Overall Study||0
6804251|NCT02318329|7736178|FG005|COMPLETED|Overall Study||0
6804252|NCT02318329|7736179|FG006|COMPLETED|Overall Study||0
6804253|NCT02318329|7736180|FG007|COMPLETED|Overall Study||0
6804254|NCT02318329|7736181|FG008|COMPLETED|Overall Study||0
6804255|NCT02318329|7736182|FG009|COMPLETED|Overall Study||0
6804256|NCT02318329|7736173|FG000|NOT COMPLETED|Overall Study||3
6804257|NCT02318329|7736174|FG001|NOT COMPLETED|Overall Study||4
6804258|NCT02318329|7736175|FG002|NOT COMPLETED|Overall Study||3
6804259|NCT02318329|7736176|FG003|NOT COMPLETED|Overall Study||3
6804260|NCT02318329|7736177|FG004|NOT COMPLETED|Overall Study||3
6804261|NCT02318329|7736178|FG005|NOT COMPLETED|Overall Study||3
6804262|NCT02318329|7736179|FG006|NOT COMPLETED|Overall Study||1
6804263|NCT02318329|7736180|FG007|NOT COMPLETED|Overall Study||1
6804264|NCT02318329|7736181|FG008|NOT COMPLETED|Overall Study||6
6804265|NCT02318329|7736182|FG009|NOT COMPLETED|Overall Study||52
6804266|NCT01602666|7736225|FG000|STARTED|Induction Chemotherapy||107
6804267|NCT01602666|7736226|FG001|STARTED|Induction Chemotherapy||137
6804268|NCT01602666|7736225|FG000|COMPLETED|Induction Chemotherapy||70
6804269|NCT01602666|7736226|FG001|COMPLETED|Induction Chemotherapy||113
6804270|NCT01602666|7736225|FG000|NOT COMPLETED|Induction Chemotherapy||37
6804271|NCT01602666|7736226|FG001|NOT COMPLETED|Induction Chemotherapy||24
6804272|NCT01602666|7736225|FG000|STARTED|Radiation Therapy on Protocol||70
6804273|NCT01602666|7736226|FG001|STARTED|Radiation Therapy on Protocol||113
6804274|NCT01602666|7736225|FG000|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||66
6804275|NCT01602666|7736226|FG001|Evaluable for Reduced Dose (30Gy)|Radiation Therapy on Protocol||0
6804276|NCT01602666|7736225|FG000|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||0
6804277|NCT01602666|7736226|FG001|Evaluable for Reduced Dose (18 Gy)|Radiation Therapy on Protocol||74
6804278|NCT01602666|7736225|FG000|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||0
6804279|NCT01602666|7736226|FG001|Evaluable for RT Dose (24Gy)|Radiation Therapy on Protocol||16
6804280|NCT01602666|7736225|FG000|COMPLETED|Radiation Therapy on Protocol||60
6804281|NCT01602666|7736226|FG001|COMPLETED|Radiation Therapy on Protocol||82
6804282|NCT01602666|7736225|FG000|NOT COMPLETED|Radiation Therapy on Protocol||10
6804283|NCT01602666|7736226|FG001|NOT COMPLETED|Radiation Therapy on Protocol||31
6804284|NCT01375959|7736236|FG000|STARTED|First Intervention (6 Weeks)||17
6804285|NCT01375959|7736237|FG001|STARTED|First Intervention (6 Weeks)||21
6804286|NCT01375959|7736236|FG000|Received Invertention|First Intervention (6 Weeks)||17
6804287|NCT01375959|7736237|FG001|Received Invertention|First Intervention (6 Weeks)||21
6804288|NCT01375959|7736236|FG000|COMPLETED|First Intervention (6 Weeks)|Two participants were withdrawn due to adverse events.|15
6804289|NCT01375959|7736237|FG001|COMPLETED|First Intervention (6 Weeks)|Three participants were withdrawn due to adverse events.|18
6804290|NCT01375959|7736236|FG000|NOT COMPLETED|First Intervention (6 Weeks)||2
6804291|NCT01375959|7736237|FG001|NOT COMPLETED|First Intervention (6 Weeks)||3
6804292|NCT01375959|7736236|FG000|STARTED|Wash-Out (3 Weeks)||15
6804293|NCT01375959|7736237|FG001|STARTED|Wash-Out (3 Weeks)||18
6804294|NCT01375959|7736236|FG000|COMPLETED|Wash-Out (3 Weeks)||15
6804295|NCT01375959|7736237|FG001|COMPLETED|Wash-Out (3 Weeks)||18
6804296|NCT01375959|7736236|FG000|NOT COMPLETED|Wash-Out (3 Weeks)||0
6804297|NCT01375959|7736237|FG001|NOT COMPLETED|Wash-Out (3 Weeks)||0
6804298|NCT01375959|7736236|FG000|STARTED|Second Intervention (6 Weeks)||15
6804299|NCT01375959|7736237|FG001|STARTED|Second Intervention (6 Weeks)||18
6804300|NCT01375959|7736236|FG000|COMPLETED|Second Intervention (6 Weeks)||15
6804301|NCT01375959|7736237|FG001|COMPLETED|Second Intervention (6 Weeks)||15
6804302|NCT01375959|7736236|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6804303|NCT01375959|7736237|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||3
6804304|NCT01224106|7736248|FG000|STARTED|Double-Blind Treatment Phase||266
6804305|NCT01224106|7736249|FG001|STARTED|Double-Blind Treatment Phase||271
6804306|NCT01224106|7736250|FG002|STARTED|Double-Blind Treatment Phase||260
6804307|NCT01224106|7736251|FG003|STARTED|Double-Blind Treatment Phase||0
6804308|NCT01224106|7736252|FG004|STARTED|Double-Blind Treatment Phase||0
6804309|NCT01224106|7736248|FG000|COMPLETED|Double-Blind Treatment Phase||187
6804310|NCT01224106|7736249|FG001|COMPLETED|Double-Blind Treatment Phase||185
6804311|NCT01224106|7736250|FG002|COMPLETED|Double-Blind Treatment Phase||180
6804312|NCT01224106|7736251|FG003|COMPLETED|Double-Blind Treatment Phase||0
6804313|NCT01224106|7736252|FG004|COMPLETED|Double-Blind Treatment Phase||0
6804314|NCT01224106|7736248|FG000|NOT COMPLETED|Double-Blind Treatment Phase||79
6804315|NCT01224106|7736249|FG001|NOT COMPLETED|Double-Blind Treatment Phase||86
6804316|NCT01224106|7736250|FG002|NOT COMPLETED|Double-Blind Treatment Phase||80
6804317|NCT01224106|7736251|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
6804318|NCT01224106|7736252|FG004|NOT COMPLETED|Double-Blind Treatment Phase||0
6804319|NCT01224106|7736248|FG000|STARTED|Open-Label Extension (OLE) Phase||0
6804320|NCT01224106|7736249|FG001|STARTED|Open-Label Extension (OLE) Phase||0
6503038|NCT01439035|7421842|FG000|STARTED|Overall Study||6
6503039|NCT01439035|7421842|FG000|COMPLETED|Overall Study||6
6503040|NCT01439035|7421842|FG000|NOT COMPLETED|Overall Study||0
6503041|NCT01439074|7421848|FG000|STARTED|Overall Study||75
6503042|NCT01439074|7421849|FG001|STARTED|Overall Study||87
6503043|NCT01439074|7421848|FG000|COMPLETED|Overall Study||66
6503044|NCT01439074|7421849|FG001|COMPLETED|Overall Study||74
6503045|NCT01439074|7421848|FG000|NOT COMPLETED|Overall Study||9
6503046|NCT01439074|7421849|FG001|NOT COMPLETED|Overall Study||13
6503047|NCT01439087|7421855|FG000|STARTED|Overall Study||2
6503048|NCT01439087|7421855|FG000|COMPLETED|Overall Study||2
6503049|NCT01439087|7421855|FG000|NOT COMPLETED|Overall Study||0
6503050|NCT01439126|7421861|FG000|STARTED|Overall Study||68
6804321|NCT01224106|7736250|FG002|STARTED|Open-Label Extension (OLE) Phase||0
6804322|NCT01224106|7736251|FG003|STARTED|Open-Label Extension (OLE) Phase||49
6804323|NCT01224106|7736252|FG004|STARTED|Open-Label Extension (OLE) Phase||105
6804324|NCT01224106|7736248|FG000|COMPLETED|Open-Label Extension (OLE) Phase||0
6804325|NCT01224106|7736249|FG001|COMPLETED|Open-Label Extension (OLE) Phase||0
6804326|NCT01224106|7736250|FG002|COMPLETED|Open-Label Extension (OLE) Phase||0
6804327|NCT01224106|7736251|FG003|COMPLETED|Open-Label Extension (OLE) Phase||33
6804328|NCT01224106|7736252|FG004|COMPLETED|Open-Label Extension (OLE) Phase||71
6804329|NCT01224106|7736248|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
6804330|NCT01224106|7736249|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
6804331|NCT01224106|7736250|FG002|NOT COMPLETED|Open-Label Extension (OLE) Phase||0
6804332|NCT01224106|7736251|FG003|NOT COMPLETED|Open-Label Extension (OLE) Phase||16
6804333|NCT01224106|7736252|FG004|NOT COMPLETED|Open-Label Extension (OLE) Phase||34
6804334|NCT00999609|7736272|FG000|STARTED|Overall Study|Before intervention|21
6804335|NCT00999609|7736273|FG001|STARTED|Overall Study||10
6804336|NCT00999609|7736272|FG000|COMPLETED|Overall Study|1 year post intervention|20
6804337|NCT00999609|7736273|FG001|COMPLETED|Overall Study|1 year post intervention|9
6804338|NCT00999609|7736272|FG000|NOT COMPLETED|Overall Study||1
6804339|NCT00999609|7736273|FG001|NOT COMPLETED|Overall Study||1
6804340|NCT00354835|7736281|FG000|STARTED|Overall Study||239
6804341|NCT00354835|7736282|FG001|STARTED|Overall Study||242
6804342|NCT00354835|7736281|FG000|COMPLETED|Overall Study||187
6804343|NCT00354835|7736282|FG001|COMPLETED|Overall Study||181
6804344|NCT00354835|7736281|FG000|NOT COMPLETED|Overall Study||52
6804345|NCT00354835|7736282|FG001|NOT COMPLETED|Overall Study||61
6564683|NCT01813071|7487407|FG002|STARTED|Overall Study||10
6564684|NCT01813071|7487408|FG003|STARTED|Overall Study||9
6564685|NCT01813071|7487409|FG004|STARTED|Overall Study||12
6564686|NCT01813071|7487410|FG005|STARTED|Overall Study||12
6564687|NCT01813071|7487411|FG006|STARTED|Overall Study||12
6564688|NCT01813071|7487412|FG007|STARTED|Overall Study||12
6564689|NCT01813071|7487413|FG008|STARTED|Overall Study||16
6564690|NCT01813071|7487405|FG000|COMPLETED|Overall Study||10
6564691|NCT01813071|7487406|FG001|COMPLETED|Overall Study||10
6564692|NCT01813071|7487407|FG002|COMPLETED|Overall Study||10
6564693|NCT01813071|7487408|FG003|COMPLETED|Overall Study||9
6564694|NCT01813071|7487409|FG004|COMPLETED|Overall Study||11
6564695|NCT01813071|7487410|FG005|COMPLETED|Overall Study||5
6564696|NCT01813071|7487411|FG006|COMPLETED|Overall Study||9
6564697|NCT01813071|7487412|FG007|COMPLETED|Overall Study||7
6564698|NCT01813071|7487413|FG008|COMPLETED|Overall Study||13
6269396|NCT00074308|7168541|FG002|NOT COMPLETED|Overall Study||0
6269397|NCT00074308|7168542|FG003|NOT COMPLETED|Overall Study||0
6269398|NCT00074308|7168543|FG004|NOT COMPLETED|Overall Study||0
6269399|NCT00074412|7168555|FG000|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
6269400|NCT00074412|7168556|FG001|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
6269401|NCT00074412|7168555|FG000|Week 8 Visit|Overall Study||759
6269402|NCT00074412|7168556|FG001|Week 8 Visit|Overall Study||759
6269403|NCT00074412|7168555|FG000|Month 3 Visit|Overall Study||759
6269404|NCT00074412|7168556|FG001|Month 3 Visit|Overall Study||755
6269405|NCT00074412|7168555|FG000|Month 4 Visit|Overall Study||758
6269406|NCT00074412|7168556|FG001|Month 4 Visit|Overall Study||752
6269407|NCT00074412|7168555|FG000|Month 5 Visit|Overall Study||756
6269408|NCT00074412|7168556|FG001|Month 5 Visit|Overall Study||750
6269409|NCT00074412|7168555|FG000|Month 6 Visit|Overall Study||748
6382834|NCT00791388|7293803|FG001|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
6382835|NCT00791388|7293804|FG002|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
6382836|NCT00791388|7293805|FG003|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
6382837|NCT00791388|7293806|FG004|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
6564699|NCT01813071|7487405|FG000|NOT COMPLETED|Overall Study||0
6564700|NCT01813071|7487406|FG001|NOT COMPLETED|Overall Study||0
6382838|NCT00791479|7293824|FG000|STARTED|Overall Study||35
6382839|NCT00791479|7293825|FG001|STARTED|Overall Study||34
6382840|NCT00791479|7293826|FG002|STARTED|Overall Study||34
6382841|NCT00791479|7293827|FG003|STARTED|Overall Study||29
6382842|NCT00791479|7293828|FG004|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
6382843|NCT00791479|7293829|FG005|STARTED|Overall Study||32
6382844|NCT00791479|7293824|FG000|Received at Least One Dose of Study Drug|Overall Study||35
6382845|NCT00791479|7293825|FG001|Received at Least One Dose of Study Drug|Overall Study||34
6382846|NCT00791479|7293826|FG002|Received at Least One Dose of Study Drug|Overall Study||34
6382847|NCT00791479|7293827|FG003|Received at Least One Dose of Study Drug|Overall Study||29
6382848|NCT00791479|7293828|FG004|Received at Least One Dose of Study Drug|Overall Study||3
6382849|NCT00791479|7293829|FG005|Received at Least One Dose of Study Drug|Overall Study||32
6382850|NCT00791479|7293824|FG000|COMPLETED|Overall Study||33
6382851|NCT00791479|7293825|FG001|COMPLETED|Overall Study||31
6382852|NCT00791479|7293826|FG002|COMPLETED|Overall Study||34
6503051|NCT01439126|7421862|FG001|STARTED|Overall Study||67
6503052|NCT01439126|7421861|FG000|COMPLETED|Overall Study||37
6503053|NCT01439126|7421862|FG001|COMPLETED|Overall Study||25
6503054|NCT01439126|7421861|FG000|NOT COMPLETED|Overall Study||31
6503055|NCT01439126|7421862|FG001|NOT COMPLETED|Overall Study||42
6503062|NCT01439204|7421879|FG000|STARTED|Overall Study||36
6503063|NCT01439204|7421880|FG001|STARTED|Overall Study||36
6503064|NCT01439204|7421879|FG000|COMPLETED|Overall Study||32
6503065|NCT01439204|7421880|FG001|COMPLETED|Overall Study||33
6503066|NCT01439204|7421879|FG000|NOT COMPLETED|Overall Study||4
6503067|NCT01439204|7421880|FG001|NOT COMPLETED|Overall Study||3
6503068|NCT01439282|7421888|FG000|STARTED|Overall Study||67
6503069|NCT01439282|7421889|FG001|STARTED|Overall Study||10
6564701|NCT01813071|7487407|FG002|NOT COMPLETED|Overall Study||0
6382853|NCT00791479|7293827|FG003|COMPLETED|Overall Study||25
6382854|NCT00791479|7293828|FG004|COMPLETED|Overall Study||0
6382855|NCT00791479|7293829|FG005|COMPLETED|Overall Study||29
6503070|NCT01439282|7421888|FG000|COMPLETED|Overall Study||59
6503071|NCT01439282|7421889|FG001|COMPLETED|Overall Study||9
6564702|NCT01813071|7487408|FG003|NOT COMPLETED|Overall Study||0
6564703|NCT01813071|7487409|FG004|NOT COMPLETED|Overall Study||1
6564704|NCT01813071|7487410|FG005|NOT COMPLETED|Overall Study||7
6382856|NCT00791479|7293824|FG000|NOT COMPLETED|Overall Study||2
6382857|NCT00791479|7293825|FG001|NOT COMPLETED|Overall Study||3
6382858|NCT00791479|7293826|FG002|NOT COMPLETED|Overall Study||0
6382859|NCT00791479|7293827|FG003|NOT COMPLETED|Overall Study||4
6382860|NCT00791479|7293828|FG004|NOT COMPLETED|Overall Study||3
6382861|NCT00791479|7293829|FG005|NOT COMPLETED|Overall Study||3
6382862|NCT00791492|7293852|FG000|STARTED|Overall Study||45
6382863|NCT00791492|7293853|FG001|STARTED|Overall Study||41
6382864|NCT00791492|7293852|FG000|TREATED|Overall Study||44
6382865|NCT00791492|7293853|FG001|TREATED|Overall Study||41
6382866|NCT00791492|7293852|FG000|COMPLETED|Overall Study||39
6382867|NCT00791492|7293853|FG001|COMPLETED|Overall Study||38
6382868|NCT00791492|7293852|FG000|NOT COMPLETED|Overall Study||6
6382869|NCT00791492|7293853|FG001|NOT COMPLETED|Overall Study||3
6382870|NCT00791518|7293859|FG000|STARTED|Overall Study||1084
6382871|NCT00791518|7293859|FG000|COMPLETED|Overall Study||991
6382872|NCT00791518|7293859|FG000|NOT COMPLETED|Overall Study||93
6382873|NCT00791557|7293878|FG000|STARTED|Overall Study||2
6382874|NCT00791557|7293878|FG000|COMPLETED|Overall Study||1
6382875|NCT00791557|7293878|FG000|NOT COMPLETED|Overall Study||1
6382876|NCT00791648|7293884|FG000|STARTED|Overall Study||308
6382877|NCT00791648|7293885|FG001|STARTED|Overall Study||309
6382878|NCT00791648|7293884|FG000|COMPLETED|Overall Study||308
6382879|NCT00791648|7293885|FG001|COMPLETED|Overall Study||307
6382880|NCT00791648|7293884|FG000|NOT COMPLETED|Overall Study||0
6382881|NCT00791648|7293885|FG001|NOT COMPLETED|Overall Study||2
6382882|NCT00791661|7293894|FG000|STARTED|Period 1||8
6382883|NCT00791661|7293895|FG001|STARTED|Period 1||8
6382884|NCT00791661|7293896|FG002|STARTED|Period 1||8
6382885|NCT00791661|7293894|FG000|Received MK-1006|Period 1||6
6382886|NCT00791661|7293895|FG001|Received MK-1006|Period 1||6
6382887|NCT00791661|7293896|FG002|Received MK-1006|Period 1||6
6382888|NCT00791661|7293894|FG000|Received Matching Placebo to MK-1006|Period 1||2
6564705|NCT01813071|7487411|FG006|NOT COMPLETED|Overall Study||3
6564706|NCT01813071|7487412|FG007|NOT COMPLETED|Overall Study||5
6564707|NCT01813071|7487413|FG008|NOT COMPLETED|Overall Study||3
6382889|NCT00791661|7293895|FG001|Received Matching Placebo to MK-1006|Period 1||2
6382890|NCT00791661|7293896|FG002|Received Matching Placebo to MK-1006|Period 1||2
6564708|NCT01813110|7487447|FG000|STARTED|Overall Study||10
6564709|NCT01813110|7487448|FG001|STARTED|Overall Study||11
6564710|NCT01813110|7487447|FG000|COMPLETED|Overall Study||10
6564711|NCT01813110|7487448|FG001|COMPLETED|Overall Study||10
6564712|NCT01813110|7487447|FG000|NOT COMPLETED|Overall Study||0
6564713|NCT01813110|7487448|FG001|NOT COMPLETED|Overall Study||1
6564714|NCT01813149|7487457|FG000|STARTED|Overall Study||90
6564715|NCT01813149|7487458|FG001|STARTED|Overall Study||38
6564716|NCT01813149|7487457|FG000|COMPLETED|Overall Study||90
6564717|NCT01813149|7487458|FG001|COMPLETED|Overall Study||38
6564718|NCT01813149|7487457|FG000|NOT COMPLETED|Overall Study||0
6564719|NCT01813149|7487458|FG001|NOT COMPLETED|Overall Study||0
6656752|NCT02464176|7587073|FG002|STARTED|Overall Study||15
6656753|NCT02464176|7587071|FG000|COMPLETED|Overall Study||50
6656754|NCT02464176|7587072|FG001|COMPLETED|Overall Study||50
6656755|NCT02464176|7587073|FG002|COMPLETED|Overall Study||15
6656756|NCT02464176|7587071|FG000|NOT COMPLETED|Overall Study||0
6656757|NCT02464176|7587072|FG001|NOT COMPLETED|Overall Study||0
6656758|NCT02464176|7587073|FG002|NOT COMPLETED|Overall Study||0
6382891|NCT00791661|7293894|FG000|COMPLETED|Period 1||8
6564720|NCT01813214|7487471|FG000|STARTED|Overall Study||3
6656759|NCT02464449|7587083|FG000|STARTED|Overall Study||166
6656760|NCT02464449|7587084|FG001|STARTED|Overall Study||112
6656761|NCT02464449|7587083|FG000|COMPLETED|Overall Study||151
6656762|NCT02464449|7587084|FG001|COMPLETED|Overall Study||100
6382892|NCT00791661|7293895|FG001|COMPLETED|Period 1||8
6382893|NCT00791661|7293896|FG002|COMPLETED|Period 1||8
6382894|NCT00791661|7293894|FG000|NOT COMPLETED|Period 1||0
6382895|NCT00791661|7293895|FG001|NOT COMPLETED|Period 1||0
6382896|NCT00791661|7293896|FG002|NOT COMPLETED|Period 1||0
6382897|NCT00791661|7293894|FG000|STARTED|7 Day Wash-out||8
6382898|NCT00791661|7293895|FG001|STARTED|7 Day Wash-out||8
6382899|NCT00791661|7293896|FG002|STARTED|7 Day Wash-out||8
6382900|NCT00791661|7293894|FG000|COMPLETED|7 Day Wash-out||8
6382901|NCT00791661|7293895|FG001|COMPLETED|7 Day Wash-out||8
6382902|NCT00791661|7293896|FG002|COMPLETED|7 Day Wash-out||6
6382903|NCT00791661|7293894|FG000|NOT COMPLETED|7 Day Wash-out||0
6382904|NCT00791661|7293895|FG001|NOT COMPLETED|7 Day Wash-out||0
6382905|NCT00791661|7293896|FG002|NOT COMPLETED|7 Day Wash-out||2
6382906|NCT00791661|7293894|FG000|STARTED|Period 2||8
6382907|NCT00791661|7293895|FG001|STARTED|Period 2||8
6382908|NCT00791661|7293896|FG002|STARTED|Period 2||6
6382909|NCT00791661|7293894|FG000|Received MK-1006|Period 2||6
6382910|NCT00791661|7293895|FG001|Received MK-1006|Period 2||6
6382911|NCT00791661|7293896|FG002|Received MK-1006|Period 2||4
6382912|NCT00791661|7293894|FG000|Received Matching Placebo to MK-1006|Period 2||2
6382913|NCT00791661|7293895|FG001|Received Matching Placebo to MK-1006|Period 2||2
6382914|NCT00791661|7293896|FG002|Received Matching Placebo to MK-1006|Period 2||2
6382915|NCT00791661|7293894|FG000|COMPLETED|Period 2||8
6382916|NCT00791661|7293895|FG001|COMPLETED|Period 2||8
6382917|NCT00791661|7293896|FG002|COMPLETED|Period 2||6
6382918|NCT00791661|7293894|FG000|NOT COMPLETED|Period 2||0
6382919|NCT00791661|7293895|FG001|NOT COMPLETED|Period 2||0
6382920|NCT00791661|7293896|FG002|NOT COMPLETED|Period 2||0
6382921|NCT00791661|7293894|FG000|STARTED|7 Day Wash-out||8
6382922|NCT00791661|7293895|FG001|STARTED|7 Day Wash-out||8
6382923|NCT00791661|7293896|FG002|STARTED|7 Day Wash-out||6
6382924|NCT00791661|7293894|FG000|COMPLETED|7 Day Wash-out||8
6382925|NCT00791661|7293895|FG001|COMPLETED|7 Day Wash-out||8
6382926|NCT00791661|7293896|FG002|COMPLETED|7 Day Wash-out||6
6382927|NCT00791661|7293894|FG000|NOT COMPLETED|7 Day Wash-out||0
6382928|NCT00791661|7293895|FG001|NOT COMPLETED|7 Day Wash-out||0
6382929|NCT00791661|7293896|FG002|NOT COMPLETED|7 Day Wash-out||0
6382930|NCT00791661|7293894|FG000|STARTED|Period 3||8
6382931|NCT00791661|7293895|FG001|STARTED|Period 3||8
6564721|NCT01813214|7487472|FG001|STARTED|Overall Study||2
6382932|NCT00791661|7293896|FG002|STARTED|Period 3||6
6382933|NCT00791661|7293894|FG000|Received MK-1006|Period 3||6
6382934|NCT00791661|7293895|FG001|Received MK-1006|Period 3||6
6382935|NCT00791661|7293896|FG002|Received MK-1006|Period 3||5
6382936|NCT00791661|7293894|FG000|Received Matching Placebo to MK-1006|Period 3||2
6382937|NCT00791661|7293895|FG001|Received Matching Placebo to MK-1006|Period 3||2
6382938|NCT00791661|7293896|FG002|Received Matching Placebo to MK-1006|Period 3||1
6382939|NCT00791661|7293894|FG000|COMPLETED|Period 3||8
6564722|NCT01813214|7487471|FG000|COMPLETED|Overall Study||3
6564723|NCT01813214|7487472|FG001|COMPLETED|Overall Study||2
6564724|NCT01813214|7487471|FG000|NOT COMPLETED|Overall Study||0
6564725|NCT01813214|7487472|FG001|NOT COMPLETED|Overall Study||0
6564726|NCT01813357|7487480|FG000|STARTED|Overall Study||40
6564727|NCT01813357|7487481|FG001|STARTED|Overall Study||44
6564728|NCT01813357|7487480|FG000|COMPLETED|Overall Study||35
6564729|NCT01813357|7487481|FG001|COMPLETED|Overall Study||38
6564730|NCT01813357|7487480|FG000|NOT COMPLETED|Overall Study||5
6564731|NCT01813357|7487481|FG001|NOT COMPLETED|Overall Study||6
6564732|NCT01813422|7487489|FG000|STARTED|Overall Study||486
6564733|NCT01813422|7487490|FG001|STARTED|Overall Study||484
6564734|NCT01813422|7487489|FG000|Received Treatment|Overall Study||484
6564735|NCT01813422|7487490|FG001|Received Treatment|Overall Study||484
6564736|NCT01813422|7487489|FG000|COMPLETED|Overall Study||466
6564737|NCT01813422|7487490|FG001|COMPLETED|Overall Study||468
6564738|NCT01813422|7487489|FG000|NOT COMPLETED|Overall Study||20
6564739|NCT01813422|7487490|FG001|NOT COMPLETED|Overall Study||16
6564740|NCT01813474|7487499|FG000|STARTED|Overall Study||4
6564741|NCT01813474|7487500|FG001|STARTED|Overall Study||7
6564742|NCT01813474|7487501|FG002|STARTED|Overall Study||12
6564743|NCT01813474|7487499|FG000|COMPLETED|Overall Study|ongoing study at final data cut off|1
6564744|NCT01813474|7487500|FG001|COMPLETED|Overall Study||0
6564745|NCT01813474|7487501|FG002|COMPLETED|Overall Study|ongoing study at final data cut off|1
6564746|NCT01813474|7487499|FG000|NOT COMPLETED|Overall Study||3
6564747|NCT01813474|7487500|FG001|NOT COMPLETED|Overall Study||7
6564748|NCT01813474|7487501|FG002|NOT COMPLETED|Overall Study||11
6564749|NCT01813721|7487510|FG000|STARTED|Overall Study|Indicates number of participants enrolled|1007
6564750|NCT01813721|7487510|FG000|COMPLETED|Overall Study||943
6564751|NCT01813721|7487510|FG000|NOT COMPLETED|Overall Study||64
6564752|NCT01813734|7487532|FG000|STARTED|Overall Study||9
6564753|NCT01813734|7487532|FG000|COMPLETED|Overall Study||9
6564754|NCT01813734|7487532|FG000|NOT COMPLETED|Overall Study||0
6564755|NCT01813890|7487539|FG000|STARTED|Overall Study||20
6564756|NCT01813890|7487540|FG001|STARTED|Overall Study||21
6564757|NCT01813890|7487541|FG002|STARTED|Overall Study||19
6564758|NCT01813890|7487539|FG000|COMPLETED|Overall Study||11
6564759|NCT01813890|7487540|FG001|COMPLETED|Overall Study||17
6656763|NCT02464449|7587083|FG000|NOT COMPLETED|Overall Study||15
6656764|NCT02464449|7587084|FG001|NOT COMPLETED|Overall Study||12
6656765|NCT02464540|7587090|FG000|STARTED|Overall Study||11
6656766|NCT02464540|7587091|FG001|STARTED|Overall Study||11
6656767|NCT02464540|7587090|FG000|COMPLETED|Overall Study||11
6656768|NCT02464540|7587091|FG001|COMPLETED|Overall Study||11
6656769|NCT02464540|7587090|FG000|NOT COMPLETED|Overall Study||0
6656770|NCT02464540|7587091|FG001|NOT COMPLETED|Overall Study||0
6656771|NCT02464657|7587100|FG000|STARTED|Overall Study||3
6382940|NCT00791661|7293895|FG001|COMPLETED|Period 3||8
6382941|NCT00791661|7293896|FG002|COMPLETED|Period 3||6
6382942|NCT00791661|7293894|FG000|NOT COMPLETED|Period 3||0
6382943|NCT00791661|7293895|FG001|NOT COMPLETED|Period 3||0
6382944|NCT00791661|7293896|FG002|NOT COMPLETED|Period 3||0
6382945|NCT00791700|7293924|FG000|STARTED|Overall Study||16
6382946|NCT00791700|7293925|FG001|STARTED|Overall Study||31
6382947|NCT00791700|7293926|FG002|STARTED|Overall Study||13
6382948|NCT00791700|7293927|FG003|STARTED|Overall Study||43
6382949|NCT00791700|7293924|FG000|COMPLETED|Overall Study||10
6382950|NCT00791700|7293925|FG001|COMPLETED|Overall Study||20
6382951|NCT00791700|7293926|FG002|COMPLETED|Overall Study||7
6382952|NCT00791700|7293927|FG003|COMPLETED|Overall Study||13
6382953|NCT00791700|7293924|FG000|NOT COMPLETED|Overall Study||6
6382954|NCT00791700|7293925|FG001|NOT COMPLETED|Overall Study||11
6564760|NCT01813890|7487541|FG002|COMPLETED|Overall Study||13
6503072|NCT01439282|7421888|FG000|NOT COMPLETED|Overall Study||8
6564761|NCT01813890|7487539|FG000|NOT COMPLETED|Overall Study||9
6503073|NCT01439282|7421889|FG001|NOT COMPLETED|Overall Study||1
6503074|NCT01439360|7421898|FG000|STARTED|Overall Study||6006
6503075|NCT01439360|7421899|FG001|STARTED|Overall Study||6012
6503076|NCT01439360|7421898|FG000|COMPLETED|Overall Study||5808
6503077|NCT01439360|7421899|FG001|COMPLETED|Overall Study||5804
6503078|NCT01439360|7421898|FG000|NOT COMPLETED|Overall Study||198
6503079|NCT01439360|7421899|FG001|NOT COMPLETED|Overall Study||208
6503080|NCT01439373|7421907|FG000|STARTED|Monotherapy (Day 1)||11
6503081|NCT01439373|7421908|FG001|STARTED|Monotherapy (Day 1)||5
6503082|NCT01439373|7421907|FG000|COMPLETED|Monotherapy (Day 1)||11
6564762|NCT01813890|7487540|FG001|NOT COMPLETED|Overall Study||4
6564763|NCT01813890|7487541|FG002|NOT COMPLETED|Overall Study||6
6382955|NCT00791700|7293926|FG002|NOT COMPLETED|Overall Study||6
6382956|NCT00791700|7293927|FG003|NOT COMPLETED|Overall Study||30
6382957|NCT00791765|7293950|FG000|STARTED|Weeks 1 to 12||62
6382958|NCT00791765|7293951|FG001|STARTED|Weeks 1 to 12||62
6382959|NCT00791765|7293950|FG000|Treated|Weeks 1 to 12||62
6382960|NCT00791765|7293951|FG001|Treated|Weeks 1 to 12||59
6382961|NCT00791765|7293950|FG000|COMPLETED|Weeks 1 to 12||54
6382962|NCT00791765|7293951|FG001|COMPLETED|Weeks 1 to 12||58
6382963|NCT00791765|7293950|FG000|NOT COMPLETED|Weeks 1 to 12||8
6382964|NCT00791765|7293951|FG001|NOT COMPLETED|Weeks 1 to 12||4
6382965|NCT00791765|7293950|FG000|STARTED|Weeks 13 to 24||54
6382966|NCT00791765|7293951|FG001|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
6382967|NCT00791765|7293950|FG000|COMPLETED|Weeks 13 to 24||49
6382968|NCT00791765|7293951|FG001|COMPLETED|Weeks 13 to 24||49
6564764|NCT01814007|7487549|FG000|STARTED|Overall Study||35
6269410|NCT00074412|7168556|FG001|Month 6 Visit|Overall Study||748
6269411|NCT00074412|7168555|FG000|Month 9 Visit|Overall Study||741
6269412|NCT00074412|7168556|FG001|Month 9 Visit|Overall Study||741
6269413|NCT00074412|7168555|FG000|Month 12 Visit|Overall Study||733
6564765|NCT01814007|7487549|FG000|COMPLETED|Overall Study||34
6564766|NCT01814007|7487549|FG000|NOT COMPLETED|Overall Study||1
6564767|NCT01814046|7487556|FG000|STARTED|Drug Administration||22
6564768|NCT01814046|7487557|FG001|STARTED|Drug Administration||2
6564769|NCT01814046|7487558|FG002|STARTED|Drug Administration||0
6564770|NCT01814046|7487556|FG000|COMPLETED|Drug Administration||21
6564771|NCT01814046|7487557|FG001|COMPLETED|Drug Administration||2
6656772|NCT02464657|7587101|FG001|STARTED|Overall Study||2
6656773|NCT02464657|7587102|FG002|STARTED|Overall Study||39
6382969|NCT00791765|7293950|FG000|NOT COMPLETED|Weeks 13 to 24||5
6382970|NCT00791765|7293951|FG001|NOT COMPLETED|Weeks 13 to 24||8
6382971|NCT00791778|7293959|FG000|STARTED|Double-blind Treatment||123
6382972|NCT00791778|7293960|FG001|STARTED|Double-blind Treatment||123
6382973|NCT00791778|7293959|FG000|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
6382974|NCT00791778|7293960|FG001|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
6382975|NCT00791778|7293959|FG000|NOT COMPLETED|Double-blind Treatment||77
6382976|NCT00791778|7293960|FG001|NOT COMPLETED|Double-blind Treatment||48
6382977|NCT00791778|7293959|FG000|STARTED|Follow-up||100
6382978|NCT00791778|7293960|FG001|STARTED|Follow-up||91
6382979|NCT00791778|7293959|FG000|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
6382980|NCT00791778|7293960|FG001|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
6382981|NCT00791778|7293959|FG000|NOT COMPLETED|Follow-up||5
6382982|NCT00791778|7293960|FG001|NOT COMPLETED|Follow-up||1
6382983|NCT00791817|7293968|FG000|STARTED|1: Single Dose Followed by Week Washout||5
6382984|NCT00791817|7293969|FG001|STARTED|1: Single Dose Followed by Week Washout||5
6382985|NCT00791817|7293968|FG000|COMPLETED|1: Single Dose Followed by Week Washout||5
6382986|NCT00791817|7293969|FG001|COMPLETED|1: Single Dose Followed by Week Washout||5
6382987|NCT00791817|7293968|FG000|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
6382988|NCT00791817|7293969|FG001|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
6382989|NCT00791817|7293968|FG000|STARTED|2: Single Dose||5
6382990|NCT00791817|7293969|FG001|STARTED|2: Single Dose||5
6382991|NCT00791817|7293968|FG000|COMPLETED|2: Single Dose||5
6382992|NCT00791817|7293969|FG001|COMPLETED|2: Single Dose||5
6382993|NCT00791817|7293968|FG000|NOT COMPLETED|2: Single Dose||0
6382994|NCT00791817|7293969|FG001|NOT COMPLETED|2: Single Dose||0
6382995|NCT00791908|7293975|FG000|STARTED|Overall Study||15
6382996|NCT00791908|7293975|FG000|COMPLETED|Overall Study||15
6382997|NCT00791908|7293975|FG000|NOT COMPLETED|Overall Study||0
6382998|NCT00791921|7293985|FG000|STARTED|Overall Study||116
6503083|NCT01439373|7421908|FG001|COMPLETED|Monotherapy (Day 1)||4
6382999|NCT00791921|7293986|FG001|STARTED|Overall Study||114
6804346|NCT04531241|7736303|FG000|STARTED|Period 1||68
6804347|NCT04531241|7736304|FG001|STARTED|Period 1||67
6804348|NCT04531241|7736303|FG000|COMPLETED|Period 1||64
6804349|NCT04531241|7736304|FG001|COMPLETED|Period 1||65
6804350|NCT04531241|7736303|FG000|NOT COMPLETED|Period 1||4
6804351|NCT04531241|7736304|FG001|NOT COMPLETED|Period 1||2
6804352|NCT04531241|7736303|FG000|STARTED|Period 2||64
6804353|NCT04531241|7736304|FG001|STARTED|Period 2||65
6804354|NCT04531241|7736303|FG000|COMPLETED|Period 2||63
6804355|NCT04531241|7736304|FG001|COMPLETED|Period 2||64
6804356|NCT04531241|7736303|FG000|NOT COMPLETED|Period 2||1
6804357|NCT04531241|7736304|FG001|NOT COMPLETED|Period 2||1
6804358|NCT04456153|7736312|FG000|STARTED|Overall Study||19
6804359|NCT04456153|7736313|FG001|STARTED|Overall Study||41
6804360|NCT04456153|7736312|FG000|COMPLETED|Overall Study||19
6804361|NCT04456153|7736313|FG001|COMPLETED|Overall Study||41
6804362|NCT04456153|7736312|FG000|NOT COMPLETED|Overall Study||0
6804363|NCT04456153|7736313|FG001|NOT COMPLETED|Overall Study||0
6804364|NCT04351243|7736335|FG000|STARTED|Overall Study||114
6804365|NCT04351243|7736336|FG001|STARTED|Overall Study||113
6804366|NCT04351243|7736335|FG000|Completed Baseline Assessment|Overall Study||113
6383000|NCT00791921|7293985|FG000|COMPLETED|Overall Study||82
6383001|NCT00791921|7293986|FG001|COMPLETED|Overall Study||18
6383002|NCT00791921|7293985|FG000|NOT COMPLETED|Overall Study||34
6383003|NCT00791921|7293986|FG001|NOT COMPLETED|Overall Study||96
6383004|NCT00791934|7293992|FG000|STARTED|Overall Study||63
6383005|NCT00791934|7293992|FG000|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
6383006|NCT00791934|7293992|FG000|NOT COMPLETED|Overall Study||15
6383007|NCT00791973|7293998|FG000|STARTED|First Intervention (1 Week)||8
6383008|NCT00791973|7293999|FG001|STARTED|First Intervention (1 Week)||7
6383009|NCT00791973|7293998|FG000|COMPLETED|First Intervention (1 Week)||8
6383010|NCT00791973|7293999|FG001|COMPLETED|First Intervention (1 Week)||7
6383011|NCT00791973|7293998|FG000|NOT COMPLETED|First Intervention (1 Week)||0
6383012|NCT00791973|7293999|FG001|NOT COMPLETED|First Intervention (1 Week)||0
6383013|NCT00791973|7293998|FG000|STARTED|Washout (1 Week)||8
6383014|NCT00791973|7293999|FG001|STARTED|Washout (1 Week)||7
6383015|NCT00791973|7293998|FG000|COMPLETED|Washout (1 Week)||8
6383016|NCT00791973|7293999|FG001|COMPLETED|Washout (1 Week)||7
6383017|NCT00791973|7293998|FG000|NOT COMPLETED|Washout (1 Week)||0
6383018|NCT00791973|7293999|FG001|NOT COMPLETED|Washout (1 Week)||0
6383019|NCT00791973|7293998|FG000|STARTED|Second Intervention (1 Week)||8
6383020|NCT00791973|7293999|FG001|STARTED|Second Intervention (1 Week)||7
6383021|NCT00791973|7293998|FG000|COMPLETED|Second Intervention (1 Week)||8
6383022|NCT00791973|7293999|FG001|COMPLETED|Second Intervention (1 Week)||7
6383023|NCT00791973|7293998|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6383024|NCT00791973|7293999|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6383025|NCT00791999|7294009|FG000|STARTED|Overall Study||72
6383026|NCT00791999|7294010|FG001|STARTED|Overall Study||82
6383027|NCT00791999|7294011|FG002|STARTED|Overall Study||85
6383028|NCT00791999|7294012|FG003|STARTED|Overall Study||77
6383029|NCT00791999|7294009|FG000|COMPLETED|Overall Study||51
6383030|NCT00791999|7294010|FG001|COMPLETED|Overall Study||66
6383031|NCT00791999|7294011|FG002|COMPLETED|Overall Study||65
6383032|NCT00791999|7294012|FG003|COMPLETED|Overall Study||25
6383033|NCT00791999|7294009|FG000|NOT COMPLETED|Overall Study||21
6383034|NCT00791999|7294010|FG001|NOT COMPLETED|Overall Study||16
6383035|NCT00791999|7294011|FG002|NOT COMPLETED|Overall Study||20
6383036|NCT00791999|7294012|FG003|NOT COMPLETED|Overall Study||52
6383037|NCT00792077|7294022|FG000|STARTED|Overall Study||6
6383038|NCT00792077|7294022|FG000|Day 15+/- 3 Days|Overall Study||6
6383039|NCT00792077|7294022|FG000|Day 29+/-3 Days|Overall Study||6
6383040|NCT00792077|7294022|FG000|Day 43+/-3 Days|Overall Study||6
6383041|NCT00792077|7294022|FG000|Day 57+/-3 Days|Overall Study||6
6383042|NCT00792077|7294022|FG000|COMPLETED|Overall Study||6
6383043|NCT00792077|7294022|FG000|NOT COMPLETED|Overall Study||0
6383044|NCT00792103|7294026|FG000|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
6383045|NCT00792103|7294026|FG000|COMPLETED|Overall Study||65
6383046|NCT00792103|7294026|FG000|NOT COMPLETED|Overall Study||133
6383047|NCT00792142|7294030|FG000|STARTED|Overall Study||45
6383048|NCT00792142|7294030|FG000|COMPLETED|Overall Study||45
6383049|NCT00792142|7294030|FG000|NOT COMPLETED|Overall Study||0
6383050|NCT00792298|7294034|FG000|STARTED|Treatment Period 1||31
6383051|NCT00792298|7294035|FG001|STARTED|Treatment Period 1||32
6383052|NCT00792298|7294036|FG002|STARTED|Treatment Period 1||33
6383053|NCT00792298|7294037|FG003|STARTED|Treatment Period 1||32
6383054|NCT00792298|7294038|FG004|STARTED|Treatment Period 1||32
6383055|NCT00792298|7294039|FG005|STARTED|Treatment Period 1||32
6383056|NCT00792298|7294040|FG006|STARTED|Treatment Period 1||31
6383057|NCT00792298|7294041|FG007|STARTED|Treatment Period 1||31
6383058|NCT00792298|7294034|FG000|COMPLETED|Treatment Period 1||30
6383059|NCT00792298|7294035|FG001|COMPLETED|Treatment Period 1||31
6383060|NCT00792298|7294036|FG002|COMPLETED|Treatment Period 1||31
6383061|NCT00792298|7294037|FG003|COMPLETED|Treatment Period 1||28
6383062|NCT00792298|7294038|FG004|COMPLETED|Treatment Period 1||32
6383063|NCT00792298|7294039|FG005|COMPLETED|Treatment Period 1||29
6383064|NCT00792298|7294040|FG006|COMPLETED|Treatment Period 1||27
6383065|NCT00792298|7294041|FG007|COMPLETED|Treatment Period 1||30
6383066|NCT00792298|7294034|FG000|NOT COMPLETED|Treatment Period 1||1
6383067|NCT00792298|7294035|FG001|NOT COMPLETED|Treatment Period 1||1
6383068|NCT00792298|7294036|FG002|NOT COMPLETED|Treatment Period 1||2
6383069|NCT00792298|7294037|FG003|NOT COMPLETED|Treatment Period 1||4
6383070|NCT00792298|7294038|FG004|NOT COMPLETED|Treatment Period 1||0
6383071|NCT00792298|7294039|FG005|NOT COMPLETED|Treatment Period 1||3
6383072|NCT00792298|7294040|FG006|NOT COMPLETED|Treatment Period 1||4
6383073|NCT00792298|7294041|FG007|NOT COMPLETED|Treatment Period 1||1
6383074|NCT00792298|7294034|FG000|STARTED|Washout||30
6383075|NCT00792298|7294035|FG001|STARTED|Washout||31
6383076|NCT00792298|7294036|FG002|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
6383077|NCT00792298|7294037|FG003|STARTED|Washout||28
6383078|NCT00792298|7294038|FG004|STARTED|Washout||32
6383079|NCT00792298|7294039|FG005|STARTED|Washout||29
6383080|NCT00792298|7294040|FG006|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
6383081|NCT00792298|7294041|FG007|STARTED|Washout||30
6383082|NCT00792298|7294034|FG000|COMPLETED|Washout||30
6383083|NCT00792298|7294035|FG001|COMPLETED|Washout||31
6383084|NCT00792298|7294036|FG002|COMPLETED|Washout||31
6383085|NCT00792298|7294037|FG003|COMPLETED|Washout||28
6383086|NCT00792298|7294038|FG004|COMPLETED|Washout||32
6383087|NCT00792298|7294039|FG005|COMPLETED|Washout||27
6564772|NCT01814046|7487558|FG002|COMPLETED|Drug Administration||0
6564773|NCT01814046|7487556|FG000|NOT COMPLETED|Drug Administration||1
6564774|NCT01814046|7487557|FG001|NOT COMPLETED|Drug Administration||0
6383088|NCT00792298|7294040|FG006|COMPLETED|Washout||29
6383089|NCT00792298|7294041|FG007|COMPLETED|Washout||30
6383090|NCT00792298|7294034|FG000|NOT COMPLETED|Washout||0
6383091|NCT00792298|7294035|FG001|NOT COMPLETED|Washout||0
6383092|NCT00792298|7294036|FG002|NOT COMPLETED|Washout||1
6383093|NCT00792298|7294037|FG003|NOT COMPLETED|Washout||0
6804367|NCT04351243|7736336|FG001|Completed Baseline Assessment|Overall Study||112
6804368|NCT04351243|7736335|FG000|COMPLETED|Overall Study||74
6804369|NCT04351243|7736336|FG001|COMPLETED|Overall Study||75
6804370|NCT04351243|7736335|FG000|NOT COMPLETED|Overall Study||40
6383094|NCT00792298|7294038|FG004|NOT COMPLETED|Washout||0
6383095|NCT00792298|7294039|FG005|NOT COMPLETED|Washout||2
6383096|NCT00792298|7294040|FG006|NOT COMPLETED|Washout||0
6383097|NCT00792298|7294041|FG007|NOT COMPLETED|Washout||0
6383098|NCT00792298|7294034|FG000|STARTED|Treatment Period 2||30
6383099|NCT00792298|7294035|FG001|STARTED|Treatment Period 2||31
6383100|NCT00792298|7294036|FG002|STARTED|Treatment Period 2||31
6383101|NCT00792298|7294037|FG003|STARTED|Treatment Period 2||28
6383102|NCT00792298|7294038|FG004|STARTED|Treatment Period 2||32
6383103|NCT00792298|7294039|FG005|STARTED|Treatment Period 2||27
6383104|NCT00792298|7294040|FG006|STARTED|Treatment Period 2||29
6383105|NCT00792298|7294041|FG007|STARTED|Treatment Period 2||30
6383106|NCT00792298|7294034|FG000|COMPLETED|Treatment Period 2||29
6383107|NCT00792298|7294035|FG001|COMPLETED|Treatment Period 2||30
6383108|NCT00792298|7294036|FG002|COMPLETED|Treatment Period 2||30
6383109|NCT00792298|7294037|FG003|COMPLETED|Treatment Period 2||26
6383110|NCT00792298|7294038|FG004|COMPLETED|Treatment Period 2||30
6383111|NCT00792298|7294039|FG005|COMPLETED|Treatment Period 2||27
6383112|NCT00792298|7294040|FG006|COMPLETED|Treatment Period 2||28
6383113|NCT00792298|7294041|FG007|COMPLETED|Treatment Period 2||28
6383114|NCT00792298|7294034|FG000|NOT COMPLETED|Treatment Period 2||1
6383115|NCT00792298|7294035|FG001|NOT COMPLETED|Treatment Period 2||1
6383116|NCT00792298|7294036|FG002|NOT COMPLETED|Treatment Period 2||1
6383117|NCT00792298|7294037|FG003|NOT COMPLETED|Treatment Period 2||2
6383118|NCT00792298|7294038|FG004|NOT COMPLETED|Treatment Period 2||2
6383119|NCT00792298|7294039|FG005|NOT COMPLETED|Treatment Period 2||0
6383120|NCT00792298|7294040|FG006|NOT COMPLETED|Treatment Period 2||1
6383121|NCT00792298|7294041|FG007|NOT COMPLETED|Treatment Period 2||2
6383122|NCT00792428|7294060|FG000|STARTED|Overall Study||10
6383123|NCT00792428|7294061|FG001|STARTED|Overall Study||10
6383124|NCT00792428|7294060|FG000|COMPLETED|Overall Study||10
6383125|NCT00792428|7294061|FG001|COMPLETED|Overall Study||10
6383126|NCT00792428|7294060|FG000|NOT COMPLETED|Overall Study||0
6383127|NCT00792428|7294061|FG001|NOT COMPLETED|Overall Study||0
6395633|NCT00859638|7308240|FG000|STARTED|Overall Study||65
6395634|NCT00859638|7308241|FG001|STARTED|Overall Study||59
6395635|NCT00859638|7308240|FG000|COMPLETED|Overall Study||55
6395636|NCT00859638|7308241|FG001|COMPLETED|Overall Study||55
6395637|NCT00859638|7308240|FG000|NOT COMPLETED|Overall Study||10
6395638|NCT00859638|7308241|FG001|NOT COMPLETED|Overall Study||4
6395639|NCT00859651|7308249|FG000|STARTED|Overall Study||18
6395640|NCT00859651|7308250|FG001|STARTED|Overall Study||22
6395641|NCT00859651|7308249|FG000|COMPLETED|Overall Study||18
6395642|NCT00859651|7308250|FG001|COMPLETED|Overall Study||22
6395643|NCT00859651|7308249|FG000|NOT COMPLETED|Overall Study||0
6395644|NCT00859651|7308250|FG001|NOT COMPLETED|Overall Study||0
6503084|NCT01439373|7421907|FG000|NOT COMPLETED|Monotherapy (Day 1)||0
6503085|NCT01439373|7421908|FG001|NOT COMPLETED|Monotherapy (Day 1)||1
6503086|NCT01439373|7421907|FG000|STARTED|Combined With PEG and RIBA (Day 2 to 28)||11
6503087|NCT01439373|7421908|FG001|STARTED|Combined With PEG and RIBA (Day 2 to 28)||4
6503088|NCT01439373|7421907|FG000|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||9
6503089|NCT01439373|7421908|FG001|COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||4
6503090|NCT01439373|7421907|FG000|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||2
6503091|NCT01439373|7421908|FG001|NOT COMPLETED|Combined With PEG and RIBA (Day 2 to 28)||0
6503092|NCT01439555|7421918|FG000|STARTED|Overall Study||11
6564775|NCT01814046|7487558|FG002|NOT COMPLETED|Drug Administration||0
6804371|NCT04351243|7736336|FG001|NOT COMPLETED|Overall Study||38
6503093|NCT01439555|7421918|FG000|COMPLETED|Overall Study||10
6503094|NCT01439555|7421918|FG000|NOT COMPLETED|Overall Study||1
6503095|NCT01439568|7421924|FG000|STARTED|Overall Study||47
6503096|NCT01439568|7421925|FG001|STARTED|Overall Study||43
6503097|NCT01439568|7421924|FG000|Received at Least One Dose of Study Drug|Overall Study||47
6564776|NCT01814046|7487556|FG000|STARTED|Retreatment||0
6564777|NCT01814046|7487557|FG001|STARTED|Retreatment||0
6383128|NCT00792467|7294067|FG000|STARTED|Overall Study||24
6383129|NCT00792467|7294067|FG000|COMPLETED|Overall Study||2
6383130|NCT00792467|7294067|FG000|NOT COMPLETED|Overall Study||22
6383131|NCT00792571|7294072|FG000|STARTED|Overall Study||18
6383132|NCT00792571|7294072|FG000|COMPLETED|Overall Study||8
6383133|NCT00792571|7294072|FG000|NOT COMPLETED|Overall Study||10
6503098|NCT01439568|7421925|FG001|Received at Least One Dose of Study Drug|Overall Study||43
6503099|NCT01439568|7421924|FG000|COMPLETED|Overall Study||44
6503100|NCT01439568|7421925|FG001|COMPLETED|Overall Study||41
6503101|NCT01439568|7421924|FG000|NOT COMPLETED|Overall Study||3
6503102|NCT01439568|7421925|FG001|NOT COMPLETED|Overall Study||2
6503103|NCT01439581|7421933|FG000|STARTED|Overall Study||216
6503104|NCT01439581|7421934|FG001|STARTED|Overall Study||212
6503105|NCT01439581|7421933|FG000|COMPLETED|Overall Study||216
6503106|NCT01439581|7421934|FG001|COMPLETED|Overall Study||212
6503107|NCT01439581|7421933|FG000|NOT COMPLETED|Overall Study||0
6503108|NCT01439581|7421934|FG001|NOT COMPLETED|Overall Study||0
6503109|NCT01439594|7421940|FG000|STARTED|Overall Study||17
6503110|NCT01439594|7421940|FG000|COMPLETED|Overall Study||17
6503111|NCT01439594|7421940|FG000|NOT COMPLETED|Overall Study||0
6503112|NCT01439620|7421944|FG000|STARTED|Overall Study||7
6503113|NCT01439620|7421944|FG000|COMPLETED|Overall Study||7
6503114|NCT01439620|7421944|FG000|NOT COMPLETED|Overall Study||0
6503115|NCT01439633|7421948|FG000|STARTED|Overall Study||22
6503116|NCT01439633|7421948|FG000|COMPLETED|Overall Study||22
6503117|NCT01439633|7421948|FG000|NOT COMPLETED|Overall Study||0
6503118|NCT01439672|7421952|FG000|STARTED|Overall Study||35
6503119|NCT01439672|7421952|FG000|COMPLETED|Overall Study||11
6503120|NCT01439672|7421952|FG000|NOT COMPLETED|Overall Study||24
6503121|NCT01439711|7421956|FG000|STARTED|Overall Study||108
6503122|NCT01439711|7421956|FG000|COMPLETED|Overall Study||68
6503123|NCT01439711|7421956|FG000|NOT COMPLETED|Overall Study||40
6503124|NCT01439724|7421962|FG000|STARTED|Overall Study||47
6503125|NCT01439724|7421963|FG001|STARTED|Overall Study||47
6503126|NCT01439724|7421962|FG000|COMPLETED|Overall Study||38
6503127|NCT01439724|7421963|FG001|COMPLETED|Overall Study||39
6503128|NCT01439724|7421962|FG000|NOT COMPLETED|Overall Study||9
6503129|NCT01439724|7421963|FG001|NOT COMPLETED|Overall Study||8
6503130|NCT01439815|7421971|FG000|STARTED|Overall Study||11
6503131|NCT01439815|7421972|FG001|STARTED|Overall Study||11
6503132|NCT01439815|7421971|FG000|All Randomized Participant Population|Overall Study||11
6503133|NCT01439815|7421972|FG001|All Randomized Participant Population|Overall Study||11
6503134|NCT01439815|7421971|FG000|COMPLETED|Overall Study||11
6503135|NCT01439815|7421972|FG001|COMPLETED|Overall Study||9
6503136|NCT01439815|7421971|FG000|NOT COMPLETED|Overall Study||0
6503137|NCT01439815|7421972|FG001|NOT COMPLETED|Overall Study||2
6503138|NCT01439854|7421980|FG000|STARTED|Overall Study||8
6503139|NCT01439854|7421981|FG001|STARTED|Overall Study||10
6503140|NCT01439854|7421980|FG000|COMPLETED|Overall Study||8
6503141|NCT01439854|7421981|FG001|COMPLETED|Overall Study||10
6503142|NCT01439854|7421980|FG000|NOT COMPLETED|Overall Study||0
6503143|NCT01439854|7421981|FG001|NOT COMPLETED|Overall Study||0
6503144|NCT01439867|7421989|FG000|STARTED|Overall Study||8
6503145|NCT01439867|7421990|FG001|STARTED|Overall Study||10
6503146|NCT01439867|7421989|FG000|Received Treatment|Overall Study||7
6503147|NCT01439867|7421990|FG001|Received Treatment|Overall Study||10
6503148|NCT01439867|7421989|FG000|COMPLETED|Overall Study||2
6503149|NCT01439867|7421990|FG001|COMPLETED|Overall Study||2
6503150|NCT01439867|7421989|FG000|NOT COMPLETED|Overall Study||6
6503151|NCT01439867|7421990|FG001|NOT COMPLETED|Overall Study||8
6503152|NCT01439880|7422000|FG000|STARTED|SOC-controlled Period (Year 1)||442
6503153|NCT01439880|7422001|FG001|STARTED|SOC-controlled Period (Year 1)||882
6503154|NCT01439880|7422000|FG000|Received Evolocumab|SOC-controlled Period (Year 1)||0
6503155|NCT01439880|7422001|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||881
6383134|NCT00792610|7294076|FG000|STARTED|Overall Study||127
6383135|NCT00792610|7294076|FG000|Youths|Overall Study||127
6383136|NCT00792610|7294076|FG000|COMPLETED|Overall Study||127
6383137|NCT00792610|7294076|FG000|NOT COMPLETED|Overall Study||0
6383138|NCT00792623|7294080|FG000|STARTED|Overall Study||29
6383139|NCT00792623|7294080|FG000|COMPLETED|Overall Study||22
6383140|NCT00792623|7294080|FG000|NOT COMPLETED|Overall Study||7
6383141|NCT00792636|7294088|FG000|STARTED|Overall Study||135
6383142|NCT00792636|7294089|FG001|STARTED|Overall Study||136
6383143|NCT00792636|7294090|FG002|STARTED|Overall Study||136
6383144|NCT00792636|7294088|FG000|COMPLETED|Overall Study||67
6383145|NCT00792636|7294089|FG001|COMPLETED|Overall Study||55
6383146|NCT00792636|7294090|FG002|COMPLETED|Overall Study||55
6383147|NCT00792636|7294088|FG000|NOT COMPLETED|Overall Study||68
6383148|NCT00792636|7294089|FG001|NOT COMPLETED|Overall Study||81
6383149|NCT00792636|7294090|FG002|NOT COMPLETED|Overall Study||81
6383150|NCT00792688|7294103|FG000|STARTED|Overall Study||9
6383151|NCT00792688|7294104|FG001|STARTED|Overall Study||8
6383152|NCT00792688|7294105|FG002|STARTED|Overall Study||9
6383153|NCT00792688|7294103|FG000|COMPLETED|Overall Study||9
6503156|NCT01439880|7422000|FG000|COMPLETED|SOC-controlled Period (Year 1)||398
6503157|NCT01439880|7422001|FG001|COMPLETED|SOC-controlled Period (Year 1)||822
6383154|NCT00792688|7294104|FG001|COMPLETED|Overall Study||8
6383155|NCT00792688|7294105|FG002|COMPLETED|Overall Study||9
6383156|NCT00792688|7294103|FG000|NOT COMPLETED|Overall Study||0
6503158|NCT01439880|7422000|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||44
6503159|NCT01439880|7422001|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||60
6503160|NCT01439880|7422000|FG000|STARTED|All-IP Period (Years 2 to 5)||398
6503161|NCT01439880|7422001|FG001|STARTED|All-IP Period (Years 2 to 5)||822
6503162|NCT01439880|7422000|FG000|Received Evolocumab|All-IP Period (Years 2 to 5)||374
6503163|NCT01439880|7422001|FG001|Received Evolocumab|All-IP Period (Years 2 to 5)||777
6503164|NCT01439880|7422000|FG000|COMPLETED|All-IP Period (Years 2 to 5)||328
6503165|NCT01439880|7422001|FG001|COMPLETED|All-IP Period (Years 2 to 5)||682
6503166|NCT01439880|7422000|FG000|NOT COMPLETED|All-IP Period (Years 2 to 5)||70
6503167|NCT01439880|7422001|FG001|NOT COMPLETED|All-IP Period (Years 2 to 5)||140
6503168|NCT01439945|7422021|FG000|STARTED|Double-Blind Treatment Phase||97
6503169|NCT01439945|7422022|FG001|STARTED|Double-Blind Treatment Phase||96
6503170|NCT01439945|7422023|FG002|STARTED|Double-Blind Treatment Phase||48
6503171|NCT01439945|7422024|FG003|STARTED|Double-Blind Treatment Phase||48
6503172|NCT01439945|7422021|FG000|COMPLETED|Double-Blind Treatment Phase||93
6503173|NCT01439945|7422022|FG001|COMPLETED|Double-Blind Treatment Phase||91
6503174|NCT01439945|7422023|FG002|COMPLETED|Double-Blind Treatment Phase||45
6503175|NCT01439945|7422024|FG003|COMPLETED|Double-Blind Treatment Phase||46
6503176|NCT01439945|7422021|FG000|NOT COMPLETED|Double-Blind Treatment Phase||4
6503177|NCT01439945|7422022|FG001|NOT COMPLETED|Double-Blind Treatment Phase||5
6503178|NCT01439945|7422023|FG002|NOT COMPLETED|Double-Blind Treatment Phase||3
6503179|NCT01439945|7422024|FG003|NOT COMPLETED|Double-Blind Treatment Phase||2
6503180|NCT01439945|7422021|FG000|STARTED|Optional Continuation Phase||72
6503181|NCT01439945|7422022|FG001|STARTED|Optional Continuation Phase||44
6564778|NCT01814046|7487558|FG002|STARTED|Retreatment||3
6564779|NCT01814046|7487556|FG000|COMPLETED|Retreatment||0
6564780|NCT01814046|7487557|FG001|COMPLETED|Retreatment||0
6503182|NCT01439945|7422023|FG002|STARTED|Optional Continuation Phase||0
6503183|NCT01439945|7422024|FG003|STARTED|Optional Continuation Phase||0
6503184|NCT01439945|7422021|FG000|COMPLETED|Optional Continuation Phase||72
6503185|NCT01439945|7422022|FG001|COMPLETED|Optional Continuation Phase||44
6503186|NCT01439945|7422023|FG002|COMPLETED|Optional Continuation Phase||0
6503187|NCT01439945|7422024|FG003|COMPLETED|Optional Continuation Phase||0
6503188|NCT01439945|7422021|FG000|NOT COMPLETED|Optional Continuation Phase||0
6503189|NCT01439945|7422022|FG001|NOT COMPLETED|Optional Continuation Phase||0
6503190|NCT01439945|7422023|FG002|NOT COMPLETED|Optional Continuation Phase||0
6503191|NCT01439945|7422024|FG003|NOT COMPLETED|Optional Continuation Phase||0
6503192|NCT01439971|7422040|FG000|STARTED|Overall Study||1
6503193|NCT01439971|7422041|FG001|STARTED|Overall Study||7
6503194|NCT01439971|7422042|FG002|STARTED|Overall Study||8
6564781|NCT01814046|7487558|FG002|COMPLETED|Retreatment||3
6564782|NCT01814046|7487556|FG000|NOT COMPLETED|Retreatment||0
6503195|NCT01439971|7422043|FG003|STARTED|Overall Study||6
6503196|NCT01439971|7422044|FG004|STARTED|Overall Study||7
6503197|NCT01439971|7422040|FG000|Received Treatment|Overall Study||1
6503198|NCT01439971|7422041|FG001|Received Treatment|Overall Study||6
6503199|NCT01439971|7422042|FG002|Received Treatment|Overall Study||6
6503200|NCT01439971|7422043|FG003|Received Treatment|Overall Study||6
6503201|NCT01439971|7422044|FG004|Received Treatment|Overall Study||6
6503202|NCT01439971|7422040|FG000|COMPLETED|Overall Study||1
6503203|NCT01439971|7422041|FG001|COMPLETED|Overall Study||6
6564783|NCT01814046|7487557|FG001|NOT COMPLETED|Retreatment||0
6564784|NCT01814046|7487558|FG002|NOT COMPLETED|Retreatment||0
6564785|NCT01814072|7487597|FG000|STARTED|Overall Study||18
6564786|NCT01814072|7487598|FG001|STARTED|Overall Study||18
6564787|NCT01814072|7487599|FG002|STARTED|Overall Study||18
6564788|NCT01814072|7487600|FG003|STARTED|Overall Study||18
6564789|NCT01814072|7487601|FG004|STARTED|Overall Study||18
6564790|NCT01814072|7487602|FG005|STARTED|Overall Study||18
6804372|NCT04312256|7736342|FG000|STARTED|Overall Study||81
6804373|NCT04312256|7736342|FG000|COMPLETED|Overall Study||81
6804374|NCT04312256|7736342|FG000|NOT COMPLETED|Overall Study||0
6804375|NCT04185220|7736349|FG000|STARTED|Dose Escalation||3
6804376|NCT04185220|7736350|FG001|STARTED|Dose Escalation||3
6804377|NCT04185220|7736349|FG000|COMPLETED|Dose Escalation||3
6804378|NCT04185220|7736350|FG001|COMPLETED|Dose Escalation||1
6804379|NCT04185220|7736349|FG000|NOT COMPLETED|Dose Escalation||0
6804380|NCT04185220|7736350|FG001|NOT COMPLETED|Dose Escalation||2
6804381|NCT04185220|7736349|FG000|STARTED|Dose Expansion||0
6804382|NCT04185220|7736350|FG001|STARTED|Dose Expansion||0
6564791|NCT01814072|7487603|FG006|STARTED|Overall Study||18
6804383|NCT04185220|7736349|FG000|COMPLETED|Dose Expansion||0
6804384|NCT04185220|7736350|FG001|COMPLETED|Dose Expansion||0
6564792|NCT01814072|7487604|FG007|STARTED|Overall Study||18
6564793|NCT01814072|7487605|FG008|STARTED|Overall Study||19
6564794|NCT01814072|7487606|FG009|STARTED|Overall Study||18
6564795|NCT01814072|7487607|FG010|STARTED|Overall Study||18
6564796|NCT01814072|7487608|FG011|STARTED|Overall Study||18
6804385|NCT04185220|7736349|FG000|NOT COMPLETED|Dose Expansion||0
6804386|NCT04185220|7736350|FG001|NOT COMPLETED|Dose Expansion||0
6804387|NCT03851107|7736357|FG000|STARTED|Overall Study||9
6804388|NCT03851107|7736357|FG000|COMPLETED|Overall Study||7
6383157|NCT00792688|7294104|FG001|NOT COMPLETED|Overall Study||0
6383158|NCT00792688|7294105|FG002|NOT COMPLETED|Overall Study||0
6564797|NCT01814072|7487609|FG012|STARTED|Overall Study||18
6656774|NCT02464657|7587100|FG000|COMPLETED|Overall Study||3
6804389|NCT03851107|7736357|FG000|NOT COMPLETED|Overall Study||2
6804390|NCT03815175|7736367|FG000|STARTED|Overall Study||1605
6804391|NCT03815175|7736367|FG000|COMPLETED|Overall Study||1439
6804392|NCT03815175|7736367|FG000|NOT COMPLETED|Overall Study||166
6804393|NCT03600714|7736371|FG000|STARTED|Overall Study||26
6804394|NCT03600714|7736371|FG000|COMPLETED|Overall Study||25
6804395|NCT03600714|7736371|FG000|NOT COMPLETED|Overall Study||1
6804396|NCT03479307|7736378|FG000|STARTED|Overall Study||91
6804397|NCT03479307|7736379|FG001|STARTED|Overall Study||90
6564798|NCT01814072|7487610|FG013|STARTED|Overall Study||18
6564799|NCT01814072|7487611|FG014|STARTED|Overall Study||18
6656775|NCT02464657|7587101|FG001|COMPLETED|Overall Study||2
6656776|NCT02464657|7587102|FG002|COMPLETED|Overall Study||39
6656777|NCT02464657|7587100|FG000|NOT COMPLETED|Overall Study||0
6656778|NCT02464657|7587101|FG001|NOT COMPLETED|Overall Study||0
6383159|NCT00792701|7294115|FG000|STARTED|Overall Study||19
6656779|NCT02464657|7587102|FG002|NOT COMPLETED|Overall Study||0
6656780|NCT02464917|7587113|FG000|STARTED|Overall Study||35
6656781|NCT02464917|7587114|FG001|STARTED|Overall Study||35
6656782|NCT02464917|7587113|FG000|COMPLETED|Overall Study||35
6503204|NCT01439971|7422042|FG002|COMPLETED|Overall Study||6
6503205|NCT01439971|7422043|FG003|COMPLETED|Overall Study||6
6503206|NCT01439971|7422044|FG004|COMPLETED|Overall Study||6
6503207|NCT01439971|7422040|FG000|NOT COMPLETED|Overall Study||0
6564800|NCT01814072|7487612|FG015|STARTED|Overall Study||18
6503208|NCT01439971|7422041|FG001|NOT COMPLETED|Overall Study||1
6503209|NCT01439971|7422042|FG002|NOT COMPLETED|Overall Study||2
6503210|NCT01439971|7422043|FG003|NOT COMPLETED|Overall Study||0
6804398|NCT03479307|7736380|FG002|STARTED|Overall Study||47
6269414|NCT00074412|7168556|FG001|Month 12 Visit|Overall Study||735
6269415|NCT00074412|7168555|FG000|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
6269416|NCT00074412|7168556|FG001|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
6269417|NCT00074412|7168555|FG000|NOT COMPLETED|Overall Study||82
6269418|NCT00074412|7168556|FG001|NOT COMPLETED|Overall Study||84
6269419|NCT00074490|7168568|FG000|STARTED|Overall Study||1
6269420|NCT00074490|7168569|FG001|STARTED|Overall Study||34
6269421|NCT00074490|7168570|FG002|STARTED|Overall Study||40
6269422|NCT00074490|7168571|FG003|STARTED|Overall Study||44
6269423|NCT00074490|7168572|FG004|STARTED|Overall Study||45
6269424|NCT00074490|7168573|FG005|STARTED|Overall Study||221
6269425|NCT00074490|7168568|FG000|COMPLETED|Overall Study||1
6269426|NCT00074490|7168569|FG001|COMPLETED|Overall Study||27
6804399|NCT03479307|7736378|FG000|COMPLETED|Overall Study||90
6804400|NCT03479307|7736379|FG001|COMPLETED|Overall Study||89
6804401|NCT03479307|7736380|FG002|COMPLETED|Overall Study||47
6804402|NCT03479307|7736378|FG000|NOT COMPLETED|Overall Study||1
6804403|NCT03479307|7736379|FG001|NOT COMPLETED|Overall Study||1
6804404|NCT03479307|7736380|FG002|NOT COMPLETED|Overall Study||0
6804405|NCT03470441|7736392|FG000|STARTED|Overall Study||29
6804406|NCT03470441|7736393|FG001|STARTED|Overall Study||31
6804407|NCT03470441|7736394|FG002|STARTED|Overall Study||31
6804408|NCT03470441|7736395|FG003|STARTED|Overall Study||29
6804409|NCT03470441|7736392|FG000|COMPLETED|Overall Study||28
6804410|NCT03470441|7736393|FG001|COMPLETED|Overall Study||26
6804411|NCT03470441|7736394|FG002|COMPLETED|Overall Study||29
6804412|NCT03470441|7736395|FG003|COMPLETED|Overall Study||25
6804413|NCT03470441|7736392|FG000|NOT COMPLETED|Overall Study||1
6804414|NCT03470441|7736393|FG001|NOT COMPLETED|Overall Study||5
6269427|NCT00074490|7168570|FG002|COMPLETED|Overall Study||40
6269428|NCT00074490|7168571|FG003|COMPLETED|Overall Study||44
6269429|NCT00074490|7168572|FG004|COMPLETED|Overall Study||42
6269430|NCT00074490|7168573|FG005|COMPLETED|Overall Study||221
6269431|NCT00074490|7168568|FG000|NOT COMPLETED|Overall Study||0
6269432|NCT00074490|7168569|FG001|NOT COMPLETED|Overall Study||7
6269433|NCT00074490|7168570|FG002|NOT COMPLETED|Overall Study||0
6269434|NCT00074490|7168571|FG003|NOT COMPLETED|Overall Study||0
6269435|NCT00074490|7168572|FG004|NOT COMPLETED|Overall Study||3
6269436|NCT00074490|7168573|FG005|NOT COMPLETED|Overall Study||0
6269437|NCT00074581|7168588|FG000|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
6269438|NCT00074581|7168589|FG001|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
6503211|NCT01439971|7422044|FG004|NOT COMPLETED|Overall Study||1
6564801|NCT01814072|7487613|FG016|STARTED|Overall Study||17
6564802|NCT01814072|7487614|FG017|STARTED|Overall Study||18
6564803|NCT01814072|7487615|FG018|STARTED|Overall Study||17
6564804|NCT01814072|7487616|FG019|STARTED|Overall Study||16
6564805|NCT01814072|7487617|FG020|STARTED|Overall Study||16
6564806|NCT01814072|7487618|FG021|STARTED|Overall Study||17
6564807|NCT01814072|7487619|FG022|STARTED|Overall Study||17
6383160|NCT00792701|7294116|FG001|STARTED|Overall Study||66
6383161|NCT00792701|7294115|FG000|Eligible|Overall Study||18
6383162|NCT00792701|7294116|FG001|Eligible|Overall Study||63
6383163|NCT00792701|7294115|FG000|Eligible and Analyzable|Overall Study||17
6383164|NCT00792701|7294116|FG001|Eligible and Analyzable|Overall Study||44
6383165|NCT00792701|7294115|FG000|COMPLETED|Overall Study||0
6383166|NCT00792701|7294116|FG001|COMPLETED|Overall Study||22
6383167|NCT00792701|7294115|FG000|NOT COMPLETED|Overall Study||19
6383168|NCT00792701|7294116|FG001|NOT COMPLETED|Overall Study||44
6383169|NCT00792805|7294127|FG000|STARTED|Overall Study||188
6383170|NCT00792805|7294128|FG001|STARTED|Overall Study||188
6383171|NCT00792805|7294129|FG002|STARTED|Overall Study||187
6383172|NCT00792805|7294127|FG000|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
6383173|NCT00792805|7294128|FG001|Exposed to Study Medication or Placebo|Overall Study||188
6383174|NCT00792805|7294129|FG002|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
6383175|NCT00792805|7294127|FG000|COMPLETED|Overall Study||166
6383176|NCT00792805|7294128|FG001|COMPLETED|Overall Study||162
6383177|NCT00792805|7294129|FG002|COMPLETED|Overall Study||154
6383178|NCT00792805|7294127|FG000|NOT COMPLETED|Overall Study||22
6383179|NCT00792805|7294128|FG001|NOT COMPLETED|Overall Study||26
6383180|NCT00792805|7294129|FG002|NOT COMPLETED|Overall Study||33
6383181|NCT00792909|7294140|FG000|STARTED|Overall Study||51
6383182|NCT00792909|7294141|FG001|STARTED|Overall Study||59
6383183|NCT00792909|7294142|FG002|STARTED|Overall Study||62
6383184|NCT00792909|7294140|FG000|COMPLETED|Overall Study||51
6383185|NCT00792909|7294141|FG001|COMPLETED|Overall Study||58
6383186|NCT00792909|7294142|FG002|COMPLETED|Overall Study||62
6383187|NCT00792909|7294140|FG000|NOT COMPLETED|Overall Study||0
6383188|NCT00792909|7294141|FG001|NOT COMPLETED|Overall Study||1
6383189|NCT00792909|7294142|FG002|NOT COMPLETED|Overall Study||0
6383190|NCT00792922|7294157|FG000|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
6383191|NCT00792922|7294158|FG001|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
6383192|NCT00792922|7294159|FG002|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
6383193|NCT00792922|7294160|FG003|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|
6383194|NCT00792922|7294157|FG000|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
6383195|NCT00792922|7294158|FG001|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
6383196|NCT00792922|7294159|FG002|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
6383197|NCT00792922|7294160|FG003|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|
6383198|NCT00792922|7294157|FG000|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
6383199|NCT00792922|7294158|FG001|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
6383200|NCT00792922|7294159|FG002|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
6383201|NCT00792922|7294160|FG003|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|
6564808|NCT01814072|7487620|FG023|STARTED|Overall Study||18
6564809|NCT01814072|7487621|FG024|STARTED|Overall Study||17
6564810|NCT01814072|7487622|FG025|STARTED|Overall Study||16
6564811|NCT01814072|7487623|FG026|STARTED|Overall Study||18
6564812|NCT01814072|7487624|FG027|STARTED|Overall Study||17
6564813|NCT01814072|7487625|FG028|STARTED|Overall Study||18
6564814|NCT01814072|7487626|FG029|STARTED|Overall Study||17
6564815|NCT01814072|7487627|FG030|STARTED|Overall Study||17
6564816|NCT01814072|7487628|FG031|STARTED|Overall Study||17
6564817|NCT01814072|7487597|FG000|3-mo Visit|Overall Study||15
6564818|NCT01814072|7487598|FG001|3-mo Visit|Overall Study||18
6564819|NCT01814072|7487599|FG002|3-mo Visit|Overall Study||16
6564820|NCT01814072|7487600|FG003|3-mo Visit|Overall Study||18
6383202|NCT00792922|7294157|FG000|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
6383203|NCT00792922|7294158|FG001|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
6383204|NCT00792922|7294159|FG002|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
6383205|NCT00792922|7294160|FG003|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|
6383206|NCT00792922|7294157|FG000|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
6383207|NCT00792922|7294158|FG001|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
6383208|NCT00792922|7294159|FG002|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
6383209|NCT00792922|7294160|FG003|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|
6383210|NCT00792922|7294157|FG000|NOT COMPLETED|At Baseline||
6383211|NCT00792922|7294158|FG001|NOT COMPLETED|At Baseline||
6383212|NCT00792922|7294159|FG002|NOT COMPLETED|At Baseline||
6383213|NCT00792922|7294160|FG003|NOT COMPLETED|At Baseline||
6383214|NCT00792922|7294157|FG000|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
6383215|NCT00792922|7294158|FG001|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
6383216|NCT00792922|7294159|FG002|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
6383217|NCT00792922|7294160|FG003|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months~the trial was conducted at community level and data reported per community basis"|
6383218|NCT00792922|7294157|FG000|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383219|NCT00792922|7294158|FG001|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383220|NCT00792922|7294159|FG002|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383221|NCT00792922|7294160|FG003|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383222|NCT00792922|7294157|FG000|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383223|NCT00792922|7294158|FG001|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383224|NCT00792922|7294159|FG002|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383225|NCT00792922|7294160|FG003|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383226|NCT00792922|7294157|FG000|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383227|NCT00792922|7294158|FG001|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383228|NCT00792922|7294159|FG002|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383229|NCT00792922|7294160|FG003|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383230|NCT00792922|7294157|FG000|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383231|NCT00792922|7294158|FG001|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383232|NCT00792922|7294159|FG002|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383233|NCT00792922|7294160|FG003|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|
6383234|NCT00792922|7294157|FG000|NOT COMPLETED|At 3 Years||
6564821|NCT01814072|7487601|FG004|3-mo Visit|Overall Study||15
6564822|NCT01814072|7487602|FG005|3-mo Visit|Overall Study||15
6564823|NCT01814072|7487603|FG006|3-mo Visit|Overall Study||16
6564824|NCT01814072|7487604|FG007|3-mo Visit|Overall Study||18
6564825|NCT01814072|7487605|FG008|3-mo Visit|Overall Study||18
6564826|NCT01814072|7487606|FG009|3-mo Visit|Overall Study||15
6564827|NCT01814072|7487607|FG010|3-mo Visit|Overall Study||18
6804415|NCT03470441|7736394|FG002|NOT COMPLETED|Overall Study||2
6804416|NCT03470441|7736395|FG003|NOT COMPLETED|Overall Study||4
6804417|NCT03452397|7736409|FG000|STARTED|Overall Study||41
6564828|NCT01814072|7487608|FG011|3-mo Visit|Overall Study||17
6804418|NCT03452397|7736410|FG001|STARTED|Overall Study||41
6804419|NCT03452397|7736411|FG002|STARTED|Overall Study||41
6804420|NCT03452397|7736412|FG003|STARTED|Overall Study||42
6804421|NCT03452397|7736409|FG000|COMPLETED|Overall Study||40
6804422|NCT03452397|7736410|FG001|COMPLETED|Overall Study||41
6804423|NCT03452397|7736411|FG002|COMPLETED|Overall Study||39
6804424|NCT03452397|7736412|FG003|COMPLETED|Overall Study||41
6804425|NCT03452397|7736409|FG000|NOT COMPLETED|Overall Study||1
6804426|NCT03452397|7736410|FG001|NOT COMPLETED|Overall Study||0
6804427|NCT03452397|7736411|FG002|NOT COMPLETED|Overall Study||2
6804428|NCT03452397|7736412|FG003|NOT COMPLETED|Overall Study||1
6804429|NCT03448939|7736426|FG000|STARTED|Overall Study||243
6804430|NCT03448939|7736427|FG001|STARTED|Overall Study||118
6804431|NCT03448939|7736426|FG000|Received at Least 1 Dose of Study Drug|Overall Study||239
6564829|NCT01814072|7487609|FG012|3-mo Visit|Overall Study||16
6564830|NCT01814072|7487610|FG013|3-mo Visit|Overall Study||16
6564831|NCT01814072|7487611|FG014|3-mo Visit|Overall Study||16
6564832|NCT01814072|7487612|FG015|3-mo Visit|Overall Study||16
6564833|NCT01814072|7487613|FG016|3-mo Visit|Overall Study||16
6564834|NCT01814072|7487614|FG017|3-mo Visit|Overall Study||16
6564835|NCT01814072|7487615|FG018|3-mo Visit|Overall Study||14
6564836|NCT01814072|7487616|FG019|3-mo Visit|Overall Study||13
6564837|NCT01814072|7487617|FG020|3-mo Visit|Overall Study||15
6564838|NCT01814072|7487618|FG021|3-mo Visit|Overall Study||17
6564839|NCT01814072|7487619|FG022|3-mo Visit|Overall Study||15
6564840|NCT01814072|7487620|FG023|3-mo Visit|Overall Study||18
6564841|NCT01814072|7487621|FG024|3-mo Visit|Overall Study||13
6564842|NCT01814072|7487622|FG025|3-mo Visit|Overall Study||14
6564843|NCT01814072|7487623|FG026|3-mo Visit|Overall Study||17
6564844|NCT01814072|7487624|FG027|3-mo Visit|Overall Study||14
6564845|NCT01814072|7487625|FG028|3-mo Visit|Overall Study||15
6564846|NCT01814072|7487626|FG029|3-mo Visit|Overall Study||16
6564847|NCT01814072|7487627|FG030|3-mo Visit|Overall Study||16
6564848|NCT01814072|7487628|FG031|3-mo Visit|Overall Study||17
6564849|NCT01814072|7487597|FG000|Intent to Treat|Overall Study||4
6564850|NCT01814072|7487598|FG001|Intent to Treat|Overall Study||2
6564851|NCT01814072|7487599|FG002|Intent to Treat|Overall Study||3
6383235|NCT00792922|7294158|FG001|NOT COMPLETED|At 3 Years||
6383236|NCT00792922|7294159|FG002|NOT COMPLETED|At 3 Years||
6383237|NCT00792922|7294160|FG003|NOT COMPLETED|At 3 Years||
6383238|NCT00792935|7294174|FG000|STARTED|Overall Study||72
6383239|NCT00792935|7294175|FG001|STARTED|Overall Study||71
6383240|NCT00792935|7294174|FG000|COMPLETED|Overall Study||68
6383241|NCT00792935|7294175|FG001|COMPLETED|Overall Study||68
6383242|NCT00792935|7294174|FG000|NOT COMPLETED|Overall Study||4
6383243|NCT00792935|7294175|FG001|NOT COMPLETED|Overall Study||3
6383244|NCT00793104|7294181|FG000|STARTED|Overall Study||10
6383245|NCT00793104|7294181|FG000|COMPLETED|Overall Study||9
6383246|NCT00793104|7294181|FG000|NOT COMPLETED|Overall Study||1
6383247|NCT00793182|7294187|FG000|STARTED|Overall Study||2
6383248|NCT00793182|7294188|FG001|STARTED|Overall Study||4
6383249|NCT00793182|7294187|FG000|COMPLETED|Overall Study||2
6383250|NCT00793182|7294188|FG001|COMPLETED|Overall Study||3
6383251|NCT00793182|7294187|FG000|NOT COMPLETED|Overall Study||0
6383252|NCT00793182|7294188|FG001|NOT COMPLETED|Overall Study||1
6383253|NCT00793325|7294194|FG000|STARTED|Overall Study||909
6383254|NCT00793325|7294194|FG000|COMPLETED|Overall Study||890
6383255|NCT00793325|7294194|FG000|NOT COMPLETED|Overall Study||19
6383256|NCT00793403|7294217|FG000|STARTED|Overall Study||293
6383257|NCT00793403|7294217|FG000|COMPLETED|Overall Study||220
6383258|NCT00793403|7294217|FG000|NOT COMPLETED|Overall Study||73
6383259|NCT00793455|7294223|FG000|STARTED|Overall Study||314
6383260|NCT00793455|7294224|FG001|STARTED|Overall Study||314
6383261|NCT00793455|7294223|FG000|COMPLETED|Overall Study||314
6383262|NCT00793455|7294224|FG001|COMPLETED|Overall Study||314
6383263|NCT00793455|7294223|FG000|NOT COMPLETED|Overall Study||0
6383264|NCT00793455|7294224|FG001|NOT COMPLETED|Overall Study||0
6383265|NCT00793546|7294233|FG000|STARTED|Overall Study||14
6383266|NCT00793546|7294234|FG001|STARTED|Overall Study||28
6383267|NCT00793546|7294233|FG000|COMPLETED|Overall Study||0
6383268|NCT00793546|7294234|FG001|COMPLETED|Overall Study||0
6383269|NCT00793546|7294233|FG000|NOT COMPLETED|Overall Study||14
6383270|NCT00793546|7294234|FG001|NOT COMPLETED|Overall Study||28
6383271|NCT00793572|7294242|FG000|STARTED|Overall Study||32
6383272|NCT00793572|7294242|FG000|COMPLETED|Overall Study||32
6383273|NCT00793572|7294242|FG000|NOT COMPLETED|Overall Study||0
6383274|NCT00793585|7294248|FG000|STARTED|Overall Study||19
6383275|NCT00793585|7294249|FG001|STARTED|Overall Study||21
6383276|NCT00793585|7294248|FG000|COMPLETED|Overall Study||17
6383277|NCT00793585|7294249|FG001|COMPLETED|Overall Study||18
6564852|NCT01814072|7487600|FG003|Intent to Treat|Overall Study||0
6564853|NCT01814072|7487601|FG004|Intent to Treat|Overall Study||4
6383278|NCT00793585|7294248|FG000|NOT COMPLETED|Overall Study||2
6383279|NCT00793585|7294249|FG001|NOT COMPLETED|Overall Study||3
6383280|NCT00793598|7294260|FG000|STARTED|Overall Study||1
6383281|NCT00793598|7294261|FG001|STARTED|Overall Study||1
6564854|NCT01814072|7487602|FG005|Intent to Treat|Overall Study||6
6383282|NCT00793598|7294262|FG002|STARTED|Overall Study||1
6383283|NCT00793598|7294263|FG003|STARTED|Overall Study||2
6383284|NCT00793598|7294264|FG004|STARTED|Overall Study||8
6383285|NCT00793598|7294265|FG005|STARTED|Overall Study||8
6383286|NCT00793598|7294266|FG006|STARTED|Overall Study||4
6383287|NCT00793598|7294267|FG007|STARTED|Overall Study||4
6383288|NCT00793598|7294260|FG000|COMPLETED|Overall Study||1
6383289|NCT00793598|7294261|FG001|COMPLETED|Overall Study||0
6383290|NCT00793598|7294262|FG002|COMPLETED|Overall Study||1
6383291|NCT00793598|7294263|FG003|COMPLETED|Overall Study||2
6383292|NCT00793598|7294264|FG004|COMPLETED|Overall Study||8
6383293|NCT00793598|7294265|FG005|COMPLETED|Overall Study||7
6383294|NCT00793598|7294266|FG006|COMPLETED|Overall Study||4
6383295|NCT00793598|7294267|FG007|COMPLETED|Overall Study||3
6383296|NCT00793598|7294260|FG000|NOT COMPLETED|Overall Study||0
6383297|NCT00793598|7294261|FG001|NOT COMPLETED|Overall Study||1
6383298|NCT00793598|7294262|FG002|NOT COMPLETED|Overall Study||0
6383299|NCT00793598|7294263|FG003|NOT COMPLETED|Overall Study||0
6383300|NCT00793598|7294264|FG004|NOT COMPLETED|Overall Study||0
6383301|NCT00793598|7294265|FG005|NOT COMPLETED|Overall Study||1
6383302|NCT00793598|7294266|FG006|NOT COMPLETED|Overall Study||0
6383303|NCT00793598|7294267|FG007|NOT COMPLETED|Overall Study||1
6383304|NCT00793611|7294291|FG000|STARTED|Overall Study||10
6383305|NCT00793611|7294292|FG001|STARTED|Overall Study||10
6383306|NCT00793611|7294291|FG000|COMPLETED|Overall Study||10
6383307|NCT00793611|7294292|FG001|COMPLETED|Overall Study||10
6383308|NCT00793611|7294291|FG000|NOT COMPLETED|Overall Study||0
6383309|NCT00793611|7294292|FG001|NOT COMPLETED|Overall Study||0
6383310|NCT00793624|7294302|FG000|STARTED|Overall Study||225
6383311|NCT00793624|7294303|FG001|STARTED|Overall Study||227
6383312|NCT00793624|7294304|FG002|STARTED|Overall Study||225
6383313|NCT00793624|7294305|FG003|STARTED|Overall Study||227
6383314|NCT00793624|7294302|FG000|COMPLETED|Overall Study||168
6383315|NCT00793624|7294303|FG001|COMPLETED|Overall Study||191
6383316|NCT00793624|7294304|FG002|COMPLETED|Overall Study||186
6383317|NCT00793624|7294305|FG003|COMPLETED|Overall Study||184
6383318|NCT00793624|7294302|FG000|NOT COMPLETED|Overall Study||57
6383319|NCT00793624|7294303|FG001|NOT COMPLETED|Overall Study||36
6383320|NCT00793624|7294304|FG002|NOT COMPLETED|Overall Study||39
6383321|NCT00793624|7294305|FG003|NOT COMPLETED|Overall Study||43
6383322|NCT00793650|7294325|FG000|STARTED|Overall Study||19
6383323|NCT00793650|7294326|FG001|STARTED|Overall Study||20
6383324|NCT00793650|7294325|FG000|COMPLETED|Overall Study||19
6383325|NCT00793650|7294326|FG001|COMPLETED|Overall Study||20
6383326|NCT00793650|7294325|FG000|NOT COMPLETED|Overall Study||0
6383327|NCT00793650|7294326|FG001|NOT COMPLETED|Overall Study||0
6383328|NCT00793780|7294336|FG000|STARTED|Overall Study||12
6503212|NCT01440049|7422056|FG000|STARTED|Overall Study||160
6383329|NCT00793780|7294337|FG001|STARTED|Overall Study||12
6383330|NCT00793780|7294336|FG000|Randomization|Overall Study||12
6383331|NCT00793780|7294337|FG001|Randomization|Overall Study||12
6383332|NCT00793780|7294336|FG000|Collected Baseline Data|Overall Study||11
6269439|NCT00074581|7168588|FG000|COMPLETED|Overall Study||1545
6269440|NCT00074581|7168589|FG001|COMPLETED|Overall Study||1541
6269441|NCT00074581|7168588|FG000|NOT COMPLETED|Overall Study||244
6269442|NCT00074581|7168589|FG001|NOT COMPLETED|Overall Study||226
6269443|NCT00074711|7168597|FG000|STARTED|Overall Study||120
6269444|NCT00074711|7168598|FG001|STARTED|Overall Study||121
6269445|NCT00074711|7168597|FG000|COMPLETED|Overall Study||105
6269446|NCT00074711|7168598|FG001|COMPLETED|Overall Study||106
6269447|NCT00074711|7168597|FG000|NOT COMPLETED|Overall Study||15
6269448|NCT00074711|7168598|FG001|NOT COMPLETED|Overall Study||15
6269449|NCT00074802|7168606|FG000|STARTED|Overall Study||29
6269450|NCT00074802|7168607|FG001|STARTED|Overall Study||32
6269451|NCT00074802|7168606|FG000|COMPLETED|Overall Study||20
6269452|NCT00074802|7168607|FG001|COMPLETED|Overall Study||25
6269453|NCT00074802|7168606|FG000|NOT COMPLETED|Overall Study||9
6269454|NCT00074802|7168607|FG001|NOT COMPLETED|Overall Study||7
6269455|NCT00074815|7168616|FG000|STARTED|Overall Study||42
6269456|NCT00074815|7168617|FG001|STARTED|Overall Study||40
6269457|NCT00074815|7168618|FG002|STARTED|Overall Study||42
6269458|NCT00074815|7168616|FG000|COMPLETED|Overall Study||37
6269459|NCT00074815|7168617|FG001|COMPLETED|Overall Study||34
6269460|NCT00074815|7168618|FG002|COMPLETED|Overall Study||30
6269461|NCT00074815|7168616|FG000|NOT COMPLETED|Overall Study||5
6383333|NCT00793780|7294337|FG001|Collected Baseline Data|Overall Study||12
6383334|NCT00793780|7294336|FG000|COMPLETED|Overall Study||10
6383335|NCT00793780|7294337|FG001|COMPLETED|Overall Study||11
6383336|NCT00793780|7294336|FG000|NOT COMPLETED|Overall Study||2
6383337|NCT00793780|7294337|FG001|NOT COMPLETED|Overall Study||1
6383338|NCT00793793|7294355|FG000|STARTED|Overall Study||8
6383339|NCT00793793|7294356|FG001|STARTED|Overall Study||6
6383340|NCT00793793|7294357|FG002|STARTED|Overall Study||7
6383341|NCT00793793|7294358|FG003|STARTED|Overall Study||7
6383342|NCT00793793|7294359|FG004|STARTED|Overall Study||6
6383343|NCT00793793|7294360|FG005|STARTED|Overall Study||6
6383344|NCT00793793|7294361|FG006|STARTED|Overall Study||7
6383345|NCT00793793|7294362|FG007|STARTED|Overall Study||6
6383346|NCT00793793|7294363|FG008|STARTED|Overall Study||15
6383347|NCT00793793|7294364|FG009|STARTED|Overall Study||15
6383348|NCT00793793|7294365|FG010|STARTED|Overall Study||6
6383349|NCT00793793|7294366|FG011|STARTED|Overall Study||7
6383350|NCT00793793|7294355|FG000|COMPLETED|Overall Study||8
6383351|NCT00793793|7294356|FG001|COMPLETED|Overall Study||5
6383352|NCT00793793|7294357|FG002|COMPLETED|Overall Study||5
6383353|NCT00793793|7294358|FG003|COMPLETED|Overall Study||4
6383354|NCT00793793|7294359|FG004|COMPLETED|Overall Study||4
6383355|NCT00793793|7294360|FG005|COMPLETED|Overall Study||4
6383356|NCT00793793|7294361|FG006|COMPLETED|Overall Study||3
6383357|NCT00793793|7294362|FG007|COMPLETED|Overall Study||6
6383358|NCT00793793|7294363|FG008|COMPLETED|Overall Study||6
6383359|NCT00793793|7294364|FG009|COMPLETED|Overall Study||6
6383360|NCT00793793|7294365|FG010|COMPLETED|Overall Study||3
6383361|NCT00793793|7294366|FG011|COMPLETED|Overall Study||1
6383362|NCT00793793|7294355|FG000|NOT COMPLETED|Overall Study||0
6383363|NCT00793793|7294356|FG001|NOT COMPLETED|Overall Study||1
6383364|NCT00793793|7294357|FG002|NOT COMPLETED|Overall Study||2
6383365|NCT00793793|7294358|FG003|NOT COMPLETED|Overall Study||3
6383366|NCT00793793|7294359|FG004|NOT COMPLETED|Overall Study||2
6383367|NCT00793793|7294360|FG005|NOT COMPLETED|Overall Study||2
6503213|NCT01440049|7422056|FG000|COMPLETED|Overall Study||155
6503214|NCT01440049|7422056|FG000|NOT COMPLETED|Overall Study||5
6503215|NCT01440101|7422063|FG000|STARTED|Overall Study||12
6503216|NCT01440101|7422064|FG001|STARTED|Overall Study||47
6503217|NCT01440101|7422065|FG002|STARTED|Overall Study||47
6503218|NCT01440101|7422063|FG000|COMPLETED|Overall Study||10
6503219|NCT01440101|7422064|FG001|COMPLETED|Overall Study||43
6503220|NCT01440101|7422065|FG002|COMPLETED|Overall Study||46
6503221|NCT01440101|7422063|FG000|NOT COMPLETED|Overall Study||2
6269462|NCT00074815|7168617|FG001|NOT COMPLETED|Overall Study||6
6269463|NCT00074815|7168618|FG002|NOT COMPLETED|Overall Study||12
6269464|NCT00074958|7168626|FG000|STARTED|Overall Study||16
6269465|NCT00074958|7168626|FG000|COMPLETED|Overall Study||15
6269466|NCT00074958|7168626|FG000|NOT COMPLETED|Overall Study||1
6383368|NCT00793793|7294361|FG006|NOT COMPLETED|Overall Study||4
6383369|NCT00793793|7294362|FG007|NOT COMPLETED|Overall Study||0
6383370|NCT00793793|7294363|FG008|NOT COMPLETED|Overall Study||9
6383371|NCT00793793|7294364|FG009|NOT COMPLETED|Overall Study||9
6383372|NCT00793793|7294365|FG010|NOT COMPLETED|Overall Study||3
6383373|NCT00793793|7294366|FG011|NOT COMPLETED|Overall Study||6
6503222|NCT01440101|7422064|FG001|NOT COMPLETED|Overall Study||4
6383374|NCT00793819|7294414|FG000|STARTED|Overall Study||111
6503223|NCT01440101|7422065|FG002|NOT COMPLETED|Overall Study||1
6269467|NCT00074984|7168632|FG000|STARTED|Overall Study||31
6269468|NCT00074984|7168633|FG001|STARTED|Overall Study||51
6269469|NCT00074984|7168632|FG000|COMPLETED|Overall Study||28
6269470|NCT00074984|7168633|FG001|COMPLETED|Overall Study||43
6269471|NCT00074984|7168632|FG000|NOT COMPLETED|Overall Study||3
6383375|NCT00793819|7294415|FG001|STARTED|Overall Study||98
6503224|NCT01440283|7422074|FG000|STARTED|Overall Study||14
6564855|NCT01814072|7487603|FG006|Intent to Treat|Overall Study||4
6564856|NCT01814072|7487604|FG007|Intent to Treat|Overall Study||1
6656783|NCT02464917|7587114|FG001|COMPLETED|Overall Study||35
6656784|NCT02464917|7587113|FG000|NOT COMPLETED|Overall Study||0
6564857|NCT01814072|7487605|FG008|Intent to Treat|Overall Study||3
6564858|NCT01814072|7487606|FG009|Intent to Treat|Overall Study||5
6656785|NCT02464917|7587114|FG001|NOT COMPLETED|Overall Study||0
6656786|NCT02465034|7587122|FG000|STARTED|Overall Study||19
6564859|NCT01814072|7487607|FG010|Intent to Treat|Overall Study||1
6564860|NCT01814072|7487608|FG011|Intent to Treat|Overall Study||2
6564861|NCT01814072|7487609|FG012|Intent to Treat|Overall Study||3
6564862|NCT01814072|7487610|FG013|Intent to Treat|Overall Study||2
6564863|NCT01814072|7487611|FG014|Intent to Treat|Overall Study||3
6564864|NCT01814072|7487612|FG015|Intent to Treat|Overall Study||2
6564865|NCT01814072|7487613|FG016|Intent to Treat|Overall Study||3
6564866|NCT01814072|7487614|FG017|Intent to Treat|Overall Study||1
6564867|NCT01814072|7487615|FG018|Intent to Treat|Overall Study||3
6564868|NCT01814072|7487616|FG019|Intent to Treat|Overall Study||5
6564869|NCT01814072|7487617|FG020|Intent to Treat|Overall Study||2
6564870|NCT01814072|7487618|FG021|Intent to Treat|Overall Study||1
6564871|NCT01814072|7487619|FG022|Intent to Treat|Overall Study||4
6564872|NCT01814072|7487620|FG023|Intent to Treat|Overall Study||1
6656787|NCT02465034|7587123|FG001|STARTED|Overall Study||26
6656788|NCT02465034|7587122|FG000|Started PAS|Overall Study||12
6656789|NCT02465034|7587123|FG001|Started PAS|Overall Study||21
6656790|NCT02465034|7587122|FG000|Completed PAS|Overall Study||9
6564873|NCT01814072|7487621|FG024|Intent to Treat|Overall Study||6
6564874|NCT01814072|7487622|FG025|Intent to Treat|Overall Study||2
6656791|NCT02465034|7587123|FG001|Completed PAS|Overall Study||20
6656792|NCT02465034|7587122|FG000|Started CC-PAS|Overall Study||16
6656793|NCT02465034|7587123|FG001|Started CC-PAS|Overall Study||0
6804432|NCT03448939|7736427|FG001|Received at Least 1 Dose of Study Drug|Overall Study||113
6804433|NCT03448939|7736426|FG000|COMPLETED|Overall Study||222
6804434|NCT03448939|7736427|FG001|COMPLETED|Overall Study||107
6804435|NCT03448939|7736426|FG000|NOT COMPLETED|Overall Study||21
6804436|NCT03448939|7736427|FG001|NOT COMPLETED|Overall Study||11
6804437|NCT03410108|7736433|FG000|STARTED|Overall Study||104
6804438|NCT03410108|7736433|FG000|Safety Evaluation Lead-in Part|Overall Study||9
6804439|NCT03410108|7736433|FG000|Refractory Expansion Part: Main Cohort|Overall Study||47
6804440|NCT03410108|7736433|FG000|Refractory Expansion Part: Sub-Cohort|Overall Study||16
6804441|NCT03410108|7736433|FG000|Refractory Expansion Part|Overall Study||63
6804442|NCT03410108|7736433|FG000|All Refractory Participants|Overall Study||72
6503225|NCT01440283|7422074|FG000|COMPLETED|Overall Study||4
6269472|NCT00074984|7168633|FG001|NOT COMPLETED|Overall Study||8
6269473|NCT00075023|7168642|FG000|STARTED|Pilot Study||5
6269474|NCT00075023|7168643|FG001|STARTED|Pilot Study||5
6269475|NCT00075023|7168642|FG000|COMPLETED|Pilot Study||3
6269476|NCT00075023|7168643|FG001|COMPLETED|Pilot Study||3
6269477|NCT00075023|7168642|FG000|NOT COMPLETED|Pilot Study||2
6269478|NCT00075023|7168643|FG001|NOT COMPLETED|Pilot Study||2
6269479|NCT00075023|7168642|FG000|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
6269480|NCT00075023|7168643|FG001|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
6269481|NCT00075023|7168642|FG000|COMPLETED|Part Two||0
6269482|NCT00075023|7168643|FG001|COMPLETED|Part Two||0
6269483|NCT00075023|7168642|FG000|NOT COMPLETED|Part Two||0
6269484|NCT00075023|7168643|FG001|NOT COMPLETED|Part Two||0
6269485|NCT00075088|7168652|FG000|STARTED|Overall Study||403
6269486|NCT00075088|7168653|FG001|STARTED|Overall Study||391
6383376|NCT00793819|7294414|FG000|COMPLETED|Overall Study||97
6383377|NCT00793819|7294415|FG001|COMPLETED|Overall Study||89
6383378|NCT00793819|7294414|FG000|NOT COMPLETED|Overall Study||14
6383379|NCT00793819|7294415|FG001|NOT COMPLETED|Overall Study||9
6383380|NCT00793871|7294421|FG000|STARTED|Overall Study||60
6383381|NCT00793871|7294421|FG000|Received Treatment|Overall Study||59
6383382|NCT00793871|7294421|FG000|COMPLETED|Overall Study||0
6383383|NCT00793871|7294421|FG000|NOT COMPLETED|Overall Study||60
6383384|NCT00793910|7294427|FG000|STARTED|Overall Study||53
6383385|NCT00793910|7294428|FG001|STARTED|Overall Study||53
6383386|NCT00793910|7294427|FG000|COMPLETED|Overall Study||48
6383387|NCT00793910|7294428|FG001|COMPLETED|Overall Study||46
6383388|NCT00793910|7294427|FG000|NOT COMPLETED|Overall Study||5
6383389|NCT00793910|7294428|FG001|NOT COMPLETED|Overall Study||7
6383390|NCT00794040|7294436|FG000|STARTED|Overall Study||25
6383391|NCT00794040|7294437|FG001|STARTED|Overall Study||28
6383392|NCT00794040|7294436|FG000|COMPLETED|Overall Study||22
6383393|NCT00794040|7294437|FG001|COMPLETED|Overall Study||23
6383394|NCT00794040|7294436|FG000|NOT COMPLETED|Overall Study||3
6383395|NCT00794040|7294437|FG001|NOT COMPLETED|Overall Study||5
6383396|NCT00794118|7294443|FG000|STARTED|Overall Study||299
6383397|NCT00794118|7294443|FG000|COMPLETED|Overall Study||272
6383398|NCT00794118|7294443|FG000|NOT COMPLETED|Overall Study||27
6383399|NCT00794144|7294449|FG000|STARTED|Overall Study||66
6383400|NCT00794144|7294450|FG001|STARTED|Overall Study||66
6383401|NCT00794144|7294449|FG000|COMPLETED|Overall Study||63
6383402|NCT00794144|7294450|FG001|COMPLETED|Overall Study||63
6383403|NCT00794144|7294449|FG000|NOT COMPLETED|Overall Study||3
6383404|NCT00794144|7294450|FG001|NOT COMPLETED|Overall Study||3
6383405|NCT00794157|7294459|FG000|STARTED|Overall Study||114
6383406|NCT00794157|7294460|FG001|STARTED|Overall Study||116
6383407|NCT00794157|7294461|FG002|STARTED|Overall Study||117
6383408|NCT00794157|7294459|FG000|COMPLETED|Overall Study||104
6383409|NCT00794157|7294460|FG001|COMPLETED|Overall Study||106
6383410|NCT00794157|7294461|FG002|COMPLETED|Overall Study||98
6383411|NCT00794157|7294459|FG000|NOT COMPLETED|Overall Study||10
6383412|NCT00794157|7294460|FG001|NOT COMPLETED|Overall Study||10
6383413|NCT00794157|7294461|FG002|NOT COMPLETED|Overall Study||19
6383414|NCT00794170|7294471|FG000|STARTED|Overall Study||157
6383415|NCT00794170|7294472|FG001|STARTED|Overall Study||155
6383416|NCT00794170|7294471|FG000|COMPLETED|Overall Study||150
6383417|NCT00794170|7294472|FG001|COMPLETED|Overall Study||152
6383418|NCT00794170|7294471|FG000|NOT COMPLETED|Overall Study||7
6383419|NCT00794170|7294472|FG001|NOT COMPLETED|Overall Study||3
6383420|NCT00794196|7294480|FG000|STARTED|Overall Study||92
6383421|NCT00794196|7294481|FG001|STARTED|Overall Study||87
6383422|NCT00794196|7294480|FG000|COMPLETED|Overall Study||87
6383423|NCT00794196|7294481|FG001|COMPLETED|Overall Study||64
6383424|NCT00794196|7294480|FG000|NOT COMPLETED|Overall Study||5
6383425|NCT00794196|7294481|FG001|NOT COMPLETED|Overall Study||23
6383426|NCT00794313|7294487|FG000|STARTED|Overall Study||1
6383427|NCT00794313|7294488|FG001|STARTED|Overall Study||1
6383428|NCT00794313|7294489|FG002|STARTED|Overall Study||1
6383429|NCT00794313|7294487|FG000|COMPLETED|Overall Study||1
6383430|NCT00794313|7294488|FG001|COMPLETED|Overall Study||1
6383431|NCT00794313|7294489|FG002|COMPLETED|Overall Study||1
6383432|NCT00794313|7294487|FG000|NOT COMPLETED|Overall Study||0
6383433|NCT00794313|7294488|FG001|NOT COMPLETED|Overall Study||0
6383434|NCT00794313|7294489|FG002|NOT COMPLETED|Overall Study||0
6383435|NCT00794339|7294500|FG000|STARTED|Overall Study||73
6383436|NCT00794339|7294500|FG000|Eligible|Overall Study||69
6383437|NCT00794339|7294500|FG000|Evaluable|Overall Study||59
6383438|NCT00794339|7294500|FG000|COMPLETED|Overall Study||59
6383439|NCT00794339|7294500|FG000|NOT COMPLETED|Overall Study||14
6383440|NCT00794365|7294521|FG000|STARTED|Overall Study||330
6383441|NCT00794365|7294521|FG000|COMPLETED|Overall Study||251
6383442|NCT00794365|7294521|FG000|NOT COMPLETED|Overall Study||79
6269487|NCT00075088|7168652|FG000|COMPLETED|Overall Study||403
6269488|NCT00075088|7168653|FG001|COMPLETED|Overall Study||391
6269489|NCT00075088|7168652|FG000|NOT COMPLETED|Overall Study||0
6383443|NCT00794417|7294529|FG000|STARTED|Phase 1: Baseline (Day 1) up to Day 751||4
6383444|NCT00794417|7294530|FG001|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
6383445|NCT00794417|7294531|FG002|STARTED|Phase 1: Baseline (Day 1) up to Day 751||7
6564875|NCT01814072|7487623|FG026|Intent to Treat|Overall Study||2
6564876|NCT01814072|7487624|FG027|Intent to Treat|Overall Study||4
6383446|NCT00794417|7294532|FG003|STARTED|Phase 1: Baseline (Day 1) up to Day 751||0
6383447|NCT00794417|7294529|FG000|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||1
6383448|NCT00794417|7294530|FG001|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
6383449|NCT00794417|7294531|FG002|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||4
6383450|NCT00794417|7294532|FG003|COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
6383451|NCT00794417|7294529|FG000|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
6383452|NCT00794417|7294530|FG001|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
6383453|NCT00794417|7294531|FG002|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||3
6383454|NCT00794417|7294532|FG003|NOT COMPLETED|Phase 1: Baseline (Day 1) up to Day 751||0
6383455|NCT00794417|7294529|FG000|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
6383456|NCT00794417|7294530|FG001|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
6383457|NCT00794417|7294531|FG002|STARTED|Phase 2: Baseline (Day 421) to Day 972|Participants enrolled in phase 1 were not eligible for enrollment in phase 2.|0
6383458|NCT00794417|7294532|FG003|STARTED|Phase 2: Baseline (Day 421) to Day 972||42
6383459|NCT00794417|7294529|FG000|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
6383460|NCT00794417|7294530|FG001|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
6383461|NCT00794417|7294531|FG002|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
6383462|NCT00794417|7294532|FG003|COMPLETED|Phase 2: Baseline (Day 421) to Day 972||7
6383463|NCT00794417|7294529|FG000|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
6383464|NCT00794417|7294530|FG001|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
6383465|NCT00794417|7294531|FG002|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||0
6383466|NCT00794417|7294532|FG003|NOT COMPLETED|Phase 2: Baseline (Day 421) to Day 972||35
6383467|NCT00794469|7294544|FG000|STARTED|Overall Study||21
6383468|NCT00794469|7294544|FG000|COMPLETED|Overall Study||21
6383469|NCT00794469|7294544|FG000|NOT COMPLETED|Overall Study||0
6383470|NCT00794508|7294548|FG000|STARTED|Overall Study||10
6383471|NCT00794508|7294548|FG000|COMPLETED|Overall Study||10
6383472|NCT00794508|7294548|FG000|NOT COMPLETED|Overall Study||0
6564877|NCT01814072|7487625|FG028|Intent to Treat|Overall Study||4
6564878|NCT01814072|7487626|FG029|Intent to Treat|Overall Study||3
6564879|NCT01814072|7487627|FG030|Intent to Treat|Overall Study||2
6564880|NCT01814072|7487628|FG031|Intent to Treat|Overall Study||0
6564881|NCT01814072|7487597|FG000|COMPLETED|Overall Study||14
6564882|NCT01814072|7487598|FG001|COMPLETED|Overall Study||16
6564883|NCT01814072|7487599|FG002|COMPLETED|Overall Study||15
6804443|NCT03410108|7736433|FG000|TKI-Naive Expansion Cohort|Overall Study||32
6804444|NCT03410108|7736433|FG000|Completed|Overall Study||0
6804445|NCT03410108|7736433|FG000|COMPLETED|Overall Study||0
6804446|NCT03410108|7736433|FG000|NOT COMPLETED|Overall Study||104
6383473|NCT00794547|7294552|FG000|STARTED|Overall Study||18
6383474|NCT00794547|7294553|FG001|STARTED|Overall Study||16
6383475|NCT00794547|7294552|FG000|COMPLETED|Overall Study||18
6383476|NCT00794547|7294553|FG001|COMPLETED|Overall Study||16
6383477|NCT00794547|7294552|FG000|NOT COMPLETED|Overall Study||0
6383478|NCT00794547|7294553|FG001|NOT COMPLETED|Overall Study||0
6383479|NCT00794560|7294561|FG000|STARTED|Overall Study||36
6383480|NCT00794560|7294562|FG001|STARTED|Overall Study||36
6383481|NCT00794560|7294563|FG002|STARTED|Overall Study||44
6383482|NCT00794560|7294564|FG003|STARTED|Overall Study||38
6383483|NCT00794560|7294561|FG000|COMPLETED|Overall Study||33
6383484|NCT00794560|7294562|FG001|COMPLETED|Overall Study||32
6383485|NCT00794560|7294563|FG002|COMPLETED|Overall Study||40
6383486|NCT00794560|7294564|FG003|COMPLETED|Overall Study||34
6383487|NCT00794560|7294561|FG000|NOT COMPLETED|Overall Study||3
6383488|NCT00794560|7294562|FG001|NOT COMPLETED|Overall Study||4
6383489|NCT00794560|7294563|FG002|NOT COMPLETED|Overall Study||4
6383490|NCT00794560|7294564|FG003|NOT COMPLETED|Overall Study||4
6383491|NCT00794573|7294576|FG000|STARTED|Overall Study||151
6383492|NCT00794573|7294577|FG001|STARTED|Overall Study||151
6383493|NCT00794573|7294576|FG000|COMPLETED|Overall Study||113
6383494|NCT00794573|7294577|FG001|COMPLETED|Overall Study||106
6383495|NCT00794573|7294576|FG000|NOT COMPLETED|Overall Study||38
6383496|NCT00794573|7294577|FG001|NOT COMPLETED|Overall Study||45
6383497|NCT00794664|7294585|FG000|STARTED|Treatment Period||19
6383498|NCT00794664|7294586|FG001|STARTED|Treatment Period||39
6383499|NCT00794664|7294585|FG000|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
6383500|NCT00794664|7294586|FG001|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
6383501|NCT00794664|7294585|FG000|NOT COMPLETED|Treatment Period||1
6383502|NCT00794664|7294586|FG001|NOT COMPLETED|Treatment Period||12
6383503|NCT00794664|7294585|FG000|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
6383504|NCT00794664|7294586|FG001|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
6383505|NCT00794664|7294585|FG000|COMPLETED|Follow-up Period||15
6383506|NCT00794664|7294586|FG001|COMPLETED|Follow-up Period||28
6383507|NCT00794664|7294585|FG000|NOT COMPLETED|Follow-up Period||1
6383508|NCT00794664|7294586|FG001|NOT COMPLETED|Follow-up Period||5
6383509|NCT00794820|7294592|FG000|STARTED|Overall Study||66
6383510|NCT00794820|7294592|FG000|COMPLETED|Overall Study||50
6383511|NCT00794820|7294592|FG000|NOT COMPLETED|Overall Study||16
6383512|NCT00794950|7294596|FG000|STARTED|BCG Induction||43
6383513|NCT00794950|7294596|FG000|COMPLETED|BCG Induction||36
6383514|NCT00794950|7294596|FG000|NOT COMPLETED|BCG Induction||7
6383515|NCT00794950|7294596|FG000|STARTED|Beginning Sunitinib Treatment||36
6383516|NCT00794950|7294596|FG000|COMPLETED|Beginning Sunitinib Treatment||24
6383517|NCT00794950|7294596|FG000|NOT COMPLETED|Beginning Sunitinib Treatment||12
6383518|NCT00794963|7294603|FG000|STARTED|Overall Study||4
6383519|NCT00794963|7294604|FG001|STARTED|Overall Study||4
6383520|NCT00794963|7294603|FG000|COMPLETED|Overall Study||3
6383521|NCT00794963|7294604|FG001|COMPLETED|Overall Study||0
6383522|NCT00794963|7294603|FG000|NOT COMPLETED|Overall Study||1
6383523|NCT00794963|7294604|FG001|NOT COMPLETED|Overall Study||4
6383524|NCT00795002|7294612|FG000|STARTED|Overall Study||37
6383525|NCT00795002|7294613|FG001|STARTED|Overall Study||37
6383526|NCT00795002|7294612|FG000|COMPLETED|Overall Study||37
6383527|NCT00795002|7294613|FG001|COMPLETED|Overall Study||37
6383528|NCT00795002|7294612|FG000|NOT COMPLETED|Overall Study||0
6383529|NCT00795002|7294613|FG001|NOT COMPLETED|Overall Study||0
6383530|NCT00795132|7294619|FG000|STARTED|Overall Study||47
6383531|NCT00795132|7294619|FG000|COMPLETED|Overall Study||44
6383532|NCT00795132|7294619|FG000|NOT COMPLETED|Overall Study||3
6383533|NCT00795145|7294633|FG000|STARTED|Cohort 1||3
6383534|NCT00795145|7294634|FG001|STARTED|Cohort 1||3
6383535|NCT00795145|7294635|FG002|STARTED|Cohort 1||3
6383536|NCT00795145|7294636|FG003|STARTED|Cohort 1||0
6383537|NCT00795145|7294637|FG004|STARTED|Cohort 1||0
6383538|NCT00795145|7294638|FG005|STARTED|Cohort 1||0
6383539|NCT00795145|7294639|FG006|STARTED|Cohort 1||0
6383540|NCT00795145|7294633|FG000|COMPLETED|Cohort 1||3
6383541|NCT00795145|7294634|FG001|COMPLETED|Cohort 1||3
6383542|NCT00795145|7294635|FG002|COMPLETED|Cohort 1||3
6383543|NCT00795145|7294636|FG003|COMPLETED|Cohort 1||0
6804447|NCT03377803|7736442|FG000|STARTED|Overall Study||150
6804448|NCT03377803|7736443|FG001|STARTED|Overall Study||112
6804449|NCT03377803|7736442|FG000|COMPLETED|Overall Study||139
6804450|NCT03377803|7736443|FG001|COMPLETED|Overall Study||108
6804451|NCT03377803|7736442|FG000|NOT COMPLETED|Overall Study||11
6804452|NCT03377803|7736443|FG001|NOT COMPLETED|Overall Study||4
6804453|NCT03283371|7736451|FG000|STARTED|Placebo-controlled||34
6804454|NCT03283371|7736452|FG001|STARTED|Placebo-controlled||33
6804455|NCT03283371|7736453|FG002|STARTED|Placebo-controlled||0
6804456|NCT03283371|7736454|FG003|STARTED|Placebo-controlled||0
6804457|NCT03283371|7736451|FG000|Number of Participants Dosed|Placebo-controlled||34
6564884|NCT01814072|7487600|FG003|COMPLETED|Overall Study||18
6564885|NCT01814072|7487601|FG004|COMPLETED|Overall Study||14
6564886|NCT01814072|7487602|FG005|COMPLETED|Overall Study||12
6564887|NCT01814072|7487603|FG006|COMPLETED|Overall Study||14
6564888|NCT01814072|7487604|FG007|COMPLETED|Overall Study||17
6564889|NCT01814072|7487605|FG008|COMPLETED|Overall Study||16
6269490|NCT00075088|7168653|FG001|NOT COMPLETED|Overall Study||0
6269491|NCT00075218|7168662|FG000|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
6269492|NCT00075218|7168663|FG001|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
6269493|NCT00075218|7168664|FG002|STARTED|Double-Blind Treatment||0
6269494|NCT00075218|7168662|FG000|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
6269495|NCT00075218|7168663|FG001|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
6269496|NCT00075218|7168664|FG002|Received Double-Blind Treatment|Double-Blind Treatment||0
6269497|NCT00075218|7168662|FG000|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
6269498|NCT00075218|7168663|FG001|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
6564890|NCT01814072|7487606|FG009|COMPLETED|Overall Study||13
6564891|NCT01814072|7487607|FG010|COMPLETED|Overall Study||17
6564892|NCT01814072|7487608|FG011|COMPLETED|Overall Study||16
6564893|NCT01814072|7487609|FG012|COMPLETED|Overall Study||15
6564894|NCT01814072|7487610|FG013|COMPLETED|Overall Study||16
6564895|NCT01814072|7487611|FG014|COMPLETED|Overall Study||15
6564896|NCT01814072|7487612|FG015|COMPLETED|Overall Study||16
6269499|NCT00075218|7168664|FG002|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
6269500|NCT00075218|7168662|FG000|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
6269501|NCT00075218|7168663|FG001|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
6269502|NCT00075218|7168664|FG002|COMPLETED|Double-Blind Treatment||0
6383544|NCT00795145|7294637|FG004|COMPLETED|Cohort 1||0
6383545|NCT00795145|7294638|FG005|COMPLETED|Cohort 1||0
6383546|NCT00795145|7294639|FG006|COMPLETED|Cohort 1||0
6383547|NCT00795145|7294633|FG000|NOT COMPLETED|Cohort 1||0
6383548|NCT00795145|7294634|FG001|NOT COMPLETED|Cohort 1||0
6383549|NCT00795145|7294635|FG002|NOT COMPLETED|Cohort 1||0
6383550|NCT00795145|7294636|FG003|NOT COMPLETED|Cohort 1||0
6383551|NCT00795145|7294637|FG004|NOT COMPLETED|Cohort 1||0
6383552|NCT00795145|7294638|FG005|NOT COMPLETED|Cohort 1||0
6383553|NCT00795145|7294639|FG006|NOT COMPLETED|Cohort 1||0
6383554|NCT00795145|7294633|FG000|STARTED|Cohort 2||0
6383555|NCT00795145|7294634|FG001|STARTED|Cohort 2||0
6383556|NCT00795145|7294635|FG002|STARTED|Cohort 2||0
6383557|NCT00795145|7294636|FG003|STARTED|Cohort 2||10
6383558|NCT00795145|7294637|FG004|STARTED|Cohort 2||10
6383559|NCT00795145|7294638|FG005|STARTED|Cohort 2||10
6383560|NCT00795145|7294639|FG006|STARTED|Cohort 2||10
6383561|NCT00795145|7294633|FG000|COMPLETED|Cohort 2||0
6383562|NCT00795145|7294634|FG001|COMPLETED|Cohort 2||0
6383563|NCT00795145|7294635|FG002|COMPLETED|Cohort 2||0
6383564|NCT00795145|7294636|FG003|COMPLETED|Cohort 2||10
6383565|NCT00795145|7294637|FG004|COMPLETED|Cohort 2||10
6383566|NCT00795145|7294638|FG005|COMPLETED|Cohort 2||10
6383567|NCT00795145|7294639|FG006|COMPLETED|Cohort 2||10
6383568|NCT00795145|7294633|FG000|NOT COMPLETED|Cohort 2||0
6383569|NCT00795145|7294634|FG001|NOT COMPLETED|Cohort 2||0
6383570|NCT00795145|7294635|FG002|NOT COMPLETED|Cohort 2||0
6383571|NCT00795145|7294636|FG003|NOT COMPLETED|Cohort 2||0
6383572|NCT00795145|7294637|FG004|NOT COMPLETED|Cohort 2||0
6383573|NCT00795145|7294638|FG005|NOT COMPLETED|Cohort 2||0
6383574|NCT00795145|7294639|FG006|NOT COMPLETED|Cohort 2||0
6383575|NCT00795184|7294666|FG000|STARTED|Overall Study||65
6383576|NCT00795184|7294667|FG001|STARTED|Overall Study||57
6383577|NCT00795184|7294666|FG000|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
6383578|NCT00795184|7294667|FG001|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
6383579|NCT00795184|7294666|FG000|NOT COMPLETED|Overall Study||8
6383580|NCT00795184|7294667|FG001|NOT COMPLETED|Overall Study||13
6383581|NCT00795210|7294679|FG000|STARTED|Overall Study||8
6383582|NCT00795210|7294680|FG001|STARTED|Overall Study||12
6383583|NCT00795210|7294681|FG002|STARTED|Overall Study||5
6383584|NCT00795210|7294679|FG000|COMPLETED|Overall Study||8
6383585|NCT00795210|7294680|FG001|COMPLETED|Overall Study||11
6383586|NCT00795210|7294681|FG002|COMPLETED|Overall Study||3
6383587|NCT00795210|7294679|FG000|NOT COMPLETED|Overall Study||0
6383588|NCT00795210|7294680|FG001|NOT COMPLETED|Overall Study||1
6383589|NCT00795210|7294681|FG002|NOT COMPLETED|Overall Study||2
6383590|NCT00795275|7294691|FG000|STARTED|Overall Study||11
6383591|NCT00795275|7294692|FG001|STARTED|Overall Study||15
6383592|NCT00795275|7294691|FG000|COMPLETED|Overall Study||10
6383593|NCT00795275|7294692|FG001|COMPLETED|Overall Study||13
6383594|NCT00795275|7294691|FG000|NOT COMPLETED|Overall Study||1
6383595|NCT00795275|7294692|FG001|NOT COMPLETED|Overall Study||2
6564897|NCT01814072|7487613|FG016|COMPLETED|Overall Study||14
6503226|NCT01440283|7422074|FG000|NOT COMPLETED|Overall Study||10
6383596|NCT00795288|7294702|FG000|STARTED|Overall Study||21
6383597|NCT00795288|7294703|FG001|STARTED|Overall Study||21
6383598|NCT00795288|7294702|FG000|COMPLETED|Overall Study||21
6383599|NCT00795288|7294703|FG001|COMPLETED|Overall Study||21
6383600|NCT00795288|7294702|FG000|NOT COMPLETED|Overall Study||0
6383601|NCT00795288|7294703|FG001|NOT COMPLETED|Overall Study||0
6383602|NCT00795340|7294713|FG000|STARTED|Overall Study||153
6383603|NCT00795340|7294714|FG001|STARTED|Overall Study||153
6383604|NCT00795340|7294713|FG000|COMPLETED|Overall Study||146
6383605|NCT00795340|7294714|FG001|COMPLETED|Overall Study||153
6383606|NCT00795340|7294713|FG000|NOT COMPLETED|Overall Study||7
6383607|NCT00795340|7294714|FG001|NOT COMPLETED|Overall Study||0
6383608|NCT00795366|7294722|FG000|STARTED|Overall Study||42
6383609|NCT00795366|7294723|FG001|STARTED|Overall Study||54
6383610|NCT00795366|7294722|FG000|COMPLETED|Overall Study||42
6383611|NCT00795366|7294723|FG001|COMPLETED|Overall Study||54
6383612|NCT00795366|7294722|FG000|NOT COMPLETED|Overall Study||0
6383613|NCT00795366|7294723|FG001|NOT COMPLETED|Overall Study||0
6383614|NCT00795509|7294729|FG000|STARTED|Overall Study||374
6383615|NCT00795509|7294729|FG000|COMPLETED|Overall Study||343
6383616|NCT00795509|7294729|FG000|NOT COMPLETED|Overall Study||31
6383617|NCT00795535|7294733|FG000|STARTED|Overall Study||95
6383618|NCT00795535|7294733|FG000|COMPLETED|Overall Study||75
6383619|NCT00795535|7294733|FG000|NOT COMPLETED|Overall Study||20
6383620|NCT00795600|7294739|FG000|STARTED|Overall Study||25
6383621|NCT00795600|7294740|FG001|STARTED|Overall Study||35
6383622|NCT00795600|7294739|FG000|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
6383623|NCT00795600|7294740|FG001|Exposed to Drug|Overall Study||35
6383624|NCT00795600|7294739|FG000|COMPLETED|Overall Study||21
6383625|NCT00795600|7294740|FG001|COMPLETED|Overall Study||31
6383626|NCT00795600|7294739|FG000|NOT COMPLETED|Overall Study||4
6383627|NCT00795600|7294740|FG001|NOT COMPLETED|Overall Study||4
6383628|NCT00795639|7294748|FG000|STARTED|Overall Study||91
6383629|NCT00795639|7294749|FG001|STARTED|Overall Study||92
6383630|NCT00795639|7294748|FG000|Randomized and Not Treated|Overall Study||0
6383631|NCT00795639|7294749|FG001|Randomized and Not Treated|Overall Study||1
6383632|NCT00795639|7294748|FG000|COMPLETED|Overall Study||70
6383633|NCT00795639|7294749|FG001|COMPLETED|Overall Study||66
6383634|NCT00795639|7294748|FG000|NOT COMPLETED|Overall Study||21
6503227|NCT01440322|7422086|FG000|STARTED|Overall Study||97
6503228|NCT01440322|7422087|FG001|STARTED|Overall Study||50
6503229|NCT01440322|7422086|FG000|COMPLETED|Overall Study||90
6503230|NCT01440322|7422087|FG001|COMPLETED|Overall Study||49
6503231|NCT01440322|7422086|FG000|NOT COMPLETED|Overall Study||7
6564898|NCT01814072|7487614|FG017|COMPLETED|Overall Study||17
6564899|NCT01814072|7487615|FG018|COMPLETED|Overall Study||14
6564900|NCT01814072|7487616|FG019|COMPLETED|Overall Study||11
6564901|NCT01814072|7487617|FG020|COMPLETED|Overall Study||14
6564902|NCT01814072|7487618|FG021|COMPLETED|Overall Study||16
6564903|NCT01814072|7487619|FG022|COMPLETED|Overall Study||13
6383635|NCT00795639|7294749|FG001|NOT COMPLETED|Overall Study||26
6383636|NCT00795704|7294757|FG000|STARTED|Overall Study||12
6383637|NCT00795704|7294758|FG001|STARTED|Overall Study||12
6383638|NCT00795704|7294757|FG000|COMPLETED|Overall Study||8
6383639|NCT00795704|7294758|FG001|COMPLETED|Overall Study||9
6383640|NCT00795704|7294757|FG000|NOT COMPLETED|Overall Study||4
6383641|NCT00795704|7294758|FG001|NOT COMPLETED|Overall Study||3
6383642|NCT00795717|7294766|FG000|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
6383643|NCT00795717|7294767|FG001|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
6383644|NCT00795717|7294766|FG000|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
6383645|NCT00795717|7294767|FG001|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
6383646|NCT00795717|7294766|FG000|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
6383647|NCT00795717|7294767|FG001|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
6383648|NCT00795717|7294766|FG000|STARTED|Phase II||18
6383649|NCT00795717|7294767|FG001|STARTED|Phase II||19
6383650|NCT00795717|7294766|FG000|COMPLETED|Phase II||18
6383651|NCT00795717|7294767|FG001|COMPLETED|Phase II||18
6383652|NCT00795717|7294766|FG000|NOT COMPLETED|Phase II||0
6383653|NCT00795717|7294767|FG001|NOT COMPLETED|Phase II||1
6383654|NCT00795769|7294774|FG000|STARTED|Overall Study||49
6383655|NCT00795769|7294774|FG000|COMPLETED|Overall Study||49
6383656|NCT00795769|7294774|FG000|NOT COMPLETED|Overall Study||0
6383657|NCT00795821|7294780|FG000|STARTED|Acute Treatment Phase||250
6383658|NCT00795821|7294781|FG001|STARTED|Acute Treatment Phase||245
6383659|NCT00795821|7294780|FG000|COMPLETED|Acute Treatment Phase|4 LY-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|194
6383660|NCT00795821|7294781|FG001|COMPLETED|Acute Treatment Phase|7 placebo-treated participants in the Acute Phase chose not to enter the Long-term Extension Phase.|214
6383661|NCT00795821|7294780|FG000|NOT COMPLETED|Acute Treatment Phase||56
6383662|NCT00795821|7294781|FG001|NOT COMPLETED|Acute Treatment Phase||31
6383663|NCT00795821|7294780|FG000|STARTED|Long-term Extension Phase||190
6383664|NCT00795821|7294781|FG001|STARTED|Long-term Extension Phase|All placebo-treated participants received LY2216684 in the Long-term Extension Phase.|207
6383665|NCT00795821|7294780|FG000|COMPLETED|Long-term Extension Phase||100
6383666|NCT00795821|7294781|FG001|COMPLETED|Long-term Extension Phase||115
6383667|NCT00795821|7294780|FG000|NOT COMPLETED|Long-term Extension Phase||90
6383668|NCT00795821|7294781|FG001|NOT COMPLETED|Long-term Extension Phase||92
6383669|NCT00795821|7294780|FG000|STARTED|Taper Phase|N=240 participants entered Taper Phases: N=4 from Acute Phase; N=236 from Extension Phase.|240
6383670|NCT00795821|7294781|FG001|STARTED|Taper Phase|N=6 participants entered only Acute Taper Phase.|6
6383671|NCT00795821|7294780|FG000|COMPLETED|Taper Phase|N=231 participants completed Taper Phases: N=3 from Acute Phase; N=228 from Extension Phase.|231
6383672|NCT00795821|7294781|FG001|COMPLETED|Taper Phase|N=6 participants completed only Acute Taper Phase; N=0 participants entered Extension Taper Phase.|6
6383673|NCT00795821|7294780|FG000|NOT COMPLETED|Taper Phase||9
6383674|NCT00795821|7294781|FG001|NOT COMPLETED|Taper Phase||0
6383675|NCT00795886|7294797|FG000|STARTED|Overall Study||63
6383676|NCT00795886|7294797|FG000|COMPLETED|Overall Study||53
6383677|NCT00795886|7294797|FG000|NOT COMPLETED|Overall Study||10
6383678|NCT00795951|7294802|FG000|STARTED|Overall Study||102
6564904|NCT01814072|7487620|FG023|COMPLETED|Overall Study||17
6564905|NCT01814072|7487621|FG024|COMPLETED|Overall Study||11
6564906|NCT01814072|7487622|FG025|COMPLETED|Overall Study||14
6804458|NCT03283371|7736452|FG001|Number of Participants Dosed|Placebo-controlled||32
6804459|NCT03283371|7736453|FG002|Number of Participants Dosed|Placebo-controlled||0
6804460|NCT03283371|7736454|FG003|Number of Participants Dosed|Placebo-controlled||0
6804461|NCT03283371|7736451|FG000|COMPLETED|Placebo-controlled||31
6804462|NCT03283371|7736452|FG001|COMPLETED|Placebo-controlled||30
6383679|NCT00795951|7294802|FG000|COMPLETED|Overall Study||100
6383680|NCT00795951|7294802|FG000|NOT COMPLETED|Overall Study||2
6383681|NCT00796003|7294809|FG000|STARTED|Overall Study|Number of participants enrolled|3
6383682|NCT00796003|7294810|FG001|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
6383683|NCT00796003|7294809|FG000|Treated|Overall Study|Number of participants treated|3
6503232|NCT01440322|7422087|FG001|NOT COMPLETED|Overall Study||1
6804463|NCT03283371|7736453|FG002|COMPLETED|Placebo-controlled||0
6804464|NCT03283371|7736454|FG003|COMPLETED|Placebo-controlled||0
6804465|NCT03283371|7736451|FG000|NOT COMPLETED|Placebo-controlled||3
6804466|NCT03283371|7736452|FG001|NOT COMPLETED|Placebo-controlled||3
6804467|NCT03283371|7736453|FG002|NOT COMPLETED|Placebo-controlled||0
6804468|NCT03283371|7736454|FG003|NOT COMPLETED|Placebo-controlled||0
6804469|NCT03283371|7736451|FG000|STARTED|Open-label Phase||0
6804470|NCT03283371|7736452|FG001|STARTED|Open-label Phase||0
6804471|NCT03283371|7736453|FG002|STARTED|Open-label Phase||31
6804472|NCT03283371|7736454|FG003|STARTED|Open-label Phase||30
6804473|NCT03283371|7736451|FG000|COMPLETED|Open-label Phase||0
6804474|NCT03283371|7736452|FG001|COMPLETED|Open-label Phase||0
6804475|NCT03283371|7736453|FG002|COMPLETED|Open-label Phase||27
6804476|NCT03283371|7736454|FG003|COMPLETED|Open-label Phase||29
6804477|NCT03283371|7736451|FG000|NOT COMPLETED|Open-label Phase||0
6804478|NCT03283371|7736452|FG001|NOT COMPLETED|Open-label Phase||0
6804479|NCT03283371|7736453|FG002|NOT COMPLETED|Open-label Phase||4
6804480|NCT03283371|7736454|FG003|NOT COMPLETED|Open-label Phase||1
6804481|NCT03257254|7736464|FG000|STARTED|Overall Study||76
6804482|NCT03257254|7736464|FG000|COMPLETED|Overall Study||55
6804483|NCT03257254|7736464|FG000|NOT COMPLETED|Overall Study||21
6804484|NCT03084718|7736473|FG000|STARTED|Overall Study||120
6804485|NCT03084718|7736474|FG001|STARTED|Overall Study||120
6804486|NCT03084718|7736475|FG002|STARTED|Overall Study||122
6804487|NCT03084718|7736476|FG003|STARTED|Overall Study||124
6804488|NCT03084718|7736477|FG004|STARTED|Overall Study||124
6804489|NCT03084718|7736473|FG000|COMPLETED|Overall Study||109
6804490|NCT03084718|7736474|FG001|COMPLETED|Overall Study||110
6804491|NCT03084718|7736475|FG002|COMPLETED|Overall Study||110
6804492|NCT03084718|7736476|FG003|COMPLETED|Overall Study||110
6804493|NCT03084718|7736477|FG004|COMPLETED|Overall Study||120
6804494|NCT03084718|7736473|FG000|NOT COMPLETED|Overall Study||11
6804495|NCT03084718|7736474|FG001|NOT COMPLETED|Overall Study||10
6804496|NCT03084718|7736475|FG002|NOT COMPLETED|Overall Study||12
6804497|NCT03084718|7736476|FG003|NOT COMPLETED|Overall Study||14
6804498|NCT03084718|7736477|FG004|NOT COMPLETED|Overall Study||4
6804499|NCT03069417|7736494|FG000|STARTED|Overall Study||14
6804500|NCT03069417|7736495|FG001|STARTED|Overall Study||9
6804501|NCT03069417|7736494|FG000|Post-Treatment Assessment|Overall Study||12
6804502|NCT03069417|7736495|FG001|Post-Treatment Assessment|Overall Study||6
6804503|NCT03069417|7736494|FG000|COMPLETED|Overall Study||8
6804504|NCT03069417|7736495|FG001|COMPLETED|Overall Study||2
6804505|NCT03069417|7736494|FG000|NOT COMPLETED|Overall Study||6
6804506|NCT03069417|7736495|FG001|NOT COMPLETED|Overall Study||7
6804507|NCT03063164|7736502|FG000|STARTED|Overall Study||7
6804508|NCT03063164|7736503|FG001|STARTED|Overall Study||7
6804509|NCT03063164|7736502|FG000|COMPLETED|Overall Study||7
6804510|NCT03063164|7736503|FG001|COMPLETED|Overall Study||7
6804511|NCT03063164|7736502|FG000|NOT COMPLETED|Overall Study||0
6804512|NCT03063164|7736503|FG001|NOT COMPLETED|Overall Study||0
6804513|NCT02952365|7736510|FG000|STARTED|Overall Study||2
6804514|NCT02952365|7736510|FG000|COMPLETED|Overall Study||2
6804515|NCT02952365|7736510|FG000|NOT COMPLETED|Overall Study||0
6804516|NCT02936323|7736524|FG000|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|2
6804517|NCT02936323|7736525|FG001|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
6503233|NCT01440374|7422096|FG000|STARTED|Part 1: Open-label Phase||17
6503234|NCT01440374|7422097|FG001|STARTED|Part 1: Open-label Phase||0
6503235|NCT01440374|7422098|FG002|STARTED|Part 1: Open-label Phase||0
6503236|NCT01440374|7422099|FG003|STARTED|Part 1: Open-label Phase||0
6503237|NCT01440374|7422096|FG000|COMPLETED|Part 1: Open-label Phase||11
6503238|NCT01440374|7422097|FG001|COMPLETED|Part 1: Open-label Phase||0
6503239|NCT01440374|7422098|FG002|COMPLETED|Part 1: Open-label Phase||0
6503240|NCT01440374|7422099|FG003|COMPLETED|Part 1: Open-label Phase||0
6503241|NCT01440374|7422096|FG000|NOT COMPLETED|Part 1: Open-label Phase||6
6503242|NCT01440374|7422097|FG001|NOT COMPLETED|Part 1: Open-label Phase||0
6503243|NCT01440374|7422098|FG002|NOT COMPLETED|Part 1: Open-label Phase||0
6503244|NCT01440374|7422099|FG003|NOT COMPLETED|Part 1: Open-label Phase||0
6503245|NCT01440374|7422096|FG000|STARTED|Part 2; Double-blind Phase||0
6503246|NCT01440374|7422097|FG001|STARTED|Part 2; Double-blind Phase||47
6564907|NCT01814072|7487623|FG026|COMPLETED|Overall Study||16
6564908|NCT01814072|7487624|FG027|COMPLETED|Overall Study||13
6804518|NCT02936323|7736526|FG002|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
6804519|NCT02936323|7736527|FG003|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
6804520|NCT02936323|7736528|FG004|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
6564909|NCT01814072|7487625|FG028|COMPLETED|Overall Study||14
6564910|NCT01814072|7487626|FG029|COMPLETED|Overall Study||14
6804521|NCT02936323|7736529|FG005|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|6
6804522|NCT02936323|7736530|FG006|STARTED|Phase 1 Dose Escalation|Participants in Phase 1 did not advance to Phase 2a.|3
6804523|NCT02936323|7736531|FG007|STARTED|Phase 1 Dose Escalation||0
6804524|NCT02936323|7736532|FG008|STARTED|Phase 1 Dose Escalation||0
6804525|NCT02936323|7736533|FG009|STARTED|Phase 1 Dose Escalation||0
6804526|NCT02936323|7736524|FG000|COMPLETED|Phase 1 Dose Escalation||0
6804527|NCT02936323|7736525|FG001|COMPLETED|Phase 1 Dose Escalation||1
6804528|NCT02936323|7736526|FG002|COMPLETED|Phase 1 Dose Escalation||0
6804529|NCT02936323|7736527|FG003|COMPLETED|Phase 1 Dose Escalation||1
6804530|NCT02936323|7736528|FG004|COMPLETED|Phase 1 Dose Escalation||0
6804531|NCT02936323|7736529|FG005|COMPLETED|Phase 1 Dose Escalation||1
6804532|NCT02936323|7736530|FG006|COMPLETED|Phase 1 Dose Escalation||0
6804533|NCT02936323|7736531|FG007|COMPLETED|Phase 1 Dose Escalation||0
6804534|NCT02936323|7736532|FG008|COMPLETED|Phase 1 Dose Escalation||0
6804535|NCT02936323|7736533|FG009|COMPLETED|Phase 1 Dose Escalation||0
6269503|NCT00075218|7168662|FG000|NOT COMPLETED|Double-Blind Treatment||91
6804536|NCT02936323|7736524|FG000|NOT COMPLETED|Phase 1 Dose Escalation||2
6804537|NCT02936323|7736525|FG001|NOT COMPLETED|Phase 1 Dose Escalation||2
6804538|NCT02936323|7736526|FG002|NOT COMPLETED|Phase 1 Dose Escalation||3
6804539|NCT02936323|7736527|FG003|NOT COMPLETED|Phase 1 Dose Escalation||2
6804540|NCT02936323|7736528|FG004|NOT COMPLETED|Phase 1 Dose Escalation||3
6269504|NCT00075218|7168663|FG001|NOT COMPLETED|Double-Blind Treatment||15
6269505|NCT00075218|7168664|FG002|NOT COMPLETED|Double-Blind Treatment||0
6564911|NCT01814072|7487627|FG030|COMPLETED|Overall Study||15
6383684|NCT00796003|7294810|FG001|Treated|Overall Study|Number of participants treated|34
6383685|NCT00796003|7294809|FG000|COMPLETED|Overall Study||0
6383686|NCT00796003|7294810|FG001|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
6383687|NCT00796003|7294809|FG000|NOT COMPLETED|Overall Study||3
6383688|NCT00796003|7294810|FG001|NOT COMPLETED|Overall Study||29
6383689|NCT00796120|7294821|FG000|STARTED|Overall Study||61
6383690|NCT00796120|7294822|FG001|STARTED|Overall Study||60
6383691|NCT00796120|7294821|FG000|Treated|Overall Study||61
6383692|NCT00796120|7294822|FG001|Treated|Overall Study||57
6383693|NCT00796120|7294821|FG000|COMPLETED|Overall Study||0
6503247|NCT01440374|7422098|FG002|STARTED|Part 2; Double-blind Phase||98
6503248|NCT01440374|7422099|FG003|STARTED|Part 2; Double-blind Phase||0
6503249|NCT01440374|7422096|FG000|COMPLETED|Part 2; Double-blind Phase||0
6503250|NCT01440374|7422097|FG001|COMPLETED|Part 2; Double-blind Phase||27
6503251|NCT01440374|7422098|FG002|COMPLETED|Part 2; Double-blind Phase||43
6503252|NCT01440374|7422099|FG003|COMPLETED|Part 2; Double-blind Phase||0
6503253|NCT01440374|7422096|FG000|NOT COMPLETED|Part 2; Double-blind Phase||0
6503254|NCT01440374|7422097|FG001|NOT COMPLETED|Part 2; Double-blind Phase||20
6503255|NCT01440374|7422098|FG002|NOT COMPLETED|Part 2; Double-blind Phase||55
6503256|NCT01440374|7422099|FG003|NOT COMPLETED|Part 2; Double-blind Phase||0
6503257|NCT01440374|7422096|FG000|STARTED|Part 3: Extension||0
6503258|NCT01440374|7422097|FG001|STARTED|Part 3: Extension||0
6503259|NCT01440374|7422098|FG002|STARTED|Part 3: Extension||0
6503260|NCT01440374|7422099|FG003|STARTED|Part 3: Extension||59
6503261|NCT01440374|7422096|FG000|COMPLETED|Part 3: Extension||0
6503262|NCT01440374|7422097|FG001|COMPLETED|Part 3: Extension||0
6503263|NCT01440374|7422098|FG002|COMPLETED|Part 3: Extension||0
6503264|NCT01440374|7422099|FG003|COMPLETED|Part 3: Extension||27
6503265|NCT01440374|7422096|FG000|NOT COMPLETED|Part 3: Extension||0
6503266|NCT01440374|7422097|FG001|NOT COMPLETED|Part 3: Extension||0
6503267|NCT01440374|7422098|FG002|NOT COMPLETED|Part 3: Extension||0
6503268|NCT01440374|7422099|FG003|NOT COMPLETED|Part 3: Extension||32
6503269|NCT01440387|7422113|FG000|STARTED|Overall Study||56
6503270|NCT01440387|7422114|FG001|STARTED|Overall Study||56
6503271|NCT01440387|7422113|FG000|COMPLETED|Overall Study||56
6503272|NCT01440387|7422114|FG001|COMPLETED|Overall Study||56
6503273|NCT01440387|7422113|FG000|NOT COMPLETED|Overall Study||0
6503274|NCT01440387|7422114|FG001|NOT COMPLETED|Overall Study||0
6503275|NCT01440543|7422124|FG000|STARTED|Overall Study||106
6503276|NCT01440543|7422125|FG001|STARTED|Overall Study||105
6503277|NCT01440543|7422126|FG002|STARTED|Overall Study||102
6503278|NCT01440543|7422127|FG003|STARTED|Overall Study||107
6503279|NCT01440543|7422124|FG000|COMPLETED|Overall Study||102
6503280|NCT01440543|7422125|FG001|COMPLETED|Overall Study||101
6503281|NCT01440543|7422126|FG002|COMPLETED|Overall Study||100
6503282|NCT01440543|7422127|FG003|COMPLETED|Overall Study||101
6503283|NCT01440543|7422124|FG000|NOT COMPLETED|Overall Study||4
6503284|NCT01440543|7422125|FG001|NOT COMPLETED|Overall Study||4
6503285|NCT01440543|7422126|FG002|NOT COMPLETED|Overall Study||2
6503286|NCT01440543|7422127|FG003|NOT COMPLETED|Overall Study||6
6503287|NCT01440569|7422139|FG000|STARTED|Main Study||296
6503288|NCT01440569|7422140|FG001|STARTED|Main Study||18
6503289|NCT01440569|7422139|FG000|Enrolled and Treated|Main Study||295
6503290|NCT01440569|7422140|FG001|Enrolled and Treated|Main Study||18
6503291|NCT01440569|7422139|FG000|COMPLETED|Main Study||260
6503292|NCT01440569|7422140|FG001|COMPLETED|Main Study||14
6503293|NCT01440569|7422139|FG000|NOT COMPLETED|Main Study||36
6503294|NCT01440569|7422140|FG001|NOT COMPLETED|Main Study||4
6503295|NCT01440569|7422139|FG000|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
6503296|NCT01440569|7422140|FG001|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
6503297|NCT01440569|7422139|FG000|COMPLETED|Open-Label Rollover Phase||204
6503298|NCT01440569|7422140|FG001|COMPLETED|Open-Label Rollover Phase||7
6503299|NCT01440569|7422139|FG000|NOT COMPLETED|Open-Label Rollover Phase||47
6503300|NCT01440569|7422140|FG001|NOT COMPLETED|Open-Label Rollover Phase||6
6503301|NCT01440634|7422148|FG000|STARTED|Cross Sectional Phase||0
6503302|NCT01440634|7422149|FG001|STARTED|Cross Sectional Phase||347
6503303|NCT01440634|7422148|FG000|COMPLETED|Cross Sectional Phase||0
6503304|NCT01440634|7422149|FG001|COMPLETED|Cross Sectional Phase||347
6503305|NCT01440634|7422148|FG000|NOT COMPLETED|Cross Sectional Phase||0
6503306|NCT01440634|7422149|FG001|NOT COMPLETED|Cross Sectional Phase||0
6503307|NCT01440634|7422148|FG000|STARTED|Randomization Phase||30
6503308|NCT01440634|7422149|FG001|STARTED|Randomization Phase||24
6503309|NCT01440634|7422148|FG000|COMPLETED|Randomization Phase||24
6503310|NCT01440634|7422149|FG001|COMPLETED|Randomization Phase||14
6503311|NCT01440634|7422148|FG000|NOT COMPLETED|Randomization Phase||6
6503312|NCT01440634|7422149|FG001|NOT COMPLETED|Randomization Phase||10
6503313|NCT01440647|7422157|FG000|STARTED|Overall Study||16
6503314|NCT01440647|7422158|FG001|STARTED|Overall Study||18
6503315|NCT01440647|7422157|FG000|COMPLETED|Overall Study||14
6503316|NCT01440647|7422158|FG001|COMPLETED|Overall Study||15
6503317|NCT01440647|7422157|FG000|NOT COMPLETED|Overall Study||2
6383694|NCT00796120|7294822|FG001|COMPLETED|Overall Study||0
6383695|NCT00796120|7294821|FG000|NOT COMPLETED|Overall Study||61
6383696|NCT00796120|7294822|FG001|NOT COMPLETED|Overall Study||60
6564912|NCT01814072|7487628|FG031|COMPLETED|Overall Study||17
6564913|NCT01814072|7487597|FG000|NOT COMPLETED|Overall Study||4
6564914|NCT01814072|7487598|FG001|NOT COMPLETED|Overall Study||2
6564915|NCT01814072|7487599|FG002|NOT COMPLETED|Overall Study||3
6564916|NCT01814072|7487600|FG003|NOT COMPLETED|Overall Study||0
6383697|NCT00796224|7294830|FG000|STARTED|Overall Study||19
6383698|NCT00796224|7294831|FG001|STARTED|Overall Study||19
6383699|NCT00796224|7294830|FG000|COMPLETED|Overall Study||18
6383700|NCT00796224|7294831|FG001|COMPLETED|Overall Study||18
6383701|NCT00796224|7294830|FG000|NOT COMPLETED|Overall Study||1
6383702|NCT00796224|7294831|FG001|NOT COMPLETED|Overall Study||1
6383703|NCT00796302|7294841|FG000|STARTED|Overall Study||84
6383704|NCT00796302|7294842|FG001|STARTED|Overall Study||84
6383705|NCT00796302|7294841|FG000|COMPLETED|Overall Study||71
6383706|NCT00796302|7294842|FG001|COMPLETED|Overall Study||66
6383707|NCT00796302|7294841|FG000|NOT COMPLETED|Overall Study||13
6383708|NCT00796302|7294842|FG001|NOT COMPLETED|Overall Study||18
6383709|NCT00796315|7294849|FG000|STARTED|Overall Study||9
6383710|NCT00796315|7294850|FG001|STARTED|Overall Study||17
6383711|NCT00796315|7294851|FG002|STARTED|Overall Study||15
6383712|NCT00796315|7294849|FG000|COMPLETED|Overall Study||9
6383713|NCT00796315|7294850|FG001|COMPLETED|Overall Study||16
6383714|NCT00796315|7294851|FG002|COMPLETED|Overall Study||15
6383715|NCT00796315|7294849|FG000|NOT COMPLETED|Overall Study||0
6383716|NCT00796315|7294850|FG001|NOT COMPLETED|Overall Study||1
6383717|NCT00796315|7294851|FG002|NOT COMPLETED|Overall Study||0
6383718|NCT00796328|7294862|FG000|STARTED|Overall Study||46
6383719|NCT00796328|7294862|FG000|COMPLETED|Overall Study||40
6383720|NCT00796328|7294862|FG000|NOT COMPLETED|Overall Study||6
6383721|NCT00796367|7294869|FG000|STARTED|Overall Study||227
6383722|NCT00796367|7294870|FG001|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
6383723|NCT00796367|7294871|FG002|STARTED|Overall Study||295
6383724|NCT00796367|7294869|FG000|COMPLETED|Overall Study||197
6383725|NCT00796367|7294870|FG001|COMPLETED|Overall Study||129
6383726|NCT00796367|7294871|FG002|COMPLETED|Overall Study||248
6383727|NCT00796367|7294869|FG000|NOT COMPLETED|Overall Study||30
6383728|NCT00796367|7294870|FG001|NOT COMPLETED|Overall Study||25
6383729|NCT00796367|7294871|FG002|NOT COMPLETED|Overall Study||47
6383730|NCT00796419|7294881|FG000|STARTED|Overall Study||13
6383731|NCT00796419|7294882|FG001|STARTED|Overall Study||14
6383732|NCT00796419|7294881|FG000|COMPLETED|Overall Study||13
6383733|NCT00796419|7294882|FG001|COMPLETED|Overall Study||13
6383734|NCT00796419|7294881|FG000|NOT COMPLETED|Overall Study||0
6383735|NCT00796419|7294882|FG001|NOT COMPLETED|Overall Study||1
6383736|NCT00796445|7294890|FG000|STARTED|Overall Study||895
6383737|NCT00796445|7294891|FG001|STARTED|Overall Study||450
6383738|NCT00796445|7294890|FG000|COMPLETED|Overall Study||310
6383739|NCT00796445|7294891|FG001|COMPLETED|Overall Study||158
6383740|NCT00796445|7294890|FG000|NOT COMPLETED|Overall Study||585
6383741|NCT00796445|7294891|FG001|NOT COMPLETED|Overall Study||292
6383742|NCT00796549|7294905|FG000|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
6383743|NCT00796549|7294905|FG000|Entered|Overall Study|entered and treated|69
6383744|NCT00796549|7294905|FG000|COMPLETED|Overall Study||0
6383745|NCT00796549|7294905|FG000|NOT COMPLETED|Overall Study||218
6383746|NCT00796562|7294911|FG000|STARTED|Overall Study||96
6383747|NCT00796562|7294911|FG000|COMPLETED|Overall Study||47
6383748|NCT00796562|7294911|FG000|NOT COMPLETED|Overall Study||49
6383749|NCT00796614|7294919|FG000|STARTED|Overall Study||41
6383750|NCT00796614|7294920|FG001|STARTED|Overall Study||40
6383751|NCT00796614|7294921|FG002|STARTED|Overall Study||39
6383752|NCT00796614|7294922|FG003|STARTED|Overall Study||41
6383753|NCT00796614|7294919|FG000|Not Treated|Overall Study||0
6383754|NCT00796614|7294920|FG001|Not Treated|Overall Study||0
6383755|NCT00796614|7294921|FG002|Not Treated|Overall Study||1
6383756|NCT00796614|7294922|FG003|Not Treated|Overall Study||0
6383757|NCT00796614|7294919|FG000|COMPLETED|Overall Study||36
6383758|NCT00796614|7294920|FG001|COMPLETED|Overall Study||36
6383759|NCT00796614|7294921|FG002|COMPLETED|Overall Study||36
6383760|NCT00796614|7294922|FG003|COMPLETED|Overall Study||40
6383761|NCT00796614|7294919|FG000|NOT COMPLETED|Overall Study||5
6383762|NCT00796614|7294920|FG001|NOT COMPLETED|Overall Study||4
6383763|NCT00796614|7294921|FG002|NOT COMPLETED|Overall Study||3
6383764|NCT00796614|7294922|FG003|NOT COMPLETED|Overall Study||1
6383765|NCT00796627|7294934|FG000|STARTED|Overall Study||10
6383766|NCT00796627|7294935|FG001|STARTED|Overall Study||31
6383767|NCT00796627|7294934|FG000|COMPLETED|Overall Study||10
6383768|NCT00796627|7294935|FG001|COMPLETED|Overall Study||31
6383769|NCT00796627|7294934|FG000|NOT COMPLETED|Overall Study||0
6383770|NCT00796627|7294935|FG001|NOT COMPLETED|Overall Study||0
6383771|NCT00796653|7294945|FG000|STARTED|Overall Study||235
6383772|NCT00796653|7294946|FG001|STARTED|Overall Study||232
6383773|NCT00796653|7294947|FG002|STARTED|Overall Study||234
6383774|NCT00796653|7294948|FG003|STARTED|Overall Study||233
6383775|NCT00796653|7294945|FG000|COMPLETED|Overall Study||184
6383776|NCT00796653|7294946|FG001|COMPLETED|Overall Study||195
6383777|NCT00796653|7294947|FG002|COMPLETED|Overall Study||198
6383778|NCT00796653|7294948|FG003|COMPLETED|Overall Study||193
6383779|NCT00796653|7294945|FG000|NOT COMPLETED|Overall Study||51
6383780|NCT00796653|7294946|FG001|NOT COMPLETED|Overall Study||37
6383781|NCT00796653|7294947|FG002|NOT COMPLETED|Overall Study||36
6383782|NCT00796653|7294948|FG003|NOT COMPLETED|Overall Study||40
6383783|NCT00796666|7294968|FG000|STARTED|Overall Study||67
6564917|NCT01814072|7487601|FG004|NOT COMPLETED|Overall Study||4
6656794|NCT02465034|7587122|FG000|Completed CC-PAS|Overall Study||16
6564918|NCT01814072|7487602|FG005|NOT COMPLETED|Overall Study||6
6564919|NCT01814072|7487603|FG006|NOT COMPLETED|Overall Study||4
6564920|NCT01814072|7487604|FG007|NOT COMPLETED|Overall Study||1
6656795|NCT02465034|7587123|FG001|Completed CC-PAS|Overall Study||0
6564921|NCT01814072|7487605|FG008|NOT COMPLETED|Overall Study||3
6564922|NCT01814072|7487606|FG009|NOT COMPLETED|Overall Study||5
6804541|NCT02936323|7736529|FG005|NOT COMPLETED|Phase 1 Dose Escalation||5
6804542|NCT02936323|7736530|FG006|NOT COMPLETED|Phase 1 Dose Escalation||3
6804543|NCT02936323|7736531|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
6804544|NCT02936323|7736532|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
6804545|NCT02936323|7736533|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
6804546|NCT02936323|7736524|FG000|STARTED|Phase 2a Dose Expansion||0
6804547|NCT02936323|7736525|FG001|STARTED|Phase 2a Dose Expansion||0
6804548|NCT02936323|7736526|FG002|STARTED|Phase 2a Dose Expansion||0
6804549|NCT02936323|7736527|FG003|STARTED|Phase 2a Dose Expansion||0
6804550|NCT02936323|7736528|FG004|STARTED|Phase 2a Dose Expansion||0
6804551|NCT02936323|7736529|FG005|STARTED|Phase 2a Dose Expansion||0
6804552|NCT02936323|7736530|FG006|STARTED|Phase 2a Dose Expansion||0
6804553|NCT02936323|7736531|FG007|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|32
6804554|NCT02936323|7736532|FG008|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|15
6804555|NCT02936323|7736533|FG009|STARTED|Phase 2a Dose Expansion|Participants in Phase 2a did not participate in Phase 1|19
6804556|NCT02936323|7736524|FG000|COMPLETED|Phase 2a Dose Expansion||0
6269506|NCT00075218|7168662|FG000|STARTED|Open-Label Treatment||0
6269507|NCT00075218|7168663|FG001|STARTED|Open-Label Treatment||0
6269508|NCT00075218|7168664|FG002|STARTED|Open-Label Treatment||255
6269509|NCT00075218|7168662|FG000|COMPLETED|Open-Label Treatment||0
6269510|NCT00075218|7168663|FG001|COMPLETED|Open-Label Treatment||0
6269511|NCT00075218|7168664|FG002|COMPLETED|Open-Label Treatment||0
6269512|NCT00075218|7168662|FG000|NOT COMPLETED|Open-Label Treatment||0
6269513|NCT00075218|7168663|FG001|NOT COMPLETED|Open-Label Treatment||0
6269514|NCT00075218|7168664|FG002|NOT COMPLETED|Open-Label Treatment||255
6269515|NCT00075270|7168673|FG000|STARTED|Overall Study||291
6269516|NCT00075270|7168674|FG001|STARTED|Overall Study||288
6269517|NCT00075270|7168673|FG000|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
6269518|NCT00075270|7168674|FG001|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
6269519|NCT00075270|7168673|FG000|COMPLETED|Overall Study||5
6269520|NCT00075270|7168674|FG001|COMPLETED|Overall Study||4
6269521|NCT00075270|7168673|FG000|NOT COMPLETED|Overall Study||286
6269522|NCT00075270|7168674|FG001|NOT COMPLETED|Overall Study||284
6269523|NCT00075335|7168681|FG000|STARTED|Overall Study||8
6269524|NCT00075335|7168681|FG000|COMPLETED|Overall Study||8
6269525|NCT00075335|7168681|FG000|NOT COMPLETED|Overall Study||0
6269526|NCT00075400|7168685|FG000|STARTED|Overall Study||26
6269527|NCT00075400|7168685|FG000|COMPLETED|Overall Study|Eligible and treated patients.|23
6269528|NCT00075400|7168685|FG000|NOT COMPLETED|Overall Study||3
6269529|NCT00075478|7168696|FG000|STARTED|Overall Study||42
6269530|NCT00075478|7168697|FG001|STARTED|Overall Study||45
6269531|NCT00075478|7168696|FG000|COMPLETED|Overall Study||41
6269532|NCT00075478|7168697|FG001|COMPLETED|Overall Study||44
6269533|NCT00075478|7168696|FG000|NOT COMPLETED|Overall Study||1
6269534|NCT00075478|7168697|FG001|NOT COMPLETED|Overall Study||1
6269535|NCT00075504|7168705|FG000|STARTED|Overall Study||23
6269536|NCT00075504|7168706|FG001|STARTED|Overall Study||10
6269537|NCT00075504|7168705|FG000|COMPLETED|Overall Study||14
6269538|NCT00075504|7168706|FG001|COMPLETED|Overall Study||3
6269539|NCT00075504|7168705|FG000|NOT COMPLETED|Overall Study||9
6269540|NCT00075504|7168706|FG001|NOT COMPLETED|Overall Study||7
6269541|NCT00075582|7168714|FG000|STARTED|Overall Study||305
6269542|NCT00075582|7168715|FG001|STARTED|Overall Study||85
6269543|NCT00075582|7168714|FG000|COMPLETED|Overall Study||255
6269544|NCT00075582|7168715|FG001|COMPLETED|Overall Study||50
6269545|NCT00075582|7168714|FG000|NOT COMPLETED|Overall Study||50
6269546|NCT00075582|7168715|FG001|NOT COMPLETED|Overall Study||35
6269547|NCT00075725|7168737|FG000|STARTED|Overall Study||246
6269548|NCT00075725|7168738|FG001|STARTED|Overall Study||106
6269549|NCT00075725|7168739|FG002|STARTED|Overall Study||296
6269550|NCT00075725|7168740|FG003|STARTED|Overall Study||246
6269551|NCT00075725|7168741|FG004|STARTED|Overall Study||232
6269552|NCT00075725|7168742|FG005|STARTED|Overall Study||710
6269553|NCT00075725|7168743|FG006|STARTED|Overall Study||246
6269554|NCT00075725|7168744|FG007|STARTED|Overall Study||696
6269555|NCT00075725|7168745|FG008|STARTED|Overall Study||302
6269556|NCT00075725|7168746|FG009|STARTED|Overall Study||34
6269557|NCT00075725|7168747|FG010|STARTED|Overall Study||12
6269558|NCT00075725|7168748|FG011|STARTED|Overall Study||28
6269559|NCT00075725|7168737|FG000|COMPLETED|Overall Study||172
6269560|NCT00075725|7168738|FG001|COMPLETED|Overall Study||57
6269561|NCT00075725|7168739|FG002|COMPLETED|Overall Study||175
6269562|NCT00075725|7168740|FG003|COMPLETED|Overall Study||168
6269563|NCT00075725|7168741|FG004|COMPLETED|Overall Study||166
6269564|NCT00075725|7168742|FG005|COMPLETED|Overall Study||397
6269565|NCT00075725|7168743|FG006|COMPLETED|Overall Study||171
6383784|NCT00796666|7294969|FG001|STARTED|Overall Study||64
6383785|NCT00796666|7294968|FG000|Treated|Overall Study||66
6383786|NCT00796666|7294969|FG001|Treated|Overall Study||64
6383787|NCT00796666|7294968|FG000|Randomized and Not Treated|Overall Study||1
6383788|NCT00796666|7294969|FG001|Randomized and Not Treated|Overall Study||0
6383789|NCT00796666|7294968|FG000|COMPLETED|Overall Study||0
6383790|NCT00796666|7294969|FG001|COMPLETED|Overall Study||0
6383791|NCT00796666|7294968|FG000|NOT COMPLETED|Overall Study||67
6383792|NCT00796666|7294969|FG001|NOT COMPLETED|Overall Study||64
6383793|NCT00796705|7294979|FG000|STARTED|Overall Study||3
6383794|NCT00796705|7294980|FG001|STARTED|Overall Study||4
6383795|NCT00796705|7294981|FG002|STARTED|Overall Study||4
6383796|NCT00796705|7294982|FG003|STARTED|Overall Study||2
6383797|NCT00796705|7294979|FG000|COMPLETED|Overall Study||3
6383798|NCT00796705|7294980|FG001|COMPLETED|Overall Study||4
6383799|NCT00796705|7294981|FG002|COMPLETED|Overall Study||4
6383800|NCT00796705|7294982|FG003|COMPLETED|Overall Study||2
6383801|NCT00796705|7294979|FG000|NOT COMPLETED|Overall Study||0
6383802|NCT00796705|7294980|FG001|NOT COMPLETED|Overall Study||0
6383803|NCT00796705|7294981|FG002|NOT COMPLETED|Overall Study||0
6383804|NCT00796705|7294982|FG003|NOT COMPLETED|Overall Study||0
6383805|NCT00796718|7294994|FG000|STARTED|Overall Study||62
6383806|NCT00796718|7294994|FG000|COMPLETED|Overall Study||53
6383807|NCT00796718|7294994|FG000|NOT COMPLETED|Overall Study||9
6383808|NCT00796744|7295001|FG000|STARTED|Overall Study||24
6383809|NCT00796744|7295002|FG001|STARTED|Overall Study||26
6383810|NCT00796744|7295003|FG002|STARTED|Overall Study||28
6383811|NCT00796744|7295001|FG000|COMPLETED|Overall Study||24
6383812|NCT00796744|7295002|FG001|COMPLETED|Overall Study||26
6383813|NCT00796744|7295003|FG002|COMPLETED|Overall Study||27
6383814|NCT00796744|7295001|FG000|NOT COMPLETED|Overall Study||0
6383815|NCT00796744|7295002|FG001|NOT COMPLETED|Overall Study||0
6383816|NCT00796744|7295003|FG002|NOT COMPLETED|Overall Study||1
6383817|NCT00796757|7295013|FG000|STARTED|Overall Study||146
6383818|NCT00796757|7295013|FG000|COMPLETED|Overall Study||60
6383819|NCT00796757|7295013|FG000|NOT COMPLETED|Overall Study||86
6383820|NCT00796822|7295019|FG000|STARTED|Overall Study||13
6383821|NCT00796822|7295020|FG001|STARTED|Overall Study||13
6383822|NCT00796822|7295019|FG000|COMPLETED|Overall Study||10
6383823|NCT00796822|7295020|FG001|COMPLETED|Overall Study||13
6383824|NCT00796822|7295019|FG000|NOT COMPLETED|Overall Study||3
6383825|NCT00796822|7295020|FG001|NOT COMPLETED|Overall Study||0
6383826|NCT00796926|7295028|FG000|STARTED|Overall Study||15
6383827|NCT00796926|7295029|FG001|STARTED|Overall Study||15
6383828|NCT00796926|7295028|FG000|COMPLETED|Overall Study||14
6383829|NCT00796926|7295029|FG001|COMPLETED|Overall Study||15
6383830|NCT00796926|7295028|FG000|NOT COMPLETED|Overall Study||1
6383831|NCT00796926|7295029|FG001|NOT COMPLETED|Overall Study||0
6383832|NCT00796978|7295035|FG000|STARTED|Overall Study||56
6383833|NCT00796978|7295035|FG000|COMPLETED|Overall Study||44
6383834|NCT00796978|7295035|FG000|NOT COMPLETED|Overall Study||12
6383835|NCT00796991|7295042|FG000|STARTED|Overall Study||20
6383836|NCT00796991|7295043|FG001|STARTED|Overall Study||19
6383837|NCT00796991|7295044|FG002|STARTED|Overall Study||20
6383838|NCT00796991|7295042|FG000|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
6383839|NCT00796991|7295043|FG001|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
6383840|NCT00796991|7295044|FG002|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
6383841|NCT00796991|7295042|FG000|NOT COMPLETED|Overall Study||15
6383842|NCT00796991|7295043|FG001|NOT COMPLETED|Overall Study||12
6383843|NCT00796991|7295044|FG002|NOT COMPLETED|Overall Study||14
6383844|NCT00797108|7295055|FG000|STARTED|Overall Study||12
6383845|NCT00797108|7295056|FG001|STARTED|Overall Study||11
6383846|NCT00797108|7295057|FG002|STARTED|Overall Study||12
6383847|NCT00797108|7295055|FG000|Treated|Overall Study||10
6383848|NCT00797108|7295056|FG001|Treated|Overall Study||11
6383849|NCT00797108|7295057|FG002|Treated|Overall Study||12
6383850|NCT00797108|7295055|FG000|COMPLETED|Overall Study||8
6383851|NCT00797108|7295056|FG001|COMPLETED|Overall Study||9
6383852|NCT00797108|7295057|FG002|COMPLETED|Overall Study||6
6383853|NCT00797108|7295055|FG000|NOT COMPLETED|Overall Study||4
6383854|NCT00797108|7295056|FG001|NOT COMPLETED|Overall Study||2
6383855|NCT00797108|7295057|FG002|NOT COMPLETED|Overall Study||6
6383856|NCT00797212|7295065|FG000|STARTED|Overall Study||50
6383857|NCT00797212|7295065|FG000|COMPLETED|Overall Study||50
6383858|NCT00797212|7295065|FG000|NOT COMPLETED|Overall Study||0
6383859|NCT00797225|7295073|FG000|STARTED|Weeks 1 to 12||43
6503318|NCT01440647|7422158|FG001|NOT COMPLETED|Overall Study||3
6503319|NCT01440764|7422166|FG000|STARTED|Test Day 1||4
6503320|NCT01440764|7422167|FG001|STARTED|Test Day 1||2
6503321|NCT01440764|7422168|FG002|STARTED|Test Day 1||6
6503322|NCT01440764|7422169|FG003|STARTED|Test Day 1||1
6383860|NCT00797225|7295074|FG001|STARTED|Weeks 1 to 12||43
6503323|NCT01440764|7422170|FG004|STARTED|Test Day 1||3
6383861|NCT00797225|7295075|FG002|STARTED|Weeks 1 to 12||44
6383862|NCT00797225|7295076|FG003|STARTED|Weeks 1 to 12||44
6383863|NCT00797225|7295077|FG004|STARTED|Weeks 1 to 12||0
6383864|NCT00797225|7295078|FG005|STARTED|Weeks 1 to 12||0
6383865|NCT00797225|7295079|FG006|STARTED|Weeks 1 to 12||0
6503324|NCT01440764|7422171|FG005|STARTED|Test Day 1||5
6656796|NCT02465034|7587122|FG000|COMPLETED|Overall Study||16
6804557|NCT02936323|7736525|FG001|COMPLETED|Phase 2a Dose Expansion||0
6804558|NCT02936323|7736526|FG002|COMPLETED|Phase 2a Dose Expansion||0
6804559|NCT02936323|7736527|FG003|COMPLETED|Phase 2a Dose Expansion||0
6804560|NCT02936323|7736528|FG004|COMPLETED|Phase 2a Dose Expansion||0
6804561|NCT02936323|7736529|FG005|COMPLETED|Phase 2a Dose Expansion||0
6804562|NCT02936323|7736530|FG006|COMPLETED|Phase 2a Dose Expansion||0
6804563|NCT02936323|7736531|FG007|COMPLETED|Phase 2a Dose Expansion||15
6804564|NCT02936323|7736532|FG008|COMPLETED|Phase 2a Dose Expansion||2
6804565|NCT02936323|7736533|FG009|COMPLETED|Phase 2a Dose Expansion||5
6804566|NCT02936323|7736524|FG000|NOT COMPLETED|Phase 2a Dose Expansion||0
6804567|NCT02936323|7736525|FG001|NOT COMPLETED|Phase 2a Dose Expansion||0
6804568|NCT02936323|7736526|FG002|NOT COMPLETED|Phase 2a Dose Expansion||0
6383866|NCT00797225|7295080|FG007|STARTED|Weeks 1 to 12||0
6383867|NCT00797225|7295073|FG000|Received Study Drug|Weeks 1 to 12||43
6383868|NCT00797225|7295074|FG001|Received Study Drug|Weeks 1 to 12||43
6383869|NCT00797225|7295075|FG002|Received Study Drug|Weeks 1 to 12||44
6383870|NCT00797225|7295076|FG003|Received Study Drug|Weeks 1 to 12||44
6383871|NCT00797225|7295077|FG004|Received Study Drug|Weeks 1 to 12||0
6383872|NCT00797225|7295078|FG005|Received Study Drug|Weeks 1 to 12||0
6383873|NCT00797225|7295079|FG006|Received Study Drug|Weeks 1 to 12||0
6383874|NCT00797225|7295080|FG007|Received Study Drug|Weeks 1 to 12||0
6383875|NCT00797225|7295073|FG000|COMPLETED|Weeks 1 to 12||41
6383876|NCT00797225|7295074|FG001|COMPLETED|Weeks 1 to 12||42
6383877|NCT00797225|7295075|FG002|COMPLETED|Weeks 1 to 12||43
6804569|NCT02936323|7736527|FG003|NOT COMPLETED|Phase 2a Dose Expansion||0
6804570|NCT02936323|7736528|FG004|NOT COMPLETED|Phase 2a Dose Expansion||0
6804571|NCT02936323|7736529|FG005|NOT COMPLETED|Phase 2a Dose Expansion||0
6804572|NCT02936323|7736530|FG006|NOT COMPLETED|Phase 2a Dose Expansion||0
6804573|NCT02936323|7736531|FG007|NOT COMPLETED|Phase 2a Dose Expansion||17
6804574|NCT02936323|7736532|FG008|NOT COMPLETED|Phase 2a Dose Expansion||13
6804575|NCT02936323|7736533|FG009|NOT COMPLETED|Phase 2a Dose Expansion||14
6804576|NCT02631837|7736567|FG000|STARTED|Overall Study||35
6804577|NCT02631837|7736568|FG001|STARTED|Overall Study||35
6804578|NCT02631837|7736567|FG000|COMPLETED|Overall Study||35
6804579|NCT02631837|7736568|FG001|COMPLETED|Overall Study||35
6804580|NCT02631837|7736567|FG000|NOT COMPLETED|Overall Study||0
6804581|NCT02631837|7736568|FG001|NOT COMPLETED|Overall Study||0
6804582|NCT02437318|7736576|FG000|STARTED|Overall Study||284
6804583|NCT02437318|7736577|FG001|STARTED|Overall Study||288
6804584|NCT02437318|7736576|FG000|End of Treatment (Didn't Complete)|Overall Study||229
6804585|NCT02437318|7736577|FG001|End of Treatment (Didn't Complete)|Overall Study||241
6804586|NCT02437318|7736576|FG000|Untreated (Protocol Deviation)|Overall Study||0
6804587|NCT02437318|7736577|FG001|Untreated (Protocol Deviation)|Overall Study||1
6804588|NCT02437318|7736576|FG000|COMPLETED|Overall Study||55
6804589|NCT02437318|7736577|FG001|COMPLETED|Overall Study||46
6804590|NCT02437318|7736576|FG000|NOT COMPLETED|Overall Study||229
6804591|NCT02437318|7736577|FG001|NOT COMPLETED|Overall Study||242
6804592|NCT02429791|7736585|FG000|STARTED|Early Switch Phase (Up to Week 52)||252
6804593|NCT02429791|7736586|FG001|STARTED|Early Switch Phase (Up to Week 52)||256
6804594|NCT02429791|7736585|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||239
6804595|NCT02429791|7736586|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||238
6804596|NCT02429791|7736585|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||13
6269566|NCT00075725|7168744|FG007|COMPLETED|Overall Study||401
6269567|NCT00075725|7168745|FG008|COMPLETED|Overall Study||185
6269568|NCT00075725|7168746|FG009|COMPLETED|Overall Study||16
6269569|NCT00075725|7168747|FG010|COMPLETED|Overall Study||3
6383878|NCT00797225|7295076|FG003|COMPLETED|Weeks 1 to 12||44
6383879|NCT00797225|7295077|FG004|COMPLETED|Weeks 1 to 12||0
6804597|NCT02429791|7736586|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||18
6804598|NCT02429791|7736585|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||239
6804599|NCT02429791|7736586|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||238
6564923|NCT01814072|7487607|FG010|NOT COMPLETED|Overall Study||1
6564924|NCT01814072|7487608|FG011|NOT COMPLETED|Overall Study||2
6564925|NCT01814072|7487609|FG012|NOT COMPLETED|Overall Study||3
6564926|NCT01814072|7487610|FG013|NOT COMPLETED|Overall Study||2
6564927|NCT01814072|7487611|FG014|NOT COMPLETED|Overall Study||3
6564928|NCT01814072|7487612|FG015|NOT COMPLETED|Overall Study||2
6564929|NCT01814072|7487613|FG016|NOT COMPLETED|Overall Study||3
6383880|NCT00797225|7295078|FG005|COMPLETED|Weeks 1 to 12||0
6383881|NCT00797225|7295079|FG006|COMPLETED|Weeks 1 to 12||0
6383882|NCT00797225|7295080|FG007|COMPLETED|Weeks 1 to 12||0
6383883|NCT00797225|7295073|FG000|NOT COMPLETED|Weeks 1 to 12||2
6383884|NCT00797225|7295074|FG001|NOT COMPLETED|Weeks 1 to 12||1
6383885|NCT00797225|7295075|FG002|NOT COMPLETED|Weeks 1 to 12||1
6383886|NCT00797225|7295076|FG003|NOT COMPLETED|Weeks 1 to 12||0
6383887|NCT00797225|7295077|FG004|NOT COMPLETED|Weeks 1 to 12||0
6383888|NCT00797225|7295078|FG005|NOT COMPLETED|Weeks 1 to 12||0
6383889|NCT00797225|7295079|FG006|NOT COMPLETED|Weeks 1 to 12||0
6383890|NCT00797225|7295080|FG007|NOT COMPLETED|Weeks 1 to 12||0
6383891|NCT00797225|7295073|FG000|STARTED|Weeks 13 to 24||0
6383892|NCT00797225|7295074|FG001|STARTED|Weeks 13 to 24||42
6383893|NCT00797225|7295075|FG002|STARTED|Weeks 13 to 24||43
6383894|NCT00797225|7295076|FG003|STARTED|Weeks 13 to 24||0
6383895|NCT00797225|7295077|FG004|STARTED|Weeks 13 to 24||20
6383896|NCT00797225|7295078|FG005|STARTED|Weeks 13 to 24||21
6383897|NCT00797225|7295079|FG006|STARTED|Weeks 13 to 24||22
6383898|NCT00797225|7295080|FG007|STARTED|Weeks 13 to 24||22
6383899|NCT00797225|7295073|FG000|COMPLETED|Weeks 13 to 24||0
6383900|NCT00797225|7295074|FG001|COMPLETED|Weeks 13 to 24||38
6383901|NCT00797225|7295075|FG002|COMPLETED|Weeks 13 to 24||41
6383902|NCT00797225|7295076|FG003|COMPLETED|Weeks 13 to 24||0
6383903|NCT00797225|7295077|FG004|COMPLETED|Weeks 13 to 24||19
6383904|NCT00797225|7295078|FG005|COMPLETED|Weeks 13 to 24||21
6383905|NCT00797225|7295079|FG006|COMPLETED|Weeks 13 to 24||20
6383906|NCT00797225|7295080|FG007|COMPLETED|Weeks 13 to 24||22
6383907|NCT00797225|7295073|FG000|NOT COMPLETED|Weeks 13 to 24||0
6383908|NCT00797225|7295074|FG001|NOT COMPLETED|Weeks 13 to 24||4
6383909|NCT00797225|7295075|FG002|NOT COMPLETED|Weeks 13 to 24||2
6383910|NCT00797225|7295076|FG003|NOT COMPLETED|Weeks 13 to 24||0
6383911|NCT00797225|7295077|FG004|NOT COMPLETED|Weeks 13 to 24||1
6383912|NCT00797225|7295078|FG005|NOT COMPLETED|Weeks 13 to 24||0
6383913|NCT00797225|7295079|FG006|NOT COMPLETED|Weeks 13 to 24||2
6383914|NCT00797225|7295080|FG007|NOT COMPLETED|Weeks 13 to 24||0
6383915|NCT00797277|7295098|FG000|STARTED|Overall Study||37
6503325|NCT01440764|7422172|FG006|STARTED|Test Day 1||3
6383916|NCT00797277|7295099|FG001|STARTED|Overall Study||30
6383917|NCT00797277|7295098|FG000|COMPLETED|Overall Study||37
6383918|NCT00797277|7295099|FG001|COMPLETED|Overall Study||30
6383919|NCT00797277|7295098|FG000|NOT COMPLETED|Overall Study||0
6383920|NCT00797277|7295099|FG001|NOT COMPLETED|Overall Study||0
6383921|NCT00797316|7295108|FG000|STARTED|Overall Study||267
6383922|NCT00797316|7295109|FG001|STARTED|Overall Study||265
6383923|NCT00797316|7295108|FG000|COMPLETED|Overall Study||244
6383924|NCT00797316|7295109|FG001|COMPLETED|Overall Study||233
6383925|NCT00797316|7295108|FG000|NOT COMPLETED|Overall Study||23
6383926|NCT00797316|7295109|FG001|NOT COMPLETED|Overall Study||32
6383927|NCT00797459|7295115|FG000|STARTED|Overall Study||60
6383928|NCT00797459|7295115|FG000|COMPLETED|Overall Study||60
6383929|NCT00797459|7295115|FG000|NOT COMPLETED|Overall Study||0
6383930|NCT00797511|7295123|FG000|STARTED|Overall Study||132
6383931|NCT00797511|7295123|FG000|COMPLETED|Overall Study||131
6383932|NCT00797511|7295123|FG000|NOT COMPLETED|Overall Study||1
6383933|NCT00797563|7295128|FG000|STARTED|Overall Study|number of subjects|102
6383934|NCT00797563|7295128|FG000|COMPLETED|Overall Study||101
6383935|NCT00797563|7295128|FG000|NOT COMPLETED|Overall Study||1
6383936|NCT00797667|7295135|FG000|STARTED|Overall Study||265
6383937|NCT00797667|7295136|FG001|STARTED|Overall Study||264
6383938|NCT00797667|7295137|FG002|STARTED|Overall Study||131
6383939|NCT00797667|7295135|FG000|Treated|Overall Study||263
6383940|NCT00797667|7295136|FG001|Treated|Overall Study||263
6383941|NCT00797667|7295137|FG002|Treated|Overall Study||130
6383942|NCT00797667|7295135|FG000|COMPLETED|Overall Study||5
6383943|NCT00797667|7295136|FG001|COMPLETED|Overall Study||5
6383944|NCT00797667|7295137|FG002|COMPLETED|Overall Study||4
6383945|NCT00797667|7295135|FG000|NOT COMPLETED|Overall Study||260
6383946|NCT00797667|7295136|FG001|NOT COMPLETED|Overall Study||259
6383947|NCT00797667|7295137|FG002|NOT COMPLETED|Overall Study||127
6383948|NCT00797732|7295147|FG000|STARTED|Overall Study||21
6383949|NCT00797732|7295148|FG001|STARTED|Overall Study||21
6383950|NCT00797732|7295149|FG002|STARTED|Overall Study||154
6383951|NCT00797732|7295147|FG000|Evaluable at Baseline|Overall Study||18
6383952|NCT00797732|7295148|FG001|Evaluable at Baseline|Overall Study||18
6383953|NCT00797732|7295149|FG002|Evaluable at Baseline|Overall Study||0
6383954|NCT00797732|7295147|FG000|Evaluable at 20 Weeks|Overall Study||17
6383955|NCT00797732|7295148|FG001|Evaluable at 20 Weeks|Overall Study||18
6383956|NCT00797732|7295149|FG002|Evaluable at 20 Weeks|Overall Study||0
6383957|NCT00797732|7295147|FG000|Evaluable at 12 Months|Overall Study||17
6383958|NCT00797732|7295148|FG001|Evaluable at 12 Months|Overall Study||18
6383959|NCT00797732|7295149|FG002|Evaluable at 12 Months|Overall Study||0
6383960|NCT00797732|7295147|FG000|COMPLETED|Overall Study||16
6383961|NCT00797732|7295148|FG001|COMPLETED|Overall Study||18
6383962|NCT00797732|7295149|FG002|COMPLETED|Overall Study||0
6383963|NCT00797732|7295147|FG000|NOT COMPLETED|Overall Study||5
6383964|NCT00797732|7295148|FG001|NOT COMPLETED|Overall Study||3
6383965|NCT00797732|7295149|FG002|NOT COMPLETED|Overall Study||154
6383966|NCT00797797|7295157|FG000|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
6383967|NCT00797797|7295158|FG001|STARTED|Overall Study||184
6383968|NCT00797797|7295157|FG000|COMPLETED|Overall Study||123
6383969|NCT00797797|7295158|FG001|COMPLETED|Overall Study||141
6383970|NCT00797797|7295157|FG000|NOT COMPLETED|Overall Study||55
6383971|NCT00797797|7295158|FG001|NOT COMPLETED|Overall Study||43
6503326|NCT01440764|7422166|FG000|COMPLETED|Test Day 1||4
6503327|NCT01440764|7422167|FG001|COMPLETED|Test Day 1||2
6503328|NCT01440764|7422168|FG002|COMPLETED|Test Day 1||6
6503329|NCT01440764|7422169|FG003|COMPLETED|Test Day 1||1
6503330|NCT01440764|7422170|FG004|COMPLETED|Test Day 1||3
6503331|NCT01440764|7422171|FG005|COMPLETED|Test Day 1||5
6503332|NCT01440764|7422172|FG006|COMPLETED|Test Day 1||3
6503333|NCT01440764|7422166|FG000|NOT COMPLETED|Test Day 1||0
6503334|NCT01440764|7422167|FG001|NOT COMPLETED|Test Day 1||0
6503335|NCT01440764|7422168|FG002|NOT COMPLETED|Test Day 1||0
6503336|NCT01440764|7422169|FG003|NOT COMPLETED|Test Day 1||0
6503337|NCT01440764|7422170|FG004|NOT COMPLETED|Test Day 1||0
6503338|NCT01440764|7422171|FG005|NOT COMPLETED|Test Day 1||0
6503339|NCT01440764|7422172|FG006|NOT COMPLETED|Test Day 1||0
6503340|NCT01440764|7422166|FG000|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
6503341|NCT01440764|7422167|FG001|STARTED|Test Day 2||2
6503342|NCT01440764|7422168|FG002|STARTED|Test Day 2||6
6503343|NCT01440764|7422169|FG003|STARTED|Test Day 2||1
6503344|NCT01440764|7422170|FG004|STARTED|Test Day 2||3
6503345|NCT01440764|7422171|FG005|STARTED|Test Day 2||5
6503346|NCT01440764|7422172|FG006|STARTED|Test Day 2||3
6503347|NCT01440764|7422166|FG000|COMPLETED|Test Day 2||3
6503348|NCT01440764|7422167|FG001|COMPLETED|Test Day 2||2
6503349|NCT01440764|7422168|FG002|COMPLETED|Test Day 2||6
6503350|NCT01440764|7422169|FG003|COMPLETED|Test Day 2||1
6503351|NCT01440764|7422170|FG004|COMPLETED|Test Day 2||3
6503352|NCT01440764|7422171|FG005|COMPLETED|Test Day 2||5
6269570|NCT00075725|7168748|FG011|COMPLETED|Overall Study||10
6269571|NCT00075725|7168737|FG000|NOT COMPLETED|Overall Study||74
6269572|NCT00075725|7168738|FG001|NOT COMPLETED|Overall Study||49
6269573|NCT00075725|7168739|FG002|NOT COMPLETED|Overall Study||121
6269574|NCT00075725|7168740|FG003|NOT COMPLETED|Overall Study||78
6269575|NCT00075725|7168741|FG004|NOT COMPLETED|Overall Study||66
6269576|NCT00075725|7168742|FG005|NOT COMPLETED|Overall Study||313
6269577|NCT00075725|7168743|FG006|NOT COMPLETED|Overall Study||75
6269578|NCT00075725|7168744|FG007|NOT COMPLETED|Overall Study||295
6269579|NCT00075725|7168745|FG008|NOT COMPLETED|Overall Study||117
6269580|NCT00075725|7168746|FG009|NOT COMPLETED|Overall Study||18
6269581|NCT00075725|7168747|FG010|NOT COMPLETED|Overall Study||9
6269582|NCT00075725|7168748|FG011|NOT COMPLETED|Overall Study||18
6269583|NCT00075764|7168781|FG000|STARTED|Overall Study||345
6269584|NCT00075764|7168782|FG001|STARTED|Overall Study||349
6269585|NCT00075764|7168781|FG000|COMPLETED|Overall Study||0
6269586|NCT00075764|7168782|FG001|COMPLETED|Overall Study||0
6269587|NCT00075764|7168781|FG000|NOT COMPLETED|Overall Study||345
6269588|NCT00075764|7168782|FG001|NOT COMPLETED|Overall Study||349
6269589|NCT00075803|7168792|FG000|STARTED|Overall Study||295
6269590|NCT00075803|7168793|FG001|STARTED|Overall Study||305
6269591|NCT00075803|7168792|FG000|COMPLETED|Overall Study||295
6269592|NCT00075803|7168793|FG001|COMPLETED|Overall Study||305
6269593|NCT00075803|7168792|FG000|NOT COMPLETED|Overall Study||0
6269594|NCT00075803|7168793|FG001|NOT COMPLETED|Overall Study||0
6269595|NCT00075816|7168801|FG000|STARTED|Overall Study||278
6269596|NCT00075816|7168802|FG001|STARTED|Overall Study||273
6269597|NCT00075816|7168801|FG000|COMPLETED|Overall Study||264
6269598|NCT00075816|7168802|FG001|COMPLETED|Overall Study||262
6269599|NCT00075816|7168801|FG000|NOT COMPLETED|Overall Study||14
6269600|NCT00075816|7168802|FG001|NOT COMPLETED|Overall Study||11
6269601|NCT00075829|7168814|FG000|STARTED|Overall Study||436
6269602|NCT00075829|7168815|FG001|STARTED|Overall Study||189
6269603|NCT00075829|7168816|FG002|STARTED|Overall Study||48
6269604|NCT00075829|7168817|FG003|STARTED|Overall Study||37
6269605|NCT00075829|7168814|FG000|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
6269606|NCT00075829|7168815|FG001|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
6269607|NCT00075829|7168816|FG002|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
6269608|NCT00075829|7168817|FG003|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
6269609|NCT00075829|7168814|FG000|NOT COMPLETED|Overall Study||258
6269610|NCT00075829|7168815|FG001|NOT COMPLETED|Overall Study||118
6269611|NCT00075829|7168816|FG002|NOT COMPLETED|Overall Study||34
6269612|NCT00075829|7168817|FG003|NOT COMPLETED|Overall Study||24
6269613|NCT00075881|7168830|FG000|STARTED|Overall Study||44
6269614|NCT00075881|7168830|FG000|Eligible|Overall Study||43
6269615|NCT00075881|7168830|FG000|Treated|Overall Study||42
6269616|NCT00075881|7168830|FG000|Induction Treatment|Overall Study||42
6269617|NCT00075881|7168830|FG000|Maintenance Treatment|Overall Study||15
6269618|NCT00075881|7168830|FG000|Reinduction Treatment|Overall Study||7
6269619|NCT00075881|7168830|FG000|COMPLETED|Overall Study||1
6269620|NCT00075881|7168830|FG000|NOT COMPLETED|Overall Study||43
6269621|NCT00075946|7168840|FG000|STARTED|Overall Study||148
6269622|NCT00075946|7168841|FG001|STARTED|Overall Study||151
6269623|NCT00075946|7168842|FG002|STARTED|Overall Study||28
6269624|NCT00075946|7168843|FG003|STARTED|Overall Study||30
6503353|NCT01440764|7422172|FG006|COMPLETED|Test Day 2||3
6503354|NCT01440764|7422166|FG000|NOT COMPLETED|Test Day 2||0
6503355|NCT01440764|7422167|FG001|NOT COMPLETED|Test Day 2||0
6269625|NCT00075946|7168844|FG004|STARTED|Overall Study||188
6269626|NCT00075946|7168840|FG000|Treated and With Toxicity Data Available|Overall Study||142
6269627|NCT00075946|7168841|FG001|Treated and With Toxicity Data Available|Overall Study||148
6269628|NCT00075946|7168842|FG002|Treated and With Toxicity Data Available|Overall Study||27
6269629|NCT00075946|7168843|FG003|Treated and With Toxicity Data Available|Overall Study||29
6269630|NCT00075946|7168844|FG004|Treated and With Toxicity Data Available|Overall Study||154
6269631|NCT00075946|7168840|FG000|Included in Primary Analysis|Overall Study||143
6269632|NCT00075946|7168841|FG001|Included in Primary Analysis|Overall Study||146
6503356|NCT01440764|7422168|FG002|NOT COMPLETED|Test Day 2||0
6564930|NCT01814072|7487614|FG017|NOT COMPLETED|Overall Study||1
6564931|NCT01814072|7487615|FG018|NOT COMPLETED|Overall Study||3
6564932|NCT01814072|7487616|FG019|NOT COMPLETED|Overall Study||5
6564933|NCT01814072|7487617|FG020|NOT COMPLETED|Overall Study||2
6564934|NCT01814072|7487618|FG021|NOT COMPLETED|Overall Study||1
6564935|NCT01814072|7487619|FG022|NOT COMPLETED|Overall Study||4
6383972|NCT00797823|7295167|FG000|STARTED|Pilot Studies|Not involved in pilot studies|0
6383973|NCT00797823|7295168|FG001|STARTED|Pilot Studies|Not involved in pilot studies|0
6383974|NCT00797823|7295169|FG002|STARTED|Pilot Studies||6
6383975|NCT00797823|7295167|FG000|COMPLETED|Pilot Studies||0
6383976|NCT00797823|7295168|FG001|COMPLETED|Pilot Studies||0
6383977|NCT00797823|7295169|FG002|COMPLETED|Pilot Studies||6
6383978|NCT00797823|7295167|FG000|NOT COMPLETED|Pilot Studies||0
6383979|NCT00797823|7295168|FG001|NOT COMPLETED|Pilot Studies||0
6383980|NCT00797823|7295169|FG002|NOT COMPLETED|Pilot Studies||0
6383981|NCT00797823|7295167|FG000|STARTED|First Period (Initial Randomization)||4
6383982|NCT00797823|7295168|FG001|STARTED|First Period (Initial Randomization)||4
6383983|NCT00797823|7295169|FG002|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
6383984|NCT00797823|7295167|FG000|COMPLETED|First Period (Initial Randomization)||3
6383985|NCT00797823|7295168|FG001|COMPLETED|First Period (Initial Randomization)||4
6503357|NCT01440764|7422169|FG003|NOT COMPLETED|Test Day 2||0
6503358|NCT01440764|7422170|FG004|NOT COMPLETED|Test Day 2||0
6503359|NCT01440764|7422171|FG005|NOT COMPLETED|Test Day 2||0
6503360|NCT01440764|7422172|FG006|NOT COMPLETED|Test Day 2||0
6503361|NCT01440764|7422166|FG000|STARTED|Test Day 3||3
6503362|NCT01440764|7422167|FG001|STARTED|Test Day 3||2
6503363|NCT01440764|7422168|FG002|STARTED|Test Day 3||6
6503364|NCT01440764|7422169|FG003|STARTED|Test Day 3||1
6564936|NCT01814072|7487620|FG023|NOT COMPLETED|Overall Study||1
6383986|NCT00797823|7295169|FG002|COMPLETED|First Period (Initial Randomization)||0
6383987|NCT00797823|7295167|FG000|NOT COMPLETED|First Period (Initial Randomization)||1
6383988|NCT00797823|7295168|FG001|NOT COMPLETED|First Period (Initial Randomization)||0
6503365|NCT01440764|7422170|FG004|STARTED|Test Day 3||3
6503366|NCT01440764|7422171|FG005|STARTED|Test Day 3||5
6564937|NCT01814072|7487621|FG024|NOT COMPLETED|Overall Study||6
6564938|NCT01814072|7487622|FG025|NOT COMPLETED|Overall Study||2
6564939|NCT01814072|7487623|FG026|NOT COMPLETED|Overall Study||2
6564940|NCT01814072|7487624|FG027|NOT COMPLETED|Overall Study||4
6564941|NCT01814072|7487625|FG028|NOT COMPLETED|Overall Study||4
6564942|NCT01814072|7487626|FG029|NOT COMPLETED|Overall Study||3
6564943|NCT01814072|7487627|FG030|NOT COMPLETED|Overall Study||2
6564944|NCT01814072|7487628|FG031|NOT COMPLETED|Overall Study||0
6564945|NCT01814137|7487670|FG000|STARTED|Overall Study||20
6564946|NCT01814137|7487671|FG001|STARTED|Overall Study||20
6383989|NCT00797823|7295169|FG002|NOT COMPLETED|First Period (Initial Randomization)||0
6383990|NCT00797823|7295167|FG000|STARTED|Second Period (Crossover)||3
6383991|NCT00797823|7295168|FG001|STARTED|Second Period (Crossover)||4
6383992|NCT00797823|7295169|FG002|STARTED|Second Period (Crossover)||0
6383993|NCT00797823|7295167|FG000|COMPLETED|Second Period (Crossover)||3
6383994|NCT00797823|7295168|FG001|COMPLETED|Second Period (Crossover)||4
6383995|NCT00797823|7295169|FG002|COMPLETED|Second Period (Crossover)||0
6383996|NCT00797823|7295167|FG000|NOT COMPLETED|Second Period (Crossover)||0
6383997|NCT00797823|7295168|FG001|NOT COMPLETED|Second Period (Crossover)||0
6383998|NCT00797823|7295169|FG002|NOT COMPLETED|Second Period (Crossover)||0
6383999|NCT00797862|7295179|FG000|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
6384000|NCT00797862|7295180|FG001|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
6384001|NCT00797862|7295181|FG002|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
6384002|NCT00797862|7295179|FG000|Entered Double-Blind Treatment (FAS)|Overall Study||617
6384003|NCT00797862|7295180|FG001|Entered Double-Blind Treatment (FAS)|Overall Study||315
6384004|NCT00797862|7295181|FG002|Entered Double-Blind Treatment (FAS)|Overall Study||315
6384005|NCT00797862|7295179|FG000|COMPLETED|Overall Study||496
6384006|NCT00797862|7295180|FG001|COMPLETED|Overall Study||250
6384007|NCT00797862|7295181|FG002|COMPLETED|Overall Study||230
6384008|NCT00797862|7295179|FG000|NOT COMPLETED|Overall Study||124
6384009|NCT00797862|7295180|FG001|NOT COMPLETED|Overall Study||68
6384010|NCT00797862|7295181|FG002|NOT COMPLETED|Overall Study||86
6384011|NCT00797966|7295193|FG000|STARTED|Phase A||0
6384012|NCT00797966|7295194|FG001|STARTED|Phase A||0
6384013|NCT00797966|7295195|FG002|STARTED|Phase A||0
6384014|NCT00797966|7295196|FG003|STARTED|Phase A||0
6384015|NCT00797966|7295197|FG004|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
6384016|NCT00797966|7295198|FG005|STARTED|Phase A||0
6384017|NCT00797966|7295193|FG000|COMPLETED|Phase A||0
6384018|NCT00797966|7295194|FG001|COMPLETED|Phase A||0
6384019|NCT00797966|7295195|FG002|COMPLETED|Phase A||0
6384020|NCT00797966|7295196|FG003|COMPLETED|Phase A||0
6384021|NCT00797966|7295197|FG004|COMPLETED|Phase A||664
6384022|NCT00797966|7295198|FG005|COMPLETED|Phase A||0
6384023|NCT00797966|7295193|FG000|NOT COMPLETED|Phase A||0
6384024|NCT00797966|7295194|FG001|NOT COMPLETED|Phase A||0
6384025|NCT00797966|7295195|FG002|NOT COMPLETED|Phase A||0
6384026|NCT00797966|7295196|FG003|NOT COMPLETED|Phase A||0
6384027|NCT00797966|7295197|FG004|NOT COMPLETED|Phase A||185
6384028|NCT00797966|7295198|FG005|NOT COMPLETED|Phase A||0
6384029|NCT00797966|7295193|FG000|STARTED|Phase B|Randomized participants.|62
6384030|NCT00797966|7295194|FG001|STARTED|Phase B|Randomized participants.|120
6384031|NCT00797966|7295195|FG002|STARTED|Phase B|Randomized participants.|121
6384032|NCT00797966|7295196|FG003|STARTED|Phase B|Randomized participants.|126
6384033|NCT00797966|7295197|FG004|STARTED|Phase B||0
6384034|NCT00797966|7295198|FG005|STARTED|Phase B||0
6384035|NCT00797966|7295193|FG000|COMPLETED|Phase B||51
6384036|NCT00797966|7295194|FG001|COMPLETED|Phase B||102
6384037|NCT00797966|7295195|FG002|COMPLETED|Phase B||100
6384038|NCT00797966|7295196|FG003|COMPLETED|Phase B||110
6384039|NCT00797966|7295197|FG004|COMPLETED|Phase B||0
6384040|NCT00797966|7295198|FG005|COMPLETED|Phase B||0
6384041|NCT00797966|7295193|FG000|NOT COMPLETED|Phase B||11
6384042|NCT00797966|7295194|FG001|NOT COMPLETED|Phase B||18
6384043|NCT00797966|7295195|FG002|NOT COMPLETED|Phase B||21
6384044|NCT00797966|7295196|FG003|NOT COMPLETED|Phase B||16
6384045|NCT00797966|7295197|FG004|NOT COMPLETED|Phase B||0
6384046|NCT00797966|7295198|FG005|NOT COMPLETED|Phase B||0
6384047|NCT00797966|7295193|FG000|STARTED|Phase A+||0
6384048|NCT00797966|7295194|FG001|STARTED|Phase A+||0
6384049|NCT00797966|7295195|FG002|STARTED|Phase A+||0
6384050|NCT00797966|7295196|FG003|STARTED|Phase A+||0
6384051|NCT00797966|7295197|FG004|STARTED|Phase A+||0
6384052|NCT00797966|7295198|FG005|STARTED|Phase A+||235
6384053|NCT00797966|7295193|FG000|COMPLETED|Phase A+||0
6384054|NCT00797966|7295194|FG001|COMPLETED|Phase A+||0
6384055|NCT00797966|7295195|FG002|COMPLETED|Phase A+||0
6384056|NCT00797966|7295196|FG003|COMPLETED|Phase A+||0
6384057|NCT00797966|7295197|FG004|COMPLETED|Phase A+||0
6384058|NCT00797966|7295198|FG005|COMPLETED|Phase A+||207
6384059|NCT00797966|7295193|FG000|NOT COMPLETED|Phase A+||0
6384060|NCT00797966|7295194|FG001|NOT COMPLETED|Phase A+||0
6384061|NCT00797966|7295195|FG002|NOT COMPLETED|Phase A+||0
6384062|NCT00797966|7295196|FG003|NOT COMPLETED|Phase A+||0
6384063|NCT00797966|7295197|FG004|NOT COMPLETED|Phase A+||0
6384064|NCT00797966|7295198|FG005|NOT COMPLETED|Phase A+||28
6564947|NCT01814137|7487670|FG000|COMPLETED|Overall Study||15
6384065|NCT00798018|7295214|FG000|STARTED|Overall Study||25
6384066|NCT00798018|7295215|FG001|STARTED|Overall Study||25
6384067|NCT00798018|7295216|FG002|STARTED|Overall Study||25
6384068|NCT00798018|7295217|FG003|STARTED|Overall Study||25
6384069|NCT00798018|7295214|FG000|COMPLETED|Overall Study||25
6384070|NCT00798018|7295215|FG001|COMPLETED|Overall Study||25
6384071|NCT00798018|7295216|FG002|COMPLETED|Overall Study||25
6384072|NCT00798018|7295217|FG003|COMPLETED|Overall Study||25
6384073|NCT00798018|7295214|FG000|NOT COMPLETED|Overall Study||0
6384074|NCT00798018|7295215|FG001|NOT COMPLETED|Overall Study||0
6564948|NCT01814137|7487671|FG001|COMPLETED|Overall Study||15
6384075|NCT00798018|7295216|FG002|NOT COMPLETED|Overall Study||0
6384076|NCT00798018|7295217|FG003|NOT COMPLETED|Overall Study||0
6384077|NCT00798096|7295227|FG000|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
6384078|NCT00798096|7295227|FG000|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
6384079|NCT00798096|7295227|FG000|NOT COMPLETED|Overall Study||2
6384080|NCT00798135|7295231|FG000|STARTED|Overall Study||13
6384081|NCT00798135|7295231|FG000|COMPLETED|Overall Study||0
6384082|NCT00798135|7295231|FG000|NOT COMPLETED|Overall Study||13
6384083|NCT00798161|7295242|FG000|STARTED|Overall Study||72
6384084|NCT00798161|7295243|FG001|STARTED|Overall Study||144
6384085|NCT00798161|7295244|FG002|STARTED|Overall Study||147
6384086|NCT00798161|7295245|FG003|STARTED|Overall Study||142
6384087|NCT00798161|7295246|FG004|STARTED|Overall Study||143
6384088|NCT00798161|7295247|FG005|STARTED|Overall Study||143
6384089|NCT00798161|7295248|FG006|STARTED|Overall Study||66
6384090|NCT00798161|7295242|FG000|COMPLETED|Overall Study||54
6384091|NCT00798161|7295243|FG001|COMPLETED|Overall Study||127
6384092|NCT00798161|7295244|FG002|COMPLETED|Overall Study||126
6384093|NCT00798161|7295245|FG003|COMPLETED|Overall Study||121
6384094|NCT00798161|7295246|FG004|COMPLETED|Overall Study||127
6384095|NCT00798161|7295247|FG005|COMPLETED|Overall Study||132
6384096|NCT00798161|7295248|FG006|COMPLETED|Overall Study||56
6384097|NCT00798161|7295242|FG000|NOT COMPLETED|Overall Study||18
6384098|NCT00798161|7295243|FG001|NOT COMPLETED|Overall Study||17
6384099|NCT00798161|7295244|FG002|NOT COMPLETED|Overall Study||21
6384100|NCT00798161|7295245|FG003|NOT COMPLETED|Overall Study||21
6384101|NCT00798161|7295246|FG004|NOT COMPLETED|Overall Study||16
6384102|NCT00798161|7295247|FG005|NOT COMPLETED|Overall Study||11
6384103|NCT00798161|7295248|FG006|NOT COMPLETED|Overall Study||10
6384104|NCT00798174|7295264|FG000|STARTED|Overall Study||16
6384105|NCT00798174|7295265|FG001|STARTED|Overall Study||16
6384106|NCT00798174|7295264|FG000|COMPLETED|Overall Study||12
6384107|NCT00798174|7295265|FG001|COMPLETED|Overall Study||13
6384108|NCT00798174|7295264|FG000|NOT COMPLETED|Overall Study||4
6384109|NCT00798174|7295265|FG001|NOT COMPLETED|Overall Study||3
6384110|NCT00798304|7295272|FG000|STARTED|Overall Study||14
6384111|NCT00798304|7295273|FG001|STARTED|Overall Study||22
6384112|NCT00798304|7295274|FG002|STARTED|Overall Study||10
6384113|NCT00798304|7295272|FG000|COMPLETED|Overall Study||0
6384114|NCT00798304|7295273|FG001|COMPLETED|Overall Study||0
6384115|NCT00798304|7295274|FG002|COMPLETED|Overall Study||0
6384116|NCT00798304|7295272|FG000|NOT COMPLETED|Overall Study||14
6384117|NCT00798304|7295273|FG001|NOT COMPLETED|Overall Study||22
6384118|NCT00798304|7295274|FG002|NOT COMPLETED|Overall Study||10
6384119|NCT00798317|7295284|FG000|STARTED|Overall Study||245
6384120|NCT00798317|7295285|FG001|STARTED|Overall Study||81
6384121|NCT00798317|7295284|FG000|COMPLETED|Overall Study||235
6384122|NCT00798317|7295285|FG001|COMPLETED|Overall Study||74
6384123|NCT00798317|7295284|FG000|NOT COMPLETED|Overall Study||10
6384124|NCT00798317|7295285|FG001|NOT COMPLETED|Overall Study||7
6384125|NCT00798369|7295297|FG000|STARTED|Overall Study||28
6384126|NCT00798369|7295298|FG001|STARTED|Overall Study||29
6384127|NCT00798369|7295299|FG002|STARTED|Overall Study||29
6384128|NCT00798369|7295300|FG003|STARTED|Overall Study||29
6384129|NCT00798369|7295301|FG004|STARTED|Overall Study||28
6384130|NCT00798369|7295302|FG005|STARTED|Overall Study||57
6384131|NCT00798369|7295297|FG000|COMPLETED|Overall Study||27
6384132|NCT00798369|7295298|FG001|COMPLETED|Overall Study||28
6384133|NCT00798369|7295299|FG002|COMPLETED|Overall Study||27
6384134|NCT00798369|7295300|FG003|COMPLETED|Overall Study||28
6384135|NCT00798369|7295301|FG004|COMPLETED|Overall Study||27
6384136|NCT00798369|7295302|FG005|COMPLETED|Overall Study||54
6384137|NCT00798369|7295297|FG000|NOT COMPLETED|Overall Study||1
6384138|NCT00798369|7295298|FG001|NOT COMPLETED|Overall Study||1
6384139|NCT00798369|7295299|FG002|NOT COMPLETED|Overall Study||2
6384140|NCT00798369|7295300|FG003|NOT COMPLETED|Overall Study||1
6384141|NCT00798369|7295301|FG004|NOT COMPLETED|Overall Study||1
6384142|NCT00798369|7295302|FG005|NOT COMPLETED|Overall Study||3
6384143|NCT00798434|7295319|FG000|STARTED|Double-Blind||396
6384144|NCT00798434|7295320|FG001|STARTED|Double-Blind||398
6384145|NCT00798434|7295319|FG000|Received Treatment|Double-Blind||393
6384146|NCT00798434|7295320|FG001|Received Treatment|Double-Blind||392
6384147|NCT00798434|7295319|FG000|COMPLETED|Double-Blind||341
6384148|NCT00798434|7295320|FG001|COMPLETED|Double-Blind||314
6384149|NCT00798434|7295319|FG000|NOT COMPLETED|Double-Blind||55
6384150|NCT00798434|7295320|FG001|NOT COMPLETED|Double-Blind||84
6384151|NCT00798434|7295319|FG000|STARTED|Open-Label||341
6804600|NCT02429791|7736585|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||214
6804601|NCT02429791|7736586|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||210
6804602|NCT02429791|7736585|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||25
6804603|NCT02429791|7736586|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||28
6804604|NCT02422797|7736601|FG000|STARTED|Early Switch Phase (Up to Week 52)||261
6804605|NCT02422797|7736602|FG001|STARTED|Early Switch Phase (Up to Week 52)||255
6804606|NCT02422797|7736601|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||245
6804607|NCT02422797|7736602|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||239
6804608|NCT02422797|7736601|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
6804609|NCT02422797|7736602|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||16
6804610|NCT02422797|7736601|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||245
6384152|NCT00798434|7295320|FG001|STARTED|Open-Label||314
6384153|NCT00798434|7295319|FG000|Received Treatment|Open-Label||341
6384154|NCT00798434|7295320|FG001|Received Treatment|Open-Label||313
6384155|NCT00798434|7295319|FG000|COMPLETED|Open-Label||299
6384156|NCT00798434|7295320|FG001|COMPLETED|Open-Label||282
6384157|NCT00798434|7295319|FG000|NOT COMPLETED|Open-Label||42
6384158|NCT00798434|7295320|FG001|NOT COMPLETED|Open-Label||32
6384159|NCT00798486|7295331|FG000|STARTED|Overall Study||110
6384160|NCT00798486|7295331|FG000|COMPLETED|Overall Study||110
6384161|NCT00798486|7295331|FG000|NOT COMPLETED|Overall Study||0
6384162|NCT00798577|7295337|FG000|STARTED|Overall Study||17
6384163|NCT00798577|7295338|FG001|STARTED|Overall Study||7
6384164|NCT00798577|7295337|FG000|COMPLETED|Overall Study||17
6384165|NCT00798577|7295338|FG001|COMPLETED|Overall Study||7
6384166|NCT00798577|7295337|FG000|NOT COMPLETED|Overall Study||0
6384167|NCT00798577|7295338|FG001|NOT COMPLETED|Overall Study||0
6384168|NCT00798603|7295344|FG000|STARTED|Overall Study||62
6384169|NCT00798603|7295344|FG000|COMPLETED|Overall Study||27
6384170|NCT00798603|7295344|FG000|NOT COMPLETED|Overall Study||35
6384171|NCT00798655|7295348|FG000|STARTED|Overall Study||46
6384172|NCT00798655|7295348|FG000|COMPLETED|Overall Study||44
6384173|NCT00798655|7295348|FG000|NOT COMPLETED|Overall Study||2
6384174|NCT00798694|7295354|FG000|STARTED|Overall Study||30
6384175|NCT00798694|7295355|FG001|STARTED|Overall Study||28
6384176|NCT00798694|7295354|FG000|COMPLETED|Overall Study||28
6384177|NCT00798694|7295355|FG001|COMPLETED|Overall Study||27
6384178|NCT00798694|7295354|FG000|NOT COMPLETED|Overall Study||2
6384179|NCT00798694|7295355|FG001|NOT COMPLETED|Overall Study||1
6384180|NCT00798707|7295370|FG000|STARTED|Overall Study||235
6384181|NCT00798707|7295371|FG001|STARTED|Overall Study||237
6384182|NCT00798707|7295372|FG002|STARTED|Overall Study||237
6384183|NCT00798707|7295370|FG000|Treated|Overall Study||231
6564949|NCT01814137|7487670|FG000|NOT COMPLETED|Overall Study||5
6564950|NCT01814137|7487671|FG001|NOT COMPLETED|Overall Study||5
6623487|NCT02207829|7550626|FG001|STARTED|Overall Study||508
6623488|NCT02207829|7550625|FG000|COMPLETED|Overall Study||467
6623489|NCT02207829|7550626|FG001|COMPLETED|Overall Study||474
6623490|NCT02207829|7550625|FG000|NOT COMPLETED|Overall Study||42
6384184|NCT00798707|7295371|FG001|Treated|Overall Study||232
6384185|NCT00798707|7295372|FG002|Treated|Overall Study||236
6384186|NCT00798707|7295370|FG000|COMPLETED|Overall Study||209
6623491|NCT02207829|7550626|FG001|NOT COMPLETED|Overall Study||34
6269633|NCT00075946|7168842|FG002|Included in Primary Analysis|Overall Study||23
6269634|NCT00075946|7168843|FG003|Included in Primary Analysis|Overall Study||29
6269635|NCT00075946|7168844|FG004|Included in Primary Analysis|Overall Study||0
6269636|NCT00075946|7168840|FG000|COMPLETED|Overall Study||0
6269637|NCT00075946|7168841|FG001|COMPLETED|Overall Study||0
6269638|NCT00075946|7168842|FG002|COMPLETED|Overall Study||0
6269639|NCT00075946|7168843|FG003|COMPLETED|Overall Study||0
6269640|NCT00075946|7168844|FG004|COMPLETED|Overall Study||0
6269641|NCT00075946|7168840|FG000|NOT COMPLETED|Overall Study||148
6269642|NCT00075946|7168841|FG001|NOT COMPLETED|Overall Study||151
6269643|NCT00075946|7168842|FG002|NOT COMPLETED|Overall Study||28
6269644|NCT00075946|7168843|FG003|NOT COMPLETED|Overall Study||30
6269645|NCT00075946|7168844|FG004|NOT COMPLETED|Overall Study||188
6269646|NCT00076011|7168855|FG000|STARTED|Overall Study||52
6269647|NCT00076011|7168855|FG000|COMPLETED|Overall Study||0
6269648|NCT00076011|7168855|FG000|NOT COMPLETED|Overall Study||52
6269649|NCT00076024|7168862|FG000|STARTED|Phase 1, Lead-in||6
6269650|NCT00076024|7168863|FG001|STARTED|Phase 1, Lead-in||0
6269651|NCT00076024|7168864|FG002|STARTED|Phase 1, Lead-in||0
6269652|NCT00076024|7168865|FG003|STARTED|Phase 1, Lead-in||0
6269653|NCT00076024|7168862|FG000|COMPLETED|Phase 1, Lead-in||0
6269654|NCT00076024|7168863|FG001|COMPLETED|Phase 1, Lead-in||0
6269655|NCT00076024|7168864|FG002|COMPLETED|Phase 1, Lead-in||0
6269656|NCT00076024|7168865|FG003|COMPLETED|Phase 1, Lead-in||0
6269657|NCT00076024|7168862|FG000|NOT COMPLETED|Phase 1, Lead-in||6
6269658|NCT00076024|7168863|FG001|NOT COMPLETED|Phase 1, Lead-in||0
6269659|NCT00076024|7168864|FG002|NOT COMPLETED|Phase 1, Lead-in||0
6269660|NCT00076024|7168865|FG003|NOT COMPLETED|Phase 1, Lead-in||0
6269661|NCT00076024|7168862|FG000|STARTED|Phase 2, Double-blind||0
6384187|NCT00798707|7295371|FG001|COMPLETED|Overall Study||204
6384188|NCT00798707|7295372|FG002|COMPLETED|Overall Study||215
6384189|NCT00798707|7295370|FG000|NOT COMPLETED|Overall Study||26
6384190|NCT00798707|7295371|FG001|NOT COMPLETED|Overall Study||33
6384191|NCT00798707|7295372|FG002|NOT COMPLETED|Overall Study||22
6384192|NCT00798720|7295380|FG000|STARTED|Overall Study||18
6384193|NCT00798720|7295380|FG000|COMPLETED|Overall Study||18
6384194|NCT00798720|7295380|FG000|NOT COMPLETED|Overall Study||0
6384195|NCT00798759|7295386|FG000|STARTED|Overall Study||117
6384196|NCT00798759|7295387|FG001|STARTED|Overall Study||119
6384197|NCT00798759|7295386|FG000|COMPLETED|Overall Study||109
6384198|NCT00798759|7295387|FG001|COMPLETED|Overall Study||106
6384199|NCT00798759|7295386|FG000|NOT COMPLETED|Overall Study||8
6384200|NCT00798759|7295387|FG001|NOT COMPLETED|Overall Study||13
6384201|NCT00798889|7295393|FG000|STARTED|Overall Study||314
6384202|NCT00798889|7295393|FG000|Treated|Overall Study||311
6384203|NCT00798889|7295393|FG000|COMPLETED|Overall Study||0
6384204|NCT00798889|7295393|FG000|NOT COMPLETED|Overall Study||314
6384205|NCT00798967|7295399|FG000|STARTED|Overall Study||43
6384206|NCT00798967|7295400|FG001|STARTED|Overall Study||43
6503367|NCT01440764|7422172|FG006|STARTED|Test Day 3||3
6503368|NCT01440764|7422166|FG000|COMPLETED|Test Day 3||3
6503369|NCT01440764|7422167|FG001|COMPLETED|Test Day 3||2
6503370|NCT01440764|7422168|FG002|COMPLETED|Test Day 3||6
6503371|NCT01440764|7422169|FG003|COMPLETED|Test Day 3||1
6503372|NCT01440764|7422170|FG004|COMPLETED|Test Day 3||3
6503373|NCT01440764|7422171|FG005|COMPLETED|Test Day 3||5
6503374|NCT01440764|7422172|FG006|COMPLETED|Test Day 3||3
6503375|NCT01440764|7422166|FG000|NOT COMPLETED|Test Day 3||0
6503376|NCT01440764|7422167|FG001|NOT COMPLETED|Test Day 3||0
6503377|NCT01440764|7422168|FG002|NOT COMPLETED|Test Day 3||0
6503378|NCT01440764|7422169|FG003|NOT COMPLETED|Test Day 3||0
6503379|NCT01440764|7422170|FG004|NOT COMPLETED|Test Day 3||0
6503380|NCT01440764|7422171|FG005|NOT COMPLETED|Test Day 3||0
6503381|NCT01440764|7422172|FG006|NOT COMPLETED|Test Day 3||0
6503382|NCT01440803|7422192|FG000|STARTED|Overall Study||13
6503383|NCT01440803|7422193|FG001|STARTED|Overall Study||28
6503384|NCT01440803|7422192|FG000|Period 1 - Forteo/Placebo|Overall Study||13
6503385|NCT01440803|7422193|FG001|Period 1 - Forteo/Placebo|Overall Study||28
6269662|NCT00076024|7168863|FG001|STARTED|Phase 2, Double-blind||112
6269663|NCT00076024|7168864|FG002|STARTED|Phase 2, Double-blind||56
6269664|NCT00076024|7168865|FG003|STARTED|Phase 2, Double-blind||0
6269665|NCT00076024|7168862|FG000|Treated|Phase 2, Double-blind||0
6384207|NCT00798967|7295399|FG000|Discontinued During Dosing Period|Overall Study||4
6384208|NCT00798967|7295400|FG001|Discontinued During Dosing Period|Overall Study||4
6384209|NCT00798967|7295399|FG000|COMPLETED|Overall Study||39
6384210|NCT00798967|7295400|FG001|COMPLETED|Overall Study||39
6384211|NCT00798967|7295399|FG000|NOT COMPLETED|Overall Study||4
6384212|NCT00798967|7295400|FG001|NOT COMPLETED|Overall Study||4
6384213|NCT00799227|7295407|FG000|STARTED|Overall Study||56
6384214|NCT00799227|7295407|FG000|COMPLETED|Overall Study||53
6384215|NCT00799227|7295407|FG000|NOT COMPLETED|Overall Study||3
6564951|NCT01814241|7487677|FG000|STARTED|Overall Study||20
6564952|NCT01814241|7487677|FG000|COMPLETED|Overall Study||16
6564953|NCT01814241|7487677|FG000|NOT COMPLETED|Overall Study||4
6564954|NCT01814332|7487684|FG000|STARTED|Overall Study||63
6384216|NCT00799383|7295413|FG000|STARTED|Overall Study||23
6384217|NCT00799383|7295414|FG001|STARTED|Overall Study||24
6384218|NCT00799383|7295413|FG000|COMPLETED|Overall Study||20
6384219|NCT00799383|7295414|FG001|COMPLETED|Overall Study||18
6384220|NCT00799383|7295413|FG000|NOT COMPLETED|Overall Study||3
6384221|NCT00799383|7295414|FG001|NOT COMPLETED|Overall Study||6
6384222|NCT00799409|7295423|FG000|STARTED|Overall Study||7
6384223|NCT00799409|7295424|FG001|STARTED|Overall Study||36
6384224|NCT00799409|7295425|FG002|STARTED|Overall Study||35
6384225|NCT00799409|7295423|FG000|COMPLETED|Overall Study||0
6384226|NCT00799409|7295424|FG001|COMPLETED|Overall Study||36
6384227|NCT00799409|7295425|FG002|COMPLETED|Overall Study||35
6384228|NCT00799409|7295423|FG000|NOT COMPLETED|Overall Study||7
6384229|NCT00799409|7295424|FG001|NOT COMPLETED|Overall Study||0
6384230|NCT00799409|7295425|FG002|NOT COMPLETED|Overall Study||0
6384231|NCT00799422|7295433|FG000|STARTED|First Week of Wear||4
6384232|NCT00799422|7295434|FG001|STARTED|First Week of Wear||4
6384233|NCT00799422|7295435|FG002|STARTED|First Week of Wear||4
6384234|NCT00799422|7295436|FG003|STARTED|First Week of Wear||5
6384235|NCT00799422|7295437|FG004|STARTED|First Week of Wear||4
6384236|NCT00799422|7295438|FG005|STARTED|First Week of Wear||5
6384237|NCT00799422|7295433|FG000|COMPLETED|First Week of Wear||4
6384238|NCT00799422|7295434|FG001|COMPLETED|First Week of Wear||4
6384239|NCT00799422|7295435|FG002|COMPLETED|First Week of Wear||3
6384240|NCT00799422|7295436|FG003|COMPLETED|First Week of Wear||4
6384241|NCT00799422|7295437|FG004|COMPLETED|First Week of Wear||4
6384242|NCT00799422|7295438|FG005|COMPLETED|First Week of Wear||5
6384243|NCT00799422|7295433|FG000|NOT COMPLETED|First Week of Wear||0
6384244|NCT00799422|7295434|FG001|NOT COMPLETED|First Week of Wear||0
6384245|NCT00799422|7295435|FG002|NOT COMPLETED|First Week of Wear||1
6384246|NCT00799422|7295436|FG003|NOT COMPLETED|First Week of Wear||1
6384247|NCT00799422|7295437|FG004|NOT COMPLETED|First Week of Wear||0
6384248|NCT00799422|7295438|FG005|NOT COMPLETED|First Week of Wear||0
6384249|NCT00799422|7295433|FG000|STARTED|Second Week of Wear||4
6384250|NCT00799422|7295434|FG001|STARTED|Second Week of Wear||4
6384251|NCT00799422|7295435|FG002|STARTED|Second Week of Wear||3
6384252|NCT00799422|7295436|FG003|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
6384253|NCT00799422|7295437|FG004|STARTED|Second Week of Wear||4
6384254|NCT00799422|7295438|FG005|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
6384255|NCT00799422|7295433|FG000|COMPLETED|Second Week of Wear||4
6384256|NCT00799422|7295434|FG001|COMPLETED|Second Week of Wear||4
6384257|NCT00799422|7295435|FG002|COMPLETED|Second Week of Wear||3
6384258|NCT00799422|7295436|FG003|COMPLETED|Second Week of Wear||3
6384259|NCT00799422|7295437|FG004|COMPLETED|Second Week of Wear||4
6384260|NCT00799422|7295438|FG005|COMPLETED|Second Week of Wear||4
6384261|NCT00799422|7295433|FG000|NOT COMPLETED|Second Week of Wear||0
6384262|NCT00799422|7295434|FG001|NOT COMPLETED|Second Week of Wear||0
6384263|NCT00799422|7295435|FG002|NOT COMPLETED|Second Week of Wear||0
6804611|NCT02422797|7736602|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||239
6804612|NCT02422797|7736601|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||222
6804613|NCT02422797|7736602|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||221
6804614|NCT02422797|7736601|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||23
6804615|NCT02422797|7736602|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||18
6804616|NCT02422615|7736620|FG000|STARTED|Overall Study||484
6804617|NCT02422615|7736621|FG001|STARTED|Overall Study||242
6804618|NCT02422615|7736620|FG000|Untreated|Overall Study||1
6804619|NCT02422615|7736621|FG001|Untreated|Overall Study||1
6804620|NCT02422615|7736620|FG000|COMPLETED|Overall Study||204
6804621|NCT02422615|7736621|FG001|COMPLETED|Overall Study||76
6384264|NCT00799422|7295436|FG003|NOT COMPLETED|Second Week of Wear||0
6384265|NCT00799422|7295437|FG004|NOT COMPLETED|Second Week of Wear||0
6384266|NCT00799422|7295438|FG005|NOT COMPLETED|Second Week of Wear||0
6384267|NCT00799422|7295433|FG000|STARTED|Third Week of Wear||4
6384268|NCT00799422|7295434|FG001|STARTED|Third Week of Wear||4
6384269|NCT00799422|7295435|FG002|STARTED|Third Week of Wear||3
6384270|NCT00799422|7295436|FG003|STARTED|Third Week of Wear||3
6384271|NCT00799422|7295437|FG004|STARTED|Third Week of Wear||4
6384272|NCT00799422|7295438|FG005|STARTED|Third Week of Wear||4
6564955|NCT01814332|7487685|FG001|STARTED|Overall Study||65
6564956|NCT01814332|7487684|FG000|COMPLETED|Overall Study||47
6564957|NCT01814332|7487685|FG001|COMPLETED|Overall Study||49
6564958|NCT01814332|7487684|FG000|NOT COMPLETED|Overall Study||16
6564959|NCT01814332|7487685|FG001|NOT COMPLETED|Overall Study||16
6564960|NCT01814371|7487693|FG000|STARTED|Overall Study||248
6564961|NCT01814371|7487694|FG001|STARTED|Overall Study||226
6564962|NCT01814371|7487693|FG000|COMPLETED|Overall Study||218
6564963|NCT01814371|7487694|FG001|COMPLETED|Overall Study||199
6564964|NCT01814371|7487693|FG000|NOT COMPLETED|Overall Study||30
6564965|NCT01814371|7487694|FG001|NOT COMPLETED|Overall Study||27
6564966|NCT01814397|7487703|FG000|STARTED|Overall Study||50
6564967|NCT01814397|7487703|FG000|3 Month Evaluation|Overall Study||43
6564968|NCT01814397|7487703|FG000|COMPLETED|Overall Study||36
6564969|NCT01814397|7487703|FG000|NOT COMPLETED|Overall Study||14
6564970|NCT01814553|7487709|FG000|STARTED|Overall Study||18
6564971|NCT01814553|7487710|FG001|STARTED|Overall Study||22
6564972|NCT01814553|7487709|FG000|COMPLETED|Overall Study||0
6564973|NCT01814553|7487710|FG001|COMPLETED|Overall Study||0
6384273|NCT00799422|7295433|FG000|COMPLETED|Third Week of Wear||4
6384274|NCT00799422|7295434|FG001|COMPLETED|Third Week of Wear||4
6384275|NCT00799422|7295435|FG002|COMPLETED|Third Week of Wear||3
6384276|NCT00799422|7295436|FG003|COMPLETED|Third Week of Wear||3
6384277|NCT00799422|7295437|FG004|COMPLETED|Third Week of Wear||4
6384278|NCT00799422|7295438|FG005|COMPLETED|Third Week of Wear||4
6384279|NCT00799422|7295433|FG000|NOT COMPLETED|Third Week of Wear||0
6384280|NCT00799422|7295434|FG001|NOT COMPLETED|Third Week of Wear||0
6384281|NCT00799422|7295435|FG002|NOT COMPLETED|Third Week of Wear||0
6384282|NCT00799422|7295436|FG003|NOT COMPLETED|Third Week of Wear||0
6384283|NCT00799422|7295437|FG004|NOT COMPLETED|Third Week of Wear||0
6384284|NCT00799422|7295438|FG005|NOT COMPLETED|Third Week of Wear||0
6384285|NCT00799435|7295448|FG000|STARTED|Overall Study||1
6384286|NCT00799435|7295449|FG001|STARTED|Overall Study||1
6384287|NCT00799435|7295448|FG000|COMPLETED|Overall Study||1
6384288|NCT00799435|7295449|FG001|COMPLETED|Overall Study||1
6384289|NCT00799435|7295448|FG000|NOT COMPLETED|Overall Study||0
6384290|NCT00799435|7295449|FG001|NOT COMPLETED|Overall Study||0
6384291|NCT00799474|7295455|FG000|STARTED|Overall Study||609
6384292|NCT00799474|7295455|FG000|COMPLETED|Overall Study||609
6384293|NCT00799474|7295455|FG000|NOT COMPLETED|Overall Study||0
6384294|NCT00799487|7295462|FG000|STARTED|Dose Adjustment Period||21
6384295|NCT00799487|7295463|FG001|STARTED|Dose Adjustment Period||34
6384296|NCT00799487|7295464|FG002|STARTED|Dose Adjustment Period||34
6384297|NCT00799487|7295462|FG000|COMPLETED|Dose Adjustment Period||0
6384298|NCT00799487|7295463|FG001|COMPLETED|Dose Adjustment Period||34
6384299|NCT00799487|7295464|FG002|COMPLETED|Dose Adjustment Period||34
6384300|NCT00799487|7295462|FG000|NOT COMPLETED|Dose Adjustment Period||21
6384301|NCT00799487|7295463|FG001|NOT COMPLETED|Dose Adjustment Period||0
6384302|NCT00799487|7295464|FG002|NOT COMPLETED|Dose Adjustment Period||0
6384303|NCT00799487|7295462|FG000|STARTED|Double-Blind Assessment Period||0
6384304|NCT00799487|7295463|FG001|STARTED|Double-Blind Assessment Period||34
6384305|NCT00799487|7295464|FG002|STARTED|Double-Blind Assessment Period||34
6384306|NCT00799487|7295462|FG000|COMPLETED|Double-Blind Assessment Period||0
6384307|NCT00799487|7295463|FG001|COMPLETED|Double-Blind Assessment Period||33
6384308|NCT00799487|7295464|FG002|COMPLETED|Double-Blind Assessment Period||32
6384309|NCT00799487|7295462|FG000|NOT COMPLETED|Double-Blind Assessment Period||0
6384310|NCT00799487|7295463|FG001|NOT COMPLETED|Double-Blind Assessment Period||1
6384311|NCT00799487|7295464|FG002|NOT COMPLETED|Double-Blind Assessment Period||2
6503386|NCT01440803|7422192|FG000|Period 2 - Forteo/Forteo|Overall Study||13
6503387|NCT01440803|7422193|FG001|Period 2 - Forteo/Forteo|Overall Study||28
6384312|NCT00799578|7295475|FG000|STARTED|Overall Study||13
6384313|NCT00799578|7295475|FG000|COMPLETED|Overall Study||11
6804622|NCT02422615|7736620|FG000|NOT COMPLETED|Overall Study||280
6804623|NCT02422615|7736621|FG001|NOT COMPLETED|Overall Study||166
6804624|NCT02287493|7736629|FG000|STARTED|Overall Study||19
6269666|NCT00076024|7168863|FG001|Treated|Phase 2, Double-blind||111
6269667|NCT00076024|7168864|FG002|Treated|Phase 2, Double-blind||56
6269668|NCT00076024|7168865|FG003|Treated|Phase 2, Double-blind||0
6269669|NCT00076024|7168862|FG000|COMPLETED|Phase 2, Double-blind||0
6269670|NCT00076024|7168863|FG001|COMPLETED|Phase 2, Double-blind||0
6269671|NCT00076024|7168864|FG002|COMPLETED|Phase 2, Double-blind||0
6269672|NCT00076024|7168865|FG003|COMPLETED|Phase 2, Double-blind||0
6269673|NCT00076024|7168862|FG000|NOT COMPLETED|Phase 2, Double-blind||0
6269674|NCT00076024|7168863|FG001|NOT COMPLETED|Phase 2, Double-blind||112
6269675|NCT00076024|7168864|FG002|NOT COMPLETED|Phase 2, Double-blind||56
6269676|NCT00076024|7168865|FG003|NOT COMPLETED|Phase 2, Double-blind||0
6269677|NCT00076024|7168862|FG000|STARTED|Phase 2, Open-label||0
6269678|NCT00076024|7168863|FG001|STARTED|Phase 2, Open-label||0
6269679|NCT00076024|7168864|FG002|STARTED|Phase 2, Open-label||0
6269680|NCT00076024|7168865|FG003|STARTED|Phase 2, Open-label||16
6269681|NCT00076024|7168862|FG000|COMPLETED|Phase 2, Open-label||0
6269682|NCT00076024|7168863|FG001|COMPLETED|Phase 2, Open-label||0
6269683|NCT00076024|7168864|FG002|COMPLETED|Phase 2, Open-label||0
6269684|NCT00076024|7168865|FG003|COMPLETED|Phase 2, Open-label||0
6269685|NCT00076024|7168862|FG000|NOT COMPLETED|Phase 2, Open-label||0
6269686|NCT00076024|7168863|FG001|NOT COMPLETED|Phase 2, Open-label||0
6269687|NCT00076024|7168864|FG002|NOT COMPLETED|Phase 2, Open-label||0
6269688|NCT00076024|7168865|FG003|NOT COMPLETED|Phase 2, Open-label||16
6269689|NCT00076050|7168876|FG000|STARTED|Overall Study||122
6269690|NCT00076050|7168877|FG001|STARTED|Overall Study||126
6269691|NCT00076050|7168876|FG000|COMPLETED|Overall Study||99
6269692|NCT00076050|7168877|FG001|COMPLETED|Overall Study||83
6269693|NCT00076050|7168876|FG000|NOT COMPLETED|Overall Study||23
6269694|NCT00076050|7168877|FG001|NOT COMPLETED|Overall Study||43
6269695|NCT00076102|7168883|FG000|STARTED|Overall Study||36
6269696|NCT00076102|7168883|FG000|COMPLETED|Overall Study||31
6269697|NCT00076102|7168883|FG000|NOT COMPLETED|Overall Study||5
6269698|NCT00076219|7168891|FG000|STARTED|Overall Study||563
6269699|NCT00076219|7168892|FG001|STARTED|Overall Study||561
6269700|NCT00076219|7168891|FG000|COMPLETED|Overall Study||545
6269701|NCT00076219|7168892|FG001|COMPLETED|Overall Study||550
6269702|NCT00076219|7168891|FG000|NOT COMPLETED|Overall Study||18
6269703|NCT00076219|7168892|FG001|NOT COMPLETED|Overall Study||11
6269704|NCT00076245|7168902|FG000|STARTED|Overall Study||16
6269705|NCT00076245|7168903|FG001|STARTED|Overall Study||15
6269706|NCT00076245|7168904|FG002|STARTED|Overall Study||15
6269707|NCT00076245|7168905|FG003|STARTED|Overall Study||15
6269708|NCT00076245|7168902|FG000|COMPLETED|Overall Study||16
6269709|NCT00076245|7168903|FG001|COMPLETED|Overall Study||15
6269710|NCT00076245|7168904|FG002|COMPLETED|Overall Study||15
6269711|NCT00076245|7168905|FG003|COMPLETED|Overall Study||14
6269712|NCT00076245|7168902|FG000|NOT COMPLETED|Overall Study||0
6269713|NCT00076245|7168903|FG001|NOT COMPLETED|Overall Study||0
6269714|NCT00076245|7168904|FG002|NOT COMPLETED|Overall Study||0
6269715|NCT00076245|7168905|FG003|NOT COMPLETED|Overall Study||1
6269716|NCT00076258|7168917|FG000|STARTED|Overall Study||62
6269717|NCT00076258|7168918|FG001|STARTED|Overall Study||64
6269718|NCT00076258|7168917|FG000|COMPLETED|Overall Study||61
6269719|NCT00076258|7168918|FG001|COMPLETED|Overall Study||61
6269720|NCT00076258|7168917|FG000|NOT COMPLETED|Overall Study||1
6269721|NCT00076258|7168918|FG001|NOT COMPLETED|Overall Study||3
6269722|NCT00076336|7168926|FG000|STARTED|Overall Study||116
6269723|NCT00076336|7168927|FG001|STARTED|Overall Study||116
6269724|NCT00076336|7168926|FG000|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
6269725|NCT00076336|7168927|FG001|Safety Population|Overall Study||116
6269726|NCT00076336|7168926|FG000|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
6269727|NCT00076336|7168927|FG001|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
6804625|NCT02287493|7736630|FG001|STARTED|Overall Study||16
6804626|NCT02287493|7736629|FG000|COMPLETED|Overall Study||19
6804627|NCT02287493|7736630|FG001|COMPLETED|Overall Study||16
6804628|NCT02287493|7736629|FG000|NOT COMPLETED|Overall Study||0
6804629|NCT02287493|7736630|FG001|NOT COMPLETED|Overall Study||0
6804630|NCT02132611|7736640|FG000|STARTED|Overall Study||100
6804631|NCT02132611|7736640|FG000|COMPLETED|Overall Study||98
6804632|NCT02132611|7736640|FG000|NOT COMPLETED|Overall Study||2
6804633|NCT01796197|7736644|FG000|STARTED|Overall Study||23
6804634|NCT01796197|7736644|FG000|COMPLETED|Overall Study||21
6804635|NCT01796197|7736644|FG000|NOT COMPLETED|Overall Study||2
6269728|NCT00076336|7168926|FG000|Completed Week 52|Overall Study||97
6269729|NCT00076336|7168927|FG001|Completed Week 52|Overall Study||94
6269730|NCT00076336|7168926|FG000|Completed Week 104|Overall Study||70
6384314|NCT00799578|7295475|FG000|NOT COMPLETED|Overall Study||2
6384315|NCT00799591|7295479|FG000|STARTED|Overall Study||156
6384316|NCT00799591|7295479|FG000|COMPLETED|Overall Study||90
6384317|NCT00799591|7295479|FG000|NOT COMPLETED|Overall Study||66
6503388|NCT01440803|7422192|FG000|Period 3 - Forteo Open Label|Overall Study||13
6503389|NCT01440803|7422193|FG001|Period 3 - Forteo Open Label|Overall Study||27
6564974|NCT01814553|7487709|FG000|NOT COMPLETED|Overall Study||18
6564975|NCT01814553|7487710|FG001|NOT COMPLETED|Overall Study||22
6564976|NCT01814670|7487716|FG000|STARTED|Overall Study||185
6384318|NCT00799604|7295486|FG000|STARTED|Bolus 1 (Pre-anesthesia)||10
6384319|NCT00799604|7295487|FG001|STARTED|Bolus 1 (Pre-anesthesia)||10
6384320|NCT00799604|7295488|FG002|STARTED|Bolus 1 (Pre-anesthesia)||10
6384321|NCT00799604|7295486|FG000|COMPLETED|Bolus 1 (Pre-anesthesia)||10
6384322|NCT00799604|7295487|FG001|COMPLETED|Bolus 1 (Pre-anesthesia)||10
6384323|NCT00799604|7295488|FG002|COMPLETED|Bolus 1 (Pre-anesthesia)||10
6384324|NCT00799604|7295486|FG000|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
6384325|NCT00799604|7295487|FG001|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
6384326|NCT00799604|7295488|FG002|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
6384327|NCT00799604|7295486|FG000|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
6384328|NCT00799604|7295487|FG001|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
6384329|NCT00799604|7295488|FG002|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
6384330|NCT00799604|7295486|FG000|COMPLETED|Bolus 2 (With Anesthesia)||6
6384331|NCT00799604|7295487|FG001|COMPLETED|Bolus 2 (With Anesthesia)||12
6384332|NCT00799604|7295488|FG002|COMPLETED|Bolus 2 (With Anesthesia)||3
6384333|NCT00799604|7295486|FG000|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
6384334|NCT00799604|7295487|FG001|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
6384335|NCT00799604|7295488|FG002|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
6384336|NCT00799617|7295498|FG000|STARTED|Main Testosterone Trial||395
6384337|NCT00799617|7295499|FG001|STARTED|Main Testosterone Trial||395
6564977|NCT01814670|7487716|FG000|COMPLETED|Overall Study||173
6656797|NCT02465034|7587123|FG001|COMPLETED|Overall Study||20
6656798|NCT02465034|7587122|FG000|NOT COMPLETED|Overall Study||3
6656799|NCT02465034|7587123|FG001|NOT COMPLETED|Overall Study||6
6656800|NCT02465073|7587140|FG000|STARTED|Overall Study||17
6656801|NCT02465073|7587141|FG001|STARTED|Overall Study||16
6656802|NCT02465073|7587142|FG002|STARTED|Overall Study||16
6384338|NCT00799617|7295498|FG000|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
6384339|NCT00799617|7295499|FG001|COMPLETED|Main Testosterone Trial||374
6384340|NCT00799617|7295498|FG000|NOT COMPLETED|Main Testosterone Trial||19
6384341|NCT00799617|7295499|FG001|NOT COMPLETED|Main Testosterone Trial||21
6384342|NCT00799617|7295498|FG000|STARTED|Sexual Funtion Trial||234
6384343|NCT00799617|7295499|FG001|STARTED|Sexual Funtion Trial||236
6384344|NCT00799617|7295498|FG000|COMPLETED|Sexual Funtion Trial||218
6384345|NCT00799617|7295499|FG001|COMPLETED|Sexual Funtion Trial||215
6384346|NCT00799617|7295498|FG000|NOT COMPLETED|Sexual Funtion Trial||16
6384347|NCT00799617|7295499|FG001|NOT COMPLETED|Sexual Funtion Trial||21
6384348|NCT00799617|7295498|FG000|STARTED|Physical Function Trial||191
6384349|NCT00799617|7295499|FG001|STARTED|Physical Function Trial||196
6384350|NCT00799617|7295498|FG000|COMPLETED|Physical Function Trial||185
6384351|NCT00799617|7295499|FG001|COMPLETED|Physical Function Trial||185
6384352|NCT00799617|7295498|FG000|NOT COMPLETED|Physical Function Trial||6
6384353|NCT00799617|7295499|FG001|NOT COMPLETED|Physical Function Trial||11
6384354|NCT00799617|7295498|FG000|STARTED|Vitality Trial||236
6384355|NCT00799617|7295499|FG001|STARTED|Vitality Trial||238
6384356|NCT00799617|7295498|FG000|COMPLETED|Vitality Trial||229
6384357|NCT00799617|7295499|FG001|COMPLETED|Vitality Trial||216
6384358|NCT00799617|7295498|FG000|NOT COMPLETED|Vitality Trial||7
6384359|NCT00799617|7295499|FG001|NOT COMPLETED|Vitality Trial||22
6384360|NCT00799617|7295498|FG000|STARTED|Cardiovascular Trial||88
6384361|NCT00799617|7295499|FG001|STARTED|Cardiovascular Trial||82
6384362|NCT00799617|7295498|FG000|COMPLETED|Cardiovascular Trial||73
6384363|NCT00799617|7295499|FG001|COMPLETED|Cardiovascular Trial||65
6384364|NCT00799617|7295498|FG000|NOT COMPLETED|Cardiovascular Trial||15
6384365|NCT00799617|7295499|FG001|NOT COMPLETED|Cardiovascular Trial||17
6384366|NCT00799617|7295498|FG000|STARTED|Bone Trial||110
6384367|NCT00799617|7295499|FG001|STARTED|Bone Trial||101
6384368|NCT00799617|7295498|FG000|COMPLETED|Bone Trial||104
6384369|NCT00799617|7295499|FG001|COMPLETED|Bone Trial||85
6384370|NCT00799617|7295498|FG000|NOT COMPLETED|Bone Trial||6
6384371|NCT00799617|7295499|FG001|NOT COMPLETED|Bone Trial||16
6384372|NCT00799617|7295498|FG000|STARTED|Cognitive Function Trial||247
6384373|NCT00799617|7295499|FG001|STARTED|Cognitive Function Trial||246
6384374|NCT00799617|7295498|FG000|COMPLETED|Cognitive Function Trial||247
6384375|NCT00799617|7295499|FG001|COMPLETED|Cognitive Function Trial||245
6384376|NCT00799617|7295498|FG000|NOT COMPLETED|Cognitive Function Trial||0
6384377|NCT00799617|7295499|FG001|NOT COMPLETED|Cognitive Function Trial||1
6384378|NCT00799617|7295498|FG000|STARTED|Anemia Trial||27
6384379|NCT00799617|7295499|FG001|STARTED|Anemia Trial||35
6384380|NCT00799617|7295498|FG000|COMPLETED|Anemia Trial||24
6384381|NCT00799617|7295499|FG001|COMPLETED|Anemia Trial||32
6384382|NCT00799617|7295498|FG000|NOT COMPLETED|Anemia Trial||3
6384383|NCT00799617|7295499|FG001|NOT COMPLETED|Anemia Trial||3
6384384|NCT00799643|7295507|FG000|STARTED|Overall Study||140
6384385|NCT00799643|7295508|FG001|STARTED|Overall Study||146
6384386|NCT00799643|7295507|FG000|COMPLETED|Overall Study||115
6384387|NCT00799643|7295508|FG001|COMPLETED|Overall Study||119
6384388|NCT00799643|7295507|FG000|NOT COMPLETED|Overall Study||25
6384389|NCT00799643|7295508|FG001|NOT COMPLETED|Overall Study||27
6384390|NCT00799708|7295518|FG000|STARTED|Overall Study||10
6384391|NCT00799708|7295519|FG001|STARTED|Overall Study||6
6384392|NCT00799708|7295520|FG002|STARTED|Overall Study||11
6384393|NCT00799708|7295518|FG000|COMPLETED|Overall Study||9
6384394|NCT00799708|7295519|FG001|COMPLETED|Overall Study||6
6384395|NCT00799708|7295520|FG002|COMPLETED|Overall Study||11
6384396|NCT00799708|7295518|FG000|NOT COMPLETED|Overall Study||1
6384397|NCT00799708|7295519|FG001|NOT COMPLETED|Overall Study||0
6384398|NCT00799708|7295520|FG002|NOT COMPLETED|Overall Study||0
6384399|NCT00799812|7295530|FG000|STARTED|Overall Study||335
6384400|NCT00799812|7295530|FG000|CHG Swabstick (3 @ Once)|Overall Study||139
6384401|NCT00799812|7295530|FG000|CHG Swabstick Sequential|Overall Study||138
6384402|NCT00799812|7295530|FG000|Hibiclens|Overall Study||133
6503390|NCT01440803|7422192|FG000|COMPLETED|Overall Study||11
6503391|NCT01440803|7422193|FG001|COMPLETED|Overall Study||24
6503392|NCT01440803|7422192|FG000|NOT COMPLETED|Overall Study||2
6503393|NCT01440803|7422193|FG001|NOT COMPLETED|Overall Study||4
6503394|NCT01440816|7422202|FG000|STARTED|Overall Study||3
6503395|NCT01440816|7422203|FG001|STARTED|Overall Study||12
6503396|NCT01440816|7422202|FG000|COMPLETED|Overall Study||2
6503397|NCT01440816|7422203|FG001|COMPLETED|Overall Study||1
6503398|NCT01440816|7422202|FG000|NOT COMPLETED|Overall Study||1
6503399|NCT01440816|7422203|FG001|NOT COMPLETED|Overall Study||11
6503400|NCT01440881|7422213|FG000|STARTED|Overall Study||14
6503401|NCT01440881|7422214|FG001|STARTED|Overall Study||15
6503402|NCT01440881|7422213|FG000|COMPLETED|Overall Study||14
6384403|NCT00799812|7295530|FG000|Sterile Water Swab (3 @ Once)|Overall Study||132
6384404|NCT00799812|7295530|FG000|Sterile Water Swabstick (Sequential)|Overall Study||126
6384405|NCT00799812|7295530|FG000|COMPLETED|Overall Study||335
6804636|NCT01147822|7736650|FG000|STARTED|Overall Study||188
6804637|NCT01147822|7736651|FG001|STARTED|Overall Study||179
6804638|NCT01147822|7736650|FG000|Not Completed/Ongoing|Overall Study||111
6804639|NCT01147822|7736651|FG001|Not Completed/Ongoing|Overall Study||102
6804640|NCT01147822|7736650|FG000|COMPLETED|Overall Study||0
6804641|NCT01147822|7736651|FG001|COMPLETED|Overall Study||0
6804642|NCT01147822|7736650|FG000|NOT COMPLETED|Overall Study||188
6804643|NCT01147822|7736651|FG001|NOT COMPLETED|Overall Study||179
6804644|NCT00328653|7736660|FG000|STARTED|Period I||40
6804645|NCT00328653|7736661|FG001|STARTED|Period I||39
6804646|NCT00328653|7736662|FG002|STARTED|Period I||39
6804647|NCT00328653|7736660|FG000|COMPLETED|Period I||36
6804648|NCT00328653|7736661|FG001|COMPLETED|Period I||39
6804649|NCT00328653|7736662|FG002|COMPLETED|Period I||36
6804650|NCT00328653|7736660|FG000|NOT COMPLETED|Period I||4
6804651|NCT00328653|7736661|FG001|NOT COMPLETED|Period I||0
6804652|NCT00328653|7736662|FG002|NOT COMPLETED|Period I||3
6804653|NCT00328653|7736660|FG000|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (i.e. CsA 0.05% or 0.1%) as four times or twice daily instillations in both eyes for an additional 3 month period.|0
6804654|NCT00328653|7736661|FG001|STARTED|Period II||58
6804655|NCT00328653|7736662|FG002|STARTED|Period II||53
6804656|NCT00328653|7736660|FG000|COMPLETED|Period II||0
6804657|NCT00328653|7736661|FG001|COMPLETED|Period II||50
6804658|NCT00328653|7736662|FG002|COMPLETED|Period II||49
6804659|NCT00328653|7736660|FG000|NOT COMPLETED|Period II||0
6564978|NCT01814670|7487716|FG000|NOT COMPLETED|Overall Study||12
6564979|NCT01814696|7487722|FG000|STARTED|Overall Study||15
6564980|NCT01814696|7487723|FG001|STARTED|Overall Study||11
6564981|NCT01814696|7487722|FG000|COMPLETED|Overall Study||13
6564982|NCT01814696|7487723|FG001|COMPLETED|Overall Study||11
6564983|NCT01814696|7487722|FG000|NOT COMPLETED|Overall Study||2
6564984|NCT01814696|7487723|FG001|NOT COMPLETED|Overall Study||0
6564985|NCT01814748|7487731|FG000|STARTED|Overall Study||102
6564986|NCT01814748|7487732|FG001|STARTED|Overall Study||101
6564987|NCT01814748|7487731|FG000|COMPLETED|Overall Study||94
6564988|NCT01814748|7487732|FG001|COMPLETED|Overall Study||94
6564989|NCT01814748|7487731|FG000|NOT COMPLETED|Overall Study||8
6564990|NCT01814748|7487732|FG001|NOT COMPLETED|Overall Study||7
6804660|NCT00328653|7736661|FG001|NOT COMPLETED|Period II||8
6804661|NCT00328653|7736662|FG002|NOT COMPLETED|Period II||4
6564991|NCT01814761|7487740|FG000|STARTED|Overall Study||42
6564992|NCT01814761|7487741|FG001|STARTED|Overall Study||270
6269731|NCT00076336|7168927|FG001|Completed Week 104|Overall Study||62
6384406|NCT00799812|7295530|FG000|NOT COMPLETED|Overall Study||0
6384407|NCT00799825|7295542|FG000|STARTED|Overall Study||344
6384408|NCT00799825|7295542|FG000|COMPLETED|Overall Study||296
6384409|NCT00799825|7295542|FG000|NOT COMPLETED|Overall Study||48
6384410|NCT00799903|7295548|FG000|STARTED|Overall Study||7904
6384411|NCT00799903|7295549|FG001|STARTED|Overall Study||7924
6384412|NCT00799903|7295548|FG000|COMPLETED|Overall Study||7631
6384413|NCT00799903|7295549|FG001|COMPLETED|Overall Study||7646
6384414|NCT00799903|7295548|FG000|NOT COMPLETED|Overall Study||273
6384415|NCT00799903|7295549|FG001|NOT COMPLETED|Overall Study||278
6384416|NCT00799981|7295555|FG000|STARTED|Overall Study||10
6384417|NCT00799981|7295556|FG001|STARTED|Overall Study||9
6384418|NCT00799981|7295557|FG002|STARTED|Overall Study||10
6384419|NCT00799981|7295558|FG003|STARTED|Overall Study||10
6384420|NCT00799981|7295559|FG004|STARTED|Overall Study||11
6384421|NCT00799981|7295560|FG005|STARTED|Overall Study||10
6503403|NCT01440881|7422214|FG001|COMPLETED|Overall Study||14
6503404|NCT01440881|7422213|FG000|NOT COMPLETED|Overall Study||0
6503405|NCT01440881|7422214|FG001|NOT COMPLETED|Overall Study||1
6503406|NCT01440920|7422224|FG000|STARTED|Overall Study||3
6503407|NCT01440920|7422225|FG001|STARTED|Overall Study||3
6503408|NCT01440920|7422226|FG002|STARTED|Overall Study||3
6503409|NCT01440920|7422224|FG000|COMPLETED|Overall Study||3
6503410|NCT01440920|7422225|FG001|COMPLETED|Overall Study||3
6503411|NCT01440920|7422226|FG002|COMPLETED|Overall Study||3
6269732|NCT00076336|7168926|FG000|COMPLETED|Overall Study||64
6269733|NCT00076336|7168927|FG001|COMPLETED|Overall Study||60
6269734|NCT00076336|7168926|FG000|NOT COMPLETED|Overall Study||52
6269735|NCT00076336|7168927|FG001|NOT COMPLETED|Overall Study||56
6564993|NCT01814761|7487740|FG000|COMPLETED|Overall Study||34
6564994|NCT01814761|7487741|FG001|COMPLETED|Overall Study||240
6564995|NCT01814761|7487740|FG000|NOT COMPLETED|Overall Study||8
6564996|NCT01814761|7487741|FG001|NOT COMPLETED|Overall Study||30
6564997|NCT01814774|7487747|FG000|STARTED|Overall Study||48
6564998|NCT01814774|7487747|FG000|COMPLETED|Overall Study||48
6564999|NCT01814774|7487747|FG000|NOT COMPLETED|Overall Study||0
6565000|NCT01814787|7487755|FG000|STARTED|Overall Study||685
6565001|NCT01814787|7487756|FG001|STARTED|Overall Study||684
6565002|NCT01814787|7487755|FG000|COMPLETED|Overall Study||685
6565003|NCT01814787|7487756|FG001|COMPLETED|Overall Study||684
6565004|NCT01814787|7487755|FG000|NOT COMPLETED|Overall Study||0
6565005|NCT01814787|7487756|FG001|NOT COMPLETED|Overall Study||0
6565006|NCT01814800|7487762|FG000|STARTED|Overall Study||59
6565007|NCT01814800|7487762|FG000|COMPLETED|Overall Study||54
6565008|NCT01814800|7487762|FG000|NOT COMPLETED|Overall Study||5
6565009|NCT01814813|7487769|FG000|STARTED|Overall Study||29
6565010|NCT01814813|7487770|FG001|STARTED|Overall Study||30
6565011|NCT01814813|7487771|FG002|STARTED|Overall Study||31
6565012|NCT01814813|7487769|FG000|COMPLETED|Overall Study||29
6565013|NCT01814813|7487770|FG001|COMPLETED|Overall Study||30
6565014|NCT01814813|7487771|FG002|COMPLETED|Overall Study||31
6565015|NCT01814813|7487769|FG000|NOT COMPLETED|Overall Study||0
6565016|NCT01814813|7487770|FG001|NOT COMPLETED|Overall Study||0
6565017|NCT01814813|7487771|FG002|NOT COMPLETED|Overall Study||0
6565018|NCT01814878|7487781|FG000|STARTED|Overall Study||162
6503412|NCT01440920|7422224|FG000|NOT COMPLETED|Overall Study||0
6503413|NCT01440920|7422225|FG001|NOT COMPLETED|Overall Study||0
6503414|NCT01440920|7422226|FG002|NOT COMPLETED|Overall Study||0
6503415|NCT01440946|7422236|FG000|STARTED|Overall Study||15
6503416|NCT01440946|7422237|FG001|STARTED|Overall Study||15
6503417|NCT01440946|7422236|FG000|COMPLETED|Overall Study||13
6503418|NCT01440946|7422237|FG001|COMPLETED|Overall Study||14
6503419|NCT01440946|7422236|FG000|NOT COMPLETED|Overall Study||2
6503420|NCT01440946|7422237|FG001|NOT COMPLETED|Overall Study||1
6503421|NCT01440959|7422244|FG000|STARTED|Overall Study||30
6503422|NCT01440959|7422244|FG000|COMPLETED|Overall Study||30
6503423|NCT01440959|7422244|FG000|NOT COMPLETED|Overall Study||0
6503424|NCT01440972|7422250|FG000|STARTED|Overall Study||24
6503425|NCT01440972|7422251|FG001|STARTED|Overall Study||21
6503426|NCT01440972|7422250|FG000|COMPLETED|Overall Study||21
6565019|NCT01814878|7487782|FG001|STARTED|Overall Study||158
6565020|NCT01814878|7487781|FG000|COMPLETED|Overall Study||116
6565021|NCT01814878|7487782|FG001|COMPLETED|Overall Study||128
6565022|NCT01814878|7487781|FG000|NOT COMPLETED|Overall Study||46
6565023|NCT01814878|7487782|FG001|NOT COMPLETED|Overall Study||30
6565024|NCT01815008|7487788|FG000|STARTED|Overall Study|Had difficulty in completing enrollment|19
6565025|NCT01815008|7487788|FG000|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
6565026|NCT01815008|7487788|FG000|NOT COMPLETED|Overall Study||4
6503427|NCT01440972|7422251|FG001|COMPLETED|Overall Study||19
6503428|NCT01440972|7422250|FG000|NOT COMPLETED|Overall Study||3
6503429|NCT01440972|7422251|FG001|NOT COMPLETED|Overall Study||2
6503430|NCT01441037|7422257|FG000|STARTED|Overall Study||27
6503431|NCT01441037|7422257|FG000|COMPLETED|Overall Study||27
6503432|NCT01441037|7422257|FG000|NOT COMPLETED|Overall Study||0
6503433|NCT01441063|7422261|FG000|STARTED|Tocilizumab Alone||8
6503434|NCT01441063|7422261|FG000|COMPLETED|Tocilizumab Alone||5
6503435|NCT01441063|7422261|FG000|NOT COMPLETED|Tocilizumab Alone||3
6503436|NCT01441063|7422261|FG000|STARTED|Tocilizumab + Zidovudine /Valganciclovir||3
6503437|NCT01441063|7422261|FG000|COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||2
6503438|NCT01441063|7422261|FG000|NOT COMPLETED|Tocilizumab + Zidovudine /Valganciclovir||1
6503439|NCT01441076|7422268|FG000|STARTED|Overall Study||6
6565027|NCT01815099|7487794|FG000|STARTED|Overall Study||4
6565028|NCT01815099|7487794|FG000|Began rTMS Treatment|Overall Study||3
6565029|NCT01815099|7487794|FG000|COMPLETED|Overall Study||2
6384422|NCT00799981|7295555|FG000|COMPLETED|Overall Study||10
6384423|NCT00799981|7295556|FG001|COMPLETED|Overall Study||9
6384424|NCT00799981|7295557|FG002|COMPLETED|Overall Study||10
6384425|NCT00799981|7295558|FG003|COMPLETED|Overall Study||10
6384426|NCT00799981|7295559|FG004|COMPLETED|Overall Study||11
6384427|NCT00799981|7295560|FG005|COMPLETED|Overall Study||10
6384428|NCT00799981|7295555|FG000|NOT COMPLETED|Overall Study||0
6384429|NCT00799981|7295556|FG001|NOT COMPLETED|Overall Study||0
6384430|NCT00799981|7295557|FG002|NOT COMPLETED|Overall Study||0
6384431|NCT00799981|7295558|FG003|NOT COMPLETED|Overall Study||0
6384432|NCT00799981|7295559|FG004|NOT COMPLETED|Overall Study||0
6384433|NCT00799981|7295560|FG005|NOT COMPLETED|Overall Study||0
6384434|NCT00800176|7295575|FG000|STARTED|Overall Study||66
6384435|NCT00800176|7295576|FG001|STARTED|Overall Study||66
6384436|NCT00800176|7295577|FG002|STARTED|Overall Study||65
6384437|NCT00800176|7295578|FG003|STARTED|Overall Study||66
6384438|NCT00800176|7295579|FG004|STARTED|Overall Study||64
6384439|NCT00800176|7295580|FG005|STARTED|Overall Study||67
6384440|NCT00800176|7295575|FG000|COMPLETED|Overall Study||57
6384441|NCT00800176|7295576|FG001|COMPLETED|Overall Study||60
6384442|NCT00800176|7295577|FG002|COMPLETED|Overall Study||65
6384443|NCT00800176|7295578|FG003|COMPLETED|Overall Study||62
6384444|NCT00800176|7295579|FG004|COMPLETED|Overall Study||60
6384445|NCT00800176|7295580|FG005|COMPLETED|Overall Study||62
6384446|NCT00800176|7295575|FG000|NOT COMPLETED|Overall Study||9
6384447|NCT00800176|7295576|FG001|NOT COMPLETED|Overall Study||6
6384448|NCT00800176|7295577|FG002|NOT COMPLETED|Overall Study||0
6384449|NCT00800176|7295578|FG003|NOT COMPLETED|Overall Study||4
6384450|NCT00800176|7295579|FG004|NOT COMPLETED|Overall Study||4
6384451|NCT00800176|7295580|FG005|NOT COMPLETED|Overall Study||5
6384452|NCT00800202|7295596|FG000|STARTED|Overall Study||67
6384453|NCT00800202|7295597|FG001|STARTED|Overall Study||24
6384454|NCT00800202|7295596|FG000|COMPLETED|Overall Study||0
6384455|NCT00800202|7295597|FG001|COMPLETED|Overall Study||0
6384456|NCT00800202|7295596|FG000|NOT COMPLETED|Overall Study||67
6384457|NCT00800202|7295597|FG001|NOT COMPLETED|Overall Study||24
6384458|NCT00800254|7295605|FG000|STARTED|Overall Study||35
6384459|NCT00800254|7295606|FG001|STARTED|Overall Study||31
6384460|NCT00800254|7295605|FG000|3.5 Weeks Post-operatively|Overall Study||31
6384461|NCT00800254|7295606|FG001|3.5 Weeks Post-operatively|Overall Study||31
6384462|NCT00800254|7295605|FG000|COMPLETED|Overall Study||30
6384463|NCT00800254|7295606|FG001|COMPLETED|Overall Study||25
6384464|NCT00800254|7295605|FG000|NOT COMPLETED|Overall Study||5
6384465|NCT00800254|7295606|FG001|NOT COMPLETED|Overall Study||6
6384466|NCT00800345|7295612|FG000|STARTED|Overall Study||33
6384467|NCT00800345|7295612|FG000|COMPLETED|Overall Study||33
6384468|NCT00800345|7295612|FG000|NOT COMPLETED|Overall Study||0
6384469|NCT00800384|7295618|FG000|STARTED|Overall Study||1247
6384470|NCT00800384|7295619|FG001|STARTED|Overall Study||1253
6384471|NCT00800384|7295618|FG000|COMPLETED|Overall Study||1206
6384472|NCT00800384|7295619|FG001|COMPLETED|Overall Study||1210
6384473|NCT00800384|7295618|FG000|NOT COMPLETED|Overall Study||41
6384474|NCT00800384|7295619|FG001|NOT COMPLETED|Overall Study||43
6384475|NCT00800436|7295633|FG000|STARTED|Overall Study||6
6384476|NCT00800436|7295634|FG001|STARTED|Overall Study||6
6384477|NCT00800436|7295635|FG002|STARTED|Overall Study||6
6384478|NCT00800436|7295636|FG003|STARTED|Overall Study||6
6384479|NCT00800436|7295637|FG004|STARTED|Overall Study||6
6384480|NCT00800436|7295638|FG005|STARTED|Overall Study||20
6384481|NCT00800436|7295639|FG006|STARTED|Overall Study||20
6384482|NCT00800436|7295633|FG000|COMPLETED|Overall Study||6
6384483|NCT00800436|7295634|FG001|COMPLETED|Overall Study||6
6384484|NCT00800436|7295635|FG002|COMPLETED|Overall Study||5
6384485|NCT00800436|7295636|FG003|COMPLETED|Overall Study||5
6384486|NCT00800436|7295637|FG004|COMPLETED|Overall Study||6
6269736|NCT00076570|7168935|FG000|STARTED|Overall Study||15
6269737|NCT00076570|7168936|FG001|STARTED|Overall Study||16
6269738|NCT00076570|7168935|FG000|COMPLETED|Overall Study||7
6269739|NCT00076570|7168936|FG001|COMPLETED|Overall Study||8
6269740|NCT00076570|7168935|FG000|NOT COMPLETED|Overall Study||8
6269741|NCT00076570|7168936|FG001|NOT COMPLETED|Overall Study||8
6269742|NCT00076622|7168946|FG000|STARTED|Overall Study||23
6269743|NCT00076622|7168947|FG001|STARTED|Overall Study||13
6269744|NCT00076622|7168948|FG002|STARTED|Overall Study||40
6269745|NCT00076622|7168949|FG003|STARTED|Overall Study||18
6269746|NCT00076622|7168946|FG000|COMPLETED|Overall Study||23
6269747|NCT00076622|7168947|FG001|COMPLETED|Overall Study||13
6269748|NCT00076622|7168948|FG002|COMPLETED|Overall Study||40
6269749|NCT00076622|7168949|FG003|COMPLETED|Overall Study||18
6269750|NCT00076622|7168946|FG000|NOT COMPLETED|Overall Study||0
6269751|NCT00076622|7168947|FG001|NOT COMPLETED|Overall Study||0
6269752|NCT00076622|7168948|FG002|NOT COMPLETED|Overall Study||0
6269753|NCT00076622|7168949|FG003|NOT COMPLETED|Overall Study||0
6269754|NCT00076687|7168966|FG000|STARTED|Overall Study||48
6269755|NCT00076687|7168967|FG001|STARTED|Overall Study||52
6269756|NCT00076687|7168968|FG002|STARTED|Overall Study||55
6269757|NCT00076687|7168966|FG000|COMPLETED|Overall Study||42
6269758|NCT00076687|7168967|FG001|COMPLETED|Overall Study||47
6269759|NCT00076687|7168968|FG002|COMPLETED|Overall Study||51
6269760|NCT00076687|7168966|FG000|NOT COMPLETED|Overall Study||6
6269761|NCT00076687|7168967|FG001|NOT COMPLETED|Overall Study||5
6269762|NCT00076687|7168968|FG002|NOT COMPLETED|Overall Study||4
6269763|NCT00076752|7168976|FG000|STARTED|Overall Study||9
6269764|NCT00076752|7168976|FG000|COMPLETED|Overall Study||6
6269765|NCT00076752|7168976|FG000|NOT COMPLETED|Overall Study||3
6269766|NCT00076804|7168983|FG000|STARTED|Overall Study||137
6269767|NCT00076804|7168984|FG001|STARTED|Overall Study||137
6269768|NCT00076804|7168983|FG000|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
6269769|NCT00076804|7168984|FG001|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
6269770|NCT00076804|7168983|FG000|NOT COMPLETED|Overall Study||60
6269771|NCT00076804|7168984|FG001|NOT COMPLETED|Overall Study||69
6804662|NCT04476251|7736672|FG000|STARTED|Overall Study||1
6804663|NCT04476251|7736672|FG000|COMPLETED|Overall Study||0
6804664|NCT04476251|7736672|FG000|NOT COMPLETED|Overall Study||1
6384487|NCT00800436|7295638|FG005|COMPLETED|Overall Study||20
6384488|NCT00800436|7295639|FG006|COMPLETED|Overall Study||20
6384489|NCT00800436|7295633|FG000|NOT COMPLETED|Overall Study||0
6384490|NCT00800436|7295634|FG001|NOT COMPLETED|Overall Study||0
6384491|NCT00800436|7295635|FG002|NOT COMPLETED|Overall Study||1
6384492|NCT00800436|7295636|FG003|NOT COMPLETED|Overall Study||1
6384493|NCT00800436|7295637|FG004|NOT COMPLETED|Overall Study||0
6384494|NCT00800436|7295638|FG005|NOT COMPLETED|Overall Study||0
6384495|NCT00800436|7295639|FG006|NOT COMPLETED|Overall Study||0
6384496|NCT00800540|7295655|FG000|STARTED|Period One: 6 Weeks||17
6384497|NCT00800540|7295656|FG001|STARTED|Period One: 6 Weeks||18
6384498|NCT00800540|7295655|FG000|COMPLETED|Period One: 6 Weeks||16
6384499|NCT00800540|7295656|FG001|COMPLETED|Period One: 6 Weeks||17
6565030|NCT01815099|7487794|FG000|NOT COMPLETED|Overall Study||2
6565031|NCT01815138|7487801|FG000|STARTED|Overall Study||34
6565032|NCT01815138|7487802|FG001|STARTED|Overall Study||37
6565033|NCT01815138|7487801|FG000|COMPLETED|Overall Study||26
6565034|NCT01815138|7487802|FG001|COMPLETED|Overall Study||31
6565035|NCT01815138|7487801|FG000|NOT COMPLETED|Overall Study||8
6565036|NCT01815138|7487802|FG001|NOT COMPLETED|Overall Study||6
6565037|NCT01815229|7487811|FG000|STARTED|Overall Study||13
6384500|NCT00800540|7295655|FG000|NOT COMPLETED|Period One: 6 Weeks||1
6384501|NCT00800540|7295656|FG001|NOT COMPLETED|Period One: 6 Weeks||1
6384502|NCT00800540|7295655|FG000|STARTED|Washout: 4 Weeks||16
6503440|NCT01441076|7422268|FG000|COMPLETED|Overall Study||4
6503441|NCT01441076|7422268|FG000|NOT COMPLETED|Overall Study||2
6503442|NCT01441102|7422272|FG000|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
6503443|NCT01441102|7422272|FG000|COMPLETED|Overall Study||4
6503444|NCT01441102|7422272|FG000|NOT COMPLETED|Overall Study||3
6503445|NCT01441180|7422279|FG000|STARTED|Overall Study||10
6503446|NCT01441180|7422280|FG001|STARTED|Overall Study||25
6503447|NCT01441180|7422281|FG002|STARTED|Overall Study||25
6503448|NCT01441180|7422279|FG000|COMPLETED|Overall Study||9
6503449|NCT01441180|7422280|FG001|COMPLETED|Overall Study||24
6503450|NCT01441180|7422281|FG002|COMPLETED|Overall Study||22
6503451|NCT01441180|7422279|FG000|NOT COMPLETED|Overall Study||1
6503452|NCT01441180|7422280|FG001|NOT COMPLETED|Overall Study||1
6503453|NCT01441180|7422281|FG002|NOT COMPLETED|Overall Study||3
6503454|NCT01441245|7422294|FG000|STARTED|Overall Study||30
6503455|NCT01441245|7422295|FG001|STARTED|Overall Study||27
6503456|NCT01441245|7422294|FG000|COMPLETED|Overall Study||30
6565038|NCT01815229|7487812|FG001|STARTED|Overall Study||18
6565039|NCT01815229|7487813|FG002|STARTED|Overall Study||51
6565040|NCT01815229|7487811|FG000|COMPLETED|Overall Study||13
6384503|NCT00800540|7295656|FG001|STARTED|Washout: 4 Weeks||17
6384504|NCT00800540|7295655|FG000|COMPLETED|Washout: 4 Weeks||16
6384505|NCT00800540|7295656|FG001|COMPLETED|Washout: 4 Weeks||17
6384506|NCT00800540|7295655|FG000|NOT COMPLETED|Washout: 4 Weeks||0
6384507|NCT00800540|7295656|FG001|NOT COMPLETED|Washout: 4 Weeks||0
6384508|NCT00800540|7295655|FG000|STARTED|Period 2: 6 Weeks||16
6384509|NCT00800540|7295656|FG001|STARTED|Period 2: 6 Weeks||17
6384510|NCT00800540|7295655|FG000|COMPLETED|Period 2: 6 Weeks||16
6384511|NCT00800540|7295656|FG001|COMPLETED|Period 2: 6 Weeks||16
6384512|NCT00800540|7295655|FG000|NOT COMPLETED|Period 2: 6 Weeks||0
6384513|NCT00800540|7295656|FG001|NOT COMPLETED|Period 2: 6 Weeks||1
6384514|NCT00800683|7295664|FG000|STARTED|Overall Study|Number who started treatment|65
6384515|NCT00800683|7295665|FG001|STARTED|Overall Study|Number who started treatment|68
6384516|NCT00800683|7295664|FG000|COMPLETED|Overall Study|Number who completed treatment|48
6384517|NCT00800683|7295665|FG001|COMPLETED|Overall Study|Number who completed treatment|49
6565041|NCT01815229|7487812|FG001|COMPLETED|Overall Study||18
6565042|NCT01815229|7487813|FG002|COMPLETED|Overall Study||0
6565043|NCT01815229|7487811|FG000|NOT COMPLETED|Overall Study||0
6565044|NCT01815229|7487812|FG001|NOT COMPLETED|Overall Study||0
6565045|NCT01815229|7487813|FG002|NOT COMPLETED|Overall Study||51
6804665|NCT03924765|7736676|FG000|STARTED|Overall Study||5
6804666|NCT03924765|7736676|FG000|COMPLETED|Overall Study||5
6804667|NCT03924765|7736676|FG000|NOT COMPLETED|Overall Study||0
6804668|NCT03915860|7736680|FG000|STARTED|Overall Study||47
6804669|NCT03915860|7736680|FG000|Treated|Overall Study||46
6804670|NCT03915860|7736680|FG000|COMPLETED|Overall Study||33
6804671|NCT03915860|7736680|FG000|NOT COMPLETED|Overall Study||14
6804672|NCT03817606|7736686|FG000|STARTED|Overall Study||2
6804673|NCT03817606|7736687|FG001|STARTED|Overall Study||2
6804674|NCT03817606|7736686|FG000|COMPLETED|Overall Study||0
6804675|NCT03817606|7736687|FG001|COMPLETED|Overall Study||0
6804676|NCT03817606|7736686|FG000|NOT COMPLETED|Overall Study||2
6804677|NCT03817606|7736687|FG001|NOT COMPLETED|Overall Study||2
6804678|NCT03795233|7736699|FG000|STARTED|Overall Study||4
6804679|NCT03795233|7736700|FG001|STARTED|Overall Study||1
6804680|NCT03795233|7736699|FG000|COMPLETED|Overall Study||0
6384518|NCT00800683|7295664|FG000|NOT COMPLETED|Overall Study||17
6384519|NCT00800683|7295665|FG001|NOT COMPLETED|Overall Study||19
6384520|NCT00800735|7295671|FG000|STARTED|Overall Study||30
6384521|NCT00800735|7295671|FG000|COMPLETED|Overall Study||16
6384522|NCT00800735|7295671|FG000|NOT COMPLETED|Overall Study||14
6384523|NCT00800839|7295675|FG000|STARTED|Overall Study||56
6384524|NCT00800839|7295675|FG000|COMPLETED|Overall Study||49
6384525|NCT00800839|7295675|FG000|NOT COMPLETED|Overall Study||7
6384526|NCT00800865|7295681|FG000|STARTED|Overall Study||15
6384527|NCT00800865|7295682|FG001|STARTED|Overall Study||16
6804681|NCT03795233|7736700|FG001|COMPLETED|Overall Study||0
6384528|NCT00800865|7295681|FG000|COMPLETED|Overall Study||15
6384529|NCT00800865|7295682|FG001|COMPLETED|Overall Study||16
6384530|NCT00800865|7295681|FG000|NOT COMPLETED|Overall Study||0
6384531|NCT00800865|7295682|FG001|NOT COMPLETED|Overall Study||0
6384532|NCT00800982|7295690|FG000|STARTED|Overall Study||15
6384533|NCT00800982|7295691|FG001|STARTED|Overall Study||15
6384534|NCT00800982|7295690|FG000|COMPLETED|Overall Study||13
6384535|NCT00800982|7295691|FG001|COMPLETED|Overall Study||12
6565046|NCT01815333|7487820|FG000|STARTED|Overall Study||10
6565047|NCT01815333|7487820|FG000|COMPLETED|Overall Study||10
6565048|NCT01815333|7487820|FG000|NOT COMPLETED|Overall Study||0
6565049|NCT01815424|7487827|FG000|STARTED|Week 0 to 16||90
6565050|NCT01815424|7487828|FG001|STARTED|Week 0 to 16||88
6384536|NCT00800982|7295690|FG000|NOT COMPLETED|Overall Study||2
6384537|NCT00800982|7295691|FG001|NOT COMPLETED|Overall Study||3
6384538|NCT00801099|7295697|FG000|STARTED|Overall Study||276
6384539|NCT00801099|7295697|FG000|COMPLETED|Overall Study||175
6384540|NCT00801099|7295697|FG000|NOT COMPLETED|Overall Study||101
6384541|NCT00801138|7295705|FG000|STARTED|Overall Study||54
6384542|NCT00801138|7295706|FG001|STARTED|Overall Study||56
6384543|NCT00801138|7295707|FG002|STARTED|Overall Study||54
6384544|NCT00801138|7295708|FG003|STARTED|Overall Study||54
6384545|NCT00801138|7295705|FG000|COMPLETED|Overall Study||54
6384546|NCT00801138|7295706|FG001|COMPLETED|Overall Study||56
6384547|NCT00801138|7295707|FG002|COMPLETED|Overall Study||54
6384548|NCT00801138|7295708|FG003|COMPLETED|Overall Study||54
6384549|NCT00801138|7295705|FG000|NOT COMPLETED|Overall Study||0
6384550|NCT00801138|7295706|FG001|NOT COMPLETED|Overall Study||0
6384551|NCT00801138|7295707|FG002|NOT COMPLETED|Overall Study||0
6384552|NCT00801138|7295708|FG003|NOT COMPLETED|Overall Study||0
6384553|NCT00801229|7295720|FG000|STARTED|Signed Consent||38
6565051|NCT01815424|7487829|FG002|STARTED|Week 0 to 16||88
6565052|NCT01815424|7487830|FG003|STARTED|Week 0 to 16||0
6565053|NCT01815424|7487831|FG004|STARTED|Week 0 to 16||0
6384554|NCT00801229|7295721|FG001|STARTED|Signed Consent||37
6384555|NCT00801229|7295720|FG000|COMPLETED|Signed Consent||35
6384556|NCT00801229|7295721|FG001|COMPLETED|Signed Consent||34
6384557|NCT00801229|7295720|FG000|NOT COMPLETED|Signed Consent||3
6384558|NCT00801229|7295721|FG001|NOT COMPLETED|Signed Consent||3
6384559|NCT00801229|7295720|FG000|STARTED|Received Study Drug/Placebo||35
6384560|NCT00801229|7295721|FG001|STARTED|Received Study Drug/Placebo||34
6384561|NCT00801229|7295720|FG000|COMPLETED|Received Study Drug/Placebo||31
6384562|NCT00801229|7295721|FG001|COMPLETED|Received Study Drug/Placebo||30
6384563|NCT00801229|7295720|FG000|NOT COMPLETED|Received Study Drug/Placebo||4
6384564|NCT00801229|7295721|FG001|NOT COMPLETED|Received Study Drug/Placebo||4
6384565|NCT00801242|7295727|FG000|STARTED|Overall Study|Randomized participants.|220
6384566|NCT00801242|7295727|FG000|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
6384567|NCT00801242|7295727|FG000|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
6565054|NCT01815424|7487827|FG000|COMPLETED|Week 0 to 16||83
6503457|NCT01441245|7422295|FG001|COMPLETED|Overall Study||27
6384568|NCT00801242|7295727|FG000|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
6384569|NCT00801242|7295727|FG000|Started Cycle 2|Overall Study||35
6384570|NCT00801242|7295727|FG000|Started Cycle 3|Overall Study||2
6384571|NCT00801242|7295727|FG000|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
6384572|NCT00801242|7295727|FG000|NOT COMPLETED|Overall Study||52
6384573|NCT00801398|7295737|FG000|STARTED|Overall Study||13
6384574|NCT00801398|7295738|FG001|STARTED|Overall Study||9
6384575|NCT00801398|7295739|FG002|STARTED|Overall Study||11
6384576|NCT00801398|7295740|FG003|STARTED|Overall Study||9
6384577|NCT00801398|7295741|FG004|STARTED|Overall Study||8
6384578|NCT00801398|7295742|FG005|STARTED|Overall Study||8
6384579|NCT00801398|7295737|FG000|COMPLETED|Overall Study||7
6384580|NCT00801398|7295738|FG001|COMPLETED|Overall Study||0
6384581|NCT00801398|7295739|FG002|COMPLETED|Overall Study||4
6384582|NCT00801398|7295740|FG003|COMPLETED|Overall Study||3
6384583|NCT00801398|7295741|FG004|COMPLETED|Overall Study||1
6384584|NCT00801398|7295742|FG005|COMPLETED|Overall Study||5
6384585|NCT00801398|7295737|FG000|NOT COMPLETED|Overall Study||6
6384586|NCT00801398|7295738|FG001|NOT COMPLETED|Overall Study||9
6384587|NCT00801398|7295739|FG002|NOT COMPLETED|Overall Study||7
6384588|NCT00801398|7295740|FG003|NOT COMPLETED|Overall Study||6
6384589|NCT00801398|7295741|FG004|NOT COMPLETED|Overall Study||7
6384590|NCT00801398|7295742|FG005|NOT COMPLETED|Overall Study||3
6384591|NCT00801632|7295770|FG000|STARTED|Overall Study||5
6384592|NCT00801632|7295770|FG000|COMPLETED|Overall Study||4
6384593|NCT00801632|7295770|FG000|NOT COMPLETED|Overall Study||1
6384594|NCT00801684|7295774|FG000|STARTED|Overall Study||24
6384595|NCT00801684|7295774|FG000|COMPLETED|Overall Study||24
6384596|NCT00801684|7295774|FG000|NOT COMPLETED|Overall Study||0
6384597|NCT00801723|7295793|FG000|STARTED|Overall Study||61
6384598|NCT00801723|7295794|FG001|STARTED|Overall Study||62
6384599|NCT00801723|7295793|FG000|COMPLETED|Overall Study||25
6384600|NCT00801723|7295794|FG001|COMPLETED|Overall Study||27
6384601|NCT00801723|7295793|FG000|NOT COMPLETED|Overall Study||36
6384602|NCT00801723|7295794|FG001|NOT COMPLETED|Overall Study||35
6384603|NCT00801801|7295800|FG000|STARTED|Overall Study||5
6384604|NCT00801801|7295800|FG000|COMPLETED|Overall Study||5
6384605|NCT00801801|7295800|FG000|NOT COMPLETED|Overall Study||0
6384606|NCT00801827|7295805|FG000|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
6384607|NCT00801827|7295805|FG000|COMPLETED|Overall Study||5
6384608|NCT00801827|7295805|FG000|NOT COMPLETED|Overall Study||0
6384609|NCT00801892|7295811|FG000|STARTED|Main Study Period||12
6384610|NCT00801892|7295812|FG001|STARTED|Main Study Period||11
6384611|NCT00801892|7295811|FG000|COMPLETED|Main Study Period||12
6384612|NCT00801892|7295812|FG001|COMPLETED|Main Study Period||10
6384613|NCT00801892|7295811|FG000|NOT COMPLETED|Main Study Period||0
6384614|NCT00801892|7295812|FG001|NOT COMPLETED|Main Study Period||1
6384615|NCT00801892|7295811|FG000|STARTED|Sham Crossover Period||0
6384616|NCT00801892|7295812|FG001|STARTED|Sham Crossover Period||7
6384617|NCT00801892|7295811|FG000|COMPLETED|Sham Crossover Period||0
6384618|NCT00801892|7295812|FG001|COMPLETED|Sham Crossover Period||5
6384619|NCT00801892|7295811|FG000|NOT COMPLETED|Sham Crossover Period||0
6384620|NCT00801892|7295812|FG001|NOT COMPLETED|Sham Crossover Period||2
6384621|NCT00801983|7295822|FG000|STARTED|Period 1||44
6384622|NCT00801983|7295823|FG001|STARTED|Period 1||41
6384623|NCT00801983|7295822|FG000|COMPLETED|Period 1||40
6384624|NCT00801983|7295823|FG001|COMPLETED|Period 1||33
6565055|NCT01815424|7487828|FG001|COMPLETED|Week 0 to 16||84
6565056|NCT01815424|7487829|FG002|COMPLETED|Week 0 to 16||77
6565057|NCT01815424|7487830|FG003|COMPLETED|Week 0 to 16||0
6565058|NCT01815424|7487831|FG004|COMPLETED|Week 0 to 16||0
6804682|NCT03795233|7736699|FG000|NOT COMPLETED|Overall Study||4
6804683|NCT03795233|7736700|FG001|NOT COMPLETED|Overall Study||1
6804684|NCT03786380|7736711|FG000|STARTED|Overall Study||35
6804685|NCT03786380|7736712|FG001|STARTED|Overall Study||22
6804686|NCT03786380|7736713|FG002|STARTED|Overall Study||54
6804687|NCT03786380|7736714|FG003|STARTED|Overall Study||63
6804688|NCT03786380|7736715|FG004|STARTED|Overall Study||28
6804689|NCT03786380|7736711|FG000|Safety Population|Overall Study||35
6804690|NCT03786380|7736712|FG001|Safety Population|Overall Study||22
6804691|NCT03786380|7736713|FG002|Safety Population|Overall Study||54
6804692|NCT03786380|7736714|FG003|Safety Population|Overall Study||62
6804693|NCT03786380|7736715|FG004|Safety Population|Overall Study||28
6804694|NCT03786380|7736711|FG000|COMPLETED|Overall Study||0
6804695|NCT03786380|7736712|FG001|COMPLETED|Overall Study||0
6565059|NCT01815424|7487827|FG000|NOT COMPLETED|Week 0 to 16||7
6804696|NCT03786380|7736713|FG002|COMPLETED|Overall Study||0
6804697|NCT03786380|7736714|FG003|COMPLETED|Overall Study||0
6804698|NCT03786380|7736715|FG004|COMPLETED|Overall Study||0
6269772|NCT00076999|7168994|FG000|STARTED|Overall Study||25
6269773|NCT00076999|7168995|FG001|STARTED|Overall Study||31
6269774|NCT00076999|7168996|FG002|STARTED|Overall Study||19
6269775|NCT00076999|7168997|FG003|STARTED|Overall Study||6
6269776|NCT00076999|7168998|FG004|STARTED|Overall Study||34
6269777|NCT00076999|7168994|FG000|COMPLETED|Overall Study||13
6269778|NCT00076999|7168995|FG001|COMPLETED|Overall Study||7
6269779|NCT00076999|7168996|FG002|COMPLETED|Overall Study||2
6269780|NCT00076999|7168997|FG003|COMPLETED|Overall Study||5
6269781|NCT00076999|7168998|FG004|COMPLETED|Overall Study||9
6269782|NCT00076999|7168994|FG000|NOT COMPLETED|Overall Study||12
6269783|NCT00076999|7168995|FG001|NOT COMPLETED|Overall Study||24
6269784|NCT00076999|7168996|FG002|NOT COMPLETED|Overall Study||17
6269785|NCT00076999|7168997|FG003|NOT COMPLETED|Overall Study||1
6269786|NCT00076999|7168998|FG004|NOT COMPLETED|Overall Study||25
6269787|NCT00077064|7169013|FG000|STARTED|Overall Study||17
6269788|NCT00077064|7169014|FG001|STARTED|Overall Study||16
6269789|NCT00077064|7169013|FG000|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|17
6269790|NCT00077064|7169014|FG001|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|10
6269791|NCT00077064|7169013|FG000|NOT COMPLETED|Overall Study||0
6269792|NCT00077064|7169014|FG001|NOT COMPLETED|Overall Study||6
6269793|NCT00077207|7169021|FG000|STARTED|Overall Study||66
6269794|NCT00077207|7169021|FG000|COMPLETED|Overall Study||36
6269795|NCT00077207|7169021|FG000|NOT COMPLETED|Overall Study||30
6269796|NCT00077376|7169026|FG000|STARTED|Overall Study||61
6269797|NCT00077376|7169026|FG000|Treated|Overall Study||59
6269798|NCT00077376|7169026|FG000|HER2+ in Central Testing|Overall Study||39
6269799|NCT00077376|7169026|FG000|COMPLETED|Overall Study||39
6269800|NCT00077376|7169026|FG000|NOT COMPLETED|Overall Study||22
6269801|NCT00077610|7169033|FG000|STARTED|Overall Study||223
6269802|NCT00077610|7169034|FG001|STARTED|Overall Study||224
6269803|NCT00077610|7169035|FG002|STARTED|Overall Study||226
6269804|NCT00077610|7169033|FG000|Started Treatment|Overall Study||221
6269805|NCT00077610|7169034|FG001|Started Treatment|Overall Study||220
6269806|NCT00077610|7169035|FG002|Started Treatment|Overall Study||225
6269807|NCT00077610|7169033|FG000|COMPLETED|Overall Study||169
6269808|NCT00077610|7169034|FG001|COMPLETED|Overall Study||168
6269809|NCT00077610|7169035|FG002|COMPLETED|Overall Study||180
6269810|NCT00077610|7169033|FG000|NOT COMPLETED|Overall Study||54
6269811|NCT00077610|7169034|FG001|NOT COMPLETED|Overall Study||56
6269812|NCT00077610|7169035|FG002|NOT COMPLETED|Overall Study||46
6269813|NCT00077623|7169051|FG000|STARTED|Overall Study||190
6269814|NCT00077623|7169052|FG001|STARTED|Overall Study||191
6269815|NCT00077623|7169053|FG002|STARTED|Overall Study||191
6269816|NCT00077623|7169051|FG000|COMPLETED|Overall Study||154
6269817|NCT00077623|7169052|FG001|COMPLETED|Overall Study||148
6269818|NCT00077623|7169053|FG002|COMPLETED|Overall Study||159
6269819|NCT00077623|7169051|FG000|NOT COMPLETED|Overall Study||36
6269820|NCT00077623|7169052|FG001|NOT COMPLETED|Overall Study||43
6269821|NCT00077623|7169053|FG002|NOT COMPLETED|Overall Study||32
6269822|NCT00077636|7169063|FG000|STARTED|Overall Study||736
6269823|NCT00077636|7169064|FG001|STARTED|Overall Study||733
6269824|NCT00077636|7169063|FG000|COMPLETED|Overall Study||692
6269825|NCT00077636|7169064|FG001|COMPLETED|Overall Study||641
6269826|NCT00077636|7169063|FG000|NOT COMPLETED|Overall Study||44
6269827|NCT00077636|7169064|FG001|NOT COMPLETED|Overall Study||92
6269828|NCT00077649|7169075|FG000|STARTED|Overall Study||47
6269829|NCT00077649|7169076|FG001|STARTED|Overall Study||47
6269830|NCT00077649|7169077|FG002|STARTED|Overall Study||47
6269831|NCT00077649|7169078|FG003|STARTED|Overall Study||47
6269832|NCT00077649|7169075|FG000|Completed 24 Weeks of Follow-up|Overall Study||36
6269833|NCT00077649|7169076|FG001|Completed 24 Weeks of Follow-up|Overall Study||40
6269834|NCT00077649|7169077|FG002|Completed 24 Weeks of Follow-up|Overall Study||36
6269835|NCT00077649|7169078|FG003|Completed 24 Weeks of Follow-up|Overall Study||31
6269836|NCT00077649|7169075|FG000|COMPLETED|Overall Study||33
6269837|NCT00077649|7169076|FG001|COMPLETED|Overall Study||38
6269838|NCT00077649|7169077|FG002|COMPLETED|Overall Study||32
6269839|NCT00077649|7169078|FG003|COMPLETED|Overall Study||30
6269840|NCT00077649|7169075|FG000|NOT COMPLETED|Overall Study||14
6269841|NCT00077649|7169076|FG001|NOT COMPLETED|Overall Study||9
6269842|NCT00077649|7169077|FG002|NOT COMPLETED|Overall Study||15
6269843|NCT00077649|7169078|FG003|NOT COMPLETED|Overall Study||17
6269844|NCT00077675|7169094|FG000|STARTED|Overall Study||103
6269845|NCT00077675|7169095|FG001|STARTED|Overall Study||98
6269846|NCT00077675|7169094|FG000|COMPLETED|Overall Study||92
6269847|NCT00077675|7169095|FG001|COMPLETED|Overall Study||89
6269848|NCT00077675|7169094|FG000|NOT COMPLETED|Overall Study||11
6269849|NCT00077675|7169095|FG001|NOT COMPLETED|Overall Study||9
6565060|NCT01815424|7487828|FG001|NOT COMPLETED|Week 0 to 16||4
6565061|NCT01815424|7487829|FG002|NOT COMPLETED|Week 0 to 16||11
6565062|NCT01815424|7487830|FG003|NOT COMPLETED|Week 0 to 16||0
6565063|NCT01815424|7487831|FG004|NOT COMPLETED|Week 0 to 16||0
6565064|NCT01815424|7487827|FG000|STARTED|Week 16 to 52||83
6565065|NCT01815424|7487828|FG001|STARTED|Week 16 to 52||84
6565066|NCT01815424|7487829|FG002|STARTED|Week 16 to 52||0
6565067|NCT01815424|7487830|FG003|STARTED|Week 16 to 52||38
6565068|NCT01815424|7487831|FG004|STARTED|Week 16 to 52||39
6565069|NCT01815424|7487827|FG000|COMPLETED|Week 16 to 52||81
6565070|NCT01815424|7487828|FG001|COMPLETED|Week 16 to 52||79
6565071|NCT01815424|7487829|FG002|COMPLETED|Week 16 to 52||0
6384625|NCT00801983|7295822|FG000|NOT COMPLETED|Period 1||4
6384626|NCT00801983|7295823|FG001|NOT COMPLETED|Period 1||8
6384627|NCT00801983|7295822|FG000|STARTED|Period 2||40
6384628|NCT00801983|7295823|FG001|STARTED|Period 2||33
6565072|NCT01815424|7487830|FG003|COMPLETED|Week 16 to 52||35
6565073|NCT01815424|7487831|FG004|COMPLETED|Week 16 to 52||36
6565074|NCT01815424|7487827|FG000|NOT COMPLETED|Week 16 to 52||2
6565075|NCT01815424|7487828|FG001|NOT COMPLETED|Week 16 to 52||5
6565076|NCT01815424|7487829|FG002|NOT COMPLETED|Week 16 to 52||0
6565077|NCT01815424|7487830|FG003|NOT COMPLETED|Week 16 to 52||3
6565078|NCT01815424|7487831|FG004|NOT COMPLETED|Week 16 to 52||3
6656803|NCT02465073|7587140|FG000|COMPLETED|Overall Study||15
6656804|NCT02465073|7587141|FG001|COMPLETED|Overall Study||15
6384629|NCT00801983|7295822|FG000|COMPLETED|Period 2||38
6384630|NCT00801983|7295823|FG001|COMPLETED|Period 2||32
6384631|NCT00801983|7295822|FG000|NOT COMPLETED|Period 2||2
6656805|NCT02465073|7587142|FG002|COMPLETED|Overall Study||15
6565079|NCT01815502|7487846|FG000|STARTED|Overall Study||10
6804699|NCT03786380|7736711|FG000|NOT COMPLETED|Overall Study||35
6804700|NCT03786380|7736712|FG001|NOT COMPLETED|Overall Study||22
6384632|NCT00801983|7295823|FG001|NOT COMPLETED|Period 2||1
6565080|NCT01815502|7487847|FG001|STARTED|Overall Study||10
6565081|NCT01815502|7487846|FG000|COMPLETED|Overall Study||10
6804701|NCT03786380|7736713|FG002|NOT COMPLETED|Overall Study||54
6804702|NCT03786380|7736714|FG003|NOT COMPLETED|Overall Study||63
6804703|NCT03786380|7736715|FG004|NOT COMPLETED|Overall Study||28
6804704|NCT03769376|7736729|FG000|STARTED|Overall Study||20
6804705|NCT03769376|7736730|FG001|STARTED|Overall Study||18
6804706|NCT03769376|7736729|FG000|COMPLETED|Overall Study||13
6804707|NCT03769376|7736730|FG001|COMPLETED|Overall Study||11
6804708|NCT03769376|7736729|FG000|NOT COMPLETED|Overall Study||7
6804709|NCT03769376|7736730|FG001|NOT COMPLETED|Overall Study||7
6804710|NCT03645863|7736739|FG000|STARTED|Overall Study||21
6804711|NCT03645863|7736740|FG001|STARTED|Overall Study||20
6804712|NCT03645863|7736741|FG002|STARTED|Overall Study||20
6804713|NCT03645863|7736739|FG000|COMPLETED|Overall Study||20
6804714|NCT03645863|7736740|FG001|COMPLETED|Overall Study||20
6804715|NCT03645863|7736741|FG002|COMPLETED|Overall Study||20
6804716|NCT03645863|7736739|FG000|NOT COMPLETED|Overall Study||1
6804717|NCT03645863|7736740|FG001|NOT COMPLETED|Overall Study||0
6804718|NCT03645863|7736741|FG002|NOT COMPLETED|Overall Study||0
6804719|NCT03564145|7736749|FG000|STARTED|Overall Study||547
6804720|NCT03564145|7736749|FG000|Received at Least 1 Dose of Study Drug|Overall Study||535
6804721|NCT03564145|7736749|FG000|COMPLETED|Overall Study||323
6804722|NCT03564145|7736749|FG000|NOT COMPLETED|Overall Study||224
6804723|NCT03564119|7736755|FG000|STARTED|Overall Study||250
6804724|NCT03564119|7736756|FG001|STARTED|Overall Study||122
6804725|NCT03564119|7736755|FG000|Received at Least 1 Dose of Study Drug|Overall Study||249
6804726|NCT03564119|7736756|FG001|Received at Least 1 Dose of Study Drug|Overall Study||120
6804727|NCT03564119|7736755|FG000|COMPLETED|Overall Study||235
6804728|NCT03564119|7736756|FG001|COMPLETED|Overall Study||113
6804729|NCT03564119|7736755|FG000|NOT COMPLETED|Overall Study||15
6804730|NCT03564119|7736756|FG001|NOT COMPLETED|Overall Study||9
6804731|NCT03365635|7736768|FG000|STARTED|Overall Study||3
6804732|NCT03365635|7736769|FG001|STARTED|Overall Study||0
6384633|NCT00802074|7295835|FG000|STARTED|Overall Study||9
6384634|NCT00802074|7295836|FG001|STARTED|Overall Study||8
6384635|NCT00802074|7295837|FG002|STARTED|Overall Study||7
6384636|NCT00802074|7295838|FG003|STARTED|Overall Study||7
6384637|NCT00802074|7295839|FG004|STARTED|Overall Study||7
6565082|NCT01815502|7487847|FG001|COMPLETED|Overall Study||10
6804733|NCT03365635|7736770|FG002|STARTED|Overall Study||1
6804734|NCT03365635|7736771|FG003|STARTED|Overall Study||0
6384638|NCT00802074|7295840|FG005|STARTED|Overall Study||7
6384639|NCT00802074|7295835|FG000|COMPLETED|Overall Study||7
6384640|NCT00802074|7295836|FG001|COMPLETED|Overall Study||7
6384641|NCT00802074|7295837|FG002|COMPLETED|Overall Study||6
6384642|NCT00802074|7295838|FG003|COMPLETED|Overall Study||7
6384643|NCT00802074|7295839|FG004|COMPLETED|Overall Study||7
6384644|NCT00802074|7295840|FG005|COMPLETED|Overall Study||7
6384645|NCT00802074|7295835|FG000|NOT COMPLETED|Overall Study||2
6384646|NCT00802074|7295836|FG001|NOT COMPLETED|Overall Study||1
6384647|NCT00802074|7295837|FG002|NOT COMPLETED|Overall Study||1
6384648|NCT00802074|7295838|FG003|NOT COMPLETED|Overall Study||0
6384649|NCT00802074|7295839|FG004|NOT COMPLETED|Overall Study||0
6565083|NCT01815502|7487846|FG000|NOT COMPLETED|Overall Study||0
6565084|NCT01815502|7487847|FG001|NOT COMPLETED|Overall Study||0
6804735|NCT03365635|7736772|FG004|STARTED|Overall Study||0
6804736|NCT03365635|7736773|FG005|STARTED|Overall Study||0
6804737|NCT03365635|7736768|FG000|COMPLETED|Overall Study||3
6804738|NCT03365635|7736769|FG001|COMPLETED|Overall Study||0
6804739|NCT03365635|7736770|FG002|COMPLETED|Overall Study||1
6804740|NCT03365635|7736771|FG003|COMPLETED|Overall Study||0
6804741|NCT03365635|7736772|FG004|COMPLETED|Overall Study||0
6804742|NCT03365635|7736773|FG005|COMPLETED|Overall Study||0
6804743|NCT03365635|7736768|FG000|NOT COMPLETED|Overall Study||0
6804744|NCT03365635|7736769|FG001|NOT COMPLETED|Overall Study||0
6804745|NCT03365635|7736770|FG002|NOT COMPLETED|Overall Study||0
6804746|NCT03365635|7736771|FG003|NOT COMPLETED|Overall Study||0
6804747|NCT03365635|7736772|FG004|NOT COMPLETED|Overall Study||0
6804748|NCT03365635|7736773|FG005|NOT COMPLETED|Overall Study||0
6804749|NCT03287050|7736787|FG000|STARTED|Overall Study||6
6804750|NCT03287050|7736787|FG000|COMPLETED|Overall Study||6
6804751|NCT03287050|7736787|FG000|NOT COMPLETED|Overall Study||0
6804752|NCT03223350|7736793|FG000|STARTED|Overall Study||17
6804753|NCT03223350|7736794|FG001|STARTED|Overall Study||13
6804754|NCT03223350|7736793|FG000|COMPLETED|Overall Study||17
6565085|NCT01815515|7487856|FG000|STARTED|Overall Study||17
6565086|NCT01815515|7487856|FG000|COMPLETED|Overall Study||17
6565087|NCT01815515|7487856|FG000|NOT COMPLETED|Overall Study||0
6565088|NCT01815645|7487862|FG000|STARTED|Overall Study||32
6565089|NCT01815645|7487863|FG001|STARTED|Overall Study||33
6804755|NCT03223350|7736794|FG001|COMPLETED|Overall Study||13
6804756|NCT03223350|7736793|FG000|NOT COMPLETED|Overall Study||0
6804757|NCT03223350|7736794|FG001|NOT COMPLETED|Overall Study||0
6804758|NCT03181828|7736802|FG000|STARTED|Overall Study||2
6384650|NCT00802074|7295840|FG005|NOT COMPLETED|Overall Study||0
6384651|NCT00802100|7295860|FG000|STARTED|Overall Study||6
6384652|NCT00802100|7295861|FG001|STARTED|Overall Study||9
6384653|NCT00802100|7295862|FG002|STARTED|Overall Study||6
6384654|NCT00802100|7295860|FG000|COMPLETED|Overall Study||0
6384655|NCT00802100|7295861|FG001|COMPLETED|Overall Study||2
6384656|NCT00802100|7295862|FG002|COMPLETED|Overall Study||2
6384657|NCT00802100|7295860|FG000|NOT COMPLETED|Overall Study||6
6384658|NCT00802100|7295861|FG001|NOT COMPLETED|Overall Study||7
6384659|NCT00802100|7295862|FG002|NOT COMPLETED|Overall Study||4
6384660|NCT00802113|7295873|FG000|STARTED|Overall Study||6
6384661|NCT00802113|7295874|FG001|STARTED|Overall Study||17
6384662|NCT00802113|7295873|FG000|COMPLETED|Overall Study||6
6384663|NCT00802113|7295874|FG001|COMPLETED|Overall Study||17
6384664|NCT00802113|7295873|FG000|NOT COMPLETED|Overall Study||0
6384665|NCT00802113|7295874|FG001|NOT COMPLETED|Overall Study||0
6384666|NCT00802178|7295880|FG000|STARTED|Overall Study||2448
6384667|NCT00802178|7295880|FG000|COMPLETED|Overall Study||2335
6384668|NCT00802178|7295880|FG000|NOT COMPLETED|Overall Study||113
6384669|NCT00802204|7295886|FG000|STARTED|Overall Study||9
6384670|NCT00802204|7295887|FG001|STARTED|Overall Study||19
6384671|NCT00802204|7295886|FG000|COMPLETED|Overall Study||8
6384672|NCT00802204|7295887|FG001|COMPLETED|Overall Study||18
6384673|NCT00802204|7295886|FG000|NOT COMPLETED|Overall Study||1
6384674|NCT00802204|7295887|FG001|NOT COMPLETED|Overall Study||1
6565090|NCT01815645|7487862|FG000|COMPLETED|Overall Study||32
6565091|NCT01815645|7487863|FG001|COMPLETED|Overall Study||33
6565092|NCT01815645|7487862|FG000|NOT COMPLETED|Overall Study||0
6804759|NCT03181828|7736803|FG001|STARTED|Overall Study||2
6804760|NCT03181828|7736802|FG000|COMPLETED|Overall Study||2
6804761|NCT03181828|7736803|FG001|COMPLETED|Overall Study||2
6384675|NCT00802360|7295900|FG000|STARTED|Overall Study||42
6804762|NCT03181828|7736802|FG000|NOT COMPLETED|Overall Study||0
6804763|NCT03181828|7736803|FG001|NOT COMPLETED|Overall Study||0
6804764|NCT03181529|7736811|FG000|STARTED|Overall Study||15
6804765|NCT03181529|7736812|FG001|STARTED|Overall Study||12
6804766|NCT03181529|7736811|FG000|COMPLETED|Overall Study||13
6804767|NCT03181529|7736812|FG001|COMPLETED|Overall Study||11
6384676|NCT00802360|7295901|FG001|STARTED|Overall Study||42
6384677|NCT00802360|7295902|FG002|STARTED|Overall Study||42
6384678|NCT00802360|7295903|FG003|STARTED|Overall Study||39
6384679|NCT00802360|7295900|FG000|COMPLETED|Overall Study||18
6384680|NCT00802360|7295901|FG001|COMPLETED|Overall Study||16
6565093|NCT01815645|7487863|FG001|NOT COMPLETED|Overall Study||0
6565094|NCT01815671|7487873|FG000|STARTED|Overall Study||88
6565095|NCT01815671|7487874|FG001|STARTED|Overall Study||85
6565096|NCT01815671|7487873|FG000|COMPLETED|Overall Study||88
6565097|NCT01815671|7487874|FG001|COMPLETED|Overall Study||85
6565098|NCT01815671|7487873|FG000|NOT COMPLETED|Overall Study||0
6565099|NCT01815671|7487874|FG001|NOT COMPLETED|Overall Study||0
6565100|NCT01815736|7487882|FG000|STARTED|Randomized Treatment Phase-Up to Week 96||963
6565101|NCT01815736|7487883|FG001|STARTED|Randomized Treatment Phase-Up to Week 96||480
6565102|NCT01815736|7487882|FG000|COMPLETED|Randomized Treatment Phase-Up to Week 96||914
6565103|NCT01815736|7487883|FG001|COMPLETED|Randomized Treatment Phase-Up to Week 96||445
6384681|NCT00802360|7295902|FG002|COMPLETED|Overall Study||17
6384682|NCT00802360|7295903|FG003|COMPLETED|Overall Study||17
6384683|NCT00802360|7295900|FG000|NOT COMPLETED|Overall Study||24
6384684|NCT00802360|7295901|FG001|NOT COMPLETED|Overall Study||26
6384685|NCT00802360|7295902|FG002|NOT COMPLETED|Overall Study||25
6384686|NCT00802360|7295903|FG003|NOT COMPLETED|Overall Study||22
6384687|NCT00802412|7295917|FG000|STARTED|Overall Study||65
6384688|NCT00802412|7295918|FG001|STARTED|Overall Study||67
6384689|NCT00802412|7295917|FG000|COMPLETED|Overall Study||63
6384690|NCT00802412|7295918|FG001|COMPLETED|Overall Study||66
6384691|NCT00802412|7295917|FG000|NOT COMPLETED|Overall Study||2
6384692|NCT00802412|7295918|FG001|NOT COMPLETED|Overall Study||1
6384693|NCT00802438|7295924|FG000|STARTED|Overall Study||38
6384694|NCT00802438|7295924|FG000|COMPLETED|Overall Study||10
6384695|NCT00802438|7295924|FG000|NOT COMPLETED|Overall Study||28
6384696|NCT00802464|7295932|FG000|STARTED|Month 0 - Month 8||38
6384697|NCT00802464|7295933|FG001|STARTED|Month 0 - Month 8||73
6384698|NCT00802464|7295934|FG002|STARTED|Month 0 - Month 8||149
6384699|NCT00802464|7295935|FG003|STARTED|Month 0 - Month 8||150
6384700|NCT00802464|7295932|FG000|COMPLETED|Month 0 - Month 8||38
6384701|NCT00802464|7295933|FG001|COMPLETED|Month 0 - Month 8||70
6384702|NCT00802464|7295934|FG002|COMPLETED|Month 0 - Month 8||142
6384703|NCT00802464|7295935|FG003|COMPLETED|Month 0 - Month 8||141
6384704|NCT00802464|7295932|FG000|NOT COMPLETED|Month 0 - Month 8||0
6384705|NCT00802464|7295933|FG001|NOT COMPLETED|Month 0 - Month 8||3
6384706|NCT00802464|7295934|FG002|NOT COMPLETED|Month 0 - Month 8||7
6384707|NCT00802464|7295935|FG003|NOT COMPLETED|Month 0 - Month 8||9
6384708|NCT00802464|7295932|FG000|STARTED|Month 8 - Month 14||34
6384709|NCT00802464|7295933|FG001|STARTED|Month 8 - Month 14||65
6384710|NCT00802464|7295934|FG002|STARTED|Month 8 - Month 14||130
6384711|NCT00802464|7295935|FG003|STARTED|Month 8 - Month 14||126
6384712|NCT00802464|7295932|FG000|COMPLETED|Month 8 - Month 14||33
6384713|NCT00802464|7295933|FG001|COMPLETED|Month 8 - Month 14||63
6384714|NCT00802464|7295934|FG002|COMPLETED|Month 8 - Month 14||129
6384715|NCT00802464|7295935|FG003|COMPLETED|Month 8 - Month 14||126
6384716|NCT00802464|7295932|FG000|NOT COMPLETED|Month 8 - Month 14||1
6384717|NCT00802464|7295933|FG001|NOT COMPLETED|Month 8 - Month 14||2
6384718|NCT00802464|7295934|FG002|NOT COMPLETED|Month 8 - Month 14||1
6384719|NCT00802464|7295935|FG003|NOT COMPLETED|Month 8 - Month 14||0
6384720|NCT00802503|7295949|FG000|STARTED|Overall Study||152
6384721|NCT00802503|7295950|FG001|STARTED|Overall Study||153
6384722|NCT00802503|7295949|FG000|COMPLETED|Overall Study||142
6269850|NCT00077766|7169103|FG000|STARTED|Overall Study||157
6269851|NCT00077766|7169104|FG001|STARTED|Overall Study||156
6269852|NCT00077766|7169103|FG000|COMPLETED|Overall Study||118
6269853|NCT00077766|7169104|FG001|COMPLETED|Overall Study||131
6269854|NCT00077766|7169103|FG000|NOT COMPLETED|Overall Study||39
6269855|NCT00077766|7169104|FG001|NOT COMPLETED|Overall Study||25
6269856|NCT00077857|7169113|FG000|STARTED|Overall Study||235
6269857|NCT00077857|7169114|FG001|STARTED|Overall Study||235
6269858|NCT00077857|7169113|FG000|Received Study Drug|Overall Study||231
6269859|NCT00077857|7169114|FG001|Received Study Drug|Overall Study||234
6269860|NCT00077857|7169113|FG000|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
6269861|NCT00077857|7169114|FG001|Safety Population: Actual Dose Received|Overall Study||248
6269862|NCT00077857|7169113|FG000|COMPLETED|Overall Study||34
6269863|NCT00077857|7169114|FG001|COMPLETED|Overall Study||31
6269864|NCT00077857|7169113|FG000|NOT COMPLETED|Overall Study||201
6269865|NCT00077857|7169114|FG001|NOT COMPLETED|Overall Study||204
6269866|NCT00077922|7169120|FG000|STARTED|Overall Study||15
6269867|NCT00077922|7169120|FG000|COMPLETED|Overall Study||15
6269868|NCT00077922|7169120|FG000|NOT COMPLETED|Overall Study||0
6269869|NCT00077974|7169124|FG000|STARTED|Overall Study||106
6269870|NCT00077974|7169124|FG000|COMPLETED|Overall Study||2
6269871|NCT00077974|7169124|FG000|NOT COMPLETED|Overall Study||104
6269872|NCT00078286|7169130|FG000|STARTED|Overall Study||234
6269873|NCT00078286|7169131|FG001|STARTED|Overall Study||235
6269874|NCT00078286|7169130|FG000|COMPLETED|Overall Study||138
6269875|NCT00078286|7169131|FG001|COMPLETED|Overall Study||152
6269876|NCT00078286|7169130|FG000|NOT COMPLETED|Overall Study||96
6269877|NCT00078286|7169131|FG001|NOT COMPLETED|Overall Study||83
6269878|NCT00078312|7169137|FG000|STARTED|Overall Study||328
6269879|NCT00078312|7169137|FG000|COMPLETED|Overall Study||151
6269880|NCT00078312|7169137|FG000|NOT COMPLETED|Overall Study||177
6269881|NCT00078325|7169144|FG000|STARTED|Overall Study||131
6269882|NCT00078325|7169145|FG001|STARTED|Overall Study||133
6269883|NCT00078325|7169146|FG002|STARTED|Overall Study||131
6269884|NCT00078325|7169144|FG000|COMPLETED|Overall Study||110
6269885|NCT00078325|7169145|FG001|COMPLETED|Overall Study||114
6269886|NCT00078325|7169146|FG002|COMPLETED|Overall Study||120
6269887|NCT00078325|7169144|FG000|NOT COMPLETED|Overall Study||21
6269888|NCT00078325|7169145|FG001|NOT COMPLETED|Overall Study||19
6269889|NCT00078325|7169146|FG002|NOT COMPLETED|Overall Study||11
6269890|NCT00078338|7169156|FG000|STARTED|Overall Study||386
6269891|NCT00078338|7169157|FG001|STARTED|Overall Study||378
6269892|NCT00078338|7169156|FG000|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|381
6269893|NCT00078338|7169157|FG001|Safety Population|Overall Study|Safety population=subjects who received at least 1 dose of treatment and had followup safety data.|375
6269894|NCT00078338|7169156|FG000|COMPLETED|Overall Study||301
6269895|NCT00078338|7169157|FG001|COMPLETED|Overall Study||324
6269896|NCT00078338|7169156|FG000|NOT COMPLETED|Overall Study||85
6269897|NCT00078338|7169157|FG001|NOT COMPLETED|Overall Study||54
6269898|NCT00078377|7169166|FG000|STARTED|Overall Study||67
6269899|NCT00078377|7169167|FG001|STARTED|Overall Study||65
6269900|NCT00078377|7169168|FG002|STARTED|Overall Study||64
6269901|NCT00078377|7169166|FG000|COMPLETED|Overall Study||56
6269902|NCT00078377|7169167|FG001|COMPLETED|Overall Study||49
6269903|NCT00078377|7169168|FG002|COMPLETED|Overall Study||55
6269904|NCT00078377|7169166|FG000|NOT COMPLETED|Overall Study||11
6269905|NCT00078377|7169167|FG001|NOT COMPLETED|Overall Study||16
6269906|NCT00078377|7169168|FG002|NOT COMPLETED|Overall Study||9
6269907|NCT00078403|7169180|FG000|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
6269908|NCT00078403|7169181|FG001|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
6269909|NCT00078403|7169182|FG002|STARTED|Overall Study||169
6269910|NCT00078403|7169180|FG000|COMPLETED|Overall Study||26
6269911|NCT00078403|7169181|FG001|COMPLETED|Overall Study||26
6269912|NCT00078403|7169182|FG002|COMPLETED|Overall Study||141
6269913|NCT00078403|7169180|FG000|NOT COMPLETED|Overall Study||18
6269914|NCT00078403|7169181|FG001|NOT COMPLETED|Overall Study||16
6269915|NCT00078403|7169182|FG002|NOT COMPLETED|Overall Study||28
6269916|NCT00078559|7169191|FG000|STARTED|Overall Study||10
6280645|NCT00158756|7180628|FG003|COMPLETED|Overall Study||22
6565104|NCT01815736|7487882|FG000|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||49
6565105|NCT01815736|7487883|FG001|NOT COMPLETED|Randomized Treatment Phase-Up to Week 96||35
6565106|NCT01815736|7487882|FG000|STARTED|Extension Treatment Phase- After Week 96|9 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|905
6565107|NCT01815736|7487883|FG001|STARTED|Extension Treatment Phase- After Week 96|21 participants who completed the Randomized Treatment Phase did not continue in the Extension E/C/F/TAF Treatment Phase.|424
6565108|NCT01815736|7487882|FG000|COMPLETED|Extension Treatment Phase- After Week 96||854
6565109|NCT01815736|7487883|FG001|COMPLETED|Extension Treatment Phase- After Week 96||398
6565110|NCT01815736|7487882|FG000|NOT COMPLETED|Extension Treatment Phase- After Week 96||51
6565111|NCT01815736|7487883|FG001|NOT COMPLETED|Extension Treatment Phase- After Week 96||26
6565112|NCT01815840|7487893|FG000|STARTED|Overall Study||116
6565113|NCT01815840|7487894|FG001|STARTED|Overall Study||113
6565114|NCT01815840|7487893|FG000|COMPLETED|Overall Study||57
6565115|NCT01815840|7487894|FG001|COMPLETED|Overall Study||50
6804768|NCT03181529|7736811|FG000|NOT COMPLETED|Overall Study||2
6804769|NCT03181529|7736812|FG001|NOT COMPLETED|Overall Study||1
6804770|NCT02946931|7736818|FG000|STARTED|Overall Study||1387
6804771|NCT02946931|7736818|FG000|Case Report Forms (CRFs) Collected|Overall Study||814
6804772|NCT02946931|7736818|FG000|COMPLETED|Overall Study||569
6804773|NCT02946931|7736818|FG000|NOT COMPLETED|Overall Study||818
6384723|NCT00802503|7295950|FG001|COMPLETED|Overall Study||133
6384724|NCT00802503|7295949|FG000|NOT COMPLETED|Overall Study||10
6384725|NCT00802503|7295950|FG001|NOT COMPLETED|Overall Study||20
6384726|NCT00802529|7295962|FG000|STARTED|Overall Study||30
6384727|NCT00802529|7295963|FG001|STARTED|Overall Study||30
6384728|NCT00802529|7295962|FG000|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
6384729|NCT00802529|7295963|FG001|COMPLETED|Overall Study||29
6384730|NCT00802529|7295962|FG000|NOT COMPLETED|Overall Study||0
6384731|NCT00802529|7295963|FG001|NOT COMPLETED|Overall Study||1
6384732|NCT00802633|7295971|FG000|STARTED|Overall Study||40
6384733|NCT00802633|7295972|FG001|STARTED|Overall Study||40
6384734|NCT00802633|7295971|FG000|COMPLETED|Overall Study||40
6384735|NCT00802633|7295972|FG001|COMPLETED|Overall Study||40
6384736|NCT00802633|7295971|FG000|NOT COMPLETED|Overall Study||0
6384737|NCT00802633|7295972|FG001|NOT COMPLETED|Overall Study||0
6384738|NCT00802672|7295981|FG000|STARTED|Overall Study||224
6384739|NCT00802672|7295982|FG001|STARTED|Overall Study||226
6804774|NCT02779556|7736824|FG000|STARTED|Baseline||394
6804775|NCT02779556|7736825|FG001|STARTED|Baseline||362
6804776|NCT02779556|7736824|FG000|COMPLETED|Baseline||393
6804777|NCT02779556|7736825|FG001|COMPLETED|Baseline||362
6804778|NCT02779556|7736824|FG000|NOT COMPLETED|Baseline||1
6804779|NCT02779556|7736825|FG001|NOT COMPLETED|Baseline||0
6804780|NCT02779556|7736824|FG000|STARTED|3 Months||393
6804781|NCT02779556|7736825|FG001|STARTED|3 Months||362
6804782|NCT02779556|7736824|FG000|COMPLETED|3 Months||326
6804783|NCT02779556|7736825|FG001|COMPLETED|3 Months||314
6804784|NCT02779556|7736824|FG000|NOT COMPLETED|3 Months||67
6804785|NCT02779556|7736825|FG001|NOT COMPLETED|3 Months||48
6384740|NCT00802672|7295983|FG002|STARTED|Overall Study||111
6565116|NCT01815840|7487893|FG000|NOT COMPLETED|Overall Study||59
6565117|NCT01815840|7487894|FG001|NOT COMPLETED|Overall Study||63
6565118|NCT01815918|7487902|FG000|STARTED|Overall Study||30
6565119|NCT01815918|7487903|FG001|STARTED|Overall Study||30
6565120|NCT01815918|7487902|FG000|COMPLETED|Overall Study||12
6565121|NCT01815918|7487903|FG001|COMPLETED|Overall Study||11
6565122|NCT01815918|7487902|FG000|NOT COMPLETED|Overall Study||18
6565123|NCT01815918|7487903|FG001|NOT COMPLETED|Overall Study||19
6565124|NCT01816048|7487913|FG000|STARTED|Overall Study||8
6565125|NCT01816048|7487913|FG000|COMPLETED|Overall Study||2
6565126|NCT01816048|7487913|FG000|NOT COMPLETED|Overall Study||6
6565127|NCT01816061|7487920|FG000|STARTED|Overall Study||40
6565128|NCT01816061|7487921|FG001|STARTED|Overall Study||51
6656806|NCT02465073|7587140|FG000|NOT COMPLETED|Overall Study||2
6656807|NCT02465073|7587141|FG001|NOT COMPLETED|Overall Study||1
6384741|NCT00802672|7295981|FG000|COMPLETED|Overall Study||156
6384742|NCT00802672|7295982|FG001|COMPLETED|Overall Study||174
6384743|NCT00802672|7295983|FG002|COMPLETED|Overall Study||77
6384744|NCT00802672|7295981|FG000|NOT COMPLETED|Overall Study||68
6384745|NCT00802672|7295982|FG001|NOT COMPLETED|Overall Study||52
6384746|NCT00802672|7295983|FG002|NOT COMPLETED|Overall Study||34
6384747|NCT00802685|7295993|FG000|STARTED|Overall Study||54
6384748|NCT00802685|7295994|FG001|STARTED|Overall Study||51
6384749|NCT00802685|7295993|FG000|COMPLETED|Overall Study||54
6384750|NCT00802685|7295994|FG001|COMPLETED|Overall Study||51
6384751|NCT00802685|7295993|FG000|NOT COMPLETED|Overall Study||0
6384752|NCT00802685|7295994|FG001|NOT COMPLETED|Overall Study||0
6384753|NCT00802737|7296003|FG000|STARTED|Overall Study||17
6384754|NCT00802737|7296004|FG001|STARTED|Overall Study||11
6384755|NCT00802737|7296005|FG002|STARTED|Overall Study||1
6384756|NCT00802737|7296003|FG000|COMPLETED|Overall Study||0
6384757|NCT00802737|7296004|FG001|COMPLETED|Overall Study||0
6384758|NCT00802737|7296005|FG002|COMPLETED|Overall Study||0
6384759|NCT00802737|7296003|FG000|NOT COMPLETED|Overall Study||17
6384760|NCT00802737|7296004|FG001|NOT COMPLETED|Overall Study||11
6656808|NCT02465073|7587142|FG002|NOT COMPLETED|Overall Study||1
6565129|NCT01816061|7487920|FG000|COMPLETED|Overall Study||27
6565130|NCT01816061|7487921|FG001|COMPLETED|Overall Study||27
6565131|NCT01816061|7487920|FG000|NOT COMPLETED|Overall Study||13
6565132|NCT01816061|7487921|FG001|NOT COMPLETED|Overall Study||24
6565133|NCT01816074|7487931|FG000|STARTED|Phase 1||11
6565134|NCT01816074|7487932|FG001|STARTED|Phase 1||9
6565135|NCT01816074|7487933|FG002|STARTED|Phase 1||11
6565136|NCT01816074|7487934|FG003|STARTED|Phase 1||10
6565137|NCT01816074|7487931|FG000|COMPLETED|Phase 1||11
6565138|NCT01816074|7487932|FG001|COMPLETED|Phase 1||9
6565139|NCT01816074|7487933|FG002|COMPLETED|Phase 1||10
6565140|NCT01816074|7487934|FG003|COMPLETED|Phase 1||10
6565141|NCT01816074|7487931|FG000|NOT COMPLETED|Phase 1||0
6565142|NCT01816074|7487932|FG001|NOT COMPLETED|Phase 1||0
6565143|NCT01816074|7487933|FG002|NOT COMPLETED|Phase 1||1
6565144|NCT01816074|7487934|FG003|NOT COMPLETED|Phase 1||0
6565145|NCT01816074|7487931|FG000|STARTED|Phase 2||11
6269917|NCT00078559|7169191|FG000|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
6269918|NCT00078559|7169191|FG000|NOT COMPLETED|Overall Study||0
6269919|NCT00078715|7169198|FG000|STARTED|First Intervention||2
6269920|NCT00078715|7169199|FG001|STARTED|First Intervention||4
6269921|NCT00078715|7169198|FG000|COMPLETED|First Intervention||2
6269922|NCT00078715|7169199|FG001|COMPLETED|First Intervention||4
6269923|NCT00078715|7169198|FG000|NOT COMPLETED|First Intervention||0
6269924|NCT00078715|7169199|FG001|NOT COMPLETED|First Intervention||0
6269925|NCT00078715|7169198|FG000|STARTED|Second Intervention||2
6269926|NCT00078715|7169199|FG001|STARTED|Second Intervention||4
6269927|NCT00078715|7169198|FG000|COMPLETED|Second Intervention||2
6269928|NCT00078715|7169199|FG001|COMPLETED|Second Intervention||4
6269929|NCT00078715|7169198|FG000|NOT COMPLETED|Second Intervention||0
6269930|NCT00078715|7169199|FG001|NOT COMPLETED|Second Intervention||0
6269931|NCT00078728|7169207|FG000|STARTED|Overall Study||20
6269932|NCT00078728|7169208|FG001|STARTED|Overall Study||20
6269933|NCT00078728|7169207|FG000|COMPLETED|Overall Study||16
6269934|NCT00078728|7169208|FG001|COMPLETED|Overall Study||17
6269935|NCT00078728|7169207|FG000|NOT COMPLETED|Overall Study||4
6269936|NCT00078728|7169208|FG001|NOT COMPLETED|Overall Study||3
6269937|NCT00078754|7169218|FG000|STARTED|Overall Study||29
6269938|NCT00078754|7169219|FG001|STARTED|Overall Study||30
6269939|NCT00078754|7169220|FG002|STARTED|Overall Study||31
6269940|NCT00078754|7169218|FG000|COMPLETED|Overall Study||14
6269941|NCT00078754|7169219|FG001|COMPLETED|Overall Study||11
6269942|NCT00078754|7169220|FG002|COMPLETED|Overall Study||16
6269943|NCT00078754|7169218|FG000|NOT COMPLETED|Overall Study||15
6269944|NCT00078754|7169219|FG001|NOT COMPLETED|Overall Study||19
6269945|NCT00078754|7169220|FG002|NOT COMPLETED|Overall Study||15
6269946|NCT00078767|7169233|FG000|STARTED|Overall Study||12
6269947|NCT00078767|7169234|FG001|STARTED|Overall Study||12
6269948|NCT00078767|7169233|FG000|COMPLETED|Overall Study||11
6269949|NCT00078767|7169234|FG001|COMPLETED|Overall Study||11
6269950|NCT00078767|7169233|FG000|NOT COMPLETED|Overall Study||1
6269951|NCT00078767|7169234|FG001|NOT COMPLETED|Overall Study||1
6269952|NCT00078819|7169242|FG000|STARTED|Double-blind Treatment Period: Week 1-12||105
6269953|NCT00078819|7169243|FG001|STARTED|Double-blind Treatment Period: Week 1-12||106
6269954|NCT00078819|7169244|FG002|STARTED|Double-blind Treatment Period: Week 1-12||0
6269955|NCT00078819|7169245|FG003|STARTED|Double-blind Treatment Period: Week 1-12||0
6269956|NCT00078819|7169242|FG000|Entered Escape|Double-blind Treatment Period: Week 1-12||27
6269957|NCT00078819|7169243|FG001|Entered Escape|Double-blind Treatment Period: Week 1-12||5
6269958|NCT00078819|7169244|FG002|Entered Escape|Double-blind Treatment Period: Week 1-12||0
6269959|NCT00078819|7169245|FG003|Entered Escape|Double-blind Treatment Period: Week 1-12||0
6269960|NCT00078819|7169242|FG000|COMPLETED|Double-blind Treatment Period: Week 1-12||104
6269961|NCT00078819|7169243|FG001|COMPLETED|Double-blind Treatment Period: Week 1-12||105
6269962|NCT00078819|7169244|FG002|COMPLETED|Double-blind Treatment Period: Week 1-12||0
6269963|NCT00078819|7169245|FG003|COMPLETED|Double-blind Treatment Period: Week 1-12||0
6269964|NCT00078819|7169242|FG000|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
6269965|NCT00078819|7169243|FG001|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||1
6269966|NCT00078819|7169244|FG002|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
6269967|NCT00078819|7169245|FG003|NOT COMPLETED|Double-blind Treatment Period: Week 1-12||0
6269968|NCT00078819|7169242|FG000|STARTED|Open-label Treatment Period: Weeks 13-36|One participant discontinued before starting the open-label period|103
6269969|NCT00078819|7169243|FG001|STARTED|Open-label Treatment Period: Weeks 13-36||105
6269970|NCT00078819|7169244|FG002|STARTED|Open-label Treatment Period: Weeks 13-36||0
6269971|NCT00078819|7169245|FG003|STARTED|Open-label Treatment Period: Weeks 13-36||0
6269972|NCT00078819|7169242|FG000|COMPLETED|Open-label Treatment Period: Weeks 13-36||63
6269973|NCT00078819|7169243|FG001|COMPLETED|Open-label Treatment Period: Weeks 13-36||75
6269974|NCT00078819|7169244|FG002|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
6269975|NCT00078819|7169245|FG003|COMPLETED|Open-label Treatment Period: Weeks 13-36||0
6269976|NCT00078819|7169242|FG000|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||40
6269977|NCT00078819|7169243|FG001|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||30
6269978|NCT00078819|7169244|FG002|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
6269979|NCT00078819|7169245|FG003|NOT COMPLETED|Open-label Treatment Period: Weeks 13-36||0
6269980|NCT00078819|7169242|FG000|STARTED|Withdrawal Period: Weeks 37-48||0
6269981|NCT00078819|7169243|FG001|STARTED|Withdrawal Period: Weeks 37-48||0
6269982|NCT00078819|7169244|FG002|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
6269983|NCT00078819|7169245|FG003|STARTED|Withdrawal Period: Weeks 37-48|Participants who completed week 36 with a PASI response|69
6269984|NCT00078819|7169242|FG000|Received Study Drug|Withdrawal Period: Weeks 37-48||0
6269985|NCT00078819|7169243|FG001|Received Study Drug|Withdrawal Period: Weeks 37-48||0
6565146|NCT01816074|7487932|FG001|STARTED|Phase 2||9
6384761|NCT00802737|7296005|FG002|NOT COMPLETED|Overall Study||1
6384762|NCT00802841|7296016|FG000|STARTED|Overall Study||96
6384763|NCT00802841|7296017|FG001|STARTED|Overall Study||95
6384764|NCT00802841|7296016|FG000|Full Analysis Set|Overall Study||96
6384765|NCT00802841|7296017|FG001|Full Analysis Set|Overall Study||95
6384766|NCT00802841|7296016|FG000|Safety Set|Overall Study||96
6384767|NCT00802841|7296017|FG001|Safety Set|Overall Study||93
6384768|NCT00802841|7296016|FG000|Cross-over Set|Overall Study||13
6384769|NCT00802841|7296017|FG001|Cross-over Set|Overall Study||56
6384770|NCT00802841|7296016|FG000|COMPLETED|Overall Study||0
6384771|NCT00802841|7296017|FG001|COMPLETED|Overall Study||0
6384772|NCT00802841|7296016|FG000|NOT COMPLETED|Overall Study||96
6384773|NCT00802841|7296017|FG001|NOT COMPLETED|Overall Study||95
6384774|NCT00802854|7296025|FG000|STARTED|Overall Study||244
6384775|NCT00802854|7296025|FG000|COMPLETED|Overall Study||244
6384776|NCT00802854|7296025|FG000|NOT COMPLETED|Overall Study||0
6384777|NCT00802867|7296029|FG000|STARTED|Overall Study||989
6384778|NCT00802867|7296029|FG000|COMPLETED|Overall Study||976
6384779|NCT00802867|7296029|FG000|NOT COMPLETED|Overall Study||13
6384780|NCT00802880|7296033|FG000|STARTED|Overall Study||80
6384781|NCT00802880|7296033|FG000|COMPLETED|Overall Study||80
6384782|NCT00802880|7296033|FG000|NOT COMPLETED|Overall Study||0
6384783|NCT00802919|7296043|FG000|STARTED|Overall Study||45
6384784|NCT00802919|7296044|FG001|STARTED|Overall Study||46
6384785|NCT00802919|7296043|FG000|COMPLETED|Overall Study||42
6384786|NCT00802919|7296044|FG001|COMPLETED|Overall Study||45
6384787|NCT00802919|7296043|FG000|NOT COMPLETED|Overall Study||3
6565147|NCT01816074|7487933|FG002|STARTED|Phase 2||10
6565148|NCT01816074|7487934|FG003|STARTED|Phase 2||10
6565149|NCT01816074|7487931|FG000|COMPLETED|Phase 2||9
6565150|NCT01816074|7487932|FG001|COMPLETED|Phase 2||7
6565151|NCT01816074|7487933|FG002|COMPLETED|Phase 2||10
6280646|NCT00158756|7180629|FG004|COMPLETED|Overall Study||96
6565152|NCT01816074|7487934|FG003|COMPLETED|Phase 2||9
6565153|NCT01816074|7487931|FG000|NOT COMPLETED|Phase 2||2
6565154|NCT01816074|7487932|FG001|NOT COMPLETED|Phase 2||2
6565155|NCT01816074|7487933|FG002|NOT COMPLETED|Phase 2||0
6565156|NCT01816074|7487934|FG003|NOT COMPLETED|Phase 2||1
6565157|NCT01816230|7487958|FG000|STARTED|Overall Study||36
6384788|NCT00802919|7296044|FG001|NOT COMPLETED|Overall Study||1
6384789|NCT00802945|7296053|FG000|STARTED|Overall Study||35
6384790|NCT00802945|7296054|FG001|STARTED|Overall Study||35
6384791|NCT00802945|7296053|FG000|COMPLETED|Overall Study||0
6384792|NCT00802945|7296054|FG001|COMPLETED|Overall Study||0
6384793|NCT00802945|7296053|FG000|NOT COMPLETED|Overall Study||35
6384794|NCT00802945|7296054|FG001|NOT COMPLETED|Overall Study||35
6384795|NCT00802997|7296064|FG000|STARTED|Baseline to 3 Months||34
6384796|NCT00802997|7296065|FG001|STARTED|Baseline to 3 Months||17
6384797|NCT00802997|7296064|FG000|COMPLETED|Baseline to 3 Months||34
6384798|NCT00802997|7296065|FG001|COMPLETED|Baseline to 3 Months||17
6384799|NCT00802997|7296064|FG000|NOT COMPLETED|Baseline to 3 Months||0
6384800|NCT00802997|7296065|FG001|NOT COMPLETED|Baseline to 3 Months||0
6384801|NCT00802997|7296064|FG000|STARTED|3 Months to 6 Months||34
6384802|NCT00802997|7296065|FG001|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
6384803|NCT00802997|7296064|FG000|COMPLETED|3 Months to 6 Months||27
6384804|NCT00802997|7296065|FG001|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
6384805|NCT00802997|7296064|FG000|NOT COMPLETED|3 Months to 6 Months||7
6384806|NCT00802997|7296065|FG001|NOT COMPLETED|3 Months to 6 Months||0
6384807|NCT00802997|7296064|FG000|STARTED|6 Month to 9 Months||27
6384808|NCT00802997|7296065|FG001|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
6565158|NCT01816230|7487958|FG000|COMPLETED|Overall Study||36
6565159|NCT01816230|7487958|FG000|NOT COMPLETED|Overall Study||0
6384809|NCT00802997|7296064|FG000|COMPLETED|6 Month to 9 Months||25
6384810|NCT00802997|7296065|FG001|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
6384811|NCT00802997|7296064|FG000|NOT COMPLETED|6 Month to 9 Months||2
6384812|NCT00802997|7296065|FG001|NOT COMPLETED|6 Month to 9 Months||0
6565160|NCT01816243|7487962|FG000|STARTED|Overall Study||39
6565161|NCT01816243|7487962|FG000|COMPLETED|Overall Study||27
6565162|NCT01816243|7487962|FG000|NOT COMPLETED|Overall Study||12
6565163|NCT01816295|7487968|FG000|STARTED|Double Blind Phase||357
6384813|NCT00803010|7296073|FG000|STARTED|Overall Study||37
6384814|NCT00803010|7296074|FG001|STARTED|Overall Study||37
6384815|NCT00803010|7296073|FG000|COMPLETED|Overall Study||37
6384816|NCT00803010|7296074|FG001|COMPLETED|Overall Study||37
6384817|NCT00803010|7296073|FG000|NOT COMPLETED|Overall Study||0
6384818|NCT00803010|7296074|FG001|NOT COMPLETED|Overall Study||0
6384819|NCT00803023|7296084|FG000|STARTED|Overall Study||32
6384820|NCT00803023|7296085|FG001|STARTED|Overall Study||33
6804786|NCT02779556|7736824|FG000|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (314+19=333 Enhanced Usual Care).|353
6804787|NCT02779556|7736825|FG001|STARTED|6 Month|Those who were not lost to follow-up but missed the visit from the previous period were allowed to continue in the study and complete future interviews (326+27=353 Intervention).|333
6804788|NCT02779556|7736824|FG000|COMPLETED|6 Month||320
6384821|NCT00803023|7296086|FG002|STARTED|Overall Study||31
6384822|NCT00803023|7296087|FG003|STARTED|Overall Study||33
6384823|NCT00803023|7296084|FG000|COMPLETED|Overall Study||27
6384824|NCT00803023|7296085|FG001|COMPLETED|Overall Study||25
6384825|NCT00803023|7296086|FG002|COMPLETED|Overall Study||20
6384826|NCT00803023|7296087|FG003|COMPLETED|Overall Study||25
6384827|NCT00803023|7296084|FG000|NOT COMPLETED|Overall Study||5
6384828|NCT00803023|7296085|FG001|NOT COMPLETED|Overall Study||8
6384829|NCT00803023|7296086|FG002|NOT COMPLETED|Overall Study||11
6384830|NCT00803023|7296087|FG003|NOT COMPLETED|Overall Study||8
6384831|NCT00803049|7296101|FG000|STARTED|Overall Study|Randomized in extension study|129
6384832|NCT00803049|7296102|FG001|STARTED|Overall Study|Randomized in extension study|252
6384833|NCT00803049|7296103|FG002|STARTED|Overall Study|Randomized in extension study|108
6384834|NCT00803049|7296104|FG003|STARTED|Overall Study|Randomized in extension study|253
6384835|NCT00803049|7296101|FG000|Treated|Overall Study||129
6384836|NCT00803049|7296102|FG001|Treated|Overall Study||252
6384837|NCT00803049|7296103|FG002|Treated|Overall Study||108
6384838|NCT00803049|7296104|FG003|Treated|Overall Study||251
6804789|NCT02779556|7736825|FG001|COMPLETED|6 Month||294
6804790|NCT02779556|7736824|FG000|NOT COMPLETED|6 Month||33
6804791|NCT02779556|7736825|FG001|NOT COMPLETED|6 Month||39
6384839|NCT00803049|7296101|FG000|Safety Population|Overall Study||129
6384840|NCT00803049|7296102|FG001|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
6384841|NCT00803049|7296103|FG002|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
6384842|NCT00803049|7296104|FG003|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
6384843|NCT00803049|7296101|FG000|COMPLETED|Overall Study||68
6384844|NCT00803049|7296102|FG001|COMPLETED|Overall Study||134
6384845|NCT00803049|7296103|FG002|COMPLETED|Overall Study||64
6503458|NCT01441245|7422294|FG000|NOT COMPLETED|Overall Study||0
6384846|NCT00803049|7296104|FG003|COMPLETED|Overall Study||151
6384847|NCT00803049|7296101|FG000|NOT COMPLETED|Overall Study||61
6384848|NCT00803049|7296102|FG001|NOT COMPLETED|Overall Study||118
6384849|NCT00803049|7296103|FG002|NOT COMPLETED|Overall Study||44
6565164|NCT01816295|7487969|FG001|STARTED|Double Blind Phase||358
6565165|NCT01816295|7487968|FG000|Received Study Drug|Double Blind Phase||356
6565166|NCT01816295|7487969|FG001|Received Study Drug|Double Blind Phase||354
6565167|NCT01816295|7487968|FG000|COMPLETED|Double Blind Phase||294
6565168|NCT01816295|7487969|FG001|COMPLETED|Double Blind Phase||302
6565169|NCT01816295|7487968|FG000|NOT COMPLETED|Double Blind Phase||63
6565170|NCT01816295|7487969|FG001|NOT COMPLETED|Double Blind Phase||56
6623492|NCT02207907|7550634|FG000|STARTED|Overall Study||124
6623493|NCT02207907|7550635|FG001|STARTED|Overall Study||123
6804792|NCT02779556|7736824|FG000|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
6804793|NCT02779556|7736825|FG001|STARTED|6 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
6804794|NCT02779556|7736824|FG000|COMPLETED|6 Month HbA1c||325
6804795|NCT02779556|7736825|FG001|COMPLETED|6 Month HbA1c||312
6804796|NCT02779556|7736824|FG000|NOT COMPLETED|6 Month HbA1c||69
6804797|NCT02779556|7736825|FG001|NOT COMPLETED|6 Month HbA1c||50
6804798|NCT02779556|7736824|FG000|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|394
6804799|NCT02779556|7736825|FG001|STARTED|12 Month HbA1c|All enrolled participants were eligible for the analysis of clinical values regardless of completion of 3 and 6 month interviews.|362
6804800|NCT02779556|7736824|FG000|COMPLETED|12 Month HbA1c||256
6804801|NCT02779556|7736825|FG001|COMPLETED|12 Month HbA1c||260
6804802|NCT02779556|7736824|FG000|NOT COMPLETED|12 Month HbA1c||138
6804803|NCT02779556|7736825|FG001|NOT COMPLETED|12 Month HbA1c||102
6384850|NCT00803049|7296104|FG003|NOT COMPLETED|Overall Study||102
6384851|NCT00803062|7296118|FG000|STARTED|Overall Study||114
6384852|NCT00803062|7296119|FG001|STARTED|Overall Study||115
6384853|NCT00803062|7296120|FG002|STARTED|Overall Study||111
6384854|NCT00803062|7296121|FG003|STARTED|Overall Study||112
6384855|NCT00803062|7296118|FG000|COMPLETED|Overall Study||114
6384856|NCT00803062|7296119|FG001|COMPLETED|Overall Study||115
6384857|NCT00803062|7296120|FG002|COMPLETED|Overall Study||111
6384858|NCT00803062|7296121|FG003|COMPLETED|Overall Study||112
6384859|NCT00803062|7296118|FG000|NOT COMPLETED|Overall Study||0
6384860|NCT00803062|7296119|FG001|NOT COMPLETED|Overall Study||0
6384861|NCT00803062|7296120|FG002|NOT COMPLETED|Overall Study||0
6384862|NCT00803062|7296121|FG003|NOT COMPLETED|Overall Study||0
6384863|NCT00803101|7296133|FG000|STARTED|Overall Study||88
6384864|NCT00803101|7296134|FG001|STARTED|Overall Study||88
6384865|NCT00803101|7296133|FG000|COMPLETED|Overall Study||70
6384866|NCT00803101|7296134|FG001|COMPLETED|Overall Study||66
6384867|NCT00803101|7296133|FG000|NOT COMPLETED|Overall Study||18
6384868|NCT00803101|7296134|FG001|NOT COMPLETED|Overall Study||22
6384869|NCT00803205|7296142|FG000|STARTED|Overall Study||120
6384870|NCT00803205|7296143|FG001|STARTED|Overall Study||118
6384871|NCT00803205|7296142|FG000|Completed Week 16|Overall Study||107
6565171|NCT01816295|7487968|FG000|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
6565172|NCT01816295|7487969|FG001|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
6565173|NCT01816295|7487968|FG000|COMPLETED|OLE Phase||222
6565174|NCT01816295|7487969|FG001|COMPLETED|OLE Phase||227
6565175|NCT01816295|7487968|FG000|NOT COMPLETED|OLE Phase||53
6565176|NCT01816295|7487969|FG001|NOT COMPLETED|OLE Phase||56
6565177|NCT01816451|7487979|FG000|STARTED|Overall Study||13
6565178|NCT01816451|7487980|FG001|STARTED|Overall Study||11
6565179|NCT01816451|7487981|FG002|STARTED|Overall Study||8
6565180|NCT01816451|7487979|FG000|COMPLETED|Overall Study||13
6565181|NCT01816451|7487980|FG001|COMPLETED|Overall Study||11
6565182|NCT01816451|7487981|FG002|COMPLETED|Overall Study||8
6384872|NCT00803205|7296143|FG001|Completed Week 16|Overall Study||113
6384873|NCT00803205|7296142|FG000|Completed Week 24|Overall Study||103
6384874|NCT00803205|7296143|FG001|Completed Week 24|Overall Study||110
6384875|NCT00803205|7296142|FG000|As-Treated Population*|Overall Study||120
6384876|NCT00803205|7296143|FG001|As-Treated Population*|Overall Study||118
6384877|NCT00803205|7296142|FG000|ITT Population|Overall Study||116
6269986|NCT00078819|7169244|FG002|Received Study Drug|Withdrawal Period: Weeks 37-48||69
6384878|NCT00803205|7296143|FG001|ITT Population|Overall Study||116
6384879|NCT00803205|7296142|FG000|Per Protocol Population|Overall Study||100
6384880|NCT00803205|7296143|FG001|Per Protocol Population|Overall Study||103
6384881|NCT00803205|7296142|FG000|COMPLETED|Overall Study||100
6384882|NCT00803205|7296143|FG001|COMPLETED|Overall Study||104
6384883|NCT00803205|7296142|FG000|NOT COMPLETED|Overall Study||20
6384884|NCT00803205|7296143|FG001|NOT COMPLETED|Overall Study||14
6384885|NCT00803244|7296151|FG000|STARTED|Overall Study||188
6384886|NCT00803244|7296152|FG001|STARTED|Overall Study||193
6384887|NCT00803244|7296151|FG000|COMPLETED|Overall Study||181
6384888|NCT00803244|7296152|FG001|COMPLETED|Overall Study||178
6384889|NCT00803244|7296151|FG000|NOT COMPLETED|Overall Study||7
6384890|NCT00803244|7296152|FG001|NOT COMPLETED|Overall Study||15
6384891|NCT00803270|7296160|FG000|STARTED|Overall Study||13
6384892|NCT00803270|7296161|FG001|STARTED|Overall Study||14
6384893|NCT00803270|7296160|FG000|COMPLETED|Overall Study||12
6384894|NCT00803270|7296161|FG001|COMPLETED|Overall Study||12
6384895|NCT00803270|7296160|FG000|NOT COMPLETED|Overall Study||1
6384896|NCT00803270|7296161|FG001|NOT COMPLETED|Overall Study||2
6384897|NCT00803361|7296169|FG000|STARTED|Overall Study||108
6384898|NCT00803361|7296170|FG001|STARTED|Overall Study||102
6384899|NCT00803361|7296169|FG000|COMPLETED|Overall Study||82
6384900|NCT00803361|7296170|FG001|COMPLETED|Overall Study||74
6384901|NCT00803361|7296169|FG000|NOT COMPLETED|Overall Study||26
6384902|NCT00803361|7296170|FG001|NOT COMPLETED|Overall Study||28
6384903|NCT00803400|7296178|FG000|STARTED|Overall Study||75
6384904|NCT00803400|7296179|FG001|STARTED|Overall Study||75
6384905|NCT00803400|7296178|FG000|COMPLETED|Overall Study||55
6384906|NCT00803400|7296179|FG001|COMPLETED|Overall Study||51
6384907|NCT00803400|7296178|FG000|NOT COMPLETED|Overall Study||20
6384908|NCT00803400|7296179|FG001|NOT COMPLETED|Overall Study||24
6384909|NCT00803452|7296188|FG000|STARTED|Overall Study||9
6384910|NCT00803452|7296189|FG001|STARTED|Overall Study||22
6384911|NCT00803452|7296188|FG000|COMPLETED|Overall Study||9
6384912|NCT00803452|7296189|FG001|COMPLETED|Overall Study||17
6384913|NCT00803452|7296188|FG000|NOT COMPLETED|Overall Study||0
6384914|NCT00803452|7296189|FG001|NOT COMPLETED|Overall Study||5
6384915|NCT00803543|7296197|FG000|STARTED|Overall Study||69
6384916|NCT00803543|7296198|FG001|STARTED|Overall Study||34
6384917|NCT00803543|7296197|FG000|COMPLETED|Overall Study||45
6384918|NCT00803543|7296198|FG001|COMPLETED|Overall Study||22
6384919|NCT00803543|7296197|FG000|NOT COMPLETED|Overall Study||24
6384920|NCT00803543|7296198|FG001|NOT COMPLETED|Overall Study||12
6384921|NCT00803569|7296204|FG000|STARTED|Overall Study||13
6384922|NCT00803569|7296204|FG000|COMPLETED|Overall Study||9
6384923|NCT00803569|7296204|FG000|NOT COMPLETED|Overall Study||4
6384924|NCT00803595|7296211|FG000|STARTED|Overall Study||337
6384925|NCT00803595|7296212|FG001|STARTED|Overall Study||327
6384926|NCT00803595|7296213|FG002|STARTED|Overall Study||338
6384927|NCT00803595|7296211|FG000|COMPLETED|Overall Study||322
6384928|NCT00803595|7296212|FG001|COMPLETED|Overall Study||319
6384929|NCT00803595|7296213|FG002|COMPLETED|Overall Study||322
6384930|NCT00803595|7296211|FG000|NOT COMPLETED|Overall Study||15
6384931|NCT00803595|7296212|FG001|NOT COMPLETED|Overall Study||8
6384932|NCT00803595|7296213|FG002|NOT COMPLETED|Overall Study||16
6384933|NCT00803634|7296223|FG000|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
6384934|NCT00803634|7296224|FG001|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
6384935|NCT00803634|7296223|FG000|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
6384936|NCT00803634|7296224|FG001|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
6384937|NCT00803634|7296223|FG000|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
6384938|NCT00803634|7296224|FG001|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
6384939|NCT00803634|7296223|FG000|NOT COMPLETED|Overall Study||6
6384940|NCT00803634|7296224|FG001|NOT COMPLETED|Overall Study||5
6503459|NCT01441245|7422295|FG001|NOT COMPLETED|Overall Study||0
6503460|NCT01441401|7422317|FG000|STARTED|Overall Study||82
6503461|NCT01441401|7422317|FG000|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
6503462|NCT01441401|7422317|FG000|NOT COMPLETED|Overall Study||0
6503463|NCT01441414|7422335|FG000|STARTED|Overall Study||18
6503464|NCT01441414|7422335|FG000|COMPLETED|Overall Study||3
6503465|NCT01441414|7422335|FG000|NOT COMPLETED|Overall Study||15
6503466|NCT01441440|7422354|FG000|STARTED|Overall Study|Safety analysis set|183
6503467|NCT01441440|7422355|FG001|STARTED|Overall Study|Safety analysis set|174
6503468|NCT01441440|7422356|FG002|STARTED|Overall Study|Safety analysis set|180
6503469|NCT01441440|7422354|FG000|COMPLETED|Overall Study||166
6503470|NCT01441440|7422355|FG001|COMPLETED|Overall Study||151
6503471|NCT01441440|7422356|FG002|COMPLETED|Overall Study||158
6503472|NCT01441440|7422354|FG000|NOT COMPLETED|Overall Study||17
6384941|NCT00803647|7296231|FG000|STARTED|Overall Study||20
6384942|NCT00803647|7296231|FG000|COMPLETED|Overall Study||20
6384943|NCT00803647|7296231|FG000|NOT COMPLETED|Overall Study||0
6384944|NCT00803686|7296239|FG000|STARTED|Part 1, Period 1||6
6384945|NCT00803686|7296240|FG001|STARTED|Part 1, Period 1||6
6384946|NCT00803686|7296241|FG002|STARTED|Part 1, Period 1||0
6384947|NCT00803686|7296242|FG003|STARTED|Part 1, Period 1||0
6384948|NCT00803686|7296239|FG000|COMPLETED|Part 1, Period 1||6
6384949|NCT00803686|7296240|FG001|COMPLETED|Part 1, Period 1||6
6384950|NCT00803686|7296241|FG002|COMPLETED|Part 1, Period 1||0
6384951|NCT00803686|7296242|FG003|COMPLETED|Part 1, Period 1||0
6384952|NCT00803686|7296239|FG000|NOT COMPLETED|Part 1, Period 1||0
6384953|NCT00803686|7296240|FG001|NOT COMPLETED|Part 1, Period 1||0
6384954|NCT00803686|7296241|FG002|NOT COMPLETED|Part 1, Period 1||0
6384955|NCT00803686|7296242|FG003|NOT COMPLETED|Part 1, Period 1||0
6565183|NCT01816451|7487979|FG000|NOT COMPLETED|Overall Study||0
6565184|NCT01816451|7487980|FG001|NOT COMPLETED|Overall Study||0
6565185|NCT01816451|7487981|FG002|NOT COMPLETED|Overall Study||0
6565186|NCT01816477|7487993|FG000|STARTED|Overall Study||43
6565187|NCT01816477|7487994|FG001|STARTED|Overall Study||42
6565188|NCT01816477|7487993|FG000|COMPLETED|Overall Study||27
6565189|NCT01816477|7487994|FG001|COMPLETED|Overall Study||41
6565190|NCT01816477|7487993|FG000|NOT COMPLETED|Overall Study||16
6565191|NCT01816477|7487994|FG001|NOT COMPLETED|Overall Study||1
6565192|NCT01816594|7488002|FG000|STARTED|Overall Study||25
6565193|NCT01816594|7488003|FG001|STARTED|Overall Study||25
6565194|NCT01816594|7488002|FG000|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
6565195|NCT01816594|7488003|FG001|Randomized to the wt Cohort|Overall Study|wt = PIK3CA wild-type|21
6565196|NCT01816594|7488002|FG000|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
6565197|NCT01816594|7488003|FG001|Randomized to the mt Cohort|Overall Study|mt = PIK3CA mutant|4
6565198|NCT01816594|7488002|FG000|COMPLETED|Overall Study||14
6565199|NCT01816594|7488003|FG001|COMPLETED|Overall Study||23
6565200|NCT01816594|7488002|FG000|NOT COMPLETED|Overall Study||11
6565201|NCT01816594|7488003|FG001|NOT COMPLETED|Overall Study||2
6565202|NCT01816685|7488017|FG000|STARTED|Overall Study||68
6565203|NCT01816685|7488018|FG001|STARTED|Overall Study||67
6565204|NCT01816685|7488017|FG000|COMPLETED|Overall Study||58
6565205|NCT01816685|7488018|FG001|COMPLETED|Overall Study||56
6565206|NCT01816685|7488017|FG000|NOT COMPLETED|Overall Study||10
6565207|NCT01816685|7488018|FG001|NOT COMPLETED|Overall Study||11
6656809|NCT02465099|7587152|FG000|STARTED|Overall Study||45
6565208|NCT01816711|7488026|FG000|STARTED|Overall Study||121
6565209|NCT01816711|7488027|FG001|STARTED|Overall Study||83
6565210|NCT01816711|7488026|FG000|COMPLETED|Overall Study||121
6565211|NCT01816711|7488027|FG001|COMPLETED|Overall Study||83
6565212|NCT01816711|7488026|FG000|NOT COMPLETED|Overall Study||0
6656810|NCT02465099|7587153|FG001|STARTED|Overall Study||19
6804804|NCT02724774|7736833|FG000|STARTED|Overall Study||127
6804805|NCT02724774|7736834|FG001|STARTED|Overall Study||125
6804806|NCT02724774|7736833|FG000|Infant 6 Months|Overall Study||122
6384956|NCT00803686|7296239|FG000|STARTED|Part 1, Period 2||6
6384957|NCT00803686|7296240|FG001|STARTED|Part 1, Period 2||6
6384958|NCT00803686|7296241|FG002|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
6384959|NCT00803686|7296242|FG003|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
6384960|NCT00803686|7296239|FG000|COMPLETED|Part 1, Period 2||6
6384961|NCT00803686|7296240|FG001|COMPLETED|Part 1, Period 2||6
6384962|NCT00803686|7296241|FG002|COMPLETED|Part 1, Period 2|No subjects treated.|0
6384963|NCT00803686|7296242|FG003|COMPLETED|Part 1, Period 2|No subjects treated.|0
6384964|NCT00803686|7296239|FG000|NOT COMPLETED|Part 1, Period 2||0
6384965|NCT00803686|7296240|FG001|NOT COMPLETED|Part 1, Period 2||0
6804807|NCT02724774|7736834|FG001|Infant 6 Months|Overall Study||122
6804808|NCT02724774|7736833|FG000|Infant 12 Months|Overall Study||120
6804809|NCT02724774|7736834|FG001|Infant 12 Months|Overall Study||123
6804810|NCT02724774|7736833|FG000|COMPLETED|Overall Study||120
6804811|NCT02724774|7736834|FG001|COMPLETED|Overall Study||123
6804812|NCT02724774|7736833|FG000|NOT COMPLETED|Overall Study||7
6804813|NCT02724774|7736834|FG001|NOT COMPLETED|Overall Study||2
6804814|NCT02722941|7736842|FG000|STARTED|Overall Study||15
6804815|NCT02722941|7736843|FG001|STARTED|Overall Study||15
6804816|NCT02722941|7736842|FG000|COMPLETED|Overall Study||15
6804817|NCT02722941|7736843|FG001|COMPLETED|Overall Study||15
6804818|NCT02722941|7736842|FG000|NOT COMPLETED|Overall Study||0
6565213|NCT01816711|7488027|FG001|NOT COMPLETED|Overall Study||0
6565214|NCT01816763|7488036|FG000|STARTED|Overall Study||195
6565215|NCT01816763|7488037|FG001|STARTED|Overall Study||194
6565216|NCT01816763|7488038|FG002|STARTED|Overall Study||180
6565217|NCT01816763|7488036|FG000|COMPLETED|Overall Study||191
6565218|NCT01816763|7488037|FG001|COMPLETED|Overall Study||179
6565219|NCT01816763|7488038|FG002|COMPLETED|Overall Study||169
6565220|NCT01816763|7488036|FG000|NOT COMPLETED|Overall Study||4
6565221|NCT01816763|7488037|FG001|NOT COMPLETED|Overall Study||15
6565222|NCT01816763|7488038|FG002|NOT COMPLETED|Overall Study||11
6565223|NCT01816776|7488051|FG000|STARTED|Overall Study||73
6565224|NCT01816776|7488052|FG001|STARTED|Overall Study||78
6565225|NCT01816776|7488051|FG000|6 Month Primary Effectiveness Assessed|Overall Study||68
6804819|NCT02722941|7736843|FG001|NOT COMPLETED|Overall Study||0
6384966|NCT00803686|7296241|FG002|NOT COMPLETED|Part 1, Period 2||0
6384967|NCT00803686|7296242|FG003|NOT COMPLETED|Part 1, Period 2||0
6384968|NCT00803686|7296239|FG000|STARTED|Part 2, Period 3|No subjects were treated in this period|0
6384969|NCT00803686|7296240|FG001|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
6384970|NCT00803686|7296241|FG002|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
6384971|NCT00803686|7296242|FG003|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
6384972|NCT00803686|7296239|FG000|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
6384973|NCT00803686|7296240|FG001|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
6384974|NCT00803686|7296241|FG002|COMPLETED|Part 2, Period 3|All who started this period completed|5
6384975|NCT00803686|7296242|FG003|COMPLETED|Part 2, Period 3|All who started this period completed|4
6384976|NCT00803686|7296239|FG000|NOT COMPLETED|Part 2, Period 3||0
6384977|NCT00803686|7296240|FG001|NOT COMPLETED|Part 2, Period 3||0
6384978|NCT00803686|7296241|FG002|NOT COMPLETED|Part 2, Period 3||0
6384979|NCT00803686|7296242|FG003|NOT COMPLETED|Part 2, Period 3||0
6384980|NCT00803712|7296256|FG000|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
6384981|NCT00803712|7296257|FG001|STARTED|Overall Study|155 participants were randomized to the control group|155
6384982|NCT00803712|7296256|FG000|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
6384983|NCT00803712|7296257|FG001|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
6384984|NCT00803712|7296256|FG000|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
6384985|NCT00803712|7296257|FG001|Safety Analysis Set|Overall Study|Randomized to the control group|154
6384986|NCT00803712|7296256|FG000|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
6384987|NCT00803712|7296257|FG001|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
6384988|NCT00803712|7296256|FG000|NOT COMPLETED|Overall Study||36
6384989|NCT00803712|7296257|FG001|NOT COMPLETED|Overall Study||27
6384990|NCT00803738|7296265|FG000|STARTED|Overall Study||286
6384991|NCT00803738|7296266|FG001|STARTED|Overall Study||286
6384992|NCT00803738|7296265|FG000|COMPLETED|Overall Study||192
6384993|NCT00803738|7296266|FG001|COMPLETED|Overall Study||176
6804820|NCT02675751|7736849|FG000|STARTED|Overall Study||167
6804821|NCT02675751|7736849|FG000|COMPLETED|Overall Study||151
6804822|NCT02675751|7736849|FG000|NOT COMPLETED|Overall Study||16
6804823|NCT02643381|7736855|FG000|STARTED|Overall Study||400
6804824|NCT02643381|7736856|FG001|STARTED|Overall Study||401
6804825|NCT02643381|7736855|FG000|COMPLETED|Overall Study||396
6804826|NCT02643381|7736856|FG001|COMPLETED|Overall Study||395
6804827|NCT02643381|7736855|FG000|NOT COMPLETED|Overall Study||4
6804828|NCT02643381|7736856|FG001|NOT COMPLETED|Overall Study||6
6384994|NCT00803738|7296265|FG000|NOT COMPLETED|Overall Study||94
6384995|NCT00803738|7296266|FG001|NOT COMPLETED|Overall Study||110
6384996|NCT00803751|7296274|FG000|STARTED|Overall Study||26
6384997|NCT00803751|7296275|FG001|STARTED|Overall Study||23
6384998|NCT00803751|7296274|FG000|COMPLETED|Overall Study||26
6384999|NCT00803751|7296275|FG001|COMPLETED|Overall Study||23
6385000|NCT00803751|7296274|FG000|NOT COMPLETED|Overall Study||0
6503473|NCT01441440|7422355|FG001|NOT COMPLETED|Overall Study||23
6503474|NCT01441440|7422356|FG002|NOT COMPLETED|Overall Study||22
6503475|NCT01441466|7422366|FG000|STARTED|Overall Study||37
6503476|NCT01441466|7422367|FG001|STARTED|Overall Study||11
6503477|NCT01441466|7422366|FG000|COMPLETED|Overall Study||37
6503478|NCT01441466|7422367|FG001|COMPLETED|Overall Study||11
6503479|NCT01441466|7422366|FG000|NOT COMPLETED|Overall Study||0
6385001|NCT00803751|7296275|FG001|NOT COMPLETED|Overall Study||0
6385002|NCT00803777|7296281|FG000|STARTED|Overall Study||147
6385003|NCT00803777|7296281|FG000|COMPLETED|Overall Study||147
6385004|NCT00803777|7296281|FG000|NOT COMPLETED|Overall Study||0
6385005|NCT00803959|7296287|FG000|STARTED|Overall Study||315
6385006|NCT00803959|7296288|FG001|STARTED|Overall Study||315
6385007|NCT00803959|7296287|FG000|ITT Analysis With Primary Outcome Data|Overall Study||266
6385008|NCT00803959|7296288|FG001|ITT Analysis With Primary Outcome Data|Overall Study||272
6385009|NCT00803959|7296287|FG000|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
6385010|NCT00803959|7296288|FG001|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
6385011|NCT00803959|7296287|FG000|NOT COMPLETED|Overall Study||56
6385012|NCT00803959|7296288|FG001|NOT COMPLETED|Overall Study||51
6385013|NCT00804141|7296294|FG000|STARTED|Overall Study||1040
6385014|NCT00804141|7296294|FG000|Received at Least 1 Dose of Study Drug|Overall Study||1034
6385015|NCT00804141|7296294|FG000|COMPLETED|Overall Study||477
6385016|NCT00804141|7296294|FG000|NOT COMPLETED|Overall Study||563
6503480|NCT01441466|7422367|FG001|NOT COMPLETED|Overall Study||0
6565226|NCT01816776|7488052|FG001|6 Month Primary Effectiveness Assessed|Overall Study||73
6565227|NCT01816776|7488051|FG000|COMPLETED|Overall Study||60
6565228|NCT01816776|7488052|FG001|COMPLETED|Overall Study||70
6565229|NCT01816776|7488051|FG000|NOT COMPLETED|Overall Study||13
6565230|NCT01816776|7488052|FG001|NOT COMPLETED|Overall Study||8
6565231|NCT01816893|7488060|FG000|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
6565232|NCT01816893|7488061|FG001|STARTED|Euglycemic Clamp/ Hypoglycemic Clamp||11
6565233|NCT01816893|7488060|FG000|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
6565234|NCT01816893|7488061|FG001|COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||11
6565235|NCT01816893|7488060|FG000|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
6565236|NCT01816893|7488061|FG001|NOT COMPLETED|Euglycemic Clamp/ Hypoglycemic Clamp||0
6565237|NCT01816893|7488060|FG000|STARTED|Washout Period||11
6565238|NCT01816893|7488061|FG001|STARTED|Washout Period||11
6565239|NCT01816893|7488060|FG000|COMPLETED|Washout Period||9
6565240|NCT01816893|7488061|FG001|COMPLETED|Washout Period||11
6385017|NCT00804193|7296301|FG000|STARTED|Overall Study||220
6385018|NCT00804193|7296302|FG001|STARTED|Overall Study||224
6385019|NCT00804193|7296303|FG002|STARTED|Overall Study||109
6385020|NCT00804193|7296301|FG000|COMPLETED|Overall Study||181
6385021|NCT00804193|7296302|FG001|COMPLETED|Overall Study||180
6385022|NCT00804193|7296303|FG002|COMPLETED|Overall Study||77
6385023|NCT00804193|7296301|FG000|NOT COMPLETED|Overall Study||39
6565241|NCT01816893|7488060|FG000|NOT COMPLETED|Washout Period||2
6565242|NCT01816893|7488061|FG001|NOT COMPLETED|Washout Period||0
6565243|NCT01816893|7488060|FG000|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||9
6565244|NCT01816893|7488061|FG001|STARTED|Hypoglycemic Clamp/ Euglycemic Clamp||11
6565245|NCT01816893|7488060|FG000|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||9
6565246|NCT01816893|7488061|FG001|COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||11
6565247|NCT01816893|7488060|FG000|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
6565248|NCT01816893|7488061|FG001|NOT COMPLETED|Hypoglycemic Clamp/ Euglycemic Clamp||0
6623494|NCT02207907|7550634|FG000|COMPLETED|Overall Study||113
6656811|NCT02465099|7587152|FG000|COMPLETED|Overall Study||45
6656812|NCT02465099|7587153|FG001|COMPLETED|Overall Study||19
6656813|NCT02465099|7587152|FG000|NOT COMPLETED|Overall Study||0
6656814|NCT02465099|7587153|FG001|NOT COMPLETED|Overall Study||0
6385024|NCT00804193|7296302|FG001|NOT COMPLETED|Overall Study||44
6656815|NCT02465203|7587162|FG000|STARTED|Overall Study||56
6656816|NCT02465203|7587163|FG001|STARTED|Overall Study||36
6385025|NCT00804193|7296303|FG002|NOT COMPLETED|Overall Study||32
6385026|NCT00804570|7296313|FG000|STARTED|Overall Study||187
6385027|NCT00804570|7296314|FG001|STARTED|Overall Study||188
6385028|NCT00804570|7296313|FG000|COMPLETED|Overall Study||115
6385029|NCT00804570|7296314|FG001|COMPLETED|Overall Study||94
6385030|NCT00804570|7296313|FG000|NOT COMPLETED|Overall Study||72
6385031|NCT00804570|7296314|FG001|NOT COMPLETED|Overall Study||94
6385032|NCT00804596|7296321|FG000|STARTED|Overall Study||74
6385033|NCT00804596|7296321|FG000|COMPLETED|Overall Study||74
6385034|NCT00804596|7296321|FG000|NOT COMPLETED|Overall Study||0
6385035|NCT00804609|7296327|FG000|STARTED|Overall Study||15
6385036|NCT00804609|7296328|FG001|STARTED|Overall Study||15
6385037|NCT00804609|7296327|FG000|COMPLETED|Overall Study||15
6385038|NCT00804609|7296328|FG001|COMPLETED|Overall Study||14
6385039|NCT00804609|7296327|FG000|NOT COMPLETED|Overall Study||0
6385040|NCT00804609|7296328|FG001|NOT COMPLETED|Overall Study||1
6385041|NCT00804648|7296334|FG000|STARTED|First Intervention||3
6385042|NCT00804648|7296335|FG001|STARTED|First Intervention||5
6385043|NCT00804648|7296336|FG002|STARTED|First Intervention||6
6385044|NCT00804648|7296337|FG003|STARTED|First Intervention||4
6385045|NCT00804648|7296338|FG004|STARTED|First Intervention||4
6385046|NCT00804648|7296339|FG005|STARTED|First Intervention||8
6385047|NCT00804648|7296334|FG000|COMPLETED|First Intervention||3
6385048|NCT00804648|7296335|FG001|COMPLETED|First Intervention||5
6385049|NCT00804648|7296336|FG002|COMPLETED|First Intervention||6
6385050|NCT00804648|7296337|FG003|COMPLETED|First Intervention||4
6385051|NCT00804648|7296338|FG004|COMPLETED|First Intervention||4
6385052|NCT00804648|7296339|FG005|COMPLETED|First Intervention||8
6385053|NCT00804648|7296334|FG000|NOT COMPLETED|First Intervention||0
6385054|NCT00804648|7296335|FG001|NOT COMPLETED|First Intervention||0
6385055|NCT00804648|7296336|FG002|NOT COMPLETED|First Intervention||0
6385056|NCT00804648|7296337|FG003|NOT COMPLETED|First Intervention||0
6385057|NCT00804648|7296338|FG004|NOT COMPLETED|First Intervention||0
6385058|NCT00804648|7296339|FG005|NOT COMPLETED|First Intervention||0
6385059|NCT00804648|7296334|FG000|STARTED|Second Intervention||3
6385060|NCT00804648|7296335|FG001|STARTED|Second Intervention||5
6385061|NCT00804648|7296336|FG002|STARTED|Second Intervention||6
6385062|NCT00804648|7296337|FG003|STARTED|Second Intervention||4
6385063|NCT00804648|7296338|FG004|STARTED|Second Intervention||4
6385064|NCT00804648|7296339|FG005|STARTED|Second Intervention||8
6385065|NCT00804648|7296334|FG000|COMPLETED|Second Intervention||3
6385066|NCT00804648|7296335|FG001|COMPLETED|Second Intervention||5
6385067|NCT00804648|7296336|FG002|COMPLETED|Second Intervention||6
6385068|NCT00804648|7296337|FG003|COMPLETED|Second Intervention||4
6385069|NCT00804648|7296338|FG004|COMPLETED|Second Intervention||4
6385070|NCT00804648|7296339|FG005|COMPLETED|Second Intervention||8
6385071|NCT00804648|7296334|FG000|NOT COMPLETED|Second Intervention||0
6385072|NCT00804648|7296335|FG001|NOT COMPLETED|Second Intervention||0
6385073|NCT00804648|7296336|FG002|NOT COMPLETED|Second Intervention||0
6385074|NCT00804648|7296337|FG003|NOT COMPLETED|Second Intervention||0
6385075|NCT00804648|7296338|FG004|NOT COMPLETED|Second Intervention||0
6385076|NCT00804648|7296339|FG005|NOT COMPLETED|Second Intervention||0
6385077|NCT00804648|7296334|FG000|STARTED|Third Invervention||3
6385078|NCT00804648|7296335|FG001|STARTED|Third Invervention||5
6385079|NCT00804648|7296336|FG002|STARTED|Third Invervention||6
6385080|NCT00804648|7296337|FG003|STARTED|Third Invervention||4
6385081|NCT00804648|7296338|FG004|STARTED|Third Invervention||4
6385082|NCT00804648|7296339|FG005|STARTED|Third Invervention||8
6385083|NCT00804648|7296334|FG000|COMPLETED|Third Invervention||3
6385084|NCT00804648|7296335|FG001|COMPLETED|Third Invervention||5
6385085|NCT00804648|7296336|FG002|COMPLETED|Third Invervention||6
6385086|NCT00804648|7296337|FG003|COMPLETED|Third Invervention||4
6385087|NCT00804648|7296338|FG004|COMPLETED|Third Invervention||4
6385088|NCT00804648|7296339|FG005|COMPLETED|Third Invervention||8
6385089|NCT00804648|7296334|FG000|NOT COMPLETED|Third Invervention||0
6385090|NCT00804648|7296335|FG001|NOT COMPLETED|Third Invervention||0
6385091|NCT00804648|7296336|FG002|NOT COMPLETED|Third Invervention||0
6385092|NCT00804648|7296337|FG003|NOT COMPLETED|Third Invervention||0
6804829|NCT02621424|7736864|FG000|STARTED|Overall Study||14
6804830|NCT02621424|7736865|FG001|STARTED|Overall Study||18
6804831|NCT02621424|7736864|FG000|COMPLETED|Overall Study||13
6804832|NCT02621424|7736865|FG001|COMPLETED|Overall Study||16
6804833|NCT02621424|7736864|FG000|NOT COMPLETED|Overall Study||1
6804834|NCT02621424|7736865|FG001|NOT COMPLETED|Overall Study||2
6385093|NCT00804648|7296338|FG004|NOT COMPLETED|Third Invervention||0
6385094|NCT00804648|7296339|FG005|NOT COMPLETED|Third Invervention||0
6385095|NCT00804687|7296347|FG000|STARTED|Period 1: Treatment Period||9
6385096|NCT00804687|7296348|FG001|STARTED|Period 1: Treatment Period||9
6385097|NCT00804687|7296349|FG002|STARTED|Period 1: Treatment Period||9
6385098|NCT00804687|7296350|FG003|STARTED|Period 1: Treatment Period||9
6385099|NCT00804687|7296351|FG004|STARTED|Period 1: Treatment Period||9
6385100|NCT00804687|7296352|FG005|STARTED|Period 1: Treatment Period||8
6385101|NCT00804687|7296347|FG000|COMPLETED|Period 1: Treatment Period||9
6385102|NCT00804687|7296348|FG001|COMPLETED|Period 1: Treatment Period||9
6385103|NCT00804687|7296349|FG002|COMPLETED|Period 1: Treatment Period||9
6385104|NCT00804687|7296350|FG003|COMPLETED|Period 1: Treatment Period||9
6385105|NCT00804687|7296351|FG004|COMPLETED|Period 1: Treatment Period||9
6385106|NCT00804687|7296352|FG005|COMPLETED|Period 1: Treatment Period||8
6385107|NCT00804687|7296347|FG000|NOT COMPLETED|Period 1: Treatment Period||0
6385108|NCT00804687|7296348|FG001|NOT COMPLETED|Period 1: Treatment Period||0
6385109|NCT00804687|7296349|FG002|NOT COMPLETED|Period 1: Treatment Period||0
6385110|NCT00804687|7296350|FG003|NOT COMPLETED|Period 1: Treatment Period||0
6385111|NCT00804687|7296351|FG004|NOT COMPLETED|Period 1: Treatment Period||0
6385112|NCT00804687|7296352|FG005|NOT COMPLETED|Period 1: Treatment Period||0
6385113|NCT00804687|7296347|FG000|STARTED|Period 2: Washout Period||9
6385114|NCT00804687|7296348|FG001|STARTED|Period 2: Washout Period||9
6385115|NCT00804687|7296349|FG002|STARTED|Period 2: Washout Period||9
6385116|NCT00804687|7296350|FG003|STARTED|Period 2: Washout Period||9
6385117|NCT00804687|7296351|FG004|STARTED|Period 2: Washout Period||9
6385118|NCT00804687|7296352|FG005|STARTED|Period 2: Washout Period||8
6385119|NCT00804687|7296347|FG000|COMPLETED|Period 2: Washout Period||9
6385120|NCT00804687|7296348|FG001|COMPLETED|Period 2: Washout Period||9
6385121|NCT00804687|7296349|FG002|COMPLETED|Period 2: Washout Period||9
6385122|NCT00804687|7296350|FG003|COMPLETED|Period 2: Washout Period||9
6385123|NCT00804687|7296351|FG004|COMPLETED|Period 2: Washout Period||9
6385124|NCT00804687|7296352|FG005|COMPLETED|Period 2: Washout Period||8
6385125|NCT00804687|7296347|FG000|NOT COMPLETED|Period 2: Washout Period||0
6385126|NCT00804687|7296348|FG001|NOT COMPLETED|Period 2: Washout Period||0
6385127|NCT00804687|7296349|FG002|NOT COMPLETED|Period 2: Washout Period||0
6385128|NCT00804687|7296350|FG003|NOT COMPLETED|Period 2: Washout Period||0
6385129|NCT00804687|7296351|FG004|NOT COMPLETED|Period 2: Washout Period||0
6385130|NCT00804687|7296352|FG005|NOT COMPLETED|Period 2: Washout Period||0
6385131|NCT00804687|7296347|FG000|STARTED|Period 3: Treatment Period||9
6385132|NCT00804687|7296348|FG001|STARTED|Period 3: Treatment Period||9
6385133|NCT00804687|7296349|FG002|STARTED|Period 3: Treatment Period||9
6385134|NCT00804687|7296350|FG003|STARTED|Period 3: Treatment Period||9
6385135|NCT00804687|7296351|FG004|STARTED|Period 3: Treatment Period||9
6385136|NCT00804687|7296352|FG005|STARTED|Period 3: Treatment Period||8
6385137|NCT00804687|7296347|FG000|COMPLETED|Period 3: Treatment Period||9
6385138|NCT00804687|7296348|FG001|COMPLETED|Period 3: Treatment Period||9
6385139|NCT00804687|7296349|FG002|COMPLETED|Period 3: Treatment Period||9
6385140|NCT00804687|7296350|FG003|COMPLETED|Period 3: Treatment Period||8
6385141|NCT00804687|7296351|FG004|COMPLETED|Period 3: Treatment Period||9
6385142|NCT00804687|7296352|FG005|COMPLETED|Period 3: Treatment Period||8
6385143|NCT00804687|7296347|FG000|NOT COMPLETED|Period 3: Treatment Period||0
6385144|NCT00804687|7296348|FG001|NOT COMPLETED|Period 3: Treatment Period||0
6385145|NCT00804687|7296349|FG002|NOT COMPLETED|Period 3: Treatment Period||0
6385146|NCT00804687|7296350|FG003|NOT COMPLETED|Period 3: Treatment Period||1
6385147|NCT00804687|7296351|FG004|NOT COMPLETED|Period 3: Treatment Period||0
6385148|NCT00804687|7296352|FG005|NOT COMPLETED|Period 3: Treatment Period||0
6385149|NCT00804687|7296347|FG000|STARTED|Period 4: Washout Period||9
6385150|NCT00804687|7296348|FG001|STARTED|Period 4: Washout Period||9
6385151|NCT00804687|7296349|FG002|STARTED|Period 4: Washout Period||9
6385152|NCT00804687|7296350|FG003|STARTED|Period 4: Washout Period||8
6385153|NCT00804687|7296351|FG004|STARTED|Period 4: Washout Period||9
6385154|NCT00804687|7296352|FG005|STARTED|Period 4: Washout Period||8
6385155|NCT00804687|7296347|FG000|COMPLETED|Period 4: Washout Period||9
6385156|NCT00804687|7296348|FG001|COMPLETED|Period 4: Washout Period||9
6385157|NCT00804687|7296349|FG002|COMPLETED|Period 4: Washout Period||9
6804835|NCT02595372|7736871|FG000|STARTED|Overall Study||42
6804836|NCT02595372|7736871|FG000|COMPLETED|Overall Study||33
6804837|NCT02595372|7736871|FG000|NOT COMPLETED|Overall Study||9
6804838|NCT02447133|7736875|FG000|STARTED|Overall Study||12
6804839|NCT02447133|7736875|FG000|COMPLETED|Overall Study||12
6804840|NCT02447133|7736875|FG000|NOT COMPLETED|Overall Study||0
6385158|NCT00804687|7296350|FG003|COMPLETED|Period 4: Washout Period||8
6385159|NCT00804687|7296351|FG004|COMPLETED|Period 4: Washout Period||9
6269987|NCT00078819|7169245|FG003|Received Study Drug|Withdrawal Period: Weeks 37-48||68
6269988|NCT00078819|7169242|FG000|COMPLETED|Withdrawal Period: Weeks 37-48||0
6269989|NCT00078819|7169243|FG001|COMPLETED|Withdrawal Period: Weeks 37-48||0
6269990|NCT00078819|7169244|FG002|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|40
6269991|NCT00078819|7169245|FG003|COMPLETED|Withdrawal Period: Weeks 37-48|Defined as continuing to receive blinded study drug through week 48|55
6269992|NCT00078819|7169242|FG000|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
6269993|NCT00078819|7169243|FG001|NOT COMPLETED|Withdrawal Period: Weeks 37-48||0
6269994|NCT00078819|7169244|FG002|NOT COMPLETED|Withdrawal Period: Weeks 37-48||29
6269995|NCT00078819|7169245|FG003|NOT COMPLETED|Withdrawal Period: Weeks 37-48||14
6269996|NCT00078819|7169242|FG000|STARTED|Re-treatment Period||0
6269997|NCT00078819|7169243|FG001|STARTED|Re-treatment Period||0
6269998|NCT00078819|7169244|FG002|STARTED|Re-treatment Period||29
6269999|NCT00078819|7169245|FG003|STARTED|Re-treatment Period||13
6270000|NCT00078819|7169242|FG000|Received Study Drug|Re-treatment Period||0
6270001|NCT00078819|7169243|FG001|Received Study Drug|Re-treatment Period||0
6270002|NCT00078819|7169244|FG002|Received Study Drug|Re-treatment Period|One additional participant received re-treatment without having disease relapse|30
6270003|NCT00078819|7169245|FG003|Received Study Drug|Re-treatment Period||12
6565249|NCT01816906|7488069|FG000|STARTED|Six Months||41
6565250|NCT01816906|7488070|FG001|STARTED|Six Months||41
6565251|NCT01816906|7488069|FG000|COMPLETED|Six Months||20
6385160|NCT00804687|7296352|FG005|COMPLETED|Period 4: Washout Period||8
6385161|NCT00804687|7296347|FG000|NOT COMPLETED|Period 4: Washout Period||0
6385162|NCT00804687|7296348|FG001|NOT COMPLETED|Period 4: Washout Period||0
6385163|NCT00804687|7296349|FG002|NOT COMPLETED|Period 4: Washout Period||0
6385164|NCT00804687|7296350|FG003|NOT COMPLETED|Period 4: Washout Period||0
6385165|NCT00804687|7296351|FG004|NOT COMPLETED|Period 4: Washout Period||0
6385166|NCT00804687|7296352|FG005|NOT COMPLETED|Period 4: Washout Period||0
6385167|NCT00804687|7296347|FG000|STARTED|Period 5: Treatment Period||9
6385168|NCT00804687|7296348|FG001|STARTED|Period 5: Treatment Period||9
6385169|NCT00804687|7296349|FG002|STARTED|Period 5: Treatment Period||9
6385170|NCT00804687|7296350|FG003|STARTED|Period 5: Treatment Period||8
6385171|NCT00804687|7296351|FG004|STARTED|Period 5: Treatment Period||9
6385172|NCT00804687|7296352|FG005|STARTED|Period 5: Treatment Period||8
6385173|NCT00804687|7296347|FG000|COMPLETED|Period 5: Treatment Period||8
6385174|NCT00804687|7296348|FG001|COMPLETED|Period 5: Treatment Period||9
6385175|NCT00804687|7296349|FG002|COMPLETED|Period 5: Treatment Period||8
6385176|NCT00804687|7296350|FG003|COMPLETED|Period 5: Treatment Period||8
6385177|NCT00804687|7296351|FG004|COMPLETED|Period 5: Treatment Period||8
6385178|NCT00804687|7296352|FG005|COMPLETED|Period 5: Treatment Period||8
6385179|NCT00804687|7296347|FG000|NOT COMPLETED|Period 5: Treatment Period||1
6385180|NCT00804687|7296348|FG001|NOT COMPLETED|Period 5: Treatment Period||0
6385181|NCT00804687|7296349|FG002|NOT COMPLETED|Period 5: Treatment Period||1
6385182|NCT00804687|7296350|FG003|NOT COMPLETED|Period 5: Treatment Period||0
6385183|NCT00804687|7296351|FG004|NOT COMPLETED|Period 5: Treatment Period||1
6385184|NCT00804687|7296352|FG005|NOT COMPLETED|Period 5: Treatment Period||0
6385185|NCT00804843|7296362|FG000|STARTED|Overall Study||50
6385186|NCT00804843|7296363|FG001|STARTED|Overall Study||50
6385187|NCT00804843|7296362|FG000|COMPLETED|Overall Study||40
6385188|NCT00804843|7296363|FG001|COMPLETED|Overall Study||43
6385189|NCT00804843|7296362|FG000|NOT COMPLETED|Overall Study||10
6385190|NCT00804843|7296363|FG001|NOT COMPLETED|Overall Study||7
6385191|NCT00804908|7296373|FG000|STARTED|Overall Study||115
6385192|NCT00804908|7296374|FG001|STARTED|Overall Study||116
6385193|NCT00804908|7296375|FG002|STARTED|Overall Study||115
6385194|NCT00804908|7296373|FG000|COMPLETED|Overall Study||0
6385195|NCT00804908|7296374|FG001|COMPLETED|Overall Study||0
6385196|NCT00804908|7296375|FG002|COMPLETED|Overall Study||1
6385197|NCT00804908|7296373|FG000|NOT COMPLETED|Overall Study||115
6385198|NCT00804908|7296374|FG001|NOT COMPLETED|Overall Study||116
6385199|NCT00804908|7296375|FG002|NOT COMPLETED|Overall Study||114
6385200|NCT00804973|7296386|FG000|STARTED|Overall Study||40
6385201|NCT00804973|7296387|FG001|STARTED|Overall Study||40
6385202|NCT00804973|7296388|FG002|STARTED|Overall Study||40
6385203|NCT00804973|7296386|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
6385204|NCT00804973|7296387|FG001|Received at Least 1 Dose of Study Drug|Overall Study||40
6385205|NCT00804973|7296388|FG002|Received at Least 1 Dose of Study Drug|Overall Study||40
6385206|NCT00804973|7296386|FG000|COMPLETED|Overall Study||40
6385207|NCT00804973|7296387|FG001|COMPLETED|Overall Study||40
6385208|NCT00804973|7296388|FG002|COMPLETED|Overall Study||40
6385209|NCT00804973|7296386|FG000|NOT COMPLETED|Overall Study||0
6385210|NCT00804973|7296387|FG001|NOT COMPLETED|Overall Study||0
6385211|NCT00804973|7296388|FG002|NOT COMPLETED|Overall Study||0
6385212|NCT00804986|7296402|FG000|STARTED|Overall Study||36
6385213|NCT00804986|7296403|FG001|STARTED|Overall Study||43
6385214|NCT00804986|7296404|FG002|STARTED|Overall Study||42
6385215|NCT00804986|7296405|FG003|STARTED|Overall Study||42
6385216|NCT00804986|7296406|FG004|STARTED|Overall Study||43
6385217|NCT00804986|7296407|FG005|STARTED|Overall Study||41
6385218|NCT00804986|7296402|FG000|COMPLETED|Overall Study||35
6385219|NCT00804986|7296403|FG001|COMPLETED|Overall Study||35
6385220|NCT00804986|7296404|FG002|COMPLETED|Overall Study||40
6385221|NCT00804986|7296405|FG003|COMPLETED|Overall Study||34
6385222|NCT00804986|7296406|FG004|COMPLETED|Overall Study||34
6385223|NCT00804986|7296407|FG005|COMPLETED|Overall Study||31
6385224|NCT00804986|7296402|FG000|NOT COMPLETED|Overall Study||1
6385225|NCT00804986|7296403|FG001|NOT COMPLETED|Overall Study||8
6385226|NCT00804986|7296404|FG002|NOT COMPLETED|Overall Study||2
6385227|NCT00804986|7296405|FG003|NOT COMPLETED|Overall Study||8
6385228|NCT00804986|7296406|FG004|NOT COMPLETED|Overall Study||9
6385229|NCT00804986|7296407|FG005|NOT COMPLETED|Overall Study||10
6385230|NCT00804999|7296425|FG000|STARTED|Overall Study||15
6385231|NCT00804999|7296426|FG001|STARTED|Overall Study||12
6385232|NCT00804999|7296427|FG002|STARTED|Overall Study||14
6385233|NCT00804999|7296428|FG003|STARTED|Overall Study||10
6503481|NCT01441492|7422376|FG000|STARTED|Overall Study||197
6385234|NCT00804999|7296425|FG000|COMPLETED|Overall Study||15
6385235|NCT00804999|7296426|FG001|COMPLETED|Overall Study||12
6385236|NCT00804999|7296427|FG002|COMPLETED|Overall Study||14
6565252|NCT01816906|7488070|FG001|COMPLETED|Six Months||19
6565253|NCT01816906|7488069|FG000|NOT COMPLETED|Six Months||21
6565254|NCT01816906|7488070|FG001|NOT COMPLETED|Six Months||22
6565255|NCT01816906|7488069|FG000|STARTED|12 Months||20
6565256|NCT01816906|7488070|FG001|STARTED|12 Months||19
6565257|NCT01816906|7488069|FG000|COMPLETED|12 Months||16
6565258|NCT01816906|7488070|FG001|COMPLETED|12 Months||14
6565259|NCT01816906|7488069|FG000|NOT COMPLETED|12 Months||4
6565260|NCT01816906|7488070|FG001|NOT COMPLETED|12 Months||5
6565261|NCT01816945|7488079|FG000|STARTED|Overall Study||23
6565262|NCT01816945|7488080|FG001|STARTED|Overall Study||24
6565263|NCT01816945|7488079|FG000|COMPLETED|Overall Study||21
6565264|NCT01816945|7488080|FG001|COMPLETED|Overall Study||19
6565265|NCT01816945|7488079|FG000|NOT COMPLETED|Overall Study||2
6565266|NCT01816945|7488080|FG001|NOT COMPLETED|Overall Study||5
6385237|NCT00804999|7296428|FG003|COMPLETED|Overall Study||10
6385238|NCT00804999|7296425|FG000|NOT COMPLETED|Overall Study||0
6565267|NCT01816984|7488086|FG000|STARTED|Overall Study||12
6565268|NCT01816984|7488086|FG000|COMPLETED|Overall Study||11
6565269|NCT01816984|7488086|FG000|NOT COMPLETED|Overall Study||1
6385239|NCT00804999|7296426|FG001|NOT COMPLETED|Overall Study||0
6385240|NCT00804999|7296427|FG002|NOT COMPLETED|Overall Study||0
6385241|NCT00804999|7296428|FG003|NOT COMPLETED|Overall Study||0
6385242|NCT00805025|7296438|FG000|STARTED|Overall Study||131
6385243|NCT00805025|7296438|FG000|Enrolled and Treated|Overall Study||89
6385244|NCT00805025|7296438|FG000|COMPLETED|Overall Study||82
6385245|NCT00805025|7296438|FG000|NOT COMPLETED|Overall Study||49
6385246|NCT00805038|7296444|FG000|STARTED|Overall Study||75
6385247|NCT00805038|7296445|FG001|STARTED|Overall Study||92
6385248|NCT00805038|7296444|FG000|COMPLETED|Overall Study||75
6385249|NCT00805038|7296445|FG001|COMPLETED|Overall Study||92
6385250|NCT00805038|7296444|FG000|NOT COMPLETED|Overall Study||0
6385251|NCT00805038|7296445|FG001|NOT COMPLETED|Overall Study||0
6385252|NCT00805142|7296453|FG000|STARTED|Titration Period||36
6385253|NCT00805142|7296454|FG001|STARTED|Titration Period||42
6385254|NCT00805142|7296453|FG000|COMPLETED|Titration Period||30
6385255|NCT00805142|7296454|FG001|COMPLETED|Titration Period||32
6385256|NCT00805142|7296453|FG000|NOT COMPLETED|Titration Period||6
6385257|NCT00805142|7296454|FG001|NOT COMPLETED|Titration Period||10
6385258|NCT00805142|7296453|FG000|STARTED|Maintenance Period||30
6385259|NCT00805142|7296454|FG001|STARTED|Maintenance Period||32
6385260|NCT00805142|7296453|FG000|COMPLETED|Maintenance Period||30
6385261|NCT00805142|7296454|FG001|COMPLETED|Maintenance Period||30
6385262|NCT00805142|7296453|FG000|NOT COMPLETED|Maintenance Period||0
6385263|NCT00805142|7296454|FG001|NOT COMPLETED|Maintenance Period||2
6385264|NCT00805194|7296469|FG000|STARTED|Overall Study|randomised patients|655
6385265|NCT00805194|7296470|FG001|STARTED|Overall Study|randomised patients|659
6385266|NCT00805194|7296469|FG000|COMPLETED|Overall Study||6
6385267|NCT00805194|7296470|FG001|COMPLETED|Overall Study||5
6385268|NCT00805194|7296469|FG000|NOT COMPLETED|Overall Study||649
6385269|NCT00805194|7296470|FG001|NOT COMPLETED|Overall Study||654
6385270|NCT00805207|7296490|FG000|STARTED|Overall Study||1
6385271|NCT00805207|7296491|FG001|STARTED|Overall Study||9
6385272|NCT00805207|7296492|FG002|STARTED|Overall Study||12
6385273|NCT00805207|7296493|FG003|STARTED|Overall Study||6
6385274|NCT00805207|7296494|FG004|STARTED|Overall Study||3
6385275|NCT00805207|7296495|FG005|STARTED|Overall Study||12
6385276|NCT00805207|7296496|FG006|STARTED|Overall Study||6
6385277|NCT00805207|7296497|FG007|STARTED|Overall Study||6
6385278|NCT00805207|7296498|FG008|STARTED|Overall Study||6
6385279|NCT00805207|7296490|FG000|COMPLETED|Overall Study||1
6565270|NCT01817075|7488092|FG000|STARTED|Overall Study||88
6565271|NCT01817075|7488093|FG001|STARTED|Overall Study||89
6385280|NCT00805207|7296491|FG001|COMPLETED|Overall Study||7
6385281|NCT00805207|7296492|FG002|COMPLETED|Overall Study||11
6385282|NCT00805207|7296493|FG003|COMPLETED|Overall Study||6
6385283|NCT00805207|7296494|FG004|COMPLETED|Overall Study||2
6385284|NCT00805207|7296495|FG005|COMPLETED|Overall Study||9
6385285|NCT00805207|7296496|FG006|COMPLETED|Overall Study||6
6385286|NCT00805207|7296497|FG007|COMPLETED|Overall Study||6
6385287|NCT00805207|7296498|FG008|COMPLETED|Overall Study||6
6385288|NCT00805207|7296490|FG000|NOT COMPLETED|Overall Study||0
6385289|NCT00805207|7296491|FG001|NOT COMPLETED|Overall Study||2
6385290|NCT00805207|7296492|FG002|NOT COMPLETED|Overall Study||1
6385291|NCT00805207|7296493|FG003|NOT COMPLETED|Overall Study||0
6385292|NCT00805207|7296494|FG004|NOT COMPLETED|Overall Study||1
6385293|NCT00805207|7296495|FG005|NOT COMPLETED|Overall Study||3
6385294|NCT00805207|7296496|FG006|NOT COMPLETED|Overall Study||0
6385295|NCT00805207|7296497|FG007|NOT COMPLETED|Overall Study||0
6385296|NCT00805207|7296498|FG008|NOT COMPLETED|Overall Study||0
6385297|NCT00805285|7296522|FG000|STARTED|Overall Study||1
6385298|NCT00805285|7296522|FG000|COMPLETED|Overall Study||0
6385299|NCT00805285|7296522|FG000|NOT COMPLETED|Overall Study||1
6385300|NCT00805389|7296531|FG000|STARTED|Overall Study||143
6385301|NCT00805389|7296532|FG001|STARTED|Overall Study||142
6565272|NCT01817075|7488092|FG000|COMPLETED|Overall Study||41
6503482|NCT01441492|7422377|FG001|STARTED|Overall Study||202
6385302|NCT00805389|7296533|FG002|STARTED|Overall Study||141
6385303|NCT00805389|7296534|FG003|STARTED|Overall Study||145
6385304|NCT00805389|7296535|FG004|STARTED|Overall Study||142
6385305|NCT00805389|7296531|FG000|COMPLETED|Overall Study||136
6385306|NCT00805389|7296532|FG001|COMPLETED|Overall Study||137
6385307|NCT00805389|7296533|FG002|COMPLETED|Overall Study||129
6565273|NCT01817075|7488093|FG001|COMPLETED|Overall Study||54
6804841|NCT02334722|7736883|FG000|STARTED|Overall Study||40
6804842|NCT02334722|7736884|FG001|STARTED|Overall Study||41
6804843|NCT02334722|7736883|FG000|COMPLETED|Overall Study||33
6804844|NCT02334722|7736884|FG001|COMPLETED|Overall Study||34
6804845|NCT02334722|7736883|FG000|NOT COMPLETED|Overall Study||7
6804846|NCT02334722|7736884|FG001|NOT COMPLETED|Overall Study||7
6804847|NCT02259725|7736890|FG000|STARTED|Overall Study||3
6804848|NCT02259725|7736890|FG000|COMPLETED|Overall Study||3
6804849|NCT02259725|7736890|FG000|NOT COMPLETED|Overall Study||0
6804850|NCT01966731|7736894|FG000|STARTED|Overall Study||635
6385308|NCT00805389|7296534|FG003|COMPLETED|Overall Study||128
6385309|NCT00805389|7296535|FG004|COMPLETED|Overall Study||129
6385310|NCT00805389|7296531|FG000|NOT COMPLETED|Overall Study||7
6385311|NCT00805389|7296532|FG001|NOT COMPLETED|Overall Study||5
6385312|NCT00805389|7296533|FG002|NOT COMPLETED|Overall Study||12
6385313|NCT00805389|7296534|FG003|NOT COMPLETED|Overall Study||17
6385314|NCT00805389|7296535|FG004|NOT COMPLETED|Overall Study||13
6385315|NCT00805441|7296559|FG000|STARTED|Overall Study||94
6385316|NCT00805441|7296560|FG001|STARTED|Overall Study||96
6385317|NCT00805441|7296559|FG000|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|92
6385318|NCT00805441|7296560|FG001|Full Analysis Set (FAS)|Overall Study|All randomized participants who received ≥1 dose study drug and contributed to post-baseline data.|91
6385319|NCT00805441|7296559|FG000|COMPLETED|Overall Study||60
6385320|NCT00805441|7296560|FG001|COMPLETED|Overall Study||60
6385321|NCT00805441|7296559|FG000|NOT COMPLETED|Overall Study||34
6385322|NCT00805441|7296560|FG001|NOT COMPLETED|Overall Study||36
6385323|NCT00805467|7296570|FG000|STARTED|Overall Study|Patients who received treatment|1
6385324|NCT00805467|7296571|FG001|STARTED|Overall Study|Patients who received treatment|59
6503483|NCT01441492|7422376|FG000|COMPLETED|Overall Study||170
6503484|NCT01441492|7422377|FG001|COMPLETED|Overall Study||174
6503485|NCT01441492|7422376|FG000|NOT COMPLETED|Overall Study||27
6503486|NCT01441492|7422377|FG001|NOT COMPLETED|Overall Study||28
6503487|NCT01441570|7422387|FG000|STARTED|Overall Study||6
6503488|NCT01441570|7422388|FG001|STARTED|Overall Study||5
6503489|NCT01441570|7422387|FG000|COMPLETED|Overall Study||6
6503490|NCT01441570|7422388|FG001|COMPLETED|Overall Study||5
6503491|NCT01441570|7422387|FG000|NOT COMPLETED|Overall Study||0
6804851|NCT01966731|7736894|FG000|Initiated Hydroxyurea|Overall Study||606
6385325|NCT00805467|7296572|FG002|STARTED|Overall Study|Patients who received treatment|183
6270004|NCT00078819|7169242|FG000|COMPLETED|Re-treatment Period||0
6270005|NCT00078819|7169243|FG001|COMPLETED|Re-treatment Period||0
6270006|NCT00078819|7169244|FG002|COMPLETED|Re-treatment Period||29
6270007|NCT00078819|7169245|FG003|COMPLETED|Re-treatment Period||13
6270008|NCT00078819|7169242|FG000|NOT COMPLETED|Re-treatment Period||0
6270009|NCT00078819|7169243|FG001|NOT COMPLETED|Re-treatment Period||0
6270010|NCT00078819|7169244|FG002|NOT COMPLETED|Re-treatment Period||0
6270011|NCT00078819|7169245|FG003|NOT COMPLETED|Re-treatment Period||0
6270012|NCT00078897|7169264|FG000|STARTED|Overall Study||809
6270013|NCT00078897|7169265|FG001|STARTED|Overall Study||812
6270014|NCT00078897|7169264|FG000|COMPLETED|Overall Study||685
6270015|NCT00078897|7169265|FG001|COMPLETED|Overall Study||689
6270016|NCT00078897|7169264|FG000|NOT COMPLETED|Overall Study||124
6270017|NCT00078897|7169265|FG001|NOT COMPLETED|Overall Study||123
6270018|NCT00078949|7169275|FG000|STARTED|Overall Study||310
6270019|NCT00078949|7169276|FG001|STARTED|Overall Study||309
6270020|NCT00078949|7169277|FG002|STARTED|Overall Study||115
6270021|NCT00078949|7169278|FG003|STARTED|Overall Study||115
6270022|NCT00078949|7169275|FG000|COMPLETED|Overall Study||306
6270023|NCT00078949|7169276|FG001|COMPLETED|Overall Study||304
6270024|NCT00078949|7169277|FG002|COMPLETED|Overall Study||112
6270025|NCT00078949|7169278|FG003|COMPLETED|Overall Study||112
6270026|NCT00078949|7169275|FG000|NOT COMPLETED|Overall Study||4
6270027|NCT00078949|7169276|FG001|NOT COMPLETED|Overall Study||5
6270028|NCT00078949|7169277|FG002|NOT COMPLETED|Overall Study||3
6270029|NCT00078949|7169278|FG003|NOT COMPLETED|Overall Study||3
6270030|NCT00079001|7169292|FG000|STARTED|Overall Study||323
6270031|NCT00079001|7169293|FG001|STARTED|Overall Study||322
6270032|NCT00079001|7169292|FG000|COMPLETED|Overall Study||323
6270033|NCT00079001|7169293|FG001|COMPLETED|Overall Study||322
6270034|NCT00079001|7169292|FG000|NOT COMPLETED|Overall Study||0
6270035|NCT00079001|7169293|FG001|NOT COMPLETED|Overall Study||0
6280647|NCT00158756|7180625|FG000|NOT COMPLETED|Overall Study||5
6280648|NCT00158756|7180626|FG001|NOT COMPLETED|Overall Study||0
6280649|NCT00158756|7180627|FG002|NOT COMPLETED|Overall Study||8
6280650|NCT00158756|7180628|FG003|NOT COMPLETED|Overall Study||1
6280651|NCT00158756|7180629|FG004|NOT COMPLETED|Overall Study||3
6280652|NCT00158860|7180643|FG000|STARTED|Overall Study||128
6280653|NCT00158860|7180644|FG001|STARTED|Overall Study||255
6280654|NCT00158860|7180643|FG000|COMPLETED|Overall Study||93
6280655|NCT00158860|7180644|FG001|COMPLETED|Overall Study||184
6280656|NCT00158860|7180643|FG000|NOT COMPLETED|Overall Study||35
6280657|NCT00158860|7180644|FG001|NOT COMPLETED|Overall Study||71
6280658|NCT00158925|7180651|FG000|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
6280659|NCT00158925|7180651|FG000|COMPLETED|Overall Study||84
6280660|NCT00158925|7180651|FG000|NOT COMPLETED|Overall Study||12
6280661|NCT00159250|7180657|FG000|STARTED|Overall Study||2
6280662|NCT00159250|7180658|FG001|STARTED|Overall Study||5
6280663|NCT00159250|7180657|FG000|COMPLETED|Overall Study||2
6280664|NCT00159250|7180658|FG001|COMPLETED|Overall Study||5
6280665|NCT00159250|7180657|FG000|NOT COMPLETED|Overall Study||0
6280666|NCT00159250|7180658|FG001|NOT COMPLETED|Overall Study||0
6280667|NCT00159263|7180664|FG000|STARTED|First Intervention||1
6280668|NCT00159263|7180665|FG001|STARTED|First Intervention||1
6280669|NCT00159263|7180666|FG002|STARTED|First Intervention||2
6280670|NCT00159263|7180667|FG003|STARTED|First Intervention||2
6280671|NCT00159263|7180668|FG004|STARTED|First Intervention||2
6280672|NCT00159263|7180669|FG005|STARTED|First Intervention||2
6280673|NCT00159263|7180664|FG000|COMPLETED|First Intervention||1
6280674|NCT00159263|7180665|FG001|COMPLETED|First Intervention||1
6280675|NCT00159263|7180666|FG002|COMPLETED|First Intervention||2
6280676|NCT00159263|7180667|FG003|COMPLETED|First Intervention||2
6280677|NCT00159263|7180668|FG004|COMPLETED|First Intervention||2
6280678|NCT00159263|7180669|FG005|COMPLETED|First Intervention||2
6280679|NCT00159263|7180664|FG000|NOT COMPLETED|First Intervention||0
6280680|NCT00159263|7180665|FG001|NOT COMPLETED|First Intervention||0
6280681|NCT00159263|7180666|FG002|NOT COMPLETED|First Intervention||0
6280682|NCT00159263|7180667|FG003|NOT COMPLETED|First Intervention||0
6280683|NCT00159263|7180668|FG004|NOT COMPLETED|First Intervention||0
6280684|NCT00159263|7180669|FG005|NOT COMPLETED|First Intervention||0
6280685|NCT00159263|7180664|FG000|STARTED|Washout||1
6280686|NCT00159263|7180665|FG001|STARTED|Washout||1
6280687|NCT00159263|7180666|FG002|STARTED|Washout||2
6280688|NCT00159263|7180667|FG003|STARTED|Washout||2
6280689|NCT00159263|7180668|FG004|STARTED|Washout||2
6565274|NCT01817075|7488092|FG000|NOT COMPLETED|Overall Study||47
6565275|NCT01817075|7488093|FG001|NOT COMPLETED|Overall Study||35
6565276|NCT01817374|7488099|FG000|STARTED|Overall Study||6
6565277|NCT01817374|7488099|FG000|COMPLETED|Overall Study||6
6565278|NCT01817374|7488099|FG000|NOT COMPLETED|Overall Study||0
6565279|NCT01817491|7488107|FG000|STARTED|Overall Study||32
6565280|NCT01817491|7488108|FG001|STARTED|Overall Study||28
6270036|NCT00079040|7169299|FG000|STARTED|Overall Study||65
6565281|NCT01817491|7488107|FG000|COMPLETED|Overall Study||28
6656817|NCT02465203|7587164|FG002|STARTED|Overall Study||13
6385326|NCT00805467|7296573|FG003|STARTED|Overall Study|Patients who received treatment|381
6385327|NCT00805467|7296570|FG000|Enrolled But Did Not Receive Treatment|Overall Study||0
6385328|NCT00805467|7296571|FG001|Enrolled But Did Not Receive Treatment|Overall Study||0
6385329|NCT00805467|7296572|FG002|Enrolled But Did Not Receive Treatment|Overall Study||0
6385330|NCT00805467|7296573|FG003|Enrolled But Did Not Receive Treatment|Overall Study||0
6385331|NCT00805467|7296570|FG000|COMPLETED|Overall Study|Ongoing when study terminated|1
6385332|NCT00805467|7296571|FG001|COMPLETED|Overall Study|Ongoing when study terminated|25
6385333|NCT00805467|7296572|FG002|COMPLETED|Overall Study|Ongoing when study terminated|80
6385334|NCT00805467|7296573|FG003|COMPLETED|Overall Study|Ongoing when study terminated|144
6385335|NCT00805467|7296570|FG000|NOT COMPLETED|Overall Study||0
6385336|NCT00805467|7296571|FG001|NOT COMPLETED|Overall Study||34
6385337|NCT00805467|7296572|FG002|NOT COMPLETED|Overall Study||103
6385338|NCT00805467|7296573|FG003|NOT COMPLETED|Overall Study||237
6385339|NCT00805480|7296587|FG000|STARTED|Overall Study||30
6385340|NCT00805480|7296588|FG001|STARTED|Overall Study||29
6385341|NCT00805480|7296589|FG002|STARTED|Overall Study||31
6385342|NCT00805480|7296590|FG003|STARTED|Overall Study||10
6385343|NCT00805480|7296587|FG000|Pharmacodynamic Analysis Set|Overall Study||30
6385344|NCT00805480|7296588|FG001|Pharmacodynamic Analysis Set|Overall Study||25
6385345|NCT00805480|7296589|FG002|Pharmacodynamic Analysis Set|Overall Study||29
6385346|NCT00805480|7296590|FG003|Pharmacodynamic Analysis Set|Overall Study||10
6385347|NCT00805480|7296587|FG000|COMPLETED|Overall Study||16
6385348|NCT00805480|7296588|FG001|COMPLETED|Overall Study||22
6385349|NCT00805480|7296589|FG002|COMPLETED|Overall Study||19
6385350|NCT00805480|7296590|FG003|COMPLETED|Overall Study||5
6385351|NCT00805480|7296587|FG000|NOT COMPLETED|Overall Study||14
6385352|NCT00805480|7296588|FG001|NOT COMPLETED|Overall Study||7
6385353|NCT00805480|7296589|FG002|NOT COMPLETED|Overall Study||12
6385354|NCT00805480|7296590|FG003|NOT COMPLETED|Overall Study||5
6385355|NCT00805493|7296603|FG000|STARTED|Overall Study||3
6385356|NCT00805493|7296604|FG001|STARTED|Overall Study||2
6385357|NCT00805493|7296605|FG002|STARTED|Overall Study||1
6385358|NCT00805493|7296603|FG000|COMPLETED|Overall Study||1
6385359|NCT00805493|7296604|FG001|COMPLETED|Overall Study||2
6385360|NCT00805493|7296605|FG002|COMPLETED|Overall Study||0
6385361|NCT00805493|7296603|FG000|NOT COMPLETED|Overall Study||2
6385362|NCT00805493|7296604|FG001|NOT COMPLETED|Overall Study||0
6385363|NCT00805493|7296605|FG002|NOT COMPLETED|Overall Study||1
6385364|NCT00805532|7296618|FG000|STARTED|Overall Study||42
6385365|NCT00805532|7296619|FG001|STARTED|Overall Study||39
6385366|NCT00805532|7296618|FG000|COMPLETED|Overall Study|We did intent-to-treat analyses so 42 participants' data were analyzed.|42
6385367|NCT00805532|7296619|FG001|COMPLETED|Overall Study||38
6385368|NCT00805532|7296618|FG000|NOT COMPLETED|Overall Study||0
6385369|NCT00805532|7296619|FG001|NOT COMPLETED|Overall Study||1
6385370|NCT00805545|7296629|FG000|STARTED|Overall Study||200
6385371|NCT00805545|7296630|FG001|STARTED|Overall Study||200
6385372|NCT00805545|7296629|FG000|COMPLETED|Overall Study||194
6385373|NCT00805545|7296630|FG001|COMPLETED|Overall Study||197
6385374|NCT00805545|7296629|FG000|NOT COMPLETED|Overall Study||6
6385375|NCT00805545|7296630|FG001|NOT COMPLETED|Overall Study||3
6385376|NCT00805675|7296639|FG000|STARTED|Overall Study||16
6385377|NCT00805675|7296640|FG001|STARTED|Overall Study||14
6385378|NCT00805675|7296641|FG002|STARTED|Overall Study||16
6385379|NCT00805675|7296639|FG000|COMPLETED|Overall Study||16
6385380|NCT00805675|7296640|FG001|COMPLETED|Overall Study||14
6385381|NCT00805675|7296641|FG002|COMPLETED|Overall Study||15
6385382|NCT00805675|7296639|FG000|NOT COMPLETED|Overall Study||0
6385383|NCT00805675|7296640|FG001|NOT COMPLETED|Overall Study||0
6385384|NCT00805675|7296641|FG002|NOT COMPLETED|Overall Study||1
6385385|NCT00805740|7296651|FG000|STARTED|Overall Study||28
6385386|NCT00805740|7296652|FG001|STARTED|Overall Study||13
6385387|NCT00805740|7296651|FG000|Treated|Overall Study||26
6385388|NCT00805740|7296652|FG001|Treated|Overall Study||13
6385389|NCT00805740|7296651|FG000|COMPLETED|Overall Study||17
6385390|NCT00805740|7296652|FG001|COMPLETED|Overall Study||9
6385391|NCT00805740|7296651|FG000|NOT COMPLETED|Overall Study||11
6385392|NCT00805740|7296652|FG001|NOT COMPLETED|Overall Study||4
6385393|NCT00805766|7296658|FG000|STARTED|Screening Period||45
6385394|NCT00805766|7296658|FG000|COMPLETED|Screening Period||39
6385395|NCT00805766|7296658|FG000|NOT COMPLETED|Screening Period||6
6385396|NCT00805766|7296658|FG000|STARTED|Increased Dose Period||39
6385397|NCT00805766|7296658|FG000|COMPLETED|Increased Dose Period||26
6385398|NCT00805766|7296658|FG000|NOT COMPLETED|Increased Dose Period||13
6385399|NCT00805792|7296666|FG000|STARTED|Overall Study||33
6385400|NCT00805792|7296666|FG000|COMPLETED|Overall Study||28
6385401|NCT00805792|7296666|FG000|NOT COMPLETED|Overall Study||5
6385402|NCT00805870|7296672|FG000|STARTED|Overall Study||10
6385403|NCT00805870|7296673|FG001|STARTED|Overall Study||10
6385404|NCT00805870|7296672|FG000|COMPLETED|Overall Study||10
6385405|NCT00805870|7296673|FG001|COMPLETED|Overall Study||10
6385406|NCT00805870|7296672|FG000|NOT COMPLETED|Overall Study||0
6385407|NCT00805870|7296673|FG001|NOT COMPLETED|Overall Study||0
6385408|NCT00805935|7296683|FG000|STARTED|Overall Study||25
6385409|NCT00805935|7296684|FG001|STARTED|Overall Study||27
6385410|NCT00805935|7296685|FG002|STARTED|Overall Study||28
6385411|NCT00805935|7296686|FG003|STARTED|Overall Study||30
6385412|NCT00805935|7296683|FG000|COMPLETED|Overall Study||12
6385413|NCT00805935|7296684|FG001|COMPLETED|Overall Study||8
6385414|NCT00805935|7296685|FG002|COMPLETED|Overall Study||13
6385415|NCT00805935|7296686|FG003|COMPLETED|Overall Study||19
6385416|NCT00805935|7296683|FG000|NOT COMPLETED|Overall Study||13
6385417|NCT00805935|7296684|FG001|NOT COMPLETED|Overall Study||19
6385418|NCT00805935|7296685|FG002|NOT COMPLETED|Overall Study||15
6385419|NCT00805935|7296686|FG003|NOT COMPLETED|Overall Study||11
6385420|NCT00805948|7296700|FG000|STARTED|Overall Study||154
6385421|NCT00805948|7296701|FG001|STARTED|Overall Study||195
6385422|NCT00805948|7296700|FG000|COMPLETED|Overall Study||86
6385423|NCT00805948|7296701|FG001|COMPLETED|Overall Study||99
6385424|NCT00805948|7296700|FG000|NOT COMPLETED|Overall Study||68
6385425|NCT00805948|7296701|FG001|NOT COMPLETED|Overall Study||96
6385426|NCT00806026|7296714|FG000|STARTED|Overall Study||185
6385427|NCT00806026|7296715|FG001|STARTED|Overall Study||183
6385428|NCT00806026|7296716|FG002|STARTED|Overall Study||182
6385429|NCT00806026|7296717|FG003|STARTED|Overall Study||61
6385430|NCT00806026|7296718|FG004|STARTED|Overall Study||59
6385431|NCT00806026|7296719|FG005|STARTED|Overall Study||61
6385432|NCT00806026|7296714|FG000|Treated|Overall Study||182
6385433|NCT00806026|7296715|FG001|Treated|Overall Study||178
6385434|NCT00806026|7296716|FG002|Treated|Overall Study||180
6385435|NCT00806026|7296717|FG003|Treated|Overall Study||59
6385436|NCT00806026|7296718|FG004|Treated|Overall Study||59
6385437|NCT00806026|7296719|FG005|Treated|Overall Study||61
6385438|NCT00806026|7296714|FG000|COMPLETED|Overall Study||93
6385439|NCT00806026|7296715|FG001|COMPLETED|Overall Study||82
6385440|NCT00806026|7296716|FG002|COMPLETED|Overall Study||89
6385441|NCT00806026|7296717|FG003|COMPLETED|Overall Study||32
6385442|NCT00806026|7296718|FG004|COMPLETED|Overall Study||29
6385443|NCT00806026|7296719|FG005|COMPLETED|Overall Study||29
6385444|NCT00806026|7296714|FG000|NOT COMPLETED|Overall Study||92
6385445|NCT00806026|7296715|FG001|NOT COMPLETED|Overall Study||101
6565282|NCT01817491|7488108|FG001|COMPLETED|Overall Study||28
6565283|NCT01817491|7488107|FG000|NOT COMPLETED|Overall Study||4
6565284|NCT01817491|7488108|FG001|NOT COMPLETED|Overall Study||0
6804852|NCT01966731|7736894|FG000|Completed 3 Months of Treatment|Overall Study||600
6804853|NCT01966731|7736894|FG000|Completed Study|Overall Study||0
6804854|NCT01966731|7736894|FG000|COMPLETED|Overall Study||0
6804855|NCT01966731|7736894|FG000|NOT COMPLETED|Overall Study||635
6804856|NCT01952288|7736900|FG000|STARTED|Overall Study||3
6804857|NCT01952288|7736901|FG001|STARTED|Overall Study||2
6804858|NCT01952288|7736900|FG000|COMPLETED|Overall Study||3
6804859|NCT01952288|7736901|FG001|COMPLETED|Overall Study||2
6804860|NCT01952288|7736900|FG000|NOT COMPLETED|Overall Study||0
6385446|NCT00806026|7296716|FG002|NOT COMPLETED|Overall Study||93
6385447|NCT00806026|7296717|FG003|NOT COMPLETED|Overall Study||29
6565285|NCT01817530|7488123|FG000|STARTED|Overall Study||65
6804861|NCT01952288|7736901|FG001|NOT COMPLETED|Overall Study||0
6385448|NCT00806026|7296718|FG004|NOT COMPLETED|Overall Study||30
6385449|NCT00806026|7296719|FG005|NOT COMPLETED|Overall Study||32
6565286|NCT01817530|7488124|FG001|STARTED|Overall Study||65
6565287|NCT01817530|7488125|FG002|STARTED|Overall Study||64
6565288|NCT01817530|7488126|FG003|STARTED|Overall Study||65
6565289|NCT01817530|7488127|FG004|STARTED|Overall Study||78
6565290|NCT01817530|7488128|FG005|STARTED|Overall Study||77
6565291|NCT01817530|7488129|FG006|STARTED|Overall Study||76
6565292|NCT01817530|7488130|FG007|STARTED|Overall Study||77
6565293|NCT01817530|7488123|FG000|COMPLETED|Overall Study||50
6565294|NCT01817530|7488124|FG001|COMPLETED|Overall Study||52
6656818|NCT02465203|7587162|FG000|COMPLETED|Overall Study||0
6656819|NCT02465203|7587163|FG001|COMPLETED|Overall Study||0
6565295|NCT01817530|7488125|FG002|COMPLETED|Overall Study||53
6565296|NCT01817530|7488126|FG003|COMPLETED|Overall Study||52
6565297|NCT01817530|7488127|FG004|COMPLETED|Overall Study||67
6565298|NCT01817530|7488128|FG005|COMPLETED|Overall Study||58
6565299|NCT01817530|7488129|FG006|COMPLETED|Overall Study||53
6385450|NCT00806078|7296733|FG000|STARTED|First Intervention||9
6385451|NCT00806078|7296734|FG001|STARTED|First Intervention||9
6385452|NCT00806078|7296733|FG000|COMPLETED|First Intervention||9
6385453|NCT00806078|7296734|FG001|COMPLETED|First Intervention||9
6385454|NCT00806078|7296733|FG000|NOT COMPLETED|First Intervention||0
6385455|NCT00806078|7296734|FG001|NOT COMPLETED|First Intervention||0
6385456|NCT00806078|7296733|FG000|STARTED|7 Day Washout Period||9
6385457|NCT00806078|7296734|FG001|STARTED|7 Day Washout Period||9
6385458|NCT00806078|7296733|FG000|COMPLETED|7 Day Washout Period||9
6385459|NCT00806078|7296734|FG001|COMPLETED|7 Day Washout Period||9
6385460|NCT00806078|7296733|FG000|NOT COMPLETED|7 Day Washout Period||0
6385461|NCT00806078|7296734|FG001|NOT COMPLETED|7 Day Washout Period||0
6385462|NCT00806078|7296733|FG000|STARTED|Second Intervention||9
6385463|NCT00806078|7296734|FG001|STARTED|Second Intervention||9
6565300|NCT01817530|7488130|FG007|COMPLETED|Overall Study||53
6565301|NCT01817530|7488123|FG000|NOT COMPLETED|Overall Study||15
6565302|NCT01817530|7488124|FG001|NOT COMPLETED|Overall Study||13
6565303|NCT01817530|7488125|FG002|NOT COMPLETED|Overall Study||11
6656820|NCT02465203|7587164|FG002|COMPLETED|Overall Study||0
6656821|NCT02465203|7587162|FG000|NOT COMPLETED|Overall Study||56
6804862|NCT01850082|7736909|FG000|STARTED|Overall Study||576
6804863|NCT01850082|7736910|FG001|STARTED|Overall Study||574
6804864|NCT01850082|7736909|FG000|COMPLETED|Overall Study||576
6804865|NCT01850082|7736910|FG001|COMPLETED|Overall Study||574
6804866|NCT01850082|7736909|FG000|NOT COMPLETED|Overall Study||0
6804867|NCT01850082|7736910|FG001|NOT COMPLETED|Overall Study||0
6804868|NCT01844518|7736918|FG000|STARTED|Overall Study||173
6804869|NCT01844518|7736919|FG001|STARTED|Overall Study||46
6804870|NCT01844518|7736918|FG000|COMPLETED|Overall Study||132
6385464|NCT00806078|7296733|FG000|COMPLETED|Second Intervention||9
6385465|NCT00806078|7296734|FG001|COMPLETED|Second Intervention||9
6565304|NCT01817530|7488126|FG003|NOT COMPLETED|Overall Study||13
6804871|NCT01844518|7736919|FG001|COMPLETED|Overall Study||39
6656822|NCT02465203|7587163|FG001|NOT COMPLETED|Overall Study||36
6565305|NCT01817530|7488127|FG004|NOT COMPLETED|Overall Study||11
6565306|NCT01817530|7488128|FG005|NOT COMPLETED|Overall Study||19
6565307|NCT01817530|7488129|FG006|NOT COMPLETED|Overall Study||23
6565308|NCT01817530|7488130|FG007|NOT COMPLETED|Overall Study||24
6565309|NCT01817582|7488151|FG000|STARTED|Overall Study||33
6565310|NCT01817582|7488152|FG001|STARTED|Overall Study||36
6565311|NCT01817582|7488153|FG002|STARTED|Overall Study||33
6565312|NCT01817582|7488151|FG000|Received at Least 1 Dose of Study Drug|Overall Study||33
6270037|NCT00079040|7169299|FG000|COMPLETED|Overall Study||63
6270038|NCT00079040|7169299|FG000|NOT COMPLETED|Overall Study||2
6270039|NCT00079183|7169303|FG000|STARTED|Overall Study||44
6270040|NCT00079183|7169303|FG000|Drop Outs|Overall Study||7
6270041|NCT00079183|7169303|FG000|COMPLETED|Overall Study||37
6270042|NCT00079183|7169303|FG000|NOT COMPLETED|Overall Study||7
6565313|NCT01817582|7488152|FG001|Received at Least 1 Dose of Study Drug|Overall Study||36
6270043|NCT00079274|7169315|FG000|STARTED|Overall Study||1402
6270044|NCT00079274|7169316|FG001|STARTED|Overall Study||111
6270045|NCT00079274|7169317|FG002|STARTED|Overall Study||111
6270046|NCT00079274|7169318|FG003|STARTED|Overall Study||1350
6270047|NCT00079274|7169319|FG004|STARTED|Overall Study||45
6270048|NCT00079274|7169320|FG005|STARTED|Overall Study||46
6270049|NCT00079274|7169321|FG006|STARTED|Overall Study||332
6270050|NCT00079274|7169315|FG000|COMPLETED|Overall Study||1081
6270051|NCT00079274|7169316|FG001|COMPLETED|Overall Study||84
6270052|NCT00079274|7169317|FG002|COMPLETED|Overall Study||84
6270053|NCT00079274|7169318|FG003|COMPLETED|Overall Study||906
6270054|NCT00079274|7169319|FG004|COMPLETED|Overall Study||30
6270055|NCT00079274|7169320|FG005|COMPLETED|Overall Study||26
6270056|NCT00079274|7169321|FG006|COMPLETED|Overall Study||332
6270057|NCT00079274|7169315|FG000|NOT COMPLETED|Overall Study||321
6804872|NCT01844518|7736918|FG000|NOT COMPLETED|Overall Study||41
6804873|NCT01844518|7736919|FG001|NOT COMPLETED|Overall Study||7
6804874|NCT01675479|7736928|FG000|STARTED|Overall Study||69
6804875|NCT01675479|7736928|FG000|COMPLETED|Overall Study||58
6804876|NCT01675479|7736928|FG000|NOT COMPLETED|Overall Study||11
6804877|NCT01398839|7736934|FG000|STARTED|Overall Study||35
6804878|NCT01398839|7736935|FG001|STARTED|Overall Study||37
6804879|NCT01398839|7736934|FG000|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
6804880|NCT01398839|7736935|FG001|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
6804881|NCT01398839|7736934|FG000|NOT COMPLETED|Overall Study||0
6804882|NCT01398839|7736935|FG001|NOT COMPLETED|Overall Study||0
6804883|NCT01349959|7736941|FG000|STARTED|Overall Study||40
6804884|NCT01349959|7736941|FG000|COMPLETED|Overall Study||33
6565314|NCT01817582|7488153|FG002|Received at Least 1 Dose of Study Drug|Overall Study||33
6565315|NCT01817582|7488151|FG000|COMPLETED|Overall Study||31
6565316|NCT01817582|7488152|FG001|COMPLETED|Overall Study||35
6565317|NCT01817582|7488153|FG002|COMPLETED|Overall Study||33
6565318|NCT01817582|7488151|FG000|NOT COMPLETED|Overall Study||2
6565319|NCT01817582|7488152|FG001|NOT COMPLETED|Overall Study||1
6565320|NCT01817582|7488153|FG002|NOT COMPLETED|Overall Study||0
6565321|NCT01817712|7488163|FG000|STARTED|Overall Study||271
6565322|NCT01817712|7488164|FG001|STARTED|Overall Study||270
6565323|NCT01817712|7488163|FG000|COMPLETED|Overall Study|Primary Outcome Assessed over 18 months|250
6385466|NCT00806078|7296733|FG000|NOT COMPLETED|Second Intervention||0
6385467|NCT00806078|7296734|FG001|NOT COMPLETED|Second Intervention||0
6385468|NCT00806156|7296742|FG000|STARTED|Overall Study||39
6385469|NCT00806156|7296743|FG001|STARTED|Overall Study||139
6385470|NCT00806156|7296742|FG000|COMPLETED|Overall Study||0
6385471|NCT00806156|7296743|FG001|COMPLETED|Overall Study||0
6385472|NCT00806156|7296742|FG000|NOT COMPLETED|Overall Study||39
6385473|NCT00806156|7296743|FG001|NOT COMPLETED|Overall Study||139
6385474|NCT00806195|7296765|FG000|STARTED|Overall Study||4363
6385475|NCT00806195|7296766|FG001|STARTED|Overall Study||1483
6385476|NCT00806195|7296767|FG002|STARTED|Overall Study||1409
6385477|NCT00806195|7296768|FG003|STARTED|Overall Study||489
6385478|NCT00806195|7296765|FG000|COMPLETED|Overall Study||3849
6385479|NCT00806195|7296766|FG001|COMPLETED|Overall Study||1321
6385480|NCT00806195|7296767|FG002|COMPLETED|Overall Study||1139
6385481|NCT00806195|7296768|FG003|COMPLETED|Overall Study||383
6385482|NCT00806195|7296765|FG000|NOT COMPLETED|Overall Study||514
6385483|NCT00806195|7296766|FG001|NOT COMPLETED|Overall Study||162
6565324|NCT01817712|7488164|FG001|COMPLETED|Overall Study|Primary Outcome assessed over 18 months|240
6565325|NCT01817712|7488163|FG000|NOT COMPLETED|Overall Study||21
6565326|NCT01817712|7488164|FG001|NOT COMPLETED|Overall Study||30
6565327|NCT01817725|7488170|FG000|STARTED|Overall Study||20
6565328|NCT01817725|7488170|FG000|COMPLETED|Overall Study||19
6565329|NCT01817725|7488170|FG000|NOT COMPLETED|Overall Study||1
6565330|NCT01817764|7488176|FG000|STARTED|Overall Study||353
6565331|NCT01817764|7488177|FG001|STARTED|Overall Study||353
6565332|NCT01817764|7488176|FG000|COMPLETED|Overall Study||319
6565333|NCT01817764|7488177|FG001|COMPLETED|Overall Study||315
6565334|NCT01817764|7488176|FG000|NOT COMPLETED|Overall Study||34
6385484|NCT00806195|7296767|FG002|NOT COMPLETED|Overall Study||270
6385485|NCT00806195|7296768|FG003|NOT COMPLETED|Overall Study||106
6385486|NCT00806221|7296780|FG000|STARTED|Overall Study||22
6385487|NCT00806221|7296780|FG000|COMPLETED|Overall Study||20
6385488|NCT00806221|7296780|FG000|NOT COMPLETED|Overall Study||2
6385489|NCT00806234|7296787|FG000|STARTED|Overall Study||47
6385490|NCT00806234|7296788|FG001|STARTED|Overall Study||31
6385491|NCT00806234|7296789|FG002|STARTED|Overall Study||49
6385492|NCT00806234|7296787|FG000|COMPLETED|Overall Study||34
6385493|NCT00806234|7296788|FG001|COMPLETED|Overall Study||19
6385494|NCT00806234|7296789|FG002|COMPLETED|Overall Study||37
6385495|NCT00806234|7296787|FG000|NOT COMPLETED|Overall Study||13
6385496|NCT00806234|7296788|FG001|NOT COMPLETED|Overall Study||12
6385497|NCT00806234|7296789|FG002|NOT COMPLETED|Overall Study||12
6385498|NCT00806260|7296803|FG000|STARTED|Period 1 (1 Day)||15
6385499|NCT00806260|7296804|FG001|STARTED|Period 1 (1 Day)||8
6385500|NCT00806260|7296805|FG002|STARTED|Period 1 (1 Day)||8
6385501|NCT00806260|7296806|FG003|STARTED|Period 1 (1 Day)||14
6385502|NCT00806260|7296807|FG004|STARTED|Period 1 (1 Day)||18
6385503|NCT00806260|7296808|FG005|STARTED|Period 1 (1 Day)||17
6385504|NCT00806260|7296803|FG000|COMPLETED|Period 1 (1 Day)||15
6385505|NCT00806260|7296804|FG001|COMPLETED|Period 1 (1 Day)||8
6503492|NCT01441570|7422388|FG001|NOT COMPLETED|Overall Study||0
6503493|NCT01441596|7422397|FG000|STARTED|Overall Study||40
6503494|NCT01441596|7422398|FG001|STARTED|Overall Study||38
6503495|NCT01441596|7422399|FG002|STARTED|Overall Study||43
6503496|NCT01441596|7422397|FG000|COMPLETED|Overall Study||36
6503497|NCT01441596|7422398|FG001|COMPLETED|Overall Study||35
6503498|NCT01441596|7422399|FG002|COMPLETED|Overall Study||39
6503499|NCT01441596|7422397|FG000|NOT COMPLETED|Overall Study||4
6503500|NCT01441596|7422398|FG001|NOT COMPLETED|Overall Study||3
6503501|NCT01441596|7422399|FG002|NOT COMPLETED|Overall Study||4
6385506|NCT00806260|7296805|FG002|COMPLETED|Period 1 (1 Day)||8
6385507|NCT00806260|7296806|FG003|COMPLETED|Period 1 (1 Day)||14
6385508|NCT00806260|7296807|FG004|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
6385509|NCT00806260|7296808|FG005|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
6385510|NCT00806260|7296803|FG000|NOT COMPLETED|Period 1 (1 Day)||0
6385511|NCT00806260|7296804|FG001|NOT COMPLETED|Period 1 (1 Day)||0
6385512|NCT00806260|7296805|FG002|NOT COMPLETED|Period 1 (1 Day)||0
6503502|NCT01441635|7422417|FG000|STARTED|Overall Study||32
6385513|NCT00806260|7296806|FG003|NOT COMPLETED|Period 1 (1 Day)||0
6385514|NCT00806260|7296807|FG004|NOT COMPLETED|Period 1 (1 Day)||3
6385515|NCT00806260|7296808|FG005|NOT COMPLETED|Period 1 (1 Day)||0
6385516|NCT00806260|7296803|FG000|STARTED|Period 2||15
6385517|NCT00806260|7296804|FG001|STARTED|Period 2||8
6385518|NCT00806260|7296805|FG002|STARTED|Period 2||8
6385519|NCT00806260|7296806|FG003|STARTED|Period 2||14
6385520|NCT00806260|7296807|FG004|STARTED|Period 2||0
6385521|NCT00806260|7296808|FG005|STARTED|Period 2||0
6385522|NCT00806260|7296803|FG000|COMPLETED|Period 2||13
6385523|NCT00806260|7296804|FG001|COMPLETED|Period 2||8
6503503|NCT01441635|7422418|FG001|STARTED|Overall Study||33
6503504|NCT01441635|7422419|FG002|STARTED|Overall Study||16
6503505|NCT01441635|7422420|FG003|STARTED|Overall Study||35
6503506|NCT01441635|7422421|FG004|STARTED|Overall Study||18
6385524|NCT00806260|7296805|FG002|COMPLETED|Period 2||6
6385525|NCT00806260|7296806|FG003|COMPLETED|Period 2||12
6385526|NCT00806260|7296807|FG004|COMPLETED|Period 2||0
6270058|NCT00079274|7169316|FG001|NOT COMPLETED|Overall Study||27
6270059|NCT00079274|7169317|FG002|NOT COMPLETED|Overall Study||27
6270060|NCT00079274|7169318|FG003|NOT COMPLETED|Overall Study||444
6270061|NCT00079274|7169319|FG004|NOT COMPLETED|Overall Study||15
6270062|NCT00079274|7169320|FG005|NOT COMPLETED|Overall Study||20
6270063|NCT00079274|7169321|FG006|NOT COMPLETED|Overall Study||0
6270064|NCT00079326|7169336|FG000|STARTED|Overall Study||15
6270065|NCT00079326|7169337|FG001|STARTED|Overall Study||24
6270066|NCT00079326|7169336|FG000|COMPLETED|Overall Study||15
6270067|NCT00079326|7169337|FG001|COMPLETED|Overall Study||24
6270068|NCT00079326|7169336|FG000|NOT COMPLETED|Overall Study||0
6270069|NCT00079326|7169337|FG001|NOT COMPLETED|Overall Study||0
6270070|NCT00079339|7169345|FG000|STARTED|Overall Study||5
6270071|NCT00079339|7169346|FG001|STARTED|Overall Study||40
6270072|NCT00079339|7169347|FG002|STARTED|Overall Study||6
6270073|NCT00079339|7169345|FG000|Enrolled in Phase I|Overall Study||5
6270074|NCT00079339|7169346|FG001|Enrolled in Phase I|Overall Study||6
6270075|NCT00079339|7169347|FG002|Enrolled in Phase I|Overall Study||6
6270076|NCT00079339|7169345|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
6270077|NCT00079339|7169346|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
6270078|NCT00079339|7169347|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
6270079|NCT00079339|7169345|FG000|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
6270080|NCT00079339|7169346|FG001|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
6270081|NCT00079339|7169347|FG002|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
6270082|NCT00079339|7169345|FG000|COMPLETED|Overall Study||0
6270083|NCT00079339|7169346|FG001|COMPLETED|Overall Study||1
6270084|NCT00079339|7169347|FG002|COMPLETED|Overall Study||0
6270085|NCT00079339|7169345|FG000|NOT COMPLETED|Overall Study||5
6270086|NCT00079339|7169346|FG001|NOT COMPLETED|Overall Study||39
6270087|NCT00079339|7169347|FG002|NOT COMPLETED|Overall Study||6
6270088|NCT00079391|7169360|FG000|STARTED|Overall Study|1 of these withdrew after consent.|50
6270089|NCT00079391|7169360|FG000|COMPLETED|Overall Study||49
6270090|NCT00079391|7169360|FG000|NOT COMPLETED|Overall Study||1
6270091|NCT00079417|7169366|FG000|STARTED|Overall Study||28
6270092|NCT00079417|7169366|FG000|COMPLETED|Overall Study||19
6270093|NCT00079417|7169366|FG000|NOT COMPLETED|Overall Study||9
6270094|NCT00079677|7169372|FG000|STARTED|Overall Study||131
6270095|NCT00079677|7169373|FG001|STARTED|Overall Study||132
6270096|NCT00079677|7169372|FG000|COMPLETED|Overall Study||111
6270097|NCT00079677|7169373|FG001|COMPLETED|Overall Study||118
6270098|NCT00079677|7169372|FG000|NOT COMPLETED|Overall Study||20
6270099|NCT00079677|7169373|FG001|NOT COMPLETED|Overall Study||14
6270100|NCT00079781|7169382|FG000|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
6270101|NCT00079781|7169383|FG001|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
6270102|NCT00079781|7169384|FG002|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
6270103|NCT00079781|7169382|FG000|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
6270104|NCT00079781|7169383|FG001|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
6270105|NCT00079781|7169384|FG002|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
6270106|NCT00079781|7169382|FG000|NOT COMPLETED|Pre-implant Period||3
6270107|NCT00079781|7169383|FG001|NOT COMPLETED|Pre-implant Period||1
6270108|NCT00079781|7169384|FG002|NOT COMPLETED|Pre-implant Period||1
6270109|NCT00079781|7169382|FG000|STARTED|Evaluation Period||42
6270110|NCT00079781|7169383|FG001|STARTED|Evaluation Period||9
6270111|NCT00079781|7169384|FG002|STARTED|Evaluation Period||14
6270112|NCT00079781|7169382|FG000|COMPLETED|Evaluation Period||42
6270113|NCT00079781|7169383|FG001|COMPLETED|Evaluation Period||9
6270114|NCT00079781|7169384|FG002|COMPLETED|Evaluation Period||14
6270115|NCT00079781|7169382|FG000|NOT COMPLETED|Evaluation Period||0
6565335|NCT01817764|7488177|FG001|NOT COMPLETED|Overall Study||38
6565336|NCT01817777|7488185|FG000|STARTED|Observational Phase (8 Weeks)||36
6270116|NCT00079781|7169383|FG001|NOT COMPLETED|Evaluation Period||0
6270117|NCT00079781|7169384|FG002|NOT COMPLETED|Evaluation Period||0
6270118|NCT00079781|7169382|FG000|STARTED|Follow-up Period||42
6270119|NCT00079781|7169383|FG001|STARTED|Follow-up Period||9
6270120|NCT00079781|7169384|FG002|STARTED|Follow-up Period||14
6270121|NCT00079781|7169382|FG000|COMPLETED|Follow-up Period||38
6270122|NCT00079781|7169383|FG001|COMPLETED|Follow-up Period||9
6270123|NCT00079781|7169384|FG002|COMPLETED|Follow-up Period||12
6270124|NCT00079781|7169382|FG000|NOT COMPLETED|Follow-up Period||4
6270125|NCT00079781|7169383|FG001|NOT COMPLETED|Follow-up Period||0
6270126|NCT00079781|7169384|FG002|NOT COMPLETED|Follow-up Period||2
6385527|NCT00806260|7296808|FG005|COMPLETED|Period 2||0
6385528|NCT00806260|7296803|FG000|NOT COMPLETED|Period 2||2
6385529|NCT00806260|7296804|FG001|NOT COMPLETED|Period 2||0
6385530|NCT00806260|7296805|FG002|NOT COMPLETED|Period 2||2
6385531|NCT00806260|7296806|FG003|NOT COMPLETED|Period 2||2
6385532|NCT00806260|7296807|FG004|NOT COMPLETED|Period 2||0
6385533|NCT00806260|7296808|FG005|NOT COMPLETED|Period 2||0
6385534|NCT00806260|7296803|FG000|STARTED|Period 3||13
6385535|NCT00806260|7296804|FG001|STARTED|Period 3||8
6385536|NCT00806260|7296805|FG002|STARTED|Period 3||6
6503507|NCT01441635|7422422|FG005|STARTED|Overall Study||34
6503508|NCT01441635|7422423|FG006|STARTED|Overall Study||30
6503509|NCT01441635|7422424|FG007|STARTED|Overall Study||30
6503510|NCT01441635|7422425|FG008|STARTED|Overall Study||16
6503511|NCT01441635|7422426|FG009|STARTED|Overall Study||27
6503512|NCT01441635|7422417|FG000|COMPLETED|Overall Study||26
6503513|NCT01441635|7422418|FG001|COMPLETED|Overall Study||27
6503514|NCT01441635|7422419|FG002|COMPLETED|Overall Study||13
6503515|NCT01441635|7422420|FG003|COMPLETED|Overall Study||28
6503516|NCT01441635|7422421|FG004|COMPLETED|Overall Study||16
6503517|NCT01441635|7422422|FG005|COMPLETED|Overall Study||29
6385537|NCT00806260|7296806|FG003|STARTED|Period 3||12
6503518|NCT01441635|7422423|FG006|COMPLETED|Overall Study||24
6503519|NCT01441635|7422424|FG007|COMPLETED|Overall Study||26
6503520|NCT01441635|7422425|FG008|COMPLETED|Overall Study||14
6270127|NCT00079937|7169392|FG000|STARTED|Overall Study||421
6270128|NCT00079937|7169393|FG001|STARTED|Overall Study||207
6270129|NCT00079937|7169392|FG000|COMPLETED|Overall Study||352
6270130|NCT00079937|7169393|FG001|COMPLETED|Overall Study||175
6270131|NCT00079937|7169392|FG000|NOT COMPLETED|Overall Study||69
6270132|NCT00079937|7169393|FG001|NOT COMPLETED|Overall Study||32
6270133|NCT00080119|7169403|FG000|STARTED|Overall Study||403
6270134|NCT00080119|7169404|FG001|STARTED|Overall Study||401
6270135|NCT00080119|7169405|FG002|STARTED|Overall Study||273
6270136|NCT00080119|7169406|FG003|STARTED|Overall Study||274
6270137|NCT00080119|7169403|FG000|COMPLETED|Overall Study||347
6270138|NCT00080119|7169404|FG001|COMPLETED|Overall Study||339
6270139|NCT00080119|7169405|FG002|COMPLETED|Overall Study||108
6270140|NCT00080119|7169406|FG003|COMPLETED|Overall Study||111
6270141|NCT00080119|7169403|FG000|NOT COMPLETED|Overall Study||56
6270142|NCT00080119|7169404|FG001|NOT COMPLETED|Overall Study||62
6270143|NCT00080119|7169405|FG002|NOT COMPLETED|Overall Study||165
6270144|NCT00080119|7169406|FG003|NOT COMPLETED|Overall Study||163
6270145|NCT00080223|7169418|FG000|STARTED|Overall Study||83
6270146|NCT00080223|7169418|FG000|COMPLETED|Overall Study||7
6270147|NCT00080223|7169418|FG000|NOT COMPLETED|Overall Study||76
6270148|NCT00080288|7169424|FG000|STARTED|Overall Study||127
6270149|NCT00080288|7169425|FG001|STARTED|Overall Study||127
6270150|NCT00080288|7169424|FG000|COMPLETED|Overall Study||97
6270151|NCT00080288|7169425|FG001|COMPLETED|Overall Study||89
6270152|NCT00080288|7169424|FG000|NOT COMPLETED|Overall Study||30
6270153|NCT00080288|7169425|FG001|NOT COMPLETED|Overall Study||38
6270154|NCT00080301|7169433|FG000|STARTED|Overall Study||375
6270155|NCT00080301|7169434|FG001|STARTED|Overall Study||377
6270156|NCT00080301|7169433|FG000|Never Treated|Overall Study||5
6270157|NCT00080301|7169434|FG001|Never Treated|Overall Study||10
6270158|NCT00080301|7169433|FG000|Still on Treatment|Overall Study||0
6270159|NCT00080301|7169434|FG001|Still on Treatment|Overall Study||1
6270160|NCT00080301|7169433|FG000|COMPLETED|Overall Study|Participants who are off treatment|370
6270161|NCT00080301|7169434|FG001|COMPLETED|Overall Study|Participants who are off treatment|366
6270162|NCT00080301|7169433|FG000|NOT COMPLETED|Overall Study||5
6270163|NCT00080301|7169434|FG001|NOT COMPLETED|Overall Study||11
6270164|NCT00080470|7169443|FG000|STARTED|Overall Study||45
6270165|NCT00080470|7169444|FG001|STARTED|Overall Study||42
6270166|NCT00080470|7169443|FG000|COMPLETED|Overall Study||11
6270167|NCT00080470|7169444|FG001|COMPLETED|Overall Study||14
6270168|NCT00080470|7169443|FG000|NOT COMPLETED|Overall Study||34
6270169|NCT00080470|7169444|FG001|NOT COMPLETED|Overall Study||28
6270170|NCT00080483|7169454|FG000|STARTED|Overall Study||17
6270171|NCT00080483|7169455|FG001|STARTED|Overall Study||18
6270172|NCT00080483|7169454|FG000|COMPLETED|Overall Study||15
6270173|NCT00080483|7169455|FG001|COMPLETED|Overall Study||16
6270174|NCT00080483|7169454|FG000|NOT COMPLETED|Overall Study||2
6270175|NCT00080483|7169455|FG001|NOT COMPLETED|Overall Study||2
6270176|NCT00080535|7169461|FG000|STARTED|Overall Study||10
6270177|NCT00080535|7169461|FG000|COMPLETED|Overall Study||10
6270178|NCT00080535|7169461|FG000|NOT COMPLETED|Overall Study||0
6270179|NCT00080899|7169465|FG000|STARTED|Overall Study||23
6270180|NCT00080899|7169465|FG000|COMPLETED|Overall Study||22
6270181|NCT00080899|7169465|FG000|NOT COMPLETED|Overall Study||1
6270182|NCT00080912|7169471|FG000|STARTED|Overall Study||425
6270183|NCT00080912|7169472|FG001|STARTED|Overall Study||425
6270184|NCT00080912|7169471|FG000|COMPLETED|Overall Study||425
6270185|NCT00080912|7169472|FG001|COMPLETED|Overall Study||425
6270186|NCT00080912|7169471|FG000|NOT COMPLETED|Overall Study||0
6270187|NCT00080912|7169472|FG001|NOT COMPLETED|Overall Study||0
6270188|NCT00080938|7169478|FG000|STARTED|Overall Study||26
6270189|NCT00080938|7169478|FG000|Began Protocol Therapy|Overall Study||25
6270190|NCT00080938|7169478|FG000|Eligible and Treated|Overall Study||21
6270191|NCT00080938|7169478|FG000|COMPLETED|Overall Study||2
6270192|NCT00080938|7169478|FG000|NOT COMPLETED|Overall Study||24
6270193|NCT00081159|7169484|FG000|STARTED|Overall Study||39
6270194|NCT00081159|7169485|FG001|STARTED|Overall Study||40
6270195|NCT00081159|7169484|FG000|COMPLETED|Overall Study||37
6270196|NCT00081159|7169485|FG001|COMPLETED|Overall Study||35
6270197|NCT00081159|7169484|FG000|NOT COMPLETED|Overall Study||2
6270198|NCT00081159|7169485|FG001|NOT COMPLETED|Overall Study||5
6270199|NCT00081263|7169493|FG000|STARTED|Overall Study||67
6270200|NCT00081263|7169494|FG001|STARTED|Overall Study||63
6270201|NCT00081263|7169493|FG000|COMPLETED|Overall Study||50
6270202|NCT00081263|7169494|FG001|COMPLETED|Overall Study||41
6565337|NCT01817777|7488186|FG001|STARTED|Observational Phase (8 Weeks)||0
6565338|NCT01817777|7488187|FG002|STARTED|Observational Phase (8 Weeks)||0
6565339|NCT01817777|7488185|FG000|COMPLETED|Observational Phase (8 Weeks)||31
6565340|NCT01817777|7488186|FG001|COMPLETED|Observational Phase (8 Weeks)||0
6656823|NCT02465203|7587164|FG002|NOT COMPLETED|Overall Study||13
6270203|NCT00081263|7169493|FG000|NOT COMPLETED|Overall Study||17
6270204|NCT00081263|7169494|FG001|NOT COMPLETED|Overall Study||22
6270205|NCT00081289|7169502|FG000|STARTED|Overall Study||73
6270206|NCT00081289|7169503|FG001|STARTED|Overall Study||73
6270207|NCT00081289|7169502|FG000|Primary Endpoint Population|Overall Study||48
6270208|NCT00081289|7169503|FG001|Primary Endpoint Population|Overall Study||48
6385538|NCT00806260|7296807|FG004|STARTED|Period 3||0
6385539|NCT00806260|7296808|FG005|STARTED|Period 3||0
6385540|NCT00806260|7296803|FG000|COMPLETED|Period 3||12
6385541|NCT00806260|7296804|FG001|COMPLETED|Period 3||7
6385542|NCT00806260|7296805|FG002|COMPLETED|Period 3||5
6385543|NCT00806260|7296806|FG003|COMPLETED|Period 3||12
6385544|NCT00806260|7296807|FG004|COMPLETED|Period 3||0
6385545|NCT00806260|7296808|FG005|COMPLETED|Period 3||0
6385546|NCT00806260|7296803|FG000|NOT COMPLETED|Period 3||1
6385547|NCT00806260|7296804|FG001|NOT COMPLETED|Period 3||1
6385548|NCT00806260|7296805|FG002|NOT COMPLETED|Period 3||1
6385549|NCT00806260|7296806|FG003|NOT COMPLETED|Period 3||0
6385550|NCT00806260|7296807|FG004|NOT COMPLETED|Period 3||0
6385551|NCT00806260|7296808|FG005|NOT COMPLETED|Period 3||0
6385552|NCT00806286|7296823|FG000|STARTED|Overall Study||54
6385553|NCT00806286|7296824|FG001|STARTED|Overall Study||54
6385554|NCT00806286|7296825|FG002|STARTED|Overall Study||3
6385555|NCT00806286|7296823|FG000|COMPLETED|Overall Study||0
6385556|NCT00806286|7296824|FG001|COMPLETED|Overall Study||0
6385557|NCT00806286|7296825|FG002|COMPLETED|Overall Study||0
6385558|NCT00806286|7296823|FG000|NOT COMPLETED|Overall Study||54
6385559|NCT00806286|7296824|FG001|NOT COMPLETED|Overall Study||54
6385560|NCT00806286|7296825|FG002|NOT COMPLETED|Overall Study||3
6385561|NCT00806351|7296835|FG000|STARTED|Overall Study||15
6385562|NCT00806351|7296836|FG001|STARTED|Overall Study||6
6385563|NCT00806351|7296835|FG000|COMPLETED|Overall Study||10
6385564|NCT00806351|7296836|FG001|COMPLETED|Overall Study||2
6385565|NCT00806351|7296835|FG000|NOT COMPLETED|Overall Study||5
6385566|NCT00806351|7296836|FG001|NOT COMPLETED|Overall Study||4
6385567|NCT00806442|7296842|FG000|STARTED|Overall Study||18
6385568|NCT00806442|7296843|FG001|STARTED|Overall Study||21
6385569|NCT00806442|7296842|FG000|First Intervention (3 Wks)|Overall Study||18
6503521|NCT01441635|7422426|FG009|COMPLETED|Overall Study||25
6385570|NCT00806442|7296843|FG001|First Intervention (3 Wks)|Overall Study||21
6385571|NCT00806442|7296842|FG000|Washout (3 Wks)|Overall Study||15
6385572|NCT00806442|7296843|FG001|Washout (3 Wks)|Overall Study||14
6503522|NCT01441635|7422417|FG000|NOT COMPLETED|Overall Study||6
6270209|NCT00081289|7169502|FG000|General Analysis Population|Overall Study||52
6270210|NCT00081289|7169503|FG001|General Analysis Population|Overall Study||52
6270211|NCT00081289|7169502|FG000|Full AE Population|Overall Study||70
6270212|NCT00081289|7169503|FG001|Full AE Population|Overall Study||68
6270213|NCT00081289|7169502|FG000|Surgery|Overall Study||47
6270214|NCT00081289|7169503|FG001|Surgery|Overall Study||51
6270215|NCT00081289|7169502|FG000|Global Health Status Score at End of CR|Overall Study|European Organization for Research & Treatment of Cancer Quality of Life Questionnaire [EORTC QLQ]|34
6270216|NCT00081289|7169503|FG001|Global Health Status Score at End of CR|Overall Study||32
6270217|NCT00081289|7169502|FG000|GHS at End of Post-op CT|Overall Study||20
6270218|NCT00081289|7169503|FG001|GHS at End of Post-op CT|Overall Study||28
6270219|NCT00081289|7169502|FG000|GHS at Two Years|Overall Study||21
6270220|NCT00081289|7169503|FG001|GHS at Two Years|Overall Study||20
6270221|NCT00081289|7169502|FG000|GI Symptom Score at End of CR|Overall Study||34
6270222|NCT00081289|7169503|FG001|GI Symptom Score at End of CR|Overall Study||33
6270223|NCT00081289|7169502|FG000|GI Symptom Score at End of Post-op CT|Overall Study||22
6270224|NCT00081289|7169503|FG001|GI Symptom Score at End of Post-op CT|Overall Study||27
6270225|NCT00081289|7169502|FG000|GI Symptom Score at Two Years|Overall Study||21
6270226|NCT00081289|7169503|FG001|GI Symptom Score at Two Years|Overall Study||20
6270227|NCT00081289|7169502|FG000|Defecation Symptom Score at End of CR|Overall Study||32
6270228|NCT00081289|7169503|FG001|Defecation Symptom Score at End of CR|Overall Study||32
6270229|NCT00081289|7169502|FG000|DS Score at End of Post-op CT|Overall Study||12
6270230|NCT00081289|7169503|FG001|DS Score at End of Post-op CT|Overall Study||14
6270231|NCT00081289|7169502|FG000|Defecation Symptom Score at Two Years|Overall Study||13
6270232|NCT00081289|7169503|FG001|Defecation Symptom Score at Two Years|Overall Study||15
6270233|NCT00081289|7169502|FG000|COMPLETED|Overall Study||52
6270234|NCT00081289|7169503|FG001|COMPLETED|Overall Study||52
6270235|NCT00081289|7169502|FG000|NOT COMPLETED|Overall Study||21
6270236|NCT00081289|7169503|FG001|NOT COMPLETED|Overall Study||21
6270237|NCT00081328|7169513|FG000|STARTED|Overall Study||232
6270238|NCT00081328|7169514|FG001|STARTED|Overall Study||233
6270239|NCT00081328|7169515|FG002|STARTED|Overall Study||234
6270240|NCT00081328|7169513|FG000|COMPLETED|Overall Study||232
6270241|NCT00081328|7169514|FG001|COMPLETED|Overall Study||233
6270242|NCT00081328|7169515|FG002|COMPLETED|Overall Study||234
6270243|NCT00081328|7169513|FG000|NOT COMPLETED|Overall Study||0
6270244|NCT00081328|7169514|FG001|NOT COMPLETED|Overall Study||0
6270245|NCT00081328|7169515|FG002|NOT COMPLETED|Overall Study||0
6270246|NCT00081458|7169527|FG000|STARTED|Overall Study||16
6270247|NCT00081458|7169528|FG001|STARTED|Overall Study||35
6270248|NCT00081458|7169529|FG002|STARTED|Overall Study||33
6270249|NCT00081458|7169527|FG000|Received Treatment|Overall Study||16
6270250|NCT00081458|7169528|FG001|Received Treatment|Overall Study||35
6270251|NCT00081458|7169529|FG002|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
6270252|NCT00081458|7169527|FG000|COMPLETED|Overall Study||15
6270253|NCT00081458|7169528|FG001|COMPLETED|Overall Study||27
6270254|NCT00081458|7169529|FG002|COMPLETED|Overall Study||29
6270255|NCT00081458|7169527|FG000|NOT COMPLETED|Overall Study||1
6270256|NCT00081458|7169528|FG001|NOT COMPLETED|Overall Study||8
6270257|NCT00081458|7169529|FG002|NOT COMPLETED|Overall Study||4
6270258|NCT00081497|7169540|FG000|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
6270259|NCT00081497|7169541|FG001|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
6270260|NCT00081497|7169540|FG000|COMPLETED|Overall Study||25
6270261|NCT00081497|7169541|FG001|COMPLETED|Overall Study||37
6270262|NCT00081497|7169540|FG000|NOT COMPLETED|Overall Study||3
6270263|NCT00081497|7169541|FG001|NOT COMPLETED|Overall Study||2
6270264|NCT00081653|7169555|FG000|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
6270265|NCT00081653|7169556|FG001|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
6270266|NCT00081653|7169555|FG000|COMPLETED|Overall Study|Completed 3 years of treatment|311
6385573|NCT00806442|7296842|FG000|Second Intervention (3 Wks)|Overall Study||15
6385574|NCT00806442|7296843|FG001|Second Intervention (3 Wks)|Overall Study||14
6385575|NCT00806442|7296842|FG000|COMPLETED|Overall Study||14
6385576|NCT00806442|7296843|FG001|COMPLETED|Overall Study||14
6385577|NCT00806442|7296842|FG000|NOT COMPLETED|Overall Study||4
6385578|NCT00806442|7296843|FG001|NOT COMPLETED|Overall Study||7
6385579|NCT00806494|7296851|FG000|STARTED|Overall Study||331
6385580|NCT00806494|7296851|FG000|COMPLETED|Overall Study||251
6385581|NCT00806494|7296851|FG000|NOT COMPLETED|Overall Study||80
6385582|NCT00806546|7296856|FG000|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
6385583|NCT00806546|7296856|FG000|COMPLETED|Overall Study||207
6385584|NCT00806546|7296856|FG000|NOT COMPLETED|Overall Study||307
6385585|NCT00806585|7296865|FG000|STARTED|Overall Study||137
6385586|NCT00806585|7296866|FG001|STARTED|Overall Study||134
6385587|NCT00806585|7296867|FG002|STARTED|Overall Study||141
6385588|NCT00806585|7296868|FG003|STARTED|Overall Study||71
6385589|NCT00806585|7296869|FG004|STARTED|Overall Study||137
6385590|NCT00806585|7296865|FG000|COMPLETED|Overall Study||105
6385591|NCT00806585|7296866|FG001|COMPLETED|Overall Study||103
6385592|NCT00806585|7296867|FG002|COMPLETED|Overall Study||109
6385593|NCT00806585|7296868|FG003|COMPLETED|Overall Study||56
6385594|NCT00806585|7296869|FG004|COMPLETED|Overall Study||106
6385595|NCT00806585|7296865|FG000|NOT COMPLETED|Overall Study||32
6385596|NCT00806585|7296866|FG001|NOT COMPLETED|Overall Study||31
6385597|NCT00806585|7296867|FG002|NOT COMPLETED|Overall Study||32
6385598|NCT00806585|7296868|FG003|NOT COMPLETED|Overall Study||15
6385599|NCT00806585|7296869|FG004|NOT COMPLETED|Overall Study||31
6385600|NCT00806598|7296881|FG000|STARTED|Overall Study||48
6385601|NCT00806598|7296881|FG000|COMPLETED|Overall Study||48
6385602|NCT00806598|7296881|FG000|NOT COMPLETED|Overall Study||0
6385603|NCT00806624|7296888|FG000|STARTED|Overall Study||79
6385604|NCT00806624|7296889|FG001|STARTED|Overall Study||80
6565341|NCT01817777|7488187|FG002|COMPLETED|Observational Phase (8 Weeks)||0
6565342|NCT01817777|7488185|FG000|NOT COMPLETED|Observational Phase (8 Weeks)||5
6565343|NCT01817777|7488186|FG001|NOT COMPLETED|Observational Phase (8 Weeks)||0
6565344|NCT01817777|7488187|FG002|NOT COMPLETED|Observational Phase (8 Weeks)||0
6385605|NCT00806624|7296890|FG002|STARTED|Overall Study||75
6385606|NCT00806624|7296888|FG000|COMPLETED|Overall Study||70
6385607|NCT00806624|7296889|FG001|COMPLETED|Overall Study||68
6385608|NCT00806624|7296890|FG002|COMPLETED|Overall Study||69
6385609|NCT00806624|7296888|FG000|NOT COMPLETED|Overall Study||9
6503523|NCT01441635|7422418|FG001|NOT COMPLETED|Overall Study||6
6503524|NCT01441635|7422419|FG002|NOT COMPLETED|Overall Study||3
6503525|NCT01441635|7422420|FG003|NOT COMPLETED|Overall Study||7
6503526|NCT01441635|7422421|FG004|NOT COMPLETED|Overall Study||2
6503527|NCT01441635|7422422|FG005|NOT COMPLETED|Overall Study||5
6503528|NCT01441635|7422423|FG006|NOT COMPLETED|Overall Study||6
6503529|NCT01441635|7422424|FG007|NOT COMPLETED|Overall Study||4
6503530|NCT01441635|7422425|FG008|NOT COMPLETED|Overall Study||2
6503531|NCT01441635|7422426|FG009|NOT COMPLETED|Overall Study||2
6503532|NCT01441765|7422450|FG000|STARTED|Overall Study||11
6503533|NCT01441765|7422451|FG001|STARTED|Overall Study|not opened|0
6565345|NCT01817777|7488185|FG000|STARTED|Interventional Phase (20 Weeks)||0
6565346|NCT01817777|7488186|FG001|STARTED|Interventional Phase (20 Weeks)||16
6385610|NCT00806624|7296889|FG001|NOT COMPLETED|Overall Study||12
6385611|NCT00806624|7296890|FG002|NOT COMPLETED|Overall Study||6
6385612|NCT00806676|7296901|FG000|STARTED|Overall Study||29
6385613|NCT00806676|7296902|FG001|STARTED|Overall Study||9
6385614|NCT00806676|7296903|FG002|STARTED|Overall Study||29
6385615|NCT00806676|7296901|FG000|COMPLETED|Overall Study||25
6503534|NCT01441765|7422450|FG000|COMPLETED|Overall Study||10
6503535|NCT01441765|7422451|FG001|COMPLETED|Overall Study|not opened|0
6385616|NCT00806676|7296902|FG001|COMPLETED|Overall Study||9
6503536|NCT01441765|7422450|FG000|NOT COMPLETED|Overall Study||1
6656824|NCT02465216|7587176|FG000|STARTED|Overall Study||15
6270267|NCT00081653|7169556|FG001|COMPLETED|Overall Study|Completed 3 years of treatment|324
6270268|NCT00081653|7169555|FG000|NOT COMPLETED|Overall Study||47
6270269|NCT00081653|7169556|FG001|NOT COMPLETED|Overall Study||37
6270270|NCT00081731|7169565|FG000|STARTED|Overall Study||480
6270271|NCT00081731|7169566|FG001|STARTED|Overall Study||467
6270272|NCT00081731|7169565|FG000|COMPLETED|Overall Study||472
6270273|NCT00081731|7169566|FG001|COMPLETED|Overall Study||459
6270274|NCT00081731|7169565|FG000|NOT COMPLETED|Overall Study||8
6270275|NCT00081731|7169566|FG001|NOT COMPLETED|Overall Study||8
6270276|NCT00081770|7169575|FG000|STARTED|Overall Study||1019
6270277|NCT00081770|7169576|FG001|STARTED|Overall Study||1016
6270278|NCT00081770|7169577|FG002|STARTED|Overall Study||1035
6270279|NCT00081770|7169575|FG000|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
6270280|NCT00081770|7169576|FG001|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
6270281|NCT00081770|7169577|FG002|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
6270282|NCT00081770|7169575|FG000|NOT COMPLETED|Overall Study||502
6270283|NCT00081770|7169576|FG001|NOT COMPLETED|Overall Study||546
6270284|NCT00081770|7169577|FG002|NOT COMPLETED|Overall Study||456
6270285|NCT00081861|7169585|FG000|STARTED|Overall Study||13
6270286|NCT00081861|7169585|FG000|COMPLETED|Overall Study||13
6270287|NCT00081861|7169585|FG000|NOT COMPLETED|Overall Study||0
6270288|NCT00081939|7169589|FG000|STARTED|Overall Study||303
6270289|NCT00081939|7169589|FG000|COMPLETED|Overall Study||303
6270290|NCT00081939|7169589|FG000|NOT COMPLETED|Overall Study||0
6270291|NCT00082017|7169593|FG000|STARTED|Overall Study||11
6270292|NCT00082017|7169594|FG001|STARTED|Overall Study||9
6270293|NCT00082017|7169593|FG000|COMPLETED|Overall Study||11
6270294|NCT00082017|7169594|FG001|COMPLETED|Overall Study||9
6270295|NCT00082017|7169593|FG000|NOT COMPLETED|Overall Study||0
6270296|NCT00082017|7169594|FG001|NOT COMPLETED|Overall Study||0
6270297|NCT00082173|7169602|FG000|STARTED|Overall Study||74
6270298|NCT00082173|7169603|FG001|STARTED|Overall Study||72
6270299|NCT00082173|7169602|FG000|COMPLETED|Overall Study||64
6270300|NCT00082173|7169603|FG001|COMPLETED|Overall Study||61
6270301|NCT00082173|7169602|FG000|NOT COMPLETED|Overall Study||10
6270302|NCT00082173|7169603|FG001|NOT COMPLETED|Overall Study||11
6270303|NCT00082329|7169609|FG000|STARTED|Overall Study||9
6270304|NCT00082329|7169609|FG000|COMPLETED|Overall Study||9
6270305|NCT00082329|7169609|FG000|NOT COMPLETED|Overall Study||0
6270306|NCT00082342|7169615|FG000|STARTED|Overall Study||13
6270307|NCT00082342|7169616|FG001|STARTED|Overall Study||12
6270308|NCT00082342|7169615|FG000|COMPLETED|Overall Study||13
6270309|NCT00082342|7169616|FG001|COMPLETED|Overall Study||12
6270310|NCT00082342|7169615|FG000|NOT COMPLETED|Overall Study||0
6270311|NCT00082342|7169616|FG001|NOT COMPLETED|Overall Study||0
6270312|NCT00082355|7169636|FG000|STARTED|Initial Results of Thrombolytic Therapy||30
6270313|NCT00082355|7169636|FG000|COMPLETED|Initial Results of Thrombolytic Therapy||28
6270314|NCT00082355|7169636|FG000|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
6270315|NCT00082355|7169636|FG000|STARTED|5 Year Recurrent Thromboembolism Rate||28
6270316|NCT00082355|7169636|FG000|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
6270317|NCT00082355|7169636|FG000|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
6270318|NCT00082368|7169640|FG000|STARTED|Overall Study||12
6270319|NCT00082368|7169640|FG000|COMPLETED|Overall Study||11
6270320|NCT00082368|7169640|FG000|NOT COMPLETED|Overall Study||1
6270321|NCT00082381|7169646|FG000|STARTED|Overall Study||283
6270322|NCT00082381|7169647|FG001|STARTED|Overall Study||268
6270323|NCT00082381|7169646|FG000|Received Treatment (Intent to Treat)|Overall Study||282
6270324|NCT00082381|7169647|FG001|Received Treatment (Intent to Treat)|Overall Study||267
6270325|NCT00082381|7169646|FG000|COMPLETED|Overall Study||228
6270326|NCT00082381|7169647|FG001|COMPLETED|Overall Study||242
6270327|NCT00082381|7169646|FG000|NOT COMPLETED|Overall Study||55
6270328|NCT00082381|7169647|FG001|NOT COMPLETED|Overall Study||26
6270329|NCT00082407|7169655|FG000|STARTED|Overall Study||255
6270330|NCT00082407|7169656|FG001|STARTED|Overall Study||250
6270331|NCT00082407|7169655|FG000|Received Treatment (Intent to Treat)|Overall Study||253
6270332|NCT00082407|7169656|FG001|Received Treatment (Intent to Treat)|Overall Study||248
6270333|NCT00082407|7169655|FG000|COMPLETED|Overall Study||199
6270334|NCT00082407|7169656|FG001|COMPLETED|Overall Study||223
6270335|NCT00082407|7169655|FG000|NOT COMPLETED|Overall Study||56
6270336|NCT00082407|7169656|FG001|NOT COMPLETED|Overall Study||27
6270337|NCT00082433|7169664|FG000|STARTED|Overall Study||609
6270338|NCT00082433|7169665|FG001|STARTED|Overall Study||612
6270339|NCT00082433|7169664|FG000|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
6270340|NCT00082433|7169665|FG001|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
6270341|NCT00082433|7169664|FG000|NOT COMPLETED|Overall Study||594
6270342|NCT00082433|7169665|FG001|NOT COMPLETED|Overall Study||597
6270343|NCT00082628|7169673|FG000|STARTED|Treatment Period I (Week 1 to Week 12)||81
6270344|NCT00082628|7169674|FG001|STARTED|Treatment Period I (Week 1 to Week 12)||245
6270345|NCT00082628|7169675|FG002|STARTED|Treatment Period I (Week 1 to Week 12)||0
6270346|NCT00082628|7169676|FG003|STARTED|Treatment Period I (Week 1 to Week 12)||0
6270347|NCT00082628|7169677|FG004|STARTED|Treatment Period I (Week 1 to Week 12)||0
6270348|NCT00082628|7169673|FG000|COMPLETED|Treatment Period I (Week 1 to Week 12)||73
6270349|NCT00082628|7169674|FG001|COMPLETED|Treatment Period I (Week 1 to Week 12)||185
6270350|NCT00082628|7169675|FG002|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6270351|NCT00082628|7169676|FG003|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6270352|NCT00082628|7169677|FG004|COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6270353|NCT00082628|7169673|FG000|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||8
6565347|NCT01817777|7488187|FG002|STARTED|Interventional Phase (20 Weeks)||15
6565348|NCT01817777|7488185|FG000|COMPLETED|Interventional Phase (20 Weeks)||0
6270354|NCT00082628|7169674|FG001|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||60
6270355|NCT00082628|7169675|FG002|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6270356|NCT00082628|7169676|FG003|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6270357|NCT00082628|7169677|FG004|NOT COMPLETED|Treatment Period I (Week 1 to Week 12)||0
6270358|NCT00082628|7169673|FG000|STARTED|Treatment Period II: Week 12 to Week 36||0
6270359|NCT00082628|7169674|FG001|STARTED|Treatment Period II: Week 12 to Week 36||0
6270360|NCT00082628|7169675|FG002|STARTED|Treatment Period II: Week 12 to Week 36||93
6270361|NCT00082628|7169676|FG003|STARTED|Treatment Period II: Week 12 to Week 36||92
6270362|NCT00082628|7169677|FG004|STARTED|Treatment Period II: Week 12 to Week 36||73
6270363|NCT00082628|7169673|FG000|COMPLETED|Treatment Period II: Week 12 to Week 36||0
6270364|NCT00082628|7169674|FG001|COMPLETED|Treatment Period II: Week 12 to Week 36||0
6270365|NCT00082628|7169675|FG002|COMPLETED|Treatment Period II: Week 12 to Week 36||78
6270366|NCT00082628|7169676|FG003|COMPLETED|Treatment Period II: Week 12 to Week 36||76
6270367|NCT00082628|7169677|FG004|COMPLETED|Treatment Period II: Week 12 to Week 36||55
6270368|NCT00082628|7169673|FG000|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
6270369|NCT00082628|7169674|FG001|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||0
6270370|NCT00082628|7169675|FG002|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||15
6270371|NCT00082628|7169676|FG003|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||16
6270372|NCT00082628|7169677|FG004|NOT COMPLETED|Treatment Period II: Week 12 to Week 36||18
6270373|NCT00082641|7169691|FG000|STARTED|Overall Study||11
6270374|NCT00082641|7169692|FG001|STARTED|Overall Study||12
6270375|NCT00082641|7169691|FG000|COMPLETED|Overall Study||11
6270376|NCT00082641|7169692|FG001|COMPLETED|Overall Study||12
6270377|NCT00082641|7169691|FG000|NOT COMPLETED|Overall Study||0
6270378|NCT00082641|7169692|FG001|NOT COMPLETED|Overall Study||0
6270379|NCT00082758|7169702|FG000|STARTED|Overall Study||15
6270380|NCT00082758|7169703|FG001|STARTED|Overall Study||24
6270381|NCT00082758|7169704|FG002|STARTED|Overall Study||0
6270382|NCT00082758|7169702|FG000|COMPLETED|Overall Study||0
6270383|NCT00082758|7169703|FG001|COMPLETED|Overall Study||7
6270384|NCT00082758|7169704|FG002|COMPLETED|Overall Study||0
6270385|NCT00082758|7169702|FG000|NOT COMPLETED|Overall Study||15
6270386|NCT00082758|7169703|FG001|NOT COMPLETED|Overall Study||17
6270387|NCT00082758|7169704|FG002|NOT COMPLETED|Overall Study||0
6270388|NCT00082810|7169712|FG000|STARTED|Overall Study||33
6270389|NCT00082810|7169712|FG000|COMPLETED|Overall Study||2
6270390|NCT00082810|7169712|FG000|NOT COMPLETED|Overall Study||31
6270391|NCT00082888|7169720|FG000|STARTED|Overall Study||42
6270392|NCT00082888|7169721|FG001|STARTED|Overall Study||15
6270393|NCT00082888|7169722|FG002|STARTED|Overall Study||36
6270394|NCT00082888|7169720|FG000|COMPLETED|Overall Study||41
6270395|NCT00082888|7169721|FG001|COMPLETED|Overall Study||15
6270396|NCT00082888|7169722|FG002|COMPLETED|Overall Study||36
6270397|NCT00082888|7169720|FG000|NOT COMPLETED|Overall Study||1
6270398|NCT00082888|7169721|FG001|NOT COMPLETED|Overall Study||0
6270399|NCT00082888|7169722|FG002|NOT COMPLETED|Overall Study||0
6270400|NCT00083122|7169733|FG000|STARTED|Overall Study||40
6270401|NCT00083122|7169734|FG001|STARTED|Overall Study||5
6270402|NCT00083122|7169733|FG000|COMPLETED|Overall Study||40
6270403|NCT00083122|7169734|FG001|COMPLETED|Overall Study||5
6270404|NCT00083122|7169733|FG000|NOT COMPLETED|Overall Study||0
6270405|NCT00083122|7169734|FG001|NOT COMPLETED|Overall Study||0
6270406|NCT00083174|7169742|FG000|STARTED|Randomization Period||2285
6270407|NCT00083174|7169743|FG001|STARTED|Randomization Period||2275
6270408|NCT00083174|7169744|FG002|STARTED|Randomization Period||0
6270409|NCT00083174|7169742|FG000|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2285
6565349|NCT01817777|7488186|FG001|COMPLETED|Interventional Phase (20 Weeks)||11
6385617|NCT00806676|7296903|FG002|COMPLETED|Overall Study||23
6385618|NCT00806676|7296901|FG000|NOT COMPLETED|Overall Study||4
6385619|NCT00806676|7296902|FG001|NOT COMPLETED|Overall Study||0
6385620|NCT00806676|7296903|FG002|NOT COMPLETED|Overall Study||6
6385621|NCT00806819|7296914|FG000|STARTED|Overall Study|randomised patients|353
6385622|NCT00806819|7296915|FG001|STARTED|Overall Study|randomised patients|360
6385623|NCT00806819|7296914|FG000|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
6385624|NCT00806819|7296915|FG001|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
6385625|NCT00806819|7296914|FG000|NOT COMPLETED|Overall Study||346
6385626|NCT00806819|7296915|FG001|NOT COMPLETED|Overall Study||358
6385627|NCT00806988|7296924|FG000|STARTED|Overall Study||150
6385628|NCT00806988|7296925|FG001|STARTED|Overall Study||151
6385629|NCT00806988|7296924|FG000|COMPLETED|Overall Study||123
6385630|NCT00806988|7296925|FG001|COMPLETED|Overall Study||108
6385631|NCT00806988|7296924|FG000|NOT COMPLETED|Overall Study||27
6385632|NCT00806988|7296925|FG001|NOT COMPLETED|Overall Study||43
6385633|NCT00807001|7296936|FG000|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
6385634|NCT00807001|7296937|FG001|STARTED|Overall Study||8
6385635|NCT00807001|7296938|FG002|STARTED|Overall Study||8
6385636|NCT00807001|7296939|FG003|STARTED|Overall Study||8
6385637|NCT00807001|7296940|FG004|STARTED|Overall Study||9
6385638|NCT00807001|7296936|FG000|COMPLETED|Overall Study||8
6385639|NCT00807001|7296937|FG001|COMPLETED|Overall Study||7
6385640|NCT00807001|7296938|FG002|COMPLETED|Overall Study||8
6385641|NCT00807001|7296939|FG003|COMPLETED|Overall Study||8
6385642|NCT00807001|7296940|FG004|COMPLETED|Overall Study||9
6385643|NCT00807001|7296936|FG000|NOT COMPLETED|Overall Study||0
6385644|NCT00807001|7296937|FG001|NOT COMPLETED|Overall Study||1
6385645|NCT00807001|7296938|FG002|NOT COMPLETED|Overall Study||0
6565350|NCT01817777|7488187|FG002|COMPLETED|Interventional Phase (20 Weeks)||10
6565351|NCT01817777|7488185|FG000|NOT COMPLETED|Interventional Phase (20 Weeks)||0
6565352|NCT01817777|7488186|FG001|NOT COMPLETED|Interventional Phase (20 Weeks)||5
6565353|NCT01817777|7488187|FG002|NOT COMPLETED|Interventional Phase (20 Weeks)||5
6565354|NCT01817790|7488195|FG000|STARTED|Overall Study||314
6565355|NCT01817790|7488196|FG001|STARTED|Overall Study||312
6565356|NCT01817790|7488195|FG000|COMPLETED|Overall Study||310
6565357|NCT01817790|7488196|FG001|COMPLETED|Overall Study||304
6565358|NCT01817790|7488195|FG000|NOT COMPLETED|Overall Study||4
6565359|NCT01817790|7488196|FG001|NOT COMPLETED|Overall Study||8
6565360|NCT01817855|7488208|FG000|STARTED|Overall Study||23
6565361|NCT01817855|7488209|FG001|STARTED|Overall Study||8
6565362|NCT01817855|7488210|FG002|STARTED|Overall Study||11
6565363|NCT01817855|7488211|FG003|STARTED|Overall Study||5
6565364|NCT01817855|7488208|FG000|COMPLETED|Overall Study||23
6385646|NCT00807001|7296939|FG003|NOT COMPLETED|Overall Study||0
6385647|NCT00807001|7296940|FG004|NOT COMPLETED|Overall Study||0
6385648|NCT00807014|7296954|FG000|STARTED|Overall Study||83
6385649|NCT00807014|7296955|FG001|STARTED|Overall Study||85
6385650|NCT00807014|7296954|FG000|COMPLETED|Overall Study||56
6385651|NCT00807014|7296955|FG001|COMPLETED|Overall Study||58
6385652|NCT00807014|7296954|FG000|NOT COMPLETED|Overall Study||27
6385653|NCT00807014|7296955|FG001|NOT COMPLETED|Overall Study||27
6385654|NCT00807040|7296963|FG000|STARTED|Overall Study||126
6385655|NCT00807040|7296964|FG001|STARTED|Overall Study||125
6385656|NCT00807040|7296963|FG000|COMPLETED|Overall Study||90
6385657|NCT00807040|7296964|FG001|COMPLETED|Overall Study||84
6565365|NCT01817855|7488209|FG001|COMPLETED|Overall Study||6
6565366|NCT01817855|7488210|FG002|COMPLETED|Overall Study||9
6565367|NCT01817855|7488211|FG003|COMPLETED|Overall Study||5
6565368|NCT01817855|7488208|FG000|NOT COMPLETED|Overall Study||0
6385658|NCT00807040|7296963|FG000|NOT COMPLETED|Overall Study||36
6385659|NCT00807040|7296964|FG001|NOT COMPLETED|Overall Study||41
6270410|NCT00083174|7169743|FG001|COMPLETED|Randomization Period|All women randomized were included in the analysis based on intent-to-treat principle.|2275
6270411|NCT00083174|7169744|FG002|COMPLETED|Randomization Period||0
6270412|NCT00083174|7169742|FG000|NOT COMPLETED|Randomization Period||0
6270413|NCT00083174|7169743|FG001|NOT COMPLETED|Randomization Period||0
6270414|NCT00083174|7169744|FG002|NOT COMPLETED|Randomization Period||0
6270415|NCT00083174|7169742|FG000|STARTED|Open-label Extension||0
6270416|NCT00083174|7169743|FG001|STARTED|Open-label Extension||0
6270417|NCT00083174|7169744|FG002|STARTED|Open-label Extension||2831
6270418|NCT00083174|7169742|FG000|COMPLETED|Open-label Extension||0
6270419|NCT00083174|7169743|FG001|COMPLETED|Open-label Extension||0
6270420|NCT00083174|7169744|FG002|COMPLETED|Open-label Extension||2831
6270421|NCT00083174|7169742|FG000|NOT COMPLETED|Open-label Extension||0
6270422|NCT00083174|7169743|FG001|NOT COMPLETED|Open-label Extension||0
6270423|NCT00083174|7169744|FG002|NOT COMPLETED|Open-label Extension||0
6270424|NCT00083226|7169754|FG000|STARTED|Overall Study||42
6270425|NCT00083226|7169754|FG000|COMPLETED|Overall Study||0
6270426|NCT00083226|7169754|FG000|NOT COMPLETED|Overall Study||42
6270427|NCT00083382|7169758|FG000|STARTED|Overall Study||83
6270428|NCT00083382|7169758|FG000|COMPLETED|Overall Study||83
6270429|NCT00083382|7169758|FG000|NOT COMPLETED|Overall Study||0
6270430|NCT00083551|7169764|FG000|STARTED|Overall Study||323
6270431|NCT00083551|7169765|FG001|STARTED|Overall Study||345
6270432|NCT00083551|7169764|FG000|COMPLETED|Overall Study||323
6270433|NCT00083551|7169765|FG001|COMPLETED|Overall Study||345
6270434|NCT00083551|7169764|FG000|NOT COMPLETED|Overall Study||0
6270435|NCT00083551|7169765|FG001|NOT COMPLETED|Overall Study||0
6270436|NCT00083616|7169771|FG000|STARTED|Overall Study||185
6270437|NCT00083616|7169771|FG000|Received Study Medication|Overall Study||182
6270438|NCT00083616|7169771|FG000|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
6270439|NCT00083616|7169771|FG000|NOT COMPLETED|Overall Study||31
6270440|NCT00083720|7169775|FG000|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
6270441|NCT00083720|7169775|FG000|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
6270442|NCT00083720|7169775|FG000|NOT COMPLETED|Overall Study||0
6270443|NCT00083889|7169781|FG000|STARTED|Overall Study||375
6270444|NCT00083889|7169782|FG001|STARTED|Overall Study||375
6270445|NCT00083889|7169781|FG000|Received Treatment|Overall Study||375
6270446|NCT00083889|7169782|FG001|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
6270447|NCT00083889|7169781|FG000|COMPLETED|Overall Study||0
6270448|NCT00083889|7169782|FG001|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
6270449|NCT00083889|7169781|FG000|NOT COMPLETED|Overall Study||375
6270450|NCT00083889|7169782|FG001|NOT COMPLETED|Overall Study||375
6270451|NCT00084084|7169791|FG000|STARTED|Phase 1 (Treatment With Replagal RB)||17
6270452|NCT00084084|7169791|FG000|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
6270453|NCT00084084|7169791|FG000|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
6280690|NCT00159263|7180669|FG005|STARTED|Washout||2
6280691|NCT00159263|7180664|FG000|COMPLETED|Washout||1
6270454|NCT00084084|7169791|FG000|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
6270455|NCT00084084|7169791|FG000|COMPLETED|Phase 2 (Transition to Replagal AF)||10
6270456|NCT00084084|7169791|FG000|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
6270457|NCT00084136|7169799|FG000|STARTED|PI Comparison||519
6270458|NCT00084136|7169800|FG001|STARTED|PI Comparison||526
6270459|NCT00084136|7169801|FG002|STARTED|PI Comparison||0
6270460|NCT00084136|7169799|FG000|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
6270461|NCT00084136|7169800|FG001|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
6270462|NCT00084136|7169801|FG002|COMPLETED|PI Comparison||0
6270463|NCT00084136|7169799|FG000|NOT COMPLETED|PI Comparison||55
6270464|NCT00084136|7169800|FG001|NOT COMPLETED|PI Comparison||47
6270465|NCT00084136|7169801|FG002|NOT COMPLETED|PI Comparison||0
6270466|NCT00084136|7169799|FG000|STARTED|NRTI Comparison||519
6270467|NCT00084136|7169800|FG001|STARTED|NRTI Comparison||0
6270468|NCT00084136|7169801|FG002|STARTED|NRTI Comparison||526
6270469|NCT00084136|7169799|FG000|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
6270470|NCT00084136|7169800|FG001|COMPLETED|NRTI Comparison||0
6270471|NCT00084136|7169801|FG002|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
6270472|NCT00084136|7169799|FG000|NOT COMPLETED|NRTI Comparison||101
6270473|NCT00084136|7169800|FG001|NOT COMPLETED|NRTI Comparison||0
6270474|NCT00084136|7169801|FG002|NOT COMPLETED|NRTI Comparison||82
6270475|NCT00084149|7169812|FG000|STARTED|Overall Study||36
6270476|NCT00084149|7169813|FG001|STARTED|Overall Study||18
6270477|NCT00084149|7169812|FG000|COMPLETED|Overall Study||28
6270478|NCT00084149|7169813|FG001|COMPLETED|Overall Study||13
6270479|NCT00084149|7169812|FG000|NOT COMPLETED|Overall Study||8
6270480|NCT00084149|7169813|FG001|NOT COMPLETED|Overall Study||5
6270481|NCT00084266|7169825|FG000|STARTED|Overall Study||618
6270482|NCT00084266|7169826|FG001|STARTED|Overall Study||607
6270483|NCT00084266|7169825|FG000|Treated|Overall Study||597
6270484|NCT00084266|7169826|FG001|Treated|Overall Study||587
6270485|NCT00084266|7169825|FG000|COMPLETED|Overall Study||177
6270486|NCT00084266|7169826|FG001|COMPLETED|Overall Study||184
6270487|NCT00084266|7169825|FG000|NOT COMPLETED|Overall Study||441
6270488|NCT00084266|7169826|FG001|NOT COMPLETED|Overall Study||423
6270489|NCT00084318|7169834|FG000|STARTED|Overall Study||119
6270490|NCT00084318|7169835|FG001|STARTED|Overall Study||119
6270491|NCT00084318|7169834|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
6270492|NCT00084318|7169835|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
6270493|NCT00084318|7169834|FG000|NOT COMPLETED|Overall Study||22
6270494|NCT00084318|7169835|FG001|NOT COMPLETED|Overall Study||13
6270495|NCT00084383|7169843|FG000|STARTED|Overall Study||60
6270496|NCT00084383|7169843|FG000|COMPLETED|Overall Study||13
6270497|NCT00084383|7169843|FG000|NOT COMPLETED|Overall Study||47
6270498|NCT00084409|7169849|FG000|STARTED|Overall Study|40 Current, 35 former|75
6270499|NCT00084409|7169850|FG001|STARTED|Overall Study|41 current, 36 former|77
6270500|NCT00084409|7169849|FG000|COMPLETED|Overall Study|9 current, 6 former|60
6270501|NCT00084409|7169850|FG001|COMPLETED|Overall Study|4 Current, 8 former|65
6270502|NCT00084409|7169849|FG000|NOT COMPLETED|Overall Study||15
6270503|NCT00084409|7169850|FG001|NOT COMPLETED|Overall Study||12
6270504|NCT00084487|7169858|FG000|STARTED|Overall Study||21
6270505|NCT00084487|7169858|FG000|COMPLETED|Overall Study||20
6270506|NCT00084487|7169858|FG000|NOT COMPLETED|Overall Study||1
6270507|NCT00084552|7169864|FG000|STARTED|Overall Study||54
6270508|NCT00084552|7169865|FG001|STARTED|Overall Study||62
6270509|NCT00084552|7169864|FG000|COMPLETED|Overall Study||54
6270510|NCT00084552|7169865|FG001|COMPLETED|Overall Study||62
6270511|NCT00084552|7169864|FG000|NOT COMPLETED|Overall Study||0
6270512|NCT00084552|7169865|FG001|NOT COMPLETED|Overall Study||0
6270513|NCT00084617|7169871|FG000|STARTED|Overall Study||39
6270514|NCT00084617|7169871|FG000|COMPLETED|Overall Study||30
6270515|NCT00084617|7169871|FG000|NOT COMPLETED|Overall Study||9
6270516|NCT00084682|7169875|FG000|STARTED|Overall Study||14
6270517|NCT00084682|7169875|FG000|COMPLETED|Overall Study||13
6270518|NCT00084682|7169875|FG000|NOT COMPLETED|Overall Study||1
6270519|NCT00084747|7169880|FG000|STARTED|Overall Study||30
6385660|NCT00807092|7296972|FG000|STARTED|Overall Study||72
6385661|NCT00807092|7296973|FG001|STARTED|Overall Study||73
6385662|NCT00807092|7296972|FG000|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
6385663|NCT00807092|7296973|FG001|Exposed to Drug|Overall Study||73
6385664|NCT00807092|7296972|FG000|COMPLETED|Overall Study||71
6385665|NCT00807092|7296973|FG001|COMPLETED|Overall Study||69
6385666|NCT00807092|7296972|FG000|NOT COMPLETED|Overall Study||1
6385667|NCT00807092|7296973|FG001|NOT COMPLETED|Overall Study||4
6385668|NCT00807144|7296981|FG000|STARTED|Overall Study||52
6385669|NCT00807144|7296982|FG001|STARTED|Overall Study||50
6385670|NCT00807144|7296981|FG000|COMPLETED|Overall Study||52
6385671|NCT00807144|7296982|FG001|COMPLETED|Overall Study||49
6385672|NCT00807144|7296981|FG000|NOT COMPLETED|Overall Study||0
6385673|NCT00807144|7296982|FG001|NOT COMPLETED|Overall Study||1
6385674|NCT00807209|7296991|FG000|STARTED|Overall Study||1
6385675|NCT00807209|7296992|FG001|STARTED|Overall Study||1
6385676|NCT00807209|7296993|FG002|STARTED|Overall Study||1
6385677|NCT00807209|7296991|FG000|COMPLETED|Overall Study||1
6385678|NCT00807209|7296992|FG001|COMPLETED|Overall Study||1
6385679|NCT00807209|7296993|FG002|COMPLETED|Overall Study||1
6385680|NCT00807209|7296991|FG000|NOT COMPLETED|Overall Study||0
6385681|NCT00807209|7296992|FG001|NOT COMPLETED|Overall Study||0
6385682|NCT00807209|7296993|FG002|NOT COMPLETED|Overall Study||0
6385683|NCT00807235|7297003|FG000|STARTED|Overall Study||11
6385684|NCT00807235|7297004|FG001|STARTED|Overall Study||6
6385685|NCT00807235|7297003|FG000|COMPLETED|Overall Study||10
6385686|NCT00807235|7297004|FG001|COMPLETED|Overall Study||6
6385687|NCT00807235|7297003|FG000|NOT COMPLETED|Overall Study||1
6385688|NCT00807235|7297004|FG001|NOT COMPLETED|Overall Study||0
6385689|NCT00807248|7297014|FG000|STARTED|Overall Study||71
6385690|NCT00807248|7297015|FG001|STARTED|Overall Study||140
6385691|NCT00807248|7297016|FG002|STARTED|Overall Study||139
6385692|NCT00807248|7297017|FG003|STARTED|Overall Study||140
6385693|NCT00807248|7297014|FG000|COMPLETED|Overall Study||50
6385694|NCT00807248|7297015|FG001|COMPLETED|Overall Study||128
6385695|NCT00807248|7297016|FG002|COMPLETED|Overall Study||121
6385696|NCT00807248|7297017|FG003|COMPLETED|Overall Study||126
6385697|NCT00807248|7297014|FG000|NOT COMPLETED|Overall Study||21
6385698|NCT00807248|7297015|FG001|NOT COMPLETED|Overall Study||12
6385699|NCT00807248|7297016|FG002|NOT COMPLETED|Overall Study||18
6385700|NCT00807248|7297017|FG003|NOT COMPLETED|Overall Study||14
6385701|NCT00807456|7297027|FG000|STARTED|Overall Study||65
6503537|NCT01441765|7422451|FG001|NOT COMPLETED|Overall Study||0
6503538|NCT01441843|7422459|FG000|STARTED|Overall Study||200
6503539|NCT01441843|7422460|FG001|STARTED|Overall Study||200
6503540|NCT01441843|7422459|FG000|COMPLETED|Overall Study||188
6503541|NCT01441843|7422460|FG001|COMPLETED|Overall Study||195
6503542|NCT01441843|7422459|FG000|NOT COMPLETED|Overall Study||12
6385702|NCT00807456|7297027|FG000|COMPLETED|Overall Study||65
6385703|NCT00807456|7297027|FG000|NOT COMPLETED|Overall Study||0
6385704|NCT00807495|7297036|FG000|STARTED|Overall Study||22
6503543|NCT01441843|7422460|FG001|NOT COMPLETED|Overall Study||5
6385705|NCT00807495|7297037|FG001|STARTED|Overall Study||13
6385706|NCT00807495|7297038|FG002|STARTED|Overall Study||5
6385707|NCT00807495|7297039|FG003|STARTED|Overall Study||1
6385708|NCT00807495|7297040|FG004|STARTED|Overall Study|An ATL participant had late on-study biopsy and was in DLBL, reducing ATL participants from 8 to 7.|7
6385709|NCT00807495|7297036|FG000|COMPLETED|Overall Study|Completed = participants who completed the study treatment to PD or symptomatic deterioration.|14
6385710|NCT00807495|7297037|FG001|COMPLETED|Overall Study||7
6385711|NCT00807495|7297038|FG002|COMPLETED|Overall Study||1
6270520|NCT00084747|7169880|FG000|COMPLETED|Overall Study||17
6270521|NCT00084747|7169880|FG000|NOT COMPLETED|Overall Study||13
6270522|NCT00084838|7169885|FG000|STARTED|Overall Study||25
6270523|NCT00084838|7169885|FG000|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
6270524|NCT00084838|7169885|FG000|COMPLETED|Overall Study||12
6270525|NCT00084838|7169885|FG000|NOT COMPLETED|Overall Study||13
6270526|NCT00084864|7169895|FG000|STARTED|Overall Study||10
6270527|NCT00084864|7169896|FG001|STARTED|Overall Study||7
6270528|NCT00084864|7169897|FG002|STARTED|Overall Study||4
6270529|NCT00084864|7169898|FG003|STARTED|Overall Study||4
6270530|NCT00084864|7169895|FG000|COMPLETED|Overall Study||9
6270531|NCT00084864|7169896|FG001|COMPLETED|Overall Study||7
6270532|NCT00084864|7169897|FG002|COMPLETED|Overall Study||4
6270533|NCT00084864|7169898|FG003|COMPLETED|Overall Study||4
6270534|NCT00084864|7169895|FG000|NOT COMPLETED|Overall Study||1
6270535|NCT00084864|7169896|FG001|NOT COMPLETED|Overall Study||0
6270536|NCT00084864|7169897|FG002|NOT COMPLETED|Overall Study||0
6270537|NCT00084864|7169898|FG003|NOT COMPLETED|Overall Study||0
6270538|NCT00084929|7169908|FG000|STARTED|Overall Study||2600
6270539|NCT00084929|7169908|FG000|COMPLETED|Overall Study||2531
6270540|NCT00084929|7169908|FG000|NOT COMPLETED|Overall Study||69
6270541|NCT00085098|7169918|FG000|STARTED|Overall Study||11
6270542|NCT00085098|7169919|FG001|STARTED|Overall Study||13
6270543|NCT00085098|7169918|FG000|COMPLETED|Overall Study||10
6270544|NCT00085098|7169919|FG001|COMPLETED|Overall Study||11
6565369|NCT01817855|7488209|FG001|NOT COMPLETED|Overall Study||2
6565370|NCT01817855|7488210|FG002|NOT COMPLETED|Overall Study||2
6565371|NCT01817855|7488211|FG003|NOT COMPLETED|Overall Study||0
6270545|NCT00085098|7169918|FG000|NOT COMPLETED|Overall Study||1
6270546|NCT00085098|7169919|FG001|NOT COMPLETED|Overall Study||2
6270547|NCT00085254|7169931|FG000|STARTED|Overall Study||18
6270548|NCT00085254|7169932|FG001|STARTED|Overall Study||46
6270549|NCT00085254|7169933|FG002|STARTED|Overall Study||48
6270550|NCT00085254|7169931|FG000|COMPLETED|Overall Study||18
6270551|NCT00085254|7169932|FG001|COMPLETED|Overall Study||46
6270552|NCT00085254|7169933|FG002|COMPLETED|Overall Study||48
6270553|NCT00085254|7169931|FG000|NOT COMPLETED|Overall Study||0
6270554|NCT00085254|7169932|FG001|NOT COMPLETED|Overall Study||0
6270555|NCT00085254|7169933|FG002|NOT COMPLETED|Overall Study||0
6270556|NCT00085293|7169947|FG000|STARTED|Overall Study||12
6270557|NCT00085293|7169947|FG000|COMPLETED|Overall Study||12
6270558|NCT00085293|7169947|FG000|NOT COMPLETED|Overall Study||0
6270559|NCT00085410|7169951|FG000|STARTED|Overall Study||20
6270560|NCT00085410|7169951|FG000|COMPLETED|Overall Study||20
6270561|NCT00085410|7169951|FG000|NOT COMPLETED|Overall Study||0
6270562|NCT00085423|7169956|FG000|STARTED|Overall Study||20
6270563|NCT00085423|7169956|FG000|COMPLETED|Overall Study||18
6270564|NCT00085423|7169956|FG000|NOT COMPLETED|Overall Study||2
6270565|NCT00085436|7169960|FG000|STARTED|Overall Study||18
6270566|NCT00085436|7169960|FG000|COMPLETED|Overall Study||18
6270567|NCT00085436|7169960|FG000|NOT COMPLETED|Overall Study||0
6270568|NCT00085540|7169967|FG000|STARTED|Overall Study||8
6270569|NCT00085540|7169968|FG001|STARTED|Overall Study||42
6270570|NCT00085540|7169967|FG000|COMPLETED|Overall Study||8
6270571|NCT00085540|7169968|FG001|COMPLETED|Overall Study||40
6270572|NCT00085540|7169967|FG000|NOT COMPLETED|Overall Study||0
6270573|NCT00085540|7169968|FG001|NOT COMPLETED|Overall Study||2
6270574|NCT00085566|7169977|FG000|STARTED|Overall Study||3
6270575|NCT00085566|7169978|FG001|STARTED|Overall Study||3
6270576|NCT00085566|7169979|FG002|STARTED|Overall Study||57
6270577|NCT00085566|7169977|FG000|COMPLETED|Overall Study||3
6270578|NCT00085566|7169978|FG001|COMPLETED|Overall Study||3
6270579|NCT00085566|7169979|FG002|COMPLETED|Overall Study||43
6270580|NCT00085566|7169977|FG000|NOT COMPLETED|Overall Study||0
6270581|NCT00085566|7169978|FG001|NOT COMPLETED|Overall Study||0
6270582|NCT00085566|7169979|FG002|NOT COMPLETED|Overall Study||14
6270583|NCT00085644|7169989|FG000|STARTED|Double-Blind Period||208
6270584|NCT00085644|7169990|FG001|STARTED|Double-Blind Period||107
6270585|NCT00085644|7169991|FG002|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
6270586|NCT00085644|7169989|FG000|COMPLETED|Double-Blind Period||195
6270587|NCT00085644|7169990|FG001|COMPLETED|Double-Blind Period||101
6270588|NCT00085644|7169991|FG002|COMPLETED|Double-Blind Period||0
6270589|NCT00085644|7169989|FG000|NOT COMPLETED|Double-Blind Period||13
6270590|NCT00085644|7169990|FG001|NOT COMPLETED|Double-Blind Period||6
6565372|NCT01817907|7488229|FG000|STARTED|First Intervention||8
6565373|NCT01817907|7488230|FG001|STARTED|First Intervention||7
6270591|NCT00085644|7169991|FG002|NOT COMPLETED|Double-Blind Period||0
6280692|NCT00159263|7180665|FG001|COMPLETED|Washout||1
6280693|NCT00159263|7180666|FG002|COMPLETED|Washout||2
6385712|NCT00807495|7297039|FG003|COMPLETED|Overall Study||0
6385713|NCT00807495|7297040|FG004|COMPLETED|Overall Study||2
6385714|NCT00807495|7297036|FG000|NOT COMPLETED|Overall Study||8
6385715|NCT00807495|7297037|FG001|NOT COMPLETED|Overall Study||6
6385716|NCT00807495|7297038|FG002|NOT COMPLETED|Overall Study||4
6565374|NCT01817907|7488229|FG000|COMPLETED|First Intervention||8
6565375|NCT01817907|7488230|FG001|COMPLETED|First Intervention||7
6270592|NCT00085644|7169989|FG000|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
6270593|NCT00085644|7169990|FG001|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
6270594|NCT00085644|7169991|FG002|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
6270595|NCT00085644|7169989|FG000|COMPLETED|Open-Label Period||0
6270596|NCT00085644|7169990|FG001|COMPLETED|Open-Label Period||0
6270597|NCT00085644|7169991|FG002|COMPLETED|Open-Label Period||202
6270598|NCT00085644|7169989|FG000|NOT COMPLETED|Open-Label Period||0
6270599|NCT00085644|7169990|FG001|NOT COMPLETED|Open-Label Period||0
6804885|NCT01349959|7736941|FG000|NOT COMPLETED|Overall Study||7
6804886|NCT01168219|7736945|FG000|STARTED|Overall Study||68
6804887|NCT01168219|7736945|FG000|COMPLETED|Overall Study||63
6270600|NCT00085644|7169991|FG002|NOT COMPLETED|Open-Label Period||109
6270601|NCT00085709|7170000|FG000|STARTED|Overall Study||317
6270602|NCT00085709|7170001|FG001|STARTED|Overall Study||320
6270603|NCT00085709|7170000|FG000|Eligible|Overall Study||298
6270604|NCT00085709|7170001|FG001|Eligible|Overall Study||301
6270605|NCT00085709|7170000|FG000|Eligible and Did Not Withdraw Consent|Overall Study||296
6270606|NCT00085709|7170001|FG001|Eligible and Did Not Withdraw Consent|Overall Study||300
6270607|NCT00085709|7170000|FG000|COMPLETED|Overall Study||264
6270608|NCT00085709|7170001|FG001|COMPLETED|Overall Study||270
6270609|NCT00085709|7170000|FG000|NOT COMPLETED|Overall Study||53
6270610|NCT00085709|7170001|FG001|NOT COMPLETED|Overall Study||50
6270611|NCT00085839|7170017|FG000|STARTED|Overall Study||52
6270612|NCT00085839|7170018|FG001|STARTED|Overall Study||51
6270613|NCT00085839|7170017|FG000|COMPLETED|Overall Study||52
6270614|NCT00085839|7170018|FG001|COMPLETED|Overall Study||51
6270615|NCT00085839|7170017|FG000|NOT COMPLETED|Overall Study||0
6270616|NCT00085839|7170018|FG001|NOT COMPLETED|Overall Study||0
6270617|NCT00085917|7170026|FG000|STARTED|Overall Study||15
6270618|NCT00085917|7170027|FG001|STARTED|Overall Study||14
6270619|NCT00085917|7170026|FG000|COMPLETED|Overall Study||11
6270620|NCT00085917|7170027|FG001|COMPLETED|Overall Study||11
6270621|NCT00085917|7170026|FG000|NOT COMPLETED|Overall Study||4
6270622|NCT00085917|7170027|FG001|NOT COMPLETED|Overall Study||3
6270623|NCT00086047|7170035|FG000|STARTED|Overall Study||57
6270624|NCT00086047|7170036|FG001|STARTED|Overall Study||57
6270625|NCT00086047|7170035|FG000|COMPLETED|Overall Study||50
6270626|NCT00086047|7170036|FG001|COMPLETED|Overall Study||50
6270627|NCT00086047|7170035|FG000|NOT COMPLETED|Overall Study||7
6270628|NCT00086047|7170036|FG001|NOT COMPLETED|Overall Study||7
6270629|NCT00086138|7170044|FG000|STARTED|Overall Study||64
6270630|NCT00086138|7170045|FG001|STARTED|Overall Study||67
6270631|NCT00086138|7170044|FG000|COMPLETED|Overall Study||60
6270632|NCT00086138|7170045|FG001|COMPLETED|Overall Study||64
6270633|NCT00086138|7170044|FG000|NOT COMPLETED|Overall Study||4
6270634|NCT00086138|7170045|FG001|NOT COMPLETED|Overall Study||3
6270635|NCT00086190|7170054|FG000|STARTED|Overall Study||42
6270636|NCT00086190|7170055|FG001|STARTED|Overall Study||34
6270637|NCT00086190|7170056|FG002|STARTED|Overall Study||39
6270638|NCT00086190|7170054|FG000|COMPLETED|Overall Study||34
6270639|NCT00086190|7170055|FG001|COMPLETED|Overall Study||30
6270640|NCT00086190|7170056|FG002|COMPLETED|Overall Study||33
6270641|NCT00086190|7170054|FG000|NOT COMPLETED|Overall Study||8
6270642|NCT00086190|7170055|FG001|NOT COMPLETED|Overall Study||4
6270643|NCT00086190|7170056|FG002|NOT COMPLETED|Overall Study||6
6270644|NCT00086281|7170079|FG000|STARTED|Phase 1||11
6270645|NCT00086281|7170080|FG001|STARTED|Phase 1||12
6270646|NCT00086281|7170081|FG002|STARTED|Phase 1||8
6804888|NCT01168219|7736945|FG000|NOT COMPLETED|Overall Study||5
6804889|NCT01081262|7736953|FG000|STARTED|Overall Study||13
6804890|NCT01081262|7736954|FG001|STARTED|Overall Study||13
6804891|NCT01081262|7736955|FG002|STARTED|Overall Study||13
6804892|NCT01081262|7736956|FG003|STARTED|Overall Study||11
6804893|NCT01081262|7736953|FG000|COMPLETED|Overall Study||13
6804894|NCT01081262|7736954|FG001|COMPLETED|Overall Study||13
6804895|NCT01081262|7736955|FG002|COMPLETED|Overall Study||13
6270647|NCT00086281|7170082|FG003|STARTED|Phase 1||11
6270648|NCT00086281|7170083|FG004|STARTED|Phase 1||1
6270649|NCT00086281|7170084|FG005|STARTED|Phase 1||3
6270650|NCT00086281|7170085|FG006|STARTED|Phase 1||1
6270651|NCT00086281|7170086|FG007|STARTED|Phase 1||1
6270652|NCT00086281|7170087|FG008|STARTED|Phase 1||2
6804896|NCT01081262|7736956|FG003|COMPLETED|Overall Study||11
6804897|NCT01081262|7736953|FG000|NOT COMPLETED|Overall Study||0
6804898|NCT01081262|7736954|FG001|NOT COMPLETED|Overall Study||0
6270653|NCT00086281|7170088|FG009|STARTED|Phase 1||1
6270654|NCT00086281|7170089|FG010|STARTED|Phase 1||3
6270655|NCT00086281|7170090|FG011|STARTED|Phase 1||1
6270656|NCT00086281|7170091|FG012|STARTED|Phase 1||1
6270657|NCT00086281|7170092|FG013|STARTED|Phase 1||1
6270658|NCT00086281|7170093|FG014|STARTED|Phase 1||3
6270659|NCT00086281|7170079|FG000|COMPLETED|Phase 1||11
6270660|NCT00086281|7170080|FG001|COMPLETED|Phase 1||12
6270661|NCT00086281|7170081|FG002|COMPLETED|Phase 1||8
6270662|NCT00086281|7170082|FG003|COMPLETED|Phase 1||11
6270663|NCT00086281|7170083|FG004|COMPLETED|Phase 1||1
6270664|NCT00086281|7170084|FG005|COMPLETED|Phase 1||3
6270665|NCT00086281|7170085|FG006|COMPLETED|Phase 1||1
6270666|NCT00086281|7170086|FG007|COMPLETED|Phase 1||1
6270667|NCT00086281|7170087|FG008|COMPLETED|Phase 1||2
6270668|NCT00086281|7170088|FG009|COMPLETED|Phase 1||0
6270669|NCT00086281|7170089|FG010|COMPLETED|Phase 1||0
6270670|NCT00086281|7170090|FG011|COMPLETED|Phase 1||0
6270671|NCT00086281|7170091|FG012|COMPLETED|Phase 1||0
6270672|NCT00086281|7170092|FG013|COMPLETED|Phase 1||0
6270673|NCT00086281|7170093|FG014|COMPLETED|Phase 1||0
6270674|NCT00086281|7170079|FG000|NOT COMPLETED|Phase 1||0
6270675|NCT00086281|7170080|FG001|NOT COMPLETED|Phase 1||0
6270676|NCT00086281|7170081|FG002|NOT COMPLETED|Phase 1||0
6270677|NCT00086281|7170082|FG003|NOT COMPLETED|Phase 1||0
6270678|NCT00086281|7170083|FG004|NOT COMPLETED|Phase 1||0
6270679|NCT00086281|7170084|FG005|NOT COMPLETED|Phase 1||0
6270680|NCT00086281|7170085|FG006|NOT COMPLETED|Phase 1||0
6270681|NCT00086281|7170086|FG007|NOT COMPLETED|Phase 1||0
6270682|NCT00086281|7170087|FG008|NOT COMPLETED|Phase 1||0
6270683|NCT00086281|7170088|FG009|NOT COMPLETED|Phase 1||1
6270684|NCT00086281|7170089|FG010|NOT COMPLETED|Phase 1||3
6270685|NCT00086281|7170090|FG011|NOT COMPLETED|Phase 1||1
6270686|NCT00086281|7170091|FG012|NOT COMPLETED|Phase 1||1
6270687|NCT00086281|7170092|FG013|NOT COMPLETED|Phase 1||1
6270688|NCT00086281|7170093|FG014|NOT COMPLETED|Phase 1||3
6270689|NCT00086281|7170079|FG000|STARTED|Phase 2||0
6270690|NCT00086281|7170080|FG001|STARTED|Phase 2||0
6270691|NCT00086281|7170081|FG002|STARTED|Phase 2||0
6270692|NCT00086281|7170082|FG003|STARTED|Phase 2||0
6270693|NCT00086281|7170083|FG004|STARTED|Phase 2||0
6270694|NCT00086281|7170084|FG005|STARTED|Phase 2||0
6270695|NCT00086281|7170085|FG006|STARTED|Phase 2||0
6270696|NCT00086281|7170086|FG007|STARTED|Phase 2||0
6270697|NCT00086281|7170087|FG008|STARTED|Phase 2||0
6270698|NCT00086281|7170088|FG009|STARTED|Phase 2||0
6270699|NCT00086281|7170089|FG010|STARTED|Phase 2||0
6270700|NCT00086281|7170090|FG011|STARTED|Phase 2||0
6270701|NCT00086281|7170091|FG012|STARTED|Phase 2||23
6270702|NCT00086281|7170092|FG013|STARTED|Phase 2||27
6270703|NCT00086281|7170093|FG014|STARTED|Phase 2||0
6270704|NCT00086281|7170079|FG000|COMPLETED|Phase 2||0
6270705|NCT00086281|7170080|FG001|COMPLETED|Phase 2||0
6270706|NCT00086281|7170081|FG002|COMPLETED|Phase 2||0
6270707|NCT00086281|7170082|FG003|COMPLETED|Phase 2||0
6270708|NCT00086281|7170083|FG004|COMPLETED|Phase 2||0
6270709|NCT00086281|7170084|FG005|COMPLETED|Phase 2||0
6270710|NCT00086281|7170085|FG006|COMPLETED|Phase 2||0
6270711|NCT00086281|7170086|FG007|COMPLETED|Phase 2||0
6385717|NCT00807495|7297039|FG003|NOT COMPLETED|Overall Study||1
6270712|NCT00086281|7170087|FG008|COMPLETED|Phase 2||0
6270713|NCT00086281|7170088|FG009|COMPLETED|Phase 2||0
6270714|NCT00086281|7170089|FG010|COMPLETED|Phase 2||0
6270715|NCT00086281|7170090|FG011|COMPLETED|Phase 2||0
6270716|NCT00086281|7170091|FG012|COMPLETED|Phase 2||22
6270717|NCT00086281|7170092|FG013|COMPLETED|Phase 2||26
6270718|NCT00086281|7170093|FG014|COMPLETED|Phase 2||0
6270719|NCT00086281|7170079|FG000|NOT COMPLETED|Phase 2||0
6270720|NCT00086281|7170080|FG001|NOT COMPLETED|Phase 2||0
6270721|NCT00086281|7170081|FG002|NOT COMPLETED|Phase 2||0
6270722|NCT00086281|7170082|FG003|NOT COMPLETED|Phase 2||0
6270723|NCT00086281|7170083|FG004|NOT COMPLETED|Phase 2||0
6270724|NCT00086281|7170084|FG005|NOT COMPLETED|Phase 2||0
6270725|NCT00086281|7170085|FG006|NOT COMPLETED|Phase 2||0
6270726|NCT00086281|7170086|FG007|NOT COMPLETED|Phase 2||0
6270727|NCT00086281|7170087|FG008|NOT COMPLETED|Phase 2||0
6270728|NCT00086281|7170088|FG009|NOT COMPLETED|Phase 2||0
6270729|NCT00086281|7170089|FG010|NOT COMPLETED|Phase 2||0
6270730|NCT00086281|7170090|FG011|NOT COMPLETED|Phase 2||0
6270731|NCT00086281|7170091|FG012|NOT COMPLETED|Phase 2||1
6270732|NCT00086281|7170092|FG013|NOT COMPLETED|Phase 2||1
6270733|NCT00086281|7170093|FG014|NOT COMPLETED|Phase 2||0
6270734|NCT00086307|7170106|FG000|STARTED|Overall Study||13
6385718|NCT00807495|7297040|FG004|NOT COMPLETED|Overall Study||5
6385719|NCT00807560|7297054|FG000|STARTED|Overall Study||38
6385720|NCT00807560|7297055|FG001|STARTED|Overall Study||39
6385721|NCT00807560|7297054|FG000|COMPLETED|Overall Study||38
6385722|NCT00807560|7297055|FG001|COMPLETED|Overall Study||39
6385723|NCT00807560|7297054|FG000|NOT COMPLETED|Overall Study||0
6385724|NCT00807560|7297055|FG001|NOT COMPLETED|Overall Study||0
6385725|NCT00807573|7297061|FG000|STARTED|Overall Study||44
6385726|NCT00807573|7297061|FG000|COMPLETED|Overall Study||42
6385727|NCT00807573|7297061|FG000|NOT COMPLETED|Overall Study||2
6385728|NCT00807586|7297067|FG000|STARTED|Overall Study||60
6385729|NCT00807586|7297068|FG001|STARTED|Overall Study||59
6385730|NCT00807586|7297067|FG000|COMPLETED|Overall Study||54
6385731|NCT00807586|7297068|FG001|COMPLETED|Overall Study||58
6385732|NCT00807586|7297067|FG000|NOT COMPLETED|Overall Study||6
6385733|NCT00807586|7297068|FG001|NOT COMPLETED|Overall Study||1
6385734|NCT00807599|7297076|FG000|STARTED|Overall Study||26
6385735|NCT00807599|7297077|FG001|STARTED|Overall Study||24
6385736|NCT00807599|7297078|FG002|STARTED|Overall Study||17
6385737|NCT00807599|7297076|FG000|COMPLETED|Overall Study||26
6385738|NCT00807599|7297077|FG001|COMPLETED|Overall Study||24
6385739|NCT00807599|7297078|FG002|COMPLETED|Overall Study||0
6385740|NCT00807599|7297076|FG000|NOT COMPLETED|Overall Study||0
6385741|NCT00807599|7297077|FG001|NOT COMPLETED|Overall Study||0
6385742|NCT00807599|7297078|FG002|NOT COMPLETED|Overall Study||17
6385743|NCT00807664|7297086|FG000|STARTED|Overall Study||88
6385744|NCT00807664|7297087|FG001|STARTED|Overall Study||94
6385745|NCT00807664|7297086|FG000|COMPLETED|Overall Study||77
6385746|NCT00807664|7297087|FG001|COMPLETED|Overall Study||75
6385747|NCT00807664|7297086|FG000|NOT COMPLETED|Overall Study||11
6385748|NCT00807664|7297087|FG001|NOT COMPLETED|Overall Study||19
6385749|NCT00807742|7297096|FG000|STARTED|Overall Study||172
6270735|NCT00086307|7170107|FG001|STARTED|Overall Study||13
6270736|NCT00086307|7170108|FG002|STARTED|Overall Study||13
6270737|NCT00086307|7170106|FG000|COMPLETED|Overall Study||11
6385750|NCT00807742|7297097|FG001|STARTED|Overall Study||168
6385751|NCT00807742|7297096|FG000|COMPLETED|Overall Study||126
6385752|NCT00807742|7297097|FG001|COMPLETED|Overall Study||114
6385753|NCT00807742|7297096|FG000|NOT COMPLETED|Overall Study||46
6270738|NCT00086307|7170107|FG001|COMPLETED|Overall Study||12
6270739|NCT00086307|7170108|FG002|COMPLETED|Overall Study||5
6385754|NCT00807742|7297097|FG001|NOT COMPLETED|Overall Study||54
6385755|NCT00807768|7297105|FG000|STARTED|Overall Study||301
6385756|NCT00807768|7297106|FG001|STARTED|Overall Study||300
6385757|NCT00807768|7297105|FG000|COMPLETED|Overall Study||301
6385758|NCT00807768|7297106|FG001|COMPLETED|Overall Study||300
6385759|NCT00807768|7297105|FG000|NOT COMPLETED|Overall Study||0
6385760|NCT00807768|7297106|FG001|NOT COMPLETED|Overall Study||0
6385761|NCT00807846|7297114|FG000|STARTED|Overall Study||100
6385762|NCT00807846|7297115|FG001|STARTED|Overall Study||98
6385763|NCT00807846|7297114|FG000|COMPLETED|Overall Study||88
6385764|NCT00807846|7297115|FG001|COMPLETED|Overall Study||94
6385765|NCT00807846|7297114|FG000|NOT COMPLETED|Overall Study||12
6385766|NCT00807846|7297115|FG001|NOT COMPLETED|Overall Study||4
6385767|NCT00807885|7297130|FG000|STARTED|Overall Study||10
6385768|NCT00807885|7297131|FG001|STARTED|Overall Study||11
6385769|NCT00807885|7297132|FG002|STARTED|Overall Study||11
6385770|NCT00807885|7297133|FG003|STARTED|Overall Study||10
6385771|NCT00807885|7297134|FG004|STARTED|Overall Study||12
6385772|NCT00807885|7297135|FG005|STARTED|Overall Study||12
6385773|NCT00807885|7297136|FG006|STARTED|Overall Study||12
6385774|NCT00807885|7297137|FG007|STARTED|Overall Study||11
6385775|NCT00807885|7297138|FG008|STARTED|Overall Study||11
6385776|NCT00807885|7297130|FG000|COMPLETED|Overall Study||10
6385777|NCT00807885|7297131|FG001|COMPLETED|Overall Study||11
6385778|NCT00807885|7297132|FG002|COMPLETED|Overall Study||11
6385779|NCT00807885|7297133|FG003|COMPLETED|Overall Study||10
6385780|NCT00807885|7297134|FG004|COMPLETED|Overall Study||12
6385781|NCT00807885|7297135|FG005|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
6385782|NCT00807885|7297136|FG006|COMPLETED|Overall Study||12
6385783|NCT00807885|7297137|FG007|COMPLETED|Overall Study||11
6385784|NCT00807885|7297138|FG008|COMPLETED|Overall Study||11
6385785|NCT00807885|7297130|FG000|NOT COMPLETED|Overall Study||0
6385786|NCT00807885|7297131|FG001|NOT COMPLETED|Overall Study||0
6385787|NCT00807885|7297132|FG002|NOT COMPLETED|Overall Study||0
6385788|NCT00807885|7297133|FG003|NOT COMPLETED|Overall Study||0
6385789|NCT00807885|7297134|FG004|NOT COMPLETED|Overall Study||0
6385790|NCT00807885|7297135|FG005|NOT COMPLETED|Overall Study||1
6385791|NCT00807885|7297136|FG006|NOT COMPLETED|Overall Study||0
6385792|NCT00807885|7297137|FG007|NOT COMPLETED|Overall Study||0
6385793|NCT00807885|7297138|FG008|NOT COMPLETED|Overall Study||0
6385794|NCT00807937|7297162|FG000|STARTED|Overall Study||93
6385795|NCT00807937|7297163|FG001|STARTED|Overall Study||92
6385796|NCT00807937|7297164|FG002|STARTED|Overall Study||92
6385797|NCT00807937|7297165|FG003|STARTED|Overall Study||92
6385798|NCT00807937|7297162|FG000|COMPLETED|Overall Study||66
6385799|NCT00807937|7297163|FG001|COMPLETED|Overall Study||67
6385800|NCT00807937|7297164|FG002|COMPLETED|Overall Study||78
6385801|NCT00807937|7297165|FG003|COMPLETED|Overall Study||77
6385802|NCT00807937|7297162|FG000|NOT COMPLETED|Overall Study||27
6385803|NCT00807937|7297163|FG001|NOT COMPLETED|Overall Study||25
6385804|NCT00807937|7297164|FG002|NOT COMPLETED|Overall Study||14
6385805|NCT00807937|7297165|FG003|NOT COMPLETED|Overall Study||15
6385806|NCT00807989|7297177|FG000|STARTED|Overall Study||107
6385807|NCT00807989|7297178|FG001|STARTED|Overall Study||100
6385808|NCT00807989|7297177|FG000|COMPLETED|Overall Study||104
6385809|NCT00807989|7297178|FG001|COMPLETED|Overall Study||98
6385810|NCT00807989|7297177|FG000|NOT COMPLETED|Overall Study||3
6385811|NCT00807989|7297178|FG001|NOT COMPLETED|Overall Study||2
6385812|NCT00808015|7297184|FG000|STARTED|Overall Study||1377
6385813|NCT00808015|7297184|FG000|Treated|Overall Study||1373
6385814|NCT00808015|7297184|FG000|COMPLETED|Overall Study||1033
6385815|NCT00808015|7297184|FG000|NOT COMPLETED|Overall Study||344
6385816|NCT00808028|7297192|FG000|STARTED|Stage 1 (6 Months)||121
6385817|NCT00808028|7297193|FG001|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
6385818|NCT00808028|7297194|FG002|STARTED|Stage 1 (6 Months)||198
6385819|NCT00808028|7297195|FG003|STARTED|Stage 1 (6 Months)||198
6385820|NCT00808028|7297192|FG000|COMPLETED|Stage 1 (6 Months)||116
6385821|NCT00808028|7297193|FG001|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
6385822|NCT00808028|7297194|FG002|COMPLETED|Stage 1 (6 Months)||191
6385823|NCT00808028|7297195|FG003|COMPLETED|Stage 1 (6 Months)||183
6270740|NCT00086307|7170106|FG000|NOT COMPLETED|Overall Study||2
6270741|NCT00086307|7170107|FG001|NOT COMPLETED|Overall Study||1
6270742|NCT00086307|7170108|FG002|NOT COMPLETED|Overall Study||8
6270743|NCT00086346|7170118|FG000|STARTED|Randomization||393
6270744|NCT00086346|7170119|FG001|STARTED|Randomization||214
6270745|NCT00086346|7170118|FG000|COMPLETED|Randomization||389
6270746|NCT00086346|7170119|FG001|COMPLETED|Randomization||210
6270747|NCT00086346|7170118|FG000|NOT COMPLETED|Randomization||4
6270748|NCT00086346|7170119|FG001|NOT COMPLETED|Randomization||4
6270749|NCT00086346|7170118|FG000|STARTED|Patients Dosed With Test Article||389
6270750|NCT00086346|7170119|FG001|STARTED|Patients Dosed With Test Article||210
6270751|NCT00086346|7170118|FG000|COMPLETED|Patients Dosed With Test Article||249
6270752|NCT00086346|7170119|FG001|COMPLETED|Patients Dosed With Test Article||187
6270753|NCT00086346|7170118|FG000|NOT COMPLETED|Patients Dosed With Test Article||140
6270754|NCT00086346|7170119|FG001|NOT COMPLETED|Patients Dosed With Test Article||23
6270755|NCT00086385|7170129|FG000|STARTED|Overall Study||100
6270756|NCT00086385|7170130|FG001|STARTED|Overall Study||99
6270757|NCT00086385|7170131|FG002|STARTED|Overall Study||104
6270758|NCT00086385|7170132|FG003|STARTED|Overall Study||99
6270759|NCT00086385|7170129|FG000|COMPLETED|Overall Study||98
6270760|NCT00086385|7170130|FG001|COMPLETED|Overall Study||97
6270761|NCT00086385|7170131|FG002|COMPLETED|Overall Study||103
6270762|NCT00086385|7170132|FG003|COMPLETED|Overall Study||98
6270763|NCT00086385|7170129|FG000|NOT COMPLETED|Overall Study||2
6270764|NCT00086385|7170130|FG001|NOT COMPLETED|Overall Study||2
6270765|NCT00086385|7170131|FG002|NOT COMPLETED|Overall Study||1
6270766|NCT00086385|7170132|FG003|NOT COMPLETED|Overall Study||1
6270767|NCT00086411|7170146|FG000|STARTED|Overall Study||70
6270768|NCT00086411|7170147|FG001|STARTED|Overall Study||63
6270769|NCT00086411|7170148|FG002|STARTED|Overall Study||62
6270770|NCT00086411|7170149|FG003|STARTED|Overall Study||65
6270771|NCT00086411|7170146|FG000|COMPLETED|Overall Study||59
6270772|NCT00086411|7170147|FG001|COMPLETED|Overall Study||52
6270773|NCT00086411|7170148|FG002|COMPLETED|Overall Study||49
6270774|NCT00086411|7170149|FG003|COMPLETED|Overall Study||53
6270775|NCT00086411|7170146|FG000|NOT COMPLETED|Overall Study||11
6270776|NCT00086411|7170147|FG001|NOT COMPLETED|Overall Study||11
6270777|NCT00086411|7170148|FG002|NOT COMPLETED|Overall Study||13
6270778|NCT00086411|7170149|FG003|NOT COMPLETED|Overall Study||12
6270779|NCT00086450|7170162|FG000|STARTED|Overall Study||953
6270780|NCT00086450|7170163|FG001|STARTED|Overall Study||947
6270781|NCT00086450|7170162|FG000|COMPLETED|Overall Study||953
6270782|NCT00086450|7170163|FG001|COMPLETED|Overall Study||947
6270783|NCT00086450|7170162|FG000|NOT COMPLETED|Overall Study||0
6270784|NCT00086450|7170163|FG001|NOT COMPLETED|Overall Study||0
6270785|NCT00086502|7170171|FG000|STARTED|Overall Study||175
6270786|NCT00086502|7170172|FG001|STARTED|Overall Study||178
6270787|NCT00086502|7170171|FG000|COMPLETED|Overall Study||149
6270788|NCT00086502|7170172|FG001|COMPLETED|Overall Study||158
6270789|NCT00086502|7170171|FG000|NOT COMPLETED|Overall Study||26
6804899|NCT01081262|7736955|FG002|NOT COMPLETED|Overall Study||0
6804900|NCT01081262|7736956|FG003|NOT COMPLETED|Overall Study||0
6804901|NCT00812708|7736966|FG000|STARTED|Overall Study|6 patients withdrew from the study before being taken to the operating room.|72
6804902|NCT00812708|7736966|FG000|Taken to Surgery for Device Implantation|Overall Study|2 patients could not be implanted because of intraoperative complications.|66
6804903|NCT00812708|7736966|FG000|COMPLETED|Overall Study||64
6804904|NCT00812708|7736966|FG000|NOT COMPLETED|Overall Study||8
6804905|NCT00792259|7736974|FG000|STARTED|Overall Study||15
6804906|NCT00792259|7736975|FG001|STARTED|Overall Study||20
6804907|NCT00792259|7736976|FG002|STARTED|Overall Study||13
6804908|NCT00792259|7736974|FG000|COMPLETED|Overall Study||14
6804909|NCT00792259|7736975|FG001|COMPLETED|Overall Study||20
6385824|NCT00808028|7297192|FG000|NOT COMPLETED|Stage 1 (6 Months)||5
6385825|NCT00808028|7297193|FG001|NOT COMPLETED|Stage 1 (6 Months)||1
6385826|NCT00808028|7297194|FG002|NOT COMPLETED|Stage 1 (6 Months)||7
6385827|NCT00808028|7297195|FG003|NOT COMPLETED|Stage 1 (6 Months)||15
6385828|NCT00808028|7297192|FG000|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
6385829|NCT00808028|7297193|FG001|STARTED|Stage 2 (Followed up to 48 Months )||0
6385830|NCT00808028|7297194|FG002|STARTED|Stage 2 (Followed up to 48 Months )||170
6385831|NCT00808028|7297195|FG003|STARTED|Stage 2 (Followed up to 48 Months )||151
6385832|NCT00808028|7297192|FG000|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
6385833|NCT00808028|7297193|FG001|COMPLETED|Stage 2 (Followed up to 48 Months )||0
6385834|NCT00808028|7297194|FG002|COMPLETED|Stage 2 (Followed up to 48 Months )||141
6385835|NCT00808028|7297195|FG003|COMPLETED|Stage 2 (Followed up to 48 Months )||128
6385836|NCT00808028|7297192|FG000|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
6385837|NCT00808028|7297193|FG001|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
6385838|NCT00808028|7297194|FG002|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
6385839|NCT00808028|7297195|FG003|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
6385840|NCT00808067|7297217|FG000|STARTED|Overall Study|Number of patients which are treated.|2927
6385841|NCT00808067|7297218|FG001|STARTED|Overall Study|Number of patients which are treated.|2956
6385842|NCT00808067|7297217|FG000|COMPLETED|Overall Study||2446
6385843|NCT00808067|7297218|FG001|COMPLETED|Overall Study||2438
6385844|NCT00808067|7297217|FG000|NOT COMPLETED|Overall Study||481
6385845|NCT00808067|7297218|FG001|NOT COMPLETED|Overall Study||518
6385846|NCT00808132|7297229|FG000|STARTED|Overall Study||455
6385847|NCT00808132|7297230|FG001|STARTED|Overall Study||481
6385848|NCT00808132|7297231|FG002|STARTED|Overall Study||239
6385849|NCT00808132|7297232|FG003|STARTED|Overall Study||228
6385850|NCT00808132|7297233|FG004|STARTED|Overall Study||483
6385851|NCT00808132|7297229|FG000|Treated|Overall Study||445
6385852|NCT00808132|7297230|FG001|Treated|Overall Study||474
6385853|NCT00808132|7297231|FG002|Treated|Overall Study||230
6385854|NCT00808132|7297232|FG003|Treated|Overall Study||220
6385855|NCT00808132|7297233|FG004|Treated|Overall Study||474
6385856|NCT00808132|7297229|FG000|COMPLETED|Overall Study||357
6385857|NCT00808132|7297230|FG001|COMPLETED|Overall Study||393
6385858|NCT00808132|7297231|FG002|COMPLETED|Overall Study||185
6385859|NCT00808132|7297232|FG003|COMPLETED|Overall Study||159
6385860|NCT00808132|7297233|FG004|COMPLETED|Overall Study||383
6385861|NCT00808132|7297229|FG000|NOT COMPLETED|Overall Study||98
6385862|NCT00808132|7297230|FG001|NOT COMPLETED|Overall Study||88
6385863|NCT00808132|7297231|FG002|NOT COMPLETED|Overall Study||54
6385864|NCT00808132|7297232|FG003|NOT COMPLETED|Overall Study||69
6385865|NCT00808132|7297233|FG004|NOT COMPLETED|Overall Study||100
6385866|NCT00808210|7297247|FG000|STARTED|Study Period + 48 Weeks of Follow-up||15
6385867|NCT00808210|7297248|FG001|STARTED|Study Period + 48 Weeks of Follow-up||13
6385868|NCT00808210|7297247|FG000|COMPLETED|Study Period + 48 Weeks of Follow-up||6
6385869|NCT00808210|7297248|FG001|COMPLETED|Study Period + 48 Weeks of Follow-up||4
6385870|NCT00808210|7297247|FG000|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
6385871|NCT00808210|7297248|FG001|NOT COMPLETED|Study Period + 48 Weeks of Follow-up||9
6385872|NCT00808210|7297247|FG000|STARTED|Double-Blind TX Period||15
6385873|NCT00808210|7297248|FG001|STARTED|Double-Blind TX Period||13
6385874|NCT00808210|7297247|FG000|COMPLETED|Double-Blind TX Period||13
6385875|NCT00808210|7297248|FG001|COMPLETED|Double-Blind TX Period||10
6385876|NCT00808210|7297247|FG000|NOT COMPLETED|Double-Blind TX Period||2
6385877|NCT00808210|7297248|FG001|NOT COMPLETED|Double-Blind TX Period||3
6385878|NCT00808210|7297247|FG000|STARTED|Open Label Ocrelizumab Treatment Period||9
6385879|NCT00808210|7297248|FG001|STARTED|Open Label Ocrelizumab Treatment Period||4
6385880|NCT00808210|7297247|FG000|COMPLETED|Open Label Ocrelizumab Treatment Period||0
6385881|NCT00808210|7297248|FG001|COMPLETED|Open Label Ocrelizumab Treatment Period||0
6385882|NCT00808210|7297247|FG000|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||9
6385883|NCT00808210|7297248|FG001|NOT COMPLETED|Open Label Ocrelizumab Treatment Period||4
6385884|NCT00808236|7297256|FG000|STARTED|Overall Study||96
6385885|NCT00808236|7297257|FG001|STARTED|Overall Study||104
6385886|NCT00808236|7297256|FG000|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
6385887|NCT00808236|7297257|FG001|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
6385888|NCT00808236|7297256|FG000|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
6385889|NCT00808236|7297257|FG001|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
6385890|NCT00808236|7297256|FG000|Achieved ROSC|Overall Study||33
6385891|NCT00808236|7297257|FG001|Achieved ROSC|Overall Study||43
6385892|NCT00808236|7297256|FG000|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
6385893|NCT00808236|7297257|FG001|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
6385894|NCT00808236|7297256|FG000|COMPLETED|Overall Study||14
6385895|NCT00808236|7297257|FG001|COMPLETED|Overall Study||13
6385896|NCT00808236|7297256|FG000|NOT COMPLETED|Overall Study||82
6385897|NCT00808236|7297257|FG001|NOT COMPLETED|Overall Study||91
6385898|NCT00808249|7297267|FG000|STARTED|Overall Study||107
6385899|NCT00808249|7297268|FG001|STARTED|Overall Study||106
6503544|NCT01441882|7422466|FG000|STARTED|Overall Study||19
6385900|NCT00808249|7297269|FG002|STARTED|Overall Study||105
6385901|NCT00808249|7297270|FG003|STARTED|Overall Study||106
6385902|NCT00808249|7297267|FG000|COMPLETED|Overall Study||90
6385903|NCT00808249|7297268|FG001|COMPLETED|Overall Study||91
6385904|NCT00808249|7297269|FG002|COMPLETED|Overall Study||83
6385905|NCT00808249|7297270|FG003|COMPLETED|Overall Study||90
6565376|NCT01817907|7488229|FG000|NOT COMPLETED|First Intervention||0
6656825|NCT02465216|7587177|FG001|STARTED|Overall Study||5
6656826|NCT02465216|7587178|FG002|STARTED|Overall Study||14
6270790|NCT00086502|7170172|FG001|NOT COMPLETED|Overall Study||20
6270791|NCT00086515|7170180|FG000|STARTED|Phase A (Weeks 0-24)||464
6270792|NCT00086515|7170181|FG001|STARTED|Phase A (Weeks 0-24)||237
6270793|NCT00086515|7170180|FG000|COMPLETED|Phase A (Weeks 0-24)||415
6270794|NCT00086515|7170181|FG001|COMPLETED|Phase A (Weeks 0-24)||192
6270795|NCT00086515|7170180|FG000|NOT COMPLETED|Phase A (Weeks 0-24)||49
6270796|NCT00086515|7170181|FG001|NOT COMPLETED|Phase A (Weeks 0-24)||45
6270797|NCT00086515|7170180|FG000|STARTED|Phase A to Phase B Transition Period||415
6270798|NCT00086515|7170181|FG001|STARTED|Phase A to Phase B Transition Period||192
6270799|NCT00086515|7170180|FG000|COMPLETED|Phase A to Phase B Transition Period||391
6270800|NCT00086515|7170181|FG001|COMPLETED|Phase A to Phase B Transition Period||164
6270801|NCT00086515|7170180|FG000|NOT COMPLETED|Phase A to Phase B Transition Period||24
6270802|NCT00086515|7170181|FG001|NOT COMPLETED|Phase A to Phase B Transition Period||28
6270803|NCT00086515|7170180|FG000|STARTED|Phase B (Weeks 24-104)||391
6270804|NCT00086515|7170181|FG001|STARTED|Phase B (Weeks 24-104)||164
6270805|NCT00086515|7170180|FG000|COMPLETED|Phase B (Weeks 24-104)||201
6270806|NCT00086515|7170181|FG001|COMPLETED|Phase B (Weeks 24-104)||109
6270807|NCT00086515|7170180|FG000|NOT COMPLETED|Phase B (Weeks 24-104)||190
6270808|NCT00086515|7170181|FG001|NOT COMPLETED|Phase B (Weeks 24-104)||55
6270809|NCT00086580|7170189|FG000|STARTED|Treatment Period||168
6270810|NCT00086580|7170190|FG001|STARTED|Treatment Period||167
6270811|NCT00086580|7170189|FG000|Safety Population|Treatment Period|Four participants did not receive treatment|164
6270812|NCT00086580|7170190|FG001|Safety Population|Treatment Period|Two participants did not receive treatment|165
6270813|NCT00086580|7170189|FG000|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
6270814|NCT00086580|7170190|FG001|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
6270815|NCT00086580|7170189|FG000|NOT COMPLETED|Treatment Period||65
6270816|NCT00086580|7170190|FG001|NOT COMPLETED|Treatment Period||60
6270817|NCT00086580|7170189|FG000|STARTED|Follow-up Period||141
6270818|NCT00086580|7170190|FG001|STARTED|Follow-up Period||137
6270819|NCT00086580|7170189|FG000|COMPLETED|Follow-up Period||37
6270820|NCT00086580|7170190|FG001|COMPLETED|Follow-up Period||18
6270821|NCT00086580|7170189|FG000|NOT COMPLETED|Follow-up Period||104
6270822|NCT00086580|7170190|FG001|NOT COMPLETED|Follow-up Period||119
6270823|NCT00086580|7170189|FG000|STARTED|Observation Period||95
6270824|NCT00086580|7170190|FG001|STARTED|Observation Period||121
6270825|NCT00086580|7170189|FG000|COMPLETED|Observation Period||49
6270826|NCT00086580|7170190|FG001|COMPLETED|Observation Period||56
6270827|NCT00086580|7170189|FG000|NOT COMPLETED|Observation Period||46
6270828|NCT00086580|7170190|FG001|NOT COMPLETED|Observation Period||65
6270829|NCT00086619|7170198|FG000|STARTED|Overall Study||40
6270830|NCT00086619|7170199|FG001|STARTED|Overall Study||40
6270831|NCT00086619|7170198|FG000|Completed Baseline Visit|Overall Study||34
6270832|NCT00086619|7170199|FG001|Completed Baseline Visit|Overall Study||36
6270833|NCT00086619|7170198|FG000|Completed 12 Month Visit|Overall Study||26
6270834|NCT00086619|7170199|FG001|Completed 12 Month Visit|Overall Study||26
6270835|NCT00086619|7170198|FG000|COMPLETED|Overall Study||25
6270836|NCT00086619|7170199|FG001|COMPLETED|Overall Study||23
6270837|NCT00086619|7170198|FG000|NOT COMPLETED|Overall Study||15
6270838|NCT00086619|7170199|FG001|NOT COMPLETED|Overall Study||17
6270839|NCT00086684|7170208|FG000|STARTED|Overall Study||118
6270840|NCT00086684|7170209|FG001|STARTED|Overall Study||129
6270841|NCT00086684|7170210|FG002|STARTED|Overall Study||122
6270842|NCT00086684|7170208|FG000|COMPLETED|Overall Study||63
6804910|NCT00792259|7736976|FG002|COMPLETED|Overall Study||13
6804911|NCT00792259|7736974|FG000|NOT COMPLETED|Overall Study||1
6804912|NCT00792259|7736975|FG001|NOT COMPLETED|Overall Study||0
6804913|NCT00792259|7736976|FG002|NOT COMPLETED|Overall Study||0
6804914|NCT00741988|7736986|FG000|STARTED|Overall Study||42
6804915|NCT00741988|7736987|FG001|STARTED|Overall Study||40
6804916|NCT00741988|7736986|FG000|COMPLETED|Overall Study||38
6804917|NCT00741988|7736987|FG001|COMPLETED|Overall Study||36
6804918|NCT00741988|7736986|FG000|NOT COMPLETED|Overall Study||4
6385906|NCT00808249|7297267|FG000|NOT COMPLETED|Overall Study||17
6385907|NCT00808249|7297268|FG001|NOT COMPLETED|Overall Study||15
6385908|NCT00808249|7297269|FG002|NOT COMPLETED|Overall Study||22
6385909|NCT00808249|7297270|FG003|NOT COMPLETED|Overall Study||16
6385910|NCT00808340|7297280|FG000|STARTED|First Intervention||4
6385911|NCT00808340|7297281|FG001|STARTED|First Intervention||9
6804919|NCT00741988|7736987|FG001|NOT COMPLETED|Overall Study||4
6804920|NCT00563576|7736995|FG000|STARTED|Overall Study||35
6565377|NCT01817907|7488230|FG001|NOT COMPLETED|First Intervention||0
6565378|NCT01817907|7488229|FG000|STARTED|Washout Period||8
6565379|NCT01817907|7488230|FG001|STARTED|Washout Period||7
6565380|NCT01817907|7488229|FG000|COMPLETED|Washout Period||8
6565381|NCT01817907|7488230|FG001|COMPLETED|Washout Period||7
6565382|NCT01817907|7488229|FG000|NOT COMPLETED|Washout Period||0
6565383|NCT01817907|7488230|FG001|NOT COMPLETED|Washout Period||0
6565384|NCT01817907|7488229|FG000|STARTED|Second Intervention||8
6565385|NCT01817907|7488230|FG001|STARTED|Second Intervention||7
6565386|NCT01817907|7488229|FG000|COMPLETED|Second Intervention||8
6565387|NCT01817907|7488230|FG001|COMPLETED|Second Intervention||7
6804921|NCT00563576|7736996|FG001|STARTED|Overall Study||36
6804922|NCT00563576|7736995|FG000|COMPLETED|Overall Study||21
6804923|NCT00563576|7736996|FG001|COMPLETED|Overall Study||22
6804924|NCT00563576|7736995|FG000|NOT COMPLETED|Overall Study||14
6804925|NCT00563576|7736996|FG001|NOT COMPLETED|Overall Study||14
6804926|NCT00515671|7737004|FG000|STARTED|Overall Study||60
6804927|NCT00515671|7737005|FG001|STARTED|Overall Study||58
6804928|NCT00515671|7737004|FG000|COMPLETED|Overall Study||43
6804929|NCT00515671|7737005|FG001|COMPLETED|Overall Study||41
6804930|NCT00515671|7737004|FG000|NOT COMPLETED|Overall Study||17
6804931|NCT00515671|7737005|FG001|NOT COMPLETED|Overall Study||17
6804932|NCT00455403|7737013|FG000|STARTED|Overall Study||59
6804933|NCT00455403|7737014|FG001|STARTED|Overall Study||57
6804934|NCT00455403|7737013|FG000|COMPLETED|Overall Study||56
6804935|NCT00455403|7737014|FG001|COMPLETED|Overall Study||51
6804936|NCT00455403|7737013|FG000|NOT COMPLETED|Overall Study||3
6804937|NCT00455403|7737014|FG001|NOT COMPLETED|Overall Study||6
6804938|NCT00238420|7737022|FG000|STARTED|Overall Study||22
6804939|NCT00238420|7737023|FG001|STARTED|Overall Study||48
6804940|NCT00238420|7737022|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
6804941|NCT00238420|7737023|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
6804942|NCT00238420|7737022|FG000|NOT COMPLETED|Overall Study||1
6804943|NCT00238420|7737023|FG001|NOT COMPLETED|Overall Study||1
6804944|NCT00085982|7737029|FG000|STARTED|Overall Study||11
6804945|NCT00085982|7737029|FG000|COMPLETED|Overall Study||5
6804946|NCT00085982|7737029|FG000|NOT COMPLETED|Overall Study||6
6565388|NCT01817907|7488229|FG000|NOT COMPLETED|Second Intervention||0
6565389|NCT01817907|7488230|FG001|NOT COMPLETED|Second Intervention||0
6565390|NCT01817959|7488238|FG000|STARTED|Overall Study||29
6565391|NCT01817959|7488239|FG001|STARTED|Overall Study||19
6565392|NCT01817959|7488238|FG000|COMPLETED|Overall Study||25
6565393|NCT01817959|7488239|FG001|COMPLETED|Overall Study||16
6565394|NCT01817959|7488238|FG000|NOT COMPLETED|Overall Study||4
6565395|NCT01817959|7488239|FG001|NOT COMPLETED|Overall Study||3
6565396|NCT01818063|7488247|FG000|STARTED|Overall Study||5
6565397|NCT01818063|7488248|FG001|STARTED|Overall Study||4
6565398|NCT01818063|7488247|FG000|COMPLETED|Overall Study||5
6385912|NCT00808340|7297282|FG002|STARTED|First Intervention||7
6565399|NCT01818063|7488248|FG001|COMPLETED|Overall Study||4
6656827|NCT02465216|7587179|FG003|STARTED|Overall Study||14
6385913|NCT00808340|7297283|FG003|STARTED|First Intervention||3
6565400|NCT01818063|7488247|FG000|NOT COMPLETED|Overall Study||0
6565401|NCT01818063|7488248|FG001|NOT COMPLETED|Overall Study||0
6565402|NCT01818141|7488256|FG000|STARTED|Overall Study||18
6565403|NCT01818141|7488257|FG001|STARTED|Overall Study||16
6565404|NCT01818141|7488256|FG000|COMPLETED|Overall Study||15
6565405|NCT01818141|7488257|FG001|COMPLETED|Overall Study||13
6565406|NCT01818141|7488256|FG000|NOT COMPLETED|Overall Study||3
6565407|NCT01818141|7488257|FG001|NOT COMPLETED|Overall Study||3
6565408|NCT01818245|7488265|FG000|STARTED|Intervention A||30
6385914|NCT00808340|7297284|FG004|STARTED|First Intervention||5
6385915|NCT00808340|7297285|FG005|STARTED|First Intervention||6
6385916|NCT00808340|7297280|FG000|COMPLETED|First Intervention||4
6385917|NCT00808340|7297281|FG001|COMPLETED|First Intervention||9
6385918|NCT00808340|7297282|FG002|COMPLETED|First Intervention||7
6385919|NCT00808340|7297283|FG003|COMPLETED|First Intervention||3
6385920|NCT00808340|7297284|FG004|COMPLETED|First Intervention||5
6385921|NCT00808340|7297285|FG005|COMPLETED|First Intervention||6
6385922|NCT00808340|7297280|FG000|NOT COMPLETED|First Intervention||0
6385923|NCT00808340|7297281|FG001|NOT COMPLETED|First Intervention||0
6385924|NCT00808340|7297282|FG002|NOT COMPLETED|First Intervention||0
6385925|NCT00808340|7297283|FG003|NOT COMPLETED|First Intervention||0
6385926|NCT00808340|7297284|FG004|NOT COMPLETED|First Intervention||0
6385927|NCT00808340|7297285|FG005|NOT COMPLETED|First Intervention||0
6385928|NCT00808340|7297280|FG000|STARTED|Second Intervention||4
6385929|NCT00808340|7297281|FG001|STARTED|Second Intervention||9
6385930|NCT00808340|7297282|FG002|STARTED|Second Intervention||7
6385931|NCT00808340|7297283|FG003|STARTED|Second Intervention||3
6385932|NCT00808340|7297284|FG004|STARTED|Second Intervention||5
6385933|NCT00808340|7297285|FG005|STARTED|Second Intervention||6
6385934|NCT00808340|7297280|FG000|COMPLETED|Second Intervention||4
6385935|NCT00808340|7297281|FG001|COMPLETED|Second Intervention||9
6385936|NCT00808340|7297282|FG002|COMPLETED|Second Intervention||7
6385937|NCT00808340|7297283|FG003|COMPLETED|Second Intervention||3
6385938|NCT00808340|7297284|FG004|COMPLETED|Second Intervention||5
6385939|NCT00808340|7297285|FG005|COMPLETED|Second Intervention||6
6385940|NCT00808340|7297280|FG000|NOT COMPLETED|Second Intervention||0
6385941|NCT00808340|7297281|FG001|NOT COMPLETED|Second Intervention||0
6385942|NCT00808340|7297282|FG002|NOT COMPLETED|Second Intervention||0
6385943|NCT00808340|7297283|FG003|NOT COMPLETED|Second Intervention||0
6385944|NCT00808340|7297284|FG004|NOT COMPLETED|Second Intervention||0
6385945|NCT00808340|7297285|FG005|NOT COMPLETED|Second Intervention||0
6385946|NCT00808340|7297280|FG000|STARTED|Third Intervention||4
6385947|NCT00808340|7297281|FG001|STARTED|Third Intervention||9
6385948|NCT00808340|7297282|FG002|STARTED|Third Intervention||7
6385949|NCT00808340|7297283|FG003|STARTED|Third Intervention||3
6385950|NCT00808340|7297284|FG004|STARTED|Third Intervention||5
6385951|NCT00808340|7297285|FG005|STARTED|Third Intervention||6
6385952|NCT00808340|7297280|FG000|COMPLETED|Third Intervention||4
6385953|NCT00808340|7297281|FG001|COMPLETED|Third Intervention||9
6385954|NCT00808340|7297282|FG002|COMPLETED|Third Intervention||7
6385955|NCT00808340|7297283|FG003|COMPLETED|Third Intervention||3
6385956|NCT00808340|7297284|FG004|COMPLETED|Third Intervention||5
6385957|NCT00808340|7297285|FG005|COMPLETED|Third Intervention||6
6385958|NCT00808340|7297280|FG000|NOT COMPLETED|Third Intervention||0
6385959|NCT00808340|7297281|FG001|NOT COMPLETED|Third Intervention||0
6385960|NCT00808340|7297282|FG002|NOT COMPLETED|Third Intervention||0
6385961|NCT00808340|7297283|FG003|NOT COMPLETED|Third Intervention||0
6385962|NCT00808340|7297284|FG004|NOT COMPLETED|Third Intervention||0
6385963|NCT00808340|7297285|FG005|NOT COMPLETED|Third Intervention||0
6385964|NCT00808405|7297295|FG000|STARTED|Overall Study||61
6385965|NCT00808405|7297296|FG001|STARTED|Overall Study||27
6385966|NCT00808405|7297295|FG000|COMPLETED|Overall Study||61
6385967|NCT00808405|7297296|FG001|COMPLETED|Overall Study||27
6385968|NCT00808405|7297295|FG000|NOT COMPLETED|Overall Study||0
6385969|NCT00808405|7297296|FG001|NOT COMPLETED|Overall Study||0
6385970|NCT00808444|7297304|FG000|STARTED|Overall Study||233
6385971|NCT00808444|7297305|FG001|STARTED|Overall Study||233
6385972|NCT00808444|7297304|FG000|COMPLETED|Overall Study||232
6385973|NCT00808444|7297305|FG001|COMPLETED|Overall Study||232
6385974|NCT00808444|7297304|FG000|NOT COMPLETED|Overall Study||1
6385975|NCT00808444|7297305|FG001|NOT COMPLETED|Overall Study||1
6385976|NCT00808470|7297313|FG000|STARTED|Overall Study||37
6385977|NCT00808470|7297314|FG001|STARTED|Overall Study||35
6385978|NCT00808470|7297313|FG000|COMPLETED|Overall Study||35
6385979|NCT00808470|7297314|FG001|COMPLETED|Overall Study||35
6385980|NCT00808470|7297313|FG000|NOT COMPLETED|Overall Study||2
6385981|NCT00808470|7297314|FG001|NOT COMPLETED|Overall Study||0
6385982|NCT00808483|7297326|FG000|STARTED|From 3 to 5 Months After Surgery||35
6385983|NCT00808483|7297327|FG001|STARTED|From 3 to 5 Months After Surgery||33
6503545|NCT01441882|7422466|FG000|COMPLETED|Overall Study||13
6503546|NCT01441882|7422466|FG000|NOT COMPLETED|Overall Study||6
6503547|NCT01441960|7422470|FG000|STARTED|First Neuromuscular Blocking Agent:||26
6503548|NCT01441960|7422471|FG001|STARTED|First Neuromuscular Blocking Agent:||19
6503549|NCT01441960|7422470|FG000|COMPLETED|First Neuromuscular Blocking Agent:||18
6503550|NCT01441960|7422471|FG001|COMPLETED|First Neuromuscular Blocking Agent:||13
6503551|NCT01441960|7422470|FG000|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
6503552|NCT01441960|7422471|FG001|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
6503553|NCT01441960|7422470|FG000|STARTED|Second Neuromuscular Blocking Agent||18
6503554|NCT01441960|7422471|FG001|STARTED|Second Neuromuscular Blocking Agent||13
6503555|NCT01441960|7422470|FG000|COMPLETED|Second Neuromuscular Blocking Agent||18
6385984|NCT00808483|7297326|FG000|COMPLETED|From 3 to 5 Months After Surgery||33
6385985|NCT00808483|7297327|FG001|COMPLETED|From 3 to 5 Months After Surgery||32
6385986|NCT00808483|7297326|FG000|NOT COMPLETED|From 3 to 5 Months After Surgery||2
6385987|NCT00808483|7297327|FG001|NOT COMPLETED|From 3 to 5 Months After Surgery||1
6385988|NCT00808483|7297326|FG000|STARTED|From 5 Months to 12 Months||33
6385989|NCT00808483|7297327|FG001|STARTED|From 5 Months to 12 Months||32
6385990|NCT00808483|7297326|FG000|COMPLETED|From 5 Months to 12 Months||32
6385991|NCT00808483|7297327|FG001|COMPLETED|From 5 Months to 12 Months||32
6385992|NCT00808483|7297326|FG000|NOT COMPLETED|From 5 Months to 12 Months||1
6385993|NCT00808483|7297327|FG001|NOT COMPLETED|From 5 Months to 12 Months||0
6656828|NCT02465216|7587180|FG004|STARTED|Overall Study||12
6656829|NCT02465216|7587176|FG000|COMPLETED|Overall Study||12
6656830|NCT02465216|7587177|FG001|COMPLETED|Overall Study||5
6656831|NCT02465216|7587178|FG002|COMPLETED|Overall Study||13
6656832|NCT02465216|7587179|FG003|COMPLETED|Overall Study||12
6656833|NCT02465216|7587180|FG004|COMPLETED|Overall Study||9
6385994|NCT00808509|7297342|FG000|STARTED|Randomized Phase||17
6385995|NCT00808509|7297343|FG001|STARTED|Randomized Phase||16
6385996|NCT00808509|7297342|FG000|Received Rescue Therapy|Randomized Phase||0
6385997|NCT00808509|7297343|FG001|Received Rescue Therapy|Randomized Phase||9
6385998|NCT00808509|7297342|FG000|COMPLETED|Randomized Phase||15
6385999|NCT00808509|7297343|FG001|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
6386000|NCT00808509|7297342|FG000|NOT COMPLETED|Randomized Phase||2
6386001|NCT00808509|7297343|FG001|NOT COMPLETED|Randomized Phase||5
6386002|NCT00808509|7297342|FG000|STARTED|Observation Phase|The observation phase was open to all participants|16
6386003|NCT00808509|7297343|FG001|STARTED|Observation Phase|The observation phase was open to all participants|15
6386004|NCT00808509|7297342|FG000|COMPLETED|Observation Phase||16
6386005|NCT00808509|7297343|FG001|COMPLETED|Observation Phase||15
6386006|NCT00808509|7297342|FG000|NOT COMPLETED|Observation Phase||0
6386007|NCT00808509|7297343|FG001|NOT COMPLETED|Observation Phase||0
6386008|NCT00808639|7297351|FG000|STARTED|Overall Study||39
6386009|NCT00808639|7297351|FG000|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
6386010|NCT00808639|7297351|FG000|NOT COMPLETED|Overall Study||1
6386011|NCT00808665|7297357|FG000|STARTED|Overall Study||31
6386012|NCT00808665|7297358|FG001|STARTED|Overall Study||32
6386013|NCT00808665|7297357|FG000|Medication Started|Overall Study||30
6386014|NCT00808665|7297358|FG001|Medication Started|Overall Study||32
6386015|NCT00808665|7297357|FG000|Completed Intra-operative Dose|Overall Study||26
6386016|NCT00808665|7297358|FG001|Completed Intra-operative Dose|Overall Study||32
6386017|NCT00808665|7297357|FG000|Completed Post Operative Doses|Overall Study||25
6386018|NCT00808665|7297358|FG001|Completed Post Operative Doses|Overall Study||29
6386019|NCT00808665|7297357|FG000|COMPLETED|Overall Study||25
6386020|NCT00808665|7297358|FG001|COMPLETED|Overall Study||29
6386021|NCT00808665|7297357|FG000|NOT COMPLETED|Overall Study||6
6386022|NCT00808665|7297358|FG001|NOT COMPLETED|Overall Study||3
6386023|NCT00808808|7297367|FG000|STARTED|Overall Study|Started includes all employees at participating sites.|4078
6386024|NCT00808808|7297368|FG001|STARTED|Overall Study|Started includes all employees at participating sites|3757
6386025|NCT00808808|7297369|FG002|STARTED|Overall Study|Started includes all employees at participating sites.|4387
6386026|NCT00808808|7297367|FG000|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
6386027|NCT00808808|7297368|FG001|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
6386028|NCT00808808|7297369|FG002|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
6386029|NCT00808808|7297367|FG000|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
6386030|NCT00808808|7297368|FG001|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
6386031|NCT00808808|7297369|FG002|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
6386032|NCT00808808|7297367|FG000|NOT COMPLETED|Overall Study||2817
6386033|NCT00808808|7297368|FG001|NOT COMPLETED|Overall Study||2437
6386034|NCT00808808|7297369|FG002|NOT COMPLETED|Overall Study||2557
6386035|NCT00808834|7297383|FG000|STARTED|Period 1||97
6386036|NCT00808834|7297384|FG001|STARTED|Period 1||99
6386037|NCT00808834|7297383|FG000|COMPLETED|Period 1||97
6386038|NCT00808834|7297384|FG001|COMPLETED|Period 1||99
6386039|NCT00808834|7297383|FG000|NOT COMPLETED|Period 1||0
6386040|NCT00808834|7297384|FG001|NOT COMPLETED|Period 1||0
6656834|NCT02465216|7587176|FG000|NOT COMPLETED|Overall Study||3
6804947|NCT04328961|7737035|FG000|STARTED|Overall Study||422
6804948|NCT04328961|7737036|FG001|STARTED|Overall Study||407
6804949|NCT04328961|7737035|FG000|COMPLETED|Overall Study||336
6804950|NCT04328961|7737036|FG001|COMPLETED|Overall Study||353
6804951|NCT04328961|7737035|FG000|NOT COMPLETED|Overall Study||86
6804952|NCT04328961|7737036|FG001|NOT COMPLETED|Overall Study||54
6804953|NCT04128319|7737042|FG000|STARTED|Overall Study||3
6804954|NCT04128319|7737042|FG000|Initiated T-Guard Treatment|Overall Study||3
6804955|NCT04128319|7737042|FG000|COMPLETED|Overall Study||0
6804956|NCT04128319|7737042|FG000|NOT COMPLETED|Overall Study||3
6804957|NCT03761810|7737048|FG000|STARTED|Overall Study||290
6804958|NCT03761810|7737049|FG001|STARTED|Overall Study||144
6804959|NCT03761810|7737048|FG000|Received at Least 1 Dose of Study Drug|Overall Study||281
6804960|NCT03761810|7737049|FG001|Received at Least 1 Dose of Study Drug|Overall Study||138
6804961|NCT03761810|7737048|FG000|COMPLETED|Overall Study||242
6804962|NCT03761810|7737049|FG001|COMPLETED|Overall Study||132
6804963|NCT03761810|7737048|FG000|NOT COMPLETED|Overall Study||48
6804964|NCT03761810|7737049|FG001|NOT COMPLETED|Overall Study||12
6804965|NCT03761784|7737057|FG000|STARTED|Overall Study||281
6804966|NCT03761784|7737058|FG001|STARTED|Overall Study||143
6804967|NCT03761784|7737057|FG000|Received at Least 1 Dose of Study Drug|Overall Study||274
6804968|NCT03761784|7737058|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
6804969|NCT03761784|7737057|FG000|COMPLETED|Overall Study||249
6804970|NCT03761784|7737058|FG001|COMPLETED|Overall Study||131
6804971|NCT03761784|7737057|FG000|NOT COMPLETED|Overall Study||32
6804972|NCT03761784|7737058|FG001|NOT COMPLETED|Overall Study||12
6804973|NCT03541317|7737066|FG000|STARTED|Stage 1 of the Implementation||6
6804974|NCT03541317|7737067|FG001|STARTED|Stage 1 of the Implementation||37
6804975|NCT03541317|7737068|FG002|STARTED|Stage 1 of the Implementation||38
6270843|NCT00086684|7170209|FG001|COMPLETED|Overall Study||74
6270844|NCT00086684|7170210|FG002|COMPLETED|Overall Study||69
6270845|NCT00086684|7170208|FG000|NOT COMPLETED|Overall Study||55
6270846|NCT00086684|7170209|FG001|NOT COMPLETED|Overall Study||55
6270847|NCT00086684|7170210|FG002|NOT COMPLETED|Overall Study||53
6270848|NCT00086957|7170218|FG000|STARTED|Overall Study||2
6270849|NCT00086957|7170219|FG001|STARTED|Overall Study||7
6270850|NCT00086957|7170220|FG002|STARTED|Overall Study||22
6270851|NCT00086957|7170218|FG000|COMPLETED|Overall Study||2
6270852|NCT00086957|7170219|FG001|COMPLETED|Overall Study||7
6270853|NCT00086957|7170220|FG002|COMPLETED|Overall Study||22
6270854|NCT00086957|7170218|FG000|NOT COMPLETED|Overall Study||0
6270855|NCT00086957|7170219|FG001|NOT COMPLETED|Overall Study||0
6270856|NCT00086957|7170220|FG002|NOT COMPLETED|Overall Study||0
6270857|NCT00086996|7170229|FG000|STARTED|Overall Study||98
6270858|NCT00086996|7170229|FG000|Eligible|Overall Study||93
6270859|NCT00086996|7170229|FG000|Eligible and Began Protocol Therapy|Overall Study||93
6270860|NCT00086996|7170229|FG000|COMPLETED|Overall Study||34
6270861|NCT00086996|7170229|FG000|NOT COMPLETED|Overall Study||64
6270862|NCT00087022|7170235|FG000|STARTED|Overall Study||433
6270863|NCT00087022|7170236|FG001|STARTED|Overall Study||431
6270864|NCT00087022|7170235|FG000|Treated (Safety Population)|Overall Study||431
6270865|NCT00087022|7170236|FG001|Treated (Safety Population)|Overall Study||424
6270866|NCT00087022|7170235|FG000|COMPLETED|Overall Study||379
6270867|NCT00087022|7170236|FG001|COMPLETED|Overall Study||376
6270868|NCT00087022|7170235|FG000|NOT COMPLETED|Overall Study||54
6270869|NCT00087022|7170236|FG001|NOT COMPLETED|Overall Study||55
6270870|NCT00087126|7170242|FG000|STARTED|Overall Study||27
6270871|NCT00087126|7170242|FG000|COMPLETED|Overall Study||25
6270872|NCT00087126|7170242|FG000|NOT COMPLETED|Overall Study||2
6270873|NCT00087139|7170254|FG000|STARTED|Overall Study||39
6270874|NCT00087139|7170255|FG001|STARTED|Overall Study||49
6270875|NCT00087139|7170256|FG002|STARTED|Overall Study||36
6270876|NCT00087139|7170254|FG000|Treated|Overall Study||39
6270877|NCT00087139|7170255|FG001|Treated|Overall Study||48
6270878|NCT00087139|7170256|FG002|Treated|Overall Study||36
6270879|NCT00087139|7170254|FG000|Eligible and Treated|Overall Study||35
6270880|NCT00087139|7170255|FG001|Eligible and Treated|Overall Study||42
6270881|NCT00087139|7170256|FG002|Eligible and Treated|Overall Study||32
6270882|NCT00087139|7170254|FG000|Patients for the Analysis of PSA Respons|Overall Study||30
6270883|NCT00087139|7170255|FG001|Patients for the Analysis of PSA Respons|Overall Study||34
6270884|NCT00087139|7170256|FG002|Patients for the Analysis of PSA Respons|Overall Study||22
6270885|NCT00087139|7170254|FG000|Patients With Measurable Disease|Overall Study||22
6270886|NCT00087139|7170255|FG001|Patients With Measurable Disease|Overall Study||25
6804976|NCT03541317|7737069|FG003|STARTED|Stage 1 of the Implementation||9
6804977|NCT03541317|7737070|FG004|STARTED|Stage 1 of the Implementation||43
6804978|NCT03541317|7737071|FG005|STARTED|Stage 1 of the Implementation||36
6270887|NCT00087139|7170256|FG002|Patients With Measurable Disease|Overall Study||24
6270888|NCT00087139|7170254|FG000|Patients With PSA Response|Overall Study||10
6270889|NCT00087139|7170255|FG001|Patients With PSA Response|Overall Study||8
6804979|NCT03541317|7737066|FG000|COMPLETED|Stage 1 of the Implementation||6
6804980|NCT03541317|7737067|FG001|COMPLETED|Stage 1 of the Implementation||37
6565409|NCT01818245|7488266|FG001|STARTED|Intervention A|Participants didn't participate in separate interventions and received 1 dose of LY2605541 on Day 1.|22
6565410|NCT01818245|7488265|FG000|Received One Dose of Study Drug|Intervention A||30
6565411|NCT01818245|7488266|FG001|Received One Dose of Study Drug|Intervention A||22
6565412|NCT01818245|7488265|FG000|COMPLETED|Intervention A||30
6565413|NCT01818245|7488266|FG001|COMPLETED|Intervention A||22
6565414|NCT01818245|7488265|FG000|NOT COMPLETED|Intervention A||0
6565415|NCT01818245|7488266|FG001|NOT COMPLETED|Intervention A||0
6565416|NCT01818245|7488265|FG000|STARTED|Washout (16-28 Days)||30
6565417|NCT01818245|7488266|FG001|STARTED|Washout (16-28 Days)||0
6565418|NCT01818245|7488265|FG000|COMPLETED|Washout (16-28 Days)||30
6565419|NCT01818245|7488266|FG001|COMPLETED|Washout (16-28 Days)||0
6565420|NCT01818245|7488265|FG000|NOT COMPLETED|Washout (16-28 Days)||0
6565421|NCT01818245|7488266|FG001|NOT COMPLETED|Washout (16-28 Days)||0
6565422|NCT01818245|7488265|FG000|STARTED|Intervention B||30
6565423|NCT01818245|7488266|FG001|STARTED|Intervention B||0
6565424|NCT01818245|7488265|FG000|COMPLETED|Intervention B||30
6386041|NCT00808834|7297383|FG000|STARTED|Period 2||97
6386042|NCT00808834|7297384|FG001|STARTED|Period 2||99
6386043|NCT00808834|7297383|FG000|COMPLETED|Period 2||97
6386044|NCT00808834|7297384|FG001|COMPLETED|Period 2||99
6386045|NCT00808834|7297383|FG000|NOT COMPLETED|Period 2||0
6386046|NCT00808834|7297384|FG001|NOT COMPLETED|Period 2||0
6386047|NCT00809055|7297392|FG000|STARTED|Overall Study||37
6386048|NCT00809055|7297393|FG001|STARTED|Overall Study||37
6386049|NCT00809055|7297392|FG000|COMPLETED|Overall Study||28
6386050|NCT00809055|7297393|FG001|COMPLETED|Overall Study||30
6386051|NCT00809055|7297392|FG000|NOT COMPLETED|Overall Study||9
6386052|NCT00809055|7297393|FG001|NOT COMPLETED|Overall Study||7
6386053|NCT00809094|7297401|FG000|STARTED|Overall Study||36
6386054|NCT00809094|7297402|FG001|STARTED|Overall Study||34
6386055|NCT00809094|7297401|FG000|COMPLETED|Overall Study||36
6386056|NCT00809094|7297402|FG001|COMPLETED|Overall Study||33
6386057|NCT00809094|7297401|FG000|NOT COMPLETED|Overall Study||0
6386058|NCT00809094|7297402|FG001|NOT COMPLETED|Overall Study||1
6386059|NCT00809133|7297422|FG000|STARTED|Overall Study||3
6386060|NCT00809133|7297423|FG001|STARTED|Overall Study||7
6386061|NCT00809133|7297424|FG002|STARTED|Overall Study||6
6386062|NCT00809133|7297425|FG003|STARTED|Overall Study||3
6386063|NCT00809133|7297426|FG004|STARTED|Overall Study||5
6386064|NCT00809133|7297427|FG005|STARTED|Overall Study||7
6386065|NCT00809133|7297428|FG006|STARTED|Overall Study||6
6386066|NCT00809133|7297429|FG007|STARTED|Overall Study||8
6386067|NCT00809133|7297430|FG008|STARTED|Overall Study||3
6386068|NCT00809133|7297431|FG009|STARTED|Overall Study||9
6386069|NCT00809133|7297432|FG010|STARTED|Overall Study||6
6386070|NCT00809133|7297433|FG011|STARTED|Overall Study||8
6386071|NCT00809133|7297434|FG012|STARTED|Overall Study||5
6386072|NCT00809133|7297435|FG013|STARTED|Overall Study||7
6386073|NCT00809133|7297422|FG000|COMPLETED|Overall Study||0
6386074|NCT00809133|7297423|FG001|COMPLETED|Overall Study||0
6386075|NCT00809133|7297424|FG002|COMPLETED|Overall Study||0
6386076|NCT00809133|7297425|FG003|COMPLETED|Overall Study||0
6386077|NCT00809133|7297426|FG004|COMPLETED|Overall Study||0
6386078|NCT00809133|7297427|FG005|COMPLETED|Overall Study||0
6386079|NCT00809133|7297428|FG006|COMPLETED|Overall Study||0
6386080|NCT00809133|7297429|FG007|COMPLETED|Overall Study||0
6386081|NCT00809133|7297430|FG008|COMPLETED|Overall Study||0
6386082|NCT00809133|7297431|FG009|COMPLETED|Overall Study||0
6386083|NCT00809133|7297432|FG010|COMPLETED|Overall Study||0
6386084|NCT00809133|7297433|FG011|COMPLETED|Overall Study||0
6386085|NCT00809133|7297434|FG012|COMPLETED|Overall Study||0
6386086|NCT00809133|7297435|FG013|COMPLETED|Overall Study||0
6386087|NCT00809133|7297422|FG000|NOT COMPLETED|Overall Study||3
6386088|NCT00809133|7297423|FG001|NOT COMPLETED|Overall Study||7
6386089|NCT00809133|7297424|FG002|NOT COMPLETED|Overall Study||6
6386090|NCT00809133|7297425|FG003|NOT COMPLETED|Overall Study||3
6386091|NCT00809133|7297426|FG004|NOT COMPLETED|Overall Study||5
6386092|NCT00809133|7297427|FG005|NOT COMPLETED|Overall Study||7
6386093|NCT00809133|7297428|FG006|NOT COMPLETED|Overall Study||6
6386094|NCT00809133|7297429|FG007|NOT COMPLETED|Overall Study||8
6386095|NCT00809133|7297430|FG008|NOT COMPLETED|Overall Study||3
6386096|NCT00809133|7297431|FG009|NOT COMPLETED|Overall Study||9
6386097|NCT00809133|7297432|FG010|NOT COMPLETED|Overall Study||6
6386098|NCT00809133|7297433|FG011|NOT COMPLETED|Overall Study||8
6386099|NCT00809133|7297434|FG012|NOT COMPLETED|Overall Study||5
6386100|NCT00809133|7297435|FG013|NOT COMPLETED|Overall Study||7
6386101|NCT00809146|7297480|FG000|STARTED|Overall Study||448
6386102|NCT00809146|7297481|FG001|STARTED|Overall Study||445
6386103|NCT00809146|7297480|FG000|COMPLETED|Overall Study||448
6386104|NCT00809146|7297481|FG001|COMPLETED|Overall Study||445
6386105|NCT00809146|7297480|FG000|NOT COMPLETED|Overall Study||0
6386106|NCT00809146|7297481|FG001|NOT COMPLETED|Overall Study||0
6386107|NCT00809159|7297491|FG000|STARTED|Part 1||24
6386108|NCT00809159|7297492|FG001|STARTED|Part 1||6
6386109|NCT00809159|7297493|FG002|STARTED|Part 1||0
6386110|NCT00809159|7297494|FG003|STARTED|Part 1||0
6386111|NCT00809159|7297495|FG004|STARTED|Part 1||0
6386112|NCT00809159|7297496|FG005|STARTED|Part 1||0
6386113|NCT00809159|7297491|FG000|PK Analysis Set|Part 1||24
6386114|NCT00809159|7297492|FG001|PK Analysis Set|Part 1||6
6386115|NCT00809159|7297493|FG002|PK Analysis Set|Part 1||0
6386116|NCT00809159|7297494|FG003|PK Analysis Set|Part 1||0
6386117|NCT00809159|7297495|FG004|PK Analysis Set|Part 1||0
6386118|NCT00809159|7297496|FG005|PK Analysis Set|Part 1||0
6386119|NCT00809159|7297491|FG000|PD Analysis Set|Part 1||23
6386120|NCT00809159|7297492|FG001|PD Analysis Set|Part 1||6
6386121|NCT00809159|7297493|FG002|PD Analysis Set|Part 1||0
6386122|NCT00809159|7297494|FG003|PD Analysis Set|Part 1||0
6386123|NCT00809159|7297495|FG004|PD Analysis Set|Part 1||0
6386124|NCT00809159|7297496|FG005|PD Analysis Set|Part 1||0
6386125|NCT00809159|7297491|FG000|COMPLETED|Part 1||16
6386126|NCT00809159|7297492|FG001|COMPLETED|Part 1||3
6386127|NCT00809159|7297493|FG002|COMPLETED|Part 1||0
6386128|NCT00809159|7297494|FG003|COMPLETED|Part 1||0
6565425|NCT01818245|7488266|FG001|COMPLETED|Intervention B||0
6565426|NCT01818245|7488265|FG000|NOT COMPLETED|Intervention B||0
6565427|NCT01818245|7488266|FG001|NOT COMPLETED|Intervention B||0
6565428|NCT01818245|7488265|FG000|STARTED|Washout (16-28 Days)||30
6565429|NCT01818245|7488266|FG001|STARTED|Washout (16-28 Days)||0
6565430|NCT01818245|7488265|FG000|COMPLETED|Washout (16-28 Days)||30
6565431|NCT01818245|7488266|FG001|COMPLETED|Washout (16-28 Days)||0
6565432|NCT01818245|7488265|FG000|NOT COMPLETED|Washout (16-28 Days)||0
6565433|NCT01818245|7488266|FG001|NOT COMPLETED|Washout (16-28 Days)||0
6565434|NCT01818245|7488265|FG000|STARTED|Intervention C||30
6565435|NCT01818245|7488266|FG001|STARTED|Intervention C||0
6565436|NCT01818245|7488265|FG000|COMPLETED|Intervention C||30
6565437|NCT01818245|7488266|FG001|COMPLETED|Intervention C||0
6565438|NCT01818245|7488265|FG000|NOT COMPLETED|Intervention C||0
6565439|NCT01818245|7488266|FG001|NOT COMPLETED|Intervention C||0
6270890|NCT00087139|7170256|FG002|Patients With PSA Response|Overall Study||4
6565440|NCT01818258|7488279|FG000|STARTED|Overall Study||25
6565441|NCT01818258|7488280|FG001|STARTED|Overall Study||27
6565442|NCT01818258|7488279|FG000|COMPLETED|Overall Study||22
6565443|NCT01818258|7488280|FG001|COMPLETED|Overall Study||24
6565444|NCT01818258|7488279|FG000|NOT COMPLETED|Overall Study||3
6565445|NCT01818258|7488280|FG001|NOT COMPLETED|Overall Study||3
6565446|NCT01818284|7488289|FG000|STARTED|Overall Study||11
6565447|NCT01818284|7488290|FG001|STARTED|Overall Study||11
6565448|NCT01818284|7488289|FG000|COMPLETED|Overall Study||7
6804981|NCT03541317|7737068|FG002|COMPLETED|Stage 1 of the Implementation||38
6804982|NCT03541317|7737069|FG003|COMPLETED|Stage 1 of the Implementation||9
6804983|NCT03541317|7737070|FG004|COMPLETED|Stage 1 of the Implementation||43
6804984|NCT03541317|7737071|FG005|COMPLETED|Stage 1 of the Implementation||36
6804985|NCT03541317|7737066|FG000|NOT COMPLETED|Stage 1 of the Implementation||0
6804986|NCT03541317|7737067|FG001|NOT COMPLETED|Stage 1 of the Implementation||0
6804987|NCT03541317|7737068|FG002|NOT COMPLETED|Stage 1 of the Implementation||0
6804988|NCT03541317|7737069|FG003|NOT COMPLETED|Stage 1 of the Implementation||0
6804989|NCT03541317|7737070|FG004|NOT COMPLETED|Stage 1 of the Implementation||0
6804990|NCT03541317|7737071|FG005|NOT COMPLETED|Stage 1 of the Implementation||0
6804991|NCT03541317|7737066|FG000|STARTED|Stage 2 of the Implementation||6
6804992|NCT03541317|7737067|FG001|STARTED|Stage 2 of the Implementation||37
6804993|NCT03541317|7737068|FG002|STARTED|Stage 2 of the Implementation||38
6804994|NCT03541317|7737069|FG003|STARTED|Stage 2 of the Implementation||9
6804995|NCT03541317|7737070|FG004|STARTED|Stage 2 of the Implementation||43
6804996|NCT03541317|7737071|FG005|STARTED|Stage 2 of the Implementation||36
6804997|NCT03541317|7737066|FG000|COMPLETED|Stage 2 of the Implementation||5
6804998|NCT03541317|7737067|FG001|COMPLETED|Stage 2 of the Implementation||37
6804999|NCT03541317|7737068|FG002|COMPLETED|Stage 2 of the Implementation||38
6805000|NCT03541317|7737069|FG003|COMPLETED|Stage 2 of the Implementation||9
6805001|NCT03541317|7737070|FG004|COMPLETED|Stage 2 of the Implementation||43
6805002|NCT03541317|7737071|FG005|COMPLETED|Stage 2 of the Implementation||36
6805003|NCT03541317|7737066|FG000|NOT COMPLETED|Stage 2 of the Implementation||1
6805004|NCT03541317|7737067|FG001|NOT COMPLETED|Stage 2 of the Implementation||0
6805005|NCT03541317|7737068|FG002|NOT COMPLETED|Stage 2 of the Implementation||0
6805006|NCT03541317|7737069|FG003|NOT COMPLETED|Stage 2 of the Implementation||0
6805007|NCT03541317|7737070|FG004|NOT COMPLETED|Stage 2 of the Implementation||0
6805008|NCT03541317|7737071|FG005|NOT COMPLETED|Stage 2 of the Implementation||0
6805009|NCT03457129|7737085|FG000|STARTED|Overall Study||10
6805010|NCT03457129|7737086|FG001|STARTED|Overall Study||10
6805011|NCT03457129|7737085|FG000|COMPLETED|Overall Study||7
6805012|NCT03457129|7737086|FG001|COMPLETED|Overall Study||8
6805013|NCT03457129|7737085|FG000|NOT COMPLETED|Overall Study||3
6565449|NCT01818284|7488290|FG001|COMPLETED|Overall Study||5
6565450|NCT01818284|7488289|FG000|NOT COMPLETED|Overall Study||4
6565451|NCT01818284|7488290|FG001|NOT COMPLETED|Overall Study||6
6565452|NCT01818297|7488297|FG000|STARTED|Blinded Phase (Randomization - 3 Months)||32
6565453|NCT01818297|7488298|FG001|STARTED|Blinded Phase (Randomization - 3 Months)||30
6565454|NCT01818297|7488297|FG000|Week 1|Blinded Phase (Randomization - 3 Months)||32
6565455|NCT01818297|7488298|FG001|Week 1|Blinded Phase (Randomization - 3 Months)||30
6565456|NCT01818297|7488297|FG000|Week 6|Blinded Phase (Randomization - 3 Months)||32
6386129|NCT00809159|7297495|FG004|COMPLETED|Part 1||0
6386130|NCT00809159|7297496|FG005|COMPLETED|Part 1||0
6386131|NCT00809159|7297491|FG000|NOT COMPLETED|Part 1||8
6386132|NCT00809159|7297492|FG001|NOT COMPLETED|Part 1||3
6386133|NCT00809159|7297493|FG002|NOT COMPLETED|Part 1||0
6386134|NCT00809159|7297494|FG003|NOT COMPLETED|Part 1||0
6386135|NCT00809159|7297495|FG004|NOT COMPLETED|Part 1||0
6386136|NCT00809159|7297496|FG005|NOT COMPLETED|Part 1||0
6386137|NCT00809159|7297491|FG000|STARTED|Part 1 and 2||0
6386138|NCT00809159|7297492|FG001|STARTED|Part 1 and 2||0
6386139|NCT00809159|7297493|FG002|STARTED|Part 1 and 2||30
6386140|NCT00809159|7297494|FG003|STARTED|Part 1 and 2||12
6386141|NCT00809159|7297495|FG004|STARTED|Part 1 and 2||12
6386142|NCT00809159|7297496|FG005|STARTED|Part 1 and 2||6
6386143|NCT00809159|7297491|FG000|PK Analysis Set|Part 1 and 2||0
6386144|NCT00809159|7297492|FG001|PK Analysis Set|Part 1 and 2||0
6386145|NCT00809159|7297493|FG002|PK Analysis Set|Part 1 and 2||30
6386146|NCT00809159|7297494|FG003|PK Analysis Set|Part 1 and 2||12
6386147|NCT00809159|7297495|FG004|PK Analysis Set|Part 1 and 2||12
6386148|NCT00809159|7297496|FG005|PK Analysis Set|Part 1 and 2||6
6565457|NCT01818297|7488298|FG001|Week 6|Blinded Phase (Randomization - 3 Months)||29
6565458|NCT01818297|7488297|FG000|COMPLETED|Blinded Phase (Randomization - 3 Months)||32
6565459|NCT01818297|7488298|FG001|COMPLETED|Blinded Phase (Randomization - 3 Months)||29
6565460|NCT01818297|7488297|FG000|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||0
6565461|NCT01818297|7488298|FG001|NOT COMPLETED|Blinded Phase (Randomization - 3 Months)||1
6805014|NCT03457129|7737086|FG001|NOT COMPLETED|Overall Study||2
6386149|NCT00809159|7297491|FG000|PD Analysis Set|Part 1 and 2||0
6386150|NCT00809159|7297492|FG001|PD Analysis Set|Part 1 and 2||0
6386151|NCT00809159|7297493|FG002|PD Analysis Set|Part 1 and 2||28
6386152|NCT00809159|7297494|FG003|PD Analysis Set|Part 1 and 2||12
6386153|NCT00809159|7297495|FG004|PD Analysis Set|Part 1 and 2||12
6386154|NCT00809159|7297496|FG005|PD Analysis Set|Part 1 and 2||6
6386155|NCT00809159|7297491|FG000|COMPLETED|Part 1 and 2||0
6386156|NCT00809159|7297492|FG001|COMPLETED|Part 1 and 2||0
6386157|NCT00809159|7297493|FG002|COMPLETED|Part 1 and 2||20
6386158|NCT00809159|7297494|FG003|COMPLETED|Part 1 and 2||7
6386159|NCT00809159|7297495|FG004|COMPLETED|Part 1 and 2||6
6386160|NCT00809159|7297496|FG005|COMPLETED|Part 1 and 2||3
6386161|NCT00809159|7297491|FG000|NOT COMPLETED|Part 1 and 2||0
6386162|NCT00809159|7297492|FG001|NOT COMPLETED|Part 1 and 2||0
6386163|NCT00809159|7297493|FG002|NOT COMPLETED|Part 1 and 2||10
6386164|NCT00809159|7297494|FG003|NOT COMPLETED|Part 1 and 2||5
6386165|NCT00809159|7297495|FG004|NOT COMPLETED|Part 1 and 2||6
6386166|NCT00809159|7297496|FG005|NOT COMPLETED|Part 1 and 2||3
6503556|NCT01441960|7422471|FG001|COMPLETED|Second Neuromuscular Blocking Agent||13
6503557|NCT01441960|7422470|FG000|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
6503558|NCT01441960|7422471|FG001|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
6503559|NCT01441973|7422483|FG000|STARTED|Overall Study||15
6503560|NCT01441973|7422484|FG001|STARTED|Overall Study||16
6503561|NCT01441973|7422483|FG000|COMPLETED|Overall Study|Still receiving treatment|0
6503562|NCT01441973|7422484|FG001|COMPLETED|Overall Study|Still receiving treatment|0
6503563|NCT01441973|7422483|FG000|NOT COMPLETED|Overall Study||15
6503564|NCT01441973|7422484|FG001|NOT COMPLETED|Overall Study||16
6503565|NCT01442038|7422493|FG000|STARTED|Overall Study||1332
6503566|NCT01442038|7422494|FG001|STARTED|Overall Study||1319
6503567|NCT01442038|7422493|FG000|COMPLETED|Overall Study||1029
6503568|NCT01442038|7422494|FG001|COMPLETED|Overall Study||1040
6503569|NCT01442038|7422493|FG000|NOT COMPLETED|Overall Study||303
6503570|NCT01442038|7422494|FG001|NOT COMPLETED|Overall Study||279
6503571|NCT01442064|7422506|FG000|STARTED|Overall Study||97
6503572|NCT01442064|7422507|FG001|STARTED|Overall Study||103
6503573|NCT01442064|7422508|FG002|STARTED|Overall Study||104
6503574|NCT01442064|7422509|FG003|STARTED|Overall Study||98
6503575|NCT01442064|7422510|FG004|STARTED|Overall Study||107
6503576|NCT01442064|7422511|FG005|STARTED|Overall Study||99
6503577|NCT01442064|7422506|FG000|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
6503578|NCT01442064|7422507|FG001|Ranibizumab-Treated Subjects|Overall Study||103
6503579|NCT01442064|7422508|FG002|Ranibizumab-Treated Subjects|Overall Study||104
6503580|NCT01442064|7422509|FG003|Ranibizumab-Treated Subjects|Overall Study||96
6503581|NCT01442064|7422510|FG004|Ranibizumab-Treated Subjects|Overall Study||107
6503582|NCT01442064|7422511|FG005|Ranibizumab-Treated Subjects|Overall Study||99
6503583|NCT01442064|7422506|FG000|Received Study Drug in Extension Study|Overall Study||61
6503584|NCT01442064|7422507|FG001|Received Study Drug in Extension Study|Overall Study||70
6503585|NCT01442064|7422508|FG002|Received Study Drug in Extension Study|Overall Study||60
6503586|NCT01442064|7422509|FG003|Received Study Drug in Extension Study|Overall Study||70
6656835|NCT02465216|7587177|FG001|NOT COMPLETED|Overall Study||0
6805015|NCT03361865|7737094|FG000|STARTED|Overall Study||44
6805016|NCT03361865|7737095|FG001|STARTED|Overall Study||49
6805017|NCT03361865|7737094|FG000|Intention-to-Treat (ITT)|Overall Study||44
6805018|NCT03361865|7737095|FG001|Intention-to-Treat (ITT)|Overall Study||49
6805019|NCT03361865|7737094|FG000|All Participants as Treated (APaT)|Overall Study||43
6805020|NCT03361865|7737095|FG001|All Participants as Treated (APaT)|Overall Study||49
6805021|NCT03361865|7737094|FG000|COMPLETED|Overall Study||25
6805022|NCT03361865|7737095|FG001|COMPLETED|Overall Study||22
6805023|NCT03361865|7737094|FG000|NOT COMPLETED|Overall Study||19
6503587|NCT01442064|7422510|FG004|Received Study Drug in Extension Study|Overall Study||89
6270891|NCT00087139|7170254|FG000|Patients w/ Measurable Disease Response|Overall Study||5
6270892|NCT00087139|7170255|FG001|Patients w/ Measurable Disease Response|Overall Study||2
6270893|NCT00087139|7170256|FG002|Patients w/ Measurable Disease Response|Overall Study||0
6270894|NCT00087139|7170254|FG000|COMPLETED|Overall Study||0
6270895|NCT00087139|7170255|FG001|COMPLETED|Overall Study||0
6270896|NCT00087139|7170256|FG002|COMPLETED|Overall Study||0
6270897|NCT00087139|7170254|FG000|NOT COMPLETED|Overall Study||39
6270898|NCT00087139|7170255|FG001|NOT COMPLETED|Overall Study||49
6270899|NCT00087139|7170256|FG002|NOT COMPLETED|Overall Study||36
6270900|NCT00087152|7170262|FG000|STARTED|Overall Study||27
6270901|NCT00087152|7170262|FG000|COMPLETED|Overall Study||21
6270902|NCT00087152|7170262|FG000|NOT COMPLETED|Overall Study||6
6280694|NCT00159263|7180667|FG003|COMPLETED|Washout||2
6280695|NCT00159263|7180668|FG004|COMPLETED|Washout||2
6280696|NCT00159263|7180669|FG005|COMPLETED|Washout||2
6280697|NCT00159263|7180664|FG000|NOT COMPLETED|Washout||0
6386167|NCT00809185|7297510|FG000|STARTED|Overall Study||7
6280698|NCT00159263|7180665|FG001|NOT COMPLETED|Washout||0
6280699|NCT00159263|7180666|FG002|NOT COMPLETED|Washout||0
6280700|NCT00159263|7180667|FG003|NOT COMPLETED|Washout||0
6280701|NCT00159263|7180668|FG004|NOT COMPLETED|Washout||0
6280702|NCT00159263|7180669|FG005|NOT COMPLETED|Washout||0
6280703|NCT00159263|7180664|FG000|STARTED|Second Intervention||1
6386168|NCT00809185|7297510|FG000|COMPLETED|Overall Study||7
6386169|NCT00809185|7297510|FG000|NOT COMPLETED|Overall Study||0
6386170|NCT00809276|7297515|FG000|STARTED|Overall Study||92
6386171|NCT00809276|7297515|FG000|COMPLETED|Overall Study||92
6386172|NCT00809276|7297515|FG000|NOT COMPLETED|Overall Study||0
6386173|NCT00809328|7297519|FG000|STARTED|Overall Study||102
6386174|NCT00809328|7297519|FG000|COMPLETED|Overall Study||73
6386175|NCT00809328|7297519|FG000|NOT COMPLETED|Overall Study||29
6386176|NCT00809354|7297533|FG000|STARTED|Overall Study||288
6386177|NCT00809354|7297534|FG001|STARTED|Overall Study||289
6386178|NCT00809354|7297535|FG002|STARTED|Overall Study||286
6386179|NCT00809354|7297536|FG003|STARTED|Overall Study||288
6386180|NCT00809354|7297537|FG004|STARTED|Overall Study||288
6386181|NCT00809354|7297538|FG005|STARTED|Overall Study||256
6386182|NCT00809354|7297539|FG006|STARTED|Overall Study||255
6386183|NCT00809354|7297540|FG007|STARTED|Overall Study||257
6386184|NCT00809354|7297541|FG008|STARTED|Overall Study||256
6386185|NCT00809354|7297542|FG009|STARTED|Overall Study||257
6386186|NCT00809354|7297533|FG000|Treated|Overall Study||285
6386187|NCT00809354|7297534|FG001|Treated|Overall Study||288
6386188|NCT00809354|7297535|FG002|Treated|Overall Study||280
6386189|NCT00809354|7297536|FG003|Treated|Overall Study||288
6386190|NCT00809354|7297537|FG004|Treated|Overall Study||283
6386191|NCT00809354|7297538|FG005|Treated|Overall Study||256
6386192|NCT00809354|7297539|FG006|Treated|Overall Study||254
6386193|NCT00809354|7297540|FG007|Treated|Overall Study||256
6386194|NCT00809354|7297541|FG008|Treated|Overall Study||254
6386195|NCT00809354|7297542|FG009|Treated|Overall Study||256
6386196|NCT00809354|7297533|FG000|COMPLETED|Overall Study||33
6386197|NCT00809354|7297534|FG001|COMPLETED|Overall Study||31
6386198|NCT00809354|7297535|FG002|COMPLETED|Overall Study||32
6386199|NCT00809354|7297536|FG003|COMPLETED|Overall Study||32
6386200|NCT00809354|7297537|FG004|COMPLETED|Overall Study||32
6386201|NCT00809354|7297538|FG005|COMPLETED|Overall Study||31
6386202|NCT00809354|7297539|FG006|COMPLETED|Overall Study||32
6386203|NCT00809354|7297540|FG007|COMPLETED|Overall Study||19
6386204|NCT00809354|7297541|FG008|COMPLETED|Overall Study||28
6386205|NCT00809354|7297542|FG009|COMPLETED|Overall Study||31
6386206|NCT00809354|7297533|FG000|NOT COMPLETED|Overall Study||255
6386207|NCT00809354|7297534|FG001|NOT COMPLETED|Overall Study||258
6386208|NCT00809354|7297535|FG002|NOT COMPLETED|Overall Study||254
6565462|NCT01818297|7488297|FG000|STARTED|Open Label Phase (3-12 Months)||32
6805024|NCT03361865|7737095|FG001|NOT COMPLETED|Overall Study||27
6805025|NCT03294304|7737102|FG000|STARTED|Overall Study||43
6805026|NCT03294304|7737102|FG000|COMPLETED|Overall Study||43
6805027|NCT03294304|7737102|FG000|NOT COMPLETED|Overall Study||0
6805028|NCT03122431|7737109|FG000|STARTED|Overall Study||41
6386209|NCT00809354|7297536|FG003|NOT COMPLETED|Overall Study||256
6386210|NCT00809354|7297537|FG004|NOT COMPLETED|Overall Study||256
6386211|NCT00809354|7297538|FG005|NOT COMPLETED|Overall Study||225
6386212|NCT00809354|7297539|FG006|NOT COMPLETED|Overall Study||223
6386213|NCT00809354|7297540|FG007|NOT COMPLETED|Overall Study||238
6386214|NCT00809354|7297541|FG008|NOT COMPLETED|Overall Study||228
6386215|NCT00809354|7297542|FG009|NOT COMPLETED|Overall Study||226
6386216|NCT00809445|7297572|FG000|STARTED|1 Month Follow-up||429
6386217|NCT00809445|7297573|FG001|STARTED|1 Month Follow-up||433
6386218|NCT00809445|7297574|FG002|STARTED|1 Month Follow-up||419
6386219|NCT00809445|7297572|FG000|COMPLETED|1 Month Follow-up||427
6386220|NCT00809445|7297573|FG001|COMPLETED|1 Month Follow-up||429
6386221|NCT00809445|7297574|FG002|COMPLETED|1 Month Follow-up||415
6386222|NCT00809445|7297572|FG000|NOT COMPLETED|1 Month Follow-up||2
6386223|NCT00809445|7297573|FG001|NOT COMPLETED|1 Month Follow-up||4
6386224|NCT00809445|7297574|FG002|NOT COMPLETED|1 Month Follow-up||4
6386225|NCT00809445|7297572|FG000|STARTED|6 Month Follow-up||429
6386226|NCT00809445|7297573|FG001|STARTED|6 Month Follow-up||433
6386227|NCT00809445|7297574|FG002|STARTED|6 Month Follow-up||419
6386228|NCT00809445|7297572|FG000|COMPLETED|6 Month Follow-up||405
6805029|NCT03122431|7737110|FG001|STARTED|Overall Study||32
6805030|NCT03122431|7737111|FG002|STARTED|Overall Study||20
6805031|NCT03122431|7737109|FG000|COMPLETED|Overall Study||41
6805032|NCT03122431|7737110|FG001|COMPLETED|Overall Study||32
6805033|NCT03122431|7737111|FG002|COMPLETED|Overall Study||9
6805034|NCT03122431|7737109|FG000|NOT COMPLETED|Overall Study||0
6386229|NCT00809445|7297573|FG001|COMPLETED|6 Month Follow-up||410
6386230|NCT00809445|7297574|FG002|COMPLETED|6 Month Follow-up||395
6386231|NCT00809445|7297572|FG000|NOT COMPLETED|6 Month Follow-up||24
6386232|NCT00809445|7297573|FG001|NOT COMPLETED|6 Month Follow-up||23
6386233|NCT00809445|7297574|FG002|NOT COMPLETED|6 Month Follow-up||24
6386234|NCT00809471|7297585|FG000|STARTED|Overall Study||130
6386235|NCT00809471|7297586|FG001|STARTED|Overall Study||129
6386236|NCT00809471|7297587|FG002|STARTED|Overall Study||131
6386237|NCT00809471|7297585|FG000|COMPLETED|Overall Study||110
6386238|NCT00809471|7297586|FG001|COMPLETED|Overall Study||109
6386239|NCT00809471|7297587|FG002|COMPLETED|Overall Study||114
6386240|NCT00809471|7297585|FG000|NOT COMPLETED|Overall Study||20
6386241|NCT00809471|7297586|FG001|NOT COMPLETED|Overall Study||20
6386242|NCT00809471|7297587|FG002|NOT COMPLETED|Overall Study||17
6386243|NCT00809523|7297597|FG000|STARTED|Overall Study||54
6386244|NCT00809523|7297598|FG001|STARTED|Overall Study||52
6386245|NCT00809523|7297597|FG000|COMPLETED|Overall Study||47
6386246|NCT00809523|7297598|FG001|COMPLETED|Overall Study||48
6386247|NCT00809523|7297597|FG000|NOT COMPLETED|Overall Study||7
6565463|NCT01818297|7488298|FG001|STARTED|Open Label Phase (3-12 Months)||29
6565464|NCT01818297|7488297|FG000|COMPLETED|Open Label Phase (3-12 Months)||14
6656836|NCT02465216|7587178|FG002|NOT COMPLETED|Overall Study||1
6386248|NCT00809523|7297598|FG001|NOT COMPLETED|Overall Study||4
6386249|NCT00809614|7297606|FG000|STARTED|Overall Study||28
6503588|NCT01442064|7422511|FG005|Received Study Drug in Extension Study|Overall Study||81
6503589|NCT01442064|7422506|FG000|COMPLETED|Overall Study||0
6503590|NCT01442064|7422507|FG001|COMPLETED|Overall Study||2
6503591|NCT01442064|7422508|FG002|COMPLETED|Overall Study||0
6503592|NCT01442064|7422509|FG003|COMPLETED|Overall Study||0
6503593|NCT01442064|7422510|FG004|COMPLETED|Overall Study||1
6503594|NCT01442064|7422511|FG005|COMPLETED|Overall Study||0
6503595|NCT01442064|7422506|FG000|NOT COMPLETED|Overall Study||97
6503596|NCT01442064|7422507|FG001|NOT COMPLETED|Overall Study||101
6503597|NCT01442064|7422508|FG002|NOT COMPLETED|Overall Study||104
6805035|NCT03122431|7737110|FG001|NOT COMPLETED|Overall Study||0
6805036|NCT03122431|7737111|FG002|NOT COMPLETED|Overall Study||11
6805037|NCT02929056|7737121|FG000|STARTED|Overall Study||1
6805038|NCT02929056|7737122|FG001|STARTED|Overall Study||1
6805039|NCT02929056|7737121|FG000|COMPLETED|Overall Study||1
6805040|NCT02929056|7737122|FG001|COMPLETED|Overall Study||0
6805041|NCT02929056|7737121|FG000|NOT COMPLETED|Overall Study||0
6805042|NCT02929056|7737122|FG001|NOT COMPLETED|Overall Study||1
6503598|NCT01442064|7422509|FG003|NOT COMPLETED|Overall Study||98
6503599|NCT01442064|7422510|FG004|NOT COMPLETED|Overall Study||106
6565465|NCT01818297|7488298|FG001|COMPLETED|Open Label Phase (3-12 Months)||19
6805043|NCT02896855|7737130|FG000|STARTED|Overall Study||121
6805044|NCT02896855|7737131|FG001|STARTED|Overall Study||122
6805045|NCT02896855|7737130|FG000|Received Any Study Treatment|Overall Study||120
6805046|NCT02896855|7737131|FG001|Received Any Study Treatment|Overall Study||122
6386250|NCT00809614|7297607|FG001|STARTED|Overall Study||14
6386251|NCT00809614|7297606|FG000|Pharmacokinetic Safety Set|Overall Study||27
6386252|NCT00809614|7297607|FG001|Pharmacokinetic Safety Set|Overall Study||14
6503600|NCT01442064|7422511|FG005|NOT COMPLETED|Overall Study||99
6503601|NCT01442103|7422528|FG000|STARTED|Overall Study||10
6503602|NCT01442103|7422528|FG000|COMPLETED|Overall Study||8
6503603|NCT01442103|7422528|FG000|NOT COMPLETED|Overall Study||2
6503604|NCT01442129|7422534|FG000|STARTED|Overall Study||20
6386253|NCT00809614|7297606|FG000|Pharmacodynamic (PD) Set|Overall Study||24
6386254|NCT00809614|7297607|FG001|Pharmacodynamic (PD) Set|Overall Study||13
6386255|NCT00809614|7297606|FG000|COMPLETED|Overall Study||25
6386256|NCT00809614|7297607|FG001|COMPLETED|Overall Study||10
6386257|NCT00809614|7297606|FG000|NOT COMPLETED|Overall Study||3
6386258|NCT00809614|7297607|FG001|NOT COMPLETED|Overall Study||4
6386259|NCT00809757|7297616|FG000|STARTED|Overall Study||68
6386260|NCT00809757|7297617|FG001|STARTED|Overall Study||65
6386261|NCT00809757|7297618|FG002|STARTED|Overall Study||64
6386262|NCT00809757|7297616|FG000|COMPLETED|Overall Study||62
6386263|NCT00809757|7297617|FG001|COMPLETED|Overall Study||60
6386264|NCT00809757|7297618|FG002|COMPLETED|Overall Study||53
6386265|NCT00809757|7297616|FG000|NOT COMPLETED|Overall Study||6
6386266|NCT00809757|7297617|FG001|NOT COMPLETED|Overall Study||5
6386267|NCT00809757|7297618|FG002|NOT COMPLETED|Overall Study||11
6386268|NCT00809783|7297635|FG000|STARTED|Overall Study||525
6386269|NCT00809783|7297636|FG001|STARTED|Overall Study||832
6386270|NCT00809783|7297637|FG002|STARTED|Overall Study||790
6386271|NCT00809783|7297635|FG000|Treated|Overall Study||522
6386272|NCT00809783|7297636|FG001|Treated|Overall Study||832
6386273|NCT00809783|7297637|FG002|Treated|Overall Study||788
6386274|NCT00809783|7297635|FG000|COMPLETED|Overall Study||0
6386275|NCT00809783|7297636|FG001|COMPLETED|Overall Study||0
6386276|NCT00809783|7297637|FG002|COMPLETED|Overall Study||0
6386277|NCT00809783|7297635|FG000|NOT COMPLETED|Overall Study||525
6386278|NCT00809783|7297636|FG001|NOT COMPLETED|Overall Study||832
6386279|NCT00809783|7297637|FG002|NOT COMPLETED|Overall Study||790
6386280|NCT00809809|7297647|FG000|STARTED|Overall Study||78
6386281|NCT00809809|7297648|FG001|STARTED|Overall Study||79
6386282|NCT00809809|7297647|FG000|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
6386283|NCT00809809|7297648|FG001|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
6386284|NCT00809809|7297647|FG000|NOT COMPLETED|Overall Study||3
6386285|NCT00809809|7297648|FG001|NOT COMPLETED|Overall Study||2
6386286|NCT00809835|7297658|FG000|STARTED|Overall Study||28
6386287|NCT00809835|7297659|FG001|STARTED|Overall Study||27
6386288|NCT00809835|7297660|FG002|STARTED|Overall Study||38
6386289|NCT00809835|7297661|FG003|STARTED|Overall Study||27
6386290|NCT00809835|7297658|FG000|COMPLETED|Overall Study||20
6386291|NCT00809835|7297659|FG001|COMPLETED|Overall Study||20
6386292|NCT00809835|7297660|FG002|COMPLETED|Overall Study||27
6386293|NCT00809835|7297661|FG003|COMPLETED|Overall Study||25
6386294|NCT00809835|7297658|FG000|NOT COMPLETED|Overall Study||8
6386295|NCT00809835|7297659|FG001|NOT COMPLETED|Overall Study||7
6503605|NCT01442129|7422535|FG001|STARTED|Overall Study||10
6503606|NCT01442129|7422534|FG000|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
6503607|NCT01442129|7422535|FG001|COMPLETED|Overall Study||10
6503608|NCT01442129|7422534|FG000|NOT COMPLETED|Overall Study||0
6503609|NCT01442129|7422535|FG001|NOT COMPLETED|Overall Study||0
6503610|NCT01442155|7422541|FG000|STARTED|Overall Study||74
6565466|NCT01818297|7488297|FG000|NOT COMPLETED|Open Label Phase (3-12 Months)||18
6386296|NCT00809835|7297660|FG002|NOT COMPLETED|Overall Study||11
6503611|NCT01442155|7422541|FG000|COMPLETED|Overall Study||9
6503612|NCT01442155|7422541|FG000|NOT COMPLETED|Overall Study||65
6565467|NCT01818297|7488298|FG001|NOT COMPLETED|Open Label Phase (3-12 Months)||10
6565468|NCT01818336|7488304|FG000|STARTED|Overall Study||391
6565469|NCT01818336|7488305|FG001|STARTED|Overall Study||59
6565470|NCT01818336|7488304|FG000|COMPLETED|Overall Study||391
6565471|NCT01818336|7488305|FG001|COMPLETED|Overall Study||47
6565472|NCT01818336|7488304|FG000|NOT COMPLETED|Overall Study||0
6656837|NCT02465216|7587179|FG003|NOT COMPLETED|Overall Study||2
6565473|NCT01818336|7488305|FG001|NOT COMPLETED|Overall Study||12
6565474|NCT01818414|7488313|FG000|STARTED|Overall Study||14
6386297|NCT00809835|7297661|FG003|NOT COMPLETED|Overall Study||2
6386298|NCT00809848|7297676|FG000|STARTED|Overall Study||36
6386299|NCT00809848|7297677|FG001|STARTED|Overall Study||34
6386300|NCT00809848|7297678|FG002|STARTED|Overall Study||34
6386301|NCT00809848|7297679|FG003|STARTED|Overall Study||31
6386302|NCT00809848|7297680|FG004|STARTED|Overall Study||37
6386303|NCT00809848|7297676|FG000|COMPLETED|Overall Study||36
6503613|NCT01442181|7422547|FG000|STARTED|Overall Study||14
6503614|NCT01442181|7422548|FG001|STARTED|Overall Study||11
6503615|NCT01442181|7422547|FG000|COMPLETED|Overall Study||10
6503616|NCT01442181|7422548|FG001|COMPLETED|Overall Study||8
6503617|NCT01442181|7422547|FG000|NOT COMPLETED|Overall Study||4
6503618|NCT01442181|7422548|FG001|NOT COMPLETED|Overall Study||3
6503619|NCT01442376|7422558|FG000|STARTED|Overall Study|Randomized patients|169
6503620|NCT01442376|7422559|FG001|STARTED|Overall Study|Randomized patients|169
6503621|NCT01442376|7422560|FG002|STARTED|Overall Study|Randomized patients|164
6503622|NCT01442376|7422558|FG000|COMPLETED|Overall Study||166
6503623|NCT01442376|7422559|FG001|COMPLETED|Overall Study||160
6503624|NCT01442376|7422560|FG002|COMPLETED|Overall Study||159
6503625|NCT01442376|7422558|FG000|NOT COMPLETED|Overall Study||3
6503626|NCT01442376|7422559|FG001|NOT COMPLETED|Overall Study||9
6503627|NCT01442376|7422560|FG002|NOT COMPLETED|Overall Study||5
6503628|NCT01442493|7422570|FG000|STARTED|Overall Study||149
6503629|NCT01442493|7422571|FG001|STARTED|Overall Study||151
6503630|NCT01442493|7422570|FG000|COMPLETED|Overall Study||146
6503631|NCT01442493|7422571|FG001|COMPLETED|Overall Study||149
6503632|NCT01442493|7422570|FG000|NOT COMPLETED|Overall Study||3
6503633|NCT01442493|7422571|FG001|NOT COMPLETED|Overall Study||2
6503634|NCT01442675|7422577|FG000|STARTED|Overall Study||834
6503635|NCT01442675|7422577|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
6503636|NCT01442675|7422577|FG000|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
6503637|NCT01442675|7422577|FG000|COMPLETED|Overall Study||822
6503638|NCT01442675|7422577|FG000|NOT COMPLETED|Overall Study||12
6503639|NCT01442688|7422584|FG000|STARTED|First Intervention||31
6503640|NCT01442688|7422585|FG001|STARTED|First Intervention||31
6386304|NCT00809848|7297677|FG001|COMPLETED|Overall Study||34
6386305|NCT00809848|7297678|FG002|COMPLETED|Overall Study||34
6386306|NCT00809848|7297679|FG003|COMPLETED|Overall Study||30
6503641|NCT01442688|7422584|FG000|COMPLETED|First Intervention||29
6503642|NCT01442688|7422585|FG001|COMPLETED|First Intervention||31
6503643|NCT01442688|7422584|FG000|NOT COMPLETED|First Intervention||2
6503644|NCT01442688|7422585|FG001|NOT COMPLETED|First Intervention||0
6386307|NCT00809848|7297680|FG004|COMPLETED|Overall Study||34
6386308|NCT00809848|7297676|FG000|NOT COMPLETED|Overall Study||0
6386309|NCT00809848|7297677|FG001|NOT COMPLETED|Overall Study||0
6386310|NCT00809848|7297678|FG002|NOT COMPLETED|Overall Study||0
6503645|NCT01442688|7422584|FG000|STARTED|Second Intervention||29
6503646|NCT01442688|7422585|FG001|STARTED|Second Intervention||31
6503647|NCT01442688|7422584|FG000|COMPLETED|Second Intervention||28
6503648|NCT01442688|7422585|FG001|COMPLETED|Second Intervention||31
6503649|NCT01442688|7422584|FG000|NOT COMPLETED|Second Intervention||1
6503650|NCT01442688|7422585|FG001|NOT COMPLETED|Second Intervention||0
6503651|NCT01442714|7422591|FG000|STARTED|Overall Study||33
6503652|NCT01442714|7422591|FG000|COMPLETED|Overall Study||21
6503653|NCT01442714|7422591|FG000|NOT COMPLETED|Overall Study||12
6503654|NCT01442779|7422597|FG000|STARTED|Overall Study||18
6503655|NCT01442779|7422597|FG000|COMPLETED|Overall Study||11
6503656|NCT01442779|7422597|FG000|NOT COMPLETED|Overall Study||7
6503657|NCT01442844|7422603|FG000|STARTED|Overall Study||1
6503658|NCT01442844|7422604|FG001|STARTED|Overall Study||2
6503659|NCT01442844|7422603|FG000|COMPLETED|Overall Study||1
6503660|NCT01442844|7422604|FG001|COMPLETED|Overall Study||2
6503661|NCT01442844|7422603|FG000|NOT COMPLETED|Overall Study||0
6503662|NCT01442844|7422604|FG001|NOT COMPLETED|Overall Study||0
6503663|NCT01443026|7422612|FG000|STARTED|Overall Study||29
6503664|NCT01443026|7422613|FG001|STARTED|Overall Study||37
6503665|NCT01443026|7422612|FG000|COMPLETED|Overall Study||26
6503666|NCT01443026|7422613|FG001|COMPLETED|Overall Study||32
6503667|NCT01443026|7422612|FG000|NOT COMPLETED|Overall Study||3
6503668|NCT01443026|7422613|FG001|NOT COMPLETED|Overall Study||5
6503669|NCT01443078|7422619|FG000|STARTED|Overall Study||42
6503670|NCT01443078|7422619|FG000|COMPLETED|Overall Study||13
6503671|NCT01443078|7422619|FG000|NOT COMPLETED|Overall Study||29
6503672|NCT01443130|7422629|FG000|STARTED|Overall Study||300
6503673|NCT01443130|7422630|FG001|STARTED|Overall Study||300
6503674|NCT01443130|7422631|FG002|STARTED|Overall Study||300
6503675|NCT01443130|7422632|FG003|STARTED|Overall Study||270
6503676|NCT01443130|7422633|FG004|STARTED|Overall Study||274
6503677|NCT01443130|7422634|FG005|STARTED|Overall Study||259
6503678|NCT01443130|7422629|FG000|COMPLETED|Overall Study||232
6503679|NCT01443130|7422630|FG001|COMPLETED|Overall Study||231
6503680|NCT01443130|7422631|FG002|COMPLETED|Overall Study||223
6503681|NCT01443130|7422632|FG003|COMPLETED|Overall Study||231
6503682|NCT01443130|7422633|FG004|COMPLETED|Overall Study||230
6503683|NCT01443130|7422634|FG005|COMPLETED|Overall Study||225
6503684|NCT01443130|7422629|FG000|NOT COMPLETED|Overall Study||68
6503685|NCT01443130|7422630|FG001|NOT COMPLETED|Overall Study||69
6503686|NCT01443130|7422631|FG002|NOT COMPLETED|Overall Study||77
6503687|NCT01443130|7422632|FG003|NOT COMPLETED|Overall Study||39
6503688|NCT01443130|7422633|FG004|NOT COMPLETED|Overall Study||44
6503689|NCT01443130|7422634|FG005|NOT COMPLETED|Overall Study||34
6503690|NCT01443364|7422648|FG000|STARTED|Overall Study||132
6503691|NCT01443364|7422648|FG000|COMPLETED|Overall Study||91
6503692|NCT01443364|7422648|FG000|NOT COMPLETED|Overall Study||41
6503693|NCT01443403|7422656|FG000|STARTED|Overall Study||61
6503694|NCT01443403|7422657|FG001|STARTED|Overall Study||61
6503695|NCT01443403|7422658|FG002|STARTED|Overall Study||61
6503696|NCT01443403|7422659|FG003|STARTED|Overall Study||61
6503697|NCT01443403|7422656|FG000|Received Treatment|Overall Study||61
6503698|NCT01443403|7422657|FG001|Received Treatment|Overall Study||61
6503699|NCT01443403|7422658|FG002|Received Treatment|Overall Study||60
6503700|NCT01443403|7422659|FG003|Received Treatment|Overall Study||61
6503701|NCT01443403|7422656|FG000|COMPLETED|Overall Study||55
6503702|NCT01443403|7422657|FG001|COMPLETED|Overall Study||55
6503703|NCT01443403|7422658|FG002|COMPLETED|Overall Study||54
6503704|NCT01443403|7422659|FG003|COMPLETED|Overall Study||52
6386311|NCT00809848|7297679|FG003|NOT COMPLETED|Overall Study||1
6386312|NCT00809848|7297680|FG004|NOT COMPLETED|Overall Study||3
6386313|NCT00809926|7297695|FG000|STARTED|Overall Study||232
6386314|NCT00809926|7297696|FG001|STARTED|Overall Study||219
6503705|NCT01443403|7422656|FG000|NOT COMPLETED|Overall Study||6
6503706|NCT01443403|7422657|FG001|NOT COMPLETED|Overall Study||6
6503707|NCT01443403|7422658|FG002|NOT COMPLETED|Overall Study||7
6503708|NCT01443403|7422659|FG003|NOT COMPLETED|Overall Study||9
6503709|NCT01443442|7422674|FG000|STARTED|Overall Study||12
6503710|NCT01443442|7422675|FG001|STARTED|Overall Study||11
6503711|NCT01443442|7422674|FG000|COMPLETED|Overall Study||12
6386315|NCT00809926|7297695|FG000|COMPLETED|Overall Study||201
6386316|NCT00809926|7297696|FG001|COMPLETED|Overall Study||196
6386317|NCT00809926|7297695|FG000|NOT COMPLETED|Overall Study||31
6503712|NCT01443442|7422675|FG001|COMPLETED|Overall Study||11
6503713|NCT01443442|7422674|FG000|NOT COMPLETED|Overall Study||0
6503714|NCT01443442|7422675|FG001|NOT COMPLETED|Overall Study||0
6503715|NCT01443494|7422681|FG000|STARTED|Overall Study||19
6503716|NCT01443494|7422681|FG000|COMPLETED|Overall Study||19
6503717|NCT01443494|7422681|FG000|NOT COMPLETED|Overall Study||0
6503718|NCT01443546|7422688|FG000|STARTED|Overall Study||9
6565475|NCT01818414|7488314|FG001|STARTED|Overall Study||15
6565476|NCT01818414|7488313|FG000|COMPLETED|Overall Study||14
6565477|NCT01818414|7488314|FG001|COMPLETED|Overall Study||15
6565478|NCT01818414|7488313|FG000|NOT COMPLETED|Overall Study||0
6565479|NCT01818414|7488314|FG001|NOT COMPLETED|Overall Study||0
6270903|NCT00087438|7170267|FG000|STARTED|Overall Study||59
6565480|NCT01818427|7488324|FG000|STARTED|Overall Study||239
6386318|NCT00809926|7297696|FG001|NOT COMPLETED|Overall Study||23
6386319|NCT00809965|7297705|FG000|STARTED|Overall Study||5176
6386320|NCT00809965|7297706|FG001|STARTED|Overall Study||5174
6386321|NCT00809965|7297707|FG002|STARTED|Overall Study||5176
6386322|NCT00809965|7297705|FG000|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
6386323|NCT00809965|7297706|FG001|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
6386324|NCT00809965|7297707|FG002|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
6386325|NCT00809965|7297705|FG000|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
6386326|NCT00809965|7297706|FG001|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
6503719|NCT01443546|7422689|FG001|STARTED|Overall Study||9
6503720|NCT01443546|7422690|FG002|STARTED|Overall Study||8
6565481|NCT01818427|7488325|FG001|STARTED|Overall Study||284
6656838|NCT02465216|7587180|FG004|NOT COMPLETED|Overall Study||3
6805047|NCT02896855|7737130|FG000|Crossed Over From Placebo to Receive Pertuzumab|Overall Study|From 07-March-2020, 12 participants randomized to the Placebo arm crossed over to open-label pertuzumab.|12
6805048|NCT02896855|7737131|FG001|Crossed Over From Placebo to Receive Pertuzumab|Overall Study||0
6805049|NCT02896855|7737130|FG000|COMPLETED|Overall Study||49
6805050|NCT02896855|7737131|FG001|COMPLETED|Overall Study||69
6805051|NCT02896855|7737130|FG000|NOT COMPLETED|Overall Study||72
6805052|NCT02896855|7737131|FG001|NOT COMPLETED|Overall Study||53
6805053|NCT02871778|7737144|FG000|STARTED|Part A: Treatment Period 1||43
6805054|NCT02871778|7737145|FG001|STARTED|Part A: Treatment Period 1||41
6805055|NCT02871778|7737146|FG002|STARTED|Part A: Treatment Period 1||21
6805056|NCT02871778|7737147|FG003|STARTED|Part A: Treatment Period 1||18
6805057|NCT02871778|7737148|FG004|STARTED|Part A: Treatment Period 1||0
6805058|NCT02871778|7737149|FG005|STARTED|Part A: Treatment Period 1||0
6805059|NCT02871778|7737150|FG006|STARTED|Part A: Treatment Period 1||0
6805060|NCT02871778|7737151|FG007|STARTED|Part A: Treatment Period 1||0
6805061|NCT02871778|7737144|FG000|Safety Analysis Set|Part A: Treatment Period 1|1 participant was randomized to receive HS in Period 1, but instead received VX-371 in HS in Period 1.|44
6805062|NCT02871778|7737145|FG001|Safety Analysis Set|Part A: Treatment Period 1||40
6805063|NCT02871778|7737146|FG002|Safety Analysis Set|Part A: Treatment Period 1||21
6805064|NCT02871778|7737147|FG003|Safety Analysis Set|Part A: Treatment Period 1||18
6805065|NCT02871778|7737148|FG004|Safety Analysis Set|Part A: Treatment Period 1||0
6565482|NCT01818427|7488324|FG000|COMPLETED|Overall Study||230
6565483|NCT01818427|7488325|FG001|COMPLETED|Overall Study||271
6565484|NCT01818427|7488324|FG000|NOT COMPLETED|Overall Study||9
6565485|NCT01818427|7488325|FG001|NOT COMPLETED|Overall Study||13
6565486|NCT01818492|7488331|FG000|STARTED|Overall Study||45
6565487|NCT01818492|7488331|FG000|COMPLETED|Overall Study||35
6565488|NCT01818492|7488331|FG000|NOT COMPLETED|Overall Study||10
6565489|NCT01818518|7488342|FG000|STARTED|Overall Study||310
6805066|NCT02871778|7737149|FG005|Safety Analysis Set|Part A: Treatment Period 1||0
6805067|NCT02871778|7737150|FG006|Safety Analysis Set|Part A: Treatment Period 1||0
6805068|NCT02871778|7737151|FG007|Safety Analysis Set|Part A: Treatment Period 1||0
6805069|NCT02871778|7737144|FG000|COMPLETED|Part A: Treatment Period 1||40
6805070|NCT02871778|7737145|FG001|COMPLETED|Part A: Treatment Period 1||37
6805071|NCT02871778|7737146|FG002|COMPLETED|Part A: Treatment Period 1||18
6805072|NCT02871778|7737147|FG003|COMPLETED|Part A: Treatment Period 1||16
6805073|NCT02871778|7737148|FG004|COMPLETED|Part A: Treatment Period 1||0
6805074|NCT02871778|7737149|FG005|COMPLETED|Part A: Treatment Period 1||0
6805075|NCT02871778|7737150|FG006|COMPLETED|Part A: Treatment Period 1||0
6805076|NCT02871778|7737151|FG007|COMPLETED|Part A: Treatment Period 1||0
6805077|NCT02871778|7737144|FG000|NOT COMPLETED|Part A: Treatment Period 1||3
6805078|NCT02871778|7737145|FG001|NOT COMPLETED|Part A: Treatment Period 1||4
6805079|NCT02871778|7737146|FG002|NOT COMPLETED|Part A: Treatment Period 1||3
6805080|NCT02871778|7737147|FG003|NOT COMPLETED|Part A: Treatment Period 1||2
6805081|NCT02871778|7737148|FG004|NOT COMPLETED|Part A: Treatment Period 1||0
6805082|NCT02871778|7737149|FG005|NOT COMPLETED|Part A: Treatment Period 1||0
6805083|NCT02871778|7737150|FG006|NOT COMPLETED|Part A: Treatment Period 1||0
6805084|NCT02871778|7737151|FG007|NOT COMPLETED|Part A: Treatment Period 1||0
6805085|NCT02871778|7737144|FG000|STARTED|Part A: Treatment Period 2||40
6805086|NCT02871778|7737145|FG001|STARTED|Part A: Treatment Period 2||37
6805087|NCT02871778|7737146|FG002|STARTED|Part A: Treatment Period 2||18
6805088|NCT02871778|7737147|FG003|STARTED|Part A: Treatment Period 2||16
6805089|NCT02871778|7737148|FG004|STARTED|Part A: Treatment Period 2||0
6805090|NCT02871778|7737149|FG005|STARTED|Part A: Treatment Period 2||0
6805091|NCT02871778|7737150|FG006|STARTED|Part A: Treatment Period 2||0
6805092|NCT02871778|7737151|FG007|STARTED|Part A: Treatment Period 2||0
6805093|NCT02871778|7737144|FG000|Safety Analysis Set|Part A: Treatment Period 2||40
6805094|NCT02871778|7737145|FG001|Safety Analysis Set|Part A: Treatment Period 2||37
6805095|NCT02871778|7737146|FG002|Safety Analysis Set|Part A: Treatment Period 2||18
6805096|NCT02871778|7737147|FG003|Safety Analysis Set|Part A: Treatment Period 2||16
6805097|NCT02871778|7737148|FG004|Safety Analysis Set|Part A: Treatment Period 2||0
6805098|NCT02871778|7737149|FG005|Safety Analysis Set|Part A: Treatment Period 2||0
6805099|NCT02871778|7737150|FG006|Safety Analysis Set|Part A: Treatment Period 2||0
6805100|NCT02871778|7737151|FG007|Safety Analysis Set|Part A: Treatment Period 2||0
6805101|NCT02871778|7737144|FG000|COMPLETED|Part A: Treatment Period 2||37
6805102|NCT02871778|7737145|FG001|COMPLETED|Part A: Treatment Period 2||35
6805103|NCT02871778|7737146|FG002|COMPLETED|Part A: Treatment Period 2||17
6805104|NCT02871778|7737147|FG003|COMPLETED|Part A: Treatment Period 2||15
6805105|NCT02871778|7737148|FG004|COMPLETED|Part A: Treatment Period 2||0
6805106|NCT02871778|7737149|FG005|COMPLETED|Part A: Treatment Period 2||0
6805107|NCT02871778|7737150|FG006|COMPLETED|Part A: Treatment Period 2||0
6805108|NCT02871778|7737151|FG007|COMPLETED|Part A: Treatment Period 2||0
6805109|NCT02871778|7737144|FG000|NOT COMPLETED|Part A: Treatment Period 2||3
6805110|NCT02871778|7737145|FG001|NOT COMPLETED|Part A: Treatment Period 2||2
6805111|NCT02871778|7737146|FG002|NOT COMPLETED|Part A: Treatment Period 2||1
6805112|NCT02871778|7737147|FG003|NOT COMPLETED|Part A: Treatment Period 2||1
6805113|NCT02871778|7737148|FG004|NOT COMPLETED|Part A: Treatment Period 2||0
6805114|NCT02871778|7737149|FG005|NOT COMPLETED|Part A: Treatment Period 2||0
6805115|NCT02871778|7737150|FG006|NOT COMPLETED|Part A: Treatment Period 2||0
6805116|NCT02871778|7737151|FG007|NOT COMPLETED|Part A: Treatment Period 2||0
6805117|NCT02871778|7737144|FG000|STARTED|Part B: Treatment Period 3||0
6805118|NCT02871778|7737145|FG001|STARTED|Part B: Treatment Period 3||0
6805119|NCT02871778|7737146|FG002|STARTED|Part B: Treatment Period 3||0
6805120|NCT02871778|7737147|FG003|STARTED|Part B: Treatment Period 3||0
6805121|NCT02871778|7737148|FG004|STARTED|Part B: Treatment Period 3|Out of 35 participants who were on VX-371 in HS in Treatment period 2 and completed Part A, 11 participants rolled-over to Part B.|11
6805122|NCT02871778|7737149|FG005|STARTED|Part B: Treatment Period 3|Out of 37 participants who were on HS in Treatment period 2 and completed Part A, 27 participants rolled-over to Part B.|27
6805123|NCT02871778|7737150|FG006|STARTED|Part B: Treatment Period 3|Out of 15 participants who were on VX-371 in Treatment period 2 and completed Part A, 7 participants rolled-over to Part B.|7
6805124|NCT02871778|7737151|FG007|STARTED|Part B: Treatment Period 3|Out of 17 participants who were on Placebo in Treatment period 2 and completed Part A, 12 participants rolled-over to Part B.|12
6805125|NCT02871778|7737144|FG000|Safety Analysis Set|Part B: Treatment Period 3||0
6805126|NCT02871778|7737145|FG001|Safety Analysis Set|Part B: Treatment Period 3||0
6805127|NCT02871778|7737146|FG002|Safety Analysis Set|Part B: Treatment Period 3||0
6805128|NCT02871778|7737147|FG003|Safety Analysis Set|Part B: Treatment Period 3||0
6565490|NCT01818518|7488343|FG001|STARTED|Overall Study||263
6565491|NCT01818518|7488344|FG002|STARTED|Overall Study||288
6565492|NCT01818518|7488345|FG003|STARTED|Overall Study||59
6565493|NCT01818518|7488346|FG004|STARTED|Overall Study||38
6565494|NCT01818518|7488347|FG005|STARTED|Overall Study||37
6565495|NCT01818518|7488342|FG000|COMPLETED|Overall Study||310
6565496|NCT01818518|7488343|FG001|COMPLETED|Overall Study||263
6565497|NCT01818518|7488344|FG002|COMPLETED|Overall Study||288
6565498|NCT01818518|7488345|FG003|COMPLETED|Overall Study||59
6565499|NCT01818518|7488346|FG004|COMPLETED|Overall Study||38
6565500|NCT01818518|7488347|FG005|COMPLETED|Overall Study||37
6565501|NCT01818518|7488342|FG000|NOT COMPLETED|Overall Study||0
6565502|NCT01818518|7488343|FG001|NOT COMPLETED|Overall Study||0
6805129|NCT02871778|7737148|FG004|Safety Analysis Set|Part B: Treatment Period 3||11
6805130|NCT02871778|7737149|FG005|Safety Analysis Set|Part B: Treatment Period 3||27
6805131|NCT02871778|7737150|FG006|Safety Analysis Set|Part B: Treatment Period 3||7
6805132|NCT02871778|7737151|FG007|Safety Analysis Set|Part B: Treatment Period 3||12
6805133|NCT02871778|7737144|FG000|COMPLETED|Part B: Treatment Period 3||0
6805134|NCT02871778|7737145|FG001|COMPLETED|Part B: Treatment Period 3||0
6805135|NCT02871778|7737146|FG002|COMPLETED|Part B: Treatment Period 3||0
6805136|NCT02871778|7737147|FG003|COMPLETED|Part B: Treatment Period 3||0
6805137|NCT02871778|7737148|FG004|COMPLETED|Part B: Treatment Period 3||10
6805138|NCT02871778|7737149|FG005|COMPLETED|Part B: Treatment Period 3||26
6805139|NCT02871778|7737150|FG006|COMPLETED|Part B: Treatment Period 3||6
6805140|NCT02871778|7737151|FG007|COMPLETED|Part B: Treatment Period 3||12
6805141|NCT02871778|7737144|FG000|NOT COMPLETED|Part B: Treatment Period 3||0
6805142|NCT02871778|7737145|FG001|NOT COMPLETED|Part B: Treatment Period 3||0
6805143|NCT02871778|7737146|FG002|NOT COMPLETED|Part B: Treatment Period 3||0
6805144|NCT02871778|7737147|FG003|NOT COMPLETED|Part B: Treatment Period 3||0
6805145|NCT02871778|7737148|FG004|NOT COMPLETED|Part B: Treatment Period 3||1
6805146|NCT02871778|7737149|FG005|NOT COMPLETED|Part B: Treatment Period 3||1
6805147|NCT02871778|7737150|FG006|NOT COMPLETED|Part B: Treatment Period 3||1
6805148|NCT02871778|7737151|FG007|NOT COMPLETED|Part B: Treatment Period 3||0
6805149|NCT02769000|7737175|FG000|STARTED|Overall Study||5
6270904|NCT00087438|7170267|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
6270905|NCT00087438|7170267|FG000|NOT COMPLETED|Overall Study||4
6270906|NCT00087490|7170275|FG000|STARTED|Overall Study||544
6270907|NCT00087490|7170276|FG001|STARTED|Overall Study||533
6270908|NCT00087490|7170275|FG000|Treated|Overall Study||537
6270909|NCT00087490|7170276|FG001|Treated|Overall Study||515
6270910|NCT00087490|7170275|FG000|COMPLETED|Overall Study||286
6270911|NCT00087490|7170276|FG001|COMPLETED|Overall Study||264
6270912|NCT00087490|7170275|FG000|NOT COMPLETED|Overall Study||258
6270913|NCT00087490|7170276|FG001|NOT COMPLETED|Overall Study||269
6270914|NCT00087516|7170285|FG000|STARTED|Overall Study||238
6270915|NCT00087516|7170286|FG001|STARTED|Overall Study||250
6270916|NCT00087516|7170287|FG002|STARTED|Overall Study||130
6270917|NCT00087516|7170288|FG003|STARTED|Overall Study||123
6270918|NCT00087516|7170285|FG000|COMPLETED|Overall Study||77
6270919|NCT00087516|7170286|FG001|COMPLETED|Overall Study||81
6270920|NCT00087516|7170287|FG002|COMPLETED|Overall Study||33
6270921|NCT00087516|7170288|FG003|COMPLETED|Overall Study||38
6270922|NCT00087516|7170285|FG000|NOT COMPLETED|Overall Study||161
6270923|NCT00087516|7170286|FG001|NOT COMPLETED|Overall Study||169
6270924|NCT00087516|7170287|FG002|NOT COMPLETED|Overall Study||97
6270925|NCT00087516|7170288|FG003|NOT COMPLETED|Overall Study||85
6270926|NCT00087529|7170304|FG000|STARTED|Overall Study||147
6270927|NCT00087529|7170305|FG001|STARTED|Overall Study||292
6270928|NCT00087529|7170304|FG000|COMPLETED|Overall Study||116
6270929|NCT00087529|7170305|FG001|COMPLETED|Overall Study||224
6270930|NCT00087529|7170304|FG000|NOT COMPLETED|Overall Study||31
6270931|NCT00087529|7170305|FG001|NOT COMPLETED|Overall Study||68
6270932|NCT00087555|7170314|FG000|STARTED|Overall Study||66
6270933|NCT00087555|7170315|FG001|STARTED|Overall Study||62
6270934|NCT00087555|7170316|FG002|STARTED|Overall Study||67
6270935|NCT00087555|7170314|FG000|Treated|Overall Study||65
6270936|NCT00087555|7170315|FG001|Treated|Overall Study||60
6270937|NCT00087555|7170316|FG002|Treated|Overall Study||67
6270938|NCT00087555|7170314|FG000|COMPLETED|Overall Study||54
6270939|NCT00087555|7170315|FG001|COMPLETED|Overall Study||51
6270940|NCT00087555|7170316|FG002|COMPLETED|Overall Study||46
6270941|NCT00087555|7170314|FG000|NOT COMPLETED|Overall Study||12
6270942|NCT00087555|7170315|FG001|NOT COMPLETED|Overall Study||11
6270943|NCT00087555|7170316|FG002|NOT COMPLETED|Overall Study||21
6270944|NCT00087568|7170326|FG000|STARTED|Overall Study||32
6270945|NCT00087568|7170327|FG001|STARTED|Overall Study||25
6270946|NCT00087568|7170326|FG000|COMPLETED|Overall Study||2
6270947|NCT00087568|7170327|FG001|COMPLETED|Overall Study||23
6270948|NCT00087568|7170326|FG000|NOT COMPLETED|Overall Study||30
6270949|NCT00087568|7170327|FG001|NOT COMPLETED|Overall Study||2
6270950|NCT00087594|7170335|FG000|STARTED|Overall Study||24
6270951|NCT00087594|7170336|FG001|STARTED|Overall Study||24
6270952|NCT00087594|7170335|FG000|COMPLETED|Overall Study||16
6270953|NCT00087594|7170336|FG001|COMPLETED|Overall Study||12
6270954|NCT00087594|7170335|FG000|NOT COMPLETED|Overall Study||8
6270955|NCT00087594|7170336|FG001|NOT COMPLETED|Overall Study||12
6270956|NCT00087607|7170344|FG000|STARTED|Overall Study||192
6270957|NCT00087607|7170345|FG001|STARTED|Overall Study||193
6270958|NCT00087607|7170344|FG000|COMPLETED|Overall Study||70
6270959|NCT00087607|7170345|FG001|COMPLETED|Overall Study||71
6270960|NCT00087607|7170344|FG000|NOT COMPLETED|Overall Study||122
6270961|NCT00087607|7170345|FG001|NOT COMPLETED|Overall Study||122
6270962|NCT00087633|7170357|FG000|STARTED|Overall Study|Randomized|55
6270963|NCT00087633|7170358|FG001|STARTED|Overall Study|Randomized|60
6270964|NCT00087633|7170357|FG000|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
6386327|NCT00809965|7297707|FG002|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
6386328|NCT00809965|7297705|FG000|COMPLETED|Overall Study||4393
6386329|NCT00809965|7297706|FG001|COMPLETED|Overall Study||4399
6386330|NCT00809965|7297707|FG002|COMPLETED|Overall Study||4332
6386331|NCT00809965|7297705|FG000|NOT COMPLETED|Overall Study||783
6386332|NCT00809965|7297706|FG001|NOT COMPLETED|Overall Study||775
6386333|NCT00809965|7297707|FG002|NOT COMPLETED|Overall Study||844
6386334|NCT00810043|7297717|FG000|STARTED|Overall Study||57
6386335|NCT00810043|7297718|FG001|STARTED|Overall Study||55
6386336|NCT00810043|7297719|FG002|STARTED|Overall Study||8
6386337|NCT00810043|7297717|FG000|COMPLETED|Overall Study||53
6270965|NCT00087633|7170358|FG001|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
6270966|NCT00087633|7170357|FG000|NOT COMPLETED|Overall Study||24
6270967|NCT00087633|7170358|FG001|NOT COMPLETED|Overall Study||17
6270968|NCT00087646|7170368|FG000|STARTED|Overall Study||317
6270969|NCT00087646|7170369|FG001|STARTED|Overall Study||156
6270970|NCT00087646|7170370|FG002|STARTED|Overall Study||156
6270971|NCT00087646|7170371|FG003|STARTED|Overall Study||313
6270972|NCT00087646|7170368|FG000|COMPLETED|Overall Study||182
6270973|NCT00087646|7170369|FG001|COMPLETED|Overall Study||114
6270974|NCT00087646|7170370|FG002|COMPLETED|Overall Study||91
6270975|NCT00087646|7170371|FG003|COMPLETED|Overall Study||229
6270976|NCT00087646|7170368|FG000|NOT COMPLETED|Overall Study||135
6270977|NCT00087646|7170369|FG001|NOT COMPLETED|Overall Study||42
6386338|NCT00810043|7297718|FG001|COMPLETED|Overall Study||54
6386339|NCT00810043|7297719|FG002|COMPLETED|Overall Study||0
6386340|NCT00810043|7297717|FG000|NOT COMPLETED|Overall Study||4
6386341|NCT00810043|7297718|FG001|NOT COMPLETED|Overall Study||1
6386342|NCT00810043|7297719|FG002|NOT COMPLETED|Overall Study||8
6386343|NCT00810069|7297730|FG000|STARTED|Lead-in Period I||840
6386344|NCT00810069|7297731|FG001|STARTED|Lead-in Period I||0
6386345|NCT00810069|7297732|FG002|STARTED|Lead-in Period I||0
6386346|NCT00810069|7297730|FG000|COMPLETED|Lead-in Period I||566
6386347|NCT00810069|7297731|FG001|COMPLETED|Lead-in Period I||0
6386348|NCT00810069|7297732|FG002|COMPLETED|Lead-in Period I||0
6386349|NCT00810069|7297730|FG000|NOT COMPLETED|Lead-in Period I||274
6386350|NCT00810069|7297731|FG001|NOT COMPLETED|Lead-in Period I||0
6386351|NCT00810069|7297732|FG002|NOT COMPLETED|Lead-in Period I||0
6386352|NCT00810069|7297730|FG000|STARTED|Double-Blind Period II||0
6386353|NCT00810069|7297731|FG001|STARTED|Double-Blind Period II||282
6386354|NCT00810069|7297732|FG002|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
6386355|NCT00810069|7297730|FG000|COMPLETED|Double-Blind Period II||0
6386356|NCT00810069|7297731|FG001|COMPLETED|Double-Blind Period II||226
6386357|NCT00810069|7297732|FG002|COMPLETED|Double-Blind Period II||212
6386358|NCT00810069|7297730|FG000|NOT COMPLETED|Double-Blind Period II||0
6386359|NCT00810069|7297731|FG001|NOT COMPLETED|Double-Blind Period II||56
6386360|NCT00810069|7297732|FG002|NOT COMPLETED|Double-Blind Period II||72
6386361|NCT00810082|7297743|FG000|STARTED|Overall Study||34
6386362|NCT00810082|7297744|FG001|STARTED|Overall Study||31
6386363|NCT00810082|7297743|FG000|COMPLETED|Overall Study||34
6386364|NCT00810082|7297744|FG001|COMPLETED|Overall Study||27
6386365|NCT00810082|7297743|FG000|NOT COMPLETED|Overall Study||0
6270978|NCT00087646|7170370|FG002|NOT COMPLETED|Overall Study||65
6270979|NCT00087646|7170371|FG003|NOT COMPLETED|Overall Study||84
6270980|NCT00087672|7170386|FG000|STARTED|Overall Study||41
6270981|NCT00087672|7170386|FG000|COMPLETED|Overall Study||41
6270982|NCT00087672|7170386|FG000|NOT COMPLETED|Overall Study||0
6270983|NCT00087685|7170390|FG000|STARTED|Overall Study||35
6270984|NCT00087685|7170390|FG000|COMPLETED|Overall Study||21
6270985|NCT00087685|7170390|FG000|NOT COMPLETED|Overall Study||14
6270986|NCT00087698|7170394|FG000|STARTED|Overall Study||77
6270987|NCT00087698|7170394|FG000|COMPLETED|Overall Study||41
6270988|NCT00087698|7170394|FG000|NOT COMPLETED|Overall Study||36
6270989|NCT00088153|7170400|FG000|STARTED|Overall Study||55
6270990|NCT00088153|7170401|FG001|STARTED|Overall Study||55
6270991|NCT00088153|7170400|FG000|COMPLETED|Overall Study||31
6270992|NCT00088153|7170401|FG001|COMPLETED|Overall Study||30
6270993|NCT00088153|7170400|FG000|NOT COMPLETED|Overall Study||24
6270994|NCT00088153|7170401|FG001|NOT COMPLETED|Overall Study||25
6270995|NCT00088166|7170409|FG000|STARTED|Overall Study||100
6270996|NCT00088166|7170410|FG001|STARTED|Overall Study||100
6270997|NCT00088166|7170409|FG000|COMPLETED|Overall Study||47
6270998|NCT00088166|7170410|FG001|COMPLETED|Overall Study||39
6270999|NCT00088166|7170409|FG000|NOT COMPLETED|Overall Study||53
6271000|NCT00088166|7170410|FG001|NOT COMPLETED|Overall Study||61
6271001|NCT00088205|7170416|FG000|STARTED|Overall Study||60
6271002|NCT00088205|7170416|FG000|Received at Least 1 Dose of Study Drug|Overall Study||60
6271003|NCT00088205|7170416|FG000|Efficacy Population|Overall Study|Participants with diagnosis of relapsed mantle cell lymphoma.|59
6271004|NCT00088205|7170416|FG000|COMPLETED|Overall Study||0
6271005|NCT00088205|7170416|FG000|NOT COMPLETED|Overall Study||60
6271006|NCT00088218|7170422|FG000|STARTED|Overall Study||16
6271007|NCT00088218|7170423|FG001|STARTED|Overall Study||79
6656839|NCT02465372|7587194|FG000|STARTED|Overall Study||349
6271008|NCT00088218|7170422|FG000|COMPLETED|Overall Study||16
6271009|NCT00088218|7170423|FG001|COMPLETED|Overall Study||79
6271010|NCT00088218|7170422|FG000|NOT COMPLETED|Overall Study||0
6271011|NCT00088218|7170423|FG001|NOT COMPLETED|Overall Study||0
6271012|NCT00088374|7170429|FG000|STARTED|Overall Study||9
6271013|NCT00088374|7170429|FG000|COMPLETED|Overall Study||7
6271014|NCT00088374|7170429|FG000|NOT COMPLETED|Overall Study||2
6271015|NCT00088413|7170437|FG000|STARTED|Overall Study||10
6271016|NCT00088413|7170438|FG001|STARTED|Overall Study||15
6271017|NCT00088413|7170439|FG002|STARTED|Overall Study||12
6271018|NCT00088413|7170440|FG003|STARTED|Overall Study||14
6271019|NCT00088413|7170437|FG000|COMPLETED|Overall Study||0
6271020|NCT00088413|7170438|FG001|COMPLETED|Overall Study||0
6271021|NCT00088413|7170439|FG002|COMPLETED|Overall Study||0
6271022|NCT00088413|7170440|FG003|COMPLETED|Overall Study||0
6271023|NCT00088413|7170437|FG000|NOT COMPLETED|Overall Study||10
6271024|NCT00088413|7170438|FG001|NOT COMPLETED|Overall Study||15
6271025|NCT00088413|7170439|FG002|NOT COMPLETED|Overall Study||12
6271026|NCT00088413|7170440|FG003|NOT COMPLETED|Overall Study||14
6271027|NCT00088452|7170455|FG000|STARTED|Overall Study||156
6271028|NCT00088452|7170456|FG001|STARTED|Overall Study||149
6271029|NCT00088452|7170457|FG002|STARTED|Overall Study||148
6271030|NCT00088452|7170455|FG000|COMPLETED|Overall Study||155
6271031|NCT00088452|7170456|FG001|COMPLETED|Overall Study||149
6271032|NCT00088452|7170457|FG002|COMPLETED|Overall Study||147
6271033|NCT00088452|7170455|FG000|NOT COMPLETED|Overall Study||1
6271034|NCT00088452|7170456|FG001|NOT COMPLETED|Overall Study||0
6271035|NCT00088452|7170457|FG002|NOT COMPLETED|Overall Study||1
6271036|NCT00088465|7170465|FG000|STARTED|Overall Study||931
6271037|NCT00088465|7170465|FG000|COMPLETED|Overall Study||370
6271038|NCT00088465|7170465|FG000|NOT COMPLETED|Overall Study||561
6271039|NCT00088530|7170471|FG000|STARTED|Overall Study||70
6386366|NCT00810082|7297744|FG001|NOT COMPLETED|Overall Study||4
6386367|NCT00810095|7297750|FG000|STARTED|Overall Study||40
6386368|NCT00810095|7297750|FG000|COMPLETED|Overall Study||40
6386369|NCT00810095|7297750|FG000|NOT COMPLETED|Overall Study||0
6386370|NCT00810108|7297756|FG000|STARTED|Overall Study||6
6386371|NCT00810108|7297757|FG001|STARTED|Overall Study||7
6386372|NCT00810108|7297756|FG000|COMPLETED|Overall Study||5
6386373|NCT00810108|7297757|FG001|COMPLETED|Overall Study||7
6386374|NCT00810108|7297756|FG000|NOT COMPLETED|Overall Study||1
6386375|NCT00810108|7297757|FG001|NOT COMPLETED|Overall Study||0
6386376|NCT00810199|7297764|FG000|STARTED|Overall Study||279
6386377|NCT00810199|7297765|FG001|STARTED|Overall Study||277
6386378|NCT00810199|7297764|FG000|Received Study Drug|Overall Study||277
6386379|NCT00810199|7297765|FG001|Received Study Drug|Overall Study||276
6386380|NCT00810199|7297764|FG000|Completed Week 24|Overall Study||259
6386381|NCT00810199|7297765|FG001|Completed Week 24|Overall Study||250
6386382|NCT00810199|7297764|FG000|Completed Week 52|Overall Study||243
6271040|NCT00088530|7170472|FG001|STARTED|Overall Study||70
6271041|NCT00088530|7170471|FG000|COMPLETED|Overall Study||20
6271042|NCT00088530|7170472|FG001|COMPLETED|Overall Study||16
6271043|NCT00088530|7170471|FG000|NOT COMPLETED|Overall Study||50
6271044|NCT00088530|7170472|FG001|NOT COMPLETED|Overall Study||54
6271045|NCT00088595|7170478|FG000|STARTED|Overall Study||45
6271046|NCT00088595|7170478|FG000|COMPLETED|Overall Study||17
6271047|NCT00088595|7170478|FG000|NOT COMPLETED|Overall Study||28
6271048|NCT00088621|7170492|FG000|STARTED|Overall Study||61
6271049|NCT00088621|7170492|FG000|COMPLETED|Overall Study||7
6271050|NCT00088621|7170492|FG000|NOT COMPLETED|Overall Study||54
6271051|NCT00088634|7170498|FG000|STARTED|Overall Study||90
6271052|NCT00088634|7170499|FG001|STARTED|Overall Study||90
6271053|NCT00088634|7170498|FG000|COMPLETED|Overall Study||52
6271054|NCT00088634|7170499|FG001|COMPLETED|Overall Study||47
6271055|NCT00088634|7170498|FG000|NOT COMPLETED|Overall Study||38
6271056|NCT00088634|7170499|FG001|NOT COMPLETED|Overall Study||43
6271057|NCT00088699|7170507|FG000|STARTED|Infusion 1||23
6271058|NCT00088699|7170508|FG001|STARTED|Infusion 1||19
6271059|NCT00088699|7170509|FG002|STARTED|Infusion 1||13
6271060|NCT00088699|7170510|FG003|STARTED|Infusion 1||12
6271061|NCT00088699|7170507|FG000|COMPLETED|Infusion 1||22
6271062|NCT00088699|7170508|FG001|COMPLETED|Infusion 1||19
6271063|NCT00088699|7170509|FG002|COMPLETED|Infusion 1||12
6271064|NCT00088699|7170510|FG003|COMPLETED|Infusion 1||10
6271065|NCT00088699|7170507|FG000|NOT COMPLETED|Infusion 1||1
6271066|NCT00088699|7170508|FG001|NOT COMPLETED|Infusion 1||0
6271067|NCT00088699|7170509|FG002|NOT COMPLETED|Infusion 1||1
6271068|NCT00088699|7170510|FG003|NOT COMPLETED|Infusion 1||2
6271069|NCT00088699|7170507|FG000|STARTED|Infusion 2||19
6271070|NCT00088699|7170508|FG001|STARTED|Infusion 2||18
6271071|NCT00088699|7170509|FG002|STARTED|Infusion 2||11
6271072|NCT00088699|7170510|FG003|STARTED|Infusion 2||11
6271073|NCT00088699|7170507|FG000|COMPLETED|Infusion 2||19
6271074|NCT00088699|7170508|FG001|COMPLETED|Infusion 2||18
6271075|NCT00088699|7170509|FG002|COMPLETED|Infusion 2||11
6271076|NCT00088699|7170510|FG003|COMPLETED|Infusion 2||10
6271077|NCT00088699|7170507|FG000|NOT COMPLETED|Infusion 2||0
6271078|NCT00088699|7170508|FG001|NOT COMPLETED|Infusion 2||0
6271079|NCT00088699|7170509|FG002|NOT COMPLETED|Infusion 2||0
6271080|NCT00088699|7170510|FG003|NOT COMPLETED|Infusion 2||1
6271081|NCT00088881|7170520|FG000|STARTED|Step 1 - R-CHOP||62
6271082|NCT00088881|7170520|FG000|Eligible and Treated|Step 1 - R-CHOP||53
6271083|NCT00088881|7170520|FG000|COMPLETED|Step 1 - R-CHOP||48
6271084|NCT00088881|7170520|FG000|NOT COMPLETED|Step 1 - R-CHOP||14
6271085|NCT00088881|7170520|FG000|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
6271086|NCT00088881|7170520|FG000|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
6271087|NCT00088881|7170520|FG000|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
6271088|NCT00088881|7170520|FG000|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
6271089|NCT00088881|7170520|FG000|STARTED|Step 3 - Radiation Therapy||1
6271090|NCT00088881|7170520|FG000|COMPLETED|Step 3 - Radiation Therapy||1
6271091|NCT00088881|7170520|FG000|NOT COMPLETED|Step 3 - Radiation Therapy||0
6271092|NCT00088907|7170528|FG000|STARTED|Randomized Study (Step 1)||136
6271093|NCT00088907|7170529|FG001|STARTED|Randomized Study (Step 1)||134
6271094|NCT00088907|7170528|FG000|Treated|Randomized Study (Step 1)||129
6271095|NCT00088907|7170529|FG001|Treated|Randomized Study (Step 1)||124
6271096|NCT00088907|7170528|FG000|Eligible|Randomized Study (Step 1)||117
6271097|NCT00088907|7170529|FG001|Eligible|Randomized Study (Step 1)||122
6271098|NCT00088907|7170528|FG000|Eligible and Treated|Randomized Study (Step 1)||117
6271099|NCT00088907|7170529|FG001|Eligible and Treated|Randomized Study (Step 1)||122
6271100|NCT00088907|7170528|FG000|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
6271101|NCT00088907|7170529|FG001|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
6271102|NCT00088907|7170528|FG000|NOT COMPLETED|Randomized Study (Step 1)||136
6271103|NCT00088907|7170529|FG001|NOT COMPLETED|Randomized Study (Step 1)||134
6271104|NCT00088907|7170528|FG000|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
6271105|NCT00088907|7170529|FG001|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
6271106|NCT00088907|7170528|FG000|Treated|Single Gefitinib Treatment (Step 2)||19
6271107|NCT00088907|7170529|FG001|Treated|Single Gefitinib Treatment (Step 2)||0
6271108|NCT00088907|7170528|FG000|COMPLETED|Single Gefitinib Treatment (Step 2)||0
6271109|NCT00088907|7170529|FG001|COMPLETED|Single Gefitinib Treatment (Step 2)||0
6271110|NCT00088907|7170528|FG000|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
6271111|NCT00088907|7170529|FG001|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
6386383|NCT00810199|7297765|FG001|Completed Week 52|Overall Study||229
6386384|NCT00810199|7297764|FG000|Completed Week 104|Overall Study||222
6386385|NCT00810199|7297765|FG001|Completed Week 104|Overall Study||201
6386386|NCT00810199|7297764|FG000|COMPLETED|Overall Study||220
6271112|NCT00088985|7170536|FG000|STARTED|Overall Study||7
6271113|NCT00088985|7170536|FG000|COMPLETED|Overall Study||4
6271114|NCT00088985|7170536|FG000|NOT COMPLETED|Overall Study||3
6271115|NCT00089011|7170542|FG000|STARTED|Overall Study||100
6271116|NCT00089011|7170543|FG001|STARTED|Overall Study||50
6386387|NCT00810199|7297765|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|195
6386388|NCT00810199|7297764|FG000|NOT COMPLETED|Overall Study||59
6386389|NCT00810199|7297765|FG001|NOT COMPLETED|Overall Study||82
6386390|NCT00810264|7297777|FG000|STARTED|Overall Study||2499
6386391|NCT00810264|7297777|FG000|COMPLETED|Overall Study||946
6386392|NCT00810264|7297777|FG000|NOT COMPLETED|Overall Study||1553
6386393|NCT00810277|7297785|FG000|STARTED|Overall Study||14
6386394|NCT00810277|7297785|FG000|COMPLETED|Overall Study||13
6386395|NCT00810277|7297785|FG000|NOT COMPLETED|Overall Study||1
6386396|NCT00810303|7297789|FG000|STARTED|Efavirenz Alone - Day 1-5||12
6386397|NCT00810303|7297789|FG000|COMPLETED|Efavirenz Alone - Day 1-5||12
6386398|NCT00810303|7297789|FG000|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
6386399|NCT00810303|7297789|FG000|STARTED|Ezetimibe Alone - Day 6-15||12
6386400|NCT00810303|7297789|FG000|COMPLETED|Ezetimibe Alone - Day 6-15||12
6386401|NCT00810303|7297789|FG000|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
6386402|NCT00810303|7297789|FG000|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
6386403|NCT00810303|7297789|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
6386404|NCT00810303|7297789|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
6386405|NCT00810303|7297789|FG000|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
6386406|NCT00810303|7297789|FG000|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
6386407|NCT00810303|7297789|FG000|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
6386408|NCT00810342|7297799|FG000|STARTED|Month 1 Follow-up||154
6386409|NCT00810342|7297800|FG001|STARTED|Month 1 Follow-up||157
6386410|NCT00810342|7297799|FG000|COMPLETED|Month 1 Follow-up||149
6386411|NCT00810342|7297800|FG001|COMPLETED|Month 1 Follow-up||155
6386412|NCT00810342|7297799|FG000|NOT COMPLETED|Month 1 Follow-up||5
6386413|NCT00810342|7297800|FG001|NOT COMPLETED|Month 1 Follow-up||2
6386414|NCT00810342|7297799|FG000|STARTED|6-month Follow-up||149
6386415|NCT00810342|7297800|FG001|STARTED|6-month Follow-up||155
6386416|NCT00810342|7297799|FG000|COMPLETED|6-month Follow-up||125
6386417|NCT00810342|7297800|FG001|COMPLETED|6-month Follow-up||147
6386418|NCT00810342|7297799|FG000|NOT COMPLETED|6-month Follow-up||24
6386419|NCT00810342|7297800|FG001|NOT COMPLETED|6-month Follow-up||8
6386420|NCT00810342|7297799|FG000|STARTED|12-month Followup||125
6386421|NCT00810342|7297800|FG001|STARTED|12-month Followup||147
6386422|NCT00810342|7297799|FG000|COMPLETED|12-month Followup||113
6386423|NCT00810342|7297800|FG001|COMPLETED|12-month Followup||136
6386424|NCT00810342|7297799|FG000|NOT COMPLETED|12-month Followup||12
6386425|NCT00810342|7297800|FG001|NOT COMPLETED|12-month Followup||11
6386426|NCT00810355|7297811|FG000|STARTED|Overall Study||25
6386427|NCT00810355|7297812|FG001|STARTED|Overall Study||25
6386428|NCT00810355|7297813|FG002|STARTED|Overall Study||25
6386429|NCT00810355|7297811|FG000|COMPLETED|Overall Study||11
6386430|NCT00810355|7297812|FG001|COMPLETED|Overall Study||8
6386431|NCT00810355|7297813|FG002|COMPLETED|Overall Study||14
6386432|NCT00810355|7297811|FG000|NOT COMPLETED|Overall Study||14
6386433|NCT00810355|7297812|FG001|NOT COMPLETED|Overall Study||17
6386434|NCT00810355|7297813|FG002|NOT COMPLETED|Overall Study||11
6386435|NCT00810368|7297823|FG000|STARTED|Overall Study||18
6386436|NCT00810368|7297824|FG001|STARTED|Overall Study||15
6386437|NCT00810368|7297823|FG000|COMPLETED|Overall Study||12
6386438|NCT00810368|7297824|FG001|COMPLETED|Overall Study||13
6386439|NCT00810368|7297823|FG000|NOT COMPLETED|Overall Study||6
6386440|NCT00810368|7297824|FG001|NOT COMPLETED|Overall Study||2
6386441|NCT00810394|7297832|FG000|STARTED|Overall Study||50
6386442|NCT00810394|7297832|FG000|Cycle 2 600mg Twice Daily|Overall Study||13
6386443|NCT00810394|7297832|FG000|Cycle 2 400mg Once Daily|Overall Study||22
6386444|NCT00810394|7297832|FG000|Cycle 3 800 mg Twice Daily|Overall Study||4
6386445|NCT00810394|7297832|FG000|Cycle 3 400mg Twice Daily|Overall Study||5
6386446|NCT00810394|7297832|FG000|COMPLETED|Overall Study||47
6386447|NCT00810394|7297832|FG000|NOT COMPLETED|Overall Study||3
6386448|NCT00810407|7297836|FG000|STARTED|Overall Study||594
6386449|NCT00810407|7297836|FG000|COMPLETED|Overall Study||588
6386450|NCT00810407|7297836|FG000|NOT COMPLETED|Overall Study||6
6386451|NCT00810459|7297840|FG000|STARTED|Overall Study||4
6386452|NCT00810459|7297841|FG001|STARTED|Overall Study||2
6386453|NCT00810459|7297840|FG000|COMPLETED|Overall Study||4
6386454|NCT00810459|7297841|FG001|COMPLETED|Overall Study||2
6386455|NCT00810459|7297840|FG000|NOT COMPLETED|Overall Study||0
6271117|NCT00089011|7170542|FG000|COMPLETED|Overall Study||100
6271118|NCT00089011|7170543|FG001|COMPLETED|Overall Study||50
6271119|NCT00089011|7170542|FG000|NOT COMPLETED|Overall Study||0
6271120|NCT00089011|7170543|FG001|NOT COMPLETED|Overall Study||0
6271121|NCT00089024|7170549|FG000|STARTED|Overall Study||29
6271122|NCT00089024|7170549|FG000|Treated Subjects|Overall Study||29
6271123|NCT00089024|7170549|FG000|COMPLETED|Overall Study||24
6271124|NCT00089024|7170549|FG000|NOT COMPLETED|Overall Study||5
6271125|NCT00089076|7170553|FG000|STARTED|Overall Study||18
6271126|NCT00089076|7170553|FG000|COMPLETED|Overall Study||8
6271127|NCT00089076|7170553|FG000|NOT COMPLETED|Overall Study||10
6271128|NCT00089102|7170557|FG000|STARTED|Overall Study||9
6271129|NCT00089102|7170557|FG000|COMPLETED|Overall Study||9
6271130|NCT00089102|7170557|FG000|NOT COMPLETED|Overall Study||0
6271131|NCT00089284|7170566|FG000|STARTED|Overall Study||7
6271132|NCT00089284|7170567|FG001|STARTED|Overall Study||3
6271133|NCT00089284|7170568|FG002|STARTED|Overall Study||6
6271134|NCT00089284|7170569|FG003|STARTED|Overall Study||6
6271135|NCT00089284|7170570|FG004|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
6271136|NCT00089284|7170571|FG005|STARTED|Overall Study|No patients were accrued to this cohort of 6-24% involvement due to lack of eligible patients.|0
6271137|NCT00089284|7170572|FG006|STARTED|Overall Study||8
6271138|NCT00089284|7170566|FG000|COMPLETED|Overall Study||7
6271139|NCT00089284|7170567|FG001|COMPLETED|Overall Study||3
6271140|NCT00089284|7170568|FG002|COMPLETED|Overall Study||6
6271141|NCT00089284|7170569|FG003|COMPLETED|Overall Study||6
6271142|NCT00089284|7170570|FG004|COMPLETED|Overall Study||0
6271143|NCT00089284|7170571|FG005|COMPLETED|Overall Study||0
6271144|NCT00089284|7170572|FG006|COMPLETED|Overall Study||7
6565503|NCT01818518|7488344|FG002|NOT COMPLETED|Overall Study||0
6565504|NCT01818518|7488345|FG003|NOT COMPLETED|Overall Study||0
6565505|NCT01818518|7488346|FG004|NOT COMPLETED|Overall Study||0
6565506|NCT01818518|7488347|FG005|NOT COMPLETED|Overall Study||0
6565507|NCT01818531|7488363|FG000|STARTED|Overall Study||75
6565508|NCT01818531|7488364|FG001|STARTED|Overall Study||75
6271145|NCT00089284|7170566|FG000|NOT COMPLETED|Overall Study||0
6271146|NCT00089284|7170567|FG001|NOT COMPLETED|Overall Study||0
6271147|NCT00089284|7170568|FG002|NOT COMPLETED|Overall Study||0
6271148|NCT00089284|7170569|FG003|NOT COMPLETED|Overall Study||0
6271149|NCT00089284|7170570|FG004|NOT COMPLETED|Overall Study||0
6271150|NCT00089284|7170571|FG005|NOT COMPLETED|Overall Study||0
6271151|NCT00089284|7170572|FG006|NOT COMPLETED|Overall Study||1
6271152|NCT00089297|7170594|FG000|STARTED|Overall Study||74
6271153|NCT00089297|7170594|FG000|Treated|Overall Study||70
6271154|NCT00089297|7170594|FG000|Eligible|Overall Study||63
6271155|NCT00089297|7170594|FG000|COMPLETED|Overall Study||36
6271156|NCT00089297|7170594|FG000|NOT COMPLETED|Overall Study||38
6271157|NCT00089479|7170600|FG000|STARTED|Overall Study||1304
6271158|NCT00089479|7170601|FG001|STARTED|Overall Study||1307
6271159|NCT00089479|7170600|FG000|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
6271160|NCT00089479|7170601|FG001|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
6271161|NCT00089479|7170600|FG000|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
6271162|NCT00089479|7170601|FG001|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
6271163|NCT00089479|7170600|FG000|NOT COMPLETED|Overall Study||331
6271164|NCT00089479|7170601|FG001|NOT COMPLETED|Overall Study||289
6271165|NCT00089505|7170611|FG000|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
6271166|NCT00089505|7170612|FG001|STARTED|Overall Study||120
6271167|NCT00089505|7170613|FG002|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
6271168|NCT00089505|7170614|FG003|STARTED|Overall Study||251
6271169|NCT00089505|7170611|FG000|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
6271170|NCT00089505|7170612|FG001|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
6271171|NCT00089505|7170613|FG002|COMPLETED|Overall Study||228
6271172|NCT00089505|7170614|FG003|COMPLETED|Overall Study||230
6271173|NCT00089505|7170611|FG000|NOT COMPLETED|Overall Study||9
6271174|NCT00089505|7170612|FG001|NOT COMPLETED|Overall Study||2
6271175|NCT00089505|7170613|FG002|NOT COMPLETED|Overall Study||21
6271176|NCT00089505|7170614|FG003|NOT COMPLETED|Overall Study||21
6271177|NCT00089544|7170626|FG000|STARTED|Overall Study||16
6271178|NCT00089544|7170627|FG001|STARTED|Overall Study||7
6271179|NCT00089544|7170626|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
6271180|NCT00089544|7170627|FG001|COMPLETED|Overall Study||7
6271181|NCT00089544|7170626|FG000|NOT COMPLETED|Overall Study||1
6271182|NCT00089544|7170627|FG001|NOT COMPLETED|Overall Study||0
6271183|NCT00089583|7170635|FG000|STARTED|Overall Study||20
6271184|NCT00089583|7170636|FG001|STARTED|Overall Study||89
6271185|NCT00089583|7170635|FG000|COMPLETED|Overall Study||13
6271186|NCT00089583|7170636|FG001|COMPLETED|Overall Study||51
6271187|NCT00089583|7170635|FG000|NOT COMPLETED|Overall Study||7
6271188|NCT00089583|7170636|FG001|NOT COMPLETED|Overall Study||38
6271189|NCT00089609|7170650|FG000|STARTED|Overall Study||60
6565509|NCT01818531|7488363|FG000|COMPLETED|Overall Study||74
6565510|NCT01818531|7488364|FG001|COMPLETED|Overall Study||73
6565511|NCT01818531|7488363|FG000|NOT COMPLETED|Overall Study||1
6565512|NCT01818531|7488364|FG001|NOT COMPLETED|Overall Study||2
6565513|NCT01818596|7488372|FG000|STARTED|Overall Study||246
6565514|NCT01818596|7488373|FG001|STARTED|Overall Study||6
6565515|NCT01818596|7488372|FG000|COMPLETED|Overall Study||215
6565516|NCT01818596|7488373|FG001|COMPLETED|Overall Study||6
6565517|NCT01818596|7488372|FG000|NOT COMPLETED|Overall Study||31
6565518|NCT01818596|7488373|FG001|NOT COMPLETED|Overall Study||0
6565519|NCT01818700|7488380|FG000|STARTED|Overall Study|The No. of enrolled patients|245
6565520|NCT01818700|7488380|FG000|Safety Set|Overall Study|4 subjects were not study drug administered.|241
6565521|NCT01818700|7488380|FG000|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
6656840|NCT02465372|7587195|FG001|STARTED|Overall Study||250
6656841|NCT02465372|7587194|FG000|COMPLETED|Overall Study||227
6656842|NCT02465372|7587195|FG001|COMPLETED|Overall Study||153
6656843|NCT02465372|7587194|FG000|NOT COMPLETED|Overall Study||122
6656844|NCT02465372|7587195|FG001|NOT COMPLETED|Overall Study||97
6805150|NCT02769000|7737176|FG001|STARTED|Overall Study||0
6805151|NCT02769000|7737175|FG000|COMPLETED|Overall Study||5
6805152|NCT02769000|7737176|FG001|COMPLETED|Overall Study||0
6805153|NCT02769000|7737175|FG000|NOT COMPLETED|Overall Study||0
6805154|NCT02769000|7737176|FG001|NOT COMPLETED|Overall Study||0
6805155|NCT02756208|7737184|FG000|STARTED|Overall Study||18
6805156|NCT02756208|7737185|FG001|STARTED|Overall Study||16
6805157|NCT02756208|7737186|FG002|STARTED|Overall Study||15
6805158|NCT02756208|7737187|FG003|STARTED|Overall Study||16
6623495|NCT02207907|7550635|FG001|COMPLETED|Overall Study||115
6656845|NCT02465437|7587205|FG000|STARTED|Overall Study||9
6805159|NCT02756208|7737184|FG000|COMPLETED|Overall Study||13
6805160|NCT02756208|7737185|FG001|COMPLETED|Overall Study||14
6271190|NCT00089609|7170651|FG001|STARTED|Overall Study||13
6271191|NCT00089609|7170650|FG000|COMPLETED|Overall Study||57
6271192|NCT00089609|7170651|FG001|COMPLETED|Overall Study||12
6271193|NCT00089609|7170650|FG000|NOT COMPLETED|Overall Study||3
6271194|NCT00089609|7170651|FG001|NOT COMPLETED|Overall Study||1
6271195|NCT00089635|7170660|FG000|STARTED|Overall Study||203
6271196|NCT00089635|7170660|FG000|COMPLETED|Overall Study||160
6271197|NCT00089635|7170660|FG000|NOT COMPLETED|Overall Study||43
6271198|NCT00089648|7170664|FG000|STARTED|Overall Study||61
6271199|NCT00089648|7170664|FG000|COMPLETED|Overall Study||20
6271200|NCT00089648|7170664|FG000|NOT COMPLETED|Overall Study||41
6271201|NCT00089661|7170670|FG000|STARTED|Overall Study||127
6271202|NCT00089661|7170671|FG001|STARTED|Overall Study||125
6271203|NCT00089661|7170670|FG000|COMPLETED|Overall Study||106
6271204|NCT00089661|7170671|FG001|COMPLETED|Overall Study||99
6271205|NCT00089661|7170670|FG000|NOT COMPLETED|Overall Study||21
6271206|NCT00089661|7170671|FG001|NOT COMPLETED|Overall Study||26
6271207|NCT00089674|7170679|FG000|STARTED|Overall Study||734
6271208|NCT00089674|7170680|FG001|STARTED|Overall Study||734
6271209|NCT00089674|7170679|FG000|Received Study Drug|Overall Study||730
6271210|NCT00089674|7170680|FG001|Received Study Drug|Overall Study||726
6271211|NCT00089674|7170679|FG000|COMPLETED|Overall Study||445
6271212|NCT00089674|7170680|FG001|COMPLETED|Overall Study||467
6271213|NCT00089674|7170679|FG000|NOT COMPLETED|Overall Study||289
6271214|NCT00089674|7170680|FG001|NOT COMPLETED|Overall Study||267
6271215|NCT00089752|7170688|FG000|STARTED|Overall Study||141
6271216|NCT00089752|7170689|FG001|STARTED|Overall Study||140
6271217|NCT00089752|7170688|FG000|COMPLETED|Overall Study||121
6271218|NCT00089752|7170689|FG001|COMPLETED|Overall Study||118
6271219|NCT00089752|7170688|FG000|NOT COMPLETED|Overall Study||20
6271220|NCT00089752|7170689|FG001|NOT COMPLETED|Overall Study||22
6271221|NCT00089778|7170700|FG000|STARTED|Overall Study||2
6271222|NCT00089778|7170701|FG001|STARTED|Overall Study||1
6271223|NCT00089778|7170702|FG002|STARTED|Overall Study||8
6271224|NCT00089778|7170700|FG000|COMPLETED|Overall Study||2
6271225|NCT00089778|7170701|FG001|COMPLETED|Overall Study||1
6271226|NCT00089778|7170702|FG002|COMPLETED|Overall Study||7
6271227|NCT00089778|7170700|FG000|NOT COMPLETED|Overall Study||0
6271228|NCT00089778|7170701|FG001|NOT COMPLETED|Overall Study||0
6271229|NCT00089778|7170702|FG002|NOT COMPLETED|Overall Study||1
6271230|NCT00089843|7170716|FG000|STARTED|Overall Study||19
6271231|NCT00089843|7170717|FG001|STARTED|Overall Study||20
6271232|NCT00089843|7170718|FG002|STARTED|Overall Study||20
6271233|NCT00089843|7170719|FG003|STARTED|Overall Study||18
6271234|NCT00089843|7170716|FG000|COMPLETED|Overall Study||17
6386456|NCT00810459|7297841|FG001|NOT COMPLETED|Overall Study||0
6386457|NCT00810498|7297848|FG000|STARTED|Overall Study||6
6386458|NCT00810498|7297849|FG001|STARTED|Overall Study||5
6386459|NCT00810498|7297848|FG000|COMPLETED|Overall Study||6
6386460|NCT00810498|7297849|FG001|COMPLETED|Overall Study||5
6386461|NCT00810498|7297848|FG000|NOT COMPLETED|Overall Study||0
6386462|NCT00810498|7297849|FG001|NOT COMPLETED|Overall Study||0
6386463|NCT00810511|7297857|FG000|STARTED|Overall Study||107
6386464|NCT00810511|7297858|FG001|STARTED|Overall Study||106
6386465|NCT00810511|7297857|FG000|COMPLETED|Overall Study||97
6386466|NCT00810511|7297858|FG001|COMPLETED|Overall Study||102
6386467|NCT00810511|7297857|FG000|NOT COMPLETED|Overall Study||10
6386468|NCT00810511|7297858|FG001|NOT COMPLETED|Overall Study||4
6386469|NCT00810576|7297864|FG000|STARTED|Overall Study||1
6386470|NCT00810576|7297864|FG000|COMPLETED|Overall Study||1
6386471|NCT00810576|7297864|FG000|NOT COMPLETED|Overall Study||0
6386472|NCT00810602|7297868|FG000|STARTED|Overall Study||27
6386473|NCT00810602|7297869|FG001|STARTED|Overall Study||34
6386474|NCT00810602|7297868|FG000|COMPLETED|Overall Study||19
6386475|NCT00810602|7297869|FG001|COMPLETED|Overall Study||31
6386476|NCT00810602|7297868|FG000|NOT COMPLETED|Overall Study||8
6386477|NCT00810602|7297869|FG001|NOT COMPLETED|Overall Study||3
6386478|NCT00810615|7297875|FG000|STARTED|Overall Study||25
6386479|NCT00810615|7297876|FG001|STARTED|Overall Study||25
6386480|NCT00810615|7297875|FG000|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
6386481|NCT00810615|7297876|FG001|COMPLETED|Overall Study|One male withdrawal due to personal reasons.|24
6386482|NCT00810615|7297875|FG000|NOT COMPLETED|Overall Study||1
6386483|NCT00810615|7297876|FG001|NOT COMPLETED|Overall Study||1
6386484|NCT00810641|7297897|FG000|STARTED|Overall Study||52
6271235|NCT00089843|7170717|FG001|COMPLETED|Overall Study||16
6271236|NCT00089843|7170718|FG002|COMPLETED|Overall Study||15
6271237|NCT00089843|7170719|FG003|COMPLETED|Overall Study||11
6271238|NCT00089843|7170716|FG000|NOT COMPLETED|Overall Study||2
6271239|NCT00089843|7170717|FG001|NOT COMPLETED|Overall Study||4
6271240|NCT00089843|7170718|FG002|NOT COMPLETED|Overall Study||5
6271241|NCT00089843|7170719|FG003|NOT COMPLETED|Overall Study||7
6271242|NCT00089973|7170729|FG000|STARTED|Overall Study||50
6271243|NCT00089973|7170729|FG000|COMPLETED|Overall Study||0
6271244|NCT00089973|7170729|FG000|NOT COMPLETED|Overall Study||50
6271245|NCT00089986|7170736|FG000|STARTED|Overall Study||599
6271246|NCT00089986|7170737|FG001|STARTED|Overall Study||598
6386485|NCT00810641|7297898|FG001|STARTED|Overall Study||54
6271247|NCT00089986|7170738|FG002|STARTED|Overall Study||182
6271248|NCT00089986|7170736|FG000|COMPLETED|Overall Study||584
6271249|NCT00089986|7170737|FG001|COMPLETED|Overall Study||574
6271250|NCT00089986|7170738|FG002|COMPLETED|Overall Study||172
6271251|NCT00089986|7170736|FG000|NOT COMPLETED|Overall Study||15
6271252|NCT00089986|7170737|FG001|NOT COMPLETED|Overall Study||24
6271253|NCT00089986|7170738|FG002|NOT COMPLETED|Overall Study||10
6271254|NCT00089999|7170748|FG000|STARTED|Overall Study||69
6271255|NCT00089999|7170749|FG001|STARTED|Overall Study||69
6271256|NCT00089999|7170748|FG000|COMPLETED|Overall Study||0
6271257|NCT00089999|7170749|FG001|COMPLETED|Overall Study||0
6271258|NCT00089999|7170748|FG000|NOT COMPLETED|Overall Study||69
6271259|NCT00089999|7170749|FG001|NOT COMPLETED|Overall Study||69
6271260|NCT00090051|7170758|FG000|STARTED|Overall Study||276
6271261|NCT00090051|7170759|FG001|STARTED|Overall Study||276
6271262|NCT00090051|7170758|FG000|Safety Population; Received Study Drug|Overall Study||272
6271263|NCT00090051|7170759|FG001|Safety Population; Received Study Drug|Overall Study||274
6271264|NCT00090051|7170758|FG000|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
6271265|NCT00090051|7170759|FG001|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
6271266|NCT00090051|7170758|FG000|NOT COMPLETED|Overall Study||109
6271267|NCT00090051|7170759|FG001|NOT COMPLETED|Overall Study||95
6271268|NCT00090064|7170767|FG000|STARTED|Overall Study||15
6271269|NCT00090064|7170768|FG001|STARTED|Overall Study||8
6271270|NCT00090064|7170767|FG000|COMPLETED|Overall Study||12
6271271|NCT00090064|7170768|FG001|COMPLETED|Overall Study||8
6271272|NCT00090064|7170767|FG000|NOT COMPLETED|Overall Study||3
6271273|NCT00090064|7170768|FG001|NOT COMPLETED|Overall Study||0
6271274|NCT00090103|7170780|FG000|STARTED|Four-Year Double-Blind Treatment Period||1610
6386486|NCT00810641|7297899|FG002|STARTED|Overall Study||51
6386487|NCT00810641|7297897|FG000|COMPLETED|Overall Study||52
6386488|NCT00810641|7297898|FG001|COMPLETED|Overall Study||53
6386489|NCT00810641|7297899|FG002|COMPLETED|Overall Study||49
6386490|NCT00810641|7297897|FG000|NOT COMPLETED|Overall Study||0
6386491|NCT00810641|7297898|FG001|NOT COMPLETED|Overall Study||1
6386492|NCT00810641|7297899|FG002|NOT COMPLETED|Overall Study||2
6386493|NCT00810693|7297910|FG000|STARTED|Treatment Period||254
6386494|NCT00810693|7297911|FG001|STARTED|Treatment Period|1 randomized but not treated|64
6386495|NCT00810693|7297912|FG002|STARTED|Treatment Period|1 randomized but not treated|127
6386496|NCT00810693|7297910|FG000|Participants Received Treatment|Treatment Period||254
6386497|NCT00810693|7297911|FG001|Participants Received Treatment|Treatment Period||63
6386498|NCT00810693|7297912|FG002|Participants Received Treatment|Treatment Period||126
6386499|NCT00810693|7297910|FG000|COMPLETED|Treatment Period||237
6386500|NCT00810693|7297911|FG001|COMPLETED|Treatment Period||57
6386501|NCT00810693|7297912|FG002|COMPLETED|Treatment Period||111
6386502|NCT00810693|7297910|FG000|NOT COMPLETED|Treatment Period||17
6503721|NCT01443546|7422688|FG000|COMPLETED|Overall Study||9
6503722|NCT01443546|7422689|FG001|COMPLETED|Overall Study||9
6503723|NCT01443546|7422690|FG002|COMPLETED|Overall Study||8
6503724|NCT01443546|7422688|FG000|NOT COMPLETED|Overall Study||0
6503725|NCT01443546|7422689|FG001|NOT COMPLETED|Overall Study||0
6503726|NCT01443546|7422690|FG002|NOT COMPLETED|Overall Study||0
6503727|NCT01443845|7422702|FG000|STARTED|Overall Study||1176
6503728|NCT01443845|7422703|FG001|STARTED|Overall Study||1178
6503729|NCT01443845|7422702|FG000|COMPLETED|Overall Study||922
6503730|NCT01443845|7422703|FG001|COMPLETED|Overall Study||841
6503731|NCT01443845|7422702|FG000|NOT COMPLETED|Overall Study||254
6503732|NCT01443845|7422703|FG001|NOT COMPLETED|Overall Study||337
6503733|NCT01443858|7422712|FG000|STARTED|Overall Study||25
6503734|NCT01443858|7422713|FG001|STARTED|Overall Study||25
6271275|NCT00090103|7170781|FG001|STARTED|Four-Year Double-Blind Treatment Period||1623
6271276|NCT00090103|7170782|FG002|STARTED|Four-Year Double-Blind Treatment Period||1611
6271277|NCT00090103|7170780|FG000|COMPLETED|Four-Year Double-Blind Treatment Period||1113
6271278|NCT00090103|7170781|FG001|COMPLETED|Four-Year Double-Blind Treatment Period||1093
6271279|NCT00090103|7170782|FG002|COMPLETED|Four-Year Double-Blind Treatment Period||989
6271280|NCT00090103|7170780|FG000|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
6271281|NCT00090103|7170781|FG001|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
6271282|NCT00090103|7170782|FG002|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
6271283|NCT00090103|7170780|FG000|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
6271284|NCT00090103|7170781|FG001|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
6271285|NCT00090103|7170782|FG002|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
6271286|NCT00090103|7170780|FG000|COMPLETED|16-Week Safety Follow-up Period||1224
6271287|NCT00090103|7170781|FG001|COMPLETED|16-Week Safety Follow-up Period||1205
6271288|NCT00090103|7170782|FG002|COMPLETED|16-Week Safety Follow-up Period||1143
6271289|NCT00090103|7170780|FG000|NOT COMPLETED|16-Week Safety Follow-up Period||374
6271290|NCT00090103|7170781|FG001|NOT COMPLETED|16-Week Safety Follow-up Period||410
6271291|NCT00090103|7170782|FG002|NOT COMPLETED|16-Week Safety Follow-up Period||457
6271292|NCT00090220|7170792|FG000|STARTED|Base Study Vaccination Period||1911
6271293|NCT00090220|7170793|FG001|STARTED|Base Study Vaccination Period||1908
6271294|NCT00090220|7170794|FG002|STARTED|Base Study Vaccination Period||0
6271295|NCT00090220|7170795|FG003|STARTED|Base Study Vaccination Period||0
6271296|NCT00090220|7170796|FG004|STARTED|Base Study Vaccination Period||0
6271297|NCT00090220|7170797|FG005|STARTED|Base Study Vaccination Period||0
6271298|NCT00090220|7170792|FG000|Vaccinated|Base Study Vaccination Period||1910
6271299|NCT00090220|7170793|FG001|Vaccinated|Base Study Vaccination Period||1907
6271300|NCT00090220|7170794|FG002|Vaccinated|Base Study Vaccination Period||0
6271301|NCT00090220|7170795|FG003|Vaccinated|Base Study Vaccination Period||0
6271302|NCT00090220|7170796|FG004|Vaccinated|Base Study Vaccination Period||0
6271303|NCT00090220|7170797|FG005|Vaccinated|Base Study Vaccination Period||0
6271304|NCT00090220|7170792|FG000|COMPLETED|Base Study Vaccination Period||1847
6271305|NCT00090220|7170793|FG001|COMPLETED|Base Study Vaccination Period||1845
6271306|NCT00090220|7170794|FG002|COMPLETED|Base Study Vaccination Period||0
6271307|NCT00090220|7170795|FG003|COMPLETED|Base Study Vaccination Period||0
6271308|NCT00090220|7170796|FG004|COMPLETED|Base Study Vaccination Period||0
6271309|NCT00090220|7170797|FG005|COMPLETED|Base Study Vaccination Period||0
6271310|NCT00090220|7170792|FG000|NOT COMPLETED|Base Study Vaccination Period||64
6271311|NCT00090220|7170793|FG001|NOT COMPLETED|Base Study Vaccination Period||63
6271312|NCT00090220|7170794|FG002|NOT COMPLETED|Base Study Vaccination Period||0
6271313|NCT00090220|7170795|FG003|NOT COMPLETED|Base Study Vaccination Period||0
6271314|NCT00090220|7170796|FG004|NOT COMPLETED|Base Study Vaccination Period||0
6271315|NCT00090220|7170797|FG005|NOT COMPLETED|Base Study Vaccination Period||0
6271316|NCT00090220|7170792|FG000|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
6271317|NCT00090220|7170793|FG001|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
6271318|NCT00090220|7170794|FG002|STARTED|Base Study Follow-up Period||0
6271319|NCT00090220|7170795|FG003|STARTED|Base Study Follow-up Period||0
6271320|NCT00090220|7170796|FG004|STARTED|Base Study Follow-up Period||0
6271321|NCT00090220|7170797|FG005|STARTED|Base Study Follow-up Period||0
6271322|NCT00090220|7170792|FG000|COMPLETED|Base Study Follow-up Period||1695
6271323|NCT00090220|7170793|FG001|COMPLETED|Base Study Follow-up Period||1687
6271324|NCT00090220|7170794|FG002|COMPLETED|Base Study Follow-up Period||0
6271325|NCT00090220|7170795|FG003|COMPLETED|Base Study Follow-up Period||0
6271326|NCT00090220|7170796|FG004|COMPLETED|Base Study Follow-up Period||0
6271327|NCT00090220|7170797|FG005|COMPLETED|Base Study Follow-up Period||0
6271328|NCT00090220|7170792|FG000|NOT COMPLETED|Base Study Follow-up Period||160
6271329|NCT00090220|7170793|FG001|NOT COMPLETED|Base Study Follow-up Period||164
6271330|NCT00090220|7170794|FG002|NOT COMPLETED|Base Study Follow-up Period||0
6271331|NCT00090220|7170795|FG003|NOT COMPLETED|Base Study Follow-up Period||0
6271332|NCT00090220|7170796|FG004|NOT COMPLETED|Base Study Follow-up Period||0
6271333|NCT00090220|7170797|FG005|NOT COMPLETED|Base Study Follow-up Period||0
6271334|NCT00090220|7170792|FG000|STARTED|Extension 1 (EXT1)||0
6271335|NCT00090220|7170793|FG001|STARTED|Extension 1 (EXT1)||0
6280704|NCT00159263|7180665|FG001|STARTED|Second Intervention||1
6386503|NCT00810693|7297911|FG001|NOT COMPLETED|Treatment Period||7
6386504|NCT00810693|7297912|FG002|NOT COMPLETED|Treatment Period||16
6386505|NCT00810693|7297910|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
6386506|NCT00810693|7297911|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
6386507|NCT00810693|7297912|FG002|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
6386508|NCT00810693|7297910|FG000|COMPLETED|Follow-up Period (FUP)||15
6386509|NCT00810693|7297911|FG001|COMPLETED|Follow-up Period (FUP)||4
6386510|NCT00810693|7297912|FG002|COMPLETED|Follow-up Period (FUP)||12
6386511|NCT00810693|7297910|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
6386512|NCT00810693|7297911|FG001|NOT COMPLETED|Follow-up Period (FUP)||3
6386513|NCT00810693|7297912|FG002|NOT COMPLETED|Follow-up Period (FUP)||4
6386514|NCT00810719|7297920|FG000|STARTED|Overall Study||30
6386515|NCT00810719|7297920|FG000|COMPLETED|Overall Study||30
6386516|NCT00810719|7297920|FG000|NOT COMPLETED|Overall Study||0
6386517|NCT00810771|7297927|FG000|STARTED|Overall Study||232
6386518|NCT00810771|7297928|FG001|STARTED|Overall Study||234
6386519|NCT00810771|7297929|FG002|STARTED|Overall Study||84
6386520|NCT00810771|7297927|FG000|COMPLETED|Overall Study||232
6386521|NCT00810771|7297928|FG001|COMPLETED|Overall Study||234
6386522|NCT00810771|7297929|FG002|COMPLETED|Overall Study||84
6386523|NCT00810771|7297927|FG000|NOT COMPLETED|Overall Study||0
6386524|NCT00810771|7297928|FG001|NOT COMPLETED|Overall Study||0
6386525|NCT00810771|7297929|FG002|NOT COMPLETED|Overall Study||0
6386526|NCT00810797|7297939|FG000|STARTED|Overall Study||36
6386527|NCT00810797|7297939|FG000|COMPLETED|Overall Study||36
6386528|NCT00810797|7297939|FG000|NOT COMPLETED|Overall Study||0
6386529|NCT00810810|7297947|FG000|STARTED|Overall Study||124
6386530|NCT00810810|7297948|FG001|STARTED|Overall Study||49
6386531|NCT00810810|7297949|FG002|STARTED|Overall Study||56
6386532|NCT00810810|7297950|FG003|STARTED|Overall Study||51
6386533|NCT00810810|7297947|FG000|COMPLETED|Overall Study||124
6386534|NCT00810810|7297948|FG001|COMPLETED|Overall Study||38
6386535|NCT00810810|7297949|FG002|COMPLETED|Overall Study||45
6386536|NCT00810810|7297950|FG003|COMPLETED|Overall Study||38
6386537|NCT00810810|7297947|FG000|NOT COMPLETED|Overall Study||0
6386538|NCT00810810|7297948|FG001|NOT COMPLETED|Overall Study||11
6386539|NCT00810810|7297949|FG002|NOT COMPLETED|Overall Study||11
6386540|NCT00810810|7297950|FG003|NOT COMPLETED|Overall Study||13
6386541|NCT00810888|7297963|FG000|STARTED|Overall Study||10
6386542|NCT00810888|7297964|FG001|STARTED|Overall Study||9
6386543|NCT00810888|7297965|FG002|STARTED|Overall Study||73
6386544|NCT00810888|7297963|FG000|COMPLETED|Overall Study||10
6386545|NCT00810888|7297964|FG001|COMPLETED|Overall Study||9
6271336|NCT00090220|7170794|FG002|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
6271337|NCT00090220|7170795|FG003|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
6271338|NCT00090220|7170796|FG004|STARTED|Extension 1 (EXT1)||0
6271339|NCT00090220|7170797|FG005|STARTED|Extension 1 (EXT1)||0
6271340|NCT00090220|7170792|FG000|Vaccinated|Extension 1 (EXT1)||0
6271341|NCT00090220|7170793|FG001|Vaccinated|Extension 1 (EXT1)||0
6271342|NCT00090220|7170794|FG002|Vaccinated|Extension 1 (EXT1)||1321
6271343|NCT00090220|7170795|FG003|Vaccinated|Extension 1 (EXT1)||7
6271344|NCT00090220|7170796|FG004|Vaccinated|Extension 1 (EXT1)||0
6271345|NCT00090220|7170797|FG005|Vaccinated|Extension 1 (EXT1)||0
6271346|NCT00090220|7170792|FG000|COMPLETED|Extension 1 (EXT1)||0
6271347|NCT00090220|7170793|FG001|COMPLETED|Extension 1 (EXT1)||0
6271348|NCT00090220|7170794|FG002|COMPLETED|Extension 1 (EXT1)||1267
6271349|NCT00090220|7170795|FG003|COMPLETED|Extension 1 (EXT1)||5
6271350|NCT00090220|7170796|FG004|COMPLETED|Extension 1 (EXT1)||0
6271351|NCT00090220|7170797|FG005|COMPLETED|Extension 1 (EXT1)||0
6271352|NCT00090220|7170792|FG000|NOT COMPLETED|Extension 1 (EXT1)||0
6271353|NCT00090220|7170793|FG001|NOT COMPLETED|Extension 1 (EXT1)||0
6271354|NCT00090220|7170794|FG002|NOT COMPLETED|Extension 1 (EXT1)||55
6271355|NCT00090220|7170795|FG003|NOT COMPLETED|Extension 1 (EXT1)||2
6271356|NCT00090220|7170796|FG004|NOT COMPLETED|Extension 1 (EXT1)||0
6271357|NCT00090220|7170797|FG005|NOT COMPLETED|Extension 1 (EXT1)||0
6271358|NCT00090220|7170792|FG000|STARTED|Long-term Follow-up (EXT2)||0
6271359|NCT00090220|7170793|FG001|STARTED|Long-term Follow-up (EXT2)||0
6271360|NCT00090220|7170794|FG002|STARTED|Long-term Follow-up (EXT2)||0
6271361|NCT00090220|7170795|FG003|STARTED|Long-term Follow-up (EXT2)||0
6271362|NCT00090220|7170796|FG004|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
6271363|NCT00090220|7170797|FG005|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
6271364|NCT00090220|7170792|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
6271365|NCT00090220|7170793|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
6271366|NCT00090220|7170794|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
6271367|NCT00090220|7170795|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
6271368|NCT00090220|7170796|FG004|COMPLETED|Long-term Follow-up (EXT2)||641
6271369|NCT00090220|7170797|FG005|COMPLETED|Long-term Follow-up (EXT2)||623
6271370|NCT00090220|7170792|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6271371|NCT00090220|7170793|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6271372|NCT00090220|7170794|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6271373|NCT00090220|7170795|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6271374|NCT00090220|7170796|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||44
6271375|NCT00090220|7170797|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||28
6271376|NCT00090233|7170816|FG000|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
6271377|NCT00090233|7170817|FG001|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
6271378|NCT00090233|7170816|FG000|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
6271379|NCT00090233|7170817|FG001|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
6271380|NCT00090233|7170816|FG000|Vaccinated at Visit 2|Overall Study||31052
6271381|NCT00090233|7170817|FG001|Vaccinated at Visit 2|Overall Study||31066
6565522|NCT01818700|7488380|FG000|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
6565523|NCT01818700|7488380|FG000|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
6565524|NCT01818700|7488380|FG000|NOT COMPLETED|Overall Study||104
6565525|NCT01818726|7488388|FG000|STARTED|Overall Study||10
6565526|NCT01818726|7488389|FG001|STARTED|Overall Study||5
6565527|NCT01818726|7488388|FG000|COMPLETED|Overall Study||4
6565528|NCT01818726|7488389|FG001|COMPLETED|Overall Study||3
6565529|NCT01818726|7488388|FG000|NOT COMPLETED|Overall Study||6
6565530|NCT01818726|7488389|FG001|NOT COMPLETED|Overall Study||2
6565531|NCT01818739|7488395|FG000|STARTED|Overall Study||204
6565532|NCT01818739|7488395|FG000|COMPLETED|Overall Study||204
6386546|NCT00810888|7297965|FG002|COMPLETED|Overall Study||73
6386547|NCT00810888|7297963|FG000|NOT COMPLETED|Overall Study||0
6386548|NCT00810888|7297964|FG001|NOT COMPLETED|Overall Study||0
6386549|NCT00810888|7297965|FG002|NOT COMPLETED|Overall Study||0
6386550|NCT00810901|7297975|FG000|STARTED|Overall Study||253
6386551|NCT00810901|7297976|FG001|STARTED|Overall Study||176
6386552|NCT00810901|7297975|FG000|1-month Follow up|Overall Study||242
6386553|NCT00810901|7297976|FG001|1-month Follow up|Overall Study||146
6386554|NCT00810901|7297975|FG000|6-month Follow-up|Overall Study||181
6386555|NCT00810901|7297976|FG001|6-month Follow-up|Overall Study||122
6386556|NCT00810901|7297975|FG000|COMPLETED|Overall Study||165
6386557|NCT00810901|7297976|FG001|COMPLETED|Overall Study||118
6386558|NCT00810901|7297975|FG000|NOT COMPLETED|Overall Study||88
6386559|NCT00810901|7297976|FG001|NOT COMPLETED|Overall Study||58
6386560|NCT00811018|7297982|FG000|STARTED|Overall Study||1192
6386561|NCT00811018|7297982|FG000|COMPLETED|Overall Study||224
6386562|NCT00811018|7297982|FG000|NOT COMPLETED|Overall Study||968
6386563|NCT00811057|7297989|FG000|STARTED|Overall Study||90
6386564|NCT00811057|7297990|FG001|STARTED|Overall Study||114
6565533|NCT01818739|7488395|FG000|NOT COMPLETED|Overall Study||0
6565534|NCT01818752|7488402|FG000|STARTED|Overall Study||477
6565535|NCT01818752|7488403|FG001|STARTED|Overall Study||478
6386565|NCT00811057|7297991|FG002|STARTED|Overall Study||97
6386566|NCT00811057|7297989|FG000|COMPLETED|Overall Study||85
6386567|NCT00811057|7297990|FG001|COMPLETED|Overall Study||104
6386568|NCT00811057|7297991|FG002|COMPLETED|Overall Study||87
6386569|NCT00811057|7297989|FG000|NOT COMPLETED|Overall Study||5
6386570|NCT00811057|7297990|FG001|NOT COMPLETED|Overall Study||10
6386571|NCT00811057|7297991|FG002|NOT COMPLETED|Overall Study||10
6386572|NCT00811070|7298005|FG000|STARTED|Overall Study||7
6386573|NCT00811070|7298006|FG001|STARTED|Overall Study||7
6386574|NCT00811070|7298007|FG002|STARTED|Overall Study||3
6386575|NCT00811070|7298008|FG003|STARTED|Overall Study||28
6386576|NCT00811070|7298009|FG004|STARTED|Overall Study||7
6386577|NCT00811070|7298010|FG005|STARTED|Overall Study||11
6386578|NCT00811070|7298005|FG000|COMPLETED|Overall Study||6
6386579|NCT00811070|7298006|FG001|COMPLETED|Overall Study||6
6386580|NCT00811070|7298007|FG002|COMPLETED|Overall Study||3
6386581|NCT00811070|7298008|FG003|COMPLETED|Overall Study||26
6386582|NCT00811070|7298009|FG004|COMPLETED|Overall Study||2
6386583|NCT00811070|7298010|FG005|COMPLETED|Overall Study||10
6386584|NCT00811070|7298005|FG000|NOT COMPLETED|Overall Study||1
6386585|NCT00811070|7298006|FG001|NOT COMPLETED|Overall Study||1
6386586|NCT00811070|7298007|FG002|NOT COMPLETED|Overall Study||0
6386587|NCT00811070|7298008|FG003|NOT COMPLETED|Overall Study||2
6386588|NCT00811070|7298009|FG004|NOT COMPLETED|Overall Study||5
6503735|NCT01443858|7422714|FG002|STARTED|Overall Study||25
6503736|NCT01443858|7422712|FG000|COMPLETED|Overall Study||10
6503737|NCT01443858|7422713|FG001|COMPLETED|Overall Study||12
6503738|NCT01443858|7422714|FG002|COMPLETED|Overall Study||18
6503739|NCT01443858|7422712|FG000|NOT COMPLETED|Overall Study||15
6503740|NCT01443858|7422713|FG001|NOT COMPLETED|Overall Study||13
6565536|NCT01818752|7488402|FG000|Received Treatment|Overall Study||470
6565537|NCT01818752|7488403|FG001|Received Treatment|Overall Study||474
6503741|NCT01443858|7422714|FG002|NOT COMPLETED|Overall Study||7
6503742|NCT01444027|7422725|FG000|STARTED|Overall Study||172
6503743|NCT01444027|7422726|FG001|STARTED|Overall Study||171
6503744|NCT01444027|7422727|FG002|STARTED|Overall Study||171
6503745|NCT01444027|7422725|FG000|Received Intervention as Assigned|Overall Study||168
6503746|NCT01444027|7422726|FG001|Received Intervention as Assigned|Overall Study||161
6503747|NCT01444027|7422727|FG002|Received Intervention as Assigned|Overall Study||147
6503748|NCT01444027|7422725|FG000|1 Month Follow-up|Overall Study||160
6503749|NCT01444027|7422726|FG001|1 Month Follow-up|Overall Study||159
6503750|NCT01444027|7422727|FG002|1 Month Follow-up|Overall Study||141
6503751|NCT01444027|7422725|FG000|3 Month Follow-up|Overall Study||142
6503752|NCT01444027|7422726|FG001|3 Month Follow-up|Overall Study||141
6503753|NCT01444027|7422727|FG002|3 Month Follow-up|Overall Study||133
6503754|NCT01444027|7422725|FG000|COMPLETED|Overall Study||142
6503755|NCT01444027|7422726|FG001|COMPLETED|Overall Study||141
6503756|NCT01444027|7422727|FG002|COMPLETED|Overall Study||133
6503757|NCT01444027|7422725|FG000|NOT COMPLETED|Overall Study||30
6503758|NCT01444027|7422726|FG001|NOT COMPLETED|Overall Study||30
6503759|NCT01444027|7422727|FG002|NOT COMPLETED|Overall Study||38
6503760|NCT01444287|7422735|FG000|STARTED|Period 1||22
6503761|NCT01444287|7422735|FG000|COMPLETED|Period 1||22
6503762|NCT01444287|7422735|FG000|NOT COMPLETED|Period 1||0
6503763|NCT01444287|7422735|FG000|STARTED|Period 2||22
6503764|NCT01444287|7422735|FG000|COMPLETED|Period 2||22
6503765|NCT01444287|7422735|FG000|NOT COMPLETED|Period 2||0
6503766|NCT01444287|7422735|FG000|STARTED|Period 3||22
6503767|NCT01444287|7422735|FG000|COMPLETED|Period 3||22
6503768|NCT01444287|7422735|FG000|NOT COMPLETED|Period 3||0
6386589|NCT00811070|7298010|FG005|NOT COMPLETED|Overall Study||1
6503769|NCT01444287|7422735|FG000|STARTED|Period 4||22
6503770|NCT01444287|7422735|FG000|COMPLETED|Period 4||22
6503771|NCT01444287|7422735|FG000|NOT COMPLETED|Period 4||0
6503772|NCT01444300|7422751|FG000|STARTED|Overall Study||12
6503773|NCT01444300|7422752|FG001|STARTED|Overall Study||12
6503774|NCT01444300|7422751|FG000|COMPLETED|Overall Study||8
6386590|NCT00811135|7298026|FG000|STARTED|Overall Study||88
6386591|NCT00811135|7298026|FG000|COMPLETED|Overall Study||0
6386592|NCT00811135|7298026|FG000|NOT COMPLETED|Overall Study||88
6503775|NCT01444300|7422752|FG001|COMPLETED|Overall Study||12
6503776|NCT01444300|7422751|FG000|NOT COMPLETED|Overall Study||4
6503777|NCT01444300|7422752|FG001|NOT COMPLETED|Overall Study||0
6503778|NCT01444378|7422759|FG000|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
6503779|NCT01444378|7422759|FG000|COMPLETED|Overall Study||124
6386593|NCT00811174|7298030|FG000|STARTED|Overall Study||5
6386594|NCT00811174|7298030|FG000|COMPLETED|Overall Study||2
6386595|NCT00811174|7298030|FG000|NOT COMPLETED|Overall Study||3
6386596|NCT00811187|7298036|FG000|STARTED|Overall Study||40
6386597|NCT00811187|7298037|FG001|STARTED|Overall Study||40
6386598|NCT00811187|7298036|FG000|COMPLETED|Overall Study||37
6386599|NCT00811187|7298037|FG001|COMPLETED|Overall Study||37
6386600|NCT00811187|7298036|FG000|NOT COMPLETED|Overall Study||3
6386601|NCT00811187|7298037|FG001|NOT COMPLETED|Overall Study||3
6386602|NCT00811252|7298046|FG000|STARTED|Overall Study||145
6386603|NCT00811252|7298047|FG001|STARTED|Overall Study||156
6386604|NCT00811252|7298048|FG002|STARTED|Overall Study||151
6386605|NCT00811252|7298046|FG000|COMPLETED|Overall Study||128
6386606|NCT00811252|7298047|FG001|COMPLETED|Overall Study||136
6386607|NCT00811252|7298048|FG002|COMPLETED|Overall Study||128
6386608|NCT00811252|7298046|FG000|NOT COMPLETED|Overall Study||17
6386609|NCT00811252|7298047|FG001|NOT COMPLETED|Overall Study||20
6386610|NCT00811252|7298048|FG002|NOT COMPLETED|Overall Study||23
6386611|NCT00811317|7298056|FG000|STARTED|Overall Study||11
6386612|NCT00811317|7298056|FG000|COMPLETED|Overall Study||11
6386613|NCT00811317|7298056|FG000|NOT COMPLETED|Overall Study||0
6386614|NCT00811382|7298062|FG000|STARTED|Overall Study||88
6386615|NCT00811382|7298063|FG001|STARTED|Overall Study||75
6386616|NCT00811382|7298062|FG000|COMPLETED|Overall Study||88
6386617|NCT00811382|7298063|FG001|COMPLETED|Overall Study||75
6386618|NCT00811382|7298062|FG000|NOT COMPLETED|Overall Study||0
6386619|NCT00811382|7298063|FG001|NOT COMPLETED|Overall Study||0
6386620|NCT00811395|7298077|FG000|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
6386621|NCT00811395|7298078|FG001|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
6386622|NCT00811395|7298079|FG002|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
6386623|NCT00811395|7298080|FG003|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
6386624|NCT00811395|7298081|FG004|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
6386625|NCT00811395|7298082|FG005|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
6386626|NCT00811395|7298077|FG000|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
6386627|NCT00811395|7298078|FG001|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
6386628|NCT00811395|7298079|FG002|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
6386629|NCT00811395|7298080|FG003|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
6386630|NCT00811395|7298081|FG004|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
6386631|NCT00811395|7298082|FG005|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
6386632|NCT00811395|7298077|FG000|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
6386633|NCT00811395|7298078|FG001|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
6386634|NCT00811395|7298079|FG002|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
6386635|NCT00811395|7298080|FG003|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
6386636|NCT00811395|7298081|FG004|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
6386637|NCT00811395|7298082|FG005|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
6386638|NCT00811395|7298077|FG000|STARTED|Extension Treatment|continued initial treatment|31
6386639|NCT00811395|7298078|FG001|STARTED|Extension Treatment|continued initial treatment|28
6386640|NCT00811395|7298079|FG002|STARTED|Extension Treatment|continued initial treatment|27
6386641|NCT00811395|7298080|FG003|STARTED|Extension Treatment|continued initial treatment|37
6386642|NCT00811395|7298081|FG004|STARTED|Extension Treatment|continued initial treatment|30
6386643|NCT00811395|7298082|FG005|STARTED|Extension Treatment|continued initial treatment|29
6386644|NCT00811395|7298077|FG000|COMPLETED|Extension Treatment|completed 48-week treatment|29
6386645|NCT00811395|7298078|FG001|COMPLETED|Extension Treatment|completed 48-week treatment|22
6386646|NCT00811395|7298079|FG002|COMPLETED|Extension Treatment|completed 48-week treatment|24
6386647|NCT00811395|7298080|FG003|COMPLETED|Extension Treatment|completed 48-week treatment|34
6386648|NCT00811395|7298081|FG004|COMPLETED|Extension Treatment|completed 48-week treatment|30
6386649|NCT00811395|7298082|FG005|COMPLETED|Extension Treatment|completed 48-week treatment|27
6565538|NCT01818752|7488402|FG000|COMPLETED|Overall Study|Completed treatment|290
6565539|NCT01818752|7488403|FG001|COMPLETED|Overall Study|Completed treatment|280
6565540|NCT01818752|7488402|FG000|NOT COMPLETED|Overall Study||187
6565541|NCT01818752|7488403|FG001|NOT COMPLETED|Overall Study||198
6565542|NCT01818765|7488409|FG000|STARTED|Overall Study||20
6565543|NCT01818765|7488409|FG000|COMPLETED|Overall Study||18
6565544|NCT01818765|7488409|FG000|NOT COMPLETED|Overall Study||2
6565545|NCT01818804|7488416|FG000|STARTED|Overall Study||73
6565546|NCT01818804|7488417|FG001|STARTED|Overall Study||72
6565547|NCT01818804|7488416|FG000|COMPLETED|Overall Study||68
6565548|NCT01818804|7488417|FG001|COMPLETED|Overall Study||65
6565549|NCT01818804|7488416|FG000|NOT COMPLETED|Overall Study||5
6565550|NCT01818804|7488417|FG001|NOT COMPLETED|Overall Study||7
6565551|NCT01819129|7488425|FG000|STARTED|Overall Study||345
6565552|NCT01819129|7488426|FG001|STARTED|Overall Study||344
6565553|NCT01819129|7488425|FG000|Exposed|Overall Study||341
6656846|NCT02465437|7587206|FG001|STARTED|Overall Study||9
6565554|NCT01819129|7488426|FG001|Exposed|Overall Study||341
6271382|NCT00090233|7170816|FG000|Vaccinated at Visit 3|Overall Study||29667
6271383|NCT00090233|7170817|FG001|Vaccinated at Visit 3|Overall Study||29598
6271384|NCT00090233|7170816|FG000|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
6271385|NCT00090233|7170817|FG001|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
6271386|NCT00090233|7170816|FG000|NOT COMPLETED|Overall Study||4999
6271387|NCT00090233|7170817|FG001|NOT COMPLETED|Overall Study||5065
6271388|NCT00090285|7170829|FG000|STARTED|Base Study Vaccination Period||2032
6271389|NCT00090285|7170830|FG001|STARTED|Base Study Vaccination Period||2033
6271390|NCT00090285|7170831|FG002|STARTED|Base Study Vaccination Period||0
6271391|NCT00090285|7170832|FG003|STARTED|Base Study Vaccination Period||0
6271392|NCT00090285|7170833|FG004|STARTED|Base Study Vaccination Period||0
6271393|NCT00090285|7170834|FG005|STARTED|Base Study Vaccination Period||0
6271394|NCT00090285|7170829|FG000|Vaccinated|Base Study Vaccination Period||2025
6271395|NCT00090285|7170830|FG001|Vaccinated|Base Study Vaccination Period||2030
6271396|NCT00090285|7170831|FG002|Vaccinated|Base Study Vaccination Period||0
6271397|NCT00090285|7170832|FG003|Vaccinated|Base Study Vaccination Period||0
6271398|NCT00090285|7170833|FG004|Vaccinated|Base Study Vaccination Period||0
6271399|NCT00090285|7170834|FG005|Vaccinated|Base Study Vaccination Period||0
6271400|NCT00090285|7170829|FG000|COMPLETED|Base Study Vaccination Period||1818
6271401|NCT00090285|7170830|FG001|COMPLETED|Base Study Vaccination Period||1814
6271402|NCT00090285|7170831|FG002|COMPLETED|Base Study Vaccination Period||0
6271403|NCT00090285|7170832|FG003|COMPLETED|Base Study Vaccination Period||0
6271404|NCT00090285|7170833|FG004|COMPLETED|Base Study Vaccination Period||0
6271405|NCT00090285|7170834|FG005|COMPLETED|Base Study Vaccination Period||0
6271406|NCT00090285|7170829|FG000|NOT COMPLETED|Base Study Vaccination Period||214
6271407|NCT00090285|7170830|FG001|NOT COMPLETED|Base Study Vaccination Period||219
6271408|NCT00090285|7170831|FG002|NOT COMPLETED|Base Study Vaccination Period||0
6271409|NCT00090285|7170832|FG003|NOT COMPLETED|Base Study Vaccination Period||0
6271410|NCT00090285|7170833|FG004|NOT COMPLETED|Base Study Vaccination Period||0
6271411|NCT00090285|7170834|FG005|NOT COMPLETED|Base Study Vaccination Period||0
6271412|NCT00090285|7170829|FG000|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
6271413|NCT00090285|7170830|FG001|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
6271414|NCT00090285|7170831|FG002|STARTED|Base Study Follow-up Period||0
6271415|NCT00090285|7170832|FG003|STARTED|Base Study Follow-up Period||0
6271416|NCT00090285|7170833|FG004|STARTED|Base Study Follow-up Period||0
6271417|NCT00090285|7170834|FG005|STARTED|Base Study Follow-up Period||0
6271418|NCT00090285|7170829|FG000|COMPLETED|Base Study Follow-up Period||1487
6271419|NCT00090285|7170830|FG001|COMPLETED|Base Study Follow-up Period||1479
6271420|NCT00090285|7170831|FG002|COMPLETED|Base Study Follow-up Period||0
6271421|NCT00090285|7170832|FG003|COMPLETED|Base Study Follow-up Period||0
6271422|NCT00090285|7170833|FG004|COMPLETED|Base Study Follow-up Period||0
6271423|NCT00090285|7170834|FG005|COMPLETED|Base Study Follow-up Period||0
6271424|NCT00090285|7170829|FG000|NOT COMPLETED|Base Study Follow-up Period||335
6271425|NCT00090285|7170830|FG001|NOT COMPLETED|Base Study Follow-up Period||342
6271426|NCT00090285|7170831|FG002|NOT COMPLETED|Base Study Follow-up Period||0
6271427|NCT00090285|7170832|FG003|NOT COMPLETED|Base Study Follow-up Period||0
6271428|NCT00090285|7170833|FG004|NOT COMPLETED|Base Study Follow-up Period||0
6271429|NCT00090285|7170834|FG005|NOT COMPLETED|Base Study Follow-up Period||0
6271430|NCT00090285|7170829|FG000|STARTED|Extension 1||0
6271431|NCT00090285|7170830|FG001|STARTED|Extension 1||0
6271432|NCT00090285|7170831|FG002|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
6271433|NCT00090285|7170832|FG003|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
6271434|NCT00090285|7170833|FG004|STARTED|Extension 1||0
6271435|NCT00090285|7170834|FG005|STARTED|Extension 1||0
6271436|NCT00090285|7170829|FG000|COMPLETED|Extension 1||0
6271437|NCT00090285|7170830|FG001|COMPLETED|Extension 1||0
6271438|NCT00090285|7170831|FG002|COMPLETED|Extension 1||1041
6271439|NCT00090285|7170832|FG003|COMPLETED|Extension 1||15
6271440|NCT00090285|7170833|FG004|COMPLETED|Extension 1||0
6271441|NCT00090285|7170834|FG005|COMPLETED|Extension 1||0
6271442|NCT00090285|7170829|FG000|NOT COMPLETED|Extension 1||0
6271443|NCT00090285|7170830|FG001|NOT COMPLETED|Extension 1||0
6271444|NCT00090285|7170831|FG002|NOT COMPLETED|Extension 1||57
6271445|NCT00090285|7170832|FG003|NOT COMPLETED|Extension 1||1
6271446|NCT00090285|7170833|FG004|NOT COMPLETED|Extension 1||0
6271447|NCT00090285|7170834|FG005|NOT COMPLETED|Extension 1||0
6271448|NCT00090285|7170829|FG000|STARTED|Long-term Follow-up (EXT2)||0
6271449|NCT00090285|7170830|FG001|STARTED|Long-term Follow-up (EXT2)||0
6386650|NCT00811395|7298077|FG000|NOT COMPLETED|Extension Treatment||2
6565555|NCT01819129|7488425|FG000|COMPLETED|Overall Study||301
6565556|NCT01819129|7488426|FG001|COMPLETED|Overall Study||305
6271450|NCT00090285|7170831|FG002|STARTED|Long-term Follow-up (EXT2)||0
6271451|NCT00090285|7170832|FG003|STARTED|Long-term Follow-up (EXT2)||0
6271452|NCT00090285|7170833|FG004|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|936
6271453|NCT00090285|7170834|FG005|STARTED|Long-term Follow-up (EXT2)|Not all eligible participants enrolled in LTFU (EXT2)|867
6271454|NCT00090285|7170829|FG000|COMPLETED|Long-term Follow-up (EXT2)||0
6271455|NCT00090285|7170830|FG001|COMPLETED|Long-term Follow-up (EXT2)||0
6271456|NCT00090285|7170831|FG002|COMPLETED|Long-term Follow-up (EXT2)||0
6271457|NCT00090285|7170832|FG003|COMPLETED|Long-term Follow-up (EXT2)||0
6271458|NCT00090285|7170833|FG004|COMPLETED|Long-term Follow-up (EXT2)||709
6271459|NCT00090285|7170834|FG005|COMPLETED|Long-term Follow-up (EXT2)||664
6271460|NCT00090285|7170829|FG000|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6271461|NCT00090285|7170830|FG001|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6271462|NCT00090285|7170831|FG002|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6271463|NCT00090285|7170832|FG003|NOT COMPLETED|Long-term Follow-up (EXT2)||0
6271464|NCT00090285|7170833|FG004|NOT COMPLETED|Long-term Follow-up (EXT2)||227
6271465|NCT00090285|7170834|FG005|NOT COMPLETED|Long-term Follow-up (EXT2)||203
6271466|NCT00090363|7170852|FG000|STARTED|Overall Study||107
6271467|NCT00090363|7170853|FG001|STARTED|Overall Study||107
6271468|NCT00090363|7170854|FG002|STARTED|Overall Study||98
6271469|NCT00090363|7170852|FG000|Received Study Treatment.|Overall Study||107
6271470|NCT00090363|7170853|FG001|Received Study Treatment.|Overall Study||107
6271471|NCT00090363|7170854|FG002|Received Study Treatment.|Overall Study||98
6271472|NCT00090363|7170852|FG000|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
6271473|NCT00090363|7170853|FG001|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
6271474|NCT00090363|7170854|FG002|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
6271475|NCT00090363|7170852|FG000|NOT COMPLETED|Overall Study||106
6271476|NCT00090363|7170853|FG001|NOT COMPLETED|Overall Study||107
6271477|NCT00090363|7170854|FG002|NOT COMPLETED|Overall Study||96
6271478|NCT00090402|7170865|FG000|STARTED|Overall Study||13
6271479|NCT00090402|7170866|FG001|STARTED|Overall Study||13
6271480|NCT00090402|7170867|FG002|STARTED|Overall Study||13
6271481|NCT00090402|7170865|FG000|COMPLETED|Overall Study||11
6271482|NCT00090402|7170866|FG001|COMPLETED|Overall Study||11
6271483|NCT00090402|7170867|FG002|COMPLETED|Overall Study||12
6271484|NCT00090402|7170865|FG000|NOT COMPLETED|Overall Study||2
6271485|NCT00090402|7170866|FG001|NOT COMPLETED|Overall Study||2
6271486|NCT00090402|7170867|FG002|NOT COMPLETED|Overall Study||1
6271487|NCT00090493|7170878|FG000|STARTED|Overall Study||4
6271488|NCT00090493|7170878|FG000|COMPLETED|Overall Study||2
6271489|NCT00090493|7170878|FG000|NOT COMPLETED|Overall Study||2
6271490|NCT00090519|7170884|FG000|STARTED|Overall Study||371
6271491|NCT00090519|7170885|FG001|STARTED|Overall Study||360
6271492|NCT00090519|7170884|FG000|COMPLETED|Overall Study||298
6271493|NCT00090519|7170885|FG001|COMPLETED|Overall Study||285
6271494|NCT00090519|7170884|FG000|NOT COMPLETED|Overall Study||73
6271495|NCT00090519|7170885|FG001|NOT COMPLETED|Overall Study||75
6271496|NCT00090545|7170893|FG000|STARTED|Overall Study||22
6271497|NCT00090545|7170894|FG001|STARTED|Overall Study||24
6271498|NCT00090545|7170893|FG000|COMPLETED|Overall Study||0
6271499|NCT00090545|7170894|FG001|COMPLETED|Overall Study||0
6271500|NCT00090545|7170893|FG000|NOT COMPLETED|Overall Study||22
6271501|NCT00090545|7170894|FG001|NOT COMPLETED|Overall Study||24
6271502|NCT00090584|7170904|FG000|STARTED|Baseline to 10 Weeks||154
6271503|NCT00090584|7170905|FG001|STARTED|Baseline to 10 Weeks||153
6271504|NCT00090584|7170904|FG000|COMPLETED|Baseline to 10 Weeks||139
6271505|NCT00090584|7170905|FG001|COMPLETED|Baseline to 10 Weeks||141
6271506|NCT00090584|7170904|FG000|NOT COMPLETED|Baseline to 10 Weeks||15
6271507|NCT00090584|7170905|FG001|NOT COMPLETED|Baseline to 10 Weeks||12
6271508|NCT00090584|7170904|FG000|STARTED|Baseline to 8 Months||154
6271509|NCT00090584|7170905|FG001|STARTED|Baseline to 8 Months||153
6271510|NCT00090584|7170904|FG000|COMPLETED|Baseline to 8 Months||110
6271511|NCT00090584|7170905|FG001|COMPLETED|Baseline to 8 Months||112
6271512|NCT00090584|7170904|FG000|NOT COMPLETED|Baseline to 8 Months||44
6271513|NCT00090584|7170905|FG001|NOT COMPLETED|Baseline to 8 Months||41
6271514|NCT00090610|7170921|FG000|STARTED|Overall Study||75
6271515|NCT00090610|7170922|FG001|STARTED|Overall Study||75
6271516|NCT00090610|7170921|FG000|COMPLETED|Overall Study||74
6271517|NCT00090610|7170922|FG001|COMPLETED|Overall Study||74
6271518|NCT00090610|7170921|FG000|NOT COMPLETED|Overall Study||1
6271519|NCT00090610|7170922|FG001|NOT COMPLETED|Overall Study||1
6271520|NCT00090753|7170930|FG000|STARTED|First Treatment Period||748
6271521|NCT00090753|7170931|FG001|STARTED|First Treatment Period||480
6271522|NCT00090753|7170930|FG000|COMPLETED|First Treatment Period||492
6271523|NCT00090753|7170931|FG001|COMPLETED|First Treatment Period||302
6271524|NCT00090753|7170930|FG000|NOT COMPLETED|First Treatment Period||256
6271525|NCT00090753|7170931|FG001|NOT COMPLETED|First Treatment Period||178
6271526|NCT00090753|7170930|FG000|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
6271527|NCT00090753|7170931|FG001|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
6271528|NCT00090753|7170930|FG000|COMPLETED|Extended Treatment Period||94
6271529|NCT00090753|7170931|FG001|COMPLETED|Extended Treatment Period||59
6271530|NCT00090753|7170930|FG000|NOT COMPLETED|Extended Treatment Period||359
6271531|NCT00090753|7170931|FG001|NOT COMPLETED|Extended Treatment Period||191
6271532|NCT00090766|7170940|FG000|STARTED|Overall Study||17
6271533|NCT00090766|7170941|FG001|STARTED|Overall Study||21
6271534|NCT00090766|7170942|FG002|STARTED|Overall Study||25
6386651|NCT00811395|7298078|FG001|NOT COMPLETED|Extension Treatment||6
6386652|NCT00811395|7298079|FG002|NOT COMPLETED|Extension Treatment||3
6386653|NCT00811395|7298080|FG003|NOT COMPLETED|Extension Treatment||3
6386654|NCT00811395|7298081|FG004|NOT COMPLETED|Extension Treatment||0
6386655|NCT00811395|7298082|FG005|NOT COMPLETED|Extension Treatment||2
6386656|NCT00811434|7298099|FG000|STARTED|First Intervention||7
6386657|NCT00811434|7298100|FG001|STARTED|First Intervention||5
6386658|NCT00811434|7298099|FG000|COMPLETED|First Intervention||4
6386659|NCT00811434|7298100|FG001|COMPLETED|First Intervention||5
6386660|NCT00811434|7298099|FG000|NOT COMPLETED|First Intervention||3
6386661|NCT00811434|7298100|FG001|NOT COMPLETED|First Intervention||0
6386662|NCT00811434|7298099|FG000|STARTED|Washout (1 Month)||4
6386663|NCT00811434|7298100|FG001|STARTED|Washout (1 Month)||5
6503780|NCT01444378|7422759|FG000|NOT COMPLETED|Overall Study||17
6503781|NCT01444391|7422766|FG000|STARTED|Overall Study||42
6503782|NCT01444391|7422766|FG000|COMPLETED|Overall Study||41
6503783|NCT01444391|7422766|FG000|NOT COMPLETED|Overall Study||1
6503784|NCT01444417|7422772|FG000|STARTED|Overall Study||20
6386664|NCT00811434|7298099|FG000|COMPLETED|Washout (1 Month)||4
6386665|NCT00811434|7298100|FG001|COMPLETED|Washout (1 Month)||5
6503785|NCT01444417|7422773|FG001|STARTED|Overall Study||42
6386666|NCT00811434|7298099|FG000|NOT COMPLETED|Washout (1 Month)||0
6386667|NCT00811434|7298100|FG001|NOT COMPLETED|Washout (1 Month)||0
6386668|NCT00811434|7298099|FG000|STARTED|Second Intervention||4
6386669|NCT00811434|7298100|FG001|STARTED|Second Intervention||5
6386670|NCT00811434|7298099|FG000|COMPLETED|Second Intervention||4
6386671|NCT00811434|7298100|FG001|COMPLETED|Second Intervention||5
6386672|NCT00811434|7298099|FG000|NOT COMPLETED|Second Intervention||0
6386673|NCT00811434|7298100|FG001|NOT COMPLETED|Second Intervention||0
6386674|NCT00811473|7298109|FG000|STARTED|Overall Study||93
6386675|NCT00811473|7298110|FG001|STARTED|Overall Study||100
6386676|NCT00811473|7298109|FG000|COMPLETED|Overall Study||70
6386677|NCT00811473|7298110|FG001|COMPLETED|Overall Study||74
6386678|NCT00811473|7298109|FG000|NOT COMPLETED|Overall Study||23
6386679|NCT00811473|7298110|FG001|NOT COMPLETED|Overall Study||26
6386680|NCT00811564|7298118|FG000|STARTED|Overall Study||73
6386681|NCT00811564|7298119|FG001|STARTED|Overall Study||75
6386682|NCT00811564|7298118|FG000|COMPLETED|Overall Study||64
6386683|NCT00811564|7298119|FG001|COMPLETED|Overall Study||73
6386684|NCT00811564|7298118|FG000|NOT COMPLETED|Overall Study||9
6386685|NCT00811564|7298119|FG001|NOT COMPLETED|Overall Study||2
6386686|NCT00811577|7298127|FG000|STARTED|Overall Study||126
6386687|NCT00811577|7298128|FG001|STARTED|Overall Study||24
6386688|NCT00811577|7298127|FG000|COMPLETED|Overall Study||116
6386689|NCT00811577|7298128|FG001|COMPLETED|Overall Study||23
6386690|NCT00811577|7298127|FG000|NOT COMPLETED|Overall Study||10
6386691|NCT00811577|7298128|FG001|NOT COMPLETED|Overall Study||1
6386692|NCT00811642|7298177|FG000|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
6386693|NCT00811642|7298177|FG000|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
6386694|NCT00811642|7298177|FG000|NOT COMPLETED|Overall Study||15
6386695|NCT00811655|7298181|FG000|STARTED|Overall Study||6
6386696|NCT00811655|7298181|FG000|COMPLETED|Overall Study||5
6386697|NCT00811655|7298181|FG000|NOT COMPLETED|Overall Study||1
6386698|NCT00811720|7298187|FG000|STARTED|All Randomised Patients||298
6386699|NCT00811720|7298188|FG001|STARTED|All Randomised Patients||306
6386700|NCT00811720|7298187|FG000|COMPLETED|All Randomised Patients||296
6386701|NCT00811720|7298188|FG001|COMPLETED|All Randomised Patients||302
6386702|NCT00811720|7298187|FG000|NOT COMPLETED|All Randomised Patients||2
6386703|NCT00811720|7298188|FG001|NOT COMPLETED|All Randomised Patients||4
6386704|NCT00811720|7298187|FG000|STARTED|All Treated Patients||296
6386705|NCT00811720|7298188|FG001|STARTED|All Treated Patients||302
6386706|NCT00811720|7298187|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
6386707|NCT00811720|7298188|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
6386708|NCT00811720|7298187|FG000|NOT COMPLETED|All Treated Patients||96
6386709|NCT00811720|7298188|FG001|NOT COMPLETED|All Treated Patients||164
6386710|NCT00811733|7298196|FG000|STARTED|Overall Study||15
6386711|NCT00811733|7298197|FG001|STARTED|Overall Study||22
6386712|NCT00811733|7298196|FG000|COMPLETED|Overall Study||4
6386713|NCT00811733|7298197|FG001|COMPLETED|Overall Study||12
6386714|NCT00811733|7298196|FG000|NOT COMPLETED|Overall Study||11
6386715|NCT00811733|7298197|FG001|NOT COMPLETED|Overall Study||10
6386716|NCT00811798|7298203|FG000|STARTED|Overall Study||92
6386717|NCT00811798|7298203|FG000|COMPLETED|Overall Study||92
6386718|NCT00811798|7298203|FG000|NOT COMPLETED|Overall Study||0
6386719|NCT00811850|7298207|FG000|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
6386720|NCT00811850|7298207|FG000|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
6386721|NCT00811850|7298207|FG000|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
6386722|NCT00811850|7298207|FG000|STARTED|Treatment Period 2: Wash Out||15
6386723|NCT00811850|7298207|FG000|COMPLETED|Treatment Period 2: Wash Out||15
6386724|NCT00811850|7298207|FG000|NOT COMPLETED|Treatment Period 2: Wash Out||0
6386725|NCT00811850|7298207|FG000|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
6386726|NCT00811850|7298207|FG000|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
6386727|NCT00811850|7298207|FG000|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
6386728|NCT00811928|7298215|FG000|STARTED|Overall Study||129
6386729|NCT00811928|7298216|FG001|STARTED|Overall Study||123
6656847|NCT02465437|7587207|FG002|STARTED|Overall Study||9
6386730|NCT00811928|7298215|FG000|COMPLETED|Overall Study||90
6386731|NCT00811928|7298216|FG001|COMPLETED|Overall Study||90
6386732|NCT00811928|7298215|FG000|NOT COMPLETED|Overall Study||39
6386733|NCT00811928|7298216|FG001|NOT COMPLETED|Overall Study||33
6386734|NCT00811941|7298224|FG000|STARTED|All Randomised Patients||166
6386735|NCT00811941|7298225|FG001|STARTED|All Randomised Patients||509
6386736|NCT00811941|7298224|FG000|COMPLETED|All Randomised Patients||164
6386737|NCT00811941|7298225|FG001|COMPLETED|All Randomised Patients||501
6386738|NCT00811941|7298224|FG000|NOT COMPLETED|All Randomised Patients||2
6386739|NCT00811941|7298225|FG001|NOT COMPLETED|All Randomised Patients||8
6386740|NCT00811941|7298224|FG000|STARTED|All Treated Patients||164
6386741|NCT00811941|7298225|FG001|STARTED|All Treated Patients||501
6503786|NCT01444417|7422772|FG000|Received Treatment|Overall Study||19
6503787|NCT01444417|7422773|FG001|Received Treatment|Overall Study||42
6565557|NCT01819129|7488425|FG000|NOT COMPLETED|Overall Study||44
6565558|NCT01819129|7488426|FG001|NOT COMPLETED|Overall Study||39
6565559|NCT01819194|7488432|FG000|STARTED|Overall Study||62
6565560|NCT01819194|7488432|FG000|COMPLETED|Overall Study||60
6565561|NCT01819194|7488432|FG000|NOT COMPLETED|Overall Study||2
6565562|NCT01819233|7488436|FG000|STARTED|Overall Study||38
6565563|NCT01819233|7488436|FG000|COMPLETED|Overall Study||32
6565564|NCT01819233|7488436|FG000|NOT COMPLETED|Overall Study||6
6565565|NCT01819272|7488446|FG000|STARTED|Overall Study||41
6565566|NCT01819272|7488447|FG001|STARTED|Overall Study||39
6565567|NCT01819272|7488448|FG002|STARTED|Overall Study||40
6565568|NCT01819272|7488449|FG003|STARTED|Overall Study||40
6565569|NCT01819272|7488450|FG004|STARTED|Overall Study||40
6565570|NCT01819272|7488451|FG005|STARTED|Overall Study||40
6565571|NCT01819272|7488446|FG000|COMPLETED|Overall Study||35
6565572|NCT01819272|7488447|FG001|COMPLETED|Overall Study||36
6565573|NCT01819272|7488448|FG002|COMPLETED|Overall Study||37
6565574|NCT01819272|7488449|FG003|COMPLETED|Overall Study||35
6565575|NCT01819272|7488450|FG004|COMPLETED|Overall Study||36
6565576|NCT01819272|7488451|FG005|COMPLETED|Overall Study||33
6565577|NCT01819272|7488446|FG000|NOT COMPLETED|Overall Study||6
6565578|NCT01819272|7488447|FG001|NOT COMPLETED|Overall Study||3
6271535|NCT00090766|7170940|FG000|COMPLETED|Overall Study||14
6386742|NCT00811941|7298224|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
6386743|NCT00811941|7298225|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
6386744|NCT00811941|7298224|FG000|NOT COMPLETED|All Treated Patients||52
6386745|NCT00811941|7298225|FG001|NOT COMPLETED|All Treated Patients||191
6386746|NCT00811954|7298234|FG000|STARTED|Overall Study||605
6386747|NCT00811954|7298235|FG001|STARTED|Overall Study||603
6386748|NCT00811954|7298236|FG002|STARTED|Overall Study||601
6386749|NCT00811954|7298234|FG000|COMPLETED|Overall Study||516
6386750|NCT00811954|7298235|FG001|COMPLETED|Overall Study||531
6386751|NCT00811954|7298236|FG002|COMPLETED|Overall Study||500
6386752|NCT00811954|7298234|FG000|NOT COMPLETED|Overall Study||89
6386753|NCT00811954|7298235|FG001|NOT COMPLETED|Overall Study||72
6386754|NCT00811954|7298236|FG002|NOT COMPLETED|Overall Study||101
6386755|NCT00812097|7298248|FG000|STARTED|Overall Study||572
6386756|NCT00812097|7298249|FG001|STARTED|Overall Study||190
6386757|NCT00812097|7298250|FG002|STARTED|Overall Study||124
6386758|NCT00812097|7298251|FG003|STARTED|Overall Study||69
6386759|NCT00812097|7298248|FG000|COMPLETED|Overall Study||327
6386760|NCT00812097|7298249|FG001|COMPLETED|Overall Study||101
6386761|NCT00812097|7298250|FG002|COMPLETED|Overall Study||67
6386762|NCT00812097|7298251|FG003|COMPLETED|Overall Study||34
6386763|NCT00812097|7298248|FG000|NOT COMPLETED|Overall Study||245
6386764|NCT00812097|7298249|FG001|NOT COMPLETED|Overall Study||89
6386765|NCT00812097|7298250|FG002|NOT COMPLETED|Overall Study||57
6386766|NCT00812097|7298251|FG003|NOT COMPLETED|Overall Study||35
6386767|NCT00812110|7298261|FG000|STARTED|Overall Study||292
6386768|NCT00812110|7298261|FG000|COMPLETED|Overall Study||292
6386769|NCT00812110|7298261|FG000|NOT COMPLETED|Overall Study||0
6386770|NCT00812253|7298267|FG000|STARTED|Overall Study||32
6386771|NCT00812253|7298268|FG001|STARTED|Overall Study||42
6386772|NCT00812253|7298267|FG000|COMPLETED|Overall Study||26
6386773|NCT00812253|7298268|FG001|COMPLETED|Overall Study||39
6386774|NCT00812253|7298267|FG000|NOT COMPLETED|Overall Study||6
6565579|NCT01819272|7488448|FG002|NOT COMPLETED|Overall Study||3
6565580|NCT01819272|7488449|FG003|NOT COMPLETED|Overall Study||5
6565581|NCT01819272|7488450|FG004|NOT COMPLETED|Overall Study||4
6565582|NCT01819272|7488451|FG005|NOT COMPLETED|Overall Study||7
6565583|NCT01819311|7488467|FG000|STARTED|Treatment Phase (4 Weeks)||33
6386775|NCT00812253|7298268|FG001|NOT COMPLETED|Overall Study||3
6386776|NCT00812331|7298279|FG000|STARTED|Overall Study||6
6386777|NCT00812331|7298280|FG001|STARTED|Overall Study||8
6386778|NCT00812331|7298281|FG002|STARTED|Overall Study||8
6386779|NCT00812331|7298282|FG003|STARTED|Overall Study||7
6386780|NCT00812331|7298283|FG004|STARTED|Overall Study||8
6386781|NCT00812331|7298279|FG000|COMPLETED|Overall Study||5
6386782|NCT00812331|7298280|FG001|COMPLETED|Overall Study||8
6386783|NCT00812331|7298281|FG002|COMPLETED|Overall Study||8
6565584|NCT01819311|7488468|FG001|STARTED|Treatment Phase (4 Weeks)||31
6565585|NCT01819311|7488467|FG000|COMPLETED|Treatment Phase (4 Weeks)||31
6271536|NCT00090766|7170941|FG001|COMPLETED|Overall Study||19
6271537|NCT00090766|7170942|FG002|COMPLETED|Overall Study||22
6271538|NCT00090766|7170940|FG000|NOT COMPLETED|Overall Study||3
6271539|NCT00090766|7170941|FG001|NOT COMPLETED|Overall Study||2
6271540|NCT00090766|7170942|FG002|NOT COMPLETED|Overall Study||3
6271541|NCT00090779|7170954|FG000|STARTED|Step 1||66
6271542|NCT00090779|7170955|FG001|STARTED|Step 1||64
6271543|NCT00090779|7170954|FG000|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
6271544|NCT00090779|7170955|FG001|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
6271545|NCT00090779|7170954|FG000|NOT COMPLETED|Step 1||11
6271546|NCT00090779|7170955|FG001|NOT COMPLETED|Step 1||15
6386784|NCT00812331|7298282|FG003|COMPLETED|Overall Study||7
6386785|NCT00812331|7298283|FG004|COMPLETED|Overall Study||8
6386786|NCT00812331|7298279|FG000|NOT COMPLETED|Overall Study||1
6386787|NCT00812331|7298280|FG001|NOT COMPLETED|Overall Study||0
6386788|NCT00812331|7298281|FG002|NOT COMPLETED|Overall Study||0
6386789|NCT00812331|7298282|FG003|NOT COMPLETED|Overall Study||0
6386790|NCT00812331|7298283|FG004|NOT COMPLETED|Overall Study||0
6386791|NCT00812461|7298293|FG000|STARTED|All Randomised Patients||360
6386792|NCT00812461|7298294|FG001|STARTED|All Randomised Patients||358
6386793|NCT00812461|7298293|FG000|COMPLETED|All Randomised Patients||337
6386794|NCT00812461|7298294|FG001|COMPLETED|All Randomised Patients||341
6386795|NCT00812461|7298293|FG000|NOT COMPLETED|All Randomised Patients||23
6386796|NCT00812461|7298294|FG001|NOT COMPLETED|All Randomised Patients||17
6386797|NCT00812461|7298293|FG000|STARTED|All Treated Patients||337
6386798|NCT00812461|7298294|FG001|STARTED|All Treated Patients||341
6386799|NCT00812461|7298293|FG000|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
6386800|NCT00812461|7298294|FG001|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
6386801|NCT00812461|7298293|FG000|NOT COMPLETED|All Treated Patients||132
6386802|NCT00812461|7298294|FG001|NOT COMPLETED|All Treated Patients||147
6386803|NCT00812487|7298302|FG000|STARTED|Overall Study||32
6386804|NCT00812487|7298303|FG001|STARTED|Overall Study||42
6386805|NCT00812487|7298302|FG000|COMPLETED|Overall Study||26
6386806|NCT00812487|7298303|FG001|COMPLETED|Overall Study||39
6386807|NCT00812487|7298302|FG000|NOT COMPLETED|Overall Study||6
6386808|NCT00812487|7298303|FG001|NOT COMPLETED|Overall Study||3
6386809|NCT00812565|7298317|FG000|STARTED|Overall Study||8
6386810|NCT00812565|7298318|FG001|STARTED|Overall Study||7
6386811|NCT00812565|7298319|FG002|STARTED|Overall Study||7
6386812|NCT00812565|7298320|FG003|STARTED|Overall Study||7
6386813|NCT00812565|7298321|FG004|STARTED|Overall Study||7
6386814|NCT00812565|7298322|FG005|STARTED|Overall Study||7
6386815|NCT00812565|7298323|FG006|STARTED|Overall Study||8
6386816|NCT00812565|7298324|FG007|STARTED|Overall Study||7
6386817|NCT00812565|7298317|FG000|COMPLETED|Overall Study||5
6386818|NCT00812565|7298318|FG001|COMPLETED|Overall Study||6
6386819|NCT00812565|7298319|FG002|COMPLETED|Overall Study||7
6386820|NCT00812565|7298320|FG003|COMPLETED|Overall Study||5
6386821|NCT00812565|7298321|FG004|COMPLETED|Overall Study||6
6386822|NCT00812565|7298322|FG005|COMPLETED|Overall Study||6
6386823|NCT00812565|7298323|FG006|COMPLETED|Overall Study||8
6386824|NCT00812565|7298324|FG007|COMPLETED|Overall Study||6
6386825|NCT00812565|7298317|FG000|NOT COMPLETED|Overall Study||3
6386826|NCT00812565|7298318|FG001|NOT COMPLETED|Overall Study||1
6386827|NCT00812565|7298319|FG002|NOT COMPLETED|Overall Study||0
6386828|NCT00812565|7298320|FG003|NOT COMPLETED|Overall Study||2
6386829|NCT00812565|7298321|FG004|NOT COMPLETED|Overall Study||1
6386830|NCT00812565|7298322|FG005|NOT COMPLETED|Overall Study||1
6271547|NCT00090779|7170954|FG000|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
6271548|NCT00090779|7170955|FG001|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
6271549|NCT00090779|7170954|FG000|COMPLETED|Step 2||0
6271550|NCT00090779|7170955|FG001|COMPLETED|Step 2||1
6271551|NCT00090779|7170954|FG000|NOT COMPLETED|Step 2||6
6271552|NCT00090779|7170955|FG001|NOT COMPLETED|Step 2||18
6271553|NCT00090779|7170954|FG000|STARTED|Step 3||7
6271554|NCT00090779|7170955|FG001|STARTED|Step 3||5
6271555|NCT00090779|7170954|FG000|COMPLETED|Step 3||0
6271556|NCT00090779|7170955|FG001|COMPLETED|Step 3||0
6271557|NCT00090779|7170954|FG000|NOT COMPLETED|Step 3||7
6271558|NCT00090779|7170955|FG001|NOT COMPLETED|Step 3||5
6271559|NCT00090844|7170963|FG000|STARTED|Overall Study||27
6271560|NCT00090844|7170964|FG001|STARTED|Overall Study||22
6271561|NCT00090844|7170963|FG000|COMPLETED|Overall Study||26
6271562|NCT00090844|7170964|FG001|COMPLETED|Overall Study||21
6271563|NCT00090844|7170963|FG000|NOT COMPLETED|Overall Study||1
6271564|NCT00090844|7170964|FG001|NOT COMPLETED|Overall Study||1
6271565|NCT00090857|7170973|FG000|STARTED|Overall Study||33
6271566|NCT00090857|7170974|FG001|STARTED|Overall Study||16
6271567|NCT00090857|7170973|FG000|COMPLETED|Overall Study||29
6271568|NCT00090857|7170974|FG001|COMPLETED|Overall Study||13
6271569|NCT00090857|7170973|FG000|NOT COMPLETED|Overall Study||4
6271570|NCT00090857|7170974|FG001|NOT COMPLETED|Overall Study||3
6271571|NCT00090987|7170980|FG000|STARTED|Overall Study||30
6271572|NCT00090987|7170980|FG000|COMPLETED|Overall Study||9
6271573|NCT00090987|7170980|FG000|NOT COMPLETED|Overall Study||21
6271574|NCT00091026|7170986|FG000|STARTED|Overall Study||72
6271575|NCT00091026|7170987|FG001|STARTED|Overall Study||71
6271576|NCT00091026|7170986|FG000|COMPLETED|Overall Study||71
6271577|NCT00091026|7170987|FG001|COMPLETED|Overall Study||68
6271578|NCT00091026|7170986|FG000|NOT COMPLETED|Overall Study||1
6271579|NCT00091026|7170987|FG001|NOT COMPLETED|Overall Study||3
6271580|NCT00091169|7170995|FG000|STARTED|Overall Study||189
6271581|NCT00091169|7170996|FG001|STARTED|Overall Study||187
6271582|NCT00091169|7170995|FG000|Treated|Overall Study||163
6271583|NCT00091169|7170996|FG001|Treated|Overall Study||170
6271584|NCT00091169|7170995|FG000|COMPLETED|Overall Study||132
6271585|NCT00091169|7170996|FG001|COMPLETED|Overall Study||134
6271586|NCT00091169|7170995|FG000|NOT COMPLETED|Overall Study||57
6271587|NCT00091169|7170996|FG001|NOT COMPLETED|Overall Study||53
6271588|NCT00091260|7171004|FG000|STARTED|Overall Study||82
6271589|NCT00091260|7171004|FG000|COMPLETED|Overall Study||82
6271590|NCT00091260|7171004|FG000|NOT COMPLETED|Overall Study||0
6271591|NCT00091273|7171009|FG000|STARTED|Overall Study||9
6271592|NCT00091273|7171009|FG000|COMPLETED|Overall Study||9
6271593|NCT00091273|7171009|FG000|NOT COMPLETED|Overall Study||0
6271594|NCT00091390|7171013|FG000|STARTED|Overall Study||129
6271595|NCT00091390|7171013|FG000|Eligible and Started Study Treatment|Overall Study||125
6271596|NCT00091390|7171013|FG000|Eligible, Started Treatment, Has AE Data|Overall Study||115
6271597|NCT00091390|7171013|FG000|COMPLETED|Overall Study|Subjects contributing data to results are considered to have completed the study.|125
6271598|NCT00091390|7171013|FG000|NOT COMPLETED|Overall Study||4
6271599|NCT00091442|7171019|FG000|STARTED|Overall Study||373
6271600|NCT00091442|7171020|FG001|STARTED|Overall Study||378
6271601|NCT00091442|7171019|FG000|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
6271602|NCT00091442|7171020|FG001|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
6271603|NCT00091442|7171019|FG000|NOT COMPLETED|Overall Study||369
6271604|NCT00091442|7171020|FG001|NOT COMPLETED|Overall Study||373
6271605|NCT00091507|7171028|FG000|STARTED|Overall Study||432
6271606|NCT00091507|7171029|FG001|STARTED|Overall Study||479
6271607|NCT00091507|7171028|FG000|COMPLETED|Overall Study||411
6271608|NCT00091507|7171029|FG001|COMPLETED|Overall Study||460
6271609|NCT00091507|7171028|FG000|NOT COMPLETED|Overall Study||21
6271610|NCT00091507|7171029|FG001|NOT COMPLETED|Overall Study||19
6271611|NCT00091572|7171037|FG000|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
6271612|NCT00091572|7171038|FG001|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
6271613|NCT00091572|7171037|FG000|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
6271614|NCT00091572|7171038|FG001|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
6271615|NCT00091572|7171037|FG000|NOT COMPLETED|Overall Study||95
6271616|NCT00091572|7171038|FG001|NOT COMPLETED|Overall Study||82
6271617|NCT00091793|7171046|FG000|STARTED|Overall Study||166
6271618|NCT00091793|7171047|FG001|STARTED|Overall Study||166
6271619|NCT00091793|7171046|FG000|COMPLETED|Overall Study||142
6271620|NCT00091793|7171047|FG001|COMPLETED|Overall Study||144
6271621|NCT00091793|7171046|FG000|NOT COMPLETED|Overall Study||24
6271622|NCT00091793|7171047|FG001|NOT COMPLETED|Overall Study||22
6386831|NCT00812565|7298323|FG006|NOT COMPLETED|Overall Study||0
6386832|NCT00812565|7298324|FG007|NOT COMPLETED|Overall Study||1
6386833|NCT00812604|7298344|FG000|STARTED|Overall Study||28
6386834|NCT00812604|7298345|FG001|STARTED|Overall Study||27
6386835|NCT00812604|7298344|FG000|COMPLETED|Overall Study||23
6386836|NCT00812604|7298345|FG001|COMPLETED|Overall Study||22
6386837|NCT00812604|7298344|FG000|NOT COMPLETED|Overall Study||5
6386838|NCT00812604|7298345|FG001|NOT COMPLETED|Overall Study||5
6386839|NCT00812812|7298353|FG000|STARTED|Overall Study||27
6386840|NCT00812812|7298354|FG001|STARTED|Overall Study||29
6386841|NCT00812812|7298353|FG000|COMPLETED|Overall Study||24
6386842|NCT00812812|7298354|FG001|COMPLETED|Overall Study||25
6386843|NCT00812812|7298353|FG000|NOT COMPLETED|Overall Study||3
6386844|NCT00812812|7298354|FG001|NOT COMPLETED|Overall Study||4
6386845|NCT00812838|7298364|FG000|STARTED|Treatment Period of 16 Weeks||6
6386846|NCT00812838|7298365|FG001|STARTED|Treatment Period of 16 Weeks||6
6386847|NCT00812838|7298364|FG000|COMPLETED|Treatment Period of 16 Weeks||6
6386848|NCT00812838|7298365|FG001|COMPLETED|Treatment Period of 16 Weeks||6
6386849|NCT00812838|7298364|FG000|NOT COMPLETED|Treatment Period of 16 Weeks||0
6386850|NCT00812838|7298365|FG001|NOT COMPLETED|Treatment Period of 16 Weeks||0
6386851|NCT00812838|7298364|FG000|STARTED|Optional Crossover of 16 Weeks||0
6386852|NCT00812838|7298365|FG001|STARTED|Optional Crossover of 16 Weeks||4
6386853|NCT00812838|7298364|FG000|COMPLETED|Optional Crossover of 16 Weeks||0
6386854|NCT00812838|7298365|FG001|COMPLETED|Optional Crossover of 16 Weeks||4
6386855|NCT00812838|7298364|FG000|NOT COMPLETED|Optional Crossover of 16 Weeks||0
6386856|NCT00812838|7298365|FG001|NOT COMPLETED|Optional Crossover of 16 Weeks||0
6386857|NCT00812877|7298375|FG000|STARTED|Overall Study||195
6386858|NCT00812877|7298376|FG001|STARTED|Overall Study||181
6386859|NCT00812877|7298375|FG000|COMPLETED|Overall Study||158
6386860|NCT00812877|7298376|FG001|COMPLETED|Overall Study||130
6386861|NCT00812877|7298375|FG000|NOT COMPLETED|Overall Study||37
6386862|NCT00812877|7298376|FG001|NOT COMPLETED|Overall Study||51
6386863|NCT00812916|7298382|FG000|STARTED|Overall Study|206 enrolled (consented)|206
6386864|NCT00812916|7298382|FG000|Data Available|Overall Study||205
6386865|NCT00812916|7298382|FG000|CFAE - Guided Ablation|Overall Study||203
6386866|NCT00812916|7298382|FG000|COMPLETED|Overall Study||203
6503788|NCT01444417|7422772|FG000|COMPLETED|Overall Study||18
6503789|NCT01444417|7422773|FG001|COMPLETED|Overall Study||41
6503790|NCT01444417|7422772|FG000|NOT COMPLETED|Overall Study||2
6503791|NCT01444417|7422773|FG001|NOT COMPLETED|Overall Study||1
6503792|NCT01444430|7422781|FG000|STARTED|Overall Study||5846
6503793|NCT01444430|7422782|FG001|STARTED|Overall Study||5847
6503794|NCT01444430|7422781|FG000|COMPLETED|Overall Study||5785
6503795|NCT01444430|7422782|FG001|COMPLETED|Overall Study||5766
6503796|NCT01444430|7422781|FG000|NOT COMPLETED|Overall Study||61
6503797|NCT01444430|7422782|FG001|NOT COMPLETED|Overall Study||81
6503798|NCT01444456|7422788|FG000|STARTED|Overall Study||1262
6503799|NCT01444456|7422788|FG000|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
6503800|NCT01444456|7422788|FG000|Received Darbepoetin Alfa|Overall Study||1134
6503801|NCT01444456|7422788|FG000|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
6656848|NCT02465437|7587208|FG003|STARTED|Overall Study||15
6386867|NCT00812916|7298382|FG000|NOT COMPLETED|Overall Study||3
6386868|NCT00812929|7298388|FG000|STARTED|Treatment Period 1||5
6503802|NCT01444456|7422788|FG000|NOT COMPLETED|Overall Study||285
6503803|NCT01444651|7422794|FG000|STARTED|Overall Study||36
6503804|NCT01444651|7422795|FG001|STARTED|Overall Study||37
6503805|NCT01444651|7422794|FG000|COMPLETED|Overall Study||25
6271623|NCT00091819|7171055|FG000|STARTED|Overall Study||429
6271624|NCT00091819|7171056|FG001|STARTED|Overall Study||433
6271625|NCT00091819|7171055|FG000|COMPLETED|Overall Study||387
6271626|NCT00091819|7171056|FG001|COMPLETED|Overall Study||387
6271627|NCT00091819|7171055|FG000|NOT COMPLETED|Overall Study||42
6271628|NCT00091819|7171056|FG001|NOT COMPLETED|Overall Study||46
6271629|NCT00091832|7171068|FG000|STARTED|Overall Study||43
6271630|NCT00091832|7171069|FG001|STARTED|Overall Study||42
6271631|NCT00091832|7171070|FG002|STARTED|Overall Study||42
6271632|NCT00091832|7171071|FG003|STARTED|Overall Study||43
6271633|NCT00091832|7171072|FG004|STARTED|Overall Study||42
6271634|NCT00091832|7171073|FG005|STARTED|Overall Study||43
6271635|NCT00091832|7171068|FG000|Received Study Medication|Overall Study||43
6271636|NCT00091832|7171069|FG001|Received Study Medication|Overall Study||42
6565586|NCT01819311|7488468|FG001|COMPLETED|Treatment Phase (4 Weeks)||30
6565587|NCT01819311|7488467|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||2
6271637|NCT00091832|7171070|FG002|Received Study Medication|Overall Study||41
6271638|NCT00091832|7171071|FG003|Received Study Medication|Overall Study||43
6271639|NCT00091832|7171072|FG004|Received Study Medication|Overall Study||42
6271640|NCT00091832|7171073|FG005|Received Study Medication|Overall Study||43
6271641|NCT00091832|7171068|FG000|COMPLETED|Overall Study||29
6271642|NCT00091832|7171069|FG001|COMPLETED|Overall Study||31
6271643|NCT00091832|7171070|FG002|COMPLETED|Overall Study||30
6271644|NCT00091832|7171071|FG003|COMPLETED|Overall Study||29
6271645|NCT00091832|7171072|FG004|COMPLETED|Overall Study||27
6271646|NCT00091832|7171073|FG005|COMPLETED|Overall Study||32
6271647|NCT00091832|7171068|FG000|NOT COMPLETED|Overall Study||14
6271648|NCT00091832|7171069|FG001|NOT COMPLETED|Overall Study||11
6271649|NCT00091832|7171070|FG002|NOT COMPLETED|Overall Study||12
6271650|NCT00091832|7171071|FG003|NOT COMPLETED|Overall Study||14
6271651|NCT00091832|7171072|FG004|NOT COMPLETED|Overall Study||15
6271652|NCT00091832|7171073|FG005|NOT COMPLETED|Overall Study||11
6271653|NCT00091949|7171089|FG000|STARTED|Overall Study||1939
6271654|NCT00091949|7171090|FG001|STARTED|Overall Study||1937
6271655|NCT00091949|7171089|FG000|COMPLETED|Overall Study||1764
6271656|NCT00091949|7171090|FG001|COMPLETED|Overall Study||1786
6271657|NCT00091949|7171089|FG000|NOT COMPLETED|Overall Study||175
6271658|NCT00091949|7171090|FG001|NOT COMPLETED|Overall Study||151
6271659|NCT00091962|7171099|FG000|STARTED|Overall Study||150
6271660|NCT00091962|7171100|FG001|STARTED|Overall Study||152
6271661|NCT00091962|7171101|FG002|STARTED|Overall Study||151
6271662|NCT00091962|7171099|FG000|COMPLETED|Overall Study||150
6271663|NCT00091962|7171100|FG001|COMPLETED|Overall Study||152
6271664|NCT00091962|7171101|FG002|COMPLETED|Overall Study||151
6271665|NCT00091962|7171099|FG000|NOT COMPLETED|Overall Study||0
6271666|NCT00091962|7171100|FG001|NOT COMPLETED|Overall Study||0
6271667|NCT00091962|7171101|FG002|NOT COMPLETED|Overall Study||0
6271668|NCT00092417|7171114|FG000|STARTED|Overall Study|Started Period Group 1|464
6271669|NCT00092417|7171115|FG001|STARTED|Overall Study|Started Period Group 2|234
6271670|NCT00092417|7171114|FG000|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
6271671|NCT00092417|7171115|FG001|Vaccinated|Overall Study||234
6271672|NCT00092417|7171114|FG000|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
6271673|NCT00092417|7171115|FG001|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
6271674|NCT00092417|7171114|FG000|NOT COMPLETED|Overall Study||5
6271675|NCT00092417|7171115|FG001|NOT COMPLETED|Overall Study||1
6271676|NCT00092443|7171123|FG000|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
6271677|NCT00092443|7171124|FG001|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
6271678|NCT00092443|7171123|FG000|Vaccinated at Visit 1|Overall Study||650
6271679|NCT00092443|7171124|FG001|Vaccinated at Visit 1|Overall Study||660
6271680|NCT00092443|7171123|FG000|Vaccinated at Visit 2|Overall Study||618
6271681|NCT00092443|7171124|FG001|Vaccinated at Visit 2|Overall Study||627
6271682|NCT00092443|7171123|FG000|Vaccinated at Visit 3|Overall Study||593
6271683|NCT00092443|7171124|FG001|Vaccinated at Visit 3|Overall Study||608
6271684|NCT00092443|7171123|FG000|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
6271685|NCT00092443|7171124|FG001|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
6565588|NCT01819311|7488468|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||1
6565589|NCT01819311|7488467|FG000|STARTED|Follow-up Phase (8 Weeks)||31
6271686|NCT00092443|7171123|FG000|NOT COMPLETED|Overall Study||58
6271687|NCT00092443|7171124|FG001|NOT COMPLETED|Overall Study||54
6271688|NCT00092456|7171144|FG000|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
6271689|NCT00092456|7171145|FG001|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
6271690|NCT00092456|7171146|FG002|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
6271691|NCT00092456|7171147|FG003|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
6271692|NCT00092456|7171144|FG000|Vaccinated at Visit 1|Overall Study||226
6271693|NCT00092456|7171145|FG001|Vaccinated at Visit 1|Overall Study||225
6271694|NCT00092456|7171146|FG002|Vaccinated at Visit 1|Overall Study||229
6271695|NCT00092456|7171147|FG003|Vaccinated at Visit 1|Overall Study||113
6271696|NCT00092456|7171144|FG000|Vaccinated at Visit 2|Overall Study||208
6271697|NCT00092456|7171145|FG001|Vaccinated at Visit 2|Overall Study||217
6271698|NCT00092456|7171146|FG002|Vaccinated at Visit 2|Overall Study||210
6805161|NCT02756208|7737186|FG002|COMPLETED|Overall Study||13
6805162|NCT02756208|7737187|FG003|COMPLETED|Overall Study||12
6805163|NCT02756208|7737184|FG000|NOT COMPLETED|Overall Study||5
6271699|NCT00092456|7171147|FG003|Vaccinated at Visit 2|Overall Study||104
6271700|NCT00092456|7171144|FG000|Vaccinated at Visit 3|Overall Study||202
6271701|NCT00092456|7171145|FG001|Vaccinated at Visit 3|Overall Study||210
6271702|NCT00092456|7171146|FG002|Vaccinated at Visit 3|Overall Study||200
6271703|NCT00092456|7171147|FG003|Vaccinated at Visit 3|Overall Study||98
6271704|NCT00092456|7171144|FG000|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
6271705|NCT00092456|7171145|FG001|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
6271706|NCT00092456|7171146|FG002|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
6271707|NCT00092456|7171147|FG003|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
6271708|NCT00092456|7171144|FG000|NOT COMPLETED|Overall Study||25
6271709|NCT00092456|7171145|FG001|NOT COMPLETED|Overall Study||17
6271710|NCT00092456|7171146|FG002|NOT COMPLETED|Overall Study||29
6271711|NCT00092456|7171147|FG003|NOT COMPLETED|Overall Study||16
6271712|NCT00092495|7171161|FG000|STARTED|Base Study Vaccination Period||504
6271713|NCT00092495|7171162|FG001|STARTED|Base Study Vaccination Period||514
6271714|NCT00092495|7171163|FG002|STARTED|Base Study Vaccination Period||508
6271715|NCT00092495|7171164|FG003|STARTED|Base Study Vaccination Period||1529
6271716|NCT00092495|7171165|FG004|STARTED|Base Study Vaccination Period||0
6805164|NCT02756208|7737185|FG001|NOT COMPLETED|Overall Study||2
6805165|NCT02756208|7737186|FG002|NOT COMPLETED|Overall Study||2
6805166|NCT02756208|7737187|FG003|NOT COMPLETED|Overall Study||4
6805167|NCT02714218|7737200|FG000|STARTED|Overall Study||180
6805168|NCT02714218|7737201|FG001|STARTED|Overall Study||178
6805169|NCT02714218|7737202|FG002|STARTED|Overall Study||27
6805170|NCT02714218|7737200|FG000|COMPLETED|Overall Study||50
6271717|NCT00092495|7171161|FG000|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
6280705|NCT00159263|7180666|FG002|STARTED|Second Intervention||2
6805171|NCT02714218|7737201|FG001|COMPLETED|Overall Study||35
6805172|NCT02714218|7737202|FG002|COMPLETED|Overall Study||8
6805173|NCT02714218|7737200|FG000|NOT COMPLETED|Overall Study||130
6805174|NCT02714218|7737201|FG001|NOT COMPLETED|Overall Study||143
6805175|NCT02714218|7737202|FG002|NOT COMPLETED|Overall Study||19
6565590|NCT01819311|7488468|FG001|STARTED|Follow-up Phase (8 Weeks)||30
6565591|NCT01819311|7488467|FG000|COMPLETED|Follow-up Phase (8 Weeks)||24
6565592|NCT01819311|7488468|FG001|COMPLETED|Follow-up Phase (8 Weeks)||23
6565593|NCT01819311|7488467|FG000|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
6565594|NCT01819311|7488468|FG001|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
6565595|NCT01819415|7488478|FG000|STARTED|Overall Study||10
6271718|NCT00092495|7171162|FG001|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
6271719|NCT00092495|7171163|FG002|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
6271720|NCT00092495|7171164|FG003|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
6271721|NCT00092495|7171165|FG004|With Long-term Follow-up *|Base Study Vaccination Period||0
6271722|NCT00092495|7171161|FG000|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
6271723|NCT00092495|7171162|FG001|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
6271724|NCT00092495|7171163|FG002|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
6271725|NCT00092495|7171164|FG003|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
6271726|NCT00092495|7171165|FG004|Without Long-term Follow-up|Base Study Vaccination Period||0
6271727|NCT00092495|7171161|FG000|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
6271728|NCT00092495|7171162|FG001|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
6271729|NCT00092495|7171163|FG002|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
6271730|NCT00092495|7171164|FG003|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
6271731|NCT00092495|7171165|FG004|COMPLETED|Base Study Vaccination Period||0
6271732|NCT00092495|7171161|FG000|NOT COMPLETED|Base Study Vaccination Period||37
6271733|NCT00092495|7171162|FG001|NOT COMPLETED|Base Study Vaccination Period||22
6271734|NCT00092495|7171163|FG002|NOT COMPLETED|Base Study Vaccination Period||34
6271735|NCT00092495|7171164|FG003|NOT COMPLETED|Base Study Vaccination Period||88
6271736|NCT00092495|7171165|FG004|NOT COMPLETED|Base Study Vaccination Period||0
6271737|NCT00092495|7171161|FG000|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
6271738|NCT00092495|7171162|FG001|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
6271739|NCT00092495|7171163|FG002|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
6271740|NCT00092495|7171164|FG003|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
6271741|NCT00092495|7171165|FG004|STARTED|Base Study Follow-up Period||0
6271742|NCT00092495|7171161|FG000|COMPLETED|Base Study Follow-up Period||112
6271743|NCT00092495|7171162|FG001|COMPLETED|Base Study Follow-up Period||122
6271744|NCT00092495|7171163|FG002|COMPLETED|Base Study Follow-up Period||126
6565596|NCT01819415|7488479|FG001|STARTED|Overall Study||10
6565597|NCT01819415|7488480|FG002|STARTED|Overall Study||10
6565598|NCT01819415|7488481|FG003|STARTED|Overall Study||10
6565599|NCT01819415|7488478|FG000|COMPLETED|Overall Study||7
6565600|NCT01819415|7488479|FG001|COMPLETED|Overall Study||6
6565601|NCT01819415|7488480|FG002|COMPLETED|Overall Study||9
6271745|NCT00092495|7171164|FG003|COMPLETED|Base Study Follow-up Period||446
6271746|NCT00092495|7171165|FG004|COMPLETED|Base Study Follow-up Period||0
6271747|NCT00092495|7171161|FG000|NOT COMPLETED|Base Study Follow-up Period||3
6271748|NCT00092495|7171162|FG001|NOT COMPLETED|Base Study Follow-up Period||3
6271749|NCT00092495|7171163|FG002|NOT COMPLETED|Base Study Follow-up Period||4
6271750|NCT00092495|7171164|FG003|NOT COMPLETED|Base Study Follow-up Period||14
6271751|NCT00092495|7171165|FG004|NOT COMPLETED|Base Study Follow-up Period||0
6386869|NCT00812929|7298389|FG001|STARTED|Treatment Period 1||4
6386870|NCT00812929|7298390|FG002|STARTED|Treatment Period 1||5
6565602|NCT01819415|7488481|FG003|COMPLETED|Overall Study||8
6565603|NCT01819415|7488478|FG000|NOT COMPLETED|Overall Study||3
6565604|NCT01819415|7488479|FG001|NOT COMPLETED|Overall Study||4
6565605|NCT01819415|7488480|FG002|NOT COMPLETED|Overall Study||1
6565606|NCT01819415|7488481|FG003|NOT COMPLETED|Overall Study||2
6565607|NCT01819506|7488493|FG000|STARTED|Overall Study||51
6565608|NCT01819506|7488494|FG001|STARTED|Overall Study||52
6565609|NCT01819506|7488493|FG000|COMPLETED|Overall Study||43
6565610|NCT01819506|7488494|FG001|COMPLETED|Overall Study||47
6565611|NCT01819506|7488493|FG000|NOT COMPLETED|Overall Study||8
6565612|NCT01819506|7488494|FG001|NOT COMPLETED|Overall Study||5
6565613|NCT01819597|7488500|FG000|STARTED|Overall Study||52
6565614|NCT01819597|7488500|FG000|COMPLETED|Overall Study||52
6565615|NCT01819597|7488500|FG000|NOT COMPLETED|Overall Study||0
6565616|NCT01819727|7488506|FG000|STARTED|Overall Study||131
6565617|NCT01819727|7488507|FG001|STARTED|Overall Study||130
6565618|NCT01819727|7488506|FG000|COMPLETED|Overall Study||111
6271752|NCT00092495|7171161|FG000|STARTED|Extension Study||0
6271753|NCT00092495|7171162|FG001|STARTED|Extension Study||0
6271754|NCT00092495|7171163|FG002|STARTED|Extension Study||0
6271755|NCT00092495|7171164|FG003|STARTED|Extension Study||0
6271756|NCT00092495|7171165|FG004|STARTED|Extension Study||12
6386871|NCT00812929|7298391|FG003|STARTED|Treatment Period 1||4
6386872|NCT00812929|7298392|FG004|STARTED|Treatment Period 1||5
6386873|NCT00812929|7298393|FG005|STARTED|Treatment Period 1||5
6386874|NCT00812929|7298394|FG006|STARTED|Treatment Period 1||5
6386875|NCT00812929|7298395|FG007|STARTED|Treatment Period 1||5
6386876|NCT00812929|7298396|FG008|STARTED|Treatment Period 1||4
6386877|NCT00812929|7298397|FG009|STARTED|Treatment Period 1||5
6386878|NCT00812929|7298388|FG000|COMPLETED|Treatment Period 1||5
6386879|NCT00812929|7298389|FG001|COMPLETED|Treatment Period 1||4
6503806|NCT01444651|7422795|FG001|COMPLETED|Overall Study||28
6503807|NCT01444651|7422794|FG000|NOT COMPLETED|Overall Study||11
6503808|NCT01444651|7422795|FG001|NOT COMPLETED|Overall Study||9
6503809|NCT01444716|7422801|FG000|STARTED|Overall Study||34
6503810|NCT01444716|7422801|FG000|COMPLETED|Overall Study||34
6503811|NCT01444716|7422801|FG000|NOT COMPLETED|Overall Study||0
6503812|NCT01444742|7422805|FG000|STARTED|Overall Study||81
6503813|NCT01444742|7422805|FG000|COMPLETED|Overall Study||80
6503814|NCT01444742|7422805|FG000|NOT COMPLETED|Overall Study||1
6503815|NCT01444781|7422812|FG000|STARTED|Overall Study||416
6503816|NCT01444781|7422813|FG001|STARTED|Overall Study||415
6503817|NCT01444781|7422814|FG002|STARTED|Overall Study||275
6503818|NCT01444781|7422812|FG000|COMPLETED|Overall Study||413
6503819|NCT01444781|7422813|FG001|COMPLETED|Overall Study||411
6503820|NCT01444781|7422814|FG002|COMPLETED|Overall Study||272
6503821|NCT01444781|7422812|FG000|NOT COMPLETED|Overall Study||3
6503822|NCT01444781|7422813|FG001|NOT COMPLETED|Overall Study||4
6503823|NCT01444781|7422814|FG002|NOT COMPLETED|Overall Study||3
6503824|NCT01444898|7422829|FG000|STARTED|Overall Study||10
6503825|NCT01444898|7422829|FG000|COMPLETED|Overall Study||9
6503826|NCT01444898|7422829|FG000|NOT COMPLETED|Overall Study||1
6503827|NCT01444911|7422835|FG000|STARTED|Overall Study||16
6503828|NCT01444911|7422836|FG001|STARTED|Overall Study||13
6503829|NCT01444911|7422835|FG000|COMPLETED|Overall Study||8
6503830|NCT01444911|7422836|FG001|COMPLETED|Overall Study||13
6503831|NCT01444911|7422835|FG000|NOT COMPLETED|Overall Study||8
6503832|NCT01444911|7422836|FG001|NOT COMPLETED|Overall Study||0
6503833|NCT01444924|7422844|FG000|STARTED|Overall Study||31
6503834|NCT01444924|7422845|FG001|STARTED|Overall Study||33
6503835|NCT01444924|7422844|FG000|COMPLETED|Overall Study||31
6503836|NCT01444924|7422845|FG001|COMPLETED|Overall Study||33
6503837|NCT01444924|7422844|FG000|NOT COMPLETED|Overall Study||0
6503838|NCT01444924|7422845|FG001|NOT COMPLETED|Overall Study||0
6503839|NCT01445028|7422853|FG000|STARTED|Overall Study||58
6503840|NCT01445028|7422854|FG001|STARTED|Overall Study||54
6503841|NCT01445028|7422853|FG000|COMPLETED|Overall Study||58
6503842|NCT01445028|7422854|FG001|COMPLETED|Overall Study||51
6503843|NCT01445028|7422853|FG000|NOT COMPLETED|Overall Study||0
6503844|NCT01445028|7422854|FG001|NOT COMPLETED|Overall Study||3
6503845|NCT01445080|7422869|FG000|STARTED|Overall Study||7
6503846|NCT01445080|7422870|FG001|STARTED|Overall Study||5
6503847|NCT01445080|7422871|FG002|STARTED|Overall Study||12
6503848|NCT01445080|7422872|FG003|STARTED|Overall Study||8
6503849|NCT01445080|7422873|FG004|STARTED|Overall Study||4
6503850|NCT01445080|7422874|FG005|STARTED|Overall Study||9
6503851|NCT01445080|7422875|FG006|STARTED|Overall Study||2
6503852|NCT01445080|7422876|FG007|STARTED|Overall Study||5
6503853|NCT01445080|7422877|FG008|STARTED|Overall Study||18
6503854|NCT01445080|7422869|FG000|COMPLETED|Overall Study||0
6503855|NCT01445080|7422870|FG001|COMPLETED|Overall Study||0
6503856|NCT01445080|7422871|FG002|COMPLETED|Overall Study||0
6503857|NCT01445080|7422872|FG003|COMPLETED|Overall Study||0
6503858|NCT01445080|7422873|FG004|COMPLETED|Overall Study||0
6565619|NCT01819727|7488507|FG001|COMPLETED|Overall Study||102
6503859|NCT01445080|7422874|FG005|COMPLETED|Overall Study||0
6503860|NCT01445080|7422875|FG006|COMPLETED|Overall Study||0
6503861|NCT01445080|7422876|FG007|COMPLETED|Overall Study||0
6503862|NCT01445080|7422877|FG008|COMPLETED|Overall Study||0
6503863|NCT01445080|7422869|FG000|NOT COMPLETED|Overall Study||7
6503864|NCT01445080|7422870|FG001|NOT COMPLETED|Overall Study||5
6503865|NCT01445080|7422871|FG002|NOT COMPLETED|Overall Study||12
6503866|NCT01445080|7422872|FG003|NOT COMPLETED|Overall Study||8
6503867|NCT01445080|7422873|FG004|NOT COMPLETED|Overall Study||4
6503868|NCT01445080|7422874|FG005|NOT COMPLETED|Overall Study||9
6503869|NCT01445080|7422875|FG006|NOT COMPLETED|Overall Study||2
6503870|NCT01445080|7422876|FG007|NOT COMPLETED|Overall Study||5
6503871|NCT01445080|7422877|FG008|NOT COMPLETED|Overall Study||18
6386880|NCT00812929|7298390|FG002|COMPLETED|Treatment Period 1||5
6386881|NCT00812929|7298391|FG003|COMPLETED|Treatment Period 1||4
6386882|NCT00812929|7298392|FG004|COMPLETED|Treatment Period 1||5
6386883|NCT00812929|7298393|FG005|COMPLETED|Treatment Period 1||5
6386884|NCT00812929|7298394|FG006|COMPLETED|Treatment Period 1||5
6386885|NCT00812929|7298395|FG007|COMPLETED|Treatment Period 1||5
6386886|NCT00812929|7298396|FG008|COMPLETED|Treatment Period 1||4
6386887|NCT00812929|7298397|FG009|COMPLETED|Treatment Period 1||5
6386888|NCT00812929|7298388|FG000|NOT COMPLETED|Treatment Period 1||0
6386889|NCT00812929|7298389|FG001|NOT COMPLETED|Treatment Period 1||0
6386890|NCT00812929|7298390|FG002|NOT COMPLETED|Treatment Period 1||0
6386891|NCT00812929|7298391|FG003|NOT COMPLETED|Treatment Period 1||0
6386892|NCT00812929|7298392|FG004|NOT COMPLETED|Treatment Period 1||0
6386893|NCT00812929|7298393|FG005|NOT COMPLETED|Treatment Period 1||0
6386894|NCT00812929|7298394|FG006|NOT COMPLETED|Treatment Period 1||0
6386895|NCT00812929|7298395|FG007|NOT COMPLETED|Treatment Period 1||0
6386896|NCT00812929|7298396|FG008|NOT COMPLETED|Treatment Period 1||0
6386897|NCT00812929|7298397|FG009|NOT COMPLETED|Treatment Period 1||0
6386898|NCT00812929|7298388|FG000|STARTED|Washout Period 1 (7 Days)||5
6386899|NCT00812929|7298389|FG001|STARTED|Washout Period 1 (7 Days)||4
6386900|NCT00812929|7298390|FG002|STARTED|Washout Period 1 (7 Days)||5
6386901|NCT00812929|7298391|FG003|STARTED|Washout Period 1 (7 Days)||4
6386902|NCT00812929|7298392|FG004|STARTED|Washout Period 1 (7 Days)||5
6386903|NCT00812929|7298393|FG005|STARTED|Washout Period 1 (7 Days)||5
6386904|NCT00812929|7298394|FG006|STARTED|Washout Period 1 (7 Days)||5
6386905|NCT00812929|7298395|FG007|STARTED|Washout Period 1 (7 Days)||5
6386906|NCT00812929|7298396|FG008|STARTED|Washout Period 1 (7 Days)||4
6386907|NCT00812929|7298397|FG009|STARTED|Washout Period 1 (7 Days)||5
6386908|NCT00812929|7298388|FG000|COMPLETED|Washout Period 1 (7 Days)||5
6386909|NCT00812929|7298389|FG001|COMPLETED|Washout Period 1 (7 Days)||4
6386910|NCT00812929|7298390|FG002|COMPLETED|Washout Period 1 (7 Days)||4
6386911|NCT00812929|7298391|FG003|COMPLETED|Washout Period 1 (7 Days)||4
6386912|NCT00812929|7298392|FG004|COMPLETED|Washout Period 1 (7 Days)||5
6386913|NCT00812929|7298393|FG005|COMPLETED|Washout Period 1 (7 Days)||5
6386914|NCT00812929|7298394|FG006|COMPLETED|Washout Period 1 (7 Days)||5
6386915|NCT00812929|7298395|FG007|COMPLETED|Washout Period 1 (7 Days)||5
6386916|NCT00812929|7298396|FG008|COMPLETED|Washout Period 1 (7 Days)||4
6386917|NCT00812929|7298397|FG009|COMPLETED|Washout Period 1 (7 Days)||5
6386918|NCT00812929|7298388|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386919|NCT00812929|7298389|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386920|NCT00812929|7298390|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
6386921|NCT00812929|7298391|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386922|NCT00812929|7298392|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386923|NCT00812929|7298393|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386924|NCT00812929|7298394|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386925|NCT00812929|7298395|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386926|NCT00812929|7298396|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386927|NCT00812929|7298397|FG009|NOT COMPLETED|Washout Period 1 (7 Days)||0
6386928|NCT00812929|7298388|FG000|STARTED|Treatment Period 2||5
6386929|NCT00812929|7298389|FG001|STARTED|Treatment Period 2||4
6386930|NCT00812929|7298390|FG002|STARTED|Treatment Period 2||4
6386931|NCT00812929|7298391|FG003|STARTED|Treatment Period 2||4
6386932|NCT00812929|7298392|FG004|STARTED|Treatment Period 2||5
6386933|NCT00812929|7298393|FG005|STARTED|Treatment Period 2||5
6386934|NCT00812929|7298394|FG006|STARTED|Treatment Period 2||5
6386935|NCT00812929|7298395|FG007|STARTED|Treatment Period 2||5
6386936|NCT00812929|7298396|FG008|STARTED|Treatment Period 2||4
6386937|NCT00812929|7298397|FG009|STARTED|Treatment Period 2||5
6386938|NCT00812929|7298388|FG000|COMPLETED|Treatment Period 2||5
6386939|NCT00812929|7298389|FG001|COMPLETED|Treatment Period 2||4
6386940|NCT00812929|7298390|FG002|COMPLETED|Treatment Period 2||4
6386941|NCT00812929|7298391|FG003|COMPLETED|Treatment Period 2||4
6386942|NCT00812929|7298392|FG004|COMPLETED|Treatment Period 2||5
6386943|NCT00812929|7298393|FG005|COMPLETED|Treatment Period 2||5
6386944|NCT00812929|7298394|FG006|COMPLETED|Treatment Period 2||5
6386945|NCT00812929|7298395|FG007|COMPLETED|Treatment Period 2||5
6386946|NCT00812929|7298396|FG008|COMPLETED|Treatment Period 2||4
6386947|NCT00812929|7298397|FG009|COMPLETED|Treatment Period 2||5
6386948|NCT00812929|7298388|FG000|NOT COMPLETED|Treatment Period 2||0
6386949|NCT00812929|7298389|FG001|NOT COMPLETED|Treatment Period 2||0
6386950|NCT00812929|7298390|FG002|NOT COMPLETED|Treatment Period 2||0
6386951|NCT00812929|7298391|FG003|NOT COMPLETED|Treatment Period 2||0
6386952|NCT00812929|7298392|FG004|NOT COMPLETED|Treatment Period 2||0
6386953|NCT00812929|7298393|FG005|NOT COMPLETED|Treatment Period 2||0
6386954|NCT00812929|7298394|FG006|NOT COMPLETED|Treatment Period 2||0
6386955|NCT00812929|7298395|FG007|NOT COMPLETED|Treatment Period 2||0
6386956|NCT00812929|7298396|FG008|NOT COMPLETED|Treatment Period 2||0
6386957|NCT00812929|7298397|FG009|NOT COMPLETED|Treatment Period 2||0
6386958|NCT00812929|7298388|FG000|STARTED|Washout Period 2 (7 Days)||5
6386959|NCT00812929|7298389|FG001|STARTED|Washout Period 2 (7 Days)||4
6386960|NCT00812929|7298390|FG002|STARTED|Washout Period 2 (7 Days)||4
6386961|NCT00812929|7298391|FG003|STARTED|Washout Period 2 (7 Days)||4
6386962|NCT00812929|7298392|FG004|STARTED|Washout Period 2 (7 Days)||5
6386963|NCT00812929|7298393|FG005|STARTED|Washout Period 2 (7 Days)||5
6386964|NCT00812929|7298394|FG006|STARTED|Washout Period 2 (7 Days)||5
6386965|NCT00812929|7298395|FG007|STARTED|Washout Period 2 (7 Days)||5
6386966|NCT00812929|7298396|FG008|STARTED|Washout Period 2 (7 Days)||4
6386967|NCT00812929|7298397|FG009|STARTED|Washout Period 2 (7 Days)||5
6386968|NCT00812929|7298388|FG000|COMPLETED|Washout Period 2 (7 Days)||5
6386969|NCT00812929|7298389|FG001|COMPLETED|Washout Period 2 (7 Days)||4
6386970|NCT00812929|7298390|FG002|COMPLETED|Washout Period 2 (7 Days)||4
6386971|NCT00812929|7298391|FG003|COMPLETED|Washout Period 2 (7 Days)||4
6386972|NCT00812929|7298392|FG004|COMPLETED|Washout Period 2 (7 Days)||5
6386973|NCT00812929|7298393|FG005|COMPLETED|Washout Period 2 (7 Days)||5
6386974|NCT00812929|7298394|FG006|COMPLETED|Washout Period 2 (7 Days)||5
6386975|NCT00812929|7298395|FG007|COMPLETED|Washout Period 2 (7 Days)||5
6386976|NCT00812929|7298396|FG008|COMPLETED|Washout Period 2 (7 Days)||4
6386977|NCT00812929|7298397|FG009|COMPLETED|Washout Period 2 (7 Days)||4
6386978|NCT00812929|7298388|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6386979|NCT00812929|7298389|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6386980|NCT00812929|7298390|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6565620|NCT01819727|7488506|FG000|NOT COMPLETED|Overall Study||20
6565621|NCT01819727|7488507|FG001|NOT COMPLETED|Overall Study||28
6805176|NCT02564263|7737211|FG000|STARTED|Overall Study||314
6805177|NCT02564263|7737212|FG001|STARTED|Overall Study||314
6805178|NCT02564263|7737211|FG000|Treated|Overall Study||314
6805179|NCT02564263|7737212|FG001|Treated|Overall Study||296
6805180|NCT02564263|7737211|FG000|COMPLETED|Overall Study||0
6805181|NCT02564263|7737212|FG001|COMPLETED|Overall Study||0
6805182|NCT02564263|7737211|FG000|NOT COMPLETED|Overall Study||314
6805183|NCT02564263|7737212|FG001|NOT COMPLETED|Overall Study||314
6805184|NCT02149121|7737225|FG000|STARTED|Main Study Period||161
6805185|NCT02149121|7737226|FG001|STARTED|Main Study Period||151
6565622|NCT01819844|7488513|FG000|STARTED|Overall Study||12
6565623|NCT01819844|7488513|FG000|COMPLETED|Overall Study||12
6271757|NCT00092495|7171161|FG000|COMPLETED|Extension Study||0
6271758|NCT00092495|7171162|FG001|COMPLETED|Extension Study||0
6271759|NCT00092495|7171163|FG002|COMPLETED|Extension Study||0
6271760|NCT00092495|7171164|FG003|COMPLETED|Extension Study||0
6271761|NCT00092495|7171165|FG004|COMPLETED|Extension Study||12
6271762|NCT00092495|7171161|FG000|NOT COMPLETED|Extension Study||0
6271763|NCT00092495|7171162|FG001|NOT COMPLETED|Extension Study||0
6271764|NCT00092495|7171163|FG002|NOT COMPLETED|Extension Study||0
6271765|NCT00092495|7171164|FG003|NOT COMPLETED|Extension Study||0
6271766|NCT00092495|7171165|FG004|NOT COMPLETED|Extension Study||0
6271767|NCT00092521|7171181|FG000|STARTED|Vaccination (Day 1 Through Month 7)||2723
6271768|NCT00092521|7171182|FG001|STARTED|Vaccination (Day 1 Through Month 7)||304
6271769|NCT00092521|7171183|FG002|STARTED|Vaccination (Day 1 Through Month 7)||2732
6271770|NCT00092521|7171184|FG003|STARTED|Vaccination (Day 1 Through Month 7)||0
6271771|NCT00092521|7171181|FG000|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
6271772|NCT00092521|7171182|FG001|COMPLETED|Vaccination (Day 1 Through Month 7)||290
6271773|NCT00092521|7171183|FG002|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
6271774|NCT00092521|7171184|FG003|COMPLETED|Vaccination (Day 1 Through Month 7)||0
6271775|NCT00092521|7171181|FG000|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
6271776|NCT00092521|7171182|FG001|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
6271777|NCT00092521|7171183|FG002|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
6271778|NCT00092521|7171184|FG003|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
6271779|NCT00092521|7171181|FG000|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
6271780|NCT00092521|7171182|FG001|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
6271781|NCT00092521|7171183|FG002|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
6271782|NCT00092521|7171184|FG003|STARTED|Follow-Up (After Month 7)||0
6271783|NCT00092521|7171181|FG000|COMPLETED|Follow-Up (After Month 7)||2353
6271784|NCT00092521|7171182|FG001|COMPLETED|Follow-Up (After Month 7)||155
6271785|NCT00092521|7171183|FG002|COMPLETED|Follow-Up (After Month 7)||1959
6271786|NCT00092521|7171184|FG003|COMPLETED|Follow-Up (After Month 7)||0
6271787|NCT00092521|7171181|FG000|NOT COMPLETED|Follow-Up (After Month 7)||246
6386981|NCT00812929|7298391|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6386982|NCT00812929|7298392|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6386983|NCT00812929|7298393|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6386984|NCT00812929|7298394|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
6386985|NCT00812929|7298395|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
6386986|NCT00812929|7298396|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
6386987|NCT00812929|7298397|FG009|NOT COMPLETED|Washout Period 2 (7 Days)||1
6386988|NCT00812929|7298388|FG000|STARTED|Treatment Period 3||5
6386989|NCT00812929|7298389|FG001|STARTED|Treatment Period 3||4
6386990|NCT00812929|7298390|FG002|STARTED|Treatment Period 3||4
6386991|NCT00812929|7298391|FG003|STARTED|Treatment Period 3||4
6386992|NCT00812929|7298392|FG004|STARTED|Treatment Period 3||5
6386993|NCT00812929|7298393|FG005|STARTED|Treatment Period 3||5
6386994|NCT00812929|7298394|FG006|STARTED|Treatment Period 3||5
6386995|NCT00812929|7298395|FG007|STARTED|Treatment Period 3||5
6386996|NCT00812929|7298396|FG008|STARTED|Treatment Period 3||4
6386997|NCT00812929|7298397|FG009|STARTED|Treatment Period 3||4
6386998|NCT00812929|7298388|FG000|COMPLETED|Treatment Period 3||5
6386999|NCT00812929|7298389|FG001|COMPLETED|Treatment Period 3||4
6387000|NCT00812929|7298390|FG002|COMPLETED|Treatment Period 3||4
6387001|NCT00812929|7298391|FG003|COMPLETED|Treatment Period 3||4
6387002|NCT00812929|7298392|FG004|COMPLETED|Treatment Period 3||5
6271788|NCT00092521|7171182|FG001|NOT COMPLETED|Follow-Up (After Month 7)||136
6271789|NCT00092521|7171183|FG002|NOT COMPLETED|Follow-Up (After Month 7)||648
6271790|NCT00092521|7171184|FG003|NOT COMPLETED|Follow-Up (After Month 7)||0
6271791|NCT00092521|7171181|FG000|STARTED|Extension Study (Group 4)||0
6387003|NCT00812929|7298393|FG005|COMPLETED|Treatment Period 3||5
6387004|NCT00812929|7298394|FG006|COMPLETED|Treatment Period 3||5
6387005|NCT00812929|7298395|FG007|COMPLETED|Treatment Period 3||5
6387006|NCT00812929|7298396|FG008|COMPLETED|Treatment Period 3||4
6387007|NCT00812929|7298397|FG009|COMPLETED|Treatment Period 3||4
6387008|NCT00812929|7298388|FG000|NOT COMPLETED|Treatment Period 3||0
6387009|NCT00812929|7298389|FG001|NOT COMPLETED|Treatment Period 3||0
6387010|NCT00812929|7298390|FG002|NOT COMPLETED|Treatment Period 3||0
6387011|NCT00812929|7298391|FG003|NOT COMPLETED|Treatment Period 3||0
6387012|NCT00812929|7298392|FG004|NOT COMPLETED|Treatment Period 3||0
6387013|NCT00812929|7298393|FG005|NOT COMPLETED|Treatment Period 3||0
6387014|NCT00812929|7298394|FG006|NOT COMPLETED|Treatment Period 3||0
6387015|NCT00812929|7298395|FG007|NOT COMPLETED|Treatment Period 3||0
6387016|NCT00812929|7298396|FG008|NOT COMPLETED|Treatment Period 3||0
6387017|NCT00812929|7298397|FG009|NOT COMPLETED|Treatment Period 3||0
6271792|NCT00092521|7171182|FG001|STARTED|Extension Study (Group 4)||0
6271793|NCT00092521|7171183|FG002|STARTED|Extension Study (Group 4)||0
6271794|NCT00092521|7171184|FG003|STARTED|Extension Study (Group 4)||844
6271795|NCT00092521|7171181|FG000|Initiated Extension Study|Extension Study (Group 4)||0
6271796|NCT00092521|7171182|FG001|Initiated Extension Study|Extension Study (Group 4)||0
6271797|NCT00092521|7171183|FG002|Initiated Extension Study|Extension Study (Group 4)||0
6271798|NCT00092521|7171184|FG003|Initiated Extension Study|Extension Study (Group 4)||829
6271799|NCT00092521|7171181|FG000|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
6271800|NCT00092521|7171182|FG001|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
6271801|NCT00092521|7171183|FG002|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
6271802|NCT00092521|7171184|FG003|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
6271803|NCT00092521|7171181|FG000|COMPLETED|Extension Study (Group 4)||0
6271804|NCT00092521|7171182|FG001|COMPLETED|Extension Study (Group 4)||0
6271805|NCT00092521|7171183|FG002|COMPLETED|Extension Study (Group 4)||0
6271806|NCT00092521|7171184|FG003|COMPLETED|Extension Study (Group 4)||635
6271807|NCT00092521|7171181|FG000|NOT COMPLETED|Extension Study (Group 4)||0
6271808|NCT00092521|7171182|FG001|NOT COMPLETED|Extension Study (Group 4)||0
6271809|NCT00092521|7171183|FG002|NOT COMPLETED|Extension Study (Group 4)||0
6271810|NCT00092521|7171184|FG003|NOT COMPLETED|Extension Study (Group 4)||209
6271811|NCT00092534|7171194|FG000|STARTED|Base Study Vaccination Period||6087
6271812|NCT00092534|7171195|FG001|STARTED|Base Study Vaccination Period||6080
6271813|NCT00092534|7171196|FG002|STARTED|Base Study Vaccination Period||0
6271814|NCT00092534|7171197|FG003|STARTED|Base Study Vaccination Period||0
6271815|NCT00092534|7171198|FG004|STARTED|Base Study Vaccination Period||0
6271816|NCT00092534|7171194|FG000|COMPLETED|Base Study Vaccination Period||5916
6271817|NCT00092534|7171195|FG001|COMPLETED|Base Study Vaccination Period||5954
6271818|NCT00092534|7171196|FG002|COMPLETED|Base Study Vaccination Period||0
6271819|NCT00092534|7171197|FG003|COMPLETED|Base Study Vaccination Period||0
6271820|NCT00092534|7171198|FG004|COMPLETED|Base Study Vaccination Period||0
6271821|NCT00092534|7171194|FG000|NOT COMPLETED|Base Study Vaccination Period||171
6271822|NCT00092534|7171195|FG001|NOT COMPLETED|Base Study Vaccination Period||126
6271823|NCT00092534|7171196|FG002|NOT COMPLETED|Base Study Vaccination Period||0
6271824|NCT00092534|7171197|FG003|NOT COMPLETED|Base Study Vaccination Period||0
6271825|NCT00092534|7171198|FG004|NOT COMPLETED|Base Study Vaccination Period||0
6271826|NCT00092534|7171194|FG000|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
6271827|NCT00092534|7171195|FG001|STARTED|Base Study Follow-Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
6271828|NCT00092534|7171196|FG002|STARTED|Base Study Follow-Up Period||0
6271829|NCT00092534|7171197|FG003|STARTED|Base Study Follow-Up Period||0
6271830|NCT00092534|7171198|FG004|STARTED|Base Study Follow-Up Period||0
6271831|NCT00092534|7171194|FG000|COMPLETED|Base Study Follow-Up Period||5626
6271832|NCT00092534|7171195|FG001|COMPLETED|Base Study Follow-Up Period||5277
6271833|NCT00092534|7171196|FG002|COMPLETED|Base Study Follow-Up Period||0
6271834|NCT00092534|7171197|FG003|COMPLETED|Base Study Follow-Up Period||0
6271835|NCT00092534|7171198|FG004|COMPLETED|Base Study Follow-Up Period||0
6271836|NCT00092534|7171194|FG000|NOT COMPLETED|Base Study Follow-Up Period||316
6271837|NCT00092534|7171195|FG001|NOT COMPLETED|Base Study Follow-Up Period||694
6271838|NCT00092534|7171196|FG002|NOT COMPLETED|Base Study Follow-Up Period||0
6271839|NCT00092534|7171197|FG003|NOT COMPLETED|Base Study Follow-Up Period||0
6271840|NCT00092534|7171198|FG004|NOT COMPLETED|Base Study Follow-Up Period||0
6271841|NCT00092534|7171194|FG000|STARTED|Base Study EXT||0
6271842|NCT00092534|7171195|FG001|STARTED|Base Study EXT||0
6271843|NCT00092534|7171196|FG002|STARTED|Base Study EXT||594
6271844|NCT00092534|7171197|FG003|STARTED|Base Study EXT||0
6271845|NCT00092534|7171198|FG004|STARTED|Base Study EXT||0
6271846|NCT00092534|7171194|FG000|COMPLETED|Base Study EXT||0
6271847|NCT00092534|7171195|FG001|COMPLETED|Base Study EXT||0
6271848|NCT00092534|7171196|FG002|COMPLETED|Base Study EXT||449
6271849|NCT00092534|7171197|FG003|COMPLETED|Base Study EXT||0
6271850|NCT00092534|7171198|FG004|COMPLETED|Base Study EXT||0
6271851|NCT00092534|7171194|FG000|NOT COMPLETED|Base Study EXT||0
6271852|NCT00092534|7171195|FG001|NOT COMPLETED|Base Study EXT||0
6271853|NCT00092534|7171196|FG002|NOT COMPLETED|Base Study EXT||145
6387018|NCT00812929|7298388|FG000|STARTED|Washout Period 3 (7 Days)||5
6271854|NCT00092534|7171197|FG003|NOT COMPLETED|Base Study EXT||0
6565624|NCT01819844|7488513|FG000|NOT COMPLETED|Overall Study||0
6565625|NCT01819883|7488520|FG000|STARTED|Overall Study||20
6565626|NCT01819883|7488521|FG001|STARTED|Overall Study||20
6565627|NCT01819883|7488520|FG000|COMPLETED|Overall Study||16
6565628|NCT01819883|7488521|FG001|COMPLETED|Overall Study||20
6387019|NCT00812929|7298389|FG001|STARTED|Washout Period 3 (7 Days)||4
6387020|NCT00812929|7298390|FG002|STARTED|Washout Period 3 (7 Days)||4
6387021|NCT00812929|7298391|FG003|STARTED|Washout Period 3 (7 Days)||4
6387022|NCT00812929|7298392|FG004|STARTED|Washout Period 3 (7 Days)||5
6387023|NCT00812929|7298393|FG005|STARTED|Washout Period 3 (7 Days)||5
6387024|NCT00812929|7298394|FG006|STARTED|Washout Period 3 (7 Days)||5
6387025|NCT00812929|7298395|FG007|STARTED|Washout Period 3 (7 Days)||5
6387026|NCT00812929|7298396|FG008|STARTED|Washout Period 3 (7 Days)||4
6387027|NCT00812929|7298397|FG009|STARTED|Washout Period 3 (7 Days)||4
6387028|NCT00812929|7298388|FG000|COMPLETED|Washout Period 3 (7 Days)||5
6387029|NCT00812929|7298389|FG001|COMPLETED|Washout Period 3 (7 Days)||4
6387030|NCT00812929|7298390|FG002|COMPLETED|Washout Period 3 (7 Days)||4
6387031|NCT00812929|7298391|FG003|COMPLETED|Washout Period 3 (7 Days)||4
6387032|NCT00812929|7298392|FG004|COMPLETED|Washout Period 3 (7 Days)||5
6387033|NCT00812929|7298393|FG005|COMPLETED|Washout Period 3 (7 Days)||4
6387034|NCT00812929|7298394|FG006|COMPLETED|Washout Period 3 (7 Days)||5
6387035|NCT00812929|7298395|FG007|COMPLETED|Washout Period 3 (7 Days)||5
6387036|NCT00812929|7298396|FG008|COMPLETED|Washout Period 3 (7 Days)||4
6387037|NCT00812929|7298397|FG009|COMPLETED|Washout Period 3 (7 Days)||4
6387038|NCT00812929|7298388|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
6387039|NCT00812929|7298389|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
6503872|NCT01445171|7422912|FG000|STARTED|Overall Study||295
6503873|NCT01445171|7422912|FG000|Implanted With Study Device|Overall Study||287
6503874|NCT01445171|7422912|FG000|COMPLETED|Overall Study||200
6503875|NCT01445171|7422912|FG000|NOT COMPLETED|Overall Study||95
6387040|NCT00812929|7298390|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
6387041|NCT00812929|7298391|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
6387042|NCT00812929|7298392|FG004|NOT COMPLETED|Washout Period 3 (7 Days)||0
6387043|NCT00812929|7298393|FG005|NOT COMPLETED|Washout Period 3 (7 Days)||1
6387044|NCT00812929|7298394|FG006|NOT COMPLETED|Washout Period 3 (7 Days)||0
6387045|NCT00812929|7298395|FG007|NOT COMPLETED|Washout Period 3 (7 Days)||0
6387046|NCT00812929|7298396|FG008|NOT COMPLETED|Washout Period 3 (7 Days)||0
6387047|NCT00812929|7298397|FG009|NOT COMPLETED|Washout Period 3 (7 Days)||0
6387048|NCT00812929|7298388|FG000|STARTED|Treatment Period 4||5
6387049|NCT00812929|7298389|FG001|STARTED|Treatment Period 4||4
6387050|NCT00812929|7298390|FG002|STARTED|Treatment Period 4||4
6387051|NCT00812929|7298391|FG003|STARTED|Treatment Period 4||4
6387052|NCT00812929|7298392|FG004|STARTED|Treatment Period 4||5
6503876|NCT01445301|7422921|FG000|STARTED|Overall Study||204
6503877|NCT01445301|7422922|FG001|STARTED|Overall Study||297
6503878|NCT01445301|7422923|FG002|STARTED|Overall Study||299
6503879|NCT01445301|7422921|FG000|COMPLETED|Overall Study||183
6503880|NCT01445301|7422922|FG001|COMPLETED|Overall Study||262
6503881|NCT01445301|7422923|FG002|COMPLETED|Overall Study||290
6503882|NCT01445301|7422921|FG000|NOT COMPLETED|Overall Study||21
6503883|NCT01445301|7422922|FG001|NOT COMPLETED|Overall Study||35
6503884|NCT01445301|7422923|FG002|NOT COMPLETED|Overall Study||9
6503885|NCT01445535|7422935|FG000|STARTED|Overall Study||3
6503886|NCT01445535|7422936|FG001|STARTED|Overall Study||3
6503887|NCT01445535|7422937|FG002|STARTED|Overall Study||3
6503888|NCT01445535|7422938|FG003|STARTED|Overall Study||6
6565629|NCT01819883|7488520|FG000|NOT COMPLETED|Overall Study||4
6565630|NCT01819883|7488521|FG001|NOT COMPLETED|Overall Study||0
6565631|NCT01819922|7488526|FG000|STARTED|First Intervention Period (1 Day)||6
6565632|NCT01819922|7488527|FG001|STARTED|First Intervention Period (1 Day)||6
6565633|NCT01819922|7488526|FG000|COMPLETED|First Intervention Period (1 Day)||6
6565634|NCT01819922|7488527|FG001|COMPLETED|First Intervention Period (1 Day)||6
6565635|NCT01819922|7488526|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
6565636|NCT01819922|7488527|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
6565637|NCT01819922|7488526|FG000|STARTED|Washout Period (at Least 7-10 Days)||6
6565638|NCT01819922|7488527|FG001|STARTED|Washout Period (at Least 7-10 Days)||6
6565639|NCT01819922|7488526|FG000|COMPLETED|Washout Period (at Least 7-10 Days)||6
6565640|NCT01819922|7488527|FG001|COMPLETED|Washout Period (at Least 7-10 Days)||6
6565641|NCT01819922|7488526|FG000|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
6565642|NCT01819922|7488527|FG001|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
6565643|NCT01819922|7488526|FG000|STARTED|Second Intervention Period (1 Day)||6
6565644|NCT01819922|7488527|FG001|STARTED|Second Intervention Period (1 Day)||6
6565645|NCT01819922|7488526|FG000|COMPLETED|Second Intervention Period (1 Day)||6
6565646|NCT01819922|7488527|FG001|COMPLETED|Second Intervention Period (1 Day)||6
6565647|NCT01819922|7488526|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
6565648|NCT01819922|7488527|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
6565649|NCT01819935|7488535|FG000|STARTED|Overall Study||328
6565650|NCT01819935|7488536|FG001|STARTED|Overall Study||4943
6565651|NCT01819935|7488535|FG000|COMPLETED|Overall Study||328
6565652|NCT01819935|7488536|FG001|COMPLETED|Overall Study||4943
6565653|NCT01819935|7488535|FG000|NOT COMPLETED|Overall Study||0
6565654|NCT01819935|7488536|FG001|NOT COMPLETED|Overall Study||0
6565655|NCT01820260|7488556|FG000|STARTED|Phase 1 (Part 1)||3
6565656|NCT01820260|7488557|FG001|STARTED|Phase 1 (Part 1)||12
6565657|NCT01820260|7488558|FG002|STARTED|Phase 1 (Part 1)||10
6565658|NCT01820260|7488559|FG003|STARTED|Phase 1 (Part 1)||12
6565659|NCT01820260|7488560|FG004|STARTED|Phase 1 (Part 1)||12
6565660|NCT01820260|7488561|FG005|STARTED|Phase 1 (Part 1)||10
6565661|NCT01820260|7488562|FG006|STARTED|Phase 1 (Part 1)||12
6565662|NCT01820260|7488563|FG007|STARTED|Phase 1 (Part 1)||11
6565663|NCT01820260|7488564|FG008|STARTED|Phase 1 (Part 1)||0
6565664|NCT01820260|7488565|FG009|STARTED|Phase 1 (Part 1)||0
6565665|NCT01820260|7488566|FG010|STARTED|Phase 1 (Part 1)||0
6565666|NCT01820260|7488567|FG011|STARTED|Phase 1 (Part 1)||0
6565667|NCT01820260|7488568|FG012|STARTED|Phase 1 (Part 1)||0
6565668|NCT01820260|7488569|FG013|STARTED|Phase 1 (Part 1)||0
6565669|NCT01820260|7488556|FG000|COMPLETED|Phase 1 (Part 1)||3
6565670|NCT01820260|7488557|FG001|COMPLETED|Phase 1 (Part 1)||12
6565671|NCT01820260|7488558|FG002|COMPLETED|Phase 1 (Part 1)||10
6565672|NCT01820260|7488559|FG003|COMPLETED|Phase 1 (Part 1)||12
6565673|NCT01820260|7488560|FG004|COMPLETED|Phase 1 (Part 1)||12
6565674|NCT01820260|7488561|FG005|COMPLETED|Phase 1 (Part 1)||10
6565675|NCT01820260|7488562|FG006|COMPLETED|Phase 1 (Part 1)||11
6565676|NCT01820260|7488563|FG007|COMPLETED|Phase 1 (Part 1)||11
6565677|NCT01820260|7488564|FG008|COMPLETED|Phase 1 (Part 1)||0
6565678|NCT01820260|7488565|FG009|COMPLETED|Phase 1 (Part 1)||0
6565679|NCT01820260|7488566|FG010|COMPLETED|Phase 1 (Part 1)||0
6387053|NCT00812929|7298393|FG005|STARTED|Treatment Period 4||4
6503889|NCT01445535|7422935|FG000|COMPLETED|Overall Study||2
6503890|NCT01445535|7422936|FG001|COMPLETED|Overall Study||3
6503891|NCT01445535|7422937|FG002|COMPLETED|Overall Study||2
6565680|NCT01820260|7488567|FG011|COMPLETED|Phase 1 (Part 1)||0
6565681|NCT01820260|7488568|FG012|COMPLETED|Phase 1 (Part 1)||0
6565682|NCT01820260|7488569|FG013|COMPLETED|Phase 1 (Part 1)||0
6565683|NCT01820260|7488556|FG000|NOT COMPLETED|Phase 1 (Part 1)||0
6565684|NCT01820260|7488557|FG001|NOT COMPLETED|Phase 1 (Part 1)||0
6805186|NCT02149121|7737227|FG002|STARTED|Main Study Period||60
6565685|NCT01820260|7488558|FG002|NOT COMPLETED|Phase 1 (Part 1)||0
6565686|NCT01820260|7488559|FG003|NOT COMPLETED|Phase 1 (Part 1)||0
6565687|NCT01820260|7488560|FG004|NOT COMPLETED|Phase 1 (Part 1)||0
6805187|NCT02149121|7737228|FG003|STARTED|Main Study Period||0
6805188|NCT02149121|7737229|FG004|STARTED|Main Study Period||0
6805189|NCT02149121|7737230|FG005|STARTED|Main Study Period||0
6805190|NCT02149121|7737231|FG006|STARTED|Main Study Period||0
6805191|NCT02149121|7737225|FG000|COMPLETED|Main Study Period||140
6805192|NCT02149121|7737226|FG001|COMPLETED|Main Study Period||134
6805193|NCT02149121|7737227|FG002|COMPLETED|Main Study Period||56
6805194|NCT02149121|7737228|FG003|COMPLETED|Main Study Period||0
6805195|NCT02149121|7737229|FG004|COMPLETED|Main Study Period||0
6805196|NCT02149121|7737230|FG005|COMPLETED|Main Study Period||0
6805197|NCT02149121|7737231|FG006|COMPLETED|Main Study Period||0
6805198|NCT02149121|7737225|FG000|NOT COMPLETED|Main Study Period||21
6805199|NCT02149121|7737226|FG001|NOT COMPLETED|Main Study Period||17
6805200|NCT02149121|7737227|FG002|NOT COMPLETED|Main Study Period||4
6805201|NCT02149121|7737228|FG003|NOT COMPLETED|Main Study Period||0
6805202|NCT02149121|7737229|FG004|NOT COMPLETED|Main Study Period||0
6805203|NCT02149121|7737230|FG005|NOT COMPLETED|Main Study Period||0
6805204|NCT02149121|7737231|FG006|NOT COMPLETED|Main Study Period||0
6805205|NCT02149121|7737225|FG000|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
6805206|NCT02149121|7737226|FG001|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
6805207|NCT02149121|7737227|FG002|STARTED|Extension Study Period|This group is for the Main Study Period, not for the Extension Study Period.|0
6805208|NCT02149121|7737228|FG003|STARTED|Extension Study Period|"Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9).~From 19 patients in CT-P10 who did not initiate the extension study period, one patient did not initiate the treatment course but had been included to extension period and was monitored up to week 48"|122
6805209|NCT02149121|7737229|FG004|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|64
6565688|NCT01820260|7488561|FG005|NOT COMPLETED|Phase 1 (Part 1)||0
6565689|NCT01820260|7488562|FG006|NOT COMPLETED|Phase 1 (Part 1)||1
6565690|NCT01820260|7488563|FG007|NOT COMPLETED|Phase 1 (Part 1)||0
6565691|NCT01820260|7488564|FG008|NOT COMPLETED|Phase 1 (Part 1)||0
6565692|NCT01820260|7488565|FG009|NOT COMPLETED|Phase 1 (Part 1)||0
6565693|NCT01820260|7488566|FG010|NOT COMPLETED|Phase 1 (Part 1)||0
6387054|NCT00812929|7298394|FG006|STARTED|Treatment Period 4||5
6387055|NCT00812929|7298395|FG007|STARTED|Treatment Period 4||5
6387056|NCT00812929|7298396|FG008|STARTED|Treatment Period 4||4
6387057|NCT00812929|7298397|FG009|STARTED|Treatment Period 4||4
6387058|NCT00812929|7298388|FG000|COMPLETED|Treatment Period 4||5
6387059|NCT00812929|7298389|FG001|COMPLETED|Treatment Period 4||4
6387060|NCT00812929|7298390|FG002|COMPLETED|Treatment Period 4||4
6387061|NCT00812929|7298391|FG003|COMPLETED|Treatment Period 4||4
6387062|NCT00812929|7298392|FG004|COMPLETED|Treatment Period 4||5
6387063|NCT00812929|7298393|FG005|COMPLETED|Treatment Period 4||4
6387064|NCT00812929|7298394|FG006|COMPLETED|Treatment Period 4||5
6387065|NCT00812929|7298395|FG007|COMPLETED|Treatment Period 4||5
6387066|NCT00812929|7298396|FG008|COMPLETED|Treatment Period 4||4
6387067|NCT00812929|7298397|FG009|COMPLETED|Treatment Period 4||4
6387068|NCT00812929|7298388|FG000|NOT COMPLETED|Treatment Period 4||0
6387069|NCT00812929|7298389|FG001|NOT COMPLETED|Treatment Period 4||0
6387070|NCT00812929|7298390|FG002|NOT COMPLETED|Treatment Period 4||0
6387071|NCT00812929|7298391|FG003|NOT COMPLETED|Treatment Period 4||0
6387072|NCT00812929|7298392|FG004|NOT COMPLETED|Treatment Period 4||0
6387073|NCT00812929|7298393|FG005|NOT COMPLETED|Treatment Period 4||0
6387074|NCT00812929|7298394|FG006|NOT COMPLETED|Treatment Period 4||0
6387075|NCT00812929|7298395|FG007|NOT COMPLETED|Treatment Period 4||0
6387076|NCT00812929|7298396|FG008|NOT COMPLETED|Treatment Period 4||0
6387077|NCT00812929|7298397|FG009|NOT COMPLETED|Treatment Period 4||0
6387078|NCT00812929|7298388|FG000|STARTED|Washout Period 4 (7 Days)||5
6387079|NCT00812929|7298389|FG001|STARTED|Washout Period 4 (7 Days)||4
6387080|NCT00812929|7298390|FG002|STARTED|Washout Period 4 (7 Days)||4
6387081|NCT00812929|7298391|FG003|STARTED|Washout Period 4 (7 Days)||4
6387082|NCT00812929|7298392|FG004|STARTED|Washout Period 4 (7 Days)||5
6387083|NCT00812929|7298393|FG005|STARTED|Washout Period 4 (7 Days)||4
6387084|NCT00812929|7298394|FG006|STARTED|Washout Period 4 (7 Days)||5
6387085|NCT00812929|7298395|FG007|STARTED|Washout Period 4 (7 Days)||5
6387086|NCT00812929|7298396|FG008|STARTED|Washout Period 4 (7 Days)||4
6387087|NCT00812929|7298397|FG009|STARTED|Washout Period 4 (7 Days)||4
6387088|NCT00812929|7298388|FG000|COMPLETED|Washout Period 4 (7 Days)||5
6387089|NCT00812929|7298389|FG001|COMPLETED|Washout Period 4 (7 Days)||4
6387090|NCT00812929|7298390|FG002|COMPLETED|Washout Period 4 (7 Days)||4
6387091|NCT00812929|7298391|FG003|COMPLETED|Washout Period 4 (7 Days)||4
6387092|NCT00812929|7298392|FG004|COMPLETED|Washout Period 4 (7 Days)||5
6387093|NCT00812929|7298393|FG005|COMPLETED|Washout Period 4 (7 Days)||4
6387094|NCT00812929|7298394|FG006|COMPLETED|Washout Period 4 (7 Days)||5
6387095|NCT00812929|7298395|FG007|COMPLETED|Washout Period 4 (7 Days)||5
6387096|NCT00812929|7298396|FG008|COMPLETED|Washout Period 4 (7 Days)||4
6387097|NCT00812929|7298397|FG009|COMPLETED|Washout Period 4 (7 Days)||4
6387098|NCT00812929|7298388|FG000|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387099|NCT00812929|7298389|FG001|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387100|NCT00812929|7298390|FG002|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387101|NCT00812929|7298391|FG003|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387102|NCT00812929|7298392|FG004|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387103|NCT00812929|7298393|FG005|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387104|NCT00812929|7298394|FG006|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387105|NCT00812929|7298395|FG007|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387106|NCT00812929|7298396|FG008|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387107|NCT00812929|7298397|FG009|NOT COMPLETED|Washout Period 4 (7 Days)||0
6387108|NCT00812929|7298388|FG000|STARTED|Treatment Period 5||5
6387109|NCT00812929|7298389|FG001|STARTED|Treatment Period 5||4
6387110|NCT00812929|7298390|FG002|STARTED|Treatment Period 5||4
6271855|NCT00092534|7171198|FG004|NOT COMPLETED|Base Study EXT||0
6271856|NCT00092534|7171194|FG000|STARTED|Long-Term Follow-Up (LTFU) Study||0
6271857|NCT00092534|7171195|FG001|STARTED|Long-Term Follow-Up (LTFU) Study||0
6271858|NCT00092534|7171196|FG002|STARTED|Long-Term Follow-Up (LTFU) Study||0
6271859|NCT00092534|7171197|FG003|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2750
6271860|NCT00092534|7171198|FG004|STARTED|Long-Term Follow-Up (LTFU) Study|Some Base Study participants did not consent for inclusion in the LTFU.|2097
6271861|NCT00092534|7171194|FG000|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
6271862|NCT00092534|7171195|FG001|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
6271863|NCT00092534|7171196|FG002|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||0
6271864|NCT00092534|7171197|FG003|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2650
6805210|NCT02149121|7737230|FG005|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|62
6805211|NCT02149121|7737231|FG006|STARTED|Extension Study Period|Some participants did not initiate the Extension Study Period (CT-P10: 19, Rituxan: 8, MabThera: 9)|47
6805212|NCT02149121|7737225|FG000|COMPLETED|Extension Study Period||0
6805213|NCT02149121|7737226|FG001|COMPLETED|Extension Study Period||0
6805214|NCT02149121|7737227|FG002|COMPLETED|Extension Study Period||0
6805215|NCT02149121|7737228|FG003|COMPLETED|Extension Study Period||121
6805216|NCT02149121|7737229|FG004|COMPLETED|Extension Study Period||64
6805217|NCT02149121|7737230|FG005|COMPLETED|Extension Study Period||60
6805218|NCT02149121|7737231|FG006|COMPLETED|Extension Study Period||47
6805219|NCT02149121|7737225|FG000|NOT COMPLETED|Extension Study Period||0
6805220|NCT02149121|7737226|FG001|NOT COMPLETED|Extension Study Period||0
6805221|NCT02149121|7737227|FG002|NOT COMPLETED|Extension Study Period||0
6805222|NCT02149121|7737228|FG003|NOT COMPLETED|Extension Study Period||1
6805223|NCT02149121|7737229|FG004|NOT COMPLETED|Extension Study Period||0
6805224|NCT02149121|7737230|FG005|NOT COMPLETED|Extension Study Period||2
6805225|NCT02149121|7737231|FG006|NOT COMPLETED|Extension Study Period||0
6805226|NCT01889186|7737254|FG000|STARTED|Overall Study||107
6805227|NCT01889186|7737255|FG001|STARTED|Overall Study||51
6805228|NCT01889186|7737254|FG000|COMPLETED|Overall Study||0
6805229|NCT01889186|7737255|FG001|COMPLETED|Overall Study||0
6805230|NCT01889186|7737254|FG000|NOT COMPLETED|Overall Study||107
6805231|NCT01889186|7737255|FG001|NOT COMPLETED|Overall Study||51
6805232|NCT01850004|7737263|FG000|STARTED|Overall Study||84
6805233|NCT01850004|7737263|FG000|COMPLETED|Overall Study||76
6805234|NCT01850004|7737263|FG000|NOT COMPLETED|Overall Study||8
6805235|NCT01849263|7737268|FG000|STARTED|Overall Study||40
6805236|NCT01849263|7737268|FG000|COMPLETED|Overall Study||40
6271865|NCT00092534|7171198|FG004|Started: Registry-based Effectiveness|Long-Term Follow-Up (LTFU) Study||2050
6387111|NCT00812929|7298391|FG003|STARTED|Treatment Period 5||4
6387112|NCT00812929|7298392|FG004|STARTED|Treatment Period 5||5
6387113|NCT00812929|7298393|FG005|STARTED|Treatment Period 5||4
6387114|NCT00812929|7298394|FG006|STARTED|Treatment Period 5||5
6387115|NCT00812929|7298395|FG007|STARTED|Treatment Period 5||5
6387116|NCT00812929|7298396|FG008|STARTED|Treatment Period 5||4
6387117|NCT00812929|7298397|FG009|STARTED|Treatment Period 5||4
6387118|NCT00812929|7298388|FG000|COMPLETED|Treatment Period 5||5
6387119|NCT00812929|7298389|FG001|COMPLETED|Treatment Period 5||4
6387120|NCT00812929|7298390|FG002|COMPLETED|Treatment Period 5||4
6387121|NCT00812929|7298391|FG003|COMPLETED|Treatment Period 5||4
6387122|NCT00812929|7298392|FG004|COMPLETED|Treatment Period 5||5
6387123|NCT00812929|7298393|FG005|COMPLETED|Treatment Period 5||4
6387124|NCT00812929|7298394|FG006|COMPLETED|Treatment Period 5||5
6387125|NCT00812929|7298395|FG007|COMPLETED|Treatment Period 5||5
6387126|NCT00812929|7298396|FG008|COMPLETED|Treatment Period 5||4
6387127|NCT00812929|7298397|FG009|COMPLETED|Treatment Period 5||4
6387128|NCT00812929|7298388|FG000|NOT COMPLETED|Treatment Period 5||0
6387129|NCT00812929|7298389|FG001|NOT COMPLETED|Treatment Period 5||0
6387130|NCT00812929|7298390|FG002|NOT COMPLETED|Treatment Period 5||0
6387131|NCT00812929|7298391|FG003|NOT COMPLETED|Treatment Period 5||0
6387132|NCT00812929|7298392|FG004|NOT COMPLETED|Treatment Period 5||0
6387133|NCT00812929|7298393|FG005|NOT COMPLETED|Treatment Period 5||0
6387134|NCT00812929|7298394|FG006|NOT COMPLETED|Treatment Period 5||0
6387135|NCT00812929|7298395|FG007|NOT COMPLETED|Treatment Period 5||0
6387136|NCT00812929|7298396|FG008|NOT COMPLETED|Treatment Period 5||0
6387137|NCT00812929|7298397|FG009|NOT COMPLETED|Treatment Period 5||0
6387138|NCT00812955|7298418|FG000|STARTED|Overall Study||119
6387139|NCT00812955|7298419|FG001|STARTED|Overall Study||118
6387140|NCT00812955|7298420|FG002|STARTED|Overall Study||119
6387141|NCT00812955|7298421|FG003|STARTED|Overall Study||118
6387142|NCT00812955|7298418|FG000|COMPLETED|Overall Study||109
6387143|NCT00812955|7298419|FG001|COMPLETED|Overall Study||111
6805237|NCT01849263|7737268|FG000|NOT COMPLETED|Overall Study||0
6805238|NCT01844505|7737275|FG000|STARTED|Overall Study||313
6805239|NCT01844505|7737276|FG001|STARTED|Overall Study||313
6805240|NCT01844505|7737277|FG002|STARTED|Overall Study||311
6805241|NCT01844505|7737275|FG000|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|64
6805242|NCT01844505|7737276|FG001|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|44
6271866|NCT00092534|7171194|FG000|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
6271867|NCT00092534|7171195|FG001|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
6271868|NCT00092534|7171196|FG002|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||0
6271869|NCT00092534|7171197|FG003|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||2385
6271870|NCT00092534|7171198|FG004|Started: Immunogenicity Analysis|Long-Term Follow-Up (LTFU) Study||1849
6271871|NCT00092534|7171194|FG000|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
6271872|NCT00092534|7171195|FG001|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
6271873|NCT00092534|7171196|FG002|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||0
6271874|NCT00092534|7171197|FG003|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||2448
6271875|NCT00092534|7171198|FG004|Started: Registry-based Safety|Long-Term Follow-Up (LTFU) Study||1888
6271876|NCT00092534|7171194|FG000|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6271877|NCT00092534|7171195|FG001|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6271878|NCT00092534|7171196|FG002|COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6565694|NCT01820260|7488567|FG011|NOT COMPLETED|Phase 1 (Part 1)||0
6565695|NCT01820260|7488568|FG012|NOT COMPLETED|Phase 1 (Part 1)||0
6271879|NCT00092534|7171197|FG003|COMPLETED|Long-Term Follow-Up (LTFU) Study||2749
6271880|NCT00092534|7171198|FG004|COMPLETED|Long-Term Follow-Up (LTFU) Study||2097
6271881|NCT00092534|7171194|FG000|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6271882|NCT00092534|7171195|FG001|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6271883|NCT00092534|7171196|FG002|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6271884|NCT00092534|7171197|FG003|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||1
6271885|NCT00092534|7171198|FG004|NOT COMPLETED|Long-Term Follow-Up (LTFU) Study||0
6271886|NCT00092547|7171210|FG000|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
6271887|NCT00092547|7171211|FG001|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
6271888|NCT00092547|7171212|FG002|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
6271889|NCT00092547|7171210|FG000|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
6271890|NCT00092547|7171211|FG001|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
6271891|NCT00092547|7171212|FG002|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
6271892|NCT00092547|7171210|FG000|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
6271893|NCT00092547|7171211|FG001|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
6271894|NCT00092547|7171212|FG002|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
6271895|NCT00092547|7171210|FG000|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
6271896|NCT00092547|7171211|FG001|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
6271897|NCT00092547|7171212|FG002|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
6271898|NCT00092547|7171210|FG000|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
6271899|NCT00092547|7171211|FG001|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
6271900|NCT00092547|7171212|FG002|STARTED|Base Follow-up Phase (Month 7 to 18)||0
6271901|NCT00092547|7171210|FG000|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
6271902|NCT00092547|7171211|FG001|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
6271903|NCT00092547|7171212|FG002|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
6387144|NCT00812955|7298420|FG002|COMPLETED|Overall Study||113
6387145|NCT00812955|7298421|FG003|COMPLETED|Overall Study||110
6387146|NCT00812955|7298418|FG000|NOT COMPLETED|Overall Study||10
6387147|NCT00812955|7298419|FG001|NOT COMPLETED|Overall Study||7
6387148|NCT00812955|7298420|FG002|NOT COMPLETED|Overall Study||6
6387149|NCT00812955|7298421|FG003|NOT COMPLETED|Overall Study||8
6387150|NCT00812968|7298435|FG000|STARTED|Overall Study||11
6387151|NCT00812968|7298435|FG000|COMPLETED|Overall Study||0
6387152|NCT00812968|7298435|FG000|NOT COMPLETED|Overall Study||11
6387153|NCT00812981|7298443|FG000|STARTED|Overall Study||160
6387154|NCT00812981|7298444|FG001|STARTED|Overall Study||160
6387155|NCT00812981|7298443|FG000|COMPLETED|Overall Study||160
6387156|NCT00812981|7298444|FG001|COMPLETED|Overall Study||159
6387157|NCT00812981|7298443|FG000|NOT COMPLETED|Overall Study||0
6387158|NCT00812981|7298444|FG001|NOT COMPLETED|Overall Study||1
6387159|NCT00813098|7298453|FG000|STARTED|Overall Study||49
6387160|NCT00813098|7298454|FG001|STARTED|Overall Study||54
6565696|NCT01820260|7488569|FG013|NOT COMPLETED|Phase 1 (Part 1)||0
6271904|NCT00092547|7171210|FG000|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
6271905|NCT00092547|7171211|FG001|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
6271906|NCT00092547|7171212|FG002|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
6271907|NCT00092547|7171210|FG000|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
6271908|NCT00092547|7171211|FG001|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
6271909|NCT00092547|7171212|FG002|STARTED|Base Follow-up Phase (Month 18 to 30)||0
6271910|NCT00092547|7171210|FG000|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
6271911|NCT00092547|7171211|FG001|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
6271912|NCT00092547|7171212|FG002|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
6271913|NCT00092547|7171210|FG000|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
6271914|NCT00092547|7171211|FG001|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
6271915|NCT00092547|7171212|FG002|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
6271916|NCT00092547|7171210|FG000|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
6271917|NCT00092547|7171211|FG001|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
6280706|NCT00159263|7180667|FG003|STARTED|Second Intervention||2
6280707|NCT00159263|7180668|FG004|STARTED|Second Intervention||2
6387161|NCT00813098|7298455|FG002|STARTED|Overall Study||52
6387162|NCT00813098|7298453|FG000|COMPLETED|Overall Study||46
6387163|NCT00813098|7298454|FG001|COMPLETED|Overall Study||46
6387164|NCT00813098|7298455|FG002|COMPLETED|Overall Study||50
6387165|NCT00813098|7298453|FG000|NOT COMPLETED|Overall Study||3
6387166|NCT00813098|7298454|FG001|NOT COMPLETED|Overall Study||8
6387167|NCT00813098|7298455|FG002|NOT COMPLETED|Overall Study||2
6387168|NCT00813111|7298465|FG000|STARTED|Overall Study||66
6387169|NCT00813111|7298466|FG001|STARTED|Overall Study||70
6387170|NCT00813111|7298465|FG000|COMPLETED|Overall Study||64
6387171|NCT00813111|7298466|FG001|COMPLETED|Overall Study||70
6387172|NCT00813111|7298465|FG000|NOT COMPLETED|Overall Study||2
6387173|NCT00813111|7298466|FG001|NOT COMPLETED|Overall Study||0
6387174|NCT00813124|7298472|FG000|STARTED|Overall Study||24
6387175|NCT00813124|7298472|FG000|COMPLETED|Overall Study||12
6387176|NCT00813124|7298472|FG000|NOT COMPLETED|Overall Study||12
6387177|NCT00813150|7298478|FG000|STARTED|Treatment Period|Number of randomized and treated participants|46
6387178|NCT00813150|7298479|FG001|STARTED|Treatment Period|Number of randomized and treated participants|47
6387179|NCT00813150|7298478|FG000|Intent-to-treat Participants|Treatment Period||43
6387180|NCT00813150|7298479|FG001|Intent-to-treat Participants|Treatment Period||47
6387181|NCT00813150|7298478|FG000|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
6387182|NCT00813150|7298479|FG001|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
6387183|NCT00813150|7298478|FG000|NOT COMPLETED|Treatment Period||32
6387184|NCT00813150|7298479|FG001|NOT COMPLETED|Treatment Period||32
6387185|NCT00813150|7298478|FG000|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
6387186|NCT00813150|7298479|FG001|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
6387187|NCT00813150|7298478|FG000|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
6387188|NCT00813150|7298479|FG001|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
6387189|NCT00813150|7298478|FG000|NOT COMPLETED|Long Term Follow-up||24
6387190|NCT00813150|7298479|FG001|NOT COMPLETED|Long Term Follow-up||31
6387191|NCT00813176|7298487|FG000|STARTED|Overall Study||25
6271918|NCT00092547|7171212|FG002|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
6271919|NCT00092547|7171210|FG000|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
6271920|NCT00092547|7171211|FG001|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
6271921|NCT00092547|7171212|FG002|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
6271922|NCT00092547|7171210|FG000|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
6271923|NCT00092547|7171211|FG001|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
6271924|NCT00092547|7171212|FG002|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
6271925|NCT00092547|7171210|FG000|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
6271926|NCT00092547|7171211|FG001|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
6271927|NCT00092547|7171212|FG002|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
6271928|NCT00092547|7171210|FG000|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
6271929|NCT00092547|7171211|FG001|STARTED|Long-term Follow-up (Month 42 Visit)||0
6271930|NCT00092547|7171212|FG002|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
6271931|NCT00092547|7171210|FG000|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
6271932|NCT00092547|7171211|FG001|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
6271933|NCT00092547|7171212|FG002|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
6271934|NCT00092547|7171210|FG000|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
6271935|NCT00092547|7171211|FG001|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
6271936|NCT00092547|7171212|FG002|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
6271937|NCT00092547|7171210|FG000|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
6271938|NCT00092547|7171211|FG001|STARTED|Long-term Follow-up (Month 72 Visit)||0
6271939|NCT00092547|7171212|FG002|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
6271940|NCT00092547|7171210|FG000|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
6271941|NCT00092547|7171211|FG001|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
6271942|NCT00092547|7171212|FG002|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
6271943|NCT00092547|7171210|FG000|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
6271944|NCT00092547|7171211|FG001|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
6271945|NCT00092547|7171212|FG002|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
6271946|NCT00092547|7171210|FG000|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
6271947|NCT00092547|7171211|FG001|STARTED|Long-term Follow-up (Month 96 Visit)||0
6271948|NCT00092547|7171212|FG002|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
6271949|NCT00092547|7171210|FG000|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
6271950|NCT00092547|7171211|FG001|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
6271951|NCT00092547|7171212|FG002|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
6271952|NCT00092547|7171210|FG000|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
6271953|NCT00092547|7171211|FG001|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
6271954|NCT00092547|7171212|FG002|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
6271955|NCT00092547|7171210|FG000|STARTED|Long-term Follow-up (Month 126 Visit)||454
6271956|NCT00092547|7171211|FG001|STARTED|Long-term Follow-up (Month 126 Visit)||0
6271957|NCT00092547|7171212|FG002|STARTED|Long-term Follow-up (Month 126 Visit)||211
6271958|NCT00092547|7171210|FG000|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
6271959|NCT00092547|7171211|FG001|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
6271960|NCT00092547|7171212|FG002|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
6271961|NCT00092547|7171210|FG000|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
6271962|NCT00092547|7171211|FG001|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
6271963|NCT00092547|7171212|FG002|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
6271964|NCT00093015|7171225|FG000|STARTED|Overall Study||2026
6271965|NCT00093015|7171226|FG001|STARTED|Overall Study||2012
6271966|NCT00093015|7171225|FG000|Received Study Medication|Overall Study||2019
6271967|NCT00093015|7171226|FG001|Received Study Medication|Overall Study||2004
6271968|NCT00093015|7171225|FG000|COMPLETED|Overall Study||1361
6271969|NCT00093015|7171226|FG001|COMPLETED|Overall Study||1348
6271970|NCT00093015|7171225|FG000|NOT COMPLETED|Overall Study||665
6271971|NCT00093015|7171226|FG001|NOT COMPLETED|Overall Study||664
6271972|NCT00093041|7171238|FG000|STARTED|Overall Study||4
6271973|NCT00093041|7171239|FG001|STARTED|Overall Study||4
6271974|NCT00093041|7171240|FG002|STARTED|Overall Study||5
6271975|NCT00093041|7171241|FG003|STARTED|Overall Study||4
6271976|NCT00093041|7171242|FG004|STARTED|Overall Study||4
6271977|NCT00093041|7171243|FG005|STARTED|Overall Study||7
6280708|NCT00159263|7180669|FG005|STARTED|Second Intervention||2
6271978|NCT00093041|7171238|FG000|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
6271979|NCT00093041|7171239|FG001|COMPLETED|Overall Study|Three discontinued during single dose period|1
6271980|NCT00093041|7171240|FG002|COMPLETED|Overall Study|Two discontinued during single dose period|3
6271981|NCT00093041|7171241|FG003|COMPLETED|Overall Study|One discontinued during single dose period|3
6271982|NCT00093041|7171242|FG004|COMPLETED|Overall Study|One discontinued during multiple dose period|3
6271983|NCT00093041|7171243|FG005|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
6271984|NCT00093041|7171238|FG000|NOT COMPLETED|Overall Study||2
6271985|NCT00093041|7171239|FG001|NOT COMPLETED|Overall Study||3
6271986|NCT00093041|7171240|FG002|NOT COMPLETED|Overall Study||2
6271987|NCT00093041|7171241|FG003|NOT COMPLETED|Overall Study||1
6271988|NCT00093041|7171242|FG004|NOT COMPLETED|Overall Study||1
6271989|NCT00093041|7171243|FG005|NOT COMPLETED|Overall Study||3
6271990|NCT00093145|7171257|FG000|STARTED|Overall Study||32
6271991|NCT00093145|7171257|FG000|At Least One Response Assessment|Overall Study||31
6271992|NCT00093145|7171257|FG000|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
6271993|NCT00093145|7171257|FG000|NOT COMPLETED|Overall Study||17
6271994|NCT00093379|7171261|FG000|STARTED|Overall Study||20
6271995|NCT00093379|7171261|FG000|COMPLETED|Overall Study||20
6271996|NCT00093379|7171261|FG000|NOT COMPLETED|Overall Study||0
6271997|NCT00093470|7171267|FG000|STARTED|Overall Study||73
6271998|NCT00093470|7171268|FG001|STARTED|Overall Study||71
6271999|NCT00093470|7171267|FG000|Treated|Overall Study||72
6272000|NCT00093470|7171268|FG001|Treated|Overall Study||71
6272001|NCT00093470|7171267|FG000|Patients With Toxicity Assessment|Overall Study||72
6272002|NCT00093470|7171268|FG001|Patients With Toxicity Assessment|Overall Study||69
6272003|NCT00093470|7171267|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
6272004|NCT00093470|7171268|FG001|COMPLETED|Overall Study|Patients underwent observation only.|71
6272005|NCT00093470|7171267|FG000|NOT COMPLETED|Overall Study||73
6272006|NCT00093470|7171268|FG001|NOT COMPLETED|Overall Study||0
6272007|NCT00093496|7171276|FG000|STARTED|Overall Study||15
6272008|NCT00093496|7171277|FG001|STARTED|Overall Study||14
6272009|NCT00093496|7171276|FG000|COMPLETED|Overall Study||14
6272010|NCT00093496|7171277|FG001|COMPLETED|Overall Study||11
6272011|NCT00093496|7171276|FG000|NOT COMPLETED|Overall Study||1
6272012|NCT00093496|7171277|FG001|NOT COMPLETED|Overall Study||3
6272013|NCT00093756|7171284|FG000|STARTED|Overall Study||27
6272014|NCT00093756|7171285|FG001|STARTED|Overall Study||21
6272015|NCT00093756|7171284|FG000|COMPLETED|Overall Study||27
6272016|NCT00093756|7171285|FG001|COMPLETED|Overall Study||21
6272017|NCT00093756|7171284|FG000|NOT COMPLETED|Overall Study||0
6272018|NCT00093756|7171285|FG001|NOT COMPLETED|Overall Study||0
6272019|NCT00093782|7171293|FG000|STARTED|Overall Study||36
6272020|NCT00093782|7171293|FG000|COMPLETED|Overall Study||36
6272021|NCT00093782|7171293|FG000|NOT COMPLETED|Overall Study||0
6272022|NCT00093795|7171300|FG000|STARTED|Overall Study||1630
6272023|NCT00093795|7171301|FG001|STARTED|Overall Study||1634
6272024|NCT00093795|7171302|FG002|STARTED|Overall Study||1630
6272025|NCT00093795|7171300|FG000|COMPLETED|Overall Study||1610
6272026|NCT00093795|7171301|FG001|COMPLETED|Overall Study||1618
6272027|NCT00093795|7171302|FG002|COMPLETED|Overall Study||1613
6272028|NCT00093795|7171300|FG000|NOT COMPLETED|Overall Study||20
6272029|NCT00093795|7171301|FG001|NOT COMPLETED|Overall Study||16
6272030|NCT00093795|7171302|FG002|NOT COMPLETED|Overall Study||17
6272031|NCT00093808|7171310|FG000|STARTED|Overall Study||47
6272032|NCT00093808|7171310|FG000|COMPLETED|Overall Study||45
6272033|NCT00093808|7171310|FG000|NOT COMPLETED|Overall Study||2
6272034|NCT00093847|7171316|FG000|STARTED|Overall Study||39
6272035|NCT00093847|7171317|FG001|STARTED|Overall Study||34
6272036|NCT00093847|7171316|FG000|COMPLETED|Overall Study||31
6272037|NCT00093847|7171317|FG001|COMPLETED|Overall Study||24
6272038|NCT00093847|7171316|FG000|NOT COMPLETED|Overall Study||8
6272039|NCT00093847|7171317|FG001|NOT COMPLETED|Overall Study||10
6280709|NCT00159263|7180664|FG000|COMPLETED|Second Intervention||1
6280710|NCT00159263|7180665|FG001|COMPLETED|Second Intervention||1
6280711|NCT00159263|7180666|FG002|COMPLETED|Second Intervention||2
6280712|NCT00159263|7180667|FG003|COMPLETED|Second Intervention||2
6280713|NCT00159263|7180668|FG004|COMPLETED|Second Intervention||2
6280714|NCT00159263|7180669|FG005|COMPLETED|Second Intervention||2
6280715|NCT00159263|7180664|FG000|NOT COMPLETED|Second Intervention||0
6280716|NCT00159263|7180665|FG001|NOT COMPLETED|Second Intervention||0
6280717|NCT00159263|7180666|FG002|NOT COMPLETED|Second Intervention||0
6280718|NCT00159263|7180667|FG003|NOT COMPLETED|Second Intervention||0
6280719|NCT00159263|7180668|FG004|NOT COMPLETED|Second Intervention||0
6280720|NCT00159263|7180669|FG005|NOT COMPLETED|Second Intervention||0
6280721|NCT00159263|7180664|FG000|STARTED|Washout||1
6280722|NCT00159263|7180665|FG001|STARTED|Washout||1
6280723|NCT00159263|7180666|FG002|STARTED|Washout||2
6280724|NCT00159263|7180667|FG003|STARTED|Washout||2
6280725|NCT00159263|7180668|FG004|STARTED|Washout||2
6280726|NCT00159263|7180669|FG005|STARTED|Washout||2
6280727|NCT00159263|7180664|FG000|COMPLETED|Washout||1
6272040|NCT00093964|7171325|FG000|STARTED|Overall Study||41
6272041|NCT00093964|7171326|FG001|STARTED|Overall Study||40
6272042|NCT00093964|7171325|FG000|COMPLETED|Overall Study||41
6272043|NCT00093964|7171326|FG001|COMPLETED|Overall Study||40
6272044|NCT00093964|7171325|FG000|NOT COMPLETED|Overall Study||0
6272045|NCT00093964|7171326|FG001|NOT COMPLETED|Overall Study||0
6272046|NCT00094055|7171334|FG000|STARTED|Overall Study||60
6272047|NCT00094055|7171334|FG000|COMPLETED|Overall Study||0
6272048|NCT00094055|7171334|FG000|NOT COMPLETED|Overall Study||60
6272049|NCT00094094|7171338|FG000|STARTED|Overall Study||32
6272050|NCT00094094|7171338|FG000|COMPLETED|Overall Study||0
6272051|NCT00094094|7171338|FG000|NOT COMPLETED|Overall Study||32
6272052|NCT00094107|7171342|FG000|STARTED|Overall Study||32
6272053|NCT00094107|7171342|FG000|COMPLETED|Overall Study||0
6272054|NCT00094107|7171342|FG000|NOT COMPLETED|Overall Study||32
6272055|NCT00094172|7171348|FG000|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
6272056|NCT00094172|7171349|FG001|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
6272057|NCT00094172|7171348|FG000|COMPLETED|Overall Study||36
6272058|NCT00094172|7171349|FG001|COMPLETED|Overall Study||25
6272059|NCT00094172|7171348|FG000|NOT COMPLETED|Overall Study||14
6272060|NCT00094172|7171349|FG001|NOT COMPLETED|Overall Study||7
6272061|NCT00094211|7171359|FG000|STARTED|Overall Study||221
6272062|NCT00094211|7171360|FG001|STARTED|Overall Study||259
6272063|NCT00094211|7171361|FG002|STARTED|Overall Study||230
6272064|NCT00094211|7171362|FG003|STARTED|Overall Study||186
6272065|NCT00094211|7171359|FG000|COMPLETED|Overall Study||212
6272066|NCT00094211|7171360|FG001|COMPLETED|Overall Study||251
6272067|NCT00094211|7171361|FG002|COMPLETED|Overall Study||220
6565697|NCT01820260|7488556|FG000|STARTED|Phase 2 (Part 2)||0
6565698|NCT01820260|7488557|FG001|STARTED|Phase 2 (Part 2)||0
6565699|NCT01820260|7488558|FG002|STARTED|Phase 2 (Part 2)||0
6565700|NCT01820260|7488559|FG003|STARTED|Phase 2 (Part 2)||0
6565701|NCT01820260|7488560|FG004|STARTED|Phase 2 (Part 2)||0
6565702|NCT01820260|7488561|FG005|STARTED|Phase 2 (Part 2)||0
6565703|NCT01820260|7488562|FG006|STARTED|Phase 2 (Part 2)||0
6272068|NCT00094211|7171362|FG003|COMPLETED|Overall Study||179
6272069|NCT00094211|7171359|FG000|NOT COMPLETED|Overall Study||9
6272070|NCT00094211|7171360|FG001|NOT COMPLETED|Overall Study||8
6272071|NCT00094211|7171361|FG002|NOT COMPLETED|Overall Study||10
6272072|NCT00094211|7171362|FG003|NOT COMPLETED|Overall Study||7
6272073|NCT00094302|7171378|FG000|STARTED|Overall Study||1723
6272074|NCT00094302|7171379|FG001|STARTED|Overall Study||1722
6272075|NCT00094302|7171378|FG000|COMPLETED|Overall Study||1306
6272076|NCT00094302|7171379|FG001|COMPLETED|Overall Study||1316
6272077|NCT00094302|7171378|FG000|NOT COMPLETED|Overall Study||417
6272078|NCT00094302|7171379|FG001|NOT COMPLETED|Overall Study||406
6272079|NCT00094328|7171385|FG000|STARTED|Overall Study|Received treatment|14
6272080|NCT00094328|7171385|FG000|COMPLETED|Overall Study|Completed 12 months on treatment|13
6272081|NCT00094328|7171385|FG000|NOT COMPLETED|Overall Study||1
6272082|NCT00094445|7171389|FG000|STARTED|Overall Study||50
6272083|NCT00094445|7171389|FG000|COMPLETED|Overall Study||44
6272084|NCT00094445|7171389|FG000|NOT COMPLETED|Overall Study||6
6272085|NCT00094458|7171396|FG000|STARTED|Main Study: Through Week 30||170
6272086|NCT00094458|7171397|FG001|STARTED|Main Study: Through Week 30||169
6272087|NCT00094458|7171398|FG002|STARTED|Main Study: Through Week 30||169
6272088|NCT00094458|7171399|FG003|STARTED|Main Study: Through Week 30||0
6272089|NCT00094458|7171400|FG004|STARTED|Main Study: Through Week 30||0
6272090|NCT00094458|7171401|FG005|STARTED|Main Study: Through Week 30||0
6272091|NCT00094458|7171396|FG000|COMPLETED|Main Study: Through Week 30||86
6272092|NCT00094458|7171397|FG001|COMPLETED|Main Study: Through Week 30||111
6565704|NCT01820260|7488563|FG007|STARTED|Phase 2 (Part 2)||0
6565705|NCT01820260|7488564|FG008|STARTED|Phase 2 (Part 2)||64
6565706|NCT01820260|7488565|FG009|STARTED|Phase 2 (Part 2)||62
6272093|NCT00094458|7171398|FG002|COMPLETED|Main Study: Through Week 30||121
6272094|NCT00094458|7171399|FG003|COMPLETED|Main Study: Through Week 30||0
6272095|NCT00094458|7171400|FG004|COMPLETED|Main Study: Through Week 30||0
6272096|NCT00094458|7171401|FG005|COMPLETED|Main Study: Through Week 30||0
6272097|NCT00094458|7171396|FG000|NOT COMPLETED|Main Study: Through Week 30||84
6272098|NCT00094458|7171397|FG001|NOT COMPLETED|Main Study: Through Week 30||58
6272099|NCT00094458|7171398|FG002|NOT COMPLETED|Main Study: Through Week 30||48
6272100|NCT00094458|7171399|FG003|NOT COMPLETED|Main Study: Through Week 30||0
6272101|NCT00094458|7171400|FG004|NOT COMPLETED|Main Study: Through Week 30||0
6272102|NCT00094458|7171401|FG005|NOT COMPLETED|Main Study: Through Week 30||0
6272103|NCT00094458|7171396|FG000|STARTED|Study Extension: Week 30 Through Week 50||75
6272104|NCT00094458|7171397|FG001|STARTED|Study Extension: Week 30 Through Week 50||97
6272105|NCT00094458|7171398|FG002|STARTED|Study Extension: Week 30 Through Week 50||108
6387192|NCT00813176|7298488|FG001|STARTED|Overall Study||25
6387193|NCT00813176|7298487|FG000|COMPLETED|Overall Study||25
6387194|NCT00813176|7298488|FG001|COMPLETED|Overall Study||25
6387195|NCT00813176|7298487|FG000|NOT COMPLETED|Overall Study||0
6387196|NCT00813176|7298488|FG001|NOT COMPLETED|Overall Study||0
6387197|NCT00813293|7298498|FG000|STARTED|Overall Study||10
6387198|NCT00813293|7298499|FG001|STARTED|Overall Study||10
6387199|NCT00813293|7298498|FG000|Started Treatment|Overall Study||9
6387200|NCT00813293|7298499|FG001|Started Treatment|Overall Study||10
6387201|NCT00813293|7298498|FG000|Evaluable RFA|Overall Study||7
6387202|NCT00813293|7298499|FG001|Evaluable RFA|Overall Study||8
6387203|NCT00813293|7298498|FG000|COMPLETED|Overall Study||9
6387204|NCT00813293|7298499|FG001|COMPLETED|Overall Study||9
6387205|NCT00813293|7298498|FG000|NOT COMPLETED|Overall Study||1
6387206|NCT00813293|7298499|FG001|NOT COMPLETED|Overall Study||1
6387207|NCT00813319|7298507|FG000|STARTED|Overall Study||108
6387208|NCT00813319|7298508|FG001|STARTED|Overall Study||108
6387209|NCT00813319|7298507|FG000|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
6503892|NCT01445535|7422938|FG003|COMPLETED|Overall Study||4
6503893|NCT01445535|7422935|FG000|NOT COMPLETED|Overall Study||1
6503894|NCT01445535|7422936|FG001|NOT COMPLETED|Overall Study||0
6503895|NCT01445535|7422937|FG002|NOT COMPLETED|Overall Study||1
6503896|NCT01445535|7422938|FG003|NOT COMPLETED|Overall Study||2
6503897|NCT01445548|7422949|FG000|STARTED|Overall Study||6
6503898|NCT01445548|7422949|FG000|COMPLETED|Overall Study||5
6503899|NCT01445548|7422949|FG000|NOT COMPLETED|Overall Study||1
6503900|NCT01445613|7422953|FG000|STARTED|30-day Follow-up||1200
6503901|NCT01445613|7422953|FG000|COMPLETED|30-day Follow-up||1165
6503902|NCT01445613|7422953|FG000|NOT COMPLETED|30-day Follow-up||35
6503903|NCT01445613|7422953|FG000|STARTED|1-year Follow-up||1165
6503904|NCT01445613|7422953|FG000|COMPLETED|1-year Follow-up||1088
6503905|NCT01445613|7422953|FG000|NOT COMPLETED|1-year Follow-up||77
6503906|NCT01445626|7422963|FG000|STARTED|Overall Study||87
6503907|NCT01445626|7422963|FG000|COMPLETED|Overall Study||87
6503908|NCT01445626|7422963|FG000|NOT COMPLETED|Overall Study||0
6503909|NCT01445652|7422969|FG000|STARTED|Overall Study||57
6503910|NCT01445652|7422970|FG001|STARTED|Overall Study||53
6503911|NCT01445652|7422969|FG000|COMPLETED|Overall Study||47
6503912|NCT01445652|7422970|FG001|COMPLETED|Overall Study||50
6503913|NCT01445652|7422969|FG000|NOT COMPLETED|Overall Study||10
6503914|NCT01445652|7422970|FG001|NOT COMPLETED|Overall Study||3
6656849|NCT02465437|7587205|FG000|COMPLETED|Overall Study||8
6656850|NCT02465437|7587206|FG001|COMPLETED|Overall Study||8
6656851|NCT02465437|7587207|FG002|COMPLETED|Overall Study||8
6656852|NCT02465437|7587208|FG003|COMPLETED|Overall Study||14
6656853|NCT02465437|7587205|FG000|NOT COMPLETED|Overall Study||1
6656854|NCT02465437|7587206|FG001|NOT COMPLETED|Overall Study||1
6656855|NCT02465437|7587207|FG002|NOT COMPLETED|Overall Study||1
6656856|NCT02465437|7587208|FG003|NOT COMPLETED|Overall Study||1
6656857|NCT02465450|7587219|FG000|STARTED|Treatment Period 1||26
6656858|NCT02465450|7587220|FG001|STARTED|Treatment Period 1||24
6656859|NCT02465450|7587221|FG002|STARTED|Treatment Period 1||35
6656860|NCT02465450|7587222|FG003|STARTED|Treatment Period 1||0
6805243|NCT01844505|7737277|FG002|COMPLETED|Overall Study|Completed = Number of subjects continuing in the treatment period|16
6805244|NCT01844505|7737275|FG000|NOT COMPLETED|Overall Study||249
6805245|NCT01844505|7737276|FG001|NOT COMPLETED|Overall Study||269
6503915|NCT01445678|7422978|FG000|STARTED|Overall Study||482
6503916|NCT01445678|7422979|FG001|STARTED|Overall Study||497
6503917|NCT01445678|7422978|FG000|COMPLETED|Overall Study||452
6503918|NCT01445678|7422979|FG001|COMPLETED|Overall Study||476
6503919|NCT01445678|7422978|FG000|NOT COMPLETED|Overall Study||30
6503920|NCT01445678|7422979|FG001|NOT COMPLETED|Overall Study||21
6503921|NCT01445730|7422985|FG000|STARTED|Overall Study||82
6503922|NCT01445730|7422985|FG000|COMPLETED|Overall Study||71
6805246|NCT01844505|7737277|FG002|NOT COMPLETED|Overall Study||295
6503923|NCT01445730|7422985|FG000|NOT COMPLETED|Overall Study||11
6503924|NCT01445769|7422989|FG000|STARTED|Overall Study||45
6503925|NCT01445769|7422989|FG000|COMPLETED|Overall Study||37
6656861|NCT02465450|7587223|FG004|STARTED|Treatment Period 1||0
6387210|NCT00813319|7298508|FG001|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
6387211|NCT00813319|7298507|FG000|NOT COMPLETED|Overall Study||0
6387212|NCT00813319|7298508|FG001|NOT COMPLETED|Overall Study||0
6387213|NCT00813358|7298514|FG000|STARTED|Overall Study||115
6503926|NCT01445769|7422989|FG000|NOT COMPLETED|Overall Study||8
6503927|NCT01445821|7422997|FG000|STARTED|Overall Study||22
6503928|NCT01445821|7422998|FG001|STARTED|Overall Study||22
6503929|NCT01445821|7422997|FG000|COMPLETED|Overall Study||22
6503930|NCT01445821|7422998|FG001|COMPLETED|Overall Study||22
6503931|NCT01445821|7422997|FG000|NOT COMPLETED|Overall Study||0
6503932|NCT01445821|7422998|FG001|NOT COMPLETED|Overall Study||0
6503933|NCT01445847|7423006|FG000|STARTED|Overall Study||50
6503934|NCT01445847|7423007|FG001|STARTED|Overall Study||50
6503935|NCT01445847|7423006|FG000|COMPLETED|Overall Study||36
6503936|NCT01445847|7423007|FG001|COMPLETED|Overall Study||36
6503937|NCT01445847|7423006|FG000|NOT COMPLETED|Overall Study||14
6503938|NCT01445847|7423007|FG001|NOT COMPLETED|Overall Study||14
6503939|NCT01445873|7423013|FG000|STARTED|Overall Study||36
6503940|NCT01445873|7423013|FG000|COMPLETED|Overall Study||36
6503941|NCT01445873|7423013|FG000|NOT COMPLETED|Overall Study||0
6503942|NCT01445886|7423017|FG000|STARTED|Overall Study||33
6503943|NCT01445886|7423017|FG000|COMPLETED|Overall Study||28
6503944|NCT01445886|7423017|FG000|NOT COMPLETED|Overall Study||5
6503945|NCT01445951|7423026|FG000|STARTED|Overall Study||174
6503946|NCT01445951|7423027|FG001|STARTED|Overall Study||174
6565707|NCT01820260|7488566|FG010|STARTED|Phase 2 (Part 2)||61
6565708|NCT01820260|7488567|FG011|STARTED|Phase 2 (Part 2)||64
6565709|NCT01820260|7488568|FG012|STARTED|Phase 2 (Part 2)||31
6565710|NCT01820260|7488569|FG013|STARTED|Phase 2 (Part 2)||31
6565711|NCT01820260|7488556|FG000|COMPLETED|Phase 2 (Part 2)||0
6565712|NCT01820260|7488557|FG001|COMPLETED|Phase 2 (Part 2)||0
6565713|NCT01820260|7488558|FG002|COMPLETED|Phase 2 (Part 2)||0
6565714|NCT01820260|7488559|FG003|COMPLETED|Phase 2 (Part 2)||0
6565715|NCT01820260|7488560|FG004|COMPLETED|Phase 2 (Part 2)||0
6565716|NCT01820260|7488561|FG005|COMPLETED|Phase 2 (Part 2)||0
6565717|NCT01820260|7488562|FG006|COMPLETED|Phase 2 (Part 2)||0
6565718|NCT01820260|7488563|FG007|COMPLETED|Phase 2 (Part 2)||0
6565719|NCT01820260|7488564|FG008|COMPLETED|Phase 2 (Part 2)||64
6565720|NCT01820260|7488565|FG009|COMPLETED|Phase 2 (Part 2)||61
6565721|NCT01820260|7488566|FG010|COMPLETED|Phase 2 (Part 2)||61
6565722|NCT01820260|7488567|FG011|COMPLETED|Phase 2 (Part 2)||64
6565723|NCT01820260|7488568|FG012|COMPLETED|Phase 2 (Part 2)||31
6565724|NCT01820260|7488569|FG013|COMPLETED|Phase 2 (Part 2)||31
6565725|NCT01820260|7488556|FG000|NOT COMPLETED|Phase 2 (Part 2)||0
6565726|NCT01820260|7488557|FG001|NOT COMPLETED|Phase 2 (Part 2)||0
6565727|NCT01820260|7488558|FG002|NOT COMPLETED|Phase 2 (Part 2)||0
6565728|NCT01820260|7488559|FG003|NOT COMPLETED|Phase 2 (Part 2)||0
6565729|NCT01820260|7488560|FG004|NOT COMPLETED|Phase 2 (Part 2)||0
6565730|NCT01820260|7488561|FG005|NOT COMPLETED|Phase 2 (Part 2)||0
6565731|NCT01820260|7488562|FG006|NOT COMPLETED|Phase 2 (Part 2)||0
6565732|NCT01820260|7488563|FG007|NOT COMPLETED|Phase 2 (Part 2)||0
6565733|NCT01820260|7488564|FG008|NOT COMPLETED|Phase 2 (Part 2)||0
6565734|NCT01820260|7488565|FG009|NOT COMPLETED|Phase 2 (Part 2)||1
6565735|NCT01820260|7488566|FG010|NOT COMPLETED|Phase 2 (Part 2)||0
6565736|NCT01820260|7488567|FG011|NOT COMPLETED|Phase 2 (Part 2)||0
6565737|NCT01820260|7488568|FG012|NOT COMPLETED|Phase 2 (Part 2)||0
6565738|NCT01820260|7488569|FG013|NOT COMPLETED|Phase 2 (Part 2)||0
6565739|NCT01820364|7488605|FG000|STARTED|Part I: LGX818||15
6565740|NCT01820364|7488606|FG001|STARTED|Part I: LGX818||0
6565741|NCT01820364|7488605|FG000|COMPLETED|Part I: LGX818||1
6565742|NCT01820364|7488606|FG001|COMPLETED|Part I: LGX818||0
6565743|NCT01820364|7488605|FG000|NOT COMPLETED|Part I: LGX818||14
6565744|NCT01820364|7488606|FG001|NOT COMPLETED|Part I: LGX818||0
6565745|NCT01820364|7488605|FG000|STARTED|Part II: LGX818 + MEK162||0
6565746|NCT01820364|7488606|FG001|STARTED|Part II: LGX818 + MEK162||1
6565747|NCT01820364|7488605|FG000|COMPLETED|Part II: LGX818 + MEK162||0
6565748|NCT01820364|7488606|FG001|COMPLETED|Part II: LGX818 + MEK162||0
6565749|NCT01820364|7488605|FG000|NOT COMPLETED|Part II: LGX818 + MEK162||0
6565750|NCT01820364|7488606|FG001|NOT COMPLETED|Part II: LGX818 + MEK162||1
6565751|NCT01820416|7488615|FG000|STARTED|Overall Study||12
6565752|NCT01820416|7488616|FG001|STARTED|Overall Study||12
6565753|NCT01820416|7488617|FG002|STARTED|Overall Study||11
6565754|NCT01820416|7488615|FG000|COMPLETED|Overall Study||9
6565755|NCT01820416|7488616|FG001|COMPLETED|Overall Study||10
6565756|NCT01820416|7488617|FG002|COMPLETED|Overall Study||11
6565757|NCT01820416|7488615|FG000|NOT COMPLETED|Overall Study||3
6565758|NCT01820416|7488616|FG001|NOT COMPLETED|Overall Study||2
6565759|NCT01820416|7488617|FG002|NOT COMPLETED|Overall Study||0
6565760|NCT01820559|7488628|FG000|STARTED|Overall Study||136
6565761|NCT01820559|7488629|FG001|STARTED|Overall Study||135
6565762|NCT01820559|7488630|FG002|STARTED|Overall Study||139
6565763|NCT01820559|7488628|FG000|Randomized and Treated|Overall Study||136
6565764|NCT01820559|7488629|FG001|Randomized and Treated|Overall Study||135
6565765|NCT01820559|7488630|FG002|Randomized and Treated|Overall Study||139
6565766|NCT01820559|7488628|FG000|Completed Tutration Period|Overall Study||130
6565767|NCT01820559|7488629|FG001|Completed Tutration Period|Overall Study||134
6272106|NCT00094458|7171399|FG003|STARTED|Study Extension: Week 30 Through Week 50||0
6272107|NCT00094458|7171400|FG004|STARTED|Study Extension: Week 30 Through Week 50||0
6272108|NCT00094458|7171401|FG005|STARTED|Study Extension: Week 30 Through Week 50||0
6272109|NCT00094458|7171396|FG000|COMPLETED|Study Extension: Week 30 Through Week 50||67
6272110|NCT00094458|7171397|FG001|COMPLETED|Study Extension: Week 30 Through Week 50||85
6272111|NCT00094458|7171398|FG002|COMPLETED|Study Extension: Week 30 Through Week 50||90
6272112|NCT00094458|7171399|FG003|COMPLETED|Study Extension: Week 30 Through Week 50||0
6272113|NCT00094458|7171400|FG004|COMPLETED|Study Extension: Week 30 Through Week 50||0
6272114|NCT00094458|7171401|FG005|COMPLETED|Study Extension: Week 30 Through Week 50||0
6272115|NCT00094458|7171396|FG000|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
6272116|NCT00094458|7171397|FG001|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
6272117|NCT00094458|7171398|FG002|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
6272118|NCT00094458|7171399|FG003|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
6272119|NCT00094458|7171400|FG004|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
6272120|NCT00094458|7171401|FG005|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
6272121|NCT00094458|7171396|FG000|STARTED|OLE: Open-Label Extension||0
6272122|NCT00094458|7171397|FG001|STARTED|OLE: Open-Label Extension||0
6272123|NCT00094458|7171398|FG002|STARTED|OLE: Open-Label Extension||0
6272124|NCT00094458|7171399|FG003|STARTED|OLE: Open-Label Extension||8
6272125|NCT00094458|7171400|FG004|STARTED|OLE: Open-Label Extension||18
6272126|NCT00094458|7171401|FG005|STARTED|OLE: Open-Label Extension||17
6272127|NCT00094458|7171396|FG000|COMPLETED|OLE: Open-Label Extension||0
6272128|NCT00094458|7171397|FG001|COMPLETED|OLE: Open-Label Extension||0
6272129|NCT00094458|7171398|FG002|COMPLETED|OLE: Open-Label Extension||0
6272130|NCT00094458|7171399|FG003|COMPLETED|OLE: Open-Label Extension||7
6272131|NCT00094458|7171400|FG004|COMPLETED|OLE: Open-Label Extension||13
6272132|NCT00094458|7171401|FG005|COMPLETED|OLE: Open-Label Extension||13
6272133|NCT00094458|7171396|FG000|NOT COMPLETED|OLE: Open-Label Extension||0
6272134|NCT00094458|7171397|FG001|NOT COMPLETED|OLE: Open-Label Extension||0
6272135|NCT00094458|7171398|FG002|NOT COMPLETED|OLE: Open-Label Extension||0
6272136|NCT00094458|7171399|FG003|NOT COMPLETED|OLE: Open-Label Extension||1
6272137|NCT00094458|7171400|FG004|NOT COMPLETED|OLE: Open-Label Extension||5
6272138|NCT00094458|7171401|FG005|NOT COMPLETED|OLE: Open-Label Extension||4
6272139|NCT00094497|7171417|FG000|STARTED|Overall Study||151
6272140|NCT00094497|7171418|FG001|STARTED|Overall Study||153
6272141|NCT00094497|7171417|FG000|Treated|Overall Study||148
6272142|NCT00094497|7171418|FG001|Treated|Overall Study||149
6272143|NCT00094497|7171417|FG000|Received Second Line Therapy|Overall Study||84
6272144|NCT00094497|7171418|FG001|Received Second Line Therapy|Overall Study||101
6272145|NCT00094497|7171417|FG000|COMPLETED|Overall Study||151
6272146|NCT00094497|7171418|FG001|COMPLETED|Overall Study||153
6272147|NCT00094497|7171417|FG000|NOT COMPLETED|Overall Study||0
6272148|NCT00094497|7171418|FG001|NOT COMPLETED|Overall Study||0
6272149|NCT00094536|7171424|FG000|STARTED|Inclusion Exclusion Evaluation||106
6272150|NCT00094536|7171424|FG000|COMPLETED|Inclusion Exclusion Evaluation||82
6272151|NCT00094536|7171424|FG000|NOT COMPLETED|Inclusion Exclusion Evaluation||24
6272152|NCT00094536|7171424|FG000|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
6272153|NCT00094536|7171424|FG000|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
6272154|NCT00094536|7171424|FG000|24 Month Follow-up|Treatment and Follow-up||53
6272155|NCT00094536|7171424|FG000|36 Month Follow-up|Treatment and Follow-up||51
6272156|NCT00094536|7171424|FG000|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
6272157|NCT00094536|7171424|FG000|NOT COMPLETED|Treatment and Follow-up||31
6272158|NCT00094575|7171430|FG000|STARTED|Overall Study||444
6272159|NCT00094575|7171431|FG001|STARTED|Overall Study||437
6272160|NCT00094575|7171430|FG000|COMPLETED|Overall Study||298
6272161|NCT00094575|7171431|FG001|COMPLETED|Overall Study||291
6272162|NCT00094575|7171430|FG000|NOT COMPLETED|Overall Study||146
6272163|NCT00094575|7171431|FG001|NOT COMPLETED|Overall Study||146
6272164|NCT00094653|7171442|FG000|STARTED|Overall Study||403
6272165|NCT00094653|7171443|FG001|STARTED|Overall Study||137
6272166|NCT00094653|7171444|FG002|STARTED|Overall Study||136
6272167|NCT00094653|7171442|FG000|Treated|Overall Study||381
6272168|NCT00094653|7171443|FG001|Treated|Overall Study||131
6272169|NCT00094653|7171444|FG002|Treated|Overall Study||131
6272170|NCT00094653|7171442|FG000|COMPLETED|Overall Study||82
6272171|NCT00094653|7171443|FG001|COMPLETED|Overall Study||31
6272172|NCT00094653|7171444|FG002|COMPLETED|Overall Study||10
6272173|NCT00094653|7171442|FG000|NOT COMPLETED|Overall Study||321
6272174|NCT00094653|7171443|FG001|NOT COMPLETED|Overall Study||106
6272175|NCT00094653|7171444|FG002|NOT COMPLETED|Overall Study||126
6272176|NCT00094757|7171456|FG000|STARTED|Overall Study||205
6272177|NCT00094757|7171457|FG001|STARTED|Overall Study||206
6272178|NCT00094757|7171458|FG002|STARTED|Overall Study||110
6272179|NCT00094757|7171456|FG000|COMPLETED|Overall Study||152
6272180|NCT00094757|7171457|FG001|COMPLETED|Overall Study||144
6272181|NCT00094757|7171458|FG002|COMPLETED|Overall Study||80
6272182|NCT00094757|7171456|FG000|NOT COMPLETED|Overall Study||53
6272183|NCT00094757|7171457|FG001|NOT COMPLETED|Overall Study||62
6272184|NCT00094757|7171458|FG002|NOT COMPLETED|Overall Study||30
6272185|NCT00094770|7171468|FG000|STARTED|Year 1 ( Week 0 to Week 52)||588
6272186|NCT00094770|7171469|FG001|STARTED|Year 1 ( Week 0 to Week 52)||584
6280728|NCT00159263|7180665|FG001|COMPLETED|Washout||1
6387214|NCT00813358|7298514|FG000|COMPLETED|Overall Study||46
6387215|NCT00813358|7298514|FG000|NOT COMPLETED|Overall Study||69
6387216|NCT00813488|7298518|FG000|STARTED|Titration Period 1||107
6387217|NCT00813488|7298519|FG001|STARTED|Titration Period 1||106
6387218|NCT00813488|7298518|FG000|COMPLETED|Titration Period 1||80
6387219|NCT00813488|7298519|FG001|COMPLETED|Titration Period 1||89
6387220|NCT00813488|7298518|FG000|NOT COMPLETED|Titration Period 1||27
6387221|NCT00813488|7298519|FG001|NOT COMPLETED|Titration Period 1||17
6387222|NCT00813488|7298518|FG000|STARTED|Titration Period 2||80
6387223|NCT00813488|7298519|FG001|STARTED|Titration Period 2||89
6387224|NCT00813488|7298518|FG000|COMPLETED|Titration Period 2||64
6387225|NCT00813488|7298519|FG001|COMPLETED|Titration Period 2||79
6387226|NCT00813488|7298518|FG000|NOT COMPLETED|Titration Period 2||16
6387227|NCT00813488|7298519|FG001|NOT COMPLETED|Titration Period 2||10
6387228|NCT00813488|7298518|FG000|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
6387229|NCT00813488|7298519|FG001|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
6387230|NCT00813488|7298518|FG000|COMPLETED|Double-blind Treatment Period 1||71
6387231|NCT00813488|7298519|FG001|COMPLETED|Double-blind Treatment Period 1||66
6387232|NCT00813488|7298518|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
6387233|NCT00813488|7298519|FG001|NOT COMPLETED|Double-blind Treatment Period 1||5
6387234|NCT00813488|7298518|FG000|STARTED|Double-blind Treatment Period 2||71
6387235|NCT00813488|7298519|FG001|STARTED|Double-blind Treatment Period 2||66
6387236|NCT00813488|7298518|FG000|COMPLETED|Double-blind Treatment Period 2||66
6387237|NCT00813488|7298519|FG001|COMPLETED|Double-blind Treatment Period 2||65
6387238|NCT00813488|7298518|FG000|NOT COMPLETED|Double-blind Treatment Period 2||5
6387239|NCT00813488|7298519|FG001|NOT COMPLETED|Double-blind Treatment Period 2||1
6387240|NCT00813488|7298518|FG000|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
6387241|NCT00813488|7298519|FG001|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
6656862|NCT02465450|7587224|FG005|STARTED|Treatment Period 1||0
6656863|NCT02465450|7587219|FG000|COMPLETED|Treatment Period 1||24
6656864|NCT02465450|7587220|FG001|COMPLETED|Treatment Period 1||23
6656865|NCT02465450|7587221|FG002|COMPLETED|Treatment Period 1||34
6656866|NCT02465450|7587222|FG003|COMPLETED|Treatment Period 1||0
6387242|NCT00813488|7298518|FG000|COMPLETED|Open-label Extension|This group received FBT open--label|53
6387243|NCT00813488|7298519|FG001|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
6387244|NCT00813488|7298518|FG000|NOT COMPLETED|Open-label Extension||12
6387245|NCT00813488|7298519|FG001|NOT COMPLETED|Open-label Extension||7
6387246|NCT00813592|7298529|FG000|STARTED|Overall Study||2
6387247|NCT00813592|7298529|FG000|Treated|Overall Study|Two patients were treated.|2
6387248|NCT00813592|7298529|FG000|Response Assessment|Overall Study|One patient met the response assessment.|1
6387249|NCT00813592|7298529|FG000|COMPLETED|Overall Study||0
6387250|NCT00813592|7298529|FG000|NOT COMPLETED|Overall Study||2
6387251|NCT00813709|7298537|FG000|STARTED|Double Blind Period||84
6387252|NCT00813709|7298538|FG001|STARTED|Double Blind Period||117
6387253|NCT00813709|7298539|FG002|STARTED|Double Blind Period||99
6387254|NCT00813709|7298540|FG003|STARTED|Double Blind Period||0
6387255|NCT00813709|7298541|FG004|STARTED|Double Blind Period||0
6387256|NCT00813709|7298542|FG005|STARTED|Double Blind Period||0
6387257|NCT00813709|7298537|FG000|Treated|Double Blind Period||83
6387258|NCT00813709|7298538|FG001|Treated|Double Blind Period||114
6387259|NCT00813709|7298539|FG002|Treated|Double Blind Period||98
6387260|NCT00813709|7298540|FG003|Treated|Double Blind Period||0
6387261|NCT00813709|7298541|FG004|Treated|Double Blind Period||0
6387262|NCT00813709|7298542|FG005|Treated|Double Blind Period||0
6387263|NCT00813709|7298537|FG000|COMPLETED|Double Blind Period||53
6387264|NCT00813709|7298538|FG001|COMPLETED|Double Blind Period||76
6387265|NCT00813709|7298539|FG002|COMPLETED|Double Blind Period||68
6387266|NCT00813709|7298540|FG003|COMPLETED|Double Blind Period||0
6387267|NCT00813709|7298541|FG004|COMPLETED|Double Blind Period||0
6387268|NCT00813709|7298542|FG005|COMPLETED|Double Blind Period||0
6272187|NCT00094770|7171468|FG000|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
6272188|NCT00094770|7171469|FG001|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
6272189|NCT00094770|7171468|FG000|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
6272190|NCT00094770|7171469|FG001|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
6272191|NCT00094770|7171468|FG000|STARTED|Year 2 (Week 0 to Week 104)||588
6272192|NCT00094770|7171469|FG001|STARTED|Year 2 (Week 0 to Week 104)||584
6272193|NCT00094770|7171468|FG000|COMPLETED|Year 2 (Week 0 to Week 104)||255
6272194|NCT00094770|7171469|FG001|COMPLETED|Year 2 (Week 0 to Week 104)||264
6272195|NCT00094770|7171468|FG000|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
6272196|NCT00094770|7171469|FG001|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
6272197|NCT00094809|7171477|FG000|STARTED|Overall Study||126
6272198|NCT00094809|7171478|FG001|STARTED|Overall Study||126
6272199|NCT00094809|7171477|FG000|Received Study Drug|Overall Study||124
6272200|NCT00094809|7171478|FG001|Received Study Drug|Overall Study||118
6272201|NCT00094809|7171477|FG000|Properly Consented; Received Study Drug|Overall Study||123
6272202|NCT00094809|7171478|FG001|Properly Consented; Received Study Drug|Overall Study||118
6272203|NCT00094809|7171477|FG000|Completed All 4 Cycles of Treatment|Overall Study||98
6272204|NCT00094809|7171478|FG001|Completed All 4 Cycles of Treatment|Overall Study||90
6272205|NCT00094809|7171477|FG000|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
6387269|NCT00813709|7298537|FG000|NOT COMPLETED|Double Blind Period||31
6387270|NCT00813709|7298538|FG001|NOT COMPLETED|Double Blind Period||41
6387271|NCT00813709|7298539|FG002|NOT COMPLETED|Double Blind Period||31
6387272|NCT00813709|7298540|FG003|NOT COMPLETED|Double Blind Period||0
6387273|NCT00813709|7298541|FG004|NOT COMPLETED|Double Blind Period||0
6387274|NCT00813709|7298542|FG005|NOT COMPLETED|Double Blind Period||0
6387275|NCT00813709|7298537|FG000|STARTED|Open Label Period||0
6387276|NCT00813709|7298538|FG001|STARTED|Open Label Period||0
6387277|NCT00813709|7298539|FG002|STARTED|Open Label Period||0
6387278|NCT00813709|7298540|FG003|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
6387279|NCT00813709|7298541|FG004|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
6387280|NCT00813709|7298542|FG005|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
6387281|NCT00813709|7298537|FG000|Treated|Open Label Period||0
6387282|NCT00813709|7298538|FG001|Treated|Open Label Period||0
6387283|NCT00813709|7298539|FG002|Treated|Open Label Period||0
6387284|NCT00813709|7298540|FG003|Treated|Open Label Period||57
6387285|NCT00813709|7298541|FG004|Treated|Open Label Period||51
6387286|NCT00813709|7298542|FG005|Treated|Open Label Period||45
6387287|NCT00813709|7298537|FG000|COMPLETED|Open Label Period||0
6387288|NCT00813709|7298538|FG001|COMPLETED|Open Label Period||0
6387289|NCT00813709|7298539|FG002|COMPLETED|Open Label Period||0
6387290|NCT00813709|7298540|FG003|COMPLETED|Open Label Period||38
6387291|NCT00813709|7298541|FG004|COMPLETED|Open Label Period||41
6387292|NCT00813709|7298542|FG005|COMPLETED|Open Label Period||35
6387293|NCT00813709|7298537|FG000|NOT COMPLETED|Open Label Period||0
6387294|NCT00813709|7298538|FG001|NOT COMPLETED|Open Label Period||0
6387295|NCT00813709|7298539|FG002|NOT COMPLETED|Open Label Period||0
6387296|NCT00813709|7298540|FG003|NOT COMPLETED|Open Label Period||20
6387297|NCT00813709|7298541|FG004|NOT COMPLETED|Open Label Period||10
6387298|NCT00813709|7298542|FG005|NOT COMPLETED|Open Label Period||11
6387299|NCT00813748|7298573|FG000|STARTED|Main Observational Study||30
6387300|NCT00813748|7298574|FG001|STARTED|Main Observational Study||88
6387301|NCT00813748|7298573|FG000|COMPLETED|Main Observational Study||30
6387302|NCT00813748|7298574|FG001|COMPLETED|Main Observational Study||88
6387303|NCT00813748|7298573|FG000|NOT COMPLETED|Main Observational Study||0
6387304|NCT00813748|7298574|FG001|NOT COMPLETED|Main Observational Study||0
6387305|NCT00813748|7298573|FG000|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
6387306|NCT00813748|7298574|FG001|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
6387307|NCT00813748|7298573|FG000|COMPLETED|Skin Test Substudy||3
6387308|NCT00813748|7298574|FG001|COMPLETED|Skin Test Substudy||7
6387309|NCT00813748|7298573|FG000|NOT COMPLETED|Skin Test Substudy||0
6387310|NCT00813748|7298574|FG001|NOT COMPLETED|Skin Test Substudy||1
6387311|NCT00813761|7298584|FG000|STARTED|Phase 1 (Baseline to 4 Weeks)||121
6387312|NCT00813761|7298585|FG001|STARTED|Phase 1 (Baseline to 4 Weeks)||103
6387313|NCT00813761|7298586|FG002|STARTED|Phase 1 (Baseline to 4 Weeks)||115
6387314|NCT00813761|7298587|FG003|STARTED|Phase 1 (Baseline to 4 Weeks)||107
6387315|NCT00813761|7298584|FG000|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
6387316|NCT00813761|7298585|FG001|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
6387317|NCT00813761|7298586|FG002|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
6387318|NCT00813761|7298587|FG003|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
6387319|NCT00813761|7298584|FG000|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
6387320|NCT00813761|7298585|FG001|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
6387321|NCT00813761|7298586|FG002|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
6387322|NCT00813761|7298587|FG003|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
6387323|NCT00813761|7298584|FG000|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
6387324|NCT00813761|7298585|FG001|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
6387325|NCT00813761|7298586|FG002|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
6272206|NCT00094809|7171478|FG001|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
6272207|NCT00094809|7171477|FG000|NOT COMPLETED|Overall Study||52
6272208|NCT00094809|7171478|FG001|NOT COMPLETED|Overall Study||65
6272209|NCT00094835|7171491|FG000|STARTED|Overall Study||9
6272210|NCT00094835|7171492|FG001|STARTED|Overall Study||11
6272211|NCT00094835|7171493|FG002|STARTED|Overall Study||7
6272212|NCT00094835|7171494|FG003|STARTED|Overall Study||5
6272213|NCT00094835|7171495|FG004|STARTED|Overall Study||7
6272214|NCT00094835|7171496|FG005|STARTED|Overall Study||6
6272215|NCT00094835|7171497|FG006|STARTED|Overall Study||6
6272216|NCT00094835|7171491|FG000|Treated With Motesanib|Overall Study||6
6272217|NCT00094835|7171492|FG001|Treated With Motesanib|Overall Study||11
6272218|NCT00094835|7171493|FG002|Treated With Motesanib|Overall Study||6
6272219|NCT00094835|7171494|FG003|Treated With Motesanib|Overall Study||4
6272220|NCT00094835|7171495|FG004|Treated With Motesanib|Overall Study||7
6272221|NCT00094835|7171496|FG005|Treated With Motesanib|Overall Study||5
6272222|NCT00094835|7171497|FG006|Treated With Motesanib|Overall Study||6
6272223|NCT00094835|7171491|FG000|COMPLETED|Overall Study||5
6272224|NCT00094835|7171492|FG001|COMPLETED|Overall Study||8
6272225|NCT00094835|7171493|FG002|COMPLETED|Overall Study||4
6272226|NCT00094835|7171494|FG003|COMPLETED|Overall Study||4
6272227|NCT00094835|7171495|FG004|COMPLETED|Overall Study||3
6387326|NCT00813761|7298587|FG003|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
6387327|NCT00813761|7298584|FG000|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
6387328|NCT00813761|7298585|FG001|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
6387329|NCT00813761|7298586|FG002|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
6387330|NCT00813761|7298587|FG003|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
6387331|NCT00813761|7298584|FG000|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
6387332|NCT00813761|7298585|FG001|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
6387333|NCT00813761|7298586|FG002|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
6387334|NCT00813761|7298587|FG003|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
6387335|NCT00813800|7298603|FG000|STARTED|Overall Study||11
6387336|NCT00813800|7298603|FG000|COMPLETED|Overall Study||5
6387337|NCT00813800|7298603|FG000|NOT COMPLETED|Overall Study||6
6387338|NCT00813813|7298609|FG000|STARTED|Overall Study||7
6387339|NCT00813813|7298610|FG001|STARTED|Overall Study||25
6387340|NCT00813813|7298609|FG000|COMPLETED|Overall Study||4
6387341|NCT00813813|7298610|FG001|COMPLETED|Overall Study||16
6387342|NCT00813813|7298609|FG000|NOT COMPLETED|Overall Study||3
6387343|NCT00813813|7298610|FG001|NOT COMPLETED|Overall Study||9
6387344|NCT00813865|7298616|FG000|STARTED|Overall Study||8
6387345|NCT00813865|7298616|FG000|Safety Population|Overall Study||8
6387346|NCT00813865|7298616|FG000|Pharmacodynamic (PD) Population|Overall Study||8
6387347|NCT00813865|7298616|FG000|COMPLETED|Overall Study||1
6387348|NCT00813865|7298616|FG000|NOT COMPLETED|Overall Study||7
6387349|NCT00813904|7298620|FG000|STARTED|Overall Study||31
6387350|NCT00813904|7298620|FG000|COMPLETED|Overall Study||30
6387351|NCT00813904|7298620|FG000|NOT COMPLETED|Overall Study||1
6387352|NCT00813917|7298626|FG000|STARTED|Overall Study||38
6387353|NCT00813917|7298627|FG001|STARTED|Overall Study||38
6387354|NCT00813917|7298626|FG000|COMPLETED|Overall Study||32
6387355|NCT00813917|7298627|FG001|COMPLETED|Overall Study||32
6387356|NCT00813917|7298626|FG000|NOT COMPLETED|Overall Study||6
6387357|NCT00813917|7298627|FG001|NOT COMPLETED|Overall Study||6
6503947|NCT01445951|7423028|FG002|STARTED|Overall Study||170
6272228|NCT00094835|7171496|FG005|COMPLETED|Overall Study||3
6272229|NCT00094835|7171497|FG006|COMPLETED|Overall Study||4
6272230|NCT00094835|7171491|FG000|NOT COMPLETED|Overall Study||4
6272231|NCT00094835|7171492|FG001|NOT COMPLETED|Overall Study||3
6272232|NCT00094835|7171493|FG002|NOT COMPLETED|Overall Study||3
6272233|NCT00094835|7171494|FG003|NOT COMPLETED|Overall Study||1
6272234|NCT00094835|7171495|FG004|NOT COMPLETED|Overall Study||4
6272235|NCT00094835|7171496|FG005|NOT COMPLETED|Overall Study||3
6272236|NCT00094835|7171497|FG006|NOT COMPLETED|Overall Study||2
6272237|NCT00094861|7171520|FG000|STARTED|Overall Study||46
6503948|NCT01445951|7423026|FG000|COMPLETED|Overall Study||130
6503949|NCT01445951|7423027|FG001|COMPLETED|Overall Study||138
6503950|NCT01445951|7423028|FG002|COMPLETED|Overall Study||151
6503951|NCT01445951|7423026|FG000|NOT COMPLETED|Overall Study||44
6805247|NCT01757535|7737287|FG000|STARTED|Overall Study||238
6805248|NCT01757535|7737288|FG001|STARTED|Overall Study||234
6805249|NCT01757535|7737287|FG000|Received Treatment|Overall Study||236
6805250|NCT01757535|7737288|FG001|Received Treatment|Overall Study||233
6805251|NCT01757535|7737287|FG000|COMPLETED|Overall Study||45
6805252|NCT01757535|7737288|FG001|COMPLETED|Overall Study||26
6272238|NCT00094861|7171521|FG001|STARTED|Overall Study||49
6272239|NCT00094861|7171520|FG000|Participants Treated|Overall Study||46
6272240|NCT00094861|7171521|FG001|Participants Treated|Overall Study||48
6272241|NCT00094861|7171520|FG000|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
6272242|NCT00094861|7171521|FG001|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
6272243|NCT00094861|7171520|FG000|NOT COMPLETED|Overall Study||18
6272244|NCT00094861|7171521|FG001|NOT COMPLETED|Overall Study||9
6272245|NCT00094887|7171529|FG000|STARTED|Overall Study||75
6272246|NCT00094887|7171530|FG001|STARTED|Overall Study||75
6272247|NCT00094887|7171529|FG000|Safety Population|Overall Study||75
6272248|NCT00094887|7171530|FG001|Safety Population|Overall Study||75
6272249|NCT00094887|7171529|FG000|Intent to Treat Population|Overall Study||75
6272250|NCT00094887|7171530|FG001|Intent to Treat Population|Overall Study||75
6272251|NCT00094887|7171529|FG000|Per Protocol Analysis Set|Overall Study||71
6272252|NCT00094887|7171530|FG001|Per Protocol Analysis Set|Overall Study||71
6272253|NCT00094887|7171529|FG000|Primary Efficacy Population|Overall Study||65
6272254|NCT00094887|7171530|FG001|Primary Efficacy Population|Overall Study||64
6272255|NCT00094887|7171529|FG000|COMPLETED|Overall Study||71
6272256|NCT00094887|7171530|FG001|COMPLETED|Overall Study||71
6272257|NCT00094887|7171529|FG000|NOT COMPLETED|Overall Study||4
6272258|NCT00094887|7171530|FG001|NOT COMPLETED|Overall Study||4
6272259|NCT00094900|7171536|FG000|STARTED|Overall Study||11
6272260|NCT00094900|7171536|FG000|COMPLETED|Overall Study||10
6272261|NCT00094900|7171536|FG000|NOT COMPLETED|Overall Study||1
6272262|NCT00095056|7171542|FG000|STARTED|Phase A (Weeks 0-12)||65
6272263|NCT00095056|7171543|FG001|STARTED|Phase A (Weeks 0-12)||26
6272264|NCT00095056|7171542|FG000|COMPLETED|Phase A (Weeks 0-12)||58
6272265|NCT00095056|7171543|FG001|COMPLETED|Phase A (Weeks 0-12)||25
6272266|NCT00095056|7171542|FG000|NOT COMPLETED|Phase A (Weeks 0-12)||7
6272267|NCT00095056|7171543|FG001|NOT COMPLETED|Phase A (Weeks 0-12)||1
6272268|NCT00095056|7171542|FG000|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
6272269|NCT00095056|7171543|FG001|STARTED|Phase B (Weeks 12-54)||25
6272270|NCT00095056|7171542|FG000|COMPLETED|Phase B (Weeks 12-54)||46
6272271|NCT00095056|7171543|FG001|COMPLETED|Phase B (Weeks 12-54)||20
6272272|NCT00095056|7171542|FG000|NOT COMPLETED|Phase B (Weeks 12-54)||10
6272273|NCT00095056|7171543|FG001|NOT COMPLETED|Phase B (Weeks 12-54)||5
6272274|NCT00095121|7171551|FG000|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
6272275|NCT00095121|7171552|FG001|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
6272276|NCT00095121|7171551|FG000|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
6272277|NCT00095121|7171552|FG001|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
6272278|NCT00095121|7171551|FG000|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
6272279|NCT00095121|7171552|FG001|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
6272280|NCT00095121|7171551|FG000|STARTED|Open-Label (Study Weeks 49 Through 240)||108
6272281|NCT00095121|7171552|FG001|STARTED|Open-Label (Study Weeks 49 Through 240)||54
6272282|NCT00095121|7171551|FG000|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
6272283|NCT00095121|7171552|FG001|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
6272284|NCT00095121|7171551|FG000|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
6272285|NCT00095121|7171552|FG001|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
6272286|NCT00095121|7171551|FG000|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
6272287|NCT00095121|7171552|FG001|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
6272288|NCT00095147|7171571|FG000|STARTED|Double-blind Period 1 (Days 1-197)||156
6272289|NCT00095147|7171572|FG001|STARTED|Double-blind Period 1 (Days 1-197)||165
6272290|NCT00095147|7171573|FG002|STARTED|Double-blind Period 1 (Days 1-197)||110
6272291|NCT00095147|7171574|FG003|STARTED|Double-blind Period 1 (Days 1-197)||0
6272292|NCT00095147|7171575|FG004|STARTED|Double-blind Period 1 (Days 1-197)||0
6272293|NCT00095147|7171571|FG000|COMPLETED|Double-blind Period 1 (Days 1-197)||147
6272294|NCT00095147|7171572|FG001|COMPLETED|Double-blind Period 1 (Days 1-197)||152
6272295|NCT00095147|7171573|FG002|COMPLETED|Double-blind Period 1 (Days 1-197)||107
6272296|NCT00095147|7171574|FG003|COMPLETED|Double-blind Period 1 (Days 1-197)||0
6272297|NCT00095147|7171575|FG004|COMPLETED|Double-blind Period 1 (Days 1-197)||0
6280729|NCT00159263|7180666|FG002|COMPLETED|Washout||2
6805253|NCT01757535|7737287|FG000|NOT COMPLETED|Overall Study||193
6805254|NCT01757535|7737288|FG001|NOT COMPLETED|Overall Study||208
6805255|NCT01510184|7737296|FG000|STARTED|Overall Study||36
6805256|NCT01510184|7737297|FG001|STARTED|Overall Study||43
6805257|NCT01510184|7737296|FG000|COMPLETED|Overall Study||6
6805258|NCT01510184|7737297|FG001|COMPLETED|Overall Study||8
6565768|NCT01820559|7488630|FG002|Completed Tutration Period|Overall Study||131
6565769|NCT01820559|7488628|FG000|Entered Maintenance Period|Overall Study||129
6565770|NCT01820559|7488629|FG001|Entered Maintenance Period|Overall Study||133
6565771|NCT01820559|7488630|FG002|Entered Maintenance Period|Overall Study||129
6565772|NCT01820559|7488628|FG000|Completed Maintenance Period|Overall Study||122
6565773|NCT01820559|7488629|FG001|Completed Maintenance Period|Overall Study||123
6565774|NCT01820559|7488630|FG002|Completed Maintenance Period|Overall Study||110
6565775|NCT01820559|7488628|FG000|COMPLETED|Overall Study||122
6565776|NCT01820559|7488629|FG001|COMPLETED|Overall Study||122
6272298|NCT00095147|7171571|FG000|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
6272299|NCT00095147|7171572|FG001|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
6272300|NCT00095147|7171573|FG002|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
6272301|NCT00095147|7171574|FG003|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
6272302|NCT00095147|7171575|FG004|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
6272303|NCT00095147|7171571|FG000|STARTED|Double-blind Period 2 (Days 198-365)||147
6272304|NCT00095147|7171572|FG001|STARTED|Double-blind Period 2 (Days 198-365)||152
6272305|NCT00095147|7171573|FG002|STARTED|Double-blind Period 2 (Days 198-365)||0
6272306|NCT00095147|7171574|FG003|STARTED|Double-blind Period 2 (Days 198-365)||107
6272307|NCT00095147|7171575|FG004|STARTED|Double-blind Period 2 (Days 198-365)||0
6272308|NCT00095147|7171571|FG000|COMPLETED|Double-blind Period 2 (Days 198-365)||139
6272309|NCT00095147|7171572|FG001|COMPLETED|Double-blind Period 2 (Days 198-365)||141
6272310|NCT00095147|7171573|FG002|COMPLETED|Double-blind Period 2 (Days 198-365)||0
6272311|NCT00095147|7171574|FG003|COMPLETED|Double-blind Period 2 (Days 198-365)||104
6272312|NCT00095147|7171575|FG004|COMPLETED|Double-blind Period 2 (Days 198-365)||0
6272313|NCT00095147|7171571|FG000|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
6272314|NCT00095147|7171572|FG001|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
6272315|NCT00095147|7171573|FG002|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
6272316|NCT00095147|7171574|FG003|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
6272317|NCT00095147|7171575|FG004|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
6272318|NCT00095147|7171571|FG000|STARTED|Long-term Extension Period||0
6272319|NCT00095147|7171572|FG001|STARTED|Long-term Extension Period||0
6272320|NCT00095147|7171573|FG002|STARTED|Long-term Extension Period||0
6272321|NCT00095147|7171574|FG003|STARTED|Long-term Extension Period||0
6272322|NCT00095147|7171575|FG004|STARTED|Long-term Extension Period||372
6272323|NCT00095147|7171571|FG000|COMPLETED|Long-term Extension Period||0
6272324|NCT00095147|7171572|FG001|COMPLETED|Long-term Extension Period||0
6272325|NCT00095147|7171573|FG002|COMPLETED|Long-term Extension Period||0
6272326|NCT00095147|7171574|FG003|COMPLETED|Long-term Extension Period||0
6272327|NCT00095147|7171575|FG004|COMPLETED|Long-term Extension Period||327
6272328|NCT00095147|7171571|FG000|NOT COMPLETED|Long-term Extension Period||0
6272329|NCT00095147|7171572|FG001|NOT COMPLETED|Long-term Extension Period||0
6272330|NCT00095147|7171573|FG002|NOT COMPLETED|Long-term Extension Period||0
6272331|NCT00095147|7171574|FG003|NOT COMPLETED|Long-term Extension Period||0
6272332|NCT00095147|7171575|FG004|NOT COMPLETED|Long-term Extension Period||45
6272333|NCT00095173|7171593|FG000|STARTED|Open-Label Lead-In Phase (Period A)||190
6272334|NCT00095173|7171594|FG001|STARTED|Open-Label Lead-In Phase (Period A)||0
6272335|NCT00095173|7171595|FG002|STARTED|Open-Label Lead-In Phase (Period A)||0
6272336|NCT00095173|7171596|FG003|STARTED|Open-Label Lead-In Phase (Period A)||0
6272337|NCT00095173|7171597|FG004|STARTED|Open-Label Lead-In Phase (Period A)||0
6272338|NCT00095173|7171598|FG005|STARTED|Open-Label Lead-In Phase (Period A)||0
6272339|NCT00095173|7171593|FG000|COMPLETED|Open-Label Lead-In Phase (Period A)||170
6272340|NCT00095173|7171594|FG001|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272341|NCT00095173|7171595|FG002|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272342|NCT00095173|7171596|FG003|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272343|NCT00095173|7171597|FG004|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272344|NCT00095173|7171598|FG005|COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272345|NCT00095173|7171593|FG000|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
6272346|NCT00095173|7171594|FG001|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6387358|NCT00813943|7298636|FG000|STARTED|Overall Study||88
6387359|NCT00813943|7298637|FG001|STARTED|Overall Study||88
6503952|NCT01445951|7423027|FG001|NOT COMPLETED|Overall Study||36
6565777|NCT01820559|7488630|FG002|COMPLETED|Overall Study||110
6805259|NCT01510184|7737296|FG000|NOT COMPLETED|Overall Study||30
6387360|NCT00813943|7298638|FG002|STARTED|Overall Study||89
6387361|NCT00813943|7298636|FG000|COMPLETED|Overall Study||83
6387362|NCT00813943|7298637|FG001|COMPLETED|Overall Study||83
6387363|NCT00813943|7298638|FG002|COMPLETED|Overall Study||86
6387364|NCT00813943|7298636|FG000|NOT COMPLETED|Overall Study||5
6387365|NCT00813943|7298637|FG001|NOT COMPLETED|Overall Study||5
6387366|NCT00813943|7298638|FG002|NOT COMPLETED|Overall Study||3
6387367|NCT00813982|7298647|FG000|STARTED|Overall Study||59
6387368|NCT00813982|7298647|FG000|COMPLETED|Overall Study||59
6387369|NCT00813982|7298647|FG000|NOT COMPLETED|Overall Study||0
6503953|NCT01445951|7423028|FG002|NOT COMPLETED|Overall Study||19
6503954|NCT01446003|7423036|FG000|STARTED|Period 1||16
6503955|NCT01446003|7423037|FG001|STARTED|Period 1||15
6503956|NCT01446003|7423036|FG000|COMPLETED|Period 1||14
6503957|NCT01446003|7423037|FG001|COMPLETED|Period 1||15
6503958|NCT01446003|7423036|FG000|NOT COMPLETED|Period 1||2
6503959|NCT01446003|7423037|FG001|NOT COMPLETED|Period 1||0
6503960|NCT01446003|7423036|FG000|STARTED|Period 2||14
6503961|NCT01446003|7423037|FG001|STARTED|Period 2||15
6503962|NCT01446003|7423036|FG000|COMPLETED|Period 2||13
6503963|NCT01446003|7423037|FG001|COMPLETED|Period 2||15
6503964|NCT01446003|7423036|FG000|NOT COMPLETED|Period 2||1
6503965|NCT01446003|7423037|FG001|NOT COMPLETED|Period 2||0
6503966|NCT01446042|7423046|FG000|STARTED|Overall Study||142
6503967|NCT01446042|7423047|FG001|STARTED|Overall Study||86
6503968|NCT01446042|7423048|FG002|STARTED|Overall Study||78
6503969|NCT01446042|7423046|FG000|COMPLETED|Overall Study||122
6503970|NCT01446042|7423047|FG001|COMPLETED|Overall Study||83
6503971|NCT01446042|7423048|FG002|COMPLETED|Overall Study||69
6503972|NCT01446042|7423046|FG000|NOT COMPLETED|Overall Study||20
6503973|NCT01446042|7423047|FG001|NOT COMPLETED|Overall Study||3
6503974|NCT01446042|7423048|FG002|NOT COMPLETED|Overall Study||9
6503975|NCT01446159|7423060|FG000|STARTED|Overall Study||3
6503976|NCT01446159|7423061|FG001|STARTED|Overall Study||3
6503977|NCT01446159|7423062|FG002|STARTED|Overall Study||92
6503978|NCT01446159|7423063|FG003|STARTED|Overall Study||85
6503979|NCT01446159|7423060|FG000|COMPLETED|Overall Study||0
6503980|NCT01446159|7423061|FG001|COMPLETED|Overall Study||0
6503981|NCT01446159|7423062|FG002|COMPLETED|Overall Study||21
6503982|NCT01446159|7423063|FG003|COMPLETED|Overall Study||23
6503983|NCT01446159|7423060|FG000|NOT COMPLETED|Overall Study||3
6503984|NCT01446159|7423061|FG001|NOT COMPLETED|Overall Study||3
6503985|NCT01446159|7423062|FG002|NOT COMPLETED|Overall Study||71
6503986|NCT01446159|7423063|FG003|NOT COMPLETED|Overall Study||62
6503987|NCT01446237|7423075|FG000|STARTED|Overall Study||125
6503988|NCT01446237|7423075|FG000|COMPLETED|Overall Study||115
6503989|NCT01446237|7423075|FG000|NOT COMPLETED|Overall Study||10
6387370|NCT00813995|7298655|FG000|STARTED|Overall Study||197
6387371|NCT00813995|7298656|FG001|STARTED|Overall Study||198
6387372|NCT00813995|7298655|FG000|COMPLETED|Overall Study||174
6503990|NCT01446289|7423083|FG000|STARTED|Overall Study||51
6503991|NCT01446289|7423084|FG001|STARTED|Overall Study||35
6503992|NCT01446289|7423085|FG002|STARTED|Overall Study||51
6503993|NCT01446289|7423086|FG003|STARTED|Overall Study||35
6805260|NCT01510184|7737297|FG001|NOT COMPLETED|Overall Study||35
6805261|NCT01471444|7737305|FG000|STARTED|Overall Study||133
6805262|NCT01471444|7737306|FG001|STARTED|Overall Study||123
6805263|NCT01471444|7737305|FG000|COMPLETED|Overall Study||130
6805264|NCT01471444|7737306|FG001|COMPLETED|Overall Study||120
6805265|NCT01471444|7737305|FG000|NOT COMPLETED|Overall Study||3
6805266|NCT01471444|7737306|FG001|NOT COMPLETED|Overall Study||3
6805267|NCT01238211|7737313|FG000|STARTED|Overall Study||61
6805268|NCT01238211|7737313|FG000|COMPLETED|Overall Study||3
6805269|NCT01238211|7737313|FG000|NOT COMPLETED|Overall Study||58
6805270|NCT00545766|7737317|FG000|STARTED|Overall Study||41
6805271|NCT00545766|7737317|FG000|COMPLETED|Overall Study||36
6805272|NCT00545766|7737317|FG000|NOT COMPLETED|Overall Study||5
6272347|NCT00095173|7171595|FG002|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272348|NCT00095173|7171596|FG003|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272349|NCT00095173|7171597|FG004|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272350|NCT00095173|7171598|FG005|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
6272351|NCT00095173|7171593|FG000|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
6272352|NCT00095173|7171594|FG001|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
6272353|NCT00095173|7171595|FG002|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
6272354|NCT00095173|7171596|FG003|STARTED|Double-Blind Phase (Period B)||0
6272355|NCT00095173|7171597|FG004|STARTED|Double-Blind Phase (Period B)||0
6272356|NCT00095173|7171598|FG005|STARTED|Double-Blind Phase (Period B)||0
6272357|NCT00095173|7171593|FG000|COMPLETED|Double-Blind Phase (Period B)||0
6272358|NCT00095173|7171594|FG001|COMPLETED|Double-Blind Phase (Period B)||49
6272359|NCT00095173|7171595|FG002|COMPLETED|Double-Blind Phase (Period B)||31
6272360|NCT00095173|7171596|FG003|COMPLETED|Double-Blind Phase (Period B)||0
6272361|NCT00095173|7171597|FG004|COMPLETED|Double-Blind Phase (Period B)||0
6272362|NCT00095173|7171598|FG005|COMPLETED|Double-Blind Phase (Period B)||0
6272363|NCT00095173|7171593|FG000|NOT COMPLETED|Double-Blind Phase (Period B)||0
6272364|NCT00095173|7171594|FG001|NOT COMPLETED|Double-Blind Phase (Period B)||11
6272365|NCT00095173|7171595|FG002|NOT COMPLETED|Double-Blind Phase (Period B)||31
6272366|NCT00095173|7171596|FG003|NOT COMPLETED|Double-Blind Phase (Period B)||0
6272367|NCT00095173|7171597|FG004|NOT COMPLETED|Double-Blind Phase (Period B)||0
6272368|NCT00095173|7171598|FG005|NOT COMPLETED|Double-Blind Phase (Period B)||0
6272369|NCT00095173|7171593|FG000|STARTED|Open-Label Extension Phase (Period C)||0
6272370|NCT00095173|7171594|FG001|STARTED|Open-Label Extension Phase (Period C)||0
6272371|NCT00095173|7171595|FG002|STARTED|Open-Label Extension Phase (Period C)||0
6272372|NCT00095173|7171596|FG003|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
6272373|NCT00095173|7171597|FG004|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
6272374|NCT00095173|7171598|FG005|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
6272375|NCT00095173|7171593|FG000|COMPLETED|Open-Label Extension Phase (Period C)||0
6272376|NCT00095173|7171594|FG001|COMPLETED|Open-Label Extension Phase (Period C)||0
6272377|NCT00095173|7171595|FG002|COMPLETED|Open-Label Extension Phase (Period C)||0
6272378|NCT00095173|7171596|FG003|COMPLETED|Open-Label Extension Phase (Period C)||13
6272379|NCT00095173|7171597|FG004|COMPLETED|Open-Label Extension Phase (Period C)||29
6272380|NCT00095173|7171598|FG005|COMPLETED|Open-Label Extension Phase (Period C)||27
6272381|NCT00095173|7171593|FG000|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
6272382|NCT00095173|7171594|FG001|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
6272383|NCT00095173|7171595|FG002|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
6272384|NCT00095173|7171596|FG003|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
6272385|NCT00095173|7171597|FG004|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
6272386|NCT00095173|7171598|FG005|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
6272387|NCT00095199|7171616|FG000|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
6272388|NCT00095199|7171617|FG001|STARTED|Overall Study||304
6272389|NCT00095199|7171618|FG002|STARTED|Overall Study||167
6272390|NCT00095199|7171619|FG003|STARTED|Overall Study||166
6272391|NCT00095199|7171616|FG000|COMPLETED|Overall Study||6
6272392|NCT00095199|7171617|FG001|COMPLETED|Overall Study||62
6272393|NCT00095199|7171618|FG002|COMPLETED|Overall Study||7
6272394|NCT00095199|7171619|FG003|COMPLETED|Overall Study||23
6272395|NCT00095199|7171616|FG000|NOT COMPLETED|Overall Study||296
6272396|NCT00095199|7171617|FG001|NOT COMPLETED|Overall Study||242
6272397|NCT00095199|7171618|FG002|NOT COMPLETED|Overall Study||160
6272398|NCT00095199|7171619|FG003|NOT COMPLETED|Overall Study||143
6272399|NCT00095212|7171636|FG000|STARTED|Overall Study||13
6272400|NCT00095212|7171637|FG001|STARTED|Overall Study||12
6272401|NCT00095212|7171636|FG000|COMPLETED|Overall Study||12
6272402|NCT00095212|7171637|FG001|COMPLETED|Overall Study||9
6565778|NCT01820559|7488628|FG000|NOT COMPLETED|Overall Study||14
6565779|NCT01820559|7488629|FG001|NOT COMPLETED|Overall Study||13
6272403|NCT00095212|7171636|FG000|NOT COMPLETED|Overall Study||1
6272404|NCT00095212|7171637|FG001|NOT COMPLETED|Overall Study||3
6272405|NCT00095238|7171645|FG000|STARTED|Overall Study|number randomized|2067
6272406|NCT00095238|7171646|FG001|STARTED|Overall Study|number randomized|2061
6565780|NCT01820559|7488630|FG002|NOT COMPLETED|Overall Study||29
6565781|NCT01820572|7488640|FG000|STARTED|Randomization||223
6565782|NCT01820572|7488641|FG001|STARTED|Randomization||223
6565783|NCT01820572|7488640|FG000|COMPLETED|Randomization||221
6565784|NCT01820572|7488641|FG001|COMPLETED|Randomization||222
6565785|NCT01820572|7488640|FG000|NOT COMPLETED|Randomization||2
6565786|NCT01820572|7488641|FG001|NOT COMPLETED|Randomization||1
6565787|NCT01820572|7488640|FG000|STARTED|Treatment Period||221
6565788|NCT01820572|7488641|FG001|STARTED|Treatment Period||222
6805273|NCT04101890|7737321|FG000|STARTED|Routine Diaper Care||5
6272407|NCT00095238|7171645|FG000|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
6272408|NCT00095238|7171646|FG001|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
6272409|NCT00095238|7171645|FG000|COMPLETED|Overall Study|completed double-blind therapy|1210
6272410|NCT00095238|7171646|FG001|COMPLETED|Overall Study|completed double-blind therapy|1209
6272411|NCT00095238|7171645|FG000|NOT COMPLETED|Overall Study||857
6272412|NCT00095238|7171646|FG001|NOT COMPLETED|Overall Study||852
6272413|NCT00095303|7171686|FG000|STARTED|Main Study||245
6272414|NCT00095303|7171687|FG001|STARTED|Main Study||235
6272415|NCT00095303|7171686|FG000|COMPLETED|Main Study||154
6272416|NCT00095303|7171687|FG001|COMPLETED|Main Study||148
6272417|NCT00095303|7171686|FG000|NOT COMPLETED|Main Study||91
6272418|NCT00095303|7171687|FG001|NOT COMPLETED|Main Study||87
6272419|NCT00095303|7171686|FG000|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
6272420|NCT00095303|7171687|FG001|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
6272421|NCT00095303|7171686|FG000|COMPLETED|Follow Up Study||140
6272422|NCT00095303|7171687|FG001|COMPLETED|Follow Up Study||121
6272423|NCT00095303|7171686|FG000|NOT COMPLETED|Follow Up Study||59
6272424|NCT00095303|7171687|FG001|NOT COMPLETED|Follow Up Study||58
6272425|NCT00095498|7171696|FG000|STARTED|Overall Study||76
6272426|NCT00095498|7171697|FG001|STARTED|Overall Study||73
6272427|NCT00095498|7171698|FG002|STARTED|Overall Study||78
6272428|NCT00095498|7171696|FG000|Received Investigational Product|Overall Study||72
6272429|NCT00095498|7171697|FG001|Received Investigational Product|Overall Study||71
6272430|NCT00095498|7171698|FG002|Received Investigational Product|Overall Study||75
6272431|NCT00095498|7171696|FG000|COMPLETED|Overall Study||39
6272432|NCT00095498|7171697|FG001|COMPLETED|Overall Study||38
6272433|NCT00095498|7171698|FG002|COMPLETED|Overall Study||39
6272434|NCT00095498|7171696|FG000|NOT COMPLETED|Overall Study||37
6272435|NCT00095498|7171697|FG001|NOT COMPLETED|Overall Study||35
6272436|NCT00095498|7171698|FG002|NOT COMPLETED|Overall Study||39
6272437|NCT00095563|7171706|FG000|STARTED|Overall Study||39
6272438|NCT00095563|7171706|FG000|COMPLETED|Overall Study||39
6565789|NCT01820572|7488640|FG000|COMPLETED|Treatment Period||195
6565790|NCT01820572|7488641|FG001|COMPLETED|Treatment Period||186
6565791|NCT01820572|7488640|FG000|NOT COMPLETED|Treatment Period||26
6565792|NCT01820572|7488641|FG001|NOT COMPLETED|Treatment Period||36
6565793|NCT01820585|7488651|FG000|STARTED|Overall Study||131
6805274|NCT04101890|7737321|FG000|COMPLETED|Routine Diaper Care||5
6805275|NCT04101890|7737321|FG000|NOT COMPLETED|Routine Diaper Care||0
6805276|NCT04101890|7737321|FG000|STARTED|Diaper Care With Theraworx||5
6805277|NCT04101890|7737321|FG000|COMPLETED|Diaper Care With Theraworx||5
6805278|NCT04101890|7737321|FG000|NOT COMPLETED|Diaper Care With Theraworx||0
6805279|NCT03993314|7737329|FG000|STARTED|Overall Study||9
6805280|NCT03993314|7737330|FG001|STARTED|Overall Study||6
6805281|NCT03993314|7737329|FG000|COMPLETED|Overall Study||9
6805282|NCT03993314|7737330|FG001|COMPLETED|Overall Study||6
6565794|NCT01820585|7488652|FG001|STARTED|Overall Study||130
6565795|NCT01820585|7488653|FG002|STARTED|Overall Study||135
6565796|NCT01820585|7488654|FG003|STARTED|Overall Study||132
6565797|NCT01820585|7488651|FG000|Randomized and Treated|Overall Study||131
6805283|NCT03993314|7737329|FG000|NOT COMPLETED|Overall Study||0
6805284|NCT03993314|7737330|FG001|NOT COMPLETED|Overall Study||0
6805285|NCT03874351|7737338|FG000|STARTED|Overall Study||11
6805286|NCT03874351|7737339|FG001|STARTED|Overall Study||11
6805287|NCT03874351|7737338|FG000|COMPLETED|Overall Study||7
6805288|NCT03874351|7737339|FG001|COMPLETED|Overall Study||9
6805289|NCT03874351|7737338|FG000|NOT COMPLETED|Overall Study||4
6805290|NCT03874351|7737339|FG001|NOT COMPLETED|Overall Study||2
6805291|NCT03856359|7737345|FG000|STARTED|Overall Study||10
6805292|NCT03856359|7737345|FG000|COMPLETED|Overall Study||9
6805293|NCT03856359|7737345|FG000|NOT COMPLETED|Overall Study||1
6805294|NCT03769519|7737351|FG000|STARTED|Overall Study||14
6387373|NCT00813995|7298656|FG001|COMPLETED|Overall Study||182
6387374|NCT00813995|7298655|FG000|NOT COMPLETED|Overall Study||23
6387375|NCT00813995|7298656|FG001|NOT COMPLETED|Overall Study||16
6387376|NCT00814138|7298668|FG000|STARTED|Overall Study||25
6387377|NCT00814138|7298669|FG001|STARTED|Overall Study||25
6387378|NCT00814138|7298668|FG000|COMPLETED|Overall Study||24
6387379|NCT00814138|7298669|FG001|COMPLETED|Overall Study||18
6387380|NCT00814138|7298668|FG000|NOT COMPLETED|Overall Study||1
6387381|NCT00814138|7298669|FG001|NOT COMPLETED|Overall Study||7
6272439|NCT00095563|7171706|FG000|NOT COMPLETED|Overall Study||0
6272440|NCT00095576|7171712|FG000|STARTED|Overall Study||1484
6656867|NCT02465450|7587223|FG004|COMPLETED|Treatment Period 1||0
6656868|NCT02465450|7587224|FG005|COMPLETED|Treatment Period 1||0
6656869|NCT02465450|7587219|FG000|NOT COMPLETED|Treatment Period 1||2
6805295|NCT03769519|7737352|FG001|STARTED|Overall Study||15
6805296|NCT03769519|7737351|FG000|COMPLETED|Overall Study||14
6805297|NCT03769519|7737352|FG001|COMPLETED|Overall Study||14
6805298|NCT03769519|7737351|FG000|NOT COMPLETED|Overall Study||0
6805299|NCT03769519|7737352|FG001|NOT COMPLETED|Overall Study||1
6805300|NCT03745651|7737361|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||124
6805301|NCT03745651|7737362|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||248
6805302|NCT03745651|7737363|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||246
6805303|NCT03745651|7737364|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
6805304|NCT03745651|7737365|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
6805305|NCT03745651|7737366|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
6805306|NCT03745651|7737367|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
6805307|NCT03745651|7737361|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||105
6805308|NCT03745651|7737362|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||209
6805309|NCT03745651|7737363|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||224
6565798|NCT01820585|7488652|FG001|Randomized and Treated|Overall Study||130
6565799|NCT01820585|7488653|FG002|Randomized and Treated|Overall Study||135
6565800|NCT01820585|7488654|FG003|Randomized and Treated|Overall Study||132
6565801|NCT01820585|7488651|FG000|Full Analysis Set|Overall Study||131
6565802|NCT01820585|7488652|FG001|Full Analysis Set|Overall Study||130
6565803|NCT01820585|7488653|FG002|Full Analysis Set|Overall Study||135
6565804|NCT01820585|7488654|FG003|Full Analysis Set|Overall Study||129
6565805|NCT01820585|7488651|FG000|Completed Titration Period|Overall Study||128
6565806|NCT01820585|7488652|FG001|Completed Titration Period|Overall Study||125
6565807|NCT01820585|7488653|FG002|Completed Titration Period|Overall Study||131
6565808|NCT01820585|7488654|FG003|Completed Titration Period|Overall Study||126
6565809|NCT01820585|7488651|FG000|Entered Maintenance Period|Overall Study||128
6387382|NCT00814164|7298677|FG000|STARTED|Overall Study||21
6387383|NCT00814164|7298677|FG000|COMPLETED|Overall Study||2
6387384|NCT00814164|7298677|FG000|NOT COMPLETED|Overall Study||19
6387385|NCT00814177|7298683|FG000|STARTED|Overall Study||80
6387386|NCT00814177|7298684|FG001|STARTED|Overall Study||80
6387387|NCT00814177|7298683|FG000|COMPLETED|Overall Study||80
6387388|NCT00814177|7298684|FG001|COMPLETED|Overall Study||80
6387389|NCT00814177|7298683|FG000|NOT COMPLETED|Overall Study||0
6387390|NCT00814177|7298684|FG001|NOT COMPLETED|Overall Study||0
6387391|NCT00814255|7298693|FG000|STARTED|Overall Study||8
6387392|NCT00814255|7298694|FG001|STARTED|Overall Study||7
6387393|NCT00814255|7298695|FG002|STARTED|Overall Study||8
6387394|NCT00814255|7298693|FG000|COMPLETED|Overall Study||7
6387395|NCT00814255|7298694|FG001|COMPLETED|Overall Study||7
6387396|NCT00814255|7298695|FG002|COMPLETED|Overall Study||7
6387397|NCT00814255|7298693|FG000|NOT COMPLETED|Overall Study||1
6387398|NCT00814255|7298694|FG001|NOT COMPLETED|Overall Study||0
6387399|NCT00814255|7298695|FG002|NOT COMPLETED|Overall Study||1
6387400|NCT00814307|7298710|FG000|STARTED|Overall Study||244
6387401|NCT00814307|7298711|FG001|STARTED|Overall Study||245
6387402|NCT00814307|7298712|FG002|STARTED|Overall Study||61
6387403|NCT00814307|7298713|FG003|STARTED|Overall Study||61
6387404|NCT00814307|7298710|FG000|Treated|Overall Study||243
6387405|NCT00814307|7298711|FG001|Treated|Overall Study||245
6387406|NCT00814307|7298712|FG002|Treated|Overall Study||61
6387407|NCT00814307|7298713|FG003|Treated|Overall Study||61
6503994|NCT01446289|7423083|FG000|COMPLETED|Overall Study||50
6503995|NCT01446289|7423084|FG001|COMPLETED|Overall Study||35
6503996|NCT01446289|7423085|FG002|COMPLETED|Overall Study||50
6503997|NCT01446289|7423086|FG003|COMPLETED|Overall Study||35
6503998|NCT01446289|7423083|FG000|NOT COMPLETED|Overall Study||1
6503999|NCT01446289|7423084|FG001|NOT COMPLETED|Overall Study||0
6504000|NCT01446289|7423085|FG002|NOT COMPLETED|Overall Study||1
6504001|NCT01446289|7423086|FG003|NOT COMPLETED|Overall Study||0
6504002|NCT01446419|7423100|FG000|STARTED|Overall Study||147
6504003|NCT01446419|7423101|FG001|STARTED|Overall Study||78
6504004|NCT01446419|7423100|FG000|3 Month Follow-up|Overall Study||146
6504005|NCT01446419|7423101|FG001|3 Month Follow-up|Overall Study||77
6504006|NCT01446419|7423100|FG000|6 Month Follow-up|Overall Study||144
6504007|NCT01446419|7423101|FG001|6 Month Follow-up|Overall Study||77
6504008|NCT01446419|7423100|FG000|12 Month Follow-up|Overall Study||142
6504009|NCT01446419|7423101|FG001|12 Month Follow-up|Overall Study||77
6504010|NCT01446419|7423100|FG000|COMPLETED|Overall Study||142
6504011|NCT01446419|7423101|FG001|COMPLETED|Overall Study||77
6504012|NCT01446419|7423100|FG000|NOT COMPLETED|Overall Study||5
6504013|NCT01446419|7423101|FG001|NOT COMPLETED|Overall Study||1
6504014|NCT01446666|7423107|FG000|STARTED|Overall Study|Among the 423 participants who consented, 15 withdrew the consent and one died.|407
6504015|NCT01446666|7423107|FG000|COMPLETED|Overall Study||326
6565810|NCT01820585|7488652|FG001|Entered Maintenance Period|Overall Study||124
6387408|NCT00814307|7298710|FG000|COMPLETED|Overall Study||232
6387409|NCT00814307|7298711|FG001|COMPLETED|Overall Study||218
6387410|NCT00814307|7298712|FG002|COMPLETED|Overall Study||54
6387411|NCT00814307|7298713|FG003|COMPLETED|Overall Study||51
6387412|NCT00814307|7298710|FG000|NOT COMPLETED|Overall Study||12
6387413|NCT00814307|7298711|FG001|NOT COMPLETED|Overall Study||27
6387414|NCT00814307|7298712|FG002|NOT COMPLETED|Overall Study||7
6387415|NCT00814307|7298713|FG003|NOT COMPLETED|Overall Study||10
6387416|NCT00814320|7298727|FG000|STARTED|Epoch 1 (IV Treatment)||14
6387417|NCT00814320|7298728|FG001|STARTED|Epoch 1 (IV Treatment)||73
6387418|NCT00814320|7298727|FG000|COMPLETED|Epoch 1 (IV Treatment)||13
6387419|NCT00814320|7298728|FG001|COMPLETED|Epoch 1 (IV Treatment)||71
6387420|NCT00814320|7298727|FG000|NOT COMPLETED|Epoch 1 (IV Treatment)||1
6387421|NCT00814320|7298728|FG001|NOT COMPLETED|Epoch 1 (IV Treatment)||2
6565811|NCT01820585|7488653|FG002|Entered Maintenance Period|Overall Study||131
6565812|NCT01820585|7488654|FG003|Entered Maintenance Period|Overall Study||123
6565813|NCT01820585|7488651|FG000|Completed Maintenance Period|Overall Study||105
6565814|NCT01820585|7488652|FG001|Completed Maintenance Period|Overall Study||98
6565815|NCT01820585|7488653|FG002|Completed Maintenance Period|Overall Study||101
6805310|NCT03745651|7737364|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805311|NCT03745651|7737365|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805312|NCT03745651|7737366|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805313|NCT03745651|7737367|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805314|NCT03745651|7737361|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||19
6805315|NCT03745651|7737362|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||39
6805316|NCT03745651|7737363|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||22
6805317|NCT03745651|7737364|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805318|NCT03745651|7737365|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805319|NCT03745651|7737366|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805320|NCT03745651|7737367|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805321|NCT03745651|7737361|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
6805322|NCT03745651|7737362|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
6805323|NCT03745651|7737363|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
6805324|NCT03745651|7737364|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||53
6805325|NCT03745651|7737365|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||52
6805326|NCT03745651|7737366|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||204
6805327|NCT03745651|7737367|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||221
6805328|NCT03745651|7737361|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805329|NCT03745651|7737362|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805330|NCT03745651|7737363|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805331|NCT03745651|7737364|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||33
6805332|NCT03745651|7737365|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||41
6805333|NCT03745651|7737366|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||151
6805334|NCT03745651|7737367|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||170
6805335|NCT03745651|7737361|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805336|NCT03745651|7737362|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805337|NCT03745651|7737363|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805338|NCT03745651|7737364|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||20
6805339|NCT03745651|7737365|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
6805340|NCT03745651|7737366|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||53
6805341|NCT03745651|7737367|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
6805342|NCT03745638|7737386|FG000|STARTED|Vehicle Control Period (Day 1 to Week 8)||126
6805343|NCT03745638|7737387|FG001|STARTED|Vehicle Control Period (Day 1 to Week 8)||252
6805344|NCT03745638|7737388|FG002|STARTED|Vehicle Control Period (Day 1 to Week 8)||253
6805345|NCT03745638|7737389|FG003|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
6805346|NCT03745638|7737390|FG004|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
6805347|NCT03745638|7737391|FG005|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
6805348|NCT03745638|7737392|FG006|STARTED|Vehicle Control Period (Day 1 to Week 8)||0
6805349|NCT03745638|7737386|FG000|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||95
6805350|NCT03745638|7737387|FG001|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||222
6805351|NCT03745638|7737388|FG002|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||225
6805352|NCT03745638|7737389|FG003|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805353|NCT03745638|7737390|FG004|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805354|NCT03745638|7737391|FG005|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805355|NCT03745638|7737392|FG006|COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805356|NCT03745638|7737386|FG000|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||31
6805357|NCT03745638|7737387|FG001|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||30
6805358|NCT03745638|7737388|FG002|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||28
6805359|NCT03745638|7737389|FG003|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805360|NCT03745638|7737390|FG004|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805361|NCT03745638|7737391|FG005|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805362|NCT03745638|7737392|FG006|NOT COMPLETED|Vehicle Control Period (Day 1 to Week 8)||0
6805363|NCT03745638|7737386|FG000|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
6805364|NCT03745638|7737387|FG001|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
6805365|NCT03745638|7737388|FG002|STARTED|Long-Term Safety Period (Weeks 8 to 52)||0
6805366|NCT03745638|7737389|FG003|STARTED|Long-Term Safety Period (Weeks 8 to 52)||48
6805367|NCT03745638|7737390|FG004|STARTED|Long-Term Safety Period (Weeks 8 to 52)||47
6805368|NCT03745638|7737391|FG005|STARTED|Long-Term Safety Period (Weeks 8 to 52)||222
6805369|NCT03745638|7737392|FG006|STARTED|Long-Term Safety Period (Weeks 8 to 52)||225
6805370|NCT03745638|7737386|FG000|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805371|NCT03745638|7737387|FG001|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805372|NCT03745638|7737388|FG002|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805373|NCT03745638|7737389|FG003|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||37
6805374|NCT03745638|7737390|FG004|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||38
6387422|NCT00814320|7298727|FG000|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
6387423|NCT00814320|7298728|FG001|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
6387424|NCT00814320|7298727|FG000|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
6387425|NCT00814320|7298728|FG001|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
6387426|NCT00814320|7298727|FG000|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
6387427|NCT00814320|7298728|FG001|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
6387428|NCT00814320|7298727|FG000|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
6387429|NCT00814320|7298728|FG001|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
6387430|NCT00814320|7298727|FG000|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
6387431|NCT00814320|7298728|FG001|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
6387432|NCT00814320|7298727|FG000|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
6387433|NCT00814320|7298728|FG001|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
6387434|NCT00814320|7298727|FG000|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
6387435|NCT00814320|7298728|FG001|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
6387436|NCT00814320|7298727|FG000|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
6387437|NCT00814320|7298728|FG001|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
6387438|NCT00814320|7298727|FG000|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
6805375|NCT03745638|7737391|FG005|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||176
6805376|NCT03745638|7737392|FG006|COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||174
6805377|NCT03745638|7737386|FG000|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805378|NCT03745638|7737387|FG001|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805379|NCT03745638|7737388|FG002|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||0
6805380|NCT03745638|7737389|FG003|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||11
6805381|NCT03745638|7737390|FG004|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||9
6805382|NCT03745638|7737391|FG005|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||46
6805383|NCT03745638|7737392|FG006|NOT COMPLETED|Long-Term Safety Period (Weeks 8 to 52)||51
6272441|NCT00095576|7171713|FG001|STARTED|Overall Study||1495
6272442|NCT00095576|7171712|FG000|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
6272443|NCT00095576|7171713|FG001|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
6272444|NCT00095576|7171712|FG000|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
6272445|NCT00095576|7171713|FG001|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
6272446|NCT00095576|7171712|FG000|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
6272447|NCT00095576|7171713|FG001|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
6272448|NCT00095576|7171712|FG000|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
6272449|NCT00095576|7171713|FG001|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
6272450|NCT00095576|7171712|FG000|NOT COMPLETED|Overall Study||1475
6565816|NCT01820585|7488654|FG003|Completed Maintenance Period|Overall Study||84
6565817|NCT01820585|7488651|FG000|COMPLETED|Overall Study||104
6565818|NCT01820585|7488652|FG001|COMPLETED|Overall Study||98
6272451|NCT00095576|7171713|FG001|NOT COMPLETED|Overall Study||1481
6272452|NCT00095628|7171719|FG000|STARTED|Overall Study||21
6272453|NCT00095628|7171719|FG000|COMPLETED|Overall Study||20
6272454|NCT00095628|7171719|FG000|NOT COMPLETED|Overall Study||1
6272455|NCT00095836|7171723|FG000|STARTED|Overall Study||27
6272456|NCT00095836|7171723|FG000|COMPLETED|Overall Study||23
6272457|NCT00095836|7171723|FG000|NOT COMPLETED|Overall Study||4
6272458|NCT00095875|7171729|FG000|STARTED|Overall Study||70
6272459|NCT00095875|7171730|FG001|STARTED|Overall Study||75
6272460|NCT00095875|7171729|FG000|COMPLETED|Overall Study||56
6272461|NCT00095875|7171730|FG001|COMPLETED|Overall Study||66
6272462|NCT00095875|7171729|FG000|NOT COMPLETED|Overall Study||14
6272463|NCT00095875|7171730|FG001|NOT COMPLETED|Overall Study||9
6272464|NCT00095940|7171743|FG000|STARTED|Molecular Biology Phase||2
6272465|NCT00095940|7171744|FG001|STARTED|Molecular Biology Phase||2
6272466|NCT00095940|7171745|FG002|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
6272467|NCT00095940|7171746|FG003|STARTED|Molecular Biology Phase||0
6565819|NCT01820585|7488653|FG002|COMPLETED|Overall Study||101
6565820|NCT01820585|7488654|FG003|COMPLETED|Overall Study||83
6565821|NCT01820585|7488651|FG000|NOT COMPLETED|Overall Study||27
6565822|NCT01820585|7488652|FG001|NOT COMPLETED|Overall Study||32
6805384|NCT03715764|7737411|FG000|STARTED|Baseline (Randomized (n=69)||35
6805385|NCT03715764|7737412|FG001|STARTED|Baseline (Randomized (n=69)||34
6805386|NCT03715764|7737411|FG000|COMPLETED|Baseline (Randomized (n=69)||33
6805387|NCT03715764|7737412|FG001|COMPLETED|Baseline (Randomized (n=69)||31
6805388|NCT03715764|7737411|FG000|NOT COMPLETED|Baseline (Randomized (n=69)||2
6805389|NCT03715764|7737412|FG001|NOT COMPLETED|Baseline (Randomized (n=69)||3
6805390|NCT03715764|7737411|FG000|STARTED|3 Month Follow-up||33
6272468|NCT00095940|7171747|FG004|STARTED|Molecular Biology Phase||0
6272469|NCT00095940|7171748|FG005|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
6504016|NCT01446666|7423107|FG000|NOT COMPLETED|Overall Study||81
6504017|NCT01446705|7423114|FG000|STARTED|Overall Study||50446
6504018|NCT01446705|7423115|FG001|STARTED|Overall Study||6627
6504019|NCT01446705|7423114|FG000|COMPLETED|Overall Study||50446
6504020|NCT01446705|7423115|FG001|COMPLETED|Overall Study||6627
6504021|NCT01446705|7423114|FG000|NOT COMPLETED|Overall Study||0
6504022|NCT01446705|7423115|FG001|NOT COMPLETED|Overall Study||0
6504023|NCT01446809|7423133|FG000|STARTED|Overall Study||14
6504024|NCT01446809|7423134|FG001|STARTED|Overall Study||7
6504025|NCT01446809|7423135|FG002|STARTED|Overall Study||2
6504026|NCT01446809|7423133|FG000|COMPLETED|Overall Study||14
6504027|NCT01446809|7423134|FG001|COMPLETED|Overall Study||7
6504028|NCT01446809|7423135|FG002|COMPLETED|Overall Study||0
6565823|NCT01820585|7488653|FG002|NOT COMPLETED|Overall Study||34
6565824|NCT01820585|7488654|FG003|NOT COMPLETED|Overall Study||49
6805391|NCT03715764|7737412|FG001|STARTED|3 Month Follow-up||31
6805392|NCT03715764|7737411|FG000|COMPLETED|3 Month Follow-up||30
6805393|NCT03715764|7737412|FG001|COMPLETED|3 Month Follow-up||28
6805394|NCT03715764|7737411|FG000|NOT COMPLETED|3 Month Follow-up||3
6272470|NCT00095940|7171749|FG006|STARTED|Molecular Biology Phase||2
6504029|NCT01446809|7423133|FG000|NOT COMPLETED|Overall Study||0
6504030|NCT01446809|7423134|FG001|NOT COMPLETED|Overall Study||0
6504031|NCT01446809|7423135|FG002|NOT COMPLETED|Overall Study||2
6504032|NCT01446874|7423147|FG000|STARTED|Overall Study||20
6504033|NCT01446874|7423148|FG001|STARTED|Overall Study||50
6504034|NCT01446874|7423149|FG002|STARTED|Overall Study||80
6504035|NCT01446874|7423147|FG000|COMPLETED|Overall Study||18
6504036|NCT01446874|7423148|FG001|COMPLETED|Overall Study||46
6504037|NCT01446874|7423149|FG002|COMPLETED|Overall Study||62
6504038|NCT01446874|7423147|FG000|NOT COMPLETED|Overall Study||2
6504039|NCT01446874|7423148|FG001|NOT COMPLETED|Overall Study||4
6504040|NCT01446874|7423149|FG002|NOT COMPLETED|Overall Study||18
6504041|NCT01446913|7423160|FG000|STARTED|Overall Study||86
6504042|NCT01446913|7423161|FG001|STARTED|Overall Study||82
6504043|NCT01446913|7423162|FG002|STARTED|Overall Study||84
6504044|NCT01446913|7423160|FG000|Patients With Sleep Study|Overall Study||53
6504045|NCT01446913|7423161|FG001|Patients With Sleep Study|Overall Study||56
6805395|NCT03715764|7737412|FG001|NOT COMPLETED|3 Month Follow-up||3
6805396|NCT03715764|7737411|FG000|STARTED|6 Month Follow-up||30
6805397|NCT03715764|7737412|FG001|STARTED|6 Month Follow-up||28
6805398|NCT03715764|7737411|FG000|COMPLETED|6 Month Follow-up||27
6805399|NCT03715764|7737412|FG001|COMPLETED|6 Month Follow-up||28
6805400|NCT03715764|7737411|FG000|NOT COMPLETED|6 Month Follow-up||3
6805401|NCT03715764|7737412|FG001|NOT COMPLETED|6 Month Follow-up||0
6805402|NCT03715764|7737411|FG000|STARTED|12 Month Follow-up||27
6565825|NCT01820637|7488664|FG000|STARTED|Overall Study||57
6565826|NCT01820637|7488664|FG000|COMPLETED|Overall Study||54
6565827|NCT01820637|7488664|FG000|NOT COMPLETED|Overall Study||3
6565828|NCT01820754|7488668|FG000|STARTED|Overall Study||24
6565829|NCT01820754|7488668|FG000|COMPLETED|Overall Study||24
6565830|NCT01820754|7488668|FG000|NOT COMPLETED|Overall Study||0
6565831|NCT01821105|7488672|FG000|STARTED|Overall Study||21
6565832|NCT01821105|7488672|FG000|COMPLETED|Overall Study||21
6565833|NCT01821105|7488672|FG000|NOT COMPLETED|Overall Study||0
6565834|NCT01821118|7488678|FG000|STARTED|Overall Study||24
6565835|NCT01821118|7488679|FG001|STARTED|Overall Study||12
6565836|NCT01821118|7488678|FG000|COMPLETED|Overall Study||24
6565837|NCT01821118|7488679|FG001|COMPLETED|Overall Study||11
6565838|NCT01821118|7488678|FG000|NOT COMPLETED|Overall Study||0
6565839|NCT01821118|7488679|FG001|NOT COMPLETED|Overall Study||1
6565840|NCT01821300|7488687|FG000|STARTED|Overall Study||154
6565841|NCT01821300|7488688|FG001|STARTED|Overall Study||103
6565842|NCT01821300|7488687|FG000|COMPLETED|Overall Study||154
6565843|NCT01821300|7488688|FG001|COMPLETED|Overall Study||103
6387439|NCT00814320|7298728|FG001|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
6387440|NCT00814346|7298753|FG000|STARTED|Double-blind Phase (4 Weeks)||23
6387441|NCT00814346|7298754|FG001|STARTED|Double-blind Phase (4 Weeks)||26
6387442|NCT00814346|7298753|FG000|CNE|Double-blind Phase (4 Weeks)||10
6387443|NCT00814346|7298754|FG001|CNE|Double-blind Phase (4 Weeks)||13
6387444|NCT00814346|7298753|FG000|MC|Double-blind Phase (4 Weeks)||10
6387445|NCT00814346|7298754|FG001|MC|Double-blind Phase (4 Weeks)||11
6387446|NCT00814346|7298753|FG000|AD|Double-blind Phase (4 Weeks)||3
6387447|NCT00814346|7298754|FG001|AD|Double-blind Phase (4 Weeks)||2
6387448|NCT00814346|7298753|FG000|COMPLETED|Double-blind Phase (4 Weeks)||23
6387449|NCT00814346|7298754|FG001|COMPLETED|Double-blind Phase (4 Weeks)||23
6387450|NCT00814346|7298753|FG000|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
6387451|NCT00814346|7298754|FG001|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
6387452|NCT00814346|7298753|FG000|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
6387453|NCT00814346|7298754|FG001|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
6387454|NCT00814346|7298753|FG000|CNE|Open Phase (17 Months)||21
6387455|NCT00814346|7298754|FG001|CNE|Open Phase (17 Months)||0
6387456|NCT00814346|7298753|FG000|MC|Open Phase (17 Months)||20
6387457|NCT00814346|7298754|FG001|MC|Open Phase (17 Months)||0
6387458|NCT00814346|7298753|FG000|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
6387459|NCT00814346|7298754|FG001|AD|Open Phase (17 Months)||0
6387460|NCT00814346|7298753|FG000|COMPLETED|Open Phase (17 Months)||31
6387461|NCT00814346|7298754|FG001|COMPLETED|Open Phase (17 Months)||0
6387462|NCT00814346|7298753|FG000|NOT COMPLETED|Open Phase (17 Months)||10
6387463|NCT00814346|7298754|FG001|NOT COMPLETED|Open Phase (17 Months)||0
6387464|NCT00814463|7298773|FG000|STARTED|Overall Study||1
6387465|NCT00814463|7298773|FG000|COMPLETED|Overall Study||0
6387466|NCT00814463|7298773|FG000|NOT COMPLETED|Overall Study||1
6387467|NCT00814489|7298781|FG000|STARTED|Overall Study||15
6387468|NCT00814489|7298782|FG001|STARTED|Overall Study||17
6387469|NCT00814489|7298783|FG002|STARTED|Overall Study||8
6387470|NCT00814489|7298781|FG000|COMPLETED|Overall Study||13
6387471|NCT00814489|7298782|FG001|COMPLETED|Overall Study||17
6387472|NCT00814489|7298783|FG002|COMPLETED|Overall Study||7
6387473|NCT00814489|7298781|FG000|NOT COMPLETED|Overall Study||2
6387474|NCT00814489|7298782|FG001|NOT COMPLETED|Overall Study||0
6504046|NCT01446913|7423162|FG002|Patients With Sleep Study|Overall Study||29
6504047|NCT01446913|7423160|FG000|Patients With Sleep Apnea|Overall Study||39
6504048|NCT01446913|7423161|FG001|Patients With Sleep Apnea|Overall Study||45
6504049|NCT01446913|7423162|FG002|Patients With Sleep Apnea|Overall Study||21
6504050|NCT01446913|7423160|FG000|COMPLETED|Overall Study||77
6504051|NCT01446913|7423161|FG001|COMPLETED|Overall Study||73
6504052|NCT01446913|7423162|FG002|COMPLETED|Overall Study||73
6504053|NCT01446913|7423160|FG000|NOT COMPLETED|Overall Study||9
6504054|NCT01446913|7423161|FG001|NOT COMPLETED|Overall Study||9
6504055|NCT01446913|7423162|FG002|NOT COMPLETED|Overall Study||11
6504056|NCT01446965|7423178|FG000|STARTED|Randominization||1554
6504057|NCT01446965|7423179|FG001|STARTED|Randominization||794
6504058|NCT01446965|7423178|FG000|COMPLETED|Randominization||1524
6504059|NCT01446965|7423179|FG001|COMPLETED|Randominization||778
6565844|NCT01821300|7488687|FG000|NOT COMPLETED|Overall Study||0
6565845|NCT01821300|7488688|FG001|NOT COMPLETED|Overall Study||0
6565846|NCT01821326|7488700|FG000|STARTED|Overall Study||339
6565847|NCT01821326|7488700|FG000|COMPLETED|Overall Study||339
6565848|NCT01821326|7488700|FG000|NOT COMPLETED|Overall Study||0
6565849|NCT01821352|7488706|FG000|STARTED|Overall Study||28
6565850|NCT01821352|7488707|FG001|STARTED|Overall Study||25
6565851|NCT01821352|7488706|FG000|COMPLETED|Overall Study||28
6565852|NCT01821352|7488707|FG001|COMPLETED|Overall Study||25
6565853|NCT01821352|7488706|FG000|NOT COMPLETED|Overall Study||0
6565854|NCT01821352|7488707|FG001|NOT COMPLETED|Overall Study||0
6565855|NCT01821378|7488716|FG000|STARTED|Overall Study||101
6565856|NCT01821378|7488717|FG001|STARTED|Overall Study||199
6565857|NCT01821378|7488718|FG002|STARTED|Overall Study||112
6272471|NCT00095940|7171750|FG007|STARTED|Molecular Biology Phase||2
6272472|NCT00095940|7171751|FG008|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
6272473|NCT00095940|7171743|FG000|COMPLETED|Molecular Biology Phase||2
6272474|NCT00095940|7171744|FG001|COMPLETED|Molecular Biology Phase||2
6272475|NCT00095940|7171745|FG002|COMPLETED|Molecular Biology Phase||0
6272476|NCT00095940|7171746|FG003|COMPLETED|Molecular Biology Phase||0
6272477|NCT00095940|7171747|FG004|COMPLETED|Molecular Biology Phase||0
6272478|NCT00095940|7171748|FG005|COMPLETED|Molecular Biology Phase||0
6272479|NCT00095940|7171749|FG006|COMPLETED|Molecular Biology Phase||2
6272480|NCT00095940|7171750|FG007|COMPLETED|Molecular Biology Phase||2
6272481|NCT00095940|7171751|FG008|COMPLETED|Molecular Biology Phase||0
6272482|NCT00095940|7171743|FG000|NOT COMPLETED|Molecular Biology Phase||0
6272483|NCT00095940|7171744|FG001|NOT COMPLETED|Molecular Biology Phase||0
6272484|NCT00095940|7171745|FG002|NOT COMPLETED|Molecular Biology Phase||0
6272485|NCT00095940|7171746|FG003|NOT COMPLETED|Molecular Biology Phase||0
6272486|NCT00095940|7171747|FG004|NOT COMPLETED|Molecular Biology Phase||0
6272487|NCT00095940|7171748|FG005|NOT COMPLETED|Molecular Biology Phase||0
6272488|NCT00095940|7171749|FG006|NOT COMPLETED|Molecular Biology Phase||0
6272489|NCT00095940|7171750|FG007|NOT COMPLETED|Molecular Biology Phase||0
6272490|NCT00095940|7171751|FG008|NOT COMPLETED|Molecular Biology Phase||0
6272491|NCT00095940|7171743|FG000|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
6272492|NCT00095940|7171744|FG001|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
6272493|NCT00095940|7171745|FG002|STARTED|Lapatinib Continuation/Phase II||17
6272494|NCT00095940|7171746|FG003|STARTED|Lapatinib Continuation/Phase II||0
6272495|NCT00095940|7171747|FG004|STARTED|Lapatinib Continuation/Phase II||0
6272496|NCT00095940|7171748|FG005|STARTED|Lapatinib Continuation/Phase II||13
6272497|NCT00095940|7171749|FG006|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
6272498|NCT00095940|7171750|FG007|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
6272499|NCT00095940|7171751|FG008|STARTED|Lapatinib Continuation/Phase II||14
6387475|NCT00814489|7298783|FG002|NOT COMPLETED|Overall Study||1
6387476|NCT00814502|7298795|FG000|STARTED|Overall Study||8
6387477|NCT00814502|7298796|FG001|STARTED|Overall Study||9
6387478|NCT00814502|7298795|FG000|COMPLETED|Overall Study||7
6387479|NCT00814502|7298796|FG001|COMPLETED|Overall Study||7
6387480|NCT00814502|7298795|FG000|NOT COMPLETED|Overall Study||1
6387481|NCT00814502|7298796|FG001|NOT COMPLETED|Overall Study||2
6387482|NCT00814580|7298806|FG000|STARTED|Overall Study||194
6387483|NCT00814580|7298807|FG001|STARTED|Overall Study||188
6387484|NCT00814580|7298806|FG000|COMPLETED|Overall Study||163
6387485|NCT00814580|7298807|FG001|COMPLETED|Overall Study||141
6387486|NCT00814580|7298806|FG000|NOT COMPLETED|Overall Study||31
6387487|NCT00814580|7298807|FG001|NOT COMPLETED|Overall Study||47
6387488|NCT00814632|7298825|FG000|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
6387489|NCT00814632|7298825|FG000|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
6387490|NCT00814632|7298825|FG000|NOT COMPLETED|Overall Study||2
6387491|NCT00814658|7298831|FG000|STARTED|Overall Study||9
6387492|NCT00814658|7298832|FG001|STARTED|Overall Study||12
6387493|NCT00814658|7298831|FG000|COMPLETED|Overall Study||5
6387494|NCT00814658|7298832|FG001|COMPLETED|Overall Study||8
6387495|NCT00814658|7298831|FG000|NOT COMPLETED|Overall Study||4
6565858|NCT01821378|7488716|FG000|COMPLETED|Overall Study||74
6565859|NCT01821378|7488717|FG001|COMPLETED|Overall Study||145
6565860|NCT01821378|7488718|FG002|COMPLETED|Overall Study||70
6565861|NCT01821378|7488716|FG000|NOT COMPLETED|Overall Study||27
6805403|NCT03715764|7737412|FG001|STARTED|12 Month Follow-up||28
6805404|NCT03715764|7737411|FG000|COMPLETED|12 Month Follow-up||21
6805405|NCT03715764|7737412|FG001|COMPLETED|12 Month Follow-up||23
6805406|NCT03715764|7737411|FG000|NOT COMPLETED|12 Month Follow-up||6
6805407|NCT03715764|7737412|FG001|NOT COMPLETED|12 Month Follow-up||5
6805408|NCT03663855|7737418|FG000|STARTED|Overall Study||10
6805409|NCT03663855|7737418|FG000|COMPLETED|Overall Study||10
6805410|NCT03663855|7737418|FG000|NOT COMPLETED|Overall Study||0
6805411|NCT03654729|7737425|FG000|STARTED|Overall Study||97
6805412|NCT03654729|7737426|FG001|STARTED|Overall Study||96
6805413|NCT03654729|7737427|FG002|STARTED|Overall Study||98
6805414|NCT03654729|7737425|FG000|Treated|Overall Study||96
6805415|NCT03654729|7737426|FG001|Treated|Overall Study||93
6805416|NCT03654729|7737427|FG002|Treated|Overall Study||96
6805417|NCT03654729|7737425|FG000|COMPLETED|Overall Study||66
6805418|NCT03654729|7737426|FG001|COMPLETED|Overall Study||70
6805419|NCT03654729|7737427|FG002|COMPLETED|Overall Study||69
6805420|NCT03654729|7737425|FG000|NOT COMPLETED|Overall Study||31
6805421|NCT03654729|7737426|FG001|NOT COMPLETED|Overall Study||26
6805422|NCT03654729|7737427|FG002|NOT COMPLETED|Overall Study||29
6387496|NCT00814658|7298832|FG001|NOT COMPLETED|Overall Study||4
6565862|NCT01821378|7488717|FG001|NOT COMPLETED|Overall Study||54
6565863|NCT01821378|7488718|FG002|NOT COMPLETED|Overall Study||42
6565864|NCT01821391|7488733|FG000|STARTED|Overall Study||108
6565865|NCT01821391|7488734|FG001|STARTED|Overall Study||23
6387497|NCT00814671|7298851|FG000|STARTED|Overall Study||54
6387498|NCT00814671|7298852|FG001|STARTED|Overall Study||48
6387499|NCT00814671|7298853|FG002|STARTED|Overall Study||51
6387500|NCT00814671|7298851|FG000|COMPLETED|Overall Study||47
6565866|NCT01821391|7488733|FG000|COMPLETED|Overall Study||107
6387501|NCT00814671|7298852|FG001|COMPLETED|Overall Study||44
6387502|NCT00814671|7298853|FG002|COMPLETED|Overall Study||49
6387503|NCT00814671|7298851|FG000|NOT COMPLETED|Overall Study||7
6387504|NCT00814671|7298852|FG001|NOT COMPLETED|Overall Study||4
6387505|NCT00814671|7298853|FG002|NOT COMPLETED|Overall Study||2
6387506|NCT00814697|7298865|FG000|STARTED|Overall Study||12
6387507|NCT00814697|7298865|FG000|COMPLETED|Overall Study||12
6387508|NCT00814697|7298865|FG000|NOT COMPLETED|Overall Study||0
6805423|NCT03531112|7737437|FG000|STARTED|Overall Study||20
6805424|NCT03531112|7737438|FG001|STARTED|Overall Study||0
6805425|NCT03531112|7737437|FG000|Month 4|Overall Study||17
6805426|NCT03531112|7737438|FG001|Month 4|Overall Study||0
6805427|NCT03531112|7737437|FG000|Month 6 (Follow-Up)|Overall Study||13
6805428|NCT03531112|7737438|FG001|Month 6 (Follow-Up)|Overall Study||0
6805429|NCT03531112|7737437|FG000|COMPLETED|Overall Study||13
6805430|NCT03531112|7737438|FG001|COMPLETED|Overall Study||0
6805431|NCT03531112|7737437|FG000|NOT COMPLETED|Overall Study||7
6805432|NCT03531112|7737438|FG001|NOT COMPLETED|Overall Study||0
6805433|NCT03112902|7737454|FG000|STARTED|Overall Study||2
6805434|NCT03112902|7737455|FG001|STARTED|Overall Study||2
6805435|NCT03112902|7737456|FG002|STARTED|Overall Study||3
6805436|NCT03112902|7737457|FG003|STARTED|Overall Study||1
6805437|NCT03112902|7737458|FG004|STARTED|Overall Study||1
6504060|NCT01446965|7423178|FG000|NOT COMPLETED|Randominization||30
6805438|NCT03112902|7737459|FG005|STARTED|Overall Study||3
6805439|NCT03112902|7737460|FG006|STARTED|Overall Study||9
6805440|NCT03112902|7737461|FG007|STARTED|Overall Study||3
6805441|NCT03112902|7737462|FG008|STARTED|Overall Study||0
6387509|NCT00814710|7298871|FG000|STARTED|Overall Study||240
6387510|NCT00814710|7298872|FG001|STARTED|Overall Study||120
6387511|NCT00814710|7298871|FG000|COMPLETED|Overall Study||232
6387512|NCT00814710|7298872|FG001|COMPLETED|Overall Study||117
6387513|NCT00814710|7298871|FG000|NOT COMPLETED|Overall Study||8
6387514|NCT00814710|7298872|FG001|NOT COMPLETED|Overall Study||3
6387515|NCT00814775|7298880|FG000|STARTED|Overall Study||23
6387516|NCT00814775|7298881|FG001|STARTED|Overall Study||20
6387517|NCT00814775|7298880|FG000|COMPLETED|Overall Study||23
6387518|NCT00814775|7298881|FG001|COMPLETED|Overall Study||20
6387519|NCT00814775|7298880|FG000|NOT COMPLETED|Overall Study||0
6387520|NCT00814775|7298881|FG001|NOT COMPLETED|Overall Study||0
6387521|NCT00814788|7298887|FG000|STARTED|Overall Study||24
6387522|NCT00814788|7298887|FG000|COMPLETED|Overall Study||24
6387523|NCT00814788|7298887|FG000|NOT COMPLETED|Overall Study||0
6387524|NCT00814801|7298896|FG000|STARTED|Overall Study||194
6387525|NCT00814801|7298897|FG001|STARTED|Overall Study||192
6387526|NCT00814801|7298898|FG002|STARTED|Overall Study||194
6387527|NCT00814801|7298896|FG000|COMPLETED|Overall Study||160
6387528|NCT00814801|7298897|FG001|COMPLETED|Overall Study||154
6387529|NCT00814801|7298898|FG002|COMPLETED|Overall Study||151
6387530|NCT00814801|7298896|FG000|NOT COMPLETED|Overall Study||34
6387531|NCT00814801|7298897|FG001|NOT COMPLETED|Overall Study||38
6387532|NCT00814801|7298898|FG002|NOT COMPLETED|Overall Study||43
6387533|NCT00814879|7298908|FG000|STARTED|By Week 24||28
6387534|NCT00814879|7298909|FG001|STARTED|By Week 24||30
6387535|NCT00814879|7298908|FG000|COMPLETED|By Week 24||27
6387536|NCT00814879|7298909|FG001|COMPLETED|By Week 24||29
6387537|NCT00814879|7298908|FG000|NOT COMPLETED|By Week 24||1
6387538|NCT00814879|7298909|FG001|NOT COMPLETED|By Week 24||1
6387539|NCT00814879|7298908|FG000|STARTED|By Week 48||27
6387540|NCT00814879|7298909|FG001|STARTED|By Week 48||29
6387541|NCT00814879|7298908|FG000|COMPLETED|By Week 48||25
6387542|NCT00814879|7298909|FG001|COMPLETED|By Week 48||26
6387543|NCT00814879|7298908|FG000|NOT COMPLETED|By Week 48||2
6387544|NCT00814879|7298909|FG001|NOT COMPLETED|By Week 48||3
6387545|NCT00814970|7298916|FG000|STARTED|Overall Study||196
6387546|NCT00814970|7298916|FG000|COMPLETED|Overall Study||146
6387547|NCT00814970|7298916|FG000|NOT COMPLETED|Overall Study||50
6387548|NCT00815035|7298924|FG000|STARTED|Blinded Phase||10
6387549|NCT00815035|7298925|FG001|STARTED|Blinded Phase||6
6387550|NCT00815035|7298926|FG002|STARTED|Blinded Phase||0
6387551|NCT00815035|7298924|FG000|COMPLETED|Blinded Phase||9
6387552|NCT00815035|7298925|FG001|COMPLETED|Blinded Phase||6
6387553|NCT00815035|7298926|FG002|COMPLETED|Blinded Phase||0
6387554|NCT00815035|7298924|FG000|NOT COMPLETED|Blinded Phase||1
6387555|NCT00815035|7298925|FG001|NOT COMPLETED|Blinded Phase||0
6387556|NCT00815035|7298926|FG002|NOT COMPLETED|Blinded Phase||0
6387557|NCT00815035|7298924|FG000|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
6387558|NCT00815035|7298925|FG001|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
6387559|NCT00815035|7298926|FG002|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
6387560|NCT00815035|7298924|FG000|COMPLETED|Open Label Extension Phase||0
6387561|NCT00815035|7298925|FG001|COMPLETED|Open Label Extension Phase||0
6387562|NCT00815035|7298926|FG002|COMPLETED|Open Label Extension Phase||9
6387563|NCT00815035|7298924|FG000|NOT COMPLETED|Open Label Extension Phase||0
6387564|NCT00815035|7298925|FG001|NOT COMPLETED|Open Label Extension Phase||0
6387565|NCT00815035|7298926|FG002|NOT COMPLETED|Open Label Extension Phase||6
6565867|NCT01821391|7488734|FG001|COMPLETED|Overall Study||23
6565868|NCT01821391|7488733|FG000|NOT COMPLETED|Overall Study||1
6565869|NCT01821391|7488734|FG001|NOT COMPLETED|Overall Study||0
6565870|NCT01821417|7488744|FG000|STARTED|Overall Study||37
6565871|NCT01821417|7488745|FG001|STARTED|Overall Study||31
6565872|NCT01821417|7488744|FG000|COMPLETED|Overall Study||37
6565873|NCT01821417|7488745|FG001|COMPLETED|Overall Study||31
6565874|NCT01821417|7488744|FG000|NOT COMPLETED|Overall Study||0
6565875|NCT01821417|7488745|FG001|NOT COMPLETED|Overall Study||0
6565876|NCT01821534|7488751|FG000|STARTED|Overall Study||201
6565877|NCT01821534|7488751|FG000|COMPLETED|Overall Study||201
6565878|NCT01821534|7488751|FG000|NOT COMPLETED|Overall Study||0
6565879|NCT01821560|7488757|FG000|STARTED|Overall Study||22
6565880|NCT01821560|7488758|FG001|STARTED|Overall Study||22
6565881|NCT01821560|7488757|FG000|COMPLETED|Overall Study||16
6565882|NCT01821560|7488758|FG001|COMPLETED|Overall Study||15
6565883|NCT01821560|7488757|FG000|NOT COMPLETED|Overall Study||6
6565884|NCT01821560|7488758|FG001|NOT COMPLETED|Overall Study||7
6565885|NCT01821625|7488764|FG000|STARTED|Overall Study||7
6565886|NCT01821625|7488764|FG000|COMPLETED|Overall Study||1
6565887|NCT01821625|7488764|FG000|NOT COMPLETED|Overall Study||6
6565888|NCT01821729|7488768|FG000|STARTED|Overall Study||50
6565889|NCT01821729|7488768|FG000|Received Chemoradiotherapy|Overall Study||45
6565890|NCT01821729|7488768|FG000|Underwent Attempted Surgery|Overall Study||42
6565891|NCT01821729|7488768|FG000|COMPLETED|Overall Study||49
6565892|NCT01821729|7488768|FG000|NOT COMPLETED|Overall Study||1
6565893|NCT01821807|7488774|FG000|STARTED|Overall Study||150
6565894|NCT01821807|7488775|FG001|STARTED|Overall Study||110
6565895|NCT01821807|7488774|FG000|COMPLETED|Overall Study||147
6565896|NCT01821807|7488775|FG001|COMPLETED|Overall Study||109
6565897|NCT01821807|7488774|FG000|NOT COMPLETED|Overall Study||3
6565898|NCT01821807|7488775|FG001|NOT COMPLETED|Overall Study||1
6565899|NCT01821937|7488783|FG000|STARTED|Overall Study||10
6565900|NCT01821937|7488784|FG001|STARTED|Overall Study||15
6565901|NCT01821937|7488783|FG000|COMPLETED|Overall Study||10
6565902|NCT01821937|7488784|FG001|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
6565903|NCT01821937|7488783|FG000|NOT COMPLETED|Overall Study||0
6565904|NCT01821937|7488784|FG001|NOT COMPLETED|Overall Study||3
6565905|NCT01822119|7488792|FG000|STARTED|Overall Study||27
6565906|NCT01822119|7488792|FG000|COMPLETED|Overall Study||27
6565907|NCT01822119|7488792|FG000|NOT COMPLETED|Overall Study||0
6565908|NCT01822132|7488798|FG000|STARTED|Overall Study||25
6565909|NCT01822132|7488799|FG001|STARTED|Overall Study||27
6805442|NCT03112902|7737463|FG009|STARTED|Overall Study||0
6805443|NCT03112902|7737454|FG000|COMPLETED|Overall Study||0
6805444|NCT03112902|7737455|FG001|COMPLETED|Overall Study||2
6805445|NCT03112902|7737456|FG002|COMPLETED|Overall Study||2
6805446|NCT03112902|7737457|FG003|COMPLETED|Overall Study||0
6805447|NCT03112902|7737458|FG004|COMPLETED|Overall Study||1
6805448|NCT03112902|7737459|FG005|COMPLETED|Overall Study||0
6805449|NCT03112902|7737460|FG006|COMPLETED|Overall Study||1
6805450|NCT03112902|7737461|FG007|COMPLETED|Overall Study||1
6805451|NCT03112902|7737462|FG008|COMPLETED|Overall Study||0
6272500|NCT00095940|7171743|FG000|COMPLETED|Lapatinib Continuation/Phase II||0
6272501|NCT00095940|7171744|FG001|COMPLETED|Lapatinib Continuation/Phase II||0
6272502|NCT00095940|7171745|FG002|COMPLETED|Lapatinib Continuation/Phase II||1
6272503|NCT00095940|7171746|FG003|COMPLETED|Lapatinib Continuation/Phase II||0
6565910|NCT01822132|7488798|FG000|COMPLETED|Overall Study||21
6565911|NCT01822132|7488799|FG001|COMPLETED|Overall Study||25
6805452|NCT03112902|7737463|FG009|COMPLETED|Overall Study||0
6805453|NCT03112902|7737454|FG000|NOT COMPLETED|Overall Study||2
6272504|NCT00095940|7171747|FG004|COMPLETED|Lapatinib Continuation/Phase II||0
6272505|NCT00095940|7171748|FG005|COMPLETED|Lapatinib Continuation/Phase II||0
6565912|NCT01822132|7488798|FG000|NOT COMPLETED|Overall Study||4
6565913|NCT01822132|7488799|FG001|NOT COMPLETED|Overall Study||2
6565914|NCT01822197|7488811|FG000|STARTED|Overall Study||30
6805454|NCT03112902|7737455|FG001|NOT COMPLETED|Overall Study||0
6805455|NCT03112902|7737456|FG002|NOT COMPLETED|Overall Study||1
6805456|NCT03112902|7737457|FG003|NOT COMPLETED|Overall Study||1
6805457|NCT03112902|7737458|FG004|NOT COMPLETED|Overall Study||0
6805458|NCT03112902|7737459|FG005|NOT COMPLETED|Overall Study||3
6805459|NCT03112902|7737460|FG006|NOT COMPLETED|Overall Study||8
6805460|NCT03112902|7737461|FG007|NOT COMPLETED|Overall Study||2
6805461|NCT03112902|7737462|FG008|NOT COMPLETED|Overall Study||0
6387566|NCT00815087|7298937|FG000|STARTED|Overall Study||10
6387567|NCT00815087|7298938|FG001|STARTED|Overall Study||10
6387568|NCT00815087|7298937|FG000|COMPLETED|Overall Study||10
6387569|NCT00815087|7298938|FG001|COMPLETED|Overall Study||10
6565915|NCT01822197|7488811|FG000|COMPLETED|Overall Study||30
6565916|NCT01822197|7488811|FG000|NOT COMPLETED|Overall Study||0
6565917|NCT01822223|7488817|FG000|STARTED|Overall Study||10
6565918|NCT01822223|7488818|FG001|STARTED|Overall Study||10
6565919|NCT01822223|7488817|FG000|COMPLETED|Overall Study||10
6565920|NCT01822223|7488818|FG001|COMPLETED|Overall Study||9
6565921|NCT01822223|7488817|FG000|NOT COMPLETED|Overall Study||0
6565922|NCT01822223|7488818|FG001|NOT COMPLETED|Overall Study||1
6565923|NCT01822301|7488826|FG000|STARTED|Overall Study||5
6565924|NCT01822301|7488826|FG000|COMPLETED|Overall Study||5
6565925|NCT01822301|7488826|FG000|NOT COMPLETED|Overall Study||0
6565926|NCT01822353|7488839|FG000|STARTED|Overall Study||10
6565927|NCT01822353|7488840|FG001|STARTED|Overall Study||9
6805462|NCT03112902|7737463|FG009|NOT COMPLETED|Overall Study||0
6805463|NCT02976038|7737479|FG000|STARTED|Overall Study||28
6805464|NCT02976038|7737479|FG000|COMPLETED|Overall Study||0
6805465|NCT02976038|7737479|FG000|NOT COMPLETED|Overall Study||28
6805466|NCT02631070|7737495|FG000|STARTED|Overall Study||153
6805467|NCT02631070|7737496|FG001|STARTED|Overall Study||76
6565928|NCT01822353|7488841|FG002|STARTED|Overall Study||4
6565929|NCT01822353|7488839|FG000|COMPLETED|Overall Study||6
6565930|NCT01822353|7488840|FG001|COMPLETED|Overall Study||4
6565931|NCT01822353|7488841|FG002|COMPLETED|Overall Study||3
6565932|NCT01822353|7488839|FG000|NOT COMPLETED|Overall Study||4
6805468|NCT02631070|7737495|FG000|COMPLETED|Overall Study||4
6805469|NCT02631070|7737496|FG001|COMPLETED|Overall Study||12
6805470|NCT02631070|7737495|FG000|NOT COMPLETED|Overall Study||149
6565933|NCT01822353|7488840|FG001|NOT COMPLETED|Overall Study||5
6565934|NCT01822353|7488841|FG002|NOT COMPLETED|Overall Study||1
6387570|NCT00815087|7298937|FG000|NOT COMPLETED|Overall Study||0
6387571|NCT00815087|7298938|FG001|NOT COMPLETED|Overall Study||0
6387572|NCT00815191|7298946|FG000|STARTED|Overall Study||38
6387573|NCT00815191|7298947|FG001|STARTED|Overall Study||35
6387574|NCT00815191|7298946|FG000|COMPLETED|Overall Study||37
6387575|NCT00815191|7298947|FG001|COMPLETED|Overall Study||34
6387576|NCT00815191|7298946|FG000|NOT COMPLETED|Overall Study||1
6387577|NCT00815191|7298947|FG001|NOT COMPLETED|Overall Study||1
6387578|NCT00815295|7298956|FG000|STARTED|Overall Study||8
6387579|NCT00815295|7298957|FG001|STARTED|Overall Study||8
6387580|NCT00815295|7298958|FG002|STARTED|Overall Study||12
6387581|NCT00815295|7298956|FG000|COMPLETED|Overall Study||8
6387582|NCT00815295|7298957|FG001|COMPLETED|Overall Study||7
6387583|NCT00815295|7298958|FG002|COMPLETED|Overall Study||9
6387584|NCT00815295|7298956|FG000|NOT COMPLETED|Overall Study||0
6387585|NCT00815295|7298957|FG001|NOT COMPLETED|Overall Study||1
6387586|NCT00815295|7298958|FG002|NOT COMPLETED|Overall Study||3
6387587|NCT00815308|7298966|FG000|STARTED|Overall Study||55
6387588|NCT00815308|7298966|FG000|COMPLETED|Overall Study||45
6387589|NCT00815308|7298966|FG000|NOT COMPLETED|Overall Study||10
6387590|NCT00815347|7298970|FG000|STARTED|Overall Study||11
6387591|NCT00815347|7298970|FG000|COMPLETED|Overall Study||7
6387592|NCT00815347|7298970|FG000|NOT COMPLETED|Overall Study||4
6387593|NCT00815360|7298978|FG000|STARTED|Overall Study||11
6387594|NCT00815360|7298979|FG001|STARTED|Overall Study||11
6387595|NCT00815360|7298978|FG000|COMPLETED|Overall Study||11
6387596|NCT00815360|7298979|FG001|COMPLETED|Overall Study||11
6387597|NCT00815360|7298978|FG000|NOT COMPLETED|Overall Study||0
6387598|NCT00815360|7298979|FG001|NOT COMPLETED|Overall Study||0
6387599|NCT00815490|7298987|FG000|STARTED|Overall Study||9
6387600|NCT00815490|7298988|FG001|STARTED|Overall Study||9
6387601|NCT00815490|7298987|FG000|COMPLETED|Overall Study||9
6387602|NCT00815490|7298988|FG001|COMPLETED|Overall Study||9
6387603|NCT00815490|7298987|FG000|NOT COMPLETED|Overall Study||0
6387604|NCT00815490|7298988|FG001|NOT COMPLETED|Overall Study||0
6387605|NCT00815516|7298996|FG000|STARTED|Overall Study||20
6387606|NCT00815516|7298997|FG001|STARTED|Overall Study||10
6504061|NCT01446965|7423179|FG001|NOT COMPLETED|Randominization||16
6504062|NCT01446965|7423178|FG000|STARTED|Participants Followed and Analyzed||1524
6504063|NCT01446965|7423179|FG001|STARTED|Participants Followed and Analyzed||778
6504064|NCT01446965|7423178|FG000|Received WCD|Participants Followed and Analyzed||1481
6504065|NCT01446965|7423179|FG001|Received WCD|Participants Followed and Analyzed||0
6504066|NCT01446965|7423178|FG000|Never Wore WCD|Participants Followed and Analyzed||43
6504067|NCT01446965|7423179|FG001|Never Wore WCD|Participants Followed and Analyzed||0
6504068|NCT01446965|7423178|FG000|Never Given WCD|Participants Followed and Analyzed||0
6504069|NCT01446965|7423179|FG001|Never Given WCD|Participants Followed and Analyzed||758
6504070|NCT01446965|7423178|FG000|Given WCD Out of Protocol|Participants Followed and Analyzed||0
6504071|NCT01446965|7423179|FG001|Given WCD Out of Protocol|Participants Followed and Analyzed||20
6504072|NCT01446965|7423178|FG000|COMPLETED|Participants Followed and Analyzed||1514
6504073|NCT01446965|7423179|FG001|COMPLETED|Participants Followed and Analyzed||766
6504074|NCT01446965|7423178|FG000|NOT COMPLETED|Participants Followed and Analyzed||10
6504075|NCT01446965|7423179|FG001|NOT COMPLETED|Participants Followed and Analyzed||12
6504076|NCT01447017|7423187|FG000|STARTED|Overall Study||45
6504077|NCT01447017|7423188|FG001|STARTED|Overall Study||24
6504078|NCT01447017|7423187|FG000|Performed Visit 2|Overall Study||43
6504079|NCT01447017|7423188|FG001|Performed Visit 2|Overall Study||24
6656870|NCT02465450|7587220|FG001|NOT COMPLETED|Treatment Period 1||1
6656871|NCT02465450|7587221|FG002|NOT COMPLETED|Treatment Period 1||1
6387607|NCT00815516|7298996|FG000|COMPLETED|Overall Study||16
6387608|NCT00815516|7298997|FG001|COMPLETED|Overall Study||9
6387609|NCT00815516|7298996|FG000|NOT COMPLETED|Overall Study||4
6387610|NCT00815516|7298997|FG001|NOT COMPLETED|Overall Study||1
6387611|NCT00815659|7299003|FG000|STARTED|Overall Study||97
6387612|NCT00815659|7299003|FG000|COMPLETED|Overall Study||74
6387613|NCT00815659|7299003|FG000|NOT COMPLETED|Overall Study||23
6387614|NCT00815685|7299007|FG000|STARTED|Overall Study||36
6387615|NCT00815685|7299007|FG000|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
6387616|NCT00815685|7299007|FG000|NOT COMPLETED|Overall Study||22
6387617|NCT00815698|7299013|FG000|STARTED|Overall Study||163
6387618|NCT00815698|7299014|FG001|STARTED|Overall Study||171
6387619|NCT00815698|7299013|FG000|COMPLETED|Overall Study||163
6387620|NCT00815698|7299014|FG001|COMPLETED|Overall Study||171
6387621|NCT00815698|7299013|FG000|NOT COMPLETED|Overall Study||0
6387622|NCT00815698|7299014|FG001|NOT COMPLETED|Overall Study||0
6387623|NCT00815776|7299023|FG000|STARTED|Overall Study||60
6387624|NCT00815776|7299024|FG001|STARTED|Overall Study||64
6387625|NCT00815776|7299025|FG002|STARTED|Overall Study||28
6387626|NCT00815776|7299023|FG000|COMPLETED|Overall Study||52
6387627|NCT00815776|7299024|FG001|COMPLETED|Overall Study||56
6387628|NCT00815776|7299025|FG002|COMPLETED|Overall Study||22
6387629|NCT00815776|7299023|FG000|NOT COMPLETED|Overall Study||8
6387630|NCT00815776|7299024|FG001|NOT COMPLETED|Overall Study||8
6387631|NCT00815776|7299025|FG002|NOT COMPLETED|Overall Study||6
6387632|NCT00815919|7299036|FG000|STARTED|Overall Study||22
6387633|NCT00815919|7299036|FG000|COMPLETED|Overall Study||18
6387634|NCT00815919|7299036|FG000|NOT COMPLETED|Overall Study||4
6387635|NCT00815997|7299042|FG000|STARTED|Overall Study||80
6387636|NCT00815997|7299043|FG001|STARTED|Overall Study||80
6387637|NCT00815997|7299042|FG000|COMPLETED|Overall Study||80
6387638|NCT00815997|7299043|FG001|COMPLETED|Overall Study||80
6387639|NCT00815997|7299042|FG000|NOT COMPLETED|Overall Study||0
6387640|NCT00815997|7299043|FG001|NOT COMPLETED|Overall Study||0
6387641|NCT00816023|7299055|FG000|STARTED|Overall Study||71
6387642|NCT00816023|7299056|FG001|STARTED|Overall Study||62
6387643|NCT00816023|7299057|FG002|STARTED|Overall Study||69
6387644|NCT00816023|7299058|FG003|STARTED|Overall Study||74
6387645|NCT00816023|7299055|FG000|Completed Therapy|Overall Study||65
6387646|NCT00816023|7299056|FG001|Completed Therapy|Overall Study||59
6387647|NCT00816023|7299057|FG002|Completed Therapy|Overall Study||61
6387648|NCT00816023|7299058|FG003|Completed Therapy|Overall Study||63
6387649|NCT00816023|7299055|FG000|COMPLETED|Overall Study||62
6387650|NCT00816023|7299056|FG001|COMPLETED|Overall Study||56
6387651|NCT00816023|7299057|FG002|COMPLETED|Overall Study||60
6387652|NCT00816023|7299058|FG003|COMPLETED|Overall Study||62
6387653|NCT00816023|7299055|FG000|NOT COMPLETED|Overall Study||9
6387654|NCT00816023|7299056|FG001|NOT COMPLETED|Overall Study||6
6387655|NCT00816023|7299057|FG002|NOT COMPLETED|Overall Study||9
6387656|NCT00816023|7299058|FG003|NOT COMPLETED|Overall Study||12
6387657|NCT00816036|7299070|FG000|STARTED|Overall Study||503
6387658|NCT00816036|7299071|FG001|STARTED|Overall Study||395
6387659|NCT00816036|7299070|FG000|COMPLETED|Overall Study||327
6387660|NCT00816036|7299071|FG001|COMPLETED|Overall Study||287
6387661|NCT00816036|7299070|FG000|NOT COMPLETED|Overall Study||176
6387662|NCT00816036|7299071|FG001|NOT COMPLETED|Overall Study||108
6387663|NCT00816062|7299077|FG000|STARTED|Overall Study||260
6387664|NCT00816062|7299077|FG000|COMPLETED|Overall Study||133
6387665|NCT00816062|7299077|FG000|NOT COMPLETED|Overall Study||127
6387666|NCT00816101|7299085|FG000|STARTED|Overall Study||13
6387667|NCT00816101|7299086|FG001|STARTED|Overall Study||8
6387668|NCT00816101|7299087|FG002|STARTED|Overall Study||5
6387669|NCT00816101|7299085|FG000|COMPLETED|Overall Study||13
6387670|NCT00816101|7299086|FG001|COMPLETED|Overall Study||8
6387671|NCT00816101|7299087|FG002|COMPLETED|Overall Study||5
6387672|NCT00816101|7299085|FG000|NOT COMPLETED|Overall Study||0
6387673|NCT00816101|7299086|FG001|NOT COMPLETED|Overall Study||0
6387674|NCT00816101|7299087|FG002|NOT COMPLETED|Overall Study||0
6387675|NCT00816166|7299097|FG000|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
6387676|NCT00816166|7299098|FG001|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
6387677|NCT00816166|7299097|FG000|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
6387678|NCT00816166|7299098|FG001|ITT Population (Met Eligibility)|Overall Study||53
6387679|NCT00816166|7299097|FG000|COMPLETED|Overall Study||49
6387680|NCT00816166|7299098|FG001|COMPLETED|Overall Study||41
6387681|NCT00816166|7299097|FG000|NOT COMPLETED|Overall Study||10
6387682|NCT00816166|7299098|FG001|NOT COMPLETED|Overall Study||12
6387683|NCT00816348|7299104|FG000|STARTED|Overall Study||15
6387684|NCT00816348|7299104|FG000|COMPLETED|Overall Study||15
6387685|NCT00816348|7299104|FG000|NOT COMPLETED|Overall Study||0
6387686|NCT00816361|7299115|FG000|STARTED|Overall Study||4
6387687|NCT00816361|7299116|FG001|STARTED|Overall Study||3
6387688|NCT00816361|7299117|FG002|STARTED|Overall Study||4
6805471|NCT02631070|7737496|FG001|NOT COMPLETED|Overall Study||64
6805472|NCT02513667|7737504|FG000|STARTED|Overall Study||8
6805473|NCT02513667|7737505|FG001|STARTED|Overall Study||6
6805474|NCT02513667|7737504|FG000|COMPLETED|Overall Study||8
6805475|NCT02513667|7737505|FG001|COMPLETED|Overall Study||5
6805476|NCT02513667|7737504|FG000|NOT COMPLETED|Overall Study||0
6805477|NCT02513667|7737505|FG001|NOT COMPLETED|Overall Study||1
6805478|NCT02281955|7737511|FG000|STARTED|Overall Study||114
6805479|NCT02281955|7737511|FG000|COMPLETED|Overall Study||113
6805480|NCT02281955|7737511|FG000|NOT COMPLETED|Overall Study||1
6805481|NCT02202434|7737519|FG000|STARTED|Overall Study||607
6805482|NCT02202434|7737520|FG001|STARTED|Overall Study||305
6805483|NCT02202434|7737521|FG002|STARTED|Overall Study||102
6805484|NCT02202434|7737522|FG003|STARTED|Overall Study||295
6805485|NCT02202434|7737519|FG000|COMPLETED|Overall Study||498
6805486|NCT02202434|7737520|FG001|COMPLETED|Overall Study||236
6805487|NCT02202434|7737521|FG002|COMPLETED|Overall Study||87
6805488|NCT02202434|7737522|FG003|COMPLETED|Overall Study||258
6805489|NCT02202434|7737519|FG000|NOT COMPLETED|Overall Study||109
6805490|NCT02202434|7737520|FG001|NOT COMPLETED|Overall Study||69
6805491|NCT02202434|7737521|FG002|NOT COMPLETED|Overall Study||15
6805492|NCT02202434|7737522|FG003|NOT COMPLETED|Overall Study||37
6805493|NCT02097134|7737532|FG000|STARTED|Overall Study||14
6805494|NCT02097134|7737532|FG000|COMPLETED|Overall Study||5
6805495|NCT02097134|7737532|FG000|NOT COMPLETED|Overall Study||9
6805496|NCT01727011|7737537|FG000|STARTED|Overall Study||31
6805497|NCT01727011|7737537|FG000|COMPLETED|Overall Study||26
6805498|NCT01727011|7737537|FG000|NOT COMPLETED|Overall Study||5
6805499|NCT01230242|7737541|FG000|STARTED|Overall Study||4
6805500|NCT01230242|7737541|FG000|COMPLETED|Overall Study||1
6805501|NCT01230242|7737541|FG000|NOT COMPLETED|Overall Study||3
6805502|NCT00983437|7737545|FG000|STARTED|Overall Study||47
6805503|NCT00983437|7737545|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
6805504|NCT00983437|7737545|FG000|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
6805505|NCT00983437|7737545|FG000|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
6805506|NCT00983437|7737545|FG000|NOT COMPLETED|Overall Study||47
6805507|NCT00965757|7737551|FG000|STARTED|Double-blind Phase||165
6805508|NCT00965757|7737552|FG001|STARTED|Double-blind Phase||88
6805509|NCT00965757|7737553|FG002|STARTED|Double-blind Phase||0
6805510|NCT00965757|7737554|FG003|STARTED|Double-blind Phase||0
6805511|NCT00965757|7737551|FG000|COMPLETED|Double-blind Phase||148
6805512|NCT00965757|7737552|FG001|COMPLETED|Double-blind Phase||70
6805513|NCT00965757|7737553|FG002|COMPLETED|Double-blind Phase||0
6805514|NCT00965757|7737554|FG003|COMPLETED|Double-blind Phase||0
6805515|NCT00965757|7737551|FG000|NOT COMPLETED|Double-blind Phase||17
6805516|NCT00965757|7737552|FG001|NOT COMPLETED|Double-blind Phase||18
6805517|NCT00965757|7737553|FG002|NOT COMPLETED|Double-blind Phase||0
6805518|NCT00965757|7737554|FG003|NOT COMPLETED|Double-blind Phase||0
6805519|NCT00965757|7737551|FG000|STARTED|Extension Phase||0
6805520|NCT00965757|7737552|FG001|STARTED|Extension Phase||0
6805521|NCT00965757|7737553|FG002|STARTED|Extension Phase||165
6805522|NCT00965757|7737554|FG003|STARTED|Extension Phase||88
6805523|NCT00965757|7737551|FG000|COMPLETED|Extension Phase||0
6805524|NCT00965757|7737552|FG001|COMPLETED|Extension Phase||0
6805525|NCT00965757|7737553|FG002|COMPLETED|Extension Phase||132
6805526|NCT00965757|7737554|FG003|COMPLETED|Extension Phase||64
6805527|NCT00965757|7737551|FG000|NOT COMPLETED|Extension Phase||0
6805528|NCT00965757|7737552|FG001|NOT COMPLETED|Extension Phase||0
6805529|NCT00965757|7737553|FG002|NOT COMPLETED|Extension Phase||33
6805530|NCT00965757|7737554|FG003|NOT COMPLETED|Extension Phase||24
6272506|NCT00095940|7171749|FG006|COMPLETED|Lapatinib Continuation/Phase II||0
6272507|NCT00095940|7171750|FG007|COMPLETED|Lapatinib Continuation/Phase II||0
6272508|NCT00095940|7171751|FG008|COMPLETED|Lapatinib Continuation/Phase II||1
6272509|NCT00095940|7171743|FG000|NOT COMPLETED|Lapatinib Continuation/Phase II||2
6272510|NCT00095940|7171744|FG001|NOT COMPLETED|Lapatinib Continuation/Phase II||2
6272511|NCT00095940|7171745|FG002|NOT COMPLETED|Lapatinib Continuation/Phase II||16
6272512|NCT00095940|7171746|FG003|NOT COMPLETED|Lapatinib Continuation/Phase II||0
6272513|NCT00095940|7171747|FG004|NOT COMPLETED|Lapatinib Continuation/Phase II||0
6272514|NCT00095940|7171748|FG005|NOT COMPLETED|Lapatinib Continuation/Phase II||13
6565935|NCT01822366|7488856|FG000|STARTED|Overall Study||320
6565936|NCT01822366|7488857|FG001|STARTED|Overall Study||320
6565937|NCT01822366|7488858|FG002|STARTED|Overall Study||320
6565938|NCT01822366|7488859|FG003|STARTED|Overall Study||320
6565939|NCT01822366|7488856|FG000|COMPLETED|Overall Study||315
6565940|NCT01822366|7488857|FG001|COMPLETED|Overall Study||298
6272515|NCT00095940|7171749|FG006|NOT COMPLETED|Lapatinib Continuation/Phase II||2
6272516|NCT00095940|7171750|FG007|NOT COMPLETED|Lapatinib Continuation/Phase II||2
6272517|NCT00095940|7171751|FG008|NOT COMPLETED|Lapatinib Continuation/Phase II||13
6272518|NCT00095979|7171769|FG000|STARTED|Overall Study||52
6272519|NCT00095979|7171769|FG000|COMPLETED|Overall Study||50
6272520|NCT00095979|7171769|FG000|NOT COMPLETED|Overall Study||2
6272521|NCT00096018|7171780|FG000|STARTED|Overall Study||13
6272522|NCT00096018|7171781|FG001|STARTED|Overall Study||30
6272523|NCT00096018|7171780|FG000|Treated With Study Therapy|Overall Study||13
6272524|NCT00096018|7171781|FG001|Treated With Study Therapy|Overall Study||25
6272525|NCT00096018|7171780|FG000|COMPLETED|Overall Study||11
6272526|NCT00096018|7171781|FG001|COMPLETED|Overall Study||16
6272527|NCT00096018|7171780|FG000|NOT COMPLETED|Overall Study||2
6272528|NCT00096018|7171781|FG001|NOT COMPLETED|Overall Study||14
6272529|NCT00096031|7171787|FG000|STARTED|Overall Study||63
6272530|NCT00096031|7171787|FG000|Eligible|Overall Study||57
6272531|NCT00096031|7171787|FG000|Eligible and Began Protocol Therapy|Overall Study||55
6272532|NCT00096031|7171787|FG000|COMPLETED|Overall Study||0
6272533|NCT00096031|7171787|FG000|NOT COMPLETED|Overall Study||63
6272534|NCT00096044|7171791|FG000|STARTED|Overall Study||45
6272535|NCT00096044|7171791|FG000|COMPLETED|Overall Study||11
6272536|NCT00096044|7171791|FG000|NOT COMPLETED|Overall Study||34
6272537|NCT00096109|7171795|FG000|STARTED|Overall Study||11
6272538|NCT00096109|7171795|FG000|COMPLETED|Overall Study||11
6272539|NCT00096109|7171795|FG000|NOT COMPLETED|Overall Study||0
6272540|NCT00096122|7171799|FG000|STARTED|Overall Study||95
6272541|NCT00096122|7171799|FG000|COMPLETED|Overall Study||95
6272542|NCT00096122|7171799|FG000|NOT COMPLETED|Overall Study||0
6272543|NCT00096135|7171805|FG000|STARTED|Overall Study||126
6565941|NCT01822366|7488858|FG002|COMPLETED|Overall Study||315
6565942|NCT01822366|7488859|FG003|COMPLETED|Overall Study||298
6565943|NCT01822366|7488856|FG000|NOT COMPLETED|Overall Study||5
6387689|NCT00816361|7299118|FG003|STARTED|Overall Study||3
6387690|NCT00816361|7299119|FG004|STARTED|Overall Study||3
6272544|NCT00096135|7171806|FG001|STARTED|Overall Study||42
6272545|NCT00096135|7171805|FG000|COMPLETED|Overall Study||63
6272546|NCT00096135|7171806|FG001|COMPLETED|Overall Study||27
6272547|NCT00096135|7171805|FG000|NOT COMPLETED|Overall Study||63
6272548|NCT00096135|7171806|FG001|NOT COMPLETED|Overall Study||15
6272549|NCT00096161|7171816|FG000|STARTED|Overall Study||20
6272550|NCT00096161|7171817|FG001|STARTED|Overall Study||10
6272551|NCT00096161|7171818|FG002|STARTED|Overall Study||6
6272552|NCT00096161|7171819|FG003|STARTED|Overall Study||0
6272553|NCT00096161|7171816|FG000|COMPLETED|Overall Study||20
6272554|NCT00096161|7171817|FG001|COMPLETED|Overall Study||10
6272555|NCT00096161|7171818|FG002|COMPLETED|Overall Study||6
6272556|NCT00096161|7171819|FG003|COMPLETED|Overall Study||0
6272557|NCT00096161|7171816|FG000|NOT COMPLETED|Overall Study||0
6272558|NCT00096161|7171817|FG001|NOT COMPLETED|Overall Study||0
6272559|NCT00096161|7171818|FG002|NOT COMPLETED|Overall Study||0
6272560|NCT00096161|7171819|FG003|NOT COMPLETED|Overall Study||0
6272561|NCT00096174|7171829|FG000|STARTED|Overall Study||69
6272562|NCT00096174|7171829|FG000|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
6805531|NCT00928447|7737562|FG000|STARTED|Overall Study||22
6805532|NCT00928447|7737562|FG000|Received at Least 1 Dose of rHuPH20|Overall Study||21
6805533|NCT00928447|7737562|FG000|Received at Least 1 Dose of Placebo|Overall Study||21
6805534|NCT00928447|7737562|FG000|COMPLETED|Overall Study||20
6805535|NCT00928447|7737562|FG000|NOT COMPLETED|Overall Study||2
6805536|NCT00893789|7737570|FG000|STARTED|Overall Study||29
6805537|NCT00893789|7737571|FG001|STARTED|Overall Study||30
6805538|NCT00893789|7737572|FG002|STARTED|Overall Study||29
6272563|NCT00096174|7171829|FG000|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
6272564|NCT00096174|7171829|FG000|COMPLETED|Overall Study||7
6272565|NCT00096174|7171829|FG000|NOT COMPLETED|Overall Study||62
6272566|NCT00096226|7171833|FG000|STARTED|Overall Study||60
6272567|NCT00096226|7171833|FG000|Eligible|Overall Study||57
6272568|NCT00096226|7171833|FG000|Eligible and Underwent Surgery|Overall Study||37
6272569|NCT00096226|7171833|FG000|COMPLETED|Overall Study|Subjects contributing any data to analysis are considered to have completed the study|57
6272570|NCT00096226|7171833|FG000|NOT COMPLETED|Overall Study||3
6272571|NCT00096265|7171840|FG000|STARTED|Overall Study||45
6272572|NCT00096265|7171841|FG001|STARTED|Overall Study||40
6272573|NCT00096265|7171842|FG002|STARTED|Overall Study||41
6272574|NCT00096265|7171840|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
6272575|NCT00096265|7171841|FG001|COMPLETED|Overall Study||40
6272576|NCT00096265|7171842|FG002|COMPLETED|Overall Study||41
6272577|NCT00096265|7171840|FG000|NOT COMPLETED|Overall Study||1
6272578|NCT00096265|7171841|FG001|NOT COMPLETED|Overall Study||0
6272579|NCT00096265|7171842|FG002|NOT COMPLETED|Overall Study||0
6272580|NCT00096278|7171853|FG000|STARTED|Overall Study||1356
6272581|NCT00096278|7171854|FG001|STARTED|Overall Study||1354
6272582|NCT00096278|7171853|FG000|COMPLETED|Overall Study||1338
6272583|NCT00096278|7171854|FG001|COMPLETED|Overall Study||1334
6272584|NCT00096278|7171853|FG000|NOT COMPLETED|Overall Study||18
6272585|NCT00096278|7171854|FG001|NOT COMPLETED|Overall Study||20
6387691|NCT00816361|7299120|FG005|STARTED|Overall Study||3
6387692|NCT00816361|7299121|FG006|STARTED|Overall Study||3
6387693|NCT00816361|7299122|FG007|STARTED|Overall Study||10
6387694|NCT00816361|7299123|FG008|STARTED|Overall Study||10
6387695|NCT00816361|7299115|FG000|COMPLETED|Overall Study||0
6387696|NCT00816361|7299116|FG001|COMPLETED|Overall Study||0
6387697|NCT00816361|7299117|FG002|COMPLETED|Overall Study||1
6387698|NCT00816361|7299118|FG003|COMPLETED|Overall Study||0
6805539|NCT00893789|7737573|FG003|STARTED|Overall Study||29
6805540|NCT00893789|7737570|FG000|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
6805541|NCT00893789|7737571|FG001|Safety Analysis Set (SAS)|Overall Study||30
6272586|NCT00096356|7171864|FG000|STARTED|Overall Study||122
6272587|NCT00096356|7171865|FG001|STARTED|Overall Study||114
6272588|NCT00096356|7171864|FG000|COMPLETED|Overall Study||78
6272589|NCT00096356|7171865|FG001|COMPLETED|Overall Study||61
6272590|NCT00096356|7171864|FG000|NOT COMPLETED|Overall Study||44
6272591|NCT00096356|7171865|FG001|NOT COMPLETED|Overall Study||53
6272592|NCT00096382|7171874|FG000|STARTED|Overall Study||23
6805542|NCT00893789|7737572|FG002|Safety Analysis Set (SAS)|Overall Study||29
6565944|NCT01822366|7488857|FG001|NOT COMPLETED|Overall Study||22
6565945|NCT01822366|7488858|FG002|NOT COMPLETED|Overall Study||5
6565946|NCT01822366|7488859|FG003|NOT COMPLETED|Overall Study||22
6656872|NCT02465450|7587222|FG003|NOT COMPLETED|Treatment Period 1||0
6387699|NCT00816361|7299119|FG004|COMPLETED|Overall Study||1
6272593|NCT00096382|7171875|FG001|STARTED|Overall Study||3
6272594|NCT00096382|7171874|FG000|COMPLETED|Overall Study||21
6272595|NCT00096382|7171875|FG001|COMPLETED|Overall Study||3
6272596|NCT00096382|7171874|FG000|NOT COMPLETED|Overall Study||2
6272597|NCT00096382|7171875|FG001|NOT COMPLETED|Overall Study||0
6272598|NCT00096447|7171881|FG000|STARTED|Overall Study||31
6272599|NCT00096447|7171881|FG000|COMPLETED|Overall Study|Eligible and treated patients.|30
6272600|NCT00096447|7171881|FG000|NOT COMPLETED|Overall Study||1
6272601|NCT00096460|7171892|FG000|STARTED|Overall Study||22
6272602|NCT00096460|7171893|FG001|STARTED|Overall Study||8
6272603|NCT00096460|7171892|FG000|COMPLETED|Overall Study||15
6272604|NCT00096460|7171893|FG001|COMPLETED|Overall Study||7
6272605|NCT00096460|7171892|FG000|NOT COMPLETED|Overall Study||7
6272606|NCT00096460|7171893|FG001|NOT COMPLETED|Overall Study||1
6272607|NCT00096486|7171903|FG000|STARTED|Overall Study||4
6272608|NCT00096486|7171904|FG001|STARTED|Overall Study||6
6272609|NCT00096486|7171905|FG002|STARTED|Overall Study||26
6272610|NCT00096486|7171906|FG003|STARTED|Overall Study||38
6272611|NCT00096486|7171903|FG000|COMPLETED|Overall Study||4
6272612|NCT00096486|7171904|FG001|COMPLETED|Overall Study||6
6272613|NCT00096486|7171905|FG002|COMPLETED|Overall Study||24
6272614|NCT00096486|7171906|FG003|COMPLETED|Overall Study||36
6272615|NCT00096486|7171903|FG000|NOT COMPLETED|Overall Study||0
6272616|NCT00096486|7171904|FG001|NOT COMPLETED|Overall Study||0
6272617|NCT00096486|7171905|FG002|NOT COMPLETED|Overall Study||2
6272618|NCT00096486|7171906|FG003|NOT COMPLETED|Overall Study||2
6272619|NCT00096538|7171916|FG000|STARTED|Overall Study||6
6272620|NCT00096538|7171916|FG000|COMPLETED|Overall Study||5
6272621|NCT00096538|7171916|FG000|NOT COMPLETED|Overall Study||1
6272622|NCT00096681|7171920|FG000|STARTED|Overall Study||762
6565947|NCT01822457|7488889|FG000|STARTED|Overall Study||20
6805543|NCT00893789|7737573|FG003|Safety Analysis Set (SAS)|Overall Study||29
6805544|NCT00893789|7737570|FG000|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
6272623|NCT00096681|7171920|FG000|COMPLETED|Overall Study||762
6272624|NCT00096681|7171920|FG000|NOT COMPLETED|Overall Study||0
6272625|NCT00096785|7171926|FG000|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
6272626|NCT00096785|7171927|FG001|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
6272627|NCT00096785|7171926|FG000|As-Randomized Population|Overall Study||35
6272628|NCT00096785|7171927|FG001|As-Randomized Population|Overall Study||34
6272629|NCT00096785|7171926|FG000|As-Treated Population|Overall Study||36
6272630|NCT00096785|7171927|FG001|As-Treated Population|Overall Study||33
6272631|NCT00096785|7171926|FG000|COMPLETED|Overall Study|As randomized cohort|33
6272632|NCT00096785|7171927|FG001|COMPLETED|Overall Study|As randomized cohort|33
6272633|NCT00096785|7171926|FG000|NOT COMPLETED|Overall Study||2
6272634|NCT00096785|7171927|FG001|NOT COMPLETED|Overall Study||1
6272635|NCT00096941|7171933|FG000|STARTED|Overall Study||3
6565948|NCT01822457|7488890|FG001|STARTED|Overall Study||17
6805545|NCT00893789|7737571|FG001|Full Analysis Set (FAS)|Overall Study||29
6805546|NCT00893789|7737572|FG002|Full Analysis Set (FAS)|Overall Study||28
6805547|NCT00893789|7737573|FG003|Full Analysis Set (FAS)|Overall Study||27
6805548|NCT00893789|7737570|FG000|COMPLETED|Overall Study||23
6805549|NCT00893789|7737571|FG001|COMPLETED|Overall Study||26
6805550|NCT00893789|7737572|FG002|COMPLETED|Overall Study||22
6805551|NCT00893789|7737573|FG003|COMPLETED|Overall Study||16
6805552|NCT00893789|7737570|FG000|NOT COMPLETED|Overall Study||6
6272636|NCT00096941|7171933|FG000|COMPLETED|Overall Study||0
6272637|NCT00096941|7171933|FG000|NOT COMPLETED|Overall Study||3
6272638|NCT00096954|7171939|FG000|STARTED|Overall Study||159
6272639|NCT00096954|7171940|FG001|STARTED|Overall Study||174
6272640|NCT00096954|7171939|FG000|Received Study Drug|Overall Study||157
6272641|NCT00096954|7171940|FG001|Received Study Drug|Overall Study||171
6272642|NCT00096954|7171939|FG000|COMPLETED|Overall Study||135
6272643|NCT00096954|7171940|FG001|COMPLETED|Overall Study||154
6272644|NCT00096954|7171939|FG000|NOT COMPLETED|Overall Study||24
6272645|NCT00096954|7171940|FG001|NOT COMPLETED|Overall Study||20
6272646|NCT00096993|7171948|FG000|STARTED|Overall Study||66
6272647|NCT00096993|7171949|FG001|STARTED|Overall Study||65
6272648|NCT00096993|7171948|FG000|COMPLETED|Overall Study||1
6272649|NCT00096993|7171949|FG001|COMPLETED|Overall Study||0
6272650|NCT00096993|7171948|FG000|NOT COMPLETED|Overall Study||65
6272651|NCT00096993|7171949|FG001|NOT COMPLETED|Overall Study||65
6272652|NCT00097253|7171955|FG000|STARTED|Lavender||56
6272653|NCT00097253|7171955|FG000|COMPLETED|Lavender||56
6272654|NCT00097253|7171955|FG000|NOT COMPLETED|Lavender||0
6387700|NCT00816361|7299120|FG005|COMPLETED|Overall Study||0
6387701|NCT00816361|7299121|FG006|COMPLETED|Overall Study||0
6387702|NCT00816361|7299122|FG007|COMPLETED|Overall Study||1
6387703|NCT00816361|7299123|FG008|COMPLETED|Overall Study||0
6387704|NCT00816361|7299115|FG000|NOT COMPLETED|Overall Study||4
6387705|NCT00816361|7299116|FG001|NOT COMPLETED|Overall Study||3
6387706|NCT00816361|7299117|FG002|NOT COMPLETED|Overall Study||3
6387707|NCT00816361|7299118|FG003|NOT COMPLETED|Overall Study||3
6387708|NCT00816361|7299119|FG004|NOT COMPLETED|Overall Study||2
6387709|NCT00816361|7299120|FG005|NOT COMPLETED|Overall Study||3
6387710|NCT00816361|7299121|FG006|NOT COMPLETED|Overall Study||3
6387711|NCT00816361|7299122|FG007|NOT COMPLETED|Overall Study||9
6387712|NCT00816361|7299123|FG008|NOT COMPLETED|Overall Study||10
6387713|NCT00816400|7299153|FG000|STARTED|Overall Study||3
6387714|NCT00816400|7299154|FG001|STARTED|Overall Study||3
6387715|NCT00816400|7299155|FG002|STARTED|Overall Study||5
6387716|NCT00816400|7299156|FG003|STARTED|Overall Study||3
6387717|NCT00816400|7299157|FG004|STARTED|Overall Study||3
6387718|NCT00816400|7299158|FG005|STARTED|Overall Study||3
6387719|NCT00816400|7299159|FG006|STARTED|Overall Study||3
6504080|NCT01447017|7423187|FG000|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
6504081|NCT01447017|7423188|FG001|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
6504082|NCT01447017|7423187|FG000|NOT COMPLETED|Overall Study||10
6504083|NCT01447017|7423188|FG001|NOT COMPLETED|Overall Study||10
6504084|NCT01447121|7423194|FG000|STARTED|Overall Study||118
6504085|NCT01447121|7423194|FG000|COMPLETED|Overall Study||118
6504086|NCT01447121|7423194|FG000|NOT COMPLETED|Overall Study||0
6504087|NCT01447225|7423203|FG000|STARTED|Overall Study||3
6504088|NCT01447225|7423204|FG001|STARTED|Overall Study||8
6504089|NCT01447225|7423205|FG002|STARTED|Overall Study||5
6504090|NCT01447225|7423206|FG003|STARTED|Overall Study||3
6504091|NCT01447225|7423207|FG004|STARTED|Overall Study||3
6504092|NCT01447225|7423208|FG005|STARTED|Overall Study||3
6504093|NCT01447225|7423209|FG006|STARTED|Overall Study||7
6504094|NCT01447225|7423210|FG007|STARTED|Overall Study||4
6504095|NCT01447225|7423211|FG008|STARTED|Overall Study||3
6504096|NCT01447225|7423212|FG009|STARTED|Overall Study||4
6504097|NCT01447225|7423203|FG000|COMPLETED|Overall Study||3
6504098|NCT01447225|7423204|FG001|COMPLETED|Overall Study||8
6504099|NCT01447225|7423205|FG002|COMPLETED|Overall Study||5
6272655|NCT00097253|7171955|FG000|STARTED|Lemon||56
6272656|NCT00097253|7171955|FG000|COMPLETED|Lemon||56
6272657|NCT00097253|7171955|FG000|NOT COMPLETED|Lemon||0
6272658|NCT00097253|7171955|FG000|STARTED|Water (Control)||56
6272659|NCT00097253|7171955|FG000|COMPLETED|Water (Control)||56
6272660|NCT00097253|7171955|FG000|NOT COMPLETED|Water (Control)||0
6280730|NCT00159263|7180667|FG003|COMPLETED|Washout||2
6280731|NCT00159263|7180668|FG004|COMPLETED|Washout||2
6280732|NCT00159263|7180669|FG005|COMPLETED|Washout||2
6280733|NCT00159263|7180664|FG000|NOT COMPLETED|Washout||0
6280734|NCT00159263|7180665|FG001|NOT COMPLETED|Washout||0
6280735|NCT00159263|7180666|FG002|NOT COMPLETED|Washout||0
6280736|NCT00159263|7180667|FG003|NOT COMPLETED|Washout||0
6280737|NCT00159263|7180668|FG004|NOT COMPLETED|Washout||0
6280738|NCT00159263|7180669|FG005|NOT COMPLETED|Washout||0
6280739|NCT00159263|7180664|FG000|STARTED|Third Intervention||1
6280740|NCT00159263|7180665|FG001|STARTED|Third Intervention||1
6280741|NCT00159263|7180666|FG002|STARTED|Third Intervention||2
6280742|NCT00159263|7180667|FG003|STARTED|Third Intervention||2
6280743|NCT00159263|7180668|FG004|STARTED|Third Intervention||2
6272661|NCT00097370|7171963|FG000|STARTED|Stage 1|Participants entered from study MHE100185.|37
6272662|NCT00097370|7171963|FG000|COMPLETED|Stage 1||31
6272663|NCT00097370|7171963|FG000|NOT COMPLETED|Stage 1||6
6272664|NCT00097370|7171963|FG000|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
6272665|NCT00097370|7171963|FG000|COMPLETED|Stage 2||59
6272666|NCT00097370|7171963|FG000|NOT COMPLETED|Stage 2||13
6272667|NCT00097370|7171963|FG000|STARTED|Stage 3|Participants continued from Stage 2.|59
6272668|NCT00097370|7171963|FG000|COMPLETED|Stage 3||0
6272669|NCT00097370|7171963|FG000|NOT COMPLETED|Stage 3||59
6272670|NCT00097448|7171969|FG000|STARTED|Overall Study||125
6272671|NCT00097448|7171970|FG001|STARTED|Overall Study||130
6272672|NCT00097448|7171969|FG000|COMPLETED|Overall Study||121
6272673|NCT00097448|7171970|FG001|COMPLETED|Overall Study||129
6272674|NCT00097448|7171969|FG000|NOT COMPLETED|Overall Study||4
6272675|NCT00097448|7171970|FG001|NOT COMPLETED|Overall Study||1
6272676|NCT00097500|7171978|FG000|STARTED|On-drug Period (Week 0 to Week 52)||36
6272677|NCT00097500|7171979|FG001|STARTED|On-drug Period (Week 0 to Week 52)||33
6272678|NCT00097500|7171978|FG000|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
6272679|NCT00097500|7171979|FG001|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
6272680|NCT00097500|7171978|FG000|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
6272681|NCT00097500|7171979|FG001|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
6272682|NCT00097500|7171978|FG000|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
6272683|NCT00097500|7171979|FG001|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
6272684|NCT00097500|7171978|FG000|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
6272685|NCT00097500|7171979|FG001|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
6272686|NCT00097500|7171978|FG000|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
6272687|NCT00097500|7171979|FG001|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
6272688|NCT00097539|7171992|FG000|STARTED|Overall Study||27286
6272689|NCT00097539|7171993|FG001|STARTED|Overall Study||9356
6272690|NCT00097539|7171994|FG002|STARTED|Overall Study||12519
6272691|NCT00097539|7171995|FG003|STARTED|Overall Study||5651
6272692|NCT00097539|7171996|FG004|STARTED|Overall Study||2144
6272693|NCT00097539|7171997|FG005|STARTED|Overall Study||8010
6272694|NCT00097539|7171998|FG006|STARTED|Overall Study||239
6272695|NCT00097539|7171992|FG000|COMPLETED|Overall Study||8220
6272696|NCT00097539|7171993|FG001|COMPLETED|Overall Study||2825
6272697|NCT00097539|7171994|FG002|COMPLETED|Overall Study||3411
6272698|NCT00097539|7171995|FG003|COMPLETED|Overall Study||2066
6272699|NCT00097539|7171996|FG004|COMPLETED|Overall Study||386
6272700|NCT00097539|7171997|FG005|COMPLETED|Overall Study||2118
6272701|NCT00097539|7171998|FG006|COMPLETED|Overall Study||68
6272702|NCT00097539|7171992|FG000|NOT COMPLETED|Overall Study||19066
6272703|NCT00097539|7171993|FG001|NOT COMPLETED|Overall Study||6531
6272704|NCT00097539|7171994|FG002|NOT COMPLETED|Overall Study||9108
6805553|NCT00893789|7737571|FG001|NOT COMPLETED|Overall Study||4
6805554|NCT00893789|7737572|FG002|NOT COMPLETED|Overall Study||7
6805555|NCT00893789|7737573|FG003|NOT COMPLETED|Overall Study||13
6504100|NCT01447225|7423206|FG003|COMPLETED|Overall Study||3
6504101|NCT01447225|7423207|FG004|COMPLETED|Overall Study||3
6504102|NCT01447225|7423208|FG005|COMPLETED|Overall Study||3
6504103|NCT01447225|7423209|FG006|COMPLETED|Overall Study||7
6504104|NCT01447225|7423210|FG007|COMPLETED|Overall Study||4
6504105|NCT01447225|7423211|FG008|COMPLETED|Overall Study||3
6504106|NCT01447225|7423212|FG009|COMPLETED|Overall Study||4
6504107|NCT01447225|7423203|FG000|NOT COMPLETED|Overall Study||0
6504108|NCT01447225|7423204|FG001|NOT COMPLETED|Overall Study||0
6504109|NCT01447225|7423205|FG002|NOT COMPLETED|Overall Study||0
6504110|NCT01447225|7423206|FG003|NOT COMPLETED|Overall Study||0
6504111|NCT01447225|7423207|FG004|NOT COMPLETED|Overall Study||0
6805556|NCT04349150|7737583|FG000|STARTED|Overall Study||31
6805557|NCT04349150|7737583|FG000|COMPLETED|Overall Study||27
6805558|NCT04349150|7737583|FG000|NOT COMPLETED|Overall Study||4
6805559|NCT03948698|7737587|FG000|STARTED|Overall Study||4159533
6805560|NCT03948698|7737587|FG000|COMPLETED|Overall Study||4159533
6805561|NCT03948698|7737587|FG000|NOT COMPLETED|Overall Study||0
6805562|NCT03901144|7737591|FG000|STARTED|Overall Study||50
6805563|NCT03901144|7737592|FG001|STARTED|Overall Study||50
6805564|NCT03901144|7737593|FG002|STARTED|Overall Study||50
6805565|NCT03901144|7737594|FG003|STARTED|Overall Study||50
6805566|NCT03901144|7737591|FG000|COMPLETED|Overall Study||49
6805567|NCT03901144|7737592|FG001|COMPLETED|Overall Study||49
6805568|NCT03901144|7737593|FG002|COMPLETED|Overall Study||49
6805569|NCT03901144|7737594|FG003|COMPLETED|Overall Study||49
6805570|NCT03901144|7737591|FG000|NOT COMPLETED|Overall Study||1
6805571|NCT03901144|7737592|FG001|NOT COMPLETED|Overall Study||1
6504112|NCT01447225|7423208|FG005|NOT COMPLETED|Overall Study||0
6805572|NCT03901144|7737593|FG002|NOT COMPLETED|Overall Study||1
6805573|NCT03901144|7737594|FG003|NOT COMPLETED|Overall Study||1
6805574|NCT03561701|7737606|FG000|STARTED|Overall Study||220
6565949|NCT01822457|7488889|FG000|COMPLETED|Overall Study||16
6565950|NCT01822457|7488890|FG001|COMPLETED|Overall Study||12
6565951|NCT01822457|7488889|FG000|NOT COMPLETED|Overall Study||4
6272705|NCT00097539|7171995|FG003|NOT COMPLETED|Overall Study||3585
6272706|NCT00097539|7171996|FG004|NOT COMPLETED|Overall Study||1758
6272707|NCT00097539|7171997|FG005|NOT COMPLETED|Overall Study||5892
6272708|NCT00097539|7171998|FG006|NOT COMPLETED|Overall Study||171
6272709|NCT00097591|7172016|FG000|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
6272710|NCT00097591|7172017|FG001|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
6272711|NCT00097591|7172016|FG000|COMPLETED|Overall Study||6403
6272712|NCT00097591|7172017|FG001|COMPLETED|Overall Study||6401
6272713|NCT00097591|7172016|FG000|NOT COMPLETED|Overall Study||410
6272714|NCT00097591|7172017|FG001|NOT COMPLETED|Overall Study||394
6272715|NCT00097669|7172025|FG000|STARTED|Overall Study||4089
6272716|NCT00097669|7172026|FG001|STARTED|Overall Study||4075
6272717|NCT00097669|7172025|FG000|COMPLETED|Overall Study||4089
6272718|NCT00097669|7172026|FG001|COMPLETED|Overall Study||4075
6272719|NCT00097669|7172025|FG000|NOT COMPLETED|Overall Study||0
6272720|NCT00097669|7172026|FG001|NOT COMPLETED|Overall Study||0
6272721|NCT00097695|7172036|FG000|STARTED|The Controlled Phase||27
6272722|NCT00097695|7172037|FG001|STARTED|The Controlled Phase||29
6272723|NCT00097695|7172038|FG002|STARTED|The Controlled Phase||8
6272724|NCT00097695|7172039|FG003|STARTED|The Controlled Phase||20
6272725|NCT00097695|7172036|FG000|COMPLETED|The Controlled Phase||23
6272726|NCT00097695|7172037|FG001|COMPLETED|The Controlled Phase||26
6272727|NCT00097695|7172038|FG002|COMPLETED|The Controlled Phase||3
6272728|NCT00097695|7172039|FG003|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
6272729|NCT00097695|7172036|FG000|NOT COMPLETED|The Controlled Phase||4
6272730|NCT00097695|7172037|FG001|NOT COMPLETED|The Controlled Phase||3
6272731|NCT00097695|7172038|FG002|NOT COMPLETED|The Controlled Phase||5
6272732|NCT00097695|7172039|FG003|NOT COMPLETED|The Controlled Phase||20
6272733|NCT00097695|7172036|FG000|STARTED|The Open Label Extension (OLE) Phase||23
6272734|NCT00097695|7172037|FG001|STARTED|The Open Label Extension (OLE) Phase||26
6272735|NCT00097695|7172038|FG002|STARTED|The Open Label Extension (OLE) Phase||3
6272736|NCT00097695|7172039|FG003|STARTED|The Open Label Extension (OLE) Phase||20
6272737|NCT00097695|7172036|FG000|COMPLETED|The Open Label Extension (OLE) Phase||10
6272738|NCT00097695|7172037|FG001|COMPLETED|The Open Label Extension (OLE) Phase||11
6272739|NCT00097695|7172038|FG002|COMPLETED|The Open Label Extension (OLE) Phase||1
6272740|NCT00097695|7172039|FG003|COMPLETED|The Open Label Extension (OLE) Phase||15
6272741|NCT00097695|7172036|FG000|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
6272742|NCT00097695|7172037|FG001|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
6272743|NCT00097695|7172038|FG002|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
6272744|NCT00097695|7172039|FG003|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
6272745|NCT00097708|7172054|FG000|STARTED|Overall Study||173
6272746|NCT00097708|7172055|FG001|STARTED|Overall Study||176
6272747|NCT00097708|7172056|FG002|STARTED|Overall Study||162
6272748|NCT00097708|7172054|FG000|Intent-to-Treat (ITT)|Overall Study||165
6272749|NCT00097708|7172055|FG001|Intent-to-Treat (ITT)|Overall Study||169
6272750|NCT00097708|7172056|FG002|Intent-to-Treat (ITT)|Overall Study||149
6272751|NCT00097708|7172054|FG000|Treated|Overall Study||171
6272752|NCT00097708|7172055|FG001|Treated|Overall Study||176
6272753|NCT00097708|7172056|FG002|Treated|Overall Study||160
6272754|NCT00097708|7172054|FG000|COMPLETED|Overall Study||109
6272755|NCT00097708|7172055|FG001|COMPLETED|Overall Study||120
6272756|NCT00097708|7172056|FG002|COMPLETED|Overall Study||97
6272757|NCT00097708|7172054|FG000|NOT COMPLETED|Overall Study||64
6272758|NCT00097708|7172055|FG001|NOT COMPLETED|Overall Study||56
6272759|NCT00097708|7172056|FG002|NOT COMPLETED|Overall Study||65
6272760|NCT00097721|7172066|FG000|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
6272761|NCT00097721|7172067|FG001|STARTED|Overall Study||33
6272762|NCT00097721|7172066|FG000|COMPLETED|Overall Study||0
6272763|NCT00097721|7172067|FG001|COMPLETED|Overall Study||0
6272764|NCT00097721|7172066|FG000|NOT COMPLETED|Overall Study||71
6272765|NCT00097721|7172067|FG001|NOT COMPLETED|Overall Study||33
6272766|NCT00097773|7172077|FG000|STARTED|Overall Study||76
6272767|NCT00097773|7172078|FG001|STARTED|Overall Study||76
6272768|NCT00097773|7172079|FG002|STARTED|Overall Study||76
6272769|NCT00097773|7172080|FG003|STARTED|Overall Study||76
6272770|NCT00097773|7172077|FG000|COMPLETED|Overall Study||68
6272771|NCT00097773|7172078|FG001|COMPLETED|Overall Study||68
6272772|NCT00097773|7172079|FG002|COMPLETED|Overall Study||68
6272773|NCT00097773|7172080|FG003|COMPLETED|Overall Study||73
6272774|NCT00097773|7172077|FG000|NOT COMPLETED|Overall Study||8
6272775|NCT00097773|7172078|FG001|NOT COMPLETED|Overall Study||8
6272776|NCT00097773|7172079|FG002|NOT COMPLETED|Overall Study||8
6272777|NCT00097773|7172080|FG003|NOT COMPLETED|Overall Study||3
6280744|NCT00159263|7180669|FG005|STARTED|Third Intervention||2
6565952|NCT01822457|7488890|FG001|NOT COMPLETED|Overall Study||5
6565953|NCT01822496|7488900|FG000|STARTED|Overall Study||16
6565954|NCT01822496|7488901|FG001|STARTED|Overall Study||23
6565955|NCT01822496|7488902|FG002|STARTED|Overall Study||9
6565956|NCT01822496|7488903|FG003|STARTED|Overall Study||11
6565957|NCT01822496|7488900|FG000|Eligible|Overall Study||14
6387720|NCT00816400|7299160|FG007|STARTED|Overall Study||6
6387721|NCT00816400|7299161|FG008|STARTED|Overall Study||6
6387722|NCT00816400|7299153|FG000|COMPLETED|Overall Study||1
6387723|NCT00816400|7299154|FG001|COMPLETED|Overall Study||0
6387724|NCT00816400|7299155|FG002|COMPLETED|Overall Study||0
6387725|NCT00816400|7299156|FG003|COMPLETED|Overall Study||0
6387726|NCT00816400|7299157|FG004|COMPLETED|Overall Study||1
6565958|NCT01822496|7488901|FG001|Eligible|Overall Study||21
6387727|NCT00816400|7299158|FG005|COMPLETED|Overall Study||0
6387728|NCT00816400|7299159|FG006|COMPLETED|Overall Study||1
6387729|NCT00816400|7299160|FG007|COMPLETED|Overall Study||1
6565959|NCT01822496|7488902|FG002|Eligible|Overall Study||9
6272778|NCT00097786|7172099|FG000|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
6272779|NCT00097786|7172100|FG001|STARTED|Overall Study||2315
6272780|NCT00097786|7172101|FG002|STARTED|Overall Study||2329
6272781|NCT00097786|7172102|FG003|STARTED|Overall Study||2346
6272782|NCT00097786|7172099|FG000|Complete FU for Progression to Diabetes|Overall Study||1709
6272783|NCT00097786|7172100|FG001|Complete FU for Progression to Diabetes|Overall Study||1712
6272784|NCT00097786|7172101|FG002|Complete FU for Progression to Diabetes|Overall Study||1734
6272785|NCT00097786|7172102|FG003|Complete FU for Progression to Diabetes|Overall Study||1762
6272786|NCT00097786|7172099|FG000|Complete Follow-up for Extended CV EPs|Overall Study||1969
6272787|NCT00097786|7172100|FG001|Complete Follow-up for Extended CV EPs|Overall Study||1985
6272788|NCT00097786|7172101|FG002|Complete Follow-up for Extended CV EPs|Overall Study||1987
6272789|NCT00097786|7172102|FG003|Complete Follow-up for Extended CV EPs|Overall Study||2015
6272790|NCT00097786|7172099|FG000|Complete Follow-up for Core CV EPs|Overall Study||1948
6272791|NCT00097786|7172100|FG001|Complete Follow-up for Core CV EPs|Overall Study||1963
6272792|NCT00097786|7172101|FG002|Complete Follow-up for Core CV EPs|Overall Study||1966
6272793|NCT00097786|7172102|FG003|Complete Follow-up for Core CV EPs|Overall Study||1988
6272794|NCT00097786|7172099|FG000|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
6272795|NCT00097786|7172100|FG001|COMPLETED|Overall Study||2023
6272796|NCT00097786|7172101|FG002|COMPLETED|Overall Study||2016
6272797|NCT00097786|7172102|FG003|COMPLETED|Overall Study||2036
6272798|NCT00097786|7172099|FG000|NOT COMPLETED|Overall Study||296
6272799|NCT00097786|7172100|FG001|NOT COMPLETED|Overall Study||292
6272800|NCT00097786|7172101|FG002|NOT COMPLETED|Overall Study||313
6272801|NCT00097786|7172102|FG003|NOT COMPLETED|Overall Study||310
6272802|NCT00097981|7172114|FG000|STARTED|Overall Study|Enrollment at randomization|113
6272803|NCT00097981|7172115|FG001|STARTED|Overall Study|Enrollment at randomization|112
6272804|NCT00097981|7172114|FG000|Received Study Medication|Overall Study||110
6272805|NCT00097981|7172115|FG001|Received Study Medication|Overall Study||106
6272806|NCT00097981|7172114|FG000|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
6387730|NCT00816400|7299161|FG008|COMPLETED|Overall Study||0
6387731|NCT00816400|7299153|FG000|NOT COMPLETED|Overall Study||2
6387732|NCT00816400|7299154|FG001|NOT COMPLETED|Overall Study||3
6387733|NCT00816400|7299155|FG002|NOT COMPLETED|Overall Study||5
6387734|NCT00816400|7299156|FG003|NOT COMPLETED|Overall Study||3
6387735|NCT00816400|7299157|FG004|NOT COMPLETED|Overall Study||2
6387736|NCT00816400|7299158|FG005|NOT COMPLETED|Overall Study||3
6387737|NCT00816400|7299159|FG006|NOT COMPLETED|Overall Study||2
6387738|NCT00816400|7299160|FG007|NOT COMPLETED|Overall Study||5
6387739|NCT00816400|7299161|FG008|NOT COMPLETED|Overall Study||6
6387740|NCT00816556|7299185|FG000|STARTED|Overall Study||20
6387741|NCT00816556|7299186|FG001|STARTED|Overall Study||21
6387742|NCT00816556|7299187|FG002|STARTED|Overall Study||22
6387743|NCT00816556|7299185|FG000|COMPLETED|Overall Study||18
6387744|NCT00816556|7299186|FG001|COMPLETED|Overall Study||19
6387745|NCT00816556|7299187|FG002|COMPLETED|Overall Study||19
6387746|NCT00816556|7299185|FG000|NOT COMPLETED|Overall Study||2
6387747|NCT00816556|7299186|FG001|NOT COMPLETED|Overall Study||2
6387748|NCT00816556|7299187|FG002|NOT COMPLETED|Overall Study||3
6387749|NCT00816595|7299197|FG000|STARTED|Overall Study||35
6387750|NCT00816595|7299198|FG001|STARTED|Overall Study||33
6387751|NCT00816595|7299197|FG000|COMPLETED|Overall Study||33
6387752|NCT00816595|7299198|FG001|COMPLETED|Overall Study||33
6387753|NCT00816595|7299197|FG000|NOT COMPLETED|Overall Study||2
6387754|NCT00816595|7299198|FG001|NOT COMPLETED|Overall Study||0
6387755|NCT00816751|7299208|FG000|STARTED|Overall Study||45
6504113|NCT01447225|7423209|FG006|NOT COMPLETED|Overall Study||0
6504114|NCT01447225|7423210|FG007|NOT COMPLETED|Overall Study||0
6387756|NCT00816751|7299209|FG001|STARTED|Overall Study||44
6387757|NCT00816751|7299208|FG000|COMPLETED|Overall Study||45
6387758|NCT00816751|7299209|FG001|COMPLETED|Overall Study||44
6387759|NCT00816751|7299208|FG000|NOT COMPLETED|Overall Study||0
6387760|NCT00816751|7299209|FG001|NOT COMPLETED|Overall Study||0
6387761|NCT00816829|7299217|FG000|STARTED|Overall Study||16
6387762|NCT00816829|7299218|FG001|STARTED|Overall Study||18
6387763|NCT00816829|7299217|FG000|COMPLETED|Overall Study||16
6387764|NCT00816829|7299218|FG001|COMPLETED|Overall Study||18
6387765|NCT00816829|7299217|FG000|NOT COMPLETED|Overall Study||0
6387766|NCT00816829|7299218|FG001|NOT COMPLETED|Overall Study||0
6387767|NCT00816907|7299226|FG000|STARTED|Overall Study||71
6387768|NCT00816907|7299227|FG001|STARTED|Overall Study||75
6387769|NCT00816907|7299226|FG000|COMPLETED|Overall Study||58
6387770|NCT00816907|7299227|FG001|COMPLETED|Overall Study||58
6387771|NCT00816907|7299226|FG000|NOT COMPLETED|Overall Study||13
6387772|NCT00816907|7299227|FG001|NOT COMPLETED|Overall Study||17
6387773|NCT00817063|7299237|FG000|STARTED|Overall Study||298
6387774|NCT00817063|7299238|FG001|STARTED|Overall Study||298
6387775|NCT00817063|7299237|FG000|COMPLETED|Overall Study||161
6387776|NCT00817063|7299238|FG001|COMPLETED|Overall Study||128
6387777|NCT00817063|7299237|FG000|NOT COMPLETED|Overall Study||137
6387778|NCT00817063|7299238|FG001|NOT COMPLETED|Overall Study||170
6387779|NCT00817089|7299248|FG000|STARTED|First Alcohol Challenge||6
6387780|NCT00817089|7299249|FG001|STARTED|First Alcohol Challenge||8
6387781|NCT00817089|7299250|FG002|STARTED|First Alcohol Challenge||4
6387782|NCT00817089|7299251|FG003|STARTED|First Alcohol Challenge||6
6387783|NCT00817089|7299248|FG000|COMPLETED|First Alcohol Challenge||6
6387784|NCT00817089|7299249|FG001|COMPLETED|First Alcohol Challenge||8
6387785|NCT00817089|7299250|FG002|COMPLETED|First Alcohol Challenge||4
6387786|NCT00817089|7299251|FG003|COMPLETED|First Alcohol Challenge||5
6387787|NCT00817089|7299248|FG000|NOT COMPLETED|First Alcohol Challenge||0
6387788|NCT00817089|7299249|FG001|NOT COMPLETED|First Alcohol Challenge||0
6387789|NCT00817089|7299250|FG002|NOT COMPLETED|First Alcohol Challenge||0
6387790|NCT00817089|7299251|FG003|NOT COMPLETED|First Alcohol Challenge||1
6387791|NCT00817089|7299248|FG000|STARTED|Second Alcohol Challenge||6
6387792|NCT00817089|7299249|FG001|STARTED|Second Alcohol Challenge||8
6387793|NCT00817089|7299250|FG002|STARTED|Second Alcohol Challenge||4
6387794|NCT00817089|7299251|FG003|STARTED|Second Alcohol Challenge||5
6387795|NCT00817089|7299248|FG000|COMPLETED|Second Alcohol Challenge||6
6387796|NCT00817089|7299249|FG001|COMPLETED|Second Alcohol Challenge||7
6387797|NCT00817089|7299250|FG002|COMPLETED|Second Alcohol Challenge||4
6387798|NCT00817089|7299251|FG003|COMPLETED|Second Alcohol Challenge||5
6387799|NCT00817089|7299248|FG000|NOT COMPLETED|Second Alcohol Challenge||0
6387800|NCT00817089|7299249|FG001|NOT COMPLETED|Second Alcohol Challenge||1
6387801|NCT00817089|7299250|FG002|NOT COMPLETED|Second Alcohol Challenge||0
6565960|NCT01822496|7488903|FG003|Eligible|Overall Study||7
6272807|NCT00097981|7172115|FG001|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
6805575|NCT03561701|7737607|FG001|STARTED|Overall Study||110
6805576|NCT03561701|7737606|FG000|COMPLETED|Overall Study||191
6805577|NCT03561701|7737607|FG001|COMPLETED|Overall Study||91
6805578|NCT03561701|7737606|FG000|NOT COMPLETED|Overall Study||29
6805579|NCT03561701|7737607|FG001|NOT COMPLETED|Overall Study||19
6805580|NCT03525808|7737613|FG000|STARTED|Overall Study||40
6805581|NCT03525808|7737613|FG000|COMPLETED|Overall Study||34
6805582|NCT03525808|7737613|FG000|NOT COMPLETED|Overall Study||6
6272808|NCT00097981|7172114|FG000|NOT COMPLETED|Overall Study||106
6272809|NCT00097981|7172115|FG001|NOT COMPLETED|Overall Study||100
6272810|NCT00098020|7172121|FG000|STARTED|Overall Study||12
6272811|NCT00098020|7172121|FG000|Started Isotretinoin|Overall Study||8
6272812|NCT00098020|7172121|FG000|COMPLETED|Overall Study||6
6272813|NCT00098020|7172121|FG000|NOT COMPLETED|Overall Study||6
6272814|NCT00098059|7172127|FG000|STARTED|Overall Study||27
6272815|NCT00098059|7172128|FG001|STARTED|Overall Study||47
6272816|NCT00098059|7172127|FG000|COMPLETED|Overall Study||27
6272817|NCT00098059|7172128|FG001|COMPLETED|Overall Study||46
6272818|NCT00098059|7172127|FG000|NOT COMPLETED|Overall Study||0
6272819|NCT00098059|7172128|FG001|NOT COMPLETED|Overall Study||1
6272820|NCT00098254|7172139|FG000|STARTED|Overall Study||37
6272821|NCT00098254|7172139|FG000|COMPLETED|Overall Study||34
6272822|NCT00098254|7172139|FG000|NOT COMPLETED|Overall Study||3
6565961|NCT01822496|7488900|FG000|Eligible With Disease Assessment|Overall Study||10
6565962|NCT01822496|7488901|FG001|Eligible With Disease Assessment|Overall Study||15
6565963|NCT01822496|7488902|FG002|Eligible With Disease Assessment|Overall Study||6
6565964|NCT01822496|7488903|FG003|Eligible With Disease Assessment|Overall Study||4
6565965|NCT01822496|7488900|FG000|Eligible and Started Study Treatment|Overall Study||14
6565966|NCT01822496|7488901|FG001|Eligible and Started Study Treatment|Overall Study||20
6623496|NCT02207907|7550634|FG000|NOT COMPLETED|Overall Study||11
6805583|NCT03461211|7737619|FG000|STARTED|Overall Study||37
6805584|NCT03461211|7737620|FG001|STARTED|Overall Study||14
6272823|NCT00098293|7172146|FG000|STARTED|Double-blind (DB) Phase||177
6272824|NCT00098293|7172147|FG001|STARTED|Double-blind (DB) Phase||368
6272825|NCT00098293|7172148|FG002|STARTED|Double-blind (DB) Phase||372
6272826|NCT00098293|7172149|FG003|STARTED|Double-blind (DB) Phase||0
6272827|NCT00098293|7172150|FG004|STARTED|Double-blind (DB) Phase||0
6272828|NCT00098293|7172146|FG000|Treated|Double-blind (DB) Phase||174
6272829|NCT00098293|7172147|FG001|Treated|Double-blind (DB) Phase||360
6272830|NCT00098293|7172148|FG002|Treated|Double-blind (DB) Phase||361
6272831|NCT00098293|7172149|FG003|Treated|Double-blind (DB) Phase||0
6272832|NCT00098293|7172150|FG004|Treated|Double-blind (DB) Phase||0
6272833|NCT00098293|7172146|FG000|COMPLETED|Double-blind (DB) Phase||0
6272834|NCT00098293|7172147|FG001|COMPLETED|Double-blind (DB) Phase||202
6272835|NCT00098293|7172148|FG002|COMPLETED|Double-blind (DB) Phase||202
6272836|NCT00098293|7172149|FG003|COMPLETED|Double-blind (DB) Phase||0
6272837|NCT00098293|7172150|FG004|COMPLETED|Double-blind (DB) Phase||0
6272838|NCT00098293|7172146|FG000|NOT COMPLETED|Double-blind (DB) Phase||177
6272839|NCT00098293|7172147|FG001|NOT COMPLETED|Double-blind (DB) Phase||166
6272840|NCT00098293|7172148|FG002|NOT COMPLETED|Double-blind (DB) Phase||170
6272841|NCT00098293|7172149|FG003|NOT COMPLETED|Double-blind (DB) Phase||0
6272842|NCT00098293|7172150|FG004|NOT COMPLETED|Double-blind (DB) Phase||0
6272843|NCT00098293|7172146|FG000|STARTED|Between DB and OL Phase||0
6272844|NCT00098293|7172147|FG001|STARTED|Between DB and OL Phase||202
6272845|NCT00098293|7172148|FG002|STARTED|Between DB and OL Phase||202
6272846|NCT00098293|7172149|FG003|STARTED|Between DB and OL Phase||0
6272847|NCT00098293|7172150|FG004|STARTED|Between DB and OL Phase||0
6272848|NCT00098293|7172146|FG000|COMPLETED|Between DB and OL Phase||0
6805585|NCT03461211|7737619|FG000|Proptosis Non-Responders in OPTIC|Overall Study||36
6805586|NCT03461211|7737620|FG001|Proptosis Non-Responders in OPTIC|Overall Study||5
6805587|NCT03461211|7737619|FG000|Relapsed During Follow-Up Period of OPTIC|Overall Study||1
6805588|NCT03461211|7737620|FG001|Relapsed During Follow-Up Period of OPTIC|Overall Study||9
6805589|NCT03461211|7737619|FG000|COMPLETED|Overall Study||36
6805590|NCT03461211|7737620|FG001|COMPLETED|Overall Study||12
6805591|NCT03461211|7737619|FG000|NOT COMPLETED|Overall Study||1
6805592|NCT03461211|7737620|FG001|NOT COMPLETED|Overall Study||2
6805593|NCT03282123|7737628|FG000|STARTED|Overall Study||38
6805594|NCT03282123|7737628|FG000|COMPLETED|Overall Study||33
6805595|NCT03282123|7737628|FG000|NOT COMPLETED|Overall Study||5
6805596|NCT03276780|7737635|FG000|STARTED|Overall Study||41
6805597|NCT03276780|7737636|FG001|STARTED|Overall Study||39
6805598|NCT03276780|7737635|FG000|COMPLETED|Overall Study||23
6805599|NCT03276780|7737636|FG001|COMPLETED|Overall Study||29
6805600|NCT03276780|7737635|FG000|NOT COMPLETED|Overall Study||18
6805601|NCT03276780|7737636|FG001|NOT COMPLETED|Overall Study||10
6805602|NCT03205553|7737646|FG000|STARTED|Overall Study||2
6805603|NCT03205553|7737647|FG001|STARTED|Overall Study||1
6565967|NCT01822496|7488902|FG002|Eligible and Started Study Treatment|Overall Study||9
6565968|NCT01822496|7488903|FG003|Eligible and Started Study Treatment|Overall Study||7
6565969|NCT01822496|7488900|FG000|COMPLETED|Overall Study||14
6565970|NCT01822496|7488901|FG001|COMPLETED|Overall Study||21
6565971|NCT01822496|7488902|FG002|COMPLETED|Overall Study||9
6565972|NCT01822496|7488903|FG003|COMPLETED|Overall Study||7
6565973|NCT01822496|7488900|FG000|NOT COMPLETED|Overall Study||2
6565974|NCT01822496|7488901|FG001|NOT COMPLETED|Overall Study||2
6272849|NCT00098293|7172147|FG001|COMPLETED|Between DB and OL Phase||202
6272850|NCT00098293|7172148|FG002|COMPLETED|Between DB and OL Phase||199
6272851|NCT00098293|7172149|FG003|COMPLETED|Between DB and OL Phase||0
6272852|NCT00098293|7172150|FG004|COMPLETED|Between DB and OL Phase||0
6272853|NCT00098293|7172146|FG000|NOT COMPLETED|Between DB and OL Phase||0
6272854|NCT00098293|7172147|FG001|NOT COMPLETED|Between DB and OL Phase||0
6272855|NCT00098293|7172148|FG002|NOT COMPLETED|Between DB and OL Phase||3
6272856|NCT00098293|7172149|FG003|NOT COMPLETED|Between DB and OL Phase||0
6272857|NCT00098293|7172150|FG004|NOT COMPLETED|Between DB and OL Phase||0
6272858|NCT00098293|7172146|FG000|STARTED|Open-label (OL) Phase||0
6272859|NCT00098293|7172147|FG001|STARTED|Open-label (OL) Phase||202
6272860|NCT00098293|7172148|FG002|STARTED|Open-label (OL) Phase||199
6272861|NCT00098293|7172149|FG003|STARTED|Open-label (OL) Phase||130
6272862|NCT00098293|7172150|FG004|STARTED|Open-label (OL) Phase||0
6272863|NCT00098293|7172146|FG000|COMPLETED|Open-label (OL) Phase||0
6272864|NCT00098293|7172147|FG001|COMPLETED|Open-label (OL) Phase||177
6272865|NCT00098293|7172148|FG002|COMPLETED|Open-label (OL) Phase||158
6272866|NCT00098293|7172149|FG003|COMPLETED|Open-label (OL) Phase||65
6272867|NCT00098293|7172150|FG004|COMPLETED|Open-label (OL) Phase||0
6272868|NCT00098293|7172146|FG000|NOT COMPLETED|Open-label (OL) Phase||0
6272869|NCT00098293|7172147|FG001|NOT COMPLETED|Open-label (OL) Phase||25
6272870|NCT00098293|7172148|FG002|NOT COMPLETED|Open-label (OL) Phase||41
6272871|NCT00098293|7172149|FG003|NOT COMPLETED|Open-label (OL) Phase||65
6272872|NCT00098293|7172150|FG004|NOT COMPLETED|Open-label (OL) Phase||0
6272873|NCT00098293|7172146|FG000|STARTED|Supplemental Phase (SP)||0
6272874|NCT00098293|7172147|FG001|STARTED|Supplemental Phase (SP)||0
6272875|NCT00098293|7172148|FG002|STARTED|Supplemental Phase (SP)||0
6272876|NCT00098293|7172149|FG003|STARTED|Supplemental Phase (SP)||0
6272877|NCT00098293|7172150|FG004|STARTED|Supplemental Phase (SP)||127
6272878|NCT00098293|7172146|FG000|COMPLETED|Supplemental Phase (SP)||0
6272879|NCT00098293|7172147|FG001|COMPLETED|Supplemental Phase (SP)||0
6272880|NCT00098293|7172148|FG002|COMPLETED|Supplemental Phase (SP)||0
6272881|NCT00098293|7172149|FG003|COMPLETED|Supplemental Phase (SP)||0
6272882|NCT00098293|7172150|FG004|COMPLETED|Supplemental Phase (SP)||94
6272883|NCT00098293|7172146|FG000|NOT COMPLETED|Supplemental Phase (SP)||0
6272884|NCT00098293|7172147|FG001|NOT COMPLETED|Supplemental Phase (SP)||0
6656873|NCT02465450|7587223|FG004|NOT COMPLETED|Treatment Period 1||0
6656874|NCT02465450|7587224|FG005|NOT COMPLETED|Treatment Period 1||0
6656875|NCT02465450|7587219|FG000|STARTED|Treatment Period 2||0
6656876|NCT02465450|7587220|FG001|STARTED|Treatment Period 2||0
6656877|NCT02465450|7587221|FG002|STARTED|Treatment Period 2||0
6656878|NCT02465450|7587222|FG003|STARTED|Treatment Period 2||30
6656879|NCT02465450|7587223|FG004|STARTED|Treatment Period 2||28
6272885|NCT00098293|7172148|FG002|NOT COMPLETED|Supplemental Phase (SP)||0
6272886|NCT00098293|7172149|FG003|NOT COMPLETED|Supplemental Phase (SP)||0
6387802|NCT00817089|7299251|FG003|NOT COMPLETED|Second Alcohol Challenge||0
6387803|NCT00817206|7299267|FG000|STARTED|Overall Study||163
6387804|NCT00817206|7299268|FG001|STARTED|Overall Study||163
6387805|NCT00817206|7299267|FG000|COMPLETED|Overall Study||142
6387806|NCT00817206|7299268|FG001|COMPLETED|Overall Study||154
6387807|NCT00817206|7299267|FG000|NOT COMPLETED|Overall Study||21
6387808|NCT00817206|7299268|FG001|NOT COMPLETED|Overall Study||9
6387809|NCT00817219|7299274|FG000|STARTED|Overall Study||33
6387810|NCT00817219|7299274|FG000|COMPLETED|Overall Study||33
6387811|NCT00817219|7299274|FG000|NOT COMPLETED|Overall Study||0
6387812|NCT00817336|7299280|FG000|STARTED|Overall Study||8
6387813|NCT00817336|7299281|FG001|STARTED|Overall Study||8
6387814|NCT00817336|7299280|FG000|COMPLETED|Overall Study||7
6387815|NCT00817336|7299281|FG001|COMPLETED|Overall Study||7
6656880|NCT02465450|7587224|FG005|STARTED|Treatment Period 2||23
6387816|NCT00817336|7299280|FG000|NOT COMPLETED|Overall Study||1
6387817|NCT00817336|7299281|FG001|NOT COMPLETED|Overall Study||1
6656881|NCT02465450|7587219|FG000|COMPLETED|Treatment Period 2||0
6656882|NCT02465450|7587220|FG001|COMPLETED|Treatment Period 2||0
6656883|NCT02465450|7587221|FG002|COMPLETED|Treatment Period 2||0
6805604|NCT03205553|7737646|FG000|COMPLETED|Overall Study||2
6805605|NCT03205553|7737647|FG001|COMPLETED|Overall Study||1
6805606|NCT03205553|7737646|FG000|NOT COMPLETED|Overall Study||0
6805607|NCT03205553|7737647|FG001|NOT COMPLETED|Overall Study||0
6805608|NCT03104205|7737653|FG000|STARTED|Overall Study||53
6805609|NCT03104205|7737653|FG000|COMPLETED|Overall Study||44
6805610|NCT03104205|7737653|FG000|NOT COMPLETED|Overall Study||9
6805611|NCT03050814|7737660|FG000|STARTED|Overall Study||10
6805612|NCT03050814|7737661|FG001|STARTED|Overall Study||16
6805613|NCT03050814|7737662|FG002|STARTED|Overall Study||4
6805614|NCT03050814|7737660|FG000|COMPLETED|Overall Study||10
6805615|NCT03050814|7737661|FG001|COMPLETED|Overall Study||16
6805616|NCT03050814|7737662|FG002|COMPLETED|Overall Study||0
6805617|NCT03050814|7737660|FG000|NOT COMPLETED|Overall Study||0
6805618|NCT03050814|7737661|FG001|NOT COMPLETED|Overall Study||0
6805619|NCT03050814|7737662|FG002|NOT COMPLETED|Overall Study||4
6805620|NCT02797262|7737670|FG000|STARTED|Overall Study||65
6805621|NCT02797262|7737671|FG001|STARTED|Overall Study||65
6805622|NCT02797262|7737670|FG000|Baseline|Overall Study||54
6272887|NCT00098293|7172150|FG004|NOT COMPLETED|Supplemental Phase (SP)||33
6272888|NCT00098306|7172164|FG000|STARTED|Double Blind||241
6272889|NCT00098306|7172165|FG001|STARTED|Double Blind||240
6272890|NCT00098306|7172166|FG002|STARTED|Double Blind||120
6272891|NCT00098306|7172167|FG003|STARTED|Double Blind||0
6272892|NCT00098306|7172168|FG004|STARTED|Double Blind||0
6272893|NCT00098306|7172169|FG005|STARTED|Double Blind||0
6272894|NCT00098306|7172170|FG006|STARTED|Double Blind||0
6272895|NCT00098306|7172164|FG000|Treated|Double Blind||232
6272896|NCT00098306|7172165|FG001|Treated|Double Blind||235
6272897|NCT00098306|7172166|FG002|Treated|Double Blind||118
6272898|NCT00098306|7172167|FG003|Treated|Double Blind||0
6272899|NCT00098306|7172168|FG004|Treated|Double Blind||0
6272900|NCT00098306|7172169|FG005|Treated|Double Blind||0
6272901|NCT00098306|7172170|FG006|Treated|Double Blind||0
6272902|NCT00098306|7172164|FG000|COMPLETED|Double Blind||0
6272903|NCT00098306|7172165|FG001|COMPLETED|Double Blind||0
6272904|NCT00098306|7172166|FG002|COMPLETED|Double Blind||0
6272905|NCT00098306|7172167|FG003|COMPLETED|Double Blind||0
6272906|NCT00098306|7172168|FG004|COMPLETED|Double Blind||0
6272907|NCT00098306|7172169|FG005|COMPLETED|Double Blind||0
6565975|NCT01822496|7488902|FG002|NOT COMPLETED|Overall Study||0
6565976|NCT01822496|7488903|FG003|NOT COMPLETED|Overall Study||4
6565977|NCT01822535|7488915|FG000|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
6565978|NCT01822535|7488916|FG001|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
6565979|NCT01822535|7488915|FG000|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
6805623|NCT02797262|7737671|FG001|Baseline|Overall Study||58
6272908|NCT00098306|7172170|FG006|COMPLETED|Double Blind||0
6272909|NCT00098306|7172164|FG000|NOT COMPLETED|Double Blind||241
6272910|NCT00098306|7172165|FG001|NOT COMPLETED|Double Blind||240
6272911|NCT00098306|7172166|FG002|NOT COMPLETED|Double Blind||120
6272912|NCT00098306|7172167|FG003|NOT COMPLETED|Double Blind||0
6805624|NCT02797262|7737670|FG000|COMPLETED|Overall Study||45
6805625|NCT02797262|7737671|FG001|COMPLETED|Overall Study||54
6805626|NCT02797262|7737670|FG000|NOT COMPLETED|Overall Study||20
6805627|NCT02797262|7737671|FG001|NOT COMPLETED|Overall Study||11
6805628|NCT02639910|7737679|FG000|STARTED|Overall Study||11
6805629|NCT02639910|7737680|FG001|STARTED|Overall Study||13
6805630|NCT02639910|7737679|FG000|COMPLETED|Overall Study||7
6805631|NCT02639910|7737680|FG001|COMPLETED|Overall Study||5
6805632|NCT02639910|7737679|FG000|NOT COMPLETED|Overall Study||4
6805633|NCT02639910|7737680|FG001|NOT COMPLETED|Overall Study||8
6805634|NCT02409368|7737689|FG000|STARTED|Overall Study||173
6805635|NCT02409368|7737690|FG001|STARTED|Overall Study||534
6805636|NCT02409368|7737691|FG002|STARTED|Overall Study||103
6805637|NCT02409368|7737689|FG000|COMPLETED|Overall Study||25
6805638|NCT02409368|7737690|FG001|COMPLETED|Overall Study||45
6805639|NCT02409368|7737691|FG002|COMPLETED|Overall Study||4
6805640|NCT02409368|7737689|FG000|NOT COMPLETED|Overall Study||148
6805641|NCT02409368|7737690|FG001|NOT COMPLETED|Overall Study||489
6805642|NCT02409368|7737691|FG002|NOT COMPLETED|Overall Study||99
6805643|NCT02322593|7737702|FG000|STARTED|Overall Study||356
6805644|NCT02322593|7737703|FG001|STARTED|Overall Study||355
6805645|NCT02322593|7737702|FG000|COMPLETED|Overall Study||356
6805646|NCT02322593|7737703|FG001|COMPLETED|Overall Study||355
6805647|NCT02322593|7737702|FG000|NOT COMPLETED|Overall Study||0
6805648|NCT02322593|7737703|FG001|NOT COMPLETED|Overall Study||0
6805649|NCT02277119|7737712|FG000|STARTED|Overall Study||58
6805650|NCT02277119|7737713|FG001|STARTED|Overall Study||24
6805651|NCT02277119|7737714|FG002|STARTED|Overall Study||27
6805652|NCT02277119|7737712|FG000|COMPLETED|Overall Study||55
6805653|NCT02277119|7737713|FG001|COMPLETED|Overall Study||20
6805654|NCT02277119|7737714|FG002|COMPLETED|Overall Study||19
6805655|NCT02277119|7737712|FG000|NOT COMPLETED|Overall Study||3
6805656|NCT02277119|7737713|FG001|NOT COMPLETED|Overall Study||4
6805657|NCT02277119|7737714|FG002|NOT COMPLETED|Overall Study||8
6805658|NCT02220894|7737724|FG000|STARTED|Overall Study|1 additional participant was randomized in error|637
6805659|NCT02220894|7737725|FG001|STARTED|Overall Study||637
6805660|NCT02220894|7737724|FG000|Treated|Overall Study||636
6805661|NCT02220894|7737725|FG001|Treated|Overall Study||615
6805662|NCT02220894|7737724|FG000|COMPLETED|Overall Study||0
6805663|NCT02220894|7737725|FG001|COMPLETED|Overall Study||0
6805664|NCT02220894|7737724|FG000|NOT COMPLETED|Overall Study||637
6805665|NCT02220894|7737725|FG001|NOT COMPLETED|Overall Study||637
6805666|NCT02124824|7737733|FG000|STARTED|Overall Study||15
6805667|NCT02124824|7737734|FG001|STARTED|Overall Study||15
6805668|NCT02124824|7737733|FG000|COMPLETED|Overall Study||15
6805669|NCT02124824|7737734|FG001|COMPLETED|Overall Study||15
6805670|NCT02124824|7737733|FG000|NOT COMPLETED|Overall Study||0
6805671|NCT02124824|7737734|FG001|NOT COMPLETED|Overall Study||0
6272913|NCT00098306|7172168|FG004|NOT COMPLETED|Double Blind||0
6272914|NCT00098306|7172169|FG005|NOT COMPLETED|Double Blind||0
6272915|NCT00098306|7172170|FG006|NOT COMPLETED|Double Blind||0
6272916|NCT00098306|7172164|FG000|STARTED|Open Label||0
6272917|NCT00098306|7172165|FG001|STARTED|Open Label||0
6272918|NCT00098306|7172166|FG002|STARTED|Open Label||0
6805672|NCT01772004|7737763|FG000|STARTED|Dose Escalation Phase||4
6805673|NCT01772004|7737764|FG001|STARTED|Dose Escalation Phase||13
6805674|NCT01772004|7737765|FG002|STARTED|Dose Escalation Phase||15
6387818|NCT00817414|7299291|FG000|STARTED|Overall Study||12
6387819|NCT00817414|7299292|FG001|STARTED|Overall Study||12
6387820|NCT00817414|7299293|FG002|STARTED|Overall Study||13
6387821|NCT00817414|7299294|FG003|STARTED|Overall Study||13
6387822|NCT00817414|7299295|FG004|STARTED|Overall Study||13
6387823|NCT00817414|7299291|FG000|COMPLETED|Overall Study||10
6387824|NCT00817414|7299292|FG001|COMPLETED|Overall Study||9
6387825|NCT00817414|7299293|FG002|COMPLETED|Overall Study||9
6387826|NCT00817414|7299294|FG003|COMPLETED|Overall Study||1
6387827|NCT00817414|7299295|FG004|COMPLETED|Overall Study||11
6387828|NCT00817414|7299291|FG000|NOT COMPLETED|Overall Study||2
6387829|NCT00817414|7299292|FG001|NOT COMPLETED|Overall Study||3
6387830|NCT00817414|7299293|FG002|NOT COMPLETED|Overall Study||4
6387831|NCT00817414|7299294|FG003|NOT COMPLETED|Overall Study||12
6387832|NCT00817414|7299295|FG004|NOT COMPLETED|Overall Study||2
6387833|NCT00817479|7299314|FG000|STARTED|Overall Study||6
6387834|NCT00817479|7299315|FG001|STARTED|Overall Study||14
6387835|NCT00817479|7299314|FG000|COMPLETED|Overall Study||5
6387836|NCT00817479|7299315|FG001|COMPLETED|Overall Study||13
6387837|NCT00817479|7299314|FG000|NOT COMPLETED|Overall Study||1
6387838|NCT00817479|7299315|FG001|NOT COMPLETED|Overall Study||1
6387839|NCT00817531|7299321|FG000|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
6387840|NCT00817531|7299321|FG000|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
6387841|NCT00817531|7299321|FG000|NOT COMPLETED|Overall Study||2
6387842|NCT00817596|7299325|FG000|STARTED|Overall Study||110
6387843|NCT00817596|7299325|FG000|COMPLETED|Overall Study||62
6387844|NCT00817596|7299325|FG000|NOT COMPLETED|Overall Study||48
6387845|NCT00817635|7299334|FG000|STARTED|Overall Study||32
6387846|NCT00817635|7299335|FG001|STARTED|Overall Study||26
6387847|NCT00817635|7299336|FG002|STARTED|Overall Study||31
6387848|NCT00817635|7299337|FG003|STARTED|Overall Study||33
6387849|NCT00817635|7299338|FG004|STARTED|Overall Study||33
6387850|NCT00817635|7299334|FG000|COMPLETED|Overall Study||23
6387851|NCT00817635|7299335|FG001|COMPLETED|Overall Study||22
6387852|NCT00817635|7299336|FG002|COMPLETED|Overall Study||28
6387853|NCT00817635|7299337|FG003|COMPLETED|Overall Study||28
6387854|NCT00817635|7299338|FG004|COMPLETED|Overall Study||25
6504115|NCT01447225|7423211|FG008|NOT COMPLETED|Overall Study||0
6504116|NCT01447225|7423212|FG009|NOT COMPLETED|Overall Study||0
6504117|NCT01447407|7423248|FG000|STARTED|Overall Study||41
6504118|NCT01447407|7423249|FG001|STARTED|Overall Study||40
6504119|NCT01447407|7423250|FG002|STARTED|Overall Study||41
6504120|NCT01447407|7423251|FG003|STARTED|Overall Study||42
6504121|NCT01447407|7423248|FG000|COMPLETED|Overall Study||39
6504122|NCT01447407|7423249|FG001|COMPLETED|Overall Study||40
6504123|NCT01447407|7423250|FG002|COMPLETED|Overall Study||40
6504124|NCT01447407|7423251|FG003|COMPLETED|Overall Study||40
6504125|NCT01447407|7423248|FG000|NOT COMPLETED|Overall Study||2
6504126|NCT01447407|7423249|FG001|NOT COMPLETED|Overall Study||0
6504127|NCT01447407|7423250|FG002|NOT COMPLETED|Overall Study||1
6504128|NCT01447407|7423251|FG003|NOT COMPLETED|Overall Study||2
6504129|NCT01447420|7423264|FG000|STARTED|Overall Study||39
6504130|NCT01447420|7423265|FG001|STARTED|Overall Study||72
6504131|NCT01447420|7423266|FG002|STARTED|Overall Study||18
6504132|NCT01447420|7423264|FG000|COMPLETED|Overall Study||29
6504133|NCT01447420|7423265|FG001|COMPLETED|Overall Study||45
6504134|NCT01447420|7423266|FG002|COMPLETED|Overall Study||8
6504135|NCT01447420|7423264|FG000|NOT COMPLETED|Overall Study||10
6504136|NCT01447420|7423265|FG001|NOT COMPLETED|Overall Study||27
6504137|NCT01447420|7423266|FG002|NOT COMPLETED|Overall Study||10
6272919|NCT00098306|7172167|FG003|STARTED|Open Label||327
6272920|NCT00098306|7172168|FG004|STARTED|Open Label||62
6272921|NCT00098306|7172169|FG005|STARTED|Open Label||0
6272922|NCT00098306|7172170|FG006|STARTED|Open Label||0
6272923|NCT00098306|7172164|FG000|COMPLETED|Open Label||0
6272924|NCT00098306|7172165|FG001|COMPLETED|Open Label||0
6272925|NCT00098306|7172166|FG002|COMPLETED|Open Label||0
6272926|NCT00098306|7172167|FG003|COMPLETED|Open Label||0
6272927|NCT00098306|7172168|FG004|COMPLETED|Open Label||0
6272928|NCT00098306|7172169|FG005|COMPLETED|Open Label||0
6272929|NCT00098306|7172170|FG006|COMPLETED|Open Label||0
6272930|NCT00098306|7172164|FG000|NOT COMPLETED|Open Label||0
6272931|NCT00098306|7172165|FG001|NOT COMPLETED|Open Label||0
6272932|NCT00098306|7172166|FG002|NOT COMPLETED|Open Label||0
6272933|NCT00098306|7172167|FG003|NOT COMPLETED|Open Label||327
6272934|NCT00098306|7172168|FG004|NOT COMPLETED|Open Label||62
6272935|NCT00098306|7172169|FG005|NOT COMPLETED|Open Label||0
6272936|NCT00098306|7172170|FG006|NOT COMPLETED|Open Label||0
6272937|NCT00098306|7172164|FG000|STARTED|Observational Phase||0
6272938|NCT00098306|7172165|FG001|STARTED|Observational Phase||0
6272939|NCT00098306|7172166|FG002|STARTED|Observational Phase||0
6272940|NCT00098306|7172167|FG003|STARTED|Observational Phase||0
6272941|NCT00098306|7172168|FG004|STARTED|Observational Phase||0
6272942|NCT00098306|7172169|FG005|STARTED|Observational Phase||250
6272943|NCT00098306|7172170|FG006|STARTED|Observational Phase||81
6272944|NCT00098306|7172164|FG000|COMPLETED|Observational Phase||0
6272945|NCT00098306|7172165|FG001|COMPLETED|Observational Phase||0
6272946|NCT00098306|7172166|FG002|COMPLETED|Observational Phase||0
6272947|NCT00098306|7172167|FG003|COMPLETED|Observational Phase||0
6272948|NCT00098306|7172168|FG004|COMPLETED|Observational Phase||0
6656884|NCT02465450|7587222|FG003|COMPLETED|Treatment Period 2||27
6656885|NCT02465450|7587223|FG004|COMPLETED|Treatment Period 2||24
6656886|NCT02465450|7587224|FG005|COMPLETED|Treatment Period 2||23
6656887|NCT02465450|7587219|FG000|NOT COMPLETED|Treatment Period 2||0
6656888|NCT02465450|7587220|FG001|NOT COMPLETED|Treatment Period 2||0
6656889|NCT02465450|7587221|FG002|NOT COMPLETED|Treatment Period 2||0
6656890|NCT02465450|7587222|FG003|NOT COMPLETED|Treatment Period 2||3
6272949|NCT00098306|7172169|FG005|COMPLETED|Observational Phase||204
6272950|NCT00098306|7172170|FG006|COMPLETED|Observational Phase||55
6272951|NCT00098306|7172164|FG000|NOT COMPLETED|Observational Phase||0
6272952|NCT00098306|7172165|FG001|NOT COMPLETED|Observational Phase||0
6272953|NCT00098306|7172166|FG002|NOT COMPLETED|Observational Phase||0
6272954|NCT00098306|7172167|FG003|NOT COMPLETED|Observational Phase||0
6272955|NCT00098306|7172168|FG004|NOT COMPLETED|Observational Phase||0
6272956|NCT00098306|7172169|FG005|NOT COMPLETED|Observational Phase||46
6272957|NCT00098306|7172170|FG006|NOT COMPLETED|Observational Phase||26
6272958|NCT00098345|7172183|FG000|STARTED|Overall Study||30
6387855|NCT00817635|7299334|FG000|NOT COMPLETED|Overall Study||9
6387856|NCT00817635|7299335|FG001|NOT COMPLETED|Overall Study||4
6387857|NCT00817635|7299336|FG002|NOT COMPLETED|Overall Study||3
6387858|NCT00817635|7299337|FG003|NOT COMPLETED|Overall Study||5
6387859|NCT00817635|7299338|FG004|NOT COMPLETED|Overall Study||8
6387860|NCT00817778|7299359|FG000|STARTED|Overall Study||19
6387861|NCT00817778|7299360|FG001|STARTED|Overall Study||8
6387862|NCT00817778|7299359|FG000|COMPLETED|Overall Study||16
6387863|NCT00817778|7299360|FG001|COMPLETED|Overall Study||5
6387864|NCT00817778|7299359|FG000|NOT COMPLETED|Overall Study||3
6387865|NCT00817778|7299360|FG001|NOT COMPLETED|Overall Study||3
6387866|NCT00817804|7299368|FG000|STARTED|Overall Study||1
6387867|NCT00817804|7299369|FG001|STARTED|Overall Study||2
6387868|NCT00817804|7299368|FG000|COMPLETED|Overall Study||1
6387869|NCT00817804|7299369|FG001|COMPLETED|Overall Study||2
6387870|NCT00817804|7299368|FG000|NOT COMPLETED|Overall Study||0
6387871|NCT00817804|7299369|FG001|NOT COMPLETED|Overall Study||0
6805675|NCT01772004|7737766|FG003|STARTED|Dose Escalation Phase||21
6805676|NCT01772004|7737767|FG004|STARTED|Dose Escalation Phase||8
6805677|NCT01772004|7737768|FG005|STARTED|Dose Escalation Phase||0
6805678|NCT01772004|7737769|FG006|STARTED|Dose Escalation Phase||0
6805679|NCT01772004|7737770|FG007|STARTED|Dose Escalation Phase||0
6805680|NCT01772004|7737771|FG008|STARTED|Dose Escalation Phase||0
6805681|NCT01772004|7737772|FG009|STARTED|Dose Escalation Phase||0
6805682|NCT01772004|7737773|FG010|STARTED|Dose Escalation Phase||0
6805683|NCT01772004|7737774|FG011|STARTED|Dose Escalation Phase||0
6805684|NCT01772004|7737775|FG012|STARTED|Dose Escalation Phase||0
6805685|NCT01772004|7737776|FG013|STARTED|Dose Escalation Phase||0
6805686|NCT01772004|7737777|FG014|STARTED|Dose Escalation Phase||0
6805687|NCT01772004|7737778|FG015|STARTED|Dose Escalation Phase||0
6805688|NCT01772004|7737779|FG016|STARTED|Dose Escalation Phase||0
6805689|NCT01772004|7737780|FG017|STARTED|Dose Escalation Phase||0
6805690|NCT01772004|7737781|FG018|STARTED|Dose Escalation Phase||0
6805691|NCT01772004|7737782|FG019|STARTED|Dose Escalation Phase||0
6805692|NCT01772004|7737783|FG020|STARTED|Dose Escalation Phase||0
6387872|NCT00817843|7299375|FG000|STARTED|First Period (6 Weeks)||50
6387873|NCT00817843|7299376|FG001|STARTED|First Period (6 Weeks)||50
6387874|NCT00817843|7299375|FG000|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
6387875|NCT00817843|7299376|FG001|COMPLETED|First Period (6 Weeks)||46
6387876|NCT00817843|7299375|FG000|NOT COMPLETED|First Period (6 Weeks)||8
6387877|NCT00817843|7299376|FG001|NOT COMPLETED|First Period (6 Weeks)||4
6387878|NCT00817843|7299375|FG000|STARTED|Washout Period (6 Weeks)||42
6387879|NCT00817843|7299376|FG001|STARTED|Washout Period (6 Weeks)||46
6387880|NCT00817843|7299375|FG000|COMPLETED|Washout Period (6 Weeks)||41
6387881|NCT00817843|7299376|FG001|COMPLETED|Washout Period (6 Weeks)||45
6387882|NCT00817843|7299375|FG000|NOT COMPLETED|Washout Period (6 Weeks)||1
6387883|NCT00817843|7299376|FG001|NOT COMPLETED|Washout Period (6 Weeks)||1
6387884|NCT00817843|7299375|FG000|STARTED|Second Period (6 Weeks)||41
6387885|NCT00817843|7299376|FG001|STARTED|Second Period (6 Weeks)||45
6387886|NCT00817843|7299375|FG000|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
6805693|NCT01772004|7737784|FG021|STARTED|Dose Escalation Phase||0
6805694|NCT01772004|7737785|FG022|STARTED|Dose Escalation Phase||0
6805695|NCT01772004|7737763|FG000|COMPLETED|Dose Escalation Phase||4
6805696|NCT01772004|7737764|FG001|COMPLETED|Dose Escalation Phase||13
6805697|NCT01772004|7737765|FG002|COMPLETED|Dose Escalation Phase||15
6272959|NCT00098345|7172183|FG000|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
6272960|NCT00098345|7172183|FG000|NOT COMPLETED|Overall Study||13
6272961|NCT00098371|7172187|FG000|STARTED|Overall Study||64
6272962|NCT00098371|7172187|FG000|COMPLETED|Overall Study||64
6272963|NCT00098371|7172187|FG000|NOT COMPLETED|Overall Study||0
6805698|NCT01772004|7737766|FG003|COMPLETED|Dose Escalation Phase||21
6805699|NCT01772004|7737767|FG004|COMPLETED|Dose Escalation Phase||8
6805700|NCT01772004|7737768|FG005|COMPLETED|Dose Escalation Phase||0
6805701|NCT01772004|7737769|FG006|COMPLETED|Dose Escalation Phase||0
6805702|NCT01772004|7737770|FG007|COMPLETED|Dose Escalation Phase||0
6805703|NCT01772004|7737771|FG008|COMPLETED|Dose Escalation Phase||0
6805704|NCT01772004|7737772|FG009|COMPLETED|Dose Escalation Phase||0
6805705|NCT01772004|7737773|FG010|COMPLETED|Dose Escalation Phase||0
6805706|NCT01772004|7737774|FG011|COMPLETED|Dose Escalation Phase||0
6805707|NCT01772004|7737775|FG012|COMPLETED|Dose Escalation Phase||0
6805708|NCT01772004|7737776|FG013|COMPLETED|Dose Escalation Phase||0
6805709|NCT01772004|7737777|FG014|COMPLETED|Dose Escalation Phase||0
6805710|NCT01772004|7737778|FG015|COMPLETED|Dose Escalation Phase||0
6805711|NCT01772004|7737779|FG016|COMPLETED|Dose Escalation Phase||0
6805712|NCT01772004|7737780|FG017|COMPLETED|Dose Escalation Phase||0
6805713|NCT01772004|7737781|FG018|COMPLETED|Dose Escalation Phase||0
6805714|NCT01772004|7737782|FG019|COMPLETED|Dose Escalation Phase||0
6387887|NCT00817843|7299376|FG001|COMPLETED|Second Period (6 Weeks)||44
6805715|NCT01772004|7737783|FG020|COMPLETED|Dose Escalation Phase||0
6805716|NCT01772004|7737784|FG021|COMPLETED|Dose Escalation Phase||0
6805717|NCT01772004|7737785|FG022|COMPLETED|Dose Escalation Phase||0
6805718|NCT01772004|7737763|FG000|NOT COMPLETED|Dose Escalation Phase||0
6805719|NCT01772004|7737764|FG001|NOT COMPLETED|Dose Escalation Phase||0
6565980|NCT01822535|7488916|FG001|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
6565981|NCT01822535|7488915|FG000|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
6565982|NCT01822535|7488916|FG001|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
6565983|NCT01822535|7488915|FG000|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
6565984|NCT01822535|7488916|FG001|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
6565985|NCT01822535|7488915|FG000|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
6805720|NCT01772004|7737765|FG002|NOT COMPLETED|Dose Escalation Phase||0
6805721|NCT01772004|7737766|FG003|NOT COMPLETED|Dose Escalation Phase||0
6805722|NCT01772004|7737767|FG004|NOT COMPLETED|Dose Escalation Phase||0
6805723|NCT01772004|7737768|FG005|NOT COMPLETED|Dose Escalation Phase||0
6805724|NCT01772004|7737769|FG006|NOT COMPLETED|Dose Escalation Phase||0
6805725|NCT01772004|7737770|FG007|NOT COMPLETED|Dose Escalation Phase||0
6805726|NCT01772004|7737771|FG008|NOT COMPLETED|Dose Escalation Phase||0
6805727|NCT01772004|7737772|FG009|NOT COMPLETED|Dose Escalation Phase||0
6805728|NCT01772004|7737773|FG010|NOT COMPLETED|Dose Escalation Phase||0
6805729|NCT01772004|7737774|FG011|NOT COMPLETED|Dose Escalation Phase||0
6805730|NCT01772004|7737775|FG012|NOT COMPLETED|Dose Escalation Phase||0
6805731|NCT01772004|7737776|FG013|NOT COMPLETED|Dose Escalation Phase||0
6805732|NCT01772004|7737777|FG014|NOT COMPLETED|Dose Escalation Phase||0
6805733|NCT01772004|7737778|FG015|NOT COMPLETED|Dose Escalation Phase||0
6805734|NCT01772004|7737779|FG016|NOT COMPLETED|Dose Escalation Phase||0
6805735|NCT01772004|7737780|FG017|NOT COMPLETED|Dose Escalation Phase||0
6805736|NCT01772004|7737781|FG018|NOT COMPLETED|Dose Escalation Phase||0
6805737|NCT01772004|7737782|FG019|NOT COMPLETED|Dose Escalation Phase||0
6805738|NCT01772004|7737783|FG020|NOT COMPLETED|Dose Escalation Phase||0
6805739|NCT01772004|7737784|FG021|NOT COMPLETED|Dose Escalation Phase||0
6805740|NCT01772004|7737785|FG022|NOT COMPLETED|Dose Escalation Phase||0
6805741|NCT01772004|7737763|FG000|STARTED|Dose Expansion Phase||0
6805742|NCT01772004|7737764|FG001|STARTED|Dose Expansion Phase||0
6805743|NCT01772004|7737765|FG002|STARTED|Dose Expansion Phase||0
6805744|NCT01772004|7737766|FG003|STARTED|Dose Expansion Phase||0
6805745|NCT01772004|7737767|FG004|STARTED|Dose Expansion Phase||0
6805746|NCT01772004|7737768|FG005|STARTED|Dose Expansion Phase||184
6805747|NCT01772004|7737769|FG006|STARTED|Dose Expansion Phase||156
6805748|NCT01772004|7737770|FG007|STARTED|Dose Expansion Phase||168
6805749|NCT01772004|7737771|FG008|STARTED|Dose Expansion Phase||60
6805750|NCT01772004|7737772|FG009|STARTED|Dose Expansion Phase||90
6805751|NCT01772004|7737773|FG010|STARTED|Dose Expansion Phase||21
6805752|NCT01772004|7737774|FG011|STARTED|Dose Expansion Phase||18
6805753|NCT01772004|7737775|FG012|STARTED|Dose Expansion Phase||50
6805754|NCT01772004|7737776|FG013|STARTED|Dose Expansion Phase||51
6805755|NCT01772004|7737777|FG014|STARTED|Dose Expansion Phase||53
6805756|NCT01772004|7737778|FG015|STARTED|Dose Expansion Phase||44
6805757|NCT01772004|7737779|FG016|STARTED|Dose Expansion Phase||125
6805758|NCT01772004|7737780|FG017|STARTED|Dose Expansion Phase||62
6805759|NCT01772004|7737781|FG018|STARTED|Dose Expansion Phase||20
6805760|NCT01772004|7737782|FG019|STARTED|Dose Expansion Phase||103
6805761|NCT01772004|7737783|FG020|STARTED|Dose Expansion Phase||205
6805762|NCT01772004|7737784|FG021|STARTED|Dose Expansion Phase||132
6805763|NCT01772004|7737785|FG022|STARTED|Dose Expansion Phase||153
6805764|NCT01772004|7737763|FG000|COMPLETED|Dose Expansion Phase||0
6805765|NCT01772004|7737764|FG001|COMPLETED|Dose Expansion Phase||0
6805766|NCT01772004|7737765|FG002|COMPLETED|Dose Expansion Phase||0
6805767|NCT01772004|7737766|FG003|COMPLETED|Dose Expansion Phase||0
6805768|NCT01772004|7737767|FG004|COMPLETED|Dose Expansion Phase||0
6805769|NCT01772004|7737768|FG005|COMPLETED|Dose Expansion Phase||184
6805770|NCT01772004|7737769|FG006|COMPLETED|Dose Expansion Phase||156
6805771|NCT01772004|7737770|FG007|COMPLETED|Dose Expansion Phase||168
6805772|NCT01772004|7737771|FG008|COMPLETED|Dose Expansion Phase||60
6805773|NCT01772004|7737772|FG009|COMPLETED|Dose Expansion Phase||90
6805774|NCT01772004|7737773|FG010|COMPLETED|Dose Expansion Phase||21
6273004|NCT00098670|7172217|FG000|STARTED|Overall Study||102
6273005|NCT00098670|7172217|FG000|COMPLETED|Overall Study||102
6273006|NCT00098670|7172217|FG000|NOT COMPLETED|Overall Study||0
6273007|NCT00098722|7172225|FG000|STARTED|Double Blind Phase||186
6273008|NCT00098722|7172226|FG001|STARTED|Double Blind Phase||194
6273009|NCT00098722|7172227|FG002|STARTED|Double Blind Phase||94
6273010|NCT00098722|7172228|FG003|STARTED|Double Blind Phase||0
6273011|NCT00098722|7172229|FG004|STARTED|Double Blind Phase||0
6273012|NCT00098722|7172230|FG005|STARTED|Double Blind Phase||0
6273013|NCT00098722|7172231|FG006|STARTED|Double Blind Phase||0
6273014|NCT00098722|7172225|FG000|Treated|Double Blind Phase||182
6273015|NCT00098722|7172226|FG001|Treated|Double Blind Phase||191
6273016|NCT00098722|7172227|FG002|Treated|Double Blind Phase||91
6273017|NCT00098722|7172228|FG003|Treated|Double Blind Phase||0
6565986|NCT01822535|7488916|FG001|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
6565987|NCT01822535|7488915|FG000|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
6565988|NCT01822535|7488916|FG001|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
6565989|NCT01822548|7488927|FG000|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
6565990|NCT01822548|7488928|FG001|STARTED|Overall Study||24
6565991|NCT01822548|7488927|FG000|Discontinued Intervention|Overall Study||0
6565992|NCT01822548|7488928|FG001|Discontinued Intervention|Overall Study||5
6565993|NCT01822548|7488927|FG000|COMPLETED|Overall Study||40
6565994|NCT01822548|7488928|FG001|COMPLETED|Overall Study||24
6565995|NCT01822548|7488927|FG000|NOT COMPLETED|Overall Study||0
6565996|NCT01822548|7488928|FG001|NOT COMPLETED|Overall Study||0
6565997|NCT01822561|7488934|FG000|STARTED|Overall Study||15
6565998|NCT01822561|7488934|FG000|COMPLETED|Overall Study||13
6565999|NCT01822561|7488934|FG000|NOT COMPLETED|Overall Study||2
6566000|NCT01822574|7488945|FG000|STARTED|Overall Study||30
6566001|NCT01822574|7488946|FG001|STARTED|Overall Study||30
6566002|NCT01822574|7488947|FG002|STARTED|Overall Study||30
6566003|NCT01822574|7488945|FG000|COMPLETED|Overall Study||30
6566004|NCT01822574|7488946|FG001|COMPLETED|Overall Study||30
6805775|NCT01772004|7737774|FG011|COMPLETED|Dose Expansion Phase||18
6805776|NCT01772004|7737775|FG012|COMPLETED|Dose Expansion Phase||50
6805777|NCT01772004|7737776|FG013|COMPLETED|Dose Expansion Phase||51
6805778|NCT01772004|7737777|FG014|COMPLETED|Dose Expansion Phase||53
6805779|NCT01772004|7737778|FG015|COMPLETED|Dose Expansion Phase||44
6805780|NCT01772004|7737779|FG016|COMPLETED|Dose Expansion Phase||125
6805781|NCT01772004|7737780|FG017|COMPLETED|Dose Expansion Phase||62
6805782|NCT01772004|7737781|FG018|COMPLETED|Dose Expansion Phase||20
6805783|NCT01772004|7737782|FG019|COMPLETED|Dose Expansion Phase||103
6805784|NCT01772004|7737783|FG020|COMPLETED|Dose Expansion Phase||205
6805785|NCT01772004|7737784|FG021|COMPLETED|Dose Expansion Phase||132
6805786|NCT01772004|7737785|FG022|COMPLETED|Dose Expansion Phase||153
6805787|NCT01772004|7737763|FG000|NOT COMPLETED|Dose Expansion Phase||0
6805788|NCT01772004|7737764|FG001|NOT COMPLETED|Dose Expansion Phase||0
6805789|NCT01772004|7737765|FG002|NOT COMPLETED|Dose Expansion Phase||0
6805790|NCT01772004|7737766|FG003|NOT COMPLETED|Dose Expansion Phase||0
6805791|NCT01772004|7737767|FG004|NOT COMPLETED|Dose Expansion Phase||0
6805792|NCT01772004|7737768|FG005|NOT COMPLETED|Dose Expansion Phase||0
6805793|NCT01772004|7737769|FG006|NOT COMPLETED|Dose Expansion Phase||0
6805794|NCT01772004|7737770|FG007|NOT COMPLETED|Dose Expansion Phase||0
6566005|NCT01822574|7488947|FG002|COMPLETED|Overall Study||30
6566006|NCT01822574|7488945|FG000|NOT COMPLETED|Overall Study||0
6566007|NCT01822574|7488946|FG001|NOT COMPLETED|Overall Study||0
6566008|NCT01822574|7488947|FG002|NOT COMPLETED|Overall Study||0
6566009|NCT01822587|7488958|FG000|STARTED|Overall Study||59
6805795|NCT01772004|7737771|FG008|NOT COMPLETED|Dose Expansion Phase||0
6566010|NCT01822587|7488959|FG001|STARTED|Overall Study||60
6566011|NCT01822587|7488960|FG002|STARTED|Overall Study||62
6566012|NCT01822587|7488958|FG000|COMPLETED|Overall Study||43
6566013|NCT01822587|7488959|FG001|COMPLETED|Overall Study||45
6566014|NCT01822587|7488960|FG002|COMPLETED|Overall Study||44
6566015|NCT01822587|7488958|FG000|NOT COMPLETED|Overall Study||16
6566016|NCT01822587|7488959|FG001|NOT COMPLETED|Overall Study||15
6566017|NCT01822587|7488960|FG002|NOT COMPLETED|Overall Study||18
6566018|NCT01822665|7488968|FG000|STARTED|Overall Study||28
6566019|NCT01822665|7488968|FG000|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
6566020|NCT01822665|7488968|FG000|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
6566021|NCT01822665|7488968|FG000|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
6566022|NCT01822665|7488968|FG000|Received Paracetamol Tablet (1000 mg)|Overall Study||28
6566023|NCT01822665|7488968|FG000|COMPLETED|Overall Study||20
6566024|NCT01822665|7488968|FG000|NOT COMPLETED|Overall Study||8
6566025|NCT01822678|7488989|FG000|STARTED|Overall Study||57
6566026|NCT01822678|7488990|FG001|STARTED|Overall Study||64
6566027|NCT01822678|7488991|FG002|STARTED|Overall Study||40
6566028|NCT01822678|7488989|FG000|Treated|Overall Study||57
6566029|NCT01822678|7488990|FG001|Treated|Overall Study||64
6566030|NCT01822678|7488991|FG002|Treated|Overall Study||40
6566031|NCT01822678|7488989|FG000|Safety Population|Overall Study||57
6566032|NCT01822678|7488990|FG001|Safety Population|Overall Study||64
6566033|NCT01822678|7488991|FG002|Safety Population|Overall Study||40
6566034|NCT01822678|7488989|FG000|Intention-to-Treat Population (ITT)|Overall Study||57
6566035|NCT01822678|7488990|FG001|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
6566036|NCT01822678|7488991|FG002|Intention-to-Treat Population (ITT)|Overall Study||40
6566037|NCT01822678|7488989|FG000|Per Protocol Population|Overall Study||45
6566038|NCT01822678|7488990|FG001|Per Protocol Population|Overall Study||52
6805796|NCT01772004|7737772|FG009|NOT COMPLETED|Dose Expansion Phase||0
6805797|NCT01772004|7737773|FG010|NOT COMPLETED|Dose Expansion Phase||0
6805798|NCT01772004|7737774|FG011|NOT COMPLETED|Dose Expansion Phase||0
6805799|NCT01772004|7737775|FG012|NOT COMPLETED|Dose Expansion Phase||0
6805800|NCT01772004|7737776|FG013|NOT COMPLETED|Dose Expansion Phase||0
6805801|NCT01772004|7737777|FG014|NOT COMPLETED|Dose Expansion Phase||0
6805802|NCT01772004|7737778|FG015|NOT COMPLETED|Dose Expansion Phase||0
6805803|NCT01772004|7737779|FG016|NOT COMPLETED|Dose Expansion Phase||0
6805804|NCT01772004|7737780|FG017|NOT COMPLETED|Dose Expansion Phase||0
6805805|NCT01772004|7737781|FG018|NOT COMPLETED|Dose Expansion Phase||0
6805806|NCT01772004|7737782|FG019|NOT COMPLETED|Dose Expansion Phase||0
6805807|NCT01772004|7737783|FG020|NOT COMPLETED|Dose Expansion Phase||0
6805808|NCT01772004|7737784|FG021|NOT COMPLETED|Dose Expansion Phase||0
6805809|NCT01772004|7737785|FG022|NOT COMPLETED|Dose Expansion Phase||0
6805810|NCT01721759|7737880|FG000|STARTED|Overall Study||117
6805811|NCT01721759|7737880|FG000|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
6805812|NCT01721759|7737880|FG000|NOT COMPLETED|Overall Study||102
6805813|NCT01322971|7737886|FG000|STARTED|Overall Study||1
6805814|NCT01322971|7737887|FG001|STARTED|Overall Study||1
6805815|NCT01322971|7737886|FG000|COMPLETED|Overall Study||0
6805816|NCT01322971|7737887|FG001|COMPLETED|Overall Study||0
6805817|NCT01322971|7737886|FG000|NOT COMPLETED|Overall Study||1
6805818|NCT01322971|7737887|FG001|NOT COMPLETED|Overall Study||1
6805819|NCT01285102|7737893|FG000|STARTED|Overall Study||4
6805820|NCT01285102|7737893|FG000|COMPLETED|Overall Study||0
6805821|NCT01285102|7737893|FG000|NOT COMPLETED|Overall Study||4
6805822|NCT00952692|7737897|FG000|STARTED|Overall Study||12
6805823|NCT00952692|7737897|FG000|COMPLETED|Overall Study||12
6805824|NCT00952692|7737897|FG000|NOT COMPLETED|Overall Study||0
6805825|NCT00804713|7737901|FG000|STARTED|Overall Study||1978
6805826|NCT00804713|7737901|FG000|COMPLETED|Overall Study||1978
6805827|NCT00804713|7737901|FG000|NOT COMPLETED|Overall Study||0
6805828|NCT00677560|7737912|FG000|STARTED|Overall Study||20
6805829|NCT00677560|7737913|FG001|STARTED|Overall Study||23
6805830|NCT00677560|7737914|FG002|STARTED|Overall Study||29
6805831|NCT00677560|7737915|FG003|STARTED|Overall Study||20
6805832|NCT00677560|7737916|FG004|STARTED|Overall Study||34
6805833|NCT00677560|7737912|FG000|COMPLETED|Overall Study||5
6805834|NCT00677560|7737913|FG001|COMPLETED|Overall Study||13
6805835|NCT00677560|7737914|FG002|COMPLETED|Overall Study||6
6805836|NCT00677560|7737915|FG003|COMPLETED|Overall Study||3
6805837|NCT00677560|7737916|FG004|COMPLETED|Overall Study||21
6805838|NCT00677560|7737912|FG000|NOT COMPLETED|Overall Study||15
6805839|NCT00677560|7737913|FG001|NOT COMPLETED|Overall Study||10
6805840|NCT00677560|7737914|FG002|NOT COMPLETED|Overall Study||23
6805841|NCT00677560|7737915|FG003|NOT COMPLETED|Overall Study||17
6805842|NCT00677560|7737916|FG004|NOT COMPLETED|Overall Study||13
6805843|NCT00389649|7737941|FG000|STARTED|Overall Study||2
6805844|NCT00389649|7737942|FG001|STARTED|Overall Study||2
6805845|NCT00389649|7737943|FG002|STARTED|Overall Study||3
6805846|NCT00389649|7737944|FG003|STARTED|Overall Study||2
6805847|NCT00389649|7737945|FG004|STARTED|Overall Study||2
6805848|NCT00389649|7737946|FG005|STARTED|Overall Study||2
6805849|NCT00389649|7737941|FG000|COMPLETED|Overall Study||2
6805850|NCT00389649|7737942|FG001|COMPLETED|Overall Study||2
6566039|NCT01822678|7488991|FG002|Per Protocol Population|Overall Study||34
6566040|NCT01822678|7488989|FG000|COMPLETED|Overall Study||45
6566041|NCT01822678|7488990|FG001|COMPLETED|Overall Study||49
6566042|NCT01822678|7488991|FG002|COMPLETED|Overall Study||29
6566043|NCT01822678|7488989|FG000|NOT COMPLETED|Overall Study||12
6566044|NCT01822678|7488990|FG001|NOT COMPLETED|Overall Study||15
6566045|NCT01822678|7488991|FG002|NOT COMPLETED|Overall Study||11
6566046|NCT01822691|7488999|FG000|STARTED|Overall Study||15
6566047|NCT01822691|7488999|FG000|COMPLETED|Overall Study||13
6566048|NCT01822691|7488999|FG000|NOT COMPLETED|Overall Study||2
6566049|NCT01822756|7489008|FG000|STARTED|Overall Study||16
6566050|NCT01822756|7489009|FG001|STARTED|Overall Study||4
6566051|NCT01822756|7489010|FG002|STARTED|Overall Study||10
6566052|NCT01822756|7489011|FG003|STARTED|Overall Study||4
6566053|NCT01822756|7489012|FG004|STARTED|Overall Study||8
6566054|NCT01822756|7489008|FG000|Discontinued From the Study|Overall Study||16
6566055|NCT01822756|7489009|FG001|Discontinued From the Study|Overall Study||4
6566056|NCT01822756|7489010|FG002|Discontinued From the Study|Overall Study||10
6566057|NCT01822756|7489011|FG003|Discontinued From the Study|Overall Study||4
6566058|NCT01822756|7489012|FG004|Discontinued From the Study|Overall Study||7
6566059|NCT01822756|7489008|FG000|COMPLETED|Overall Study||0
6566060|NCT01822756|7489009|FG001|COMPLETED|Overall Study||0
6566061|NCT01822756|7489010|FG002|COMPLETED|Overall Study||0
6566062|NCT01822756|7489011|FG003|COMPLETED|Overall Study||0
6566063|NCT01822756|7489012|FG004|COMPLETED|Overall Study||1
6566064|NCT01822756|7489008|FG000|NOT COMPLETED|Overall Study||16
6566065|NCT01822756|7489009|FG001|NOT COMPLETED|Overall Study||4
6566066|NCT01822756|7489010|FG002|NOT COMPLETED|Overall Study||10
6566067|NCT01822756|7489011|FG003|NOT COMPLETED|Overall Study||4
6805851|NCT00389649|7737943|FG002|COMPLETED|Overall Study||3
6805852|NCT00389649|7737944|FG003|COMPLETED|Overall Study||2
6805853|NCT00389649|7737945|FG004|COMPLETED|Overall Study||2
6805854|NCT00389649|7737946|FG005|COMPLETED|Overall Study||2
6805855|NCT00389649|7737941|FG000|NOT COMPLETED|Overall Study||0
6805856|NCT00389649|7737942|FG001|NOT COMPLETED|Overall Study||0
6805857|NCT00389649|7737943|FG002|NOT COMPLETED|Overall Study||0
6805858|NCT00389649|7737944|FG003|NOT COMPLETED|Overall Study||0
6805859|NCT00389649|7737945|FG004|NOT COMPLETED|Overall Study||0
6805860|NCT00389649|7737946|FG005|NOT COMPLETED|Overall Study||0
6566068|NCT01822756|7489012|FG004|NOT COMPLETED|Overall Study||7
6566069|NCT01822821|7489026|FG000|STARTED|Overall Study||75
6566070|NCT01822821|7489027|FG001|STARTED|Overall Study||75
6566071|NCT01822821|7489026|FG000|COMPLETED|Overall Study||73
6566072|NCT01822821|7489027|FG001|COMPLETED|Overall Study||74
6566073|NCT01822821|7489026|FG000|NOT COMPLETED|Overall Study||2
6566074|NCT01822821|7489027|FG001|NOT COMPLETED|Overall Study||1
6566075|NCT01822886|7489033|FG000|STARTED|Overall Study||20
6566076|NCT01822886|7489033|FG000|COMPLETED|Overall Study||5
6566077|NCT01822886|7489033|FG000|NOT COMPLETED|Overall Study||15
6566078|NCT01822899|7489039|FG000|STARTED|Overall Study||358
6566079|NCT01822899|7489040|FG001|STARTED|Overall Study||358
6566080|NCT01822899|7489039|FG000|COMPLETED|Overall Study||334
6566081|NCT01822899|7489040|FG001|COMPLETED|Overall Study||340
6566082|NCT01822899|7489039|FG000|NOT COMPLETED|Overall Study||24
6566083|NCT01822899|7489040|FG001|NOT COMPLETED|Overall Study||18
6566084|NCT01822925|7489050|FG000|STARTED|Overall Study||32
6566085|NCT01822925|7489051|FG001|STARTED|Overall Study||32
6566086|NCT01822925|7489052|FG002|STARTED|Overall Study||32
6566087|NCT01822925|7489053|FG003|STARTED|Overall Study||32
6566088|NCT01822925|7489050|FG000|COMPLETED|Overall Study||26
6566089|NCT01822925|7489051|FG001|COMPLETED|Overall Study||30
6566090|NCT01822925|7489052|FG002|COMPLETED|Overall Study||29
6566091|NCT01822925|7489053|FG003|COMPLETED|Overall Study||27
6566092|NCT01822925|7489050|FG000|NOT COMPLETED|Overall Study||6
6566093|NCT01822925|7489051|FG001|NOT COMPLETED|Overall Study||2
6566094|NCT01822925|7489052|FG002|NOT COMPLETED|Overall Study||3
6566095|NCT01822925|7489053|FG003|NOT COMPLETED|Overall Study||5
6566096|NCT01823107|7489063|FG000|STARTED|Overall Study||25
6566097|NCT01823107|7489063|FG000|COMPLETED|Overall Study||24
6566098|NCT01823107|7489063|FG000|NOT COMPLETED|Overall Study||1
6566099|NCT01823146|7489069|FG000|STARTED|Overall Study||55
6566100|NCT01823146|7489070|FG001|STARTED|Overall Study||51
6566101|NCT01823146|7489069|FG000|COMPLETED|Overall Study||53
6566102|NCT01823146|7489070|FG001|COMPLETED|Overall Study||49
6566103|NCT01823146|7489069|FG000|NOT COMPLETED|Overall Study||2
6566104|NCT01823146|7489070|FG001|NOT COMPLETED|Overall Study||2
6566105|NCT01823224|7489078|FG000|STARTED|Overall Study||34
6566106|NCT01823224|7489079|FG001|STARTED|Overall Study||33
6566107|NCT01823224|7489078|FG000|COMPLETED|Overall Study||28
6566108|NCT01823224|7489079|FG001|COMPLETED|Overall Study||22
6566109|NCT01823224|7489078|FG000|NOT COMPLETED|Overall Study||6
6566110|NCT01823224|7489079|FG001|NOT COMPLETED|Overall Study||11
6566111|NCT01823289|7489087|FG000|STARTED|Overall Study||71
6566112|NCT01823289|7489087|FG000|COMPLETED|Overall Study||47
6566113|NCT01823289|7489087|FG000|NOT COMPLETED|Overall Study||24
6566114|NCT01823328|7489093|FG000|STARTED|Overall Study||70
6566115|NCT01823328|7489094|FG001|STARTED|Overall Study||73
6566116|NCT01823328|7489093|FG000|COMPLETED|Overall Study||62
6566117|NCT01823328|7489094|FG001|COMPLETED|Overall Study||67
6566118|NCT01823328|7489093|FG000|NOT COMPLETED|Overall Study||8
6566119|NCT01823328|7489094|FG001|NOT COMPLETED|Overall Study||6
6566120|NCT01823341|7489100|FG000|STARTED|Overall Study||97
6566121|NCT01823341|7489100|FG000|COMPLETED|Overall Study||82
6566122|NCT01823341|7489100|FG000|NOT COMPLETED|Overall Study||15
6566123|NCT01823497|7489109|FG000|STARTED|Overall Study||19
6566124|NCT01823497|7489110|FG001|STARTED|Overall Study||17
6566125|NCT01823497|7489109|FG000|COMPLETED|Overall Study||16
6566126|NCT01823497|7489110|FG001|COMPLETED|Overall Study||9
6566127|NCT01823497|7489109|FG000|NOT COMPLETED|Overall Study||3
6566128|NCT01823497|7489110|FG001|NOT COMPLETED|Overall Study||8
6566129|NCT01823510|7489116|FG000|STARTED|Days 1-7||10
6566130|NCT01823510|7489117|FG001|STARTED|Days 1-7||10
6566131|NCT01823510|7489116|FG000|COMPLETED|Days 1-7||10
6566132|NCT01823510|7489117|FG001|COMPLETED|Days 1-7||10
6566133|NCT01823510|7489116|FG000|NOT COMPLETED|Days 1-7||0
6566134|NCT01823510|7489117|FG001|NOT COMPLETED|Days 1-7||0
6566135|NCT01823510|7489116|FG000|STARTED|Days 8-21||10
6566136|NCT01823510|7489117|FG001|STARTED|Days 8-21||10
6566137|NCT01823510|7489116|FG000|COMPLETED|Days 8-21||10
6566138|NCT01823510|7489117|FG001|COMPLETED|Days 8-21||10
6566139|NCT01823510|7489116|FG000|NOT COMPLETED|Days 8-21||0
6566140|NCT01823510|7489117|FG001|NOT COMPLETED|Days 8-21||0
6566141|NCT01823510|7489116|FG000|STARTED|Days 22-28||10
6566142|NCT01823510|7489117|FG001|STARTED|Days 22-28||10
6566143|NCT01823510|7489116|FG000|COMPLETED|Days 22-28||10
6566144|NCT01823510|7489117|FG001|COMPLETED|Days 22-28||10
6566145|NCT01823510|7489116|FG000|NOT COMPLETED|Days 22-28||0
6566146|NCT01823510|7489117|FG001|NOT COMPLETED|Days 22-28||0
6623497|NCT02207907|7550635|FG001|NOT COMPLETED|Overall Study||8
6623498|NCT02207946|7550644|FG000|STARTED|Overall Study||19
6623499|NCT02207946|7550645|FG001|STARTED|Overall Study||11
6623500|NCT02207946|7550644|FG000|COMPLETED|Overall Study||18
6623501|NCT02207946|7550645|FG001|COMPLETED|Overall Study||10
6623502|NCT02207946|7550644|FG000|NOT COMPLETED|Overall Study||1
6623503|NCT02207946|7550645|FG001|NOT COMPLETED|Overall Study||1
6623504|NCT02207972|7550654|FG000|STARTED|Overall Study||22
6623505|NCT02207972|7550655|FG001|STARTED|Overall Study||24
6623506|NCT02207972|7550654|FG000|COMPLETED|Overall Study||22
6623507|NCT02207972|7550655|FG001|COMPLETED|Overall Study||24
6623508|NCT02207972|7550654|FG000|NOT COMPLETED|Overall Study||0
6623509|NCT02207972|7550655|FG001|NOT COMPLETED|Overall Study||0
6623510|NCT02208037|7550665|FG000|STARTED|Overall Study||93
6623511|NCT02208037|7550666|FG001|STARTED|Overall Study||93
6623512|NCT02208037|7550667|FG002|STARTED|Overall Study||93
6623513|NCT02208037|7550665|FG000|COMPLETED|Overall Study||89
6623514|NCT02208037|7550666|FG001|COMPLETED|Overall Study||92
6623515|NCT02208037|7550667|FG002|COMPLETED|Overall Study||92
6623516|NCT02208037|7550665|FG000|NOT COMPLETED|Overall Study||4
6623517|NCT02208037|7550666|FG001|NOT COMPLETED|Overall Study||1
6273018|NCT00098722|7172229|FG004|Treated|Double Blind Phase||0
6273019|NCT00098722|7172230|FG005|Treated|Double Blind Phase||0
6273020|NCT00098722|7172231|FG006|Treated|Double Blind Phase||0
6273021|NCT00098722|7172225|FG000|COMPLETED|Double Blind Phase||0
6566147|NCT01823536|7489129|FG000|STARTED|Overall Study||73
6566148|NCT01823536|7489130|FG001|STARTED|Overall Study||103
6566149|NCT01823536|7489131|FG002|STARTED|Overall Study||120
6566150|NCT01823536|7489132|FG003|STARTED|Overall Study||66
6566151|NCT01823536|7489133|FG004|STARTED|Overall Study||101
6566152|NCT01823536|7489134|FG005|STARTED|Overall Study||2
6566153|NCT01823536|7489129|FG000|COMPLETED|Overall Study||71
6566154|NCT01823536|7489130|FG001|COMPLETED|Overall Study||101
6566155|NCT01823536|7489131|FG002|COMPLETED|Overall Study||119
6566156|NCT01823536|7489132|FG003|COMPLETED|Overall Study||64
6566157|NCT01823536|7489133|FG004|COMPLETED|Overall Study||99
6566158|NCT01823536|7489134|FG005|COMPLETED|Overall Study||2
6566159|NCT01823536|7489129|FG000|NOT COMPLETED|Overall Study||2
6566160|NCT01823536|7489130|FG001|NOT COMPLETED|Overall Study||2
6566161|NCT01823536|7489131|FG002|NOT COMPLETED|Overall Study||1
6566162|NCT01823536|7489132|FG003|NOT COMPLETED|Overall Study||2
6566163|NCT01823536|7489133|FG004|NOT COMPLETED|Overall Study||2
6566164|NCT01823536|7489134|FG005|NOT COMPLETED|Overall Study||0
6566165|NCT01823614|7489153|FG000|STARTED|Overall Study||179
6566166|NCT01823614|7489154|FG001|STARTED|Overall Study||140
6566167|NCT01823614|7489155|FG002|STARTED|Overall Study||176
6566168|NCT01823614|7489156|FG003|STARTED|Overall Study||122
6566169|NCT01823614|7489157|FG004|STARTED|Overall Study||172
6566170|NCT01823614|7489158|FG005|STARTED|Overall Study||154
6566171|NCT01823614|7489153|FG000|COMPLETED|Overall Study||179
6566172|NCT01823614|7489154|FG001|COMPLETED|Overall Study||140
6566173|NCT01823614|7489155|FG002|COMPLETED|Overall Study||176
6566174|NCT01823614|7489156|FG003|COMPLETED|Overall Study||122
6566175|NCT01823614|7489157|FG004|COMPLETED|Overall Study||172
6566176|NCT01823614|7489158|FG005|COMPLETED|Overall Study||154
6566177|NCT01823614|7489153|FG000|NOT COMPLETED|Overall Study||0
6566178|NCT01823614|7489154|FG001|NOT COMPLETED|Overall Study||0
6566179|NCT01823614|7489155|FG002|NOT COMPLETED|Overall Study||0
6566180|NCT01823614|7489156|FG003|NOT COMPLETED|Overall Study||0
6566181|NCT01823614|7489157|FG004|NOT COMPLETED|Overall Study||0
6566182|NCT01823614|7489158|FG005|NOT COMPLETED|Overall Study||0
6566183|NCT01823653|7489178|FG000|STARTED|Overall Study||60
6566184|NCT01823653|7489178|FG000|COMPLETED|Overall Study||60
6566185|NCT01823653|7489178|FG000|NOT COMPLETED|Overall Study||0
6566186|NCT01823679|7489185|FG000|STARTED|Overall Study||2
6566187|NCT01823679|7489185|FG000|COMPLETED|Overall Study||1
6566188|NCT01823679|7489185|FG000|NOT COMPLETED|Overall Study||1
6566189|NCT01823835|7489205|FG000|STARTED|Overall Study||3
6566190|NCT01823835|7489206|FG001|STARTED|Overall Study||4
6566191|NCT01823835|7489207|FG002|STARTED|Overall Study||4
6566192|NCT01823835|7489208|FG003|STARTED|Overall Study||6
6566193|NCT01823835|7489209|FG004|STARTED|Overall Study||6
6566194|NCT01823835|7489210|FG005|STARTED|Overall Study||6
6566195|NCT01823835|7489211|FG006|STARTED|Overall Study||6
6566196|NCT01823835|7489212|FG007|STARTED|Overall Study||3
6566197|NCT01823835|7489213|FG008|STARTED|Overall Study||3
6566198|NCT01823835|7489214|FG009|STARTED|Overall Study||19
6566199|NCT01823835|7489215|FG010|STARTED|Overall Study||10
6566200|NCT01823835|7489216|FG011|STARTED|Overall Study||53
6566201|NCT01823835|7489217|FG012|STARTED|Overall Study||19
6566202|NCT01823835|7489218|FG013|STARTED|Overall Study||4
6566203|NCT01823835|7489219|FG014|STARTED|Overall Study||6
6566204|NCT01823835|7489205|FG000|COMPLETED|Overall Study||0
6566205|NCT01823835|7489206|FG001|COMPLETED|Overall Study||0
6566206|NCT01823835|7489207|FG002|COMPLETED|Overall Study||0
6566207|NCT01823835|7489208|FG003|COMPLETED|Overall Study||0
6566208|NCT01823835|7489209|FG004|COMPLETED|Overall Study||0
6273022|NCT00098722|7172226|FG001|COMPLETED|Double Blind Phase||0
6273023|NCT00098722|7172227|FG002|COMPLETED|Double Blind Phase||0
6273024|NCT00098722|7172228|FG003|COMPLETED|Double Blind Phase||0
6273025|NCT00098722|7172229|FG004|COMPLETED|Double Blind Phase||0
6273026|NCT00098722|7172230|FG005|COMPLETED|Double Blind Phase||0
6566209|NCT01823835|7489210|FG005|COMPLETED|Overall Study||0
6566210|NCT01823835|7489211|FG006|COMPLETED|Overall Study||0
6566211|NCT01823835|7489212|FG007|COMPLETED|Overall Study||0
6566212|NCT01823835|7489213|FG008|COMPLETED|Overall Study||0
6566213|NCT01823835|7489214|FG009|COMPLETED|Overall Study||0
6566214|NCT01823835|7489215|FG010|COMPLETED|Overall Study||0
6566215|NCT01823835|7489216|FG011|COMPLETED|Overall Study||0
6566216|NCT01823835|7489217|FG012|COMPLETED|Overall Study||0
6566217|NCT01823835|7489218|FG013|COMPLETED|Overall Study||0
6566218|NCT01823835|7489219|FG014|COMPLETED|Overall Study||0
6566219|NCT01823835|7489205|FG000|NOT COMPLETED|Overall Study||3
6566220|NCT01823835|7489206|FG001|NOT COMPLETED|Overall Study||4
6566221|NCT01823835|7489207|FG002|NOT COMPLETED|Overall Study||4
6566222|NCT01823835|7489208|FG003|NOT COMPLETED|Overall Study||6
6566223|NCT01823835|7489209|FG004|NOT COMPLETED|Overall Study||6
6566224|NCT01823835|7489210|FG005|NOT COMPLETED|Overall Study||6
6566225|NCT01823835|7489211|FG006|NOT COMPLETED|Overall Study||6
6566226|NCT01823835|7489212|FG007|NOT COMPLETED|Overall Study||3
6566227|NCT01823835|7489213|FG008|NOT COMPLETED|Overall Study||3
6566228|NCT01823835|7489214|FG009|NOT COMPLETED|Overall Study||19
6566229|NCT01823835|7489215|FG010|NOT COMPLETED|Overall Study||10
6566230|NCT01823835|7489216|FG011|NOT COMPLETED|Overall Study||53
6566231|NCT01823835|7489217|FG012|NOT COMPLETED|Overall Study||19
6566232|NCT01823835|7489218|FG013|NOT COMPLETED|Overall Study||4
6566233|NCT01823835|7489219|FG014|NOT COMPLETED|Overall Study||6
6566234|NCT01823861|7489261|FG000|STARTED|4 Month Follow up||249
6566235|NCT01823861|7489262|FG001|STARTED|4 Month Follow up||251
6566236|NCT01823861|7489261|FG000|COMPLETED|4 Month Follow up||211
6566237|NCT01823861|7489262|FG001|COMPLETED|4 Month Follow up||220
6566238|NCT01823861|7489261|FG000|NOT COMPLETED|4 Month Follow up||38
6566239|NCT01823861|7489262|FG001|NOT COMPLETED|4 Month Follow up||31
6566240|NCT01823861|7489261|FG000|STARTED|12 Month Follow up||211
6566241|NCT01823861|7489262|FG001|STARTED|12 Month Follow up||220
6566242|NCT01823861|7489261|FG000|COMPLETED|12 Month Follow up||169
6566243|NCT01823861|7489262|FG001|COMPLETED|12 Month Follow up||159
6566244|NCT01823861|7489261|FG000|NOT COMPLETED|12 Month Follow up||42
6566245|NCT01823861|7489262|FG001|NOT COMPLETED|12 Month Follow up||61
6566246|NCT01823991|7489270|FG000|STARTED|Overall Study||18
6566247|NCT01823991|7489271|FG001|STARTED|Overall Study||18
6566248|NCT01823991|7489270|FG000|COMPLETED|Overall Study||10
6566249|NCT01823991|7489271|FG001|COMPLETED|Overall Study||13
6566250|NCT01823991|7489270|FG000|NOT COMPLETED|Overall Study||8
6566251|NCT01823991|7489271|FG001|NOT COMPLETED|Overall Study||5
6566252|NCT01824082|7489283|FG000|STARTED|Initial Treatment||71
6566253|NCT01824082|7489284|FG001|STARTED|Initial Treatment||73
6566254|NCT01824082|7489283|FG000|COMPLETED|Initial Treatment||71
6566255|NCT01824082|7489284|FG001|COMPLETED|Initial Treatment||73
6566256|NCT01824082|7489283|FG000|NOT COMPLETED|Initial Treatment||0
6566257|NCT01824082|7489284|FG001|NOT COMPLETED|Initial Treatment||0
6566258|NCT01824082|7489283|FG000|STARTED|Optional Crossover Treatment||40
6273027|NCT00098722|7172231|FG006|COMPLETED|Double Blind Phase||0
6273028|NCT00098722|7172225|FG000|NOT COMPLETED|Double Blind Phase||186
6273029|NCT00098722|7172226|FG001|NOT COMPLETED|Double Blind Phase||194
6273030|NCT00098722|7172227|FG002|NOT COMPLETED|Double Blind Phase||94
6273031|NCT00098722|7172228|FG003|NOT COMPLETED|Double Blind Phase||0
6273032|NCT00098722|7172229|FG004|NOT COMPLETED|Double Blind Phase||0
6273033|NCT00098722|7172230|FG005|NOT COMPLETED|Double Blind Phase||0
6273034|NCT00098722|7172231|FG006|NOT COMPLETED|Double Blind Phase||0
6273035|NCT00098722|7172225|FG000|STARTED|Open Label Phase||0
6273036|NCT00098722|7172226|FG001|STARTED|Open Label Phase||0
6273037|NCT00098722|7172227|FG002|STARTED|Open Label Phase||0
6273038|NCT00098722|7172228|FG003|STARTED|Open Label Phase||272
6273039|NCT00098722|7172229|FG004|STARTED|Open Label Phase||50
6273040|NCT00098722|7172230|FG005|STARTED|Open Label Phase||0
6273041|NCT00098722|7172231|FG006|STARTED|Open Label Phase||0
6273042|NCT00098722|7172225|FG000|COMPLETED|Open Label Phase||0
6273043|NCT00098722|7172226|FG001|COMPLETED|Open Label Phase||0
6273044|NCT00098722|7172227|FG002|COMPLETED|Open Label Phase||0
6273045|NCT00098722|7172228|FG003|COMPLETED|Open Label Phase||0
6273046|NCT00098722|7172229|FG004|COMPLETED|Open Label Phase||0
6387888|NCT00817843|7299375|FG000|NOT COMPLETED|Second Period (6 Weeks)||0
6387889|NCT00817843|7299376|FG001|NOT COMPLETED|Second Period (6 Weeks)||1
6387890|NCT00817999|7299383|FG000|STARTED|Grapefruit Juice||15
6273047|NCT00098722|7172230|FG005|COMPLETED|Open Label Phase||0
6273048|NCT00098722|7172231|FG006|COMPLETED|Open Label Phase||0
6273049|NCT00098722|7172225|FG000|NOT COMPLETED|Open Label Phase||0
6273050|NCT00098722|7172226|FG001|NOT COMPLETED|Open Label Phase||0
6273051|NCT00098722|7172227|FG002|NOT COMPLETED|Open Label Phase||0
6566259|NCT01824082|7489284|FG001|STARTED|Optional Crossover Treatment||25
6566260|NCT01824082|7489283|FG000|COMPLETED|Optional Crossover Treatment||40
6566261|NCT01824082|7489284|FG001|COMPLETED|Optional Crossover Treatment||25
6566262|NCT01824082|7489283|FG000|NOT COMPLETED|Optional Crossover Treatment||0
6566263|NCT01824082|7489284|FG001|NOT COMPLETED|Optional Crossover Treatment||0
6566264|NCT01824160|7489294|FG000|STARTED|Overall Study||50
6566265|NCT01824160|7489294|FG000|COMPLETED|Overall Study||50
6566266|NCT01824160|7489294|FG000|NOT COMPLETED|Overall Study||0
6566267|NCT01824290|7489300|FG000|STARTED|Period 1: Double Blind||18
6566268|NCT01824290|7489301|FG001|STARTED|Period 1: Double Blind||17
6566269|NCT01824290|7489302|FG002|STARTED|Period 1: Double Blind||0
6566270|NCT01824290|7489303|FG003|STARTED|Period 1: Double Blind||0
6566271|NCT01824290|7489300|FG000|Received at Least One Dose of Study Drug|Period 1: Double Blind||18
6566272|NCT01824290|7489301|FG001|Received at Least One Dose of Study Drug|Period 1: Double Blind||17
6566273|NCT01824290|7489302|FG002|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
6566274|NCT01824290|7489303|FG003|Received at Least One Dose of Study Drug|Period 1: Double Blind||0
6566275|NCT01824290|7489300|FG000|Received 20 mg|Period 1: Double Blind||0
6566276|NCT01824290|7489301|FG001|Received 20 mg|Period 1: Double Blind||4
6566277|NCT01824290|7489302|FG002|Received 20 mg|Period 1: Double Blind||0
6566278|NCT01824290|7489303|FG003|Received 20 mg|Period 1: Double Blind||0
6566279|NCT01824290|7489300|FG000|Received 40 mg|Period 1: Double Blind||0
6566280|NCT01824290|7489301|FG001|Received 40 mg|Period 1: Double Blind||13
6566281|NCT01824290|7489302|FG002|Received 40 mg|Period 1: Double Blind||0
6566282|NCT01824290|7489303|FG003|Received 40 mg|Period 1: Double Blind||0
6566283|NCT01824290|7489300|FG000|COMPLETED|Period 1: Double Blind||15
6566284|NCT01824290|7489301|FG001|COMPLETED|Period 1: Double Blind||15
6566285|NCT01824290|7489302|FG002|COMPLETED|Period 1: Double Blind||0
6566286|NCT01824290|7489303|FG003|COMPLETED|Period 1: Double Blind||0
6566287|NCT01824290|7489300|FG000|NOT COMPLETED|Period 1: Double Blind||3
6566288|NCT01824290|7489301|FG001|NOT COMPLETED|Period 1: Double Blind||2
6566289|NCT01824290|7489302|FG002|NOT COMPLETED|Period 1: Double Blind||0
6566290|NCT01824290|7489303|FG003|NOT COMPLETED|Period 1: Double Blind||0
6566291|NCT01824290|7489300|FG000|STARTED|Period 2: Open-Label Treatment||0
6566292|NCT01824290|7489301|FG001|STARTED|Period 2: Open-Label Treatment||0
6566293|NCT01824290|7489302|FG002|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
6566294|NCT01824290|7489303|FG003|STARTED|Period 2: Open-Label Treatment|As per the protocol, period 2 eligibility were participants who completed period 1 or experienced clinical worsening (CW) in period 1. 1 participant that had CW in period 1 continued to period 2.|16
6566295|NCT01824290|7489300|FG000|Received 20 mg|Period 2: Open-Label Treatment||0
6566296|NCT01824290|7489301|FG001|Received 20 mg|Period 2: Open-Label Treatment||0
6566297|NCT01824290|7489302|FG002|Received 20 mg|Period 2: Open-Label Treatment||3
6566298|NCT01824290|7489303|FG003|Received 20 mg|Period 2: Open-Label Treatment||3
6273052|NCT00098722|7172228|FG003|NOT COMPLETED|Open Label Phase||272
6273053|NCT00098722|7172229|FG004|NOT COMPLETED|Open Label Phase||50
6273054|NCT00098722|7172230|FG005|NOT COMPLETED|Open Label Phase||0
6387891|NCT00817999|7299384|FG001|STARTED|Grapefruit Juice||17
6387892|NCT00817999|7299383|FG000|COMPLETED|Grapefruit Juice||15
6387893|NCT00817999|7299384|FG001|COMPLETED|Grapefruit Juice||17
6387894|NCT00817999|7299383|FG000|NOT COMPLETED|Grapefruit Juice||0
6387895|NCT00817999|7299384|FG001|NOT COMPLETED|Grapefruit Juice||0
6566299|NCT01824290|7489300|FG000|Received 40 mg|Period 2: Open-Label Treatment||0
6566300|NCT01824290|7489301|FG001|Received 40 mg|Period 2: Open-Label Treatment||0
6566301|NCT01824290|7489302|FG002|Received 40 mg|Period 2: Open-Label Treatment||13
6566302|NCT01824290|7489303|FG003|Received 40 mg|Period 2: Open-Label Treatment||13
6566303|NCT01824290|7489300|FG000|COMPLETED|Period 2: Open-Label Treatment||0
6566304|NCT01824290|7489301|FG001|COMPLETED|Period 2: Open-Label Treatment||0
6566305|NCT01824290|7489302|FG002|COMPLETED|Period 2: Open-Label Treatment||13
6566306|NCT01824290|7489303|FG003|COMPLETED|Period 2: Open-Label Treatment||13
6566307|NCT01824290|7489300|FG000|NOT COMPLETED|Period 2: Open-Label Treatment||0
6566308|NCT01824290|7489301|FG001|NOT COMPLETED|Period 2: Open-Label Treatment||0
6566309|NCT01824290|7489302|FG002|NOT COMPLETED|Period 2: Open-Label Treatment||3
6566310|NCT01824290|7489303|FG003|NOT COMPLETED|Period 2: Open-Label Treatment||3
6566311|NCT01824303|7489317|FG000|STARTED|Randomized Study||16
6566312|NCT01824303|7489318|FG001|STARTED|Randomized Study||14
6566313|NCT01824303|7489317|FG000|COMPLETED|Randomized Study||14
6566314|NCT01824303|7489318|FG001|COMPLETED|Randomized Study||13
6566315|NCT01824303|7489317|FG000|NOT COMPLETED|Randomized Study||2
6566316|NCT01824303|7489318|FG001|NOT COMPLETED|Randomized Study||1
6566317|NCT01824303|7489317|FG000|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
6566318|NCT01824303|7489318|FG001|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
6566319|NCT01824303|7489317|FG000|COMPLETED|Open Label Extension||12
6566320|NCT01824303|7489318|FG001|COMPLETED|Open Label Extension||11
6566321|NCT01824303|7489317|FG000|NOT COMPLETED|Open Label Extension||0
6566322|NCT01824303|7489318|FG001|NOT COMPLETED|Open Label Extension||0
6566323|NCT01824342|7489328|FG000|STARTED|Overall Study||11
6566324|NCT01824342|7489329|FG001|STARTED|Overall Study||7
6566325|NCT01824342|7489328|FG000|COMPLETED|Overall Study||2
6566326|NCT01824342|7489329|FG001|COMPLETED|Overall Study||2
6805861|NCT04644328|7737956|FG000|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to high-intensity treatment. A total of 3,545 ZCTAs (of which 2,702 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
6805862|NCT04644328|7737957|FG001|STARTED|Thanksgiving Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Thanksgiving experiment: 410 counties were assigned to low-intensity treatment. A total of 3,453 ZCTAs (of which 2,549 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
6805863|NCT04644328|7737956|FG000|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
6805864|NCT04644328|7737957|FG001|COMPLETED|Thanksgiving Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
6805865|NCT04644328|7737956|FG000|NOT COMPLETED|Thanksgiving Period||
6805866|NCT04644328|7737957|FG001|NOT COMPLETED|Thanksgiving Period||
6805867|NCT04644328|7737956|FG000|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 386 counties were assigned to high-intensity treatment. A total of 5,077 ZCTAs (of which 3,818 were in high-intensity counties) were treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
6805868|NCT04644328|7737957|FG001|STARTED|Christmas Period|"Two separate, sequential experiments were run within the study using the same counties (with differences in exclusion criteria explained in the pre-assignment details).~Christmas experiment: 381 counties were assigned to low-intensity treatment. A total of 5,102 ZCTAs (of which 3,833 were in low-intensity counties) were not treated.~Counties randomized to intervention, data collected at the population level, actual number of participants unknown."|
6805869|NCT04644328|7737956|FG000|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
6805870|NCT04644328|7737957|FG001|COMPLETED|Christmas Period|Counties randomized to intervention, data collected at the population level, actual number of participants unknown.|
6805871|NCT04644328|7737956|FG000|NOT COMPLETED|Christmas Period||
6805872|NCT04644328|7737957|FG001|NOT COMPLETED|Christmas Period||
6805873|NCT04246554|7737967|FG000|STARTED|Overall Study||26
6805874|NCT04246554|7737968|FG001|STARTED|Overall Study||23
6387896|NCT00817999|7299383|FG000|STARTED|No Grapefruit Juice||15
6566327|NCT01824342|7489328|FG000|NOT COMPLETED|Overall Study||9
6566328|NCT01824342|7489329|FG001|NOT COMPLETED|Overall Study||5
6566329|NCT01824355|7489335|FG000|STARTED|Overall Study||113
6566330|NCT01824355|7489335|FG000|COMPLETED|Overall Study||110
6566331|NCT01824355|7489335|FG000|NOT COMPLETED|Overall Study||3
6805875|NCT04246554|7737967|FG000|COMPLETED|Overall Study||26
6805876|NCT04246554|7737968|FG001|COMPLETED|Overall Study||22
6805877|NCT04246554|7737967|FG000|NOT COMPLETED|Overall Study||0
6805878|NCT04246554|7737968|FG001|NOT COMPLETED|Overall Study||1
6387897|NCT00817999|7299384|FG001|STARTED|No Grapefruit Juice||17
6504138|NCT01447433|7423275|FG000|STARTED|Overall Study||26
6504139|NCT01447433|7423276|FG001|STARTED|Overall Study||27
6504140|NCT01447433|7423275|FG000|COMPLETED|Overall Study||22
6387898|NCT00817999|7299383|FG000|COMPLETED|No Grapefruit Juice||15
6387899|NCT00817999|7299384|FG001|COMPLETED|No Grapefruit Juice||17
6387900|NCT00817999|7299383|FG000|NOT COMPLETED|No Grapefruit Juice||0
6387901|NCT00817999|7299384|FG001|NOT COMPLETED|No Grapefruit Juice||0
6387902|NCT00818116|7299392|FG000|STARTED|Overall Study||34
6387903|NCT00818116|7299392|FG000|COMPLETED|Overall Study||34
6387904|NCT00818116|7299392|FG000|NOT COMPLETED|Overall Study||0
6387905|NCT00818168|7299396|FG000|STARTED|Overall Study||320
6387906|NCT00818168|7299396|FG000|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
6387907|NCT00818168|7299396|FG000|NOT COMPLETED|Overall Study||70
6387908|NCT00818207|7299402|FG000|STARTED|Overall Study||696
6387909|NCT00818207|7299403|FG001|STARTED|Overall Study||684
6387910|NCT00818207|7299402|FG000|COMPLETED|Overall Study||474
6387911|NCT00818207|7299403|FG001|COMPLETED|Overall Study||417
6387912|NCT00818207|7299402|FG000|NOT COMPLETED|Overall Study||222
6387913|NCT00818207|7299403|FG001|NOT COMPLETED|Overall Study||267
6387914|NCT00818246|7299409|FG000|STARTED|Overall Study||40
6387915|NCT00818246|7299409|FG000|COMPLETED|Overall Study|split-face study|35
6387916|NCT00818246|7299409|FG000|NOT COMPLETED|Overall Study||5
6387917|NCT00818259|7299420|FG000|STARTED|Randomization||12
6387918|NCT00818259|7299421|FG001|STARTED|Randomization||11
6387919|NCT00818259|7299422|FG002|STARTED|Randomization||19
6504141|NCT01447433|7423276|FG001|COMPLETED|Overall Study||21
6387920|NCT00818259|7299423|FG003|STARTED|Randomization||20
6273055|NCT00098722|7172231|FG006|NOT COMPLETED|Open Label Phase||0
6273056|NCT00098722|7172225|FG000|STARTED|Observation Phase||0
6273057|NCT00098722|7172226|FG001|STARTED|Observation Phase||0
6273058|NCT00098722|7172227|FG002|STARTED|Observation Phase||0
6273059|NCT00098722|7172228|FG003|STARTED|Observation Phase||0
6273060|NCT00098722|7172229|FG004|STARTED|Observation Phase||0
6273061|NCT00098722|7172230|FG005|STARTED|Observation Phase||205
6273062|NCT00098722|7172231|FG006|STARTED|Observation Phase||65
6273063|NCT00098722|7172225|FG000|COMPLETED|Observation Phase||0
6273064|NCT00098722|7172226|FG001|COMPLETED|Observation Phase||0
6273065|NCT00098722|7172227|FG002|COMPLETED|Observation Phase||0
6273066|NCT00098722|7172228|FG003|COMPLETED|Observation Phase||0
6273067|NCT00098722|7172229|FG004|COMPLETED|Observation Phase||0
6273068|NCT00098722|7172230|FG005|COMPLETED|Observation Phase||160
6273069|NCT00098722|7172231|FG006|COMPLETED|Observation Phase||48
6273070|NCT00098722|7172225|FG000|NOT COMPLETED|Observation Phase||0
6273071|NCT00098722|7172226|FG001|NOT COMPLETED|Observation Phase||0
6273072|NCT00098722|7172227|FG002|NOT COMPLETED|Observation Phase||0
6273073|NCT00098722|7172228|FG003|NOT COMPLETED|Observation Phase||0
6273074|NCT00098722|7172229|FG004|NOT COMPLETED|Observation Phase||0
6273075|NCT00098722|7172230|FG005|NOT COMPLETED|Observation Phase||45
6273076|NCT00098722|7172231|FG006|NOT COMPLETED|Observation Phase||17
6273077|NCT00098748|7172246|FG000|STARTED|Assigned to Study Treatment||63
6273078|NCT00098748|7172247|FG001|STARTED|Assigned to Study Treatment||63
6273079|NCT00098748|7172248|FG002|STARTED|Assigned to Study Treatment||64
6273080|NCT00098748|7172246|FG000|COMPLETED|Assigned to Study Treatment||63
6273081|NCT00098748|7172247|FG001|COMPLETED|Assigned to Study Treatment||61
6805879|NCT03877926|7737978|FG000|STARTED|Overall Study||1103
6805880|NCT03877926|7737979|FG001|STARTED|Overall Study||1103
6805881|NCT03877926|7737980|FG002|STARTED|Overall Study||1098
6805882|NCT03877926|7737981|FG003|STARTED|Overall Study||558
6805883|NCT03877926|7737978|FG000|Received at Least One Study Vaccination|Overall Study||1100
6805884|NCT03877926|7737979|FG001|Received at Least One Study Vaccination|Overall Study||1102
6805885|NCT03877926|7737980|FG002|Received at Least One Study Vaccination|Overall Study||1097
6805886|NCT03877926|7737981|FG003|Received at Least One Study Vaccination|Overall Study||558
6805887|NCT03877926|7737978|FG000|Did Not Receive Any Study Vaccination|Overall Study||3
6805888|NCT03877926|7737979|FG001|Did Not Receive Any Study Vaccination|Overall Study||1
6805889|NCT03877926|7737980|FG002|Did Not Receive Any Study Vaccination|Overall Study||1
6805890|NCT03877926|7737981|FG003|Did Not Receive Any Study Vaccination|Overall Study||0
6805891|NCT03877926|7737978|FG000|COMPLETED|Overall Study||1032
6805892|NCT03877926|7737979|FG001|COMPLETED|Overall Study||1026
6805893|NCT03877926|7737980|FG002|COMPLETED|Overall Study||1035
6805894|NCT03877926|7737981|FG003|COMPLETED|Overall Study||537
6805895|NCT03877926|7737978|FG000|NOT COMPLETED|Overall Study||71
6805896|NCT03877926|7737979|FG001|NOT COMPLETED|Overall Study||77
6805897|NCT03877926|7737980|FG002|NOT COMPLETED|Overall Study||63
6805898|NCT03877926|7737981|FG003|NOT COMPLETED|Overall Study||21
6805899|NCT03862807|7738004|FG000|STARTED|Overall Study||24
6805900|NCT03862807|7738004|FG000|Treated|Overall Study||23
6805901|NCT03862807|7738004|FG000|Completed Treatment|Overall Study||22
6805902|NCT03862807|7738004|FG000|COMPLETED|Overall Study||23
6805903|NCT03862807|7738004|FG000|NOT COMPLETED|Overall Study||1
6805904|NCT03857867|7738008|FG000|STARTED|Overall Study||7
6805905|NCT03857867|7738008|FG000|COMPLETED|Overall Study||6
6805906|NCT03857867|7738008|FG000|NOT COMPLETED|Overall Study||1
6805907|NCT03691571|7738015|FG000|STARTED|Overall Study||31
6805908|NCT03691571|7738016|FG001|STARTED|Overall Study||24
6805909|NCT03691571|7738015|FG000|COMPLETED|Overall Study||22
6805910|NCT03691571|7738016|FG001|COMPLETED|Overall Study||22
6805911|NCT03691571|7738015|FG000|NOT COMPLETED|Overall Study||9
6805912|NCT03691571|7738016|FG001|NOT COMPLETED|Overall Study||2
6805913|NCT03436199|7738026|FG000|STARTED|Overall Study||187
6805914|NCT03436199|7738027|FG001|STARTED|Overall Study||185
6805915|NCT03436199|7738028|FG002|STARTED|Overall Study||186
6805916|NCT03436199|7738026|FG000|COMPLETED|Overall Study||165
6805917|NCT03436199|7738027|FG001|COMPLETED|Overall Study||132
6805918|NCT03436199|7738028|FG002|COMPLETED|Overall Study||174
6805919|NCT03436199|7738026|FG000|NOT COMPLETED|Overall Study||22
6805920|NCT03436199|7738027|FG001|NOT COMPLETED|Overall Study||53
6805921|NCT03436199|7738028|FG002|NOT COMPLETED|Overall Study||12
6805922|NCT03353233|7738038|FG000|STARTED|Overall Study||25
6805923|NCT03353233|7738039|FG001|STARTED|Overall Study||25
6273082|NCT00098748|7172248|FG002|COMPLETED|Assigned to Study Treatment||62
6273083|NCT00098748|7172246|FG000|NOT COMPLETED|Assigned to Study Treatment||0
6273084|NCT00098748|7172247|FG001|NOT COMPLETED|Assigned to Study Treatment||2
6805924|NCT03353233|7738038|FG000|COMPLETED|Overall Study||25
6805925|NCT03353233|7738039|FG001|COMPLETED|Overall Study||25
6805926|NCT03353233|7738038|FG000|NOT COMPLETED|Overall Study||0
6805927|NCT03353233|7738039|FG001|NOT COMPLETED|Overall Study||0
6805928|NCT03250273|7738047|FG000|STARTED|Overall Study||13
6805929|NCT03250273|7738048|FG001|STARTED|Overall Study||30
6805930|NCT03250273|7738047|FG000|COMPLETED|Overall Study||11
6805931|NCT03250273|7738048|FG001|COMPLETED|Overall Study||18
6273085|NCT00098748|7172248|FG002|NOT COMPLETED|Assigned to Study Treatment||2
6273086|NCT00098748|7172246|FG000|STARTED|Received Study Treatment||63
6273087|NCT00098748|7172247|FG001|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
6273088|NCT00098748|7172248|FG002|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
6273089|NCT00098748|7172246|FG000|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
6273090|NCT00098748|7172247|FG001|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
6273091|NCT00098748|7172248|FG002|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
6273092|NCT00098748|7172246|FG000|COMPLETED|Received Study Treatment||15
6273093|NCT00098748|7172247|FG001|COMPLETED|Received Study Treatment||25
6273094|NCT00098748|7172248|FG002|COMPLETED|Received Study Treatment||18
6273095|NCT00098748|7172246|FG000|NOT COMPLETED|Received Study Treatment||48
6273096|NCT00098748|7172247|FG001|NOT COMPLETED|Received Study Treatment||36
6273097|NCT00098748|7172248|FG002|NOT COMPLETED|Received Study Treatment||44
6273098|NCT00098748|7172246|FG000|STARTED|Continued on Open-Label Treatment||15
6273099|NCT00098748|7172247|FG001|STARTED|Continued on Open-Label Treatment||25
6273100|NCT00098748|7172248|FG002|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
6273101|NCT00098748|7172246|FG000|COMPLETED|Continued on Open-Label Treatment||7
6273102|NCT00098748|7172247|FG001|COMPLETED|Continued on Open-Label Treatment||10
6273103|NCT00098748|7172248|FG002|COMPLETED|Continued on Open-Label Treatment||0
6273104|NCT00098748|7172246|FG000|NOT COMPLETED|Continued on Open-Label Treatment||8
6273105|NCT00098748|7172247|FG001|NOT COMPLETED|Continued on Open-Label Treatment||15
6273106|NCT00098748|7172248|FG002|NOT COMPLETED|Continued on Open-Label Treatment||0
6273107|NCT00098774|7172256|FG000|STARTED|Overall Study||44
6273108|NCT00098774|7172256|FG000|COMPLETED|Overall Study||26
6273109|NCT00098774|7172256|FG000|NOT COMPLETED|Overall Study||18
6273110|NCT00098787|7172263|FG000|STARTED|Overall Study||73
6273111|NCT00098787|7172264|FG001|STARTED|Overall Study||75
6273112|NCT00098787|7172265|FG002|STARTED|Overall Study||63
6273113|NCT00098787|7172263|FG000|Treated|Overall Study||70
6273114|NCT00098787|7172264|FG001|Treated|Overall Study||73
6273115|NCT00098787|7172265|FG002|Treated|Overall Study||62
6273116|NCT00098787|7172263|FG000|Eligible and Treated|Overall Study||61
6273117|NCT00098787|7172264|FG001|Eligible and Treated|Overall Study||66
6273118|NCT00098787|7172265|FG002|Eligible and Treated|Overall Study||59
6273119|NCT00098787|7172263|FG000|COMPLETED|Overall Study||0
6805932|NCT03250273|7738047|FG000|NOT COMPLETED|Overall Study||2
6805933|NCT03250273|7738048|FG001|NOT COMPLETED|Overall Study||12
6805934|NCT03217136|7738056|FG000|STARTED|Overall Study||71
6805935|NCT03217136|7738057|FG001|STARTED|Overall Study||23
6805936|NCT03217136|7738056|FG000|Treated|Overall Study||70
6805937|NCT03217136|7738057|FG001|Treated|Overall Study||21
6805938|NCT03217136|7738056|FG000|COMPLETED|Overall Study||67
6805939|NCT03217136|7738057|FG001|COMPLETED|Overall Study||20
6805940|NCT03217136|7738056|FG000|NOT COMPLETED|Overall Study||4
6805941|NCT03217136|7738057|FG001|NOT COMPLETED|Overall Study||3
6805942|NCT03181542|7738065|FG000|STARTED|Overall Study||80
6805943|NCT03181542|7738066|FG001|STARTED|Overall Study||80
6805944|NCT03181542|7738065|FG000|COMPLETED|Overall Study||79
6805945|NCT03181542|7738066|FG001|COMPLETED|Overall Study||80
6805946|NCT03181542|7738065|FG000|NOT COMPLETED|Overall Study||1
6805947|NCT03181542|7738066|FG001|NOT COMPLETED|Overall Study||0
6805948|NCT02983617|7738074|FG000|STARTED|Overall Study||6
6805949|NCT02983617|7738075|FG001|STARTED|Overall Study||30
6805950|NCT02983617|7738074|FG000|COMPLETED|Overall Study||6
6805951|NCT02983617|7738075|FG001|COMPLETED|Overall Study||21
6805952|NCT02983617|7738074|FG000|NOT COMPLETED|Overall Study||0
6805953|NCT02983617|7738075|FG001|NOT COMPLETED|Overall Study||9
6805954|NCT02964377|7738084|FG000|STARTED|Overall Study||5
6805955|NCT02964377|7738085|FG001|STARTED|Overall Study||5
6805956|NCT02964377|7738086|FG002|STARTED|Overall Study||5
6805957|NCT02964377|7738084|FG000|COMPLETED|Overall Study||5
6805958|NCT02964377|7738085|FG001|COMPLETED|Overall Study||5
6805959|NCT02964377|7738086|FG002|COMPLETED|Overall Study||5
6805960|NCT02964377|7738084|FG000|NOT COMPLETED|Overall Study||0
6805961|NCT02964377|7738085|FG001|NOT COMPLETED|Overall Study||0
6805962|NCT02964377|7738086|FG002|NOT COMPLETED|Overall Study||0
6805963|NCT02790034|7738097|FG000|STARTED|Overall Study||33
6805964|NCT02790034|7738098|FG001|STARTED|Overall Study||56
6805965|NCT02790034|7738099|FG002|STARTED|Overall Study||40
6805966|NCT02790034|7738097|FG000|COMPLETED|Overall Study||27
6805967|NCT02790034|7738098|FG001|COMPLETED|Overall Study||46
6805968|NCT02790034|7738099|FG002|COMPLETED|Overall Study||36
6805969|NCT02790034|7738097|FG000|NOT COMPLETED|Overall Study||6
6805970|NCT02790034|7738098|FG001|NOT COMPLETED|Overall Study||10
6805971|NCT02790034|7738099|FG002|NOT COMPLETED|Overall Study||4
6805972|NCT02649946|7738109|FG000|STARTED|Overall Study||142
6805973|NCT02649946|7738110|FG001|STARTED|Overall Study||138
6805974|NCT02649946|7738109|FG000|COMPLETED|Overall Study||130
6805975|NCT02649946|7738110|FG001|COMPLETED|Overall Study||123
6805976|NCT02649946|7738109|FG000|NOT COMPLETED|Overall Study||12
6805977|NCT02649946|7738110|FG001|NOT COMPLETED|Overall Study||15
6805978|NCT02431247|7738118|FG000|STARTED|BL to EOE-Test and BL to Switch- Control||362
6805979|NCT02431247|7738119|FG001|STARTED|BL to EOE-Test and BL to Switch- Control||363
6805980|NCT02431247|7738120|FG002|STARTED|BL to EOE-Test and BL to Switch- Control||0
6805981|NCT02431247|7738118|FG000|COMPLETED|BL to EOE-Test and BL to Switch- Control||296
6805982|NCT02431247|7738119|FG001|COMPLETED|BL to EOE-Test and BL to Switch- Control||322
6805983|NCT02431247|7738120|FG002|COMPLETED|BL to EOE-Test and BL to Switch- Control||0
6805984|NCT02431247|7738118|FG000|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||66
6805985|NCT02431247|7738119|FG001|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||41
6805986|NCT02431247|7738120|FG002|NOT COMPLETED|BL to EOE-Test and BL to Switch- Control||0
6805987|NCT02431247|7738118|FG000|STARTED|Switch to D/C/F/TAF (Until EOE)||0
6805988|NCT02431247|7738119|FG001|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|0
6805989|NCT02431247|7738120|FG002|STARTED|Switch to D/C/F/TAF (Until EOE)|322 participants from DRV/COBI+ FTC/TDF (Control) group switched to D/C/F/TAF (Test) Group|322
6805990|NCT02431247|7738118|FG000|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
6805991|NCT02431247|7738119|FG001|COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
6805992|NCT02431247|7738120|FG002|COMPLETED|Switch to D/C/F/TAF (Until EOE)||289
6805993|NCT02431247|7738118|FG000|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
6805994|NCT02431247|7738119|FG001|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||0
6805995|NCT02431247|7738120|FG002|NOT COMPLETED|Switch to D/C/F/TAF (Until EOE)||33
6805996|NCT02345850|7738135|FG000|STARTED|Overall Study||114
6805997|NCT02345850|7738136|FG001|STARTED|Overall Study||114
6805998|NCT02345850|7738137|FG002|STARTED|Overall Study||118
6805999|NCT02345850|7738135|FG000|COMPLETED|Overall Study||101
6806000|NCT02345850|7738136|FG001|COMPLETED|Overall Study||106
6806001|NCT02345850|7738137|FG002|COMPLETED|Overall Study||112
6806002|NCT02345850|7738135|FG000|NOT COMPLETED|Overall Study||13
6806003|NCT02345850|7738136|FG001|NOT COMPLETED|Overall Study||8
6806004|NCT02345850|7738137|FG002|NOT COMPLETED|Overall Study||6
6806005|NCT02343302|7738147|FG000|STARTED|Overall Study||1
6806006|NCT02343302|7738148|FG001|STARTED|Overall Study||1
6806007|NCT02343302|7738147|FG000|COMPLETED|Overall Study||0
6806008|NCT02343302|7738148|FG001|COMPLETED|Overall Study||0
6806009|NCT02343302|7738147|FG000|NOT COMPLETED|Overall Study||1
6806010|NCT02343302|7738148|FG001|NOT COMPLETED|Overall Study||1
6806011|NCT02281084|7738158|FG000|STARTED|Overall Study||32
6806012|NCT02281084|7738159|FG001|STARTED|Overall Study||22
6806013|NCT02281084|7738160|FG002|STARTED|Overall Study||6
6806014|NCT02281084|7738161|FG003|STARTED|Overall Study||5
6806015|NCT02281084|7738158|FG000|COMPLETED|Overall Study||10
6806016|NCT02281084|7738159|FG001|COMPLETED|Overall Study||4
6806017|NCT02281084|7738160|FG002|COMPLETED|Overall Study||2
6806018|NCT02281084|7738161|FG003|COMPLETED|Overall Study||0
6806019|NCT02281084|7738158|FG000|NOT COMPLETED|Overall Study||22
6806020|NCT02281084|7738159|FG001|NOT COMPLETED|Overall Study||18
6806021|NCT02281084|7738160|FG002|NOT COMPLETED|Overall Study||4
6806022|NCT02281084|7738161|FG003|NOT COMPLETED|Overall Study||5
6806023|NCT02053584|7738171|FG000|STARTED|Overall Study||230
6566332|NCT01824394|7489342|FG000|STARTED|Overall Study||174
6566333|NCT01824394|7489343|FG001|STARTED|Overall Study||169
6566334|NCT01824394|7489344|FG002|STARTED|Overall Study||125
6566335|NCT01824394|7489342|FG000|Intent to Treat Population|Overall Study||151
6566336|NCT01824394|7489343|FG001|Intent to Treat Population|Overall Study||149
6566337|NCT01824394|7489344|FG002|Intent to Treat Population|Overall Study|Calibration Roll-in patients are not included in the ITT|0
6566338|NCT01824394|7489342|FG000|Safety Population|Overall Study||151
6566339|NCT01824394|7489343|FG001|Safety Population|Overall Study||149
6806024|NCT02053584|7738171|FG000|COMPLETED|Overall Study|68 subjects (day one participants) were excluded from the final analysis.|230
6806025|NCT02053584|7738171|FG000|NOT COMPLETED|Overall Study||0
6806026|NCT01962792|7738182|FG000|STARTED|Overall Study||3
6566340|NCT01824394|7489344|FG002|Safety Population|Overall Study|Calibration Roll-in patients are included in the safety population|104
6566341|NCT01824394|7489342|FG000|Per-Protocol Population|Overall Study||150
6566342|NCT01824394|7489343|FG001|Per-Protocol Population|Overall Study||148
6623518|NCT02208037|7550667|FG002|NOT COMPLETED|Overall Study||1
6806027|NCT01962792|7738183|FG001|STARTED|Overall Study||5
6806028|NCT01962792|7738184|FG002|STARTED|Overall Study||17
6806029|NCT01962792|7738185|FG003|STARTED|Overall Study||59
6806030|NCT01962792|7738182|FG000|COMPLETED|Overall Study||3
6806031|NCT01962792|7738183|FG001|COMPLETED|Overall Study||5
6806032|NCT01962792|7738184|FG002|COMPLETED|Overall Study||17
6806033|NCT01962792|7738185|FG003|COMPLETED|Overall Study||59
6806034|NCT01962792|7738182|FG000|NOT COMPLETED|Overall Study||0
6566343|NCT01824394|7489344|FG002|Per-Protocol Population|Overall Study|Calibration Roll-in patients are not included in the per protocol population|0
6566344|NCT01824394|7489342|FG000|COMPLETED|Overall Study||55
6806035|NCT01962792|7738183|FG001|NOT COMPLETED|Overall Study||0
6806036|NCT01962792|7738184|FG002|NOT COMPLETED|Overall Study||0
6806037|NCT01962792|7738185|FG003|NOT COMPLETED|Overall Study||0
6806038|NCT01878500|7738196|FG000|STARTED|Overall Study||47
6806039|NCT01878500|7738196|FG000|COMPLETED|Overall Study||47
6806040|NCT01878500|7738196|FG000|NOT COMPLETED|Overall Study||0
6806041|NCT01464164|7738207|FG000|STARTED|Overall Study||3
6806042|NCT01464164|7738208|FG001|STARTED|Overall Study||4
6806043|NCT01464164|7738209|FG002|STARTED|Overall Study||4
6806044|NCT01464164|7738210|FG003|STARTED|Overall Study||2
6806045|NCT01464164|7738211|FG004|STARTED|Overall Study||3
6806046|NCT01464164|7738212|FG005|STARTED|Overall Study||0
6806047|NCT01464164|7738213|FG006|STARTED|Overall Study||3
6806048|NCT01464164|7738207|FG000|COMPLETED|Overall Study||3
6806049|NCT01464164|7738208|FG001|COMPLETED|Overall Study||3
6806050|NCT01464164|7738209|FG002|COMPLETED|Overall Study||2
6806051|NCT01464164|7738210|FG003|COMPLETED|Overall Study||2
6806052|NCT01464164|7738211|FG004|COMPLETED|Overall Study||3
6806053|NCT01464164|7738212|FG005|COMPLETED|Overall Study||0
6806054|NCT01464164|7738213|FG006|COMPLETED|Overall Study||1
6806055|NCT01464164|7738207|FG000|NOT COMPLETED|Overall Study||0
6806056|NCT01464164|7738208|FG001|NOT COMPLETED|Overall Study||1
6806057|NCT01464164|7738209|FG002|NOT COMPLETED|Overall Study||2
6806058|NCT01464164|7738210|FG003|NOT COMPLETED|Overall Study||0
6387921|NCT00818259|7299424|FG004|STARTED|Randomization||19
6566345|NCT01824394|7489343|FG001|COMPLETED|Overall Study||53
6566346|NCT01824394|7489344|FG002|COMPLETED|Overall Study||51
6566347|NCT01824394|7489342|FG000|NOT COMPLETED|Overall Study||119
6566348|NCT01824394|7489343|FG001|NOT COMPLETED|Overall Study||116
6566349|NCT01824394|7489344|FG002|NOT COMPLETED|Overall Study||74
6566350|NCT01824446|7489352|FG000|STARTED|Overall Study||6
6566351|NCT01824446|7489352|FG000|COMPLETED|Overall Study||6
6566352|NCT01824446|7489352|FG000|NOT COMPLETED|Overall Study||0
6566353|NCT01824472|7489359|FG000|STARTED|Overall Study||17
6566354|NCT01824472|7489360|FG001|STARTED|Overall Study||13
6806059|NCT01464164|7738211|FG004|NOT COMPLETED|Overall Study||0
6806060|NCT01464164|7738212|FG005|NOT COMPLETED|Overall Study||0
6806061|NCT01464164|7738213|FG006|NOT COMPLETED|Overall Study||2
6806062|NCT01318317|7738232|FG000|STARTED|Overall Study||1
6806063|NCT01318317|7738233|FG001|STARTED|Overall Study||4
6806064|NCT01318317|7738234|FG002|STARTED|Overall Study||3
6806065|NCT01318317|7738232|FG000|COMPLETED|Overall Study||1
6806066|NCT01318317|7738233|FG001|COMPLETED|Overall Study||4
6806067|NCT01318317|7738234|FG002|COMPLETED|Overall Study||3
6806068|NCT01318317|7738232|FG000|NOT COMPLETED|Overall Study||0
6806069|NCT01318317|7738233|FG001|NOT COMPLETED|Overall Study||0
6806070|NCT01318317|7738234|FG002|NOT COMPLETED|Overall Study||0
6806071|NCT01111565|7738243|FG000|STARTED|Phase B (Weeks 0 to 8)||137
6806072|NCT01111565|7738244|FG001|STARTED|Phase B (Weeks 0 to 8)||0
6806073|NCT01111565|7738245|FG002|STARTED|Phase B (Weeks 0 to 8)||0
6806074|NCT01111565|7738246|FG003|STARTED|Phase B (Weeks 0 to 8)||0
6806075|NCT01111565|7738247|FG004|STARTED|Phase B (Weeks 0 to 8)||0
6806076|NCT01111565|7738243|FG000|COMPLETED|Phase B (Weeks 0 to 8)||71
6806077|NCT01111565|7738244|FG001|COMPLETED|Phase B (Weeks 0 to 8)||0
6806078|NCT01111565|7738245|FG002|COMPLETED|Phase B (Weeks 0 to 8)||0
6806079|NCT01111565|7738246|FG003|COMPLETED|Phase B (Weeks 0 to 8)||0
6806080|NCT01111565|7738247|FG004|COMPLETED|Phase B (Weeks 0 to 8)||0
6806081|NCT01111565|7738243|FG000|NOT COMPLETED|Phase B (Weeks 0 to 8)||66
6806082|NCT01111565|7738244|FG001|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
6806083|NCT01111565|7738245|FG002|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
6806084|NCT01111565|7738246|FG003|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
6806085|NCT01111565|7738247|FG004|NOT COMPLETED|Phase B (Weeks 0 to 8)||0
6806086|NCT01111565|7738243|FG000|STARTED|Phase B + and Phase C (Weeks 9 to 14)||0
6806087|NCT01111565|7738244|FG001|STARTED|Phase B + and Phase C (Weeks 9 to 14)||26
6806088|NCT01111565|7738245|FG002|STARTED|Phase B + and Phase C (Weeks 9 to 14)||16
6806089|NCT01111565|7738246|FG003|STARTED|Phase B + and Phase C (Weeks 9 to 14)||14
6806090|NCT01111565|7738247|FG004|STARTED|Phase B + and Phase C (Weeks 9 to 14)||15
6806091|NCT01111565|7738243|FG000|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
6806092|NCT01111565|7738244|FG001|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||19
6806093|NCT01111565|7738245|FG002|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
6806094|NCT01111565|7738246|FG003|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||10
6806095|NCT01111565|7738247|FG004|COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||11
6806096|NCT01111565|7738243|FG000|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||0
6806097|NCT01111565|7738244|FG001|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||7
6806098|NCT01111565|7738245|FG002|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||5
6806099|NCT01111565|7738246|FG003|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
6806100|NCT01111565|7738247|FG004|NOT COMPLETED|Phase B + and Phase C (Weeks 9 to 14)||4
6806101|NCT01092117|7738257|FG000|STARTED|Index Procedure to 1 Month||161
6806102|NCT01092117|7738257|FG000|COMPLETED|Index Procedure to 1 Month||160
6806103|NCT01092117|7738257|FG000|NOT COMPLETED|Index Procedure to 1 Month||1
6806104|NCT01092117|7738257|FG000|STARTED|1 Month||160
6806105|NCT01092117|7738257|FG000|COMPLETED|1 Month||157
6806106|NCT01092117|7738257|FG000|NOT COMPLETED|1 Month||3
6806107|NCT01092117|7738257|FG000|STARTED|6 Months||157
6806108|NCT01092117|7738257|FG000|COMPLETED|6 Months||152
6806109|NCT01092117|7738257|FG000|NOT COMPLETED|6 Months||5
6806110|NCT01092117|7738257|FG000|STARTED|12 Month||152
6806111|NCT01092117|7738257|FG000|COMPLETED|12 Month||138
6806112|NCT01092117|7738257|FG000|NOT COMPLETED|12 Month||14
6806113|NCT01092117|7738257|FG000|STARTED|Year 2||138
6806114|NCT01092117|7738257|FG000|COMPLETED|Year 2||128
6806115|NCT01092117|7738257|FG000|NOT COMPLETED|Year 2||10
6566355|NCT01824472|7489361|FG002|STARTED|Overall Study||15
6806116|NCT01092117|7738257|FG000|STARTED|Year 3||128
6806117|NCT01092117|7738257|FG000|COMPLETED|Year 3||109
6806118|NCT01092117|7738257|FG000|NOT COMPLETED|Year 3||19
6806119|NCT01092117|7738257|FG000|STARTED|Year 4||109
6806120|NCT01092117|7738257|FG000|COMPLETED|Year 4||93
6806121|NCT01092117|7738257|FG000|NOT COMPLETED|Year 4||16
6806122|NCT00950989|7738265|FG000|STARTED|Overall Study||63
6806123|NCT00950989|7738266|FG001|STARTED|Overall Study||63
6806124|NCT00950989|7738267|FG002|STARTED|Overall Study||63
6806125|NCT00950989|7738268|FG003|STARTED|Overall Study||63
6806126|NCT00950989|7738265|FG000|COMPLETED|Overall Study||59
6806127|NCT00950989|7738266|FG001|COMPLETED|Overall Study||60
6806128|NCT00950989|7738267|FG002|COMPLETED|Overall Study||60
6806129|NCT00950989|7738268|FG003|COMPLETED|Overall Study||63
6806130|NCT00950989|7738265|FG000|NOT COMPLETED|Overall Study||4
6806131|NCT00950989|7738266|FG001|NOT COMPLETED|Overall Study||3
6806132|NCT00950989|7738267|FG002|NOT COMPLETED|Overall Study||3
6806133|NCT00950989|7738268|FG003|NOT COMPLETED|Overall Study||0
6806134|NCT00489307|7738283|FG000|STARTED|Overall Study||67
6806135|NCT00489307|7738284|FG001|STARTED|Overall Study||65
6806136|NCT00489307|7738283|FG000|COMPLETED|Overall Study||43
6806137|NCT00489307|7738284|FG001|COMPLETED|Overall Study||41
6806138|NCT00489307|7738283|FG000|NOT COMPLETED|Overall Study||24
6806139|NCT00489307|7738284|FG001|NOT COMPLETED|Overall Study||24
6806140|NCT00072410|7738292|FG000|STARTED|Overall Study||3
6806141|NCT00072410|7738293|FG001|STARTED|Overall Study||4
6806142|NCT00072410|7738292|FG000|COMPLETED|Overall Study||3
6806143|NCT00072410|7738293|FG001|COMPLETED|Overall Study||1
6806144|NCT00072410|7738292|FG000|NOT COMPLETED|Overall Study||0
6806145|NCT00072410|7738293|FG001|NOT COMPLETED|Overall Study||3
6806146|NCT05057923|7738299|FG000|STARTED|Overall Study||6
6806147|NCT05057923|7738299|FG000|COMPLETED|Overall Study||6
6806148|NCT05057923|7738299|FG000|NOT COMPLETED|Overall Study||0
6806149|NCT04632706|7738307|FG000|STARTED|Overall Study||6
6806150|NCT04632706|7738308|FG001|STARTED|Overall Study||6
6806151|NCT04632706|7738309|FG002|STARTED|Overall Study||6
6806152|NCT04632706|7738310|FG003|STARTED|Overall Study||6
6806153|NCT04632706|7738307|FG000|COMPLETED|Overall Study||6
6806154|NCT04632706|7738308|FG001|COMPLETED|Overall Study||6
6806155|NCT04632706|7738309|FG002|COMPLETED|Overall Study||5
6806156|NCT04632706|7738310|FG003|COMPLETED|Overall Study||6
6806157|NCT04632706|7738307|FG000|NOT COMPLETED|Overall Study||0
6806158|NCT04632706|7738308|FG001|NOT COMPLETED|Overall Study||0
6806159|NCT04632706|7738309|FG002|NOT COMPLETED|Overall Study||1
6806160|NCT04632706|7738310|FG003|NOT COMPLETED|Overall Study||0
6806231|NCT04151290|7738382|FG000|STARTED|Overall Study||711
6806232|NCT04151290|7738382|FG000|COMPLETED|Overall Study||425
6806233|NCT04151290|7738382|FG000|NOT COMPLETED|Overall Study||286
6806234|NCT04038385|7738388|FG000|STARTED|Overall Study||160
6806235|NCT04038385|7738389|FG001|STARTED|Overall Study||137
6806236|NCT04038385|7738388|FG000|COMPLETED|Overall Study||143
6806237|NCT04038385|7738389|FG001|COMPLETED|Overall Study||130
6806238|NCT04038385|7738388|FG000|NOT COMPLETED|Overall Study||17
6806239|NCT04038385|7738389|FG001|NOT COMPLETED|Overall Study||7
6806240|NCT03978091|7738401|FG000|STARTED|Overall Study||8
6806241|NCT03978091|7738402|FG001|STARTED|Overall Study||8
6806242|NCT03978091|7738403|FG002|STARTED|Overall Study||8
6806243|NCT03978091|7738404|FG003|STARTED|Overall Study||8
6806244|NCT03978091|7738405|FG004|STARTED|Overall Study||8
6806245|NCT03978091|7738406|FG005|STARTED|Overall Study||8
6806246|NCT03978091|7738401|FG000|COMPLETED|Overall Study||8
6806247|NCT03978091|7738402|FG001|COMPLETED|Overall Study||8
6806248|NCT03978091|7738403|FG002|COMPLETED|Overall Study||7
6806249|NCT03978091|7738404|FG003|COMPLETED|Overall Study||7
6806250|NCT03978091|7738405|FG004|COMPLETED|Overall Study||7
6806251|NCT03978091|7738406|FG005|COMPLETED|Overall Study||8
6806252|NCT03978091|7738401|FG000|NOT COMPLETED|Overall Study||0
6806253|NCT03978091|7738402|FG001|NOT COMPLETED|Overall Study||0
6806254|NCT03978091|7738403|FG002|NOT COMPLETED|Overall Study||1
6806255|NCT03978091|7738404|FG003|NOT COMPLETED|Overall Study||1
6806256|NCT03978091|7738405|FG004|NOT COMPLETED|Overall Study||1
6806257|NCT03978091|7738406|FG005|NOT COMPLETED|Overall Study||0
6806258|NCT03923738|7738420|FG000|STARTED|Period 1||24
6806259|NCT03923738|7738420|FG000|COMPLETED|Period 1||22
6806260|NCT03923738|7738420|FG000|NOT COMPLETED|Period 1||2
6806261|NCT03923738|7738420|FG000|STARTED|Period 2||22
6806262|NCT03923738|7738420|FG000|COMPLETED|Period 2||22
6806263|NCT03923738|7738420|FG000|NOT COMPLETED|Period 2||0
6806264|NCT03887117|7738430|FG000|STARTED|Overall Study||25
6806265|NCT03887117|7738431|FG001|STARTED|Overall Study||15
6806266|NCT03887117|7738432|FG002|STARTED|Overall Study||26
6806267|NCT03887117|7738433|FG003|STARTED|Overall Study||27
6806268|NCT03887117|7738430|FG000|COMPLETED|Overall Study||25
6806269|NCT03887117|7738431|FG001|COMPLETED|Overall Study||14
6806270|NCT03887117|7738432|FG002|COMPLETED|Overall Study||25
6806271|NCT03887117|7738433|FG003|COMPLETED|Overall Study||25
6806272|NCT03887117|7738430|FG000|NOT COMPLETED|Overall Study||0
6806273|NCT03887117|7738431|FG001|NOT COMPLETED|Overall Study||1
6806274|NCT03887117|7738432|FG002|NOT COMPLETED|Overall Study||1
6806275|NCT03887117|7738433|FG003|NOT COMPLETED|Overall Study||2
6806276|NCT03858634|7738454|FG000|STARTED|Overall Study||39
6806277|NCT03858634|7738455|FG001|STARTED|Overall Study||19
6806278|NCT03858634|7738454|FG000|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||4
6806279|NCT03858634|7738455|FG001|Participants With Chronic Idiopathic Urticaria (CIU)|Overall Study||2
6806280|NCT03858634|7738454|FG000|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||14
6806281|NCT03858634|7738455|FG001|Participants With Chronic Idiopathic Pruritus (CIP)|Overall Study||9
6806282|NCT03858634|7738454|FG000|Participants With Lichen Planus (LP)|Overall Study||3
6806283|NCT03858634|7738455|FG001|Participants With Lichen Planus (LP)|Overall Study||0
6806284|NCT03858634|7738454|FG000|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||4
6806285|NCT03858634|7738455|FG001|Participants With Lichen Simplex Chronicus (LSC)|Overall Study||1
6806286|NCT03858634|7738454|FG000|Participants With Plaque Psoriasis (PPs)|Overall Study||14
6806287|NCT03858634|7738455|FG001|Participants With Plaque Psoriasis (PPs)|Overall Study||7
6806288|NCT03858634|7738454|FG000|COMPLETED|Overall Study||36
6806289|NCT03858634|7738455|FG001|COMPLETED|Overall Study||17
6806290|NCT03858634|7738454|FG000|NOT COMPLETED|Overall Study||3
6806291|NCT03858634|7738455|FG001|NOT COMPLETED|Overall Study||2
6806292|NCT03819114|7738473|FG000|STARTED|Overall Study||17
6806293|NCT03819114|7738474|FG001|STARTED|Overall Study||36
6806294|NCT03819114|7738475|FG002|STARTED|Overall Study||35
6806295|NCT03819114|7738476|FG003|STARTED|Overall Study||34
6806296|NCT03819114|7738473|FG000|Received LNG Treatment|Overall Study||17
6806297|NCT03819114|7738474|FG001|Received LNG Treatment|Overall Study||36
6806298|NCT03819114|7738475|FG002|Received LNG Treatment|Overall Study||35
6806161|NCT04544358|7738324|FG000|STARTED|Overall Study||12
6806162|NCT04544358|7738325|FG001|STARTED|Overall Study||10
6806163|NCT04544358|7738324|FG000|COMPLETED|Overall Study||12
6806164|NCT04544358|7738325|FG001|COMPLETED|Overall Study||10
6806165|NCT04544358|7738324|FG000|NOT COMPLETED|Overall Study||0
6806166|NCT04544358|7738325|FG001|NOT COMPLETED|Overall Study||0
6806167|NCT04498247|7738340|FG000|STARTED|Overall Study||21
6806168|NCT04498247|7738341|FG001|STARTED|Overall Study||80
6806169|NCT04498247|7738342|FG002|STARTED|Overall Study||4
6806170|NCT04498247|7738343|FG003|STARTED|Overall Study||81
6806171|NCT04498247|7738344|FG004|STARTED|Overall Study||4
6806172|NCT04498247|7738345|FG005|STARTED|Overall Study||20
6806173|NCT04498247|7738346|FG006|STARTED|Overall Study||51
6806174|NCT04498247|7738347|FG007|STARTED|Overall Study||2
6806175|NCT04498247|7738340|FG000|Vaccination 1|Overall Study||20
6806176|NCT04498247|7738341|FG001|Vaccination 1|Overall Study||80
6806177|NCT04498247|7738342|FG002|Vaccination 1|Overall Study||4
6806178|NCT04498247|7738343|FG003|Vaccination 1|Overall Study||81
6806179|NCT04498247|7738344|FG004|Vaccination 1|Overall Study||4
6806180|NCT04498247|7738345|FG005|Vaccination 1|Overall Study||20
6806181|NCT04498247|7738346|FG006|Vaccination 1|Overall Study||51
6806182|NCT04498247|7738347|FG007|Vaccination 1|Overall Study||2
6806183|NCT04498247|7738340|FG000|Vaccination 2|Overall Study||0
6806184|NCT04498247|7738341|FG001|Vaccination 2|Overall Study||0
6806185|NCT04498247|7738342|FG002|Vaccination 2|Overall Study||4
6806186|NCT04498247|7738343|FG003|Vaccination 2|Overall Study||0
6806187|NCT04498247|7738344|FG004|Vaccination 2|Overall Study||4
6806188|NCT04498247|7738345|FG005|Vaccination 2|Overall Study||0
6806189|NCT04498247|7738346|FG006|Vaccination 2|Overall Study||0
6806190|NCT04498247|7738347|FG007|Vaccination 2|Overall Study||2
6806191|NCT04498247|7738340|FG000|COMPLETED|Overall Study||20
6806192|NCT04498247|7738341|FG001|COMPLETED|Overall Study||68
6806193|NCT04498247|7738342|FG002|COMPLETED|Overall Study||4
6806194|NCT04498247|7738343|FG003|COMPLETED|Overall Study||70
6806195|NCT04498247|7738344|FG004|COMPLETED|Overall Study||4
6806196|NCT04498247|7738345|FG005|COMPLETED|Overall Study||20
6806197|NCT04498247|7738346|FG006|COMPLETED|Overall Study||43
6806198|NCT04498247|7738347|FG007|COMPLETED|Overall Study||2
6806199|NCT04498247|7738340|FG000|NOT COMPLETED|Overall Study||1
6806200|NCT04498247|7738341|FG001|NOT COMPLETED|Overall Study||12
6806201|NCT04498247|7738342|FG002|NOT COMPLETED|Overall Study||0
6806202|NCT04498247|7738343|FG003|NOT COMPLETED|Overall Study||11
6806203|NCT04498247|7738344|FG004|NOT COMPLETED|Overall Study||0
6806204|NCT04498247|7738345|FG005|NOT COMPLETED|Overall Study||0
6806205|NCT04498247|7738346|FG006|NOT COMPLETED|Overall Study||8
6806206|NCT04498247|7738347|FG007|NOT COMPLETED|Overall Study||0
6806207|NCT04472650|7738364|FG000|STARTED|Period 1 (Up to 15 Days)||13
6806208|NCT04472650|7738365|FG001|STARTED|Period 1 (Up to 15 Days)||13
6806209|NCT04472650|7738364|FG000|COMPLETED|Period 1 (Up to 15 Days)||13
6806210|NCT04472650|7738365|FG001|COMPLETED|Period 1 (Up to 15 Days)||13
6806211|NCT04472650|7738364|FG000|NOT COMPLETED|Period 1 (Up to 15 Days)||0
6806212|NCT04472650|7738365|FG001|NOT COMPLETED|Period 1 (Up to 15 Days)||0
6806213|NCT04472650|7738364|FG000|STARTED|Washout Period (Minimum 14 Days)||13
6806214|NCT04472650|7738365|FG001|STARTED|Washout Period (Minimum 14 Days)||13
6806215|NCT04472650|7738364|FG000|COMPLETED|Washout Period (Minimum 14 Days)||12
6806216|NCT04472650|7738365|FG001|COMPLETED|Washout Period (Minimum 14 Days)||13
6806217|NCT04472650|7738364|FG000|NOT COMPLETED|Washout Period (Minimum 14 Days)||1
6806218|NCT04472650|7738365|FG001|NOT COMPLETED|Washout Period (Minimum 14 Days)||0
6806219|NCT04472650|7738364|FG000|STARTED|Period 2 (Up to 15 Days)||12
6806220|NCT04472650|7738365|FG001|STARTED|Period 2 (Up to 15 Days)||13
6806221|NCT04472650|7738364|FG000|COMPLETED|Period 2 (Up to 15 Days)||12
6806222|NCT04472650|7738365|FG001|COMPLETED|Period 2 (Up to 15 Days)||13
6806223|NCT04472650|7738364|FG000|NOT COMPLETED|Period 2 (Up to 15 Days)||0
6806224|NCT04472650|7738365|FG001|NOT COMPLETED|Period 2 (Up to 15 Days)||0
6806225|NCT04359797|7738375|FG000|STARTED|Overall Study||243
6806226|NCT04359797|7738376|FG001|STARTED|Overall Study||258
6806227|NCT04359797|7738375|FG000|COMPLETED|Overall Study||243
6806228|NCT04359797|7738376|FG001|COMPLETED|Overall Study||258
6806229|NCT04359797|7738375|FG000|NOT COMPLETED|Overall Study||0
6806230|NCT04359797|7738376|FG001|NOT COMPLETED|Overall Study||0
6806299|NCT03819114|7738476|FG003|Received LNG Treatment|Overall Study||34
6806300|NCT03819114|7738473|FG000|COMPLETED|Overall Study||17
6806301|NCT03819114|7738474|FG001|COMPLETED|Overall Study||35
6806302|NCT03819114|7738475|FG002|COMPLETED|Overall Study||33
6806303|NCT03819114|7738476|FG003|COMPLETED|Overall Study||34
6806304|NCT03819114|7738473|FG000|NOT COMPLETED|Overall Study||0
6806305|NCT03819114|7738474|FG001|NOT COMPLETED|Overall Study||1
6806306|NCT03819114|7738475|FG002|NOT COMPLETED|Overall Study||2
6806307|NCT03819114|7738476|FG003|NOT COMPLETED|Overall Study||0
6806308|NCT03804268|7738490|FG000|STARTED|Overall Study||160
6806309|NCT03804268|7738491|FG001|STARTED|Overall Study||163
6806310|NCT03804268|7738490|FG000|COMPLETED|Overall Study||153
6806311|NCT03804268|7738491|FG001|COMPLETED|Overall Study||161
6806312|NCT03804268|7738490|FG000|NOT COMPLETED|Overall Study||7
6806313|NCT03804268|7738491|FG001|NOT COMPLETED|Overall Study||2
6273120|NCT00098787|7172264|FG001|COMPLETED|Overall Study||0
6387922|NCT00818259|7299425|FG005|STARTED|Randomization||0
6387923|NCT00818259|7299426|FG006|STARTED|Randomization||5
6387924|NCT00818259|7299427|FG007|STARTED|Randomization||0
6387925|NCT00818259|7299428|FG008|STARTED|Randomization||6
6387926|NCT00818259|7299420|FG000|COMPLETED|Randomization||12
6387927|NCT00818259|7299421|FG001|COMPLETED|Randomization||11
6387928|NCT00818259|7299422|FG002|COMPLETED|Randomization||19
6387929|NCT00818259|7299423|FG003|COMPLETED|Randomization||20
6387930|NCT00818259|7299424|FG004|COMPLETED|Randomization||19
6387931|NCT00818259|7299425|FG005|COMPLETED|Randomization||0
6387932|NCT00818259|7299426|FG006|COMPLETED|Randomization||5
6387933|NCT00818259|7299427|FG007|COMPLETED|Randomization||0
6387934|NCT00818259|7299428|FG008|COMPLETED|Randomization||6
6387935|NCT00818259|7299420|FG000|NOT COMPLETED|Randomization||0
6387936|NCT00818259|7299421|FG001|NOT COMPLETED|Randomization||0
6387937|NCT00818259|7299422|FG002|NOT COMPLETED|Randomization||0
6387938|NCT00818259|7299423|FG003|NOT COMPLETED|Randomization||0
6387939|NCT00818259|7299424|FG004|NOT COMPLETED|Randomization||0
6387940|NCT00818259|7299425|FG005|NOT COMPLETED|Randomization||0
6387941|NCT00818259|7299426|FG006|NOT COMPLETED|Randomization||0
6387942|NCT00818259|7299427|FG007|NOT COMPLETED|Randomization||0
6387943|NCT00818259|7299428|FG008|NOT COMPLETED|Randomization||0
6387944|NCT00818259|7299420|FG000|STARTED|Part I|Newly enrolled participants|12
6387945|NCT00818259|7299421|FG001|STARTED|Part I|Newly enrolled participants|11
6387946|NCT00818259|7299422|FG002|STARTED|Part I||0
6387947|NCT00818259|7299423|FG003|STARTED|Part I||0
6387948|NCT00818259|7299424|FG004|STARTED|Part I||0
6387949|NCT00818259|7299425|FG005|STARTED|Part I||0
6387950|NCT00818259|7299426|FG006|STARTED|Part I||0
6387951|NCT00818259|7299427|FG007|STARTED|Part I||0
6387952|NCT00818259|7299428|FG008|STARTED|Part I||0
6387953|NCT00818259|7299420|FG000|COMPLETED|Part I||11
6387954|NCT00818259|7299421|FG001|COMPLETED|Part I||11
6387955|NCT00818259|7299422|FG002|COMPLETED|Part I||0
6387956|NCT00818259|7299423|FG003|COMPLETED|Part I||0
6387957|NCT00818259|7299424|FG004|COMPLETED|Part I||0
6387958|NCT00818259|7299425|FG005|COMPLETED|Part I||0
6387959|NCT00818259|7299426|FG006|COMPLETED|Part I||0
6387960|NCT00818259|7299427|FG007|COMPLETED|Part I||0
6387961|NCT00818259|7299428|FG008|COMPLETED|Part I||0
6387962|NCT00818259|7299420|FG000|NOT COMPLETED|Part I||1
6387963|NCT00818259|7299421|FG001|NOT COMPLETED|Part I||0
6387964|NCT00818259|7299422|FG002|NOT COMPLETED|Part I||0
6387965|NCT00818259|7299423|FG003|NOT COMPLETED|Part I||0
6387966|NCT00818259|7299424|FG004|NOT COMPLETED|Part I||0
6387967|NCT00818259|7299425|FG005|NOT COMPLETED|Part I||0
6387968|NCT00818259|7299426|FG006|NOT COMPLETED|Part I||0
6387969|NCT00818259|7299427|FG007|NOT COMPLETED|Part I||0
6387970|NCT00818259|7299428|FG008|NOT COMPLETED|Part I||0
6387971|NCT00818259|7299420|FG000|STARTED|Part II||0
6387972|NCT00818259|7299421|FG001|STARTED|Part II||0
6387973|NCT00818259|7299422|FG002|STARTED|Part II|Newly enrolled participants|19
6387974|NCT00818259|7299423|FG003|STARTED|Part II|Newly enrolled participants|20
6387975|NCT00818259|7299424|FG004|STARTED|Part II||0
6387976|NCT00818259|7299425|FG005|STARTED|Part II||0
6387977|NCT00818259|7299426|FG006|STARTED|Part II||0
6387978|NCT00818259|7299427|FG007|STARTED|Part II||0
6387979|NCT00818259|7299428|FG008|STARTED|Part II||0
6387980|NCT00818259|7299420|FG000|Treated|Part II||0
6387981|NCT00818259|7299421|FG001|Treated|Part II||0
6387982|NCT00818259|7299422|FG002|Treated|Part II||19
6387983|NCT00818259|7299423|FG003|Treated|Part II||19
6387984|NCT00818259|7299424|FG004|Treated|Part II||0
6387985|NCT00818259|7299425|FG005|Treated|Part II||0
6387986|NCT00818259|7299426|FG006|Treated|Part II||0
6387987|NCT00818259|7299427|FG007|Treated|Part II||0
6387988|NCT00818259|7299428|FG008|Treated|Part II||0
6387989|NCT00818259|7299420|FG000|COMPLETED|Part II||0
6387990|NCT00818259|7299421|FG001|COMPLETED|Part II||0
6387991|NCT00818259|7299422|FG002|COMPLETED|Part II||18
6387992|NCT00818259|7299423|FG003|COMPLETED|Part II||18
6387993|NCT00818259|7299424|FG004|COMPLETED|Part II||0
6387994|NCT00818259|7299425|FG005|COMPLETED|Part II||0
6387995|NCT00818259|7299426|FG006|COMPLETED|Part II||0
6387996|NCT00818259|7299427|FG007|COMPLETED|Part II||0
6387997|NCT00818259|7299428|FG008|COMPLETED|Part II||0
6387998|NCT00818259|7299420|FG000|NOT COMPLETED|Part II||0
6273121|NCT00098787|7172265|FG002|COMPLETED|Overall Study||0
6273122|NCT00098787|7172263|FG000|NOT COMPLETED|Overall Study||73
6273123|NCT00098787|7172264|FG001|NOT COMPLETED|Overall Study||75
6273124|NCT00098787|7172265|FG002|NOT COMPLETED|Overall Study||63
6273125|NCT00098813|7172273|FG000|STARTED|Overall Study||20
6273126|NCT00098813|7172273|FG000|COMPLETED|Overall Study||1
6273127|NCT00098813|7172273|FG000|NOT COMPLETED|Overall Study||19
6273128|NCT00098839|7172279|FG000|STARTED|Overall Study||56
6273129|NCT00098839|7172280|FG001|STARTED|Overall Study||60
6273130|NCT00098839|7172279|FG000|COMPLETED|Overall Study||24
6273131|NCT00098839|7172280|FG001|COMPLETED|Overall Study||27
6273132|NCT00098839|7172279|FG000|NOT COMPLETED|Overall Study||32
6273133|NCT00098839|7172280|FG001|NOT COMPLETED|Overall Study||33
6273134|NCT00098865|7172287|FG000|STARTED|Overall Study||15
6273135|NCT00098865|7172287|FG000|COMPLETED|Overall Study||6
6273136|NCT00098865|7172287|FG000|NOT COMPLETED|Overall Study||9
6273137|NCT00098956|7172291|FG000|STARTED|Overall Study||19
6273138|NCT00098956|7172291|FG000|COMPLETED|Overall Study||19
6273139|NCT00098956|7172291|FG000|NOT COMPLETED|Overall Study||0
6273140|NCT00099021|7172295|FG000|STARTED|Overall Study||21
6273141|NCT00099021|7172295|FG000|COMPLETED|Overall Study||21
6273142|NCT00099021|7172295|FG000|NOT COMPLETED|Overall Study||0
6273143|NCT00099047|7172301|FG000|STARTED|Overall Study||11
6273144|NCT00099047|7172302|FG001|STARTED|Overall Study||12
6273145|NCT00099047|7172301|FG000|COMPLETED|Overall Study||11
6273146|NCT00099047|7172302|FG001|COMPLETED|Overall Study||12
6273147|NCT00099047|7172301|FG000|NOT COMPLETED|Overall Study||0
6273148|NCT00099047|7172302|FG001|NOT COMPLETED|Overall Study||0
6273149|NCT00099268|7172310|FG000|STARTED|Overall Study||374
6273150|NCT00099268|7172311|FG001|STARTED|Overall Study||373
6273151|NCT00099268|7172310|FG000|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
6273152|NCT00099268|7172311|FG001|Intent-to-Treat|Overall Study||372
6273153|NCT00099268|7172310|FG000|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
6273154|NCT00099268|7172311|FG001|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
6273155|NCT00099268|7172310|FG000|NOT COMPLETED|Overall Study||92
6273156|NCT00099268|7172311|FG001|NOT COMPLETED|Overall Study||82
6273157|NCT00099359|7172320|FG000|STARTED|Overall Study||581
6273158|NCT00099359|7172321|FG001|STARTED|Overall Study||580
6273159|NCT00099359|7172322|FG002|STARTED|Overall Study||574
6273160|NCT00099359|7172320|FG000|COMPLETED|Overall Study||527
6273161|NCT00099359|7172321|FG001|COMPLETED|Overall Study||515
6273162|NCT00099359|7172322|FG002|COMPLETED|Overall Study||506
6273163|NCT00099359|7172320|FG000|NOT COMPLETED|Overall Study||54
6273164|NCT00099359|7172321|FG001|NOT COMPLETED|Overall Study||65
6273165|NCT00099359|7172322|FG002|NOT COMPLETED|Overall Study||68
6273166|NCT00099372|7172342|FG000|STARTED|Enrolled in Extended CARE Trial||104
6273167|NCT00099372|7172343|FG001|STARTED|Enrolled in Extended CARE Trial||111
6273168|NCT00099372|7172342|FG000|COMPLETED|Enrolled in Extended CARE Trial||104
6273169|NCT00099372|7172343|FG001|COMPLETED|Enrolled in Extended CARE Trial||111
6273170|NCT00099372|7172342|FG000|NOT COMPLETED|Enrolled in Extended CARE Trial||0
6273171|NCT00099372|7172343|FG001|NOT COMPLETED|Enrolled in Extended CARE Trial||0
6273172|NCT00099372|7172342|FG000|STARTED|Followed up 5 Years After Index Surgery||104
6273173|NCT00099372|7172343|FG001|STARTED|Followed up 5 Years After Index Surgery||111
6273174|NCT00099372|7172342|FG000|COMPLETED|Followed up 5 Years After Index Surgery||89
6273175|NCT00099372|7172343|FG001|COMPLETED|Followed up 5 Years After Index Surgery||92
6273176|NCT00099372|7172342|FG000|NOT COMPLETED|Followed up 5 Years After Index Surgery||15
6273177|NCT00099372|7172343|FG001|NOT COMPLETED|Followed up 5 Years After Index Surgery||19
6273178|NCT00099372|7172342|FG000|STARTED|Followed up 7 Years After Index Surgery||89
6273179|NCT00099372|7172343|FG001|STARTED|Followed up 7 Years After Index Surgery||92
6273180|NCT00099372|7172342|FG000|COMPLETED|Followed up 7 Years After Index Surgery||66
6273181|NCT00099372|7172343|FG001|COMPLETED|Followed up 7 Years After Index Surgery||60
6387999|NCT00818259|7299421|FG001|NOT COMPLETED|Part II||0
6388000|NCT00818259|7299422|FG002|NOT COMPLETED|Part II||1
6388001|NCT00818259|7299423|FG003|NOT COMPLETED|Part II||2
6388002|NCT00818259|7299424|FG004|NOT COMPLETED|Part II||0
6388003|NCT00818259|7299425|FG005|NOT COMPLETED|Part II||0
6388004|NCT00818259|7299426|FG006|NOT COMPLETED|Part II||0
6388005|NCT00818259|7299427|FG007|NOT COMPLETED|Part II||0
6388006|NCT00818259|7299428|FG008|NOT COMPLETED|Part II||0
6388007|NCT00818259|7299420|FG000|STARTED|Part III||0
6388008|NCT00818259|7299421|FG001|STARTED|Part III||0
6388009|NCT00818259|7299422|FG002|STARTED|Part III||0
6388010|NCT00818259|7299423|FG003|STARTED|Part III||0
6388011|NCT00818259|7299424|FG004|STARTED|Part III|Newly enrolled participants|19
6388012|NCT00818259|7299425|FG005|STARTED|Part III||0
6388013|NCT00818259|7299426|FG006|STARTED|Part III||0
6388014|NCT00818259|7299427|FG007|STARTED|Part III||0
6388015|NCT00818259|7299428|FG008|STARTED|Part III||0
6388016|NCT00818259|7299420|FG000|COMPLETED|Part III||0
6388017|NCT00818259|7299421|FG001|COMPLETED|Part III||0
6388018|NCT00818259|7299422|FG002|COMPLETED|Part III||0
6388019|NCT00818259|7299423|FG003|COMPLETED|Part III||0
6388020|NCT00818259|7299424|FG004|COMPLETED|Part III||19
6388021|NCT00818259|7299425|FG005|COMPLETED|Part III||0
6388022|NCT00818259|7299426|FG006|COMPLETED|Part III||0
6388023|NCT00818259|7299427|FG007|COMPLETED|Part III||0
6273182|NCT00099372|7172342|FG000|NOT COMPLETED|Followed up 7 Years After Index Surgery||23
6273183|NCT00099372|7172343|FG001|NOT COMPLETED|Followed up 7 Years After Index Surgery||32
6273184|NCT00099632|7172357|FG000|STARTED|Overall Study||73
6273185|NCT00099632|7172358|FG001|STARTED|Overall Study||68
6273186|NCT00099632|7172359|FG002|STARTED|Overall Study||75
6273187|NCT00099632|7172360|FG003|STARTED|Overall Study||67
6273188|NCT00099632|7172361|FG004|STARTED|Overall Study||71
6273189|NCT00099632|7172362|FG005|STARTED|Overall Study||68
6273190|NCT00099632|7172357|FG000|COMPLETED|Overall Study||72
6273191|NCT00099632|7172358|FG001|COMPLETED|Overall Study||67
6273192|NCT00099632|7172359|FG002|COMPLETED|Overall Study||72
6273193|NCT00099632|7172360|FG003|COMPLETED|Overall Study||66
6273194|NCT00099632|7172361|FG004|COMPLETED|Overall Study||70
6273195|NCT00099632|7172362|FG005|COMPLETED|Overall Study||66
6273196|NCT00099632|7172357|FG000|NOT COMPLETED|Overall Study||1
6273197|NCT00099632|7172358|FG001|NOT COMPLETED|Overall Study||1
6273198|NCT00099632|7172359|FG002|NOT COMPLETED|Overall Study||3
6273199|NCT00099632|7172360|FG003|NOT COMPLETED|Overall Study||1
6273200|NCT00099632|7172361|FG004|NOT COMPLETED|Overall Study||1
6273201|NCT00099632|7172362|FG005|NOT COMPLETED|Overall Study||2
6273202|NCT00099983|7172378|FG000|STARTED|Overall Study||147
6273203|NCT00099983|7172379|FG001|STARTED|Overall Study||149
6273204|NCT00099983|7172378|FG000|COMPLETED|Overall Study||123
6273205|NCT00099983|7172379|FG001|COMPLETED|Overall Study||124
6273206|NCT00099983|7172378|FG000|NOT COMPLETED|Overall Study||24
6273207|NCT00099983|7172379|FG001|NOT COMPLETED|Overall Study||25
6566356|NCT01824472|7489359|FG000|COMPLETED|Overall Study||16
6566357|NCT01824472|7489360|FG001|COMPLETED|Overall Study||6
6566358|NCT01824472|7489361|FG002|COMPLETED|Overall Study||11
6273208|NCT00100048|7172390|FG000|STARTED|Cohort I-Monotherapy Phase 10 Days||7
6273209|NCT00100048|7172391|FG001|STARTED|Cohort I-Monotherapy Phase 10 Days||7
6273210|NCT00100048|7172392|FG002|STARTED|Cohort I-Monotherapy Phase 10 Days||6
6273211|NCT00100048|7172393|FG003|STARTED|Cohort I-Monotherapy Phase 10 Days||8
6273212|NCT00100048|7172394|FG004|STARTED|Cohort I-Monotherapy Phase 10 Days||7
6273213|NCT00100048|7172395|FG005|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
6273214|NCT00100048|7172390|FG000|Treated|Cohort I-Monotherapy Phase 10 Days||7
6273215|NCT00100048|7172391|FG001|Treated|Cohort I-Monotherapy Phase 10 Days||7
6273216|NCT00100048|7172392|FG002|Treated|Cohort I-Monotherapy Phase 10 Days||6
6273217|NCT00100048|7172393|FG003|Treated|Cohort I-Monotherapy Phase 10 Days||8
6273218|NCT00100048|7172394|FG004|Treated|Cohort I-Monotherapy Phase 10 Days||7
6273219|NCT00100048|7172395|FG005|Treated|Cohort I-Monotherapy Phase 10 Days||0
6273220|NCT00100048|7172390|FG000|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
6273221|NCT00100048|7172391|FG001|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
6273222|NCT00100048|7172392|FG002|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
6273223|NCT00100048|7172393|FG003|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
6273224|NCT00100048|7172394|FG004|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
6273225|NCT00100048|7172395|FG005|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6273226|NCT00100048|7172390|FG000|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6273227|NCT00100048|7172391|FG001|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6273228|NCT00100048|7172392|FG002|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6273229|NCT00100048|7172393|FG003|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6273230|NCT00100048|7172394|FG004|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6273231|NCT00100048|7172395|FG005|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
6273232|NCT00100048|7172390|FG000|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
6273233|NCT00100048|7172391|FG001|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
6273234|NCT00100048|7172392|FG002|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
6273235|NCT00100048|7172393|FG003|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
6273236|NCT00100048|7172394|FG004|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
6273237|NCT00100048|7172395|FG005|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
6273238|NCT00100048|7172390|FG000|Treated|Cohort I & II-Combination Therapy Phase||39
6273239|NCT00100048|7172391|FG001|Treated|Cohort I & II-Combination Therapy Phase||40
6388024|NCT00818259|7299428|FG008|COMPLETED|Part III||0
6388025|NCT00818259|7299420|FG000|NOT COMPLETED|Part III||0
6388026|NCT00818259|7299421|FG001|NOT COMPLETED|Part III||0
6388027|NCT00818259|7299422|FG002|NOT COMPLETED|Part III||0
6388028|NCT00818259|7299423|FG003|NOT COMPLETED|Part III||0
6388029|NCT00818259|7299424|FG004|NOT COMPLETED|Part III||0
6388030|NCT00818259|7299425|FG005|NOT COMPLETED|Part III||0
6388031|NCT00818259|7299426|FG006|NOT COMPLETED|Part III||0
6273240|NCT00100048|7172392|FG002|Treated|Cohort I & II-Combination Therapy Phase||41
6273241|NCT00100048|7172393|FG003|Treated|Cohort I & II-Combination Therapy Phase||40
6273242|NCT00100048|7172394|FG004|Treated|Cohort I & II-Combination Therapy Phase||0
6273243|NCT00100048|7172395|FG005|Treated|Cohort I & II-Combination Therapy Phase||38
6273244|NCT00100048|7172390|FG000|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
6273245|NCT00100048|7172391|FG001|Never Treated|Cohort I & II-Combination Therapy Phase||0
6273246|NCT00100048|7172392|FG002|Never Treated|Cohort I & II-Combination Therapy Phase||0
6273247|NCT00100048|7172393|FG003|Never Treated|Cohort I & II-Combination Therapy Phase||0
6273248|NCT00100048|7172394|FG004|Never Treated|Cohort I & II-Combination Therapy Phase||0
6273249|NCT00100048|7172395|FG005|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
6273250|NCT00100048|7172390|FG000|COMPLETED|Cohort I & II-Combination Therapy Phase||27
6273251|NCT00100048|7172391|FG001|COMPLETED|Cohort I & II-Combination Therapy Phase||31
6273252|NCT00100048|7172392|FG002|COMPLETED|Cohort I & II-Combination Therapy Phase||28
6273253|NCT00100048|7172393|FG003|COMPLETED|Cohort I & II-Combination Therapy Phase||30
6273254|NCT00100048|7172394|FG004|COMPLETED|Cohort I & II-Combination Therapy Phase||0
6273255|NCT00100048|7172395|FG005|COMPLETED|Cohort I & II-Combination Therapy Phase||26
6273256|NCT00100048|7172390|FG000|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
6273257|NCT00100048|7172391|FG001|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
6273258|NCT00100048|7172392|FG002|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
6273259|NCT00100048|7172393|FG003|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
6273260|NCT00100048|7172394|FG004|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
6273261|NCT00100048|7172395|FG005|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
6273262|NCT00100165|7172423|FG000|STARTED|Baseline||10
6388032|NCT00818259|7299427|FG007|NOT COMPLETED|Part III||0
6388033|NCT00818259|7299428|FG008|NOT COMPLETED|Part III||0
6388034|NCT00818259|7299420|FG000|STARTED|Part IV||0
6566359|NCT01824472|7489359|FG000|NOT COMPLETED|Overall Study||1
6566360|NCT01824472|7489360|FG001|NOT COMPLETED|Overall Study||7
6566361|NCT01824472|7489361|FG002|NOT COMPLETED|Overall Study||4
6566362|NCT01824498|7489375|FG000|STARTED|1st Intervention (8 Weeks)||5
6388035|NCT00818259|7299421|FG001|STARTED|Part IV||0
6388036|NCT00818259|7299422|FG002|STARTED|Part IV||0
6388037|NCT00818259|7299423|FG003|STARTED|Part IV||0
6388038|NCT00818259|7299424|FG004|STARTED|Part IV||0
6388039|NCT00818259|7299425|FG005|STARTED|Part IV|Participants continuing from Part III|15
6388040|NCT00818259|7299426|FG006|STARTED|Part IV|Newly enrolled participants|5
6388041|NCT00818259|7299427|FG007|STARTED|Part IV||0
6388042|NCT00818259|7299428|FG008|STARTED|Part IV||0
6388043|NCT00818259|7299420|FG000|COMPLETED|Part IV||0
6388044|NCT00818259|7299421|FG001|COMPLETED|Part IV||0
6388045|NCT00818259|7299422|FG002|COMPLETED|Part IV||0
6388046|NCT00818259|7299423|FG003|COMPLETED|Part IV||0
6388047|NCT00818259|7299424|FG004|COMPLETED|Part IV||0
6388048|NCT00818259|7299425|FG005|COMPLETED|Part IV||14
6388049|NCT00818259|7299426|FG006|COMPLETED|Part IV||5
6388050|NCT00818259|7299427|FG007|COMPLETED|Part IV||0
6388051|NCT00818259|7299428|FG008|COMPLETED|Part IV||0
6388052|NCT00818259|7299420|FG000|NOT COMPLETED|Part IV||0
6388053|NCT00818259|7299421|FG001|NOT COMPLETED|Part IV||0
6388054|NCT00818259|7299422|FG002|NOT COMPLETED|Part IV||0
6388055|NCT00818259|7299423|FG003|NOT COMPLETED|Part IV||0
6388056|NCT00818259|7299424|FG004|NOT COMPLETED|Part IV||0
6388057|NCT00818259|7299425|FG005|NOT COMPLETED|Part IV||1
6388058|NCT00818259|7299426|FG006|NOT COMPLETED|Part IV||0
6388059|NCT00818259|7299427|FG007|NOT COMPLETED|Part IV||0
6388060|NCT00818259|7299428|FG008|NOT COMPLETED|Part IV||0
6388061|NCT00818259|7299420|FG000|STARTED|Part V||0
6388062|NCT00818259|7299421|FG001|STARTED|Part V||0
6388063|NCT00818259|7299422|FG002|STARTED|Part V||0
6388064|NCT00818259|7299423|FG003|STARTED|Part V||0
6388065|NCT00818259|7299424|FG004|STARTED|Part V||0
6388066|NCT00818259|7299425|FG005|STARTED|Part V||0
6388067|NCT00818259|7299426|FG006|STARTED|Part V||0
6388068|NCT00818259|7299427|FG007|STARTED|Part V|Participants continuing from Part IV|17
6566363|NCT01824498|7489376|FG001|STARTED|1st Intervention (8 Weeks)||2
6388069|NCT00818259|7299428|FG008|STARTED|Part V|Newly enrolled participants|6
6388070|NCT00818259|7299420|FG000|COMPLETED|Part V||0
6388071|NCT00818259|7299421|FG001|COMPLETED|Part V||0
6388072|NCT00818259|7299422|FG002|COMPLETED|Part V||0
6388073|NCT00818259|7299423|FG003|COMPLETED|Part V||0
6388074|NCT00818259|7299424|FG004|COMPLETED|Part V||0
6388075|NCT00818259|7299425|FG005|COMPLETED|Part V||0
6388076|NCT00818259|7299426|FG006|COMPLETED|Part V||0
6388077|NCT00818259|7299427|FG007|COMPLETED|Part V||16
6388078|NCT00818259|7299428|FG008|COMPLETED|Part V||6
6388079|NCT00818259|7299420|FG000|NOT COMPLETED|Part V||0
6388080|NCT00818259|7299421|FG001|NOT COMPLETED|Part V||0
6388081|NCT00818259|7299422|FG002|NOT COMPLETED|Part V||0
6388082|NCT00818259|7299423|FG003|NOT COMPLETED|Part V||0
6388083|NCT00818259|7299424|FG004|NOT COMPLETED|Part V||0
6388084|NCT00818259|7299425|FG005|NOT COMPLETED|Part V||0
6388085|NCT00818259|7299426|FG006|NOT COMPLETED|Part V||0
6388086|NCT00818259|7299427|FG007|NOT COMPLETED|Part V||1
6388087|NCT00818259|7299428|FG008|NOT COMPLETED|Part V||0
6388088|NCT00818272|7299444|FG000|STARTED|Overall Study||148
6388089|NCT00818272|7299444|FG000|COMPLETED|Overall Study||74
6388090|NCT00818272|7299444|FG000|NOT COMPLETED|Overall Study||74
6388091|NCT00818324|7299448|FG000|STARTED|Overall Study||154
6388092|NCT00818324|7299448|FG000|COMPLETED|Overall Study||127
6388093|NCT00818324|7299448|FG000|NOT COMPLETED|Overall Study||27
6388094|NCT00818337|7299452|FG000|STARTED|Overall Study||36
6388095|NCT00818337|7299452|FG000|COMPLETED|Overall Study||36
6388096|NCT00818337|7299452|FG000|NOT COMPLETED|Overall Study||0
6388097|NCT00818363|7299459|FG000|STARTED|Overall Study||40
6388098|NCT00818363|7299460|FG001|STARTED|Overall Study||20
6388099|NCT00818363|7299459|FG000|COMPLETED|Overall Study||40
6388100|NCT00818363|7299460|FG001|COMPLETED|Overall Study||19
6388101|NCT00818363|7299459|FG000|NOT COMPLETED|Overall Study||0
6388102|NCT00818363|7299460|FG001|NOT COMPLETED|Overall Study||1
6388103|NCT00818389|7299468|FG000|STARTED|Overall Study||40
6388104|NCT00818389|7299469|FG001|STARTED|Overall Study||44
6388105|NCT00818389|7299468|FG000|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
6388106|NCT00818389|7299469|FG001|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
6388107|NCT00818389|7299468|FG000|NOT COMPLETED|Overall Study||4
6388108|NCT00818389|7299469|FG001|NOT COMPLETED|Overall Study||6
6388109|NCT00818441|7299477|FG000|STARTED|Overall Study||89
6566364|NCT01824498|7489377|FG002|STARTED|1st Intervention (8 Weeks)||6
6566365|NCT01824498|7489378|FG003|STARTED|1st Intervention (8 Weeks)||3
6388110|NCT00818441|7299478|FG001|STARTED|Overall Study||30
6388111|NCT00818441|7299477|FG000|COMPLETED|Overall Study||0
6388112|NCT00818441|7299478|FG001|COMPLETED|Overall Study||0
6388113|NCT00818441|7299477|FG000|NOT COMPLETED|Overall Study||89
6388114|NCT00818441|7299478|FG001|NOT COMPLETED|Overall Study||30
6388115|NCT00818454|7299485|FG000|STARTED|Treatment Period 1||115
6388116|NCT00818454|7299486|FG001|STARTED|Treatment Period 1||111
6388117|NCT00818454|7299487|FG002|STARTED|Treatment Period 1||0
6388118|NCT00818454|7299488|FG003|STARTED|Treatment Period 1||0
6388119|NCT00818454|7299485|FG000|COMPLETED|Treatment Period 1||112
6388120|NCT00818454|7299486|FG001|COMPLETED|Treatment Period 1||110
6388121|NCT00818454|7299487|FG002|COMPLETED|Treatment Period 1||0
6388122|NCT00818454|7299488|FG003|COMPLETED|Treatment Period 1||0
6388123|NCT00818454|7299485|FG000|NOT COMPLETED|Treatment Period 1||3
6388124|NCT00818454|7299486|FG001|NOT COMPLETED|Treatment Period 1||1
6388125|NCT00818454|7299487|FG002|NOT COMPLETED|Treatment Period 1||0
6388126|NCT00818454|7299488|FG003|NOT COMPLETED|Treatment Period 1||0
6388127|NCT00818454|7299485|FG000|STARTED|Washout Period of 1 Week||112
6566366|NCT01824498|7489379|FG004|STARTED|1st Intervention (8 Weeks)||4
6566367|NCT01824498|7489380|FG005|STARTED|1st Intervention (8 Weeks)||4
6566368|NCT01824498|7489375|FG000|COMPLETED|1st Intervention (8 Weeks)||5
6566369|NCT01824498|7489376|FG001|COMPLETED|1st Intervention (8 Weeks)||2
6566370|NCT01824498|7489377|FG002|COMPLETED|1st Intervention (8 Weeks)||6
6388128|NCT00818454|7299486|FG001|STARTED|Washout Period of 1 Week||110
6388129|NCT00818454|7299487|FG002|STARTED|Washout Period of 1 Week||0
6388130|NCT00818454|7299488|FG003|STARTED|Washout Period of 1 Week||0
6388131|NCT00818454|7299485|FG000|COMPLETED|Washout Period of 1 Week||108
6388132|NCT00818454|7299486|FG001|COMPLETED|Washout Period of 1 Week||107
6388133|NCT00818454|7299487|FG002|COMPLETED|Washout Period of 1 Week||0
6388134|NCT00818454|7299488|FG003|COMPLETED|Washout Period of 1 Week||0
6388135|NCT00818454|7299485|FG000|NOT COMPLETED|Washout Period of 1 Week||4
6388136|NCT00818454|7299486|FG001|NOT COMPLETED|Washout Period of 1 Week||3
6388137|NCT00818454|7299487|FG002|NOT COMPLETED|Washout Period of 1 Week||0
6388138|NCT00818454|7299488|FG003|NOT COMPLETED|Washout Period of 1 Week||0
6388139|NCT00818454|7299485|FG000|STARTED|Treatment Period 2||108
6388140|NCT00818454|7299486|FG001|STARTED|Treatment Period 2||107
6388141|NCT00818454|7299487|FG002|STARTED|Treatment Period 2||0
6388142|NCT00818454|7299488|FG003|STARTED|Treatment Period 2||0
6388143|NCT00818454|7299485|FG000|COMPLETED|Treatment Period 2||106
6388144|NCT00818454|7299486|FG001|COMPLETED|Treatment Period 2||106
6388145|NCT00818454|7299487|FG002|COMPLETED|Treatment Period 2||0
6388146|NCT00818454|7299488|FG003|COMPLETED|Treatment Period 2||0
6388147|NCT00818454|7299485|FG000|NOT COMPLETED|Treatment Period 2||2
6388148|NCT00818454|7299486|FG001|NOT COMPLETED|Treatment Period 2||1
6388149|NCT00818454|7299487|FG002|NOT COMPLETED|Treatment Period 2||0
6388150|NCT00818454|7299488|FG003|NOT COMPLETED|Treatment Period 2||0
6388151|NCT00818454|7299485|FG000|STARTED|Treatment Period 3||0
6388152|NCT00818454|7299486|FG001|STARTED|Treatment Period 3||0
6388153|NCT00818454|7299487|FG002|STARTED|Treatment Period 3||26
6388154|NCT00818454|7299488|FG003|STARTED|Treatment Period 3||139
6388155|NCT00818454|7299485|FG000|COMPLETED|Treatment Period 3||0
6388156|NCT00818454|7299486|FG001|COMPLETED|Treatment Period 3||0
6388157|NCT00818454|7299487|FG002|COMPLETED|Treatment Period 3||26
6388158|NCT00818454|7299488|FG003|COMPLETED|Treatment Period 3||138
6388159|NCT00818454|7299485|FG000|NOT COMPLETED|Treatment Period 3||0
6388160|NCT00818454|7299486|FG001|NOT COMPLETED|Treatment Period 3||0
6388161|NCT00818454|7299487|FG002|NOT COMPLETED|Treatment Period 3||0
6388162|NCT00818454|7299488|FG003|NOT COMPLETED|Treatment Period 3||1
6388163|NCT00818519|7299500|FG000|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
6388164|NCT00818519|7299501|FG001|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
6388165|NCT00818519|7299500|FG000|Participants Received Treatment|Overall Study|= Baseline|87
6388166|NCT00818519|7299501|FG001|Participants Received Treatment|Overall Study|= Baseline|86
6388167|NCT00818519|7299500|FG000|COMPLETED|Overall Study||75
6388168|NCT00818519|7299501|FG001|COMPLETED|Overall Study||71
6388169|NCT00818519|7299500|FG000|NOT COMPLETED|Overall Study||14
6388170|NCT00818519|7299501|FG001|NOT COMPLETED|Overall Study||19
6388171|NCT00818623|7299515|FG000|STARTED|Overall Study||26
6388172|NCT00818623|7299516|FG001|STARTED|Overall Study||12
6388173|NCT00818623|7299517|FG002|STARTED|Overall Study||13
6388174|NCT00818623|7299518|FG003|STARTED|Overall Study||24
6388175|NCT00818623|7299519|FG004|STARTED|Overall Study||27
6388176|NCT00818623|7299520|FG005|STARTED|Overall Study||24
6388177|NCT00818623|7299521|FG006|STARTED|Overall Study||27
6388178|NCT00818623|7299522|FG007|STARTED|Overall Study||27
6388179|NCT00818623|7299515|FG000|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
6388180|NCT00818623|7299516|FG001|Intent-to-treat (ITT) Population|Overall Study||12
6388181|NCT00818623|7299517|FG002|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
6388182|NCT00818623|7299518|FG003|Intent-to-treat (ITT) Population|Overall Study||24
6388183|NCT00818623|7299519|FG004|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
6388184|NCT00818623|7299520|FG005|Intent-to-treat (ITT) Population|Overall Study||24
6388185|NCT00818623|7299521|FG006|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
6388186|NCT00818623|7299522|FG007|Intent-to-treat (ITT) Population|Overall Study||27
6388187|NCT00818623|7299515|FG000|COMPLETED|Overall Study||24
6388188|NCT00818623|7299516|FG001|COMPLETED|Overall Study||8
6388189|NCT00818623|7299517|FG002|COMPLETED|Overall Study||9
6388190|NCT00818623|7299518|FG003|COMPLETED|Overall Study||19
6388191|NCT00818623|7299519|FG004|COMPLETED|Overall Study||23
6388192|NCT00818623|7299520|FG005|COMPLETED|Overall Study||21
6388193|NCT00818623|7299521|FG006|COMPLETED|Overall Study||23
6388194|NCT00818623|7299522|FG007|COMPLETED|Overall Study||26
6388195|NCT00818623|7299515|FG000|NOT COMPLETED|Overall Study||2
6388196|NCT00818623|7299516|FG001|NOT COMPLETED|Overall Study||4
6388197|NCT00818623|7299517|FG002|NOT COMPLETED|Overall Study||4
6388198|NCT00818623|7299518|FG003|NOT COMPLETED|Overall Study||5
6388199|NCT00818623|7299519|FG004|NOT COMPLETED|Overall Study||4
6388200|NCT00818623|7299520|FG005|NOT COMPLETED|Overall Study||3
6388201|NCT00818623|7299521|FG006|NOT COMPLETED|Overall Study||4
6388202|NCT00818623|7299522|FG007|NOT COMPLETED|Overall Study||1
6388203|NCT00818649|7299540|FG000|STARTED|Overall Study||16
6388204|NCT00818649|7299540|FG000|COMPLETED|Overall Study||12
6388205|NCT00818649|7299540|FG000|NOT COMPLETED|Overall Study||4
6388206|NCT00818662|7299549|FG000|STARTED|Overall Study||127
6388207|NCT00818662|7299550|FG001|STARTED|Overall Study||135
6388208|NCT00818662|7299551|FG002|STARTED|Overall Study||58
6566371|NCT01824498|7489378|FG003|COMPLETED|1st Intervention (8 Weeks)||3
6566372|NCT01824498|7489379|FG004|COMPLETED|1st Intervention (8 Weeks)||4
6566373|NCT01824498|7489380|FG005|COMPLETED|1st Intervention (8 Weeks)||4
6566374|NCT01824498|7489375|FG000|NOT COMPLETED|1st Intervention (8 Weeks)||0
6566375|NCT01824498|7489376|FG001|NOT COMPLETED|1st Intervention (8 Weeks)||0
6566376|NCT01824498|7489377|FG002|NOT COMPLETED|1st Intervention (8 Weeks)||0
6566377|NCT01824498|7489378|FG003|NOT COMPLETED|1st Intervention (8 Weeks)||0
6566378|NCT01824498|7489379|FG004|NOT COMPLETED|1st Intervention (8 Weeks)||0
6566379|NCT01824498|7489380|FG005|NOT COMPLETED|1st Intervention (8 Weeks)||0
6566380|NCT01824498|7489375|FG000|STARTED|Washout (8 Weeks)|2 dropped out|5
6566381|NCT01824498|7489376|FG001|STARTED|Washout (8 Weeks)||2
6566382|NCT01824498|7489377|FG002|STARTED|Washout (8 Weeks)|2 dropped out|6
6566383|NCT01824498|7489378|FG003|STARTED|Washout (8 Weeks)|1 dropped out|3
6566384|NCT01824498|7489379|FG004|STARTED|Washout (8 Weeks)|1 dropped out|4
6566385|NCT01824498|7489380|FG005|STARTED|Washout (8 Weeks)||4
6566386|NCT01824498|7489375|FG000|COMPLETED|Washout (8 Weeks)||3
6566387|NCT01824498|7489376|FG001|COMPLETED|Washout (8 Weeks)||2
6566388|NCT01824498|7489377|FG002|COMPLETED|Washout (8 Weeks)||4
6566389|NCT01824498|7489378|FG003|COMPLETED|Washout (8 Weeks)||2
6566390|NCT01824498|7489379|FG004|COMPLETED|Washout (8 Weeks)||3
6566391|NCT01824498|7489380|FG005|COMPLETED|Washout (8 Weeks)||4
6566392|NCT01824498|7489375|FG000|NOT COMPLETED|Washout (8 Weeks)||2
6273263|NCT00100165|7172424|FG001|STARTED|Baseline||10
6273264|NCT00100165|7172425|FG002|STARTED|Baseline||9
6273265|NCT00100165|7172423|FG000|COMPLETED|Baseline||10
6566393|NCT01824498|7489376|FG001|NOT COMPLETED|Washout (8 Weeks)||0
6566394|NCT01824498|7489377|FG002|NOT COMPLETED|Washout (8 Weeks)||2
6566395|NCT01824498|7489378|FG003|NOT COMPLETED|Washout (8 Weeks)||1
6273266|NCT00100165|7172424|FG001|COMPLETED|Baseline||10
6273267|NCT00100165|7172425|FG002|COMPLETED|Baseline||9
6273268|NCT00100165|7172423|FG000|NOT COMPLETED|Baseline||0
6273269|NCT00100165|7172424|FG001|NOT COMPLETED|Baseline||0
6273270|NCT00100165|7172425|FG002|NOT COMPLETED|Baseline||0
6273271|NCT00100165|7172423|FG000|STARTED|First Intervention (4 Weeks)||10
6273272|NCT00100165|7172424|FG001|STARTED|First Intervention (4 Weeks)||10
6273273|NCT00100165|7172425|FG002|STARTED|First Intervention (4 Weeks)||9
6273274|NCT00100165|7172423|FG000|COMPLETED|First Intervention (4 Weeks)||10
6273275|NCT00100165|7172424|FG001|COMPLETED|First Intervention (4 Weeks)||10
6273276|NCT00100165|7172425|FG002|COMPLETED|First Intervention (4 Weeks)||9
6273277|NCT00100165|7172423|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6273278|NCT00100165|7172424|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6273279|NCT00100165|7172425|FG002|NOT COMPLETED|First Intervention (4 Weeks)||0
6273280|NCT00100165|7172423|FG000|STARTED|Washout (1 Week)||10
6273281|NCT00100165|7172424|FG001|STARTED|Washout (1 Week)||10
6273282|NCT00100165|7172425|FG002|STARTED|Washout (1 Week)||9
6273283|NCT00100165|7172423|FG000|COMPLETED|Washout (1 Week)||10
6273284|NCT00100165|7172424|FG001|COMPLETED|Washout (1 Week)||10
6273285|NCT00100165|7172425|FG002|COMPLETED|Washout (1 Week)||9
6273286|NCT00100165|7172423|FG000|NOT COMPLETED|Washout (1 Week)||0
6273287|NCT00100165|7172424|FG001|NOT COMPLETED|Washout (1 Week)||0
6273288|NCT00100165|7172425|FG002|NOT COMPLETED|Washout (1 Week)||0
6273289|NCT00100165|7172423|FG000|STARTED|Second Intervention (4 Weeks)||10
6273290|NCT00100165|7172424|FG001|STARTED|Second Intervention (4 Weeks)||10
6273291|NCT00100165|7172425|FG002|STARTED|Second Intervention (4 Weeks)||9
6273292|NCT00100165|7172423|FG000|COMPLETED|Second Intervention (4 Weeks)||10
6273293|NCT00100165|7172424|FG001|COMPLETED|Second Intervention (4 Weeks)||10
6273294|NCT00100165|7172425|FG002|COMPLETED|Second Intervention (4 Weeks)||9
6273295|NCT00100165|7172423|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6273296|NCT00100165|7172424|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
6273297|NCT00100165|7172425|FG002|NOT COMPLETED|Second Intervention (4 Weeks)||0
6273298|NCT00100165|7172423|FG000|STARTED|Washout (1 Week)||10
6273299|NCT00100165|7172424|FG001|STARTED|Washout (1 Week)||10
6273300|NCT00100165|7172425|FG002|STARTED|Washout (1 Week)||9
6273301|NCT00100165|7172423|FG000|COMPLETED|Washout (1 Week)||10
6273302|NCT00100165|7172424|FG001|COMPLETED|Washout (1 Week)||10
6273303|NCT00100165|7172425|FG002|COMPLETED|Washout (1 Week)||9
6273304|NCT00100165|7172423|FG000|NOT COMPLETED|Washout (1 Week)||0
6273305|NCT00100165|7172424|FG001|NOT COMPLETED|Washout (1 Week)||0
6273306|NCT00100165|7172425|FG002|NOT COMPLETED|Washout (1 Week)||0
6273307|NCT00100165|7172423|FG000|STARTED|Third Intervention (4 Weeks)||10
6273308|NCT00100165|7172424|FG001|STARTED|Third Intervention (4 Weeks)||10
6273309|NCT00100165|7172425|FG002|STARTED|Third Intervention (4 Weeks)||9
6273310|NCT00100165|7172423|FG000|COMPLETED|Third Intervention (4 Weeks)||10
6273311|NCT00100165|7172424|FG001|COMPLETED|Third Intervention (4 Weeks)||10
6273312|NCT00100165|7172425|FG002|COMPLETED|Third Intervention (4 Weeks)||9
6273313|NCT00100165|7172423|FG000|NOT COMPLETED|Third Intervention (4 Weeks)||0
6273314|NCT00100165|7172424|FG001|NOT COMPLETED|Third Intervention (4 Weeks)||0
6273315|NCT00100165|7172425|FG002|NOT COMPLETED|Third Intervention (4 Weeks)||0
6273316|NCT00100178|7172439|FG000|STARTED|Overall Study||41
6273317|NCT00100178|7172440|FG001|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
6273318|NCT00100178|7172441|FG002|STARTED|Overall Study||42
6273319|NCT00100178|7172439|FG000|COMPLETED|Overall Study||32
6273320|NCT00100178|7172440|FG001|COMPLETED|Overall Study||21
6273321|NCT00100178|7172441|FG002|COMPLETED|Overall Study||32
6273322|NCT00100178|7172439|FG000|NOT COMPLETED|Overall Study||9
6273323|NCT00100178|7172440|FG001|NOT COMPLETED|Overall Study||10
6273324|NCT00100178|7172441|FG002|NOT COMPLETED|Overall Study||10
6273325|NCT00100230|7172451|FG000|STARTED|Overall Study||41
6273326|NCT00100230|7172452|FG001|STARTED|Overall Study||37
6273327|NCT00100230|7172451|FG000|COMPLETED|Overall Study||29
6273328|NCT00100230|7172452|FG001|COMPLETED|Overall Study||22
6273329|NCT00100230|7172451|FG000|NOT COMPLETED|Overall Study||12
6273330|NCT00100230|7172452|FG001|NOT COMPLETED|Overall Study||15
6273331|NCT00100659|7172462|FG000|STARTED|Overall Study||55
6566396|NCT01824498|7489379|FG004|NOT COMPLETED|Washout (8 Weeks)||1
6566397|NCT01824498|7489380|FG005|NOT COMPLETED|Washout (8 Weeks)||0
6566398|NCT01824498|7489375|FG000|STARTED|2nd Intervention (8 Weeks)||3
6566399|NCT01824498|7489376|FG001|STARTED|2nd Intervention (8 Weeks)||2
6566400|NCT01824498|7489377|FG002|STARTED|2nd Intervention (8 Weeks)||4
6566401|NCT01824498|7489378|FG003|STARTED|2nd Intervention (8 Weeks)||2
6566402|NCT01824498|7489379|FG004|STARTED|2nd Intervention (8 Weeks)||3
6566403|NCT01824498|7489380|FG005|STARTED|2nd Intervention (8 Weeks)||4
6566404|NCT01824498|7489375|FG000|COMPLETED|2nd Intervention (8 Weeks)||3
6566405|NCT01824498|7489376|FG001|COMPLETED|2nd Intervention (8 Weeks)||2
6566406|NCT01824498|7489377|FG002|COMPLETED|2nd Intervention (8 Weeks)||4
6566407|NCT01824498|7489378|FG003|COMPLETED|2nd Intervention (8 Weeks)||2
6566408|NCT01824498|7489379|FG004|COMPLETED|2nd Intervention (8 Weeks)||3
6566409|NCT01824498|7489380|FG005|COMPLETED|2nd Intervention (8 Weeks)||4
6566410|NCT01824498|7489375|FG000|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6566411|NCT01824498|7489376|FG001|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6566412|NCT01824498|7489377|FG002|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6566413|NCT01824498|7489378|FG003|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6566414|NCT01824498|7489379|FG004|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6566415|NCT01824498|7489380|FG005|NOT COMPLETED|2nd Intervention (8 Weeks)||0
6566416|NCT01824498|7489375|FG000|STARTED|Washout (8 Weeks)||3
6566417|NCT01824498|7489376|FG001|STARTED|Washout (8 Weeks)||2
6566418|NCT01824498|7489377|FG002|STARTED|Washout (8 Weeks)||4
6566419|NCT01824498|7489378|FG003|STARTED|Washout (8 Weeks)||2
6566420|NCT01824498|7489379|FG004|STARTED|Washout (8 Weeks)||3
6566421|NCT01824498|7489380|FG005|STARTED|Washout (8 Weeks)||4
6566422|NCT01824498|7489375|FG000|COMPLETED|Washout (8 Weeks)||3
6566423|NCT01824498|7489376|FG001|COMPLETED|Washout (8 Weeks)||2
6566424|NCT01824498|7489377|FG002|COMPLETED|Washout (8 Weeks)||4
6566425|NCT01824498|7489378|FG003|COMPLETED|Washout (8 Weeks)||2
6806314|NCT04435808|7738500|FG000|STARTED|Overall Study||0
6806315|NCT04435808|7738501|FG001|STARTED|Overall Study||1
6806316|NCT04435808|7738500|FG000|COMPLETED|Overall Study||0
6806317|NCT04435808|7738501|FG001|COMPLETED|Overall Study|Study stopped prior to any data collection for this lone participant|0
6806318|NCT04435808|7738500|FG000|NOT COMPLETED|Overall Study||0
6806319|NCT04435808|7738501|FG001|NOT COMPLETED|Overall Study||1
6806320|NCT04409262|7738509|FG000|STARTED|Overall Study||215
6806321|NCT04409262|7738510|FG001|STARTED|Overall Study||434
6806322|NCT04409262|7738509|FG000|COMPLETED|Overall Study||140
6806323|NCT04409262|7738510|FG001|COMPLETED|Overall Study||300
6656891|NCT02465450|7587223|FG004|NOT COMPLETED|Treatment Period 2||4
6656892|NCT02465450|7587224|FG005|NOT COMPLETED|Treatment Period 2||0
6656893|NCT02465463|7587244|FG000|STARTED|Overall Study||8
6656894|NCT02465463|7587245|FG001|STARTED|Overall Study||5
6656895|NCT02465463|7587244|FG000|COMPLETED|Overall Study||4
6273332|NCT00100659|7172463|FG001|STARTED|Overall Study||59
6656896|NCT02465463|7587245|FG001|COMPLETED|Overall Study||4
6656897|NCT02465463|7587244|FG000|NOT COMPLETED|Overall Study||4
6656898|NCT02465463|7587245|FG001|NOT COMPLETED|Overall Study||1
6273333|NCT00100659|7172462|FG000|COMPLETED|Overall Study||52
6273334|NCT00100659|7172463|FG001|COMPLETED|Overall Study||57
6273335|NCT00100659|7172462|FG000|NOT COMPLETED|Overall Study||3
6273336|NCT00100659|7172463|FG001|NOT COMPLETED|Overall Study||2
6273337|NCT00100698|7172473|FG000|STARTED|Overall Study||27
6273338|NCT00100698|7172474|FG001|STARTED|Overall Study||29
6273339|NCT00100698|7172473|FG000|COMPLETED|Overall Study||21
6273340|NCT00100698|7172474|FG001|COMPLETED|Overall Study||27
6273341|NCT00100698|7172473|FG000|NOT COMPLETED|Overall Study||6
6388209|NCT00818662|7299552|FG003|STARTED|Overall Study||63
6388210|NCT00818662|7299549|FG000|COMPLETED|Overall Study||104
6388211|NCT00818662|7299550|FG001|COMPLETED|Overall Study||102
6388212|NCT00818662|7299551|FG002|COMPLETED|Overall Study||49
6388213|NCT00818662|7299552|FG003|COMPLETED|Overall Study||47
6388214|NCT00818662|7299549|FG000|NOT COMPLETED|Overall Study||23
6388215|NCT00818662|7299550|FG001|NOT COMPLETED|Overall Study||33
6388216|NCT00818662|7299551|FG002|NOT COMPLETED|Overall Study||9
6388217|NCT00818662|7299552|FG003|NOT COMPLETED|Overall Study||16
6388218|NCT00818753|7299566|FG000|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
6388219|NCT00818753|7299567|FG001|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
6388220|NCT00818753|7299568|FG002|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
6388221|NCT00818753|7299566|FG000|COMPLETED|Overall Study||19
6388222|NCT00818753|7299567|FG001|COMPLETED|Overall Study||21
6388223|NCT00818753|7299568|FG002|COMPLETED|Overall Study||9
6388224|NCT00818753|7299566|FG000|NOT COMPLETED|Overall Study||3
6388225|NCT00818753|7299567|FG001|NOT COMPLETED|Overall Study||0
6388226|NCT00818753|7299568|FG002|NOT COMPLETED|Overall Study||1
6388227|NCT00818766|7299578|FG000|STARTED|Overall Study||125
6388228|NCT00818766|7299579|FG001|STARTED|Overall Study||126
6388229|NCT00818766|7299578|FG000|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
6388230|NCT00818766|7299579|FG001|Received Allocated Intervention|Overall Study||126
6388231|NCT00818766|7299578|FG000|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
6388232|NCT00818766|7299579|FG001|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
6388233|NCT00818766|7299578|FG000|COMPLETED|Overall Study||110
6388234|NCT00818766|7299579|FG001|COMPLETED|Overall Study||116
6388235|NCT00818766|7299578|FG000|NOT COMPLETED|Overall Study||15
6388236|NCT00818766|7299579|FG001|NOT COMPLETED|Overall Study||10
6388237|NCT00818779|7299587|FG000|STARTED|Overall Study||22
6566426|NCT01824498|7489379|FG004|COMPLETED|Washout (8 Weeks)||3
6388238|NCT00818779|7299588|FG001|STARTED|Overall Study||16
6388239|NCT00818779|7299587|FG000|COMPLETED|Overall Study||16
6388240|NCT00818779|7299588|FG001|COMPLETED|Overall Study||15
6388241|NCT00818779|7299587|FG000|NOT COMPLETED|Overall Study||6
6388242|NCT00818779|7299588|FG001|NOT COMPLETED|Overall Study||1
6388243|NCT00818805|7299594|FG000|STARTED|First Intervention||25
6388244|NCT00818805|7299595|FG001|STARTED|First Intervention||25
6388245|NCT00818805|7299594|FG000|COMPLETED|First Intervention||25
6388246|NCT00818805|7299595|FG001|COMPLETED|First Intervention||25
6388247|NCT00818805|7299594|FG000|NOT COMPLETED|First Intervention||0
6388248|NCT00818805|7299595|FG001|NOT COMPLETED|First Intervention||0
6388249|NCT00818805|7299594|FG000|STARTED|Second Intervention||25
6388250|NCT00818805|7299595|FG001|STARTED|Second Intervention||25
6388251|NCT00818805|7299594|FG000|COMPLETED|Second Intervention||25
6388252|NCT00818805|7299595|FG001|COMPLETED|Second Intervention||25
6388253|NCT00818805|7299594|FG000|NOT COMPLETED|Second Intervention||0
6388254|NCT00818805|7299595|FG001|NOT COMPLETED|Second Intervention||0
6388255|NCT00818883|7299607|FG000|STARTED|Overall Study||303
6388256|NCT00818883|7299608|FG001|STARTED|Overall Study||306
6388257|NCT00818883|7299607|FG000|COMPLETED|Overall Study||252
6388258|NCT00818883|7299608|FG001|COMPLETED|Overall Study||260
6388259|NCT00818883|7299607|FG000|NOT COMPLETED|Overall Study||51
6388260|NCT00818883|7299608|FG001|NOT COMPLETED|Overall Study||46
6388261|NCT00818961|7299614|FG000|STARTED|Overall Study||36
6388262|NCT00818961|7299614|FG000|COMPLETED|Overall Study||36
6388263|NCT00818961|7299614|FG000|NOT COMPLETED|Overall Study||0
6388264|NCT00819013|7299622|FG000|STARTED|Overall Study||22
6388265|NCT00819013|7299623|FG001|STARTED|Overall Study||23
6388266|NCT00819013|7299624|FG002|STARTED|Overall Study||21
6388267|NCT00819013|7299625|FG003|STARTED|Overall Study||21
6388268|NCT00819013|7299622|FG000|COMPLETED|Overall Study||19
6388269|NCT00819013|7299623|FG001|COMPLETED|Overall Study||22
6388270|NCT00819013|7299624|FG002|COMPLETED|Overall Study||16
6388271|NCT00819013|7299625|FG003|COMPLETED|Overall Study||17
6388272|NCT00819013|7299622|FG000|NOT COMPLETED|Overall Study||3
6388273|NCT00819013|7299623|FG001|NOT COMPLETED|Overall Study||1
6388274|NCT00819013|7299624|FG002|NOT COMPLETED|Overall Study||5
6388275|NCT00819013|7299625|FG003|NOT COMPLETED|Overall Study||4
6388276|NCT00819039|7299638|FG000|STARTED|Overall Study||46
6388277|NCT00819039|7299639|FG001|STARTED|Overall Study||27
6388278|NCT00819039|7299640|FG002|STARTED|Overall Study||25
6388279|NCT00819039|7299638|FG000|COMPLETED|Overall Study||44
6388280|NCT00819039|7299639|FG001|COMPLETED|Overall Study||27
6388281|NCT00819039|7299640|FG002|COMPLETED|Overall Study||24
6388282|NCT00819039|7299638|FG000|NOT COMPLETED|Overall Study||2
6388283|NCT00819039|7299639|FG001|NOT COMPLETED|Overall Study||0
6388284|NCT00819039|7299640|FG002|NOT COMPLETED|Overall Study||1
6388285|NCT00819052|7299652|FG000|STARTED|Overall Study||148
6388286|NCT00819052|7299653|FG001|STARTED|Overall Study||295
6388287|NCT00819052|7299652|FG000|COMPLETED|Overall Study||142
6388288|NCT00819052|7299653|FG001|COMPLETED|Overall Study||281
6388289|NCT00819052|7299652|FG000|NOT COMPLETED|Overall Study||6
6388290|NCT00819052|7299653|FG001|NOT COMPLETED|Overall Study||14
6388291|NCT00819091|7299664|FG000|STARTED|Overall Study||84
6388292|NCT00819091|7299665|FG001|STARTED|Overall Study||161
6388293|NCT00819091|7299664|FG000|COMPLETED|Overall Study||77
6388294|NCT00819091|7299665|FG001|COMPLETED|Overall Study||151
6388295|NCT00819091|7299664|FG000|NOT COMPLETED|Overall Study||7
6388296|NCT00819091|7299665|FG001|NOT COMPLETED|Overall Study||10
6388297|NCT00819156|7299677|FG000|STARTED|Overall Study||30
6388298|NCT00819156|7299678|FG001|STARTED|Overall Study||33
6388299|NCT00819156|7299679|FG002|STARTED|Overall Study||32
6388300|NCT00819156|7299680|FG003|STARTED|Overall Study||30
6388301|NCT00819156|7299681|FG004|STARTED|Overall Study||33
6388302|NCT00819156|7299682|FG005|STARTED|Overall Study||31
6388303|NCT00819156|7299677|FG000|Randomised and Treated (ITT Population)|Overall Study||30
6388304|NCT00819156|7299678|FG001|Randomised and Treated (ITT Population)|Overall Study||32
6388305|NCT00819156|7299679|FG002|Randomised and Treated (ITT Population)|Overall Study||32
6388306|NCT00819156|7299680|FG003|Randomised and Treated (ITT Population)|Overall Study||30
6388307|NCT00819156|7299681|FG004|Randomised and Treated (ITT Population)|Overall Study||33
6388308|NCT00819156|7299682|FG005|Randomised and Treated (ITT Population)|Overall Study||30
6388309|NCT00819156|7299677|FG000|COMPLETED|Overall Study||20
6388310|NCT00819156|7299678|FG001|COMPLETED|Overall Study||23
6388311|NCT00819156|7299679|FG002|COMPLETED|Overall Study||26
6388312|NCT00819156|7299680|FG003|COMPLETED|Overall Study||28
6388313|NCT00819156|7299681|FG004|COMPLETED|Overall Study||27
6388314|NCT00819156|7299682|FG005|COMPLETED|Overall Study||23
6388315|NCT00819156|7299677|FG000|NOT COMPLETED|Overall Study||10
6388316|NCT00819156|7299678|FG001|NOT COMPLETED|Overall Study||10
6388317|NCT00819156|7299679|FG002|NOT COMPLETED|Overall Study||6
6388318|NCT00819156|7299680|FG003|NOT COMPLETED|Overall Study||2
6388319|NCT00819156|7299681|FG004|NOT COMPLETED|Overall Study||6
6388320|NCT00819156|7299682|FG005|NOT COMPLETED|Overall Study||8
6388321|NCT00819182|7299707|FG000|STARTED|Overall Study|Consented participants allocated to this arm.|88
6388322|NCT00819182|7299708|FG001|STARTED|Overall Study|Consented participants allocated to this arm.|86
6388323|NCT00819182|7299709|FG002|STARTED|Overall Study|Consented participants allocated to this arm.|44
6388324|NCT00819182|7299707|FG000|Week 16 Visit|Overall Study||75
6388325|NCT00819182|7299708|FG001|Week 16 Visit|Overall Study||78
6388326|NCT00819182|7299709|FG002|Week 16 Visit|Overall Study||43
6388327|NCT00819182|7299707|FG000|COMPLETED|Overall Study||75
6388328|NCT00819182|7299708|FG001|COMPLETED|Overall Study||78
6388329|NCT00819182|7299709|FG002|COMPLETED|Overall Study||43
6388330|NCT00819182|7299707|FG000|NOT COMPLETED|Overall Study||13
6388331|NCT00819182|7299708|FG001|NOT COMPLETED|Overall Study||8
6388332|NCT00819182|7299709|FG002|NOT COMPLETED|Overall Study||1
6388333|NCT00819234|7299717|FG000|STARTED|Overall Study||31
6388334|NCT00819234|7299718|FG001|STARTED|Overall Study||35
6388335|NCT00819234|7299719|FG002|STARTED|Overall Study||36
6388336|NCT00819234|7299720|FG003|STARTED|Overall Study||28
6388337|NCT00819234|7299721|FG004|STARTED|Overall Study||13
6388338|NCT00819234|7299722|FG005|STARTED|Overall Study||14
6388339|NCT00819234|7299723|FG006|STARTED|Overall Study||13
6388340|NCT00819234|7299724|FG007|STARTED|Overall Study||29
6388341|NCT00819234|7299725|FG008|STARTED|Overall Study||37
6388342|NCT00819234|7299726|FG009|STARTED|Overall Study||37
6388343|NCT00819234|7299717|FG000|COMPLETED|Overall Study||21
6388344|NCT00819234|7299718|FG001|COMPLETED|Overall Study||20
6388345|NCT00819234|7299719|FG002|COMPLETED|Overall Study||28
6388346|NCT00819234|7299720|FG003|COMPLETED|Overall Study||22
6388347|NCT00819234|7299721|FG004|COMPLETED|Overall Study||12
6388348|NCT00819234|7299722|FG005|COMPLETED|Overall Study||7
6388349|NCT00819234|7299723|FG006|COMPLETED|Overall Study||8
6388350|NCT00819234|7299724|FG007|COMPLETED|Overall Study||20
6388351|NCT00819234|7299725|FG008|COMPLETED|Overall Study||31
6388352|NCT00819234|7299726|FG009|COMPLETED|Overall Study||30
6388353|NCT00819234|7299717|FG000|NOT COMPLETED|Overall Study||10
6388354|NCT00819234|7299718|FG001|NOT COMPLETED|Overall Study||15
6388355|NCT00819234|7299719|FG002|NOT COMPLETED|Overall Study||8
6388356|NCT00819234|7299720|FG003|NOT COMPLETED|Overall Study||6
6388357|NCT00819234|7299721|FG004|NOT COMPLETED|Overall Study||1
6388358|NCT00819234|7299722|FG005|NOT COMPLETED|Overall Study||7
6388359|NCT00819234|7299723|FG006|NOT COMPLETED|Overall Study||5
6504142|NCT01447433|7423275|FG000|NOT COMPLETED|Overall Study||4
6504143|NCT01447433|7423276|FG001|NOT COMPLETED|Overall Study||6
6504144|NCT01447446|7423288|FG000|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
6504145|NCT01447446|7423289|FG001|STARTED|Overall Study||496
6504146|NCT01447446|7423290|FG002|STARTED|Overall Study||292
6504147|NCT01447446|7423291|FG003|STARTED|Overall Study||93
6504148|NCT01447446|7423292|FG004|STARTED|Overall Study||821
6504149|NCT01447446|7423293|FG005|STARTED|Overall Study||86
6504150|NCT01447446|7423288|FG000|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
6504151|NCT01447446|7423289|FG001|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
6504152|NCT01447446|7423290|FG002|COMPLETED|Overall Study||192
6504153|NCT01447446|7423291|FG003|COMPLETED|Overall Study||60
6504154|NCT01447446|7423292|FG004|COMPLETED|Overall Study||610
6388360|NCT00819234|7299724|FG007|NOT COMPLETED|Overall Study||9
6388361|NCT00819234|7299725|FG008|NOT COMPLETED|Overall Study||6
6388362|NCT00819234|7299726|FG009|NOT COMPLETED|Overall Study||7
6504155|NCT01447446|7423293|FG005|COMPLETED|Overall Study||54
6504156|NCT01447446|7423288|FG000|NOT COMPLETED|Overall Study||722
6504157|NCT01447446|7423289|FG001|NOT COMPLETED|Overall Study||165
6273342|NCT00100698|7172474|FG001|NOT COMPLETED|Overall Study||2
6273343|NCT00100789|7172480|FG000|STARTED|Overall Study||67
6273344|NCT00100789|7172480|FG000|Eligible|Overall Study||64
6273345|NCT00100789|7172480|FG000|Eligible and Began Protocol Therapy|Overall Study||63
6273346|NCT00100789|7172480|FG000|COMPLETED|Overall Study||3
6273347|NCT00100789|7172480|FG000|NOT COMPLETED|Overall Study||64
6273348|NCT00100802|7172485|FG000|STARTED|Overall Study||118
6273349|NCT00100802|7172485|FG000|COMPLETED|Overall Study||38
6273350|NCT00100802|7172485|FG000|NOT COMPLETED|Overall Study||80
6273351|NCT00100815|7172489|FG000|STARTED|Overall Study||50
6273352|NCT00100815|7172489|FG000|COMPLETED|Overall Study||1
6273353|NCT00100815|7172489|FG000|NOT COMPLETED|Overall Study||49
6273354|NCT00100841|7172493|FG000|STARTED|Overall Study||66
6273355|NCT00100841|7172493|FG000|COMPLETED|Overall Study||66
6273356|NCT00100841|7172493|FG000|NOT COMPLETED|Overall Study||0
6273357|NCT00100932|7172499|FG000|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
6273358|NCT00100932|7172500|FG001|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
6273359|NCT00100932|7172499|FG000|COMPLETED|Overall Study||5
6273360|NCT00100932|7172500|FG001|COMPLETED|Overall Study||1
6273361|NCT00100932|7172499|FG000|NOT COMPLETED|Overall Study||73
6273362|NCT00100932|7172500|FG001|NOT COMPLETED|Overall Study||27
6273363|NCT00101010|7172506|FG000|STARTED|Overall Study||80
6273364|NCT00101010|7172506|FG000|COMPLETED|Overall Study||79
6273365|NCT00101010|7172506|FG000|NOT COMPLETED|Overall Study||1
6273366|NCT00101036|7172512|FG000|STARTED|Overall Study||17
6273367|NCT00101036|7172513|FG001|STARTED|Overall Study||40
6273368|NCT00101036|7172512|FG000|COMPLETED|Overall Study||17
6273369|NCT00101036|7172513|FG001|COMPLETED|Overall Study||40
6273370|NCT00101036|7172512|FG000|NOT COMPLETED|Overall Study||0
6273371|NCT00101036|7172513|FG001|NOT COMPLETED|Overall Study||0
6273372|NCT00101101|7172519|FG000|STARTED|Overall Study||43
6273373|NCT00101101|7172519|FG000|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
6273374|NCT00101101|7172519|FG000|NOT COMPLETED|Overall Study||20
6273375|NCT00101166|7172523|FG000|STARTED|Overall Study||28
6273376|NCT00101166|7172523|FG000|COMPLETED|Overall Study||18
6273377|NCT00101166|7172523|FG000|NOT COMPLETED|Overall Study||10
6273378|NCT00101192|7172527|FG000|STARTED|Overall Study||76
6273379|NCT00101192|7172527|FG000|COMPLETED|Overall Study||69
6273380|NCT00101192|7172527|FG000|NOT COMPLETED|Overall Study||7
6273381|NCT00101283|7172533|FG000|STARTED|Overall Study||16
6273382|NCT00101283|7172534|FG001|STARTED|Overall Study||16
6273383|NCT00101283|7172533|FG000|Began Treatment|Overall Study||16
6273384|NCT00101283|7172534|FG001|Began Treatment|Overall Study||13
6273385|NCT00101283|7172533|FG000|COMPLETED|Overall Study||16
6273386|NCT00101283|7172534|FG001|COMPLETED|Overall Study||13
6273387|NCT00101283|7172533|FG000|NOT COMPLETED|Overall Study||0
6273388|NCT00101283|7172534|FG001|NOT COMPLETED|Overall Study||3
6273389|NCT00101361|7172542|FG000|STARTED|Overall Study||108
6273390|NCT00101361|7172543|FG001|STARTED|Overall Study||104
6273391|NCT00101361|7172542|FG000|COMPLETED|Overall Study||108
6273392|NCT00101361|7172543|FG001|COMPLETED|Overall Study||104
6273393|NCT00101361|7172542|FG000|NOT COMPLETED|Overall Study||0
6273394|NCT00101361|7172543|FG001|NOT COMPLETED|Overall Study||0
6273395|NCT00101400|7172549|FG000|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
6273396|NCT00101400|7172549|FG000|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
6273397|NCT00101400|7172549|FG000|NOT COMPLETED|Treatment||0
6273398|NCT00101400|7172549|FG000|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
6273399|NCT00101400|7172549|FG000|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
6273400|NCT00101400|7172549|FG000|NOT COMPLETED|Survival Follow-Up||7
6273401|NCT00101413|7172553|FG000|STARTED|Overall Study||52
6273402|NCT00101413|7172553|FG000|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
6273403|NCT00101413|7172553|FG000|NOT COMPLETED|Overall Study||0
6273404|NCT00101452|7172560|FG000|STARTED|Overall Study||65
6273405|NCT00101452|7172561|FG001|STARTED|Overall Study||69
6273406|NCT00101452|7172562|FG002|STARTED|Overall Study||65
6273407|NCT00101452|7172560|FG000|COMPLETED|Overall Study||21
6273408|NCT00101452|7172561|FG001|COMPLETED|Overall Study||26
6273409|NCT00101452|7172562|FG002|COMPLETED|Overall Study||22
6273410|NCT00101452|7172560|FG000|NOT COMPLETED|Overall Study||44
6273411|NCT00101452|7172561|FG001|NOT COMPLETED|Overall Study||43
6273412|NCT00101452|7172562|FG002|NOT COMPLETED|Overall Study||43
6273413|NCT00101582|7172576|FG000|STARTED|Overall Study||94
6388363|NCT00819247|7299784|FG000|STARTED|Overall Study||43
6388364|NCT00819247|7299785|FG001|STARTED|Overall Study||46
6388365|NCT00819247|7299786|FG002|STARTED|Overall Study||40
6388366|NCT00819247|7299784|FG000|Randomized|Overall Study||43
6388367|NCT00819247|7299785|FG001|Randomized|Overall Study||46
6388368|NCT00819247|7299786|FG002|Randomized|Overall Study||40
6388369|NCT00819247|7299784|FG000|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
6388370|NCT00819247|7299785|FG001|Intent-to-treat Population|Overall Study||46
6388371|NCT00819247|7299786|FG002|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
6388372|NCT00819247|7299784|FG000|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
6388373|NCT00819247|7299785|FG001|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
6388374|NCT00819247|7299786|FG002|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
6388375|NCT00819247|7299784|FG000|COMPLETED|Overall Study||32
6388376|NCT00819247|7299785|FG001|COMPLETED|Overall Study||30
6388377|NCT00819247|7299786|FG002|COMPLETED|Overall Study||26
6388378|NCT00819247|7299784|FG000|NOT COMPLETED|Overall Study||11
6388379|NCT00819247|7299785|FG001|NOT COMPLETED|Overall Study||16
6388380|NCT00819247|7299786|FG002|NOT COMPLETED|Overall Study||14
6388381|NCT00819260|7299794|FG000|STARTED|Overall Study||31
6388382|NCT00819260|7299794|FG000|COMPLETED|Overall Study||31
6388383|NCT00819260|7299794|FG000|NOT COMPLETED|Overall Study||0
6388384|NCT00819286|7299802|FG000|STARTED|Overall Study||70
6388385|NCT00819286|7299803|FG001|STARTED|Overall Study||70
6388386|NCT00819286|7299802|FG000|COMPLETED|Overall Study||56
6388387|NCT00819286|7299803|FG001|COMPLETED|Overall Study||45
6388388|NCT00819286|7299802|FG000|NOT COMPLETED|Overall Study||14
6388389|NCT00819286|7299803|FG001|NOT COMPLETED|Overall Study||25
6388390|NCT00819390|7299813|FG000|STARTED|Overall Study||16
6388391|NCT00819390|7299814|FG001|STARTED|Overall Study||17
6388392|NCT00819390|7299815|FG002|STARTED|Overall Study||18
6388393|NCT00819390|7299816|FG003|STARTED|Overall Study||19
6388394|NCT00819390|7299813|FG000|COMPLETED|Overall Study||13
6388395|NCT00819390|7299814|FG001|COMPLETED|Overall Study||16
6388396|NCT00819390|7299815|FG002|COMPLETED|Overall Study||17
6388397|NCT00819390|7299816|FG003|COMPLETED|Overall Study||19
6388398|NCT00819390|7299813|FG000|NOT COMPLETED|Overall Study||3
6388399|NCT00819390|7299814|FG001|NOT COMPLETED|Overall Study||1
6388400|NCT00819390|7299815|FG002|NOT COMPLETED|Overall Study||1
6388401|NCT00819390|7299816|FG003|NOT COMPLETED|Overall Study||0
6388402|NCT00819403|7299831|FG000|STARTED|First Intervention (6 Weeks)||7
6388403|NCT00819403|7299832|FG001|STARTED|First Intervention (6 Weeks)||8
6388404|NCT00819403|7299831|FG000|COMPLETED|First Intervention (6 Weeks)||7
6388405|NCT00819403|7299832|FG001|COMPLETED|First Intervention (6 Weeks)||8
6388406|NCT00819403|7299831|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
6388407|NCT00819403|7299832|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
6388408|NCT00819403|7299831|FG000|STARTED|Washout (14 Days)||7
6388409|NCT00819403|7299832|FG001|STARTED|Washout (14 Days)||8
6388410|NCT00819403|7299831|FG000|COMPLETED|Washout (14 Days)||7
6388411|NCT00819403|7299832|FG001|COMPLETED|Washout (14 Days)||8
6388412|NCT00819403|7299831|FG000|NOT COMPLETED|Washout (14 Days)||0
6388413|NCT00819403|7299832|FG001|NOT COMPLETED|Washout (14 Days)||0
6388414|NCT00819403|7299831|FG000|STARTED|Second Intervention (6 Weeks)||7
6566427|NCT01824498|7489380|FG005|COMPLETED|Washout (8 Weeks)||4
6566428|NCT01824498|7489375|FG000|NOT COMPLETED|Washout (8 Weeks)||0
6566429|NCT01824498|7489376|FG001|NOT COMPLETED|Washout (8 Weeks)||0
6566430|NCT01824498|7489377|FG002|NOT COMPLETED|Washout (8 Weeks)||0
6566431|NCT01824498|7489378|FG003|NOT COMPLETED|Washout (8 Weeks)||0
6566432|NCT01824498|7489379|FG004|NOT COMPLETED|Washout (8 Weeks)||0
6566433|NCT01824498|7489380|FG005|NOT COMPLETED|Washout (8 Weeks)||0
6566434|NCT01824498|7489375|FG000|STARTED|3rd Intervention (8 Weeks)||3
6566435|NCT01824498|7489376|FG001|STARTED|3rd Intervention (8 Weeks)||2
6273414|NCT00101582|7172577|FG001|STARTED|Overall Study||94
6273415|NCT00101582|7172576|FG000|Received Study Drug|Overall Study||91
6273416|NCT00101582|7172577|FG001|Received Study Drug|Overall Study||94
6273417|NCT00101582|7172576|FG000|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
6273418|NCT00101582|7172577|FG001|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
6273419|NCT00101582|7172576|FG000|NOT COMPLETED|Overall Study||11
6273420|NCT00101582|7172577|FG001|NOT COMPLETED|Overall Study||15
6273421|NCT00101647|7172585|FG000|STARTED|Overall Study|Randomized|13
6273422|NCT00101647|7172586|FG001|STARTED|Overall Study|Randomized|161
6273423|NCT00101647|7172585|FG000|COMPLETED|Overall Study||13
6273424|NCT00101647|7172586|FG001|COMPLETED|Overall Study||161
6273425|NCT00101647|7172585|FG000|NOT COMPLETED|Overall Study||0
6273426|NCT00101647|7172586|FG001|NOT COMPLETED|Overall Study||0
6273427|NCT00101660|7172604|FG000|STARTED|Overall Study||99
6273428|NCT00101660|7172605|FG001|STARTED|Overall Study||288
6273429|NCT00101660|7172604|FG000|COMPLETED|Overall Study||99
6273430|NCT00101660|7172605|FG001|COMPLETED|Overall Study||288
6273431|NCT00101660|7172604|FG000|NOT COMPLETED|Overall Study||0
6273432|NCT00101660|7172605|FG001|NOT COMPLETED|Overall Study||0
6273433|NCT00101686|7172627|FG000|STARTED|Overall Study||71
6273434|NCT00101686|7172628|FG001|STARTED|Overall Study||73
6273435|NCT00101686|7172629|FG002|STARTED|Overall Study||69
6273436|NCT00101686|7172630|FG003|STARTED|Overall Study||72
6273437|NCT00101686|7172631|FG004|STARTED|Overall Study||73
6273438|NCT00101686|7172632|FG005|STARTED|Overall Study||72
6273439|NCT00101686|7172633|FG006|STARTED|Overall Study||27
6273440|NCT00101686|7172634|FG007|STARTED|Overall Study||30
6273441|NCT00101686|7172635|FG008|STARTED|Overall Study||30
6273442|NCT00101686|7172636|FG009|STARTED|Overall Study||30
6273443|NCT00101686|7172627|FG000|Received Treatment|Overall Study||70
6273444|NCT00101686|7172628|FG001|Received Treatment|Overall Study||67
6273445|NCT00101686|7172629|FG002|Received Treatment|Overall Study||67
6273446|NCT00101686|7172630|FG003|Received Treatment|Overall Study||70
6273447|NCT00101686|7172631|FG004|Received Treatment|Overall Study||71
6273448|NCT00101686|7172632|FG005|Received Treatment|Overall Study||70
6273449|NCT00101686|7172633|FG006|Received Treatment|Overall Study||27
6273450|NCT00101686|7172634|FG007|Received Treatment|Overall Study||29
6273451|NCT00101686|7172635|FG008|Received Treatment|Overall Study||30
6273452|NCT00101686|7172636|FG009|Received Treatment|Overall Study||29
6273453|NCT00101686|7172627|FG000|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273454|NCT00101686|7172628|FG001|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273455|NCT00101686|7172629|FG002|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273456|NCT00101686|7172630|FG003|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273457|NCT00101686|7172631|FG004|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273458|NCT00101686|7172632|FG005|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273459|NCT00101686|7172633|FG006|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273460|NCT00101686|7172634|FG007|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273461|NCT00101686|7172635|FG008|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273462|NCT00101686|7172636|FG009|COMPLETED|Overall Study|Patients treated until disease progression.|0
6273463|NCT00101686|7172627|FG000|NOT COMPLETED|Overall Study||71
6273464|NCT00101686|7172628|FG001|NOT COMPLETED|Overall Study||73
6273465|NCT00101686|7172629|FG002|NOT COMPLETED|Overall Study||69
6273466|NCT00101686|7172630|FG003|NOT COMPLETED|Overall Study||72
6273467|NCT00101686|7172631|FG004|NOT COMPLETED|Overall Study||73
6273468|NCT00101686|7172632|FG005|NOT COMPLETED|Overall Study||72
6273469|NCT00101686|7172633|FG006|NOT COMPLETED|Overall Study||27
6273470|NCT00101686|7172634|FG007|NOT COMPLETED|Overall Study||30
6388415|NCT00819403|7299832|FG001|STARTED|Second Intervention (6 Weeks)||8
6388416|NCT00819403|7299831|FG000|COMPLETED|Second Intervention (6 Weeks)||7
6388417|NCT00819403|7299832|FG001|COMPLETED|Second Intervention (6 Weeks)||8
6388418|NCT00819403|7299831|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6388419|NCT00819403|7299832|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6504158|NCT01447446|7423290|FG002|NOT COMPLETED|Overall Study||100
6504159|NCT01447446|7423291|FG003|NOT COMPLETED|Overall Study||33
6504160|NCT01447446|7423292|FG004|NOT COMPLETED|Overall Study||211
6504161|NCT01447446|7423293|FG005|NOT COMPLETED|Overall Study||32
6504162|NCT01447511|7423318|FG000|STARTED|Control Period||8
6504163|NCT01447511|7423319|FG001|STARTED|Control Period||5
6504164|NCT01447511|7423320|FG002|STARTED|Control Period||9
6504165|NCT01447511|7423321|FG003|STARTED|Control Period||3
6504166|NCT01447511|7423322|FG004|STARTED|Control Period||4
6504167|NCT01447511|7423318|FG000|COMPLETED|Control Period||8
6504168|NCT01447511|7423319|FG001|COMPLETED|Control Period||5
6504169|NCT01447511|7423320|FG002|COMPLETED|Control Period||9
6504170|NCT01447511|7423321|FG003|COMPLETED|Control Period||3
6504171|NCT01447511|7423322|FG004|COMPLETED|Control Period||4
6504172|NCT01447511|7423318|FG000|NOT COMPLETED|Control Period||0
6504173|NCT01447511|7423319|FG001|NOT COMPLETED|Control Period||0
6504174|NCT01447511|7423320|FG002|NOT COMPLETED|Control Period||0
6504175|NCT01447511|7423321|FG003|NOT COMPLETED|Control Period||0
6504176|NCT01447511|7423322|FG004|NOT COMPLETED|Control Period||0
6566436|NCT01824498|7489377|FG002|STARTED|3rd Intervention (8 Weeks)||4
6566437|NCT01824498|7489378|FG003|STARTED|3rd Intervention (8 Weeks)||2
6504177|NCT01447511|7423318|FG000|STARTED|Fluconazole Period||8
6504178|NCT01447511|7423319|FG001|STARTED|Fluconazole Period||0
6504179|NCT01447511|7423320|FG002|STARTED|Fluconazole Period||9
6504180|NCT01447511|7423321|FG003|STARTED|Fluconazole Period||3
6504181|NCT01447511|7423322|FG004|STARTED|Fluconazole Period||4
6504182|NCT01447511|7423318|FG000|COMPLETED|Fluconazole Period||8
6504183|NCT01447511|7423319|FG001|COMPLETED|Fluconazole Period||0
6504184|NCT01447511|7423320|FG002|COMPLETED|Fluconazole Period||8
6504185|NCT01447511|7423321|FG003|COMPLETED|Fluconazole Period||3
6504186|NCT01447511|7423322|FG004|COMPLETED|Fluconazole Period||4
6504187|NCT01447511|7423318|FG000|NOT COMPLETED|Fluconazole Period||0
6504188|NCT01447511|7423319|FG001|NOT COMPLETED|Fluconazole Period||0
6504189|NCT01447511|7423320|FG002|NOT COMPLETED|Fluconazole Period||1
6504190|NCT01447511|7423321|FG003|NOT COMPLETED|Fluconazole Period||0
6504191|NCT01447511|7423322|FG004|NOT COMPLETED|Fluconazole Period||0
6504192|NCT01447511|7423318|FG000|STARTED|Rifampin Period||8
6504193|NCT01447511|7423319|FG001|STARTED|Rifampin Period||5
6504194|NCT01447511|7423320|FG002|STARTED|Rifampin Period||8
6504195|NCT01447511|7423321|FG003|STARTED|Rifampin Period||3
6388420|NCT00819507|7299839|FG000|STARTED|Overall Study||25
6388421|NCT00819507|7299839|FG000|COMPLETED|Overall Study||25
6388422|NCT00819507|7299839|FG000|NOT COMPLETED|Overall Study||0
6388423|NCT00819585|7299850|FG000|STARTED|Core Study|Participants who started the core study are included in the randomized and full analysis sets.|55
6388424|NCT00819585|7299851|FG001|STARTED|Core Study||54
6388425|NCT00819585|7299852|FG002|STARTED|Core Study||54
6388426|NCT00819585|7299853|FG003|STARTED|Core Study||54
6388427|NCT00819585|7299854|FG004|STARTED|Core Study||53
6388428|NCT00819585|7299855|FG005|STARTED|Core Study||54
6388429|NCT00819585|7299856|FG006|STARTED|Core Study||108
6388430|NCT00819585|7299857|FG007|STARTED|Core Study|There were no participants in this arm during the core study.|0
6388431|NCT00819585|7299858|FG008|STARTED|Core Study|There were no participants in this arm during the core study.|0
6388432|NCT00819585|7299859|FG009|STARTED|Core Study|There were no participants in this arm during the core study.|0
6388433|NCT00819585|7299860|FG010|STARTED|Core Study|There were no participants in this arm during the core study.|0
6388434|NCT00819585|7299850|FG000|Received Study Medication|Core Study|Participants who received study medication are included in the safety population.|55
6388435|NCT00819585|7299851|FG001|Received Study Medication|Core Study||54
6388436|NCT00819585|7299852|FG002|Received Study Medication|Core Study||54
6388437|NCT00819585|7299853|FG003|Received Study Medication|Core Study||54
6388438|NCT00819585|7299854|FG004|Received Study Medication|Core Study||53
6388439|NCT00819585|7299855|FG005|Received Study Medication|Core Study|One participant in this treatment arm was HIV+ve and did not receive any study medication.|53
6388440|NCT00819585|7299856|FG006|Received Study Medication|Core Study||108
6388441|NCT00819585|7299857|FG007|Received Study Medication|Core Study||0
6388442|NCT00819585|7299858|FG008|Received Study Medication|Core Study||0
6388443|NCT00819585|7299859|FG009|Received Study Medication|Core Study||0
6388444|NCT00819585|7299860|FG010|Received Study Medication|Core Study||0
6388445|NCT00819585|7299850|FG000|COMPLETED|Core Study||49
6388446|NCT00819585|7299851|FG001|COMPLETED|Core Study||48
6388447|NCT00819585|7299852|FG002|COMPLETED|Core Study||48
6388448|NCT00819585|7299853|FG003|COMPLETED|Core Study||49
6388449|NCT00819585|7299854|FG004|COMPLETED|Core Study||50
6388450|NCT00819585|7299855|FG005|COMPLETED|Core Study||52
6388451|NCT00819585|7299856|FG006|COMPLETED|Core Study||95
6388452|NCT00819585|7299857|FG007|COMPLETED|Core Study||0
6388453|NCT00819585|7299858|FG008|COMPLETED|Core Study||0
6388454|NCT00819585|7299859|FG009|COMPLETED|Core Study||0
6388455|NCT00819585|7299860|FG010|COMPLETED|Core Study||0
6388456|NCT00819585|7299850|FG000|NOT COMPLETED|Core Study||6
6388457|NCT00819585|7299851|FG001|NOT COMPLETED|Core Study||6
6388458|NCT00819585|7299852|FG002|NOT COMPLETED|Core Study||6
6388459|NCT00819585|7299853|FG003|NOT COMPLETED|Core Study||5
6388460|NCT00819585|7299854|FG004|NOT COMPLETED|Core Study||3
6388461|NCT00819585|7299855|FG005|NOT COMPLETED|Core Study||2
6388462|NCT00819585|7299856|FG006|NOT COMPLETED|Core Study||13
6388463|NCT00819585|7299857|FG007|NOT COMPLETED|Core Study||0
6388464|NCT00819585|7299858|FG008|NOT COMPLETED|Core Study||0
6388465|NCT00819585|7299859|FG009|NOT COMPLETED|Core Study||0
6388466|NCT00819585|7299860|FG010|NOT COMPLETED|Core Study||0
6388467|NCT00819585|7299850|FG000|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6388468|NCT00819585|7299851|FG001|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6388469|NCT00819585|7299852|FG002|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6388470|NCT00819585|7299853|FG003|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6388471|NCT00819585|7299854|FG004|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6388472|NCT00819585|7299855|FG005|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6388473|NCT00819585|7299856|FG006|STARTED|Extension Study|There were no participants in this arm during the extension study.|0
6388474|NCT00819585|7299857|FG007|STARTED|Extension Study||75
6388475|NCT00819585|7299858|FG008|STARTED|Extension Study||181
6388476|NCT00819585|7299859|FG009|STARTED|Extension Study||25
6388477|NCT00819585|7299860|FG010|STARTED|Extension Study||60
6388478|NCT00819585|7299850|FG000|COMPLETED|Extension Study||0
6388479|NCT00819585|7299851|FG001|COMPLETED|Extension Study||0
6388480|NCT00819585|7299852|FG002|COMPLETED|Extension Study||0
6388481|NCT00819585|7299853|FG003|COMPLETED|Extension Study||0
6388482|NCT00819585|7299854|FG004|COMPLETED|Extension Study||0
6388483|NCT00819585|7299855|FG005|COMPLETED|Extension Study||0
6388484|NCT00819585|7299856|FG006|COMPLETED|Extension Study||0
6388485|NCT00819585|7299857|FG007|COMPLETED|Extension Study||75
6388486|NCT00819585|7299858|FG008|COMPLETED|Extension Study||173
6388487|NCT00819585|7299859|FG009|COMPLETED|Extension Study||24
6388488|NCT00819585|7299860|FG010|COMPLETED|Extension Study||58
6388489|NCT00819585|7299850|FG000|NOT COMPLETED|Extension Study||0
6388490|NCT00819585|7299851|FG001|NOT COMPLETED|Extension Study||0
6388491|NCT00819585|7299852|FG002|NOT COMPLETED|Extension Study||0
6388492|NCT00819585|7299853|FG003|NOT COMPLETED|Extension Study||0
6388493|NCT00819585|7299854|FG004|NOT COMPLETED|Extension Study||0
6388494|NCT00819585|7299855|FG005|NOT COMPLETED|Extension Study||0
6388495|NCT00819585|7299856|FG006|NOT COMPLETED|Extension Study||0
6388496|NCT00819585|7299857|FG007|NOT COMPLETED|Extension Study||0
6388497|NCT00819585|7299858|FG008|NOT COMPLETED|Extension Study||8
6388498|NCT00819585|7299859|FG009|NOT COMPLETED|Extension Study||1
6806324|NCT04409262|7738509|FG000|NOT COMPLETED|Overall Study||75
6806325|NCT04409262|7738510|FG001|NOT COMPLETED|Overall Study||134
6806326|NCT04305912|7738519|FG000|STARTED|First Intervention||26
6806327|NCT04305912|7738520|FG001|STARTED|First Intervention||25
6806328|NCT04305912|7738519|FG000|COMPLETED|First Intervention||24
6806329|NCT04305912|7738520|FG001|COMPLETED|First Intervention||24
6806330|NCT04305912|7738519|FG000|NOT COMPLETED|First Intervention||2
6806331|NCT04305912|7738520|FG001|NOT COMPLETED|First Intervention||1
6806332|NCT04305912|7738519|FG000|STARTED|Second Intervention||24
6806333|NCT04305912|7738520|FG001|STARTED|Second Intervention||24
6806334|NCT04305912|7738519|FG000|COMPLETED|Second Intervention||24
6806335|NCT04305912|7738520|FG001|COMPLETED|Second Intervention||23
6806336|NCT04305912|7738519|FG000|NOT COMPLETED|Second Intervention||0
6806337|NCT04305912|7738520|FG001|NOT COMPLETED|Second Intervention||1
6566438|NCT01824498|7489379|FG004|STARTED|3rd Intervention (8 Weeks)||3
6566439|NCT01824498|7489380|FG005|STARTED|3rd Intervention (8 Weeks)||4
6566440|NCT01824498|7489375|FG000|COMPLETED|3rd Intervention (8 Weeks)||3
6566441|NCT01824498|7489376|FG001|COMPLETED|3rd Intervention (8 Weeks)||2
6806338|NCT04030416|7738526|FG000|STARTED|Overall Study||120
6273471|NCT00101686|7172635|FG008|NOT COMPLETED|Overall Study||30
6273472|NCT00101686|7172636|FG009|NOT COMPLETED|Overall Study||30
6273473|NCT00101816|7172655|FG000|STARTED|Overall Study||10
6273474|NCT00101816|7172656|FG001|STARTED|Overall Study||99
6273475|NCT00101816|7172655|FG000|COMPLETED|Overall Study||10
6273476|NCT00101816|7172656|FG001|COMPLETED|Overall Study||99
6273477|NCT00101816|7172655|FG000|NOT COMPLETED|Overall Study||0
6273478|NCT00101816|7172656|FG001|NOT COMPLETED|Overall Study||0
6566442|NCT01824498|7489377|FG002|COMPLETED|3rd Intervention (8 Weeks)||4
6806339|NCT04030416|7738526|FG000|COMPLETED|Overall Study||119
6806340|NCT04030416|7738526|FG000|NOT COMPLETED|Overall Study||1
6806341|NCT04028648|7738530|FG000|STARTED|Overall Study||150
6806342|NCT04028648|7738530|FG000|COMPLETED|Overall Study||150
6806343|NCT04028648|7738530|FG000|NOT COMPLETED|Overall Study||0
6806344|NCT03987919|7738539|FG000|STARTED|Overall Study||471
6806345|NCT03987919|7738540|FG001|STARTED|Overall Study||469
6806346|NCT03987919|7738541|FG002|STARTED|Overall Study||470
6806347|NCT03987919|7738542|FG003|STARTED|Overall Study||469
6806348|NCT03987919|7738539|FG000|Received at Least One Dose of Study Drug|Overall Study||470
6806349|NCT03987919|7738540|FG001|Received at Least One Dose of Study Drug|Overall Study||469
6806350|NCT03987919|7738541|FG002|Received at Least One Dose of Study Drug|Overall Study||470
6806351|NCT03987919|7738542|FG003|Received at Least One Dose of Study Drug|Overall Study||469
6806352|NCT03987919|7738539|FG000|COMPLETED|Overall Study||452
6806353|NCT03987919|7738540|FG001|COMPLETED|Overall Study||442
6806354|NCT03987919|7738541|FG002|COMPLETED|Overall Study||446
6806355|NCT03987919|7738542|FG003|COMPLETED|Overall Study||443
6806356|NCT03987919|7738539|FG000|NOT COMPLETED|Overall Study||19
6806357|NCT03987919|7738540|FG001|NOT COMPLETED|Overall Study||27
6806358|NCT03987919|7738541|FG002|NOT COMPLETED|Overall Study||24
6806359|NCT03987919|7738542|FG003|NOT COMPLETED|Overall Study||26
6806360|NCT03980145|7738559|FG000|STARTED|Overall Study||7
6806361|NCT03980145|7738560|FG001|STARTED|Overall Study||8
6806362|NCT03980145|7738559|FG000|COMPLETED|Overall Study||7
6806363|NCT03980145|7738560|FG001|COMPLETED|Overall Study||8
6806364|NCT03980145|7738559|FG000|NOT COMPLETED|Overall Study||0
6806365|NCT03980145|7738560|FG001|NOT COMPLETED|Overall Study||0
6806366|NCT03861039|7738571|FG000|STARTED|Overall Study||148
6806367|NCT03861039|7738572|FG001|STARTED|Overall Study||147
6806368|NCT03861039|7738573|FG002|STARTED|Overall Study||148
6806369|NCT03861039|7738571|FG000|Received at Least One Dose of Study Drug|Overall Study||148
6806370|NCT03861039|7738572|FG001|Received at Least One Dose of Study Drug|Overall Study||147
6806371|NCT03861039|7738573|FG002|Received at Least One Dose of Study Drug|Overall Study||148
6273479|NCT00101868|7172672|FG000|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
6273480|NCT00101868|7172673|FG001|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
6273481|NCT00101868|7172672|FG000|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
6806372|NCT03861039|7738571|FG000|COMPLETED|Overall Study||145
6566443|NCT01824498|7489378|FG003|COMPLETED|3rd Intervention (8 Weeks)||2
6566444|NCT01824498|7489379|FG004|COMPLETED|3rd Intervention (8 Weeks)||3
6566445|NCT01824498|7489380|FG005|COMPLETED|3rd Intervention (8 Weeks)||4
6566446|NCT01824498|7489375|FG000|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6566447|NCT01824498|7489376|FG001|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6566448|NCT01824498|7489377|FG002|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6388499|NCT00819585|7299860|FG010|NOT COMPLETED|Extension Study||2
6388500|NCT00819637|7299891|FG000|STARTED|Overall Study||2
6388501|NCT00819637|7299892|FG001|STARTED|Overall Study||0
6566449|NCT01824498|7489378|FG003|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6566450|NCT01824498|7489379|FG004|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6566451|NCT01824498|7489380|FG005|NOT COMPLETED|3rd Intervention (8 Weeks)||0
6566452|NCT01824576|7489388|FG000|STARTED|Overall Study||9
6566453|NCT01824576|7489388|FG000|COMPLETED|Overall Study||7
6388502|NCT00819637|7299893|FG002|STARTED|Overall Study||0
6388503|NCT00819637|7299891|FG000|COMPLETED|Overall Study||2
6388504|NCT00819637|7299892|FG001|COMPLETED|Overall Study||0
6388505|NCT00819637|7299893|FG002|COMPLETED|Overall Study||0
6388506|NCT00819637|7299891|FG000|NOT COMPLETED|Overall Study||0
6388507|NCT00819637|7299892|FG001|NOT COMPLETED|Overall Study||0
6388508|NCT00819637|7299893|FG002|NOT COMPLETED|Overall Study||0
6388509|NCT00819741|7299903|FG000|STARTED|Overall Study||218
6388510|NCT00819741|7299904|FG001|STARTED|Overall Study||215
6388511|NCT00819741|7299903|FG000|Exposed to Drug|Overall Study||218
6388512|NCT00819741|7299904|FG001|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
6388513|NCT00819741|7299903|FG000|COMPLETED|Overall Study||196
6388514|NCT00819741|7299904|FG001|COMPLETED|Overall Study||201
6388515|NCT00819741|7299903|FG000|NOT COMPLETED|Overall Study||22
6388516|NCT00819741|7299904|FG001|NOT COMPLETED|Overall Study||14
6388517|NCT00819767|7299912|FG000|STARTED|Overall Study||33
6388518|NCT00819767|7299913|FG001|STARTED|Overall Study||35
6388519|NCT00819767|7299912|FG000|COMPLETED|Overall Study||32
6388520|NCT00819767|7299913|FG001|COMPLETED|Overall Study||33
6388521|NCT00819767|7299912|FG000|NOT COMPLETED|Overall Study||1
6388522|NCT00819767|7299913|FG001|NOT COMPLETED|Overall Study||2
6388523|NCT00819780|7299921|FG000|STARTED|Overall Study||142
6388524|NCT00819780|7299922|FG001|STARTED|Overall Study||143
6388525|NCT00819780|7299921|FG000|Received Study Treatment|Overall Study||139
6388526|NCT00819780|7299922|FG001|Received Study Treatment|Overall Study||139
6388527|NCT00819780|7299921|FG000|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
6388528|NCT00819780|7299922|FG001|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
6388529|NCT00819780|7299921|FG000|NOT COMPLETED|Overall Study||28
6388530|NCT00819780|7299922|FG001|NOT COMPLETED|Overall Study||21
6388531|NCT00819793|7299928|FG000|STARTED|Overall Study||32
6388532|NCT00819793|7299928|FG000|COMPLETED|Overall Study||32
6388533|NCT00819793|7299928|FG000|NOT COMPLETED|Overall Study||0
6388534|NCT00819910|7299937|FG000|STARTED|Overall Study||10
6388535|NCT00819910|7299938|FG001|STARTED|Overall Study||10
6388536|NCT00819910|7299939|FG002|STARTED|Overall Study||10
6388537|NCT00819910|7299940|FG003|STARTED|Overall Study||11
6388538|NCT00819910|7299937|FG000|COMPLETED|Overall Study||8
6388539|NCT00819910|7299938|FG001|COMPLETED|Overall Study||9
6388540|NCT00819910|7299939|FG002|COMPLETED|Overall Study||7
6388541|NCT00819910|7299940|FG003|COMPLETED|Overall Study||10
6388542|NCT00819910|7299937|FG000|NOT COMPLETED|Overall Study||2
6388543|NCT00819910|7299938|FG001|NOT COMPLETED|Overall Study||1
6388544|NCT00819910|7299939|FG002|NOT COMPLETED|Overall Study||3
6388545|NCT00819910|7299940|FG003|NOT COMPLETED|Overall Study||1
6388546|NCT00820040|7299952|FG000|STARTED|Overall Study||10
6388547|NCT00820040|7299952|FG000|Safety Evaluable Population|Overall Study||8
6388548|NCT00820040|7299952|FG000|Full Analysis Set|Overall Study||8
6388549|NCT00820040|7299952|FG000|COMPLETED|Overall Study||7
6388550|NCT00820040|7299952|FG000|NOT COMPLETED|Overall Study||3
6388551|NCT00820170|7299961|FG000|STARTED|Overall Study||3
6388552|NCT00820170|7299962|FG001|STARTED|Overall Study||5
6388553|NCT00820170|7299963|FG002|STARTED|Overall Study||3
6388554|NCT00820170|7299964|FG003|STARTED|Overall Study||40
6388555|NCT00820170|7299965|FG004|STARTED|Overall Study||4
6388556|NCT00820170|7299961|FG000|COMPLETED|Overall Study||3
6388557|NCT00820170|7299962|FG001|COMPLETED|Overall Study||5
6388558|NCT00820170|7299963|FG002|COMPLETED|Overall Study||3
6388559|NCT00820170|7299964|FG003|COMPLETED|Overall Study||40
6388560|NCT00820170|7299965|FG004|COMPLETED|Overall Study||0
6388561|NCT00820170|7299961|FG000|NOT COMPLETED|Overall Study||0
6388562|NCT00820170|7299962|FG001|NOT COMPLETED|Overall Study||0
6388563|NCT00820170|7299963|FG002|NOT COMPLETED|Overall Study||0
6388564|NCT00820170|7299964|FG003|NOT COMPLETED|Overall Study||0
6388565|NCT00820170|7299965|FG004|NOT COMPLETED|Overall Study||4
6388566|NCT00820222|7299984|FG000|STARTED|Overall Study||271
6388567|NCT00820222|7299985|FG001|STARTED|Overall Study||269
6388568|NCT00820222|7299984|FG000|COMPLETED|Overall Study||95
6388569|NCT00820222|7299985|FG001|COMPLETED|Overall Study||79
6388570|NCT00820222|7299984|FG000|NOT COMPLETED|Overall Study||176
6388571|NCT00820222|7299985|FG001|NOT COMPLETED|Overall Study||190
6388572|NCT00820235|7299994|FG000|STARTED|Overall Study||48
6388573|NCT00820235|7299995|FG001|STARTED|Overall Study||49
6388574|NCT00820235|7299996|FG002|STARTED|Overall Study||44
6388575|NCT00820235|7299994|FG000|COMPLETED|Overall Study||33
6388576|NCT00820235|7299995|FG001|COMPLETED|Overall Study||28
6388577|NCT00820235|7299996|FG002|COMPLETED|Overall Study||27
6388578|NCT00820235|7299994|FG000|NOT COMPLETED|Overall Study||15
6388579|NCT00820235|7299995|FG001|NOT COMPLETED|Overall Study||21
6388580|NCT00820235|7299996|FG002|NOT COMPLETED|Overall Study||17
6388581|NCT00820248|7300006|FG000|STARTED|Overall Study||160
6388582|NCT00820248|7300007|FG001|STARTED|Overall Study||160
6388583|NCT00820248|7300006|FG000|Received Protocol Treatment|Overall Study||156
6388584|NCT00820248|7300007|FG001|Received Protocol Treatment|Overall Study||159
6388585|NCT00820248|7300006|FG000|COMPLETED|Overall Study||156
6388586|NCT00820248|7300007|FG001|COMPLETED|Overall Study||159
6388587|NCT00820248|7300006|FG000|NOT COMPLETED|Overall Study||4
6388588|NCT00820248|7300007|FG001|NOT COMPLETED|Overall Study||1
6388589|NCT00820443|7300013|FG000|STARTED|Pre-Op||253
6388590|NCT00820443|7300013|FG000|COMPLETED|Pre-Op||253
6388591|NCT00820443|7300013|FG000|NOT COMPLETED|Pre-Op||0
6388592|NCT00820443|7300013|FG000|STARTED|Op||253
6388593|NCT00820443|7300013|FG000|COMPLETED|Op||253
6388594|NCT00820443|7300013|FG000|NOT COMPLETED|Op||0
6388595|NCT00820443|7300013|FG000|STARTED|Immediately||253
6388596|NCT00820443|7300013|FG000|COMPLETED|Immediately||248
6388597|NCT00820443|7300013|FG000|NOT COMPLETED|Immediately||5
6388598|NCT00820443|7300013|FG000|STARTED|3 Month||253
6388599|NCT00820443|7300013|FG000|COMPLETED|3 Month||244
6388600|NCT00820443|7300013|FG000|NOT COMPLETED|3 Month||9
6388601|NCT00820443|7300013|FG000|STARTED|6 Month||253
6388602|NCT00820443|7300013|FG000|COMPLETED|6 Month||233
6388603|NCT00820443|7300013|FG000|NOT COMPLETED|6 Month||20
6388604|NCT00820443|7300013|FG000|STARTED|12 Month||250
6388605|NCT00820443|7300013|FG000|COMPLETED|12 Month||226
6388606|NCT00820443|7300013|FG000|NOT COMPLETED|12 Month||24
6388607|NCT00820443|7300013|FG000|STARTED|24 Month||245
6388608|NCT00820443|7300013|FG000|COMPLETED|24 Month||202
6388609|NCT00820443|7300013|FG000|NOT COMPLETED|24 Month||43
6388610|NCT00820534|7300020|FG000|STARTED|Overall Study||64
6388611|NCT00820534|7300021|FG001|STARTED|Overall Study||62
6388612|NCT00820534|7300020|FG000|COMPLETED|Overall Study||64
6388613|NCT00820534|7300021|FG001|COMPLETED|Overall Study||62
6388614|NCT00820534|7300020|FG000|NOT COMPLETED|Overall Study||0
6388615|NCT00820534|7300021|FG001|NOT COMPLETED|Overall Study||0
6388616|NCT00820573|7300031|FG000|STARTED|Overall Study||4
6388617|NCT00820573|7300032|FG001|STARTED|Overall Study||4
6388618|NCT00820573|7300033|FG002|STARTED|Overall Study||4
6388619|NCT00820573|7300034|FG003|STARTED|Overall Study||4
6388620|NCT00820573|7300031|FG000|COMPLETED|Overall Study||4
6388621|NCT00820573|7300032|FG001|COMPLETED|Overall Study||4
6388622|NCT00820573|7300033|FG002|COMPLETED|Overall Study||4
6388623|NCT00820573|7300034|FG003|COMPLETED|Overall Study||4
6388624|NCT00820573|7300031|FG000|NOT COMPLETED|Overall Study||0
6388625|NCT00820573|7300032|FG001|NOT COMPLETED|Overall Study||0
6388626|NCT00820573|7300033|FG002|NOT COMPLETED|Overall Study||0
6388627|NCT00820573|7300034|FG003|NOT COMPLETED|Overall Study||0
6388628|NCT00820599|7300053|FG000|STARTED|Overall Study||211
6388629|NCT00820599|7300053|FG000|COMPLETED|Overall Study||80
6388630|NCT00820599|7300053|FG000|NOT COMPLETED|Overall Study||131
6388631|NCT00820612|7300059|FG000|STARTED|Overall Study||307
6388632|NCT00820612|7300060|FG001|STARTED|Overall Study||295
6388633|NCT00820612|7300059|FG000|COMPLETED|Overall Study||307
6388634|NCT00820612|7300060|FG001|COMPLETED|Overall Study||295
6388635|NCT00820612|7300059|FG000|NOT COMPLETED|Overall Study||0
6388636|NCT00820612|7300060|FG001|NOT COMPLETED|Overall Study||0
6388637|NCT00820664|7300069|FG000|STARTED|Overall Study||9
6388638|NCT00820664|7300070|FG001|STARTED|Overall Study||11
6388639|NCT00820664|7300071|FG002|STARTED|Overall Study||9
6388640|NCT00820664|7300069|FG000|COMPLETED|Overall Study||9
6388641|NCT00820664|7300070|FG001|COMPLETED|Overall Study||11
6388642|NCT00820664|7300071|FG002|COMPLETED|Overall Study||9
6566454|NCT01824576|7489388|FG000|NOT COMPLETED|Overall Study||2
6566455|NCT01824589|7489396|FG000|STARTED|Overall Study||1
6566456|NCT01824589|7489397|FG001|STARTED|Overall Study||0
6566457|NCT01824589|7489398|FG002|STARTED|Overall Study||0
6566458|NCT01824589|7489399|FG003|STARTED|Overall Study||0
6566459|NCT01824589|7489396|FG000|COMPLETED|Overall Study||1
6566460|NCT01824589|7489397|FG001|COMPLETED|Overall Study||0
6388643|NCT00820664|7300069|FG000|NOT COMPLETED|Overall Study||0
6388644|NCT00820664|7300070|FG001|NOT COMPLETED|Overall Study||0
6566461|NCT01824589|7489398|FG002|COMPLETED|Overall Study||0
6566462|NCT01824589|7489399|FG003|COMPLETED|Overall Study||0
6566463|NCT01824589|7489396|FG000|NOT COMPLETED|Overall Study||0
6566464|NCT01824589|7489397|FG001|NOT COMPLETED|Overall Study||0
6566465|NCT01824589|7489398|FG002|NOT COMPLETED|Overall Study||0
6566466|NCT01824589|7489399|FG003|NOT COMPLETED|Overall Study||0
6566467|NCT01824602|7489413|FG000|STARTED|Overall Study||11
6566468|NCT01824602|7489414|FG001|STARTED|Overall Study||8
6566469|NCT01824602|7489415|FG002|STARTED|Overall Study||9
6566470|NCT01824602|7489416|FG003|STARTED|Overall Study||10
6566471|NCT01824602|7489413|FG000|Safety Population|Overall Study||11
6566472|NCT01824602|7489414|FG001|Safety Population|Overall Study||8
6566473|NCT01824602|7489415|FG002|Safety Population|Overall Study||9
6566474|NCT01824602|7489416|FG003|Safety Population|Overall Study||10
6656899|NCT02465489|7587252|FG000|STARTED|Overall Study||20
6566475|NCT01824602|7489413|FG000|Intent-to-treat Population|Overall Study||11
6566476|NCT01824602|7489414|FG001|Intent-to-treat Population|Overall Study||8
6566477|NCT01824602|7489415|FG002|Intent-to-treat Population|Overall Study||9
6566478|NCT01824602|7489416|FG003|Intent-to-treat Population|Overall Study||9
6566479|NCT01824602|7489413|FG000|COMPLETED|Overall Study||10
6566480|NCT01824602|7489414|FG001|COMPLETED|Overall Study||8
6566481|NCT01824602|7489415|FG002|COMPLETED|Overall Study||5
6566482|NCT01824602|7489416|FG003|COMPLETED|Overall Study||5
6566483|NCT01824602|7489413|FG000|NOT COMPLETED|Overall Study||1
6566484|NCT01824602|7489414|FG001|NOT COMPLETED|Overall Study||0
6566485|NCT01824602|7489415|FG002|NOT COMPLETED|Overall Study||4
6566486|NCT01824602|7489416|FG003|NOT COMPLETED|Overall Study||5
6566487|NCT01824693|7489429|FG000|STARTED|Overall Study||6
6566488|NCT01824693|7489430|FG001|STARTED|Overall Study||9
6566489|NCT01824693|7489431|FG002|STARTED|Overall Study||15
6566490|NCT01824693|7489429|FG000|COMPLETED|Overall Study||5
6566491|NCT01824693|7489430|FG001|COMPLETED|Overall Study||2
6388645|NCT00820664|7300071|FG002|NOT COMPLETED|Overall Study||0
6566492|NCT01824693|7489431|FG002|COMPLETED|Overall Study||0
6566493|NCT01824693|7489429|FG000|NOT COMPLETED|Overall Study||1
6566494|NCT01824693|7489430|FG001|NOT COMPLETED|Overall Study||7
6566495|NCT01824693|7489431|FG002|NOT COMPLETED|Overall Study||15
6566496|NCT01824823|7489440|FG000|STARTED|Overall Study||2
6566497|NCT01824823|7489441|FG001|STARTED|Overall Study||1
6566498|NCT01824823|7489440|FG000|COMPLETED|Overall Study||0
6566499|NCT01824823|7489441|FG001|COMPLETED|Overall Study||0
6566500|NCT01824823|7489440|FG000|NOT COMPLETED|Overall Study||2
6388646|NCT00820755|7300079|FG000|STARTED|Period 1: Combination Therapy Phase||583
6566501|NCT01824823|7489441|FG001|NOT COMPLETED|Overall Study||1
6566502|NCT01824901|7489447|FG000|STARTED|Overall Study||2
6388647|NCT00820755|7300080|FG001|STARTED|Period 1: Combination Therapy Phase||0
6388648|NCT00820755|7300081|FG002|STARTED|Period 1: Combination Therapy Phase||0
6388649|NCT00820755|7300079|FG000|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
6388650|NCT00820755|7300080|FG001|COMPLETED|Period 1: Combination Therapy Phase||0
6388651|NCT00820755|7300081|FG002|COMPLETED|Period 1: Combination Therapy Phase||0
6388652|NCT00820755|7300079|FG000|NOT COMPLETED|Period 1: Combination Therapy Phase||270
6504196|NCT01447511|7423322|FG004|STARTED|Rifampin Period||4
6504197|NCT01447511|7423318|FG000|COMPLETED|Rifampin Period||8
6504198|NCT01447511|7423319|FG001|COMPLETED|Rifampin Period||5
6504199|NCT01447511|7423320|FG002|COMPLETED|Rifampin Period||8
6504200|NCT01447511|7423321|FG003|COMPLETED|Rifampin Period||2
6504201|NCT01447511|7423322|FG004|COMPLETED|Rifampin Period||4
6504202|NCT01447511|7423318|FG000|NOT COMPLETED|Rifampin Period||0
6504203|NCT01447511|7423319|FG001|NOT COMPLETED|Rifampin Period||0
6504204|NCT01447511|7423320|FG002|NOT COMPLETED|Rifampin Period||0
6504205|NCT01447511|7423321|FG003|NOT COMPLETED|Rifampin Period||1
6504206|NCT01447511|7423322|FG004|NOT COMPLETED|Rifampin Period||0
6504207|NCT01447576|7423334|FG000|STARTED|Overall Study||1036
6504208|NCT01447576|7423334|FG000|COMPLETED|Overall Study||560
6504209|NCT01447576|7423334|FG000|NOT COMPLETED|Overall Study||476
6504210|NCT01447706|7423340|FG000|STARTED|Overall Study||140
6504211|NCT01447706|7423341|FG001|STARTED|Overall Study|3 patients enrolled but not dosed|83
6504212|NCT01447706|7423340|FG000|COMPLETED|Overall Study||140
6504213|NCT01447706|7423341|FG001|COMPLETED|Overall Study||80
6504214|NCT01447706|7423340|FG000|NOT COMPLETED|Overall Study||0
6504215|NCT01447706|7423341|FG001|NOT COMPLETED|Overall Study||3
6504216|NCT01447719|7423351|FG000|STARTED|Overall Study||152
6504217|NCT01447719|7423351|FG000|Valid AV-45 Scan Acquired|Overall Study||147
6504218|NCT01447719|7423351|FG000|Deceased <2 Years After AV-45 Scan|Overall Study||66
6504219|NCT01447719|7423351|FG000|COMPLETED|Overall Study||59
6504220|NCT01447719|7423351|FG000|NOT COMPLETED|Overall Study||93
6504221|NCT01447849|7423364|FG000|STARTED|First Intervention||10
6504222|NCT01447849|7423365|FG001|STARTED|First Intervention||10
6504223|NCT01447849|7423366|FG002|STARTED|First Intervention||10
6504224|NCT01447849|7423367|FG003|STARTED|First Intervention||10
6504225|NCT01447849|7423364|FG000|COMPLETED|First Intervention||10
6504226|NCT01447849|7423365|FG001|COMPLETED|First Intervention||10
6504227|NCT01447849|7423366|FG002|COMPLETED|First Intervention||10
6504228|NCT01447849|7423367|FG003|COMPLETED|First Intervention||10
6504229|NCT01447849|7423364|FG000|NOT COMPLETED|First Intervention||0
6504230|NCT01447849|7423365|FG001|NOT COMPLETED|First Intervention||0
6504231|NCT01447849|7423366|FG002|NOT COMPLETED|First Intervention||0
6388653|NCT00820755|7300080|FG001|NOT COMPLETED|Period 1: Combination Therapy Phase||0
6388654|NCT00820755|7300081|FG002|NOT COMPLETED|Period 1: Combination Therapy Phase||0
6504232|NCT01447849|7423367|FG003|NOT COMPLETED|First Intervention||0
6504233|NCT01447849|7423364|FG000|STARTED|Washout Period for 1 Week||10
6504234|NCT01447849|7423365|FG001|STARTED|Washout Period for 1 Week||10
6504235|NCT01447849|7423366|FG002|STARTED|Washout Period for 1 Week||10
6504236|NCT01447849|7423367|FG003|STARTED|Washout Period for 1 Week||10
6504237|NCT01447849|7423364|FG000|COMPLETED|Washout Period for 1 Week||10
6504238|NCT01447849|7423365|FG001|COMPLETED|Washout Period for 1 Week||10
6504239|NCT01447849|7423366|FG002|COMPLETED|Washout Period for 1 Week||10
6504240|NCT01447849|7423367|FG003|COMPLETED|Washout Period for 1 Week||10
6504241|NCT01447849|7423364|FG000|NOT COMPLETED|Washout Period for 1 Week||0
6504242|NCT01447849|7423365|FG001|NOT COMPLETED|Washout Period for 1 Week||0
6504243|NCT01447849|7423366|FG002|NOT COMPLETED|Washout Period for 1 Week||0
6504244|NCT01447849|7423367|FG003|NOT COMPLETED|Washout Period for 1 Week||0
6504245|NCT01447849|7423364|FG000|STARTED|Second Intervention||10
6566503|NCT01824901|7489448|FG001|STARTED|Overall Study||0
6273482|NCT00101868|7172673|FG001|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
6273483|NCT00101868|7172672|FG000|NOT COMPLETED|Overall Study||29
6273484|NCT00101868|7172673|FG001|NOT COMPLETED|Overall Study||32
6273485|NCT00101907|7172687|FG000|STARTED|Overall Study||8
6273486|NCT00101907|7172688|FG001|STARTED|Overall Study||8
6273487|NCT00101907|7172689|FG002|STARTED|Overall Study||6
6273488|NCT00101907|7172690|FG003|STARTED|Overall Study||6
6273489|NCT00101907|7172691|FG004|STARTED|Overall Study||11
6273490|NCT00101907|7172692|FG005|STARTED|Overall Study||2
6273491|NCT00101907|7172687|FG000|COMPLETED|Overall Study||6
6273492|NCT00101907|7172688|FG001|COMPLETED|Overall Study||7
6273493|NCT00101907|7172689|FG002|COMPLETED|Overall Study||5
6273494|NCT00101907|7172690|FG003|COMPLETED|Overall Study||5
6273495|NCT00101907|7172691|FG004|COMPLETED|Overall Study||6
6273496|NCT00101907|7172692|FG005|COMPLETED|Overall Study||2
6273497|NCT00101907|7172687|FG000|NOT COMPLETED|Overall Study||2
6273498|NCT00101907|7172688|FG001|NOT COMPLETED|Overall Study||1
6273499|NCT00101907|7172689|FG002|NOT COMPLETED|Overall Study||1
6273500|NCT00101907|7172690|FG003|NOT COMPLETED|Overall Study||1
6273501|NCT00101907|7172691|FG004|NOT COMPLETED|Overall Study||5
6273502|NCT00101907|7172692|FG005|NOT COMPLETED|Overall Study||0
6273503|NCT00101933|7172715|FG000|STARTED|Overall Study||54
6273504|NCT00101933|7172716|FG001|STARTED|Overall Study||55
6273505|NCT00101933|7172715|FG000|COMPLETED|Overall Study||54
6273506|NCT00101933|7172716|FG001|COMPLETED|Overall Study||55
6273507|NCT00101933|7172715|FG000|NOT COMPLETED|Overall Study||0
6273508|NCT00101933|7172716|FG001|NOT COMPLETED|Overall Study||0
6273509|NCT00102063|7172726|FG000|STARTED|Overall Study||100
6273510|NCT00102063|7172727|FG001|STARTED|Overall Study||102
6273511|NCT00102063|7172728|FG002|STARTED|Overall Study||100
6273512|NCT00102063|7172726|FG000|COMPLETED|Overall Study||84
6273513|NCT00102063|7172727|FG001|COMPLETED|Overall Study||84
6273514|NCT00102063|7172728|FG002|COMPLETED|Overall Study||90
6273515|NCT00102063|7172726|FG000|NOT COMPLETED|Overall Study||16
6273516|NCT00102063|7172727|FG001|NOT COMPLETED|Overall Study||18
6273517|NCT00102063|7172728|FG002|NOT COMPLETED|Overall Study||10
6273518|NCT00102440|7172739|FG000|STARTED|Overall Study||256
6273519|NCT00102440|7172740|FG001|STARTED|Overall Study||251
6273520|NCT00102440|7172741|FG002|STARTED|Overall Study||253
6273521|NCT00102440|7172739|FG000|COMPLETED|Overall Study||168
6273522|NCT00102440|7172740|FG001|COMPLETED|Overall Study||153
6273523|NCT00102440|7172741|FG002|COMPLETED|Overall Study||187
6388655|NCT00820755|7300079|FG000|STARTED|Period 2: Maintenance Therapy Phase||0
6388656|NCT00820755|7300080|FG001|STARTED|Period 2: Maintenance Therapy Phase||157
6388657|NCT00820755|7300081|FG002|STARTED|Period 2: Maintenance Therapy Phase||154
6388658|NCT00820755|7300079|FG000|COMPLETED|Period 2: Maintenance Therapy Phase||0
6388659|NCT00820755|7300080|FG001|COMPLETED|Period 2: Maintenance Therapy Phase||112
6566504|NCT01824901|7489449|FG002|STARTED|Overall Study||0
6273524|NCT00102440|7172739|FG000|NOT COMPLETED|Overall Study||88
6273525|NCT00102440|7172740|FG001|NOT COMPLETED|Overall Study||98
6273526|NCT00102440|7172741|FG002|NOT COMPLETED|Overall Study||66
6273527|NCT00102518|7172749|FG000|STARTED|Overall Study||325
6273528|NCT00102518|7172749|FG000|COMPLETED|Overall Study||238
6273529|NCT00102518|7172749|FG000|NOT COMPLETED|Overall Study||87
6273530|NCT00102531|7172755|FG000|STARTED|Overall Study||7
6273531|NCT00102531|7172756|FG001|STARTED|Overall Study||12
6273532|NCT00102531|7172755|FG000|COMPLETED|Overall Study||2
6273533|NCT00102531|7172756|FG001|COMPLETED|Overall Study||1
6273534|NCT00102531|7172755|FG000|NOT COMPLETED|Overall Study||5
6273535|NCT00102531|7172756|FG001|NOT COMPLETED|Overall Study||11
6273536|NCT00102596|7172762|FG000|STARTED|Part A||11
6273537|NCT00102596|7172763|FG001|STARTED|Part A||0
6273538|NCT00102596|7172762|FG000|Participants Assigned Treatment|Part A||5
6273539|NCT00102596|7172763|FG001|Participants Assigned Treatment|Part A||0
6273540|NCT00102596|7172762|FG000|COMPLETED|Part A||4
6273541|NCT00102596|7172763|FG001|COMPLETED|Part A||0
6273542|NCT00102596|7172762|FG000|NOT COMPLETED|Part A||7
6273543|NCT00102596|7172763|FG001|NOT COMPLETED|Part A||0
6273544|NCT00102596|7172762|FG000|STARTED|Part B|Participants from Part A did not continue to Part B|0
6273545|NCT00102596|7172763|FG001|STARTED|Part B||10
6273546|NCT00102596|7172762|FG000|COMPLETED|Part B||0
6273547|NCT00102596|7172763|FG001|COMPLETED|Part B||10
6273548|NCT00102596|7172762|FG000|NOT COMPLETED|Part B||0
6273549|NCT00102596|7172763|FG001|NOT COMPLETED|Part B||0
6273550|NCT00102596|7172762|FG000|STARTED|Part C||0
6273551|NCT00102596|7172763|FG001|STARTED|Part C|Only 2 patients participated in Part C|2
6273552|NCT00102596|7172762|FG000|COMPLETED|Part C||0
6273553|NCT00102596|7172763|FG001|COMPLETED|Part C||2
6273554|NCT00102596|7172762|FG000|NOT COMPLETED|Part C||0
6273555|NCT00102596|7172763|FG001|NOT COMPLETED|Part C||0
6273556|NCT00102687|7172773|FG000|STARTED|Initial Period||50
6273557|NCT00102687|7172774|FG001|STARTED|Initial Period||50
6273558|NCT00102687|7172775|FG002|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
6273559|NCT00102687|7172776|FG003|STARTED|Initial Period||0
6273560|NCT00102687|7172777|FG004|STARTED|Initial Period||0
6273561|NCT00102687|7172773|FG000|COMPLETED|Initial Period||32
6273562|NCT00102687|7172774|FG001|COMPLETED|Initial Period||22
6273563|NCT00102687|7172775|FG002|COMPLETED|Initial Period||25
6273564|NCT00102687|7172776|FG003|COMPLETED|Initial Period||0
6273565|NCT00102687|7172777|FG004|COMPLETED|Initial Period||0
6273566|NCT00102687|7172773|FG000|NOT COMPLETED|Initial Period||18
6273567|NCT00102687|7172774|FG001|NOT COMPLETED|Initial Period||28
6273568|NCT00102687|7172775|FG002|NOT COMPLETED|Initial Period||26
6273569|NCT00102687|7172776|FG003|NOT COMPLETED|Initial Period||0
6273570|NCT00102687|7172777|FG004|NOT COMPLETED|Initial Period||0
6273571|NCT00102687|7172773|FG000|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
6273572|NCT00102687|7172774|FG001|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
6273573|NCT00102687|7172775|FG002|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
6280745|NCT00159263|7180664|FG000|COMPLETED|Third Intervention||1
6566505|NCT01824901|7489450|FG003|STARTED|Overall Study||0
6388660|NCT00820755|7300081|FG002|COMPLETED|Period 2: Maintenance Therapy Phase||109
6388661|NCT00820755|7300079|FG000|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
6388662|NCT00820755|7300080|FG001|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
6388663|NCT00820755|7300081|FG002|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
6388664|NCT00820872|7300089|FG000|STARTED|Overall Study||30
6388665|NCT00820872|7300089|FG000|COMPLETED|Overall Study||30
6388666|NCT00820872|7300089|FG000|NOT COMPLETED|Overall Study||0
6388667|NCT00820898|7300093|FG000|STARTED|Overall Study||24
6388668|NCT00820898|7300093|FG000|COMPLETED|Overall Study||23
6388669|NCT00820898|7300093|FG000|NOT COMPLETED|Overall Study||1
6388670|NCT00821015|7300103|FG000|STARTED|Overall Study||27
6388671|NCT00821015|7300103|FG000|COMPLETED|Overall Study||15
6388672|NCT00821015|7300103|FG000|NOT COMPLETED|Overall Study||12
6388673|NCT00821041|7300109|FG000|STARTED|Overall Study||59
6388674|NCT00821041|7300110|FG001|STARTED|Overall Study||59
6388675|NCT00821041|7300109|FG000|COMPLETED|Overall Study||59
6388676|NCT00821041|7300110|FG001|COMPLETED|Overall Study||59
6388677|NCT00821041|7300109|FG000|NOT COMPLETED|Overall Study||0
6388678|NCT00821041|7300110|FG001|NOT COMPLETED|Overall Study||0
6388679|NCT00821093|7300118|FG000|STARTED|Overall Study||560
6388680|NCT00821093|7300119|FG001|STARTED|Overall Study||563
6388681|NCT00821093|7300118|FG000|Exposed to Drug|Overall Study||559
6388682|NCT00821093|7300119|FG001|Exposed to Drug|Overall Study||562
6388683|NCT00821093|7300118|FG000|COMPLETED|Overall Study||511
6388684|NCT00821093|7300119|FG001|COMPLETED|Overall Study||523
6388685|NCT00821093|7300118|FG000|NOT COMPLETED|Overall Study||49
6388686|NCT00821093|7300119|FG001|NOT COMPLETED|Overall Study||40
6388687|NCT00821119|7300127|FG000|STARTED|Overall Study||100
6388688|NCT00821119|7300128|FG001|STARTED|Overall Study||100
6388689|NCT00821119|7300127|FG000|COMPLETED|Overall Study||100
6388690|NCT00821119|7300128|FG001|COMPLETED|Overall Study||100
6388691|NCT00821119|7300127|FG000|NOT COMPLETED|Overall Study||0
6388692|NCT00821119|7300128|FG001|NOT COMPLETED|Overall Study||0
6388693|NCT00821184|7300138|FG000|STARTED|Overall Study||6
6388694|NCT00821184|7300139|FG001|STARTED|Overall Study||6
6388695|NCT00821184|7300138|FG000|COMPLETED|Overall Study||6
6388696|NCT00821184|7300139|FG001|COMPLETED|Overall Study||6
6388697|NCT00821184|7300138|FG000|NOT COMPLETED|Overall Study||0
6388698|NCT00821184|7300139|FG001|NOT COMPLETED|Overall Study||0
6504246|NCT01447849|7423365|FG001|STARTED|Second Intervention||10
6504247|NCT01447849|7423366|FG002|STARTED|Second Intervention||10
6504248|NCT01447849|7423367|FG003|STARTED|Second Intervention||10
6504249|NCT01447849|7423364|FG000|COMPLETED|Second Intervention||10
6504250|NCT01447849|7423365|FG001|COMPLETED|Second Intervention||10
6504251|NCT01447849|7423366|FG002|COMPLETED|Second Intervention||10
6504252|NCT01447849|7423367|FG003|COMPLETED|Second Intervention||10
6504253|NCT01447849|7423364|FG000|NOT COMPLETED|Second Intervention||0
6504254|NCT01447849|7423365|FG001|NOT COMPLETED|Second Intervention||0
6504255|NCT01447849|7423366|FG002|NOT COMPLETED|Second Intervention||0
6504256|NCT01447849|7423367|FG003|NOT COMPLETED|Second Intervention||0
6504257|NCT01447888|7423379|FG000|STARTED|Overall Study||45
6566506|NCT01824901|7489447|FG000|COMPLETED|Overall Study||2
6504258|NCT01447888|7423380|FG001|STARTED|Overall Study||55
6504259|NCT01447888|7423379|FG000|COMPLETED|Overall Study||45
6504260|NCT01447888|7423380|FG001|COMPLETED|Overall Study||55
6504261|NCT01447888|7423379|FG000|NOT COMPLETED|Overall Study||0
6504262|NCT01447888|7423380|FG001|NOT COMPLETED|Overall Study||0
6273574|NCT00102687|7172776|FG003|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
6273575|NCT00102687|7172777|FG004|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
6273576|NCT00102687|7172773|FG000|COMPLETED|Maintenance Period||6
6273577|NCT00102687|7172774|FG001|COMPLETED|Maintenance Period||2
6273578|NCT00102687|7172775|FG002|COMPLETED|Maintenance Period||2
6388699|NCT04187989|7300149|FG000|STARTED|Overall Study - 3-Month Follow-Up||76
6388700|NCT04187989|7300150|FG001|STARTED|Overall Study - 3-Month Follow-Up||73
6388701|NCT04187989|7300149|FG000|COMPLETED|Overall Study - 3-Month Follow-Up||70
6388702|NCT04187989|7300150|FG001|COMPLETED|Overall Study - 3-Month Follow-Up||65
6388703|NCT04187989|7300149|FG000|NOT COMPLETED|Overall Study - 3-Month Follow-Up||6
6388704|NCT04187989|7300150|FG001|NOT COMPLETED|Overall Study - 3-Month Follow-Up||8
6388705|NCT04187989|7300149|FG000|STARTED|Overall Study - 6-Month Follow-Up||76
6388706|NCT04187989|7300150|FG001|STARTED|Overall Study - 6-Month Follow-Up||73
6388707|NCT04187989|7300149|FG000|COMPLETED|Overall Study - 6-Month Follow-Up||68
6388708|NCT04187989|7300150|FG001|COMPLETED|Overall Study - 6-Month Follow-Up||65
6388709|NCT04187989|7300149|FG000|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
6388710|NCT04187989|7300150|FG001|NOT COMPLETED|Overall Study - 6-Month Follow-Up||8
6504263|NCT01447914|7423386|FG000|STARTED|Overall Study||16
6504264|NCT01447914|7423386|FG000|COMPLETED|Overall Study||16
6504265|NCT01447914|7423386|FG000|NOT COMPLETED|Overall Study||0
6504266|NCT01447927|7423392|FG000|STARTED|Overall Study||38
6504267|NCT01447927|7423393|FG001|STARTED|Overall Study||36
6504268|NCT01447927|7423392|FG000|COMPLETED|Overall Study||33
6504269|NCT01447927|7423393|FG001|COMPLETED|Overall Study||33
6504270|NCT01447927|7423392|FG000|NOT COMPLETED|Overall Study||5
6504271|NCT01447927|7423393|FG001|NOT COMPLETED|Overall Study||3
6504272|NCT01448044|7423401|FG000|STARTED|Treatment Period||82
6504273|NCT01448044|7423402|FG001|STARTED|Treatment Period||42
6504274|NCT01448044|7423401|FG000|COMPLETED|Treatment Period||59
6504275|NCT01448044|7423402|FG001|COMPLETED|Treatment Period||26
6504276|NCT01448044|7423401|FG000|NOT COMPLETED|Treatment Period||23
6504277|NCT01448044|7423402|FG001|NOT COMPLETED|Treatment Period||16
6504278|NCT01448044|7423401|FG000|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
6504279|NCT01448044|7423402|FG001|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
6504280|NCT01448044|7423401|FG000|COMPLETED|Follow Up Period||65
6504281|NCT01448044|7423402|FG001|COMPLETED|Follow Up Period||26
6504282|NCT01448044|7423401|FG000|NOT COMPLETED|Follow Up Period||12
6504283|NCT01448044|7423402|FG001|NOT COMPLETED|Follow Up Period||14
6504284|NCT01448057|7423410|FG000|STARTED|Overall Study||170
6504285|NCT01448057|7423411|FG001|STARTED|Overall Study||171
6504286|NCT01448057|7423410|FG000|COMPLETED|Overall Study||162
6504287|NCT01448057|7423411|FG001|COMPLETED|Overall Study||167
6504288|NCT01448057|7423410|FG000|NOT COMPLETED|Overall Study||8
6504289|NCT01448057|7423411|FG001|NOT COMPLETED|Overall Study||4
6504290|NCT01448213|7423419|FG000|STARTED|Overall Study||130
6504291|NCT01448213|7423420|FG001|STARTED|Overall Study||134
6504292|NCT01448213|7423419|FG000|COMPLETED|Overall Study||113
6504293|NCT01448213|7423420|FG001|COMPLETED|Overall Study||112
6504294|NCT01448213|7423419|FG000|NOT COMPLETED|Overall Study||17
6504295|NCT01448213|7423420|FG001|NOT COMPLETED|Overall Study||22
6504296|NCT01448356|7423426|FG000|STARTED|Overall Study||10
6504297|NCT01448356|7423426|FG000|COMPLETED|Overall Study|cross-over|10
6504298|NCT01448356|7423426|FG000|NOT COMPLETED|Overall Study||0
6504299|NCT01448421|7423431|FG000|STARTED|Overall Study||37
6504300|NCT01448421|7423431|FG000|COMPLETED|Overall Study||37
6504301|NCT01448421|7423431|FG000|NOT COMPLETED|Overall Study||0
6504302|NCT01448447|7423437|FG000|STARTED|Overall Study||20
6504303|NCT01448447|7423438|FG001|STARTED|Overall Study||0
6504304|NCT01448447|7423437|FG000|COMPLETED|Overall Study||20
6504305|NCT01448447|7423438|FG001|COMPLETED|Overall Study||0
6504306|NCT01448447|7423437|FG000|NOT COMPLETED|Overall Study||0
6504307|NCT01448447|7423438|FG001|NOT COMPLETED|Overall Study||0
6504308|NCT01448486|7423446|FG000|STARTED|Overall Study||3
6504309|NCT01448486|7423447|FG001|STARTED|Overall Study||3
6504310|NCT01448486|7423446|FG000|COMPLETED|Overall Study||3
6504311|NCT01448486|7423447|FG001|COMPLETED|Overall Study||3
6504312|NCT01448486|7423446|FG000|NOT COMPLETED|Overall Study||0
6504313|NCT01448486|7423447|FG001|NOT COMPLETED|Overall Study||0
6504314|NCT01448525|7423455|FG000|STARTED|Overall Study||44
6504315|NCT01448525|7423456|FG001|STARTED|Overall Study||44
6504316|NCT01448525|7423455|FG000|COMPLETED|Overall Study||43
6504317|NCT01448525|7423456|FG001|COMPLETED|Overall Study||42
6504318|NCT01448525|7423455|FG000|NOT COMPLETED|Overall Study||1
6273579|NCT00102687|7172776|FG003|COMPLETED|Maintenance Period||12
6273580|NCT00102687|7172777|FG004|COMPLETED|Maintenance Period||8
6273581|NCT00102687|7172773|FG000|NOT COMPLETED|Maintenance Period||7
6273582|NCT00102687|7172774|FG001|NOT COMPLETED|Maintenance Period||4
6273583|NCT00102687|7172775|FG002|NOT COMPLETED|Maintenance Period||6
6273584|NCT00102687|7172776|FG003|NOT COMPLETED|Maintenance Period||10
6273585|NCT00102687|7172777|FG004|NOT COMPLETED|Maintenance Period||13
6273586|NCT00102804|7172795|FG000|STARTED|Overall Study||441
6273587|NCT00102804|7172796|FG001|STARTED|Overall Study||222
6273588|NCT00102804|7172795|FG000|Received at Least 1 Dose of Study Drug|Overall Study||434
6273589|NCT00102804|7172796|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
6273590|NCT00102804|7172795|FG000|COMPLETED|Overall Study||0
6273591|NCT00102804|7172796|FG001|COMPLETED|Overall Study||0
6273592|NCT00102804|7172795|FG000|NOT COMPLETED|Overall Study||441
6273593|NCT00102804|7172796|FG001|NOT COMPLETED|Overall Study||222
6273594|NCT00102960|7172805|FG000|STARTED|Overall Study||125
6273595|NCT00102960|7172806|FG001|STARTED|Overall Study||126
6273596|NCT00102960|7172807|FG002|STARTED|Overall Study||126
6273597|NCT00102960|7172805|FG000|COMPLETED|Overall Study||95
6273598|NCT00102960|7172806|FG001|COMPLETED|Overall Study||103
6273599|NCT00102960|7172807|FG002|COMPLETED|Overall Study||98
6273600|NCT00102960|7172805|FG000|NOT COMPLETED|Overall Study||30
6273601|NCT00102960|7172806|FG001|NOT COMPLETED|Overall Study||23
6273602|NCT00102960|7172807|FG002|NOT COMPLETED|Overall Study||28
6273603|NCT00103012|7172822|FG000|STARTED|Overall Study||17
6273604|NCT00103012|7172823|FG001|STARTED|Overall Study||14
6273605|NCT00103012|7172824|FG002|STARTED|Overall Study||16
6273606|NCT00103012|7172822|FG000|COMPLETED|Overall Study||14
6273607|NCT00103012|7172823|FG001|COMPLETED|Overall Study||13
6273608|NCT00103012|7172824|FG002|COMPLETED|Overall Study||12
6273609|NCT00103012|7172822|FG000|NOT COMPLETED|Overall Study||3
6273610|NCT00103012|7172823|FG001|NOT COMPLETED|Overall Study||1
6273611|NCT00103012|7172824|FG002|NOT COMPLETED|Overall Study||4
6273612|NCT00103116|7172832|FG000|STARTED|Overall Study||32
6273613|NCT00103116|7172832|FG000|COMPLETED|Overall Study||32
6273614|NCT00103116|7172832|FG000|NOT COMPLETED|Overall Study||0
6273615|NCT00103142|7172838|FG000|STARTED|Overall Study||36
6273616|NCT00103142|7172839|FG001|STARTED|Overall Study||37
6273617|NCT00103142|7172838|FG000|COMPLETED|Overall Study||33
6566507|NCT01824901|7489448|FG001|COMPLETED|Overall Study||0
6566508|NCT01824901|7489449|FG002|COMPLETED|Overall Study||0
6566509|NCT01824901|7489450|FG003|COMPLETED|Overall Study||0
6566510|NCT01824901|7489447|FG000|NOT COMPLETED|Overall Study||0
6273618|NCT00103142|7172839|FG001|COMPLETED|Overall Study||36
6273619|NCT00103142|7172838|FG000|NOT COMPLETED|Overall Study||3
6273620|NCT00103142|7172839|FG001|NOT COMPLETED|Overall Study||1
6273621|NCT00103194|7172847|FG000|STARTED|Overall Study||49
6273622|NCT00103194|7172847|FG000|Treated|Overall Study||49
6273623|NCT00103194|7172847|FG000|Eligible|Overall Study||35
6273624|NCT00103194|7172847|FG000|Eligible and Treated|Overall Study||35
6273625|NCT00103194|7172847|FG000|COMPLETED|Overall Study||18
6273626|NCT00103194|7172847|FG000|NOT COMPLETED|Overall Study||31
6273627|NCT00103207|7172851|FG000|STARTED|Overall Study||72
6273628|NCT00103207|7172851|FG000|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
6273629|NCT00103207|7172851|FG000|Eligible Patients w/ Smoking Status Data|Overall Study||37
6273630|NCT00103207|7172851|FG000|COMPLETED|Overall Study||34
6273631|NCT00103207|7172851|FG000|NOT COMPLETED|Overall Study||38
6273632|NCT00103259|7172859|FG000|STARTED|Overall Study||27
6273633|NCT00103259|7172860|FG001|STARTED|Overall Study||44
6273634|NCT00103259|7172859|FG000|Eligible|Overall Study||27
6273635|NCT00103259|7172860|FG001|Eligible|Overall Study||41
6273636|NCT00103259|7172859|FG000|Treated|Overall Study||23
6273637|NCT00103259|7172860|FG001|Treated|Overall Study||41
6273638|NCT00103259|7172859|FG000|Eligible and Treated|Overall Study||23
6273639|NCT00103259|7172860|FG001|Eligible and Treated|Overall Study||38
6273640|NCT00103259|7172859|FG000|Cross Over to the Other Arm|Overall Study||0
6273641|NCT00103259|7172860|FG001|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
6273642|NCT00103259|7172859|FG000|Eligible Patients Who Cross Over|Overall Study||0
6273643|NCT00103259|7172860|FG001|Eligible Patients Who Cross Over|Overall Study||10
6566511|NCT01824901|7489448|FG001|NOT COMPLETED|Overall Study||0
6273644|NCT00103259|7172859|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
6273645|NCT00103259|7172860|FG001|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
6806373|NCT03861039|7738572|FG001|COMPLETED|Overall Study||139
6504319|NCT01448525|7423456|FG001|NOT COMPLETED|Overall Study||2
6504320|NCT01448616|7423465|FG000|STARTED|Lead-In (Observational Phase)||73
6504321|NCT01448616|7423466|FG001|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
6504322|NCT01448616|7423467|FG002|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
6504323|NCT01448616|7423468|FG003|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
6504324|NCT01448616|7423465|FG000|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
6504325|NCT01448616|7423466|FG001|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
6504326|NCT01448616|7423467|FG002|COMPLETED|Lead-In (Observational Phase)||0
6504327|NCT01448616|7423468|FG003|COMPLETED|Lead-In (Observational Phase)||0
6504328|NCT01448616|7423465|FG000|NOT COMPLETED|Lead-In (Observational Phase)||9
6504329|NCT01448616|7423466|FG001|NOT COMPLETED|Lead-In (Observational Phase)||0
6806374|NCT03861039|7738573|FG002|COMPLETED|Overall Study||133
6806375|NCT03861039|7738571|FG000|NOT COMPLETED|Overall Study||3
6806376|NCT03861039|7738572|FG001|NOT COMPLETED|Overall Study||8
6806377|NCT03861039|7738573|FG002|NOT COMPLETED|Overall Study||15
6806378|NCT03759587|7738583|FG000|STARTED|Overall Study||19
6806379|NCT03759587|7738583|FG000|COMPLETED|Overall Study||0
6806380|NCT03759587|7738583|FG000|NOT COMPLETED|Overall Study||19
6806381|NCT03730662|7738591|FG000|STARTED|Treatment Period (52 Weeks)||329
6806382|NCT03730662|7738592|FG001|STARTED|Treatment Period (52 Weeks)||330
6806383|NCT03730662|7738593|FG002|STARTED|Treatment Period (52 Weeks)||338
6806384|NCT03730662|7738594|FG003|STARTED|Treatment Period (52 Weeks)||1005
6806385|NCT03730662|7738591|FG000|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||329
6806386|NCT03730662|7738592|FG001|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||328
6806387|NCT03730662|7738593|FG002|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||338
6806388|NCT03730662|7738594|FG003|Received at Least One Dose of Study Drug|Treatment Period (52 Weeks)||1000
6806389|NCT03730662|7738591|FG000|COMPLETED|Treatment Period (52 Weeks)||308
6806390|NCT03730662|7738592|FG001|COMPLETED|Treatment Period (52 Weeks)||319
6806391|NCT03730662|7738593|FG002|COMPLETED|Treatment Period (52 Weeks)||329
6806392|NCT03730662|7738594|FG003|COMPLETED|Treatment Period (52 Weeks)||953
6806393|NCT03730662|7738591|FG000|NOT COMPLETED|Treatment Period (52 Weeks)||21
6806394|NCT03730662|7738592|FG001|NOT COMPLETED|Treatment Period (52 Weeks)||11
6806395|NCT03730662|7738593|FG002|NOT COMPLETED|Treatment Period (52 Weeks)||9
6806396|NCT03730662|7738594|FG003|NOT COMPLETED|Treatment Period (52 Weeks)||52
6806397|NCT03730662|7738591|FG000|STARTED|Variable Treatment Period||308
6806398|NCT03730662|7738592|FG001|STARTED|Variable Treatment Period||319
6806399|NCT03730662|7738593|FG002|STARTED|Variable Treatment Period||329
6806400|NCT03730662|7738594|FG003|STARTED|Variable Treatment Period||953
6806401|NCT03730662|7738591|FG000|COMPLETED|Variable Treatment Period||294
6806402|NCT03730662|7738592|FG001|COMPLETED|Variable Treatment Period||312
6806403|NCT03730662|7738593|FG002|COMPLETED|Variable Treatment Period||313
6806404|NCT03730662|7738594|FG003|COMPLETED|Variable Treatment Period||882
6566512|NCT01824901|7489449|FG002|NOT COMPLETED|Overall Study||0
6566513|NCT01824901|7489450|FG003|NOT COMPLETED|Overall Study||0
6566514|NCT01824979|7489456|FG000|STARTED|Overall Study||50
6566515|NCT01824979|7489457|FG001|STARTED|Overall Study||50
6388711|NCT04109118|7300156|FG000|STARTED|Overall Study||4
6388712|NCT04109118|7300156|FG000|COMPLETED|Overall Study||1
6388713|NCT04109118|7300156|FG000|NOT COMPLETED|Overall Study||3
6566516|NCT01824979|7489456|FG000|COMPLETED|Overall Study||37
6566517|NCT01824979|7489457|FG001|COMPLETED|Overall Study||37
6388714|NCT04045132|7300163|FG000|STARTED|Overall Study||37
6388715|NCT04045132|7300164|FG001|STARTED|Overall Study||38
6388716|NCT04045132|7300163|FG000|COMPLETED|Overall Study||34
6388717|NCT04045132|7300164|FG001|COMPLETED|Overall Study||31
6388718|NCT04045132|7300163|FG000|NOT COMPLETED|Overall Study||3
6388719|NCT04045132|7300164|FG001|NOT COMPLETED|Overall Study||7
6388720|NCT03846219|7300175|FG000|STARTED|Overall Study||72
6388721|NCT03846219|7300176|FG001|STARTED|Overall Study||69
6388722|NCT03846219|7300177|FG002|STARTED|Overall Study||69
6388723|NCT03846219|7300175|FG000|Patients Treated|Overall Study||71
6388724|NCT03846219|7300176|FG001|Patients Treated|Overall Study||69
6388725|NCT03846219|7300177|FG002|Patients Treated|Overall Study||69
6388726|NCT03846219|7300175|FG000|COMPLETED|Overall Study||69
6388727|NCT03846219|7300176|FG001|COMPLETED|Overall Study||65
6388728|NCT03846219|7300177|FG002|COMPLETED|Overall Study||64
6388729|NCT03846219|7300175|FG000|NOT COMPLETED|Overall Study||3
6504330|NCT01448616|7423467|FG002|NOT COMPLETED|Lead-In (Observational Phase)||0
6504331|NCT01448616|7423468|FG003|NOT COMPLETED|Lead-In (Observational Phase)||0
6504332|NCT01448616|7423465|FG000|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
6504333|NCT01448616|7423466|FG001|STARTED|Study Drug (Treatment Phase)||24
6504334|NCT01448616|7423467|FG002|STARTED|Study Drug (Treatment Phase)||27
6504335|NCT01448616|7423468|FG003|STARTED|Study Drug (Treatment Phase)||13
6504336|NCT01448616|7423465|FG000|COMPLETED|Study Drug (Treatment Phase)||0
6504337|NCT01448616|7423466|FG001|COMPLETED|Study Drug (Treatment Phase)||22
6504338|NCT01448616|7423467|FG002|COMPLETED|Study Drug (Treatment Phase)||23
6504339|NCT01448616|7423468|FG003|COMPLETED|Study Drug (Treatment Phase)||9
6504340|NCT01448616|7423465|FG000|NOT COMPLETED|Study Drug (Treatment Phase)||0
6504341|NCT01448616|7423466|FG001|NOT COMPLETED|Study Drug (Treatment Phase)||2
6504342|NCT01448616|7423467|FG002|NOT COMPLETED|Study Drug (Treatment Phase)||4
6504343|NCT01448616|7423468|FG003|NOT COMPLETED|Study Drug (Treatment Phase)||4
6504344|NCT01448707|7423483|FG000|STARTED|Overall Study||137
6504345|NCT01448707|7423484|FG001|STARTED|Overall Study||136
6504346|NCT01448707|7423483|FG000|COMPLETED|Overall Study||119
6504347|NCT01448707|7423484|FG001|COMPLETED|Overall Study||118
6504348|NCT01448707|7423483|FG000|NOT COMPLETED|Overall Study||18
6504349|NCT01448707|7423484|FG001|NOT COMPLETED|Overall Study||18
6504350|NCT01448824|7423498|FG000|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
6504351|NCT01448824|7423499|FG001|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
6504352|NCT01448824|7423500|FG002|STARTED|Part 1 Period 1: Multiple Ascending Dose||4
6504353|NCT01448824|7423501|FG003|STARTED|Part 1 Period 1: Multiple Ascending Dose||10
6504354|NCT01448824|7423502|FG004|STARTED|Part 1 Period 1: Multiple Ascending Dose||16
6504355|NCT01448824|7423503|FG005|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
6504356|NCT01448824|7423504|FG006|STARTED|Part 1 Period 1: Multiple Ascending Dose||12
6504357|NCT01448824|7423505|FG007|STARTED|Part 1 Period 1: Multiple Ascending Dose||0
6504358|NCT01448824|7423498|FG000|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
6504359|NCT01448824|7423499|FG001|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
6504360|NCT01448824|7423500|FG002|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||4
6504361|NCT01448824|7423501|FG003|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||10
6504362|NCT01448824|7423502|FG004|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||16
6504363|NCT01448824|7423503|FG005|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
6504364|NCT01448824|7423504|FG006|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||12
6504365|NCT01448824|7423505|FG007|Received at Least 1 Dose of Study Drug|Part 1 Period 1: Multiple Ascending Dose||0
6504366|NCT01448824|7423498|FG000|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||12
6504367|NCT01448824|7423499|FG001|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
6504368|NCT01448824|7423500|FG002|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||4
6656900|NCT02465489|7587252|FG000|COMPLETED|Overall Study||15
6388730|NCT03846219|7300176|FG001|NOT COMPLETED|Overall Study||4
6388731|NCT03846219|7300177|FG002|NOT COMPLETED|Overall Study||5
6388732|NCT03758404|7300196|FG000|STARTED|Overall Study||3
6388733|NCT03758404|7300197|FG001|STARTED|Overall Study||3
6388734|NCT03758404|7300198|FG002|STARTED|Overall Study||5
6273646|NCT00103259|7172859|FG000|NOT COMPLETED|Overall Study||12
6273647|NCT00103259|7172860|FG001|NOT COMPLETED|Overall Study||12
6273648|NCT00103285|7172868|FG000|STARTED|Induction||5377
6273649|NCT00103285|7172869|FG001|STARTED|Induction||0
6273650|NCT00103285|7172870|FG002|STARTED|Induction||0
6273651|NCT00103285|7172871|FG003|STARTED|Induction||0
6273652|NCT00103285|7172872|FG004|STARTED|Induction||0
6273653|NCT00103285|7172873|FG005|STARTED|Induction||0
6273654|NCT00103285|7172874|FG006|STARTED|Induction||0
6273655|NCT00103285|7172875|FG007|STARTED|Induction||0
6273656|NCT00103285|7172868|FG000|COMPLETED|Induction||4028
6273657|NCT00103285|7172869|FG001|COMPLETED|Induction||0
6273658|NCT00103285|7172870|FG002|COMPLETED|Induction||0
6273659|NCT00103285|7172871|FG003|COMPLETED|Induction||0
6566518|NCT01824979|7489456|FG000|NOT COMPLETED|Overall Study||13
6566519|NCT01824979|7489457|FG001|NOT COMPLETED|Overall Study||13
6566520|NCT01825057|7489466|FG000|STARTED|Patient Study Flow||336
6566521|NCT01825057|7489467|FG001|STARTED|Patient Study Flow||379
6566522|NCT01825057|7489468|FG002|STARTED|Patient Study Flow||458
6566523|NCT01825057|7489466|FG000|COMPLETED|Patient Study Flow||336
6566524|NCT01825057|7489467|FG001|COMPLETED|Patient Study Flow||379
6566525|NCT01825057|7489468|FG002|COMPLETED|Patient Study Flow||458
6273660|NCT00103285|7172872|FG004|COMPLETED|Induction||0
6273661|NCT00103285|7172873|FG005|COMPLETED|Induction||0
6273662|NCT00103285|7172874|FG006|COMPLETED|Induction||0
6273663|NCT00103285|7172875|FG007|COMPLETED|Induction||0
6273664|NCT00103285|7172868|FG000|NOT COMPLETED|Induction||1349
6273665|NCT00103285|7172869|FG001|NOT COMPLETED|Induction||0
6273666|NCT00103285|7172870|FG002|NOT COMPLETED|Induction||0
6273667|NCT00103285|7172871|FG003|NOT COMPLETED|Induction||0
6273668|NCT00103285|7172872|FG004|NOT COMPLETED|Induction||0
6273669|NCT00103285|7172873|FG005|NOT COMPLETED|Induction||0
6273670|NCT00103285|7172874|FG006|NOT COMPLETED|Induction||0
6273671|NCT00103285|7172875|FG007|NOT COMPLETED|Induction||0
6566526|NCT01825057|7489466|FG000|NOT COMPLETED|Patient Study Flow||0
6566527|NCT01825057|7489467|FG001|NOT COMPLETED|Patient Study Flow||0
6566528|NCT01825057|7489468|FG002|NOT COMPLETED|Patient Study Flow||0
6566529|NCT01825057|7489466|FG000|STARTED|Provider Study Flow||13
6566530|NCT01825057|7489467|FG001|STARTED|Provider Study Flow||12
6566531|NCT01825057|7489468|FG002|STARTED|Provider Study Flow||13
6273672|NCT00103285|7172868|FG000|STARTED|Response Assignment||0
6273673|NCT00103285|7172869|FG001|STARTED|Response Assignment||939
6273674|NCT00103285|7172870|FG002|STARTED|Response Assignment||937
6273675|NCT00103285|7172871|FG003|STARTED|Response Assignment||503
6273676|NCT00103285|7172872|FG004|STARTED|Response Assignment||509
6273677|NCT00103285|7172873|FG005|STARTED|Response Assignment||249
6273678|NCT00103285|7172874|FG006|STARTED|Response Assignment||248
6273679|NCT00103285|7172875|FG007|STARTED|Response Assignment||643
6273680|NCT00103285|7172868|FG000|COMPLETED|Response Assignment||0
6273681|NCT00103285|7172869|FG001|COMPLETED|Response Assignment||807
6273682|NCT00103285|7172870|FG002|COMPLETED|Response Assignment||853
6273683|NCT00103285|7172871|FG003|COMPLETED|Response Assignment||441
6273684|NCT00103285|7172872|FG004|COMPLETED|Response Assignment||425
6273685|NCT00103285|7172873|FG005|COMPLETED|Response Assignment||201
6273686|NCT00103285|7172874|FG006|COMPLETED|Response Assignment||199
6273687|NCT00103285|7172875|FG007|COMPLETED|Response Assignment||523
6273688|NCT00103285|7172868|FG000|NOT COMPLETED|Response Assignment||0
6273689|NCT00103285|7172869|FG001|NOT COMPLETED|Response Assignment||132
6273690|NCT00103285|7172870|FG002|NOT COMPLETED|Response Assignment||84
6273691|NCT00103285|7172871|FG003|NOT COMPLETED|Response Assignment||62
6273692|NCT00103285|7172872|FG004|NOT COMPLETED|Response Assignment||84
6273693|NCT00103285|7172873|FG005|NOT COMPLETED|Response Assignment||48
6273694|NCT00103285|7172874|FG006|NOT COMPLETED|Response Assignment||49
6273695|NCT00103285|7172875|FG007|NOT COMPLETED|Response Assignment||120
6273696|NCT00103311|7172902|FG000|STARTED|Overall Study||33
6273697|NCT00103311|7172903|FG001|STARTED|Overall Study||31
6273698|NCT00103311|7172902|FG000|COMPLETED|Overall Study||29
6273699|NCT00103311|7172903|FG001|COMPLETED|Overall Study||30
6273700|NCT00103311|7172902|FG000|NOT COMPLETED|Overall Study||4
6273701|NCT00103311|7172903|FG001|NOT COMPLETED|Overall Study||1
6273702|NCT00103376|7172912|FG000|STARTED|Overall Study||8
6273703|NCT00103376|7172913|FG001|STARTED|Overall Study||7
6566532|NCT01825057|7489466|FG000|COMPLETED|Provider Study Flow||13
6566533|NCT01825057|7489467|FG001|COMPLETED|Provider Study Flow||12
6273704|NCT00103376|7172914|FG002|STARTED|Overall Study||8
6273705|NCT00103376|7172912|FG000|COMPLETED|Overall Study||8
6273706|NCT00103376|7172913|FG001|COMPLETED|Overall Study||7
6273707|NCT00103376|7172914|FG002|COMPLETED|Overall Study||8
6273708|NCT00103376|7172912|FG000|NOT COMPLETED|Overall Study||0
6273709|NCT00103376|7172913|FG001|NOT COMPLETED|Overall Study||0
6273710|NCT00103376|7172914|FG002|NOT COMPLETED|Overall Study||0
6273711|NCT00103402|7172930|FG000|STARTED|Overall Study||138
6273712|NCT00103402|7172931|FG001|STARTED|Overall Study||134
6273713|NCT00103402|7172930|FG000|COMPLETED|Overall Study||116
6273714|NCT00103402|7172931|FG001|COMPLETED|Overall Study||117
6273715|NCT00103402|7172930|FG000|NOT COMPLETED|Overall Study||22
6273716|NCT00103402|7172931|FG001|NOT COMPLETED|Overall Study||17
6273717|NCT00103506|7172939|FG000|STARTED|Overall Study||322
6273718|NCT00103506|7172940|FG001|STARTED|Overall Study||324
6273719|NCT00103506|7172939|FG000|COMPLETED|Overall Study||0
6273720|NCT00103506|7172940|FG001|COMPLETED|Overall Study||0
6388735|NCT03758404|7300196|FG000|COMPLETED|Overall Study||3
6273721|NCT00103506|7172939|FG000|NOT COMPLETED|Overall Study||322
6273722|NCT00103506|7172940|FG001|NOT COMPLETED|Overall Study||324
6273723|NCT00103610|7172948|FG000|STARTED|Overall Study||150
6273724|NCT00103610|7172949|FG001|STARTED|Overall Study||148
6273725|NCT00103610|7172948|FG000|COMPLETED|Overall Study||112
6273726|NCT00103610|7172949|FG001|COMPLETED|Overall Study||68
6273727|NCT00103610|7172948|FG000|NOT COMPLETED|Overall Study||38
6388736|NCT03758404|7300197|FG001|COMPLETED|Overall Study||3
6566534|NCT01825057|7489468|FG002|COMPLETED|Provider Study Flow||13
6566535|NCT01825057|7489466|FG000|NOT COMPLETED|Provider Study Flow||0
6566536|NCT01825057|7489467|FG001|NOT COMPLETED|Provider Study Flow||0
6566537|NCT01825057|7489468|FG002|NOT COMPLETED|Provider Study Flow||0
6273728|NCT00103610|7172949|FG001|NOT COMPLETED|Overall Study||80
6273729|NCT00103662|7172958|FG000|STARTED|Overall Study||148
6273730|NCT00103662|7172959|FG001|STARTED|Overall Study||154
6273731|NCT00103662|7172958|FG000|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
6566538|NCT01825122|7489481|FG000|STARTED|Overall Study||77
6566539|NCT01825122|7489482|FG001|STARTED|Overall Study||78
6273732|NCT00103662|7172959|FG001|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
6273733|NCT00103662|7172958|FG000|NOT COMPLETED|Overall Study||19
6273734|NCT00103662|7172959|FG001|NOT COMPLETED|Overall Study||33
6273735|NCT00103740|7172967|FG000|STARTED|Period 1 - Core||92
6273736|NCT00103740|7172968|FG001|STARTED|Period 1 - Core||93
6273737|NCT00103740|7172967|FG000|COMPLETED|Period 1 - Core||85
6273738|NCT00103740|7172968|FG001|COMPLETED|Period 1 - Core||89
6388737|NCT03758404|7300198|FG002|COMPLETED|Overall Study||5
6388738|NCT03758404|7300196|FG000|NOT COMPLETED|Overall Study||0
6388739|NCT03758404|7300197|FG001|NOT COMPLETED|Overall Study||0
6388740|NCT03758404|7300198|FG002|NOT COMPLETED|Overall Study||0
6388741|NCT03698708|7300208|FG000|STARTED|Overall Study||17
6388742|NCT03698708|7300209|FG001|STARTED|Overall Study||20
6388743|NCT03698708|7300208|FG000|COMPLETED|Overall Study||13
6388744|NCT03698708|7300209|FG001|COMPLETED|Overall Study||16
6388745|NCT03698708|7300208|FG000|NOT COMPLETED|Overall Study||4
6388746|NCT03698708|7300209|FG001|NOT COMPLETED|Overall Study||4
6388747|NCT03608696|7300215|FG000|STARTED|Overall Study||10
6388748|NCT03608696|7300215|FG000|COMPLETED|Overall Study||10
6388749|NCT03608696|7300215|FG000|NOT COMPLETED|Overall Study||0
6388750|NCT03606668|7300219|FG000|STARTED|Overall Study||20
6388751|NCT03606668|7300219|FG000|COMPLETED|Overall Study||18
6388752|NCT03606668|7300219|FG000|NOT COMPLETED|Overall Study||2
6388753|NCT03575897|7300225|FG000|STARTED|Overall Study||25
6388754|NCT03575897|7300226|FG001|STARTED|Overall Study||25
6806405|NCT03730662|7738591|FG000|NOT COMPLETED|Variable Treatment Period||14
6806406|NCT03730662|7738592|FG001|NOT COMPLETED|Variable Treatment Period||7
6806407|NCT03730662|7738593|FG002|NOT COMPLETED|Variable Treatment Period||16
6388755|NCT03575897|7300225|FG000|COMPLETED|Overall Study||13
6388756|NCT03575897|7300226|FG001|COMPLETED|Overall Study||12
6388757|NCT03575897|7300225|FG000|NOT COMPLETED|Overall Study||12
6388758|NCT03575897|7300226|FG001|NOT COMPLETED|Overall Study||13
6388759|NCT03343626|7300240|FG000|STARTED|Overall Study||31
6388760|NCT03343626|7300241|FG001|STARTED|Overall Study||31
6388761|NCT03343626|7300242|FG002|STARTED|Overall Study||31
6388762|NCT03343626|7300243|FG003|STARTED|Overall Study||32
6388763|NCT03343626|7300244|FG004|STARTED|Overall Study||36
6388764|NCT03343626|7300245|FG005|STARTED|Overall Study||37
6388765|NCT03343626|7300246|FG006|STARTED|Overall Study||37
6388766|NCT03343626|7300247|FG007|STARTED|Overall Study||36
6566540|NCT01825122|7489481|FG000|COMPLETED|Overall Study||67
6566541|NCT01825122|7489482|FG001|COMPLETED|Overall Study||59
6566542|NCT01825122|7489481|FG000|NOT COMPLETED|Overall Study||10
6566543|NCT01825122|7489482|FG001|NOT COMPLETED|Overall Study||19
6566544|NCT01825200|7489490|FG000|STARTED|Overall Study||1319
6806408|NCT03730662|7738594|FG003|NOT COMPLETED|Variable Treatment Period||71
6806409|NCT03538444|7738610|FG000|STARTED|Overall Study||4
6806410|NCT03538444|7738611|FG001|STARTED|Overall Study||3
6806411|NCT03538444|7738610|FG000|COMPLETED|Overall Study||3
6806412|NCT03538444|7738611|FG001|COMPLETED|Overall Study||3
6806413|NCT03538444|7738610|FG000|NOT COMPLETED|Overall Study||1
6806414|NCT03538444|7738611|FG001|NOT COMPLETED|Overall Study||0
6388767|NCT03343626|7300240|FG000|Safety Analysis Set|Overall Study||31
6388768|NCT03343626|7300241|FG001|Safety Analysis Set|Overall Study||31
6388769|NCT03343626|7300242|FG002|Safety Analysis Set|Overall Study||31
6388770|NCT03343626|7300243|FG003|Safety Analysis Set|Overall Study||32
6566545|NCT01825200|7489491|FG001|STARTED|Overall Study||1321
6566546|NCT01825200|7489490|FG000|COMPLETED|Overall Study||1314
6566547|NCT01825200|7489491|FG001|COMPLETED|Overall Study||1314
6566548|NCT01825200|7489490|FG000|NOT COMPLETED|Overall Study||5
6566549|NCT01825200|7489491|FG001|NOT COMPLETED|Overall Study||7
6566550|NCT01825408|7489501|FG000|STARTED|Overall Study||7
6566551|NCT01825408|7489502|FG001|STARTED|Overall Study||7
6566552|NCT01825408|7489503|FG002|STARTED|Overall Study||14
6566553|NCT01825408|7489504|FG003|STARTED|Overall Study||12
6566554|NCT01825408|7489501|FG000|COMPLETED|Overall Study||7
6566555|NCT01825408|7489502|FG001|COMPLETED|Overall Study||7
6566556|NCT01825408|7489503|FG002|COMPLETED|Overall Study||14
6566557|NCT01825408|7489504|FG003|COMPLETED|Overall Study||12
6566558|NCT01825408|7489501|FG000|NOT COMPLETED|Overall Study||0
6566559|NCT01825408|7489502|FG001|NOT COMPLETED|Overall Study||0
6566560|NCT01825408|7489503|FG002|NOT COMPLETED|Overall Study||0
6566561|NCT01825408|7489504|FG003|NOT COMPLETED|Overall Study||0
6566562|NCT01825512|7489516|FG000|STARTED|Baseline||194
6566563|NCT01825512|7489517|FG001|STARTED|Baseline||199
6388771|NCT03343626|7300244|FG004|Safety Analysis Set|Overall Study||36
6388772|NCT03343626|7300245|FG005|Safety Analysis Set|Overall Study||37
6388773|NCT03343626|7300246|FG006|Safety Analysis Set|Overall Study||37
6388774|NCT03343626|7300247|FG007|Safety Analysis Set|Overall Study||36
6388775|NCT03343626|7300240|FG000|Full Analysis Set|Overall Study||30
6388776|NCT03343626|7300241|FG001|Full Analysis Set|Overall Study||28
6388777|NCT03343626|7300242|FG002|Full Analysis Set|Overall Study||31
6388778|NCT03343626|7300243|FG003|Full Analysis Set|Overall Study||30
6504369|NCT01448824|7423501|FG003|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||9
6504370|NCT01448824|7423502|FG004|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||14
6504371|NCT01448824|7423503|FG005|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||10
6504372|NCT01448824|7423504|FG006|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||11
6504373|NCT01448824|7423505|FG007|COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6504374|NCT01448824|7423498|FG000|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6504375|NCT01448824|7423499|FG001|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6388779|NCT03343626|7300244|FG004|Full Analysis Set|Overall Study||34
6388780|NCT03343626|7300245|FG005|Full Analysis Set|Overall Study||34
6388781|NCT03343626|7300246|FG006|Full Analysis Set|Overall Study||34
6388782|NCT03343626|7300247|FG007|Full Analysis Set|Overall Study||34
6388783|NCT03343626|7300240|FG000|Per Protocol Set|Overall Study||28
6388784|NCT03343626|7300241|FG001|Per Protocol Set|Overall Study||25
6388785|NCT03343626|7300242|FG002|Per Protocol Set|Overall Study||29
6388786|NCT03343626|7300243|FG003|Per Protocol Set|Overall Study||30
6388787|NCT03343626|7300244|FG004|Per Protocol Set|Overall Study||34
6504376|NCT01448824|7423500|FG002|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6504377|NCT01448824|7423501|FG003|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
6504378|NCT01448824|7423502|FG004|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
6273739|NCT00103740|7172967|FG000|NOT COMPLETED|Period 1 - Core||7
6273740|NCT00103740|7172968|FG001|NOT COMPLETED|Period 1 - Core||4
6273741|NCT00103740|7172967|FG000|STARTED|Period 2 - Extended Observation Period||78
6273742|NCT00103740|7172968|FG001|STARTED|Period 2 - Extended Observation Period||63
6273743|NCT00103740|7172967|FG000|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
6273744|NCT00103740|7172968|FG001|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
6273745|NCT00103740|7172967|FG000|NOT COMPLETED|Period 2 - Extended Observation Period||69
6273746|NCT00103740|7172968|FG001|NOT COMPLETED|Period 2 - Extended Observation Period||36
6273747|NCT00103844|7172976|FG000|STARTED|Overall Study||101
6273748|NCT00103844|7172977|FG001|STARTED|Overall Study||49
6273749|NCT00103844|7172976|FG000|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
6273750|NCT00103844|7172977|FG001|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
6273751|NCT00103844|7172976|FG000|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
6273752|NCT00103844|7172977|FG001|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
6273753|NCT00103844|7172976|FG000|NOT COMPLETED|Overall Study||0
6388788|NCT03343626|7300245|FG005|Per Protocol Set|Overall Study||33
6388789|NCT03343626|7300246|FG006|Per Protocol Set|Overall Study||34
6388790|NCT03343626|7300247|FG007|Per Protocol Set|Overall Study||33
6388791|NCT03343626|7300240|FG000|COMPLETED|Overall Study||25
6388792|NCT03343626|7300241|FG001|COMPLETED|Overall Study||26
6388793|NCT03343626|7300242|FG002|COMPLETED|Overall Study||29
6388794|NCT03343626|7300243|FG003|COMPLETED|Overall Study||24
6388795|NCT03343626|7300244|FG004|COMPLETED|Overall Study||29
6388796|NCT03343626|7300245|FG005|COMPLETED|Overall Study||32
6388797|NCT03343626|7300246|FG006|COMPLETED|Overall Study||32
6388798|NCT03343626|7300247|FG007|COMPLETED|Overall Study||25
6388799|NCT03343626|7300240|FG000|NOT COMPLETED|Overall Study||6
6388800|NCT03343626|7300241|FG001|NOT COMPLETED|Overall Study||5
6388801|NCT03343626|7300242|FG002|NOT COMPLETED|Overall Study||2
6388802|NCT03343626|7300243|FG003|NOT COMPLETED|Overall Study||8
6388803|NCT03343626|7300244|FG004|NOT COMPLETED|Overall Study||7
6388804|NCT03343626|7300245|FG005|NOT COMPLETED|Overall Study||5
6388805|NCT03343626|7300246|FG006|NOT COMPLETED|Overall Study||5
6388806|NCT03343626|7300247|FG007|NOT COMPLETED|Overall Study||11
6504379|NCT01448824|7423503|FG005|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||2
6504380|NCT01448824|7423504|FG006|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||1
6504381|NCT01448824|7423505|FG007|NOT COMPLETED|Part 1 Period 1: Multiple Ascending Dose||0
6504382|NCT01448824|7423498|FG000|STARTED|Part 1: Washout Period||12
6504383|NCT01448824|7423499|FG001|STARTED|Part 1: Washout Period||4
6504384|NCT01448824|7423500|FG002|STARTED|Part 1: Washout Period||4
6504385|NCT01448824|7423501|FG003|STARTED|Part 1: Washout Period|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
6504386|NCT01448824|7423502|FG004|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort B participated in Period 1 only.|0
6504387|NCT01448824|7423503|FG005|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort C participated in Period 1 only.|0
6504388|NCT01448824|7423504|FG006|STARTED|Part 1: Washout Period|Participants in Part 1 Cohort D participated in Period 1 only.|0
6504389|NCT01448824|7423505|FG007|STARTED|Part 1: Washout Period||0
6504390|NCT01448824|7423498|FG000|COMPLETED|Part 1: Washout Period||11
6504391|NCT01448824|7423499|FG001|COMPLETED|Part 1: Washout Period||4
6504392|NCT01448824|7423500|FG002|COMPLETED|Part 1: Washout Period||4
6504393|NCT01448824|7423501|FG003|COMPLETED|Part 1: Washout Period||0
6504394|NCT01448824|7423502|FG004|COMPLETED|Part 1: Washout Period||0
6504395|NCT01448824|7423503|FG005|COMPLETED|Part 1: Washout Period||0
6504396|NCT01448824|7423504|FG006|COMPLETED|Part 1: Washout Period||0
6504397|NCT01448824|7423505|FG007|COMPLETED|Part 1: Washout Period||0
6504398|NCT01448824|7423498|FG000|NOT COMPLETED|Part 1: Washout Period||1
6388807|NCT03088930|7300268|FG000|STARTED|Overall Study||3
6388808|NCT03088930|7300268|FG000|COMPLETED|Overall Study||3
6388809|NCT03088930|7300268|FG000|NOT COMPLETED|Overall Study||0
6388810|NCT02960204|7300276|FG000|STARTED|Overall Study||65
6388811|NCT02960204|7300277|FG001|STARTED|Overall Study||65
6388812|NCT02960204|7300278|FG002|STARTED|Overall Study||66
6388813|NCT02960204|7300279|FG003|STARTED|Overall Study||67
6388814|NCT02960204|7300276|FG000|Randomized|Overall Study||65
6388815|NCT02960204|7300277|FG001|Randomized|Overall Study||65
6388816|NCT02960204|7300278|FG002|Randomized|Overall Study||66
6388817|NCT02960204|7300279|FG003|Randomized|Overall Study||67
6388818|NCT02960204|7300276|FG000|Completed Week 24 of Study|Overall Study||62
6388819|NCT02960204|7300277|FG001|Completed Week 24 of Study|Overall Study||62
6388820|NCT02960204|7300278|FG002|Completed Week 24 of Study|Overall Study||60
6388821|NCT02960204|7300279|FG003|Completed Week 24 of Study|Overall Study||66
6388822|NCT02960204|7300276|FG000|Completed Week 48 of Study|Overall Study||55
6388823|NCT02960204|7300277|FG001|Completed Week 48 of Study|Overall Study||55
6388824|NCT02960204|7300278|FG002|Completed Week 48 of Study|Overall Study||50
6388825|NCT02960204|7300279|FG003|Completed Week 48 of Study|Overall Study||59
6388826|NCT02960204|7300276|FG000|COMPLETED|Overall Study||36
6388827|NCT02960204|7300277|FG001|COMPLETED|Overall Study||44
6388828|NCT02960204|7300278|FG002|COMPLETED|Overall Study||37
6388829|NCT02960204|7300279|FG003|COMPLETED|Overall Study||38
6388830|NCT02960204|7300276|FG000|NOT COMPLETED|Overall Study||29
6388831|NCT02960204|7300277|FG001|NOT COMPLETED|Overall Study||21
6388832|NCT02960204|7300278|FG002|NOT COMPLETED|Overall Study||29
6388833|NCT02960204|7300279|FG003|NOT COMPLETED|Overall Study||29
6388834|NCT02856269|7300291|FG000|STARTED|Overall Study||25
6388835|NCT02856269|7300292|FG001|STARTED|Overall Study||27
6388836|NCT02856269|7300291|FG000|COMPLETED|Overall Study||24
6388837|NCT02856269|7300292|FG001|COMPLETED|Overall Study||24
6388838|NCT02856269|7300291|FG000|NOT COMPLETED|Overall Study||1
6388839|NCT02856269|7300292|FG001|NOT COMPLETED|Overall Study||3
6388840|NCT02807363|7300302|FG000|STARTED|Dosing Period||9
6388841|NCT02807363|7300303|FG001|STARTED|Dosing Period||9
6388842|NCT02807363|7300304|FG002|STARTED|Dosing Period||5
6388843|NCT02807363|7300305|FG003|STARTED|Dosing Period||12
6388844|NCT02807363|7300302|FG000|COMPLETED|Dosing Period||9
6388845|NCT02807363|7300303|FG001|COMPLETED|Dosing Period||8
6388846|NCT02807363|7300304|FG002|COMPLETED|Dosing Period||5
6388847|NCT02807363|7300305|FG003|COMPLETED|Dosing Period||12
6388848|NCT02807363|7300302|FG000|NOT COMPLETED|Dosing Period||0
6388849|NCT02807363|7300303|FG001|NOT COMPLETED|Dosing Period||1
6388850|NCT02807363|7300304|FG002|NOT COMPLETED|Dosing Period||0
6388851|NCT02807363|7300305|FG003|NOT COMPLETED|Dosing Period||0
6388852|NCT02807363|7300302|FG000|STARTED|Post- Dosing Period||9
6388853|NCT02807363|7300303|FG001|STARTED|Post- Dosing Period||8
6388854|NCT02807363|7300304|FG002|STARTED|Post- Dosing Period||5
6388855|NCT02807363|7300305|FG003|STARTED|Post- Dosing Period||12
6388856|NCT02807363|7300302|FG000|COMPLETED|Post- Dosing Period||9
6388857|NCT02807363|7300303|FG001|COMPLETED|Post- Dosing Period||8
6388858|NCT02807363|7300304|FG002|COMPLETED|Post- Dosing Period||5
6388859|NCT02807363|7300305|FG003|COMPLETED|Post- Dosing Period||12
6388860|NCT02807363|7300302|FG000|NOT COMPLETED|Post- Dosing Period||0
6388861|NCT02807363|7300303|FG001|NOT COMPLETED|Post- Dosing Period||0
6388862|NCT02807363|7300304|FG002|NOT COMPLETED|Post- Dosing Period||0
6388863|NCT02807363|7300305|FG003|NOT COMPLETED|Post- Dosing Period||0
6388864|NCT02756403|7300321|FG000|STARTED|Overall Study||46
6388865|NCT02756403|7300322|FG001|STARTED|Overall Study||45
6388866|NCT02756403|7300323|FG002|STARTED|Overall Study||43
6388867|NCT02756403|7300324|FG003|STARTED|Overall Study||47
6388868|NCT02756403|7300321|FG000|COMPLETED|Overall Study||46
6388869|NCT02756403|7300322|FG001|COMPLETED|Overall Study||42
6388870|NCT02756403|7300323|FG002|COMPLETED|Overall Study||41
6388871|NCT02756403|7300324|FG003|COMPLETED|Overall Study||45
6388872|NCT02756403|7300321|FG000|NOT COMPLETED|Overall Study||0
6388873|NCT02756403|7300322|FG001|NOT COMPLETED|Overall Study||3
6388874|NCT02756403|7300323|FG002|NOT COMPLETED|Overall Study||2
6388875|NCT02756403|7300324|FG003|NOT COMPLETED|Overall Study||2
6388876|NCT02751502|7300334|FG000|STARTED|Overall Study||4
6388877|NCT02751502|7300334|FG000|COMPLETED|Overall Study||0
6388878|NCT02751502|7300334|FG000|NOT COMPLETED|Overall Study||4
6388879|NCT02487797|7300340|FG000|STARTED|Overall Study||502
6388880|NCT02487797|7300341|FG001|STARTED|Overall Study||501
6388881|NCT02487797|7300340|FG000|COMPLETED|Overall Study||502
6388882|NCT02487797|7300341|FG001|COMPLETED|Overall Study||501
6388883|NCT02487797|7300340|FG000|NOT COMPLETED|Overall Study||0
6388884|NCT02487797|7300341|FG001|NOT COMPLETED|Overall Study||0
6388885|NCT02348359|7300351|FG000|STARTED|Overall Study||40
6388886|NCT02348359|7300352|FG001|STARTED|Overall Study||39
6388887|NCT02348359|7300353|FG002|STARTED|Overall Study||39
6388888|NCT02348359|7300354|FG003|STARTED|Overall Study||39
6388889|NCT02348359|7300351|FG000|COMPLETED|Overall Study||29
6388890|NCT02348359|7300352|FG001|COMPLETED|Overall Study||22
6566564|NCT01825512|7489516|FG000|COMPLETED|Baseline||193
6566565|NCT01825512|7489517|FG001|COMPLETED|Baseline||197
6566566|NCT01825512|7489516|FG000|NOT COMPLETED|Baseline||1
6566567|NCT01825512|7489517|FG001|NOT COMPLETED|Baseline||2
6566568|NCT01825512|7489516|FG000|STARTED|Treatment||193
6566569|NCT01825512|7489517|FG001|STARTED|Treatment||197
6566570|NCT01825512|7489516|FG000|COMPLETED|Treatment||140
6566571|NCT01825512|7489517|FG001|COMPLETED|Treatment||170
6566572|NCT01825512|7489516|FG000|NOT COMPLETED|Treatment||53
6566573|NCT01825512|7489517|FG001|NOT COMPLETED|Treatment||27
6566574|NCT01825577|7489523|FG000|STARTED|Overall Study||14
6566575|NCT01825577|7489523|FG000|COMPLETED|Overall Study||6
6566576|NCT01825577|7489523|FG000|NOT COMPLETED|Overall Study||8
6566577|NCT01825655|7489529|FG000|STARTED|Overall Study||0
6566578|NCT01825655|7489530|FG001|STARTED|Overall Study||2
6566579|NCT01825655|7489529|FG000|COMPLETED|Overall Study||0
6388891|NCT02348359|7300353|FG002|COMPLETED|Overall Study||25
6388892|NCT02348359|7300354|FG003|COMPLETED|Overall Study||27
6388893|NCT02348359|7300351|FG000|NOT COMPLETED|Overall Study||11
6388894|NCT02348359|7300352|FG001|NOT COMPLETED|Overall Study||17
6388895|NCT02348359|7300353|FG002|NOT COMPLETED|Overall Study||14
6388896|NCT02348359|7300354|FG003|NOT COMPLETED|Overall Study||12
6388897|NCT02285062|7300366|FG000|STARTED|Overall Study||285
6388898|NCT02285062|7300367|FG001|STARTED|Overall Study||285
6388899|NCT02285062|7300366|FG000|Received Study Treatment|Overall Study||283
6388900|NCT02285062|7300367|FG001|Received Study Treatment|Overall Study||284
6388901|NCT02285062|7300366|FG000|Ongoing Study Treatment|Overall Study||0
6388902|NCT02285062|7300367|FG001|Ongoing Study Treatment|Overall Study||0
6388903|NCT02285062|7300366|FG000|COMPLETED|Overall Study||207
6388904|NCT02285062|7300367|FG001|COMPLETED|Overall Study||201
6388905|NCT02285062|7300366|FG000|NOT COMPLETED|Overall Study||78
6388906|NCT02285062|7300367|FG001|NOT COMPLETED|Overall Study||84
6388907|NCT02264977|7300373|FG000|STARTED|Overall Study||9
6388908|NCT02264977|7300373|FG000|COMPLETED|Overall Study||4
6388909|NCT02264977|7300373|FG000|NOT COMPLETED|Overall Study||5
6388910|NCT01981096|7300379|FG000|STARTED|Overall Study||20
6388911|NCT01981096|7300380|FG001|STARTED|Overall Study||20
6388912|NCT01981096|7300379|FG000|Post-treatment|Overall Study||17
6388913|NCT01981096|7300380|FG001|Post-treatment|Overall Study||19
6388914|NCT01981096|7300379|FG000|COMPLETED|Overall Study||17
6388915|NCT01981096|7300380|FG001|COMPLETED|Overall Study||19
6388916|NCT01981096|7300379|FG000|NOT COMPLETED|Overall Study||3
6388917|NCT01981096|7300380|FG001|NOT COMPLETED|Overall Study||1
6388918|NCT01935336|7300390|FG000|STARTED|Overall Study|Only one subject was treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|6
6388919|NCT01935336|7300391|FG001|STARTED|Overall Study|no subjects were treated in this arm|3
6388920|NCT01935336|7300392|FG002|STARTED|Overall Study|Only three subjects were treated due to the black box warning RE: ponatinib-associated vascular issues. The protocol was modified with additional inclusion and exclusion criteria, which severely limited the number of cases treated with the drug|47
6388921|NCT01935336|7300393|FG003|STARTED|Overall Study|No subjects were treated in this arm|66
6388922|NCT01935336|7300390|FG000|Started Treatment|Overall Study||1
6388923|NCT01935336|7300391|FG001|Started Treatment|Overall Study||0
6388924|NCT01935336|7300392|FG002|Started Treatment|Overall Study||3
6388925|NCT01935336|7300393|FG003|Started Treatment|Overall Study||0
6388926|NCT01935336|7300390|FG000|COMPLETED|Overall Study||0
6388927|NCT01935336|7300391|FG001|COMPLETED|Overall Study||0
6388928|NCT01935336|7300392|FG002|COMPLETED|Overall Study||0
6806415|NCT03410693|7738619|FG000|STARTED|Overall Study||87
6806416|NCT03410693|7738620|FG001|STARTED|Overall Study||88
6806417|NCT03410693|7738619|FG000|Started Treatment|Overall Study||86
6806418|NCT03410693|7738620|FG001|Started Treatment|Overall Study||82
6806419|NCT03410693|7738619|FG000|Active Follow-up Performed|Overall Study||61
6806420|NCT03410693|7738620|FG001|Active Follow-up Performed|Overall Study||56
6388929|NCT01935336|7300393|FG003|COMPLETED|Overall Study||0
6388930|NCT01935336|7300390|FG000|NOT COMPLETED|Overall Study||6
6388931|NCT01935336|7300391|FG001|NOT COMPLETED|Overall Study||3
6388932|NCT01935336|7300392|FG002|NOT COMPLETED|Overall Study||47
6388933|NCT01935336|7300393|FG003|NOT COMPLETED|Overall Study||66
6806421|NCT03410693|7738619|FG000|Entered Long Term Follow-up|Overall Study||56
6806422|NCT03410693|7738620|FG001|Entered Long Term Follow-up|Overall Study||69
6806423|NCT03410693|7738619|FG000|COMPLETED|Overall Study|Completed treatment|0
6806424|NCT03410693|7738620|FG001|COMPLETED|Overall Study|Completed treatment|0
6806425|NCT03410693|7738619|FG000|NOT COMPLETED|Overall Study||87
6806426|NCT03410693|7738620|FG001|NOT COMPLETED|Overall Study||88
6806427|NCT03359356|7738634|FG000|STARTED|Overall Study||20
6504399|NCT01448824|7423499|FG001|NOT COMPLETED|Part 1: Washout Period||0
6504400|NCT01448824|7423500|FG002|NOT COMPLETED|Part 1: Washout Period||0
6504401|NCT01448824|7423501|FG003|NOT COMPLETED|Part 1: Washout Period||0
6504402|NCT01448824|7423502|FG004|NOT COMPLETED|Part 1: Washout Period||0
6504403|NCT01448824|7423503|FG005|NOT COMPLETED|Part 1: Washout Period||0
6273754|NCT00103844|7172977|FG001|NOT COMPLETED|Overall Study||0
6273755|NCT00103857|7172990|FG000|STARTED|54-Week Base Study||179
6273756|NCT00103857|7172991|FG001|STARTED|54-Week Base Study||182
6273757|NCT00103857|7172992|FG002|STARTED|54-Week Base Study||182
6273758|NCT00103857|7172993|FG003|STARTED|54-Week Base Study||190
6273759|NCT00103857|7172994|FG004|STARTED|54-Week Base Study||182
6273760|NCT00103857|7172995|FG005|STARTED|54-Week Base Study||176
6273761|NCT00103857|7172996|FG006|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
6273762|NCT00103857|7172990|FG000|COMPLETED|54-Week Base Study||122
6273763|NCT00103857|7172991|FG001|COMPLETED|54-Week Base Study||126
6273764|NCT00103857|7172992|FG002|COMPLETED|54-Week Base Study||135
6273765|NCT00103857|7172993|FG003|COMPLETED|54-Week Base Study||148
6273766|NCT00103857|7172994|FG004|COMPLETED|54-Week Base Study||141
6273767|NCT00103857|7172995|FG005|COMPLETED|54-Week Base Study||115
6273768|NCT00103857|7172996|FG006|COMPLETED|54-Week Base Study||79
6273769|NCT00103857|7172990|FG000|NOT COMPLETED|54-Week Base Study||57
6273770|NCT00103857|7172991|FG001|NOT COMPLETED|54-Week Base Study||56
6273771|NCT00103857|7172992|FG002|NOT COMPLETED|54-Week Base Study||47
6273772|NCT00103857|7172993|FG003|NOT COMPLETED|54-Week Base Study||42
6273773|NCT00103857|7172994|FG004|NOT COMPLETED|54-Week Base Study||41
6273774|NCT00103857|7172995|FG005|NOT COMPLETED|54-Week Base Study||61
6273775|NCT00103857|7172996|FG006|NOT COMPLETED|54-Week Base Study||38
6273776|NCT00103857|7172990|FG000|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
6273777|NCT00103857|7172991|FG001|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
6273778|NCT00103857|7172992|FG002|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
6273779|NCT00103857|7172993|FG003|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
6273780|NCT00103857|7172994|FG004|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
6273781|NCT00103857|7172995|FG005|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
6273782|NCT00103857|7172996|FG006|STARTED|50-Week Extension Study||0
6273783|NCT00103857|7172990|FG000|COMPLETED|50-Week Extension Study||65
6273784|NCT00103857|7172991|FG001|COMPLETED|50-Week Extension Study||80
6273785|NCT00103857|7172992|FG002|COMPLETED|50-Week Extension Study||95
6273786|NCT00103857|7172993|FG003|COMPLETED|50-Week Extension Study||98
6273787|NCT00103857|7172994|FG004|COMPLETED|50-Week Extension Study||101
6273788|NCT00103857|7172995|FG005|COMPLETED|50-Week Extension Study||78
6273789|NCT00103857|7172996|FG006|COMPLETED|50-Week Extension Study||0
6273790|NCT00103857|7172990|FG000|NOT COMPLETED|50-Week Extension Study||38
6273791|NCT00103857|7172991|FG001|NOT COMPLETED|50-Week Extension Study||27
6273792|NCT00103857|7172992|FG002|NOT COMPLETED|50-Week Extension Study||26
6273793|NCT00103857|7172993|FG003|NOT COMPLETED|50-Week Extension Study||36
6273794|NCT00103857|7172994|FG004|NOT COMPLETED|50-Week Extension Study||21
6273795|NCT00103857|7172995|FG005|NOT COMPLETED|50-Week Extension Study||20
6273796|NCT00103857|7172996|FG006|NOT COMPLETED|50-Week Extension Study||0
6273797|NCT00104052|7173011|FG000|STARTED|Overall Study||107
6273798|NCT00104052|7173011|FG000|COMPLETED|Overall Study||78
6273799|NCT00104052|7173011|FG000|NOT COMPLETED|Overall Study||29
6273800|NCT00104104|7173017|FG000|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
6273801|NCT00104104|7173018|FG001|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
6273802|NCT00104104|7173017|FG000|Safety Population (Including Site 74)|Overall Study||88
6273803|NCT00104104|7173018|FG001|Safety Population (Including Site 74)|Overall Study||88
6273804|NCT00104104|7173017|FG000|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
6273805|NCT00104104|7173018|FG001|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
6273806|NCT00104104|7173017|FG000|COMPLETED|Overall Study||15
6273807|NCT00104104|7173018|FG001|COMPLETED|Overall Study||17
6273808|NCT00104104|7173017|FG000|NOT COMPLETED|Overall Study||75
6273809|NCT00104104|7173018|FG001|NOT COMPLETED|Overall Study||72
6273810|NCT00104234|7173026|FG000|STARTED|Overall Study||19
6273811|NCT00104234|7173027|FG001|STARTED|Overall Study||20
6273812|NCT00104234|7173026|FG000|COMPLETED|Overall Study||19
6273813|NCT00104234|7173027|FG001|COMPLETED|Overall Study||19
6273814|NCT00104234|7173026|FG000|NOT COMPLETED|Overall Study||0
6273815|NCT00104234|7173027|FG001|NOT COMPLETED|Overall Study||1
6273816|NCT00104247|7173035|FG000|STARTED|Overall Study||42
6273817|NCT00104247|7173036|FG001|STARTED|Overall Study||47
6273818|NCT00104247|7173035|FG000|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
6273819|NCT00104247|7173036|FG001|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
6273820|NCT00104247|7173035|FG000|NOT COMPLETED|Overall Study||1
6273821|NCT00104247|7173036|FG001|NOT COMPLETED|Overall Study||1
6273822|NCT00104299|7173044|FG000|STARTED|Overall Study||99
6273823|NCT00104299|7173045|FG001|STARTED|Overall Study||98
6273824|NCT00104299|7173044|FG000|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
6273825|NCT00104299|7173045|FG001|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
6273826|NCT00104299|7173044|FG000|NOT COMPLETED|Overall Study||9
6388934|NCT01712490|7300411|FG000|STARTED|Overall Study||664
6388935|NCT01712490|7300412|FG001|STARTED|Overall Study||670
6388936|NCT01712490|7300411|FG000|Treated|Overall Study||662
6388937|NCT01712490|7300412|FG001|Treated|Overall Study||659
6388938|NCT01712490|7300411|FG000|COMPLETED|Overall Study||0
6388939|NCT01712490|7300412|FG001|COMPLETED|Overall Study||0
6388940|NCT01712490|7300411|FG000|NOT COMPLETED|Overall Study||664
6388941|NCT01712490|7300412|FG001|NOT COMPLETED|Overall Study||670
6388942|NCT01702805|7300420|FG000|STARTED|Overall Study||911
6388943|NCT01702805|7300421|FG001|STARTED|Overall Study||913
6388944|NCT01702805|7300420|FG000|Completed Assessment for Neurodevelopmental Impairment|Overall Study||699
6388945|NCT01702805|7300421|FG001|Completed Assessment for Neurodevelopmental Impairment|Overall Study||712
6388946|NCT01702805|7300420|FG000|Died After Discharge|Overall Study||19
6388947|NCT01702805|7300421|FG001|Died After Discharge|Overall Study||10
6388948|NCT01702805|7300420|FG000|Died Before Discharge|Overall Study||127
6388949|NCT01702805|7300421|FG001|Died Before Discharge|Overall Study||125
6388950|NCT01702805|7300420|FG000|Survived to Discharge|Overall Study||781
6388951|NCT01702805|7300421|FG001|Survived to Discharge|Overall Study||781
6504404|NCT01448824|7423504|FG006|NOT COMPLETED|Part 1: Washout Period||0
6504405|NCT01448824|7423505|FG007|NOT COMPLETED|Part 1: Washout Period||0
6504406|NCT01448824|7423498|FG000|STARTED|Part 1 Period 2: Multiple Ascending Dose||11
6504407|NCT01448824|7423499|FG001|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
6504408|NCT01448824|7423500|FG002|STARTED|Part 1 Period 2: Multiple Ascending Dose||4
6504409|NCT01448824|7423501|FG003|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohorts B through D participated in Period 1 only.|0
6504410|NCT01448824|7423502|FG004|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort B participated in Period 1 only.|0
6504411|NCT01448824|7423503|FG005|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort C participated in Period 1 only.|0
6504412|NCT01448824|7423504|FG006|STARTED|Part 1 Period 2: Multiple Ascending Dose|Participants in Part 1 Cohort D participated in Period 1 only.|0
6504413|NCT01448824|7423505|FG007|STARTED|Part 1 Period 2: Multiple Ascending Dose||0
6504414|NCT01448824|7423498|FG000|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||11
6504415|NCT01448824|7423499|FG001|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
6504416|NCT01448824|7423500|FG002|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||4
6504417|NCT01448824|7423501|FG003|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6504418|NCT01448824|7423502|FG004|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6504419|NCT01448824|7423503|FG005|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6504420|NCT01448824|7423504|FG006|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6388952|NCT01702805|7300420|FG000|COMPLETED|Overall Study||845
6388953|NCT01702805|7300421|FG001|COMPLETED|Overall Study||847
6388954|NCT01702805|7300420|FG000|NOT COMPLETED|Overall Study||66
6388955|NCT01702805|7300421|FG001|NOT COMPLETED|Overall Study||66
6388956|NCT01499160|7300427|FG000|STARTED|Overall Study||7
6566580|NCT01825655|7489530|FG001|COMPLETED|Overall Study||2
6566581|NCT01825655|7489529|FG000|NOT COMPLETED|Overall Study||0
6566582|NCT01825655|7489530|FG001|NOT COMPLETED|Overall Study||0
6566583|NCT01825785|7489543|FG000|STARTED|Overall Study||12
6273827|NCT00104299|7173045|FG001|NOT COMPLETED|Overall Study||10
6273828|NCT00104416|7173053|FG000|STARTED|Double-Blind Phase||77
6273829|NCT00104416|7173054|FG001|STARTED|Double-Blind Phase||76
6273830|NCT00104416|7173055|FG002|STARTED|Double-Blind Phase||0
6273831|NCT00104416|7173056|FG003|STARTED|Double-Blind Phase||0
6273832|NCT00104416|7173057|FG004|STARTED|Double-Blind Phase||0
6273833|NCT00104416|7173053|FG000|COMPLETED|Double-Blind Phase||69
6273834|NCT00104416|7173054|FG001|COMPLETED|Double-Blind Phase||66
6273835|NCT00104416|7173055|FG002|COMPLETED|Double-Blind Phase||0
6273836|NCT00104416|7173056|FG003|COMPLETED|Double-Blind Phase||0
6273837|NCT00104416|7173057|FG004|COMPLETED|Double-Blind Phase||0
6273838|NCT00104416|7173053|FG000|NOT COMPLETED|Double-Blind Phase||8
6273839|NCT00104416|7173054|FG001|NOT COMPLETED|Double-Blind Phase||10
6273840|NCT00104416|7173055|FG002|NOT COMPLETED|Double-Blind Phase||0
6273841|NCT00104416|7173056|FG003|NOT COMPLETED|Double-Blind Phase||0
6273842|NCT00104416|7173057|FG004|NOT COMPLETED|Double-Blind Phase||0
6273843|NCT00104416|7173053|FG000|STARTED|Continuation Phase||0
6273844|NCT00104416|7173054|FG001|STARTED|Continuation Phase||0
6273845|NCT00104416|7173055|FG002|STARTED|Continuation Phase||69
6273846|NCT00104416|7173056|FG003|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
6273847|NCT00104416|7173057|FG004|STARTED|Continuation Phase||32
6273848|NCT00104416|7173053|FG000|COMPLETED|Continuation Phase||0
6273849|NCT00104416|7173054|FG001|COMPLETED|Continuation Phase||0
6273850|NCT00104416|7173055|FG002|COMPLETED|Continuation Phase||63
6273851|NCT00104416|7173056|FG003|COMPLETED|Continuation Phase||65
6273852|NCT00104416|7173057|FG004|COMPLETED|Continuation Phase||27
6273853|NCT00104416|7173053|FG000|NOT COMPLETED|Continuation Phase||0
6273854|NCT00104416|7173054|FG001|NOT COMPLETED|Continuation Phase||0
6566584|NCT01825785|7489544|FG001|STARTED|Overall Study||6
6566585|NCT01825785|7489545|FG002|STARTED|Overall Study||6
6566586|NCT01825785|7489546|FG003|STARTED|Overall Study||6
6566587|NCT01825785|7489547|FG004|STARTED|Overall Study||6
6566588|NCT01825785|7489548|FG005|STARTED|Overall Study||6
6566589|NCT01825785|7489549|FG006|STARTED|Overall Study||6
6566590|NCT01825785|7489543|FG000|COMPLETED|Overall Study||12
6566591|NCT01825785|7489544|FG001|COMPLETED|Overall Study||6
6566592|NCT01825785|7489545|FG002|COMPLETED|Overall Study||6
6566593|NCT01825785|7489546|FG003|COMPLETED|Overall Study||6
6566594|NCT01825785|7489547|FG004|COMPLETED|Overall Study||4
6566595|NCT01825785|7489548|FG005|COMPLETED|Overall Study||5
6566596|NCT01825785|7489549|FG006|COMPLETED|Overall Study||6
6566597|NCT01825785|7489543|FG000|NOT COMPLETED|Overall Study||0
6566598|NCT01825785|7489544|FG001|NOT COMPLETED|Overall Study||0
6566599|NCT01825785|7489545|FG002|NOT COMPLETED|Overall Study||0
6566600|NCT01825785|7489546|FG003|NOT COMPLETED|Overall Study||0
6656901|NCT02465489|7587252|FG000|NOT COMPLETED|Overall Study||5
6566601|NCT01825785|7489547|FG004|NOT COMPLETED|Overall Study||2
6566602|NCT01825785|7489548|FG005|NOT COMPLETED|Overall Study||1
6566603|NCT01825785|7489549|FG006|NOT COMPLETED|Overall Study||0
6566604|NCT01825798|7489573|FG000|STARTED|Overall Study||32
6273855|NCT00104416|7173055|FG002|NOT COMPLETED|Continuation Phase||6
6273856|NCT00104416|7173056|FG003|NOT COMPLETED|Continuation Phase||2
6273857|NCT00104416|7173057|FG004|NOT COMPLETED|Continuation Phase||5
6273858|NCT00104520|7173071|FG000|STARTED|Overall Study||76
6273859|NCT00104520|7173072|FG001|STARTED|Overall Study||135
6273860|NCT00104520|7173071|FG000|COMPLETED|Overall Study||26
6273861|NCT00104520|7173072|FG001|COMPLETED|Overall Study||64
6273862|NCT00104520|7173071|FG000|NOT COMPLETED|Overall Study||50
6273863|NCT00104520|7173072|FG001|NOT COMPLETED|Overall Study||71
6273864|NCT00104572|7173081|FG000|STARTED|Overall Study|These are the analysed subjects|13
6273865|NCT00104572|7173082|FG001|STARTED|Overall Study|These are the analysed subjects|13
6273866|NCT00104572|7173083|FG002|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
6273867|NCT00104572|7173081|FG000|COMPLETED|Overall Study||10
6273868|NCT00104572|7173082|FG001|COMPLETED|Overall Study||10
6273869|NCT00104572|7173083|FG002|COMPLETED|Overall Study||9
6273870|NCT00104572|7173081|FG000|NOT COMPLETED|Overall Study||3
6388957|NCT01499160|7300427|FG000|COMPLETED|Overall Study|"1 pt-withdrew consent~1pt-had cardiac toxicity"|5
6388958|NCT01499160|7300427|FG000|NOT COMPLETED|Overall Study||2
6388959|NCT01333436|7300434|FG000|STARTED|Overall Study||43
6388960|NCT01333436|7300435|FG001|STARTED|Overall Study||50
6388961|NCT01333436|7300434|FG000|COMPLETED|Overall Study||43
6388962|NCT01333436|7300435|FG001|COMPLETED|Overall Study||50
6388963|NCT01333436|7300434|FG000|NOT COMPLETED|Overall Study||0
6388964|NCT01333436|7300435|FG001|NOT COMPLETED|Overall Study||0
6388965|NCT01307631|7300441|FG000|STARTED|Overall Study||9
6388966|NCT01307631|7300442|FG001|STARTED|Overall Study||28
6388967|NCT01307631|7300441|FG000|COMPLETED|Overall Study||9
6388968|NCT01307631|7300442|FG001|COMPLETED|Overall Study||28
6388969|NCT01307631|7300441|FG000|NOT COMPLETED|Overall Study||0
6388970|NCT01307631|7300442|FG001|NOT COMPLETED|Overall Study||0
6388971|NCT01256086|7300452|FG000|STARTED|Treatment Day 1||11
6388972|NCT01256086|7300453|FG001|STARTED|Treatment Day 1||11
6388973|NCT01256086|7300454|FG002|STARTED|Treatment Day 1||11
6388974|NCT01256086|7300455|FG003|STARTED|Treatment Day 1||11
6388975|NCT01256086|7300452|FG000|COMPLETED|Treatment Day 1||11
6388976|NCT01256086|7300453|FG001|COMPLETED|Treatment Day 1||11
6388977|NCT01256086|7300454|FG002|COMPLETED|Treatment Day 1||11
6388978|NCT01256086|7300455|FG003|COMPLETED|Treatment Day 1||11
6388979|NCT01256086|7300452|FG000|NOT COMPLETED|Treatment Day 1||0
6388980|NCT01256086|7300453|FG001|NOT COMPLETED|Treatment Day 1||0
6388981|NCT01256086|7300454|FG002|NOT COMPLETED|Treatment Day 1||0
6388982|NCT01256086|7300455|FG003|NOT COMPLETED|Treatment Day 1||0
6388983|NCT01256086|7300452|FG000|STARTED|Treatment Day 2||11
6388984|NCT01256086|7300453|FG001|STARTED|Treatment Day 2||10
6388985|NCT01256086|7300454|FG002|STARTED|Treatment Day 2||9
6388986|NCT01256086|7300455|FG003|STARTED|Treatment Day 2||11
6388987|NCT01256086|7300452|FG000|COMPLETED|Treatment Day 2||11
6388988|NCT01256086|7300453|FG001|COMPLETED|Treatment Day 2||10
6388989|NCT01256086|7300454|FG002|COMPLETED|Treatment Day 2||9
6388990|NCT01256086|7300455|FG003|COMPLETED|Treatment Day 2||11
6388991|NCT01256086|7300452|FG000|NOT COMPLETED|Treatment Day 2||0
6388992|NCT01256086|7300453|FG001|NOT COMPLETED|Treatment Day 2||0
6388993|NCT01256086|7300454|FG002|NOT COMPLETED|Treatment Day 2||0
6388994|NCT01256086|7300455|FG003|NOT COMPLETED|Treatment Day 2||0
6388995|NCT01256086|7300452|FG000|STARTED|Treatment Day 3||11
6388996|NCT01256086|7300453|FG001|STARTED|Treatment Day 3||10
6566605|NCT01825798|7489574|FG001|STARTED|Overall Study||28
6566606|NCT01825798|7489573|FG000|COMPLETED|Overall Study||30
6566607|NCT01825798|7489574|FG001|COMPLETED|Overall Study||23
6566608|NCT01825798|7489573|FG000|NOT COMPLETED|Overall Study||2
6566609|NCT01825798|7489574|FG001|NOT COMPLETED|Overall Study||5
6388997|NCT01256086|7300454|FG002|STARTED|Treatment Day 3||9
6388998|NCT01256086|7300455|FG003|STARTED|Treatment Day 3||11
6388999|NCT01256086|7300452|FG000|COMPLETED|Treatment Day 3||11
6389000|NCT01256086|7300453|FG001|COMPLETED|Treatment Day 3||10
6389001|NCT01256086|7300454|FG002|COMPLETED|Treatment Day 3||9
6389002|NCT01256086|7300455|FG003|COMPLETED|Treatment Day 3||11
6389003|NCT01256086|7300452|FG000|NOT COMPLETED|Treatment Day 3||0
6389004|NCT01256086|7300453|FG001|NOT COMPLETED|Treatment Day 3||0
6389005|NCT01256086|7300454|FG002|NOT COMPLETED|Treatment Day 3||0
6389006|NCT01256086|7300455|FG003|NOT COMPLETED|Treatment Day 3||0
6389007|NCT01256086|7300452|FG000|STARTED|Treatment Day 4||11
6389008|NCT01256086|7300453|FG001|STARTED|Treatment Day 4||10
6389009|NCT01256086|7300454|FG002|STARTED|Treatment Day 4||9
6389010|NCT01256086|7300455|FG003|STARTED|Treatment Day 4||11
6389011|NCT01256086|7300452|FG000|COMPLETED|Treatment Day 4||11
6566610|NCT01825837|7489584|FG000|STARTED|PART I||0
6389012|NCT01256086|7300453|FG001|COMPLETED|Treatment Day 4||10
6273871|NCT00104572|7173082|FG001|NOT COMPLETED|Overall Study||3
6273872|NCT00104572|7173083|FG002|NOT COMPLETED|Overall Study||0
6389013|NCT01256086|7300454|FG002|COMPLETED|Treatment Day 4||9
6566611|NCT01825837|7489585|FG001|STARTED|PART I||0
6566612|NCT01825837|7489586|FG002|STARTED|PART I||0
6566613|NCT01825837|7489587|FG003|STARTED|PART I||104
6566614|NCT01825837|7489584|FG000|Enrolled|PART I||0
6566615|NCT01825837|7489585|FG001|Enrolled|PART I||0
6566616|NCT01825837|7489586|FG002|Enrolled|PART I||0
6566617|NCT01825837|7489587|FG003|Enrolled|PART I||104
6566618|NCT01825837|7489584|FG000|Safety Population (Open-Label)|PART I||0
6566619|NCT01825837|7489585|FG001|Safety Population (Open-Label)|PART I||0
6566620|NCT01825837|7489586|FG002|Safety Population (Open-Label)|PART I||0
6566621|NCT01825837|7489587|FG003|Safety Population (Open-Label)|PART I||104
6273873|NCT00104637|7173091|FG000|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
6273874|NCT00104637|7173092|FG001|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
6273875|NCT00104637|7173091|FG000|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
6566622|NCT01825837|7489584|FG000|COMPLETED|PART I||0
6656902|NCT02465515|7587266|FG000|STARTED|Overall Study||4732
6806428|NCT03359356|7738635|FG001|STARTED|Overall Study||40
6806429|NCT03359356|7738634|FG000|COMPLETED|Overall Study||20
6806430|NCT03359356|7738635|FG001|COMPLETED|Overall Study||40
6806431|NCT03359356|7738634|FG000|NOT COMPLETED|Overall Study||0
6806432|NCT03359356|7738635|FG001|NOT COMPLETED|Overall Study||0
6806433|NCT03252925|7738647|FG000|STARTED|Overall Study||80
6806434|NCT03252925|7738648|FG001|STARTED|Overall Study||80
6806435|NCT03252925|7738647|FG000|COMPLETED|Overall Study||66
6806436|NCT03252925|7738648|FG001|COMPLETED|Overall Study||74
6806437|NCT03252925|7738647|FG000|NOT COMPLETED|Overall Study||14
6806438|NCT03252925|7738648|FG001|NOT COMPLETED|Overall Study||6
6273876|NCT00104637|7173092|FG001|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
6273877|NCT00104637|7173091|FG000|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
6273878|NCT00104637|7173092|FG001|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
6273879|NCT00104637|7173091|FG000|STARTED|Period 2 (WASHOUT: 1 Week)||5
6273880|NCT00104637|7173092|FG001|STARTED|Period 2 (WASHOUT: 1 Week)||4
6273881|NCT00104637|7173091|FG000|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
6273882|NCT00104637|7173092|FG001|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
6566623|NCT01825837|7489585|FG001|COMPLETED|PART I||0
6566624|NCT01825837|7489586|FG002|COMPLETED|PART I||0
6566625|NCT01825837|7489587|FG003|COMPLETED|PART I||87
6656903|NCT02465515|7587267|FG001|STARTED|Overall Study||4731
6273883|NCT00104637|7173091|FG000|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
6273884|NCT00104637|7173092|FG001|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
6273885|NCT00104637|7173091|FG000|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
6273886|NCT00104637|7173092|FG001|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
6273887|NCT00104637|7173091|FG000|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
6273888|NCT00104637|7173092|FG001|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
6504421|NCT01448824|7423505|FG007|Received at Least 1 Dose|Part 1 Period 2: Multiple Ascending Dose||0
6389014|NCT01256086|7300455|FG003|COMPLETED|Treatment Day 4||11
6389015|NCT01256086|7300452|FG000|NOT COMPLETED|Treatment Day 4||0
6389016|NCT01256086|7300453|FG001|NOT COMPLETED|Treatment Day 4||0
6389017|NCT01256086|7300454|FG002|NOT COMPLETED|Treatment Day 4||0
6389018|NCT01256086|7300455|FG003|NOT COMPLETED|Treatment Day 4||0
6389019|NCT01061151|7300469|FG000|STARTED|Protocol Version 2.0: 04/2011-09/2012||855
6389020|NCT01061151|7300470|FG001|STARTED|Protocol Version 2.0: 04/2011-09/2012||861
6389021|NCT01061151|7300471|FG002|STARTED|Protocol Version 2.0: 04/2011-09/2012||25
6389022|NCT01061151|7300472|FG003|STARTED|Protocol Version 2.0: 04/2011-09/2012||129
6504422|NCT01448824|7423498|FG000|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||11
6504423|NCT01448824|7423499|FG001|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
6504424|NCT01448824|7423500|FG002|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||4
6504425|NCT01448824|7423501|FG003|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6566626|NCT01825837|7489584|FG000|NOT COMPLETED|PART I||0
6566627|NCT01825837|7489585|FG001|NOT COMPLETED|PART I||0
6566628|NCT01825837|7489586|FG002|NOT COMPLETED|PART I||0
6566629|NCT01825837|7489587|FG003|NOT COMPLETED|PART I||17
6389023|NCT01061151|7300469|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||853
6389024|NCT01061151|7300470|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||861
6389025|NCT01061151|7300471|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||24
6389026|NCT01061151|7300472|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 2.0: 04/2011-09/2012||129
6389027|NCT01061151|7300469|FG000|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||623
6389028|NCT01061151|7300470|FG001|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||620
6389029|NCT01061151|7300471|FG002|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||16
6389030|NCT01061151|7300472|FG003|COMPLETED|Protocol Version 2.0: 04/2011-09/2012||101
6389031|NCT01061151|7300469|FG000|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||232
6389032|NCT01061151|7300470|FG001|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||241
6389033|NCT01061151|7300471|FG002|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||9
6389034|NCT01061151|7300472|FG003|NOT COMPLETED|Protocol Version 2.0: 04/2011-09/2012||28
6389035|NCT01061151|7300469|FG000|STARTED|Protocol Version 3.0: 10/2012-10/2014||694
6389036|NCT01061151|7300470|FG001|STARTED|Protocol Version 3.0: 10/2012-10/2014||686
6389037|NCT01061151|7300471|FG002|STARTED|Protocol Version 3.0: 10/2012-10/2014||422
6389038|NCT01061151|7300472|FG003|STARTED|Protocol Version 3.0: 10/2012-10/2014||75
6389039|NCT01061151|7300469|FG000|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||694
6389040|NCT01061151|7300470|FG001|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||684
6389041|NCT01061151|7300471|FG002|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||421
6389042|NCT01061151|7300472|FG003|Mothers That Met All Inclusion Criteria|Protocol Version 3.0: 10/2012-10/2014||75
6389043|NCT01061151|7300469|FG000|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||542
6389044|NCT01061151|7300470|FG001|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||548
6389045|NCT01061151|7300471|FG002|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||345
6389046|NCT01061151|7300472|FG003|COMPLETED|Protocol Version 3.0: 10/2012-10/2014||55
6389047|NCT01061151|7300469|FG000|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||152
6389048|NCT01061151|7300470|FG001|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||138
6566630|NCT01825837|7489584|FG000|STARTED|PART II||35
6566631|NCT01825837|7489585|FG001|STARTED|PART II||26
6566632|NCT01825837|7489586|FG002|STARTED|PART II||26
6566633|NCT01825837|7489587|FG003|STARTED|PART II||0
6566634|NCT01825837|7489584|FG000|Randomized Patients|PART II||35
6566635|NCT01825837|7489585|FG001|Randomized Patients|PART II||26
6566636|NCT01825837|7489586|FG002|Randomized Patients|PART II||26
6389049|NCT01061151|7300471|FG002|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||77
6389050|NCT01061151|7300472|FG003|NOT COMPLETED|Protocol Version 3.0: 10/2012-10/2014||20
6389051|NCT00981058|7300494|FG000|STARTED|Overall Study||545
6389052|NCT00981058|7300495|FG001|STARTED|Overall Study||548
6389053|NCT00981058|7300494|FG000|Received at Least 1 Dose of Study Drug|Overall Study||538
6389054|NCT00981058|7300495|FG001|Received at Least 1 Dose of Study Drug|Overall Study||541
6389055|NCT00981058|7300494|FG000|Death Due to Any Cause|Overall Study||418
6389056|NCT00981058|7300495|FG001|Death Due to Any Cause|Overall Study||442
6389057|NCT00981058|7300494|FG000|COMPLETED|Overall Study||425
6389058|NCT00981058|7300495|FG001|COMPLETED|Overall Study||451
6389059|NCT00981058|7300494|FG000|NOT COMPLETED|Overall Study||120
6389060|NCT00981058|7300495|FG001|NOT COMPLETED|Overall Study||97
6389061|NCT00885495|7300503|FG000|STARTED|Overall Study||8
6566637|NCT01825837|7489587|FG003|Randomized Patients|PART II||0
6566638|NCT01825837|7489584|FG000|Safety Population (Double-Blind)|PART II||35
6566639|NCT01825837|7489585|FG001|Safety Population (Double-Blind)|PART II||26
6566640|NCT01825837|7489586|FG002|Safety Population (Double-Blind)|PART II||26
6273889|NCT00104637|7173091|FG000|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
6273890|NCT00104637|7173092|FG001|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
6273891|NCT00104650|7173104|FG000|STARTED|Treatment Period (25 Weeks)||37
6273892|NCT00104650|7173105|FG001|STARTED|Treatment Period (25 Weeks)||36
6273893|NCT00104650|7173106|FG002|STARTED|Treatment Period (25 Weeks)||38
6273894|NCT00104650|7173104|FG000|Received Investigational Product|Treatment Period (25 Weeks)||35
6273895|NCT00104650|7173105|FG001|Received Investigational Product|Treatment Period (25 Weeks)||35
6273896|NCT00104650|7173106|FG002|Received Investigational Product|Treatment Period (25 Weeks)||38
6273897|NCT00104650|7173104|FG000|COMPLETED|Treatment Period (25 Weeks)||25
6273898|NCT00104650|7173105|FG001|COMPLETED|Treatment Period (25 Weeks)||25
6273899|NCT00104650|7173106|FG002|COMPLETED|Treatment Period (25 Weeks)||28
6273900|NCT00104650|7173104|FG000|NOT COMPLETED|Treatment Period (25 Weeks)||12
6273901|NCT00104650|7173105|FG001|NOT COMPLETED|Treatment Period (25 Weeks)||11
6273902|NCT00104650|7173106|FG002|NOT COMPLETED|Treatment Period (25 Weeks)||10
6273903|NCT00104650|7173104|FG000|STARTED|Follow-up Period||25
6273904|NCT00104650|7173105|FG001|STARTED|Follow-up Period||25
6273905|NCT00104650|7173106|FG002|STARTED|Follow-up Period||28
6273906|NCT00104650|7173104|FG000|COMPLETED|Follow-up Period||14
6273907|NCT00104650|7173105|FG001|COMPLETED|Follow-up Period||12
6273908|NCT00104650|7173106|FG002|COMPLETED|Follow-up Period||18
6273909|NCT00104650|7173104|FG000|NOT COMPLETED|Follow-up Period||11
6273910|NCT00104650|7173105|FG001|NOT COMPLETED|Follow-up Period||13
6273911|NCT00104650|7173106|FG002|NOT COMPLETED|Follow-up Period||10
6273912|NCT00104676|7173116|FG000|STARTED|Overall Study||98
6273913|NCT00104676|7173117|FG001|STARTED|Overall Study||105
6273914|NCT00104676|7173116|FG000|COMPLETED|Overall Study||91
6273915|NCT00104676|7173117|FG001|COMPLETED|Overall Study||91
6273916|NCT00104676|7173116|FG000|NOT COMPLETED|Overall Study||7
6273917|NCT00104676|7173117|FG001|NOT COMPLETED|Overall Study||14
6273918|NCT00104858|7173123|FG000|STARTED|Overall Study||52
6273919|NCT00104858|7173123|FG000|COMPLETED|Overall Study||52
6273920|NCT00104858|7173123|FG000|NOT COMPLETED|Overall Study||0
6273921|NCT00104871|7173129|FG000|STARTED|Overall Study||22
6273922|NCT00104871|7173129|FG000|COMPLETED|Overall Study||21
6273923|NCT00104871|7173129|FG000|NOT COMPLETED|Overall Study||1
6273924|NCT00104884|7173133|FG000|STARTED|Overall Study||4
6273925|NCT00104884|7173133|FG000|COMPLETED|Overall Study||0
6273926|NCT00104884|7173133|FG000|NOT COMPLETED|Overall Study||4
6273927|NCT00105001|7173140|FG000|STARTED|Overall Study||70
6273928|NCT00105001|7173141|FG001|STARTED|Overall Study||71
6273929|NCT00105001|7173142|FG002|STARTED|Overall Study||69
6273930|NCT00105001|7173140|FG000|COMPLETED|Overall Study||70
6273931|NCT00105001|7173141|FG001|COMPLETED|Overall Study||71
6273932|NCT00105001|7173142|FG002|COMPLETED|Overall Study||69
6273933|NCT00105001|7173140|FG000|NOT COMPLETED|Overall Study||0
6273934|NCT00105001|7173141|FG001|NOT COMPLETED|Overall Study||0
6273935|NCT00105001|7173142|FG002|NOT COMPLETED|Overall Study||0
6273936|NCT00105027|7173156|FG000|STARTED|Overall Study||88
6273937|NCT00105027|7173157|FG001|STARTED|Overall Study||92
6273938|NCT00105027|7173158|FG002|STARTED|Overall Study||91
6273939|NCT00105027|7173159|FG003|STARTED|Overall Study||137
6273940|NCT00105027|7173160|FG004|STARTED|Overall Study||136
6273941|NCT00105027|7173161|FG005|STARTED|Overall Study||138
6273942|NCT00105027|7173156|FG000|COMPLETED|Overall Study||73
6566641|NCT01825837|7489587|FG003|Safety Population (Double-Blind)|PART II||0
6566642|NCT01825837|7489584|FG000|Intent-to-Treat Population|PART II||34
6656904|NCT02465515|7587266|FG000|COMPLETED|Overall Study||4578
6273943|NCT00105027|7173157|FG001|COMPLETED|Overall Study||83
6273944|NCT00105027|7173158|FG002|COMPLETED|Overall Study||82
6273945|NCT00105027|7173159|FG003|COMPLETED|Overall Study||121
6273946|NCT00105027|7173160|FG004|COMPLETED|Overall Study||121
6273947|NCT00105027|7173161|FG005|COMPLETED|Overall Study||125
6273948|NCT00105027|7173156|FG000|NOT COMPLETED|Overall Study||15
6273949|NCT00105027|7173157|FG001|NOT COMPLETED|Overall Study||9
6273950|NCT00105027|7173158|FG002|NOT COMPLETED|Overall Study||9
6273951|NCT00105027|7173159|FG003|NOT COMPLETED|Overall Study||16
6273952|NCT00105027|7173160|FG004|NOT COMPLETED|Overall Study||15
6273953|NCT00105027|7173161|FG005|NOT COMPLETED|Overall Study||13
6273954|NCT00105066|7173177|FG000|STARTED|Overall Study||27
6273955|NCT00105066|7173178|FG001|STARTED|Overall Study||50
6273956|NCT00105066|7173177|FG000|COMPLETED|Overall Study||25
6273957|NCT00105066|7173178|FG001|COMPLETED|Overall Study||45
6273958|NCT00105066|7173177|FG000|NOT COMPLETED|Overall Study||2
6273959|NCT00105066|7173178|FG001|NOT COMPLETED|Overall Study||5
6273960|NCT00105079|7173186|FG000|STARTED|Overall Study||167
6273961|NCT00105079|7173187|FG001|STARTED|Overall Study||170
6273962|NCT00105079|7173186|FG000|Safety Population|Overall Study||163
6273963|NCT00105079|7173187|FG001|Safety Population|Overall Study||168
6273964|NCT00105079|7173186|FG000|COMPLETED|Overall Study||128
6273965|NCT00105079|7173187|FG001|COMPLETED|Overall Study||135
6273966|NCT00105079|7173186|FG000|NOT COMPLETED|Overall Study||39
6273967|NCT00105079|7173187|FG001|NOT COMPLETED|Overall Study||35
6273968|NCT00105157|7173197|FG000|STARTED|Double-Blind (DB)||44
6273969|NCT00105157|7173198|FG001|STARTED|Double-Blind (DB)||45
6273970|NCT00105157|7173199|FG002|STARTED|Double-Blind (DB)||45
6273971|NCT00105157|7173200|FG003|STARTED|Double-Blind (DB)||45
6273972|NCT00105157|7173197|FG000|Treated|Double-Blind (DB)||43
6273973|NCT00105157|7173198|FG001|Treated|Double-Blind (DB)||45
6273974|NCT00105157|7173199|FG002|Treated|Double-Blind (DB)||45
6273975|NCT00105157|7173200|FG003|Treated|Double-Blind (DB)||45
6273976|NCT00105157|7173197|FG000|COMPLETED|Double-Blind (DB)||30
6273977|NCT00105157|7173198|FG001|COMPLETED|Double-Blind (DB)||31
6273978|NCT00105157|7173199|FG002|COMPLETED|Double-Blind (DB)||33
6273979|NCT00105157|7173200|FG003|COMPLETED|Double-Blind (DB)||6
6273980|NCT00105157|7173197|FG000|NOT COMPLETED|Double-Blind (DB)||14
6273981|NCT00105157|7173198|FG001|NOT COMPLETED|Double-Blind (DB)||14
6273982|NCT00105157|7173199|FG002|NOT COMPLETED|Double-Blind (DB)||12
6273983|NCT00105157|7173200|FG003|NOT COMPLETED|Double-Blind (DB)||39
6273984|NCT00105157|7173197|FG000|STARTED|Open-Label Continuation of DB||30
6273985|NCT00105157|7173198|FG001|STARTED|Open-Label Continuation of DB||31
6273986|NCT00105157|7173199|FG002|STARTED|Open-Label Continuation of DB||33
6389062|NCT00885495|7300504|FG001|STARTED|Overall Study||9
6389063|NCT00885495|7300503|FG000|COMPLETED|Overall Study||6
6389064|NCT00885495|7300504|FG001|COMPLETED|Overall Study||6
6389065|NCT00885495|7300503|FG000|NOT COMPLETED|Overall Study||2
6389066|NCT00885495|7300504|FG001|NOT COMPLETED|Overall Study||3
6389067|NCT00084799|7300517|FG000|STARTED|Overall Study||5
6389068|NCT00084799|7300518|FG001|STARTED|Overall Study||5
6389069|NCT00084799|7300517|FG000|COMPLETED|Overall Study||4
6389070|NCT00084799|7300518|FG001|COMPLETED|Overall Study||5
6389071|NCT00084799|7300517|FG000|NOT COMPLETED|Overall Study||1
6389072|NCT00084799|7300518|FG001|NOT COMPLETED|Overall Study||0
6389073|NCT00821236|7300527|FG000|STARTED|Overall Study||40
6389074|NCT00821236|7300527|FG000|COMPLETED|Overall Study||37
6273987|NCT00105157|7173200|FG003|STARTED|Open-Label Continuation of DB||6
6273988|NCT00105157|7173197|FG000|COMPLETED|Open-Label Continuation of DB||23
6389075|NCT00821236|7300527|FG000|NOT COMPLETED|Overall Study||3
6273989|NCT00105157|7173198|FG001|COMPLETED|Open-Label Continuation of DB||21
6273990|NCT00105157|7173199|FG002|COMPLETED|Open-Label Continuation of DB||24
6273991|NCT00105157|7173200|FG003|COMPLETED|Open-Label Continuation of DB||5
6273992|NCT00105157|7173197|FG000|NOT COMPLETED|Open-Label Continuation of DB||7
6273993|NCT00105157|7173198|FG001|NOT COMPLETED|Open-Label Continuation of DB||10
6389076|NCT00821327|7300535|FG000|STARTED|Overall Study||36
6656905|NCT02465515|7587267|FG001|COMPLETED|Overall Study||4620
6656906|NCT02465515|7587266|FG000|NOT COMPLETED|Overall Study||154
6806439|NCT03185832|7738658|FG000|STARTED|Overall Study||69
6806440|NCT03185832|7738659|FG001|STARTED|Overall Study||102
6806441|NCT03185832|7738660|FG002|STARTED|Overall Study||68
6806442|NCT03185832|7738661|FG003|STARTED|Overall Study||115
6806443|NCT03185832|7738658|FG000|COMPLETED|Overall Study||60
6806444|NCT03185832|7738659|FG001|COMPLETED|Overall Study||87
6806445|NCT03185832|7738660|FG002|COMPLETED|Overall Study||58
6806446|NCT03185832|7738661|FG003|COMPLETED|Overall Study||104
6806447|NCT03185832|7738658|FG000|NOT COMPLETED|Overall Study||9
6806448|NCT03185832|7738659|FG001|NOT COMPLETED|Overall Study||15
6806449|NCT03185832|7738660|FG002|NOT COMPLETED|Overall Study||10
6656907|NCT02465515|7587267|FG001|NOT COMPLETED|Overall Study||111
6656908|NCT02465528|7587277|FG000|STARTED|Overall Study||1
6566643|NCT01825837|7489585|FG001|Intent-to-Treat Population|PART II||25
6566644|NCT01825837|7489586|FG002|Intent-to-Treat Population|PART II||26
6566645|NCT01825837|7489587|FG003|Intent-to-Treat Population|PART II||0
6566646|NCT01825837|7489584|FG000|Per-Protocol Population|PART II||32
6566647|NCT01825837|7489585|FG001|Per-Protocol Population|PART II||23
6566648|NCT01825837|7489586|FG002|Per-Protocol Population|PART II||24
6566649|NCT01825837|7489587|FG003|Per-Protocol Population|PART II||0
6566650|NCT01825837|7489584|FG000|COMPLETED|PART II||16
6566651|NCT01825837|7489585|FG001|COMPLETED|PART II||12
6566652|NCT01825837|7489586|FG002|COMPLETED|PART II||7
6566653|NCT01825837|7489587|FG003|COMPLETED|PART II||0
6566654|NCT01825837|7489584|FG000|NOT COMPLETED|PART II||19
6566655|NCT01825837|7489585|FG001|NOT COMPLETED|PART II||14
6566656|NCT01825837|7489586|FG002|NOT COMPLETED|PART II||19
6566657|NCT01825837|7489587|FG003|NOT COMPLETED|PART II||0
6566658|NCT01825876|7489595|FG000|STARTED|Period 1||17
6389077|NCT00821327|7300535|FG000|COMPLETED|Overall Study||1
6389078|NCT00821327|7300535|FG000|NOT COMPLETED|Overall Study||35
6389079|NCT00821431|7300541|FG000|STARTED|Overall Study||38
6389080|NCT00821431|7300542|FG001|STARTED|Overall Study||52
6389081|NCT00821431|7300541|FG000|COMPLETED|Overall Study||23
6389082|NCT00821431|7300542|FG001|COMPLETED|Overall Study||47
6389083|NCT00821431|7300541|FG000|NOT COMPLETED|Overall Study||15
6389084|NCT00821431|7300542|FG001|NOT COMPLETED|Overall Study||5
6389085|NCT00821509|7300551|FG000|STARTED|Overall Study||257
6389086|NCT00821509|7300552|FG001|STARTED|Overall Study||202
6389087|NCT00821509|7300553|FG002|STARTED|Overall Study||224
6389088|NCT00821509|7300551|FG000|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
6389089|NCT00821509|7300552|FG001|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
6389090|NCT00821509|7300553|FG002|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
6389091|NCT00821509|7300551|FG000|NOT COMPLETED|Overall Study||12
6389092|NCT00821509|7300552|FG001|NOT COMPLETED|Overall Study||11
6389093|NCT00821509|7300553|FG002|NOT COMPLETED|Overall Study||34
6389094|NCT00821626|7300563|FG000|STARTED|Overall Study||60
6389095|NCT00821626|7300564|FG001|STARTED|Overall Study||33
6389096|NCT00821626|7300563|FG000|COMPLETED|Overall Study||60
6389097|NCT00821626|7300564|FG001|COMPLETED|Overall Study||33
6389098|NCT00821626|7300563|FG000|NOT COMPLETED|Overall Study||0
6389099|NCT00821626|7300564|FG001|NOT COMPLETED|Overall Study||0
6389100|NCT00821678|7300574|FG000|STARTED|Overall Study||133
6389101|NCT00821678|7300575|FG001|STARTED|Overall Study||132
6389102|NCT00821678|7300574|FG000|COMPLETED|Overall Study||112
6389103|NCT00821678|7300575|FG001|COMPLETED|Overall Study||118
6389104|NCT00821678|7300574|FG000|NOT COMPLETED|Overall Study||21
6389105|NCT00821678|7300575|FG001|NOT COMPLETED|Overall Study||14
6389106|NCT00821795|7300585|FG000|STARTED|Overall Study||50
6566659|NCT01825876|7489596|FG001|STARTED|Period 1||0
6389107|NCT00821795|7300586|FG001|STARTED|Overall Study||64
6389108|NCT00821795|7300585|FG000|COMPLETED|Overall Study||44
6566660|NCT01825876|7489595|FG000|Received 1 Dose of Study Drug|Period 1||17
6566661|NCT01825876|7489596|FG001|Received 1 Dose of Study Drug|Period 1||0
6566662|NCT01825876|7489595|FG000|COMPLETED|Period 1||17
6656909|NCT02465528|7587278|FG001|STARTED|Overall Study||4
6566663|NCT01825876|7489596|FG001|COMPLETED|Period 1||0
6566664|NCT01825876|7489595|FG000|NOT COMPLETED|Period 1||0
6566665|NCT01825876|7489596|FG001|NOT COMPLETED|Period 1||0
6566666|NCT01825876|7489595|FG000|STARTED|Period 2|Participants received a different treatment in Period 2.|0
6566667|NCT01825876|7489596|FG001|STARTED|Period 2|Participants received a different treatment in Period 1.|17
6566668|NCT01825876|7489595|FG000|Received 1 Dose of Study Drug|Period 2||0
6566669|NCT01825876|7489596|FG001|Received 1 Dose of Study Drug|Period 2||17
6566670|NCT01825876|7489595|FG000|COMPLETED|Period 2||0
6566671|NCT01825876|7489596|FG001|COMPLETED|Period 2||16
6566672|NCT01825876|7489595|FG000|NOT COMPLETED|Period 2||0
6566673|NCT01825876|7489596|FG001|NOT COMPLETED|Period 2||1
6566674|NCT01825889|7489607|FG000|STARTED|Overall Study||10
6566675|NCT01825889|7489608|FG001|STARTED|Overall Study||10
6566676|NCT01825889|7489607|FG000|Received One Dose of Study Drug|Overall Study||10
6566677|NCT01825889|7489608|FG001|Received One Dose of Study Drug|Overall Study||10
6566678|NCT01825889|7489607|FG000|COMPLETED|Overall Study||10
6566679|NCT01825889|7489608|FG001|COMPLETED|Overall Study||10
6566680|NCT01825889|7489607|FG000|NOT COMPLETED|Overall Study||0
6566681|NCT01825889|7489608|FG001|NOT COMPLETED|Overall Study||0
6566682|NCT01825941|7489616|FG000|STARTED|Overall Study||104
6273994|NCT00105157|7173199|FG002|NOT COMPLETED|Open-Label Continuation of DB||9
6273995|NCT00105157|7173200|FG003|NOT COMPLETED|Open-Label Continuation of DB||1
6273996|NCT00105157|7173197|FG000|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
6273997|NCT00105157|7173198|FG001|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
6273998|NCT00105157|7173199|FG002|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
6273999|NCT00105157|7173200|FG003|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
6274000|NCT00105157|7173197|FG000|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
6274001|NCT00105157|7173198|FG001|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
6274002|NCT00105157|7173199|FG002|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
6274003|NCT00105157|7173200|FG003|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
6274004|NCT00105157|7173197|FG000|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
6274005|NCT00105157|7173198|FG001|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
6274006|NCT00105157|7173199|FG002|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
6274007|NCT00105157|7173200|FG003|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
6274008|NCT00105183|7173211|FG000|STARTED|Overall Study|Randomized|82
6274009|NCT00105183|7173212|FG001|STARTED|Overall Study|Randomized|79
6274010|NCT00105183|7173213|FG002|STARTED|Overall Study|Randomized|62
6274011|NCT00105183|7173211|FG000|COMPLETED|Overall Study|Completed at least 12 months follow up|60
6274012|NCT00105183|7173212|FG001|COMPLETED|Overall Study|Completed at least 12 months follow up|60
6274013|NCT00105183|7173213|FG002|COMPLETED|Overall Study|Completed at least 12 months follow up|39
6274014|NCT00105183|7173211|FG000|NOT COMPLETED|Overall Study||22
6274015|NCT00105183|7173212|FG001|NOT COMPLETED|Overall Study||19
6274016|NCT00105183|7173213|FG002|NOT COMPLETED|Overall Study||23
6274017|NCT00105196|7173223|FG000|STARTED|Overall Study||177
6274018|NCT00105196|7173224|FG001|STARTED|Overall Study||172
6274019|NCT00105196|7173223|FG000|COMPLETED|Overall Study||147
6274020|NCT00105196|7173224|FG001|COMPLETED|Overall Study||149
6274021|NCT00105196|7173223|FG000|NOT COMPLETED|Overall Study||30
6274022|NCT00105196|7173224|FG001|NOT COMPLETED|Overall Study||23
6274023|NCT00105235|7173230|FG000|STARTED|Overall Study||27
6274024|NCT00105235|7173230|FG000|COMPLETED|Overall Study||20
6274025|NCT00105235|7173230|FG000|NOT COMPLETED|Overall Study||7
6274026|NCT00105443|7173240|FG000|STARTED|Double-Blind Treatment||242
6274027|NCT00105443|7173241|FG001|STARTED|Double-Blind Treatment||57
6274028|NCT00105443|7173242|FG002|STARTED|Double-Blind Treatment||256
6274029|NCT00105443|7173243|FG003|STARTED|Double-Blind Treatment||47
6274030|NCT00105443|7173240|FG000|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
6389109|NCT00821795|7300586|FG001|COMPLETED|Overall Study||60
6389110|NCT00821795|7300585|FG000|NOT COMPLETED|Overall Study||6
6389111|NCT00821795|7300586|FG001|NOT COMPLETED|Overall Study||4
6389112|NCT00821821|7300595|FG000|STARTED|Overall Study||12
6389113|NCT00821821|7300596|FG001|STARTED|Overall Study||13
6389114|NCT00821821|7300597|FG002|STARTED|Overall Study||11
6389115|NCT00821821|7300595|FG000|COMPLETED|Overall Study||12
6389116|NCT00821821|7300596|FG001|COMPLETED|Overall Study||13
6389117|NCT00821821|7300597|FG002|COMPLETED|Overall Study||11
6389118|NCT00821821|7300595|FG000|NOT COMPLETED|Overall Study||0
6389119|NCT00821821|7300596|FG001|NOT COMPLETED|Overall Study||0
6389120|NCT00821821|7300597|FG002|NOT COMPLETED|Overall Study||0
6389121|NCT00821873|7300607|FG000|STARTED|Overall Study||9
6389122|NCT00821873|7300607|FG000|COMPLETED|Overall Study||5
6389123|NCT00821873|7300607|FG000|NOT COMPLETED|Overall Study||4
6389124|NCT00821886|7300611|FG000|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
6389125|NCT00821886|7300611|FG000|COMPLETED|Overall Study||49
6389126|NCT00821886|7300611|FG000|NOT COMPLETED|Overall Study||9
6389127|NCT00821951|7300615|FG000|STARTED|Overall Study||17
6389128|NCT00821951|7300615|FG000|COMPLETED|Overall Study||12
6389129|NCT00821951|7300615|FG000|NOT COMPLETED|Overall Study||5
6389130|NCT00821964|7300619|FG000|STARTED|Overall Study||15
6389131|NCT00821964|7300619|FG000|Evaluable for Clinical Response|Overall Study||14
6389132|NCT00821964|7300619|FG000|Evaluable for Pathologic Response|Overall Study||7
6389133|NCT00821964|7300619|FG000|COMPLETED|Overall Study||9
6389134|NCT00821964|7300619|FG000|NOT COMPLETED|Overall Study||6
6274031|NCT00105443|7173241|FG001|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
6274032|NCT00105443|7173242|FG002|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
6274033|NCT00105443|7173243|FG003|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
6274034|NCT00105443|7173240|FG000|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
6274035|NCT00105443|7173241|FG001|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
6274036|NCT00105443|7173242|FG002|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
6274037|NCT00105443|7173243|FG003|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
6274038|NCT00105443|7173240|FG000|NOT COMPLETED|Double-Blind Treatment||14
6274039|NCT00105443|7173241|FG001|NOT COMPLETED|Double-Blind Treatment||0
6274040|NCT00105443|7173242|FG002|NOT COMPLETED|Double-Blind Treatment||11
6274041|NCT00105443|7173243|FG003|NOT COMPLETED|Double-Blind Treatment||0
6274042|NCT00105443|7173240|FG000|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
6274043|NCT00105443|7173241|FG001|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
6274044|NCT00105443|7173242|FG002|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
6274045|NCT00105443|7173243|FG003|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
6274046|NCT00105443|7173240|FG000|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
6274047|NCT00105443|7173241|FG001|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
6274048|NCT00105443|7173242|FG002|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
6274049|NCT00105443|7173243|FG003|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
6274050|NCT00105443|7173240|FG000|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
6274051|NCT00105443|7173241|FG001|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
6274052|NCT00105443|7173242|FG002|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
6274053|NCT00105443|7173243|FG003|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
6274054|NCT00105443|7173240|FG000|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
6274055|NCT00105443|7173241|FG001|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
6274056|NCT00105443|7173242|FG002|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
6274057|NCT00105443|7173243|FG003|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
6274058|NCT00105443|7173240|FG000|COMPLETED|Follow-up and/or Open Label Nexavar||0
6274059|NCT00105443|7173241|FG001|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
6274060|NCT00105443|7173242|FG002|COMPLETED|Follow-up and/or Open Label Nexavar||0
6274061|NCT00105443|7173243|FG003|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
6274062|NCT00105443|7173240|FG000|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
6274063|NCT00105443|7173241|FG001|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
6274064|NCT00105443|7173242|FG002|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
6274065|NCT00105443|7173243|FG003|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
6274066|NCT00105469|7173254|FG000|STARTED|Overall Study||365
6274067|NCT00105469|7173255|FG001|STARTED|Overall Study||378
6274068|NCT00105469|7173254|FG000|COMPLETED|Overall Study||343
6274069|NCT00105469|7173255|FG001|COMPLETED|Overall Study||367
6274070|NCT00105469|7173254|FG000|NOT COMPLETED|Overall Study||22
6274071|NCT00105469|7173255|FG001|NOT COMPLETED|Overall Study||11
6274072|NCT00105482|7173263|FG000|STARTED|Overall Study||87
6274073|NCT00105482|7173264|FG001|STARTED|Overall Study||85
6274074|NCT00105482|7173263|FG000|COMPLETED|Overall Study||28
6274075|NCT00105482|7173264|FG001|COMPLETED|Overall Study||30
6274076|NCT00105482|7173263|FG000|NOT COMPLETED|Overall Study||59
6274077|NCT00105482|7173264|FG001|NOT COMPLETED|Overall Study||55
6274078|NCT00105508|7173272|FG000|STARTED|Overall Study||253
6274079|NCT00105508|7173273|FG001|STARTED|Overall Study||253
6389135|NCT00822094|7300628|FG000|STARTED|Overall Study||81
6389136|NCT00822094|7300629|FG001|STARTED|Overall Study||45
6389137|NCT00822094|7300628|FG000|COMPLETED|Overall Study||37
6389138|NCT00822094|7300629|FG001|COMPLETED|Overall Study||20
6389139|NCT00822094|7300628|FG000|NOT COMPLETED|Overall Study||44
6389140|NCT00822094|7300629|FG001|NOT COMPLETED|Overall Study||25
6389141|NCT00822107|7300635|FG000|STARTED|Overall Study||5
6389142|NCT00822107|7300635|FG000|COMPLETED|Overall Study||5
6389143|NCT00822107|7300635|FG000|NOT COMPLETED|Overall Study||0
6389144|NCT00822172|7300641|FG000|STARTED|Overall Study||80
6389145|NCT00822172|7300642|FG001|STARTED|Overall Study||83
6389146|NCT00822172|7300641|FG000|COMPLETED|Overall Study||65
6389147|NCT00822172|7300642|FG001|COMPLETED|Overall Study||64
6389148|NCT00822172|7300641|FG000|NOT COMPLETED|Overall Study||15
6389149|NCT00822172|7300642|FG001|NOT COMPLETED|Overall Study||19
6389150|NCT00822185|7300653|FG000|STARTED|Overall Study||6
6389151|NCT00822185|7300654|FG001|STARTED|Overall Study||6
6389152|NCT00822185|7300655|FG002|STARTED|Overall Study||6
6389153|NCT00822185|7300656|FG003|STARTED|Overall Study||6
6389154|NCT00822185|7300657|FG004|STARTED|Overall Study||8
6389155|NCT00822185|7300653|FG000|COMPLETED|Overall Study||6
6389156|NCT00822185|7300654|FG001|COMPLETED|Overall Study||6
6389157|NCT00822185|7300655|FG002|COMPLETED|Overall Study||6
6389158|NCT00822185|7300656|FG003|COMPLETED|Overall Study||6
6389159|NCT00822185|7300657|FG004|COMPLETED|Overall Study||8
6389160|NCT00822185|7300653|FG000|NOT COMPLETED|Overall Study||0
6389161|NCT00822185|7300654|FG001|NOT COMPLETED|Overall Study||0
6389162|NCT00822185|7300655|FG002|NOT COMPLETED|Overall Study||0
6389163|NCT00822185|7300656|FG003|NOT COMPLETED|Overall Study||0
6389164|NCT00822185|7300657|FG004|NOT COMPLETED|Overall Study||0
6389165|NCT00822237|7300671|FG000|STARTED|Dose 1 Vaccination|Number randomized|299
6389166|NCT00822237|7300672|FG001|STARTED|Dose 1 Vaccination|Number randomized|299
6389167|NCT00822237|7300671|FG000|COMPLETED|Dose 1 Vaccination||274
6389168|NCT00822237|7300672|FG001|COMPLETED|Dose 1 Vaccination||273
6389169|NCT00822237|7300671|FG000|NOT COMPLETED|Dose 1 Vaccination||25
6389170|NCT00822237|7300672|FG001|NOT COMPLETED|Dose 1 Vaccination||26
6389171|NCT00822237|7300671|FG000|STARTED|Dose 2 Vaccination|Number who received second dose|274
6389172|NCT00822237|7300672|FG001|STARTED|Dose 2 Vaccination|Number who received second dose|273
6389173|NCT00822237|7300671|FG000|COMPLETED|Dose 2 Vaccination||270
6389174|NCT00822237|7300672|FG001|COMPLETED|Dose 2 Vaccination||262
6389175|NCT00822237|7300671|FG000|NOT COMPLETED|Dose 2 Vaccination||4
6389176|NCT00822237|7300672|FG001|NOT COMPLETED|Dose 2 Vaccination||11
6389177|NCT00822328|7300679|FG000|STARTED|Overall Study||12
6389178|NCT00822328|7300680|FG001|STARTED|Overall Study||12
6389179|NCT00822328|7300679|FG000|COMPLETED|Overall Study||12
6389180|NCT00822328|7300680|FG001|COMPLETED|Overall Study||12
6389181|NCT00822328|7300679|FG000|NOT COMPLETED|Overall Study||0
6389182|NCT00822328|7300680|FG001|NOT COMPLETED|Overall Study||0
6389183|NCT00822354|7300688|FG000|STARTED|First Intervention (28 Days)||5
6389184|NCT00822354|7300689|FG001|STARTED|First Intervention (28 Days)||5
6389185|NCT00822354|7300688|FG000|COMPLETED|First Intervention (28 Days)||4
6389186|NCT00822354|7300689|FG001|COMPLETED|First Intervention (28 Days)||5
6389187|NCT00822354|7300688|FG000|NOT COMPLETED|First Intervention (28 Days)||1
6389188|NCT00822354|7300689|FG001|NOT COMPLETED|First Intervention (28 Days)||0
6389189|NCT00822354|7300688|FG000|STARTED|Washout (7 Days)||4
6389190|NCT00822354|7300689|FG001|STARTED|Washout (7 Days)||5
6389191|NCT00822354|7300688|FG000|COMPLETED|Washout (7 Days)||4
6389192|NCT00822354|7300689|FG001|COMPLETED|Washout (7 Days)||5
6389193|NCT00822354|7300688|FG000|NOT COMPLETED|Washout (7 Days)||0
6389194|NCT00822354|7300689|FG001|NOT COMPLETED|Washout (7 Days)||0
6389195|NCT00822354|7300688|FG000|STARTED|Second Intervention (28 Days)||4
6389196|NCT00822354|7300689|FG001|STARTED|Second Intervention (28 Days)||5
6389197|NCT00822354|7300688|FG000|COMPLETED|Second Intervention (28 Days)||3
6389198|NCT00822354|7300689|FG001|COMPLETED|Second Intervention (28 Days)||5
6389199|NCT00822354|7300688|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
6389200|NCT00822354|7300689|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
6389201|NCT00822510|7300699|FG000|STARTED|Overall Study||38
6389202|NCT00822510|7300700|FG001|STARTED|Overall Study||41
6389203|NCT00822510|7300699|FG000|COMPLETED|Overall Study||35
6389204|NCT00822510|7300700|FG001|COMPLETED|Overall Study||36
6389205|NCT00822510|7300699|FG000|NOT COMPLETED|Overall Study||3
6389206|NCT00822510|7300700|FG001|NOT COMPLETED|Overall Study||5
6389207|NCT00822523|7300711|FG000|STARTED|Overall Study||5
6389208|NCT00822523|7300712|FG001|STARTED|Overall Study||4
6389209|NCT00822523|7300713|FG002|STARTED|Overall Study||4
6389210|NCT00822523|7300711|FG000|COMPLETED|Overall Study||5
6389211|NCT00822523|7300712|FG001|COMPLETED|Overall Study||4
6389212|NCT00822523|7300713|FG002|COMPLETED|Overall Study||4
6389213|NCT00822523|7300711|FG000|NOT COMPLETED|Overall Study||0
6389214|NCT00822523|7300712|FG001|NOT COMPLETED|Overall Study||0
6389215|NCT00822523|7300713|FG002|NOT COMPLETED|Overall Study||0
6389216|NCT00822588|7300731|FG000|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
6389217|NCT00822588|7300732|FG001|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
6389218|NCT00822588|7300731|FG000|COMPLETED|Overall Study|APT/ITT analysis set|106
6389219|NCT00822588|7300732|FG001|COMPLETED|Overall Study|APT/ITT analysis set|110
6389220|NCT00822588|7300731|FG000|NOT COMPLETED|Overall Study||7
6389221|NCT00822588|7300732|FG001|NOT COMPLETED|Overall Study||4
6389222|NCT00822692|7300740|FG000|STARTED|Overall Study|July 1, 2008|63
6389223|NCT00822692|7300741|FG001|STARTED|Overall Study|July 1, 2008|76
6389224|NCT00822692|7300740|FG000|COMPLETED|Overall Study|June 1, 2009|46
6389225|NCT00822692|7300741|FG001|COMPLETED|Overall Study|June 1 , 2009|51
6389226|NCT00822692|7300740|FG000|NOT COMPLETED|Overall Study||17
6389227|NCT00822692|7300741|FG001|NOT COMPLETED|Overall Study||25
6389228|NCT00822757|7300749|FG000|STARTED|Overall Study||41
6389229|NCT00822757|7300750|FG001|STARTED|Overall Study||10
6389230|NCT00822757|7300749|FG000|COMPLETED|Overall Study||41
6566683|NCT01825941|7489617|FG001|STARTED|Overall Study||104
6566684|NCT01825941|7489616|FG000|COMPLETED|Overall Study||100
6566685|NCT01825941|7489617|FG001|COMPLETED|Overall Study||103
6566686|NCT01825941|7489616|FG000|NOT COMPLETED|Overall Study||4
6566687|NCT01825941|7489617|FG001|NOT COMPLETED|Overall Study||1
6389231|NCT00822757|7300750|FG001|COMPLETED|Overall Study||10
6389232|NCT00822757|7300749|FG000|NOT COMPLETED|Overall Study||0
6389233|NCT00822757|7300750|FG001|NOT COMPLETED|Overall Study||0
6389234|NCT00822770|7300758|FG000|STARTED|Overall Study||18
6389235|NCT00822770|7300759|FG001|STARTED|Overall Study||29
6389236|NCT00822770|7300758|FG000|COMPLETED|Overall Study||15
6389237|NCT00822770|7300759|FG001|COMPLETED|Overall Study||28
6389238|NCT00822770|7300758|FG000|NOT COMPLETED|Overall Study||3
6389239|NCT00822770|7300759|FG001|NOT COMPLETED|Overall Study||1
6389240|NCT00822900|7300767|FG000|STARTED|Overall Study||442
6389241|NCT00822900|7300768|FG001|STARTED|Overall Study||440
6389242|NCT00822900|7300767|FG000|COMPLETED|Overall Study||334
6389243|NCT00822900|7300768|FG001|COMPLETED|Overall Study||347
6389244|NCT00822900|7300767|FG000|NOT COMPLETED|Overall Study||108
6389245|NCT00822900|7300768|FG001|NOT COMPLETED|Overall Study||93
6389246|NCT00822926|7300776|FG000|STARTED|First Injection Visit||2
6389247|NCT00822926|7300777|FG001|STARTED|First Injection Visit||3
6389248|NCT00822926|7300776|FG000|COMPLETED|First Injection Visit||2
6389249|NCT00822926|7300777|FG001|COMPLETED|First Injection Visit||3
6389250|NCT00822926|7300776|FG000|NOT COMPLETED|First Injection Visit||0
6389251|NCT00822926|7300777|FG001|NOT COMPLETED|First Injection Visit||0
6389252|NCT00822926|7300776|FG000|STARTED|Washout (Varies Based on Scheduling)||2
6566688|NCT01826201|7489623|FG000|STARTED|Overall Study|Subjects in each arm are same|21
6274080|NCT00105508|7173272|FG000|COMPLETED|Overall Study||213
6274081|NCT00105508|7173273|FG001|COMPLETED|Overall Study||217
6274082|NCT00105508|7173272|FG000|NOT COMPLETED|Overall Study||40
6274083|NCT00105508|7173273|FG001|NOT COMPLETED|Overall Study||36
6274084|NCT00105521|7173283|FG000|STARTED|Overall Study||98
6274085|NCT00105521|7173284|FG001|STARTED|Overall Study||101
6274086|NCT00105521|7173285|FG002|STARTED|Overall Study||97
6274087|NCT00105521|7173286|FG003|STARTED|Overall Study||102
6274088|NCT00105521|7173283|FG000|COMPLETED|Overall Study||83
6274089|NCT00105521|7173284|FG001|COMPLETED|Overall Study||90
6274090|NCT00105521|7173285|FG002|COMPLETED|Overall Study||80
6274091|NCT00105521|7173286|FG003|COMPLETED|Overall Study||85
6274092|NCT00105521|7173283|FG000|NOT COMPLETED|Overall Study||15
6274093|NCT00105521|7173284|FG001|NOT COMPLETED|Overall Study||11
6274094|NCT00105521|7173285|FG002|NOT COMPLETED|Overall Study||17
6274095|NCT00105521|7173286|FG003|NOT COMPLETED|Overall Study||17
6274096|NCT00105534|7173298|FG000|STARTED|Overall Study||335
6274097|NCT00105534|7173299|FG001|STARTED|Overall Study||350
6274098|NCT00105534|7173298|FG000|COMPLETED|Overall Study||313
6274099|NCT00105534|7173299|FG001|COMPLETED|Overall Study||317
6274100|NCT00105534|7173298|FG000|NOT COMPLETED|Overall Study||22
6274101|NCT00105534|7173299|FG001|NOT COMPLETED|Overall Study||33
6274102|NCT00105586|7173307|FG000|STARTED|Overall Study||92
6274103|NCT00105586|7173308|FG001|STARTED|Overall Study||85
6274104|NCT00105586|7173307|FG000|COMPLETED|Overall Study||75
6274105|NCT00105586|7173308|FG001|COMPLETED|Overall Study||69
6274106|NCT00105586|7173307|FG000|NOT COMPLETED|Overall Study||17
6274107|NCT00105586|7173308|FG001|NOT COMPLETED|Overall Study||16
6274108|NCT00105989|7173316|FG000|STARTED|Acute - Open Label: Week 0-10||514
6274109|NCT00105989|7173317|FG001|STARTED|Acute - Open Label: Week 0-10||0
6274110|NCT00105989|7173316|FG000|COMPLETED|Acute - Open Label: Week 0-10||413
6274111|NCT00105989|7173317|FG001|COMPLETED|Acute - Open Label: Week 0-10||0
6274112|NCT00105989|7173316|FG000|NOT COMPLETED|Acute - Open Label: Week 0-10||101
6274113|NCT00105989|7173317|FG001|NOT COMPLETED|Acute - Open Label: Week 0-10||0
6274114|NCT00105989|7173316|FG000|STARTED|Continuation - Open Label:Week 10-34||413
6274115|NCT00105989|7173317|FG001|STARTED|Continuation - Open Label:Week 10-34||0
6274116|NCT00105989|7173316|FG000|COMPLETED|Continuation - Open Label:Week 10-34||288
6566689|NCT01826201|7489623|FG000|COMPLETED|Overall Study||17
6566690|NCT01826201|7489623|FG000|NOT COMPLETED|Overall Study||4
6566691|NCT01826214|7489631|FG000|STARTED|Overall Study||35
6566692|NCT01826214|7489632|FG001|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
6566693|NCT01826214|7489631|FG000|Untreated|Overall Study|Untreated = did not receive study drug|0
6389253|NCT00822926|7300777|FG001|STARTED|Washout (Varies Based on Scheduling)||3
6389254|NCT00822926|7300776|FG000|COMPLETED|Washout (Varies Based on Scheduling)||2
6389255|NCT00822926|7300777|FG001|COMPLETED|Washout (Varies Based on Scheduling)||3
6389256|NCT00822926|7300776|FG000|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
6389257|NCT00822926|7300777|FG001|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
6389258|NCT00822926|7300776|FG000|STARTED|Second Injection Visit||2
6389259|NCT00822926|7300777|FG001|STARTED|Second Injection Visit||3
6389260|NCT00822926|7300776|FG000|COMPLETED|Second Injection Visit||1
6504426|NCT01448824|7423502|FG004|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504427|NCT01448824|7423503|FG005|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504428|NCT01448824|7423504|FG006|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504429|NCT01448824|7423505|FG007|COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504430|NCT01448824|7423498|FG000|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504431|NCT01448824|7423499|FG001|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504432|NCT01448824|7423500|FG002|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504433|NCT01448824|7423501|FG003|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504434|NCT01448824|7423502|FG004|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504435|NCT01448824|7423503|FG005|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504436|NCT01448824|7423504|FG006|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504437|NCT01448824|7423505|FG007|NOT COMPLETED|Part 1 Period 2: Multiple Ascending Dose||0
6504438|NCT01448824|7423498|FG000|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6504439|NCT01448824|7423499|FG001|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6504440|NCT01448824|7423500|FG002|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6504441|NCT01448824|7423501|FG003|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6504442|NCT01448824|7423502|FG004|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6504443|NCT01448824|7423503|FG005|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6504444|NCT01448824|7423504|FG006|STARTED|Part 2 Period 1: Drug-drug Interaction||0
6566694|NCT01826214|7489632|FG001|Untreated|Overall Study|Untreated = did not receive study drug|1
6566695|NCT01826214|7489631|FG000|Treated|Overall Study|Treated = received at least one dose of study drug|35
6566696|NCT01826214|7489632|FG001|Treated|Overall Study|Treated = received at least one dose of study drug|34
6566697|NCT01826214|7489631|FG000|COMPLETED|Overall Study||0
6566698|NCT01826214|7489632|FG001|COMPLETED|Overall Study||0
6566699|NCT01826214|7489631|FG000|NOT COMPLETED|Overall Study||35
6566700|NCT01826214|7489632|FG001|NOT COMPLETED|Overall Study||34
6566701|NCT01826227|7489638|FG000|STARTED|Overall Study||5
6566702|NCT01826227|7489638|FG000|COMPLETED|Overall Study||5
6389261|NCT00822926|7300777|FG001|COMPLETED|Second Injection Visit||2
6389262|NCT00822926|7300776|FG000|NOT COMPLETED|Second Injection Visit||1
6389263|NCT00822926|7300777|FG001|NOT COMPLETED|Second Injection Visit||1
6389264|NCT00823043|7300786|FG000|STARTED|Overall Study||64
6274117|NCT00105989|7173317|FG001|COMPLETED|Continuation - Open Label:Week 10-34||0
6274118|NCT00105989|7173316|FG000|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
6274119|NCT00105989|7173317|FG001|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
6274120|NCT00105989|7173316|FG000|STARTED|Maintenance - Double-Blind:Week 34-86||146
6274121|NCT00105989|7173317|FG001|STARTED|Maintenance - Double-Blind:Week 34-86||142
6274122|NCT00105989|7173316|FG000|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
6274123|NCT00105989|7173317|FG001|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
6274124|NCT00105989|7173316|FG000|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
6274125|NCT00105989|7173317|FG001|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
6274126|NCT00106002|7173333|FG000|STARTED|Overall Study||37
6274127|NCT00106002|7173333|FG000|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
6274128|NCT00106002|7173333|FG000|NOT COMPLETED|Overall Study||2
6274129|NCT00106028|7173339|FG000|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
6274130|NCT00106028|7173340|FG001|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
6274131|NCT00106028|7173339|FG000|Month 12 Completed/Started Open Label|Overall Study||49
6274132|NCT00106028|7173340|FG001|Month 12 Completed/Started Open Label|Overall Study||87
6274133|NCT00106028|7173339|FG000|COMPLETED|Overall Study|Completed Month 36|43
6274134|NCT00106028|7173340|FG001|COMPLETED|Overall Study|Completed Month 36|82
6274135|NCT00106028|7173339|FG000|NOT COMPLETED|Overall Study||6
6274136|NCT00106028|7173340|FG001|NOT COMPLETED|Overall Study||12
6274137|NCT00106080|7173350|FG000|STARTED|Overall Study||194
6274138|NCT00106080|7173351|FG001|STARTED|Overall Study||182
6274139|NCT00106080|7173350|FG000|COMPLETED|Overall Study||151
6274140|NCT00106080|7173351|FG001|COMPLETED|Overall Study||155
6274141|NCT00106080|7173350|FG000|NOT COMPLETED|Overall Study||43
6274142|NCT00106080|7173351|FG001|NOT COMPLETED|Overall Study||27
6274143|NCT00106106|7173359|FG000|STARTED|Overall Study||26
6274144|NCT00106106|7173360|FG001|STARTED|Overall Study||23
6274145|NCT00106106|7173359|FG000|Completed Both MRS Scans|Overall Study||18
6274146|NCT00106106|7173360|FG001|Completed Both MRS Scans|Overall Study||15
6274147|NCT00106106|7173359|FG000|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
6274148|NCT00106106|7173360|FG001|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
6274149|NCT00106106|7173359|FG000|NOT COMPLETED|Overall Study||4
6274150|NCT00106106|7173360|FG001|NOT COMPLETED|Overall Study||4
6274151|NCT00106119|7173366|FG000|STARTED|First Intervention||7
6274152|NCT00106119|7173367|FG001|STARTED|First Intervention||7
6274153|NCT00106119|7173366|FG000|COMPLETED|First Intervention||7
6274154|NCT00106119|7173367|FG001|COMPLETED|First Intervention||7
6274155|NCT00106119|7173366|FG000|NOT COMPLETED|First Intervention||0
6274156|NCT00106119|7173367|FG001|NOT COMPLETED|First Intervention||0
6274157|NCT00106119|7173366|FG000|STARTED|Washout Period of 30 Days||7
6274158|NCT00106119|7173367|FG001|STARTED|Washout Period of 30 Days||7
6274159|NCT00106119|7173366|FG000|COMPLETED|Washout Period of 30 Days||7
6274160|NCT00106119|7173367|FG001|COMPLETED|Washout Period of 30 Days||7
6274161|NCT00106119|7173366|FG000|NOT COMPLETED|Washout Period of 30 Days||0
6274162|NCT00106119|7173367|FG001|NOT COMPLETED|Washout Period of 30 Days||0
6274163|NCT00106119|7173366|FG000|STARTED|Second Intervention||7
6274164|NCT00106119|7173367|FG001|STARTED|Second Intervention||7
6274165|NCT00106119|7173366|FG000|COMPLETED|Second Intervention||7
6566703|NCT01826227|7489638|FG000|NOT COMPLETED|Overall Study||0
6566704|NCT01826370|7489642|FG000|STARTED|Overall Study||678
6566705|NCT01826370|7489642|FG000|COMPLETED|Overall Study||658
6806450|NCT03185832|7738661|FG003|NOT COMPLETED|Overall Study||11
6806451|NCT02963714|7738671|FG000|STARTED|Overall Study||176
6806452|NCT02963714|7738672|FG001|STARTED|Overall Study||176
6806453|NCT02963714|7738671|FG000|COMPLETED|Overall Study||126
6806454|NCT02963714|7738672|FG001|COMPLETED|Overall Study||126
6806455|NCT02963714|7738671|FG000|NOT COMPLETED|Overall Study||50
6806456|NCT02963714|7738672|FG001|NOT COMPLETED|Overall Study||50
6806457|NCT02959918|7738692|FG000|STARTED|Overall Study||3
6806458|NCT02959918|7738693|FG001|STARTED|Overall Study||3
6806459|NCT02959918|7738694|FG002|STARTED|Overall Study||9
6806460|NCT02959918|7738695|FG003|STARTED|Overall Study||10
6806461|NCT02959918|7738696|FG004|STARTED|Overall Study||6
6806462|NCT02959918|7738697|FG005|STARTED|Overall Study||11
6806463|NCT02959918|7738698|FG006|STARTED|Overall Study||11
6806464|NCT02959918|7738699|FG007|STARTED|Overall Study||12
6806465|NCT02959918|7738700|FG008|STARTED|Overall Study||14
6806466|NCT02959918|7738701|FG009|STARTED|Overall Study||13
6806467|NCT02959918|7738702|FG010|STARTED|Overall Study||14
6806468|NCT02959918|7738703|FG011|STARTED|Overall Study||23
6806469|NCT02959918|7738704|FG012|STARTED|Overall Study||11
6806470|NCT02959918|7738705|FG013|STARTED|Overall Study||12
6806471|NCT02959918|7738692|FG000|COMPLETED|Overall Study||0
6806472|NCT02959918|7738693|FG001|COMPLETED|Overall Study||0
6806473|NCT02959918|7738694|FG002|COMPLETED|Overall Study||1
6806474|NCT02959918|7738695|FG003|COMPLETED|Overall Study||1
6806475|NCT02959918|7738696|FG004|COMPLETED|Overall Study||1
6806476|NCT02959918|7738697|FG005|COMPLETED|Overall Study||5
6806477|NCT02959918|7738698|FG006|COMPLETED|Overall Study||6
6806478|NCT02959918|7738699|FG007|COMPLETED|Overall Study||6
6806479|NCT02959918|7738700|FG008|COMPLETED|Overall Study||7
6806480|NCT02959918|7738701|FG009|COMPLETED|Overall Study||7
6806481|NCT02959918|7738702|FG010|COMPLETED|Overall Study||8
6806482|NCT02959918|7738703|FG011|COMPLETED|Overall Study||11
6566706|NCT01826370|7489642|FG000|NOT COMPLETED|Overall Study||20
6566707|NCT01826422|7489648|FG000|STARTED|Overall Study||18
6566708|NCT01826422|7489649|FG001|STARTED|Overall Study||22
6566709|NCT01826422|7489648|FG000|COMPLETED|Overall Study||17
6566710|NCT01826422|7489649|FG001|COMPLETED|Overall Study||19
6566711|NCT01826422|7489648|FG000|NOT COMPLETED|Overall Study||1
6389265|NCT00823043|7300787|FG001|STARTED|Overall Study||39
6389266|NCT00823043|7300786|FG000|COMPLETED|Overall Study||64
6389267|NCT00823043|7300787|FG001|COMPLETED|Overall Study||39
6389268|NCT00823043|7300786|FG000|NOT COMPLETED|Overall Study||0
6389269|NCT00823043|7300787|FG001|NOT COMPLETED|Overall Study||0
6389270|NCT00823069|7300792|FG000|STARTED|Overall Study||60
6389271|NCT00823069|7300792|FG000|COMPLETED|Overall Study||60
6389272|NCT00823069|7300792|FG000|NOT COMPLETED|Overall Study||0
6389273|NCT00823082|7300801|FG000|STARTED|Overall Study||100
6389274|NCT00823082|7300802|FG001|STARTED|Overall Study||100
6389275|NCT00823082|7300801|FG000|Safety Population|Overall Study||100
6389276|NCT00823082|7300802|FG001|Safety Population|Overall Study||99
6389277|NCT00823082|7300801|FG000|Intent-to-Treat/Per Protocol Populations|Overall Study||100
6389278|NCT00823082|7300802|FG001|Intent-to-Treat/Per Protocol Populations|Overall Study||94
6389279|NCT00823082|7300801|FG000|COMPLETED|Overall Study||100
6389280|NCT00823082|7300802|FG001|COMPLETED|Overall Study||99
6566712|NCT01826422|7489649|FG001|NOT COMPLETED|Overall Study||3
6566713|NCT01826448|7489657|FG000|STARTED|Overall Study||4
6566714|NCT01826448|7489658|FG001|STARTED|Overall Study||9
6566715|NCT01826448|7489657|FG000|COMPLETED|Overall Study||0
6389281|NCT00823082|7300801|FG000|NOT COMPLETED|Overall Study||0
6389282|NCT00823082|7300802|FG001|NOT COMPLETED|Overall Study||1
6389283|NCT00823134|7300808|FG000|STARTED|Overall Study||23
6389284|NCT00823134|7300808|FG000|COMPLETED|Overall Study||22
6274166|NCT00106119|7173367|FG001|COMPLETED|Second Intervention||7
6274167|NCT00106119|7173366|FG000|NOT COMPLETED|Second Intervention||0
6274168|NCT00106119|7173367|FG001|NOT COMPLETED|Second Intervention||0
6274169|NCT00106184|7173375|FG000|STARTED|Overall Study||96
6274170|NCT00106184|7173376|FG001|STARTED|Overall Study||104
6274171|NCT00106184|7173375|FG000|Treated|Overall Study|96 subjects were randomized.|93
6274172|NCT00106184|7173376|FG001|Treated|Overall Study|104 subjects were randomized.|102
6274173|NCT00106184|7173375|FG000|COMPLETED|Overall Study||93
6274174|NCT00106184|7173376|FG001|COMPLETED|Overall Study||102
6274175|NCT00106184|7173375|FG000|NOT COMPLETED|Overall Study||3
6274176|NCT00106184|7173376|FG001|NOT COMPLETED|Overall Study||2
6274177|NCT00106249|7173386|FG000|STARTED|Overall Study||14
6274178|NCT00106249|7173387|FG001|STARTED|Overall Study||13
6274179|NCT00106249|7173386|FG000|COMPLETED|Overall Study||11
6274180|NCT00106249|7173387|FG001|COMPLETED|Overall Study||11
6274181|NCT00106249|7173386|FG000|NOT COMPLETED|Overall Study||3
6274182|NCT00106249|7173387|FG001|NOT COMPLETED|Overall Study||2
6274183|NCT00106353|7173395|FG000|STARTED|Part 1||4
6274184|NCT00106353|7173396|FG001|STARTED|Part 1||5
6274185|NCT00106353|7173397|FG002|STARTED|Part 1||3
6274186|NCT00106353|7173398|FG003|STARTED|Part 1||7
6274187|NCT00106353|7173399|FG004|STARTED|Part 1||0
6274188|NCT00106353|7173400|FG005|STARTED|Part 1||0
6274189|NCT00106353|7173401|FG006|STARTED|Part 1||0
6274190|NCT00106353|7173395|FG000|COMPLETED|Part 1||0
6274191|NCT00106353|7173396|FG001|COMPLETED|Part 1||0
6274192|NCT00106353|7173397|FG002|COMPLETED|Part 1||0
6274193|NCT00106353|7173398|FG003|COMPLETED|Part 1||0
6274194|NCT00106353|7173399|FG004|COMPLETED|Part 1||0
6274195|NCT00106353|7173400|FG005|COMPLETED|Part 1||0
6274196|NCT00106353|7173401|FG006|COMPLETED|Part 1||0
6274197|NCT00106353|7173395|FG000|NOT COMPLETED|Part 1||4
6274198|NCT00106353|7173396|FG001|NOT COMPLETED|Part 1||5
6274199|NCT00106353|7173397|FG002|NOT COMPLETED|Part 1||3
6274200|NCT00106353|7173398|FG003|NOT COMPLETED|Part 1||7
6274201|NCT00106353|7173399|FG004|NOT COMPLETED|Part 1||0
6274202|NCT00106353|7173400|FG005|NOT COMPLETED|Part 1||0
6274203|NCT00106353|7173401|FG006|NOT COMPLETED|Part 1||0
6274204|NCT00106353|7173395|FG000|STARTED|Part 2||0
6274205|NCT00106353|7173396|FG001|STARTED|Part 2||0
6274206|NCT00106353|7173397|FG002|STARTED|Part 2||0
6274207|NCT00106353|7173398|FG003|STARTED|Part 2||0
6274208|NCT00106353|7173399|FG004|STARTED|Part 2||17
6274209|NCT00106353|7173400|FG005|STARTED|Part 2||19
6274210|NCT00106353|7173401|FG006|STARTED|Part 2||16
6274211|NCT00106353|7173395|FG000|COMPLETED|Part 2||0
6274212|NCT00106353|7173396|FG001|COMPLETED|Part 2||0
6274213|NCT00106353|7173397|FG002|COMPLETED|Part 2||0
6274214|NCT00106353|7173398|FG003|COMPLETED|Part 2||0
6274215|NCT00106353|7173399|FG004|COMPLETED|Part 2||1
6274216|NCT00106353|7173400|FG005|COMPLETED|Part 2||1
6274217|NCT00106353|7173401|FG006|COMPLETED|Part 2||0
6274218|NCT00106353|7173395|FG000|NOT COMPLETED|Part 2||0
6274219|NCT00106353|7173396|FG001|NOT COMPLETED|Part 2||0
6274220|NCT00106353|7173397|FG002|NOT COMPLETED|Part 2||0
6274221|NCT00106353|7173398|FG003|NOT COMPLETED|Part 2||0
6274222|NCT00106353|7173399|FG004|NOT COMPLETED|Part 2||16
6274223|NCT00106353|7173400|FG005|NOT COMPLETED|Part 2||18
6274224|NCT00106353|7173401|FG006|NOT COMPLETED|Part 2||16
6274225|NCT00106392|7173424|FG000|STARTED|Overall Study||62
6274226|NCT00106392|7173425|FG001|STARTED|Overall Study||69
6274227|NCT00106392|7173424|FG000|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
6274228|NCT00106392|7173425|FG001|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
6274229|NCT00106392|7173424|FG000|Full Analysis Set (FAS)|Overall Study||53
6274230|NCT00106392|7173425|FG001|Full Analysis Set (FAS)|Overall Study||61
6274231|NCT00106392|7173424|FG000|COMPLETED|Overall Study||36
6274232|NCT00106392|7173425|FG001|COMPLETED|Overall Study||42
6274233|NCT00106392|7173424|FG000|NOT COMPLETED|Overall Study||26
6274234|NCT00106392|7173425|FG001|NOT COMPLETED|Overall Study||27
6274235|NCT00106431|7173431|FG000|STARTED|Overall Study||102
6274236|NCT00106431|7173431|FG000|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
6274237|NCT00106431|7173431|FG000|NOT COMPLETED|Overall Study||65
6274238|NCT00106535|7173438|FG000|STARTED|2-year Placebo Controlled Period||394
6274239|NCT00106535|7173439|FG001|STARTED|2-year Placebo Controlled Period||401
6274240|NCT00106535|7173440|FG002|STARTED|2-year Placebo Controlled Period||401
6274241|NCT00106535|7173441|FG003|STARTED|2-year Placebo Controlled Period||0
6274242|NCT00106535|7173438|FG000|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
6274243|NCT00106535|7173439|FG001|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
6566716|NCT01826448|7489658|FG001|COMPLETED|Overall Study||0
6566717|NCT01826448|7489657|FG000|NOT COMPLETED|Overall Study||4
6566718|NCT01826448|7489658|FG001|NOT COMPLETED|Overall Study||9
6566719|NCT01826487|7489666|FG000|STARTED|Overall Study||115
6566720|NCT01826487|7489667|FG001|STARTED|Overall Study||115
6566721|NCT01826487|7489666|FG000|As-treated Population|Overall Study||115
6566722|NCT01826487|7489667|FG001|As-treated Population|Overall Study||115
6389285|NCT00823134|7300808|FG000|NOT COMPLETED|Overall Study||1
6389286|NCT00823199|7300813|FG000|STARTED|Overall Study||10
6566723|NCT01826487|7489666|FG000|ITT Population|Overall Study||114
6566724|NCT01826487|7489667|FG001|ITT Population|Overall Study||114
6566725|NCT01826487|7489666|FG000|COMPLETED|Overall Study||111
6566726|NCT01826487|7489667|FG001|COMPLETED|Overall Study||110
6566727|NCT01826487|7489666|FG000|NOT COMPLETED|Overall Study||4
6566728|NCT01826487|7489667|FG001|NOT COMPLETED|Overall Study||5
6566729|NCT01826513|7489677|FG000|STARTED|Overall Study||5
6566730|NCT01826513|7489678|FG001|STARTED|Overall Study||10
6566731|NCT01826513|7489679|FG002|STARTED|Overall Study||10
6389287|NCT00823199|7300813|FG000|COMPLETED|Overall Study||8
6389288|NCT00823199|7300813|FG000|NOT COMPLETED|Overall Study||2
6389289|NCT00823212|7300820|FG000|STARTED|Overall Study||762
6389290|NCT00823212|7300821|FG001|STARTED|Overall Study||768
6389291|NCT00823212|7300820|FG000|COMPLETED|Overall Study|12-month follow-up|727
6389292|NCT00823212|7300821|FG001|COMPLETED|Overall Study|12-month follow-up|735
6389293|NCT00823212|7300820|FG000|NOT COMPLETED|Overall Study||35
6389294|NCT00823212|7300821|FG001|NOT COMPLETED|Overall Study||33
6389295|NCT00823264|7300831|FG000|STARTED|Overall Study||10
6389296|NCT00823264|7300832|FG001|STARTED|Overall Study||7
6389297|NCT00823264|7300831|FG000|COMPLETED|Overall Study||8
6389298|NCT00823264|7300832|FG001|COMPLETED|Overall Study||7
6389299|NCT00823264|7300831|FG000|NOT COMPLETED|Overall Study||2
6389300|NCT00823264|7300832|FG001|NOT COMPLETED|Overall Study||0
6389301|NCT00823303|7300840|FG000|STARTED|Overall Study||54
6389302|NCT00823303|7300841|FG001|STARTED|Overall Study||56
6389303|NCT00823303|7300840|FG000|COMPLETED|Overall Study||45
6389304|NCT00823303|7300841|FG001|COMPLETED|Overall Study||45
6389305|NCT00823303|7300840|FG000|NOT COMPLETED|Overall Study||9
6389306|NCT00823303|7300841|FG001|NOT COMPLETED|Overall Study||11
6389307|NCT00823459|7300847|FG000|STARTED|Overall Study||58
6566732|NCT01826513|7489677|FG000|COMPLETED|Overall Study||5
6566733|NCT01826513|7489678|FG001|COMPLETED|Overall Study||10
6566734|NCT01826513|7489679|FG002|COMPLETED|Overall Study||10
6274244|NCT00106535|7173440|FG002|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
6274245|NCT00106535|7173441|FG003|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
6274246|NCT00106535|7173438|FG000|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
6274247|NCT00106535|7173439|FG001|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
6274248|NCT00106535|7173440|FG002|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
6274249|NCT00106535|7173441|FG003|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
6274250|NCT00106535|7173438|FG000|Completed Week 24|2-year Placebo Controlled Period||356
6274251|NCT00106535|7173439|FG001|Completed Week 24|2-year Placebo Controlled Period||373
6274252|NCT00106535|7173440|FG002|Completed Week 24|2-year Placebo Controlled Period||366
6274253|NCT00106535|7173441|FG003|Completed Week 24|2-year Placebo Controlled Period||0
6274254|NCT00106535|7173438|FG000|Completed Week 52|2-year Placebo Controlled Period||326
6274255|NCT00106535|7173439|FG001|Completed Week 52|2-year Placebo Controlled Period||342
6274256|NCT00106535|7173440|FG002|Completed Week 52|2-year Placebo Controlled Period||338
6274257|NCT00106535|7173441|FG003|Completed Week 52|2-year Placebo Controlled Period||0
6274258|NCT00106535|7173438|FG000|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
6274259|NCT00106535|7173439|FG001|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
6274260|NCT00106535|7173440|FG002|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
6274261|NCT00106535|7173441|FG003|COMPLETED|2-year Placebo Controlled Period||0
6274262|NCT00106535|7173438|FG000|NOT COMPLETED|2-year Placebo Controlled Period||107
6274263|NCT00106535|7173439|FG001|NOT COMPLETED|2-year Placebo Controlled Period||92
6274264|NCT00106535|7173440|FG002|NOT COMPLETED|2-year Placebo Controlled Period||91
6274265|NCT00106535|7173441|FG003|NOT COMPLETED|2-year Placebo Controlled Period||0
6274266|NCT00106535|7173438|FG000|STARTED|Long-term Extension Period (Year 3 to 5)||0
6389308|NCT00823459|7300847|FG000|COMPLETED|Overall Study||58
6389309|NCT00823459|7300847|FG000|NOT COMPLETED|Overall Study||0
6389310|NCT00823472|7300854|FG000|STARTED|Overall Study||80
6389311|NCT00823472|7300855|FG001|STARTED|Overall Study||67
6389312|NCT00823472|7300854|FG000|COMPLETED|Overall Study||56
6389313|NCT00823472|7300855|FG001|COMPLETED|Overall Study||39
6389314|NCT00823472|7300854|FG000|NOT COMPLETED|Overall Study||24
6389315|NCT00823472|7300855|FG001|NOT COMPLETED|Overall Study||28
6389316|NCT00823615|7300861|FG000|STARTED|Period 1||19
6389317|NCT00823615|7300862|FG001|STARTED|Period 1||19
6389318|NCT00823615|7300861|FG000|COMPLETED|Period 1||19
6389319|NCT00823615|7300862|FG001|COMPLETED|Period 1||19
6389320|NCT00823615|7300861|FG000|NOT COMPLETED|Period 1||0
6389321|NCT00823615|7300862|FG001|NOT COMPLETED|Period 1||0
6389322|NCT00823615|7300861|FG000|STARTED|Period 2||19
6389323|NCT00823615|7300862|FG001|STARTED|Period 2||19
6389324|NCT00823615|7300861|FG000|COMPLETED|Period 2||16
6389325|NCT00823615|7300862|FG001|COMPLETED|Period 2||17
6389326|NCT00823615|7300861|FG000|NOT COMPLETED|Period 2||3
6389327|NCT00823615|7300862|FG001|NOT COMPLETED|Period 2||2
6389328|NCT00823719|7300870|FG000|STARTED|Overall Study||26
6389329|NCT00823719|7300871|FG001|STARTED|Overall Study||35
6389330|NCT00823719|7300870|FG000|COMPLETED|Overall Study||20
6389331|NCT00823719|7300871|FG001|COMPLETED|Overall Study||24
6389332|NCT00823719|7300870|FG000|NOT COMPLETED|Overall Study||6
6389333|NCT00823719|7300871|FG001|NOT COMPLETED|Overall Study||11
6389334|NCT00823797|7300881|FG000|STARTED|Overall Study||29
6389335|NCT00823797|7300882|FG001|STARTED|Overall Study||16
6389336|NCT00823797|7300881|FG000|COMPLETED|Overall Study||29
6389337|NCT00823797|7300882|FG001|COMPLETED|Overall Study||16
6389338|NCT00823797|7300881|FG000|NOT COMPLETED|Overall Study||0
6389339|NCT00823797|7300882|FG001|NOT COMPLETED|Overall Study||0
6389340|NCT00823823|7300889|FG000|STARTED|Overall Study||109
6389341|NCT00823823|7300890|FG001|STARTED|Overall Study||107
6389342|NCT00823823|7300889|FG000|COMPLETED|Overall Study||101
6389343|NCT00823823|7300890|FG001|COMPLETED|Overall Study||101
6389344|NCT00823823|7300889|FG000|NOT COMPLETED|Overall Study||8
6389345|NCT00823823|7300890|FG001|NOT COMPLETED|Overall Study||6
6389346|NCT00823836|7300898|FG000|STARTED|NV and PR/XR Switching Phases||156
6389347|NCT00823836|7300899|FG001|STARTED|NV and PR/XR Switching Phases||146
6389348|NCT00823836|7300898|FG000|COMPLETED|NV and PR/XR Switching Phases||124
6389349|NCT00823836|7300899|FG001|COMPLETED|NV and PR/XR Switching Phases||117
6389350|NCT00823836|7300898|FG000|NOT COMPLETED|NV and PR/XR Switching Phases||32
6389351|NCT00823836|7300899|FG001|NOT COMPLETED|NV and PR/XR Switching Phases||29
6566735|NCT01826513|7489677|FG000|NOT COMPLETED|Overall Study||0
6566736|NCT01826513|7489678|FG001|NOT COMPLETED|Overall Study||0
6566737|NCT01826513|7489679|FG002|NOT COMPLETED|Overall Study||0
6566738|NCT01826604|7489688|FG000|STARTED|Overall Study||144
6566739|NCT01826604|7489689|FG001|STARTED|Overall Study||157
6566740|NCT01826604|7489688|FG000|COMPLETED|Overall Study||136
6566741|NCT01826604|7489689|FG001|COMPLETED|Overall Study||148
6566742|NCT01826604|7489688|FG000|NOT COMPLETED|Overall Study||8
6566743|NCT01826604|7489689|FG001|NOT COMPLETED|Overall Study||9
6566744|NCT01826812|7489697|FG000|STARTED|Overall Study||167
6566745|NCT01826812|7489698|FG001|STARTED|Overall Study||33
6566746|NCT01826812|7489697|FG000|COMPLETED|Overall Study||167
6274267|NCT00106535|7173439|FG001|STARTED|Long-term Extension Period (Year 3 to 5)||0
6274268|NCT00106535|7173440|FG002|STARTED|Long-term Extension Period (Year 3 to 5)||0
6274269|NCT00106535|7173441|FG003|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
6274270|NCT00106535|7173438|FG000|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6274271|NCT00106535|7173439|FG001|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6274272|NCT00106535|7173440|FG002|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6274273|NCT00106535|7173441|FG003|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
6274274|NCT00106535|7173438|FG000|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6274275|NCT00106535|7173439|FG001|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6274276|NCT00106535|7173440|FG002|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
6274277|NCT00106535|7173441|FG003|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
6274278|NCT00106639|7173456|FG000|STARTED|Overall Study||20
6274279|NCT00106639|7173457|FG001|STARTED|Overall Study||20
6566747|NCT01826812|7489698|FG001|COMPLETED|Overall Study||32
6566748|NCT01826812|7489697|FG000|NOT COMPLETED|Overall Study||0
6389352|NCT00823836|7300898|FG000|STARTED|Long-term Phase||73
6389353|NCT00823836|7300899|FG001|STARTED|Long-term Phase||84
6389354|NCT00823836|7300898|FG000|COMPLETED|Long-term Phase||68
6389355|NCT00823836|7300899|FG001|COMPLETED|Long-term Phase||79
6389356|NCT00823836|7300898|FG000|NOT COMPLETED|Long-term Phase||5
6389357|NCT00823836|7300899|FG001|NOT COMPLETED|Long-term Phase||5
6389358|NCT00823901|7300910|FG000|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
6389359|NCT00823901|7300911|FG001|STARTED|Overall Study|Randomized to placebo gel|40
6389360|NCT00823901|7300910|FG000|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
6389361|NCT00823901|7300911|FG001|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
6389362|NCT00823901|7300910|FG000|NOT COMPLETED|Overall Study||4
6389363|NCT00823901|7300911|FG001|NOT COMPLETED|Overall Study||2
6389364|NCT00823966|7300917|FG000|STARTED|Overall Study||3
6389365|NCT00823966|7300917|FG000|COMPLETED|Overall Study||3
6389366|NCT00823966|7300917|FG000|NOT COMPLETED|Overall Study||0
6389367|NCT00823979|7300924|FG000|STARTED|Overall Study||35
6389368|NCT00823979|7300925|FG001|STARTED|Overall Study||35
6389369|NCT00823979|7300926|FG002|STARTED|Overall Study||35
6389370|NCT00823979|7300924|FG000|Treated|Overall Study||31
6389371|NCT00823979|7300925|FG001|Treated|Overall Study||32
6389372|NCT00823979|7300926|FG002|Treated|Overall Study||34
6389373|NCT00823979|7300924|FG000|COMPLETED|Overall Study||6
6389374|NCT00823979|7300925|FG001|COMPLETED|Overall Study||3
6389375|NCT00823979|7300926|FG002|COMPLETED|Overall Study||11
6389376|NCT00823979|7300924|FG000|NOT COMPLETED|Overall Study||29
6389377|NCT00823979|7300925|FG001|NOT COMPLETED|Overall Study||32
6389378|NCT00823979|7300926|FG002|NOT COMPLETED|Overall Study||24
6389379|NCT00824005|7300936|FG000|STARTED|Overall Study||31
6389380|NCT00824005|7300937|FG001|STARTED|Overall Study||61
6389381|NCT00824005|7300936|FG000|COMPLETED|Overall Study||31
6389382|NCT00824005|7300937|FG001|COMPLETED|Overall Study||59
6389383|NCT00824005|7300936|FG000|NOT COMPLETED|Overall Study||0
6389384|NCT00824005|7300937|FG001|NOT COMPLETED|Overall Study||2
6389385|NCT00824044|7300945|FG000|STARTED|Overall Study||23
6389386|NCT00824044|7300946|FG001|STARTED|Overall Study||16
6389387|NCT00824044|7300945|FG000|COMPLETED|Overall Study||14
6389388|NCT00824044|7300946|FG001|COMPLETED|Overall Study||10
6389389|NCT00824044|7300945|FG000|NOT COMPLETED|Overall Study||9
6389390|NCT00824044|7300946|FG001|NOT COMPLETED|Overall Study||6
6389391|NCT00824070|7300959|FG000|STARTED|Overall Study||34
6389392|NCT00824070|7300960|FG001|STARTED|Overall Study||35
6389393|NCT00824070|7300961|FG002|STARTED|Overall Study||36
6389394|NCT00824070|7300959|FG000|COMPLETED|Overall Study||34
6389395|NCT00824070|7300960|FG001|COMPLETED|Overall Study||35
6389396|NCT00824070|7300961|FG002|COMPLETED|Overall Study||36
6389397|NCT00824070|7300959|FG000|NOT COMPLETED|Overall Study||0
6389398|NCT00824070|7300960|FG001|NOT COMPLETED|Overall Study||0
6389399|NCT00824070|7300961|FG002|NOT COMPLETED|Overall Study||0
6389400|NCT00824161|7300969|FG000|STARTED|Overall Study||28
6389401|NCT00824161|7300969|FG000|COMPLETED|Overall Study||26
6389402|NCT00824161|7300969|FG000|NOT COMPLETED|Overall Study||2
6389403|NCT00824265|7300976|FG000|STARTED|Treatment Phase||183
6389404|NCT00824265|7300977|FG001|STARTED|Treatment Phase||182
6389405|NCT00824265|7300976|FG000|COMPLETED|Treatment Phase||119
6389406|NCT00824265|7300977|FG001|COMPLETED|Treatment Phase||102
6389407|NCT00824265|7300976|FG000|NOT COMPLETED|Treatment Phase||64
6389408|NCT00824265|7300977|FG001|NOT COMPLETED|Treatment Phase||80
6389409|NCT00824265|7300976|FG000|STARTED|Follow-up Phase||172
6389410|NCT00824265|7300977|FG001|STARTED|Follow-up Phase||160
6389411|NCT00824265|7300976|FG000|COMPLETED|Follow-up Phase||154
6389412|NCT00824265|7300977|FG001|COMPLETED|Follow-up Phase||129
6389413|NCT00824265|7300976|FG000|NOT COMPLETED|Follow-up Phase||18
6389414|NCT00824265|7300977|FG001|NOT COMPLETED|Follow-up Phase||31
6389415|NCT00824265|7300976|FG000|STARTED|Survival Follow-up Phase||96
6389416|NCT00824265|7300977|FG001|STARTED|Survival Follow-up Phase||89
6389417|NCT00824265|7300976|FG000|COMPLETED|Survival Follow-up Phase||87
6389418|NCT00824265|7300977|FG001|COMPLETED|Survival Follow-up Phase||73
6389419|NCT00824265|7300976|FG000|NOT COMPLETED|Survival Follow-up Phase||9
6389420|NCT00824265|7300977|FG001|NOT COMPLETED|Survival Follow-up Phase||16
6389421|NCT00824291|7300989|FG000|STARTED|Overall Study||285
6389422|NCT00824291|7300990|FG001|STARTED|Overall Study||142
6389423|NCT00824291|7300989|FG000|COMPLETED|Overall Study||231
6274280|NCT00106639|7173458|FG002|STARTED|Overall Study||21
6274281|NCT00106639|7173456|FG000|COMPLETED|Overall Study||17
6274282|NCT00106639|7173457|FG001|COMPLETED|Overall Study||13
6274283|NCT00106639|7173458|FG002|COMPLETED|Overall Study||19
6274284|NCT00106639|7173456|FG000|NOT COMPLETED|Overall Study||3
6274285|NCT00106639|7173457|FG001|NOT COMPLETED|Overall Study||7
6274286|NCT00106639|7173458|FG002|NOT COMPLETED|Overall Study||2
6274287|NCT00106704|7173469|FG000|STARTED|Overall Study||222
6274288|NCT00106704|7173470|FG001|STARTED|Overall Study||219
6274289|NCT00106704|7173469|FG000|COMPLETED|Overall Study||91
6274290|NCT00106704|7173470|FG001|COMPLETED|Overall Study||68
6274291|NCT00106704|7173469|FG000|NOT COMPLETED|Overall Study||131
6274292|NCT00106704|7173470|FG001|NOT COMPLETED|Overall Study||151
6274293|NCT00106938|7173478|FG000|STARTED|Overall Study||1089
6274294|NCT00106938|7173479|FG001|STARTED|Overall Study||364
6274295|NCT00106938|7173478|FG000|COMPLETED|Overall Study||913
6274296|NCT00106938|7173479|FG001|COMPLETED|Overall Study||293
6274297|NCT00106938|7173478|FG000|NOT COMPLETED|Overall Study||176
6274298|NCT00106938|7173479|FG001|NOT COMPLETED|Overall Study||71
6274299|NCT00106964|7173488|FG000|STARTED|Overall Study||118
6274300|NCT00106964|7173489|FG001|STARTED|Overall Study||126
6274301|NCT00106964|7173490|FG002|STARTED|Overall Study||127
6274302|NCT00106964|7173488|FG000|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
6274303|NCT00106964|7173489|FG001|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
6274304|NCT00106964|7173490|FG002|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
6274305|NCT00106964|7173488|FG000|NOT COMPLETED|Overall Study||13
6274306|NCT00106964|7173489|FG001|NOT COMPLETED|Overall Study||15
6274307|NCT00106964|7173490|FG002|NOT COMPLETED|Overall Study||7
6274308|NCT00107042|7173509|FG000|STARTED|Overall Study||60
6274309|NCT00107042|7173510|FG001|STARTED|Overall Study||63
6274310|NCT00107042|7173509|FG000|COMPLETED|Overall Study||38
6274311|NCT00107042|7173510|FG001|COMPLETED|Overall Study||47
6274312|NCT00107042|7173509|FG000|NOT COMPLETED|Overall Study||22
6274313|NCT00107042|7173510|FG001|NOT COMPLETED|Overall Study||16
6280746|NCT00159263|7180665|FG001|COMPLETED|Third Intervention||1
6274314|NCT00107120|7173560|FG000|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
6274315|NCT00107120|7173561|FG001|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
6274316|NCT00107120|7173560|FG000|COMPLETED|Overall Study||126
6274317|NCT00107120|7173561|FG001|COMPLETED|Overall Study||133
6274318|NCT00107120|7173560|FG000|NOT COMPLETED|Overall Study||29
6274319|NCT00107120|7173561|FG001|NOT COMPLETED|Overall Study||24
6274320|NCT00107172|7173569|FG000|STARTED|Overall Study||114
6274321|NCT00107172|7173570|FG001|STARTED|Overall Study||108
6274322|NCT00107172|7173569|FG000|COMPLETED|Overall Study||109
6274323|NCT00107172|7173570|FG001|COMPLETED|Overall Study||103
6274324|NCT00107172|7173569|FG000|NOT COMPLETED|Overall Study||5
6274325|NCT00107172|7173570|FG001|NOT COMPLETED|Overall Study||5
6274326|NCT00107198|7173576|FG000|STARTED|Overall Study||188
6274327|NCT00107198|7173576|FG000|COMPLETED|Overall Study||136
6274328|NCT00107198|7173576|FG000|NOT COMPLETED|Overall Study||52
6274329|NCT00107276|7173580|FG000|STARTED|Overall Study||112
6274330|NCT00107276|7173580|FG000|Eligible|Overall Study||96
6274331|NCT00107276|7173580|FG000|COMPLETED|Overall Study||40
6274332|NCT00107276|7173580|FG000|NOT COMPLETED|Overall Study||72
6274333|NCT00107380|7173585|FG000|STARTED|Overall Study||86
6274334|NCT00107380|7173585|FG000|Eligible|Overall Study||84
6274335|NCT00107380|7173585|FG000|COMPLETED|Overall Study||56
6274336|NCT00107380|7173585|FG000|NOT COMPLETED|Overall Study||30
6280747|NCT00159263|7180666|FG002|COMPLETED|Third Intervention||2
6280748|NCT00159263|7180667|FG003|COMPLETED|Third Intervention||2
6280749|NCT00159263|7180668|FG004|COMPLETED|Third Intervention||2
6280750|NCT00159263|7180669|FG005|COMPLETED|Third Intervention||2
6280751|NCT00159263|7180664|FG000|NOT COMPLETED|Third Intervention||0
6280752|NCT00159263|7180665|FG001|NOT COMPLETED|Third Intervention||0
6280753|NCT00159263|7180666|FG002|NOT COMPLETED|Third Intervention||0
6280754|NCT00159263|7180667|FG003|NOT COMPLETED|Third Intervention||0
6280755|NCT00159263|7180668|FG004|NOT COMPLETED|Third Intervention||0
6280756|NCT00159263|7180669|FG005|NOT COMPLETED|Third Intervention||0
6280757|NCT00159263|7180664|FG000|STARTED|Washout||1
6280758|NCT00159263|7180665|FG001|STARTED|Washout||1
6280759|NCT00159263|7180666|FG002|STARTED|Washout||2
6280760|NCT00159263|7180667|FG003|STARTED|Washout||2
6280761|NCT00159263|7180668|FG004|STARTED|Washout||2
6280762|NCT00159263|7180669|FG005|STARTED|Washout||2
6280763|NCT00159263|7180664|FG000|COMPLETED|Washout||1
6280764|NCT00159263|7180665|FG001|COMPLETED|Washout||1
6280765|NCT00159263|7180666|FG002|COMPLETED|Washout||2
6280766|NCT00159263|7180667|FG003|COMPLETED|Washout||2
6280767|NCT00159263|7180668|FG004|COMPLETED|Washout||2
6280768|NCT00159263|7180669|FG005|COMPLETED|Washout||2
6280769|NCT00159263|7180664|FG000|NOT COMPLETED|Washout||0
6280770|NCT00159263|7180665|FG001|NOT COMPLETED|Washout||0
6280771|NCT00159263|7180666|FG002|NOT COMPLETED|Washout||0
6280772|NCT00159263|7180667|FG003|NOT COMPLETED|Washout||0
6280773|NCT00159263|7180668|FG004|NOT COMPLETED|Washout||0
6280774|NCT00159263|7180669|FG005|NOT COMPLETED|Washout||0
6280775|NCT00159263|7180664|FG000|STARTED|Fourth Intervention||1
6280776|NCT00159263|7180665|FG001|STARTED|Fourth Intervention||1
6280777|NCT00159263|7180666|FG002|STARTED|Fourth Intervention||2
6280778|NCT00159263|7180667|FG003|STARTED|Fourth Intervention||2
6280779|NCT00159263|7180668|FG004|STARTED|Fourth Intervention||2
6280780|NCT00159263|7180669|FG005|STARTED|Fourth Intervention||2
6280781|NCT00159263|7180664|FG000|COMPLETED|Fourth Intervention||1
6280782|NCT00159263|7180665|FG001|COMPLETED|Fourth Intervention||1
6280783|NCT00159263|7180666|FG002|COMPLETED|Fourth Intervention||2
6280784|NCT00159263|7180667|FG003|COMPLETED|Fourth Intervention||2
6280785|NCT00159263|7180668|FG004|COMPLETED|Fourth Intervention||2
6280786|NCT00159263|7180669|FG005|COMPLETED|Fourth Intervention||2
6280787|NCT00159263|7180664|FG000|NOT COMPLETED|Fourth Intervention||0
6280788|NCT00159263|7180665|FG001|NOT COMPLETED|Fourth Intervention||0
6280789|NCT00159263|7180666|FG002|NOT COMPLETED|Fourth Intervention||0
6280790|NCT00159263|7180667|FG003|NOT COMPLETED|Fourth Intervention||0
6280791|NCT00159263|7180668|FG004|NOT COMPLETED|Fourth Intervention||0
6280792|NCT00159263|7180669|FG005|NOT COMPLETED|Fourth Intervention||0
6280793|NCT00159263|7180664|FG000|STARTED|Washout||1
6280794|NCT00159263|7180665|FG001|STARTED|Washout||1
6280795|NCT00159263|7180666|FG002|STARTED|Washout||2
6280796|NCT00159263|7180667|FG003|STARTED|Washout||2
6280797|NCT00159263|7180668|FG004|STARTED|Washout||2
6280798|NCT00159263|7180669|FG005|STARTED|Washout||2
6280799|NCT00159263|7180664|FG000|COMPLETED|Washout||1
6280800|NCT00159263|7180665|FG001|COMPLETED|Washout||1
6280801|NCT00159263|7180666|FG002|COMPLETED|Washout||2
6280802|NCT00159263|7180667|FG003|COMPLETED|Washout||2
6280803|NCT00159263|7180668|FG004|COMPLETED|Washout||2
6280804|NCT00159263|7180669|FG005|COMPLETED|Washout||2
6280805|NCT00159263|7180664|FG000|NOT COMPLETED|Washout||0
6280806|NCT00159263|7180665|FG001|NOT COMPLETED|Washout||0
6280807|NCT00159263|7180666|FG002|NOT COMPLETED|Washout||0
6280808|NCT00159263|7180667|FG003|NOT COMPLETED|Washout||0
6280809|NCT00159263|7180668|FG004|NOT COMPLETED|Washout||0
6280810|NCT00159263|7180669|FG005|NOT COMPLETED|Washout||0
6389424|NCT00824291|7300990|FG001|COMPLETED|Overall Study||107
6389425|NCT00824291|7300989|FG000|NOT COMPLETED|Overall Study||54
6389426|NCT00824291|7300990|FG001|NOT COMPLETED|Overall Study||35
6389427|NCT00824369|7301002|FG000|STARTED|Overall Study||5
6389428|NCT00824369|7301003|FG001|STARTED|Overall Study||4
6389429|NCT00824369|7301004|FG002|STARTED|Overall Study||3
6389430|NCT00824369|7301005|FG003|STARTED|Overall Study||11
6389431|NCT00824369|7301006|FG004|STARTED|Overall Study||12
6389432|NCT00824369|7301007|FG005|STARTED|Overall Study||17
6389433|NCT00824369|7301002|FG000|COMPLETED|Overall Study||4
6389434|NCT00824369|7301003|FG001|COMPLETED|Overall Study||4
6389435|NCT00824369|7301004|FG002|COMPLETED|Overall Study||2
6389436|NCT00824369|7301005|FG003|COMPLETED|Overall Study||9
6389437|NCT00824369|7301006|FG004|COMPLETED|Overall Study||11
6389438|NCT00824369|7301007|FG005|COMPLETED|Overall Study||16
6389439|NCT00824369|7301002|FG000|NOT COMPLETED|Overall Study||1
6389440|NCT00824369|7301003|FG001|NOT COMPLETED|Overall Study||0
6389441|NCT00824369|7301004|FG002|NOT COMPLETED|Overall Study||1
6389442|NCT00824369|7301005|FG003|NOT COMPLETED|Overall Study||2
6389443|NCT00824369|7301006|FG004|NOT COMPLETED|Overall Study||1
6389444|NCT00824369|7301007|FG005|NOT COMPLETED|Overall Study||1
6389445|NCT00824382|7301025|FG000|STARTED|Overall Study||79
6389446|NCT00824382|7301026|FG001|STARTED|Overall Study||84
6389447|NCT00824382|7301027|FG002|STARTED|Overall Study||79
6389448|NCT00824382|7301028|FG003|STARTED|Overall Study||86
6389449|NCT00824382|7301025|FG000|COMPLETED|Overall Study||74
6389450|NCT00824382|7301026|FG001|COMPLETED|Overall Study||82
6389451|NCT00824382|7301027|FG002|COMPLETED|Overall Study||76
6389452|NCT00824382|7301028|FG003|COMPLETED|Overall Study||81
6389453|NCT00824382|7301025|FG000|NOT COMPLETED|Overall Study||5
6389454|NCT00824382|7301026|FG001|NOT COMPLETED|Overall Study||2
6389455|NCT00824382|7301027|FG002|NOT COMPLETED|Overall Study||3
6389456|NCT00824382|7301028|FG003|NOT COMPLETED|Overall Study||5
6389457|NCT00824408|7301045|FG000|STARTED|Run-in Phase||6
6389458|NCT00824408|7301046|FG001|STARTED|Run-in Phase||6
6389459|NCT00824408|7301047|FG002|STARTED|Run-in Phase||0
6389460|NCT00824408|7301048|FG003|STARTED|Run-in Phase||0
6389461|NCT00824408|7301049|FG004|STARTED|Run-in Phase||0
6389462|NCT00824408|7301045|FG000|COMPLETED|Run-in Phase||0
6389463|NCT00824408|7301046|FG001|COMPLETED|Run-in Phase||0
6389464|NCT00824408|7301047|FG002|COMPLETED|Run-in Phase||0
6389465|NCT00824408|7301048|FG003|COMPLETED|Run-in Phase||0
6389466|NCT00824408|7301049|FG004|COMPLETED|Run-in Phase||0
6389467|NCT00824408|7301045|FG000|NOT COMPLETED|Run-in Phase||6
6389468|NCT00824408|7301046|FG001|NOT COMPLETED|Run-in Phase||6
6389469|NCT00824408|7301047|FG002|NOT COMPLETED|Run-in Phase||0
6389470|NCT00824408|7301048|FG003|NOT COMPLETED|Run-in Phase||0
6389471|NCT00824408|7301049|FG004|NOT COMPLETED|Run-in Phase||0
6389472|NCT00824408|7301045|FG000|STARTED|Randomized Phase||0
6389473|NCT00824408|7301046|FG001|STARTED|Randomized Phase||0
6389474|NCT00824408|7301047|FG002|STARTED|Randomized Phase||37
6389475|NCT00824408|7301048|FG003|STARTED|Randomized Phase||47
6389476|NCT00824408|7301049|FG004|STARTED|Randomized Phase||47
6389477|NCT00824408|7301045|FG000|COMPLETED|Randomized Phase||0
6389478|NCT00824408|7301046|FG001|COMPLETED|Randomized Phase||0
6389479|NCT00824408|7301047|FG002|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
6389480|NCT00824408|7301048|FG003|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
6389481|NCT00824408|7301049|FG004|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
6389482|NCT00824408|7301045|FG000|NOT COMPLETED|Randomized Phase||0
6389483|NCT00824408|7301046|FG001|NOT COMPLETED|Randomized Phase||0
6389484|NCT00824408|7301047|FG002|NOT COMPLETED|Randomized Phase||36
6389485|NCT00824408|7301048|FG003|NOT COMPLETED|Randomized Phase||46
6389486|NCT00824408|7301049|FG004|NOT COMPLETED|Randomized Phase||46
6389487|NCT00824421|7301070|FG000|STARTED|Overall Study||66
6389488|NCT00824421|7301071|FG001|STARTED|Overall Study||66
6389489|NCT00824421|7301072|FG002|STARTED|Overall Study||63
6389490|NCT00824421|7301070|FG000|Treated|Overall Study||65
6389491|NCT00824421|7301071|FG001|Treated|Overall Study||65
6389492|NCT00824421|7301072|FG002|Treated|Overall Study||63
6389493|NCT00824421|7301070|FG000|COMPLETED|Overall Study||49
6389494|NCT00824421|7301071|FG001|COMPLETED|Overall Study||44
6389495|NCT00824421|7301072|FG002|COMPLETED|Overall Study||49
6389496|NCT00824421|7301070|FG000|NOT COMPLETED|Overall Study||17
6389497|NCT00824421|7301071|FG001|NOT COMPLETED|Overall Study||22
6389498|NCT00824421|7301072|FG002|NOT COMPLETED|Overall Study||14
6389499|NCT00824434|7301082|FG000|STARTED|Overall Study||100
6389500|NCT00824434|7301082|FG000|COMPLETED|Overall Study||100
6389501|NCT00824434|7301082|FG000|NOT COMPLETED|Overall Study||0
6389502|NCT00824460|7301092|FG000|STARTED|Overall Study||26
6389503|NCT00824460|7301093|FG001|STARTED|Overall Study||26
6389504|NCT00824460|7301094|FG002|STARTED|Overall Study||25
6389505|NCT00824460|7301095|FG003|STARTED|Overall Study||27
6389506|NCT00824460|7301096|FG004|STARTED|Overall Study||24
6389507|NCT00824460|7301097|FG005|STARTED|Overall Study||26
6389508|NCT00824460|7301092|FG000|COMPLETED|Overall Study||18
6389509|NCT00824460|7301093|FG001|COMPLETED|Overall Study||17
6389510|NCT00824460|7301094|FG002|COMPLETED|Overall Study||20
6389511|NCT00824460|7301095|FG003|COMPLETED|Overall Study||15
6389512|NCT00824460|7301096|FG004|COMPLETED|Overall Study||15
6389513|NCT00824460|7301097|FG005|COMPLETED|Overall Study||18
6389514|NCT00824460|7301092|FG000|NOT COMPLETED|Overall Study||8
6274337|NCT00107536|7173590|FG000|STARTED|Overall Study||26
6274338|NCT00107536|7173590|FG000|COMPLETED|Overall Study||26
6274339|NCT00107536|7173590|FG000|NOT COMPLETED|Overall Study||0
6274340|NCT00107575|7173596|FG000|STARTED|Overall Study||119
6274341|NCT00107575|7173597|FG001|STARTED|Overall Study||117
6274342|NCT00107575|7173596|FG000|COMPLETED|Overall Study||108
6274343|NCT00107575|7173597|FG001|COMPLETED|Overall Study||107
6274344|NCT00107575|7173596|FG000|NOT COMPLETED|Overall Study||11
6274345|NCT00107575|7173597|FG001|NOT COMPLETED|Overall Study||10
6274346|NCT00107653|7173605|FG000|STARTED|Overall Study||269
6274347|NCT00107653|7173606|FG001|STARTED|Overall Study||300
6274348|NCT00107653|7173605|FG000|COMPLETED|Overall Study||190
6274349|NCT00107653|7173606|FG001|COMPLETED|Overall Study||224
6274350|NCT00107653|7173605|FG000|NOT COMPLETED|Overall Study||79
6274351|NCT00107653|7173606|FG001|NOT COMPLETED|Overall Study||76
6274352|NCT00107744|7173615|FG000|STARTED|Intervention 1 (8 Weeks)||117
6274353|NCT00107744|7173616|FG001|STARTED|Intervention 1 (8 Weeks)||117
6274354|NCT00107744|7173617|FG002|STARTED|Intervention 1 (8 Weeks)||118
6274355|NCT00107744|7173615|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
6274356|NCT00107744|7173616|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
6274357|NCT00107744|7173617|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
6274358|NCT00107744|7173615|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
6274359|NCT00107744|7173616|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
6274360|NCT00107744|7173617|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
6274361|NCT00107744|7173615|FG000|STARTED|Intervention 2 (8 Weeks)||101
6274362|NCT00107744|7173616|FG001|STARTED|Intervention 2 (8 Weeks)||104
6274363|NCT00107744|7173617|FG002|STARTED|Intervention 2 (8 Weeks)||101
6274364|NCT00107744|7173615|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
6274365|NCT00107744|7173616|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
6274366|NCT00107744|7173617|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
6274367|NCT00107744|7173615|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
6274368|NCT00107744|7173616|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
6274369|NCT00107744|7173617|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
6274370|NCT00107744|7173615|FG000|STARTED|Intervention 3 (8 Weeks)||93
6274371|NCT00107744|7173616|FG001|STARTED|Intervention 3 (8 Weeks)||92
6274372|NCT00107744|7173617|FG002|STARTED|Intervention 3 (8 Weeks)||88
6274373|NCT00107744|7173615|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
6274374|NCT00107744|7173616|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
6274375|NCT00107744|7173617|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
6274376|NCT00107744|7173615|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6274377|NCT00107744|7173616|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6274378|NCT00107744|7173617|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6274379|NCT00107783|7173627|FG000|STARTED|Overall Study||20
6274380|NCT00107783|7173628|FG001|STARTED|Overall Study||20
6274381|NCT00107783|7173627|FG000|COMPLETED|Overall Study||17
6274382|NCT00107783|7173628|FG001|COMPLETED|Overall Study||16
6274383|NCT00107783|7173627|FG000|NOT COMPLETED|Overall Study||3
6274384|NCT00107783|7173628|FG001|NOT COMPLETED|Overall Study||4
6274385|NCT00107900|7173640|FG000|STARTED|Overall Study||85
6274386|NCT00107900|7173641|FG001|STARTED|Overall Study||75
6274387|NCT00107900|7173642|FG002|STARTED|Overall Study||129
6274388|NCT00107900|7173643|FG003|STARTED|Overall Study||99
6274389|NCT00107900|7173644|FG004|STARTED|Overall Study||115
6274390|NCT00107900|7173645|FG005|STARTED|Overall Study||103
6274391|NCT00107900|7173640|FG000|COMPLETED|Overall Study||75
6274392|NCT00107900|7173641|FG001|COMPLETED|Overall Study||72
6274393|NCT00107900|7173642|FG002|COMPLETED|Overall Study||104
6274394|NCT00107900|7173643|FG003|COMPLETED|Overall Study||87
6274395|NCT00107900|7173644|FG004|COMPLETED|Overall Study||94
6274396|NCT00107900|7173645|FG005|COMPLETED|Overall Study||94
6274397|NCT00107900|7173640|FG000|NOT COMPLETED|Overall Study||10
6274398|NCT00107900|7173641|FG001|NOT COMPLETED|Overall Study||3
6274399|NCT00107900|7173642|FG002|NOT COMPLETED|Overall Study||25
6274400|NCT00107900|7173643|FG003|NOT COMPLETED|Overall Study||12
6274401|NCT00107900|7173644|FG004|NOT COMPLETED|Overall Study||21
6274402|NCT00107900|7173645|FG005|NOT COMPLETED|Overall Study||9
6274403|NCT00107952|7173661|FG000|STARTED|Overall Study||381
6274404|NCT00107952|7173662|FG001|STARTED|Overall Study||380
6274405|NCT00107952|7173661|FG000|COMPLETED|Overall Study||286
6274406|NCT00107952|7173662|FG001|COMPLETED|Overall Study||299
6274407|NCT00107952|7173661|FG000|NOT COMPLETED|Overall Study||95
6274408|NCT00107952|7173662|FG001|NOT COMPLETED|Overall Study||81
6274409|NCT00107978|7173670|FG000|STARTED|Overall Study||458
6274410|NCT00107978|7173671|FG001|STARTED|Overall Study||481
6274411|NCT00107978|7173670|FG000|COMPLETED|Overall Study||425
6274412|NCT00107978|7173671|FG001|COMPLETED|Overall Study||431
6274413|NCT00107978|7173670|FG000|NOT COMPLETED|Overall Study||33
6274414|NCT00107978|7173671|FG001|NOT COMPLETED|Overall Study||50
6274415|NCT00107991|7173677|FG000|STARTED|Eligibility Assessment||38
6274416|NCT00107991|7173677|FG000|COMPLETED|Eligibility Assessment||15
6274417|NCT00107991|7173677|FG000|NOT COMPLETED|Eligibility Assessment||23
6274418|NCT00107991|7173677|FG000|STARTED|12 Week Treatment Period||15
6274419|NCT00107991|7173677|FG000|COMPLETED|12 Week Treatment Period||10
6274420|NCT00107991|7173677|FG000|NOT COMPLETED|12 Week Treatment Period||5
6806483|NCT02959918|7738704|FG012|COMPLETED|Overall Study||4
6806484|NCT02959918|7738705|FG013|COMPLETED|Overall Study||6
6806485|NCT02959918|7738692|FG000|NOT COMPLETED|Overall Study||3
6806486|NCT02959918|7738693|FG001|NOT COMPLETED|Overall Study||3
6806487|NCT02959918|7738694|FG002|NOT COMPLETED|Overall Study||8
6806488|NCT02959918|7738695|FG003|NOT COMPLETED|Overall Study||9
6806489|NCT02959918|7738696|FG004|NOT COMPLETED|Overall Study||5
6806490|NCT02959918|7738697|FG005|NOT COMPLETED|Overall Study||6
6806491|NCT02959918|7738698|FG006|NOT COMPLETED|Overall Study||5
6806492|NCT02959918|7738699|FG007|NOT COMPLETED|Overall Study||6
6566749|NCT01826812|7489698|FG001|NOT COMPLETED|Overall Study||1
6566750|NCT01826825|7489708|FG000|STARTED|Overall Study||100
6566751|NCT01826825|7489709|FG001|STARTED|Overall Study||100
6566752|NCT01826825|7489708|FG000|COMPLETED|Overall Study||100
6566753|NCT01826825|7489709|FG001|COMPLETED|Overall Study||98
6566754|NCT01826825|7489708|FG000|NOT COMPLETED|Overall Study||0
6566755|NCT01826825|7489709|FG001|NOT COMPLETED|Overall Study||2
6566756|NCT01826851|7489719|FG000|STARTED|Overall Study||38
6566757|NCT01826851|7489720|FG001|STARTED|Overall Study||41
6566758|NCT01826851|7489719|FG000|COMPLETED|Overall Study||38
6566759|NCT01826851|7489720|FG001|COMPLETED|Overall Study||41
6566760|NCT01826851|7489719|FG000|NOT COMPLETED|Overall Study||0
6566761|NCT01826851|7489720|FG001|NOT COMPLETED|Overall Study||0
6566762|NCT01826981|7489741|FG000|STARTED|Overall Study||19
6566763|NCT01826981|7489742|FG001|STARTED|Overall Study||10
6566764|NCT01826981|7489743|FG002|STARTED|Overall Study||25
6566765|NCT01826981|7489744|FG003|STARTED|Overall Study||26
6806493|NCT02959918|7738700|FG008|NOT COMPLETED|Overall Study||7
6389515|NCT00824460|7301093|FG001|NOT COMPLETED|Overall Study||9
6566766|NCT01826981|7489745|FG004|STARTED|Overall Study||25
6566767|NCT01826981|7489746|FG005|STARTED|Overall Study||26
6806494|NCT02959918|7738701|FG009|NOT COMPLETED|Overall Study||6
6806495|NCT02959918|7738702|FG010|NOT COMPLETED|Overall Study||6
6806496|NCT02959918|7738703|FG011|NOT COMPLETED|Overall Study||12
6806497|NCT02959918|7738704|FG012|NOT COMPLETED|Overall Study||7
6806498|NCT02959918|7738705|FG013|NOT COMPLETED|Overall Study||6
6806499|NCT02485691|7738740|FG000|STARTED|Overall Study||129
6806500|NCT02485691|7738741|FG001|STARTED|Overall Study||126
6806501|NCT02485691|7738740|FG000|Treated|Overall Study||126
6806502|NCT02485691|7738741|FG001|Treated|Overall Study||124
6806503|NCT02485691|7738740|FG000|COMPLETED|Overall Study||0
6566768|NCT01826981|7489747|FG006|STARTED|Overall Study||25
6806504|NCT02485691|7738741|FG001|COMPLETED|Overall Study||0
6389516|NCT00824460|7301094|FG002|NOT COMPLETED|Overall Study||5
6389517|NCT00824460|7301095|FG003|NOT COMPLETED|Overall Study||12
6389518|NCT00824460|7301096|FG004|NOT COMPLETED|Overall Study||9
6389519|NCT00824460|7301097|FG005|NOT COMPLETED|Overall Study||8
6389520|NCT00824473|7301121|FG000|STARTED|Overall Study|1 subject was randomized in error|255
6389521|NCT00824473|7301122|FG001|STARTED|Overall Study||251
6389522|NCT00824473|7301121|FG000|COMPLETED|Overall Study||240
6389523|NCT00824473|7301122|FG001|COMPLETED|Overall Study||238
6389524|NCT00824473|7301121|FG000|NOT COMPLETED|Overall Study||15
6389525|NCT00824473|7301122|FG001|NOT COMPLETED|Overall Study||13
6389526|NCT00824512|7301130|FG000|STARTED|Overall Study||11
6389527|NCT00824512|7301131|FG001|STARTED|Overall Study||11
6389528|NCT00824512|7301130|FG000|COMPLETED|Overall Study||11
6389529|NCT00824512|7301131|FG001|COMPLETED|Overall Study||11
6389530|NCT00824512|7301130|FG000|NOT COMPLETED|Overall Study||0
6389531|NCT00824512|7301131|FG001|NOT COMPLETED|Overall Study||0
6389532|NCT00824538|7301137|FG000|STARTED|Overall Study|13 patients entered the study|13
6389533|NCT00824538|7301137|FG000|COMPLETED|Overall Study||11
6389534|NCT00824538|7301137|FG000|NOT COMPLETED|Overall Study||2
6389535|NCT00824564|7301144|FG000|STARTED|Overall Study||42
6389536|NCT00824564|7301145|FG001|STARTED|Overall Study||40
6389537|NCT00824564|7301144|FG000|Treated|Overall Study||41
6389538|NCT00824564|7301145|FG001|Treated|Overall Study||40
6389539|NCT00824564|7301144|FG000|COMPLETED|Overall Study||34
6389540|NCT00824564|7301145|FG001|COMPLETED|Overall Study||30
6389541|NCT00824564|7301144|FG000|NOT COMPLETED|Overall Study||8
6389542|NCT00824564|7301145|FG001|NOT COMPLETED|Overall Study||10
6389543|NCT00824616|7301153|FG000|STARTED|Overall Study||34
6389544|NCT00824616|7301154|FG001|STARTED|Overall Study||34
6389545|NCT00824616|7301153|FG000|COMPLETED|Overall Study||28
6389546|NCT00824616|7301154|FG001|COMPLETED|Overall Study||27
6389547|NCT00824616|7301153|FG000|NOT COMPLETED|Overall Study||6
6389548|NCT00824616|7301154|FG001|NOT COMPLETED|Overall Study||7
6389549|NCT00824655|7301162|FG000|STARTED|Infant Series (5 Months of Age)||118
6389550|NCT00824655|7301163|FG001|STARTED|Infant Series (5 Months of Age)||0
6389551|NCT00824655|7301162|FG000|COMPLETED|Infant Series (5 Months of Age)||118
6389552|NCT00824655|7301163|FG001|COMPLETED|Infant Series (5 Months of Age)||0
6389553|NCT00824655|7301162|FG000|NOT COMPLETED|Infant Series (5 Months of Age)||0
6389554|NCT00824655|7301163|FG001|NOT COMPLETED|Infant Series (5 Months of Age)||0
6389555|NCT00824655|7301162|FG000|STARTED|After Infant Dose (6 Months of Age)||118
6389556|NCT00824655|7301163|FG001|STARTED|After Infant Dose (6 Months of Age)||0
6389557|NCT00824655|7301162|FG000|COMPLETED|After Infant Dose (6 Months of Age)||118
6389558|NCT00824655|7301163|FG001|COMPLETED|After Infant Dose (6 Months of Age)||0
6389559|NCT00824655|7301162|FG000|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
6389560|NCT00824655|7301163|FG001|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
6389561|NCT00824655|7301162|FG000|STARTED|Toddler Dose (12 Months of Age)||118
6389562|NCT00824655|7301163|FG001|STARTED|Toddler Dose (12 Months of Age)||116
6389563|NCT00824655|7301162|FG000|COMPLETED|Toddler Dose (12 Months of Age)||116
6389564|NCT00824655|7301163|FG001|COMPLETED|Toddler Dose (12 Months of Age)||116
6389565|NCT00824655|7301162|FG000|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
6389566|NCT00824655|7301163|FG001|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
6389567|NCT00824720|7301174|FG000|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
6389568|NCT00824720|7301175|FG001|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
6389569|NCT00824720|7301176|FG002|STARTED|Overall Study||20
6389570|NCT00824720|7301174|FG000|COMPLETED|Overall Study||16
6389571|NCT00824720|7301175|FG001|COMPLETED|Overall Study||15
6389572|NCT00824720|7301176|FG002|COMPLETED|Overall Study||19
6389573|NCT00824720|7301174|FG000|NOT COMPLETED|Overall Study||3
6389574|NCT00824720|7301175|FG001|NOT COMPLETED|Overall Study||1
6389575|NCT00824720|7301176|FG002|NOT COMPLETED|Overall Study||1
6389576|NCT00824733|7301184|FG000|STARTED|Overall Study||6
6389577|NCT00824733|7301184|FG000|COMPLETED|Overall Study||6
6389578|NCT00824733|7301184|FG000|NOT COMPLETED|Overall Study||0
6389579|NCT00824746|7301188|FG000|STARTED|Overall Study||23
6389580|NCT00824746|7301188|FG000|COMPLETED|Overall Study||23
6566769|NCT01826981|7489748|FG007|STARTED|Overall Study||51
6274421|NCT00107991|7173677|FG000|STARTED|18-Week Post Treatment Assessment||10
6274422|NCT00107991|7173677|FG000|COMPLETED|18-Week Post Treatment Assessment||8
6274423|NCT00107991|7173677|FG000|NOT COMPLETED|18-Week Post Treatment Assessment||2
6274424|NCT00108069|7173683|FG000|STARTED|Overall Study||30
6274425|NCT00108069|7173684|FG001|STARTED|Overall Study||13
6274426|NCT00108069|7173683|FG000|COMPLETED|Overall Study||0
6274427|NCT00108069|7173684|FG001|COMPLETED|Overall Study||0
6274428|NCT00108069|7173683|FG000|NOT COMPLETED|Overall Study||30
6274429|NCT00108069|7173684|FG001|NOT COMPLETED|Overall Study||13
6274430|NCT00108082|7173699|FG000|STARTED|Overall Study||91
6274431|NCT00108082|7173700|FG001|STARTED|Overall Study||100
6274432|NCT00108082|7173701|FG002|STARTED|Overall Study||96
6274433|NCT00108082|7173699|FG000|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
6274434|NCT00108082|7173700|FG001|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
6274435|NCT00108082|7173701|FG002|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
6274436|NCT00108082|7173699|FG000|NOT COMPLETED|Overall Study||38
6389581|NCT00824746|7301188|FG000|NOT COMPLETED|Overall Study||0
6389582|NCT00824772|7301194|FG000|STARTED|Overall Study||204
6389583|NCT00824772|7301194|FG000|COMPLETED|Overall Study||196
6389584|NCT00824772|7301194|FG000|NOT COMPLETED|Overall Study||8
6389585|NCT00824824|7301200|FG000|STARTED|Overall Study||4
6389586|NCT00824824|7301201|FG001|STARTED|Overall Study||3
6389587|NCT00824824|7301200|FG000|COMPLETED|Overall Study||4
6389588|NCT00824824|7301201|FG001|COMPLETED|Overall Study||3
6389589|NCT00824824|7301200|FG000|NOT COMPLETED|Overall Study||0
6389590|NCT00824824|7301201|FG001|NOT COMPLETED|Overall Study||0
6389591|NCT00824850|7301209|FG000|STARTED|Overall Study||38
6389592|NCT00824850|7301210|FG001|STARTED|Overall Study||37
6389593|NCT00824850|7301209|FG000|Received Vaccination 13vPnC|Overall Study||38
6389594|NCT00824850|7301210|FG001|Received Vaccination 13vPnC|Overall Study||36
6389595|NCT00824850|7301209|FG000|COMPLETED|Overall Study||38
6389596|NCT00824850|7301210|FG001|COMPLETED|Overall Study||36
6389597|NCT00824850|7301209|FG000|NOT COMPLETED|Overall Study||0
6389598|NCT00824850|7301210|FG001|NOT COMPLETED|Overall Study||1
6504445|NCT01448824|7423505|FG007|STARTED|Part 2 Period 1: Drug-drug Interaction||12
6504446|NCT01448824|7423498|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6504447|NCT01448824|7423499|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6504448|NCT01448824|7423500|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6504449|NCT01448824|7423501|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6504450|NCT01448824|7423502|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6504451|NCT01448824|7423503|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6504452|NCT01448824|7423504|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||0
6504453|NCT01448824|7423505|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 1: Drug-drug Interaction||12
6504454|NCT01448824|7423498|FG000|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504455|NCT01448824|7423499|FG001|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504456|NCT01448824|7423500|FG002|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504457|NCT01448824|7423501|FG003|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504458|NCT01448824|7423502|FG004|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504459|NCT01448824|7423503|FG005|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504460|NCT01448824|7423504|FG006|COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504461|NCT01448824|7423505|FG007|COMPLETED|Part 2 Period 1: Drug-drug Interaction||11
6504462|NCT01448824|7423498|FG000|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504463|NCT01448824|7423499|FG001|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504464|NCT01448824|7423500|FG002|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504465|NCT01448824|7423501|FG003|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504466|NCT01448824|7423502|FG004|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504467|NCT01448824|7423503|FG005|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6566770|NCT01826981|7489749|FG008|STARTED|Overall Study||20
6274437|NCT00108082|7173700|FG001|NOT COMPLETED|Overall Study||32
6274438|NCT00108082|7173701|FG002|NOT COMPLETED|Overall Study||43
6274439|NCT00108160|7173711|FG000|STARTED|Overall Study||83
6274440|NCT00108160|7173712|FG001|STARTED|Overall Study||63
6274441|NCT00108160|7173711|FG000|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
6274442|NCT00108160|7173712|FG001|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
6274443|NCT00108160|7173711|FG000|Completed Visit 1 (2 Wks)|Overall Study||72
6274444|NCT00108160|7173712|FG001|Completed Visit 1 (2 Wks)|Overall Study||54
6274445|NCT00108160|7173711|FG000|Completed Visit 2 (3 mo)|Overall Study||54
6274446|NCT00108160|7173712|FG001|Completed Visit 2 (3 mo)|Overall Study||46
6274447|NCT00108160|7173711|FG000|Completed Visit 3 (6 mo)|Overall Study||44
6274448|NCT00108160|7173712|FG001|Completed Visit 3 (6 mo)|Overall Study||38
6274449|NCT00108160|7173711|FG000|Completed Visit 4 (9 mo)|Overall Study||38
6274450|NCT00108160|7173712|FG001|Completed Visit 4 (9 mo)|Overall Study||37
6274451|NCT00108160|7173711|FG000|Completed Visit 5 (12 mo)|Overall Study||37
6274452|NCT00108160|7173712|FG001|Completed Visit 5 (12 mo)|Overall Study||37
6274453|NCT00108160|7173711|FG000|Completed Visit 6 (15 mo)|Overall Study||36
6274454|NCT00108160|7173712|FG001|Completed Visit 6 (15 mo)|Overall Study||33
6274455|NCT00108160|7173711|FG000|Completed Visit 7 (18 mo)|Overall Study||34
6274456|NCT00108160|7173712|FG001|Completed Visit 7 (18 mo)|Overall Study||31
6274457|NCT00108160|7173711|FG000|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
6274458|NCT00108160|7173712|FG001|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
6274459|NCT00108160|7173711|FG000|NOT COMPLETED|Overall Study||39
6389599|NCT00824993|7301224|FG000|STARTED|Overall Study||39
6389600|NCT00824993|7301225|FG001|STARTED|Overall Study||39
6389601|NCT00824993|7301224|FG000|6 Month Follow up|Overall Study||33
6389602|NCT00824993|7301225|FG001|6 Month Follow up|Overall Study||27
6389603|NCT00824993|7301224|FG000|COMPLETED|Overall Study||25
6389604|NCT00824993|7301225|FG001|COMPLETED|Overall Study||22
6389605|NCT00824993|7301224|FG000|NOT COMPLETED|Overall Study||14
6389606|NCT00824993|7301225|FG001|NOT COMPLETED|Overall Study||17
6389607|NCT00825162|7301234|FG000|STARTED|Overall Study||710
6389608|NCT00825162|7301235|FG001|STARTED|Overall Study||880
6389609|NCT00825162|7301236|FG002|STARTED|Overall Study||402
6389610|NCT00825162|7301234|FG000|COMPLETED|Overall Study||682
6389611|NCT00825162|7301235|FG001|COMPLETED|Overall Study||859
6389612|NCT00825162|7301236|FG002|COMPLETED|Overall Study||396
6389613|NCT00825162|7301234|FG000|NOT COMPLETED|Overall Study||28
6389614|NCT00825162|7301235|FG001|NOT COMPLETED|Overall Study||21
6389615|NCT00825162|7301236|FG002|NOT COMPLETED|Overall Study||6
6389616|NCT00825175|7301251|FG000|STARTED|Overall Study||10
6389617|NCT00825175|7301252|FG001|STARTED|Overall Study||12
6389618|NCT00825175|7301251|FG000|COMPLETED|Overall Study||10
6389619|NCT00825175|7301252|FG001|COMPLETED|Overall Study||7
6389620|NCT00825175|7301251|FG000|NOT COMPLETED|Overall Study||0
6389621|NCT00825175|7301252|FG001|NOT COMPLETED|Overall Study||5
6566771|NCT01826981|7489750|FG009|STARTED|Overall Study||27
6566772|NCT01826981|7489751|FG010|STARTED|Overall Study||24
6389622|NCT00825266|7301260|FG000|STARTED|Overall Study||1
6389623|NCT00825266|7301261|FG001|STARTED|Overall Study||1
6389624|NCT00825266|7301260|FG000|COMPLETED|Overall Study||1
6389625|NCT00825266|7301261|FG001|COMPLETED|Overall Study||1
6389626|NCT00825266|7301260|FG000|NOT COMPLETED|Overall Study||0
6389627|NCT00825266|7301261|FG001|NOT COMPLETED|Overall Study||0
6389628|NCT00825305|7301269|FG000|STARTED|Overall Study||550
6389629|NCT00825305|7301270|FG001|STARTED|Overall Study||275
6389630|NCT00825305|7301269|FG000|COMPLETED|Overall Study||533
6389631|NCT00825305|7301270|FG001|COMPLETED|Overall Study||252
6389632|NCT00825305|7301269|FG000|NOT COMPLETED|Overall Study||17
6389633|NCT00825305|7301270|FG001|NOT COMPLETED|Overall Study||23
6389634|NCT00825318|7301276|FG000|STARTED|Overall Study||13
6389635|NCT00825318|7301276|FG000|COMPLETED|Overall Study||12
6566773|NCT01826981|7489752|FG011|STARTED|Overall Study||27
6389636|NCT00825318|7301276|FG000|NOT COMPLETED|Overall Study||1
6389637|NCT00825344|7301286|FG000|STARTED|Overall Study||34
6389638|NCT00825344|7301287|FG001|STARTED|Overall Study||43
6566774|NCT01826981|7489753|FG012|STARTED|Overall Study||26
6274460|NCT00108160|7173712|FG001|NOT COMPLETED|Overall Study||21
6274461|NCT00108277|7173723|FG000|STARTED|Overall Study||29
6274462|NCT00108277|7173724|FG001|STARTED|Overall Study||28
6274463|NCT00108277|7173725|FG002|STARTED|Overall Study||35
6274464|NCT00108277|7173723|FG000|COMPLETED|Overall Study||19
6274465|NCT00108277|7173724|FG001|COMPLETED|Overall Study||16
6274466|NCT00108277|7173725|FG002|COMPLETED|Overall Study||19
6274467|NCT00108277|7173723|FG000|NOT COMPLETED|Overall Study||10
6274468|NCT00108277|7173724|FG001|NOT COMPLETED|Overall Study||12
6274469|NCT00108277|7173725|FG002|NOT COMPLETED|Overall Study||16
6274470|NCT00108303|7173736|FG000|STARTED|Overall Study||179
6274471|NCT00108303|7173737|FG001|STARTED|Overall Study||179
6274472|NCT00108303|7173738|FG002|STARTED|Overall Study||180
6274473|NCT00108303|7173736|FG000|COMPLETED|Overall Study||179
6274474|NCT00108303|7173737|FG001|COMPLETED|Overall Study||179
6274475|NCT00108303|7173738|FG002|COMPLETED|Overall Study||180
6274476|NCT00108303|7173736|FG000|NOT COMPLETED|Overall Study||0
6274477|NCT00108303|7173737|FG001|NOT COMPLETED|Overall Study||0
6274478|NCT00108303|7173738|FG002|NOT COMPLETED|Overall Study||0
6274479|NCT00108355|7173752|FG000|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
6274480|NCT00108355|7173753|FG001|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
6274481|NCT00108355|7173752|FG000|COMPLETED|Overall Study||13
6274482|NCT00108355|7173753|FG001|COMPLETED|Overall Study||12
6274483|NCT00108355|7173752|FG000|NOT COMPLETED|Overall Study||2
6274484|NCT00108355|7173753|FG001|NOT COMPLETED|Overall Study||2
6274485|NCT00108485|7173761|FG000|STARTED|Overall Study||5
6274486|NCT00108485|7173762|FG001|STARTED|Overall Study||4
6274487|NCT00108485|7173761|FG000|COMPLETED|Overall Study||2
6274488|NCT00108485|7173762|FG001|COMPLETED|Overall Study||2
6274489|NCT00108485|7173761|FG000|NOT COMPLETED|Overall Study||3
6274490|NCT00108485|7173762|FG001|NOT COMPLETED|Overall Study||2
6274491|NCT00108524|7173770|FG000|STARTED|Overall Study||81
6274492|NCT00108524|7173771|FG001|STARTED|Overall Study||79
6274493|NCT00108524|7173770|FG000|COMPLETED|Overall Study||52
6274494|NCT00108524|7173771|FG001|COMPLETED|Overall Study||61
6274495|NCT00108524|7173770|FG000|NOT COMPLETED|Overall Study||29
6274496|NCT00108524|7173771|FG001|NOT COMPLETED|Overall Study||18
6274497|NCT00108550|7173779|FG000|STARTED|Overall Study||55
6274498|NCT00108550|7173780|FG001|STARTED|Overall Study||53
6274499|NCT00108550|7173779|FG000|COMPLETED|Overall Study||39
6274500|NCT00108550|7173780|FG001|COMPLETED|Overall Study||37
6274501|NCT00108550|7173779|FG000|NOT COMPLETED|Overall Study||16
6274502|NCT00108550|7173780|FG001|NOT COMPLETED|Overall Study||16
6274503|NCT00108628|7173788|FG000|STARTED|Overall Study||61
6274504|NCT00108628|7173789|FG001|STARTED|Overall Study||63
6274505|NCT00108628|7173788|FG000|Received One or More Sessions|Overall Study||53
6274506|NCT00108628|7173789|FG001|Received One or More Sessions|Overall Study||58
6274507|NCT00108628|7173788|FG000|Completed Treatment|Overall Study||42
6274508|NCT00108628|7173789|FG001|Completed Treatment|Overall Study||57
6274509|NCT00108628|7173788|FG000|COMPLETED|Overall Study||41
6274510|NCT00108628|7173789|FG001|COMPLETED|Overall Study||53
6274511|NCT00108628|7173788|FG000|NOT COMPLETED|Overall Study||20
6274512|NCT00108628|7173789|FG001|NOT COMPLETED|Overall Study||10
6274513|NCT00108732|7173795|FG000|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
6274514|NCT00108732|7173795|FG000|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
6274515|NCT00108732|7173795|FG000|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
6274516|NCT00108732|7173795|FG000|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
6274517|NCT00108732|7173795|FG000|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
6274518|NCT00108732|7173795|FG000|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
6274519|NCT00108732|7173795|FG000|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
6274520|NCT00108745|7173802|FG000|STARTED|Overall Study||387
6274521|NCT00108745|7173803|FG001|STARTED|Overall Study||384
6274522|NCT00108745|7173804|FG002|STARTED|Overall Study||386
6274523|NCT00108745|7173802|FG000|COMPLETED|Overall Study||353
6566775|NCT01826981|7489754|FG013|STARTED|Overall Study||20
6566776|NCT01826981|7489755|FG014|STARTED|Overall Study||8
6566777|NCT01826981|7489741|FG000|COMPLETED|Overall Study||19
6566778|NCT01826981|7489742|FG001|COMPLETED|Overall Study||9
6566779|NCT01826981|7489743|FG002|COMPLETED|Overall Study||25
6566780|NCT01826981|7489744|FG003|COMPLETED|Overall Study||26
6274524|NCT00108745|7173803|FG001|COMPLETED|Overall Study||349
6389639|NCT00825344|7301286|FG000|COMPLETED|Overall Study||33
6274525|NCT00108745|7173804|FG002|COMPLETED|Overall Study||349
6274526|NCT00108745|7173802|FG000|NOT COMPLETED|Overall Study||34
6274527|NCT00108745|7173803|FG001|NOT COMPLETED|Overall Study||35
6274528|NCT00108745|7173804|FG002|NOT COMPLETED|Overall Study||37
6274529|NCT00108862|7173814|FG000|STARTED|Overall Study||405
6274530|NCT00108862|7173815|FG001|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
6566781|NCT01826981|7489745|FG004|COMPLETED|Overall Study||18
6566782|NCT01826981|7489746|FG005|COMPLETED|Overall Study||25
6566783|NCT01826981|7489747|FG006|COMPLETED|Overall Study||24
6656910|NCT02465528|7587279|FG002|STARTED|Overall Study||12
6656911|NCT02465528|7587280|FG003|STARTED|Overall Study||5
6656912|NCT02465528|7587277|FG000|COMPLETED|Overall Study||0
6274531|NCT00108862|7173814|FG000|COMPLETED|Overall Study||337
6274532|NCT00108862|7173815|FG001|COMPLETED|Overall Study||339
6389640|NCT00825344|7301287|FG001|COMPLETED|Overall Study||42
6389641|NCT00825344|7301286|FG000|NOT COMPLETED|Overall Study||1
6566784|NCT01826981|7489748|FG007|COMPLETED|Overall Study||40
6566785|NCT01826981|7489749|FG008|COMPLETED|Overall Study||13
6389642|NCT00825344|7301287|FG001|NOT COMPLETED|Overall Study||1
6389643|NCT00825370|7301295|FG000|STARTED|Overall Study||175
6389644|NCT00825370|7301296|FG001|STARTED|Overall Study||175
6389645|NCT00825370|7301295|FG000|COMPLETED|Overall Study||175
6389646|NCT00825370|7301296|FG001|COMPLETED|Overall Study||175
6389647|NCT00825370|7301295|FG000|NOT COMPLETED|Overall Study||0
6389648|NCT00825370|7301296|FG001|NOT COMPLETED|Overall Study||0
6389649|NCT00825500|7301305|FG000|STARTED|Overall Study||125
6389650|NCT00825500|7301306|FG001|STARTED|Overall Study||121
6389651|NCT00825500|7301307|FG002|STARTED|Overall Study||120
6389652|NCT00825500|7301305|FG000|COMPLETED|Overall Study||125
6389653|NCT00825500|7301306|FG001|COMPLETED|Overall Study||121
6389654|NCT00825500|7301307|FG002|COMPLETED|Overall Study||120
6389655|NCT00825500|7301305|FG000|NOT COMPLETED|Overall Study||0
6389656|NCT00825500|7301306|FG001|NOT COMPLETED|Overall Study||0
6566786|NCT01826981|7489750|FG009|COMPLETED|Overall Study||26
6389657|NCT00825500|7301307|FG002|NOT COMPLETED|Overall Study||0
6566787|NCT01826981|7489751|FG010|COMPLETED|Overall Study||22
6566788|NCT01826981|7489752|FG011|COMPLETED|Overall Study||25
6566789|NCT01826981|7489753|FG012|COMPLETED|Overall Study||25
6566790|NCT01826981|7489754|FG013|COMPLETED|Overall Study||15
6566791|NCT01826981|7489755|FG014|COMPLETED|Overall Study||8
6566792|NCT01826981|7489741|FG000|NOT COMPLETED|Overall Study||0
6566793|NCT01826981|7489742|FG001|NOT COMPLETED|Overall Study||1
6566794|NCT01826981|7489743|FG002|NOT COMPLETED|Overall Study||0
6656913|NCT02465528|7587278|FG001|COMPLETED|Overall Study||0
6566795|NCT01826981|7489744|FG003|NOT COMPLETED|Overall Study||0
6566796|NCT01826981|7489745|FG004|NOT COMPLETED|Overall Study||7
6566797|NCT01826981|7489746|FG005|NOT COMPLETED|Overall Study||1
6566798|NCT01826981|7489747|FG006|NOT COMPLETED|Overall Study||1
6566799|NCT01826981|7489748|FG007|NOT COMPLETED|Overall Study||11
6566800|NCT01826981|7489749|FG008|NOT COMPLETED|Overall Study||7
6566801|NCT01826981|7489750|FG009|NOT COMPLETED|Overall Study||1
6566802|NCT01826981|7489751|FG010|NOT COMPLETED|Overall Study||2
6566803|NCT01826981|7489752|FG011|NOT COMPLETED|Overall Study||2
6566804|NCT01826981|7489753|FG012|NOT COMPLETED|Overall Study||1
6566805|NCT01826981|7489754|FG013|NOT COMPLETED|Overall Study||5
6566806|NCT01826981|7489755|FG014|NOT COMPLETED|Overall Study||0
6806505|NCT02485691|7738740|FG000|NOT COMPLETED|Overall Study||129
6274533|NCT00108862|7173814|FG000|NOT COMPLETED|Overall Study||68
6274534|NCT00108862|7173815|FG001|NOT COMPLETED|Overall Study||62
6274535|NCT00108953|7173823|FG000|STARTED|Treatment Period|ITT population|47
6274536|NCT00108953|7173824|FG001|STARTED|Treatment Period|ITT population|49
6274537|NCT00108953|7173823|FG000|COMPLETED|Treatment Period|No patient under study medication anymore|47
6274538|NCT00108953|7173824|FG001|COMPLETED|Treatment Period|No patient under study medication anymore|49
6274539|NCT00108953|7173823|FG000|NOT COMPLETED|Treatment Period||0
6274540|NCT00108953|7173824|FG001|NOT COMPLETED|Treatment Period||0
6274541|NCT00108953|7173823|FG000|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
6274542|NCT00108953|7173824|FG001|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
6274543|NCT00108953|7173823|FG000|COMPLETED|Follow-up||11
6274544|NCT00108953|7173824|FG001|COMPLETED|Follow-up||12
6274545|NCT00108953|7173823|FG000|NOT COMPLETED|Follow-up||29
6274546|NCT00108953|7173824|FG001|NOT COMPLETED|Follow-up||33
6274547|NCT00109005|7173834|FG000|STARTED|Overall Study||8
6274548|NCT00109005|7173835|FG001|STARTED|Overall Study||9
6274549|NCT00109005|7173834|FG000|COMPLETED|Overall Study||8
6274550|NCT00109005|7173835|FG001|COMPLETED|Overall Study||9
6274551|NCT00109005|7173834|FG000|NOT COMPLETED|Overall Study||0
6274552|NCT00109005|7173835|FG001|NOT COMPLETED|Overall Study||0
6274553|NCT00109031|7173846|FG000|STARTED|Overall Study||11
6274554|NCT00109031|7173847|FG001|STARTED|Overall Study||10
6274555|NCT00109031|7173848|FG002|STARTED|Overall Study||14
6274556|NCT00109031|7173849|FG003|STARTED|Overall Study||12
6274557|NCT00109031|7173846|FG000|COMPLETED|Overall Study||11
6274558|NCT00109031|7173847|FG001|COMPLETED|Overall Study||8
6274559|NCT00109031|7173848|FG002|COMPLETED|Overall Study||12
6274560|NCT00109031|7173849|FG003|COMPLETED|Overall Study||12
6274561|NCT00109031|7173846|FG000|NOT COMPLETED|Overall Study||0
6274562|NCT00109031|7173847|FG001|NOT COMPLETED|Overall Study||2
6274563|NCT00109031|7173848|FG002|NOT COMPLETED|Overall Study||2
6274564|NCT00109031|7173849|FG003|NOT COMPLETED|Overall Study||0
6274565|NCT00109343|7173862|FG000|STARTED|Overall Study||510
6274566|NCT00109343|7173863|FG001|STARTED|Overall Study||258
6274567|NCT00109343|7173864|FG002|STARTED|Overall Study||259
6274568|NCT00109343|7173862|FG000|Vaccinated at Visit 1|Overall Study||510
6274569|NCT00109343|7173863|FG001|Vaccinated at Visit 1|Overall Study||258
6274570|NCT00109343|7173864|FG002|Vaccinated at Visit 1|Overall Study||259
6274571|NCT00109343|7173862|FG000|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
6274572|NCT00109343|7173863|FG001|Vaccinated at Visit 2|Overall Study||246
6389658|NCT00825565|7301315|FG000|STARTED|Overall Study||8
6389659|NCT00825565|7301315|FG000|COMPLETED|Overall Study||8
6566807|NCT01827046|7489793|FG000|STARTED|Overall Study||250
6566808|NCT01827046|7489794|FG001|STARTED|Overall Study||249
6566809|NCT01827046|7489793|FG000|COMPLETED|Overall Study||249
6806506|NCT02485691|7738741|FG001|NOT COMPLETED|Overall Study||126
6806507|NCT02472964|7738750|FG000|STARTED|Part 1 (up to Week 24)||246
6806508|NCT02472964|7738751|FG001|STARTED|Part 1 (up to Week 24)||247
6389660|NCT00825565|7301315|FG000|NOT COMPLETED|Overall Study||0
6389661|NCT00825630|7301329|FG000|STARTED|Overall Study||29
6389662|NCT00825630|7301330|FG001|STARTED|Overall Study||62
6389663|NCT00825630|7301331|FG002|STARTED|Overall Study||19
6389664|NCT00825630|7301332|FG003|STARTED|Overall Study||13
6389665|NCT00825630|7301329|FG000|COMPLETED|Overall Study||29
6274573|NCT00109343|7173864|FG002|Vaccinated at Visit 2|Overall Study||246
6274574|NCT00109343|7173862|FG000|Vaccinated at Visit 4|Overall Study||466
6274575|NCT00109343|7173863|FG001|Vaccinated at Visit 4|Overall Study||235
6274576|NCT00109343|7173864|FG002|Vaccinated at Visit 4|Overall Study||240
6274577|NCT00109343|7173862|FG000|COMPLETED|Overall Study||446
6274578|NCT00109343|7173863|FG001|COMPLETED|Overall Study||221
6274579|NCT00109343|7173864|FG002|COMPLETED|Overall Study||229
6274580|NCT00109343|7173862|FG000|NOT COMPLETED|Overall Study||64
6274581|NCT00109343|7173863|FG001|NOT COMPLETED|Overall Study||37
6389666|NCT00825630|7301330|FG001|COMPLETED|Overall Study||62
6389667|NCT00825630|7301331|FG002|COMPLETED|Overall Study||19
6389668|NCT00825630|7301332|FG003|COMPLETED|Overall Study||13
6389669|NCT00825630|7301329|FG000|NOT COMPLETED|Overall Study||0
6389670|NCT00825630|7301330|FG001|NOT COMPLETED|Overall Study||0
6389671|NCT00825630|7301331|FG002|NOT COMPLETED|Overall Study||0
6389672|NCT00825630|7301332|FG003|NOT COMPLETED|Overall Study||0
6389673|NCT00825682|7301344|FG000|STARTED|Overall Study||47
6389674|NCT00825682|7301345|FG001|STARTED|Overall Study||25
6504468|NCT01448824|7423504|FG006|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||0
6504469|NCT01448824|7423505|FG007|NOT COMPLETED|Part 2 Period 1: Drug-drug Interaction||1
6504470|NCT01448824|7423498|FG000|STARTED|Part 2: Washout Period||0
6504471|NCT01448824|7423499|FG001|STARTED|Part 2: Washout Period||0
6504472|NCT01448824|7423500|FG002|STARTED|Part 2: Washout Period||0
6504473|NCT01448824|7423501|FG003|STARTED|Part 2: Washout Period||0
6806509|NCT02472964|7738750|FG000|COMPLETED|Part 1 (up to Week 24)||171
6806510|NCT02472964|7738751|FG001|COMPLETED|Part 1 (up to Week 24)||185
6806511|NCT02472964|7738750|FG000|NOT COMPLETED|Part 1 (up to Week 24)||75
6806512|NCT02472964|7738751|FG001|NOT COMPLETED|Part 1 (up to Week 24)||62
6806513|NCT02472964|7738750|FG000|STARTED|Part 2 (Week 24-week 48)||163
6806514|NCT02472964|7738751|FG001|STARTED|Part 2 (Week 24-week 48)||179
6806515|NCT02472964|7738750|FG000|COMPLETED|Part 2 (Week 24-week 48)||98
6806516|NCT02472964|7738751|FG001|COMPLETED|Part 2 (Week 24-week 48)||116
6806517|NCT02472964|7738750|FG000|NOT COMPLETED|Part 2 (Week 24-week 48)||65
6806518|NCT02472964|7738751|FG001|NOT COMPLETED|Part 2 (Week 24-week 48)||63
6806519|NCT02178722|7738762|FG000|STARTED|Overall Study||4
6806520|NCT02178722|7738763|FG001|STARTED|Overall Study||20
6806521|NCT02178722|7738764|FG002|STARTED|Overall Study||18
6806522|NCT02178722|7738765|FG003|STARTED|Overall Study||20
6806523|NCT02178722|7738766|FG004|STARTED|Overall Study||382
6806524|NCT02178722|7738762|FG000|COMPLETED|Overall Study||0
6806525|NCT02178722|7738763|FG001|COMPLETED|Overall Study||0
6806526|NCT02178722|7738764|FG002|COMPLETED|Overall Study||0
6806527|NCT02178722|7738765|FG003|COMPLETED|Overall Study||0
6806528|NCT02178722|7738766|FG004|COMPLETED|Overall Study||0
6806529|NCT02178722|7738762|FG000|NOT COMPLETED|Overall Study||4
6806530|NCT02178722|7738763|FG001|NOT COMPLETED|Overall Study||20
6806531|NCT02178722|7738764|FG002|NOT COMPLETED|Overall Study||18
6806532|NCT02178722|7738765|FG003|NOT COMPLETED|Overall Study||20
6806533|NCT02178722|7738766|FG004|NOT COMPLETED|Overall Study||382
6806534|NCT01258803|7738781|FG000|STARTED|Treatment Period 1 (1 Dose)||15
6806535|NCT01258803|7738782|FG001|STARTED|Treatment Period 1 (1 Dose)||16
6806536|NCT01258803|7738783|FG002|STARTED|Treatment Period 1 (1 Dose)||15
6806537|NCT01258803|7738784|FG003|STARTED|Treatment Period 1 (1 Dose)||15
6806538|NCT01258803|7738785|FG004|STARTED|Treatment Period 1 (1 Dose)||15
6806539|NCT01258803|7738786|FG005|STARTED|Treatment Period 1 (1 Dose)||16
6806540|NCT01258803|7738781|FG000|COMPLETED|Treatment Period 1 (1 Dose)||15
6806541|NCT01258803|7738782|FG001|COMPLETED|Treatment Period 1 (1 Dose)||16
6806542|NCT01258803|7738783|FG002|COMPLETED|Treatment Period 1 (1 Dose)||15
6274582|NCT00109343|7173864|FG002|NOT COMPLETED|Overall Study||30
6274583|NCT00109473|7173874|FG000|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
6504474|NCT01448824|7423502|FG004|STARTED|Part 2: Washout Period||0
6504475|NCT01448824|7423503|FG005|STARTED|Part 2: Washout Period||0
6806543|NCT01258803|7738784|FG003|COMPLETED|Treatment Period 1 (1 Dose)||15
6389675|NCT00825682|7301344|FG000|COMPLETED|Overall Study||34
6389676|NCT00825682|7301345|FG001|COMPLETED|Overall Study||20
6389677|NCT00825682|7301344|FG000|NOT COMPLETED|Overall Study||13
6389678|NCT00825682|7301345|FG001|NOT COMPLETED|Overall Study||5
6389679|NCT00825734|7301352|FG000|STARTED|Phase I||4
6389680|NCT00825734|7301353|FG001|STARTED|Phase I||3
6389681|NCT00825734|7301354|FG002|STARTED|Phase I||3
6389682|NCT00825734|7301352|FG000|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6389683|NCT00825734|7301353|FG001|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
6389684|NCT00825734|7301354|FG002|COMPLETED|Phase I||3
6389685|NCT00825734|7301352|FG000|NOT COMPLETED|Phase I||4
6389686|NCT00825734|7301353|FG001|NOT COMPLETED|Phase I||3
6389687|NCT00825734|7301354|FG002|NOT COMPLETED|Phase I||0
6389688|NCT00825734|7301352|FG000|STARTED|Phase II||0
6389689|NCT00825734|7301353|FG001|STARTED|Phase II||0
6389690|NCT00825734|7301354|FG002|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
6389691|NCT00825734|7301352|FG000|COMPLETED|Phase II||0
6504476|NCT01448824|7423504|FG006|STARTED|Part 2: Washout Period||0
6504477|NCT01448824|7423505|FG007|STARTED|Part 2: Washout Period||11
6504478|NCT01448824|7423498|FG000|COMPLETED|Part 2: Washout Period||0
6504479|NCT01448824|7423499|FG001|COMPLETED|Part 2: Washout Period||0
6504480|NCT01448824|7423500|FG002|COMPLETED|Part 2: Washout Period||0
6504481|NCT01448824|7423501|FG003|COMPLETED|Part 2: Washout Period||0
6504482|NCT01448824|7423502|FG004|COMPLETED|Part 2: Washout Period||0
6504483|NCT01448824|7423503|FG005|COMPLETED|Part 2: Washout Period||0
6504484|NCT01448824|7423504|FG006|COMPLETED|Part 2: Washout Period||0
6504485|NCT01448824|7423505|FG007|COMPLETED|Part 2: Washout Period||11
6504486|NCT01448824|7423498|FG000|NOT COMPLETED|Part 2: Washout Period||0
6504487|NCT01448824|7423499|FG001|NOT COMPLETED|Part 2: Washout Period||0
6504488|NCT01448824|7423500|FG002|NOT COMPLETED|Part 2: Washout Period||0
6504489|NCT01448824|7423501|FG003|NOT COMPLETED|Part 2: Washout Period||0
6504490|NCT01448824|7423502|FG004|NOT COMPLETED|Part 2: Washout Period||0
6504491|NCT01448824|7423503|FG005|NOT COMPLETED|Part 2: Washout Period||0
6504492|NCT01448824|7423504|FG006|NOT COMPLETED|Part 2: Washout Period||0
6504493|NCT01448824|7423505|FG007|NOT COMPLETED|Part 2: Washout Period||0
6504494|NCT01448824|7423498|FG000|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6504495|NCT01448824|7423499|FG001|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6504496|NCT01448824|7423500|FG002|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6504497|NCT01448824|7423501|FG003|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6504498|NCT01448824|7423502|FG004|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6504499|NCT01448824|7423503|FG005|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6504500|NCT01448824|7423504|FG006|STARTED|Part 2 Period 2: Drug-drug Interaction||0
6504501|NCT01448824|7423505|FG007|STARTED|Part 2 Period 2: Drug-drug Interaction||11
6504502|NCT01448824|7423498|FG000|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6504503|NCT01448824|7423499|FG001|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6504504|NCT01448824|7423500|FG002|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6504505|NCT01448824|7423501|FG003|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6504506|NCT01448824|7423502|FG004|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6504507|NCT01448824|7423503|FG005|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6504508|NCT01448824|7423504|FG006|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||0
6504509|NCT01448824|7423505|FG007|Received at Least 1 Dose of Study Drug|Part 2 Period 2: Drug-drug Interaction||11
6504510|NCT01448824|7423498|FG000|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6504511|NCT01448824|7423499|FG001|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6504512|NCT01448824|7423500|FG002|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6504513|NCT01448824|7423501|FG003|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6504514|NCT01448824|7423502|FG004|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6504515|NCT01448824|7423503|FG005|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6504516|NCT01448824|7423504|FG006|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||0
6504517|NCT01448824|7423505|FG007|Completed Dosing on Day 5|Part 2 Period 2: Drug-drug Interaction||10
6566810|NCT01827046|7489794|FG001|COMPLETED|Overall Study||240
6389692|NCT00825734|7301353|FG001|COMPLETED|Phase II||0
6389693|NCT00825734|7301354|FG002|COMPLETED|Phase II||0
6389694|NCT00825734|7301352|FG000|NOT COMPLETED|Phase II||0
6389695|NCT00825734|7301353|FG001|NOT COMPLETED|Phase II||0
6274584|NCT00109473|7173875|FG001|STARTED|Baseline (0 Through 12 Weeks)||10
6274585|NCT00109473|7173874|FG000|Analyzed|Baseline (0 Through 12 Weeks)||10
6274586|NCT00109473|7173875|FG001|Analyzed|Baseline (0 Through 12 Weeks)||10
6274587|NCT00109473|7173874|FG000|COMPLETED|Baseline (0 Through 12 Weeks)||10
6274588|NCT00109473|7173875|FG001|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
6274589|NCT00109473|7173874|FG000|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
6274590|NCT00109473|7173875|FG001|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
6274591|NCT00109473|7173874|FG000|STARTED|Week 12 to Week 24||10
6274592|NCT00109473|7173875|FG001|STARTED|Week 12 to Week 24||9
6274593|NCT00109473|7173874|FG000|Analyzed|Week 12 to Week 24||9
6274594|NCT00109473|7173875|FG001|Analyzed|Week 12 to Week 24||9
6274595|NCT00109473|7173874|FG000|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
6274596|NCT00109473|7173875|FG001|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
6274597|NCT00109473|7173874|FG000|NOT COMPLETED|Week 12 to Week 24||1
6274598|NCT00109473|7173875|FG001|NOT COMPLETED|Week 12 to Week 24||0
6274599|NCT00109473|7173874|FG000|STARTED|52 Week Extension Phase||9
6274600|NCT00109473|7173875|FG001|STARTED|52 Week Extension Phase||8
6274601|NCT00109473|7173874|FG000|Analyzed|52 Week Extension Phase||9
6274602|NCT00109473|7173875|FG001|Analyzed|52 Week Extension Phase||8
6274603|NCT00109473|7173874|FG000|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
6274604|NCT00109473|7173875|FG001|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
6274605|NCT00109473|7173874|FG000|NOT COMPLETED|52 Week Extension Phase||4
6274606|NCT00109473|7173875|FG001|NOT COMPLETED|52 Week Extension Phase||5
6274607|NCT00109577|7173886|FG000|STARTED|Overall Study||20
6274608|NCT00109577|7173887|FG001|STARTED|Overall Study||20
6274609|NCT00109577|7173886|FG000|COMPLETED|Overall Study||17
6274610|NCT00109577|7173887|FG001|COMPLETED|Overall Study||17
6274611|NCT00109577|7173886|FG000|NOT COMPLETED|Overall Study||3
6274612|NCT00109577|7173887|FG001|NOT COMPLETED|Overall Study||3
6274613|NCT00109590|7173896|FG000|STARTED|Overall Study||57
6274614|NCT00109590|7173897|FG001|STARTED|Overall Study||58
6274615|NCT00109590|7173898|FG002|STARTED|Overall Study||60
6274616|NCT00109590|7173896|FG000|RECEIVED TREATMENT|Overall Study||56
6274617|NCT00109590|7173897|FG001|RECEIVED TREATMENT|Overall Study||56
6274618|NCT00109590|7173898|FG002|RECEIVED TREATMENT|Overall Study||57
6274619|NCT00109590|7173896|FG000|COMPLETED|Overall Study||55
6274620|NCT00109590|7173897|FG001|COMPLETED|Overall Study||56
6274621|NCT00109590|7173898|FG002|COMPLETED|Overall Study||56
6274622|NCT00109590|7173896|FG000|NOT COMPLETED|Overall Study||2
6274623|NCT00109590|7173897|FG001|NOT COMPLETED|Overall Study||2
6274624|NCT00109590|7173898|FG002|NOT COMPLETED|Overall Study||4
6274625|NCT00109707|7173923|FG000|STARTED|Overall Study||321
6274626|NCT00109707|7173924|FG001|STARTED|Overall Study||137
6566811|NCT01827046|7489793|FG000|NOT COMPLETED|Overall Study||1
6274627|NCT00109707|7173925|FG002|STARTED|Overall Study||49
6274628|NCT00109707|7173923|FG000|Entered Extension Study|Overall Study||106
6274629|NCT00109707|7173924|FG001|Entered Extension Study|Overall Study||15
6274630|NCT00109707|7173925|FG002|Entered Extension Study|Overall Study||15
6274631|NCT00109707|7173923|FG000|COMPLETED|Overall Study||67
6274632|NCT00109707|7173924|FG001|COMPLETED|Overall Study||8
6274633|NCT00109707|7173925|FG002|COMPLETED|Overall Study||8
6274634|NCT00109707|7173923|FG000|NOT COMPLETED|Overall Study||254
6274635|NCT00109707|7173924|FG001|NOT COMPLETED|Overall Study||129
6274636|NCT00109707|7173925|FG002|NOT COMPLETED|Overall Study||41
6274637|NCT00109733|7173939|FG000|STARTED|Overall Study||15
6274638|NCT00109733|7173940|FG001|STARTED|Overall Study||16
6274639|NCT00109733|7173939|FG000|COMPLETED|Overall Study||13
6274640|NCT00109733|7173940|FG001|COMPLETED|Overall Study||12
6274641|NCT00109733|7173939|FG000|NOT COMPLETED|Overall Study||2
6274642|NCT00109733|7173940|FG001|NOT COMPLETED|Overall Study||4
6274643|NCT00109772|7173948|FG000|STARTED|Double-blind Treatment||90
6274644|NCT00109772|7173949|FG001|STARTED|Double-blind Treatment||94
6274645|NCT00109772|7173948|FG000|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
6274646|NCT00109772|7173949|FG001|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
6274647|NCT00109772|7173948|FG000|COMPLETED|Double-blind Treatment||68
6274648|NCT00109772|7173949|FG001|COMPLETED|Double-blind Treatment||79
6274649|NCT00109772|7173948|FG000|NOT COMPLETED|Double-blind Treatment||22
6274650|NCT00109772|7173949|FG001|NOT COMPLETED|Double-blind Treatment||15
6274651|NCT00109772|7173948|FG000|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
6274652|NCT00109772|7173949|FG001|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
6274653|NCT00109772|7173948|FG000|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
6280811|NCT00159263|7180664|FG000|STARTED|Fifth Intervention||1
6566812|NCT01827046|7489794|FG001|NOT COMPLETED|Overall Study||9
6566813|NCT01827163|7489800|FG000|STARTED|Overall Study||20
6566814|NCT01827163|7489800|FG000|COMPLETED|Overall Study||9
6274654|NCT00109772|7173949|FG001|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
6274655|NCT00109772|7173948|FG000|NOT COMPLETED|Open-label Extension||45
6274656|NCT00109772|7173949|FG001|NOT COMPLETED|Open-label Extension||49
6274657|NCT00109837|7173955|FG000|STARTED|Overall Study||79
6274658|NCT00109837|7173955|FG000|Eligible|Overall Study||78
6274659|NCT00109837|7173955|FG000|Eligible and Ph-|Overall Study||61
6274660|NCT00109837|7173955|FG000|Eligible and Ph- and Treated|Overall Study||60
6274661|NCT00109837|7173955|FG000|COMPLETED|Overall Study||56
6274662|NCT00109837|7173955|FG000|NOT COMPLETED|Overall Study||23
6274663|NCT00109850|7173963|FG000|STARTED|Overall Study||22
6274664|NCT00109850|7173963|FG000|Eligible|Overall Study||21
6274665|NCT00109850|7173963|FG000|Eligible and Began Protocol Therapy|Overall Study||21
6274666|NCT00109850|7173963|FG000|COMPLETED|Overall Study||18
6274667|NCT00109850|7173963|FG000|NOT COMPLETED|Overall Study||4
6274668|NCT00109876|7173967|FG000|STARTED|Overall Study||51
6274669|NCT00109876|7173967|FG000|COMPLETED|Overall Study||51
6274670|NCT00109876|7173967|FG000|NOT COMPLETED|Overall Study||0
6274671|NCT00109928|7173971|FG000|STARTED|Overall Study||34
6274672|NCT00109928|7173971|FG000|Eligible|Overall Study||33
6274673|NCT00109928|7173971|FG000|Eligible and Began Protocol Therapy|Overall Study||33
6274674|NCT00109928|7173971|FG000|COMPLETED|Overall Study||21
6274675|NCT00109928|7173971|FG000|NOT COMPLETED|Overall Study||13
6274676|NCT00109967|7173978|FG000|STARTED|Overall Study||50
6274677|NCT00109967|7173979|FG001|STARTED|Overall Study||21
6274678|NCT00109967|7173978|FG000|COMPLETED|Overall Study||30
6274679|NCT00109967|7173979|FG001|COMPLETED|Overall Study||15
6274680|NCT00109967|7173978|FG000|NOT COMPLETED|Overall Study||20
6274681|NCT00109967|7173979|FG001|NOT COMPLETED|Overall Study||6
6274682|NCT00110019|7173987|FG000|STARTED|Overall Study||410
6274683|NCT00110019|7173988|FG001|STARTED|Overall Study||413
6274684|NCT00110019|7173987|FG000|Eligible|Overall Study||395
6274685|NCT00110019|7173988|FG001|Eligible|Overall Study||398
6274686|NCT00110019|7173987|FG000|Treated|Overall Study||393
6274687|NCT00110019|7173988|FG001|Treated|Overall Study||397
6274688|NCT00110019|7173987|FG000|COMPLETED|Overall Study||4
6274689|NCT00110019|7173988|FG001|COMPLETED|Overall Study||0
6274690|NCT00110019|7173987|FG000|NOT COMPLETED|Overall Study||406
6274691|NCT00110019|7173988|FG001|NOT COMPLETED|Overall Study||413
6274692|NCT00110084|7173994|FG000|STARTED|Overall Study||50
6274693|NCT00110084|7173994|FG000|COMPLETED|Overall Study||22
6274694|NCT00110084|7173994|FG000|NOT COMPLETED|Overall Study||28
6274695|NCT00110136|7173998|FG000|STARTED|Overall Study||9
6274696|NCT00110136|7173998|FG000|COMPLETED|Overall Study||9
6274697|NCT00110136|7173998|FG000|NOT COMPLETED|Overall Study||0
6274698|NCT00110149|7174003|FG000|STARTED|Overall Study|total number that signed consent to be screened.|12
6274699|NCT00110149|7174003|FG000|Received Treatment|Overall Study|total number of patient that passed screening and received treatment.|9
6274700|NCT00110149|7174003|FG000|COMPLETED|Overall Study||9
6274701|NCT00110149|7174003|FG000|NOT COMPLETED|Overall Study||3
6274702|NCT00110214|7174010|FG000|STARTED|Overall Study||526
6274703|NCT00110214|7174011|FG001|STARTED|Overall Study||524
6274704|NCT00110214|7174010|FG000|COMPLETED|Overall Study||17
6274705|NCT00110214|7174011|FG001|COMPLETED|Overall Study||21
6274706|NCT00110214|7174010|FG000|NOT COMPLETED|Overall Study||509
6274707|NCT00110214|7174011|FG001|NOT COMPLETED|Overall Study||503
6274708|NCT00110266|7174017|FG000|STARTED|Overall Study||173
6274709|NCT00110266|7174017|FG000|COMPLETED|Overall Study||95
6274710|NCT00110266|7174017|FG000|NOT COMPLETED|Overall Study||78
6274711|NCT00110305|7174026|FG000|STARTED|Overall Study||279
6274712|NCT00110305|7174027|FG001|STARTED|Overall Study||89
6274713|NCT00110305|7174026|FG000|COMPLETED|Overall Study||165
6274714|NCT00110305|7174027|FG001|COMPLETED|Overall Study||57
6274715|NCT00110305|7174026|FG000|NOT COMPLETED|Overall Study||114
6274716|NCT00110305|7174027|FG001|NOT COMPLETED|Overall Study||32
6274717|NCT00110357|7174046|FG000|STARTED|Overall Study||27
6274718|NCT00110357|7174047|FG001|STARTED|Overall Study||19
6274719|NCT00110357|7174046|FG000|COMPLETED|Overall Study|Number Still on Study|0
6274720|NCT00110357|7174047|FG001|COMPLETED|Overall Study|Number Still on Study|0
6806544|NCT01258803|7738785|FG004|COMPLETED|Treatment Period 1 (1 Dose)||15
6806545|NCT01258803|7738786|FG005|COMPLETED|Treatment Period 1 (1 Dose)||16
6806546|NCT01258803|7738781|FG000|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6806547|NCT01258803|7738782|FG001|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6806548|NCT01258803|7738783|FG002|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6806549|NCT01258803|7738784|FG003|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6806550|NCT01258803|7738785|FG004|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6806551|NCT01258803|7738786|FG005|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
6806552|NCT01258803|7738781|FG000|STARTED|Treatment Period 2 (1 Dose)||15
6806553|NCT01258803|7738782|FG001|STARTED|Treatment Period 2 (1 Dose)||16
6806554|NCT01258803|7738783|FG002|STARTED|Treatment Period 2 (1 Dose)||15
6806555|NCT01258803|7738784|FG003|STARTED|Treatment Period 2 (1 Dose)||15
6806556|NCT01258803|7738785|FG004|STARTED|Treatment Period 2 (1 Dose)||15
6806557|NCT01258803|7738786|FG005|STARTED|Treatment Period 2 (1 Dose)||16
6806558|NCT01258803|7738781|FG000|COMPLETED|Treatment Period 2 (1 Dose)||14
6806559|NCT01258803|7738782|FG001|COMPLETED|Treatment Period 2 (1 Dose)||14
6806560|NCT01258803|7738783|FG002|COMPLETED|Treatment Period 2 (1 Dose)||15
6806561|NCT01258803|7738784|FG003|COMPLETED|Treatment Period 2 (1 Dose)||15
6806562|NCT01258803|7738785|FG004|COMPLETED|Treatment Period 2 (1 Dose)||15
6806563|NCT01258803|7738786|FG005|COMPLETED|Treatment Period 2 (1 Dose)||15
6806564|NCT01258803|7738781|FG000|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
6806565|NCT01258803|7738782|FG001|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
6806566|NCT01258803|7738783|FG002|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
6806567|NCT01258803|7738784|FG003|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
6806568|NCT01258803|7738785|FG004|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
6806569|NCT01258803|7738786|FG005|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
6806570|NCT01258803|7738781|FG000|STARTED|Treatment Period 3 (1 Dose)||14
6806571|NCT01258803|7738782|FG001|STARTED|Treatment Period 3 (1 Dose)||14
6806572|NCT01258803|7738783|FG002|STARTED|Treatment Period 3 (1 Dose)||15
6806573|NCT01258803|7738784|FG003|STARTED|Treatment Period 3 (1 Dose)||15
6806574|NCT01258803|7738785|FG004|STARTED|Treatment Period 3 (1 Dose)||15
6806575|NCT01258803|7738786|FG005|STARTED|Treatment Period 3 (1 Dose)||15
6806576|NCT01258803|7738781|FG000|COMPLETED|Treatment Period 3 (1 Dose)||14
6806577|NCT01258803|7738782|FG001|COMPLETED|Treatment Period 3 (1 Dose)||14
6806578|NCT01258803|7738783|FG002|COMPLETED|Treatment Period 3 (1 Dose)||14
6806579|NCT01258803|7738784|FG003|COMPLETED|Treatment Period 3 (1 Dose)||15
6806580|NCT01258803|7738785|FG004|COMPLETED|Treatment Period 3 (1 Dose)||15
6806581|NCT01258803|7738786|FG005|COMPLETED|Treatment Period 3 (1 Dose)||15
6806582|NCT01258803|7738781|FG000|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6806583|NCT01258803|7738782|FG001|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6806584|NCT01258803|7738783|FG002|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
6806585|NCT01258803|7738784|FG003|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6806586|NCT01258803|7738785|FG004|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6806587|NCT01258803|7738786|FG005|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
6806588|NCT01258803|7738781|FG000|STARTED|Treatment Period 4 (1 Dose)||14
6806589|NCT01258803|7738782|FG001|STARTED|Treatment Period 4 (1 Dose)||14
6806590|NCT01258803|7738783|FG002|STARTED|Treatment Period 4 (1 Dose)||14
6806591|NCT01258803|7738784|FG003|STARTED|Treatment Period 4 (1 Dose)||15
6806592|NCT01258803|7738785|FG004|STARTED|Treatment Period 4 (1 Dose)||15
6806593|NCT01258803|7738786|FG005|STARTED|Treatment Period 4 (1 Dose)||15
6806594|NCT01258803|7738781|FG000|COMPLETED|Treatment Period 4 (1 Dose)||14
6806595|NCT01258803|7738782|FG001|COMPLETED|Treatment Period 4 (1 Dose)||14
6806596|NCT01258803|7738783|FG002|COMPLETED|Treatment Period 4 (1 Dose)||14
6806597|NCT01258803|7738784|FG003|COMPLETED|Treatment Period 4 (1 Dose)||15
6806598|NCT01258803|7738785|FG004|COMPLETED|Treatment Period 4 (1 Dose)||15
6806599|NCT01258803|7738786|FG005|COMPLETED|Treatment Period 4 (1 Dose)||15
6806600|NCT01258803|7738781|FG000|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6389696|NCT00825734|7301354|FG002|NOT COMPLETED|Phase II||76
6389697|NCT00825786|7301361|FG000|STARTED|Overall Study||52
6389698|NCT00825786|7301362|FG001|STARTED|Overall Study||51
6389699|NCT00825786|7301361|FG000|COMPLETED|Overall Study||52
6389700|NCT00825786|7301362|FG001|COMPLETED|Overall Study||51
6389701|NCT00825786|7301361|FG000|NOT COMPLETED|Overall Study||0
6389702|NCT00825786|7301362|FG001|NOT COMPLETED|Overall Study||0
6389703|NCT00825812|7301372|FG000|STARTED|Overall Study||29
6389704|NCT00825812|7301373|FG001|STARTED|Overall Study||32
6389705|NCT00825812|7301374|FG002|STARTED|Overall Study||126
6389706|NCT00825812|7301375|FG003|STARTED|Overall Study||121
6389707|NCT00825812|7301372|FG000|TREATED|Overall Study||29
6389708|NCT00825812|7301373|FG001|TREATED|Overall Study||31
6389709|NCT00825812|7301374|FG002|TREATED|Overall Study||120
6389710|NCT00825812|7301375|FG003|TREATED|Overall Study||111
6389711|NCT00825812|7301372|FG000|COMPLETED|Overall Study||29
6389712|NCT00825812|7301373|FG001|COMPLETED|Overall Study||31
6389713|NCT00825812|7301374|FG002|COMPLETED|Overall Study||120
6389714|NCT00825812|7301375|FG003|COMPLETED|Overall Study||111
6389715|NCT00825812|7301372|FG000|NOT COMPLETED|Overall Study||0
6389716|NCT00825812|7301373|FG001|NOT COMPLETED|Overall Study||1
6389717|NCT00825812|7301374|FG002|NOT COMPLETED|Overall Study||6
6389718|NCT00825812|7301375|FG003|NOT COMPLETED|Overall Study||10
6389719|NCT00825825|7301385|FG000|STARTED|First Medication Period (14 Days)||6
6389720|NCT00825825|7301386|FG001|STARTED|First Medication Period (14 Days)||4
6389721|NCT00825825|7301387|FG002|STARTED|First Medication Period (14 Days)||3
6389722|NCT00825825|7301388|FG003|STARTED|First Medication Period (14 Days)||5
6389723|NCT00825825|7301389|FG004|STARTED|First Medication Period (14 Days)||4
6389724|NCT00825825|7301390|FG005|STARTED|First Medication Period (14 Days)||5
6389725|NCT00825825|7301385|FG000|COMPLETED|First Medication Period (14 Days)||3
6389726|NCT00825825|7301386|FG001|COMPLETED|First Medication Period (14 Days)||4
6389727|NCT00825825|7301387|FG002|COMPLETED|First Medication Period (14 Days)||2
6389728|NCT00825825|7301388|FG003|COMPLETED|First Medication Period (14 Days)||5
6389729|NCT00825825|7301389|FG004|COMPLETED|First Medication Period (14 Days)||4
6389730|NCT00825825|7301390|FG005|COMPLETED|First Medication Period (14 Days)||3
6389731|NCT00825825|7301385|FG000|NOT COMPLETED|First Medication Period (14 Days)||3
6389732|NCT00825825|7301386|FG001|NOT COMPLETED|First Medication Period (14 Days)||0
6389733|NCT00825825|7301387|FG002|NOT COMPLETED|First Medication Period (14 Days)||1
6389734|NCT00825825|7301388|FG003|NOT COMPLETED|First Medication Period (14 Days)||0
6389735|NCT00825825|7301389|FG004|NOT COMPLETED|First Medication Period (14 Days)||0
6389736|NCT00825825|7301390|FG005|NOT COMPLETED|First Medication Period (14 Days)||2
6504518|NCT01448824|7423498|FG000|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504519|NCT01448824|7423499|FG001|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504520|NCT01448824|7423500|FG002|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504521|NCT01448824|7423501|FG003|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6566815|NCT01827163|7489800|FG000|NOT COMPLETED|Overall Study||11
6566816|NCT01827254|7489804|FG000|STARTED|Overall Study||61
6274721|NCT00110357|7174046|FG000|NOT COMPLETED|Overall Study||27
6274722|NCT00110357|7174047|FG001|NOT COMPLETED|Overall Study||19
6274723|NCT00110396|7174080|FG000|STARTED|Overall Study||260
6274724|NCT00110396|7174080|FG000|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
6274725|NCT00110396|7174080|FG000|NOT COMPLETED|Overall Study||36
6274726|NCT00110461|7174087|FG000|STARTED|30-Week, Double-blind Treatment Phase||98
6274727|NCT00110461|7174088|FG001|STARTED|30-Week, Double-blind Treatment Phase||99
6274728|NCT00110461|7174089|FG002|STARTED|30-Week, Double-blind Treatment Phase||99
6274729|NCT00110461|7174087|FG000|COMPLETED|30-Week, Double-blind Treatment Phase||34
6274730|NCT00110461|7174088|FG001|COMPLETED|30-Week, Double-blind Treatment Phase||22
6274731|NCT00110461|7174089|FG002|COMPLETED|30-Week, Double-blind Treatment Phase||12
6274732|NCT00110461|7174087|FG000|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
6274733|NCT00110461|7174088|FG001|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
6274734|NCT00110461|7174089|FG002|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
6274735|NCT00110461|7174087|FG000|STARTED|Acute Phase||98
6274736|NCT00110461|7174088|FG001|STARTED|Acute Phase||99
6274737|NCT00110461|7174089|FG002|STARTED|Acute Phase||99
6274738|NCT00110461|7174087|FG000|COMPLETED|Acute Phase||84
6274739|NCT00110461|7174088|FG001|COMPLETED|Acute Phase||77
6274740|NCT00110461|7174089|FG002|COMPLETED|Acute Phase||76
6274741|NCT00110461|7174087|FG000|NOT COMPLETED|Acute Phase||14
6274742|NCT00110461|7174088|FG001|NOT COMPLETED|Acute Phase||22
6274743|NCT00110461|7174089|FG002|NOT COMPLETED|Acute Phase||23
6274744|NCT00110513|7174097|FG000|STARTED|Overall Study||18
6274745|NCT00110513|7174097|FG000|COMPLETED|Overall Study||18
6274746|NCT00110513|7174097|FG000|NOT COMPLETED|Overall Study||0
6274747|NCT00110617|7174103|FG000|STARTED|Overall Study||135
6274748|NCT00110617|7174104|FG001|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
6274749|NCT00110617|7174103|FG000|Safety Set 1; Received Study Drug|Overall Study||135
6274750|NCT00110617|7174104|FG001|Safety Set 1; Received Study Drug|Overall Study||56
6274751|NCT00110617|7174103|FG000|Full Analysis 2; Received ICL670|Overall Study||135
6274752|NCT00110617|7174104|FG001|Full Analysis 2; Received ICL670|Overall Study||53
6274753|NCT00110617|7174103|FG000|On Going at Week 24|Overall Study||126
6274754|NCT00110617|7174104|FG001|On Going at Week 24|Overall Study||53
6274755|NCT00110617|7174103|FG000|COMPLETED|Overall Study||96
6274756|NCT00110617|7174104|FG001|COMPLETED|Overall Study||39
6274757|NCT00110617|7174103|FG000|NOT COMPLETED|Overall Study||39
6274758|NCT00110617|7174104|FG001|NOT COMPLETED|Overall Study||29
6274759|NCT00110812|7174115|FG000|STARTED|Main Study||91
6274760|NCT00110812|7174116|FG001|STARTED|Main Study||89
6274761|NCT00110812|7174117|FG002|STARTED|Main Study||87
6274762|NCT00110812|7174115|FG000|COMPLETED|Main Study||83
6274763|NCT00110812|7174116|FG001|COMPLETED|Main Study||78
6274764|NCT00110812|7174117|FG002|COMPLETED|Main Study||74
6274765|NCT00110812|7174115|FG000|NOT COMPLETED|Main Study||8
6274766|NCT00110812|7174116|FG001|NOT COMPLETED|Main Study||11
6274767|NCT00110812|7174117|FG002|NOT COMPLETED|Main Study||13
6274768|NCT00110812|7174115|FG000|STARTED|Extended Follow-up||80
6274769|NCT00110812|7174116|FG001|STARTED|Extended Follow-up||69
6274770|NCT00110812|7174117|FG002|STARTED|Extended Follow-up||73
6274771|NCT00110812|7174115|FG000|COMPLETED|Extended Follow-up||78
6274772|NCT00110812|7174116|FG001|COMPLETED|Extended Follow-up||65
6274773|NCT00110812|7174117|FG002|COMPLETED|Extended Follow-up||69
6274774|NCT00110812|7174115|FG000|NOT COMPLETED|Extended Follow-up||2
6274775|NCT00110812|7174116|FG001|NOT COMPLETED|Extended Follow-up||4
6274776|NCT00110812|7174117|FG002|NOT COMPLETED|Extended Follow-up||4
6274777|NCT00110890|7174132|FG000|STARTED|Overall Study||368
6274778|NCT00110890|7174133|FG001|STARTED|Overall Study||184
6274779|NCT00110890|7174132|FG000|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
6274780|NCT00110890|7174133|FG001|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
6274781|NCT00110890|7174132|FG000|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
6274782|NCT00110890|7174133|FG001|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
6274783|NCT00110890|7174132|FG000|COMPLETED|Overall Study|Follow-up Phase|7
6274784|NCT00110890|7174133|FG001|COMPLETED|Overall Study|Follow-up Phase|5
6274785|NCT00110890|7174132|FG000|NOT COMPLETED|Overall Study||361
6274786|NCT00110890|7174133|FG001|NOT COMPLETED|Overall Study||179
6274787|NCT00110994|7174141|FG000|STARTED|Double-blind (DB) Treatment|ITT population|51
6274788|NCT00110994|7174142|FG001|STARTED|Double-blind (DB) Treatment|ITT population|50
6274789|NCT00110994|7174141|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|51
6566817|NCT01827254|7489804|FG000|Evaluable Population|Overall Study||52
6389737|NCT00825825|7301385|FG000|STARTED|First Washout Period (14 Days)||3
6389738|NCT00825825|7301386|FG001|STARTED|First Washout Period (14 Days)||4
6389739|NCT00825825|7301387|FG002|STARTED|First Washout Period (14 Days)||2
6389740|NCT00825825|7301388|FG003|STARTED|First Washout Period (14 Days)||5
6389741|NCT00825825|7301389|FG004|STARTED|First Washout Period (14 Days)||4
6389742|NCT00825825|7301390|FG005|STARTED|First Washout Period (14 Days)||3
6389743|NCT00825825|7301385|FG000|COMPLETED|First Washout Period (14 Days)||3
6389744|NCT00825825|7301386|FG001|COMPLETED|First Washout Period (14 Days)||4
6389745|NCT00825825|7301387|FG002|COMPLETED|First Washout Period (14 Days)||2
6389746|NCT00825825|7301388|FG003|COMPLETED|First Washout Period (14 Days)||5
6389747|NCT00825825|7301389|FG004|COMPLETED|First Washout Period (14 Days)||4
6389748|NCT00825825|7301390|FG005|COMPLETED|First Washout Period (14 Days)||3
6389749|NCT00825825|7301385|FG000|NOT COMPLETED|First Washout Period (14 Days)||0
6389750|NCT00825825|7301386|FG001|NOT COMPLETED|First Washout Period (14 Days)||0
6389751|NCT00825825|7301387|FG002|NOT COMPLETED|First Washout Period (14 Days)||0
6389752|NCT00825825|7301388|FG003|NOT COMPLETED|First Washout Period (14 Days)||0
6389753|NCT00825825|7301389|FG004|NOT COMPLETED|First Washout Period (14 Days)||0
6389754|NCT00825825|7301390|FG005|NOT COMPLETED|First Washout Period (14 Days)||0
6389755|NCT00825825|7301385|FG000|STARTED|Second Medication Period (14 Days)||3
6389756|NCT00825825|7301386|FG001|STARTED|Second Medication Period (14 Days)||4
6389757|NCT00825825|7301387|FG002|STARTED|Second Medication Period (14 Days)||2
6389758|NCT00825825|7301388|FG003|STARTED|Second Medication Period (14 Days)||5
6389759|NCT00825825|7301389|FG004|STARTED|Second Medication Period (14 Days)||4
6389760|NCT00825825|7301390|FG005|STARTED|Second Medication Period (14 Days)||3
6389761|NCT00825825|7301385|FG000|COMPLETED|Second Medication Period (14 Days)||1
6389762|NCT00825825|7301386|FG001|COMPLETED|Second Medication Period (14 Days)||4
6389763|NCT00825825|7301387|FG002|COMPLETED|Second Medication Period (14 Days)||2
6389764|NCT00825825|7301388|FG003|COMPLETED|Second Medication Period (14 Days)||3
6389765|NCT00825825|7301389|FG004|COMPLETED|Second Medication Period (14 Days)||3
6389766|NCT00825825|7301390|FG005|COMPLETED|Second Medication Period (14 Days)||3
6389767|NCT00825825|7301385|FG000|NOT COMPLETED|Second Medication Period (14 Days)||2
6389768|NCT00825825|7301386|FG001|NOT COMPLETED|Second Medication Period (14 Days)||0
6389769|NCT00825825|7301387|FG002|NOT COMPLETED|Second Medication Period (14 Days)||0
6389770|NCT00825825|7301388|FG003|NOT COMPLETED|Second Medication Period (14 Days)||2
6389771|NCT00825825|7301389|FG004|NOT COMPLETED|Second Medication Period (14 Days)||1
6389772|NCT00825825|7301390|FG005|NOT COMPLETED|Second Medication Period (14 Days)||0
6389773|NCT00825825|7301385|FG000|STARTED|Second Washout Period (14 Days)||1
6389774|NCT00825825|7301386|FG001|STARTED|Second Washout Period (14 Days)||4
6389775|NCT00825825|7301387|FG002|STARTED|Second Washout Period (14 Days)||2
6389776|NCT00825825|7301388|FG003|STARTED|Second Washout Period (14 Days)||3
6389777|NCT00825825|7301389|FG004|STARTED|Second Washout Period (14 Days)||3
6389778|NCT00825825|7301390|FG005|STARTED|Second Washout Period (14 Days)||3
6389779|NCT00825825|7301385|FG000|COMPLETED|Second Washout Period (14 Days)||1
6389780|NCT00825825|7301386|FG001|COMPLETED|Second Washout Period (14 Days)||4
6389781|NCT00825825|7301387|FG002|COMPLETED|Second Washout Period (14 Days)||2
6389782|NCT00825825|7301388|FG003|COMPLETED|Second Washout Period (14 Days)||3
6389783|NCT00825825|7301389|FG004|COMPLETED|Second Washout Period (14 Days)||3
6389784|NCT00825825|7301390|FG005|COMPLETED|Second Washout Period (14 Days)||3
6389785|NCT00825825|7301385|FG000|NOT COMPLETED|Second Washout Period (14 Days)||0
6389786|NCT00825825|7301386|FG001|NOT COMPLETED|Second Washout Period (14 Days)||0
6389787|NCT00825825|7301387|FG002|NOT COMPLETED|Second Washout Period (14 Days)||0
6389788|NCT00825825|7301388|FG003|NOT COMPLETED|Second Washout Period (14 Days)||0
6389789|NCT00825825|7301389|FG004|NOT COMPLETED|Second Washout Period (14 Days)||0
6389790|NCT00825825|7301390|FG005|NOT COMPLETED|Second Washout Period (14 Days)||0
6389791|NCT00825825|7301385|FG000|STARTED|Third Medication Period (14 Days)||1
6389792|NCT00825825|7301386|FG001|STARTED|Third Medication Period (14 Days)||4
6389793|NCT00825825|7301387|FG002|STARTED|Third Medication Period (14 Days)||2
6389794|NCT00825825|7301388|FG003|STARTED|Third Medication Period (14 Days)||3
6389795|NCT00825825|7301389|FG004|STARTED|Third Medication Period (14 Days)||3
6389796|NCT00825825|7301390|FG005|STARTED|Third Medication Period (14 Days)||3
6389797|NCT00825825|7301385|FG000|COMPLETED|Third Medication Period (14 Days)||1
6389798|NCT00825825|7301386|FG001|COMPLETED|Third Medication Period (14 Days)||2
6389799|NCT00825825|7301387|FG002|COMPLETED|Third Medication Period (14 Days)||2
6389800|NCT00825825|7301388|FG003|COMPLETED|Third Medication Period (14 Days)||3
6389801|NCT00825825|7301389|FG004|COMPLETED|Third Medication Period (14 Days)||3
6389802|NCT00825825|7301390|FG005|COMPLETED|Third Medication Period (14 Days)||1
6504522|NCT01448824|7423502|FG004|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504523|NCT01448824|7423503|FG005|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504524|NCT01448824|7423504|FG006|COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504525|NCT01448824|7423505|FG007|COMPLETED|Part 2 Period 2: Drug-drug Interaction||8
6504526|NCT01448824|7423498|FG000|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6274790|NCT00110994|7174142|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|50
6274791|NCT00110994|7174141|FG000|COMPLETED|Double-blind (DB) Treatment||9
6274792|NCT00110994|7174142|FG001|COMPLETED|Double-blind (DB) Treatment||3
6274793|NCT00110994|7174141|FG000|NOT COMPLETED|Double-blind (DB) Treatment||42
6274794|NCT00110994|7174142|FG001|NOT COMPLETED|Double-blind (DB) Treatment||47
6274795|NCT00110994|7174141|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
6274796|NCT00110994|7174142|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
6274797|NCT00110994|7174141|FG000|COMPLETED|Active Follow-up||0
6274798|NCT00110994|7174142|FG001|COMPLETED|Active Follow-up||0
6274799|NCT00110994|7174141|FG000|NOT COMPLETED|Active Follow-up||1
6389803|NCT00825825|7301385|FG000|NOT COMPLETED|Third Medication Period (14 Days)||0
6389804|NCT00825825|7301386|FG001|NOT COMPLETED|Third Medication Period (14 Days)||2
6504527|NCT01448824|7423499|FG001|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504528|NCT01448824|7423500|FG002|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504529|NCT01448824|7423501|FG003|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504530|NCT01448824|7423502|FG004|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504531|NCT01448824|7423503|FG005|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504532|NCT01448824|7423504|FG006|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||0
6504533|NCT01448824|7423505|FG007|NOT COMPLETED|Part 2 Period 2: Drug-drug Interaction||3
6504534|NCT01448850|7423535|FG000|STARTED|Overall Study||164
6504535|NCT01448850|7423536|FG001|STARTED|Overall Study||160
6504536|NCT01448850|7423535|FG000|COMPLETED|Overall Study||130
6504537|NCT01448850|7423536|FG001|COMPLETED|Overall Study||120
6504538|NCT01448850|7423535|FG000|NOT COMPLETED|Overall Study||34
6504539|NCT01448850|7423536|FG001|NOT COMPLETED|Overall Study||40
6504540|NCT01449006|7423545|FG000|STARTED|Overall Study||8
6504541|NCT01449006|7423546|FG001|STARTED|Overall Study||9
6504542|NCT01449006|7423545|FG000|COMPLETED|Overall Study||5
6566818|NCT01827254|7489804|FG000|COMPLETED|Overall Study||2
6566819|NCT01827254|7489804|FG000|NOT COMPLETED|Overall Study||59
6566820|NCT01827267|7489814|FG000|STARTED|Overall Study|18 subjects were randomized but 17 received treatment.|18
6566821|NCT01827267|7489815|FG001|STARTED|Overall Study|44 subjects were randomized; 43 subjects were treated.|44
6566822|NCT01827267|7489814|FG000|Received Study Drug|Overall Study||17
6566823|NCT01827267|7489815|FG001|Received Study Drug|Overall Study||43
6566824|NCT01827267|7489814|FG000|Crossed Over to Neratinib + Temsirolimus|Overall Study||11
6566825|NCT01827267|7489815|FG001|Crossed Over to Neratinib + Temsirolimus|Overall Study||0
6566826|NCT01827267|7489814|FG000|COMPLETED|Overall Study||13
6566827|NCT01827267|7489815|FG001|COMPLETED|Overall Study||32
6566828|NCT01827267|7489814|FG000|NOT COMPLETED|Overall Study||5
6566829|NCT01827267|7489815|FG001|NOT COMPLETED|Overall Study||12
6566830|NCT01827306|7489824|FG000|STARTED|Overall Study||21
6566831|NCT01827306|7489825|FG001|STARTED|Overall Study||13
6566832|NCT01827306|7489824|FG000|COMPLETED|Overall Study||10
6566833|NCT01827306|7489825|FG001|COMPLETED|Overall Study||8
6566834|NCT01827306|7489824|FG000|NOT COMPLETED|Overall Study||11
6566835|NCT01827306|7489825|FG001|NOT COMPLETED|Overall Study||5
6566836|NCT01827319|7489831|FG000|STARTED|Overall Study||203
6274800|NCT00110994|7174142|FG001|NOT COMPLETED|Active Follow-up||2
6280812|NCT00159263|7180665|FG001|STARTED|Fifth Intervention||1
6280813|NCT00159263|7180666|FG002|STARTED|Fifth Intervention||2
6280814|NCT00159263|7180667|FG003|STARTED|Fifth Intervention||2
6280815|NCT00159263|7180668|FG004|STARTED|Fifth Intervention||2
6280816|NCT00159263|7180669|FG005|STARTED|Fifth Intervention||2
6280817|NCT00159263|7180664|FG000|COMPLETED|Fifth Intervention||1
6280818|NCT00159263|7180665|FG001|COMPLETED|Fifth Intervention||1
6280819|NCT00159263|7180666|FG002|COMPLETED|Fifth Intervention||2
6280820|NCT00159263|7180667|FG003|COMPLETED|Fifth Intervention||2
6280821|NCT00159263|7180668|FG004|COMPLETED|Fifth Intervention||2
6389805|NCT00825825|7301387|FG002|NOT COMPLETED|Third Medication Period (14 Days)||0
6389806|NCT00825825|7301388|FG003|NOT COMPLETED|Third Medication Period (14 Days)||0
6389807|NCT00825825|7301389|FG004|NOT COMPLETED|Third Medication Period (14 Days)||0
6389808|NCT00825825|7301390|FG005|NOT COMPLETED|Third Medication Period (14 Days)||2
6389809|NCT00825916|7301400|FG000|STARTED|Overall Study||19
6389810|NCT00825916|7301401|FG001|STARTED|Overall Study||20
6389811|NCT00825916|7301402|FG002|STARTED|Overall Study||20
6389812|NCT00825916|7301400|FG000|COMPLETED|Overall Study||15
6566837|NCT01827319|7489831|FG000|COMPLETED|Overall Study||200
6389813|NCT00825916|7301401|FG001|COMPLETED|Overall Study||18
6389814|NCT00825916|7301402|FG002|COMPLETED|Overall Study||19
6389815|NCT00825916|7301400|FG000|NOT COMPLETED|Overall Study||4
6389816|NCT00825916|7301401|FG001|NOT COMPLETED|Overall Study||2
6389817|NCT00825916|7301402|FG002|NOT COMPLETED|Overall Study||1
6389818|NCT00825994|7301443|FG000|STARTED|Overall Study||24
6389819|NCT00825994|7301443|FG000|COMPLETED|Overall Study||19
6389820|NCT00825994|7301443|FG000|NOT COMPLETED|Overall Study||5
6389821|NCT00826007|7301449|FG000|STARTED|Overall Study|Retrospective review|308
6389822|NCT00826007|7301450|FG001|STARTED|Overall Study||279
6389823|NCT00826007|7301449|FG000|COMPLETED|Overall Study|Retrospective review|308
6389824|NCT00826007|7301450|FG001|COMPLETED|Overall Study||279
6566838|NCT01827319|7489831|FG000|NOT COMPLETED|Overall Study||3
6806601|NCT01258803|7738782|FG001|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6274801|NCT00110994|7174141|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
6274802|NCT00110994|7174142|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
6274803|NCT00110994|7174141|FG000|COMPLETED|Long Term Follow-up||22
6274804|NCT00110994|7174142|FG001|COMPLETED|Long Term Follow-up||30
6274805|NCT00110994|7174141|FG000|NOT COMPLETED|Long Term Follow-up||19
6274806|NCT00110994|7174142|FG001|NOT COMPLETED|Long Term Follow-up||17
6274807|NCT00111007|7174150|FG000|STARTED|Double-blind (DB) Treatment|ITT population|135
6274808|NCT00111007|7174151|FG001|STARTED|Double-blind (DB) Treatment|ITT population|135
6274809|NCT00111007|7174150|FG000|Received Treatment|Double-blind (DB) Treatment|Safety population|134
6274810|NCT00111007|7174151|FG001|Received Treatment|Double-blind (DB) Treatment|Safety population|134
6274811|NCT00111007|7174150|FG000|COMPLETED|Double-blind (DB) Treatment||27
6389825|NCT00826007|7301449|FG000|NOT COMPLETED|Overall Study||0
6389826|NCT00826007|7301450|FG001|NOT COMPLETED|Overall Study||0
6389827|NCT00826020|7301455|FG000|STARTED|Overall Study||72
6389828|NCT00826020|7301455|FG000|COMPLETED|Overall Study||72
6389829|NCT00826020|7301455|FG000|NOT COMPLETED|Overall Study||0
6389830|NCT00826111|7301461|FG000|STARTED|Overall Study||14
6389831|NCT00826111|7301462|FG001|STARTED|Overall Study||5
6389832|NCT00826111|7301461|FG000|COMPLETED|Overall Study||7
6389833|NCT00826111|7301462|FG001|COMPLETED|Overall Study||3
6389834|NCT00826111|7301461|FG000|NOT COMPLETED|Overall Study||7
6389835|NCT00826111|7301462|FG001|NOT COMPLETED|Overall Study||2
6389836|NCT00826150|7301474|FG000|STARTED|Overall Study||8
6389837|NCT00826150|7301475|FG001|STARTED|Overall Study||3
6389838|NCT00826150|7301476|FG002|STARTED|Overall Study||3
6389839|NCT00826150|7301474|FG000|COMPLETED|Overall Study||2
6389840|NCT00826150|7301475|FG001|COMPLETED|Overall Study||1
6389841|NCT00826150|7301476|FG002|COMPLETED|Overall Study||0
6389842|NCT00826150|7301474|FG000|NOT COMPLETED|Overall Study||6
6389843|NCT00826150|7301475|FG001|NOT COMPLETED|Overall Study||2
6389844|NCT00826150|7301476|FG002|NOT COMPLETED|Overall Study||3
6389845|NCT00826176|7301488|FG000|STARTED|Overall Study|enrolled|128
6389846|NCT00826176|7301489|FG001|STARTED|Overall Study|enrolled|36
6389847|NCT00826176|7301488|FG000|COMPLETED|Overall Study|treated and completed|115
6566839|NCT01827332|7489837|FG000|STARTED|Overall Study||8
6566840|NCT01827332|7489838|FG001|STARTED|Overall Study||8
6389848|NCT00826176|7301489|FG001|COMPLETED|Overall Study|treated and completed|36
6389849|NCT00826176|7301488|FG000|NOT COMPLETED|Overall Study||13
6389850|NCT00826176|7301489|FG001|NOT COMPLETED|Overall Study||0
6389851|NCT00826202|7301497|FG000|STARTED|Overall Study||20
6389852|NCT00826202|7301498|FG001|STARTED|Overall Study||24
6389853|NCT00826202|7301497|FG000|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
6389854|NCT00826202|7301498|FG001|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
6389855|NCT00826202|7301497|FG000|COMPLETED|Overall Study||10
6389856|NCT00826202|7301498|FG001|COMPLETED|Overall Study||11
6389857|NCT00826202|7301497|FG000|NOT COMPLETED|Overall Study||10
6389858|NCT00826202|7301498|FG001|NOT COMPLETED|Overall Study||13
6389859|NCT00826228|7301504|FG000|STARTED|Overall Study||12
6389860|NCT00826228|7301504|FG000|COMPLETED|Overall Study||11
6389861|NCT00826228|7301504|FG000|NOT COMPLETED|Overall Study||1
6389862|NCT00826241|7301509|FG000|STARTED|Overall Study||58
6389863|NCT00826241|7301509|FG000|COMPLETED|Overall Study||31
6389864|NCT00826241|7301509|FG000|NOT COMPLETED|Overall Study||27
6389865|NCT00826267|7301516|FG000|STARTED|Overall Study||10
6389866|NCT00826267|7301517|FG001|STARTED|Overall Study||8
6389867|NCT00826267|7301518|FG002|STARTED|Overall Study||11
6389868|NCT00826267|7301516|FG000|COMPLETED|Overall Study||9
6389869|NCT00826267|7301517|FG001|COMPLETED|Overall Study||8
6504543|NCT01449006|7423546|FG001|COMPLETED|Overall Study||9
6566841|NCT01827332|7489837|FG000|COMPLETED|Overall Study||6
6566842|NCT01827332|7489838|FG001|COMPLETED|Overall Study||7
6389870|NCT00826267|7301518|FG002|COMPLETED|Overall Study||11
6389871|NCT00826267|7301516|FG000|NOT COMPLETED|Overall Study||1
6389872|NCT00826267|7301517|FG001|NOT COMPLETED|Overall Study||0
6389873|NCT00826267|7301518|FG002|NOT COMPLETED|Overall Study||0
6389874|NCT00826280|7301530|FG000|STARTED|Overall Study||114
6389875|NCT00826280|7301531|FG001|STARTED|Overall Study||116
6389876|NCT00826280|7301532|FG002|STARTED|Overall Study||117
6504544|NCT01449006|7423545|FG000|NOT COMPLETED|Overall Study||3
6566843|NCT01827332|7489837|FG000|NOT COMPLETED|Overall Study||2
6566844|NCT01827332|7489838|FG001|NOT COMPLETED|Overall Study||1
6566845|NCT01827358|7489846|FG000|STARTED|Overall Study||80
6656914|NCT02465528|7587279|FG002|COMPLETED|Overall Study||0
6656915|NCT02465528|7587280|FG003|COMPLETED|Overall Study||0
6504545|NCT01449006|7423546|FG001|NOT COMPLETED|Overall Study||0
6274812|NCT00111007|7174151|FG001|COMPLETED|Double-blind (DB) Treatment||24
6274813|NCT00111007|7174150|FG000|NOT COMPLETED|Double-blind (DB) Treatment||108
6274814|NCT00111007|7174151|FG001|NOT COMPLETED|Double-blind (DB) Treatment||111
6274815|NCT00111007|7174150|FG000|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
6274816|NCT00111007|7174151|FG001|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
6274817|NCT00111007|7174150|FG000|COMPLETED|Active Follow-up||0
6274818|NCT00111007|7174151|FG001|COMPLETED|Active Follow-up||2
6274819|NCT00111007|7174150|FG000|NOT COMPLETED|Active Follow-up||6
6274820|NCT00111007|7174151|FG001|NOT COMPLETED|Active Follow-up||2
6274821|NCT00111007|7174150|FG000|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
6274822|NCT00111007|7174151|FG001|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
6274823|NCT00111007|7174150|FG000|COMPLETED|Long Term Follow-up||54
6274824|NCT00111007|7174151|FG001|COMPLETED|Long Term Follow-up||62
6274825|NCT00111007|7174150|FG000|NOT COMPLETED|Long Term Follow-up||47
6274826|NCT00111007|7174151|FG001|NOT COMPLETED|Long Term Follow-up||45
6274827|NCT00111228|7174160|FG000|STARTED|Overall Study||54
6274828|NCT00111228|7174161|FG001|STARTED|Overall Study||54
6274829|NCT00111228|7174162|FG002|STARTED|Overall Study||54
6274830|NCT00111228|7174160|FG000|COMPLETED|Overall Study||49
6274831|NCT00111228|7174161|FG001|COMPLETED|Overall Study||53
6274832|NCT00111228|7174162|FG002|COMPLETED|Overall Study||54
6274833|NCT00111228|7174160|FG000|NOT COMPLETED|Overall Study||5
6274834|NCT00111228|7174161|FG001|NOT COMPLETED|Overall Study||1
6274835|NCT00111228|7174162|FG002|NOT COMPLETED|Overall Study||0
6274836|NCT00111241|7174172|FG000|STARTED|Overall Study||45
6274837|NCT00111241|7174173|FG001|STARTED|Overall Study||70
6274838|NCT00111241|7174172|FG000|COMPLETED|Overall Study||30
6274839|NCT00111241|7174173|FG001|COMPLETED|Overall Study||62
6274840|NCT00111241|7174172|FG000|NOT COMPLETED|Overall Study||15
6274841|NCT00111241|7174173|FG001|NOT COMPLETED|Overall Study||8
6274842|NCT00111475|7174191|FG000|STARTED|Overall Study||4
6274843|NCT00111475|7174192|FG001|STARTED|Overall Study||4
6274844|NCT00111475|7174193|FG002|STARTED|Overall Study||4
6274845|NCT00111475|7174194|FG003|STARTED|Overall Study||4
6274846|NCT00111475|7174195|FG004|STARTED|Overall Study||4
6274847|NCT00111475|7174196|FG005|STARTED|Overall Study||4
6274848|NCT00111475|7174197|FG006|STARTED|Overall Study||4
6274849|NCT00111475|7174198|FG007|STARTED|Overall Study||8
6274850|NCT00111475|7174199|FG008|STARTED|Overall Study||8
6274851|NCT00111475|7174200|FG009|STARTED|Overall Study||1
6274852|NCT00111475|7174191|FG000|COMPLETED|Overall Study||4
6274853|NCT00111475|7174192|FG001|COMPLETED|Overall Study||4
6274854|NCT00111475|7174193|FG002|COMPLETED|Overall Study||4
6274855|NCT00111475|7174194|FG003|COMPLETED|Overall Study||4
6274856|NCT00111475|7174195|FG004|COMPLETED|Overall Study||4
6274857|NCT00111475|7174196|FG005|COMPLETED|Overall Study||3
6274858|NCT00111475|7174197|FG006|COMPLETED|Overall Study||4
6274859|NCT00111475|7174198|FG007|COMPLETED|Overall Study||8
6274860|NCT00111475|7174199|FG008|COMPLETED|Overall Study||8
6274861|NCT00111475|7174200|FG009|COMPLETED|Overall Study||1
6274862|NCT00111475|7174191|FG000|NOT COMPLETED|Overall Study||0
6274863|NCT00111475|7174192|FG001|NOT COMPLETED|Overall Study||0
6274864|NCT00111475|7174193|FG002|NOT COMPLETED|Overall Study||0
6274865|NCT00111475|7174194|FG003|NOT COMPLETED|Overall Study||0
6274866|NCT00111475|7174195|FG004|NOT COMPLETED|Overall Study||0
6274867|NCT00111475|7174196|FG005|NOT COMPLETED|Overall Study||1
6274868|NCT00111475|7174197|FG006|NOT COMPLETED|Overall Study||0
6274869|NCT00111475|7174198|FG007|NOT COMPLETED|Overall Study||0
6274870|NCT00111475|7174199|FG008|NOT COMPLETED|Overall Study||0
6274871|NCT00111475|7174200|FG009|NOT COMPLETED|Overall Study||0
6274872|NCT00111657|7174227|FG000|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
6274873|NCT00111657|7174227|FG000|COMPLETED|Overall Study|Completed all intended doses.|21
6274874|NCT00111657|7174227|FG000|NOT COMPLETED|Overall Study||16
6274875|NCT00111761|7174235|FG000|STARTED|Part 1|This treatment group was not initiated until Part 2|0
6274876|NCT00111761|7174236|FG001|STARTED|Part 1||19
6274877|NCT00111761|7174235|FG000|COMPLETED|Part 1||0
6274878|NCT00111761|7174236|FG001|COMPLETED|Part 1|Completed through safety followup|14
6274879|NCT00111761|7174235|FG000|NOT COMPLETED|Part 1||0
6274880|NCT00111761|7174236|FG001|NOT COMPLETED|Part 1||5
6274881|NCT00111761|7174235|FG000|STARTED|Part 2||24
6274882|NCT00111761|7174236|FG001|STARTED|Part 2|This treatment group was used in Part 1 only|0
6274883|NCT00111761|7174235|FG000|COMPLETED|Part 2||16
6274884|NCT00111761|7174236|FG001|COMPLETED|Part 2||0
6274885|NCT00111761|7174235|FG000|NOT COMPLETED|Part 2||8
6274886|NCT00111761|7174236|FG001|NOT COMPLETED|Part 2||0
6274887|NCT00111800|7174248|FG000|STARTED|Period 1: Main Phase (12 Weeks)||64
6274888|NCT00111800|7174249|FG001|STARTED|Period 1: Main Phase (12 Weeks)||61
6274889|NCT00111800|7174250|FG002|STARTED|Period 1: Main Phase (12 Weeks)||63
6274890|NCT00111800|7174251|FG003|STARTED|Period 1: Main Phase (12 Weeks)||66
6274891|NCT00111800|7174252|FG004|STARTED|Period 1: Main Phase (12 Weeks)||60
6274892|NCT00111800|7174253|FG005|STARTED|Period 1: Main Phase (12 Weeks)||61
6274893|NCT00111800|7174248|FG000|COMPLETED|Period 1: Main Phase (12 Weeks)||49
6274894|NCT00111800|7174249|FG001|COMPLETED|Period 1: Main Phase (12 Weeks)||47
6274895|NCT00111800|7174250|FG002|COMPLETED|Period 1: Main Phase (12 Weeks)||54
6274896|NCT00111800|7174251|FG003|COMPLETED|Period 1: Main Phase (12 Weeks)||60
6656916|NCT02465528|7587277|FG000|NOT COMPLETED|Overall Study||1
6656917|NCT02465528|7587278|FG001|NOT COMPLETED|Overall Study||4
6656918|NCT02465528|7587279|FG002|NOT COMPLETED|Overall Study||12
6656919|NCT02465528|7587280|FG003|NOT COMPLETED|Overall Study||5
6656920|NCT02465567|7587296|FG000|STARTED|Overall Study||2157
6656921|NCT02465567|7587297|FG001|STARTED|Overall Study||2137
6656922|NCT02465567|7587298|FG002|STARTED|Overall Study||2143
6656923|NCT02465567|7587299|FG003|STARTED|Overall Study||2151
6389877|NCT00826280|7301530|FG000|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
6389878|NCT00826280|7301531|FG001|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
6389879|NCT00826280|7301532|FG002|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
6389880|NCT00826280|7301530|FG000|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
6389881|NCT00826280|7301531|FG001|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
6389882|NCT00826280|7301532|FG002|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
6566846|NCT01827358|7489847|FG001|STARTED|Overall Study||75
6566847|NCT01827358|7489846|FG000|COMPLETED|Overall Study||45
6566848|NCT01827358|7489847|FG001|COMPLETED|Overall Study||44
6566849|NCT01827358|7489846|FG000|NOT COMPLETED|Overall Study||35
6566850|NCT01827358|7489847|FG001|NOT COMPLETED|Overall Study||31
6566851|NCT01827371|7489857|FG000|STARTED|Overall Study||115
6566852|NCT01827371|7489858|FG001|STARTED|Overall Study||96
6566853|NCT01827371|7489859|FG002|STARTED|Overall Study||104
6566854|NCT01827371|7489860|FG003|STARTED|Overall Study||120
6566855|NCT01827371|7489857|FG000|COMPLETED|Overall Study||102
6566856|NCT01827371|7489858|FG001|COMPLETED|Overall Study||89
6566857|NCT01827371|7489859|FG002|COMPLETED|Overall Study||93
6566858|NCT01827371|7489860|FG003|COMPLETED|Overall Study||97
6566859|NCT01827371|7489857|FG000|NOT COMPLETED|Overall Study||13
6566860|NCT01827371|7489858|FG001|NOT COMPLETED|Overall Study||7
6566861|NCT01827371|7489859|FG002|NOT COMPLETED|Overall Study||11
6566862|NCT01827371|7489860|FG003|NOT COMPLETED|Overall Study||23
6566863|NCT01827462|7489873|FG000|STARTED|Overall Study||59
6566864|NCT01827462|7489874|FG001|STARTED|Overall Study||37
6566865|NCT01827462|7489875|FG002|STARTED|Overall Study||40
6566866|NCT01827462|7489873|FG000|COMPLETED|Overall Study||18
6566867|NCT01827462|7489874|FG001|COMPLETED|Overall Study||19
6566868|NCT01827462|7489875|FG002|COMPLETED|Overall Study||12
6566869|NCT01827462|7489873|FG000|NOT COMPLETED|Overall Study||41
6566870|NCT01827462|7489874|FG001|NOT COMPLETED|Overall Study||18
6566871|NCT01827462|7489875|FG002|NOT COMPLETED|Overall Study||28
6566872|NCT01827475|7489889|FG000|STARTED|Overall Study||30
6566873|NCT01827475|7489890|FG001|STARTED|Overall Study||30
6566874|NCT01827475|7489891|FG002|STARTED|Overall Study||30
6566875|NCT01827475|7489889|FG000|COMPLETED|Overall Study||30
6566876|NCT01827475|7489890|FG001|COMPLETED|Overall Study||30
6566877|NCT01827475|7489891|FG002|COMPLETED|Overall Study||30
6566878|NCT01827475|7489889|FG000|NOT COMPLETED|Overall Study||0
6566879|NCT01827475|7489890|FG001|NOT COMPLETED|Overall Study||0
6566880|NCT01827475|7489891|FG002|NOT COMPLETED|Overall Study||0
6566881|NCT01827592|7489902|FG000|STARTED|Overall Study|Randomized patients.|126
6566882|NCT01827592|7489903|FG001|STARTED|Overall Study|Randomized patients.|126
6566883|NCT01827592|7489904|FG002|STARTED|Overall Study|Randomized patients.|124
6566884|NCT01827592|7489902|FG000|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
6566885|NCT01827592|7489903|FG001|Safety Analysis Set|Overall Study||126
6566886|NCT01827592|7489904|FG002|Safety Analysis Set|Overall Study||124
6566887|NCT01827592|7489902|FG000|COMPLETED|Overall Study||52
6566888|NCT01827592|7489903|FG001|COMPLETED|Overall Study||46
6566889|NCT01827592|7489904|FG002|COMPLETED|Overall Study||48
6566890|NCT01827592|7489902|FG000|NOT COMPLETED|Overall Study||74
6566891|NCT01827592|7489903|FG001|NOT COMPLETED|Overall Study||80
6566892|NCT01827592|7489904|FG002|NOT COMPLETED|Overall Study||76
6566893|NCT01827670|7489914|FG000|STARTED|Overall Study||60
6566894|NCT01827670|7489915|FG001|STARTED|Overall Study||59
6566895|NCT01827670|7489914|FG000|COMPLETED|Overall Study||57
6566896|NCT01827670|7489915|FG001|COMPLETED|Overall Study||56
6566897|NCT01827670|7489914|FG000|NOT COMPLETED|Overall Study||3
6566898|NCT01827670|7489915|FG001|NOT COMPLETED|Overall Study||3
6566899|NCT01827787|7489928|FG000|STARTED|Overall Study||45
6566900|NCT01827787|7489929|FG001|STARTED|Overall Study||38
6566901|NCT01827787|7489928|FG000|COMPLETED|Overall Study||45
6566902|NCT01827787|7489929|FG001|COMPLETED|Overall Study||38
6566903|NCT01827787|7489928|FG000|NOT COMPLETED|Overall Study||0
6566904|NCT01827787|7489929|FG001|NOT COMPLETED|Overall Study||0
6274897|NCT00111800|7174252|FG004|COMPLETED|Period 1: Main Phase (12 Weeks)||55
6389883|NCT00826280|7301530|FG000|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
6389884|NCT00826280|7301531|FG001|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
6389885|NCT00826280|7301532|FG002|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
6389886|NCT00826280|7301530|FG000|NOT COMPLETED|Overall Study||48
6389887|NCT00826280|7301531|FG001|NOT COMPLETED|Overall Study||46
6389888|NCT00826280|7301532|FG002|NOT COMPLETED|Overall Study||46
6389889|NCT00826449|7301542|FG000|STARTED|Overall Study||47
6389890|NCT00826449|7301542|FG000|Phase I|Overall Study||12
6389891|NCT00826449|7301542|FG000|Phase II|Overall Study||35
6389892|NCT00826449|7301542|FG000|COMPLETED|Overall Study||42
6389893|NCT00826449|7301542|FG000|NOT COMPLETED|Overall Study||5
6389894|NCT00826514|7301549|FG000|STARTED|Overall Study||30
6389895|NCT00826514|7301550|FG001|STARTED|Overall Study||32
6389896|NCT00826514|7301549|FG000|COMPLETED|Overall Study||27
6389897|NCT00826514|7301550|FG001|COMPLETED|Overall Study||27
6389898|NCT00826514|7301549|FG000|NOT COMPLETED|Overall Study||3
6389899|NCT00826514|7301550|FG001|NOT COMPLETED|Overall Study||5
6389900|NCT00826540|7301556|FG000|STARTED|Overall Study||83
6389901|NCT00826540|7301556|FG000|COMPLETED|Overall Study||79
6389902|NCT00826540|7301556|FG000|NOT COMPLETED|Overall Study||4
6389903|NCT00826618|7301560|FG000|STARTED|Overall Study||6
6389904|NCT00826618|7301560|FG000|COMPLETED|Overall Study||5
6389905|NCT00826618|7301560|FG000|NOT COMPLETED|Overall Study||1
6504546|NCT01449240|7423552|FG000|STARTED|Overall Study||10
6504547|NCT01449240|7423552|FG000|COMPLETED|Overall Study||10
6504548|NCT01449240|7423552|FG000|NOT COMPLETED|Overall Study||0
6504549|NCT01449266|7423556|FG000|STARTED|Overall Study||10
6504550|NCT01449266|7423556|FG000|COMPLETED|Overall Study||10
6504551|NCT01449266|7423556|FG000|NOT COMPLETED|Overall Study||0
6504552|NCT01449279|7423560|FG000|STARTED|Overall Study||22
6504553|NCT01449279|7423560|FG000|COMPLETED|Overall Study||15
6504554|NCT01449279|7423560|FG000|NOT COMPLETED|Overall Study||7
6504555|NCT01449305|7423564|FG000|STARTED|Overall Study||44
6504556|NCT01449305|7423564|FG000|COMPLETED|Overall Study||42
6504557|NCT01449305|7423564|FG000|NOT COMPLETED|Overall Study||2
6504558|NCT01449370|7423593|FG000|STARTED|Overall Study||6
6566905|NCT01827839|7489938|FG000|STARTED|Overall Study||96
6566906|NCT01827839|7489938|FG000|COMPLETED|Overall Study||93
6566907|NCT01827839|7489938|FG000|NOT COMPLETED|Overall Study||3
6566908|NCT01827930|7489952|FG000|STARTED|Overall Study||24
6566909|NCT01827930|7489953|FG001|STARTED|Overall Study||25
6656924|NCT02465567|7587296|FG000|COMPLETED|Overall Study||1708
6566910|NCT01827930|7489954|FG002|STARTED|Overall Study||19
6566911|NCT01827930|7489952|FG000|COMPLETED|Overall Study||24
6566912|NCT01827930|7489953|FG001|COMPLETED|Overall Study||25
6566913|NCT01827930|7489954|FG002|COMPLETED|Overall Study||19
6566914|NCT01827930|7489952|FG000|NOT COMPLETED|Overall Study||0
6566915|NCT01827930|7489953|FG001|NOT COMPLETED|Overall Study||0
6566916|NCT01827930|7489954|FG002|NOT COMPLETED|Overall Study||0
6566917|NCT01827943|7489962|FG000|STARTED|Overall Study||54
6566918|NCT01827943|7489962|FG000|Safety Population|Overall Study||53
6566919|NCT01827943|7489962|FG000|COMPLETED|Overall Study||45
6566920|NCT01827943|7489962|FG000|NOT COMPLETED|Overall Study||9
6566921|NCT01828034|7489970|FG000|STARTED|Overall Study||3
6274898|NCT00111800|7174253|FG005|COMPLETED|Period 1: Main Phase (12 Weeks)||56
6274899|NCT00111800|7174248|FG000|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||15
6274900|NCT00111800|7174249|FG001|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||14
6274901|NCT00111800|7174250|FG002|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||9
6274902|NCT00111800|7174251|FG003|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||6
6274903|NCT00111800|7174252|FG004|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
6274904|NCT00111800|7174253|FG005|NOT COMPLETED|Period 1: Main Phase (12 Weeks)||5
6274905|NCT00111800|7174248|FG000|STARTED|Period 2: Extension Phase (12 Weeks)||48
6274906|NCT00111800|7174249|FG001|STARTED|Period 2: Extension Phase (12 Weeks)||47
6274907|NCT00111800|7174250|FG002|STARTED|Period 2: Extension Phase (12 Weeks)||54
6274908|NCT00111800|7174251|FG003|STARTED|Period 2: Extension Phase (12 Weeks)||59
6274909|NCT00111800|7174252|FG004|STARTED|Period 2: Extension Phase (12 Weeks)||55
6274910|NCT00111800|7174253|FG005|STARTED|Period 2: Extension Phase (12 Weeks)||55
6274911|NCT00111800|7174248|FG000|COMPLETED|Period 2: Extension Phase (12 Weeks)||46
6274912|NCT00111800|7174249|FG001|COMPLETED|Period 2: Extension Phase (12 Weeks)||40
6274913|NCT00111800|7174250|FG002|COMPLETED|Period 2: Extension Phase (12 Weeks)||47
6274914|NCT00111800|7174251|FG003|COMPLETED|Period 2: Extension Phase (12 Weeks)||54
6274915|NCT00111800|7174252|FG004|COMPLETED|Period 2: Extension Phase (12 Weeks)||51
6274916|NCT00111800|7174253|FG005|COMPLETED|Period 2: Extension Phase (12 Weeks)||53
6274917|NCT00111800|7174248|FG000|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
6274918|NCT00111800|7174249|FG001|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
6274919|NCT00111800|7174250|FG002|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||7
6274920|NCT00111800|7174251|FG003|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||5
6274921|NCT00111800|7174252|FG004|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||4
6274922|NCT00111800|7174253|FG005|NOT COMPLETED|Period 2: Extension Phase (12 Weeks)||2
6274923|NCT00111813|7174276|FG000|STARTED|Overall Study||3
6274924|NCT00111813|7174277|FG001|STARTED|Overall Study||3
6274925|NCT00111813|7174278|FG002|STARTED|Overall Study||10
6274926|NCT00111813|7174279|FG003|STARTED|Overall Study||6
6274927|NCT00111813|7174280|FG004|STARTED|Overall Study||6
6274928|NCT00111813|7174281|FG005|STARTED|Overall Study||6
6274929|NCT00111813|7174276|FG000|COMPLETED|Overall Study||0
6274930|NCT00111813|7174277|FG001|COMPLETED|Overall Study||0
6274931|NCT00111813|7174278|FG002|COMPLETED|Overall Study||0
6274932|NCT00111813|7174279|FG003|COMPLETED|Overall Study||1
6274933|NCT00111813|7174280|FG004|COMPLETED|Overall Study||0
6274934|NCT00111813|7174281|FG005|COMPLETED|Overall Study||0
6274935|NCT00111813|7174276|FG000|NOT COMPLETED|Overall Study||3
6274936|NCT00111813|7174277|FG001|NOT COMPLETED|Overall Study||3
6274937|NCT00111813|7174278|FG002|NOT COMPLETED|Overall Study||10
6274938|NCT00111813|7174279|FG003|NOT COMPLETED|Overall Study||5
6274939|NCT00111813|7174280|FG004|NOT COMPLETED|Overall Study||6
6274940|NCT00111813|7174281|FG005|NOT COMPLETED|Overall Study||6
6274941|NCT00111839|7174299|FG000|STARTED|Overall Study||50
6274942|NCT00111839|7174300|FG001|STARTED|Overall Study||51
6274943|NCT00111839|7174301|FG002|STARTED|Overall Study||49
6274944|NCT00111839|7174299|FG000|Treated|Overall Study||50
6274945|NCT00111839|7174300|FG001|Treated|Overall Study||51
6274946|NCT00111839|7174301|FG002|Treated|Overall Study||47
6274947|NCT00111839|7174299|FG000|COMPLETED|Overall Study||2
6274948|NCT00111839|7174300|FG001|COMPLETED|Overall Study||5
6274949|NCT00111839|7174301|FG002|COMPLETED|Overall Study||0
6274950|NCT00111839|7174299|FG000|NOT COMPLETED|Overall Study||48
6274951|NCT00111839|7174300|FG001|NOT COMPLETED|Overall Study||46
6274952|NCT00111839|7174301|FG002|NOT COMPLETED|Overall Study||49
6274953|NCT00111917|7174311|FG000|STARTED|Overall Study||9
6274954|NCT00111917|7174312|FG001|STARTED|Overall Study||4
6274955|NCT00111917|7174311|FG000|COMPLETED|Overall Study||8
6274956|NCT00111917|7174312|FG001|COMPLETED|Overall Study||3
6274957|NCT00111917|7174311|FG000|NOT COMPLETED|Overall Study||1
6274958|NCT00111917|7174312|FG001|NOT COMPLETED|Overall Study||1
6274959|NCT00112047|7174324|FG000|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
6274960|NCT00112047|7174325|FG001|STARTED|Randomized Phase|ITT analysis population|254
6274961|NCT00112047|7174324|FG000|COMPLETED|Randomized Phase||187
6274962|NCT00112047|7174325|FG001|COMPLETED|Randomized Phase||166
6274963|NCT00112047|7174324|FG000|NOT COMPLETED|Randomized Phase||70
6274964|NCT00112047|7174325|FG001|NOT COMPLETED|Randomized Phase||88
6274965|NCT00112047|7174324|FG000|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
6274966|NCT00112047|7174325|FG001|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
6274967|NCT00112047|7174324|FG000|COMPLETED|Atripla Phase||142
6566922|NCT01828034|7489971|FG001|STARTED|Overall Study||6
6566923|NCT01828034|7489972|FG002|STARTED|Overall Study||3
6274968|NCT00112047|7174325|FG001|COMPLETED|Atripla Phase||106
6274969|NCT00112047|7174324|FG000|NOT COMPLETED|Atripla Phase||18
6274970|NCT00112047|7174325|FG001|NOT COMPLETED|Atripla Phase||20
6274971|NCT00112112|7174338|FG000|STARTED|Overall Study||10
6274972|NCT00112112|7174339|FG001|STARTED|Overall Study||10
6274973|NCT00112112|7174338|FG000|COMPLETED|Overall Study||10
6274974|NCT00112112|7174339|FG001|COMPLETED|Overall Study||10
6274975|NCT00112112|7174338|FG000|NOT COMPLETED|Overall Study||0
6274976|NCT00112112|7174339|FG001|NOT COMPLETED|Overall Study||0
6274977|NCT00112125|7174347|FG000|STARTED|Overall Study||213
6274978|NCT00112125|7174348|FG001|STARTED|Overall Study||215
6274979|NCT00112125|7174347|FG000|COMPLETED|Overall Study||189
6274980|NCT00112125|7174348|FG001|COMPLETED|Overall Study||193
6274981|NCT00112125|7174347|FG000|NOT COMPLETED|Overall Study||24
6274982|NCT00112125|7174348|FG001|NOT COMPLETED|Overall Study||22
6274983|NCT00112151|7174360|FG000|STARTED|Overall Study||28
6274984|NCT00112151|7174361|FG001|STARTED|Overall Study||28
6274985|NCT00112151|7174362|FG002|STARTED|Overall Study||28
6274986|NCT00112151|7174363|FG003|STARTED|Overall Study||27
6274987|NCT00112151|7174364|FG004|STARTED|Overall Study||28
6274988|NCT00112151|7174365|FG005|STARTED|Overall Study||28
6274989|NCT00112151|7174360|FG000|COMPLETED|Overall Study||24
6274990|NCT00112151|7174361|FG001|COMPLETED|Overall Study||23
6274991|NCT00112151|7174362|FG002|COMPLETED|Overall Study||25
6274992|NCT00112151|7174363|FG003|COMPLETED|Overall Study||24
6274993|NCT00112151|7174364|FG004|COMPLETED|Overall Study||22
6274994|NCT00112151|7174365|FG005|COMPLETED|Overall Study||25
6274995|NCT00112151|7174360|FG000|NOT COMPLETED|Overall Study||4
6274996|NCT00112151|7174361|FG001|NOT COMPLETED|Overall Study||5
6274997|NCT00112151|7174362|FG002|NOT COMPLETED|Overall Study||3
6274998|NCT00112151|7174363|FG003|NOT COMPLETED|Overall Study||3
6274999|NCT00112151|7174364|FG004|NOT COMPLETED|Overall Study||6
6389906|NCT00826748|7301567|FG000|STARTED|Overall Study||6
6389907|NCT00826748|7301568|FG001|STARTED|Overall Study||4
6389908|NCT00826748|7301569|FG002|STARTED|Overall Study||12
6566924|NCT01828034|7489973|FG003|STARTED|Overall Study||30
6566925|NCT01828034|7489970|FG000|COMPLETED|Overall Study||3
6566926|NCT01828034|7489971|FG001|COMPLETED|Overall Study||6
6389909|NCT00826748|7301567|FG000|COMPLETED|Overall Study||6
6389910|NCT00826748|7301568|FG001|COMPLETED|Overall Study||4
6389911|NCT00826748|7301569|FG002|COMPLETED|Overall Study||8
6389912|NCT00826748|7301567|FG000|NOT COMPLETED|Overall Study||0
6389913|NCT00826748|7301568|FG001|NOT COMPLETED|Overall Study||0
6389914|NCT00826748|7301569|FG002|NOT COMPLETED|Overall Study||4
6389915|NCT00826800|7301577|FG000|STARTED|Overall Study||2
6389916|NCT00826800|7301577|FG000|COMPLETED|Overall Study||2
6389917|NCT00826800|7301577|FG000|NOT COMPLETED|Overall Study||0
6389918|NCT00826943|7301581|FG000|STARTED|Overall Study||6
6389919|NCT00826943|7301582|FG001|STARTED|Overall Study||6
6389920|NCT00826943|7301583|FG002|STARTED|Overall Study||4
6389921|NCT00826943|7301584|FG003|STARTED|Overall Study||5
6389922|NCT00826943|7301585|FG004|STARTED|Overall Study||7
6389923|NCT00826943|7301586|FG005|STARTED|Overall Study||2
6389924|NCT00826943|7301581|FG000|COMPLETED|Overall Study||6
6389925|NCT00826943|7301582|FG001|COMPLETED|Overall Study||6
6389926|NCT00826943|7301583|FG002|COMPLETED|Overall Study||4
6389927|NCT00826943|7301584|FG003|COMPLETED|Overall Study||5
6389928|NCT00826943|7301585|FG004|COMPLETED|Overall Study||6
6389929|NCT00826943|7301586|FG005|COMPLETED|Overall Study||2
6389930|NCT00826943|7301581|FG000|NOT COMPLETED|Overall Study||0
6389931|NCT00826943|7301582|FG001|NOT COMPLETED|Overall Study||0
6389932|NCT00826943|7301583|FG002|NOT COMPLETED|Overall Study||0
6389933|NCT00826943|7301584|FG003|NOT COMPLETED|Overall Study||0
6389934|NCT00826943|7301585|FG004|NOT COMPLETED|Overall Study||1
6389935|NCT00826943|7301586|FG005|NOT COMPLETED|Overall Study||0
6389936|NCT00827073|7301596|FG000|STARTED|Overall Study||20
6389937|NCT00827073|7301597|FG001|STARTED|Overall Study||20
6389938|NCT00827073|7301596|FG000|COMPLETED|Overall Study||20
6389939|NCT00827073|7301597|FG001|COMPLETED|Overall Study||20
6389940|NCT00827073|7301596|FG000|NOT COMPLETED|Overall Study||0
6389941|NCT00827073|7301597|FG001|NOT COMPLETED|Overall Study||0
6389942|NCT00827099|7301603|FG000|STARTED|Overall Study||5
6389943|NCT00827099|7301603|FG000|COMPLETED|Overall Study||5
6389944|NCT00827099|7301603|FG000|NOT COMPLETED|Overall Study||0
6389945|NCT00827112|7301609|FG000|STARTED|Overall Study||65
6389946|NCT00827112|7301610|FG001|STARTED|Overall Study||64
6389947|NCT00827112|7301609|FG000|Treated|Overall Study||60
6275000|NCT00112151|7174365|FG005|NOT COMPLETED|Overall Study||3
6275001|NCT00112242|7174381|FG000|STARTED|Overall Study||10
6275002|NCT00112242|7174382|FG001|STARTED|Overall Study||5
6275003|NCT00112242|7174383|FG002|STARTED|Overall Study||5
6389948|NCT00827112|7301610|FG001|Treated|Overall Study||61
6389949|NCT00827112|7301609|FG000|COMPLETED|Overall Study||50
6389950|NCT00827112|7301610|FG001|COMPLETED|Overall Study||52
6389951|NCT00827112|7301609|FG000|NOT COMPLETED|Overall Study||15
6389952|NCT00827112|7301610|FG001|NOT COMPLETED|Overall Study||12
6389953|NCT00827242|7301618|FG000|STARTED|Overall Study||161
6566927|NCT01828034|7489972|FG002|COMPLETED|Overall Study||3
6389954|NCT00827242|7301619|FG001|STARTED|Overall Study||164
6389955|NCT00827242|7301618|FG000|COMPLETED|Overall Study||148
6389956|NCT00827242|7301619|FG001|COMPLETED|Overall Study||152
6389957|NCT00827242|7301618|FG000|NOT COMPLETED|Overall Study||13
6389958|NCT00827242|7301619|FG001|NOT COMPLETED|Overall Study||12
6389959|NCT00827255|7301625|FG000|STARTED|Overall Study||35
6389960|NCT00827255|7301625|FG000|COMPLETED|Overall Study||35
6389961|NCT00827255|7301625|FG000|NOT COMPLETED|Overall Study||0
6389962|NCT00827359|7301629|FG000|STARTED|Overall Study||25
6389963|NCT00827359|7301629|FG000|Treated|Overall Study||24
6389964|NCT00827359|7301629|FG000|COMPLETED|Overall Study||0
6389965|NCT00827359|7301629|FG000|NOT COMPLETED|Overall Study||25
6389966|NCT00827372|7301633|FG000|STARTED|Overall Study||10
6389967|NCT00827372|7301633|FG000|COMPLETED|Overall Study||2
6389968|NCT00827372|7301633|FG000|NOT COMPLETED|Overall Study||8
6389969|NCT00827502|7301638|FG000|STARTED|Overall Study||421
6389970|NCT00827502|7301638|FG000|Received Treatment (Number Treated)|Overall Study||410
6389971|NCT00827502|7301638|FG000|COMPLETED|Overall Study||400
6389972|NCT00827502|7301638|FG000|NOT COMPLETED|Overall Study||21
6389973|NCT00827541|7301644|FG000|STARTED|Overall Study||19
6389974|NCT00827541|7301645|FG001|STARTED|Overall Study||96
6389975|NCT00827541|7301644|FG000|COMPLETED|Overall Study||15
6389976|NCT00827541|7301645|FG001|COMPLETED|Overall Study||85
6389977|NCT00827541|7301644|FG000|NOT COMPLETED|Overall Study||4
6389978|NCT00827541|7301645|FG001|NOT COMPLETED|Overall Study||11
6389979|NCT00827606|7301653|FG000|STARTED|Overall Study||139
6389980|NCT00827606|7301654|FG001|STARTED|Overall Study||132
6389981|NCT00827606|7301653|FG000|COMPLETED|Overall Study||112
6389982|NCT00827606|7301654|FG001|COMPLETED|Overall Study||94
6389983|NCT00827606|7301653|FG000|NOT COMPLETED|Overall Study||27
6389984|NCT00827606|7301654|FG001|NOT COMPLETED|Overall Study||38
6389985|NCT00827632|7301668|FG000|STARTED|Overall Study||128
6389986|NCT00827632|7301669|FG001|STARTED|Overall Study||98
6389987|NCT00827632|7301668|FG000|COMPLETED|Overall Study||106
6389988|NCT00827632|7301669|FG001|COMPLETED|Overall Study||75
6389989|NCT00827632|7301668|FG000|NOT COMPLETED|Overall Study||22
6389990|NCT00827632|7301669|FG001|NOT COMPLETED|Overall Study||23
6389991|NCT00827775|7301677|FG000|STARTED|Overall Study||25
6389992|NCT00827775|7301678|FG001|STARTED|Overall Study||30
6389993|NCT00827775|7301677|FG000|COMPLETED|Overall Study||25
6389994|NCT00827775|7301678|FG001|COMPLETED|Overall Study||25
6389995|NCT00827775|7301677|FG000|NOT COMPLETED|Overall Study||0
6389996|NCT00827775|7301678|FG001|NOT COMPLETED|Overall Study||5
6389997|NCT00827827|7301686|FG000|STARTED|Overall Study||22
6389998|NCT00827827|7301687|FG001|STARTED|Overall Study||16
6389999|NCT00827827|7301686|FG000|COMPLETED|Overall Study||14
6390000|NCT00827827|7301687|FG001|COMPLETED|Overall Study||16
6390001|NCT00827827|7301686|FG000|NOT COMPLETED|Overall Study||8
6390002|NCT00827827|7301687|FG001|NOT COMPLETED|Overall Study||0
6390003|NCT00827918|7301697|FG000|STARTED|Overall Study||86
6390004|NCT00827918|7301698|FG001|STARTED|Overall Study||47
6390005|NCT00827918|7301699|FG002|STARTED|Overall Study||83
6390006|NCT00827918|7301697|FG000|COMPLETED|Overall Study||58
6390007|NCT00827918|7301698|FG001|COMPLETED|Overall Study||38
6390008|NCT00827918|7301699|FG002|COMPLETED|Overall Study||62
6390009|NCT00827918|7301697|FG000|NOT COMPLETED|Overall Study||28
6390010|NCT00827918|7301698|FG001|NOT COMPLETED|Overall Study||9
6390011|NCT00827918|7301699|FG002|NOT COMPLETED|Overall Study||21
6390012|NCT00827931|7301709|FG000|STARTED|Overall Study||49
6390013|NCT00827931|7301710|FG001|STARTED|Overall Study||45
6390014|NCT00827931|7301709|FG000|COMPLETED|Overall Study||43
6390015|NCT00827931|7301710|FG001|COMPLETED|Overall Study||39
6390016|NCT00827931|7301709|FG000|NOT COMPLETED|Overall Study||6
6390017|NCT00827931|7301710|FG001|NOT COMPLETED|Overall Study||6
6390018|NCT00827944|7301718|FG000|STARTED|Overall Study||304
6390019|NCT00827944|7301719|FG001|STARTED|Overall Study||299
6390020|NCT00827944|7301718|FG000|COMPLETED|Overall Study||241
6390021|NCT00827944|7301719|FG001|COMPLETED|Overall Study||240
6390022|NCT00827944|7301718|FG000|NOT COMPLETED|Overall Study||63
6390023|NCT00827944|7301719|FG001|NOT COMPLETED|Overall Study||59
6390024|NCT00827983|7301727|FG000|STARTED|Overall Study|All randomised patients|339
6390025|NCT00827983|7301728|FG001|STARTED|Overall Study|all randomised patients|344
6390026|NCT00827983|7301727|FG000|COMPLETED|Overall Study|patients who performed the pregnancy test|321
6390027|NCT00827983|7301728|FG001|COMPLETED|Overall Study|patients who performed the pregnancy test|328
6390028|NCT00827983|7301727|FG000|NOT COMPLETED|Overall Study||18
6390029|NCT00827983|7301728|FG001|NOT COMPLETED|Overall Study||16
6390030|NCT00828009|7301734|FG000|STARTED|Step 1 - Chemo RT/Consolidation Chemo||70
6390031|NCT00828009|7301734|FG000|Started Treatment|Step 1 - Chemo RT/Consolidation Chemo||68
6390032|NCT00828009|7301734|FG000|COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||39
6390033|NCT00828009|7301734|FG000|NOT COMPLETED|Step 1 - Chemo RT/Consolidation Chemo||31
6390034|NCT00828009|7301734|FG000|STARTED|Step 2 - Maintenance Therapy|Among 39 pts with tx completion, 4 did not register to step 2 and 2 had PD at the end of step 1.|33
6390035|NCT00828009|7301734|FG000|COMPLETED|Step 2 - Maintenance Therapy|Max maintenance therapy was 34 cycles. No patients were off treatment due to completion of 34 cycles|0
6390036|NCT00828009|7301734|FG000|NOT COMPLETED|Step 2 - Maintenance Therapy||33
6390037|NCT00828061|7301739|FG000|STARTED|Period 1||4
6390038|NCT00828061|7301740|FG001|STARTED|Period 1||3
6390039|NCT00828061|7301741|FG002|STARTED|Period 1||3
6275004|NCT00112242|7174384|FG003|STARTED|Overall Study||10
6275005|NCT00112242|7174385|FG004|STARTED|Overall Study|One patient received only 1 vaccine however this minimum dose allowed the safety evaluation|9
6275006|NCT00112242|7174381|FG000|Cycle 1 Completed|Overall Study||10
6275007|NCT00112242|7174382|FG001|Cycle 1 Completed|Overall Study||5
6275008|NCT00112242|7174383|FG002|Cycle 1 Completed|Overall Study||5
6275009|NCT00112242|7174384|FG003|Cycle 1 Completed|Overall Study||9
6275010|NCT00112242|7174385|FG004|Cycle 1 Completed|Overall Study||7
6275011|NCT00112242|7174381|FG000|Cycle 2 Completed|Overall Study||8
6275012|NCT00112242|7174382|FG001|Cycle 2 Completed|Overall Study||3
6275013|NCT00112242|7174383|FG002|Cycle 2 Completed|Overall Study||4
6275014|NCT00112242|7174384|FG003|Cycle 2 Completed|Overall Study||8
6275015|NCT00112242|7174385|FG004|Cycle 2 Completed|Overall Study||4
6275016|NCT00112242|7174381|FG000|Cycle 3 Completed|Overall Study||5
6275017|NCT00112242|7174382|FG001|Cycle 3 Completed|Overall Study||3
6275018|NCT00112242|7174383|FG002|Cycle 3 Completed|Overall Study||4
6275019|NCT00112242|7174384|FG003|Cycle 3 Completed|Overall Study||4
6275020|NCT00112242|7174385|FG004|Cycle 3 Completed|Overall Study||2
6275021|NCT00112242|7174381|FG000|COMPLETED|Overall Study||5
6275022|NCT00112242|7174382|FG001|COMPLETED|Overall Study||3
6275023|NCT00112242|7174383|FG002|COMPLETED|Overall Study||4
6275024|NCT00112242|7174384|FG003|COMPLETED|Overall Study||4
6275025|NCT00112242|7174385|FG004|COMPLETED|Overall Study||2
6275026|NCT00112242|7174381|FG000|NOT COMPLETED|Overall Study||5
6275027|NCT00112242|7174382|FG001|NOT COMPLETED|Overall Study||2
6275028|NCT00112242|7174383|FG002|NOT COMPLETED|Overall Study||1
6275029|NCT00112242|7174384|FG003|NOT COMPLETED|Overall Study||6
6275030|NCT00112242|7174385|FG004|NOT COMPLETED|Overall Study||7
6275031|NCT00112294|7174407|FG000|STARTED|Overall Study|338 randomized and 325 treated.|325
6275032|NCT00112294|7174408|FG001|STARTED|Overall Study|338 randomized and 320 treated.|320
6275033|NCT00112294|7174407|FG000|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
6275034|NCT00112294|7174408|FG001|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
6275035|NCT00112294|7174407|FG000|COMPLETED|Overall Study|Off all study therapies.|320
6275036|NCT00112294|7174408|FG001|COMPLETED|Overall Study|Off all study therapies.|320
6275037|NCT00112294|7174407|FG000|NOT COMPLETED|Overall Study||5
6275038|NCT00112294|7174408|FG001|NOT COMPLETED|Overall Study||0
6275039|NCT00112359|7174416|FG000|STARTED|Overall Study||84
6275040|NCT00112359|7174417|FG001|STARTED|Overall Study||80
6275041|NCT00112359|7174416|FG000|COMPLETED|Overall Study||57
6275042|NCT00112359|7174417|FG001|COMPLETED|Overall Study||67
6275043|NCT00112359|7174416|FG000|NOT COMPLETED|Overall Study||27
6275044|NCT00112359|7174417|FG001|NOT COMPLETED|Overall Study||13
6275045|NCT00112385|7174425|FG000|STARTED|Overall Study||11
6275046|NCT00112385|7174426|FG001|STARTED|Overall Study||5
6275047|NCT00112385|7174425|FG000|COMPLETED|Overall Study||10
6275048|NCT00112385|7174426|FG001|COMPLETED|Overall Study||4
6275049|NCT00112385|7174425|FG000|NOT COMPLETED|Overall Study||1
6275050|NCT00112385|7174426|FG001|NOT COMPLETED|Overall Study||1
6275051|NCT00112437|7174437|FG000|STARTED|Year 1 (12-Month Base Study)||83
6275052|NCT00112437|7174438|FG001|STARTED|Year 1 (12-Month Base Study)||82
6275053|NCT00112437|7174439|FG002|STARTED|Year 1 (12-Month Base Study)||77
6275054|NCT00112437|7174440|FG003|STARTED|Year 1 (12-Month Base Study)||79
6275055|NCT00112437|7174441|FG004|STARTED|Year 1 (12-Month Base Study)||78
6275056|NCT00112437|7174442|FG005|STARTED|Year 1 (12-Month Base Study)||0
6275057|NCT00112437|7174443|FG006|STARTED|Year 1 (12-Month Base Study)||0
6275058|NCT00112437|7174444|FG007|STARTED|Year 1 (12-Month Base Study)||0
6275059|NCT00112437|7174445|FG008|STARTED|Year 1 (12-Month Base Study)||0
6275060|NCT00112437|7174446|FG009|STARTED|Year 1 (12-Month Base Study)||0
6275061|NCT00112437|7174447|FG010|STARTED|Year 1 (12-Month Base Study)||0
6275062|NCT00112437|7174448|FG011|STARTED|Year 1 (12-Month Base Study)||0
6275063|NCT00112437|7174449|FG012|STARTED|Year 1 (12-Month Base Study)||0
6275064|NCT00112437|7174450|FG013|STARTED|Year 1 (12-Month Base Study)||0
6275065|NCT00112437|7174451|FG014|STARTED|Year 1 (12-Month Base Study)||0
6275066|NCT00112437|7174452|FG015|STARTED|Year 1 (12-Month Base Study)||0
6275067|NCT00112437|7174453|FG016|STARTED|Year 1 (12-Month Base Study)||0
6275068|NCT00112437|7174454|FG017|STARTED|Year 1 (12-Month Base Study)||0
6275069|NCT00112437|7174455|FG018|STARTED|Year 1 (12-Month Base Study)||0
6275070|NCT00112437|7174456|FG019|STARTED|Year 1 (12-Month Base Study)||0
6275071|NCT00112437|7174457|FG020|STARTED|Year 1 (12-Month Base Study)||0
6275072|NCT00112437|7174458|FG021|STARTED|Year 1 (12-Month Base Study)||0
6275073|NCT00112437|7174459|FG022|STARTED|Year 1 (12-Month Base Study)||0
6275074|NCT00112437|7174460|FG023|STARTED|Year 1 (12-Month Base Study)||0
6275075|NCT00112437|7174461|FG024|STARTED|Year 1 (12-Month Base Study)||0
6275076|NCT00112437|7174462|FG025|STARTED|Year 1 (12-Month Base Study)||0
6275077|NCT00112437|7174437|FG000|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|68
6275078|NCT00112437|7174438|FG001|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in completed total.|64
6275079|NCT00112437|7174439|FG002|COMPLETED|Year 1 (12-Month Base Study)||65
6275080|NCT00112437|7174440|FG003|COMPLETED|Year 1 (12-Month Base Study)||71
6390040|NCT00828061|7301742|FG003|STARTED|Period 1||3
6390041|NCT00828061|7301743|FG004|STARTED|Period 1||3
6390042|NCT00828061|7301744|FG005|STARTED|Period 1||3
6390043|NCT00828061|7301739|FG000|COMPLETED|Period 1||4
6390044|NCT00828061|7301740|FG001|COMPLETED|Period 1||3
6390045|NCT00828061|7301741|FG002|COMPLETED|Period 1||3
6390046|NCT00828061|7301742|FG003|COMPLETED|Period 1||3
6390047|NCT00828061|7301743|FG004|COMPLETED|Period 1||3
6390048|NCT00828061|7301744|FG005|COMPLETED|Period 1||3
6390049|NCT00828061|7301739|FG000|NOT COMPLETED|Period 1||0
6390050|NCT00828061|7301740|FG001|NOT COMPLETED|Period 1||0
6390051|NCT00828061|7301741|FG002|NOT COMPLETED|Period 1||0
6390052|NCT00828061|7301742|FG003|NOT COMPLETED|Period 1||0
6390053|NCT00828061|7301743|FG004|NOT COMPLETED|Period 1||0
6390054|NCT00828061|7301744|FG005|NOT COMPLETED|Period 1||0
6390055|NCT00828061|7301739|FG000|STARTED|Period 2||4
6390056|NCT00828061|7301740|FG001|STARTED|Period 2||3
6390057|NCT00828061|7301741|FG002|STARTED|Period 2||3
6390058|NCT00828061|7301742|FG003|STARTED|Period 2||3
6390059|NCT00828061|7301743|FG004|STARTED|Period 2||3
6390060|NCT00828061|7301744|FG005|STARTED|Period 2||3
6390061|NCT00828061|7301739|FG000|COMPLETED|Period 2||4
6390062|NCT00828061|7301740|FG001|COMPLETED|Period 2||3
6390063|NCT00828061|7301741|FG002|COMPLETED|Period 2||3
6390064|NCT00828061|7301742|FG003|COMPLETED|Period 2||3
6390065|NCT00828061|7301743|FG004|COMPLETED|Period 2||3
6390066|NCT00828061|7301744|FG005|COMPLETED|Period 2||3
6390067|NCT00828061|7301739|FG000|NOT COMPLETED|Period 2||0
6390068|NCT00828061|7301740|FG001|NOT COMPLETED|Period 2||0
6390069|NCT00828061|7301741|FG002|NOT COMPLETED|Period 2||0
6390070|NCT00828061|7301742|FG003|NOT COMPLETED|Period 2||0
6390071|NCT00828061|7301743|FG004|NOT COMPLETED|Period 2||0
6390072|NCT00828061|7301744|FG005|NOT COMPLETED|Period 2||0
6390073|NCT00828061|7301739|FG000|STARTED|Period 3||4
6390074|NCT00828061|7301740|FG001|STARTED|Period 3||3
6390075|NCT00828061|7301741|FG002|STARTED|Period 3||3
6390076|NCT00828061|7301742|FG003|STARTED|Period 3||3
6390077|NCT00828061|7301743|FG004|STARTED|Period 3||3
6390078|NCT00828061|7301744|FG005|STARTED|Period 3||3
6390079|NCT00828061|7301739|FG000|COMPLETED|Period 3||4
6390080|NCT00828061|7301740|FG001|COMPLETED|Period 3||3
6390081|NCT00828061|7301741|FG002|COMPLETED|Period 3||3
6390082|NCT00828061|7301742|FG003|COMPLETED|Period 3||3
6390083|NCT00828061|7301743|FG004|COMPLETED|Period 3||3
6390084|NCT00828061|7301744|FG005|COMPLETED|Period 3||3
6390085|NCT00828061|7301739|FG000|NOT COMPLETED|Period 3||0
6390086|NCT00828061|7301740|FG001|NOT COMPLETED|Period 3||0
6390087|NCT00828061|7301741|FG002|NOT COMPLETED|Period 3||0
6390088|NCT00828061|7301742|FG003|NOT COMPLETED|Period 3||0
6390089|NCT00828061|7301743|FG004|NOT COMPLETED|Period 3||0
6390090|NCT00828061|7301744|FG005|NOT COMPLETED|Period 3||0
6390091|NCT00828074|7301754|FG000|STARTED|Overall Study||6
6390092|NCT00828074|7301755|FG001|STARTED|Overall Study||5
6390093|NCT00828074|7301756|FG002|STARTED|Overall Study||35
6390094|NCT00828074|7301754|FG000|COMPLETED|Overall Study||6
6390095|NCT00828074|7301755|FG001|COMPLETED|Overall Study||5
6390096|NCT00828074|7301756|FG002|COMPLETED|Overall Study||35
6390097|NCT00828074|7301754|FG000|NOT COMPLETED|Overall Study||0
6390098|NCT00828074|7301755|FG001|NOT COMPLETED|Overall Study||0
6390099|NCT00828074|7301756|FG002|NOT COMPLETED|Overall Study||0
6390100|NCT00828113|7301768|FG000|STARTED|Overall Study||50
6390101|NCT00828113|7301769|FG001|STARTED|Overall Study||51
6390102|NCT00828113|7301768|FG000|COMPLETED|Overall Study||20
6390103|NCT00828113|7301769|FG001|COMPLETED|Overall Study||20
6390104|NCT00828113|7301768|FG000|NOT COMPLETED|Overall Study||30
6390105|NCT00828113|7301769|FG001|NOT COMPLETED|Overall Study||31
6390106|NCT00828139|7301779|FG000|STARTED|Overall Study||42
6390107|NCT00828139|7301780|FG001|STARTED|Overall Study||41
6390108|NCT00828139|7301781|FG002|STARTED|Overall Study||55
6390109|NCT00828139|7301782|FG003|STARTED|Overall Study||51
6390110|NCT00828139|7301779|FG000|COMPLETED|Overall Study||1
6390111|NCT00828139|7301780|FG001|COMPLETED|Overall Study||0
6390112|NCT00828139|7301781|FG002|COMPLETED|Overall Study||0
6390113|NCT00828139|7301782|FG003|COMPLETED|Overall Study||0
6390114|NCT00828139|7301779|FG000|NOT COMPLETED|Overall Study||41
6390115|NCT00828139|7301780|FG001|NOT COMPLETED|Overall Study||41
6390116|NCT00828139|7301781|FG002|NOT COMPLETED|Overall Study||55
6390117|NCT00828139|7301782|FG003|NOT COMPLETED|Overall Study||51
6390118|NCT00828178|7301794|FG000|STARTED|Overall Study||42
6390119|NCT00828178|7301795|FG001|STARTED|Overall Study|Eighty seven participants were randomized.|45
6390120|NCT00828178|7301794|FG000|COMPLETED|Overall Study||42
6390121|NCT00828178|7301795|FG001|COMPLETED|Overall Study|Two patients did not complete the study.|43
6390122|NCT00828178|7301794|FG000|NOT COMPLETED|Overall Study||0
6390123|NCT00828178|7301795|FG001|NOT COMPLETED|Overall Study||2
6390124|NCT00828191|7301805|FG000|STARTED|Overall Study|Randomized patients|400
6390125|NCT00828191|7301806|FG001|STARTED|Overall Study|Randomized patients|400
6390126|NCT00828191|7301805|FG000|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
6390127|NCT00828191|7301806|FG001|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
6390128|NCT00828191|7301805|FG000|NOT COMPLETED|Overall Study||8
6390129|NCT00828191|7301806|FG001|NOT COMPLETED|Overall Study||10
6390130|NCT00828204|7301814|FG000|STARTED|Main Study: Prior to Study Suspension||21
6275081|NCT00112437|7174441|FG004|COMPLETED|Year 1 (12-Month Base Study)|1 patient completed base study after December 19, 2006 and is not included in the completed total.|66
6275082|NCT00112437|7174442|FG005|COMPLETED|Year 1 (12-Month Base Study)||0
6275083|NCT00112437|7174443|FG006|COMPLETED|Year 1 (12-Month Base Study)||0
6275084|NCT00112437|7174444|FG007|COMPLETED|Year 1 (12-Month Base Study)||0
6275085|NCT00112437|7174445|FG008|COMPLETED|Year 1 (12-Month Base Study)||0
6275086|NCT00112437|7174446|FG009|COMPLETED|Year 1 (12-Month Base Study)||0
6275087|NCT00112437|7174447|FG010|COMPLETED|Year 1 (12-Month Base Study)||0
6275088|NCT00112437|7174448|FG011|COMPLETED|Year 1 (12-Month Base Study)||0
6275089|NCT00112437|7174449|FG012|COMPLETED|Year 1 (12-Month Base Study)||0
6275090|NCT00112437|7174450|FG013|COMPLETED|Year 1 (12-Month Base Study)||0
6275091|NCT00112437|7174451|FG014|COMPLETED|Year 1 (12-Month Base Study)||0
6275092|NCT00112437|7174452|FG015|COMPLETED|Year 1 (12-Month Base Study)||0
6275093|NCT00112437|7174453|FG016|COMPLETED|Year 1 (12-Month Base Study)||0
6275094|NCT00112437|7174454|FG017|COMPLETED|Year 1 (12-Month Base Study)||0
6275095|NCT00112437|7174455|FG018|COMPLETED|Year 1 (12-Month Base Study)||0
6275096|NCT00112437|7174456|FG019|COMPLETED|Year 1 (12-Month Base Study)||0
6275097|NCT00112437|7174457|FG020|COMPLETED|Year 1 (12-Month Base Study)||0
6275098|NCT00112437|7174458|FG021|COMPLETED|Year 1 (12-Month Base Study)||0
6275099|NCT00112437|7174459|FG022|COMPLETED|Year 1 (12-Month Base Study)||0
6275100|NCT00112437|7174460|FG023|COMPLETED|Year 1 (12-Month Base Study)||0
6275101|NCT00112437|7174461|FG024|COMPLETED|Year 1 (12-Month Base Study)||0
6275102|NCT00112437|7174462|FG025|COMPLETED|Year 1 (12-Month Base Study)||0
6275103|NCT00112437|7174437|FG000|NOT COMPLETED|Year 1 (12-Month Base Study)||15
6275104|NCT00112437|7174438|FG001|NOT COMPLETED|Year 1 (12-Month Base Study)||18
6275105|NCT00112437|7174439|FG002|NOT COMPLETED|Year 1 (12-Month Base Study)||12
6275106|NCT00112437|7174440|FG003|NOT COMPLETED|Year 1 (12-Month Base Study)||8
6275107|NCT00112437|7174441|FG004|NOT COMPLETED|Year 1 (12-Month Base Study)||12
6275108|NCT00112437|7174442|FG005|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275109|NCT00112437|7174443|FG006|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275110|NCT00112437|7174444|FG007|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275111|NCT00112437|7174445|FG008|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275112|NCT00112437|7174446|FG009|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275113|NCT00112437|7174447|FG010|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275114|NCT00112437|7174448|FG011|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275115|NCT00112437|7174449|FG012|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275116|NCT00112437|7174450|FG013|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275117|NCT00112437|7174451|FG014|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275118|NCT00112437|7174452|FG015|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275119|NCT00112437|7174453|FG016|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275120|NCT00112437|7174454|FG017|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275121|NCT00112437|7174455|FG018|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275122|NCT00112437|7174456|FG019|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275123|NCT00112437|7174457|FG020|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275124|NCT00112437|7174458|FG021|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275125|NCT00112437|7174459|FG022|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275126|NCT00112437|7174460|FG023|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275127|NCT00112437|7174461|FG024|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275128|NCT00112437|7174462|FG025|NOT COMPLETED|Year 1 (12-Month Base Study)||0
6275129|NCT00112437|7174437|FG000|STARTED|Year 2 (12-Month Extension)||0
6275130|NCT00112437|7174438|FG001|STARTED|Year 2 (12-Month Extension)||0
6275131|NCT00112437|7174439|FG002|STARTED|Year 2 (12-Month Extension)||0
6275132|NCT00112437|7174440|FG003|STARTED|Year 2 (12-Month Extension)||0
6275133|NCT00112437|7174441|FG004|STARTED|Year 2 (12-Month Extension)||0
6275134|NCT00112437|7174442|FG005|STARTED|Year 2 (12-Month Extension)||63
6275135|NCT00112437|7174443|FG006|STARTED|Year 2 (12-Month Extension)||62
6275136|NCT00112437|7174444|FG007|STARTED|Year 2 (12-Month Extension)||63
6275137|NCT00112437|7174445|FG008|STARTED|Year 2 (12-Month Extension)||69
6275138|NCT00112437|7174446|FG009|STARTED|Year 2 (12-Month Extension)||63
6566928|NCT01828034|7489973|FG003|COMPLETED|Overall Study||29
6566929|NCT01828034|7489970|FG000|NOT COMPLETED|Overall Study||0
6566930|NCT01828034|7489971|FG001|NOT COMPLETED|Overall Study||0
6806602|NCT01258803|7738783|FG002|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6806603|NCT01258803|7738784|FG003|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6806604|NCT01258803|7738785|FG004|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6806605|NCT01258803|7738786|FG005|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
6806606|NCT01104922|7738800|FG000|STARTED|Overall Study||48
6806607|NCT01104922|7738800|FG000|COMPLETED|Overall Study||48
6806608|NCT01104922|7738800|FG000|NOT COMPLETED|Overall Study||0
6806609|NCT00862251|7738807|FG000|STARTED|Overall Study||322
6806610|NCT00862251|7738808|FG001|STARTED|Overall Study||162
6806611|NCT00862251|7738809|FG002|STARTED|Overall Study||324
6806612|NCT00862251|7738807|FG000|COMPLETED|Overall Study||303
6806613|NCT00862251|7738808|FG001|COMPLETED|Overall Study||157
6806614|NCT00862251|7738809|FG002|COMPLETED|Overall Study||315
6806615|NCT00862251|7738807|FG000|NOT COMPLETED|Overall Study||19
6566931|NCT01828034|7489972|FG002|NOT COMPLETED|Overall Study||0
6566932|NCT01828034|7489973|FG003|NOT COMPLETED|Overall Study||1
6566933|NCT01828073|7489982|FG000|STARTED|Overall Study||22
6566934|NCT01828073|7489983|FG001|STARTED|Overall Study||18
6566935|NCT01828073|7489982|FG000|COMPLETED|Overall Study||21
6566936|NCT01828073|7489983|FG001|COMPLETED|Overall Study||16
6566937|NCT01828073|7489982|FG000|NOT COMPLETED|Overall Study||1
6566938|NCT01828073|7489983|FG001|NOT COMPLETED|Overall Study||2
6275139|NCT00112437|7174447|FG010|STARTED|Year 2 (12-Month Extension)||0
6275140|NCT00112437|7174448|FG011|STARTED|Year 2 (12-Month Extension)||0
6275141|NCT00112437|7174449|FG012|STARTED|Year 2 (12-Month Extension)||0
6275142|NCT00112437|7174450|FG013|STARTED|Year 2 (12-Month Extension)||0
6275143|NCT00112437|7174451|FG014|STARTED|Year 2 (12-Month Extension)||0
6275144|NCT00112437|7174452|FG015|STARTED|Year 2 (12-Month Extension)||0
6275145|NCT00112437|7174453|FG016|STARTED|Year 2 (12-Month Extension)||0
6275146|NCT00112437|7174454|FG017|STARTED|Year 2 (12-Month Extension)||0
6275147|NCT00112437|7174455|FG018|STARTED|Year 2 (12-Month Extension)||0
6275148|NCT00112437|7174456|FG019|STARTED|Year 2 (12-Month Extension)||0
6275149|NCT00112437|7174457|FG020|STARTED|Year 2 (12-Month Extension)||0
6275150|NCT00112437|7174458|FG021|STARTED|Year 2 (12-Month Extension)||0
6275151|NCT00112437|7174459|FG022|STARTED|Year 2 (12-Month Extension)||0
6275152|NCT00112437|7174460|FG023|STARTED|Year 2 (12-Month Extension)||0
6275153|NCT00112437|7174461|FG024|STARTED|Year 2 (12-Month Extension)||0
6275154|NCT00112437|7174462|FG025|STARTED|Year 2 (12-Month Extension)||0
6275155|NCT00112437|7174437|FG000|COMPLETED|Year 2 (12-Month Extension)||0
6275156|NCT00112437|7174438|FG001|COMPLETED|Year 2 (12-Month Extension)||0
6275157|NCT00112437|7174439|FG002|COMPLETED|Year 2 (12-Month Extension)||0
6504559|NCT01449370|7423594|FG001|STARTED|Overall Study||6
6275158|NCT00112437|7174440|FG003|COMPLETED|Year 2 (12-Month Extension)||0
6275159|NCT00112437|7174441|FG004|COMPLETED|Year 2 (12-Month Extension)||0
6275160|NCT00112437|7174442|FG005|COMPLETED|Year 2 (12-Month Extension)||60
6566939|NCT01828164|7489995|FG000|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
6566940|NCT01828164|7489995|FG000|COMPLETED|Overall Study||32
6806616|NCT00862251|7738808|FG001|NOT COMPLETED|Overall Study||5
6806617|NCT00862251|7738809|FG002|NOT COMPLETED|Overall Study||9
6806618|NCT00783263|7738824|FG000|STARTED|Overall Study||99
6806619|NCT00783263|7738825|FG001|STARTED|Overall Study||98
6806620|NCT00783263|7738826|FG002|STARTED|Overall Study||122
6806621|NCT00783263|7738827|FG003|STARTED|Overall Study||121
6806622|NCT00783263|7738824|FG000|COMPLETED|Overall Study||95
6806623|NCT00783263|7738825|FG001|COMPLETED|Overall Study||96
6806624|NCT00783263|7738826|FG002|COMPLETED|Overall Study||119
6806625|NCT00783263|7738827|FG003|COMPLETED|Overall Study||118
6806626|NCT00783263|7738824|FG000|NOT COMPLETED|Overall Study||4
6806627|NCT00783263|7738825|FG001|NOT COMPLETED|Overall Study||2
6806628|NCT00783263|7738826|FG002|NOT COMPLETED|Overall Study||3
6806629|NCT00783263|7738827|FG003|NOT COMPLETED|Overall Study||3
6275161|NCT00112437|7174443|FG006|COMPLETED|Year 2 (12-Month Extension)||53
6275162|NCT00112437|7174444|FG007|COMPLETED|Year 2 (12-Month Extension)||55
6275163|NCT00112437|7174445|FG008|COMPLETED|Year 2 (12-Month Extension)||62
6275164|NCT00112437|7174446|FG009|COMPLETED|Year 2 (12-Month Extension)||50
6275165|NCT00112437|7174447|FG010|COMPLETED|Year 2 (12-Month Extension)||0
6275166|NCT00112437|7174448|FG011|COMPLETED|Year 2 (12-Month Extension)||0
6275167|NCT00112437|7174449|FG012|COMPLETED|Year 2 (12-Month Extension)||0
6275168|NCT00112437|7174450|FG013|COMPLETED|Year 2 (12-Month Extension)||0
6275169|NCT00112437|7174451|FG014|COMPLETED|Year 2 (12-Month Extension)||0
6275170|NCT00112437|7174452|FG015|COMPLETED|Year 2 (12-Month Extension)||0
6275171|NCT00112437|7174453|FG016|COMPLETED|Year 2 (12-Month Extension)||0
6275172|NCT00112437|7174454|FG017|COMPLETED|Year 2 (12-Month Extension)||0
6275173|NCT00112437|7174455|FG018|COMPLETED|Year 2 (12-Month Extension)||0
6275174|NCT00112437|7174456|FG019|COMPLETED|Year 2 (12-Month Extension)||0
6275175|NCT00112437|7174457|FG020|COMPLETED|Year 2 (12-Month Extension)||0
6275176|NCT00112437|7174458|FG021|COMPLETED|Year 2 (12-Month Extension)||0
6275177|NCT00112437|7174459|FG022|COMPLETED|Year 2 (12-Month Extension)||0
6275178|NCT00112437|7174460|FG023|COMPLETED|Year 2 (12-Month Extension)||0
6275179|NCT00112437|7174461|FG024|COMPLETED|Year 2 (12-Month Extension)||0
6275180|NCT00112437|7174462|FG025|COMPLETED|Year 2 (12-Month Extension)||0
6275181|NCT00112437|7174437|FG000|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275182|NCT00112437|7174438|FG001|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275183|NCT00112437|7174439|FG002|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275184|NCT00112437|7174440|FG003|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275185|NCT00112437|7174441|FG004|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275186|NCT00112437|7174442|FG005|NOT COMPLETED|Year 2 (12-Month Extension)||3
6275187|NCT00112437|7174443|FG006|NOT COMPLETED|Year 2 (12-Month Extension)||9
6275188|NCT00112437|7174444|FG007|NOT COMPLETED|Year 2 (12-Month Extension)||8
6275189|NCT00112437|7174445|FG008|NOT COMPLETED|Year 2 (12-Month Extension)||7
6275190|NCT00112437|7174446|FG009|NOT COMPLETED|Year 2 (12-Month Extension)||13
6275191|NCT00112437|7174447|FG010|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275192|NCT00112437|7174448|FG011|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275193|NCT00112437|7174449|FG012|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275194|NCT00112437|7174450|FG013|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275195|NCT00112437|7174451|FG014|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275196|NCT00112437|7174452|FG015|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275197|NCT00112437|7174453|FG016|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275198|NCT00112437|7174454|FG017|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275199|NCT00112437|7174455|FG018|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275200|NCT00112437|7174456|FG019|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275201|NCT00112437|7174457|FG020|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275202|NCT00112437|7174458|FG021|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275203|NCT00112437|7174459|FG022|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275204|NCT00112437|7174460|FG023|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275205|NCT00112437|7174461|FG024|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275206|NCT00112437|7174462|FG025|NOT COMPLETED|Year 2 (12-Month Extension)||0
6275207|NCT00112437|7174437|FG000|STARTED|Year 3 (12-Month Extension)||0
6275208|NCT00112437|7174438|FG001|STARTED|Year 3 (12-Month Extension)||0
6275209|NCT00112437|7174439|FG002|STARTED|Year 3 (12-Month Extension)||0
6275210|NCT00112437|7174440|FG003|STARTED|Year 3 (12-Month Extension)||0
6275211|NCT00112437|7174441|FG004|STARTED|Year 3 (12-Month Extension)||0
6275212|NCT00112437|7174442|FG005|STARTED|Year 3 (12-Month Extension)||0
6275213|NCT00112437|7174443|FG006|STARTED|Year 3 (12-Month Extension)||0
6275214|NCT00112437|7174444|FG007|STARTED|Year 3 (12-Month Extension)||0
6275215|NCT00112437|7174445|FG008|STARTED|Year 3 (12-Month Extension)||0
6275216|NCT00112437|7174446|FG009|STARTED|Year 3 (12-Month Extension)||0
6275217|NCT00112437|7174447|FG010|STARTED|Year 3 (12-Month Extension)||19
6275218|NCT00112437|7174448|FG011|STARTED|Year 3 (12-Month Extension)||22
6275219|NCT00112437|7174449|FG012|STARTED|Year 3 (12-Month Extension)||18
6275220|NCT00112437|7174450|FG013|STARTED|Year 3 (12-Month Extension)||17
6275221|NCT00112437|7174451|FG014|STARTED|Year 3 (12-Month Extension)||18
6275222|NCT00112437|7174452|FG015|STARTED|Year 3 (12-Month Extension)||17
6275223|NCT00112437|7174453|FG016|STARTED|Year 3 (12-Month Extension)||19
6275224|NCT00112437|7174454|FG017|STARTED|Year 3 (12-Month Extension)||21
6275225|NCT00112437|7174455|FG018|STARTED|Year 3 (12-Month Extension)||18
6275226|NCT00112437|7174456|FG019|STARTED|Year 3 (12-Month Extension)||20
6275227|NCT00112437|7174457|FG020|STARTED|Year 3 (12-Month Extension)||0
6275228|NCT00112437|7174458|FG021|STARTED|Year 3 (12-Month Extension)||0
6275229|NCT00112437|7174459|FG022|STARTED|Year 3 (12-Month Extension)||0
6275230|NCT00112437|7174460|FG023|STARTED|Year 3 (12-Month Extension)||0
6275231|NCT00112437|7174461|FG024|STARTED|Year 3 (12-Month Extension)||0
6275232|NCT00112437|7174462|FG025|STARTED|Year 3 (12-Month Extension)||0
6275233|NCT00112437|7174437|FG000|COMPLETED|Year 3 (12-Month Extension)||0
6275234|NCT00112437|7174438|FG001|COMPLETED|Year 3 (12-Month Extension)||0
6275235|NCT00112437|7174439|FG002|COMPLETED|Year 3 (12-Month Extension)||0
6390131|NCT00828204|7301815|FG001|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
6390132|NCT00828204|7301814|FG000|Completed Manual Injection|Main Study: Prior to Study Suspension||21
6390133|NCT00828204|7301815|FG001|Completed Manual Injection|Main Study: Prior to Study Suspension||0
6390134|NCT00828204|7301814|FG000|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
6390135|NCT00828204|7301815|FG001|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
6390136|NCT00828204|7301814|FG000|COMPLETED|Main Study: Prior to Study Suspension||7
6390137|NCT00828204|7301815|FG001|COMPLETED|Main Study: Prior to Study Suspension||0
6390138|NCT00828204|7301814|FG000|NOT COMPLETED|Main Study: Prior to Study Suspension||14
6390139|NCT00828204|7301815|FG001|NOT COMPLETED|Main Study: Prior to Study Suspension||0
6390140|NCT00828204|7301814|FG000|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
6390141|NCT00828204|7301815|FG001|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
6390142|NCT00828204|7301814|FG000|Completed Manual Injection|Main Study: After Study Restart||0
6390143|NCT00828204|7301815|FG001|Completed Manual Injection|Main Study: After Study Restart||74
6390144|NCT00828204|7301814|FG000|Continued With Autoinjector Injections|Main Study: After Study Restart||0
6390145|NCT00828204|7301815|FG001|Continued With Autoinjector Injections|Main Study: After Study Restart||72
6390146|NCT00828204|7301814|FG000|COMPLETED|Main Study: After Study Restart||0
6390147|NCT00828204|7301815|FG001|COMPLETED|Main Study: After Study Restart||71
6390148|NCT00828204|7301814|FG000|NOT COMPLETED|Main Study: After Study Restart||0
6390149|NCT00828204|7301815|FG001|NOT COMPLETED|Main Study: After Study Restart||3
6390150|NCT00828204|7301814|FG000|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
6390151|NCT00828204|7301815|FG001|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
6390152|NCT00828204|7301814|FG000|COMPLETED|Extension Study||0
6390153|NCT00828204|7301815|FG001|COMPLETED|Extension Study||61
6390154|NCT00828204|7301814|FG000|NOT COMPLETED|Extension Study||0
6390155|NCT00828204|7301815|FG001|NOT COMPLETED|Extension Study||3
6390156|NCT00828295|7301824|FG000|STARTED|Overall Study||75
6390157|NCT00828295|7301825|FG001|STARTED|Overall Study||75
6390158|NCT00828295|7301824|FG000|COMPLETED|Overall Study||75
6390159|NCT00828295|7301825|FG001|COMPLETED|Overall Study||75
6390160|NCT00828295|7301824|FG000|NOT COMPLETED|Overall Study||0
6390161|NCT00828295|7301825|FG001|NOT COMPLETED|Overall Study||0
6390162|NCT00828347|7301833|FG000|STARTED|Overall Study||12
6390163|NCT00828347|7301834|FG001|STARTED|Overall Study||11
6390164|NCT00828347|7301833|FG000|COMPLETED|Overall Study||12
6390165|NCT00828347|7301834|FG001|COMPLETED|Overall Study||11
6390166|NCT00828347|7301833|FG000|NOT COMPLETED|Overall Study||0
6390167|NCT00828347|7301834|FG001|NOT COMPLETED|Overall Study||0
6390168|NCT00828412|7301842|FG000|STARTED|Overall Study||50
6390169|NCT00828412|7301843|FG001|STARTED|Overall Study||50
6390170|NCT00828412|7301842|FG000|COMPLETED|Overall Study||41
6390171|NCT00828412|7301843|FG001|COMPLETED|Overall Study||48
6390172|NCT00828412|7301842|FG000|NOT COMPLETED|Overall Study||9
6390173|NCT00828412|7301843|FG001|NOT COMPLETED|Overall Study||2
6390174|NCT00828451|7301849|FG000|STARTED|Overall Study||29
6390175|NCT00828451|7301849|FG000|COMPLETED|Overall Study||18
6390176|NCT00828451|7301849|FG000|NOT COMPLETED|Overall Study||11
6390177|NCT00828464|7301853|FG000|STARTED|Overall Study||30
6390178|NCT00828464|7301853|FG000|COMPLETED|Overall Study||29
6390179|NCT00828464|7301853|FG000|NOT COMPLETED|Overall Study||1
6390180|NCT00828516|7301857|FG000|STARTED|Clinical Phase: Series 1||35
6390181|NCT00828516|7301857|FG000|COMPLETED|Clinical Phase: Series 1||33
6390182|NCT00828516|7301857|FG000|NOT COMPLETED|Clinical Phase: Series 1||2
6390183|NCT00828516|7301857|FG000|STARTED|Clinical Phase: Series 2||30
6390184|NCT00828516|7301857|FG000|COMPLETED|Clinical Phase: Series 2||30
6390185|NCT00828516|7301857|FG000|NOT COMPLETED|Clinical Phase: Series 2||0
6390186|NCT00828542|7301863|FG000|STARTED|Overall Study||23
6390187|NCT00828542|7301864|FG001|STARTED|Overall Study||23
6390188|NCT00828542|7301863|FG000|COMPLETED|Overall Study||20
6390189|NCT00828542|7301864|FG001|COMPLETED|Overall Study||20
6390190|NCT00828542|7301863|FG000|NOT COMPLETED|Overall Study||3
6390191|NCT00828542|7301864|FG001|NOT COMPLETED|Overall Study||3
6390192|NCT00828568|7301873|FG000|STARTED|Randomized||184
6390193|NCT00828568|7301874|FG001|STARTED|Randomized||179
6390194|NCT00828568|7301875|FG002|STARTED|Randomized||62
6390195|NCT00828568|7301873|FG000|COMPLETED|Randomized||183
6806630|NCT00782184|7738852|FG000|STARTED|Overall Study||120
6806631|NCT00782184|7738853|FG001|STARTED|Overall Study||130
6806632|NCT00782184|7738852|FG000|COMPLETED|Overall Study||116
6806633|NCT00782184|7738853|FG001|COMPLETED|Overall Study||125
6806634|NCT00782184|7738852|FG000|NOT COMPLETED|Overall Study||4
6806635|NCT00782184|7738853|FG001|NOT COMPLETED|Overall Study||5
6806636|NCT00635882|7738866|FG000|STARTED|Overall Study||20
6806637|NCT00635882|7738867|FG001|STARTED|Overall Study||17
6806638|NCT00635882|7738868|FG002|STARTED|Overall Study||12
6806639|NCT00635882|7738869|FG003|STARTED|Overall Study||15
6806640|NCT00635882|7738870|FG004|STARTED|Overall Study||16
6806641|NCT00635882|7738871|FG005|STARTED|Overall Study||13
6390196|NCT00828568|7301874|FG001|COMPLETED|Randomized||179
6390197|NCT00828568|7301875|FG002|COMPLETED|Randomized||60
6390198|NCT00828568|7301873|FG000|NOT COMPLETED|Randomized||1
6390199|NCT00828568|7301874|FG001|NOT COMPLETED|Randomized||0
6390200|NCT00828568|7301875|FG002|NOT COMPLETED|Randomized||2
6390201|NCT00828568|7301873|FG000|STARTED|Treated - Received at Least One Dose||183
6275236|NCT00112437|7174440|FG003|COMPLETED|Year 3 (12-Month Extension)||0
6275237|NCT00112437|7174441|FG004|COMPLETED|Year 3 (12-Month Extension)||0
6275238|NCT00112437|7174442|FG005|COMPLETED|Year 3 (12-Month Extension)||0
6275239|NCT00112437|7174443|FG006|COMPLETED|Year 3 (12-Month Extension)||0
6275240|NCT00112437|7174444|FG007|COMPLETED|Year 3 (12-Month Extension)||0
6275241|NCT00112437|7174445|FG008|COMPLETED|Year 3 (12-Month Extension)||0
6275242|NCT00112437|7174446|FG009|COMPLETED|Year 3 (12-Month Extension)||0
6275243|NCT00112437|7174447|FG010|COMPLETED|Year 3 (12-Month Extension)||17
6275244|NCT00112437|7174448|FG011|COMPLETED|Year 3 (12-Month Extension)||17
6504560|NCT01449370|7423595|FG002|STARTED|Overall Study||8
6275245|NCT00112437|7174449|FG012|COMPLETED|Year 3 (12-Month Extension)||18
6275246|NCT00112437|7174450|FG013|COMPLETED|Year 3 (12-Month Extension)||16
6566941|NCT01828164|7489995|FG000|NOT COMPLETED|Overall Study||17
6566942|NCT01828216|7490005|FG000|STARTED|Overall Study||159
6566943|NCT01828216|7490006|FG001|STARTED|Overall Study||157
6566944|NCT01828216|7490005|FG000|COMPLETED|Overall Study||159
6566945|NCT01828216|7490006|FG001|COMPLETED|Overall Study||157
6806642|NCT00635882|7738866|FG000|COMPLETED|Overall Study||19
6806643|NCT00635882|7738867|FG001|COMPLETED|Overall Study||17
6806644|NCT00635882|7738868|FG002|COMPLETED|Overall Study||12
6806645|NCT00635882|7738869|FG003|COMPLETED|Overall Study||15
6806646|NCT00635882|7738870|FG004|COMPLETED|Overall Study||16
6806647|NCT00635882|7738871|FG005|COMPLETED|Overall Study||13
6806648|NCT00635882|7738866|FG000|NOT COMPLETED|Overall Study||1
6806649|NCT00635882|7738867|FG001|NOT COMPLETED|Overall Study||0
6806650|NCT00635882|7738868|FG002|NOT COMPLETED|Overall Study||0
6806651|NCT00635882|7738869|FG003|NOT COMPLETED|Overall Study||0
6806652|NCT00635882|7738870|FG004|NOT COMPLETED|Overall Study||0
6806653|NCT00635882|7738871|FG005|NOT COMPLETED|Overall Study||0
6806654|NCT00594620|7738887|FG000|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
6566946|NCT01828216|7490005|FG000|NOT COMPLETED|Overall Study||0
6566947|NCT01828216|7490006|FG001|NOT COMPLETED|Overall Study||0
6566948|NCT01828255|7490016|FG000|STARTED|Overall Study||20
6566949|NCT01828255|7490017|FG001|STARTED|Overall Study||20
6806655|NCT00594620|7738888|FG001|STARTED|Overall Study|Study was terminated early due to low accrual. Study was blinded and no data was collected|0
6806656|NCT00594620|7738887|FG000|COMPLETED|Overall Study||0
6806657|NCT00594620|7738888|FG001|COMPLETED|Overall Study||0
6566950|NCT01828255|7490016|FG000|COMPLETED|Overall Study||20
6566951|NCT01828255|7490017|FG001|COMPLETED|Overall Study||20
6566952|NCT01828255|7490016|FG000|NOT COMPLETED|Overall Study||0
6566953|NCT01828255|7490017|FG001|NOT COMPLETED|Overall Study||0
6566954|NCT01828281|7490027|FG000|STARTED|Overall Study||45
6566955|NCT01828281|7490028|FG001|STARTED|Overall Study||45
6566956|NCT01828281|7490027|FG000|COMPLETED|Overall Study||44
6275247|NCT00112437|7174451|FG014|COMPLETED|Year 3 (12-Month Extension)||17
6390202|NCT00828568|7301874|FG001|STARTED|Treated - Received at Least One Dose||179
6390203|NCT00828568|7301875|FG002|STARTED|Treated - Received at Least One Dose||60
6390204|NCT00828568|7301873|FG000|COMPLETED|Treated - Received at Least One Dose||153
6390205|NCT00828568|7301874|FG001|COMPLETED|Treated - Received at Least One Dose||150
6390206|NCT00828568|7301875|FG002|COMPLETED|Treated - Received at Least One Dose||55
6390207|NCT00828568|7301873|FG000|NOT COMPLETED|Treated - Received at Least One Dose||30
6390208|NCT00828568|7301874|FG001|NOT COMPLETED|Treated - Received at Least One Dose||29
6390209|NCT00828568|7301875|FG002|NOT COMPLETED|Treated - Received at Least One Dose||5
6390210|NCT00828672|7301886|FG000|STARTED|Pre-treatment (Baseline)||43
6390211|NCT00828672|7301887|FG001|STARTED|Pre-treatment (Baseline)||41
6390212|NCT00828672|7301886|FG000|COMPLETED|Pre-treatment (Baseline)||43
6390213|NCT00828672|7301887|FG001|COMPLETED|Pre-treatment (Baseline)||41
6390214|NCT00828672|7301886|FG000|NOT COMPLETED|Pre-treatment (Baseline)||0
6390215|NCT00828672|7301887|FG001|NOT COMPLETED|Pre-treatment (Baseline)||0
6390216|NCT00828672|7301886|FG000|STARTED|Study Treatment||43
6390217|NCT00828672|7301887|FG001|STARTED|Study Treatment||41
6390218|NCT00828672|7301886|FG000|COMPLETED|Study Treatment||41
6390219|NCT00828672|7301887|FG001|COMPLETED|Study Treatment||39
6390220|NCT00828672|7301886|FG000|NOT COMPLETED|Study Treatment||2
6390221|NCT00828672|7301887|FG001|NOT COMPLETED|Study Treatment||2
6390222|NCT00828672|7301886|FG000|STARTED|Post-surgery (<30 Days)||41
6390223|NCT00828672|7301887|FG001|STARTED|Post-surgery (<30 Days)||39
6390224|NCT00828672|7301886|FG000|COMPLETED|Post-surgery (<30 Days)||41
6390225|NCT00828672|7301887|FG001|COMPLETED|Post-surgery (<30 Days)||38
6390226|NCT00828672|7301886|FG000|NOT COMPLETED|Post-surgery (<30 Days)||0
6390227|NCT00828672|7301887|FG001|NOT COMPLETED|Post-surgery (<30 Days)||1
6390228|NCT00828672|7301886|FG000|STARTED|Follow-up|Patient in Arm 1 with clinical complete response and no surgery is in follow up (joined this period)|42
6390229|NCT00828672|7301887|FG001|STARTED|Follow-up|Patients with no central review material and with adverse event are in followup (joined this period)|41
6390230|NCT00828672|7301886|FG000|COMPLETED|Follow-up||42
6390231|NCT00828672|7301887|FG001|COMPLETED|Follow-up||41
6390232|NCT00828672|7301886|FG000|NOT COMPLETED|Follow-up||0
6390233|NCT00828672|7301887|FG001|NOT COMPLETED|Follow-up||0
6390234|NCT00828711|7301896|FG000|STARTED|Overall Study||118
6390235|NCT00828711|7301897|FG001|STARTED|Overall Study||125
6390236|NCT00828711|7301898|FG002|STARTED|Overall Study||131
6390237|NCT00828711|7301896|FG000|COMPLETED|Overall Study||117
6390238|NCT00828711|7301897|FG001|COMPLETED|Overall Study||125
6390239|NCT00828711|7301898|FG002|COMPLETED|Overall Study||131
6390240|NCT00828711|7301896|FG000|NOT COMPLETED|Overall Study||1
6390241|NCT00828711|7301897|FG001|NOT COMPLETED|Overall Study||0
6390242|NCT00828711|7301898|FG002|NOT COMPLETED|Overall Study||0
6390243|NCT00828750|7301906|FG000|STARTED|Overall Study||19
6390244|NCT00828750|7301906|FG000|COMPLETED|Overall Study||15
6390245|NCT00828750|7301906|FG000|NOT COMPLETED|Overall Study||4
6390246|NCT00828841|7301914|FG000|STARTED|Overall Study||235
6390247|NCT00828841|7301915|FG001|STARTED|Overall Study||236
6390248|NCT00828841|7301916|FG002|STARTED|Overall Study||130
6390249|NCT00828841|7301914|FG000|COMPLETED|Overall Study||231
6390250|NCT00828841|7301915|FG001|COMPLETED|Overall Study||232
6566957|NCT01828281|7490028|FG001|COMPLETED|Overall Study||45
6275248|NCT00112437|7174452|FG015|COMPLETED|Year 3 (12-Month Extension)||13
6275249|NCT00112437|7174453|FG016|COMPLETED|Year 3 (12-Month Extension)||16
6275250|NCT00112437|7174454|FG017|COMPLETED|Year 3 (12-Month Extension)||20
6275251|NCT00112437|7174455|FG018|COMPLETED|Year 3 (12-Month Extension)||16
6275252|NCT00112437|7174456|FG019|COMPLETED|Year 3 (12-Month Extension)||19
6275253|NCT00112437|7174457|FG020|COMPLETED|Year 3 (12-Month Extension)||0
6275254|NCT00112437|7174458|FG021|COMPLETED|Year 3 (12-Month Extension)||0
6275255|NCT00112437|7174459|FG022|COMPLETED|Year 3 (12-Month Extension)||0
6275256|NCT00112437|7174460|FG023|COMPLETED|Year 3 (12-Month Extension)||0
6275257|NCT00112437|7174461|FG024|COMPLETED|Year 3 (12-Month Extension)||0
6275258|NCT00112437|7174462|FG025|COMPLETED|Year 3 (12-Month Extension)||0
6275259|NCT00112437|7174437|FG000|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275260|NCT00112437|7174438|FG001|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275261|NCT00112437|7174439|FG002|NOT COMPLETED|Year 3 (12-Month Extension)||0
6390251|NCT00828841|7301916|FG002|COMPLETED|Overall Study||126
6390252|NCT00828841|7301914|FG000|NOT COMPLETED|Overall Study||4
6390253|NCT00828841|7301915|FG001|NOT COMPLETED|Overall Study||4
6390254|NCT00828841|7301916|FG002|NOT COMPLETED|Overall Study||4
6390255|NCT00828945|7301926|FG000|STARTED|Overall Study||257
6390256|NCT00828945|7301926|FG000|COMPLETED|Overall Study||216
6390257|NCT00828945|7301926|FG000|NOT COMPLETED|Overall Study||41
6390258|NCT00828984|7301933|FG000|STARTED|Overall Study||28
6566958|NCT01828281|7490027|FG000|NOT COMPLETED|Overall Study||1
6566959|NCT01828281|7490028|FG001|NOT COMPLETED|Overall Study||0
6566960|NCT01828476|7490037|FG000|STARTED|Overall Study||13
6275262|NCT00112437|7174440|FG003|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275263|NCT00112437|7174441|FG004|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275264|NCT00112437|7174442|FG005|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275265|NCT00112437|7174443|FG006|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275266|NCT00112437|7174444|FG007|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275267|NCT00112437|7174445|FG008|NOT COMPLETED|Year 3 (12-Month Extension)||0
6390259|NCT00828984|7301934|FG001|STARTED|Overall Study||31
6275268|NCT00112437|7174446|FG009|NOT COMPLETED|Year 3 (12-Month Extension)||0
6390260|NCT00828984|7301935|FG002|STARTED|Overall Study||28
6390261|NCT00828984|7301933|FG000|Randomization|Overall Study||28
6390262|NCT00828984|7301934|FG001|Randomization|Overall Study||31
6390263|NCT00828984|7301935|FG002|Randomization|Overall Study||28
6390264|NCT00828984|7301933|FG000|Treatment|Overall Study||24
6390265|NCT00828984|7301934|FG001|Treatment|Overall Study||26
6390266|NCT00828984|7301935|FG002|Treatment|Overall Study||24
6390267|NCT00828984|7301933|FG000|Flexible Sigmoidoscopy|Overall Study||20
6390268|NCT00828984|7301934|FG001|Flexible Sigmoidoscopy|Overall Study||19
6390269|NCT00828984|7301935|FG002|Flexible Sigmoidoscopy|Overall Study||19
6390270|NCT00828984|7301933|FG000|Post Intervention Follow-Up|Overall Study||15
6390271|NCT00828984|7301934|FG001|Post Intervention Follow-Up|Overall Study||16
6390272|NCT00828984|7301935|FG002|Post Intervention Follow-Up|Overall Study||19
6390273|NCT00828984|7301933|FG000|COMPLETED|Overall Study||14
6390274|NCT00828984|7301934|FG001|COMPLETED|Overall Study||15
6390275|NCT00828984|7301935|FG002|COMPLETED|Overall Study||19
6390276|NCT00828984|7301933|FG000|NOT COMPLETED|Overall Study||14
6390277|NCT00828984|7301934|FG001|NOT COMPLETED|Overall Study||16
6390278|NCT00828984|7301935|FG002|NOT COMPLETED|Overall Study||9
6390279|NCT00829010|7301948|FG000|STARTED|Overall Study||83
6390280|NCT00829010|7301949|FG001|STARTED|Overall Study||101
6390281|NCT00829010|7301950|FG002|STARTED|Overall Study||100
6390282|NCT00829010|7301951|FG003|STARTED|Overall Study||100
6390283|NCT00829010|7301952|FG004|STARTED|Overall Study||100
6390284|NCT00829010|7301948|FG000|COMPLETED|Overall Study||73
6390285|NCT00829010|7301949|FG001|COMPLETED|Overall Study||92
6390286|NCT00829010|7301950|FG002|COMPLETED|Overall Study||97
6390287|NCT00829010|7301951|FG003|COMPLETED|Overall Study||92
6390288|NCT00829010|7301952|FG004|COMPLETED|Overall Study||98
6390289|NCT00829010|7301948|FG000|NOT COMPLETED|Overall Study||10
6390290|NCT00829010|7301949|FG001|NOT COMPLETED|Overall Study||9
6390291|NCT00829010|7301950|FG002|NOT COMPLETED|Overall Study||3
6390292|NCT00829010|7301951|FG003|NOT COMPLETED|Overall Study||8
6390293|NCT00829010|7301952|FG004|NOT COMPLETED|Overall Study||2
6390294|NCT00829036|7301964|FG000|STARTED|Overall Study||24
6390295|NCT00829036|7301964|FG000|COMPLETED|Overall Study||24
6390296|NCT00829036|7301964|FG000|NOT COMPLETED|Overall Study||0
6390297|NCT00829049|7301970|FG000|STARTED|Overall Study||77
6390298|NCT00829049|7301971|FG001|STARTED|Overall Study||88
6390299|NCT00829049|7301970|FG000|COMPLETED|Overall Study||60
6390300|NCT00829049|7301971|FG001|COMPLETED|Overall Study||68
6390301|NCT00829049|7301970|FG000|NOT COMPLETED|Overall Study||17
6390302|NCT00829049|7301971|FG001|NOT COMPLETED|Overall Study||20
6390303|NCT00829166|7301979|FG000|STARTED|Overall Study||495
6390304|NCT00829166|7301980|FG001|STARTED|Overall Study||496
6390305|NCT00829166|7301979|FG000|Treated|Overall Study||490
6390306|NCT00829166|7301980|FG001|Treated|Overall Study||488
6390307|NCT00829166|7301979|FG000|COMPLETED|Overall Study||0
6390308|NCT00829166|7301980|FG001|COMPLETED|Overall Study||0
6390309|NCT00829166|7301979|FG000|NOT COMPLETED|Overall Study||495
6390310|NCT00829166|7301980|FG001|NOT COMPLETED|Overall Study||496
6390311|NCT00829179|7301987|FG000|STARTED|Overall Study||20
6390312|NCT00829179|7301987|FG000|COMPLETED|Overall Study||19
6390313|NCT00829179|7301987|FG000|NOT COMPLETED|Overall Study||1
6390314|NCT00829244|7301993|FG000|STARTED|Overall Study||96
6390315|NCT00829244|7301994|FG001|STARTED|Overall Study||104
6390316|NCT00829244|7301993|FG000|COMPLETED|Overall Study||82
6390317|NCT00829244|7301994|FG001|COMPLETED|Overall Study||83
6390318|NCT00829244|7301993|FG000|NOT COMPLETED|Overall Study||14
6390319|NCT00829244|7301994|FG001|NOT COMPLETED|Overall Study||21
6390320|NCT00829283|7302002|FG000|STARTED|Overall Study||39
6390321|NCT00829283|7302003|FG001|STARTED|Overall Study||152
6390322|NCT00829283|7302002|FG000|COMPLETED|Overall Study||32
6390323|NCT00829283|7302003|FG001|COMPLETED|Overall Study||127
6390324|NCT00829283|7302002|FG000|NOT COMPLETED|Overall Study||7
6390325|NCT00829283|7302003|FG001|NOT COMPLETED|Overall Study||25
6390326|NCT00829296|7302011|FG000|STARTED|Overall Study||34
6390327|NCT00829296|7302012|FG001|STARTED|Overall Study||36
6390328|NCT00829296|7302011|FG000|COMPLETED|Overall Study||29
6390329|NCT00829296|7302012|FG001|COMPLETED|Overall Study||32
6390330|NCT00829296|7302011|FG000|NOT COMPLETED|Overall Study||5
6390331|NCT00829296|7302012|FG001|NOT COMPLETED|Overall Study||4
6390332|NCT00829387|7302020|FG000|STARTED|Overall Study||23
6390333|NCT00829387|7302021|FG001|STARTED|Overall Study||24
6390334|NCT00829387|7302020|FG000|COMPLETED|Overall Study||20
6390335|NCT00829387|7302021|FG001|COMPLETED|Overall Study||21
6390336|NCT00829387|7302020|FG000|NOT COMPLETED|Overall Study||3
6390337|NCT00829387|7302021|FG001|NOT COMPLETED|Overall Study||3
6390338|NCT00829413|7302027|FG000|STARTED|Overall Study||353
6390339|NCT00829413|7302027|FG000|COMPLETED|Overall Study||259
6390340|NCT00829413|7302027|FG000|NOT COMPLETED|Overall Study||94
6390341|NCT00829439|7302038|FG000|STARTED|Overall Study||3
6390342|NCT00829439|7302039|FG001|STARTED|Overall Study||3
6390343|NCT00829439|7302040|FG002|STARTED|Overall Study||6
6275269|NCT00112437|7174447|FG010|NOT COMPLETED|Year 3 (12-Month Extension)||2
6275270|NCT00112437|7174448|FG011|NOT COMPLETED|Year 3 (12-Month Extension)||5
6275271|NCT00112437|7174449|FG012|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275272|NCT00112437|7174450|FG013|NOT COMPLETED|Year 3 (12-Month Extension)||1
6275273|NCT00112437|7174451|FG014|NOT COMPLETED|Year 3 (12-Month Extension)||1
6275274|NCT00112437|7174452|FG015|NOT COMPLETED|Year 3 (12-Month Extension)||4
6275275|NCT00112437|7174453|FG016|NOT COMPLETED|Year 3 (12-Month Extension)||3
6275276|NCT00112437|7174454|FG017|NOT COMPLETED|Year 3 (12-Month Extension)||1
6275277|NCT00112437|7174455|FG018|NOT COMPLETED|Year 3 (12-Month Extension)||2
6275278|NCT00112437|7174456|FG019|NOT COMPLETED|Year 3 (12-Month Extension)||1
6275279|NCT00112437|7174457|FG020|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275280|NCT00112437|7174458|FG021|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275281|NCT00112437|7174459|FG022|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275282|NCT00112437|7174460|FG023|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275283|NCT00112437|7174461|FG024|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275284|NCT00112437|7174462|FG025|NOT COMPLETED|Year 3 (12-Month Extension)||0
6275285|NCT00112437|7174437|FG000|STARTED|Years 4-5 (24-Month Extension)||0
6275286|NCT00112437|7174438|FG001|STARTED|Years 4-5 (24-Month Extension)||0
6275287|NCT00112437|7174439|FG002|STARTED|Years 4-5 (24-Month Extension)||0
6275288|NCT00112437|7174440|FG003|STARTED|Years 4-5 (24-Month Extension)||0
6275289|NCT00112437|7174441|FG004|STARTED|Years 4-5 (24-Month Extension)||0
6275290|NCT00112437|7174442|FG005|STARTED|Years 4-5 (24-Month Extension)||0
6275291|NCT00112437|7174443|FG006|STARTED|Years 4-5 (24-Month Extension)||0
6275292|NCT00112437|7174444|FG007|STARTED|Years 4-5 (24-Month Extension)||0
6275293|NCT00112437|7174445|FG008|STARTED|Years 4-5 (24-Month Extension)||0
6566961|NCT01828476|7490038|FG001|STARTED|Overall Study||0
6566962|NCT01828476|7490037|FG000|COMPLETED|Overall Study||13
6566963|NCT01828476|7490038|FG001|COMPLETED|Overall Study||0
6566964|NCT01828476|7490037|FG000|NOT COMPLETED|Overall Study||0
6806658|NCT00594620|7738887|FG000|NOT COMPLETED|Overall Study||0
6275294|NCT00112437|7174446|FG009|STARTED|Years 4-5 (24-Month Extension)||0
6275295|NCT00112437|7174447|FG010|STARTED|Years 4-5 (24-Month Extension)||0
6275296|NCT00112437|7174448|FG011|STARTED|Years 4-5 (24-Month Extension)||0
6275297|NCT00112437|7174449|FG012|STARTED|Years 4-5 (24-Month Extension)||0
6806659|NCT00594620|7738888|FG001|NOT COMPLETED|Overall Study||0
6806660|NCT00535405|7738899|FG000|STARTED|Overall Study||257
6806661|NCT00535405|7738900|FG001|STARTED|Overall Study||259
6806662|NCT00535405|7738901|FG002|STARTED|Overall Study||259
6806663|NCT00535405|7738902|FG003|STARTED|Overall Study||257
6806664|NCT00535405|7738903|FG004|STARTED|Overall Study||257
6806665|NCT00535405|7738899|FG000|COMPLETED|Overall Study||240
6806666|NCT00535405|7738900|FG001|COMPLETED|Overall Study||233
6806667|NCT00535405|7738901|FG002|COMPLETED|Overall Study||241
6806668|NCT00535405|7738902|FG003|COMPLETED|Overall Study||235
6806669|NCT00535405|7738903|FG004|COMPLETED|Overall Study||241
6806670|NCT00535405|7738899|FG000|NOT COMPLETED|Overall Study||17
6806671|NCT00535405|7738900|FG001|NOT COMPLETED|Overall Study||26
6806672|NCT00535405|7738901|FG002|NOT COMPLETED|Overall Study||18
6806673|NCT00535405|7738902|FG003|NOT COMPLETED|Overall Study||22
6806674|NCT00535405|7738903|FG004|NOT COMPLETED|Overall Study||16
6806675|NCT00496730|7738917|FG000|STARTED|Overall Study||130
6806676|NCT00496730|7738918|FG001|STARTED|Overall Study||126
6806677|NCT00496730|7738917|FG000|COMPLETED|Overall Study||124
6806678|NCT00496730|7738918|FG001|COMPLETED|Overall Study||121
6806679|NCT00496730|7738917|FG000|NOT COMPLETED|Overall Study||6
6806680|NCT00496730|7738918|FG001|NOT COMPLETED|Overall Study||5
6806681|NCT00462748|7738927|FG000|STARTED|Overall Study||261
6806682|NCT00462748|7738928|FG001|STARTED|Overall Study||263
6275298|NCT00112437|7174450|FG013|STARTED|Years 4-5 (24-Month Extension)||0
6275299|NCT00112437|7174451|FG014|STARTED|Years 4-5 (24-Month Extension)||0
6275300|NCT00112437|7174452|FG015|STARTED|Years 4-5 (24-Month Extension)||0
6275301|NCT00112437|7174453|FG016|STARTED|Years 4-5 (24-Month Extension)||0
6275302|NCT00112437|7174454|FG017|STARTED|Years 4-5 (24-Month Extension)||0
6275303|NCT00112437|7174455|FG018|STARTED|Years 4-5 (24-Month Extension)||0
6275304|NCT00112437|7174456|FG019|STARTED|Years 4-5 (24-Month Extension)||0
6275305|NCT00112437|7174457|FG020|STARTED|Years 4-5 (24-Month Extension)||41
6275306|NCT00112437|7174458|FG021|STARTED|Years 4-5 (24-Month Extension)||100
6566965|NCT01828476|7490038|FG001|NOT COMPLETED|Overall Study||0
6806683|NCT00462748|7738929|FG002|STARTED|Overall Study||262
6806684|NCT00462748|7738927|FG000|COMPLETED|Overall Study||249
6806685|NCT00462748|7738928|FG001|COMPLETED|Overall Study||252
6806686|NCT00462748|7738929|FG002|COMPLETED|Overall Study||251
6806687|NCT00462748|7738927|FG000|NOT COMPLETED|Overall Study||12
6390344|NCT00829439|7302041|FG003|STARTED|Overall Study||4
6390345|NCT00829439|7302038|FG000|COMPLETED|Overall Study||3
6390346|NCT00829439|7302039|FG001|COMPLETED|Overall Study||3
6390347|NCT00829439|7302040|FG002|COMPLETED|Overall Study||5
6390348|NCT00829439|7302041|FG003|COMPLETED|Overall Study||4
6390349|NCT00829439|7302038|FG000|NOT COMPLETED|Overall Study||0
6390350|NCT00829439|7302039|FG001|NOT COMPLETED|Overall Study||0
6390351|NCT00829439|7302040|FG002|NOT COMPLETED|Overall Study||1
6390352|NCT00829439|7302041|FG003|NOT COMPLETED|Overall Study||0
6390353|NCT00829621|7302047|FG000|STARTED|Overall Study||8
6390354|NCT00829621|7302048|FG001|STARTED|Overall Study||12
6390355|NCT00829621|7302047|FG000|COMPLETED|Overall Study||4
6390356|NCT00829621|7302048|FG001|COMPLETED|Overall Study||8
6390357|NCT00829621|7302047|FG000|NOT COMPLETED|Overall Study||4
6390358|NCT00829621|7302048|FG001|NOT COMPLETED|Overall Study||4
6390359|NCT00829738|7302054|FG000|STARTED|Overall Study||4188
6390360|NCT00829738|7302054|FG000|COMPLETED|Overall Study||4180
6390361|NCT00829738|7302054|FG000|NOT COMPLETED|Overall Study||8
6390362|NCT00829829|7302062|FG000|STARTED|Overall Study||80
6390363|NCT00829829|7302063|FG001|STARTED|Overall Study||80
6390364|NCT00829829|7302064|FG002|STARTED|Overall Study||81
6390365|NCT00829829|7302062|FG000|Treated|Overall Study||79
6390366|NCT00829829|7302063|FG001|Treated|Overall Study||80
6390367|NCT00829829|7302064|FG002|Treated|Overall Study||81
6390368|NCT00829829|7302062|FG000|COMPLETED|Overall Study||58
6390369|NCT00829829|7302063|FG001|COMPLETED|Overall Study||64
6390370|NCT00829829|7302064|FG002|COMPLETED|Overall Study||70
6504561|NCT01449370|7423596|FG003|STARTED|Overall Study||4
6504562|NCT01449370|7423597|FG004|STARTED|Overall Study||3
6504563|NCT01449370|7423598|FG005|STARTED|Overall Study||3
6504564|NCT01449370|7423599|FG006|STARTED|Overall Study||3
6504565|NCT01449370|7423600|FG007|STARTED|Overall Study||3
6504566|NCT01449370|7423601|FG008|STARTED|Overall Study||12
6504567|NCT01449370|7423602|FG009|STARTED|Overall Study||3
6504568|NCT01449370|7423603|FG010|STARTED|Overall Study||3
6504569|NCT01449370|7423604|FG011|STARTED|Overall Study||3
6504570|NCT01449370|7423605|FG012|STARTED|Overall Study||3
6504571|NCT01449370|7423606|FG013|STARTED|Overall Study||11
6504572|NCT01449370|7423607|FG014|STARTED|Overall Study||3
6504573|NCT01449370|7423608|FG015|STARTED|Overall Study||3
6504574|NCT01449370|7423609|FG016|STARTED|Overall Study||7
6504575|NCT01449370|7423610|FG017|STARTED|Overall Study||3
6504576|NCT01449370|7423611|FG018|STARTED|Overall Study||3
6275307|NCT00112437|7174459|FG022|STARTED|Years 4-5 (24-Month Extension)||0
6275308|NCT00112437|7174460|FG023|STARTED|Years 4-5 (24-Month Extension)||0
6275309|NCT00112437|7174461|FG024|STARTED|Years 4-5 (24-Month Extension)||0
6275310|NCT00112437|7174462|FG025|STARTED|Years 4-5 (24-Month Extension)||0
6275311|NCT00112437|7174437|FG000|COMPLETED|Years 4-5 (24-Month Extension)||0
6275312|NCT00112437|7174438|FG001|COMPLETED|Years 4-5 (24-Month Extension)||0
6275313|NCT00112437|7174439|FG002|COMPLETED|Years 4-5 (24-Month Extension)||0
6275314|NCT00112437|7174440|FG003|COMPLETED|Years 4-5 (24-Month Extension)||0
6275315|NCT00112437|7174441|FG004|COMPLETED|Years 4-5 (24-Month Extension)||0
6275316|NCT00112437|7174442|FG005|COMPLETED|Years 4-5 (24-Month Extension)||0
6390371|NCT00829829|7302062|FG000|NOT COMPLETED|Overall Study||22
6390372|NCT00829829|7302063|FG001|NOT COMPLETED|Overall Study||16
6390373|NCT00829829|7302064|FG002|NOT COMPLETED|Overall Study||11
6390374|NCT00829933|7302077|FG000|STARTED|Overall Study||135
6390375|NCT00829933|7302078|FG001|STARTED|Overall Study||135
6390376|NCT00829933|7302079|FG002|STARTED|Overall Study||132
6504577|NCT01449370|7423612|FG019|STARTED|Overall Study||3
6566966|NCT01828515|7490046|FG000|STARTED|First Intervention (19 Days)||13
6566967|NCT01828515|7490047|FG001|STARTED|First Intervention (19 Days)||11
6806688|NCT00462748|7738928|FG001|NOT COMPLETED|Overall Study||11
6806689|NCT00462748|7738929|FG002|NOT COMPLETED|Overall Study||11
6806690|NCT00418834|7738939|FG000|STARTED|Overall Study||526
6806691|NCT00418834|7738940|FG001|STARTED|Overall Study||527
6806692|NCT00418834|7738939|FG000|COMPLETED|Overall Study||503
6806693|NCT00418834|7738940|FG001|COMPLETED|Overall Study||507
6806694|NCT00418834|7738939|FG000|NOT COMPLETED|Overall Study||23
6806695|NCT00418834|7738940|FG001|NOT COMPLETED|Overall Study||20
6806696|NCT00409773|7738951|FG000|STARTED|Overall Study||229
6806697|NCT00409773|7738952|FG001|STARTED|Overall Study||229
6806698|NCT00409773|7738953|FG002|STARTED|Overall Study||229
6806699|NCT00409773|7738954|FG003|STARTED|Overall Study||228
6390377|NCT00829933|7302080|FG003|STARTED|Overall Study||134
6390378|NCT00829933|7302077|FG000|Baseline Analysis Population|Overall Study||131
6390379|NCT00829933|7302078|FG001|Baseline Analysis Population|Overall Study||134
6390380|NCT00829933|7302079|FG002|Baseline Analysis Population|Overall Study||131
6390381|NCT00829933|7302080|FG003|Baseline Analysis Population|Overall Study||129
6390382|NCT00829933|7302077|FG000|COMPLETED|Overall Study||121
6390383|NCT00829933|7302078|FG001|COMPLETED|Overall Study||122
6390384|NCT00829933|7302079|FG002|COMPLETED|Overall Study||119
6390385|NCT00829933|7302080|FG003|COMPLETED|Overall Study||120
6390386|NCT00829933|7302077|FG000|NOT COMPLETED|Overall Study||14
6390387|NCT00829933|7302078|FG001|NOT COMPLETED|Overall Study||13
6390388|NCT00829933|7302079|FG002|NOT COMPLETED|Overall Study||13
6390389|NCT00829933|7302080|FG003|NOT COMPLETED|Overall Study||14
6390390|NCT00829985|7302092|FG000|STARTED|Overall Study||28
6390391|NCT00829985|7302093|FG001|STARTED|Overall Study||26
6390392|NCT00829985|7302092|FG000|COMPLETED|Overall Study||19
6390393|NCT00829985|7302093|FG001|COMPLETED|Overall Study||22
6390394|NCT00829985|7302092|FG000|NOT COMPLETED|Overall Study||9
6390395|NCT00829985|7302093|FG001|NOT COMPLETED|Overall Study||4
6390396|NCT00830037|7302101|FG000|STARTED|Overall Study||67
6390397|NCT00830037|7302102|FG001|STARTED|Overall Study||69
6390398|NCT00830037|7302101|FG000|COMPLETED|Overall Study||49
6390399|NCT00830037|7302102|FG001|COMPLETED|Overall Study||50
6390400|NCT00830037|7302101|FG000|NOT COMPLETED|Overall Study||18
6390401|NCT00830037|7302102|FG001|NOT COMPLETED|Overall Study||19
6390402|NCT00830063|7302112|FG000|STARTED|Overall Study||208
6390403|NCT00830063|7302113|FG001|STARTED|Overall Study||208
6390404|NCT00830063|7302114|FG002|STARTED|Overall Study||208
6390405|NCT00830063|7302115|FG003|STARTED|Overall Study||208
6390406|NCT00830063|7302112|FG000|Treated|Overall Study||208
6390407|NCT00830063|7302113|FG001|Treated|Overall Study||206
6390408|NCT00830063|7302114|FG002|Treated|Overall Study||208
6390409|NCT00830063|7302115|FG003|Treated|Overall Study||206
6390410|NCT00830063|7302112|FG000|COMPLETED|Overall Study||8
6390411|NCT00830063|7302113|FG001|COMPLETED|Overall Study||16
6390412|NCT00830063|7302114|FG002|COMPLETED|Overall Study||10
6390413|NCT00830063|7302115|FG003|COMPLETED|Overall Study||13
6390414|NCT00830063|7302112|FG000|NOT COMPLETED|Overall Study||200
6390415|NCT00830063|7302113|FG001|NOT COMPLETED|Overall Study||192
6390416|NCT00830063|7302114|FG002|NOT COMPLETED|Overall Study||198
6390417|NCT00830063|7302115|FG003|NOT COMPLETED|Overall Study||195
6390418|NCT00830076|7302127|FG000|STARTED|Sitagliptin + Placebo Metformin||18
6390419|NCT00830076|7302127|FG000|COMPLETED|Sitagliptin + Placebo Metformin||18
6390420|NCT00830076|7302127|FG000|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
6390421|NCT00830076|7302127|FG000|STARTED|7-day Washout||18
6390422|NCT00830076|7302127|FG000|COMPLETED|7-day Washout||18
6806700|NCT00409773|7738955|FG004|STARTED|Overall Study||228
6806701|NCT00409773|7738951|FG000|COMPLETED|Overall Study||220
6806702|NCT00409773|7738952|FG001|COMPLETED|Overall Study||222
6806703|NCT00409773|7738953|FG002|COMPLETED|Overall Study||220
6806704|NCT00409773|7738954|FG003|COMPLETED|Overall Study||216
6806705|NCT00409773|7738955|FG004|COMPLETED|Overall Study||218
6806706|NCT00409773|7738951|FG000|NOT COMPLETED|Overall Study||9
6806707|NCT00409773|7738952|FG001|NOT COMPLETED|Overall Study||7
6806708|NCT00409773|7738953|FG002|NOT COMPLETED|Overall Study||9
6806709|NCT00409773|7738954|FG003|NOT COMPLETED|Overall Study||12
6390423|NCT00830076|7302127|FG000|NOT COMPLETED|7-day Washout||0
6390424|NCT00830076|7302127|FG000|STARTED|Metformin + Placebo Sitagliptin||18
6390425|NCT00830076|7302127|FG000|COMPLETED|Metformin + Placebo Sitagliptin||18
6390426|NCT00830076|7302127|FG000|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
6390427|NCT00830076|7302127|FG000|STARTED|7-day Washout||18
6390428|NCT00830076|7302127|FG000|COMPLETED|7-day Washout||18
6390429|NCT00830076|7302127|FG000|NOT COMPLETED|7-day Washout||0
6390430|NCT00830076|7302127|FG000|STARTED|Sitagliptin + Metformin||18
6390431|NCT00830076|7302127|FG000|COMPLETED|Sitagliptin + Metformin||18
6390432|NCT00830076|7302127|FG000|NOT COMPLETED|Sitagliptin + Metformin||0
6390433|NCT00830076|7302127|FG000|STARTED|7-day Washout||18
6390434|NCT00830076|7302127|FG000|COMPLETED|7-day Washout||18
6390435|NCT00830076|7302127|FG000|NOT COMPLETED|7-day Washout||0
6390436|NCT00830076|7302127|FG000|STARTED|Placebo Sitagliptin + Placebo Metformin||18
6806710|NCT00409773|7738955|FG004|NOT COMPLETED|Overall Study||10
6806711|NCT00276484|7738969|FG000|STARTED|Overall Study||288
6275317|NCT00112437|7174443|FG006|COMPLETED|Years 4-5 (24-Month Extension)||0
6275318|NCT00112437|7174444|FG007|COMPLETED|Years 4-5 (24-Month Extension)||0
6275319|NCT00112437|7174445|FG008|COMPLETED|Years 4-5 (24-Month Extension)||0
6275320|NCT00112437|7174446|FG009|COMPLETED|Years 4-5 (24-Month Extension)||0
6275321|NCT00112437|7174447|FG010|COMPLETED|Years 4-5 (24-Month Extension)||0
6275322|NCT00112437|7174448|FG011|COMPLETED|Years 4-5 (24-Month Extension)||0
6275323|NCT00112437|7174449|FG012|COMPLETED|Years 4-5 (24-Month Extension)||0
6275324|NCT00112437|7174450|FG013|COMPLETED|Years 4-5 (24-Month Extension)||0
6275325|NCT00112437|7174451|FG014|COMPLETED|Years 4-5 (24-Month Extension)||0
6275326|NCT00112437|7174452|FG015|COMPLETED|Years 4-5 (24-Month Extension)||0
6275327|NCT00112437|7174453|FG016|COMPLETED|Years 4-5 (24-Month Extension)||0
6275328|NCT00112437|7174454|FG017|COMPLETED|Years 4-5 (24-Month Extension)||0
6275329|NCT00112437|7174455|FG018|COMPLETED|Years 4-5 (24-Month Extension)||0
6275330|NCT00112437|7174456|FG019|COMPLETED|Years 4-5 (24-Month Extension)||0
6275331|NCT00112437|7174457|FG020|COMPLETED|Years 4-5 (24-Month Extension)||37
6275332|NCT00112437|7174458|FG021|COMPLETED|Years 4-5 (24-Month Extension)||92
6275333|NCT00112437|7174459|FG022|COMPLETED|Years 4-5 (24-Month Extension)||0
6275334|NCT00112437|7174460|FG023|COMPLETED|Years 4-5 (24-Month Extension)||0
6275335|NCT00112437|7174461|FG024|COMPLETED|Years 4-5 (24-Month Extension)||0
6275336|NCT00112437|7174462|FG025|COMPLETED|Years 4-5 (24-Month Extension)||0
6275337|NCT00112437|7174437|FG000|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275338|NCT00112437|7174438|FG001|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275339|NCT00112437|7174439|FG002|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275340|NCT00112437|7174440|FG003|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275341|NCT00112437|7174441|FG004|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275342|NCT00112437|7174442|FG005|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275343|NCT00112437|7174443|FG006|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275344|NCT00112437|7174444|FG007|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275345|NCT00112437|7174445|FG008|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275346|NCT00112437|7174446|FG009|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275347|NCT00112437|7174447|FG010|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275348|NCT00112437|7174448|FG011|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275349|NCT00112437|7174449|FG012|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275350|NCT00112437|7174450|FG013|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275351|NCT00112437|7174451|FG014|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275352|NCT00112437|7174452|FG015|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275353|NCT00112437|7174453|FG016|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275354|NCT00112437|7174454|FG017|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275355|NCT00112437|7174455|FG018|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275356|NCT00112437|7174456|FG019|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275357|NCT00112437|7174457|FG020|NOT COMPLETED|Years 4-5 (24-Month Extension)||4
6275358|NCT00112437|7174458|FG021|NOT COMPLETED|Years 4-5 (24-Month Extension)||8
6275359|NCT00112437|7174459|FG022|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275360|NCT00112437|7174460|FG023|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275361|NCT00112437|7174461|FG024|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275362|NCT00112437|7174462|FG025|NOT COMPLETED|Years 4-5 (24-Month Extension)||0
6275363|NCT00112437|7174437|FG000|STARTED|Years 6-10 (60-Month Extension)||0
6275364|NCT00112437|7174438|FG001|STARTED|Years 6-10 (60-Month Extension)||0
6275365|NCT00112437|7174439|FG002|STARTED|Years 6-10 (60-Month Extension)||0
6806712|NCT00276484|7738970|FG001|STARTED|Overall Study||291
6806713|NCT00276484|7738969|FG000|COMPLETED|Overall Study||279
6806714|NCT00276484|7738970|FG001|COMPLETED|Overall Study||278
6806715|NCT00276484|7738969|FG000|NOT COMPLETED|Overall Study||9
6806716|NCT00276484|7738970|FG001|NOT COMPLETED|Overall Study||13
6806717|NCT00276458|7738978|FG000|STARTED|Overall Study||98
6806718|NCT00276458|7738979|FG001|STARTED|Overall Study||98
6806719|NCT00276458|7738978|FG000|COMPLETED|Overall Study||92
6806720|NCT00276458|7738979|FG001|COMPLETED|Overall Study||91
6806721|NCT00276458|7738978|FG000|NOT COMPLETED|Overall Study||6
6806722|NCT00276458|7738979|FG001|NOT COMPLETED|Overall Study||7
6806723|NCT00271817|7738988|FG000|STARTED|Part 1||272
6806724|NCT00271817|7738989|FG001|STARTED|Part 1||272
6806725|NCT00271817|7738990|FG002|STARTED|Part 1||676
6806726|NCT00271817|7738988|FG000|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
6806727|NCT00271817|7738989|FG001|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
6806728|NCT00271817|7738990|FG002|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
6806729|NCT00271817|7738988|FG000|NOT COMPLETED|Part 1||106
6275366|NCT00112437|7174440|FG003|STARTED|Years 6-10 (60-Month Extension)||0
6275367|NCT00112437|7174441|FG004|STARTED|Years 6-10 (60-Month Extension)||0
6275368|NCT00112437|7174442|FG005|STARTED|Years 6-10 (60-Month Extension)||0
6275369|NCT00112437|7174443|FG006|STARTED|Years 6-10 (60-Month Extension)||0
6275370|NCT00112437|7174444|FG007|STARTED|Years 6-10 (60-Month Extension)||0
6275371|NCT00112437|7174445|FG008|STARTED|Years 6-10 (60-Month Extension)||0
6275372|NCT00112437|7174446|FG009|STARTED|Years 6-10 (60-Month Extension)||0
6275373|NCT00112437|7174447|FG010|STARTED|Years 6-10 (60-Month Extension)||0
6806730|NCT00271817|7738989|FG001|NOT COMPLETED|Part 1||59
6566968|NCT01828515|7490046|FG000|COMPLETED|First Intervention (19 Days)||11
6566969|NCT01828515|7490047|FG001|COMPLETED|First Intervention (19 Days)||9
6566970|NCT01828515|7490046|FG000|NOT COMPLETED|First Intervention (19 Days)||2
6566971|NCT01828515|7490047|FG001|NOT COMPLETED|First Intervention (19 Days)||2
6566972|NCT01828515|7490046|FG000|STARTED|Washout (23 Days)||11
6566973|NCT01828515|7490047|FG001|STARTED|Washout (23 Days)||9
6566974|NCT01828515|7490046|FG000|COMPLETED|Washout (23 Days)||6
6806731|NCT00271817|7738990|FG002|NOT COMPLETED|Part 1||285
6806732|NCT00271817|7738988|FG000|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
6806733|NCT00271817|7738989|FG001|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
6806734|NCT00271817|7738990|FG002|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
6806735|NCT00271817|7738988|FG000|COMPLETED|Part 2||0
6806736|NCT00271817|7738989|FG001|COMPLETED|Part 2||234
6806737|NCT00271817|7738990|FG002|COMPLETED|Part 2||401
6806738|NCT00271817|7738988|FG000|NOT COMPLETED|Part 2||0
6806739|NCT00271817|7738989|FG001|NOT COMPLETED|Part 2||32
6806740|NCT00271817|7738990|FG002|NOT COMPLETED|Part 2||84
6566975|NCT01828515|7490047|FG001|COMPLETED|Washout (23 Days)||8
6566976|NCT01828515|7490046|FG000|NOT COMPLETED|Washout (23 Days)||5
6566977|NCT01828515|7490047|FG001|NOT COMPLETED|Washout (23 Days)||1
6566978|NCT01828515|7490046|FG000|STARTED|Second Intervention (19 Days)||6
6566979|NCT01828515|7490047|FG001|STARTED|Second Intervention (19 Days)||8
6566980|NCT01828515|7490046|FG000|COMPLETED|Second Intervention (19 Days)||6
6566981|NCT01828515|7490047|FG001|COMPLETED|Second Intervention (19 Days)||5
6566982|NCT01828515|7490046|FG000|NOT COMPLETED|Second Intervention (19 Days)||0
6566983|NCT01828515|7490047|FG001|NOT COMPLETED|Second Intervention (19 Days)||3
6275374|NCT00112437|7174448|FG011|STARTED|Years 6-10 (60-Month Extension)||0
6275375|NCT00112437|7174449|FG012|STARTED|Years 6-10 (60-Month Extension)||0
6275376|NCT00112437|7174450|FG013|STARTED|Years 6-10 (60-Month Extension)||0
6275377|NCT00112437|7174451|FG014|STARTED|Years 6-10 (60-Month Extension)||0
6275378|NCT00112437|7174452|FG015|STARTED|Years 6-10 (60-Month Extension)||0
6275379|NCT00112437|7174453|FG016|STARTED|Years 6-10 (60-Month Extension)||0
6275380|NCT00112437|7174454|FG017|STARTED|Years 6-10 (60-Month Extension)||0
6275381|NCT00112437|7174455|FG018|STARTED|Years 6-10 (60-Month Extension)||0
6275382|NCT00112437|7174456|FG019|STARTED|Years 6-10 (60-Month Extension)||0
6275383|NCT00112437|7174457|FG020|STARTED|Years 6-10 (60-Month Extension)||0
6275384|NCT00112437|7174458|FG021|STARTED|Years 6-10 (60-Month Extension)||0
6566984|NCT01828554|7490053|FG000|STARTED|Overall Study||8
6566985|NCT01828554|7490053|FG000|COMPLETED|Overall Study||8
6566986|NCT01828554|7490053|FG000|NOT COMPLETED|Overall Study||0
6566987|NCT01828567|7490059|FG000|STARTED|Overall Study||208
6566988|NCT01828567|7490060|FG001|STARTED|Overall Study||209
6566989|NCT01828567|7490059|FG000|1 Month|Overall Study||172
6566990|NCT01828567|7490060|FG001|1 Month|Overall Study||192
6566991|NCT01828567|7490059|FG000|COMPLETED|Overall Study||177
6566992|NCT01828567|7490060|FG001|COMPLETED|Overall Study||199
6566993|NCT01828567|7490059|FG000|NOT COMPLETED|Overall Study||31
6566994|NCT01828567|7490060|FG001|NOT COMPLETED|Overall Study||10
6566995|NCT01828593|7490069|FG000|STARTED|Placebo-Controlled Phase||36
6566996|NCT01828593|7490070|FG001|STARTED|Placebo-Controlled Phase||34
6566997|NCT01828593|7490071|FG002|STARTED|Placebo-Controlled Phase||33
6566998|NCT01828593|7490069|FG000|COMPLETED|Placebo-Controlled Phase||36
6566999|NCT01828593|7490070|FG001|COMPLETED|Placebo-Controlled Phase||34
6567000|NCT01828593|7490071|FG002|COMPLETED|Placebo-Controlled Phase||32
6567001|NCT01828593|7490069|FG000|NOT COMPLETED|Placebo-Controlled Phase||0
6656925|NCT02465567|7587297|FG001|COMPLETED|Overall Study||1713
6390437|NCT00830076|7302127|FG000|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
6390438|NCT00830076|7302127|FG000|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
6390439|NCT00830115|7302134|FG000|STARTED|Overall Study||1045
6390440|NCT00830115|7302134|FG000|COMPLETED|Overall Study||1042
6390441|NCT00830115|7302134|FG000|NOT COMPLETED|Overall Study||3
6390442|NCT00830128|7302140|FG000|STARTED|Overall Study||106
6390443|NCT00830128|7302140|FG000|COMPLETED|Overall Study||87
6390444|NCT00830128|7302140|FG000|NOT COMPLETED|Overall Study||19
6390445|NCT00830167|7302146|FG000|STARTED|Overall Study|Treated|248
6390446|NCT00830167|7302147|FG001|STARTED|Overall Study|Treated|250
6390447|NCT00830167|7302146|FG000|COMPLETED|Overall Study||208
6504578|NCT01449370|7423613|FG020|STARTED|Overall Study||6
6504579|NCT01449370|7423614|FG021|STARTED|Overall Study||4
6504580|NCT01449370|7423615|FG022|STARTED|Overall Study||4
6504581|NCT01449370|7423616|FG023|STARTED|Overall Study||10
6504582|NCT01449370|7423617|FG024|STARTED|Overall Study||8
6504583|NCT01449370|7423593|FG000|COMPLETED|Overall Study||0
6504584|NCT01449370|7423594|FG001|COMPLETED|Overall Study||0
6504585|NCT01449370|7423595|FG002|COMPLETED|Overall Study||0
6504586|NCT01449370|7423596|FG003|COMPLETED|Overall Study||0
6504587|NCT01449370|7423597|FG004|COMPLETED|Overall Study||0
6504588|NCT01449370|7423598|FG005|COMPLETED|Overall Study||0
6567002|NCT01828593|7490070|FG001|NOT COMPLETED|Placebo-Controlled Phase||0
6567003|NCT01828593|7490071|FG002|NOT COMPLETED|Placebo-Controlled Phase||1
6567004|NCT01828593|7490069|FG000|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
6656926|NCT02465567|7587298|FG002|COMPLETED|Overall Study||1580
6567005|NCT01828593|7490070|FG001|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
6656927|NCT02465567|7587299|FG003|COMPLETED|Overall Study||1643
6806741|NCT03660865|7739004|FG000|STARTED|Overall Study||105
6806742|NCT03660865|7739005|FG001|STARTED|Overall Study||105
6806743|NCT03660865|7739004|FG000|COMPLETED|Overall Study||105
6806744|NCT03660865|7739005|FG001|COMPLETED|Overall Study||105
6806745|NCT03660865|7739004|FG000|NOT COMPLETED|Overall Study||0
6806746|NCT03660865|7739005|FG001|NOT COMPLETED|Overall Study||0
6806747|NCT03493126|7739013|FG000|STARTED|Overall Study||31
6806748|NCT03493126|7739014|FG001|STARTED|Overall Study||28
6806749|NCT03493126|7739013|FG000|COMPLETED|Overall Study||28
6806750|NCT03493126|7739014|FG001|COMPLETED|Overall Study||28
6806751|NCT03493126|7739013|FG000|NOT COMPLETED|Overall Study||3
6806752|NCT03493126|7739014|FG001|NOT COMPLETED|Overall Study||0
6806753|NCT03420781|7739022|FG000|STARTED|Treatment Period (40 Weeks)||236
6806754|NCT03420781|7739023|FG001|STARTED|Treatment Period (40 Weeks)||231
6806755|NCT03420781|7739024|FG002|STARTED|Treatment Period (40 Weeks)||0
6806756|NCT03420781|7739025|FG003|STARTED|Treatment Period (40 Weeks)||0
6806757|NCT03420781|7739026|FG004|STARTED|Treatment Period (40 Weeks)||0
6806758|NCT03420781|7739022|FG000|Safety Population|Treatment Period (40 Weeks)||235
6806759|NCT03420781|7739023|FG001|Safety Population|Treatment Period (40 Weeks)||231
6806760|NCT03420781|7739024|FG002|Safety Population|Treatment Period (40 Weeks)||0
6806761|NCT03420781|7739025|FG003|Safety Population|Treatment Period (40 Weeks)||0
6567006|NCT01828593|7490071|FG002|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
6567007|NCT01828593|7490069|FG000|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
6806762|NCT03420781|7739026|FG004|Safety Population|Treatment Period (40 Weeks)||0
6806763|NCT03420781|7739022|FG000|COMPLETED|Treatment Period (40 Weeks)||92
6806764|NCT03420781|7739023|FG001|COMPLETED|Treatment Period (40 Weeks)||105
6806765|NCT03420781|7739024|FG002|COMPLETED|Treatment Period (40 Weeks)||0
6806766|NCT03420781|7739025|FG003|COMPLETED|Treatment Period (40 Weeks)||0
6806767|NCT03420781|7739026|FG004|COMPLETED|Treatment Period (40 Weeks)||0
6806768|NCT03420781|7739022|FG000|NOT COMPLETED|Treatment Period (40 Weeks)||144
6806769|NCT03420781|7739023|FG001|NOT COMPLETED|Treatment Period (40 Weeks)||126
6806770|NCT03420781|7739024|FG002|NOT COMPLETED|Treatment Period (40 Weeks)||0
6806771|NCT03420781|7739025|FG003|NOT COMPLETED|Treatment Period (40 Weeks)||0
6806772|NCT03420781|7739026|FG004|NOT COMPLETED|Treatment Period (40 Weeks)||0
6806773|NCT03420781|7739022|FG000|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
6806774|NCT03420781|7739023|FG001|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||0
6390448|NCT00830167|7302147|FG001|COMPLETED|Overall Study||207
6390449|NCT00830167|7302146|FG000|NOT COMPLETED|Overall Study||40
6390450|NCT00830167|7302147|FG001|NOT COMPLETED|Overall Study||43
6390451|NCT00830180|7302153|FG000|STARTED|Overall Study||41
6504589|NCT01449370|7423599|FG006|COMPLETED|Overall Study||0
6504590|NCT01449370|7423600|FG007|COMPLETED|Overall Study||0
6504591|NCT01449370|7423601|FG008|COMPLETED|Overall Study||0
6504592|NCT01449370|7423602|FG009|COMPLETED|Overall Study||0
6504593|NCT01449370|7423603|FG010|COMPLETED|Overall Study||0
6504594|NCT01449370|7423604|FG011|COMPLETED|Overall Study||0
6504595|NCT01449370|7423605|FG012|COMPLETED|Overall Study||0
6504596|NCT01449370|7423606|FG013|COMPLETED|Overall Study||0
6623519|NCT02208050|7550677|FG000|STARTED|Baseline Assessment Period: 2 Weeks||36
6806775|NCT03420781|7739024|FG002|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||91
6806776|NCT03420781|7739025|FG003|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||59
6806777|NCT03420781|7739026|FG004|STARTED|RW Period: 6 Weeks (Week 41 to Week 46)||43
6806778|NCT03420781|7739022|FG000|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
6806779|NCT03420781|7739023|FG001|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
6806780|NCT03420781|7739024|FG002|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||85
6806781|NCT03420781|7739025|FG003|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||54
6806782|NCT03420781|7739026|FG004|COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||38
6567008|NCT01828593|7490070|FG001|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
6567009|NCT01828593|7490071|FG002|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
6567010|NCT01828593|7490069|FG000|NOT COMPLETED|Placebo-Free Phase||0
6504597|NCT01449370|7423607|FG014|COMPLETED|Overall Study||0
6504598|NCT01449370|7423608|FG015|COMPLETED|Overall Study||0
6504599|NCT01449370|7423609|FG016|COMPLETED|Overall Study||0
6504600|NCT01449370|7423610|FG017|COMPLETED|Overall Study||0
6504601|NCT01449370|7423611|FG018|COMPLETED|Overall Study||0
6504602|NCT01449370|7423612|FG019|COMPLETED|Overall Study||0
6567011|NCT01828593|7490070|FG001|NOT COMPLETED|Placebo-Free Phase||6
6567012|NCT01828593|7490071|FG002|NOT COMPLETED|Placebo-Free Phase||6
6567013|NCT01828983|7490084|FG000|STARTED|Overall Study||80
6806783|NCT03420781|7739022|FG000|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
6806784|NCT03420781|7739023|FG001|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||0
6806785|NCT03420781|7739024|FG002|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||6
6504603|NCT01449370|7423613|FG020|COMPLETED|Overall Study||0
6504604|NCT01449370|7423614|FG021|COMPLETED|Overall Study||0
6504605|NCT01449370|7423615|FG022|COMPLETED|Overall Study||0
6806786|NCT03420781|7739025|FG003|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
6806787|NCT03420781|7739026|FG004|NOT COMPLETED|RW Period: 6 Weeks (Week 41 to Week 46)||5
6806788|NCT03316586|7739042|FG000|STARTED|Overall Study||18
6806789|NCT03316586|7739042|FG000|COMPLETED|Overall Study||0
6806790|NCT03316586|7739042|FG000|NOT COMPLETED|Overall Study||18
6806791|NCT03277066|7739049|FG000|STARTED|Overall Study||71
6806792|NCT03277066|7739050|FG001|STARTED|Overall Study||72
6806793|NCT03277066|7739051|FG002|STARTED|Overall Study||146
6806794|NCT03277066|7739049|FG000|COMPLETED|Overall Study||69
6806795|NCT03277066|7739050|FG001|COMPLETED|Overall Study||71
6806796|NCT03277066|7739051|FG002|COMPLETED|Overall Study||143
6806797|NCT03277066|7739049|FG000|NOT COMPLETED|Overall Study||2
6806798|NCT03277066|7739050|FG001|NOT COMPLETED|Overall Study||1
6806799|NCT03277066|7739051|FG002|NOT COMPLETED|Overall Study||3
6504606|NCT01449370|7423616|FG023|COMPLETED|Overall Study||0
6504607|NCT01449370|7423617|FG024|COMPLETED|Overall Study||0
6504608|NCT01449370|7423593|FG000|NOT COMPLETED|Overall Study||6
6567014|NCT01828983|7490085|FG001|STARTED|Overall Study||81
6567015|NCT01828983|7490084|FG000|COMPLETED|Overall Study||80
6567016|NCT01828983|7490085|FG001|COMPLETED|Overall Study||81
6567017|NCT01828983|7490084|FG000|NOT COMPLETED|Overall Study||0
6567018|NCT01828983|7490085|FG001|NOT COMPLETED|Overall Study||0
6567019|NCT01829048|7490096|FG000|STARTED|Overall Study||6
6567020|NCT01829048|7490097|FG001|STARTED|Overall Study||8
6567021|NCT01829048|7490098|FG002|STARTED|Overall Study||7
6567022|NCT01829048|7490099|FG003|STARTED|Overall Study||14
6567023|NCT01829048|7490100|FG004|STARTED|Overall Study||2
6567024|NCT01829048|7490096|FG000|COMPLETED|Overall Study||6
6806800|NCT03269695|7739061|FG000|STARTED|Overall Study||10
6806801|NCT03269695|7739062|FG001|STARTED|Overall Study||10
6806802|NCT03269695|7739061|FG000|Treated|Overall Study||10
6275385|NCT00112437|7174459|FG022|STARTED|Years 6-10 (60-Month Extension)||28
6275386|NCT00112437|7174460|FG023|STARTED|Years 6-10 (60-Month Extension)||34
6275387|NCT00112437|7174461|FG024|STARTED|Years 6-10 (60-Month Extension)||23
6806803|NCT03269695|7739062|FG001|Treated|Overall Study||10
6806804|NCT03269695|7739061|FG000|COMPLETED|Overall Study||8
6806805|NCT03269695|7739062|FG001|COMPLETED|Overall Study||7
6806806|NCT03269695|7739061|FG000|NOT COMPLETED|Overall Study||2
6806807|NCT03269695|7739062|FG001|NOT COMPLETED|Overall Study||3
6806808|NCT03227757|7739069|FG000|STARTED|Overall Study||85
6806809|NCT03227757|7739069|FG000|COMPLETED|Overall Study||69
6806810|NCT03227757|7739069|FG000|NOT COMPLETED|Overall Study||16
6806811|NCT03222128|7739073|FG000|STARTED|Overall Study||1074
6806812|NCT03222128|7739073|FG000|Valve-Implanted|Overall Study||1069
6806813|NCT03222128|7739073|FG000|COMPLETED|Overall Study||968
6806814|NCT03222128|7739073|FG000|NOT COMPLETED|Overall Study||106
6806815|NCT03142334|7739079|FG000|STARTED|Overall Study||496
6806816|NCT03142334|7739080|FG001|STARTED|Overall Study||498
6806817|NCT03142334|7739079|FG000|Treated|Overall Study||488
6806818|NCT03142334|7739080|FG001|Treated|Overall Study||496
6806819|NCT03142334|7739079|FG000|Continuing Study Treatment|Overall Study||0
6806820|NCT03142334|7739080|FG001|Continuing Study Treatment|Overall Study||1
6806821|NCT03142334|7739079|FG000|Completed Study Treatment|Overall Study||298
6806822|NCT03142334|7739080|FG001|Completed Study Treatment|Overall Study||365
6806823|NCT03142334|7739079|FG000|Discontinued Study Treatment|Overall Study||190
6806824|NCT03142334|7739080|FG001|Discontinued Study Treatment|Overall Study||130
6806825|NCT03142334|7739079|FG000|COMPLETED|Overall Study||0
6806826|NCT03142334|7739080|FG001|COMPLETED|Overall Study||0
6806827|NCT03142334|7739079|FG000|NOT COMPLETED|Overall Study||496
6806828|NCT03142334|7739080|FG001|NOT COMPLETED|Overall Study||498
6806829|NCT03093701|7739089|FG000|STARTED|Overall Study||10
6806830|NCT03093701|7739090|FG001|STARTED|Overall Study||10
6806831|NCT03093701|7739091|FG002|STARTED|Overall Study||11
6806832|NCT03093701|7739092|FG003|STARTED|Overall Study||0
6806833|NCT03093701|7739089|FG000|COMPLETED|Overall Study||10
6806834|NCT03093701|7739090|FG001|COMPLETED|Overall Study||7
6806835|NCT03093701|7739091|FG002|COMPLETED|Overall Study||11
6806836|NCT03093701|7739092|FG003|COMPLETED|Overall Study||0
6806837|NCT03093701|7739089|FG000|NOT COMPLETED|Overall Study||0
6806838|NCT03093701|7739090|FG001|NOT COMPLETED|Overall Study||3
6806839|NCT03093701|7739091|FG002|NOT COMPLETED|Overall Study||0
6806840|NCT03093701|7739092|FG003|NOT COMPLETED|Overall Study||0
6806841|NCT03093246|7739102|FG000|STARTED|Overall Study||19
6806842|NCT03093246|7739103|FG001|STARTED|Overall Study||19
6806843|NCT03093246|7739102|FG000|COMPLETED|Overall Study||19
6806844|NCT03093246|7739103|FG001|COMPLETED|Overall Study||19
6806845|NCT03093246|7739102|FG000|NOT COMPLETED|Overall Study||0
6806846|NCT03093246|7739103|FG001|NOT COMPLETED|Overall Study||0
6806847|NCT02991599|7739111|FG000|STARTED|Overall Study||98
6806848|NCT02991599|7739112|FG001|STARTED|Overall Study||98
6806849|NCT02991599|7739111|FG000|COMPLETED|Overall Study||60
6275388|NCT00112437|7174462|FG025|STARTED|Years 6-10 (60-Month Extension)||32
6275389|NCT00112437|7174437|FG000|COMPLETED|Years 6-10 (60-Month Extension)||0
6275390|NCT00112437|7174438|FG001|COMPLETED|Years 6-10 (60-Month Extension)||0
6275391|NCT00112437|7174439|FG002|COMPLETED|Years 6-10 (60-Month Extension)||0
6275392|NCT00112437|7174440|FG003|COMPLETED|Years 6-10 (60-Month Extension)||0
6275393|NCT00112437|7174441|FG004|COMPLETED|Years 6-10 (60-Month Extension)||0
6567025|NCT01829048|7490097|FG001|COMPLETED|Overall Study||8
6567026|NCT01829048|7490098|FG002|COMPLETED|Overall Study||7
6567027|NCT01829048|7490099|FG003|COMPLETED|Overall Study||12
6567028|NCT01829048|7490100|FG004|COMPLETED|Overall Study||2
6806850|NCT02991599|7739112|FG001|COMPLETED|Overall Study||61
6806851|NCT02991599|7739111|FG000|NOT COMPLETED|Overall Study||38
6806852|NCT02991599|7739112|FG001|NOT COMPLETED|Overall Study||37
6806853|NCT02976129|7739120|FG000|STARTED|Overall Study||82
6806854|NCT02976129|7739121|FG001|STARTED|Overall Study||43
6806855|NCT02976129|7739120|FG000|COMPLETED|Overall Study||77
6806856|NCT02976129|7739121|FG001|COMPLETED|Overall Study||41
6806857|NCT02976129|7739120|FG000|NOT COMPLETED|Overall Study||5
6806858|NCT02976129|7739121|FG001|NOT COMPLETED|Overall Study||2
6275394|NCT00112437|7174442|FG005|COMPLETED|Years 6-10 (60-Month Extension)||0
6275395|NCT00112437|7174443|FG006|COMPLETED|Years 6-10 (60-Month Extension)||0
6275396|NCT00112437|7174444|FG007|COMPLETED|Years 6-10 (60-Month Extension)||0
6275397|NCT00112437|7174445|FG008|COMPLETED|Years 6-10 (60-Month Extension)||0
6275398|NCT00112437|7174446|FG009|COMPLETED|Years 6-10 (60-Month Extension)||0
6275399|NCT00112437|7174447|FG010|COMPLETED|Years 6-10 (60-Month Extension)||0
6275400|NCT00112437|7174448|FG011|COMPLETED|Years 6-10 (60-Month Extension)||0
6275401|NCT00112437|7174449|FG012|COMPLETED|Years 6-10 (60-Month Extension)||0
6275402|NCT00112437|7174450|FG013|COMPLETED|Years 6-10 (60-Month Extension)||0
6275403|NCT00112437|7174451|FG014|COMPLETED|Years 6-10 (60-Month Extension)||0
6275404|NCT00112437|7174452|FG015|COMPLETED|Years 6-10 (60-Month Extension)||0
6275405|NCT00112437|7174453|FG016|COMPLETED|Years 6-10 (60-Month Extension)||0
6275406|NCT00112437|7174454|FG017|COMPLETED|Years 6-10 (60-Month Extension)||0
6275407|NCT00112437|7174455|FG018|COMPLETED|Years 6-10 (60-Month Extension)||0
6275408|NCT00112437|7174456|FG019|COMPLETED|Years 6-10 (60-Month Extension)||0
6275409|NCT00112437|7174457|FG020|COMPLETED|Years 6-10 (60-Month Extension)||0
6275410|NCT00112437|7174458|FG021|COMPLETED|Years 6-10 (60-Month Extension)||0
6275411|NCT00112437|7174459|FG022|COMPLETED|Years 6-10 (60-Month Extension)||23
6275412|NCT00112437|7174460|FG023|COMPLETED|Years 6-10 (60-Month Extension)||22
6275413|NCT00112437|7174461|FG024|COMPLETED|Years 6-10 (60-Month Extension)||22
6275414|NCT00112437|7174462|FG025|COMPLETED|Years 6-10 (60-Month Extension)||27
6275415|NCT00112437|7174437|FG000|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275416|NCT00112437|7174438|FG001|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275417|NCT00112437|7174439|FG002|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275418|NCT00112437|7174440|FG003|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275419|NCT00112437|7174441|FG004|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275420|NCT00112437|7174442|FG005|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275421|NCT00112437|7174443|FG006|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275422|NCT00112437|7174444|FG007|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275423|NCT00112437|7174445|FG008|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275424|NCT00112437|7174446|FG009|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275425|NCT00112437|7174447|FG010|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275426|NCT00112437|7174448|FG011|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275427|NCT00112437|7174449|FG012|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275428|NCT00112437|7174450|FG013|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275429|NCT00112437|7174451|FG014|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275430|NCT00112437|7174452|FG015|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275431|NCT00112437|7174453|FG016|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275432|NCT00112437|7174454|FG017|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275433|NCT00112437|7174455|FG018|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275434|NCT00112437|7174456|FG019|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275435|NCT00112437|7174457|FG020|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275436|NCT00112437|7174458|FG021|NOT COMPLETED|Years 6-10 (60-Month Extension)||0
6275437|NCT00112437|7174459|FG022|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
6275438|NCT00112437|7174460|FG023|NOT COMPLETED|Years 6-10 (60-Month Extension)||12
6275439|NCT00112437|7174461|FG024|NOT COMPLETED|Years 6-10 (60-Month Extension)||1
6275440|NCT00112437|7174462|FG025|NOT COMPLETED|Years 6-10 (60-Month Extension)||5
6275441|NCT00112463|7174516|FG000|STARTED|Overall Study||40
6275442|NCT00112463|7174516|FG000|COMPLETED|Overall Study||1
6275443|NCT00112463|7174516|FG000|NOT COMPLETED|Overall Study||39
6275444|NCT00112489|7174521|FG000|STARTED|Overall Study|All patients enrolled on study|55
6275445|NCT00112489|7174521|FG000|COMPLETED|Overall Study|Completed regimen due to progression|15
6275446|NCT00112489|7174521|FG000|NOT COMPLETED|Overall Study||40
6275447|NCT00112502|7174539|FG000|STARTED|Overall Study||22
6275448|NCT00112502|7174540|FG001|STARTED|Overall Study||22
6275449|NCT00112502|7174541|FG002|STARTED|Overall Study||22
6275450|NCT00112502|7174542|FG003|STARTED|Overall Study||22
6275451|NCT00112502|7174543|FG004|STARTED|Overall Study||23
6275452|NCT00112502|7174544|FG005|STARTED|Overall Study||22
6275453|NCT00112502|7174545|FG006|STARTED|Overall Study||23
6275454|NCT00112502|7174546|FG007|STARTED|Overall Study||22
6275455|NCT00112502|7174539|FG000|COMPLETED|Overall Study||22
6275456|NCT00112502|7174540|FG001|COMPLETED|Overall Study||21
6275457|NCT00112502|7174541|FG002|COMPLETED|Overall Study||21
6275458|NCT00112502|7174542|FG003|COMPLETED|Overall Study||18
6275459|NCT00112502|7174543|FG004|COMPLETED|Overall Study||21
6275460|NCT00112502|7174544|FG005|COMPLETED|Overall Study||17
6275461|NCT00112502|7174545|FG006|COMPLETED|Overall Study||20
6275462|NCT00112502|7174546|FG007|COMPLETED|Overall Study||15
6275463|NCT00112502|7174539|FG000|NOT COMPLETED|Overall Study||0
6275464|NCT00112502|7174540|FG001|NOT COMPLETED|Overall Study||1
6806859|NCT02970136|7739129|FG000|STARTED|Overall Study||377
6806860|NCT02970136|7739130|FG001|STARTED|Overall Study||377
6806861|NCT02970136|7739129|FG000|COMPLETED|Overall Study||297
6806862|NCT02970136|7739130|FG001|COMPLETED|Overall Study||282
6806863|NCT02970136|7739129|FG000|NOT COMPLETED|Overall Study||80
6806864|NCT02970136|7739130|FG001|NOT COMPLETED|Overall Study||95
6806865|NCT02969928|7739138|FG000|STARTED|Overall Study||23
6806866|NCT02969928|7739139|FG001|STARTED|Overall Study||23
6806867|NCT02969928|7739138|FG000|COMPLETED|Overall Study||23
6806868|NCT02969928|7739139|FG001|COMPLETED|Overall Study||23
6806869|NCT02969928|7739138|FG000|NOT COMPLETED|Overall Study||0
6806870|NCT02969928|7739139|FG001|NOT COMPLETED|Overall Study||0
6806871|NCT02949297|7739145|FG000|STARTED|1 Month||75
6806872|NCT02949297|7739145|FG000|COMPLETED|1 Month||75
6806873|NCT02949297|7739145|FG000|NOT COMPLETED|1 Month||0
6806874|NCT02949297|7739145|FG000|STARTED|6 Months||75
6806875|NCT02949297|7739145|FG000|COMPLETED|6 Months||72
6806876|NCT02949297|7739145|FG000|NOT COMPLETED|6 Months||3
6806877|NCT02949297|7739145|FG000|STARTED|12 Months||72
6806878|NCT02949297|7739145|FG000|COMPLETED|12 Months||67
6806879|NCT02949297|7739145|FG000|NOT COMPLETED|12 Months||5
6806880|NCT02945787|7739151|FG000|STARTED|Overall Study||714
6806881|NCT02945787|7739152|FG001|STARTED|Overall Study||703
6806882|NCT02945787|7739151|FG000|COMPLETED|Overall Study||714
6806883|NCT02945787|7739152|FG001|COMPLETED|Overall Study||703
6806884|NCT02945787|7739151|FG000|NOT COMPLETED|Overall Study||0
6504609|NCT01449370|7423594|FG001|NOT COMPLETED|Overall Study||6
6504610|NCT01449370|7423595|FG002|NOT COMPLETED|Overall Study||8
6504611|NCT01449370|7423596|FG003|NOT COMPLETED|Overall Study||4
6504612|NCT01449370|7423597|FG004|NOT COMPLETED|Overall Study||3
6504613|NCT01449370|7423598|FG005|NOT COMPLETED|Overall Study||3
6504614|NCT01449370|7423599|FG006|NOT COMPLETED|Overall Study||3
6504615|NCT01449370|7423600|FG007|NOT COMPLETED|Overall Study||3
6504616|NCT01449370|7423601|FG008|NOT COMPLETED|Overall Study||12
6504617|NCT01449370|7423602|FG009|NOT COMPLETED|Overall Study||3
6504618|NCT01449370|7423603|FG010|NOT COMPLETED|Overall Study||3
6504619|NCT01449370|7423604|FG011|NOT COMPLETED|Overall Study||3
6806885|NCT02945787|7739152|FG001|NOT COMPLETED|Overall Study||0
6806886|NCT02857426|7739160|FG000|STARTED|Overall Study||47
6567029|NCT01829048|7490096|FG000|NOT COMPLETED|Overall Study||0
6567030|NCT01829048|7490097|FG001|NOT COMPLETED|Overall Study||0
6567031|NCT01829048|7490098|FG002|NOT COMPLETED|Overall Study||0
6567032|NCT01829048|7490099|FG003|NOT COMPLETED|Overall Study||2
6806887|NCT02857426|7739161|FG001|STARTED|Overall Study||19
6806888|NCT02857426|7739160|FG000|COMPLETED|Overall Study||0
6275465|NCT00112502|7174541|FG002|NOT COMPLETED|Overall Study||1
6275466|NCT00112502|7174542|FG003|NOT COMPLETED|Overall Study||4
6275467|NCT00112502|7174543|FG004|NOT COMPLETED|Overall Study||2
6275468|NCT00112502|7174544|FG005|NOT COMPLETED|Overall Study||5
6275469|NCT00112502|7174545|FG006|NOT COMPLETED|Overall Study||3
6275470|NCT00112502|7174546|FG007|NOT COMPLETED|Overall Study||7
6806889|NCT02857426|7739161|FG001|COMPLETED|Overall Study||0
6806890|NCT02857426|7739160|FG000|NOT COMPLETED|Overall Study||47
6806891|NCT02857426|7739161|FG001|NOT COMPLETED|Overall Study||19
6806892|NCT02855125|7739169|FG000|STARTED|Overall Study||64
6806893|NCT02855125|7739170|FG001|STARTED|Overall Study||64
6806894|NCT02855125|7739169|FG000|Treated|Overall Study||64
6806895|NCT02855125|7739170|FG001|Treated|Overall Study||63
6806896|NCT02855125|7739169|FG000|COMPLETED|Overall Study||0
6806897|NCT02855125|7739170|FG001|COMPLETED|Overall Study||0
6806898|NCT02855125|7739169|FG000|NOT COMPLETED|Overall Study||64
6806899|NCT02855125|7739170|FG001|NOT COMPLETED|Overall Study||64
6806900|NCT02836236|7739178|FG000|STARTED|Overall Study||105
6806901|NCT02836236|7739179|FG001|STARTED|Overall Study||50
6806902|NCT02836236|7739178|FG000|COMPLETED|Overall Study||0
6806903|NCT02836236|7739179|FG001|COMPLETED|Overall Study||0
6806904|NCT02836236|7739178|FG000|NOT COMPLETED|Overall Study||105
6806905|NCT02836236|7739179|FG001|NOT COMPLETED|Overall Study||50
6806906|NCT02728752|7739187|FG000|STARTED|First Period||48
6806907|NCT02728752|7739188|FG001|STARTED|First Period||47
6806908|NCT02728752|7739187|FG000|COMPLETED|First Period||46
6806909|NCT02728752|7739188|FG001|COMPLETED|First Period||45
6806910|NCT02728752|7739187|FG000|NOT COMPLETED|First Period||2
6806911|NCT02728752|7739188|FG001|NOT COMPLETED|First Period||2
6806912|NCT02728752|7739187|FG000|STARTED|Extension Period||46
6806913|NCT02728752|7739188|FG001|STARTED|Extension Period||45
6806914|NCT02728752|7739187|FG000|COMPLETED|Extension Period||35
6806915|NCT02728752|7739188|FG001|COMPLETED|Extension Period||34
6806916|NCT02728752|7739187|FG000|NOT COMPLETED|Extension Period||11
6806917|NCT02728752|7739188|FG001|NOT COMPLETED|Extension Period||11
6806918|NCT02680587|7739197|FG000|STARTED|Overall Study||18
6806919|NCT02680587|7739198|FG001|STARTED|Overall Study||36
6275471|NCT00112580|7174576|FG000|STARTED|Overall Study||8
6275472|NCT00112580|7174577|FG001|STARTED|Overall Study||19
6275473|NCT00112580|7174576|FG000|COMPLETED|Overall Study||0
6275474|NCT00112580|7174577|FG001|COMPLETED|Overall Study||0
6275475|NCT00112580|7174576|FG000|NOT COMPLETED|Overall Study||8
6275476|NCT00112580|7174577|FG001|NOT COMPLETED|Overall Study||19
6275477|NCT00112593|7174582|FG000|STARTED|Overall Study||5
6567033|NCT01829048|7490100|FG004|NOT COMPLETED|Overall Study||0
6806920|NCT02680587|7739197|FG000|COMPLETED|Overall Study||17
6806921|NCT02680587|7739198|FG001|COMPLETED|Overall Study||36
6806922|NCT02680587|7739197|FG000|NOT COMPLETED|Overall Study||1
6806923|NCT02680587|7739198|FG001|NOT COMPLETED|Overall Study||0
6806924|NCT02667639|7739210|FG000|STARTED|Overall Study||25
6806925|NCT02667639|7739211|FG001|STARTED|Overall Study||10
6390452|NCT00830180|7302153|FG000|Received Tanezumab in Parent Study A4091003|Overall Study||19
6390453|NCT00830180|7302153|FG000|Received Placebo in Parent Study A4091003|Overall Study||22
6390454|NCT00830180|7302153|FG000|COMPLETED|Overall Study||15
6390455|NCT00830180|7302153|FG000|NOT COMPLETED|Overall Study||26
6390456|NCT00830232|7302161|FG000|STARTED|Overall Study||20
6390457|NCT00830232|7302162|FG001|STARTED|Overall Study||20
6390458|NCT00830232|7302161|FG000|COMPLETED|Overall Study||20
6390459|NCT00830232|7302162|FG001|COMPLETED|Overall Study||20
6390460|NCT00830232|7302161|FG000|NOT COMPLETED|Overall Study||0
6390461|NCT00830232|7302162|FG001|NOT COMPLETED|Overall Study||0
6390462|NCT00830284|7302168|FG000|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
6390463|NCT00830284|7302168|FG000|COMPLETED|Overall Study||10
6390464|NCT00830284|7302168|FG000|NOT COMPLETED|Overall Study||2
6390465|NCT00830310|7302172|FG000|STARTED|Overall Study||43
6390466|NCT00830310|7302172|FG000|COMPLETED|Overall Study||30
6390467|NCT00830310|7302172|FG000|NOT COMPLETED|Overall Study||13
6504620|NCT01449370|7423605|FG012|NOT COMPLETED|Overall Study||3
6504621|NCT01449370|7423606|FG013|NOT COMPLETED|Overall Study||11
6504622|NCT01449370|7423607|FG014|NOT COMPLETED|Overall Study||3
6504623|NCT01449370|7423608|FG015|NOT COMPLETED|Overall Study||3
6504624|NCT01449370|7423609|FG016|NOT COMPLETED|Overall Study||7
6504625|NCT01449370|7423610|FG017|NOT COMPLETED|Overall Study||3
6504626|NCT01449370|7423611|FG018|NOT COMPLETED|Overall Study||3
6504627|NCT01449370|7423612|FG019|NOT COMPLETED|Overall Study||3
6504628|NCT01449370|7423613|FG020|NOT COMPLETED|Overall Study||6
6504629|NCT01449370|7423614|FG021|NOT COMPLETED|Overall Study||4
6504630|NCT01449370|7423615|FG022|NOT COMPLETED|Overall Study||4
6504631|NCT01449370|7423616|FG023|NOT COMPLETED|Overall Study||10
6504632|NCT01449370|7423617|FG024|NOT COMPLETED|Overall Study||8
6504633|NCT01449461|7423696|FG000|STARTED|Overall Study||6
6504634|NCT01449461|7423697|FG001|STARTED|Overall Study||18
6504635|NCT01449461|7423698|FG002|STARTED|Overall Study||18
6504636|NCT01449461|7423699|FG003|STARTED|Overall Study||32
6504637|NCT01449461|7423700|FG004|STARTED|Overall Study||48
6504638|NCT01449461|7423701|FG005|STARTED|Overall Study||15
6504639|NCT01449461|7423696|FG000|COMPLETED|Overall Study||0
6504640|NCT01449461|7423697|FG001|COMPLETED|Overall Study||0
6504641|NCT01449461|7423698|FG002|COMPLETED|Overall Study||0
6504642|NCT01449461|7423699|FG003|COMPLETED|Overall Study||0
6504643|NCT01449461|7423700|FG004|COMPLETED|Overall Study||0
6504644|NCT01449461|7423701|FG005|COMPLETED|Overall Study||0
6504645|NCT01449461|7423696|FG000|NOT COMPLETED|Overall Study||6
6504646|NCT01449461|7423697|FG001|NOT COMPLETED|Overall Study||18
6504647|NCT01449461|7423698|FG002|NOT COMPLETED|Overall Study||18
6504648|NCT01449461|7423699|FG003|NOT COMPLETED|Overall Study||32
6504649|NCT01449461|7423700|FG004|NOT COMPLETED|Overall Study||48
6504650|NCT01449461|7423701|FG005|NOT COMPLETED|Overall Study||15
6504651|NCT01449513|7423726|FG000|STARTED|Overall Study||16
6504652|NCT01449513|7423727|FG001|STARTED|Overall Study||8
6504653|NCT01449513|7423726|FG000|COMPLETED|Overall Study||16
6504654|NCT01449513|7423727|FG001|COMPLETED|Overall Study||8
6504655|NCT01449513|7423726|FG000|NOT COMPLETED|Overall Study||0
6504656|NCT01449513|7423727|FG001|NOT COMPLETED|Overall Study||0
6504657|NCT01449526|7423735|FG000|STARTED|Overall Study||83
6504658|NCT01449526|7423736|FG001|STARTED|Overall Study||83
6504659|NCT01449526|7423735|FG000|COMPLETED|Overall Study||81
6504660|NCT01449526|7423736|FG001|COMPLETED|Overall Study||77
6504661|NCT01449526|7423735|FG000|NOT COMPLETED|Overall Study||2
6504662|NCT01449526|7423736|FG001|NOT COMPLETED|Overall Study||6
6504663|NCT01449539|7423742|FG000|STARTED|Overall Study||8
6504664|NCT01449539|7423742|FG000|COMPLETED|Overall Study||4
6504665|NCT01449539|7423742|FG000|NOT COMPLETED|Overall Study||4
6504666|NCT01449630|7423755|FG000|STARTED|Period 1||2
6504667|NCT01449630|7423756|FG001|STARTED|Period 1||6
6504668|NCT01449630|7423757|FG002|STARTED|Period 1||2
6504669|NCT01449630|7423758|FG003|STARTED|Period 1||2
6504670|NCT01449630|7423759|FG004|STARTED|Period 1||5
6504671|NCT01449630|7423760|FG005|STARTED|Period 1||2
6504672|NCT01449630|7423761|FG006|STARTED|Period 1||2
6504673|NCT01449630|7423762|FG007|STARTED|Period 1||6
6504674|NCT01449630|7423763|FG008|STARTED|Period 1||2
6504675|NCT01449630|7423755|FG000|Received at Least 1 Dose|Period 1||2
6504676|NCT01449630|7423756|FG001|Received at Least 1 Dose|Period 1||6
6504677|NCT01449630|7423757|FG002|Received at Least 1 Dose|Period 1||2
6504678|NCT01449630|7423758|FG003|Received at Least 1 Dose|Period 1||2
6504679|NCT01449630|7423759|FG004|Received at Least 1 Dose|Period 1||5
6504680|NCT01449630|7423760|FG005|Received at Least 1 Dose|Period 1||1
6567034|NCT01829113|7490115|FG000|STARTED|Overall Study|Three patients were enrolled and randomized but never received treatment.|77
6567035|NCT01829113|7490116|FG001|STARTED|Overall Study|Two patients were enrolled and randomized but never received treatment.|78
6567036|NCT01829113|7490115|FG000|COMPLETED|Overall Study||0
6567037|NCT01829113|7490116|FG001|COMPLETED|Overall Study||0
6567038|NCT01829113|7490115|FG000|NOT COMPLETED|Overall Study||77
6567039|NCT01829113|7490116|FG001|NOT COMPLETED|Overall Study||78
6806926|NCT02667639|7739210|FG000|COMPLETED|Overall Study||25
6806927|NCT02667639|7739211|FG001|COMPLETED|Overall Study||10
6806928|NCT02667639|7739210|FG000|NOT COMPLETED|Overall Study||0
6656928|NCT02465567|7587296|FG000|NOT COMPLETED|Overall Study||449
6806929|NCT02667639|7739211|FG001|NOT COMPLETED|Overall Study||0
6806930|NCT02652949|7739219|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
6806931|NCT02652949|7739219|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
6806932|NCT02652949|7739219|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
6806933|NCT02652949|7739219|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
6806934|NCT02652949|7739219|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
6806935|NCT02652949|7739219|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
6806936|NCT02652949|7739219|FG000|STARTED|6-Month Follow-up Secondary Endpoint|Note that 6-month follow up is not mandatory for OUS subjects.|99
6806937|NCT02652949|7739219|FG000|COMPLETED|6-Month Follow-up Secondary Endpoint||91
6806938|NCT02652949|7739219|FG000|NOT COMPLETED|6-Month Follow-up Secondary Endpoint||8
6806939|NCT02652949|7739219|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
6806940|NCT02652949|7739219|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
6806941|NCT02652949|7739219|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
6806942|NCT02652949|7739219|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
6567040|NCT01829165|7490126|FG000|STARTED|Overall Study||20
6567041|NCT01829165|7490127|FG001|STARTED|Overall Study||13
6275478|NCT00112593|7174582|FG000|COMPLETED|Overall Study||5
6275479|NCT00112593|7174582|FG000|NOT COMPLETED|Overall Study||0
6275480|NCT00112671|7174586|FG000|STARTED|Overall Study||17
6275481|NCT00112671|7174586|FG000|COMPLETED|Overall Study||17
6275482|NCT00112671|7174586|FG000|NOT COMPLETED|Overall Study||0
6275483|NCT00112723|7174590|FG000|STARTED|Overall Study||13
6275484|NCT00112723|7174591|FG001|STARTED|Overall Study||19
6275485|NCT00112723|7174592|FG002|STARTED|Overall Study||14
6567042|NCT01829165|7490126|FG000|COMPLETED|Overall Study||18
6806943|NCT02652949|7739219|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52
6806944|NCT02652949|7739219|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
6275486|NCT00112723|7174590|FG000|Patients Evaluable for Toxicity|Overall Study||11
6567043|NCT01829165|7490127|FG001|COMPLETED|Overall Study||13
6567044|NCT01829165|7490126|FG000|NOT COMPLETED|Overall Study||2
6390468|NCT00830362|7302178|FG000|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
6390469|NCT00830362|7302179|FG001|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
6390470|NCT00830362|7302178|FG000|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
6390471|NCT00830362|7302179|FG001|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
6390472|NCT00830362|7302178|FG000|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
6806945|NCT02574455|7739231|FG000|STARTED|Overall Study||267
6806946|NCT02574455|7739232|FG001|STARTED|Overall Study||262
6806947|NCT02574455|7739231|FG000|Enrolled and Treated|Overall Study||258
6806948|NCT02574455|7739232|FG001|Enrolled and Treated|Overall Study||224
6806949|NCT02574455|7739231|FG000|COMPLETED|Overall Study||0
6806950|NCT02574455|7739232|FG001|COMPLETED|Overall Study||0
6806951|NCT02574455|7739231|FG000|NOT COMPLETED|Overall Study||267
6806952|NCT02574455|7739232|FG001|NOT COMPLETED|Overall Study||262
6806953|NCT02527798|7739244|FG000|STARTED|Overall Study||32
6806954|NCT02527798|7739245|FG001|STARTED|Overall Study||10
6806955|NCT02527798|7739246|FG002|STARTED|Overall Study||30
6806956|NCT02527798|7739247|FG003|STARTED|Overall Study||10
6806957|NCT02527798|7739248|FG004|STARTED|Overall Study||0
6806958|NCT02527798|7739249|FG005|STARTED|Overall Study||0
6806959|NCT02527798|7739244|FG000|Randomized, Not Dosed|Overall Study||31
6806960|NCT02527798|7739245|FG001|Randomized, Not Dosed|Overall Study||9
6806961|NCT02527798|7739246|FG002|Randomized, Not Dosed|Overall Study||30
6806962|NCT02527798|7739247|FG003|Randomized, Not Dosed|Overall Study||10
6390473|NCT00830362|7302179|FG001|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
6390474|NCT00830362|7302178|FG000|NOT COMPLETED|Overall Study||4
6390475|NCT00830362|7302179|FG001|NOT COMPLETED|Overall Study||4
6390476|NCT00830375|7302185|FG000|STARTED|Overall Study||10
6390477|NCT00830375|7302185|FG000|COMPLETED|Overall Study||9
6390478|NCT00830375|7302185|FG000|NOT COMPLETED|Overall Study||1
6390479|NCT00830388|7302189|FG000|STARTED|Overall Study||11
6390480|NCT00830388|7302189|FG000|COMPLETED|Overall Study||11
6390481|NCT00830388|7302189|FG000|NOT COMPLETED|Overall Study||0
6806963|NCT02527798|7739248|FG004|Randomized, Not Dosed|Overall Study||0
6806964|NCT02527798|7739249|FG005|Randomized, Not Dosed|Overall Study||0
6806965|NCT02527798|7739244|FG000|Pharmacokinetic (PK) Population|Overall Study||20
6806966|NCT02527798|7739245|FG001|Pharmacokinetic (PK) Population|Overall Study||0
6390482|NCT00830440|7302195|FG000|STARTED|Overall Study||32
6390483|NCT00830440|7302196|FG001|STARTED|Overall Study||11
6390484|NCT00830440|7302195|FG000|Received Device|Overall Study||26
6390485|NCT00830440|7302196|FG001|Received Device|Overall Study||0
6390486|NCT00830440|7302195|FG000|Completed 12 Week Follow up|Overall Study||24
6390487|NCT00830440|7302196|FG001|Completed 12 Week Follow up|Overall Study||11
6390488|NCT00830440|7302195|FG000|Completed 16 Week Follow up|Overall Study||4
6390489|NCT00830440|7302196|FG001|Completed 16 Week Follow up|Overall Study||0
6390490|NCT00830440|7302195|FG000|Completed 24 Week Follow up|Overall Study||3
6390491|NCT00830440|7302196|FG001|Completed 24 Week Follow up|Overall Study||0
6390492|NCT00830440|7302195|FG000|COMPLETED|Overall Study||24
6390493|NCT00830440|7302196|FG001|COMPLETED|Overall Study||11
6390494|NCT00830440|7302195|FG000|NOT COMPLETED|Overall Study||8
6390495|NCT00830440|7302196|FG001|NOT COMPLETED|Overall Study||0
6390496|NCT00830518|7302205|FG000|STARTED|Overall Study||46
6390497|NCT00830518|7302206|FG001|STARTED|Overall Study||11
6390498|NCT00830518|7302205|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|0
6390499|NCT00830518|7302206|FG001|COMPLETED|Overall Study||0
6390500|NCT00830518|7302205|FG000|NOT COMPLETED|Overall Study||46
6390501|NCT00830518|7302206|FG001|NOT COMPLETED|Overall Study||11
6390502|NCT00830596|7302216|FG000|STARTED|Overall Study||74
6390503|NCT00830596|7302217|FG001|STARTED|Overall Study||74
6390504|NCT00830596|7302218|FG002|STARTED|Overall Study||73
6390505|NCT00830596|7302216|FG000|COMPLETED|Overall Study||72
6390506|NCT00830596|7302217|FG001|COMPLETED|Overall Study||72
6390507|NCT00830596|7302218|FG002|COMPLETED|Overall Study||67
6390508|NCT00830596|7302216|FG000|NOT COMPLETED|Overall Study||2
6390509|NCT00830596|7302217|FG001|NOT COMPLETED|Overall Study||2
6390510|NCT00830596|7302218|FG002|NOT COMPLETED|Overall Study||6
6390511|NCT00830765|7302228|FG000|STARTED|Overall Study||73
6390512|NCT00830765|7302229|FG001|STARTED|Overall Study||71
6390513|NCT00830765|7302228|FG000|COMPLETED|Overall Study||70
6390514|NCT00830765|7302229|FG001|COMPLETED|Overall Study||69
6390515|NCT00830765|7302228|FG000|NOT COMPLETED|Overall Study||3
6390516|NCT00830765|7302229|FG001|NOT COMPLETED|Overall Study||2
6390517|NCT00830791|7302241|FG000|STARTED|Overall Study||8
6390518|NCT00830791|7302242|FG001|STARTED|Overall Study||8
6390519|NCT00830791|7302243|FG002|STARTED|Overall Study||8
6390520|NCT00830791|7302244|FG003|STARTED|Overall Study||8
6390521|NCT00830791|7302245|FG004|STARTED|Overall Study||0
6390522|NCT00830791|7302246|FG005|STARTED|Overall Study||0
6390523|NCT00830791|7302241|FG000|COMPLETED|Overall Study||8
6390524|NCT00830791|7302242|FG001|COMPLETED|Overall Study||8
6390525|NCT00830791|7302243|FG002|COMPLETED|Overall Study||8
6390526|NCT00830791|7302244|FG003|COMPLETED|Overall Study||8
6390527|NCT00830791|7302245|FG004|COMPLETED|Overall Study||0
6390528|NCT00830791|7302246|FG005|COMPLETED|Overall Study||0
6504681|NCT01449630|7423761|FG006|Received at Least 1 Dose|Period 1||2
6504682|NCT01449630|7423762|FG007|Received at Least 1 Dose|Period 1||6
6504683|NCT01449630|7423763|FG008|Received at Least 1 Dose|Period 1||2
6504684|NCT01449630|7423755|FG000|COMPLETED|Period 1||1
6504685|NCT01449630|7423756|FG001|COMPLETED|Period 1||6
6504686|NCT01449630|7423757|FG002|COMPLETED|Period 1||2
6806967|NCT02527798|7739246|FG002|Pharmacokinetic (PK) Population|Overall Study||19
6806968|NCT02527798|7739247|FG003|Pharmacokinetic (PK) Population|Overall Study||0
6806969|NCT02527798|7739248|FG004|Pharmacokinetic (PK) Population|Overall Study||0
6806970|NCT02527798|7739249|FG005|Pharmacokinetic (PK) Population|Overall Study||0
6806971|NCT02527798|7739244|FG000|COMPLETED|Overall Study||29
6806972|NCT02527798|7739245|FG001|COMPLETED|Overall Study||8
6806973|NCT02527798|7739246|FG002|COMPLETED|Overall Study||25
6806974|NCT02527798|7739247|FG003|COMPLETED|Overall Study||9
6806975|NCT02527798|7739248|FG004|COMPLETED|Overall Study||0
6806976|NCT02527798|7739249|FG005|COMPLETED|Overall Study||0
6806977|NCT02527798|7739244|FG000|NOT COMPLETED|Overall Study||3
6806978|NCT02527798|7739245|FG001|NOT COMPLETED|Overall Study||2
6806979|NCT02527798|7739246|FG002|NOT COMPLETED|Overall Study||5
6806980|NCT02527798|7739247|FG003|NOT COMPLETED|Overall Study||1
6806981|NCT02527798|7739248|FG004|NOT COMPLETED|Overall Study||0
6806982|NCT02527798|7739249|FG005|NOT COMPLETED|Overall Study||0
6390529|NCT00830791|7302241|FG000|NOT COMPLETED|Overall Study||0
6390530|NCT00830791|7302242|FG001|NOT COMPLETED|Overall Study||0
6390531|NCT00830791|7302243|FG002|NOT COMPLETED|Overall Study||0
6390532|NCT00830791|7302244|FG003|NOT COMPLETED|Overall Study||0
6390533|NCT00830791|7302245|FG004|NOT COMPLETED|Overall Study||0
6390534|NCT00830791|7302246|FG005|NOT COMPLETED|Overall Study||0
6390535|NCT00830804|7302259|FG000|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
6390536|NCT00830804|7302259|FG000|COMPLETED|Overall Study||97
6390537|NCT00830804|7302259|FG000|NOT COMPLETED|Overall Study||15
6390538|NCT00830869|7302276|FG000|STARTED|Period 1: Part 1||1
6504687|NCT01449630|7423758|FG003|COMPLETED|Period 1||1
6806983|NCT02416492|7739280|FG000|STARTED|Overall Study||15
6806984|NCT02416492|7739281|FG001|STARTED|Overall Study||15
6806985|NCT02416492|7739282|FG002|STARTED|Overall Study||16
6806986|NCT02416492|7739283|FG003|STARTED|Overall Study||15
6390539|NCT00830869|7302277|FG001|STARTED|Period 1: Part 1||1
6390540|NCT00830869|7302278|FG002|STARTED|Period 1: Part 1||1
6390541|NCT00830869|7302279|FG003|STARTED|Period 1: Part 1||7
6390542|NCT00830869|7302280|FG004|STARTED|Period 1: Part 1||4
6390543|NCT00830869|7302281|FG005|STARTED|Period 1: Part 1||6
6390544|NCT00830869|7302282|FG006|STARTED|Period 1: Part 1||3
6390545|NCT00830869|7302283|FG007|STARTED|Period 1: Part 1||0
6390546|NCT00830869|7302284|FG008|STARTED|Period 1: Part 1||0
6390547|NCT00830869|7302285|FG009|STARTED|Period 1: Part 1||0
6390548|NCT00830869|7302286|FG010|STARTED|Period 1: Part 1||0
6390549|NCT00830869|7302287|FG011|STARTED|Period 1: Part 1||0
6390550|NCT00830869|7302276|FG000|COMPLETED|Period 1: Part 1||0
6390551|NCT00830869|7302277|FG001|COMPLETED|Period 1: Part 1||0
6390552|NCT00830869|7302278|FG002|COMPLETED|Period 1: Part 1||0
6390553|NCT00830869|7302279|FG003|COMPLETED|Period 1: Part 1||0
6390554|NCT00830869|7302280|FG004|COMPLETED|Period 1: Part 1||0
6390555|NCT00830869|7302281|FG005|COMPLETED|Period 1: Part 1||0
6390556|NCT00830869|7302282|FG006|COMPLETED|Period 1: Part 1||0
6390557|NCT00830869|7302283|FG007|COMPLETED|Period 1: Part 1||0
6390558|NCT00830869|7302284|FG008|COMPLETED|Period 1: Part 1||0
6390559|NCT00830869|7302285|FG009|COMPLETED|Period 1: Part 1||0
6390560|NCT00830869|7302286|FG010|COMPLETED|Period 1: Part 1||0
6390561|NCT00830869|7302287|FG011|COMPLETED|Period 1: Part 1||0
6390562|NCT00830869|7302276|FG000|NOT COMPLETED|Period 1: Part 1||1
6390563|NCT00830869|7302277|FG001|NOT COMPLETED|Period 1: Part 1||1
6390564|NCT00830869|7302278|FG002|NOT COMPLETED|Period 1: Part 1||1
6390565|NCT00830869|7302279|FG003|NOT COMPLETED|Period 1: Part 1||7
6390566|NCT00830869|7302280|FG004|NOT COMPLETED|Period 1: Part 1||4
6806987|NCT02416492|7739280|FG000|COMPLETED|Overall Study||15
6806988|NCT02416492|7739281|FG001|COMPLETED|Overall Study||15
6390567|NCT00830869|7302281|FG005|NOT COMPLETED|Period 1: Part 1||6
6806989|NCT02416492|7739282|FG002|COMPLETED|Overall Study||16
6806990|NCT02416492|7739283|FG003|COMPLETED|Overall Study||15
6806991|NCT02416492|7739280|FG000|NOT COMPLETED|Overall Study||0
6806992|NCT02416492|7739281|FG001|NOT COMPLETED|Overall Study||0
6806993|NCT02416492|7739282|FG002|NOT COMPLETED|Overall Study||0
6806994|NCT02416492|7739283|FG003|NOT COMPLETED|Overall Study||0
6806995|NCT02324816|7739296|FG000|STARTED|Overall Study||19
6806996|NCT02324816|7739296|FG000|COMPLETED|Overall Study||19
6390568|NCT00830869|7302282|FG006|NOT COMPLETED|Period 1: Part 1||3
6390569|NCT00830869|7302283|FG007|NOT COMPLETED|Period 1: Part 1||0
6390570|NCT00830869|7302284|FG008|NOT COMPLETED|Period 1: Part 1||0
6806997|NCT02324816|7739296|FG000|NOT COMPLETED|Overall Study||0
6390571|NCT00830869|7302285|FG009|NOT COMPLETED|Period 1: Part 1||0
6390572|NCT00830869|7302286|FG010|NOT COMPLETED|Period 1: Part 1||0
6390573|NCT00830869|7302287|FG011|NOT COMPLETED|Period 1: Part 1||0
6390574|NCT00830869|7302276|FG000|STARTED|Period 2: Part 2||0
6390575|NCT00830869|7302277|FG001|STARTED|Period 2: Part 2||0
6806998|NCT02279745|7739300|FG000|STARTED|Overall Study||45
6806999|NCT02279745|7739300|FG000|COMPLETED|Overall Study||25
6807000|NCT02279745|7739300|FG000|NOT COMPLETED|Overall Study||20
6807001|NCT02067975|7739306|FG000|STARTED|Overall Study||20
6807002|NCT02067975|7739307|FG001|STARTED|Overall Study||18
6807003|NCT02067975|7739308|FG002|STARTED|Overall Study||21
6807004|NCT02067975|7739309|FG003|STARTED|Overall Study||18
6807005|NCT02067975|7739310|FG004|STARTED|Overall Study||8
6807006|NCT02067975|7739311|FG005|STARTED|Overall Study||8
6807007|NCT02067975|7739306|FG000|COMPLETED|Overall Study||16
6807008|NCT02067975|7739307|FG001|COMPLETED|Overall Study||16
6807009|NCT02067975|7739308|FG002|COMPLETED|Overall Study||19
6807010|NCT02067975|7739309|FG003|COMPLETED|Overall Study||14
6807011|NCT02067975|7739310|FG004|COMPLETED|Overall Study||0
6807012|NCT02067975|7739311|FG005|COMPLETED|Overall Study||0
6807013|NCT02067975|7739306|FG000|NOT COMPLETED|Overall Study||4
6807014|NCT02067975|7739307|FG001|NOT COMPLETED|Overall Study||2
6807015|NCT02067975|7739308|FG002|NOT COMPLETED|Overall Study||2
6807016|NCT02067975|7739309|FG003|NOT COMPLETED|Overall Study||4
6807017|NCT02067975|7739310|FG004|NOT COMPLETED|Overall Study||8
6807018|NCT02067975|7739311|FG005|NOT COMPLETED|Overall Study||8
6807019|NCT02030938|7739323|FG000|STARTED|Overall Study||34
6807020|NCT02030938|7739323|FG000|COMPLETED|Overall Study||29
6807021|NCT02030938|7739323|FG000|NOT COMPLETED|Overall Study||5
6807022|NCT02006147|7739335|FG000|STARTED|Overall Study||5
6807023|NCT02006147|7739336|FG001|STARTED|Overall Study||9
6807024|NCT02006147|7739337|FG002|STARTED|Overall Study||0
6807025|NCT02006147|7739338|FG003|STARTED|Overall Study||0
6807026|NCT02006147|7739335|FG000|COMPLETED|Overall Study||3
6807027|NCT02006147|7739336|FG001|COMPLETED|Overall Study||7
6807028|NCT02006147|7739337|FG002|COMPLETED|Overall Study||0
6807029|NCT02006147|7739338|FG003|COMPLETED|Overall Study||0
6807030|NCT02006147|7739335|FG000|NOT COMPLETED|Overall Study||2
6807031|NCT02006147|7739336|FG001|NOT COMPLETED|Overall Study||2
6807032|NCT02006147|7739337|FG002|NOT COMPLETED|Overall Study||0
6275487|NCT00112723|7174591|FG001|Patients Evaluable for Toxicity|Overall Study||12
6275488|NCT00112723|7174592|FG002|Patients Evaluable for Toxicity|Overall Study||12
6275489|NCT00112723|7174590|FG000|COMPLETED|Overall Study||11
6275490|NCT00112723|7174591|FG001|COMPLETED|Overall Study||12
6275491|NCT00112723|7174592|FG002|COMPLETED|Overall Study||12
6275492|NCT00112723|7174590|FG000|NOT COMPLETED|Overall Study||2
6275493|NCT00112723|7174591|FG001|NOT COMPLETED|Overall Study||7
6275494|NCT00112723|7174592|FG002|NOT COMPLETED|Overall Study||2
6275495|NCT00112736|7174616|FG000|STARTED|Overall Study||22
6275496|NCT00112736|7174617|FG001|STARTED|Overall Study||47
6275497|NCT00112736|7174616|FG000|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
6275498|NCT00112736|7174617|FG001|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
6275499|NCT00112736|7174616|FG000|NOT COMPLETED|Overall Study||1
6275500|NCT00112736|7174617|FG001|NOT COMPLETED|Overall Study||0
6390576|NCT00830869|7302278|FG002|STARTED|Period 2: Part 2||0
6807033|NCT02006147|7739338|FG003|NOT COMPLETED|Overall Study||0
6807034|NCT01999179|7739344|FG000|STARTED|Overall Study||27
6807035|NCT01999179|7739344|FG000|COMPLETED|Overall Study||20
6807036|NCT01999179|7739344|FG000|NOT COMPLETED|Overall Study||7
6807037|NCT01940341|7739350|FG000|STARTED|Double-Blind Phase||285
6807038|NCT01940341|7739351|FG001|STARTED|Double-Blind Phase||141
6807039|NCT01940341|7739350|FG000|COMPLETED|Double-Blind Phase||4
6807040|NCT01940341|7739351|FG001|COMPLETED|Double-Blind Phase||1
6807041|NCT01940341|7739350|FG000|NOT COMPLETED|Double-Blind Phase||281
6807042|NCT01940341|7739351|FG001|NOT COMPLETED|Double-Blind Phase||140
6807043|NCT01940341|7739350|FG000|STARTED|Open-label Extension Phase||4
6807044|NCT01940341|7739351|FG001|STARTED|Open-label Extension Phase||1
6807045|NCT01940341|7739350|FG000|COMPLETED|Open-label Extension Phase||0
6807046|NCT01940341|7739351|FG001|COMPLETED|Open-label Extension Phase||0
6807047|NCT01940341|7739350|FG000|NOT COMPLETED|Open-label Extension Phase||4
6275501|NCT00112827|7174634|FG000|STARTED|Overall Study||3
6275502|NCT00112827|7174635|FG001|STARTED|Overall Study||4
6275503|NCT00112827|7174636|FG002|STARTED|Overall Study||4
6275504|NCT00112827|7174637|FG003|STARTED|Overall Study||36
6275505|NCT00112827|7174638|FG004|STARTED|Overall Study||7
6275506|NCT00112827|7174634|FG000|COMPLETED|Overall Study||3
6275507|NCT00112827|7174635|FG001|COMPLETED|Overall Study||4
6807048|NCT01940341|7739351|FG001|NOT COMPLETED|Open-label Extension Phase||1
6807049|NCT01925794|7739359|FG000|STARTED|30 Days||296
6807050|NCT01925794|7739359|FG000|COMPLETED|30 Days||296
6807051|NCT01925794|7739359|FG000|NOT COMPLETED|30 Days||0
6807052|NCT01925794|7739359|FG000|STARTED|180 Days||296
6807053|NCT01925794|7739359|FG000|COMPLETED|180 Days||292
6567045|NCT01829165|7490127|FG001|NOT COMPLETED|Overall Study||0
6567046|NCT01829191|7490135|FG000|STARTED|Overall Study||63
6567047|NCT01829191|7490136|FG001|STARTED|Overall Study||64
6567048|NCT01829191|7490135|FG000|COMPLETED|Overall Study||56
6567049|NCT01829191|7490136|FG001|COMPLETED|Overall Study||50
6656929|NCT02465567|7587297|FG001|NOT COMPLETED|Overall Study||424
6807054|NCT01925794|7739359|FG000|NOT COMPLETED|180 Days||4
6807055|NCT01925794|7739359|FG000|STARTED|270 Days||292
6807056|NCT01925794|7739359|FG000|COMPLETED|270 Days||287
6807057|NCT01925794|7739359|FG000|NOT COMPLETED|270 Days||5
6807058|NCT01907360|7739369|FG000|STARTED|Overall Study||18
6807059|NCT01907360|7739370|FG001|STARTED|Overall Study||11
6807060|NCT01907360|7739369|FG000|COMPLETED|Overall Study||18
6807061|NCT01907360|7739370|FG001|COMPLETED|Overall Study||11
6807062|NCT01907360|7739369|FG000|NOT COMPLETED|Overall Study||0
6807063|NCT01907360|7739370|FG001|NOT COMPLETED|Overall Study||0
6807064|NCT01856868|7739376|FG000|STARTED|Overall Study||7
6807065|NCT01856868|7739376|FG000|COMPLETED|Overall Study||7
6807066|NCT01856868|7739376|FG000|NOT COMPLETED|Overall Study||0
6807067|NCT01849250|7739382|FG000|STARTED|Overall Study||32
6807068|NCT01849250|7739383|FG001|STARTED|Overall Study||32
6807069|NCT01849250|7739382|FG000|COMPLETED|Overall Study||25
6807070|NCT01849250|7739383|FG001|COMPLETED|Overall Study||29
6807071|NCT01849250|7739382|FG000|NOT COMPLETED|Overall Study||7
6807072|NCT01849250|7739383|FG001|NOT COMPLETED|Overall Study||3
6807073|NCT01592643|7739390|FG000|STARTED|Overall Study||30
6807074|NCT01592643|7739390|FG000|COMPLETED|Overall Study||30
6807075|NCT01592643|7739390|FG000|NOT COMPLETED|Overall Study||0
6807076|NCT01441115|7739394|FG000|STARTED|Overall Study||2
6807077|NCT01441115|7739394|FG000|COMPLETED|Overall Study||1
6807078|NCT01441115|7739394|FG000|NOT COMPLETED|Overall Study||1
6807079|NCT01295944|7739401|FG000|STARTED|Overall Study||35
6807080|NCT01295944|7739401|FG000|COMPLETED|Overall Study||17
6807081|NCT01295944|7739401|FG000|NOT COMPLETED|Overall Study||18
6807082|NCT01199302|7739409|FG000|STARTED|Overall Study||20
6807083|NCT01199302|7739410|FG001|STARTED|Overall Study||16
6807084|NCT01199302|7739411|FG002|STARTED|Overall Study||20
6807085|NCT01199302|7739412|FG003|STARTED|Overall Study||11
6807086|NCT01199302|7739409|FG000|COMPLETED|Overall Study||0
6807087|NCT01199302|7739410|FG001|COMPLETED|Overall Study||0
6807088|NCT01199302|7739411|FG002|COMPLETED|Overall Study||0
6807089|NCT01199302|7739412|FG003|COMPLETED|Overall Study||0
6807090|NCT01199302|7739409|FG000|NOT COMPLETED|Overall Study||20
6807091|NCT01199302|7739410|FG001|NOT COMPLETED|Overall Study||16
6807092|NCT01199302|7739411|FG002|NOT COMPLETED|Overall Study||20
6807093|NCT01199302|7739412|FG003|NOT COMPLETED|Overall Study||11
6807094|NCT01123707|7739423|FG000|STARTED|Overall Study||44
6807095|NCT01123707|7739424|FG001|STARTED|Overall Study||41
6807096|NCT01123707|7739425|FG002|STARTED|Overall Study||38
6807097|NCT01123707|7739426|FG003|STARTED|Overall Study||50
6807098|NCT01123707|7739423|FG000|Safety Sample|Overall Study||44
6807099|NCT01123707|7739424|FG001|Safety Sample|Overall Study||41
6807100|NCT01123707|7739425|FG002|Safety Sample|Overall Study||36
6567050|NCT01829191|7490135|FG000|NOT COMPLETED|Overall Study||7
6567051|NCT01829191|7490136|FG001|NOT COMPLETED|Overall Study||14
6567052|NCT01829217|7490141|FG000|STARTED|Overall Study||13
6807101|NCT01123707|7739426|FG003|Safety Sample|Overall Study||49
6807102|NCT01123707|7739423|FG000|COMPLETED|Overall Study||0
6807103|NCT01123707|7739424|FG001|COMPLETED|Overall Study||0
6807104|NCT01123707|7739425|FG002|COMPLETED|Overall Study||0
6807105|NCT01123707|7739426|FG003|COMPLETED|Overall Study||0
6807106|NCT01123707|7739423|FG000|NOT COMPLETED|Overall Study||44
6807107|NCT01123707|7739424|FG001|NOT COMPLETED|Overall Study||41
6807108|NCT01123707|7739425|FG002|NOT COMPLETED|Overall Study||38
6807109|NCT01123707|7739426|FG003|NOT COMPLETED|Overall Study||50
6807110|NCT00894244|7739436|FG000|STARTED|Overall Study||25
6807111|NCT00894244|7739436|FG000|COMPLETED|Overall Study||24
6807112|NCT00894244|7739436|FG000|NOT COMPLETED|Overall Study||1
6807113|NCT00462943|7739443|FG000|STARTED|Overall Study||46
6807114|NCT00462943|7739444|FG001|STARTED|Overall Study||31
6567053|NCT01829217|7490141|FG000|COMPLETED|Overall Study||13
6807115|NCT00462943|7739445|FG002|STARTED|Overall Study||23
6807116|NCT00462943|7739443|FG000|COMPLETED|Overall Study||1
6807117|NCT00462943|7739444|FG001|COMPLETED|Overall Study||1
6807118|NCT00462943|7739445|FG002|COMPLETED|Overall Study||0
6807119|NCT00462943|7739443|FG000|NOT COMPLETED|Overall Study||45
6807120|NCT00462943|7739444|FG001|NOT COMPLETED|Overall Study||30
6807121|NCT00462943|7739445|FG002|NOT COMPLETED|Overall Study||23
6807122|NCT00248287|7739455|FG000|STARTED|Overall Study||75
6807123|NCT00248287|7739456|FG001|STARTED|Overall Study||79
6807124|NCT00248287|7739455|FG000|COMPLETED|Overall Study||51
6807125|NCT00248287|7739456|FG001|COMPLETED|Overall Study||60
6807126|NCT00248287|7739455|FG000|NOT COMPLETED|Overall Study||24
6807127|NCT00248287|7739456|FG001|NOT COMPLETED|Overall Study||19
6807128|NCT00182728|7739462|FG000|STARTED|Overall Study||71
6807129|NCT00182728|7739462|FG000|COMPLETED|Overall Study||71
6807130|NCT00182728|7739462|FG000|NOT COMPLETED|Overall Study||0
6807131|NCT00105560|7739466|FG000|STARTED|Overall Study||59
6807132|NCT00105560|7739466|FG000|COMPLETED|Overall Study||58
6807133|NCT00105560|7739466|FG000|NOT COMPLETED|Overall Study||1
6807134|NCT00038727|7739482|FG000|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|916
6807135|NCT00038727|7739483|FG001|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|927
6807136|NCT00038727|7739484|FG002|STARTED|Overall Study|Includes all enrollees from DPPOS 1-3|936
6807137|NCT00038727|7739482|FG000|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|910
6807138|NCT00038727|7739483|FG001|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|924
6807139|NCT00038727|7739484|FG002|DPPOS Phase 1 Primary|Overall Study|As reported in the Lancet 2009|932
6807140|NCT00038727|7739482|FG000|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|915
6807141|NCT00038727|7739483|FG001|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|926
6807142|NCT00038727|7739484|FG002|DPPOS Phase 2 Enrolled|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|935
6807143|NCT00038727|7739482|FG000|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|751
6807144|NCT00038727|7739483|FG001|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|772
6807145|NCT00038727|7739484|FG002|DPPOS Phase 2 Primary|Overall Study|As reported in Lancet Diabetes and Endocrinology 2015|780
6807146|NCT00038727|7739482|FG000|DPPOS Phase 3 Enrolled|Overall Study||916
6807147|NCT00038727|7739483|FG001|DPPOS Phase 3 Enrolled|Overall Study||927
6807148|NCT00038727|7739484|FG002|DPPOS Phase 3 Enrolled|Overall Study||936
6567054|NCT01829217|7490141|FG000|NOT COMPLETED|Overall Study||0
6275508|NCT00112827|7174636|FG002|COMPLETED|Overall Study||4
6275509|NCT00112827|7174637|FG003|COMPLETED|Overall Study||36
6275510|NCT00112827|7174638|FG004|COMPLETED|Overall Study||7
6275511|NCT00112827|7174634|FG000|NOT COMPLETED|Overall Study||0
6275512|NCT00112827|7174635|FG001|NOT COMPLETED|Overall Study||0
6275513|NCT00112827|7174636|FG002|NOT COMPLETED|Overall Study||0
6275514|NCT00112827|7174637|FG003|NOT COMPLETED|Overall Study||0
6275515|NCT00112827|7174638|FG004|NOT COMPLETED|Overall Study||0
6275516|NCT00112866|7174653|FG000|STARTED|Overall Study||15
6275517|NCT00112866|7174654|FG001|STARTED|Overall Study||15
6275518|NCT00112866|7174653|FG000|COMPLETED|Overall Study||13
6275519|NCT00112866|7174654|FG001|COMPLETED|Overall Study||13
6275520|NCT00112866|7174653|FG000|NOT COMPLETED|Overall Study||2
6275521|NCT00112866|7174654|FG001|NOT COMPLETED|Overall Study||2
6807149|NCT00038727|7739482|FG000|COMPLETED|Overall Study||916
6807150|NCT00038727|7739483|FG001|COMPLETED|Overall Study||927
6807151|NCT00038727|7739484|FG002|COMPLETED|Overall Study||936
6807152|NCT00038727|7739482|FG000|NOT COMPLETED|Overall Study||0
6807153|NCT00038727|7739483|FG001|NOT COMPLETED|Overall Study||0
6807154|NCT00038727|7739484|FG002|NOT COMPLETED|Overall Study||0
6275522|NCT00112905|7174668|FG000|STARTED|Overall Study||27
6275523|NCT00112905|7174668|FG000|Eligible and Treated|Overall Study||22
6275524|NCT00112905|7174668|FG000|COMPLETED|Overall Study||15
6275525|NCT00112905|7174668|FG000|NOT COMPLETED|Overall Study||12
6275526|NCT00112918|7174675|FG000|STARTED|Overall Study||1151
6275527|NCT00112918|7174676|FG001|STARTED|Overall Study||1155
6275528|NCT00112918|7174677|FG002|STARTED|Overall Study||1145
6275529|NCT00112918|7174675|FG000|Received Treatment|Overall Study||1126
6275530|NCT00112918|7174676|FG001|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
6275531|NCT00112918|7174677|FG002|Received Treatment|Overall Study||1135
6275532|NCT00112918|7174675|FG000|Stage III Disease Population|Overall Study||955
6275533|NCT00112918|7174676|FG001|Stage III Disease Population|Overall Study||960
6275534|NCT00112918|7174677|FG002|Stage III Disease Population|Overall Study||952
6275535|NCT00112918|7174675|FG000|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
6275536|NCT00112918|7174676|FG001|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
6275537|NCT00112918|7174677|FG002|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
6390577|NCT00830869|7302279|FG003|STARTED|Period 2: Part 2||0
6390578|NCT00830869|7302280|FG004|STARTED|Period 2: Part 2||0
6390579|NCT00830869|7302281|FG005|STARTED|Period 2: Part 2||0
6390580|NCT00830869|7302282|FG006|STARTED|Period 2: Part 2||0
6390581|NCT00830869|7302283|FG007|STARTED|Period 2: Part 2||20
6390582|NCT00830869|7302284|FG008|STARTED|Period 2: Part 2||22
6390583|NCT00830869|7302285|FG009|STARTED|Period 2: Part 2||20
6390584|NCT00830869|7302286|FG010|STARTED|Period 2: Part 2||11
6390585|NCT00830869|7302287|FG011|STARTED|Period 2: Part 2||20
6390586|NCT00830869|7302276|FG000|COMPLETED|Period 2: Part 2||0
6390587|NCT00830869|7302277|FG001|COMPLETED|Period 2: Part 2||0
6390588|NCT00830869|7302278|FG002|COMPLETED|Period 2: Part 2||0
6390589|NCT00830869|7302279|FG003|COMPLETED|Period 2: Part 2||0
6390590|NCT00830869|7302280|FG004|COMPLETED|Period 2: Part 2||0
6390591|NCT00830869|7302281|FG005|COMPLETED|Period 2: Part 2||0
6390592|NCT00830869|7302282|FG006|COMPLETED|Period 2: Part 2||0
6390593|NCT00830869|7302283|FG007|COMPLETED|Period 2: Part 2||0
6390594|NCT00830869|7302284|FG008|COMPLETED|Period 2: Part 2||0
6390595|NCT00830869|7302285|FG009|COMPLETED|Period 2: Part 2||0
6390596|NCT00830869|7302286|FG010|COMPLETED|Period 2: Part 2||0
6390597|NCT00830869|7302287|FG011|COMPLETED|Period 2: Part 2||0
6390598|NCT00830869|7302276|FG000|NOT COMPLETED|Period 2: Part 2||0
6390599|NCT00830869|7302277|FG001|NOT COMPLETED|Period 2: Part 2||0
6390600|NCT00830869|7302278|FG002|NOT COMPLETED|Period 2: Part 2||0
6390601|NCT00830869|7302279|FG003|NOT COMPLETED|Period 2: Part 2||0
6390602|NCT00830869|7302280|FG004|NOT COMPLETED|Period 2: Part 2||0
6390603|NCT00830869|7302281|FG005|NOT COMPLETED|Period 2: Part 2||0
6390604|NCT00830869|7302282|FG006|NOT COMPLETED|Period 2: Part 2||0
6390605|NCT00830869|7302283|FG007|NOT COMPLETED|Period 2: Part 2||20
6390606|NCT00830869|7302284|FG008|NOT COMPLETED|Period 2: Part 2||22
6390607|NCT00830869|7302285|FG009|NOT COMPLETED|Period 2: Part 2||20
6390608|NCT00830869|7302286|FG010|NOT COMPLETED|Period 2: Part 2||11
6390609|NCT00830869|7302287|FG011|NOT COMPLETED|Period 2: Part 2||20
6390610|NCT00830947|7302316|FG000|STARTED|Overall Study||23
6390611|NCT00830947|7302317|FG001|STARTED|Overall Study||22
6504688|NCT01449630|7423759|FG004|COMPLETED|Period 1||5
6504689|NCT01449630|7423760|FG005|COMPLETED|Period 1||1
6504690|NCT01449630|7423761|FG006|COMPLETED|Period 1||2
6504691|NCT01449630|7423762|FG007|COMPLETED|Period 1||6
6504692|NCT01449630|7423763|FG008|COMPLETED|Period 1||2
6504693|NCT01449630|7423755|FG000|NOT COMPLETED|Period 1||1
6504694|NCT01449630|7423756|FG001|NOT COMPLETED|Period 1||0
6504695|NCT01449630|7423757|FG002|NOT COMPLETED|Period 1||0
6504696|NCT01449630|7423758|FG003|NOT COMPLETED|Period 1||1
6504697|NCT01449630|7423759|FG004|NOT COMPLETED|Period 1||0
6504698|NCT01449630|7423760|FG005|NOT COMPLETED|Period 1||1
6504699|NCT01449630|7423761|FG006|NOT COMPLETED|Period 1||0
6504700|NCT01449630|7423762|FG007|NOT COMPLETED|Period 1||0
6504701|NCT01449630|7423763|FG008|NOT COMPLETED|Period 1||0
6504702|NCT01449630|7423755|FG000|STARTED|Period 2||1
6504703|NCT01449630|7423756|FG001|STARTED|Period 2||6
6504704|NCT01449630|7423757|FG002|STARTED|Period 2||2
6390612|NCT00830947|7302316|FG000|COMPLETED|Overall Study||19
6390613|NCT00830947|7302317|FG001|COMPLETED|Overall Study||18
6390614|NCT00830947|7302316|FG000|NOT COMPLETED|Overall Study||4
6390615|NCT00830947|7302317|FG001|NOT COMPLETED|Overall Study||4
6390616|NCT00830960|7302329|FG000|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
6390617|NCT00830960|7302330|FG001|STARTED|Overall Study||124
6390618|NCT00830960|7302331|FG002|STARTED|Overall Study||137
6504705|NCT01449630|7423758|FG003|STARTED|Period 2||1
6504706|NCT01449630|7423759|FG004|STARTED|Period 2||5
6504707|NCT01449630|7423760|FG005|STARTED|Period 2||1
6504708|NCT01449630|7423761|FG006|STARTED|Period 2||2
6504709|NCT01449630|7423762|FG007|STARTED|Period 2||6
6504710|NCT01449630|7423763|FG008|STARTED|Period 2||2
6504711|NCT01449630|7423755|FG000|COMPLETED|Period 2||1
6504712|NCT01449630|7423756|FG001|COMPLETED|Period 2||6
6390619|NCT00830960|7302332|FG003|STARTED|Overall Study||138
6390620|NCT00830960|7302333|FG004|STARTED|Overall Study||96
6390621|NCT00830960|7302334|FG005|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
6390622|NCT00830960|7302329|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
6390623|NCT00830960|7302330|FG001|Received at Least 1 Dose of Study Drug|Overall Study||122
6390624|NCT00830960|7302331|FG002|Received at Least 1 Dose of Study Drug|Overall Study||133
6390625|NCT00830960|7302332|FG003|Received at Least 1 Dose of Study Drug|Overall Study||135
6390626|NCT00830960|7302333|FG004|Received at Least 1 Dose of Study Drug|Overall Study||91
6390627|NCT00830960|7302334|FG005|Received at Least 1 Dose of Study Drug|Overall Study||93
6390628|NCT00830960|7302329|FG000|COMPLETED|Overall Study||91
6390629|NCT00830960|7302330|FG001|COMPLETED|Overall Study||96
6390630|NCT00830960|7302331|FG002|COMPLETED|Overall Study||108
6390631|NCT00830960|7302332|FG003|COMPLETED|Overall Study||106
6567055|NCT01829230|7490147|FG000|STARTED|Overall Study||40
6567056|NCT01829230|7490148|FG001|STARTED|Overall Study||42
6567057|NCT01829230|7490147|FG000|COMPLETED|Overall Study||39
6807155|NCT04569786|7739500|FG000|STARTED|Overall Study||39
6807156|NCT04569786|7739501|FG001|STARTED|Overall Study||39
6807157|NCT04569786|7739502|FG002|STARTED|Overall Study||42
6807158|NCT04569786|7739503|FG003|STARTED|Overall Study||56
6807159|NCT04569786|7739504|FG004|STARTED|Overall Study||56
6807160|NCT04569786|7739500|FG000|COMPLETED|Overall Study||38
6807161|NCT04569786|7739501|FG001|COMPLETED|Overall Study||39
6807162|NCT04569786|7739502|FG002|COMPLETED|Overall Study||38
6807163|NCT04569786|7739503|FG003|COMPLETED|Overall Study||49
6807164|NCT04569786|7739504|FG004|COMPLETED|Overall Study||55
6807165|NCT04569786|7739500|FG000|NOT COMPLETED|Overall Study||1
6807166|NCT04569786|7739501|FG001|NOT COMPLETED|Overall Study||0
6807167|NCT04569786|7739502|FG002|NOT COMPLETED|Overall Study||4
6807168|NCT04569786|7739503|FG003|NOT COMPLETED|Overall Study||7
6807169|NCT04569786|7739504|FG004|NOT COMPLETED|Overall Study||1
6275538|NCT00112918|7174675|FG000|NOT COMPLETED|Overall Study||297
6275539|NCT00112918|7174676|FG001|NOT COMPLETED|Overall Study||345
6275540|NCT00112918|7174677|FG002|NOT COMPLETED|Overall Study||299
6275541|NCT00112957|7174685|FG000|STARTED|Overall Study||23
6275542|NCT00112957|7174685|FG000|COMPLETED|Overall Study||4
6275543|NCT00112957|7174685|FG000|NOT COMPLETED|Overall Study||19
6275544|NCT00113022|7174691|FG000|STARTED|Overall Study||5
6275545|NCT00113022|7174692|FG001|STARTED|Overall Study||4
6275546|NCT00113022|7174691|FG000|COMPLETED|Overall Study||2
6567058|NCT01829230|7490148|FG001|COMPLETED|Overall Study||38
6275547|NCT00113022|7174692|FG001|COMPLETED|Overall Study||2
6275548|NCT00113022|7174691|FG000|NOT COMPLETED|Overall Study||3
6807170|NCT04409041|7739516|FG000|STARTED|Overall Study||43
6807171|NCT04409041|7739516|FG000|COMPLETED|Overall Study||26
6807172|NCT04409041|7739516|FG000|NOT COMPLETED|Overall Study||17
6807173|NCT04129944|7739525|FG000|STARTED|Overall Study||46
6807174|NCT04129944|7739526|FG001|STARTED|Overall Study||45
6807175|NCT04129944|7739527|FG002|STARTED|Overall Study||46
6807176|NCT04129944|7739528|FG003|STARTED|Overall Study||46
6807177|NCT04129944|7739525|FG000|COMPLETED|Overall Study||44
6807178|NCT04129944|7739526|FG001|COMPLETED|Overall Study||45
6807179|NCT04129944|7739527|FG002|COMPLETED|Overall Study||45
6807180|NCT04129944|7739528|FG003|COMPLETED|Overall Study||43
6807181|NCT04129944|7739525|FG000|NOT COMPLETED|Overall Study||2
6807182|NCT04129944|7739526|FG001|NOT COMPLETED|Overall Study||0
6807183|NCT04129944|7739527|FG002|NOT COMPLETED|Overall Study||1
6807184|NCT04129944|7739528|FG003|NOT COMPLETED|Overall Study||3
6807185|NCT03861728|7739540|FG000|STARTED|Overall Study||6
6807186|NCT03861728|7739541|FG001|STARTED|Overall Study||5
6807187|NCT03861728|7739540|FG000|COMPLETED|Overall Study||6
6807188|NCT03861728|7739541|FG001|COMPLETED|Overall Study||5
6807189|NCT03861728|7739540|FG000|NOT COMPLETED|Overall Study||0
6807190|NCT03861728|7739541|FG001|NOT COMPLETED|Overall Study||0
6807191|NCT03857542|7739549|FG000|STARTED|Overall Study||215
6807192|NCT03857542|7739550|FG001|STARTED|Overall Study||212
6807193|NCT03857542|7739549|FG000|COMPLETED|Overall Study||209
6807194|NCT03857542|7739550|FG001|COMPLETED|Overall Study||207
6807195|NCT03857542|7739549|FG000|NOT COMPLETED|Overall Study||6
6807196|NCT03857542|7739550|FG001|NOT COMPLETED|Overall Study||5
6807197|NCT03848832|7739560|FG000|STARTED|Overall Study||10
6807198|NCT03848832|7739561|FG001|STARTED|Overall Study||9
6807199|NCT03848832|7739562|FG002|STARTED|Overall Study||10
6807200|NCT03848832|7739560|FG000|COMPLETED|Overall Study||7
6807201|NCT03848832|7739561|FG001|COMPLETED|Overall Study||6
6807202|NCT03848832|7739562|FG002|COMPLETED|Overall Study||4
6807203|NCT03848832|7739560|FG000|NOT COMPLETED|Overall Study||3
6807204|NCT03848832|7739561|FG001|NOT COMPLETED|Overall Study||3
6807205|NCT03848832|7739562|FG002|NOT COMPLETED|Overall Study||6
6275549|NCT00113022|7174692|FG001|NOT COMPLETED|Overall Study||2
6275550|NCT00113087|7174700|FG000|STARTED|Overall Study||115
6275551|NCT00113087|7174701|FG001|STARTED|Overall Study||115
6275552|NCT00113087|7174700|FG000|COMPLETED|Overall Study||91
6275553|NCT00113087|7174701|FG001|COMPLETED|Overall Study||94
6275554|NCT00113087|7174700|FG000|NOT COMPLETED|Overall Study||24
6275555|NCT00113087|7174701|FG001|NOT COMPLETED|Overall Study||21
6275556|NCT00113217|7174707|FG000|STARTED|Overall Study||50
6275557|NCT00113217|7174707|FG000|COMPLETED|Overall Study||50
6275558|NCT00113217|7174707|FG000|NOT COMPLETED|Overall Study||0
6275559|NCT00113230|7174711|FG000|STARTED|Overall Study||25
6275560|NCT00113230|7174711|FG000|COMPLETED|Overall Study||25
6275561|NCT00113230|7174711|FG000|NOT COMPLETED|Overall Study||0
6275562|NCT00113269|7174719|FG000|STARTED|Overall Study||76
6275563|NCT00113269|7174720|FG001|STARTED|Overall Study||70
6275564|NCT00113269|7174721|FG002|STARTED|Overall Study||175
6275565|NCT00113269|7174722|FG003|STARTED|Overall Study||180
6275566|NCT00113269|7174719|FG000|Received Treatment|Overall Study||70
6275567|NCT00113269|7174720|FG001|Received Treatment|Overall Study||69
6275568|NCT00113269|7174721|FG002|Received Treatment|Overall Study||164
6275569|NCT00113269|7174722|FG003|Received Treatment|Overall Study||171
6275570|NCT00113269|7174719|FG000|COMPLETED|Overall Study||51
6275571|NCT00113269|7174720|FG001|COMPLETED|Overall Study||48
6275572|NCT00113269|7174721|FG002|COMPLETED|Overall Study||134
6275573|NCT00113269|7174722|FG003|COMPLETED|Overall Study||140
6275574|NCT00113269|7174719|FG000|NOT COMPLETED|Overall Study||25
6275575|NCT00113269|7174720|FG001|NOT COMPLETED|Overall Study||22
6275576|NCT00113269|7174721|FG002|NOT COMPLETED|Overall Study||41
6275577|NCT00113269|7174722|FG003|NOT COMPLETED|Overall Study||40
6275578|NCT00113295|7174734|FG000|STARTED|Overall Study||11
6275579|NCT00113295|7174735|FG001|STARTED|Overall Study||11
6275580|NCT00113295|7174734|FG000|COMPLETED|Overall Study||6
6275581|NCT00113295|7174735|FG001|COMPLETED|Overall Study||10
6275582|NCT00113295|7174734|FG000|NOT COMPLETED|Overall Study||5
6275583|NCT00113295|7174735|FG001|NOT COMPLETED|Overall Study||1
6275584|NCT00113321|7174743|FG000|STARTED|Overall Study||16
6275585|NCT00113321|7174743|FG000|COMPLETED|Overall Study||16
6275586|NCT00113321|7174743|FG000|NOT COMPLETED|Overall Study||0
6275587|NCT00113334|7174747|FG000|STARTED|Overall Study||6
6275588|NCT00113334|7174747|FG000|COMPLETED|Overall Study||6
6567059|NCT01829230|7490147|FG000|NOT COMPLETED|Overall Study||1
6567060|NCT01829230|7490148|FG001|NOT COMPLETED|Overall Study||4
6567061|NCT01829243|7490154|FG000|STARTED|First Intervention||11
6807206|NCT03688802|7739574|FG000|STARTED|Overall Study||12
6807207|NCT03688802|7739575|FG001|STARTED|Overall Study||6
6807208|NCT03688802|7739574|FG000|COMPLETED|Overall Study||11
6807209|NCT03688802|7739575|FG001|COMPLETED|Overall Study||6
6807210|NCT03688802|7739574|FG000|NOT COMPLETED|Overall Study||1
6807211|NCT03688802|7739575|FG001|NOT COMPLETED|Overall Study||0
6807212|NCT03656744|7739584|FG000|STARTED|Overall Study||34
6807213|NCT03656744|7739585|FG001|STARTED|Overall Study||34
6807214|NCT03656744|7739586|FG002|STARTED|Overall Study||33
6807215|NCT03656744|7739584|FG000|COMPLETED|Overall Study||29
6807216|NCT03656744|7739585|FG001|COMPLETED|Overall Study||27
6807217|NCT03656744|7739586|FG002|COMPLETED|Overall Study||32
6807218|NCT03656744|7739584|FG000|NOT COMPLETED|Overall Study||5
6807219|NCT03656744|7739585|FG001|NOT COMPLETED|Overall Study||7
6807220|NCT03656744|7739586|FG002|NOT COMPLETED|Overall Study||1
6807221|NCT03510598|7739594|FG000|STARTED|Overall Study||16
6807222|NCT03510598|7739594|FG000|COMPLETED|Overall Study||15
6807223|NCT03510598|7739594|FG000|NOT COMPLETED|Overall Study||1
6807224|NCT03487796|7739602|FG000|STARTED|Overall Study||41
6807225|NCT03487796|7739603|FG001|STARTED|Overall Study||31
6807226|NCT03487796|7739602|FG000|2 Month Follow-up|Overall Study||24
6807227|NCT03487796|7739603|FG001|2 Month Follow-up|Overall Study||26
6275589|NCT00113334|7174747|FG000|NOT COMPLETED|Overall Study||0
6275590|NCT00113360|7174751|FG000|STARTED|Overall Study|67 participants were enrolled for screening.|67
6275591|NCT00113360|7174751|FG000|COMPLETED|Overall Study||60
6275592|NCT00113360|7174751|FG000|NOT COMPLETED|Overall Study||7
6275593|NCT00113373|7174755|FG000|STARTED|Overall Study||28
6275594|NCT00113373|7174755|FG000|COMPLETED|Overall Study|Eligible and treated patients.|25
6275595|NCT00113373|7174755|FG000|NOT COMPLETED|Overall Study||3
6807228|NCT03487796|7739602|FG000|COMPLETED|Overall Study||23
6807229|NCT03487796|7739603|FG001|COMPLETED|Overall Study||25
6807230|NCT03487796|7739602|FG000|NOT COMPLETED|Overall Study||18
6390632|NCT00830960|7302333|FG004|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
6390633|NCT00830960|7302334|FG005|COMPLETED|Overall Study||63
6390634|NCT00830960|7302329|FG000|NOT COMPLETED|Overall Study||33
6390635|NCT00830960|7302330|FG001|NOT COMPLETED|Overall Study||28
6390636|NCT00830960|7302331|FG002|NOT COMPLETED|Overall Study||29
6390637|NCT00830960|7302332|FG003|NOT COMPLETED|Overall Study||32
6390638|NCT00830960|7302333|FG004|NOT COMPLETED|Overall Study||32
6390639|NCT00830960|7302334|FG005|NOT COMPLETED|Overall Study||37
6390640|NCT00831129|7302373|FG000|STARTED|Overall Study||20
6390641|NCT00831129|7302374|FG001|STARTED|Overall Study||33
6390642|NCT00831129|7302373|FG000|COMPLETED|Overall Study||20
6390643|NCT00831129|7302374|FG001|COMPLETED|Overall Study||23
6390644|NCT00831129|7302373|FG000|NOT COMPLETED|Overall Study||0
6390645|NCT00831129|7302374|FG001|NOT COMPLETED|Overall Study||10
6390646|NCT00831181|7302380|FG000|STARTED|Overall Study||27
6390647|NCT00831181|7302380|FG000|COMPLETED|Overall Study||15
6390648|NCT00831181|7302380|FG000|NOT COMPLETED|Overall Study||12
6390649|NCT00831233|7302387|FG000|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
6390650|NCT00831233|7302388|FG001|STARTED|Overall Study|ITT population.|13
6390651|NCT00831233|7302387|FG000|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
6390652|NCT00831233|7302388|FG001|Full Analysis Set (FAS)|Overall Study||13
6390653|NCT00831233|7302387|FG000|Per Protocol (PP) Analysis Set|Overall Study||26
6390654|NCT00831233|7302388|FG001|Per Protocol (PP) Analysis Set|Overall Study||11
6390655|NCT00831233|7302387|FG000|COMPLETED|Overall Study||26
6390656|NCT00831233|7302388|FG001|COMPLETED|Overall Study||12
6390657|NCT00831233|7302387|FG000|NOT COMPLETED|Overall Study||3
6390658|NCT00831233|7302388|FG001|NOT COMPLETED|Overall Study||1
6390659|NCT00831272|7302398|FG000|STARTED|Overall Study||38
6390660|NCT00831272|7302399|FG001|STARTED|Overall Study||44
6390661|NCT00831272|7302400|FG002|STARTED|Overall Study||73
6390662|NCT00831272|7302401|FG003|STARTED|Overall Study||66
6390663|NCT00831272|7302398|FG000|COMPLETED|Overall Study||30
6390664|NCT00831272|7302399|FG001|COMPLETED|Overall Study||37
6390665|NCT00831272|7302400|FG002|COMPLETED|Overall Study||63
6390666|NCT00831272|7302401|FG003|COMPLETED|Overall Study||56
6390667|NCT00831272|7302398|FG000|NOT COMPLETED|Overall Study||8
6390668|NCT00831272|7302399|FG001|NOT COMPLETED|Overall Study||7
6390669|NCT00831272|7302400|FG002|NOT COMPLETED|Overall Study||10
6390670|NCT00831272|7302401|FG003|NOT COMPLETED|Overall Study||10
6390671|NCT00831311|7302413|FG000|STARTED|Overall Study||312
6390672|NCT00831311|7302414|FG001|STARTED|Overall Study||312
6390673|NCT00831311|7302413|FG000|COMPLETED|Overall Study||300
6390674|NCT00831311|7302414|FG001|COMPLETED|Overall Study||304
6390675|NCT00831311|7302413|FG000|NOT COMPLETED|Overall Study||12
6390676|NCT00831311|7302414|FG001|NOT COMPLETED|Overall Study||8
6390677|NCT00831389|7302423|FG000|STARTED|Overall Study||6
6390678|NCT00831389|7302424|FG001|STARTED|Overall Study||7
6504713|NCT01449630|7423757|FG002|COMPLETED|Period 2||2
6504714|NCT01449630|7423758|FG003|COMPLETED|Period 2||1
6504715|NCT01449630|7423759|FG004|COMPLETED|Period 2||5
6504716|NCT01449630|7423760|FG005|COMPLETED|Period 2||1
6504717|NCT01449630|7423761|FG006|COMPLETED|Period 2||1
6504718|NCT01449630|7423762|FG007|COMPLETED|Period 2||6
6504719|NCT01449630|7423763|FG008|COMPLETED|Period 2||2
6504720|NCT01449630|7423755|FG000|NOT COMPLETED|Period 2||0
6504721|NCT01449630|7423756|FG001|NOT COMPLETED|Period 2||0
6504722|NCT01449630|7423757|FG002|NOT COMPLETED|Period 2||0
6390679|NCT00831389|7302423|FG000|COMPLETED|Overall Study||6
6390680|NCT00831389|7302424|FG001|COMPLETED|Overall Study||6
6390681|NCT00831389|7302423|FG000|NOT COMPLETED|Overall Study||0
6390682|NCT00831389|7302424|FG001|NOT COMPLETED|Overall Study||1
6390683|NCT00831415|7302430|FG000|STARTED|Overall Study||304
6390684|NCT00831415|7302430|FG000|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
6390685|NCT00831415|7302430|FG000|"Study Completers"|Overall Study|"Defined as participants whose conclusion of study participation status was study completed."|227
6390686|NCT00831415|7302430|FG000|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
6390687|NCT00831415|7302430|FG000|NOT COMPLETED|Overall Study||75
6504723|NCT01449630|7423758|FG003|NOT COMPLETED|Period 2||0
6504724|NCT01449630|7423759|FG004|NOT COMPLETED|Period 2||0
6504725|NCT01449630|7423760|FG005|NOT COMPLETED|Period 2||0
6504726|NCT01449630|7423761|FG006|NOT COMPLETED|Period 2||1
6275596|NCT00113425|7174764|FG000|STARTED|Overall Study||44
6275597|NCT00113425|7174764|FG000|COMPLETED|Overall Study||29
6275598|NCT00113425|7174764|FG000|NOT COMPLETED|Overall Study||15
6275599|NCT00113490|7174771|FG000|STARTED|Overall Study||66
6275600|NCT00113490|7174772|FG001|STARTED|Overall Study||70
6275601|NCT00113490|7174771|FG000|COMPLETED|Overall Study||64
6275602|NCT00113490|7174772|FG001|COMPLETED|Overall Study||67
6275603|NCT00113490|7174771|FG000|NOT COMPLETED|Overall Study||2
6275604|NCT00113490|7174772|FG001|NOT COMPLETED|Overall Study||3
6275605|NCT00113516|7174778|FG000|STARTED|Part 1||84
6275606|NCT00113516|7174779|FG001|STARTED|Part 1||0
6275607|NCT00113516|7174778|FG000|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
6275608|NCT00113516|7174779|FG001|COMPLETED|Part 1||0
6275609|NCT00113516|7174778|FG000|NOT COMPLETED|Part 1||84
6275610|NCT00113516|7174779|FG001|NOT COMPLETED|Part 1||0
6275611|NCT00113516|7174778|FG000|STARTED|Part 2||0
6275612|NCT00113516|7174779|FG001|STARTED|Part 2||66
6275613|NCT00113516|7174778|FG000|COMPLETED|Part 2||0
6275614|NCT00113516|7174779|FG001|COMPLETED|Part 2||0
6275615|NCT00113516|7174778|FG000|NOT COMPLETED|Part 2||0
6275616|NCT00113516|7174779|FG001|NOT COMPLETED|Part 2||66
6275617|NCT00113529|7174785|FG000|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
6275618|NCT00113529|7174785|FG000|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
6275619|NCT00113529|7174785|FG000|NOT COMPLETED|Overall Study||34
6275620|NCT00113555|7174789|FG000|STARTED|Overall Study||221
6275621|NCT00113555|7174789|FG000|TREATED|Overall Study|1 Additional Patient was treated on a compassionate use basis.|162
6275622|NCT00113555|7174789|FG000|COMPLETED|Overall Study|All treated patients were considered in the Intent to Treat analysis.|142
6275623|NCT00113555|7174789|FG000|NOT COMPLETED|Overall Study||79
6275624|NCT00113568|7174794|FG000|STARTED|Overall Study||784
6275625|NCT00113568|7174794|FG000|Intent to Treat Population|Overall Study||723
6275626|NCT00113568|7174794|FG000|COMPLETED|Overall Study||239
6275627|NCT00113568|7174794|FG000|NOT COMPLETED|Overall Study||545
6807231|NCT03487796|7739603|FG001|NOT COMPLETED|Overall Study||6
6807232|NCT03446612|7739617|FG000|STARTED|Overall Study||2
6807233|NCT03446612|7739618|FG001|STARTED|Overall Study||3
6280822|NCT00159263|7180669|FG005|COMPLETED|Fifth Intervention||2
6280823|NCT00159263|7180664|FG000|NOT COMPLETED|Fifth Intervention||0
6280824|NCT00159263|7180665|FG001|NOT COMPLETED|Fifth Intervention||0
6280825|NCT00159263|7180666|FG002|NOT COMPLETED|Fifth Intervention||0
6280826|NCT00159263|7180667|FG003|NOT COMPLETED|Fifth Intervention||0
6280827|NCT00159263|7180668|FG004|NOT COMPLETED|Fifth Intervention||0
6280828|NCT00159263|7180669|FG005|NOT COMPLETED|Fifth Intervention||0
6567062|NCT01829243|7490155|FG001|STARTED|First Intervention||15
6567063|NCT01829243|7490154|FG000|COMPLETED|First Intervention||7
6807234|NCT03446612|7739617|FG000|COMPLETED|Overall Study||2
6807235|NCT03446612|7739618|FG001|COMPLETED|Overall Study||2
6807236|NCT03446612|7739617|FG000|NOT COMPLETED|Overall Study||0
6807237|NCT03446612|7739618|FG001|NOT COMPLETED|Overall Study||1
6807238|NCT03436433|7739629|FG000|STARTED|Overall Study||1
6807239|NCT03436433|7739630|FG001|STARTED|Overall Study||2
6807240|NCT03436433|7739631|FG002|STARTED|Overall Study||1
6807241|NCT03436433|7739629|FG000|COMPLETED|Overall Study||1
6807242|NCT03436433|7739630|FG001|COMPLETED|Overall Study||2
6807243|NCT03436433|7739631|FG002|COMPLETED|Overall Study||1
6807244|NCT03436433|7739629|FG000|NOT COMPLETED|Overall Study||0
6807245|NCT03436433|7739630|FG001|NOT COMPLETED|Overall Study||0
6807246|NCT03436433|7739631|FG002|NOT COMPLETED|Overall Study||0
6807247|NCT03370120|7739639|FG000|STARTED|Overall Study||406
6280829|NCT00159263|7180664|FG000|STARTED|Washout||1
6280830|NCT00159263|7180665|FG001|STARTED|Washout||1
6280831|NCT00159263|7180666|FG002|STARTED|Washout||2
6280832|NCT00159263|7180667|FG003|STARTED|Washout||2
6280833|NCT00159263|7180668|FG004|STARTED|Washout||2
6280834|NCT00159263|7180669|FG005|STARTED|Washout||2
6280835|NCT00159263|7180664|FG000|COMPLETED|Washout||1
6280836|NCT00159263|7180665|FG001|COMPLETED|Washout||1
6280837|NCT00159263|7180666|FG002|COMPLETED|Washout||2
6280838|NCT00159263|7180667|FG003|COMPLETED|Washout||2
6280839|NCT00159263|7180668|FG004|COMPLETED|Washout||2
6567064|NCT01829243|7490155|FG001|COMPLETED|First Intervention||13
6807248|NCT03370120|7739639|FG000|COMPLETED|Overall Study||0
6807249|NCT03370120|7739639|FG000|NOT COMPLETED|Overall Study||406
6567065|NCT01829243|7490154|FG000|NOT COMPLETED|First Intervention||4
6567066|NCT01829243|7490155|FG001|NOT COMPLETED|First Intervention||2
6567067|NCT01829243|7490154|FG000|STARTED|Washout Period of 1 Week||7
6567068|NCT01829243|7490155|FG001|STARTED|Washout Period of 1 Week||13
6567069|NCT01829243|7490154|FG000|COMPLETED|Washout Period of 1 Week||7
6567070|NCT01829243|7490155|FG001|COMPLETED|Washout Period of 1 Week||13
6390688|NCT00831428|7302434|FG000|STARTED|Overall Study||97
6567071|NCT01829243|7490154|FG000|NOT COMPLETED|Washout Period of 1 Week||0
6567072|NCT01829243|7490155|FG001|NOT COMPLETED|Washout Period of 1 Week||0
6807250|NCT03367429|7739648|FG000|STARTED|Overall Study||0
6807251|NCT03367429|7739649|FG001|STARTED|Overall Study||1
6807252|NCT03367429|7739650|FG002|STARTED|Overall Study||2
6807253|NCT03367429|7739648|FG000|COMPLETED|Overall Study||0
6807254|NCT03367429|7739649|FG001|COMPLETED|Overall Study||1
6807255|NCT03367429|7739650|FG002|COMPLETED|Overall Study||2
6807256|NCT03367429|7739648|FG000|NOT COMPLETED|Overall Study||0
6807257|NCT03367429|7739649|FG001|NOT COMPLETED|Overall Study||0
6807258|NCT03367429|7739650|FG002|NOT COMPLETED|Overall Study||0
6807259|NCT03143829|7739662|FG000|STARTED|Overall Study||38
6807260|NCT03143829|7739663|FG001|STARTED|Overall Study||42
6807261|NCT03143829|7739662|FG000|COMPLETED|Overall Study||33
6807262|NCT03143829|7739663|FG001|COMPLETED|Overall Study||32
6807263|NCT03143829|7739662|FG000|NOT COMPLETED|Overall Study||5
6807264|NCT03143829|7739663|FG001|NOT COMPLETED|Overall Study||10
6807265|NCT03099863|7739671|FG000|STARTED|Overall Study||121
6807266|NCT03099863|7739672|FG001|STARTED|Overall Study||121
6807267|NCT03099863|7739671|FG000|COMPLETED|Overall Study||111
6807268|NCT03099863|7739672|FG001|COMPLETED|Overall Study||105
6807269|NCT03099863|7739671|FG000|NOT COMPLETED|Overall Study||10
6807270|NCT03099863|7739672|FG001|NOT COMPLETED|Overall Study||16
6807271|NCT02963610|7739678|FG000|STARTED|Overall Study||3
6807272|NCT02963610|7739678|FG000|COMPLETED|Overall Study||0
6807273|NCT02963610|7739678|FG000|NOT COMPLETED|Overall Study||3
6807274|NCT02766335|7739685|FG000|STARTED|Initial Registration||68
6807275|NCT02766335|7739686|FG001|STARTED|Initial Registration||30
6807276|NCT02766335|7739687|FG002|STARTED|Initial Registration||0
6807277|NCT02766335|7739685|FG000|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||32
6807278|NCT02766335|7739686|FG001|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||30
6807279|NCT02766335|7739687|FG002|Eligible Participants Enrolled Before Docetaxel Arm Closed|Initial Registration||0
6807280|NCT02766335|7739685|FG000|COMPLETED|Initial Registration||10
6807281|NCT02766335|7739686|FG001|COMPLETED|Initial Registration||0
6807282|NCT02766335|7739687|FG002|COMPLETED|Initial Registration||0
6807283|NCT02766335|7739685|FG000|NOT COMPLETED|Initial Registration||58
6807284|NCT02766335|7739686|FG001|NOT COMPLETED|Initial Registration||30
6807285|NCT02766335|7739687|FG002|NOT COMPLETED|Initial Registration||0
6807286|NCT02766335|7739685|FG000|STARTED|Re-registration of Arm I to MEDI4738||0
6807287|NCT02766335|7739686|FG001|STARTED|Re-registration of Arm I to MEDI4738||0
6807288|NCT02766335|7739687|FG002|STARTED|Re-registration of Arm I to MEDI4738||4
6807289|NCT02766335|7739685|FG000|COMPLETED|Re-registration of Arm I to MEDI4738||0
6807290|NCT02766335|7739686|FG001|COMPLETED|Re-registration of Arm I to MEDI4738||0
6807291|NCT02766335|7739687|FG002|COMPLETED|Re-registration of Arm I to MEDI4738||2
6390689|NCT00831428|7302434|FG000|COMPLETED|Overall Study||97
6567073|NCT01829243|7490154|FG000|STARTED|Second Intervention||7
6807292|NCT02766335|7739685|FG000|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
6807293|NCT02766335|7739686|FG001|NOT COMPLETED|Re-registration of Arm I to MEDI4738||0
6807294|NCT02766335|7739687|FG002|NOT COMPLETED|Re-registration of Arm I to MEDI4738||2
6275628|NCT00113607|7174800|FG000|STARTED|Overall Study|Number of randomized participants|335
6275629|NCT00113607|7174801|FG001|STARTED|Overall Study|Number of randomized participants|337
6275630|NCT00113607|7174800|FG000|COMPLETED|Overall Study||0
6275631|NCT00113607|7174801|FG001|COMPLETED|Overall Study||0
6275632|NCT00113607|7174800|FG000|NOT COMPLETED|Overall Study||335
6275633|NCT00113607|7174801|FG001|NOT COMPLETED|Overall Study||337
6275634|NCT00113763|7174810|FG000|STARTED|Overall Study||231
6275635|NCT00113763|7174811|FG001|STARTED|Overall Study||232
6275636|NCT00113763|7174810|FG000|Received Study Drug|Overall Study||229
6275637|NCT00113763|7174811|FG001|Received Study Drug|Overall Study||0
6275638|NCT00113763|7174810|FG000|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
6275639|NCT00113763|7174811|FG001|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
6275640|NCT00113763|7174810|FG000|NOT COMPLETED|Overall Study||73
6275641|NCT00113763|7174811|FG001|NOT COMPLETED|Overall Study||26
6275642|NCT00113841|7174820|FG000|STARTED|Overall Study||16
6275643|NCT00113841|7174821|FG001|STARTED|Overall Study||17
6275644|NCT00113841|7174820|FG000|COMPLETED|Overall Study||15
6275645|NCT00113841|7174821|FG001|COMPLETED|Overall Study||15
6275646|NCT00113841|7174820|FG000|NOT COMPLETED|Overall Study||1
6275647|NCT00113841|7174821|FG001|NOT COMPLETED|Overall Study||2
6275648|NCT00113880|7174830|FG000|STARTED|Overall Study||63061
6275649|NCT00113880|7174831|FG001|STARTED|Overall Study||71949
6275650|NCT00113880|7174832|FG002|STARTED|Overall Study||62492
6275651|NCT00113880|7174830|FG000|COMPLETED|Overall Study||63061
6275652|NCT00113880|7174831|FG001|COMPLETED|Overall Study||71949
6275653|NCT00113880|7174832|FG002|COMPLETED|Overall Study||62492
6275654|NCT00113880|7174830|FG000|NOT COMPLETED|Overall Study||0
6275655|NCT00113880|7174831|FG001|NOT COMPLETED|Overall Study||0
6275656|NCT00113880|7174832|FG002|NOT COMPLETED|Overall Study||0
6275657|NCT00114114|7174853|FG000|STARTED|Overall Study||26
6275658|NCT00114114|7174854|FG001|STARTED|Overall Study||25
6275659|NCT00114114|7174855|FG002|STARTED|Overall Study||31
6275660|NCT00114114|7174856|FG003|STARTED|Overall Study||35
6807295|NCT02606136|7739693|FG000|STARTED|Overall Study||21
6807296|NCT02606136|7739693|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
6807297|NCT02606136|7739693|FG000|COMPLETED|Overall Study||15
6807298|NCT02606136|7739693|FG000|NOT COMPLETED|Overall Study||6
6807299|NCT02228382|7739702|FG000|STARTED|Overall Study||46
6807300|NCT02228382|7739703|FG001|STARTED|Overall Study||61
6807301|NCT02228382|7739704|FG002|STARTED|Overall Study||49
6807302|NCT02228382|7739705|FG003|STARTED|Overall Study||4
6807303|NCT02228382|7739706|FG004|STARTED|Overall Study||3
6807304|NCT02228382|7739702|FG000|COMPLETED|Overall Study||36
6807305|NCT02228382|7739703|FG001|COMPLETED|Overall Study||43
6807306|NCT02228382|7739704|FG002|COMPLETED|Overall Study||28
6807307|NCT02228382|7739705|FG003|COMPLETED|Overall Study||2
6807308|NCT02228382|7739706|FG004|COMPLETED|Overall Study||1
6807309|NCT02228382|7739702|FG000|NOT COMPLETED|Overall Study||10
6807310|NCT02228382|7739703|FG001|NOT COMPLETED|Overall Study||18
6807311|NCT02228382|7739704|FG002|NOT COMPLETED|Overall Study||21
6807312|NCT02228382|7739705|FG003|NOT COMPLETED|Overall Study||2
6807313|NCT02228382|7739706|FG004|NOT COMPLETED|Overall Study||2
6807314|NCT02090998|7739725|FG000|STARTED|Overall Study||2
6807315|NCT02090998|7739726|FG001|STARTED|Overall Study||8
6807316|NCT02090998|7739725|FG000|COMPLETED|Overall Study||2
6807317|NCT02090998|7739726|FG001|COMPLETED|Overall Study||8
6807318|NCT02090998|7739725|FG000|NOT COMPLETED|Overall Study||0
6807319|NCT02090998|7739726|FG001|NOT COMPLETED|Overall Study||0
6807320|NCT02051309|7739734|FG000|STARTED|Overall Study||58
6807321|NCT02051309|7739735|FG001|STARTED|Overall Study||63
6807322|NCT02051309|7739734|FG000|COMPLETED|Overall Study||26
6807323|NCT02051309|7739735|FG001|COMPLETED|Overall Study||35
6807324|NCT02051309|7739734|FG000|NOT COMPLETED|Overall Study||32
6807325|NCT02051309|7739735|FG001|NOT COMPLETED|Overall Study||28
6807326|NCT02001623|7739756|FG000|STARTED|Overall Study||3
6807327|NCT02001623|7739757|FG001|STARTED|Overall Study||3
6807328|NCT02001623|7739758|FG002|STARTED|Overall Study||3
6807329|NCT02001623|7739759|FG003|STARTED|Overall Study||3
6807330|NCT02001623|7739760|FG004|STARTED|Overall Study||3
6807331|NCT02001623|7739761|FG005|STARTED|Overall Study||3
6807332|NCT02001623|7739762|FG006|STARTED|Overall Study||3
6807333|NCT02001623|7739763|FG007|STARTED|Overall Study||6
6807334|NCT02001623|7739764|FG008|STARTED|Overall Study||15
6807335|NCT02001623|7739765|FG009|STARTED|Overall Study||55
6807336|NCT02001623|7739766|FG010|STARTED|Overall Study||14
6807337|NCT02001623|7739767|FG011|STARTED|Overall Study||15
6807338|NCT02001623|7739768|FG012|STARTED|Overall Study||15
6807339|NCT02001623|7739769|FG013|STARTED|Overall Study||36
6807340|NCT02001623|7739770|FG014|STARTED|Overall Study||18
6807341|NCT02001623|7739756|FG000|Completed 4 Cycles of Treatment|Overall Study||0
6807342|NCT02001623|7739757|FG001|Completed 4 Cycles of Treatment|Overall Study||1
6807343|NCT02001623|7739758|FG002|Completed 4 Cycles of Treatment|Overall Study||1
6807344|NCT02001623|7739759|FG003|Completed 4 Cycles of Treatment|Overall Study||2
6807345|NCT02001623|7739760|FG004|Completed 4 Cycles of Treatment|Overall Study||0
6807346|NCT02001623|7739761|FG005|Completed 4 Cycles of Treatment|Overall Study||2
6807347|NCT02001623|7739762|FG006|Completed 4 Cycles of Treatment|Overall Study||2
6807348|NCT02001623|7739763|FG007|Completed 4 Cycles of Treatment|Overall Study||1
6807349|NCT02001623|7739764|FG008|Completed 4 Cycles of Treatment|Overall Study||5
6807350|NCT02001623|7739765|FG009|Completed 4 Cycles of Treatment|Overall Study||31
6807351|NCT02001623|7739766|FG010|Completed 4 Cycles of Treatment|Overall Study||6
6807352|NCT02001623|7739767|FG011|Completed 4 Cycles of Treatment|Overall Study||4
6807353|NCT02001623|7739768|FG012|Completed 4 Cycles of Treatment|Overall Study||6
6807354|NCT02001623|7739769|FG013|Completed 4 Cycles of Treatment|Overall Study||22
6807355|NCT02001623|7739770|FG014|Completed 4 Cycles of Treatment|Overall Study||7
6807356|NCT02001623|7739756|FG000|Completed 12 Cycles of Treatment|Overall Study||0
6807357|NCT02001623|7739757|FG001|Completed 12 Cycles of Treatment|Overall Study||1
6807358|NCT02001623|7739758|FG002|Completed 12 Cycles of Treatment|Overall Study||0
6807359|NCT02001623|7739759|FG003|Completed 12 Cycles of Treatment|Overall Study||1
6807360|NCT02001623|7739760|FG004|Completed 12 Cycles of Treatment|Overall Study||0
6807361|NCT02001623|7739761|FG005|Completed 12 Cycles of Treatment|Overall Study||0
6807362|NCT02001623|7739762|FG006|Completed 12 Cycles of Treatment|Overall Study||0
6807363|NCT02001623|7739763|FG007|Completed 12 Cycles of Treatment|Overall Study||0
6807364|NCT02001623|7739764|FG008|Completed 12 Cycles of Treatment|Overall Study||0
6807365|NCT02001623|7739765|FG009|Completed 12 Cycles of Treatment|Overall Study||3
6807366|NCT02001623|7739766|FG010|Completed 12 Cycles of Treatment|Overall Study||0
6807367|NCT02001623|7739767|FG011|Completed 12 Cycles of Treatment|Overall Study||0
6807368|NCT02001623|7739768|FG012|Completed 12 Cycles of Treatment|Overall Study||1
6807369|NCT02001623|7739769|FG013|Completed 12 Cycles of Treatment|Overall Study||1
6807370|NCT02001623|7739770|FG014|Completed 12 Cycles of Treatment|Overall Study||0
6807371|NCT02001623|7739756|FG000|COMPLETED|Overall Study||0
6807372|NCT02001623|7739757|FG001|COMPLETED|Overall Study||0
6807373|NCT02001623|7739758|FG002|COMPLETED|Overall Study||0
6807374|NCT02001623|7739759|FG003|COMPLETED|Overall Study||1
6275661|NCT00114114|7174857|FG004|STARTED|Overall Study||29
6275662|NCT00114114|7174858|FG005|STARTED|Overall Study||31
6807375|NCT02001623|7739760|FG004|COMPLETED|Overall Study||0
6807376|NCT02001623|7739761|FG005|COMPLETED|Overall Study||0
6807377|NCT02001623|7739762|FG006|COMPLETED|Overall Study||0
6807378|NCT02001623|7739763|FG007|COMPLETED|Overall Study||0
6807379|NCT02001623|7739764|FG008|COMPLETED|Overall Study||0
6807380|NCT02001623|7739765|FG009|COMPLETED|Overall Study||2
6807381|NCT02001623|7739766|FG010|COMPLETED|Overall Study||0
6807382|NCT02001623|7739767|FG011|COMPLETED|Overall Study||0
6807383|NCT02001623|7739768|FG012|COMPLETED|Overall Study||1
6807384|NCT02001623|7739769|FG013|COMPLETED|Overall Study||1
6807385|NCT02001623|7739770|FG014|COMPLETED|Overall Study||0
6807386|NCT02001623|7739756|FG000|NOT COMPLETED|Overall Study||3
6807387|NCT02001623|7739757|FG001|NOT COMPLETED|Overall Study||3
6807388|NCT02001623|7739758|FG002|NOT COMPLETED|Overall Study||3
6807389|NCT02001623|7739759|FG003|NOT COMPLETED|Overall Study||2
6807390|NCT02001623|7739760|FG004|NOT COMPLETED|Overall Study||3
6807391|NCT02001623|7739761|FG005|NOT COMPLETED|Overall Study||3
6807392|NCT02001623|7739762|FG006|NOT COMPLETED|Overall Study||3
6807393|NCT02001623|7739763|FG007|NOT COMPLETED|Overall Study||6
6807394|NCT02001623|7739764|FG008|NOT COMPLETED|Overall Study||15
6807395|NCT02001623|7739765|FG009|NOT COMPLETED|Overall Study||53
6807396|NCT02001623|7739766|FG010|NOT COMPLETED|Overall Study||14
6807397|NCT02001623|7739767|FG011|NOT COMPLETED|Overall Study||15
6807398|NCT02001623|7739768|FG012|NOT COMPLETED|Overall Study||14
6807399|NCT02001623|7739769|FG013|NOT COMPLETED|Overall Study||35
6807400|NCT02001623|7739770|FG014|NOT COMPLETED|Overall Study||18
6807401|NCT01900002|7739819|FG000|STARTED|Overall Study||40
6807402|NCT01900002|7739819|FG000|COMPLETED|Overall Study||34
6807403|NCT01900002|7739819|FG000|NOT COMPLETED|Overall Study||6
6807404|NCT01595061|7739823|FG000|STARTED|Overall Study||57
6807405|NCT01595061|7739823|FG000|COMPLETED|Overall Study||53
6807406|NCT01595061|7739823|FG000|NOT COMPLETED|Overall Study||4
6567074|NCT01829243|7490155|FG001|STARTED|Second Intervention||13
6567075|NCT01829243|7490154|FG000|COMPLETED|Second Intervention||7
6807407|NCT04442230|7739829|FG000|STARTED|Overall Study||23
6807408|NCT04442230|7739830|FG001|STARTED|Overall Study||25
6807409|NCT04442230|7739829|FG000|COMPLETED|Overall Study||23
6807410|NCT04442230|7739830|FG001|COMPLETED|Overall Study||24
6807411|NCT04442230|7739829|FG000|NOT COMPLETED|Overall Study||0
6807412|NCT04442230|7739830|FG001|NOT COMPLETED|Overall Study||1
6807413|NCT04388527|7739836|FG000|STARTED|Overall Study||32
6807414|NCT04388527|7739836|FG000|COMPLETED|Overall Study||15
6807415|NCT04388527|7739836|FG000|NOT COMPLETED|Overall Study||17
6807416|NCT04238429|7739842|FG000|STARTED|Overall Study||43
6807417|NCT04238429|7739843|FG001|STARTED|Overall Study||43
6807418|NCT04238429|7739842|FG000|COMPLETED|Overall Study||40
6807419|NCT04238429|7739843|FG001|COMPLETED|Overall Study||41
6807420|NCT04238429|7739842|FG000|NOT COMPLETED|Overall Study||3
6807421|NCT04238429|7739843|FG001|NOT COMPLETED|Overall Study||2
6807422|NCT04126083|7739849|FG000|STARTED|Overall Study||6
6807423|NCT04126083|7739849|FG000|COMPLETED|Overall Study||5
6807424|NCT04126083|7739849|FG000|NOT COMPLETED|Overall Study||1
6807425|NCT03901300|7739855|FG000|STARTED|Overall Study|Children were enrolled study participants. Parents were not study participants.|35
6807426|NCT03901300|7739856|FG001|STARTED|Overall Study||37
6807427|NCT03901300|7739855|FG000|COMPLETED|Overall Study||32
6807428|NCT03901300|7739856|FG001|COMPLETED|Overall Study||37
6807429|NCT03901300|7739855|FG000|NOT COMPLETED|Overall Study||3
6807430|NCT03901300|7739856|FG001|NOT COMPLETED|Overall Study||0
6807431|NCT03744637|7739872|FG000|STARTED|Overall Study||2
6807432|NCT03744637|7739873|FG001|STARTED|Overall Study||2
6807433|NCT03744637|7739874|FG002|STARTED|Overall Study||2
6807434|NCT03744637|7739875|FG003|STARTED|Overall Study||1
6807435|NCT03744637|7739876|FG004|STARTED|Overall Study||1
6807436|NCT03744637|7739877|FG005|STARTED|Overall Study||1
6807437|NCT03744637|7739878|FG006|STARTED|Overall Study||8
6807438|NCT03744637|7739879|FG007|STARTED|Overall Study||4
6807439|NCT03744637|7739880|FG008|STARTED|Overall Study||3
6807440|NCT03744637|7739881|FG009|STARTED|Overall Study||1
6807441|NCT03744637|7739872|FG000|COMPLETED|Overall Study||2
6807442|NCT03744637|7739873|FG001|COMPLETED|Overall Study||2
6807443|NCT03744637|7739874|FG002|COMPLETED|Overall Study||2
6807444|NCT03744637|7739875|FG003|COMPLETED|Overall Study||1
6807445|NCT03744637|7739876|FG004|COMPLETED|Overall Study|Participant did not receive MK-5475 240 ug in Part 2 as planned.|1
6807446|NCT03744637|7739877|FG005|COMPLETED|Overall Study|Participant received 165 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|1
6807447|NCT03744637|7739878|FG006|COMPLETED|Overall Study||8
6807448|NCT03744637|7739879|FG007|COMPLETED|Overall Study|Participants received 120 ug in Part 2 Periods 2 and 3, instead of planned 360 ug.|4
6807449|NCT03744637|7739880|FG008|COMPLETED|Overall Study||3
6807450|NCT03744637|7739881|FG009|COMPLETED|Overall Study|Participant did not receive 120 ug in Part 2 Period 3 as planned.|1
6807451|NCT03744637|7739872|FG000|NOT COMPLETED|Overall Study||0
6807452|NCT03744637|7739873|FG001|NOT COMPLETED|Overall Study||0
6807453|NCT03744637|7739874|FG002|NOT COMPLETED|Overall Study||0
6807454|NCT03744637|7739875|FG003|NOT COMPLETED|Overall Study||0
6807455|NCT03744637|7739876|FG004|NOT COMPLETED|Overall Study||0
6807456|NCT03744637|7739877|FG005|NOT COMPLETED|Overall Study||0
6807457|NCT03744637|7739878|FG006|NOT COMPLETED|Overall Study||0
6807458|NCT03744637|7739879|FG007|NOT COMPLETED|Overall Study||0
6807459|NCT03744637|7739880|FG008|NOT COMPLETED|Overall Study||0
6807460|NCT03744637|7739881|FG009|NOT COMPLETED|Overall Study||0
6807461|NCT03576144|7739948|FG000|STARTED|Overall Study||10
6807462|NCT03576144|7739949|FG001|STARTED|Overall Study||8
6807463|NCT03576144|7739950|FG002|STARTED|Overall Study||8
6807464|NCT03576144|7739951|FG003|STARTED|Overall Study||8
6807465|NCT03576144|7739952|FG004|STARTED|Overall Study||8
6807466|NCT03576144|7739953|FG005|STARTED|Overall Study||8
6807467|NCT03576144|7739948|FG000|COMPLETED|Overall Study||10
6807468|NCT03576144|7739949|FG001|COMPLETED|Overall Study||8
6807469|NCT03576144|7739950|FG002|COMPLETED|Overall Study||8
6807470|NCT03576144|7739951|FG003|COMPLETED|Overall Study||8
6807471|NCT03576144|7739952|FG004|COMPLETED|Overall Study||8
6807472|NCT03576144|7739953|FG005|COMPLETED|Overall Study||8
6567076|NCT01829243|7490155|FG001|COMPLETED|Second Intervention||13
6567077|NCT01829243|7490154|FG000|NOT COMPLETED|Second Intervention||0
6807473|NCT03576144|7739948|FG000|NOT COMPLETED|Overall Study||0
6807474|NCT03576144|7739949|FG001|NOT COMPLETED|Overall Study||0
6807475|NCT03576144|7739950|FG002|NOT COMPLETED|Overall Study||0
6807476|NCT03576144|7739951|FG003|NOT COMPLETED|Overall Study||0
6807477|NCT03576144|7739952|FG004|NOT COMPLETED|Overall Study||0
6807478|NCT03576144|7739953|FG005|NOT COMPLETED|Overall Study||0
6807479|NCT03444038|7739972|FG000|STARTED|Overall Study||85
6807480|NCT03444038|7739972|FG000|COMPLETED|Overall Study||56
6807481|NCT03444038|7739972|FG000|NOT COMPLETED|Overall Study||29
6807482|NCT03432897|7739976|FG000|STARTED|Overall Study||1
6807483|NCT03432897|7739976|FG000|COMPLETED|Overall Study||1
6807484|NCT03432897|7739976|FG000|NOT COMPLETED|Overall Study||0
6807485|NCT03265665|7739982|FG000|STARTED|24-week Data Collection||25
6807486|NCT03265665|7739983|FG001|STARTED|24-week Data Collection||28
6807487|NCT03265665|7739982|FG000|COMPLETED|24-week Data Collection||19
6807488|NCT03265665|7739983|FG001|COMPLETED|24-week Data Collection||21
6807489|NCT03265665|7739982|FG000|NOT COMPLETED|24-week Data Collection||6
6807490|NCT03265665|7739983|FG001|NOT COMPLETED|24-week Data Collection||7
6807491|NCT03265665|7739982|FG000|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|23
6807492|NCT03265665|7739983|FG001|STARTED|36-week Data Collection|Used the number of participants that did not withdraw from the study. If a participant did not complete the 24 week week data collection, they were still allowed to complete the 36-week data collection. Thus the number we started with for this period was the total number of participants in each group that did not withdraw from the study.|26
6807493|NCT03265665|7739982|FG000|COMPLETED|36-week Data Collection||17
6807494|NCT03265665|7739983|FG001|COMPLETED|36-week Data Collection||18
6807495|NCT03265665|7739982|FG000|NOT COMPLETED|36-week Data Collection||6
6807496|NCT03265665|7739983|FG001|NOT COMPLETED|36-week Data Collection||8
6807497|NCT03196180|7739991|FG000|STARTED|Overall Study||13
6807498|NCT03196180|7739991|FG000|COMPLETED|Overall Study||11
6807499|NCT03196180|7739991|FG000|NOT COMPLETED|Overall Study||2
6807500|NCT02725593|7739997|FG000|STARTED|Blinded Treatment Period||39
6807501|NCT02725593|7739998|FG001|STARTED|Blinded Treatment Period||33
6807502|NCT02725593|7739997|FG000|Received Treatment|Blinded Treatment Period||39
6807503|NCT02725593|7739998|FG001|Received Treatment|Blinded Treatment Period||33
6807504|NCT02725593|7739997|FG000|COMPLETED|Blinded Treatment Period||34
6807505|NCT02725593|7739998|FG001|COMPLETED|Blinded Treatment Period||27
6807506|NCT02725593|7739997|FG000|NOT COMPLETED|Blinded Treatment Period||5
6807507|NCT02725593|7739998|FG001|NOT COMPLETED|Blinded Treatment Period||6
6807508|NCT02725593|7739997|FG000|STARTED|Long Term Extension|1 participant who completed Period 1 did not enter the long-term extension period.|33
6807509|NCT02725593|7739998|FG001|STARTED|Long Term Extension||27
6807510|NCT02725593|7739997|FG000|COMPLETED|Long Term Extension||32
6807511|NCT02725593|7739998|FG001|COMPLETED|Long Term Extension||24
6807512|NCT02725593|7739997|FG000|NOT COMPLETED|Long Term Extension||1
6275663|NCT00114114|7174853|FG000|COMPLETED|Overall Study||21
6275664|NCT00114114|7174854|FG001|COMPLETED|Overall Study||24
6275665|NCT00114114|7174855|FG002|COMPLETED|Overall Study||30
6275666|NCT00114114|7174856|FG003|COMPLETED|Overall Study||31
6275667|NCT00114114|7174857|FG004|COMPLETED|Overall Study||27
6275668|NCT00114114|7174858|FG005|COMPLETED|Overall Study||30
6807513|NCT02725593|7739998|FG001|NOT COMPLETED|Long Term Extension||3
6807514|NCT02716675|7740007|FG000|STARTED|Overall Study||903
6807515|NCT02716675|7740008|FG001|STARTED|Overall Study||899
6807516|NCT02716675|7740009|FG002|STARTED|Overall Study||897
6807517|NCT02716675|7740007|FG000|Modified Intent-to-treat Population|Overall Study||898
6807518|NCT02716675|7740008|FG001|Modified Intent-to-treat Population|Overall Study||895
6807519|NCT02716675|7740009|FG002|Modified Intent-to-treat Population|Overall Study||894
6807520|NCT02716675|7740007|FG000|COMPLETED|Overall Study||703
6807521|NCT02716675|7740008|FG001|COMPLETED|Overall Study||702
6807522|NCT02716675|7740009|FG002|COMPLETED|Overall Study||686
6807523|NCT02716675|7740007|FG000|NOT COMPLETED|Overall Study||200
6807524|NCT02716675|7740008|FG001|NOT COMPLETED|Overall Study||197
6807525|NCT02716675|7740009|FG002|NOT COMPLETED|Overall Study||211
6807526|NCT02636946|7740024|FG000|STARTED|Cycle 1 (Day 1 to Week 15)||72
6807527|NCT02636946|7740025|FG001|STARTED|Cycle 1 (Day 1 to Week 15)||72
6807528|NCT02636946|7740024|FG000|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||72
6807529|NCT02636946|7740025|FG001|Received Treatment in Either Eye|Cycle 1 (Day 1 to Week 15)||70
6807530|NCT02636946|7740024|FG000|COMPLETED|Cycle 1 (Day 1 to Week 15)||71
6807531|NCT02636946|7740025|FG001|COMPLETED|Cycle 1 (Day 1 to Week 15)||67
6807532|NCT02636946|7740024|FG000|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||1
6807533|NCT02636946|7740025|FG001|NOT COMPLETED|Cycle 1 (Day 1 to Week 15)||5
6807534|NCT02636946|7740024|FG000|STARTED|Cycle 2 (Week 16 to Week 31)||65
6807535|NCT02636946|7740025|FG001|STARTED|Cycle 2 (Week 16 to Week 31)||62
6807536|NCT02636946|7740024|FG000|COMPLETED|Cycle 2 (Week 16 to Week 31)||63
6807537|NCT02636946|7740025|FG001|COMPLETED|Cycle 2 (Week 16 to Week 31)||61
6807538|NCT02636946|7740024|FG000|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||2
6807539|NCT02636946|7740025|FG001|NOT COMPLETED|Cycle 2 (Week 16 to Week 31)||1
6807540|NCT02636946|7740024|FG000|STARTED|Cycle 3 (Week 32 to Week 52)||17
6807541|NCT02636946|7740025|FG001|STARTED|Cycle 3 (Week 32 to Week 52)||16
6807542|NCT02636946|7740024|FG000|COMPLETED|Cycle 3 (Week 32 to Week 52)||17
6807543|NCT02636946|7740025|FG001|COMPLETED|Cycle 3 (Week 32 to Week 52)||16
6807544|NCT02636946|7740024|FG000|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
6807545|NCT02636946|7740025|FG001|NOT COMPLETED|Cycle 3 (Week 32 to Week 52)||0
6807546|NCT02631941|7740041|FG000|STARTED|Overall Study||9
6807547|NCT02631941|7740042|FG001|STARTED|Overall Study||10
6807548|NCT02631941|7740043|FG002|STARTED|Overall Study||9
6807549|NCT02631941|7740044|FG003|STARTED|Overall Study||9
6807550|NCT02631941|7740045|FG004|STARTED|Overall Study||9
6807551|NCT02631941|7740046|FG005|STARTED|Overall Study||8
6807552|NCT02631941|7740047|FG006|STARTED|Overall Study||9
6807553|NCT02631941|7740048|FG007|STARTED|Overall Study||9
6807554|NCT02631941|7740049|FG008|STARTED|Overall Study||10
6807555|NCT02631941|7740050|FG009|STARTED|Overall Study||9
6807556|NCT02631941|7740041|FG000|A|Overall Study||9
6807557|NCT02631941|7740042|FG001|A|Overall Study||8
6807558|NCT02631941|7740043|FG002|A|Overall Study||9
6807559|NCT02631941|7740044|FG003|A|Overall Study||9
6807560|NCT02631941|7740045|FG004|A|Overall Study||9
6807561|NCT02631941|7740046|FG005|A|Overall Study||8
6807562|NCT02631941|7740047|FG006|A|Overall Study||9
6807563|NCT02631941|7740048|FG007|A|Overall Study||9
6807564|NCT02631941|7740049|FG008|A|Overall Study||9
6807565|NCT02631941|7740050|FG009|A|Overall Study||9
6807566|NCT02631941|7740041|FG000|B1|Overall Study||9
6807567|NCT02631941|7740042|FG001|B1|Overall Study||10
6807568|NCT02631941|7740043|FG002|B1|Overall Study||9
6807569|NCT02631941|7740044|FG003|B1|Overall Study||9
6807570|NCT02631941|7740045|FG004|B1|Overall Study||8
6807571|NCT02631941|7740046|FG005|B1|Overall Study||8
6807572|NCT02631941|7740047|FG006|B1|Overall Study||9
6807573|NCT02631941|7740048|FG007|B1|Overall Study||9
6807574|NCT02631941|7740049|FG008|B1|Overall Study||10
6807575|NCT02631941|7740050|FG009|B1|Overall Study||9
6807576|NCT02631941|7740041|FG000|B2|Overall Study||9
6807577|NCT02631941|7740042|FG001|B2|Overall Study||8
6807578|NCT02631941|7740043|FG002|B2|Overall Study||9
6807579|NCT02631941|7740044|FG003|B2|Overall Study||9
6807580|NCT02631941|7740045|FG004|B2|Overall Study||9
6807581|NCT02631941|7740046|FG005|B2|Overall Study||8
6807582|NCT02631941|7740047|FG006|B2|Overall Study||9
6807583|NCT02631941|7740048|FG007|B2|Overall Study||9
6807584|NCT02631941|7740049|FG008|B2|Overall Study||9
6807585|NCT02631941|7740050|FG009|B2|Overall Study||9
6807586|NCT02631941|7740041|FG000|C|Overall Study||9
6807587|NCT02631941|7740042|FG001|C|Overall Study||8
6807588|NCT02631941|7740043|FG002|C|Overall Study||9
6807589|NCT02631941|7740044|FG003|C|Overall Study||9
6807590|NCT02631941|7740045|FG004|C|Overall Study||8
6275669|NCT00114114|7174853|FG000|NOT COMPLETED|Overall Study||5
6275670|NCT00114114|7174854|FG001|NOT COMPLETED|Overall Study||1
6275671|NCT00114114|7174855|FG002|NOT COMPLETED|Overall Study||1
6807591|NCT02631941|7740046|FG005|C|Overall Study||8
6807592|NCT02631941|7740047|FG006|C|Overall Study||9
6807593|NCT02631941|7740048|FG007|C|Overall Study||8
6807594|NCT02631941|7740049|FG008|C|Overall Study||9
6807595|NCT02631941|7740050|FG009|C|Overall Study||9
6807596|NCT02631941|7740041|FG000|D|Overall Study||9
6807597|NCT02631941|7740042|FG001|D|Overall Study||8
6567078|NCT01829243|7490155|FG001|NOT COMPLETED|Second Intervention||0
6807598|NCT02631941|7740043|FG002|D|Overall Study||9
6807599|NCT02631941|7740044|FG003|D|Overall Study||9
6807600|NCT02631941|7740045|FG004|D|Overall Study||8
6807601|NCT02631941|7740046|FG005|D|Overall Study||8
6807602|NCT02631941|7740047|FG006|D|Overall Study||9
6807603|NCT02631941|7740048|FG007|D|Overall Study||9
6807604|NCT02631941|7740049|FG008|D|Overall Study||9
6807605|NCT02631941|7740050|FG009|D|Overall Study||9
6807606|NCT02631941|7740041|FG000|COMPLETED|Overall Study||9
6807607|NCT02631941|7740042|FG001|COMPLETED|Overall Study||8
6807608|NCT02631941|7740043|FG002|COMPLETED|Overall Study||9
6807609|NCT02631941|7740044|FG003|COMPLETED|Overall Study||9
6807610|NCT02631941|7740045|FG004|COMPLETED|Overall Study||8
6807611|NCT02631941|7740046|FG005|COMPLETED|Overall Study||8
6807612|NCT02631941|7740047|FG006|COMPLETED|Overall Study||9
6807613|NCT02631941|7740048|FG007|COMPLETED|Overall Study||8
6807614|NCT02631941|7740049|FG008|COMPLETED|Overall Study||9
6807615|NCT02631941|7740050|FG009|COMPLETED|Overall Study||9
6807616|NCT02631941|7740041|FG000|NOT COMPLETED|Overall Study||0
6807617|NCT02631941|7740042|FG001|NOT COMPLETED|Overall Study||2
6807618|NCT02631941|7740043|FG002|NOT COMPLETED|Overall Study||0
6807619|NCT02631941|7740044|FG003|NOT COMPLETED|Overall Study||0
6807620|NCT02631941|7740045|FG004|NOT COMPLETED|Overall Study||1
6807621|NCT02631941|7740046|FG005|NOT COMPLETED|Overall Study||0
6807622|NCT02631941|7740047|FG006|NOT COMPLETED|Overall Study||0
6807623|NCT02631941|7740048|FG007|NOT COMPLETED|Overall Study||1
6807624|NCT02631941|7740049|FG008|NOT COMPLETED|Overall Study||1
6807625|NCT02631941|7740050|FG009|NOT COMPLETED|Overall Study||0
6807626|NCT02568215|7740063|FG000|STARTED|Overall Study||637
6807627|NCT02568215|7740064|FG001|STARTED|Overall Study||642
6807628|NCT02568215|7740065|FG002|STARTED|Overall Study||645
6807629|NCT02568215|7740063|FG000|Modified Intent-to-treat Population|Overall Study||637
6807630|NCT02568215|7740064|FG001|Modified Intent-to-treat Population|Overall Study||642
6807631|NCT02568215|7740065|FG002|Modified Intent-to-treat Population|Overall Study||645
6807632|NCT02568215|7740063|FG000|COMPLETED|Overall Study||558
6807633|NCT02568215|7740064|FG001|COMPLETED|Overall Study||562
6807634|NCT02568215|7740065|FG002|COMPLETED|Overall Study||555
6807635|NCT02568215|7740063|FG000|NOT COMPLETED|Overall Study||79
6807636|NCT02568215|7740064|FG001|NOT COMPLETED|Overall Study||80
6807637|NCT02568215|7740065|FG002|NOT COMPLETED|Overall Study||90
6807638|NCT02562378|7740081|FG000|STARTED|Overall Study||3
6807639|NCT02562378|7740082|FG001|STARTED|Overall Study||3
6807640|NCT02562378|7740083|FG002|STARTED|Overall Study||9
6807641|NCT02562378|7740081|FG000|COMPLETED|Overall Study||3
6807642|NCT02562378|7740082|FG001|COMPLETED|Overall Study||3
6807643|NCT02562378|7740083|FG002|COMPLETED|Overall Study||9
6807644|NCT02562378|7740081|FG000|NOT COMPLETED|Overall Study||0
6807645|NCT02562378|7740082|FG001|NOT COMPLETED|Overall Study||0
6807646|NCT02562378|7740083|FG002|NOT COMPLETED|Overall Study||0
6807647|NCT02528643|7740093|FG000|STARTED|DB (Median Duration up to 14.65 Months)||55
6807648|NCT02528643|7740094|FG001|STARTED|DB (Median Duration up to 14.65 Months)||110
6807649|NCT02528643|7740093|FG000|Treated|DB (Median Duration up to 14.65 Months)||55
6807650|NCT02528643|7740094|FG001|Treated|DB (Median Duration up to 14.65 Months)||107
6807651|NCT02528643|7740093|FG000|COMPLETED|DB (Median Duration up to 14.65 Months)||0
6807652|NCT02528643|7740094|FG001|COMPLETED|DB (Median Duration up to 14.65 Months)||0
6807653|NCT02528643|7740093|FG000|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||55
6807654|NCT02528643|7740094|FG001|NOT COMPLETED|DB (Median Duration up to 14.65 Months)||110
6807655|NCT02528643|7740093|FG000|STARTED|OL (Median Duration up to 27.56 Months)||0
6807656|NCT02528643|7740094|FG001|STARTED|OL (Median Duration up to 27.56 Months)||1
6807657|NCT02528643|7740093|FG000|COMPLETED|OL (Median Duration up to 27.56 Months)||0
6807658|NCT02528643|7740094|FG001|COMPLETED|OL (Median Duration up to 27.56 Months)||0
6807659|NCT02528643|7740093|FG000|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||0
6807660|NCT02528643|7740094|FG001|NOT COMPLETED|OL (Median Duration up to 27.56 Months)||1
6807661|NCT02527434|7740105|FG000|STARTED|Overall Study||32
6807662|NCT02527434|7740106|FG001|STARTED|Overall Study||12
6807663|NCT02527434|7740107|FG002|STARTED|Overall Study||20
6807664|NCT02527434|7740105|FG000|Started Retreatment Phase (COMBO)|Overall Study||7
6807665|NCT02527434|7740106|FG001|Started Retreatment Phase (COMBO)|Overall Study||5
6807666|NCT02527434|7740107|FG002|Started Retreatment Phase (COMBO)|Overall Study||4
6807667|NCT02527434|7740105|FG000|Started Retreatment Phase (MEDI)|Overall Study||4
6807668|NCT02527434|7740106|FG001|Started Retreatment Phase (MEDI)|Overall Study||0
6807669|NCT02527434|7740107|FG002|Started Retreatment Phase (MEDI)|Overall Study||1
6807670|NCT02527434|7740105|FG000|COMPLETED|Overall Study||4
6807671|NCT02527434|7740106|FG001|COMPLETED|Overall Study||1
6807672|NCT02527434|7740107|FG002|COMPLETED|Overall Study||0
6807673|NCT02527434|7740105|FG000|NOT COMPLETED|Overall Study||28
6807674|NCT02527434|7740106|FG001|NOT COMPLETED|Overall Study||11
6807675|NCT02527434|7740107|FG002|NOT COMPLETED|Overall Study||20
6567079|NCT01829295|7490165|FG000|STARTED|0-6 Months||107
6807676|NCT02416011|7740128|FG000|STARTED|Overall Study||575
6807677|NCT02416011|7740129|FG001|STARTED|Overall Study||1154
6807678|NCT02416011|7740130|FG002|STARTED|Overall Study||1167
6807679|NCT02416011|7740128|FG000|COMPLETED|Overall Study||561
6807680|NCT02416011|7740129|FG001|COMPLETED|Overall Study||1101
6807681|NCT02416011|7740130|FG002|COMPLETED|Overall Study||1114
6807682|NCT02416011|7740128|FG000|NOT COMPLETED|Overall Study||14
6807683|NCT02416011|7740129|FG001|NOT COMPLETED|Overall Study||53
6807684|NCT02416011|7740130|FG002|NOT COMPLETED|Overall Study||53
6807685|NCT02237508|7740161|FG000|STARTED|Overall Study||9
6807686|NCT02237508|7740162|FG001|STARTED|Overall Study||9
6807687|NCT02237508|7740163|FG002|STARTED|Overall Study||9
6807688|NCT02237508|7740164|FG003|STARTED|Overall Study||9
6807689|NCT02237508|7740165|FG004|STARTED|Overall Study||9
6807690|NCT02237508|7740166|FG005|STARTED|Overall Study||9
6807691|NCT02237508|7740167|FG006|STARTED|Overall Study||9
6807692|NCT02237508|7740168|FG007|STARTED|Overall Study||9
6807693|NCT02237508|7740169|FG008|STARTED|Overall Study||9
6567080|NCT01829295|7490166|FG001|STARTED|0-6 Months||109
6567081|NCT01829295|7490167|FG002|STARTED|0-6 Months||0
6567082|NCT01829295|7490168|FG003|STARTED|0-6 Months||0
6567083|NCT01829295|7490165|FG000|COMPLETED|0-6 Months||96
6567084|NCT01829295|7490166|FG001|COMPLETED|0-6 Months||98
6567085|NCT01829295|7490167|FG002|COMPLETED|0-6 Months||0
6567086|NCT01829295|7490168|FG003|COMPLETED|0-6 Months||0
6567087|NCT01829295|7490165|FG000|NOT COMPLETED|0-6 Months||11
6567088|NCT01829295|7490166|FG001|NOT COMPLETED|0-6 Months||11
6807694|NCT02237508|7740170|FG009|STARTED|Overall Study||9
6807695|NCT02237508|7740161|FG000|A|Overall Study||9
6807696|NCT02237508|7740162|FG001|A|Overall Study||6
6807697|NCT02237508|7740163|FG002|A|Overall Study||8
6807698|NCT02237508|7740164|FG003|A|Overall Study||8
6807699|NCT02237508|7740165|FG004|A|Overall Study||9
6807700|NCT02237508|7740166|FG005|A|Overall Study||8
6807701|NCT02237508|7740167|FG006|A|Overall Study||8
6807702|NCT02237508|7740168|FG007|A|Overall Study||9
6807703|NCT02237508|7740169|FG008|A|Overall Study||9
6807704|NCT02237508|7740170|FG009|A|Overall Study||9
6807705|NCT02237508|7740161|FG000|B1|Overall Study||9
6807706|NCT02237508|7740162|FG001|B1|Overall Study||9
6807707|NCT02237508|7740163|FG002|B1|Overall Study||9
6807708|NCT02237508|7740164|FG003|B1|Overall Study||8
6807709|NCT02237508|7740165|FG004|B1|Overall Study||9
6807710|NCT02237508|7740166|FG005|B1|Overall Study||9
6807711|NCT02237508|7740167|FG006|B1|Overall Study||9
6807712|NCT02237508|7740168|FG007|B1|Overall Study||9
6807713|NCT02237508|7740169|FG008|B1|Overall Study||9
6807714|NCT02237508|7740170|FG009|B1|Overall Study||9
6807715|NCT02237508|7740161|FG000|B2|Overall Study||9
6807716|NCT02237508|7740162|FG001|B2|Overall Study||6
6807717|NCT02237508|7740163|FG002|B2|Overall Study||9
6807718|NCT02237508|7740164|FG003|B2|Overall Study||9
6807719|NCT02237508|7740165|FG004|B2|Overall Study||9
6807720|NCT02237508|7740166|FG005|B2|Overall Study||9
6807721|NCT02237508|7740167|FG006|B2|Overall Study||9
6807722|NCT02237508|7740168|FG007|B2|Overall Study||9
6807723|NCT02237508|7740169|FG008|B2|Overall Study||8
6807724|NCT02237508|7740170|FG009|B2|Overall Study||9
6807725|NCT02237508|7740161|FG000|C|Overall Study||9
6807726|NCT02237508|7740162|FG001|C|Overall Study||8
6807727|NCT02237508|7740163|FG002|C|Overall Study||9
6807728|NCT02237508|7740164|FG003|C|Overall Study||8
6807729|NCT02237508|7740165|FG004|C|Overall Study||9
6807730|NCT02237508|7740166|FG005|C|Overall Study||9
6807731|NCT02237508|7740167|FG006|C|Overall Study||9
6807732|NCT02237508|7740168|FG007|C|Overall Study||9
6807733|NCT02237508|7740169|FG008|C|Overall Study||9
6807734|NCT02237508|7740170|FG009|C|Overall Study||9
6807735|NCT02237508|7740161|FG000|D|Overall Study||9
6807736|NCT02237508|7740162|FG001|D|Overall Study||6
6807737|NCT02237508|7740163|FG002|D|Overall Study||9
6807738|NCT02237508|7740164|FG003|D|Overall Study||9
6807739|NCT02237508|7740165|FG004|D|Overall Study||9
6807740|NCT02237508|7740166|FG005|D|Overall Study||9
6567089|NCT01829295|7490167|FG002|NOT COMPLETED|0-6 Months||0
6567090|NCT01829295|7490168|FG003|NOT COMPLETED|0-6 Months||0
6807741|NCT02237508|7740167|FG006|D|Overall Study||9
6807742|NCT02237508|7740168|FG007|D|Overall Study||9
6807743|NCT02237508|7740169|FG008|D|Overall Study||8
6807744|NCT02237508|7740170|FG009|D|Overall Study||9
6807745|NCT02237508|7740161|FG000|COMPLETED|Overall Study||9
6807746|NCT02237508|7740162|FG001|COMPLETED|Overall Study||6
6807747|NCT02237508|7740163|FG002|COMPLETED|Overall Study||8
6807748|NCT02237508|7740164|FG003|COMPLETED|Overall Study||8
6807749|NCT02237508|7740165|FG004|COMPLETED|Overall Study||9
6807750|NCT02237508|7740166|FG005|COMPLETED|Overall Study||8
6807751|NCT02237508|7740167|FG006|COMPLETED|Overall Study||8
6807752|NCT02237508|7740168|FG007|COMPLETED|Overall Study||9
6807753|NCT02237508|7740169|FG008|COMPLETED|Overall Study||8
6807754|NCT02237508|7740170|FG009|COMPLETED|Overall Study||9
6807755|NCT02237508|7740161|FG000|NOT COMPLETED|Overall Study||0
6807756|NCT02237508|7740162|FG001|NOT COMPLETED|Overall Study||3
6807757|NCT02237508|7740163|FG002|NOT COMPLETED|Overall Study||1
6807758|NCT02237508|7740164|FG003|NOT COMPLETED|Overall Study||1
6807759|NCT02237508|7740165|FG004|NOT COMPLETED|Overall Study||0
6807760|NCT02237508|7740166|FG005|NOT COMPLETED|Overall Study||1
6807761|NCT02237508|7740167|FG006|NOT COMPLETED|Overall Study||1
6807762|NCT02237508|7740168|FG007|NOT COMPLETED|Overall Study||0
6807763|NCT02237508|7740169|FG008|NOT COMPLETED|Overall Study||1
6807764|NCT02237508|7740170|FG009|NOT COMPLETED|Overall Study||0
6807765|NCT02197234|7740188|FG000|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
6807766|NCT02197234|7740188|FG000|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
6807767|NCT02197234|7740188|FG000|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
6807768|NCT02197234|7740188|FG000|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
6807769|NCT02197234|7740188|FG000|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
6807770|NCT02197234|7740188|FG000|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
6807771|NCT02197234|7740188|FG000|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
6807772|NCT02197234|7740188|FG000|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
6807773|NCT02197234|7740188|FG000|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
6807774|NCT02197234|7740188|FG000|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
6807775|NCT02197234|7740188|FG000|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
6807776|NCT02197234|7740188|FG000|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
6807777|NCT02163733|7740197|FG000|STARTED|Part A: Day 1-9 (1st Intervention)||18
6807778|NCT02163733|7740198|FG001|STARTED|Part A: Day 1-9 (1st Intervention)||20
6807779|NCT02163733|7740199|FG002|STARTED|Part A: Day 1-9 (1st Intervention)||0
6807780|NCT02163733|7740197|FG000|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
6807781|NCT02163733|7740198|FG001|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
6807782|NCT02163733|7740199|FG002|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
6807783|NCT02163733|7740197|FG000|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
6807784|NCT02163733|7740198|FG001|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
6807785|NCT02163733|7740199|FG002|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
6807786|NCT02163733|7740197|FG000|STARTED|Part A: Day 10-15 (2nd Intervention)||18
6807787|NCT02163733|7740198|FG001|STARTED|Part A: Day 10-15 (2nd Intervention)||20
6807788|NCT02163733|7740199|FG002|STARTED|Part A: Day 10-15 (2nd Intervention)||0
6807789|NCT02163733|7740197|FG000|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
6567091|NCT01829295|7490165|FG000|STARTED|6-12 Months|64 patients were a treatment success on methotrexate at 6 mo and had the option to continue|64
6623520|NCT02208050|7550678|FG001|STARTED|Baseline Assessment Period: 2 Weeks||28
6807790|NCT02163733|7740198|FG001|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
6807791|NCT02163733|7740199|FG002|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
6807792|NCT02163733|7740197|FG000|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
6807793|NCT02163733|7740198|FG001|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
6807794|NCT02163733|7740199|FG002|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
6807795|NCT02163733|7740197|FG000|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
6807796|NCT02163733|7740198|FG001|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
6807797|NCT02163733|7740199|FG002|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
6807798|NCT02163733|7740197|FG000|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
6807799|NCT02163733|7740198|FG001|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
6807800|NCT02163733|7740199|FG002|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
6807801|NCT02163733|7740197|FG000|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
6807802|NCT02163733|7740198|FG001|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
6807803|NCT02163733|7740199|FG002|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
6807804|NCT02157883|7740206|FG000|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
6807805|NCT02157883|7740206|FG000|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
6807806|NCT02157883|7740206|FG000|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
6807807|NCT02157883|7740206|FG000|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
6807808|NCT02157883|7740206|FG000|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
6807809|NCT02157883|7740206|FG000|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
6807810|NCT02157883|7740206|FG000|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
6807811|NCT02157883|7740206|FG000|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
6807812|NCT02157883|7740206|FG000|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
6807813|NCT01802632|7740219|FG000|STARTED|Overall Study||201
6807814|NCT01802632|7740220|FG001|STARTED|Overall Study||31
6567092|NCT01829295|7490166|FG001|STARTED|6-12 Months|56 patients were a treatment success on mycophenolate mofetil at 6 mo and had the option to continue|56
6567093|NCT01829295|7490167|FG002|STARTED|6-12 Months|32 patients failed methotrexate within the first 6 months|32
6567094|NCT01829295|7490168|FG003|STARTED|6-12 Months|42 patients failed on mycophenolate mofetil within the first 6 months|42
6567095|NCT01829295|7490165|FG000|COMPLETED|6-12 Months||60
6567096|NCT01829295|7490166|FG001|COMPLETED|6-12 Months||54
6567097|NCT01829295|7490167|FG002|COMPLETED|6-12 Months||20
6390690|NCT00831428|7302434|FG000|NOT COMPLETED|Overall Study||0
6807815|NCT01802632|7740221|FG002|STARTED|Overall Study||271
6807816|NCT01802632|7740222|FG003|STARTED|Overall Study||60
6807817|NCT01802632|7740223|FG004|STARTED|Overall Study||12
6807818|NCT01802632|7740224|FG005|STARTED|Overall Study||28
6807819|NCT01802632|7740219|FG000|COMPLETED|Overall Study||0
6807820|NCT01802632|7740220|FG001|COMPLETED|Overall Study||0
6807821|NCT01802632|7740221|FG002|COMPLETED|Overall Study||0
6807822|NCT01802632|7740222|FG003|COMPLETED|Overall Study||0
6807823|NCT01802632|7740223|FG004|COMPLETED|Overall Study||0
6807824|NCT01802632|7740224|FG005|COMPLETED|Overall Study||0
6807825|NCT01802632|7740219|FG000|NOT COMPLETED|Overall Study||201
6807826|NCT01802632|7740220|FG001|NOT COMPLETED|Overall Study||31
6807827|NCT01802632|7740221|FG002|NOT COMPLETED|Overall Study||271
6807828|NCT01802632|7740222|FG003|NOT COMPLETED|Overall Study||60
6807829|NCT01802632|7740223|FG004|NOT COMPLETED|Overall Study||12
6807830|NCT01802632|7740224|FG005|NOT COMPLETED|Overall Study||28
6807831|NCT01706705|7740236|FG000|STARTED|Overall Study||57
6807832|NCT01706705|7740236|FG000|COMPLETED|Overall Study||37
6807833|NCT01706705|7740236|FG000|NOT COMPLETED|Overall Study||20
6807834|NCT01625286|7740248|FG000|STARTED|Overall Study||12
6807835|NCT01625286|7740249|FG001|STARTED|Overall Study||8
6807836|NCT01625286|7740250|FG002|STARTED|Overall Study||5
6807837|NCT01625286|7740251|FG003|STARTED|Overall Study||7
6807838|NCT01625286|7740252|FG004|STARTED|Overall Study||6
6807839|NCT01625286|7740253|FG005|STARTED|Overall Study||54
6807840|NCT01625286|7740254|FG006|STARTED|Overall Study||56
6807841|NCT01625286|7740248|FG000|Received AZD5363/Placebo Treatment|Overall Study||12
6807842|NCT01625286|7740249|FG001|Received AZD5363/Placebo Treatment|Overall Study||8
6807843|NCT01625286|7740250|FG002|Received AZD5363/Placebo Treatment|Overall Study||5
6807844|NCT01625286|7740251|FG003|Received AZD5363/Placebo Treatment|Overall Study||7
6807845|NCT01625286|7740252|FG004|Received AZD5363/Placebo Treatment|Overall Study||6
6807846|NCT01625286|7740253|FG005|Received AZD5363/Placebo Treatment|Overall Study||54
6807847|NCT01625286|7740254|FG006|Received AZD5363/Placebo Treatment|Overall Study||55
6807848|NCT01625286|7740248|FG000|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6807849|NCT01625286|7740249|FG001|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6807850|NCT01625286|7740250|FG002|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6807851|NCT01625286|7740251|FG003|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6807852|NCT01625286|7740252|FG004|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6807853|NCT01625286|7740253|FG005|Did Not Receive AZD5363/Placebo Trt|Overall Study||0
6807854|NCT01625286|7740254|FG006|Did Not Receive AZD5363/Placebo Trt|Overall Study||1
6807855|NCT01625286|7740248|FG000|COMPLETED|Overall Study||0
6807856|NCT01625286|7740249|FG001|COMPLETED|Overall Study||0
6807857|NCT01625286|7740250|FG002|COMPLETED|Overall Study||0
6807858|NCT01625286|7740251|FG003|COMPLETED|Overall Study||0
6807859|NCT01625286|7740252|FG004|COMPLETED|Overall Study||0
6807860|NCT01625286|7740253|FG005|COMPLETED|Overall Study||0
6567098|NCT01829295|7490168|FG003|COMPLETED|6-12 Months||29
6567099|NCT01829295|7490165|FG000|NOT COMPLETED|6-12 Months||4
6567100|NCT01829295|7490166|FG001|NOT COMPLETED|6-12 Months||2
6567101|NCT01829295|7490167|FG002|NOT COMPLETED|6-12 Months||12
6567102|NCT01829295|7490168|FG003|NOT COMPLETED|6-12 Months||13
6807861|NCT01625286|7740254|FG006|COMPLETED|Overall Study||0
6807862|NCT01625286|7740248|FG000|NOT COMPLETED|Overall Study||12
6807863|NCT01625286|7740249|FG001|NOT COMPLETED|Overall Study||8
6807864|NCT01625286|7740250|FG002|NOT COMPLETED|Overall Study||5
6807865|NCT01625286|7740251|FG003|NOT COMPLETED|Overall Study||7
6807866|NCT01625286|7740252|FG004|NOT COMPLETED|Overall Study||6
6807867|NCT01625286|7740253|FG005|NOT COMPLETED|Overall Study||54
6807868|NCT01625286|7740254|FG006|NOT COMPLETED|Overall Study||56
6807869|NCT01609842|7740274|FG000|STARTED|Pre-Intervention Control||0
6567103|NCT01829347|7490180|FG000|STARTED|VTI-210||9
6807870|NCT01609842|7740275|FG001|STARTED|Pre-Intervention Control|Intervention sites patients prior to enrollment period who did not receive the intervention|6081
6807871|NCT01609842|7740274|FG000|COMPLETED|Pre-Intervention Control||0
6807872|NCT01609842|7740275|FG001|COMPLETED|Pre-Intervention Control||6081
6807873|NCT01609842|7740274|FG000|NOT COMPLETED|Pre-Intervention Control||0
6807874|NCT01609842|7740275|FG001|NOT COMPLETED|Pre-Intervention Control||0
6807875|NCT01609842|7740274|FG000|STARTED|Post-Intervention Control||0
6807876|NCT01609842|7740275|FG001|STARTED|Post-Intervention Control|Intervention sites patients after enrollment period ended who did not receive the intervention.|2917
6807877|NCT01609842|7740274|FG000|COMPLETED|Post-Intervention Control||0
6807878|NCT01609842|7740275|FG001|COMPLETED|Post-Intervention Control||2917
6807879|NCT01609842|7740274|FG000|NOT COMPLETED|Post-Intervention Control||0
6807880|NCT01609842|7740275|FG001|NOT COMPLETED|Post-Intervention Control||0
6807881|NCT01609842|7740274|FG000|STARTED|Concurrent Intervention Control||708
6807882|NCT01609842|7740275|FG001|STARTED|Concurrent Intervention Control|Nonintervention sites patients during the period prior and post enrollment at the intervention sites|4869
6807883|NCT01609842|7740274|FG000|COMPLETED|Concurrent Intervention Control||706
6807884|NCT01609842|7740275|FG001|COMPLETED|Concurrent Intervention Control||4869
6807885|NCT01609842|7740274|FG000|NOT COMPLETED|Concurrent Intervention Control||2
6807886|NCT01609842|7740275|FG001|NOT COMPLETED|Concurrent Intervention Control||0
6807887|NCT01341600|7740288|FG000|STARTED|Clopidogrel 75 mg||6
6807888|NCT01341600|7740289|FG001|STARTED|Clopidogrel 75 mg||6
6807889|NCT01341600|7740290|FG002|STARTED|Clopidogrel 75 mg||6
6807890|NCT01341600|7740288|FG000|COMPLETED|Clopidogrel 75 mg||6
6807891|NCT01341600|7740289|FG001|COMPLETED|Clopidogrel 75 mg||6
6807892|NCT01341600|7740290|FG002|COMPLETED|Clopidogrel 75 mg||6
6807893|NCT01341600|7740288|FG000|NOT COMPLETED|Clopidogrel 75 mg||0
6807894|NCT01341600|7740289|FG001|NOT COMPLETED|Clopidogrel 75 mg||0
6807895|NCT01341600|7740290|FG002|NOT COMPLETED|Clopidogrel 75 mg||0
6807896|NCT01341600|7740288|FG000|STARTED|Clopidogrel 150 mg||6
6807897|NCT01341600|7740289|FG001|STARTED|Clopidogrel 150 mg||6
6807898|NCT01341600|7740290|FG002|STARTED|Clopidogrel 150 mg||6
6807899|NCT01341600|7740288|FG000|COMPLETED|Clopidogrel 150 mg||6
6807900|NCT01341600|7740289|FG001|COMPLETED|Clopidogrel 150 mg||6
6807901|NCT01341600|7740290|FG002|COMPLETED|Clopidogrel 150 mg||6
6807902|NCT01341600|7740288|FG000|NOT COMPLETED|Clopidogrel 150 mg||0
6807903|NCT01341600|7740289|FG001|NOT COMPLETED|Clopidogrel 150 mg||0
6807904|NCT01341600|7740290|FG002|NOT COMPLETED|Clopidogrel 150 mg||0
6807905|NCT01341600|7740288|FG000|STARTED|Clopidogrel 225 mg||6
6807906|NCT01341600|7740289|FG001|STARTED|Clopidogrel 225 mg||6
6807907|NCT01341600|7740290|FG002|STARTED|Clopidogrel 225 mg||6
6807908|NCT01341600|7740288|FG000|COMPLETED|Clopidogrel 225 mg||6
6807909|NCT01341600|7740289|FG001|COMPLETED|Clopidogrel 225 mg||6
6807910|NCT01341600|7740290|FG002|COMPLETED|Clopidogrel 225 mg||6
6807911|NCT01341600|7740288|FG000|NOT COMPLETED|Clopidogrel 225 mg||0
6807912|NCT01341600|7740289|FG001|NOT COMPLETED|Clopidogrel 225 mg||0
6807913|NCT01341600|7740290|FG002|NOT COMPLETED|Clopidogrel 225 mg||0
6807914|NCT01341600|7740288|FG000|STARTED|Clopidogrel Plus Omeprazole||5
6807915|NCT01341600|7740289|FG001|STARTED|Clopidogrel Plus Omeprazole||5
6807916|NCT01341600|7740290|FG002|STARTED|Clopidogrel Plus Omeprazole||4
6807917|NCT01341600|7740288|FG000|COMPLETED|Clopidogrel Plus Omeprazole||5
6807918|NCT01341600|7740289|FG001|COMPLETED|Clopidogrel Plus Omeprazole||5
6807919|NCT01341600|7740290|FG002|COMPLETED|Clopidogrel Plus Omeprazole||4
6807920|NCT01341600|7740288|FG000|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
6275672|NCT00114114|7174856|FG003|NOT COMPLETED|Overall Study||4
6275673|NCT00114114|7174857|FG004|NOT COMPLETED|Overall Study||2
6275674|NCT00114114|7174858|FG005|NOT COMPLETED|Overall Study||1
6807921|NCT01341600|7740289|FG001|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
6807922|NCT01341600|7740290|FG002|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
6807923|NCT01044901|7740300|FG000|STARTED|Overall Study||38
6807924|NCT01044901|7740301|FG001|STARTED|Overall Study||13
6807925|NCT01044901|7740300|FG000|COMPLETED|Overall Study||38
6807926|NCT01044901|7740301|FG001|COMPLETED|Overall Study||13
6807927|NCT01044901|7740300|FG000|NOT COMPLETED|Overall Study||0
6807928|NCT01044901|7740301|FG001|NOT COMPLETED|Overall Study||0
6807929|NCT00288080|7740309|FG000|STARTED|Overall Study||307
6807930|NCT00288080|7740310|FG001|STARTED|Overall Study||305
6807931|NCT00288080|7740309|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
6807932|NCT00288080|7740310|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
6807933|NCT00288080|7740309|FG000|NOT COMPLETED|Overall Study||26
6807934|NCT00288080|7740310|FG001|NOT COMPLETED|Overall Study||23
6807935|NCT00099437|7740318|FG000|STARTED|Overall Study|randomised patients|374
6807936|NCT00099437|7740319|FG001|STARTED|Overall Study|randomised patients|362
6807937|NCT00099437|7740318|FG000|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
6807938|NCT00099437|7740319|FG001|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
6807939|NCT00099437|7740318|FG000|NOT COMPLETED|Overall Study||366
6807940|NCT00099437|7740319|FG001|NOT COMPLETED|Overall Study||349
6807941|NCT00003479|7740325|FG000|STARTED|Overall Study||9
6807942|NCT00003479|7740325|FG000|COMPLETED|Overall Study||6
6807943|NCT00003479|7740325|FG000|NOT COMPLETED|Overall Study||3
6567104|NCT01829347|7490181|FG001|STARTED|VTI-210||9
6567105|NCT01829347|7490180|FG000|COMPLETED|VTI-210||3
6567106|NCT01829347|7490181|FG001|COMPLETED|VTI-210||6
6807944|NCT04160195|7740331|FG000|STARTED|Overall Study||2
6807945|NCT04160195|7740332|FG001|STARTED|Overall Study||0
6807946|NCT04160195|7740331|FG000|COMPLETED|Overall Study||1
6807947|NCT04160195|7740332|FG001|COMPLETED|Overall Study||0
6807948|NCT04160195|7740331|FG000|NOT COMPLETED|Overall Study||1
6807949|NCT04160195|7740332|FG001|NOT COMPLETED|Overall Study||0
6807950|NCT04159701|7740342|FG000|STARTED|Period 1: Treatment Period||39
6807951|NCT04159701|7740343|FG001|STARTED|Period 1: Treatment Period||13
6807952|NCT04159701|7740342|FG000|Received at Least One Dose of Study Drug|Period 1: Treatment Period||39
6807953|NCT04159701|7740343|FG001|Received at Least One Dose of Study Drug|Period 1: Treatment Period||13
6807954|NCT04159701|7740342|FG000|COMPLETED|Period 1: Treatment Period||31
6807955|NCT04159701|7740343|FG001|COMPLETED|Period 1: Treatment Period||12
6807956|NCT04159701|7740342|FG000|NOT COMPLETED|Period 1: Treatment Period||8
6807957|NCT04159701|7740343|FG001|NOT COMPLETED|Period 1: Treatment Period||1
6807958|NCT04159701|7740342|FG000|STARTED|Washout Period||31
6807959|NCT04159701|7740343|FG001|STARTED|Washout Period||12
6807960|NCT04159701|7740342|FG000|COMPLETED|Washout Period||18
6807961|NCT04159701|7740343|FG001|COMPLETED|Washout Period||8
6807962|NCT04159701|7740342|FG000|NOT COMPLETED|Washout Period||13
6807963|NCT04159701|7740343|FG001|NOT COMPLETED|Washout Period||4
6807964|NCT04159701|7740342|FG000|STARTED|Period 2: Treatment Period (Crossover)||18
6807965|NCT04159701|7740343|FG001|STARTED|Period 2: Treatment Period (Crossover)||8
6807966|NCT04159701|7740342|FG000|COMPLETED|Period 2: Treatment Period (Crossover)||18
6807967|NCT04159701|7740343|FG001|COMPLETED|Period 2: Treatment Period (Crossover)||5
6807968|NCT04159701|7740342|FG000|NOT COMPLETED|Period 2: Treatment Period (Crossover)||0
6807969|NCT04159701|7740343|FG001|NOT COMPLETED|Period 2: Treatment Period (Crossover)||3
6807970|NCT04159701|7740342|FG000|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|29
6807971|NCT04159701|7740343|FG001|STARTED|Post-treatment Follow-up|All participants who received study drug could move to post-treatment follow-up.|9
6807972|NCT04159701|7740342|FG000|COMPLETED|Post-treatment Follow-up||19
6807973|NCT04159701|7740343|FG001|COMPLETED|Post-treatment Follow-up||6
6807974|NCT04159701|7740342|FG000|NOT COMPLETED|Post-treatment Follow-up||10
6807975|NCT04159701|7740343|FG001|NOT COMPLETED|Post-treatment Follow-up||3
6807976|NCT04152447|7740355|FG000|STARTED|Overall Study||16
6807977|NCT04152447|7740356|FG001|STARTED|Overall Study||19
6807978|NCT04152447|7740355|FG000|COMPLETED|Overall Study||13
6807979|NCT04152447|7740356|FG001|COMPLETED|Overall Study||14
6807980|NCT04152447|7740355|FG000|NOT COMPLETED|Overall Study||3
6807981|NCT04152447|7740356|FG001|NOT COMPLETED|Overall Study||5
6807982|NCT04011475|7740365|FG000|STARTED|Overall Study||239
6807983|NCT04011475|7740366|FG001|STARTED|Overall Study||937
6807984|NCT04011475|7740367|FG002|STARTED|Overall Study||441
6807985|NCT04011475|7740365|FG000|Propensity Score Matched Cohort|Overall Study||114
6807986|NCT04011475|7740366|FG001|Propensity Score Matched Cohort|Overall Study||114
6807987|NCT04011475|7740367|FG002|Propensity Score Matched Cohort|Overall Study||114
6807988|NCT04011475|7740365|FG000|COMPLETED|Overall Study||239
6807989|NCT04011475|7740366|FG001|COMPLETED|Overall Study||937
6807990|NCT04011475|7740367|FG002|COMPLETED|Overall Study||441
6807991|NCT04011475|7740365|FG000|NOT COMPLETED|Overall Study||0
6807992|NCT04011475|7740366|FG001|NOT COMPLETED|Overall Study||0
6807993|NCT04011475|7740367|FG002|NOT COMPLETED|Overall Study||0
6807994|NCT03965962|7740379|FG000|STARTED|Overall Study||320
6807995|NCT03965962|7740380|FG001|STARTED|Overall Study||107
6807996|NCT03965962|7740381|FG002|STARTED|Overall Study||107
6807997|NCT03965962|7740382|FG003|STARTED|Overall Study||106
6807998|NCT03965962|7740379|FG000|Vaccination 1 (Day 0)|Overall Study||318
6807999|NCT03965962|7740380|FG001|Vaccination 1 (Day 0)|Overall Study||107
6808000|NCT03965962|7740381|FG002|Vaccination 1 (Day 0)|Overall Study||107
6808001|NCT03965962|7740382|FG003|Vaccination 1 (Day 0)|Overall Study||106
6808002|NCT03965962|7740379|FG000|Vaccination 2 (Day 3)|Overall Study||317
6808003|NCT03965962|7740380|FG001|Vaccination 2 (Day 3)|Overall Study||104
6808004|NCT03965962|7740381|FG002|Vaccination 2 (Day 3)|Overall Study||107
6808005|NCT03965962|7740382|FG003|Vaccination 2 (Day 3)|Overall Study||106
6808006|NCT03965962|7740379|FG000|Vaccination 3 (Day 7)|Overall Study||311
6808007|NCT03965962|7740380|FG001|Vaccination 3 (Day 7)|Overall Study||103
6808008|NCT03965962|7740381|FG002|Vaccination 3 (Day 7)|Overall Study||105
6808009|NCT03965962|7740382|FG003|Vaccination 3 (Day 7)|Overall Study||105
6808010|NCT03965962|7740379|FG000|Vaccination 4 (Day 14)|Overall Study||301
6808011|NCT03965962|7740380|FG001|Vaccination 4 (Day 14)|Overall Study||101
6808012|NCT03965962|7740381|FG002|Vaccination 4 (Day 14)|Overall Study||101
6808013|NCT03965962|7740382|FG003|Vaccination 4 (Day 14)|Overall Study||103
6808014|NCT03965962|7740379|FG000|Vaccination 5 (Day 28)|Overall Study||294
6808015|NCT03965962|7740380|FG001|Vaccination 5 (Day 28)|Overall Study||98
6808016|NCT03965962|7740381|FG002|Vaccination 5 (Day 28)|Overall Study||97
6808017|NCT03965962|7740382|FG003|Vaccination 5 (Day 28)|Overall Study||98
6808018|NCT03965962|7740379|FG000|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|320
6808019|NCT03965962|7740380|FG001|Safety Analysis Set (SafAS)|Overall Study||107
6808020|NCT03965962|7740381|FG002|Safety Analysis Set (SafAS)|Overall Study||107
6808021|NCT03965962|7740382|FG003|Safety Analysis Set (SafAS)|Overall Study|2 participants randomized to Group 4: VRVg-2 received vaccination in Group 1: VRVg-2+HRIG and were considered in Group 1 for safety analysis purpose.|104
6808022|NCT03965962|7740379|FG000|COMPLETED|Overall Study||295
6808023|NCT03965962|7740380|FG001|COMPLETED|Overall Study||102
6808024|NCT03965962|7740381|FG002|COMPLETED|Overall Study||97
6808025|NCT03965962|7740382|FG003|COMPLETED|Overall Study||100
6808026|NCT03965962|7740379|FG000|NOT COMPLETED|Overall Study||25
6808027|NCT03965962|7740380|FG001|NOT COMPLETED|Overall Study||5
6808028|NCT03965962|7740381|FG002|NOT COMPLETED|Overall Study||10
6808029|NCT03965962|7740382|FG003|NOT COMPLETED|Overall Study||6
6808030|NCT03861481|7740394|FG000|STARTED|Overall Study||17
6808031|NCT03861481|7740395|FG001|STARTED|Overall Study||17
6808032|NCT03861481|7740394|FG000|COMPLETED|Overall Study||11
6808033|NCT03861481|7740395|FG001|COMPLETED|Overall Study||10
6808034|NCT03861481|7740394|FG000|NOT COMPLETED|Overall Study||6
6808035|NCT03861481|7740395|FG001|NOT COMPLETED|Overall Study||7
6808036|NCT03834974|7740403|FG000|STARTED|Overall Study||34
6808037|NCT03834974|7740404|FG001|STARTED|Overall Study||32
6808038|NCT03834974|7740403|FG000|COMPLETED|Overall Study||34
6808039|NCT03834974|7740404|FG001|COMPLETED|Overall Study||32
6808040|NCT03834974|7740403|FG000|NOT COMPLETED|Overall Study||0
6808041|NCT03834974|7740404|FG001|NOT COMPLETED|Overall Study||0
6808042|NCT03794544|7740415|FG000|STARTED|Overall Study||27
6808043|NCT03794544|7740416|FG001|STARTED|Overall Study||21
6808044|NCT03794544|7740417|FG002|STARTED|Overall Study||20
6808045|NCT03794544|7740418|FG003|STARTED|Overall Study||16
6808046|NCT03794544|7740415|FG000|Treated|Overall Study||26
6808047|NCT03794544|7740416|FG001|Treated|Overall Study||21
6808048|NCT03794544|7740417|FG002|Treated|Overall Study||20
6808049|NCT03794544|7740418|FG003|Treated|Overall Study||16
6808050|NCT03794544|7740415|FG000|COMPLETED|Overall Study||26
6808051|NCT03794544|7740416|FG001|COMPLETED|Overall Study||18
6808052|NCT03794544|7740417|FG002|COMPLETED|Overall Study||19
6808053|NCT03794544|7740418|FG003|COMPLETED|Overall Study||15
6808054|NCT03794544|7740415|FG000|NOT COMPLETED|Overall Study||1
6808055|NCT03794544|7740416|FG001|NOT COMPLETED|Overall Study||3
6808056|NCT03794544|7740417|FG002|NOT COMPLETED|Overall Study||1
6808057|NCT03794544|7740418|FG003|NOT COMPLETED|Overall Study||1
6808058|NCT03732807|7740435|FG000|STARTED|Treatment Period (up to Week 24)||132
6808059|NCT03732807|7740436|FG001|STARTED|Treatment Period (up to Week 24)||130
6808060|NCT03732807|7740437|FG002|STARTED|Treatment Period (up to Week 24)||130
6808061|NCT03732807|7740438|FG003|STARTED|Treatment Period (up to Week 24)||132
6808062|NCT03732807|7740439|FG004|STARTED|Treatment Period (up to Week 24)||63
6808063|NCT03732807|7740440|FG005|STARTED|Treatment Period (up to Week 24)||65
6808064|NCT03732807|7740441|FG006|STARTED|Treatment Period (up to Week 24)||66
6808065|NCT03732807|7740435|FG000|COMPLETED|Treatment Period (up to Week 24)||122
6808066|NCT03732807|7740436|FG001|COMPLETED|Treatment Period (up to Week 24)||124
6808067|NCT03732807|7740437|FG002|COMPLETED|Treatment Period (up to Week 24)||121
6808068|NCT03732807|7740438|FG003|COMPLETED|Treatment Period (up to Week 24)||117
6808069|NCT03732807|7740439|FG004|COMPLETED|Treatment Period (up to Week 24)||58
6808070|NCT03732807|7740440|FG005|COMPLETED|Treatment Period (up to Week 24)||63
6808071|NCT03732807|7740441|FG006|COMPLETED|Treatment Period (up to Week 24)||61
6808072|NCT03732807|7740435|FG000|NOT COMPLETED|Treatment Period (up to Week 24)||10
6808073|NCT03732807|7740436|FG001|NOT COMPLETED|Treatment Period (up to Week 24)||6
6808074|NCT03732807|7740437|FG002|NOT COMPLETED|Treatment Period (up to Week 24)||9
6808075|NCT03732807|7740438|FG003|NOT COMPLETED|Treatment Period (up to Week 24)||15
6808076|NCT03732807|7740439|FG004|NOT COMPLETED|Treatment Period (up to Week 24)||5
6808077|NCT03732807|7740440|FG005|NOT COMPLETED|Treatment Period (up to Week 24)||2
6808078|NCT03732807|7740441|FG006|NOT COMPLETED|Treatment Period (up to Week 24)||5
6808079|NCT03732807|7740435|FG000|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|113
6808080|NCT03732807|7740436|FG001|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|111
6808081|NCT03732807|7740437|FG002|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|108
6808082|NCT03732807|7740438|FG003|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|106
6808083|NCT03732807|7740439|FG004|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|49
6808084|NCT03732807|7740440|FG005|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|59
6808085|NCT03732807|7740441|FG006|STARTED|Treatment Extension (Week 25 up to 48)|Participants continued dosing according to their assigned sequence in the preceding period.|57
6808086|NCT03732807|7740435|FG000|COMPLETED|Treatment Extension (Week 25 up to 48)||107
6808087|NCT03732807|7740436|FG001|COMPLETED|Treatment Extension (Week 25 up to 48)||100
6808088|NCT03732807|7740437|FG002|COMPLETED|Treatment Extension (Week 25 up to 48)||103
6808089|NCT03732807|7740438|FG003|COMPLETED|Treatment Extension (Week 25 up to 48)||97
6808090|NCT03732807|7740439|FG004|COMPLETED|Treatment Extension (Week 25 up to 48)||44
6567107|NCT01829347|7490180|FG000|NOT COMPLETED|VTI-210||6
6567108|NCT01829347|7490181|FG001|NOT COMPLETED|VTI-210||3
6567109|NCT01829347|7490180|FG000|STARTED|VTI-210E||3
6567110|NCT01829347|7490181|FG001|STARTED|VTI-210E||6
6567111|NCT01829347|7490180|FG000|COMPLETED|VTI-210E||0
6567112|NCT01829347|7490181|FG001|COMPLETED|VTI-210E||0
6567113|NCT01829347|7490180|FG000|NOT COMPLETED|VTI-210E||3
6808091|NCT03732807|7740440|FG005|COMPLETED|Treatment Extension (Week 25 up to 48)||56
6808092|NCT03732807|7740441|FG006|COMPLETED|Treatment Extension (Week 25 up to 48)||53
6808093|NCT03732807|7740435|FG000|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||6
6808094|NCT03732807|7740436|FG001|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||11
6808095|NCT03732807|7740437|FG002|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
6808096|NCT03732807|7740438|FG003|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||9
6567114|NCT01829347|7490181|FG001|NOT COMPLETED|VTI-210E||6
6567115|NCT01829360|7490191|FG000|STARTED|Overall Study||8
6808097|NCT03732807|7740439|FG004|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||5
6808098|NCT03732807|7740440|FG005|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||3
6808099|NCT03732807|7740441|FG006|NOT COMPLETED|Treatment Extension (Week 25 up to 48)||4
6808100|NCT03731364|7740463|FG000|STARTED|Overall Study||9
6808101|NCT03731364|7740464|FG001|STARTED|Overall Study||9
6808102|NCT03731364|7740465|FG002|STARTED|Overall Study||13
6808103|NCT03731364|7740466|FG003|STARTED|Overall Study||13
6808104|NCT03731364|7740467|FG004|STARTED|Overall Study||11
6808105|NCT03731364|7740463|FG000|COMPLETED|Overall Study||9
6808106|NCT03731364|7740464|FG001|COMPLETED|Overall Study||9
6808107|NCT03731364|7740465|FG002|COMPLETED|Overall Study||12
6808108|NCT03731364|7740466|FG003|COMPLETED|Overall Study||11
6808109|NCT03731364|7740467|FG004|COMPLETED|Overall Study||10
6808110|NCT03731364|7740463|FG000|NOT COMPLETED|Overall Study||0
6808111|NCT03731364|7740464|FG001|NOT COMPLETED|Overall Study||0
6808112|NCT03731364|7740465|FG002|NOT COMPLETED|Overall Study||1
6808113|NCT03731364|7740466|FG003|NOT COMPLETED|Overall Study||2
6808114|NCT03731364|7740467|FG004|NOT COMPLETED|Overall Study||1
6808115|NCT03724422|7740481|FG000|STARTED|Overall Study||1
6808116|NCT03724422|7740482|FG001|STARTED|Overall Study||2
6808117|NCT03724422|7740481|FG000|COMPLETED|Overall Study||1
6808118|NCT03724422|7740482|FG001|COMPLETED|Overall Study|Patients had interval healing then lost follow up|0
6808119|NCT03724422|7740481|FG000|NOT COMPLETED|Overall Study||0
6808120|NCT03724422|7740482|FG001|NOT COMPLETED|Overall Study||2
6808121|NCT03720899|7740490|FG000|STARTED|Overall Study||21
6808122|NCT03720899|7740491|FG001|STARTED|Overall Study||24
6808123|NCT03720899|7740490|FG000|COMPLETED|Overall Study||13
6808124|NCT03720899|7740491|FG001|COMPLETED|Overall Study||13
6808125|NCT03720899|7740490|FG000|NOT COMPLETED|Overall Study||8
6808126|NCT03720899|7740491|FG001|NOT COMPLETED|Overall Study||11
6808127|NCT03716869|7740499|FG000|STARTED|Overall Study||6436
6808128|NCT03716869|7740500|FG001|STARTED|Overall Study||6473
6808129|NCT03716869|7740499|FG000|COMPLETED|Overall Study||6436
6808130|NCT03716869|7740500|FG001|COMPLETED|Overall Study||6473
6808131|NCT03716869|7740499|FG000|NOT COMPLETED|Overall Study||0
6808132|NCT03716869|7740500|FG001|NOT COMPLETED|Overall Study||0
6808133|NCT04598152|7740506|FG000|STARTED|Overall Study||3
6808134|NCT04598152|7740507|FG001|STARTED|Overall Study||1
6808135|NCT04598152|7740506|FG000|COMPLETED|Overall Study||3
6808136|NCT04598152|7740507|FG001|COMPLETED|Overall Study||0
6808137|NCT04598152|7740506|FG000|NOT COMPLETED|Overall Study||0
6808138|NCT04598152|7740507|FG001|NOT COMPLETED|Overall Study||1
6808139|NCT04353271|7740515|FG000|STARTED|Overall Study||1
6808140|NCT04353271|7740516|FG001|STARTED|Overall Study||2
6808141|NCT04353271|7740515|FG000|COMPLETED|Overall Study||1
6808142|NCT04353271|7740516|FG001|COMPLETED|Overall Study||1
6808143|NCT04353271|7740515|FG000|NOT COMPLETED|Overall Study||0
6808144|NCT04353271|7740516|FG001|NOT COMPLETED|Overall Study||1
6808145|NCT05166824|7740526|FG000|STARTED|Overall Study||1
6808146|NCT05166824|7740527|FG001|STARTED|Overall Study||10
6808147|NCT05166824|7740528|FG002|STARTED|Overall Study||68
6808148|NCT05166824|7740529|FG003|STARTED|Overall Study||10
6808149|NCT05166824|7740526|FG000|COMPLETED|Overall Study||1
6808150|NCT05166824|7740527|FG001|COMPLETED|Overall Study||10
6808151|NCT05166824|7740528|FG002|COMPLETED|Overall Study||59
6808152|NCT05166824|7740529|FG003|COMPLETED|Overall Study||10
6808153|NCT05166824|7740526|FG000|NOT COMPLETED|Overall Study||0
6808154|NCT05166824|7740527|FG001|NOT COMPLETED|Overall Study||0
6808155|NCT05166824|7740528|FG002|NOT COMPLETED|Overall Study||9
6808156|NCT05166824|7740529|FG003|NOT COMPLETED|Overall Study||0
6808157|NCT04570670|7740541|FG000|STARTED|Overall Study||25
6808158|NCT04570670|7740542|FG001|STARTED|Overall Study||25
6808159|NCT04570670|7740541|FG000|COMPLETED|Overall Study||24
6808160|NCT04570670|7740542|FG001|COMPLETED|Overall Study||25
6808161|NCT04570670|7740541|FG000|NOT COMPLETED|Overall Study||1
6808162|NCT04570670|7740542|FG001|NOT COMPLETED|Overall Study||0
6808163|NCT04552704|7740551|FG000|STARTED|Overall Study||3
6808164|NCT04552704|7740551|FG000|COMPLETED|Overall Study||3
6808165|NCT04552704|7740551|FG000|NOT COMPLETED|Overall Study||0
6808166|NCT04546581|7740558|FG000|STARTED|Overall Study||301
6808167|NCT04546581|7740559|FG001|STARTED|Overall Study||292
6808168|NCT04546581|7740558|FG000|COMPLETED|Overall Study||288
6808169|NCT04546581|7740559|FG001|COMPLETED|Overall Study||279
6808170|NCT04546581|7740558|FG000|NOT COMPLETED|Overall Study||13
6808171|NCT04546581|7740559|FG001|NOT COMPLETED|Overall Study||13
6808172|NCT04236245|7740565|FG000|STARTED|Overall Study||25
6808173|NCT04236245|7740565|FG000|COMPLETED|Overall Study||25
6808174|NCT04236245|7740565|FG000|NOT COMPLETED|Overall Study||0
6808175|NCT03915626|7740569|FG000|STARTED|Overall Study||7
6808176|NCT03915626|7740569|FG000|COMPLETED|Overall Study||6
6808177|NCT03915626|7740569|FG000|NOT COMPLETED|Overall Study||1
6808178|NCT03698279|7740585|FG000|STARTED|Overall Study||124
6808179|NCT03698279|7740586|FG001|STARTED|Overall Study||122
6808180|NCT03698279|7740587|FG002|STARTED|Overall Study||159
6808181|NCT03698279|7740588|FG003|STARTED|Overall Study||234
6808182|NCT03698279|7740589|FG004|STARTED|Overall Study||13
6808183|NCT03698279|7740590|FG005|STARTED|Overall Study||13
6808184|NCT03698279|7740585|FG000|Safety Analysis Set Population (SafAS)|Overall Study||122
6808185|NCT03698279|7740586|FG001|Safety Analysis Set Population (SafAS)|Overall Study||121
6808186|NCT03698279|7740587|FG002|Safety Analysis Set Population (SafAS)|Overall Study||158
6808187|NCT03698279|7740588|FG003|Safety Analysis Set Population (SafAS)|Overall Study||234
6808188|NCT03698279|7740589|FG004|Safety Analysis Set Population (SafAS)|Overall Study||13
6808189|NCT03698279|7740590|FG005|Safety Analysis Set Population (SafAS)|Overall Study||13
6808190|NCT03698279|7740585|FG000|COMPLETED|Overall Study||119
6808191|NCT03698279|7740586|FG001|COMPLETED|Overall Study||120
6808192|NCT03698279|7740587|FG002|COMPLETED|Overall Study||152
6808193|NCT03698279|7740588|FG003|COMPLETED|Overall Study||228
6808194|NCT03698279|7740589|FG004|COMPLETED|Overall Study||13
6808195|NCT03698279|7740590|FG005|COMPLETED|Overall Study||13
6808196|NCT03698279|7740585|FG000|NOT COMPLETED|Overall Study||5
6808197|NCT03698279|7740586|FG001|NOT COMPLETED|Overall Study||2
6808198|NCT03698279|7740587|FG002|NOT COMPLETED|Overall Study||7
6808199|NCT03698279|7740588|FG003|NOT COMPLETED|Overall Study||6
6808200|NCT03698279|7740589|FG004|NOT COMPLETED|Overall Study||0
6808201|NCT03698279|7740590|FG005|NOT COMPLETED|Overall Study||0
6808202|NCT03559010|7740609|FG000|STARTED|Overall Study|The number of participants to start a period is not equal to the number who completed previous period|189
6808203|NCT03559010|7740609|FG000|Purchaser Population|Overall Study||113
6808204|NCT03559010|7740609|FG000|Use Phase Norgestrel 0.075 mg|Overall Study||109
6808205|NCT03559010|7740609|FG000|COMPLETED|Overall Study||189
6808206|NCT03559010|7740609|FG000|NOT COMPLETED|Overall Study||0
6390691|NCT00831441|7302440|FG000|STARTED|Randomized||3687
6390692|NCT00831441|7302441|FG001|STARTED|Randomized||3705
6390693|NCT00831441|7302440|FG000|Treated|Randomized||3643
6390694|NCT00831441|7302441|FG001|Treated|Randomized||3672
6390695|NCT00831441|7302440|FG000|COMPLETED|Randomized||0
6390696|NCT00831441|7302441|FG001|COMPLETED|Randomized||0
6390697|NCT00831441|7302440|FG000|NOT COMPLETED|Randomized||3687
6390698|NCT00831441|7302441|FG001|NOT COMPLETED|Randomized||3705
6390699|NCT00831441|7302440|FG000|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
6390700|NCT00831441|7302441|FG001|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
6390701|NCT00831441|7302440|FG000|COMPLETED|Follow Up (30 Days)||3375
6390702|NCT00831441|7302441|FG001|COMPLETED|Follow Up (30 Days)||3355
6390703|NCT00831441|7302440|FG000|NOT COMPLETED|Follow Up (30 Days)||133
6390704|NCT00831441|7302441|FG001|NOT COMPLETED|Follow Up (30 Days)||174
6390705|NCT00831480|7302448|FG000|STARTED|Overall Study||9
6390706|NCT00831480|7302448|FG000|COMPLETED|Overall Study||7
6390707|NCT00831480|7302448|FG000|NOT COMPLETED|Overall Study||2
6390708|NCT00831493|7302452|FG000|STARTED|Overall Study||3
6390709|NCT00831493|7302452|FG000|COMPLETED|Overall Study||2
6390710|NCT00831493|7302452|FG000|NOT COMPLETED|Overall Study||1
6390711|NCT00831675|7302458|FG000|STARTED|Overall Study||12
6808207|NCT03478930|7740620|FG000|STARTED|Overall Study||126
6808208|NCT03478930|7740621|FG001|STARTED|Overall Study||123
6808209|NCT03478930|7740620|FG000|COMPLETED|Overall Study||117
6808210|NCT03478930|7740621|FG001|COMPLETED|Overall Study||114
6808211|NCT03478930|7740620|FG000|NOT COMPLETED|Overall Study||9
6808212|NCT03478930|7740621|FG001|NOT COMPLETED|Overall Study||9
6808213|NCT03434353|7740632|FG000|STARTED|Overall Study||30
6808214|NCT03434353|7740633|FG001|STARTED|Overall Study||12
6808215|NCT03434353|7740634|FG002|STARTED|Overall Study||30
6808216|NCT03434353|7740635|FG003|STARTED|Overall Study||21
6808217|NCT03434353|7740636|FG004|STARTED|Overall Study||30
6808218|NCT03434353|7740632|FG000|COMPLETED|Overall Study||16
6808219|NCT03434353|7740633|FG001|COMPLETED|Overall Study||9
6808220|NCT03434353|7740634|FG002|COMPLETED|Overall Study||16
6808221|NCT03434353|7740635|FG003|COMPLETED|Overall Study||18
6808222|NCT03434353|7740636|FG004|COMPLETED|Overall Study||12
6808223|NCT03434353|7740632|FG000|NOT COMPLETED|Overall Study||14
6808224|NCT03434353|7740633|FG001|NOT COMPLETED|Overall Study||3
6808225|NCT03434353|7740634|FG002|NOT COMPLETED|Overall Study||14
6808226|NCT03434353|7740635|FG003|NOT COMPLETED|Overall Study||3
6808227|NCT03434353|7740636|FG004|NOT COMPLETED|Overall Study||18
6808228|NCT03415022|7740650|FG000|STARTED|Overall Study||21
6808229|NCT03415022|7740651|FG001|STARTED|Overall Study||20
6808230|NCT03415022|7740650|FG000|COMPLETED|Overall Study||16
6808231|NCT03415022|7740651|FG001|COMPLETED|Overall Study||15
6808232|NCT03415022|7740650|FG000|NOT COMPLETED|Overall Study||5
6808233|NCT03415022|7740651|FG001|NOT COMPLETED|Overall Study||5
6808234|NCT03401749|7740660|FG000|STARTED|Overall Study||59
6808235|NCT03401749|7740661|FG001|STARTED|Overall Study||67
6808236|NCT03401749|7740662|FG002|STARTED|Overall Study||77
6808237|NCT03401749|7740660|FG000|COMPLETED|Overall Study||39
6808238|NCT03401749|7740661|FG001|COMPLETED|Overall Study||51
6808239|NCT03401749|7740662|FG002|COMPLETED|Overall Study||51
6808240|NCT03401749|7740660|FG000|NOT COMPLETED|Overall Study||20
6808241|NCT03401749|7740661|FG001|NOT COMPLETED|Overall Study||16
6808242|NCT03401749|7740662|FG002|NOT COMPLETED|Overall Study||26
6808243|NCT03351244|7740673|FG000|STARTED|Overall Study||89
6808244|NCT03351244|7740674|FG001|STARTED|Overall Study||88
6808245|NCT03351244|7740675|FG002|STARTED|Overall Study||87
6808246|NCT03351244|7740673|FG000|COMPLETED|Overall Study||62
6808247|NCT03351244|7740674|FG001|COMPLETED|Overall Study||48
6808248|NCT03351244|7740675|FG002|COMPLETED|Overall Study||53
6808249|NCT03351244|7740673|FG000|NOT COMPLETED|Overall Study||27
6808250|NCT03351244|7740674|FG001|NOT COMPLETED|Overall Study||40
6808251|NCT03351244|7740675|FG002|NOT COMPLETED|Overall Study||34
6808252|NCT03283670|7740685|FG000|STARTED|Placebo Gas||24
6808253|NCT03283670|7740685|FG000|COMPLETED|Placebo Gas||22
6808254|NCT03283670|7740685|FG000|NOT COMPLETED|Placebo Gas||2
6808255|NCT03283670|7740685|FG000|STARTED|25% Nitrous Oxide||24
6808256|NCT03283670|7740685|FG000|COMPLETED|25% Nitrous Oxide||20
6808257|NCT03283670|7740685|FG000|NOT COMPLETED|25% Nitrous Oxide||4
6808258|NCT03283670|7740685|FG000|STARTED|50% Nitrous Oxide||24
6808259|NCT03283670|7740685|FG000|COMPLETED|50% Nitrous Oxide||23
6808260|NCT03283670|7740685|FG000|NOT COMPLETED|50% Nitrous Oxide||1
6808261|NCT03233217|7740698|FG000|STARTED|Overall Study||5
6808262|NCT03233217|7740699|FG001|STARTED|Overall Study||5
6808263|NCT03233217|7740700|FG002|STARTED|Overall Study||55
6808264|NCT03233217|7740701|FG003|STARTED|Overall Study||55
6808265|NCT03233217|7740702|FG004|STARTED|Overall Study||55
6808266|NCT03233217|7740698|FG000|Safety Analysis Set (SafAS)|Overall Study||5
6808267|NCT03233217|7740699|FG001|Safety Analysis Set (SafAS)|Overall Study||5
6808268|NCT03233217|7740700|FG002|Safety Analysis Set (SafAS)|Overall Study||55
6808269|NCT03233217|7740701|FG003|Safety Analysis Set (SafAS)|Overall Study||55
6808270|NCT03233217|7740702|FG004|Safety Analysis Set (SafAS)|Overall Study||55
6808271|NCT03233217|7740698|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||5
6808272|NCT03233217|7740699|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||5
6808273|NCT03233217|7740700|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||55
6808274|NCT03233217|7740701|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||55
6808275|NCT03233217|7740702|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||54
6808276|NCT03233217|7740698|FG000|COMPLETED|Overall Study||5
6808277|NCT03233217|7740699|FG001|COMPLETED|Overall Study||5
6808278|NCT03233217|7740700|FG002|COMPLETED|Overall Study||55
6808279|NCT03233217|7740701|FG003|COMPLETED|Overall Study||55
6808280|NCT03233217|7740702|FG004|COMPLETED|Overall Study||55
6808281|NCT03233217|7740698|FG000|NOT COMPLETED|Overall Study||0
6808282|NCT03233217|7740699|FG001|NOT COMPLETED|Overall Study||0
6808283|NCT03233217|7740700|FG002|NOT COMPLETED|Overall Study||0
6808284|NCT03233217|7740701|FG003|NOT COMPLETED|Overall Study||0
6808285|NCT03233217|7740702|FG004|NOT COMPLETED|Overall Study||0
6808286|NCT03219567|7740716|FG000|STARTED|Overall Study||18
6808287|NCT03219567|7740717|FG001|STARTED|Overall Study||64
6808288|NCT03219567|7740716|FG000|COMPLETED|Overall Study||18
6808289|NCT03219567|7740717|FG001|COMPLETED|Overall Study||63
6808290|NCT03219567|7740716|FG000|NOT COMPLETED|Overall Study||0
6808291|NCT03219567|7740717|FG001|NOT COMPLETED|Overall Study||1
6808292|NCT03205358|7740726|FG000|STARTED|Overall Study||94
6808293|NCT03205358|7740727|FG001|STARTED|Overall Study||94
6808294|NCT03205358|7740726|FG000|COMPLETED|Overall Study||94
6808295|NCT03205358|7740727|FG001|COMPLETED|Overall Study||94
6808296|NCT03205358|7740726|FG000|NOT COMPLETED|Overall Study||0
6808297|NCT03205358|7740727|FG001|NOT COMPLETED|Overall Study||0
6808298|NCT03194646|7740737|FG000|STARTED|Overall Study||363
6808299|NCT03194646|7740738|FG001|STARTED|Overall Study||361
6808300|NCT03194646|7740739|FG002|STARTED|Overall Study||183
6808301|NCT03194646|7740740|FG003|STARTED|Overall Study||365
6808302|NCT03194646|7740737|FG000|Treated|Overall Study||349
6808303|NCT03194646|7740738|FG001|Treated|Overall Study||347
6808304|NCT03194646|7740739|FG002|Treated|Overall Study||177
6808305|NCT03194646|7740740|FG003|Treated|Overall Study||365
6808306|NCT03194646|7740737|FG000|COMPLETED|Overall Study||61
6808307|NCT03194646|7740738|FG001|COMPLETED|Overall Study||93
6808308|NCT03194646|7740739|FG002|COMPLETED|Overall Study||44
6808309|NCT03194646|7740740|FG003|COMPLETED|Overall Study||85
6808310|NCT03194646|7740737|FG000|NOT COMPLETED|Overall Study||302
6808311|NCT03194646|7740738|FG001|NOT COMPLETED|Overall Study||268
6808312|NCT03194646|7740739|FG002|NOT COMPLETED|Overall Study||139
6808313|NCT03194646|7740740|FG003|NOT COMPLETED|Overall Study||280
6808314|NCT03153111|7740757|FG000|STARTED|Overall Study||71
6808315|NCT03153111|7740758|FG001|STARTED|Overall Study||71
6808316|NCT03153111|7740757|FG000|COMPLETED|Overall Study||60
6808317|NCT03153111|7740758|FG001|COMPLETED|Overall Study||62
6808318|NCT03153111|7740757|FG000|NOT COMPLETED|Overall Study||11
6808319|NCT03153111|7740758|FG001|NOT COMPLETED|Overall Study||9
6808320|NCT03128411|7740764|FG000|STARTED|Treatment Phase||60
6808321|NCT03128411|7740764|FG000|Received Treatment|Treatment Phase||60
6808322|NCT03128411|7740764|FG000|COMPLETED|Treatment Phase||36
6808323|NCT03128411|7740764|FG000|NOT COMPLETED|Treatment Phase||24
6808324|NCT03128411|7740764|FG000|STARTED|Long Term Follow-up Phase|Participants who discontinued treatment phase, entered in long term follow up phase.|24
6808325|NCT03128411|7740764|FG000|COMPLETED|Long Term Follow-up Phase||22
6808326|NCT03128411|7740764|FG000|NOT COMPLETED|Long Term Follow-up Phase||2
6808327|NCT03073733|7740771|FG000|STARTED|Overall Study||29
6808328|NCT03073733|7740772|FG001|STARTED|Overall Study||27
6808329|NCT03073733|7740773|FG002|STARTED|Overall Study||27
6390712|NCT00831675|7302459|FG001|STARTED|Overall Study||18
6390713|NCT00831675|7302458|FG000|COMPLETED|Overall Study||12
6390714|NCT00831675|7302459|FG001|COMPLETED|Overall Study||18
6390715|NCT00831675|7302458|FG000|NOT COMPLETED|Overall Study||0
6390716|NCT00831675|7302459|FG001|NOT COMPLETED|Overall Study||0
6390717|NCT00831701|7302467|FG000|STARTED|Overall Study||50
6808330|NCT03073733|7740771|FG000|COMPLETED|Overall Study||28
6808331|NCT03073733|7740772|FG001|COMPLETED|Overall Study||26
6808332|NCT03073733|7740773|FG002|COMPLETED|Overall Study||26
6808333|NCT03073733|7740771|FG000|NOT COMPLETED|Overall Study||1
6808334|NCT03073733|7740772|FG001|NOT COMPLETED|Overall Study||1
6808335|NCT03073733|7740773|FG002|NOT COMPLETED|Overall Study||1
6808336|NCT02821000|7740783|FG000|STARTED|Overall Study||103
6808337|NCT02821000|7740783|FG000|Treated|Overall Study||103
6808338|NCT02821000|7740783|FG000|COMPLETED|Overall Study||0
6808339|NCT02821000|7740783|FG000|NOT COMPLETED|Overall Study||103
6808340|NCT02749968|7740789|FG000|STARTED|Overall Study||50
6808341|NCT02749968|7740790|FG001|STARTED|Overall Study||50
6808342|NCT02749968|7740789|FG000|Interim Analysis|Overall Study||25
6808343|NCT02749968|7740790|FG001|Interim Analysis|Overall Study||25
6808344|NCT02749968|7740789|FG000|COMPLETED|Overall Study||50
6567116|NCT01829360|7490192|FG001|STARTED|Overall Study||9
6567117|NCT01829360|7490193|FG002|STARTED|Overall Study||10
6567118|NCT01829360|7490194|FG003|STARTED|Overall Study||8
6567119|NCT01829360|7490191|FG000|COMPLETED|Overall Study||8
6808345|NCT02749968|7740790|FG001|COMPLETED|Overall Study||50
6808346|NCT02749968|7740789|FG000|NOT COMPLETED|Overall Study||0
6808347|NCT02749968|7740790|FG001|NOT COMPLETED|Overall Study||0
6808348|NCT02738255|7740798|FG000|STARTED|Overall Study||11
6808349|NCT02738255|7740799|FG001|STARTED|Overall Study||15
6808350|NCT02738255|7740798|FG000|COMPLETED|Overall Study||11
6808351|NCT02738255|7740799|FG001|COMPLETED|Overall Study||14
6808352|NCT02738255|7740798|FG000|NOT COMPLETED|Overall Study||0
6567120|NCT01829360|7490192|FG001|COMPLETED|Overall Study||9
6567121|NCT01829360|7490193|FG002|COMPLETED|Overall Study||9
6567122|NCT01829360|7490194|FG003|COMPLETED|Overall Study||8
6808353|NCT02738255|7740799|FG001|NOT COMPLETED|Overall Study||1
6808354|NCT02702414|7740811|FG000|STARTED|Overall Study||105
6808355|NCT02702414|7740812|FG001|STARTED|Overall Study||51
6808356|NCT02702414|7740811|FG000|Treated|Overall Study||104
6808357|NCT02702414|7740812|FG001|Treated|Overall Study||51
6808358|NCT02702414|7740811|FG000|COMPLETED|Overall Study||0
6808359|NCT02702414|7740812|FG001|COMPLETED|Overall Study||0
6808360|NCT02702414|7740811|FG000|NOT COMPLETED|Overall Study||105
6808361|NCT02702414|7740812|FG001|NOT COMPLETED|Overall Study||51
6808362|NCT02605616|7740822|FG000|STARTED|Overall Study||46
6808363|NCT02605616|7740823|FG001|STARTED|Overall Study||47
6808364|NCT02605616|7740822|FG000|COMPLETED|Overall Study||42
6808365|NCT02605616|7740823|FG001|COMPLETED|Overall Study||43
6808366|NCT02605616|7740822|FG000|NOT COMPLETED|Overall Study||4
6808367|NCT02605616|7740823|FG001|NOT COMPLETED|Overall Study||4
6808368|NCT02573233|7740831|FG000|STARTED|Overall Study||22
6808369|NCT02573233|7740832|FG001|STARTED|Overall Study||20
6808370|NCT02573233|7740831|FG000|COMPLETED|Overall Study||22
6808371|NCT02573233|7740832|FG001|COMPLETED|Overall Study||20
6808372|NCT02573233|7740831|FG000|NOT COMPLETED|Overall Study||0
6808373|NCT02573233|7740832|FG001|NOT COMPLETED|Overall Study||0
6567123|NCT01829360|7490191|FG000|NOT COMPLETED|Overall Study||0
6567124|NCT01829360|7490192|FG001|NOT COMPLETED|Overall Study||0
6567125|NCT01829360|7490193|FG002|NOT COMPLETED|Overall Study||1
6567126|NCT01829360|7490194|FG003|NOT COMPLETED|Overall Study||0
6567127|NCT01829399|7490210|FG000|STARTED|Visit 1||12
6567128|NCT01829399|7490211|FG001|STARTED|Visit 1||12
6567129|NCT01829399|7490210|FG000|COMPLETED|Visit 1||12
6567130|NCT01829399|7490211|FG001|COMPLETED|Visit 1||12
6567131|NCT01829399|7490210|FG000|NOT COMPLETED|Visit 1||0
6567132|NCT01829399|7490211|FG001|NOT COMPLETED|Visit 1||0
6567133|NCT01829399|7490210|FG000|STARTED|Visit 2 (One Month Later)||12
6567134|NCT01829399|7490211|FG001|STARTED|Visit 2 (One Month Later)||12
6567135|NCT01829399|7490210|FG000|COMPLETED|Visit 2 (One Month Later)||12
6567136|NCT01829399|7490211|FG001|COMPLETED|Visit 2 (One Month Later)||12
6567137|NCT01829399|7490210|FG000|NOT COMPLETED|Visit 2 (One Month Later)||0
6567138|NCT01829399|7490211|FG001|NOT COMPLETED|Visit 2 (One Month Later)||0
6567139|NCT01829425|7490221|FG000|STARTED|Overall Study||78
6567140|NCT01829425|7490222|FG001|STARTED|Overall Study||74
6567141|NCT01829425|7490221|FG000|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=72|72
6567142|NCT01829425|7490222|FG001|COMPLETED|Overall Study|completed primary outcome 2 month f/u N=70|70
6567143|NCT01829425|7490221|FG000|NOT COMPLETED|Overall Study||6
6567144|NCT01829425|7490222|FG001|NOT COMPLETED|Overall Study||4
6567145|NCT01829464|7490231|FG000|STARTED|Overall Study||30
6567146|NCT01829464|7490232|FG001|STARTED|Overall Study||31
6567147|NCT01829464|7490233|FG002|STARTED|Overall Study||29
6567148|NCT01829464|7490231|FG000|COMPLETED|Overall Study||2
6567149|NCT01829464|7490232|FG001|COMPLETED|Overall Study||2
6808374|NCT02438410|7740839|FG000|STARTED|Overall Study||13
6808375|NCT02438410|7740839|FG000|COMPLETED|Overall Study||13
6808376|NCT02438410|7740839|FG000|NOT COMPLETED|Overall Study||0
6808377|NCT02425904|7740845|FG000|STARTED|Overall Study||20
6808378|NCT02425904|7740846|FG001|STARTED|Overall Study||5
6808379|NCT02425904|7740845|FG000|Efficacy Analysis|Overall Study||20
6808380|NCT02425904|7740846|FG001|Efficacy Analysis|Overall Study|1 patient was incorrectly assigned to LCH-related disorders cohort but it is actually LCH patients, so excluded from efficacy analysis.|4
6808381|NCT02425904|7740845|FG000|COMPLETED|Overall Study||17
6808382|NCT02425904|7740846|FG001|COMPLETED|Overall Study||2
6808383|NCT02425904|7740845|FG000|NOT COMPLETED|Overall Study||3
6808384|NCT02425904|7740846|FG001|NOT COMPLETED|Overall Study||3
6808385|NCT02420795|7740856|FG000|STARTED|Overall Study||4
6808386|NCT02420795|7740857|FG001|STARTED|Overall Study||2
6808387|NCT02420795|7740858|FG002|STARTED|Overall Study||5
6808388|NCT02420795|7740856|FG000|COMPLETED|Overall Study||0
6808389|NCT02420795|7740857|FG001|COMPLETED|Overall Study||0
6808390|NCT02420795|7740858|FG002|COMPLETED|Overall Study||0
6808391|NCT02420795|7740856|FG000|NOT COMPLETED|Overall Study||4
6808392|NCT02420795|7740857|FG001|NOT COMPLETED|Overall Study||2
6808393|NCT02420795|7740858|FG002|NOT COMPLETED|Overall Study||5
6567150|NCT01829464|7490233|FG002|COMPLETED|Overall Study||3
6567151|NCT01829464|7490231|FG000|NOT COMPLETED|Overall Study||28
6567152|NCT01829464|7490232|FG001|NOT COMPLETED|Overall Study||29
6808394|NCT02240485|7740870|FG000|STARTED|3 Months Post-admission||44
6808395|NCT02240485|7740871|FG001|STARTED|3 Months Post-admission||36
6808396|NCT02240485|7740870|FG000|COMPLETED|3 Months Post-admission|Couple modality: 1 couple refused and one gambler refused but his partner continued|41
6390718|NCT00831701|7302468|FG001|STARTED|Overall Study||50
6390719|NCT00831701|7302467|FG000|COMPLETED|Overall Study||45
6390720|NCT00831701|7302468|FG001|COMPLETED|Overall Study||45
6390721|NCT00831701|7302467|FG000|NOT COMPLETED|Overall Study||5
6390722|NCT00831701|7302468|FG001|NOT COMPLETED|Overall Study||5
6390723|NCT00831753|7302476|FG000|STARTED|Overall Study||132
6390724|NCT00831753|7302477|FG001|STARTED|Overall Study||131
6390725|NCT00831753|7302476|FG000|COMPLETED|Overall Study||132
6390726|NCT00831753|7302477|FG001|COMPLETED|Overall Study||131
6390727|NCT00831753|7302476|FG000|NOT COMPLETED|Overall Study||0
6390728|NCT00831753|7302477|FG001|NOT COMPLETED|Overall Study||0
6390729|NCT00831766|7302485|FG000|STARTED|Overall Study||23
6390730|NCT00831766|7302486|FG001|STARTED|Overall Study||28
6390731|NCT00831766|7302485|FG000|COMPLETED|Overall Study||23
6390732|NCT00831766|7302486|FG001|COMPLETED|Overall Study||28
6390733|NCT00831766|7302485|FG000|NOT COMPLETED|Overall Study||0
6390734|NCT00831766|7302486|FG001|NOT COMPLETED|Overall Study||0
6390735|NCT00831779|7302495|FG000|STARTED|Overall Study||21
6390736|NCT00831779|7302496|FG001|STARTED|Overall Study||23
6390737|NCT00831779|7302495|FG000|COMPLETED|Overall Study||20
6390738|NCT00831779|7302496|FG001|COMPLETED|Overall Study||22
6390739|NCT00831779|7302495|FG000|NOT COMPLETED|Overall Study||1
6390740|NCT00831779|7302496|FG001|NOT COMPLETED|Overall Study||1
6390741|NCT00831792|7302502|FG000|STARTED|Overall Study||46
6390742|NCT00831792|7302502|FG000|COMPLETED|Overall Study||40
6390743|NCT00831792|7302502|FG000|NOT COMPLETED|Overall Study||6
6390744|NCT00831844|7302516|FG000|STARTED|Overall Study||10
6390745|NCT00831844|7302517|FG001|STARTED|Overall Study||12
6390746|NCT00831844|7302518|FG002|STARTED|Overall Study||21
6390747|NCT00831844|7302519|FG003|STARTED|Overall Study||10
6808397|NCT02240485|7740871|FG001|COMPLETED|3 Months Post-admission||30
6390748|NCT00831844|7302520|FG004|STARTED|Overall Study||14
6390749|NCT00831844|7302521|FG005|STARTED|Overall Study||20
6390750|NCT00831844|7302522|FG006|STARTED|Overall Study||10
6390751|NCT00831844|7302523|FG007|STARTED|Overall Study||10
6390752|NCT00831844|7302524|FG008|STARTED|Overall Study||9
6390753|NCT00831844|7302525|FG009|STARTED|Overall Study||0
6390754|NCT00831844|7302516|FG000|COMPLETED|Overall Study||0
6567153|NCT01829464|7490233|FG002|NOT COMPLETED|Overall Study||26
6567154|NCT01829503|7490241|FG000|STARTED|Overall Study||44
6390755|NCT00831844|7302517|FG001|COMPLETED|Overall Study||0
6567155|NCT01829503|7490241|FG000|COMPLETED|Overall Study||44
6808398|NCT02240485|7740870|FG000|NOT COMPLETED|3 Months Post-admission||3
6808399|NCT02240485|7740871|FG001|NOT COMPLETED|3 Months Post-admission||6
6808400|NCT02240485|7740870|FG000|STARTED|9 Months Post-admission||41
6808401|NCT02240485|7740871|FG001|STARTED|9 Months Post-admission||30
6808402|NCT02240485|7740870|FG000|COMPLETED|9 Months Post-admission||38
6808403|NCT02240485|7740871|FG001|COMPLETED|9 Months Post-admission|26 couples completed + 1 individual (partner lost)|26
6808404|NCT02240485|7740870|FG000|NOT COMPLETED|9 Months Post-admission||3
6808405|NCT02240485|7740871|FG001|NOT COMPLETED|9 Months Post-admission||4
6808406|NCT02240485|7740870|FG000|STARTED|18 Months Post-admission||38
6808407|NCT02240485|7740871|FG001|STARTED|18 Months Post-admission||26
6808408|NCT02240485|7740870|FG000|COMPLETED|18 Months Post-admission||35
6808409|NCT02240485|7740871|FG001|COMPLETED|18 Months Post-admission||21
6808410|NCT02240485|7740870|FG000|NOT COMPLETED|18 Months Post-admission||3
6808411|NCT02240485|7740871|FG001|NOT COMPLETED|18 Months Post-admission||5
6808412|NCT02227147|7740883|FG000|STARTED|Controlled Treatment Period||24
6808413|NCT02227147|7740884|FG001|STARTED|Controlled Treatment Period||24
6808414|NCT02227147|7740883|FG000|COMPLETED|Controlled Treatment Period||18
6808415|NCT02227147|7740884|FG001|COMPLETED|Controlled Treatment Period||21
6808416|NCT02227147|7740883|FG000|NOT COMPLETED|Controlled Treatment Period||6
6808417|NCT02227147|7740884|FG001|NOT COMPLETED|Controlled Treatment Period||3
6808418|NCT02227147|7740883|FG000|STARTED|Follow-up Period||18
6808419|NCT02227147|7740884|FG001|STARTED|Follow-up Period||21
6808420|NCT02227147|7740883|FG000|COMPLETED|Follow-up Period||15
6808421|NCT02227147|7740884|FG001|COMPLETED|Follow-up Period||16
6808422|NCT02227147|7740883|FG000|NOT COMPLETED|Follow-up Period||3
6567156|NCT01829503|7490241|FG000|NOT COMPLETED|Overall Study||0
6567157|NCT01829516|7490247|FG000|STARTED|First Intervention||18
6656930|NCT02465567|7587298|FG002|NOT COMPLETED|Overall Study||563
6808423|NCT02227147|7740884|FG001|NOT COMPLETED|Follow-up Period||5
6808424|NCT02199691|7740898|FG000|STARTED|Overall Study||505
6808425|NCT02199691|7740899|FG001|STARTED|Overall Study||507
6808426|NCT02199691|7740900|FG002|STARTED|Overall Study||403
6808427|NCT02199691|7740901|FG003|STARTED|Overall Study||300
6808428|NCT02199691|7740898|FG000|Safety Analysis Set (SafAS)|Overall Study||503
6656931|NCT02465567|7587299|FG003|NOT COMPLETED|Overall Study||508
6808429|NCT02199691|7740899|FG001|Safety Analysis Set (SafAS)|Overall Study||501
6808430|NCT02199691|7740900|FG002|Safety Analysis Set (SafAS)|Overall Study||392
6808431|NCT02199691|7740901|FG003|Safety Analysis Set (SafAS)|Overall Study||296
6808432|NCT02199691|7740898|FG000|COMPLETED|Overall Study||495
6808433|NCT02199691|7740899|FG001|COMPLETED|Overall Study||500
6808434|NCT02199691|7740900|FG002|COMPLETED|Overall Study||376
6808435|NCT02199691|7740901|FG003|COMPLETED|Overall Study||270
6808436|NCT02199691|7740898|FG000|NOT COMPLETED|Overall Study||10
6808437|NCT02199691|7740899|FG001|NOT COMPLETED|Overall Study||7
6808438|NCT02199691|7740900|FG002|NOT COMPLETED|Overall Study||27
6808439|NCT02199691|7740901|FG003|NOT COMPLETED|Overall Study||30
6808440|NCT02163694|7740915|FG000|STARTED|Overall Study||172
6808441|NCT02163694|7740916|FG001|STARTED|Overall Study||337
6808442|NCT02163694|7740915|FG000|COMPLETED|Overall Study||18
6808443|NCT02163694|7740916|FG001|COMPLETED|Overall Study||70
6808444|NCT02163694|7740915|FG000|NOT COMPLETED|Overall Study||154
6808445|NCT02163694|7740916|FG001|NOT COMPLETED|Overall Study||267
6808446|NCT02143726|7740924|FG000|STARTED|Overall Study||18
6808447|NCT02143726|7740925|FG001|STARTED|Overall Study||17
6808448|NCT02143726|7740924|FG000|Received Everolimus After Disease Progression|Overall Study||11
6808449|NCT02143726|7740925|FG001|Received Everolimus After Disease Progression|Overall Study||0
6808450|NCT02143726|7740924|FG000|COMPLETED|Overall Study||16
6808451|NCT02143726|7740925|FG001|COMPLETED|Overall Study||17
6808452|NCT02143726|7740924|FG000|NOT COMPLETED|Overall Study||2
6808453|NCT02143726|7740925|FG001|NOT COMPLETED|Overall Study||0
6808454|NCT02046512|7740933|FG000|STARTED|Overall Study||45
6808455|NCT02046512|7740934|FG001|STARTED|Overall Study||44
6808456|NCT02046512|7740933|FG000|COMPLETED|Overall Study||44
6808457|NCT02046512|7740934|FG001|COMPLETED|Overall Study||44
6567158|NCT01829516|7490248|FG001|STARTED|First Intervention||14
6567159|NCT01829516|7490247|FG000|COMPLETED|First Intervention||18
6656932|NCT02465632|7587312|FG000|STARTED|Overall Study||440
6808458|NCT02046512|7740933|FG000|NOT COMPLETED|Overall Study||1
6808459|NCT02046512|7740934|FG001|NOT COMPLETED|Overall Study||0
6808460|NCT01958593|7740942|FG000|STARTED|Overall Study||2
6808461|NCT01958593|7740943|FG001|STARTED|Overall Study||4
6808462|NCT01958593|7740942|FG000|COMPLETED|Overall Study||2
6808463|NCT01958593|7740943|FG001|COMPLETED|Overall Study||4
6808464|NCT01958593|7740942|FG000|NOT COMPLETED|Overall Study||0
6808465|NCT01958593|7740943|FG001|NOT COMPLETED|Overall Study||0
6808466|NCT01842035|7740950|FG000|STARTED|Overall Study||90
6808467|NCT01842035|7740950|FG000|COMPLETED|Overall Study||90
6808468|NCT01842035|7740950|FG000|NOT COMPLETED|Overall Study||0
6808469|NCT01751984|7740957|FG000|STARTED|Overall Study||37
6808470|NCT01751984|7740958|FG001|STARTED|Overall Study||19
6808471|NCT01751984|7740957|FG000|COMPLETED|Overall Study||31
6808472|NCT01751984|7740958|FG001|COMPLETED|Overall Study||15
6808473|NCT01751984|7740957|FG000|NOT COMPLETED|Overall Study||6
6808474|NCT01751984|7740958|FG001|NOT COMPLETED|Overall Study||4
6808475|NCT01732627|7740966|FG000|STARTED|Overall Study||201
6808476|NCT01732627|7740967|FG001|STARTED|Overall Study||100
6808477|NCT01732627|7740966|FG000|Safety Analysis Set (SafAS)|Overall Study||199
6808478|NCT01732627|7740967|FG001|Safety Analysis Set (SafAS)|Overall Study||100
6808479|NCT01732627|7740966|FG000|COMPLETED|Overall Study||200
6808480|NCT01732627|7740967|FG001|COMPLETED|Overall Study||100
6808481|NCT01732627|7740966|FG000|NOT COMPLETED|Overall Study||1
6808482|NCT01732627|7740967|FG001|NOT COMPLETED|Overall Study||0
6808483|NCT01702571|7740975|FG000|STARTED|Overall Study||2003
6808484|NCT01702571|7740976|FG001|STARTED|Overall Study||182
6808485|NCT01702571|7740975|FG000|COMPLETED|Overall Study|For one participant, the site incorrectly answered the question 'Did the participant complete follow-up as per protocol?' It was answered No, however the participant was in survival follow-up and the site should have answered Yes. This participant is wrongly counted in the 'discontinued from study' number.|494
6808486|NCT01702571|7740976|FG001|COMPLETED|Overall Study||65
6808487|NCT01702571|7740975|FG000|NOT COMPLETED|Overall Study||1509
6808488|NCT01702571|7740976|FG001|NOT COMPLETED|Overall Study||117
6808489|NCT01578239|7740984|FG000|STARTED|Treatment Period||117
6808490|NCT01578239|7740985|FG001|STARTED|Treatment Period||114
6808491|NCT01578239|7740984|FG000|Full Analysis Set (FAS)|Treatment Period||117
6808492|NCT01578239|7740985|FG001|Full Analysis Set (FAS)|Treatment Period||114
6808493|NCT01578239|7740984|FG000|Safety Analysis Set (SAF)|Treatment Period||111
6808494|NCT01578239|7740985|FG001|Safety Analysis Set (SAF)|Treatment Period||112
6808495|NCT01578239|7740984|FG000|FAS-Entered Long-term Follow-up|Treatment Period||101
6808496|NCT01578239|7740985|FG001|FAS-Entered Long-term Follow-up|Treatment Period||99
6808497|NCT01578239|7740984|FG000|COMPLETED|Treatment Period||50
6808498|NCT01578239|7740985|FG001|COMPLETED|Treatment Period||13
6808499|NCT01578239|7740984|FG000|NOT COMPLETED|Treatment Period||67
6808500|NCT01578239|7740985|FG001|NOT COMPLETED|Treatment Period||101
6808501|NCT01578239|7740984|FG000|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|101
6808502|NCT01578239|7740985|FG001|STARTED|Long-term Follow-Up Period|FAS-Entered long-term follow-up|99
6808503|NCT01578239|7740984|FG000|COMPLETED|Long-term Follow-Up Period||24
6808504|NCT01578239|7740985|FG001|COMPLETED|Long-term Follow-Up Period||19
6808505|NCT01578239|7740984|FG000|NOT COMPLETED|Long-term Follow-Up Period||77
6808506|NCT01578239|7740985|FG001|NOT COMPLETED|Long-term Follow-Up Period||80
6808507|NCT01458340|7740994|FG000|STARTED|Overall Study||97
6808508|NCT01458340|7740995|FG001|STARTED|Overall Study||99
6808509|NCT01458340|7740996|FG002|STARTED|Overall Study||99
6808510|NCT01458340|7740994|FG000|Received Study Treatment|Overall Study||97
6808511|NCT01458340|7740995|FG001|Received Study Treatment|Overall Study||98
6808512|NCT01458340|7740996|FG002|Received Study Treatment|Overall Study||98
6808513|NCT01458340|7740994|FG000|COMPLETED|Overall Study||70
6808514|NCT01458340|7740995|FG001|COMPLETED|Overall Study||78
6808515|NCT01458340|7740996|FG002|COMPLETED|Overall Study||76
6808516|NCT01458340|7740994|FG000|NOT COMPLETED|Overall Study||27
6808517|NCT01458340|7740995|FG001|NOT COMPLETED|Overall Study||21
6808518|NCT01458340|7740996|FG002|NOT COMPLETED|Overall Study||23
6808519|NCT01411267|7741014|FG000|STARTED|Overall Study||0
6808520|NCT01411267|7741015|FG001|STARTED|Overall Study||3
6808521|NCT01411267|7741016|FG002|STARTED|Overall Study||2
6808522|NCT01411267|7741017|FG003|STARTED|Overall Study||5
6808523|NCT01411267|7741018|FG004|STARTED|Overall Study||2
6808524|NCT01411267|7741019|FG005|STARTED|Overall Study||12
6808525|NCT01411267|7741020|FG006|STARTED|Overall Study||0
6808526|NCT01411267|7741021|FG007|STARTED|Overall Study||0
6808527|NCT01411267|7741022|FG008|STARTED|Overall Study||0
6808528|NCT01411267|7741023|FG009|STARTED|Overall Study||0
6808529|NCT01411267|7741014|FG000|COMPLETED|Overall Study||0
6808530|NCT01411267|7741015|FG001|COMPLETED|Overall Study||3
6808531|NCT01411267|7741016|FG002|COMPLETED|Overall Study||2
6808532|NCT01411267|7741017|FG003|COMPLETED|Overall Study||4
6808533|NCT01411267|7741018|FG004|COMPLETED|Overall Study||0
6808534|NCT01411267|7741019|FG005|COMPLETED|Overall Study||10
6656933|NCT02465632|7587313|FG001|STARTED|Overall Study||440
6808535|NCT01411267|7741020|FG006|COMPLETED|Overall Study||0
6808536|NCT01411267|7741021|FG007|COMPLETED|Overall Study||0
6808537|NCT01411267|7741022|FG008|COMPLETED|Overall Study||0
6808538|NCT01411267|7741023|FG009|COMPLETED|Overall Study||0
6808539|NCT01411267|7741014|FG000|NOT COMPLETED|Overall Study||0
6808540|NCT01411267|7741015|FG001|NOT COMPLETED|Overall Study||0
6656934|NCT02465632|7587314|FG002|STARTED|Overall Study||220
6808541|NCT01411267|7741016|FG002|NOT COMPLETED|Overall Study||0
6808542|NCT01411267|7741017|FG003|NOT COMPLETED|Overall Study||1
6808543|NCT01411267|7741018|FG004|NOT COMPLETED|Overall Study||2
6808544|NCT01411267|7741019|FG005|NOT COMPLETED|Overall Study||2
6808545|NCT01411267|7741020|FG006|NOT COMPLETED|Overall Study||0
6808546|NCT01411267|7741021|FG007|NOT COMPLETED|Overall Study||0
6808547|NCT01411267|7741022|FG008|NOT COMPLETED|Overall Study||0
6808548|NCT01411267|7741023|FG009|NOT COMPLETED|Overall Study||0
6567160|NCT01829516|7490248|FG001|COMPLETED|First Intervention||14
6567161|NCT01829516|7490247|FG000|NOT COMPLETED|First Intervention||0
6567162|NCT01829516|7490248|FG001|NOT COMPLETED|First Intervention||0
6567163|NCT01829516|7490247|FG000|STARTED|Washout Period - 1 Week||18
6656935|NCT02465632|7587312|FG000|COMPLETED|Overall Study||409
6656936|NCT02465632|7587313|FG001|COMPLETED|Overall Study||417
6656937|NCT02465632|7587314|FG002|COMPLETED|Overall Study||203
6656938|NCT02465632|7587312|FG000|NOT COMPLETED|Overall Study||31
6656939|NCT02465632|7587313|FG001|NOT COMPLETED|Overall Study||23
6656940|NCT02465632|7587314|FG002|NOT COMPLETED|Overall Study||17
6656941|NCT02465866|7587323|FG000|STARTED|Period 1||5
6656942|NCT02465866|7587324|FG001|STARTED|Period 1||5
6567164|NCT01829516|7490248|FG001|STARTED|Washout Period - 1 Week||14
6567165|NCT01829516|7490247|FG000|COMPLETED|Washout Period - 1 Week||18
6567166|NCT01829516|7490248|FG001|COMPLETED|Washout Period - 1 Week||14
6656943|NCT02465866|7587325|FG002|STARTED|Period 1||5
6656944|NCT02465866|7587326|FG003|STARTED|Period 1||5
6808549|NCT01336634|7741044|FG000|STARTED|Overall Study||84
6808550|NCT01336634|7741045|FG001|STARTED|Overall Study||57
6808551|NCT01336634|7741046|FG002|STARTED|Overall Study|includes 34 subjects from Cohort C and 2 subjects enrolled as protocol deviations from Cohort B.|36
6808552|NCT01336634|7741044|FG000|2nd Line Plus All Treated|Overall Study||78
6808553|NCT01336634|7741045|FG001|2nd Line Plus All Treated|Overall Study||57
6808554|NCT01336634|7741046|FG002|2nd Line Plus All Treated|Overall Study||0
6808555|NCT01336634|7741044|FG000|1st Line All Treated|Overall Study||6
6808556|NCT01336634|7741045|FG001|1st Line All Treated|Overall Study||2
6808557|NCT01336634|7741046|FG002|1st Line All Treated|Overall Study||34
6808558|NCT01336634|7741044|FG000|Crossover|Overall Study||20
6808559|NCT01336634|7741045|FG001|Crossover|Overall Study||0
6808560|NCT01336634|7741046|FG002|Crossover|Overall Study||0
6808561|NCT01336634|7741044|FG000|COMPLETED|Overall Study||70
6808562|NCT01336634|7741045|FG001|COMPLETED|Overall Study||49
6808563|NCT01336634|7741046|FG002|COMPLETED|Overall Study||27
6808564|NCT01336634|7741044|FG000|NOT COMPLETED|Overall Study||14
6808565|NCT01336634|7741045|FG001|NOT COMPLETED|Overall Study||8
6808566|NCT01336634|7741046|FG002|NOT COMPLETED|Overall Study||9
6808567|NCT01155375|7741059|FG000|STARTED|Overall Study||8
6808568|NCT01155375|7741060|FG001|STARTED|Overall Study||6
6808569|NCT01155375|7741059|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6808570|NCT01155375|7741060|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6808571|NCT01155375|7741059|FG000|COMPLETED|Overall Study||7
6808572|NCT01155375|7741060|FG001|COMPLETED|Overall Study||6
6808573|NCT01155375|7741059|FG000|NOT COMPLETED|Overall Study||1
6808574|NCT01155375|7741060|FG001|NOT COMPLETED|Overall Study||0
6808575|NCT00785798|7741067|FG000|STARTED|Overall Study||17
6808576|NCT00785798|7741067|FG000|COMPLETED|Overall Study||16
6808577|NCT00785798|7741067|FG000|NOT COMPLETED|Overall Study||1
6808578|NCT00628095|7741073|FG000|STARTED|Overall Study||53
6808579|NCT00628095|7741074|FG001|STARTED|Overall Study||47
6808580|NCT00628095|7741073|FG000|COMPLETED|Overall Study||46
6808581|NCT00628095|7741074|FG001|COMPLETED|Overall Study||40
6808582|NCT00628095|7741073|FG000|NOT COMPLETED|Overall Study||7
6808583|NCT00628095|7741074|FG001|NOT COMPLETED|Overall Study||7
6808584|NCT04246021|7741082|FG000|STARTED|Overall Study||84
6808585|NCT04246021|7741082|FG000|COMPLETED|Overall Study||84
6808586|NCT04246021|7741082|FG000|NOT COMPLETED|Overall Study||0
6808587|NCT04098497|7741096|FG000|STARTED|Overall Study||30
6808588|NCT04098497|7741096|FG000|Initial Interview|Overall Study||30
6808589|NCT04098497|7741096|FG000|Set Up Study App|Overall Study||29
6808590|NCT04098497|7741096|FG000|Logged Symptoms Into Study App at Least Once|Overall Study||26
6808591|NCT04098497|7741096|FG000|Linked Fitbit to Study Database|Overall Study||27
6808592|NCT04098497|7741096|FG000|Used Fitbit|Overall Study||24
6808593|NCT04098497|7741096|FG000|Exit Interview|Overall Study||29
6808594|NCT04098497|7741096|FG000|COMPLETED|Overall Study||30
6808595|NCT04098497|7741096|FG000|NOT COMPLETED|Overall Study||0
6808596|NCT03945825|7741106|FG000|STARTED|Overall Study||41
6808597|NCT03945825|7741107|FG001|STARTED|Overall Study||37
6808598|NCT03945825|7741108|FG002|STARTED|Overall Study||40
6808599|NCT03945825|7741109|FG003|STARTED|Overall Study||41
6808600|NCT03945825|7741110|FG004|STARTED|Overall Study||39
6808601|NCT03945825|7741111|FG005|STARTED|Overall Study||43
6808602|NCT03945825|7741106|FG000|COMPLETED|Overall Study||39
6808603|NCT03945825|7741107|FG001|COMPLETED|Overall Study||32
6808604|NCT03945825|7741108|FG002|COMPLETED|Overall Study||39
6808605|NCT03945825|7741109|FG003|COMPLETED|Overall Study||39
6808606|NCT03945825|7741110|FG004|COMPLETED|Overall Study||36
6808607|NCT03945825|7741111|FG005|COMPLETED|Overall Study||40
6808608|NCT03945825|7741106|FG000|NOT COMPLETED|Overall Study||2
6808609|NCT03945825|7741107|FG001|NOT COMPLETED|Overall Study||5
6808610|NCT03945825|7741108|FG002|NOT COMPLETED|Overall Study||1
6808611|NCT03945825|7741109|FG003|NOT COMPLETED|Overall Study||2
6808612|NCT03945825|7741110|FG004|NOT COMPLETED|Overall Study||3
6808613|NCT03945825|7741111|FG005|NOT COMPLETED|Overall Study||3
6808614|NCT03937141|7741134|FG000|STARTED|Overall Study||16
6808615|NCT03937141|7741134|FG000|COMPLETED|Overall Study||16
6808616|NCT03937141|7741134|FG000|NOT COMPLETED|Overall Study||0
6808617|NCT03678402|7741138|FG000|STARTED|Overall Study||521
6808618|NCT03678402|7741138|FG000|COMPLETED|Overall Study||521
6808619|NCT03678402|7741138|FG000|NOT COMPLETED|Overall Study||0
6808620|NCT03641937|7741142|FG000|STARTED|Overall Study||10
6808621|NCT03641937|7741142|FG000|COMPLETED|Overall Study||10
6808622|NCT03641937|7741142|FG000|NOT COMPLETED|Overall Study||0
6808623|NCT03572244|7741148|FG000|STARTED|Overall Study||6
6808624|NCT03572244|7741149|FG001|STARTED|Overall Study||6
6808625|NCT03572244|7741148|FG000|COMPLETED|Overall Study||6
6808626|NCT03572244|7741149|FG001|COMPLETED|Overall Study||6
6808627|NCT03572244|7741148|FG000|NOT COMPLETED|Overall Study||0
6808628|NCT03572244|7741149|FG001|NOT COMPLETED|Overall Study||0
6808629|NCT03562767|7741158|FG000|STARTED|Overall Study||10
6808630|NCT03562767|7741159|FG001|STARTED|Overall Study||10
6808631|NCT03562767|7741160|FG002|STARTED|Overall Study||0
6808632|NCT03562767|7741158|FG000|COMPLETED|Overall Study||7
6808633|NCT03562767|7741159|FG001|COMPLETED|Overall Study||7
6808634|NCT03562767|7741160|FG002|COMPLETED|Overall Study||0
6808635|NCT03562767|7741158|FG000|NOT COMPLETED|Overall Study||3
6808636|NCT03562767|7741159|FG001|NOT COMPLETED|Overall Study||3
6808637|NCT03562767|7741160|FG002|NOT COMPLETED|Overall Study||0
6808638|NCT03559699|7741172|FG000|STARTED|Overall Study||27
6808639|NCT03559699|7741172|FG000|COMPLETED|Overall Study||20
6808640|NCT03559699|7741172|FG000|NOT COMPLETED|Overall Study||7
6808641|NCT03333057|7741179|FG000|STARTED|Overall Study||111
6808642|NCT03333057|7741180|FG001|STARTED|Overall Study||114
6808643|NCT03333057|7741181|FG002|STARTED|Overall Study||111
6808644|NCT03333057|7741179|FG000|COMPLETED|Overall Study||105
6808645|NCT03333057|7741180|FG001|COMPLETED|Overall Study||110
6808646|NCT03333057|7741181|FG002|COMPLETED|Overall Study||108
6808647|NCT03333057|7741179|FG000|NOT COMPLETED|Overall Study||6
6808648|NCT03333057|7741180|FG001|NOT COMPLETED|Overall Study||4
6808649|NCT03333057|7741181|FG002|NOT COMPLETED|Overall Study||3
6808650|NCT03305016|7741189|FG000|STARTED|Overall Study||146
6808651|NCT03305016|7741189|FG000|COMPLETED|Overall Study||144
6808652|NCT03305016|7741189|FG000|NOT COMPLETED|Overall Study||2
6808653|NCT03300336|7741195|FG000|STARTED|Overall Study||7267
6808654|NCT03300336|7741196|FG001|STARTED|Overall Study||6859
6808655|NCT03300336|7741195|FG000|COMPLETED|Overall Study||7267
6808656|NCT03300336|7741196|FG001|COMPLETED|Overall Study||6859
6808657|NCT03300336|7741195|FG000|NOT COMPLETED|Overall Study||0
6808658|NCT03300336|7741196|FG001|NOT COMPLETED|Overall Study||0
6504727|NCT01449630|7423762|FG007|NOT COMPLETED|Period 2||0
6808659|NCT03291067|7741206|FG000|STARTED|Overall Study||94
6808660|NCT03291067|7741207|FG001|STARTED|Overall Study||92
6808661|NCT03291067|7741208|FG002|STARTED|Overall Study||94
6808662|NCT03291067|7741209|FG003|STARTED|Overall Study||94
6808663|NCT03291067|7741206|FG000|Treated|Overall Study||95
6808664|NCT03291067|7741207|FG001|Treated|Overall Study||90
6808665|NCT03291067|7741208|FG002|Treated|Overall Study||93
6808666|NCT03291067|7741209|FG003|Treated|Overall Study||90
6808667|NCT03291067|7741206|FG000|COMPLETED|Overall Study||84
6808668|NCT03291067|7741207|FG001|COMPLETED|Overall Study||78
6808669|NCT03291067|7741208|FG002|COMPLETED|Overall Study||61
6808670|NCT03291067|7741209|FG003|COMPLETED|Overall Study||77
6808671|NCT03291067|7741206|FG000|NOT COMPLETED|Overall Study||10
6808672|NCT03291067|7741207|FG001|NOT COMPLETED|Overall Study||14
6808673|NCT03291067|7741208|FG002|NOT COMPLETED|Overall Study||33
6808674|NCT03291067|7741209|FG003|NOT COMPLETED|Overall Study||17
6808675|NCT03271047|7741223|FG000|STARTED|Phase 1b: Dose Finding Period||10
6808676|NCT03271047|7741224|FG001|STARTED|Phase 1b: Dose Finding Period||11
6808677|NCT03271047|7741225|FG002|STARTED|Phase 1b: Dose Finding Period||0
6808678|NCT03271047|7741226|FG003|STARTED|Phase 1b: Dose Finding Period||0
6808679|NCT03271047|7741223|FG000|COMPLETED|Phase 1b: Dose Finding Period||0
6808680|NCT03271047|7741224|FG001|COMPLETED|Phase 1b: Dose Finding Period||0
6808681|NCT03271047|7741225|FG002|COMPLETED|Phase 1b: Dose Finding Period||0
6808682|NCT03271047|7741226|FG003|COMPLETED|Phase 1b: Dose Finding Period||0
6808683|NCT03271047|7741223|FG000|NOT COMPLETED|Phase 1b: Dose Finding Period||10
6808684|NCT03271047|7741224|FG001|NOT COMPLETED|Phase 1b: Dose Finding Period||11
6808685|NCT03271047|7741225|FG002|NOT COMPLETED|Phase 1b: Dose Finding Period||0
6808686|NCT03271047|7741226|FG003|NOT COMPLETED|Phase 1b: Dose Finding Period||0
6808687|NCT03271047|7741223|FG000|STARTED|Randomized Phase 2 Period||0
6808688|NCT03271047|7741224|FG001|STARTED|Randomized Phase 2 Period||0
6808689|NCT03271047|7741225|FG002|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
6808690|NCT03271047|7741226|FG003|STARTED|Randomized Phase 2 Period|Participants randomized to Phase 2 of the study.|27
6808691|NCT03271047|7741223|FG000|COMPLETED|Randomized Phase 2 Period||0
6808692|NCT03271047|7741224|FG001|COMPLETED|Randomized Phase 2 Period||0
6808693|NCT03271047|7741225|FG002|COMPLETED|Randomized Phase 2 Period||0
6808694|NCT03271047|7741226|FG003|COMPLETED|Randomized Phase 2 Period||0
6808695|NCT03271047|7741223|FG000|NOT COMPLETED|Randomized Phase 2 Period||0
6808696|NCT03271047|7741224|FG001|NOT COMPLETED|Randomized Phase 2 Period||0
6808697|NCT03271047|7741225|FG002|NOT COMPLETED|Randomized Phase 2 Period||27
6808698|NCT03271047|7741226|FG003|NOT COMPLETED|Randomized Phase 2 Period||27
6808699|NCT03257436|7741238|FG000|STARTED|Overall Study||584
6808700|NCT03257436|7741238|FG000|COMPLETED|Overall Study||489
6808701|NCT03257436|7741238|FG000|NOT COMPLETED|Overall Study||95
6808702|NCT03171480|7741244|FG000|STARTED|Overall Study||89
6808703|NCT03171480|7741245|FG001|STARTED|Overall Study||87
6808704|NCT03171480|7741244|FG000|COMPLETED|Overall Study||89
6808705|NCT03171480|7741245|FG001|COMPLETED|Overall Study||87
6808706|NCT03171480|7741244|FG000|NOT COMPLETED|Overall Study||0
6808707|NCT03171480|7741245|FG001|NOT COMPLETED|Overall Study||0
6808708|NCT03158285|7741255|FG000|STARTED|Placebo-controlled Period: Week 0 - 24||246
6808709|NCT03158285|7741256|FG001|STARTED|Placebo-controlled Period: Week 0 - 24||248
6808710|NCT03158285|7741257|FG002|STARTED|Placebo-controlled Period: Week 0 - 24||245
6808711|NCT03158285|7741255|FG000|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (255) = 77 (CNTO1959PSA3001[NCT03162796]) + 178 (CNTO1959PSA3002)|255
6808712|NCT03158285|7741256|FG001|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (230)= 72 (CNTO1959PSA3001) + 158 (CNTO1959PSA3002)|230
6808713|NCT03158285|7741257|FG002|Pooled Population: Enthesitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (243)= 73 (CNTO1959PSA3001) + 170 (CNTO1959PSA3002)|243
6808714|NCT03158285|7741255|FG000|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (154) = 55 (CNTO1959PSA3001) + 99 (CNTO1959PSA3002)|154
6808715|NCT03158285|7741256|FG001|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (160) = 49 (CNTO1959PSA3001) + 111 (CNTO1959PSA3002)|160
6808716|NCT03158285|7741257|FG002|Pooled Population: Dactylitis Assessment|Placebo-controlled Period: Week 0 - 24|Pooled population (159) = 38 (CNTO1959PSA3001) + 121 (CNTO1959PSA3002)|159
6808717|NCT03158285|7741255|FG000|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
6808718|NCT03158285|7741256|FG001|COMPLETED|Placebo-controlled Period: Week 0 - 24||240
6808719|NCT03158285|7741257|FG002|COMPLETED|Placebo-controlled Period: Week 0 - 24||236
6808720|NCT03158285|7741255|FG000|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||6
6808721|NCT03158285|7741256|FG001|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||8
6808722|NCT03158285|7741257|FG002|NOT COMPLETED|Placebo-controlled Period: Week 0 - 24||9
6808723|NCT03158285|7741255|FG000|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|238
6808724|NCT03158285|7741256|FG001|STARTED|Active Treatment Period: Week 24 - 52||240
6808725|NCT03158285|7741257|FG002|STARTED|Active Treatment Period: Week 24 - 52|2 participants did not enter the active treatment.|234
6808726|NCT03158285|7741255|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||228
6808727|NCT03158285|7741256|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||234
6808728|NCT03158285|7741257|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||227
6808729|NCT03158285|7741255|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||10
6808730|NCT03158285|7741256|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||6
6808731|NCT03158285|7741257|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
6808732|NCT03158285|7741255|FG000|STARTED|Active Treatment Period: Week 52-100||228
6808733|NCT03158285|7741256|FG001|STARTED|Active Treatment Period: Week 52-100|2 participants did not enter the active treatment.|232
6808734|NCT03158285|7741257|FG002|STARTED|Active Treatment Period: Week 52-100||227
6808735|NCT03158285|7741255|FG000|COMPLETED|Active Treatment Period: Week 52-100||210
6808736|NCT03158285|7741256|FG001|COMPLETED|Active Treatment Period: Week 52-100||223
6808737|NCT03158285|7741257|FG002|COMPLETED|Active Treatment Period: Week 52-100||219
6808738|NCT03158285|7741255|FG000|NOT COMPLETED|Active Treatment Period: Week 52-100||18
6808739|NCT03158285|7741256|FG001|NOT COMPLETED|Active Treatment Period: Week 52-100||9
6808740|NCT03158285|7741257|FG002|NOT COMPLETED|Active Treatment Period: Week 52-100||8
6808741|NCT04723173|7741270|FG000|STARTED|Measure of Detection Threshold (in dB)||10
6808742|NCT04723173|7741270|FG000|Feature for Soft Sounds On|Measure of Detection Threshold (in dB)||10
6808743|NCT04723173|7741270|FG000|Feature for Soft Sounds Off|Measure of Detection Threshold (in dB)||10
6808744|NCT04723173|7741270|FG000|COMPLETED|Measure of Detection Threshold (in dB)||10
6808745|NCT04723173|7741270|FG000|NOT COMPLETED|Measure of Detection Threshold (in dB)||0
6808746|NCT04723173|7741270|FG000|STARTED|Subjective Listening Effort Scaling|The test in this test period is independent (also temporally) from the previous test period. That is the reason, why the number of participants, who started this test period is lesser than the number of participants, who completed the previous period.|9
6808747|NCT04723173|7741270|FG000|DNC on|Subjective Listening Effort Scaling||9
6808748|NCT04723173|7741270|FG000|DNC Off|Subjective Listening Effort Scaling||9
6808749|NCT04723173|7741270|FG000|COMPLETED|Subjective Listening Effort Scaling||8
6808750|NCT04723173|7741270|FG000|NOT COMPLETED|Subjective Listening Effort Scaling||1
6808751|NCT04723173|7741270|FG000|STARTED|Subjective Ratings of Sound Samples|The test in this test period is independent (also temporal) from the previous test period. That is the reason, why the number of participants, who started this test period is greater than the number of participants, who completed the previous period.|9
6808752|NCT04723173|7741270|FG000|DNC on|Subjective Ratings of Sound Samples||9
6808753|NCT04723173|7741270|FG000|DNC Off|Subjective Ratings of Sound Samples||9
6808754|NCT04723173|7741270|FG000|COMPLETED|Subjective Ratings of Sound Samples|"All participants completed this study period, but just the results of 8 participants could be used.~This was because technical issues limited the reliability of the measures made for one participant.~N.B. this test was independent from the other tests in the study. Therefore the results are not influenced by other test periods. The number of people included in the analysis described here relates only to this test."|9
6808755|NCT04723173|7741270|FG000|NOT COMPLETED|Subjective Ratings of Sound Samples||0
6808756|NCT04552470|7741286|FG000|STARTED|Overall Study||9
6808757|NCT04552470|7741287|FG001|STARTED|Overall Study||10
6808758|NCT04552470|7741288|FG002|STARTED|Overall Study||9
6808759|NCT04552470|7741289|FG003|STARTED|Overall Study||9
6808760|NCT04552470|7741286|FG000|COMPLETED|Overall Study||9
6808761|NCT04552470|7741287|FG001|COMPLETED|Overall Study||10
6808762|NCT04552470|7741288|FG002|COMPLETED|Overall Study||9
6808763|NCT04552470|7741289|FG003|COMPLETED|Overall Study||9
6808764|NCT04552470|7741286|FG000|NOT COMPLETED|Overall Study||0
6808765|NCT04552470|7741287|FG001|NOT COMPLETED|Overall Study||0
6808766|NCT04552470|7741288|FG002|NOT COMPLETED|Overall Study||0
6808767|NCT04552470|7741289|FG003|NOT COMPLETED|Overall Study||0
6808768|NCT04251884|7741304|FG000|STARTED|Overall Study||23
6808769|NCT04251884|7741305|FG001|STARTED|Overall Study||26
6808770|NCT04251884|7741304|FG000|COMPLETED|Overall Study||23
6808771|NCT04251884|7741305|FG001|COMPLETED|Overall Study||26
6808772|NCT04251884|7741304|FG000|NOT COMPLETED|Overall Study||0
6808773|NCT04251884|7741305|FG001|NOT COMPLETED|Overall Study||0
6808774|NCT03683823|7741314|FG000|STARTED|Post-treatment Assessment||11
6808775|NCT03683823|7741315|FG001|STARTED|Post-treatment Assessment||10
6808776|NCT03683823|7741314|FG000|COMPLETED|Post-treatment Assessment||10
6808777|NCT03683823|7741315|FG001|COMPLETED|Post-treatment Assessment||8
6808778|NCT03683823|7741314|FG000|NOT COMPLETED|Post-treatment Assessment||1
6808779|NCT03683823|7741315|FG001|NOT COMPLETED|Post-treatment Assessment||2
6808780|NCT03683823|7741314|FG000|STARTED|1-week Follow-up||10
6808781|NCT03683823|7741315|FG001|STARTED|1-week Follow-up||8
6808782|NCT03683823|7741314|FG000|COMPLETED|1-week Follow-up||9
6808783|NCT03683823|7741315|FG001|COMPLETED|1-week Follow-up||7
6808784|NCT03683823|7741314|FG000|NOT COMPLETED|1-week Follow-up||1
6808785|NCT03683823|7741315|FG001|NOT COMPLETED|1-week Follow-up||1
6808786|NCT03546439|7741324|FG000|STARTED|Overall Study||203
6808787|NCT03546439|7741325|FG001|STARTED|Overall Study||156
6808788|NCT03546439|7741326|FG002|STARTED|Overall Study||75
6808789|NCT03546439|7741324|FG000|COMPLETED|Overall Study||203
6808790|NCT03546439|7741325|FG001|COMPLETED|Overall Study||156
6808791|NCT03546439|7741326|FG002|COMPLETED|Overall Study||75
6808792|NCT03546439|7741324|FG000|NOT COMPLETED|Overall Study||0
6808793|NCT03546439|7741325|FG001|NOT COMPLETED|Overall Study||0
6808794|NCT03546439|7741326|FG002|NOT COMPLETED|Overall Study||0
6808795|NCT03515551|7741341|FG000|STARTED|Overall Study||4
6275675|NCT00114127|7174876|FG000|STARTED|Overall Study||13
6390756|NCT00831844|7302518|FG002|COMPLETED|Overall Study||1
6656945|NCT02465866|7587323|FG000|COMPLETED|Period 1||5
6656946|NCT02465866|7587324|FG001|COMPLETED|Period 1||5
6808796|NCT03515551|7741342|FG001|STARTED|Overall Study||3
6808797|NCT03515551|7741343|FG002|STARTED|Overall Study||5
6808798|NCT03515551|7741344|FG003|STARTED|Overall Study||3
6808799|NCT03515551|7741345|FG004|STARTED|Overall Study|1 participant from the 10 mcg cohort was sequentially enrolled in the 30-100 mcg cohort and is counted as starting in both columns; reason for study discontinuation recorded as part of 30-100 mcg cohort.|5
6808800|NCT03515551|7741346|FG005|STARTED|Overall Study||4
6808801|NCT03515551|7741347|FG006|STARTED|Overall Study||5
6808802|NCT03515551|7741341|FG000|COMPLETED|Overall Study||0
6808803|NCT03515551|7741342|FG001|COMPLETED|Overall Study||0
6808804|NCT03515551|7741343|FG002|COMPLETED|Overall Study||0
6567167|NCT01829516|7490247|FG000|NOT COMPLETED|Washout Period - 1 Week||0
6567168|NCT01829516|7490248|FG001|NOT COMPLETED|Washout Period - 1 Week||0
6567169|NCT01829516|7490247|FG000|STARTED|2nd Intervention||18
6808805|NCT03515551|7741344|FG003|COMPLETED|Overall Study||0
6808806|NCT03515551|7741345|FG004|COMPLETED|Overall Study||0
6808807|NCT03515551|7741346|FG005|COMPLETED|Overall Study||0
6808808|NCT03515551|7741347|FG006|COMPLETED|Overall Study||0
6808809|NCT03515551|7741341|FG000|NOT COMPLETED|Overall Study||4
6808810|NCT03515551|7741342|FG001|NOT COMPLETED|Overall Study||3
6808811|NCT03515551|7741343|FG002|NOT COMPLETED|Overall Study||5
6808812|NCT03515551|7741344|FG003|NOT COMPLETED|Overall Study||3
6808813|NCT03515551|7741345|FG004|NOT COMPLETED|Overall Study||5
6808814|NCT03515551|7741346|FG005|NOT COMPLETED|Overall Study||4
6808815|NCT03515551|7741347|FG006|NOT COMPLETED|Overall Study||5
6808816|NCT03385265|7741372|FG000|STARTED|Overall Study||20
6808817|NCT03385265|7741373|FG001|STARTED|Overall Study||11
6808818|NCT03385265|7741374|FG002|STARTED|Overall Study||20
6808819|NCT03385265|7741375|FG003|STARTED|Overall Study||11
6808820|NCT03385265|7741372|FG000|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
6808821|NCT03385265|7741373|FG001|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
6808822|NCT03385265|7741374|FG002|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|15
6808823|NCT03385265|7741375|FG003|COMPLETED|Overall Study|this is Time 3 or 33 weeks post-baseline|9
6808824|NCT03385265|7741372|FG000|NOT COMPLETED|Overall Study||5
6808825|NCT03385265|7741373|FG001|NOT COMPLETED|Overall Study||2
6808826|NCT03385265|7741374|FG002|NOT COMPLETED|Overall Study||5
6808827|NCT03385265|7741375|FG003|NOT COMPLETED|Overall Study||2
6808828|NCT03316807|7741389|FG000|STARTED|Overall Study||91
6808829|NCT03316807|7741390|FG001|STARTED|Overall Study||91
6808830|NCT03316807|7741389|FG000|COMPLETED|Overall Study||60
6808831|NCT03316807|7741390|FG001|COMPLETED|Overall Study||65
6808832|NCT03316807|7741389|FG000|NOT COMPLETED|Overall Study||31
6808833|NCT03316807|7741390|FG001|NOT COMPLETED|Overall Study||26
6808834|NCT03138538|7741402|FG000|STARTED|Overall Study||3
6808835|NCT03138538|7741403|FG001|STARTED|Overall Study||3
6808836|NCT03138538|7741404|FG002|STARTED|Overall Study||3
6808837|NCT03138538|7741405|FG003|STARTED|Overall Study||8
6808838|NCT03138538|7741406|FG004|STARTED|Overall Study||7
6808839|NCT03138538|7741407|FG005|STARTED|Overall Study||3
6808840|NCT03138538|7741402|FG000|COMPLETED|Overall Study||3
6808841|NCT03138538|7741403|FG001|COMPLETED|Overall Study||3
6808842|NCT03138538|7741404|FG002|COMPLETED|Overall Study||3
6808843|NCT03138538|7741405|FG003|COMPLETED|Overall Study||8
6808844|NCT03138538|7741406|FG004|COMPLETED|Overall Study||7
6808845|NCT03138538|7741407|FG005|COMPLETED|Overall Study||3
6808846|NCT03138538|7741402|FG000|NOT COMPLETED|Overall Study||0
6808847|NCT03138538|7741403|FG001|NOT COMPLETED|Overall Study||0
6808848|NCT03138538|7741404|FG002|NOT COMPLETED|Overall Study||0
6808849|NCT03138538|7741405|FG003|NOT COMPLETED|Overall Study||0
6808850|NCT03138538|7741406|FG004|NOT COMPLETED|Overall Study||0
6808851|NCT03138538|7741407|FG005|NOT COMPLETED|Overall Study||0
6808852|NCT02987543|7741430|FG000|STARTED|Overall Study||162
6808853|NCT02987543|7741431|FG001|STARTED|Overall Study||83
6808854|NCT02987543|7741432|FG002|STARTED|Overall Study||94
6808855|NCT02987543|7741433|FG003|STARTED|Overall Study||48
6808856|NCT02987543|7741430|FG000|COMPLETED|Overall Study||0
6808857|NCT02987543|7741431|FG001|COMPLETED|Overall Study||0
6808858|NCT02987543|7741432|FG002|COMPLETED|Overall Study||0
6808859|NCT02987543|7741433|FG003|COMPLETED|Overall Study||0
6808860|NCT02987543|7741430|FG000|NOT COMPLETED|Overall Study||162
6808861|NCT02987543|7741431|FG001|NOT COMPLETED|Overall Study||83
6808862|NCT02987543|7741432|FG002|NOT COMPLETED|Overall Study||94
6808863|NCT02987543|7741433|FG003|NOT COMPLETED|Overall Study||48
6808864|NCT02919306|7741441|FG000|STARTED|Overall Study||18
6808865|NCT02919306|7741442|FG001|STARTED|Overall Study||9
6808866|NCT02919306|7741441|FG000|COMPLETED|Overall Study||16
6808867|NCT02919306|7741442|FG001|COMPLETED|Overall Study||9
6808868|NCT02919306|7741441|FG000|NOT COMPLETED|Overall Study||2
6808869|NCT02919306|7741442|FG001|NOT COMPLETED|Overall Study||0
6567170|NCT01829516|7490248|FG001|STARTED|2nd Intervention||14
6567171|NCT01829516|7490247|FG000|COMPLETED|2nd Intervention||18
6567172|NCT01829516|7490248|FG001|COMPLETED|2nd Intervention||14
6567173|NCT01829516|7490247|FG000|NOT COMPLETED|2nd Intervention||0
6808870|NCT02763189|7741450|FG000|STARTED|Overall Study||4
6808871|NCT02763189|7741451|FG001|STARTED|Overall Study||4
6808872|NCT02763189|7741450|FG000|COMPLETED|Overall Study||4
6808873|NCT02763189|7741451|FG001|COMPLETED|Overall Study||2
6808874|NCT02763189|7741450|FG000|NOT COMPLETED|Overall Study||0
6808875|NCT02763189|7741451|FG001|NOT COMPLETED|Overall Study||2
6808876|NCT02700945|7741459|FG000|STARTED|Overall Study||242
6808877|NCT02700945|7741460|FG001|STARTED|Overall Study||250
6808878|NCT02700945|7741459|FG000|COMPLETED|Overall Study||210
6808879|NCT02700945|7741460|FG001|COMPLETED|Overall Study||207
6808880|NCT02700945|7741459|FG000|NOT COMPLETED|Overall Study||32
6808881|NCT02700945|7741460|FG001|NOT COMPLETED|Overall Study||43
6808882|NCT02659514|7741468|FG000|STARTED|Overall Study||33
6567174|NCT01829516|7490248|FG001|NOT COMPLETED|2nd Intervention||0
6567175|NCT01829919|7490256|FG000|STARTED|Overall Study||24
6567176|NCT01829919|7490256|FG000|COMPLETED|Overall Study||24
6567177|NCT01829919|7490256|FG000|NOT COMPLETED|Overall Study||0
6567178|NCT01829997|7490260|FG000|STARTED|Overall Study||22
6567179|NCT01829997|7490260|FG000|COMPLETED|Overall Study||16
6567180|NCT01829997|7490260|FG000|NOT COMPLETED|Overall Study||6
6567181|NCT01830127|7490266|FG000|STARTED|Overall Study||18
6567182|NCT01830127|7490267|FG001|STARTED|Overall Study||17
6808883|NCT02659514|7741469|FG001|STARTED|Overall Study||34
6808884|NCT02659514|7741468|FG000|Safety Population|Overall Study||33
6808885|NCT02659514|7741469|FG001|Safety Population|Overall Study||34
6808886|NCT02659514|7741468|FG000|Evaluable Population|Overall Study||30
6808887|NCT02659514|7741469|FG001|Evaluable Population|Overall Study||27
6808888|NCT02659514|7741468|FG000|COMPLETED|Overall Study||1
6808889|NCT02659514|7741469|FG001|COMPLETED|Overall Study||0
6808890|NCT02659514|7741468|FG000|NOT COMPLETED|Overall Study||32
6808891|NCT02659514|7741469|FG001|NOT COMPLETED|Overall Study||34
6808892|NCT02435173|7741478|FG000|STARTED|Overall Study||6
6808893|NCT02435173|7741479|FG001|STARTED|Overall Study||21
6808894|NCT02435173|7741480|FG002|STARTED|Overall Study||10
6808895|NCT02435173|7741478|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||6
6808896|NCT02435173|7741479|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||19
6808897|NCT02435173|7741480|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
6808898|NCT02435173|7741478|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
6808899|NCT02435173|7741479|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||19
6808900|NCT02435173|7741480|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||8
6808901|NCT02435173|7741478|FG000|COMPLETED|Overall Study||6
6808902|NCT02435173|7741479|FG001|COMPLETED|Overall Study||21
6808903|NCT02435173|7741480|FG002|COMPLETED|Overall Study||10
6808904|NCT02435173|7741478|FG000|NOT COMPLETED|Overall Study||0
6808905|NCT02435173|7741479|FG001|NOT COMPLETED|Overall Study||0
6808906|NCT02435173|7741480|FG002|NOT COMPLETED|Overall Study||0
6808907|NCT02390245|7741494|FG000|STARTED|Phase I. Telemedicine Screening||906
6808908|NCT02390245|7741495|FG001|STARTED|Phase I. Telemedicine Screening||0
6808909|NCT02390245|7741496|FG002|STARTED|Phase I. Telemedicine Screening||0
6808910|NCT02390245|7741494|FG000|COMPLETED|Phase I. Telemedicine Screening||906
6808911|NCT02390245|7741495|FG001|COMPLETED|Phase I. Telemedicine Screening||0
6808912|NCT02390245|7741496|FG002|COMPLETED|Phase I. Telemedicine Screening||0
6808913|NCT02390245|7741494|FG000|NOT COMPLETED|Phase I. Telemedicine Screening||0
6808914|NCT02390245|7741495|FG001|NOT COMPLETED|Phase I. Telemedicine Screening||0
6808915|NCT02390245|7741496|FG002|NOT COMPLETED|Phase I. Telemedicine Screening||0
6808916|NCT02390245|7741494|FG000|STARTED|Phase 2. Randomization Into 2 Groups|Remaining 355 participants from Phase I Telemedicine Screening had normal eye examinations requiring no further follow-up.|0
6808917|NCT02390245|7741495|FG001|STARTED|Phase 2. Randomization Into 2 Groups||275
6808918|NCT02390245|7741496|FG002|STARTED|Phase 2. Randomization Into 2 Groups||276
6808919|NCT02390245|7741494|FG000|COMPLETED|Phase 2. Randomization Into 2 Groups||0
6808920|NCT02390245|7741495|FG001|COMPLETED|Phase 2. Randomization Into 2 Groups||171
6808921|NCT02390245|7741496|FG002|COMPLETED|Phase 2. Randomization Into 2 Groups||171
6808922|NCT02390245|7741494|FG000|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||0
6808923|NCT02390245|7741495|FG001|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||104
6567183|NCT01830127|7490266|FG000|COMPLETED|Overall Study||13
6567184|NCT01830127|7490267|FG001|COMPLETED|Overall Study||8
6567185|NCT01830127|7490266|FG000|NOT COMPLETED|Overall Study||5
6567186|NCT01830127|7490267|FG001|NOT COMPLETED|Overall Study||9
6567187|NCT01830140|7490275|FG000|STARTED|Overall Study||233
6567188|NCT01830140|7490276|FG001|STARTED|Overall Study||233
6567189|NCT01830140|7490275|FG000|COMPLETED|Overall Study||226
6567190|NCT01830140|7490276|FG001|COMPLETED|Overall Study||229
6808924|NCT02390245|7741496|FG002|NOT COMPLETED|Phase 2. Randomization Into 2 Groups||105
6808925|NCT02390245|7741494|FG000|STARTED|Phase 3. Ophthalmic Follow-up Adherence||0
6808926|NCT02390245|7741495|FG001|STARTED|Phase 3. Ophthalmic Follow-up Adherence||171
6808927|NCT02390245|7741496|FG002|STARTED|Phase 3. Ophthalmic Follow-up Adherence||171
6808928|NCT02390245|7741494|FG000|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
6808929|NCT02390245|7741495|FG001|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||77
6808930|NCT02390245|7741496|FG002|COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||66
6808931|NCT02390245|7741494|FG000|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||0
6567191|NCT01830140|7490275|FG000|NOT COMPLETED|Overall Study||7
6567192|NCT01830140|7490276|FG001|NOT COMPLETED|Overall Study||4
6567193|NCT01830205|7490286|FG000|STARTED|Overall Study||12
6567194|NCT01830205|7490287|FG001|STARTED|Overall Study||6
6567195|NCT01830205|7490288|FG002|STARTED|Overall Study||6
6808932|NCT02390245|7741495|FG001|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||94
6808933|NCT02390245|7741496|FG002|NOT COMPLETED|Phase 3. Ophthalmic Follow-up Adherence||105
6808934|NCT02254278|7741505|FG000|STARTED|Overall Study||158
6808935|NCT02254278|7741506|FG001|STARTED|Overall Study||150
6808936|NCT02254278|7741505|FG000|Eligible|Overall Study||157
6808937|NCT02254278|7741506|FG001|Eligible|Overall Study||149
6808938|NCT02254278|7741505|FG000|Started Study Treatment|Overall Study||152
6808939|NCT02254278|7741506|FG001|Started Study Treatment|Overall Study||147
6808940|NCT02254278|7741505|FG000|Negative Post-treatment PET|Overall Study||58
6808941|NCT02254278|7741506|FG001|Negative Post-treatment PET|Overall Study||57
6808942|NCT02254278|7741505|FG000|COMPLETED|Overall Study||157
6808943|NCT02254278|7741506|FG001|COMPLETED|Overall Study||149
6808944|NCT02254278|7741505|FG000|NOT COMPLETED|Overall Study||1
6808945|NCT02254278|7741506|FG001|NOT COMPLETED|Overall Study||1
6808946|NCT01850524|7741517|FG000|STARTED|Overall Study||354
6808947|NCT01850524|7741518|FG001|STARTED|Overall Study||351
6808948|NCT01850524|7741517|FG000|Intent-to-Treat (ITT) Population|Overall Study||354
6808949|NCT01850524|7741518|FG001|Intent-to-Treat (ITT) Population|Overall Study||351
6808950|NCT01850524|7741517|FG000|Safety Population|Overall Study|1 participant in this arm who withdrew from the study was not included in the safety population.|349
6808951|NCT01850524|7741518|FG001|Safety Population|Overall Study|Included 4 participants from placebo who received ixazomib; 1 participant who withdrew was excluded.|354
6808952|NCT01850524|7741517|FG000|Participants Completed Study Treatment Per Protocol|Overall Study||270
6808953|NCT01850524|7741518|FG001|Participants Completed Study Treatment Per Protocol|Overall Study||264
6808954|NCT01850524|7741517|FG000|Per Protocol (PP) Population|Overall Study||295
6808955|NCT01850524|7741518|FG001|Per Protocol (PP) Population|Overall Study||298
6567196|NCT01830205|7490289|FG003|STARTED|Overall Study||12
6567197|NCT01830205|7490286|FG000|COMPLETED|Overall Study||12
6567198|NCT01830205|7490287|FG001|COMPLETED|Overall Study||6
6567199|NCT01830205|7490288|FG002|COMPLETED|Overall Study||6
6567200|NCT01830205|7490289|FG003|COMPLETED|Overall Study||12
6808956|NCT01850524|7741517|FG000|Participants With Exposure of ≥ 19 Cycles|Overall Study||189
6808957|NCT01850524|7741518|FG001|Participants With Exposure of ≥ 19 Cycles|Overall Study||191
6808958|NCT01850524|7741517|FG000|COMPLETED|Overall Study||0
6808959|NCT01850524|7741518|FG001|COMPLETED|Overall Study||0
6808960|NCT01850524|7741517|FG000|NOT COMPLETED|Overall Study||354
6808961|NCT01850524|7741518|FG001|NOT COMPLETED|Overall Study||351
6808962|NCT01673867|7741528|FG000|STARTED|Randomization||292
6808963|NCT01673867|7741529|FG001|STARTED|Randomization||290
6808964|NCT01673867|7741528|FG000|COMPLETED|Randomization||287
6808965|NCT01673867|7741529|FG001|COMPLETED|Randomization||268
6808966|NCT01673867|7741528|FG000|NOT COMPLETED|Randomization||5
6808967|NCT01673867|7741529|FG001|NOT COMPLETED|Randomization||22
6808968|NCT01673867|7741528|FG000|STARTED|Treatment||287
6808969|NCT01673867|7741529|FG001|STARTED|Treatment||268
6808970|NCT01673867|7741528|FG000|COMPLETED|Treatment||43
6808971|NCT01673867|7741529|FG001|COMPLETED|Treatment||0
6808972|NCT01673867|7741528|FG000|NOT COMPLETED|Treatment||244
6808973|NCT01673867|7741529|FG001|NOT COMPLETED|Treatment||268
6808974|NCT01182727|7741535|FG000|STARTED|Overall Study||10
6808975|NCT01182727|7741535|FG000|COMPLETED|Overall Study||10
6808976|NCT01182727|7741535|FG000|NOT COMPLETED|Overall Study||0
6808977|NCT00335777|7741539|FG000|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
6808978|NCT00335777|7741539|FG000|COMPLETED|Enrolled and Dispensed Study Medication||35
6808979|NCT00335777|7741539|FG000|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
6808980|NCT00335777|7741539|FG000|STARTED|Treated 2 Headaches Per Protocol||35
6808981|NCT00335777|7741539|FG000|COMPLETED|Treated 2 Headaches Per Protocol||22
6808982|NCT00335777|7741539|FG000|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
6808983|NCT00159588|7741547|FG000|STARTED|5 Month Follow-up||19
6808984|NCT00159588|7741548|FG001|STARTED|5 Month Follow-up||22
6808985|NCT00159588|7741549|FG002|STARTED|5 Month Follow-up||20
6808986|NCT00159588|7741547|FG000|COMPLETED|5 Month Follow-up||17
6808987|NCT00159588|7741548|FG001|COMPLETED|5 Month Follow-up||18
6808988|NCT00159588|7741549|FG002|COMPLETED|5 Month Follow-up||18
6808989|NCT00159588|7741547|FG000|NOT COMPLETED|5 Month Follow-up||2
6808990|NCT00159588|7741548|FG001|NOT COMPLETED|5 Month Follow-up||4
6808991|NCT00159588|7741549|FG002|NOT COMPLETED|5 Month Follow-up||2
6808992|NCT00159588|7741547|FG000|STARTED|1-year Follow-up for Group 1 and 2||17
6808993|NCT00159588|7741548|FG001|STARTED|1-year Follow-up for Group 1 and 2||18
6808994|NCT00159588|7741549|FG002|STARTED|1-year Follow-up for Group 1 and 2||18
6808995|NCT00159588|7741547|FG000|COMPLETED|1-year Follow-up for Group 1 and 2||16
6808996|NCT00159588|7741548|FG001|COMPLETED|1-year Follow-up for Group 1 and 2||14
6808997|NCT00159588|7741549|FG002|COMPLETED|1-year Follow-up for Group 1 and 2||18
6808998|NCT00159588|7741547|FG000|NOT COMPLETED|1-year Follow-up for Group 1 and 2||1
6808999|NCT00159588|7741548|FG001|NOT COMPLETED|1-year Follow-up for Group 1 and 2||4
6809000|NCT00159588|7741549|FG002|NOT COMPLETED|1-year Follow-up for Group 1 and 2||0
6809001|NCT03051217|7741563|FG000|STARTED|Initial Period (Week 0 to Week 16)||26
6809002|NCT03051217|7741564|FG001|STARTED|Initial Period (Week 0 to Week 16)||48
6809003|NCT03051217|7741565|FG002|STARTED|Initial Period (Week 0 to Week 16)||53
6809004|NCT03051217|7741566|FG003|STARTED|Initial Period (Week 0 to Week 16)||0
6809005|NCT03051217|7741567|FG004|STARTED|Initial Period (Week 0 to Week 16)||0
6809006|NCT03051217|7741568|FG005|STARTED|Initial Period (Week 0 to Week 16)||0
6567201|NCT01830205|7490286|FG000|NOT COMPLETED|Overall Study||0
6809007|NCT03051217|7741569|FG006|STARTED|Initial Period (Week 0 to Week 16)||0
6809008|NCT03051217|7741563|FG000|COMPLETED|Initial Period (Week 0 to Week 16)||23
6809009|NCT03051217|7741564|FG001|COMPLETED|Initial Period (Week 0 to Week 16)||46
6809010|NCT03051217|7741565|FG002|COMPLETED|Initial Period (Week 0 to Week 16)||51
6809011|NCT03051217|7741566|FG003|COMPLETED|Initial Period (Week 0 to Week 16)||0
6809012|NCT03051217|7741567|FG004|COMPLETED|Initial Period (Week 0 to Week 16)||0
6809013|NCT03051217|7741568|FG005|COMPLETED|Initial Period (Week 0 to Week 16)||0
6809014|NCT03051217|7741569|FG006|COMPLETED|Initial Period (Week 0 to Week 16)||0
6809015|NCT03051217|7741563|FG000|NOT COMPLETED|Initial Period (Week 0 to Week 16)||3
6809016|NCT03051217|7741564|FG001|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
6809017|NCT03051217|7741565|FG002|NOT COMPLETED|Initial Period (Week 0 to Week 16)||2
6809018|NCT03051217|7741566|FG003|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6809019|NCT03051217|7741567|FG004|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6809020|NCT03051217|7741568|FG005|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6809021|NCT03051217|7741569|FG006|NOT COMPLETED|Initial Period (Week 0 to Week 16)||0
6809022|NCT03051217|7741563|FG000|STARTED|Maintenance Period (Week 16 to Week 52)||0
6809023|NCT03051217|7741564|FG001|STARTED|Maintenance Period (Week 16 to Week 52)||0
6809024|NCT03051217|7741565|FG002|STARTED|Maintenance Period (Week 16 to Week 52)||0
6809025|NCT03051217|7741566|FG003|STARTED|Maintenance Period (Week 16 to Week 52)||23
6809026|NCT03051217|7741567|FG004|STARTED|Maintenance Period (Week 16 to Week 52)||51
6809027|NCT03051217|7741568|FG005|STARTED|Maintenance Period (Week 16 to Week 52)||26
6809028|NCT03051217|7741569|FG006|STARTED|Maintenance Period (Week 16 to Week 52)||20
6809029|NCT03051217|7741563|FG000|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
6809030|NCT03051217|7741564|FG001|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
6809031|NCT03051217|7741565|FG002|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||0
6809032|NCT03051217|7741566|FG003|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||21
6809033|NCT03051217|7741567|FG004|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
6809034|NCT03051217|7741568|FG005|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||7
6809035|NCT03051217|7741569|FG006|Received Escape Treatment|Maintenance Period (Week 16 to Week 52)||3
6809036|NCT03051217|7741563|FG000|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6809037|NCT03051217|7741564|FG001|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6809038|NCT03051217|7741565|FG002|COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6809039|NCT03051217|7741566|FG003|COMPLETED|Maintenance Period (Week 16 to Week 52)||20
6809040|NCT03051217|7741567|FG004|COMPLETED|Maintenance Period (Week 16 to Week 52)||48
6809041|NCT03051217|7741568|FG005|COMPLETED|Maintenance Period (Week 16 to Week 52)||24
6809042|NCT03051217|7741569|FG006|COMPLETED|Maintenance Period (Week 16 to Week 52)||19
6809043|NCT03051217|7741563|FG000|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6809044|NCT03051217|7741564|FG001|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6809045|NCT03051217|7741565|FG002|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||0
6809046|NCT03051217|7741566|FG003|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
6809047|NCT03051217|7741567|FG004|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||3
6809048|NCT03051217|7741568|FG005|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||2
6809049|NCT03051217|7741569|FG006|NOT COMPLETED|Maintenance Period (Week 16 to Week 52)||1
6809050|NCT03025542|7741585|FG000|STARTED|Overall Study||32
6809051|NCT03025542|7741586|FG001|STARTED|Overall Study||17
6390757|NCT00831844|7302519|FG003|COMPLETED|Overall Study||0
6390758|NCT00831844|7302520|FG004|COMPLETED|Overall Study||0
6809052|NCT03025542|7741585|FG000|COMPLETED|Overall Study||30
6809053|NCT03025542|7741586|FG001|COMPLETED|Overall Study||15
6809054|NCT03025542|7741585|FG000|NOT COMPLETED|Overall Study||2
6809055|NCT03025542|7741586|FG001|NOT COMPLETED|Overall Study||2
6809056|NCT02958319|7741598|FG000|STARTED|Overall Study||145
6809057|NCT02958319|7741599|FG001|STARTED|Overall Study||133
6809058|NCT02958319|7741598|FG000|COMPLETED|Overall Study||145
6809059|NCT02958319|7741599|FG001|COMPLETED|Overall Study||133
6809060|NCT02958319|7741598|FG000|NOT COMPLETED|Overall Study||0
6809061|NCT02958319|7741599|FG001|NOT COMPLETED|Overall Study||0
6809062|NCT02929069|7741608|FG000|STARTED|Overall Study||100
6809063|NCT02929069|7741609|FG001|STARTED|Overall Study||102
6809064|NCT02929069|7741610|FG002|STARTED|Overall Study||52
6809065|NCT02929069|7741608|FG000|Completed 4 Month Follow Up|Overall Study||83
6809066|NCT02929069|7741609|FG001|Completed 4 Month Follow Up|Overall Study||76
6809067|NCT02929069|7741610|FG002|Completed 4 Month Follow Up|Overall Study||43
6809068|NCT02929069|7741608|FG000|Completed 8 Month Follow Up|Overall Study||82
6809069|NCT02929069|7741609|FG001|Completed 8 Month Follow Up|Overall Study||77
6809070|NCT02929069|7741610|FG002|Completed 8 Month Follow Up|Overall Study||36
6809071|NCT02929069|7741608|FG000|Assessed STI 12 Month|Overall Study||74
6809072|NCT02929069|7741609|FG001|Assessed STI 12 Month|Overall Study||75
6809073|NCT02929069|7741610|FG002|Assessed STI 12 Month|Overall Study||38
6809074|NCT02929069|7741608|FG000|Assessed HIV 12 Month|Overall Study||76
6809075|NCT02929069|7741609|FG001|Assessed HIV 12 Month|Overall Study||76
6275676|NCT00114127|7174877|FG001|STARTED|Overall Study||15
6275677|NCT00114127|7174876|FG000|COMPLETED|Overall Study||9
6275678|NCT00114127|7174877|FG001|COMPLETED|Overall Study||11
6275679|NCT00114127|7174876|FG000|NOT COMPLETED|Overall Study||4
6275680|NCT00114127|7174877|FG001|NOT COMPLETED|Overall Study||4
6275681|NCT00114140|7174883|FG000|STARTED|Overall Study||136
6275682|NCT00114140|7174883|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|129
6275683|NCT00114140|7174883|FG000|NOT COMPLETED|Overall Study||7
6275684|NCT00114166|7174896|FG000|STARTED|Overall Study||15
6275685|NCT00114166|7174897|FG001|STARTED|Overall Study||66
6275686|NCT00114166|7174896|FG000|COMPLETED|Overall Study||15
6275687|NCT00114166|7174897|FG001|COMPLETED|Overall Study||65
6275688|NCT00114166|7174896|FG000|NOT COMPLETED|Overall Study||0
6275689|NCT00114166|7174897|FG001|NOT COMPLETED|Overall Study||1
6275690|NCT00114218|7174905|FG000|STARTED|Overall Study||28
6275691|NCT00114218|7174905|FG000|COMPLETED|Overall Study||24
6275692|NCT00114218|7174905|FG000|NOT COMPLETED|Overall Study||4
6275693|NCT00114231|7174911|FG000|STARTED|Overall Study||62
6275694|NCT00114231|7174912|FG001|STARTED|Overall Study||28
6275695|NCT00114231|7174911|FG000|COMPLETED|Overall Study||53
6275696|NCT00114231|7174912|FG001|COMPLETED|Overall Study||26
6275697|NCT00114231|7174911|FG000|NOT COMPLETED|Overall Study||9
6275698|NCT00114231|7174912|FG001|NOT COMPLETED|Overall Study||2
6275699|NCT00114244|7174919|FG000|STARTED|Overall Study||15
6275700|NCT00114244|7174920|FG001|STARTED|Overall Study||37
6275701|NCT00114244|7174919|FG000|COMPLETED|Overall Study||13
6275702|NCT00114244|7174920|FG001|COMPLETED|Overall Study||30
6275703|NCT00114244|7174919|FG000|NOT COMPLETED|Overall Study||2
6275704|NCT00114244|7174920|FG001|NOT COMPLETED|Overall Study||7
6275705|NCT00114504|7174928|FG000|STARTED|Overall Study||21
6275706|NCT00114504|7174929|FG001|STARTED|Overall Study||22
6275707|NCT00114504|7174928|FG000|COMPLETED|Overall Study||21
6275708|NCT00114504|7174929|FG001|COMPLETED|Overall Study||22
6567202|NCT01830205|7490287|FG001|NOT COMPLETED|Overall Study||0
6567203|NCT01830205|7490288|FG002|NOT COMPLETED|Overall Study||0
6275709|NCT00114504|7174928|FG000|NOT COMPLETED|Overall Study||0
6275710|NCT00114504|7174929|FG001|NOT COMPLETED|Overall Study||0
6275711|NCT00114517|7174943|FG000|STARTED|Overall Study||137
6275712|NCT00114517|7174944|FG001|STARTED|Overall Study||134
6275713|NCT00114517|7174945|FG002|STARTED|Overall Study||186
6275714|NCT00114517|7174946|FG003|STARTED|Overall Study||186
6275715|NCT00114517|7174943|FG000|COMPLETED|Overall Study||125
6275716|NCT00114517|7174944|FG001|COMPLETED|Overall Study||123
6275717|NCT00114517|7174945|FG002|COMPLETED|Overall Study||172
6275718|NCT00114517|7174946|FG003|COMPLETED|Overall Study||176
6275719|NCT00114517|7174943|FG000|NOT COMPLETED|Overall Study||12
6275720|NCT00114517|7174944|FG001|NOT COMPLETED|Overall Study||11
6275721|NCT00114517|7174945|FG002|NOT COMPLETED|Overall Study||14
6275722|NCT00114517|7174946|FG003|NOT COMPLETED|Overall Study||10
6275723|NCT00114530|7174954|FG000|STARTED|Overall Study||36
6275724|NCT00114530|7174955|FG001|STARTED|Overall Study||39
6809076|NCT02929069|7741610|FG002|Assessed HIV 12 Month|Overall Study||39
6809077|NCT02929069|7741608|FG000|Complete 12 Month Follow Up|Overall Study||81
6809078|NCT02929069|7741609|FG001|Complete 12 Month Follow Up|Overall Study||81
6809079|NCT02929069|7741610|FG002|Complete 12 Month Follow Up|Overall Study||42
6275725|NCT00114530|7174954|FG000|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|27
6275726|NCT00114530|7174955|FG001|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient's 54 mo visit)|19
6275727|NCT00114530|7174954|FG000|NOT COMPLETED|Overall Study||9
6275728|NCT00114530|7174955|FG001|NOT COMPLETED|Overall Study||20
6275729|NCT00114634|7174965|FG000|STARTED|Overall Study||13
6275730|NCT00114634|7174965|FG000|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
6275731|NCT00114634|7174965|FG000|NOT COMPLETED|Overall Study||3
6809080|NCT02929069|7741608|FG000|COMPLETED|Overall Study||81
6809081|NCT02929069|7741609|FG001|COMPLETED|Overall Study||81
6809082|NCT02929069|7741610|FG002|COMPLETED|Overall Study||42
6809083|NCT02929069|7741608|FG000|NOT COMPLETED|Overall Study||19
6809084|NCT02929069|7741609|FG001|NOT COMPLETED|Overall Study||21
6809085|NCT02929069|7741610|FG002|NOT COMPLETED|Overall Study||10
6809086|NCT02889809|7741622|FG000|STARTED|Overall Study||239
6809087|NCT02889809|7741623|FG001|STARTED|Overall Study||238
6809088|NCT02889809|7741622|FG000|COMPLETED|Overall Study||196
6809089|NCT02889809|7741623|FG001|COMPLETED|Overall Study||205
6809090|NCT02889809|7741622|FG000|NOT COMPLETED|Overall Study||43
6809091|NCT02889809|7741623|FG001|NOT COMPLETED|Overall Study||33
6809092|NCT02849587|7741632|FG000|STARTED|Overall Study||65
6809093|NCT02849587|7741633|FG001|STARTED|Overall Study||70
6809094|NCT02849587|7741634|FG002|STARTED|Overall Study||64
6809095|NCT02849587|7741632|FG000|COMPLETED|Overall Study||63
6809096|NCT02849587|7741633|FG001|COMPLETED|Overall Study||66
6809097|NCT02849587|7741634|FG002|COMPLETED|Overall Study||62
6809098|NCT02849587|7741632|FG000|NOT COMPLETED|Overall Study||2
6809099|NCT02849587|7741633|FG001|NOT COMPLETED|Overall Study||4
6809100|NCT02849587|7741634|FG002|NOT COMPLETED|Overall Study||2
6809101|NCT02815540|7741646|FG000|STARTED|Overall Study||2
6809102|NCT02815540|7741646|FG000|COMPLETED|Overall Study||0
6809103|NCT02815540|7741646|FG000|NOT COMPLETED|Overall Study||2
6809104|NCT02814708|7741657|FG000|STARTED|Overall Study||20
6809105|NCT02814708|7741658|FG001|STARTED|Overall Study||20
6809106|NCT02814708|7741659|FG002|STARTED|Overall Study||20
6809107|NCT02814708|7741660|FG003|STARTED|Overall Study||20
6809108|NCT02814708|7741661|FG004|STARTED|Overall Study||20
6809109|NCT02814708|7741662|FG005|STARTED|Overall Study||20
6809110|NCT02814708|7741663|FG006|STARTED|Overall Study||20
6809111|NCT02814708|7741657|FG000|COMPLETED|Overall Study||18
6809112|NCT02814708|7741658|FG001|COMPLETED|Overall Study||17
6809113|NCT02814708|7741659|FG002|COMPLETED|Overall Study||19
6809114|NCT02814708|7741660|FG003|COMPLETED|Overall Study||20
6809115|NCT02814708|7741661|FG004|COMPLETED|Overall Study||17
6809116|NCT02814708|7741662|FG005|COMPLETED|Overall Study||16
6809117|NCT02814708|7741663|FG006|COMPLETED|Overall Study||19
6809118|NCT02814708|7741657|FG000|NOT COMPLETED|Overall Study||2
6809119|NCT02814708|7741658|FG001|NOT COMPLETED|Overall Study||3
6809120|NCT02814708|7741659|FG002|NOT COMPLETED|Overall Study||1
6809121|NCT02814708|7741660|FG003|NOT COMPLETED|Overall Study||0
6809122|NCT02814708|7741661|FG004|NOT COMPLETED|Overall Study||3
6809123|NCT02814708|7741662|FG005|NOT COMPLETED|Overall Study||4
6809124|NCT02814708|7741663|FG006|NOT COMPLETED|Overall Study||1
6809125|NCT02781727|7741681|FG000|STARTED|Pre-dosing Period|106 subjects were randomized to the lonapegsomatropin arm, but 1 subject withdrew consent before receiving the first dose of study drug.|106
6809126|NCT02781727|7741682|FG001|STARTED|Pre-dosing Period||56
6809127|NCT02781727|7741681|FG000|COMPLETED|Pre-dosing Period||105
6809128|NCT02781727|7741682|FG001|COMPLETED|Pre-dosing Period||56
6809129|NCT02781727|7741681|FG000|NOT COMPLETED|Pre-dosing Period||1
6809130|NCT02781727|7741682|FG001|NOT COMPLETED|Pre-dosing Period||0
6809131|NCT02781727|7741681|FG000|STARTED|Treatment Period||105
6809132|NCT02781727|7741682|FG001|STARTED|Treatment Period||56
6809133|NCT02781727|7741681|FG000|COMPLETED|Treatment Period||104
6809134|NCT02781727|7741682|FG001|COMPLETED|Treatment Period||55
6809135|NCT02781727|7741681|FG000|NOT COMPLETED|Treatment Period||1
6809136|NCT02781727|7741682|FG001|NOT COMPLETED|Treatment Period||1
6809137|NCT02778204|7741692|FG000|STARTED|Overall Study||8
6809138|NCT02778204|7741693|FG001|STARTED|Overall Study||7
6809139|NCT02778204|7741694|FG002|STARTED|Overall Study||16
6809140|NCT02778204|7741695|FG003|STARTED|Overall Study||16
6809141|NCT02778204|7741692|FG000|COMPLETED|Overall Study||6
6809142|NCT02778204|7741693|FG001|COMPLETED|Overall Study||7
6809143|NCT02778204|7741694|FG002|COMPLETED|Overall Study||12
6809144|NCT02778204|7741695|FG003|COMPLETED|Overall Study||12
6809145|NCT02778204|7741692|FG000|NOT COMPLETED|Overall Study||2
6809146|NCT02778204|7741693|FG001|NOT COMPLETED|Overall Study||0
6809147|NCT02778204|7741694|FG002|NOT COMPLETED|Overall Study||4
6809148|NCT02778204|7741695|FG003|NOT COMPLETED|Overall Study||4
6809149|NCT02743364|7741709|FG000|STARTED|Overall Study||6
6809150|NCT02743364|7741710|FG001|STARTED|Overall Study||2
6809151|NCT02743364|7741709|FG000|COMPLETED|Overall Study||6
6809152|NCT02743364|7741710|FG001|COMPLETED|Overall Study||2
6809153|NCT02743364|7741709|FG000|NOT COMPLETED|Overall Study||0
6809154|NCT02743364|7741710|FG001|NOT COMPLETED|Overall Study||0
6809155|NCT02496611|7741718|FG000|STARTED|Overall Study||33
6809156|NCT02496611|7741719|FG001|STARTED|Overall Study||33
6809157|NCT02496611|7741718|FG000|COMPLETED|Overall Study||26
6809158|NCT02496611|7741719|FG001|COMPLETED|Overall Study||30
6809159|NCT02496611|7741718|FG000|NOT COMPLETED|Overall Study||7
6809160|NCT02496611|7741719|FG001|NOT COMPLETED|Overall Study||3
6809161|NCT02245308|7741728|FG000|STARTED|Overall Study||63
6809162|NCT02245308|7741729|FG001|STARTED|Overall Study||64
6567204|NCT01830205|7490289|FG003|NOT COMPLETED|Overall Study||0
6567205|NCT01830543|7490313|FG000|STARTED|Overall Study||709
6567206|NCT01830543|7490314|FG001|STARTED|Overall Study||709
6567207|NCT01830543|7490315|FG002|STARTED|Overall Study||706
6567208|NCT01830543|7490313|FG000|Treated|Overall Study||696
6567209|NCT01830543|7490314|FG001|Treated|Overall Study||706
6567210|NCT01830543|7490315|FG002|Treated|Overall Study||697
6567211|NCT01830543|7490313|FG000|COMPLETED|Overall Study||550
6567212|NCT01830543|7490314|FG001|COMPLETED|Overall Study||557
6567213|NCT01830543|7490315|FG002|COMPLETED|Overall Study||492
6567214|NCT01830543|7490313|FG000|NOT COMPLETED|Overall Study||159
6567215|NCT01830543|7490314|FG001|NOT COMPLETED|Overall Study||152
6567216|NCT01830543|7490315|FG002|NOT COMPLETED|Overall Study||214
6623521|NCT02208050|7550677|FG000|COMPLETED|Baseline Assessment Period: 2 Weeks||36
6623522|NCT02208050|7550678|FG001|COMPLETED|Baseline Assessment Period: 2 Weeks||28
6623523|NCT02208050|7550677|FG000|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
6623524|NCT02208050|7550678|FG001|NOT COMPLETED|Baseline Assessment Period: 2 Weeks||0
6623525|NCT02208050|7550677|FG000|STARTED|Treatment Period 1: 8 Weeks Treatment||36
6623526|NCT02208050|7550678|FG001|STARTED|Treatment Period 1: 8 Weeks Treatment||28
6623527|NCT02208050|7550677|FG000|COMPLETED|Treatment Period 1: 8 Weeks Treatment||36
6623528|NCT02208050|7550678|FG001|COMPLETED|Treatment Period 1: 8 Weeks Treatment||28
6809163|NCT02245308|7741728|FG000|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|63
6809164|NCT02245308|7741729|FG001|COMPLETED|Overall Study|Using intent-to-treat analyses, i.e., missing=smoking|64
6809165|NCT02245308|7741728|FG000|NOT COMPLETED|Overall Study||0
6809166|NCT02245308|7741729|FG001|NOT COMPLETED|Overall Study||0
6809167|NCT02227199|7741738|FG000|STARTED|Overall Study||3
6809168|NCT02227199|7741739|FG001|STARTED|Overall Study||3
6809169|NCT02227199|7741740|FG002|STARTED|Overall Study||39
6809170|NCT02227199|7741738|FG000|COMPLETED|Overall Study||3
6809171|NCT02227199|7741739|FG001|COMPLETED|Overall Study||3
6809172|NCT02227199|7741740|FG002|COMPLETED|Overall Study||35
6809173|NCT02227199|7741738|FG000|NOT COMPLETED|Overall Study||0
6809174|NCT02227199|7741739|FG001|NOT COMPLETED|Overall Study||0
6809175|NCT02227199|7741740|FG002|NOT COMPLETED|Overall Study||4
6809176|NCT02177695|7741754|FG000|STARTED|ITT Analysis||120
6809177|NCT02177695|7741755|FG001|STARTED|ITT Analysis||117
6809178|NCT02177695|7741754|FG000|COMPLETED|ITT Analysis||115
6809179|NCT02177695|7741755|FG001|COMPLETED|ITT Analysis||112
6809180|NCT02177695|7741754|FG000|NOT COMPLETED|ITT Analysis||5
6809181|NCT02177695|7741755|FG001|NOT COMPLETED|ITT Analysis||5
6809182|NCT02177695|7741754|FG000|STARTED|Primary COXEN Analysis||115
6809183|NCT02177695|7741755|FG001|STARTED|Primary COXEN Analysis||112
6809184|NCT02177695|7741754|FG000|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||33
6809185|NCT02177695|7741755|FG001|Participants Excluded From Primary COXEN Analysis|Primary COXEN Analysis||27
6809186|NCT02177695|7741754|FG000|COMPLETED|Primary COXEN Analysis||82
6809187|NCT02177695|7741755|FG001|COMPLETED|Primary COXEN Analysis||85
6809188|NCT02177695|7741754|FG000|NOT COMPLETED|Primary COXEN Analysis||33
6809189|NCT02177695|7741755|FG001|NOT COMPLETED|Primary COXEN Analysis||27
6809190|NCT02145403|7741767|FG000|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
6809191|NCT02145403|7741768|FG001|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809192|NCT02145403|7741769|FG002|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809193|NCT02145403|7741770|FG003|STARTED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809194|NCT02145403|7741767|FG000|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||3
6809195|NCT02145403|7741768|FG001|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809196|NCT02145403|7741769|FG002|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809197|NCT02145403|7741770|FG003|COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809198|NCT02145403|7741767|FG000|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809199|NCT02145403|7741768|FG001|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809200|NCT02145403|7741769|FG002|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809201|NCT02145403|7741770|FG003|NOT COMPLETED|Phase I: Max Dose 20 mg/m^2 (Day 1-7)||0
6809202|NCT02145403|7741767|FG000|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809203|NCT02145403|7741768|FG001|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
6809204|NCT02145403|7741769|FG002|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809205|NCT02145403|7741770|FG003|STARTED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809206|NCT02145403|7741767|FG000|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809207|NCT02145403|7741768|FG001|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||3
6809208|NCT02145403|7741769|FG002|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809209|NCT02145403|7741770|FG003|COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809210|NCT02145403|7741767|FG000|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809211|NCT02145403|7741768|FG001|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809212|NCT02145403|7741769|FG002|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6623529|NCT02208050|7550677|FG000|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
6809213|NCT02145403|7741770|FG003|NOT COMPLETED|Phase I: Max Dose 27 mg/m^2 (Day 1-7)||0
6809214|NCT02145403|7741767|FG000|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809215|NCT02145403|7741768|FG001|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809216|NCT02145403|7741769|FG002|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||4
6809217|NCT02145403|7741770|FG003|STARTED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809218|NCT02145403|7741767|FG000|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809219|NCT02145403|7741768|FG001|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809220|NCT02145403|7741769|FG002|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||3
6809221|NCT02145403|7741770|FG003|COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809222|NCT02145403|7741767|FG000|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809223|NCT02145403|7741768|FG001|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809224|NCT02145403|7741769|FG002|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||1
6809225|NCT02145403|7741770|FG003|NOT COMPLETED|Phase I: Max Dose 36 mg/m^2 (Day 1-7)||0
6809226|NCT02145403|7741767|FG000|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809227|NCT02145403|7741768|FG001|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809228|NCT02145403|7741769|FG002|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809229|NCT02145403|7741770|FG003|STARTED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||4
6809230|NCT02145403|7741767|FG000|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809231|NCT02145403|7741768|FG001|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809232|NCT02145403|7741769|FG002|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809233|NCT02145403|7741770|FG003|COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
6809234|NCT02145403|7741767|FG000|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809235|NCT02145403|7741768|FG001|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809236|NCT02145403|7741769|FG002|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||0
6809237|NCT02145403|7741770|FG003|NOT COMPLETED|Phase I: Max Dose 45 mg/m^2 (Day 1-7)||2
6809238|NCT02145403|7741767|FG000|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809239|NCT02145403|7741768|FG001|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809240|NCT02145403|7741769|FG002|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||37
6390759|NCT00831844|7302521|FG005|COMPLETED|Overall Study||1
6390760|NCT00831844|7302522|FG006|COMPLETED|Overall Study||0
6390761|NCT00831844|7302523|FG007|COMPLETED|Overall Study||0
6390762|NCT00831844|7302524|FG008|COMPLETED|Overall Study||0
6390763|NCT00831844|7302525|FG009|COMPLETED|Overall Study||0
6390764|NCT00831844|7302516|FG000|NOT COMPLETED|Overall Study||10
6390765|NCT00831844|7302517|FG001|NOT COMPLETED|Overall Study||12
6390766|NCT00831844|7302518|FG002|NOT COMPLETED|Overall Study||20
6390767|NCT00831844|7302519|FG003|NOT COMPLETED|Overall Study||10
6390768|NCT00831844|7302520|FG004|NOT COMPLETED|Overall Study||14
6390769|NCT00831844|7302521|FG005|NOT COMPLETED|Overall Study||19
6390770|NCT00831844|7302522|FG006|NOT COMPLETED|Overall Study||10
6390771|NCT00831844|7302523|FG007|NOT COMPLETED|Overall Study||10
6390772|NCT00831844|7302524|FG008|NOT COMPLETED|Overall Study||9
6390773|NCT00831844|7302525|FG009|NOT COMPLETED|Overall Study||0
6390774|NCT00831987|7302549|FG000|STARTED|Overall Study||60
6390775|NCT00831987|7302550|FG001|STARTED|Overall Study||60
6390776|NCT00831987|7302549|FG000|COMPLETED|Overall Study||60
6390777|NCT00831987|7302550|FG001|COMPLETED|Overall Study||60
6390778|NCT00831987|7302549|FG000|NOT COMPLETED|Overall Study||0
6390779|NCT00831987|7302550|FG001|NOT COMPLETED|Overall Study||0
6390780|NCT00832000|7302556|FG000|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
6390781|NCT00832000|7302557|FG001|STARTED|Overall Study|Placebo|30
6390782|NCT00832000|7302556|FG000|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
6390783|NCT00832000|7302557|FG001|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
6390784|NCT00832000|7302556|FG000|COMPLETED|Overall Study||23
6390785|NCT00832000|7302557|FG001|COMPLETED|Overall Study||29
6390786|NCT00832000|7302556|FG000|NOT COMPLETED|Overall Study||6
6390787|NCT00832000|7302557|FG001|NOT COMPLETED|Overall Study||1
6390788|NCT00832078|7302592|FG000|STARTED|Test Day 1- 1 Period||13
6390789|NCT00832078|7302593|FG001|STARTED|Test Day 1- 1 Period||12
6390790|NCT00832078|7302592|FG000|COMPLETED|Test Day 1- 1 Period||13
6390791|NCT00832078|7302593|FG001|COMPLETED|Test Day 1- 1 Period||12
6390792|NCT00832078|7302592|FG000|NOT COMPLETED|Test Day 1- 1 Period||0
6390793|NCT00832078|7302593|FG001|NOT COMPLETED|Test Day 1- 1 Period||0
6390794|NCT00832078|7302592|FG000|STARTED|Test Day 1-2 Period||13
6390795|NCT00832078|7302593|FG001|STARTED|Test Day 1-2 Period||12
6390796|NCT00832078|7302592|FG000|COMPLETED|Test Day 1-2 Period||13
6390797|NCT00832078|7302593|FG001|COMPLETED|Test Day 1-2 Period||10
6809241|NCT02145403|7741770|FG003|STARTED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809242|NCT02145403|7741767|FG000|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809243|NCT02145403|7741768|FG001|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809244|NCT02145403|7741769|FG002|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||36
6809245|NCT02145403|7741770|FG003|COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809246|NCT02145403|7741767|FG000|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809247|NCT02145403|7741768|FG001|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809248|NCT02145403|7741769|FG002|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||1
6809249|NCT02145403|7741770|FG003|NOT COMPLETED|Phase II: Max Dose 36 mg/m^2 (Day 1-7)||0
6809250|NCT02105636|7741785|FG000|STARTED|Overall Study||236
6809251|NCT02105636|7741786|FG001|STARTED|Overall Study||111
6809252|NCT02105636|7741785|FG000|COMPLETED|Overall Study|Completed=Still on Treatment|41
6809253|NCT02105636|7741786|FG001|COMPLETED|Overall Study|Completed=Still on Treatment|3
6809254|NCT02105636|7741785|FG000|NOT COMPLETED|Overall Study||195
6809255|NCT02105636|7741786|FG001|NOT COMPLETED|Overall Study||108
6809256|NCT02038946|7741793|FG000|STARTED|Overall Study||92
6809257|NCT02038946|7741793|FG000|COMPLETED|Overall Study||80
6809258|NCT02038946|7741793|FG000|NOT COMPLETED|Overall Study||12
6809259|NCT01988571|7741799|FG000|STARTED|Overall Study||139
6809260|NCT01988571|7741800|FG001|STARTED|Overall Study||140
6809261|NCT01988571|7741799|FG000|Completed Baseline|Overall Study||136
6809262|NCT01988571|7741800|FG001|Completed Baseline|Overall Study||139
6809263|NCT01988571|7741799|FG000|Completed 6 Month Visit|Overall Study||122
6809264|NCT01988571|7741800|FG001|Completed 6 Month Visit|Overall Study||126
6809265|NCT01988571|7741799|FG000|COMPLETED|Overall Study||100
6809266|NCT01988571|7741800|FG001|COMPLETED|Overall Study||105
6809267|NCT01988571|7741799|FG000|NOT COMPLETED|Overall Study||39
6809268|NCT01988571|7741800|FG001|NOT COMPLETED|Overall Study||35
6809269|NCT01715285|7741808|FG000|STARTED|Treatment Period||597
6809270|NCT01715285|7741809|FG001|STARTED|Treatment Period||602
6809271|NCT01715285|7741810|FG002|STARTED|Treatment Period||0
6809272|NCT01715285|7741808|FG000|ITT Population|Treatment Period||597
6809273|NCT01715285|7741809|FG001|ITT Population|Treatment Period||602
6809274|NCT01715285|7741810|FG002|ITT Population|Treatment Period||0
6809275|NCT01715285|7741808|FG000|Safety Population|Treatment Period||597
6809276|NCT01715285|7741809|FG001|Safety Population|Treatment Period||602
6809277|NCT01715285|7741810|FG002|Safety Population|Treatment Period||0
6809278|NCT01715285|7741808|FG000|COMPLETED|Treatment Period||0
6809279|NCT01715285|7741809|FG001|COMPLETED|Treatment Period||0
6809280|NCT01715285|7741810|FG002|COMPLETED|Treatment Period||0
6809281|NCT01715285|7741808|FG000|NOT COMPLETED|Treatment Period||597
6809282|NCT01715285|7741809|FG001|NOT COMPLETED|Treatment Period||602
6809283|NCT01715285|7741810|FG002|NOT COMPLETED|Treatment Period||0
6809284|NCT01715285|7741808|FG000|STARTED|Open-label (OL) Extension Phase||157
6809285|NCT01715285|7741809|FG001|STARTED|Open-label (OL) Extension Phase||0
6809286|NCT01715285|7741810|FG002|STARTED|Open-label (OL) Extension Phase||72
6809287|NCT01715285|7741808|FG000|COMPLETED|Open-label (OL) Extension Phase||0
6809288|NCT01715285|7741809|FG001|COMPLETED|Open-label (OL) Extension Phase||0
6809289|NCT01715285|7741810|FG002|COMPLETED|Open-label (OL) Extension Phase||0
6809290|NCT01715285|7741808|FG000|NOT COMPLETED|Open-label (OL) Extension Phase||157
6809291|NCT01715285|7741809|FG001|NOT COMPLETED|Open-label (OL) Extension Phase||0
6809292|NCT01715285|7741810|FG002|NOT COMPLETED|Open-label (OL) Extension Phase||72
6809293|NCT01398852|7741817|FG000|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
6809294|NCT01398852|7741817|FG000|COMPLETED|Overall Study||0
6809295|NCT01398852|7741817|FG000|NOT COMPLETED|Overall Study||372
6809296|NCT01332266|7741826|FG000|STARTED|Phase 1b||4
6809297|NCT01332266|7741827|FG001|STARTED|Phase 1b||5
6809298|NCT01332266|7741828|FG002|STARTED|Phase 1b||3
6809299|NCT01332266|7741829|FG003|STARTED|Phase 1b||0
6809300|NCT01332266|7741830|FG004|STARTED|Phase 1b||0
6809301|NCT01332266|7741826|FG000|COMPLETED|Phase 1b||0
6809302|NCT01332266|7741827|FG001|COMPLETED|Phase 1b||0
6809303|NCT01332266|7741828|FG002|COMPLETED|Phase 1b||0
6809304|NCT01332266|7741829|FG003|COMPLETED|Phase 1b||0
6809305|NCT01332266|7741830|FG004|COMPLETED|Phase 1b||0
6809306|NCT01332266|7741826|FG000|NOT COMPLETED|Phase 1b||4
6809307|NCT01332266|7741827|FG001|NOT COMPLETED|Phase 1b||5
6809308|NCT01332266|7741828|FG002|NOT COMPLETED|Phase 1b||3
6809309|NCT01332266|7741829|FG003|NOT COMPLETED|Phase 1b||0
6809310|NCT01332266|7741830|FG004|NOT COMPLETED|Phase 1b||0
6809311|NCT01332266|7741826|FG000|STARTED|Phase 2||0
6809312|NCT01332266|7741827|FG001|STARTED|Phase 2||0
6809313|NCT01332266|7741828|FG002|STARTED|Phase 2||0
6809314|NCT01332266|7741829|FG003|STARTED|Phase 2||42
6809315|NCT01332266|7741830|FG004|STARTED|Phase 2||41
6809316|NCT01332266|7741826|FG000|COMPLETED|Phase 2||0
6809317|NCT01332266|7741827|FG001|COMPLETED|Phase 2||0
6809318|NCT01332266|7741828|FG002|COMPLETED|Phase 2||0
6809319|NCT01332266|7741829|FG003|COMPLETED|Phase 2||0
6809320|NCT01332266|7741830|FG004|COMPLETED|Phase 2||0
6809321|NCT01332266|7741826|FG000|NOT COMPLETED|Phase 2||0
6809322|NCT01332266|7741827|FG001|NOT COMPLETED|Phase 2||0
6809323|NCT01332266|7741828|FG002|NOT COMPLETED|Phase 2||0
6809324|NCT01332266|7741829|FG003|NOT COMPLETED|Phase 2||42
6809325|NCT01332266|7741830|FG004|NOT COMPLETED|Phase 2||41
6809326|NCT01150890|7741847|FG000|STARTED|Overall Study||32
6809327|NCT01150890|7741848|FG001|STARTED|Overall Study||32
6809328|NCT01150890|7741849|FG002|STARTED|Overall Study||33
6809329|NCT01150890|7741850|FG003|STARTED|Overall Study||33
6809330|NCT01150890|7741847|FG000|Received Study Drug|Overall Study||32
6809331|NCT01150890|7741848|FG001|Received Study Drug|Overall Study||31
6809332|NCT01150890|7741849|FG002|Received Study Drug|Overall Study||32
6809333|NCT01150890|7741850|FG003|Received Study Drug|Overall Study||33
6809334|NCT01150890|7741847|FG000|COMPLETED|Overall Study||28
6809335|NCT01150890|7741848|FG001|COMPLETED|Overall Study||19
6809336|NCT01150890|7741849|FG002|COMPLETED|Overall Study||21
6809337|NCT01150890|7741850|FG003|COMPLETED|Overall Study||16
6809338|NCT01150890|7741847|FG000|NOT COMPLETED|Overall Study||4
6809339|NCT01150890|7741848|FG001|NOT COMPLETED|Overall Study||13
6809340|NCT01150890|7741849|FG002|NOT COMPLETED|Overall Study||12
6809341|NCT01150890|7741850|FG003|NOT COMPLETED|Overall Study||17
6809342|NCT01140867|7741863|FG000|STARTED|Overall Study||121
6809343|NCT01140867|7741863|FG000|COMPLETED|Overall Study||88
6809344|NCT01140867|7741863|FG000|NOT COMPLETED|Overall Study||33
6809345|NCT01137773|7741869|FG000|STARTED|Overall Study||33
6809346|NCT01137773|7741870|FG001|STARTED|Overall Study||23
6809347|NCT01137773|7741869|FG000|COMPLETED|Overall Study||24
6809348|NCT01137773|7741870|FG001|COMPLETED|Overall Study||20
6809349|NCT01137773|7741869|FG000|NOT COMPLETED|Overall Study||9
6809350|NCT01137773|7741870|FG001|NOT COMPLETED|Overall Study||3
6809351|NCT01127256|7741880|FG000|STARTED|Overall Study||96
6809352|NCT01127256|7741881|FG001|STARTED|Overall Study||104
6809353|NCT01127256|7741880|FG000|COMPLETED|Overall Study||57
6809354|NCT01127256|7741881|FG001|COMPLETED|Overall Study||65
6809355|NCT01127256|7741880|FG000|NOT COMPLETED|Overall Study||39
6809356|NCT01127256|7741881|FG001|NOT COMPLETED|Overall Study||39
6809357|NCT01004861|7741900|FG000|STARTED|Overall Study||3
6809358|NCT01004861|7741901|FG001|STARTED|Overall Study||6
6809359|NCT01004861|7741902|FG002|STARTED|Overall Study||6
6809360|NCT01004861|7741903|FG003|STARTED|Overall Study||6
6809361|NCT01004861|7741904|FG004|STARTED|Overall Study||7
6809362|NCT01004861|7741905|FG005|STARTED|Overall Study||6
6809363|NCT01004861|7741906|FG006|STARTED|Overall Study||7
6809364|NCT01004861|7741907|FG007|STARTED|Overall Study||4
6809365|NCT01004861|7741908|FG008|STARTED|Overall Study||39
6809366|NCT01004861|7741909|FG009|STARTED|Overall Study||11
6809367|NCT01004861|7741910|FG010|STARTED|Overall Study||9
6809368|NCT01004861|7741911|FG011|STARTED|Overall Study||8
6809369|NCT01004861|7741912|FG012|STARTED|Overall Study||20
6809370|NCT01004861|7741900|FG000|COMPLETED|Overall Study||0
6809371|NCT01004861|7741901|FG001|COMPLETED|Overall Study||0
6809372|NCT01004861|7741902|FG002|COMPLETED|Overall Study||0
6809373|NCT01004861|7741903|FG003|COMPLETED|Overall Study||0
6809374|NCT01004861|7741904|FG004|COMPLETED|Overall Study||0
6809375|NCT01004861|7741905|FG005|COMPLETED|Overall Study||0
6809376|NCT01004861|7741906|FG006|COMPLETED|Overall Study||0
6809377|NCT01004861|7741907|FG007|COMPLETED|Overall Study||0
6809378|NCT01004861|7741908|FG008|COMPLETED|Overall Study||0
6809379|NCT01004861|7741909|FG009|COMPLETED|Overall Study||0
6809380|NCT01004861|7741910|FG010|COMPLETED|Overall Study||0
6809381|NCT01004861|7741911|FG011|COMPLETED|Overall Study||0
6809382|NCT01004861|7741912|FG012|COMPLETED|Overall Study||0
6809383|NCT01004861|7741900|FG000|NOT COMPLETED|Overall Study||3
6809384|NCT01004861|7741901|FG001|NOT COMPLETED|Overall Study||6
6809385|NCT01004861|7741902|FG002|NOT COMPLETED|Overall Study||6
6809386|NCT01004861|7741903|FG003|NOT COMPLETED|Overall Study||6
6809387|NCT01004861|7741904|FG004|NOT COMPLETED|Overall Study||7
6809388|NCT01004861|7741905|FG005|NOT COMPLETED|Overall Study||6
6809389|NCT01004861|7741906|FG006|NOT COMPLETED|Overall Study||7
6809390|NCT01004861|7741907|FG007|NOT COMPLETED|Overall Study||4
6809391|NCT01004861|7741908|FG008|NOT COMPLETED|Overall Study||39
6809392|NCT01004861|7741909|FG009|NOT COMPLETED|Overall Study||11
6809393|NCT01004861|7741910|FG010|NOT COMPLETED|Overall Study||9
6809394|NCT01004861|7741911|FG011|NOT COMPLETED|Overall Study||8
6809395|NCT01004861|7741912|FG012|NOT COMPLETED|Overall Study||20
6809396|NCT00912223|7741944|FG000|STARTED|Overall Study||65
6809397|NCT00912223|7741944|FG000|COMPLETED|Overall Study||62
6809398|NCT00912223|7741944|FG000|NOT COMPLETED|Overall Study||3
6809399|NCT00381381|7741948|FG000|STARTED|Overall Study||199
6809400|NCT00381381|7741948|FG000|COMPLETED|Overall Study||135
6809401|NCT00381381|7741948|FG000|NOT COMPLETED|Overall Study||64
6809402|NCT00038675|7741952|FG000|STARTED|Overall Study||125
6809403|NCT00038675|7741952|FG000|COMPLETED|Overall Study||125
6809404|NCT00038675|7741952|FG000|NOT COMPLETED|Overall Study||0
6567217|NCT01830595|7490323|FG000|STARTED|First Period||26
6567218|NCT01830595|7490324|FG001|STARTED|First Period||28
6567219|NCT01830595|7490323|FG000|Received at Least One Dose|First Period||26
6567220|NCT01830595|7490324|FG001|Received at Least One Dose|First Period||28
6567221|NCT01830595|7490323|FG000|COMPLETED|First Period||25
6567222|NCT01830595|7490324|FG001|COMPLETED|First Period||25
6567223|NCT01830595|7490323|FG000|NOT COMPLETED|First Period||1
6567224|NCT01830595|7490324|FG001|NOT COMPLETED|First Period||3
6567225|NCT01830595|7490323|FG000|STARTED|Washout||25
6567226|NCT01830595|7490324|FG001|STARTED|Washout||25
6567227|NCT01830595|7490323|FG000|COMPLETED|Washout||23
6567228|NCT01830595|7490324|FG001|COMPLETED|Washout||23
6567229|NCT01830595|7490323|FG000|NOT COMPLETED|Washout||2
6567230|NCT01830595|7490324|FG001|NOT COMPLETED|Washout||2
6567231|NCT01830595|7490323|FG000|STARTED|Second Period||23
6567232|NCT01830595|7490324|FG001|STARTED|Second Period||23
6567233|NCT01830595|7490323|FG000|COMPLETED|Second Period||23
6567234|NCT01830595|7490324|FG001|COMPLETED|Second Period||23
6567235|NCT01830595|7490323|FG000|NOT COMPLETED|Second Period||0
6567236|NCT01830595|7490324|FG001|NOT COMPLETED|Second Period||0
6567237|NCT01830621|7490332|FG000|STARTED|Overall Study||138
6567238|NCT01830621|7490333|FG001|STARTED|Overall Study||144
6567239|NCT01830621|7490332|FG000|COMPLETED|Overall Study||138
6567240|NCT01830621|7490333|FG001|COMPLETED|Overall Study||144
6567241|NCT01830621|7490332|FG000|NOT COMPLETED|Overall Study||0
6567242|NCT01830621|7490333|FG001|NOT COMPLETED|Overall Study||0
6567243|NCT01830699|7490341|FG000|STARTED|Overall Study||13
6567244|NCT01830699|7490342|FG001|STARTED|Overall Study||20
6567245|NCT01830699|7490341|FG000|COMPLETED|Overall Study||13
6809405|NCT04957498|7741958|FG000|STARTED|Overall Study||20
6809406|NCT04957498|7741959|FG001|STARTED|Overall Study||20
6809407|NCT04957498|7741958|FG000|COMPLETED|Overall Study||19
6809408|NCT04957498|7741959|FG001|COMPLETED|Overall Study||18
6809409|NCT04957498|7741958|FG000|NOT COMPLETED|Overall Study||1
6809410|NCT04957498|7741959|FG001|NOT COMPLETED|Overall Study||2
6809411|NCT04706403|7741972|FG000|STARTED|Overall Study||172
6809412|NCT04706403|7741973|FG001|STARTED|Overall Study||121
6809413|NCT04706403|7741974|FG002|STARTED|Overall Study||165
6809414|NCT04706403|7741975|FG003|STARTED|Overall Study||146
6809415|NCT04706403|7741976|FG004|STARTED|Overall Study||152
6809416|NCT04706403|7741972|FG000|COMPLETED|Overall Study||172
6567246|NCT01830699|7490342|FG001|COMPLETED|Overall Study||20
6567247|NCT01830699|7490341|FG000|NOT COMPLETED|Overall Study||0
6567248|NCT01830699|7490342|FG001|NOT COMPLETED|Overall Study||0
6567249|NCT01830816|7490351|FG000|STARTED|Overall Study||20
6567250|NCT01830816|7490352|FG001|STARTED|Overall Study||14
6567251|NCT01830816|7490353|FG002|STARTED|Overall Study||7
6567252|NCT01830816|7490351|FG000|Pharmacokinetic-Evaluable Population|Overall Study|Participants are considered to have completed study treatment if they are PK evaluable.|18
6567253|NCT01830816|7490352|FG001|Pharmacokinetic-Evaluable Population|Overall Study||14
6567254|NCT01830816|7490353|FG002|Pharmacokinetic-Evaluable Population|Overall Study||6
6567255|NCT01830816|7490351|FG000|COMPLETED|Overall Study||0
6567256|NCT01830816|7490352|FG001|COMPLETED|Overall Study||0
6567257|NCT01830816|7490353|FG002|COMPLETED|Overall Study||0
6567258|NCT01830816|7490351|FG000|NOT COMPLETED|Overall Study||20
6567259|NCT01830816|7490352|FG001|NOT COMPLETED|Overall Study||14
6567260|NCT01830816|7490353|FG002|NOT COMPLETED|Overall Study||7
6567261|NCT01830842|7490366|FG000|STARTED|Overall Study||30
6567262|NCT01830842|7490367|FG001|STARTED|Overall Study||24
6567263|NCT01830842|7490366|FG000|COMPLETED|Overall Study||25
6567264|NCT01830842|7490367|FG001|COMPLETED|Overall Study||22
6567265|NCT01830842|7490366|FG000|NOT COMPLETED|Overall Study||5
6567266|NCT01830842|7490367|FG001|NOT COMPLETED|Overall Study||2
6567267|NCT01830855|7490377|FG000|STARTED|Overall Study||1508
6567268|NCT01830855|7490378|FG001|STARTED|Overall Study||598
6567269|NCT01830855|7490379|FG002|STARTED|Overall Study||587
6809417|NCT04706403|7741973|FG001|COMPLETED|Overall Study||121
6809418|NCT04706403|7741974|FG002|COMPLETED|Overall Study||164
6809419|NCT04706403|7741975|FG003|COMPLETED|Overall Study||145
6809420|NCT04706403|7741976|FG004|COMPLETED|Overall Study||150
6809421|NCT04706403|7741972|FG000|NOT COMPLETED|Overall Study||0
6809422|NCT04706403|7741973|FG001|NOT COMPLETED|Overall Study||0
6809423|NCT04706403|7741974|FG002|NOT COMPLETED|Overall Study||1
6809424|NCT04706403|7741975|FG003|NOT COMPLETED|Overall Study||1
6809425|NCT04706403|7741976|FG004|NOT COMPLETED|Overall Study||2
6809426|NCT04389333|7741990|FG000|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and underwent non-contract MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
6809427|NCT04389333|7741991|FG001|STARTED|Overall Study|From March 26th to April 26th, 2020, 20 patients were enrolled and accept MCE in Changhai hpospital and the first medical center of PLA general hospital.|20
6809428|NCT04389333|7741990|FG000|COMPLETED|Overall Study||20
6809429|NCT04389333|7741991|FG001|COMPLETED|Overall Study||20
6809430|NCT04389333|7741990|FG000|NOT COMPLETED|Overall Study||0
6809431|NCT04389333|7741991|FG001|NOT COMPLETED|Overall Study||0
6809432|NCT03712124|7742000|FG000|STARTED|Overall Study||10
6809433|NCT03712124|7742001|FG001|STARTED|Overall Study||11
6809434|NCT03712124|7742000|FG000|Received at Least 1 Dose of Study Drug|Overall Study||10
6809435|NCT03712124|7742001|FG001|Received at Least 1 Dose of Study Drug|Overall Study||11
6809436|NCT03712124|7742000|FG000|COMPLETED|Overall Study||9
6809437|NCT03712124|7742001|FG001|COMPLETED|Overall Study||11
6809438|NCT03712124|7742000|FG000|NOT COMPLETED|Overall Study||1
6809439|NCT03712124|7742001|FG001|NOT COMPLETED|Overall Study||0
6809440|NCT03689582|7742007|FG000|STARTED|Overall Study||11
6809441|NCT03689582|7742007|FG000|COMPLETED|Overall Study||11
6809442|NCT03689582|7742007|FG000|NOT COMPLETED|Overall Study||0
6809443|NCT03535740|7742013|FG000|STARTED|Overall Study||103
6809444|NCT03535740|7742013|FG000|Participants Who Received Escalated Dose of Brigatinib 240 mg|Overall Study||13
6809445|NCT03535740|7742013|FG000|COMPLETED|Overall Study||0
6809446|NCT03535740|7742013|FG000|NOT COMPLETED|Overall Study||103
6809447|NCT03503318|7742021|FG000|STARTED|Overall Study||181
6567270|NCT01830855|7490380|FG003|STARTED|Overall Study||897
6567271|NCT01830855|7490377|FG000|COMPLETED|Overall Study||1353
6567272|NCT01830855|7490378|FG001|COMPLETED|Overall Study||537
6567273|NCT01830855|7490379|FG002|COMPLETED|Overall Study||521
6567274|NCT01830855|7490380|FG003|COMPLETED|Overall Study||815
6567275|NCT01830855|7490377|FG000|NOT COMPLETED|Overall Study||155
6656947|NCT02465866|7587325|FG002|COMPLETED|Period 1||5
6656948|NCT02465866|7587326|FG003|COMPLETED|Period 1||5
6656949|NCT02465866|7587323|FG000|NOT COMPLETED|Period 1||0
6656950|NCT02465866|7587324|FG001|NOT COMPLETED|Period 1||0
6656951|NCT02465866|7587325|FG002|NOT COMPLETED|Period 1||0
6656952|NCT02465866|7587326|FG003|NOT COMPLETED|Period 1||0
6656953|NCT02465866|7587323|FG000|STARTED|Period 1: Washout (14 Days)||5
6656954|NCT02465866|7587324|FG001|STARTED|Period 1: Washout (14 Days)||5
6656955|NCT02465866|7587325|FG002|STARTED|Period 1: Washout (14 Days)||5
6656956|NCT02465866|7587326|FG003|STARTED|Period 1: Washout (14 Days)||5
6656957|NCT02465866|7587323|FG000|COMPLETED|Period 1: Washout (14 Days)||5
6656958|NCT02465866|7587324|FG001|COMPLETED|Period 1: Washout (14 Days)||5
6809448|NCT03503318|7742022|FG001|STARTED|Overall Study||183
6809449|NCT03503318|7742023|FG002|STARTED|Overall Study||180
6809450|NCT03503318|7742021|FG000|Received at Least 1 Dose of Study Drug|Overall Study||179
6809451|NCT03503318|7742022|FG001|Received at Least 1 Dose of Study Drug|Overall Study||183
6809452|NCT03503318|7742023|FG002|Received at Least 1 Dose of Study Drug|Overall Study||180
6809453|NCT03503318|7742021|FG000|COMPLETED|Overall Study||142
6809454|NCT03503318|7742022|FG001|COMPLETED|Overall Study||144
6809455|NCT03503318|7742023|FG002|COMPLETED|Overall Study||140
6809456|NCT03503318|7742021|FG000|NOT COMPLETED|Overall Study||39
6809457|NCT03503318|7742022|FG001|NOT COMPLETED|Overall Study||39
6809458|NCT03503318|7742023|FG002|NOT COMPLETED|Overall Study||40
6809459|NCT02986789|7742033|FG000|STARTED|Overall Study||43
6809460|NCT02986789|7742034|FG001|STARTED|Overall Study||0
6809461|NCT02986789|7742033|FG000|COMPLETED|Overall Study||43
6809462|NCT02986789|7742034|FG001|COMPLETED|Overall Study||0
6809463|NCT02986789|7742033|FG000|NOT COMPLETED|Overall Study||0
6809464|NCT02986789|7742034|FG001|NOT COMPLETED|Overall Study||0
6809465|NCT02974907|7742042|FG000|STARTED|Overall Study||299
6809466|NCT02974907|7742043|FG001|STARTED|Overall Study||302
6809467|NCT02974907|7742042|FG000|COMPLETED|Overall Study||286
6809468|NCT02974907|7742043|FG001|COMPLETED|Overall Study||292
6809469|NCT02974907|7742042|FG000|NOT COMPLETED|Overall Study||13
6809470|NCT02974907|7742043|FG001|NOT COMPLETED|Overall Study||10
6809471|NCT02921789|7742051|FG000|STARTED|Overall Study||34
6809472|NCT02921789|7742052|FG001|STARTED|Overall Study||29
6809473|NCT02921789|7742051|FG000|Randomized and Took Study Drug|Overall Study||34
6809474|NCT02921789|7742052|FG001|Randomized and Took Study Drug|Overall Study||29
6809475|NCT02921789|7742051|FG000|COMPLETED|Overall Study||26
6809476|NCT02921789|7742052|FG001|COMPLETED|Overall Study||25
6809477|NCT02921789|7742051|FG000|NOT COMPLETED|Overall Study||8
6809478|NCT02921789|7742052|FG001|NOT COMPLETED|Overall Study||4
6809479|NCT02918500|7742060|FG000|STARTED|Overall Study||2
6809480|NCT02918500|7742061|FG001|STARTED|Overall Study||2
6809481|NCT02918500|7742060|FG000|COMPLETED|Overall Study||2
6809482|NCT02918500|7742061|FG001|COMPLETED|Overall Study||2
6809483|NCT02918500|7742060|FG000|NOT COMPLETED|Overall Study||0
6809484|NCT02918500|7742061|FG001|NOT COMPLETED|Overall Study||0
6390798|NCT00832078|7302592|FG000|NOT COMPLETED|Test Day 1-2 Period||0
6809485|NCT02896257|7742072|FG000|STARTED|Providers||88
6809486|NCT02896257|7742073|FG001|STARTED|Providers||93
6809487|NCT02896257|7742072|FG000|PCPs Assigned to 1 Primary Care Team|Providers||68
6809488|NCT02896257|7742073|FG001|PCPs Assigned to 1 Primary Care Team|Providers||79
6809489|NCT02896257|7742072|FG000|PCPs Assigned to Two Primary Care Teams|Providers||18
6809490|NCT02896257|7742073|FG001|PCPs Assigned to Two Primary Care Teams|Providers||12
6809491|NCT02896257|7742072|FG000|PCPs Assigned to 3 Primary Care Teams|Providers||1
6809492|NCT02896257|7742073|FG001|PCPs Assigned to 3 Primary Care Teams|Providers||2
6809493|NCT02896257|7742072|FG000|PCPs Assigned to Four Primary Care Teams|Providers||1
6809494|NCT02896257|7742073|FG001|PCPs Assigned to Four Primary Care Teams|Providers||0
6809495|NCT02896257|7742072|FG000|COMPLETED|Providers||67
6809496|NCT02896257|7742073|FG001|COMPLETED|Providers||65
6809497|NCT02896257|7742072|FG000|NOT COMPLETED|Providers||21
6809498|NCT02896257|7742073|FG001|NOT COMPLETED|Providers||28
6809499|NCT02896257|7742072|FG000|STARTED|Patients|Eligible patient participants assigned to a usual care PCP=344|344
6809500|NCT02896257|7742073|FG001|STARTED|Patients|Eligible patient participants assigned to an intervention PCP=342|342
6809501|NCT02896257|7742072|FG000|COMPLETED|Patients|Patients with an eligible primary care appointment with a usual care PCP who were assigned an index date=281|281
6809502|NCT02896257|7742073|FG001|COMPLETED|Patients|Patients with an eligible primary care appointment with an intervention PCP who were assigned an index date=269|269
6809503|NCT02896257|7742072|FG000|NOT COMPLETED|Patients||63
6809504|NCT02896257|7742073|FG001|NOT COMPLETED|Patients||73
6809505|NCT02774265|7742082|FG000|STARTED|Overall Study||164
6809506|NCT02774265|7742083|FG001|STARTED|Overall Study||165
6809507|NCT02774265|7742082|FG000|COMPLETED|Overall Study||151
6809508|NCT02774265|7742083|FG001|COMPLETED|Overall Study||159
6809509|NCT02774265|7742082|FG000|NOT COMPLETED|Overall Study||13
6809510|NCT02774265|7742083|FG001|NOT COMPLETED|Overall Study||6
6809511|NCT02736617|7742089|FG000|STARTED|Treatment||10
6809512|NCT02736617|7742089|FG000|COMPLETED|Treatment||7
6809513|NCT02736617|7742089|FG000|NOT COMPLETED|Treatment||3
6809514|NCT02736617|7742089|FG000|STARTED|Maintenance||7
6809515|NCT02736617|7742089|FG000|COMPLETED|Maintenance||2
6809516|NCT02736617|7742089|FG000|NOT COMPLETED|Maintenance||5
6809517|NCT02652468|7742094|FG000|STARTED|Overall Study||11
6809518|NCT02652468|7742094|FG000|COMPLETED|Overall Study||11
6809519|NCT02652468|7742094|FG000|NOT COMPLETED|Overall Study||0
6809520|NCT02579265|7742100|FG000|STARTED|Overall Study||83
6275732|NCT00114738|7174971|FG000|STARTED|Bortezomib Then Bortezomib + Induction||53
6275733|NCT00114738|7174972|FG001|STARTED|Bortezomib Then Bortezomib + Induction||0
6275734|NCT00114738|7174973|FG002|STARTED|Bortezomib Then Bortezomib + Induction||0
6275735|NCT00114738|7174971|FG000|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||47
6275736|NCT00114738|7174972|FG001|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
6275737|NCT00114738|7174973|FG002|Started With Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
6275738|NCT00114738|7174971|FG000|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||6
6275739|NCT00114738|7174972|FG001|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
6275740|NCT00114738|7174973|FG002|Skipped Bortezomib Alone|Bortezomib Then Bortezomib + Induction||0
6275741|NCT00114738|7174971|FG000|COMPLETED|Bortezomib Then Bortezomib + Induction||51
6275742|NCT00114738|7174972|FG001|COMPLETED|Bortezomib Then Bortezomib + Induction||0
6275743|NCT00114738|7174973|FG002|COMPLETED|Bortezomib Then Bortezomib + Induction||0
6275744|NCT00114738|7174971|FG000|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||2
6275745|NCT00114738|7174972|FG001|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
6275746|NCT00114738|7174973|FG002|NOT COMPLETED|Bortezomib Then Bortezomib + Induction||0
6275747|NCT00114738|7174971|FG000|STARTED|Screening for Randomization||51
6275748|NCT00114738|7174972|FG001|STARTED|Screening for Randomization||0
6275749|NCT00114738|7174973|FG002|STARTED|Screening for Randomization||0
6275750|NCT00114738|7174971|FG000|COMPLETED|Screening for Randomization||30
6275751|NCT00114738|7174972|FG001|COMPLETED|Screening for Randomization||0
6275752|NCT00114738|7174973|FG002|COMPLETED|Screening for Randomization||0
6275753|NCT00114738|7174971|FG000|NOT COMPLETED|Screening for Randomization||21
6275754|NCT00114738|7174972|FG001|NOT COMPLETED|Screening for Randomization||0
6275755|NCT00114738|7174973|FG002|NOT COMPLETED|Screening for Randomization||0
6275756|NCT00114738|7174971|FG000|STARTED|Randomization||0
6275757|NCT00114738|7174972|FG001|STARTED|Randomization||14
6275758|NCT00114738|7174973|FG002|STARTED|Randomization||16
6275759|NCT00114738|7174971|FG000|COMPLETED|Randomization||0
6275760|NCT00114738|7174972|FG001|COMPLETED|Randomization||14
6275761|NCT00114738|7174973|FG002|COMPLETED|Randomization||16
6275762|NCT00114738|7174971|FG000|NOT COMPLETED|Randomization||0
6275763|NCT00114738|7174972|FG001|NOT COMPLETED|Randomization||0
6275764|NCT00114738|7174973|FG002|NOT COMPLETED|Randomization||0
6275765|NCT00114777|7174983|FG000|STARTED|Randomization to Month 36||184
6275766|NCT00114777|7174984|FG001|STARTED|Randomization to Month 36||175
6275767|NCT00114777|7174985|FG002|STARTED|Randomization to Month 36||184
6275768|NCT00114777|7174983|FG000|COMPLETED|Randomization to Month 36||109
6809521|NCT02579265|7742101|FG001|STARTED|Overall Study||78
6809522|NCT02579265|7742100|FG000|COMPLETED|Overall Study||33
6809523|NCT02579265|7742101|FG001|COMPLETED|Overall Study||33
6809524|NCT02579265|7742100|FG000|NOT COMPLETED|Overall Study||50
6809525|NCT02579265|7742101|FG001|NOT COMPLETED|Overall Study||45
6809526|NCT02013167|7742109|FG000|STARTED|Overall Study||134
6809527|NCT02013167|7742110|FG001|STARTED|Overall Study||271
6809528|NCT02013167|7742109|FG000|Received Treatment|Overall Study||109
6809529|NCT02013167|7742110|FG001|Received Treatment|Overall Study||267
6809530|NCT02013167|7742109|FG000|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
6809531|NCT02013167|7742110|FG001|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
6809532|NCT02013167|7742109|FG000|NOT COMPLETED|Overall Study||101
6809533|NCT02013167|7742110|FG001|NOT COMPLETED|Overall Study||178
6809534|NCT02004522|7742119|FG000|STARTED|Overall Study||160
6809535|NCT02004522|7742120|FG001|STARTED|Overall Study||159
6809536|NCT02004522|7742119|FG000|Number of Subjects Treated|Overall Study||158
6809537|NCT02004522|7742120|FG001|Number of Subjects Treated|Overall Study||155
6809538|NCT02004522|7742119|FG000|COMPLETED|Overall Study|Completed defined here as still on treatment.|34
6809539|NCT02004522|7742120|FG001|COMPLETED|Overall Study|Completed defined here as still on treatment.|0
6809540|NCT02004522|7742119|FG000|NOT COMPLETED|Overall Study||126
6809541|NCT02004522|7742120|FG001|NOT COMPLETED|Overall Study||159
6809542|NCT02000427|7742126|FG000|STARTED|Overall Study||45
6809543|NCT02000427|7742126|FG000|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
6809544|NCT02000427|7742126|FG000|NOT COMPLETED|Overall Study||22
6809545|NCT01981850|7742137|FG000|STARTED|Main Phase Stage 1||8
6809546|NCT01981850|7742138|FG001|STARTED|Main Phase Stage 1||7
6809547|NCT01981850|7742139|FG002|STARTED|Main Phase Stage 1||6
6809548|NCT01981850|7742140|FG003|STARTED|Main Phase Stage 1||6
6809549|NCT01981850|7742141|FG004|STARTED|Main Phase Stage 1||0
6809550|NCT01981850|7742142|FG005|STARTED|Main Phase Stage 1||0
6809551|NCT01981850|7742143|FG006|STARTED|Main Phase Stage 1||0
6809552|NCT01981850|7742144|FG007|STARTED|Main Phase Stage 1||0
6809553|NCT01981850|7742145|FG008|STARTED|Main Phase Stage 1||0
6809554|NCT01981850|7742146|FG009|STARTED|Main Phase Stage 1||0
6809555|NCT01981850|7742137|FG000|COMPLETED|Main Phase Stage 1||5
6809556|NCT01981850|7742138|FG001|COMPLETED|Main Phase Stage 1||5
6809557|NCT01981850|7742139|FG002|COMPLETED|Main Phase Stage 1||4
6809558|NCT01981850|7742140|FG003|COMPLETED|Main Phase Stage 1||6
6809559|NCT01981850|7742141|FG004|COMPLETED|Main Phase Stage 1||0
6809560|NCT01981850|7742142|FG005|COMPLETED|Main Phase Stage 1||0
6809561|NCT01981850|7742143|FG006|COMPLETED|Main Phase Stage 1||0
6809562|NCT01981850|7742144|FG007|COMPLETED|Main Phase Stage 1||0
6809563|NCT01981850|7742145|FG008|COMPLETED|Main Phase Stage 1||0
6809564|NCT01981850|7742146|FG009|COMPLETED|Main Phase Stage 1||0
6809565|NCT01981850|7742137|FG000|NOT COMPLETED|Main Phase Stage 1||3
6809566|NCT01981850|7742138|FG001|NOT COMPLETED|Main Phase Stage 1||2
6809567|NCT01981850|7742139|FG002|NOT COMPLETED|Main Phase Stage 1||2
6809568|NCT01981850|7742140|FG003|NOT COMPLETED|Main Phase Stage 1||0
6809569|NCT01981850|7742141|FG004|NOT COMPLETED|Main Phase Stage 1||0
6809570|NCT01981850|7742142|FG005|NOT COMPLETED|Main Phase Stage 1||0
6809571|NCT01981850|7742143|FG006|NOT COMPLETED|Main Phase Stage 1||0
6809572|NCT01981850|7742144|FG007|NOT COMPLETED|Main Phase Stage 1||0
6809573|NCT01981850|7742145|FG008|NOT COMPLETED|Main Phase Stage 1||0
6809574|NCT01981850|7742146|FG009|NOT COMPLETED|Main Phase Stage 1||0
6809575|NCT01981850|7742137|FG000|STARTED|Main Phase Stage 2||0
6809576|NCT01981850|7742138|FG001|STARTED|Main Phase Stage 2||0
6809577|NCT01981850|7742139|FG002|STARTED|Main Phase Stage 2||0
6809578|NCT01981850|7742140|FG003|STARTED|Main Phase Stage 2||0
6809579|NCT01981850|7742141|FG004|STARTED|Main Phase Stage 2||33
6390799|NCT00832078|7302593|FG001|NOT COMPLETED|Test Day 1-2 Period||2
6390800|NCT00832078|7302592|FG000|STARTED|Test Day 2 - 1 Period||13
6390801|NCT00832078|7302593|FG001|STARTED|Test Day 2 - 1 Period||10
6390802|NCT00832078|7302592|FG000|COMPLETED|Test Day 2 - 1 Period||13
6390803|NCT00832078|7302593|FG001|COMPLETED|Test Day 2 - 1 Period||10
6390804|NCT00832078|7302592|FG000|NOT COMPLETED|Test Day 2 - 1 Period||0
6390805|NCT00832078|7302593|FG001|NOT COMPLETED|Test Day 2 - 1 Period||0
6390806|NCT00832078|7302592|FG000|STARTED|Test Day 2 - 2 Period||13
6809580|NCT01981850|7742142|FG005|STARTED|Main Phase Stage 2||32
6809581|NCT01981850|7742143|FG006|STARTED|Main Phase Stage 2||32
6809582|NCT01981850|7742144|FG007|STARTED|Main Phase Stage 2||0
6809583|NCT01981850|7742145|FG008|STARTED|Main Phase Stage 2||0
6809584|NCT01981850|7742146|FG009|STARTED|Main Phase Stage 2||0
6809585|NCT01981850|7742137|FG000|COMPLETED|Main Phase Stage 2||0
6809586|NCT01981850|7742138|FG001|COMPLETED|Main Phase Stage 2||0
6809587|NCT01981850|7742139|FG002|COMPLETED|Main Phase Stage 2||0
6809588|NCT01981850|7742140|FG003|COMPLETED|Main Phase Stage 2||0
6809589|NCT01981850|7742141|FG004|COMPLETED|Main Phase Stage 2||20
6809590|NCT01981850|7742142|FG005|COMPLETED|Main Phase Stage 2||16
6809591|NCT01981850|7742143|FG006|COMPLETED|Main Phase Stage 2||15
6809592|NCT01981850|7742144|FG007|COMPLETED|Main Phase Stage 2||0
6809593|NCT01981850|7742145|FG008|COMPLETED|Main Phase Stage 2||0
6809594|NCT01981850|7742146|FG009|COMPLETED|Main Phase Stage 2||0
6809595|NCT01981850|7742137|FG000|NOT COMPLETED|Main Phase Stage 2||0
6809596|NCT01981850|7742138|FG001|NOT COMPLETED|Main Phase Stage 2||0
6809597|NCT01981850|7742139|FG002|NOT COMPLETED|Main Phase Stage 2||0
6809598|NCT01981850|7742140|FG003|NOT COMPLETED|Main Phase Stage 2||0
6809599|NCT01981850|7742141|FG004|NOT COMPLETED|Main Phase Stage 2||13
6809600|NCT01981850|7742142|FG005|NOT COMPLETED|Main Phase Stage 2||16
6809601|NCT01981850|7742143|FG006|NOT COMPLETED|Main Phase Stage 2||17
6809602|NCT01981850|7742144|FG007|NOT COMPLETED|Main Phase Stage 2||0
6809603|NCT01981850|7742145|FG008|NOT COMPLETED|Main Phase Stage 2||0
6809604|NCT01981850|7742146|FG009|NOT COMPLETED|Main Phase Stage 2||0
6809605|NCT01981850|7742137|FG000|STARTED|Open Label Extension (OLE)||0
6809606|NCT01981850|7742138|FG001|STARTED|Open Label Extension (OLE)||0
6809607|NCT01981850|7742139|FG002|STARTED|Open Label Extension (OLE)||0
6809608|NCT01981850|7742140|FG003|STARTED|Open Label Extension (OLE)||0
6809609|NCT01981850|7742141|FG004|STARTED|Open Label Extension (OLE)||0
6809610|NCT01981850|7742142|FG005|STARTED|Open Label Extension (OLE)||0
6809611|NCT01981850|7742143|FG006|STARTED|Open Label Extension (OLE)||0
6809612|NCT01981850|7742144|FG007|STARTED|Open Label Extension (OLE)||13
6809613|NCT01981850|7742145|FG008|STARTED|Open Label Extension (OLE)||5
6809614|NCT01981850|7742146|FG009|STARTED|Open Label Extension (OLE)||48
6809615|NCT01981850|7742137|FG000|COMPLETED|Open Label Extension (OLE)||0
6809616|NCT01981850|7742138|FG001|COMPLETED|Open Label Extension (OLE)||0
6809617|NCT01981850|7742139|FG002|COMPLETED|Open Label Extension (OLE)||0
6809618|NCT01981850|7742140|FG003|COMPLETED|Open Label Extension (OLE)||0
6809619|NCT01981850|7742141|FG004|COMPLETED|Open Label Extension (OLE)||0
6809620|NCT01981850|7742142|FG005|COMPLETED|Open Label Extension (OLE)||0
6809621|NCT01981850|7742143|FG006|COMPLETED|Open Label Extension (OLE)||0
6809622|NCT01981850|7742144|FG007|COMPLETED|Open Label Extension (OLE)||1
6390807|NCT00832078|7302593|FG001|STARTED|Test Day 2 - 2 Period||10
6809623|NCT01981850|7742145|FG008|COMPLETED|Open Label Extension (OLE)||0
6809624|NCT01981850|7742146|FG009|COMPLETED|Open Label Extension (OLE)||0
6390808|NCT00832078|7302592|FG000|COMPLETED|Test Day 2 - 2 Period||12
6809625|NCT01981850|7742137|FG000|NOT COMPLETED|Open Label Extension (OLE)||0
6809626|NCT01981850|7742138|FG001|NOT COMPLETED|Open Label Extension (OLE)||0
6809627|NCT01981850|7742139|FG002|NOT COMPLETED|Open Label Extension (OLE)||0
6809628|NCT01981850|7742140|FG003|NOT COMPLETED|Open Label Extension (OLE)||0
6809629|NCT01981850|7742141|FG004|NOT COMPLETED|Open Label Extension (OLE)||0
6809630|NCT01981850|7742142|FG005|NOT COMPLETED|Open Label Extension (OLE)||0
6809631|NCT01981850|7742143|FG006|NOT COMPLETED|Open Label Extension (OLE)||0
6809632|NCT01981850|7742144|FG007|NOT COMPLETED|Open Label Extension (OLE)||12
6809633|NCT01981850|7742145|FG008|NOT COMPLETED|Open Label Extension (OLE)||5
6809634|NCT01981850|7742146|FG009|NOT COMPLETED|Open Label Extension (OLE)||48
6809635|NCT01804816|7742178|FG000|STARTED|No Acupuncture (Initial 5 Weeks)||14
6809636|NCT01804816|7742178|FG000|COMPLETED|No Acupuncture (Initial 5 Weeks)||11
6809637|NCT01804816|7742178|FG000|NOT COMPLETED|No Acupuncture (Initial 5 Weeks)||3
6809638|NCT01804816|7742178|FG000|STARTED|Acupuncture (Second 5 Weeks)||11
6809639|NCT01804816|7742178|FG000|COMPLETED|Acupuncture (Second 5 Weeks)||10
6809640|NCT01804816|7742178|FG000|NOT COMPLETED|Acupuncture (Second 5 Weeks)||1
6809641|NCT01572207|7742187|FG000|STARTED|Overall Study||14
6809642|NCT01572207|7742188|FG001|STARTED|Overall Study||16
6809643|NCT01572207|7742187|FG000|COMPLETED|Overall Study||12
6809644|NCT01572207|7742188|FG001|COMPLETED|Overall Study||13
6809645|NCT01572207|7742187|FG000|NOT COMPLETED|Overall Study||2
6809646|NCT01572207|7742188|FG001|NOT COMPLETED|Overall Study||3
6809647|NCT01550315|7742196|FG000|STARTED|Overall Study||7
6809648|NCT01550315|7742197|FG001|STARTED|Overall Study||7
6809649|NCT01550315|7742198|FG002|STARTED|Overall Study||6
6809650|NCT01550315|7742199|FG003|STARTED|Overall Study||7
6809651|NCT01550315|7742196|FG000|COMPLETED|Overall Study||7
6809652|NCT01550315|7742197|FG001|COMPLETED|Overall Study||7
6809653|NCT01550315|7742198|FG002|COMPLETED|Overall Study||6
6809654|NCT01550315|7742199|FG003|COMPLETED|Overall Study||7
6809655|NCT01550315|7742196|FG000|NOT COMPLETED|Overall Study||0
6809656|NCT01550315|7742197|FG001|NOT COMPLETED|Overall Study||0
6809657|NCT01550315|7742198|FG002|NOT COMPLETED|Overall Study||0
6809658|NCT01550315|7742199|FG003|NOT COMPLETED|Overall Study||0
6809659|NCT01519960|7742212|FG000|STARTED|Overall Study||101
6809660|NCT01519960|7742213|FG001|STARTED|Overall Study||50
6809661|NCT01519960|7742214|FG002|STARTED|Overall Study||10
6809662|NCT01519960|7742212|FG000|Completed Week 48|Overall Study||99
6809663|NCT01519960|7742213|FG001|Completed Week 48|Overall Study||47
6809664|NCT01519960|7742214|FG002|Completed Week 48|Overall Study||10
6809665|NCT01519960|7742212|FG000|Completed Follow-Up (FU) Week 12|Overall Study||101
6809666|NCT01519960|7742213|FG001|Completed Follow-Up (FU) Week 12|Overall Study||26
6809667|NCT01519960|7742214|FG002|Completed Follow-Up (FU) Week 12|Overall Study||10
6809668|NCT01519960|7742212|FG000|Completed FU Week 24|Overall Study||101
6809669|NCT01519960|7742213|FG001|Completed FU Week 24|Overall Study||15
6809670|NCT01519960|7742214|FG002|Completed FU Week 24|Overall Study||10
6809671|NCT01519960|7742212|FG000|COMPLETED|Overall Study||0
6809672|NCT01519960|7742213|FG001|COMPLETED|Overall Study||0
6809673|NCT01519960|7742214|FG002|COMPLETED|Overall Study||0
6809674|NCT01519960|7742212|FG000|NOT COMPLETED|Overall Study||101
6809675|NCT01519960|7742213|FG001|NOT COMPLETED|Overall Study||50
6809676|NCT01519960|7742214|FG002|NOT COMPLETED|Overall Study||10
6809677|NCT00688376|7742227|FG000|STARTED|Double-Blind Phase||40
6809678|NCT00688376|7742228|FG001|STARTED|Double-Blind Phase||32
6809679|NCT00688376|7742227|FG000|Safety Population|Double-Blind Phase||40
6809680|NCT00688376|7742228|FG001|Safety Population|Double-Blind Phase||31
6809681|NCT00688376|7742227|FG000|COMPLETED|Double-Blind Phase||34
6809682|NCT00688376|7742228|FG001|COMPLETED|Double-Blind Phase||25
6809683|NCT00688376|7742227|FG000|NOT COMPLETED|Double-Blind Phase||6
6809684|NCT00688376|7742228|FG001|NOT COMPLETED|Double-Blind Phase||7
6809685|NCT00688376|7742227|FG000|STARTED|Blinded Extension Phase||34
6809686|NCT00688376|7742228|FG001|STARTED|Blinded Extension Phase||25
6809687|NCT00688376|7742227|FG000|COMPLETED|Blinded Extension Phase||29
6809688|NCT00688376|7742228|FG001|COMPLETED|Blinded Extension Phase||20
6809689|NCT00688376|7742227|FG000|NOT COMPLETED|Blinded Extension Phase||5
6809690|NCT00688376|7742228|FG001|NOT COMPLETED|Blinded Extension Phase||5
6809691|NCT00604201|7742236|FG000|STARTED|Overall Study||31
6809692|NCT00604201|7742236|FG000|COMPLETED|Overall Study||21
6809693|NCT00604201|7742236|FG000|NOT COMPLETED|Overall Study||10
6809694|NCT00492349|7742242|FG000|STARTED|Overall Study||35
6809695|NCT00492349|7742243|FG001|STARTED|Overall Study||34
6809696|NCT00492349|7742242|FG000|Week 2|Overall Study||32
6809697|NCT00492349|7742243|FG001|Week 2|Overall Study||33
6809698|NCT00492349|7742242|FG000|Week 8|Overall Study||32
6809699|NCT00492349|7742243|FG001|Week 8|Overall Study||27
6809700|NCT00492349|7742242|FG000|COMPLETED|Overall Study||32
6809701|NCT00492349|7742243|FG001|COMPLETED|Overall Study||27
6809702|NCT00492349|7742242|FG000|NOT COMPLETED|Overall Study||3
6809703|NCT00492349|7742243|FG001|NOT COMPLETED|Overall Study||7
6809704|NCT00121108|7742255|FG000|STARTED|Overall Study||710
6809705|NCT00121108|7742256|FG001|STARTED|Overall Study||1417
6809706|NCT00121108|7742255|FG000|COMPLETED|Overall Study||589
6809707|NCT00121108|7742256|FG001|COMPLETED|Overall Study||1192
6809708|NCT00121108|7742255|FG000|NOT COMPLETED|Overall Study||121
6809709|NCT00121108|7742256|FG001|NOT COMPLETED|Overall Study||225
6809710|NCT00003102|7742266|FG000|STARTED|Overall Study||3
6809711|NCT00003102|7742267|FG001|STARTED|Overall Study||9
6809712|NCT00003102|7742268|FG002|STARTED|Overall Study||3
6809713|NCT00003102|7742266|FG000|COMPLETED|Overall Study||2
6809714|NCT00003102|7742267|FG001|COMPLETED|Overall Study||6
6809715|NCT00003102|7742268|FG002|COMPLETED|Overall Study||1
6809716|NCT00003102|7742266|FG000|NOT COMPLETED|Overall Study||1
6809717|NCT00003102|7742267|FG001|NOT COMPLETED|Overall Study||3
6809718|NCT00003102|7742268|FG002|NOT COMPLETED|Overall Study||2
6390809|NCT00832078|7302593|FG001|COMPLETED|Test Day 2 - 2 Period||10
6390810|NCT00832078|7302592|FG000|NOT COMPLETED|Test Day 2 - 2 Period||1
6390811|NCT00832078|7302593|FG001|NOT COMPLETED|Test Day 2 - 2 Period||0
6390812|NCT00832091|7302601|FG000|STARTED|Overall Study||17
6390813|NCT00832091|7302602|FG001|STARTED|Overall Study||55
6390814|NCT00832091|7302601|FG000|COMPLETED|Overall Study||12
6390815|NCT00832091|7302602|FG001|COMPLETED|Overall Study||53
6390816|NCT00832091|7302601|FG000|NOT COMPLETED|Overall Study||5
6390817|NCT00832091|7302602|FG001|NOT COMPLETED|Overall Study||2
6390818|NCT00832117|7302610|FG000|STARTED|Overall Study||29
6390819|NCT00832117|7302610|FG000|COMPLETED|Overall Study||17
6390820|NCT00832117|7302610|FG000|NOT COMPLETED|Overall Study||12
6390821|NCT00832130|7302619|FG000|STARTED|Overall Study||69
6390822|NCT00832130|7302620|FG001|STARTED|Overall Study||70
6390823|NCT00832130|7302619|FG000|COMPLETED|Overall Study||69
6390824|NCT00832130|7302620|FG001|COMPLETED|Overall Study||70
6390825|NCT00832130|7302619|FG000|NOT COMPLETED|Overall Study||0
6390826|NCT00832130|7302620|FG001|NOT COMPLETED|Overall Study||0
6390827|NCT00832260|7302626|FG000|STARTED|Overall Study||70
6390828|NCT00832260|7302626|FG000|COMPLETED|Overall Study||70
6390829|NCT00832260|7302626|FG000|NOT COMPLETED|Overall Study||0
6390830|NCT00832338|7302630|FG000|STARTED|Overall Study||23
6390831|NCT00832338|7302630|FG000|COMPLETED|Overall Study||23
6390832|NCT00832338|7302630|FG000|NOT COMPLETED|Overall Study||0
6390833|NCT00832377|7302634|FG000|STARTED|Overall Study||37
6390834|NCT00832377|7302634|FG000|COMPLETED|Overall Study||36
6390835|NCT00832377|7302634|FG000|NOT COMPLETED|Overall Study||1
6390836|NCT00832390|7302641|FG000|STARTED|Overall Study||12
6390837|NCT00832390|7302642|FG001|STARTED|Overall Study||16
6390838|NCT00832390|7302643|FG002|STARTED|Overall Study||1
6390839|NCT00832390|7302641|FG000|COMPLETED|Overall Study||12
6390840|NCT00832390|7302642|FG001|COMPLETED|Overall Study||16
6390841|NCT00832390|7302643|FG002|COMPLETED|Overall Study||1
6390842|NCT00832390|7302641|FG000|NOT COMPLETED|Overall Study||0
6390843|NCT00832390|7302642|FG001|NOT COMPLETED|Overall Study||0
6390844|NCT00832390|7302643|FG002|NOT COMPLETED|Overall Study||0
6390845|NCT00832416|7302655|FG000|STARTED|Overall Study||110
6390846|NCT00832416|7302656|FG001|STARTED|Overall Study||113
6390847|NCT00832416|7302657|FG002|STARTED|Overall Study||115
6390848|NCT00832416|7302658|FG003|STARTED|Overall Study||227
6390849|NCT00832416|7302655|FG000|COMPLETED|Overall Study||64
6390850|NCT00832416|7302656|FG001|COMPLETED|Overall Study||60
6390851|NCT00832416|7302657|FG002|COMPLETED|Overall Study||54
6390852|NCT00832416|7302658|FG003|COMPLETED|Overall Study||144
6390853|NCT00832416|7302655|FG000|NOT COMPLETED|Overall Study||46
6390854|NCT00832416|7302656|FG001|NOT COMPLETED|Overall Study||53
6390855|NCT00832416|7302657|FG002|NOT COMPLETED|Overall Study||61
6390856|NCT00832416|7302658|FG003|NOT COMPLETED|Overall Study||83
6390857|NCT00832585|7302668|FG000|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
6390858|NCT00832585|7302668|FG000|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
6390859|NCT00832585|7302668|FG000|NOT COMPLETED|Overall Study||2
6390860|NCT00832637|7302672|FG000|STARTED|Overall Study||33
6390861|NCT00832637|7302672|FG000|COMPLETED|Overall Study||33
6390862|NCT00832637|7302672|FG000|NOT COMPLETED|Overall Study||0
6390863|NCT00832650|7302679|FG000|STARTED|Overall Study||25
6390864|NCT00832650|7302680|FG001|STARTED|Overall Study||12
6390865|NCT00832650|7302681|FG002|STARTED|Overall Study||23
6390866|NCT00832650|7302679|FG000|Treated|Overall Study||25
6390867|NCT00832650|7302680|FG001|Treated|Overall Study||12
6390868|NCT00832650|7302681|FG002|Treated|Overall Study||22
6390869|NCT00832650|7302679|FG000|COMPLETED|Overall Study||25
6390870|NCT00832650|7302680|FG001|COMPLETED|Overall Study||12
6390871|NCT00832650|7302681|FG002|COMPLETED|Overall Study||22
6390872|NCT00832650|7302679|FG000|NOT COMPLETED|Overall Study||0
6390873|NCT00832650|7302680|FG001|NOT COMPLETED|Overall Study||0
6390874|NCT00832650|7302681|FG002|NOT COMPLETED|Overall Study||1
6390875|NCT00832767|7302691|FG000|STARTED|Overall Study||121
6809719|NCT04633837|7742278|FG000|STARTED|Overall Study||5
6809720|NCT04633837|7742279|FG001|STARTED|Overall Study||0
6567276|NCT01830855|7490378|FG001|NOT COMPLETED|Overall Study||61
6567277|NCT01830855|7490379|FG002|NOT COMPLETED|Overall Study||66
6567278|NCT01830855|7490380|FG003|NOT COMPLETED|Overall Study||82
6809721|NCT04633837|7742278|FG000|COMPLETED|Overall Study||0
6809722|NCT04633837|7742279|FG001|COMPLETED|Overall Study||0
6809723|NCT04633837|7742278|FG000|NOT COMPLETED|Overall Study||5
6809724|NCT04633837|7742279|FG001|NOT COMPLETED|Overall Study||0
6809725|NCT04057937|7742287|FG000|STARTED|Placebo-controlled Phase||44
6809726|NCT04057937|7742288|FG001|STARTED|Placebo-controlled Phase||46
6809727|NCT04057937|7742287|FG000|COMPLETED|Placebo-controlled Phase||41
6809728|NCT04057937|7742288|FG001|COMPLETED|Placebo-controlled Phase||46
6809729|NCT04057937|7742287|FG000|NOT COMPLETED|Placebo-controlled Phase||3
6809730|NCT04057937|7742288|FG001|NOT COMPLETED|Placebo-controlled Phase||0
6809731|NCT04057937|7742287|FG000|STARTED|Active-treatment Phase||41
6809732|NCT04057937|7742288|FG001|STARTED|Active-treatment Phase||46
6809733|NCT04057937|7742287|FG000|COMPLETED|Active-treatment Phase||40
6809734|NCT04057937|7742288|FG001|COMPLETED|Active-treatment Phase||44
6809735|NCT04057937|7742287|FG000|NOT COMPLETED|Active-treatment Phase||1
6809736|NCT04057937|7742288|FG001|NOT COMPLETED|Active-treatment Phase||2
6809737|NCT03566732|7742295|FG000|STARTED|Overall Study|1683 eligible cases identified and screened, 914 participants enrolled.|914
6809738|NCT03566732|7742295|FG000|COMPLETED|Overall Study|914 completed questionnaires|914
6809739|NCT03566732|7742295|FG000|NOT COMPLETED|Overall Study||0
6809740|NCT03032510|7742301|FG000|STARTED|Overall Study||603
6809741|NCT03032510|7742302|FG001|STARTED|Overall Study||602
6809742|NCT03032510|7742301|FG000|COMPLETED|Overall Study||576
6809743|NCT03032510|7742302|FG001|COMPLETED|Overall Study||584
6809744|NCT03032510|7742301|FG000|NOT COMPLETED|Overall Study||27
6809745|NCT03032510|7742302|FG001|NOT COMPLETED|Overall Study||18
6809746|NCT03029000|7742312|FG000|STARTED|Overall Study||1
6567279|NCT01830881|7490397|FG000|STARTED|Overall Study||62
6567280|NCT01830881|7490398|FG001|STARTED|Overall Study||62
6567281|NCT01830881|7490397|FG000|COMPLETED|Overall Study||62
6567282|NCT01830881|7490398|FG001|COMPLETED|Overall Study||61
6567283|NCT01830881|7490397|FG000|NOT COMPLETED|Overall Study||0
6567284|NCT01830881|7490398|FG001|NOT COMPLETED|Overall Study||1
6567285|NCT01830920|7490411|FG000|STARTED|Overall Study||126
6567286|NCT01830920|7490412|FG001|STARTED|Overall Study||46
6567287|NCT01830920|7490413|FG002|STARTED|Overall Study||48
6809747|NCT03029000|7742312|FG000|COMPLETED|Overall Study||1
6809748|NCT03029000|7742312|FG000|NOT COMPLETED|Overall Study||0
6809749|NCT03022292|7742316|FG000|STARTED|Overall Study||26
6809750|NCT03022292|7742316|FG000|COMPLETED|Overall Study||24
6809751|NCT03022292|7742316|FG000|NOT COMPLETED|Overall Study||2
6809752|NCT02968602|7742322|FG000|STARTED|Overall Study||16
6809753|NCT02968602|7742323|FG001|STARTED|Overall Study||16
6809754|NCT02968602|7742322|FG000|COMPLETED|Overall Study||16
6809755|NCT02968602|7742323|FG001|COMPLETED|Overall Study||16
6809756|NCT02968602|7742322|FG000|NOT COMPLETED|Overall Study||0
6809757|NCT02968602|7742323|FG001|NOT COMPLETED|Overall Study||0
6809758|NCT02946047|7742333|FG000|STARTED|Overall Study||4
6809759|NCT02946047|7742334|FG001|STARTED|Overall Study||3
6809760|NCT02946047|7742335|FG002|STARTED|Overall Study||3
6809761|NCT02946047|7742336|FG003|STARTED|Overall Study||7
6809762|NCT02946047|7742333|FG000|COMPLETED|Overall Study||3
6809763|NCT02946047|7742334|FG001|COMPLETED|Overall Study||3
6809764|NCT02946047|7742335|FG002|COMPLETED|Overall Study||3
6809765|NCT02946047|7742336|FG003|COMPLETED|Overall Study||7
6809766|NCT02946047|7742333|FG000|NOT COMPLETED|Overall Study||1
6809767|NCT02946047|7742334|FG001|NOT COMPLETED|Overall Study||0
6809768|NCT02946047|7742335|FG002|NOT COMPLETED|Overall Study||0
6809769|NCT02946047|7742336|FG003|NOT COMPLETED|Overall Study||0
6809770|NCT02830165|7742346|FG000|STARTED|Overall Study||11
6809771|NCT02830165|7742346|FG000|COMPLETED|Overall Study||11
6809772|NCT02830165|7742346|FG000|NOT COMPLETED|Overall Study||0
6809773|NCT02784704|7742354|FG000|STARTED|Overall Study||250
6809774|NCT02784704|7742355|FG001|STARTED|Overall Study||250
6809775|NCT02784704|7742354|FG000|Treated|Overall Study||250
6809776|NCT02784704|7742355|FG001|Treated|Overall Study||249
6809777|NCT02784704|7742354|FG000|COMPLETED|Overall Study||237
6809778|NCT02784704|7742355|FG001|COMPLETED|Overall Study||241
6809779|NCT02784704|7742354|FG000|NOT COMPLETED|Overall Study||13
6809780|NCT02784704|7742355|FG001|NOT COMPLETED|Overall Study||9
6809781|NCT04831515|7742363|FG000|STARTED|First Intervention||24
6809782|NCT04831515|7742364|FG001|STARTED|First Intervention||24
6809783|NCT04831515|7742363|FG000|COMPLETED|First Intervention||24
6809784|NCT04831515|7742364|FG001|COMPLETED|First Intervention||23
6809785|NCT04831515|7742363|FG000|NOT COMPLETED|First Intervention||0
6809786|NCT04831515|7742364|FG001|NOT COMPLETED|First Intervention||1
6809787|NCT04831515|7742363|FG000|STARTED|Second Intervention||24
6809788|NCT04831515|7742364|FG001|STARTED|Second Intervention||23
6809789|NCT04831515|7742363|FG000|COMPLETED|Second Intervention||24
6809790|NCT04831515|7742364|FG001|COMPLETED|Second Intervention||23
6809791|NCT04831515|7742363|FG000|NOT COMPLETED|Second Intervention||0
6567288|NCT01830920|7490414|FG003|STARTED|Overall Study||125
6567289|NCT01830920|7490415|FG004|STARTED|Overall Study||107
6567290|NCT01830920|7490411|FG000|Received Allocated Drug|Overall Study||115
6809792|NCT04831515|7742364|FG001|NOT COMPLETED|Second Intervention||0
6809793|NCT04343989|7742373|FG000|STARTED|Overall Study||78
6809794|NCT04343989|7742374|FG001|STARTED|Overall Study||26
6809795|NCT04343989|7742375|FG002|STARTED|Overall Study||74
6809796|NCT04343989|7742373|FG000|COMPLETED|Overall Study||78
6809797|NCT04343989|7742374|FG001|COMPLETED|Overall Study||26
6809798|NCT04343989|7742375|FG002|COMPLETED|Overall Study||74
6809799|NCT04343989|7742373|FG000|NOT COMPLETED|Overall Study||0
6809800|NCT04343989|7742374|FG001|NOT COMPLETED|Overall Study||0
6809801|NCT04343989|7742375|FG002|NOT COMPLETED|Overall Study||0
6809802|NCT04253834|7742385|FG000|STARTED|Overall Study||10
6809803|NCT04253834|7742386|FG001|STARTED|Overall Study||10
6809804|NCT04253834|7742385|FG000|COMPLETED|Overall Study||10
6809805|NCT04253834|7742386|FG001|COMPLETED|Overall Study||10
6809806|NCT04253834|7742385|FG000|NOT COMPLETED|Overall Study||0
6809807|NCT04253834|7742386|FG001|NOT COMPLETED|Overall Study||0
6809808|NCT03881059|7742395|FG000|STARTED|Treatment Period - Part A||66
6809809|NCT03881059|7742396|FG001|STARTED|Treatment Period - Part A||70
6809810|NCT03881059|7742397|FG002|STARTED|Treatment Period - Part A||67
6809811|NCT03881059|7742395|FG000|COMPLETED|Treatment Period - Part A||58
6809812|NCT03881059|7742396|FG001|COMPLETED|Treatment Period - Part A||63
6809813|NCT03881059|7742397|FG002|COMPLETED|Treatment Period - Part A||59
6809814|NCT03881059|7742395|FG000|NOT COMPLETED|Treatment Period - Part A||8
6809815|NCT03881059|7742396|FG001|NOT COMPLETED|Treatment Period - Part A||7
6809816|NCT03881059|7742397|FG002|NOT COMPLETED|Treatment Period - Part A||8
6809817|NCT03881059|7742395|FG000|STARTED|Treatment Period - Part B||55
6809818|NCT03881059|7742396|FG001|STARTED|Treatment Period - Part B||60
6809819|NCT03881059|7742397|FG002|STARTED|Treatment Period - Part B||58
6809820|NCT03881059|7742395|FG000|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||0
6809821|NCT03881059|7742396|FG001|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||13
6809822|NCT03881059|7742397|FG002|Participants Maintaining Same Treatment as in Part A|Treatment Period - Part B||16
6809823|NCT03881059|7742395|FG000|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||55
6809824|NCT03881059|7742396|FG001|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||47
6809825|NCT03881059|7742397|FG002|Participants Treated With Ustekinumab in Part B|Treatment Period - Part B||42
6809826|NCT03881059|7742395|FG000|COMPLETED|Treatment Period - Part B||47
6809827|NCT03881059|7742396|FG001|COMPLETED|Treatment Period - Part B||54
6809828|NCT03881059|7742397|FG002|COMPLETED|Treatment Period - Part B||47
6809829|NCT03881059|7742395|FG000|NOT COMPLETED|Treatment Period - Part B||8
6809830|NCT03881059|7742396|FG001|NOT COMPLETED|Treatment Period - Part B||6
6809831|NCT03881059|7742397|FG002|NOT COMPLETED|Treatment Period - Part B||11
6809832|NCT03878277|7742410|FG000|STARTED|Overall Study||10
6809833|NCT03878277|7742410|FG000|COMPLETED|Overall Study||10
6809834|NCT03878277|7742410|FG000|NOT COMPLETED|Overall Study||0
6809835|NCT03817853|7742414|FG000|STARTED|Induction Phase||113
6809836|NCT03817853|7742415|FG001|STARTED|Induction Phase||0
6809837|NCT03817853|7742416|FG002|STARTED|Induction Phase||0
6809838|NCT03817853|7742414|FG000|COMPLETED|Induction Phase||62
6809839|NCT03817853|7742415|FG001|COMPLETED|Induction Phase||0
6809840|NCT03817853|7742416|FG002|COMPLETED|Induction Phase||0
6809841|NCT03817853|7742414|FG000|NOT COMPLETED|Induction Phase||51
6809842|NCT03817853|7742415|FG001|NOT COMPLETED|Induction Phase||0
6809843|NCT03817853|7742416|FG002|NOT COMPLETED|Induction Phase||0
6809844|NCT03817853|7742414|FG000|STARTED|Maintenance/ Follow-up Phase||0
6809845|NCT03817853|7742415|FG001|STARTED|Maintenance/ Follow-up Phase||56
6809846|NCT03817853|7742416|FG002|STARTED|Maintenance/ Follow-up Phase||17
6809847|NCT03817853|7742414|FG000|COMPLETED|Maintenance/ Follow-up Phase||0
6809848|NCT03817853|7742415|FG001|COMPLETED|Maintenance/ Follow-up Phase||0
6809849|NCT03817853|7742416|FG002|COMPLETED|Maintenance/ Follow-up Phase||11
6809850|NCT03817853|7742414|FG000|NOT COMPLETED|Maintenance/ Follow-up Phase||0
6809851|NCT03817853|7742415|FG001|NOT COMPLETED|Maintenance/ Follow-up Phase||56
6809852|NCT03817853|7742416|FG002|NOT COMPLETED|Maintenance/ Follow-up Phase||6
6809853|NCT03450629|7742426|FG000|STARTED|Overall Study||341
6809854|NCT03450629|7742427|FG001|STARTED|Overall Study||341
6809855|NCT03450629|7742426|FG000|COMPLETED|Overall Study||293
6809856|NCT03450629|7742427|FG001|COMPLETED|Overall Study||307
6809857|NCT03450629|7742426|FG000|NOT COMPLETED|Overall Study||48
6809858|NCT03450629|7742427|FG001|NOT COMPLETED|Overall Study||34
6809859|NCT03367403|7742436|FG000|STARTED|Overall Study||131
6809860|NCT03367403|7742437|FG001|STARTED|Overall Study||126
6809861|NCT03367403|7742438|FG002|STARTED|Overall Study||15
6809862|NCT03367403|7742436|FG000|Received at Least One Dose of Study Drug|Overall Study||131
6809863|NCT03367403|7742437|FG001|Received at Least One Dose of Study Drug|Overall Study||125
6809864|NCT03367403|7742438|FG002|Received at Least One Dose of Study Drug|Overall Study||15
6809865|NCT03367403|7742436|FG000|COMPLETED|Overall Study||94
6809866|NCT03367403|7742437|FG001|COMPLETED|Overall Study||93
6809867|NCT03367403|7742438|FG002|COMPLETED|Overall Study||12
6809868|NCT03367403|7742436|FG000|NOT COMPLETED|Overall Study||37
6809869|NCT03367403|7742437|FG001|NOT COMPLETED|Overall Study||33
6809870|NCT03367403|7742438|FG002|NOT COMPLETED|Overall Study||3
6809871|NCT03286426|7742446|FG000|STARTED|Overall Study||3
6809872|NCT03286426|7742446|FG000|COMPLETED|Overall Study||0
6809873|NCT03286426|7742446|FG000|NOT COMPLETED|Overall Study||3
6809874|NCT03135249|7742450|FG000|STARTED|Overall Study|Nine patient entered the study|9
6809875|NCT03135249|7742450|FG000|COMPLETED|Overall Study|Eight patient completed the study.|7
6809876|NCT03135249|7742450|FG000|NOT COMPLETED|Overall Study||2
6809877|NCT02818582|7742456|FG000|STARTED|Overall Study||20
6809878|NCT02818582|7742457|FG001|STARTED|Overall Study||18
6809879|NCT02818582|7742456|FG000|COMPLETED|Overall Study||20
6809880|NCT02818582|7742457|FG001|COMPLETED|Overall Study||18
6809881|NCT02818582|7742456|FG000|NOT COMPLETED|Overall Study||0
6809882|NCT02818582|7742457|FG001|NOT COMPLETED|Overall Study||0
6809883|NCT02809677|7742463|FG000|STARTED|Overall Study||205
6809884|NCT02809677|7742463|FG000|COMPLETED|Overall Study||197
6809885|NCT02809677|7742463|FG000|NOT COMPLETED|Overall Study||8
6809886|NCT02728258|7742468|FG000|STARTED|Overall Study||11
6809887|NCT02728258|7742468|FG000|COMPLETED|Overall Study||11
6809888|NCT02728258|7742468|FG000|NOT COMPLETED|Overall Study||0
6809889|NCT02554253|7742474|FG000|STARTED|Overall Study||26
6809890|NCT02554253|7742475|FG001|STARTED|Overall Study||26
6809891|NCT02554253|7742474|FG000|COMPLETED|Overall Study||25
6809892|NCT02554253|7742475|FG001|COMPLETED|Overall Study||24
6809893|NCT02554253|7742474|FG000|NOT COMPLETED|Overall Study||1
6809894|NCT02554253|7742475|FG001|NOT COMPLETED|Overall Study||2
6809895|NCT02498600|7742484|FG000|STARTED|Overall Study||49
6809896|NCT02498600|7742485|FG001|STARTED|Overall Study||51
6809897|NCT02498600|7742484|FG000|COMPLETED|Overall Study||49
6809898|NCT02498600|7742485|FG001|COMPLETED|Overall Study||51
6809899|NCT02498600|7742484|FG000|NOT COMPLETED|Overall Study||0
6809900|NCT02498600|7742485|FG001|NOT COMPLETED|Overall Study||0
6809901|NCT01524536|7742491|FG000|STARTED|Overall Study||23
6809902|NCT01524536|7742491|FG000|COMPLETED|Overall Study||23
6809903|NCT01524536|7742491|FG000|NOT COMPLETED|Overall Study||0
6809904|NCT01307046|7742503|FG000|STARTED|Overall Study||166
6809905|NCT01307046|7742504|FG001|STARTED|Overall Study||170
6809906|NCT01307046|7742503|FG000|COMPLETED|Overall Study||154
6809907|NCT01307046|7742504|FG001|COMPLETED|Overall Study||159
6809908|NCT01307046|7742503|FG000|NOT COMPLETED|Overall Study||12
6809909|NCT01307046|7742504|FG001|NOT COMPLETED|Overall Study||11
6809910|NCT01307033|7742512|FG000|STARTED|8-week Double-blind Period||144
6809911|NCT01307033|7742513|FG001|STARTED|8-week Double-blind Period||134
6809912|NCT01307033|7742514|FG002|STARTED|8-week Double-blind Period||0
6809913|NCT01307033|7742515|FG003|STARTED|8-week Double-blind Period||0
6809914|NCT01307033|7742512|FG000|COMPLETED|8-week Double-blind Period||131
6809915|NCT01307033|7742513|FG001|COMPLETED|8-week Double-blind Period||127
6809916|NCT01307033|7742514|FG002|COMPLETED|8-week Double-blind Period||0
6809917|NCT01307033|7742515|FG003|COMPLETED|8-week Double-blind Period||0
6809918|NCT01307033|7742512|FG000|NOT COMPLETED|8-week Double-blind Period||13
6809919|NCT01307033|7742513|FG001|NOT COMPLETED|8-week Double-blind Period||7
6809920|NCT01307033|7742514|FG002|NOT COMPLETED|8-week Double-blind Period||0
6809921|NCT01307033|7742515|FG003|NOT COMPLETED|8-week Double-blind Period||0
6809922|NCT01307033|7742512|FG000|STARTED|44-week Open-label Extension||0
6809923|NCT01307033|7742513|FG001|STARTED|44-week Open-label Extension||0
6809924|NCT01307033|7742514|FG002|STARTED|44-week Open-label Extension||131
6809925|NCT01307033|7742515|FG003|STARTED|44-week Open-label Extension||127
6809926|NCT01307033|7742512|FG000|COMPLETED|44-week Open-label Extension||0
6809927|NCT01307033|7742513|FG001|COMPLETED|44-week Open-label Extension||0
6809928|NCT01307033|7742514|FG002|COMPLETED|44-week Open-label Extension||120
6809929|NCT01307033|7742515|FG003|COMPLETED|44-week Open-label Extension||115
6809930|NCT01307033|7742512|FG000|NOT COMPLETED|44-week Open-label Extension||0
6809931|NCT01307033|7742513|FG001|NOT COMPLETED|44-week Open-label Extension||0
6809932|NCT01307033|7742514|FG002|NOT COMPLETED|44-week Open-label Extension||11
6809933|NCT01307033|7742515|FG003|NOT COMPLETED|44-week Open-label Extension||12
6809934|NCT00739674|7742529|FG000|STARTED|Overall Study||535
6809935|NCT00739674|7742530|FG001|STARTED|Overall Study||457
6809936|NCT00739674|7742529|FG000|Screening Failures|Overall Study||19
6809937|NCT00739674|7742530|FG001|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
6809938|NCT00739674|7742529|FG000|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
6809939|NCT00739674|7742530|FG001|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
6809940|NCT00739674|7742529|FG000|No Follow-up Data|Overall Study||33
6809941|NCT00739674|7742530|FG001|No Follow-up Data|Overall Study||18
6809942|NCT00739674|7742529|FG000|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
6809943|NCT00739674|7742530|FG001|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
6809944|NCT00739674|7742529|FG000|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
6809945|NCT00739674|7742530|FG001|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
6809946|NCT00739674|7742529|FG000|COMPLETED|Overall Study||354
6809947|NCT00739674|7742530|FG001|COMPLETED|Overall Study||335
6809948|NCT00739674|7742529|FG000|NOT COMPLETED|Overall Study||181
6809949|NCT00739674|7742530|FG001|NOT COMPLETED|Overall Study||122
6809950|NCT00546754|7742538|FG000|STARTED|Overall Study|Number of patients enrolled and randomized|425
6809951|NCT00546754|7742539|FG001|STARTED|Overall Study|Number of patients enrolled and randomized|383
6809952|NCT00546754|7742538|FG000|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
6809953|NCT00546754|7742539|FG001|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
6809954|NCT00546754|7742538|FG000|Week 6|Overall Study||396
6809955|NCT00546754|7742539|FG001|Week 6|Overall Study||347
6275769|NCT00114777|7174984|FG001|COMPLETED|Randomization to Month 36||114
6275770|NCT00114777|7174985|FG002|COMPLETED|Randomization to Month 36||100
6275771|NCT00114777|7174983|FG000|NOT COMPLETED|Randomization to Month 36||75
6275772|NCT00114777|7174984|FG001|NOT COMPLETED|Randomization to Month 36||61
6275773|NCT00114777|7174985|FG002|NOT COMPLETED|Randomization to Month 36||84
6275774|NCT00114777|7174983|FG000|STARTED|Long-Term Extension to Month 84||104
6275775|NCT00114777|7174984|FG001|STARTED|Long-Term Extension to Month 84||113
6275776|NCT00114777|7174985|FG002|STARTED|Long-Term Extension to Month 84||87
6275777|NCT00114777|7174983|FG000|COMPLETED|Long-Term Extension to Month 84||74
6275778|NCT00114777|7174984|FG001|COMPLETED|Long-Term Extension to Month 84||84
6275779|NCT00114777|7174985|FG002|COMPLETED|Long-Term Extension to Month 84||57
6275780|NCT00114777|7174983|FG000|NOT COMPLETED|Long-Term Extension to Month 84||30
6275781|NCT00114777|7174984|FG001|NOT COMPLETED|Long-Term Extension to Month 84||29
6275782|NCT00114777|7174985|FG002|NOT COMPLETED|Long-Term Extension to Month 84||30
6275783|NCT00114959|7174994|FG000|STARTED|Overall Study||15
6275784|NCT00114959|7174994|FG000|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
6275785|NCT00114959|7174994|FG000|NOT COMPLETED|Overall Study||8
6275786|NCT00114972|7175000|FG000|STARTED|Overall Study||897
6275787|NCT00114972|7175001|FG001|STARTED|Overall Study||903
6275788|NCT00114972|7175000|FG000|COMPLETED|Overall Study||849
6275789|NCT00114972|7175001|FG001|COMPLETED|Overall Study||891
6275790|NCT00114972|7175000|FG000|NOT COMPLETED|Overall Study||48
6275791|NCT00114972|7175001|FG001|NOT COMPLETED|Overall Study||12
6275792|NCT00115037|7175009|FG000|STARTED|Phase1||152
6275793|NCT00115037|7175010|FG001|STARTED|Phase1||150
6275794|NCT00115037|7175011|FG002|STARTED|Phase1||0
6275795|NCT00115037|7175012|FG003|STARTED|Phase1||0
6275796|NCT00115037|7175013|FG004|STARTED|Phase1||0
6275797|NCT00115037|7175014|FG005|STARTED|Phase1||0
6275798|NCT00115037|7175009|FG000|COMPLETED|Phase1||127
6275799|NCT00115037|7175010|FG001|COMPLETED|Phase1||123
6275800|NCT00115037|7175011|FG002|COMPLETED|Phase1||0
6275801|NCT00115037|7175012|FG003|COMPLETED|Phase1||0
6275802|NCT00115037|7175013|FG004|COMPLETED|Phase1||0
6275803|NCT00115037|7175014|FG005|COMPLETED|Phase1||0
6275804|NCT00115037|7175009|FG000|NOT COMPLETED|Phase1||25
6567291|NCT01830920|7490412|FG001|Received Allocated Drug|Overall Study||45
6567292|NCT01830920|7490413|FG002|Received Allocated Drug|Overall Study||47
6567293|NCT01830920|7490414|FG003|Received Allocated Drug|Overall Study||119
6567294|NCT01830920|7490415|FG004|Received Allocated Drug|Overall Study||105
6567295|NCT01830920|7490411|FG000|COMPLETED|Overall Study||105
6567296|NCT01830920|7490412|FG001|COMPLETED|Overall Study||40
6275805|NCT00115037|7175010|FG001|NOT COMPLETED|Phase1||27
6275806|NCT00115037|7175011|FG002|NOT COMPLETED|Phase1||0
6275807|NCT00115037|7175012|FG003|NOT COMPLETED|Phase1||0
6275808|NCT00115037|7175013|FG004|NOT COMPLETED|Phase1||0
6275809|NCT00115037|7175014|FG005|NOT COMPLETED|Phase1||0
6275810|NCT00115037|7175009|FG000|STARTED|Phase2||0
6275811|NCT00115037|7175010|FG001|STARTED|Phase2||0
6275812|NCT00115037|7175011|FG002|STARTED|Phase2||91
6275813|NCT00115037|7175012|FG003|STARTED|Phase2||92
6275814|NCT00115037|7175013|FG004|STARTED|Phase2||34
6275815|NCT00115037|7175014|FG005|STARTED|Phase2||33
6275816|NCT00115037|7175009|FG000|COMPLETED|Phase2||0
6275817|NCT00115037|7175010|FG001|COMPLETED|Phase2||0
6275818|NCT00115037|7175011|FG002|COMPLETED|Phase2||76
6275819|NCT00115037|7175012|FG003|COMPLETED|Phase2||77
6275820|NCT00115037|7175013|FG004|COMPLETED|Phase2||28
6275821|NCT00115037|7175014|FG005|COMPLETED|Phase2||21
6275822|NCT00115037|7175009|FG000|NOT COMPLETED|Phase2||0
6275823|NCT00115037|7175010|FG001|NOT COMPLETED|Phase2||0
6275824|NCT00115037|7175011|FG002|NOT COMPLETED|Phase2||15
6275825|NCT00115037|7175012|FG003|NOT COMPLETED|Phase2||15
6275826|NCT00115037|7175013|FG004|NOT COMPLETED|Phase2||6
6275827|NCT00115037|7175014|FG005|NOT COMPLETED|Phase2||12
6275828|NCT00115063|7175030|FG000|STARTED|Overall Study||200
6275829|NCT00115063|7175031|FG001|STARTED|Overall Study||190
6275830|NCT00115063|7175030|FG000|COMPLETED|Overall Study||101
6275831|NCT00115063|7175031|FG001|COMPLETED|Overall Study||86
6275832|NCT00115063|7175030|FG000|NOT COMPLETED|Overall Study||99
6275833|NCT00115063|7175031|FG001|NOT COMPLETED|Overall Study||104
6275834|NCT00115076|7175037|FG000|STARTED|Overall Study||30
6275835|NCT00115076|7175037|FG000|COMPLETED|Overall Study||30
6275836|NCT00115076|7175037|FG000|NOT COMPLETED|Overall Study||0
6275837|NCT00115297|7175043|FG000|STARTED|Overall Study||30
6275838|NCT00115297|7175044|FG001|STARTED|Overall Study||32
6275839|NCT00115297|7175043|FG000|COMPLETED|Overall Study||30
6275840|NCT00115297|7175044|FG001|COMPLETED|Overall Study||32
6275841|NCT00115297|7175043|FG000|NOT COMPLETED|Overall Study||0
6275842|NCT00115297|7175044|FG001|NOT COMPLETED|Overall Study||0
6567297|NCT01830920|7490413|FG002|COMPLETED|Overall Study||40
6567298|NCT01830920|7490414|FG003|COMPLETED|Overall Study||109
6809956|NCT00546754|7742538|FG000|Week 12|Overall Study||375
6809957|NCT00546754|7742539|FG001|Week 12|Overall Study||334
6809958|NCT00546754|7742538|FG000|COMPLETED|Overall Study||375
6809959|NCT00546754|7742539|FG001|COMPLETED|Overall Study||334
6809960|NCT00546754|7742538|FG000|NOT COMPLETED|Overall Study||50
6809961|NCT00546754|7742539|FG001|NOT COMPLETED|Overall Study||49
6809962|NCT00479713|7742547|FG000|STARTED|Overall Study||314
6809963|NCT00479713|7742548|FG001|STARTED|Overall Study||304
6809964|NCT00479713|7742547|FG000|COMPLETED|Overall Study||301
6809965|NCT00479713|7742548|FG001|COMPLETED|Overall Study||295
6809966|NCT00479713|7742547|FG000|NOT COMPLETED|Overall Study||13
6809967|NCT00479713|7742548|FG001|NOT COMPLETED|Overall Study||9
6809968|NCT00406783|7742556|FG000|STARTED|Overall Study||276
6809969|NCT00406783|7742557|FG001|STARTED|Overall Study||271
6809970|NCT00406783|7742556|FG000|COMPLETED|Overall Study||262
6809971|NCT00406783|7742557|FG001|COMPLETED|Overall Study||256
6809972|NCT00406783|7742556|FG000|NOT COMPLETED|Overall Study||14
6567299|NCT01830920|7490415|FG004|COMPLETED|Overall Study||99
6567300|NCT01830920|7490411|FG000|NOT COMPLETED|Overall Study||21
6809973|NCT00406783|7742557|FG001|NOT COMPLETED|Overall Study||15
6809974|NCT00405964|7742565|FG000|STARTED|Overall Study||360
6809975|NCT00405964|7742566|FG001|STARTED|Overall Study||356
6809976|NCT00405964|7742565|FG000|COMPLETED|Overall Study||301
6809977|NCT00405964|7742566|FG001|COMPLETED|Overall Study||261
6809978|NCT00405964|7742565|FG000|NOT COMPLETED|Overall Study||59
6809979|NCT00405964|7742566|FG001|NOT COMPLETED|Overall Study||95
6809980|NCT00383721|7742577|FG000|STARTED|26-Week Double-Blind Treatment Period||225
6809981|NCT00383721|7742578|FG001|STARTED|26-Week Double-Blind Treatment Period||239
6809982|NCT00383721|7742579|FG002|STARTED|26-Week Double-Blind Treatment Period||253
6809983|NCT00383721|7742580|FG003|STARTED|26-Week Double-Blind Treatment Period||243
6809984|NCT00383721|7742581|FG004|STARTED|26-Week Double-Blind Treatment Period||236
6809985|NCT00383721|7742577|FG000|COMPLETED|26-Week Double-Blind Treatment Period|"1 participant listed as ongoing since the participant status could not be formally confirmed."|190
6809986|NCT00383721|7742578|FG001|COMPLETED|26-Week Double-Blind Treatment Period||202
6809987|NCT00383721|7742579|FG002|COMPLETED|26-Week Double-Blind Treatment Period||202
6809988|NCT00383721|7742580|FG003|COMPLETED|26-Week Double-Blind Treatment Period||193
6809989|NCT00383721|7742581|FG004|COMPLETED|26-Week Double-Blind Treatment Period||169
6809990|NCT00383721|7742577|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
6809991|NCT00383721|7742578|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
6809992|NCT00383721|7742579|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
6809993|NCT00383721|7742580|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
6809994|NCT00383721|7742581|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
6809995|NCT00383721|7742577|FG000|STARTED|26-Week Treatment Safety Extension||145
6809996|NCT00383721|7742578|FG001|STARTED|26-Week Treatment Safety Extension||153
6809997|NCT00383721|7742579|FG002|STARTED|26-Week Treatment Safety Extension||149
6809998|NCT00383721|7742580|FG003|STARTED|26-Week Treatment Safety Extension||148
6809999|NCT00383721|7742581|FG004|STARTED|26-Week Treatment Safety Extension||8
6810000|NCT00383721|7742577|FG000|COMPLETED|26-Week Treatment Safety Extension||126
6810001|NCT00383721|7742578|FG001|COMPLETED|26-Week Treatment Safety Extension||136
6810002|NCT00383721|7742579|FG002|COMPLETED|26-Week Treatment Safety Extension||126
6810003|NCT00383721|7742580|FG003|COMPLETED|26-Week Treatment Safety Extension||131
6810004|NCT00383721|7742581|FG004|COMPLETED|26-Week Treatment Safety Extension||8
6810005|NCT00383721|7742577|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||19
6810006|NCT00383721|7742578|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||17
6810007|NCT00383721|7742579|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||23
6810008|NCT00383721|7742580|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||17
6810009|NCT00383721|7742581|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||0
6810010|NCT00383552|7742597|FG000|STARTED|Overall Study||182
6810011|NCT00383552|7742598|FG001|STARTED|Overall Study||188
6810012|NCT00383552|7742599|FG002|STARTED|Overall Study||188
6810013|NCT00383552|7742600|FG003|STARTED|Overall Study||188
6810014|NCT00383552|7742597|FG000|COMPLETED|Overall Study||146
6810015|NCT00383552|7742598|FG001|COMPLETED|Overall Study||147
6810016|NCT00383552|7742599|FG002|COMPLETED|Overall Study||127
6810017|NCT00383552|7742600|FG003|COMPLETED|Overall Study||116
6810018|NCT00383552|7742597|FG000|NOT COMPLETED|Overall Study||36
6810019|NCT00383552|7742598|FG001|NOT COMPLETED|Overall Study||41
6810020|NCT00383552|7742599|FG002|NOT COMPLETED|Overall Study||61
6810021|NCT00383552|7742600|FG003|NOT COMPLETED|Overall Study||72
6810022|NCT00383435|7742620|FG000|STARTED|26-Week Double-Blind Treatment Period||217
6810023|NCT00383435|7742621|FG001|STARTED|26-Week Double-Blind Treatment Period||207
6810024|NCT00383435|7742622|FG002|STARTED|26-Week Double-Blind Treatment Period||210
6810025|NCT00383435|7742623|FG003|STARTED|26-Week Double-Blind Treatment Period||209
6810026|NCT00383435|7742624|FG004|STARTED|26-Week Double-Blind Treatment Period||212
6810027|NCT00383435|7742620|FG000|COMPLETED|26-Week Double-Blind Treatment Period||176
6810028|NCT00383435|7742621|FG001|COMPLETED|26-Week Double-Blind Treatment Period||169
6810029|NCT00383435|7742622|FG002|COMPLETED|26-Week Double-Blind Treatment Period||164
6810030|NCT00383435|7742623|FG003|COMPLETED|26-Week Double-Blind Treatment Period||172
6810031|NCT00383435|7742624|FG004|COMPLETED|26-Week Double-Blind Treatment Period||159
6567301|NCT01830920|7490412|FG001|NOT COMPLETED|Overall Study||6
6810032|NCT00383435|7742620|FG000|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
6810033|NCT00383435|7742621|FG001|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
6810034|NCT00383435|7742622|FG002|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
6810035|NCT00383435|7742623|FG003|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
6810036|NCT00383435|7742624|FG004|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
6810037|NCT00383435|7742620|FG000|STARTED|26-Week Treatment Safety Extension||131
6810038|NCT00383435|7742621|FG001|STARTED|26-Week Treatment Safety Extension||130
6810039|NCT00383435|7742622|FG002|STARTED|26-Week Treatment Safety Extension||124
6810040|NCT00383435|7742623|FG003|STARTED|26-Week Treatment Safety Extension||131
6810041|NCT00383435|7742624|FG004|STARTED|26-Week Treatment Safety Extension||13
6810042|NCT00383435|7742620|FG000|COMPLETED|26-Week Treatment Safety Extension||117
6810043|NCT00383435|7742621|FG001|COMPLETED|26-Week Treatment Safety Extension||121
6810044|NCT00383435|7742622|FG002|COMPLETED|26-Week Treatment Safety Extension||108
6810045|NCT00383435|7742623|FG003|COMPLETED|26-Week Treatment Safety Extension||116
6810046|NCT00383435|7742624|FG004|COMPLETED|26-Week Treatment Safety Extension||10
6810047|NCT00383435|7742620|FG000|NOT COMPLETED|26-Week Treatment Safety Extension||14
6810048|NCT00383435|7742621|FG001|NOT COMPLETED|26-Week Treatment Safety Extension||9
6810049|NCT00383435|7742622|FG002|NOT COMPLETED|26-Week Treatment Safety Extension||16
6810050|NCT00383435|7742623|FG003|NOT COMPLETED|26-Week Treatment Safety Extension||15
6810051|NCT00383435|7742624|FG004|NOT COMPLETED|26-Week Treatment Safety Extension||3
6810052|NCT00381485|7742639|FG000|STARTED|Open-Label Run-In Period||834
6810053|NCT00381485|7742640|FG001|STARTED|Open-Label Run-In Period||0
6810054|NCT00381485|7742641|FG002|STARTED|Open-Label Run-In Period||0
6810055|NCT00381485|7742642|FG003|STARTED|Open-Label Run-In Period||0
6810056|NCT00381485|7742639|FG000|COMPLETED|Open-Label Run-In Period||728
6810057|NCT00381485|7742640|FG001|COMPLETED|Open-Label Run-In Period||0
6810058|NCT00381485|7742641|FG002|COMPLETED|Open-Label Run-In Period||0
6810059|NCT00381485|7742642|FG003|COMPLETED|Open-Label Run-In Period||0
6810060|NCT00381485|7742639|FG000|NOT COMPLETED|Open-Label Run-In Period||106
6810061|NCT00381485|7742640|FG001|NOT COMPLETED|Open-Label Run-In Period||0
6810062|NCT00381485|7742641|FG002|NOT COMPLETED|Open-Label Run-In Period||0
6810063|NCT00381485|7742642|FG003|NOT COMPLETED|Open-Label Run-In Period||0
6810064|NCT00381485|7742639|FG000|STARTED|Double-Blind Treatment Period||0
6810065|NCT00381485|7742640|FG001|STARTED|Double-Blind Treatment Period||255
6810066|NCT00381485|7742641|FG002|STARTED|Double-Blind Treatment Period||233
6810067|NCT00381485|7742642|FG003|STARTED|Double-Blind Treatment Period||240
6810068|NCT00381485|7742639|FG000|COMPLETED|Double-Blind Treatment Period||0
6810069|NCT00381485|7742640|FG001|COMPLETED|Double-Blind Treatment Period||228
6810070|NCT00381485|7742641|FG002|COMPLETED|Double-Blind Treatment Period||208
6810071|NCT00381485|7742642|FG003|COMPLETED|Double-Blind Treatment Period||207
6810072|NCT00381485|7742639|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6810073|NCT00381485|7742640|FG001|NOT COMPLETED|Double-Blind Treatment Period||27
6810074|NCT00381485|7742641|FG002|NOT COMPLETED|Double-Blind Treatment Period||25
6810075|NCT00381485|7742642|FG003|NOT COMPLETED|Double-Blind Treatment Period||33
6810076|NCT00379288|7742655|FG000|STARTED|Overall Study||141
6810077|NCT00379288|7742656|FG001|STARTED|Overall Study||130
6656959|NCT02465866|7587325|FG002|COMPLETED|Period 1: Washout (14 Days)||5
6656960|NCT02465866|7587326|FG003|COMPLETED|Period 1: Washout (14 Days)||5
6810078|NCT00379288|7742657|FG002|STARTED|Overall Study||68
6810079|NCT00379288|7742658|FG003|STARTED|Overall Study||65
6810080|NCT00379288|7742655|FG000|COMPLETED|Overall Study||122
6810081|NCT00379288|7742656|FG001|COMPLETED|Overall Study||108
6810082|NCT00379288|7742657|FG002|COMPLETED|Overall Study||58
6810083|NCT00379288|7742658|FG003|COMPLETED|Overall Study||57
6810084|NCT00379288|7742655|FG000|NOT COMPLETED|Overall Study||19
6810085|NCT00379288|7742656|FG001|NOT COMPLETED|Overall Study||22
6810086|NCT00379288|7742657|FG002|NOT COMPLETED|Overall Study||10
6810087|NCT00379288|7742658|FG003|NOT COMPLETED|Overall Study||8
6810088|NCT00378378|7742671|FG000|STARTED|Overall Study||51
6810089|NCT00378378|7742672|FG001|STARTED|Overall Study||50
6810090|NCT00378378|7742673|FG002|STARTED|Overall Study||26
6810091|NCT00378378|7742671|FG000|COMPLETED|Overall Study||51
6810092|NCT00378378|7742672|FG001|COMPLETED|Overall Study||49
6810093|NCT00378378|7742673|FG002|COMPLETED|Overall Study||24
6810094|NCT00378378|7742671|FG000|NOT COMPLETED|Overall Study||0
6810095|NCT00378378|7742672|FG001|NOT COMPLETED|Overall Study||1
6810096|NCT00378378|7742673|FG002|NOT COMPLETED|Overall Study||2
6810097|NCT00089895|7742683|FG000|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
6810098|NCT00089895|7742684|FG001|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
6810099|NCT00089895|7742683|FG000|COMPLETED|Overall Study|Number of Subjects treated|4687
6810100|NCT00089895|7742684|FG001|COMPLETED|Overall Study|Number of Subjects treated|4642
6810101|NCT00089895|7742683|FG000|NOT COMPLETED|Overall Study||35
6810102|NCT00089895|7742684|FG001|NOT COMPLETED|Overall Study||42
6810103|NCT02577354|7742692|FG000|STARTED|Overall Study||102
6810104|NCT02577354|7742693|FG001|STARTED|Overall Study||102
6810105|NCT02577354|7742692|FG000|120 Day Primary Endpoint|Overall Study||100
6810106|NCT02577354|7742693|FG001|120 Day Primary Endpoint|Overall Study||101
6810107|NCT02577354|7742692|FG000|COMPLETED|Overall Study||87
6656961|NCT02465866|7587323|FG000|NOT COMPLETED|Period 1: Washout (14 Days)||0
6656962|NCT02465866|7587324|FG001|NOT COMPLETED|Period 1: Washout (14 Days)||0
6656963|NCT02465866|7587325|FG002|NOT COMPLETED|Period 1: Washout (14 Days)||0
6567302|NCT01830920|7490413|FG002|NOT COMPLETED|Overall Study||8
6567303|NCT01830920|7490414|FG003|NOT COMPLETED|Overall Study||16
6567304|NCT01830920|7490415|FG004|NOT COMPLETED|Overall Study||8
6810108|NCT02577354|7742693|FG001|COMPLETED|Overall Study||89
6810109|NCT02577354|7742692|FG000|NOT COMPLETED|Overall Study||15
6810110|NCT02577354|7742693|FG001|NOT COMPLETED|Overall Study||13
6810111|NCT02551718|7742709|FG000|STARTED|Overall Study||34
6810112|NCT02551718|7742709|FG000|COMPLETED|Overall Study||34
6810113|NCT02551718|7742709|FG000|NOT COMPLETED|Overall Study||0
6810114|NCT02471807|7742713|FG000|STARTED|Overall Study||34
6810115|NCT02471807|7742713|FG000|COMPLETED|Overall Study||11
6810116|NCT02471807|7742713|FG000|NOT COMPLETED|Overall Study||23
6810117|NCT02321514|7742717|FG000|STARTED|Overall Study||191
6810118|NCT02321514|7742717|FG000|COMPLETED|Overall Study||166
6810119|NCT02321514|7742717|FG000|NOT COMPLETED|Overall Study||25
6810120|NCT02118610|7742723|FG000|STARTED|Overall Study||30
6810121|NCT02118610|7742724|FG001|STARTED|Overall Study||33
6810122|NCT02118610|7742723|FG000|COMPLETED|Overall Study||29
6810123|NCT02118610|7742724|FG001|COMPLETED|Overall Study||32
6810124|NCT02118610|7742723|FG000|NOT COMPLETED|Overall Study||1
6810125|NCT02118610|7742724|FG001|NOT COMPLETED|Overall Study||1
6810126|NCT01909570|7742732|FG000|STARTED|Overall Study||84
6810127|NCT01909570|7742733|FG001|STARTED|Overall Study||91
6810128|NCT01909570|7742732|FG000|COMPLETED|Overall Study||57
6810129|NCT01909570|7742733|FG001|COMPLETED|Overall Study||64
6810130|NCT01909570|7742732|FG000|NOT COMPLETED|Overall Study||27
6810131|NCT01909570|7742733|FG001|NOT COMPLETED|Overall Study||27
6810132|NCT01453946|7742739|FG000|STARTED|Overall Study||50
6810133|NCT01453946|7742739|FG000|COMPLETED|Overall Study||41
6810134|NCT01453946|7742739|FG000|NOT COMPLETED|Overall Study||9
6810135|NCT01444092|7742743|FG000|STARTED|Overall Study||108
6810136|NCT01444092|7742743|FG000|INFORMED CONSENT OBTAINED|Overall Study||108
6810137|NCT01444092|7742743|FG000|COMPLETED|Overall Study||91
6810138|NCT01444092|7742743|FG000|NOT COMPLETED|Overall Study||17
6810139|NCT01332968|7742749|FG000|STARTED|Induction Period||699
6810140|NCT01332968|7742750|FG001|STARTED|Induction Period||702
6810141|NCT01332968|7742751|FG002|STARTED|Induction Period||0
6810142|NCT01332968|7742752|FG003|STARTED|Induction Period||0
6810143|NCT01332968|7742753|FG004|STARTED|Induction Period||0
6567305|NCT01830933|7490429|FG000|STARTED|Overall Study||823
6567306|NCT01830933|7490430|FG001|STARTED|Overall Study||812
6567307|NCT01830933|7490429|FG000|Completed Meet-up|Overall Study||675
6275843|NCT00115336|7175055|FG000|STARTED|Overall Study||6
6275844|NCT00115336|7175056|FG001|STARTED|Overall Study||4
6275845|NCT00115336|7175055|FG000|COMPLETED|Overall Study||6
6275846|NCT00115336|7175056|FG001|COMPLETED|Overall Study||3
6275847|NCT00115336|7175055|FG000|NOT COMPLETED|Overall Study||0
6275848|NCT00115336|7175056|FG001|NOT COMPLETED|Overall Study||1
6275849|NCT00115349|7175066|FG000|STARTED|Overall Study|Target was 43 subjects in this arm.|11
6275850|NCT00115349|7175067|FG001|STARTED|Overall Study|Target was 43 subjects in this arm.|9
6275851|NCT00115349|7175066|FG000|COMPLETED|Overall Study|Study closed due to low enrollment.|0
6275852|NCT00115349|7175067|FG001|COMPLETED|Overall Study|study closed due to low enrollment.|0
6275853|NCT00115349|7175066|FG000|NOT COMPLETED|Overall Study||11
6275854|NCT00115349|7175067|FG001|NOT COMPLETED|Overall Study||9
6275855|NCT00115739|7175073|FG000|STARTED|Overall Study||11
6275856|NCT00115739|7175073|FG000|COMPLETED|Overall Study||8
6275857|NCT00115739|7175073|FG000|NOT COMPLETED|Overall Study||3
6275858|NCT00115765|7175083|FG000|STARTED|Overall Study||115
6275859|NCT00115765|7175084|FG001|STARTED|Overall Study||413
6275860|NCT00115765|7175085|FG002|STARTED|Overall Study||410
6275861|NCT00115765|7175086|FG003|STARTED|Overall Study||115
6275862|NCT00115765|7175083|FG000|COMPLETED|Overall Study|Participants who were on study at closure or died|80
6275863|NCT00115765|7175084|FG001|COMPLETED|Overall Study|Participants who were on study at closure or died|313
6275864|NCT00115765|7175085|FG002|COMPLETED|Overall Study|Participants who were on study at closure or died|289
6567308|NCT01830933|7490430|FG001|Completed Meet-up|Overall Study||603
6567309|NCT01830933|7490429|FG000|COMPLETED|Overall Study||655
6567310|NCT01830933|7490430|FG001|COMPLETED|Overall Study||580
6567311|NCT01830933|7490429|FG000|NOT COMPLETED|Overall Study||168
6810144|NCT01332968|7742754|FG005|STARTED|Induction Period||0
6810145|NCT01332968|7742755|FG006|STARTED|Induction Period||0
6810146|NCT01332968|7742756|FG007|STARTED|Induction Period||0
6810147|NCT01332968|7742749|FG000|COMPLETED|Induction Period||641
6810148|NCT01332968|7742750|FG001|COMPLETED|Induction Period||646
6810149|NCT01332968|7742751|FG002|COMPLETED|Induction Period||0
6810150|NCT01332968|7742752|FG003|COMPLETED|Induction Period||0
6810151|NCT01332968|7742753|FG004|COMPLETED|Induction Period||0
6810152|NCT01332968|7742754|FG005|COMPLETED|Induction Period||0
6810153|NCT01332968|7742755|FG006|COMPLETED|Induction Period||0
6810154|NCT01332968|7742756|FG007|COMPLETED|Induction Period||0
6810155|NCT01332968|7742749|FG000|NOT COMPLETED|Induction Period||58
6810156|NCT01332968|7742750|FG001|NOT COMPLETED|Induction Period||56
6810157|NCT01332968|7742751|FG002|NOT COMPLETED|Induction Period||0
6810158|NCT01332968|7742752|FG003|NOT COMPLETED|Induction Period||0
6810159|NCT01332968|7742753|FG004|NOT COMPLETED|Induction Period||0
6810160|NCT01332968|7742754|FG005|NOT COMPLETED|Induction Period||0
6810161|NCT01332968|7742755|FG006|NOT COMPLETED|Induction Period||0
6810162|NCT01332968|7742756|FG007|NOT COMPLETED|Induction Period||0
6810163|NCT01332968|7742749|FG000|STARTED|Maintenance/Observation Period||0
6810164|NCT01332968|7742750|FG001|STARTED|Maintenance/Observation Period||0
6810165|NCT01332968|7742751|FG002|STARTED|Maintenance/Observation Period||612
6810166|NCT01332968|7742752|FG003|STARTED|Maintenance/Observation Period||624
6810167|NCT01332968|7742753|FG004|STARTED|Maintenance/Observation Period||12
6810168|NCT01332968|7742754|FG005|STARTED|Maintenance/Observation Period||11
6810169|NCT01332968|7742755|FG006|STARTED|Maintenance/Observation Period||0
6810170|NCT01332968|7742756|FG007|STARTED|Maintenance/Observation Period||0
6810171|NCT01332968|7742749|FG000|COMPLETED|Maintenance/Observation Period||0
6810172|NCT01332968|7742750|FG001|COMPLETED|Maintenance/Observation Period||0
6810173|NCT01332968|7742751|FG002|COMPLETED|Maintenance/Observation Period||399
6810174|NCT01332968|7742752|FG003|COMPLETED|Maintenance/Observation Period||417
6810175|NCT01332968|7742753|FG004|COMPLETED|Maintenance/Observation Period||2
6810176|NCT01332968|7742754|FG005|COMPLETED|Maintenance/Observation Period||2
6810177|NCT01332968|7742755|FG006|COMPLETED|Maintenance/Observation Period||0
6810178|NCT01332968|7742756|FG007|COMPLETED|Maintenance/Observation Period||0
6810179|NCT01332968|7742749|FG000|NOT COMPLETED|Maintenance/Observation Period||0
6810180|NCT01332968|7742750|FG001|NOT COMPLETED|Maintenance/Observation Period||0
6810181|NCT01332968|7742751|FG002|NOT COMPLETED|Maintenance/Observation Period||213
6810182|NCT01332968|7742752|FG003|NOT COMPLETED|Maintenance/Observation Period||207
6810183|NCT01332968|7742753|FG004|NOT COMPLETED|Maintenance/Observation Period||10
6810184|NCT01332968|7742754|FG005|NOT COMPLETED|Maintenance/Observation Period||9
6810185|NCT01332968|7742755|FG006|NOT COMPLETED|Maintenance/Observation Period||0
6810186|NCT01332968|7742756|FG007|NOT COMPLETED|Maintenance/Observation Period||0
6810187|NCT01332968|7742749|FG000|STARTED|Follow-Up Period||0
6810188|NCT01332968|7742750|FG001|STARTED|Follow-Up Period||0
6810189|NCT01332968|7742751|FG002|STARTED|Follow-Up Period||0
6810190|NCT01332968|7742752|FG003|STARTED|Follow-Up Period||0
6810191|NCT01332968|7742753|FG004|STARTED|Follow-Up Period||0
6810192|NCT01332968|7742754|FG005|STARTED|Follow-Up Period||0
6810193|NCT01332968|7742755|FG006|STARTED|Follow-Up Period||542
6810194|NCT01332968|7742756|FG007|STARTED|Follow-Up Period||531
6810195|NCT01332968|7742749|FG000|COMPLETED|Follow-Up Period||0
6810196|NCT01332968|7742750|FG001|COMPLETED|Follow-Up Period||0
6810197|NCT01332968|7742751|FG002|COMPLETED|Follow-Up Period||0
6567312|NCT01830933|7490430|FG001|NOT COMPLETED|Overall Study||232
6567313|NCT01830972|7490438|FG000|STARTED|Part I||46
6567314|NCT01830972|7490439|FG001|STARTED|Part I|Not applicable; participants in this arm entered during Part 2.|0
6810198|NCT01332968|7742752|FG003|COMPLETED|Follow-Up Period||0
6810199|NCT01332968|7742753|FG004|COMPLETED|Follow-Up Period||0
6810200|NCT01332968|7742754|FG005|COMPLETED|Follow-Up Period||0
6810201|NCT01332968|7742755|FG006|COMPLETED|Follow-Up Period||0
6810202|NCT01332968|7742756|FG007|COMPLETED|Follow-Up Period||0
6810203|NCT01332968|7742749|FG000|NOT COMPLETED|Follow-Up Period||0
6810204|NCT01332968|7742750|FG001|NOT COMPLETED|Follow-Up Period||0
6810205|NCT01332968|7742751|FG002|NOT COMPLETED|Follow-Up Period||0
6810206|NCT01332968|7742752|FG003|NOT COMPLETED|Follow-Up Period||0
6810207|NCT01332968|7742753|FG004|NOT COMPLETED|Follow-Up Period||0
6810208|NCT01332968|7742754|FG005|NOT COMPLETED|Follow-Up Period||0
6810209|NCT01332968|7742755|FG006|NOT COMPLETED|Follow-Up Period||542
6810210|NCT01332968|7742756|FG007|NOT COMPLETED|Follow-Up Period||531
6810211|NCT01265784|7742767|FG000|STARTED|Overall Study||56
6810212|NCT01265784|7742768|FG001|STARTED|Overall Study||57
6810213|NCT01265784|7742769|FG002|STARTED|Overall Study||30
6810214|NCT01265784|7742767|FG000|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
6810215|NCT01265784|7742768|FG001|Received at Least 1 Dose of Study Drug|Overall Study||56
6810216|NCT01265784|7742769|FG002|Received at Least 1 Dose of Study Drug|Overall Study||29
6567315|NCT01830972|7490438|FG000|COMPLETED|Part I||46
6567316|NCT01830972|7490439|FG001|COMPLETED|Part I|Not applicable; participants in this arm entered during Part 2.|0
6567317|NCT01830972|7490438|FG000|NOT COMPLETED|Part I||0
6567318|NCT01830972|7490439|FG001|NOT COMPLETED|Part I||0
6656964|NCT02465866|7587326|FG003|NOT COMPLETED|Period 1: Washout (14 Days)||0
6656965|NCT02465866|7587323|FG000|STARTED|Period 2||5
6656966|NCT02465866|7587324|FG001|STARTED|Period 2||5
6656967|NCT02465866|7587325|FG002|STARTED|Period 2||5
6656968|NCT02465866|7587326|FG003|STARTED|Period 2||5
6656969|NCT02465866|7587323|FG000|COMPLETED|Period 2||5
6656970|NCT02465866|7587324|FG001|COMPLETED|Period 2||5
6656971|NCT02465866|7587325|FG002|COMPLETED|Period 2||5
6656972|NCT02465866|7587326|FG003|COMPLETED|Period 2||5
6656973|NCT02465866|7587323|FG000|NOT COMPLETED|Period 2||0
6656974|NCT02465866|7587324|FG001|NOT COMPLETED|Period 2||0
6656975|NCT02465866|7587325|FG002|NOT COMPLETED|Period 2||0
6810217|NCT01265784|7742767|FG000|COMPLETED|Overall Study||44
6810218|NCT01265784|7742768|FG001|COMPLETED|Overall Study||49
6810219|NCT01265784|7742769|FG002|COMPLETED|Overall Study||26
6567319|NCT01830972|7490438|FG000|STARTED|Part II||46
6567320|NCT01830972|7490439|FG001|STARTED|Part II|Entered study at Part 2|13
6810220|NCT01265784|7742767|FG000|NOT COMPLETED|Overall Study||12
6810221|NCT01265784|7742768|FG001|NOT COMPLETED|Overall Study||8
6810222|NCT01265784|7742769|FG002|NOT COMPLETED|Overall Study||4
6810223|NCT00577577|7742779|FG000|STARTED|Overall Study||34
6810224|NCT00577577|7742780|FG001|STARTED|Overall Study||35
6810225|NCT00577577|7742779|FG000|Received Treatment|Overall Study||34
6810226|NCT00577577|7742780|FG001|Received Treatment|Overall Study||35
6810227|NCT00577577|7742779|FG000|COMPLETED|Overall Study||29
6810228|NCT00577577|7742780|FG001|COMPLETED|Overall Study||30
6810229|NCT00577577|7742779|FG000|NOT COMPLETED|Overall Study||5
6810230|NCT00577577|7742780|FG001|NOT COMPLETED|Overall Study||5
6810231|NCT00392327|7742794|FG000|STARTED|Overall Study||87
6810232|NCT00392327|7742795|FG001|STARTED|Overall Study||93
6810233|NCT00392327|7742796|FG002|STARTED|Overall Study||56
6810234|NCT00392327|7742797|FG003|STARTED|Overall Study||58
6810235|NCT00392327|7742798|FG004|STARTED|Overall Study||23
6810236|NCT00392327|7742799|FG005|STARTED|Overall Study||19
6810237|NCT00392327|7742800|FG006|STARTED|Overall Study||21
6810238|NCT00392327|7742801|FG007|STARTED|Overall Study||22
6810239|NCT00392327|7742794|FG000|COMPLETED|Overall Study||72
6810240|NCT00392327|7742795|FG001|COMPLETED|Overall Study||74
6810241|NCT00392327|7742796|FG002|COMPLETED|Overall Study||36
6810242|NCT00392327|7742797|FG003|COMPLETED|Overall Study||42
6810243|NCT00392327|7742798|FG004|COMPLETED|Overall Study||20
6810244|NCT00392327|7742799|FG005|COMPLETED|Overall Study||14
6810245|NCT00392327|7742800|FG006|COMPLETED|Overall Study||12
6810246|NCT00392327|7742801|FG007|COMPLETED|Overall Study||11
6810247|NCT00392327|7742794|FG000|NOT COMPLETED|Overall Study||15
6810248|NCT00392327|7742795|FG001|NOT COMPLETED|Overall Study||19
6810249|NCT00392327|7742796|FG002|NOT COMPLETED|Overall Study||20
6810250|NCT00392327|7742797|FG003|NOT COMPLETED|Overall Study||16
6810251|NCT00392327|7742798|FG004|NOT COMPLETED|Overall Study||3
6810252|NCT00392327|7742799|FG005|NOT COMPLETED|Overall Study||5
6810253|NCT00392327|7742800|FG006|NOT COMPLETED|Overall Study||9
6810254|NCT00392327|7742801|FG007|NOT COMPLETED|Overall Study||11
6567321|NCT01830972|7490438|FG000|COMPLETED|Part II||44
6810255|NCT00085202|7742821|FG000|STARTED|Overall Study||269
6810256|NCT00085202|7742822|FG001|STARTED|Overall Study||144
6810257|NCT00085202|7742821|FG000|COMPLETED|Overall Study||251
6810258|NCT00085202|7742822|FG001|COMPLETED|Overall Study||120
6810259|NCT00085202|7742821|FG000|NOT COMPLETED|Overall Study||18
6810260|NCT00085202|7742822|FG001|NOT COMPLETED|Overall Study||24
6810261|NCT05007639|7742841|FG000|STARTED|Overall Study||274
6810262|NCT05007639|7742841|FG000|COMPLETED|Overall Study||274
6810263|NCT05007639|7742841|FG000|NOT COMPLETED|Overall Study||0
6810264|NCT04739735|7742847|FG000|STARTED|Overall Study||25
6810265|NCT04739735|7742848|FG001|STARTED|Overall Study||25
6810266|NCT04739735|7742847|FG000|COMPLETED|Overall Study||25
6810267|NCT04739735|7742848|FG001|COMPLETED|Overall Study||25
6810268|NCT04739735|7742847|FG000|NOT COMPLETED|Overall Study||0
6810269|NCT04739735|7742848|FG001|NOT COMPLETED|Overall Study||0
6810270|NCT04552535|7742856|FG000|STARTED|Overall Study||99
6810271|NCT04552535|7742857|FG001|STARTED|Overall Study||101
6810272|NCT04552535|7742856|FG000|COMPLETED|Overall Study||99
6810273|NCT04552535|7742857|FG001|COMPLETED|Overall Study||101
6810274|NCT04552535|7742856|FG000|NOT COMPLETED|Overall Study||0
6810275|NCT04552535|7742857|FG001|NOT COMPLETED|Overall Study||0
6810276|NCT04502472|7742868|FG000|STARTED|Overall Study||61
6810277|NCT04502472|7742869|FG001|STARTED|Overall Study||48
6810278|NCT04502472|7742868|FG000|COMPLETED|Overall Study||58
6810279|NCT04502472|7742869|FG001|COMPLETED|Overall Study||45
6810280|NCT04502472|7742868|FG000|NOT COMPLETED|Overall Study||3
6810281|NCT04502472|7742869|FG001|NOT COMPLETED|Overall Study||3
6810282|NCT04495166|7742878|FG000|STARTED|Overall Study||37
6810283|NCT04495166|7742879|FG001|STARTED|Overall Study||44
6810284|NCT04495166|7742878|FG000|COMPLETED|Overall Study||30
6810285|NCT04495166|7742879|FG001|COMPLETED|Overall Study||41
6810286|NCT04495166|7742878|FG000|NOT COMPLETED|Overall Study||7
6810287|NCT04495166|7742879|FG001|NOT COMPLETED|Overall Study||3
6810288|NCT04461483|7742891|FG000|STARTED|Part 1 (Day 1)||6
6810289|NCT04461483|7742892|FG001|STARTED|Part 1 (Day 1)||6
6810290|NCT04461483|7742893|FG002|STARTED|Part 1 (Day 1)||6
6810291|NCT04461483|7742894|FG003|STARTED|Part 1 (Day 1)||6
6810292|NCT04461483|7742895|FG004|STARTED|Part 1 (Day 1)||0
6810293|NCT04461483|7742896|FG005|STARTED|Part 1 (Day 1)||0
6810294|NCT04461483|7742891|FG000|COMPLETED|Part 1 (Day 1)||6
6810295|NCT04461483|7742892|FG001|COMPLETED|Part 1 (Day 1)||6
6810296|NCT04461483|7742893|FG002|COMPLETED|Part 1 (Day 1)||6
6810297|NCT04461483|7742894|FG003|COMPLETED|Part 1 (Day 1)||6
6810298|NCT04461483|7742895|FG004|COMPLETED|Part 1 (Day 1)||0
6810299|NCT04461483|7742896|FG005|COMPLETED|Part 1 (Day 1)||0
6810300|NCT04461483|7742891|FG000|NOT COMPLETED|Part 1 (Day 1)||0
6810301|NCT04461483|7742892|FG001|NOT COMPLETED|Part 1 (Day 1)||0
6810302|NCT04461483|7742893|FG002|NOT COMPLETED|Part 1 (Day 1)||0
6810303|NCT04461483|7742894|FG003|NOT COMPLETED|Part 1 (Day 1)||0
6810304|NCT04461483|7742895|FG004|NOT COMPLETED|Part 1 (Day 1)||0
6810305|NCT04461483|7742896|FG005|NOT COMPLETED|Part 1 (Day 1)||0
6810306|NCT04461483|7742891|FG000|STARTED|Part 2 (Day 1 to 21)||0
6810307|NCT04461483|7742892|FG001|STARTED|Part 2 (Day 1 to 21)||0
6810308|NCT04461483|7742893|FG002|STARTED|Part 2 (Day 1 to 21)||0
6810309|NCT04461483|7742894|FG003|STARTED|Part 2 (Day 1 to 21)||0
6810310|NCT04461483|7742895|FG004|STARTED|Part 2 (Day 1 to 21)||3
6810311|NCT04461483|7742896|FG005|STARTED|Part 2 (Day 1 to 21)||6
6810312|NCT04461483|7742891|FG000|COMPLETED|Part 2 (Day 1 to 21)||0
6810313|NCT04461483|7742892|FG001|COMPLETED|Part 2 (Day 1 to 21)||0
6810314|NCT04461483|7742893|FG002|COMPLETED|Part 2 (Day 1 to 21)||0
6810315|NCT04461483|7742894|FG003|COMPLETED|Part 2 (Day 1 to 21)||0
6810316|NCT04461483|7742895|FG004|COMPLETED|Part 2 (Day 1 to 21)||3
6810317|NCT04461483|7742896|FG005|COMPLETED|Part 2 (Day 1 to 21)||6
6810318|NCT04461483|7742891|FG000|NOT COMPLETED|Part 2 (Day 1 to 21)||0
6810319|NCT04461483|7742892|FG001|NOT COMPLETED|Part 2 (Day 1 to 21)||0
6810320|NCT04461483|7742893|FG002|NOT COMPLETED|Part 2 (Day 1 to 21)||0
6810321|NCT04461483|7742894|FG003|NOT COMPLETED|Part 2 (Day 1 to 21)||0
6810322|NCT04461483|7742895|FG004|NOT COMPLETED|Part 2 (Day 1 to 21)||0
6810323|NCT04461483|7742896|FG005|NOT COMPLETED|Part 2 (Day 1 to 21)||0
6810324|NCT04386616|7742923|FG000|STARTED|Overall Study||134
6810325|NCT04386616|7742924|FG001|STARTED|Overall Study||130
6810326|NCT04386616|7742925|FG002|STARTED|Overall Study||132
6810327|NCT04386616|7742923|FG000|Received at Least One Dose of Study Drug|Overall Study|In this arm, 68 and 66 participants received MSTT1041A-matched placebo and UTTR1147A-matched placebo, respectively.|134
6810328|NCT04386616|7742924|FG001|Received at Least One Dose of Study Drug|Overall Study||130
6810329|NCT04386616|7742925|FG002|Received at Least One Dose of Study Drug|Overall Study||132
6810330|NCT04386616|7742923|FG000|Completed Both Doses of Study Drug at Day 15|Overall Study||31
6810331|NCT04386616|7742924|FG001|Completed Both Doses of Study Drug at Day 15|Overall Study||27
6810332|NCT04386616|7742925|FG002|Completed Both Doses of Study Drug at Day 15|Overall Study||25
6810333|NCT04386616|7742923|FG000|COMPLETED|Overall Study||104
6810334|NCT04386616|7742924|FG001|COMPLETED|Overall Study||95
6810335|NCT04386616|7742925|FG002|COMPLETED|Overall Study||104
6810336|NCT04386616|7742923|FG000|NOT COMPLETED|Overall Study||30
6810337|NCT04386616|7742924|FG001|NOT COMPLETED|Overall Study||35
6810338|NCT04386616|7742925|FG002|NOT COMPLETED|Overall Study||28
6810339|NCT04377711|7742944|FG000|STARTED|Overall Study||197
6810340|NCT04377711|7742945|FG001|STARTED|Overall Study||203
6810341|NCT04377711|7742944|FG000|COMPLETED|Overall Study||178
6810342|NCT04377711|7742945|FG001|COMPLETED|Overall Study||181
6810343|NCT04377711|7742944|FG000|NOT COMPLETED|Overall Study||19
6810344|NCT04377711|7742945|FG001|NOT COMPLETED|Overall Study||22
6810345|NCT04347408|7742951|FG000|STARTED|Overall Study||992
6810346|NCT04347408|7742951|FG000|COMPLETED|Overall Study||992
6810347|NCT04347408|7742951|FG000|NOT COMPLETED|Overall Study||0
6810348|NCT04296942|7742958|FG000|STARTED|Overall Study||1
6810349|NCT04296942|7742959|FG001|STARTED|Overall Study||0
6810350|NCT04296942|7742960|FG002|STARTED|Overall Study||0
6810351|NCT04296942|7742958|FG000|COMPLETED|Overall Study||0
6810352|NCT04296942|7742959|FG001|COMPLETED|Overall Study||0
6810353|NCT04296942|7742960|FG002|COMPLETED|Overall Study||0
6810354|NCT04296942|7742958|FG000|NOT COMPLETED|Overall Study||1
6810355|NCT04296942|7742959|FG001|NOT COMPLETED|Overall Study||0
6810356|NCT04296942|7742960|FG002|NOT COMPLETED|Overall Study||0
6810357|NCT04278872|7742972|FG000|STARTED|Overall Study||7
6810358|NCT04278872|7742973|FG001|STARTED|Overall Study||6
6810359|NCT04278872|7742972|FG000|COMPLETED|Overall Study||4
6810360|NCT04278872|7742973|FG001|COMPLETED|Overall Study||5
6810361|NCT04278872|7742972|FG000|NOT COMPLETED|Overall Study||3
6810362|NCT04278872|7742973|FG001|NOT COMPLETED|Overall Study||1
6810363|NCT04213807|7742982|FG000|STARTED|Overall Study||5
6810364|NCT04213807|7742983|FG001|STARTED|Overall Study||6
6810365|NCT04213807|7742984|FG002|STARTED|Overall Study||7
6810366|NCT04213807|7742982|FG000|COMPLETED|Overall Study||5
6810367|NCT04213807|7742983|FG001|COMPLETED|Overall Study||6
6810368|NCT04213807|7742984|FG002|COMPLETED|Overall Study||6
6810369|NCT04213807|7742982|FG000|NOT COMPLETED|Overall Study||0
6810370|NCT04213807|7742983|FG001|NOT COMPLETED|Overall Study||0
6810371|NCT04213807|7742984|FG002|NOT COMPLETED|Overall Study||1
6504728|NCT01449630|7423763|FG008|NOT COMPLETED|Period 2||0
6504729|NCT01449630|7423755|FG000|STARTED|Period 3||1
6810372|NCT04172467|7742994|FG000|STARTED|Overall Study||1086
6810373|NCT04172467|7742994|FG000|COMPLETED|Overall Study||1086
6810374|NCT04172467|7742994|FG000|NOT COMPLETED|Overall Study||0
6810375|NCT04132804|7743001|FG000|STARTED|Overall Study||31
6810376|NCT04132804|7743001|FG000|COMPLETED|Overall Study||20
6810377|NCT04132804|7743001|FG000|NOT COMPLETED|Overall Study||11
6810378|NCT03963011|7743007|FG000|STARTED|Overall Study||8
6810379|NCT03963011|7743008|FG001|STARTED|Overall Study||6
6810380|NCT03963011|7743007|FG000|COMPLETED|Overall Study||8
6810381|NCT03963011|7743008|FG001|COMPLETED|Overall Study||6
6810382|NCT03963011|7743007|FG000|NOT COMPLETED|Overall Study||0
6810383|NCT03963011|7743008|FG001|NOT COMPLETED|Overall Study||0
6810384|NCT03894501|7743016|FG000|STARTED|Overall Study||15
6810385|NCT03894501|7743017|FG001|STARTED|Overall Study||15
6810386|NCT03894501|7743016|FG000|COMPLETED|Overall Study||15
6810387|NCT03894501|7743017|FG001|COMPLETED|Overall Study||15
6810388|NCT03894501|7743016|FG000|NOT COMPLETED|Overall Study||0
6810389|NCT03894501|7743017|FG001|NOT COMPLETED|Overall Study||0
6810390|NCT03874325|7743038|FG000|STARTED|Overall Study||17
6810391|NCT03874325|7743039|FG001|STARTED|Overall Study||0
6810392|NCT03874325|7743038|FG000|COMPLETED|Overall Study||17
6810393|NCT03874325|7743039|FG001|COMPLETED|Overall Study||0
6810394|NCT03874325|7743038|FG000|NOT COMPLETED|Overall Study||0
6810395|NCT03874325|7743039|FG001|NOT COMPLETED|Overall Study||0
6656976|NCT02465866|7587326|FG003|NOT COMPLETED|Period 2||0
6656977|NCT02465866|7587323|FG000|STARTED|Period 2: Washout (14 Days)||5
6656978|NCT02465866|7587324|FG001|STARTED|Period 2: Washout (14 Days)||5
6567322|NCT01830972|7490439|FG001|COMPLETED|Part II||11
6567323|NCT01830972|7490438|FG000|NOT COMPLETED|Part II||2
6567324|NCT01830972|7490439|FG001|NOT COMPLETED|Part II||2
6567325|NCT01830972|7490438|FG000|STARTED|Part III|2 participants withdrew consent and did not enter Part 3|44
6567326|NCT01830972|7490439|FG001|STARTED|Part III||11
6656979|NCT02465866|7587325|FG002|STARTED|Period 2: Washout (14 Days)||5
6810396|NCT03837184|7743043|FG000|STARTED|Overall Study||2
6810397|NCT03837184|7743043|FG000|COMPLETED|Overall Study||2
6810398|NCT03837184|7743043|FG000|NOT COMPLETED|Overall Study||0
6810399|NCT03735420|7743049|FG000|STARTED|Overall Study||16
6810400|NCT03735420|7743050|FG001|STARTED|Overall Study||14
6810401|NCT03735420|7743049|FG000|COMPLETED|Overall Study||16
6810402|NCT03735420|7743050|FG001|COMPLETED|Overall Study||14
6810403|NCT03735420|7743049|FG000|NOT COMPLETED|Overall Study||0
6810404|NCT03735420|7743050|FG001|NOT COMPLETED|Overall Study||0
6567327|NCT01830972|7490438|FG000|COMPLETED|Part III||42
6567328|NCT01830972|7490439|FG001|COMPLETED|Part III||11
6275865|NCT00115765|7175086|FG003|COMPLETED|Overall Study|Participants who were on study at closure or died|84
6275866|NCT00115765|7175083|FG000|NOT COMPLETED|Overall Study||35
6275867|NCT00115765|7175084|FG001|NOT COMPLETED|Overall Study||100
6275868|NCT00115765|7175085|FG002|NOT COMPLETED|Overall Study||121
6275869|NCT00115765|7175086|FG003|NOT COMPLETED|Overall Study||31
6275870|NCT00115778|7175094|FG000|STARTED|Overall Study||6
6275871|NCT00115778|7175095|FG001|STARTED|Overall Study||5
6275872|NCT00115778|7175094|FG000|COMPLETED|Overall Study||6
6275873|NCT00115778|7175095|FG001|COMPLETED|Overall Study||4
6275874|NCT00115778|7175094|FG000|NOT COMPLETED|Overall Study||0
6275875|NCT00115778|7175095|FG001|NOT COMPLETED|Overall Study||1
6275876|NCT00115804|7175101|FG000|STARTED|Overall Study||6
6275877|NCT00115804|7175101|FG000|COMPLETED|Overall Study||4
6275878|NCT00115804|7175101|FG000|NOT COMPLETED|Overall Study||2
6275879|NCT00115869|7175109|FG000|STARTED|Overall Study||4211
6275880|NCT00115869|7175110|FG001|STARTED|Overall Study||4177
6275881|NCT00115869|7175109|FG000|Completed Data Collection at 12th Grade|Overall Study||3876
6275882|NCT00115869|7175110|FG001|Completed Data Collection at 12th Grade|Overall Study||3847
6275883|NCT00115869|7175109|FG000|COMPLETED|Overall Study||3894
6275884|NCT00115869|7175110|FG001|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
6275885|NCT00115869|7175109|FG000|NOT COMPLETED|Overall Study||317
6275886|NCT00115869|7175110|FG001|NOT COMPLETED|Overall Study||296
6280840|NCT00159263|7180669|FG005|COMPLETED|Washout||2
6567329|NCT01830972|7490438|FG000|NOT COMPLETED|Part III||2
6567330|NCT01830972|7490439|FG001|NOT COMPLETED|Part III||0
6810405|NCT03721328|7743058|FG000|STARTED|Overall Study||15
6810406|NCT03721328|7743058|FG000|COMPLETED|Overall Study||15
6810407|NCT03721328|7743058|FG000|NOT COMPLETED|Overall Study||0
6810408|NCT03721107|7743066|FG000|STARTED|Overall Study||80
6810409|NCT03721107|7743067|FG001|STARTED|Overall Study||84
6810410|NCT03721107|7743068|FG002|STARTED|Overall Study||98
6810411|NCT03721107|7743069|FG003|STARTED|Overall Study||104
6810412|NCT03721107|7743066|FG000|Treated|Overall Study||80
6810413|NCT03721107|7743067|FG001|Treated|Overall Study||84
6810414|NCT03721107|7743068|FG002|Treated|Overall Study||97
6810415|NCT03721107|7743069|FG003|Treated|Overall Study||104
6810416|NCT03721107|7743066|FG000|COMPLETED|Overall Study||75
6810417|NCT03721107|7743067|FG001|COMPLETED|Overall Study||81
6810418|NCT03721107|7743068|FG002|COMPLETED|Overall Study||83
6810419|NCT03721107|7743069|FG003|COMPLETED|Overall Study||92
6810420|NCT03721107|7743066|FG000|NOT COMPLETED|Overall Study||5
6810421|NCT03721107|7743067|FG001|NOT COMPLETED|Overall Study||3
6810422|NCT03721107|7743068|FG002|NOT COMPLETED|Overall Study||15
6810423|NCT03721107|7743069|FG003|NOT COMPLETED|Overall Study||12
6810424|NCT03691727|7743081|FG000|STARTED|Overall Study||18
6810425|NCT03691727|7743082|FG001|STARTED|Overall Study||12
6810426|NCT03691727|7743081|FG000|COMPLETED|Overall Study||16
6810427|NCT03691727|7743082|FG001|COMPLETED|Overall Study||11
6810428|NCT03691727|7743081|FG000|NOT COMPLETED|Overall Study||2
6810429|NCT03691727|7743082|FG001|NOT COMPLETED|Overall Study||1
6810430|NCT03689920|7743090|FG000|STARTED|Overall Study||47
6810431|NCT03689920|7743091|FG001|STARTED|Overall Study||52
6810432|NCT03689920|7743090|FG000|COMPLETED|Overall Study||41
6810433|NCT03689920|7743091|FG001|COMPLETED|Overall Study||48
6810434|NCT03689920|7743090|FG000|NOT COMPLETED|Overall Study||6
6810435|NCT03689920|7743091|FG001|NOT COMPLETED|Overall Study||4
6810436|NCT03672227|7743099|FG000|STARTED|Overall Study||112
6810437|NCT03672227|7743100|FG001|STARTED|Overall Study||52
6810438|NCT03672227|7743099|FG000|Teachers Started|Overall Study||8
6810439|NCT03672227|7743100|FG001|Teachers Started|Overall Study||6
6810440|NCT03672227|7743099|FG000|Children Started|Overall Study||52
6810441|NCT03672227|7743100|FG001|Children Started|Overall Study||23
6810442|NCT03672227|7743099|FG000|Parents Started|Overall Study||52
6810443|NCT03672227|7743100|FG001|Parents Started|Overall Study||23
6810444|NCT03672227|7743099|FG000|COMPLETED|Overall Study||105
6810445|NCT03672227|7743100|FG001|COMPLETED|Overall Study||52
6810446|NCT03672227|7743099|FG000|NOT COMPLETED|Overall Study||7
6810447|NCT03672227|7743100|FG001|NOT COMPLETED|Overall Study||0
6810448|NCT03644849|7743109|FG000|STARTED|Overall Study||24
6810449|NCT03644849|7743110|FG001|STARTED|Overall Study||24
6810450|NCT03644849|7743109|FG000|COMPLETED|Overall Study||23
6810451|NCT03644849|7743110|FG001|COMPLETED|Overall Study||21
6810452|NCT03644849|7743109|FG000|NOT COMPLETED|Overall Study||1
6810453|NCT03644849|7743110|FG001|NOT COMPLETED|Overall Study||3
6810454|NCT03604159|7743118|FG000|STARTED|Overall Study||26
6810455|NCT03604159|7743119|FG001|STARTED|Overall Study||26
6810456|NCT03604159|7743118|FG000|COMPLETED|Overall Study||20
6810457|NCT03604159|7743119|FG001|COMPLETED|Overall Study||19
6810458|NCT03604159|7743118|FG000|NOT COMPLETED|Overall Study||6
6810459|NCT03604159|7743119|FG001|NOT COMPLETED|Overall Study||7
6810460|NCT03602885|7743127|FG000|STARTED|Overall Study||5
6810461|NCT03602885|7743128|FG001|STARTED|Overall Study||5
6810462|NCT03602885|7743127|FG000|COMPLETED|Overall Study||2
6810463|NCT03602885|7743128|FG001|COMPLETED|Overall Study||5
6810464|NCT03602885|7743127|FG000|NOT COMPLETED|Overall Study||3
6810465|NCT03602885|7743128|FG001|NOT COMPLETED|Overall Study||0
6810466|NCT03539601|7743138|FG000|STARTED|Overall Study||60
6810467|NCT03539601|7743139|FG001|STARTED|Overall Study||59
6810468|NCT03539601|7743140|FG002|STARTED|Overall Study||71
6810469|NCT03539601|7743141|FG003|STARTED|Overall Study||47
6810470|NCT03539601|7743138|FG000|Treated|Overall Study||59
6810471|NCT03539601|7743139|FG001|Treated|Overall Study||58
6810472|NCT03539601|7743140|FG002|Treated|Overall Study||71
6810473|NCT03539601|7743141|FG003|Treated|Overall Study||47
6810474|NCT03539601|7743138|FG000|COMPLETED|Overall Study||54
6810475|NCT03539601|7743139|FG001|COMPLETED|Overall Study||52
6810476|NCT03539601|7743140|FG002|COMPLETED|Overall Study||65
6810477|NCT03539601|7743141|FG003|COMPLETED|Overall Study||46
6810478|NCT03539601|7743138|FG000|NOT COMPLETED|Overall Study||6
6810479|NCT03539601|7743139|FG001|NOT COMPLETED|Overall Study||7
6810480|NCT03539601|7743140|FG002|NOT COMPLETED|Overall Study||6
6810481|NCT03539601|7743141|FG003|NOT COMPLETED|Overall Study||1
6810482|NCT03539458|7743159|FG000|STARTED|Overall Study||11
6810483|NCT03539458|7743159|FG000|COMPLETED|Overall Study||10
6810484|NCT03539458|7743159|FG000|NOT COMPLETED|Overall Study||1
6810485|NCT03532451|7743165|FG000|STARTED|Overall Study||13
6810486|NCT03532451|7743166|FG001|STARTED|Overall Study||30
6810487|NCT03532451|7743165|FG000|COMPLETED|Overall Study||12
6810488|NCT03532451|7743166|FG001|COMPLETED|Overall Study||29
6810489|NCT03532451|7743165|FG000|NOT COMPLETED|Overall Study||1
6810490|NCT03532451|7743166|FG001|NOT COMPLETED|Overall Study||1
6810491|NCT03505099|7743174|FG000|STARTED|Overall Study||14
6810492|NCT03505099|7743175|FG001|STARTED|Overall Study||15
6810493|NCT03505099|7743174|FG000|Received AVXS-101|Overall Study||14
6810494|NCT03505099|7743175|FG001|Received AVXS-101|Overall Study||15
6810495|NCT03505099|7743174|FG000|COMPLETED|Overall Study||14
6810496|NCT03505099|7743175|FG001|COMPLETED|Overall Study||15
6810497|NCT03505099|7743174|FG000|NOT COMPLETED|Overall Study||0
6810498|NCT03505099|7743175|FG001|NOT COMPLETED|Overall Study||0
6810499|NCT03464136|7743183|FG000|STARTED|Overall Study||195
6810500|NCT03464136|7743184|FG001|STARTED|Overall Study||191
6810501|NCT03464136|7743183|FG000|COMPLETED|Overall Study||165
6810502|NCT03464136|7743184|FG001|COMPLETED|Overall Study||166
6810503|NCT03464136|7743183|FG000|NOT COMPLETED|Overall Study||30
6810504|NCT03464136|7743184|FG001|NOT COMPLETED|Overall Study||25
6567331|NCT01830972|7490438|FG000|STARTED|Part IV||42
6567332|NCT01830972|7490439|FG001|STARTED|Part IV||11
6656980|NCT02465866|7587326|FG003|STARTED|Period 2: Washout (14 Days)||5
6567333|NCT01830972|7490438|FG000|COMPLETED|Part IV||39
6810505|NCT03439657|7743192|FG000|STARTED|Overall Study||449
6810506|NCT03439657|7743193|FG001|STARTED|Overall Study||463
6810507|NCT03439657|7743192|FG000|COMPLETED|Overall Study||442
6810508|NCT03439657|7743193|FG001|COMPLETED|Overall Study||459
6810509|NCT03439657|7743192|FG000|NOT COMPLETED|Overall Study||7
6810510|NCT03439657|7743193|FG001|NOT COMPLETED|Overall Study||4
6810511|NCT03377790|7743203|FG000|STARTED|Overall Study||160
6810512|NCT03377790|7743204|FG001|STARTED|Overall Study||106
6810513|NCT03377790|7743203|FG000|COMPLETED|Overall Study||150
6810514|NCT03377790|7743204|FG001|COMPLETED|Overall Study||100
6810515|NCT03377790|7743203|FG000|NOT COMPLETED|Overall Study||10
6810516|NCT03377790|7743204|FG001|NOT COMPLETED|Overall Study||6
6810517|NCT03353675|7743210|FG000|STARTED|Overall Study||44
6810518|NCT03353675|7743210|FG000|COMPLETED|Overall Study||40
6810519|NCT03353675|7743210|FG000|NOT COMPLETED|Overall Study||4
6810520|NCT03294109|7743216|FG000|STARTED|Overall Study||46
6810521|NCT03294109|7743217|FG001|STARTED|Overall Study||57
6810522|NCT03294109|7743216|FG000|Underwent Surgery|Overall Study||40
6810523|NCT03294109|7743217|FG001|Underwent Surgery|Overall Study||52
6810524|NCT03294109|7743216|FG000|COMPLETED|Overall Study||40
6810525|NCT03294109|7743217|FG001|COMPLETED|Overall Study||52
6810526|NCT03294109|7743216|FG000|NOT COMPLETED|Overall Study||6
6810527|NCT03294109|7743217|FG001|NOT COMPLETED|Overall Study||5
6810528|NCT03268005|7743226|FG000|STARTED|Overall Study||546
6810529|NCT03268005|7743227|FG001|STARTED|Overall Study||545
6810530|NCT03268005|7743226|FG000|Full Analysis Set|Overall Study||546
6656981|NCT02465866|7587323|FG000|COMPLETED|Period 2: Washout (14 Days)||5
6656982|NCT02465866|7587324|FG001|COMPLETED|Period 2: Washout (14 Days)||5
6656983|NCT02465866|7587325|FG002|COMPLETED|Period 2: Washout (14 Days)||5
6810531|NCT03268005|7743227|FG001|Full Analysis Set|Overall Study||545
6567334|NCT01830972|7490439|FG001|COMPLETED|Part IV||10
6567335|NCT01830972|7490438|FG000|NOT COMPLETED|Part IV||3
6567336|NCT01830972|7490439|FG001|NOT COMPLETED|Part IV||1
6567337|NCT01831089|7490461|FG000|STARTED|Cohort I: Dose Level 1||3
6567338|NCT01831089|7490462|FG001|STARTED|Cohort I: Dose Level 1||0
6567339|NCT01831089|7490463|FG002|STARTED|Cohort I: Dose Level 1||0
6567340|NCT01831089|7490464|FG003|STARTED|Cohort I: Dose Level 1||0
6810532|NCT03268005|7743226|FG000|Safety Analysis Set|Overall Study||544
6810533|NCT03268005|7743227|FG001|Safety Analysis Set|Overall Study||544
6810534|NCT03268005|7743226|FG000|COMPLETED|Overall Study||531
6810535|NCT03268005|7743227|FG001|COMPLETED|Overall Study||531
6810536|NCT03268005|7743226|FG000|NOT COMPLETED|Overall Study||15
6810537|NCT03268005|7743227|FG001|NOT COMPLETED|Overall Study||14
6810538|NCT03225170|7743236|FG000|STARTED|Overall Study||23
6810539|NCT03225170|7743237|FG001|STARTED|Overall Study||22
6810540|NCT03225170|7743238|FG002|STARTED|Overall Study||2
6810541|NCT03225170|7743236|FG000|COMPLETED|Overall Study||19
6810542|NCT03225170|7743237|FG001|COMPLETED|Overall Study||17
6810543|NCT03225170|7743238|FG002|COMPLETED|Overall Study||2
6810544|NCT03225170|7743236|FG000|NOT COMPLETED|Overall Study||4
6810545|NCT03225170|7743237|FG001|NOT COMPLETED|Overall Study||5
6810546|NCT03225170|7743238|FG002|NOT COMPLETED|Overall Study||0
6810547|NCT03220854|7743247|FG000|STARTED|Overall Study||4
6810548|NCT03220854|7743248|FG001|STARTED|Overall Study||0
6810549|NCT03220854|7743249|FG002|STARTED|Overall Study||1
6810550|NCT03220854|7743247|FG000|COMPLETED|Overall Study||4
6810551|NCT03220854|7743248|FG001|COMPLETED|Overall Study||0
6810552|NCT03220854|7743249|FG002|COMPLETED|Overall Study||1
6810553|NCT03220854|7743247|FG000|NOT COMPLETED|Overall Study||0
6810554|NCT03220854|7743248|FG001|NOT COMPLETED|Overall Study||0
6810555|NCT03220854|7743249|FG002|NOT COMPLETED|Overall Study||0
6810556|NCT03219034|7743262|FG000|STARTED|Overall Study||31
6810557|NCT03219034|7743263|FG001|STARTED|Overall Study||31
6810558|NCT03219034|7743262|FG000|COMPLETED|Overall Study||20
6810559|NCT03219034|7743263|FG001|COMPLETED|Overall Study||16
6810560|NCT03219034|7743262|FG000|NOT COMPLETED|Overall Study||11
6810561|NCT03219034|7743263|FG001|NOT COMPLETED|Overall Study||15
6810562|NCT03168438|7743273|FG000|STARTED|Overall Study||3
6810563|NCT03168438|7743274|FG001|STARTED|Overall Study||3
6810564|NCT03168438|7743273|FG000|COMPLETED|Overall Study||3
6810565|NCT03168438|7743274|FG001|COMPLETED|Overall Study||2
6810566|NCT03168438|7743273|FG000|NOT COMPLETED|Overall Study||0
6810567|NCT03168438|7743274|FG001|NOT COMPLETED|Overall Study||1
6810568|NCT03110380|7743283|FG000|STARTED|Double-Blind Treatment Phase||284
6810569|NCT03110380|7743284|FG001|STARTED|Double-Blind Treatment Phase||283
6810570|NCT03110380|7743285|FG002|STARTED|Double-Blind Treatment Phase||0
6810571|NCT03110380|7743286|FG003|STARTED|Double-Blind Treatment Phase||0
6810572|NCT03110380|7743283|FG000|Safety Analysis Set|Double-Blind Treatment Phase||284
6810573|NCT03110380|7743284|FG001|Safety Analysis Set|Double-Blind Treatment Phase||281
6810574|NCT03110380|7743285|FG002|Safety Analysis Set|Double-Blind Treatment Phase||0
6810575|NCT03110380|7743286|FG003|Safety Analysis Set|Double-Blind Treatment Phase||0
6810576|NCT03110380|7743283|FG000|COMPLETED|Double-Blind Treatment Phase||263
6567341|NCT01831089|7490465|FG004|STARTED|Cohort I: Dose Level 1||0
6810577|NCT03110380|7743284|FG001|COMPLETED|Double-Blind Treatment Phase||253
6810578|NCT03110380|7743285|FG002|COMPLETED|Double-Blind Treatment Phase||0
6810579|NCT03110380|7743286|FG003|COMPLETED|Double-Blind Treatment Phase||0
6810580|NCT03110380|7743283|FG000|NOT COMPLETED|Double-Blind Treatment Phase||21
6810581|NCT03110380|7743284|FG001|NOT COMPLETED|Double-Blind Treatment Phase||30
6567342|NCT01831089|7490466|FG005|STARTED|Cohort I: Dose Level 1||0
6567343|NCT01831089|7490461|FG000|COMPLETED|Cohort I: Dose Level 1||0
6810582|NCT03110380|7743285|FG002|NOT COMPLETED|Double-Blind Treatment Phase||0
6810583|NCT03110380|7743286|FG003|NOT COMPLETED|Double-Blind Treatment Phase||0
6810584|NCT03110380|7743283|FG000|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
6810585|NCT03110380|7743284|FG001|STARTED|Open-label B/F/TAF Extension Phase|Following the end of Double-Blind treatment phase, participants in a country where B/F/TAF FDC was not available were given the option to receive open-label B/F/TAF.|0
6810586|NCT03110380|7743285|FG002|STARTED|Open-label B/F/TAF Extension Phase|138 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|125
6810587|NCT03110380|7743286|FG003|STARTED|Open-label B/F/TAF Extension Phase|137 participants completed the Double-Blind treatment phase, but did not continue in the Open-label B/F/TAF extension phase.|116
6810588|NCT03110380|7743283|FG000|COMPLETED|Open-label B/F/TAF Extension Phase||0
6810589|NCT03110380|7743284|FG001|COMPLETED|Open-label B/F/TAF Extension Phase||0
6810590|NCT03110380|7743285|FG002|COMPLETED|Open-label B/F/TAF Extension Phase||121
6810591|NCT03110380|7743286|FG003|COMPLETED|Open-label B/F/TAF Extension Phase||113
6810592|NCT03110380|7743283|FG000|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
6810593|NCT03110380|7743284|FG001|NOT COMPLETED|Open-label B/F/TAF Extension Phase||0
6810594|NCT03110380|7743285|FG002|NOT COMPLETED|Open-label B/F/TAF Extension Phase||4
6810595|NCT03110380|7743286|FG003|NOT COMPLETED|Open-label B/F/TAF Extension Phase||3
6810596|NCT03109262|7743294|FG000|STARTED|Overall Study||42
6810597|NCT03109262|7743294|FG000|COMPLETED|Overall Study||42
6810598|NCT03109262|7743294|FG000|NOT COMPLETED|Overall Study||0
6810599|NCT03078478|7743302|FG000|STARTED|Titration Period (16 Weeks)||805
6810600|NCT03078478|7743303|FG001|STARTED|Titration Period (16 Weeks)||804
6810601|NCT03078478|7743302|FG000|Full Analysis Set|Titration Period (16 Weeks)||805
6810602|NCT03078478|7743303|FG001|Full Analysis Set|Titration Period (16 Weeks)||804
6810603|NCT03078478|7743302|FG000|Safety Analysis Set|Titration Period (16 Weeks)||802
6810604|NCT03078478|7743303|FG001|Safety Analysis Set|Titration Period (16 Weeks)||798
6810605|NCT03078478|7743302|FG000|COMPLETED|Titration Period (16 Weeks)||805
6810606|NCT03078478|7743303|FG001|COMPLETED|Titration Period (16 Weeks)||804
6810607|NCT03078478|7743302|FG000|NOT COMPLETED|Titration Period (16 Weeks)||0
6810608|NCT03078478|7743303|FG001|NOT COMPLETED|Titration Period (16 Weeks)||0
6810609|NCT03078478|7743302|FG000|STARTED|Maintenance Period 1 (36 Weeks)||805
6810610|NCT03078478|7743303|FG001|STARTED|Maintenance Period 1 (36 Weeks)||804
6810611|NCT03078478|7743302|FG000|COMPLETED|Maintenance Period 1 (36 Weeks)||758
6810612|NCT03078478|7743303|FG001|COMPLETED|Maintenance Period 1 (36 Weeks)||761
6810613|NCT03078478|7743302|FG000|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||47
6810614|NCT03078478|7743303|FG001|NOT COMPLETED|Maintenance Period 1 (36 Weeks)||43
6810615|NCT03078478|7743302|FG000|STARTED|Maintencance Period 2 (36 Weeks)||758
6810616|NCT03078478|7743303|FG001|STARTED|Maintencance Period 2 (36 Weeks)||761
6810617|NCT03078478|7743302|FG000|COMPLETED|Maintencance Period 2 (36 Weeks)||733
6810618|NCT03078478|7743303|FG001|COMPLETED|Maintencance Period 2 (36 Weeks)||734
6810619|NCT03078478|7743302|FG000|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||25
6810620|NCT03078478|7743303|FG001|NOT COMPLETED|Maintencance Period 2 (36 Weeks)||27
6810621|NCT03040661|7743311|FG000|STARTED|Overall Study||35
6810622|NCT03040661|7743312|FG001|STARTED|Overall Study||35
6275887|NCT00115934|7175120|FG000|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
6275888|NCT00115934|7175121|FG001|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
6567344|NCT01831089|7490462|FG001|COMPLETED|Cohort I: Dose Level 1||0
6567345|NCT01831089|7490463|FG002|COMPLETED|Cohort I: Dose Level 1||0
6567346|NCT01831089|7490464|FG003|COMPLETED|Cohort I: Dose Level 1||0
6275889|NCT00115934|7175120|FG000|COMPLETED|Overall Study||275
6275890|NCT00115934|7175121|FG001|COMPLETED|Overall Study||274
6275891|NCT00115934|7175120|FG000|NOT COMPLETED|Overall Study||4
6275892|NCT00115934|7175121|FG001|NOT COMPLETED|Overall Study||2
6275893|NCT00116168|7175131|FG000|STARTED|Overall Study||6
6275894|NCT00116168|7175132|FG001|STARTED|Overall Study||11
6275895|NCT00116168|7175133|FG002|STARTED|Overall Study||6
6275896|NCT00116168|7175134|FG003|STARTED|Overall Study||6
6275897|NCT00116168|7175131|FG000|COMPLETED|Overall Study||0
6275898|NCT00116168|7175132|FG001|COMPLETED|Overall Study||6
6275899|NCT00116168|7175133|FG002|COMPLETED|Overall Study||6
6275900|NCT00116168|7175134|FG003|COMPLETED|Overall Study||6
6275901|NCT00116168|7175131|FG000|NOT COMPLETED|Overall Study||6
6275902|NCT00116168|7175132|FG001|NOT COMPLETED|Overall Study||5
6275903|NCT00116168|7175133|FG002|NOT COMPLETED|Overall Study||0
6275904|NCT00116168|7175134|FG003|NOT COMPLETED|Overall Study||0
6275905|NCT00116207|7175146|FG000|STARTED|Overall Study||22
6275906|NCT00116207|7175147|FG001|STARTED|Overall Study||22
6275907|NCT00116207|7175146|FG000|COMPLETED|Overall Study||13
6275908|NCT00116207|7175147|FG001|COMPLETED|Overall Study||18
6275909|NCT00116207|7175146|FG000|NOT COMPLETED|Overall Study||9
6275910|NCT00116207|7175147|FG001|NOT COMPLETED|Overall Study||4
6275911|NCT00116272|7175155|FG000|STARTED|Overall Study||370
6275912|NCT00116272|7175156|FG001|STARTED|Overall Study||164
6275913|NCT00116272|7175155|FG000|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
6275914|NCT00116272|7175156|FG001|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
6275915|NCT00116272|7175155|FG000|NOT COMPLETED|Overall Study||11
6567347|NCT01831089|7490465|FG004|COMPLETED|Cohort I: Dose Level 1||0
6567348|NCT01831089|7490466|FG005|COMPLETED|Cohort I: Dose Level 1||0
6567349|NCT01831089|7490461|FG000|NOT COMPLETED|Cohort I: Dose Level 1||3
6567350|NCT01831089|7490462|FG001|NOT COMPLETED|Cohort I: Dose Level 1||0
6810623|NCT03040661|7743311|FG000|COMPLETED|Overall Study||35
6275916|NCT00116272|7175156|FG001|NOT COMPLETED|Overall Study||6
6275917|NCT00116337|7175164|FG000|STARTED|Overall Study||17
6275918|NCT00116337|7175164|FG000|COMPLETED|Overall Study||17
6275919|NCT00116337|7175164|FG000|NOT COMPLETED|Overall Study||0
6275920|NCT00116428|7175177|FG000|STARTED|Overall Study||106
6275921|NCT00116428|7175178|FG001|STARTED|Overall Study||61
6275922|NCT00116428|7175177|FG000|Underwent Study Ablation Procedure|Overall Study||103
6275923|NCT00116428|7175178|FG001|Underwent Study Ablation Procedure|Overall Study||36
6275924|NCT00116428|7175177|FG000|COMPLETED|Overall Study||103
6275925|NCT00116428|7175178|FG001|COMPLETED|Overall Study||56
6810624|NCT03040661|7743312|FG001|COMPLETED|Overall Study||35
6810625|NCT03040661|7743311|FG000|NOT COMPLETED|Overall Study||0
6810626|NCT03040661|7743312|FG001|NOT COMPLETED|Overall Study||0
6810627|NCT02993263|7743318|FG000|STARTED|Overall Study||323
6810628|NCT02993263|7743318|FG000|COMPLETED|Overall Study||0
6810629|NCT02993263|7743318|FG000|NOT COMPLETED|Overall Study||323
6275926|NCT00116428|7175177|FG000|NOT COMPLETED|Overall Study||3
6275927|NCT00116428|7175178|FG001|NOT COMPLETED|Overall Study||5
6275928|NCT00116558|7175190|FG000|STARTED|Overall Study||80
6275929|NCT00116558|7175191|FG001|STARTED|Overall Study||26
6275930|NCT00116558|7175192|FG002|STARTED|Overall Study||47
6567351|NCT01831089|7490463|FG002|NOT COMPLETED|Cohort I: Dose Level 1||0
6810630|NCT02985684|7743322|FG000|STARTED|6-Month Clinical Success Evaluation||125
6810631|NCT02985684|7743322|FG000|COMPLETED|6-Month Clinical Success Evaluation||120
6810632|NCT02985684|7743322|FG000|NOT COMPLETED|6-Month Clinical Success Evaluation||5
6810633|NCT02985684|7743322|FG000|STARTED|6-Month Closure Success Evaluation||120
6810634|NCT02985684|7743322|FG000|COMPLETED|6-Month Closure Success Evaluation||112
6810635|NCT02985684|7743322|FG000|NOT COMPLETED|6-Month Closure Success Evaluation||8
6810636|NCT02964897|7743328|FG000|STARTED|Overall Study||43
6810637|NCT02964897|7743329|FG001|STARTED|Overall Study||36
6810638|NCT02964897|7743328|FG000|COMPLETED|Overall Study||43
6810639|NCT02964897|7743329|FG001|COMPLETED|Overall Study||36
6810640|NCT02964897|7743328|FG000|NOT COMPLETED|Overall Study||0
6810641|NCT02964897|7743329|FG001|NOT COMPLETED|Overall Study||0
6810642|NCT02873195|7743337|FG000|STARTED|Overall Study||87
6810643|NCT02873195|7743338|FG001|STARTED|Overall Study||46
6810644|NCT02873195|7743337|FG000|Never Began Treatment (Cancel)|Overall Study||1
6810645|NCT02873195|7743338|FG001|Never Began Treatment (Cancel)|Overall Study||0
6810646|NCT02873195|7743337|FG000|COMPLETED|Overall Study||82
6810647|NCT02873195|7743338|FG001|COMPLETED|Overall Study||46
6810648|NCT02873195|7743337|FG000|NOT COMPLETED|Overall Study||5
6810649|NCT02873195|7743338|FG001|NOT COMPLETED|Overall Study||0
6810650|NCT02785952|7743346|FG000|STARTED|Overall Study||125
6810651|NCT02785952|7743347|FG001|STARTED|Overall Study||127
6810652|NCT02785952|7743346|FG000|COMPLETED|Overall Study||0
6810653|NCT02785952|7743347|FG001|COMPLETED|Overall Study||0
6810654|NCT02785952|7743346|FG000|NOT COMPLETED|Overall Study||125
6810655|NCT02785952|7743347|FG001|NOT COMPLETED|Overall Study||127
6810656|NCT02758717|7743355|FG000|STARTED|Overall Study||46
6810657|NCT02758717|7743355|FG000|COMPLETED|Overall Study||46
6810658|NCT02758717|7743355|FG000|NOT COMPLETED|Overall Study||0
6810659|NCT02748616|7743359|FG000|STARTED|Overall Study||9
6810660|NCT02748616|7743359|FG000|COMPLETED|Overall Study||2
6810661|NCT02748616|7743359|FG000|NOT COMPLETED|Overall Study||7
6810662|NCT02719522|7743363|FG000|STARTED|Overall Study|In 1 consented subject, device deployment was not attempted due to significant arterial stenosis.|204
6810663|NCT02719522|7743363|FG000|COMPLETED|Overall Study||193
6810664|NCT02719522|7743363|FG000|NOT COMPLETED|Overall Study||11
6810665|NCT02664181|7743369|FG000|STARTED|Overall Study||8
6810666|NCT02664181|7743370|FG001|STARTED|Overall Study||5
6810667|NCT02664181|7743369|FG000|COMPLETED|Overall Study||8
6810668|NCT02664181|7743370|FG001|COMPLETED|Overall Study||5
6810669|NCT02664181|7743369|FG000|NOT COMPLETED|Overall Study||0
6810670|NCT02664181|7743370|FG001|NOT COMPLETED|Overall Study||0
6810671|NCT02633241|7743376|FG000|STARTED|Overall Study||30
6810672|NCT02633241|7743376|FG000|COMPLETED|Overall Study||27
6810673|NCT02633241|7743376|FG000|NOT COMPLETED|Overall Study||3
6810674|NCT02585232|7743384|FG000|STARTED|Overall Study||40
6810675|NCT02585232|7743385|FG001|STARTED|Overall Study||42
6810676|NCT02585232|7743384|FG000|COMPLETED|Overall Study||28
6810677|NCT02585232|7743385|FG001|COMPLETED|Overall Study||26
6810678|NCT02585232|7743384|FG000|NOT COMPLETED|Overall Study||12
6810679|NCT02585232|7743385|FG001|NOT COMPLETED|Overall Study||16
6810680|NCT02583269|7743396|FG000|STARTED|Overall Study||3
6810681|NCT02583269|7743397|FG001|STARTED|Overall Study||7
6810682|NCT02583269|7743398|FG002|STARTED|Overall Study||3
6810683|NCT02583269|7743399|FG003|STARTED|Overall Study||5
6810684|NCT02583269|7743400|FG004|STARTED|Overall Study||6
6810685|NCT02583269|7743396|FG000|COMPLETED|Overall Study||2
6810686|NCT02583269|7743397|FG001|COMPLETED|Overall Study||7
6810687|NCT02583269|7743398|FG002|COMPLETED|Overall Study||3
6810688|NCT02583269|7743399|FG003|COMPLETED|Overall Study||5
6810689|NCT02583269|7743400|FG004|COMPLETED|Overall Study||6
6810690|NCT02583269|7743396|FG000|NOT COMPLETED|Overall Study||1
6810691|NCT02583269|7743397|FG001|NOT COMPLETED|Overall Study||0
6810692|NCT02583269|7743398|FG002|NOT COMPLETED|Overall Study||0
6810693|NCT02583269|7743399|FG003|NOT COMPLETED|Overall Study||0
6810694|NCT02583269|7743400|FG004|NOT COMPLETED|Overall Study||0
6810695|NCT02556606|7743417|FG000|STARTED|Overall Study||4
6810696|NCT02556606|7743418|FG001|STARTED|Overall Study||5
6810697|NCT02556606|7743419|FG002|STARTED|Overall Study||11
6810698|NCT02556606|7743420|FG003|STARTED|Overall Study||13
6810699|NCT02556606|7743417|FG000|COMPLETED|Overall Study||4
6810700|NCT02556606|7743418|FG001|COMPLETED|Overall Study||5
6810701|NCT02556606|7743419|FG002|COMPLETED|Overall Study||11
6810702|NCT02556606|7743420|FG003|COMPLETED|Overall Study||13
6810703|NCT02556606|7743417|FG000|NOT COMPLETED|Overall Study||0
6810704|NCT02556606|7743418|FG001|NOT COMPLETED|Overall Study||0
6810705|NCT02556606|7743419|FG002|NOT COMPLETED|Overall Study||0
6810706|NCT02556606|7743420|FG003|NOT COMPLETED|Overall Study||0
6810707|NCT02545283|7743436|FG000|STARTED|Overall Study||149
6810708|NCT02545283|7743437|FG001|STARTED|Overall Study||298
6810709|NCT02545283|7743436|FG000|Received Treatment|Overall Study||149
6810710|NCT02545283|7743437|FG001|Received Treatment|Overall Study||292
6810711|NCT02545283|7743436|FG000|Safety Follow Up|Overall Study|I participant was not treated and 1 participant entered from the Idasanutlin arm|149
6810712|NCT02545283|7743437|FG001|Safety Follow Up|Overall Study|5 participants were not treated, 1 participant did not receive Idasanutlin and was moved to the Placebo arm|292
6810713|NCT02545283|7743436|FG000|COMPLETED|Overall Study||0
6810714|NCT02545283|7743437|FG001|COMPLETED|Overall Study||0
6810715|NCT02545283|7743436|FG000|NOT COMPLETED|Overall Study||149
6810716|NCT02545283|7743437|FG001|NOT COMPLETED|Overall Study||298
6810717|NCT02524171|7743447|FG000|STARTED|6-month Follow-up||172
6810718|NCT02524171|7743448|FG001|STARTED|6-month Follow-up||169
6810719|NCT02524171|7743447|FG000|COMPLETED|6-month Follow-up||119
6810720|NCT02524171|7743448|FG001|COMPLETED|6-month Follow-up||124
6810721|NCT02524171|7743447|FG000|NOT COMPLETED|6-month Follow-up||53
6810722|NCT02524171|7743448|FG001|NOT COMPLETED|6-month Follow-up||45
6810723|NCT02524171|7743447|FG000|STARTED|12-month Follow-up Interview||172
6810724|NCT02524171|7743448|FG001|STARTED|12-month Follow-up Interview||169
6810725|NCT02524171|7743447|FG000|COMPLETED|12-month Follow-up Interview||127
6810726|NCT02524171|7743448|FG001|COMPLETED|12-month Follow-up Interview||128
6810727|NCT02524171|7743447|FG000|NOT COMPLETED|12-month Follow-up Interview||45
6810728|NCT02524171|7743448|FG001|NOT COMPLETED|12-month Follow-up Interview||41
6810729|NCT02489422|7743456|FG000|STARTED|Overall Study||23
6810730|NCT02489422|7743457|FG001|STARTED|Overall Study||21
6810731|NCT02489422|7743456|FG000|COMPLETED|Overall Study||23
6810732|NCT02489422|7743457|FG001|COMPLETED|Overall Study||21
6810733|NCT02489422|7743456|FG000|NOT COMPLETED|Overall Study||0
6810734|NCT02489422|7743457|FG001|NOT COMPLETED|Overall Study||0
6810735|NCT02487251|7743468|FG000|STARTED|Overall Study||434
6810736|NCT02487251|7743469|FG001|STARTED|Overall Study||65
6810737|NCT02487251|7743470|FG002|STARTED|Overall Study||152
6810738|NCT02487251|7743471|FG003|STARTED|Overall Study||159
6810739|NCT02487251|7743468|FG000|COMPLETED|Overall Study||366
6810740|NCT02487251|7743469|FG001|COMPLETED|Overall Study||55
6810741|NCT02487251|7743470|FG002|COMPLETED|Overall Study||125
6810742|NCT02487251|7743471|FG003|COMPLETED|Overall Study||134
6810743|NCT02487251|7743468|FG000|NOT COMPLETED|Overall Study||68
6810744|NCT02487251|7743469|FG001|NOT COMPLETED|Overall Study||10
6810745|NCT02487251|7743470|FG002|NOT COMPLETED|Overall Study||27
6810746|NCT02487251|7743471|FG003|NOT COMPLETED|Overall Study||25
6810747|NCT02476968|7743484|FG000|STARTED|Overall Study||145
6810748|NCT02476968|7743485|FG001|STARTED|Overall Study||33
6810749|NCT02476968|7743486|FG002|STARTED|Overall Study||3
6810750|NCT02476968|7743484|FG000|Received Treatment|Overall Study||143
6810751|NCT02476968|7743485|FG001|Received Treatment|Overall Study||32
6810752|NCT02476968|7743486|FG002|Received Treatment|Overall Study||2
6810753|NCT02476968|7743484|FG000|COMPLETED|Overall Study||71
6810754|NCT02476968|7743485|FG001|COMPLETED|Overall Study||18
6810755|NCT02476968|7743486|FG002|COMPLETED|Overall Study||1
6810756|NCT02476968|7743484|FG000|NOT COMPLETED|Overall Study||74
6810757|NCT02476968|7743485|FG001|NOT COMPLETED|Overall Study||15
6810758|NCT02476968|7743486|FG002|NOT COMPLETED|Overall Study||2
6810759|NCT02306122|7743503|FG000|STARTED|Initial Physician Randomization||0
6810760|NCT02306122|7743504|FG001|STARTED|Initial Physician Randomization||0
6810761|NCT02306122|7743505|FG002|STARTED|Initial Physician Randomization||0
6810762|NCT02306122|7743506|FG003|STARTED|Initial Physician Randomization||0
6810763|NCT02306122|7743507|FG004|STARTED|Initial Physician Randomization||0
6810764|NCT02306122|7743508|FG005|STARTED|Initial Physician Randomization||0
6810765|NCT02306122|7743509|FG006|STARTED|Initial Physician Randomization||0
6810766|NCT02306122|7743510|FG007|STARTED|Initial Physician Randomization||0
6810767|NCT02306122|7743511|FG008|STARTED|Initial Physician Randomization||29
6810768|NCT02306122|7743512|FG009|STARTED|Initial Physician Randomization||31
6810769|NCT02306122|7743513|FG010|STARTED|Initial Physician Randomization||31
6810770|NCT02306122|7743503|FG000|COMPLETED|Initial Physician Randomization||0
6810771|NCT02306122|7743504|FG001|COMPLETED|Initial Physician Randomization||0
6810772|NCT02306122|7743505|FG002|COMPLETED|Initial Physician Randomization||0
6810773|NCT02306122|7743506|FG003|COMPLETED|Initial Physician Randomization||0
6810774|NCT02306122|7743507|FG004|COMPLETED|Initial Physician Randomization||0
6810775|NCT02306122|7743508|FG005|COMPLETED|Initial Physician Randomization||0
6810776|NCT02306122|7743509|FG006|COMPLETED|Initial Physician Randomization||0
6810777|NCT02306122|7743510|FG007|COMPLETED|Initial Physician Randomization||0
6810778|NCT02306122|7743511|FG008|COMPLETED|Initial Physician Randomization||28
6810779|NCT02306122|7743512|FG009|COMPLETED|Initial Physician Randomization||31
6810780|NCT02306122|7743513|FG010|COMPLETED|Initial Physician Randomization||31
6810781|NCT02306122|7743503|FG000|NOT COMPLETED|Initial Physician Randomization||0
6810782|NCT02306122|7743504|FG001|NOT COMPLETED|Initial Physician Randomization||0
6810783|NCT02306122|7743505|FG002|NOT COMPLETED|Initial Physician Randomization||0
6810784|NCT02306122|7743506|FG003|NOT COMPLETED|Initial Physician Randomization||0
6810785|NCT02306122|7743507|FG004|NOT COMPLETED|Initial Physician Randomization||0
6810786|NCT02306122|7743508|FG005|NOT COMPLETED|Initial Physician Randomization||0
6810787|NCT02306122|7743509|FG006|NOT COMPLETED|Initial Physician Randomization||0
6810788|NCT02306122|7743510|FG007|NOT COMPLETED|Initial Physician Randomization||0
6810789|NCT02306122|7743511|FG008|NOT COMPLETED|Initial Physician Randomization||1
6810790|NCT02306122|7743512|FG009|NOT COMPLETED|Initial Physician Randomization||0
6810791|NCT02306122|7743513|FG010|NOT COMPLETED|Initial Physician Randomization||0
6810792|NCT02306122|7743503|FG000|STARTED|Post Nonadherence Subgroup Randomization||244
6810793|NCT02306122|7743504|FG001|STARTED|Post Nonadherence Subgroup Randomization||123
6810794|NCT02306122|7743505|FG002|STARTED|Post Nonadherence Subgroup Randomization||121
6810795|NCT02306122|7743506|FG003|STARTED|Post Nonadherence Subgroup Randomization||274
6810796|NCT02306122|7743507|FG004|STARTED|Post Nonadherence Subgroup Randomization||134
6810797|NCT02306122|7743508|FG005|STARTED|Post Nonadherence Subgroup Randomization||137
6810798|NCT02306122|7743509|FG006|STARTED|Post Nonadherence Subgroup Randomization||220
6810799|NCT02306122|7743510|FG007|STARTED|Post Nonadherence Subgroup Randomization||221
6810800|NCT02306122|7743511|FG008|STARTED|Post Nonadherence Subgroup Randomization||28
6810801|NCT02306122|7743512|FG009|STARTED|Post Nonadherence Subgroup Randomization||31
6810802|NCT02306122|7743513|FG010|STARTED|Post Nonadherence Subgroup Randomization||31
6810803|NCT02306122|7743503|FG000|COMPLETED|Post Nonadherence Subgroup Randomization||244
6810804|NCT02306122|7743504|FG001|COMPLETED|Post Nonadherence Subgroup Randomization||123
6810805|NCT02306122|7743505|FG002|COMPLETED|Post Nonadherence Subgroup Randomization||121
6810806|NCT02306122|7743506|FG003|COMPLETED|Post Nonadherence Subgroup Randomization||274
6810807|NCT02306122|7743507|FG004|COMPLETED|Post Nonadherence Subgroup Randomization||134
6810808|NCT02306122|7743508|FG005|COMPLETED|Post Nonadherence Subgroup Randomization||137
6810809|NCT02306122|7743509|FG006|COMPLETED|Post Nonadherence Subgroup Randomization||220
6810810|NCT02306122|7743510|FG007|COMPLETED|Post Nonadherence Subgroup Randomization||221
6810811|NCT02306122|7743511|FG008|COMPLETED|Post Nonadherence Subgroup Randomization||28
6810812|NCT02306122|7743512|FG009|COMPLETED|Post Nonadherence Subgroup Randomization||31
6810813|NCT02306122|7743513|FG010|COMPLETED|Post Nonadherence Subgroup Randomization||31
6810814|NCT02306122|7743503|FG000|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810815|NCT02306122|7743504|FG001|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810816|NCT02306122|7743505|FG002|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810817|NCT02306122|7743506|FG003|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810818|NCT02306122|7743507|FG004|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810819|NCT02306122|7743508|FG005|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810820|NCT02306122|7743509|FG006|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810821|NCT02306122|7743510|FG007|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810822|NCT02306122|7743511|FG008|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810823|NCT02306122|7743512|FG009|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810824|NCT02306122|7743513|FG010|NOT COMPLETED|Post Nonadherence Subgroup Randomization||0
6810825|NCT02304991|7743533|FG000|STARTED|Overall Study||25
6810826|NCT02304991|7743534|FG001|STARTED|Overall Study||25
6810827|NCT02304991|7743533|FG000|COMPLETED|Overall Study||18
6810828|NCT02304991|7743534|FG001|COMPLETED|Overall Study||15
6810829|NCT02304991|7743533|FG000|NOT COMPLETED|Overall Study||7
6810830|NCT02304991|7743534|FG001|NOT COMPLETED|Overall Study||10
6810831|NCT02223520|7743542|FG000|STARTED|Overall Study||147
6810832|NCT02223520|7743543|FG001|STARTED|Overall Study||160
6810833|NCT02223520|7743542|FG000|COMPLETED|Overall Study|101 neonates of these parents were enrolled. 12 were lost to follow-up.|147
6810834|NCT02223520|7743543|FG001|COMPLETED|Overall Study|107 neonates of these parents were enrolled. 6 were lost to follow-up.|160
6810835|NCT02223520|7743542|FG000|NOT COMPLETED|Overall Study||0
6810836|NCT02223520|7743543|FG001|NOT COMPLETED|Overall Study||0
6810837|NCT02147184|7743551|FG000|STARTED|Overall Study||127
6810838|NCT02147184|7743552|FG001|STARTED|Overall Study||137
6810839|NCT02147184|7743551|FG000|COMPLETED|Overall Study||78
6810840|NCT02147184|7743552|FG001|COMPLETED|Overall Study||110
6810841|NCT02147184|7743551|FG000|NOT COMPLETED|Overall Study||49
6810842|NCT02147184|7743552|FG001|NOT COMPLETED|Overall Study||27
6810843|NCT02122198|7743560|FG000|STARTED|Overall Study||5
6810844|NCT02122198|7743561|FG001|STARTED|Overall Study||12
6504730|NCT01449630|7423756|FG001|STARTED|Period 3||6
6504731|NCT01449630|7423757|FG002|STARTED|Period 3||2
6504732|NCT01449630|7423758|FG003|STARTED|Period 3||1
6504733|NCT01449630|7423759|FG004|STARTED|Period 3||5
6504734|NCT01449630|7423760|FG005|STARTED|Period 3||1
6810845|NCT02122198|7743560|FG000|COMPLETED|Overall Study||3
6810846|NCT02122198|7743561|FG001|COMPLETED|Overall Study||10
6810847|NCT02122198|7743560|FG000|NOT COMPLETED|Overall Study||2
6810848|NCT02122198|7743561|FG001|NOT COMPLETED|Overall Study||2
6810849|NCT02055053|7743570|FG000|STARTED|Overall Study||35
6810850|NCT02055053|7743571|FG001|STARTED|Overall Study||35
6810851|NCT02055053|7743570|FG000|COMPLETED|Overall Study||35
6810852|NCT02055053|7743571|FG001|COMPLETED|Overall Study||35
6810853|NCT02055053|7743570|FG000|NOT COMPLETED|Overall Study||0
6810854|NCT02055053|7743571|FG001|NOT COMPLETED|Overall Study||0
6810855|NCT02000219|7743577|FG000|STARTED|14-Week Study Period||12
6810856|NCT02000219|7743577|FG000|COMPLETED|14-Week Study Period||9
6810857|NCT02000219|7743577|FG000|NOT COMPLETED|14-Week Study Period||3
6504735|NCT01449630|7423761|FG006|STARTED|Period 3||1
6504736|NCT01449630|7423762|FG007|STARTED|Period 3||6
6504737|NCT01449630|7423763|FG008|STARTED|Period 3||2
6504738|NCT01449630|7423755|FG000|COMPLETED|Period 3||1
6810858|NCT02000219|7743577|FG000|STARTED|Continuation Period||8
6810859|NCT02000219|7743577|FG000|COMPLETED|Continuation Period||3
6810860|NCT02000219|7743577|FG000|NOT COMPLETED|Continuation Period||5
6810861|NCT01978938|7743583|FG000|STARTED|Overall Study||455
6810862|NCT01978938|7743584|FG001|STARTED|Overall Study||453
6810863|NCT01978938|7743583|FG000|Received at Least 1 Dose of Study Drug|Overall Study||454
6810864|NCT01978938|7743584|FG001|Received at Least 1 Dose of Study Drug|Overall Study||451
6810865|NCT01978938|7743583|FG000|COMPLETED|Overall Study||432
6810866|NCT01978938|7743584|FG001|COMPLETED|Overall Study||439
6810867|NCT01978938|7743583|FG000|NOT COMPLETED|Overall Study||23
6810868|NCT01978938|7743584|FG001|NOT COMPLETED|Overall Study||14
6810869|NCT01854385|7743590|FG000|STARTED|Pre-Treatment||40
6810870|NCT01854385|7743590|FG000|COMPLETED|Pre-Treatment||17
6810871|NCT01854385|7743590|FG000|NOT COMPLETED|Pre-Treatment||23
6810872|NCT01854385|7743590|FG000|STARTED|Treatment||17
6810873|NCT01854385|7743590|FG000|COMPLETED|Treatment||16
6810874|NCT01854385|7743590|FG000|NOT COMPLETED|Treatment||1
6810875|NCT01844856|7743596|FG000|STARTED|Overall Study||270
6810876|NCT01844856|7743597|FG001|STARTED|Overall Study||271
6810877|NCT01844856|7743596|FG000|Received at Least 1 Dose of Study Drug|Overall Study||270
6810878|NCT01844856|7743597|FG001|Received at Least 1 Dose of Study Drug|Overall Study||268
6810879|NCT01844856|7743596|FG000|COMPLETED|Overall Study||246
6810880|NCT01844856|7743597|FG001|COMPLETED|Overall Study||255
6810881|NCT01844856|7743596|FG000|NOT COMPLETED|Overall Study||24
6810882|NCT01844856|7743597|FG001|NOT COMPLETED|Overall Study||16
6810883|NCT01788306|7743605|FG000|STARTED|Overall Study||125
6810884|NCT01788306|7743606|FG001|STARTED|Overall Study||131
6810885|NCT01788306|7743605|FG000|COMPLETED|Overall Study||115
6810886|NCT01788306|7743606|FG001|COMPLETED|Overall Study||126
6810887|NCT01788306|7743605|FG000|NOT COMPLETED|Overall Study||10
6810888|NCT01788306|7743606|FG001|NOT COMPLETED|Overall Study||5
6810889|NCT01776723|7743623|FG000|STARTED|Overall Study||6
6810890|NCT01776723|7743624|FG001|STARTED|Overall Study||4
6810891|NCT01776723|7743625|FG002|STARTED|Overall Study||5
6810892|NCT01776723|7743626|FG003|STARTED|Overall Study||5
6810893|NCT01776723|7743627|FG004|STARTED|Overall Study||30
6810894|NCT01776723|7743623|FG000|COMPLETED|Overall Study||6
6810895|NCT01776723|7743624|FG001|COMPLETED|Overall Study||4
6810896|NCT01776723|7743625|FG002|COMPLETED|Overall Study||5
6810897|NCT01776723|7743626|FG003|COMPLETED|Overall Study||5
6810898|NCT01776723|7743627|FG004|COMPLETED|Overall Study||30
6810899|NCT01776723|7743623|FG000|NOT COMPLETED|Overall Study||0
6810900|NCT01776723|7743624|FG001|NOT COMPLETED|Overall Study||0
6810901|NCT01776723|7743625|FG002|NOT COMPLETED|Overall Study||0
6810902|NCT01776723|7743626|FG003|NOT COMPLETED|Overall Study||0
6810903|NCT01776723|7743627|FG004|NOT COMPLETED|Overall Study||0
6810904|NCT01744041|7743645|FG000|STARTED|Overall Study||21
6810905|NCT01744041|7743646|FG001|STARTED|Overall Study||21
6810906|NCT01744041|7743645|FG000|COMPLETED|Overall Study||15
6810907|NCT01744041|7743646|FG001|COMPLETED|Overall Study||13
6810908|NCT01744041|7743645|FG000|NOT COMPLETED|Overall Study||6
6810909|NCT01744041|7743646|FG001|NOT COMPLETED|Overall Study||8
6504739|NCT01449630|7423756|FG001|COMPLETED|Period 3||6
6810910|NCT01733147|7743654|FG000|STARTED|Overall Study||30
6810911|NCT01733147|7743655|FG001|STARTED|Overall Study||30
6810912|NCT01733147|7743654|FG000|COMPLETED|Overall Study||30
6810913|NCT01733147|7743655|FG001|COMPLETED|Overall Study||30
6810914|NCT01733147|7743654|FG000|NOT COMPLETED|Overall Study||0
6810915|NCT01733147|7743655|FG001|NOT COMPLETED|Overall Study||0
6810916|NCT01712789|7743661|FG000|STARTED|Overall Study||682
6810917|NCT01712789|7743661|FG000|Received Study Treatment|Overall Study||676
6810918|NCT01712789|7743661|FG000|COMPLETED|Overall Study||0
6810919|NCT01712789|7743661|FG000|NOT COMPLETED|Overall Study||682
6810920|NCT01651403|7743667|FG000|STARTED|Double-Blind Period (Through Week 48/72)||60
6810921|NCT01651403|7743668|FG001|STARTED|Double-Blind Period (Through Week 48/72)||30
6810922|NCT01651403|7743667|FG000|COMPLETED|Double-Blind Period (Through Week 48/72)||56
6810923|NCT01651403|7743668|FG001|COMPLETED|Double-Blind Period (Through Week 48/72)||25
6810924|NCT01651403|7743667|FG000|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||4
6810925|NCT01651403|7743668|FG001|NOT COMPLETED|Double-Blind Period (Through Week 48/72)||5
6810926|NCT01651403|7743667|FG000|STARTED|Open-Label Phase (Weeks 49/73-192)||56
6810927|NCT01651403|7743668|FG001|STARTED|Open-Label Phase (Weeks 49/73-192)||25
6810928|NCT01651403|7743667|FG000|COMPLETED|Open-Label Phase (Weeks 49/73-192)||35
6810929|NCT01651403|7743668|FG001|COMPLETED|Open-Label Phase (Weeks 49/73-192)||11
6810930|NCT01651403|7743667|FG000|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||21
6810931|NCT01651403|7743668|FG001|NOT COMPLETED|Open-Label Phase (Weeks 49/73-192)||14
6810932|NCT01543633|7743679|FG000|STARTED|Overall Study||36
6810933|NCT01543633|7743679|FG000|COMPLETED|Overall Study||17
6810934|NCT01543633|7743679|FG000|NOT COMPLETED|Overall Study||19
6810935|NCT01542736|7743683|FG000|STARTED|Overall Study||8
6810936|NCT01542736|7743683|FG000|COMPLETED|Overall Study||7
6810937|NCT01542736|7743683|FG000|NOT COMPLETED|Overall Study||1
6810938|NCT01535807|7743689|FG000|STARTED|Overall Study||22
6810939|NCT01535807|7743690|FG001|STARTED|Overall Study||22
6810940|NCT01535807|7743689|FG000|COMPLETED|Overall Study||20
6810941|NCT01535807|7743690|FG001|COMPLETED|Overall Study||20
6810942|NCT01535807|7743689|FG000|NOT COMPLETED|Overall Study||2
6810943|NCT01535807|7743690|FG001|NOT COMPLETED|Overall Study||2
6810944|NCT01147666|7743711|FG000|STARTED|Dosing Period 1: 6-Week Treatment||12
6810945|NCT01147666|7743712|FG001|STARTED|Dosing Period 1: 6-Week Treatment||12
6810946|NCT01147666|7743713|FG002|STARTED|Dosing Period 1: 6-Week Treatment||12
6810947|NCT01147666|7743714|FG003|STARTED|Dosing Period 1: 6-Week Treatment||12
6810948|NCT01147666|7743715|FG004|STARTED|Dosing Period 1: 6-Week Treatment||12
6810949|NCT01147666|7743716|FG005|STARTED|Dosing Period 1: 6-Week Treatment||12
6810950|NCT01147666|7743717|FG006|STARTED|Dosing Period 1: 6-Week Treatment||12
6810951|NCT01147666|7743718|FG007|STARTED|Dosing Period 1: 6-Week Treatment||12
6810952|NCT01147666|7743719|FG008|STARTED|Dosing Period 1: 6-Week Treatment||2
6810953|NCT01147666|7743720|FG009|STARTED|Dosing Period 1: 6-Week Treatment||10
6810954|NCT01147666|7743721|FG010|STARTED|Dosing Period 1: 6-Week Treatment||36
6810955|NCT01147666|7743722|FG011|STARTED|Dosing Period 1: 6-Week Treatment||4
6810956|NCT01147666|7743723|FG012|STARTED|Dosing Period 1: 6-Week Treatment||5
6810957|NCT01147666|7743724|FG013|STARTED|Dosing Period 1: 6-Week Treatment||4
6810958|NCT01147666|7743725|FG014|STARTED|Dosing Period 1: 6-Week Treatment||4
6810959|NCT01147666|7743711|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
6810960|NCT01147666|7743712|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
6810961|NCT01147666|7743713|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
6810962|NCT01147666|7743714|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
6567352|NCT01831089|7490464|FG003|NOT COMPLETED|Cohort I: Dose Level 1||0
6567353|NCT01831089|7490465|FG004|NOT COMPLETED|Cohort I: Dose Level 1||0
6567354|NCT01831089|7490466|FG005|NOT COMPLETED|Cohort I: Dose Level 1||0
6567355|NCT01831089|7490461|FG000|STARTED|Cohort II: Dose Level 2||0
6567356|NCT01831089|7490462|FG001|STARTED|Cohort II: Dose Level 2||3
6567357|NCT01831089|7490463|FG002|STARTED|Cohort II: Dose Level 2||0
6810963|NCT01147666|7743715|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
6567358|NCT01831089|7490464|FG003|STARTED|Cohort II: Dose Level 2||0
6567359|NCT01831089|7490465|FG004|STARTED|Cohort II: Dose Level 2||0
6567360|NCT01831089|7490466|FG005|STARTED|Cohort II: Dose Level 2||0
6567361|NCT01831089|7490461|FG000|COMPLETED|Cohort II: Dose Level 2||0
6567362|NCT01831089|7490462|FG001|COMPLETED|Cohort II: Dose Level 2||0
6567363|NCT01831089|7490463|FG002|COMPLETED|Cohort II: Dose Level 2||0
6567364|NCT01831089|7490464|FG003|COMPLETED|Cohort II: Dose Level 2||0
6567365|NCT01831089|7490465|FG004|COMPLETED|Cohort II: Dose Level 2||0
6567366|NCT01831089|7490466|FG005|COMPLETED|Cohort II: Dose Level 2||0
6810964|NCT01147666|7743716|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
6810965|NCT01147666|7743717|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
6810966|NCT01147666|7743718|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||12
6810967|NCT01147666|7743719|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||2
6810968|NCT01147666|7743720|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||10
6810969|NCT01147666|7743721|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||36
6810970|NCT01147666|7743722|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
6810971|NCT01147666|7743723|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||5
6567367|NCT01831089|7490461|FG000|NOT COMPLETED|Cohort II: Dose Level 2||0
6567368|NCT01831089|7490462|FG001|NOT COMPLETED|Cohort II: Dose Level 2||3
6810972|NCT01147666|7743724|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
6810973|NCT01147666|7743725|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 1: 6-Week Treatment||4
6810974|NCT01147666|7743711|FG000|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
6810975|NCT01147666|7743712|FG001|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
6810976|NCT01147666|7743713|FG002|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||9
6810977|NCT01147666|7743714|FG003|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
6810978|NCT01147666|7743715|FG004|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
6810979|NCT01147666|7743716|FG005|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
6810980|NCT01147666|7743717|FG006|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||11
6810981|NCT01147666|7743718|FG007|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
6810982|NCT01147666|7743719|FG008|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||2
6810983|NCT01147666|7743720|FG009|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||10
6810984|NCT01147666|7743721|FG010|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||31
6810985|NCT01147666|7743722|FG011|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||1
6567369|NCT01831089|7490463|FG002|NOT COMPLETED|Cohort II: Dose Level 2||0
6567370|NCT01831089|7490464|FG003|NOT COMPLETED|Cohort II: Dose Level 2||0
6567371|NCT01831089|7490465|FG004|NOT COMPLETED|Cohort II: Dose Level 2||0
6567372|NCT01831089|7490466|FG005|NOT COMPLETED|Cohort II: Dose Level 2||0
6567373|NCT01831089|7490461|FG000|STARTED|Cohort III: Dose Level 3||0
6567374|NCT01831089|7490462|FG001|STARTED|Cohort III: Dose Level 3||0
6810986|NCT01147666|7743723|FG012|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
6810987|NCT01147666|7743724|FG013|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||4
6810988|NCT01147666|7743725|FG014|Efficacy Evaluable (EE) Population|Dosing Period 1: 6-Week Treatment||3
6810989|NCT01147666|7743711|FG000|COMPLETED|Dosing Period 1: 6-Week Treatment||10
6810990|NCT01147666|7743712|FG001|COMPLETED|Dosing Period 1: 6-Week Treatment||10
6810991|NCT01147666|7743713|FG002|COMPLETED|Dosing Period 1: 6-Week Treatment||11
6810992|NCT01147666|7743714|FG003|COMPLETED|Dosing Period 1: 6-Week Treatment||10
6810993|NCT01147666|7743715|FG004|COMPLETED|Dosing Period 1: 6-Week Treatment||7
6810994|NCT01147666|7743716|FG005|COMPLETED|Dosing Period 1: 6-Week Treatment||9
6810995|NCT01147666|7743717|FG006|COMPLETED|Dosing Period 1: 6-Week Treatment||9
6810996|NCT01147666|7743718|FG007|COMPLETED|Dosing Period 1: 6-Week Treatment||9
6810997|NCT01147666|7743719|FG008|COMPLETED|Dosing Period 1: 6-Week Treatment||2
6810998|NCT01147666|7743720|FG009|COMPLETED|Dosing Period 1: 6-Week Treatment||8
6810999|NCT01147666|7743721|FG010|COMPLETED|Dosing Period 1: 6-Week Treatment||33
6811000|NCT01147666|7743722|FG011|COMPLETED|Dosing Period 1: 6-Week Treatment||2
6811001|NCT01147666|7743723|FG012|COMPLETED|Dosing Period 1: 6-Week Treatment||1
6811002|NCT01147666|7743724|FG013|COMPLETED|Dosing Period 1: 6-Week Treatment||3
6811003|NCT01147666|7743725|FG014|COMPLETED|Dosing Period 1: 6-Week Treatment||0
6811004|NCT01147666|7743711|FG000|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
6811005|NCT01147666|7743712|FG001|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
6811006|NCT01147666|7743713|FG002|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
6811007|NCT01147666|7743714|FG003|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
6811008|NCT01147666|7743715|FG004|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||5
6811009|NCT01147666|7743716|FG005|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
6811010|NCT01147666|7743717|FG006|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
6811011|NCT01147666|7743718|FG007|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
6811012|NCT01147666|7743719|FG008|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||0
6811013|NCT01147666|7743720|FG009|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
6811014|NCT01147666|7743721|FG010|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||3
6811015|NCT01147666|7743722|FG011|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||2
6811016|NCT01147666|7743723|FG012|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
6811017|NCT01147666|7743724|FG013|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||1
6567375|NCT01831089|7490463|FG002|STARTED|Cohort III: Dose Level 3||6
6567376|NCT01831089|7490464|FG003|STARTED|Cohort III: Dose Level 3||0
6567377|NCT01831089|7490465|FG004|STARTED|Cohort III: Dose Level 3||0
6567378|NCT01831089|7490466|FG005|STARTED|Cohort III: Dose Level 3||0
6567379|NCT01831089|7490461|FG000|COMPLETED|Cohort III: Dose Level 3||0
6567380|NCT01831089|7490462|FG001|COMPLETED|Cohort III: Dose Level 3||0
6567381|NCT01831089|7490463|FG002|COMPLETED|Cohort III: Dose Level 3||0
6567382|NCT01831089|7490464|FG003|COMPLETED|Cohort III: Dose Level 3||0
6567383|NCT01831089|7490465|FG004|COMPLETED|Cohort III: Dose Level 3||0
6567384|NCT01831089|7490466|FG005|COMPLETED|Cohort III: Dose Level 3||0
6567385|NCT01831089|7490461|FG000|NOT COMPLETED|Cohort III: Dose Level 3||0
6567386|NCT01831089|7490462|FG001|NOT COMPLETED|Cohort III: Dose Level 3||0
6567387|NCT01831089|7490463|FG002|NOT COMPLETED|Cohort III: Dose Level 3||6
6567388|NCT01831089|7490464|FG003|NOT COMPLETED|Cohort III: Dose Level 3||0
6567389|NCT01831089|7490465|FG004|NOT COMPLETED|Cohort III: Dose Level 3||0
6567390|NCT01831089|7490466|FG005|NOT COMPLETED|Cohort III: Dose Level 3||0
6567391|NCT01831089|7490461|FG000|STARTED|Cohort IV: Dose Level 4||0
6567392|NCT01831089|7490462|FG001|STARTED|Cohort IV: Dose Level 4||0
6567393|NCT01831089|7490463|FG002|STARTED|Cohort IV: Dose Level 4||0
6567394|NCT01831089|7490464|FG003|STARTED|Cohort IV: Dose Level 4||6
6567395|NCT01831089|7490465|FG004|STARTED|Cohort IV: Dose Level 4||0
6811018|NCT01147666|7743725|FG014|NOT COMPLETED|Dosing Period 1: 6-Week Treatment||4
6811019|NCT01147666|7743711|FG000|STARTED|Dosing Period 2: 19-Week Treatment||0
6275931|NCT00116558|7175190|FG000|COMPLETED|Overall Study||49
6567396|NCT01831089|7490466|FG005|STARTED|Cohort IV: Dose Level 4||0
6567397|NCT01831089|7490461|FG000|COMPLETED|Cohort IV: Dose Level 4||0
6567398|NCT01831089|7490462|FG001|COMPLETED|Cohort IV: Dose Level 4||0
6567399|NCT01831089|7490463|FG002|COMPLETED|Cohort IV: Dose Level 4||0
6567400|NCT01831089|7490464|FG003|COMPLETED|Cohort IV: Dose Level 4||0
6567401|NCT01831089|7490465|FG004|COMPLETED|Cohort IV: Dose Level 4||0
6567402|NCT01831089|7490466|FG005|COMPLETED|Cohort IV: Dose Level 4||0
6567403|NCT01831089|7490461|FG000|NOT COMPLETED|Cohort IV: Dose Level 4||0
6567404|NCT01831089|7490462|FG001|NOT COMPLETED|Cohort IV: Dose Level 4||0
6567405|NCT01831089|7490463|FG002|NOT COMPLETED|Cohort IV: Dose Level 4||0
6567406|NCT01831089|7490464|FG003|NOT COMPLETED|Cohort IV: Dose Level 4||6
6567407|NCT01831089|7490465|FG004|NOT COMPLETED|Cohort IV: Dose Level 4||0
6567408|NCT01831089|7490466|FG005|NOT COMPLETED|Cohort IV: Dose Level 4||0
6567409|NCT01831089|7490461|FG000|STARTED|Cohort V: Dose Level 5||0
6567410|NCT01831089|7490462|FG001|STARTED|Cohort V: Dose Level 5||0
6567411|NCT01831089|7490463|FG002|STARTED|Cohort V: Dose Level 5||0
6567412|NCT01831089|7490464|FG003|STARTED|Cohort V: Dose Level 5||0
6567413|NCT01831089|7490465|FG004|STARTED|Cohort V: Dose Level 5||37
6567414|NCT01831089|7490466|FG005|STARTED|Cohort V: Dose Level 5||0
6567415|NCT01831089|7490461|FG000|COMPLETED|Cohort V: Dose Level 5||0
6567416|NCT01831089|7490462|FG001|COMPLETED|Cohort V: Dose Level 5||0
6567417|NCT01831089|7490463|FG002|COMPLETED|Cohort V: Dose Level 5||0
6567418|NCT01831089|7490464|FG003|COMPLETED|Cohort V: Dose Level 5||0
6567419|NCT01831089|7490465|FG004|COMPLETED|Cohort V: Dose Level 5||0
6567420|NCT01831089|7490466|FG005|COMPLETED|Cohort V: Dose Level 5||0
6567421|NCT01831089|7490461|FG000|NOT COMPLETED|Cohort V: Dose Level 5||0
6811020|NCT01147666|7743712|FG001|STARTED|Dosing Period 2: 19-Week Treatment||0
6811021|NCT01147666|7743713|FG002|STARTED|Dosing Period 2: 19-Week Treatment||0
6811022|NCT01147666|7743714|FG003|STARTED|Dosing Period 2: 19-Week Treatment||7
6811023|NCT01147666|7743715|FG004|STARTED|Dosing Period 2: 19-Week Treatment||12
6811024|NCT01147666|7743716|FG005|STARTED|Dosing Period 2: 19-Week Treatment||12
6811025|NCT01147666|7743717|FG006|STARTED|Dosing Period 2: 19-Week Treatment||12
6811026|NCT01147666|7743718|FG007|STARTED|Dosing Period 2: 19-Week Treatment||12
6811027|NCT01147666|7743719|FG008|STARTED|Dosing Period 2: 19-Week Treatment||2
6811028|NCT01147666|7743720|FG009|STARTED|Dosing Period 2: 19-Week Treatment||10
6811029|NCT01147666|7743721|FG010|STARTED|Dosing Period 2: 19-Week Treatment||23
6811030|NCT01147666|7743722|FG011|STARTED|Dosing Period 2: 19-Week Treatment||0
6811031|NCT01147666|7743723|FG012|STARTED|Dosing Period 2: 19-Week Treatment||5
6811032|NCT01147666|7743724|FG013|STARTED|Dosing Period 2: 19-Week Treatment||3
6811033|NCT01147666|7743725|FG014|STARTED|Dosing Period 2: 19-Week Treatment||3
6811034|NCT01147666|7743711|FG000|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
6811035|NCT01147666|7743712|FG001|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
6811036|NCT01147666|7743713|FG002|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
6811037|NCT01147666|7743714|FG003|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||7
6811038|NCT01147666|7743715|FG004|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
6811039|NCT01147666|7743716|FG005|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
6811040|NCT01147666|7743717|FG006|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
6811041|NCT01147666|7743718|FG007|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||12
6811042|NCT01147666|7743719|FG008|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||2
6811043|NCT01147666|7743720|FG009|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||10
6811044|NCT01147666|7743721|FG010|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||23
6811045|NCT01147666|7743722|FG011|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||0
6811046|NCT01147666|7743723|FG012|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||5
6811047|NCT01147666|7743724|FG013|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
6811048|NCT01147666|7743725|FG014|Received at Least 1 Dose of Study Drug|Dosing Period 2: 19-Week Treatment||3
6811049|NCT01147666|7743711|FG000|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
6811050|NCT01147666|7743712|FG001|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
6811051|NCT01147666|7743713|FG002|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
6811052|NCT01147666|7743714|FG003|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||6
6811053|NCT01147666|7743715|FG004|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
6811054|NCT01147666|7743716|FG005|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
6811055|NCT01147666|7743717|FG006|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||11
6811056|NCT01147666|7743718|FG007|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
6811057|NCT01147666|7743719|FG008|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
6811058|NCT01147666|7743720|FG009|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||10
6811059|NCT01147666|7743721|FG010|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||22
6811060|NCT01147666|7743722|FG011|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||0
6811061|NCT01147666|7743723|FG012|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
6811062|NCT01147666|7743724|FG013|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||3
6811063|NCT01147666|7743725|FG014|EE Population for 19-week Treatment|Dosing Period 2: 19-Week Treatment||2
6811064|NCT01147666|7743711|FG000|COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811065|NCT01147666|7743712|FG001|COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811066|NCT01147666|7743713|FG002|COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811067|NCT01147666|7743714|FG003|COMPLETED|Dosing Period 2: 19-Week Treatment||5
6811068|NCT01147666|7743715|FG004|COMPLETED|Dosing Period 2: 19-Week Treatment||7
6811069|NCT01147666|7743716|FG005|COMPLETED|Dosing Period 2: 19-Week Treatment||9
6811070|NCT01147666|7743717|FG006|COMPLETED|Dosing Period 2: 19-Week Treatment||9
6811071|NCT01147666|7743718|FG007|COMPLETED|Dosing Period 2: 19-Week Treatment||9
6811072|NCT01147666|7743719|FG008|COMPLETED|Dosing Period 2: 19-Week Treatment||2
6811073|NCT01147666|7743720|FG009|COMPLETED|Dosing Period 2: 19-Week Treatment||8
6811074|NCT01147666|7743721|FG010|COMPLETED|Dosing Period 2: 19-Week Treatment||21
6811075|NCT01147666|7743722|FG011|COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811076|NCT01147666|7743723|FG012|COMPLETED|Dosing Period 2: 19-Week Treatment||1
6811077|NCT01147666|7743724|FG013|COMPLETED|Dosing Period 2: 19-Week Treatment||2
6811078|NCT01147666|7743725|FG014|COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811079|NCT01147666|7743711|FG000|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811080|NCT01147666|7743712|FG001|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811081|NCT01147666|7743713|FG002|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811082|NCT01147666|7743714|FG003|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
6811083|NCT01147666|7743715|FG004|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||5
6811084|NCT01147666|7743716|FG005|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
6811085|NCT01147666|7743717|FG006|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
6811086|NCT01147666|7743718|FG007|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
6811087|NCT01147666|7743719|FG008|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811088|NCT01147666|7743720|FG009|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
6811089|NCT01147666|7743721|FG010|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||2
6811090|NCT01147666|7743722|FG011|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||0
6811091|NCT01147666|7743723|FG012|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||4
6811092|NCT01147666|7743724|FG013|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||1
6811093|NCT01147666|7743725|FG014|NOT COMPLETED|Dosing Period 2: 19-Week Treatment||3
6811094|NCT00982111|7743789|FG000|STARTED|Overall Study||315
6811095|NCT00982111|7743790|FG001|STARTED|Overall Study||318
6811096|NCT00982111|7743789|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
6811097|NCT00982111|7743790|FG001|Received at Least 1 Dose of Study Drug|Overall Study||312
6567422|NCT01831089|7490462|FG001|NOT COMPLETED|Cohort V: Dose Level 5||0
6567423|NCT01831089|7490463|FG002|NOT COMPLETED|Cohort V: Dose Level 5||0
6567424|NCT01831089|7490464|FG003|NOT COMPLETED|Cohort V: Dose Level 5||0
6567425|NCT01831089|7490465|FG004|NOT COMPLETED|Cohort V: Dose Level 5||37
6567426|NCT01831089|7490466|FG005|NOT COMPLETED|Cohort V: Dose Level 5||0
6567427|NCT01831089|7490461|FG000|STARTED|Cohort B: Arm B||0
6567428|NCT01831089|7490462|FG001|STARTED|Cohort B: Arm B||0
6567429|NCT01831089|7490463|FG002|STARTED|Cohort B: Arm B||0
6567430|NCT01831089|7490464|FG003|STARTED|Cohort B: Arm B||0
6811098|NCT00982111|7743789|FG000|Death Due to Any Cause|Overall Study||236
6811099|NCT00982111|7743790|FG001|Death Due to Any Cause|Overall Study||246
6811100|NCT00982111|7743789|FG000|COMPLETED|Overall Study||236
6811101|NCT00982111|7743790|FG001|COMPLETED|Overall Study||246
6811102|NCT00982111|7743789|FG000|NOT COMPLETED|Overall Study||79
6811103|NCT00982111|7743790|FG001|NOT COMPLETED|Overall Study||72
6811104|NCT00193219|7743797|FG000|STARTED|Overall Study||36
6811105|NCT00193219|7743797|FG000|COMPLETED|Overall Study||6
6811106|NCT00193219|7743797|FG000|NOT COMPLETED|Overall Study||30
6811107|NCT00116142|7743804|FG000|STARTED|Overall Study||175
6811108|NCT00116142|7743805|FG001|STARTED|Overall Study||175
6811109|NCT00116142|7743804|FG000|Treated|Overall Study||174
6811110|NCT00116142|7743805|FG001|Treated|Overall Study||171
6811111|NCT00116142|7743804|FG000|COMPLETED|Overall Study||156
6811112|NCT00116142|7743805|FG001|COMPLETED|Overall Study||155
6567431|NCT01831089|7490465|FG004|STARTED|Cohort B: Arm B||0
6567432|NCT01831089|7490466|FG005|STARTED|Cohort B: Arm B||14
6567433|NCT01831089|7490461|FG000|COMPLETED|Cohort B: Arm B||0
6567434|NCT01831089|7490462|FG001|COMPLETED|Cohort B: Arm B||0
6567435|NCT01831089|7490463|FG002|COMPLETED|Cohort B: Arm B||0
6567436|NCT01831089|7490464|FG003|COMPLETED|Cohort B: Arm B||0
6811113|NCT00116142|7743804|FG000|NOT COMPLETED|Overall Study||19
6811114|NCT00116142|7743805|FG001|NOT COMPLETED|Overall Study||20
6811115|NCT00070018|7743814|FG000|STARTED|Overall Study||46
6811116|NCT00070018|7743814|FG000|Eligible|Overall Study||46
6811117|NCT00070018|7743814|FG000|Eligible and Began Protocol Therapy|Overall Study||46
6811118|NCT00070018|7743814|FG000|COMPLETED|Overall Study||42
6567437|NCT01831089|7490465|FG004|COMPLETED|Cohort B: Arm B||0
6567438|NCT01831089|7490466|FG005|COMPLETED|Cohort B: Arm B||0
6567439|NCT01831089|7490461|FG000|NOT COMPLETED|Cohort B: Arm B||0
6567440|NCT01831089|7490462|FG001|NOT COMPLETED|Cohort B: Arm B||0
6811119|NCT00070018|7743814|FG000|NOT COMPLETED|Overall Study||4
6567441|NCT01831089|7490463|FG002|NOT COMPLETED|Cohort B: Arm B||0
6567442|NCT01831089|7490464|FG003|NOT COMPLETED|Cohort B: Arm B||0
6567443|NCT01831089|7490465|FG004|NOT COMPLETED|Cohort B: Arm B||0
6567444|NCT01831089|7490466|FG005|NOT COMPLETED|Cohort B: Arm B||14
6567445|NCT01831154|7490484|FG000|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
6567446|NCT01831154|7490485|FG001|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
6811120|NCT04631796|7743818|FG000|STARTED|Overall Study||35
6811121|NCT04631796|7743818|FG000|COMPLETED|Overall Study||35
6811122|NCT04631796|7743818|FG000|NOT COMPLETED|Overall Study||0
6811123|NCT04447287|7743827|FG000|STARTED|Period 1: Run-in Period||23
6811124|NCT04447287|7743828|FG001|STARTED|Period 1: Run-in Period||0
6811125|NCT04447287|7743829|FG002|STARTED|Period 1: Run-in Period||0
6811126|NCT04447287|7743827|FG000|COMPLETED|Period 1: Run-in Period||19
6811127|NCT04447287|7743828|FG001|COMPLETED|Period 1: Run-in Period||0
6811128|NCT04447287|7743829|FG002|COMPLETED|Period 1: Run-in Period||0
6811129|NCT04447287|7743827|FG000|NOT COMPLETED|Period 1: Run-in Period||4
6811130|NCT04447287|7743828|FG001|NOT COMPLETED|Period 1: Run-in Period||0
6811131|NCT04447287|7743829|FG002|NOT COMPLETED|Period 1: Run-in Period||0
6811132|NCT04447287|7743827|FG000|STARTED|Period 2: Investigational Period||1
6811133|NCT04447287|7743828|FG001|STARTED|Period 2: Investigational Period||12
6811134|NCT04447287|7743829|FG002|STARTED|Period 2: Investigational Period||6
6811135|NCT04447287|7743827|FG000|COMPLETED|Period 2: Investigational Period||0
6811136|NCT04447287|7743828|FG001|COMPLETED|Period 2: Investigational Period||12
6811137|NCT04447287|7743829|FG002|COMPLETED|Period 2: Investigational Period||6
6811138|NCT04447287|7743827|FG000|NOT COMPLETED|Period 2: Investigational Period||1
6811139|NCT04447287|7743828|FG001|NOT COMPLETED|Period 2: Investigational Period||0
6811140|NCT04447287|7743829|FG002|NOT COMPLETED|Period 2: Investigational Period||0
6811141|NCT04447287|7743827|FG000|STARTED|Period 3: Down-Titration Period||0
6811142|NCT04447287|7743828|FG001|STARTED|Period 3: Down-Titration Period||12
6811143|NCT04447287|7743829|FG002|STARTED|Period 3: Down-Titration Period||6
6811144|NCT04447287|7743827|FG000|COMPLETED|Period 3: Down-Titration Period||0
6811145|NCT04447287|7743828|FG001|COMPLETED|Period 3: Down-Titration Period||12
6811146|NCT04447287|7743829|FG002|COMPLETED|Period 3: Down-Titration Period||6
6811147|NCT04447287|7743827|FG000|NOT COMPLETED|Period 3: Down-Titration Period||0
6811148|NCT04447287|7743828|FG001|NOT COMPLETED|Period 3: Down-Titration Period||0
6811149|NCT04447287|7743829|FG002|NOT COMPLETED|Period 3: Down-Titration Period||0
6811150|NCT04203537|7743852|FG000|STARTED|Overall Study||6
6811151|NCT04203537|7743853|FG001|STARTED|Overall Study||6
6811152|NCT04203537|7743854|FG002|STARTED|Overall Study||6
6811153|NCT04203537|7743855|FG003|STARTED|Overall Study||6
6811154|NCT04203537|7743856|FG004|STARTED|Overall Study||54
6811155|NCT04203537|7743857|FG005|STARTED|Overall Study||55
6811156|NCT04203537|7743858|FG006|STARTED|Overall Study||60
6811157|NCT04203537|7743852|FG000|COMPLETED|Overall Study||6
6811158|NCT04203537|7743853|FG001|COMPLETED|Overall Study||6
6275932|NCT00116558|7175191|FG001|COMPLETED|Overall Study||11
6275933|NCT00116558|7175192|FG002|COMPLETED|Overall Study||14
6567447|NCT01831154|7490486|FG002|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
6567448|NCT01831154|7490484|FG000|COMPLETED|Overall Study||15
6567449|NCT01831154|7490485|FG001|COMPLETED|Overall Study||11
6567450|NCT01831154|7490486|FG002|COMPLETED|Overall Study||11
6567451|NCT01831154|7490484|FG000|NOT COMPLETED|Overall Study||0
6811159|NCT04203537|7743854|FG002|COMPLETED|Overall Study||6
6275934|NCT00116558|7175190|FG000|NOT COMPLETED|Overall Study||31
6275935|NCT00116558|7175191|FG001|NOT COMPLETED|Overall Study||15
6275936|NCT00116558|7175192|FG002|NOT COMPLETED|Overall Study||33
6275937|NCT00116584|7175201|FG000|STARTED|Overall Study||36
6275938|NCT00116584|7175202|FG001|STARTED|Overall Study||36
6275939|NCT00116584|7175201|FG000|COMPLETED|Overall Study||34
6275940|NCT00116584|7175202|FG001|COMPLETED|Overall Study||35
6275941|NCT00116584|7175201|FG000|NOT COMPLETED|Overall Study||2
6275942|NCT00116584|7175202|FG001|NOT COMPLETED|Overall Study||1
6275943|NCT00116649|7175208|FG000|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
6275944|NCT00116649|7175208|FG000|COMPLETED|Overall Study||396
6275945|NCT00116649|7175208|FG000|NOT COMPLETED|Overall Study||155
6275946|NCT00116688|7175214|FG000|STARTED|Overall Study||292
6275947|NCT00116688|7175215|FG001|STARTED|Overall Study||21
6275948|NCT00116688|7175214|FG000|Received Study Medication|Overall Study||291
6275949|NCT00116688|7175215|FG001|Received Study Medication|Overall Study||20
6275950|NCT00116688|7175214|FG000|COMPLETED|Overall Study||200
6275951|NCT00116688|7175215|FG001|COMPLETED|Overall Study||17
6275952|NCT00116688|7175214|FG000|NOT COMPLETED|Overall Study||92
6275953|NCT00116688|7175215|FG001|NOT COMPLETED|Overall Study||4
6811160|NCT04203537|7743855|FG003|COMPLETED|Overall Study||6
6811161|NCT04203537|7743856|FG004|COMPLETED|Overall Study||54
6811162|NCT04203537|7743857|FG005|COMPLETED|Overall Study||55
6811163|NCT04203537|7743858|FG006|COMPLETED|Overall Study||60
6811164|NCT04203537|7743852|FG000|NOT COMPLETED|Overall Study||0
6811165|NCT04203537|7743853|FG001|NOT COMPLETED|Overall Study||0
6811166|NCT04203537|7743854|FG002|NOT COMPLETED|Overall Study||0
6811167|NCT04203537|7743855|FG003|NOT COMPLETED|Overall Study||0
6811168|NCT04203537|7743856|FG004|NOT COMPLETED|Overall Study||0
6811169|NCT04203537|7743857|FG005|NOT COMPLETED|Overall Study||0
6811170|NCT04203537|7743858|FG006|NOT COMPLETED|Overall Study||0
6811171|NCT04125745|7743868|FG000|STARTED|Overall Study||1
6811172|NCT04125745|7743868|FG000|COMPLETED|Overall Study||1
6811173|NCT04125745|7743868|FG000|NOT COMPLETED|Overall Study||0
6811174|NCT04074928|7743874|FG000|STARTED|Overall Study||1605
6811175|NCT04074928|7743875|FG001|STARTED|Overall Study||809
6811176|NCT04074928|7743874|FG000|Received Study Vaccine|Overall Study||1597
6811177|NCT04074928|7743875|FG001|Received Study Vaccine|Overall Study||805
6811178|NCT04074928|7743874|FG000|COMPLETED|Overall Study||1370
6811179|NCT04074928|7743875|FG001|COMPLETED|Overall Study||710
6811180|NCT04074928|7743874|FG000|NOT COMPLETED|Overall Study||235
6811181|NCT04074928|7743875|FG001|NOT COMPLETED|Overall Study||99
6811182|NCT04039503|7743885|FG000|STARTED|Overall Study||116
6811183|NCT04039503|7743886|FG001|STARTED|Overall Study||119
6811184|NCT04039503|7743887|FG002|STARTED|Overall Study||120
6811185|NCT04039503|7743888|FG003|STARTED|Overall Study||120
6811186|NCT04039503|7743885|FG000|Received at Least One Dose of Study Drug|Overall Study||116
6811187|NCT04039503|7743886|FG001|Received at Least One Dose of Study Drug|Overall Study||119
6811188|NCT04039503|7743887|FG002|Received at Least One Dose of Study Drug|Overall Study||120
6811189|NCT04039503|7743888|FG003|Received at Least One Dose of Study Drug|Overall Study||120
6811190|NCT04039503|7743885|FG000|COMPLETED|Overall Study||109
6811191|NCT04039503|7743886|FG001|COMPLETED|Overall Study||115
6811192|NCT04039503|7743887|FG002|COMPLETED|Overall Study||110
6811193|NCT04039503|7743888|FG003|COMPLETED|Overall Study||117
6811194|NCT04039503|7743885|FG000|NOT COMPLETED|Overall Study||7
6811195|NCT04039503|7743886|FG001|NOT COMPLETED|Overall Study||4
6811196|NCT04039503|7743887|FG002|NOT COMPLETED|Overall Study||10
6811197|NCT04039503|7743888|FG003|NOT COMPLETED|Overall Study||3
6811198|NCT03695172|7743906|FG000|STARTED|Overall Study||5
6811199|NCT03695172|7743907|FG001|STARTED|Overall Study||4
6811200|NCT03695172|7743908|FG002|STARTED|Overall Study||3
6811201|NCT03695172|7743906|FG000|COMPLETED|Overall Study||4
6811202|NCT03695172|7743907|FG001|COMPLETED|Overall Study||3
6811203|NCT03695172|7743908|FG002|COMPLETED|Overall Study||3
6811204|NCT03695172|7743906|FG000|NOT COMPLETED|Overall Study||1
6811205|NCT03695172|7743907|FG001|NOT COMPLETED|Overall Study||1
6811206|NCT03695172|7743908|FG002|NOT COMPLETED|Overall Study||0
6811207|NCT03485287|7743916|FG000|STARTED|Overall Study||4
6811208|NCT03485287|7743916|FG000|COMPLETED|Overall Study||3
6811209|NCT03485287|7743916|FG000|NOT COMPLETED|Overall Study||1
6811210|NCT03433040|7743923|FG000|STARTED|Overall Study||19
6811211|NCT03433040|7743924|FG001|STARTED|Overall Study||16
6811212|NCT03433040|7743925|FG002|STARTED|Overall Study||9
6811213|NCT03433040|7743923|FG000|COMPLETED|Overall Study||17
6811214|NCT03433040|7743924|FG001|COMPLETED|Overall Study||8
6811215|NCT03433040|7743925|FG002|COMPLETED|Overall Study||5
6811216|NCT03433040|7743923|FG000|NOT COMPLETED|Overall Study||2
6811217|NCT03433040|7743924|FG001|NOT COMPLETED|Overall Study||8
6811218|NCT03433040|7743925|FG002|NOT COMPLETED|Overall Study||4
6811219|NCT03394027|7743936|FG000|STARTED|Overall Study||10
6811220|NCT03394027|7743937|FG001|STARTED|Overall Study||6
6811221|NCT03394027|7743938|FG002|STARTED|Overall Study||14
6811222|NCT03394027|7743936|FG000|COMPLETED|Overall Study||7
6811223|NCT03394027|7743937|FG001|COMPLETED|Overall Study||5
6811224|NCT03394027|7743938|FG002|COMPLETED|Overall Study||10
6811225|NCT03394027|7743936|FG000|NOT COMPLETED|Overall Study||3
6811226|NCT03394027|7743937|FG001|NOT COMPLETED|Overall Study||1
6811227|NCT03394027|7743938|FG002|NOT COMPLETED|Overall Study||4
6811228|NCT03357952|7743966|FG000|STARTED|Overall Study||9
6811229|NCT03357952|7743967|FG001|STARTED|Overall Study||1
6811230|NCT03357952|7743966|FG000|COMPLETED|Overall Study||0
6811231|NCT03357952|7743967|FG001|COMPLETED|Overall Study||0
6811232|NCT03357952|7743966|FG000|NOT COMPLETED|Overall Study||9
6811233|NCT03357952|7743967|FG001|NOT COMPLETED|Overall Study||1
6811234|NCT03237234|7743975|FG000|STARTED|Overall Study||14
6811235|NCT03237234|7743976|FG001|STARTED|Overall Study||11
6811236|NCT03237234|7743975|FG000|COMPLETED|Overall Study||14
6811237|NCT03237234|7743976|FG001|COMPLETED|Overall Study||11
6811238|NCT03237234|7743975|FG000|NOT COMPLETED|Overall Study||0
6811239|NCT03237234|7743976|FG001|NOT COMPLETED|Overall Study||0
6811240|NCT03170869|7743982|FG000|STARTED|Overall Study||11
6811241|NCT03170869|7743982|FG000|COMPLETED|Overall Study||3
6811242|NCT03170869|7743982|FG000|NOT COMPLETED|Overall Study||8
6811243|NCT03066622|7743989|FG000|STARTED|Overall Study||61
6811244|NCT03066622|7743990|FG001|STARTED|Overall Study||61
6811245|NCT03066622|7743989|FG000|COMPLETED|Overall Study||35
6811246|NCT03066622|7743990|FG001|COMPLETED|Overall Study||35
6811247|NCT03066622|7743989|FG000|NOT COMPLETED|Overall Study||26
6811248|NCT03066622|7743990|FG001|NOT COMPLETED|Overall Study||26
6811249|NCT03052920|7743996|FG000|STARTED|Overall Study||40
6811250|NCT03052920|7743996|FG000|COMPLETED|Overall Study||39
6811251|NCT03052920|7743996|FG000|NOT COMPLETED|Overall Study||1
6811252|NCT03029104|7744003|FG000|STARTED|Overall Study||745
6811253|NCT03029104|7744004|FG001|STARTED|Overall Study||735
6811254|NCT03029104|7744005|FG002|STARTED|Overall Study||748
6811255|NCT03029104|7744003|FG000|COMPLETED|Overall Study||612
6811256|NCT03029104|7744004|FG001|COMPLETED|Overall Study||597
6811257|NCT03029104|7744005|FG002|COMPLETED|Overall Study||623
6811258|NCT03029104|7744003|FG000|NOT COMPLETED|Overall Study||133
6811259|NCT03029104|7744004|FG001|NOT COMPLETED|Overall Study||138
6811260|NCT03029104|7744005|FG002|NOT COMPLETED|Overall Study||125
6811261|NCT03016312|7744015|FG000|STARTED|Overall Study||391
6811262|NCT03016312|7744016|FG001|STARTED|Overall Study||380
6811263|NCT03016312|7744015|FG000|COMPLETED|Overall Study||150
6811264|NCT03016312|7744016|FG001|COMPLETED|Overall Study||162
6811265|NCT03016312|7744015|FG000|NOT COMPLETED|Overall Study||241
6811266|NCT03016312|7744016|FG001|NOT COMPLETED|Overall Study||218
6811267|NCT02876172|7744024|FG000|STARTED|Overall Study||6
6811268|NCT02876172|7744025|FG001|STARTED|Overall Study||6
6811269|NCT02876172|7744024|FG000|COMPLETED|Overall Study||6
6811270|NCT02876172|7744025|FG001|COMPLETED|Overall Study||6
6811271|NCT02876172|7744024|FG000|NOT COMPLETED|Overall Study||0
6811272|NCT02876172|7744025|FG001|NOT COMPLETED|Overall Study||0
6811273|NCT02722434|7744034|FG000|STARTED|Overall Study||25
6811274|NCT02722434|7744035|FG001|STARTED|Overall Study||25
6811275|NCT02722434|7744034|FG000|Started Treatment|Overall Study||24
6811276|NCT02722434|7744035|FG001|Started Treatment|Overall Study||25
6811277|NCT02722434|7744034|FG000|COMPLETED|Overall Study||24
6811278|NCT02722434|7744035|FG001|COMPLETED|Overall Study||22
6811279|NCT02722434|7744034|FG000|NOT COMPLETED|Overall Study||1
6811280|NCT02722434|7744035|FG001|NOT COMPLETED|Overall Study||3
6811281|NCT02721979|7744041|FG000|STARTED|Overall Study||23
6811282|NCT02721979|7744041|FG000|COMPLETED|Overall Study||22
6811283|NCT02721979|7744041|FG000|NOT COMPLETED|Overall Study||1
6811284|NCT02604511|7744045|FG000|STARTED|Overall Study||31
6811285|NCT02604511|7744045|FG000|COMPLETED|Overall Study||19
6811286|NCT02604511|7744045|FG000|NOT COMPLETED|Overall Study||12
6811287|NCT02369536|7744051|FG000|STARTED|Overall Study||62
6811288|NCT02369536|7744052|FG001|STARTED|Overall Study||64
6811289|NCT02369536|7744051|FG000|COMPLETED|Overall Study||55
6811290|NCT02369536|7744052|FG001|COMPLETED|Overall Study||58
6811291|NCT02369536|7744051|FG000|NOT COMPLETED|Overall Study||7
6811292|NCT02369536|7744052|FG001|NOT COMPLETED|Overall Study||6
6811293|NCT02358681|7744062|FG000|STARTED|Overall Study||29
6811294|NCT02358681|7744063|FG001|STARTED|Overall Study||30
6811295|NCT02358681|7744062|FG000|COMPLETED|Overall Study||27
6811296|NCT02358681|7744063|FG001|COMPLETED|Overall Study||29
6811297|NCT02358681|7744062|FG000|NOT COMPLETED|Overall Study||2
6811298|NCT02358681|7744063|FG001|NOT COMPLETED|Overall Study||1
6811299|NCT02101788|7744071|FG000|STARTED|Overall Study||130
6811300|NCT02101788|7744072|FG001|STARTED|Overall Study||130
6811301|NCT02101788|7744071|FG000|Crossover From Arm A to Arm B|Overall Study||88
6811302|NCT02101788|7744072|FG001|Crossover From Arm A to Arm B|Overall Study||0
6811303|NCT02101788|7744071|FG000|COMPLETED|Overall Study||120
6811304|NCT02101788|7744072|FG001|COMPLETED|Overall Study||116
6811305|NCT02101788|7744071|FG000|NOT COMPLETED|Overall Study||10
6811306|NCT02101788|7744072|FG001|NOT COMPLETED|Overall Study||14
6811307|NCT01963728|7744087|FG000|STARTED|Overall Study||0
6811308|NCT01963728|7744088|FG001|STARTED|Overall Study||1
6811309|NCT01963728|7744087|FG000|COMPLETED|Overall Study|study terminated early|0
6811310|NCT01963728|7744088|FG001|COMPLETED|Overall Study|study terminated early|0
6811311|NCT01963728|7744087|FG000|NOT COMPLETED|Overall Study||0
6811312|NCT01963728|7744088|FG001|NOT COMPLETED|Overall Study||1
6811313|NCT01248247|7744098|FG000|STARTED|Overall Study||22
6811314|NCT01248247|7744099|FG001|STARTED|Overall Study||42
6811315|NCT01248247|7744100|FG002|STARTED|Overall Study||75
6811316|NCT01248247|7744101|FG003|STARTED|Overall Study||61
6811317|NCT01248247|7744098|FG000|COMPLETED|Overall Study||0
6811318|NCT01248247|7744099|FG001|COMPLETED|Overall Study||0
6811319|NCT01248247|7744100|FG002|COMPLETED|Overall Study||0
6811320|NCT01248247|7744101|FG003|COMPLETED|Overall Study||0
6811321|NCT01248247|7744098|FG000|NOT COMPLETED|Overall Study||22
6811322|NCT01248247|7744099|FG001|NOT COMPLETED|Overall Study||42
6811323|NCT01248247|7744100|FG002|NOT COMPLETED|Overall Study||75
6811324|NCT01248247|7744101|FG003|NOT COMPLETED|Overall Study||61
6811325|NCT01164228|7744113|FG000|STARTED|Overall Study||47
6811326|NCT01164228|7744114|FG001|STARTED|Overall Study||40
6811327|NCT01164228|7744113|FG000|Receipt of Protocol Therapy|Overall Study||46
6811328|NCT01164228|7744114|FG001|Receipt of Protocol Therapy|Overall Study||37
6811329|NCT01164228|7744113|FG000|Treated and Eligible Patients|Overall Study||45
6811330|NCT01164228|7744114|FG001|Treated and Eligible Patients|Overall Study||37
6811331|NCT01164228|7744113|FG000|COMPLETED|Overall Study||3
6811332|NCT01164228|7744114|FG001|COMPLETED|Overall Study||2
6811333|NCT01164228|7744113|FG000|NOT COMPLETED|Overall Study||44
6811334|NCT01164228|7744114|FG001|NOT COMPLETED|Overall Study||38
6811335|NCT01012167|7744123|FG000|STARTED|Overall Study||17
6811336|NCT01012167|7744124|FG001|STARTED|Overall Study||20
6811337|NCT01012167|7744125|FG002|STARTED|Overall Study||21
6811338|NCT01012167|7744123|FG000|Withdrawn Prior to Study Drug Exposure|Overall Study||1
6811339|NCT01012167|7744124|FG001|Withdrawn Prior to Study Drug Exposure|Overall Study||0
6811340|NCT01012167|7744125|FG002|Withdrawn Prior to Study Drug Exposure|Overall Study||1
6811341|NCT01012167|7744123|FG000|Exposed to Study Drug|Overall Study||16
6811342|NCT01012167|7744124|FG001|Exposed to Study Drug|Overall Study||20
6811343|NCT01012167|7744125|FG002|Exposed to Study Drug|Overall Study||20
6811344|NCT01012167|7744123|FG000|COMPLETED|Overall Study||15
6811345|NCT01012167|7744124|FG001|COMPLETED|Overall Study||18
6811346|NCT01012167|7744125|FG002|COMPLETED|Overall Study||17
6811347|NCT01012167|7744123|FG000|NOT COMPLETED|Overall Study||2
6811348|NCT01012167|7744124|FG001|NOT COMPLETED|Overall Study||2
6811349|NCT01012167|7744125|FG002|NOT COMPLETED|Overall Study||4
6811350|NCT00924326|7744149|FG000|STARTED|Dose Administration||8
6811351|NCT00924326|7744150|FG001|STARTED|Dose Administration||2
6811352|NCT00924326|7744151|FG002|STARTED|Dose Administration||5
6811353|NCT00924326|7744152|FG003|STARTED|Dose Administration||6
6811354|NCT00924326|7744153|FG004|STARTED|Dose Administration||7
6567452|NCT01831154|7490485|FG001|NOT COMPLETED|Overall Study||0
6567453|NCT01831154|7490486|FG002|NOT COMPLETED|Overall Study||0
6275954|NCT00116753|7175224|FG000|STARTED|Overall Study|Randomised.|153
6811355|NCT00924326|7744154|FG005|STARTED|Dose Administration||10
6811356|NCT00924326|7744155|FG006|STARTED|Dose Administration||1
6811357|NCT00924326|7744156|FG007|STARTED|Dose Administration||2
6811358|NCT00924326|7744157|FG008|STARTED|Dose Administration||2
6811359|NCT00924326|7744149|FG000|COMPLETED|Dose Administration||8
6811360|NCT00924326|7744150|FG001|COMPLETED|Dose Administration||2
6811361|NCT00924326|7744151|FG002|COMPLETED|Dose Administration||5
6811362|NCT00924326|7744152|FG003|COMPLETED|Dose Administration||6
6811363|NCT00924326|7744153|FG004|COMPLETED|Dose Administration||7
6811364|NCT00924326|7744154|FG005|COMPLETED|Dose Administration||10
6811365|NCT00924326|7744155|FG006|COMPLETED|Dose Administration||1
6811366|NCT00924326|7744156|FG007|COMPLETED|Dose Administration||2
6811367|NCT00924326|7744157|FG008|COMPLETED|Dose Administration||2
6811368|NCT00924326|7744149|FG000|NOT COMPLETED|Dose Administration||0
6811369|NCT00924326|7744150|FG001|NOT COMPLETED|Dose Administration||0
6811370|NCT00924326|7744151|FG002|NOT COMPLETED|Dose Administration||0
6811371|NCT00924326|7744152|FG003|NOT COMPLETED|Dose Administration||0
6811372|NCT00924326|7744153|FG004|NOT COMPLETED|Dose Administration||0
6811373|NCT00924326|7744154|FG005|NOT COMPLETED|Dose Administration||0
6811374|NCT00924326|7744155|FG006|NOT COMPLETED|Dose Administration||0
6811375|NCT00924326|7744156|FG007|NOT COMPLETED|Dose Administration||0
6811376|NCT00924326|7744157|FG008|NOT COMPLETED|Dose Administration||0
6811377|NCT00924326|7744149|FG000|STARTED|1x10^9-1x10^10 + High Dose Retreat||3
6811378|NCT00924326|7744150|FG001|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6811379|NCT00924326|7744151|FG002|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6811380|NCT00924326|7744152|FG003|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6811381|NCT00924326|7744153|FG004|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6811382|NCT00924326|7744154|FG005|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6811383|NCT00924326|7744155|FG006|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6811384|NCT00924326|7744156|FG007|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6811385|NCT00924326|7744157|FG008|STARTED|1x10^9-1x10^10 + High Dose Retreat||0
6811386|NCT00924326|7744149|FG000|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||3
6811387|NCT00924326|7744150|FG001|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811388|NCT00924326|7744151|FG002|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811389|NCT00924326|7744152|FG003|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6567454|NCT01831219|7490496|FG000|STARTED|Overall Study||73
6567455|NCT01831219|7490497|FG001|STARTED|Overall Study||45
6567456|NCT01831219|7490496|FG000|COMPLETED|Overall Study||40
6811390|NCT00924326|7744153|FG004|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811391|NCT00924326|7744154|FG005|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811392|NCT00924326|7744155|FG006|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811393|NCT00924326|7744156|FG007|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811394|NCT00924326|7744157|FG008|COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811395|NCT00924326|7744149|FG000|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811396|NCT00924326|7744150|FG001|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811397|NCT00924326|7744151|FG002|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811398|NCT00924326|7744152|FG003|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811399|NCT00924326|7744153|FG004|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811400|NCT00924326|7744154|FG005|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811401|NCT00924326|7744155|FG006|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811402|NCT00924326|7744156|FG007|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811403|NCT00924326|7744157|FG008|NOT COMPLETED|1x10^9-1x10^10 + High Dose Retreat||0
6811404|NCT00591318|7744181|FG000|STARTED|Overall Study||5
6811405|NCT00591318|7744182|FG001|STARTED|Overall Study||5
6811406|NCT00591318|7744181|FG000|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant, regardless of whether the participant completed the study treatments.|1
6811407|NCT00591318|7744182|FG001|COMPLETED|Overall Study|For our protocol, participants in both treatment arms were considered completers if they completed at least 6 weeks. At the 6 week point, if response on PANS was not sufficient (15% or greater), they were considered unlikely to respond and therefore were not given the option of the 2 additional weeks of ceftriaxone or placebo. For the analysis, we used the last observed rating between baseline to week 8 for each participant regardless of whether the participant completed the study treatments..|5
6811408|NCT00591318|7744181|FG000|NOT COMPLETED|Overall Study||4
6811409|NCT00591318|7744182|FG001|NOT COMPLETED|Overall Study||0
6811410|NCT00321100|7744194|FG000|STARTED|Overall Study||12
6811411|NCT00321100|7744195|FG001|STARTED|Overall Study||11
6811412|NCT00321100|7744194|FG000|COMPLETED|Overall Study||12
6811413|NCT00321100|7744195|FG001|COMPLETED|Overall Study||11
6811414|NCT00321100|7744194|FG000|NOT COMPLETED|Overall Study||0
6811415|NCT00321100|7744195|FG001|NOT COMPLETED|Overall Study||0
6811416|NCT04534517|7744203|FG000|STARTED|Overall Study||114
6811417|NCT04534517|7744203|FG000|COMPLETED|Overall Study||110
6811418|NCT04534517|7744203|FG000|NOT COMPLETED|Overall Study||4
6811419|NCT04494646|7744209|FG000|STARTED|Overall Study||21
6811420|NCT04494646|7744210|FG001|STARTED|Overall Study||19
6811421|NCT04494646|7744209|FG000|COMPLETED|Overall Study||21
6811422|NCT04494646|7744210|FG001|COMPLETED|Overall Study||17
6811423|NCT04494646|7744209|FG000|NOT COMPLETED|Overall Study||0
6811424|NCT04494646|7744210|FG001|NOT COMPLETED|Overall Study||2
6811472|NCT03232736|7744274|FG000|STARTED|Overall Study||9
6811473|NCT03232736|7744275|FG001|STARTED|Overall Study||13
6811474|NCT03232736|7744274|FG000|COMPLETED|Overall Study||9
6811475|NCT03232736|7744275|FG001|COMPLETED|Overall Study||13
6811476|NCT03232736|7744274|FG000|NOT COMPLETED|Overall Study||0
6811477|NCT03232736|7744275|FG001|NOT COMPLETED|Overall Study||0
6811478|NCT03208530|7744285|FG000|STARTED|Overall Study||75
6811479|NCT03208530|7744285|FG000|COMPLETED|Overall Study||48
6811480|NCT03208530|7744285|FG000|NOT COMPLETED|Overall Study||27
6811481|NCT03158688|7744291|FG000|STARTED|Overall Study||154
6811482|NCT03158688|7744292|FG001|STARTED|Overall Study||312
6811483|NCT03158688|7744291|FG000|Treated|Overall Study||153
6811484|NCT03158688|7744292|FG001|Treated|Overall Study||308
6811485|NCT03158688|7744291|FG000|COMPLETED|Overall Study||0
6811486|NCT03158688|7744292|FG001|COMPLETED|Overall Study||0
6811487|NCT03158688|7744291|FG000|NOT COMPLETED|Overall Study||154
6811488|NCT03158688|7744292|FG001|NOT COMPLETED|Overall Study||312
6811489|NCT03103321|7744302|FG000|STARTED|Overall Study||25
6811490|NCT03103321|7744303|FG001|STARTED|Overall Study||39
6811491|NCT03103321|7744304|FG002|STARTED|Overall Study||44
6811492|NCT03103321|7744305|FG003|STARTED|Overall Study||50
6811493|NCT03103321|7744302|FG000|COMPLETED|Overall Study||24
6811494|NCT03103321|7744303|FG001|COMPLETED|Overall Study||38
6811495|NCT03103321|7744304|FG002|COMPLETED|Overall Study||43
6811496|NCT03103321|7744305|FG003|COMPLETED|Overall Study||50
6811497|NCT03103321|7744302|FG000|NOT COMPLETED|Overall Study||1
6811498|NCT03103321|7744303|FG001|NOT COMPLETED|Overall Study||1
6811499|NCT03103321|7744304|FG002|NOT COMPLETED|Overall Study||1
6811500|NCT03103321|7744305|FG003|NOT COMPLETED|Overall Study||0
6811501|NCT03079869|7744317|FG000|STARTED|Overall Study||28
6811502|NCT03079869|7744318|FG001|STARTED|Overall Study||27
6811503|NCT03079869|7744317|FG000|COMPLETED|Overall Study||15
6811504|NCT03079869|7744318|FG001|COMPLETED|Overall Study||16
6811505|NCT03079869|7744317|FG000|NOT COMPLETED|Overall Study||13
6811506|NCT03079869|7744318|FG001|NOT COMPLETED|Overall Study||11
6811507|NCT03033875|7744327|FG000|STARTED|Overall Study||96
6811508|NCT03033875|7744328|FG001|STARTED|Overall Study||111
6811509|NCT03033875|7744329|FG002|STARTED|Overall Study||54
6811510|NCT03033875|7744327|FG000|Completed Month 3 Assessment|Overall Study||71
6811511|NCT03033875|7744328|FG001|Completed Month 3 Assessment|Overall Study||83
6811512|NCT03033875|7744329|FG002|Completed Month 3 Assessment|Overall Study||43
6811513|NCT03033875|7744327|FG000|Completed Month 6 Assessment|Overall Study||73
6811514|NCT03033875|7744328|FG001|Completed Month 6 Assessment|Overall Study||81
6811515|NCT03033875|7744329|FG002|Completed Month 6 Assessment|Overall Study||46
6811516|NCT03033875|7744327|FG000|COMPLETED|Overall Study||77
6811517|NCT03033875|7744328|FG001|COMPLETED|Overall Study||87
6811518|NCT03033875|7744329|FG002|COMPLETED|Overall Study||42
6811519|NCT03033875|7744327|FG000|NOT COMPLETED|Overall Study||19
6811520|NCT03033875|7744328|FG001|NOT COMPLETED|Overall Study||24
6811521|NCT03033875|7744329|FG002|NOT COMPLETED|Overall Study||12
6811522|NCT02935595|7744337|FG000|STARTED|Overall Study||5
6811523|NCT02935595|7744337|FG000|COMPLETED|Overall Study||4
6811425|NCT04258020|7744218|FG000|STARTED|Overall Study||4
6811426|NCT04258020|7744219|FG001|STARTED|Overall Study||0
6811427|NCT04258020|7744218|FG000|COMPLETED|Overall Study||3
6811428|NCT04258020|7744219|FG001|COMPLETED|Overall Study||0
6811429|NCT04258020|7744218|FG000|NOT COMPLETED|Overall Study||1
6811430|NCT04258020|7744219|FG001|NOT COMPLETED|Overall Study||0
6811431|NCT04234464|7744227|FG000|STARTED|Period 1 (First Treatment Intervention)||29
6811432|NCT04234464|7744228|FG001|STARTED|Period 1 (First Treatment Intervention)||31
6811433|NCT04234464|7744227|FG000|COMPLETED|Period 1 (First Treatment Intervention)||29
6811434|NCT04234464|7744228|FG001|COMPLETED|Period 1 (First Treatment Intervention)||31
6811435|NCT04234464|7744227|FG000|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
6811436|NCT04234464|7744228|FG001|NOT COMPLETED|Period 1 (First Treatment Intervention)||0
6811437|NCT04234464|7744227|FG000|STARTED|Period 2 (Second Treatment Intervention)||29
6811438|NCT04234464|7744228|FG001|STARTED|Period 2 (Second Treatment Intervention)||31
6811439|NCT04234464|7744227|FG000|COMPLETED|Period 2 (Second Treatment Intervention)||28
6811440|NCT04234464|7744228|FG001|COMPLETED|Period 2 (Second Treatment Intervention)||31
6811441|NCT04234464|7744227|FG000|NOT COMPLETED|Period 2 (Second Treatment Intervention)||1
6811442|NCT04234464|7744228|FG001|NOT COMPLETED|Period 2 (Second Treatment Intervention)||0
6811443|NCT03852316|7744234|FG000|STARTED|Overall Study||1585
6811444|NCT03852316|7744234|FG000|COMPLETED|Overall Study||1581
6811445|NCT03852316|7744234|FG000|NOT COMPLETED|Overall Study||4
6811446|NCT03789318|7744243|FG000|STARTED|Overall Study||9
6811447|NCT03789318|7744244|FG001|STARTED|Overall Study||9
6811448|NCT03789318|7744245|FG002|STARTED|Overall Study||12
6811449|NCT03789318|7744246|FG003|STARTED|Overall Study||12
6811450|NCT03789318|7744247|FG004|STARTED|Overall Study||12
6811451|NCT03789318|7744243|FG000|COMPLETED|Overall Study||9
6811452|NCT03789318|7744244|FG001|COMPLETED|Overall Study||9
6811453|NCT03789318|7744245|FG002|COMPLETED|Overall Study||9
6811454|NCT03789318|7744246|FG003|COMPLETED|Overall Study||11
6811455|NCT03789318|7744247|FG004|COMPLETED|Overall Study||12
6811456|NCT03789318|7744243|FG000|NOT COMPLETED|Overall Study||0
6811457|NCT03789318|7744244|FG001|NOT COMPLETED|Overall Study||0
6811458|NCT03789318|7744245|FG002|NOT COMPLETED|Overall Study||3
6811459|NCT03789318|7744246|FG003|NOT COMPLETED|Overall Study||1
6811460|NCT03789318|7744247|FG004|NOT COMPLETED|Overall Study||0
6811461|NCT03774875|7744261|FG000|STARTED|Overall Study||92
6811462|NCT03774875|7744262|FG001|STARTED|Overall Study||185
6811463|NCT03774875|7744261|FG000|Received Study Drug|Overall Study||91
6811464|NCT03774875|7744262|FG001|Received Study Drug|Overall Study||185
6811465|NCT03774875|7744261|FG000|COMPLETED|Overall Study||69
6811466|NCT03774875|7744262|FG001|COMPLETED|Overall Study||152
6811467|NCT03774875|7744261|FG000|NOT COMPLETED|Overall Study||23
6811468|NCT03774875|7744262|FG001|NOT COMPLETED|Overall Study||33
6811469|NCT03613662|7744268|FG000|STARTED|Overall Study||19
6811470|NCT03613662|7744268|FG000|COMPLETED|Overall Study||19
6811471|NCT03613662|7744268|FG000|NOT COMPLETED|Overall Study||0
6811524|NCT02935595|7744337|FG000|NOT COMPLETED|Overall Study||1
6811525|NCT02887248|7744341|FG000|STARTED|Overall Study||3
6811526|NCT02887248|7744341|FG000|COMPLETED|Overall Study||0
6811527|NCT02887248|7744341|FG000|NOT COMPLETED|Overall Study||3
6811528|NCT02849990|7744345|FG000|STARTED|Overall Study||22
6811529|NCT02849990|7744345|FG000|COMPLETED|Overall Study||20
6811530|NCT02849990|7744345|FG000|NOT COMPLETED|Overall Study||2
6811531|NCT02673151|7744349|FG000|STARTED|Overall Study||61
6811532|NCT02673151|7744349|FG000|COMPLETED|Overall Study||61
6811533|NCT02673151|7744349|FG000|NOT COMPLETED|Overall Study||0
6811534|NCT02523274|7744361|FG000|STARTED|Overall Study||20
6811535|NCT02523274|7744362|FG001|STARTED|Overall Study||20
6811536|NCT02523274|7744363|FG002|STARTED|Overall Study||20
6811537|NCT02523274|7744361|FG000|COMPLETED|Overall Study||19
6811538|NCT02523274|7744362|FG001|COMPLETED|Overall Study||18
6811539|NCT02523274|7744363|FG002|COMPLETED|Overall Study||18
6811540|NCT02523274|7744361|FG000|NOT COMPLETED|Overall Study||1
6567457|NCT01831219|7490497|FG001|COMPLETED|Overall Study||21
6567458|NCT01831219|7490496|FG000|NOT COMPLETED|Overall Study||33
6567459|NCT01831219|7490497|FG001|NOT COMPLETED|Overall Study||24
6567460|NCT01831232|7490503|FG000|STARTED|Overall Study||24
6567461|NCT01831232|7490503|FG000|COMPLETED|Overall Study||24
6811541|NCT02523274|7744362|FG001|NOT COMPLETED|Overall Study||2
6567462|NCT01831232|7490503|FG000|NOT COMPLETED|Overall Study||0
6811542|NCT02523274|7744363|FG002|NOT COMPLETED|Overall Study||2
6811543|NCT02467270|7744378|FG000|STARTED|Overall Study||94
6811544|NCT02467270|7744379|FG001|STARTED|Overall Study||95
6811545|NCT02467270|7744380|FG002|STARTED|Overall Study||94
6811546|NCT02467270|7744378|FG000|Treated (Safety Population)|Overall Study||94
6811547|NCT02467270|7744379|FG001|Treated (Safety Population)|Overall Study||94
6811548|NCT02467270|7744380|FG002|Treated (Safety Population)|Overall Study||94
6811549|NCT02467270|7744378|FG000|COMPLETED|Overall Study||0
6811550|NCT02467270|7744379|FG001|COMPLETED|Overall Study||0
6811551|NCT02467270|7744380|FG002|COMPLETED|Overall Study||0
6811552|NCT02467270|7744378|FG000|NOT COMPLETED|Overall Study||94
6811553|NCT02467270|7744379|FG001|NOT COMPLETED|Overall Study||95
6811554|NCT02467270|7744380|FG002|NOT COMPLETED|Overall Study||94
6811555|NCT02452554|7744394|FG000|STARTED|Overall Study||17
6811556|NCT02452554|7744395|FG001|STARTED|Overall Study||17
6811557|NCT02452554|7744396|FG002|STARTED|Overall Study||12
6811558|NCT02452554|7744397|FG003|STARTED|Overall Study||1
6811559|NCT02452554|7744398|FG004|STARTED|Overall Study||5
6811560|NCT02452554|7744399|FG005|STARTED|Overall Study||10
6811561|NCT02452554|7744394|FG000|COMPLETED|Overall Study||0
6811562|NCT02452554|7744395|FG001|COMPLETED|Overall Study||0
6811563|NCT02452554|7744396|FG002|COMPLETED|Overall Study||1
6811564|NCT02452554|7744397|FG003|COMPLETED|Overall Study||0
6811565|NCT02452554|7744398|FG004|COMPLETED|Overall Study||0
6811566|NCT02452554|7744399|FG005|COMPLETED|Overall Study||1
6811567|NCT02452554|7744394|FG000|NOT COMPLETED|Overall Study||17
6811568|NCT02452554|7744395|FG001|NOT COMPLETED|Overall Study||17
6811569|NCT02452554|7744396|FG002|NOT COMPLETED|Overall Study||11
6811570|NCT02452554|7744397|FG003|NOT COMPLETED|Overall Study||1
6811571|NCT02452554|7744398|FG004|NOT COMPLETED|Overall Study||5
6811572|NCT02452554|7744399|FG005|NOT COMPLETED|Overall Study||9
6811573|NCT02427568|7744416|FG000|STARTED|Overall Study||5
6811574|NCT02427568|7744417|FG001|STARTED|Overall Study||13
6811575|NCT02427568|7744416|FG000|COMPLETED|Overall Study||5
6811576|NCT02427568|7744417|FG001|COMPLETED|Overall Study||13
6811577|NCT02427568|7744416|FG000|NOT COMPLETED|Overall Study||0
6811578|NCT02427568|7744417|FG001|NOT COMPLETED|Overall Study||0
6811579|NCT02318277|7744435|FG000|STARTED|Overall Study||6
6811580|NCT02318277|7744436|FG001|STARTED|Overall Study||3
6811581|NCT02318277|7744437|FG002|STARTED|Overall Study||4
6811582|NCT02318277|7744438|FG003|STARTED|Overall Study||4
6811583|NCT02318277|7744439|FG004|STARTED|Overall Study||8
6811584|NCT02318277|7744440|FG005|STARTED|Overall Study||9
6811585|NCT02318277|7744441|FG006|STARTED|Overall Study||49
6811586|NCT02318277|7744442|FG007|STARTED|Overall Study||93
6811587|NCT02318277|7744435|FG000|COMPLETED|Overall Study||0
6811588|NCT02318277|7744436|FG001|COMPLETED|Overall Study||0
6811589|NCT02318277|7744437|FG002|COMPLETED|Overall Study||0
6811590|NCT02318277|7744438|FG003|COMPLETED|Overall Study||0
6811591|NCT02318277|7744439|FG004|COMPLETED|Overall Study||0
6811592|NCT02318277|7744440|FG005|COMPLETED|Overall Study||0
6811593|NCT02318277|7744441|FG006|COMPLETED|Overall Study||0
6811594|NCT02318277|7744442|FG007|COMPLETED|Overall Study||0
6811595|NCT02318277|7744435|FG000|NOT COMPLETED|Overall Study||6
6811596|NCT02318277|7744436|FG001|NOT COMPLETED|Overall Study||3
6811597|NCT02318277|7744437|FG002|NOT COMPLETED|Overall Study||4
6811598|NCT02318277|7744438|FG003|NOT COMPLETED|Overall Study||4
6811599|NCT02318277|7744439|FG004|NOT COMPLETED|Overall Study||8
6811600|NCT02318277|7744440|FG005|NOT COMPLETED|Overall Study||9
6811601|NCT02318277|7744441|FG006|NOT COMPLETED|Overall Study||49
6811602|NCT02318277|7744442|FG007|NOT COMPLETED|Overall Study||93
6811603|NCT02296801|7744478|FG000|STARTED|Overall Study||103
6811604|NCT02296801|7744479|FG001|STARTED|Overall Study||68
6811605|NCT02296801|7744480|FG002|STARTED|Overall Study||69
6811606|NCT02296801|7744481|FG003|STARTED|Overall Study||67
6811607|NCT02296801|7744478|FG000|COMPLETED|Overall Study||83
6811608|NCT02296801|7744479|FG001|COMPLETED|Overall Study||53
6811609|NCT02296801|7744480|FG002|COMPLETED|Overall Study||50
6811610|NCT02296801|7744481|FG003|COMPLETED|Overall Study||58
6811611|NCT02296801|7744478|FG000|NOT COMPLETED|Overall Study||20
6811612|NCT02296801|7744479|FG001|NOT COMPLETED|Overall Study||15
6811613|NCT02296801|7744480|FG002|NOT COMPLETED|Overall Study||19
6811614|NCT02296801|7744481|FG003|NOT COMPLETED|Overall Study||9
6811615|NCT02143063|7744498|FG000|STARTED|Overall Study||61
6811616|NCT02143063|7744499|FG001|STARTED|Overall Study||105
6811617|NCT02143063|7744500|FG002|STARTED|Overall Study||108
6811618|NCT02143063|7744498|FG000|COMPLETED|Overall Study||45
6811619|NCT02143063|7744499|FG001|COMPLETED|Overall Study||75
6811620|NCT02143063|7744500|FG002|COMPLETED|Overall Study||78
6811621|NCT02143063|7744498|FG000|NOT COMPLETED|Overall Study||16
6811622|NCT02143063|7744499|FG001|NOT COMPLETED|Overall Study||30
6811623|NCT02143063|7744500|FG002|NOT COMPLETED|Overall Study||30
6811624|NCT02017964|7744508|FG000|STARTED|Overall Study||26
6811625|NCT02017964|7744508|FG000|COMPLETED|Overall Study||25
6811626|NCT02017964|7744508|FG000|NOT COMPLETED|Overall Study||1
6811627|NCT01968785|7744514|FG000|STARTED|Overall Study||2
6811628|NCT01968785|7744515|FG001|STARTED|Overall Study||0
6811629|NCT01968785|7744514|FG000|COMPLETED|Overall Study||1
6811630|NCT01968785|7744515|FG001|COMPLETED|Overall Study||0
6811631|NCT01968785|7744514|FG000|NOT COMPLETED|Overall Study||1
6811632|NCT01968785|7744515|FG001|NOT COMPLETED|Overall Study||0
6811633|NCT01956110|7744523|FG000|STARTED|Overall Study||665
6811634|NCT01956110|7744524|FG001|STARTED|Overall Study||661
6811635|NCT01956110|7744523|FG000|COMPLETED|Overall Study||630
6811636|NCT01956110|7744524|FG001|COMPLETED|Overall Study||639
6811637|NCT01956110|7744523|FG000|NOT COMPLETED|Overall Study||35
6811638|NCT01956110|7744524|FG001|NOT COMPLETED|Overall Study||22
6811639|NCT01648023|7744533|FG000|STARTED|Overall Study||25
6811640|NCT01648023|7744534|FG001|STARTED|Overall Study||24
6811641|NCT01648023|7744533|FG000|COMPLETED|Overall Study||24
6811642|NCT01648023|7744534|FG001|COMPLETED|Overall Study||22
6811643|NCT01648023|7744533|FG000|NOT COMPLETED|Overall Study||1
6811644|NCT01648023|7744534|FG001|NOT COMPLETED|Overall Study||2
6811645|NCT01335581|7744542|FG000|STARTED|Overall Study||9
6811646|NCT01335581|7744543|FG001|STARTED|Overall Study||9
6811647|NCT01335581|7744542|FG000|COMPLETED|Overall Study||5
6811648|NCT01335581|7744543|FG001|COMPLETED|Overall Study||3
6811649|NCT01335581|7744542|FG000|NOT COMPLETED|Overall Study||4
6811650|NCT01335581|7744543|FG001|NOT COMPLETED|Overall Study||6
6811651|NCT01209923|7744549|FG000|STARTED|Overall Study||362
6811652|NCT01209923|7744549|FG000|COMPLETED|Overall Study||362
6811653|NCT01209923|7744549|FG000|NOT COMPLETED|Overall Study||0
6811654|NCT01083433|7744557|FG000|STARTED|Overall Study||22
6811655|NCT01083433|7744558|FG001|STARTED|Overall Study||23
6811656|NCT01083433|7744559|FG002|STARTED|Overall Study||23
6811657|NCT01083433|7744557|FG000|COMPLETED|Overall Study||20
6567463|NCT01831258|7490507|FG000|STARTED|Overall Study||35
6567464|NCT01831258|7490508|FG001|STARTED|Overall Study||35
6567465|NCT01831258|7490507|FG000|COMPLETED|Overall Study||30
6811658|NCT01083433|7744558|FG001|COMPLETED|Overall Study||17
6811659|NCT01083433|7744559|FG002|COMPLETED|Overall Study||18
6811660|NCT01083433|7744557|FG000|NOT COMPLETED|Overall Study||2
6811661|NCT01083433|7744558|FG001|NOT COMPLETED|Overall Study||6
6811662|NCT01083433|7744559|FG002|NOT COMPLETED|Overall Study||5
6811663|NCT00787176|7744575|FG000|STARTED|Overall Study||69
6811664|NCT00787176|7744576|FG001|STARTED|Overall Study||62
6811665|NCT00787176|7744577|FG002|STARTED|Overall Study||60
6811666|NCT00787176|7744578|FG003|STARTED|Overall Study||60
6811667|NCT00787176|7744575|FG000|COMPLETED|Overall Study||62
6811668|NCT00787176|7744576|FG001|COMPLETED|Overall Study||59
6811669|NCT00787176|7744577|FG002|COMPLETED|Overall Study||54
6811670|NCT00787176|7744578|FG003|COMPLETED|Overall Study||55
6811671|NCT00787176|7744575|FG000|NOT COMPLETED|Overall Study||7
6811672|NCT00787176|7744576|FG001|NOT COMPLETED|Overall Study||3
6811673|NCT00787176|7744577|FG002|NOT COMPLETED|Overall Study||6
6811674|NCT00787176|7744578|FG003|NOT COMPLETED|Overall Study||5
6811675|NCT00352534|7744591|FG000|STARTED|Initial Staging||211
6811676|NCT00352534|7744592|FG001|STARTED|Initial Staging||597
6811677|NCT00352534|7744593|FG002|STARTED|Initial Staging||0
6811678|NCT00352534|7744594|FG003|STARTED|Initial Staging||0
6811679|NCT00352534|7744595|FG004|STARTED|Initial Staging||0
6811680|NCT00352534|7744596|FG005|STARTED|Initial Staging||0
6811681|NCT00352534|7744597|FG006|STARTED|Initial Staging||0
6811682|NCT00352534|7744591|FG000|COMPLETED|Initial Staging||203
6811683|NCT00352534|7744592|FG001|COMPLETED|Initial Staging||588
6811684|NCT00352534|7744593|FG002|COMPLETED|Initial Staging||0
6811685|NCT00352534|7744594|FG003|COMPLETED|Initial Staging||0
6811686|NCT00352534|7744595|FG004|COMPLETED|Initial Staging||0
6811687|NCT00352534|7744596|FG005|COMPLETED|Initial Staging||0
6567466|NCT01831258|7490508|FG001|COMPLETED|Overall Study||32
6567467|NCT01831258|7490507|FG000|NOT COMPLETED|Overall Study||5
6567468|NCT01831258|7490508|FG001|NOT COMPLETED|Overall Study||3
6567469|NCT01831427|7490527|FG000|STARTED|Overall Study||5
6567470|NCT01831427|7490528|FG001|STARTED|Overall Study||5
6567471|NCT01831427|7490529|FG002|STARTED|Overall Study||5
6811688|NCT00352534|7744597|FG006|COMPLETED|Initial Staging||0
6811689|NCT00352534|7744591|FG000|NOT COMPLETED|Initial Staging||8
6811690|NCT00352534|7744592|FG001|NOT COMPLETED|Initial Staging||9
6811691|NCT00352534|7744593|FG002|NOT COMPLETED|Initial Staging||0
6811692|NCT00352534|7744594|FG003|NOT COMPLETED|Initial Staging||0
6811693|NCT00352534|7744595|FG004|NOT COMPLETED|Initial Staging||0
6811694|NCT00352534|7744596|FG005|NOT COMPLETED|Initial Staging||0
6811695|NCT00352534|7744597|FG006|NOT COMPLETED|Initial Staging||0
6811696|NCT00352534|7744591|FG000|STARTED|Final Risk Group Assignment||0
6811697|NCT00352534|7744592|FG001|STARTED|Final Risk Group Assignment||0
6811698|NCT00352534|7744593|FG002|STARTED|Final Risk Group Assignment||119
6811699|NCT00352534|7744594|FG003|STARTED|Final Risk Group Assignment||52
6811700|NCT00352534|7744595|FG004|STARTED|Final Risk Group Assignment||32
6811701|NCT00352534|7744596|FG005|STARTED|Final Risk Group Assignment||548
6811702|NCT00352534|7744597|FG006|STARTED|Final Risk Group Assignment||40
6811703|NCT00352534|7744591|FG000|COMPLETED|Final Risk Group Assignment||0
6811704|NCT00352534|7744592|FG001|COMPLETED|Final Risk Group Assignment||0
6811705|NCT00352534|7744593|FG002|COMPLETED|Final Risk Group Assignment||116
6811706|NCT00352534|7744594|FG003|COMPLETED|Final Risk Group Assignment||49
6811707|NCT00352534|7744595|FG004|COMPLETED|Final Risk Group Assignment||31
6811708|NCT00352534|7744596|FG005|COMPLETED|Final Risk Group Assignment||503
6811709|NCT00352534|7744597|FG006|COMPLETED|Final Risk Group Assignment||1
6811710|NCT00352534|7744591|FG000|NOT COMPLETED|Final Risk Group Assignment||0
6811711|NCT00352534|7744592|FG001|NOT COMPLETED|Final Risk Group Assignment||0
6811712|NCT00352534|7744593|FG002|NOT COMPLETED|Final Risk Group Assignment||3
6811713|NCT00352534|7744594|FG003|NOT COMPLETED|Final Risk Group Assignment||3
6567472|NCT01831427|7490530|FG003|STARTED|Overall Study||5
6567473|NCT01831427|7490531|FG004|STARTED|Overall Study||4
6811714|NCT00352534|7744595|FG004|NOT COMPLETED|Final Risk Group Assignment||1
6811715|NCT00352534|7744596|FG005|NOT COMPLETED|Final Risk Group Assignment||45
6811716|NCT00352534|7744597|FG006|NOT COMPLETED|Final Risk Group Assignment||39
6811717|NCT00033293|7744609|FG000|STARTED|Overall Study||26
6811718|NCT00033293|7744610|FG001|STARTED|Overall Study||27
6811719|NCT00033293|7744609|FG000|COMPLETED|Overall Study||16
6811720|NCT00033293|7744610|FG001|COMPLETED|Overall Study||9
6811721|NCT00033293|7744609|FG000|NOT COMPLETED|Overall Study||10
6811722|NCT00033293|7744610|FG001|NOT COMPLETED|Overall Study||18
6567474|NCT01831427|7490532|FG005|STARTED|Overall Study||8
6567475|NCT01831427|7490533|FG006|STARTED|Overall Study||8
6567476|NCT01831427|7490534|FG007|STARTED|Overall Study||8
6567477|NCT01831427|7490535|FG008|STARTED|Overall Study||8
6567478|NCT01831427|7490536|FG009|STARTED|Overall Study||10
6811723|NCT04497415|7744620|FG000|STARTED|Overall Study||229
6567479|NCT01831427|7490537|FG010|STARTED|Overall Study||8
6567480|NCT01831427|7490527|FG000|COMPLETED|Overall Study||5
6567481|NCT01831427|7490528|FG001|COMPLETED|Overall Study||4
6567482|NCT01831427|7490529|FG002|COMPLETED|Overall Study||5
6567483|NCT01831427|7490530|FG003|COMPLETED|Overall Study||4
6567484|NCT01831427|7490531|FG004|COMPLETED|Overall Study||4
6567485|NCT01831427|7490532|FG005|COMPLETED|Overall Study||7
6567486|NCT01831427|7490533|FG006|COMPLETED|Overall Study||6
6567487|NCT01831427|7490534|FG007|COMPLETED|Overall Study||7
6567488|NCT01831427|7490535|FG008|COMPLETED|Overall Study||8
6811724|NCT04497415|7744621|FG001|STARTED|Overall Study||121
6811725|NCT04497415|7744620|FG000|Post-intervention Assessment (Day 1)|Overall Study||229
6811726|NCT04497415|7744621|FG001|Post-intervention Assessment (Day 1)|Overall Study||121
6811727|NCT04497415|7744620|FG000|First Follow-up Assessment (Day 14)|Overall Study||195
6811728|NCT04497415|7744621|FG001|First Follow-up Assessment (Day 14)|Overall Study||102
6811729|NCT04497415|7744620|FG000|COMPLETED|Overall Study||186
6811730|NCT04497415|7744621|FG001|COMPLETED|Overall Study||94
6811731|NCT04497415|7744620|FG000|NOT COMPLETED|Overall Study||43
6811732|NCT04497415|7744621|FG001|NOT COMPLETED|Overall Study||27
6811733|NCT04231396|7744627|FG000|STARTED|Overall Study||27
6811734|NCT04231396|7744627|FG000|COMPLETED|Overall Study||27
6811735|NCT04231396|7744627|FG000|NOT COMPLETED|Overall Study||0
6811736|NCT04118348|7744636|FG000|STARTED|Overall Study||3445
6811737|NCT04118348|7744637|FG001|STARTED|Overall Study||3312
6811738|NCT04118348|7744638|FG002|STARTED|Overall Study||3461
6811739|NCT04118348|7744639|FG003|STARTED|Overall Study||3262
6811740|NCT04118348|7744636|FG000|COMPLETED|Overall Study||3445
6811741|NCT04118348|7744637|FG001|COMPLETED|Overall Study||3312
6811742|NCT04118348|7744638|FG002|COMPLETED|Overall Study||3461
6811743|NCT04118348|7744639|FG003|COMPLETED|Overall Study||3262
6811744|NCT04118348|7744636|FG000|NOT COMPLETED|Overall Study||0
6811745|NCT04118348|7744637|FG001|NOT COMPLETED|Overall Study||0
6811746|NCT04118348|7744638|FG002|NOT COMPLETED|Overall Study||0
6811747|NCT04118348|7744639|FG003|NOT COMPLETED|Overall Study||0
6811748|NCT03894540|7744655|FG000|STARTED|Overall Study||1
6811749|NCT03894540|7744656|FG001|STARTED|Overall Study||1
6811750|NCT03894540|7744657|FG002|STARTED|Overall Study||1
6275955|NCT00116753|7175225|FG001|STARTED|Overall Study||155
6275956|NCT00116753|7175226|FG002|STARTED|Overall Study||152
6275957|NCT00116753|7175224|FG000|ITT Population|Overall Study||150
6275958|NCT00116753|7175225|FG001|ITT Population|Overall Study||150
6275959|NCT00116753|7175226|FG002|ITT Population|Overall Study||147
6275960|NCT00116753|7175224|FG000|COMPLETED|Overall Study||121
6275961|NCT00116753|7175225|FG001|COMPLETED|Overall Study||125
6275962|NCT00116753|7175226|FG002|COMPLETED|Overall Study||128
6275963|NCT00116753|7175224|FG000|NOT COMPLETED|Overall Study||32
6567489|NCT01831427|7490536|FG009|COMPLETED|Overall Study||9
6811751|NCT03894540|7744658|FG003|STARTED|Overall Study||4
6811752|NCT03894540|7744659|FG004|STARTED|Overall Study||11
6811753|NCT03894540|7744660|FG005|STARTED|Overall Study||4
6275964|NCT00116753|7175225|FG001|NOT COMPLETED|Overall Study||30
6275965|NCT00116753|7175226|FG002|NOT COMPLETED|Overall Study||24
6275966|NCT00116779|7175236|FG000|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
6275967|NCT00116779|7175237|FG001|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
6275968|NCT00116779|7175236|FG000|COMPLETED|Overall Study||42
6275969|NCT00116779|7175237|FG001|COMPLETED|Overall Study||45
6275970|NCT00116779|7175236|FG000|NOT COMPLETED|Overall Study||21
6567490|NCT01831427|7490537|FG010|COMPLETED|Overall Study||5
6567491|NCT01831427|7490527|FG000|NOT COMPLETED|Overall Study||0
6811754|NCT03894540|7744655|FG000|COMPLETED|Overall Study||0
6811755|NCT03894540|7744656|FG001|COMPLETED|Overall Study||0
6811756|NCT03894540|7744657|FG002|COMPLETED|Overall Study||0
6811757|NCT03894540|7744658|FG003|COMPLETED|Overall Study||0
6811758|NCT03894540|7744659|FG004|COMPLETED|Overall Study||0
6811759|NCT03894540|7744660|FG005|COMPLETED|Overall Study||0
6811760|NCT03894540|7744655|FG000|NOT COMPLETED|Overall Study||1
6811761|NCT03894540|7744656|FG001|NOT COMPLETED|Overall Study||1
6811762|NCT03894540|7744657|FG002|NOT COMPLETED|Overall Study||1
6811763|NCT03894540|7744658|FG003|NOT COMPLETED|Overall Study||4
6811764|NCT03894540|7744659|FG004|NOT COMPLETED|Overall Study||11
6811765|NCT03894540|7744660|FG005|NOT COMPLETED|Overall Study||4
6811766|NCT03816202|7744678|FG000|STARTED|Overall Study||100
6811767|NCT03816202|7744678|FG000|COMPLETED|Overall Study||100
6811768|NCT03816202|7744678|FG000|NOT COMPLETED|Overall Study||0
6811769|NCT03725293|7744684|FG000|STARTED|Overall Study||106
6811770|NCT03725293|7744685|FG001|STARTED|Overall Study||106
6811771|NCT03725293|7744684|FG000|COMPLETED|Overall Study||94
6811772|NCT03725293|7744685|FG001|COMPLETED|Overall Study||97
6811773|NCT03725293|7744684|FG000|NOT COMPLETED|Overall Study||12
6811774|NCT03725293|7744685|FG001|NOT COMPLETED|Overall Study||9
6811775|NCT03702231|7744694|FG000|STARTED|Overall Study||59
6811776|NCT03702231|7744695|FG001|STARTED|Overall Study||29
6811777|NCT03702231|7744696|FG002|STARTED|Overall Study||28
6811778|NCT03702231|7744694|FG000|COMPLETED|Overall Study||55
6811779|NCT03702231|7744695|FG001|COMPLETED|Overall Study||25
6811780|NCT03702231|7744696|FG002|COMPLETED|Overall Study||26
6811781|NCT03702231|7744694|FG000|NOT COMPLETED|Overall Study||4
6811782|NCT03702231|7744695|FG001|NOT COMPLETED|Overall Study||4
6811783|NCT03702231|7744696|FG002|NOT COMPLETED|Overall Study||2
6811784|NCT03690284|7744706|FG000|STARTED|Overall Study||25
6811785|NCT03690284|7744707|FG001|STARTED|Overall Study||25
6811786|NCT03690284|7744706|FG000|COMPLETED|Overall Study||25
6811787|NCT03690284|7744707|FG001|COMPLETED|Overall Study||25
6811788|NCT03690284|7744706|FG000|NOT COMPLETED|Overall Study||0
6811789|NCT03690284|7744707|FG001|NOT COMPLETED|Overall Study||0
6811790|NCT03670277|7744715|FG000|STARTED|Overall Study||20
6811791|NCT03670277|7744716|FG001|STARTED|Overall Study||8
6811792|NCT03670277|7744715|FG000|COMPLETED|Overall Study||20
6811793|NCT03670277|7744716|FG001|COMPLETED|Overall Study||8
6811794|NCT03670277|7744715|FG000|NOT COMPLETED|Overall Study||0
6811795|NCT03670277|7744716|FG001|NOT COMPLETED|Overall Study||0
6811796|NCT03556358|7744727|FG000|STARTED|Overall Study||404
6811797|NCT03556358|7744728|FG001|STARTED|Overall Study||405
6811798|NCT03556358|7744727|FG000|Subjects Treated|Overall Study||401
6811799|NCT03556358|7744728|FG001|Subjects Treated|Overall Study||405
6811800|NCT03556358|7744727|FG000|Subjects Receiving TX05 or Herceptin|Overall Study||394
6811801|NCT03556358|7744728|FG001|Subjects Receiving TX05 or Herceptin|Overall Study||400
6811802|NCT03556358|7744727|FG000|COMPLETED|Overall Study||393
6811803|NCT03556358|7744728|FG001|COMPLETED|Overall Study||393
6811804|NCT03556358|7744727|FG000|NOT COMPLETED|Overall Study||11
6811805|NCT03556358|7744728|FG001|NOT COMPLETED|Overall Study||12
6811806|NCT03290781|7744741|FG000|STARTED|Overall Study||73
6811807|NCT03290781|7744742|FG001|STARTED|Overall Study||71
6811808|NCT03290781|7744743|FG002|STARTED|Overall Study||86
6811809|NCT03290781|7744744|FG003|STARTED|Overall Study||82
6811810|NCT03290781|7744745|FG004|STARTED|Overall Study||11
6811811|NCT03290781|7744746|FG005|STARTED|Overall Study||22
6811812|NCT03290781|7744747|FG006|STARTED|Overall Study||21
6811813|NCT03290781|7744741|FG000|COMPLETED|Overall Study||24
6811814|NCT03290781|7744742|FG001|COMPLETED|Overall Study||53
6811815|NCT03290781|7744743|FG002|COMPLETED|Overall Study||30
6811816|NCT03290781|7744744|FG003|COMPLETED|Overall Study||59
6811817|NCT03290781|7744745|FG004|COMPLETED|Overall Study||6
6811818|NCT03290781|7744746|FG005|COMPLETED|Overall Study||19
6811819|NCT03290781|7744747|FG006|COMPLETED|Overall Study||17
6811820|NCT03290781|7744741|FG000|NOT COMPLETED|Overall Study||49
6811821|NCT03290781|7744742|FG001|NOT COMPLETED|Overall Study||18
6811822|NCT03290781|7744743|FG002|NOT COMPLETED|Overall Study||56
6811823|NCT03290781|7744744|FG003|NOT COMPLETED|Overall Study||23
6811824|NCT03290781|7744745|FG004|NOT COMPLETED|Overall Study||5
6811825|NCT03290781|7744746|FG005|NOT COMPLETED|Overall Study||3
6811826|NCT03290781|7744747|FG006|NOT COMPLETED|Overall Study||4
6811827|NCT03263195|7744774|FG000|STARTED|Overall Study||174
6811828|NCT03263195|7744775|FG001|STARTED|Overall Study||0
6811829|NCT03263195|7744776|FG002|STARTED|Overall Study||0
6811830|NCT03263195|7744777|FG003|STARTED|Overall Study||26
6811831|NCT03263195|7744778|FG004|STARTED|Overall Study||170
6811832|NCT03263195|7744779|FG005|STARTED|Overall Study||0
6811833|NCT03263195|7744780|FG006|STARTED|Overall Study||0
6811834|NCT03263195|7744781|FG007|STARTED|Overall Study||25
6811835|NCT03263195|7744774|FG000|COMPLETED|Overall Study||168
6811836|NCT03263195|7744775|FG001|COMPLETED|Overall Study||0
6811837|NCT03263195|7744776|FG002|COMPLETED|Overall Study||0
6811838|NCT03263195|7744777|FG003|COMPLETED|Overall Study||23
6811839|NCT03263195|7744778|FG004|COMPLETED|Overall Study||155
6811840|NCT03263195|7744779|FG005|COMPLETED|Overall Study||0
6811841|NCT03263195|7744780|FG006|COMPLETED|Overall Study||0
6811842|NCT03263195|7744781|FG007|COMPLETED|Overall Study||19
6811843|NCT03263195|7744774|FG000|NOT COMPLETED|Overall Study||6
6811844|NCT03263195|7744775|FG001|NOT COMPLETED|Overall Study||0
6811845|NCT03263195|7744776|FG002|NOT COMPLETED|Overall Study||0
6811846|NCT03263195|7744777|FG003|NOT COMPLETED|Overall Study||3
6811847|NCT03263195|7744778|FG004|NOT COMPLETED|Overall Study||15
6811848|NCT03263195|7744779|FG005|NOT COMPLETED|Overall Study||0
6811849|NCT03263195|7744780|FG006|NOT COMPLETED|Overall Study||0
6811850|NCT03263195|7744781|FG007|NOT COMPLETED|Overall Study||6
6811851|NCT03228680|7744806|FG000|STARTED|Overall Study||170
6811852|NCT03228680|7744807|FG001|STARTED|Overall Study||178
6811853|NCT03228680|7744806|FG000|COMPLETED|Overall Study||147
6811854|NCT03228680|7744807|FG001|COMPLETED|Overall Study||143
6811855|NCT03228680|7744806|FG000|NOT COMPLETED|Overall Study||23
6811856|NCT03228680|7744807|FG001|NOT COMPLETED|Overall Study||35
6811857|NCT03196167|7744816|FG000|STARTED|Overall Study||45
6811858|NCT03196167|7744817|FG001|STARTED|Overall Study||45
6811859|NCT03196167|7744816|FG000|COMPLETED|Overall Study||40
6811860|NCT03196167|7744817|FG001|COMPLETED|Overall Study||43
6811861|NCT03196167|7744816|FG000|NOT COMPLETED|Overall Study||5
6811862|NCT03196167|7744817|FG001|NOT COMPLETED|Overall Study||2
6811863|NCT03077204|7744827|FG000|STARTED|Overall Study||20
6811864|NCT03077204|7744827|FG000|COMPLETED|Overall Study||20
6811865|NCT03077204|7744827|FG000|NOT COMPLETED|Overall Study||0
6504740|NCT01449630|7423757|FG002|COMPLETED|Period 3||2
6504741|NCT01449630|7423758|FG003|COMPLETED|Period 3||1
6811866|NCT03029611|7744832|FG000|STARTED|Overall Study|We had 11 patients sign consent with 2 patients deciding not to continue to receive treatment.|9
6811867|NCT03029611|7744832|FG000|COMPLETED|Overall Study|Please note that we did not fully enroll this study due to lack of funding. The complete date here relates to the last treatment administration.|9
6811868|NCT03029611|7744832|FG000|NOT COMPLETED|Overall Study||0
6811869|NCT02891798|7744838|FG000|STARTED|Overall Study||62
6811870|NCT02891798|7744839|FG001|STARTED|Overall Study||16
6811871|NCT02891798|7744838|FG000|COMPLETED|Overall Study||62
6811872|NCT02891798|7744839|FG001|COMPLETED|Overall Study||16
6811873|NCT02891798|7744838|FG000|NOT COMPLETED|Overall Study||0
6811874|NCT02891798|7744839|FG001|NOT COMPLETED|Overall Study||0
6811875|NCT02679781|7744847|FG000|STARTED|Overall Study||37
6811876|NCT02679781|7744848|FG001|STARTED|Overall Study||33
6811877|NCT02679781|7744847|FG000|COMPLETED|Overall Study||30
6811878|NCT02679781|7744848|FG001|COMPLETED|Overall Study||30
6811879|NCT02679781|7744847|FG000|NOT COMPLETED|Overall Study||7
6811880|NCT02679781|7744848|FG001|NOT COMPLETED|Overall Study||3
6811881|NCT02624869|7744857|FG000|STARTED|Overall Study||49
6811882|NCT02624869|7744858|FG001|STARTED|Overall Study||101
6811883|NCT02624869|7744859|FG002|STARTED|Overall Study||13
6811884|NCT02624869|7744857|FG000|Received Study Drug|Overall Study||49
6811885|NCT02624869|7744858|FG001|Received Study Drug|Overall Study||101
6811886|NCT02624869|7744859|FG002|Received Study Drug|Overall Study||12
6811887|NCT02624869|7744857|FG000|COMPLETED|Overall Study||48
6811888|NCT02624869|7744858|FG001|COMPLETED|Overall Study||98
6811889|NCT02624869|7744859|FG002|COMPLETED|Overall Study||11
6811890|NCT02624869|7744857|FG000|NOT COMPLETED|Overall Study||1
6811891|NCT02624869|7744858|FG001|NOT COMPLETED|Overall Study||3
6811892|NCT02624869|7744859|FG002|NOT COMPLETED|Overall Study||2
6811893|NCT02614690|7744871|FG000|STARTED|Overall Study||20
6811894|NCT02614690|7744872|FG001|STARTED|Overall Study||20
6811895|NCT02614690|7744873|FG002|STARTED|Overall Study||20
6811896|NCT02614690|7744871|FG000|COMPLETED|Overall Study||20
6811897|NCT02614690|7744872|FG001|COMPLETED|Overall Study||20
6811898|NCT02614690|7744873|FG002|COMPLETED|Overall Study||20
6811899|NCT02614690|7744871|FG000|NOT COMPLETED|Overall Study||0
6811900|NCT02614690|7744872|FG001|NOT COMPLETED|Overall Study||0
6811901|NCT02614690|7744873|FG002|NOT COMPLETED|Overall Study||0
6811902|NCT02569242|7744883|FG000|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|210
6811903|NCT02569242|7744884|FG001|STARTED|Overall Study|Included in intention-to-treat analysis for overall survival and progression-free survival|209
6811904|NCT02569242|7744883|FG000|COMPLETED|Overall Study|Analysed for safety|209
6811905|NCT02569242|7744884|FG001|COMPLETED|Overall Study|Analysed for safety|208
6811906|NCT02569242|7744883|FG000|NOT COMPLETED|Overall Study||1
6811907|NCT02569242|7744884|FG001|NOT COMPLETED|Overall Study||1
6811908|NCT02516969|7744892|FG000|STARTED|Overall Study||3
6811909|NCT02516969|7744893|FG001|STARTED|Overall Study||4
6811910|NCT02516969|7744892|FG000|COMPLETED|Overall Study||3
6811911|NCT02516969|7744893|FG001|COMPLETED|Overall Study||4
6811912|NCT02516969|7744892|FG000|NOT COMPLETED|Overall Study||0
6811913|NCT02516969|7744893|FG001|NOT COMPLETED|Overall Study||0
6811914|NCT02507960|7744901|FG000|STARTED|Overall Study||17
6811915|NCT02507960|7744901|FG000|COMPLETED|Overall Study||17
6811916|NCT02507960|7744901|FG000|NOT COMPLETED|Overall Study||0
6811917|NCT02435433|7744907|FG000|STARTED|Overall Study||197
6811918|NCT02435433|7744908|FG001|STARTED|Overall Study||95
6275971|NCT00116779|7175237|FG001|NOT COMPLETED|Overall Study||19
6275972|NCT00116805|7175245|FG000|STARTED|Double-blind Period Through Week 48||176
6275973|NCT00116805|7175246|FG001|STARTED|Double-blind Period Through Week 48||90
6275974|NCT00116805|7175245|FG000|COMPLETED|Double-blind Period Through Week 48||165
6275975|NCT00116805|7175246|FG001|COMPLETED|Double-blind Period Through Week 48||85
6275976|NCT00116805|7175245|FG000|NOT COMPLETED|Double-blind Period Through Week 48||11
6275977|NCT00116805|7175246|FG001|NOT COMPLETED|Double-blind Period Through Week 48||5
6275978|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
6275979|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
6275980|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 49 - 96||144
6275981|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 49 - 96||83
6275982|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
6275983|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
6275984|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 97 - 144||144
6275985|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 97 - 144||83
6275986|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 97 - 144||133
6811919|NCT02435433|7744909|FG002|STARTED|Overall Study||0
6811920|NCT02435433|7744910|FG003|STARTED|Overall Study||0
6811921|NCT02435433|7744911|FG004|STARTED|Overall Study||0
6811922|NCT02435433|7744907|FG000|Participants Who Received Study Drug|Overall Study||197
6811923|NCT02435433|7744908|FG001|Participants Who Received Study Drug|Overall Study||95
6811924|NCT02435433|7744909|FG002|Participants Who Received Study Drug|Overall Study||0
6811925|NCT02435433|7744910|FG003|Participants Who Received Study Drug|Overall Study||0
6811926|NCT02435433|7744911|FG004|Participants Who Received Study Drug|Overall Study||0
6811927|NCT02435433|7744907|FG000|COMPLETED|Overall Study||182
6811928|NCT02435433|7744908|FG001|COMPLETED|Overall Study||90
6811929|NCT02435433|7744909|FG002|COMPLETED|Overall Study||0
6811930|NCT02435433|7744910|FG003|COMPLETED|Overall Study||0
6811931|NCT02435433|7744911|FG004|COMPLETED|Overall Study||0
6811932|NCT02435433|7744907|FG000|NOT COMPLETED|Overall Study||15
6811933|NCT02435433|7744908|FG001|NOT COMPLETED|Overall Study||5
6811934|NCT02435433|7744909|FG002|NOT COMPLETED|Overall Study||0
6811935|NCT02435433|7744910|FG003|NOT COMPLETED|Overall Study||0
6811936|NCT02435433|7744911|FG004|NOT COMPLETED|Overall Study||0
6811937|NCT02426125|7744921|FG000|STARTED|Overall Study||263
6811938|NCT02426125|7744922|FG001|STARTED|Overall Study||267
6811939|NCT02426125|7744921|FG000|Received at Least One Dose of Study Drug|Overall Study||258
6811940|NCT02426125|7744922|FG001|Received at Least One Dose of Study Drug|Overall Study||265
6811941|NCT02426125|7744921|FG000|First Randomized Participants|Overall Study||216
6811942|NCT02426125|7744922|FG001|First Randomized Participants|Overall Study||221
6811943|NCT02426125|7744921|FG000|COMPLETED|Overall Study||234
6811944|NCT02426125|7744922|FG001|COMPLETED|Overall Study||241
6811945|NCT02426125|7744921|FG000|NOT COMPLETED|Overall Study||29
6811946|NCT02426125|7744922|FG001|NOT COMPLETED|Overall Study||26
6811947|NCT02417142|7744932|FG000|STARTED|Overall Study||35
6811948|NCT02417142|7744933|FG001|STARTED|Overall Study||35
6811949|NCT02417142|7744932|FG000|COMPLETED|Overall Study||19
6811950|NCT02417142|7744933|FG001|COMPLETED|Overall Study||22
6811951|NCT02417142|7744932|FG000|NOT COMPLETED|Overall Study||16
6811952|NCT02417142|7744933|FG001|NOT COMPLETED|Overall Study||13
6567492|NCT01831427|7490528|FG001|NOT COMPLETED|Overall Study||1
6567493|NCT01831427|7490529|FG002|NOT COMPLETED|Overall Study||0
6567494|NCT01831427|7490530|FG003|NOT COMPLETED|Overall Study||1
6567495|NCT01831427|7490531|FG004|NOT COMPLETED|Overall Study||0
6567496|NCT01831427|7490532|FG005|NOT COMPLETED|Overall Study||1
6567497|NCT01831427|7490533|FG006|NOT COMPLETED|Overall Study||2
6567498|NCT01831427|7490534|FG007|NOT COMPLETED|Overall Study||1
6567499|NCT01831427|7490535|FG008|NOT COMPLETED|Overall Study||0
6567500|NCT01831427|7490536|FG009|NOT COMPLETED|Overall Study||1
6567501|NCT01831427|7490537|FG010|NOT COMPLETED|Overall Study||3
6567502|NCT01831466|7490584|FG000|STARTED|Overall Study|Treated|71
6567503|NCT01831466|7490585|FG001|STARTED|Overall Study|Treated|70
6567504|NCT01831466|7490586|FG002|STARTED|Overall Study|Treated|71
6567505|NCT01831466|7490587|FG003|STARTED|Overall Study|Treated|70
6567506|NCT01831466|7490588|FG004|STARTED|Overall Study|Treated|74
6567507|NCT01831466|7490589|FG005|STARTED|Overall Study|Treated|74
6567508|NCT01831466|7490590|FG006|STARTED|Overall Study|Treated|7
6567509|NCT01831466|7490591|FG007|STARTED|Overall Study|Treated|7
6567510|NCT01831466|7490592|FG008|STARTED|Overall Study|Treated|7
6567511|NCT01831466|7490593|FG009|STARTED|Overall Study|Treated|7
6567512|NCT01831466|7490594|FG010|STARTED|Overall Study|Treated|6
6567513|NCT01831466|7490595|FG011|STARTED|Overall Study|Treated|7
6567514|NCT01831466|7490584|FG000|COMPLETED|Overall Study||55
6567515|NCT01831466|7490585|FG001|COMPLETED|Overall Study||52
6567516|NCT01831466|7490586|FG002|COMPLETED|Overall Study||48
6567517|NCT01831466|7490587|FG003|COMPLETED|Overall Study||51
6567518|NCT01831466|7490588|FG004|COMPLETED|Overall Study||57
6811953|NCT02368886|7744943|FG000|STARTED|Overall Study||29
6811954|NCT02368886|7744944|FG001|STARTED|Overall Study||27
6811955|NCT02368886|7744945|FG002|STARTED|Overall Study||34
6811956|NCT02368886|7744946|FG003|STARTED|Overall Study||33
6811957|NCT02368886|7744943|FG000|COMPLETED|Overall Study||28
6811958|NCT02368886|7744944|FG001|COMPLETED|Overall Study||26
6811959|NCT02368886|7744945|FG002|COMPLETED|Overall Study||33
6811960|NCT02368886|7744946|FG003|COMPLETED|Overall Study||29
6811961|NCT02368886|7744943|FG000|NOT COMPLETED|Overall Study||1
6811962|NCT02368886|7744944|FG001|NOT COMPLETED|Overall Study||1
6811963|NCT02368886|7744945|FG002|NOT COMPLETED|Overall Study||1
6811964|NCT02368886|7744946|FG003|NOT COMPLETED|Overall Study||4
6811965|NCT02354703|7744958|FG000|STARTED|Overall Study||12
6811966|NCT02354703|7744959|FG001|STARTED|Overall Study||34
6811967|NCT02354703|7744960|FG002|STARTED|Overall Study||39
6811968|NCT02354703|7744961|FG003|STARTED|Overall Study||10
6811969|NCT02354703|7744958|FG000|COMPLETED|Overall Study||9
6811970|NCT02354703|7744959|FG001|COMPLETED|Overall Study||26
6811971|NCT02354703|7744960|FG002|COMPLETED|Overall Study||28
6811972|NCT02354703|7744961|FG003|COMPLETED|Overall Study||7
6811973|NCT02354703|7744958|FG000|NOT COMPLETED|Overall Study||3
6811974|NCT02354703|7744959|FG001|NOT COMPLETED|Overall Study||8
6811975|NCT02354703|7744960|FG002|NOT COMPLETED|Overall Study||11
6811976|NCT02354703|7744961|FG003|NOT COMPLETED|Overall Study||3
6811977|NCT01981551|7744973|FG000|STARTED|Overall Study||17
6811978|NCT01981551|7744973|FG000|COMPLETED|Overall Study||8
6811979|NCT01981551|7744973|FG000|NOT COMPLETED|Overall Study||9
6811980|NCT00740181|7744977|FG000|STARTED|Overall Study||9
6811981|NCT00740181|7744977|FG000|COMPLETED|Overall Study||9
6811982|NCT00740181|7744977|FG000|NOT COMPLETED|Overall Study||0
6811983|NCT00468130|7744983|FG000|STARTED|Overall Study||7
6811984|NCT00468130|7744984|FG001|STARTED|Overall Study||6
6811985|NCT00468130|7744983|FG000|COMPLETED|Overall Study||5
6811986|NCT00468130|7744984|FG001|COMPLETED|Overall Study||4
6811987|NCT00468130|7744983|FG000|NOT COMPLETED|Overall Study||2
6811988|NCT00468130|7744984|FG001|NOT COMPLETED|Overall Study||2
6811989|NCT00384111|7744992|FG000|STARTED|Overall Study||26
6811990|NCT00384111|7744992|FG000|COMPLETED|Overall Study||0
6811991|NCT00384111|7744992|FG000|NOT COMPLETED|Overall Study||26
6811992|NCT04854642|7744996|FG000|STARTED|Overall Study||18
6390876|NCT00832767|7302692|FG001|STARTED|Overall Study||81
6390877|NCT00832767|7302691|FG000|COMPLETED|Overall Study||99
6390878|NCT00832767|7302692|FG001|COMPLETED|Overall Study||63
6390879|NCT00832767|7302691|FG000|NOT COMPLETED|Overall Study||22
6656984|NCT02465866|7587326|FG003|COMPLETED|Period 2: Washout (14 Days)||5
6656985|NCT02465866|7587323|FG000|NOT COMPLETED|Period 2: Washout (14 Days)||0
6656986|NCT02465866|7587324|FG001|NOT COMPLETED|Period 2: Washout (14 Days)||0
6656987|NCT02465866|7587325|FG002|NOT COMPLETED|Period 2: Washout (14 Days)||0
6656988|NCT02465866|7587326|FG003|NOT COMPLETED|Period 2: Washout (14 Days)||0
6656989|NCT02465866|7587323|FG000|STARTED|Period 3||5
6390880|NCT00832767|7302692|FG001|NOT COMPLETED|Overall Study||18
6390881|NCT00832780|7302700|FG000|STARTED|Overall Study||44
6390882|NCT00832780|7302700|FG000|COMPLETED|Overall Study||19
6390883|NCT00832780|7302700|FG000|NOT COMPLETED|Overall Study||25
6656990|NCT02465866|7587324|FG001|STARTED|Period 3||5
6811993|NCT04854642|7744997|FG001|STARTED|Overall Study||18
6811994|NCT04854642|7744996|FG000|Safety Set|Overall Study||18
6811995|NCT04854642|7744997|FG001|Safety Set|Overall Study||18
6811996|NCT04854642|7744996|FG000|PK Set 1|Overall Study||18
6811997|NCT04854642|7744997|FG001|PK Set 1|Overall Study||18
6811998|NCT04854642|7744996|FG000|PK Set 2|Overall Study||18
6811999|NCT04854642|7744997|FG001|PK Set 2|Overall Study||18
6812000|NCT04854642|7744996|FG000|COMPLETED|Overall Study||17
6812001|NCT04854642|7744997|FG001|COMPLETED|Overall Study||15
6812002|NCT04854642|7744996|FG000|NOT COMPLETED|Overall Study||1
6812003|NCT04854642|7744997|FG001|NOT COMPLETED|Overall Study||3
6567519|NCT01831466|7490589|FG005|COMPLETED|Overall Study||48
6567520|NCT01831466|7490590|FG006|COMPLETED|Overall Study||6
6567521|NCT01831466|7490591|FG007|COMPLETED|Overall Study||5
6567522|NCT01831466|7490592|FG008|COMPLETED|Overall Study||4
6567523|NCT01831466|7490593|FG009|COMPLETED|Overall Study||2
6656991|NCT02465866|7587325|FG002|STARTED|Period 3||5
6656992|NCT02465866|7587326|FG003|STARTED|Period 3||5
6656993|NCT02465866|7587323|FG000|COMPLETED|Period 3||5
6656994|NCT02465866|7587324|FG001|COMPLETED|Period 3||4
6656995|NCT02465866|7587325|FG002|COMPLETED|Period 3||5
6656996|NCT02465866|7587326|FG003|COMPLETED|Period 3||5
6567524|NCT01831466|7490594|FG010|COMPLETED|Overall Study||4
6567525|NCT01831466|7490595|FG011|COMPLETED|Overall Study||3
6567526|NCT01831466|7490584|FG000|NOT COMPLETED|Overall Study||16
6567527|NCT01831466|7490585|FG001|NOT COMPLETED|Overall Study||18
6567528|NCT01831466|7490586|FG002|NOT COMPLETED|Overall Study||23
6567529|NCT01831466|7490587|FG003|NOT COMPLETED|Overall Study||19
6567530|NCT01831466|7490588|FG004|NOT COMPLETED|Overall Study||17
6567531|NCT01831466|7490589|FG005|NOT COMPLETED|Overall Study||26
6656997|NCT02465866|7587323|FG000|NOT COMPLETED|Period 3||0
6656998|NCT02465866|7587324|FG001|NOT COMPLETED|Period 3||1
6656999|NCT02465866|7587325|FG002|NOT COMPLETED|Period 3||0
6657000|NCT02465866|7587326|FG003|NOT COMPLETED|Period 3||0
6657001|NCT02465866|7587323|FG000|STARTED|Period 3: Washout (14 Days)||5
6657002|NCT02465866|7587324|FG001|STARTED|Period 3: Washout (14 Days)||4
6657003|NCT02465866|7587325|FG002|STARTED|Period 3: Washout (14 Days)||5
6657004|NCT02465866|7587326|FG003|STARTED|Period 3: Washout (14 Days)||5
6657005|NCT02465866|7587323|FG000|COMPLETED|Period 3: Washout (14 Days)||5
6657006|NCT02465866|7587324|FG001|COMPLETED|Period 3: Washout (14 Days)||4
6657007|NCT02465866|7587325|FG002|COMPLETED|Period 3: Washout (14 Days)||5
6657008|NCT02465866|7587326|FG003|COMPLETED|Period 3: Washout (14 Days)||5
6657009|NCT02465866|7587323|FG000|NOT COMPLETED|Period 3: Washout (14 Days)||0
6657010|NCT02465866|7587324|FG001|NOT COMPLETED|Period 3: Washout (14 Days)||0
6657011|NCT02465866|7587325|FG002|NOT COMPLETED|Period 3: Washout (14 Days)||0
6657012|NCT02465866|7587326|FG003|NOT COMPLETED|Period 3: Washout (14 Days)||0
6657013|NCT02465866|7587323|FG000|STARTED|Period 4||5
6657014|NCT02465866|7587324|FG001|STARTED|Period 4||4
6657015|NCT02465866|7587325|FG002|STARTED|Period 4||5
6657016|NCT02465866|7587326|FG003|STARTED|Period 4||5
6812004|NCT04608344|7745007|FG000|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||14
6812005|NCT04608344|7745008|FG001|STARTED|Period 1 (AB: 3 Days, BA: 11 Days)||13
6812006|NCT04608344|7745007|FG000|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||13
6812007|NCT04608344|7745008|FG001|COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||12
6812008|NCT04608344|7745007|FG000|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
6812009|NCT04608344|7745008|FG001|NOT COMPLETED|Period 1 (AB: 3 Days, BA: 11 Days)||1
6812010|NCT04608344|7745007|FG000|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||13
6812011|NCT04608344|7745008|FG001|STARTED|Period 2 (AB: 11 Days, BA: 3 Days)||12
6812012|NCT04608344|7745007|FG000|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||13
6812013|NCT04608344|7745008|FG001|COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||12
6812014|NCT04608344|7745007|FG000|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
6812015|NCT04608344|7745008|FG001|NOT COMPLETED|Period 2 (AB: 11 Days, BA: 3 Days)||0
6812072|NCT04310566|7745093|FG001|COMPLETED|Period 2||9
6812073|NCT04310566|7745092|FG000|NOT COMPLETED|Period 2||7
6812074|NCT04310566|7745093|FG001|NOT COMPLETED|Period 2||5
6567532|NCT01831466|7490590|FG006|NOT COMPLETED|Overall Study||1
6567533|NCT01831466|7490591|FG007|NOT COMPLETED|Overall Study||2
6390884|NCT00832819|7302707|FG000|STARTED|Overall Study||6
6567534|NCT01831466|7490592|FG008|NOT COMPLETED|Overall Study||3
6567535|NCT01831466|7490593|FG009|NOT COMPLETED|Overall Study||5
6567536|NCT01831466|7490594|FG010|NOT COMPLETED|Overall Study||2
6567537|NCT01831466|7490595|FG011|NOT COMPLETED|Overall Study||4
6567538|NCT01831544|7490615|FG000|STARTED|Overall Study||11
6567539|NCT01831544|7490615|FG000|COMPLETED|Overall Study||8
6567540|NCT01831544|7490615|FG000|NOT COMPLETED|Overall Study||3
6567541|NCT01831726|7490619|FG000|STARTED|Overall Study||80
6390885|NCT00832819|7302708|FG001|STARTED|Overall Study||6
6567542|NCT01831726|7490619|FG000|COMPLETED|Overall Study||0
6657017|NCT02465866|7587323|FG000|COMPLETED|Period 4||5
6812016|NCT04583592|7745024|FG000|STARTED|Overall Study||194
6812017|NCT04583592|7745025|FG001|STARTED|Overall Study||101
6812018|NCT04583592|7745024|FG000|COMPLETED|Overall Study||194
6812019|NCT04583592|7745025|FG001|COMPLETED|Overall Study||100
6812020|NCT04583592|7745024|FG000|NOT COMPLETED|Overall Study||0
6812021|NCT04583592|7745025|FG001|NOT COMPLETED|Overall Study||1
6812022|NCT04572399|7745031|FG000|STARTED|Overall Study||5
6812023|NCT04572399|7745031|FG000|COMPLETED|Overall Study||5
6812024|NCT04572399|7745031|FG000|NOT COMPLETED|Overall Study||0
6812025|NCT04388787|7745035|FG000|STARTED|Blinded Period||16
6812026|NCT04388787|7745035|FG000|Completed First Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
6812027|NCT04388787|7745035|FG000|Completed Second Assessment - Approximately 15 Minutes (Specific Treatment Unknown)|Blinded Period||15
6812028|NCT04388787|7745035|FG000|COMPLETED|Blinded Period||15
6812029|NCT04388787|7745035|FG000|NOT COMPLETED|Blinded Period||1
6812030|NCT04388787|7745035|FG000|STARTED|Unblinded Period||15
6812031|NCT04388787|7745035|FG000|COMPLETED|Unblinded Period||6
6812032|NCT04388787|7745035|FG000|NOT COMPLETED|Unblinded Period||9
6812033|NCT04380090|7745045|FG000|STARTED|Overall Study||76
6812034|NCT04380090|7745046|FG001|STARTED|Overall Study||78
6812035|NCT04380090|7745045|FG000|COMPLETED|Overall Study||60
6812036|NCT04380090|7745046|FG001|COMPLETED|Overall Study||58
6812037|NCT04380090|7745045|FG000|NOT COMPLETED|Overall Study||16
6812038|NCT04380090|7745046|FG001|NOT COMPLETED|Overall Study||20
6812039|NCT04377620|7745059|FG000|STARTED|Overall Study||77
6812040|NCT04377620|7745060|FG001|STARTED|Overall Study||87
6812041|NCT04377620|7745061|FG002|STARTED|Overall Study||47
6812042|NCT04377620|7745059|FG000|COMPLETED|Overall Study||35
6812043|NCT04377620|7745060|FG001|COMPLETED|Overall Study||37
6812044|NCT04377620|7745061|FG002|COMPLETED|Overall Study||11
6812045|NCT04377620|7745059|FG000|NOT COMPLETED|Overall Study||42
6812046|NCT04377620|7745060|FG001|NOT COMPLETED|Overall Study||50
6812047|NCT04377620|7745061|FG002|NOT COMPLETED|Overall Study||36
6812048|NCT04355169|7745074|FG000|STARTED|Overall Study||0
6812049|NCT04355169|7745075|FG001|STARTED|Overall Study||0
6812050|NCT04355169|7745076|FG002|STARTED|Overall Study||0
6812051|NCT04355169|7745077|FG003|STARTED|Overall Study||0
6812052|NCT04355169|7745074|FG000|COMPLETED|Overall Study||0
6812053|NCT04355169|7745075|FG001|COMPLETED|Overall Study||0
6812054|NCT04355169|7745076|FG002|COMPLETED|Overall Study||0
6812055|NCT04355169|7745077|FG003|COMPLETED|Overall Study||0
6812056|NCT04355169|7745074|FG000|NOT COMPLETED|Overall Study||0
6812057|NCT04355169|7745075|FG001|NOT COMPLETED|Overall Study||0
6812058|NCT04355169|7745076|FG002|NOT COMPLETED|Overall Study||0
6812059|NCT04355169|7745077|FG003|NOT COMPLETED|Overall Study||0
6812060|NCT04338971|7745087|FG000|STARTED|Overall Study||24
6812061|NCT04338971|7745087|FG000|COMPLETED|Overall Study||17
6812062|NCT04338971|7745087|FG000|NOT COMPLETED|Overall Study||7
6812063|NCT04310566|7745092|FG000|STARTED|Period 1||31
6812064|NCT04310566|7745093|FG001|STARTED|Period 1||34
6812065|NCT04310566|7745092|FG000|COMPLETED|Period 1||15
6812066|NCT04310566|7745093|FG001|COMPLETED|Period 1||14
6812067|NCT04310566|7745092|FG000|NOT COMPLETED|Period 1||16
6812068|NCT04310566|7745093|FG001|NOT COMPLETED|Period 1||20
6812069|NCT04310566|7745092|FG000|STARTED|Period 2||15
6812070|NCT04310566|7745093|FG001|STARTED|Period 2||14
6812071|NCT04310566|7745092|FG000|COMPLETED|Period 2||8
6812075|NCT04206020|7745101|FG000|STARTED|Overall Study||306
6812076|NCT04206020|7745102|FG001|STARTED|Overall Study||304
6812077|NCT04206020|7745101|FG000|COMPLETED|Overall Study||298
6812078|NCT04206020|7745102|FG001|COMPLETED|Overall Study||297
6812079|NCT04206020|7745101|FG000|NOT COMPLETED|Overall Study||8
6812080|NCT04206020|7745102|FG001|NOT COMPLETED|Overall Study||7
6812081|NCT04097301|7745108|FG000|STARTED|Overall Study|Enrolled patients. Overall, 8 patients were enrolled in the study and underwent the screening phase to evaluate the compliance to the clinical inclusion / exclusion criteria as well as the CD44v6 expression by tumor cells.|8
6812082|NCT04097301|7745108|FG000|Treated Patients|Overall Study|Of the 8 enrolled patients, 2 were treated with MLM-CAR44.1 T-cell at the first dose level.|2
6812083|NCT04097301|7745108|FG000|COMPLETED|Overall Study||1
6812084|NCT04097301|7745108|FG000|NOT COMPLETED|Overall Study||7
6812085|NCT04054375|7745114|FG000|STARTED|Overall Study||20
6812086|NCT04054375|7745114|FG000|COMPLETED|Overall Study|Due to COVID-19, some participants were not able to come to our site to complete all outcome measurements. Our study team worked with individuals to make them feel safe and collect as much data as we possibly could. This is the reason why some outcome metrics have less than 20 data points. All 20 patients completed the study and took the medication for all 24 weeks.|20
6812087|NCT04054375|7745114|FG000|NOT COMPLETED|Overall Study||0
6812088|NCT03953079|7745121|FG000|STARTED|Core Study||21
6812089|NCT03953079|7745122|FG001|STARTED|Core Study||22
6812090|NCT03953079|7745123|FG002|STARTED|Core Study||13
6812091|NCT03953079|7745121|FG000|COMPLETED|Core Study||20
6812092|NCT03953079|7745122|FG001|COMPLETED|Core Study||18
6812093|NCT03953079|7745123|FG002|COMPLETED|Core Study||12
6812094|NCT03953079|7745121|FG000|NOT COMPLETED|Core Study||1
6812095|NCT03953079|7745122|FG001|NOT COMPLETED|Core Study||4
6812096|NCT03953079|7745123|FG002|NOT COMPLETED|Core Study||1
6812097|NCT03953079|7745121|FG000|STARTED|Extension Study||12
6812098|NCT03953079|7745122|FG001|STARTED|Extension Study||10
6812099|NCT03953079|7745123|FG002|STARTED|Extension Study||6
6812100|NCT03953079|7745121|FG000|COMPLETED|Extension Study||6
6812101|NCT03953079|7745122|FG001|COMPLETED|Extension Study||4
6812102|NCT03953079|7745123|FG002|COMPLETED|Extension Study||1
6812103|NCT03953079|7745121|FG000|NOT COMPLETED|Extension Study||6
6390886|NCT00832819|7302709|FG002|STARTED|Overall Study||16
6390887|NCT00832819|7302707|FG000|COMPLETED|Overall Study||6
6390888|NCT00832819|7302708|FG001|COMPLETED|Overall Study||5
6390889|NCT00832819|7302709|FG002|COMPLETED|Overall Study||15
6390890|NCT00832819|7302707|FG000|NOT COMPLETED|Overall Study||0
6390891|NCT00832819|7302708|FG001|NOT COMPLETED|Overall Study||1
6390892|NCT00832819|7302709|FG002|NOT COMPLETED|Overall Study||1
6390893|NCT00832871|7302715|FG000|STARTED|Overall Study||4
6390894|NCT00832871|7302715|FG000|COMPLETED|Overall Study||4
6390895|NCT00832871|7302715|FG000|NOT COMPLETED|Overall Study||0
6390896|NCT00832975|7302719|FG000|STARTED|Overall Study||157
6390897|NCT00832975|7302719|FG000|COMPLETED|Overall Study||118
6390898|NCT00832975|7302719|FG000|NOT COMPLETED|Overall Study||39
6390899|NCT00833027|7302723|FG000|STARTED|Overall Study||608
6390900|NCT00833027|7302723|FG000|COMPLETED|Overall Study||397
6390901|NCT00833027|7302723|FG000|NOT COMPLETED|Overall Study||211
6390902|NCT00833040|7302727|FG000|STARTED|Overall Study||6
6390903|NCT00833040|7302728|FG001|STARTED|Overall Study||6
6390904|NCT00833040|7302729|FG002|STARTED|Overall Study||6
6390905|NCT00833040|7302730|FG003|STARTED|Overall Study||6
6390906|NCT00833040|7302731|FG004|STARTED|Overall Study||5
6390907|NCT00833040|7302732|FG005|STARTED|Overall Study||5
6390908|NCT00833040|7302727|FG000|COMPLETED|Overall Study||6
6390909|NCT00833040|7302728|FG001|COMPLETED|Overall Study||6
6390910|NCT00833040|7302729|FG002|COMPLETED|Overall Study||6
6390911|NCT00833040|7302730|FG003|COMPLETED|Overall Study||6
6390912|NCT00833040|7302731|FG004|COMPLETED|Overall Study||5
6390913|NCT00833040|7302732|FG005|COMPLETED|Overall Study||4
6390914|NCT00833040|7302727|FG000|NOT COMPLETED|Overall Study||0
6390915|NCT00833040|7302728|FG001|NOT COMPLETED|Overall Study||0
6390916|NCT00833040|7302729|FG002|NOT COMPLETED|Overall Study||0
6390917|NCT00833040|7302730|FG003|NOT COMPLETED|Overall Study||0
6390918|NCT00833040|7302731|FG004|NOT COMPLETED|Overall Study||0
6390919|NCT00833040|7302732|FG005|NOT COMPLETED|Overall Study||1
6390920|NCT00833053|7302739|FG000|STARTED|Overall Study||19
6390921|NCT00833053|7302740|FG001|STARTED|Overall Study||20
6390922|NCT00833053|7302739|FG000|COMPLETED|Overall Study||10
6390923|NCT00833053|7302740|FG001|COMPLETED|Overall Study||17
6390924|NCT00833053|7302739|FG000|NOT COMPLETED|Overall Study||9
6390925|NCT00833053|7302740|FG001|NOT COMPLETED|Overall Study||3
6390926|NCT00833092|7302748|FG000|STARTED|Overall Study||54
6390927|NCT00833092|7302749|FG001|STARTED|Overall Study||57
6390928|NCT00833092|7302748|FG000|COMPLETED|Overall Study||50
6390929|NCT00833092|7302749|FG001|COMPLETED|Overall Study||50
6390930|NCT00833092|7302748|FG000|NOT COMPLETED|Overall Study||4
6390931|NCT00833092|7302749|FG001|NOT COMPLETED|Overall Study||7
6390932|NCT00833105|7302755|FG000|STARTED|Overall Study||13
6812104|NCT03953079|7745122|FG001|NOT COMPLETED|Extension Study||6
6812105|NCT03953079|7745123|FG002|NOT COMPLETED|Extension Study||5
6812106|NCT03922750|7745135|FG000|STARTED|Overall Study||50
6812107|NCT03922750|7745136|FG001|STARTED|Overall Study||54
6812108|NCT03922750|7745137|FG002|STARTED|Overall Study||50
6812109|NCT03922750|7745135|FG000|Full Analysis Set (FAS)|Overall Study||50
6812110|NCT03922750|7745136|FG001|Full Analysis Set (FAS)|Overall Study||54
6812111|NCT03922750|7745137|FG002|Full Analysis Set (FAS)|Overall Study||50
6812112|NCT03922750|7745135|FG000|Safety Analysis Set (SAS)|Overall Study||50
6812113|NCT03922750|7745136|FG001|Safety Analysis Set (SAS)|Overall Study||54
6812114|NCT03922750|7745137|FG002|Safety Analysis Set (SAS)|Overall Study||50
6812115|NCT03922750|7745135|FG000|COMPLETED|Overall Study||50
6812116|NCT03922750|7745136|FG001|COMPLETED|Overall Study||53
6812117|NCT03922750|7745137|FG002|COMPLETED|Overall Study||49
6812118|NCT03922750|7745135|FG000|NOT COMPLETED|Overall Study||0
6812119|NCT03922750|7745136|FG001|NOT COMPLETED|Overall Study||1
6812120|NCT03922750|7745137|FG002|NOT COMPLETED|Overall Study||1
6812121|NCT03910673|7745150|FG000|STARTED|Overall Study||7
6812122|NCT03910673|7745151|FG001|STARTED|Overall Study||6
6812123|NCT03910673|7745152|FG002|STARTED|Overall Study||7
6812124|NCT03910673|7745153|FG003|STARTED|Overall Study||13
6812125|NCT03910673|7745154|FG004|STARTED|Overall Study||6
6812126|NCT03910673|7745150|FG000|Enrolled and Randomized|Overall Study||6
6812127|NCT03910673|7745151|FG001|Enrolled and Randomized|Overall Study||6
6812128|NCT03910673|7745152|FG002|Enrolled and Randomized|Overall Study||6
6812129|NCT03910673|7745153|FG003|Enrolled and Randomized|Overall Study||6
6812130|NCT03910673|7745154|FG004|Enrolled and Randomized|Overall Study||6
6812131|NCT03910673|7745150|FG000|Enrolled as Replacement|Overall Study||1
6812132|NCT03910673|7745151|FG001|Enrolled as Replacement|Overall Study||0
6812133|NCT03910673|7745152|FG002|Enrolled as Replacement|Overall Study||1
6812134|NCT03910673|7745153|FG003|Enrolled as Replacement|Overall Study||7
6812135|NCT03910673|7745154|FG004|Enrolled as Replacement|Overall Study||0
6812136|NCT03910673|7745150|FG000|Began Infusion of Dose 1|Overall Study||7
6812137|NCT03910673|7745151|FG001|Began Infusion of Dose 1|Overall Study||6
6812138|NCT03910673|7745152|FG002|Began Infusion of Dose 1|Overall Study||7
6812139|NCT03910673|7745153|FG003|Began Infusion of Dose 1|Overall Study||13
6812140|NCT03910673|7745154|FG004|Began Infusion of Dose 1|Overall Study||6
6812141|NCT03910673|7745150|FG000|Completed Dose 1|Overall Study||7
6812142|NCT03910673|7745151|FG001|Completed Dose 1|Overall Study||6
6812143|NCT03910673|7745152|FG002|Completed Dose 1|Overall Study||7
6812144|NCT03910673|7745153|FG003|Completed Dose 1|Overall Study||13
6812145|NCT03910673|7745154|FG004|Completed Dose 1|Overall Study||6
6812146|NCT03910673|7745150|FG000|Completed Dose 2|Overall Study||7
6812147|NCT03910673|7745151|FG001|Completed Dose 2|Overall Study||6
6812148|NCT03910673|7745152|FG002|Completed Dose 2|Overall Study||7
6812149|NCT03910673|7745153|FG003|Completed Dose 2|Overall Study||13
6812150|NCT03910673|7745154|FG004|Completed Dose 2|Overall Study||6
6812151|NCT03910673|7745150|FG000|Completed Dose 3|Overall Study||6
6812152|NCT03910673|7745151|FG001|Completed Dose 3|Overall Study||6
6812153|NCT03910673|7745152|FG002|Completed Dose 3|Overall Study||7
6812154|NCT03910673|7745153|FG003|Completed Dose 3|Overall Study||12
6812155|NCT03910673|7745154|FG004|Completed Dose 3|Overall Study||6
6812156|NCT03910673|7745150|FG000|Completed All Scheduled Treatment|Overall Study||6
6812157|NCT03910673|7745151|FG001|Completed All Scheduled Treatment|Overall Study||6
6812158|NCT03910673|7745152|FG002|Completed All Scheduled Treatment|Overall Study||7
6812159|NCT03910673|7745153|FG003|Completed All Scheduled Treatment|Overall Study||12
6812160|NCT03910673|7745154|FG004|Completed All Scheduled Treatment|Overall Study||6
6812161|NCT03910673|7745150|FG000|Completed All PK Blood Draws|Overall Study||6
6812162|NCT03910673|7745151|FG001|Completed All PK Blood Draws|Overall Study||6
6812163|NCT03910673|7745152|FG002|Completed All PK Blood Draws|Overall Study||6
6812164|NCT03910673|7745153|FG003|Completed All PK Blood Draws|Overall Study||6
6812165|NCT03910673|7745154|FG004|Completed All PK Blood Draws|Overall Study||6
6812166|NCT03910673|7745150|FG000|Completed Bronchoscopy With BAL|Overall Study||6
6812167|NCT03910673|7745151|FG001|Completed Bronchoscopy With BAL|Overall Study||6
6812168|NCT03910673|7745152|FG002|Completed Bronchoscopy With BAL|Overall Study||6
6812169|NCT03910673|7745153|FG003|Completed Bronchoscopy With BAL|Overall Study||6
6812170|NCT03910673|7745154|FG004|Completed Bronchoscopy With BAL|Overall Study||6
6812171|NCT03910673|7745150|FG000|Completed All Plasma Urea Samples|Overall Study||6
6812172|NCT03910673|7745151|FG001|Completed All Plasma Urea Samples|Overall Study||6
6812173|NCT03910673|7745152|FG002|Completed All Plasma Urea Samples|Overall Study||6
6812174|NCT03910673|7745153|FG003|Completed All Plasma Urea Samples|Overall Study||6
6812175|NCT03910673|7745154|FG004|Completed All Plasma Urea Samples|Overall Study||6
6812176|NCT03910673|7745150|FG000|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
6812177|NCT03910673|7745151|FG001|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
6812178|NCT03910673|7745152|FG002|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
6812179|NCT03910673|7745153|FG003|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
6812180|NCT03910673|7745154|FG004|At Least One PK Blood Draw Concurrent With BAL Timepoint|Overall Study||6
6812181|NCT03910673|7745150|FG000|COMPLETED|Overall Study||7
6812182|NCT03910673|7745151|FG001|COMPLETED|Overall Study||6
6812183|NCT03910673|7745152|FG002|COMPLETED|Overall Study||7
6812184|NCT03910673|7745153|FG003|COMPLETED|Overall Study||11
6812185|NCT03910673|7745154|FG004|COMPLETED|Overall Study||6
6812186|NCT03910673|7745150|FG000|NOT COMPLETED|Overall Study||0
6812187|NCT03910673|7745151|FG001|NOT COMPLETED|Overall Study||0
6812188|NCT03910673|7745152|FG002|NOT COMPLETED|Overall Study||0
6812189|NCT03910673|7745153|FG003|NOT COMPLETED|Overall Study||2
6812190|NCT03910673|7745154|FG004|NOT COMPLETED|Overall Study||0
6567543|NCT01831726|7490619|FG000|NOT COMPLETED|Overall Study||80
6567544|NCT01831765|7490626|FG000|STARTED|Overall Study||381
6567545|NCT01831765|7490627|FG001|STARTED|Overall Study||382
6567546|NCT01831765|7490628|FG002|STARTED|Overall Study||380
6567547|NCT01831765|7490626|FG000|Completed 26 Weeks|Overall Study||351
6567548|NCT01831765|7490627|FG001|Completed 26 Weeks|Overall Study||355
6812191|NCT03885999|7745158|FG000|STARTED|Overall Study||12
6812192|NCT03885999|7745158|FG000|COMPLETED|Overall Study||11
6812193|NCT03885999|7745158|FG000|NOT COMPLETED|Overall Study||1
6812194|NCT03882970|7745166|FG000|STARTED|Overall Study||359
6812195|NCT03882970|7745167|FG001|STARTED|Overall Study||361
6812196|NCT03882970|7745168|FG002|STARTED|Overall Study||359
6812197|NCT03882970|7745169|FG003|STARTED|Overall Study||365
6812198|NCT03882970|7745166|FG000|Received at Least One Dose of Study Drug|Overall Study||358
6812199|NCT03882970|7745167|FG001|Received at Least One Dose of Study Drug|Overall Study||360
6812200|NCT03882970|7745168|FG002|Received at Least One Dose of Study Drug|Overall Study||359
6812201|NCT03882970|7745169|FG003|Received at Least One Dose of Study Drug|Overall Study||360
6812202|NCT03882970|7745166|FG000|COMPLETED|Overall Study||333
6812203|NCT03882970|7745167|FG001|COMPLETED|Overall Study||321
6812204|NCT03882970|7745168|FG002|COMPLETED|Overall Study||340
6812205|NCT03882970|7745169|FG003|COMPLETED|Overall Study||331
6812206|NCT03882970|7745166|FG000|NOT COMPLETED|Overall Study||26
6812207|NCT03882970|7745167|FG001|NOT COMPLETED|Overall Study||40
6812208|NCT03882970|7745168|FG002|NOT COMPLETED|Overall Study||19
6812209|NCT03882970|7745169|FG003|NOT COMPLETED|Overall Study||34
6812210|NCT03879525|7745185|FG000|STARTED|Overall Study||15
6812211|NCT03879525|7745186|FG001|STARTED|Overall Study||15
6812212|NCT03879525|7745185|FG000|COMPLETED|Overall Study||15
6812213|NCT03879525|7745186|FG001|COMPLETED|Overall Study||15
6812214|NCT03879525|7745185|FG000|NOT COMPLETED|Overall Study||0
6812215|NCT03879525|7745186|FG001|NOT COMPLETED|Overall Study||0
6812216|NCT03867734|7745193|FG000|STARTED|Overall Study||32
6812217|NCT03867734|7745193|FG000|COMPLETED|Overall Study||30
6812218|NCT03867734|7745193|FG000|NOT COMPLETED|Overall Study||2
6812219|NCT03781778|7745203|FG000|STARTED|Overall Study||4
6812220|NCT03781778|7745204|FG001|STARTED|Overall Study||6
6812221|NCT03781778|7745203|FG000|Started Intervention|Overall Study||3
6812222|NCT03781778|7745204|FG001|Started Intervention|Overall Study||4
6812223|NCT03781778|7745203|FG000|COMPLETED|Overall Study||2
6812224|NCT03781778|7745204|FG001|COMPLETED|Overall Study||4
6812225|NCT03781778|7745203|FG000|NOT COMPLETED|Overall Study||2
6812226|NCT03781778|7745204|FG001|NOT COMPLETED|Overall Study||2
6812227|NCT03770455|7745210|FG000|STARTED|Overall Study||5
6812228|NCT03770455|7745210|FG000|COMPLETED|Overall Study||5
6812229|NCT03770455|7745210|FG000|NOT COMPLETED|Overall Study||0
6812230|NCT03764735|7745217|FG000|STARTED|Overall Study||151
6812231|NCT03764735|7745218|FG001|STARTED|Overall Study||150
6812232|NCT03764735|7745219|FG002|STARTED|Overall Study||151
6812233|NCT03764735|7745217|FG000|COMPLETED|Overall Study||147
6812234|NCT03764735|7745218|FG001|COMPLETED|Overall Study||144
6812235|NCT03764735|7745219|FG002|COMPLETED|Overall Study||147
6812236|NCT03764735|7745217|FG000|NOT COMPLETED|Overall Study||4
6812237|NCT03764735|7745218|FG001|NOT COMPLETED|Overall Study||6
6812238|NCT03764735|7745219|FG002|NOT COMPLETED|Overall Study||4
6812239|NCT03730480|7745227|FG000|STARTED|Overall Study||372
6812240|NCT03730480|7745227|FG000|COMPLETED|Overall Study||371
6812241|NCT03730480|7745227|FG000|NOT COMPLETED|Overall Study||1
6812242|NCT03713073|7745232|FG000|STARTED|Overall Study||19
6812243|NCT03713073|7745232|FG000|Allogenic Amnion Chorion Membrane|Overall Study||19
6812244|NCT03713073|7745232|FG000|Collagen Dressing|Overall Study||19
6812245|NCT03713073|7745232|FG000|COMPLETED|Overall Study||19
6812246|NCT03713073|7745232|FG000|NOT COMPLETED|Overall Study||0
6812247|NCT03713034|7745240|FG000|STARTED|Overall Study||150
6812248|NCT03713034|7745241|FG001|STARTED|Overall Study||146
6812249|NCT03713034|7745240|FG000|COMPLETED|Overall Study||145
6812250|NCT03713034|7745241|FG001|COMPLETED|Overall Study||142
6812251|NCT03713034|7745240|FG000|NOT COMPLETED|Overall Study||5
6812252|NCT03713034|7745241|FG001|NOT COMPLETED|Overall Study||4
6812253|NCT03654404|7745249|FG000|STARTED|Overall Study||20
6812254|NCT03654404|7745249|FG000|COMPLETED|Overall Study||12
6812255|NCT03654404|7745249|FG000|NOT COMPLETED|Overall Study||8
6812256|NCT03567057|7745256|FG000|STARTED|Overall Study||159
6812257|NCT03567057|7745257|FG001|STARTED|Overall Study||151
6812258|NCT03567057|7745258|FG002|STARTED|Overall Study||114
6812259|NCT03567057|7745256|FG000|COMPLETED|Overall Study||64
6812260|NCT03567057|7745257|FG001|COMPLETED|Overall Study||64
6812261|NCT03567057|7745258|FG002|COMPLETED|Overall Study||68
6812262|NCT03567057|7745256|FG000|NOT COMPLETED|Overall Study||95
6812263|NCT03567057|7745257|FG001|NOT COMPLETED|Overall Study||87
6812264|NCT03567057|7745258|FG002|NOT COMPLETED|Overall Study||46
6812265|NCT03548987|7745268|FG000|STARTED|Run-in Period (Week 0 to Week 20)||902
6812266|NCT03548987|7745269|FG001|STARTED|Run-in Period (Week 0 to Week 20)||0
6812267|NCT03548987|7745268|FG000|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||902
6812268|NCT03548987|7745269|FG001|Safety Analysis Set (SAS)|Run-in Period (Week 0 to Week 20)||0
6812269|NCT03548987|7745268|FG000|COMPLETED|Run-in Period (Week 0 to Week 20)||803
6812270|NCT03548987|7745269|FG001|COMPLETED|Run-in Period (Week 0 to Week 20)||0
6812271|NCT03548987|7745268|FG000|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||99
6812272|NCT03548987|7745269|FG001|NOT COMPLETED|Run-in Period (Week 0 to Week 20)||0
6812273|NCT03548987|7745268|FG000|STARTED|Maintenance Period (Week 20 to Week 68)||535
6812274|NCT03548987|7745269|FG001|STARTED|Maintenance Period (Week 20 to Week 68)||268
6812275|NCT03548987|7745268|FG000|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||535
6812276|NCT03548987|7745269|FG001|Full Analysis Set (FAS)|Maintenance Period (Week 20 to Week 68)||268
6812277|NCT03548987|7745268|FG000|COMPLETED|Maintenance Period (Week 20 to Week 68)||504
6812278|NCT03548987|7745269|FG001|COMPLETED|Maintenance Period (Week 20 to Week 68)||237
6567549|NCT01831765|7490628|FG002|Completed 26 Weeks|Overall Study||356
6567550|NCT01831765|7490626|FG000|Completed 52 Weeks|Overall Study||337
6567551|NCT01831765|7490627|FG001|Completed 52 Weeks|Overall Study|This arm did not continue in the trial after 26 weeks ( 26 to 52 weeks).|0
6567552|NCT01831765|7490628|FG002|Completed 52 Weeks|Overall Study||338
6567553|NCT01831765|7490626|FG000|COMPLETED|Overall Study||337
6567554|NCT01831765|7490627|FG001|COMPLETED|Overall Study||355
6567555|NCT01831765|7490628|FG002|COMPLETED|Overall Study||338
6567556|NCT01831765|7490626|FG000|NOT COMPLETED|Overall Study||44
6567557|NCT01831765|7490627|FG001|NOT COMPLETED|Overall Study||27
6567558|NCT01831765|7490628|FG002|NOT COMPLETED|Overall Study||42
6567559|NCT01831791|7490638|FG000|STARTED|Overall Study||120
6567560|NCT01831791|7490638|FG000|COMPLETED|Overall Study||110
6567561|NCT01831791|7490638|FG000|NOT COMPLETED|Overall Study||10
6567562|NCT01831804|7490651|FG000|STARTED|Overall Study||4
6567563|NCT01831804|7490652|FG001|STARTED|Overall Study||3
6567564|NCT01831804|7490653|FG002|STARTED|Overall Study||9
6567565|NCT01831804|7490654|FG003|STARTED|Overall Study||5
6812279|NCT03548987|7745268|FG000|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
6812280|NCT03548987|7745269|FG001|NOT COMPLETED|Maintenance Period (Week 20 to Week 68)||31
6812281|NCT03548064|7745284|FG000|STARTED|Overall Study||12
6812282|NCT03548064|7745285|FG001|STARTED|Overall Study||12
6812283|NCT03548064|7745286|FG002|STARTED|Overall Study||6
6812284|NCT03548064|7745287|FG003|STARTED|Overall Study||12
6567566|NCT01831804|7490655|FG004|STARTED|Overall Study||5
6567567|NCT01831804|7490656|FG005|STARTED|Overall Study||3
6567568|NCT01831804|7490657|FG006|STARTED|Overall Study||4
6567569|NCT01831804|7490658|FG007|STARTED|Overall Study||26
6567570|NCT01831804|7490659|FG008|STARTED|Overall Study||4
6567571|NCT01831804|7490651|FG000|COMPLETED|Overall Study||3
6567572|NCT01831804|7490652|FG001|COMPLETED|Overall Study||1
6812285|NCT03548064|7745288|FG004|STARTED|Overall Study||12
6812286|NCT03548064|7745289|FG005|STARTED|Overall Study||6
6812287|NCT03548064|7745290|FG006|STARTED|Overall Study||12
6812288|NCT03548064|7745291|FG007|STARTED|Overall Study||3
6812289|NCT03548064|7745284|FG000|COMPLETED|Overall Study||12
6812290|NCT03548064|7745285|FG001|COMPLETED|Overall Study||12
6812291|NCT03548064|7745286|FG002|COMPLETED|Overall Study||6
6812292|NCT03548064|7745287|FG003|COMPLETED|Overall Study||11
6812293|NCT03548064|7745288|FG004|COMPLETED|Overall Study||0
6812294|NCT03548064|7745289|FG005|COMPLETED|Overall Study||3
6812295|NCT03548064|7745290|FG006|COMPLETED|Overall Study||12
6812296|NCT03548064|7745291|FG007|COMPLETED|Overall Study||3
6812297|NCT03548064|7745284|FG000|NOT COMPLETED|Overall Study||0
6812298|NCT03548064|7745285|FG001|NOT COMPLETED|Overall Study||0
6812299|NCT03548064|7745286|FG002|NOT COMPLETED|Overall Study||0
6812300|NCT03548064|7745287|FG003|NOT COMPLETED|Overall Study||1
6812301|NCT03548064|7745288|FG004|NOT COMPLETED|Overall Study||12
6812302|NCT03548064|7745289|FG005|NOT COMPLETED|Overall Study||3
6812303|NCT03548064|7745290|FG006|NOT COMPLETED|Overall Study||0
6812304|NCT03548064|7745291|FG007|NOT COMPLETED|Overall Study||0
6812305|NCT03446456|7745317|FG000|STARTED|Overall Study||20
6812306|NCT03446456|7745318|FG001|STARTED|Overall Study||20
6812307|NCT03446456|7745317|FG000|COMPLETED|Overall Study||16
6812308|NCT03446456|7745318|FG001|COMPLETED|Overall Study||16
6812309|NCT03446456|7745317|FG000|NOT COMPLETED|Overall Study||4
6812310|NCT03446456|7745318|FG001|NOT COMPLETED|Overall Study||4
6567573|NCT01831804|7490653|FG002|COMPLETED|Overall Study||3
6567574|NCT01831804|7490654|FG003|COMPLETED|Overall Study||5
6567575|NCT01831804|7490655|FG004|COMPLETED|Overall Study||3
6567576|NCT01831804|7490656|FG005|COMPLETED|Overall Study||3
6812311|NCT03382834|7745326|FG000|STARTED|Overall Study||21
6812312|NCT03382834|7745327|FG001|STARTED|Overall Study||10
6812313|NCT03382834|7745326|FG000|COMPLETED|Overall Study||20
6812314|NCT03382834|7745327|FG001|COMPLETED|Overall Study||9
6812315|NCT03382834|7745326|FG000|NOT COMPLETED|Overall Study||1
6812316|NCT03382834|7745327|FG001|NOT COMPLETED|Overall Study||1
6812317|NCT03371823|7745335|FG000|STARTED|Overall Study||8
6390933|NCT00833105|7302755|FG000|COMPLETED|Overall Study||10
6390934|NCT00833105|7302755|FG000|NOT COMPLETED|Overall Study||3
6390935|NCT00833248|7302763|FG000|STARTED|Overall Study||181
6812318|NCT03371823|7745336|FG001|STARTED|Overall Study|We had trouble enrolling naive to therapy women with high blood pressure|0
6812319|NCT03371823|7745335|FG000|COMPLETED|Overall Study||7
6812320|NCT03371823|7745336|FG001|COMPLETED|Overall Study||0
6812321|NCT03371823|7745335|FG000|NOT COMPLETED|Overall Study||1
6812322|NCT03371823|7745336|FG001|NOT COMPLETED|Overall Study||0
6812323|NCT03353350|7745346|FG000|STARTED|30-week Core Treatment Period||102
6812324|NCT03353350|7745347|FG001|STARTED|30-week Core Treatment Period||100
6812325|NCT03353350|7745348|FG002|STARTED|30-week Core Treatment Period||101
6812326|NCT03353350|7745349|FG003|STARTED|30-week Core Treatment Period||103
6812327|NCT03353350|7745346|FG000|COMPLETED|30-week Core Treatment Period||80
6812328|NCT03353350|7745347|FG001|COMPLETED|30-week Core Treatment Period||81
6812329|NCT03353350|7745348|FG002|COMPLETED|30-week Core Treatment Period||77
6812330|NCT03353350|7745349|FG003|COMPLETED|30-week Core Treatment Period||81
6812331|NCT03353350|7745346|FG000|NOT COMPLETED|30-week Core Treatment Period||22
6812332|NCT03353350|7745347|FG001|NOT COMPLETED|30-week Core Treatment Period||19
6812333|NCT03353350|7745348|FG002|NOT COMPLETED|30-week Core Treatment Period||24
6812334|NCT03353350|7745349|FG003|NOT COMPLETED|30-week Core Treatment Period||22
6812335|NCT03353350|7745346|FG000|STARTED|26-week Treatment Extension Period||80
6812336|NCT03353350|7745347|FG001|STARTED|26-week Treatment Extension Period||81
6812337|NCT03353350|7745348|FG002|STARTED|26-week Treatment Extension Period||77
6812338|NCT03353350|7745349|FG003|STARTED|26-week Treatment Extension Period||81
6812339|NCT03353350|7745346|FG000|COMPLETED|26-week Treatment Extension Period||75
6812340|NCT03353350|7745347|FG001|COMPLETED|26-week Treatment Extension Period||78
6812341|NCT03353350|7745348|FG002|COMPLETED|26-week Treatment Extension Period||73
6812342|NCT03353350|7745349|FG003|COMPLETED|26-week Treatment Extension Period||67
6812343|NCT03353350|7745346|FG000|NOT COMPLETED|26-week Treatment Extension Period||5
6812344|NCT03353350|7745347|FG001|NOT COMPLETED|26-week Treatment Extension Period||3
6812345|NCT03353350|7745348|FG002|NOT COMPLETED|26-week Treatment Extension Period||4
6812346|NCT03353350|7745349|FG003|NOT COMPLETED|26-week Treatment Extension Period||14
6812347|NCT03350503|7745359|FG000|STARTED|Overall Study||121
6812348|NCT03350503|7745359|FG000|COMPLETED|Overall Study||116
6812349|NCT03350503|7745359|FG000|NOT COMPLETED|Overall Study||5
6812350|NCT03326193|7745363|FG000|STARTED|Overall Study||105
6812351|NCT03326193|7745363|FG000|COMPLETED|Overall Study||52
6812352|NCT03326193|7745363|FG000|NOT COMPLETED|Overall Study||53
6567577|NCT01831804|7490657|FG006|COMPLETED|Overall Study||3
6567578|NCT01831804|7490658|FG007|COMPLETED|Overall Study||23
6567579|NCT01831804|7490659|FG008|COMPLETED|Overall Study||2
6567580|NCT01831804|7490651|FG000|NOT COMPLETED|Overall Study||1
6567581|NCT01831804|7490652|FG001|NOT COMPLETED|Overall Study||2
6567582|NCT01831804|7490653|FG002|NOT COMPLETED|Overall Study||6
6812353|NCT03287687|7745369|FG000|STARTED|Overall Study||88
6812354|NCT03287687|7745370|FG001|STARTED|Overall Study||90
6812355|NCT03287687|7745369|FG000|Procedures|Overall Study||88
6812356|NCT03287687|7745370|FG001|Procedures|Overall Study||90
6812357|NCT03287687|7745369|FG000|COMPLETED|Overall Study||88
6812358|NCT03287687|7745370|FG001|COMPLETED|Overall Study||90
6812359|NCT03287687|7745369|FG000|NOT COMPLETED|Overall Study||0
6812360|NCT03287687|7745370|FG001|NOT COMPLETED|Overall Study||0
6812361|NCT03282565|7745379|FG000|STARTED|Overall Study||10
6812362|NCT03282565|7745380|FG001|STARTED|Overall Study||10
6812363|NCT03282565|7745381|FG002|STARTED|Overall Study||10
6812364|NCT03282565|7745379|FG000|COMPLETED|Overall Study||10
6812365|NCT03282565|7745380|FG001|COMPLETED|Overall Study||8
6812366|NCT03282565|7745381|FG002|COMPLETED|Overall Study||8
6812367|NCT03282565|7745379|FG000|NOT COMPLETED|Overall Study||0
6812368|NCT03282565|7745380|FG001|NOT COMPLETED|Overall Study||2
6812369|NCT03282565|7745381|FG002|NOT COMPLETED|Overall Study||2
6812370|NCT03276936|7745391|FG000|STARTED|Overall Study||332
6812371|NCT03276936|7745392|FG001|STARTED|Overall Study||172
6812372|NCT03276936|7745391|FG000|COMPLETED|Overall Study||276
6812373|NCT03276936|7745392|FG001|COMPLETED|Overall Study||134
6812374|NCT03276936|7745391|FG000|NOT COMPLETED|Overall Study||56
6812375|NCT03276936|7745392|FG001|NOT COMPLETED|Overall Study||38
6812376|NCT03271021|7745400|FG000|STARTED|Overall Study||738
6812377|NCT03271021|7745401|FG001|STARTED|Overall Study||750
6812378|NCT03271021|7745400|FG000|COMPLETED|Overall Study||649
6812379|NCT03271021|7745401|FG001|COMPLETED|Overall Study||644
6812380|NCT03271021|7745400|FG000|NOT COMPLETED|Overall Study||89
6812381|NCT03271021|7745401|FG001|NOT COMPLETED|Overall Study||106
6812382|NCT03255083|7745411|FG000|STARTED|Overall Study||6
6812383|NCT03255083|7745412|FG001|STARTED|Overall Study||3
6812384|NCT03255083|7745413|FG002|STARTED|Overall Study||3
6812385|NCT03255083|7745414|FG003|STARTED|Overall Study||1
6812386|NCT03255083|7745411|FG000|COMPLETED|Overall Study||0
6567583|NCT01831804|7490654|FG003|NOT COMPLETED|Overall Study||0
6567584|NCT01831804|7490655|FG004|NOT COMPLETED|Overall Study||2
6812387|NCT03255083|7745412|FG001|COMPLETED|Overall Study||0
6812388|NCT03255083|7745413|FG002|COMPLETED|Overall Study||0
6812389|NCT03255083|7745414|FG003|COMPLETED|Overall Study||0
6812390|NCT03255083|7745411|FG000|NOT COMPLETED|Overall Study||6
6812391|NCT03255083|7745412|FG001|NOT COMPLETED|Overall Study||3
6812392|NCT03255083|7745413|FG002|NOT COMPLETED|Overall Study||3
6812393|NCT03255083|7745414|FG003|NOT COMPLETED|Overall Study||1
6812394|NCT03227471|7745439|FG000|STARTED|Overall Study||9
6812395|NCT03227471|7745440|FG001|STARTED|Overall Study||30
6812396|NCT03227471|7745441|FG002|STARTED|Overall Study||8
6812397|NCT03227471|7745442|FG003|STARTED|Overall Study||7
6812398|NCT03227471|7745443|FG004|STARTED|Overall Study||25
6812399|NCT03227471|7745444|FG005|STARTED|Overall Study||6
6812400|NCT03227471|7745445|FG006|STARTED|Overall Study||17
6812401|NCT03227471|7745446|FG007|STARTED|Overall Study||12
6812402|NCT03227471|7745447|FG008|STARTED|Overall Study||10
6812403|NCT03227471|7745448|FG009|STARTED|Overall Study||22
6812404|NCT03227471|7745449|FG010|STARTED|Overall Study||21
6812405|NCT03227471|7745450|FG011|STARTED|Overall Study||7
6812406|NCT03227471|7745451|FG012|STARTED|Overall Study||21
6812407|NCT03227471|7745452|FG013|STARTED|Overall Study||8
6812408|NCT03227471|7745453|FG014|STARTED|Overall Study||22
6812409|NCT03227471|7745439|FG000|Safety Set|Overall Study||9
6812410|NCT03227471|7745440|FG001|Safety Set|Overall Study||30
6812411|NCT03227471|7745441|FG002|Safety Set|Overall Study||8
6812412|NCT03227471|7745442|FG003|Safety Set|Overall Study||7
6812413|NCT03227471|7745443|FG004|Safety Set|Overall Study||25
6812414|NCT03227471|7745444|FG005|Safety Set|Overall Study||6
6812415|NCT03227471|7745445|FG006|Safety Set|Overall Study||17
6812416|NCT03227471|7745446|FG007|Safety Set|Overall Study||12
6812417|NCT03227471|7745447|FG008|Safety Set|Overall Study||10
6812418|NCT03227471|7745448|FG009|Safety Set|Overall Study||22
6812419|NCT03227471|7745449|FG010|Safety Set|Overall Study||21
6812420|NCT03227471|7745450|FG011|Safety Set|Overall Study||7
6812421|NCT03227471|7745451|FG012|Safety Set|Overall Study||21
6812422|NCT03227471|7745452|FG013|Safety Set|Overall Study||8
6812423|NCT03227471|7745453|FG014|Safety Set|Overall Study||21
6812424|NCT03227471|7745439|FG000|COMPLETED|Overall Study||9
6812425|NCT03227471|7745440|FG001|COMPLETED|Overall Study||30
6812426|NCT03227471|7745441|FG002|COMPLETED|Overall Study||8
6812427|NCT03227471|7745442|FG003|COMPLETED|Overall Study||7
6812428|NCT03227471|7745443|FG004|COMPLETED|Overall Study||24
6812429|NCT03227471|7745444|FG005|COMPLETED|Overall Study||6
6812430|NCT03227471|7745445|FG006|COMPLETED|Overall Study||17
6812431|NCT03227471|7745446|FG007|COMPLETED|Overall Study||12
6812432|NCT03227471|7745447|FG008|COMPLETED|Overall Study||10
6812433|NCT03227471|7745448|FG009|COMPLETED|Overall Study||22
6812434|NCT03227471|7745449|FG010|COMPLETED|Overall Study||21
6812435|NCT03227471|7745450|FG011|COMPLETED|Overall Study||7
6812436|NCT03227471|7745451|FG012|COMPLETED|Overall Study||20
6812437|NCT03227471|7745452|FG013|COMPLETED|Overall Study||8
6812438|NCT03227471|7745453|FG014|COMPLETED|Overall Study||21
6812439|NCT03227471|7745439|FG000|NOT COMPLETED|Overall Study||0
6812440|NCT03227471|7745440|FG001|NOT COMPLETED|Overall Study||0
6812441|NCT03227471|7745441|FG002|NOT COMPLETED|Overall Study||0
6812442|NCT03227471|7745442|FG003|NOT COMPLETED|Overall Study||0
6812443|NCT03227471|7745443|FG004|NOT COMPLETED|Overall Study||1
6812444|NCT03227471|7745444|FG005|NOT COMPLETED|Overall Study||0
6812445|NCT03227471|7745445|FG006|NOT COMPLETED|Overall Study||0
6812446|NCT03227471|7745446|FG007|NOT COMPLETED|Overall Study||0
6812447|NCT03227471|7745447|FG008|NOT COMPLETED|Overall Study||0
6812448|NCT03227471|7745448|FG009|NOT COMPLETED|Overall Study||0
6812449|NCT03227471|7745449|FG010|NOT COMPLETED|Overall Study||0
6812450|NCT03227471|7745450|FG011|NOT COMPLETED|Overall Study||0
6812451|NCT03227471|7745451|FG012|NOT COMPLETED|Overall Study||1
6812452|NCT03227471|7745452|FG013|NOT COMPLETED|Overall Study||0
6812453|NCT03227471|7745453|FG014|NOT COMPLETED|Overall Study||1
6812454|NCT03221842|7745514|FG000|STARTED|Period 1 (Open-label)||63
6812455|NCT03221842|7745515|FG001|STARTED|Period 1 (Open-label)||0
6812456|NCT03221842|7745514|FG000|COMPLETED|Period 1 (Open-label)||53
6812457|NCT03221842|7745515|FG001|COMPLETED|Period 1 (Open-label)||0
6812458|NCT03221842|7745514|FG000|NOT COMPLETED|Period 1 (Open-label)||10
6812459|NCT03221842|7745515|FG001|NOT COMPLETED|Period 1 (Open-label)||0
6812460|NCT03221842|7745514|FG000|STARTED|Period 2 (Randomized, Blinded)||7
6812461|NCT03221842|7745515|FG001|STARTED|Period 2 (Randomized, Blinded)||6
6812462|NCT03221842|7745514|FG000|COMPLETED|Period 2 (Randomized, Blinded)||6
6812463|NCT03221842|7745515|FG001|COMPLETED|Period 2 (Randomized, Blinded)||5
6812464|NCT03221842|7745514|FG000|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
6812465|NCT03221842|7745515|FG001|NOT COMPLETED|Period 2 (Randomized, Blinded)||1
6812466|NCT03194321|7745525|FG000|STARTED|Overall Study||20
6812467|NCT03194321|7745525|FG000|COMPLETED|Overall Study||17
6812468|NCT03194321|7745525|FG000|NOT COMPLETED|Overall Study||3
6812469|NCT03085095|7745531|FG000|STARTED|Overall Study||624
6812470|NCT03085095|7745532|FG001|STARTED|Overall Study||310
6812471|NCT03085095|7745531|FG000|Received at Least 1 Dose of Study Drug|Overall Study||622
6812472|NCT03085095|7745532|FG001|Received at Least 1 Dose of Study Drug|Overall Study||308
6812473|NCT03085095|7745531|FG000|COMPLETED|Overall Study||563
6812474|NCT03085095|7745532|FG001|COMPLETED|Overall Study||276
6812475|NCT03085095|7745531|FG000|NOT COMPLETED|Overall Study||61
6812476|NCT03085095|7745532|FG001|NOT COMPLETED|Overall Study||34
6812477|NCT03048422|7745544|FG000|STARTED|Overall Study||217
6812478|NCT03048422|7745545|FG001|STARTED|Overall Study||215
6812479|NCT03048422|7745546|FG002|STARTED|Overall Study||211
6812480|NCT03048422|7745544|FG000|COMPLETED|Overall Study||200
6812481|NCT03048422|7745545|FG001|COMPLETED|Overall Study||205
6812482|NCT03048422|7745546|FG002|COMPLETED|Overall Study||202
6812483|NCT03048422|7745544|FG000|NOT COMPLETED|Overall Study||17
6812484|NCT03048422|7745545|FG001|NOT COMPLETED|Overall Study||10
6812485|NCT03048422|7745546|FG002|NOT COMPLETED|Overall Study||9
6812486|NCT03032068|7745564|FG000|STARTED|Overall Study||10
6812487|NCT03032068|7745564|FG000|Preoperative Visit|Overall Study||10
6812488|NCT03032068|7745564|FG000|Postoperative Home Care Visit 1|Overall Study||10
6812489|NCT03032068|7745564|FG000|Postoperative Home Care Visit 2|Overall Study||10
6812490|NCT03032068|7745564|FG000|Postoperative Home Care Visit 3|Overall Study||10
6812491|NCT03032068|7745564|FG000|4 Weeks Postoperative Visit|Overall Study||9
6812492|NCT03032068|7745564|FG000|8 Weeks Postoperative Visit|Overall Study||9
6812493|NCT03032068|7745564|FG000|12 Weeks Postoperative Visit|Overall Study||9
6567585|NCT01831804|7490656|FG005|NOT COMPLETED|Overall Study||0
6567586|NCT01831804|7490657|FG006|NOT COMPLETED|Overall Study||1
6567587|NCT01831804|7490658|FG007|NOT COMPLETED|Overall Study||3
6657018|NCT02465866|7587324|FG001|COMPLETED|Period 4||4
6812494|NCT03032068|7745564|FG000|COMPLETED|Overall Study||9
6812495|NCT03032068|7745564|FG000|NOT COMPLETED|Overall Study||1
6812496|NCT02965729|7745571|FG000|STARTED|Overall Study||24
6812497|NCT02965729|7745572|FG001|STARTED|Overall Study||25
6812498|NCT02965729|7745573|FG002|STARTED|Overall Study||56
6812499|NCT02965729|7745571|FG000|COMPLETED|Overall Study||17
6812500|NCT02965729|7745572|FG001|COMPLETED|Overall Study||22
6812501|NCT02965729|7745573|FG002|COMPLETED|Overall Study||45
6812502|NCT02965729|7745571|FG000|NOT COMPLETED|Overall Study||7
6812503|NCT02965729|7745572|FG001|NOT COMPLETED|Overall Study||3
6812504|NCT02965729|7745573|FG002|NOT COMPLETED|Overall Study||11
6812505|NCT02835690|7745584|FG000|STARTED|Overall Study||14
6812506|NCT02835690|7745585|FG001|STARTED|Overall Study||15
6504742|NCT01449630|7423759|FG004|COMPLETED|Period 3||5
6504743|NCT01449630|7423760|FG005|COMPLETED|Period 3||1
6504744|NCT01449630|7423761|FG006|COMPLETED|Period 3||1
6504745|NCT01449630|7423762|FG007|COMPLETED|Period 3||6
6504746|NCT01449630|7423763|FG008|COMPLETED|Period 3||2
6504747|NCT01449630|7423755|FG000|NOT COMPLETED|Period 3||0
6504748|NCT01449630|7423756|FG001|NOT COMPLETED|Period 3||0
6504749|NCT01449630|7423757|FG002|NOT COMPLETED|Period 3||0
6504750|NCT01449630|7423758|FG003|NOT COMPLETED|Period 3||0
6504751|NCT01449630|7423759|FG004|NOT COMPLETED|Period 3||0
6504752|NCT01449630|7423760|FG005|NOT COMPLETED|Period 3||0
6504753|NCT01449630|7423761|FG006|NOT COMPLETED|Period 3||0
6504754|NCT01449630|7423762|FG007|NOT COMPLETED|Period 3||0
6504755|NCT01449630|7423763|FG008|NOT COMPLETED|Period 3||0
6567588|NCT01831804|7490659|FG008|NOT COMPLETED|Overall Study||2
6567589|NCT01831817|7490692|FG000|STARTED|Overall Study||35
6567590|NCT01831817|7490693|FG001|STARTED|Overall Study||34
6657019|NCT02465866|7587325|FG002|COMPLETED|Period 4||5
6812507|NCT02835690|7745586|FG002|STARTED|Overall Study||15
6812508|NCT02835690|7745584|FG000|Treated|Overall Study||14
6812509|NCT02835690|7745585|FG001|Treated|Overall Study||13
6812510|NCT02835690|7745586|FG002|Treated|Overall Study||15
6812511|NCT02835690|7745584|FG000|COMPLETED|Overall Study||0
6812512|NCT02835690|7745585|FG001|COMPLETED|Overall Study||0
6812513|NCT02835690|7745586|FG002|COMPLETED|Overall Study||0
6812514|NCT02835690|7745584|FG000|NOT COMPLETED|Overall Study||14
6812515|NCT02835690|7745585|FG001|NOT COMPLETED|Overall Study||15
6812516|NCT02835690|7745586|FG002|NOT COMPLETED|Overall Study||15
6812517|NCT02828982|7745594|FG000|STARTED|First Intervention (3 Weeks)||5
6812518|NCT02828982|7745595|FG001|STARTED|First Intervention (3 Weeks)||7
6812519|NCT02828982|7745594|FG000|Received Intervention|First Intervention (3 Weeks)||5
6812520|NCT02828982|7745595|FG001|Received Intervention|First Intervention (3 Weeks)||7
6812521|NCT02828982|7745594|FG000|COMPLETED|First Intervention (3 Weeks)||4
6812522|NCT02828982|7745595|FG001|COMPLETED|First Intervention (3 Weeks)||6
6812523|NCT02828982|7745594|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
6812524|NCT02828982|7745595|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
6812525|NCT02828982|7745594|FG000|STARTED|Second Intervention (3 Weeks)||4
6812526|NCT02828982|7745595|FG001|STARTED|Second Intervention (3 Weeks)||6
6812527|NCT02828982|7745594|FG000|Received Intervention|Second Intervention (3 Weeks)||4
6657020|NCT02465866|7587326|FG003|COMPLETED|Period 4||5
6567591|NCT01831817|7490694|FG002|STARTED|Overall Study||35
6567592|NCT01831817|7490695|FG003|STARTED|Overall Study||36
6567593|NCT01831817|7490692|FG000|COMPLETED|Overall Study||31
6812528|NCT02828982|7745595|FG001|Received Intervention|Second Intervention (3 Weeks)||6
6812529|NCT02828982|7745594|FG000|COMPLETED|Second Intervention (3 Weeks)||4
6812530|NCT02828982|7745595|FG001|COMPLETED|Second Intervention (3 Weeks)||6
6812531|NCT02828982|7745594|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6812532|NCT02828982|7745595|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6812533|NCT02823457|7745603|FG000|STARTED|Overall Study||20
6812534|NCT02823457|7745603|FG000|COMPLETED|Overall Study||15
6812535|NCT02823457|7745603|FG000|NOT COMPLETED|Overall Study||5
6812536|NCT02815280|7745609|FG000|STARTED|Double-Blind Phase||333
6812537|NCT02815280|7745610|FG001|STARTED|Double-Blind Phase||162
6812538|NCT02815280|7745609|FG000|COMPLETED|Double-Blind Phase||297
6812539|NCT02815280|7745610|FG001|COMPLETED|Double-Blind Phase||137
6812540|NCT02815280|7745609|FG000|NOT COMPLETED|Double-Blind Phase||36
6812541|NCT02815280|7745610|FG001|NOT COMPLETED|Double-Blind Phase||25
6812542|NCT02815280|7745609|FG000|STARTED|Open-Label Phase||256
6812543|NCT02815280|7745610|FG001|STARTED|Open-Label Phase||117
6812544|NCT02815280|7745609|FG000|COMPLETED|Open-Label Phase||169
6812545|NCT02815280|7745610|FG001|COMPLETED|Open-Label Phase||73
6812546|NCT02815280|7745609|FG000|NOT COMPLETED|Open-Label Phase||87
6812547|NCT02815280|7745610|FG001|NOT COMPLETED|Open-Label Phase||44
6812548|NCT02815267|7745622|FG000|STARTED|Double-Blind Phase||307
6812549|NCT02815267|7745623|FG001|STARTED|Double-Blind Phase||159
6812550|NCT02815267|7745622|FG000|COMPLETED|Double-Blind Phase||274
6812551|NCT02815267|7745623|FG001|COMPLETED|Double-Blind Phase||128
6812552|NCT02815267|7745622|FG000|NOT COMPLETED|Double-Blind Phase||33
6812553|NCT02815267|7745623|FG001|NOT COMPLETED|Double-Blind Phase||31
6812554|NCT02815267|7745622|FG000|STARTED|Open-Label Phase||193
6812555|NCT02815267|7745623|FG001|STARTED|Open-Label Phase||91
6812556|NCT02815267|7745622|FG000|COMPLETED|Open-Label Phase||122
6812557|NCT02815267|7745623|FG001|COMPLETED|Open-Label Phase||50
6812558|NCT02815267|7745622|FG000|NOT COMPLETED|Open-Label Phase||71
6812559|NCT02815267|7745623|FG001|NOT COMPLETED|Open-Label Phase||41
6812560|NCT02802228|7745635|FG000|STARTED|Overall Study||20
6812561|NCT02802228|7745636|FG001|STARTED|Overall Study||10
6812562|NCT02802228|7745635|FG000|COMPLETED|Overall Study||15
6812563|NCT02802228|7745636|FG001|COMPLETED|Overall Study||10
6812564|NCT02802228|7745635|FG000|NOT COMPLETED|Overall Study||5
6812565|NCT02802228|7745636|FG001|NOT COMPLETED|Overall Study||0
6812566|NCT02719691|7745647|FG000|STARTED|Overall Study||3
6812567|NCT02719691|7745648|FG001|STARTED|Overall Study||4
6812568|NCT02719691|7745649|FG002|STARTED|Overall Study||6
6812569|NCT02719691|7745650|FG003|STARTED|Overall Study||2
6812570|NCT02719691|7745651|FG004|STARTED|Overall Study||31
6812571|NCT02719691|7745647|FG000|COMPLETED|Overall Study||3
6812572|NCT02719691|7745648|FG001|COMPLETED|Overall Study||4
6812573|NCT02719691|7745649|FG002|COMPLETED|Overall Study||6
6812574|NCT02719691|7745650|FG003|COMPLETED|Overall Study||2
6812575|NCT02719691|7745651|FG004|COMPLETED|Overall Study||31
6812576|NCT02719691|7745647|FG000|NOT COMPLETED|Overall Study||0
6812577|NCT02719691|7745648|FG001|NOT COMPLETED|Overall Study||0
6812578|NCT02719691|7745649|FG002|NOT COMPLETED|Overall Study||0
6812579|NCT02719691|7745650|FG003|NOT COMPLETED|Overall Study||0
6812580|NCT02719691|7745651|FG004|NOT COMPLETED|Overall Study||0
6812581|NCT02674516|7745667|FG000|STARTED|Overall Study||17
6812582|NCT02674516|7745668|FG001|STARTED|Overall Study||15
6812583|NCT02674516|7745667|FG000|COMPLETED|Overall Study||13
6812584|NCT02674516|7745668|FG001|COMPLETED|Overall Study||11
6812585|NCT02674516|7745667|FG000|NOT COMPLETED|Overall Study||4
6812586|NCT02674516|7745668|FG001|NOT COMPLETED|Overall Study||4
6812587|NCT02655016|7745676|FG000|STARTED|Overall Study||246
6812588|NCT02655016|7745677|FG001|STARTED|Overall Study||487
6812589|NCT02655016|7745676|FG000|Received Study Treatment|Overall Study|2 participants never received treatment due to screen failure after randomization.|244
6812590|NCT02655016|7745677|FG001|Received Study Treatment|Overall Study|3 participants never received treatment (2 failed screening & 1 withdrew consent before first dose).|484
6812591|NCT02655016|7745676|FG000|Ongoing With Treatment in the Study|Overall Study||69
6812592|NCT02655016|7745677|FG001|Ongoing With Treatment in the Study|Overall Study||177
6812593|NCT02655016|7745676|FG000|COMPLETED|Overall Study|69 participants are ongoing in the study.|191
6812594|NCT02655016|7745677|FG001|COMPLETED|Overall Study|177 participants are ongoing in the study.|397
6812595|NCT02655016|7745676|FG000|NOT COMPLETED|Overall Study||55
6812596|NCT02655016|7745677|FG001|NOT COMPLETED|Overall Study||90
6812597|NCT02607046|7745686|FG000|STARTED|Overall Study||22
6812598|NCT02607046|7745687|FG001|STARTED|Overall Study||13
6812599|NCT02607046|7745686|FG000|COMPLETED|Overall Study||14
6812600|NCT02607046|7745687|FG001|COMPLETED|Overall Study||10
6812601|NCT02607046|7745686|FG000|NOT COMPLETED|Overall Study||8
6812602|NCT02607046|7745687|FG001|NOT COMPLETED|Overall Study||3
6812603|NCT02505425|7745697|FG000|STARTED|Overall Study||208
6812604|NCT02505425|7745698|FG001|STARTED|Overall Study||207
6812605|NCT02505425|7745699|FG002|STARTED|Overall Study||82
6812606|NCT02505425|7745700|FG003|STARTED|Overall Study||76
6812607|NCT02505425|7745697|FG000|COMPLETED|Overall Study||120
6812608|NCT02505425|7745698|FG001|COMPLETED|Overall Study||125
6812609|NCT02505425|7745699|FG002|COMPLETED|Overall Study||32
6812610|NCT02505425|7745700|FG003|COMPLETED|Overall Study||50
6812611|NCT02505425|7745697|FG000|NOT COMPLETED|Overall Study||88
6812612|NCT02505425|7745698|FG001|NOT COMPLETED|Overall Study||82
6812613|NCT02505425|7745699|FG002|NOT COMPLETED|Overall Study||50
6812614|NCT02505425|7745700|FG003|NOT COMPLETED|Overall Study||26
6812615|NCT02487979|7745710|FG000|STARTED|Overall Study||22
6812616|NCT02487979|7745710|FG000|COMPLETED|Overall Study||1
6812617|NCT02487979|7745710|FG000|NOT COMPLETED|Overall Study||21
6812618|NCT02463448|7745714|FG000|STARTED|Enrollment Through 6 Months||23
6812619|NCT02463448|7745714|FG000|COMPLETED|Enrollment Through 6 Months||20
6812620|NCT02463448|7745714|FG000|NOT COMPLETED|Enrollment Through 6 Months||3
6812621|NCT02463448|7745714|FG000|STARTED|6 Months Through 12 Months||20
6812622|NCT02463448|7745714|FG000|COMPLETED|6 Months Through 12 Months||18
6812623|NCT02463448|7745714|FG000|NOT COMPLETED|6 Months Through 12 Months||2
6812624|NCT02463448|7745714|FG000|STARTED|12 Months Through End of Study||18
6812625|NCT02463448|7745714|FG000|COMPLETED|12 Months Through End of Study||17
6812626|NCT02463448|7745714|FG000|NOT COMPLETED|12 Months Through End of Study||1
6812627|NCT02288897|7745720|FG000|STARTED|Overall Study||12
6812628|NCT02288897|7745721|FG001|STARTED|Overall Study||8
6812629|NCT02288897|7745720|FG000|COMPLETED|Overall Study||12
6812630|NCT02288897|7745721|FG001|COMPLETED|Overall Study||8
6812631|NCT02288897|7745720|FG000|NOT COMPLETED|Overall Study||0
6812632|NCT02288897|7745721|FG001|NOT COMPLETED|Overall Study||0
6812633|NCT02276547|7745727|FG000|STARTED|Overall Study||27
6812634|NCT02276547|7745727|FG000|COMPLETED|Overall Study||23
6812635|NCT02276547|7745727|FG000|NOT COMPLETED|Overall Study||4
6812636|NCT02263885|7745731|FG000|STARTED|Overall Study||20
6812637|NCT02263885|7745731|FG000|COMPLETED|Overall Study||10
6812638|NCT02263885|7745731|FG000|NOT COMPLETED|Overall Study||10
6812639|NCT02213926|7745736|FG000|STARTED|Overall Study||124
6812640|NCT02213926|7745736|FG000|COMPLETED|Overall Study||0
6812641|NCT02213926|7745736|FG000|NOT COMPLETED|Overall Study||124
6812642|NCT02008396|7745742|FG000|STARTED|Overall Study||4
6812643|NCT02008396|7745743|FG001|STARTED|Overall Study||8
6812644|NCT02008396|7745742|FG000|COMPLETED|Overall Study||4
6812645|NCT02008396|7745743|FG001|COMPLETED|Overall Study||7
6812646|NCT02008396|7745742|FG000|NOT COMPLETED|Overall Study||0
6812647|NCT02008396|7745743|FG001|NOT COMPLETED|Overall Study||1
6812648|NCT01995175|7745750|FG000|STARTED|Overall Study||2401
6812649|NCT01995175|7745750|FG000|COMPLETED|Overall Study||2148
6567594|NCT01831817|7490693|FG001|COMPLETED|Overall Study||34
6567595|NCT01831817|7490694|FG002|COMPLETED|Overall Study||35
6567596|NCT01831817|7490695|FG003|COMPLETED|Overall Study||36
6567597|NCT01831817|7490692|FG000|NOT COMPLETED|Overall Study||4
6567598|NCT01831817|7490693|FG001|NOT COMPLETED|Overall Study||0
6567599|NCT01831817|7490694|FG002|NOT COMPLETED|Overall Study||0
6567600|NCT01831817|7490695|FG003|NOT COMPLETED|Overall Study||0
6567601|NCT01831856|7490707|FG000|STARTED|Overall Study||67
6812650|NCT01995175|7745750|FG000|NOT COMPLETED|Overall Study||253
6812651|NCT01883804|7745754|FG000|STARTED|Overall Study||25
6812652|NCT01883804|7745754|FG000|COMPLETED|Overall Study||20
6812653|NCT01883804|7745754|FG000|NOT COMPLETED|Overall Study||5
6812654|NCT01804296|7745758|FG000|STARTED|Overall Study||4
6812655|NCT01804296|7745758|FG000|COMPLETED|Overall Study||4
6812656|NCT01804296|7745758|FG000|NOT COMPLETED|Overall Study||0
6812657|NCT01804270|7745764|FG000|STARTED|Overall Study||2
6812658|NCT01804270|7745765|FG001|STARTED|Overall Study||4
6812659|NCT01804270|7745764|FG000|COMPLETED|Overall Study||1
6812660|NCT01804270|7745765|FG001|COMPLETED|Overall Study||3
6812661|NCT01804270|7745764|FG000|NOT COMPLETED|Overall Study||1
6812662|NCT01804270|7745765|FG001|NOT COMPLETED|Overall Study||1
6812663|NCT01781390|7745774|FG000|STARTED|Overall Study||35
6812664|NCT01781390|7745775|FG001|STARTED|Overall Study||35
6812665|NCT01781390|7745776|FG002|STARTED|Overall Study||36
6812666|NCT01781390|7745774|FG000|COMPLETED|Overall Study||32
6812667|NCT01781390|7745775|FG001|COMPLETED|Overall Study||28
6812668|NCT01781390|7745776|FG002|COMPLETED|Overall Study||32
6567602|NCT01831856|7490708|FG001|STARTED|Overall Study||67
6567603|NCT01831856|7490707|FG000|COMPLETED|Overall Study||33
6567604|NCT01831856|7490708|FG001|COMPLETED|Overall Study||30
6567605|NCT01831856|7490707|FG000|NOT COMPLETED|Overall Study||34
6567606|NCT01831856|7490708|FG001|NOT COMPLETED|Overall Study||37
6567607|NCT01831921|7490716|FG000|STARTED|Overall Study||150
6567608|NCT01831921|7490717|FG001|STARTED|Overall Study||75
6567609|NCT01831921|7490716|FG000|6 Months|Overall Study||122
6567610|NCT01831921|7490717|FG001|6 Months|Overall Study||63
6567611|NCT01831921|7490716|FG000|12 Months|Overall Study|All participants were followed for 12 months to 24 months, depending on date of randomization.|120
6657021|NCT02465866|7587323|FG000|NOT COMPLETED|Period 4||0
6657022|NCT02465866|7587324|FG001|NOT COMPLETED|Period 4||0
6657023|NCT02465866|7587325|FG002|NOT COMPLETED|Period 4||0
6657024|NCT02465866|7587326|FG003|NOT COMPLETED|Period 4||0
6657025|NCT02465866|7587323|FG000|STARTED|Period 4: Washout (14 Days)||5
6657026|NCT02465866|7587324|FG001|STARTED|Period 4: Washout (14 Days)||4
6657027|NCT02465866|7587325|FG002|STARTED|Period 4: Washout (14 Days)||5
6657028|NCT02465866|7587326|FG003|STARTED|Period 4: Washout (14 Days)||5
6657029|NCT02465866|7587323|FG000|COMPLETED|Period 4: Washout (14 Days)||5
6657030|NCT02465866|7587324|FG001|COMPLETED|Period 4: Washout (14 Days)||4
6657031|NCT02465866|7587325|FG002|COMPLETED|Period 4: Washout (14 Days)||5
6657032|NCT02465866|7587326|FG003|COMPLETED|Period 4: Washout (14 Days)||5
6657033|NCT02465866|7587323|FG000|NOT COMPLETED|Period 4: Washout (14 Days)||0
6657034|NCT02465866|7587324|FG001|NOT COMPLETED|Period 4: Washout (14 Days)||0
6657035|NCT02465866|7587325|FG002|NOT COMPLETED|Period 4: Washout (14 Days)||0
6657036|NCT02465866|7587326|FG003|NOT COMPLETED|Period 4: Washout (14 Days)||0
6657037|NCT02465931|7587338|FG000|STARTED|Overall Study||55
6657038|NCT02465931|7587339|FG001|STARTED|Overall Study||56
6657039|NCT02465931|7587338|FG000|COMPLETED|Overall Study||44
6657040|NCT02465931|7587339|FG001|COMPLETED|Overall Study||45
6657041|NCT02465931|7587338|FG000|NOT COMPLETED|Overall Study||11
6567612|NCT01831921|7490717|FG001|12 Months|Overall Study||62
6567613|NCT01831921|7490716|FG000|18 Months|Overall Study|Of 118 eligible for this visit.|90
6567614|NCT01831921|7490717|FG001|18 Months|Overall Study|Of 59 eligible for this visit.|49
6567615|NCT01831921|7490716|FG000|COMPLETED|Overall Study|Of 85 eligible for this visit.|66
6567616|NCT01831921|7490717|FG001|COMPLETED|Overall Study|Of 42 eligible for this visit.|36
6567617|NCT01831921|7490716|FG000|NOT COMPLETED|Overall Study||84
6567618|NCT01831921|7490717|FG001|NOT COMPLETED|Overall Study||39
6567619|NCT01831934|7490728|FG000|STARTED|Overall Study||12
6567620|NCT01831934|7490729|FG001|STARTED|Overall Study||10
6567621|NCT01831934|7490728|FG000|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
6567622|NCT01831934|7490729|FG001|COMPLETED|Overall Study||10
6567623|NCT01831934|7490728|FG000|NOT COMPLETED|Overall Study||1
6567624|NCT01831934|7490729|FG001|NOT COMPLETED|Overall Study||0
6567625|NCT01831960|7490737|FG000|STARTED|Overall Study||20
6567626|NCT01831960|7490738|FG001|STARTED|Overall Study||22
6567627|NCT01831960|7490737|FG000|COMPLETED|Overall Study||20
6567628|NCT01831960|7490738|FG001|COMPLETED|Overall Study||22
6567629|NCT01831960|7490737|FG000|NOT COMPLETED|Overall Study||0
6567630|NCT01831960|7490738|FG001|NOT COMPLETED|Overall Study||0
6567631|NCT01832038|7490745|FG000|STARTED|Overall Study||473
6567632|NCT01832038|7490745|FG000|COMPLETED|Overall Study||238
6567633|NCT01832038|7490745|FG000|NOT COMPLETED|Overall Study||235
6567634|NCT01832090|7490752|FG000|STARTED|Overall Study||89
6567635|NCT01832090|7490753|FG001|STARTED|Overall Study||29
6567636|NCT01832090|7490752|FG000|COMPLETED|Overall Study||83
6567637|NCT01832090|7490753|FG001|COMPLETED|Overall Study||28
6567638|NCT01832090|7490752|FG000|NOT COMPLETED|Overall Study||6
6567639|NCT01832090|7490753|FG001|NOT COMPLETED|Overall Study||1
6567640|NCT01832155|7490781|FG000|STARTED|Beginning of Study: Baseline at 0 Week||18
6567641|NCT01832155|7490782|FG001|STARTED|Beginning of Study: Baseline at 0 Week||18
6567642|NCT01832155|7490781|FG000|COMPLETED|Beginning of Study: Baseline at 0 Week||17
6567643|NCT01832155|7490782|FG001|COMPLETED|Beginning of Study: Baseline at 0 Week||18
6567644|NCT01832155|7490781|FG000|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
6567645|NCT01832155|7490782|FG001|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
6567646|NCT01832155|7490781|FG000|STARTED|Mid-point of Study: 0 - 4 Weeks||17
6567647|NCT01832155|7490782|FG001|STARTED|Mid-point of Study: 0 - 4 Weeks||18
6567648|NCT01832155|7490781|FG000|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
6567649|NCT01832155|7490782|FG001|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
6567650|NCT01832155|7490781|FG000|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
6657042|NCT02465931|7587339|FG001|NOT COMPLETED|Overall Study||11
6657043|NCT02466009|7587345|FG000|STARTED|Overall Study||27
6812669|NCT01781390|7745774|FG000|NOT COMPLETED|Overall Study||3
6812670|NCT01781390|7745775|FG001|NOT COMPLETED|Overall Study||7
6812671|NCT01781390|7745776|FG002|NOT COMPLETED|Overall Study||4
6812672|NCT01566695|7745786|FG000|STARTED|Overall Study||107
6567651|NCT01832155|7490782|FG001|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
6567652|NCT01832155|7490781|FG000|STARTED|End of Study: 4 - 8 Weeks||16
6567653|NCT01832155|7490782|FG001|STARTED|End of Study: 4 - 8 Weeks||18
6567654|NCT01832155|7490781|FG000|COMPLETED|End of Study: 4 - 8 Weeks||16
6567655|NCT01832155|7490782|FG001|COMPLETED|End of Study: 4 - 8 Weeks||18
6567656|NCT01832155|7490781|FG000|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
6567657|NCT01832155|7490782|FG001|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
6567658|NCT01832259|7490796|FG000|STARTED|Overall Study||15
6275987|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 97 - 144||74
6275988|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
6812673|NCT01566695|7745787|FG001|STARTED|Overall Study||109
6812674|NCT01566695|7745786|FG000|COMPLETED|Overall Study||12
6812675|NCT01566695|7745787|FG001|COMPLETED|Overall Study||10
6812676|NCT01566695|7745786|FG000|NOT COMPLETED|Overall Study||95
6812677|NCT01566695|7745787|FG001|NOT COMPLETED|Overall Study||99
6812678|NCT01338636|7745793|FG000|STARTED|Overall Study||30
6812679|NCT01338636|7745793|FG000|COMPLETED|Overall Study||22
6812680|NCT01338636|7745793|FG000|NOT COMPLETED|Overall Study||8
6812681|NCT01208974|7745797|FG000|STARTED|NAC-Sparing Mastectomy||21
6812682|NCT01208974|7745798|FG001|STARTED|NAC-Sparing Mastectomy||0
6812683|NCT01208974|7745799|FG002|STARTED|NAC-Sparing Mastectomy||0
6812684|NCT01208974|7745800|FG003|STARTED|NAC-Sparing Mastectomy||0
6812685|NCT01208974|7745797|FG000|COMPLETED|NAC-Sparing Mastectomy||21
6812686|NCT01208974|7745798|FG001|COMPLETED|NAC-Sparing Mastectomy||0
6812687|NCT01208974|7745799|FG002|COMPLETED|NAC-Sparing Mastectomy||0
6812688|NCT01208974|7745800|FG003|COMPLETED|NAC-Sparing Mastectomy||0
6812689|NCT01208974|7745797|FG000|NOT COMPLETED|NAC-Sparing Mastectomy||0
6812690|NCT01208974|7745798|FG001|NOT COMPLETED|NAC-Sparing Mastectomy||0
6812691|NCT01208974|7745799|FG002|NOT COMPLETED|NAC-Sparing Mastectomy||0
6812692|NCT01208974|7745800|FG003|NOT COMPLETED|NAC-Sparing Mastectomy||0
6812693|NCT01208974|7745797|FG000|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||21
6812694|NCT01208974|7745798|FG001|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812695|NCT01208974|7745799|FG002|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812696|NCT01208974|7745800|FG003|STARTED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812697|NCT01208974|7745797|FG000|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||18
6812698|NCT01208974|7745798|FG001|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812699|NCT01208974|7745799|FG002|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812700|NCT01208974|7745800|FG003|COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812701|NCT01208974|7745797|FG000|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||3
6812702|NCT01208974|7745798|FG001|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812703|NCT01208974|7745799|FG002|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812704|NCT01208974|7745800|FG003|NOT COMPLETED|Post-Mastectomy Period (Weeks 1 to 4)||0
6812705|NCT01208974|7745797|FG000|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||0
6812706|NCT01208974|7745798|FG001|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
6812707|NCT01208974|7745799|FG002|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
6812708|NCT01208974|7745800|FG003|STARTED|Prophylactic NAC RT (Weeks 5 to 8)||6
6812709|NCT01208974|7745797|FG000|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
6812710|NCT01208974|7745798|FG001|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||6
6812711|NCT01208974|7745799|FG002|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
6812712|NCT01208974|7745800|FG003|Cohort 1: Starting Dose|Prophylactic NAC RT (Weeks 5 to 8)||0
6812713|NCT01208974|7745797|FG000|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
6812714|NCT01208974|7745798|FG001|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
6812715|NCT01208974|7745799|FG002|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
6812716|NCT01208974|7745800|FG003|Cohort 2: 1st Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
6812717|NCT01208974|7745797|FG000|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
6812718|NCT01208974|7745798|FG001|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
6567659|NCT01832259|7490797|FG001|STARTED|Overall Study||15
6567660|NCT01832259|7490796|FG000|COMPLETED|Overall Study||15
6812719|NCT01208974|7745799|FG002|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||0
6812720|NCT01208974|7745800|FG003|Cohort 3: 2nd Dose Escalation|Prophylactic NAC RT (Weeks 5 to 8)||6
6812721|NCT01208974|7745797|FG000|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
6812722|NCT01208974|7745798|FG001|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
6812723|NCT01208974|7745799|FG002|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
6812724|NCT01208974|7745800|FG003|COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||6
6812725|NCT01208974|7745797|FG000|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
6812726|NCT01208974|7745798|FG001|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
6812727|NCT01208974|7745799|FG002|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
6812728|NCT01208974|7745800|FG003|NOT COMPLETED|Prophylactic NAC RT (Weeks 5 to 8)||0
6812729|NCT00938912|7745807|FG000|STARTED|Overall Study||365
6812730|NCT00938912|7745807|FG000|COMPLETED|Overall Study||254
6812731|NCT00938912|7745807|FG000|NOT COMPLETED|Overall Study||111
6812732|NCT00925652|7745818|FG000|STARTED|Overall Study||13
6812733|NCT00925652|7745819|FG001|STARTED|Overall Study||13
6812734|NCT00925652|7745820|FG002|STARTED|Overall Study||11
6812735|NCT00925652|7745821|FG003|STARTED|Overall Study||13
6812736|NCT00925652|7745818|FG000|Withdraw|Overall Study||6
6812737|NCT00925652|7745819|FG001|Withdraw|Overall Study||5
6812738|NCT00925652|7745820|FG002|Withdraw|Overall Study||3
6812739|NCT00925652|7745821|FG003|Withdraw|Overall Study||1
6812740|NCT00925652|7745818|FG000|Off Treatment Because of Other Complicating Disease|Overall Study||0
6812741|NCT00925652|7745819|FG001|Off Treatment Because of Other Complicating Disease|Overall Study||0
6812742|NCT00925652|7745820|FG002|Off Treatment Because of Other Complicating Disease|Overall Study||2
6812743|NCT00925652|7745821|FG003|Off Treatment Because of Other Complicating Disease|Overall Study||3
6812744|NCT00925652|7745818|FG000|Off Treatment Because of Disease Recurrence|Overall Study||1
6812745|NCT00925652|7745819|FG001|Off Treatment Because of Disease Recurrence|Overall Study||3
6812746|NCT00925652|7745820|FG002|Off Treatment Because of Disease Recurrence|Overall Study||0
6812747|NCT00925652|7745821|FG003|Off Treatment Because of Disease Recurrence|Overall Study||0
6812748|NCT00925652|7745818|FG000|Lost of Follow-up|Overall Study||0
6812749|NCT00925652|7745819|FG001|Lost of Follow-up|Overall Study||1
6812750|NCT00925652|7745820|FG002|Lost of Follow-up|Overall Study||0
6567661|NCT01832259|7490797|FG001|COMPLETED|Overall Study||15
6567662|NCT01832259|7490796|FG000|NOT COMPLETED|Overall Study||0
6567663|NCT01832259|7490797|FG001|NOT COMPLETED|Overall Study||0
6567664|NCT01832402|7490805|FG000|STARTED|Overall Study||19
6567665|NCT01832402|7490806|FG001|STARTED|Overall Study||16
6567666|NCT01832402|7490805|FG000|Received Allocated Medication|Overall Study||12
6812751|NCT00925652|7745821|FG003|Lost of Follow-up|Overall Study||0
6812752|NCT00925652|7745818|FG000|Death|Overall Study||0
6812753|NCT00925652|7745819|FG001|Death|Overall Study||0
6812754|NCT00925652|7745820|FG002|Death|Overall Study||0
6812755|NCT00925652|7745821|FG003|Death|Overall Study||3
6812756|NCT00925652|7745818|FG000|COMPLETED|Overall Study||6
6812757|NCT00925652|7745819|FG001|COMPLETED|Overall Study||4
6812758|NCT00925652|7745820|FG002|COMPLETED|Overall Study||6
6812759|NCT00925652|7745821|FG003|COMPLETED|Overall Study||6
6812760|NCT00925652|7745818|FG000|NOT COMPLETED|Overall Study||7
6812761|NCT00925652|7745819|FG001|NOT COMPLETED|Overall Study||9
6812762|NCT00925652|7745820|FG002|NOT COMPLETED|Overall Study||5
6812763|NCT00925652|7745821|FG003|NOT COMPLETED|Overall Study||7
6812764|NCT00676715|7745843|FG000|STARTED|Overall Study||54
6812765|NCT00676715|7745844|FG001|STARTED|Overall Study||55
6567667|NCT01832402|7490806|FG001|Received Allocated Medication|Overall Study||12
6812766|NCT00676715|7745845|FG002|STARTED|Overall Study||55
6812767|NCT00676715|7745846|FG003|STARTED|Overall Study||54
6812768|NCT00676715|7745843|FG000|COMPLETED|Overall Study||14
6812769|NCT00676715|7745844|FG001|COMPLETED|Overall Study||8
6812770|NCT00676715|7745845|FG002|COMPLETED|Overall Study||14
6812771|NCT00676715|7745846|FG003|COMPLETED|Overall Study||14
6812772|NCT00676715|7745843|FG000|NOT COMPLETED|Overall Study||40
6812773|NCT00676715|7745844|FG001|NOT COMPLETED|Overall Study||47
6812774|NCT00676715|7745845|FG002|NOT COMPLETED|Overall Study||41
6812775|NCT00676715|7745846|FG003|NOT COMPLETED|Overall Study||40
6812776|NCT00579826|7745858|FG000|STARTED|Overall Study||29
6812777|NCT00579826|7745859|FG001|STARTED|Overall Study||26
6812778|NCT00579826|7745858|FG000|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
6812779|NCT00579826|7745859|FG001|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
6812780|NCT00579826|7745858|FG000|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
6812781|NCT00579826|7745859|FG001|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
6812782|NCT00579826|7745858|FG000|NOT COMPLETED|Overall Study||5
6812783|NCT00579826|7745859|FG001|NOT COMPLETED|Overall Study||3
6812784|NCT00322218|7745867|FG000|STARTED|Overall Study||34
6812785|NCT00322218|7745868|FG001|STARTED|Overall Study||34
6812786|NCT00322218|7745867|FG000|Per-Protocol Set|Overall Study||33
6812787|NCT00322218|7745868|FG001|Per-Protocol Set|Overall Study||32
6812788|NCT00322218|7745867|FG000|COMPLETED|Overall Study||31
6812789|NCT00322218|7745868|FG001|COMPLETED|Overall Study||28
6812790|NCT00322218|7745867|FG000|NOT COMPLETED|Overall Study||3
6812791|NCT00322218|7745868|FG001|NOT COMPLETED|Overall Study||6
6812792|NCT00186888|7745877|FG000|STARTED|Overall Study||23
6812793|NCT00186888|7745878|FG001|STARTED|Overall Study||27
6812794|NCT00186888|7745879|FG002|STARTED|Overall Study||55
6812795|NCT00186888|7745877|FG000|Window Therapy|Overall Study||0
6812796|NCT00186888|7745878|FG001|Window Therapy|Overall Study||27
6812797|NCT00186888|7745879|FG002|Window Therapy|Overall Study||0
6812798|NCT00186888|7745877|FG000|COMPLETED|Overall Study||19
6812799|NCT00186888|7745878|FG001|COMPLETED|Overall Study||24
6812800|NCT00186888|7745879|FG002|COMPLETED|Overall Study||55
6812801|NCT00186888|7745877|FG000|NOT COMPLETED|Overall Study||4
6812802|NCT00186888|7745878|FG001|NOT COMPLETED|Overall Study||3
6812803|NCT00186888|7745879|FG002|NOT COMPLETED|Overall Study||0
6812804|NCT04579549|7745914|FG000|STARTED|Overall Study||464
6812805|NCT04579549|7745914|FG000|Number of Individuals Trained In COVID-19 Assay|Overall Study||11
6812806|NCT04579549|7745914|FG000|COMPLETED|Overall Study||464
6812807|NCT04579549|7745914|FG000|NOT COMPLETED|Overall Study||0
6812808|NCT04460690|7745920|FG000|STARTED|Overall Study||93
6812809|NCT04460690|7745920|FG000|Community Participants|Overall Study||83
6812810|NCT04460690|7745920|FG000|Investigator Participants|Overall Study||10
6812811|NCT04460690|7745920|FG000|COMPLETED|Overall Study||93
6812812|NCT04460690|7745920|FG000|NOT COMPLETED|Overall Study||0
6812881|NCT03086369|7745999|FG000|STARTED|Overall Study||3
6812882|NCT03086369|7746000|FG001|STARTED|Overall Study||7
6812883|NCT03086369|7746001|FG002|STARTED|Overall Study||12
6812884|NCT03086369|7746002|FG003|STARTED|Overall Study||82
6812885|NCT03086369|7746003|FG004|STARTED|Overall Study||80
6812886|NCT03086369|7745999|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6812887|NCT03086369|7746000|FG001|Received at Least 1 Dose of Study Drug|Overall Study||7
6812888|NCT03086369|7746001|FG002|Received at Least 1 Dose of Study Drug|Overall Study||12
6812889|NCT03086369|7746002|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
6812890|NCT03086369|7746003|FG004|Received at Least 1 Dose of Study Drug|Overall Study||78
6812891|NCT03086369|7745999|FG000|COMPLETED|Overall Study||2
6812892|NCT03086369|7746000|FG001|COMPLETED|Overall Study||7
6812893|NCT03086369|7746001|FG002|COMPLETED|Overall Study||12
6812894|NCT03086369|7746002|FG003|COMPLETED|Overall Study||55
6812895|NCT03086369|7746003|FG004|COMPLETED|Overall Study||59
6812896|NCT03086369|7745999|FG000|NOT COMPLETED|Overall Study||1
6812897|NCT03086369|7746000|FG001|NOT COMPLETED|Overall Study||0
6812898|NCT03086369|7746001|FG002|NOT COMPLETED|Overall Study||0
6812899|NCT03086369|7746002|FG003|NOT COMPLETED|Overall Study||27
6812900|NCT03086369|7746003|FG004|NOT COMPLETED|Overall Study||21
6812901|NCT03053362|7746019|FG000|STARTED|Overall Study||100
6812902|NCT03053362|7746020|FG001|STARTED|Overall Study||58
6812903|NCT03053362|7746019|FG000|COMPLETED|Overall Study||83
6812904|NCT03053362|7746020|FG001|COMPLETED|Overall Study||50
6812905|NCT03053362|7746019|FG000|NOT COMPLETED|Overall Study||17
6812906|NCT03053362|7746020|FG001|NOT COMPLETED|Overall Study||8
6812907|NCT02849626|7746029|FG000|STARTED|Core Phase (up to 23 Weeks)||149
6812908|NCT02849626|7746030|FG001|STARTED|Core Phase (up to 23 Weeks)||31
6812909|NCT02849626|7746029|FG000|COMPLETED|Core Phase (up to 23 Weeks)||122
6812910|NCT02849626|7746030|FG001|COMPLETED|Core Phase (up to 23 Weeks)||24
6812911|NCT02849626|7746029|FG000|NOT COMPLETED|Core Phase (up to 23 Weeks)||27
6812912|NCT02849626|7746030|FG001|NOT COMPLETED|Core Phase (up to 23 Weeks)||7
6812913|NCT02849626|7746029|FG000|STARTED|Extension Phase A (up to 29 Weeks)||116
6812914|NCT02849626|7746030|FG001|STARTED|Extension Phase A (up to 29 Weeks)||20
6812915|NCT02849626|7746029|FG000|COMPLETED|Extension Phase A (up to 29 Weeks)||105
6812916|NCT02849626|7746030|FG001|COMPLETED|Extension Phase A (up to 29 Weeks)||17
6812917|NCT02849626|7746029|FG000|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||11
6812918|NCT02849626|7746030|FG001|NOT COMPLETED|Extension Phase A (up to 29 Weeks)||3
6812919|NCT02779855|7746049|FG000|STARTED|Overall Study||4
6812920|NCT02779855|7746050|FG001|STARTED|Overall Study||6
6812921|NCT02779855|7746051|FG002|STARTED|Overall Study||40
6812922|NCT02779855|7746049|FG000|COMPLETED|Overall Study||3
6812923|NCT02779855|7746050|FG001|COMPLETED|Overall Study||6
6812924|NCT02779855|7746051|FG002|COMPLETED|Overall Study||40
6812925|NCT02779855|7746049|FG000|NOT COMPLETED|Overall Study||1
6812926|NCT02779855|7746050|FG001|NOT COMPLETED|Overall Study||0
6812927|NCT02779855|7746051|FG002|NOT COMPLETED|Overall Study||0
6812928|NCT02654132|7746062|FG000|STARTED|Overall Study||60
6812929|NCT02654132|7746063|FG001|STARTED|Overall Study||57
6812930|NCT02654132|7746062|FG000|COMPLETED|Overall Study||24
6812931|NCT02654132|7746063|FG001|COMPLETED|Overall Study||11
6812932|NCT02654132|7746062|FG000|NOT COMPLETED|Overall Study||36
6812933|NCT02654132|7746063|FG001|NOT COMPLETED|Overall Study||46
6812934|NCT02603432|7746072|FG000|STARTED|Overall Study||350
6812935|NCT02603432|7746073|FG001|STARTED|Overall Study||350
6812936|NCT02603432|7746072|FG000|COMPLETED|Overall Study||0
6812937|NCT02603432|7746073|FG001|COMPLETED|Overall Study||0
6812938|NCT02603432|7746072|FG000|NOT COMPLETED|Overall Study||350
6812939|NCT02603432|7746073|FG001|NOT COMPLETED|Overall Study||350
6812940|NCT02600923|7746079|FG000|STARTED|Overall Study||131
6812941|NCT02600923|7746079|FG000|Treated|Overall Study||130
6812942|NCT02600923|7746079|FG000|COMPLETED|Overall Study||0
6812943|NCT02600923|7746079|FG000|NOT COMPLETED|Overall Study||131
6567668|NCT01832402|7490805|FG000|Completed Study With Correct Dose|Overall Study||10
6567669|NCT01832402|7490806|FG001|Completed Study With Correct Dose|Overall Study||9
6567670|NCT01832402|7490805|FG000|Completed Study With Incorrect Dose|Overall Study||2
6812944|NCT02597790|7746085|FG000|STARTED|Overall Study||45
6812945|NCT02597790|7746086|FG001|STARTED|Overall Study||41
6812946|NCT02597790|7746085|FG000|COMPLETED|Overall Study||36
6812947|NCT02597790|7746086|FG001|COMPLETED|Overall Study||29
6812948|NCT02597790|7746085|FG000|NOT COMPLETED|Overall Study||9
6812949|NCT02597790|7746086|FG001|NOT COMPLETED|Overall Study||12
6812950|NCT02484664|7746097|FG000|STARTED|Overall Study||12
6812951|NCT02484664|7746097|FG000|COMPLETED|Overall Study||9
6812952|NCT02484664|7746097|FG000|NOT COMPLETED|Overall Study||3
6812953|NCT02412735|7746104|FG000|STARTED|Overall Study||143
6812954|NCT02412735|7746105|FG001|STARTED|Overall Study||129
6812955|NCT02412735|7746106|FG002|STARTED|Overall Study||132
6812956|NCT02412735|7746104|FG000|Received Treatment|Overall Study||140
6812813|NCT04374019|7745931|FG000|STARTED|Overall Study||1
6812814|NCT04374019|7745932|FG001|STARTED|Overall Study||1
6812815|NCT04374019|7745933|FG002|STARTED|Overall Study||6
6812816|NCT04374019|7745934|FG003|STARTED|Overall Study||5
6812817|NCT04374019|7745931|FG000|COMPLETED|Overall Study||1
6812818|NCT04374019|7745932|FG001|COMPLETED|Overall Study||1
6812819|NCT04374019|7745933|FG002|COMPLETED|Overall Study||5
6812820|NCT04374019|7745934|FG003|COMPLETED|Overall Study||5
6812821|NCT04374019|7745931|FG000|NOT COMPLETED|Overall Study||0
6812822|NCT04374019|7745932|FG001|NOT COMPLETED|Overall Study||0
6812823|NCT04374019|7745933|FG002|NOT COMPLETED|Overall Study||1
6812824|NCT04374019|7745934|FG003|NOT COMPLETED|Overall Study||0
6812825|NCT04357730|7745948|FG000|STARTED|Phase 1||17
6812826|NCT04357730|7745949|FG001|STARTED|Phase 1||19
6812827|NCT04357730|7745950|FG002|STARTED|Phase 1||0
6812828|NCT04357730|7745948|FG000|COMPLETED|Phase 1||17
6812829|NCT04357730|7745949|FG001|COMPLETED|Phase 1||19
6812830|NCT04357730|7745950|FG002|COMPLETED|Phase 1||0
6812831|NCT04357730|7745948|FG000|NOT COMPLETED|Phase 1||0
6812832|NCT04357730|7745949|FG001|NOT COMPLETED|Phase 1||0
6812833|NCT04357730|7745950|FG002|NOT COMPLETED|Phase 1||0
6812834|NCT04357730|7745948|FG000|STARTED|Phase 2||8
6812835|NCT04357730|7745949|FG001|STARTED|Phase 2||0
6812836|NCT04357730|7745950|FG002|STARTED|Phase 2||6
6812837|NCT04357730|7745948|FG000|COMPLETED|Phase 2||8
6812838|NCT04357730|7745949|FG001|COMPLETED|Phase 2||0
6812839|NCT04357730|7745950|FG002|COMPLETED|Phase 2||6
6812840|NCT04357730|7745948|FG000|NOT COMPLETED|Phase 2||0
6812841|NCT04357730|7745949|FG001|NOT COMPLETED|Phase 2||0
6812842|NCT04357730|7745950|FG002|NOT COMPLETED|Phase 2||0
6812843|NCT04311463|7745964|FG000|STARTED|Period 1 (Up to Day 3)||19
6812844|NCT04311463|7745965|FG001|STARTED|Period 1 (Up to Day 3)||19
6812845|NCT04311463|7745964|FG000|COMPLETED|Period 1 (Up to Day 3)||18
6812846|NCT04311463|7745965|FG001|COMPLETED|Period 1 (Up to Day 3)||19
6812847|NCT04311463|7745964|FG000|NOT COMPLETED|Period 1 (Up to Day 3)||1
6812848|NCT04311463|7745965|FG001|NOT COMPLETED|Period 1 (Up to Day 3)||0
6812849|NCT04311463|7745964|FG000|STARTED|Washout Period (Up to Day 7)||18
6812850|NCT04311463|7745965|FG001|STARTED|Washout Period (Up to Day 7)||19
6812851|NCT04311463|7745964|FG000|COMPLETED|Washout Period (Up to Day 7)||17
6812852|NCT04311463|7745965|FG001|COMPLETED|Washout Period (Up to Day 7)||18
6812853|NCT04311463|7745964|FG000|NOT COMPLETED|Washout Period (Up to Day 7)||1
6812854|NCT04311463|7745965|FG001|NOT COMPLETED|Washout Period (Up to Day 7)||1
6812855|NCT04311463|7745964|FG000|STARTED|Period 2 (Up to Day 3)||17
6812856|NCT04311463|7745965|FG001|STARTED|Period 2 (Up to Day 3)||18
6812857|NCT04311463|7745964|FG000|COMPLETED|Period 2 (Up to Day 3)||15
6812858|NCT04311463|7745965|FG001|COMPLETED|Period 2 (Up to Day 3)||17
6812859|NCT04311463|7745964|FG000|NOT COMPLETED|Period 2 (Up to Day 3)||2
6812860|NCT04311463|7745965|FG001|NOT COMPLETED|Period 2 (Up to Day 3)||1
6812861|NCT04175509|7745974|FG000|STARTED|Overall Study||19
6812862|NCT04175509|7745975|FG001|STARTED|Overall Study||21
6812863|NCT04175509|7745974|FG000|COMPLETED|Overall Study||17
6812864|NCT04175509|7745975|FG001|COMPLETED|Overall Study||19
6812865|NCT04175509|7745974|FG000|NOT COMPLETED|Overall Study||2
6812866|NCT04175509|7745975|FG001|NOT COMPLETED|Overall Study||2
6812867|NCT03930186|7745981|FG000|STARTED|Weeks 0 to 16||152
6812868|NCT03930186|7745981|FG000|Received Study Drug|Weeks 0 to 16||152
6812869|NCT03930186|7745981|FG000|COMPLETED|Weeks 0 to 16||140
6812870|NCT03930186|7745981|FG000|NOT COMPLETED|Weeks 0 to 16||12
6812871|NCT03930186|7745981|FG000|STARTED|Weeks 16 to 32||140
6812872|NCT03930186|7745981|FG000|COMPLETED|Weeks 16 to 32||136
6812873|NCT03930186|7745981|FG000|NOT COMPLETED|Weeks 16 to 32||4
6812874|NCT03740100|7745985|FG000|STARTED|Overall Study|Note: Ten patients were consented, but two died before starting therapy.|8
6567671|NCT01832402|7490806|FG001|Completed Study With Incorrect Dose|Overall Study||3
6567672|NCT01832402|7490805|FG000|COMPLETED|Overall Study||12
6567673|NCT01832402|7490806|FG001|COMPLETED|Overall Study||12
6567674|NCT01832402|7490805|FG000|NOT COMPLETED|Overall Study||7
6657044|NCT02466009|7587345|FG000|COMPLETED|Overall Study||27
6657045|NCT02466009|7587345|FG000|NOT COMPLETED|Overall Study||0
6657046|NCT02466087|7587349|FG000|STARTED|First Intervention: Weeks 1-6||62
6657047|NCT02466087|7587350|FG001|STARTED|First Intervention: Weeks 1-6||64
6657048|NCT02466087|7587349|FG000|COMPLETED|First Intervention: Weeks 1-6||55
6657049|NCT02466087|7587350|FG001|COMPLETED|First Intervention: Weeks 1-6||57
6657050|NCT02466087|7587349|FG000|NOT COMPLETED|First Intervention: Weeks 1-6||7
6657051|NCT02466087|7587350|FG001|NOT COMPLETED|First Intervention: Weeks 1-6||7
6812875|NCT03740100|7745985|FG000|Confirmed Partial Response|Overall Study|"Using a Simon's optimal two-stage design, we planned to enroll up to 10 evaluable patients in the first stage.~Two of eight treated patients were not evaluable for response based on toxicity.~We did not reach this milestone."|1
6812876|NCT03740100|7745985|FG000|COMPLETED|Overall Study||6
6812877|NCT03740100|7745985|FG000|NOT COMPLETED|Overall Study||2
6812878|NCT03597295|7745989|FG000|STARTED|Overall Study||94
6812879|NCT03597295|7745989|FG000|COMPLETED|Overall Study||0
6812880|NCT03597295|7745989|FG000|NOT COMPLETED|Overall Study||94
6567675|NCT01832402|7490806|FG001|NOT COMPLETED|Overall Study||4
6567676|NCT01832480|7490818|FG000|STARTED|Overall Study||311
6567677|NCT01832480|7490819|FG001|STARTED|Overall Study||312
6567678|NCT01832480|7490818|FG000|COMPLETED|Overall Study||270
6567679|NCT01832480|7490819|FG001|COMPLETED|Overall Study||270
6567680|NCT01832480|7490818|FG000|NOT COMPLETED|Overall Study||41
6657052|NCT02466087|7587349|FG000|STARTED|Second Intervention: Weeks 7-12||55
6812957|NCT02412735|7746105|FG001|Received Treatment|Overall Study||128
6812958|NCT02412735|7746106|FG002|Received Treatment|Overall Study||130
6812959|NCT02412735|7746104|FG000|COMPLETED|Overall Study||97
6812960|NCT02412735|7746105|FG001|COMPLETED|Overall Study||85
6812961|NCT02412735|7746106|FG002|COMPLETED|Overall Study||86
6812962|NCT02412735|7746104|FG000|NOT COMPLETED|Overall Study||46
6812963|NCT02412735|7746105|FG001|NOT COMPLETED|Overall Study||44
6812964|NCT02412735|7746106|FG002|NOT COMPLETED|Overall Study||46
6812965|NCT02371889|7746116|FG000|STARTED|Overall Study||85
6812966|NCT02371889|7746117|FG001|STARTED|Overall Study||85
6812967|NCT02371889|7746116|FG000|COMPLETED|Overall Study||66
6812968|NCT02371889|7746117|FG001|COMPLETED|Overall Study||71
6812969|NCT02371889|7746116|FG000|NOT COMPLETED|Overall Study||19
6812970|NCT02371889|7746117|FG001|NOT COMPLETED|Overall Study||14
6812971|NCT02272803|7746129|FG000|STARTED|Overall Study||40
6812972|NCT02272803|7746130|FG001|STARTED|Overall Study||42
6812973|NCT02272803|7746129|FG000|COMPLETED|Overall Study|Completed = Still receiving treatment|31
6812974|NCT02272803|7746130|FG001|COMPLETED|Overall Study|Completed = Still receiving treatment|25
6812975|NCT02272803|7746129|FG000|NOT COMPLETED|Overall Study||9
6812976|NCT02272803|7746130|FG001|NOT COMPLETED|Overall Study||17
6812977|NCT02186834|7746136|FG000|STARTED|Dose Escalation||6
6812978|NCT02186834|7746137|FG001|STARTED|Dose Escalation||3
6812979|NCT02186834|7746138|FG002|STARTED|Dose Escalation||0
6812980|NCT02186834|7746139|FG003|STARTED|Dose Escalation||7
6812981|NCT02186834|7746140|FG004|STARTED|Dose Escalation||4
6812982|NCT02186834|7746141|FG005|STARTED|Dose Escalation||0
6812983|NCT02186834|7746136|FG000|COMPLETED|Dose Escalation||6
6812984|NCT02186834|7746137|FG001|COMPLETED|Dose Escalation||3
6812985|NCT02186834|7746138|FG002|COMPLETED|Dose Escalation||0
6812986|NCT02186834|7746139|FG003|COMPLETED|Dose Escalation||6
6812987|NCT02186834|7746140|FG004|COMPLETED|Dose Escalation||4
6812988|NCT02186834|7746141|FG005|COMPLETED|Dose Escalation||0
6812989|NCT02186834|7746136|FG000|NOT COMPLETED|Dose Escalation||0
6812990|NCT02186834|7746137|FG001|NOT COMPLETED|Dose Escalation||0
6812991|NCT02186834|7746138|FG002|NOT COMPLETED|Dose Escalation||0
6812992|NCT02186834|7746139|FG003|NOT COMPLETED|Dose Escalation||1
6812993|NCT02186834|7746140|FG004|NOT COMPLETED|Dose Escalation||0
6812994|NCT02186834|7746141|FG005|NOT COMPLETED|Dose Escalation||0
6812995|NCT02186834|7746136|FG000|STARTED|Treatment at RP2D||0
6567681|NCT01832480|7490819|FG001|NOT COMPLETED|Overall Study||42
6567682|NCT01832493|7490825|FG000|STARTED|Overall Study||50
6567683|NCT01832493|7490825|FG000|COMPLETED|Overall Study||42
6567684|NCT01832493|7490825|FG000|NOT COMPLETED|Overall Study||8
6812996|NCT02186834|7746137|FG001|STARTED|Treatment at RP2D||0
6812997|NCT02186834|7746138|FG002|STARTED|Treatment at RP2D||0
6812998|NCT02186834|7746139|FG003|STARTED|Treatment at RP2D||0
6812999|NCT02186834|7746140|FG004|STARTED|Treatment at RP2D||0
6813000|NCT02186834|7746141|FG005|STARTED|Treatment at RP2D||14
6813001|NCT02186834|7746136|FG000|COMPLETED|Treatment at RP2D||0
6813002|NCT02186834|7746137|FG001|COMPLETED|Treatment at RP2D||0
6813003|NCT02186834|7746138|FG002|COMPLETED|Treatment at RP2D||0
6813004|NCT02186834|7746139|FG003|COMPLETED|Treatment at RP2D||0
6813005|NCT02186834|7746140|FG004|COMPLETED|Treatment at RP2D||0
6813006|NCT02186834|7746141|FG005|COMPLETED|Treatment at RP2D||13
6813007|NCT02186834|7746136|FG000|NOT COMPLETED|Treatment at RP2D||0
6567685|NCT01832506|7490832|FG000|STARTED|Overall Study||3
6813008|NCT02186834|7746137|FG001|NOT COMPLETED|Treatment at RP2D||0
6813009|NCT02186834|7746138|FG002|NOT COMPLETED|Treatment at RP2D||0
6813010|NCT02186834|7746139|FG003|NOT COMPLETED|Treatment at RP2D||0
6813011|NCT02186834|7746140|FG004|NOT COMPLETED|Treatment at RP2D||0
6813012|NCT02186834|7746141|FG005|NOT COMPLETED|Treatment at RP2D||1
6813013|NCT02121158|7746152|FG000|STARTED|Overall Study||85
6813014|NCT02121158|7746153|FG001|STARTED|Overall Study||82
6813015|NCT02121158|7746152|FG000|COMPLETED|Overall Study||85
6813016|NCT02121158|7746153|FG001|COMPLETED|Overall Study||82
6813017|NCT02121158|7746152|FG000|NOT COMPLETED|Overall Study||0
6813018|NCT02121158|7746153|FG001|NOT COMPLETED|Overall Study||0
6813019|NCT02100722|7746161|FG000|STARTED|Overall Study||757
6813020|NCT02100722|7746162|FG001|STARTED|Overall Study||743
6813021|NCT02100722|7746161|FG000|Underwent Alternate Procedure|Overall Study||11
6813022|NCT02100722|7746162|FG001|Underwent Alternate Procedure|Overall Study||37
6813023|NCT02100722|7746161|FG000|COMPLETED|Overall Study||0
6813024|NCT02100722|7746162|FG001|COMPLETED|Overall Study||0
6813025|NCT02100722|7746161|FG000|NOT COMPLETED|Overall Study||757
6813026|NCT02100722|7746162|FG001|NOT COMPLETED|Overall Study||743
6813027|NCT02059265|7746169|FG000|STARTED|Overall Study||32
6813028|NCT02059265|7746169|FG000|COMPLETED|Overall Study||28
6813029|NCT02059265|7746169|FG000|NOT COMPLETED|Overall Study||4
6813030|NCT02046096|7746175|FG000|STARTED|Overall Study||149
6813031|NCT02046096|7746176|FG001|STARTED|Overall Study||324
6813032|NCT02046096|7746175|FG000|COMPLETED|Overall Study||105
6813033|NCT02046096|7746176|FG001|COMPLETED|Overall Study||223
6813034|NCT02046096|7746175|FG000|NOT COMPLETED|Overall Study||44
6813035|NCT02046096|7746176|FG001|NOT COMPLETED|Overall Study||101
6813036|NCT01945775|7746186|FG000|STARTED|Overall Study||287
6813037|NCT01945775|7746187|FG001|STARTED|Overall Study||144
6813038|NCT01945775|7746186|FG000|Treated|Overall Study||286
6813039|NCT01945775|7746187|FG001|Treated|Overall Study||126
6813040|NCT01945775|7746186|FG000|COMPLETED|Overall Study||0
6813041|NCT01945775|7746187|FG001|COMPLETED|Overall Study||0
6813042|NCT01945775|7746186|FG000|NOT COMPLETED|Overall Study||287
6813043|NCT01945775|7746187|FG001|NOT COMPLETED|Overall Study||144
6813044|NCT01781637|7746195|FG000|STARTED|Overall Study||28
6813045|NCT01781637|7746196|FG001|STARTED|Overall Study||8
6813046|NCT01781637|7746195|FG000|COMPLETED|Overall Study||24
6813047|NCT01781637|7746196|FG001|COMPLETED|Overall Study||2
6813048|NCT01781637|7746195|FG000|NOT COMPLETED|Overall Study||4
6813049|NCT01781637|7746196|FG001|NOT COMPLETED|Overall Study||6
6813050|NCT01711541|7746207|FG000|STARTED|Overall Study||4
6813051|NCT01711541|7746208|FG001|STARTED|Overall Study||4
6813052|NCT01711541|7746209|FG002|STARTED|Overall Study||3
6813053|NCT01711541|7746210|FG003|STARTED|Overall Study||6
6813054|NCT01711541|7746211|FG004|STARTED|Overall Study||7
6813055|NCT01711541|7746207|FG000|COMPLETED|Overall Study||4
6813056|NCT01711541|7746208|FG001|COMPLETED|Overall Study||3
6813057|NCT01711541|7746209|FG002|COMPLETED|Overall Study||3
6813058|NCT01711541|7746210|FG003|COMPLETED|Overall Study||5
6813059|NCT01711541|7746211|FG004|COMPLETED|Overall Study||7
6813060|NCT01711541|7746207|FG000|NOT COMPLETED|Overall Study||0
6813061|NCT01711541|7746208|FG001|NOT COMPLETED|Overall Study||1
6813062|NCT01711541|7746209|FG002|NOT COMPLETED|Overall Study||0
6813063|NCT01711541|7746210|FG003|NOT COMPLETED|Overall Study||1
6813064|NCT01711541|7746211|FG004|NOT COMPLETED|Overall Study||0
6813065|NCT01670539|7746228|FG000|STARTED|Overall Study||26
6813066|NCT01670539|7746229|FG001|STARTED|Overall Study||21
6813067|NCT01670539|7746228|FG000|COMPLETED|Overall Study||20
6813068|NCT01670539|7746229|FG001|COMPLETED|Overall Study||16
6813069|NCT01670539|7746228|FG000|NOT COMPLETED|Overall Study||6
6813070|NCT01670539|7746229|FG001|NOT COMPLETED|Overall Study||5
6813071|NCT00407602|7746236|FG000|STARTED|Overall Study||30
6813072|NCT00407602|7746236|FG000|COMPLETED|Overall Study||23
6813073|NCT00407602|7746236|FG000|NOT COMPLETED|Overall Study||7
6813074|NCT00345345|7746243|FG000|STARTED|Overall Study||29
6813075|NCT00345345|7746243|FG000|COMPLETED|Overall Study||27
6813076|NCT00345345|7746243|FG000|NOT COMPLETED|Overall Study||2
6813077|NCT05143541|7746247|FG000|STARTED|Overall Study||80
6813078|NCT05143541|7746247|FG000|COMPLETED|Overall Study||80
6813079|NCT05143541|7746247|FG000|NOT COMPLETED|Overall Study||0
6813080|NCT04685213|7746253|FG000|STARTED|Overall Study||9
6813081|NCT04685213|7746254|FG001|STARTED|Overall Study||10
6567686|NCT01832506|7490833|FG001|STARTED|Overall Study||3
6567687|NCT01832506|7490834|FG002|STARTED|Overall Study||6
6813082|NCT04685213|7746253|FG000|COMPLETED|Overall Study||8
6813083|NCT04685213|7746254|FG001|COMPLETED|Overall Study||7
6813084|NCT04685213|7746253|FG000|NOT COMPLETED|Overall Study||1
6813085|NCT04685213|7746254|FG001|NOT COMPLETED|Overall Study||3
6813086|NCT04567186|7746260|FG000|STARTED|Period 1||38
6813087|NCT04567186|7746261|FG001|STARTED|Period 1||40
6813088|NCT04567186|7746260|FG000|COMPLETED|Period 1||37
6813089|NCT04567186|7746261|FG001|COMPLETED|Period 1||37
6813090|NCT04567186|7746260|FG000|NOT COMPLETED|Period 1||1
6813091|NCT04567186|7746261|FG001|NOT COMPLETED|Period 1||3
6813092|NCT04567186|7746260|FG000|STARTED|Period 2||37
6813093|NCT04567186|7746261|FG001|STARTED|Period 2||37
6813094|NCT04567186|7746260|FG000|COMPLETED|Period 2||37
6813095|NCT04567186|7746261|FG001|COMPLETED|Period 2||34
6813096|NCT04567186|7746260|FG000|NOT COMPLETED|Period 2||0
6813097|NCT04567186|7746261|FG001|NOT COMPLETED|Period 2||3
6813098|NCT04567186|7746260|FG000|STARTED|Period 3||37
6813099|NCT04567186|7746261|FG001|STARTED|Period 3||34
6813100|NCT04567186|7746260|FG000|COMPLETED|Period 3||36
6813101|NCT04567186|7746261|FG001|COMPLETED|Period 3||34
6813102|NCT04567186|7746260|FG000|NOT COMPLETED|Period 3||1
6813103|NCT04567186|7746261|FG001|NOT COMPLETED|Period 3||0
6813104|NCT04190693|7746271|FG000|STARTED|Overall Study||4
6813105|NCT04190693|7746272|FG001|STARTED|Overall Study||7
6813106|NCT04190693|7746273|FG002|STARTED|Overall Study||12
6813107|NCT04190693|7746274|FG003|STARTED|Overall Study||7
6813108|NCT04190693|7746271|FG000|COMPLETED|Overall Study||4
6813109|NCT04190693|7746272|FG001|COMPLETED|Overall Study||7
6813110|NCT04190693|7746273|FG002|COMPLETED|Overall Study||12
6813111|NCT04190693|7746274|FG003|COMPLETED|Overall Study||7
6813112|NCT04190693|7746271|FG000|NOT COMPLETED|Overall Study||0
6813113|NCT04190693|7746272|FG001|NOT COMPLETED|Overall Study||0
6813114|NCT04190693|7746273|FG002|NOT COMPLETED|Overall Study||0
6813115|NCT04190693|7746274|FG003|NOT COMPLETED|Overall Study||0
6813116|NCT04065074|7746284|FG000|STARTED|Overall Study||16
6813117|NCT04065074|7746284|FG000|COMPLETED|Overall Study||14
6813118|NCT04065074|7746284|FG000|NOT COMPLETED|Overall Study||2
6813119|NCT03980730|7746290|FG000|STARTED|Overall Study||21
6813120|NCT03980730|7746291|FG001|STARTED|Overall Study||22
6813121|NCT03980730|7746290|FG000|COMPLETED|Overall Study||19
6813122|NCT03980730|7746291|FG001|COMPLETED|Overall Study||18
6813123|NCT03980730|7746290|FG000|NOT COMPLETED|Overall Study||2
6813124|NCT03980730|7746291|FG001|NOT COMPLETED|Overall Study||4
6813125|NCT03793010|7746299|FG000|STARTED|Overall Study||35
6813126|NCT03793010|7746300|FG001|STARTED|Overall Study||35
6813127|NCT03793010|7746299|FG000|Randomized But Not Dosed|Overall Study||2
6813128|NCT03793010|7746300|FG001|Randomized But Not Dosed|Overall Study||0
6813129|NCT03793010|7746299|FG000|COMPLETED|Overall Study||7
6813130|NCT03793010|7746300|FG001|COMPLETED|Overall Study||8
6813131|NCT03793010|7746299|FG000|NOT COMPLETED|Overall Study||28
6813132|NCT03793010|7746300|FG001|NOT COMPLETED|Overall Study||27
6813133|NCT03644017|7746306|FG000|STARTED|Overall Study||46
6813134|NCT03644017|7746306|FG000|COMPLETED|Overall Study||39
6813135|NCT03644017|7746306|FG000|NOT COMPLETED|Overall Study||7
6813136|NCT03592186|7746312|FG000|STARTED|Overall Study||60
6813137|NCT03592186|7746313|FG001|STARTED|Overall Study||62
6813138|NCT03592186|7746312|FG000|6-week Follow-up|Overall Study||49
6813139|NCT03592186|7746313|FG001|6-week Follow-up|Overall Study||56
6813140|NCT03592186|7746312|FG000|12-week Follow-up|Overall Study||47
6813141|NCT03592186|7746313|FG001|12-week Follow-up|Overall Study||51
6813142|NCT03592186|7746312|FG000|COMPLETED|Overall Study||43
6813143|NCT03592186|7746313|FG001|COMPLETED|Overall Study||51
6813144|NCT03592186|7746312|FG000|NOT COMPLETED|Overall Study||17
6813145|NCT03592186|7746313|FG001|NOT COMPLETED|Overall Study||11
6813146|NCT03529942|7746319|FG000|STARTED|Overall Study||129
6813147|NCT03529942|7746319|FG000|Reached Week 6 With Paired MRI|Overall Study||108
6813148|NCT03529942|7746319|FG000|COMPLETED|Overall Study||106
6813149|NCT03529942|7746319|FG000|NOT COMPLETED|Overall Study||23
6813150|NCT03373760|7746328|FG000|STARTED|Overall Study||58
6813151|NCT03373760|7746328|FG000|COMPLETED|Overall Study||0
6813152|NCT03373760|7746328|FG000|NOT COMPLETED|Overall Study||58
6813153|NCT03349775|7746337|FG000|STARTED|Overall Study||10
6813154|NCT03349775|7746338|FG001|STARTED|Overall Study||11
6813155|NCT03349775|7746337|FG000|COMPLETED|Overall Study||8
6813156|NCT03349775|7746338|FG001|COMPLETED|Overall Study||7
6813157|NCT03349775|7746337|FG000|NOT COMPLETED|Overall Study||2
6813158|NCT03349775|7746338|FG001|NOT COMPLETED|Overall Study||4
6813159|NCT03292471|7746346|FG000|STARTED|Overall Study||8
6813160|NCT03292471|7746347|FG001|STARTED|Overall Study||8
6813161|NCT03292471|7746346|FG000|COMPLETED|Overall Study||8
6813162|NCT03292471|7746347|FG001|COMPLETED|Overall Study||8
6813163|NCT03292471|7746346|FG000|NOT COMPLETED|Overall Study||0
6567688|NCT01832506|7490832|FG000|COMPLETED|Overall Study||3
6567689|NCT01832506|7490833|FG001|COMPLETED|Overall Study||3
6813164|NCT03292471|7746347|FG001|NOT COMPLETED|Overall Study||0
6813165|NCT03256344|7746355|FG000|STARTED|Overall Study||11
6813166|NCT03256344|7746356|FG001|STARTED|Overall Study||25
6813167|NCT03256344|7746355|FG000|Received Talimogene Laherparepvec|Overall Study||8
6813168|NCT03256344|7746356|FG001|Received Talimogene Laherparepvec|Overall Study||23
6813169|NCT03256344|7746355|FG000|Received Atezolizumab|Overall Study||10
6813170|NCT03256344|7746356|FG001|Received Atezolizumab|Overall Study||24
6813171|NCT03256344|7746355|FG000|COMPLETED|Overall Study||0
6813172|NCT03256344|7746356|FG001|COMPLETED|Overall Study||0
6813173|NCT03256344|7746355|FG000|NOT COMPLETED|Overall Study||11
6813174|NCT03256344|7746356|FG001|NOT COMPLETED|Overall Study||25
6567690|NCT01832506|7490834|FG002|COMPLETED|Overall Study||6
6567691|NCT01832506|7490832|FG000|NOT COMPLETED|Overall Study||0
6813175|NCT03207815|7746364|FG000|STARTED|Overall Study||38
6813176|NCT03207815|7746365|FG001|STARTED|Overall Study||36
6813177|NCT03207815|7746364|FG000|COMPLETED|Overall Study||30
6813178|NCT03207815|7746365|FG001|COMPLETED|Overall Study||29
6813179|NCT03207815|7746364|FG000|NOT COMPLETED|Overall Study||8
6813180|NCT03207815|7746365|FG001|NOT COMPLETED|Overall Study||7
6813181|NCT03077737|7746373|FG000|STARTED|Week 6 (10 Weeks After Enrollment)||97
6813182|NCT03077737|7746374|FG001|STARTED|Week 6 (10 Weeks After Enrollment)||93
6813183|NCT03077737|7746373|FG000|COMPLETED|Week 6 (10 Weeks After Enrollment)||89
6813184|NCT03077737|7746374|FG001|COMPLETED|Week 6 (10 Weeks After Enrollment)||79
6813185|NCT03077737|7746373|FG000|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||8
6813186|NCT03077737|7746374|FG001|NOT COMPLETED|Week 6 (10 Weeks After Enrollment)||14
6813187|NCT03077737|7746373|FG000|STARTED|Week 14 (18 Weeks After Enrollment)||97
6813188|NCT03077737|7746374|FG001|STARTED|Week 14 (18 Weeks After Enrollment)||93
6813189|NCT03077737|7746373|FG000|COMPLETED|Week 14 (18 Weeks After Enrollment)||83
6813190|NCT03077737|7746374|FG001|COMPLETED|Week 14 (18 Weeks After Enrollment)||76
6813191|NCT03077737|7746373|FG000|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||14
6813192|NCT03077737|7746374|FG001|NOT COMPLETED|Week 14 (18 Weeks After Enrollment)||17
6813193|NCT03077737|7746373|FG000|STARTED|Week 28 (32 Weeks After Enrollment)||49
6813194|NCT03077737|7746374|FG001|STARTED|Week 28 (32 Weeks After Enrollment)||47
6813195|NCT03077737|7746373|FG000|COMPLETED|Week 28 (32 Weeks After Enrollment)||39
6813196|NCT03077737|7746374|FG001|COMPLETED|Week 28 (32 Weeks After Enrollment)||40
6813197|NCT03077737|7746373|FG000|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||10
6813198|NCT03077737|7746374|FG001|NOT COMPLETED|Week 28 (32 Weeks After Enrollment)||7
6813199|NCT02991937|7746382|FG000|STARTED|Overall Study||20
6813200|NCT02991937|7746383|FG001|STARTED|Overall Study||19
6813201|NCT02991937|7746382|FG000|COMPLETED|Overall Study||20
6813202|NCT02991937|7746383|FG001|COMPLETED|Overall Study||19
6813203|NCT02991937|7746382|FG000|NOT COMPLETED|Overall Study||0
6813204|NCT02991937|7746383|FG001|NOT COMPLETED|Overall Study||0
6813205|NCT02968563|7746391|FG000|STARTED|Overall Study||5
6813206|NCT02968563|7746392|FG001|STARTED|Overall Study||30
6813207|NCT02968563|7746391|FG000|COMPLETED|Overall Study||4
6813208|NCT02968563|7746392|FG001|COMPLETED|Overall Study||22
6813209|NCT02968563|7746391|FG000|NOT COMPLETED|Overall Study||1
6813210|NCT02968563|7746392|FG001|NOT COMPLETED|Overall Study||8
6813211|NCT02915783|7746398|FG000|STARTED|Overall Study||31
6813212|NCT02915783|7746398|FG000|COMPLETED|Overall Study||17
6567692|NCT01832506|7490833|FG001|NOT COMPLETED|Overall Study||0
6567693|NCT01832506|7490834|FG002|NOT COMPLETED|Overall Study||0
6567694|NCT01832532|7490849|FG000|STARTED|Overall Study||23
6567695|NCT01832532|7490850|FG001|STARTED|Overall Study||11
6567696|NCT01832532|7490849|FG000|COMPLETED|Overall Study||18
6567697|NCT01832532|7490850|FG001|COMPLETED|Overall Study||9
6657053|NCT02466087|7587350|FG001|STARTED|Second Intervention: Weeks 7-12||57
6657054|NCT02466087|7587349|FG000|COMPLETED|Second Intervention: Weeks 7-12||55
6657055|NCT02466087|7587350|FG001|COMPLETED|Second Intervention: Weeks 7-12||57
6657056|NCT02466087|7587349|FG000|NOT COMPLETED|Second Intervention: Weeks 7-12||0
6657057|NCT02466087|7587350|FG001|NOT COMPLETED|Second Intervention: Weeks 7-12||0
6657058|NCT02466126|7587359|FG000|STARTED|Baseline||109
6657059|NCT02466126|7587360|FG001|STARTED|Baseline||80
6657060|NCT02466126|7587359|FG000|COMPLETED|Baseline||109
6657061|NCT02466126|7587360|FG001|COMPLETED|Baseline||80
6657062|NCT02466126|7587359|FG000|NOT COMPLETED|Baseline||0
6657063|NCT02466126|7587360|FG001|NOT COMPLETED|Baseline||0
6657064|NCT02466126|7587359|FG000|STARTED|4 Month Assessment||109
6657065|NCT02466126|7587360|FG001|STARTED|4 Month Assessment||80
6657066|NCT02466126|7587359|FG000|COMPLETED|4 Month Assessment||93
6657067|NCT02466126|7587360|FG001|COMPLETED|4 Month Assessment||71
6657068|NCT02466126|7587359|FG000|NOT COMPLETED|4 Month Assessment||16
6657069|NCT02466126|7587360|FG001|NOT COMPLETED|4 Month Assessment||9
6657070|NCT02466126|7587359|FG000|STARTED|8 Month Assessment||93
6657071|NCT02466126|7587360|FG001|STARTED|8 Month Assessment||71
6813213|NCT02915783|7746398|FG000|NOT COMPLETED|Overall Study||14
6813214|NCT02913482|7746405|FG000|STARTED|Overall Study||4
6813215|NCT02913482|7746406|FG001|STARTED|Overall Study||17
6567698|NCT01832532|7490849|FG000|NOT COMPLETED|Overall Study||5
6567699|NCT01832532|7490850|FG001|NOT COMPLETED|Overall Study||2
6567700|NCT01832610|7490856|FG000|STARTED|Overall Study||101
6567701|NCT01832610|7490856|FG000|COMPLETED|Overall Study||97
6567702|NCT01832610|7490856|FG000|NOT COMPLETED|Overall Study||4
6567703|NCT01832727|7490869|FG000|STARTED|Overall Study||9
6567704|NCT01832727|7490870|FG001|STARTED|Overall Study||7
6657072|NCT02466126|7587359|FG000|COMPLETED|8 Month Assessment||86
6657073|NCT02466126|7587360|FG001|COMPLETED|8 Month Assessment||68
6657074|NCT02466126|7587359|FG000|NOT COMPLETED|8 Month Assessment||7
6657075|NCT02466126|7587360|FG001|NOT COMPLETED|8 Month Assessment||3
6657076|NCT02466126|7587359|FG000|STARTED|12 Month Assessment||86
6657077|NCT02466126|7587360|FG001|STARTED|12 Month Assessment||68
6567705|NCT01832727|7490871|FG002|STARTED|Overall Study||3
6567706|NCT01832727|7490872|FG003|STARTED|Overall Study||4
6567707|NCT01832727|7490873|FG004|STARTED|Overall Study||4
6567708|NCT01832727|7490874|FG005|STARTED|Overall Study||6
6567709|NCT01832727|7490875|FG006|STARTED|Overall Study||8
6567710|NCT01832727|7490876|FG007|STARTED|Overall Study||6
6567711|NCT01832727|7490877|FG008|STARTED|Overall Study||18
6567712|NCT01832727|7490869|FG000|COMPLETED|Overall Study||0
6813216|NCT02913482|7746407|FG002|STARTED|Overall Study||41
6813217|NCT02913482|7746405|FG000|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|3
6813218|NCT02913482|7746406|FG001|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|14
6813219|NCT02913482|7746407|FG002|COMPLETED|Overall Study|Participants remaining in the study at CCOD of 12 Nov 2020|38
6813220|NCT02913482|7746405|FG000|NOT COMPLETED|Overall Study||1
6813221|NCT02913482|7746406|FG001|NOT COMPLETED|Overall Study||3
6813222|NCT02913482|7746407|FG002|NOT COMPLETED|Overall Study||3
6813223|NCT02787044|7746419|FG000|STARTED|Overall Study||2630
6813224|NCT02787044|7746420|FG001|STARTED|Overall Study||2630
6813225|NCT02787044|7746419|FG000|COMPLETED|Overall Study||2615
6813226|NCT02787044|7746420|FG001|COMPLETED|Overall Study||2611
6813227|NCT02787044|7746419|FG000|NOT COMPLETED|Overall Study||15
6813228|NCT02787044|7746420|FG001|NOT COMPLETED|Overall Study||19
6813229|NCT02698163|7746432|FG000|STARTED|Overall Study||1
6813230|NCT02698163|7746433|FG001|STARTED|Overall Study||3
6813231|NCT02698163|7746432|FG000|COMPLETED|Overall Study||1
6813232|NCT02698163|7746433|FG001|COMPLETED|Overall Study||2
6813233|NCT02698163|7746432|FG000|NOT COMPLETED|Overall Study||0
6813234|NCT02698163|7746433|FG001|NOT COMPLETED|Overall Study||1
6813235|NCT02586675|7746439|FG000|STARTED|Overall Study||7
6813236|NCT02586675|7746439|FG000|COMPLETED|Overall Study||7
6813237|NCT02586675|7746439|FG000|NOT COMPLETED|Overall Study||0
6813238|NCT02367105|7746445|FG000|STARTED|Overall Study||41
6813239|NCT02367105|7746446|FG001|STARTED|Overall Study||42
6813240|NCT02367105|7746445|FG000|COMPLETED|Overall Study||36
6813241|NCT02367105|7746446|FG001|COMPLETED|Overall Study||34
6813242|NCT02367105|7746445|FG000|NOT COMPLETED|Overall Study||5
6813243|NCT02367105|7746446|FG001|NOT COMPLETED|Overall Study||8
6813244|NCT02352948|7746464|FG000|STARTED|Overall Study||62
6813245|NCT02352948|7746465|FG001|STARTED|Overall Study||64
6813246|NCT02352948|7746466|FG002|STARTED|Overall Study||174
6813247|NCT02352948|7746467|FG003|STARTED|Overall Study||118
6813248|NCT02352948|7746468|FG004|STARTED|Overall Study||117
6567713|NCT01832727|7490870|FG001|COMPLETED|Overall Study||0
6813249|NCT02352948|7746469|FG005|STARTED|Overall Study||60
6813250|NCT02352948|7746464|FG000|Received Treatment|Overall Study||62
6813251|NCT02352948|7746465|FG001|Received Treatment|Overall Study||63
6813252|NCT02352948|7746466|FG002|Received Treatment|Overall Study||173
6813253|NCT02352948|7746467|FG003|Received Treatment|Overall Study||110
6813254|NCT02352948|7746468|FG004|Received Treatment|Overall Study||117
6813255|NCT02352948|7746469|FG005|Received Treatment|Overall Study||60
6813256|NCT02352948|7746464|FG000|Completed Study Treatment|Overall Study||15
6813257|NCT02352948|7746465|FG001|Completed Study Treatment|Overall Study||0
6813258|NCT02352948|7746466|FG002|Completed Study Treatment|Overall Study||36
6390936|NCT00833248|7302764|FG001|STARTED|Overall Study||65
6390937|NCT00833248|7302763|FG000|Full Analysis Set (FAS)|Overall Study||180
6390938|NCT00833248|7302764|FG001|Full Analysis Set (FAS)|Overall Study||64
6390939|NCT00833248|7302763|FG000|Per Protocol (PP) Analysis Set|Overall Study||164
6390940|NCT00833248|7302764|FG001|Per Protocol (PP) Analysis Set|Overall Study||57
6390941|NCT00833248|7302763|FG000|Safety Analysis Set|Overall Study||181
6390942|NCT00833248|7302764|FG001|Safety Analysis Set|Overall Study||64
6390943|NCT00833248|7302763|FG000|COMPLETED|Overall Study||177
6390944|NCT00833248|7302764|FG001|COMPLETED|Overall Study||62
6390945|NCT00833248|7302763|FG000|NOT COMPLETED|Overall Study||4
6390946|NCT00833248|7302764|FG001|NOT COMPLETED|Overall Study||3
6390947|NCT00833261|7302770|FG000|STARTED|Overall Study||37
6390948|NCT00833261|7302770|FG000|COMPLETED|Overall Study|3 patients withdrew from the study prior to treatment & 1 receiving it did not complete the course.|33
6390949|NCT00833261|7302770|FG000|NOT COMPLETED|Overall Study||4
6390950|NCT00833365|7302776|FG000|STARTED|Overall Study||9
6390951|NCT00833365|7302777|FG001|STARTED|Overall Study||6
6390952|NCT00833365|7302776|FG000|COMPLETED|Overall Study||9
6390953|NCT00833365|7302777|FG001|COMPLETED|Overall Study||6
6390954|NCT00833365|7302776|FG000|NOT COMPLETED|Overall Study||0
6390955|NCT00833365|7302777|FG001|NOT COMPLETED|Overall Study||0
6390956|NCT00833417|7302785|FG000|STARTED|Overall Study||33
6390957|NCT00833417|7302786|FG001|STARTED|Overall Study||71
6390958|NCT00833417|7302785|FG000|COMPLETED|Overall Study||0
6390959|NCT00833417|7302786|FG001|COMPLETED|Overall Study||0
6390960|NCT00833417|7302785|FG000|NOT COMPLETED|Overall Study||33
6390961|NCT00833417|7302786|FG001|NOT COMPLETED|Overall Study||71
6390962|NCT00833443|7302795|FG000|STARTED|Overall Study||41
6390963|NCT00833443|7302796|FG001|STARTED|Overall Study||43
6390964|NCT00833443|7302795|FG000|COMPLETED|Overall Study||21
6390965|NCT00833443|7302796|FG001|COMPLETED|Overall Study||15
6390966|NCT00833443|7302795|FG000|NOT COMPLETED|Overall Study||20
6390967|NCT00833443|7302796|FG001|NOT COMPLETED|Overall Study||28
6390968|NCT00833469|7302804|FG000|STARTED|Overall Study||5
6390969|NCT00833469|7302804|FG000|COMPLETED|Overall Study||3
6390970|NCT00833469|7302804|FG000|NOT COMPLETED|Overall Study||2
6390971|NCT00833482|7302810|FG000|STARTED|Days 1-3|Participants who received treatment|24
6390972|NCT00833482|7302811|FG001|STARTED|Days 1-3|Participants who received treatment|0
6390973|NCT00833482|7302812|FG002|STARTED|Days 1-3||0
6390974|NCT00833482|7302813|FG003|STARTED|Days 1-3||8
6504756|NCT01449682|7423787|FG000|STARTED|Overall Study||5
6567714|NCT01832727|7490871|FG002|COMPLETED|Overall Study||0
6813259|NCT02352948|7746467|FG003|Completed Study Treatment|Overall Study||0
6813260|NCT02352948|7746468|FG004|Completed Study Treatment|Overall Study||23
6813261|NCT02352948|7746469|FG005|Completed Study Treatment|Overall Study||4
6390975|NCT00833482|7302814|FG004|STARTED|Days 1-3||0
6390976|NCT00833482|7302815|FG005|STARTED|Days 1-3||0
6390977|NCT00833482|7302810|FG000|COMPLETED|Days 1-3||24
6390978|NCT00833482|7302811|FG001|COMPLETED|Days 1-3||0
6390979|NCT00833482|7302812|FG002|COMPLETED|Days 1-3||0
6390980|NCT00833482|7302813|FG003|COMPLETED|Days 1-3||8
6390981|NCT00833482|7302814|FG004|COMPLETED|Days 1-3||0
6390982|NCT00833482|7302815|FG005|COMPLETED|Days 1-3||0
6390983|NCT00833482|7302810|FG000|NOT COMPLETED|Days 1-3||0
6390984|NCT00833482|7302811|FG001|NOT COMPLETED|Days 1-3||0
6390985|NCT00833482|7302812|FG002|NOT COMPLETED|Days 1-3||0
6390986|NCT00833482|7302813|FG003|NOT COMPLETED|Days 1-3||0
6390987|NCT00833482|7302814|FG004|NOT COMPLETED|Days 1-3||0
6390988|NCT00833482|7302815|FG005|NOT COMPLETED|Days 1-3||0
6390989|NCT00833482|7302810|FG000|STARTED|Days 11-20||0
6390990|NCT00833482|7302811|FG001|STARTED|Days 11-20|Participants who received treatment.|24
6390991|NCT00833482|7302812|FG002|STARTED|Days 11-20||0
6390992|NCT00833482|7302813|FG003|STARTED|Days 11-20||0
6390993|NCT00833482|7302814|FG004|STARTED|Days 11-20||0
6390994|NCT00833482|7302815|FG005|STARTED|Days 11-20|Participants who received treatment.|8
6390995|NCT00833482|7302810|FG000|COMPLETED|Days 11-20||0
6390996|NCT00833482|7302811|FG001|COMPLETED|Days 11-20||21
6390997|NCT00833482|7302812|FG002|COMPLETED|Days 11-20||0
6390998|NCT00833482|7302813|FG003|COMPLETED|Days 11-20||0
6390999|NCT00833482|7302814|FG004|COMPLETED|Days 11-20||0
6391000|NCT00833482|7302815|FG005|COMPLETED|Days 11-20||8
6391001|NCT00833482|7302810|FG000|NOT COMPLETED|Days 11-20||0
6391002|NCT00833482|7302811|FG001|NOT COMPLETED|Days 11-20||3
6391003|NCT00833482|7302812|FG002|NOT COMPLETED|Days 11-20||0
6391004|NCT00833482|7302813|FG003|NOT COMPLETED|Days 11-20||0
6391005|NCT00833482|7302814|FG004|NOT COMPLETED|Days 11-20||0
6813262|NCT02352948|7746464|FG000|COMPLETED|Overall Study||13
6813263|NCT02352948|7746465|FG001|COMPLETED|Overall Study||5
6813264|NCT02352948|7746466|FG002|COMPLETED|Overall Study||45
6813265|NCT02352948|7746467|FG003|COMPLETED|Overall Study||19
6813266|NCT02352948|7746468|FG004|COMPLETED|Overall Study||29
6813267|NCT02352948|7746469|FG005|COMPLETED|Overall Study||11
6813268|NCT02352948|7746464|FG000|NOT COMPLETED|Overall Study||49
6813269|NCT02352948|7746465|FG001|NOT COMPLETED|Overall Study||59
6813270|NCT02352948|7746466|FG002|NOT COMPLETED|Overall Study||129
6813271|NCT02352948|7746467|FG003|NOT COMPLETED|Overall Study||99
6813272|NCT02352948|7746468|FG004|NOT COMPLETED|Overall Study||88
6813273|NCT02352948|7746469|FG005|NOT COMPLETED|Overall Study||49
6813274|NCT01816165|7746491|FG000|STARTED|Overall Study||5
6813275|NCT01816165|7746492|FG001|STARTED|Overall Study||4
6813276|NCT01816165|7746493|FG002|STARTED|Overall Study||5
6813277|NCT01816165|7746494|FG003|STARTED|Overall Study||4
6813278|NCT01816165|7746491|FG000|Completed Intervention 1|Overall Study||4
6813279|NCT01816165|7746492|FG001|Completed Intervention 1|Overall Study||4
6813280|NCT01816165|7746493|FG002|Completed Intervention 1|Overall Study||5
6813281|NCT01816165|7746494|FG003|Completed Intervention 1|Overall Study||4
6813282|NCT01816165|7746491|FG000|Completed ~2 Week Washout|Overall Study||4
6813283|NCT01816165|7746492|FG001|Completed ~2 Week Washout|Overall Study||4
6813284|NCT01816165|7746493|FG002|Completed ~2 Week Washout|Overall Study||5
6813285|NCT01816165|7746494|FG003|Completed ~2 Week Washout|Overall Study||4
6813286|NCT01816165|7746491|FG000|Started Second Intervention|Overall Study||4
6813287|NCT01816165|7746492|FG001|Started Second Intervention|Overall Study||4
6813288|NCT01816165|7746493|FG002|Started Second Intervention|Overall Study||5
6813289|NCT01816165|7746494|FG003|Started Second Intervention|Overall Study||4
6813290|NCT01816165|7746491|FG000|COMPLETED|Overall Study||4
6813291|NCT01816165|7746492|FG001|COMPLETED|Overall Study||4
6813292|NCT01816165|7746493|FG002|COMPLETED|Overall Study||5
6813293|NCT01816165|7746494|FG003|COMPLETED|Overall Study||4
6813294|NCT01816165|7746491|FG000|NOT COMPLETED|Overall Study||1
6813295|NCT01816165|7746492|FG001|NOT COMPLETED|Overall Study||0
6813296|NCT01816165|7746493|FG002|NOT COMPLETED|Overall Study||0
6813297|NCT01816165|7746494|FG003|NOT COMPLETED|Overall Study||0
6813298|NCT01813929|7746516|FG000|STARTED|Overall Study||5
6813299|NCT01813929|7746517|FG001|STARTED|Overall Study||12
6391006|NCT00833482|7302815|FG005|NOT COMPLETED|Days 11-20||0
6391007|NCT00833482|7302810|FG000|STARTED|Days 21-30||0
6391008|NCT00833482|7302811|FG001|STARTED|Days 21-30||0
6391009|NCT00833482|7302812|FG002|STARTED|Days 21-30||21
6391010|NCT00833482|7302813|FG003|STARTED|Days 21-30||0
6391011|NCT00833482|7302814|FG004|STARTED|Days 21-30||8
6391012|NCT00833482|7302815|FG005|STARTED|Days 21-30||0
6813300|NCT01813929|7746516|FG000|Completed Intervention 1|Overall Study||5
6813301|NCT01813929|7746517|FG001|Completed Intervention 1|Overall Study||12
6813302|NCT01813929|7746516|FG000|Completed Washout (2weeks up to 2 Months)|Overall Study||5
6813303|NCT01813929|7746517|FG001|Completed Washout (2weeks up to 2 Months)|Overall Study||11
6813304|NCT01813929|7746516|FG000|Started Intervention 2|Overall Study||5
6813305|NCT01813929|7746517|FG001|Started Intervention 2|Overall Study||11
6813306|NCT01813929|7746516|FG000|COMPLETED|Overall Study||5
6813307|NCT01813929|7746517|FG001|COMPLETED|Overall Study||11
6813308|NCT01813929|7746516|FG000|NOT COMPLETED|Overall Study||0
6813309|NCT01813929|7746517|FG001|NOT COMPLETED|Overall Study||1
6813310|NCT01502085|7746523|FG000|STARTED|Overall Study||25
6813311|NCT01502085|7746523|FG000|COMPLETED|Overall Study||25
6813312|NCT01502085|7746523|FG000|NOT COMPLETED|Overall Study||0
6813313|NCT01178814|7746527|FG000|STARTED|Overall Study||57
6813314|NCT01178814|7746527|FG000|COMPLETED|Overall Study||57
6813315|NCT01178814|7746527|FG000|NOT COMPLETED|Overall Study||0
6813316|NCT01125176|7746531|FG000|STARTED|Treatment Phase||14
6813317|NCT01125176|7746531|FG000|COMPLETED|Treatment Phase||13
6813318|NCT01125176|7746531|FG000|NOT COMPLETED|Treatment Phase||1
6813319|NCT01125176|7746531|FG000|STARTED|Post-treatment Follow-up Phase||13
6813320|NCT01125176|7746531|FG000|COMPLETED|Post-treatment Follow-up Phase||2
6813321|NCT01125176|7746531|FG000|NOT COMPLETED|Post-treatment Follow-up Phase||11
6813322|NCT00882050|7746538|FG000|STARTED|Overall Study||32
6813323|NCT00882050|7746539|FG001|STARTED|Overall Study||33
6813324|NCT00882050|7746540|FG002|STARTED|Overall Study||39
6813325|NCT00882050|7746538|FG000|COMPLETED|Overall Study||31
6813326|NCT00882050|7746539|FG001|COMPLETED|Overall Study||33
6813327|NCT00882050|7746540|FG002|COMPLETED|Overall Study||39
6813328|NCT00882050|7746538|FG000|NOT COMPLETED|Overall Study||1
6813329|NCT00882050|7746539|FG001|NOT COMPLETED|Overall Study||0
6813330|NCT00882050|7746540|FG002|NOT COMPLETED|Overall Study||0
6813331|NCT00070564|7746554|FG000|STARTED|Overall Study||678
6813332|NCT00070564|7746555|FG001|STARTED|Overall Study||693
6813333|NCT00070564|7746556|FG002|STARTED|Overall Study||697
6813334|NCT00070564|7746557|FG003|STARTED|Overall Study||648
6813335|NCT00070564|7746558|FG004|STARTED|Overall Study||282
6813336|NCT00070564|7746559|FG005|STARTED|Overall Study||296
6813337|NCT00070564|7746554|FG000|COMPLETED|Overall Study||478
6813338|NCT00070564|7746555|FG001|COMPLETED|Overall Study||490
6813339|NCT00070564|7746556|FG002|COMPLETED|Overall Study||526
6813340|NCT00070564|7746557|FG003|COMPLETED|Overall Study||481
6813341|NCT00070564|7746558|FG004|COMPLETED|Overall Study||203
6813342|NCT00070564|7746559|FG005|COMPLETED|Overall Study||244
6813343|NCT00070564|7746554|FG000|NOT COMPLETED|Overall Study||200
6813344|NCT00070564|7746555|FG001|NOT COMPLETED|Overall Study||203
6813345|NCT00070564|7746556|FG002|NOT COMPLETED|Overall Study||171
6813346|NCT00070564|7746557|FG003|NOT COMPLETED|Overall Study||167
6813347|NCT00070564|7746558|FG004|NOT COMPLETED|Overall Study||79
6813348|NCT00070564|7746559|FG005|NOT COMPLETED|Overall Study||52
6567715|NCT01832727|7490872|FG003|COMPLETED|Overall Study||0
6813349|NCT05167370|7746579|FG000|STARTED|Overall Study||2
6813350|NCT05167370|7746579|FG000|COMPLETED|Overall Study||2
6813351|NCT05167370|7746579|FG000|NOT COMPLETED|Overall Study||0
6813352|NCT04500821|7746583|FG000|STARTED|Overall Study||44
6813353|NCT04500821|7746583|FG000|COMPLETED|Overall Study||44
6813354|NCT04500821|7746583|FG000|NOT COMPLETED|Overall Study||0
6813355|NCT04425720|7746590|FG000|STARTED|Overall Study||150
6813356|NCT04425720|7746591|FG001|STARTED|Overall Study||150
6813357|NCT04425720|7746590|FG000|COMPLETED|Overall Study||150
6813358|NCT04425720|7746591|FG001|COMPLETED|Overall Study||130
6813359|NCT04425720|7746590|FG000|NOT COMPLETED|Overall Study||0
6813360|NCT04425720|7746591|FG001|NOT COMPLETED|Overall Study||20
6813361|NCT04409509|7746600|FG000|STARTED|Overall Study||61
6567716|NCT01832727|7490873|FG004|COMPLETED|Overall Study||0
6567717|NCT01832727|7490874|FG005|COMPLETED|Overall Study||0
6813362|NCT04409509|7746601|FG001|STARTED|Overall Study||63
6813363|NCT04409509|7746600|FG000|COMPLETED|Overall Study||48
6813364|NCT04409509|7746601|FG001|COMPLETED|Overall Study||43
6813365|NCT04409509|7746600|FG000|NOT COMPLETED|Overall Study||13
6813366|NCT04409509|7746601|FG001|NOT COMPLETED|Overall Study||20
6813367|NCT04380519|7746611|FG000|STARTED|Overall Study||124
6813368|NCT04380519|7746612|FG001|STARTED|Overall Study||124
6813369|NCT04380519|7746613|FG002|STARTED|Overall Study||124
6813370|NCT04380519|7746611|FG000|Intent-to-Treat (ITT)|Overall Study||124
6813371|NCT04380519|7746612|FG001|Intent-to-Treat (ITT)|Overall Study||124
6813372|NCT04380519|7746613|FG002|Intent-to-Treat (ITT)|Overall Study||124
6567718|NCT01832727|7490875|FG006|COMPLETED|Overall Study||0
6567719|NCT01832727|7490876|FG007|COMPLETED|Overall Study||0
6813373|NCT04380519|7746611|FG000|Modified Intent-to-Treat (mITT)|Overall Study||115
6813374|NCT04380519|7746612|FG001|Modified Intent-to-Treat (mITT)|Overall Study||119
6813375|NCT04380519|7746613|FG002|Modified Intent-to-Treat (mITT)|Overall Study||118
6813376|NCT04380519|7746611|FG000|Safety Population|Overall Study||123
6813377|NCT04380519|7746612|FG001|Safety Population|Overall Study||124
6813378|NCT04380519|7746613|FG002|Safety Population|Overall Study||124
6813379|NCT04380519|7746611|FG000|COMPLETED|Overall Study||106
6813380|NCT04380519|7746612|FG001|COMPLETED|Overall Study||113
6813381|NCT04380519|7746613|FG002|COMPLETED|Overall Study||117
6813382|NCT04380519|7746611|FG000|NOT COMPLETED|Overall Study||18
6813383|NCT04380519|7746612|FG001|NOT COMPLETED|Overall Study||11
6813384|NCT04380519|7746613|FG002|NOT COMPLETED|Overall Study||7
6813385|NCT04362813|7746623|FG000|STARTED|Overall Study||227
6813386|NCT04362813|7746624|FG001|STARTED|Overall Study||227
6813387|NCT04362813|7746623|FG000|Safety Set|Overall Study||225
6813388|NCT04362813|7746624|FG001|Safety Set|Overall Study||223
6813389|NCT04362813|7746623|FG000|Completed Day 29|Overall Study||211
6813390|NCT04362813|7746624|FG001|Completed Day 29|Overall Study||206
6813391|NCT04362813|7746623|FG000|COMPLETED|Overall Study||209
6813392|NCT04362813|7746624|FG001|COMPLETED|Overall Study||202
6813393|NCT04362813|7746623|FG000|NOT COMPLETED|Overall Study||18
6813394|NCT04362813|7746624|FG001|NOT COMPLETED|Overall Study||25
6813395|NCT04231409|7746632|FG000|STARTED|Overall Study||5
6813396|NCT04231409|7746633|FG001|STARTED|Overall Study||4
6813397|NCT04231409|7746632|FG000|COMPLETED|Overall Study||0
6813398|NCT04231409|7746633|FG001|COMPLETED|Overall Study||0
6813399|NCT04231409|7746632|FG000|NOT COMPLETED|Overall Study||5
6813400|NCT04231409|7746633|FG001|NOT COMPLETED|Overall Study||4
6567720|NCT01832727|7490877|FG008|COMPLETED|Overall Study||0
6567721|NCT01832727|7490869|FG000|NOT COMPLETED|Overall Study||9
6567722|NCT01832727|7490870|FG001|NOT COMPLETED|Overall Study||7
6567723|NCT01832727|7490871|FG002|NOT COMPLETED|Overall Study||3
6567724|NCT01832727|7490872|FG003|NOT COMPLETED|Overall Study||4
6567725|NCT01832727|7490873|FG004|NOT COMPLETED|Overall Study||4
6567726|NCT01832727|7490874|FG005|NOT COMPLETED|Overall Study||6
6567727|NCT01832727|7490875|FG006|NOT COMPLETED|Overall Study||8
6567728|NCT01832727|7490876|FG007|NOT COMPLETED|Overall Study||6
6567729|NCT01832727|7490877|FG008|NOT COMPLETED|Overall Study||18
6567730|NCT01832753|7490909|FG000|STARTED|Observation Phase (Months 0-6)||5
6567731|NCT01832753|7490910|FG001|STARTED|Observation Phase (Months 0-6)||4
6567732|NCT01832753|7490911|FG002|STARTED|Observation Phase (Months 0-6)||3
6567733|NCT01832753|7490909|FG000|COMPLETED|Observation Phase (Months 0-6)||5
6567734|NCT01832753|7490910|FG001|COMPLETED|Observation Phase (Months 0-6)||4
6567735|NCT01832753|7490911|FG002|COMPLETED|Observation Phase (Months 0-6)||1
6567736|NCT01832753|7490909|FG000|NOT COMPLETED|Observation Phase (Months 0-6)||0
6567737|NCT01832753|7490910|FG001|NOT COMPLETED|Observation Phase (Months 0-6)||0
6567738|NCT01832753|7490911|FG002|NOT COMPLETED|Observation Phase (Months 0-6)||2
6567739|NCT01832753|7490909|FG000|STARTED|Randomization Phase (Months 6-12)||5
6567740|NCT01832753|7490910|FG001|STARTED|Randomization Phase (Months 6-12)||4
6567741|NCT01832753|7490911|FG002|STARTED|Randomization Phase (Months 6-12)|1 subject was not randomized as they did not meet inclusion criteria at the end of observation phase|0
6567742|NCT01832753|7490909|FG000|COMPLETED|Randomization Phase (Months 6-12)||4
6567743|NCT01832753|7490910|FG001|COMPLETED|Randomization Phase (Months 6-12)||3
6567744|NCT01832753|7490911|FG002|COMPLETED|Randomization Phase (Months 6-12)||0
6567745|NCT01832753|7490909|FG000|NOT COMPLETED|Randomization Phase (Months 6-12)||1
6567746|NCT01832753|7490910|FG001|NOT COMPLETED|Randomization Phase (Months 6-12)||1
6567747|NCT01832753|7490911|FG002|NOT COMPLETED|Randomization Phase (Months 6-12)||0
6567748|NCT01832753|7490909|FG000|STARTED|Open Label Dose Phase (Months 12-18)||3
6567749|NCT01832753|7490910|FG001|STARTED|Open Label Dose Phase (Months 12-18)||3
6567750|NCT01832753|7490911|FG002|STARTED|Open Label Dose Phase (Months 12-18)||0
6813401|NCT04136548|7746639|FG000|STARTED|Enrolled & Randomized||19
6813402|NCT04136548|7746640|FG001|STARTED|Enrolled & Randomized||19
6813403|NCT04136548|7746639|FG000|COMPLETED|Enrolled & Randomized||13
6813404|NCT04136548|7746640|FG001|COMPLETED|Enrolled & Randomized||15
6813405|NCT04136548|7746639|FG000|NOT COMPLETED|Enrolled & Randomized||6
6813406|NCT04136548|7746640|FG001|NOT COMPLETED|Enrolled & Randomized||4
6813407|NCT04136548|7746639|FG000|STARTED|First Visit||13
6813408|NCT04136548|7746640|FG001|STARTED|First Visit||15
6813409|NCT04136548|7746639|FG000|COMPLETED|First Visit||13
6813410|NCT04136548|7746640|FG001|COMPLETED|First Visit||15
6813411|NCT04136548|7746639|FG000|NOT COMPLETED|First Visit||0
6813412|NCT04136548|7746640|FG001|NOT COMPLETED|First Visit||0
6813413|NCT04136548|7746639|FG000|STARTED|Washout (at Least 48 Hours)||13
6813414|NCT04136548|7746640|FG001|STARTED|Washout (at Least 48 Hours)||15
6813415|NCT04136548|7746639|FG000|COMPLETED|Washout (at Least 48 Hours)||13
6813416|NCT04136548|7746640|FG001|COMPLETED|Washout (at Least 48 Hours)||15
6813417|NCT04136548|7746639|FG000|NOT COMPLETED|Washout (at Least 48 Hours)||0
6813418|NCT04136548|7746640|FG001|NOT COMPLETED|Washout (at Least 48 Hours)||0
6813419|NCT04136548|7746639|FG000|STARTED|Second Visit||13
6813420|NCT04136548|7746640|FG001|STARTED|Second Visit||15
6813421|NCT04136548|7746639|FG000|COMPLETED|Second Visit||13
6813422|NCT04136548|7746640|FG001|COMPLETED|Second Visit||15
6813423|NCT04136548|7746639|FG000|NOT COMPLETED|Second Visit||0
6813424|NCT04136548|7746640|FG001|NOT COMPLETED|Second Visit||0
6813425|NCT04126057|7746648|FG000|STARTED|Overall Study||50
6813426|NCT04126057|7746649|FG001|STARTED|Overall Study||50
6813427|NCT04126057|7746648|FG000|COMPLETED|Overall Study||47
6813428|NCT04126057|7746649|FG001|COMPLETED|Overall Study||46
6813429|NCT04126057|7746648|FG000|NOT COMPLETED|Overall Study||3
6813430|NCT04126057|7746649|FG001|NOT COMPLETED|Overall Study||4
6813431|NCT04087395|7746655|FG000|STARTED|Overall Study||30
6813432|NCT04087395|7746655|FG000|COMPLETED|Overall Study||30
6813433|NCT04087395|7746655|FG000|NOT COMPLETED|Overall Study||0
6813434|NCT04072432|7746666|FG000|STARTED|Overall Study||6
6813435|NCT04072432|7746667|FG001|STARTED|Overall Study||6
6813436|NCT04072432|7746668|FG002|STARTED|Overall Study||6
6813437|NCT04072432|7746666|FG000|COMPLETED|Overall Study||6
6813438|NCT04072432|7746667|FG001|COMPLETED|Overall Study||6
6813439|NCT04072432|7746668|FG002|COMPLETED|Overall Study||6
6813440|NCT04072432|7746666|FG000|NOT COMPLETED|Overall Study||0
6813441|NCT04072432|7746667|FG001|NOT COMPLETED|Overall Study||0
6813442|NCT04072432|7746668|FG002|NOT COMPLETED|Overall Study||0
6813443|NCT04069585|7746676|FG000|STARTED|Overall Study||30
6813444|NCT04069585|7746676|FG000|COMPLETED|Overall Study||30
6813445|NCT04069585|7746676|FG000|NOT COMPLETED|Overall Study||0
6813446|NCT03922321|7746682|FG000|STARTED|Overall Study||7
6813447|NCT03922321|7746682|FG000|COMPLETED|Overall Study||5
6813448|NCT03922321|7746682|FG000|NOT COMPLETED|Overall Study||2
6813449|NCT03911713|7746691|FG000|STARTED|Overall Study||12
6813450|NCT03911713|7746692|FG001|STARTED|Overall Study||6
6813451|NCT03911713|7746693|FG002|STARTED|Overall Study||11
6813452|NCT03911713|7746694|FG003|STARTED|Overall Study||24
6813453|NCT03911713|7746695|FG004|STARTED|Overall Study||24
6813454|NCT03911713|7746691|FG000|Full Analysis Set|Overall Study||11
6813455|NCT03911713|7746692|FG001|Full Analysis Set|Overall Study||6
6813456|NCT03911713|7746693|FG002|Full Analysis Set|Overall Study||11
6813457|NCT03911713|7746694|FG003|Full Analysis Set|Overall Study||23
6813458|NCT03911713|7746695|FG004|Full Analysis Set|Overall Study||24
6813459|NCT03911713|7746691|FG000|COMPLETED|Overall Study||11
6813460|NCT03911713|7746692|FG001|COMPLETED|Overall Study||4
6813461|NCT03911713|7746693|FG002|COMPLETED|Overall Study||11
6813462|NCT03911713|7746694|FG003|COMPLETED|Overall Study||22
6813463|NCT03911713|7746695|FG004|COMPLETED|Overall Study||24
6813464|NCT03911713|7746691|FG000|NOT COMPLETED|Overall Study||1
6813465|NCT03911713|7746692|FG001|NOT COMPLETED|Overall Study||2
6813466|NCT03911713|7746693|FG002|NOT COMPLETED|Overall Study||0
6813467|NCT03911713|7746694|FG003|NOT COMPLETED|Overall Study||2
6813468|NCT03911713|7746695|FG004|NOT COMPLETED|Overall Study||0
6813469|NCT03879642|7746711|FG000|STARTED|Overall Study||22
6813470|NCT03879642|7746712|FG001|STARTED|Overall Study||21
6813471|NCT03879642|7746711|FG000|COMPLETED|Overall Study||19
6813472|NCT03879642|7746712|FG001|COMPLETED|Overall Study||18
6813473|NCT03879642|7746711|FG000|NOT COMPLETED|Overall Study||3
6813474|NCT03879642|7746712|FG001|NOT COMPLETED|Overall Study||3
6813475|NCT03852459|7746720|FG000|STARTED|Overall Study||126
6813476|NCT03852459|7746721|FG001|STARTED|Overall Study||125
6813477|NCT03852459|7746720|FG000|COMPLETED|Overall Study||123
6813478|NCT03852459|7746721|FG001|COMPLETED|Overall Study||122
6813479|NCT03852459|7746720|FG000|NOT COMPLETED|Overall Study||3
6813480|NCT03852459|7746721|FG001|NOT COMPLETED|Overall Study||3
6567751|NCT01832753|7490909|FG000|COMPLETED|Open Label Dose Phase (Months 12-18)||3
6567752|NCT01832753|7490910|FG001|COMPLETED|Open Label Dose Phase (Months 12-18)||3
6567753|NCT01832753|7490911|FG002|COMPLETED|Open Label Dose Phase (Months 12-18)||0
6567754|NCT01832753|7490909|FG000|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
6567755|NCT01832753|7490910|FG001|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
6567756|NCT01832753|7490911|FG002|NOT COMPLETED|Open Label Dose Phase (Months 12-18)||0
6567757|NCT01832766|7490920|FG000|STARTED|First Intervention||7
6567758|NCT01832766|7490921|FG001|STARTED|First Intervention||6
6567759|NCT01832766|7490920|FG000|COMPLETED|First Intervention||7
6813481|NCT03740919|7746730|FG000|STARTED|Lead-in Period||751
6813482|NCT03740919|7746731|FG001|STARTED|Lead-in Period||0
6813483|NCT03740919|7746732|FG002|STARTED|Lead-in Period||0
6813484|NCT03740919|7746733|FG003|STARTED|Lead-in Period||0
6813485|NCT03740919|7746730|FG000|Received at Least One Dose of Study Drug|Lead-in Period||751
6813486|NCT03740919|7746731|FG001|Received at Least One Dose of Study Drug|Lead-in Period||0
6813487|NCT03740919|7746732|FG002|Received at Least One Dose of Study Drug|Lead-in Period||0
6813488|NCT03740919|7746733|FG003|Received at Least One Dose of Study Drug|Lead-in Period||0
6813489|NCT03740919|7746730|FG000|COMPLETED|Lead-in Period||716
6813490|NCT03740919|7746731|FG001|COMPLETED|Lead-in Period||0
6813491|NCT03740919|7746732|FG002|COMPLETED|Lead-in Period||0
6813492|NCT03740919|7746733|FG003|COMPLETED|Lead-in Period||0
6813493|NCT03740919|7746730|FG000|NOT COMPLETED|Lead-in Period||35
6813494|NCT03740919|7746731|FG001|NOT COMPLETED|Lead-in Period||0
6813495|NCT03740919|7746732|FG002|NOT COMPLETED|Lead-in Period||0
6813496|NCT03740919|7746733|FG003|NOT COMPLETED|Lead-in Period||0
6813497|NCT03740919|7746730|FG000|STARTED|Treatment Period||0
6813498|NCT03740919|7746731|FG001|STARTED|Treatment Period|Participants were randomized from Lead-in Period to Insulin Lispro (Humalog).|298
6813499|NCT03740919|7746732|FG002|STARTED|Treatment Period|Participants were randomized from Lead-in Period to LY900014.|280
6813500|NCT03740919|7746733|FG003|STARTED|Treatment Period|Participants were randomized from Lead-in Period to open-label LY900014.|138
6813501|NCT03740919|7746730|FG000|Received at Least One Dose of Study Drug|Treatment Period||0
6813502|NCT03740919|7746731|FG001|Received at Least One Dose of Study Drug|Treatment Period||298
6813503|NCT03740919|7746732|FG002|Received at Least One Dose of Study Drug|Treatment Period||280
6813504|NCT03740919|7746733|FG003|Received at Least One Dose of Study Drug|Treatment Period||138
6813505|NCT03740919|7746730|FG000|COMPLETED|Treatment Period||0
6813506|NCT03740919|7746731|FG001|COMPLETED|Treatment Period||288
6813507|NCT03740919|7746732|FG002|COMPLETED|Treatment Period||266
6813508|NCT03740919|7746733|FG003|COMPLETED|Treatment Period||135
6813509|NCT03740919|7746730|FG000|NOT COMPLETED|Treatment Period||0
6813510|NCT03740919|7746731|FG001|NOT COMPLETED|Treatment Period||10
6813511|NCT03740919|7746732|FG002|NOT COMPLETED|Treatment Period||14
6813512|NCT03740919|7746733|FG003|NOT COMPLETED|Treatment Period||3
6813513|NCT03700970|7746746|FG000|STARTED|Overall Study||30
6813514|NCT03700970|7746747|FG001|STARTED|Overall Study||30
6813515|NCT03700970|7746746|FG000|COMPLETED|Overall Study||21
6813516|NCT03700970|7746747|FG001|COMPLETED|Overall Study||19
6813517|NCT03700970|7746746|FG000|NOT COMPLETED|Overall Study||9
6813518|NCT03700970|7746747|FG001|NOT COMPLETED|Overall Study||11
6813519|NCT03652454|7746757|FG000|STARTED|Overall Study||14
6657078|NCT02466126|7587359|FG000|COMPLETED|12 Month Assessment||85
6657079|NCT02466126|7587360|FG001|COMPLETED|12 Month Assessment||66
6657080|NCT02466126|7587359|FG000|NOT COMPLETED|12 Month Assessment||1
6657081|NCT02466126|7587360|FG001|NOT COMPLETED|12 Month Assessment||2
6657082|NCT02466230|7587366|FG000|STARTED|Overall Study||28
6657083|NCT02466230|7587366|FG000|COMPLETED|Overall Study||28
6813520|NCT03652454|7746758|FG001|STARTED|Overall Study||14
6813521|NCT03652454|7746757|FG000|COMPLETED|Overall Study||14
6813522|NCT03652454|7746758|FG001|COMPLETED|Overall Study||14
6813523|NCT03652454|7746757|FG000|NOT COMPLETED|Overall Study||0
6813524|NCT03652454|7746758|FG001|NOT COMPLETED|Overall Study||0
6813525|NCT03647488|7746767|FG000|STARTED|Overall Study||18
6813526|NCT03647488|7746768|FG001|STARTED|Overall Study|Randomized part was not opened|0
6813527|NCT03647488|7746769|FG002|STARTED|Overall Study|Randomized part was not opened|0
6813528|NCT03647488|7746767|FG000|COMPLETED|Overall Study||0
6567760|NCT01832766|7490921|FG001|COMPLETED|First Intervention|one participant did not return for cross over visit|6
6567761|NCT01832766|7490920|FG000|NOT COMPLETED|First Intervention||0
6567762|NCT01832766|7490921|FG001|NOT COMPLETED|First Intervention||0
6813529|NCT03647488|7746768|FG001|COMPLETED|Overall Study||0
6813530|NCT03647488|7746769|FG002|COMPLETED|Overall Study||0
6813531|NCT03647488|7746767|FG000|NOT COMPLETED|Overall Study||18
6813532|NCT03647488|7746768|FG001|NOT COMPLETED|Overall Study||0
6813533|NCT03647488|7746769|FG002|NOT COMPLETED|Overall Study||0
6813534|NCT03614923|7746778|FG000|STARTED|Overall Study||35
6813535|NCT03614923|7746779|FG001|STARTED|Overall Study||35
6813536|NCT03614923|7746780|FG002|STARTED|Overall Study||35
6813537|NCT03614923|7746778|FG000|COMPLETED|Overall Study||30
6813538|NCT03614923|7746779|FG001|COMPLETED|Overall Study||30
6813539|NCT03614923|7746780|FG002|COMPLETED|Overall Study||30
6567763|NCT01832766|7490920|FG000|STARTED|Washout||7
6567764|NCT01832766|7490921|FG001|STARTED|Washout||6
6657084|NCT02466230|7587366|FG000|NOT COMPLETED|Overall Study||0
6657085|NCT02466386|7587370|FG000|STARTED|Overall Study||113
6813540|NCT03614923|7746778|FG000|NOT COMPLETED|Overall Study||5
6813541|NCT03614923|7746779|FG001|NOT COMPLETED|Overall Study||5
6813542|NCT03614923|7746780|FG002|NOT COMPLETED|Overall Study||5
6813543|NCT03502187|7746791|FG000|STARTED|Overall Study||43
6813544|NCT03502187|7746792|FG001|STARTED|Overall Study||43
6813545|NCT03502187|7746793|FG002|STARTED|Overall Study||42
6813546|NCT03502187|7746791|FG000|COMPLETED|Overall Study||34
6813547|NCT03502187|7746792|FG001|COMPLETED|Overall Study||36
6813548|NCT03502187|7746793|FG002|COMPLETED|Overall Study||34
6813549|NCT03502187|7746791|FG000|NOT COMPLETED|Overall Study||9
6813550|NCT03502187|7746792|FG001|NOT COMPLETED|Overall Study||7
6813551|NCT03502187|7746793|FG002|NOT COMPLETED|Overall Study||8
6813552|NCT03447262|7746801|FG000|STARTED|Overall Study||481
6813553|NCT03447262|7746801|FG000|COMPLETED|Overall Study||2
6813554|NCT03447262|7746801|FG000|NOT COMPLETED|Overall Study||479
6813555|NCT03432819|7746810|FG000|STARTED|Overall Study||38
6813556|NCT03432819|7746811|FG001|STARTED|Overall Study||38
6813557|NCT03432819|7746810|FG000|COMPLETED|Overall Study||31
6813558|NCT03432819|7746811|FG001|COMPLETED|Overall Study||33
6813559|NCT03432819|7746810|FG000|NOT COMPLETED|Overall Study||7
6813560|NCT03432819|7746811|FG001|NOT COMPLETED|Overall Study||5
6813561|NCT03365791|7746817|FG000|STARTED|Overall Study||76
6813562|NCT03365791|7746817|FG000|Full Analysis Set (FAS)|Overall Study||75
6813563|NCT03365791|7746817|FG000|COMPLETED|Overall Study||4
6813564|NCT03365791|7746817|FG000|NOT COMPLETED|Overall Study||72
6813565|NCT03323749|7746824|FG000|STARTED|Double-blind Period||109
6813566|NCT03323749|7746825|FG001|STARTED|Double-blind Period||109
6813567|NCT03323749|7746824|FG000|COMPLETED|Double-blind Period||102
6813568|NCT03323749|7746825|FG001|COMPLETED|Double-blind Period||103
6813569|NCT03323749|7746824|FG000|NOT COMPLETED|Double-blind Period||7
6813570|NCT03323749|7746825|FG001|NOT COMPLETED|Double-blind Period||6
6813571|NCT03323749|7746824|FG000|STARTED|Open-Label Period||93
6813572|NCT03323749|7746825|FG001|STARTED|Open-Label Period||103
6813573|NCT03323749|7746824|FG000|COMPLETED|Open-Label Period||0
6813574|NCT03323749|7746825|FG001|COMPLETED|Open-Label Period||0
6813575|NCT03323749|7746824|FG000|NOT COMPLETED|Open-Label Period||93
6813576|NCT03323749|7746825|FG001|NOT COMPLETED|Open-Label Period||103
6813577|NCT03322566|7746838|FG000|STARTED|Overall Study||91
6813578|NCT03322566|7746839|FG001|STARTED|Overall Study||87
6813579|NCT03322566|7746840|FG002|STARTED|Overall Study||55
6813580|NCT03322566|7746838|FG000|COMPLETED|Overall Study||46
6813581|NCT03322566|7746839|FG001|COMPLETED|Overall Study||42
6813582|NCT03322566|7746840|FG002|COMPLETED|Overall Study||22
6813583|NCT03322566|7746838|FG000|NOT COMPLETED|Overall Study||45
6813584|NCT03322566|7746839|FG001|NOT COMPLETED|Overall Study||45
6813585|NCT03322566|7746840|FG002|NOT COMPLETED|Overall Study||33
6813586|NCT03322540|7746850|FG000|STARTED|Overall Study||77
6813587|NCT03322540|7746851|FG001|STARTED|Overall Study||77
6813588|NCT03322540|7746850|FG000|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||75
6813589|NCT03322540|7746851|FG001|Number of Subjects Received Treatment (Actual Treatment) (ASaT)|Overall Study||77
6813590|NCT03322540|7746850|FG000|COMPLETED|Overall Study||46
6813591|NCT03322540|7746851|FG001|COMPLETED|Overall Study||40
6813592|NCT03322540|7746850|FG000|NOT COMPLETED|Overall Study||31
6813593|NCT03322540|7746851|FG001|NOT COMPLETED|Overall Study||37
6567765|NCT01832766|7490920|FG000|COMPLETED|Washout||7
6567766|NCT01832766|7490921|FG001|COMPLETED|Washout||5
6567767|NCT01832766|7490920|FG000|NOT COMPLETED|Washout||0
6567768|NCT01832766|7490921|FG001|NOT COMPLETED|Washout||1
6567769|NCT01832766|7490920|FG000|STARTED|Second Intervention||7
6567770|NCT01832766|7490921|FG001|STARTED|Second Intervention||5
6567771|NCT01832766|7490920|FG000|COMPLETED|Second Intervention||7
6567772|NCT01832766|7490921|FG001|COMPLETED|Second Intervention||5
6567773|NCT01832766|7490920|FG000|NOT COMPLETED|Second Intervention||0
6567774|NCT01832766|7490921|FG001|NOT COMPLETED|Second Intervention||0
6567775|NCT01832818|7490927|FG000|STARTED|Overall Study||14
6567776|NCT01832818|7490927|FG000|COMPLETED|Overall Study||8
6567777|NCT01832818|7490927|FG000|NOT COMPLETED|Overall Study||6
6567778|NCT01832961|7490931|FG000|STARTED|First Intervention||8
6567779|NCT01832961|7490932|FG001|STARTED|First Intervention||7
6567780|NCT01832961|7490931|FG000|COMPLETED|First Intervention||8
6567781|NCT01832961|7490932|FG001|COMPLETED|First Intervention||7
6567782|NCT01832961|7490931|FG000|NOT COMPLETED|First Intervention||0
6567783|NCT01832961|7490932|FG001|NOT COMPLETED|First Intervention||0
6567784|NCT01832961|7490931|FG000|STARTED|Washout||8
6567785|NCT01832961|7490932|FG001|STARTED|Washout||7
6567786|NCT01832961|7490931|FG000|COMPLETED|Washout||8
6567787|NCT01832961|7490932|FG001|COMPLETED|Washout||7
6657086|NCT02466386|7587370|FG000|COMPLETED|Overall Study||69
6657087|NCT02466386|7587370|FG000|NOT COMPLETED|Overall Study||44
6657088|NCT02466399|7587376|FG000|STARTED|Overall Study||53
6657089|NCT02466399|7587377|FG001|STARTED|Overall Study||27
6657090|NCT02466399|7587376|FG000|COMPLETED|Overall Study||51
6657091|NCT02466399|7587377|FG001|COMPLETED|Overall Study||27
6657092|NCT02466399|7587376|FG000|NOT COMPLETED|Overall Study||2
6657093|NCT02466399|7587377|FG001|NOT COMPLETED|Overall Study||0
6657094|NCT02466412|7587385|FG000|STARTED|Washout Period of 1 Day (Day -1)||24
6657095|NCT02466412|7587386|FG001|STARTED|Washout Period of 1 Day (Day -1)||24
6657096|NCT02466412|7587385|FG000|COMPLETED|Washout Period of 1 Day (Day -1)||24
6657097|NCT02466412|7587386|FG001|COMPLETED|Washout Period of 1 Day (Day -1)||24
6657098|NCT02466412|7587385|FG000|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
6657099|NCT02466412|7587386|FG001|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
6657100|NCT02466412|7587385|FG000|STARTED|First Intervention (Day 1)||24
6657101|NCT02466412|7587386|FG001|STARTED|First Intervention (Day 1)||24
6657102|NCT02466412|7587385|FG000|COMPLETED|First Intervention (Day 1)||24
6657103|NCT02466412|7587386|FG001|COMPLETED|First Intervention (Day 1)||24
6657104|NCT02466412|7587385|FG000|NOT COMPLETED|First Intervention (Day 1)||0
6657105|NCT02466412|7587386|FG001|NOT COMPLETED|First Intervention (Day 1)||0
6657106|NCT02466412|7587385|FG000|STARTED|Washout Period of 1 Day (Day 2)||24
6657107|NCT02466412|7587386|FG001|STARTED|Washout Period of 1 Day (Day 2)||24
6657108|NCT02466412|7587385|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||24
6657109|NCT02466412|7587386|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||24
6657110|NCT02466412|7587385|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6657111|NCT02466412|7587386|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6657112|NCT02466412|7587385|FG000|STARTED|Second Intervention (Day 3)||24
6657113|NCT02466412|7587386|FG001|STARTED|Second Intervention (Day 3)||24
6657114|NCT02466412|7587385|FG000|COMPLETED|Second Intervention (Day 3)||24
6657115|NCT02466412|7587386|FG001|COMPLETED|Second Intervention (Day 3)||24
6657116|NCT02466412|7587385|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
6657117|NCT02466412|7587386|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
6657118|NCT02466425|7587395|FG000|STARTED|Overall Study||132
6657119|NCT02466425|7587396|FG001|STARTED|Overall Study||132
6657120|NCT02466425|7587395|FG000|Treated|Overall Study||131
6657121|NCT02466425|7587396|FG001|Treated|Overall Study||132
6657122|NCT02466425|7587395|FG000|COMPLETED|Overall Study||118
6657123|NCT02466425|7587396|FG001|COMPLETED|Overall Study||116
6657124|NCT02466425|7587395|FG000|NOT COMPLETED|Overall Study||14
6657125|NCT02466425|7587396|FG001|NOT COMPLETED|Overall Study||16
6657126|NCT02466516|7587407|FG000|STARTED|Overall Study||20
6657127|NCT02466516|7587408|FG001|STARTED|Overall Study||22
6657128|NCT02466516|7587409|FG002|STARTED|Overall Study||10
6813594|NCT03240601|7746861|FG000|STARTED|Overall Study||9
6813595|NCT03240601|7746862|FG001|STARTED|Overall Study||9
6813596|NCT03240601|7746861|FG000|COMPLETED|Overall Study||8
6813597|NCT03240601|7746862|FG001|COMPLETED|Overall Study||8
6813598|NCT03240601|7746861|FG000|NOT COMPLETED|Overall Study||1
6567788|NCT01832961|7490931|FG000|NOT COMPLETED|Washout||0
6567789|NCT01832961|7490932|FG001|NOT COMPLETED|Washout||0
6567790|NCT01832961|7490931|FG000|STARTED|Second Intervention||8
6567791|NCT01832961|7490932|FG001|STARTED|Second Intervention||7
6567792|NCT01832961|7490931|FG000|COMPLETED|Second Intervention||8
6567793|NCT01832961|7490932|FG001|COMPLETED|Second Intervention||7
6567794|NCT01832961|7490931|FG000|NOT COMPLETED|Second Intervention||0
6567795|NCT01832961|7490932|FG001|NOT COMPLETED|Second Intervention||0
6657129|NCT02466516|7587410|FG003|STARTED|Overall Study||10
6657130|NCT02466516|7587411|FG004|STARTED|Overall Study||10
6657131|NCT02466516|7587407|FG000|COMPLETED|Overall Study||16
6657132|NCT02466516|7587408|FG001|COMPLETED|Overall Study||21
6567796|NCT01832961|7490931|FG000|STARTED|Third Intervention||8
6657133|NCT02466516|7587409|FG002|COMPLETED|Overall Study||9
6813599|NCT03240601|7746862|FG001|NOT COMPLETED|Overall Study||1
6813600|NCT03189719|7746870|FG000|STARTED|Overall Study||373
6813601|NCT03189719|7746871|FG001|STARTED|Overall Study||376
6813602|NCT03189719|7746870|FG000|Treated|Overall Study||370
6813603|NCT03189719|7746871|FG001|Treated|Overall Study||370
6813604|NCT03189719|7746870|FG000|COMPLETED|Overall Study||0
6813605|NCT03189719|7746871|FG001|COMPLETED|Overall Study||0
6813606|NCT03189719|7746870|FG000|NOT COMPLETED|Overall Study||373
6813607|NCT03189719|7746871|FG001|NOT COMPLETED|Overall Study||376
6813608|NCT03155997|7746879|FG000|STARTED|Overall Study||2808
6813609|NCT03155997|7746880|FG001|STARTED|Overall Study||2829
6813610|NCT03155997|7746879|FG000|Received at Least One Dose of Study Drug|Overall Study||2791
6813611|NCT03155997|7746880|FG001|Received at Least One Dose of Study Drug|Overall Study||2800
6813612|NCT03155997|7746879|FG000|COMPLETED|Overall Study||650
6813613|NCT03155997|7746880|FG001|COMPLETED|Overall Study||607
6813614|NCT03155997|7746879|FG000|NOT COMPLETED|Overall Study||2158
6813615|NCT03155997|7746880|FG001|NOT COMPLETED|Overall Study||2222
6813616|NCT03104400|7746890|FG000|STARTED|Overall Study||211
6813617|NCT03104400|7746891|FG001|STARTED|Overall Study||212
6813618|NCT03104400|7746892|FG002|STARTED|Overall Study||429
6813619|NCT03104400|7746893|FG003|STARTED|Overall Study||430
6813620|NCT03104400|7746894|FG004|STARTED|Overall Study||423
6813621|NCT03104400|7746890|FG000|Received Study Drug|Overall Study||211
6813622|NCT03104400|7746891|FG001|Received Study Drug|Overall Study||212
6813623|NCT03104400|7746892|FG002|Received Study Drug|Overall Study||429
6813624|NCT03104400|7746893|FG003|Received Study Drug|Overall Study||429
6813625|NCT03104400|7746894|FG004|Received Study Drug|Overall Study||423
6813626|NCT03104400|7746890|FG000|Completed Week 24|Overall Study||190
6813627|NCT03104400|7746891|FG001|Completed Week 24|Overall Study||193
6813628|NCT03104400|7746892|FG002|Completed Week 24|Overall Study||404
6813629|NCT03104400|7746893|FG003|Completed Week 24|Overall Study||408
6813630|NCT03104400|7746894|FG004|Completed Week 24|Overall Study||394
6813631|NCT03104400|7746890|FG000|COMPLETED|Overall Study||177
6813632|NCT03104400|7746891|FG001|COMPLETED|Overall Study||178
6813633|NCT03104400|7746892|FG002|COMPLETED|Overall Study||370
6813634|NCT03104400|7746893|FG003|COMPLETED|Overall Study||379
6813635|NCT03104400|7746894|FG004|COMPLETED|Overall Study||366
6813636|NCT03104400|7746890|FG000|NOT COMPLETED|Overall Study||34
6813637|NCT03104400|7746891|FG001|NOT COMPLETED|Overall Study||34
6813638|NCT03104400|7746892|FG002|NOT COMPLETED|Overall Study||59
6813639|NCT03104400|7746893|FG003|NOT COMPLETED|Overall Study||51
6813640|NCT03104400|7746894|FG004|NOT COMPLETED|Overall Study||57
6813641|NCT03104374|7746911|FG000|STARTED|Overall Study||106
6813642|NCT03104374|7746912|FG001|STARTED|Overall Study||106
6813643|NCT03104374|7746913|FG002|STARTED|Overall Study||211
6813644|NCT03104374|7746914|FG003|STARTED|Overall Study||219
6813645|NCT03104374|7746911|FG000|Received Study Drug|Overall Study||106
6813646|NCT03104374|7746912|FG001|Received Study Drug|Overall Study||106
6813647|NCT03104374|7746913|FG002|Received Study Drug|Overall Study||211
6813648|NCT03104374|7746914|FG003|Received Study Drug|Overall Study||218
6813649|NCT03104374|7746911|FG000|Completed Week 24|Overall Study||81
6813650|NCT03104374|7746912|FG001|Completed Week 24|Overall Study||92
6813651|NCT03104374|7746913|FG002|Completed Week 24|Overall Study||192
6813652|NCT03104374|7746914|FG003|Completed Week 24|Overall Study||195
6813653|NCT03104374|7746911|FG000|COMPLETED|Overall Study||69
6813654|NCT03104374|7746912|FG001|COMPLETED|Overall Study||77
6813655|NCT03104374|7746913|FG002|COMPLETED|Overall Study||167
6813656|NCT03104374|7746914|FG003|COMPLETED|Overall Study||166
6813657|NCT03104374|7746911|FG000|NOT COMPLETED|Overall Study||37
6813658|NCT03104374|7746912|FG001|NOT COMPLETED|Overall Study||29
6813659|NCT03104374|7746913|FG002|NOT COMPLETED|Overall Study||44
6813660|NCT03104374|7746914|FG003|NOT COMPLETED|Overall Study||53
6813661|NCT03072043|7746927|FG000|STARTED|Overall Study||3
6813662|NCT03072043|7746928|FG001|STARTED|Overall Study||3
6813663|NCT03072043|7746929|FG002|STARTED|Overall Study||49
6813664|NCT03072043|7746927|FG000|COMPLETED|Overall Study||3
6813665|NCT03072043|7746928|FG001|COMPLETED|Overall Study||3
6813666|NCT03072043|7746929|FG002|COMPLETED|Overall Study||40
6813667|NCT03072043|7746927|FG000|NOT COMPLETED|Overall Study||0
6813668|NCT03072043|7746928|FG001|NOT COMPLETED|Overall Study||0
6813669|NCT03072043|7746929|FG002|NOT COMPLETED|Overall Study||9
6813670|NCT02970981|7746941|FG000|STARTED|Overall Study||16
6813671|NCT02970981|7746941|FG000|COMPLETED|Overall Study||16
6813672|NCT02970981|7746941|FG000|NOT COMPLETED|Overall Study||0
6813673|NCT02946853|7746947|FG000|STARTED|Overall Study||13
6813674|NCT02946853|7746948|FG001|STARTED|Overall Study||13
6813675|NCT02946853|7746947|FG000|COMPLETED|Overall Study||12
6813676|NCT02946853|7746948|FG001|COMPLETED|Overall Study||13
6813677|NCT02946853|7746947|FG000|NOT COMPLETED|Overall Study||1
6813678|NCT02946853|7746948|FG001|NOT COMPLETED|Overall Study||0
6813679|NCT02905032|7746957|FG000|STARTED|Overall Study||467
6813680|NCT02905032|7746958|FG001|STARTED|Overall Study||475
6813681|NCT02905032|7746959|FG002|STARTED|Overall Study||244
6813682|NCT02905032|7746957|FG000|COMPLETED|Overall Study||459
6813683|NCT02905032|7746958|FG001|COMPLETED|Overall Study||463
6813684|NCT02905032|7746959|FG002|COMPLETED|Overall Study||244
6813685|NCT02905032|7746957|FG000|NOT COMPLETED|Overall Study||8
6813686|NCT02905032|7746958|FG001|NOT COMPLETED|Overall Study||12
6813687|NCT02905032|7746959|FG002|NOT COMPLETED|Overall Study||0
6813688|NCT02837029|7746969|FG000|STARTED|Screening||15
6813689|NCT02837029|7746970|FG001|STARTED|Screening||12
6813690|NCT02837029|7746971|FG002|STARTED|Screening||0
6813691|NCT02837029|7746969|FG000|COMPLETED|Screening||8
6813692|NCT02837029|7746970|FG001|COMPLETED|Screening||9
6813693|NCT02837029|7746971|FG002|COMPLETED|Screening||0
6813694|NCT02837029|7746969|FG000|NOT COMPLETED|Screening||7
6813695|NCT02837029|7746970|FG001|NOT COMPLETED|Screening||3
6813696|NCT02837029|7746971|FG002|NOT COMPLETED|Screening||0
6813697|NCT02837029|7746969|FG000|STARTED|Induction Treatment With Y90||8
6813698|NCT02837029|7746970|FG001|STARTED|Induction Treatment With Y90||9
6813699|NCT02837029|7746971|FG002|STARTED|Induction Treatment With Y90||0
6813700|NCT02837029|7746969|FG000|COMPLETED|Induction Treatment With Y90||8
6813701|NCT02837029|7746970|FG001|COMPLETED|Induction Treatment With Y90||9
6813702|NCT02837029|7746971|FG002|COMPLETED|Induction Treatment With Y90||0
6813703|NCT02837029|7746969|FG000|NOT COMPLETED|Induction Treatment With Y90||0
6813704|NCT02837029|7746970|FG001|NOT COMPLETED|Induction Treatment With Y90||0
6813705|NCT02837029|7746971|FG002|NOT COMPLETED|Induction Treatment With Y90||0
6813706|NCT02837029|7746969|FG000|STARTED|Cycle 1 (DLT Monitoring Period)||8
6813707|NCT02837029|7746970|FG001|STARTED|Cycle 1 (DLT Monitoring Period)||9
6813708|NCT02837029|7746971|FG002|STARTED|Cycle 1 (DLT Monitoring Period)||0
6813709|NCT02837029|7746969|FG000|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||6
6813710|NCT02837029|7746970|FG001|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||7
6813711|NCT02837029|7746971|FG002|Received Nivolumab Dose|Cycle 1 (DLT Monitoring Period)||0
6813712|NCT02837029|7746969|FG000|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
6813713|NCT02837029|7746970|FG001|COMPLETED|Cycle 1 (DLT Monitoring Period)||6
6813714|NCT02837029|7746971|FG002|COMPLETED|Cycle 1 (DLT Monitoring Period)||0
6813715|NCT02837029|7746969|FG000|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||2
6813716|NCT02837029|7746970|FG001|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||3
6813717|NCT02837029|7746971|FG002|NOT COMPLETED|Cycle 1 (DLT Monitoring Period)||0
6813718|NCT02837029|7746969|FG000|STARTED|Cycle 2 and Beyond||6
6813719|NCT02837029|7746970|FG001|STARTED|Cycle 2 and Beyond||6
6567797|NCT01832961|7490932|FG001|STARTED|Third Intervention||7
6567798|NCT01832961|7490931|FG000|COMPLETED|Third Intervention||8
6567799|NCT01832961|7490932|FG001|COMPLETED|Third Intervention||7
6567800|NCT01832961|7490931|FG000|NOT COMPLETED|Third Intervention||0
6813720|NCT02837029|7746971|FG002|STARTED|Cycle 2 and Beyond||0
6813721|NCT02837029|7746969|FG000|COMPLETED|Cycle 2 and Beyond||5
6813722|NCT02837029|7746970|FG001|COMPLETED|Cycle 2 and Beyond||6
6813723|NCT02837029|7746971|FG002|COMPLETED|Cycle 2 and Beyond||0
6813724|NCT02837029|7746969|FG000|NOT COMPLETED|Cycle 2 and Beyond||1
6813725|NCT02837029|7746970|FG001|NOT COMPLETED|Cycle 2 and Beyond||0
6813726|NCT02837029|7746971|FG002|NOT COMPLETED|Cycle 2 and Beyond||0
6813727|NCT02837029|7746969|FG000|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|6
6813728|NCT02837029|7746970|FG001|STARTED|2 Year Follow-up|All patients who receive at least one dose of nivolumab go into follow-up.|7
6813729|NCT02837029|7746971|FG002|STARTED|2 Year Follow-up||0
6813730|NCT02837029|7746969|FG000|COMPLETED|2 Year Follow-up||0
6813731|NCT02837029|7746970|FG001|COMPLETED|2 Year Follow-up||0
6813732|NCT02837029|7746971|FG002|COMPLETED|2 Year Follow-up||0
6813733|NCT02837029|7746969|FG000|NOT COMPLETED|2 Year Follow-up||6
6813734|NCT02837029|7746970|FG001|NOT COMPLETED|2 Year Follow-up||7
6813735|NCT02837029|7746971|FG002|NOT COMPLETED|2 Year Follow-up||0
6813736|NCT02740127|7746982|FG000|STARTED|Overall Study||24
6813737|NCT02740127|7746983|FG001|STARTED|Overall Study||28
6813738|NCT02740127|7746982|FG000|COMPLETED|Overall Study||24
6813739|NCT02740127|7746983|FG001|COMPLETED|Overall Study||28
6813740|NCT02740127|7746982|FG000|NOT COMPLETED|Overall Study||0
6813741|NCT02740127|7746983|FG001|NOT COMPLETED|Overall Study||0
6813742|NCT02737553|7746991|FG000|STARTED|Overall Study||49
6813743|NCT02737553|7746992|FG001|STARTED|Overall Study||48
6813744|NCT02737553|7746991|FG000|COMPLETED|Overall Study||49
6813745|NCT02737553|7746992|FG001|COMPLETED|Overall Study||48
6813746|NCT02737553|7746991|FG000|NOT COMPLETED|Overall Study||0
6813747|NCT02737553|7746992|FG001|NOT COMPLETED|Overall Study||0
6813748|NCT02737475|7747026|FG000|STARTED|Overall Study||4
6813749|NCT02737475|7747027|FG001|STARTED|Overall Study||4
6813750|NCT02737475|7747028|FG002|STARTED|Overall Study||4
6813751|NCT02737475|7747029|FG003|STARTED|Overall Study||4
6813752|NCT02737475|7747030|FG004|STARTED|Overall Study||4
6813753|NCT02737475|7747031|FG005|STARTED|Overall Study||7
6813754|NCT02737475|7747032|FG006|STARTED|Overall Study||8
6813755|NCT02737475|7747033|FG007|STARTED|Overall Study||12
6813756|NCT02737475|7747034|FG008|STARTED|Overall Study||8
6813757|NCT02737475|7747035|FG009|STARTED|Overall Study||8
6813758|NCT02737475|7747036|FG010|STARTED|Overall Study||4
6813759|NCT02737475|7747037|FG011|STARTED|Overall Study||10
6813760|NCT02737475|7747038|FG012|STARTED|Overall Study||7
6813761|NCT02737475|7747039|FG013|STARTED|Overall Study||8
6813762|NCT02737475|7747040|FG014|STARTED|Overall Study||6
6813763|NCT02737475|7747041|FG015|STARTED|Overall Study||18
6813764|NCT02737475|7747042|FG016|STARTED|Overall Study||12
6567801|NCT01832961|7490932|FG001|NOT COMPLETED|Third Intervention||0
6813765|NCT02737475|7747043|FG017|STARTED|Overall Study||6
6813766|NCT02737475|7747044|FG018|STARTED|Overall Study||7
6813767|NCT02737475|7747045|FG019|STARTED|Overall Study||1
6813768|NCT02737475|7747046|FG020|STARTED|Overall Study||6
6813769|NCT02737475|7747047|FG021|STARTED|Overall Study||9
6813770|NCT02737475|7747048|FG022|STARTED|Overall Study||2
6813771|NCT02737475|7747049|FG023|STARTED|Overall Study||2
6813772|NCT02737475|7747050|FG024|STARTED|Overall Study||2
6813773|NCT02737475|7747051|FG025|STARTED|Overall Study||2
6567802|NCT01833026|7490949|FG000|STARTED|Overall Study||22
6813774|NCT02737475|7747052|FG026|STARTED|Overall Study||1
6813775|NCT02737475|7747026|FG000|COMPLETED|Overall Study||3
6813776|NCT02737475|7747027|FG001|COMPLETED|Overall Study||4
6813777|NCT02737475|7747028|FG002|COMPLETED|Overall Study||4
6813778|NCT02737475|7747029|FG003|COMPLETED|Overall Study||3
6813779|NCT02737475|7747030|FG004|COMPLETED|Overall Study||3
6813780|NCT02737475|7747031|FG005|COMPLETED|Overall Study||4
6813781|NCT02737475|7747032|FG006|COMPLETED|Overall Study||8
6813782|NCT02737475|7747033|FG007|COMPLETED|Overall Study||10
6813783|NCT02737475|7747034|FG008|COMPLETED|Overall Study||7
6813784|NCT02737475|7747035|FG009|COMPLETED|Overall Study||8
6813785|NCT02737475|7747036|FG010|COMPLETED|Overall Study||3
6813786|NCT02737475|7747037|FG011|COMPLETED|Overall Study||6
6813787|NCT02737475|7747038|FG012|COMPLETED|Overall Study||5
6813788|NCT02737475|7747039|FG013|COMPLETED|Overall Study||6
6813789|NCT02737475|7747040|FG014|COMPLETED|Overall Study||5
6567803|NCT01833026|7490950|FG001|STARTED|Overall Study||34
6567804|NCT01833026|7490949|FG000|COMPLETED|Overall Study||22
6813790|NCT02737475|7747041|FG015|COMPLETED|Overall Study||15
6813791|NCT02737475|7747042|FG016|COMPLETED|Overall Study||10
6813792|NCT02737475|7747043|FG017|COMPLETED|Overall Study||2
6813793|NCT02737475|7747044|FG018|COMPLETED|Overall Study||5
6813794|NCT02737475|7747045|FG019|COMPLETED|Overall Study||1
6813795|NCT02737475|7747046|FG020|COMPLETED|Overall Study||4
6813796|NCT02737475|7747047|FG021|COMPLETED|Overall Study||8
6813797|NCT02737475|7747048|FG022|COMPLETED|Overall Study||2
6813798|NCT02737475|7747049|FG023|COMPLETED|Overall Study||1
6813799|NCT02737475|7747050|FG024|COMPLETED|Overall Study||1
6813800|NCT02737475|7747051|FG025|COMPLETED|Overall Study||1
6813801|NCT02737475|7747052|FG026|COMPLETED|Overall Study||0
6813802|NCT02737475|7747026|FG000|NOT COMPLETED|Overall Study||1
6813803|NCT02737475|7747027|FG001|NOT COMPLETED|Overall Study||0
6813804|NCT02737475|7747028|FG002|NOT COMPLETED|Overall Study||0
6813805|NCT02737475|7747029|FG003|NOT COMPLETED|Overall Study||1
6813806|NCT02737475|7747030|FG004|NOT COMPLETED|Overall Study||1
6813807|NCT02737475|7747031|FG005|NOT COMPLETED|Overall Study||3
6813808|NCT02737475|7747032|FG006|NOT COMPLETED|Overall Study||0
6813809|NCT02737475|7747033|FG007|NOT COMPLETED|Overall Study||2
6813810|NCT02737475|7747034|FG008|NOT COMPLETED|Overall Study||1
6813811|NCT02737475|7747035|FG009|NOT COMPLETED|Overall Study||0
6813812|NCT02737475|7747036|FG010|NOT COMPLETED|Overall Study||1
6813813|NCT02737475|7747037|FG011|NOT COMPLETED|Overall Study||4
6813814|NCT02737475|7747038|FG012|NOT COMPLETED|Overall Study||2
6567805|NCT01833026|7490950|FG001|COMPLETED|Overall Study||34
6567806|NCT01833026|7490949|FG000|NOT COMPLETED|Overall Study||0
6813815|NCT02737475|7747039|FG013|NOT COMPLETED|Overall Study||2
6813816|NCT02737475|7747040|FG014|NOT COMPLETED|Overall Study||1
6813817|NCT02737475|7747041|FG015|NOT COMPLETED|Overall Study||3
6813818|NCT02737475|7747042|FG016|NOT COMPLETED|Overall Study||2
6813819|NCT02737475|7747043|FG017|NOT COMPLETED|Overall Study||4
6813820|NCT02737475|7747044|FG018|NOT COMPLETED|Overall Study||2
6813821|NCT02737475|7747045|FG019|NOT COMPLETED|Overall Study||0
6813822|NCT02737475|7747046|FG020|NOT COMPLETED|Overall Study||2
6813823|NCT02737475|7747047|FG021|NOT COMPLETED|Overall Study||1
6813824|NCT02737475|7747048|FG022|NOT COMPLETED|Overall Study||0
6813825|NCT02737475|7747049|FG023|NOT COMPLETED|Overall Study||1
6813826|NCT02737475|7747050|FG024|NOT COMPLETED|Overall Study||1
6813827|NCT02737475|7747051|FG025|NOT COMPLETED|Overall Study||1
6280841|NCT00159263|7180664|FG000|NOT COMPLETED|Washout||0
6813828|NCT02737475|7747052|FG026|NOT COMPLETED|Overall Study||1
6813829|NCT02703714|7747140|FG000|STARTED|Overall Study||42
6813830|NCT02703714|7747140|FG000|COMPLETED|Overall Study||42
6813831|NCT02703714|7747140|FG000|NOT COMPLETED|Overall Study||0
6813832|NCT02642965|7747144|FG000|STARTED|Overall Study||38
6813833|NCT02642965|7747144|FG000|COMPLETED|Overall Study||25
6391013|NCT00833482|7302810|FG000|COMPLETED|Days 21-30||0
6391014|NCT00833482|7302811|FG001|COMPLETED|Days 21-30||0
6391015|NCT00833482|7302812|FG002|COMPLETED|Days 21-30||20
6391016|NCT00833482|7302813|FG003|COMPLETED|Days 21-30||0
6391017|NCT00833482|7302814|FG004|COMPLETED|Days 21-30||7
6391018|NCT00833482|7302815|FG005|COMPLETED|Days 21-30||0
6813834|NCT02642965|7747144|FG000|NOT COMPLETED|Overall Study||13
6813835|NCT02629159|7747151|FG000|STARTED|Overall Study||651
6813836|NCT02629159|7747152|FG001|STARTED|Overall Study||327
6813837|NCT02629159|7747153|FG002|STARTED|Overall Study||651
6813838|NCT02629159|7747151|FG000|Received Assigned Study Drug|Overall Study||651
6813839|NCT02629159|7747152|FG001|Received Assigned Study Drug|Overall Study||327
6813840|NCT02629159|7747153|FG002|Received Assigned Study Drug|Overall Study|One participant received a placebo injection but no oral study drug before discontinuing the study|650
6813841|NCT02629159|7747151|FG000|Completed Week 14 on Study Drug|Overall Study||620
6813842|NCT02629159|7747152|FG001|Completed Week 14 on Study Drug|Overall Study||300
6813843|NCT02629159|7747153|FG002|Completed Week 14 on Study Drug|Overall Study||620
6813844|NCT02629159|7747151|FG000|Rescued at Week 14|Overall Study||231
6813845|NCT02629159|7747152|FG001|Rescued at Week 14|Overall Study||56
6813846|NCT02629159|7747153|FG002|Rescued at Week 14|Overall Study||78
6813847|NCT02629159|7747151|FG000|Rescued at Week 18|Overall Study|One participant rescued at week 18 did not receive any dose of upadacitinib|48
6813848|NCT02629159|7747152|FG001|Rescued at Week 18|Overall Study||14
6813849|NCT02629159|7747153|FG002|Rescued at Week 18|Overall Study||29
6813850|NCT02629159|7747151|FG000|Rescued at Week 22|Overall Study||26
6813851|NCT02629159|7747152|FG001|Rescued at Week 22|Overall Study||7
6813852|NCT02629159|7747153|FG002|Rescued at Week 22|Overall Study||18
6813853|NCT02629159|7747151|FG000|COMPLETED|Overall Study||595
6813854|NCT02629159|7747152|FG001|COMPLETED|Overall Study||288
6813855|NCT02629159|7747153|FG002|COMPLETED|Overall Study||600
6813856|NCT02629159|7747151|FG000|NOT COMPLETED|Overall Study||56
6813857|NCT02629159|7747152|FG001|NOT COMPLETED|Overall Study||39
6813858|NCT02629159|7747153|FG002|NOT COMPLETED|Overall Study||51
6813859|NCT02604433|7747166|FG000|STARTED|Overall Study||224
6813860|NCT02604433|7747167|FG001|STARTED|Overall Study||112
6813861|NCT02604433|7747166|FG000|Participants Treated|Overall Study||223
6813862|NCT02604433|7747167|FG001|Participants Treated|Overall Study||109
6813863|NCT02604433|7747166|FG000|Completed 24 Weeks of Treatment|Overall Study||211
6813864|NCT02604433|7747167|FG001|Completed 24 Weeks of Treatment|Overall Study||102
6813865|NCT02604433|7747166|FG000|Completed 48 Weeks of Treatment|Overall Study||202
6813866|NCT02604433|7747167|FG001|Completed 48 Weeks of Treatment|Overall Study||96
6813867|NCT02604433|7747166|FG000|Completed 96 Weeks of Treatment|Overall Study||155
6813868|NCT02604433|7747167|FG001|Completed 96 Weeks of Treatment|Overall Study||3
6813869|NCT02604433|7747166|FG000|Completed 144 Weeks of Treatment|Overall Study||125
6813870|NCT02604433|7747167|FG001|Completed 144 Weeks of Treatment|Overall Study||0
6813871|NCT02604433|7747166|FG000|Completed 192 Weeks of Treatment|Overall Study||6
6813872|NCT02604433|7747167|FG001|Completed 192 Weeks of Treatment|Overall Study||0
6813873|NCT02604433|7747166|FG000|COMPLETED|Overall Study||6
6813874|NCT02604433|7747167|FG001|COMPLETED|Overall Study||6
6813875|NCT02604433|7747166|FG000|NOT COMPLETED|Overall Study||218
6813876|NCT02604433|7747167|FG001|NOT COMPLETED|Overall Study||106
6391019|NCT00833482|7302810|FG000|NOT COMPLETED|Days 21-30||0
6813877|NCT02550652|7747175|FG000|STARTED|Overall Study||63
6813878|NCT02550652|7747176|FG001|STARTED|Overall Study||62
6813879|NCT02550652|7747175|FG000|COMPLETED|Overall Study||42
6813880|NCT02550652|7747176|FG001|COMPLETED|Overall Study||41
6813881|NCT02550652|7747175|FG000|NOT COMPLETED|Overall Study||21
6813882|NCT02550652|7747176|FG001|NOT COMPLETED|Overall Study||21
6813883|NCT02519738|7747185|FG000|STARTED|Overall Study||20
6813884|NCT02519738|7747186|FG001|STARTED|Overall Study||17
6391020|NCT00833482|7302811|FG001|NOT COMPLETED|Days 21-30||0
6391021|NCT00833482|7302812|FG002|NOT COMPLETED|Days 21-30||1
6391022|NCT00833482|7302813|FG003|NOT COMPLETED|Days 21-30||0
6391023|NCT00833482|7302814|FG004|NOT COMPLETED|Days 21-30||1
6391024|NCT00833482|7302815|FG005|NOT COMPLETED|Days 21-30||0
6391025|NCT00833547|7302839|FG000|STARTED|Overall Study||13
6391026|NCT00833547|7302840|FG001|STARTED|Overall Study||12
6391027|NCT00833547|7302839|FG000|COMPLETED|Overall Study||11
6391028|NCT00833547|7302840|FG001|COMPLETED|Overall Study||10
6391029|NCT00833547|7302839|FG000|NOT COMPLETED|Overall Study||2
6391030|NCT00833547|7302840|FG001|NOT COMPLETED|Overall Study||2
6391031|NCT00833560|7302846|FG000|STARTED|Overall Study||395
6391032|NCT00833560|7302846|FG000|COMPLETED|Overall Study||353
6391033|NCT00833560|7302846|FG000|NOT COMPLETED|Overall Study||42
6391034|NCT00833638|7302853|FG000|STARTED|Phase 2: Double-blind Treatment Phase||121
6391035|NCT00833638|7302854|FG001|STARTED|Phase 2: Double-blind Treatment Phase||118
6391036|NCT00833638|7302855|FG002|STARTED|Phase 2: Double-blind Treatment Phase||133
6391037|NCT00833638|7302853|FG000|COMPLETED|Phase 2: Double-blind Treatment Phase||111
6391038|NCT00833638|7302854|FG001|COMPLETED|Phase 2: Double-blind Treatment Phase||108
6391039|NCT00833638|7302855|FG002|COMPLETED|Phase 2: Double-blind Treatment Phase||124
6391040|NCT00833638|7302853|FG000|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
6813885|NCT02519738|7747187|FG002|STARTED|Overall Study||15
6813886|NCT02519738|7747185|FG000|COMPLETED|Overall Study||6
6813887|NCT02519738|7747186|FG001|COMPLETED|Overall Study||4
6813888|NCT02519738|7747187|FG002|COMPLETED|Overall Study||3
6813889|NCT02519738|7747185|FG000|NOT COMPLETED|Overall Study||14
6813890|NCT02519738|7747186|FG001|NOT COMPLETED|Overall Study||13
6813891|NCT02519738|7747187|FG002|NOT COMPLETED|Overall Study||12
6813892|NCT02502071|7747195|FG000|STARTED|Overall Study||45
6813893|NCT02502071|7747195|FG000|COMPLETED|Overall Study||45
6813894|NCT02502071|7747195|FG000|NOT COMPLETED|Overall Study||0
6813895|NCT02420821|7747201|FG000|STARTED|Overall Study||461
6813896|NCT02420821|7747202|FG001|STARTED|Overall Study||454
6813897|NCT02420821|7747201|FG000|COMPLETED|Overall Study||293
6813898|NCT02420821|7747202|FG001|COMPLETED|Overall Study||317
6813899|NCT02420821|7747201|FG000|NOT COMPLETED|Overall Study||168
6813900|NCT02420821|7747202|FG001|NOT COMPLETED|Overall Study||137
6813901|NCT02412670|7747211|FG000|STARTED|Overall Study||30
6813902|NCT02412670|7747212|FG001|STARTED|Overall Study||6
6813903|NCT02412670|7747211|FG000|Eligible and Treated|Overall Study||29
6813904|NCT02412670|7747212|FG001|Eligible and Treated|Overall Study||6
6813905|NCT02412670|7747211|FG000|COMPLETED|Overall Study||23
6813906|NCT02412670|7747212|FG001|COMPLETED|Overall Study||5
6813907|NCT02412670|7747211|FG000|NOT COMPLETED|Overall Study||7
6813908|NCT02412670|7747212|FG001|NOT COMPLETED|Overall Study||1
6813909|NCT02410343|7747220|FG000|STARTED|Core Period (24 Weeks)||6
6813910|NCT02410343|7747221|FG001|STARTED|Core Period (24 Weeks)||8
6813911|NCT02410343|7747220|FG000|COMPLETED|Core Period (24 Weeks)||1
6813912|NCT02410343|7747221|FG001|COMPLETED|Core Period (24 Weeks)||1
6813913|NCT02410343|7747220|FG000|NOT COMPLETED|Core Period (24 Weeks)||5
6813914|NCT02410343|7747221|FG001|NOT COMPLETED|Core Period (24 Weeks)||7
6813915|NCT02410343|7747220|FG000|STARTED|Extension Period (12 Months)||1
6813916|NCT02410343|7747221|FG001|STARTED|Extension Period (12 Months)||1
6813917|NCT02410343|7747220|FG000|COMPLETED|Extension Period (12 Months)||0
6813918|NCT02410343|7747221|FG001|COMPLETED|Extension Period (12 Months)||0
6813919|NCT02410343|7747220|FG000|NOT COMPLETED|Extension Period (12 Months)||1
6813920|NCT02410343|7747221|FG001|NOT COMPLETED|Extension Period (12 Months)||1
6813921|NCT02343224|7747228|FG000|STARTED|Overall Study||9
6813922|NCT02343224|7747228|FG000|COMPLETED|Overall Study||0
6813923|NCT02343224|7747228|FG000|NOT COMPLETED|Overall Study||9
6813924|NCT02339740|7747234|FG000|STARTED|Overall Study||101
6813925|NCT02339740|7747235|FG001|STARTED|Overall Study||57
6813926|NCT02339740|7747234|FG000|COMPLETED|Overall Study||92
6813927|NCT02339740|7747235|FG001|COMPLETED|Overall Study||53
6813928|NCT02339740|7747234|FG000|NOT COMPLETED|Overall Study||9
6813929|NCT02339740|7747235|FG001|NOT COMPLETED|Overall Study||4
6813930|NCT02291445|7747243|FG000|STARTED|Overall Study||4
6813931|NCT02291445|7747244|FG001|STARTED|Overall Study||4
6567807|NCT01833026|7490950|FG001|NOT COMPLETED|Overall Study||0
6567808|NCT01833065|7490959|FG000|STARTED|Overall Study|Randomized patients - As treated|65
6567809|NCT01833065|7490960|FG001|STARTED|Overall Study|Randomized patients - As treated|53
6567810|NCT01833065|7490961|FG002|STARTED|Overall Study|Randomized patients - As treated|35
6567811|NCT01833065|7490962|FG003|STARTED|Overall Study|Randomized patients - As treated|50
6813932|NCT02291445|7747243|FG000|COMPLETED|Overall Study||4
6813933|NCT02291445|7747244|FG001|COMPLETED|Overall Study||4
6813934|NCT02291445|7747243|FG000|NOT COMPLETED|Overall Study||0
6813935|NCT02291445|7747244|FG001|NOT COMPLETED|Overall Study||0
6813936|NCT02248688|7747252|FG000|STARTED|Overall Study||5
6813937|NCT02248688|7747252|FG000|COMPLETED|Overall Study||5
6813938|NCT02248688|7747252|FG000|NOT COMPLETED|Overall Study||0
6813939|NCT02045303|7747258|FG000|STARTED|Overall Study||6
6813940|NCT02045303|7747259|FG001|STARTED|Overall Study||3
6813941|NCT02045303|7747260|FG002|STARTED|Overall Study||2
6813942|NCT02045303|7747258|FG000|COMPLETED|Overall Study||4
6813943|NCT02045303|7747259|FG001|COMPLETED|Overall Study||0
6813944|NCT02045303|7747260|FG002|COMPLETED|Overall Study||2
6813945|NCT02045303|7747258|FG000|NOT COMPLETED|Overall Study||2
6813946|NCT02045303|7747259|FG001|NOT COMPLETED|Overall Study||3
6813947|NCT02045303|7747260|FG002|NOT COMPLETED|Overall Study||0
6813948|NCT02025556|7747272|FG000|STARTED|Overall Study||104
6813949|NCT02025556|7747273|FG001|STARTED|Overall Study||96
6813950|NCT02025556|7747274|FG002|STARTED|Overall Study||97
6813951|NCT02025556|7747272|FG000|Safety Analysis Set|Overall Study||104
6813952|NCT02025556|7747273|FG001|Safety Analysis Set|Overall Study||96
6813953|NCT02025556|7747274|FG002|Safety Analysis Set|Overall Study||96
6813954|NCT02025556|7747272|FG000|Intent-to-treat (ITT) Set|Overall Study||104
6813955|NCT02025556|7747273|FG001|Intent-to-treat (ITT) Set|Overall Study||95
6813956|NCT02025556|7747274|FG002|Intent-to-treat (ITT) Set|Overall Study||96
6813957|NCT02025556|7747272|FG000|COMPLETED|Overall Study||98
6813958|NCT02025556|7747273|FG001|COMPLETED|Overall Study||83
6813959|NCT02025556|7747274|FG002|COMPLETED|Overall Study||88
6813960|NCT02025556|7747272|FG000|NOT COMPLETED|Overall Study||6
6813961|NCT02025556|7747273|FG001|NOT COMPLETED|Overall Study||13
6813962|NCT02025556|7747274|FG002|NOT COMPLETED|Overall Study||9
6813963|NCT01986933|7747287|FG000|STARTED|Placebo-controlled (Part A)||53
6813964|NCT01986933|7747288|FG001|STARTED|Placebo-controlled (Part A)||53
6813965|NCT01986933|7747289|FG002|STARTED|Placebo-controlled (Part A)||54
6813966|NCT01986933|7747290|FG003|STARTED|Placebo-controlled (Part A)||52
6813967|NCT01986933|7747291|FG004|STARTED|Placebo-controlled (Part A)||52
6813968|NCT01986933|7747287|FG000|COMPLETED|Placebo-controlled (Part A)||44
6813969|NCT01986933|7747288|FG001|COMPLETED|Placebo-controlled (Part A)||44
6813970|NCT01986933|7747289|FG002|COMPLETED|Placebo-controlled (Part A)||45
6813971|NCT01986933|7747290|FG003|COMPLETED|Placebo-controlled (Part A)||45
6813972|NCT01986933|7747291|FG004|COMPLETED|Placebo-controlled (Part A)||38
6813973|NCT01986933|7747287|FG000|NOT COMPLETED|Placebo-controlled (Part A)||9
6813974|NCT01986933|7747288|FG001|NOT COMPLETED|Placebo-controlled (Part A)||9
6813975|NCT01986933|7747289|FG002|NOT COMPLETED|Placebo-controlled (Part A)||9
6813976|NCT01986933|7747290|FG003|NOT COMPLETED|Placebo-controlled (Part A)||7
6813977|NCT01986933|7747291|FG004|NOT COMPLETED|Placebo-controlled (Part A)||14
6813978|NCT01986933|7747287|FG000|STARTED|Active-to-active (Part B)||0
6813979|NCT01986933|7747288|FG001|STARTED|Active-to-active (Part B)||41
6813980|NCT01986933|7747289|FG002|STARTED|Active-to-active (Part B)||38
6813981|NCT01986933|7747290|FG003|STARTED|Active-to-active (Part B)||39
6813982|NCT01986933|7747291|FG004|STARTED|Active-to-active (Part B)||35
6813983|NCT01986933|7747287|FG000|COMPLETED|Active-to-active (Part B)||0
6813984|NCT01986933|7747288|FG001|COMPLETED|Active-to-active (Part B)||31
6813985|NCT01986933|7747289|FG002|COMPLETED|Active-to-active (Part B)||28
6813986|NCT01986933|7747290|FG003|COMPLETED|Active-to-active (Part B)||30
6813987|NCT01986933|7747291|FG004|COMPLETED|Active-to-active (Part B)||19
6813988|NCT01986933|7747287|FG000|NOT COMPLETED|Active-to-active (Part B)||0
6813989|NCT01986933|7747288|FG001|NOT COMPLETED|Active-to-active (Part B)||10
6813990|NCT01986933|7747289|FG002|NOT COMPLETED|Active-to-active (Part B)||10
6813991|NCT01986933|7747290|FG003|NOT COMPLETED|Active-to-active (Part B)||9
6813992|NCT01986933|7747291|FG004|NOT COMPLETED|Active-to-active (Part B)||16
6813993|NCT01986933|7747287|FG000|STARTED|Placebo-to-active (Part B)||0
6813994|NCT01986933|7747288|FG001|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
6813995|NCT01986933|7747289|FG002|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|12
6813996|NCT01986933|7747290|FG003|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were re-randomized into Nemoliozumab groups (0.1, 0.5 or 2.0 mg/kg Q4W) in Part B.|13
6813997|NCT01986933|7747291|FG004|STARTED|Placebo-to-active (Part B)|Patients in the initial placebo group were not re-randomized into Nemoliozumab (2.0 mg/kg) Q8W group in Part B.|0
6813998|NCT01986933|7747287|FG000|COMPLETED|Placebo-to-active (Part B)||0
6813999|NCT01986933|7747288|FG001|COMPLETED|Placebo-to-active (Part B)||8
6814000|NCT01986933|7747289|FG002|COMPLETED|Placebo-to-active (Part B)||7
6814001|NCT01986933|7747290|FG003|COMPLETED|Placebo-to-active (Part B)||8
6814002|NCT01986933|7747291|FG004|COMPLETED|Placebo-to-active (Part B)||0
6814003|NCT01986933|7747287|FG000|NOT COMPLETED|Placebo-to-active (Part B)||0
6814004|NCT01986933|7747288|FG001|NOT COMPLETED|Placebo-to-active (Part B)||5
6814005|NCT01986933|7747289|FG002|NOT COMPLETED|Placebo-to-active (Part B)||5
6814006|NCT01986933|7747290|FG003|NOT COMPLETED|Placebo-to-active (Part B)||5
6814007|NCT01986933|7747291|FG004|NOT COMPLETED|Placebo-to-active (Part B)||0
6814008|NCT01986075|7747313|FG000|STARTED|Initial CBT + CM (Pre-randomization)||0
6814009|NCT01986075|7747314|FG001|STARTED|Initial CBT + CM (Pre-randomization)||0
6814010|NCT01986075|7747315|FG002|STARTED|Initial CBT + CM (Pre-randomization)||145
6814011|NCT01986075|7747313|FG000|COMPLETED|Initial CBT + CM (Pre-randomization)||0
6814012|NCT01986075|7747314|FG001|COMPLETED|Initial CBT + CM (Pre-randomization)||0
6814013|NCT01986075|7747315|FG002|COMPLETED|Initial CBT + CM (Pre-randomization)||86
6814014|NCT01986075|7747313|FG000|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
6814015|NCT01986075|7747314|FG001|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||0
6814016|NCT01986075|7747315|FG002|NOT COMPLETED|Initial CBT + CM (Pre-randomization)||59
6814017|NCT01986075|7747313|FG000|STARTED|Randomized Intervention||45
6814018|NCT01986075|7747314|FG001|STARTED|Randomized Intervention||41
6814019|NCT01986075|7747315|FG002|STARTED|Randomized Intervention||0
6814020|NCT01986075|7747313|FG000|COMPLETED|Randomized Intervention||30
6814021|NCT01986075|7747314|FG001|COMPLETED|Randomized Intervention||27
6814022|NCT01986075|7747315|FG002|COMPLETED|Randomized Intervention||0
6814023|NCT01986075|7747313|FG000|NOT COMPLETED|Randomized Intervention||15
6814024|NCT01986075|7747314|FG001|NOT COMPLETED|Randomized Intervention||14
6814025|NCT01986075|7747315|FG002|NOT COMPLETED|Randomized Intervention||0
6814026|NCT01841333|7747322|FG000|STARTED|Overall Study||31
6814027|NCT01841333|7747322|FG000|COMPLETED|Overall Study||31
6814028|NCT01841333|7747322|FG000|NOT COMPLETED|Overall Study||0
6814029|NCT01802788|7747328|FG000|STARTED|Overall Study||941
6814030|NCT01802788|7747329|FG001|STARTED|Overall Study||59
6814031|NCT01802788|7747328|FG000|COMPLETED|Overall Study||755
6814032|NCT01802788|7747329|FG001|COMPLETED|Overall Study||59
6814033|NCT01802788|7747328|FG000|NOT COMPLETED|Overall Study||186
6814034|NCT01802788|7747329|FG001|NOT COMPLETED|Overall Study||0
6814035|NCT01701674|7747333|FG000|STARTED|Overall Study||13
6814036|NCT01701674|7747333|FG000|COMPLETED|Overall Study||12
6814037|NCT01701674|7747333|FG000|NOT COMPLETED|Overall Study||1
6814038|NCT01597388|7747346|FG000|STARTED|Overall Study||6
6814039|NCT01597388|7747347|FG001|STARTED|Overall Study||13
6814040|NCT01597388|7747348|FG002|STARTED|Overall Study||14
6814041|NCT01597388|7747349|FG003|STARTED|Overall Study||10
6814042|NCT01597388|7747350|FG004|STARTED|Overall Study||37
6814043|NCT01597388|7747351|FG005|STARTED|Overall Study||4
6814044|NCT01597388|7747352|FG006|STARTED|Overall Study||8
6814045|NCT01597388|7747353|FG007|STARTED|Overall Study||5
6814046|NCT01597388|7747354|FG008|STARTED|Overall Study||2
6814047|NCT01597388|7747346|FG000|COMPLETED|Overall Study||6
6814048|NCT01597388|7747347|FG001|COMPLETED|Overall Study||13
6814049|NCT01597388|7747348|FG002|COMPLETED|Overall Study||14
6814050|NCT01597388|7747349|FG003|COMPLETED|Overall Study||10
6814051|NCT01597388|7747350|FG004|COMPLETED|Overall Study||37
6814052|NCT01597388|7747351|FG005|COMPLETED|Overall Study||4
6814053|NCT01597388|7747352|FG006|COMPLETED|Overall Study||8
6814054|NCT01597388|7747353|FG007|COMPLETED|Overall Study||5
6814055|NCT01597388|7747354|FG008|COMPLETED|Overall Study||2
6814056|NCT01597388|7747346|FG000|NOT COMPLETED|Overall Study||0
6814057|NCT01597388|7747347|FG001|NOT COMPLETED|Overall Study||0
6814058|NCT01597388|7747348|FG002|NOT COMPLETED|Overall Study||0
6814059|NCT01597388|7747349|FG003|NOT COMPLETED|Overall Study||0
6814060|NCT01597388|7747350|FG004|NOT COMPLETED|Overall Study||0
6814061|NCT01597388|7747351|FG005|NOT COMPLETED|Overall Study||0
6814062|NCT01597388|7747352|FG006|NOT COMPLETED|Overall Study||0
6814063|NCT01597388|7747353|FG007|NOT COMPLETED|Overall Study||0
6814064|NCT01597388|7747354|FG008|NOT COMPLETED|Overall Study||0
6814065|NCT01563107|7747395|FG000|STARTED|Overall Study|12 Healthy Controls were randomized to receive LS diet followed by HS diet|12
6814066|NCT01563107|7747396|FG001|STARTED|Overall Study|5 Healthy Controls were randomized to receive HS diet followed by LS diet|5
6814067|NCT01563107|7747397|FG002|STARTED|Overall Study|10 POTS patients were randomized to receive LS diet followed by HS diet|10
6814068|NCT01563107|7747398|FG003|STARTED|Overall Study|11 POTS patients were randomized to receive HS diet followed by LS diet|11
6814069|NCT01563107|7747395|FG000|Phase 1 Baseline Labs|Overall Study||12
6814070|NCT01563107|7747396|FG001|Phase 1 Baseline Labs|Overall Study|1 healthy control was unable to find time to schedule study|4
6814071|NCT01563107|7747397|FG002|Phase 1 Baseline Labs|Overall Study|2 patients with POTS did not discontinue medication that was prohibited by protocol.|8
6814072|NCT01563107|7747398|FG003|Phase 1 Baseline Labs|Overall Study|1 patient with POTS did not discontinue medication that was prohibited by protocol, 1 patient was unable to find time to schedule the study, 1 was noted to be too old to participate, and 1 became pregnant between enrollment and the start of phase 1.|7
6814073|NCT01563107|7747395|FG000|Phase 1-150 mEq Sodium/Day|Overall Study||12
6814074|NCT01563107|7747396|FG001|Phase 1-150 mEq Sodium/Day|Overall Study||4
6814075|NCT01563107|7747397|FG002|Phase 1-150 mEq Sodium/Day|Overall Study||8
6814076|NCT01563107|7747398|FG003|Phase 1-150 mEq Sodium/Day|Overall Study||7
6814077|NCT01563107|7747395|FG000|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||12
6814078|NCT01563107|7747396|FG001|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||4
6814079|NCT01563107|7747397|FG002|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||8
6814080|NCT01563107|7747398|FG003|Phase 1-start Low Sodium or High Sodium Diet|Overall Study||7
6814081|NCT01563107|7747395|FG000|Phase 1-finish|Overall Study|1 healthy control withdrew with migraines during phase 1 (low Na+).|11
6814082|NCT01563107|7747396|FG001|Phase 1-finish|Overall Study|2 healthy controls withdrew during phase 1 (high Na+): 1 unable to tolerate study diet and another with difficulty cooperating with investigators.|2
6814083|NCT01563107|7747397|FG002|Phase 1-finish|Overall Study||8
6814084|NCT01563107|7747398|FG003|Phase 1-finish|Overall Study|1 patient with POTS withdrew during phase 1 due to a family illness.|6
6814085|NCT01563107|7747395|FG000|Phase 2-150 mEq Sodium/Day|Overall Study||11
6814086|NCT01563107|7747396|FG001|Phase 2-150 mEq Sodium/Day|Overall Study||2
6814087|NCT01563107|7747397|FG002|Phase 2-150 mEq Sodium/Day|Overall Study||8
6814088|NCT01563107|7747398|FG003|Phase 2-150 mEq Sodium/Day|Overall Study||6
6814089|NCT01563107|7747395|FG000|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||11
6814090|NCT01563107|7747396|FG001|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||2
6814091|NCT01563107|7747397|FG002|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||8
6814092|NCT01563107|7747398|FG003|Phase 2-start Low Sodium or High Sodium Diet|Overall Study||6
6814093|NCT01563107|7747395|FG000|Phase 2-finish|Overall Study||11
6814094|NCT01563107|7747396|FG001|Phase 2-finish|Overall Study||2
6814095|NCT01563107|7747397|FG002|Phase 2-finish|Overall Study||8
6814096|NCT01563107|7747398|FG003|Phase 2-finish|Overall Study||6
6814097|NCT01563107|7747395|FG000|COMPLETED|Overall Study||11
6814098|NCT01563107|7747396|FG001|COMPLETED|Overall Study||2
6814099|NCT01563107|7747397|FG002|COMPLETED|Overall Study||8
6814100|NCT01563107|7747398|FG003|COMPLETED|Overall Study||6
6814101|NCT01563107|7747395|FG000|NOT COMPLETED|Overall Study||1
6814102|NCT01563107|7747396|FG001|NOT COMPLETED|Overall Study||3
6814103|NCT01563107|7747397|FG002|NOT COMPLETED|Overall Study||2
6814104|NCT01563107|7747398|FG003|NOT COMPLETED|Overall Study||5
6814105|NCT01320072|7747460|FG000|STARTED|Overall Study||16
6814106|NCT01320072|7747461|FG001|STARTED|Overall Study||13
6814107|NCT01320072|7747460|FG000|COMPLETED|Overall Study||16
6814108|NCT01320072|7747461|FG001|COMPLETED|Overall Study||13
6814109|NCT01320072|7747460|FG000|NOT COMPLETED|Overall Study||0
6814110|NCT01320072|7747461|FG001|NOT COMPLETED|Overall Study||0
6814111|NCT01116648|7747483|FG000|STARTED|Phase 1 Dose Level 0||3
6814112|NCT01116648|7747484|FG001|STARTED|Phase 1 Dose Level 0||0
6814113|NCT01116648|7747485|FG002|STARTED|Phase 1 Dose Level 0||0
6814114|NCT01116648|7747486|FG003|STARTED|Phase 1 Dose Level 0||0
6814115|NCT01116648|7747487|FG004|STARTED|Phase 1 Dose Level 0||0
6814116|NCT01116648|7747488|FG005|STARTED|Phase 1 Dose Level 0||0
6814117|NCT01116648|7747489|FG006|STARTED|Phase 1 Dose Level 0||0
6814118|NCT01116648|7747490|FG007|STARTED|Phase 1 Dose Level 0||0
6814119|NCT01116648|7747491|FG008|STARTED|Phase 1 Dose Level 0||0
6814120|NCT01116648|7747492|FG009|STARTED|Phase 1 Dose Level 0||0
6814121|NCT01116648|7747493|FG010|STARTED|Phase 1 Dose Level 0||0
6814122|NCT01116648|7747494|FG011|STARTED|Phase 1 Dose Level 0||0
6814123|NCT01116648|7747495|FG012|STARTED|Phase 1 Dose Level 0||0
6814124|NCT01116648|7747496|FG013|STARTED|Phase 1 Dose Level 0||0
6814125|NCT01116648|7747497|FG014|STARTED|Phase 1 Dose Level 0||0
6814126|NCT01116648|7747483|FG000|COMPLETED|Phase 1 Dose Level 0||3
6814127|NCT01116648|7747484|FG001|COMPLETED|Phase 1 Dose Level 0||0
6814128|NCT01116648|7747485|FG002|COMPLETED|Phase 1 Dose Level 0||0
6814129|NCT01116648|7747486|FG003|COMPLETED|Phase 1 Dose Level 0||0
6814130|NCT01116648|7747487|FG004|COMPLETED|Phase 1 Dose Level 0||0
6814131|NCT01116648|7747488|FG005|COMPLETED|Phase 1 Dose Level 0||0
6814132|NCT01116648|7747489|FG006|COMPLETED|Phase 1 Dose Level 0||0
6814133|NCT01116648|7747490|FG007|COMPLETED|Phase 1 Dose Level 0||0
6814134|NCT01116648|7747491|FG008|COMPLETED|Phase 1 Dose Level 0||0
6814135|NCT01116648|7747492|FG009|COMPLETED|Phase 1 Dose Level 0||0
6814136|NCT01116648|7747493|FG010|COMPLETED|Phase 1 Dose Level 0||0
6814137|NCT01116648|7747494|FG011|COMPLETED|Phase 1 Dose Level 0||0
6814138|NCT01116648|7747495|FG012|COMPLETED|Phase 1 Dose Level 0||0
6814139|NCT01116648|7747496|FG013|COMPLETED|Phase 1 Dose Level 0||0
6814140|NCT01116648|7747497|FG014|COMPLETED|Phase 1 Dose Level 0||0
6814141|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1 Dose Level 0||0
6814142|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1 Dose Level 0||0
6814143|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1 Dose Level 0||0
6814144|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1 Dose Level 0||0
6814145|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1 Dose Level 0||0
6814146|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1 Dose Level 0||0
6814147|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1 Dose Level 0||0
6814148|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1 Dose Level 0||0
6814149|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1 Dose Level 0||0
6814150|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1 Dose Level 0||0
6814151|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1 Dose Level 0||0
6814152|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1 Dose Level 0||0
6814153|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1 Dose Level 0||0
6814154|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1 Dose Level 0||0
6814155|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1 Dose Level 0||0
6814156|NCT01116648|7747483|FG000|STARTED|Phase 1 Dose Level 1||0
6814157|NCT01116648|7747484|FG001|STARTED|Phase 1 Dose Level 1||3
6814158|NCT01116648|7747485|FG002|STARTED|Phase 1 Dose Level 1||0
6814159|NCT01116648|7747486|FG003|STARTED|Phase 1 Dose Level 1||0
6814160|NCT01116648|7747487|FG004|STARTED|Phase 1 Dose Level 1||0
6814161|NCT01116648|7747488|FG005|STARTED|Phase 1 Dose Level 1||0
6814162|NCT01116648|7747489|FG006|STARTED|Phase 1 Dose Level 1||0
6814163|NCT01116648|7747490|FG007|STARTED|Phase 1 Dose Level 1||0
6814164|NCT01116648|7747491|FG008|STARTED|Phase 1 Dose Level 1||0
6814165|NCT01116648|7747492|FG009|STARTED|Phase 1 Dose Level 1||0
6814166|NCT01116648|7747493|FG010|STARTED|Phase 1 Dose Level 1||0
6814167|NCT01116648|7747494|FG011|STARTED|Phase 1 Dose Level 1||0
6814168|NCT01116648|7747495|FG012|STARTED|Phase 1 Dose Level 1||0
6814169|NCT01116648|7747496|FG013|STARTED|Phase 1 Dose Level 1||0
6814170|NCT01116648|7747497|FG014|STARTED|Phase 1 Dose Level 1||0
6814171|NCT01116648|7747483|FG000|COMPLETED|Phase 1 Dose Level 1||0
6814172|NCT01116648|7747484|FG001|COMPLETED|Phase 1 Dose Level 1||3
6814173|NCT01116648|7747485|FG002|COMPLETED|Phase 1 Dose Level 1||0
6814174|NCT01116648|7747486|FG003|COMPLETED|Phase 1 Dose Level 1||0
6814175|NCT01116648|7747487|FG004|COMPLETED|Phase 1 Dose Level 1||0
6814176|NCT01116648|7747488|FG005|COMPLETED|Phase 1 Dose Level 1||0
6814177|NCT01116648|7747489|FG006|COMPLETED|Phase 1 Dose Level 1||0
6814178|NCT01116648|7747490|FG007|COMPLETED|Phase 1 Dose Level 1||0
6814179|NCT01116648|7747491|FG008|COMPLETED|Phase 1 Dose Level 1||0
6814180|NCT01116648|7747492|FG009|COMPLETED|Phase 1 Dose Level 1||0
6814181|NCT01116648|7747493|FG010|COMPLETED|Phase 1 Dose Level 1||0
6814182|NCT01116648|7747494|FG011|COMPLETED|Phase 1 Dose Level 1||0
6814183|NCT01116648|7747495|FG012|COMPLETED|Phase 1 Dose Level 1||0
6814184|NCT01116648|7747496|FG013|COMPLETED|Phase 1 Dose Level 1||0
6814185|NCT01116648|7747497|FG014|COMPLETED|Phase 1 Dose Level 1||0
6814186|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1 Dose Level 1||0
6814187|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1 Dose Level 1||0
6814188|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1 Dose Level 1||0
6814189|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1 Dose Level 1||0
6814190|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1 Dose Level 1||0
6814191|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1 Dose Level 1||0
6814192|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1 Dose Level 1||0
6814193|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1 Dose Level 1||0
6814194|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1 Dose Level 1||0
6814195|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1 Dose Level 1||0
6814196|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1 Dose Level 1||0
6814197|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1 Dose Level 1||0
6814198|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1 Dose Level 1||0
6814199|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1 Dose Level 1||0
6814200|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1 Dose Level 1||0
6814201|NCT01116648|7747483|FG000|STARTED|Phase 1 Dose Level 2||0
6814202|NCT01116648|7747484|FG001|STARTED|Phase 1 Dose Level 2||0
6814203|NCT01116648|7747485|FG002|STARTED|Phase 1 Dose Level 2||7
6814204|NCT01116648|7747486|FG003|STARTED|Phase 1 Dose Level 2||0
6814205|NCT01116648|7747487|FG004|STARTED|Phase 1 Dose Level 2||0
6814206|NCT01116648|7747488|FG005|STARTED|Phase 1 Dose Level 2||0
6814207|NCT01116648|7747489|FG006|STARTED|Phase 1 Dose Level 2||0
6814208|NCT01116648|7747490|FG007|STARTED|Phase 1 Dose Level 2||0
6814209|NCT01116648|7747491|FG008|STARTED|Phase 1 Dose Level 2||0
6814210|NCT01116648|7747492|FG009|STARTED|Phase 1 Dose Level 2||0
6814211|NCT01116648|7747493|FG010|STARTED|Phase 1 Dose Level 2||0
6814212|NCT01116648|7747494|FG011|STARTED|Phase 1 Dose Level 2||0
6814213|NCT01116648|7747495|FG012|STARTED|Phase 1 Dose Level 2||0
6814214|NCT01116648|7747496|FG013|STARTED|Phase 1 Dose Level 2||0
6814215|NCT01116648|7747497|FG014|STARTED|Phase 1 Dose Level 2||0
6814216|NCT01116648|7747483|FG000|COMPLETED|Phase 1 Dose Level 2||0
6814217|NCT01116648|7747484|FG001|COMPLETED|Phase 1 Dose Level 2||0
6814218|NCT01116648|7747485|FG002|COMPLETED|Phase 1 Dose Level 2||7
6814219|NCT01116648|7747486|FG003|COMPLETED|Phase 1 Dose Level 2||0
6814220|NCT01116648|7747487|FG004|COMPLETED|Phase 1 Dose Level 2||0
6814221|NCT01116648|7747488|FG005|COMPLETED|Phase 1 Dose Level 2||0
6814222|NCT01116648|7747489|FG006|COMPLETED|Phase 1 Dose Level 2||0
6814223|NCT01116648|7747490|FG007|COMPLETED|Phase 1 Dose Level 2||0
6814224|NCT01116648|7747491|FG008|COMPLETED|Phase 1 Dose Level 2||0
6814225|NCT01116648|7747492|FG009|COMPLETED|Phase 1 Dose Level 2||0
6814226|NCT01116648|7747493|FG010|COMPLETED|Phase 1 Dose Level 2||0
6814227|NCT01116648|7747494|FG011|COMPLETED|Phase 1 Dose Level 2||0
6814228|NCT01116648|7747495|FG012|COMPLETED|Phase 1 Dose Level 2||0
6814229|NCT01116648|7747496|FG013|COMPLETED|Phase 1 Dose Level 2||0
6814230|NCT01116648|7747497|FG014|COMPLETED|Phase 1 Dose Level 2||0
6814231|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1 Dose Level 2||0
6814232|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1 Dose Level 2||0
6814233|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1 Dose Level 2||0
6814234|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1 Dose Level 2||0
6814235|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1 Dose Level 2||0
6814236|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1 Dose Level 2||0
6814237|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1 Dose Level 2||0
6814238|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1 Dose Level 2||0
6814239|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1 Dose Level 2||0
6814240|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1 Dose Level 2||0
6814241|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1 Dose Level 2||0
6814242|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1 Dose Level 2||0
6814243|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1 Dose Level 2||0
6814244|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1 Dose Level 2||0
6814245|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1 Dose Level 2||0
6814246|NCT01116648|7747483|FG000|STARTED|Phase 1 Dose Level 3||0
6814247|NCT01116648|7747484|FG001|STARTED|Phase 1 Dose Level 3||0
6814248|NCT01116648|7747485|FG002|STARTED|Phase 1 Dose Level 3||0
6814249|NCT01116648|7747486|FG003|STARTED|Phase 1 Dose Level 3||6
6814250|NCT01116648|7747487|FG004|STARTED|Phase 1 Dose Level 3||0
6814251|NCT01116648|7747488|FG005|STARTED|Phase 1 Dose Level 3||0
6814252|NCT01116648|7747489|FG006|STARTED|Phase 1 Dose Level 3||0
6814253|NCT01116648|7747490|FG007|STARTED|Phase 1 Dose Level 3||0
6567812|NCT01833065|7490963|FG004|STARTED|Overall Study|Randomized patients - As treated|110
6567813|NCT01833065|7490959|FG000|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
6567814|NCT01833065|7490960|FG001|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
6814254|NCT01116648|7747491|FG008|STARTED|Phase 1 Dose Level 3||0
6814255|NCT01116648|7747492|FG009|STARTED|Phase 1 Dose Level 3||0
6814256|NCT01116648|7747493|FG010|STARTED|Phase 1 Dose Level 3||0
6814257|NCT01116648|7747494|FG011|STARTED|Phase 1 Dose Level 3||0
6814258|NCT01116648|7747495|FG012|STARTED|Phase 1 Dose Level 3||0
6814259|NCT01116648|7747496|FG013|STARTED|Phase 1 Dose Level 3||0
6814260|NCT01116648|7747497|FG014|STARTED|Phase 1 Dose Level 3||0
6814261|NCT01116648|7747483|FG000|COMPLETED|Phase 1 Dose Level 3||0
6814262|NCT01116648|7747484|FG001|COMPLETED|Phase 1 Dose Level 3||0
6814263|NCT01116648|7747485|FG002|COMPLETED|Phase 1 Dose Level 3||0
6814264|NCT01116648|7747486|FG003|COMPLETED|Phase 1 Dose Level 3||4
6814265|NCT01116648|7747487|FG004|COMPLETED|Phase 1 Dose Level 3||0
6814266|NCT01116648|7747488|FG005|COMPLETED|Phase 1 Dose Level 3||0
6814267|NCT01116648|7747489|FG006|COMPLETED|Phase 1 Dose Level 3||0
6814268|NCT01116648|7747490|FG007|COMPLETED|Phase 1 Dose Level 3||0
6814269|NCT01116648|7747491|FG008|COMPLETED|Phase 1 Dose Level 3||0
6814270|NCT01116648|7747492|FG009|COMPLETED|Phase 1 Dose Level 3||0
6814271|NCT01116648|7747493|FG010|COMPLETED|Phase 1 Dose Level 3||0
6814272|NCT01116648|7747494|FG011|COMPLETED|Phase 1 Dose Level 3||0
6814273|NCT01116648|7747495|FG012|COMPLETED|Phase 1 Dose Level 3||0
6814274|NCT01116648|7747496|FG013|COMPLETED|Phase 1 Dose Level 3||0
6814275|NCT01116648|7747497|FG014|COMPLETED|Phase 1 Dose Level 3||0
6814276|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1 Dose Level 3||0
6814277|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1 Dose Level 3||0
6814278|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1 Dose Level 3||0
6814279|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1 Dose Level 3||2
6814280|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1 Dose Level 3||0
6814281|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1 Dose Level 3||0
6814282|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1 Dose Level 3||0
6814283|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1 Dose Level 3||0
6814284|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1 Dose Level 3||0
6814285|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1 Dose Level 3||0
6814286|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1 Dose Level 3||0
6814287|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1 Dose Level 3||0
6814288|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1 Dose Level 3||0
6814289|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1 Dose Level 3||0
6814290|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1 Dose Level 3||0
6814291|NCT01116648|7747483|FG000|STARTED|Expansion at Maximum Tolerated Dose||0
6814292|NCT01116648|7747484|FG001|STARTED|Expansion at Maximum Tolerated Dose||0
6814293|NCT01116648|7747485|FG002|STARTED|Expansion at Maximum Tolerated Dose||0
6814294|NCT01116648|7747486|FG003|STARTED|Expansion at Maximum Tolerated Dose||0
6814295|NCT01116648|7747487|FG004|STARTED|Expansion at Maximum Tolerated Dose||9
6814296|NCT01116648|7747488|FG005|STARTED|Expansion at Maximum Tolerated Dose||0
6814297|NCT01116648|7747489|FG006|STARTED|Expansion at Maximum Tolerated Dose||0
6814298|NCT01116648|7747490|FG007|STARTED|Expansion at Maximum Tolerated Dose||0
6814299|NCT01116648|7747491|FG008|STARTED|Expansion at Maximum Tolerated Dose||0
6814300|NCT01116648|7747492|FG009|STARTED|Expansion at Maximum Tolerated Dose||0
6814301|NCT01116648|7747493|FG010|STARTED|Expansion at Maximum Tolerated Dose||0
6814302|NCT01116648|7747494|FG011|STARTED|Expansion at Maximum Tolerated Dose||0
6814303|NCT01116648|7747495|FG012|STARTED|Expansion at Maximum Tolerated Dose||0
6814304|NCT01116648|7747496|FG013|STARTED|Expansion at Maximum Tolerated Dose||0
6814305|NCT01116648|7747497|FG014|STARTED|Expansion at Maximum Tolerated Dose||0
6814306|NCT01116648|7747483|FG000|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814307|NCT01116648|7747484|FG001|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814308|NCT01116648|7747485|FG002|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814309|NCT01116648|7747486|FG003|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814310|NCT01116648|7747487|FG004|COMPLETED|Expansion at Maximum Tolerated Dose||9
6814311|NCT01116648|7747488|FG005|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814312|NCT01116648|7747489|FG006|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814313|NCT01116648|7747490|FG007|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814314|NCT01116648|7747491|FG008|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814315|NCT01116648|7747492|FG009|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814316|NCT01116648|7747493|FG010|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814317|NCT01116648|7747494|FG011|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814318|NCT01116648|7747495|FG012|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814319|NCT01116648|7747496|FG013|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814320|NCT01116648|7747497|FG014|COMPLETED|Expansion at Maximum Tolerated Dose||0
6814321|NCT01116648|7747483|FG000|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814322|NCT01116648|7747484|FG001|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814323|NCT01116648|7747485|FG002|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814324|NCT01116648|7747486|FG003|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814325|NCT01116648|7747487|FG004|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814326|NCT01116648|7747488|FG005|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814327|NCT01116648|7747489|FG006|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814328|NCT01116648|7747490|FG007|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814329|NCT01116648|7747491|FG008|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814330|NCT01116648|7747492|FG009|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814331|NCT01116648|7747493|FG010|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814332|NCT01116648|7747494|FG011|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814333|NCT01116648|7747495|FG012|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814334|NCT01116648|7747496|FG013|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814335|NCT01116648|7747497|FG014|NOT COMPLETED|Expansion at Maximum Tolerated Dose||0
6814336|NCT01116648|7747483|FG000|STARTED|Phase 2||0
6814337|NCT01116648|7747484|FG001|STARTED|Phase 2||0
6814338|NCT01116648|7747485|FG002|STARTED|Phase 2||0
6814339|NCT01116648|7747486|FG003|STARTED|Phase 2||0
6814340|NCT01116648|7747487|FG004|STARTED|Phase 2||0
6814341|NCT01116648|7747488|FG005|STARTED|Phase 2||46
6814342|NCT01116648|7747489|FG006|STARTED|Phase 2||44
6814343|NCT01116648|7747490|FG007|STARTED|Phase 2||0
6814344|NCT01116648|7747491|FG008|STARTED|Phase 2||0
6814345|NCT01116648|7747492|FG009|STARTED|Phase 2||0
6814346|NCT01116648|7747493|FG010|STARTED|Phase 2||0
6814347|NCT01116648|7747494|FG011|STARTED|Phase 2||0
6814348|NCT01116648|7747495|FG012|STARTED|Phase 2||0
6814349|NCT01116648|7747496|FG013|STARTED|Phase 2||0
6814350|NCT01116648|7747497|FG014|STARTED|Phase 2||0
6814351|NCT01116648|7747483|FG000|COMPLETED|Phase 2||0
6814352|NCT01116648|7747484|FG001|COMPLETED|Phase 2||0
6814353|NCT01116648|7747485|FG002|COMPLETED|Phase 2||0
6814354|NCT01116648|7747486|FG003|COMPLETED|Phase 2||0
6814355|NCT01116648|7747487|FG004|COMPLETED|Phase 2||0
6814356|NCT01116648|7747488|FG005|COMPLETED|Phase 2||46
6814357|NCT01116648|7747489|FG006|COMPLETED|Phase 2||44
6814358|NCT01116648|7747490|FG007|COMPLETED|Phase 2||0
6814359|NCT01116648|7747491|FG008|COMPLETED|Phase 2||0
6814360|NCT01116648|7747492|FG009|COMPLETED|Phase 2||0
6814361|NCT01116648|7747493|FG010|COMPLETED|Phase 2||0
6814362|NCT01116648|7747494|FG011|COMPLETED|Phase 2||0
6814363|NCT01116648|7747495|FG012|COMPLETED|Phase 2||0
6814364|NCT01116648|7747496|FG013|COMPLETED|Phase 2||0
6814365|NCT01116648|7747497|FG014|COMPLETED|Phase 2||0
6814366|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 2||0
6814367|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 2||0
6814368|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 2||0
6814369|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 2||0
6814370|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 2||0
6814371|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 2||0
6814372|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 2||0
6814373|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 2||0
6814374|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 2||0
6814375|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 2||0
6814376|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 2||0
6814377|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 2||0
6814378|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 2||0
6814379|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 2||0
6814380|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 2||0
6814381|NCT01116648|7747483|FG000|STARTED|Phase 1-T Dose Level 0-TA||0
6814382|NCT01116648|7747484|FG001|STARTED|Phase 1-T Dose Level 0-TA||0
6814383|NCT01116648|7747485|FG002|STARTED|Phase 1-T Dose Level 0-TA||0
6814384|NCT01116648|7747486|FG003|STARTED|Phase 1-T Dose Level 0-TA||0
6814385|NCT01116648|7747487|FG004|STARTED|Phase 1-T Dose Level 0-TA||0
6814386|NCT01116648|7747488|FG005|STARTED|Phase 1-T Dose Level 0-TA||0
6814387|NCT01116648|7747489|FG006|STARTED|Phase 1-T Dose Level 0-TA||0
6814388|NCT01116648|7747490|FG007|STARTED|Phase 1-T Dose Level 0-TA||3
6814389|NCT01116648|7747491|FG008|STARTED|Phase 1-T Dose Level 0-TA||0
6814390|NCT01116648|7747492|FG009|STARTED|Phase 1-T Dose Level 0-TA||0
6814391|NCT01116648|7747493|FG010|STARTED|Phase 1-T Dose Level 0-TA||0
6814392|NCT01116648|7747494|FG011|STARTED|Phase 1-T Dose Level 0-TA||0
6814393|NCT01116648|7747495|FG012|STARTED|Phase 1-T Dose Level 0-TA||0
6814394|NCT01116648|7747496|FG013|STARTED|Phase 1-T Dose Level 0-TA||0
6814395|NCT01116648|7747497|FG014|STARTED|Phase 1-T Dose Level 0-TA||0
6814396|NCT01116648|7747483|FG000|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814397|NCT01116648|7747484|FG001|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814398|NCT01116648|7747485|FG002|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814399|NCT01116648|7747486|FG003|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814400|NCT01116648|7747487|FG004|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814401|NCT01116648|7747488|FG005|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814402|NCT01116648|7747489|FG006|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814403|NCT01116648|7747490|FG007|COMPLETED|Phase 1-T Dose Level 0-TA||3
6814404|NCT01116648|7747491|FG008|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814405|NCT01116648|7747492|FG009|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814406|NCT01116648|7747493|FG010|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814407|NCT01116648|7747494|FG011|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814408|NCT01116648|7747495|FG012|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814409|NCT01116648|7747496|FG013|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814410|NCT01116648|7747497|FG014|COMPLETED|Phase 1-T Dose Level 0-TA||0
6814411|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814412|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814413|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814414|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814415|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814416|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814417|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814418|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814419|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814420|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814421|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814422|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814423|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814424|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814425|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TA||0
6814426|NCT01116648|7747483|FG000|STARTED|Phase 1-T Dose Level 1-TA||0
6814427|NCT01116648|7747484|FG001|STARTED|Phase 1-T Dose Level 1-TA||0
6814428|NCT01116648|7747485|FG002|STARTED|Phase 1-T Dose Level 1-TA||0
6814429|NCT01116648|7747486|FG003|STARTED|Phase 1-T Dose Level 1-TA||0
6814430|NCT01116648|7747487|FG004|STARTED|Phase 1-T Dose Level 1-TA||0
6814431|NCT01116648|7747488|FG005|STARTED|Phase 1-T Dose Level 1-TA||0
6814432|NCT01116648|7747489|FG006|STARTED|Phase 1-T Dose Level 1-TA||0
6814433|NCT01116648|7747490|FG007|STARTED|Phase 1-T Dose Level 1-TA||0
6814434|NCT01116648|7747491|FG008|STARTED|Phase 1-T Dose Level 1-TA||6
6814435|NCT01116648|7747492|FG009|STARTED|Phase 1-T Dose Level 1-TA||0
6814436|NCT01116648|7747493|FG010|STARTED|Phase 1-T Dose Level 1-TA||0
6814437|NCT01116648|7747494|FG011|STARTED|Phase 1-T Dose Level 1-TA||0
6814438|NCT01116648|7747495|FG012|STARTED|Phase 1-T Dose Level 1-TA||0
6814439|NCT01116648|7747496|FG013|STARTED|Phase 1-T Dose Level 1-TA||0
6814440|NCT01116648|7747497|FG014|STARTED|Phase 1-T Dose Level 1-TA||0
6814441|NCT01116648|7747483|FG000|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814442|NCT01116648|7747484|FG001|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814443|NCT01116648|7747485|FG002|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814444|NCT01116648|7747486|FG003|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814445|NCT01116648|7747487|FG004|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814446|NCT01116648|7747488|FG005|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814447|NCT01116648|7747489|FG006|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814448|NCT01116648|7747490|FG007|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814449|NCT01116648|7747491|FG008|COMPLETED|Phase 1-T Dose Level 1-TA||6
6814450|NCT01116648|7747492|FG009|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814451|NCT01116648|7747493|FG010|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814452|NCT01116648|7747494|FG011|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814453|NCT01116648|7747495|FG012|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814454|NCT01116648|7747496|FG013|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814455|NCT01116648|7747497|FG014|COMPLETED|Phase 1-T Dose Level 1-TA||0
6814456|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814457|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814458|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814459|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814460|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814461|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814462|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814463|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814464|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814465|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814466|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814467|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814468|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814469|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814470|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TA||0
6814471|NCT01116648|7747483|FG000|STARTED|Phase 1-T Dose Level 2-TA||0
6814472|NCT01116648|7747484|FG001|STARTED|Phase 1-T Dose Level 2-TA||0
6814473|NCT01116648|7747485|FG002|STARTED|Phase 1-T Dose Level 2-TA||0
6814474|NCT01116648|7747486|FG003|STARTED|Phase 1-T Dose Level 2-TA||0
6814475|NCT01116648|7747487|FG004|STARTED|Phase 1-T Dose Level 2-TA||0
6814476|NCT01116648|7747488|FG005|STARTED|Phase 1-T Dose Level 2-TA||0
6814477|NCT01116648|7747489|FG006|STARTED|Phase 1-T Dose Level 2-TA||0
6814478|NCT01116648|7747490|FG007|STARTED|Phase 1-T Dose Level 2-TA||0
6814479|NCT01116648|7747491|FG008|STARTED|Phase 1-T Dose Level 2-TA||0
6814480|NCT01116648|7747492|FG009|STARTED|Phase 1-T Dose Level 2-TA||3
6814481|NCT01116648|7747493|FG010|STARTED|Phase 1-T Dose Level 2-TA||0
6814482|NCT01116648|7747494|FG011|STARTED|Phase 1-T Dose Level 2-TA||0
6814483|NCT01116648|7747495|FG012|STARTED|Phase 1-T Dose Level 2-TA||0
6814484|NCT01116648|7747496|FG013|STARTED|Phase 1-T Dose Level 2-TA||0
6814485|NCT01116648|7747497|FG014|STARTED|Phase 1-T Dose Level 2-TA||0
6814486|NCT01116648|7747483|FG000|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814487|NCT01116648|7747484|FG001|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814488|NCT01116648|7747485|FG002|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814489|NCT01116648|7747486|FG003|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814490|NCT01116648|7747487|FG004|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814491|NCT01116648|7747488|FG005|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814492|NCT01116648|7747489|FG006|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814493|NCT01116648|7747490|FG007|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814494|NCT01116648|7747491|FG008|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814495|NCT01116648|7747492|FG009|COMPLETED|Phase 1-T Dose Level 2-TA||3
6814496|NCT01116648|7747493|FG010|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814497|NCT01116648|7747494|FG011|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814498|NCT01116648|7747495|FG012|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814499|NCT01116648|7747496|FG013|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814500|NCT01116648|7747497|FG014|COMPLETED|Phase 1-T Dose Level 2-TA||0
6814501|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814502|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814503|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814504|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814505|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814506|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814507|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814508|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814509|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814510|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814511|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814512|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814513|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814514|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814515|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TA||0
6814516|NCT01116648|7747483|FG000|STARTED|Phase 1-T Dose Level 0-TB||0
6814517|NCT01116648|7747484|FG001|STARTED|Phase 1-T Dose Level 0-TB||0
6814518|NCT01116648|7747485|FG002|STARTED|Phase 1-T Dose Level 0-TB||0
6814519|NCT01116648|7747486|FG003|STARTED|Phase 1-T Dose Level 0-TB||0
6814520|NCT01116648|7747487|FG004|STARTED|Phase 1-T Dose Level 0-TB||0
6814521|NCT01116648|7747488|FG005|STARTED|Phase 1-T Dose Level 0-TB||0
6814522|NCT01116648|7747489|FG006|STARTED|Phase 1-T Dose Level 0-TB||0
6814523|NCT01116648|7747490|FG007|STARTED|Phase 1-T Dose Level 0-TB||0
6814524|NCT01116648|7747491|FG008|STARTED|Phase 1-T Dose Level 0-TB||0
6814525|NCT01116648|7747492|FG009|STARTED|Phase 1-T Dose Level 0-TB||0
6814526|NCT01116648|7747493|FG010|STARTED|Phase 1-T Dose Level 0-TB||3
6814527|NCT01116648|7747494|FG011|STARTED|Phase 1-T Dose Level 0-TB||0
6814528|NCT01116648|7747495|FG012|STARTED|Phase 1-T Dose Level 0-TB||0
6814529|NCT01116648|7747496|FG013|STARTED|Phase 1-T Dose Level 0-TB||0
6814530|NCT01116648|7747497|FG014|STARTED|Phase 1-T Dose Level 0-TB||0
6814531|NCT01116648|7747483|FG000|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814532|NCT01116648|7747484|FG001|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814533|NCT01116648|7747485|FG002|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814534|NCT01116648|7747486|FG003|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814535|NCT01116648|7747487|FG004|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814536|NCT01116648|7747488|FG005|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814537|NCT01116648|7747489|FG006|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814538|NCT01116648|7747490|FG007|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814539|NCT01116648|7747491|FG008|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814540|NCT01116648|7747492|FG009|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814541|NCT01116648|7747493|FG010|COMPLETED|Phase 1-T Dose Level 0-TB||3
6814542|NCT01116648|7747494|FG011|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814543|NCT01116648|7747495|FG012|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814544|NCT01116648|7747496|FG013|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814545|NCT01116648|7747497|FG014|COMPLETED|Phase 1-T Dose Level 0-TB||0
6814546|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814547|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814548|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814549|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814550|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814551|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6567815|NCT01833065|7490961|FG002|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
6567816|NCT01833065|7490962|FG003|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
6814552|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814553|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814554|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814555|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814556|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814557|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814558|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814559|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814560|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1-T Dose Level 0-TB||0
6814561|NCT01116648|7747483|FG000|STARTED|Phase 1-T Dose Level 1-TB||0
6814562|NCT01116648|7747484|FG001|STARTED|Phase 1-T Dose Level 1-TB||0
6814563|NCT01116648|7747485|FG002|STARTED|Phase 1-T Dose Level 1-TB||0
6814564|NCT01116648|7747486|FG003|STARTED|Phase 1-T Dose Level 1-TB||0
6814565|NCT01116648|7747487|FG004|STARTED|Phase 1-T Dose Level 1-TB||0
6814566|NCT01116648|7747488|FG005|STARTED|Phase 1-T Dose Level 1-TB||0
6814567|NCT01116648|7747489|FG006|STARTED|Phase 1-T Dose Level 1-TB||0
6814568|NCT01116648|7747490|FG007|STARTED|Phase 1-T Dose Level 1-TB||0
6814569|NCT01116648|7747491|FG008|STARTED|Phase 1-T Dose Level 1-TB||0
6814570|NCT01116648|7747492|FG009|STARTED|Phase 1-T Dose Level 1-TB||0
6814571|NCT01116648|7747493|FG010|STARTED|Phase 1-T Dose Level 1-TB||0
6814572|NCT01116648|7747494|FG011|STARTED|Phase 1-T Dose Level 1-TB||3
6814573|NCT01116648|7747495|FG012|STARTED|Phase 1-T Dose Level 1-TB||0
6814574|NCT01116648|7747496|FG013|STARTED|Phase 1-T Dose Level 1-TB||0
6814575|NCT01116648|7747497|FG014|STARTED|Phase 1-T Dose Level 1-TB||0
6814576|NCT01116648|7747483|FG000|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814577|NCT01116648|7747484|FG001|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814578|NCT01116648|7747485|FG002|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814579|NCT01116648|7747486|FG003|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814580|NCT01116648|7747487|FG004|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814581|NCT01116648|7747488|FG005|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814582|NCT01116648|7747489|FG006|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814583|NCT01116648|7747490|FG007|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814584|NCT01116648|7747491|FG008|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814585|NCT01116648|7747492|FG009|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814586|NCT01116648|7747493|FG010|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814587|NCT01116648|7747494|FG011|COMPLETED|Phase 1-T Dose Level 1-TB||3
6814588|NCT01116648|7747495|FG012|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814589|NCT01116648|7747496|FG013|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814590|NCT01116648|7747497|FG014|COMPLETED|Phase 1-T Dose Level 1-TB||0
6814591|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814592|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814593|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814594|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814595|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814596|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814597|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814598|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814599|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814600|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814601|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814602|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814603|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814604|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814605|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1-T Dose Level 1-TB||0
6814606|NCT01116648|7747483|FG000|STARTED|Phase 1-T Dose Level 2-TB||0
6814607|NCT01116648|7747484|FG001|STARTED|Phase 1-T Dose Level 2-TB||0
6814608|NCT01116648|7747485|FG002|STARTED|Phase 1-T Dose Level 2-TB||0
6814609|NCT01116648|7747486|FG003|STARTED|Phase 1-T Dose Level 2-TB||0
6814610|NCT01116648|7747487|FG004|STARTED|Phase 1-T Dose Level 2-TB||0
6814611|NCT01116648|7747488|FG005|STARTED|Phase 1-T Dose Level 2-TB||0
6814612|NCT01116648|7747489|FG006|STARTED|Phase 1-T Dose Level 2-TB||0
6814613|NCT01116648|7747490|FG007|STARTED|Phase 1-T Dose Level 2-TB||0
6814614|NCT01116648|7747491|FG008|STARTED|Phase 1-T Dose Level 2-TB||0
6814615|NCT01116648|7747492|FG009|STARTED|Phase 1-T Dose Level 2-TB||0
6814616|NCT01116648|7747493|FG010|STARTED|Phase 1-T Dose Level 2-TB||0
6814617|NCT01116648|7747494|FG011|STARTED|Phase 1-T Dose Level 2-TB||0
6814618|NCT01116648|7747495|FG012|STARTED|Phase 1-T Dose Level 2-TB||6
6814619|NCT01116648|7747496|FG013|STARTED|Phase 1-T Dose Level 2-TB||0
6814620|NCT01116648|7747497|FG014|STARTED|Phase 1-T Dose Level 2-TB||0
6814621|NCT01116648|7747483|FG000|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814622|NCT01116648|7747484|FG001|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814623|NCT01116648|7747485|FG002|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814624|NCT01116648|7747486|FG003|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814625|NCT01116648|7747487|FG004|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814626|NCT01116648|7747488|FG005|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814627|NCT01116648|7747489|FG006|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814628|NCT01116648|7747490|FG007|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814629|NCT01116648|7747491|FG008|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814630|NCT01116648|7747492|FG009|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814631|NCT01116648|7747493|FG010|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814632|NCT01116648|7747494|FG011|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814633|NCT01116648|7747495|FG012|COMPLETED|Phase 1-T Dose Level 2-TB||6
6814634|NCT01116648|7747496|FG013|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814635|NCT01116648|7747497|FG014|COMPLETED|Phase 1-T Dose Level 2-TB||0
6814636|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814637|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814638|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814639|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814640|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814641|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814642|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814643|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814644|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814645|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814646|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814647|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814648|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814649|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814650|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1-T Dose Level 2-TB||0
6814651|NCT01116648|7747483|FG000|STARTED|Phase 1-T PKOlap Expansion||0
6814652|NCT01116648|7747484|FG001|STARTED|Phase 1-T PKOlap Expansion||0
6814653|NCT01116648|7747485|FG002|STARTED|Phase 1-T PKOlap Expansion||0
6814654|NCT01116648|7747486|FG003|STARTED|Phase 1-T PKOlap Expansion||0
6814655|NCT01116648|7747487|FG004|STARTED|Phase 1-T PKOlap Expansion||0
6814656|NCT01116648|7747488|FG005|STARTED|Phase 1-T PKOlap Expansion||0
6814657|NCT01116648|7747489|FG006|STARTED|Phase 1-T PKOlap Expansion||0
6814658|NCT01116648|7747490|FG007|STARTED|Phase 1-T PKOlap Expansion||0
6814659|NCT01116648|7747491|FG008|STARTED|Phase 1-T PKOlap Expansion||0
6814660|NCT01116648|7747492|FG009|STARTED|Phase 1-T PKOlap Expansion||0
6814661|NCT01116648|7747493|FG010|STARTED|Phase 1-T PKOlap Expansion||0
6814662|NCT01116648|7747494|FG011|STARTED|Phase 1-T PKOlap Expansion||0
6814663|NCT01116648|7747495|FG012|STARTED|Phase 1-T PKOlap Expansion||0
6814664|NCT01116648|7747496|FG013|STARTED|Phase 1-T PKOlap Expansion||6
6814665|NCT01116648|7747497|FG014|STARTED|Phase 1-T PKOlap Expansion||0
6814666|NCT01116648|7747483|FG000|COMPLETED|Phase 1-T PKOlap Expansion||0
6814667|NCT01116648|7747484|FG001|COMPLETED|Phase 1-T PKOlap Expansion||0
6814668|NCT01116648|7747485|FG002|COMPLETED|Phase 1-T PKOlap Expansion||0
6814669|NCT01116648|7747486|FG003|COMPLETED|Phase 1-T PKOlap Expansion||0
6814670|NCT01116648|7747487|FG004|COMPLETED|Phase 1-T PKOlap Expansion||0
6814671|NCT01116648|7747488|FG005|COMPLETED|Phase 1-T PKOlap Expansion||0
6814672|NCT01116648|7747489|FG006|COMPLETED|Phase 1-T PKOlap Expansion||0
6814673|NCT01116648|7747490|FG007|COMPLETED|Phase 1-T PKOlap Expansion||0
6814674|NCT01116648|7747491|FG008|COMPLETED|Phase 1-T PKOlap Expansion||0
6814675|NCT01116648|7747492|FG009|COMPLETED|Phase 1-T PKOlap Expansion||0
6814676|NCT01116648|7747493|FG010|COMPLETED|Phase 1-T PKOlap Expansion||0
6814677|NCT01116648|7747494|FG011|COMPLETED|Phase 1-T PKOlap Expansion||0
6814678|NCT01116648|7747495|FG012|COMPLETED|Phase 1-T PKOlap Expansion||0
6814679|NCT01116648|7747496|FG013|COMPLETED|Phase 1-T PKOlap Expansion||6
6814680|NCT01116648|7747497|FG014|COMPLETED|Phase 1-T PKOlap Expansion||0
6814681|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814682|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814683|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814684|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814685|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814686|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814687|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814688|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814689|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814690|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814691|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6567817|NCT01833065|7490963|FG004|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
6814692|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814693|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814694|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814695|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1-T PKOlap Expansion||0
6814696|NCT01116648|7747483|FG000|STARTED|Phase 1-T PKCed Expansion||0
6814697|NCT01116648|7747484|FG001|STARTED|Phase 1-T PKCed Expansion||0
6814698|NCT01116648|7747485|FG002|STARTED|Phase 1-T PKCed Expansion||0
6814699|NCT01116648|7747486|FG003|STARTED|Phase 1-T PKCed Expansion||0
6814700|NCT01116648|7747487|FG004|STARTED|Phase 1-T PKCed Expansion||0
6814701|NCT01116648|7747488|FG005|STARTED|Phase 1-T PKCed Expansion||0
6814702|NCT01116648|7747489|FG006|STARTED|Phase 1-T PKCed Expansion||0
6814703|NCT01116648|7747490|FG007|STARTED|Phase 1-T PKCed Expansion||0
6814704|NCT01116648|7747491|FG008|STARTED|Phase 1-T PKCed Expansion||0
6567818|NCT01833065|7490959|FG000|COMPLETED|Overall Study||41
6567819|NCT01833065|7490960|FG001|COMPLETED|Overall Study||40
6567820|NCT01833065|7490961|FG002|COMPLETED|Overall Study||23
6814705|NCT01116648|7747492|FG009|STARTED|Phase 1-T PKCed Expansion||0
6814706|NCT01116648|7747493|FG010|STARTED|Phase 1-T PKCed Expansion||0
6814707|NCT01116648|7747494|FG011|STARTED|Phase 1-T PKCed Expansion||0
6814708|NCT01116648|7747495|FG012|STARTED|Phase 1-T PKCed Expansion||0
6814709|NCT01116648|7747496|FG013|STARTED|Phase 1-T PKCed Expansion||0
6814710|NCT01116648|7747497|FG014|STARTED|Phase 1-T PKCed Expansion||7
6814711|NCT01116648|7747483|FG000|COMPLETED|Phase 1-T PKCed Expansion||0
6814712|NCT01116648|7747484|FG001|COMPLETED|Phase 1-T PKCed Expansion||0
6814713|NCT01116648|7747485|FG002|COMPLETED|Phase 1-T PKCed Expansion||0
6814714|NCT01116648|7747486|FG003|COMPLETED|Phase 1-T PKCed Expansion||0
6814715|NCT01116648|7747487|FG004|COMPLETED|Phase 1-T PKCed Expansion||0
6814716|NCT01116648|7747488|FG005|COMPLETED|Phase 1-T PKCed Expansion||0
6814717|NCT01116648|7747489|FG006|COMPLETED|Phase 1-T PKCed Expansion||0
6814718|NCT01116648|7747490|FG007|COMPLETED|Phase 1-T PKCed Expansion||0
6567821|NCT01833065|7490962|FG003|COMPLETED|Overall Study||41
6567822|NCT01833065|7490963|FG004|COMPLETED|Overall Study||74
6567823|NCT01833065|7490959|FG000|NOT COMPLETED|Overall Study||24
6567824|NCT01833065|7490960|FG001|NOT COMPLETED|Overall Study||13
6567825|NCT01833065|7490961|FG002|NOT COMPLETED|Overall Study||12
6567826|NCT01833065|7490962|FG003|NOT COMPLETED|Overall Study||9
6567827|NCT01833065|7490963|FG004|NOT COMPLETED|Overall Study||36
6567828|NCT01833078|7490973|FG000|STARTED|Overall Study||5
6567829|NCT01833078|7490973|FG000|COMPLETED|Overall Study||5
6567830|NCT01833078|7490973|FG000|NOT COMPLETED|Overall Study||0
6567831|NCT01833117|7490979|FG000|STARTED|Overall Study||43
6567832|NCT01833117|7490980|FG001|STARTED|Overall Study||19
6567833|NCT01833117|7490979|FG000|COMPLETED|Overall Study||43
6567834|NCT01833117|7490980|FG001|COMPLETED|Overall Study||19
6567835|NCT01833117|7490979|FG000|NOT COMPLETED|Overall Study||0
6814719|NCT01116648|7747491|FG008|COMPLETED|Phase 1-T PKCed Expansion||0
6814720|NCT01116648|7747492|FG009|COMPLETED|Phase 1-T PKCed Expansion||0
6814721|NCT01116648|7747493|FG010|COMPLETED|Phase 1-T PKCed Expansion||0
6814722|NCT01116648|7747494|FG011|COMPLETED|Phase 1-T PKCed Expansion||0
6814723|NCT01116648|7747495|FG012|COMPLETED|Phase 1-T PKCed Expansion||0
6814724|NCT01116648|7747496|FG013|COMPLETED|Phase 1-T PKCed Expansion||0
6814725|NCT01116648|7747497|FG014|COMPLETED|Phase 1-T PKCed Expansion||7
6814726|NCT01116648|7747483|FG000|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814727|NCT01116648|7747484|FG001|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814728|NCT01116648|7747485|FG002|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814729|NCT01116648|7747486|FG003|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814730|NCT01116648|7747487|FG004|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814731|NCT01116648|7747488|FG005|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814732|NCT01116648|7747489|FG006|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814733|NCT01116648|7747490|FG007|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814734|NCT01116648|7747491|FG008|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814735|NCT01116648|7747492|FG009|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814736|NCT01116648|7747493|FG010|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814737|NCT01116648|7747494|FG011|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814738|NCT01116648|7747495|FG012|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814739|NCT01116648|7747496|FG013|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814740|NCT01116648|7747497|FG014|NOT COMPLETED|Phase 1-T PKCed Expansion||0
6814741|NCT01064479|7747524|FG000|STARTED|Overall Study||60
6814742|NCT01064479|7747525|FG001|STARTED|Overall Study||59
6814743|NCT01064479|7747524|FG000|COMPLETED|Overall Study||45
6814744|NCT01064479|7747525|FG001|COMPLETED|Overall Study||42
6814745|NCT01064479|7747524|FG000|NOT COMPLETED|Overall Study||15
6814746|NCT01064479|7747525|FG001|NOT COMPLETED|Overall Study||17
6814747|NCT01042522|7747533|FG000|STARTED|Overall Study||31
6814748|NCT01042522|7747534|FG001|STARTED|Overall Study||32
6814749|NCT01042522|7747533|FG000|COMPLETED|Overall Study|Completed 6 cycles of protocol regimen|23
6814750|NCT01042522|7747534|FG001|COMPLETED|Overall Study|Completed 4 cycles of protocol regimen|26
6814751|NCT01042522|7747533|FG000|NOT COMPLETED|Overall Study||8
6814752|NCT01042522|7747534|FG001|NOT COMPLETED|Overall Study||6
6814753|NCT00944528|7747543|FG000|STARTED|Overall Study||9
6814754|NCT00944528|7747544|FG001|STARTED|Overall Study||10
6814755|NCT00944528|7747545|FG002|STARTED|Overall Study||16
6814756|NCT00944528|7747543|FG000|COMPLETED|Overall Study||8
6814757|NCT00944528|7747544|FG001|COMPLETED|Overall Study||8
6814758|NCT00944528|7747545|FG002|COMPLETED|Overall Study||16
6814759|NCT00944528|7747543|FG000|NOT COMPLETED|Overall Study||1
6814760|NCT00944528|7747544|FG001|NOT COMPLETED|Overall Study||2
6814761|NCT00944528|7747545|FG002|NOT COMPLETED|Overall Study||0
6814762|NCT00941915|7747554|FG000|STARTED|Overall Study||60
6814763|NCT00941915|7747554|FG000|COMPLETED|Overall Study||60
6814764|NCT00941915|7747554|FG000|NOT COMPLETED|Overall Study||0
6814765|NCT00826462|7747561|FG000|STARTED|Overall Study||59
6814766|NCT00826462|7747562|FG001|STARTED|Overall Study||58
6814767|NCT00826462|7747563|FG002|STARTED|Overall Study||60
6814768|NCT00826462|7747561|FG000|COMPLETED|Overall Study||52
6567836|NCT01833117|7490980|FG001|NOT COMPLETED|Overall Study||0
6567837|NCT01833130|7490988|FG000|STARTED|Overall Study||25
6567838|NCT01833130|7490989|FG001|STARTED|Overall Study||27
6567839|NCT01833130|7490988|FG000|COMPLETED|Overall Study||15
6567840|NCT01833130|7490989|FG001|COMPLETED|Overall Study||8
6567841|NCT01833130|7490988|FG000|NOT COMPLETED|Overall Study||10
6567842|NCT01833130|7490989|FG001|NOT COMPLETED|Overall Study||19
6567843|NCT01833143|7490995|FG000|STARTED|Overall Study||17
6814769|NCT00826462|7747562|FG001|COMPLETED|Overall Study||53
6814770|NCT00826462|7747563|FG002|COMPLETED|Overall Study||52
6814771|NCT00826462|7747561|FG000|NOT COMPLETED|Overall Study||7
6814772|NCT00826462|7747562|FG001|NOT COMPLETED|Overall Study||5
6814773|NCT00826462|7747563|FG002|NOT COMPLETED|Overall Study||8
6814774|NCT00710970|7747573|FG000|STARTED|Overall Study||28
6814775|NCT00710970|7747573|FG000|COMPLETED|Overall Study||25
6814776|NCT00710970|7747573|FG000|NOT COMPLETED|Overall Study||3
6814777|NCT00685919|7747581|FG000|STARTED|Overall Study|8 healthy controls were randomized to receive placebo followed by carbidopa. 1 received only 50 mg doses of carbidopa and her data were excluded.|8
6814778|NCT00685919|7747582|FG001|STARTED|Overall Study|9 healthy controls were randomized to receive carbidopa followed by placebo.|9
6814779|NCT00685919|7747583|FG002|STARTED|Overall Study|8 patients with POTS were randomized to receive placebo followed by carbidopa. 1 of these received only 50 mg doses of carbidopa and her data are excluded.|8
6814780|NCT00685919|7747584|FG003|STARTED|Overall Study|3 patients with POTS were randomized to receive carbidopa followed by placebo.|3
6814781|NCT00685919|7747581|FG000|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|8
6814782|NCT00685919|7747582|FG001|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|9
6814783|NCT00685919|7747583|FG002|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection. 1 patient withdrew after orthostatic symptoms during baseline.|8
6814784|NCT00685919|7747584|FG003|Baseline A|Overall Study|After achieving sodium balance on 200 mEq/day sodium diet, subjects collected baseline 24hr urine. They fasted from 7pm until the next morning. In the morning, while still supine, heart rate and blood pressure were recorded and blood was drawn. Participants then stood for 10 min. Heart rate and blood pressure were measured at intervals and an upright blood sample was collected. Urine was collected to end the 24hr collection.|3
6814785|NCT00685919|7747581|FG000|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
6814786|NCT00685919|7747582|FG001|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
6814787|NCT00685919|7747583|FG002|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|8
6814788|NCT00685919|7747584|FG003|Treatment A|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
6814789|NCT00685919|7747581|FG000|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
6814790|NCT00685919|7747582|FG001|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|9
6814791|NCT00685919|7747583|FG002|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|7
6814792|NCT00685919|7747584|FG003|24 hr Post-treatment A|Overall Study|Urine was collected for 24 hr after the last dose of Treatment A.|3
6814793|NCT00685919|7747581|FG000|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
6814794|NCT00685919|7747582|FG001|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|9
6814795|NCT00685919|7747583|FG002|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|7
6814796|NCT00685919|7747584|FG003|Baseline B|Overall Study|After at least a 1-day washout period, patients underwent baseline procedures as described previously.|3
6814797|NCT00685919|7747581|FG000|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
6814798|NCT00685919|7747582|FG001|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|9
6814799|NCT00685919|7747583|FG002|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, carbidopa 200 mg was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|7
6814800|NCT00685919|7747584|FG003|Treatment B|Overall Study|Following the urine collection to end the baseline urine and the baseline testing, placebo was given orally. Additional doses were given every 6 hours with the last dose at 7am the following morning. Urine was collected over 24hr and supine and upright heart rates, blood pressures and blood samples were collected.|3
6814801|NCT00685919|7747581|FG000|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
6814802|NCT00685919|7747582|FG001|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|9
6814803|NCT00685919|7747583|FG002|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|7
6814804|NCT00685919|7747584|FG003|24 hr Post Treatment B|Overall Study|Urine was collected for 24 hr after last dose of Treatment B.|3
6814805|NCT00685919|7747581|FG000|COMPLETED|Overall Study||7
6814806|NCT00685919|7747582|FG001|COMPLETED|Overall Study||9
6814807|NCT00685919|7747583|FG002|COMPLETED|Overall Study||7
6814808|NCT00685919|7747584|FG003|COMPLETED|Overall Study||3
6814809|NCT00685919|7747581|FG000|NOT COMPLETED|Overall Study||1
6814810|NCT00685919|7747582|FG001|NOT COMPLETED|Overall Study||0
6814811|NCT00685919|7747583|FG002|NOT COMPLETED|Overall Study||1
6814812|NCT00685919|7747584|FG003|NOT COMPLETED|Overall Study||0
6814813|NCT00344487|7747594|FG000|STARTED|Overall Study||3
6814814|NCT00344487|7747594|FG000|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
6814815|NCT00344487|7747594|FG000|NOT COMPLETED|Overall Study||1
6814816|NCT00281658|7747602|FG000|STARTED|Double-blind, Randomized Phase||222
6814817|NCT00281658|7747603|FG001|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
6814818|NCT00281658|7747604|FG002|STARTED|Double-blind, Randomized Phase||0
6814819|NCT00281658|7747602|FG000|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
6814820|NCT00281658|7747603|FG001|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
6814821|NCT00281658|7747604|FG002|COMPLETED|Double-blind, Randomized Phase||0
6814822|NCT00281658|7747602|FG000|NOT COMPLETED|Double-blind, Randomized Phase||137
6814823|NCT00281658|7747603|FG001|NOT COMPLETED|Double-blind, Randomized Phase||54
6814824|NCT00281658|7747604|FG002|NOT COMPLETED|Double-blind, Randomized Phase||0
6814825|NCT00281658|7747602|FG000|STARTED|Open-label Monotherapy Extension Phase||0
6814826|NCT00281658|7747603|FG001|STARTED|Open-label Monotherapy Extension Phase||0
6814827|NCT00281658|7747604|FG002|STARTED|Open-label Monotherapy Extension Phase||149
6814828|NCT00281658|7747602|FG000|COMPLETED|Open-label Monotherapy Extension Phase||0
6814829|NCT00281658|7747603|FG001|COMPLETED|Open-label Monotherapy Extension Phase||0
6814830|NCT00281658|7747604|FG002|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
6814831|NCT00281658|7747602|FG000|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
6814832|NCT00281658|7747603|FG001|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
6814833|NCT00281658|7747604|FG002|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
6567844|NCT01833143|7490995|FG000|COMPLETED|Overall Study||16
6567845|NCT01833143|7490995|FG000|NOT COMPLETED|Overall Study||1
6567846|NCT01833169|7490999|FG000|STARTED|Overall Study||146
6814834|NCT04368910|7747613|FG000|STARTED|Overall Study||15
6814835|NCT04368910|7747614|FG001|STARTED|Overall Study||15
6814836|NCT04368910|7747613|FG000|COMPLETED|Overall Study||15
6814837|NCT04368910|7747614|FG001|COMPLETED|Overall Study||15
6814838|NCT04368910|7747613|FG000|NOT COMPLETED|Overall Study||0
6814839|NCT04368910|7747614|FG001|NOT COMPLETED|Overall Study||0
6814840|NCT04365985|7747623|FG000|STARTED|Overall Study||9
6814841|NCT04365985|7747624|FG001|STARTED|Overall Study||9
6814842|NCT04365985|7747625|FG002|STARTED|Overall Study||52
6814843|NCT04365985|7747623|FG000|COMPLETED|Overall Study||9
6814844|NCT04365985|7747624|FG001|COMPLETED|Overall Study||9
6814845|NCT04365985|7747625|FG002|COMPLETED|Overall Study||52
6391041|NCT00833638|7302854|FG001|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
6391042|NCT00833638|7302855|FG002|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
6567847|NCT01833169|7490999|FG000|Consented to be Followed for Survival|Overall Study||128
6567848|NCT01833169|7490999|FG000|COMPLETED|Overall Study||0
6814846|NCT04365985|7747623|FG000|NOT COMPLETED|Overall Study||0
6814847|NCT04365985|7747624|FG001|NOT COMPLETED|Overall Study||0
6814848|NCT04365985|7747625|FG002|NOT COMPLETED|Overall Study||0
6814849|NCT04034355|7747635|FG000|STARTED|Overall Study||151
6814850|NCT04034355|7747636|FG001|STARTED|Overall Study||150
6814851|NCT04034355|7747635|FG000|Treated|Overall Study||147
6814852|NCT04034355|7747636|FG001|Treated|Overall Study||150
6814853|NCT04034355|7747635|FG000|COMPLETED|Overall Study||117
6814854|NCT04034355|7747636|FG001|COMPLETED|Overall Study||115
6814855|NCT04034355|7747635|FG000|NOT COMPLETED|Overall Study||34
6814856|NCT04034355|7747636|FG001|NOT COMPLETED|Overall Study||35
6814857|NCT03781726|7747642|FG000|STARTED|Overall Study||30
6814858|NCT03781726|7747642|FG000|COMPLETED|Overall Study||28
6814859|NCT03781726|7747642|FG000|NOT COMPLETED|Overall Study||2
6814860|NCT03721276|7747648|FG000|STARTED|Overall Study||30
6814861|NCT03721276|7747649|FG001|STARTED|Overall Study||30
6814862|NCT03721276|7747648|FG000|Three-month Pre-intervention|Overall Study|Participants in this arm started therapy immediately after randomization, and therefore, did not have a three-month waiting period prior to receiving the intervention.|0
6814863|NCT03721276|7747649|FG001|Three-month Pre-intervention|Overall Study||30
6814864|NCT03721276|7747648|FG000|Immediate Pre-intervention|Overall Study||30
6814865|NCT03721276|7747649|FG001|Immediate Pre-intervention|Overall Study||29
6814866|NCT03721276|7747648|FG000|Post-intervention|Overall Study||25
6814867|NCT03721276|7747649|FG001|Post-intervention|Overall Study||26
6814868|NCT03721276|7747648|FG000|Three-month Follow-up (Post Intervention)|Overall Study||25
6814869|NCT03721276|7747649|FG001|Three-month Follow-up (Post Intervention)|Overall Study|Participants in this arm started therapy three months after randomization (waitlist) and therefore, were not assessed at the three-month follow-up time point due to completion of the study|0
6814870|NCT03721276|7747648|FG000|COMPLETED|Overall Study||25
6814871|NCT03721276|7747649|FG001|COMPLETED|Overall Study||26
6814872|NCT03721276|7747648|FG000|NOT COMPLETED|Overall Study||5
6814873|NCT03721276|7747649|FG001|NOT COMPLETED|Overall Study||4
6814874|NCT03700658|7747655|FG000|STARTED|Overall Study||27
6814875|NCT03700658|7747655|FG000|Received at Least 1 Dose of Study Drug|Overall Study||27
6814876|NCT03700658|7747655|FG000|COMPLETED|Overall Study||27
6814877|NCT03700658|7747655|FG000|NOT COMPLETED|Overall Study||0
6814878|NCT03637491|7747672|FG000|STARTED|Overall Study||10
6814879|NCT03637491|7747673|FG001|STARTED|Overall Study||12
6814880|NCT03637491|7747674|FG002|STARTED|Overall Study||7
6814881|NCT03637491|7747675|FG003|STARTED|Overall Study||6
6814882|NCT03637491|7747672|FG000|Received Treatment|Overall Study||10
6814883|NCT03637491|7747673|FG001|Received Treatment|Overall Study||12
6814884|NCT03637491|7747674|FG002|Received Treatment|Overall Study||7
6814885|NCT03637491|7747675|FG003|Received Treatment|Overall Study||6
6814886|NCT03637491|7747672|FG000|COMPLETED|Overall Study||0
6814887|NCT03637491|7747673|FG001|COMPLETED|Overall Study||0
6814888|NCT03637491|7747674|FG002|COMPLETED|Overall Study||0
6814889|NCT03637491|7747675|FG003|COMPLETED|Overall Study||0
6814890|NCT03637491|7747672|FG000|NOT COMPLETED|Overall Study||10
6814891|NCT03637491|7747673|FG001|NOT COMPLETED|Overall Study||12
6814892|NCT03637491|7747674|FG002|NOT COMPLETED|Overall Study||7
6814893|NCT03637491|7747675|FG003|NOT COMPLETED|Overall Study||6
6814894|NCT03610334|7747699|FG000|STARTED|Period 1: 2.5mg (1 Day)||6
6814895|NCT03610334|7747700|FG001|STARTED|Period 1: 2.5mg (1 Day)||2
6814896|NCT03610334|7747701|FG002|STARTED|Period 1: 2.5mg (1 Day)||0
6814897|NCT03610334|7747702|FG003|STARTED|Period 1: 2.5mg (1 Day)||0
6814898|NCT03610334|7747703|FG004|STARTED|Period 1: 2.5mg (1 Day)||0
6814899|NCT03610334|7747704|FG005|STARTED|Period 1: 2.5mg (1 Day)||0
6814900|NCT03610334|7747705|FG006|STARTED|Period 1: 2.5mg (1 Day)||0
6814901|NCT03610334|7747706|FG007|STARTED|Period 1: 2.5mg (1 Day)||0
6814902|NCT03610334|7747707|FG008|STARTED|Period 1: 2.5mg (1 Day)||0
6814903|NCT03610334|7747708|FG009|STARTED|Period 1: 2.5mg (1 Day)||0
6814904|NCT03610334|7747709|FG010|STARTED|Period 1: 2.5mg (1 Day)||0
6814905|NCT03610334|7747710|FG011|STARTED|Period 1: 2.5mg (1 Day)||0
6814906|NCT03610334|7747711|FG012|STARTED|Period 1: 2.5mg (1 Day)||0
6814907|NCT03610334|7747712|FG013|STARTED|Period 1: 2.5mg (1 Day)||0
6814908|NCT03610334|7747713|FG014|STARTED|Period 1: 2.5mg (1 Day)||0
6814909|NCT03610334|7747714|FG015|STARTED|Period 1: 2.5mg (1 Day)||0
6814910|NCT03610334|7747715|FG016|STARTED|Period 1: 2.5mg (1 Day)||0
6814911|NCT03610334|7747716|FG017|STARTED|Period 1: 2.5mg (1 Day)||0
6814912|NCT03610334|7747699|FG000|COMPLETED|Period 1: 2.5mg (1 Day)||6
6814913|NCT03610334|7747700|FG001|COMPLETED|Period 1: 2.5mg (1 Day)||2
6814914|NCT03610334|7747701|FG002|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814915|NCT03610334|7747702|FG003|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814916|NCT03610334|7747703|FG004|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814917|NCT03610334|7747704|FG005|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814918|NCT03610334|7747705|FG006|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814919|NCT03610334|7747706|FG007|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814920|NCT03610334|7747707|FG008|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814921|NCT03610334|7747708|FG009|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814922|NCT03610334|7747709|FG010|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814923|NCT03610334|7747710|FG011|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814924|NCT03610334|7747711|FG012|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814925|NCT03610334|7747712|FG013|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814926|NCT03610334|7747713|FG014|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814927|NCT03610334|7747714|FG015|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814928|NCT03610334|7747715|FG016|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814929|NCT03610334|7747716|FG017|COMPLETED|Period 1: 2.5mg (1 Day)||0
6814930|NCT03610334|7747699|FG000|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814931|NCT03610334|7747700|FG001|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814932|NCT03610334|7747701|FG002|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814933|NCT03610334|7747702|FG003|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814934|NCT03610334|7747703|FG004|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814935|NCT03610334|7747704|FG005|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814936|NCT03610334|7747705|FG006|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814937|NCT03610334|7747706|FG007|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814938|NCT03610334|7747707|FG008|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814939|NCT03610334|7747708|FG009|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814940|NCT03610334|7747709|FG010|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6391043|NCT00833638|7302853|FG000|STARTED|Phase 3: Open-label Extension Phase||111
6391044|NCT00833638|7302854|FG001|STARTED|Phase 3: Open-label Extension Phase||108
6391045|NCT00833638|7302855|FG002|STARTED|Phase 3: Open-label Extension Phase||124
6391046|NCT00833638|7302853|FG000|COMPLETED|Phase 3: Open-label Extension Phase||110
6391047|NCT00833638|7302854|FG001|COMPLETED|Phase 3: Open-label Extension Phase||105
6391048|NCT00833638|7302855|FG002|COMPLETED|Phase 3: Open-label Extension Phase||122
6391049|NCT00833638|7302853|FG000|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
6391050|NCT00833638|7302854|FG001|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
6391051|NCT00833638|7302855|FG002|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
6391052|NCT00833690|7302874|FG000|STARTED|Overall Study||25
6391053|NCT00833690|7302875|FG001|STARTED|Overall Study||24
6391054|NCT00833690|7302876|FG002|STARTED|Overall Study||26
6391055|NCT00833690|7302874|FG000|COMPLETED|Overall Study||21
6391056|NCT00833690|7302875|FG001|COMPLETED|Overall Study||22
6391057|NCT00833690|7302876|FG002|COMPLETED|Overall Study||26
6391058|NCT00833690|7302874|FG000|NOT COMPLETED|Overall Study||4
6391059|NCT00833690|7302875|FG001|NOT COMPLETED|Overall Study||2
6504757|NCT01449682|7423788|FG001|STARTED|Overall Study||5
6504758|NCT01449682|7423787|FG000|COMPLETED|Overall Study||4
6504759|NCT01449682|7423788|FG001|COMPLETED|Overall Study||4
6504760|NCT01449682|7423787|FG000|NOT COMPLETED|Overall Study||1
6504761|NCT01449682|7423788|FG001|NOT COMPLETED|Overall Study||1
6814941|NCT03610334|7747710|FG011|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814942|NCT03610334|7747711|FG012|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814943|NCT03610334|7747712|FG013|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814944|NCT03610334|7747713|FG014|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814945|NCT03610334|7747714|FG015|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814946|NCT03610334|7747715|FG016|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814947|NCT03610334|7747716|FG017|NOT COMPLETED|Period 1: 2.5mg (1 Day)||0
6814948|NCT03610334|7747699|FG000|STARTED|Period 2: 5.0mg (1 Day)||6
6814949|NCT03610334|7747700|FG001|STARTED|Period 2: 5.0mg (1 Day)||2
6814950|NCT03610334|7747701|FG002|STARTED|Period 2: 5.0mg (1 Day)||6
6814951|NCT03610334|7747702|FG003|STARTED|Period 2: 5.0mg (1 Day)||2
6814952|NCT03610334|7747703|FG004|STARTED|Period 2: 5.0mg (1 Day)||0
6814953|NCT03610334|7747704|FG005|STARTED|Period 2: 5.0mg (1 Day)||0
6814954|NCT03610334|7747705|FG006|STARTED|Period 2: 5.0mg (1 Day)||0
6814955|NCT03610334|7747706|FG007|STARTED|Period 2: 5.0mg (1 Day)||0
6814956|NCT03610334|7747707|FG008|STARTED|Period 2: 5.0mg (1 Day)||0
6814957|NCT03610334|7747708|FG009|STARTED|Period 2: 5.0mg (1 Day)||0
6814958|NCT03610334|7747709|FG010|STARTED|Period 2: 5.0mg (1 Day)||0
6814959|NCT03610334|7747710|FG011|STARTED|Period 2: 5.0mg (1 Day)||0
6814960|NCT03610334|7747711|FG012|STARTED|Period 2: 5.0mg (1 Day)||0
6391060|NCT00833690|7302876|FG002|NOT COMPLETED|Overall Study||0
6391061|NCT00833703|7302886|FG000|STARTED|Overall Study|Included|23
6391062|NCT00833703|7302887|FG001|STARTED|Overall Study|Included|26
6504762|NCT01449708|7423796|FG000|STARTED|Overall Study||61
6504763|NCT01449708|7423797|FG001|STARTED|Overall Study||63
6814961|NCT03610334|7747712|FG013|STARTED|Period 2: 5.0mg (1 Day)||0
6814962|NCT03610334|7747713|FG014|STARTED|Period 2: 5.0mg (1 Day)||0
6814963|NCT03610334|7747714|FG015|STARTED|Period 2: 5.0mg (1 Day)||0
6814964|NCT03610334|7747715|FG016|STARTED|Period 2: 5.0mg (1 Day)||0
6814965|NCT03610334|7747716|FG017|STARTED|Period 2: 5.0mg (1 Day)||0
6814966|NCT03610334|7747699|FG000|COMPLETED|Period 2: 5.0mg (1 Day)||6
6814967|NCT03610334|7747700|FG001|COMPLETED|Period 2: 5.0mg (1 Day)||2
6814968|NCT03610334|7747701|FG002|COMPLETED|Period 2: 5.0mg (1 Day)||6
6814969|NCT03610334|7747702|FG003|COMPLETED|Period 2: 5.0mg (1 Day)||2
6814970|NCT03610334|7747703|FG004|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814971|NCT03610334|7747704|FG005|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814972|NCT03610334|7747705|FG006|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814973|NCT03610334|7747706|FG007|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814974|NCT03610334|7747707|FG008|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814975|NCT03610334|7747708|FG009|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814976|NCT03610334|7747709|FG010|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814977|NCT03610334|7747710|FG011|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814978|NCT03610334|7747711|FG012|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814979|NCT03610334|7747712|FG013|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814980|NCT03610334|7747713|FG014|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814981|NCT03610334|7747714|FG015|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814982|NCT03610334|7747715|FG016|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814983|NCT03610334|7747716|FG017|COMPLETED|Period 2: 5.0mg (1 Day)||0
6814984|NCT03610334|7747699|FG000|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814985|NCT03610334|7747700|FG001|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814986|NCT03610334|7747701|FG002|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814987|NCT03610334|7747702|FG003|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814988|NCT03610334|7747703|FG004|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814989|NCT03610334|7747704|FG005|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814990|NCT03610334|7747705|FG006|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814991|NCT03610334|7747706|FG007|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814992|NCT03610334|7747707|FG008|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814993|NCT03610334|7747708|FG009|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814994|NCT03610334|7747709|FG010|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814995|NCT03610334|7747710|FG011|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814996|NCT03610334|7747711|FG012|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814997|NCT03610334|7747712|FG013|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814998|NCT03610334|7747713|FG014|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6814999|NCT03610334|7747714|FG015|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6815000|NCT03610334|7747715|FG016|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6815001|NCT03610334|7747716|FG017|NOT COMPLETED|Period 2: 5.0mg (1 Day)||0
6815002|NCT03610334|7747699|FG000|STARTED|Period 3: 10.0mg (1 Day)||6
6815003|NCT03610334|7747700|FG001|STARTED|Period 3: 10.0mg (1 Day)||2
6815004|NCT03610334|7747701|FG002|STARTED|Period 3: 10.0mg (1 Day)||6
6815005|NCT03610334|7747702|FG003|STARTED|Period 3: 10.0mg (1 Day)||2
6815006|NCT03610334|7747703|FG004|STARTED|Period 3: 10.0mg (1 Day)||6
6815007|NCT03610334|7747704|FG005|STARTED|Period 3: 10.0mg (1 Day)||2
6815008|NCT03610334|7747705|FG006|STARTED|Period 3: 10.0mg (1 Day)||0
6815009|NCT03610334|7747706|FG007|STARTED|Period 3: 10.0mg (1 Day)||0
6815010|NCT03610334|7747707|FG008|STARTED|Period 3: 10.0mg (1 Day)||0
6815011|NCT03610334|7747708|FG009|STARTED|Period 3: 10.0mg (1 Day)||0
6815012|NCT03610334|7747709|FG010|STARTED|Period 3: 10.0mg (1 Day)||0
6815013|NCT03610334|7747710|FG011|STARTED|Period 3: 10.0mg (1 Day)||0
6815014|NCT03610334|7747711|FG012|STARTED|Period 3: 10.0mg (1 Day)||0
6815015|NCT03610334|7747712|FG013|STARTED|Period 3: 10.0mg (1 Day)||0
6815016|NCT03610334|7747713|FG014|STARTED|Period 3: 10.0mg (1 Day)||0
6815017|NCT03610334|7747714|FG015|STARTED|Period 3: 10.0mg (1 Day)||0
6815018|NCT03610334|7747715|FG016|STARTED|Period 3: 10.0mg (1 Day)||0
6815019|NCT03610334|7747716|FG017|STARTED|Period 3: 10.0mg (1 Day)||0
6815020|NCT03610334|7747699|FG000|COMPLETED|Period 3: 10.0mg (1 Day)||6
6657134|NCT02466516|7587410|FG003|COMPLETED|Overall Study||10
6657135|NCT02466516|7587411|FG004|COMPLETED|Overall Study||10
6657136|NCT02466516|7587407|FG000|NOT COMPLETED|Overall Study||4
6815021|NCT03610334|7747700|FG001|COMPLETED|Period 3: 10.0mg (1 Day)||2
6815022|NCT03610334|7747701|FG002|COMPLETED|Period 3: 10.0mg (1 Day)||6
6815023|NCT03610334|7747702|FG003|COMPLETED|Period 3: 10.0mg (1 Day)||2
6815024|NCT03610334|7747703|FG004|COMPLETED|Period 3: 10.0mg (1 Day)||6
6815025|NCT03610334|7747704|FG005|COMPLETED|Period 3: 10.0mg (1 Day)||2
6815026|NCT03610334|7747705|FG006|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815027|NCT03610334|7747706|FG007|COMPLETED|Period 3: 10.0mg (1 Day)||0
6504764|NCT01449708|7423796|FG000|COMPLETED|Overall Study||59
6504765|NCT01449708|7423797|FG001|COMPLETED|Overall Study||60
6504766|NCT01449708|7423796|FG000|NOT COMPLETED|Overall Study||2
6504767|NCT01449708|7423797|FG001|NOT COMPLETED|Overall Study||3
6504768|NCT01449721|7423808|FG000|STARTED|Overall Study||112
6504769|NCT01449721|7423809|FG001|STARTED|Overall Study||30
6504770|NCT01449721|7423808|FG000|COMPLETED|Overall Study||112
6504771|NCT01449721|7423809|FG001|COMPLETED|Overall Study||28
6815028|NCT03610334|7747707|FG008|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815029|NCT03610334|7747708|FG009|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815030|NCT03610334|7747709|FG010|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815031|NCT03610334|7747710|FG011|COMPLETED|Period 3: 10.0mg (1 Day)||0
6657137|NCT02466516|7587408|FG001|NOT COMPLETED|Overall Study||1
6815032|NCT03610334|7747711|FG012|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815033|NCT03610334|7747712|FG013|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815034|NCT03610334|7747713|FG014|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815035|NCT03610334|7747714|FG015|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815036|NCT03610334|7747715|FG016|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815037|NCT03610334|7747716|FG017|COMPLETED|Period 3: 10.0mg (1 Day)||0
6815038|NCT03610334|7747699|FG000|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815039|NCT03610334|7747700|FG001|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815040|NCT03610334|7747701|FG002|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815041|NCT03610334|7747702|FG003|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815042|NCT03610334|7747703|FG004|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815043|NCT03610334|7747704|FG005|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815044|NCT03610334|7747705|FG006|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815045|NCT03610334|7747706|FG007|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815046|NCT03610334|7747707|FG008|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815047|NCT03610334|7747708|FG009|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815048|NCT03610334|7747709|FG010|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815049|NCT03610334|7747710|FG011|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815050|NCT03610334|7747711|FG012|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815051|NCT03610334|7747712|FG013|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815052|NCT03610334|7747713|FG014|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815053|NCT03610334|7747714|FG015|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815054|NCT03610334|7747715|FG016|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815055|NCT03610334|7747716|FG017|NOT COMPLETED|Period 3: 10.0mg (1 Day)||0
6815056|NCT03610334|7747699|FG000|STARTED|Period 4: 20.0mg (1 Day)||6
6815057|NCT03610334|7747700|FG001|STARTED|Period 4: 20.0mg (1 Day)||2
6815058|NCT03610334|7747701|FG002|STARTED|Period 4: 20.0mg (1 Day)||6
6815059|NCT03610334|7747702|FG003|STARTED|Period 4: 20.0mg (1 Day)||2
6815060|NCT03610334|7747703|FG004|STARTED|Period 4: 20.0mg (1 Day)||6
6815061|NCT03610334|7747704|FG005|STARTED|Period 4: 20.0mg (1 Day)||2
6815062|NCT03610334|7747705|FG006|STARTED|Period 4: 20.0mg (1 Day)||6
6815063|NCT03610334|7747706|FG007|STARTED|Period 4: 20.0mg (1 Day)||2
6815064|NCT03610334|7747707|FG008|STARTED|Period 4: 20.0mg (1 Day)||0
6815065|NCT03610334|7747708|FG009|STARTED|Period 4: 20.0mg (1 Day)||0
6815066|NCT03610334|7747709|FG010|STARTED|Period 4: 20.0mg (1 Day)||0
6815067|NCT03610334|7747710|FG011|STARTED|Period 4: 20.0mg (1 Day)||0
6815068|NCT03610334|7747711|FG012|STARTED|Period 4: 20.0mg (1 Day)||0
6815069|NCT03610334|7747712|FG013|STARTED|Period 4: 20.0mg (1 Day)||0
6815070|NCT03610334|7747713|FG014|STARTED|Period 4: 20.0mg (1 Day)||0
6815071|NCT03610334|7747714|FG015|STARTED|Period 4: 20.0mg (1 Day)||0
6815072|NCT03610334|7747715|FG016|STARTED|Period 4: 20.0mg (1 Day)||0
6815073|NCT03610334|7747716|FG017|STARTED|Period 4: 20.0mg (1 Day)||0
6815074|NCT03610334|7747699|FG000|COMPLETED|Period 4: 20.0mg (1 Day)||6
6815075|NCT03610334|7747700|FG001|COMPLETED|Period 4: 20.0mg (1 Day)||2
6815076|NCT03610334|7747701|FG002|COMPLETED|Period 4: 20.0mg (1 Day)||6
6815077|NCT03610334|7747702|FG003|COMPLETED|Period 4: 20.0mg (1 Day)||2
6815078|NCT03610334|7747703|FG004|COMPLETED|Period 4: 20.0mg (1 Day)||6
6815079|NCT03610334|7747704|FG005|COMPLETED|Period 4: 20.0mg (1 Day)||2
6815080|NCT03610334|7747705|FG006|COMPLETED|Period 4: 20.0mg (1 Day)||6
6815081|NCT03610334|7747706|FG007|COMPLETED|Period 4: 20.0mg (1 Day)||2
6815082|NCT03610334|7747707|FG008|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815083|NCT03610334|7747708|FG009|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815084|NCT03610334|7747709|FG010|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815085|NCT03610334|7747710|FG011|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815086|NCT03610334|7747711|FG012|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815087|NCT03610334|7747712|FG013|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815088|NCT03610334|7747713|FG014|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815089|NCT03610334|7747714|FG015|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815090|NCT03610334|7747715|FG016|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815091|NCT03610334|7747716|FG017|COMPLETED|Period 4: 20.0mg (1 Day)||0
6815092|NCT03610334|7747699|FG000|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815093|NCT03610334|7747700|FG001|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815094|NCT03610334|7747701|FG002|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815095|NCT03610334|7747702|FG003|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815096|NCT03610334|7747703|FG004|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815097|NCT03610334|7747704|FG005|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815098|NCT03610334|7747705|FG006|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815099|NCT03610334|7747706|FG007|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815100|NCT03610334|7747707|FG008|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815101|NCT03610334|7747708|FG009|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815102|NCT03610334|7747709|FG010|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815103|NCT03610334|7747710|FG011|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815104|NCT03610334|7747711|FG012|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815105|NCT03610334|7747712|FG013|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815106|NCT03610334|7747713|FG014|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815107|NCT03610334|7747714|FG015|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815108|NCT03610334|7747715|FG016|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815109|NCT03610334|7747716|FG017|NOT COMPLETED|Period 4: 20.0mg (1 Day)||0
6815110|NCT03610334|7747699|FG000|STARTED|Period 5: 40.0mg (1 Day)||6
6815111|NCT03610334|7747700|FG001|STARTED|Period 5: 40.0mg (1 Day)||2
6815112|NCT03610334|7747701|FG002|STARTED|Period 5: 40.0mg (1 Day)||6
6815113|NCT03610334|7747702|FG003|STARTED|Period 5: 40.0mg (1 Day)||2
6815114|NCT03610334|7747703|FG004|STARTED|Period 5: 40.0mg (1 Day)||6
6815115|NCT03610334|7747704|FG005|STARTED|Period 5: 40.0mg (1 Day)||2
6815116|NCT03610334|7747705|FG006|STARTED|Period 5: 40.0mg (1 Day)||6
6815117|NCT03610334|7747706|FG007|STARTED|Period 5: 40.0mg (1 Day)||2
6815118|NCT03610334|7747707|FG008|STARTED|Period 5: 40.0mg (1 Day)||6
6815119|NCT03610334|7747708|FG009|STARTED|Period 5: 40.0mg (1 Day)||2
6815120|NCT03610334|7747709|FG010|STARTED|Period 5: 40.0mg (1 Day)||0
6815121|NCT03610334|7747710|FG011|STARTED|Period 5: 40.0mg (1 Day)||0
6815122|NCT03610334|7747711|FG012|STARTED|Period 5: 40.0mg (1 Day)||0
6815123|NCT03610334|7747712|FG013|STARTED|Period 5: 40.0mg (1 Day)||0
6815124|NCT03610334|7747713|FG014|STARTED|Period 5: 40.0mg (1 Day)||0
6815125|NCT03610334|7747714|FG015|STARTED|Period 5: 40.0mg (1 Day)||0
6815126|NCT03610334|7747715|FG016|STARTED|Period 5: 40.0mg (1 Day)||0
6815127|NCT03610334|7747716|FG017|STARTED|Period 5: 40.0mg (1 Day)||0
6815128|NCT03610334|7747699|FG000|COMPLETED|Period 5: 40.0mg (1 Day)||6
6815129|NCT03610334|7747700|FG001|COMPLETED|Period 5: 40.0mg (1 Day)||2
6815130|NCT03610334|7747701|FG002|COMPLETED|Period 5: 40.0mg (1 Day)||6
6815131|NCT03610334|7747702|FG003|COMPLETED|Period 5: 40.0mg (1 Day)||2
6815132|NCT03610334|7747703|FG004|COMPLETED|Period 5: 40.0mg (1 Day)||6
6815133|NCT03610334|7747704|FG005|COMPLETED|Period 5: 40.0mg (1 Day)||2
6815134|NCT03610334|7747705|FG006|COMPLETED|Period 5: 40.0mg (1 Day)||6
6815135|NCT03610334|7747706|FG007|COMPLETED|Period 5: 40.0mg (1 Day)||2
6815136|NCT03610334|7747707|FG008|COMPLETED|Period 5: 40.0mg (1 Day)||6
6815137|NCT03610334|7747708|FG009|COMPLETED|Period 5: 40.0mg (1 Day)||2
6815138|NCT03610334|7747709|FG010|COMPLETED|Period 5: 40.0mg (1 Day)||0
6815139|NCT03610334|7747710|FG011|COMPLETED|Period 5: 40.0mg (1 Day)||0
6815140|NCT03610334|7747711|FG012|COMPLETED|Period 5: 40.0mg (1 Day)||0
6815141|NCT03610334|7747712|FG013|COMPLETED|Period 5: 40.0mg (1 Day)||0
6815142|NCT03610334|7747713|FG014|COMPLETED|Period 5: 40.0mg (1 Day)||0
6815143|NCT03610334|7747714|FG015|COMPLETED|Period 5: 40.0mg (1 Day)||0
6815144|NCT03610334|7747715|FG016|COMPLETED|Period 5: 40.0mg (1 Day)||0
6815145|NCT03610334|7747716|FG017|COMPLETED|Period 5: 40.0mg (1 Day)||0
6815146|NCT03610334|7747699|FG000|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815147|NCT03610334|7747700|FG001|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815148|NCT03610334|7747701|FG002|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815149|NCT03610334|7747702|FG003|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815150|NCT03610334|7747703|FG004|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815151|NCT03610334|7747704|FG005|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815152|NCT03610334|7747705|FG006|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815153|NCT03610334|7747706|FG007|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815154|NCT03610334|7747707|FG008|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815155|NCT03610334|7747708|FG009|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815156|NCT03610334|7747709|FG010|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815157|NCT03610334|7747710|FG011|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815158|NCT03610334|7747711|FG012|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815159|NCT03610334|7747712|FG013|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815160|NCT03610334|7747713|FG014|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815161|NCT03610334|7747714|FG015|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815162|NCT03610334|7747715|FG016|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815163|NCT03610334|7747716|FG017|NOT COMPLETED|Period 5: 40.0mg (1 Day)||0
6815164|NCT03610334|7747699|FG000|STARTED|Period 6: 60.0mg (1 Day)||6
6815165|NCT03610334|7747700|FG001|STARTED|Period 6: 60.0mg (1 Day)||2
6815166|NCT03610334|7747701|FG002|STARTED|Period 6: 60.0mg (1 Day)||6
6815167|NCT03610334|7747702|FG003|STARTED|Period 6: 60.0mg (1 Day)||2
6815168|NCT03610334|7747703|FG004|STARTED|Period 6: 60.0mg (1 Day)||6
6815169|NCT03610334|7747704|FG005|STARTED|Period 6: 60.0mg (1 Day)||2
6815170|NCT03610334|7747705|FG006|STARTED|Period 6: 60.0mg (1 Day)||6
6815171|NCT03610334|7747706|FG007|STARTED|Period 6: 60.0mg (1 Day)||2
6815172|NCT03610334|7747707|FG008|STARTED|Period 6: 60.0mg (1 Day)||6
6815173|NCT03610334|7747708|FG009|STARTED|Period 6: 60.0mg (1 Day)||2
6815174|NCT03610334|7747709|FG010|STARTED|Period 6: 60.0mg (1 Day)||6
6815175|NCT03610334|7747710|FG011|STARTED|Period 6: 60.0mg (1 Day)||2
6815176|NCT03610334|7747711|FG012|STARTED|Period 6: 60.0mg (1 Day)||0
6815177|NCT03610334|7747712|FG013|STARTED|Period 6: 60.0mg (1 Day)||0
6815178|NCT03610334|7747713|FG014|STARTED|Period 6: 60.0mg (1 Day)||0
6815179|NCT03610334|7747714|FG015|STARTED|Period 6: 60.0mg (1 Day)||0
6815180|NCT03610334|7747715|FG016|STARTED|Period 6: 60.0mg (1 Day)||0
6815181|NCT03610334|7747716|FG017|STARTED|Period 6: 60.0mg (1 Day)||0
6815182|NCT03610334|7747699|FG000|COMPLETED|Period 6: 60.0mg (1 Day)||6
6815183|NCT03610334|7747700|FG001|COMPLETED|Period 6: 60.0mg (1 Day)||2
6815184|NCT03610334|7747701|FG002|COMPLETED|Period 6: 60.0mg (1 Day)||6
6815185|NCT03610334|7747702|FG003|COMPLETED|Period 6: 60.0mg (1 Day)||2
6815186|NCT03610334|7747703|FG004|COMPLETED|Period 6: 60.0mg (1 Day)||6
6815187|NCT03610334|7747704|FG005|COMPLETED|Period 6: 60.0mg (1 Day)||2
6815188|NCT03610334|7747705|FG006|COMPLETED|Period 6: 60.0mg (1 Day)||6
6815189|NCT03610334|7747706|FG007|COMPLETED|Period 6: 60.0mg (1 Day)||2
6815190|NCT03610334|7747707|FG008|COMPLETED|Period 6: 60.0mg (1 Day)||6
6815191|NCT03610334|7747708|FG009|COMPLETED|Period 6: 60.0mg (1 Day)||2
6815192|NCT03610334|7747709|FG010|COMPLETED|Period 6: 60.0mg (1 Day)||6
6815193|NCT03610334|7747710|FG011|COMPLETED|Period 6: 60.0mg (1 Day)||2
6815194|NCT03610334|7747711|FG012|COMPLETED|Period 6: 60.0mg (1 Day)||0
6815195|NCT03610334|7747712|FG013|COMPLETED|Period 6: 60.0mg (1 Day)||0
6815196|NCT03610334|7747713|FG014|COMPLETED|Period 6: 60.0mg (1 Day)||0
6815197|NCT03610334|7747714|FG015|COMPLETED|Period 6: 60.0mg (1 Day)||0
6815198|NCT03610334|7747715|FG016|COMPLETED|Period 6: 60.0mg (1 Day)||0
6815199|NCT03610334|7747716|FG017|COMPLETED|Period 6: 60.0mg (1 Day)||0
6815200|NCT03610334|7747699|FG000|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815201|NCT03610334|7747700|FG001|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815202|NCT03610334|7747701|FG002|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815203|NCT03610334|7747702|FG003|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815204|NCT03610334|7747703|FG004|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815205|NCT03610334|7747704|FG005|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815206|NCT03610334|7747705|FG006|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815207|NCT03610334|7747706|FG007|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815208|NCT03610334|7747707|FG008|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815209|NCT03610334|7747708|FG009|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815210|NCT03610334|7747709|FG010|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815211|NCT03610334|7747710|FG011|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6567849|NCT01833169|7490999|FG000|NOT COMPLETED|Overall Study||146
6567850|NCT01833247|7491003|FG000|STARTED|Overall Study||12
6567851|NCT01833247|7491003|FG000|COMPLETED|Overall Study||12
6567852|NCT01833247|7491003|FG000|NOT COMPLETED|Overall Study||0
6815212|NCT03610334|7747711|FG012|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815213|NCT03610334|7747712|FG013|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815214|NCT03610334|7747713|FG014|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6657138|NCT02466516|7587409|FG002|NOT COMPLETED|Overall Study||1
6815215|NCT03610334|7747714|FG015|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815216|NCT03610334|7747715|FG016|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815217|NCT03610334|7747716|FG017|NOT COMPLETED|Period 6: 60.0mg (1 Day)||0
6815218|NCT03610334|7747699|FG000|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
6815219|NCT03610334|7747700|FG001|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
6815220|NCT03610334|7747701|FG002|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
6815221|NCT03610334|7747702|FG003|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
6815222|NCT03610334|7747703|FG004|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
6815223|NCT03610334|7747704|FG005|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
6815224|NCT03610334|7747705|FG006|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
6815225|NCT03610334|7747706|FG007|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
6815226|NCT03610334|7747707|FG008|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
6815227|NCT03610334|7747708|FG009|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
6815228|NCT03610334|7747709|FG010|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
6815229|NCT03610334|7747710|FG011|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
6815230|NCT03610334|7747711|FG012|STARTED|Period 7: 15.0mg (Day 1 to 14)||6
6815231|NCT03610334|7747712|FG013|STARTED|Period 7: 15.0mg (Day 1 to 14)||2
6815232|NCT03610334|7747713|FG014|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
6815233|NCT03610334|7747714|FG015|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
6815234|NCT03610334|7747715|FG016|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
6815235|NCT03610334|7747716|FG017|STARTED|Period 7: 15.0mg (Day 1 to 14)||0
6815236|NCT03610334|7747699|FG000|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
6815237|NCT03610334|7747700|FG001|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
6815238|NCT03610334|7747701|FG002|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
6815239|NCT03610334|7747702|FG003|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
6815240|NCT03610334|7747703|FG004|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
6815241|NCT03610334|7747704|FG005|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
6815242|NCT03610334|7747705|FG006|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
6815243|NCT03610334|7747706|FG007|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
6815244|NCT03610334|7747707|FG008|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
6815245|NCT03610334|7747708|FG009|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
6815246|NCT03610334|7747709|FG010|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
6815247|NCT03610334|7747710|FG011|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
6815248|NCT03610334|7747711|FG012|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||6
6815249|NCT03610334|7747712|FG013|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||2
6815250|NCT03610334|7747713|FG014|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6657139|NCT02466516|7587410|FG003|NOT COMPLETED|Overall Study||0
6657140|NCT02466516|7587411|FG004|NOT COMPLETED|Overall Study||0
6657141|NCT02466555|7587423|FG000|STARTED|Overall Study||30
6657142|NCT02466555|7587423|FG000|COMPLETED|Overall Study||28
6657143|NCT02466555|7587423|FG000|NOT COMPLETED|Overall Study||2
6815251|NCT03610334|7747714|FG015|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815252|NCT03610334|7747715|FG016|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815253|NCT03610334|7747716|FG017|COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815254|NCT03610334|7747699|FG000|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815255|NCT03610334|7747700|FG001|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815256|NCT03610334|7747701|FG002|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815257|NCT03610334|7747702|FG003|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815258|NCT03610334|7747703|FG004|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815259|NCT03610334|7747704|FG005|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815260|NCT03610334|7747705|FG006|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815261|NCT03610334|7747706|FG007|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815262|NCT03610334|7747707|FG008|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6280842|NCT00159263|7180665|FG001|NOT COMPLETED|Washout||0
6504772|NCT01449721|7423808|FG000|NOT COMPLETED|Overall Study||0
6504773|NCT01449721|7423809|FG001|NOT COMPLETED|Overall Study||2
6504774|NCT01449734|7423815|FG000|STARTED|Overall Study||215
6504775|NCT01449734|7423815|FG000|COMPLETED|Overall Study||215
6504776|NCT01449734|7423815|FG000|NOT COMPLETED|Overall Study||0
6504777|NCT01449747|7423821|FG000|STARTED|Overall Study||12
6657144|NCT02466646|7587431|FG000|STARTED|Overall Study||14
6815263|NCT03610334|7747708|FG009|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815264|NCT03610334|7747709|FG010|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815265|NCT03610334|7747710|FG011|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815266|NCT03610334|7747711|FG012|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815267|NCT03610334|7747712|FG013|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815268|NCT03610334|7747713|FG014|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815269|NCT03610334|7747714|FG015|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815270|NCT03610334|7747715|FG016|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815271|NCT03610334|7747716|FG017|NOT COMPLETED|Period 7: 15.0mg (Day 1 to 14)||0
6815272|NCT03610334|7747699|FG000|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
6815273|NCT03610334|7747700|FG001|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
6815274|NCT03610334|7747701|FG002|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
6815275|NCT03610334|7747702|FG003|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
6815276|NCT03610334|7747703|FG004|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
6815277|NCT03610334|7747704|FG005|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
6815278|NCT03610334|7747705|FG006|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
6815279|NCT03610334|7747706|FG007|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
6815280|NCT03610334|7747707|FG008|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
6815281|NCT03610334|7747708|FG009|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
6815282|NCT03610334|7747709|FG010|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
6815283|NCT03610334|7747710|FG011|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
6815284|NCT03610334|7747711|FG012|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
6815285|NCT03610334|7747712|FG013|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
6815286|NCT03610334|7747713|FG014|STARTED|Period 8: 30.0mg (Day 1 to 14)||6
6815287|NCT03610334|7747714|FG015|STARTED|Period 8: 30.0mg (Day 1 to 14)||2
6815288|NCT03610334|7747715|FG016|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
6815289|NCT03610334|7747716|FG017|STARTED|Period 8: 30.0mg (Day 1 to 14)||0
6815290|NCT03610334|7747699|FG000|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
6815291|NCT03610334|7747700|FG001|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
6815292|NCT03610334|7747701|FG002|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
6815293|NCT03610334|7747702|FG003|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
6815294|NCT03610334|7747703|FG004|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
6815295|NCT03610334|7747704|FG005|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
6815296|NCT03610334|7747705|FG006|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
6815297|NCT03610334|7747706|FG007|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
6815298|NCT03610334|7747707|FG008|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
6815299|NCT03610334|7747708|FG009|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
6815300|NCT03610334|7747709|FG010|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
6815301|NCT03610334|7747710|FG011|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
6815302|NCT03610334|7747711|FG012|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
6815303|NCT03610334|7747712|FG013|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
6815304|NCT03610334|7747713|FG014|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||6
6815305|NCT03610334|7747714|FG015|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||2
6815306|NCT03610334|7747715|FG016|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815307|NCT03610334|7747716|FG017|COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815308|NCT03610334|7747699|FG000|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815309|NCT03610334|7747700|FG001|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815310|NCT03610334|7747701|FG002|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815311|NCT03610334|7747702|FG003|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815312|NCT03610334|7747703|FG004|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815313|NCT03610334|7747704|FG005|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815314|NCT03610334|7747705|FG006|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815315|NCT03610334|7747706|FG007|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815316|NCT03610334|7747707|FG008|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815317|NCT03610334|7747708|FG009|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815318|NCT03610334|7747709|FG010|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815319|NCT03610334|7747710|FG011|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815320|NCT03610334|7747711|FG012|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815321|NCT03610334|7747712|FG013|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815322|NCT03610334|7747713|FG014|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815323|NCT03610334|7747714|FG015|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815324|NCT03610334|7747715|FG016|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815325|NCT03610334|7747716|FG017|NOT COMPLETED|Period 8: 30.0mg (Day 1 to 14)||0
6815326|NCT03610334|7747699|FG000|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815327|NCT03610334|7747700|FG001|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815328|NCT03610334|7747701|FG002|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815329|NCT03610334|7747702|FG003|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815330|NCT03610334|7747703|FG004|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815331|NCT03610334|7747704|FG005|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815332|NCT03610334|7747705|FG006|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815333|NCT03610334|7747706|FG007|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815334|NCT03610334|7747707|FG008|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815335|NCT03610334|7747708|FG009|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815336|NCT03610334|7747709|FG010|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815337|NCT03610334|7747710|FG011|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815338|NCT03610334|7747711|FG012|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815339|NCT03610334|7747712|FG013|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815340|NCT03610334|7747713|FG014|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815341|NCT03610334|7747714|FG015|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815342|NCT03610334|7747715|FG016|STARTED|Period 9: 50.0mg (Day 1 to 14)||6
6815343|NCT03610334|7747716|FG017|STARTED|Period 9: 50.0mg (Day 1 to 14)||2
6815344|NCT03610334|7747699|FG000|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815345|NCT03610334|7747700|FG001|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815346|NCT03610334|7747701|FG002|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815347|NCT03610334|7747702|FG003|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815348|NCT03610334|7747703|FG004|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815349|NCT03610334|7747704|FG005|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815350|NCT03610334|7747705|FG006|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815351|NCT03610334|7747706|FG007|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815352|NCT03610334|7747707|FG008|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815353|NCT03610334|7747708|FG009|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815354|NCT03610334|7747709|FG010|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815355|NCT03610334|7747710|FG011|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815356|NCT03610334|7747711|FG012|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815357|NCT03610334|7747712|FG013|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815358|NCT03610334|7747713|FG014|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815359|NCT03610334|7747714|FG015|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815360|NCT03610334|7747715|FG016|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||6
6815361|NCT03610334|7747716|FG017|COMPLETED|Period 9: 50.0mg (Day 1 to 14)||2
6815362|NCT03610334|7747699|FG000|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815363|NCT03610334|7747700|FG001|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815364|NCT03610334|7747701|FG002|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815365|NCT03610334|7747702|FG003|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815366|NCT03610334|7747703|FG004|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815367|NCT03610334|7747704|FG005|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815368|NCT03610334|7747705|FG006|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815369|NCT03610334|7747706|FG007|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815370|NCT03610334|7747707|FG008|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815371|NCT03610334|7747708|FG009|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815372|NCT03610334|7747709|FG010|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815373|NCT03610334|7747710|FG011|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815374|NCT03610334|7747711|FG012|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815375|NCT03610334|7747712|FG013|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815376|NCT03610334|7747713|FG014|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815377|NCT03610334|7747714|FG015|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815378|NCT03610334|7747715|FG016|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6504778|NCT01449747|7423822|FG001|STARTED|Overall Study||12
6815379|NCT03610334|7747716|FG017|NOT COMPLETED|Period 9: 50.0mg (Day 1 to 14)||0
6815380|NCT03334539|7747766|FG000|STARTED|Overall Study||50
6815381|NCT03334539|7747767|FG001|STARTED|Overall Study||50
6815382|NCT03334539|7747768|FG002|STARTED|Overall Study||50
6815383|NCT03334539|7747766|FG000|COMPLETED|Overall Study||46
6815384|NCT03334539|7747767|FG001|COMPLETED|Overall Study||43
6815385|NCT03334539|7747768|FG002|COMPLETED|Overall Study||49
6815386|NCT03334539|7747766|FG000|NOT COMPLETED|Overall Study||4
6815387|NCT03334539|7747767|FG001|NOT COMPLETED|Overall Study||7
6815388|NCT03334539|7747768|FG002|NOT COMPLETED|Overall Study||1
6815389|NCT03311854|7747781|FG000|STARTED|Overall Study||14
6815390|NCT03311854|7747781|FG000|COMPLETED|Overall Study||14
6815391|NCT03311854|7747781|FG000|NOT COMPLETED|Overall Study||0
6815392|NCT03269344|7747790|FG000|STARTED|Overall Study||33
6815393|NCT03269344|7747791|FG001|STARTED|Overall Study||32
6815394|NCT03269344|7747790|FG000|COMPLETED|Overall Study||29
6815395|NCT03269344|7747791|FG001|COMPLETED|Overall Study||29
6815396|NCT03269344|7747790|FG000|NOT COMPLETED|Overall Study||4
6815397|NCT03269344|7747791|FG001|NOT COMPLETED|Overall Study||3
6815398|NCT03079284|7747797|FG000|STARTED|Overall Study||10
6815399|NCT03079284|7747797|FG000|COMPLETED|Overall Study||10
6815400|NCT03079284|7747797|FG000|NOT COMPLETED|Overall Study||0
6815401|NCT03076775|7747805|FG000|STARTED|Overall Study||44
6815402|NCT03076775|7747806|FG001|STARTED|Overall Study||42
6815403|NCT03076775|7747805|FG000|Neonates Born During Study|Overall Study||43
6815404|NCT03076775|7747806|FG001|Neonates Born During Study|Overall Study||42
6815405|NCT03076775|7747805|FG000|Umbilical Cord Blood Collected|Overall Study||33
6815406|NCT03076775|7747806|FG001|Umbilical Cord Blood Collected|Overall Study||38
6815407|NCT03076775|7747805|FG000|COMPLETED|Overall Study||43
6815408|NCT03076775|7747806|FG001|COMPLETED|Overall Study||42
6815409|NCT03076775|7747805|FG000|NOT COMPLETED|Overall Study||1
6815410|NCT03076775|7747806|FG001|NOT COMPLETED|Overall Study||0
6567853|NCT01833403|7491007|FG000|STARTED|Overall Study||4
6567854|NCT01833403|7491007|FG000|COMPLETED|Overall Study||4
6567855|NCT01833403|7491007|FG000|NOT COMPLETED|Overall Study||0
6567856|NCT01833455|7491014|FG000|STARTED|Overall Study||4
6567857|NCT01833455|7491015|FG001|STARTED|Overall Study||4
6567858|NCT01833455|7491014|FG000|Completed 1st Baseline|Overall Study||4
6567859|NCT01833455|7491015|FG001|Completed 1st Baseline|Overall Study||4
6567860|NCT01833455|7491014|FG000|Completed 1st Intervention|Overall Study||3
6567861|NCT01833455|7491015|FG001|Completed 1st Intervention|Overall Study||4
6567862|NCT01833455|7491014|FG000|Completed 2nd Baseline (Washout)|Overall Study||3
6815411|NCT02933944|7747816|FG000|STARTED|Overall Study||6
6815412|NCT02933944|7747816|FG000|COMPLETED|Overall Study||6
6815413|NCT02933944|7747816|FG000|NOT COMPLETED|Overall Study||0
6815414|NCT02921997|7747825|FG000|STARTED|Overall Study||10
6815415|NCT02921997|7747826|FG001|STARTED|Overall Study||10
6815416|NCT02921997|7747827|FG002|STARTED|Overall Study||10
6815417|NCT02921997|7747825|FG000|COMPLETED|Overall Study||10
6275989|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
6275990|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 145 - 192||133
6275991|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 145 - 192||74
6275992|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 145 - 192||123
6275993|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 145 - 192||68
6275994|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
6275995|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
6275996|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 193 - 240||123
6275997|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 193 - 240||68
6275998|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 193 - 240||110
6275999|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 193 - 240||64
6815418|NCT02921997|7747826|FG001|COMPLETED|Overall Study||10
6815419|NCT02921997|7747827|FG002|COMPLETED|Overall Study||10
6815420|NCT02921997|7747825|FG000|NOT COMPLETED|Overall Study||0
6815421|NCT02921997|7747826|FG001|NOT COMPLETED|Overall Study||0
6815422|NCT02921997|7747827|FG002|NOT COMPLETED|Overall Study||0
6815423|NCT02833935|7747839|FG000|STARTED|Overall Study||12
6815424|NCT02833935|7747840|FG001|STARTED|Overall Study||12
6815425|NCT02833935|7747839|FG000|COMPLETED|Overall Study||10
6815426|NCT02833935|7747840|FG001|COMPLETED|Overall Study||12
6815427|NCT02833935|7747839|FG000|NOT COMPLETED|Overall Study||2
6815428|NCT02833935|7747840|FG001|NOT COMPLETED|Overall Study||0
6815429|NCT02660827|7747846|FG000|STARTED|From Study to End of Continued Access||151
6815430|NCT02660827|7747846|FG000|COMPLETED|From Study to End of Continued Access||120
6815431|NCT02660827|7747846|FG000|NOT COMPLETED|From Study to End of Continued Access||31
6815432|NCT02660827|7747846|FG000|STARTED|Period 1: Study Period||151
6815433|NCT02660827|7747846|FG000|COMPLETED|Period 1: Study Period||150
6815434|NCT02660827|7747846|FG000|NOT COMPLETED|Period 1: Study Period||1
6815435|NCT02660827|7747846|FG000|STARTED|Period 2: Continued Access Period||145
6815436|NCT02660827|7747846|FG000|COMPLETED|Period 2: Continued Access Period||120
6815437|NCT02660827|7747846|FG000|NOT COMPLETED|Period 2: Continued Access Period||25
6815438|NCT02627963|7747855|FG000|STARTED|Overall Study||175
6815439|NCT02627963|7747856|FG001|STARTED|Overall Study||175
6815440|NCT02627963|7747855|FG000|COMPLETED|Overall Study||139
6815441|NCT02627963|7747856|FG001|COMPLETED|Overall Study||161
6815442|NCT02627963|7747855|FG000|NOT COMPLETED|Overall Study||36
6815443|NCT02627963|7747856|FG001|NOT COMPLETED|Overall Study||14
6815444|NCT02581930|7747862|FG000|STARTED|Overall Study||18
6815445|NCT02581930|7747862|FG000|COMPLETED|Overall Study||16
6815446|NCT02581930|7747862|FG000|NOT COMPLETED|Overall Study||2
6815447|NCT02425644|7747868|FG000|STARTED|Overall Study||567
6815448|NCT02425644|7747869|FG001|STARTED|Overall Study||566
6815449|NCT02425644|7747868|FG000|Treated|Overall Study||565
6815450|NCT02425644|7747869|FG001|Treated|Overall Study||566
6815451|NCT02425644|7747868|FG000|COMPLETED|Overall Study||490
6815452|NCT02425644|7747869|FG001|COMPLETED|Overall Study||495
6815453|NCT02425644|7747868|FG000|NOT COMPLETED|Overall Study||77
6815454|NCT02425644|7747869|FG001|NOT COMPLETED|Overall Study||71
6815455|NCT02395614|7747875|FG000|STARTED|Overall Study||88
6815456|NCT02395614|7747875|FG000|Chlorhexidine Irrigation|Overall Study||88
6815457|NCT02395614|7747875|FG000|Triple Antibiotic Irrigation|Overall Study||88
6815458|NCT02395614|7747875|FG000|COMPLETED|Overall Study||88
6815459|NCT02395614|7747875|FG000|NOT COMPLETED|Overall Study||0
6815460|NCT02340221|7747882|FG000|STARTED|Overall Study||214
6815461|NCT02340221|7747883|FG001|STARTED|Overall Study||417
6815462|NCT02340221|7747882|FG000|COMPLETED|Overall Study||0
6815463|NCT02340221|7747883|FG001|COMPLETED|Overall Study||0
6815464|NCT02340221|7747882|FG000|NOT COMPLETED|Overall Study||214
6815465|NCT02340221|7747883|FG001|NOT COMPLETED|Overall Study||417
6815466|NCT02270957|7747892|FG000|STARTED|Overall Study||31
6815467|NCT02270957|7747893|FG001|STARTED|Overall Study||35
6815468|NCT02270957|7747892|FG000|COMPLETED|Overall Study||27
6815469|NCT02270957|7747893|FG001|COMPLETED|Overall Study||31
6815470|NCT02270957|7747892|FG000|NOT COMPLETED|Overall Study||4
6815471|NCT02270957|7747893|FG001|NOT COMPLETED|Overall Study||4
6815472|NCT02134925|7747902|FG000|STARTED|Overall Study||54
6815473|NCT02134925|7747903|FG001|STARTED|Overall Study||56
6815474|NCT02134925|7747902|FG000|Received at Least One Dose of Treatment|Overall Study||53
6815475|NCT02134925|7747903|FG001|Received at Least One Dose of Treatment|Overall Study||50
6815476|NCT02134925|7747902|FG000|COMPLETED|Overall Study||52
6815477|NCT02134925|7747903|FG001|COMPLETED|Overall Study||50
6815478|NCT02134925|7747902|FG000|NOT COMPLETED|Overall Study||2
6815479|NCT02134925|7747903|FG001|NOT COMPLETED|Overall Study||6
6815480|NCT02054104|7747911|FG000|STARTED|Overall Study||10
6815481|NCT02054104|7747912|FG001|STARTED|Overall Study||11
6815482|NCT02054104|7747911|FG000|COMPLETED|Overall Study||2
6815483|NCT02054104|7747912|FG001|COMPLETED|Overall Study||2
6815484|NCT02054104|7747911|FG000|NOT COMPLETED|Overall Study||8
6815485|NCT02054104|7747912|FG001|NOT COMPLETED|Overall Study||9
6815486|NCT01899144|7747918|FG000|STARTED|Treatment Period 1||61
6815487|NCT01899144|7747918|FG000|COMPLETED|Treatment Period 1||61
6815488|NCT01899144|7747918|FG000|NOT COMPLETED|Treatment Period 1||0
6815489|NCT01899144|7747918|FG000|STARTED|Treatment Period 2||61
6815490|NCT01899144|7747918|FG000|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
6815491|NCT01899144|7747918|FG000|NOT COMPLETED|Treatment Period 2||1
6815492|NCT01899144|7747918|FG000|STARTED|Treatment Period 3||60
6815493|NCT01899144|7747918|FG000|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
6815494|NCT01899144|7747918|FG000|NOT COMPLETED|Treatment Period 3||2
6815495|NCT01899144|7747918|FG000|STARTED|Treatment Period 4||58
6815496|NCT01899144|7747918|FG000|COMPLETED|Treatment Period 4||58
6815497|NCT01899144|7747918|FG000|NOT COMPLETED|Treatment Period 4||0
6815498|NCT01899144|7747918|FG000|STARTED|Treatment Period 5||58
6815499|NCT01899144|7747918|FG000|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
6815500|NCT01899144|7747918|FG000|NOT COMPLETED|Treatment Period 5||1
6815501|NCT01793610|7747933|FG000|STARTED|Overall Study||6
6815502|NCT01793610|7747934|FG001|STARTED|Overall Study||9
6815503|NCT01793610|7747935|FG002|STARTED|Overall Study||13
6815504|NCT01793610|7747933|FG000|COMPLETED|Overall Study||5
6815505|NCT01793610|7747934|FG001|COMPLETED|Overall Study||9
6815506|NCT01793610|7747935|FG002|COMPLETED|Overall Study||12
6815507|NCT01793610|7747933|FG000|NOT COMPLETED|Overall Study||1
6815508|NCT01793610|7747934|FG001|NOT COMPLETED|Overall Study||0
6815509|NCT01793610|7747935|FG002|NOT COMPLETED|Overall Study||1
6815510|NCT01757665|7747949|FG000|STARTED|Overall Study||694
6815511|NCT01757665|7747950|FG001|STARTED|Overall Study||83
6815512|NCT01757665|7747949|FG000|Implanted With Device|Overall Study||689
6815513|NCT01757665|7747950|FG001|Implanted With Device|Overall Study||82
6815514|NCT01757665|7747949|FG000|COMPLETED|Overall Study||0
6815515|NCT01757665|7747950|FG001|COMPLETED|Overall Study||0
6815516|NCT01757665|7747949|FG000|NOT COMPLETED|Overall Study||694
6815517|NCT01757665|7747950|FG001|NOT COMPLETED|Overall Study||83
6815518|NCT01482195|7747971|FG000|STARTED|Overall Study||6
6815519|NCT01482195|7747971|FG000|One Year Results|Overall Study||6
6815520|NCT01482195|7747971|FG000|COMPLETED|Overall Study||6
6815521|NCT01482195|7747971|FG000|NOT COMPLETED|Overall Study||0
6815522|NCT01468831|7747978|FG000|STARTED|Overall Study||4
6815523|NCT01468831|7747979|FG001|STARTED|Overall Study||5
6815524|NCT01468831|7747978|FG000|Month 12 (Primary Outcome)|Overall Study||4
6815525|NCT01468831|7747979|FG001|Month 12 (Primary Outcome)|Overall Study||4
6815526|NCT01468831|7747978|FG000|COMPLETED|Overall Study||4
6815527|NCT01468831|7747979|FG001|COMPLETED|Overall Study||4
6815528|NCT01468831|7747978|FG000|NOT COMPLETED|Overall Study||0
6815529|NCT01468831|7747979|FG001|NOT COMPLETED|Overall Study||1
6815530|NCT01383109|7747985|FG000|STARTED|Overall Study||6
6815531|NCT01383109|7747985|FG000|COMPLETED|Overall Study||6
6815532|NCT01383109|7747985|FG000|NOT COMPLETED|Overall Study||0
6815533|NCT00822120|7747991|FG000|STARTED|Initial Registration||358
6815534|NCT00822120|7747992|FG001|STARTED|Initial Registration||13
6815535|NCT00822120|7747993|FG002|STARTED|Initial Registration||0
6815536|NCT00822120|7747994|FG003|STARTED|Initial Registration||0
6815537|NCT00822120|7747995|FG004|STARTED|Initial Registration||0
6815538|NCT00822120|7747996|FG005|STARTED|Initial Registration||0
6815539|NCT00822120|7747991|FG000|Eligible and Evaluable Patients|Initial Registration||336
6815540|NCT00822120|7747992|FG001|Eligible and Evaluable Patients|Initial Registration||12
6815541|NCT00822120|7747993|FG002|Eligible and Evaluable Patients|Initial Registration||0
6815542|NCT00822120|7747994|FG003|Eligible and Evaluable Patients|Initial Registration||0
6815543|NCT00822120|7747995|FG004|Eligible and Evaluable Patients|Initial Registration||0
6815544|NCT00822120|7747996|FG005|Eligible and Evaluable Patients|Initial Registration||0
6815545|NCT00822120|7747991|FG000|COMPLETED|Initial Registration||332
6815546|NCT00822120|7747992|FG001|COMPLETED|Initial Registration||12
6815547|NCT00822120|7747993|FG002|COMPLETED|Initial Registration||0
6815548|NCT00822120|7747994|FG003|COMPLETED|Initial Registration||0
6815549|NCT00822120|7747995|FG004|COMPLETED|Initial Registration||0
6815550|NCT00822120|7747996|FG005|COMPLETED|Initial Registration||0
6815551|NCT00822120|7747991|FG000|NOT COMPLETED|Initial Registration||26
6815552|NCT00822120|7747992|FG001|NOT COMPLETED|Initial Registration||1
6815553|NCT00822120|7747993|FG002|NOT COMPLETED|Initial Registration||0
6815554|NCT00822120|7747994|FG003|NOT COMPLETED|Initial Registration||0
6815555|NCT00822120|7747995|FG004|NOT COMPLETED|Initial Registration||0
6815556|NCT00822120|7747996|FG005|NOT COMPLETED|Initial Registration||0
6815557|NCT00822120|7747991|FG000|STARTED|PET-directed Therapy||0
6815558|NCT00822120|7747992|FG001|STARTED|PET-directed Therapy||0
6815559|NCT00822120|7747993|FG002|STARTED|PET-directed Therapy||270
6815560|NCT00822120|7747994|FG003|STARTED|PET-directed Therapy||55
6815561|NCT00822120|7747995|FG004|STARTED|PET-directed Therapy||10
6815562|NCT00822120|7747996|FG005|STARTED|PET-directed Therapy||1
6815563|NCT00822120|7747991|FG000|Eligibile and Evaluable Patients|PET-directed Therapy||0
6815564|NCT00822120|7747992|FG001|Eligibile and Evaluable Patients|PET-directed Therapy||0
6815565|NCT00822120|7747993|FG002|Eligibile and Evaluable Patients|PET-directed Therapy||270
6815566|NCT00822120|7747994|FG003|Eligibile and Evaluable Patients|PET-directed Therapy||55
6815567|NCT00822120|7747995|FG004|Eligibile and Evaluable Patients|PET-directed Therapy||10
6815568|NCT00822120|7747996|FG005|Eligibile and Evaluable Patients|PET-directed Therapy||1
6815569|NCT00822120|7747991|FG000|COMPLETED|PET-directed Therapy||0
6815570|NCT00822120|7747992|FG001|COMPLETED|PET-directed Therapy||0
6815571|NCT00822120|7747993|FG002|COMPLETED|PET-directed Therapy||270
6815572|NCT00822120|7747994|FG003|COMPLETED|PET-directed Therapy||45
6815573|NCT00822120|7747995|FG004|COMPLETED|PET-directed Therapy||10
6815574|NCT00822120|7747996|FG005|COMPLETED|PET-directed Therapy||1
6815575|NCT00822120|7747991|FG000|NOT COMPLETED|PET-directed Therapy||0
6815576|NCT00822120|7747992|FG001|NOT COMPLETED|PET-directed Therapy||0
6815577|NCT00822120|7747993|FG002|NOT COMPLETED|PET-directed Therapy||0
6815578|NCT00822120|7747994|FG003|NOT COMPLETED|PET-directed Therapy||10
6815579|NCT00822120|7747995|FG004|NOT COMPLETED|PET-directed Therapy||0
6815580|NCT00822120|7747996|FG005|NOT COMPLETED|PET-directed Therapy||0
6815581|NCT00603954|7748019|FG000|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|50
6815582|NCT00603954|7748020|FG001|STARTED|Overall Study|5 patients in Screening failure between inclusion and transplantation|47
6815583|NCT00603954|7748019|FG000|COMPLETED|Overall Study||49
6815584|NCT00603954|7748020|FG001|COMPLETED|Overall Study||45
6815585|NCT00603954|7748019|FG000|NOT COMPLETED|Overall Study||1
6815586|NCT00603954|7748020|FG001|NOT COMPLETED|Overall Study||2
6567863|NCT01833455|7491015|FG001|Completed 2nd Baseline (Washout)|Overall Study||4
6567864|NCT01833455|7491014|FG000|COMPLETED|Overall Study||3
6567865|NCT01833455|7491015|FG001|COMPLETED|Overall Study||4
6567866|NCT01833455|7491014|FG000|NOT COMPLETED|Overall Study||1
6391063|NCT00833703|7302886|FG000|Treated|Overall Study||23
6391064|NCT00833703|7302887|FG001|Treated|Overall Study||26
6391065|NCT00833703|7302886|FG000|Completed Treatment|Overall Study||22
6391066|NCT00833703|7302887|FG001|Completed Treatment|Overall Study||24
6391067|NCT00833703|7302886|FG000|COMPLETED|Overall Study|Completed follow-up|23
6391068|NCT00833703|7302887|FG001|COMPLETED|Overall Study|Completed follow-up|25
6391069|NCT00833703|7302886|FG000|NOT COMPLETED|Overall Study||0
6391070|NCT00833703|7302887|FG001|NOT COMPLETED|Overall Study||1
6391071|NCT00833755|7302897|FG000|STARTED|Overall Study||16
6391072|NCT00833755|7302898|FG001|STARTED|Overall Study||18
6391073|NCT00833755|7302899|FG002|STARTED|Overall Study||22
6391074|NCT00833755|7302900|FG003|STARTED|Overall Study||23
6391075|NCT00833755|7302897|FG000|COMPLETED|Overall Study||12
6504779|NCT01449747|7423821|FG000|COMPLETED|Overall Study||12
6504780|NCT01449747|7423822|FG001|COMPLETED|Overall Study||12
6504781|NCT01449747|7423821|FG000|NOT COMPLETED|Overall Study||0
6504782|NCT01449747|7423822|FG001|NOT COMPLETED|Overall Study||0
6504783|NCT01449812|7423831|FG000|STARTED|Overall Study||272
6504784|NCT01449812|7423832|FG001|STARTED|Overall Study||273
6504785|NCT01449812|7423833|FG002|STARTED|Overall Study||280
6504786|NCT01449812|7423831|FG000|COMPLETED|Overall Study||270
6504787|NCT01449812|7423832|FG001|COMPLETED|Overall Study||273
6504788|NCT01449812|7423833|FG002|COMPLETED|Overall Study||279
6504789|NCT01449812|7423831|FG000|NOT COMPLETED|Overall Study||2
6504790|NCT01449812|7423832|FG001|NOT COMPLETED|Overall Study||0
6504791|NCT01449812|7423833|FG002|NOT COMPLETED|Overall Study||1
6504792|NCT01449864|7423841|FG000|STARTED|Overall Study||22
6504793|NCT01449864|7423841|FG000|COMPLETED|Overall Study||17
6504794|NCT01449864|7423841|FG000|NOT COMPLETED|Overall Study||5
6504795|NCT01449929|7423847|FG000|STARTED|Randomization Phase 96 Week||242
6391076|NCT00833755|7302898|FG001|COMPLETED|Overall Study||13
6391077|NCT00833755|7302899|FG002|COMPLETED|Overall Study||20
6504796|NCT01449929|7423848|FG001|STARTED|Randomization Phase 96 Week||242
6567867|NCT01833455|7491015|FG001|NOT COMPLETED|Overall Study||0
6567868|NCT01833481|7491036|FG000|STARTED|Overall Study||10
6815587|NCT05087524|7748027|FG000|STARTED|Overall Study||65
6815588|NCT05087524|7748027|FG000|COMPLETED|Overall Study||65
6815589|NCT05087524|7748027|FG000|NOT COMPLETED|Overall Study||0
6815590|NCT04532294|7748034|FG000|STARTED|Overall Study||4
6815591|NCT04532294|7748035|FG001|STARTED|Overall Study||6
6815592|NCT04532294|7748036|FG002|STARTED|Overall Study||8
6815593|NCT04532294|7748034|FG000|COMPLETED|Overall Study||4
6815594|NCT04532294|7748035|FG001|COMPLETED|Overall Study||6
6815595|NCT04532294|7748036|FG002|COMPLETED|Overall Study||5
6815596|NCT04532294|7748034|FG000|NOT COMPLETED|Overall Study||0
6815597|NCT04532294|7748035|FG001|NOT COMPLETED|Overall Study||0
6657145|NCT02466646|7587432|FG001|STARTED|Overall Study||14
6657146|NCT02466646|7587433|FG002|STARTED|Overall Study||14
6815598|NCT04532294|7748036|FG002|NOT COMPLETED|Overall Study||3
6815599|NCT04250077|7748049|FG000|STARTED|Overall Study||15
6815600|NCT04250077|7748050|FG001|STARTED|Overall Study||15
6815601|NCT04250077|7748051|FG002|STARTED|Overall Study||15
6815602|NCT04250077|7748049|FG000|COMPLETED|Overall Study||13
6815603|NCT04250077|7748050|FG001|COMPLETED|Overall Study||11
6815604|NCT04250077|7748051|FG002|COMPLETED|Overall Study||15
6815605|NCT04250077|7748049|FG000|NOT COMPLETED|Overall Study||2
6815606|NCT04250077|7748050|FG001|NOT COMPLETED|Overall Study||4
6815607|NCT04250077|7748051|FG002|NOT COMPLETED|Overall Study||0
6815608|NCT04068142|7748063|FG000|STARTED|Overall Study||17
6815609|NCT04068142|7748064|FG001|STARTED|Overall Study||20
6815610|NCT04068142|7748063|FG000|COMPLETED|Overall Study||15
6815611|NCT04068142|7748064|FG001|COMPLETED|Overall Study||16
6815612|NCT04068142|7748063|FG000|NOT COMPLETED|Overall Study||2
6815613|NCT04068142|7748064|FG001|NOT COMPLETED|Overall Study||4
6815614|NCT03961009|7748070|FG000|STARTED|Overall Study||47
6815615|NCT03961009|7748070|FG000|COMPLETED|Overall Study||47
6815616|NCT03961009|7748070|FG000|NOT COMPLETED|Overall Study||0
6815617|NCT03875495|7748074|FG000|STARTED|Overall Study||3
6815618|NCT03875495|7748074|FG000|COMPLETED|Overall Study||0
6815619|NCT03875495|7748074|FG000|NOT COMPLETED|Overall Study||3
6815620|NCT03702439|7748078|FG000|STARTED|Overall Study||408
6815621|NCT03702439|7748078|FG000|COMPLETED|Overall Study||408
6815622|NCT03702439|7748078|FG000|NOT COMPLETED|Overall Study||0
6815623|NCT03687190|7748086|FG000|STARTED|Overall Study||12
6815624|NCT03687190|7748087|FG001|STARTED|Overall Study||9
6815625|NCT03687190|7748086|FG000|COMPLETED|Overall Study||12
6815626|NCT03687190|7748087|FG001|COMPLETED|Overall Study||9
6815627|NCT03687190|7748086|FG000|NOT COMPLETED|Overall Study||0
6815628|NCT03687190|7748087|FG001|NOT COMPLETED|Overall Study||0
6815629|NCT03583931|7748095|FG000|STARTED|Overall Study||5
6815630|NCT03583931|7748096|FG001|STARTED|Overall Study||5
6815631|NCT03583931|7748095|FG000|COMPLETED|Overall Study||5
6815632|NCT03583931|7748096|FG001|COMPLETED|Overall Study||5
6815633|NCT03583931|7748095|FG000|NOT COMPLETED|Overall Study||0
6815634|NCT03583931|7748096|FG001|NOT COMPLETED|Overall Study||0
6815635|NCT03296553|7748104|FG000|STARTED|Overall Study||20
6815636|NCT03296553|7748105|FG001|STARTED|Overall Study||20
6815637|NCT03296553|7748104|FG000|COMPLETED|Overall Study||18
6815638|NCT03296553|7748105|FG001|COMPLETED|Overall Study||19
6815639|NCT03296553|7748104|FG000|NOT COMPLETED|Overall Study||2
6815640|NCT03296553|7748105|FG001|NOT COMPLETED|Overall Study||1
6815641|NCT03148795|7748111|FG000|STARTED|Overall Study||128
6815642|NCT03148795|7748111|FG000|Treated|Overall Study||127
6815643|NCT03148795|7748111|FG000|COMPLETED|Overall Study||0
6815644|NCT03148795|7748111|FG000|NOT COMPLETED|Overall Study||128
6815645|NCT03000569|7748117|FG000|STARTED|Overall Study||15
6815646|NCT03000569|7748118|FG001|STARTED|Overall Study||14
6815647|NCT03000569|7748117|FG000|COMPLETED|Overall Study||14
6815648|NCT03000569|7748118|FG001|COMPLETED|Overall Study||14
6815649|NCT03000569|7748117|FG000|NOT COMPLETED|Overall Study||1
6815650|NCT03000569|7748118|FG001|NOT COMPLETED|Overall Study||0
6815651|NCT03000530|7748135|FG000|STARTED|Overall Study||13
6815652|NCT03000530|7748136|FG001|STARTED|Overall Study||44
6815653|NCT03000530|7748137|FG002|STARTED|Overall Study||45
6815654|NCT03000530|7748135|FG000|COMPLETED|Overall Study||13
6815655|NCT03000530|7748136|FG001|COMPLETED|Overall Study||39
6815656|NCT03000530|7748137|FG002|COMPLETED|Overall Study||41
6815657|NCT03000530|7748135|FG000|NOT COMPLETED|Overall Study||0
6815658|NCT03000530|7748136|FG001|NOT COMPLETED|Overall Study||5
6815659|NCT03000530|7748137|FG002|NOT COMPLETED|Overall Study||4
6815660|NCT02978781|7748151|FG000|STARTED|Part A||2
6815661|NCT02978781|7748152|FG001|STARTED|Part A||14
6815662|NCT02978781|7748153|FG002|STARTED|Part A||0
6815663|NCT02978781|7748154|FG003|STARTED|Part A||0
6815664|NCT02978781|7748155|FG004|STARTED|Part A||0
6815665|NCT02978781|7748151|FG000|COMPLETED|Part A||1
6815666|NCT02978781|7748152|FG001|COMPLETED|Part A||12
6815667|NCT02978781|7748153|FG002|COMPLETED|Part A||0
6815668|NCT02978781|7748154|FG003|COMPLETED|Part A||0
6815669|NCT02978781|7748155|FG004|COMPLETED|Part A||0
6815670|NCT02978781|7748151|FG000|NOT COMPLETED|Part A||1
6815671|NCT02978781|7748152|FG001|NOT COMPLETED|Part A||2
6815672|NCT02978781|7748153|FG002|NOT COMPLETED|Part A||0
6815673|NCT02978781|7748154|FG003|NOT COMPLETED|Part A||0
6815674|NCT02978781|7748155|FG004|NOT COMPLETED|Part A||0
6815675|NCT02978781|7748151|FG000|STARTED|Part B||0
6815676|NCT02978781|7748152|FG001|STARTED|Part B||0
6815677|NCT02978781|7748153|FG002|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
6657147|NCT02466646|7587431|FG000|COMPLETED|Overall Study||14
6815678|NCT02978781|7748154|FG003|STARTED|Part B|Include participants who tolerated a dose ≥10 mg in Part A and achieved response on Day 8.|4
6815679|NCT02978781|7748155|FG004|STARTED|Part B||0
6815680|NCT02978781|7748151|FG000|COMPLETED|Part B||0
6815681|NCT02978781|7748152|FG001|COMPLETED|Part B||0
6815682|NCT02978781|7748153|FG002|COMPLETED|Part B||4
6815683|NCT02978781|7748154|FG003|COMPLETED|Part B||3
6815684|NCT02978781|7748155|FG004|COMPLETED|Part B||0
6815685|NCT02978781|7748151|FG000|NOT COMPLETED|Part B||0
6815686|NCT02978781|7748152|FG001|NOT COMPLETED|Part B||0
6815687|NCT02978781|7748153|FG002|NOT COMPLETED|Part B||0
6815688|NCT02978781|7748154|FG003|NOT COMPLETED|Part B||1
6815689|NCT02978781|7748155|FG004|NOT COMPLETED|Part B||0
6815690|NCT02978781|7748151|FG000|STARTED|Part C||0
6815691|NCT02978781|7748152|FG001|STARTED|Part C||0
6815692|NCT02978781|7748153|FG002|STARTED|Part C||0
6815693|NCT02978781|7748154|FG003|STARTED|Part C||0
6815694|NCT02978781|7748155|FG004|STARTED|Part C||18
6815695|NCT02978781|7748151|FG000|COMPLETED|Part C||0
6815696|NCT02978781|7748152|FG001|COMPLETED|Part C||0
6815697|NCT02978781|7748153|FG002|COMPLETED|Part C||0
6815698|NCT02978781|7748154|FG003|COMPLETED|Part C||0
6815699|NCT02978781|7748155|FG004|COMPLETED|Part C||14
6815700|NCT02978781|7748151|FG000|NOT COMPLETED|Part C||0
6815701|NCT02978781|7748152|FG001|NOT COMPLETED|Part C||0
6815702|NCT02978781|7748153|FG002|NOT COMPLETED|Part C||0
6815703|NCT02978781|7748154|FG003|NOT COMPLETED|Part C||0
6815704|NCT02978781|7748155|FG004|NOT COMPLETED|Part C||4
6815705|NCT02964507|7748189|FG000|STARTED|Overall Study||33
6815706|NCT02964507|7748190|FG001|STARTED|Overall Study||12
6815707|NCT02964507|7748191|FG002|STARTED|Overall Study||42
6815708|NCT02964507|7748192|FG003|STARTED|Overall Study||7
6815709|NCT02964507|7748193|FG004|STARTED|Overall Study||18
6815710|NCT02964507|7748194|FG005|STARTED|Overall Study||11
6815711|NCT02964507|7748195|FG006|STARTED|Overall Study||0
6815712|NCT02964507|7748196|FG007|STARTED|Overall Study||0
6815713|NCT02964507|7748189|FG000|COMPLETED|Overall Study||7
6815714|NCT02964507|7748190|FG001|COMPLETED|Overall Study||1
6815715|NCT02964507|7748191|FG002|COMPLETED|Overall Study||17
6815716|NCT02964507|7748192|FG003|COMPLETED|Overall Study||1
6815717|NCT02964507|7748193|FG004|COMPLETED|Overall Study||2
6815718|NCT02964507|7748194|FG005|COMPLETED|Overall Study||3
6815719|NCT02964507|7748195|FG006|COMPLETED|Overall Study||0
6815720|NCT02964507|7748196|FG007|COMPLETED|Overall Study||0
6815721|NCT02964507|7748189|FG000|NOT COMPLETED|Overall Study||26
6815722|NCT02964507|7748190|FG001|NOT COMPLETED|Overall Study||11
6815723|NCT02964507|7748191|FG002|NOT COMPLETED|Overall Study||25
6815724|NCT02964507|7748192|FG003|NOT COMPLETED|Overall Study||6
6815725|NCT02964507|7748193|FG004|NOT COMPLETED|Overall Study||16
6815726|NCT02964507|7748194|FG005|NOT COMPLETED|Overall Study||8
6815727|NCT02964507|7748195|FG006|NOT COMPLETED|Overall Study||0
6815728|NCT02964507|7748196|FG007|NOT COMPLETED|Overall Study||0
6815729|NCT02964078|7748215|FG000|STARTED|Overall Study||27
6815730|NCT02964078|7748215|FG000|COMPLETED|Overall Study||27
6815731|NCT02964078|7748215|FG000|NOT COMPLETED|Overall Study||0
6815732|NCT02942277|7748230|FG000|STARTED|Year 1||5
6815733|NCT02942277|7748231|FG001|STARTED|Year 1||10
6815734|NCT02942277|7748232|FG002|STARTED|Year 1||5
6815735|NCT02942277|7748233|FG003|STARTED|Year 1||10
6815736|NCT02942277|7748234|FG004|STARTED|Year 1||56
6815737|NCT02942277|7748235|FG005|STARTED|Year 1||61
6815738|NCT02942277|7748236|FG006|STARTED|Year 1||5
6815739|NCT02942277|7748237|FG007|STARTED|Year 1||10
6815740|NCT02942277|7748238|FG008|STARTED|Year 1||10
6815741|NCT02942277|7748239|FG009|STARTED|Year 1||10
6815742|NCT02942277|7748240|FG010|STARTED|Year 1||119
6815743|NCT02942277|7748230|FG000|COMPLETED|Year 1||5
6815744|NCT02942277|7748231|FG001|COMPLETED|Year 1||8
6815745|NCT02942277|7748232|FG002|COMPLETED|Year 1||5
6815746|NCT02942277|7748233|FG003|COMPLETED|Year 1||9
6815747|NCT02942277|7748234|FG004|COMPLETED|Year 1||49
6815748|NCT02942277|7748235|FG005|COMPLETED|Year 1||51
6815749|NCT02942277|7748236|FG006|COMPLETED|Year 1||5
6815750|NCT02942277|7748237|FG007|COMPLETED|Year 1||9
6815751|NCT02942277|7748238|FG008|COMPLETED|Year 1||10
6815752|NCT02942277|7748239|FG009|COMPLETED|Year 1||10
6815753|NCT02942277|7748240|FG010|COMPLETED|Year 1||104
6815754|NCT02942277|7748230|FG000|NOT COMPLETED|Year 1||0
6815755|NCT02942277|7748231|FG001|NOT COMPLETED|Year 1||2
6815756|NCT02942277|7748232|FG002|NOT COMPLETED|Year 1||0
6815757|NCT02942277|7748233|FG003|NOT COMPLETED|Year 1||1
6815758|NCT02942277|7748234|FG004|NOT COMPLETED|Year 1||7
6815759|NCT02942277|7748235|FG005|NOT COMPLETED|Year 1||10
6815760|NCT02942277|7748236|FG006|NOT COMPLETED|Year 1||0
6815761|NCT02942277|7748237|FG007|NOT COMPLETED|Year 1||1
6815762|NCT02942277|7748238|FG008|NOT COMPLETED|Year 1||0
6815763|NCT02942277|7748239|FG009|NOT COMPLETED|Year 1||0
6815764|NCT02942277|7748240|FG010|NOT COMPLETED|Year 1||15
6815765|NCT02942277|7748230|FG000|STARTED|Year 2||5
6815766|NCT02942277|7748231|FG001|STARTED|Year 2||8
6815767|NCT02942277|7748232|FG002|STARTED|Year 2||5
6815768|NCT02942277|7748233|FG003|STARTED|Year 2||9
6815769|NCT02942277|7748234|FG004|STARTED|Year 2||49
6815770|NCT02942277|7748235|FG005|STARTED|Year 2||51
6815771|NCT02942277|7748236|FG006|STARTED|Year 2||5
6815772|NCT02942277|7748237|FG007|STARTED|Year 2||9
6815773|NCT02942277|7748238|FG008|STARTED|Year 2||10
6815774|NCT02942277|7748239|FG009|STARTED|Year 2||10
6815775|NCT02942277|7748240|FG010|STARTED|Year 2||104
6815776|NCT02942277|7748230|FG000|COMPLETED|Year 2||5
6815777|NCT02942277|7748231|FG001|COMPLETED|Year 2||7
6815778|NCT02942277|7748232|FG002|COMPLETED|Year 2||4
6815779|NCT02942277|7748233|FG003|COMPLETED|Year 2||8
6815780|NCT02942277|7748234|FG004|COMPLETED|Year 2||36
6815781|NCT02942277|7748235|FG005|COMPLETED|Year 2||40
6815782|NCT02942277|7748236|FG006|COMPLETED|Year 2||4
6815783|NCT02942277|7748237|FG007|COMPLETED|Year 2||8
6815784|NCT02942277|7748238|FG008|COMPLETED|Year 2||10
6815785|NCT02942277|7748239|FG009|COMPLETED|Year 2||9
6815786|NCT02942277|7748240|FG010|COMPLETED|Year 2||79
6815787|NCT02942277|7748230|FG000|NOT COMPLETED|Year 2||0
6815788|NCT02942277|7748231|FG001|NOT COMPLETED|Year 2||1
6815789|NCT02942277|7748232|FG002|NOT COMPLETED|Year 2||1
6815790|NCT02942277|7748233|FG003|NOT COMPLETED|Year 2||1
6815791|NCT02942277|7748234|FG004|NOT COMPLETED|Year 2||13
6815792|NCT02942277|7748235|FG005|NOT COMPLETED|Year 2||11
6815793|NCT02942277|7748236|FG006|NOT COMPLETED|Year 2||1
6815794|NCT02942277|7748237|FG007|NOT COMPLETED|Year 2||1
6815795|NCT02942277|7748238|FG008|NOT COMPLETED|Year 2||0
6815796|NCT02942277|7748239|FG009|NOT COMPLETED|Year 2||1
6815797|NCT02942277|7748240|FG010|NOT COMPLETED|Year 2||25
6815798|NCT02942017|7748269|FG000|STARTED|Overall Study||54
6815799|NCT02942017|7748270|FG001|STARTED|Overall Study||54
6815800|NCT02942017|7748269|FG000|Treated|Overall Study||53
6815801|NCT02942017|7748270|FG001|Treated|Overall Study||51
6815802|NCT02942017|7748269|FG000|COMPLETED|Overall Study||52
6815803|NCT02942017|7748270|FG001|COMPLETED|Overall Study||48
6815804|NCT02942017|7748269|FG000|NOT COMPLETED|Overall Study||2
6815805|NCT02942017|7748270|FG001|NOT COMPLETED|Overall Study||6
6815806|NCT02942004|7748279|FG000|STARTED|Overall Study||46
6815807|NCT02942004|7748280|FG001|STARTED|Overall Study||47
6815808|NCT02942004|7748281|FG002|STARTED|Overall Study||45
6815809|NCT02942004|7748279|FG000|Participants Who Received Study Drug|Overall Study||43
6815810|NCT02942004|7748280|FG001|Participants Who Received Study Drug|Overall Study||38
6815811|NCT02942004|7748281|FG002|Participants Who Received Study Drug|Overall Study||41
6815812|NCT02942004|7748279|FG000|COMPLETED|Overall Study||42
6815813|NCT02942004|7748280|FG001|COMPLETED|Overall Study||35
6815814|NCT02942004|7748281|FG002|COMPLETED|Overall Study||36
6815815|NCT02942004|7748279|FG000|NOT COMPLETED|Overall Study||4
6815816|NCT02942004|7748280|FG001|NOT COMPLETED|Overall Study||12
6815817|NCT02942004|7748281|FG002|NOT COMPLETED|Overall Study||9
6815818|NCT02861014|7748289|FG000|STARTED|Primary Analysis||680
6815819|NCT02861014|7748289|FG000|COMPLETED|Primary Analysis||641
6815820|NCT02861014|7748289|FG000|NOT COMPLETED|Primary Analysis||39
6567869|NCT01833481|7491037|FG001|STARTED|Overall Study||10
6567870|NCT01833481|7491038|FG002|STARTED|Overall Study||10
6567871|NCT01833481|7491036|FG000|COMPLETED|Overall Study||10
6567872|NCT01833481|7491037|FG001|COMPLETED|Overall Study||10
6567873|NCT01833481|7491038|FG002|COMPLETED|Overall Study||10
6567874|NCT01833481|7491036|FG000|NOT COMPLETED|Overall Study||0
6567875|NCT01833481|7491037|FG001|NOT COMPLETED|Overall Study||0
6567876|NCT01833481|7491038|FG002|NOT COMPLETED|Overall Study||0
6567877|NCT01833494|7491046|FG000|STARTED|Overall Study||161
6567878|NCT01833494|7491046|FG000|COMPLETED|Overall Study||116
6567879|NCT01833494|7491046|FG000|NOT COMPLETED|Overall Study||45
6567880|NCT01833520|7491052|FG000|STARTED|Overall Study||3
6567881|NCT01833520|7491053|FG001|STARTED|Overall Study||3
6815821|NCT02861014|7748289|FG000|STARTED|Safety Follow-up||64
6815822|NCT02861014|7748289|FG000|COMPLETED|Safety Follow-up||14
6815823|NCT02861014|7748289|FG000|NOT COMPLETED|Safety Follow-up||50
6815824|NCT02775435|7748297|FG000|STARTED|Overall Study||278
6815825|NCT02775435|7748298|FG001|STARTED|Overall Study||281
6815826|NCT02775435|7748297|FG000|Treated|Overall Study||278
6815827|NCT02775435|7748298|FG001|Treated|Overall Study||280
6815828|NCT02775435|7748297|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
6815829|NCT02775435|7748298|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||75
6815830|NCT02775435|7748297|FG000|COMPLETED|Overall Study||0
6815831|NCT02775435|7748298|FG001|COMPLETED|Overall Study||0
6815832|NCT02775435|7748297|FG000|NOT COMPLETED|Overall Study||278
6567882|NCT01833520|7491054|FG002|STARTED|Overall Study||9
6567883|NCT01833520|7491055|FG003|STARTED|Overall Study||3
6567884|NCT01833520|7491052|FG000|COMPLETED|Overall Study||0
6567885|NCT01833520|7491053|FG001|COMPLETED|Overall Study||0
6567886|NCT01833520|7491054|FG002|COMPLETED|Overall Study||1
6815833|NCT02775435|7748298|FG001|NOT COMPLETED|Overall Study||281
6815834|NCT02767531|7748304|FG000|STARTED|Period 1|Orlistat therapy|1
6815835|NCT02767531|7748305|FG001|STARTED|Period 1|Off Orlistat|1
6815836|NCT02767531|7748304|FG000|COMPLETED|Period 1||1
6815837|NCT02767531|7748305|FG001|COMPLETED|Period 1||1
6815838|NCT02767531|7748304|FG000|NOT COMPLETED|Period 1||0
6815839|NCT02767531|7748305|FG001|NOT COMPLETED|Period 1||0
6815840|NCT02767531|7748304|FG000|STARTED|Period 2|Off Orlistat|1
6815841|NCT02767531|7748305|FG001|STARTED|Period 2|Orlistat Therapy|1
6815842|NCT02767531|7748304|FG000|COMPLETED|Period 2||1
6815843|NCT02767531|7748305|FG001|COMPLETED|Period 2||1
6815844|NCT02767531|7748304|FG000|NOT COMPLETED|Period 2||0
6815845|NCT02767531|7748305|FG001|NOT COMPLETED|Period 2||0
6815846|NCT02767531|7748304|FG000|STARTED|Period 3|Orlistat Therapy|1
6815847|NCT02767531|7748305|FG001|STARTED|Period 3|Off Orlistat|1
6815848|NCT02767531|7748304|FG000|COMPLETED|Period 3||1
6815849|NCT02767531|7748305|FG001|COMPLETED|Period 3||1
6815850|NCT02767531|7748304|FG000|NOT COMPLETED|Period 3||0
6815851|NCT02767531|7748305|FG001|NOT COMPLETED|Period 3||0
6815852|NCT02767531|7748304|FG000|STARTED|Period 4|Off Orlistat|1
6815853|NCT02767531|7748305|FG001|STARTED|Period 4|Orlistat Therapy|1
6815854|NCT02767531|7748304|FG000|COMPLETED|Period 4||1
6815855|NCT02767531|7748305|FG001|COMPLETED|Period 4||1
6815856|NCT02767531|7748304|FG000|NOT COMPLETED|Period 4||0
6815857|NCT02767531|7748305|FG001|NOT COMPLETED|Period 4||0
6815858|NCT02726880|7748313|FG000|STARTED|Overall Study||17
6815859|NCT02726880|7748314|FG001|STARTED|Overall Study||19
6815860|NCT02726880|7748313|FG000|COMPLETED|Overall Study||14
6815861|NCT02726880|7748314|FG001|COMPLETED|Overall Study||16
6815862|NCT02726880|7748313|FG000|NOT COMPLETED|Overall Study||3
6815863|NCT02726880|7748314|FG001|NOT COMPLETED|Overall Study||3
6815864|NCT02614547|7748323|FG000|STARTED|Overall Study||11
6815865|NCT02614547|7748324|FG001|STARTED|Overall Study||10
6815866|NCT02614547|7748323|FG000|COMPLETED|Overall Study||11
6815867|NCT02614547|7748324|FG001|COMPLETED|Overall Study||10
6815868|NCT02614547|7748323|FG000|NOT COMPLETED|Overall Study||0
6815869|NCT02614547|7748324|FG001|NOT COMPLETED|Overall Study||0
6815870|NCT02592551|7748336|FG000|STARTED|Overall Study||9
6815871|NCT02592551|7748337|FG001|STARTED|Overall Study||11
6815872|NCT02592551|7748338|FG002|STARTED|Overall Study||4
6815873|NCT02592551|7748336|FG000|COMPLETED|Overall Study|One participant completed all study procedures and got the tumor sample for analysis. However, the sample was too small to analyze in the lab and so that it was not evaluable for primary and secondary analysis.|8
6815874|NCT02592551|7748337|FG001|COMPLETED|Overall Study||8
6815875|NCT02592551|7748338|FG002|COMPLETED|Overall Study||4
6815876|NCT02592551|7748336|FG000|NOT COMPLETED|Overall Study||1
6815877|NCT02592551|7748337|FG001|NOT COMPLETED|Overall Study||3
6815878|NCT02592551|7748338|FG002|NOT COMPLETED|Overall Study||0
6815879|NCT02583048|7748350|FG000|STARTED|Overall Study||28
6815880|NCT02583048|7748351|FG001|STARTED|Overall Study||28
6815881|NCT02583048|7748352|FG002|STARTED|Overall Study||28
6815882|NCT02583048|7748350|FG000|COMPLETED|Overall Study||28
6815883|NCT02583048|7748351|FG001|COMPLETED|Overall Study||27
6815884|NCT02583048|7748352|FG002|COMPLETED|Overall Study||27
6815885|NCT02583048|7748350|FG000|NOT COMPLETED|Overall Study||0
6815886|NCT02583048|7748351|FG001|NOT COMPLETED|Overall Study||1
6815887|NCT02583048|7748352|FG002|NOT COMPLETED|Overall Study||1
6815888|NCT02546986|7748365|FG000|STARTED|Treatment Period||51
6815889|NCT02546986|7748366|FG001|STARTED|Treatment Period||49
6815890|NCT02546986|7748365|FG000|COMPLETED|Treatment Period||0
6815891|NCT02546986|7748366|FG001|COMPLETED|Treatment Period||0
6815892|NCT02546986|7748365|FG000|NOT COMPLETED|Treatment Period||51
6815893|NCT02546986|7748366|FG001|NOT COMPLETED|Treatment Period||49
6815894|NCT02546986|7748365|FG000|STARTED|Survival Follow-Up Phase||36
6815895|NCT02546986|7748366|FG001|STARTED|Survival Follow-Up Phase||35
6815896|NCT02546986|7748365|FG000|COMPLETED|Survival Follow-Up Phase||0
6815897|NCT02546986|7748366|FG001|COMPLETED|Survival Follow-Up Phase||0
6815898|NCT02546986|7748365|FG000|NOT COMPLETED|Survival Follow-Up Phase||36
6815899|NCT02546986|7748366|FG001|NOT COMPLETED|Survival Follow-Up Phase||35
6815900|NCT02539160|7748374|FG000|STARTED|Phase 1 Pre-crossover||24
6815901|NCT02539160|7748375|FG001|STARTED|Phase 1 Pre-crossover||24
6815902|NCT02539160|7748376|FG002|STARTED|Phase 1 Pre-crossover||22
6815903|NCT02539160|7748377|FG003|STARTED|Phase 1 Pre-crossover||22
6815904|NCT02539160|7748374|FG000|COMPLETED|Phase 1 Pre-crossover||19
6815905|NCT02539160|7748375|FG001|COMPLETED|Phase 1 Pre-crossover||20
6815906|NCT02539160|7748376|FG002|COMPLETED|Phase 1 Pre-crossover||19
6815907|NCT02539160|7748377|FG003|COMPLETED|Phase 1 Pre-crossover||19
6815908|NCT02539160|7748374|FG000|NOT COMPLETED|Phase 1 Pre-crossover||5
6815909|NCT02539160|7748375|FG001|NOT COMPLETED|Phase 1 Pre-crossover||4
6815910|NCT02539160|7748376|FG002|NOT COMPLETED|Phase 1 Pre-crossover||3
6815911|NCT02539160|7748377|FG003|NOT COMPLETED|Phase 1 Pre-crossover||3
6815912|NCT02539160|7748374|FG000|STARTED|Phase 2 Post-crossover||19
6815913|NCT02539160|7748375|FG001|STARTED|Phase 2 Post-crossover||20
6815914|NCT02539160|7748376|FG002|STARTED|Phase 2 Post-crossover||19
6815915|NCT02539160|7748377|FG003|STARTED|Phase 2 Post-crossover||19
6815916|NCT02539160|7748374|FG000|COMPLETED|Phase 2 Post-crossover||19
6815917|NCT02539160|7748375|FG001|COMPLETED|Phase 2 Post-crossover||20
6815918|NCT02539160|7748376|FG002|COMPLETED|Phase 2 Post-crossover||19
6815919|NCT02539160|7748377|FG003|COMPLETED|Phase 2 Post-crossover||19
6815920|NCT02539160|7748374|FG000|NOT COMPLETED|Phase 2 Post-crossover||0
6815921|NCT02539160|7748375|FG001|NOT COMPLETED|Phase 2 Post-crossover||0
6815922|NCT02539160|7748376|FG002|NOT COMPLETED|Phase 2 Post-crossover||0
6815923|NCT02539160|7748377|FG003|NOT COMPLETED|Phase 2 Post-crossover||0
6815924|NCT02507973|7748387|FG000|STARTED|Overall Study||8
6815925|NCT02507973|7748387|FG000|COMPLETED|Overall Study||7
6815926|NCT02507973|7748387|FG000|NOT COMPLETED|Overall Study||1
6815927|NCT02477696|7748395|FG000|STARTED|Overall Study|3 patients withdrew after being randomized but prior to receiving Acalabrutinib treatment.|268
6815928|NCT02477696|7748396|FG001|STARTED|Overall Study|1 patient withdrew after being randomized but prior to receiving Ibrutinib treatment.|265
6815929|NCT02477696|7748395|FG000|COMPLETED|Overall Study||127
6815930|NCT02477696|7748396|FG001|COMPLETED|Overall Study||110
6815931|NCT02477696|7748395|FG000|NOT COMPLETED|Overall Study||141
6815932|NCT02477696|7748396|FG001|NOT COMPLETED|Overall Study||155
6815933|NCT02477618|7748404|FG000|STARTED|Overall Study||65
6815934|NCT02477618|7748405|FG001|STARTED|Overall Study||67
6815935|NCT02477618|7748404|FG000|Intent-to-Treat Analysis Set|Overall Study||66
6815936|NCT02477618|7748405|FG001|Intent-to-Treat Analysis Set|Overall Study||66
6815937|NCT02477618|7748404|FG000|COMPLETED|Overall Study||50
6815938|NCT02477618|7748405|FG001|COMPLETED|Overall Study||53
6815939|NCT02477618|7748404|FG000|NOT COMPLETED|Overall Study||15
6815940|NCT02477618|7748405|FG001|NOT COMPLETED|Overall Study||14
6815941|NCT02424851|7748413|FG000|STARTED|Overall Study||16
6815942|NCT02424851|7748414|FG001|STARTED|Overall Study||15
6815943|NCT02424851|7748413|FG000|COMPLETED|Overall Study||14
6815944|NCT02424851|7748414|FG001|COMPLETED|Overall Study||12
6815945|NCT02424851|7748413|FG000|NOT COMPLETED|Overall Study||2
6815946|NCT02424851|7748414|FG001|NOT COMPLETED|Overall Study||3
6815947|NCT02285504|7748420|FG000|STARTED|Overall Study||4
6815948|NCT02285504|7748420|FG000|COMPLETED|Overall Study||4
6815949|NCT02285504|7748420|FG000|NOT COMPLETED|Overall Study||0
6815950|NCT02257528|7748424|FG000|STARTED|Overall Study||26
6815951|NCT02257528|7748424|FG000|COMPLETED|Overall Study||25
6815952|NCT02257528|7748424|FG000|NOT COMPLETED|Overall Study||1
6815953|NCT02227394|7748428|FG000|STARTED|Overall Study||10
6815954|NCT02227394|7748429|FG001|STARTED|Overall Study||10
6815955|NCT02227394|7748428|FG000|COMPLETED|Overall Study||10
6815956|NCT02227394|7748429|FG001|COMPLETED|Overall Study||10
6815957|NCT02227394|7748428|FG000|NOT COMPLETED|Overall Study||0
6815958|NCT02227394|7748429|FG001|NOT COMPLETED|Overall Study||0
6815959|NCT02073968|7748435|FG000|STARTED|Overall Study||35
6815960|NCT02073968|7748435|FG000|COMPLETED|Overall Study||35
6815961|NCT02073968|7748435|FG000|NOT COMPLETED|Overall Study||0
6815962|NCT02003924|7748441|FG000|STARTED|Double-blind Phase||933
6815963|NCT02003924|7748442|FG001|STARTED|Double-blind Phase||468
6815964|NCT02003924|7748443|FG002|STARTED|Double-blind Phase||0
6815965|NCT02003924|7748441|FG000|Treated|Double-blind Phase||930
6815966|NCT02003924|7748442|FG001|Treated|Double-blind Phase||465
6815967|NCT02003924|7748443|FG002|Treated|Double-blind Phase||0
6815968|NCT02003924|7748441|FG000|COMPLETED|Double-blind Phase||478
6815969|NCT02003924|7748442|FG001|COMPLETED|Double-blind Phase||87
6815970|NCT02003924|7748443|FG002|COMPLETED|Double-blind Phase||0
6815971|NCT02003924|7748441|FG000|NOT COMPLETED|Double-blind Phase||455
6815972|NCT02003924|7748442|FG001|NOT COMPLETED|Double-blind Phase||381
6815973|NCT02003924|7748443|FG002|NOT COMPLETED|Double-blind Phase||0
6815974|NCT02003924|7748441|FG000|STARTED|Open-label Phase||478
6815975|NCT02003924|7748442|FG001|STARTED|Open-label Phase|Participants were offered to switch from double blind placebo to open label Enzalutamide.|0
6815976|NCT02003924|7748443|FG002|STARTED|Open-label Phase|Participants previously treated with placebo, switched to receive open label Enzalutamide.|87
6815977|NCT02003924|7748441|FG000|Treated|Open-label Phase||478
6815978|NCT02003924|7748442|FG001|Treated|Open-label Phase||0
6815979|NCT02003924|7748443|FG002|Treated|Open-label Phase||87
6815980|NCT02003924|7748441|FG000|COMPLETED|Open-label Phase||378
6815981|NCT02003924|7748442|FG001|COMPLETED|Open-label Phase||0
6815982|NCT02003924|7748443|FG002|COMPLETED|Open-label Phase||70
6815983|NCT02003924|7748441|FG000|NOT COMPLETED|Open-label Phase||100
6815984|NCT02003924|7748442|FG001|NOT COMPLETED|Open-label Phase||0
6815985|NCT02003924|7748443|FG002|NOT COMPLETED|Open-label Phase||17
6815986|NCT02003924|7748441|FG000|STARTED|Long-term Follow-up Phase|Participants followed up after discontinuing study drug in either double blind or open label phase.|933
6815987|NCT02003924|7748442|FG001|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in double blind phase.|381
6815988|NCT02003924|7748443|FG002|STARTED|Long-term Follow-up Phase|Participants were followed up after study drug discontinuation in open label phase.|87
6815989|NCT02003924|7748441|FG000|COMPLETED|Long-term Follow-up Phase||566
6815990|NCT02003924|7748442|FG001|COMPLETED|Long-term Follow-up Phase||144
6815991|NCT02003924|7748443|FG002|COMPLETED|Long-term Follow-up Phase||80
6815992|NCT02003924|7748441|FG000|NOT COMPLETED|Long-term Follow-up Phase||367
6815993|NCT02003924|7748442|FG001|NOT COMPLETED|Long-term Follow-up Phase||237
6815994|NCT02003924|7748443|FG002|NOT COMPLETED|Long-term Follow-up Phase||7
6815995|NCT01971970|7748452|FG000|STARTED|Baseline Until Week 6||24
6815996|NCT01971970|7748453|FG001|STARTED|Baseline Until Week 6||21
6815997|NCT01971970|7748452|FG000|Receiving Standard Therapy|Baseline Until Week 6||23
6815998|NCT01971970|7748453|FG001|Receiving Standard Therapy|Baseline Until Week 6||21
6815999|NCT01971970|7748452|FG000|Therapy Escalation|Baseline Until Week 6||1
6816000|NCT01971970|7748453|FG001|Therapy Escalation|Baseline Until Week 6||0
6816001|NCT01971970|7748452|FG000|COMPLETED|Baseline Until Week 6||23
6816002|NCT01971970|7748453|FG001|COMPLETED|Baseline Until Week 6||21
6816003|NCT01971970|7748452|FG000|NOT COMPLETED|Baseline Until Week 6||1
6816004|NCT01971970|7748453|FG001|NOT COMPLETED|Baseline Until Week 6||0
6816005|NCT01971970|7748452|FG000|STARTED|Week 6 Until Week 8||23
6816006|NCT01971970|7748453|FG001|STARTED|Week 6 Until Week 8||21
6816007|NCT01971970|7748452|FG000|Receiving Standard Therapy|Week 6 Until Week 8||23
6816008|NCT01971970|7748453|FG001|Receiving Standard Therapy|Week 6 Until Week 8||20
6816009|NCT01971970|7748452|FG000|COMPLETED|Week 6 Until Week 8||23
6816010|NCT01971970|7748453|FG001|COMPLETED|Week 6 Until Week 8||20
6816011|NCT01971970|7748452|FG000|NOT COMPLETED|Week 6 Until Week 8||0
6816012|NCT01971970|7748453|FG001|NOT COMPLETED|Week 6 Until Week 8||1
6816013|NCT01971970|7748452|FG000|STARTED|Week 8 Until Week 14||23
6816014|NCT01971970|7748453|FG001|STARTED|Week 8 Until Week 14||20
6816015|NCT01971970|7748452|FG000|Receiving Standard Therapy|Week 8 Until Week 14||16
6816016|NCT01971970|7748453|FG001|Receiving Standard Therapy|Week 8 Until Week 14||19
6816017|NCT01971970|7748452|FG000|Therapy Escalation|Week 8 Until Week 14||7
6816018|NCT01971970|7748453|FG001|Therapy Escalation|Week 8 Until Week 14||1
6816019|NCT01971970|7748452|FG000|COMPLETED|Week 8 Until Week 14||23
6816020|NCT01971970|7748453|FG001|COMPLETED|Week 8 Until Week 14||20
6816021|NCT01971970|7748452|FG000|NOT COMPLETED|Week 8 Until Week 14||0
6816022|NCT01971970|7748453|FG001|NOT COMPLETED|Week 8 Until Week 14||0
6816023|NCT01971970|7748452|FG000|STARTED|Week 14 Until Week 22||23
6816024|NCT01971970|7748453|FG001|STARTED|Week 14 Until Week 22||20
6816025|NCT01971970|7748452|FG000|Receiving Standard Therapy|Week 14 Until Week 22||12
6816026|NCT01971970|7748453|FG001|Receiving Standard Therapy|Week 14 Until Week 22||16
6816027|NCT01971970|7748452|FG000|Therapy Escalation|Week 14 Until Week 22||3
6816028|NCT01971970|7748453|FG001|Therapy Escalation|Week 14 Until Week 22||2
6816029|NCT01971970|7748452|FG000|COMPLETED|Week 14 Until Week 22||23
6816030|NCT01971970|7748453|FG001|COMPLETED|Week 14 Until Week 22||19
6816031|NCT01971970|7748452|FG000|NOT COMPLETED|Week 14 Until Week 22||0
6816032|NCT01971970|7748453|FG001|NOT COMPLETED|Week 14 Until Week 22||1
6816033|NCT01971970|7748452|FG000|STARTED|Week 22 Until Week 52||23
6816034|NCT01971970|7748453|FG001|STARTED|Week 22 Until Week 52||19
6816035|NCT01971970|7748452|FG000|Receiving Standard Therapy|Week 22 Until Week 52||5
6816036|NCT01971970|7748453|FG001|Receiving Standard Therapy|Week 22 Until Week 52||9
6816037|NCT01971970|7748452|FG000|Therapy Escalation|Week 22 Until Week 52||6
6816038|NCT01971970|7748453|FG001|Therapy Escalation|Week 22 Until Week 52||6
6816039|NCT01971970|7748452|FG000|COMPLETED|Week 22 Until Week 52||15
6816040|NCT01971970|7748453|FG001|COMPLETED|Week 22 Until Week 52||15
6816041|NCT01971970|7748452|FG000|NOT COMPLETED|Week 22 Until Week 52||8
6816042|NCT01971970|7748453|FG001|NOT COMPLETED|Week 22 Until Week 52||4
6816043|NCT01971970|7748452|FG000|STARTED|Week 52 Until Week 78||15
6816044|NCT01971970|7748453|FG001|STARTED|Week 52 Until Week 78||15
6816045|NCT01971970|7748452|FG000|COMPLETED|Week 52 Until Week 78||14
6816046|NCT01971970|7748453|FG001|COMPLETED|Week 52 Until Week 78||12
6816047|NCT01971970|7748452|FG000|NOT COMPLETED|Week 52 Until Week 78||1
6816048|NCT01971970|7748453|FG001|NOT COMPLETED|Week 52 Until Week 78||3
6816049|NCT01969409|7748466|FG000|STARTED|Overall Study||28
6816050|NCT01969409|7748467|FG001|STARTED|Overall Study||30
6816051|NCT01969409|7748466|FG000|COMPLETED|Overall Study||25
6816052|NCT01969409|7748467|FG001|COMPLETED|Overall Study||26
6816053|NCT01969409|7748466|FG000|NOT COMPLETED|Overall Study||3
6816054|NCT01969409|7748467|FG001|NOT COMPLETED|Overall Study||4
6816055|NCT01665144|7748475|FG000|STARTED|Overall Study||1105
6816056|NCT01665144|7748476|FG001|STARTED|Overall Study||546
6816057|NCT01665144|7748475|FG000|Safety Set|Overall Study||1099
6816058|NCT01665144|7748476|FG001|Safety Set|Overall Study||546
6816059|NCT01665144|7748475|FG000|Full Analysis Set|Overall Study||1099
6816060|NCT01665144|7748476|FG001|Full Analysis Set|Overall Study||546
6816061|NCT01665144|7748475|FG000|COMPLETED|Overall Study||903
6816062|NCT01665144|7748476|FG001|COMPLETED|Overall Study||424
6816063|NCT01665144|7748475|FG000|NOT COMPLETED|Overall Study||202
6816064|NCT01665144|7748476|FG001|NOT COMPLETED|Overall Study||122
6816065|NCT01307787|7748484|FG000|STARTED|Overall Study||19
6816066|NCT01307787|7748485|FG001|STARTED|Overall Study||15
6816067|NCT01307787|7748484|FG000|T1= After 9 Weeks Post Intervention|Overall Study||18
6816068|NCT01307787|7748485|FG001|T1= After 9 Weeks Post Intervention|Overall Study||15
6816069|NCT01307787|7748484|FG000|T2= After 22 Weeks at Follow-up|Overall Study||17
6816070|NCT01307787|7748485|FG001|T2= After 22 Weeks at Follow-up|Overall Study||15
6816071|NCT01307787|7748484|FG000|COMPLETED|Overall Study||17
6816072|NCT01307787|7748485|FG001|COMPLETED|Overall Study||15
6816073|NCT01307787|7748484|FG000|NOT COMPLETED|Overall Study||2
6816074|NCT01307787|7748485|FG001|NOT COMPLETED|Overall Study||0
6816075|NCT01250912|7748496|FG000|STARTED|Overall Study||20
6391078|NCT00833755|7302900|FG003|COMPLETED|Overall Study||17
6391079|NCT00833755|7302897|FG000|NOT COMPLETED|Overall Study||4
6391080|NCT00833755|7302898|FG001|NOT COMPLETED|Overall Study||5
6391081|NCT00833755|7302899|FG002|NOT COMPLETED|Overall Study||2
6391082|NCT00833755|7302900|FG003|NOT COMPLETED|Overall Study||6
6391083|NCT00833781|7302913|FG000|STARTED|Overall Study||10
6391084|NCT00833781|7302914|FG001|STARTED|Overall Study||5
6391085|NCT00833781|7302913|FG000|COMPLETED|Overall Study||10
6391086|NCT00833781|7302914|FG001|COMPLETED|Overall Study||5
6391087|NCT00833781|7302913|FG000|NOT COMPLETED|Overall Study||0
6391088|NCT00833781|7302914|FG001|NOT COMPLETED|Overall Study||0
6391089|NCT00833794|7302921|FG000|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
6391090|NCT00833794|7302922|FG001|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
6391091|NCT00833794|7302921|FG000|Entered run-in Period|Open-label Phase||1027
6391092|NCT00833794|7302922|FG001|Entered run-in Period|Open-label Phase||0
6391093|NCT00833794|7302921|FG000|Received Open-Label Treatment|Open-label Phase||1023
6391094|NCT00833794|7302922|FG001|Received Open-Label Treatment|Open-label Phase||0
6504797|NCT01449929|7423849|FG002|STARTED|Randomization Phase 96 Week||0
6504798|NCT01449929|7423847|FG000|COMPLETED|Randomization Phase 96 Week||209
6504799|NCT01449929|7423848|FG001|COMPLETED|Randomization Phase 96 Week||189
6504800|NCT01449929|7423849|FG002|COMPLETED|Randomization Phase 96 Week||0
6504801|NCT01449929|7423847|FG000|NOT COMPLETED|Randomization Phase 96 Week||33
6504802|NCT01449929|7423848|FG001|NOT COMPLETED|Randomization Phase 96 Week||53
6504803|NCT01449929|7423849|FG002|NOT COMPLETED|Randomization Phase 96 Week||0
6504804|NCT01449929|7423847|FG000|STARTED|Extension Phase Approximately 3 Years||0
6504805|NCT01449929|7423848|FG001|STARTED|Extension Phase Approximately 3 Years||0
6504806|NCT01449929|7423849|FG002|STARTED|Extension Phase Approximately 3 Years||123
6504807|NCT01449929|7423847|FG000|COMPLETED|Extension Phase Approximately 3 Years||0
6504808|NCT01449929|7423848|FG001|COMPLETED|Extension Phase Approximately 3 Years||0
6816076|NCT01250912|7748496|FG000|COMPLETED|Overall Study||19
6816077|NCT01250912|7748496|FG000|NOT COMPLETED|Overall Study||1
6816078|NCT01218555|7748503|FG000|STARTED|Overall Study||3
6816079|NCT01218555|7748504|FG001|STARTED|Overall Study||3
6816080|NCT01218555|7748505|FG002|STARTED|Overall Study||5
6816081|NCT01218555|7748506|FG003|STARTED|Overall Study||3
6816082|NCT01218555|7748507|FG004|STARTED|Overall Study||8
6816083|NCT01218555|7748508|FG005|STARTED|Overall Study||22
6816084|NCT01218555|7748503|FG000|COMPLETED|Overall Study||3
6816085|NCT01218555|7748504|FG001|COMPLETED|Overall Study||3
6816086|NCT01218555|7748505|FG002|COMPLETED|Overall Study||5
6816087|NCT01218555|7748506|FG003|COMPLETED|Overall Study||3
6816088|NCT01218555|7748507|FG004|COMPLETED|Overall Study||8
6816089|NCT01218555|7748508|FG005|COMPLETED|Overall Study||22
6816090|NCT01218555|7748503|FG000|NOT COMPLETED|Overall Study||0
6816091|NCT01218555|7748504|FG001|NOT COMPLETED|Overall Study||0
6816092|NCT01218555|7748505|FG002|NOT COMPLETED|Overall Study||0
6816093|NCT01218555|7748506|FG003|NOT COMPLETED|Overall Study||0
6816094|NCT01218555|7748507|FG004|NOT COMPLETED|Overall Study||0
6816095|NCT01218555|7748508|FG005|NOT COMPLETED|Overall Study||0
6816096|NCT01141712|7748512|FG000|STARTED|Overall Study||43
6816097|NCT01141712|7748512|FG000|COMPLETED|Overall Study||40
6816098|NCT01141712|7748512|FG000|NOT COMPLETED|Overall Study||3
6816099|NCT01111305|7748518|FG000|STARTED|Overall Study||4
6816100|NCT01111305|7748519|FG001|STARTED|Overall Study||4
6816101|NCT01111305|7748518|FG000|COMPLETED|Overall Study||4
6816102|NCT01111305|7748519|FG001|COMPLETED|Overall Study||4
6816103|NCT01111305|7748518|FG000|NOT COMPLETED|Overall Study||0
6816104|NCT01111305|7748519|FG001|NOT COMPLETED|Overall Study||0
6816105|NCT00659646|7748529|FG000|STARTED|Overall Study||38
6816106|NCT00659646|7748530|FG001|STARTED|Overall Study||18
6816107|NCT00659646|7748529|FG000|COMPLETED|Overall Study||23
6816108|NCT00659646|7748530|FG001|COMPLETED|Overall Study||10
6816109|NCT00659646|7748529|FG000|NOT COMPLETED|Overall Study||15
6816110|NCT00659646|7748530|FG001|NOT COMPLETED|Overall Study||8
6816111|NCT00567580|7748541|FG000|STARTED|Overall Study||592
6816112|NCT00567580|7748542|FG001|STARTED|Overall Study||602
6816113|NCT00567580|7748543|FG002|STARTED|Overall Study||598
6816114|NCT00567580|7748541|FG000|Eligible|Overall Study||564
6816115|NCT00567580|7748542|FG001|Eligible|Overall Study||578
6816116|NCT00567580|7748543|FG002|Eligible|Overall Study||574
6816117|NCT00567580|7748541|FG000|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||547
6816118|NCT00567580|7748542|FG001|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
6816119|NCT00567580|7748543|FG002|Eligible, Started Study Treatment, and Have Adverse Event Data|Overall Study||563
6816120|NCT00567580|7748541|FG000|COMPLETED|Overall Study||564
6816121|NCT00567580|7748542|FG001|COMPLETED|Overall Study||578
6816122|NCT00567580|7748543|FG002|COMPLETED|Overall Study||574
6816123|NCT00567580|7748541|FG000|NOT COMPLETED|Overall Study||28
6816124|NCT00567580|7748542|FG001|NOT COMPLETED|Overall Study||24
6816125|NCT00567580|7748543|FG002|NOT COMPLETED|Overall Study||24
6816126|NCT00477412|7748558|FG000|STARTED|Overall Study||4
6816127|NCT00477412|7748559|FG001|STARTED|Overall Study||3
6816128|NCT00477412|7748560|FG002|STARTED|Overall Study||5
6816129|NCT00477412|7748561|FG003|STARTED|Overall Study||95
6816130|NCT00477412|7748558|FG000|COMPLETED|Overall Study||3
6816131|NCT00477412|7748559|FG001|COMPLETED|Overall Study||3
6816132|NCT00477412|7748560|FG002|COMPLETED|Overall Study||4
6816133|NCT00477412|7748561|FG003|COMPLETED|Overall Study||87
6816134|NCT00477412|7748558|FG000|NOT COMPLETED|Overall Study||1
6816135|NCT00477412|7748559|FG001|NOT COMPLETED|Overall Study||0
6816136|NCT00477412|7748560|FG002|NOT COMPLETED|Overall Study||1
6816137|NCT00477412|7748561|FG003|NOT COMPLETED|Overall Study||8
6816138|NCT00369317|7748569|FG000|STARTED|Overall Study||205
6816139|NCT00369317|7748569|FG000|COMPLETED|Overall Study||185
6816140|NCT00369317|7748569|FG000|NOT COMPLETED|Overall Study||20
6816141|NCT00261807|7748574|FG000|STARTED|Overall Study||25
6816142|NCT00261807|7748574|FG000|COMPLETED|Overall Study||18
6816143|NCT00261807|7748574|FG000|NOT COMPLETED|Overall Study||7
6567887|NCT01833520|7491055|FG003|COMPLETED|Overall Study||0
6816144|NCT04964193|7748579|FG000|STARTED|1st Intervention||12
6816145|NCT04964193|7748580|FG001|STARTED|1st Intervention||12
6816146|NCT04964193|7748579|FG000|COMPLETED|1st Intervention||12
6816147|NCT04964193|7748580|FG001|COMPLETED|1st Intervention||12
6816148|NCT04964193|7748579|FG000|NOT COMPLETED|1st Intervention||0
6816149|NCT04964193|7748580|FG001|NOT COMPLETED|1st Intervention||0
6816150|NCT04964193|7748579|FG000|STARTED|Washout = Three Weeks||12
6816151|NCT04964193|7748580|FG001|STARTED|Washout = Three Weeks||12
6816152|NCT04964193|7748579|FG000|COMPLETED|Washout = Three Weeks||12
6816153|NCT04964193|7748580|FG001|COMPLETED|Washout = Three Weeks||12
6816154|NCT04964193|7748579|FG000|NOT COMPLETED|Washout = Three Weeks||0
6816155|NCT04964193|7748580|FG001|NOT COMPLETED|Washout = Three Weeks||0
6816156|NCT04964193|7748579|FG000|STARTED|2nd Intervention||12
6816157|NCT04964193|7748580|FG001|STARTED|2nd Intervention||12
6816158|NCT04964193|7748579|FG000|COMPLETED|2nd Intervention||12
6816159|NCT04964193|7748580|FG001|COMPLETED|2nd Intervention||12
6816160|NCT04964193|7748579|FG000|NOT COMPLETED|2nd Intervention||0
6816161|NCT04964193|7748580|FG001|NOT COMPLETED|2nd Intervention||0
6816162|NCT04826731|7748588|FG000|STARTED|Overall Study||10
6816163|NCT04826731|7748589|FG001|STARTED|Overall Study||4
6816164|NCT04826731|7748588|FG000|COMPLETED|Overall Study|All patients were initially accepted as the study group per study design, with those unable to utilize respiratory exerciser (n=4) were later removed to standard care group.|10
6816165|NCT04826731|7748589|FG001|COMPLETED|Overall Study|Patients who could not use the respiratory exerciser (n=2) or refused to do so (n=2) were accepted as the control group.|4
6816166|NCT04826731|7748588|FG000|NOT COMPLETED|Overall Study||0
6816167|NCT04826731|7748589|FG001|NOT COMPLETED|Overall Study||0
6816168|NCT04620798|7748597|FG000|STARTED|Overall Study||536
6816169|NCT04620798|7748598|FG001|STARTED|Overall Study||540
6816170|NCT04620798|7748597|FG000|Completed Behavioral Survey|Overall Study||477
6816171|NCT04620798|7748598|FG001|Completed Behavioral Survey|Overall Study||508
6816172|NCT04620798|7748597|FG000|COMPLETED|Overall Study||410
6816173|NCT04620798|7748598|FG001|COMPLETED|Overall Study||402
6816174|NCT04620798|7748597|FG000|NOT COMPLETED|Overall Study||126
6816175|NCT04620798|7748598|FG001|NOT COMPLETED|Overall Study||138
6816176|NCT04507321|7748604|FG000|STARTED|Treatment Period 1 (8 Days)||5
6816177|NCT04507321|7748604|FG000|COMPLETED|Treatment Period 1 (8 Days)||5
6816178|NCT04507321|7748604|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6816179|NCT04507321|7748604|FG000|STARTED|Treatment Period 2 (8 Days)||5
6816180|NCT04507321|7748604|FG000|COMPLETED|Treatment Period 2 (8 Days)||5
6816181|NCT04507321|7748604|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6816182|NCT04256629|7748623|FG000|STARTED|Overall Study||4
6816183|NCT04256629|7748624|FG001|STARTED|Overall Study||4
6816184|NCT04256629|7748625|FG002|STARTED|Overall Study||4
6816185|NCT04256629|7748626|FG003|STARTED|Overall Study||4
6816186|NCT04256629|7748627|FG004|STARTED|Overall Study||4
6816187|NCT04256629|7748628|FG005|STARTED|Overall Study||4
6816188|NCT04256629|7748623|FG000|COMPLETED|Overall Study||4
6816189|NCT04256629|7748624|FG001|COMPLETED|Overall Study||3
6816190|NCT04256629|7748625|FG002|COMPLETED|Overall Study||4
6816191|NCT04256629|7748626|FG003|COMPLETED|Overall Study||4
6816192|NCT04256629|7748627|FG004|COMPLETED|Overall Study||4
6816193|NCT04256629|7748628|FG005|COMPLETED|Overall Study||3
6816194|NCT04256629|7748623|FG000|NOT COMPLETED|Overall Study||0
6816195|NCT04256629|7748624|FG001|NOT COMPLETED|Overall Study||1
6816196|NCT04256629|7748625|FG002|NOT COMPLETED|Overall Study||0
6816197|NCT04256629|7748626|FG003|NOT COMPLETED|Overall Study||0
6816198|NCT04256629|7748627|FG004|NOT COMPLETED|Overall Study||0
6816199|NCT04256629|7748628|FG005|NOT COMPLETED|Overall Study||1
6816200|NCT04174521|7748636|FG000|STARTED|Overall Study|A unit is defined as a mother-child pair; each unit was comprised of two participants: the mother and the child.|20670
6816201|NCT04174521|7748636|FG000|COMPLETED|Overall Study|This was a retrospective observational study so there really was no drop-out.|20670
6816202|NCT04174521|7748636|FG000|NOT COMPLETED|Overall Study||0
6816203|NCT04014075|7748640|FG000|STARTED|Overall Study||79
6816204|NCT04014075|7748640|FG000|COMPLETED|Overall Study||23
6816205|NCT04014075|7748640|FG000|NOT COMPLETED|Overall Study||56
6816206|NCT03554850|7748644|FG000|STARTED|Overall Study||201
6816207|NCT03554850|7748644|FG000|COMPLETED|Overall Study||190
6816208|NCT03554850|7748644|FG000|NOT COMPLETED|Overall Study||11
6816209|NCT03284853|7748654|FG000|STARTED|Overall Study||218
6816210|NCT03284853|7748655|FG001|STARTED|Overall Study||212
6816211|NCT03284853|7748654|FG000|Intent-to-Treat Population|Overall Study||218
6816212|NCT03284853|7748655|FG001|Intent-to-Treat Population|Overall Study||212
6816213|NCT03284853|7748654|FG000|Per-Protocol Population|Overall Study||169
6816214|NCT03284853|7748655|FG001|Per-Protocol Population|Overall Study||170
6567888|NCT01833520|7491052|FG000|NOT COMPLETED|Overall Study||3
6816215|NCT03284853|7748654|FG000|Safety Population|Overall Study||218
6816216|NCT03284853|7748655|FG001|Safety Population|Overall Study||212
6816217|NCT03284853|7748654|FG000|COMPLETED|Overall Study||163
6816218|NCT03284853|7748655|FG001|COMPLETED|Overall Study||199
6816219|NCT03284853|7748654|FG000|NOT COMPLETED|Overall Study||55
6567889|NCT01833520|7491053|FG001|NOT COMPLETED|Overall Study||3
6816220|NCT03284853|7748655|FG001|NOT COMPLETED|Overall Study||13
6816221|NCT03032250|7748663|FG000|STARTED|Overall Study||17
6816222|NCT03032250|7748664|FG001|STARTED|Overall Study||18
6567890|NCT01833520|7491054|FG002|NOT COMPLETED|Overall Study||8
6816223|NCT03032250|7748663|FG000|COMPLETED|Overall Study||17
6816224|NCT03032250|7748664|FG001|COMPLETED|Overall Study||18
6816225|NCT03032250|7748663|FG000|NOT COMPLETED|Overall Study||0
6816226|NCT03032250|7748664|FG001|NOT COMPLETED|Overall Study||0
6816227|NCT02942966|7748672|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|233
6816228|NCT02942966|7748672|FG000|COMPLETED|Overall Study|Completed 6-month follow-up|205
6816229|NCT02942966|7748672|FG000|NOT COMPLETED|Overall Study||28
6816230|NCT02774889|7748678|FG000|STARTED|Overall Study||23
6816231|NCT02774889|7748679|FG001|STARTED|Overall Study||22
6816232|NCT02774889|7748678|FG000|COMPLETED|Overall Study||21
6816233|NCT02774889|7748679|FG001|COMPLETED|Overall Study||21
6816234|NCT02774889|7748678|FG000|NOT COMPLETED|Overall Study||2
6816235|NCT02774889|7748679|FG001|NOT COMPLETED|Overall Study||1
6816236|NCT02721069|7748687|FG000|STARTED|Overall Study||175
6816237|NCT02721069|7748687|FG000|COMPLETED|Overall Study||117
6816238|NCT02721069|7748687|FG000|NOT COMPLETED|Overall Study||58
6816239|NCT02297438|7748699|FG000|STARTED|Overall Study||169
6816240|NCT02297438|7748700|FG001|STARTED|Overall Study||171
6816241|NCT02297438|7748699|FG000|Received Treatment|Overall Study||168
6816242|NCT02297438|7748700|FG001|Received Treatment|Overall Study||171
6816243|NCT02297438|7748699|FG000|COMPLETED|Overall Study||0
6816244|NCT02297438|7748700|FG001|COMPLETED|Overall Study||0
6816245|NCT02297438|7748699|FG000|NOT COMPLETED|Overall Study||169
6816246|NCT02297438|7748700|FG001|NOT COMPLETED|Overall Study||171
6816247|NCT02297412|7748708|FG000|STARTED|Overall Study||23
6816248|NCT02297412|7748709|FG001|STARTED|Overall Study||24
6816249|NCT02297412|7748708|FG000|COMPLETED|Overall Study||22
6816250|NCT02297412|7748709|FG001|COMPLETED|Overall Study||23
6816251|NCT02297412|7748708|FG000|NOT COMPLETED|Overall Study||1
6816252|NCT02297412|7748709|FG001|NOT COMPLETED|Overall Study||1
6816253|NCT02292758|7748717|FG000|STARTED|Overall Study||19
6816254|NCT02292758|7748718|FG001|STARTED|Overall Study||17
6816255|NCT02292758|7748717|FG000|COMPLETED|Overall Study||19
6816256|NCT02292758|7748718|FG001|COMPLETED|Overall Study||17
6816257|NCT02292758|7748717|FG000|NOT COMPLETED|Overall Study||0
6816258|NCT02292758|7748718|FG001|NOT COMPLETED|Overall Study||0
6816259|NCT02250326|7748727|FG000|STARTED|Treatment Period||81
6816260|NCT02250326|7748728|FG001|STARTED|Treatment Period||79
6816261|NCT02250326|7748729|FG002|STARTED|Treatment Period||80
6816262|NCT02250326|7748727|FG000|Treated Population|Treatment Period||79
6816263|NCT02250326|7748728|FG001|Treated Population|Treatment Period||78
6816264|NCT02250326|7748729|FG002|Treated Population|Treatment Period||79
6567891|NCT01833520|7491055|FG003|NOT COMPLETED|Overall Study||3
6567892|NCT01833533|7491069|FG000|STARTED|Overall Study||100
6567893|NCT01833533|7491070|FG001|STARTED|Overall Study||205
6816265|NCT02250326|7748727|FG000|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|0
6816266|NCT02250326|7748728|FG001|COMPLETED|Treatment Period|Data Cut-off Date = 23 December 2017|15
6816267|NCT02250326|7748729|FG002|COMPLETED|Treatment Period|Data Cut-off Date = 30 August 2017|3
6816268|NCT02250326|7748727|FG000|NOT COMPLETED|Treatment Period||81
6816269|NCT02250326|7748728|FG001|NOT COMPLETED|Treatment Period||64
6816270|NCT02250326|7748729|FG002|NOT COMPLETED|Treatment Period||77
6816271|NCT02250326|7748727|FG000|STARTED|Follow-Up Period||67
6816272|NCT02250326|7748728|FG001|STARTED|Follow-Up Period||43
6816273|NCT02250326|7748729|FG002|STARTED|Follow-Up Period||64
6816274|NCT02250326|7748727|FG000|COMPLETED|Follow-Up Period||18
6816275|NCT02250326|7748728|FG001|COMPLETED|Follow-Up Period||13
6816276|NCT02250326|7748729|FG002|COMPLETED|Follow-Up Period||26
6816277|NCT02250326|7748727|FG000|NOT COMPLETED|Follow-Up Period||49
6816278|NCT02250326|7748728|FG001|NOT COMPLETED|Follow-Up Period||30
6816279|NCT02250326|7748729|FG002|NOT COMPLETED|Follow-Up Period||38
6816280|NCT01856270|7748740|FG000|STARTED|Overall Study||24
6816281|NCT01856270|7748741|FG001|STARTED|Overall Study||26
6816282|NCT01856270|7748740|FG000|COMPLETED|Overall Study||13
6816283|NCT01856270|7748741|FG001|COMPLETED|Overall Study||14
6816284|NCT01856270|7748740|FG000|NOT COMPLETED|Overall Study||11
6816285|NCT01856270|7748741|FG001|NOT COMPLETED|Overall Study||12
6816286|NCT01503515|7748751|FG000|STARTED|Overall Study||145
6816287|NCT01503515|7748752|FG001|STARTED|Overall Study||147
6816288|NCT01503515|7748751|FG000|COMPLETED|Overall Study||124
6567894|NCT01833533|7491069|FG000|COMPLETED|Overall Study||94
6567895|NCT01833533|7491070|FG001|COMPLETED|Overall Study||184
6567896|NCT01833533|7491069|FG000|NOT COMPLETED|Overall Study||6
6567897|NCT01833533|7491070|FG001|NOT COMPLETED|Overall Study||21
6567898|NCT01833546|7491080|FG000|STARTED|Overall Study||3
6567899|NCT01833546|7491081|FG001|STARTED|Overall Study||3
6567900|NCT01833546|7491082|FG002|STARTED|Overall Study||8
6567901|NCT01833546|7491083|FG003|STARTED|Overall Study||6
6816289|NCT01503515|7748752|FG001|COMPLETED|Overall Study||112
6816290|NCT01503515|7748751|FG000|NOT COMPLETED|Overall Study||21
6816291|NCT01503515|7748752|FG001|NOT COMPLETED|Overall Study||35
6816292|NCT01491893|7748758|FG000|STARTED|Overall Study||1
6816293|NCT01491893|7748759|FG001|STARTED|Overall Study||1
6816294|NCT01491893|7748760|FG002|STARTED|Overall Study||1
6816295|NCT01491893|7748761|FG003|STARTED|Overall Study||1
6816296|NCT01491893|7748762|FG004|STARTED|Overall Study||4
6816297|NCT01491893|7748763|FG005|STARTED|Overall Study||1
6816298|NCT01491893|7748764|FG006|STARTED|Overall Study||6
6816299|NCT01491893|7748765|FG007|STARTED|Overall Study||24
6816300|NCT01491893|7748766|FG008|STARTED|Overall Study||15
6816301|NCT01491893|7748767|FG009|STARTED|Overall Study||7
6816302|NCT01491893|7748758|FG000|COMPLETED|Overall Study||1
6816303|NCT01491893|7748759|FG001|COMPLETED|Overall Study||1
6816304|NCT01491893|7748760|FG002|COMPLETED|Overall Study||1
6816305|NCT01491893|7748761|FG003|COMPLETED|Overall Study||1
6816306|NCT01491893|7748762|FG004|COMPLETED|Overall Study||4
6816307|NCT01491893|7748763|FG005|COMPLETED|Overall Study||1
6816308|NCT01491893|7748764|FG006|COMPLETED|Overall Study||6
6816309|NCT01491893|7748765|FG007|COMPLETED|Overall Study||24
6816310|NCT01491893|7748766|FG008|COMPLETED|Overall Study||15
6816311|NCT01491893|7748767|FG009|COMPLETED|Overall Study||7
6816312|NCT01491893|7748758|FG000|NOT COMPLETED|Overall Study||0
6816313|NCT01491893|7748759|FG001|NOT COMPLETED|Overall Study||0
6816314|NCT01491893|7748760|FG002|NOT COMPLETED|Overall Study||0
6816315|NCT01491893|7748761|FG003|NOT COMPLETED|Overall Study||0
6816316|NCT01491893|7748762|FG004|NOT COMPLETED|Overall Study||0
6816317|NCT01491893|7748763|FG005|NOT COMPLETED|Overall Study||0
6816318|NCT01491893|7748764|FG006|NOT COMPLETED|Overall Study||0
6816319|NCT01491893|7748765|FG007|NOT COMPLETED|Overall Study||0
6816320|NCT01491893|7748766|FG008|NOT COMPLETED|Overall Study||0
6816321|NCT01491893|7748767|FG009|NOT COMPLETED|Overall Study||0
6816322|NCT00245960|7748785|FG000|STARTED|Period 1 (Double Blind): 1-12 Weeks||379
6816323|NCT00245960|7748786|FG001|STARTED|Period 1 (Double Blind): 1-12 Weeks||373
6567902|NCT01833546|7491080|FG000|COMPLETED|Overall Study||3
6567903|NCT01833546|7491081|FG001|COMPLETED|Overall Study||3
6567904|NCT01833546|7491082|FG002|COMPLETED|Overall Study||8
6816324|NCT00245960|7748785|FG000|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||364
6816325|NCT00245960|7748786|FG001|COMPLETED|Period 1 (Double Blind): 1-12 Weeks||362
6816326|NCT00245960|7748785|FG000|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||15
6816327|NCT00245960|7748786|FG001|NOT COMPLETED|Period 1 (Double Blind): 1-12 Weeks||11
6816328|NCT00245960|7748785|FG000|STARTED|Period 2 (Open Label): 13-24 Weeks||364
6816329|NCT00245960|7748786|FG001|STARTED|Period 2 (Open Label): 13-24 Weeks||362
6816330|NCT00245960|7748785|FG000|COMPLETED|Period 2 (Open Label): 13-24 Weeks||350
6816331|NCT00245960|7748786|FG001|COMPLETED|Period 2 (Open Label): 13-24 Weeks||344
6567905|NCT01833546|7491083|FG003|COMPLETED|Overall Study||6
6816332|NCT00245960|7748785|FG000|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||14
6816333|NCT00245960|7748786|FG001|NOT COMPLETED|Period 2 (Open Label): 13-24 Weeks||18
6567906|NCT01833546|7491080|FG000|NOT COMPLETED|Overall Study||0
6816334|NCT04565353|7748812|FG000|STARTED|Overall Study||3742
6816335|NCT04565353|7748813|FG001|STARTED|Overall Study||3737
6567907|NCT01833546|7491081|FG001|NOT COMPLETED|Overall Study||0
6567908|NCT01833546|7491082|FG002|NOT COMPLETED|Overall Study||0
6567909|NCT01833546|7491083|FG003|NOT COMPLETED|Overall Study||0
6816336|NCT04565353|7748814|FG002|STARTED|Overall Study||3709
6567910|NCT01833741|7491094|FG000|STARTED|Overall Study||1137
6567911|NCT01833741|7491094|FG000|COMPLETED|Overall Study||997
6567912|NCT01833741|7491094|FG000|NOT COMPLETED|Overall Study||140
6567913|NCT01833754|7491101|FG000|STARTED|Overall Study||8
6567914|NCT01833754|7491102|FG001|STARTED|Overall Study||8
6567915|NCT01833754|7491103|FG002|STARTED|Overall Study||8
6567916|NCT01833754|7491101|FG000|COMPLETED|Overall Study||8
6567917|NCT01833754|7491102|FG001|COMPLETED|Overall Study||8
6567918|NCT01833754|7491103|FG002|COMPLETED|Overall Study||8
6567919|NCT01833754|7491101|FG000|NOT COMPLETED|Overall Study||0
6567920|NCT01833754|7491102|FG001|NOT COMPLETED|Overall Study||0
6567921|NCT01833754|7491103|FG002|NOT COMPLETED|Overall Study||0
6816337|NCT04565353|7748815|FG003|STARTED|Overall Study||3735
6816338|NCT04565353|7748816|FG004|STARTED|Overall Study||3758
6816339|NCT04565353|7748817|FG005|STARTED|Overall Study||3769
6816340|NCT04565353|7748818|FG006|STARTED|Overall Study||3719
6816341|NCT04565353|7748819|FG007|STARTED|Overall Study||3732
6816342|NCT04565353|7748820|FG008|STARTED|Overall Study||3728
6816343|NCT04565353|7748821|FG009|STARTED|Overall Study||3777
6816344|NCT04565353|7748822|FG010|STARTED|Overall Study||3672
6816345|NCT04565353|7748823|FG011|STARTED|Overall Study||3751
6816346|NCT04565353|7748824|FG012|STARTED|Overall Study||3737
6816347|NCT04565353|7748825|FG013|STARTED|Overall Study||3714
6816348|NCT04565353|7748826|FG014|STARTED|Overall Study||3773
6816349|NCT04565353|7748827|FG015|STARTED|Overall Study||3739
6816350|NCT04565353|7748828|FG016|STARTED|Overall Study||3776
6816351|NCT04565353|7748829|FG017|STARTED|Overall Study||3744
6816352|NCT04565353|7748830|FG018|STARTED|Overall Study||3741
6816353|NCT04565353|7748831|FG019|STARTED|Overall Study||3758
6816354|NCT04565353|7748812|FG000|COMPLETED|Overall Study||3742
6816355|NCT04565353|7748813|FG001|COMPLETED|Overall Study||3688
6816356|NCT04565353|7748814|FG002|COMPLETED|Overall Study||3670
6816357|NCT04565353|7748815|FG003|COMPLETED|Overall Study||3693
6816358|NCT04565353|7748816|FG004|COMPLETED|Overall Study||3717
6816359|NCT04565353|7748817|FG005|COMPLETED|Overall Study||3716
6816360|NCT04565353|7748818|FG006|COMPLETED|Overall Study||3665
6816361|NCT04565353|7748819|FG007|COMPLETED|Overall Study||3693
6816362|NCT04565353|7748820|FG008|COMPLETED|Overall Study||3662
6816363|NCT04565353|7748821|FG009|COMPLETED|Overall Study||3734
6816364|NCT04565353|7748822|FG010|COMPLETED|Overall Study||3623
6816365|NCT04565353|7748823|FG011|COMPLETED|Overall Study||3710
6816366|NCT04565353|7748824|FG012|COMPLETED|Overall Study||3685
6816367|NCT04565353|7748825|FG013|COMPLETED|Overall Study||3664
6816368|NCT04565353|7748826|FG014|COMPLETED|Overall Study||3736
6816369|NCT04565353|7748827|FG015|COMPLETED|Overall Study||3690
6816370|NCT04565353|7748828|FG016|COMPLETED|Overall Study||3734
6816371|NCT04565353|7748829|FG017|COMPLETED|Overall Study||3696
6816372|NCT04565353|7748830|FG018|COMPLETED|Overall Study||3698
6816373|NCT04565353|7748831|FG019|COMPLETED|Overall Study||3712
6816374|NCT04565353|7748812|FG000|NOT COMPLETED|Overall Study||0
6816375|NCT04565353|7748813|FG001|NOT COMPLETED|Overall Study||49
6816376|NCT04565353|7748814|FG002|NOT COMPLETED|Overall Study||39
6816377|NCT04565353|7748815|FG003|NOT COMPLETED|Overall Study||42
6816378|NCT04565353|7748816|FG004|NOT COMPLETED|Overall Study||41
6816379|NCT04565353|7748817|FG005|NOT COMPLETED|Overall Study||53
6816380|NCT04565353|7748818|FG006|NOT COMPLETED|Overall Study||54
6816381|NCT04565353|7748819|FG007|NOT COMPLETED|Overall Study||39
6816382|NCT04565353|7748820|FG008|NOT COMPLETED|Overall Study||66
6816383|NCT04565353|7748821|FG009|NOT COMPLETED|Overall Study||43
6816384|NCT04565353|7748822|FG010|NOT COMPLETED|Overall Study||49
6816385|NCT04565353|7748823|FG011|NOT COMPLETED|Overall Study||41
6816386|NCT04565353|7748824|FG012|NOT COMPLETED|Overall Study||52
6816387|NCT04565353|7748825|FG013|NOT COMPLETED|Overall Study||50
6816388|NCT04565353|7748826|FG014|NOT COMPLETED|Overall Study||37
6816389|NCT04565353|7748827|FG015|NOT COMPLETED|Overall Study||49
6816390|NCT04565353|7748828|FG016|NOT COMPLETED|Overall Study||42
6816391|NCT04565353|7748829|FG017|NOT COMPLETED|Overall Study||48
6816392|NCT04565353|7748830|FG018|NOT COMPLETED|Overall Study||43
6816393|NCT04565353|7748831|FG019|NOT COMPLETED|Overall Study||46
6567922|NCT01833832|7491111|FG000|STARTED|Overall Study||11
6567923|NCT01833832|7491111|FG000|COMPLETED|Overall Study||10
6567924|NCT01833832|7491111|FG000|NOT COMPLETED|Overall Study||1
6567925|NCT01833845|7491115|FG000|STARTED|Overall Study||4
6567926|NCT01833845|7491115|FG000|COMPLETED|Overall Study||4
6567927|NCT01833845|7491115|FG000|NOT COMPLETED|Overall Study||0
6567928|NCT01833897|7491119|FG000|STARTED|Overall Study||8
6567929|NCT01833897|7491119|FG000|COMPLETED|Overall Study||7
6567930|NCT01833897|7491119|FG000|NOT COMPLETED|Overall Study||1
6567931|NCT01833936|7491125|FG000|STARTED|Overall Study||20
6816394|NCT04015336|7748873|FG000|STARTED|Overall Study||1
6816395|NCT04015336|7748873|FG000|COMPLETED|Overall Study||0
6816396|NCT04015336|7748873|FG000|NOT COMPLETED|Overall Study||1
6816397|NCT03972813|7748895|FG000|STARTED|Overall Study||85
6816398|NCT03972813|7748896|FG001|STARTED|Overall Study||49
6816399|NCT03972813|7748897|FG002|STARTED|Overall Study||58
6816400|NCT03972813|7748898|FG003|STARTED|Overall Study||55
6816401|NCT03972813|7748899|FG004|STARTED|Overall Study||52
6816402|NCT03972813|7748900|FG005|STARTED|Overall Study||51
6816403|NCT03972813|7748901|FG006|STARTED|Overall Study||53
6816404|NCT03972813|7748902|FG007|STARTED|Overall Study||55
6816405|NCT03972813|7748903|FG008|STARTED|Overall Study||58
6816406|NCT03972813|7748904|FG009|STARTED|Overall Study||60
6816407|NCT03972813|7748905|FG010|STARTED|Overall Study||62
6816408|NCT03972813|7748906|FG011|STARTED|Overall Study||55
6816409|NCT03972813|7748907|FG012|STARTED|Overall Study||58
6816410|NCT03972813|7748908|FG013|STARTED|Overall Study||55
6816411|NCT03972813|7748909|FG014|STARTED|Overall Study||58
6816412|NCT03972813|7748910|FG015|STARTED|Overall Study||56
6816413|NCT03972813|7748911|FG016|STARTED|Overall Study||51
6816414|NCT03972813|7748912|FG017|STARTED|Overall Study||50
6816415|NCT03972813|7748895|FG000|COMPLETED|Overall Study||79
6816416|NCT03972813|7748896|FG001|COMPLETED|Overall Study||45
6816417|NCT03972813|7748897|FG002|COMPLETED|Overall Study||52
6816418|NCT03972813|7748898|FG003|COMPLETED|Overall Study||51
6816419|NCT03972813|7748899|FG004|COMPLETED|Overall Study||48
6816420|NCT03972813|7748900|FG005|COMPLETED|Overall Study||49
6816421|NCT03972813|7748901|FG006|COMPLETED|Overall Study||49
6816422|NCT03972813|7748902|FG007|COMPLETED|Overall Study||52
6816423|NCT03972813|7748903|FG008|COMPLETED|Overall Study||53
6816424|NCT03972813|7748904|FG009|COMPLETED|Overall Study||58
6816425|NCT03972813|7748905|FG010|COMPLETED|Overall Study||57
6816426|NCT03972813|7748906|FG011|COMPLETED|Overall Study||51
6816427|NCT03972813|7748907|FG012|COMPLETED|Overall Study||55
6816428|NCT03972813|7748908|FG013|COMPLETED|Overall Study||52
6816429|NCT03972813|7748909|FG014|COMPLETED|Overall Study||56
6816430|NCT03972813|7748910|FG015|COMPLETED|Overall Study||50
6816431|NCT03972813|7748911|FG016|COMPLETED|Overall Study||48
6816432|NCT03972813|7748912|FG017|COMPLETED|Overall Study||48
6816433|NCT03972813|7748895|FG000|NOT COMPLETED|Overall Study||6
6816434|NCT03972813|7748896|FG001|NOT COMPLETED|Overall Study||4
6816435|NCT03972813|7748897|FG002|NOT COMPLETED|Overall Study||6
6816436|NCT03972813|7748898|FG003|NOT COMPLETED|Overall Study||4
6816437|NCT03972813|7748899|FG004|NOT COMPLETED|Overall Study||4
6816438|NCT03972813|7748900|FG005|NOT COMPLETED|Overall Study||2
6816439|NCT03972813|7748901|FG006|NOT COMPLETED|Overall Study||4
6816440|NCT03972813|7748902|FG007|NOT COMPLETED|Overall Study||3
6816441|NCT03972813|7748903|FG008|NOT COMPLETED|Overall Study||5
6816442|NCT03972813|7748904|FG009|NOT COMPLETED|Overall Study||2
6816443|NCT03972813|7748905|FG010|NOT COMPLETED|Overall Study||5
6816444|NCT03972813|7748906|FG011|NOT COMPLETED|Overall Study||4
6816445|NCT03972813|7748907|FG012|NOT COMPLETED|Overall Study||3
6816446|NCT03972813|7748908|FG013|NOT COMPLETED|Overall Study||3
6816447|NCT03972813|7748909|FG014|NOT COMPLETED|Overall Study||2
6816448|NCT03972813|7748910|FG015|NOT COMPLETED|Overall Study||6
6816449|NCT03972813|7748911|FG016|NOT COMPLETED|Overall Study||3
6816450|NCT03972813|7748912|FG017|NOT COMPLETED|Overall Study||2
6816451|NCT03920280|7748952|FG000|STARTED|Overall Study||41
6816452|NCT03920280|7748953|FG001|STARTED|Overall Study||78
6816453|NCT03920280|7748952|FG000|COMPLETED|Overall Study||38
6816454|NCT03920280|7748953|FG001|COMPLETED|Overall Study||72
6816455|NCT03920280|7748952|FG000|NOT COMPLETED|Overall Study||3
6816456|NCT03920280|7748953|FG001|NOT COMPLETED|Overall Study||6
6816457|NCT03913091|7748964|FG000|STARTED|Overall Study||92
6816458|NCT03913091|7748965|FG001|STARTED|Overall Study||92
6816459|NCT03913091|7748964|FG000|COMPLETED|Overall Study||72
6816460|NCT03913091|7748965|FG001|COMPLETED|Overall Study||78
6816461|NCT03913091|7748964|FG000|NOT COMPLETED|Overall Study||20
6816462|NCT03913091|7748965|FG001|NOT COMPLETED|Overall Study||14
6816463|NCT03802565|7748976|FG000|STARTED|Overall Study||82
6816464|NCT03802565|7748977|FG001|STARTED|Overall Study||87
6816465|NCT03802565|7748978|FG002|STARTED|Overall Study||83
6816466|NCT03802565|7748979|FG003|STARTED|Overall Study||85
6816467|NCT03802565|7748980|FG004|STARTED|Overall Study||78
6816468|NCT03802565|7748976|FG000|COMPLETED|Overall Study||77
6816469|NCT03802565|7748977|FG001|COMPLETED|Overall Study||83
6816470|NCT03802565|7748978|FG002|COMPLETED|Overall Study||74
6816471|NCT03802565|7748979|FG003|COMPLETED|Overall Study||77
6816472|NCT03802565|7748980|FG004|COMPLETED|Overall Study||72
6816473|NCT03802565|7748976|FG000|NOT COMPLETED|Overall Study||5
6816474|NCT03802565|7748977|FG001|NOT COMPLETED|Overall Study||4
6816475|NCT03802565|7748978|FG002|NOT COMPLETED|Overall Study||9
6816476|NCT03802565|7748979|FG003|NOT COMPLETED|Overall Study||8
6816477|NCT03802565|7748980|FG004|NOT COMPLETED|Overall Study||6
6816478|NCT03769194|7748996|FG000|STARTED|Overall Study||29
6816479|NCT03769194|7748997|FG001|STARTED|Overall Study||214
6816480|NCT03769194|7748998|FG002|STARTED|Overall Study||205
6816481|NCT03769194|7748999|FG003|STARTED|Overall Study||124
6816482|NCT03769194|7748996|FG000|COMPLETED|Overall Study||25
6816483|NCT03769194|7748997|FG001|COMPLETED|Overall Study||196
6816484|NCT03769194|7748998|FG002|COMPLETED|Overall Study||197
6816485|NCT03769194|7748999|FG003|COMPLETED|Overall Study||115
6816486|NCT03769194|7748996|FG000|NOT COMPLETED|Overall Study||4
6816487|NCT03769194|7748997|FG001|NOT COMPLETED|Overall Study||18
6816488|NCT03769194|7748998|FG002|NOT COMPLETED|Overall Study||8
6816489|NCT03769194|7748999|FG003|NOT COMPLETED|Overall Study||9
6816490|NCT03738332|7749009|FG000|STARTED|Overall Study||12
6816491|NCT03738332|7749009|FG000|COMPLETED|Overall Study||11
6816492|NCT03738332|7749009|FG000|NOT COMPLETED|Overall Study||1
6816493|NCT03451786|7749014|FG000|STARTED|Overall Study||369
6816494|NCT03451786|7749014|FG000|COMPLETED|Overall Study||310
6816495|NCT03451786|7749014|FG000|NOT COMPLETED|Overall Study||59
6816496|NCT03416179|7749022|FG000|STARTED|Overall Study||201
6816497|NCT03416179|7749023|FG001|STARTED|Overall Study||203
6816498|NCT03416179|7749024|FG002|STARTED|Overall Study||163
6816499|NCT03416179|7749025|FG003|STARTED|Overall Study||162
6816500|NCT03416179|7749022|FG000|COMPLETED|Overall Study||0
6816501|NCT03416179|7749023|FG001|COMPLETED|Overall Study||0
6816502|NCT03416179|7749024|FG002|COMPLETED|Overall Study||0
6816503|NCT03416179|7749025|FG003|COMPLETED|Overall Study||0
6816504|NCT03416179|7749022|FG000|NOT COMPLETED|Overall Study||201
6816505|NCT03416179|7749023|FG001|NOT COMPLETED|Overall Study||203
6816506|NCT03416179|7749024|FG002|NOT COMPLETED|Overall Study||163
6816507|NCT03416179|7749025|FG003|NOT COMPLETED|Overall Study||162
6816508|NCT03353922|7749035|FG000|STARTED|Overall Study||6
6816509|NCT03353922|7749036|FG001|STARTED|Overall Study||6
6816510|NCT03353922|7749037|FG002|STARTED|Overall Study||6
6816511|NCT03353922|7749038|FG003|STARTED|Overall Study||6
6816512|NCT03353922|7749039|FG004|STARTED|Overall Study||5
6816513|NCT03353922|7749040|FG005|STARTED|Overall Study||6
6816514|NCT03353922|7749035|FG000|COMPLETED|Overall Study||5
6816515|NCT03353922|7749036|FG001|COMPLETED|Overall Study||5
6816516|NCT03353922|7749037|FG002|COMPLETED|Overall Study||5
6816517|NCT03353922|7749038|FG003|COMPLETED|Overall Study||5
6816518|NCT03353922|7749039|FG004|COMPLETED|Overall Study||5
6816519|NCT03353922|7749040|FG005|COMPLETED|Overall Study||6
6816520|NCT03353922|7749035|FG000|NOT COMPLETED|Overall Study||1
6816521|NCT03353922|7749036|FG001|NOT COMPLETED|Overall Study||1
6816522|NCT03353922|7749037|FG002|NOT COMPLETED|Overall Study||1
6816523|NCT03353922|7749038|FG003|NOT COMPLETED|Overall Study||1
6816524|NCT03353922|7749039|FG004|NOT COMPLETED|Overall Study||0
6816525|NCT03353922|7749040|FG005|NOT COMPLETED|Overall Study||0
6816526|NCT03322384|7749051|FG000|STARTED|Overall Study||20
6816527|NCT03322384|7749051|FG000|COMPLETED|Overall Study||14
6816528|NCT03322384|7749051|FG000|NOT COMPLETED|Overall Study||6
6816529|NCT03243071|7749057|FG000|STARTED|Overall Study||59
6816530|NCT03243071|7749058|FG001|STARTED|Overall Study||53
6816531|NCT03243071|7749057|FG000|COMPLETED|Overall Study||59
6816532|NCT03243071|7749058|FG001|COMPLETED|Overall Study||53
6816533|NCT03243071|7749057|FG000|NOT COMPLETED|Overall Study||0
6816534|NCT03243071|7749058|FG001|NOT COMPLETED|Overall Study||0
6816535|NCT03173456|7749075|FG000|STARTED|Baseline||120
6816536|NCT03173456|7749076|FG001|STARTED|Baseline||120
6816537|NCT03173456|7749077|FG002|STARTED|Baseline||120
6816538|NCT03173456|7749078|FG003|STARTED|Baseline||120
6816539|NCT03173456|7749079|FG004|STARTED|Baseline||120
6816540|NCT03173456|7749075|FG000|COMPLETED|Baseline||120
6816541|NCT03173456|7749076|FG001|COMPLETED|Baseline||119
6816542|NCT03173456|7749077|FG002|COMPLETED|Baseline||120
6816543|NCT03173456|7749078|FG003|COMPLETED|Baseline||120
6816544|NCT03173456|7749079|FG004|COMPLETED|Baseline||118
6816545|NCT03173456|7749075|FG000|NOT COMPLETED|Baseline||0
6816546|NCT03173456|7749076|FG001|NOT COMPLETED|Baseline||1
6816547|NCT03173456|7749077|FG002|NOT COMPLETED|Baseline||0
6816548|NCT03173456|7749078|FG003|NOT COMPLETED|Baseline||0
6816549|NCT03173456|7749079|FG004|NOT COMPLETED|Baseline||2
6816550|NCT03173456|7749075|FG000|STARTED|2 Hour Follow-up||120
6816551|NCT03173456|7749076|FG001|STARTED|2 Hour Follow-up||119
6816552|NCT03173456|7749077|FG002|STARTED|2 Hour Follow-up||120
6816553|NCT03173456|7749078|FG003|STARTED|2 Hour Follow-up||120
6816554|NCT03173456|7749079|FG004|STARTED|2 Hour Follow-up||118
6816555|NCT03173456|7749075|FG000|COMPLETED|2 Hour Follow-up||120
6816556|NCT03173456|7749076|FG001|COMPLETED|2 Hour Follow-up||118
6816557|NCT03173456|7749077|FG002|COMPLETED|2 Hour Follow-up||119
6816558|NCT03173456|7749078|FG003|COMPLETED|2 Hour Follow-up||119
6816559|NCT03173456|7749079|FG004|COMPLETED|2 Hour Follow-up||116
6816560|NCT03173456|7749075|FG000|NOT COMPLETED|2 Hour Follow-up||0
6816561|NCT03173456|7749076|FG001|NOT COMPLETED|2 Hour Follow-up||1
6816562|NCT03173456|7749077|FG002|NOT COMPLETED|2 Hour Follow-up||1
6567932|NCT01833936|7491126|FG001|STARTED|Overall Study||20
6567933|NCT01833936|7491125|FG000|COMPLETED|Overall Study||16
6567934|NCT01833936|7491126|FG001|COMPLETED|Overall Study||18
6567935|NCT01833936|7491125|FG000|NOT COMPLETED|Overall Study||4
6816563|NCT03173456|7749078|FG003|NOT COMPLETED|2 Hour Follow-up||1
6816564|NCT03173456|7749079|FG004|NOT COMPLETED|2 Hour Follow-up||2
6816565|NCT03101566|7749093|FG000|STARTED|Overall Study||37
6816566|NCT03101566|7749094|FG001|STARTED|Overall Study||38
6816567|NCT03101566|7749093|FG000|Received at Least One Dose of Protocol Therapy|Overall Study||35
6816568|NCT03101566|7749094|FG001|Received at Least One Dose of Protocol Therapy|Overall Study||33
6816569|NCT03101566|7749093|FG000|Assessed for Primary and Secondary Progression-free Survival|Overall Study||32
6816570|NCT03101566|7749094|FG001|Assessed for Primary and Secondary Progression-free Survival|Overall Study||33
6816571|NCT03101566|7749093|FG000|COMPLETED|Overall Study||31
6816572|NCT03101566|7749094|FG001|COMPLETED|Overall Study||31
6816573|NCT03101566|7749093|FG000|NOT COMPLETED|Overall Study||6
6816574|NCT03101566|7749094|FG001|NOT COMPLETED|Overall Study||7
6816575|NCT03020160|7749102|FG000|STARTED|Overall Study||7
6816576|NCT03020160|7749103|FG001|STARTED|Overall Study||41
6816577|NCT03020160|7749102|FG000|Completed 24 Weeks in the Study|Overall Study||7
6816578|NCT03020160|7749103|FG001|Completed 24 Weeks in the Study|Overall Study||41
6816579|NCT03020160|7749102|FG000|COMPLETED|Overall Study||0
6816580|NCT03020160|7749103|FG001|COMPLETED|Overall Study||0
6816581|NCT03020160|7749102|FG000|NOT COMPLETED|Overall Study||7
6816582|NCT03020160|7749103|FG001|NOT COMPLETED|Overall Study||41
6816583|NCT03003520|7749112|FG000|STARTED|Induction||43
6816584|NCT03003520|7749113|FG001|STARTED|Induction||3
6816585|NCT03003520|7749112|FG000|Safety Population|Induction||43
6816586|NCT03003520|7749113|FG001|Safety Population|Induction||3
6816587|NCT03003520|7749112|FG000|Efficacy Evaluable Population|Induction||37
6816588|NCT03003520|7749113|FG001|Efficacy Evaluable Population|Induction||3
6816589|NCT03003520|7749112|FG000|COMPLETED|Induction||30
6567936|NCT01833936|7491126|FG001|NOT COMPLETED|Overall Study||2
6567937|NCT01833988|7491132|FG000|STARTED|Overall Study||16
6567938|NCT01833988|7491133|FG001|STARTED|Overall Study||16
6567939|NCT01833988|7491132|FG000|COMPLETED|Overall Study||16
6567940|NCT01833988|7491133|FG001|COMPLETED|Overall Study||16
6567941|NCT01833988|7491132|FG000|NOT COMPLETED|Overall Study||0
6816590|NCT03003520|7749113|FG001|COMPLETED|Induction||3
6816591|NCT03003520|7749112|FG000|NOT COMPLETED|Induction||13
6816592|NCT03003520|7749113|FG001|NOT COMPLETED|Induction||0
6816593|NCT03003520|7749112|FG000|STARTED|Consolidation||25
6816594|NCT03003520|7749113|FG001|STARTED|Consolidation||3
6816595|NCT03003520|7749112|FG000|COMPLETED|Consolidation||1
6816596|NCT03003520|7749113|FG001|COMPLETED|Consolidation||2
6816597|NCT03003520|7749112|FG000|NOT COMPLETED|Consolidation||24
6816598|NCT03003520|7749113|FG001|NOT COMPLETED|Consolidation||1
6816599|NCT03003520|7749112|FG000|STARTED|Follow-up||14
6816600|NCT03003520|7749113|FG001|STARTED|Follow-up||3
6816601|NCT03003520|7749112|FG000|COMPLETED|Follow-up||0
6816602|NCT03003520|7749113|FG001|COMPLETED|Follow-up||0
6816603|NCT03003520|7749112|FG000|NOT COMPLETED|Follow-up||14
6816604|NCT03003520|7749113|FG001|NOT COMPLETED|Follow-up||3
6816605|NCT02862457|7749134|FG000|STARTED|Overall Study||3
6816606|NCT02862457|7749135|FG001|STARTED|Overall Study||3
6816607|NCT02862457|7749136|FG002|STARTED|Overall Study||3
6816608|NCT02862457|7749137|FG003|STARTED|Overall Study||6
6816609|NCT02862457|7749138|FG004|STARTED|Overall Study||7
6816610|NCT02862457|7749139|FG005|STARTED|Overall Study||6
6816611|NCT02862457|7749140|FG006|STARTED|Overall Study||6
6816612|NCT02862457|7749134|FG000|COMPLETED|Overall Study||1
6816613|NCT02862457|7749135|FG001|COMPLETED|Overall Study||0
6816614|NCT02862457|7749136|FG002|COMPLETED|Overall Study||0
6816615|NCT02862457|7749137|FG003|COMPLETED|Overall Study||2
6816616|NCT02862457|7749138|FG004|COMPLETED|Overall Study||7
6816617|NCT02862457|7749139|FG005|COMPLETED|Overall Study||3
6816618|NCT02862457|7749140|FG006|COMPLETED|Overall Study||5
6816619|NCT02862457|7749134|FG000|NOT COMPLETED|Overall Study||2
6816620|NCT02862457|7749135|FG001|NOT COMPLETED|Overall Study||3
6816621|NCT02862457|7749136|FG002|NOT COMPLETED|Overall Study||3
6816622|NCT02862457|7749137|FG003|NOT COMPLETED|Overall Study||4
6816623|NCT02862457|7749138|FG004|NOT COMPLETED|Overall Study||0
6816624|NCT02862457|7749139|FG005|NOT COMPLETED|Overall Study||3
6816625|NCT02862457|7749140|FG006|NOT COMPLETED|Overall Study||1
6816626|NCT02820753|7749166|FG000|STARTED|Baseline||256
6816627|NCT02820753|7749167|FG001|STARTED|Baseline||421
6816628|NCT02820753|7749166|FG000|COMPLETED|Baseline||256
6816629|NCT02820753|7749167|FG001|COMPLETED|Baseline||421
6816630|NCT02820753|7749166|FG000|NOT COMPLETED|Baseline||0
6816631|NCT02820753|7749167|FG001|NOT COMPLETED|Baseline||0
6816632|NCT02820753|7749166|FG000|STARTED|2 Month||256
6816633|NCT02820753|7749167|FG001|STARTED|2 Month||421
6816634|NCT02820753|7749166|FG000|COMPLETED|2 Month||178
6816635|NCT02820753|7749167|FG001|COMPLETED|2 Month||379
6816636|NCT02820753|7749166|FG000|NOT COMPLETED|2 Month||78
6816637|NCT02820753|7749167|FG001|NOT COMPLETED|2 Month||42
6816638|NCT02820753|7749166|FG000|STARTED|6 Month||253
6816639|NCT02820753|7749167|FG001|STARTED|6 Month||418
6816640|NCT02820753|7749166|FG000|COMPLETED|6 Month||150
6816641|NCT02820753|7749167|FG001|COMPLETED|6 Month||307
6816642|NCT02820753|7749166|FG000|NOT COMPLETED|6 Month||103
6816643|NCT02820753|7749167|FG001|NOT COMPLETED|6 Month||111
6816644|NCT02733042|7749192|FG000|STARTED|Treatment Period||3
6816645|NCT02733042|7749193|FG001|STARTED|Treatment Period||3
6816646|NCT02733042|7749194|FG002|STARTED|Treatment Period||8
6816647|NCT02733042|7749195|FG003|STARTED|Treatment Period||3
6816648|NCT02733042|7749196|FG004|STARTED|Treatment Period||4
6816649|NCT02733042|7749197|FG005|STARTED|Treatment Period||3
6816650|NCT02733042|7749198|FG006|STARTED|Treatment Period||1
6816651|NCT02733042|7749199|FG007|STARTED|Treatment Period||4
6816652|NCT02733042|7749200|FG008|STARTED|Treatment Period||5
6816653|NCT02733042|7749201|FG009|STARTED|Treatment Period||10
6816654|NCT02733042|7749202|FG010|STARTED|Treatment Period||10
6816655|NCT02733042|7749203|FG011|STARTED|Treatment Period||10
6816656|NCT02733042|7749204|FG012|STARTED|Treatment Period||10
6816657|NCT02733042|7749205|FG013|STARTED|Treatment Period||5
6816658|NCT02733042|7749206|FG014|STARTED|Treatment Period||5
6816659|NCT02733042|7749207|FG015|STARTED|Treatment Period||10
6816660|NCT02733042|7749208|FG016|STARTED|Treatment Period||2
6816661|NCT02733042|7749209|FG017|STARTED|Treatment Period||5
6816662|NCT02733042|7749210|FG018|STARTED|Treatment Period||5
6816663|NCT02733042|7749192|FG000|COMPLETED|Treatment Period||0
6816664|NCT02733042|7749193|FG001|COMPLETED|Treatment Period||1
6816665|NCT02733042|7749194|FG002|COMPLETED|Treatment Period||1
6816666|NCT02733042|7749195|FG003|COMPLETED|Treatment Period||0
6816667|NCT02733042|7749196|FG004|COMPLETED|Treatment Period||0
6816668|NCT02733042|7749197|FG005|COMPLETED|Treatment Period||0
6816669|NCT02733042|7749198|FG006|COMPLETED|Treatment Period||0
6816670|NCT02733042|7749199|FG007|COMPLETED|Treatment Period||1
6816671|NCT02733042|7749200|FG008|COMPLETED|Treatment Period||0
6816672|NCT02733042|7749201|FG009|COMPLETED|Treatment Period||0
6816673|NCT02733042|7749202|FG010|COMPLETED|Treatment Period||0
6816674|NCT02733042|7749203|FG011|COMPLETED|Treatment Period||4
6816675|NCT02733042|7749204|FG012|COMPLETED|Treatment Period||1
6567942|NCT01833988|7491133|FG001|NOT COMPLETED|Overall Study||0
6567943|NCT01834027|7491146|FG000|STARTED|Overall Study||28
6567944|NCT01834027|7491147|FG001|STARTED|Overall Study||28
6567945|NCT01834027|7491146|FG000|COMPLETED|Overall Study||28
6567946|NCT01834027|7491147|FG001|COMPLETED|Overall Study||28
6567947|NCT01834027|7491146|FG000|NOT COMPLETED|Overall Study||0
6816676|NCT02733042|7749205|FG013|COMPLETED|Treatment Period||1
6816677|NCT02733042|7749206|FG014|COMPLETED|Treatment Period||0
6816678|NCT02733042|7749207|FG015|COMPLETED|Treatment Period||0
6816679|NCT02733042|7749208|FG016|COMPLETED|Treatment Period||0
6816680|NCT02733042|7749209|FG017|COMPLETED|Treatment Period||0
6816681|NCT02733042|7749210|FG018|COMPLETED|Treatment Period||0
6816682|NCT02733042|7749192|FG000|NOT COMPLETED|Treatment Period||3
6816683|NCT02733042|7749193|FG001|NOT COMPLETED|Treatment Period||2
6816684|NCT02733042|7749194|FG002|NOT COMPLETED|Treatment Period||7
6816685|NCT02733042|7749195|FG003|NOT COMPLETED|Treatment Period||3
6816686|NCT02733042|7749196|FG004|NOT COMPLETED|Treatment Period||4
6816687|NCT02733042|7749197|FG005|NOT COMPLETED|Treatment Period||3
6816688|NCT02733042|7749198|FG006|NOT COMPLETED|Treatment Period||1
6816689|NCT02733042|7749199|FG007|NOT COMPLETED|Treatment Period||3
6816690|NCT02733042|7749200|FG008|NOT COMPLETED|Treatment Period||5
6816691|NCT02733042|7749201|FG009|NOT COMPLETED|Treatment Period||10
6816692|NCT02733042|7749202|FG010|NOT COMPLETED|Treatment Period||10
6816693|NCT02733042|7749203|FG011|NOT COMPLETED|Treatment Period||6
6816694|NCT02733042|7749204|FG012|NOT COMPLETED|Treatment Period||9
6816695|NCT02733042|7749205|FG013|NOT COMPLETED|Treatment Period||4
6816696|NCT02733042|7749206|FG014|NOT COMPLETED|Treatment Period||5
6816697|NCT02733042|7749207|FG015|NOT COMPLETED|Treatment Period||10
6816698|NCT02733042|7749208|FG016|NOT COMPLETED|Treatment Period||2
6816699|NCT02733042|7749209|FG017|NOT COMPLETED|Treatment Period||5
6816700|NCT02733042|7749210|FG018|NOT COMPLETED|Treatment Period||5
6816701|NCT02733042|7749192|FG000|STARTED|Follow-up Period||3
6816702|NCT02733042|7749193|FG001|STARTED|Follow-up Period||3
6816703|NCT02733042|7749194|FG002|STARTED|Follow-up Period||6
6816704|NCT02733042|7749195|FG003|STARTED|Follow-up Period||3
6816705|NCT02733042|7749196|FG004|STARTED|Follow-up Period||1
6816706|NCT02733042|7749197|FG005|STARTED|Follow-up Period||2
6816707|NCT02733042|7749198|FG006|STARTED|Follow-up Period||0
6816708|NCT02733042|7749199|FG007|STARTED|Follow-up Period||4
6816709|NCT02733042|7749200|FG008|STARTED|Follow-up Period||4
6816710|NCT02733042|7749201|FG009|STARTED|Follow-up Period||2
6816711|NCT02733042|7749202|FG010|STARTED|Follow-up Period||5
6816712|NCT02733042|7749203|FG011|STARTED|Follow-up Period||9
6816713|NCT02733042|7749204|FG012|STARTED|Follow-up Period||9
6816714|NCT02733042|7749205|FG013|STARTED|Follow-up Period||4
6816715|NCT02733042|7749206|FG014|STARTED|Follow-up Period||1
6816716|NCT02733042|7749207|FG015|STARTED|Follow-up Period||5
6816717|NCT02733042|7749208|FG016|STARTED|Follow-up Period||0
6816718|NCT02733042|7749209|FG017|STARTED|Follow-up Period||3
6816719|NCT02733042|7749210|FG018|STARTED|Follow-up Period||2
6816720|NCT02733042|7749192|FG000|COMPLETED|Follow-up Period||0
6816721|NCT02733042|7749193|FG001|COMPLETED|Follow-up Period||0
6816722|NCT02733042|7749194|FG002|COMPLETED|Follow-up Period||0
6816723|NCT02733042|7749195|FG003|COMPLETED|Follow-up Period||0
6816724|NCT02733042|7749196|FG004|COMPLETED|Follow-up Period||0
6816725|NCT02733042|7749197|FG005|COMPLETED|Follow-up Period||0
6816726|NCT02733042|7749198|FG006|COMPLETED|Follow-up Period||0
6816727|NCT02733042|7749199|FG007|COMPLETED|Follow-up Period||0
6816728|NCT02733042|7749200|FG008|COMPLETED|Follow-up Period||0
6816729|NCT02733042|7749201|FG009|COMPLETED|Follow-up Period||0
6816730|NCT02733042|7749202|FG010|COMPLETED|Follow-up Period||0
6816731|NCT02733042|7749203|FG011|COMPLETED|Follow-up Period||0
6816732|NCT02733042|7749204|FG012|COMPLETED|Follow-up Period||0
6391095|NCT00833794|7302921|FG000|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
6391096|NCT00833794|7302922|FG001|COMPLETED|Open-label Phase||0
6391097|NCT00833794|7302921|FG000|NOT COMPLETED|Open-label Phase||382
6391098|NCT00833794|7302922|FG001|NOT COMPLETED|Open-label Phase||0
6391099|NCT00833794|7302921|FG000|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
6391100|NCT00833794|7302922|FG001|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
6391101|NCT00833794|7302921|FG000|COMPLETED|Double-blind Phase||326
6391102|NCT00833794|7302922|FG001|COMPLETED|Double-blind Phase||165
6391103|NCT00833794|7302921|FG000|NOT COMPLETED|Double-blind Phase||106
6391104|NCT00833794|7302922|FG001|NOT COMPLETED|Double-blind Phase||49
6391105|NCT00833833|7302936|FG000|STARTED|Phase 1 (as of 01 April 2011)||6
6391106|NCT00833833|7302937|FG001|STARTED|Phase 1 (as of 01 April 2011)||8
6391107|NCT00833833|7302938|FG002|STARTED|Phase 1 (as of 01 April 2011)||14
6391108|NCT00833833|7302939|FG003|STARTED|Phase 1 (as of 01 April 2011)||10
6391109|NCT00833833|7302940|FG004|STARTED|Phase 1 (as of 01 April 2011)||0
6391110|NCT00833833|7302941|FG005|STARTED|Phase 1 (as of 01 April 2011)||0
6391111|NCT00833833|7302936|FG000|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
6391112|NCT00833833|7302937|FG001|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
6391113|NCT00833833|7302938|FG002|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
6391114|NCT00833833|7302939|FG003|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
6391115|NCT00833833|7302940|FG004|COMPLETED|Phase 1 (as of 01 April 2011)||0
6816733|NCT02733042|7749205|FG013|COMPLETED|Follow-up Period||0
6816734|NCT02733042|7749206|FG014|COMPLETED|Follow-up Period||0
6816735|NCT02733042|7749207|FG015|COMPLETED|Follow-up Period||0
6816736|NCT02733042|7749208|FG016|COMPLETED|Follow-up Period||0
6816737|NCT02733042|7749209|FG017|COMPLETED|Follow-up Period||1
6816738|NCT02733042|7749210|FG018|COMPLETED|Follow-up Period||0
6816739|NCT02733042|7749192|FG000|NOT COMPLETED|Follow-up Period||3
6816740|NCT02733042|7749193|FG001|NOT COMPLETED|Follow-up Period||3
6816741|NCT02733042|7749194|FG002|NOT COMPLETED|Follow-up Period||6
6816742|NCT02733042|7749195|FG003|NOT COMPLETED|Follow-up Period||3
6816743|NCT02733042|7749196|FG004|NOT COMPLETED|Follow-up Period||1
6816744|NCT02733042|7749197|FG005|NOT COMPLETED|Follow-up Period||2
6816745|NCT02733042|7749198|FG006|NOT COMPLETED|Follow-up Period||0
6816746|NCT02733042|7749199|FG007|NOT COMPLETED|Follow-up Period||4
6816747|NCT02733042|7749200|FG008|NOT COMPLETED|Follow-up Period||4
6816748|NCT02733042|7749201|FG009|NOT COMPLETED|Follow-up Period||2
6816749|NCT02733042|7749202|FG010|NOT COMPLETED|Follow-up Period||5
6816750|NCT02733042|7749203|FG011|NOT COMPLETED|Follow-up Period||9
6816751|NCT02733042|7749204|FG012|NOT COMPLETED|Follow-up Period||9
6816752|NCT02733042|7749205|FG013|NOT COMPLETED|Follow-up Period||4
6816753|NCT02733042|7749206|FG014|NOT COMPLETED|Follow-up Period||1
6816754|NCT02733042|7749207|FG015|NOT COMPLETED|Follow-up Period||5
6816755|NCT02733042|7749208|FG016|NOT COMPLETED|Follow-up Period||0
6816756|NCT02733042|7749209|FG017|NOT COMPLETED|Follow-up Period||2
6816757|NCT02733042|7749210|FG018|NOT COMPLETED|Follow-up Period||2
6816758|NCT02668874|7749260|FG000|STARTED|Overall Study||104
6816759|NCT02668874|7749261|FG001|STARTED|Overall Study||104
6816760|NCT02668874|7749260|FG000|6 Months After Placement|Overall Study||59
6816761|NCT02668874|7749261|FG001|6 Months After Placement|Overall Study||59
6816762|NCT02668874|7749260|FG000|COMPLETED|Overall Study||47
6816763|NCT02668874|7749261|FG001|COMPLETED|Overall Study||47
6816764|NCT02668874|7749260|FG000|NOT COMPLETED|Overall Study||57
6816765|NCT02668874|7749261|FG001|NOT COMPLETED|Overall Study||57
6816766|NCT02609737|7749267|FG000|STARTED|Overall Study||20
6816767|NCT02609737|7749267|FG000|COMPLETED|Overall Study||20
6816768|NCT02609737|7749267|FG000|NOT COMPLETED|Overall Study||0
6816769|NCT02574286|7749271|FG000|STARTED|Overall Study||21
6816770|NCT02574286|7749271|FG000|COMPLETED|Overall Study||16
6816771|NCT02574286|7749271|FG000|NOT COMPLETED|Overall Study||5
6816772|NCT02471144|7749279|FG000|STARTED|Induction Period (Up to Week 12)||40
6816773|NCT02471144|7749280|FG001|STARTED|Induction Period (Up to Week 12)||40
6816774|NCT02471144|7749281|FG002|STARTED|Induction Period (Up to Week 12)||41
6816775|NCT02471144|7749282|FG003|STARTED|Induction Period (Up to Week 12)||41
6816776|NCT02471144|7749283|FG004|STARTED|Induction Period (Up to Week 12)||0
6816777|NCT02471144|7749284|FG005|STARTED|Induction Period (Up to Week 12)||0
6816778|NCT02471144|7749285|FG006|STARTED|Induction Period (Up to Week 12)||0
6816779|NCT02471144|7749286|FG007|STARTED|Induction Period (Up to Week 12)||0
6816780|NCT02471144|7749287|FG008|STARTED|Induction Period (Up to Week 12)||0
6816781|NCT02471144|7749288|FG009|STARTED|Induction Period (Up to Week 12)||0
6816782|NCT02471144|7749289|FG010|STARTED|Induction Period (Up to Week 12)||0
6816783|NCT02471144|7749279|FG000|COMPLETED|Induction Period (Up to Week 12)||39
6816784|NCT02471144|7749280|FG001|COMPLETED|Induction Period (Up to Week 12)||38
6816785|NCT02471144|7749281|FG002|COMPLETED|Induction Period (Up to Week 12)||39
6816786|NCT02471144|7749282|FG003|COMPLETED|Induction Period (Up to Week 12)||40
6816787|NCT02471144|7749283|FG004|COMPLETED|Induction Period (Up to Week 12)||0
6816788|NCT02471144|7749284|FG005|COMPLETED|Induction Period (Up to Week 12)||0
6816789|NCT02471144|7749285|FG006|COMPLETED|Induction Period (Up to Week 12)||0
6816790|NCT02471144|7749286|FG007|COMPLETED|Induction Period (Up to Week 12)||0
6816791|NCT02471144|7749287|FG008|COMPLETED|Induction Period (Up to Week 12)||0
6816792|NCT02471144|7749288|FG009|COMPLETED|Induction Period (Up to Week 12)||0
6816793|NCT02471144|7749289|FG010|COMPLETED|Induction Period (Up to Week 12)||0
6816794|NCT02471144|7749279|FG000|NOT COMPLETED|Induction Period (Up to Week 12)||1
6816795|NCT02471144|7749280|FG001|NOT COMPLETED|Induction Period (Up to Week 12)||2
6816796|NCT02471144|7749281|FG002|NOT COMPLETED|Induction Period (Up to Week 12)||2
6816797|NCT02471144|7749282|FG003|NOT COMPLETED|Induction Period (Up to Week 12)||1
6816798|NCT02471144|7749283|FG004|NOT COMPLETED|Induction Period (Up to Week 12)||0
6816799|NCT02471144|7749284|FG005|NOT COMPLETED|Induction Period (Up to Week 12)||0
6816800|NCT02471144|7749285|FG006|NOT COMPLETED|Induction Period (Up to Week 12)||0
6816801|NCT02471144|7749286|FG007|NOT COMPLETED|Induction Period (Up to Week 12)||0
6816802|NCT02471144|7749287|FG008|NOT COMPLETED|Induction Period (Up to Week 12)||0
6816803|NCT02471144|7749288|FG009|NOT COMPLETED|Induction Period (Up to Week 12)||0
6816804|NCT02471144|7749289|FG010|NOT COMPLETED|Induction Period (Up to Week 12)||0
6816805|NCT02471144|7749279|FG000|STARTED|Maintenance Period (Week 12 to Week 52)||0
6816806|NCT02471144|7749280|FG001|STARTED|Maintenance Period (Week 12 to Week 52)||0
6816807|NCT02471144|7749281|FG002|STARTED|Maintenance Period (Week 12 to Week 52)||0
6816808|NCT02471144|7749282|FG003|STARTED|Maintenance Period (Week 12 to Week 52)||0
6816809|NCT02471144|7749283|FG004|STARTED|Maintenance Period (Week 12 to Week 52)||39
6816810|NCT02471144|7749284|FG005|STARTED|Maintenance Period (Week 12 to Week 52)||38
6816811|NCT02471144|7749285|FG006|STARTED|Maintenance Period (Week 12 to Week 52)||16
6816812|NCT02471144|7749286|FG007|STARTED|Maintenance Period (Week 12 to Week 52)||18
6816813|NCT02471144|7749287|FG008|STARTED|Maintenance Period (Week 12 to Week 52)||40
6816814|NCT02471144|7749288|FG009|STARTED|Maintenance Period (Week 12 to Week 52)||0
6816815|NCT02471144|7749289|FG010|STARTED|Maintenance Period (Week 12 to Week 52)||0
6816816|NCT02471144|7749279|FG000|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816817|NCT02471144|7749280|FG001|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816818|NCT02471144|7749281|FG002|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816819|NCT02471144|7749282|FG003|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816820|NCT02471144|7749283|FG004|COMPLETED|Maintenance Period (Week 12 to Week 52)||38
6816821|NCT02471144|7749284|FG005|COMPLETED|Maintenance Period (Week 12 to Week 52)||37
6816822|NCT02471144|7749285|FG006|COMPLETED|Maintenance Period (Week 12 to Week 52)||15
6816823|NCT02471144|7749286|FG007|COMPLETED|Maintenance Period (Week 12 to Week 52)||16
6816824|NCT02471144|7749287|FG008|COMPLETED|Maintenance Period (Week 12 to Week 52)||34
6816825|NCT02471144|7749288|FG009|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816826|NCT02471144|7749289|FG010|COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816827|NCT02471144|7749279|FG000|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816828|NCT02471144|7749280|FG001|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816829|NCT02471144|7749281|FG002|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816830|NCT02471144|7749282|FG003|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816831|NCT02471144|7749283|FG004|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
6816832|NCT02471144|7749284|FG005|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
6816833|NCT02471144|7749285|FG006|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||1
6816834|NCT02471144|7749286|FG007|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||2
6816835|NCT02471144|7749287|FG008|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||6
6816836|NCT02471144|7749288|FG009|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816837|NCT02471144|7749289|FG010|NOT COMPLETED|Maintenance Period (Week 12 to Week 52)||0
6816838|NCT02471144|7749279|FG000|STARTED|Extension Period (Week 52 to Week 236)||0
6816839|NCT02471144|7749280|FG001|STARTED|Extension Period (Week 52 to Week 236)||0
6816840|NCT02471144|7749281|FG002|STARTED|Extension Period (Week 52 to Week 236)||0
6816841|NCT02471144|7749282|FG003|STARTED|Extension Period (Week 52 to Week 236)||0
6816842|NCT02471144|7749283|FG004|STARTED|Extension Period (Week 52 to Week 236)||0
6816843|NCT02471144|7749284|FG005|STARTED|Extension Period (Week 52 to Week 236)||0
6816844|NCT02471144|7749285|FG006|STARTED|Extension Period (Week 52 to Week 236)||0
6816845|NCT02471144|7749286|FG007|STARTED|Extension Period (Week 52 to Week 236)||0
6816846|NCT02471144|7749287|FG008|STARTED|Extension Period (Week 52 to Week 236)||0
6816847|NCT02471144|7749288|FG009|STARTED|Extension Period (Week 52 to Week 236)||53
6816848|NCT02471144|7749289|FG010|STARTED|Extension Period (Week 52 to Week 236)||53
6816849|NCT02471144|7749279|FG000|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816850|NCT02471144|7749280|FG001|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816851|NCT02471144|7749281|FG002|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816852|NCT02471144|7749282|FG003|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816853|NCT02471144|7749283|FG004|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816854|NCT02471144|7749284|FG005|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816855|NCT02471144|7749285|FG006|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816856|NCT02471144|7749286|FG007|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816857|NCT02471144|7749287|FG008|COMPLETED|Extension Period (Week 52 to Week 236)||0
6816858|NCT02471144|7749288|FG009|COMPLETED|Extension Period (Week 52 to Week 236)||46
6816859|NCT02471144|7749289|FG010|COMPLETED|Extension Period (Week 52 to Week 236)||49
6816860|NCT02471144|7749279|FG000|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816861|NCT02471144|7749280|FG001|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816862|NCT02471144|7749281|FG002|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816863|NCT02471144|7749282|FG003|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816864|NCT02471144|7749283|FG004|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816865|NCT02471144|7749284|FG005|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816866|NCT02471144|7749285|FG006|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816867|NCT02471144|7749286|FG007|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816868|NCT02471144|7749287|FG008|NOT COMPLETED|Extension Period (Week 52 to Week 236)||0
6816869|NCT02471144|7749288|FG009|NOT COMPLETED|Extension Period (Week 52 to Week 236)||7
6816870|NCT02471144|7749289|FG010|NOT COMPLETED|Extension Period (Week 52 to Week 236)||4
6816871|NCT02440464|7749307|FG000|STARTED|Overall Study||21
6816872|NCT02440464|7749308|FG001|STARTED|Overall Study||22
6816873|NCT02440464|7749307|FG000|COMPLETED|Overall Study||18
6816874|NCT02440464|7749308|FG001|COMPLETED|Overall Study||20
6816875|NCT02440464|7749307|FG000|NOT COMPLETED|Overall Study||3
6816876|NCT02440464|7749308|FG001|NOT COMPLETED|Overall Study||2
6816877|NCT02384421|7749315|FG000|STARTED|Overall Study||22
6816878|NCT02384421|7749315|FG000|COMPLETED|Overall Study||22
6816879|NCT02384421|7749315|FG000|NOT COMPLETED|Overall Study||0
6816880|NCT02366728|7749325|FG000|STARTED|Overall Study||27
6816881|NCT02366728|7749326|FG001|STARTED|Overall Study||28
6816882|NCT02366728|7749327|FG002|STARTED|Overall Study||9
6816883|NCT02366728|7749325|FG000|Received at Least One ppp65 Vaccine|Overall Study||25
6816884|NCT02366728|7749326|FG001|Received at Least One ppp65 Vaccine|Overall Study||27
6816885|NCT02366728|7749327|FG002|Received at Least One ppp65 Vaccine|Overall Study||8
6816886|NCT02366728|7749325|FG000|COMPLETED|Overall Study||23
6816887|NCT02366728|7749326|FG001|COMPLETED|Overall Study||27
6816888|NCT02366728|7749327|FG002|COMPLETED|Overall Study||8
6816889|NCT02366728|7749325|FG000|NOT COMPLETED|Overall Study||4
6816890|NCT02366728|7749326|FG001|NOT COMPLETED|Overall Study||1
6816891|NCT02366728|7749327|FG002|NOT COMPLETED|Overall Study||1
6816892|NCT02236572|7749335|FG000|STARTED|Overall Study||17
6816893|NCT02236572|7749335|FG000|COMPLETED|Overall Study||14
6816894|NCT02236572|7749335|FG000|NOT COMPLETED|Overall Study||3
6816895|NCT02083354|7749339|FG000|STARTED|Overall Study||77
6816896|NCT02083354|7749339|FG000|COMPLETED|Overall Study||13
6816897|NCT02083354|7749339|FG000|NOT COMPLETED|Overall Study||64
6816898|NCT01775813|7749347|FG000|STARTED|Overall Study||47
6567948|NCT01834027|7491147|FG001|NOT COMPLETED|Overall Study||0
6567949|NCT01834222|7491153|FG000|STARTED|Overall Study||659
6567950|NCT01834222|7491153|FG000|Treated|Overall Study||658
6567951|NCT01834222|7491153|FG000|COMPLETED|Overall Study||658
6567952|NCT01834222|7491153|FG000|NOT COMPLETED|Overall Study||1
6567953|NCT01834261|7491159|FG000|STARTED|MIT fMRI and MEG Resting State Study||11
6567954|NCT01834261|7491160|FG001|STARTED|MIT fMRI and MEG Resting State Study||10
6567955|NCT01834261|7491159|FG000|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
6567956|NCT01834261|7491160|FG001|COMPLETED|MIT fMRI and MEG Resting State Study||9
6567957|NCT01834261|7491159|FG000|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
6567958|NCT01834261|7491160|FG001|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
6657148|NCT02466646|7587432|FG001|COMPLETED|Overall Study||14
6816899|NCT01775813|7749348|FG001|STARTED|Overall Study||13
6816900|NCT01775813|7749349|FG002|STARTED|Overall Study||24
6816901|NCT01775813|7749350|FG003|STARTED|Overall Study||20
6816902|NCT01775813|7749347|FG000|Study Visit 2 (Tanner 4)|Overall Study||36
6816903|NCT01775813|7749348|FG001|Study Visit 2 (Tanner 4)|Overall Study||4
6816904|NCT01775813|7749349|FG002|Study Visit 2 (Tanner 4)|Overall Study||11
6816905|NCT01775813|7749350|FG003|Study Visit 2 (Tanner 4)|Overall Study||11
6816906|NCT01775813|7749347|FG000|Study Visit 3 (Tanner 5)|Overall Study||34
6816907|NCT01775813|7749348|FG001|Study Visit 3 (Tanner 5)|Overall Study||8
6816908|NCT01775813|7749349|FG002|Study Visit 3 (Tanner 5)|Overall Study||12
6816909|NCT01775813|7749350|FG003|Study Visit 3 (Tanner 5)|Overall Study||11
6816910|NCT01775813|7749347|FG000|Study Visit 4 (Post-Puberty)|Overall Study||10
6816911|NCT01775813|7749348|FG001|Study Visit 4 (Post-Puberty)|Overall Study||0
6816912|NCT01775813|7749349|FG002|Study Visit 4 (Post-Puberty)|Overall Study||13
6816913|NCT01775813|7749350|FG003|Study Visit 4 (Post-Puberty)|Overall Study||11
6816914|NCT01775813|7749347|FG000|COMPLETED|Overall Study||34
6816915|NCT01775813|7749348|FG001|COMPLETED|Overall Study||8
6816916|NCT01775813|7749349|FG002|COMPLETED|Overall Study||12
6816917|NCT01775813|7749350|FG003|COMPLETED|Overall Study||11
6816918|NCT01775813|7749347|FG000|NOT COMPLETED|Overall Study||13
6816919|NCT01775813|7749348|FG001|NOT COMPLETED|Overall Study||5
6816920|NCT01775813|7749349|FG002|NOT COMPLETED|Overall Study||12
6816921|NCT01775813|7749350|FG003|NOT COMPLETED|Overall Study||9
6816922|NCT01694069|7749367|FG000|STARTED|Overall Study||6
6816923|NCT01694069|7749367|FG000|COMPLETED|Overall Study||6
6816924|NCT01694069|7749367|FG000|NOT COMPLETED|Overall Study||0
6816925|NCT01446016|7749373|FG000|STARTED|Overall Study||38
6816926|NCT01446016|7749373|FG000|COMPLETED|Overall Study||31
6816927|NCT01446016|7749373|FG000|NOT COMPLETED|Overall Study||7
6816928|NCT01445327|7749380|FG000|STARTED|Overall Study||3
6816929|NCT01445327|7749381|FG001|STARTED|Overall Study||1
6816930|NCT01445327|7749382|FG002|STARTED|Overall Study||5
6816931|NCT01445327|7749380|FG000|COMPLETED|Overall Study||3
6816932|NCT01445327|7749381|FG001|COMPLETED|Overall Study||1
6816933|NCT01445327|7749382|FG002|COMPLETED|Overall Study||5
6816934|NCT01445327|7749380|FG000|NOT COMPLETED|Overall Study||0
6816935|NCT01445327|7749381|FG001|NOT COMPLETED|Overall Study||0
6816936|NCT01445327|7749382|FG002|NOT COMPLETED|Overall Study||0
6816937|NCT01434602|7749395|FG000|STARTED|Phase I Dose Escalation||6
6816938|NCT01434602|7749396|FG001|STARTED|Phase I Dose Escalation||7
6816939|NCT01434602|7749397|FG002|STARTED|Phase I Dose Escalation||0
6816940|NCT01434602|7749398|FG003|STARTED|Phase I Dose Escalation||0
6816941|NCT01434602|7749399|FG004|STARTED|Phase I Dose Escalation||0
6816942|NCT01434602|7749395|FG000|COMPLETED|Phase I Dose Escalation||6
6816943|NCT01434602|7749396|FG001|COMPLETED|Phase I Dose Escalation||6
6816944|NCT01434602|7749397|FG002|COMPLETED|Phase I Dose Escalation||0
6816945|NCT01434602|7749398|FG003|COMPLETED|Phase I Dose Escalation||0
6816946|NCT01434602|7749399|FG004|COMPLETED|Phase I Dose Escalation||0
6816947|NCT01434602|7749395|FG000|NOT COMPLETED|Phase I Dose Escalation||0
6816948|NCT01434602|7749396|FG001|NOT COMPLETED|Phase I Dose Escalation||1
6816949|NCT01434602|7749397|FG002|NOT COMPLETED|Phase I Dose Escalation||0
6816950|NCT01434602|7749398|FG003|NOT COMPLETED|Phase I Dose Escalation||0
6816951|NCT01434602|7749399|FG004|NOT COMPLETED|Phase I Dose Escalation||0
6816952|NCT01434602|7749395|FG000|STARTED|Phase II Recommended Phase 2 Dose||0
6816953|NCT01434602|7749396|FG001|STARTED|Phase II Recommended Phase 2 Dose||0
6816954|NCT01434602|7749397|FG002|STARTED|Phase II Recommended Phase 2 Dose||12
6816955|NCT01434602|7749398|FG003|STARTED|Phase II Recommended Phase 2 Dose||40
6816956|NCT01434602|7749399|FG004|STARTED|Phase II Recommended Phase 2 Dose||21
6816957|NCT01434602|7749395|FG000|COMPLETED|Phase II Recommended Phase 2 Dose||0
6816958|NCT01434602|7749396|FG001|COMPLETED|Phase II Recommended Phase 2 Dose||0
6816959|NCT01434602|7749397|FG002|COMPLETED|Phase II Recommended Phase 2 Dose||12
6816960|NCT01434602|7749398|FG003|COMPLETED|Phase II Recommended Phase 2 Dose||31
6816961|NCT01434602|7749399|FG004|COMPLETED|Phase II Recommended Phase 2 Dose||19
6816962|NCT01434602|7749395|FG000|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
6816963|NCT01434602|7749396|FG001|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
6816964|NCT01434602|7749397|FG002|NOT COMPLETED|Phase II Recommended Phase 2 Dose||0
6816965|NCT01434602|7749398|FG003|NOT COMPLETED|Phase II Recommended Phase 2 Dose||9
6816966|NCT01434602|7749399|FG004|NOT COMPLETED|Phase II Recommended Phase 2 Dose||2
6816967|NCT01411332|7749420|FG000|STARTED|Overall Study||10
6816968|NCT01411332|7749421|FG001|STARTED|Overall Study||9
6816969|NCT01411332|7749420|FG000|COMPLETED|Overall Study||8
6816970|NCT01411332|7749421|FG001|COMPLETED|Overall Study||7
6816971|NCT01411332|7749420|FG000|NOT COMPLETED|Overall Study||2
6816972|NCT01411332|7749421|FG001|NOT COMPLETED|Overall Study||2
6816973|NCT01399918|7749427|FG000|STARTED|Overall Study||57
6816974|NCT01399918|7749427|FG000|COMPLETED|Overall Study||55
6816975|NCT01399918|7749427|FG000|NOT COMPLETED|Overall Study||2
6816976|NCT01377753|7749431|FG000|STARTED|Overall Study||15
6816977|NCT01377753|7749431|FG000|COMPLETED|Overall Study||15
6816978|NCT01377753|7749431|FG000|NOT COMPLETED|Overall Study||0
6567959|NCT01834261|7491159|FG000|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
6567960|NCT01834261|7491160|FG001|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
6567961|NCT01834261|7491159|FG000|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
6816979|NCT01147653|7749437|FG000|STARTED|Year 1||32
6816980|NCT01147653|7749438|FG001|STARTED|Year 1||31
6816981|NCT01147653|7749437|FG000|COMPLETED|Year 1||32
6816982|NCT01147653|7749438|FG001|COMPLETED|Year 1||31
6816983|NCT01147653|7749437|FG000|NOT COMPLETED|Year 1||0
6816984|NCT01147653|7749438|FG001|NOT COMPLETED|Year 1||0
6816985|NCT01147653|7749437|FG000|STARTED|Year 2||32
6816986|NCT01147653|7749438|FG001|STARTED|Year 2||31
6816987|NCT01147653|7749437|FG000|COMPLETED|Year 2||30
6816988|NCT01147653|7749438|FG001|COMPLETED|Year 2||28
6816989|NCT01147653|7749437|FG000|NOT COMPLETED|Year 2||2
6816990|NCT01147653|7749438|FG001|NOT COMPLETED|Year 2||3
6816991|NCT01078454|7749458|FG000|STARTED|Overall Study||6
6816992|NCT01078454|7749459|FG001|STARTED|Overall Study||5
6567962|NCT01834261|7491160|FG001|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
6567963|NCT01834261|7491159|FG000|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
6567964|NCT01834261|7491160|FG001|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
6567965|NCT01834274|7491168|FG000|STARTED|Overall Study||50
6567966|NCT01834274|7491169|FG001|STARTED|Overall Study||46
6567967|NCT01834274|7491168|FG000|COMPLETED|Overall Study||3
6567968|NCT01834274|7491169|FG001|COMPLETED|Overall Study||5
6567969|NCT01834274|7491168|FG000|NOT COMPLETED|Overall Study||47
6567970|NCT01834274|7491169|FG001|NOT COMPLETED|Overall Study||41
6567971|NCT01834326|7491177|FG000|STARTED|Overall Study||10
6567972|NCT01834326|7491178|FG001|STARTED|Overall Study||8
6657149|NCT02466646|7587433|FG002|COMPLETED|Overall Study||14
6657150|NCT02466646|7587431|FG000|NOT COMPLETED|Overall Study||0
6657151|NCT02466646|7587432|FG001|NOT COMPLETED|Overall Study||0
6657152|NCT02466646|7587433|FG002|NOT COMPLETED|Overall Study||0
6657153|NCT02466659|7587446|FG000|STARTED|Overall Study||5
6657154|NCT02466659|7587447|FG001|STARTED|Overall Study||3
6657155|NCT02466659|7587446|FG000|COMPLETED|Overall Study||0
6657156|NCT02466659|7587447|FG001|COMPLETED|Overall Study||1
6657157|NCT02466659|7587446|FG000|NOT COMPLETED|Overall Study||5
6657158|NCT02466659|7587447|FG001|NOT COMPLETED|Overall Study||2
6657159|NCT02466958|7587455|FG000|STARTED|Overall Study||17
6657160|NCT02466958|7587456|FG001|STARTED|Overall Study||12
6657161|NCT02466958|7587455|FG000|COMPLETED|Overall Study||7
6657162|NCT02466958|7587456|FG001|COMPLETED|Overall Study||9
6657163|NCT02466958|7587455|FG000|NOT COMPLETED|Overall Study||10
6657164|NCT02466958|7587456|FG001|NOT COMPLETED|Overall Study||3
6657165|NCT02467075|7587464|FG000|STARTED|Initial CT Scan||0
6657166|NCT02467075|7587465|FG001|STARTED|Initial CT Scan||1
6657167|NCT02467075|7587464|FG000|COMPLETED|Initial CT Scan||0
6816993|NCT01078454|7749458|FG000|COMPLETED|Overall Study||5
6816994|NCT01078454|7749459|FG001|COMPLETED|Overall Study||3
6816995|NCT01078454|7749458|FG000|NOT COMPLETED|Overall Study||1
6816996|NCT01078454|7749459|FG001|NOT COMPLETED|Overall Study||2
6816997|NCT00687596|7749467|FG000|STARTED|Overall Study||26
6816998|NCT00687596|7749468|FG001|STARTED|Overall Study||26
6816999|NCT00687596|7749467|FG000|COMPLETED|Overall Study||0
6817000|NCT00687596|7749468|FG001|COMPLETED|Overall Study||0
6817001|NCT00687596|7749467|FG000|NOT COMPLETED|Overall Study||26
6817002|NCT00687596|7749468|FG001|NOT COMPLETED|Overall Study||26
6657168|NCT02467075|7587465|FG001|COMPLETED|Initial CT Scan||1
6657169|NCT02467075|7587464|FG000|NOT COMPLETED|Initial CT Scan||0
6817003|NCT00458536|7749474|FG000|STARTED|Overall Study||38
6817004|NCT00458536|7749474|FG000|COMPLETED|Overall Study||19
6817005|NCT00458536|7749474|FG000|NOT COMPLETED|Overall Study||19
6817006|NCT00112840|7749481|FG000|STARTED|Overall Study||8
6817007|NCT00112840|7749482|FG001|STARTED|Overall Study||6
6817008|NCT00112840|7749483|FG002|STARTED|Overall Study||46
6817009|NCT00112840|7749481|FG000|COMPLETED|Overall Study||6
6817010|NCT00112840|7749482|FG001|COMPLETED|Overall Study||6
6817011|NCT00112840|7749483|FG002|COMPLETED|Overall Study||40
6817012|NCT00112840|7749481|FG000|NOT COMPLETED|Overall Study||2
6817013|NCT00112840|7749482|FG001|NOT COMPLETED|Overall Study||0
6817014|NCT00112840|7749483|FG002|NOT COMPLETED|Overall Study||6
6657170|NCT02467075|7587465|FG001|NOT COMPLETED|Initial CT Scan||0
6657171|NCT02467075|7587464|FG000|STARTED|48 Hour Follow-up||0
6657172|NCT02467075|7587465|FG001|STARTED|48 Hour Follow-up||1
6657173|NCT02467075|7587464|FG000|COMPLETED|48 Hour Follow-up||0
6657174|NCT02467075|7587465|FG001|COMPLETED|48 Hour Follow-up||1
6657175|NCT02467075|7587464|FG000|NOT COMPLETED|48 Hour Follow-up||0
6657176|NCT02467075|7587465|FG001|NOT COMPLETED|48 Hour Follow-up||0
6657177|NCT02467075|7587464|FG000|STARTED|72 Hour Follow-up||0
6817015|NCT04957732|7749498|FG000|STARTED|Overall Study||19
6817016|NCT04957732|7749499|FG001|STARTED|Overall Study||16
6817017|NCT04957732|7749498|FG000|COMPLETED|Overall Study||18
6817018|NCT04957732|7749499|FG001|COMPLETED|Overall Study||12
6817019|NCT04957732|7749498|FG000|NOT COMPLETED|Overall Study||1
6817020|NCT04957732|7749499|FG001|NOT COMPLETED|Overall Study||4
6817021|NCT04207749|7749512|FG000|STARTED|Overall Study||78
6817022|NCT04207749|7749513|FG001|STARTED|Overall Study||156
6817023|NCT04207749|7749512|FG000|COMPLETED|Overall Study||74
6817024|NCT04207749|7749513|FG001|COMPLETED|Overall Study||149
6817025|NCT04207749|7749512|FG000|NOT COMPLETED|Overall Study||4
6817026|NCT04207749|7749513|FG001|NOT COMPLETED|Overall Study||7
6817027|NCT04167345|7749527|FG000|STARTED|Overall Study||10
6817028|NCT04167345|7749528|FG001|STARTED|Overall Study||4
6817029|NCT04167345|7749529|FG002|STARTED|Overall Study||3
6817030|NCT04167345|7749530|FG003|STARTED|Overall Study||13
6817031|NCT04167345|7749531|FG004|STARTED|Overall Study||18
6817032|NCT04167345|7749527|FG000|COMPLETED|Overall Study||9
6817033|NCT04167345|7749528|FG001|COMPLETED|Overall Study||3
6817034|NCT04167345|7749529|FG002|COMPLETED|Overall Study||3
6817035|NCT04167345|7749530|FG003|COMPLETED|Overall Study||13
6817036|NCT04167345|7749531|FG004|COMPLETED|Overall Study||18
6817037|NCT04167345|7749527|FG000|NOT COMPLETED|Overall Study||1
6817038|NCT04167345|7749528|FG001|NOT COMPLETED|Overall Study||1
6817039|NCT04167345|7749529|FG002|NOT COMPLETED|Overall Study||0
6817040|NCT04167345|7749530|FG003|NOT COMPLETED|Overall Study||0
6817041|NCT04167345|7749531|FG004|NOT COMPLETED|Overall Study||0
6817042|NCT04042077|7749549|FG000|STARTED|Overall Study||134
6817043|NCT04042077|7749550|FG001|STARTED|Overall Study||132
6817044|NCT04042077|7749549|FG000|Vancomycin IV|Overall Study||0
6817045|NCT04042077|7749550|FG001|Vancomycin IV|Overall Study||2
6817046|NCT04042077|7749549|FG000|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||0
6817047|NCT04042077|7749550|FG001|Linezolid IV, With the Option to Switch to Linezolid Oral|Overall Study||8
6817048|NCT04042077|7749549|FG000|Piperacillin/Tazobactam IV|Overall Study||0
6817049|NCT04042077|7749550|FG001|Piperacillin/Tazobactam IV|Overall Study||68
6817050|NCT04042077|7749549|FG000|Tigecycline IV|Overall Study||0
6817051|NCT04042077|7749550|FG001|Tigecycline IV|Overall Study||54
6817052|NCT04042077|7749549|FG000|COMPLETED|Overall Study||127
6817053|NCT04042077|7749550|FG001|COMPLETED|Overall Study||127
6817054|NCT04042077|7749549|FG000|NOT COMPLETED|Overall Study||7
6276000|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
6276001|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
6276002|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 241 - 288||110
6276003|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 241 - 288||64
6276004|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 241 - 288||104
6276005|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 241 - 288||64
6276006|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
6276007|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
6391116|NCT00833833|7302941|FG005|COMPLETED|Phase 1 (as of 01 April 2011)||0
6567973|NCT01834326|7491177|FG000|COMPLETED|Overall Study||8
6567974|NCT01834326|7491178|FG001|COMPLETED|Overall Study||2
6567975|NCT01834326|7491177|FG000|NOT COMPLETED|Overall Study||2
6567976|NCT01834326|7491178|FG001|NOT COMPLETED|Overall Study||6
6567977|NCT01834404|7491186|FG000|STARTED|Overall Study||12
6567978|NCT01834404|7491187|FG001|STARTED|Overall Study||12
6567979|NCT01834404|7491186|FG000|COMPLETED|Overall Study||12
6567980|NCT01834404|7491187|FG001|COMPLETED|Overall Study||12
6567981|NCT01834404|7491186|FG000|NOT COMPLETED|Overall Study||0
6567982|NCT01834404|7491187|FG001|NOT COMPLETED|Overall Study||0
6567983|NCT01834586|7491193|FG000|STARTED|Overall Study||30
6567984|NCT01834586|7491193|FG000|COMPLETED|Overall Study||29
6567985|NCT01834586|7491193|FG000|NOT COMPLETED|Overall Study||1
6567986|NCT01834651|7491197|FG000|STARTED|Overall Study||17
6567987|NCT01834651|7491197|FG000|COMPLETED|Overall Study|Evaluable for primary outcome assessment at 12 weeks|16
6567988|NCT01834651|7491197|FG000|NOT COMPLETED|Overall Study||1
6567989|NCT01834716|7491205|FG000|STARTED|Overall Study||4
6567990|NCT01834716|7491206|FG001|STARTED|Overall Study||12
6567991|NCT01834716|7491205|FG000|COMPLETED|Overall Study||4
6567992|NCT01834716|7491206|FG001|COMPLETED|Overall Study||11
6567993|NCT01834716|7491205|FG000|NOT COMPLETED|Overall Study||0
6567994|NCT01834716|7491206|FG001|NOT COMPLETED|Overall Study||1
6567995|NCT01834729|7491216|FG000|STARTED|Overall Study||18
6567996|NCT01834729|7491217|FG001|STARTED|Overall Study||20
6567997|NCT01834729|7491218|FG002|STARTED|Overall Study||18
6567998|NCT01834729|7491219|FG003|STARTED|Overall Study||18
6567999|NCT01834729|7491216|FG000|COMPLETED|Overall Study||17
6568000|NCT01834729|7491217|FG001|COMPLETED|Overall Study||19
6568001|NCT01834729|7491218|FG002|COMPLETED|Overall Study||15
6568002|NCT01834729|7491219|FG003|COMPLETED|Overall Study||16
6568003|NCT01834729|7491216|FG000|NOT COMPLETED|Overall Study||1
6817055|NCT04042077|7749550|FG001|NOT COMPLETED|Overall Study||5
6817056|NCT04001803|7749562|FG000|STARTED|Overall Study||115
6817057|NCT04001803|7749562|FG000|COMPLETED|Overall Study||1
6817058|NCT04001803|7749562|FG000|NOT COMPLETED|Overall Study||114
6817059|NCT03936699|7749569|FG000|STARTED|Overall Study||83
6817060|NCT03936699|7749570|FG001|STARTED|Overall Study||78
6817061|NCT03936699|7749569|FG000|COMPLETED|Overall Study||61
6817062|NCT03936699|7749570|FG001|COMPLETED|Overall Study||55
6817063|NCT03936699|7749569|FG000|NOT COMPLETED|Overall Study||22
6817064|NCT03936699|7749570|FG001|NOT COMPLETED|Overall Study||23
6817065|NCT03925324|7749578|FG000|STARTED|Overall Study||2
6817066|NCT03925324|7749579|FG001|STARTED|Overall Study||2
6817067|NCT03925324|7749578|FG000|COMPLETED|Overall Study||1
6817068|NCT03925324|7749579|FG001|COMPLETED|Overall Study||1
6817069|NCT03925324|7749578|FG000|NOT COMPLETED|Overall Study||1
6817070|NCT03925324|7749579|FG001|NOT COMPLETED|Overall Study||1
6817071|NCT03875092|7749587|FG000|STARTED|Overall Study||65
6817072|NCT03875092|7749588|FG001|STARTED|Overall Study||60
6817073|NCT03875092|7749587|FG000|Treated|Overall Study||65
6817074|NCT03875092|7749588|FG001|Treated|Overall Study||60
6817075|NCT03875092|7749587|FG000|Switched to Pembrolizumab+Chemotherapy|Overall Study||0
6817076|NCT03875092|7749588|FG001|Switched to Pembrolizumab+Chemotherapy|Overall Study||38
6817077|NCT03875092|7749587|FG000|COMPLETED|Overall Study||0
6817078|NCT03875092|7749588|FG001|COMPLETED|Overall Study||0
6817079|NCT03875092|7749587|FG000|NOT COMPLETED|Overall Study||65
6817080|NCT03875092|7749588|FG001|NOT COMPLETED|Overall Study||60
6817081|NCT03814382|7749594|FG000|STARTED|Overall Study||10
6817082|NCT03814382|7749594|FG000|COMPLETED|Overall Study||10
6817083|NCT03814382|7749594|FG000|NOT COMPLETED|Overall Study||0
6817084|NCT03738397|7749600|FG000|STARTED|Overall Study||344
6817085|NCT03738397|7749601|FG001|STARTED|Overall Study||348
6817086|NCT03738397|7749600|FG000|COMPLETED|Overall Study||320
6817087|NCT03738397|7749601|FG001|COMPLETED|Overall Study||318
6817088|NCT03738397|7749600|FG000|NOT COMPLETED|Overall Study||24
6817089|NCT03738397|7749601|FG001|NOT COMPLETED|Overall Study||30
6817090|NCT03666624|7749609|FG000|STARTED|Overall Study||15
6817091|NCT03666624|7749610|FG001|STARTED|Overall Study||15
6817092|NCT03666624|7749609|FG000|COMPLETED|Overall Study||14
6817093|NCT03666624|7749610|FG001|COMPLETED|Overall Study||15
6817094|NCT03666624|7749609|FG000|NOT COMPLETED|Overall Study||1
6817095|NCT03666624|7749610|FG001|NOT COMPLETED|Overall Study||0
6817096|NCT03649217|7749616|FG000|STARTED|Overall Study||23
6817097|NCT03649217|7749616|FG000|COMPLETED|Overall Study||21
6817098|NCT03649217|7749616|FG000|NOT COMPLETED|Overall Study||2
6817099|NCT03576976|7749622|FG000|STARTED|Overall Study||27
6817100|NCT03576976|7749623|FG001|STARTED|Overall Study||28
6817101|NCT03576976|7749622|FG000|COMPLETED|Overall Study||18
6817102|NCT03576976|7749623|FG001|COMPLETED|Overall Study||17
6817103|NCT03576976|7749622|FG000|NOT COMPLETED|Overall Study||9
6817104|NCT03576976|7749623|FG001|NOT COMPLETED|Overall Study||11
6568004|NCT01834729|7491217|FG001|NOT COMPLETED|Overall Study||1
6657178|NCT02467075|7587465|FG001|STARTED|72 Hour Follow-up||1
6391117|NCT00833833|7302936|FG000|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
6391118|NCT00833833|7302937|FG001|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
6391119|NCT00833833|7302938|FG002|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
6391120|NCT00833833|7302939|FG003|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
6391121|NCT00833833|7302940|FG004|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
6391122|NCT00833833|7302941|FG005|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
6391123|NCT00833833|7302936|FG000|STARTED|Phase 2 (as of 01 April 2011)||0
6391124|NCT00833833|7302937|FG001|STARTED|Phase 2 (as of 01 April 2011)||0
6391125|NCT00833833|7302938|FG002|STARTED|Phase 2 (as of 01 April 2011)||0
6391126|NCT00833833|7302939|FG003|STARTED|Phase 2 (as of 01 April 2011)||0
6391127|NCT00833833|7302940|FG004|STARTED|Phase 2 (as of 01 April 2011)||113
6391128|NCT00833833|7302941|FG005|STARTED|Phase 2 (as of 01 April 2011)||108
6391129|NCT00833833|7302936|FG000|Safety Population|Phase 2 (as of 01 April 2011)||0
6391130|NCT00833833|7302937|FG001|Safety Population|Phase 2 (as of 01 April 2011)||0
6391131|NCT00833833|7302938|FG002|Safety Population|Phase 2 (as of 01 April 2011)||0
6391132|NCT00833833|7302939|FG003|Safety Population|Phase 2 (as of 01 April 2011)||0
6391133|NCT00833833|7302940|FG004|Safety Population|Phase 2 (as of 01 April 2011)||112
6391134|NCT00833833|7302941|FG005|Safety Population|Phase 2 (as of 01 April 2011)||107
6568005|NCT01834729|7491218|FG002|NOT COMPLETED|Overall Study||3
6817105|NCT03569293|7749635|FG000|STARTED|Overall Study||241
6817106|NCT03569293|7749636|FG001|STARTED|Overall Study||239
6817107|NCT03569293|7749637|FG002|STARTED|Overall Study||243
6817108|NCT03569293|7749638|FG003|STARTED|Overall Study||61
6817109|NCT03569293|7749639|FG004|STARTED|Overall Study||64
6817110|NCT03569293|7749640|FG005|STARTED|Overall Study||64
6817111|NCT03569293|7749635|FG000|Received Study Drug|Overall Study||241
6817112|NCT03569293|7749636|FG001|Received Study Drug|Overall Study||239
6817113|NCT03569293|7749637|FG002|Received Study Drug|Overall Study||243
6817114|NCT03569293|7749638|FG003|Received Study Drug|Overall Study||61
6817115|NCT03569293|7749639|FG004|Received Study Drug|Overall Study||64
6817116|NCT03569293|7749640|FG005|Received Study Drug|Overall Study||64
6817117|NCT03569293|7749635|FG000|COMPLETED|Overall Study||204
6817118|NCT03569293|7749636|FG001|COMPLETED|Overall Study||230
6817119|NCT03569293|7749637|FG002|COMPLETED|Overall Study||229
6817120|NCT03569293|7749638|FG003|COMPLETED|Overall Study||57
6817121|NCT03569293|7749639|FG004|COMPLETED|Overall Study||64
6817122|NCT03569293|7749640|FG005|COMPLETED|Overall Study||64
6817123|NCT03569293|7749635|FG000|NOT COMPLETED|Overall Study||37
6817124|NCT03569293|7749636|FG001|NOT COMPLETED|Overall Study||9
6817125|NCT03569293|7749637|FG002|NOT COMPLETED|Overall Study||14
6817126|NCT03569293|7749638|FG003|NOT COMPLETED|Overall Study||4
6817127|NCT03569293|7749639|FG004|NOT COMPLETED|Overall Study||0
6817128|NCT03569293|7749640|FG005|NOT COMPLETED|Overall Study||0
6817129|NCT03564353|7749658|FG000|STARTED|Overall Study||10
6817130|NCT03564353|7749659|FG001|STARTED|Overall Study||10
6568006|NCT01834729|7491219|FG003|NOT COMPLETED|Overall Study||2
6568007|NCT01835015|7491235|FG000|STARTED|Overall Study||6
6568008|NCT01835015|7491236|FG001|STARTED|Overall Study||6
6568009|NCT01835015|7491237|FG002|STARTED|Overall Study||7
6568010|NCT01835015|7491238|FG003|STARTED|Overall Study||6
6568011|NCT01835015|7491239|FG004|STARTED|Overall Study||6
6817131|NCT03564353|7749660|FG002|STARTED|Overall Study||10
6817132|NCT03564353|7749661|FG003|STARTED|Overall Study||10
6817133|NCT03564353|7749658|FG000|COMPLETED|Overall Study||10
6817134|NCT03564353|7749659|FG001|COMPLETED|Overall Study||10
6817135|NCT03564353|7749660|FG002|COMPLETED|Overall Study||10
6817136|NCT03564353|7749661|FG003|COMPLETED|Overall Study||10
6817137|NCT03564353|7749658|FG000|NOT COMPLETED|Overall Study||0
6817138|NCT03564353|7749659|FG001|NOT COMPLETED|Overall Study||0
6817139|NCT03564353|7749660|FG002|NOT COMPLETED|Overall Study||0
6817140|NCT03564353|7749661|FG003|NOT COMPLETED|Overall Study||0
6817141|NCT03541499|7749675|FG000|STARTED|Overall Study||15
6817142|NCT03541499|7749676|FG001|STARTED|Overall Study||15
6817143|NCT03541499|7749677|FG002|STARTED|Overall Study||5
6817144|NCT03541499|7749678|FG003|STARTED|Overall Study||15
6817145|NCT03541499|7749675|FG000|COMPLETED|Overall Study||15
6817146|NCT03541499|7749676|FG001|COMPLETED|Overall Study||15
6817147|NCT03541499|7749677|FG002|COMPLETED|Overall Study||5
6817148|NCT03541499|7749678|FG003|COMPLETED|Overall Study||15
6817149|NCT03541499|7749675|FG000|NOT COMPLETED|Overall Study||0
6817150|NCT03541499|7749676|FG001|NOT COMPLETED|Overall Study||0
6817151|NCT03541499|7749677|FG002|NOT COMPLETED|Overall Study||0
6817152|NCT03541499|7749678|FG003|NOT COMPLETED|Overall Study||0
6568012|NCT01835015|7491235|FG000|COMPLETED|Overall Study||6
6817153|NCT03473977|7749690|FG000|STARTED|Overall Study||13
6817154|NCT03473977|7749691|FG001|STARTED|Overall Study||13
6817155|NCT03473977|7749690|FG000|COMPLETED|Overall Study||13
6817156|NCT03473977|7749691|FG001|COMPLETED|Overall Study||13
6817157|NCT03473977|7749690|FG000|NOT COMPLETED|Overall Study||0
6817158|NCT03473977|7749691|FG001|NOT COMPLETED|Overall Study||0
6817159|NCT03373110|7749700|FG000|STARTED|Overall Study||133
6817160|NCT03373110|7749701|FG001|STARTED|Overall Study||137
6817161|NCT03373110|7749702|FG002|STARTED|Overall Study||70
6817162|NCT03373110|7749700|FG000|Provided Fitbit Data|Overall Study||123
6817163|NCT03373110|7749701|FG001|Provided Fitbit Data|Overall Study||130
6817164|NCT03373110|7749702|FG002|Provided Fitbit Data|Overall Study||63
6817165|NCT03373110|7749700|FG000|COMPLETED|Overall Study||55
6817166|NCT03373110|7749701|FG001|COMPLETED|Overall Study||58
6817167|NCT03373110|7749702|FG002|COMPLETED|Overall Study||26
6817168|NCT03373110|7749700|FG000|NOT COMPLETED|Overall Study||78
6817169|NCT03373110|7749701|FG001|NOT COMPLETED|Overall Study||79
6817170|NCT03373110|7749702|FG002|NOT COMPLETED|Overall Study||44
6817171|NCT03365102|7749713|FG000|STARTED|Overall Study||22
6817172|NCT03365102|7749714|FG001|STARTED|Overall Study||22
6817173|NCT03365102|7749715|FG002|STARTED|Overall Study||20
6817174|NCT03365102|7749713|FG000|COMPLETED|Overall Study||18
6817175|NCT03365102|7749714|FG001|COMPLETED|Overall Study||21
6817176|NCT03365102|7749715|FG002|COMPLETED|Overall Study||19
6817177|NCT03365102|7749713|FG000|NOT COMPLETED|Overall Study||4
6817178|NCT03365102|7749714|FG001|NOT COMPLETED|Overall Study||1
6817179|NCT03365102|7749715|FG002|NOT COMPLETED|Overall Study||1
6817180|NCT03318003|7749725|FG000|STARTED|Overall Study||21
6817181|NCT03318003|7749726|FG001|STARTED|Overall Study||22
6817182|NCT03318003|7749725|FG000|COMPLETED|Overall Study|completed means the presence of 3rd trimester ultrasound and delivery information.|20
6817183|NCT03318003|7749726|FG001|COMPLETED|Overall Study||20
6817184|NCT03318003|7749725|FG000|NOT COMPLETED|Overall Study||1
6817185|NCT03318003|7749726|FG001|NOT COMPLETED|Overall Study||2
6817186|NCT03309072|7749734|FG000|STARTED|Overall Study||15
6817187|NCT03309072|7749735|FG001|STARTED|Overall Study||15
6817188|NCT03309072|7749734|FG000|COMPLETED|Overall Study||15
6817189|NCT03309072|7749735|FG001|COMPLETED|Overall Study||15
6817190|NCT03309072|7749734|FG000|NOT COMPLETED|Overall Study||0
6817191|NCT03309072|7749735|FG001|NOT COMPLETED|Overall Study||0
6817192|NCT03216499|7749741|FG000|STARTED|Overall Study||24
6817193|NCT03216499|7749741|FG000|COMPLETED|Overall Study||24
6568013|NCT01835015|7491236|FG001|COMPLETED|Overall Study||6
6568014|NCT01835015|7491237|FG002|COMPLETED|Overall Study||6
6568015|NCT01835015|7491238|FG003|COMPLETED|Overall Study||6
6817194|NCT03216499|7749741|FG000|NOT COMPLETED|Overall Study||0
6817195|NCT03138590|7749747|FG000|STARTED|Overall Study||10
6817196|NCT03138590|7749748|FG001|STARTED|Overall Study||10
6817197|NCT03138590|7749747|FG000|COMPLETED|Overall Study||10
6817198|NCT03138590|7749748|FG001|COMPLETED|Overall Study||10
6817199|NCT03138590|7749747|FG000|NOT COMPLETED|Overall Study||0
6817200|NCT03138590|7749748|FG001|NOT COMPLETED|Overall Study||0
6817201|NCT03132753|7749756|FG000|STARTED|Baseline - 6 Month Follow-Up||46
6817202|NCT03132753|7749757|FG001|STARTED|Baseline - 6 Month Follow-Up||54
6817203|NCT03132753|7749756|FG000|COMPLETED|Baseline - 6 Month Follow-Up||19
6817204|NCT03132753|7749757|FG001|COMPLETED|Baseline - 6 Month Follow-Up||22
6817205|NCT03132753|7749756|FG000|NOT COMPLETED|Baseline - 6 Month Follow-Up||27
6817206|NCT03132753|7749757|FG001|NOT COMPLETED|Baseline - 6 Month Follow-Up||32
6817207|NCT03132753|7749756|FG000|STARTED|6 Month Follow-Up - 12 Month Follow-Up||19
6817208|NCT03132753|7749757|FG001|STARTED|6 Month Follow-Up - 12 Month Follow-Up||22
6817209|NCT03132753|7749756|FG000|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||13
6817210|NCT03132753|7749757|FG001|COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||20
6817211|NCT03132753|7749756|FG000|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||6
6817212|NCT03132753|7749757|FG001|NOT COMPLETED|6 Month Follow-Up - 12 Month Follow-Up||2
6817213|NCT03085680|7749765|FG000|STARTED|Overall Study||9
6817214|NCT03085680|7749766|FG001|STARTED|Overall Study||8
6817215|NCT03085680|7749765|FG000|COMPLETED|Overall Study||9
6817216|NCT03085680|7749766|FG001|COMPLETED|Overall Study||8
6817217|NCT03085680|7749765|FG000|NOT COMPLETED|Overall Study||0
6817218|NCT03085680|7749766|FG001|NOT COMPLETED|Overall Study||0
6817219|NCT03067077|7749772|FG000|STARTED|Overall Study||44
6817220|NCT03067077|7749773|FG001|STARTED|Overall Study||44
6568016|NCT01835015|7491239|FG004|COMPLETED|Overall Study||6
6568017|NCT01835015|7491235|FG000|NOT COMPLETED|Overall Study||0
6817221|NCT03067077|7749772|FG000|Received Surgery|Overall Study||40
6817222|NCT03067077|7749773|FG001|Received Surgery|Overall Study||39
6817223|NCT03067077|7749772|FG000|COMPLETED|Overall Study||37
6817224|NCT03067077|7749773|FG001|COMPLETED|Overall Study||37
6817225|NCT03067077|7749772|FG000|NOT COMPLETED|Overall Study||7
6817226|NCT03067077|7749773|FG001|NOT COMPLETED|Overall Study||7
6817227|NCT03059446|7749779|FG000|STARTED|Overall Study||167
6817228|NCT03059446|7749779|FG000|COMPLETED|Overall Study||0
6817229|NCT03059446|7749779|FG000|NOT COMPLETED|Overall Study||167
6817230|NCT03035409|7749783|FG000|STARTED|Overall Study||45
6817231|NCT03035409|7749783|FG000|Day 15|Overall Study||28
6817232|NCT03035409|7749783|FG000|Day 29|Overall Study||28
6817233|NCT03035409|7749783|FG000|Day 43|Overall Study||28
6817234|NCT03035409|7749783|FG000|COMPLETED|Overall Study||28
6817235|NCT03035409|7749783|FG000|NOT COMPLETED|Overall Study||17
6817236|NCT03019575|7749787|FG000|STARTED|Overall Study||17
6817237|NCT03019575|7749787|FG000|COMPLETED|Overall Study||17
6817238|NCT03019575|7749787|FG000|NOT COMPLETED|Overall Study||0
6568018|NCT01835015|7491236|FG001|NOT COMPLETED|Overall Study||0
6568019|NCT01835015|7491237|FG002|NOT COMPLETED|Overall Study||1
6568020|NCT01835015|7491238|FG003|NOT COMPLETED|Overall Study||0
6817239|NCT03011034|7749793|FG000|STARTED|Overall Study||1
6817240|NCT03011034|7749794|FG001|STARTED|Overall Study||33
6817241|NCT03011034|7749793|FG000|COMPLETED|Overall Study||0
6817242|NCT03011034|7749794|FG001|COMPLETED|Overall Study||33
6817243|NCT03011034|7749793|FG000|NOT COMPLETED|Overall Study||1
6817244|NCT03011034|7749794|FG001|NOT COMPLETED|Overall Study||0
6817245|NCT02980666|7749802|FG000|STARTED|Overall Study||8
6817246|NCT02980666|7749803|FG001|STARTED|Overall Study||2
6817247|NCT02980666|7749802|FG000|COMPLETED|Overall Study||8
6817248|NCT02980666|7749803|FG001|COMPLETED|Overall Study||2
6817249|NCT02980666|7749802|FG000|NOT COMPLETED|Overall Study||0
6817250|NCT02980666|7749803|FG001|NOT COMPLETED|Overall Study||0
6817251|NCT02962102|7749812|FG000|STARTED|Overall Study||51
6817252|NCT02962102|7749813|FG001|STARTED|Overall Study||50
6817253|NCT02962102|7749814|FG002|STARTED|Overall Study||49
6817254|NCT02962102|7749812|FG000|COMPLETED|Overall Study||51
6817255|NCT02962102|7749813|FG001|COMPLETED|Overall Study||50
6817256|NCT02962102|7749814|FG002|COMPLETED|Overall Study||49
6817257|NCT02962102|7749812|FG000|NOT COMPLETED|Overall Study||0
6817258|NCT02962102|7749813|FG001|NOT COMPLETED|Overall Study||0
6817259|NCT02962102|7749814|FG002|NOT COMPLETED|Overall Study||0
6817260|NCT02853331|7749824|FG000|STARTED|Overall Study||432
6817261|NCT02853331|7749825|FG001|STARTED|Overall Study||429
6817262|NCT02853331|7749824|FG000|Treated|Overall Study||429
6817263|NCT02853331|7749825|FG001|Treated|Overall Study||425
6817264|NCT02853331|7749824|FG000|COMPLETED|Overall Study||0
6817265|NCT02853331|7749825|FG001|COMPLETED|Overall Study||0
6817266|NCT02853331|7749824|FG000|NOT COMPLETED|Overall Study||432
6817267|NCT02853331|7749825|FG001|NOT COMPLETED|Overall Study||429
6817268|NCT02847637|7749835|FG000|STARTED|Overall Study||18
6817269|NCT02847637|7749836|FG001|STARTED|Overall Study||36
6817270|NCT02847637|7749837|FG002|STARTED|Overall Study||35
6817271|NCT02847637|7749838|FG003|STARTED|Overall Study||63
6817272|NCT02847637|7749835|FG000|Completed 24 Weeks on No Prophylaxis|Overall Study|One participant switched to emicizumab prior to completing 24 weeks No Prophylaxis (at 23.5 weeks).|16
6817273|NCT02847637|7749836|FG001|Completed 24 Weeks on No Prophylaxis|Overall Study||0
6568021|NCT01835015|7491239|FG004|NOT COMPLETED|Overall Study||0
6568022|NCT01835132|7491252|FG000|STARTED|Initial Phase||8
6568023|NCT01835132|7491252|FG000|COMPLETED|Initial Phase||6
6817274|NCT02847637|7749837|FG002|Completed 24 Weeks on No Prophylaxis|Overall Study||0
6817275|NCT02847637|7749838|FG003|Completed 24 Weeks on No Prophylaxis|Overall Study||0
6817276|NCT02847637|7749835|FG000|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||16
6817277|NCT02847637|7749836|FG001|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
6817278|NCT02847637|7749837|FG002|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
6817279|NCT02847637|7749838|FG003|Switched to Emicizumab 3 mg/kg/2 Weeks|Overall Study||0
6817280|NCT02847637|7749835|FG000|Completed 24 Weeks Emicizumab Treatment|Overall Study|Participants started on 24 weeks No Prophylaxis first before switching to emicizumab.|1
6817281|NCT02847637|7749836|FG001|Completed 24 Weeks Emicizumab Treatment|Overall Study||35
6817282|NCT02847637|7749837|FG002|Completed 24 Weeks Emicizumab Treatment|Overall Study||34
6817283|NCT02847637|7749838|FG003|Completed 24 Weeks Emicizumab Treatment|Overall Study||58
6817284|NCT02847637|7749835|FG000|COMPLETED|Overall Study||1
6817285|NCT02847637|7749836|FG001|COMPLETED|Overall Study||1
6817286|NCT02847637|7749837|FG002|COMPLETED|Overall Study||0
6817287|NCT02847637|7749838|FG003|COMPLETED|Overall Study||0
6817288|NCT02847637|7749835|FG000|NOT COMPLETED|Overall Study||17
6817289|NCT02847637|7749836|FG001|NOT COMPLETED|Overall Study||35
6817290|NCT02847637|7749837|FG002|NOT COMPLETED|Overall Study||35
6817291|NCT02847637|7749838|FG003|NOT COMPLETED|Overall Study||63
6817292|NCT02841644|7749860|FG000|STARTED|Overall Study||60
6817293|NCT02841644|7749861|FG001|STARTED|Overall Study||120
6817294|NCT02841644|7749860|FG000|COMPLETED|Overall Study||60
6817295|NCT02841644|7749861|FG001|COMPLETED|Overall Study||120
6817296|NCT02841644|7749860|FG000|NOT COMPLETED|Overall Study||0
6817297|NCT02841644|7749861|FG001|NOT COMPLETED|Overall Study||0
6568024|NCT01835132|7491252|FG000|NOT COMPLETED|Initial Phase||2
6568025|NCT01835132|7491252|FG000|STARTED|1st Extension Phase||6
6817298|NCT02749045|7749867|FG000|STARTED|Overall Study||27
6817299|NCT02749045|7749867|FG000|COMPLETED|Overall Study||27
6817300|NCT02749045|7749867|FG000|NOT COMPLETED|Overall Study||0
6817301|NCT02667587|7749873|FG000|STARTED|Pre-Treatment||358
6817302|NCT02667587|7749874|FG001|STARTED|Pre-Treatment||358
6817303|NCT02667587|7749873|FG000|COMPLETED|Pre-Treatment||354
6817304|NCT02667587|7749874|FG001|COMPLETED|Pre-Treatment||355
6817305|NCT02667587|7749873|FG000|NOT COMPLETED|Pre-Treatment||4
6817306|NCT02667587|7749874|FG001|NOT COMPLETED|Pre-Treatment||3
6817307|NCT02667587|7749873|FG000|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|355
6817308|NCT02667587|7749874|FG001|STARTED|End of Treatment|1 participant was randomized to Radiotherapy, Temozolomide plus Placebo but received Radiotherapy, Temozolomide plus Nivolumab.|354
6817309|NCT02667587|7749873|FG000|COMPLETED|End of Treatment||37
6817310|NCT02667587|7749874|FG001|COMPLETED|End of Treatment||44
6817311|NCT02667587|7749873|FG000|NOT COMPLETED|End of Treatment||318
6817312|NCT02667587|7749874|FG001|NOT COMPLETED|End of Treatment||310
6817313|NCT02659605|7749882|FG000|STARTED|Overall Study||40
6817314|NCT02659605|7749883|FG001|STARTED|Overall Study||34
6276008|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 289 - 336||104
6276009|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 289 - 336||64
6276010|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 289 - 336||98
6276011|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 289 - 336||57
6276012|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
6276013|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
6276014|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 337 - 384||98
6276015|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 337 - 384||57
6276016|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 337 - 384||90
6276017|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 337 - 384||56
6276018|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
6276019|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
6276020|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
6276021|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
6276022|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 385 - 432||57
6276023|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 385 - 432||30
6276024|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
6276025|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
6276026|NCT00116805|7175245|FG000|STARTED|Open-label Period Weeks 433 - 480||57
6276027|NCT00116805|7175246|FG001|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
6276028|NCT00116805|7175245|FG000|COMPLETED|Open-label Period Weeks 433 - 480||53
6276029|NCT00116805|7175246|FG001|COMPLETED|Open-label Period Weeks 433 - 480||29
6276030|NCT00116805|7175245|FG000|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
6276031|NCT00116805|7175246|FG001|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
6276032|NCT00116831|7175263|FG000|STARTED|Overall Study||337
6276033|NCT00116831|7175264|FG001|STARTED|Overall Study||331
6276034|NCT00116831|7175263|FG000|COMPLETED|Overall Study||264
6276035|NCT00116831|7175264|FG001|COMPLETED|Overall Study||259
6276036|NCT00116831|7175263|FG000|NOT COMPLETED|Overall Study||73
6276037|NCT00116831|7175264|FG001|NOT COMPLETED|Overall Study||72
6276038|NCT00116844|7175272|FG000|STARTED|Period 1: Treatment Period 1 (60 Days)||35
6276039|NCT00116844|7175273|FG001|STARTED|Period 1: Treatment Period 1 (60 Days)||36
6276040|NCT00116844|7175272|FG000|COMPLETED|Period 1: Treatment Period 1 (60 Days)||28
6276041|NCT00116844|7175273|FG001|COMPLETED|Period 1: Treatment Period 1 (60 Days)||33
6276042|NCT00116844|7175272|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||7
6276043|NCT00116844|7175273|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (60 Days)||3
6276044|NCT00116844|7175272|FG000|STARTED|Period 2: Washout Period (7 Days)||28
6276045|NCT00116844|7175273|FG001|STARTED|Period 2: Washout Period (7 Days)||33
6276046|NCT00116844|7175272|FG000|COMPLETED|Period 2: Washout Period (7 Days)||28
6276047|NCT00116844|7175273|FG001|COMPLETED|Period 2: Washout Period (7 Days)||33
6276048|NCT00116844|7175272|FG000|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6276049|NCT00116844|7175273|FG001|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
6276050|NCT00116844|7175272|FG000|STARTED|Period 1: Treatment Period 2 (60 Days)||28
6276051|NCT00116844|7175273|FG001|STARTED|Period 1: Treatment Period 2 (60 Days)||33
6276052|NCT00116844|7175272|FG000|COMPLETED|Period 1: Treatment Period 2 (60 Days)||24
6276053|NCT00116844|7175273|FG001|COMPLETED|Period 1: Treatment Period 2 (60 Days)||28
6276054|NCT00116844|7175272|FG000|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||4
6276055|NCT00116844|7175273|FG001|NOT COMPLETED|Period 1: Treatment Period 2 (60 Days)||5
6276056|NCT00116857|7175281|FG000|STARTED|Overall Study||62
6276057|NCT00116857|7175282|FG001|STARTED|Overall Study||60
6276058|NCT00116857|7175281|FG000|COMPLETED|Overall Study||59
6817315|NCT02659605|7749882|FG000|COMPLETED|Overall Study||31
6817316|NCT02659605|7749883|FG001|COMPLETED|Overall Study||30
6817317|NCT02659605|7749882|FG000|NOT COMPLETED|Overall Study||9
6817318|NCT02659605|7749883|FG001|NOT COMPLETED|Overall Study||4
6817319|NCT02601014|7749891|FG000|STARTED|Overall Study||15
6817320|NCT02601014|7749892|FG001|STARTED|Overall Study||15
6817321|NCT02601014|7749891|FG000|COMPLETED|Overall Study||5
6817322|NCT02601014|7749892|FG001|COMPLETED|Overall Study||3
6817323|NCT02601014|7749891|FG000|NOT COMPLETED|Overall Study||10
6817324|NCT02601014|7749892|FG001|NOT COMPLETED|Overall Study||12
6817325|NCT02579096|7749900|FG000|STARTED|Phase 1, Weeks 0 - 24||468
6817326|NCT02579096|7749901|FG001|STARTED|Phase 1, Weeks 0 - 24||472
6817327|NCT02579096|7749900|FG000|COMPLETED|Phase 1, Weeks 0 - 24||411
6817328|NCT02579096|7749901|FG001|COMPLETED|Phase 1, Weeks 0 - 24||422
6817329|NCT02579096|7749900|FG000|NOT COMPLETED|Phase 1, Weeks 0 - 24||57
6817330|NCT02579096|7749901|FG001|NOT COMPLETED|Phase 1, Weeks 0 - 24||50
6817331|NCT02579096|7749900|FG000|STARTED|Phase 2, Weeks 25 - 48||411
6817332|NCT02579096|7749901|FG001|STARTED|Phase 2, Weeks 25 - 48||422
6817333|NCT02579096|7749900|FG000|COMPLETED|Phase 2, Weeks 25 - 48||389
6817334|NCT02579096|7749901|FG001|COMPLETED|Phase 2, Weeks 25 - 48||391
6817335|NCT02579096|7749900|FG000|NOT COMPLETED|Phase 2, Weeks 25 - 48||22
6817336|NCT02579096|7749901|FG001|NOT COMPLETED|Phase 2, Weeks 25 - 48||31
6817337|NCT02579096|7749900|FG000|STARTED|Phase 3, Weeks 49 - 72||389
6817338|NCT02579096|7749901|FG001|STARTED|Phase 3, Weeks 49 - 72||391
6817339|NCT02579096|7749900|FG000|COMPLETED|Phase 3, Weeks 49 - 72||367
6817340|NCT02579096|7749901|FG001|COMPLETED|Phase 3, Weeks 49 - 72||373
6817341|NCT02579096|7749900|FG000|NOT COMPLETED|Phase 3, Weeks 49 - 72||22
6817342|NCT02579096|7749901|FG001|NOT COMPLETED|Phase 3, Weeks 49 - 72||18
6817343|NCT02538666|7749910|FG000|STARTED|Overall Study||275
6817344|NCT02538666|7749911|FG001|STARTED|Overall Study||280
6817345|NCT02538666|7749912|FG002|STARTED|Overall Study||279
6817346|NCT02538666|7749910|FG000|COMPLETED|Overall Study||273
6817347|NCT02538666|7749911|FG001|COMPLETED|Overall Study||279
6817348|NCT02538666|7749912|FG002|COMPLETED|Overall Study||278
6817349|NCT02538666|7749910|FG000|NOT COMPLETED|Overall Study||2
6817350|NCT02538666|7749911|FG001|NOT COMPLETED|Overall Study||1
6817351|NCT02538666|7749912|FG002|NOT COMPLETED|Overall Study||1
6817352|NCT02527200|7749925|FG000|STARTED|Overall Study||20
6817353|NCT02527200|7749926|FG001|STARTED|Overall Study||12
6817354|NCT02527200|7749927|FG002|STARTED|Overall Study||17
6817355|NCT02527200|7749928|FG003|STARTED|Overall Study||7
6817356|NCT02527200|7749925|FG000|Safety Analysis Set (SAS)|Overall Study||20
6817357|NCT02527200|7749926|FG001|Safety Analysis Set (SAS)|Overall Study||12
6817358|NCT02527200|7749927|FG002|Safety Analysis Set (SAS)|Overall Study||17
6817359|NCT02527200|7749928|FG003|Safety Analysis Set (SAS)|Overall Study||7
6817360|NCT02527200|7749925|FG000|Full Analysis Set (FAS)|Overall Study||19
6817361|NCT02527200|7749926|FG001|Full Analysis Set (FAS)|Overall Study||12
6817362|NCT02527200|7749927|FG002|Full Analysis Set (FAS)|Overall Study||17
6817363|NCT02527200|7749928|FG003|Full Analysis Set (FAS)|Overall Study||7
6817364|NCT02527200|7749925|FG000|COMPLETED|Overall Study||17
6817365|NCT02527200|7749926|FG001|COMPLETED|Overall Study||9
6817366|NCT02527200|7749927|FG002|COMPLETED|Overall Study||15
6817367|NCT02527200|7749928|FG003|COMPLETED|Overall Study||7
6817368|NCT02527200|7749925|FG000|NOT COMPLETED|Overall Study||3
6817369|NCT02527200|7749926|FG001|NOT COMPLETED|Overall Study||3
6817370|NCT02527200|7749927|FG002|NOT COMPLETED|Overall Study||2
6817371|NCT02527200|7749928|FG003|NOT COMPLETED|Overall Study||0
6817372|NCT02511106|7749944|FG000|STARTED|Overall Study||339
6817373|NCT02511106|7749945|FG001|STARTED|Overall Study||343
6817374|NCT02511106|7749944|FG000|Received Treatment|Overall Study||337
6568026|NCT01835132|7491252|FG000|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
6657179|NCT02467075|7587464|FG000|COMPLETED|72 Hour Follow-up||0
6817375|NCT02511106|7749945|FG001|Received Treatment|Overall Study||343
6817376|NCT02511106|7749944|FG000|COMPLETED|Overall Study||8
6817377|NCT02511106|7749945|FG001|COMPLETED|Overall Study||20
6817378|NCT02511106|7749944|FG000|NOT COMPLETED|Overall Study||331
6817379|NCT02511106|7749945|FG001|NOT COMPLETED|Overall Study||323
6817380|NCT02477358|7749955|FG000|STARTED|Overall Study||18
6817381|NCT02477358|7749956|FG001|STARTED|Overall Study||18
6817382|NCT02477358|7749955|FG000|COMPLETED|Overall Study||18
6817383|NCT02477358|7749956|FG001|COMPLETED|Overall Study||18
6817384|NCT02477358|7749955|FG000|NOT COMPLETED|Overall Study||0
6817385|NCT02477358|7749956|FG001|NOT COMPLETED|Overall Study||0
6817386|NCT02432209|7749966|FG000|STARTED|Overall Study||188
6817387|NCT02432209|7749967|FG001|STARTED|Overall Study||191
6817388|NCT02432209|7749966|FG000|COMPLETED|Overall Study||157
6817389|NCT02432209|7749967|FG001|COMPLETED|Overall Study||151
6817390|NCT02432209|7749966|FG000|NOT COMPLETED|Overall Study||31
6817391|NCT02432209|7749967|FG001|NOT COMPLETED|Overall Study||40
6817392|NCT02392637|7749975|FG000|STARTED|Overall Study||32
6817393|NCT02392637|7749976|FG001|STARTED|Overall Study||28
6817394|NCT02392637|7749975|FG000|COMPLETED|Overall Study||32
6817395|NCT02392637|7749976|FG001|COMPLETED|Overall Study||28
6817396|NCT02392637|7749975|FG000|NOT COMPLETED|Overall Study||0
6817397|NCT02392637|7749976|FG001|NOT COMPLETED|Overall Study||0
6817398|NCT02253316|7749985|FG000|STARTED|Consolidation||236
6817399|NCT02253316|7749986|FG001|STARTED|Consolidation||0
6817400|NCT02253316|7749987|FG002|STARTED|Consolidation||0
6817401|NCT02253316|7749985|FG000|COMPLETED|Consolidation||220
6817402|NCT02253316|7749986|FG001|COMPLETED|Consolidation||0
6817403|NCT02253316|7749987|FG002|COMPLETED|Consolidation||0
6817404|NCT02253316|7749985|FG000|NOT COMPLETED|Consolidation||16
6817405|NCT02253316|7749986|FG001|NOT COMPLETED|Consolidation||0
6817406|NCT02253316|7749987|FG002|NOT COMPLETED|Consolidation||0
6817407|NCT02253316|7749985|FG000|STARTED|Maintenance||0
6817408|NCT02253316|7749986|FG001|STARTED|Maintenance||99
6817409|NCT02253316|7749987|FG002|STARTED|Maintenance||116
6817410|NCT02253316|7749985|FG000|COMPLETED|Maintenance||0
6817411|NCT02253316|7749986|FG001|COMPLETED|Maintenance||53
6817412|NCT02253316|7749987|FG002|COMPLETED|Maintenance||49
6817413|NCT02253316|7749985|FG000|NOT COMPLETED|Maintenance||0
6817414|NCT02253316|7749986|FG001|NOT COMPLETED|Maintenance||46
6817415|NCT02253316|7749987|FG002|NOT COMPLETED|Maintenance||67
6817416|NCT02224573|7749997|FG000|STARTED|Treatment Phase||315
6817417|NCT02224573|7749998|FG001|STARTED|Treatment Phase||366
6817418|NCT02224573|7749997|FG000|COMPLETED|Treatment Phase||170
6817419|NCT02224573|7749998|FG001|COMPLETED|Treatment Phase||243
6817420|NCT02224573|7749997|FG000|NOT COMPLETED|Treatment Phase||145
6817421|NCT02224573|7749998|FG001|NOT COMPLETED|Treatment Phase||123
6817422|NCT02224573|7749997|FG000|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|79
6817423|NCT02224573|7749998|FG001|STARTED|Taper Phase|The number of participants to start the Taper Phase is not equal to the number who completed the Treatment Phase because not all participants tapered IMP.|71
6817424|NCT02224573|7749997|FG000|COMPLETED|Taper Phase||76
6817425|NCT02224573|7749998|FG001|COMPLETED|Taper Phase||67
6817426|NCT02224573|7749997|FG000|NOT COMPLETED|Taper Phase||3
6817427|NCT02224573|7749998|FG001|NOT COMPLETED|Taper Phase||4
6817428|NCT01991067|7750007|FG000|STARTED|Overall Study||19
6817429|NCT01991067|7750008|FG001|STARTED|Overall Study||15
6817430|NCT01991067|7750007|FG000|COMPLETED|Overall Study||13
6817431|NCT01991067|7750008|FG001|COMPLETED|Overall Study||10
6817432|NCT01991067|7750007|FG000|NOT COMPLETED|Overall Study||6
6817433|NCT01991067|7750008|FG001|NOT COMPLETED|Overall Study||5
6817434|NCT01966471|7750016|FG000|STARTED|Overall Study||918
6817435|NCT01966471|7750017|FG001|STARTED|Overall Study||928
6817436|NCT01966471|7750016|FG000|COMPLETED|Overall Study||815
6817437|NCT01966471|7750017|FG001|COMPLETED|Overall Study||815
6817438|NCT01966471|7750016|FG000|NOT COMPLETED|Overall Study||103
6817439|NCT01966471|7750017|FG001|NOT COMPLETED|Overall Study||113
6817440|NCT01928732|7750025|FG000|STARTED|Overall Study||455
6817441|NCT01928732|7750026|FG001|STARTED|Overall Study||461
6817442|NCT01928732|7750025|FG000|COMPLETED|Overall Study||326
6817443|NCT01928732|7750026|FG001|COMPLETED|Overall Study||334
6817444|NCT01928732|7750025|FG000|NOT COMPLETED|Overall Study||129
6817445|NCT01928732|7750026|FG001|NOT COMPLETED|Overall Study||127
6817446|NCT01925573|7750032|FG000|STARTED|Overall Study||7
6817447|NCT01925573|7750032|FG000|COMPLETED|Overall Study||0
6817448|NCT01925573|7750032|FG000|NOT COMPLETED|Overall Study||7
6817449|NCT01774721|7750038|FG000|STARTED|Overall Study||227
6817450|NCT01774721|7750039|FG001|STARTED|Overall Study||225
6817451|NCT01774721|7750038|FG000|Treated|Overall Study||227
6817452|NCT01774721|7750039|FG001|Treated|Overall Study||224
6817453|NCT01774721|7750038|FG000|COMPLETED|Overall Study||0
6817454|NCT01774721|7750039|FG001|COMPLETED|Overall Study||0
6817455|NCT01774721|7750038|FG000|NOT COMPLETED|Overall Study||227
6817456|NCT01774721|7750039|FG001|NOT COMPLETED|Overall Study||225
6817457|NCT01747447|7750049|FG000|STARTED|Overall Study||388
6817458|NCT01747447|7750050|FG001|STARTED|Overall Study||383
6817459|NCT01747447|7750049|FG000|COMPLETED|Overall Study||347
6817460|NCT01747447|7750050|FG001|COMPLETED|Overall Study||340
6817461|NCT01747447|7750049|FG000|NOT COMPLETED|Overall Study||41
6817462|NCT01747447|7750050|FG001|NOT COMPLETED|Overall Study||43
6817463|NCT01709331|7750056|FG000|STARTED|Overall Study||18
6817464|NCT01709331|7750056|FG000|COMPLETED|Overall Study||17
6817465|NCT01709331|7750056|FG000|NOT COMPLETED|Overall Study||1
6817466|NCT01689740|7750063|FG000|STARTED|Overall Study||2
6817467|NCT01689740|7750064|FG001|STARTED|Overall Study||3
6817468|NCT01689740|7750065|FG002|STARTED|Overall Study||5
6817469|NCT01689740|7750063|FG000|COMPLETED|Overall Study||2
6817470|NCT01689740|7750064|FG001|COMPLETED|Overall Study||3
6817471|NCT01689740|7750065|FG002|COMPLETED|Overall Study||5
6817472|NCT01689740|7750063|FG000|NOT COMPLETED|Overall Study||0
6817473|NCT01689740|7750064|FG001|NOT COMPLETED|Overall Study||0
6817474|NCT01689740|7750065|FG002|NOT COMPLETED|Overall Study||0
6817475|NCT01656434|7750077|FG000|STARTED|Overall Study||2553
6817476|NCT01656434|7750078|FG001|STARTED|Overall Study||620
6817477|NCT01656434|7750077|FG000|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
6817478|NCT01656434|7750078|FG001|Treated|Overall Study||604
6817479|NCT01656434|7750077|FG000|COMPLETED|Overall Study||152
6817480|NCT01656434|7750078|FG001|COMPLETED|Overall Study||40
6817481|NCT01656434|7750077|FG000|NOT COMPLETED|Overall Study||2401
6817482|NCT01656434|7750078|FG001|NOT COMPLETED|Overall Study||580
6817483|NCT01518517|7750087|FG000|STARTED|Overall Study||29
6817484|NCT01518517|7750088|FG001|STARTED|Overall Study||30
6817485|NCT01518517|7750089|FG002|STARTED|Overall Study||26
6817486|NCT01518517|7750087|FG000|COMPLETED|Overall Study||1
6817487|NCT01518517|7750088|FG001|COMPLETED|Overall Study||3
6817488|NCT01518517|7750089|FG002|COMPLETED|Overall Study||0
6568027|NCT01835132|7491252|FG000|NOT COMPLETED|1st Extension Phase||0
6568028|NCT01835132|7491252|FG000|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
6568029|NCT01835132|7491252|FG000|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
6568030|NCT01835132|7491252|FG000|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
6568031|NCT01835158|7491258|FG000|STARTED|Overall Study||79
6657180|NCT02467075|7587465|FG001|COMPLETED|72 Hour Follow-up||1
6817489|NCT01518517|7750087|FG000|NOT COMPLETED|Overall Study||28
6817490|NCT01518517|7750088|FG001|NOT COMPLETED|Overall Study||27
6817491|NCT01518517|7750089|FG002|NOT COMPLETED|Overall Study||26
6817492|NCT01496118|7750107|FG000|STARTED|Overall Study||4
6817493|NCT01496118|7750108|FG001|STARTED|Overall Study||3
6817494|NCT01496118|7750109|FG002|STARTED|Overall Study||3
6817495|NCT01496118|7750110|FG003|STARTED|Overall Study||3
6817496|NCT01496118|7750111|FG004|STARTED|Overall Study||3
6817497|NCT01496118|7750112|FG005|STARTED|Overall Study||3
6817498|NCT01496118|7750113|FG006|STARTED|Overall Study||31
6817499|NCT01496118|7750114|FG007|STARTED|Overall Study||30
6817500|NCT01496118|7750107|FG000|COMPLETED|Overall Study||0
6817501|NCT01496118|7750108|FG001|COMPLETED|Overall Study||0
6817502|NCT01496118|7750109|FG002|COMPLETED|Overall Study||0
6817503|NCT01496118|7750110|FG003|COMPLETED|Overall Study||0
6817504|NCT01496118|7750111|FG004|COMPLETED|Overall Study||0
6817505|NCT01496118|7750112|FG005|COMPLETED|Overall Study||0
6817506|NCT01496118|7750113|FG006|COMPLETED|Overall Study||0
6817507|NCT01496118|7750114|FG007|COMPLETED|Overall Study||0
6817508|NCT01496118|7750107|FG000|NOT COMPLETED|Overall Study||4
6817509|NCT01496118|7750108|FG001|NOT COMPLETED|Overall Study||3
6817510|NCT01496118|7750109|FG002|NOT COMPLETED|Overall Study||3
6817511|NCT01496118|7750110|FG003|NOT COMPLETED|Overall Study||3
6817512|NCT01496118|7750111|FG004|NOT COMPLETED|Overall Study||3
6817513|NCT01496118|7750112|FG005|NOT COMPLETED|Overall Study||3
6817514|NCT01496118|7750113|FG006|NOT COMPLETED|Overall Study||31
6817515|NCT01496118|7750114|FG007|NOT COMPLETED|Overall Study||30
6817516|NCT01350934|7750134|FG000|STARTED|Base Study||111
6817517|NCT01350934|7750135|FG001|STARTED|Base Study||108
6817518|NCT01350934|7750134|FG000|COMPLETED|Base Study||100
6817519|NCT01350934|7750135|FG001|COMPLETED|Base Study||105
6817520|NCT01350934|7750134|FG000|NOT COMPLETED|Base Study||11
6817521|NCT01350934|7750135|FG001|NOT COMPLETED|Base Study||3
6817522|NCT01350934|7750134|FG000|STARTED|Extension Study||100
6817523|NCT01350934|7750135|FG001|STARTED|Extension Study||105
6817524|NCT01350934|7750134|FG000|COMPLETED|Extension Study||95
6817525|NCT01350934|7750135|FG001|COMPLETED|Extension Study||101
6817526|NCT01350934|7750134|FG000|NOT COMPLETED|Extension Study||5
6817527|NCT01350934|7750135|FG001|NOT COMPLETED|Extension Study||4
6817528|NCT01286207|7750144|FG000|STARTED|Overall Study||751
6817529|NCT01286207|7750145|FG001|STARTED|Overall Study||857
6817530|NCT01286207|7750146|FG002|STARTED|Overall Study||351
6817531|NCT01286207|7750144|FG000|COMPLETED|Overall Study||453
6817532|NCT01286207|7750145|FG001|COMPLETED|Overall Study||609
6817533|NCT01286207|7750146|FG002|COMPLETED|Overall Study||261
6817534|NCT01286207|7750144|FG000|NOT COMPLETED|Overall Study||298
6817535|NCT01286207|7750145|FG001|NOT COMPLETED|Overall Study||248
6817536|NCT01286207|7750146|FG002|NOT COMPLETED|Overall Study||90
6817537|NCT01263769|7750154|FG000|STARTED|Overall Study||25
6817538|NCT01263769|7750154|FG000|COMPLETED|Overall Study||24
6817539|NCT01263769|7750154|FG000|NOT COMPLETED|Overall Study||1
6817540|NCT01227187|7750162|FG000|STARTED|Overall Study||1
6817541|NCT01227187|7750163|FG001|STARTED|Overall Study||3
6817542|NCT01227187|7750164|FG002|STARTED|Overall Study||3
6817543|NCT01227187|7750165|FG003|STARTED|Overall Study||5
6817544|NCT01227187|7750162|FG000|COMPLETED|Overall Study||1
6817545|NCT01227187|7750163|FG001|COMPLETED|Overall Study||3
6817546|NCT01227187|7750164|FG002|COMPLETED|Overall Study||3
6817547|NCT01227187|7750165|FG003|COMPLETED|Overall Study||4
6817548|NCT01227187|7750162|FG000|NOT COMPLETED|Overall Study||0
6817549|NCT01227187|7750163|FG001|NOT COMPLETED|Overall Study||0
6817550|NCT01227187|7750164|FG002|NOT COMPLETED|Overall Study||0
6817551|NCT01227187|7750165|FG003|NOT COMPLETED|Overall Study||1
6817552|NCT01222247|7750177|FG000|STARTED|Overall Study||1429
6817553|NCT01222247|7750178|FG001|STARTED|Overall Study||1402
6817554|NCT01222247|7750177|FG000|Received 2 Doses|Overall Study||860
6817555|NCT01222247|7750178|FG001|Received 2 Doses|Overall Study||826
6817556|NCT01222247|7750177|FG000|Received 1 Dose|Overall Study||568
6817557|NCT01222247|7750178|FG001|Received 1 Dose|Overall Study||571
6817558|NCT01222247|7750177|FG000|Did Not Receive Assigned Medication|Overall Study||1
6817559|NCT01222247|7750178|FG001|Did Not Receive Assigned Medication|Overall Study||5
6817560|NCT01222247|7750177|FG000|COMPLETED|Overall Study||1427
6817561|NCT01222247|7750178|FG001|COMPLETED|Overall Study||1400
6817562|NCT01222247|7750177|FG000|NOT COMPLETED|Overall Study||2
6817563|NCT01222247|7750178|FG001|NOT COMPLETED|Overall Study||2
6817564|NCT01211405|7750187|FG000|STARTED|Overall Study||7
6817565|NCT01211405|7750188|FG001|STARTED|Overall Study||7
6817566|NCT01211405|7750189|FG002|STARTED|Overall Study||12
6817567|NCT01211405|7750187|FG000|Completed Primary Endpoint|Overall Study||7
6817568|NCT01211405|7750188|FG001|Completed Primary Endpoint|Overall Study||7
6817569|NCT01211405|7750189|FG002|Completed Primary Endpoint|Overall Study||12
6817570|NCT01211405|7750187|FG000|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
6817571|NCT01211405|7750188|FG001|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||6
6817572|NCT01211405|7750189|FG002|Completed Three Open-Label Sessions, Secondary, and End of Stage 2 Assessment|Overall Study||12
6817573|NCT01211405|7750187|FG000|COMPLETED|Overall Study||6
6817574|NCT01211405|7750188|FG001|COMPLETED|Overall Study||7
6817575|NCT01211405|7750189|FG002|COMPLETED|Overall Study||11
6817576|NCT01211405|7750187|FG000|NOT COMPLETED|Overall Study||1
6817577|NCT01211405|7750188|FG001|NOT COMPLETED|Overall Study||0
6817578|NCT01211405|7750189|FG002|NOT COMPLETED|Overall Study||1
6817579|NCT01146418|7750199|FG000|STARTED|Base Study P06029 (NCT01144416)||694
6817580|NCT01146418|7750200|FG001|STARTED|Base Study P06029 (NCT01144416)||696
6817581|NCT01146418|7750201|FG002|STARTED|Base Study P06029 (NCT01144416)||0
6817582|NCT01146418|7750202|FG003|STARTED|Base Study P06029 (NCT01144416)||0
6817583|NCT01146418|7750199|FG000|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
6817584|NCT01146418|7750200|FG001|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
6817585|NCT01146418|7750201|FG002|COMPLETED|Base Study P06029 (NCT01144416)||0
6817586|NCT01146418|7750202|FG003|COMPLETED|Base Study P06029 (NCT01144416)||0
6817587|NCT01146418|7750199|FG000|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
6817588|NCT01146418|7750200|FG001|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
6817589|NCT01146418|7750201|FG002|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
6568032|NCT01835158|7491259|FG001|STARTED|Overall Study||78
6568033|NCT01835158|7491258|FG000|COMPLETED|Overall Study||78
6568034|NCT01835158|7491259|FG001|COMPLETED|Overall Study||72
6568035|NCT01835158|7491258|FG000|NOT COMPLETED|Overall Study||1
6817590|NCT01146418|7750202|FG003|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
6817591|NCT01146418|7750199|FG000|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
6817592|NCT01146418|7750200|FG001|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
6817593|NCT01146418|7750201|FG002|STARTED|Women/Expectant Mother Follow Up||0
6817594|NCT01146418|7750202|FG003|STARTED|Women/Expectant Mother Follow Up||0
6817595|NCT01146418|7750199|FG000|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
6276059|NCT00116857|7175282|FG001|COMPLETED|Overall Study||56
6276060|NCT00116857|7175281|FG000|NOT COMPLETED|Overall Study||3
6276061|NCT00116857|7175282|FG001|NOT COMPLETED|Overall Study||4
6276062|NCT00117143|7175292|FG000|STARTED|Overall Study||4
6276063|NCT00117143|7175293|FG001|STARTED|Overall Study||4
6276064|NCT00117143|7175294|FG002|STARTED|Overall Study||7
6276065|NCT00117143|7175295|FG003|STARTED|Overall Study||1
6276066|NCT00117143|7175292|FG000|Received First Dose|Overall Study||4
6276067|NCT00117143|7175293|FG001|Received First Dose|Overall Study||4
6276068|NCT00117143|7175294|FG002|Received First Dose|Overall Study||7
6276069|NCT00117143|7175295|FG003|Received First Dose|Overall Study||1
6276070|NCT00117143|7175292|FG000|Received Second Dose|Overall Study||4
6276071|NCT00117143|7175293|FG001|Received Second Dose|Overall Study||4
6276072|NCT00117143|7175294|FG002|Received Second Dose|Overall Study||6
6276073|NCT00117143|7175295|FG003|Received Second Dose|Overall Study||0
6276074|NCT00117143|7175292|FG000|COMPLETED|Overall Study||4
6276075|NCT00117143|7175293|FG001|COMPLETED|Overall Study||4
6276076|NCT00117143|7175294|FG002|COMPLETED|Overall Study||7
6568036|NCT01835158|7491259|FG001|NOT COMPLETED|Overall Study||6
6568037|NCT01835223|7491267|FG000|STARTED|Overall Study||30
6568038|NCT01835223|7491268|FG001|STARTED|Overall Study||3
6568039|NCT01835223|7491267|FG000|COMPLETED|Overall Study||21
6568040|NCT01835223|7491268|FG001|COMPLETED|Overall Study||2
6276077|NCT00117143|7175295|FG003|COMPLETED|Overall Study||1
6276078|NCT00117143|7175292|FG000|NOT COMPLETED|Overall Study||0
6276079|NCT00117143|7175293|FG001|NOT COMPLETED|Overall Study||0
6276080|NCT00117143|7175294|FG002|NOT COMPLETED|Overall Study||0
6276081|NCT00117143|7175295|FG003|NOT COMPLETED|Overall Study||0
6276082|NCT00117156|7175305|FG000|STARTED|Overall Study||26
6276083|NCT00117156|7175305|FG000|COMPLETED|Overall Study||15
6276084|NCT00117156|7175305|FG000|NOT COMPLETED|Overall Study||11
6276085|NCT00117286|7175311|FG000|STARTED|Overall Study|Safety analysis set|30
6276086|NCT00117286|7175312|FG001|STARTED|Overall Study||27
6276087|NCT00117286|7175311|FG000|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
6276088|NCT00117286|7175312|FG001|Switched to Higher Dose|Overall Study||17
6276089|NCT00117286|7175311|FG000|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
6276090|NCT00117286|7175312|FG001|COMPLETED|Overall Study||6
6276091|NCT00117286|7175311|FG000|NOT COMPLETED|Overall Study||28
6276092|NCT00117286|7175312|FG001|NOT COMPLETED|Overall Study||21
6276093|NCT00117312|7175322|FG000|STARTED|Overall Study||10
6276094|NCT00117312|7175323|FG001|STARTED|Overall Study||24
6276095|NCT00117312|7175324|FG002|STARTED|Overall Study||24
6276096|NCT00117312|7175325|FG003|STARTED|Overall Study||24
6276097|NCT00117312|7175322|FG000|Started FE200486 CS06A|Overall Study||1
6276098|NCT00117312|7175323|FG001|Started FE200486 CS06A|Overall Study||11
6276099|NCT00117312|7175324|FG002|Started FE200486 CS06A|Overall Study||16
6276100|NCT00117312|7175325|FG003|Started FE200486 CS06A|Overall Study||9
6276101|NCT00117312|7175322|FG000|COMPLETED|Overall Study||0
6276102|NCT00117312|7175323|FG001|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
6276103|NCT00117312|7175324|FG002|COMPLETED|Overall Study||0
6276104|NCT00117312|7175325|FG003|COMPLETED|Overall Study||3
6276105|NCT00117312|7175322|FG000|NOT COMPLETED|Overall Study||10
6276106|NCT00117312|7175323|FG001|NOT COMPLETED|Overall Study||20
6276107|NCT00117312|7175324|FG002|NOT COMPLETED|Overall Study||24
6276108|NCT00117312|7175325|FG003|NOT COMPLETED|Overall Study||21
6276109|NCT00117325|7175337|FG000|STARTED|Overall Study||173
6276110|NCT00117325|7175338|FG001|STARTED|Overall Study||179
6276111|NCT00117325|7175337|FG000|COMPLETED|Overall Study||160
6276112|NCT00117325|7175338|FG001|COMPLETED|Overall Study||167
6276113|NCT00117325|7175337|FG000|NOT COMPLETED|Overall Study||13
6276114|NCT00117325|7175338|FG001|NOT COMPLETED|Overall Study||12
6276115|NCT00117507|7175345|FG000|STARTED|Overall Study||24
6276116|NCT00117507|7175345|FG000|COMPLETED|Overall Study||9
6276117|NCT00117507|7175345|FG000|NOT COMPLETED|Overall Study||15
6276118|NCT00117559|7175352|FG000|STARTED|Overall Study||9
6276119|NCT00117559|7175353|FG001|STARTED|Overall Study||10
6276120|NCT00117559|7175352|FG000|COMPLETED|Overall Study||8
6276121|NCT00117559|7175353|FG001|COMPLETED|Overall Study||9
6276122|NCT00117559|7175352|FG000|NOT COMPLETED|Overall Study||1
6276123|NCT00117559|7175353|FG001|NOT COMPLETED|Overall Study||1
6276124|NCT00117572|7175361|FG000|STARTED|Overall Study||144
6276125|NCT00117572|7175362|FG001|STARTED|Overall Study||141
6276126|NCT00117572|7175361|FG000|COMPLETED|Overall Study||138
6276127|NCT00117572|7175362|FG001|COMPLETED|Overall Study||135
6568041|NCT01835223|7491267|FG000|NOT COMPLETED|Overall Study||9
6276128|NCT00117572|7175361|FG000|NOT COMPLETED|Overall Study||6
6568042|NCT01835223|7491268|FG001|NOT COMPLETED|Overall Study||1
6817596|NCT01146418|7750200|FG001|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
6817597|NCT01146418|7750201|FG002|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
6817598|NCT01146418|7750202|FG003|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
6817599|NCT01146418|7750199|FG000|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
6817600|NCT01146418|7750200|FG001|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
6817601|NCT01146418|7750201|FG002|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
6817602|NCT01146418|7750202|FG003|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
6817603|NCT01146418|7750199|FG000|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
6817604|NCT01146418|7750200|FG001|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
6817605|NCT01146418|7750201|FG002|COMPLETED|Women/Expectant Mother Follow Up||0
6817606|NCT01146418|7750202|FG003|COMPLETED|Women/Expectant Mother Follow Up||0
6817607|NCT01146418|7750199|FG000|NOT COMPLETED|Women/Expectant Mother Follow Up||44
6817608|NCT01146418|7750200|FG001|NOT COMPLETED|Women/Expectant Mother Follow Up||40
6817609|NCT01146418|7750201|FG002|NOT COMPLETED|Women/Expectant Mother Follow Up||0
6817610|NCT01146418|7750202|FG003|NOT COMPLETED|Women/Expectant Mother Follow Up||0
6276129|NCT00117572|7175362|FG001|NOT COMPLETED|Overall Study||6
6276130|NCT00117585|7175368|FG000|STARTED|Overall Study||341
6276131|NCT00117585|7175368|FG000|COMPLETED|Overall Study||341
6276132|NCT00117585|7175368|FG000|NOT COMPLETED|Overall Study||0
6276133|NCT00117598|7175375|FG000|STARTED|Prior to Treatment Cross Over||57
6276134|NCT00117598|7175376|FG001|STARTED|Prior to Treatment Cross Over||56
6276135|NCT00117598|7175377|FG002|STARTED|Prior to Treatment Cross Over||56
6276136|NCT00117598|7175378|FG003|STARTED|Prior to Treatment Cross Over||0
6276137|NCT00117598|7175379|FG004|STARTED|Prior to Treatment Cross Over||0
6276138|NCT00117598|7175375|FG000|COMPLETED|Prior to Treatment Cross Over||0
6276139|NCT00117598|7175376|FG001|COMPLETED|Prior to Treatment Cross Over||3
6276140|NCT00117598|7175377|FG002|COMPLETED|Prior to Treatment Cross Over||4
6276141|NCT00117598|7175378|FG003|COMPLETED|Prior to Treatment Cross Over||0
6276142|NCT00117598|7175379|FG004|COMPLETED|Prior to Treatment Cross Over||0
6276143|NCT00117598|7175375|FG000|NOT COMPLETED|Prior to Treatment Cross Over||57
6276144|NCT00117598|7175376|FG001|NOT COMPLETED|Prior to Treatment Cross Over||53
6276145|NCT00117598|7175377|FG002|NOT COMPLETED|Prior to Treatment Cross Over||52
6276146|NCT00117598|7175378|FG003|NOT COMPLETED|Prior to Treatment Cross Over||0
6276147|NCT00117598|7175379|FG004|NOT COMPLETED|Prior to Treatment Cross Over||0
6276148|NCT00117598|7175375|FG000|STARTED|After Treament Cross Over||0
6276149|NCT00117598|7175376|FG001|STARTED|After Treament Cross Over||0
6276150|NCT00117598|7175377|FG002|STARTED|After Treament Cross Over||0
6276151|NCT00117598|7175378|FG003|STARTED|After Treament Cross Over||3
6276152|NCT00117598|7175379|FG004|STARTED|After Treament Cross Over||4
6276153|NCT00117598|7175375|FG000|COMPLETED|After Treament Cross Over||0
6276154|NCT00117598|7175376|FG001|COMPLETED|After Treament Cross Over||0
6276155|NCT00117598|7175377|FG002|COMPLETED|After Treament Cross Over||0
6276156|NCT00117598|7175378|FG003|COMPLETED|After Treament Cross Over||0
6276157|NCT00117598|7175379|FG004|COMPLETED|After Treament Cross Over||0
6276158|NCT00117598|7175375|FG000|NOT COMPLETED|After Treament Cross Over||0
6276159|NCT00117598|7175376|FG001|NOT COMPLETED|After Treament Cross Over||0
6276160|NCT00117598|7175377|FG002|NOT COMPLETED|After Treament Cross Over||0
6276161|NCT00117598|7175378|FG003|NOT COMPLETED|After Treament Cross Over||3
6276162|NCT00117598|7175379|FG004|NOT COMPLETED|After Treament Cross Over||4
6276163|NCT00117637|7175391|FG000|STARTED|First Intervention (Period 1)||97
6276164|NCT00117637|7175392|FG001|STARTED|First Intervention (Period 1)||92
6276165|NCT00117637|7175391|FG000|Subjects Received Treatment|First Intervention (Period 1)||97
6276166|NCT00117637|7175392|FG001|Subjects Received Treatment|First Intervention (Period 1)||90
6276167|NCT00117637|7175391|FG000|COMPLETED|First Intervention (Period 1)||79
6276168|NCT00117637|7175392|FG001|COMPLETED|First Intervention (Period 1)||67
6276169|NCT00117637|7175391|FG000|NOT COMPLETED|First Intervention (Period 1)||18
6817611|NCT01146418|7750199|FG000|STARTED|Live-Born Infant Follow Up||0
6817612|NCT01146418|7750200|FG001|STARTED|Live-Born Infant Follow Up||0
6817613|NCT01146418|7750201|FG002|STARTED|Live-Born Infant Follow Up||61
6817614|NCT01146418|7750202|FG003|STARTED|Live-Born Infant Follow Up||56
6817615|NCT01146418|7750199|FG000|COMPLETED|Live-Born Infant Follow Up||0
6817616|NCT01146418|7750200|FG001|COMPLETED|Live-Born Infant Follow Up||0
6817617|NCT01146418|7750201|FG002|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
6817618|NCT01146418|7750202|FG003|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
6817619|NCT01146418|7750199|FG000|NOT COMPLETED|Live-Born Infant Follow Up||0
6817620|NCT01146418|7750200|FG001|NOT COMPLETED|Live-Born Infant Follow Up||0
6817621|NCT01146418|7750201|FG002|NOT COMPLETED|Live-Born Infant Follow Up||6
6817622|NCT01146418|7750202|FG003|NOT COMPLETED|Live-Born Infant Follow Up||5
6817623|NCT01144416|7750214|FG000|STARTED|Intervention Period||694
6817624|NCT01144416|7750215|FG001|STARTED|Intervention Period||696
6817625|NCT01144416|7750214|FG000|COMPLETED|Intervention Period||632
6817626|NCT01144416|7750215|FG001|COMPLETED|Intervention Period||647
6817627|NCT01144416|7750214|FG000|NOT COMPLETED|Intervention Period||62
6817628|NCT01144416|7750215|FG001|NOT COMPLETED|Intervention Period||49
6817629|NCT01144416|7750214|FG000|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
6817630|NCT01144416|7750215|FG001|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
6817631|NCT01144416|7750214|FG000|COMPLETED|Pregnancy Follow-up Period||146
6817632|NCT01144416|7750215|FG001|COMPLETED|Pregnancy Follow-up Period||157
6817633|NCT01144416|7750214|FG000|NOT COMPLETED|Pregnancy Follow-up Period||8
6817634|NCT01144416|7750215|FG001|NOT COMPLETED|Pregnancy Follow-up Period||10
6817635|NCT01140048|7750225|FG000|STARTED|Overall Study||343
6817636|NCT01140048|7750225|FG000|COMPLETED|Overall Study||298
6817637|NCT01140048|7750225|FG000|NOT COMPLETED|Overall Study||45
6817638|NCT01077817|7750229|FG000|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
6817639|NCT01077817|7750229|FG000|COMPLETED|Overall Study||684815
6817640|NCT01077817|7750229|FG000|NOT COMPLETED|Overall Study||0
6817641|NCT01065779|7750240|FG000|STARTED|Overall Study||880
6817642|NCT01065779|7750240|FG000|COMPLETED|Overall Study||798
6817643|NCT01065779|7750240|FG000|NOT COMPLETED|Overall Study||82
6817644|NCT00974571|7750247|FG000|STARTED|Overall Study||630
6817645|NCT00974571|7750248|FG001|STARTED|Overall Study||122
6817646|NCT00974571|7750249|FG002|STARTED|Overall Study||613
6817647|NCT00974571|7750247|FG000|COMPLETED|Overall Study||562
6817648|NCT00974571|7750248|FG001|COMPLETED|Overall Study||106
6817649|NCT00974571|7750249|FG002|COMPLETED|Overall Study||530
6817650|NCT00974571|7750247|FG000|NOT COMPLETED|Overall Study||68
6817651|NCT00974571|7750248|FG001|NOT COMPLETED|Overall Study||16
6817652|NCT00974571|7750249|FG002|NOT COMPLETED|Overall Study||83
6817653|NCT00972738|7750260|FG000|STARTED|Overall Study||522
6817654|NCT00972738|7750261|FG001|STARTED|Overall Study||171
6817655|NCT00972738|7750262|FG002|STARTED|Overall Study||521
6817656|NCT00972738|7750260|FG000|COMPLETED|Overall Study||501
6817657|NCT00972738|7750261|FG001|COMPLETED|Overall Study||165
6817658|NCT00972738|7750262|FG002|COMPLETED|Overall Study||492
6817659|NCT00972738|7750260|FG000|NOT COMPLETED|Overall Study||21
6817660|NCT00972738|7750261|FG001|NOT COMPLETED|Overall Study||6
6817661|NCT00972738|7750262|FG002|NOT COMPLETED|Overall Study||29
6817662|NCT00968201|7750272|FG000|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
6817663|NCT00968201|7750273|FG001|STARTED|Base Study - (Period II)||0
6817664|NCT00968201|7750274|FG002|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
6817665|NCT00968201|7750272|FG000|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
6817666|NCT00968201|7750273|FG001|COMPLETED|Base Study - (Period II)||0
6817667|NCT00968201|7750274|FG002|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
6817668|NCT00968201|7750272|FG000|NOT COMPLETED|Base Study - (Period II)||26
6817669|NCT00968201|7750273|FG001|NOT COMPLETED|Base Study - (Period II)||0
6817670|NCT00968201|7750274|FG002|NOT COMPLETED|Base Study - (Period II)||45
6817671|NCT00968201|7750272|FG000|STARTED|Extension Study - (Period III)||0
6817672|NCT00968201|7750273|FG001|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
6817673|NCT00968201|7750274|FG002|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
6817674|NCT00968201|7750272|FG000|COMPLETED|Extension Study - (Period III)||0
6817675|NCT00968201|7750273|FG001|COMPLETED|Extension Study - (Period III)||33
6817676|NCT00968201|7750274|FG002|COMPLETED|Extension Study - (Period III)||84
6817677|NCT00968201|7750272|FG000|NOT COMPLETED|Extension Study - (Period III)||0
6817678|NCT00968201|7750273|FG001|NOT COMPLETED|Extension Study - (Period III)||124
6817679|NCT00968201|7750274|FG002|NOT COMPLETED|Extension Study - (Period III)||280
6817680|NCT00968149|7750285|FG000|STARTED|Overall Study||280
6817681|NCT00968149|7750286|FG001|STARTED|Overall Study||133
6817682|NCT00968149|7750285|FG000|COMPLETED|Overall Study||269
6817683|NCT00968149|7750286|FG001|COMPLETED|Overall Study||127
6817684|NCT00968149|7750285|FG000|NOT COMPLETED|Overall Study||11
6817685|NCT00968149|7750286|FG001|NOT COMPLETED|Overall Study||6
6817686|NCT00963469|7750295|FG000|STARTED|Overall Study||451
6817687|NCT00963469|7750296|FG001|STARTED|Overall Study||448
6817688|NCT00963469|7750297|FG002|STARTED|Overall Study||180
6817689|NCT00963469|7750295|FG000|COMPLETED|Overall Study||410
6817690|NCT00963469|7750296|FG001|COMPLETED|Overall Study||420
6817691|NCT00963469|7750297|FG002|COMPLETED|Overall Study||170
6817692|NCT00963469|7750295|FG000|NOT COMPLETED|Overall Study||41
6817693|NCT00963469|7750296|FG001|NOT COMPLETED|Overall Study||28
6817694|NCT00963469|7750297|FG002|NOT COMPLETED|Overall Study||10
6817695|NCT00960141|7750308|FG000|STARTED|Overall Study||333
6817696|NCT00960141|7750309|FG001|STARTED|Overall Study||326
6817697|NCT00960141|7750310|FG002|STARTED|Overall Study||170
6817698|NCT00960141|7750308|FG000|COMPLETED|Overall Study||323
6817699|NCT00960141|7750309|FG001|COMPLETED|Overall Study||309
6817700|NCT00960141|7750310|FG002|COMPLETED|Overall Study||163
6817701|NCT00960141|7750308|FG000|NOT COMPLETED|Overall Study||10
6817702|NCT00960141|7750309|FG001|NOT COMPLETED|Overall Study||17
6817703|NCT00960141|7750310|FG002|NOT COMPLETED|Overall Study||7
6817704|NCT00943683|7750320|FG000|STARTED|Overall Study||81
6817705|NCT00943683|7750321|FG001|STARTED|Overall Study||175
6817706|NCT00943683|7750320|FG000|COMPLETED|Overall Study||74
6817707|NCT00943683|7750321|FG001|COMPLETED|Overall Study||169
6817708|NCT00943683|7750320|FG000|NOT COMPLETED|Overall Study||7
6817709|NCT00943683|7750321|FG001|NOT COMPLETED|Overall Study||6
6817710|NCT00943397|7750329|FG000|STARTED|Overall Study||32
6817711|NCT00943397|7750330|FG001|STARTED|Overall Study||158
6817712|NCT00943397|7750329|FG000|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
6817713|NCT00943397|7750330|FG001|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
6817714|NCT00943397|7750329|FG000|NOT COMPLETED|Overall Study||15
6817715|NCT00943397|7750330|FG001|NOT COMPLETED|Overall Study||72
6817716|NCT00937937|7750336|FG000|STARTED|Overall Study||72
6817717|NCT00937937|7750336|FG000|COMPLETED|Overall Study||0
6817718|NCT00937937|7750336|FG000|NOT COMPLETED|Overall Study||72
6817719|NCT00911547|7750345|FG000|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
6817720|NCT00911547|7750346|FG001|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
6817721|NCT00911547|7750347|FG002|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
6817722|NCT00911547|7750348|FG003|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
6817723|NCT00911547|7750345|FG000|COMPLETED|Overall Study||37
6817724|NCT00911547|7750346|FG001|COMPLETED|Overall Study||159
6817725|NCT00911547|7750347|FG002|COMPLETED|Overall Study||178
6817726|NCT00911547|7750348|FG003|COMPLETED|Overall Study||177
6817727|NCT00911547|7750345|FG000|NOT COMPLETED|Overall Study||11
6817728|NCT00911547|7750346|FG001|NOT COMPLETED|Overall Study||42
6817729|NCT00911547|7750347|FG002|NOT COMPLETED|Overall Study||22
6817730|NCT00911547|7750348|FG003|NOT COMPLETED|Overall Study||16
6817731|NCT00899379|7750363|FG000|STARTED|Overall Study|Patients who were allocated study drug|95
6817732|NCT00899379|7750364|FG001|STARTED|Overall Study|Patients who were allocated study drug|95
6817733|NCT00899379|7750365|FG002|STARTED|Overall Study|Patients who were allocated study drug|95
6817734|NCT00899379|7750366|FG003|STARTED|Overall Study|Patients who were allocated study drug|94
6817735|NCT00899379|7750367|FG004|STARTED|Overall Study|Patients who were allocated study drug|94
6817736|NCT00899379|7750363|FG000|Patients Treated|Overall Study|Patients who took study drug|83
6817737|NCT00899379|7750364|FG001|Patients Treated|Overall Study|Patients who took study drug|82
6817738|NCT00899379|7750365|FG002|Patients Treated|Overall Study|Patients who took study drug|84
6817739|NCT00899379|7750366|FG003|Patients Treated|Overall Study|Patients who took study drug|77
6817740|NCT00899379|7750367|FG004|Patients Treated|Overall Study|Patients who took study drug|81
6817741|NCT00899379|7750363|FG000|Patients Not Treated|Overall Study|Patients who did not take study drug|12
6817742|NCT00899379|7750364|FG001|Patients Not Treated|Overall Study|Patients who did not take study drug|13
6817743|NCT00899379|7750365|FG002|Patients Not Treated|Overall Study|Patients who did not take study drug|11
6817744|NCT00899379|7750366|FG003|Patients Not Treated|Overall Study|Patients who did not take study drug|17
6817745|NCT00899379|7750367|FG004|Patients Not Treated|Overall Study|Patients who did not take study drug|13
6817746|NCT00899379|7750363|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
6817747|NCT00899379|7750364|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
6817748|NCT00899379|7750365|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
6817749|NCT00899379|7750366|FG003|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
6817750|NCT00899379|7750367|FG004|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
6817751|NCT00899379|7750363|FG000|NOT COMPLETED|Overall Study||34
6817752|NCT00899379|7750364|FG001|NOT COMPLETED|Overall Study||29
6817753|NCT00899379|7750365|FG002|NOT COMPLETED|Overall Study||29
6817754|NCT00899379|7750366|FG003|NOT COMPLETED|Overall Study||37
6817755|NCT00899379|7750367|FG004|NOT COMPLETED|Overall Study||31
6817756|NCT00898677|7750377|FG000|STARTED|Overall Study||180
6817757|NCT00898677|7750378|FG001|STARTED|Overall Study||455
6817758|NCT00898677|7750379|FG002|STARTED|Overall Study||455
6391135|NCT00833833|7302936|FG000|COMPLETED|Phase 2 (as of 01 April 2011)||0
6817759|NCT00898677|7750380|FG003|STARTED|Overall Study||178
6817760|NCT00898677|7750377|FG000|Patients Treated|Overall Study|Patients Not Treated: 16|164
6817761|NCT00898677|7750378|FG001|Patients Treated|Overall Study|Patients Not Treated: 68|387
6817762|NCT00898677|7750379|FG002|Patients Treated|Overall Study|Patients Not Treated: 67|388
6817763|NCT00898677|7750380|FG003|Patients Treated|Overall Study|Patients Not Treated: 18|160
6817764|NCT00898677|7750377|FG000|COMPLETED|Overall Study||163
6817765|NCT00898677|7750378|FG001|COMPLETED|Overall Study||386
6817766|NCT00898677|7750379|FG002|COMPLETED|Overall Study||383
6817767|NCT00898677|7750380|FG003|COMPLETED|Overall Study||159
6817768|NCT00898677|7750377|FG000|NOT COMPLETED|Overall Study||17
6817769|NCT00898677|7750378|FG001|NOT COMPLETED|Overall Study||69
6817770|NCT00898677|7750379|FG002|NOT COMPLETED|Overall Study||72
6817771|NCT00898677|7750380|FG003|NOT COMPLETED|Overall Study||19
6817772|NCT00897949|7750393|FG000|STARTED|Overall Study|Patients who were allocated study drug|554
6817773|NCT00897949|7750394|FG001|STARTED|Overall Study|Patients who were allocated study drug|549
6817774|NCT00897949|7750395|FG002|STARTED|Overall Study|Patients who were allocated study drug|370
6817775|NCT00897949|7750393|FG000|Patients Treated|Overall Study|Patients who took study drug|458
6817776|NCT00897949|7750394|FG001|Patients Treated|Overall Study|Patients who took study drug|456
6817777|NCT00897949|7750395|FG002|Patients Treated|Overall Study|Patients who took study drug|304
6817778|NCT00897949|7750393|FG000|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
6817779|NCT00897949|7750394|FG001|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
6817780|NCT00897949|7750395|FG002|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
6817781|NCT00897949|7750393|FG000|NOT COMPLETED|Overall Study||104
6817782|NCT00897949|7750394|FG001|NOT COMPLETED|Overall Study||103
6817783|NCT00897949|7750395|FG002|NOT COMPLETED|Overall Study||69
6817784|NCT00897104|7750412|FG000|STARTED|Overall Study|Participants who were allocated study drug|418
6817785|NCT00897104|7750413|FG001|STARTED|Overall Study|Participants who were allocated study drug|428
6817786|NCT00897104|7750414|FG002|STARTED|Overall Study|Participants who were allocated study drug|87
6817787|NCT00897104|7750412|FG000|Participants Treated|Overall Study|Participants who took study drug|355
6817788|NCT00897104|7750413|FG001|Participants Treated|Overall Study|Participants who took study drug|357
6817789|NCT00897104|7750414|FG002|Participants Treated|Overall Study|Participants who took study drug|80
6817790|NCT00897104|7750412|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|63
6817791|NCT00897104|7750413|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|71
6817792|NCT00897104|7750414|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|7
6817793|NCT00897104|7750412|FG000|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
6817794|NCT00897104|7750413|FG001|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
6817795|NCT00897104|7750414|FG002|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
6817796|NCT00897104|7750412|FG000|NOT COMPLETED|Overall Study||64
6817797|NCT00897104|7750413|FG001|NOT COMPLETED|Overall Study||71
6817798|NCT00897104|7750414|FG002|NOT COMPLETED|Overall Study||8
6817799|NCT00803790|7750424|FG000|STARTED|Period 1||125
6817800|NCT00803790|7750425|FG001|STARTED|Period 1||126
6817801|NCT00803790|7750426|FG002|STARTED|Period 1||32
6817802|NCT00803790|7750427|FG003|STARTED|Period 1||35
6817803|NCT00803790|7750424|FG000|COMPLETED|Period 1||116
6817804|NCT00803790|7750425|FG001|COMPLETED|Period 1||114
6817805|NCT00803790|7750426|FG002|COMPLETED|Period 1||31
6817806|NCT00803790|7750427|FG003|COMPLETED|Period 1||31
6817807|NCT00803790|7750424|FG000|NOT COMPLETED|Period 1||9
6817808|NCT00803790|7750425|FG001|NOT COMPLETED|Period 1||12
6817809|NCT00803790|7750426|FG002|NOT COMPLETED|Period 1||1
6817810|NCT00803790|7750427|FG003|NOT COMPLETED|Period 1||4
6817811|NCT00803790|7750424|FG000|STARTED|Period 2||116
6817812|NCT00803790|7750425|FG001|STARTED|Period 2||114
6817813|NCT00803790|7750426|FG002|STARTED|Period 2||31
6817814|NCT00803790|7750427|FG003|STARTED|Period 2||31
6817815|NCT00803790|7750424|FG000|COMPLETED|Period 2||114
6817816|NCT00803790|7750425|FG001|COMPLETED|Period 2||114
6817817|NCT00803790|7750426|FG002|COMPLETED|Period 2||30
6817818|NCT00803790|7750427|FG003|COMPLETED|Period 2||30
6817819|NCT00803790|7750424|FG000|NOT COMPLETED|Period 2||2
6817820|NCT00803790|7750425|FG001|NOT COMPLETED|Period 2||0
6817821|NCT00803790|7750426|FG002|NOT COMPLETED|Period 2||1
6817822|NCT00803790|7750427|FG003|NOT COMPLETED|Period 2||1
6817823|NCT00725491|7750440|FG000|STARTED|Overall Study|Intent-to-Treat Group|113
6817824|NCT00725491|7750441|FG001|STARTED|Overall Study|Intent-to-Treat Group|120
6817825|NCT00725491|7750440|FG000|COMPLETED|Overall Study||104
6817826|NCT00725491|7750441|FG001|COMPLETED|Overall Study||102
6817827|NCT00725491|7750440|FG000|NOT COMPLETED|Overall Study||9
6817828|NCT00725491|7750441|FG001|NOT COMPLETED|Overall Study||18
6817829|NCT00703014|7750449|FG000|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
6817830|NCT00703014|7750450|FG001|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
6817831|NCT00703014|7750451|FG002|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
6817832|NCT00703014|7750452|FG003|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
6817833|NCT00703014|7750449|FG000|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
6817834|NCT00703014|7750450|FG001|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
6568043|NCT01835262|7491278|FG000|STARTED|Overall Study||45
6568044|NCT01835262|7491279|FG001|STARTED|Overall Study||45
6817835|NCT00703014|7750451|FG002|Treated|Mothers Base Trial P05787 (NCT00696800)||0
6817836|NCT00703014|7750452|FG003|Treated|Mothers Base Trial P05787 (NCT00696800)||0
6817837|NCT00703014|7750449|FG000|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
6817838|NCT00703014|7750450|FG001|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
6817839|NCT00703014|7750451|FG002|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
6817840|NCT00703014|7750452|FG003|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
6817841|NCT00703014|7750449|FG000|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
6817842|NCT00703014|7750450|FG001|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
6817843|NCT00703014|7750451|FG002|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
6817844|NCT00703014|7750452|FG003|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
6817845|NCT00703014|7750449|FG000|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
6817846|NCT00703014|7750450|FG001|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
6817847|NCT00703014|7750451|FG002|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
6817848|NCT00703014|7750452|FG003|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
6817849|NCT00703014|7750449|FG000|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
6817850|NCT00703014|7750450|FG001|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
6817851|NCT00703014|7750451|FG002|STARTED|Mothers Follow Up Trial P05712||0
6817852|NCT00703014|7750452|FG003|STARTED|Mothers Follow Up Trial P05712||0
6817853|NCT00703014|7750449|FG000|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
6817854|NCT00703014|7750450|FG001|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
6817855|NCT00703014|7750451|FG002|COMPLETED|Mothers Follow Up Trial P05712||0
6817856|NCT00703014|7750452|FG003|COMPLETED|Mothers Follow Up Trial P05712||0
6817857|NCT00703014|7750449|FG000|NOT COMPLETED|Mothers Follow Up Trial P05712||33
6817858|NCT00703014|7750450|FG001|NOT COMPLETED|Mothers Follow Up Trial P05712||32
6817859|NCT00703014|7750451|FG002|NOT COMPLETED|Mothers Follow Up Trial P05712||0
6817860|NCT00703014|7750452|FG003|NOT COMPLETED|Mothers Follow Up Trial P05712||0
6817861|NCT00703014|7750449|FG000|STARTED|Fetuses/Infants Follow Up Trial P05712||0
6817862|NCT00703014|7750450|FG001|STARTED|Fetuses/Infants Follow Up Trial P05712||0
6817863|NCT00703014|7750451|FG002|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
6817864|NCT00703014|7750452|FG003|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
6817865|NCT00703014|7750449|FG000|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
6817866|NCT00703014|7750450|FG001|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
6817867|NCT00703014|7750451|FG002|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
6817868|NCT00703014|7750452|FG003|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
6817869|NCT00703014|7750449|FG000|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
6391136|NCT00833833|7302937|FG001|COMPLETED|Phase 2 (as of 01 April 2011)||0
6391137|NCT00833833|7302938|FG002|COMPLETED|Phase 2 (as of 01 April 2011)||0
6391138|NCT00833833|7302939|FG003|COMPLETED|Phase 2 (as of 01 April 2011)||0
6391139|NCT00833833|7302940|FG004|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
6391140|NCT00833833|7302941|FG005|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
6568045|NCT01835262|7491278|FG000|COMPLETED|Overall Study||45
6817870|NCT00703014|7750450|FG001|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
6817871|NCT00703014|7750451|FG002|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
6568046|NCT01835262|7491279|FG001|COMPLETED|Overall Study||45
6568047|NCT01835262|7491278|FG000|NOT COMPLETED|Overall Study||0
6568048|NCT01835262|7491279|FG001|NOT COMPLETED|Overall Study||0
6568049|NCT01835379|7491287|FG000|STARTED|Overall Study||41
6817872|NCT00703014|7750452|FG003|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
6817873|NCT00703014|7750449|FG000|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
6817874|NCT00703014|7750450|FG001|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
6817875|NCT00703014|7750451|FG002|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
6817876|NCT00703014|7750452|FG003|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
6817877|NCT00702845|7750464|FG000|STARTED|Overall Study||268
6817878|NCT00702845|7750465|FG001|STARTED|Overall Study|Includes one treated participant who was not randomized|129
6817879|NCT00702845|7750464|FG000|Randomized|Overall Study||268
6817880|NCT00702845|7750465|FG001|Randomized|Overall Study||128
6817881|NCT00702845|7750464|FG000|COMPLETED|Overall Study||246
6817882|NCT00702845|7750465|FG001|COMPLETED|Overall Study||121
6817883|NCT00702845|7750464|FG000|NOT COMPLETED|Overall Study||22
6817884|NCT00702845|7750465|FG001|NOT COMPLETED|Overall Study||8
6817885|NCT00702624|7750473|FG000|STARTED|Base Study P05690 (NCT00702845)||268
6817886|NCT00702624|7750474|FG001|STARTED|Base Study P05690 (NCT00702845)||128
6817887|NCT00702624|7750475|FG002|STARTED|Base Study P05690 (NCT00702845)||0
6817888|NCT00702624|7750476|FG003|STARTED|Base Study P05690 (NCT00702845)||0
6568050|NCT01835379|7491288|FG001|STARTED|Overall Study||41
6568051|NCT01835379|7491287|FG000|COMPLETED|Overall Study||41
6817889|NCT00702624|7750473|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
6817890|NCT00702624|7750474|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
6817891|NCT00702624|7750475|FG002|COMPLETED|Base Study P05690 (NCT00702845)||0
6817892|NCT00702624|7750476|FG003|COMPLETED|Base Study P05690 (NCT00702845)||0
6817893|NCT00702624|7750473|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
6817894|NCT00702624|7750474|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
6817895|NCT00702624|7750475|FG002|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
6568052|NCT01835379|7491288|FG001|COMPLETED|Overall Study||41
6568053|NCT01835379|7491287|FG000|NOT COMPLETED|Overall Study||0
6568054|NCT01835379|7491288|FG001|NOT COMPLETED|Overall Study||0
6568055|NCT01835431|7491296|FG000|STARTED|Overall Study||182
6568056|NCT01835431|7491297|FG001|STARTED|Overall Study||180
6568057|NCT01835431|7491296|FG000|Exposed|Overall Study|One subject was withdrawn before exposure.|181
6568058|NCT01835431|7491297|FG001|Exposed|Overall Study|One subject was withdrawn before exposure|179
6817896|NCT00702624|7750476|FG003|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
6817897|NCT00702624|7750473|FG000|STARTED|Expectant Mother Follow-up||68
6817898|NCT00702624|7750474|FG001|STARTED|Expectant Mother Follow-up||45
6817899|NCT00702624|7750475|FG002|STARTED|Expectant Mother Follow-up||0
6817900|NCT00702624|7750476|FG003|STARTED|Expectant Mother Follow-up||0
6817901|NCT00702624|7750473|FG000|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
6817902|NCT00702624|7750474|FG001|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
6817903|NCT00702624|7750475|FG002|COMPLETED|Expectant Mother Follow-up||0
6817904|NCT00702624|7750476|FG003|COMPLETED|Expectant Mother Follow-up||0
6817905|NCT00702624|7750473|FG000|NOT COMPLETED|Expectant Mother Follow-up||7
6817906|NCT00702624|7750474|FG001|NOT COMPLETED|Expectant Mother Follow-up||0
6817907|NCT00702624|7750475|FG002|NOT COMPLETED|Expectant Mother Follow-up||0
6817908|NCT00702624|7750476|FG003|NOT COMPLETED|Expectant Mother Follow-up||0
6817909|NCT00702624|7750473|FG000|STARTED|Fetuses/Infant Follow-up||0
6817910|NCT00702624|7750474|FG001|STARTED|Fetuses/Infant Follow-up||0
6568059|NCT01835431|7491296|FG000|COMPLETED|Overall Study||174
6568060|NCT01835431|7491297|FG001|COMPLETED|Overall Study||168
6568061|NCT01835431|7491296|FG000|NOT COMPLETED|Overall Study||8
6568062|NCT01835431|7491297|FG001|NOT COMPLETED|Overall Study||12
6568063|NCT01835470|7491303|FG000|STARTED|Short Term Treatment Period (to Week 16)||20
6568064|NCT01835470|7491303|FG000|COMPLETED|Short Term Treatment Period (to Week 16)||20
6568065|NCT01835470|7491303|FG000|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
6568066|NCT01835470|7491303|FG000|STARTED|Long Term Treatment Period||20
6568067|NCT01835470|7491303|FG000|COMPLETED|Long Term Treatment Period|Completed LT period|16
6817911|NCT00702624|7750475|FG002|STARTED|Fetuses/Infant Follow-up||88
6817912|NCT00702624|7750476|FG003|STARTED|Fetuses/Infant Follow-up||55
6817913|NCT00702624|7750473|FG000|Live Born Infants|Fetuses/Infant Follow-up||0
6817914|NCT00702624|7750474|FG001|Live Born Infants|Fetuses/Infant Follow-up||0
6817915|NCT00702624|7750475|FG002|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
6817916|NCT00702624|7750476|FG003|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
6817917|NCT00702624|7750473|FG000|COMPLETED|Fetuses/Infant Follow-up||0
6817918|NCT00702624|7750474|FG001|COMPLETED|Fetuses/Infant Follow-up||0
6817919|NCT00702624|7750475|FG002|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
6817920|NCT00702624|7750476|FG003|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
6817921|NCT00702624|7750473|FG000|NOT COMPLETED|Fetuses/Infant Follow-up||0
6817922|NCT00702624|7750474|FG001|NOT COMPLETED|Fetuses/Infant Follow-up||0
6817923|NCT00702624|7750475|FG002|NOT COMPLETED|Fetuses/Infant Follow-up||10
6817924|NCT00702624|7750476|FG003|NOT COMPLETED|Fetuses/Infant Follow-up||0
6817925|NCT00702546|7750491|FG000|STARTED|Base Study P05690 (NCT00702845)||268
6817926|NCT00702546|7750492|FG001|STARTED|Base Study P05690 (NCT00702845)||128
6817927|NCT00702546|7750491|FG000|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
6817928|NCT00702546|7750492|FG001|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
6817929|NCT00702546|7750491|FG000|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
6817930|NCT00702546|7750492|FG001|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
6817931|NCT00702546|7750491|FG000|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
6817932|NCT00702546|7750492|FG001|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
6817933|NCT00702546|7750491|FG000|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
6817934|NCT00702546|7750492|FG001|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
6817935|NCT00702546|7750491|FG000|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
6817936|NCT00702546|7750492|FG001|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
6391141|NCT00833833|7302936|FG000|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
6568068|NCT01835470|7491303|FG000|NOT COMPLETED|Long Term Treatment Period||4
6657181|NCT02467075|7587464|FG000|NOT COMPLETED|72 Hour Follow-up||0
6817937|NCT00702520|7750500|FG000|STARTED|Base Study P05788 - Assigned Treatment||25
6817938|NCT00702520|7750501|FG001|STARTED|Base Study P05788 - Assigned Treatment||25
6817939|NCT00702520|7750502|FG002|STARTED|Base Study P05788 - Assigned Treatment||0
6817940|NCT00702520|7750503|FG003|STARTED|Base Study P05788 - Assigned Treatment||0
6817941|NCT00702520|7750500|FG000|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
6817942|NCT00702520|7750501|FG001|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
6817943|NCT00702520|7750502|FG002|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
6817944|NCT00702520|7750503|FG003|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
6817945|NCT00702520|7750500|FG000|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
6817946|NCT00702520|7750501|FG001|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
6817947|NCT00702520|7750502|FG002|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
6817948|NCT00702520|7750503|FG003|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
6817949|NCT00702520|7750500|FG000|COMPLETED|Base Study P05788 - Assigned Treatment||25
6817950|NCT00702520|7750501|FG001|COMPLETED|Base Study P05788 - Assigned Treatment||24
6817951|NCT00702520|7750502|FG002|COMPLETED|Base Study P05788 - Assigned Treatment||0
6817952|NCT00702520|7750503|FG003|COMPLETED|Base Study P05788 - Assigned Treatment||0
6817953|NCT00702520|7750500|FG000|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
6817954|NCT00702520|7750501|FG001|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
6817955|NCT00702520|7750502|FG002|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
6276170|NCT00117637|7175392|FG001|NOT COMPLETED|First Intervention (Period 1)||25
6276171|NCT00117637|7175391|FG000|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
6276172|NCT00117637|7175392|FG001|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
6276173|NCT00117637|7175391|FG000|Subjects Received Treatment|Second Intervention (Period 2)||49
6276174|NCT00117637|7175392|FG001|Subjects Received Treatment|Second Intervention (Period 2)||61
6276175|NCT00117637|7175391|FG000|COMPLETED|Second Intervention (Period 2)||39
6276176|NCT00117637|7175392|FG001|COMPLETED|Second Intervention (Period 2)||39
6276177|NCT00117637|7175391|FG000|NOT COMPLETED|Second Intervention (Period 2)||10
6276178|NCT00117637|7175392|FG001|NOT COMPLETED|Second Intervention (Period 2)||22
6276179|NCT00117676|7175407|FG000|STARTED|Double-blind Period Through Week 48||254
6276180|NCT00117676|7175408|FG001|STARTED|Double-blind Period Through Week 48||128
6276181|NCT00117676|7175407|FG000|COMPLETED|Double-blind Period Through Week 48||244
6276182|NCT00117676|7175408|FG001|COMPLETED|Double-blind Period Through Week 48||121
6276183|NCT00117676|7175407|FG000|NOT COMPLETED|Double-blind Period Through Week 48||10
6276184|NCT00117676|7175408|FG001|NOT COMPLETED|Double-blind Period Through Week 48||7
6276185|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
6276186|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
6276187|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 49 - 96||225
6276188|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 49 - 96||110
6276189|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
6276190|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
6276191|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 97 - 144||225
6276192|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 97 - 144||110
6276193|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 97 - 144||219
6276194|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 97 - 144||109
6276195|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
6276196|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
6276197|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 145 - 192||219
6276198|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 145 - 192||109
6276199|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 145 - 192||209
6276200|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 145 - 192||106
6276201|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
6276202|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
6276203|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 193 - 240||209
6276204|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 193 - 240||106
6276205|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 193 - 240||202
6276206|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 193 - 240||103
6276207|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
6276208|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
6276209|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 241 - 288||202
6276210|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 241 - 288||103
6276211|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 241 - 288||192
6817956|NCT00702520|7750503|FG003|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
6817957|NCT00702520|7750500|FG000|STARTED|Base Study P05788 - Embryo Transfer||25
6817958|NCT00702520|7750501|FG001|STARTED|Base Study P05788 - Embryo Transfer||24
6817959|NCT00702520|7750502|FG002|STARTED|Base Study P05788 - Embryo Transfer||0
6817960|NCT00702520|7750503|FG003|STARTED|Base Study P05788 - Embryo Transfer||0
6817961|NCT00702520|7750500|FG000|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
6817962|NCT00702520|7750501|FG001|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
6817963|NCT00702520|7750502|FG002|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
6817964|NCT00702520|7750503|FG003|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
6817965|NCT00702520|7750500|FG000|COMPLETED|Base Study P05788 - Embryo Transfer||22
6817966|NCT00702520|7750501|FG001|COMPLETED|Base Study P05788 - Embryo Transfer||18
6817967|NCT00702520|7750502|FG002|COMPLETED|Base Study P05788 - Embryo Transfer||0
6817968|NCT00702520|7750503|FG003|COMPLETED|Base Study P05788 - Embryo Transfer||0
6817969|NCT00702520|7750500|FG000|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
6817970|NCT00702520|7750501|FG001|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
6817971|NCT00702520|7750502|FG002|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
6817972|NCT00702520|7750503|FG003|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
6817973|NCT00702520|7750500|FG000|STARTED|Base Study P05788 - Follow-Up||22
6817974|NCT00702520|7750501|FG001|STARTED|Base Study P05788 - Follow-Up||18
6817975|NCT00702520|7750502|FG002|STARTED|Base Study P05788 - Follow-Up||0
6817976|NCT00702520|7750503|FG003|STARTED|Base Study P05788 - Follow-Up||0
6817977|NCT00702520|7750500|FG000|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
6817978|NCT00702520|7750501|FG001|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
6817979|NCT00702520|7750502|FG002|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
6817980|NCT00702520|7750503|FG003|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
6817981|NCT00702520|7750500|FG000|COMPLETED|Base Study P05788 - Follow-Up||7
6817982|NCT00702520|7750501|FG001|COMPLETED|Base Study P05788 - Follow-Up||8
6817983|NCT00702520|7750502|FG002|COMPLETED|Base Study P05788 - Follow-Up||0
6817984|NCT00702520|7750503|FG003|COMPLETED|Base Study P05788 - Follow-Up||0
6817985|NCT00702520|7750500|FG000|NOT COMPLETED|Base Study P05788 - Follow-Up||15
6817986|NCT00702520|7750501|FG001|NOT COMPLETED|Base Study P05788 - Follow-Up||10
6817987|NCT00702520|7750502|FG002|NOT COMPLETED|Base Study P05788 - Follow-Up||0
6817988|NCT00702520|7750503|FG003|NOT COMPLETED|Base Study P05788 - Follow-Up||0
6817989|NCT00702520|7750500|FG000|STARTED|Follow-up Study P05783||7
6817990|NCT00702520|7750501|FG001|STARTED|Follow-up Study P05783||8
6817991|NCT00702520|7750502|FG002|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
6817992|NCT00702520|7750503|FG003|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
6817993|NCT00702520|7750500|FG000|COMPLETED|Follow-up Study P05783||7
6817994|NCT00702520|7750501|FG001|COMPLETED|Follow-up Study P05783||8
6817995|NCT00702520|7750502|FG002|COMPLETED|Follow-up Study P05783||8
6817996|NCT00702520|7750503|FG003|COMPLETED|Follow-up Study P05783||11
6817997|NCT00702520|7750500|FG000|NOT COMPLETED|Follow-up Study P05783||0
6817998|NCT00702520|7750501|FG001|NOT COMPLETED|Follow-up Study P05783||0
6817999|NCT00702520|7750502|FG002|NOT COMPLETED|Follow-up Study P05783||0
6818000|NCT00702520|7750503|FG003|NOT COMPLETED|Follow-up Study P05783||0
6818001|NCT00702338|7750513|FG000|STARTED|Base Study (NCT00697255)||5
6818002|NCT00702338|7750514|FG001|STARTED|Base Study (NCT00697255)||3
6818003|NCT00702338|7750515|FG002|STARTED|Base Study (NCT00697255)||0
6818004|NCT00702338|7750513|FG000|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
6818005|NCT00702338|7750514|FG001|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
6818006|NCT00702338|7750515|FG002|COMPLETED|Base Study (NCT00697255)||0
6818007|NCT00702338|7750513|FG000|NOT COMPLETED|Base Study (NCT00697255)||3
6818008|NCT00702338|7750514|FG001|NOT COMPLETED|Base Study (NCT00697255)||2
6818009|NCT00702338|7750515|FG002|NOT COMPLETED|Base Study (NCT00697255)||0
6818010|NCT00702338|7750513|FG000|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
6818011|NCT00702338|7750514|FG001|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
6818012|NCT00702338|7750515|FG002|STARTED|Follow-up Study: Expectant Mothers FU||0
6818013|NCT00702338|7750513|FG000|COMPLETED|Follow-up Study: Expectant Mothers FU||0
6818014|NCT00702338|7750514|FG001|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
6818015|NCT00702338|7750515|FG002|COMPLETED|Follow-up Study: Expectant Mothers FU||0
6818016|NCT00702338|7750513|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
6818017|NCT00702338|7750514|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
6818018|NCT00702338|7750515|FG002|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
6818019|NCT00702338|7750513|FG000|STARTED|Follow-up Study: Infant FU||0
6818020|NCT00702338|7750514|FG001|STARTED|Follow-up Study: Infant FU||0
6818021|NCT00702338|7750515|FG002|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
6818022|NCT00702338|7750513|FG000|COMPLETED|Follow-up Study: Infant FU||0
6818023|NCT00702338|7750514|FG001|COMPLETED|Follow-up Study: Infant FU||0
6818024|NCT00702338|7750515|FG002|COMPLETED|Follow-up Study: Infant FU||0
6818025|NCT00702338|7750513|FG000|NOT COMPLETED|Follow-up Study: Infant FU||0
6818026|NCT00702338|7750514|FG001|NOT COMPLETED|Follow-up Study: Infant FU||0
6818027|NCT00702338|7750515|FG002|NOT COMPLETED|Follow-up Study: Infant FU||2
6818028|NCT00702273|7750525|FG000|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
6818029|NCT00702273|7750526|FG001|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
6818030|NCT00702273|7750525|FG000|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
6818031|NCT00702273|7750526|FG001|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
6818032|NCT00702273|7750525|FG000|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
6818033|NCT00702273|7750526|FG001|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
6818034|NCT00702273|7750525|FG000|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
6818035|NCT00702273|7750526|FG001|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
6818036|NCT00702273|7750525|FG000|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
6818037|NCT00702273|7750526|FG001|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
6818038|NCT00702273|7750525|FG000|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
6818039|NCT00702273|7750526|FG001|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
6818040|NCT00702273|7750525|FG000|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
6818041|NCT00702273|7750526|FG001|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
6818042|NCT00702234|7750532|FG000|STARTED|Base Study (NCT00696878)||682
6818043|NCT00702234|7750533|FG001|STARTED|Base Study (NCT00696878)||0
6818044|NCT00702234|7750532|FG000|COMPLETED|Base Study (NCT00696878)||178
6818045|NCT00702234|7750533|FG001|COMPLETED|Base Study (NCT00696878)||0
6818046|NCT00702234|7750532|FG000|NOT COMPLETED|Base Study (NCT00696878)||504
6818047|NCT00702234|7750533|FG001|NOT COMPLETED|Base Study (NCT00696878)||0
6818048|NCT00702234|7750532|FG000|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
6818049|NCT00702234|7750533|FG001|STARTED|Follow-up Study: Expectant Mothers||0
6818050|NCT00702234|7750532|FG000|COMPLETED|Follow-up Study: Expectant Mothers||246
6818051|NCT00702234|7750533|FG001|COMPLETED|Follow-up Study: Expectant Mothers||0
6818052|NCT00702234|7750532|FG000|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
6818053|NCT00702234|7750533|FG001|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
6818054|NCT00702234|7750532|FG000|STARTED|Follow-up Study: Fetuses/Infants||0
6818055|NCT00702234|7750533|FG001|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
6818056|NCT00702234|7750532|FG000|Live Born Infants|Follow-up Study: Fetuses/Infants||0
6818057|NCT00702234|7750533|FG001|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
6818058|NCT00702234|7750532|FG000|COMPLETED|Follow-up Study: Fetuses/Infants||0
6818059|NCT00702234|7750533|FG001|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
6818060|NCT00702234|7750532|FG000|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
6818061|NCT00702234|7750533|FG001|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
6818062|NCT00697255|7750542|FG000|STARTED|Stage 1a||5
6818063|NCT00697255|7750543|FG001|STARTED|Stage 1a||0
6818064|NCT00697255|7750542|FG000|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
6818065|NCT00697255|7750543|FG001|COMPLETED|Stage 1a||0
6818066|NCT00697255|7750542|FG000|NOT COMPLETED|Stage 1a||3
6818067|NCT00697255|7750543|FG001|NOT COMPLETED|Stage 1a||0
6818068|NCT00697255|7750542|FG000|STARTED|Stage 1b||0
6818069|NCT00697255|7750543|FG001|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
6818070|NCT00697255|7750542|FG000|COMPLETED|Stage 1b||0
6818071|NCT00697255|7750543|FG001|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
6818072|NCT00697255|7750542|FG000|NOT COMPLETED|Stage 1b||0
6818073|NCT00697255|7750543|FG001|NOT COMPLETED|Stage 1b||2
6818074|NCT00696878|7750549|FG000|STARTED|Overall Study||682
6818075|NCT00696878|7750549|FG000|COMPLETED|Overall Study||178
6818076|NCT00696878|7750549|FG000|NOT COMPLETED|Overall Study||504
6818077|NCT00696800|7750555|FG000|STARTED|Overall Study||757
6818078|NCT00696800|7750556|FG001|STARTED|Overall Study||752
6818079|NCT00696800|7750555|FG000|Treated (ITT)|Overall Study|The ITT group|756
6818080|NCT00696800|7750556|FG001|Treated (ITT)|Overall Study|The ITT group|750
6818081|NCT00696800|7750555|FG000|COMPLETED|Overall Study|Participants who had embryos transferred|672
6818082|NCT00696800|7750556|FG001|COMPLETED|Overall Study|Participants who had embryos transferred|704
6818083|NCT00696800|7750555|FG000|NOT COMPLETED|Overall Study||85
6818084|NCT00696800|7750556|FG001|NOT COMPLETED|Overall Study||48
6818085|NCT00616967|7750564|FG000|STARTED|Overall Study||6
6818086|NCT00616967|7750565|FG001|STARTED|Overall Study||31
6818087|NCT00616967|7750566|FG002|STARTED|Overall Study||31
6818088|NCT00616967|7750564|FG000|COMPLETED|Overall Study||6
6818089|NCT00616967|7750565|FG001|COMPLETED|Overall Study||31
6818090|NCT00616967|7750566|FG002|COMPLETED|Overall Study||30
6818091|NCT00616967|7750564|FG000|NOT COMPLETED|Overall Study||0
6818092|NCT00616967|7750565|FG001|NOT COMPLETED|Overall Study||0
6818093|NCT00616967|7750566|FG002|NOT COMPLETED|Overall Study||1
6818094|NCT00461032|7750586|FG000|STARTED|Overall Study||582
6818095|NCT00461032|7750587|FG001|STARTED|Overall Study||580
6818096|NCT00461032|7750586|FG000|COMPLETED|Overall Study||545
6818097|NCT00461032|7750587|FG001|COMPLETED|Overall Study||536
6818098|NCT00461032|7750586|FG000|NOT COMPLETED|Overall Study||37
6818099|NCT00461032|7750587|FG001|NOT COMPLETED|Overall Study||44
6818100|NCT00442338|7750596|FG000|STARTED|Overall Study||30
6818101|NCT00442338|7750597|FG001|STARTED|Overall Study||30
6818102|NCT00442338|7750598|FG002|STARTED|Overall Study||31
6818103|NCT00442338|7750596|FG000|COMPLETED|Overall Study||30
6818104|NCT00442338|7750597|FG001|COMPLETED|Overall Study||30
6818105|NCT00442338|7750598|FG002|COMPLETED|Overall Study||31
6818106|NCT00442338|7750596|FG000|NOT COMPLETED|Overall Study||0
6818107|NCT00442338|7750597|FG001|NOT COMPLETED|Overall Study||0
6818108|NCT00442338|7750598|FG002|NOT COMPLETED|Overall Study||0
6818109|NCT00289874|7750608|FG000|STARTED|Overall Study||203
6818110|NCT00289874|7750609|FG001|STARTED|Overall Study||218
6818111|NCT00289874|7750608|FG000|COMPLETED|Overall Study||197
6818112|NCT00289874|7750609|FG001|COMPLETED|Overall Study||210
6818113|NCT00289874|7750608|FG000|NOT COMPLETED|Overall Study||6
6818114|NCT00289874|7750609|FG001|NOT COMPLETED|Overall Study||8
6504809|NCT01449929|7423849|FG002|COMPLETED|Extension Phase Approximately 3 Years||115
6568069|NCT01835496|7491308|FG000|STARTED|Overall Study||8
6818115|NCT00250458|7750617|FG000|STARTED|Overall Study||232
6818116|NCT00250458|7750618|FG001|STARTED|Overall Study||114
6818117|NCT00250458|7750617|FG000|COMPLETED|Overall Study||200
6818118|NCT00250458|7750618|FG001|COMPLETED|Overall Study||97
6818119|NCT00250458|7750617|FG000|NOT COMPLETED|Overall Study||32
6818120|NCT00250458|7750618|FG001|NOT COMPLETED|Overall Study||17
6818121|NCT00245570|7750624|FG000|STARTED|Treatment Period II||7
6818122|NCT00245570|7750625|FG001|STARTED|Treatment Period II||8
6818123|NCT00245570|7750626|FG002|STARTED|Treatment Period II||8
6818124|NCT00245570|7750627|FG003|STARTED|Treatment Period II||8
6818125|NCT00245570|7750628|FG004|STARTED|Treatment Period II||8
6818126|NCT00245570|7750629|FG005|STARTED|Treatment Period II||8
6818127|NCT00245570|7750624|FG000|COMPLETED|Treatment Period II||7
6818128|NCT00245570|7750625|FG001|COMPLETED|Treatment Period II||8
6818129|NCT00245570|7750626|FG002|COMPLETED|Treatment Period II||8
6818130|NCT00245570|7750627|FG003|COMPLETED|Treatment Period II||8
6818131|NCT00245570|7750628|FG004|COMPLETED|Treatment Period II||8
6818132|NCT00245570|7750629|FG005|COMPLETED|Treatment Period II||8
6818133|NCT00245570|7750624|FG000|NOT COMPLETED|Treatment Period II||0
6818134|NCT00245570|7750625|FG001|NOT COMPLETED|Treatment Period II||0
6818135|NCT00245570|7750626|FG002|NOT COMPLETED|Treatment Period II||0
6818136|NCT00245570|7750627|FG003|NOT COMPLETED|Treatment Period II||0
6818137|NCT00245570|7750628|FG004|NOT COMPLETED|Treatment Period II||0
6818138|NCT00245570|7750629|FG005|NOT COMPLETED|Treatment Period II||0
6818139|NCT00245570|7750624|FG000|STARTED|Washout Between Periods II and III||7
6818140|NCT00245570|7750625|FG001|STARTED|Washout Between Periods II and III||8
6818141|NCT00245570|7750626|FG002|STARTED|Washout Between Periods II and III||8
6818142|NCT00245570|7750627|FG003|STARTED|Washout Between Periods II and III||8
6818143|NCT00245570|7750628|FG004|STARTED|Washout Between Periods II and III||8
6818144|NCT00245570|7750629|FG005|STARTED|Washout Between Periods II and III||8
6818145|NCT00245570|7750624|FG000|COMPLETED|Washout Between Periods II and III||7
6818146|NCT00245570|7750625|FG001|COMPLETED|Washout Between Periods II and III||8
6818147|NCT00245570|7750626|FG002|COMPLETED|Washout Between Periods II and III||8
6818148|NCT00245570|7750627|FG003|COMPLETED|Washout Between Periods II and III||8
6818149|NCT00245570|7750628|FG004|COMPLETED|Washout Between Periods II and III||8
6818150|NCT00245570|7750629|FG005|COMPLETED|Washout Between Periods II and III||8
6818151|NCT00245570|7750624|FG000|NOT COMPLETED|Washout Between Periods II and III||0
6818152|NCT00245570|7750625|FG001|NOT COMPLETED|Washout Between Periods II and III||0
6818153|NCT00245570|7750626|FG002|NOT COMPLETED|Washout Between Periods II and III||0
6818154|NCT00245570|7750627|FG003|NOT COMPLETED|Washout Between Periods II and III||0
6818155|NCT00245570|7750628|FG004|NOT COMPLETED|Washout Between Periods II and III||0
6818156|NCT00245570|7750629|FG005|NOT COMPLETED|Washout Between Periods II and III||0
6568070|NCT01835496|7491308|FG000|COMPLETED|Overall Study||8
6568071|NCT01835496|7491308|FG000|NOT COMPLETED|Overall Study||0
6568072|NCT01835548|7491314|FG000|STARTED|Screening/Washout Period||0
6568073|NCT01835548|7491315|FG001|STARTED|Screening/Washout Period||0
6568074|NCT01835548|7491316|FG002|STARTED|Screening/Washout Period||87
6568075|NCT01835548|7491314|FG000|COMPLETED|Screening/Washout Period||0
6818157|NCT00245570|7750624|FG000|STARTED|Treatment Period III||7
6818158|NCT00245570|7750625|FG001|STARTED|Treatment Period III||8
6818159|NCT00245570|7750626|FG002|STARTED|Treatment Period III||8
6818160|NCT00245570|7750627|FG003|STARTED|Treatment Period III||8
6818161|NCT00245570|7750628|FG004|STARTED|Treatment Period III||8
6818162|NCT00245570|7750629|FG005|STARTED|Treatment Period III||8
6818163|NCT00245570|7750624|FG000|COMPLETED|Treatment Period III||7
6818164|NCT00245570|7750625|FG001|COMPLETED|Treatment Period III||8
6818165|NCT00245570|7750626|FG002|COMPLETED|Treatment Period III||8
6818166|NCT00245570|7750627|FG003|COMPLETED|Treatment Period III||8
6818167|NCT00245570|7750628|FG004|COMPLETED|Treatment Period III||8
6818168|NCT00245570|7750629|FG005|COMPLETED|Treatment Period III||8
6818169|NCT00245570|7750624|FG000|NOT COMPLETED|Treatment Period III||0
6818170|NCT00245570|7750625|FG001|NOT COMPLETED|Treatment Period III||0
6818171|NCT00245570|7750626|FG002|NOT COMPLETED|Treatment Period III||0
6818172|NCT00245570|7750627|FG003|NOT COMPLETED|Treatment Period III||0
6818173|NCT00245570|7750628|FG004|NOT COMPLETED|Treatment Period III||0
6818174|NCT00245570|7750629|FG005|NOT COMPLETED|Treatment Period III||0
6818175|NCT00245570|7750624|FG000|STARTED|Washout Between Periods III and IV||7
6818176|NCT00245570|7750625|FG001|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
6818177|NCT00245570|7750626|FG002|STARTED|Washout Between Periods III and IV||8
6818178|NCT00245570|7750627|FG003|STARTED|Washout Between Periods III and IV||8
6818179|NCT00245570|7750628|FG004|STARTED|Washout Between Periods III and IV||8
6818180|NCT00245570|7750629|FG005|STARTED|Washout Between Periods III and IV||8
6818181|NCT00245570|7750624|FG000|COMPLETED|Washout Between Periods III and IV||7
6818182|NCT00245570|7750625|FG001|COMPLETED|Washout Between Periods III and IV||7
6568076|NCT01835548|7491315|FG001|COMPLETED|Screening/Washout Period||0
6818183|NCT00245570|7750626|FG002|COMPLETED|Washout Between Periods III and IV||8
6818184|NCT00245570|7750627|FG003|COMPLETED|Washout Between Periods III and IV||8
6818185|NCT00245570|7750628|FG004|COMPLETED|Washout Between Periods III and IV||8
6818186|NCT00245570|7750629|FG005|COMPLETED|Washout Between Periods III and IV||8
6818187|NCT00245570|7750624|FG000|NOT COMPLETED|Washout Between Periods III and IV||0
6818188|NCT00245570|7750625|FG001|NOT COMPLETED|Washout Between Periods III and IV||1
6818189|NCT00245570|7750626|FG002|NOT COMPLETED|Washout Between Periods III and IV||0
6818190|NCT00245570|7750627|FG003|NOT COMPLETED|Washout Between Periods III and IV||0
6818191|NCT00245570|7750628|FG004|NOT COMPLETED|Washout Between Periods III and IV||0
6818192|NCT00245570|7750629|FG005|NOT COMPLETED|Washout Between Periods III and IV||0
6818193|NCT00245570|7750624|FG000|STARTED|Treatment Period IV||7
6818194|NCT00245570|7750625|FG001|STARTED|Treatment Period IV||7
6818195|NCT00245570|7750626|FG002|STARTED|Treatment Period IV||8
6818196|NCT00245570|7750627|FG003|STARTED|Treatment Period IV||8
6818197|NCT00245570|7750628|FG004|STARTED|Treatment Period IV||8
6818198|NCT00245570|7750629|FG005|STARTED|Treatment Period IV||8
6818199|NCT00245570|7750624|FG000|COMPLETED|Treatment Period IV||7
6818200|NCT00245570|7750625|FG001|COMPLETED|Treatment Period IV||7
6818201|NCT00245570|7750626|FG002|COMPLETED|Treatment Period IV||8
6818202|NCT00245570|7750627|FG003|COMPLETED|Treatment Period IV||8
6818203|NCT00245570|7750628|FG004|COMPLETED|Treatment Period IV||8
6818204|NCT00245570|7750629|FG005|COMPLETED|Treatment Period IV||8
6818205|NCT00245570|7750624|FG000|NOT COMPLETED|Treatment Period IV||0
6818206|NCT00245570|7750625|FG001|NOT COMPLETED|Treatment Period IV||0
6818207|NCT00245570|7750626|FG002|NOT COMPLETED|Treatment Period IV||0
6818208|NCT00245570|7750627|FG003|NOT COMPLETED|Treatment Period IV||0
6818209|NCT00245570|7750628|FG004|NOT COMPLETED|Treatment Period IV||0
6818210|NCT00245570|7750629|FG005|NOT COMPLETED|Treatment Period IV||0
6818211|NCT00229970|7750643|FG000|STARTED|Overall Study||78
6818212|NCT00229970|7750644|FG001|STARTED|Overall Study||72
6818213|NCT00229970|7750645|FG002|STARTED|Overall Study||75
6818214|NCT00229970|7750643|FG000|COMPLETED|Overall Study||78
6276212|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 241 - 288||100
6276213|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
6276214|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
6276215|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 289 - 336||192
6276216|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 289 - 336||100
6276217|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 289 - 336||183
6276218|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 289 - 336||93
6818215|NCT00229970|7750644|FG001|COMPLETED|Overall Study||72
6818216|NCT00229970|7750645|FG002|COMPLETED|Overall Study||75
6818217|NCT00229970|7750643|FG000|NOT COMPLETED|Overall Study||0
6818218|NCT00229970|7750644|FG001|NOT COMPLETED|Overall Study||0
6818219|NCT00229970|7750645|FG002|NOT COMPLETED|Overall Study||0
6818220|NCT00092131|7750653|FG000|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
6818221|NCT00092131|7750654|FG001|STARTED|Treatment Period I||26
6818222|NCT00092131|7750653|FG000|COMPLETED|Treatment Period I||24
6818223|NCT00092131|7750654|FG001|COMPLETED|Treatment Period I||26
6818224|NCT00092131|7750653|FG000|NOT COMPLETED|Treatment Period I||1
6818225|NCT00092131|7750654|FG001|NOT COMPLETED|Treatment Period I||0
6818226|NCT00092131|7750653|FG000|STARTED|Treatment Period II||24
6818227|NCT00092131|7750654|FG001|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
6818228|NCT00092131|7750653|FG000|COMPLETED|Treatment Period II||24
6818229|NCT00092131|7750654|FG001|COMPLETED|Treatment Period II||25
6818230|NCT00092131|7750653|FG000|NOT COMPLETED|Treatment Period II||0
6818231|NCT00092131|7750654|FG001|NOT COMPLETED|Treatment Period II||1
6818232|NCT00092118|7750662|FG000|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
6818233|NCT00092118|7750663|FG001|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
6818234|NCT00092118|7750662|FG000|COMPLETED|Overall Study||906
6818235|NCT00092118|7750663|FG001|COMPLETED|Overall Study||913
6818236|NCT00092118|7750662|FG000|NOT COMPLETED|Overall Study||84
6818237|NCT00092118|7750663|FG001|NOT COMPLETED|Overall Study||89
6818238|NCT00090142|7750669|FG000|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
6818239|NCT00090142|7750670|FG001|STARTED|Treatment Period I||31
6818240|NCT00090142|7750669|FG000|COMPLETED|Treatment Period I||26
6818241|NCT00090142|7750670|FG001|COMPLETED|Treatment Period I||28
6818242|NCT00090142|7750669|FG000|NOT COMPLETED|Treatment Period I||5
6818243|NCT00090142|7750670|FG001|NOT COMPLETED|Treatment Period I||3
6818244|NCT00090142|7750669|FG000|STARTED|Treatment Period II||26
6818245|NCT00090142|7750670|FG001|STARTED|Treatment Period II||28
6818246|NCT00090142|7750669|FG000|COMPLETED|Treatment Period II||25
6818247|NCT00090142|7750670|FG001|COMPLETED|Treatment Period II||28
6818248|NCT00090142|7750669|FG000|NOT COMPLETED|Treatment Period II||1
6818249|NCT00090142|7750670|FG001|NOT COMPLETED|Treatment Period II||0
6818250|NCT00043108|7750676|FG000|STARTED|Overall Study||19
6818251|NCT00043108|7750676|FG000|COMPLETED|Overall Study||19
6818252|NCT00043108|7750676|FG000|NOT COMPLETED|Overall Study||0
6818253|NCT04771013|7750682|FG000|STARTED|Overall Study||22
6818254|NCT04771013|7750683|FG001|STARTED|Overall Study||22
6818255|NCT04771013|7750682|FG000|COMPLETED|Overall Study||20
6818256|NCT04771013|7750683|FG001|COMPLETED|Overall Study||16
6818257|NCT04771013|7750682|FG000|NOT COMPLETED|Overall Study||2
6818258|NCT04771013|7750683|FG001|NOT COMPLETED|Overall Study||6
6818259|NCT04497987|7750691|FG000|STARTED|Overall Study||592
6818260|NCT04497987|7750692|FG001|STARTED|Overall Study||588
6818261|NCT04497987|7750691|FG000|Received at Least One Dose of Study Drug|Overall Study||587
6568077|NCT01835548|7491316|FG002|COMPLETED|Screening/Washout Period||87
6568078|NCT01835548|7491314|FG000|NOT COMPLETED|Screening/Washout Period||0
6568079|NCT01835548|7491315|FG001|NOT COMPLETED|Screening/Washout Period||0
6568080|NCT01835548|7491316|FG002|NOT COMPLETED|Screening/Washout Period||0
6568081|NCT01835548|7491314|FG000|STARTED|Dose Optimization Period||0
6818262|NCT04497987|7750692|FG001|Received at Least One Dose of Study Drug|Overall Study||588
6818263|NCT04497987|7750691|FG000|Prevention Population|Overall Study||485
6818264|NCT04497987|7750692|FG001|Prevention Population|Overall Study||487
6818265|NCT04497987|7750691|FG000|Treatment Population|Overall Study||68
6818266|NCT04497987|7750692|FG001|Treatment Population|Overall Study||66
6818267|NCT04497987|7750691|FG000|Serology Positive|Overall Study||36
6818268|NCT04497987|7750692|FG001|Serology Positive|Overall Study||35
6818269|NCT04497987|7750691|FG000|COMPLETED|Overall Study||493
6818270|NCT04497987|7750692|FG001|COMPLETED|Overall Study||521
6818271|NCT04497987|7750691|FG000|NOT COMPLETED|Overall Study||99
6818272|NCT04497987|7750692|FG001|NOT COMPLETED|Overall Study||67
6818273|NCT04198584|7750701|FG000|STARTED|Overall Study||24
6818274|NCT04198584|7750702|FG001|STARTED|Overall Study||8
6818275|NCT04198584|7750701|FG000|Randomized to Wave 1|Overall Study||5
6818276|NCT04198584|7750702|FG001|Randomized to Wave 1|Overall Study||2
6818277|NCT04198584|7750701|FG000|Randomized to Wave 2|Overall Study||7
6818278|NCT04198584|7750702|FG001|Randomized to Wave 2|Overall Study||2
6818279|NCT04198584|7750701|FG000|Randomized to Wave 3|Overall Study||6
6818280|NCT04198584|7750702|FG001|Randomized to Wave 3|Overall Study||2
6818281|NCT04198584|7750701|FG000|Randomized to Wave 4|Overall Study||6
6818282|NCT04198584|7750702|FG001|Randomized to Wave 4|Overall Study||2
6818283|NCT04198584|7750701|FG000|Total Randomized|Overall Study||24
6818284|NCT04198584|7750702|FG001|Total Randomized|Overall Study||8
6818285|NCT04198584|7750701|FG000|Actually Received Treatment|Overall Study||21
6818286|NCT04198584|7750702|FG001|Actually Received Treatment|Overall Study||8
6818287|NCT04198584|7750701|FG000|COMPLETED|Overall Study||19
6818288|NCT04198584|7750702|FG001|COMPLETED|Overall Study||8
6818289|NCT04198584|7750701|FG000|NOT COMPLETED|Overall Study||5
6818290|NCT04198584|7750702|FG001|NOT COMPLETED|Overall Study||0
6818291|NCT04013932|7750715|FG000|STARTED|Overall Study||33
6818292|NCT04013932|7750716|FG001|STARTED|Overall Study||33
6818293|NCT04013932|7750715|FG000|COMPLETED|Overall Study||33
6818294|NCT04013932|7750716|FG001|COMPLETED|Overall Study||28
6568082|NCT01835548|7491315|FG001|STARTED|Dose Optimization Period||0
6568083|NCT01835548|7491316|FG002|STARTED|Dose Optimization Period||87
6568084|NCT01835548|7491314|FG000|COMPLETED|Dose Optimization Period||0
6818295|NCT04013932|7750715|FG000|NOT COMPLETED|Overall Study||0
6818296|NCT04013932|7750716|FG001|NOT COMPLETED|Overall Study||5
6818297|NCT03840616|7750726|FG000|STARTED|2-Week Induction Phase||147
6818298|NCT03840616|7750727|FG001|STARTED|2-Week Induction Phase||72
6818299|NCT03840616|7750726|FG000|COMPLETED|2-Week Induction Phase||123
6818300|NCT03840616|7750727|FG001|COMPLETED|2-Week Induction Phase||62
6818301|NCT03840616|7750726|FG000|NOT COMPLETED|2-Week Induction Phase||24
6818302|NCT03840616|7750727|FG001|NOT COMPLETED|2-Week Induction Phase||10
6818303|NCT03840616|7750726|FG000|STARTED|48-Week Maintenance Phase||123
6818304|NCT03840616|7750727|FG001|STARTED|48-Week Maintenance Phase||62
6818305|NCT03840616|7750726|FG000|COMPLETED|48-Week Maintenance Phase||112
6818306|NCT03840616|7750727|FG001|COMPLETED|48-Week Maintenance Phase||55
6818307|NCT03840616|7750726|FG000|NOT COMPLETED|48-Week Maintenance Phase||11
6818308|NCT03840616|7750727|FG001|NOT COMPLETED|48-Week Maintenance Phase||7
6818309|NCT03623373|7750735|FG000|STARTED|Overall Study||13
6818310|NCT03623373|7750735|FG000|COMPLETED|Overall Study||13
6818311|NCT03623373|7750735|FG000|NOT COMPLETED|Overall Study||0
6818312|NCT03581279|7750741|FG000|STARTED|Overall Study||18
6818313|NCT03581279|7750742|FG001|STARTED|Overall Study||0
6818314|NCT03581279|7750741|FG000|COMPLETED|Overall Study||16
6818315|NCT03581279|7750742|FG001|COMPLETED|Overall Study||0
6818316|NCT03581279|7750741|FG000|NOT COMPLETED|Overall Study||2
6818317|NCT03581279|7750742|FG001|NOT COMPLETED|Overall Study||0
6818318|NCT03512210|7750748|FG000|STARTED|Step 1: MINMON Intervention||400
6818319|NCT03512210|7750748|FG000|COMPLETED|Step 1: MINMON Intervention||396
6818320|NCT03512210|7750748|FG000|NOT COMPLETED|Step 1: MINMON Intervention||4
6818321|NCT03512210|7750748|FG000|STARTED|Step 2:Post-MINMON||396
6818322|NCT03512210|7750748|FG000|COMPLETED|Step 2:Post-MINMON||362
6818323|NCT03512210|7750748|FG000|NOT COMPLETED|Step 2:Post-MINMON||34
6818324|NCT03506412|7750754|FG000|STARTED|Overall Study||18
6818325|NCT03506412|7750755|FG001|STARTED|Overall Study||19
6818326|NCT03506412|7750754|FG000|COMPLETED|Overall Study||18
6818327|NCT03506412|7750755|FG001|COMPLETED|Overall Study||19
6818328|NCT03506412|7750754|FG000|NOT COMPLETED|Overall Study||0
6818329|NCT03506412|7750755|FG001|NOT COMPLETED|Overall Study||0
6818330|NCT03493854|7750763|FG000|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|252
6818331|NCT03493854|7750764|FG001|STARTED|Neoadjuvant Treatment Phase (24 Weeks)|This includes all randomized participants.|248
6818332|NCT03493854|7750763|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||252
6818333|NCT03493854|7750764|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment Phase (24 Weeks)||248
6818334|NCT03493854|7750763|FG000|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||242
6818335|NCT03493854|7750764|FG001|COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||234
6818336|NCT03493854|7750763|FG000|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||10
6818337|NCT03493854|7750764|FG001|NOT COMPLETED|Neoadjuvant Treatment Phase (24 Weeks)||14
6818338|NCT03493854|7750763|FG000|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||242
6818339|NCT03493854|7750764|FG001|STARTED|Surgery & Adjuvant Treatment (42 Weeks)||234
6818340|NCT03493854|7750763|FG000|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||239
6818341|NCT03493854|7750764|FG001|Completed Surgery|Surgery & Adjuvant Treatment (42 Weeks)||234
6818342|NCT03493854|7750763|FG000|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
6818343|NCT03493854|7750764|FG001|COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||0
6818344|NCT03493854|7750763|FG000|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||242
6818345|NCT03493854|7750764|FG001|NOT COMPLETED|Surgery & Adjuvant Treatment (42 Weeks)||234
6818346|NCT03493854|7750763|FG000|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|19
6818347|NCT03493854|7750764|FG001|STARTED|Treatment-Free Follow-Up (up to 3 Years)|Participants prematurely withdrew from treatment in other periods and entered the follow-up phase.|17
6818348|NCT03493854|7750763|FG000|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
6818349|NCT03493854|7750764|FG001|COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||0
6818350|NCT03493854|7750763|FG000|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||19
6818351|NCT03493854|7750764|FG001|NOT COMPLETED|Treatment-Free Follow-Up (up to 3 Years)||17
6818352|NCT03420768|7750773|FG000|STARTED|Overall Study||18
6818353|NCT03420768|7750774|FG001|STARTED|Overall Study||28
6818354|NCT03420768|7750775|FG002|STARTED|Overall Study||15
6818355|NCT03420768|7750773|FG000|COMPLETED|Overall Study||18
6818356|NCT03420768|7750774|FG001|COMPLETED|Overall Study||28
6818357|NCT03420768|7750775|FG002|COMPLETED|Overall Study||15
6818358|NCT03420768|7750773|FG000|NOT COMPLETED|Overall Study||0
6818359|NCT03420768|7750774|FG001|NOT COMPLETED|Overall Study||0
6818360|NCT03420768|7750775|FG002|NOT COMPLETED|Overall Study||0
6818361|NCT03395288|7750786|FG000|STARTED|Overall Study||28
6818362|NCT03395288|7750787|FG001|STARTED|Overall Study||29
6818363|NCT03395288|7750788|FG002|STARTED|Overall Study||4
6818364|NCT03395288|7750786|FG000|COMPLETED|Overall Study||19
6818365|NCT03395288|7750787|FG001|COMPLETED|Overall Study||25
6818366|NCT03395288|7750788|FG002|COMPLETED|Overall Study||3
6818367|NCT03395288|7750786|FG000|NOT COMPLETED|Overall Study||9
6818368|NCT03395288|7750787|FG001|NOT COMPLETED|Overall Study||4
6818369|NCT03395288|7750788|FG002|NOT COMPLETED|Overall Study||1
6818370|NCT03180307|7750798|FG000|STARTED|Overall Study||134
6818371|NCT03180307|7750799|FG001|STARTED|Overall Study||6
6818372|NCT03180307|7750798|FG000|Safety Analysis Set|Overall Study||134
6818373|NCT03180307|7750799|FG001|Safety Analysis Set|Overall Study||16
6818374|NCT03180307|7750798|FG000|Full Analysis Set/ Intent to Image Set|Overall Study||134
6818375|NCT03180307|7750799|FG001|Full Analysis Set/ Intent to Image Set|Overall Study||0
6818376|NCT03180307|7750798|FG000|Per Protocol Analysis Set|Overall Study||106
6818377|NCT03180307|7750799|FG001|Per Protocol Analysis Set|Overall Study||0
6818378|NCT03180307|7750798|FG000|Pharmacokinetic Analysis Set|Overall Study||122
6818379|NCT03180307|7750799|FG001|Pharmacokinetic Analysis Set|Overall Study||6
6818380|NCT03180307|7750798|FG000|COMPLETED|Overall Study||128
6818381|NCT03180307|7750799|FG001|COMPLETED|Overall Study||6
6818382|NCT03180307|7750798|FG000|NOT COMPLETED|Overall Study||6
6818383|NCT03180307|7750799|FG001|NOT COMPLETED|Overall Study||0
6818384|NCT03151083|7750806|FG000|STARTED|Overall Study||27
6818385|NCT03151083|7750807|FG001|STARTED|Overall Study||20
6818386|NCT03151083|7750808|FG002|STARTED|Overall Study||30
6818387|NCT03151083|7750806|FG000|COMPLETED|Overall Study||25
6818388|NCT03151083|7750807|FG001|COMPLETED|Overall Study||19
6818389|NCT03151083|7750808|FG002|COMPLETED|Overall Study||26
6818390|NCT03151083|7750806|FG000|NOT COMPLETED|Overall Study||2
6818391|NCT03151083|7750807|FG001|NOT COMPLETED|Overall Study||1
6818392|NCT03151083|7750808|FG002|NOT COMPLETED|Overall Study||4
6818393|NCT02668822|7750818|FG000|STARTED|Overall Study||9
6818394|NCT02668822|7750819|FG001|STARTED|Overall Study||9
6818395|NCT02668822|7750818|FG000|COMPLETED|Overall Study||0
6818396|NCT02668822|7750819|FG001|COMPLETED|Overall Study||0
6818397|NCT02668822|7750818|FG000|NOT COMPLETED|Overall Study||9
6818398|NCT02668822|7750819|FG001|NOT COMPLETED|Overall Study||9
6818399|NCT02668783|7750827|FG000|STARTED|Overall Study||13
6818400|NCT02668783|7750828|FG001|STARTED|Overall Study||12
6818401|NCT02668783|7750827|FG000|Treated|Overall Study||13
6818402|NCT02668783|7750828|FG001|Treated|Overall Study||11
6818403|NCT02668783|7750827|FG000|COMPLETED|Overall Study||0
6818404|NCT02668783|7750828|FG001|COMPLETED|Overall Study||0
6818405|NCT02668783|7750827|FG000|NOT COMPLETED|Overall Study||13
6818406|NCT02668783|7750828|FG001|NOT COMPLETED|Overall Study||12
6818407|NCT02616146|7750836|FG000|STARTED|Overall Study||1512
6818408|NCT02616146|7750837|FG001|STARTED|Overall Study||504
6818409|NCT02616146|7750836|FG000|COMPLETED|Overall Study|Due to termination of study, ENG-E2 reporting group received only up to 10 cycles of treatment.|0
6818410|NCT02616146|7750837|FG001|COMPLETED|Overall Study|Due to termination of study, LNG-EE reporting group received only up to 9 cycles of treatment.|0
6818411|NCT02616146|7750836|FG000|NOT COMPLETED|Overall Study||1512
6818412|NCT02616146|7750837|FG001|NOT COMPLETED|Overall Study||504
6818413|NCT02538510|7750845|FG000|STARTED|Overall Study||25
6818414|NCT02538510|7750846|FG001|STARTED|Overall Study||25
6818415|NCT02538510|7750845|FG000|COMPLETED|Overall Study||25
6818416|NCT02538510|7750846|FG001|COMPLETED|Overall Study||25
6818417|NCT02538510|7750845|FG000|NOT COMPLETED|Overall Study||0
6818418|NCT02538510|7750846|FG001|NOT COMPLETED|Overall Study||0
6818419|NCT02524288|7750856|FG000|STARTED|Overall Study||1941
6818420|NCT02524288|7750856|FG000|Treated|Overall Study||1936
6818421|NCT02524288|7750856|FG000|COMPLETED|Overall Study||0
6818422|NCT02524288|7750856|FG000|NOT COMPLETED|Overall Study||1941
6818423|NCT02489942|7750860|FG000|STARTED|Overall Study||8145
6818424|NCT02489942|7750860|FG000|Case Report Form (CRF) Collected|Overall Study||8059
6818425|NCT02489942|7750860|FG000|Treated|Overall Study||8057
6818426|NCT02489942|7750860|FG000|COMPLETED|Overall Study||4729
6818427|NCT02489942|7750860|FG000|NOT COMPLETED|Overall Study||3416
6818428|NCT02409342|7750866|FG000|STARTED|Overall Study||287
6818429|NCT02409342|7750867|FG001|STARTED|Overall Study||285
6818430|NCT02409342|7750866|FG000|COMPLETED|Overall Study||0
6818431|NCT02409342|7750867|FG001|COMPLETED|Overall Study||0
6818432|NCT02409342|7750866|FG000|NOT COMPLETED|Overall Study||287
6818433|NCT02409342|7750867|FG001|NOT COMPLETED|Overall Study||285
6818434|NCT02293655|7750877|FG000|STARTED|Overall Study||92
6818435|NCT02293655|7750878|FG001|STARTED|Overall Study||17
6818436|NCT02293655|7750877|FG000|COMPLETED|Overall Study||85
6818437|NCT02293655|7750878|FG001|COMPLETED|Overall Study||15
6818438|NCT02293655|7750877|FG000|NOT COMPLETED|Overall Study||7
6818439|NCT02293655|7750878|FG001|NOT COMPLETED|Overall Study||2
6818440|NCT02275546|7750884|FG000|STARTED|Treatment Period 1||81
6818441|NCT02275546|7750885|FG001|STARTED|Treatment Period 1||83
6818442|NCT02275546|7750884|FG000|COMPLETED|Treatment Period 1||81
6818443|NCT02275546|7750885|FG001|COMPLETED|Treatment Period 1||83
6818444|NCT02275546|7750884|FG000|NOT COMPLETED|Treatment Period 1||0
6818445|NCT02275546|7750885|FG001|NOT COMPLETED|Treatment Period 1||0
6818446|NCT02275546|7750884|FG000|STARTED|Treatment Period 2||81
6818447|NCT02275546|7750885|FG001|STARTED|Treatment Period 2||83
6818448|NCT02275546|7750884|FG000|COMPLETED|Treatment Period 2||79
6818449|NCT02275546|7750885|FG001|COMPLETED|Treatment Period 2||81
6818450|NCT02275546|7750884|FG000|NOT COMPLETED|Treatment Period 2||2
6818451|NCT02275546|7750885|FG001|NOT COMPLETED|Treatment Period 2||2
6818452|NCT02077166|7750898|FG000|STARTED|Overall Study||12
6818453|NCT02077166|7750899|FG001|STARTED|Overall Study||7
6818454|NCT02077166|7750900|FG002|STARTED|Overall Study||9
6818455|NCT02077166|7750901|FG003|STARTED|Overall Study||9
6818456|NCT02077166|7750902|FG004|STARTED|Overall Study||8
6818457|NCT02077166|7750903|FG005|STARTED|Overall Study||55
6818458|NCT02077166|7750904|FG006|STARTED|Overall Study||34
6391142|NCT00833833|7302937|FG001|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
6818459|NCT02077166|7750898|FG000|COMPLETED|Overall Study||0
6818460|NCT02077166|7750899|FG001|COMPLETED|Overall Study||0
6818461|NCT02077166|7750900|FG002|COMPLETED|Overall Study||0
6818462|NCT02077166|7750901|FG003|COMPLETED|Overall Study||0
6818463|NCT02077166|7750902|FG004|COMPLETED|Overall Study||0
6818464|NCT02077166|7750903|FG005|COMPLETED|Overall Study||0
6818465|NCT02077166|7750904|FG006|COMPLETED|Overall Study||0
6818466|NCT02077166|7750898|FG000|NOT COMPLETED|Overall Study||12
6818467|NCT02077166|7750899|FG001|NOT COMPLETED|Overall Study||7
6818468|NCT02077166|7750900|FG002|NOT COMPLETED|Overall Study||9
6818469|NCT02077166|7750901|FG003|NOT COMPLETED|Overall Study||9
6818470|NCT02077166|7750902|FG004|NOT COMPLETED|Overall Study||8
6818471|NCT02077166|7750903|FG005|NOT COMPLETED|Overall Study||55
6818472|NCT02077166|7750904|FG006|NOT COMPLETED|Overall Study||34
6818473|NCT01891344|7750929|FG000|STARTED|Overall Study||40
6818474|NCT01891344|7750930|FG001|STARTED|Overall Study||82
6818475|NCT01891344|7750931|FG002|STARTED|Overall Study||70
6818476|NCT01891344|7750932|FG003|STARTED|Overall Study||12
6818477|NCT01891344|7750933|FG004|STARTED|Overall Study||84
6818478|NCT01891344|7750934|FG005|STARTED|Overall Study||73
6818479|NCT01891344|7750935|FG006|STARTED|Overall Study||107
6818480|NCT01891344|7750936|FG007|STARTED|Overall Study||23
6818481|NCT01891344|7750929|FG000|COMPLETED|Overall Study||34
6818482|NCT01891344|7750930|FG001|COMPLETED|Overall Study||80
6818483|NCT01891344|7750931|FG002|COMPLETED|Overall Study||70
6818484|NCT01891344|7750932|FG003|COMPLETED|Overall Study||11
6818485|NCT01891344|7750933|FG004|COMPLETED|Overall Study||80
6818486|NCT01891344|7750934|FG005|COMPLETED|Overall Study||72
6818487|NCT01891344|7750935|FG006|COMPLETED|Overall Study||107
6818488|NCT01891344|7750936|FG007|COMPLETED|Overall Study||23
6818489|NCT01891344|7750929|FG000|NOT COMPLETED|Overall Study||6
6818490|NCT01891344|7750930|FG001|NOT COMPLETED|Overall Study||2
6391143|NCT00833833|7302938|FG002|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
6391144|NCT00833833|7302939|FG003|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
6391145|NCT00833833|7302940|FG004|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
6391146|NCT00833833|7302941|FG005|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
6391147|NCT00833898|7302963|FG000|STARTED|Overall Study||74
6391148|NCT00833898|7302964|FG001|STARTED|Overall Study||74
6818491|NCT01891344|7750931|FG002|NOT COMPLETED|Overall Study||0
6818492|NCT01891344|7750932|FG003|NOT COMPLETED|Overall Study||1
6818493|NCT01891344|7750933|FG004|NOT COMPLETED|Overall Study||4
6818494|NCT01891344|7750934|FG005|NOT COMPLETED|Overall Study||1
6818495|NCT01891344|7750935|FG006|NOT COMPLETED|Overall Study||0
6818496|NCT01891344|7750936|FG007|NOT COMPLETED|Overall Study||0
6818497|NCT01847274|7750958|FG000|STARTED|Overall Study||138
6818498|NCT01847274|7750959|FG001|STARTED|Overall Study||65
6818499|NCT01847274|7750960|FG002|STARTED|Overall Study||234
6818500|NCT01847274|7750961|FG003|STARTED|Overall Study||116
6818501|NCT01847274|7750958|FG000|COMPLETED|Overall Study||47
6818502|NCT01847274|7750959|FG001|COMPLETED|Overall Study||4
6818503|NCT01847274|7750960|FG002|COMPLETED|Overall Study||46
6818504|NCT01847274|7750961|FG003|COMPLETED|Overall Study||12
6818505|NCT01847274|7750958|FG000|NOT COMPLETED|Overall Study||91
6818506|NCT01847274|7750959|FG001|NOT COMPLETED|Overall Study||61
6818507|NCT01847274|7750960|FG002|NOT COMPLETED|Overall Study||188
6818508|NCT01847274|7750961|FG003|NOT COMPLETED|Overall Study||104
6818509|NCT01670656|7750976|FG000|STARTED|Overall Study||86
6818510|NCT01670656|7750977|FG001|STARTED|Overall Study||91
6818511|NCT01670656|7750978|FG002|STARTED|Overall Study||87
6818512|NCT01670656|7750979|FG003|STARTED|Overall Study||85
6818513|NCT01670656|7750980|FG004|STARTED|Overall Study||90
6818514|NCT01670656|7750976|FG000|Treated|Overall Study||86
6818515|NCT01670656|7750977|FG001|Treated|Overall Study||91
6818516|NCT01670656|7750978|FG002|Treated|Overall Study||86
6818517|NCT01670656|7750979|FG003|Treated|Overall Study||85
6818518|NCT01670656|7750980|FG004|Treated|Overall Study||90
6818519|NCT01670656|7750976|FG000|COMPLETED|Overall Study||83
6818520|NCT01670656|7750977|FG001|COMPLETED|Overall Study||84
6818521|NCT01670656|7750978|FG002|COMPLETED|Overall Study||79
6818522|NCT01670656|7750979|FG003|COMPLETED|Overall Study||79
6818523|NCT01670656|7750980|FG004|COMPLETED|Overall Study||79
6818524|NCT01670656|7750976|FG000|NOT COMPLETED|Overall Study||3
6818525|NCT01670656|7750977|FG001|NOT COMPLETED|Overall Study||7
6818526|NCT01670656|7750978|FG002|NOT COMPLETED|Overall Study||8
6818527|NCT01670656|7750979|FG003|NOT COMPLETED|Overall Study||6
6818528|NCT01670656|7750980|FG004|NOT COMPLETED|Overall Study||11
6818529|NCT01501955|7750994|FG000|STARTED|Overall Study||11
6818530|NCT01501955|7750995|FG001|STARTED|Overall Study||9
6818531|NCT01501955|7750994|FG000|Surgery|Overall Study||11
6818532|NCT01501955|7750995|FG001|Surgery|Overall Study||9
6818533|NCT01501955|7750994|FG000|6 Weeks Postop|Overall Study|1 patient withdrew on own request|10
6818534|NCT01501955|7750995|FG001|6 Weeks Postop|Overall Study||9
6818535|NCT01501955|7750994|FG000|1 Year Postop|Overall Study|1 patient terminated due to stem revision|9
6818536|NCT01501955|7750995|FG001|1 Year Postop|Overall Study|2 patients terminated due to stem revision|7
6818537|NCT01501955|7750994|FG000|2 Years Postop|Overall Study||9
6818538|NCT01501955|7750995|FG001|2 Years Postop|Overall Study|1 patient terminated due to stem revision|6
6818539|NCT01501955|7750994|FG000|COMPLETED|Overall Study||9
6818540|NCT01501955|7750995|FG001|COMPLETED|Overall Study||6
6818541|NCT01501955|7750994|FG000|NOT COMPLETED|Overall Study||2
6818542|NCT01501955|7750995|FG001|NOT COMPLETED|Overall Study||3
6818543|NCT01335399|7751003|FG000|STARTED|Pre-treatment Period||374
6818544|NCT01335399|7751004|FG001|STARTED|Pre-treatment Period||374
6818545|NCT01335399|7751003|FG000|COMPLETED|Pre-treatment Period||371
6818546|NCT01335399|7751004|FG001|COMPLETED|Pre-treatment Period||371
6818547|NCT01335399|7751003|FG000|NOT COMPLETED|Pre-treatment Period||3
6818548|NCT01335399|7751004|FG001|NOT COMPLETED|Pre-treatment Period||3
6818549|NCT01335399|7751003|FG000|STARTED|Treatment Period||371
6818550|NCT01335399|7751004|FG001|STARTED|Treatment Period||371
6818551|NCT01335399|7751003|FG000|COMPLETED|Treatment Period||38
6818552|NCT01335399|7751004|FG001|COMPLETED|Treatment Period||32
6818553|NCT01335399|7751003|FG000|NOT COMPLETED|Treatment Period||333
6818554|NCT01335399|7751004|FG001|NOT COMPLETED|Treatment Period||339
6818555|NCT01277211|7751012|FG000|STARTED|Overall Study||738
6818556|NCT01277211|7751013|FG001|STARTED|Overall Study||245
6818557|NCT01277211|7751012|FG000|Treated|Overall Study||714
6818558|NCT01277211|7751013|FG001|Treated|Overall Study||232
6818559|NCT01277211|7751012|FG000|COMPLETED|Overall Study||588
6818560|NCT01277211|7751013|FG001|COMPLETED|Overall Study||182
6818561|NCT01277211|7751012|FG000|NOT COMPLETED|Overall Study||150
6818562|NCT01277211|7751013|FG001|NOT COMPLETED|Overall Study||63
6818563|NCT01267812|7751019|FG000|STARTED|Overall Study||23
6818564|NCT01267812|7751019|FG000|COMPLETED|Overall Study||23
6818565|NCT01267812|7751019|FG000|NOT COMPLETED|Overall Study||0
6818566|NCT01244828|7751023|FG000|STARTED|Overall Study|Received study drug|157
6818567|NCT01244828|7751023|FG000|COMPLETED|Overall Study||79
6818568|NCT01244828|7751023|FG000|NOT COMPLETED|Overall Study||78
6818569|NCT01207492|7751027|FG000|STARTED|Overall Study||17
6818570|NCT01207492|7751027|FG000|COMPLETED|Overall Study||2
6818571|NCT01207492|7751027|FG000|NOT COMPLETED|Overall Study||15
6818572|NCT01181778|7751031|FG000|STARTED|Overall Study||1919
6818573|NCT01181778|7751031|FG000|COMPLETED|Overall Study||1871
6818574|NCT01181778|7751031|FG000|NOT COMPLETED|Overall Study||48
6818575|NCT01047540|7751042|FG000|STARTED|Overall Study||34
6818576|NCT01047540|7751043|FG001|STARTED|Overall Study||32
6818577|NCT01047540|7751044|FG002|STARTED|Overall Study||29
6818578|NCT01047540|7751045|FG003|STARTED|Overall Study||31
6818579|NCT01047540|7751046|FG004|STARTED|Overall Study||30
6818580|NCT01047540|7751042|FG000|COMPLETED|Overall Study||29
6818581|NCT01047540|7751043|FG001|COMPLETED|Overall Study||32
6818582|NCT01047540|7751044|FG002|COMPLETED|Overall Study||26
6818583|NCT01047540|7751045|FG003|COMPLETED|Overall Study||31
6818584|NCT01047540|7751046|FG004|COMPLETED|Overall Study||29
6818585|NCT01047540|7751042|FG000|NOT COMPLETED|Overall Study||5
6818586|NCT01047540|7751043|FG001|NOT COMPLETED|Overall Study||0
6818587|NCT01047540|7751044|FG002|NOT COMPLETED|Overall Study||3
6818588|NCT01047540|7751045|FG003|NOT COMPLETED|Overall Study||0
6818589|NCT01047540|7751046|FG004|NOT COMPLETED|Overall Study||1
6818590|NCT01044056|7751061|FG000|STARTED|Overall Study||8
6818591|NCT01044056|7751062|FG001|STARTED|Overall Study||8
6818592|NCT01044056|7751063|FG002|STARTED|Overall Study||8
6818593|NCT01044056|7751061|FG000|COMPLETED|Overall Study||8
6818594|NCT01044056|7751062|FG001|COMPLETED|Overall Study||8
6818595|NCT01044056|7751063|FG002|COMPLETED|Overall Study||8
6818596|NCT01044056|7751061|FG000|NOT COMPLETED|Overall Study||0
6818597|NCT01044056|7751062|FG001|NOT COMPLETED|Overall Study||0
6818598|NCT01044056|7751063|FG002|NOT COMPLETED|Overall Study||0
6818599|NCT00944216|7751071|FG000|STARTED|Overall Study||1
6818600|NCT00944216|7751071|FG000|COMPLETED|Overall Study||1
6818601|NCT00944216|7751071|FG000|NOT COMPLETED|Overall Study||0
6818602|NCT00886691|7751078|FG000|STARTED|Overall Study||75
6818603|NCT00886691|7751079|FG001|STARTED|Overall Study||75
6818604|NCT00886691|7751078|FG000|COMPLETED|Overall Study||75
6818605|NCT00886691|7751079|FG001|COMPLETED|Overall Study||75
6818606|NCT00886691|7751078|FG000|NOT COMPLETED|Overall Study||0
6818607|NCT00886691|7751079|FG001|NOT COMPLETED|Overall Study||0
6818608|NCT00778999|7751091|FG000|STARTED|Overall Study||223
6818609|NCT00778999|7751092|FG001|STARTED|Overall Study||219
6818610|NCT00778999|7751091|FG000|COMPLETED|Overall Study||195
6818611|NCT00778999|7751092|FG001|COMPLETED|Overall Study||185
6818612|NCT00778999|7751091|FG000|NOT COMPLETED|Overall Study||28
6818613|NCT00778999|7751092|FG001|NOT COMPLETED|Overall Study||34
6818614|NCT00620464|7751100|FG000|STARTED|Overall Study||52
6818615|NCT00620464|7751101|FG001|STARTED|Overall Study||56
6818616|NCT00620464|7751100|FG000|COMPLETED|Overall Study||32
6818617|NCT00620464|7751101|FG001|COMPLETED|Overall Study||32
6818618|NCT00620464|7751100|FG000|NOT COMPLETED|Overall Study||20
6818619|NCT00620464|7751101|FG001|NOT COMPLETED|Overall Study||24
6568085|NCT01835548|7491315|FG001|COMPLETED|Dose Optimization Period||0
6568086|NCT01835548|7491316|FG002|COMPLETED|Dose Optimization Period||85
6568087|NCT01835548|7491314|FG000|NOT COMPLETED|Dose Optimization Period||0
6568088|NCT01835548|7491315|FG001|NOT COMPLETED|Dose Optimization Period||0
6568089|NCT01835548|7491316|FG002|NOT COMPLETED|Dose Optimization Period||2
6568090|NCT01835548|7491314|FG000|STARTED|Dose Stabilization Period||0
6568091|NCT01835548|7491315|FG001|STARTED|Dose Stabilization Period||0
6568092|NCT01835548|7491316|FG002|STARTED|Dose Stabilization Period||85
6568093|NCT01835548|7491314|FG000|COMPLETED|Dose Stabilization Period||0
6818620|NCT00620035|7751107|FG000|STARTED|Overall Study||301
6818621|NCT00620035|7751107|FG000|COMPLETED|Overall Study||156
6818622|NCT00620035|7751107|FG000|NOT COMPLETED|Overall Study||145
6818623|NCT00210249|7751111|FG000|STARTED|Overall Study||364
6568094|NCT01835548|7491315|FG001|COMPLETED|Dose Stabilization Period||0
6568095|NCT01835548|7491316|FG002|COMPLETED|Dose Stabilization Period||85
6568096|NCT01835548|7491314|FG000|NOT COMPLETED|Dose Stabilization Period||0
6568097|NCT01835548|7491315|FG001|NOT COMPLETED|Dose Stabilization Period||0
6568098|NCT01835548|7491316|FG002|NOT COMPLETED|Dose Stabilization Period||0
6568099|NCT01835548|7491314|FG000|STARTED|Double-Blind Treatment Period||44
6818624|NCT00210249|7751111|FG000|COMPLETED|Overall Study||348
6818625|NCT00210249|7751111|FG000|NOT COMPLETED|Overall Study||16
6568100|NCT01835548|7491315|FG001|STARTED|Double-Blind Treatment Period||41
6568101|NCT01835548|7491316|FG002|STARTED|Double-Blind Treatment Period||0
6568102|NCT01835548|7491314|FG000|COMPLETED|Double-Blind Treatment Period||44
6568103|NCT01835548|7491315|FG001|COMPLETED|Double-Blind Treatment Period||39
6568104|NCT01835548|7491316|FG002|COMPLETED|Double-Blind Treatment Period||0
6568105|NCT01835548|7491314|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6568106|NCT01835548|7491315|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
6568107|NCT01835548|7491316|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
6568108|NCT01835587|7491332|FG000|STARTED|Overall Study||3
6568109|NCT01835587|7491333|FG001|STARTED|Overall Study||4
6568110|NCT01835587|7491334|FG002|STARTED|Overall Study||4
6568111|NCT01835587|7491335|FG003|STARTED|Overall Study||19
6568112|NCT01835587|7491332|FG000|COMPLETED|Overall Study||1
6568113|NCT01835587|7491333|FG001|COMPLETED|Overall Study||0
6568114|NCT01835587|7491334|FG002|COMPLETED|Overall Study||2
6568115|NCT01835587|7491335|FG003|COMPLETED|Overall Study||10
6568116|NCT01835587|7491332|FG000|NOT COMPLETED|Overall Study||2
6568117|NCT01835587|7491333|FG001|NOT COMPLETED|Overall Study||4
6568118|NCT01835587|7491334|FG002|NOT COMPLETED|Overall Study||2
6568119|NCT01835587|7491335|FG003|NOT COMPLETED|Overall Study||9
6568120|NCT01835626|7491352|FG000|STARTED|Overall Study||24
6568121|NCT01835626|7491352|FG000|COMPLETED|Overall Study||17
6568122|NCT01835626|7491352|FG000|NOT COMPLETED|Overall Study||7
6568123|NCT01835743|7491358|FG000|STARTED|Overall Study||37
6568124|NCT01835743|7491359|FG001|STARTED|Overall Study||32
6568125|NCT01835743|7491358|FG000|COMPLETED|Overall Study||37
6568126|NCT01835743|7491359|FG001|COMPLETED|Overall Study||32
6568127|NCT01835743|7491358|FG000|NOT COMPLETED|Overall Study||0
6568128|NCT01835743|7491359|FG001|NOT COMPLETED|Overall Study||0
6568129|NCT01835756|7491367|FG000|STARTED|Overall Study||31
6568130|NCT01835756|7491368|FG001|STARTED|Overall Study||31
6568131|NCT01835756|7491367|FG000|COMPLETED|Overall Study||31
6568132|NCT01835756|7491368|FG001|COMPLETED|Overall Study||31
6568133|NCT01835756|7491367|FG000|NOT COMPLETED|Overall Study||0
6568134|NCT01835756|7491368|FG001|NOT COMPLETED|Overall Study||0
6568135|NCT01835899|7491379|FG000|STARTED|Overall Study||6
6568136|NCT01835899|7491380|FG001|STARTED|Overall Study||9
6568137|NCT01835899|7491381|FG002|STARTED|Overall Study||9
6568138|NCT01835899|7491379|FG000|COMPLETED|Overall Study||6
6568139|NCT01835899|7491380|FG001|COMPLETED|Overall Study||8
6568140|NCT01835899|7491381|FG002|COMPLETED|Overall Study||8
6568141|NCT01835899|7491379|FG000|NOT COMPLETED|Overall Study||0
6568142|NCT01835899|7491380|FG001|NOT COMPLETED|Overall Study||1
6568143|NCT01835899|7491381|FG002|NOT COMPLETED|Overall Study||1
6568144|NCT01835912|7491391|FG000|STARTED|Overall Study||10
6568145|NCT01835912|7491391|FG000|Acute|Overall Study||10
6568146|NCT01835912|7491391|FG000|Acute Placebo|Overall Study||10
6568147|NCT01835912|7491391|FG000|Chronic|Overall Study||10
6568148|NCT01835912|7491391|FG000|Chronic Placebo|Overall Study||10
6568149|NCT01835912|7491391|FG000|COMPLETED|Overall Study||10
6568150|NCT01835912|7491391|FG000|NOT COMPLETED|Overall Study||0
6568151|NCT01836029|7491403|FG000|STARTED|Overall Study||100
6568152|NCT01836029|7491404|FG001|STARTED|Overall Study||95
6568153|NCT01836029|7491403|FG000|COMPLETED|Overall Study||100
6568154|NCT01836029|7491404|FG001|COMPLETED|Overall Study||95
6568155|NCT01836029|7491403|FG000|NOT COMPLETED|Overall Study||0
6568156|NCT01836029|7491404|FG001|NOT COMPLETED|Overall Study||0
6568157|NCT01836042|7491413|FG000|STARTED|Overall Study||51
6568158|NCT01836042|7491414|FG001|STARTED|Overall Study||35
6568159|NCT01836042|7491415|FG002|STARTED|Overall Study||22
6568160|NCT01836042|7491413|FG000|COMPLETED|Overall Study||51
6568161|NCT01836042|7491414|FG001|COMPLETED|Overall Study||35
6568162|NCT01836042|7491415|FG002|COMPLETED|Overall Study||22
6568163|NCT01836042|7491413|FG000|NOT COMPLETED|Overall Study||0
6568164|NCT01836042|7491414|FG001|NOT COMPLETED|Overall Study||0
6568165|NCT01836042|7491415|FG002|NOT COMPLETED|Overall Study||0
6568166|NCT01836133|7491423|FG000|STARTED|Overall Study||70
6568167|NCT01836133|7491423|FG000|COMPLETED|Overall Study||70
6568168|NCT01836133|7491423|FG000|NOT COMPLETED|Overall Study||0
6568169|NCT01836185|7491431|FG000|STARTED|Overall Study||10
6568170|NCT01836185|7491432|FG001|STARTED|Overall Study||8
6568171|NCT01836185|7491433|FG002|STARTED|Overall Study||8
6568172|NCT01836185|7491434|FG003|STARTED|Overall Study||6
6568173|NCT01836185|7491431|FG000|Received Single Dose of Study Treatment|Overall Study||10
6568174|NCT01836185|7491432|FG001|Received Single Dose of Study Treatment|Overall Study||8
6568175|NCT01836185|7491433|FG002|Received Single Dose of Study Treatment|Overall Study||8
6568176|NCT01836185|7491434|FG003|Received Single Dose of Study Treatment|Overall Study||6
6568177|NCT01836185|7491431|FG000|COMPLETED|Overall Study||10
6568178|NCT01836185|7491432|FG001|COMPLETED|Overall Study||8
6568179|NCT01836185|7491433|FG002|COMPLETED|Overall Study||8
6568180|NCT01836185|7491434|FG003|COMPLETED|Overall Study||6
6568181|NCT01836185|7491431|FG000|NOT COMPLETED|Overall Study||0
6568182|NCT01836185|7491432|FG001|NOT COMPLETED|Overall Study||0
6568183|NCT01836185|7491433|FG002|NOT COMPLETED|Overall Study||0
6568184|NCT01836185|7491434|FG003|NOT COMPLETED|Overall Study||0
6568185|NCT01836198|7491446|FG000|STARTED|Part A, Period 1||15
6568186|NCT01836198|7491447|FG001|STARTED|Part A, Period 1||15
6568187|NCT01836198|7491448|FG002|STARTED|Part A, Period 1||0
6568188|NCT01836198|7491446|FG000|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
6568189|NCT01836198|7491447|FG001|Received at Least 1 Dose of Study Drug|Part A, Period 1||15
6657182|NCT02467075|7587465|FG001|NOT COMPLETED|72 Hour Follow-up||0
6657183|NCT02467075|7587464|FG000|STARTED|30 Day Follow-up||0
6657184|NCT02467075|7587465|FG001|STARTED|30 Day Follow-up||1
6657185|NCT02467075|7587464|FG000|COMPLETED|30 Day Follow-up||0
6657186|NCT02467075|7587465|FG001|COMPLETED|30 Day Follow-up||1
6657187|NCT02467075|7587464|FG000|NOT COMPLETED|30 Day Follow-up||0
6568190|NCT01836198|7491448|FG002|Received at Least 1 Dose of Study Drug|Part A, Period 1||0
6568191|NCT01836198|7491446|FG000|COMPLETED|Part A, Period 1||15
6568192|NCT01836198|7491447|FG001|COMPLETED|Part A, Period 1||15
6568193|NCT01836198|7491448|FG002|COMPLETED|Part A, Period 1||0
6568194|NCT01836198|7491446|FG000|NOT COMPLETED|Part A, Period 1||0
6568195|NCT01836198|7491447|FG001|NOT COMPLETED|Part A, Period 1||0
6568196|NCT01836198|7491448|FG002|NOT COMPLETED|Part A, Period 1||0
6568197|NCT01836198|7491446|FG000|STARTED|Part A, Period 2||15
6568198|NCT01836198|7491447|FG001|STARTED|Part A, Period 2||15
6568199|NCT01836198|7491448|FG002|STARTED|Part A, Period 2||0
6568200|NCT01836198|7491446|FG000|Completed Part A, Entered Part B|Part A, Period 2||6
6568201|NCT01836198|7491447|FG001|Completed Part A, Entered Part B|Part A, Period 2||6
6568202|NCT01836198|7491448|FG002|Completed Part A, Entered Part B|Part A, Period 2||0
6568203|NCT01836198|7491446|FG000|COMPLETED|Part A, Period 2||15
6568204|NCT01836198|7491447|FG001|COMPLETED|Part A, Period 2||14
6568205|NCT01836198|7491448|FG002|COMPLETED|Part A, Period 2||0
6568206|NCT01836198|7491446|FG000|NOT COMPLETED|Part A, Period 2||0
6568207|NCT01836198|7491447|FG001|NOT COMPLETED|Part A, Period 2||1
6568208|NCT01836198|7491448|FG002|NOT COMPLETED|Part A, Period 2||0
6568209|NCT01836198|7491446|FG000|STARTED|Part B||0
6568210|NCT01836198|7491447|FG001|STARTED|Part B||0
6568211|NCT01836198|7491448|FG002|STARTED|Part B||12
6568212|NCT01836198|7491446|FG000|Received at Least 1 Dose of Study Drug|Part B||0
6568213|NCT01836198|7491447|FG001|Received at Least 1 Dose of Study Drug|Part B||0
6568214|NCT01836198|7491448|FG002|Received at Least 1 Dose of Study Drug|Part B||12
6568215|NCT01836198|7491446|FG000|COMPLETED|Part B||0
6568216|NCT01836198|7491447|FG001|COMPLETED|Part B||0
6568217|NCT01836198|7491448|FG002|COMPLETED|Part B||12
6568218|NCT01836198|7491446|FG000|NOT COMPLETED|Part B||0
6568219|NCT01836198|7491447|FG001|NOT COMPLETED|Part B||0
6568220|NCT01836198|7491448|FG002|NOT COMPLETED|Part B||0
6568221|NCT01836276|7491466|FG000|STARTED|Overall Study||224
6657188|NCT02467075|7587465|FG001|NOT COMPLETED|30 Day Follow-up||0
6568222|NCT01836276|7491467|FG001|STARTED|Overall Study||225
6568223|NCT01836276|7491466|FG000|Week 4|Overall Study||198
6568224|NCT01836276|7491467|FG001|Week 4|Overall Study||186
6568225|NCT01836276|7491466|FG000|Week 12|Overall Study||183
6568226|NCT01836276|7491467|FG001|Week 12|Overall Study||165
6568227|NCT01836276|7491466|FG000|COMPLETED|Overall Study||196
6568228|NCT01836276|7491467|FG001|COMPLETED|Overall Study||174
6568229|NCT01836276|7491466|FG000|NOT COMPLETED|Overall Study||28
6657189|NCT02467166|7587473|FG000|STARTED|Overall Study||36
6568230|NCT01836276|7491467|FG001|NOT COMPLETED|Overall Study||51
6391149|NCT00833898|7302963|FG000|Month 1 (Post Transplantation)|Overall Study||72
6391150|NCT00833898|7302964|FG001|Month 1 (Post Transplantation)|Overall Study||74
6391151|NCT00833898|7302963|FG000|Month 3 (Post Transplantation)|Overall Study||66
6391152|NCT00833898|7302964|FG001|Month 3 (Post Transplantation)|Overall Study||64
6391153|NCT00833898|7302963|FG000|Month 6 (Post Transplantation)|Overall Study||59
6391154|NCT00833898|7302964|FG001|Month 6 (Post Transplantation)|Overall Study||54
6391155|NCT00833898|7302963|FG000|Month 12 (Post Transplantation)|Overall Study||50
6391156|NCT00833898|7302964|FG001|Month 12 (Post Transplantation)|Overall Study||50
6391157|NCT00833898|7302963|FG000|COMPLETED|Overall Study||34
6391158|NCT00833898|7302964|FG001|COMPLETED|Overall Study||38
6391159|NCT00833898|7302963|FG000|NOT COMPLETED|Overall Study||40
6391160|NCT00833898|7302964|FG001|NOT COMPLETED|Overall Study||36
6391161|NCT00833911|7302970|FG000|STARTED|Titration||392
6568231|NCT01836445|7491475|FG000|STARTED|Intervention Modules||445
6568232|NCT01836445|7491476|FG001|STARTED|Intervention Modules||456
6568233|NCT01836445|7491475|FG000|COMPLETED|Intervention Modules||375
6568234|NCT01836445|7491476|FG001|COMPLETED|Intervention Modules||434
6568235|NCT01836445|7491475|FG000|NOT COMPLETED|Intervention Modules||70
6276219|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
6276220|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
6276221|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 337 - 384||183
6276222|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 337 - 384||93
6276223|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 337 - 384||176
6276224|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 337 - 384||90
6276225|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
6276226|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
6276227|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
6276228|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
6276229|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 385 - 432||82
6276230|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 385 - 432||44
6276231|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
6391162|NCT00833911|7302970|FG000|COMPLETED|Titration||371
6391163|NCT00833911|7302970|FG000|NOT COMPLETED|Titration||21
6391164|NCT00833911|7302970|FG000|STARTED|Maintenance Phase I||371
6391165|NCT00833911|7302970|FG000|COMPLETED|Maintenance Phase I||273
6391166|NCT00833911|7302970|FG000|NOT COMPLETED|Maintenance Phase I||98
6391167|NCT00833911|7302970|FG000|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
6391168|NCT00833911|7302970|FG000|COMPLETED|Maintenance Phase II||166
6391169|NCT00833911|7302970|FG000|NOT COMPLETED|Maintenance Phase II||10
6391170|NCT00833924|7302978|FG000|STARTED|Overall Study||120
6391171|NCT00833924|7302978|FG000|30-day|Overall Study||120
6391172|NCT00833924|7302978|FG000|12-month|Overall Study||113
6391173|NCT00833924|7302978|FG000|COMPLETED|Overall Study||11
6391174|NCT00833924|7302978|FG000|NOT COMPLETED|Overall Study||109
6391175|NCT00833976|7302982|FG000|STARTED|Overall Study||65
6391176|NCT00833976|7302982|FG000|COMPLETED|Overall Study||14
6391177|NCT00833976|7302982|FG000|NOT COMPLETED|Overall Study||51
6391178|NCT00833989|7302990|FG000|STARTED|Overall Study||17
6391179|NCT00833989|7302991|FG001|STARTED|Overall Study||8
6391180|NCT00833989|7302992|FG002|STARTED|Overall Study||9
6391181|NCT00833989|7302993|FG003|STARTED|Overall Study||8
6391182|NCT00833989|7302990|FG000|COMPLETED|Overall Study||14
6391183|NCT00833989|7302991|FG001|COMPLETED|Overall Study||8
6391184|NCT00833989|7302992|FG002|COMPLETED|Overall Study||8
6391185|NCT00833989|7302993|FG003|COMPLETED|Overall Study||6
6391186|NCT00833989|7302990|FG000|NOT COMPLETED|Overall Study||3
6391187|NCT00833989|7302991|FG001|NOT COMPLETED|Overall Study||0
6391188|NCT00833989|7302992|FG002|NOT COMPLETED|Overall Study||1
6391189|NCT00833989|7302993|FG003|NOT COMPLETED|Overall Study||2
6391190|NCT00834041|7303008|FG000|STARTED|Overall Study||19
6391191|NCT00834041|7303009|FG001|STARTED|Overall Study||20
6391192|NCT00834041|7303008|FG000|COMPLETED|Overall Study||18
6391193|NCT00834041|7303009|FG001|COMPLETED|Overall Study||19
6391194|NCT00834041|7303008|FG000|NOT COMPLETED|Overall Study||1
6391195|NCT00834041|7303009|FG001|NOT COMPLETED|Overall Study||1
6391196|NCT00834080|7303015|FG000|STARTED|Overall Study||38
6391197|NCT00834080|7303015|FG000|COMPLETED|Overall Study||15
6391198|NCT00834080|7303015|FG000|NOT COMPLETED|Overall Study||23
6391199|NCT00834106|7303021|FG000|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
6568236|NCT01836445|7491476|FG001|NOT COMPLETED|Intervention Modules||22
6657190|NCT02467166|7587473|FG000|COMPLETED|Overall Study||36
6568237|NCT01836445|7491475|FG000|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
6568238|NCT01836445|7491476|FG001|STARTED|3 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|456
6568239|NCT01836445|7491475|FG000|COMPLETED|3 Month Follow-up Assessment||348
6568240|NCT01836445|7491476|FG001|COMPLETED|3 Month Follow-up Assessment||409
6568241|NCT01836445|7491475|FG000|NOT COMPLETED|3 Month Follow-up Assessment||97
6568242|NCT01836445|7491476|FG001|NOT COMPLETED|3 Month Follow-up Assessment||47
6623530|NCT02208050|7550678|FG001|NOT COMPLETED|Treatment Period 1: 8 Weeks Treatment||0
6504810|NCT01449929|7423847|FG000|NOT COMPLETED|Extension Phase Approximately 3 Years||0
6504811|NCT01449929|7423848|FG001|NOT COMPLETED|Extension Phase Approximately 3 Years||0
6504812|NCT01449929|7423849|FG002|NOT COMPLETED|Extension Phase Approximately 3 Years||8
6504813|NCT01449955|7423861|FG000|STARTED|Overall Study||28
6504814|NCT01449955|7423862|FG001|STARTED|Overall Study||26
6504815|NCT01449955|7423861|FG000|COMPLETED|Overall Study||27
6504816|NCT01449955|7423862|FG001|COMPLETED|Overall Study||24
6504817|NCT01449955|7423861|FG000|NOT COMPLETED|Overall Study||1
6504818|NCT01449955|7423862|FG001|NOT COMPLETED|Overall Study||2
6504819|NCT01450007|7423878|FG000|STARTED|Overall Study||44
6504820|NCT01450007|7423879|FG001|STARTED|Overall Study||42
6504821|NCT01450007|7423880|FG002|STARTED|Overall Study||44
6504822|NCT01450007|7423878|FG000|COMPLETED|Overall Study||42
6504823|NCT01450007|7423879|FG001|COMPLETED|Overall Study||37
6504824|NCT01450007|7423880|FG002|COMPLETED|Overall Study||41
6504825|NCT01450007|7423878|FG000|NOT COMPLETED|Overall Study||2
6504826|NCT01450007|7423879|FG001|NOT COMPLETED|Overall Study||5
6391200|NCT00834106|7303022|FG001|STARTED|Base Study (Day 1 to Month 30)|Randomized participants|1503
6391201|NCT00834106|7303021|FG000|Vaccinated|Base Study (Day 1 to Month 30)||1503
6391202|NCT00834106|7303022|FG001|Vaccinated|Base Study (Day 1 to Month 30)||1503
6391203|NCT00834106|7303021|FG000|Completed Vaccinations|Base Study (Day 1 to Month 30)||1473
6391204|NCT00834106|7303022|FG001|Completed Vaccinations|Base Study (Day 1 to Month 30)||1463
6391205|NCT00834106|7303021|FG000|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1401
6391206|NCT00834106|7303022|FG001|COMPLETED|Base Study (Day 1 to Month 30)|Completed Month 30 follow-up|1358
6391207|NCT00834106|7303021|FG000|NOT COMPLETED|Base Study (Day 1 to Month 30)||102
6391208|NCT00834106|7303022|FG001|NOT COMPLETED|Base Study (Day 1 to Month 30)||145
6391209|NCT00834106|7303021|FG000|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1404
6391210|NCT00834106|7303022|FG001|STARTED|Extension Study (Month 42 to Month 90)|Some participants missed the Month 30 visit but returned for the Month 42 visit|1368
6391211|NCT00834106|7303021|FG000|COMPLETED|Extension Study (Month 42 to Month 90)||1308
6391212|NCT00834106|7303022|FG001|COMPLETED|Extension Study (Month 42 to Month 90)||1294
6391213|NCT00834106|7303021|FG000|NOT COMPLETED|Extension Study (Month 42 to Month 90)||96
6391214|NCT00834106|7303022|FG001|NOT COMPLETED|Extension Study (Month 42 to Month 90)||74
6391215|NCT00834171|7303030|FG000|STARTED|Overall Study||43
6391216|NCT00834171|7303031|FG001|STARTED|Overall Study||7
6391217|NCT00834171|7303030|FG000|COMPLETED|Overall Study||43
6391218|NCT00834171|7303031|FG001|COMPLETED|Overall Study||7
6391219|NCT00834171|7303030|FG000|NOT COMPLETED|Overall Study||0
6391220|NCT00834171|7303031|FG001|NOT COMPLETED|Overall Study||0
6391221|NCT00834210|7303039|FG000|STARTED|Overall Study||86
6391222|NCT00834210|7303040|FG001|STARTED|Overall Study||85
6391223|NCT00834210|7303039|FG000|COMPLETED|Overall Study||83
6391224|NCT00834210|7303040|FG001|COMPLETED|Overall Study||77
6391225|NCT00834210|7303039|FG000|NOT COMPLETED|Overall Study||3
6391226|NCT00834210|7303040|FG001|NOT COMPLETED|Overall Study||8
6391227|NCT00834236|7303048|FG000|STARTED|Overall Study||29
6391228|NCT00834236|7303049|FG001|STARTED|Overall Study||47
6391229|NCT00834236|7303048|FG000|COMPLETED|Overall Study||29
6391230|NCT00834236|7303049|FG001|COMPLETED|Overall Study||47
6391231|NCT00834236|7303048|FG000|NOT COMPLETED|Overall Study||0
6504827|NCT01450007|7423880|FG002|NOT COMPLETED|Overall Study||3
6504828|NCT01450098|7423890|FG000|STARTED|Period 1||8
6568243|NCT01836445|7491475|FG000|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
6568244|NCT01836445|7491476|FG001|STARTED|6 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
6568245|NCT01836445|7491475|FG000|COMPLETED|6 Month Follow-up Assessment||342
6568246|NCT01836445|7491476|FG001|COMPLETED|6 Month Follow-up Assessment||380
6568247|NCT01836445|7491475|FG000|NOT COMPLETED|6 Month Follow-up Assessment||103
6504829|NCT01450098|7423891|FG001|STARTED|Period 1||31
6504830|NCT01450098|7423890|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
6504831|NCT01450098|7423891|FG001|Received at Least 1 Dose of Study Drug|Period 1||31
6504832|NCT01450098|7423890|FG000|COMPLETED|Period 1||8
6504833|NCT01450098|7423891|FG001|COMPLETED|Period 1||31
6504834|NCT01450098|7423890|FG000|NOT COMPLETED|Period 1||0
6504835|NCT01450098|7423891|FG001|NOT COMPLETED|Period 1||0
6504836|NCT01450098|7423890|FG000|STARTED|Washout Period of at Least 14 Days||8
6504837|NCT01450098|7423891|FG001|STARTED|Washout Period of at Least 14 Days||31
6504838|NCT01450098|7423890|FG000|COMPLETED|Washout Period of at Least 14 Days||8
6504839|NCT01450098|7423891|FG001|COMPLETED|Washout Period of at Least 14 Days||31
6504840|NCT01450098|7423890|FG000|NOT COMPLETED|Washout Period of at Least 14 Days||0
6504841|NCT01450098|7423891|FG001|NOT COMPLETED|Washout Period of at Least 14 Days||0
6504842|NCT01450098|7423890|FG000|STARTED|Period 2||8
6568248|NCT01836445|7491476|FG001|NOT COMPLETED|6 Month Follow-up Assessment||75
6568249|NCT01836445|7491475|FG000|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
6568250|NCT01836445|7491476|FG001|STARTED|12 Month Follow-up Assessment|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
6568251|NCT01836445|7491475|FG000|COMPLETED|12 Month Follow-up Assessment||370
6568252|NCT01836445|7491476|FG001|COMPLETED|12 Month Follow-up Assessment||391
6568253|NCT01836445|7491475|FG000|NOT COMPLETED|12 Month Follow-up Assessment||75
6568254|NCT01836445|7491476|FG001|NOT COMPLETED|12 Month Follow-up Assessment||64
6568255|NCT01836445|7491475|FG000|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|445
6568256|NCT01836445|7491476|FG001|STARTED|12 Month STI Testing|All enrolled participants allowed to complete follow-up regardless of if they completed intervention|455
6568257|NCT01836445|7491475|FG000|COMPLETED|12 Month STI Testing||365
6568258|NCT01836445|7491476|FG001|COMPLETED|12 Month STI Testing||378
6568259|NCT01836445|7491475|FG000|NOT COMPLETED|12 Month STI Testing||80
6568260|NCT01836445|7491476|FG001|NOT COMPLETED|12 Month STI Testing||77
6568261|NCT01836458|7491486|FG000|STARTED|Overall Study||7
6568262|NCT01836458|7491487|FG001|STARTED|Overall Study||4
6568263|NCT01836458|7491488|FG002|STARTED|Overall Study||7
6568264|NCT01836458|7491489|FG003|STARTED|Overall Study||7
6568265|NCT01836458|7491486|FG000|COMPLETED|Overall Study||4
6568266|NCT01836458|7491487|FG001|COMPLETED|Overall Study||2
6568267|NCT01836458|7491488|FG002|COMPLETED|Overall Study||2
6568268|NCT01836458|7491489|FG003|COMPLETED|Overall Study||1
6568269|NCT01836458|7491486|FG000|NOT COMPLETED|Overall Study||3
6568270|NCT01836458|7491487|FG001|NOT COMPLETED|Overall Study||2
6568271|NCT01836458|7491488|FG002|NOT COMPLETED|Overall Study||5
6568272|NCT01836458|7491489|FG003|NOT COMPLETED|Overall Study||6
6568273|NCT01836471|7491504|FG000|STARTED|Overall Study||93
6568274|NCT01836471|7491505|FG001|STARTED|Overall Study||94
6568275|NCT01836471|7491506|FG002|STARTED|Overall Study||51
6568276|NCT01836471|7491507|FG003|STARTED|Overall Study||42
6568277|NCT01836471|7491508|FG004|STARTED|Overall Study||54
6568278|NCT01836471|7491504|FG000|COMPLETED|Overall Study||82
6568279|NCT01836471|7491505|FG001|COMPLETED|Overall Study||85
6568280|NCT01836471|7491506|FG002|COMPLETED|Overall Study||49
6568281|NCT01836471|7491507|FG003|COMPLETED|Overall Study||40
6568282|NCT01836471|7491508|FG004|COMPLETED|Overall Study||49
6568283|NCT01836471|7491504|FG000|NOT COMPLETED|Overall Study||11
6568284|NCT01836471|7491505|FG001|NOT COMPLETED|Overall Study||9
6568285|NCT01836471|7491506|FG002|NOT COMPLETED|Overall Study||2
6568286|NCT01836471|7491507|FG003|NOT COMPLETED|Overall Study||2
6568287|NCT01836471|7491508|FG004|NOT COMPLETED|Overall Study||5
6568288|NCT01836523|7491525|FG000|STARTED|Overall Study||351
6568289|NCT01836523|7491526|FG001|STARTED|Overall Study||350
6568290|NCT01836523|7491527|FG002|STARTED|Overall Study||349
6568291|NCT01836523|7491528|FG003|STARTED|Overall Study||348
6568292|NCT01836523|7491525|FG000|Exposed|Overall Study||350
6568293|NCT01836523|7491526|FG001|Exposed|Overall Study||348
6568294|NCT01836523|7491527|FG002|Exposed|Overall Study||347
6568295|NCT01836523|7491528|FG003|Exposed|Overall Study||348
6568296|NCT01836523|7491525|FG000|COMPLETED|Overall Study||300
6568297|NCT01836523|7491526|FG001|COMPLETED|Overall Study||265
6568298|NCT01836523|7491527|FG002|COMPLETED|Overall Study||258
6568299|NCT01836523|7491528|FG003|COMPLETED|Overall Study||274
6568300|NCT01836523|7491525|FG000|NOT COMPLETED|Overall Study||51
6568301|NCT01836523|7491526|FG001|NOT COMPLETED|Overall Study||85
6391232|NCT00834236|7303049|FG001|NOT COMPLETED|Overall Study||0
6391233|NCT00834288|7303057|FG000|STARTED|Treatment Phase I||13
6391234|NCT00834288|7303058|FG001|STARTED|Treatment Phase I||13
6391235|NCT00834288|7303057|FG000|COMPLETED|Treatment Phase I||13
6391236|NCT00834288|7303058|FG001|COMPLETED|Treatment Phase I||13
6657191|NCT02467166|7587473|FG000|NOT COMPLETED|Overall Study||0
6657192|NCT02467179|7587479|FG000|STARTED|Overall Study||25
6657193|NCT02467179|7587480|FG001|STARTED|Overall Study||25
6657194|NCT02467179|7587479|FG000|COMPLETED|Overall Study||25
6657195|NCT02467179|7587480|FG001|COMPLETED|Overall Study||25
6657196|NCT02467179|7587479|FG000|NOT COMPLETED|Overall Study||0
6657197|NCT02467179|7587480|FG001|NOT COMPLETED|Overall Study||0
6657198|NCT02467192|7587486|FG000|STARTED|Overall Study||203
6657199|NCT02467192|7587486|FG000|COMPLETED|Overall Study||200
6657200|NCT02467192|7587486|FG000|NOT COMPLETED|Overall Study||3
6276232|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
6276233|NCT00117676|7175407|FG000|STARTED|Open-label Period: Weeks 433 - 480||82
6276234|NCT00117676|7175408|FG001|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
6276235|NCT00117676|7175407|FG000|COMPLETED|Open-label Period: Weeks 433 - 480||80
6276236|NCT00117676|7175408|FG001|COMPLETED|Open-label Period: Weeks 433 - 480||41
6276237|NCT00117676|7175407|FG000|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
6276238|NCT00117676|7175408|FG001|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
6276239|NCT00117715|7175419|FG000|STARTED|Overall Study||121
6276240|NCT00117715|7175419|FG000|1 Year|Overall Study||88
6276241|NCT00117715|7175419|FG000|1.5 Year|Overall Study||85
6276242|NCT00117715|7175419|FG000|2 Year|Overall Study||76
6276243|NCT00117715|7175419|FG000|2.5 Year|Overall Study||70
6276244|NCT00117715|7175419|FG000|3 Year|Overall Study||61
6276245|NCT00117715|7175419|FG000|3.5 Year|Overall Study||60
6276246|NCT00117715|7175419|FG000|4 Year|Overall Study||58
6276247|NCT00117715|7175419|FG000|4.5 Year|Overall Study||55
6276248|NCT00117715|7175419|FG000|5 Year|Overall Study||49
6276249|NCT00117715|7175419|FG000|COMPLETED|Overall Study||49
6276250|NCT00117715|7175419|FG000|NOT COMPLETED|Overall Study||72
6276251|NCT00117793|7175423|FG000|STARTED|Overall Study||17
6276252|NCT00117793|7175423|FG000|COMPLETED|Overall Study||5
6276253|NCT00117793|7175423|FG000|NOT COMPLETED|Overall Study||12
6276254|NCT00117806|7175430|FG000|STARTED|Overall Study||81
6276255|NCT00117806|7175431|FG001|STARTED|Overall Study||76
6276256|NCT00117806|7175430|FG000|COMPLETED|Overall Study||43
6276257|NCT00117806|7175431|FG001|COMPLETED|Overall Study||60
6276258|NCT00117806|7175430|FG000|NOT COMPLETED|Overall Study||38
6276259|NCT00117806|7175431|FG001|NOT COMPLETED|Overall Study||16
6276260|NCT00117845|7175440|FG000|STARTED|Overall Study||17
6276261|NCT00117845|7175440|FG000|COMPLETED|Overall Study||16
6391237|NCT00834288|7303057|FG000|NOT COMPLETED|Treatment Phase I||0
6391238|NCT00834288|7303058|FG001|NOT COMPLETED|Treatment Phase I||0
6391239|NCT00834288|7303057|FG000|STARTED|Treatment Phase II||13
6391240|NCT00834288|7303058|FG001|STARTED|Treatment Phase II||13
6391241|NCT00834288|7303057|FG000|COMPLETED|Treatment Phase II||13
6391242|NCT00834288|7303058|FG001|COMPLETED|Treatment Phase II||13
6391243|NCT00834288|7303057|FG000|NOT COMPLETED|Treatment Phase II||0
6391244|NCT00834288|7303058|FG001|NOT COMPLETED|Treatment Phase II||0
6391245|NCT00834366|7303066|FG000|STARTED|Treatment Period 1||13
6391246|NCT00834366|7303067|FG001|STARTED|Treatment Period 1||13
6391247|NCT00834366|7303066|FG000|COMPLETED|Treatment Period 1||12
6391248|NCT00834366|7303067|FG001|COMPLETED|Treatment Period 1||12
6391249|NCT00834366|7303066|FG000|NOT COMPLETED|Treatment Period 1||1
6391250|NCT00834366|7303067|FG001|NOT COMPLETED|Treatment Period 1||1
6391251|NCT00834366|7303066|FG000|STARTED|Treatment Period 2||12
6391252|NCT00834366|7303067|FG001|STARTED|Treatment Period 2||12
6391253|NCT00834366|7303066|FG000|COMPLETED|Treatment Period 2||12
6391254|NCT00834366|7303067|FG001|COMPLETED|Treatment Period 2||12
6391255|NCT00834366|7303066|FG000|NOT COMPLETED|Treatment Period 2||0
6391256|NCT00834366|7303067|FG001|NOT COMPLETED|Treatment Period 2||0
6391257|NCT00834483|7303075|FG000|STARTED|Overall Study||31
6391258|NCT00834483|7303076|FG001|STARTED|Overall Study||29
6391259|NCT00834483|7303075|FG000|COMPLETED|Overall Study||31
6391260|NCT00834483|7303076|FG001|COMPLETED|Overall Study||29
6276262|NCT00117845|7175440|FG000|NOT COMPLETED|Overall Study||1
6276263|NCT00117949|7175448|FG000|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
6276264|NCT00117949|7175449|FG001|STARTED|Overall Study||24
6276265|NCT00117949|7175450|FG002|STARTED|Overall Study||24
6276266|NCT00117949|7175451|FG003|STARTED|Overall Study||24
6276267|NCT00117949|7175448|FG000|COMPLETED|Overall Study||0
6276268|NCT00117949|7175449|FG001|COMPLETED|Overall Study||0
6276269|NCT00117949|7175450|FG002|COMPLETED|Overall Study||0
6276270|NCT00117949|7175451|FG003|COMPLETED|Overall Study||0
6276271|NCT00117949|7175448|FG000|NOT COMPLETED|Overall Study||10
6276272|NCT00117949|7175449|FG001|NOT COMPLETED|Overall Study||24
6276273|NCT00117949|7175450|FG002|NOT COMPLETED|Overall Study||24
6276274|NCT00117949|7175451|FG003|NOT COMPLETED|Overall Study||24
6276275|NCT00117962|7175463|FG000|STARTED|Overall Study||48
6276276|NCT00117962|7175464|FG001|STARTED|Overall Study||53
6276277|NCT00117962|7175463|FG000|COMPLETED|Overall Study||26
6276278|NCT00117962|7175464|FG001|COMPLETED|Overall Study||28
6276279|NCT00117962|7175463|FG000|NOT COMPLETED|Overall Study||22
6276280|NCT00117962|7175464|FG001|NOT COMPLETED|Overall Study||25
6276281|NCT00117988|7175470|FG000|STARTED|Overall Study||22
6276282|NCT00117988|7175470|FG000|COMPLETED|Overall Study||18
6276283|NCT00117988|7175470|FG000|NOT COMPLETED|Overall Study||4
6276284|NCT00118040|7175477|FG000|STARTED|Overall Study||20
6276285|NCT00118040|7175478|FG001|STARTED|Overall Study||20
6276286|NCT00118040|7175479|FG002|STARTED|Overall Study||20
6276287|NCT00118040|7175477|FG000|COMPLETED|Overall Study||19
6276288|NCT00118040|7175478|FG001|COMPLETED|Overall Study||18
6276289|NCT00118040|7175479|FG002|COMPLETED|Overall Study||14
6276290|NCT00118040|7175477|FG000|NOT COMPLETED|Overall Study||1
6276291|NCT00118040|7175478|FG001|NOT COMPLETED|Overall Study||2
6276292|NCT00118040|7175479|FG002|NOT COMPLETED|Overall Study||6
6276293|NCT00118092|7175492|FG000|STARTED|Overall Study||17
6276294|NCT00118092|7175492|FG000|COMPLETED|Overall Study||15
6276295|NCT00118092|7175492|FG000|NOT COMPLETED|Overall Study||2
6276296|NCT00118131|7175497|FG000|STARTED|Overall Study||49
6276297|NCT00118131|7175497|FG000|COMPLETED|Overall Study||49
6276298|NCT00118131|7175497|FG000|NOT COMPLETED|Overall Study||0
6276299|NCT00118144|7175501|FG000|STARTED|Overall Study||42
6391261|NCT00834483|7303075|FG000|NOT COMPLETED|Overall Study||0
6391262|NCT00834483|7303076|FG001|NOT COMPLETED|Overall Study||0
6391263|NCT00834626|7303082|FG000|STARTED|Overall Study||30
6391264|NCT00834626|7303082|FG000|1 Year Follow-up|Overall Study||30
6391265|NCT00834626|7303082|FG000|COMPLETED|Overall Study||30
6391266|NCT00834626|7303082|FG000|NOT COMPLETED|Overall Study||0
6276300|NCT00118144|7175501|FG000|COMPLETED|Overall Study||41
6276301|NCT00118144|7175501|FG000|NOT COMPLETED|Overall Study||1
6276302|NCT00118157|7175506|FG000|STARTED|Overall Study||19
6276303|NCT00118157|7175506|FG000|COMPLETED|Overall Study||7
6276304|NCT00118157|7175506|FG000|NOT COMPLETED|Overall Study||12
6276305|NCT00118209|7175513|FG000|STARTED|Overall Study||262
6276306|NCT00118209|7175514|FG001|STARTED|Overall Study||262
6276307|NCT00118209|7175513|FG000|Evaluable for Primary Endpoint|Overall Study||250
6276308|NCT00118209|7175514|FG001|Evaluable for Primary Endpoint|Overall Study||241
6276309|NCT00118209|7175513|FG000|Evaluable for Safety Analysis|Overall Study||243
6276310|NCT00118209|7175514|FG001|Evaluable for Safety Analysis|Overall Study||237
6276311|NCT00118209|7175513|FG000|COMPLETED|Overall Study||250
6276312|NCT00118209|7175514|FG001|COMPLETED|Overall Study||241
6276313|NCT00118209|7175513|FG000|NOT COMPLETED|Overall Study||12
6276314|NCT00118209|7175514|FG001|NOT COMPLETED|Overall Study||21
6276315|NCT00118248|7175522|FG000|STARTED|Overall Study||17
6276316|NCT00118248|7175523|FG001|STARTED|Overall Study||24
6276317|NCT00118248|7175522|FG000|COMPLETED|Overall Study||17
6276318|NCT00118248|7175523|FG001|COMPLETED|Overall Study||24
6276319|NCT00118248|7175522|FG000|NOT COMPLETED|Overall Study||0
6276320|NCT00118248|7175523|FG001|NOT COMPLETED|Overall Study||0
6276321|NCT00118274|7175532|FG000|STARTED|Overall Study||41
6276322|NCT00118274|7175533|FG001|STARTED|Overall Study||43
6276323|NCT00118274|7175534|FG002|STARTED|Overall Study||42
6276324|NCT00118274|7175535|FG003|STARTED|Overall Study||44
6276325|NCT00118274|7175532|FG000|COMPLETED|Overall Study||21
6568302|NCT01836523|7491527|FG002|NOT COMPLETED|Overall Study||91
6568303|NCT01836523|7491528|FG003|NOT COMPLETED|Overall Study||74
6623531|NCT02208050|7550677|FG000|STARTED|Washout Period 1: 2 Weeks||36
6623532|NCT02208050|7550678|FG001|STARTED|Washout Period 1: 2 Weeks||28
6623533|NCT02208050|7550677|FG000|COMPLETED|Washout Period 1: 2 Weeks||35
6623534|NCT02208050|7550678|FG001|COMPLETED|Washout Period 1: 2 Weeks||28
6623535|NCT02208050|7550677|FG000|NOT COMPLETED|Washout Period 1: 2 Weeks||1
6623536|NCT02208050|7550678|FG001|NOT COMPLETED|Washout Period 1: 2 Weeks||0
6568304|NCT01836549|7491544|FG000|STARTED|Overall Study||1
6568305|NCT01836549|7491545|FG001|STARTED|Overall Study||1
6391267|NCT00834652|7303089|FG000|STARTED|Overall Study||104
6568306|NCT01836549|7491546|FG002|STARTED|Overall Study||1
6568307|NCT01836549|7491547|FG003|STARTED|Overall Study||9
6568308|NCT01836549|7491548|FG004|STARTED|Overall Study||18
6568309|NCT01836549|7491549|FG005|STARTED|Overall Study||4
6568310|NCT01836549|7491550|FG006|STARTED|Overall Study||9
6568311|NCT01836549|7491544|FG000|COMPLETED|Overall Study||1
6568312|NCT01836549|7491545|FG001|COMPLETED|Overall Study||1
6568313|NCT01836549|7491546|FG002|COMPLETED|Overall Study||0
6568314|NCT01836549|7491547|FG003|COMPLETED|Overall Study||8
6568315|NCT01836549|7491548|FG004|COMPLETED|Overall Study||18
6568316|NCT01836549|7491549|FG005|COMPLETED|Overall Study||4
6568317|NCT01836549|7491550|FG006|COMPLETED|Overall Study||8
6568318|NCT01836549|7491544|FG000|NOT COMPLETED|Overall Study||0
6657201|NCT02467387|7587494|FG000|STARTED|First Intervention||11
6657202|NCT02467387|7587495|FG001|STARTED|First Intervention||12
6657203|NCT02467387|7587494|FG000|Received Treatment as Randomized|First Intervention||10
6657204|NCT02467387|7587495|FG001|Received Treatment as Randomized|First Intervention||12
6657205|NCT02467387|7587494|FG000|COMPLETED|First Intervention||10
6657206|NCT02467387|7587495|FG001|COMPLETED|First Intervention||12
6657207|NCT02467387|7587494|FG000|NOT COMPLETED|First Intervention||1
6657208|NCT02467387|7587495|FG001|NOT COMPLETED|First Intervention||0
6657209|NCT02467387|7587494|FG000|STARTED|Second Intervention||10
6657210|NCT02467387|7587495|FG001|STARTED|Second Intervention||12
6657211|NCT02467387|7587494|FG000|COMPLETED|Second Intervention||7
6657212|NCT02467387|7587495|FG001|COMPLETED|Second Intervention||12
6657213|NCT02467387|7587494|FG000|NOT COMPLETED|Second Intervention||3
6657214|NCT02467387|7587495|FG001|NOT COMPLETED|Second Intervention||0
6657215|NCT02467465|7587505|FG000|STARTED|Overall Study||15
6657216|NCT02467465|7587506|FG001|STARTED|Overall Study||15
6657217|NCT02467465|7587505|FG000|COMPLETED|Overall Study||15
6657218|NCT02467465|7587506|FG001|COMPLETED|Overall Study||15
6657219|NCT02467465|7587505|FG000|NOT COMPLETED|Overall Study||0
6657220|NCT02467465|7587506|FG001|NOT COMPLETED|Overall Study||0
6657221|NCT02467491|7587514|FG000|STARTED|Overall Study||12
6657222|NCT02467491|7587514|FG000|COMPLETED|Overall Study||12
6657223|NCT02467491|7587514|FG000|NOT COMPLETED|Overall Study||0
6657224|NCT02467504|7587520|FG000|STARTED|Overall Study||23
6657225|NCT02467504|7587521|FG001|STARTED|Overall Study||24
6657226|NCT02467504|7587520|FG000|COMPLETED|Overall Study||17
6568319|NCT01836549|7491545|FG001|NOT COMPLETED|Overall Study||0
6568320|NCT01836549|7491546|FG002|NOT COMPLETED|Overall Study||1
6568321|NCT01836549|7491547|FG003|NOT COMPLETED|Overall Study||1
6568322|NCT01836549|7491548|FG004|NOT COMPLETED|Overall Study||0
6568323|NCT01836549|7491549|FG005|NOT COMPLETED|Overall Study||0
6568324|NCT01836549|7491550|FG006|NOT COMPLETED|Overall Study||1
6568325|NCT01837069|7491568|FG000|STARTED|Overall Study||103
6391268|NCT00834652|7303090|FG001|STARTED|Overall Study||102
6568326|NCT01837069|7491569|FG001|STARTED|Overall Study||95
6568327|NCT01837069|7491568|FG000|COMPLETED|Overall Study||103
6568328|NCT01837069|7491569|FG001|COMPLETED|Overall Study||95
6568329|NCT01837069|7491568|FG000|NOT COMPLETED|Overall Study||0
6568330|NCT01837069|7491569|FG001|NOT COMPLETED|Overall Study||0
6568331|NCT01837524|7491577|FG000|STARTED|Overall Study||28
6568332|NCT01837524|7491578|FG001|STARTED|Overall Study||27
6568333|NCT01837524|7491577|FG000|COMPLETED|Overall Study||25
6568334|NCT01837524|7491578|FG001|COMPLETED|Overall Study||25
6568335|NCT01837524|7491577|FG000|NOT COMPLETED|Overall Study||3
6568336|NCT01837524|7491578|FG001|NOT COMPLETED|Overall Study||2
6568337|NCT01837537|7491584|FG000|STARTED|Overall Study||90
6657227|NCT02467504|7587521|FG001|COMPLETED|Overall Study||23
6568338|NCT01837537|7491584|FG000|COMPLETED|Overall Study||90
6568339|NCT01837537|7491584|FG000|NOT COMPLETED|Overall Study||0
6568340|NCT01837550|7491590|FG000|STARTED|T0-T1, 5 Weeks||37
6568341|NCT01837550|7491591|FG001|STARTED|T0-T1, 5 Weeks||37
6568342|NCT01837550|7491590|FG000|COMPLETED|T0-T1, 5 Weeks||37
6568343|NCT01837550|7491591|FG001|COMPLETED|T0-T1, 5 Weeks||37
6568344|NCT01837550|7491590|FG000|NOT COMPLETED|T0-T1, 5 Weeks||0
6568345|NCT01837550|7491591|FG001|NOT COMPLETED|T0-T1, 5 Weeks||0
6568346|NCT01837550|7491590|FG000|STARTED|T0-T2, 6 Months Follow-up||37
6568347|NCT01837550|7491591|FG001|STARTED|T0-T2, 6 Months Follow-up||37
6568348|NCT01837550|7491590|FG000|COMPLETED|T0-T2, 6 Months Follow-up||37
6568349|NCT01837550|7491591|FG001|COMPLETED|T0-T2, 6 Months Follow-up||37
6568350|NCT01837550|7491590|FG000|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
6568351|NCT01837550|7491591|FG001|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
6568352|NCT01837654|7491599|FG000|STARTED|Overall Study||11
6568353|NCT01837654|7491600|FG001|STARTED|Overall Study||11
6568354|NCT01837654|7491599|FG000|COMPLETED|Overall Study||11
6568355|NCT01837654|7491600|FG001|COMPLETED|Overall Study||11
6568356|NCT01837654|7491599|FG000|NOT COMPLETED|Overall Study||0
6568357|NCT01837654|7491600|FG001|NOT COMPLETED|Overall Study||0
6568358|NCT01837680|7491608|FG000|STARTED|Overall Study||52
6568359|NCT01837680|7491609|FG001|STARTED|Overall Study||53
6568360|NCT01837680|7491608|FG000|COMPLETED|Overall Study||42
6568361|NCT01837680|7491609|FG001|COMPLETED|Overall Study||45
6568362|NCT01837680|7491608|FG000|NOT COMPLETED|Overall Study||10
6568363|NCT01837680|7491609|FG001|NOT COMPLETED|Overall Study||8
6568364|NCT01837719|7491615|FG000|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
6568365|NCT01837719|7491615|FG000|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
6568366|NCT01837719|7491615|FG000|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
6568367|NCT01837719|7491615|FG000|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
6568368|NCT01837719|7491615|FG000|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
6568369|NCT01837719|7491615|FG000|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
6568370|NCT01837719|7491615|FG000|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
6568371|NCT01837719|7491615|FG000|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
6568372|NCT01837719|7491615|FG000|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
6568373|NCT01837719|7491615|FG000|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
6568374|NCT01837719|7491615|FG000|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
6568375|NCT01837719|7491615|FG000|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
6568376|NCT01837719|7491615|FG000|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
6568377|NCT01837719|7491615|FG000|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
6568378|NCT01837719|7491615|FG000|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
6276326|NCT00118274|7175533|FG001|COMPLETED|Overall Study||21
6276327|NCT00118274|7175534|FG002|COMPLETED|Overall Study||25
6276328|NCT00118274|7175535|FG003|COMPLETED|Overall Study||29
6276329|NCT00118274|7175532|FG000|NOT COMPLETED|Overall Study||20
6276330|NCT00118274|7175533|FG001|NOT COMPLETED|Overall Study||22
6276331|NCT00118274|7175534|FG002|NOT COMPLETED|Overall Study||17
6276332|NCT00118274|7175535|FG003|NOT COMPLETED|Overall Study||15
6276333|NCT00118287|7175545|FG000|STARTED|Overall Study||32
6276334|NCT00118287|7175545|FG000|COMPLETED|Overall Study||30
6276335|NCT00118287|7175545|FG000|NOT COMPLETED|Overall Study||2
6276336|NCT00118352|7175552|FG000|STARTED|Overall Study||12
6276337|NCT00118352|7175553|FG001|STARTED|Overall Study||0
6276338|NCT00118352|7175554|FG002|STARTED|Overall Study||0
6276339|NCT00118352|7175552|FG000|COMPLETED|Overall Study||12
6276340|NCT00118352|7175553|FG001|COMPLETED|Overall Study||0
6276341|NCT00118352|7175554|FG002|COMPLETED|Overall Study||0
6276342|NCT00118352|7175552|FG000|NOT COMPLETED|Overall Study||0
6276343|NCT00118352|7175553|FG001|NOT COMPLETED|Overall Study||0
6276344|NCT00118352|7175554|FG002|NOT COMPLETED|Overall Study||0
6276345|NCT00118365|7175564|FG000|STARTED|Overall Study||191
6276346|NCT00118365|7175565|FG001|STARTED|Overall Study||184
6276347|NCT00118365|7175564|FG000|COMPLETED|Overall Study||132
6276348|NCT00118365|7175565|FG001|COMPLETED|Overall Study||124
6276349|NCT00118365|7175564|FG000|NOT COMPLETED|Overall Study||59
6276350|NCT00118365|7175565|FG001|NOT COMPLETED|Overall Study||60
6276351|NCT00118378|7175603|FG000|STARTED|Overall Study||62
6276352|NCT00118378|7175604|FG001|STARTED|Overall Study||53
6276353|NCT00118378|7175603|FG000|COMPLETED|Overall Study||60
6276354|NCT00118378|7175604|FG001|COMPLETED|Overall Study||45
6276355|NCT00118378|7175603|FG000|NOT COMPLETED|Overall Study||2
6276356|NCT00118378|7175604|FG001|NOT COMPLETED|Overall Study||8
6276357|NCT00118404|7175615|FG000|STARTED|Overall Study||86
6276358|NCT00118404|7175616|FG001|STARTED|Overall Study||86
6276359|NCT00118404|7175617|FG002|STARTED|Overall Study||69
6276360|NCT00118404|7175615|FG000|COMPLETED|Overall Study||62
6276361|NCT00118404|7175616|FG001|COMPLETED|Overall Study||70
6276362|NCT00118404|7175617|FG002|COMPLETED|Overall Study||49
6276363|NCT00118404|7175615|FG000|NOT COMPLETED|Overall Study||24
6276364|NCT00118404|7175616|FG001|NOT COMPLETED|Overall Study||16
6276365|NCT00118404|7175617|FG002|NOT COMPLETED|Overall Study||20
6276366|NCT00118417|7175625|FG000|STARTED|Phase I (Weeks 0 to 6)||39
6276367|NCT00118417|7175626|FG001|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
6276368|NCT00118417|7175625|FG000|COMPLETED|Phase I (Weeks 0 to 6)||21
6391269|NCT00834652|7303089|FG000|COMPLETED|Overall Study||66
6391270|NCT00834652|7303090|FG001|COMPLETED|Overall Study||62
6391271|NCT00834652|7303089|FG000|NOT COMPLETED|Overall Study||38
6391272|NCT00834652|7303090|FG001|NOT COMPLETED|Overall Study||40
6391273|NCT00834678|7303096|FG000|STARTED|Overall Study||11
6391274|NCT00834678|7303096|FG000|COMPLETED|Overall Study||11
6391275|NCT00834678|7303096|FG000|NOT COMPLETED|Overall Study||0
6391276|NCT00834808|7303105|FG000|STARTED|Treatment Period 1 (Day 1)||9
6391277|NCT00834808|7303106|FG001|STARTED|Treatment Period 1 (Day 1)||9
6391278|NCT00834808|7303107|FG002|STARTED|Treatment Period 1 (Day 1)||9
6276369|NCT00118417|7175626|FG001|COMPLETED|Phase I (Weeks 0 to 6)||0
6276370|NCT00118417|7175625|FG000|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
6276371|NCT00118417|7175626|FG001|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
6276372|NCT00118417|7175625|FG000|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
6276373|NCT00118417|7175626|FG001|STARTED|Phase II (Weeks 6 to 12)||13
6276374|NCT00118417|7175625|FG000|COMPLETED|Phase II (Weeks 6 to 12)||9
6276375|NCT00118417|7175626|FG001|COMPLETED|Phase II (Weeks 6 to 12)||10
6276376|NCT00118417|7175625|FG000|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
6276377|NCT00118417|7175626|FG001|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
6276378|NCT00118417|7175625|FG000|STARTED|Phase III (Weeks 12 to 24)||9
6276379|NCT00118417|7175626|FG001|STARTED|Phase III (Weeks 12 to 24)||10
6276380|NCT00118417|7175625|FG000|COMPLETED|Phase III (Weeks 12 to 24)||8
6276381|NCT00118417|7175626|FG001|COMPLETED|Phase III (Weeks 12 to 24)||9
6276382|NCT00118417|7175625|FG000|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
6276383|NCT00118417|7175626|FG001|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
6276384|NCT00118430|7175639|FG000|STARTED|Overall Study||123
6276385|NCT00118430|7175640|FG001|STARTED|Overall Study||127
6276386|NCT00118430|7175641|FG002|STARTED|Overall Study||250
6276387|NCT00118430|7175639|FG000|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
6276388|NCT00118430|7175640|FG001|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
6276389|NCT00118430|7175641|FG002|COMPLETED|Overall Study||222
6276390|NCT00118430|7175639|FG000|NOT COMPLETED|Overall Study||21
6276391|NCT00118430|7175640|FG001|NOT COMPLETED|Overall Study||24
6276392|NCT00118430|7175641|FG002|NOT COMPLETED|Overall Study||28
6276393|NCT00118482|7175650|FG000|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
6276394|NCT00118482|7175651|FG001|STARTED|Overall Study||105
6276395|NCT00118482|7175650|FG000|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
6504843|NCT01450098|7423891|FG001|STARTED|Period 2||31
6504844|NCT01450098|7423890|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
6504845|NCT01450098|7423891|FG001|Received at Least 1 Dose of Study Drug|Period 2||31
6568379|NCT01837797|7491633|FG000|STARTED|Period 1||129
6568380|NCT01837797|7491634|FG001|STARTED|Period 1||0
6568381|NCT01837797|7491635|FG002|STARTED|Period 1||0
6568382|NCT01837797|7491636|FG003|STARTED|Period 1||0
6568383|NCT01837797|7491637|FG004|STARTED|Period 1||0
6568384|NCT01837797|7491633|FG000|COMPLETED|Period 1||27
6568385|NCT01837797|7491634|FG001|COMPLETED|Period 1||0
6568386|NCT01837797|7491635|FG002|COMPLETED|Period 1||0
6568387|NCT01837797|7491636|FG003|COMPLETED|Period 1||0
6568388|NCT01837797|7491637|FG004|COMPLETED|Period 1||0
6568389|NCT01837797|7491633|FG000|NOT COMPLETED|Period 1||102
6568390|NCT01837797|7491634|FG001|NOT COMPLETED|Period 1||0
6568391|NCT01837797|7491635|FG002|NOT COMPLETED|Period 1||0
6504846|NCT01450098|7423890|FG000|COMPLETED|Period 2||8
6504847|NCT01450098|7423891|FG001|COMPLETED|Period 2||31
6504848|NCT01450098|7423890|FG000|NOT COMPLETED|Period 2||0
6504849|NCT01450098|7423891|FG001|NOT COMPLETED|Period 2||0
6504850|NCT01450098|7423890|FG000|STARTED|Washout of at Least 14 Days||8
6504851|NCT01450098|7423891|FG001|STARTED|Washout of at Least 14 Days||31
6504852|NCT01450098|7423890|FG000|COMPLETED|Washout of at Least 14 Days||8
6568392|NCT01837797|7491636|FG003|NOT COMPLETED|Period 1||0
6568393|NCT01837797|7491637|FG004|NOT COMPLETED|Period 1||0
6276396|NCT00118482|7175651|FG001|COMPLETED|Overall Study||76
6276397|NCT00118482|7175650|FG000|NOT COMPLETED|Overall Study||30
6276398|NCT00118482|7175651|FG001|NOT COMPLETED|Overall Study||29
6276399|NCT00118534|7175659|FG000|STARTED|Overall Study||472
6276400|NCT00118534|7175660|FG001|STARTED|Overall Study||471
6276401|NCT00118534|7175659|FG000|COMPLETED|Overall Study||472
6276402|NCT00118534|7175660|FG001|COMPLETED|Overall Study||471
6276403|NCT00118534|7175659|FG000|NOT COMPLETED|Overall Study||0
6276404|NCT00118534|7175660|FG001|NOT COMPLETED|Overall Study||0
6276405|NCT00118703|7175669|FG000|STARTED|Overall Study||173
6276406|NCT00118703|7175670|FG001|STARTED|Overall Study||174
6276407|NCT00118703|7175669|FG000|COMPLETED|Overall Study||168
6276408|NCT00118703|7175670|FG001|COMPLETED|Overall Study||165
6276409|NCT00118703|7175669|FG000|NOT COMPLETED|Overall Study||5
6276410|NCT00118703|7175670|FG001|NOT COMPLETED|Overall Study||9
6276411|NCT00118716|7175678|FG000|STARTED|Overall Study||124
6276412|NCT00118716|7175679|FG001|STARTED|Overall Study||124
6276413|NCT00118716|7175678|FG000|COMPLETED|Overall Study||111
6276414|NCT00118716|7175679|FG001|COMPLETED|Overall Study||102
6276415|NCT00118716|7175678|FG000|NOT COMPLETED|Overall Study||13
6276416|NCT00118716|7175679|FG001|NOT COMPLETED|Overall Study||22
6568394|NCT01837797|7491633|FG000|STARTED|Period 2||0
6276417|NCT00118742|7175687|FG000|STARTED|Overall Study||145
6276418|NCT00118742|7175688|FG001|STARTED|Overall Study||148
6276419|NCT00118742|7175687|FG000|COMPLETED|Overall Study||96
6276420|NCT00118742|7175688|FG001|COMPLETED|Overall Study||82
6276421|NCT00118742|7175687|FG000|NOT COMPLETED|Overall Study||49
6276422|NCT00118742|7175688|FG001|NOT COMPLETED|Overall Study||66
6276423|NCT00118755|7175696|FG000|STARTED|Overall Study||217
6276424|NCT00118755|7175697|FG001|STARTED|Overall Study||218
6276425|NCT00118755|7175696|FG000|Safety Population|Overall Study||208
6568395|NCT01837797|7491634|FG001|STARTED|Period 2||6
6276426|NCT00118755|7175697|FG001|Safety Population|Overall Study||211
6276427|NCT00118755|7175696|FG000|COMPLETED|Overall Study||7
6276428|NCT00118755|7175697|FG001|COMPLETED|Overall Study||3
6276429|NCT00118755|7175696|FG000|NOT COMPLETED|Overall Study||210
6276430|NCT00118755|7175697|FG001|NOT COMPLETED|Overall Study||215
6276431|NCT00118898|7175707|FG000|STARTED|Overall Study||464
6276432|NCT00118898|7175708|FG001|STARTED|Overall Study||465
6276433|NCT00118898|7175709|FG002|STARTED|Overall Study||465
6276434|NCT00118898|7175710|FG003|STARTED|Overall Study||463
6276435|NCT00118898|7175707|FG000|Initiated Treatment|Overall Study||461
6568396|NCT01837797|7491635|FG002|STARTED|Period 2||3
6568397|NCT01837797|7491636|FG003|STARTED|Period 2||6
6568398|NCT01837797|7491637|FG004|STARTED|Period 2||0
6568399|NCT01837797|7491633|FG000|COMPLETED|Period 2||0
6568400|NCT01837797|7491634|FG001|COMPLETED|Period 2||1
6568401|NCT01837797|7491635|FG002|COMPLETED|Period 2||1
6568402|NCT01837797|7491636|FG003|COMPLETED|Period 2||1
6568403|NCT01837797|7491637|FG004|COMPLETED|Period 2||0
6568404|NCT01837797|7491633|FG000|NOT COMPLETED|Period 2||0
6568405|NCT01837797|7491634|FG001|NOT COMPLETED|Period 2||5
6568406|NCT01837797|7491635|FG002|NOT COMPLETED|Period 2||2
6568407|NCT01837797|7491636|FG003|NOT COMPLETED|Period 2||5
6568408|NCT01837797|7491637|FG004|NOT COMPLETED|Period 2||0
6568409|NCT01837797|7491633|FG000|STARTED|Period 3||0
6568410|NCT01837797|7491634|FG001|STARTED|Period 3||0
6568411|NCT01837797|7491635|FG002|STARTED|Period 3||0
6568412|NCT01837797|7491636|FG003|STARTED|Period 3||0
6568413|NCT01837797|7491637|FG004|STARTED|Period 3||47
6568414|NCT01837797|7491633|FG000|COMPLETED|Period 3||0
6568415|NCT01837797|7491634|FG001|COMPLETED|Period 3||0
6568416|NCT01837797|7491635|FG002|COMPLETED|Period 3||0
6568417|NCT01837797|7491636|FG003|COMPLETED|Period 3||0
6568418|NCT01837797|7491637|FG004|COMPLETED|Period 3||24
6568419|NCT01837797|7491633|FG000|NOT COMPLETED|Period 3||0
6568420|NCT01837797|7491634|FG001|NOT COMPLETED|Period 3||0
6568421|NCT01837797|7491635|FG002|NOT COMPLETED|Period 3||0
6568422|NCT01837797|7491636|FG003|NOT COMPLETED|Period 3||0
6568423|NCT01837797|7491637|FG004|NOT COMPLETED|Period 3||23
6568424|NCT01837823|7491645|FG000|STARTED|Overall Study||91
6568425|NCT01837823|7491645|FG000|COMPLETED|Overall Study||85
6568426|NCT01837823|7491645|FG000|NOT COMPLETED|Overall Study||6
6568427|NCT01837901|7491656|FG000|STARTED|Overall Study||22
6568428|NCT01837901|7491657|FG001|STARTED|Overall Study||21
6568429|NCT01837901|7491658|FG002|STARTED|Overall Study||20
6568430|NCT01837901|7491656|FG000|COMPLETED|Overall Study||20
6568431|NCT01837901|7491657|FG001|COMPLETED|Overall Study||15
6568432|NCT01837901|7491658|FG002|COMPLETED|Overall Study||17
6568433|NCT01837901|7491656|FG000|NOT COMPLETED|Overall Study||2
6568434|NCT01837901|7491657|FG001|NOT COMPLETED|Overall Study||6
6568435|NCT01837901|7491658|FG002|NOT COMPLETED|Overall Study||3
6568436|NCT01837966|7491668|FG000|STARTED|Overall Study||47
6568437|NCT01837966|7491669|FG001|STARTED|Overall Study||46
6568438|NCT01837966|7491668|FG000|COMPLETED|Overall Study||45
6568439|NCT01837966|7491669|FG001|COMPLETED|Overall Study||45
6568440|NCT01837966|7491668|FG000|NOT COMPLETED|Overall Study||2
6568441|NCT01837966|7491669|FG001|NOT COMPLETED|Overall Study||1
6568442|NCT01838044|7491677|FG000|STARTED|Overall Study||89
6568443|NCT01838044|7491678|FG001|STARTED|Overall Study||91
6568444|NCT01838044|7491677|FG000|COMPLETED|Overall Study||81
6568445|NCT01838044|7491678|FG001|COMPLETED|Overall Study||75
6568446|NCT01838044|7491677|FG000|NOT COMPLETED|Overall Study||8
6568447|NCT01838044|7491678|FG001|NOT COMPLETED|Overall Study||16
6568448|NCT01838200|7491687|FG000|STARTED|Overall Study||3
6568449|NCT01838200|7491688|FG001|STARTED|Overall Study||2
6568450|NCT01838200|7491687|FG000|COMPLETED|Overall Study||0
6568451|NCT01838200|7491688|FG001|COMPLETED|Overall Study||0
6568452|NCT01838200|7491687|FG000|NOT COMPLETED|Overall Study||3
6568453|NCT01838200|7491688|FG001|NOT COMPLETED|Overall Study||2
6568454|NCT01838213|7491696|FG000|STARTED|Overall Study||247
6568455|NCT01838213|7491697|FG001|STARTED|Overall Study||453
6568456|NCT01838213|7491696|FG000|COMPLETED|Overall Study||81
6568457|NCT01838213|7491697|FG001|COMPLETED|Overall Study||262
6568458|NCT01838213|7491696|FG000|NOT COMPLETED|Overall Study||166
6568459|NCT01838213|7491697|FG001|NOT COMPLETED|Overall Study||191
6568460|NCT01838226|7491705|FG000|STARTED|Overall Study||202
6568461|NCT01838226|7491706|FG001|STARTED|Overall Study||199
6568462|NCT01838226|7491705|FG000|COMPLETED|Overall Study||126
6568463|NCT01838226|7491706|FG001|COMPLETED|Overall Study||128
6568464|NCT01838226|7491705|FG000|NOT COMPLETED|Overall Study||76
6568465|NCT01838226|7491706|FG001|NOT COMPLETED|Overall Study||71
6568466|NCT01838304|7491714|FG000|STARTED|Overall Study||20
6568467|NCT01838304|7491715|FG001|STARTED|Overall Study||20
6568468|NCT01838304|7491714|FG000|COMPLETED|Overall Study||19
6568469|NCT01838304|7491715|FG001|COMPLETED|Overall Study||20
6568470|NCT01838304|7491714|FG000|NOT COMPLETED|Overall Study||1
6568471|NCT01838304|7491715|FG001|NOT COMPLETED|Overall Study||0
6568472|NCT01838317|7491723|FG000|STARTED|Overall Study||9
6568473|NCT01838317|7491724|FG001|STARTED|Overall Study||5
6568474|NCT01838317|7491723|FG000|COMPLETED|Overall Study||9
6568475|NCT01838317|7491724|FG001|COMPLETED|Overall Study||5
6568476|NCT01838317|7491723|FG000|NOT COMPLETED|Overall Study||0
6568477|NCT01838317|7491724|FG001|NOT COMPLETED|Overall Study||0
6568478|NCT01838447|7491732|FG000|STARTED|Overall Study||22
6568479|NCT01838447|7491733|FG001|STARTED|Overall Study||24
6568480|NCT01838447|7491732|FG000|COMPLETED|Overall Study||20
6568481|NCT01838447|7491733|FG001|COMPLETED|Overall Study||21
6568482|NCT01838447|7491732|FG000|NOT COMPLETED|Overall Study||2
6568483|NCT01838447|7491733|FG001|NOT COMPLETED|Overall Study||3
6568484|NCT01838499|7491741|FG000|STARTED|Overall Study||55
6568485|NCT01838499|7491742|FG001|STARTED|Overall Study||54
6568486|NCT01838499|7491741|FG000|COMPLETED|Overall Study||31
6568487|NCT01838499|7491742|FG001|COMPLETED|Overall Study||37
6568488|NCT01838499|7491741|FG000|NOT COMPLETED|Overall Study||24
6568489|NCT01838499|7491742|FG001|NOT COMPLETED|Overall Study||17
6568490|NCT01838551|7491748|FG000|STARTED|Overall Study|94 subjects were enrolled and received at least 1 dose of levoketoconazole|94
6568491|NCT01838551|7491748|FG000|COMPLETED|Overall Study|46 subjects completed the Extended Evaluation phase|46
6568492|NCT01838551|7491748|FG000|NOT COMPLETED|Overall Study||48
6568493|NCT01838590|7491756|FG000|STARTED|Overall Study||52
6657228|NCT02467504|7587520|FG000|NOT COMPLETED|Overall Study||6
6657229|NCT02467504|7587521|FG001|NOT COMPLETED|Overall Study||1
6657230|NCT02467621|7587529|FG000|STARTED|Overall Study||1645
6657231|NCT02467621|7587530|FG001|STARTED|Overall Study||1653
6568494|NCT01838590|7491757|FG001|STARTED|Overall Study||51
6568495|NCT01838590|7491756|FG000|COMPLETED|Overall Study||40
6568496|NCT01838590|7491757|FG001|COMPLETED|Overall Study||46
6568497|NCT01838590|7491756|FG000|NOT COMPLETED|Overall Study||12
6657232|NCT02467621|7587529|FG000|COMPLETED|Overall Study||1644
6657233|NCT02467621|7587530|FG001|COMPLETED|Overall Study||1647
6657234|NCT02467621|7587529|FG000|NOT COMPLETED|Overall Study||1
6657235|NCT02467621|7587530|FG001|NOT COMPLETED|Overall Study||6
6657236|NCT02467777|7587538|FG000|STARTED|Overall Study||23
6657237|NCT02467777|7587539|FG001|STARTED|Overall Study||27
6657238|NCT02467777|7587538|FG000|COMPLETED|Overall Study||23
6657239|NCT02467777|7587539|FG001|COMPLETED|Overall Study||27
6657240|NCT02467777|7587538|FG000|NOT COMPLETED|Overall Study||0
6568498|NCT01838590|7491757|FG001|NOT COMPLETED|Overall Study||5
6568499|NCT01838616|7491769|FG000|STARTED|Titration Period||130
6568500|NCT01838616|7491770|FG001|STARTED|Titration Period||128
6568501|NCT01838616|7491769|FG000|No Post Baseline Pain Intensity Values|Titration Period||0
6568502|NCT01838616|7491770|FG001|No Post Baseline Pain Intensity Values|Titration Period||2
6568503|NCT01838616|7491769|FG000|Major Protocol Deviations|Titration Period||13
6568504|NCT01838616|7491770|FG001|Major Protocol Deviations|Titration Period||16
6568505|NCT01838616|7491769|FG000|Switched to Pick-up Arm|Titration Period||0
6568506|NCT01838616|7491770|FG001|Switched to Pick-up Arm|Titration Period||43
6568507|NCT01838616|7491769|FG000|Full Analysis Set|Titration Period||130
6568508|NCT01838616|7491770|FG001|Full Analysis Set|Titration Period||128
6568509|NCT01838616|7491769|FG000|Per Protocol Set|Titration Period||117
6568510|NCT01838616|7491770|FG001|Per Protocol Set|Titration Period||112
6568511|NCT01838616|7491769|FG000|COMPLETED|Titration Period||100
6568512|NCT01838616|7491770|FG001|COMPLETED|Titration Period||62
6568513|NCT01838616|7491769|FG000|NOT COMPLETED|Titration Period||30
6568514|NCT01838616|7491770|FG001|NOT COMPLETED|Titration Period||66
6568515|NCT01838616|7491769|FG000|STARTED|Continuation Period||100
6568516|NCT01838616|7491770|FG001|STARTED|Continuation Period||62
6568517|NCT01838616|7491769|FG000|Switched to Pick-up Arm|Continuation Period||0
6568518|NCT01838616|7491770|FG001|Switched to Pick-up Arm|Continuation Period||7
6568519|NCT01838616|7491769|FG000|COMPLETED|Continuation Period||86
6568520|NCT01838616|7491770|FG001|COMPLETED|Continuation Period||48
6568521|NCT01838616|7491769|FG000|NOT COMPLETED|Continuation Period||14
6568522|NCT01838616|7491770|FG001|NOT COMPLETED|Continuation Period||14
6568523|NCT01838616|7491769|FG000|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
6568524|NCT01838616|7491770|FG001|STARTED|Pick-up Arm||0
6568525|NCT01838616|7491769|FG000|Full Analysis Set|Pick-up Arm||49
6568526|NCT01838616|7491770|FG001|Full Analysis Set|Pick-up Arm||0
6568527|NCT01838616|7491769|FG000|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
6568528|NCT01838616|7491770|FG001|COMPLETED|Pick-up Arm||0
6568529|NCT01838616|7491769|FG000|NOT COMPLETED|Pick-up Arm||15
6568530|NCT01838616|7491770|FG001|NOT COMPLETED|Pick-up Arm||0
6568531|NCT01838642|7491781|FG000|STARTED|Overall Study||3
6568532|NCT01838642|7491781|FG000|COMPLETED|Overall Study||2
6568533|NCT01838642|7491781|FG000|NOT COMPLETED|Overall Study||1
6568534|NCT01838655|7491786|FG000|STARTED|Overall Study||5
6568535|NCT01838655|7491786|FG000|COMPLETED|Overall Study||5
6568536|NCT01838655|7491786|FG000|NOT COMPLETED|Overall Study||0
6568537|NCT01838681|7491790|FG000|STARTED|Period A||1986
6568538|NCT01838681|7491791|FG001|STARTED|Period A||0
6568539|NCT01838681|7491792|FG002|STARTED|Period A||0
6568540|NCT01838681|7491793|FG003|STARTED|Period A||0
6568541|NCT01838681|7491790|FG000|COMPLETED|Period A||1661
6568542|NCT01838681|7491791|FG001|COMPLETED|Period A||0
6568543|NCT01838681|7491792|FG002|COMPLETED|Period A||0
6568544|NCT01838681|7491793|FG003|COMPLETED|Period A||0
6568545|NCT01838681|7491790|FG000|NOT COMPLETED|Period A||325
6568546|NCT01838681|7491791|FG001|NOT COMPLETED|Period A||0
6568547|NCT01838681|7491792|FG002|NOT COMPLETED|Period A||0
6568548|NCT01838681|7491793|FG003|NOT COMPLETED|Period A||0
6568549|NCT01838681|7491790|FG000|STARTED|Period B/A+||0
6568550|NCT01838681|7491791|FG001|STARTED|Period B/A+||442
6568551|NCT01838681|7491792|FG002|STARTED|Period B/A+||444
6568552|NCT01838681|7491793|FG003|STARTED|Period B/A+||770
6568553|NCT01838681|7491790|FG000|COMPLETED|Period B/A+||0
6568554|NCT01838681|7491791|FG001|COMPLETED|Period B/A+||380
6568555|NCT01838681|7491792|FG002|COMPLETED|Period B/A+||349
6568556|NCT01838681|7491793|FG003|COMPLETED|Period B/A+||653
6568557|NCT01838681|7491790|FG000|NOT COMPLETED|Period B/A+||0
6568558|NCT01838681|7491791|FG001|NOT COMPLETED|Period B/A+||62
6568559|NCT01838681|7491792|FG002|NOT COMPLETED|Period B/A+||95
6568560|NCT01838681|7491793|FG003|NOT COMPLETED|Period B/A+||117
6568561|NCT01838694|7491801|FG000|STARTED|Overall Study||8
6568562|NCT01838694|7491802|FG001|STARTED|Overall Study||22
6568563|NCT01838694|7491801|FG000|COMPLETED|Overall Study||8
6568564|NCT01838694|7491802|FG001|COMPLETED|Overall Study||21
6657241|NCT02467777|7587539|FG001|NOT COMPLETED|Overall Study||0
6657242|NCT02467842|7587548|FG000|STARTED|Overall Study||752
6657243|NCT02467842|7587549|FG001|STARTED|Overall Study||373
6657244|NCT02467842|7587550|FG002|STARTED|Overall Study||378
6657245|NCT02467842|7587548|FG000|COMPLETED|Overall Study||752
6568565|NCT01838694|7491801|FG000|NOT COMPLETED|Overall Study||0
6568566|NCT01838694|7491802|FG001|NOT COMPLETED|Overall Study||1
6657246|NCT02467842|7587549|FG001|COMPLETED|Overall Study||373
6568567|NCT01838785|7491811|FG000|STARTED|Overall Study||25
6568568|NCT01838785|7491811|FG000|COMPLETED|Overall Study||25
6568569|NCT01838785|7491811|FG000|NOT COMPLETED|Overall Study||0
6568570|NCT01838863|7491817|FG000|STARTED|Overall Study||75
6568571|NCT01838863|7491818|FG001|STARTED|Overall Study||69
6657247|NCT02467842|7587550|FG002|COMPLETED|Overall Study||378
6657248|NCT02467842|7587548|FG000|NOT COMPLETED|Overall Study||0
6657249|NCT02467842|7587549|FG001|NOT COMPLETED|Overall Study||0
6657250|NCT02467842|7587550|FG002|NOT COMPLETED|Overall Study||0
6657251|NCT02468154|7587562|FG000|STARTED|Overall Study||29
6568572|NCT01838863|7491817|FG000|COMPLETED|Overall Study||65
6568573|NCT01838863|7491818|FG001|COMPLETED|Overall Study||60
6568574|NCT01838863|7491817|FG000|NOT COMPLETED|Overall Study||10
6568575|NCT01838863|7491818|FG001|NOT COMPLETED|Overall Study||9
6568576|NCT01838876|7491824|FG000|STARTED|Overall Study||442
6568577|NCT01838876|7491824|FG000|Safety Population; Received Study Drug|Overall Study||345
6568578|NCT01838876|7491824|FG000|Entered Safety Follow-up Period|Overall Study||287
6568579|NCT01838876|7491824|FG000|COMPLETED|Overall Study||209
6568580|NCT01838876|7491824|FG000|NOT COMPLETED|Overall Study||233
6568581|NCT01838941|7491830|FG000|STARTED|Overall Study||12
6568582|NCT01838941|7491830|FG000|COMPLETED|Overall Study||10
6568583|NCT01838941|7491830|FG000|NOT COMPLETED|Overall Study||2
6568584|NCT01838980|7491835|FG000|STARTED|Overall Study||15
6568585|NCT01838980|7491835|FG000|COMPLETED|Overall Study||15
6568586|NCT01838980|7491835|FG000|NOT COMPLETED|Overall Study||0
6657252|NCT02468154|7587563|FG001|STARTED|Overall Study||28
6657253|NCT02468154|7587562|FG000|COMPLETED|Overall Study||29
6657254|NCT02468154|7587563|FG001|COMPLETED|Overall Study||28
6657255|NCT02468154|7587562|FG000|NOT COMPLETED|Overall Study||0
6657256|NCT02468154|7587563|FG001|NOT COMPLETED|Overall Study||0
6657257|NCT02468193|7587569|FG000|STARTED|Overall Study||9
6657258|NCT02468193|7587569|FG000|Completed Week-12 (Study Period I)|Overall Study||7
6657259|NCT02468193|7587569|FG000|Discontinued at or Prior to Week-12|Overall Study||2
6657260|NCT02468193|7587569|FG000|Completed Week-12, Did Not Enter Per. II|Overall Study||3
6657261|NCT02468193|7587569|FG000|Completed Week-12, Entered Study Per. II|Overall Study||4
6657262|NCT02468193|7587569|FG000|Completed Week-48 (Study Period II)|Overall Study||2
6657263|NCT02468193|7587569|FG000|Discontinued at or Prior to Week48|Overall Study||2
6657264|NCT02468193|7587569|FG000|Compl. Wk-48, Didn't Enter Opt. Ext. Per|Overall Study||0
6657265|NCT02468193|7587569|FG000|Compl. Wk-48, Entered Opt. Ext. Period|Overall Study||2
6657266|NCT02468193|7587569|FG000|Completed Optional Extension Period|Overall Study||0
6657267|NCT02468193|7587569|FG000|Discontinued Study in Optional Ext. Per.|Overall Study||2
6657268|NCT02468193|7587569|FG000|COMPLETED|Overall Study||3
6391279|NCT00834808|7303105|FG000|COMPLETED|Treatment Period 1 (Day 1)||9
6391280|NCT00834808|7303106|FG001|COMPLETED|Treatment Period 1 (Day 1)||9
6391281|NCT00834808|7303107|FG002|COMPLETED|Treatment Period 1 (Day 1)||9
6391282|NCT00834808|7303105|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6568587|NCT01839058|7491841|FG000|STARTED|Overall Study||21
6568588|NCT01839058|7491842|FG001|STARTED|Overall Study||19
6568589|NCT01839058|7491841|FG000|COMPLETED|Overall Study||17
6568590|NCT01839058|7491842|FG001|COMPLETED|Overall Study||16
6568591|NCT01839058|7491841|FG000|NOT COMPLETED|Overall Study||4
6568592|NCT01839058|7491842|FG001|NOT COMPLETED|Overall Study||3
6568593|NCT01839110|7491851|FG000|STARTED|Overall Study||7
6568594|NCT01839110|7491852|FG001|STARTED|Overall Study||6
6568595|NCT01839110|7491853|FG002|STARTED|Overall Study||9
6568596|NCT01839110|7491851|FG000|COMPLETED|Overall Study||4
6276436|NCT00118898|7175708|FG001|Initiated Treatment|Overall Study||461
6276437|NCT00118898|7175709|FG002|Initiated Treatment|Overall Study||464
6276438|NCT00118898|7175710|FG003|Initiated Treatment|Overall Study||462
6276439|NCT00118898|7175707|FG000|COMPLETED|Overall Study||343
6276440|NCT00118898|7175708|FG001|COMPLETED|Overall Study||324
6276441|NCT00118898|7175709|FG002|COMPLETED|Overall Study||342
6276442|NCT00118898|7175710|FG003|COMPLETED|Overall Study||322
6276443|NCT00118898|7175707|FG000|NOT COMPLETED|Overall Study||121
6276444|NCT00118898|7175708|FG001|NOT COMPLETED|Overall Study||141
6276445|NCT00118898|7175709|FG002|NOT COMPLETED|Overall Study||123
6276446|NCT00118898|7175710|FG003|NOT COMPLETED|Overall Study||141
6276447|NCT00118911|7175722|FG000|STARTED|Overall Study||43
6276448|NCT00118911|7175723|FG001|STARTED|Overall Study||43
6276449|NCT00118911|7175722|FG000|Received Intervention as Assigned|Overall Study||41
6276450|NCT00118911|7175723|FG001|Received Intervention as Assigned|Overall Study||38
6276451|NCT00118911|7175722|FG000|Completed Post-Treatment Assessment|Overall Study||41
6276452|NCT00118911|7175723|FG001|Completed Post-Treatment Assessment|Overall Study||37
6276453|NCT00118911|7175722|FG000|6 Month Follow-up|Overall Study||37
6276454|NCT00118911|7175723|FG001|6 Month Follow-up|Overall Study||30
6276455|NCT00118911|7175722|FG000|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
6276456|NCT00118911|7175723|FG001|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
6391283|NCT00834808|7303106|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6276457|NCT00118911|7175722|FG000|COMPLETED|Overall Study||41
6276458|NCT00118911|7175723|FG001|COMPLETED|Overall Study||38
6276459|NCT00118911|7175722|FG000|NOT COMPLETED|Overall Study||2
6276460|NCT00118911|7175723|FG001|NOT COMPLETED|Overall Study||5
6568597|NCT01839110|7491852|FG001|COMPLETED|Overall Study||4
6568598|NCT01839110|7491853|FG002|COMPLETED|Overall Study||6
6568599|NCT01839110|7491851|FG000|NOT COMPLETED|Overall Study||3
6568600|NCT01839110|7491852|FG001|NOT COMPLETED|Overall Study||2
6568601|NCT01839110|7491853|FG002|NOT COMPLETED|Overall Study||3
6568602|NCT01839188|7491861|FG000|STARTED|Overall Study||385
6568603|NCT01839188|7491861|FG000|Treated|Overall Study||385
6568604|NCT01839188|7491861|FG000|COMPLETED|Overall Study|N=1 treated participant withdrew before receiving V3|384
6568605|NCT01839188|7491861|FG000|NOT COMPLETED|Overall Study||1
6568606|NCT01839279|7491873|FG000|STARTED|Overall Study||72
6391284|NCT00834808|7303107|FG002|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6568607|NCT01839279|7491874|FG001|STARTED|Overall Study||32
6568608|NCT01839279|7491875|FG002|STARTED|Overall Study||32
6568609|NCT01839279|7491873|FG000|QT/QTc Analysis Set|Overall Study||72
6568610|NCT01839279|7491874|FG001|QT/QTc Analysis Set|Overall Study||32
6568611|NCT01839279|7491875|FG002|QT/QTc Analysis Set|Overall Study||32
6568612|NCT01839279|7491873|FG000|PK Analysis Set|Overall Study||70
6568613|NCT01839279|7491874|FG001|PK Analysis Set|Overall Study||0
6568614|NCT01839279|7491875|FG002|PK Analysis Set|Overall Study||0
6568615|NCT01839279|7491873|FG000|Moxifloxacin/Placebo Analysis Set|Overall Study||0
6568616|NCT01839279|7491874|FG001|Moxifloxacin/Placebo Analysis Set|Overall Study||31
6568617|NCT01839279|7491875|FG002|Moxifloxacin/Placebo Analysis Set|Overall Study||30
6568618|NCT01839279|7491873|FG000|PK/QTc Analysis Set|Overall Study||70
6568619|NCT01839279|7491874|FG001|PK/QTc Analysis Set|Overall Study||0
6568620|NCT01839279|7491875|FG002|PK/QTc Analysis Set|Overall Study||0
6568621|NCT01839279|7491873|FG000|COMPLETED|Overall Study||59
6568622|NCT01839279|7491874|FG001|COMPLETED|Overall Study||30
6568623|NCT01839279|7491875|FG002|COMPLETED|Overall Study||30
6568624|NCT01839279|7491873|FG000|NOT COMPLETED|Overall Study||13
6568625|NCT01839279|7491874|FG001|NOT COMPLETED|Overall Study||2
6568626|NCT01839279|7491875|FG002|NOT COMPLETED|Overall Study||2
6568627|NCT01839318|7491890|FG000|STARTED|Period 1, First Day of Wear||4
6568628|NCT01839318|7491891|FG001|STARTED|Period 1, First Day of Wear||4
6568629|NCT01839318|7491892|FG002|STARTED|Period 1, First Day of Wear||5
6568630|NCT01839318|7491893|FG003|STARTED|Period 1, First Day of Wear||6
6568631|NCT01839318|7491894|FG004|STARTED|Period 1, First Day of Wear||7
6568632|NCT01839318|7491895|FG005|STARTED|Period 1, First Day of Wear||2
6568633|NCT01839318|7491890|FG000|COMPLETED|Period 1, First Day of Wear||4
6568634|NCT01839318|7491891|FG001|COMPLETED|Period 1, First Day of Wear||4
6391285|NCT00834808|7303105|FG000|STARTED|Treatment Period 2 (Day 8)||9
6391286|NCT00834808|7303106|FG001|STARTED|Treatment Period 2 (Day 8)||9
6391287|NCT00834808|7303107|FG002|STARTED|Treatment Period 2 (Day 8)||9
6391288|NCT00834808|7303105|FG000|COMPLETED|Treatment Period 2 (Day 8)||9
6391289|NCT00834808|7303106|FG001|COMPLETED|Treatment Period 2 (Day 8)||9
6391290|NCT00834808|7303107|FG002|COMPLETED|Treatment Period 2 (Day 8)||9
6391291|NCT00834808|7303105|FG000|NOT COMPLETED|Treatment Period 2 (Day 8)||0
6391292|NCT00834808|7303106|FG001|NOT COMPLETED|Treatment Period 2 (Day 8)||0
6391293|NCT00834808|7303107|FG002|NOT COMPLETED|Treatment Period 2 (Day 8)||0
6568635|NCT01839318|7491892|FG002|COMPLETED|Period 1, First Day of Wear||5
6568636|NCT01839318|7491893|FG003|COMPLETED|Period 1, First Day of Wear||6
6568637|NCT01839318|7491894|FG004|COMPLETED|Period 1, First Day of Wear||7
6568638|NCT01839318|7491895|FG005|COMPLETED|Period 1, First Day of Wear||2
6568639|NCT01839318|7491890|FG000|NOT COMPLETED|Period 1, First Day of Wear||0
6568640|NCT01839318|7491891|FG001|NOT COMPLETED|Period 1, First Day of Wear||0
6568641|NCT01839318|7491892|FG002|NOT COMPLETED|Period 1, First Day of Wear||0
6568642|NCT01839318|7491893|FG003|NOT COMPLETED|Period 1, First Day of Wear||0
6568643|NCT01839318|7491894|FG004|NOT COMPLETED|Period 1, First Day of Wear||0
6568644|NCT01839318|7491895|FG005|NOT COMPLETED|Period 1, First Day of Wear||0
6568645|NCT01839318|7491890|FG000|STARTED|Period 2, Second Day of Wear||4
6568646|NCT01839318|7491891|FG001|STARTED|Period 2, Second Day of Wear||4
6568647|NCT01839318|7491892|FG002|STARTED|Period 2, Second Day of Wear||5
6657269|NCT02468193|7587569|FG000|NOT COMPLETED|Overall Study||6
6657270|NCT02468557|7587589|FG000|STARTED|Overall Study||16
6657271|NCT02468557|7587589|FG000|COMPLETED|Overall Study||0
6657272|NCT02468557|7587589|FG000|NOT COMPLETED|Overall Study||16
6657273|NCT02468570|7587599|FG000|STARTED|Overall Study||6
6657274|NCT02468570|7587600|FG001|STARTED|Overall Study||3
6657275|NCT02468570|7587599|FG000|COMPLETED|Overall Study||6
6657276|NCT02468570|7587600|FG001|COMPLETED|Overall Study||3
6657277|NCT02468570|7587599|FG000|NOT COMPLETED|Overall Study||0
6657278|NCT02468570|7587600|FG001|NOT COMPLETED|Overall Study||0
6657279|NCT02468648|7587606|FG000|STARTED|Overall Study||72
6657280|NCT02468648|7587606|FG000|COMPLETED|Overall Study||71
6657281|NCT02468648|7587606|FG000|NOT COMPLETED|Overall Study||1
6568648|NCT01839318|7491893|FG003|STARTED|Period 2, Second Day of Wear||6
6568649|NCT01839318|7491894|FG004|STARTED|Period 2, Second Day of Wear||7
6568650|NCT01839318|7491895|FG005|STARTED|Period 2, Second Day of Wear||2
6568651|NCT01839318|7491890|FG000|COMPLETED|Period 2, Second Day of Wear||4
6568652|NCT01839318|7491891|FG001|COMPLETED|Period 2, Second Day of Wear||4
6568653|NCT01839318|7491892|FG002|COMPLETED|Period 2, Second Day of Wear||5
6568654|NCT01839318|7491893|FG003|COMPLETED|Period 2, Second Day of Wear||6
6568655|NCT01839318|7491894|FG004|COMPLETED|Period 2, Second Day of Wear||7
6568656|NCT01839318|7491895|FG005|COMPLETED|Period 2, Second Day of Wear||2
6391294|NCT00834808|7303105|FG000|STARTED|Treatment Period 3 (Day 15)||9
6568657|NCT01839318|7491890|FG000|NOT COMPLETED|Period 2, Second Day of Wear||0
6568658|NCT01839318|7491891|FG001|NOT COMPLETED|Period 2, Second Day of Wear||0
6568659|NCT01839318|7491892|FG002|NOT COMPLETED|Period 2, Second Day of Wear||0
6568660|NCT01839318|7491893|FG003|NOT COMPLETED|Period 2, Second Day of Wear||0
6568661|NCT01839318|7491894|FG004|NOT COMPLETED|Period 2, Second Day of Wear||0
6568662|NCT01839318|7491895|FG005|NOT COMPLETED|Period 2, Second Day of Wear||0
6391295|NCT00834808|7303106|FG001|STARTED|Treatment Period 3 (Day 15)||9
6391296|NCT00834808|7303107|FG002|STARTED|Treatment Period 3 (Day 15)||9
6391297|NCT00834808|7303105|FG000|COMPLETED|Treatment Period 3 (Day 15)||9
6391298|NCT00834808|7303106|FG001|COMPLETED|Treatment Period 3 (Day 15)||9
6391299|NCT00834808|7303107|FG002|COMPLETED|Treatment Period 3 (Day 15)||9
6391300|NCT00834808|7303105|FG000|NOT COMPLETED|Treatment Period 3 (Day 15)||0
6391301|NCT00834808|7303106|FG001|NOT COMPLETED|Treatment Period 3 (Day 15)||0
6391302|NCT00834808|7303107|FG002|NOT COMPLETED|Treatment Period 3 (Day 15)||0
6391303|NCT00834834|7303117|FG000|STARTED|Overall Study||42
6391304|NCT00834834|7303118|FG001|STARTED|Overall Study||42
6391305|NCT00834834|7303117|FG000|COMPLETED|Overall Study||38
6391306|NCT00834834|7303118|FG001|COMPLETED|Overall Study||39
6391307|NCT00834834|7303117|FG000|NOT COMPLETED|Overall Study||4
6391308|NCT00834834|7303118|FG001|NOT COMPLETED|Overall Study||3
6391309|NCT00834886|7303128|FG000|STARTED|Overall Study||10
6391310|NCT00834886|7303129|FG001|STARTED|Overall Study||10
6391311|NCT00834886|7303130|FG002|STARTED|Overall Study||10
6391312|NCT00834886|7303131|FG003|STARTED|Overall Study||10
6391313|NCT00834886|7303128|FG000|COMPLETED|Overall Study||10
6391314|NCT00834886|7303129|FG001|COMPLETED|Overall Study||9
6391315|NCT00834886|7303130|FG002|COMPLETED|Overall Study||9
6391316|NCT00834886|7303131|FG003|COMPLETED|Overall Study||10
6391317|NCT00834886|7303128|FG000|NOT COMPLETED|Overall Study||0
6391318|NCT00834886|7303129|FG001|NOT COMPLETED|Overall Study||1
6391319|NCT00834886|7303130|FG002|NOT COMPLETED|Overall Study||1
6391320|NCT00834886|7303131|FG003|NOT COMPLETED|Overall Study||0
6391321|NCT00834899|7303143|FG000|STARTED|Overall Study||9
6391322|NCT00834899|7303144|FG001|STARTED|Overall Study||4
6504853|NCT01450098|7423891|FG001|COMPLETED|Washout of at Least 14 Days||31
6504854|NCT01450098|7423890|FG000|NOT COMPLETED|Washout of at Least 14 Days||0
6504855|NCT01450098|7423891|FG001|NOT COMPLETED|Washout of at Least 14 Days||0
6504856|NCT01450098|7423890|FG000|STARTED|Period 3||8
6504857|NCT01450098|7423891|FG001|STARTED|Period 3||31
6504858|NCT01450098|7423890|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
6504859|NCT01450098|7423891|FG001|Received at Least 1 Dose of Study Drug|Period 3||30
6504860|NCT01450098|7423890|FG000|COMPLETED|Period 3||8
6504861|NCT01450098|7423891|FG001|COMPLETED|Period 3||28
6504862|NCT01450098|7423890|FG000|NOT COMPLETED|Period 3||0
6504863|NCT01450098|7423891|FG001|NOT COMPLETED|Period 3||3
6504864|NCT01450137|7423906|FG000|STARTED|Up to Week 12||20
6504865|NCT01450137|7423907|FG001|STARTED|Up to Week 12||10
6504866|NCT01450137|7423906|FG000|COMPLETED|Up to Week 12||18
6504867|NCT01450137|7423907|FG001|COMPLETED|Up to Week 12||7
6504868|NCT01450137|7423906|FG000|NOT COMPLETED|Up to Week 12||2
6504869|NCT01450137|7423907|FG001|NOT COMPLETED|Up to Week 12||3
6504870|NCT01450137|7423906|FG000|STARTED|Week 12 to Study End||18
6504871|NCT01450137|7423907|FG001|STARTED|Week 12 to Study End||7
6504872|NCT01450137|7423906|FG000|COMPLETED|Week 12 to Study End||18
6504873|NCT01450137|7423907|FG001|COMPLETED|Week 12 to Study End||5
6504874|NCT01450137|7423906|FG000|NOT COMPLETED|Week 12 to Study End||0
6504875|NCT01450137|7423907|FG001|NOT COMPLETED|Week 12 to Study End||2
6504876|NCT01450189|7423916|FG000|STARTED|Overall Study||9
6504877|NCT01450189|7423917|FG001|STARTED|Overall Study||18
6504878|NCT01450189|7423918|FG002|STARTED|Overall Study||19
6504879|NCT01450189|7423916|FG000|COMPLETED|Overall Study||9
6504880|NCT01450189|7423917|FG001|COMPLETED|Overall Study||18
6504881|NCT01450189|7423918|FG002|COMPLETED|Overall Study||19
6504882|NCT01450189|7423916|FG000|NOT COMPLETED|Overall Study||0
6504883|NCT01450189|7423917|FG001|NOT COMPLETED|Overall Study||0
6504884|NCT01450189|7423918|FG002|NOT COMPLETED|Overall Study||0
6504885|NCT01450306|7423935|FG000|STARTED|Overall Study||10
6504886|NCT01450306|7423936|FG001|STARTED|Overall Study||10
6504887|NCT01450306|7423935|FG000|COMPLETED|Overall Study||10
6504888|NCT01450306|7423936|FG001|COMPLETED|Overall Study||10
6568663|NCT01839318|7491890|FG000|STARTED|Period 3, Third Day of Wear||4
6568664|NCT01839318|7491891|FG001|STARTED|Period 3, Third Day of Wear||4
6568665|NCT01839318|7491892|FG002|STARTED|Period 3, Third Day of Wear||5
6568666|NCT01839318|7491893|FG003|STARTED|Period 3, Third Day of Wear||6
6568667|NCT01839318|7491894|FG004|STARTED|Period 3, Third Day of Wear||7
6568668|NCT01839318|7491895|FG005|STARTED|Period 3, Third Day of Wear||2
6568669|NCT01839318|7491890|FG000|COMPLETED|Period 3, Third Day of Wear||4
6568670|NCT01839318|7491891|FG001|COMPLETED|Period 3, Third Day of Wear||4
6568671|NCT01839318|7491892|FG002|COMPLETED|Period 3, Third Day of Wear||5
6568672|NCT01839318|7491893|FG003|COMPLETED|Period 3, Third Day of Wear||6
6568673|NCT01839318|7491894|FG004|COMPLETED|Period 3, Third Day of Wear||7
6504889|NCT01450306|7423935|FG000|NOT COMPLETED|Overall Study||0
6504890|NCT01450306|7423936|FG001|NOT COMPLETED|Overall Study||0
6504891|NCT01450319|7423942|FG000|STARTED|Overall Study||70
6504892|NCT01450319|7423942|FG000|COMPLETED|Overall Study||70
6504893|NCT01450319|7423942|FG000|NOT COMPLETED|Overall Study||0
6504894|NCT01450397|7423946|FG000|STARTED|Overall Study||5
6504895|NCT01450397|7423946|FG000|COMPLETED|Overall Study||5
6504896|NCT01450397|7423946|FG000|NOT COMPLETED|Overall Study||0
6504897|NCT01450540|7423952|FG000|STARTED|Overall Study||123
6504898|NCT01450540|7423953|FG001|STARTED|Overall Study||118
6391323|NCT00834899|7303143|FG000|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
6391324|NCT00834899|7303144|FG001|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
6391325|NCT00834899|7303143|FG000|NOT COMPLETED|Overall Study||1
6391326|NCT00834899|7303144|FG001|NOT COMPLETED|Overall Study||1
6391327|NCT00834912|7303156|FG000|STARTED|Treatment Period 1||6
6391328|NCT00834912|7303157|FG001|STARTED|Treatment Period 1||6
6391329|NCT00834912|7303158|FG002|STARTED|Treatment Period 1||6
6391330|NCT00834912|7303159|FG003|STARTED|Treatment Period 1||6
6391331|NCT00834912|7303160|FG004|STARTED|Treatment Period 1||6
6391332|NCT00834912|7303161|FG005|STARTED|Treatment Period 1||6
6391333|NCT00834912|7303156|FG000|COMPLETED|Treatment Period 1||6
6391334|NCT00834912|7303157|FG001|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
6391335|NCT00834912|7303158|FG002|COMPLETED|Treatment Period 1||6
6391336|NCT00834912|7303159|FG003|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
6391337|NCT00834912|7303160|FG004|COMPLETED|Treatment Period 1||6
6391338|NCT00834912|7303161|FG005|COMPLETED|Treatment Period 1||6
6391339|NCT00834912|7303156|FG000|NOT COMPLETED|Treatment Period 1||0
6391340|NCT00834912|7303157|FG001|NOT COMPLETED|Treatment Period 1||1
6391341|NCT00834912|7303158|FG002|NOT COMPLETED|Treatment Period 1||0
6391342|NCT00834912|7303159|FG003|NOT COMPLETED|Treatment Period 1||1
6391343|NCT00834912|7303160|FG004|NOT COMPLETED|Treatment Period 1||0
6391344|NCT00834912|7303161|FG005|NOT COMPLETED|Treatment Period 1||0
6391345|NCT00834912|7303156|FG000|STARTED|Treatment Period 2||6
6391346|NCT00834912|7303157|FG001|STARTED|Treatment Period 2||5
6391347|NCT00834912|7303158|FG002|STARTED|Treatment Period 2||6
6391348|NCT00834912|7303159|FG003|STARTED|Treatment Period 2||5
6391349|NCT00834912|7303160|FG004|STARTED|Treatment Period 2||6
6391350|NCT00834912|7303161|FG005|STARTED|Treatment Period 2||6
6391351|NCT00834912|7303156|FG000|COMPLETED|Treatment Period 2||6
6391352|NCT00834912|7303157|FG001|COMPLETED|Treatment Period 2||5
6391353|NCT00834912|7303158|FG002|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
6391354|NCT00834912|7303159|FG003|COMPLETED|Treatment Period 2||5
6391355|NCT00834912|7303160|FG004|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
6391356|NCT00834912|7303161|FG005|COMPLETED|Treatment Period 2||6
6391357|NCT00834912|7303156|FG000|NOT COMPLETED|Treatment Period 2||0
6391358|NCT00834912|7303157|FG001|NOT COMPLETED|Treatment Period 2||0
6568674|NCT01839318|7491895|FG005|COMPLETED|Period 3, Third Day of Wear||2
6568675|NCT01839318|7491890|FG000|NOT COMPLETED|Period 3, Third Day of Wear||0
6568676|NCT01839318|7491891|FG001|NOT COMPLETED|Period 3, Third Day of Wear||0
6568677|NCT01839318|7491892|FG002|NOT COMPLETED|Period 3, Third Day of Wear||0
6568678|NCT01839318|7491893|FG003|NOT COMPLETED|Period 3, Third Day of Wear||0
6568679|NCT01839318|7491894|FG004|NOT COMPLETED|Period 3, Third Day of Wear||0
6568680|NCT01839318|7491895|FG005|NOT COMPLETED|Period 3, Third Day of Wear||0
6568681|NCT01839487|7491905|FG000|STARTED|Run-in Phase (Maximum Exposure:295 Days)||16
6568682|NCT01839487|7491906|FG001|STARTED|Run-in Phase (Maximum Exposure:295 Days)||7
6568683|NCT01839487|7491907|FG002|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
6568684|NCT01839487|7491908|FG003|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
6568685|NCT01839487|7491909|FG004|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
6568686|NCT01839487|7491910|FG005|STARTED|Run-in Phase (Maximum Exposure:295 Days)||0
6568687|NCT01839487|7491905|FG000|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6391359|NCT00834912|7303158|FG002|NOT COMPLETED|Treatment Period 2||1
6391360|NCT00834912|7303159|FG003|NOT COMPLETED|Treatment Period 2||0
6391361|NCT00834912|7303160|FG004|NOT COMPLETED|Treatment Period 2||1
6391362|NCT00834912|7303161|FG005|NOT COMPLETED|Treatment Period 2||0
6391363|NCT00834912|7303156|FG000|STARTED|Treatment Period 3||6
6391364|NCT00834912|7303157|FG001|STARTED|Treatment Period 3||5
6391365|NCT00834912|7303158|FG002|STARTED|Treatment Period 3||5
6391366|NCT00834912|7303159|FG003|STARTED|Treatment Period 3||5
6391367|NCT00834912|7303160|FG004|STARTED|Treatment Period 3||5
6391368|NCT00834912|7303161|FG005|STARTED|Treatment Period 3||6
6391369|NCT00834912|7303156|FG000|COMPLETED|Treatment Period 3||6
6391370|NCT00834912|7303157|FG001|COMPLETED|Treatment Period 3||5
6391371|NCT00834912|7303158|FG002|COMPLETED|Treatment Period 3||5
6391372|NCT00834912|7303159|FG003|COMPLETED|Treatment Period 3||5
6391373|NCT00834912|7303160|FG004|COMPLETED|Treatment Period 3||5
6391374|NCT00834912|7303161|FG005|COMPLETED|Treatment Period 3||6
6391375|NCT00834912|7303156|FG000|NOT COMPLETED|Treatment Period 3||0
6391376|NCT00834912|7303157|FG001|NOT COMPLETED|Treatment Period 3||0
6391377|NCT00834912|7303158|FG002|NOT COMPLETED|Treatment Period 3||0
6391378|NCT00834912|7303159|FG003|NOT COMPLETED|Treatment Period 3||0
6391379|NCT00834912|7303160|FG004|NOT COMPLETED|Treatment Period 3||0
6391380|NCT00834912|7303161|FG005|NOT COMPLETED|Treatment Period 3||0
6391381|NCT00835003|7303171|FG000|STARTED|Overall Study||636
6391382|NCT00835003|7303172|FG001|STARTED|Overall Study||638
6391383|NCT00835003|7303171|FG000|COMPLETED|Overall Study||636
6391384|NCT00835003|7303172|FG001|COMPLETED|Overall Study||638
6391385|NCT00835003|7303171|FG000|NOT COMPLETED|Overall Study||0
6391386|NCT00835003|7303172|FG001|NOT COMPLETED|Overall Study||0
6391387|NCT00835068|7303180|FG000|STARTED|Overall Study||57
6391388|NCT00835068|7303181|FG001|STARTED|Overall Study||1
6391389|NCT00835068|7303180|FG000|COMPLETED|Overall Study||47
6391390|NCT00835068|7303181|FG001|COMPLETED|Overall Study||0
6391391|NCT00835068|7303180|FG000|NOT COMPLETED|Overall Study||10
6391392|NCT00835068|7303181|FG001|NOT COMPLETED|Overall Study||1
6391393|NCT00835120|7303187|FG000|STARTED|Overall Study||34
6391394|NCT00835120|7303187|FG000|COMPLETED|Overall Study||26
6391395|NCT00835120|7303187|FG000|NOT COMPLETED|Overall Study||8
6391396|NCT00835159|7303193|FG000|STARTED|Overall Study||11
6391397|NCT00835159|7303194|FG001|STARTED|Overall Study||17
6391398|NCT00835159|7303193|FG000|COMPLETED|Overall Study||11
6391399|NCT00835159|7303194|FG001|COMPLETED|Overall Study||17
6391400|NCT00835159|7303193|FG000|NOT COMPLETED|Overall Study||0
6391401|NCT00835159|7303194|FG001|NOT COMPLETED|Overall Study||0
6391402|NCT00835185|7303200|FG000|STARTED|Overall Study||44
6391403|NCT00835185|7303200|FG000|Received at Least 1 Dose of Study Drug|Overall Study||44
6391404|NCT00835185|7303200|FG000|COMPLETED|Overall Study||44
6391405|NCT00835185|7303200|FG000|NOT COMPLETED|Overall Study||0
6391406|NCT00835198|7303207|FG000|STARTED|Overall Study||82
6391407|NCT00835198|7303208|FG001|STARTED|Overall Study||81
6391408|NCT00835198|7303207|FG000|COMPLETED|Overall Study||74
6391409|NCT00835198|7303208|FG001|COMPLETED|Overall Study||74
6391410|NCT00835198|7303207|FG000|NOT COMPLETED|Overall Study||8
6391411|NCT00835198|7303208|FG001|NOT COMPLETED|Overall Study||7
6391412|NCT00835224|7303214|FG000|STARTED|Overall Study||34
6391413|NCT00835224|7303214|FG000|COMPLETED|Overall Study||24
6568688|NCT01839487|7491906|FG001|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568689|NCT01839487|7491907|FG002|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568690|NCT01839487|7491908|FG003|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568691|NCT01839487|7491909|FG004|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568692|NCT01839487|7491910|FG005|COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568693|NCT01839487|7491905|FG000|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||16
6568694|NCT01839487|7491906|FG001|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||7
6568695|NCT01839487|7491907|FG002|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568696|NCT01839487|7491908|FG003|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568697|NCT01839487|7491909|FG004|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568698|NCT01839487|7491910|FG005|NOT COMPLETED|Run-in Phase (Maximum Exposure:295 Days)||0
6568699|NCT01839487|7491905|FG000|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
6568700|NCT01839487|7491906|FG001|STARTED|Phase 2 (Maximum Exposure:935 Days)||0
6568701|NCT01839487|7491907|FG002|STARTED|Phase 2 (Maximum Exposure:935 Days)||61
6568702|NCT01839487|7491908|FG003|STARTED|Phase 2 (Maximum Exposure:935 Days)||62
6568703|NCT01839487|7491909|FG004|STARTED|Phase 2 (Maximum Exposure:935 Days)||89
6276461|NCT00119015|7175731|FG000|STARTED|Open-Label Phase (2 Weeks)||102
6276462|NCT00119015|7175732|FG001|STARTED|Open-Label Phase (2 Weeks)||0
6276463|NCT00119015|7175733|FG002|STARTED|Open-Label Phase (2 Weeks)||0
6276464|NCT00119015|7175731|FG000|COMPLETED|Open-Label Phase (2 Weeks)||54
6276465|NCT00119015|7175732|FG001|COMPLETED|Open-Label Phase (2 Weeks)||0
6276466|NCT00119015|7175733|FG002|COMPLETED|Open-Label Phase (2 Weeks)||0
6568704|NCT01839487|7491910|FG005|STARTED|Phase 2 (Maximum Exposure:935 Days)||44
6276467|NCT00119015|7175731|FG000|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
6276468|NCT00119015|7175732|FG001|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
6276469|NCT00119015|7175733|FG002|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
6276470|NCT00119015|7175731|FG000|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
6276471|NCT00119015|7175732|FG001|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
6276472|NCT00119015|7175733|FG002|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
6568705|NCT01839487|7491905|FG000|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6568706|NCT01839487|7491906|FG001|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6276473|NCT00119015|7175731|FG000|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
6276474|NCT00119015|7175732|FG001|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
6276475|NCT00119015|7175733|FG002|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
6276476|NCT00119015|7175731|FG000|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
6276477|NCT00119015|7175732|FG001|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
6276478|NCT00119015|7175733|FG002|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
6276479|NCT00119041|7175742|FG000|STARTED|Overall Study||199
6276480|NCT00119041|7175743|FG001|STARTED|Overall Study||83
6276481|NCT00119041|7175744|FG002|STARTED|Overall Study||22
6276482|NCT00119041|7175742|FG000|COMPLETED|Overall Study||199
6276483|NCT00119041|7175743|FG001|COMPLETED|Overall Study||83
6276484|NCT00119041|7175744|FG002|COMPLETED|Overall Study||22
6276485|NCT00119041|7175742|FG000|NOT COMPLETED|Overall Study||0
6276486|NCT00119041|7175743|FG001|NOT COMPLETED|Overall Study||0
6276487|NCT00119041|7175744|FG002|NOT COMPLETED|Overall Study||0
6276488|NCT00119106|7175755|FG000|STARTED|Overall Study||1204
6276489|NCT00119106|7175756|FG001|STARTED|Overall Study|2 participants later found to be HIV infected at baseline. Therefore 1207 in mITT analysis|1209
6276490|NCT00119106|7175755|FG000|COMPLETED|Overall Study||1025
6276491|NCT00119106|7175756|FG001|COMPLETED|Overall Study||1031
6276492|NCT00119106|7175755|FG000|NOT COMPLETED|Overall Study||179
6276493|NCT00119106|7175756|FG001|NOT COMPLETED|Overall Study||178
6276494|NCT00119158|7175772|FG000|STARTED|Active Treatment|patients are self controls|45
6276495|NCT00119158|7175773|FG001|STARTED|Active Treatment||45
6276496|NCT00119158|7175772|FG000|COMPLETED|Active Treatment||45
6276497|NCT00119158|7175773|FG001|COMPLETED|Active Treatment||45
6276498|NCT00119158|7175772|FG000|NOT COMPLETED|Active Treatment||0
6276499|NCT00119158|7175773|FG001|NOT COMPLETED|Active Treatment||0
6276500|NCT00119158|7175772|FG000|STARTED|Placebo Treatment||45
6276501|NCT00119158|7175773|FG001|STARTED|Placebo Treatment||45
6276502|NCT00119158|7175772|FG000|COMPLETED|Placebo Treatment||45
6276503|NCT00119158|7175773|FG001|COMPLETED|Placebo Treatment||45
6276504|NCT00119158|7175772|FG000|NOT COMPLETED|Placebo Treatment||0
6276505|NCT00119158|7175773|FG001|NOT COMPLETED|Placebo Treatment||0
6276506|NCT00119262|7175781|FG000|STARTED|Overall Study||104
6276507|NCT00119262|7175782|FG001|STARTED|Overall Study||122
6276508|NCT00119262|7175781|FG000|Eligible|Overall Study||103
6276509|NCT00119262|7175782|FG001|Eligible|Overall Study||120
6276510|NCT00119262|7175781|FG000|Treated|Overall Study||103
6276511|NCT00119262|7175782|FG001|Treated|Overall Study||120
6276512|NCT00119262|7175781|FG000|Eligible and Treated|Overall Study||102
6276513|NCT00119262|7175782|FG001|Eligible and Treated|Overall Study||119
6276514|NCT00119262|7175781|FG000|COMPLETED|Overall Study||58
6276515|NCT00119262|7175782|FG001|COMPLETED|Overall Study||64
6276516|NCT00119262|7175781|FG000|NOT COMPLETED|Overall Study||46
6276517|NCT00119262|7175782|FG001|NOT COMPLETED|Overall Study||58
6276518|NCT00119379|7175790|FG000|STARTED|Overall Study||26
6276519|NCT00119379|7175791|FG001|STARTED|Overall Study||24
6276520|NCT00119379|7175790|FG000|COMPLETED|Overall Study||22
6276521|NCT00119379|7175791|FG001|COMPLETED|Overall Study||23
6276522|NCT00119379|7175790|FG000|NOT COMPLETED|Overall Study||4
6276523|NCT00119379|7175791|FG001|NOT COMPLETED|Overall Study||1
6276524|NCT00119392|7175797|FG000|STARTED|Overall Study||45
6391414|NCT00835224|7303214|FG000|NOT COMPLETED|Overall Study||10
6391415|NCT00835237|7303230|FG000|STARTED|Overall Study||887
6391416|NCT00835237|7303231|FG001|STARTED|Overall Study||445
6391417|NCT00835237|7303230|FG000|COMPLETED|Overall Study||881
6391418|NCT00835237|7303231|FG001|COMPLETED|Overall Study||445
6391419|NCT00835237|7303230|FG000|NOT COMPLETED|Overall Study||6
6391420|NCT00835237|7303231|FG001|NOT COMPLETED|Overall Study||0
6504899|NCT01450540|7423952|FG000|COMPLETED|Overall Study||101
6504900|NCT01450540|7423953|FG001|COMPLETED|Overall Study||82
6504901|NCT01450540|7423952|FG000|NOT COMPLETED|Overall Study||22
6504902|NCT01450540|7423953|FG001|NOT COMPLETED|Overall Study||36
6504903|NCT01450631|7423963|FG000|STARTED|Overall Study||46
6504904|NCT01450631|7423964|FG001|STARTED|Overall Study||46
6504905|NCT01450631|7423963|FG000|COMPLETED|Overall Study||43
6504906|NCT01450631|7423964|FG001|COMPLETED|Overall Study||42
6504907|NCT01450631|7423963|FG000|NOT COMPLETED|Overall Study||3
6504908|NCT01450631|7423964|FG001|NOT COMPLETED|Overall Study||4
6276525|NCT00119392|7175797|FG000|COMPLETED|Overall Study||40
6276526|NCT00119392|7175797|FG000|NOT COMPLETED|Overall Study||5
6276527|NCT00119405|7175801|FG000|STARTED|Overall Study||18
6276528|NCT00119405|7175801|FG000|COMPLETED|Overall Study||17
6276529|NCT00119405|7175801|FG000|NOT COMPLETED|Overall Study||1
6276530|NCT00119678|7175807|FG000|STARTED|Double-blind Treatment Period||122
6276531|NCT00119678|7175808|FG001|STARTED|Double-blind Treatment Period||61
6276532|NCT00119678|7175807|FG000|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
6504909|NCT01450683|7423970|FG000|STARTED|Overall Study||4
6568707|NCT01839487|7491907|FG002|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6568708|NCT01839487|7491908|FG003|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6568709|NCT01839487|7491909|FG004|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||1
6568710|NCT01839487|7491910|FG005|COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6568711|NCT01839487|7491905|FG000|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6568712|NCT01839487|7491906|FG001|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||0
6568713|NCT01839487|7491907|FG002|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||61
6568714|NCT01839487|7491908|FG003|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||62
6568715|NCT01839487|7491909|FG004|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||88
6276533|NCT00119678|7175808|FG001|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
6276534|NCT00119678|7175807|FG000|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
6276535|NCT00119678|7175808|FG001|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
6276536|NCT00119678|7175807|FG000|COMPLETED|Double-blind Treatment Period||81
6276537|NCT00119678|7175808|FG001|COMPLETED|Double-blind Treatment Period||35
6276538|NCT00119678|7175807|FG000|NOT COMPLETED|Double-blind Treatment Period||41
6276539|NCT00119678|7175808|FG001|NOT COMPLETED|Double-blind Treatment Period||26
6276540|NCT00119678|7175807|FG000|STARTED|Open-label Treatment Period|Number of participants treated|110
6276541|NCT00119678|7175808|FG001|STARTED|Open-label Treatment Period||0
6276542|NCT00119678|7175807|FG000|COMPLETED|Open-label Treatment Period||0
6276543|NCT00119678|7175808|FG001|COMPLETED|Open-label Treatment Period||0
6276544|NCT00119678|7175807|FG000|NOT COMPLETED|Open-label Treatment Period||110
6276545|NCT00119678|7175808|FG001|NOT COMPLETED|Open-label Treatment Period||0
6276546|NCT00119847|7175818|FG000|STARTED|Overall Study||149
6276547|NCT00119847|7175819|FG001|STARTED|Overall Study||151
6276548|NCT00119847|7175818|FG000|COMPLETED|Overall Study||118
6276549|NCT00119847|7175819|FG001|COMPLETED|Overall Study||119
6276550|NCT00119847|7175818|FG000|NOT COMPLETED|Overall Study||31
6276551|NCT00119847|7175819|FG001|NOT COMPLETED|Overall Study||32
6276552|NCT00120250|7175825|FG000|STARTED|Overall Study||13
6276553|NCT00120250|7175826|FG001|STARTED|Overall Study||14
6276554|NCT00120250|7175825|FG000|COMPLETED|Overall Study||12
6276555|NCT00120250|7175826|FG001|COMPLETED|Overall Study||12
6276556|NCT00120250|7175825|FG000|NOT COMPLETED|Overall Study||1
6276557|NCT00120250|7175826|FG001|NOT COMPLETED|Overall Study||2
6276558|NCT00120289|7175835|FG000|STARTED|Overall Study||1718
6276559|NCT00120289|7175836|FG001|STARTED|Overall Study||1696
6276560|NCT00120289|7175835|FG000|COMPLETED|Overall Study||1597
6276561|NCT00120289|7175836|FG001|COMPLETED|Overall Study||1587
6276562|NCT00120289|7175835|FG000|NOT COMPLETED|Overall Study||121
6276563|NCT00120289|7175836|FG001|NOT COMPLETED|Overall Study||109
6280843|NCT00159263|7180666|FG002|NOT COMPLETED|Washout||0
6280844|NCT00159263|7180667|FG003|NOT COMPLETED|Washout||0
6280845|NCT00159263|7180668|FG004|NOT COMPLETED|Washout||0
6280846|NCT00159263|7180669|FG005|NOT COMPLETED|Washout||0
6280847|NCT00159263|7180664|FG000|STARTED|Sixth Intervention||1
6280848|NCT00159263|7180665|FG001|STARTED|Sixth Intervention||1
6280849|NCT00159263|7180666|FG002|STARTED|Sixth Intervention||2
6280850|NCT00159263|7180667|FG003|STARTED|Sixth Intervention||2
6280851|NCT00159263|7180668|FG004|STARTED|Sixth Intervention||2
6280852|NCT00159263|7180669|FG005|STARTED|Sixth Intervention||2
6280853|NCT00159263|7180664|FG000|COMPLETED|Sixth Intervention||1
6280854|NCT00159263|7180665|FG001|COMPLETED|Sixth Intervention||1
6280855|NCT00159263|7180666|FG002|COMPLETED|Sixth Intervention||2
6280856|NCT00159263|7180667|FG003|COMPLETED|Sixth Intervention||2
6280857|NCT00159263|7180668|FG004|COMPLETED|Sixth Intervention||2
6280858|NCT00159263|7180669|FG005|COMPLETED|Sixth Intervention||2
6280859|NCT00159263|7180664|FG000|NOT COMPLETED|Sixth Intervention||0
6280860|NCT00159263|7180665|FG001|NOT COMPLETED|Sixth Intervention||0
6280861|NCT00159263|7180666|FG002|NOT COMPLETED|Sixth Intervention||0
6280862|NCT00159263|7180667|FG003|NOT COMPLETED|Sixth Intervention||0
6280863|NCT00159263|7180668|FG004|NOT COMPLETED|Sixth Intervention||0
6280864|NCT00159263|7180669|FG005|NOT COMPLETED|Sixth Intervention||0
6280865|NCT00159419|7180685|FG000|STARTED|Overall Study||9
6280866|NCT00159419|7180686|FG001|STARTED|Overall Study||9
6568716|NCT01839487|7491910|FG005|NOT COMPLETED|Phase 2 (Maximum Exposure:935 Days)||44
6568717|NCT01839604|7491923|FG000|STARTED|Overall Study||6
6568718|NCT01839604|7491924|FG001|STARTED|Overall Study||6
6568719|NCT01839604|7491925|FG002|STARTED|Overall Study||7
6391421|NCT00835341|7303239|FG000|STARTED|Overall Study||35
6391422|NCT00835341|7303240|FG001|STARTED|Overall Study||58
6391423|NCT00835341|7303239|FG000|COMPLETED|Overall Study||32
6276564|NCT00120406|7175844|FG000|STARTED|Overall Study||236
6276565|NCT00120406|7175845|FG001|STARTED|Overall Study||238
6276566|NCT00120406|7175844|FG000|COMPLETED|Overall Study||217
6276567|NCT00120406|7175845|FG001|COMPLETED|Overall Study||222
6276568|NCT00120406|7175844|FG000|NOT COMPLETED|Overall Study||19
6276569|NCT00120406|7175845|FG001|NOT COMPLETED|Overall Study||16
6276570|NCT00120523|7175853|FG000|STARTED|Treatment Period||1205
6276571|NCT00120523|7175854|FG001|STARTED|Treatment Period||1213
6276572|NCT00120523|7175853|FG000|COMPLETED|Treatment Period||836
6276573|NCT00120523|7175854|FG001|COMPLETED|Treatment Period||874
6276574|NCT00120523|7175853|FG000|NOT COMPLETED|Treatment Period||369
6276575|NCT00120523|7175854|FG001|NOT COMPLETED|Treatment Period||339
6276576|NCT00120523|7175853|FG000|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
6276577|NCT00120523|7175854|FG001|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
6276578|NCT00120523|7175853|FG000|COMPLETED|Follow-Up Period||90
6276579|NCT00120523|7175854|FG001|COMPLETED|Follow-Up Period||46
6276580|NCT00120523|7175853|FG000|NOT COMPLETED|Follow-Up Period||30
6276581|NCT00120523|7175854|FG001|NOT COMPLETED|Follow-Up Period||24
6276582|NCT00120627|7175863|FG000|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
6276583|NCT00120627|7175864|FG001|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
6276584|NCT00120627|7175863|FG000|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
6276585|NCT00120627|7175864|FG001|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
6276586|NCT00120627|7175863|FG000|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
6276587|NCT00120627|7175864|FG001|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
6276588|NCT00120627|7175863|FG000|COMPLETED|Overall Study||66
6276589|NCT00120627|7175864|FG001|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
6276590|NCT00120627|7175863|FG000|NOT COMPLETED|Overall Study||5
6276591|NCT00120627|7175864|FG001|NOT COMPLETED|Overall Study||5
6276592|NCT00120874|7175881|FG000|STARTED|Overall Study||10
6276593|NCT00120874|7175882|FG001|STARTED|Overall Study||10
6276594|NCT00120874|7175881|FG000|Completed Study; Started Extension Study|Overall Study||10
6276595|NCT00120874|7175882|FG001|Completed Study; Started Extension Study|Overall Study||10
6276596|NCT00120874|7175881|FG000|COMPLETED|Overall Study||10
6276597|NCT00120874|7175882|FG001|COMPLETED|Overall Study||9
6276598|NCT00120874|7175881|FG000|NOT COMPLETED|Overall Study||0
6276599|NCT00120874|7175882|FG001|NOT COMPLETED|Overall Study||1
6276600|NCT00121134|7175892|FG000|STARTED|Overall Study||40
6568720|NCT01839604|7491926|FG003|STARTED|Overall Study||5
6568721|NCT01839604|7491927|FG004|STARTED|Overall Study||15
6568722|NCT01839604|7491923|FG000|COMPLETED|Overall Study||6
6568723|NCT01839604|7491924|FG001|COMPLETED|Overall Study||6
6568724|NCT01839604|7491925|FG002|COMPLETED|Overall Study||7
6568725|NCT01839604|7491926|FG003|COMPLETED|Overall Study||5
6568726|NCT01839604|7491927|FG004|COMPLETED|Overall Study||15
6568727|NCT01839604|7491923|FG000|NOT COMPLETED|Overall Study||0
6568728|NCT01839604|7491924|FG001|NOT COMPLETED|Overall Study||0
6568729|NCT01839604|7491925|FG002|NOT COMPLETED|Overall Study||0
6568730|NCT01839604|7491926|FG003|NOT COMPLETED|Overall Study||0
6568731|NCT01839604|7491927|FG004|NOT COMPLETED|Overall Study||0
6568732|NCT01839656|7491941|FG000|STARTED|Overall Study||5
6276601|NCT00121134|7175893|FG001|STARTED|Overall Study||41
6276602|NCT00121134|7175894|FG002|STARTED|Overall Study||41
6276603|NCT00121134|7175895|FG003|STARTED|Overall Study||40
6276604|NCT00121134|7175892|FG000|COMPLETED|Overall Study||24
6276605|NCT00121134|7175893|FG001|COMPLETED|Overall Study||26
6276606|NCT00121134|7175894|FG002|COMPLETED|Overall Study||20
6276607|NCT00121134|7175895|FG003|COMPLETED|Overall Study||31
6391424|NCT00835341|7303240|FG001|COMPLETED|Overall Study||46
6391425|NCT00835341|7303239|FG000|NOT COMPLETED|Overall Study||3
6391426|NCT00835341|7303240|FG001|NOT COMPLETED|Overall Study||12
6391427|NCT00835380|7303246|FG000|STARTED|Overall Study||80
6391428|NCT00835380|7303246|FG000|COMPLETED|Overall Study||78
6391429|NCT00835380|7303246|FG000|NOT COMPLETED|Overall Study||2
6391430|NCT00835510|7303253|FG000|STARTED|Overall Study||219
6391431|NCT00835510|7303254|FG001|STARTED|Overall Study||221
6391432|NCT00835510|7303255|FG002|STARTED|Overall Study||108
6391433|NCT00835510|7303253|FG000|Positive Fungal Culture|Overall Study||149
6391434|NCT00835510|7303254|FG001|Positive Fungal Culture|Overall Study||155
6391435|NCT00835510|7303255|FG002|Positive Fungal Culture|Overall Study||71
6391436|NCT00835510|7303253|FG000|COMPLETED|Overall Study||143
6391437|NCT00835510|7303254|FG001|COMPLETED|Overall Study||152
6391438|NCT00835510|7303255|FG002|COMPLETED|Overall Study||70
6391439|NCT00835510|7303253|FG000|NOT COMPLETED|Overall Study||76
6391440|NCT00835510|7303254|FG001|NOT COMPLETED|Overall Study||69
6391441|NCT00835510|7303255|FG002|NOT COMPLETED|Overall Study||38
6391442|NCT00835731|7303265|FG000|STARTED|Overall Study||64
6391443|NCT00835731|7303266|FG001|STARTED|Overall Study||61
6391444|NCT00835731|7303265|FG000|COMPLETED|Overall Study||62
6391445|NCT00835731|7303266|FG001|COMPLETED|Overall Study||60
6391446|NCT00835731|7303265|FG000|NOT COMPLETED|Overall Study||2
6391447|NCT00835731|7303266|FG001|NOT COMPLETED|Overall Study||1
6391448|NCT00835770|7303274|FG000|STARTED|Overall Study||868
6391449|NCT00835770|7303275|FG001|STARTED|Overall Study||868
6391450|NCT00835770|7303274|FG000|COMPLETED|Overall Study||384
6391451|NCT00835770|7303275|FG001|COMPLETED|Overall Study||375
6391452|NCT00835770|7303274|FG000|NOT COMPLETED|Overall Study||484
6391453|NCT00835770|7303275|FG001|NOT COMPLETED|Overall Study||493
6391454|NCT00835861|7303289|FG000|STARTED|Overall Study||15
6391455|NCT00835861|7303290|FG001|STARTED|Overall Study||16
6391456|NCT00835861|7303289|FG000|COMPLETED|Overall Study||14
6391457|NCT00835861|7303290|FG001|COMPLETED|Overall Study||14
6391458|NCT00835861|7303289|FG000|NOT COMPLETED|Overall Study||1
6391459|NCT00835861|7303290|FG001|NOT COMPLETED|Overall Study||2
6391460|NCT00835900|7303298|FG000|STARTED|Overall Study||32
6391461|NCT00835900|7303299|FG001|STARTED|Overall Study||28
6391462|NCT00835900|7303298|FG000|COMPLETED|Overall Study||27
6391463|NCT00835900|7303299|FG001|COMPLETED|Overall Study||22
6391464|NCT00835900|7303298|FG000|NOT COMPLETED|Overall Study||5
6391465|NCT00835900|7303299|FG001|NOT COMPLETED|Overall Study||6
6391466|NCT00835926|7303307|FG000|STARTED|Overall Study||61
6391467|NCT00835926|7303308|FG001|STARTED|Overall Study||60
6391468|NCT00835926|7303307|FG000|COMPLETED|Overall Study||61
6391469|NCT00835926|7303308|FG001|COMPLETED|Overall Study||60
6391470|NCT00835926|7303307|FG000|NOT COMPLETED|Overall Study||0
6391471|NCT00835926|7303308|FG001|NOT COMPLETED|Overall Study||0
6391472|NCT00835978|7303318|FG000|STARTED|Overall Study||56
6391473|NCT00835978|7303319|FG001|STARTED|Overall Study||56
6391474|NCT00835978|7303320|FG002|STARTED|Overall Study||91
6391475|NCT00835978|7303321|FG003|STARTED|Overall Study||10
6391476|NCT00835978|7303318|FG000|Treated|Overall Study||56
6391477|NCT00835978|7303319|FG001|Treated|Overall Study||56
6391478|NCT00835978|7303320|FG002|Treated|Overall Study||91
6391479|NCT00835978|7303321|FG003|Treated|Overall Study||10
6391480|NCT00835978|7303318|FG000|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
6391481|NCT00835978|7303319|FG001|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
6391482|NCT00835978|7303320|FG002|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
6391483|NCT00835978|7303321|FG003|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
6391484|NCT00835978|7303318|FG000|NOT COMPLETED|Overall Study||56
6391485|NCT00835978|7303319|FG001|NOT COMPLETED|Overall Study||56
6391486|NCT00835978|7303320|FG002|NOT COMPLETED|Overall Study||91
6391487|NCT00835978|7303321|FG003|NOT COMPLETED|Overall Study||10
6391488|NCT00836017|7303336|FG000|STARTED|Overall Study||1046
6391489|NCT00836017|7303336|FG000|COMPLETED|Overall Study||502
6391490|NCT00836017|7303336|FG000|NOT COMPLETED|Overall Study||544
6391491|NCT00836095|7303342|FG000|STARTED|Overall Study||22
6391492|NCT00836095|7303343|FG001|STARTED|Overall Study||30
6391493|NCT00836095|7303342|FG000|COMPLETED|Overall Study||22
6391494|NCT00836095|7303343|FG001|COMPLETED|Overall Study||27
6391495|NCT00836095|7303342|FG000|NOT COMPLETED|Overall Study||0
6391496|NCT00836095|7303343|FG001|NOT COMPLETED|Overall Study||3
6391497|NCT00836186|7303349|FG000|STARTED|Overall Study||82
6391498|NCT00836186|7303349|FG000|COMPLETED|Overall Study||81
6391499|NCT00836186|7303349|FG000|NOT COMPLETED|Overall Study||1
6391500|NCT00836277|7303354|FG000|STARTED|Overall Study||24
6391501|NCT00836277|7303354|FG000|COMPLETED|Overall Study||18
6391502|NCT00836277|7303354|FG000|NOT COMPLETED|Overall Study||6
6391503|NCT00836342|7303361|FG000|STARTED|Overall Study||22
6391504|NCT00836342|7303362|FG001|STARTED|Overall Study||23
6391505|NCT00836342|7303363|FG002|STARTED|Overall Study||36
6391506|NCT00836342|7303361|FG000|COMPLETED|Overall Study||22
6391507|NCT00836342|7303362|FG001|COMPLETED|Overall Study||23
6391508|NCT00836342|7303363|FG002|COMPLETED|Overall Study||36
6391509|NCT00836342|7303361|FG000|NOT COMPLETED|Overall Study||0
6391510|NCT00836342|7303362|FG001|NOT COMPLETED|Overall Study||0
6391511|NCT00836342|7303363|FG002|NOT COMPLETED|Overall Study||0
6391512|NCT00836407|7303375|FG000|STARTED|Overall Study||15
6391513|NCT00836407|7303376|FG001|STARTED|Overall Study||15
6391514|NCT00836407|7303375|FG000|COMPLETED|Overall Study||4
6391515|NCT00836407|7303376|FG001|COMPLETED|Overall Study||7
6391516|NCT00836407|7303375|FG000|NOT COMPLETED|Overall Study||11
6391517|NCT00836407|7303376|FG001|NOT COMPLETED|Overall Study||8
6391518|NCT00836433|7303384|FG000|STARTED|Overall Study||361
6391519|NCT00836433|7303385|FG001|STARTED|Overall Study||328
6391520|NCT00836433|7303384|FG000|COMPLETED|Overall Study||349
6391521|NCT00836433|7303385|FG001|COMPLETED|Overall Study||321
6391522|NCT00836433|7303384|FG000|NOT COMPLETED|Overall Study||12
6391523|NCT00836433|7303385|FG001|NOT COMPLETED|Overall Study||7
6391524|NCT00836498|7303395|FG000|STARTED|Overall Study||44
6391525|NCT00836498|7303396|FG001|STARTED|Overall Study||22
6391526|NCT00836498|7303395|FG000|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
6391527|NCT00836498|7303396|FG001|COMPLETED|Overall Study||21
6391528|NCT00836498|7303395|FG000|NOT COMPLETED|Overall Study||4
6391529|NCT00836498|7303396|FG001|NOT COMPLETED|Overall Study||1
6391530|NCT00836589|7303403|FG000|STARTED|Overall Study||1997
6391531|NCT00836589|7303403|FG000|COMPLETED|Overall Study||731
6391532|NCT00836589|7303403|FG000|NOT COMPLETED|Overall Study||1266
6391533|NCT00836641|7303417|FG000|STARTED|Overall Study||36
6568733|NCT01839656|7491942|FG001|STARTED|Overall Study||16
6568734|NCT01839656|7491941|FG000|Completed Loading Dose Period|Overall Study||4
6568735|NCT01839656|7491942|FG001|Completed Loading Dose Period|Overall Study||15
6568736|NCT01839656|7491941|FG000|COMPLETED|Overall Study||2
6568737|NCT01839656|7491942|FG001|COMPLETED|Overall Study||0
6391534|NCT00836641|7303418|FG001|STARTED|Overall Study||34
6391535|NCT00836641|7303417|FG000|COMPLETED|Overall Study||36
6391536|NCT00836641|7303418|FG001|COMPLETED|Overall Study||34
6391537|NCT00836641|7303417|FG000|NOT COMPLETED|Overall Study||0
6391538|NCT00836641|7303418|FG001|NOT COMPLETED|Overall Study||0
6391539|NCT00836693|7303425|FG000|STARTED|Overall Study||147
6391540|NCT00836693|7303426|FG001|STARTED|Overall Study||70
6391541|NCT00836693|7303425|FG000|COMPLETED|Overall Study||130
6391542|NCT00836693|7303426|FG001|COMPLETED|Overall Study||64
6391543|NCT00836693|7303425|FG000|NOT COMPLETED|Overall Study||17
6391544|NCT00836693|7303426|FG001|NOT COMPLETED|Overall Study||6
6391545|NCT00836719|7303432|FG000|STARTED|Overall Study||10
6391546|NCT00836719|7303432|FG000|COMPLETED|Overall Study||10
6391547|NCT00836719|7303432|FG000|NOT COMPLETED|Overall Study||0
6391548|NCT00836745|7303436|FG000|STARTED|Overall Study||36
6391549|NCT00836745|7303436|FG000|COMPLETED|Overall Study||15
6391550|NCT00836745|7303436|FG000|NOT COMPLETED|Overall Study||21
6391551|NCT00836758|7303440|FG000|STARTED|Overall Study||115
6391552|NCT00836758|7303440|FG000|COMPLETED|Overall Study||115
6391553|NCT00836758|7303440|FG000|NOT COMPLETED|Overall Study||0
6391554|NCT00836810|7303448|FG000|STARTED|Overall Study||5
6391555|NCT00836810|7303449|FG001|STARTED|Overall Study||6
6391556|NCT00836810|7303448|FG000|COMPLETED|Overall Study|1 patient was subsequently diagnosed with SLE and, per protocol, was not included.|4
6391557|NCT00836810|7303449|FG001|COMPLETED|Overall Study||6
6391558|NCT00836810|7303448|FG000|NOT COMPLETED|Overall Study||1
6391559|NCT00836810|7303449|FG001|NOT COMPLETED|Overall Study||0
6391560|NCT00836875|7303457|FG000|STARTED|Overall Study||11
6391561|NCT00836875|7303458|FG001|STARTED|Overall Study||20
6391562|NCT00836875|7303457|FG000|COMPLETED|Overall Study||8
6391563|NCT00836875|7303458|FG001|COMPLETED|Overall Study||17
6391564|NCT00836875|7303457|FG000|NOT COMPLETED|Overall Study||3
6391565|NCT00836875|7303458|FG001|NOT COMPLETED|Overall Study||3
6391566|NCT00836888|7303468|FG000|STARTED|Overall Study||3
6391567|NCT00836888|7303469|FG001|STARTED|Overall Study||5
6391568|NCT00836888|7303470|FG002|STARTED|Overall Study||6
6391569|NCT00836888|7303471|FG003|STARTED|Overall Study||3
6391570|NCT00836888|7303468|FG000|COMPLETED|Overall Study||0
6391571|NCT00836888|7303469|FG001|COMPLETED|Overall Study||2
6391572|NCT00836888|7303470|FG002|COMPLETED|Overall Study||0
6391573|NCT00836888|7303471|FG003|COMPLETED|Overall Study||0
6391574|NCT00836888|7303468|FG000|NOT COMPLETED|Overall Study||3
6391575|NCT00836888|7303469|FG001|NOT COMPLETED|Overall Study||3
6391576|NCT00836888|7303470|FG002|NOT COMPLETED|Overall Study||6
6391577|NCT00836888|7303471|FG003|NOT COMPLETED|Overall Study||3
6568738|NCT01839656|7491941|FG000|NOT COMPLETED|Overall Study||3
6568739|NCT01839656|7491942|FG001|NOT COMPLETED|Overall Study||16
6568740|NCT01839695|7491948|FG000|STARTED|Overall Study||9
6568741|NCT01839695|7491948|FG000|COMPLETED|Overall Study||9
6568742|NCT01839695|7491948|FG000|NOT COMPLETED|Overall Study||0
6568743|NCT01839708|7491954|FG000|STARTED|Overall Study||387
6568744|NCT01839708|7491955|FG001|STARTED|Overall Study||182
6568745|NCT01839708|7491954|FG000|COMPLETED|Overall Study||311
6568746|NCT01839708|7491955|FG001|COMPLETED|Overall Study||115
6568747|NCT01839708|7491954|FG000|NOT COMPLETED|Overall Study||76
6568748|NCT01839708|7491955|FG001|NOT COMPLETED|Overall Study||67
6568749|NCT01839799|7491963|FG000|STARTED|Overall Study||17
6568750|NCT01839799|7491964|FG001|STARTED|Overall Study||15
6568751|NCT01839799|7491963|FG000|COMPLETED|Overall Study||17
6568752|NCT01839799|7491964|FG001|COMPLETED|Overall Study||15
6391578|NCT00836927|7303486|FG000|STARTED|Overall Study||3
6391579|NCT00836927|7303487|FG001|STARTED|Overall Study||1
6391580|NCT00836927|7303488|FG002|STARTED|Overall Study|One participant received ridaforolimus 3 mg IV infusion before being switched to the oral tablet.|1
6391581|NCT00836927|7303489|FG003|STARTED|Overall Study||1
6391582|NCT00836927|7303490|FG004|STARTED|Overall Study||1
6391583|NCT00836927|7303486|FG000|Completed Dosing Through 03 Apr 2017|Overall Study||0
6391584|NCT00836927|7303487|FG001|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
6391585|NCT00836927|7303488|FG002|Completed Dosing Through 03 Apr 2017|Overall Study|Participant continued to receive study drug past the data cut-off date of 03 Apr 2017|1
6391586|NCT00836927|7303489|FG003|Completed Dosing Through 03 Apr 2017|Overall Study||0
6391587|NCT00836927|7303490|FG004|Completed Dosing Through 03 Apr 2017|Overall Study||0
6391588|NCT00836927|7303486|FG000|COMPLETED|Overall Study||0
6391589|NCT00836927|7303487|FG001|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
6391590|NCT00836927|7303488|FG002|COMPLETED|Overall Study|Participant completed treatment by 04 Feb 2018|1
6391591|NCT00836927|7303489|FG003|COMPLETED|Overall Study||0
6391592|NCT00836927|7303490|FG004|COMPLETED|Overall Study||0
6391593|NCT00836927|7303486|FG000|NOT COMPLETED|Overall Study||3
6391594|NCT00836927|7303487|FG001|NOT COMPLETED|Overall Study||0
6391595|NCT00836927|7303488|FG002|NOT COMPLETED|Overall Study||0
6391596|NCT00836927|7303489|FG003|NOT COMPLETED|Overall Study||1
6391597|NCT00836927|7303490|FG004|NOT COMPLETED|Overall Study||1
6391598|NCT00836953|7303504|FG000|STARTED|Overall Study||33
6391599|NCT00836953|7303504|FG000|COMPLETED|Overall Study||31
6391600|NCT00836953|7303504|FG000|NOT COMPLETED|Overall Study||2
6391601|NCT00837031|7303508|FG000|STARTED|Overall Study||72
6391602|NCT00837031|7303508|FG000|COMPLETED|Overall Study||72
6391603|NCT00837031|7303508|FG000|NOT COMPLETED|Overall Study||0
6391604|NCT00837096|7303514|FG000|STARTED|Overall Study||10
6391605|NCT00837096|7303515|FG001|STARTED|Overall Study||9
6391606|NCT00837096|7303514|FG000|COMPLETED|Overall Study||0
6391607|NCT00837096|7303515|FG001|COMPLETED|Overall Study||0
6391608|NCT00837096|7303514|FG000|NOT COMPLETED|Overall Study||10
6391609|NCT00837096|7303515|FG001|NOT COMPLETED|Overall Study||9
6391610|NCT00837148|7303521|FG000|STARTED|Overall Study||37
6391611|NCT00837148|7303521|FG000|COMPLETED|Overall Study||35
6391612|NCT00837148|7303521|FG000|NOT COMPLETED|Overall Study||2
6391613|NCT00837161|7303525|FG000|STARTED|Overall Study||11
6391614|NCT00837161|7303525|FG000|COMPLETED|Overall Study||9
6391615|NCT00837161|7303525|FG000|NOT COMPLETED|Overall Study||2
6391616|NCT00837200|7303529|FG000|STARTED|Overall Study||13
6391617|NCT00837200|7303529|FG000|COMPLETED|Overall Study||13
6391618|NCT00837200|7303529|FG000|NOT COMPLETED|Overall Study||0
6504910|NCT01450683|7423970|FG000|COMPLETED|Overall Study||2
6504911|NCT01450683|7423970|FG000|NOT COMPLETED|Overall Study||2
6504912|NCT01450696|7423976|FG000|STARTED|Overall Study||148
6504913|NCT01450696|7423977|FG001|STARTED|Overall Study||148
6391619|NCT00837213|7303535|FG000|STARTED|Overall Study||16
6504914|NCT01450696|7423976|FG000|Treated (Safety Population)|Overall Study||147
6276608|NCT00121134|7175892|FG000|NOT COMPLETED|Overall Study||16
6276609|NCT00121134|7175893|FG001|NOT COMPLETED|Overall Study||15
6276610|NCT00121134|7175894|FG002|NOT COMPLETED|Overall Study||21
6276611|NCT00121134|7175895|FG003|NOT COMPLETED|Overall Study||9
6276612|NCT00121173|7175908|FG000|STARTED|Overall Study||4
6276613|NCT00121173|7175909|FG001|STARTED|Overall Study||3
6276614|NCT00121173|7175910|FG002|STARTED|Overall Study||9
6276615|NCT00121173|7175908|FG000|COMPLETED|Overall Study||3
6276616|NCT00121173|7175909|FG001|COMPLETED|Overall Study||3
6276617|NCT00121173|7175910|FG002|COMPLETED|Overall Study||9
6276618|NCT00121173|7175908|FG000|NOT COMPLETED|Overall Study||1
6276619|NCT00121173|7175909|FG001|NOT COMPLETED|Overall Study||0
6276620|NCT00121173|7175910|FG002|NOT COMPLETED|Overall Study||0
6276621|NCT00121186|7175921|FG000|STARTED|Overall Study||1
6276622|NCT00121186|7175921|FG000|COMPLETED|Overall Study||1
6276623|NCT00121186|7175921|FG000|NOT COMPLETED|Overall Study||0
6276624|NCT00121199|7175925|FG000|STARTED|Overall Study||73
6276625|NCT00121199|7175925|FG000|Eligible|Overall Study||64
6276626|NCT00121199|7175925|FG000|Eligible and Began Protocol Therapy|Overall Study||64
6276627|NCT00121199|7175925|FG000|COMPLETED|Overall Study||45
6276628|NCT00121199|7175925|FG000|NOT COMPLETED|Overall Study||28
6276629|NCT00121225|7175929|FG000|STARTED|Overall Study||32
6276630|NCT00121225|7175929|FG000|COMPLETED|Overall Study||32
6276631|NCT00121225|7175929|FG000|NOT COMPLETED|Overall Study||0
6276632|NCT00121238|7175934|FG000|STARTED|Overall Study||16
6276633|NCT00121238|7175934|FG000|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
6276634|NCT00121238|7175934|FG000|NOT COMPLETED|Overall Study||3
6276635|NCT00121251|7175938|FG000|STARTED|Overall Study||17
6276636|NCT00121251|7175938|FG000|COMPLETED|Overall Study||17
6276637|NCT00121251|7175938|FG000|NOT COMPLETED|Overall Study||0
6276638|NCT00121472|7175942|FG000|STARTED|Overall Study||194
6276639|NCT00121472|7175942|FG000|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
6276640|NCT00121472|7175942|FG000|NOT COMPLETED|Overall Study||0
6276641|NCT00121485|7175952|FG000|STARTED|Overall Study||134
6276642|NCT00121485|7175953|FG001|STARTED|Overall Study||66
6276643|NCT00121485|7175952|FG000|COMPLETED|Overall Study||133
6504915|NCT01450696|7423977|FG001|Treated (Safety Population)|Overall Study||147
6504916|NCT01450696|7423976|FG000|COMPLETED|Overall Study||0
6504917|NCT01450696|7423977|FG001|COMPLETED|Overall Study||0
6504918|NCT01450696|7423976|FG000|NOT COMPLETED|Overall Study||148
6504919|NCT01450696|7423977|FG001|NOT COMPLETED|Overall Study||148
6568753|NCT01839799|7491963|FG000|NOT COMPLETED|Overall Study||0
6568754|NCT01839799|7491964|FG001|NOT COMPLETED|Overall Study||0
6568755|NCT01839916|7491970|FG000|STARTED|Overall Study||77
6568756|NCT01839916|7491970|FG000|COMPLETED|Overall Study||36
6568757|NCT01839916|7491970|FG000|NOT COMPLETED|Overall Study||41
6568758|NCT01840072|7491976|FG000|STARTED|Overall Study||2038
6568759|NCT01840072|7491977|FG001|STARTED|Overall Study||2033
6568760|NCT01840072|7491976|FG000|COMPLETED|Overall Study||2031
6568761|NCT01840072|7491977|FG001|COMPLETED|Overall Study||1986
6568762|NCT01840072|7491976|FG000|NOT COMPLETED|Overall Study||7
6568763|NCT01840072|7491977|FG001|NOT COMPLETED|Overall Study||47
6568764|NCT01840163|7491987|FG000|STARTED|First Follow up -Primary Outcome||267
6568765|NCT01840163|7491988|FG001|STARTED|First Follow up -Primary Outcome||270
6568766|NCT01840163|7491987|FG000|COMPLETED|First Follow up -Primary Outcome||248
6568767|NCT01840163|7491988|FG001|COMPLETED|First Follow up -Primary Outcome||254
6568768|NCT01840163|7491987|FG000|NOT COMPLETED|First Follow up -Primary Outcome||19
6568769|NCT01840163|7491988|FG001|NOT COMPLETED|First Follow up -Primary Outcome||16
6568770|NCT01840163|7491987|FG000|STARTED|Systemic Follow Up-secondary Outcome|From primary outcome to secondary outcome prd 1 participant withdrew and 1 became deceased|265
6568771|NCT01840163|7491988|FG001|STARTED|Systemic Follow Up-secondary Outcome|4 participants became unreachable and lost to follow up before sending 9 mo follow up|266
6504920|NCT01450761|7423985|FG000|STARTED|Randomization||566
6504921|NCT01450761|7423986|FG001|STARTED|Randomization||566
6504922|NCT01450761|7423985|FG000|COMPLETED|Randomization||562
6504923|NCT01450761|7423986|FG001|COMPLETED|Randomization||561
6504924|NCT01450761|7423985|FG000|NOT COMPLETED|Randomization||4
6568772|NCT01840163|7491987|FG000|COMPLETED|Systemic Follow Up-secondary Outcome||174
6504925|NCT01450761|7423986|FG001|NOT COMPLETED|Randomization||5
6568773|NCT01840163|7491988|FG001|COMPLETED|Systemic Follow Up-secondary Outcome||191
6568774|NCT01840163|7491987|FG000|NOT COMPLETED|Systemic Follow Up-secondary Outcome||91
6568775|NCT01840163|7491988|FG001|NOT COMPLETED|Systemic Follow Up-secondary Outcome||75
6568776|NCT01840228|7491996|FG000|STARTED|Overall Study||19
6568777|NCT01840228|7491997|FG001|STARTED|Overall Study||19
6568778|NCT01840228|7491996|FG000|COMPLETED|Overall Study||18
6568779|NCT01840228|7491997|FG001|COMPLETED|Overall Study||18
6568780|NCT01840228|7491996|FG000|NOT COMPLETED|Overall Study||1
6568781|NCT01840228|7491997|FG001|NOT COMPLETED|Overall Study||1
6568782|NCT01840319|7492007|FG000|STARTED|Overall Study||156
6568783|NCT01840319|7492007|FG000|COMPLETED|Overall Study||156
6568784|NCT01840319|7492007|FG000|NOT COMPLETED|Overall Study||0
6568785|NCT01840345|7492011|FG000|STARTED|Overall Study||11
6568786|NCT01840345|7492011|FG000|COMPLETED|Overall Study||10
6276644|NCT00121485|7175953|FG001|COMPLETED|Overall Study||59
6276645|NCT00121485|7175952|FG000|NOT COMPLETED|Overall Study||1
6276646|NCT00121485|7175953|FG001|NOT COMPLETED|Overall Study||7
6276647|NCT00121641|7175964|FG000|STARTED|24-week Short-term Treatment Period||102
6276648|NCT00121641|7175965|FG001|STARTED|24-week Short-term Treatment Period||106
6276649|NCT00121641|7175966|FG002|STARTED|24-week Short-term Treatment Period||98
6276650|NCT00121641|7175967|FG003|STARTED|24-week Short-term Treatment Period||95
6568787|NCT01840345|7492011|FG000|NOT COMPLETED|Overall Study||1
6568788|NCT01840410|7492017|FG000|STARTED|Overall Study||119
6568789|NCT01840410|7492018|FG001|STARTED|Overall Study||59
6568790|NCT01840410|7492017|FG000|Safety Set|Overall Study||119
6568791|NCT01840410|7492018|FG001|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
6568792|NCT01840410|7492017|FG000|Full Analysis Set|Overall Study||119
6568793|NCT01840410|7492018|FG001|Full Analysis Set|Overall Study||59
6568794|NCT01840410|7492017|FG000|COMPLETED|Overall Study||112
6568795|NCT01840410|7492018|FG001|COMPLETED|Overall Study||55
6568796|NCT01840410|7492017|FG000|NOT COMPLETED|Overall Study||7
6568797|NCT01840410|7492018|FG001|NOT COMPLETED|Overall Study||4
6568798|NCT01840579|7492036|FG000|STARTED|Overall Study||3
6568799|NCT01840579|7492037|FG001|STARTED|Overall Study||7
6568800|NCT01840579|7492038|FG002|STARTED|Overall Study||6
6568801|NCT01840579|7492039|FG003|STARTED|Overall Study||6
6568802|NCT01840579|7492040|FG004|STARTED|Overall Study||8
6568803|NCT01840579|7492041|FG005|STARTED|Overall Study||6
6568804|NCT01840579|7492042|FG006|STARTED|Overall Study||6
6568805|NCT01840579|7492043|FG007|STARTED|Overall Study||6
6568806|NCT01840579|7492044|FG008|STARTED|Overall Study||6
6568807|NCT01840579|7492045|FG009|STARTED|Overall Study||3
6568808|NCT01840579|7492036|FG000|COMPLETED|Overall Study||0
6657282|NCT02468674|7587619|FG000|STARTED|Overall Study||5
6657283|NCT02468674|7587620|FG001|STARTED|Overall Study||5
6657284|NCT02468674|7587621|FG002|STARTED|Overall Study||5
6657285|NCT02468674|7587622|FG003|STARTED|Overall Study||4
6568809|NCT01840579|7492037|FG001|COMPLETED|Overall Study||0
6568810|NCT01840579|7492038|FG002|COMPLETED|Overall Study||4
6568811|NCT01840579|7492039|FG003|COMPLETED|Overall Study||3
6568812|NCT01840579|7492040|FG004|COMPLETED|Overall Study||4
6657286|NCT02468674|7587623|FG004|STARTED|Overall Study||7
6657287|NCT02468674|7587624|FG005|STARTED|Overall Study||7
6657288|NCT02468674|7587625|FG006|STARTED|Overall Study||15
6657289|NCT02468674|7587626|FG007|STARTED|Overall Study||69
6657290|NCT02468674|7587627|FG008|STARTED|Overall Study||43
6657291|NCT02468674|7587619|FG000|COMPLETED|Overall Study||4
6657292|NCT02468674|7587620|FG001|COMPLETED|Overall Study||5
6657293|NCT02468674|7587621|FG002|COMPLETED|Overall Study||5
6657294|NCT02468674|7587622|FG003|COMPLETED|Overall Study||3
6657295|NCT02468674|7587623|FG004|COMPLETED|Overall Study||6
6657296|NCT02468674|7587624|FG005|COMPLETED|Overall Study||6
6657297|NCT02468674|7587625|FG006|COMPLETED|Overall Study||14
6657298|NCT02468674|7587626|FG007|COMPLETED|Overall Study||65
6657299|NCT02468674|7587627|FG008|COMPLETED|Overall Study||40
6657300|NCT02468674|7587619|FG000|NOT COMPLETED|Overall Study||1
6657301|NCT02468674|7587620|FG001|NOT COMPLETED|Overall Study||0
6391620|NCT00837213|7303536|FG001|STARTED|Overall Study||17
6391621|NCT00837213|7303535|FG000|COMPLETED|Overall Study||10
6391622|NCT00837213|7303536|FG001|COMPLETED|Overall Study||12
6391623|NCT00837213|7303535|FG000|NOT COMPLETED|Overall Study||6
6391624|NCT00837213|7303536|FG001|NOT COMPLETED|Overall Study||5
6391625|NCT00837252|7303542|FG000|STARTED|Overall Study||5
6568813|NCT01840579|7492041|FG005|COMPLETED|Overall Study||2
6568814|NCT01840579|7492042|FG006|COMPLETED|Overall Study||4
6568815|NCT01840579|7492043|FG007|COMPLETED|Overall Study||3
6657302|NCT02468674|7587621|FG002|NOT COMPLETED|Overall Study||0
6657303|NCT02468674|7587622|FG003|NOT COMPLETED|Overall Study||1
6657304|NCT02468674|7587623|FG004|NOT COMPLETED|Overall Study||1
6391626|NCT00837252|7303542|FG000|COMPLETED|Overall Study||5
6568816|NCT01840579|7492044|FG008|COMPLETED|Overall Study||3
6657305|NCT02468674|7587624|FG005|NOT COMPLETED|Overall Study||1
6568817|NCT01840579|7492045|FG009|COMPLETED|Overall Study||0
6568818|NCT01840579|7492036|FG000|NOT COMPLETED|Overall Study||3
6391627|NCT00837252|7303542|FG000|NOT COMPLETED|Overall Study||0
6391628|NCT00837330|7303548|FG000|STARTED|Overall Study||10
6391629|NCT00837330|7303549|FG001|STARTED|Overall Study||10
6391630|NCT00837330|7303548|FG000|COMPLETED|Overall Study||9
6391631|NCT00837330|7303549|FG001|COMPLETED|Overall Study||7
6391632|NCT00837330|7303548|FG000|NOT COMPLETED|Overall Study||1
6391633|NCT00837330|7303549|FG001|NOT COMPLETED|Overall Study||3
6391634|NCT00837434|7303557|FG000|STARTED|Overall Study||43
6391635|NCT00837434|7303558|FG001|STARTED|Overall Study||20
6391636|NCT00837434|7303557|FG000|COMPLETED|Overall Study||34
6504926|NCT01450761|7423985|FG000|STARTED|Lead-in Chemotherapy||562
6504927|NCT01450761|7423986|FG001|STARTED|Lead-in Chemotherapy||561
6504928|NCT01450761|7423985|FG000|COMPLETED|Lead-in Chemotherapy||478
6504929|NCT01450761|7423986|FG001|COMPLETED|Lead-in Chemotherapy||476
6504930|NCT01450761|7423985|FG000|NOT COMPLETED|Lead-in Chemotherapy||84
6504931|NCT01450761|7423986|FG001|NOT COMPLETED|Lead-in Chemotherapy||85
6504932|NCT01450761|7423985|FG000|STARTED|Treatment With Blinded Study Therapy||478
6504933|NCT01450761|7423986|FG001|STARTED|Treatment With Blinded Study Therapy||476
6504934|NCT01450761|7423985|FG000|COMPLETED|Treatment With Blinded Study Therapy||0
6504935|NCT01450761|7423986|FG001|COMPLETED|Treatment With Blinded Study Therapy||0
6504936|NCT01450761|7423985|FG000|NOT COMPLETED|Treatment With Blinded Study Therapy||478
6504937|NCT01450761|7423986|FG001|NOT COMPLETED|Treatment With Blinded Study Therapy||476
6504938|NCT01450787|7423994|FG000|STARTED|Overall Study||38
6504939|NCT01450787|7423995|FG001|STARTED|Overall Study||25
6504940|NCT01450787|7423994|FG000|COMPLETED|Overall Study||38
6504941|NCT01450787|7423995|FG001|COMPLETED|Overall Study||25
6504942|NCT01450787|7423994|FG000|NOT COMPLETED|Overall Study||0
6504943|NCT01450787|7423995|FG001|NOT COMPLETED|Overall Study||0
6504944|NCT01450800|7424003|FG000|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
6504945|NCT01450800|7424004|FG001|STARTED|Overall Study|81 participants were randomized to placebo|81
6504946|NCT01450800|7424003|FG000|COMPLETED|Overall Study||81
6504947|NCT01450800|7424004|FG001|COMPLETED|Overall Study||78
6504948|NCT01450800|7424003|FG000|NOT COMPLETED|Overall Study||1
6504949|NCT01450800|7424004|FG001|NOT COMPLETED|Overall Study||3
6504950|NCT01450813|7424016|FG000|STARTED|Overall Study||20
6504951|NCT01450813|7424017|FG001|STARTED|Overall Study||20
6504952|NCT01450813|7424018|FG002|STARTED|Overall Study||20
6504953|NCT01450813|7424019|FG003|STARTED|Overall Study||20
6504954|NCT01450813|7424016|FG000|COMPLETED|Overall Study||19
6504955|NCT01450813|7424017|FG001|COMPLETED|Overall Study||19
6504956|NCT01450813|7424018|FG002|COMPLETED|Overall Study||20
6504957|NCT01450813|7424019|FG003|COMPLETED|Overall Study||17
6504958|NCT01450813|7424016|FG000|NOT COMPLETED|Overall Study||1
6504959|NCT01450813|7424017|FG001|NOT COMPLETED|Overall Study||1
6504960|NCT01450813|7424018|FG002|NOT COMPLETED|Overall Study||0
6504961|NCT01450813|7424019|FG003|NOT COMPLETED|Overall Study||3
6504962|NCT01450826|7424033|FG000|STARTED|Overall Study||70
6504963|NCT01450826|7424034|FG001|STARTED|Overall Study||66
6504964|NCT01450826|7424033|FG000|COMPLETED|Overall Study||70
6504965|NCT01450826|7424034|FG001|COMPLETED|Overall Study||66
6504966|NCT01450826|7424033|FG000|NOT COMPLETED|Overall Study||0
6504967|NCT01450826|7424034|FG001|NOT COMPLETED|Overall Study||0
6504968|NCT01450943|7424043|FG000|STARTED|Overall Study||28
6504969|NCT01450943|7424044|FG001|STARTED|Overall Study||42
6391637|NCT00837434|7303558|FG001|COMPLETED|Overall Study||19
6391638|NCT00837434|7303557|FG000|NOT COMPLETED|Overall Study||9
6504970|NCT01450943|7424045|FG002|STARTED|Overall Study||48
6504971|NCT01450943|7424043|FG000|COMPLETED|Overall Study||26
6504972|NCT01450943|7424044|FG001|COMPLETED|Overall Study||35
6568819|NCT01840579|7492037|FG001|NOT COMPLETED|Overall Study||7
6568820|NCT01840579|7492038|FG002|NOT COMPLETED|Overall Study||2
6568821|NCT01840579|7492039|FG003|NOT COMPLETED|Overall Study||3
6568822|NCT01840579|7492040|FG004|NOT COMPLETED|Overall Study||4
6568823|NCT01840579|7492041|FG005|NOT COMPLETED|Overall Study||4
6568824|NCT01840579|7492042|FG006|NOT COMPLETED|Overall Study||2
6568825|NCT01840579|7492043|FG007|NOT COMPLETED|Overall Study||3
6568826|NCT01840579|7492044|FG008|NOT COMPLETED|Overall Study||3
6568827|NCT01840579|7492045|FG009|NOT COMPLETED|Overall Study||3
6568828|NCT01840605|7492081|FG000|STARTED|Overall Study||151
6568829|NCT01840605|7492082|FG001|STARTED|Overall Study||152
6568830|NCT01840605|7492081|FG000|COMPLETED|Overall Study||149
6568831|NCT01840605|7492082|FG001|COMPLETED|Overall Study||150
6568832|NCT01840605|7492081|FG000|NOT COMPLETED|Overall Study||2
6568833|NCT01840605|7492082|FG001|NOT COMPLETED|Overall Study||2
6568834|NCT01840722|7492090|FG000|STARTED|Overall Study||201
6568835|NCT01840722|7492091|FG001|STARTED|Overall Study||199
6568836|NCT01840722|7492090|FG000|COMPLETED|Overall Study||201
6568837|NCT01840722|7492091|FG001|COMPLETED|Overall Study||130
6568838|NCT01840722|7492090|FG000|NOT COMPLETED|Overall Study||0
6568839|NCT01840722|7492091|FG001|NOT COMPLETED|Overall Study||69
6568840|NCT01840943|7492099|FG000|STARTED|Overall Study||14
6568841|NCT01840943|7492100|FG001|STARTED|Overall Study||12
6568842|NCT01840943|7492099|FG000|COMPLETED|Overall Study||1
6568843|NCT01840943|7492100|FG001|COMPLETED|Overall Study||0
6568844|NCT01840943|7492099|FG000|NOT COMPLETED|Overall Study||13
6568845|NCT01840943|7492100|FG001|NOT COMPLETED|Overall Study||12
6568846|NCT01841021|7492106|FG000|STARTED|Overall Study||1
6568847|NCT01841021|7492106|FG000|COMPLETED|Overall Study||1
6568848|NCT01841021|7492106|FG000|NOT COMPLETED|Overall Study||0
6568849|NCT01841047|7492110|FG000|STARTED|Overall Study||48
6568850|NCT01841047|7492110|FG000|COMPLETED|Overall Study||48
6568851|NCT01841047|7492110|FG000|NOT COMPLETED|Overall Study||0
6568852|NCT01841060|7492114|FG000|STARTED|Overall Study||42
6568853|NCT01841060|7492114|FG000|COMPLETED|Overall Study||32
6568854|NCT01841060|7492114|FG000|NOT COMPLETED|Overall Study||10
6568855|NCT01841073|7492120|FG000|STARTED|Overall Study||22
6568856|NCT01841073|7492121|FG001|STARTED|Overall Study||22
6568857|NCT01841073|7492120|FG000|COMPLETED|Overall Study||20
6568858|NCT01841073|7492121|FG001|COMPLETED|Overall Study||19
6276651|NCT00121641|7175968|FG004|STARTED|24-week Short-term Treatment Period||66
6568859|NCT01841073|7492120|FG000|NOT COMPLETED|Overall Study||2
6568860|NCT01841073|7492121|FG001|NOT COMPLETED|Overall Study||3
6568861|NCT01841216|7492131|FG000|STARTED|Overall Study||15
6568862|NCT01841216|7492132|FG001|STARTED|Overall Study||15
6568863|NCT01841216|7492131|FG000|COMPLETED|Overall Study||15
6568864|NCT01841216|7492132|FG001|COMPLETED|Overall Study||15
6568865|NCT01841216|7492131|FG000|NOT COMPLETED|Overall Study||0
6391639|NCT00837434|7303558|FG001|NOT COMPLETED|Overall Study||1
6391640|NCT00837447|7303564|FG000|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
6391641|NCT00837447|7303564|FG000|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
6568866|NCT01841216|7492132|FG001|NOT COMPLETED|Overall Study||0
6568867|NCT01841281|7492140|FG000|STARTED|First Intervention (12 Weeks)||11
6568868|NCT01841281|7492141|FG001|STARTED|First Intervention (12 Weeks)||12
6568869|NCT01841281|7492142|FG002|STARTED|First Intervention (12 Weeks)||13
6568870|NCT01841281|7492143|FG003|STARTED|First Intervention (12 Weeks)||14
6568871|NCT01841281|7492140|FG000|COMPLETED|First Intervention (12 Weeks)||11
6657306|NCT02468674|7587625|FG006|NOT COMPLETED|Overall Study||1
6657307|NCT02468674|7587626|FG007|NOT COMPLETED|Overall Study||4
6657308|NCT02468674|7587627|FG008|NOT COMPLETED|Overall Study||3
6657309|NCT02468700|7587649|FG000|STARTED|Overall Study||22
6657310|NCT02468700|7587650|FG001|STARTED|Overall Study||21
6657311|NCT02468700|7587649|FG000|COMPLETED|Overall Study||20
6568872|NCT01841281|7492141|FG001|COMPLETED|First Intervention (12 Weeks)||12
6568873|NCT01841281|7492142|FG002|COMPLETED|First Intervention (12 Weeks)||13
6568874|NCT01841281|7492143|FG003|COMPLETED|First Intervention (12 Weeks)||14
6568875|NCT01841281|7492140|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
6657312|NCT02468700|7587650|FG001|COMPLETED|Overall Study||19
6568876|NCT01841281|7492141|FG001|NOT COMPLETED|First Intervention (12 Weeks)||0
6568877|NCT01841281|7492142|FG002|NOT COMPLETED|First Intervention (12 Weeks)||0
6280867|NCT00159419|7180685|FG000|COMPLETED|Overall Study||9
6568878|NCT01841281|7492143|FG003|NOT COMPLETED|First Intervention (12 Weeks)||0
6568879|NCT01841281|7492140|FG000|STARTED|Washout (6 Weeks)||11
6657313|NCT02468700|7587649|FG000|NOT COMPLETED|Overall Study||2
6568880|NCT01841281|7492141|FG001|STARTED|Washout (6 Weeks)||12
6568881|NCT01841281|7492142|FG002|STARTED|Washout (6 Weeks)||13
6568882|NCT01841281|7492143|FG003|STARTED|Washout (6 Weeks)||14
6568883|NCT01841281|7492140|FG000|COMPLETED|Washout (6 Weeks)||9
6568884|NCT01841281|7492141|FG001|COMPLETED|Washout (6 Weeks)||9
6568885|NCT01841281|7492142|FG002|COMPLETED|Washout (6 Weeks)||10
6568886|NCT01841281|7492143|FG003|COMPLETED|Washout (6 Weeks)||13
6568887|NCT01841281|7492140|FG000|NOT COMPLETED|Washout (6 Weeks)||2
6568888|NCT01841281|7492141|FG001|NOT COMPLETED|Washout (6 Weeks)||3
6276652|NCT00121641|7175964|FG000|COMPLETED|24-week Short-term Treatment Period||73
6276653|NCT00121641|7175965|FG001|COMPLETED|24-week Short-term Treatment Period||68
6276654|NCT00121641|7175966|FG002|COMPLETED|24-week Short-term Treatment Period||69
6276655|NCT00121641|7175967|FG003|COMPLETED|24-week Short-term Treatment Period||55
6276656|NCT00121641|7175968|FG004|COMPLETED|24-week Short-term Treatment Period||25
6276657|NCT00121641|7175964|FG000|NOT COMPLETED|24-week Short-term Treatment Period||29
6568889|NCT01841281|7492142|FG002|NOT COMPLETED|Washout (6 Weeks)||3
6568890|NCT01841281|7492143|FG003|NOT COMPLETED|Washout (6 Weeks)||1
6276658|NCT00121641|7175965|FG001|NOT COMPLETED|24-week Short-term Treatment Period||38
6276659|NCT00121641|7175966|FG002|NOT COMPLETED|24-week Short-term Treatment Period||29
6276660|NCT00121641|7175967|FG003|NOT COMPLETED|24-week Short-term Treatment Period||40
6276661|NCT00121641|7175968|FG004|NOT COMPLETED|24-week Short-term Treatment Period||41
6276662|NCT00121641|7175964|FG000|STARTED|48-month Short Term + Long Term Period||102
6276663|NCT00121641|7175965|FG001|STARTED|48-month Short Term + Long Term Period||106
6276664|NCT00121641|7175966|FG002|STARTED|48-month Short Term + Long Term Period||98
6276665|NCT00121641|7175967|FG003|STARTED|48-month Short Term + Long Term Period||95
6276666|NCT00121641|7175968|FG004|STARTED|48-month Short Term + Long Term Period||66
6276667|NCT00121641|7175964|FG000|COMPLETED|48-month Short Term + Long Term Period||23
6276668|NCT00121641|7175965|FG001|COMPLETED|48-month Short Term + Long Term Period||24
6276669|NCT00121641|7175966|FG002|COMPLETED|48-month Short Term + Long Term Period||28
6276670|NCT00121641|7175967|FG003|COMPLETED|48-month Short Term + Long Term Period||24
6276671|NCT00121641|7175968|FG004|COMPLETED|48-month Short Term + Long Term Period||8
6276672|NCT00121641|7175964|FG000|NOT COMPLETED|48-month Short Term + Long Term Period||79
6276673|NCT00121641|7175965|FG001|NOT COMPLETED|48-month Short Term + Long Term Period||82
6276674|NCT00121641|7175966|FG002|NOT COMPLETED|48-month Short Term + Long Term Period||70
6276675|NCT00121641|7175967|FG003|NOT COMPLETED|48-month Short Term + Long Term Period||71
6276676|NCT00121641|7175968|FG004|NOT COMPLETED|48-month Short Term + Long Term Period||58
6276677|NCT00121667|7175986|FG000|STARTED|Short Term (ST) Period||192
6568891|NCT01841281|7492140|FG000|STARTED|Second Intervention (12 Weeks)||9
6568892|NCT01841281|7492141|FG001|STARTED|Second Intervention (12 Weeks)||9
6568893|NCT01841281|7492142|FG002|STARTED|Second Intervention (12 Weeks)||10
6568894|NCT01841281|7492143|FG003|STARTED|Second Intervention (12 Weeks)||13
6568895|NCT01841281|7492140|FG000|COMPLETED|Second Intervention (12 Weeks)||9
6568896|NCT01841281|7492141|FG001|COMPLETED|Second Intervention (12 Weeks)||6
6504973|NCT01450943|7424045|FG002|COMPLETED|Overall Study||42
6504974|NCT01450943|7424043|FG000|NOT COMPLETED|Overall Study||2
6504975|NCT01450943|7424044|FG001|NOT COMPLETED|Overall Study||7
6504976|NCT01450943|7424045|FG002|NOT COMPLETED|Overall Study||6
6504977|NCT01451164|7424061|FG000|STARTED|Overall Study||115
6504978|NCT01451164|7424062|FG001|STARTED|Overall Study||115
6276678|NCT00121667|7175987|FG001|STARTED|Short Term (ST) Period||191
6568897|NCT01841281|7492142|FG002|COMPLETED|Second Intervention (12 Weeks)||10
6568898|NCT01841281|7492143|FG003|COMPLETED|Second Intervention (12 Weeks)||13
6568899|NCT01841281|7492140|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||0
6568900|NCT01841281|7492141|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||3
6657314|NCT02468700|7587650|FG001|NOT COMPLETED|Overall Study||2
6568901|NCT01841281|7492142|FG002|NOT COMPLETED|Second Intervention (12 Weeks)||0
6276679|NCT00121667|7175988|FG002|STARTED|Short Term (ST) Period||181
6276680|NCT00121667|7175989|FG003|STARTED|Short Term (ST) Period||179
6391642|NCT00837447|7303564|FG000|NOT COMPLETED|Overall Study||0
6391643|NCT00837473|7303569|FG000|STARTED|Overall Study||15
6391644|NCT00837473|7303569|FG000|COMPLETED|Overall Study||12
6391645|NCT00837473|7303569|FG000|NOT COMPLETED|Overall Study||3
6391646|NCT00837486|7303575|FG000|STARTED|Blinded-treatment Phase||16
6391647|NCT00837486|7303576|FG001|STARTED|Blinded-treatment Phase||14
6391648|NCT00837486|7303575|FG000|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
6391649|NCT00837486|7303576|FG001|COMPLETED|Blinded-treatment Phase||14
6391650|NCT00837486|7303575|FG000|NOT COMPLETED|Blinded-treatment Phase||1
6391651|NCT00837486|7303576|FG001|NOT COMPLETED|Blinded-treatment Phase||0
6391652|NCT00837486|7303575|FG000|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
6391653|NCT00837486|7303576|FG001|STARTED|Long-term Follow-up Phase - Open Label||0
6568902|NCT01841281|7492143|FG003|NOT COMPLETED|Second Intervention (12 Weeks)||0
6568903|NCT01841554|7492159|FG000|STARTED|Overall Study||61
6568904|NCT01841554|7492159|FG000|Implanted|Overall Study||60
6391654|NCT00837486|7303575|FG000|COMPLETED|Long-term Follow-up Phase - Open Label||24
6391655|NCT00837486|7303576|FG001|COMPLETED|Long-term Follow-up Phase - Open Label||0
6391656|NCT00837486|7303575|FG000|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
6391657|NCT00837486|7303576|FG001|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
6391658|NCT00837512|7303584|FG000|STARTED|First Intervention (6hrs) - RANDOMIZED||8
6391659|NCT00837512|7303585|FG001|STARTED|First Intervention (6hrs) - RANDOMIZED||8
6391660|NCT00837512|7303584|FG000|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
6391661|NCT00837512|7303585|FG001|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
6391662|NCT00837512|7303584|FG000|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
6568905|NCT01841554|7492159|FG000|1 Year Follow Up|Overall Study||42
6568906|NCT01841554|7492159|FG000|COMPLETED|Overall Study||42
6568907|NCT01841554|7492159|FG000|NOT COMPLETED|Overall Study||19
6568908|NCT01841567|7492163|FG000|STARTED|Overall Study||60
6568909|NCT01841567|7492163|FG000|COMPLETED|Overall Study||57
6568910|NCT01841567|7492163|FG000|NOT COMPLETED|Overall Study||3
6568911|NCT01841593|7492169|FG000|STARTED|First Intervention (Days 1 to 7)||12
6568912|NCT01841593|7492170|FG001|STARTED|First Intervention (Days 1 to 7)||7
6568913|NCT01841593|7492169|FG000|COMPLETED|First Intervention (Days 1 to 7)||12
6568914|NCT01841593|7492170|FG001|COMPLETED|First Intervention (Days 1 to 7)||6
6568915|NCT01841593|7492169|FG000|NOT COMPLETED|First Intervention (Days 1 to 7)||0
6568916|NCT01841593|7492170|FG001|NOT COMPLETED|First Intervention (Days 1 to 7)||1
6568917|NCT01841593|7492169|FG000|STARTED|Second Intervention (Days 8 to 14)||12
6568918|NCT01841593|7492170|FG001|STARTED|Second Intervention (Days 8 to 14)||6
6568919|NCT01841593|7492169|FG000|COMPLETED|Second Intervention (Days 8 to 14)||11
6568920|NCT01841593|7492170|FG001|COMPLETED|Second Intervention (Days 8 to 14)||6
6568921|NCT01841593|7492169|FG000|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
6568922|NCT01841593|7492170|FG001|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
6568923|NCT01841593|7492169|FG000|STARTED|Third Intervention (Days 15 to 21)||11
6568924|NCT01841593|7492170|FG001|STARTED|Third Intervention (Days 15 to 21)||6
6568925|NCT01841593|7492169|FG000|COMPLETED|Third Intervention (Days 15 to 21)||11
6568926|NCT01841593|7492170|FG001|COMPLETED|Third Intervention (Days 15 to 21)||6
6568927|NCT01841593|7492169|FG000|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
6568928|NCT01841593|7492170|FG001|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
6568929|NCT01841606|7492182|FG000|STARTED|Overall Study||25
6568930|NCT01841606|7492183|FG001|STARTED|Overall Study||27
6568931|NCT01841606|7492182|FG000|COMPLETED|Overall Study||25
6568932|NCT01841606|7492183|FG001|COMPLETED|Overall Study||27
6568933|NCT01841606|7492182|FG000|NOT COMPLETED|Overall Study||0
6568934|NCT01841606|7492183|FG001|NOT COMPLETED|Overall Study||0
6568935|NCT01841619|7492189|FG000|STARTED|Overall Study||16
6568936|NCT01841619|7492189|FG000|COMPLETED|Overall Study||16
6568937|NCT01841619|7492189|FG000|NOT COMPLETED|Overall Study||0
6568938|NCT01841632|7492193|FG000|STARTED|Overall Study||3
6568939|NCT01841632|7492193|FG000|COMPLETED|Overall Study||3
6568940|NCT01841632|7492193|FG000|NOT COMPLETED|Overall Study||0
6568941|NCT01841697|7492199|FG000|STARTED|Overall Study||322
6568942|NCT01841697|7492200|FG001|STARTED|Overall Study||320
6568943|NCT01841697|7492199|FG000|COMPLETED|Overall Study||302
6568944|NCT01841697|7492200|FG001|COMPLETED|Overall Study||302
6568945|NCT01841697|7492199|FG000|NOT COMPLETED|Overall Study||20
6568946|NCT01841697|7492200|FG001|NOT COMPLETED|Overall Study||18
6568947|NCT01841762|7492206|FG000|STARTED|Screening Period||335
6568948|NCT01841762|7492206|FG000|COMPLETED|Screening Period||284
6568949|NCT01841762|7492206|FG000|NOT COMPLETED|Screening Period||51
6568950|NCT01841762|7492206|FG000|STARTED|Treatment Period||284
6568951|NCT01841762|7492206|FG000|COMPLETED|Treatment Period||252
6568952|NCT01841762|7492206|FG000|NOT COMPLETED|Treatment Period||32
6568953|NCT01841762|7492206|FG000|STARTED|Post-Treatment Safety Follow-Up Period||284
6568954|NCT01841762|7492206|FG000|COMPLETED|Post-Treatment Safety Follow-Up Period||269
6568955|NCT01841762|7492206|FG000|NOT COMPLETED|Post-Treatment Safety Follow-Up Period||15
6568956|NCT01841970|7492210|FG000|STARTED|Overall Study||20
6568957|NCT01841970|7492210|FG000|COMPLETED|Overall Study||9
6568958|NCT01841970|7492210|FG000|NOT COMPLETED|Overall Study||11
6568959|NCT01842061|7492219|FG000|STARTED|Overall Study||13
6568960|NCT01842061|7492220|FG001|STARTED|Overall Study||12
6568961|NCT01842061|7492219|FG000|COMPLETED|Overall Study||12
6568962|NCT01842061|7492220|FG001|COMPLETED|Overall Study||8
6568963|NCT01842061|7492219|FG000|NOT COMPLETED|Overall Study||1
6568964|NCT01842061|7492220|FG001|NOT COMPLETED|Overall Study||4
6568965|NCT01842308|7492231|FG000|STARTED|Overall Study||6
6568966|NCT01842308|7492232|FG001|STARTED|Overall Study||3
6568967|NCT01842308|7492233|FG002|STARTED|Overall Study||3
6568968|NCT01842308|7492234|FG003|STARTED|Overall Study||2
6568969|NCT01842308|7492235|FG004|STARTED|Overall Study||36
6568970|NCT01842308|7492231|FG000|COMPLETED|Overall Study||6
6568971|NCT01842308|7492232|FG001|COMPLETED|Overall Study||3
6568972|NCT01842308|7492233|FG002|COMPLETED|Overall Study||3
6568973|NCT01842308|7492234|FG003|COMPLETED|Overall Study||2
6568974|NCT01842308|7492235|FG004|COMPLETED|Overall Study||35
6568975|NCT01842308|7492231|FG000|NOT COMPLETED|Overall Study||0
6568976|NCT01842308|7492232|FG001|NOT COMPLETED|Overall Study||0
6568977|NCT01842308|7492233|FG002|NOT COMPLETED|Overall Study||0
6568978|NCT01842308|7492234|FG003|NOT COMPLETED|Overall Study||0
6568979|NCT01842308|7492235|FG004|NOT COMPLETED|Overall Study||1
6568980|NCT01842334|7492250|FG000|STARTED|Overall Study||5
6568981|NCT01842334|7492251|FG001|STARTED|Overall Study||7
6568982|NCT01842334|7492250|FG000|COMPLETED|Overall Study||2
6568983|NCT01842334|7492251|FG001|COMPLETED|Overall Study||3
6568984|NCT01842334|7492250|FG000|NOT COMPLETED|Overall Study||3
6568985|NCT01842334|7492251|FG001|NOT COMPLETED|Overall Study||4
6568986|NCT01842438|7492259|FG000|STARTED|T1: Immediately After the Intervention||42
6568987|NCT01842438|7492260|FG001|STARTED|T1: Immediately After the Intervention||44
6568988|NCT01842438|7492259|FG000|COMPLETED|T1: Immediately After the Intervention||36
6568989|NCT01842438|7492260|FG001|COMPLETED|T1: Immediately After the Intervention||36
6568990|NCT01842438|7492259|FG000|NOT COMPLETED|T1: Immediately After the Intervention||6
6568991|NCT01842438|7492260|FG001|NOT COMPLETED|T1: Immediately After the Intervention||8
6568992|NCT01842438|7492259|FG000|STARTED|T2: 6month Follow-up||36
6568993|NCT01842438|7492260|FG001|STARTED|T2: 6month Follow-up||36
6568994|NCT01842438|7492259|FG000|COMPLETED|T2: 6month Follow-up||32
6568995|NCT01842438|7492260|FG001|COMPLETED|T2: 6month Follow-up||32
6568996|NCT01842438|7492259|FG000|NOT COMPLETED|T2: 6month Follow-up||4
6568997|NCT01842438|7492260|FG001|NOT COMPLETED|T2: 6month Follow-up||4
6568998|NCT01842464|7492270|FG000|STARTED|Overall Study||44
6568999|NCT01842464|7492270|FG000|COMPLETED|Overall Study||44
6569000|NCT01842464|7492270|FG000|NOT COMPLETED|Overall Study||0
6569001|NCT01842581|7492277|FG000|STARTED|Overall Study||113
6569002|NCT01842581|7492278|FG001|STARTED|Overall Study||109
6569003|NCT01842581|7492277|FG000|Received at Least 1 Dose of Study Drug|Overall Study||113
6569004|NCT01842581|7492278|FG001|Received at Least 1 Dose of Study Drug|Overall Study||108
6569005|NCT01842581|7492277|FG000|COMPLETED|Overall Study||69
6569006|NCT01842581|7492278|FG001|COMPLETED|Overall Study||79
6569007|NCT01842581|7492277|FG000|NOT COMPLETED|Overall Study||44
6569008|NCT01842581|7492278|FG001|NOT COMPLETED|Overall Study||30
6569009|NCT01842594|7492284|FG000|STARTED|Overall Study||13
6569010|NCT01842594|7492284|FG000|COMPLETED|Overall Study||10
6569011|NCT01842594|7492284|FG000|NOT COMPLETED|Overall Study||3
6569012|NCT01842607|7492288|FG000|STARTED|Overall Study||651
6569013|NCT01842607|7492288|FG000|COMPLETED|Overall Study||585
6569014|NCT01842607|7492288|FG000|NOT COMPLETED|Overall Study||66
6569015|NCT01842620|7492292|FG000|STARTED|Period 1||13
6569016|NCT01842620|7492293|FG001|STARTED|Period 1||12
6569017|NCT01842620|7492292|FG000|COMPLETED|Period 1||12
6569018|NCT01842620|7492293|FG001|COMPLETED|Period 1||12
6569019|NCT01842620|7492292|FG000|NOT COMPLETED|Period 1||1
6569020|NCT01842620|7492293|FG001|NOT COMPLETED|Period 1||0
6569021|NCT01842620|7492292|FG000|STARTED|Washout Period||12
6569022|NCT01842620|7492293|FG001|STARTED|Washout Period||12
6569023|NCT01842620|7492292|FG000|COMPLETED|Washout Period||12
6569024|NCT01842620|7492293|FG001|COMPLETED|Washout Period||12
6569025|NCT01842620|7492292|FG000|NOT COMPLETED|Washout Period||0
6569026|NCT01842620|7492293|FG001|NOT COMPLETED|Washout Period||0
6569027|NCT01842620|7492292|FG000|STARTED|Period 2||12
6569028|NCT01842620|7492293|FG001|STARTED|Period 2||12
6569029|NCT01842620|7492292|FG000|COMPLETED|Period 2||12
6569030|NCT01842620|7492293|FG001|COMPLETED|Period 2||12
6569031|NCT01842620|7492292|FG000|NOT COMPLETED|Period 2||0
6569032|NCT01842620|7492293|FG001|NOT COMPLETED|Period 2||0
6569033|NCT01842633|7492302|FG000|STARTED|Overall Study||65
6569034|NCT01842633|7492303|FG001|STARTED|Overall Study||66
6569035|NCT01842633|7492304|FG002|STARTED|Overall Study||34
6569036|NCT01842633|7492302|FG000|COMPLETED|Overall Study||62
6569037|NCT01842633|7492303|FG001|COMPLETED|Overall Study||64
6569038|NCT01842633|7492304|FG002|COMPLETED|Overall Study||34
6569039|NCT01842633|7492302|FG000|NOT COMPLETED|Overall Study||3
6657315|NCT02468804|7587658|FG000|STARTED|Overall Study||37
6569040|NCT01842633|7492303|FG001|NOT COMPLETED|Overall Study||2
6569041|NCT01842633|7492304|FG002|NOT COMPLETED|Overall Study||0
6569042|NCT01842646|7492314|FG000|STARTED|Overall Study||35
6569043|NCT01842646|7492314|FG000|COMPLETED|Overall Study||35
6569044|NCT01842646|7492314|FG000|NOT COMPLETED|Overall Study||0
6569045|NCT01842789|7492320|FG000|STARTED|Overall Study||10
6569046|NCT01842789|7492321|FG001|STARTED|Overall Study||8
6569047|NCT01842789|7492320|FG000|COMPLETED|Overall Study||10
6569048|NCT01842789|7492321|FG001|COMPLETED|Overall Study||8
6569049|NCT01842789|7492320|FG000|NOT COMPLETED|Overall Study||0
6569050|NCT01842789|7492321|FG001|NOT COMPLETED|Overall Study||0
6569051|NCT01842815|7492328|FG000|STARTED|Overall Study||20
6569052|NCT01842815|7492328|FG000|COMPLETED|Overall Study||16
6569053|NCT01842815|7492328|FG000|NOT COMPLETED|Overall Study||4
6569054|NCT01842841|7492333|FG000|STARTED|Overall Study||5
6569055|NCT01842841|7492333|FG000|COMPLETED|Overall Study||5
6569056|NCT01842841|7492333|FG000|NOT COMPLETED|Overall Study||0
6569057|NCT01842906|7492339|FG000|STARTED|Overall Study||115
6569058|NCT01842906|7492340|FG001|STARTED|Overall Study||104
6569059|NCT01842906|7492339|FG000|COMPLETED|Overall Study||115
6569060|NCT01842906|7492340|FG001|COMPLETED|Overall Study||104
6569061|NCT01842906|7492339|FG000|NOT COMPLETED|Overall Study||0
6569062|NCT01842906|7492340|FG001|NOT COMPLETED|Overall Study||0
6569063|NCT01842958|7492348|FG000|STARTED|Overall Study||25
6569064|NCT01842958|7492349|FG001|STARTED|Overall Study||25
6569065|NCT01842958|7492348|FG000|Randomized|Overall Study|One subject was randomized to 3.3 mm implant, but received the 4.1 mm implant.|25
6569066|NCT01842958|7492349|FG001|Randomized|Overall Study||25
6569067|NCT01842958|7492348|FG000|COMPLETED|Overall Study||24
6569068|NCT01842958|7492349|FG001|COMPLETED|Overall Study||24
6569069|NCT01842958|7492348|FG000|NOT COMPLETED|Overall Study||1
6569070|NCT01842958|7492349|FG001|NOT COMPLETED|Overall Study||1
6569071|NCT01843023|7492357|FG000|STARTED|Overall Study||144
6569072|NCT01843023|7492358|FG001|STARTED|Overall Study||144
6569073|NCT01843023|7492357|FG000|3 Months|Overall Study||110
6569074|NCT01843023|7492358|FG001|3 Months|Overall Study||114
6569075|NCT01843023|7492357|FG000|COMPLETED|Overall Study||111
6569076|NCT01843023|7492358|FG001|COMPLETED|Overall Study||109
6569077|NCT01843023|7492357|FG000|NOT COMPLETED|Overall Study||33
6569078|NCT01843023|7492358|FG001|NOT COMPLETED|Overall Study||35
6569079|NCT01843062|7492366|FG000|STARTED|Overall Study||155
6569080|NCT01843062|7492367|FG001|STARTED|Overall Study||78
6569081|NCT01843062|7492366|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||155
6569082|NCT01843062|7492367|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||78
6569083|NCT01843062|7492366|FG000|Safety Analysis Set|Overall Study||154
6569084|NCT01843062|7492367|FG001|Safety Analysis Set|Overall Study||77
6569085|NCT01843062|7492366|FG000|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||91
6569086|NCT01843062|7492367|FG001|BRAF/NRAS Mutation Positive Analysis Set|Overall Study||51
6569087|NCT01843062|7492366|FG000|Ongoing at Primary Analysis Data Cut-off|Overall Study||134
6569088|NCT01843062|7492367|FG001|Ongoing at Primary Analysis Data Cut-off|Overall Study||71
6569089|NCT01843062|7492366|FG000|COMPLETED|Overall Study||133
6569090|NCT01843062|7492367|FG001|COMPLETED|Overall Study||69
6569091|NCT01843062|7492366|FG000|NOT COMPLETED|Overall Study||22
6569092|NCT01843062|7492367|FG001|NOT COMPLETED|Overall Study||9
6569093|NCT01843192|7492376|FG000|STARTED|Overall Study||26
6569094|NCT01843192|7492377|FG001|STARTED|Overall Study||34
6569095|NCT01843192|7492378|FG002|STARTED|Overall Study||11
6569096|NCT01843192|7492376|FG000|COMPLETED|Overall Study||24
6569097|NCT01843192|7492377|FG001|COMPLETED|Overall Study||28
6569098|NCT01843192|7492378|FG002|COMPLETED|Overall Study||9
6569099|NCT01843192|7492376|FG000|NOT COMPLETED|Overall Study||2
6569100|NCT01843192|7492377|FG001|NOT COMPLETED|Overall Study||6
6569101|NCT01843192|7492378|FG002|NOT COMPLETED|Overall Study||2
6569102|NCT01843205|7492386|FG000|STARTED|First Treatment (11 Days)||5
6569103|NCT01843205|7492387|FG001|STARTED|First Treatment (11 Days)||4
6569104|NCT01843205|7492386|FG000|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to buspirone for Condition 2.|4
6569105|NCT01843205|7492387|FG001|COMPLETED|First Treatment (11 Days)|4 completing subjects switched to placebo for Condition 2.|4
6569106|NCT01843205|7492386|FG000|NOT COMPLETED|First Treatment (11 Days)||1
6569107|NCT01843205|7492387|FG001|NOT COMPLETED|First Treatment (11 Days)||0
6569108|NCT01843205|7492386|FG000|STARTED|Second Treatment (11 Days)||4
6569109|NCT01843205|7492387|FG001|STARTED|Second Treatment (11 Days)||4
6569110|NCT01843205|7492386|FG000|COMPLETED|Second Treatment (11 Days)||4
6569111|NCT01843205|7492387|FG001|COMPLETED|Second Treatment (11 Days)||4
6569112|NCT01843205|7492386|FG000|NOT COMPLETED|Second Treatment (11 Days)||0
6569113|NCT01843205|7492387|FG001|NOT COMPLETED|Second Treatment (11 Days)||0
6569114|NCT01843348|7492396|FG000|STARTED|Overall Study||205
6569115|NCT01843348|7492397|FG001|STARTED|Overall Study||208
6569116|NCT01843348|7492398|FG002|STARTED|Overall Study||199
6569117|NCT01843348|7492396|FG000|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
6569118|NCT01843348|7492397|FG001|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
6569119|NCT01843348|7492398|FG002|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
6569120|NCT01843348|7492396|FG000|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
6569121|NCT01843348|7492397|FG001|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
6569122|NCT01843348|7492398|FG002|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
6569123|NCT01843348|7492396|FG000|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
6569124|NCT01843348|7492397|FG001|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
6569125|NCT01843348|7492398|FG002|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
6569126|NCT01843348|7492396|FG000|COMPLETED|Overall Study||182
6569127|NCT01843348|7492397|FG001|COMPLETED|Overall Study||168
6569128|NCT01843348|7492398|FG002|COMPLETED|Overall Study||158
6569129|NCT01843348|7492396|FG000|NOT COMPLETED|Overall Study||23
6569130|NCT01843348|7492397|FG001|NOT COMPLETED|Overall Study||40
6569131|NCT01843348|7492398|FG002|NOT COMPLETED|Overall Study||41
6569132|NCT01843465|7492408|FG000|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
6569133|NCT01843465|7492408|FG000|COMPLETED|Overall Study||34
6569134|NCT01843465|7492408|FG000|NOT COMPLETED|Overall Study||0
6569135|NCT01843621|7492412|FG000|STARTED|Overall Study||7
6569136|NCT01843621|7492412|FG000|COMPLETED|Overall Study||7
6569137|NCT01843621|7492412|FG000|NOT COMPLETED|Overall Study||0
6569138|NCT01843660|7492424|FG000|STARTED|Overall Study||1059
6569139|NCT01843660|7492424|FG000|COMPLETED|Overall Study||1029
6569140|NCT01843660|7492424|FG000|NOT COMPLETED|Overall Study||30
6569141|NCT01843673|7492428|FG000|STARTED|Overall Study||16
6569142|NCT01843673|7492428|FG000|COMPLETED|Overall Study||10
6569143|NCT01843673|7492428|FG000|NOT COMPLETED|Overall Study||6
6569144|NCT01843751|7492436|FG000|STARTED|Overall Study||11
6569145|NCT01843751|7492437|FG001|STARTED|Overall Study||10
6569146|NCT01843751|7492436|FG000|COMPLETED|Overall Study||0
6569147|NCT01843751|7492437|FG001|COMPLETED|Overall Study||3
6569148|NCT01843751|7492436|FG000|NOT COMPLETED|Overall Study||11
6569149|NCT01843751|7492437|FG001|NOT COMPLETED|Overall Study||7
6569150|NCT01843777|7492445|FG000|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
6569151|NCT01843777|7492446|FG001|STARTED|Overall Study|Number of participants randomized to treatment.|10
6569152|NCT01843777|7492445|FG000|Per Protocol Population|Overall Study||11
6569153|NCT01843777|7492446|FG001|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
6569154|NCT01843777|7492445|FG000|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
6569155|NCT01843777|7492446|FG001|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
6569156|NCT01843777|7492445|FG000|NOT COMPLETED|Overall Study||1
6569157|NCT01843777|7492446|FG001|NOT COMPLETED|Overall Study||0
6569158|NCT01843803|7492454|FG000|STARTED|Overall Study||137
6569159|NCT01843803|7492455|FG001|STARTED|Overall Study||139
6569160|NCT01843803|7492454|FG000|COMPLETED|Overall Study||136
6569161|NCT01843803|7492455|FG001|COMPLETED|Overall Study||136
6569162|NCT01843803|7492454|FG000|NOT COMPLETED|Overall Study||1
6569163|NCT01843803|7492455|FG001|NOT COMPLETED|Overall Study||3
6569164|NCT01843842|7492463|FG000|STARTED|Overall Study||154
6657316|NCT02468804|7587659|FG001|STARTED|Overall Study||58
6657317|NCT02468804|7587658|FG000|COMPLETED|Overall Study||36
6657318|NCT02468804|7587659|FG001|COMPLETED|Overall Study||50
6657319|NCT02468804|7587658|FG000|NOT COMPLETED|Overall Study||1
6657320|NCT02468804|7587659|FG001|NOT COMPLETED|Overall Study||8
6657321|NCT02468830|7587665|FG000|STARTED|Overall Study||58
6657322|NCT02468830|7587665|FG000|COMPLETED|Overall Study||55
6657323|NCT02468830|7587665|FG000|NOT COMPLETED|Overall Study||3
6657324|NCT02468934|7587669|FG000|STARTED|Overall Study||27
6657325|NCT02468934|7587669|FG000|Enrolled/Received Leads|Overall Study||24
6657326|NCT02468934|7587669|FG000|Underwent Total Knee Arthroplasty|Overall Study||20
6657327|NCT02468934|7587669|FG000|COMPLETED|Overall Study||20
6657328|NCT02468934|7587669|FG000|NOT COMPLETED|Overall Study||7
6657329|NCT02469038|7587677|FG000|STARTED|Overall Study||26
6657330|NCT02469038|7587678|FG001|STARTED|Overall Study||24
6657331|NCT02469038|7587677|FG000|COMPLETED|Overall Study||22
6657332|NCT02469038|7587678|FG001|COMPLETED|Overall Study||19
6657333|NCT02469038|7587677|FG000|NOT COMPLETED|Overall Study||4
6657334|NCT02469038|7587678|FG001|NOT COMPLETED|Overall Study||5
6657335|NCT02469064|7587686|FG000|STARTED|Overall Study||64
6657336|NCT02469064|7587687|FG001|STARTED|Overall Study||62
6657337|NCT02469064|7587686|FG000|COMPLETED|Overall Study||63
6657338|NCT02469064|7587687|FG001|COMPLETED|Overall Study||59
6657339|NCT02469064|7587686|FG000|NOT COMPLETED|Overall Study||1
6657340|NCT02469064|7587687|FG001|NOT COMPLETED|Overall Study||3
6657341|NCT02469077|7587695|FG000|STARTED|Pre Randomization - Pre Intervention||44
6657342|NCT02469077|7587696|FG001|STARTED|Pre Randomization - Pre Intervention||49
6657343|NCT02469077|7587695|FG000|Pre Intervention Placebo|Pre Randomization - Pre Intervention||44
6657344|NCT02469077|7587696|FG001|Pre Intervention Placebo|Pre Randomization - Pre Intervention||49
6657345|NCT02469077|7587695|FG000|Pre Intervention Morpine|Pre Randomization - Pre Intervention||44
6657346|NCT02469077|7587696|FG001|Pre Intervention Morpine|Pre Randomization - Pre Intervention||49
6657347|NCT02469077|7587695|FG000|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||44
6657348|NCT02469077|7587696|FG001|Pre Intervention Naloxone|Pre Randomization - Pre Intervention||49
6657349|NCT02469077|7587695|FG000|COMPLETED|Pre Randomization - Pre Intervention||44
6657350|NCT02469077|7587696|FG001|COMPLETED|Pre Randomization - Pre Intervention||49
6657351|NCT02469077|7587695|FG000|NOT COMPLETED|Pre Randomization - Pre Intervention||0
6657352|NCT02469077|7587696|FG001|NOT COMPLETED|Pre Randomization - Pre Intervention||0
6657353|NCT02469077|7587695|FG000|STARTED|Post Randomization/Intervention Period||44
6657354|NCT02469077|7587696|FG001|STARTED|Post Randomization/Intervention Period||49
6657355|NCT02469077|7587695|FG000|COMPLETED|Post Randomization/Intervention Period||40
6657356|NCT02469077|7587696|FG001|COMPLETED|Post Randomization/Intervention Period||45
6657357|NCT02469077|7587695|FG000|NOT COMPLETED|Post Randomization/Intervention Period||4
6657358|NCT02469077|7587696|FG001|NOT COMPLETED|Post Randomization/Intervention Period||4
6657359|NCT02469077|7587695|FG000|STARTED|Post Intervention /Followup||40
6657360|NCT02469077|7587696|FG001|STARTED|Post Intervention /Followup||45
6657361|NCT02469077|7587695|FG000|Post Intervention Placebo|Post Intervention /Followup||39
6569165|NCT01843842|7492464|FG001|STARTED|Overall Study||152
6569166|NCT01843842|7492463|FG000|COMPLETED|Overall Study||153
6569167|NCT01843842|7492464|FG001|COMPLETED|Overall Study||151
6569168|NCT01843842|7492463|FG000|NOT COMPLETED|Overall Study||1
6569169|NCT01843842|7492464|FG001|NOT COMPLETED|Overall Study||1
6569170|NCT01843920|7492472|FG000|STARTED|Overall Study||12
6569171|NCT01843920|7492473|FG001|STARTED|Overall Study||9
6569172|NCT01843920|7492472|FG000|COMPLETED|Overall Study||12
6569173|NCT01843920|7492473|FG001|COMPLETED|Overall Study||9
6569174|NCT01843920|7492472|FG000|NOT COMPLETED|Overall Study||0
6569175|NCT01843920|7492473|FG001|NOT COMPLETED|Overall Study||0
6569176|NCT01843933|7492481|FG000|STARTED|Overall Study||104
6569177|NCT01843933|7492482|FG001|STARTED|Overall Study||107
6569178|NCT01843933|7492481|FG000|COMPLETED|Overall Study||98
6569179|NCT01843933|7492482|FG001|COMPLETED|Overall Study||103
6569180|NCT01843933|7492481|FG000|NOT COMPLETED|Overall Study||6
6569181|NCT01843933|7492482|FG001|NOT COMPLETED|Overall Study||4
6623537|NCT02208050|7550677|FG000|STARTED|Treatment Period 2: 8 Weeks Treatment||35
6623538|NCT02208050|7550678|FG001|STARTED|Treatment Period 2: 8 Weeks Treatment||28
6623539|NCT02208050|7550677|FG000|COMPLETED|Treatment Period 2: 8 Weeks Treatment||33
6623540|NCT02208050|7550678|FG001|COMPLETED|Treatment Period 2: 8 Weeks Treatment||28
6623541|NCT02208050|7550677|FG000|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||2
6623542|NCT02208050|7550678|FG001|NOT COMPLETED|Treatment Period 2: 8 Weeks Treatment||0
6623543|NCT02208050|7550677|FG000|STARTED|Washout Period 2: 2 Weeks Washout.||33
6623544|NCT02208050|7550678|FG001|STARTED|Washout Period 2: 2 Weeks Washout.||28
6657362|NCT02469077|7587696|FG001|Post Intervention Placebo|Post Intervention /Followup||45
6657363|NCT02469077|7587695|FG000|Post Intervention Morphine|Post Intervention /Followup||40
6657364|NCT02469077|7587696|FG001|Post Intervention Morphine|Post Intervention /Followup||45
6657365|NCT02469077|7587695|FG000|Post Intervention Naloxone|Post Intervention /Followup||39
6657366|NCT02469077|7587696|FG001|Post Intervention Naloxone|Post Intervention /Followup||44
6657367|NCT02469077|7587695|FG000|COMPLETED|Post Intervention /Followup||38
6657368|NCT02469077|7587696|FG001|COMPLETED|Post Intervention /Followup||44
6657369|NCT02469077|7587695|FG000|NOT COMPLETED|Post Intervention /Followup||2
6657370|NCT02469077|7587696|FG001|NOT COMPLETED|Post Intervention /Followup||1
6657371|NCT02469090|7587708|FG000|STARTED|Period 1: Dose Titration Phase||141
6657372|NCT02469090|7587709|FG001|STARTED|Period 1: Dose Titration Phase||0
6657373|NCT02469090|7587710|FG002|STARTED|Period 1: Dose Titration Phase||0
6657374|NCT02469090|7587708|FG000|COMPLETED|Period 1: Dose Titration Phase||109
6657375|NCT02469090|7587709|FG001|COMPLETED|Period 1: Dose Titration Phase||0
6657376|NCT02469090|7587710|FG002|COMPLETED|Period 1: Dose Titration Phase||0
6657377|NCT02469090|7587708|FG000|NOT COMPLETED|Period 1: Dose Titration Phase||32
6657378|NCT02469090|7587709|FG001|NOT COMPLETED|Period 1: Dose Titration Phase||0
6657379|NCT02469090|7587710|FG002|NOT COMPLETED|Period 1: Dose Titration Phase||0
6657380|NCT02469090|7587708|FG000|STARTED|Period 2: Maintenance Treatment Phase|Subjects who completed the Titration Phase were eligible to proceed to Maintenance Treatment Phase|0
6657381|NCT02469090|7587709|FG001|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to Placebo in the Maintenance Phase|55
6657382|NCT02469090|7587710|FG002|STARTED|Period 2: Maintenance Treatment Phase|subjects who completed the Titration Phase and were randomized to APL-130277 Maintenance Phase|54
6657383|NCT02469090|7587708|FG000|COMPLETED|Period 2: Maintenance Treatment Phase||0
6657384|NCT02469090|7587709|FG001|COMPLETED|Period 2: Maintenance Treatment Phase||46
6657385|NCT02469090|7587710|FG002|COMPLETED|Period 2: Maintenance Treatment Phase||34
6657386|NCT02469090|7587708|FG000|NOT COMPLETED|Period 2: Maintenance Treatment Phase||0
6657387|NCT02469090|7587709|FG001|NOT COMPLETED|Period 2: Maintenance Treatment Phase||9
6657388|NCT02469090|7587710|FG002|NOT COMPLETED|Period 2: Maintenance Treatment Phase||20
6657389|NCT02469116|7587717|FG000|STARTED|Overall Study||18
6657390|NCT02469116|7587717|FG000|COMPLETED|Overall Study||18
6276681|NCT00121667|7175986|FG000|COMPLETED|Short Term (ST) Period||148
6623545|NCT02208050|7550677|FG000|COMPLETED|Washout Period 2: 2 Weeks Washout.||33
6569182|NCT01843972|7492498|FG000|STARTED|Overall Study||13
6569183|NCT01843972|7492499|FG001|STARTED|Overall Study||6
6569184|NCT01843972|7492500|FG002|STARTED|Overall Study||5
6569185|NCT01843972|7492501|FG003|STARTED|Overall Study||6
6569186|NCT01843972|7492502|FG004|STARTED|Overall Study||6
6569187|NCT01843972|7492503|FG005|STARTED|Overall Study||6
6569188|NCT01843972|7492504|FG006|STARTED|Overall Study||5
6569189|NCT01843972|7492505|FG007|STARTED|Overall Study||5
6569190|NCT01843972|7492506|FG008|STARTED|Overall Study||17
6569191|NCT01843972|7492507|FG009|STARTED|Overall Study||12
6569192|NCT01843972|7492498|FG000|COMPLETED|Overall Study||13
6569193|NCT01843972|7492499|FG001|COMPLETED|Overall Study||6
6569194|NCT01843972|7492500|FG002|COMPLETED|Overall Study||5
6569195|NCT01843972|7492501|FG003|COMPLETED|Overall Study||6
6569196|NCT01843972|7492502|FG004|COMPLETED|Overall Study||5
6569197|NCT01843972|7492503|FG005|COMPLETED|Overall Study||6
6569198|NCT01843972|7492504|FG006|COMPLETED|Overall Study||5
6569199|NCT01843972|7492505|FG007|COMPLETED|Overall Study||5
6569200|NCT01843972|7492506|FG008|COMPLETED|Overall Study||17
6569201|NCT01843972|7492507|FG009|COMPLETED|Overall Study||12
6569202|NCT01843972|7492498|FG000|NOT COMPLETED|Overall Study||0
6569203|NCT01843972|7492499|FG001|NOT COMPLETED|Overall Study||0
6569204|NCT01843972|7492500|FG002|NOT COMPLETED|Overall Study||0
6569205|NCT01843972|7492501|FG003|NOT COMPLETED|Overall Study||0
6569206|NCT01843972|7492502|FG004|NOT COMPLETED|Overall Study||1
6569207|NCT01843972|7492503|FG005|NOT COMPLETED|Overall Study||0
6569208|NCT01843972|7492504|FG006|NOT COMPLETED|Overall Study||0
6569209|NCT01843972|7492505|FG007|NOT COMPLETED|Overall Study||0
6569210|NCT01843972|7492506|FG008|NOT COMPLETED|Overall Study||0
6569211|NCT01843972|7492507|FG009|NOT COMPLETED|Overall Study||0
6569212|NCT01844076|7492547|FG000|STARTED|Overall Study||3
6569213|NCT01844076|7492548|FG001|STARTED|Overall Study||6
6569214|NCT01844076|7492549|FG002|STARTED|Overall Study||3
6569215|NCT01844076|7492550|FG003|STARTED|Overall Study||7
6569216|NCT01844076|7492547|FG000|COMPLETED|Overall Study||1
6569217|NCT01844076|7492548|FG001|COMPLETED|Overall Study||6
6569218|NCT01844076|7492549|FG002|COMPLETED|Overall Study||3
6569219|NCT01844076|7492550|FG003|COMPLETED|Overall Study||7
6569220|NCT01844076|7492547|FG000|NOT COMPLETED|Overall Study||2
6569221|NCT01844076|7492548|FG001|NOT COMPLETED|Overall Study||0
6569222|NCT01844076|7492549|FG002|NOT COMPLETED|Overall Study||0
6569223|NCT01844076|7492550|FG003|NOT COMPLETED|Overall Study||0
6569224|NCT01844115|7492562|FG000|STARTED|Overall Study||202
6569225|NCT01844115|7492563|FG001|STARTED|Overall Study||202
6569226|NCT01844115|7492562|FG000|COMPLETED|Overall Study||163
6569227|NCT01844115|7492563|FG001|COMPLETED|Overall Study||144
6569228|NCT01844115|7492562|FG000|NOT COMPLETED|Overall Study||39
6569229|NCT01844115|7492563|FG001|NOT COMPLETED|Overall Study||58
6569230|NCT01844193|7492571|FG000|STARTED|Overall Study||19
6569231|NCT01844193|7492572|FG001|STARTED|Overall Study||21
6569232|NCT01844193|7492571|FG000|COMPLETED|Overall Study||13
6569233|NCT01844193|7492572|FG001|COMPLETED|Overall Study||15
6569234|NCT01844193|7492571|FG000|NOT COMPLETED|Overall Study||6
6569235|NCT01844193|7492572|FG001|NOT COMPLETED|Overall Study||6
6569236|NCT01844284|7492580|FG000|STARTED|Overall Study|Intent-to-treat (ITT) population|266
6569237|NCT01844284|7492581|FG001|STARTED|Overall Study|Intent-to-treat (ITT) population|134
6569238|NCT01844284|7492580|FG000|COMPLETED|Overall Study||254
6569239|NCT01844284|7492581|FG001|COMPLETED|Overall Study||127
6569240|NCT01844284|7492580|FG000|NOT COMPLETED|Overall Study||12
6569241|NCT01844284|7492581|FG001|NOT COMPLETED|Overall Study||7
6569242|NCT01844375|7492589|FG000|STARTED|Overall Study||35
6569243|NCT01844375|7492590|FG001|STARTED|Overall Study||35
6569244|NCT01844375|7492589|FG000|COMPLETED|Overall Study||34
6569245|NCT01844375|7492590|FG001|COMPLETED|Overall Study||34
6569246|NCT01844375|7492589|FG000|NOT COMPLETED|Overall Study||1
6569247|NCT01844375|7492590|FG001|NOT COMPLETED|Overall Study||1
6569248|NCT01844388|7492598|FG000|STARTED|Overall Study||244
6569249|NCT01844388|7492599|FG001|STARTED|Overall Study||121
6569250|NCT01844388|7492598|FG000|COMPLETED|Overall Study||236
6569251|NCT01844388|7492599|FG001|COMPLETED|Overall Study||114
6569252|NCT01844388|7492598|FG000|NOT COMPLETED|Overall Study||8
6569253|NCT01844388|7492599|FG001|NOT COMPLETED|Overall Study||7
6569254|NCT01844479|7492605|FG000|STARTED|First Intervention up to 30 Minutes||14
6569255|NCT01844479|7492606|FG001|STARTED|First Intervention up to 30 Minutes||13
6569256|NCT01844479|7492605|FG000|COMPLETED|First Intervention up to 30 Minutes||14
6569257|NCT01844479|7492606|FG001|COMPLETED|First Intervention up to 30 Minutes||13
6569258|NCT01844479|7492605|FG000|NOT COMPLETED|First Intervention up to 30 Minutes||0
6569259|NCT01844479|7492606|FG001|NOT COMPLETED|First Intervention up to 30 Minutes||0
6569260|NCT01844479|7492605|FG000|STARTED|Second Intervention up to 30 Minutes||14
6569261|NCT01844479|7492606|FG001|STARTED|Second Intervention up to 30 Minutes||13
6569262|NCT01844479|7492605|FG000|COMPLETED|Second Intervention up to 30 Minutes||14
6569263|NCT01844479|7492606|FG001|COMPLETED|Second Intervention up to 30 Minutes||13
6569264|NCT01844479|7492605|FG000|NOT COMPLETED|Second Intervention up to 30 Minutes||0
6569265|NCT01844479|7492606|FG001|NOT COMPLETED|Second Intervention up to 30 Minutes||0
6569266|NCT01844531|7492617|FG000|STARTED|Overall Study||6
6569267|NCT01844531|7492618|FG001|STARTED|Overall Study||6
6569268|NCT01844531|7492619|FG002|STARTED|Overall Study||6
6569269|NCT01844531|7492620|FG003|STARTED|Overall Study||6
6569270|NCT01844531|7492617|FG000|COMPLETED|Overall Study||6
6569271|NCT01844531|7492618|FG001|COMPLETED|Overall Study||5
6569272|NCT01844531|7492619|FG002|COMPLETED|Overall Study||6
6569273|NCT01844531|7492620|FG003|COMPLETED|Overall Study||6
6569274|NCT01844531|7492617|FG000|NOT COMPLETED|Overall Study||0
6569275|NCT01844531|7492618|FG001|NOT COMPLETED|Overall Study||1
6569276|NCT01844531|7492619|FG002|NOT COMPLETED|Overall Study||0
6569277|NCT01844531|7492620|FG003|NOT COMPLETED|Overall Study||0
6569278|NCT01844583|7492632|FG000|STARTED|Overall Study||26
6569279|NCT01844583|7492633|FG001|STARTED|Overall Study||29
6569280|NCT01844583|7492632|FG000|COMPLETED|Overall Study|Completed=Completed protocol-specified dosing and PK/ECG assessment.|18
6569281|NCT01844583|7492633|FG001|COMPLETED|Overall Study||19
6569282|NCT01844583|7492632|FG000|NOT COMPLETED|Overall Study||8
6569283|NCT01844583|7492633|FG001|NOT COMPLETED|Overall Study||10
6569284|NCT01844687|7492644|FG000|STARTED|Visit 1||50
6569285|NCT01844687|7492644|FG000|COMPLETED|Visit 1||42
6569286|NCT01844687|7492644|FG000|NOT COMPLETED|Visit 1||8
6569287|NCT01844687|7492644|FG000|STARTED|Visit 2||42
6569288|NCT01844687|7492644|FG000|COMPLETED|Visit 2||40
6569289|NCT01844687|7492644|FG000|NOT COMPLETED|Visit 2||2
6569290|NCT01844687|7492644|FG000|STARTED|Visit 3||40
6569291|NCT01844687|7492644|FG000|COMPLETED|Visit 3||35
6276682|NCT00121667|7175987|FG001|COMPLETED|Short Term (ST) Period||143
6569292|NCT01844687|7492644|FG000|NOT COMPLETED|Visit 3||5
6569293|NCT01844687|7492644|FG000|STARTED|Visit 4||35
6569294|NCT01844687|7492644|FG000|COMPLETED|Visit 4||31
6569295|NCT01844687|7492644|FG000|NOT COMPLETED|Visit 4||4
6569296|NCT01844687|7492644|FG000|STARTED|Visit 5||31
6569297|NCT01844687|7492644|FG000|COMPLETED|Visit 5||31
6569298|NCT01844687|7492644|FG000|NOT COMPLETED|Visit 5||0
6569299|NCT01844687|7492644|FG000|STARTED|Visit 6||31
6569300|NCT01844687|7492644|FG000|COMPLETED|Visit 6||31
6569301|NCT01844687|7492644|FG000|NOT COMPLETED|Visit 6||0
6569302|NCT01844687|7492644|FG000|STARTED|Visit 7||31
6569303|NCT01844687|7492644|FG000|COMPLETED|Visit 7||31
6569304|NCT01844687|7492644|FG000|NOT COMPLETED|Visit 7||0
6569305|NCT01844687|7492644|FG000|STARTED|Visit 8||31
6569306|NCT01844687|7492644|FG000|COMPLETED|Visit 8||31
6569307|NCT01844687|7492644|FG000|NOT COMPLETED|Visit 8||0
6569308|NCT01844700|7492668|FG000|STARTED|Overall Study||4
6569309|NCT01844700|7492669|FG001|STARTED|Overall Study||3
6569310|NCT01844700|7492668|FG000|COMPLETED|Overall Study||1
6569311|NCT01844700|7492669|FG001|COMPLETED|Overall Study||2
6569312|NCT01844700|7492668|FG000|NOT COMPLETED|Overall Study||3
6569313|NCT01844700|7492669|FG001|NOT COMPLETED|Overall Study||1
6569314|NCT01844765|7492677|FG000|STARTED|Overall Study||34
6569315|NCT01844765|7492678|FG001|STARTED|Overall Study||25
6569316|NCT01844765|7492677|FG000|Treated|Overall Study||33
6569317|NCT01844765|7492678|FG001|Treated|Overall Study||25
6569318|NCT01844765|7492677|FG000|Untreated|Overall Study|Did not receive study drug due to adverse event (AE).|1
6569319|NCT01844765|7492678|FG001|Untreated|Overall Study||0
6569320|NCT01844765|7492677|FG000|COMPLETED|Overall Study||19
6569321|NCT01844765|7492678|FG001|COMPLETED|Overall Study||10
6569322|NCT01844765|7492677|FG000|NOT COMPLETED|Overall Study||15
6569323|NCT01844765|7492678|FG001|NOT COMPLETED|Overall Study||15
6569324|NCT01844778|7492692|FG000|STARTED|Overall Study||14
6569325|NCT01844778|7492693|FG001|STARTED|Overall Study||28
6569326|NCT01844778|7492694|FG002|STARTED|Overall Study||18
6569327|NCT01844778|7492692|FG000|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
6569328|NCT01844778|7492693|FG001|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
6569329|NCT01844778|7492694|FG002|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
6569330|NCT01844778|7492692|FG000|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
6569331|NCT01844778|7492693|FG001|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
6569332|NCT01844778|7492694|FG002|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
6569333|NCT01844778|7492692|FG000|COMPLETED|Overall Study||12
6569334|NCT01844778|7492693|FG001|COMPLETED|Overall Study||25
6569335|NCT01844778|7492694|FG002|COMPLETED|Overall Study||14
6569336|NCT01844778|7492692|FG000|NOT COMPLETED|Overall Study||2
6569337|NCT01844778|7492693|FG001|NOT COMPLETED|Overall Study||3
6569338|NCT01844778|7492694|FG002|NOT COMPLETED|Overall Study||4
6569339|NCT01844817|7492708|FG000|STARTED|Enrolled and Randomized||66
6569340|NCT01844817|7492709|FG001|STARTED|Enrolled and Randomized||66
6569341|NCT01844817|7492708|FG000|COMPLETED|Enrolled and Randomized||64
6569342|NCT01844817|7492709|FG001|COMPLETED|Enrolled and Randomized||63
6569343|NCT01844817|7492708|FG000|NOT COMPLETED|Enrolled and Randomized||2
6569344|NCT01844817|7492709|FG001|NOT COMPLETED|Enrolled and Randomized||3
6569345|NCT01844817|7492708|FG000|STARTED|Treatment||64
6569346|NCT01844817|7492709|FG001|STARTED|Treatment||63
6569347|NCT01844817|7492708|FG000|COMPLETED|Treatment||0
6569348|NCT01844817|7492709|FG001|COMPLETED|Treatment||0
6569349|NCT01844817|7492708|FG000|NOT COMPLETED|Treatment||64
6569350|NCT01844817|7492709|FG001|NOT COMPLETED|Treatment||63
6569351|NCT01844830|7492718|FG000|STARTED|Overall Study||60
6569352|NCT01844830|7492719|FG001|STARTED|Overall Study||30
6569353|NCT01844830|7492718|FG000|100 µL Dose|Overall Study||16
6569354|NCT01844830|7492719|FG001|100 µL Dose|Overall Study||8
6569355|NCT01844830|7492718|FG000|200 µL Dose|Overall Study||24
6569356|NCT01844830|7492719|FG001|200 µL Dose|Overall Study||12
6569357|NCT01844830|7492718|FG000|400 µL Dose|Overall Study||20
6569358|NCT01844830|7492719|FG001|400 µL Dose|Overall Study||10
6569359|NCT01844830|7492718|FG000|COMPLETED|Overall Study||59
6569360|NCT01844830|7492719|FG001|COMPLETED|Overall Study||30
6569361|NCT01844830|7492718|FG000|NOT COMPLETED|Overall Study||1
6569362|NCT01844830|7492719|FG001|NOT COMPLETED|Overall Study||0
6569363|NCT01844895|7492725|FG000|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
6569364|NCT01844895|7492725|FG000|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
6569365|NCT01844895|7492725|FG000|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
6569366|NCT01844895|7492725|FG000|STARTED|Day 29 - Day113 - Autoinjector||117
6569367|NCT01844895|7492725|FG000|COMPLETED|Day 29 - Day113 - Autoinjector||111
6569368|NCT01844895|7492725|FG000|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
6657391|NCT02469116|7587717|FG000|NOT COMPLETED|Overall Study||0
6657392|NCT02469168|7587723|FG000|STARTED|Overall Study||1
6657393|NCT02469168|7587724|FG001|STARTED|Overall Study||0
6657394|NCT02469168|7587723|FG000|COMPLETED|Overall Study||0
6657395|NCT02469168|7587724|FG001|COMPLETED|Overall Study||0
6657396|NCT02469168|7587723|FG000|NOT COMPLETED|Overall Study||1
6657397|NCT02469168|7587724|FG001|NOT COMPLETED|Overall Study||0
6657398|NCT02469246|7587732|FG000|STARTED|Double-Blind Phase||285
6657399|NCT02469246|7587733|FG001|STARTED|Double-Blind Phase||282
6657400|NCT02469246|7587732|FG000|COMPLETED|Double-Blind Phase||218
6657401|NCT02469246|7587733|FG001|COMPLETED|Double-Blind Phase||226
6657402|NCT02469246|7587732|FG000|NOT COMPLETED|Double-Blind Phase||67
6569369|NCT01845025|7492740|FG000|STARTED|Overall Study||411
6569370|NCT01845025|7492741|FG001|STARTED|Overall Study||409
6569371|NCT01845025|7492740|FG000|COMPLETED|Overall Study||326
6569372|NCT01845025|7492741|FG001|COMPLETED|Overall Study||332
6569373|NCT01845025|7492740|FG000|NOT COMPLETED|Overall Study||85
6657403|NCT02469246|7587733|FG001|NOT COMPLETED|Double-Blind Phase||56
6504979|NCT01451164|7424063|FG002|STARTED|Overall Study||113
6504980|NCT01451164|7424064|FG003|STARTED|Overall Study||116
6504981|NCT01451164|7424061|FG000|COMPLETED|Overall Study||72
6504982|NCT01451164|7424062|FG001|COMPLETED|Overall Study||81
6504983|NCT01451164|7424063|FG002|COMPLETED|Overall Study||68
6504984|NCT01451164|7424064|FG003|COMPLETED|Overall Study||70
6504985|NCT01451164|7424061|FG000|NOT COMPLETED|Overall Study||43
6391663|NCT00837512|7303585|FG001|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
6391664|NCT00837512|7303584|FG000|STARTED|Both Arms: Washout (7-28 Days)||8
6391665|NCT00837512|7303585|FG001|STARTED|Both Arms: Washout (7-28 Days)||8
6391666|NCT00837512|7303584|FG000|COMPLETED|Both Arms: Washout (7-28 Days)||8
6391667|NCT00837512|7303585|FG001|COMPLETED|Both Arms: Washout (7-28 Days)||8
6391668|NCT00837512|7303584|FG000|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
6391669|NCT00837512|7303585|FG001|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
6391670|NCT00837512|7303584|FG000|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
6391671|NCT00837512|7303585|FG001|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
6391672|NCT00837512|7303584|FG000|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
6391673|NCT00837512|7303585|FG001|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
6391674|NCT00837512|7303584|FG000|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
6391675|NCT00837512|7303585|FG001|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
6391676|NCT00837577|7303593|FG000|STARTED|Double-blind Period||70
6391677|NCT00837577|7303594|FG001|STARTED|Double-blind Period||63
6391678|NCT00837577|7303593|FG000|COMPLETED|Double-blind Period||68
6391679|NCT00837577|7303594|FG001|COMPLETED|Double-blind Period||63
6391680|NCT00837577|7303593|FG000|NOT COMPLETED|Double-blind Period||2
6391681|NCT00837577|7303594|FG001|NOT COMPLETED|Double-blind Period||0
6391682|NCT00837577|7303593|FG000|STARTED|Open-label Period||68
6391683|NCT00837577|7303594|FG001|STARTED|Open-label Period||63
6391684|NCT00837577|7303593|FG000|COMPLETED|Open-label Period||60
6391685|NCT00837577|7303594|FG001|COMPLETED|Open-label Period||54
6391686|NCT00837577|7303593|FG000|NOT COMPLETED|Open-label Period||8
6391687|NCT00837577|7303594|FG001|NOT COMPLETED|Open-label Period||9
6504986|NCT01451164|7424062|FG001|NOT COMPLETED|Overall Study||34
6504987|NCT01451164|7424063|FG002|NOT COMPLETED|Overall Study||45
6504988|NCT01451164|7424064|FG003|NOT COMPLETED|Overall Study||46
6504989|NCT01451203|7424076|FG000|STARTED|Double-blind Treatment Period||158
6504990|NCT01451203|7424077|FG001|STARTED|Double-blind Treatment Period||161
6569374|NCT01845025|7492741|FG001|NOT COMPLETED|Overall Study||77
6569375|NCT01845077|7492750|FG000|STARTED|Treatment Period 1||12
6391688|NCT00837590|7303604|FG000|STARTED|Overall Study||6
6391689|NCT00837590|7303605|FG001|STARTED|Overall Study||5
6391690|NCT00837590|7303606|FG002|STARTED|Overall Study||5
6391691|NCT00837590|7303604|FG000|COMPLETED|Overall Study||6
6391692|NCT00837590|7303605|FG001|COMPLETED|Overall Study||4
6391693|NCT00837590|7303606|FG002|COMPLETED|Overall Study||4
6391694|NCT00837590|7303604|FG000|NOT COMPLETED|Overall Study||0
6391695|NCT00837590|7303605|FG001|NOT COMPLETED|Overall Study||1
6504991|NCT01451203|7424076|FG000|Received Treatment|Double-blind Treatment Period||157
6504992|NCT01451203|7424077|FG001|Received Treatment|Double-blind Treatment Period||159
6504993|NCT01451203|7424076|FG000|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
6504994|NCT01451203|7424077|FG001|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
6504995|NCT01451203|7424076|FG000|COMPLETED|Double-blind Treatment Period||73
6504996|NCT01451203|7424077|FG001|COMPLETED|Double-blind Treatment Period||111
6391696|NCT00837590|7303606|FG002|NOT COMPLETED|Overall Study||1
6391697|NCT00837616|7303616|FG000|STARTED|Overall Study||20
6657404|NCT02469246|7587732|FG000|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|6
6657405|NCT02469246|7587733|FG001|STARTED|Open-Label Extension (OLE)|Only participants in countries where F/TAF was not commercially available were eligible for the OLE.|5
6657406|NCT02469246|7587732|FG000|COMPLETED|Open-Label Extension (OLE)||6
6657407|NCT02469246|7587733|FG001|COMPLETED|Open-Label Extension (OLE)||5
6657408|NCT02469246|7587732|FG000|NOT COMPLETED|Open-Label Extension (OLE)||0
6657409|NCT02469246|7587733|FG001|NOT COMPLETED|Open-Label Extension (OLE)||0
6657410|NCT02469298|7587745|FG000|STARTED|Overall Study||15
6657411|NCT02469298|7587746|FG001|STARTED|Overall Study||7
6657412|NCT02469298|7587747|FG002|STARTED|Overall Study||16
6657413|NCT02469298|7587748|FG003|STARTED|Overall Study||7
6657414|NCT02469298|7587745|FG000|COMPLETED|Overall Study||14
6657415|NCT02469298|7587746|FG001|COMPLETED|Overall Study||6
6657416|NCT02469298|7587747|FG002|COMPLETED|Overall Study||14
6657417|NCT02469298|7587748|FG003|COMPLETED|Overall Study||5
6657418|NCT02469298|7587745|FG000|NOT COMPLETED|Overall Study||1
6657419|NCT02469298|7587746|FG001|NOT COMPLETED|Overall Study||1
6569376|NCT01845077|7492751|FG001|STARTED|Treatment Period 1||12
6569377|NCT01845077|7492752|FG002|STARTED|Treatment Period 1||12
6569378|NCT01845077|7492753|FG003|STARTED|Treatment Period 1||12
6569379|NCT01845077|7492754|FG004|STARTED|Treatment Period 1||12
6569380|NCT01845077|7492755|FG005|STARTED|Treatment Period 1||12
6569381|NCT01845077|7492750|FG000|COMPLETED|Treatment Period 1||12
6569382|NCT01845077|7492751|FG001|COMPLETED|Treatment Period 1||12
6569383|NCT01845077|7492752|FG002|COMPLETED|Treatment Period 1||12
6569384|NCT01845077|7492753|FG003|COMPLETED|Treatment Period 1||12
6569385|NCT01845077|7492754|FG004|COMPLETED|Treatment Period 1||12
6657420|NCT02469298|7587747|FG002|NOT COMPLETED|Overall Study||2
6391698|NCT00837616|7303617|FG001|STARTED|Overall Study||21
6391699|NCT00837616|7303616|FG000|COMPLETED|Overall Study||20
6391700|NCT00837616|7303617|FG001|COMPLETED|Overall Study||20
6391701|NCT00837616|7303616|FG000|NOT COMPLETED|Overall Study||0
6391702|NCT00837616|7303617|FG001|NOT COMPLETED|Overall Study||1
6504997|NCT01451203|7424076|FG000|NOT COMPLETED|Double-blind Treatment Period||85
6504998|NCT01451203|7424077|FG001|NOT COMPLETED|Double-blind Treatment Period||50
6504999|NCT01451203|7424076|FG000|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
6505000|NCT01451203|7424077|FG001|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
6569386|NCT01845077|7492755|FG005|COMPLETED|Treatment Period 1||12
6569387|NCT01845077|7492750|FG000|NOT COMPLETED|Treatment Period 1||0
6569388|NCT01845077|7492751|FG001|NOT COMPLETED|Treatment Period 1||0
6569389|NCT01845077|7492752|FG002|NOT COMPLETED|Treatment Period 1||0
6569390|NCT01845077|7492753|FG003|NOT COMPLETED|Treatment Period 1||0
6569391|NCT01845077|7492754|FG004|NOT COMPLETED|Treatment Period 1||0
6569392|NCT01845077|7492755|FG005|NOT COMPLETED|Treatment Period 1||0
6276683|NCT00121667|7175988|FG002|COMPLETED|Short Term (ST) Period||140
6276684|NCT00121667|7175989|FG003|COMPLETED|Short Term (ST) Period||112
6276685|NCT00121667|7175986|FG000|NOT COMPLETED|Short Term (ST) Period||44
6276686|NCT00121667|7175987|FG001|NOT COMPLETED|Short Term (ST) Period||48
6276687|NCT00121667|7175988|FG002|NOT COMPLETED|Short Term (ST) Period||41
6276688|NCT00121667|7175989|FG003|NOT COMPLETED|Short Term (ST) Period||67
6276689|NCT00121667|7175986|FG000|STARTED|Short Term (ST) + Long Term (LT) Period||192
6276690|NCT00121667|7175987|FG001|STARTED|Short Term (ST) + Long Term (LT) Period||191
6276691|NCT00121667|7175988|FG002|STARTED|Short Term (ST) + Long Term (LT) Period||181
6276692|NCT00121667|7175989|FG003|STARTED|Short Term (ST) + Long Term (LT) Period||179
6276693|NCT00121667|7175986|FG000|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
6276694|NCT00121667|7175987|FG001|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
6276695|NCT00121667|7175988|FG002|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
6276696|NCT00121667|7175989|FG003|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
6569393|NCT01845077|7492750|FG000|STARTED|Washout Period||12
6569394|NCT01845077|7492751|FG001|STARTED|Washout Period||12
6569395|NCT01845077|7492752|FG002|STARTED|Washout Period||12
6569396|NCT01845077|7492753|FG003|STARTED|Washout Period||12
6569397|NCT01845077|7492754|FG004|STARTED|Washout Period||12
6569398|NCT01845077|7492755|FG005|STARTED|Washout Period||12
6569399|NCT01845077|7492750|FG000|COMPLETED|Washout Period||11
6569400|NCT01845077|7492751|FG001|COMPLETED|Washout Period||11
6569401|NCT01845077|7492752|FG002|COMPLETED|Washout Period||11
6569402|NCT01845077|7492753|FG003|COMPLETED|Washout Period||10
6569403|NCT01845077|7492754|FG004|COMPLETED|Washout Period||11
6569404|NCT01845077|7492755|FG005|COMPLETED|Washout Period||11
6569405|NCT01845077|7492750|FG000|NOT COMPLETED|Washout Period||1
6569406|NCT01845077|7492751|FG001|NOT COMPLETED|Washout Period||1
6569407|NCT01845077|7492752|FG002|NOT COMPLETED|Washout Period||1
6276697|NCT00121667|7175986|FG000|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
6276698|NCT00121667|7175987|FG001|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
6276699|NCT00121667|7175988|FG002|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
6276700|NCT00121667|7175989|FG003|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
6276701|NCT00121667|7175986|FG000|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
6276702|NCT00121667|7175987|FG001|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
6276703|NCT00121667|7175988|FG002|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
6276704|NCT00121667|7175989|FG003|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
6276705|NCT00121719|7176011|FG000|STARTED|Dose Escalation (4 Weeks)||4
6276706|NCT00121719|7176012|FG001|STARTED|Dose Escalation (4 Weeks)||4
6276707|NCT00121719|7176013|FG002|STARTED|Dose Escalation (4 Weeks)||4
6276708|NCT00121719|7176014|FG003|STARTED|Dose Escalation (4 Weeks)||3
6276709|NCT00121719|7176015|FG004|STARTED|Dose Escalation (4 Weeks)||3
6276710|NCT00121719|7176016|FG005|STARTED|Dose Escalation (4 Weeks)||3
6569408|NCT01845077|7492753|FG003|NOT COMPLETED|Washout Period||2
6569409|NCT01845077|7492754|FG004|NOT COMPLETED|Washout Period||1
6276711|NCT00121719|7176017|FG006|STARTED|Dose Escalation (4 Weeks)||12
6276712|NCT00121719|7176018|FG007|STARTED|Dose Escalation (4 Weeks)||9
6276713|NCT00121719|7176019|FG008|STARTED|Dose Escalation (4 Weeks)||6
6276714|NCT00121719|7176020|FG009|STARTED|Dose Escalation (4 Weeks)||3
6276715|NCT00121719|7176021|FG010|STARTED|Dose Escalation (4 Weeks)||0
6276716|NCT00121719|7176022|FG011|STARTED|Dose Escalation (4 Weeks)||0
6276717|NCT00121719|7176023|FG012|STARTED|Dose Escalation (4 Weeks)||24
6276718|NCT00121719|7176024|FG013|STARTED|Dose Escalation (4 Weeks)||7
6276719|NCT00121719|7176011|FG000|COMPLETED|Dose Escalation (4 Weeks)||4
6276720|NCT00121719|7176012|FG001|COMPLETED|Dose Escalation (4 Weeks)||4
6276721|NCT00121719|7176013|FG002|COMPLETED|Dose Escalation (4 Weeks)||4
6276722|NCT00121719|7176014|FG003|COMPLETED|Dose Escalation (4 Weeks)||3
6276723|NCT00121719|7176015|FG004|COMPLETED|Dose Escalation (4 Weeks)||3
6276724|NCT00121719|7176016|FG005|COMPLETED|Dose Escalation (4 Weeks)||3
6276725|NCT00121719|7176017|FG006|COMPLETED|Dose Escalation (4 Weeks)||12
6276726|NCT00121719|7176018|FG007|COMPLETED|Dose Escalation (4 Weeks)||9
6276727|NCT00121719|7176019|FG008|COMPLETED|Dose Escalation (4 Weeks)||6
6276728|NCT00121719|7176020|FG009|COMPLETED|Dose Escalation (4 Weeks)||3
6276729|NCT00121719|7176021|FG010|COMPLETED|Dose Escalation (4 Weeks)||0
6276730|NCT00121719|7176022|FG011|COMPLETED|Dose Escalation (4 Weeks)||0
6276731|NCT00121719|7176023|FG012|COMPLETED|Dose Escalation (4 Weeks)||24
6276732|NCT00121719|7176024|FG013|COMPLETED|Dose Escalation (4 Weeks)||7
6276733|NCT00121719|7176011|FG000|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276734|NCT00121719|7176012|FG001|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276735|NCT00121719|7176013|FG002|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276736|NCT00121719|7176014|FG003|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276737|NCT00121719|7176015|FG004|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276738|NCT00121719|7176016|FG005|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276739|NCT00121719|7176017|FG006|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276740|NCT00121719|7176018|FG007|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276741|NCT00121719|7176019|FG008|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276742|NCT00121719|7176020|FG009|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276743|NCT00121719|7176021|FG010|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6569410|NCT01845077|7492755|FG005|NOT COMPLETED|Washout Period||1
6569411|NCT01845077|7492750|FG000|STARTED|Treatment Period 2||11
6569412|NCT01845077|7492751|FG001|STARTED|Treatment Period 2||11
6569413|NCT01845077|7492752|FG002|STARTED|Treatment Period 2||11
6569414|NCT01845077|7492753|FG003|STARTED|Treatment Period 2||10
6569415|NCT01845077|7492754|FG004|STARTED|Treatment Period 2||11
6569416|NCT01845077|7492755|FG005|STARTED|Treatment Period 2||11
6569417|NCT01845077|7492750|FG000|COMPLETED|Treatment Period 2||11
6569418|NCT01845077|7492751|FG001|COMPLETED|Treatment Period 2||11
6569419|NCT01845077|7492752|FG002|COMPLETED|Treatment Period 2||11
6391703|NCT00837694|7303629|FG000|STARTED|Overall Study||10
6505001|NCT01451203|7424076|FG000|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
6505002|NCT01451203|7424077|FG001|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
6505003|NCT01451203|7424076|FG000|COMPLETED|Post-treatment Period||57
6505004|NCT01451203|7424077|FG001|COMPLETED|Post-treatment Period||74
6505005|NCT01451203|7424076|FG000|NOT COMPLETED|Post-treatment Period||14
6505006|NCT01451203|7424077|FG001|NOT COMPLETED|Post-treatment Period||34
6569420|NCT01845077|7492753|FG003|COMPLETED|Treatment Period 2||10
6569421|NCT01845077|7492754|FG004|COMPLETED|Treatment Period 2||11
6569422|NCT01845077|7492755|FG005|COMPLETED|Treatment Period 2||11
6569423|NCT01845077|7492750|FG000|NOT COMPLETED|Treatment Period 2||0
6569424|NCT01845077|7492751|FG001|NOT COMPLETED|Treatment Period 2||0
6569425|NCT01845077|7492752|FG002|NOT COMPLETED|Treatment Period 2||0
6569426|NCT01845077|7492753|FG003|NOT COMPLETED|Treatment Period 2||0
6569427|NCT01845077|7492754|FG004|NOT COMPLETED|Treatment Period 2||0
6569428|NCT01845077|7492755|FG005|NOT COMPLETED|Treatment Period 2||0
6569429|NCT01845103|7492770|FG000|STARTED|Overall Study||1
6569430|NCT01845103|7492770|FG000|COMPLETED|Overall Study||1
6569431|NCT01845103|7492770|FG000|NOT COMPLETED|Overall Study||0
6569432|NCT01845155|7492776|FG000|STARTED|Overall Study||146
6569433|NCT01845155|7492777|FG001|STARTED|Overall Study||144
6569434|NCT01845155|7492776|FG000|COMPLETED|Overall Study||145
6505007|NCT01451372|7424083|FG000|STARTED|Overall Study||69
6505008|NCT01451372|7424083|FG000|COMPLETED|Overall Study||69
6505009|NCT01451372|7424083|FG000|NOT COMPLETED|Overall Study||0
6505010|NCT01451385|7424087|FG000|STARTED|Overall Study||376
6505011|NCT01451385|7424087|FG000|COMPLETED|Overall Study||285
6505012|NCT01451385|7424087|FG000|NOT COMPLETED|Overall Study||91
6505013|NCT01451398|7424093|FG000|STARTED|Overall Study||177
6505014|NCT01451398|7424094|FG001|STARTED|Overall Study||176
6505015|NCT01451398|7424093|FG000|COMPLETED|Overall Study||150
6569435|NCT01845155|7492777|FG001|COMPLETED|Overall Study||144
6569436|NCT01845155|7492776|FG000|NOT COMPLETED|Overall Study||1
6569437|NCT01845155|7492777|FG001|NOT COMPLETED|Overall Study||0
6569438|NCT01845220|7492783|FG000|STARTED|Overall Study||30
6569439|NCT01845220|7492784|FG001|STARTED|Overall Study||30
6569440|NCT01845220|7492783|FG000|COMPLETED|Overall Study||30
6569441|NCT01845220|7492784|FG001|COMPLETED|Overall Study||30
6569442|NCT01845220|7492783|FG000|NOT COMPLETED|Overall Study||0
6569443|NCT01845220|7492784|FG001|NOT COMPLETED|Overall Study||0
6569444|NCT01845636|7492790|FG000|STARTED|Overall Study||41
6569445|NCT01845636|7492790|FG000|COMPLETED|Overall Study||37
6569446|NCT01845636|7492790|FG000|NOT COMPLETED|Overall Study||4
6569447|NCT01845792|7492796|FG000|STARTED|Overall Study||5
6569448|NCT01845792|7492797|FG001|STARTED|Overall Study||2
6569449|NCT01845792|7492796|FG000|COMPLETED|Overall Study||5
6569450|NCT01845792|7492797|FG001|COMPLETED|Overall Study||2
6569451|NCT01845792|7492796|FG000|NOT COMPLETED|Overall Study||0
6569452|NCT01845792|7492797|FG001|NOT COMPLETED|Overall Study||0
6569453|NCT01845818|7492805|FG000|STARTED|Overall Study||126
6569454|NCT01845818|7492806|FG001|STARTED|Overall Study||57
6569455|NCT01845818|7492805|FG000|COMPLETED|Overall Study||81
6569456|NCT01845818|7492806|FG001|COMPLETED|Overall Study||40
6569457|NCT01845818|7492805|FG000|NOT COMPLETED|Overall Study||45
6569458|NCT01845818|7492806|FG001|NOT COMPLETED|Overall Study||17
6569459|NCT01845831|7492816|FG000|STARTED|Inpatient Phase||140
6569460|NCT01845831|7492817|FG001|STARTED|Inpatient Phase||139
6657421|NCT02469298|7587748|FG003|NOT COMPLETED|Overall Study||2
6657422|NCT02469389|7587767|FG000|STARTED|Overall Study||53
6569461|NCT01845831|7492818|FG002|STARTED|Inpatient Phase||0
6657423|NCT02469389|7587768|FG001|STARTED|Overall Study||52
6505016|NCT01451398|7424094|FG001|COMPLETED|Overall Study||139
6505017|NCT01451398|7424093|FG000|NOT COMPLETED|Overall Study||27
6505018|NCT01451398|7424094|FG001|NOT COMPLETED|Overall Study||37
6505019|NCT01451411|7424102|FG000|STARTED|Overall Study||3
6505020|NCT01451411|7424103|FG001|STARTED|Overall Study||1
6505021|NCT01451411|7424102|FG000|COMPLETED|Overall Study||3
6505022|NCT01451411|7424103|FG001|COMPLETED|Overall Study||1
6505023|NCT01451411|7424102|FG000|NOT COMPLETED|Overall Study||0
6505024|NCT01451411|7424103|FG001|NOT COMPLETED|Overall Study||0
6569462|NCT01845831|7492819|FG003|STARTED|Inpatient Phase||0
6569463|NCT01845831|7492820|FG004|STARTED|Inpatient Phase||0
6569464|NCT01845831|7492816|FG000|COMPLETED|Inpatient Phase||139
6569465|NCT01845831|7492817|FG001|COMPLETED|Inpatient Phase||138
6569466|NCT01845831|7492818|FG002|COMPLETED|Inpatient Phase||0
6569467|NCT01845831|7492819|FG003|COMPLETED|Inpatient Phase||0
6569468|NCT01845831|7492820|FG004|COMPLETED|Inpatient Phase||0
6569469|NCT01845831|7492816|FG000|NOT COMPLETED|Inpatient Phase||1
6569470|NCT01845831|7492817|FG001|NOT COMPLETED|Inpatient Phase||1
6569471|NCT01845831|7492818|FG002|NOT COMPLETED|Inpatient Phase||0
6569472|NCT01845831|7492819|FG003|NOT COMPLETED|Inpatient Phase||0
6569473|NCT01845831|7492820|FG004|NOT COMPLETED|Inpatient Phase||0
6569474|NCT01845831|7492816|FG000|STARTED|Outpatient Phase||0
6569475|NCT01845831|7492817|FG001|STARTED|Outpatient Phase||0
6569476|NCT01845831|7492818|FG002|STARTED|Outpatient Phase||68
6569477|NCT01845831|7492819|FG003|STARTED|Outpatient Phase||98
6569478|NCT01845831|7492820|FG004|STARTED|Outpatient Phase||87
6569479|NCT01845831|7492816|FG000|COMPLETED|Outpatient Phase||0
6569480|NCT01845831|7492817|FG001|COMPLETED|Outpatient Phase||0
6569481|NCT01845831|7492818|FG002|COMPLETED|Outpatient Phase||68
6569482|NCT01845831|7492819|FG003|COMPLETED|Outpatient Phase||98
6569483|NCT01845831|7492820|FG004|COMPLETED|Outpatient Phase||87
6569484|NCT01845831|7492816|FG000|NOT COMPLETED|Outpatient Phase||0
6657424|NCT02469389|7587767|FG000|Completed 12-week Assessment|Overall Study|13 lost to contact or refused|40
6569485|NCT01845831|7492817|FG001|NOT COMPLETED|Outpatient Phase||0
6569486|NCT01845831|7492818|FG002|NOT COMPLETED|Outpatient Phase||0
6569487|NCT01845831|7492819|FG003|NOT COMPLETED|Outpatient Phase||0
6569488|NCT01845831|7492820|FG004|NOT COMPLETED|Outpatient Phase||0
6569489|NCT01845974|7492833|FG000|STARTED|Overall Study||4
6569490|NCT01845974|7492834|FG001|STARTED|Overall Study||9
6569491|NCT01845974|7492833|FG000|COMPLETED|Overall Study||3
6569492|NCT01845974|7492834|FG001|COMPLETED|Overall Study||9
6569493|NCT01845974|7492833|FG000|NOT COMPLETED|Overall Study||1
6569494|NCT01845974|7492834|FG001|NOT COMPLETED|Overall Study||0
6569495|NCT01846039|7492840|FG000|STARTED|Overall Study||29
6569496|NCT01846039|7492840|FG000|COMPLETED|Overall Study||27
6276744|NCT00121719|7176022|FG011|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276745|NCT00121719|7176023|FG012|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276746|NCT00121719|7176024|FG013|NOT COMPLETED|Dose Escalation (4 Weeks)||0
6276747|NCT00121719|7176011|FG000|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276748|NCT00121719|7176012|FG001|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276749|NCT00121719|7176013|FG002|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276750|NCT00121719|7176014|FG003|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276751|NCT00121719|7176015|FG004|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276752|NCT00121719|7176016|FG005|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276753|NCT00121719|7176017|FG006|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276754|NCT00121719|7176018|FG007|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276755|NCT00121719|7176019|FG008|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276756|NCT00121719|7176020|FG009|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276757|NCT00121719|7176021|FG010|STARTED|Food-Effect Pilot Study (4 Weeks)||6
6276758|NCT00121719|7176022|FG011|STARTED|Food-Effect Pilot Study (4 Weeks)||5
6276759|NCT00121719|7176023|FG012|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276760|NCT00121719|7176024|FG013|STARTED|Food-Effect Pilot Study (4 Weeks)||0
6276761|NCT00121719|7176011|FG000|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276762|NCT00121719|7176012|FG001|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276763|NCT00121719|7176013|FG002|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276764|NCT00121719|7176014|FG003|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276765|NCT00121719|7176015|FG004|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276766|NCT00121719|7176016|FG005|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276767|NCT00121719|7176017|FG006|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276768|NCT00121719|7176018|FG007|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276769|NCT00121719|7176019|FG008|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6569497|NCT01846039|7492840|FG000|NOT COMPLETED|Overall Study||2
6569498|NCT01846104|7492844|FG000|STARTED|Overall Study||4
6569499|NCT01846104|7492844|FG000|COMPLETED|Overall Study||3
6569500|NCT01846104|7492844|FG000|NOT COMPLETED|Overall Study||1
6569501|NCT01846208|7492851|FG000|STARTED|Overall Study||28
6569502|NCT01846208|7492852|FG001|STARTED|Overall Study||24
6569503|NCT01846208|7492853|FG002|STARTED|Overall Study||40
6246655|NCT03604549|7146049|FG000|STARTED|Overall Study||29
6246656|NCT03604549|7146050|FG001|STARTED|Overall Study||29
6246657|NCT03604549|7146049|FG000|COMPLETED|Overall Study||24
6246658|NCT03604549|7146050|FG001|COMPLETED|Overall Study||24
6246659|NCT03604549|7146049|FG000|NOT COMPLETED|Overall Study||5
6246660|NCT03604549|7146050|FG001|NOT COMPLETED|Overall Study||5
6246661|NCT04823221|7146056|FG000|STARTED|Overall Study||22
6246662|NCT04823221|7146056|FG000|COMPLETED|Overall Study||22
6246663|NCT04823221|7146056|FG000|NOT COMPLETED|Overall Study||0
6246664|NCT04579393|7146062|FG000|STARTED|Overall Study||30
6246665|NCT04579393|7146063|FG001|STARTED|Overall Study||29
6246666|NCT04579393|7146062|FG000|COMPLETED|Overall Study||27
6246667|NCT04579393|7146063|FG001|COMPLETED|Overall Study||24
6246668|NCT04579393|7146062|FG000|NOT COMPLETED|Overall Study||3
6246669|NCT04579393|7146063|FG001|NOT COMPLETED|Overall Study||5
6246670|NCT04426656|7146072|FG000|STARTED|Overall Study||24
6246671|NCT04426656|7146073|FG001|STARTED|Overall Study||46
6246672|NCT04426656|7146072|FG000|COMPLETED|Overall Study||21
6246673|NCT04426656|7146073|FG001|COMPLETED|Overall Study||43
6246674|NCT04426656|7146072|FG000|NOT COMPLETED|Overall Study||3
6246675|NCT04426656|7146073|FG001|NOT COMPLETED|Overall Study||3
6246676|NCT04325906|7146081|FG000|STARTED|Overall Study||112
6246677|NCT04325906|7146082|FG001|STARTED|Overall Study||112
6246678|NCT04325906|7146081|FG000|COMPLETED|Overall Study||110
6246679|NCT04325906|7146082|FG001|COMPLETED|Overall Study||112
6246680|NCT04325906|7146081|FG000|NOT COMPLETED|Overall Study||2
6246681|NCT04325906|7146082|FG001|NOT COMPLETED|Overall Study||0
6246682|NCT04319445|7146088|FG000|STARTED|Overall Study||144
6246683|NCT04319445|7146088|FG000|COMPLETED|Overall Study||144
6246684|NCT04319445|7146088|FG000|NOT COMPLETED|Overall Study||0
6246685|NCT04203667|7146092|FG000|STARTED|Overall Study||66
6246686|NCT04203667|7146092|FG000|Per Protocol Population|Overall Study||45
6246687|NCT04203667|7146092|FG000|COMPLETED|Overall Study||62
6246688|NCT04203667|7146092|FG000|NOT COMPLETED|Overall Study||4
6246689|NCT03796637|7146097|FG000|STARTED|Overall Study||6
6246690|NCT03796637|7146097|FG000|COMPLETED|Overall Study||6
6246691|NCT03796637|7146097|FG000|NOT COMPLETED|Overall Study||0
6246692|NCT03679884|7146106|FG000|STARTED|Overall Study||142
6246693|NCT03679884|7146107|FG001|STARTED|Overall Study||268
6246694|NCT03679884|7146108|FG002|STARTED|Overall Study||137
6246695|NCT03679884|7146109|FG003|STARTED|Overall Study||128
6246696|NCT03679884|7146110|FG004|STARTED|Overall Study||126
6246697|NCT03679884|7146106|FG000|COMPLETED|Overall Study||99
6246698|NCT03679884|7146107|FG001|COMPLETED|Overall Study||190
6246699|NCT03679884|7146108|FG002|COMPLETED|Overall Study||93
6246700|NCT03679884|7146109|FG003|COMPLETED|Overall Study||78
6246701|NCT03679884|7146110|FG004|COMPLETED|Overall Study||90
6246702|NCT03679884|7146106|FG000|NOT COMPLETED|Overall Study||43
6246703|NCT03679884|7146107|FG001|NOT COMPLETED|Overall Study||78
6246704|NCT03679884|7146108|FG002|NOT COMPLETED|Overall Study||44
6246705|NCT03679884|7146109|FG003|NOT COMPLETED|Overall Study||50
6246706|NCT03679884|7146110|FG004|NOT COMPLETED|Overall Study||36
6246707|NCT03653026|7146124|FG000|STARTED|Part 1: Placebo-controlled Period||345
6246708|NCT03653026|7146125|FG001|STARTED|Part 1: Placebo-controlled Period||177
6246709|NCT03653026|7146126|FG002|STARTED|Part 1: Placebo-controlled Period||0
6246710|NCT03653026|7146127|FG003|STARTED|Part 1: Placebo-controlled Period||0
6246711|NCT03653026|7146124|FG000|Received Treatment|Part 1: Placebo-controlled Period||344
6246712|NCT03653026|7146125|FG001|Received Treatment|Part 1: Placebo-controlled Period||177
6246713|NCT03653026|7146126|FG002|Received Treatment|Part 1: Placebo-controlled Period||0
6246714|NCT03653026|7146127|FG003|Received Treatment|Part 1: Placebo-controlled Period||0
6246715|NCT03653026|7146124|FG000|COMPLETED|Part 1: Placebo-controlled Period||334
6246716|NCT03653026|7146125|FG001|COMPLETED|Part 1: Placebo-controlled Period||164
6246717|NCT03653026|7146126|FG002|COMPLETED|Part 1: Placebo-controlled Period||0
6246718|NCT03653026|7146127|FG003|COMPLETED|Part 1: Placebo-controlled Period||0
6246719|NCT03653026|7146124|FG000|NOT COMPLETED|Part 1: Placebo-controlled Period||11
6246720|NCT03653026|7146125|FG001|NOT COMPLETED|Part 1: Placebo-controlled Period||13
6246721|NCT03653026|7146126|FG002|NOT COMPLETED|Part 1: Placebo-controlled Period||0
6246722|NCT03653026|7146127|FG003|NOT COMPLETED|Part 1: Placebo-controlled Period||0
6246723|NCT03653026|7146124|FG000|STARTED|Part 2: Open-label Extension||0
6246724|NCT03653026|7146125|FG001|STARTED|Part 2: Open-label Extension||0
6246725|NCT03653026|7146126|FG002|STARTED|Part 2: Open-label Extension||68
6246726|NCT03653026|7146127|FG003|STARTED|Part 2: Open-label Extension||116
6246727|NCT03653026|7146124|FG000|COMPLETED|Part 2: Open-label Extension||0
6246728|NCT03653026|7146125|FG001|COMPLETED|Part 2: Open-label Extension||0
6246729|NCT03653026|7146126|FG002|COMPLETED|Part 2: Open-label Extension||65
6246730|NCT03653026|7146127|FG003|COMPLETED|Part 2: Open-label Extension||111
6391704|NCT00837694|7303630|FG001|STARTED|Overall Study||11
6391705|NCT00837694|7303631|FG002|STARTED|Overall Study||10
6391706|NCT00837694|7303632|FG003|STARTED|Overall Study||11
6391707|NCT00837694|7303633|FG004|STARTED|Overall Study||12
6391708|NCT00837694|7303634|FG005|STARTED|Overall Study||11
6391709|NCT00837694|7303629|FG000|COMPLETED|Overall Study||8
6391710|NCT00837694|7303630|FG001|COMPLETED|Overall Study||11
6391711|NCT00837694|7303631|FG002|COMPLETED|Overall Study||8
6391712|NCT00837694|7303632|FG003|COMPLETED|Overall Study||10
6246731|NCT03653026|7146124|FG000|NOT COMPLETED|Part 2: Open-label Extension||0
6246732|NCT03653026|7146125|FG001|NOT COMPLETED|Part 2: Open-label Extension||0
6246733|NCT03653026|7146126|FG002|NOT COMPLETED|Part 2: Open-label Extension||3
6246734|NCT03653026|7146127|FG003|NOT COMPLETED|Part 2: Open-label Extension||5
6246735|NCT03648827|7146135|FG000|STARTED|Overall Study||20
6391713|NCT00837694|7303633|FG004|COMPLETED|Overall Study||11
6569504|NCT01846208|7492851|FG000|Initiatiated Treatment|Overall Study||27
6569505|NCT01846208|7492852|FG001|Initiatiated Treatment|Overall Study||23
6569506|NCT01846208|7492853|FG002|Initiatiated Treatment|Overall Study||39
6569507|NCT01846208|7492851|FG000|Year 1 Desensitization OFC|Overall Study||23
6569508|NCT01846208|7492852|FG001|Year 1 Desensitization OFC|Overall Study||20
6569509|NCT01846208|7492853|FG002|Year 1 Desensitization OFC|Overall Study||34
6569510|NCT01846208|7492851|FG000|Year 2 Desensitization OFC|Overall Study||19
6569511|NCT01846208|7492852|FG001|Year 2 Desensitization OFC|Overall Study||20
6569512|NCT01846208|7492853|FG002|Year 2 Desensitization OFC|Overall Study||33
6569513|NCT01846208|7492851|FG000|Year 2 Sustained Unresponsiveness OFC|Overall Study||4
6569514|NCT01846208|7492852|FG001|Year 2 Sustained Unresponsiveness OFC|Overall Study||18
6569515|NCT01846208|7492853|FG002|Year 2 Sustained Unresponsiveness OFC|Overall Study||21
6246736|NCT03648827|7146135|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
6246737|NCT03648827|7146135|FG000|COMPLETED|Overall Study||20
6246738|NCT03648827|7146135|FG000|NOT COMPLETED|Overall Study||0
6246739|NCT03553498|7146141|FG000|STARTED|Overall Study||81
6246740|NCT03553498|7146142|FG001|STARTED|Overall Study||81
6246741|NCT03553498|7146141|FG000|COMPLETED|Overall Study||80
6246742|NCT03553498|7146142|FG001|COMPLETED|Overall Study||79
6246743|NCT03553498|7146141|FG000|NOT COMPLETED|Overall Study||1
6246744|NCT03553498|7146142|FG001|NOT COMPLETED|Overall Study||2
6276770|NCT00121719|7176020|FG009|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276771|NCT00121719|7176021|FG010|COMPLETED|Food-Effect Pilot Study (4 Weeks)||6
6276772|NCT00121719|7176022|FG011|COMPLETED|Food-Effect Pilot Study (4 Weeks)||5
6276773|NCT00121719|7176023|FG012|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276774|NCT00121719|7176024|FG013|COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276775|NCT00121719|7176011|FG000|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276776|NCT00121719|7176012|FG001|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276777|NCT00121719|7176013|FG002|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276778|NCT00121719|7176014|FG003|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276779|NCT00121719|7176015|FG004|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276780|NCT00121719|7176016|FG005|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276781|NCT00121719|7176017|FG006|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276782|NCT00121719|7176018|FG007|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276783|NCT00121719|7176019|FG008|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276784|NCT00121719|7176020|FG009|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276785|NCT00121719|7176021|FG010|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276786|NCT00121719|7176022|FG011|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276787|NCT00121719|7176023|FG012|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276788|NCT00121719|7176024|FG013|NOT COMPLETED|Food-Effect Pilot Study (4 Weeks)||0
6276789|NCT00121810|7176068|FG000|STARTED|Overall Study||151
6276790|NCT00121810|7176069|FG001|STARTED|Overall Study||154
6276791|NCT00121810|7176068|FG000|Safety Population|Overall Study||148
6276792|NCT00121810|7176069|FG001|Safety Population|Overall Study||153
6276793|NCT00121810|7176068|FG000|Intent-to-Treat (ITT) Population|Overall Study||148
6276794|NCT00121810|7176069|FG001|Intent-to-Treat (ITT) Population|Overall Study||151
6276795|NCT00121810|7176068|FG000|COMPLETED|Overall Study||121
6276796|NCT00121810|7176069|FG001|COMPLETED|Overall Study||115
6276797|NCT00121810|7176068|FG000|NOT COMPLETED|Overall Study||30
6276798|NCT00121810|7176069|FG001|NOT COMPLETED|Overall Study||39
6276799|NCT00121836|7176075|FG000|STARTED|Overall Study||109
6276800|NCT00121836|7176075|FG000|COMPLETED|Overall Study||54
6276801|NCT00121836|7176075|FG000|NOT COMPLETED|Overall Study||55
6276802|NCT00121992|7176082|FG000|STARTED|Overall Study||521
6276803|NCT00121992|7176083|FG001|STARTED|Overall Study||539
6276804|NCT00121992|7176082|FG000|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||28
6276805|NCT00121992|7176083|FG001|Hormone-receptor Positive and HER2 Positive Status Subjects|Overall Study||30
6276806|NCT00121992|7176082|FG000|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||24
6276807|NCT00121992|7176083|FG001|Hormone-receptor Negative and HER2 Positive Status Subjects|Overall Study||22
6280868|NCT00159419|7180686|FG001|COMPLETED|Overall Study||9
6246745|NCT03505749|7146150|FG000|STARTED|Overall Study||38
6246746|NCT03505749|7146151|FG001|STARTED|Overall Study||45
6246747|NCT03505749|7146150|FG000|COMPLETED|Overall Study||22
6246748|NCT03505749|7146151|FG001|COMPLETED|Overall Study||28
6246749|NCT03505749|7146150|FG000|NOT COMPLETED|Overall Study||16
6246750|NCT03505749|7146151|FG001|NOT COMPLETED|Overall Study||17
6246751|NCT03472885|7146160|FG000|STARTED|Overall Study||12
6246752|NCT03472885|7146160|FG000|Safety Population: Received at Least 1 Dose of Study Drug|Overall Study||12
6246753|NCT03472885|7146160|FG000|Efficacy Population: Received Study Drug for at Least 4 Weeks|Overall Study||11
6246754|NCT03472885|7146160|FG000|COMPLETED|Overall Study||11
6246755|NCT03472885|7146160|FG000|NOT COMPLETED|Overall Study||1
6246756|NCT03311269|7146166|FG000|STARTED|Overall Study||10
6246757|NCT03311269|7146167|FG001|STARTED|Overall Study||9
6246758|NCT03311269|7146166|FG000|COMPLETED|Overall Study||10
6246759|NCT03311269|7146167|FG001|COMPLETED|Overall Study||9
6246760|NCT03311269|7146166|FG000|NOT COMPLETED|Overall Study||0
6246761|NCT03311269|7146167|FG001|NOT COMPLETED|Overall Study||0
6276808|NCT00121992|7176082|FG000|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||209
6276809|NCT00121992|7176083|FG001|Hormone-receptor Positive and HER2 Negative Status Subjects|Overall Study||220
6276810|NCT00121992|7176082|FG000|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||92
6276811|NCT00121992|7176083|FG001|Hormone-receptor Negative and HER2 Negative Status Subjects|Overall Study||103
6276812|NCT00121992|7176082|FG000|COMPLETED|Overall Study||519
6276813|NCT00121992|7176083|FG001|COMPLETED|Overall Study||528
6276814|NCT00121992|7176082|FG000|NOT COMPLETED|Overall Study||2
6276815|NCT00121992|7176083|FG001|NOT COMPLETED|Overall Study||11
6276816|NCT00122109|7176091|FG000|STARTED|Overall Study|ITT|61
6276817|NCT00122109|7176092|FG001|STARTED|Overall Study|ITT|64
6276818|NCT00122109|7176091|FG000|COMPLETED|Overall Study||55
6276819|NCT00122109|7176092|FG001|COMPLETED|Overall Study||57
6276820|NCT00122109|7176091|FG000|NOT COMPLETED|Overall Study||6
6276821|NCT00122109|7176092|FG001|NOT COMPLETED|Overall Study||7
6276822|NCT00122135|7176103|FG000|STARTED|Overall Study||60
6276823|NCT00122135|7176104|FG001|STARTED|Overall Study||60
6276824|NCT00122135|7176103|FG000|COMPLETED|Overall Study||57
6276825|NCT00122135|7176104|FG001|COMPLETED|Overall Study||60
6276826|NCT00122135|7176103|FG000|NOT COMPLETED|Overall Study||3
6276827|NCT00122135|7176104|FG001|NOT COMPLETED|Overall Study||0
6276828|NCT00122187|7176112|FG000|STARTED|Overall Study||4
6276829|NCT00122187|7176113|FG001|STARTED|Overall Study||4
6276830|NCT00122187|7176112|FG000|Matched by Colonoscopy Volume|Overall Study||4
6276831|NCT00122187|7176113|FG001|Matched by Colonoscopy Volume|Overall Study||4
6276832|NCT00122187|7176112|FG000|Randomized to Intervention or Usual Care|Overall Study||4
6276833|NCT00122187|7176113|FG001|Randomized to Intervention or Usual Care|Overall Study||4
6276834|NCT00122187|7176112|FG000|Intervention Implemented|Overall Study||3
6276835|NCT00122187|7176113|FG001|Intervention Implemented|Overall Study||4
6246762|NCT03143153|7146176|FG000|STARTED|Pre-Treatment||325
6246763|NCT03143153|7146177|FG001|STARTED|Pre-Treatment||321
6246764|NCT03143153|7146178|FG002|STARTED|Pre-Treatment||324
6246765|NCT03143153|7146176|FG000|COMPLETED|Pre-Treatment||322
6246766|NCT03143153|7146177|FG001|COMPLETED|Pre-Treatment||310
6246767|NCT03143153|7146178|FG002|COMPLETED|Pre-Treatment||304
6246768|NCT03143153|7146176|FG000|NOT COMPLETED|Pre-Treatment||3
6246769|NCT03143153|7146177|FG001|NOT COMPLETED|Pre-Treatment||11
6246770|NCT03143153|7146178|FG002|NOT COMPLETED|Pre-Treatment||20
6246771|NCT03143153|7146176|FG000|STARTED|Treatment||322
6246772|NCT03143153|7146177|FG001|STARTED|Treatment||310
6246773|NCT03143153|7146178|FG002|STARTED|Treatment||304
6246774|NCT03143153|7146176|FG000|COMPLETED|Treatment||21
6246775|NCT03143153|7146177|FG001|COMPLETED|Treatment||25
6246776|NCT03143153|7146178|FG002|COMPLETED|Treatment||4
6246777|NCT03143153|7146176|FG000|NOT COMPLETED|Treatment||301
6246778|NCT03143153|7146177|FG001|NOT COMPLETED|Treatment||285
6246779|NCT03143153|7146178|FG002|NOT COMPLETED|Treatment||300
6246780|NCT03118570|7146191|FG000|STARTED|Overall Study||31
6246781|NCT03118570|7146192|FG001|STARTED|Overall Study||29
6246782|NCT03118570|7146193|FG002|STARTED|Overall Study||30
6246783|NCT03118570|7146194|FG003|STARTED|Overall Study||2
6246784|NCT03118570|7146195|FG004|STARTED|Overall Study||20
6246785|NCT03118570|7146191|FG000|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
6246786|NCT03118570|7146192|FG001|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
6246787|NCT03118570|7146193|FG002|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
6246788|NCT03118570|7146194|FG003|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||0
6246789|NCT03118570|7146195|FG004|Reassigned From Placebo to 20 mg/kg Open-Label Setrusumab|Overall Study||19
6246790|NCT03118570|7146191|FG000|COMPLETED|Overall Study||26
6246791|NCT03118570|7146192|FG001|COMPLETED|Overall Study||22
6246792|NCT03118570|7146193|FG002|COMPLETED|Overall Study||25
6246793|NCT03118570|7146194|FG003|COMPLETED|Overall Study||2
6246794|NCT03118570|7146195|FG004|COMPLETED|Overall Study||15
6246795|NCT03118570|7146191|FG000|NOT COMPLETED|Overall Study||5
6246796|NCT03118570|7146192|FG001|NOT COMPLETED|Overall Study||7
6246797|NCT03118570|7146193|FG002|NOT COMPLETED|Overall Study||5
6246798|NCT03118570|7146194|FG003|NOT COMPLETED|Overall Study||0
6246799|NCT03118570|7146195|FG004|NOT COMPLETED|Overall Study||5
6246800|NCT03094416|7146208|FG000|STARTED|Run-in||66
6246801|NCT03094416|7146208|FG000|COMPLETED|Run-in||47
6246802|NCT03094416|7146208|FG000|NOT COMPLETED|Run-in||19
6246803|NCT03094416|7146208|FG000|STARTED|Treatment Period||47
6246804|NCT03094416|7146208|FG000|COMPLETED|Treatment Period||45
6246805|NCT03094416|7146208|FG000|NOT COMPLETED|Treatment Period||2
6246806|NCT02811861|7146216|FG000|STARTED|Overall Study||357
6246807|NCT02811861|7146217|FG001|STARTED|Overall Study||355
6246808|NCT02811861|7146218|FG002|STARTED|Overall Study||357
6246809|NCT02811861|7146216|FG000|Treated|Overall Study||355
6246810|NCT02811861|7146217|FG001|Treated|Overall Study||352
6246811|NCT02811861|7146218|FG002|Treated|Overall Study||340
6246812|NCT02811861|7146216|FG000|COMPLETED|Overall Study||0
6246813|NCT02811861|7146217|FG001|COMPLETED|Overall Study||0
6246814|NCT02811861|7146218|FG002|COMPLETED|Overall Study||0
6246815|NCT02811861|7146216|FG000|NOT COMPLETED|Overall Study||357
6246816|NCT02811861|7146217|FG001|NOT COMPLETED|Overall Study||355
6246817|NCT02811861|7146218|FG002|NOT COMPLETED|Overall Study||357
6246818|NCT02734667|7146228|FG000|STARTED|Overall Study||84
6246819|NCT02734667|7146229|FG001|STARTED|Overall Study||36
6246820|NCT02734667|7146228|FG000|Youth|Overall Study||42
6246821|NCT02734667|7146229|FG001|Youth|Overall Study||18
6246822|NCT02734667|7146228|FG000|Parent|Overall Study||42
6569516|NCT01846208|7492851|FG000|COMPLETED|Overall Study||19
6246823|NCT02734667|7146229|FG001|Parent|Overall Study||18
6246824|NCT02734667|7146228|FG000|COMPLETED|Overall Study||82
6246825|NCT02734667|7146229|FG001|COMPLETED|Overall Study||30
6246826|NCT02734667|7146228|FG000|NOT COMPLETED|Overall Study||2
6246827|NCT02734667|7146229|FG001|NOT COMPLETED|Overall Study||6
6246828|NCT02709317|7146237|FG000|STARTED|Overall Study||50
6246829|NCT02709317|7146238|FG001|STARTED|Overall Study||58
6246830|NCT02709317|7146237|FG000|COMPLETED|Overall Study||18
6246831|NCT02709317|7146238|FG001|COMPLETED|Overall Study||31
6246832|NCT02709317|7146237|FG000|NOT COMPLETED|Overall Study||32
6246833|NCT02709317|7146238|FG001|NOT COMPLETED|Overall Study||27
6276836|NCT00122187|7176112|FG000|Post-intervention Data Collection|Overall Study||2
6276837|NCT00122187|7176113|FG001|Post-intervention Data Collection|Overall Study||2
6276838|NCT00122187|7176112|FG000|COMPLETED|Overall Study||2
6276839|NCT00122187|7176113|FG001|COMPLETED|Overall Study||2
6276840|NCT00122187|7176112|FG000|NOT COMPLETED|Overall Study||2
6276841|NCT00122187|7176113|FG001|NOT COMPLETED|Overall Study||2
6276842|NCT00122278|7176123|FG000|STARTED|Overall Study||106
6276843|NCT00122278|7176124|FG001|STARTED|Overall Study||99
6276844|NCT00122278|7176123|FG000|COMPLETED|Overall Study||104
6276845|NCT00122278|7176124|FG001|COMPLETED|Overall Study||99
6276846|NCT00122278|7176123|FG000|NOT COMPLETED|Overall Study||2
6276847|NCT00122278|7176124|FG001|NOT COMPLETED|Overall Study||0
6276848|NCT00122317|7176130|FG000|STARTED|Overall Study||187
6276849|NCT00122317|7176130|FG000|COMPLETED|Overall Study||176
6505025|NCT01451424|7424113|FG000|STARTED|Overall Study||9
6505026|NCT01451424|7424114|FG001|STARTED|Overall Study||9
6505027|NCT01451424|7424115|FG002|STARTED|Overall Study||12
6505028|NCT01451424|7424116|FG003|STARTED|Overall Study||10
6505029|NCT01451424|7424113|FG000|COMPLETED|Overall Study||8
6505030|NCT01451424|7424114|FG001|COMPLETED|Overall Study||7
6505031|NCT01451424|7424115|FG002|COMPLETED|Overall Study||11
6505032|NCT01451424|7424116|FG003|COMPLETED|Overall Study||5
6505033|NCT01451424|7424113|FG000|NOT COMPLETED|Overall Study||1
6505034|NCT01451424|7424114|FG001|NOT COMPLETED|Overall Study||2
6505035|NCT01451424|7424115|FG002|NOT COMPLETED|Overall Study||1
6505036|NCT01451424|7424116|FG003|NOT COMPLETED|Overall Study||5
6505037|NCT01451437|7424140|FG000|STARTED|Overall Study||1
6505038|NCT01451437|7424141|FG001|STARTED|Overall Study||1
6505039|NCT01451437|7424142|FG002|STARTED|Overall Study||3
6505040|NCT01451437|7424143|FG003|STARTED|Overall Study||1
6505041|NCT01451437|7424144|FG004|STARTED|Overall Study||4
6505042|NCT01451437|7424145|FG005|STARTED|Overall Study||3
6505043|NCT01451437|7424146|FG006|STARTED|Overall Study||6
6505044|NCT01451437|7424147|FG007|STARTED|Overall Study||3
6505045|NCT01451437|7424148|FG008|STARTED|Overall Study||4
6505046|NCT01451437|7424140|FG000|COMPLETED|Overall Study||0
6505047|NCT01451437|7424141|FG001|COMPLETED|Overall Study||0
6505048|NCT01451437|7424142|FG002|COMPLETED|Overall Study||0
6505049|NCT01451437|7424143|FG003|COMPLETED|Overall Study||0
6505050|NCT01451437|7424144|FG004|COMPLETED|Overall Study||0
6505051|NCT01451437|7424145|FG005|COMPLETED|Overall Study||0
6505052|NCT01451437|7424146|FG006|COMPLETED|Overall Study||0
6505053|NCT01451437|7424147|FG007|COMPLETED|Overall Study||0
6505054|NCT01451437|7424148|FG008|COMPLETED|Overall Study||0
6505055|NCT01451437|7424140|FG000|NOT COMPLETED|Overall Study||1
6505056|NCT01451437|7424141|FG001|NOT COMPLETED|Overall Study||1
6505057|NCT01451437|7424142|FG002|NOT COMPLETED|Overall Study||3
6505058|NCT01451437|7424143|FG003|NOT COMPLETED|Overall Study||1
6505059|NCT01451437|7424144|FG004|NOT COMPLETED|Overall Study||4
6505060|NCT01451437|7424145|FG005|NOT COMPLETED|Overall Study||3
6505061|NCT01451437|7424146|FG006|NOT COMPLETED|Overall Study||6
6505062|NCT01451437|7424147|FG007|NOT COMPLETED|Overall Study||3
6505063|NCT01451437|7424148|FG008|NOT COMPLETED|Overall Study||4
6246834|NCT02607930|7146246|FG000|STARTED|Double-Blinded Treatment Phase||316
6246835|NCT02607930|7146247|FG001|STARTED|Double-Blinded Treatment Phase||315
6246836|NCT02607930|7146248|FG002|STARTED|Double-Blinded Treatment Phase||0
6246837|NCT02607930|7146249|FG003|STARTED|Double-Blinded Treatment Phase||0
6505064|NCT01451463|7424177|FG000|STARTED|Overall Study||11
6505065|NCT01451463|7424177|FG000|COMPLETED|Overall Study||11
6505066|NCT01451463|7424177|FG000|NOT COMPLETED|Overall Study||0
6505067|NCT01451541|7424189|FG000|STARTED|Overall Study||283
6505068|NCT01451541|7424190|FG001|STARTED|Overall Study||282
6505069|NCT01451541|7424191|FG002|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
6505070|NCT01451541|7424189|FG000|COMPLETED|Overall Study||247
6505071|NCT01451541|7424190|FG001|COMPLETED|Overall Study||257
6505072|NCT01451541|7424191|FG002|COMPLETED|Overall Study||254
6505073|NCT01451541|7424189|FG000|NOT COMPLETED|Overall Study||36
6505074|NCT01451541|7424190|FG001|NOT COMPLETED|Overall Study||25
6505075|NCT01451541|7424191|FG002|NOT COMPLETED|Overall Study||27
6505076|NCT01451554|7424203|FG000|STARTED|Overall Study||33
6505077|NCT01451554|7424204|FG001|STARTED|Overall Study||32
6505078|NCT01451554|7424203|FG000|COMPLETED|Overall Study||19
6505079|NCT01451554|7424204|FG001|COMPLETED|Overall Study||23
6505080|NCT01451554|7424203|FG000|NOT COMPLETED|Overall Study||14
6505081|NCT01451554|7424204|FG001|NOT COMPLETED|Overall Study||9
6505082|NCT01451606|7424212|FG000|STARTED|Overall Study||16
6505083|NCT01451606|7424213|FG001|STARTED|Overall Study||18
6505084|NCT01451606|7424212|FG000|COMPLETED|Overall Study||12
6505085|NCT01451606|7424213|FG001|COMPLETED|Overall Study||15
6505086|NCT01451606|7424212|FG000|NOT COMPLETED|Overall Study||4
6505087|NCT01451606|7424213|FG001|NOT COMPLETED|Overall Study||3
6505088|NCT01451632|7424221|FG000|STARTED|Overall Study||8
6505089|NCT01451632|7424222|FG001|STARTED|Overall Study||4
6505090|NCT01451632|7424223|FG002|STARTED|Overall Study||3
6505091|NCT01451632|7424224|FG003|STARTED|Overall Study||3
6505092|NCT01451632|7424225|FG004|STARTED|Overall Study||4
6505093|NCT01451632|7424226|FG005|STARTED|Overall Study||4
6505094|NCT01451632|7424227|FG006|STARTED|Overall Study||8
6505095|NCT01451632|7424228|FG007|STARTED|Overall Study||6
6505096|NCT01451632|7424229|FG008|STARTED|Overall Study||4
6505097|NCT01451632|7424230|FG009|STARTED|Overall Study||4
6505098|NCT01451632|7424221|FG000|COMPLETED|Overall Study||8
6505099|NCT01451632|7424222|FG001|COMPLETED|Overall Study||4
6505100|NCT01451632|7424223|FG002|COMPLETED|Overall Study||3
6505101|NCT01451632|7424224|FG003|COMPLETED|Overall Study||3
6505102|NCT01451632|7424225|FG004|COMPLETED|Overall Study||4
6505103|NCT01451632|7424226|FG005|COMPLETED|Overall Study||4
6505104|NCT01451632|7424227|FG006|COMPLETED|Overall Study||8
6505105|NCT01451632|7424228|FG007|COMPLETED|Overall Study||6
6505106|NCT01451632|7424229|FG008|COMPLETED|Overall Study||4
6505107|NCT01451632|7424230|FG009|COMPLETED|Overall Study||4
6505108|NCT01451632|7424221|FG000|NOT COMPLETED|Overall Study||0
6505109|NCT01451632|7424222|FG001|NOT COMPLETED|Overall Study||0
6505110|NCT01451632|7424223|FG002|NOT COMPLETED|Overall Study||0
6505111|NCT01451632|7424224|FG003|NOT COMPLETED|Overall Study||0
6505112|NCT01451632|7424225|FG004|NOT COMPLETED|Overall Study||0
6505113|NCT01451632|7424226|FG005|NOT COMPLETED|Overall Study||0
6505114|NCT01451632|7424227|FG006|NOT COMPLETED|Overall Study||0
6505115|NCT01451632|7424228|FG007|NOT COMPLETED|Overall Study||0
6505116|NCT01451632|7424229|FG008|NOT COMPLETED|Overall Study||0
6505117|NCT01451632|7424230|FG009|NOT COMPLETED|Overall Study||0
6505118|NCT01451645|7424257|FG000|STARTED|Overall Study||41
6505119|NCT01451645|7424258|FG001|STARTED|Overall Study||41
6505120|NCT01451645|7424257|FG000|COMPLETED|Overall Study||32
6505121|NCT01451645|7424258|FG001|COMPLETED|Overall Study||33
6505122|NCT01451645|7424257|FG000|NOT COMPLETED|Overall Study||9
6505123|NCT01451645|7424258|FG001|NOT COMPLETED|Overall Study||8
6505124|NCT01451749|7424266|FG000|STARTED|Overall Study||216
6505125|NCT01451749|7424267|FG001|STARTED|Overall Study||108
6505126|NCT01451749|7424266|FG000|COMPLETED|Overall Study||184
6505127|NCT01451749|7424267|FG001|COMPLETED|Overall Study||94
6505128|NCT01451749|7424266|FG000|NOT COMPLETED|Overall Study||32
6505129|NCT01451749|7424267|FG001|NOT COMPLETED|Overall Study||14
6505130|NCT01451762|7424278|FG000|STARTED|Overall Study||30
6505131|NCT01451762|7424279|FG001|STARTED|Overall Study||30
6505132|NCT01451762|7424280|FG002|STARTED|Overall Study||30
6505133|NCT01451762|7424278|FG000|COMPLETED|Overall Study||27
6505134|NCT01451762|7424279|FG001|COMPLETED|Overall Study||24
6505135|NCT01451762|7424280|FG002|COMPLETED|Overall Study||24
6505136|NCT01451762|7424278|FG000|NOT COMPLETED|Overall Study||3
6505137|NCT01451762|7424279|FG001|NOT COMPLETED|Overall Study||6
6505138|NCT01451762|7424280|FG002|NOT COMPLETED|Overall Study||6
6657425|NCT02469389|7587768|FG001|Completed 12-week Assessment|Overall Study|8 lost to contact or refused|44
6246838|NCT02607930|7146246|FG000|COMPLETED|Double-Blinded Treatment Phase||262
6246839|NCT02607930|7146247|FG001|COMPLETED|Double-Blinded Treatment Phase||262
6246840|NCT02607930|7146248|FG002|COMPLETED|Double-Blinded Treatment Phase||0
6246841|NCT02607930|7146249|FG003|COMPLETED|Double-Blinded Treatment Phase||0
6246842|NCT02607930|7146246|FG000|NOT COMPLETED|Double-Blinded Treatment Phase||54
6246843|NCT02607930|7146247|FG001|NOT COMPLETED|Double-Blinded Treatment Phase||53
6246844|NCT02607930|7146248|FG002|NOT COMPLETED|Double-Blinded Treatment Phase||0
6246845|NCT02607930|7146249|FG003|NOT COMPLETED|Double-Blinded Treatment Phase||0
6246846|NCT02607930|7146246|FG000|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
6246847|NCT02607930|7146247|FG001|STARTED|Open-Label B/F/TAF Extension Phase|At the End of Blinded Treatment Visit, participants were given the option to receive B/F/TAF FDC in an OL extension phase for up to 96 weeks.|0
6246848|NCT02607930|7146248|FG002|STARTED|Open-Label B/F/TAF Extension Phase|10 participants from B/F/TAF arm did not enter the Open-Label Extension Phase.|252
6246849|NCT02607930|7146249|FG003|STARTED|Open-Label B/F/TAF Extension Phase|8 participants from the ABC/DTG/3TC arm did not enter the Open-Label Extension Phase.|254
6246850|NCT02607930|7146246|FG000|COMPLETED|Open-Label B/F/TAF Extension Phase||0
6246851|NCT02607930|7146247|FG001|COMPLETED|Open-Label B/F/TAF Extension Phase||0
6246852|NCT02607930|7146248|FG002|COMPLETED|Open-Label B/F/TAF Extension Phase||218
6246853|NCT02607930|7146249|FG003|COMPLETED|Open-Label B/F/TAF Extension Phase||221
6246854|NCT02607930|7146246|FG000|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
6246855|NCT02607930|7146247|FG001|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||0
6246856|NCT02607930|7146248|FG002|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||34
6246857|NCT02607930|7146249|FG003|NOT COMPLETED|Open-Label B/F/TAF Extension Phase||33
6246858|NCT02580058|7146262|FG000|STARTED|Overall Study||188
6246859|NCT02580058|7146263|FG001|STARTED|Overall Study||188
6246860|NCT02580058|7146264|FG002|STARTED|Overall Study||190
6246861|NCT02580058|7146262|FG000|Treated|Overall Study||187
6246862|NCT02580058|7146263|FG001|Treated|Overall Study||182
6246863|NCT02580058|7146264|FG002|Treated|Overall Study||177
6246864|NCT02580058|7146262|FG000|COMPLETED|Overall Study||109
6246865|NCT02580058|7146263|FG001|COMPLETED|Overall Study||102
6246866|NCT02580058|7146264|FG002|COMPLETED|Overall Study||104
6246867|NCT02580058|7146262|FG000|NOT COMPLETED|Overall Study||79
6246868|NCT02580058|7146263|FG001|NOT COMPLETED|Overall Study||86
6246869|NCT02580058|7146264|FG002|NOT COMPLETED|Overall Study||86
6246870|NCT02578680|7146274|FG000|STARTED|Overall Study||410
6246871|NCT02578680|7146275|FG001|STARTED|Overall Study||206
6246872|NCT02578680|7146274|FG000|Treated|Overall Study||405
6246873|NCT02578680|7146275|FG001|Treated|Overall Study||202
6246874|NCT02578680|7146274|FG000|Switched to Pembrolizumab|Overall Study||0
6246875|NCT02578680|7146275|FG001|Switched to Pembrolizumab|Overall Study||67
6246876|NCT02578680|7146274|FG000|COMPLETED|Overall Study||0
6246877|NCT02578680|7146275|FG001|COMPLETED|Overall Study||0
6246878|NCT02578680|7146274|FG000|NOT COMPLETED|Overall Study||410
6246879|NCT02578680|7146275|FG001|NOT COMPLETED|Overall Study||206
6246880|NCT02568566|7146281|FG000|STARTED|Overall Study||201
6246881|NCT02568566|7146281|FG000|COMPLETED|Overall Study||187
6246882|NCT02568566|7146281|FG000|NOT COMPLETED|Overall Study||14
6276850|NCT00122317|7176130|FG000|NOT COMPLETED|Overall Study||11
6276851|NCT00122369|7176137|FG000|STARTED|Overall Study||76
6276852|NCT00122369|7176138|FG001|STARTED|Overall Study||82
6276853|NCT00122369|7176139|FG002|STARTED|Overall Study||78
6276854|NCT00122369|7176137|FG000|COMPLETED|Overall Study||76
6276855|NCT00122369|7176138|FG001|COMPLETED|Overall Study||82
6276856|NCT00122369|7176139|FG002|COMPLETED|Overall Study||78
6276857|NCT00122369|7176137|FG000|NOT COMPLETED|Overall Study||0
6276858|NCT00122369|7176138|FG001|NOT COMPLETED|Overall Study||0
6276859|NCT00122369|7176139|FG002|NOT COMPLETED|Overall Study||0
6276860|NCT00122382|7176152|FG000|STARTED|Double-Blind Study|participants randomized|256
6276861|NCT00122382|7176153|FG001|STARTED|Double-Blind Study|participants randomized|255
6276862|NCT00122382|7176154|FG002|STARTED|Double-Blind Study||0
6276863|NCT00122382|7176152|FG000|Treated|Double-Blind Study||256
6276864|NCT00122382|7176153|FG001|Treated|Double-Blind Study||253
6276865|NCT00122382|7176154|FG002|Treated|Double-Blind Study||0
6569517|NCT01846208|7492852|FG001|COMPLETED|Overall Study||20
6569518|NCT01846208|7492853|FG002|COMPLETED|Overall Study||32
6569519|NCT01846208|7492851|FG000|NOT COMPLETED|Overall Study||9
6569520|NCT01846208|7492852|FG001|NOT COMPLETED|Overall Study||4
6569521|NCT01846208|7492853|FG002|NOT COMPLETED|Overall Study||8
6569522|NCT01846221|7492863|FG000|STARTED|Overall Study||50
6569523|NCT01846221|7492864|FG001|STARTED|Overall Study||51
6569524|NCT01846221|7492863|FG000|COMPLETED|Overall Study||47
6569525|NCT01846221|7492864|FG001|COMPLETED|Overall Study||51
6569526|NCT01846221|7492863|FG000|NOT COMPLETED|Overall Study||3
6569527|NCT01846221|7492864|FG001|NOT COMPLETED|Overall Study||0
6569528|NCT01846299|7492872|FG000|STARTED|Overall Study||118
6569529|NCT01846299|7492873|FG001|STARTED|Overall Study||60
6569530|NCT01846299|7492872|FG000|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
6569531|NCT01846299|7492873|FG001|Full Analysis Set|Overall Study||60
6569532|NCT01846299|7492872|FG000|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
6569533|NCT01846299|7492873|FG001|Safety Set|Overall Study||58
6569534|NCT01846299|7492872|FG000|COMPLETED|Overall Study||106
6569535|NCT01846299|7492873|FG001|COMPLETED|Overall Study||50
6246883|NCT02476201|7146285|FG000|STARTED|Overall Study||105
6246884|NCT02476201|7146285|FG000|Implant Attempts|Overall Study||103
6246885|NCT02476201|7146285|FG000|Sucessful Implants|Overall Study||102
6246886|NCT02476201|7146285|FG000|6 Months Visit|Overall Study||82
6246887|NCT02476201|7146285|FG000|COMPLETED|Overall Study||79
6246888|NCT02476201|7146285|FG000|NOT COMPLETED|Overall Study||26
6246889|NCT02454933|7146292|FG000|STARTED|Overall Study||17
6246890|NCT02454933|7146293|FG001|STARTED|Overall Study|2 subjects switched to osimertinib monotherapy Cycle 1 Day 1|12
6246891|NCT02454933|7146292|FG000|Treatment Group Randomised to|Overall Study||15
6246892|NCT02454933|7146293|FG001|Treatment Group Randomised to|Overall Study||14
6246893|NCT02454933|7146292|FG000|COMPLETED|Overall Study||9
6246894|NCT02454933|7146293|FG001|COMPLETED|Overall Study||4
6246895|NCT02454933|7146292|FG000|NOT COMPLETED|Overall Study||8
6246896|NCT02454933|7146293|FG001|NOT COMPLETED|Overall Study||8
6246897|NCT02337751|7146300|FG000|STARTED|Overall Study||95
6246898|NCT02337751|7146301|FG001|STARTED|Overall Study||103
6246899|NCT02337751|7146300|FG000|COMPLETED|Overall Study||84
6246900|NCT02337751|7146301|FG001|COMPLETED|Overall Study||87
6246901|NCT02337751|7146300|FG000|NOT COMPLETED|Overall Study||11
6246902|NCT02337751|7146301|FG001|NOT COMPLETED|Overall Study||16
6246903|NCT02337725|7146310|FG000|STARTED|Overall Study||126
6246904|NCT02337725|7146311|FG001|STARTED|Overall Study||118
6246905|NCT02337725|7146310|FG000|COMPLETED|Overall Study||100
6246906|NCT02337725|7146311|FG001|COMPLETED|Overall Study||110
6246907|NCT02337725|7146310|FG000|NOT COMPLETED|Overall Study||26
6246908|NCT02337725|7146311|FG001|NOT COMPLETED|Overall Study||8
6276866|NCT00122382|7176152|FG000|COMPLETED|Double-Blind Study||232
6276867|NCT00122382|7176153|FG001|COMPLETED|Double-Blind Study||227
6276868|NCT00122382|7176154|FG002|COMPLETED|Double-Blind Study||0
6276869|NCT00122382|7176152|FG000|NOT COMPLETED|Double-Blind Study||24
6276870|NCT00122382|7176153|FG001|NOT COMPLETED|Double-Blind Study||28
6276871|NCT00122382|7176154|FG002|NOT COMPLETED|Double-Blind Study||0
6276872|NCT00122382|7176152|FG000|STARTED|Open-Label Study||0
6276873|NCT00122382|7176153|FG001|STARTED|Open-Label Study||0
6276874|NCT00122382|7176154|FG002|STARTED|Open-Label Study||459
6276875|NCT00122382|7176152|FG000|COMPLETED|Open-Label Study||0
6276876|NCT00122382|7176153|FG001|COMPLETED|Open-Label Study||0
6276877|NCT00122382|7176154|FG002|COMPLETED|Open-Label Study||433
6276878|NCT00122382|7176152|FG000|NOT COMPLETED|Open-Label Study||0
6276879|NCT00122382|7176153|FG001|NOT COMPLETED|Open-Label Study||0
6276880|NCT00122382|7176154|FG002|NOT COMPLETED|Open-Label Study||26
6276881|NCT00122447|7176176|FG000|STARTED|Overall Study||18
6276882|NCT00122447|7176177|FG001|STARTED|Overall Study||18
6276883|NCT00122447|7176178|FG002|STARTED|Overall Study||17
6276884|NCT00122447|7176179|FG003|STARTED|Overall Study||17
6276885|NCT00122447|7176176|FG000|COMPLETED|Overall Study||17
6276886|NCT00122447|7176177|FG001|COMPLETED|Overall Study||13
6276887|NCT00122447|7176178|FG002|COMPLETED|Overall Study||16
6276888|NCT00122447|7176179|FG003|COMPLETED|Overall Study||14
6276889|NCT00122447|7176176|FG000|NOT COMPLETED|Overall Study||1
6276890|NCT00122447|7176177|FG001|NOT COMPLETED|Overall Study||5
6276891|NCT00122447|7176178|FG002|NOT COMPLETED|Overall Study||1
6276892|NCT00122447|7176179|FG003|NOT COMPLETED|Overall Study||3
6276893|NCT00122460|7176195|FG000|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
6276894|NCT00122460|7176196|FG001|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
6276895|NCT00122460|7176195|FG000|COMPLETED|Overall Study||215
6276896|NCT00122460|7176196|FG001|COMPLETED|Overall Study||219
6276897|NCT00122460|7176195|FG000|NOT COMPLETED|Overall Study||7
6276898|NCT00122460|7176196|FG001|NOT COMPLETED|Overall Study||1
6505139|NCT01451775|7424288|FG000|STARTED|Overall Study||3
6505140|NCT01451775|7424289|FG001|STARTED|Overall Study||3
6505141|NCT01451775|7424290|FG002|STARTED|Overall Study||3
6505142|NCT01451775|7424291|FG003|STARTED|Overall Study||3
6505143|NCT01451775|7424292|FG004|STARTED|Overall Study||3
6505144|NCT01451775|7424293|FG005|STARTED|Overall Study||3
6505145|NCT01451775|7424288|FG000|COMPLETED|Overall Study||3
6505146|NCT01451775|7424289|FG001|COMPLETED|Overall Study||3
6505147|NCT01451775|7424290|FG002|COMPLETED|Overall Study||3
6505148|NCT01451775|7424291|FG003|COMPLETED|Overall Study||3
6246909|NCT02332655|7146317|FG000|STARTED|Overall Study||5
6246910|NCT02332655|7146317|FG000|COMPLETED|Overall Study||4
6246911|NCT02332655|7146317|FG000|NOT COMPLETED|Overall Study||1
6246912|NCT02184195|7146323|FG000|STARTED|Overall Study||92
6246913|NCT02184195|7146324|FG001|STARTED|Overall Study||62
6246914|NCT02184195|7146323|FG000|COMPLETED|Overall Study||49
6246915|NCT02184195|7146324|FG001|COMPLETED|Overall Study||27
6246916|NCT02184195|7146323|FG000|NOT COMPLETED|Overall Study||43
6246917|NCT02184195|7146324|FG001|NOT COMPLETED|Overall Study||35
6246918|NCT02130687|7146333|FG000|STARTED|Washout||36
6246919|NCT02130687|7146334|FG001|STARTED|Washout||35
6246920|NCT02130687|7146335|FG002|STARTED|Washout||35
6246921|NCT02130687|7146333|FG000|COMPLETED|Washout||36
6246922|NCT02130687|7146334|FG001|COMPLETED|Washout||33
6246923|NCT02130687|7146335|FG002|COMPLETED|Washout||31
6246924|NCT02130687|7146333|FG000|NOT COMPLETED|Washout||0
6246925|NCT02130687|7146334|FG001|NOT COMPLETED|Washout||2
6246926|NCT02130687|7146335|FG002|NOT COMPLETED|Washout||4
6246927|NCT02130687|7146333|FG000|STARTED|Drug 1 Only||36
6246928|NCT02130687|7146334|FG001|STARTED|Drug 1 Only||33
6569536|NCT01846299|7492872|FG000|NOT COMPLETED|Overall Study||12
6569537|NCT01846299|7492873|FG001|NOT COMPLETED|Overall Study||10
6569538|NCT01846416|7492884|FG000|STARTED|Treatment Phase||31
6246929|NCT02130687|7146335|FG002|STARTED|Drug 1 Only||31
6246930|NCT02130687|7146333|FG000|COMPLETED|Drug 1 Only||33
6246931|NCT02130687|7146334|FG001|COMPLETED|Drug 1 Only||30
6246932|NCT02130687|7146335|FG002|COMPLETED|Drug 1 Only||30
6246933|NCT02130687|7146333|FG000|NOT COMPLETED|Drug 1 Only||3
6246934|NCT02130687|7146334|FG001|NOT COMPLETED|Drug 1 Only||3
6246935|NCT02130687|7146335|FG002|NOT COMPLETED|Drug 1 Only||1
6246936|NCT02130687|7146333|FG000|STARTED|Crossover Period 1||33
6246937|NCT02130687|7146334|FG001|STARTED|Crossover Period 1||30
6246938|NCT02130687|7146335|FG002|STARTED|Crossover Period 1||30
6246939|NCT02130687|7146333|FG000|COMPLETED|Crossover Period 1||33
6246940|NCT02130687|7146334|FG001|COMPLETED|Crossover Period 1||30
6246941|NCT02130687|7146335|FG002|COMPLETED|Crossover Period 1||30
6246942|NCT02130687|7146333|FG000|NOT COMPLETED|Crossover Period 1||0
6246943|NCT02130687|7146334|FG001|NOT COMPLETED|Crossover Period 1||0
6246944|NCT02130687|7146335|FG002|NOT COMPLETED|Crossover Period 1||0
6246945|NCT02130687|7146333|FG000|STARTED|Drug 1 Only Between Periods 1 and 2||33
6246946|NCT02130687|7146334|FG001|STARTED|Drug 1 Only Between Periods 1 and 2||30
6246947|NCT02130687|7146335|FG002|STARTED|Drug 1 Only Between Periods 1 and 2||30
6246948|NCT02130687|7146333|FG000|COMPLETED|Drug 1 Only Between Periods 1 and 2||33
6246949|NCT02130687|7146334|FG001|COMPLETED|Drug 1 Only Between Periods 1 and 2||26
6246950|NCT02130687|7146335|FG002|COMPLETED|Drug 1 Only Between Periods 1 and 2||29
6246951|NCT02130687|7146333|FG000|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||0
6246952|NCT02130687|7146334|FG001|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||4
6246953|NCT02130687|7146335|FG002|NOT COMPLETED|Drug 1 Only Between Periods 1 and 2||1
6246954|NCT02130687|7146333|FG000|STARTED|Crossover Period 2||33
6246955|NCT02130687|7146334|FG001|STARTED|Crossover Period 2||26
6246956|NCT02130687|7146335|FG002|STARTED|Crossover Period 2||29
6246957|NCT02130687|7146333|FG000|COMPLETED|Crossover Period 2||33
6246958|NCT02130687|7146334|FG001|COMPLETED|Crossover Period 2||26
6246959|NCT02130687|7146335|FG002|COMPLETED|Crossover Period 2||29
6246960|NCT02130687|7146333|FG000|NOT COMPLETED|Crossover Period 2||0
6246961|NCT02130687|7146334|FG001|NOT COMPLETED|Crossover Period 2||0
6246962|NCT02130687|7146335|FG002|NOT COMPLETED|Crossover Period 2||0
6246963|NCT02130687|7146333|FG000|STARTED|Drug 1 Only Between Periods 2 and 3||33
6246964|NCT02130687|7146334|FG001|STARTED|Drug 1 Only Between Periods 2 and 3||26
6246965|NCT02130687|7146335|FG002|STARTED|Drug 1 Only Between Periods 2 and 3||29
6246966|NCT02130687|7146333|FG000|COMPLETED|Drug 1 Only Between Periods 2 and 3||33
6246967|NCT02130687|7146334|FG001|COMPLETED|Drug 1 Only Between Periods 2 and 3||25
6246968|NCT02130687|7146335|FG002|COMPLETED|Drug 1 Only Between Periods 2 and 3||27
6246969|NCT02130687|7146333|FG000|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||0
6246970|NCT02130687|7146334|FG001|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||1
6246971|NCT02130687|7146335|FG002|NOT COMPLETED|Drug 1 Only Between Periods 2 and 3||2
6246972|NCT02130687|7146333|FG000|STARTED|Crossover Period 3||33
6246973|NCT02130687|7146334|FG001|STARTED|Crossover Period 3||25
6246974|NCT02130687|7146335|FG002|STARTED|Crossover Period 3||27
6246975|NCT02130687|7146333|FG000|COMPLETED|Crossover Period 3||33
6246976|NCT02130687|7146334|FG001|COMPLETED|Crossover Period 3||25
6246977|NCT02130687|7146335|FG002|COMPLETED|Crossover Period 3||27
6246978|NCT02130687|7146333|FG000|NOT COMPLETED|Crossover Period 3||0
6246979|NCT02130687|7146334|FG001|NOT COMPLETED|Crossover Period 3||0
6246980|NCT02130687|7146335|FG002|NOT COMPLETED|Crossover Period 3||0
6276899|NCT00122681|7176204|FG000|STARTED|Overall Study||9325
6276900|NCT00122681|7176205|FG001|STARTED|Overall Study||9319
6276901|NCT00122681|7176204|FG000|COMPLETED|Overall Study||7811
6276902|NCT00122681|7176205|FG001|COMPLETED|Overall Study||7798
6276903|NCT00122681|7176204|FG000|NOT COMPLETED|Overall Study||1514
6276904|NCT00122681|7176205|FG001|NOT COMPLETED|Overall Study||1521
6276905|NCT00122954|7176221|FG000|STARTED|Overall Study||18
6276906|NCT00122954|7176222|FG001|STARTED|Overall Study||21
6276907|NCT00122954|7176221|FG000|COMPLETED|Overall Study||16
6276908|NCT00122954|7176222|FG001|COMPLETED|Overall Study||18
6276909|NCT00122954|7176221|FG000|NOT COMPLETED|Overall Study||2
6276910|NCT00122954|7176222|FG001|NOT COMPLETED|Overall Study||3
6276911|NCT00122980|7176230|FG000|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
6276912|NCT00122980|7176231|FG001|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
6276913|NCT00122980|7176230|FG000|COMPLETED|Overall Study|Study terminated early|24
6276914|NCT00122980|7176231|FG001|COMPLETED|Overall Study|Study terminated early|26
6276915|NCT00122980|7176230|FG000|NOT COMPLETED|Overall Study||43
6276916|NCT00122980|7176231|FG001|NOT COMPLETED|Overall Study||40
6569539|NCT01846416|7492885|FG001|STARTED|Treatment Phase||93
6569540|NCT01846416|7492886|FG002|STARTED|Treatment Phase||13
6246981|NCT01994382|7146378|FG000|STARTED|Overall Study||3
6246982|NCT01994382|7146379|FG001|STARTED|Overall Study||6
6246983|NCT01994382|7146380|FG002|STARTED|Overall Study||7
6246984|NCT01994382|7146381|FG003|STARTED|Overall Study||3
6246985|NCT01994382|7146382|FG004|STARTED|Overall Study||3
6246986|NCT01994382|7146383|FG005|STARTED|Overall Study||3
6246987|NCT01994382|7146384|FG006|STARTED|Overall Study||4
6246988|NCT01994382|7146385|FG007|STARTED|Overall Study||6
6246989|NCT01994382|7146386|FG008|STARTED|Overall Study||3
6246990|NCT01994382|7146387|FG009|STARTED|Overall Study||5
6246991|NCT01994382|7146388|FG010|STARTED|Overall Study||42
6246992|NCT01994382|7146389|FG011|STARTED|Overall Study||12
6246993|NCT01994382|7146390|FG012|STARTED|Overall Study||26
6246994|NCT01994382|7146391|FG013|STARTED|Overall Study||6
6246995|NCT01994382|7146392|FG014|STARTED|Overall Study||28
6246996|NCT01994382|7146393|FG015|STARTED|Overall Study||65
6246997|NCT01994382|7146394|FG016|STARTED|Overall Study||41
6246998|NCT01994382|7146378|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6246999|NCT01994382|7146379|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6247000|NCT01994382|7146380|FG002|Received at Least 1 Dose of Study Drug|Overall Study||7
6247001|NCT01994382|7146381|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6247002|NCT01994382|7146382|FG004|Received at Least 1 Dose of Study Drug|Overall Study||3
6247003|NCT01994382|7146383|FG005|Received at Least 1 Dose of Study Drug|Overall Study||3
6247004|NCT01994382|7146384|FG006|Received at Least 1 Dose of Study Drug|Overall Study||4
6247005|NCT01994382|7146385|FG007|Received at Least 1 Dose of Study Drug|Overall Study||6
6247006|NCT01994382|7146386|FG008|Received at Least 1 Dose of Study Drug|Overall Study||3
6247007|NCT01994382|7146387|FG009|Received at Least 1 Dose of Study Drug|Overall Study||5
6247008|NCT01994382|7146388|FG010|Received at Least 1 Dose of Study Drug|Overall Study||42
6247009|NCT01994382|7146389|FG011|Received at Least 1 Dose of Study Drug|Overall Study||12
6247010|NCT01994382|7146390|FG012|Received at Least 1 Dose of Study Drug|Overall Study||26
6247011|NCT01994382|7146391|FG013|Received at Least 1 Dose of Study Drug|Overall Study||6
6247012|NCT01994382|7146392|FG014|Received at Least 1 Dose of Study Drug|Overall Study||28
6247013|NCT01994382|7146393|FG015|Received at Least 1 Dose of Study Drug|Overall Study||65
6247014|NCT01994382|7146394|FG016|Received at Least 1 Dose of Study Drug|Overall Study||41
6247015|NCT01994382|7146378|FG000|COMPLETED|Overall Study||0
6247016|NCT01994382|7146379|FG001|COMPLETED|Overall Study||0
6247017|NCT01994382|7146380|FG002|COMPLETED|Overall Study||0
6247018|NCT01994382|7146381|FG003|COMPLETED|Overall Study||0
6247019|NCT01994382|7146382|FG004|COMPLETED|Overall Study||0
6247020|NCT01994382|7146383|FG005|COMPLETED|Overall Study||0
6247021|NCT01994382|7146384|FG006|COMPLETED|Overall Study||0
6247022|NCT01994382|7146385|FG007|COMPLETED|Overall Study||0
6247023|NCT01994382|7146386|FG008|COMPLETED|Overall Study||0
6247024|NCT01994382|7146387|FG009|COMPLETED|Overall Study||0
6569541|NCT01846416|7492884|FG000|COMPLETED|Treatment Phase||0
6569542|NCT01846416|7492885|FG001|COMPLETED|Treatment Phase||0
6569543|NCT01846416|7492886|FG002|COMPLETED|Treatment Phase||0
6569544|NCT01846416|7492884|FG000|NOT COMPLETED|Treatment Phase||31
6569545|NCT01846416|7492885|FG001|NOT COMPLETED|Treatment Phase||93
6569546|NCT01846416|7492886|FG002|NOT COMPLETED|Treatment Phase||13
6569547|NCT01846416|7492884|FG000|STARTED|Survival Follow-up||28
6569548|NCT01846416|7492885|FG001|STARTED|Survival Follow-up||80
6569549|NCT01846416|7492886|FG002|STARTED|Survival Follow-up||12
6247025|NCT01994382|7146388|FG010|COMPLETED|Overall Study||0
6247026|NCT01994382|7146389|FG011|COMPLETED|Overall Study||0
6247027|NCT01994382|7146390|FG012|COMPLETED|Overall Study||0
6247028|NCT01994382|7146391|FG013|COMPLETED|Overall Study||0
6247029|NCT01994382|7146392|FG014|COMPLETED|Overall Study||0
6247030|NCT01994382|7146393|FG015|COMPLETED|Overall Study||0
6247031|NCT01994382|7146394|FG016|COMPLETED|Overall Study||0
6247032|NCT01994382|7146378|FG000|NOT COMPLETED|Overall Study||3
6247033|NCT01994382|7146379|FG001|NOT COMPLETED|Overall Study||6
6247034|NCT01994382|7146380|FG002|NOT COMPLETED|Overall Study||7
6247035|NCT01994382|7146381|FG003|NOT COMPLETED|Overall Study||3
6247036|NCT01994382|7146382|FG004|NOT COMPLETED|Overall Study||3
6247037|NCT01994382|7146383|FG005|NOT COMPLETED|Overall Study||3
6247038|NCT01994382|7146384|FG006|NOT COMPLETED|Overall Study||4
6247039|NCT01994382|7146385|FG007|NOT COMPLETED|Overall Study||6
6247040|NCT01994382|7146386|FG008|NOT COMPLETED|Overall Study||3
6247041|NCT01994382|7146387|FG009|NOT COMPLETED|Overall Study||5
6247042|NCT01994382|7146388|FG010|NOT COMPLETED|Overall Study||42
6247043|NCT01994382|7146389|FG011|NOT COMPLETED|Overall Study||12
6247044|NCT01994382|7146390|FG012|NOT COMPLETED|Overall Study||26
6247045|NCT01994382|7146391|FG013|NOT COMPLETED|Overall Study||6
6247046|NCT01994382|7146392|FG014|NOT COMPLETED|Overall Study||28
6505149|NCT01451775|7424292|FG004|COMPLETED|Overall Study||3
6505150|NCT01451775|7424293|FG005|COMPLETED|Overall Study||3
6247047|NCT01994382|7146393|FG015|NOT COMPLETED|Overall Study||65
6247048|NCT01994382|7146394|FG016|NOT COMPLETED|Overall Study||41
6505151|NCT01451775|7424288|FG000|NOT COMPLETED|Overall Study||0
6505152|NCT01451775|7424289|FG001|NOT COMPLETED|Overall Study||0
6276917|NCT00123110|7176240|FG000|STARTED|Overall Study||12
6505153|NCT01451775|7424290|FG002|NOT COMPLETED|Overall Study||0
6505154|NCT01451775|7424291|FG003|NOT COMPLETED|Overall Study||0
6505155|NCT01451775|7424292|FG004|NOT COMPLETED|Overall Study||0
6505156|NCT01451775|7424293|FG005|NOT COMPLETED|Overall Study||0
6505157|NCT01451814|7424303|FG000|STARTED|Overall Study||35
6276918|NCT00123110|7176241|FG001|STARTED|Overall Study||12
6276919|NCT00123110|7176242|FG002|STARTED|Overall Study||11
6276920|NCT00123110|7176240|FG000|COMPLETED|Overall Study||12
6276921|NCT00123110|7176241|FG001|COMPLETED|Overall Study||12
6276922|NCT00123110|7176242|FG002|COMPLETED|Overall Study||11
6505158|NCT01451814|7424304|FG001|STARTED|Overall Study||31
6505159|NCT01451814|7424303|FG000|Attended a Session|Overall Study||35
6247049|NCT01896531|7146439|FG000|STARTED|Overall Study||71
6247050|NCT01896531|7146440|FG001|STARTED|Overall Study||82
6247051|NCT01896531|7146439|FG000|Treated|Overall Study||70
6247052|NCT01896531|7146440|FG001|Treated|Overall Study||82
6247053|NCT01896531|7146439|FG000|COMPLETED|Overall Study||0
6247054|NCT01896531|7146440|FG001|COMPLETED|Overall Study||0
6247055|NCT01896531|7146439|FG000|NOT COMPLETED|Overall Study||71
6247056|NCT01896531|7146440|FG001|NOT COMPLETED|Overall Study||82
6247057|NCT01864603|7146448|FG000|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|79818
6247058|NCT01864603|7146449|FG001|STARTED|Stage 1|Describes # of participants who were residents and aged 15+yrs at baseline|70577
6247059|NCT01864603|7146448|FG000|COMPLETED|Stage 1||71028
6247060|NCT01864603|7146449|FG001|COMPLETED|Stage 1||62912
6247061|NCT01864603|7146448|FG000|NOT COMPLETED|Stage 1||8790
6247062|NCT01864603|7146449|FG001|NOT COMPLETED|Stage 1||7665
6247063|NCT01864603|7146448|FG000|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|91533
6276923|NCT00123110|7176240|FG000|NOT COMPLETED|Overall Study||0
6247064|NCT01864603|7146449|FG001|STARTED|Stage 2|Describes # of participants who were residents and aged 15+yrs at the start of Stage 2|92558
6247065|NCT01864603|7146448|FG000|COMPLETED|Stage 2||5477
6247066|NCT01864603|7146449|FG001|COMPLETED|Stage 2||0
6247067|NCT01864603|7146448|FG000|NOT COMPLETED|Stage 2||86056
6247068|NCT01864603|7146449|FG001|NOT COMPLETED|Stage 2||92558
6276924|NCT00123110|7176241|FG001|NOT COMPLETED|Overall Study||0
6276925|NCT00123110|7176242|FG002|NOT COMPLETED|Overall Study||0
6276926|NCT00123123|7176253|FG000|STARTED|Overall Study||59
6276927|NCT00123123|7176254|FG001|STARTED|Overall Study||58
6276928|NCT00123123|7176255|FG002|STARTED|Overall Study||58
6276929|NCT00123123|7176253|FG000|COMPLETED|Overall Study||59
6276930|NCT00123123|7176254|FG001|COMPLETED|Overall Study||58
6276931|NCT00123123|7176255|FG002|COMPLETED|Overall Study||58
6276932|NCT00123123|7176253|FG000|NOT COMPLETED|Overall Study||0
6276933|NCT00123123|7176254|FG001|NOT COMPLETED|Overall Study||0
6276934|NCT00123123|7176255|FG002|NOT COMPLETED|Overall Study||0
6276935|NCT00123162|7176265|FG000|STARTED|Overall Study||13
6276936|NCT00123162|7176266|FG001|STARTED|Overall Study||12
6276937|NCT00123162|7176265|FG000|COMPLETED|Overall Study||13
6276938|NCT00123162|7176266|FG001|COMPLETED|Overall Study||12
6276939|NCT00123162|7176265|FG000|NOT COMPLETED|Overall Study||0
6276940|NCT00123162|7176266|FG001|NOT COMPLETED|Overall Study||0
6276941|NCT00123409|7176274|FG000|STARTED|Overall Study||72
6276942|NCT00123409|7176275|FG001|STARTED|Overall Study||74
6276943|NCT00123409|7176274|FG000|COMPLETED|Overall Study||68
6276944|NCT00123409|7176275|FG001|COMPLETED|Overall Study||71
6276945|NCT00123409|7176274|FG000|NOT COMPLETED|Overall Study||4
6276946|NCT00123409|7176275|FG001|NOT COMPLETED|Overall Study||3
6276947|NCT00123422|7176286|FG000|STARTED|Overall Study||35
6276948|NCT00123422|7176287|FG001|STARTED|Overall Study||33
6276949|NCT00123422|7176288|FG002|STARTED|Overall Study||35
6276950|NCT00123422|7176286|FG000|8-week Testing|Overall Study||32
6276951|NCT00123422|7176287|FG001|8-week Testing|Overall Study||30
6276952|NCT00123422|7176288|FG002|8-week Testing|Overall Study||27
6276953|NCT00123422|7176286|FG000|COMPLETED|Overall Study||31
6276954|NCT00123422|7176287|FG001|COMPLETED|Overall Study||27
6276955|NCT00123422|7176288|FG002|COMPLETED|Overall Study||25
6276956|NCT00123422|7176286|FG000|NOT COMPLETED|Overall Study||4
6276957|NCT00123422|7176287|FG001|NOT COMPLETED|Overall Study||6
6276958|NCT00123422|7176288|FG002|NOT COMPLETED|Overall Study||10
6276959|NCT00123474|7176300|FG000|STARTED|Randomized to Treatment||167
6276960|NCT00123474|7176301|FG001|STARTED|Randomized to Treatment||167
6276961|NCT00123474|7176302|FG002|STARTED|Randomized to Treatment||168
6276962|NCT00123474|7176303|FG003|STARTED|Randomized to Treatment||168
6276963|NCT00123474|7176300|FG000|COMPLETED|Randomized to Treatment||166
6276964|NCT00123474|7176301|FG001|COMPLETED|Randomized to Treatment||163
6276965|NCT00123474|7176302|FG002|COMPLETED|Randomized to Treatment||166
6276966|NCT00123474|7176303|FG003|COMPLETED|Randomized to Treatment||167
6276967|NCT00123474|7176300|FG000|NOT COMPLETED|Randomized to Treatment||1
6276968|NCT00123474|7176301|FG001|NOT COMPLETED|Randomized to Treatment||4
6276969|NCT00123474|7176302|FG002|NOT COMPLETED|Randomized to Treatment||2
6276970|NCT00123474|7176303|FG003|NOT COMPLETED|Randomized to Treatment||1
6276971|NCT00123474|7176300|FG000|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
6505160|NCT01451814|7424304|FG001|Attended a Session|Overall Study||31
6505161|NCT01451814|7424303|FG000|COMPLETED|Overall Study||29
6505162|NCT01451814|7424304|FG001|COMPLETED|Overall Study||26
6505163|NCT01451814|7424303|FG000|NOT COMPLETED|Overall Study||6
6505164|NCT01451814|7424304|FG001|NOT COMPLETED|Overall Study||5
6505165|NCT01451827|7424314|FG000|STARTED|Overall Study||45
6505166|NCT01451827|7424315|FG001|STARTED|Overall Study||45
6505167|NCT01451827|7424316|FG002|STARTED|Overall Study||44
6505168|NCT01451827|7424317|FG003|STARTED|Overall Study||43
6505169|NCT01451827|7424314|FG000|COMPLETED|Overall Study||42
6505170|NCT01451827|7424315|FG001|COMPLETED|Overall Study||40
6505171|NCT01451827|7424316|FG002|COMPLETED|Overall Study||42
6505172|NCT01451827|7424317|FG003|COMPLETED|Overall Study||39
6505173|NCT01451827|7424314|FG000|NOT COMPLETED|Overall Study||3
6505174|NCT01451827|7424315|FG001|NOT COMPLETED|Overall Study||5
6505175|NCT01451827|7424316|FG002|NOT COMPLETED|Overall Study||2
6505176|NCT01451827|7424317|FG003|NOT COMPLETED|Overall Study||4
6505177|NCT01451931|7424330|FG000|STARTED|Overall Study||909
6505178|NCT01451931|7424331|FG001|STARTED|Overall Study||901
6505179|NCT01451931|7424332|FG002|STARTED|Overall Study||966
6505180|NCT01451931|7424330|FG000|Baseline Data Collection|Overall Study||908
6505181|NCT01451931|7424331|FG001|Baseline Data Collection|Overall Study||893
6505182|NCT01451931|7424332|FG002|Baseline Data Collection|Overall Study||958
6505183|NCT01451931|7424330|FG000|6-month Follow up|Overall Study||876
6505184|NCT01451931|7424331|FG001|6-month Follow up|Overall Study||843
6505185|NCT01451931|7424332|FG002|6-month Follow up|Overall Study||923
6505186|NCT01451931|7424330|FG000|COMPLETED|Overall Study||876
6505187|NCT01451931|7424331|FG001|COMPLETED|Overall Study||843
6505188|NCT01451931|7424332|FG002|COMPLETED|Overall Study||923
6505189|NCT01451931|7424330|FG000|NOT COMPLETED|Overall Study||33
6505190|NCT01451931|7424331|FG001|NOT COMPLETED|Overall Study||58
6505191|NCT01451931|7424332|FG002|NOT COMPLETED|Overall Study||43
6505192|NCT01451983|7424345|FG000|STARTED|Overall Study||26
6247069|NCT01399658|7146460|FG000|STARTED|Overall Study||93
6247070|NCT01399658|7146460|FG000|COMPLETED|Overall Study||87
6247071|NCT01399658|7146460|FG000|NOT COMPLETED|Overall Study||6
6247072|NCT01397968|7146466|FG000|STARTED|Double-blind Period of Study YKP3089C013||113
6247073|NCT01397968|7146467|FG001|STARTED|Double-blind Period of Study YKP3089C013||109
6247074|NCT01397968|7146466|FG000|COMPLETED|Double-blind Period of Study YKP3089C013||102
6247075|NCT01397968|7146467|FG001|COMPLETED|Double-blind Period of Study YKP3089C013||99
6247076|NCT01397968|7146466|FG000|NOT COMPLETED|Double-blind Period of Study YKP3089C013||11
6247077|NCT01397968|7146467|FG001|NOT COMPLETED|Double-blind Period of Study YKP3089C013||10
6247078|NCT01397968|7146466|FG000|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|76
6247079|NCT01397968|7146467|FG001|STARTED|Open-label Extension Study YKP3089C013|Not all subjects from double-blind rolled over to open-label.|73
6247080|NCT01397968|7146466|FG000|COMPLETED|Open-label Extension Study YKP3089C013||40
6247081|NCT01397968|7146467|FG001|COMPLETED|Open-label Extension Study YKP3089C013||37
6247082|NCT01397968|7146466|FG000|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
6247083|NCT01397968|7146467|FG001|NOT COMPLETED|Open-label Extension Study YKP3089C013||36
6247093|NCT01169259|7146492|FG000|STARTED|Overall Study||6463
6247094|NCT01169259|7146493|FG001|STARTED|Overall Study||6464
6247095|NCT01169259|7146494|FG002|STARTED|Overall Study||6470
6247096|NCT01169259|7146495|FG003|STARTED|Overall Study||6474
6247097|NCT01169259|7146492|FG000|COMPLETED|Overall Study||6463
6247098|NCT01169259|7146493|FG001|COMPLETED|Overall Study||6464
6247099|NCT01169259|7146494|FG002|COMPLETED|Overall Study||6470
6569550|NCT01846416|7492884|FG000|COMPLETED|Survival Follow-up||0
6569551|NCT01846416|7492885|FG001|COMPLETED|Survival Follow-up||0
6569552|NCT01846416|7492886|FG002|COMPLETED|Survival Follow-up||0
6569553|NCT01846416|7492884|FG000|NOT COMPLETED|Survival Follow-up||28
6569554|NCT01846416|7492885|FG001|NOT COMPLETED|Survival Follow-up||80
6569555|NCT01846416|7492886|FG002|NOT COMPLETED|Survival Follow-up||12
6569556|NCT01846442|7492899|FG000|STARTED|Overall Study||54
6569557|NCT01846442|7492900|FG001|STARTED|Overall Study||54
6569558|NCT01846442|7492901|FG002|STARTED|Overall Study||56
6569559|NCT01846442|7492902|FG003|STARTED|Overall Study||54
6247100|NCT01169259|7146495|FG003|COMPLETED|Overall Study||6474
6247101|NCT01169259|7146492|FG000|NOT COMPLETED|Overall Study||0
6247102|NCT01169259|7146493|FG001|NOT COMPLETED|Overall Study||0
6247103|NCT01169259|7146494|FG002|NOT COMPLETED|Overall Study||0
6247104|NCT01169259|7146495|FG003|NOT COMPLETED|Overall Study||0
6247105|NCT00966953|7146511|FG000|STARTED|1st Intervention||6
6247106|NCT00966953|7146512|FG001|STARTED|1st Intervention||6
6247107|NCT00966953|7146513|FG002|STARTED|1st Intervention||6
6247108|NCT00966953|7146514|FG003|STARTED|1st Intervention||7
6247109|NCT00966953|7146511|FG000|COMPLETED|1st Intervention||6
6247110|NCT00966953|7146512|FG001|COMPLETED|1st Intervention||6
6247111|NCT00966953|7146513|FG002|COMPLETED|1st Intervention||6
6247112|NCT00966953|7146514|FG003|COMPLETED|1st Intervention||7
6247113|NCT00966953|7146511|FG000|NOT COMPLETED|1st Intervention||0
6247114|NCT00966953|7146512|FG001|NOT COMPLETED|1st Intervention||0
6247115|NCT00966953|7146513|FG002|NOT COMPLETED|1st Intervention||0
6247116|NCT00966953|7146514|FG003|NOT COMPLETED|1st Intervention||0
6247117|NCT00966953|7146511|FG000|STARTED|1 Week Washout After 1st Intervention||6
6247118|NCT00966953|7146512|FG001|STARTED|1 Week Washout After 1st Intervention||6
6247119|NCT00966953|7146513|FG002|STARTED|1 Week Washout After 1st Intervention||6
6247120|NCT00966953|7146514|FG003|STARTED|1 Week Washout After 1st Intervention||7
6247121|NCT00966953|7146511|FG000|COMPLETED|1 Week Washout After 1st Intervention||6
6247122|NCT00966953|7146512|FG001|COMPLETED|1 Week Washout After 1st Intervention||6
6247123|NCT00966953|7146513|FG002|COMPLETED|1 Week Washout After 1st Intervention||6
6247124|NCT00966953|7146514|FG003|COMPLETED|1 Week Washout After 1st Intervention||7
6247125|NCT00966953|7146511|FG000|NOT COMPLETED|1 Week Washout After 1st Intervention||0
6247126|NCT00966953|7146512|FG001|NOT COMPLETED|1 Week Washout After 1st Intervention||0
6247127|NCT00966953|7146513|FG002|NOT COMPLETED|1 Week Washout After 1st Intervention||0
6247128|NCT00966953|7146514|FG003|NOT COMPLETED|1 Week Washout After 1st Intervention||0
6569560|NCT01846442|7492899|FG000|Safety Population|Overall Study||54
6569561|NCT01846442|7492900|FG001|Safety Population|Overall Study||53
6569562|NCT01846442|7492901|FG002|Safety Population|Overall Study||56
6569563|NCT01846442|7492902|FG003|Safety Population|Overall Study||54
6569564|NCT01846442|7492899|FG000|ITT Population|Overall Study||53
6247129|NCT00966953|7146511|FG000|STARTED|2nd Intervention||6
6247130|NCT00966953|7146512|FG001|STARTED|2nd Intervention||6
6247131|NCT00966953|7146513|FG002|STARTED|2nd Intervention||6
6247132|NCT00966953|7146514|FG003|STARTED|2nd Intervention||7
6247133|NCT00966953|7146511|FG000|COMPLETED|2nd Intervention||6
6247134|NCT00966953|7146512|FG001|COMPLETED|2nd Intervention||6
6247135|NCT00966953|7146513|FG002|COMPLETED|2nd Intervention||6
6569565|NCT01846442|7492900|FG001|ITT Population|Overall Study||53
6569566|NCT01846442|7492901|FG002|ITT Population|Overall Study||56
6569567|NCT01846442|7492902|FG003|ITT Population|Overall Study||54
6569568|NCT01846442|7492899|FG000|COMPLETED|Overall Study||48
6569569|NCT01846442|7492900|FG001|COMPLETED|Overall Study||48
6569570|NCT01846442|7492901|FG002|COMPLETED|Overall Study||52
6247084|NCT01365195|7146478|FG000|STARTED|Overall Study||6
6247085|NCT01365195|7146479|FG001|STARTED|Overall Study||8
6247086|NCT01365195|7146480|FG002|STARTED|Overall Study||7
6247087|NCT01365195|7146478|FG000|COMPLETED|Overall Study||6
6247088|NCT01365195|7146479|FG001|COMPLETED|Overall Study||8
6247089|NCT01365195|7146480|FG002|COMPLETED|Overall Study||7
6247090|NCT01365195|7146478|FG000|NOT COMPLETED|Overall Study||0
6247091|NCT01365195|7146479|FG001|NOT COMPLETED|Overall Study||0
6247092|NCT01365195|7146480|FG002|NOT COMPLETED|Overall Study||0
6247136|NCT00966953|7146514|FG003|COMPLETED|2nd Intervention||7
6247137|NCT00966953|7146511|FG000|NOT COMPLETED|2nd Intervention||0
6247138|NCT00966953|7146512|FG001|NOT COMPLETED|2nd Intervention||0
6247139|NCT00966953|7146513|FG002|NOT COMPLETED|2nd Intervention||0
6247140|NCT00966953|7146514|FG003|NOT COMPLETED|2nd Intervention||0
6247141|NCT00966953|7146511|FG000|STARTED|1 Week Washout After 2nd Intervention||6
6247142|NCT00966953|7146512|FG001|STARTED|1 Week Washout After 2nd Intervention||6
6247143|NCT00966953|7146513|FG002|STARTED|1 Week Washout After 2nd Intervention||6
6247144|NCT00966953|7146514|FG003|STARTED|1 Week Washout After 2nd Intervention||7
6247145|NCT00966953|7146511|FG000|COMPLETED|1 Week Washout After 2nd Intervention||6
6247146|NCT00966953|7146512|FG001|COMPLETED|1 Week Washout After 2nd Intervention||6
6247147|NCT00966953|7146513|FG002|COMPLETED|1 Week Washout After 2nd Intervention||6
6247148|NCT00966953|7146514|FG003|COMPLETED|1 Week Washout After 2nd Intervention||7
6247149|NCT00966953|7146511|FG000|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
6247150|NCT00966953|7146512|FG001|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
6247151|NCT00966953|7146513|FG002|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
6247152|NCT00966953|7146514|FG003|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
6247153|NCT00966953|7146511|FG000|STARTED|3rd Intervention Order||6
6247154|NCT00966953|7146512|FG001|STARTED|3rd Intervention Order||6
6247155|NCT00966953|7146513|FG002|STARTED|3rd Intervention Order||6
6569571|NCT01846442|7492902|FG003|COMPLETED|Overall Study||51
6569572|NCT01846442|7492899|FG000|NOT COMPLETED|Overall Study||6
6569573|NCT01846442|7492900|FG001|NOT COMPLETED|Overall Study||6
6569574|NCT01846442|7492901|FG002|NOT COMPLETED|Overall Study||4
6247156|NCT00966953|7146514|FG003|STARTED|3rd Intervention Order||7
6247157|NCT00966953|7146511|FG000|COMPLETED|3rd Intervention Order||6
6247158|NCT00966953|7146512|FG001|COMPLETED|3rd Intervention Order||6
6247159|NCT00966953|7146513|FG002|COMPLETED|3rd Intervention Order||6
6569575|NCT01846442|7492902|FG003|NOT COMPLETED|Overall Study||3
6569576|NCT01846455|7492917|FG000|STARTED|Overall Study||9
6569577|NCT01846455|7492918|FG001|STARTED|Overall Study||8
6569578|NCT01846455|7492919|FG002|STARTED|Overall Study||8
6569579|NCT01846455|7492920|FG003|STARTED|Overall Study||10
6569580|NCT01846455|7492921|FG004|STARTED|Overall Study||8
6569581|NCT01846455|7492917|FG000|PK Population|Overall Study||6
6569582|NCT01846455|7492918|FG001|PK Population|Overall Study||7
6569583|NCT01846455|7492919|FG002|PK Population|Overall Study||6
6569584|NCT01846455|7492920|FG003|PK Population|Overall Study||6
6569585|NCT01846455|7492921|FG004|PK Population|Overall Study||8
6569586|NCT01846455|7492917|FG000|COMPLETED|Overall Study||9
6247160|NCT00966953|7146514|FG003|COMPLETED|3rd Intervention Order||7
6247161|NCT00966953|7146511|FG000|NOT COMPLETED|3rd Intervention Order||0
6247162|NCT00966953|7146512|FG001|NOT COMPLETED|3rd Intervention Order||0
6247163|NCT00966953|7146513|FG002|NOT COMPLETED|3rd Intervention Order||0
6247164|NCT00966953|7146514|FG003|NOT COMPLETED|3rd Intervention Order||0
6247165|NCT00966953|7146511|FG000|STARTED|1 Week Washout After 3rd Intervention||6
6247166|NCT00966953|7146512|FG001|STARTED|1 Week Washout After 3rd Intervention||6
6247167|NCT00966953|7146513|FG002|STARTED|1 Week Washout After 3rd Intervention||6
6247168|NCT00966953|7146514|FG003|STARTED|1 Week Washout After 3rd Intervention||7
6247169|NCT00966953|7146511|FG000|COMPLETED|1 Week Washout After 3rd Intervention||6
6247170|NCT00966953|7146512|FG001|COMPLETED|1 Week Washout After 3rd Intervention||6
6247171|NCT00966953|7146513|FG002|COMPLETED|1 Week Washout After 3rd Intervention||6
6247172|NCT00966953|7146514|FG003|COMPLETED|1 Week Washout After 3rd Intervention||7
6247173|NCT00966953|7146511|FG000|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
6247174|NCT00966953|7146512|FG001|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
6247175|NCT00966953|7146513|FG002|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
6247176|NCT00966953|7146514|FG003|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
6247177|NCT00966953|7146511|FG000|STARTED|4th Intervention Order||6
6247178|NCT00966953|7146512|FG001|STARTED|4th Intervention Order||6
6247179|NCT00966953|7146513|FG002|STARTED|4th Intervention Order||6
6247180|NCT00966953|7146514|FG003|STARTED|4th Intervention Order||7
6247181|NCT00966953|7146511|FG000|COMPLETED|4th Intervention Order||6
6247182|NCT00966953|7146512|FG001|COMPLETED|4th Intervention Order||6
6247183|NCT00966953|7146513|FG002|COMPLETED|4th Intervention Order||6
6247184|NCT00966953|7146514|FG003|COMPLETED|4th Intervention Order||7
6247185|NCT00966953|7146511|FG000|NOT COMPLETED|4th Intervention Order||0
6247186|NCT00966953|7146512|FG001|NOT COMPLETED|4th Intervention Order||0
6247187|NCT00966953|7146513|FG002|NOT COMPLETED|4th Intervention Order||0
6247188|NCT00966953|7146514|FG003|NOT COMPLETED|4th Intervention Order||0
6247189|NCT00961805|7146522|FG000|STARTED|Overall Study||40
6247190|NCT00961805|7146523|FG001|STARTED|Overall Study||40
6247191|NCT00961805|7146522|FG000|COMPLETED|Overall Study||40
6247192|NCT00961805|7146523|FG001|COMPLETED|Overall Study||40
6247193|NCT00961805|7146522|FG000|NOT COMPLETED|Overall Study||0
6247194|NCT00961805|7146523|FG001|NOT COMPLETED|Overall Study||0
6247195|NCT00950937|7146529|FG000|STARTED|Overall Study||14
6247196|NCT00950937|7146530|FG001|STARTED|Overall Study||14
6247197|NCT00950937|7146529|FG000|COMPLETED|Overall Study||14
6247198|NCT00950937|7146530|FG001|COMPLETED|Overall Study||14
6247199|NCT00950937|7146529|FG000|NOT COMPLETED|Overall Study||0
6247200|NCT00950937|7146530|FG001|NOT COMPLETED|Overall Study||0
6247201|NCT00947518|7146537|FG000|STARTED|Overall Study||20
6247202|NCT00947518|7146538|FG001|STARTED|Overall Study||20
6247203|NCT00947518|7146539|FG002|STARTED|Overall Study||20
6247204|NCT00947518|7146537|FG000|COMPLETED|Overall Study||20
6247205|NCT00947518|7146538|FG001|COMPLETED|Overall Study||20
6247206|NCT00947518|7146539|FG002|COMPLETED|Overall Study||20
6247207|NCT00947518|7146537|FG000|NOT COMPLETED|Overall Study||0
6247208|NCT00947518|7146538|FG001|NOT COMPLETED|Overall Study||0
6247209|NCT00947518|7146539|FG002|NOT COMPLETED|Overall Study||0
6247210|NCT00934921|7146546|FG000|STARTED|First Intervention||12
6247211|NCT00934921|7146547|FG001|STARTED|First Intervention||12
6247212|NCT00934921|7146546|FG000|COMPLETED|First Intervention||12
6247213|NCT00934921|7146547|FG001|COMPLETED|First Intervention||12
6247214|NCT00934921|7146546|FG000|NOT COMPLETED|First Intervention||0
6247215|NCT00934921|7146547|FG001|NOT COMPLETED|First Intervention||0
6247216|NCT00934921|7146546|FG000|STARTED|Second Intervention||12
6247217|NCT00934921|7146547|FG001|STARTED|Second Intervention||12
6247218|NCT00934921|7146546|FG000|COMPLETED|Second Intervention||12
6247219|NCT00934921|7146547|FG001|COMPLETED|Second Intervention||12
6247220|NCT00934921|7146546|FG000|NOT COMPLETED|Second Intervention||0
6247221|NCT00934921|7146547|FG001|NOT COMPLETED|Second Intervention||0
6247222|NCT00934180|7146553|FG000|STARTED|First Intervention||12
6247223|NCT00934180|7146554|FG001|STARTED|First Intervention||12
6247224|NCT00934180|7146553|FG000|COMPLETED|First Intervention||12
6247225|NCT00934180|7146554|FG001|COMPLETED|First Intervention||12
6247226|NCT00934180|7146553|FG000|NOT COMPLETED|First Intervention||0
6247227|NCT00934180|7146554|FG001|NOT COMPLETED|First Intervention||0
6247228|NCT00934180|7146553|FG000|STARTED|Second Intervention||12
6247229|NCT00934180|7146554|FG001|STARTED|Second Intervention||12
6247230|NCT00934180|7146553|FG000|COMPLETED|Second Intervention||12
6247231|NCT00934180|7146554|FG001|COMPLETED|Second Intervention||12
6247232|NCT00934180|7146553|FG000|NOT COMPLETED|Second Intervention||0
6247233|NCT00934180|7146554|FG001|NOT COMPLETED|Second Intervention||0
6247234|NCT00924833|7146561|FG000|STARTED|Overall Study||9
6247235|NCT00924833|7146562|FG001|STARTED|Overall Study||9
6247236|NCT00924833|7146563|FG002|STARTED|Overall Study||9
6247237|NCT00924833|7146561|FG000|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
6247238|NCT00924833|7146562|FG001|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
6247239|NCT00924833|7146563|FG002|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
6247240|NCT00924833|7146561|FG000|NOT COMPLETED|Overall Study||0
6247241|NCT00924833|7146562|FG001|NOT COMPLETED|Overall Study||0
6247242|NCT00924833|7146563|FG002|NOT COMPLETED|Overall Study||0
6247243|NCT00919893|7146570|FG000|STARTED|Overall Study||70
6247244|NCT00919893|7146571|FG001|STARTED|Overall Study||69
6247245|NCT00919893|7146570|FG000|COMPLETED|Overall Study||51
6247246|NCT00919893|7146571|FG001|COMPLETED|Overall Study||60
6247247|NCT00919893|7146570|FG000|NOT COMPLETED|Overall Study||19
6247248|NCT00919893|7146571|FG001|NOT COMPLETED|Overall Study||9
6247249|NCT00912158|7146578|FG000|STARTED|Overall Study||44
6247250|NCT00912158|7146579|FG001|STARTED|Overall Study||44
6247251|NCT00912158|7146580|FG002|STARTED|Overall Study||41
6247252|NCT00912158|7146578|FG000|COMPLETED|Overall Study||44
6247253|NCT00912158|7146579|FG001|COMPLETED|Overall Study||44
6247254|NCT00912158|7146580|FG002|COMPLETED|Overall Study||41
6247255|NCT00912158|7146578|FG000|NOT COMPLETED|Overall Study||0
6247256|NCT00912158|7146579|FG001|NOT COMPLETED|Overall Study||0
6247257|NCT00912158|7146580|FG002|NOT COMPLETED|Overall Study||0
6247258|NCT00911443|7146590|FG000|STARTED|Overall Study||97
6247259|NCT00911443|7146591|FG001|STARTED|Overall Study||97
6247260|NCT00911443|7146592|FG002|STARTED|Overall Study||98
6247261|NCT00911443|7146593|FG003|STARTED|Overall Study||99
6247262|NCT00911443|7146594|FG004|STARTED|Overall Study||97
6247263|NCT00911443|7146590|FG000|COMPLETED|Overall Study||97
6247264|NCT00911443|7146591|FG001|COMPLETED|Overall Study||97
6247265|NCT00911443|7146592|FG002|COMPLETED|Overall Study||98
6247266|NCT00911443|7146593|FG003|COMPLETED|Overall Study||99
6247267|NCT00911443|7146594|FG004|COMPLETED|Overall Study||97
6247268|NCT00911443|7146590|FG000|NOT COMPLETED|Overall Study||0
6247269|NCT00911443|7146591|FG001|NOT COMPLETED|Overall Study||0
6247270|NCT00911443|7146592|FG002|NOT COMPLETED|Overall Study||0
6247271|NCT00911443|7146593|FG003|NOT COMPLETED|Overall Study||0
6247272|NCT00911443|7146594|FG004|NOT COMPLETED|Overall Study||0
6247273|NCT00911274|7146603|FG000|STARTED|Period 1||27
6247274|NCT00911274|7146604|FG001|STARTED|Period 1||26
6569587|NCT01846455|7492918|FG001|COMPLETED|Overall Study||8
6569588|NCT01846455|7492919|FG002|COMPLETED|Overall Study||8
6569589|NCT01846455|7492920|FG003|COMPLETED|Overall Study||10
6569590|NCT01846455|7492921|FG004|COMPLETED|Overall Study||8
6569591|NCT01846455|7492917|FG000|NOT COMPLETED|Overall Study||0
6569592|NCT01846455|7492918|FG001|NOT COMPLETED|Overall Study||0
6569593|NCT01846455|7492919|FG002|NOT COMPLETED|Overall Study||0
6569594|NCT01846455|7492920|FG003|NOT COMPLETED|Overall Study||0
6247275|NCT00911274|7146603|FG000|COMPLETED|Period 1||27
6247276|NCT00911274|7146604|FG001|COMPLETED|Period 1||26
6247277|NCT00911274|7146603|FG000|NOT COMPLETED|Period 1||0
6247278|NCT00911274|7146604|FG001|NOT COMPLETED|Period 1||0
6247279|NCT00911274|7146603|FG000|STARTED|Period 2||27
6247280|NCT00911274|7146604|FG001|STARTED|Period 2||26
6247281|NCT00911274|7146603|FG000|COMPLETED|Period 2||27
6247282|NCT00911274|7146604|FG001|COMPLETED|Period 2||26
6569595|NCT01846455|7492921|FG004|NOT COMPLETED|Overall Study||0
6569596|NCT01846494|7492935|FG000|STARTED|Overall Study||50
6569597|NCT01846494|7492936|FG001|STARTED|Overall Study||63
6569598|NCT01846494|7492935|FG000|COMPLETED|Overall Study||20
6247283|NCT00911274|7146603|FG000|NOT COMPLETED|Period 2||0
6247284|NCT00911274|7146604|FG001|NOT COMPLETED|Period 2||0
6247285|NCT00909753|7146610|FG000|STARTED|Period: First Intervention||46
6247286|NCT00909753|7146611|FG001|STARTED|Period: First Intervention||46
6247287|NCT00909753|7146610|FG000|COMPLETED|Period: First Intervention||46
6247288|NCT00909753|7146611|FG001|COMPLETED|Period: First Intervention||46
6247289|NCT00909753|7146610|FG000|NOT COMPLETED|Period: First Intervention||0
6247290|NCT00909753|7146611|FG001|NOT COMPLETED|Period: First Intervention||0
6247291|NCT00909753|7146610|FG000|STARTED|Period: Washout of 28 Days||46
6247292|NCT00909753|7146611|FG001|STARTED|Period: Washout of 28 Days||46
6247293|NCT00909753|7146610|FG000|COMPLETED|Period: Washout of 28 Days||44
6247294|NCT00909753|7146611|FG001|COMPLETED|Period: Washout of 28 Days||43
6247295|NCT00909753|7146610|FG000|NOT COMPLETED|Period: Washout of 28 Days||2
6247296|NCT00909753|7146611|FG001|NOT COMPLETED|Period: Washout of 28 Days||3
6247297|NCT00909753|7146610|FG000|STARTED|Period: Second Intervention||44
6247298|NCT00909753|7146611|FG001|STARTED|Period: Second Intervention||43
6247299|NCT00909753|7146610|FG000|COMPLETED|Period: Second Intervention||43
6247300|NCT00909753|7146611|FG001|COMPLETED|Period: Second Intervention||43
6247301|NCT00909753|7146610|FG000|NOT COMPLETED|Period: Second Intervention||1
6247302|NCT00909753|7146611|FG001|NOT COMPLETED|Period: Second Intervention||0
6247303|NCT00909649|7146617|FG000|STARTED|Overall Study||25
6247304|NCT00909649|7146618|FG001|STARTED|Overall Study||25
6247305|NCT00909649|7146617|FG000|COMPLETED|Overall Study||25
6247306|NCT00909649|7146618|FG001|COMPLETED|Overall Study||25
6247307|NCT00909649|7146617|FG000|NOT COMPLETED|Overall Study||0
6247308|NCT00909649|7146618|FG001|NOT COMPLETED|Overall Study||0
6247309|NCT00909610|7146624|FG000|STARTED|Period: First Intervention||40
6247310|NCT00909610|7146625|FG001|STARTED|Period: First Intervention||40
6247311|NCT00909610|7146624|FG000|COMPLETED|Period: First Intervention||40
6247312|NCT00909610|7146625|FG001|COMPLETED|Period: First Intervention||39
6247313|NCT00909610|7146624|FG000|NOT COMPLETED|Period: First Intervention||0
6247314|NCT00909610|7146625|FG001|NOT COMPLETED|Period: First Intervention||1
6247315|NCT00909610|7146624|FG000|STARTED|Period: Washout of 28 Days||40
6247316|NCT00909610|7146625|FG001|STARTED|Period: Washout of 28 Days||39
6247317|NCT00909610|7146624|FG000|COMPLETED|Period: Washout of 28 Days||37
6247318|NCT00909610|7146625|FG001|COMPLETED|Period: Washout of 28 Days||33
6569599|NCT01846494|7492936|FG001|COMPLETED|Overall Study||25
6569600|NCT01846494|7492935|FG000|NOT COMPLETED|Overall Study||30
6569601|NCT01846494|7492936|FG001|NOT COMPLETED|Overall Study||38
6569602|NCT01846507|7492942|FG000|STARTED|Overall Study||32
6569603|NCT01846507|7492942|FG000|COMPLETED|Overall Study||25
6569604|NCT01846507|7492942|FG000|NOT COMPLETED|Overall Study||7
6569605|NCT01846611|7492950|FG000|STARTED|Overall Study||289
6569606|NCT01846611|7492951|FG001|STARTED|Overall Study||287
6247319|NCT00909610|7146624|FG000|NOT COMPLETED|Period: Washout of 28 Days||3
6247320|NCT00909610|7146625|FG001|NOT COMPLETED|Period: Washout of 28 Days||6
6247321|NCT00909610|7146624|FG000|STARTED|Period: Second Intervention||37
6247322|NCT00909610|7146625|FG001|STARTED|Period: Second Intervention||33
6247323|NCT00909610|7146624|FG000|COMPLETED|Period: Second Intervention||36
6247324|NCT00909610|7146625|FG001|COMPLETED|Period: Second Intervention||33
6247325|NCT00909610|7146624|FG000|NOT COMPLETED|Period: Second Intervention||1
6247326|NCT00909610|7146625|FG001|NOT COMPLETED|Period: Second Intervention||0
6276972|NCT00123474|7176301|FG001|STARTED|As Treated at Study Closure||163
6276973|NCT00123474|7176302|FG002|STARTED|As Treated at Study Closure||167
6276974|NCT00123474|7176303|FG003|STARTED|As Treated at Study Closure||167
6276975|NCT00123474|7176300|FG000|COMPLETED|As Treated at Study Closure||0
6276976|NCT00123474|7176301|FG001|COMPLETED|As Treated at Study Closure||0
6276977|NCT00123474|7176302|FG002|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
6276978|NCT00123474|7176303|FG003|COMPLETED|As Treated at Study Closure||0
6276979|NCT00123474|7176300|FG000|NOT COMPLETED|As Treated at Study Closure||165
6276980|NCT00123474|7176301|FG001|NOT COMPLETED|As Treated at Study Closure||163
6276981|NCT00123474|7176302|FG002|NOT COMPLETED|As Treated at Study Closure||167
6276982|NCT00123474|7176303|FG003|NOT COMPLETED|As Treated at Study Closure||167
6276983|NCT00123487|7176336|FG000|STARTED|Randomized||306
6276984|NCT00123487|7176337|FG001|STARTED|Randomized||305
6276985|NCT00123487|7176336|FG000|COMPLETED|Randomized||305
6276986|NCT00123487|7176337|FG001|COMPLETED|Randomized||304
6276987|NCT00123487|7176336|FG000|NOT COMPLETED|Randomized||1
6276988|NCT00123487|7176337|FG001|NOT COMPLETED|Randomized||1
6276989|NCT00123487|7176336|FG000|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
6276990|NCT00123487|7176337|FG001|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
6276991|NCT00123487|7176336|FG000|COMPLETED|Treated With Study Drug||0
6276992|NCT00123487|7176337|FG001|COMPLETED|Treated With Study Drug||0
6276993|NCT00123487|7176336|FG000|NOT COMPLETED|Treated With Study Drug||304
6276994|NCT00123487|7176337|FG001|NOT COMPLETED|Treated With Study Drug||305
6276995|NCT00123604|7176346|FG000|STARTED|Overall Study||19
6276996|NCT00123604|7176347|FG001|STARTED|Overall Study||17
6276997|NCT00123604|7176346|FG000|COMPLETED|Overall Study||18
6276998|NCT00123604|7176347|FG001|COMPLETED|Overall Study||16
6276999|NCT00123604|7176346|FG000|NOT COMPLETED|Overall Study||1
6277000|NCT00123604|7176347|FG001|NOT COMPLETED|Overall Study||1
6277001|NCT00123630|7176355|FG000|STARTED|Overall Study||15
6277002|NCT00123630|7176356|FG001|STARTED|Overall Study||15
6277003|NCT00123630|7176355|FG000|COMPLETED|Overall Study||15
6277004|NCT00123630|7176356|FG001|COMPLETED|Overall Study||15
6277005|NCT00123630|7176355|FG000|NOT COMPLETED|Overall Study||0
6277006|NCT00123630|7176356|FG001|NOT COMPLETED|Overall Study||0
6277007|NCT00123643|7176364|FG000|STARTED|Overall Study||20
6277008|NCT00123643|7176365|FG001|STARTED|Overall Study||16
6505193|NCT01451983|7424346|FG001|STARTED|Overall Study||27
6505194|NCT01451983|7424347|FG002|STARTED|Overall Study||61
6505195|NCT01451983|7424348|FG003|STARTED|Overall Study||24
6505196|NCT01451983|7424345|FG000|COMPLETED|Overall Study||26
6505197|NCT01451983|7424346|FG001|COMPLETED|Overall Study||27
6505198|NCT01451983|7424347|FG002|COMPLETED|Overall Study||61
6505199|NCT01451983|7424348|FG003|COMPLETED|Overall Study||24
6505200|NCT01451983|7424345|FG000|NOT COMPLETED|Overall Study||0
6505201|NCT01451983|7424346|FG001|NOT COMPLETED|Overall Study||0
6505202|NCT01451983|7424347|FG002|NOT COMPLETED|Overall Study||0
6505203|NCT01451983|7424348|FG003|NOT COMPLETED|Overall Study||0
6505204|NCT01451996|7424362|FG000|STARTED|Overall Study||83
6505205|NCT01451996|7424363|FG001|STARTED|Overall Study||87
6505206|NCT01451996|7424364|FG002|STARTED|Overall Study||85
6505207|NCT01451996|7424365|FG003|STARTED|Overall Study||85
6505208|NCT01451996|7424362|FG000|COMPLETED|Overall Study||83
6505209|NCT01451996|7424363|FG001|COMPLETED|Overall Study||87
6505210|NCT01451996|7424364|FG002|COMPLETED|Overall Study||85
6505211|NCT01451996|7424365|FG003|COMPLETED|Overall Study||85
6505212|NCT01451996|7424362|FG000|NOT COMPLETED|Overall Study||0
6569607|NCT01846611|7492950|FG000|Treated|Overall Study||286
6569608|NCT01846611|7492951|FG001|Treated|Overall Study||282
6569609|NCT01846611|7492950|FG000|COMPLETED|Overall Study||251
6569610|NCT01846611|7492951|FG001|COMPLETED|Overall Study||244
6277009|NCT00123643|7176364|FG000|COMPLETED|Overall Study||20
6277010|NCT00123643|7176365|FG001|COMPLETED|Overall Study||16
6277011|NCT00123643|7176364|FG000|NOT COMPLETED|Overall Study||0
6569611|NCT01846611|7492950|FG000|NOT COMPLETED|Overall Study||38
6569612|NCT01846611|7492951|FG001|NOT COMPLETED|Overall Study||43
6569613|NCT01846624|7492957|FG000|STARTED|Overall Study||13
6569614|NCT01846624|7492957|FG000|COMPLETED|Overall Study||12
6569615|NCT01846624|7492957|FG000|NOT COMPLETED|Overall Study||1
6569616|NCT01846702|7492968|FG000|STARTED|Overall Study||6
6505213|NCT01451996|7424363|FG001|NOT COMPLETED|Overall Study||0
6569617|NCT01846702|7492969|FG001|STARTED|Overall Study||6
6569618|NCT01846702|7492970|FG002|STARTED|Overall Study||7
6569619|NCT01846702|7492971|FG003|STARTED|Overall Study||6
6657426|NCT02469389|7587767|FG000|Completed 24-week Assessment|Overall Study|16 lost to contact or refused|37
6657427|NCT02469389|7587768|FG001|Completed 24-week Assessment|Overall Study|6 lost to contact or refused|46
6657428|NCT02469389|7587767|FG000|COMPLETED|Overall Study||37
6657429|NCT02469389|7587768|FG001|COMPLETED|Overall Study||44
6505214|NCT01451996|7424364|FG002|NOT COMPLETED|Overall Study||0
6505215|NCT01451996|7424365|FG003|NOT COMPLETED|Overall Study||0
6505216|NCT01452126|7424375|FG000|STARTED|Overall Study||49
6505217|NCT01452126|7424375|FG000|COMPLETED|Overall Study||49
6505218|NCT01452126|7424375|FG000|NOT COMPLETED|Overall Study||0
6505219|NCT01452191|7424386|FG000|STARTED|Overall Study||373
6247327|NCT00908648|7146632|FG000|STARTED|Overall Study||108
6247328|NCT00908648|7146633|FG001|STARTED|Overall Study||103
6247329|NCT00908648|7146632|FG000|COMPLETED|Overall Study||108
6247330|NCT00908648|7146633|FG001|COMPLETED|Overall Study||103
6247331|NCT00908648|7146632|FG000|NOT COMPLETED|Overall Study||0
6247332|NCT00908648|7146633|FG001|NOT COMPLETED|Overall Study||0
6247333|NCT00908128|7146639|FG000|STARTED|Period 1||20
6247334|NCT00908128|7146640|FG001|STARTED|Period 1||20
6247335|NCT00908128|7146639|FG000|COMPLETED|Period 1||20
6247336|NCT00908128|7146640|FG001|COMPLETED|Period 1||20
6247337|NCT00908128|7146639|FG000|NOT COMPLETED|Period 1||0
6247338|NCT00908128|7146640|FG001|NOT COMPLETED|Period 1||0
6247339|NCT00908128|7146639|FG000|STARTED|Period 2||20
6247340|NCT00908128|7146640|FG001|STARTED|Period 2||20
6247341|NCT00908128|7146639|FG000|COMPLETED|Period 2||20
6247342|NCT00908128|7146640|FG001|COMPLETED|Period 2||20
6247343|NCT00908128|7146639|FG000|NOT COMPLETED|Period 2||0
6247344|NCT00908128|7146640|FG001|NOT COMPLETED|Period 2||0
6247345|NCT00908128|7146639|FG000|STARTED|Period 3||20
6247346|NCT00908128|7146640|FG001|STARTED|Period 3||20
6247347|NCT00908128|7146639|FG000|COMPLETED|Period 3||20
6247348|NCT00908128|7146640|FG001|COMPLETED|Period 3||20
6247349|NCT00908128|7146639|FG000|NOT COMPLETED|Period 3||0
6247350|NCT00908128|7146640|FG001|NOT COMPLETED|Period 3||0
6247351|NCT00908128|7146639|FG000|STARTED|Period 4||20
6247352|NCT00908128|7146640|FG001|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
6247353|NCT00908128|7146639|FG000|COMPLETED|Period 4||20
6247354|NCT00908128|7146640|FG001|COMPLETED|Period 4||19
6247355|NCT00908128|7146639|FG000|NOT COMPLETED|Period 4||0
6247356|NCT00908128|7146640|FG001|NOT COMPLETED|Period 4||0
6247357|NCT00907907|7146646|FG000|STARTED|Period 1||20
6247358|NCT00907907|7146647|FG001|STARTED|Period 1||20
6247359|NCT00907907|7146646|FG000|COMPLETED|Period 1||20
6247360|NCT00907907|7146647|FG001|COMPLETED|Period 1||20
6247361|NCT00907907|7146646|FG000|NOT COMPLETED|Period 1||0
6247362|NCT00907907|7146647|FG001|NOT COMPLETED|Period 1||0
6247363|NCT00907907|7146646|FG000|STARTED|Period 2||20
6247364|NCT00907907|7146647|FG001|STARTED|Period 2||20
6247365|NCT00907907|7146646|FG000|COMPLETED|Period 2||20
6247366|NCT00907907|7146647|FG001|COMPLETED|Period 2||20
6247367|NCT00907907|7146646|FG000|NOT COMPLETED|Period 2||0
6247368|NCT00907907|7146647|FG001|NOT COMPLETED|Period 2||0
6247369|NCT00907907|7146646|FG000|STARTED|Period 3||20
6247370|NCT00907907|7146647|FG001|STARTED|Period 3||20
6569620|NCT01846702|7492972|FG004|STARTED|Overall Study||6
6569621|NCT01846702|7492973|FG005|STARTED|Overall Study||6
6569622|NCT01846702|7492974|FG006|STARTED|Overall Study||6
6569623|NCT01846702|7492968|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6657430|NCT02469389|7587767|FG000|NOT COMPLETED|Overall Study||16
6247371|NCT00907907|7146646|FG000|COMPLETED|Period 3||20
6247372|NCT00907907|7146647|FG001|COMPLETED|Period 3||20
6247373|NCT00907907|7146646|FG000|NOT COMPLETED|Period 3||0
6247374|NCT00907907|7146647|FG001|NOT COMPLETED|Period 3||0
6247375|NCT00907907|7146646|FG000|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
6247376|NCT00907907|7146647|FG001|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
6247377|NCT00907907|7146646|FG000|COMPLETED|Period 4||19
6247378|NCT00907907|7146647|FG001|COMPLETED|Period 4||18
6247379|NCT00907907|7146646|FG000|NOT COMPLETED|Period 4||0
6247380|NCT00907907|7146647|FG001|NOT COMPLETED|Period 4||0
6247381|NCT00905606|7146653|FG000|STARTED|Period 1||15
6247382|NCT00905606|7146654|FG001|STARTED|Period 1||15
6247383|NCT00905606|7146653|FG000|COMPLETED|Period 1||15
6247384|NCT00905606|7146654|FG001|COMPLETED|Period 1||14
6247385|NCT00905606|7146653|FG000|NOT COMPLETED|Period 1||0
6247386|NCT00905606|7146654|FG001|NOT COMPLETED|Period 1||1
6247387|NCT00905606|7146653|FG000|STARTED|Washout||15
6247388|NCT00905606|7146654|FG001|STARTED|Washout||14
6247389|NCT00905606|7146653|FG000|COMPLETED|Washout||14
6247390|NCT00905606|7146654|FG001|COMPLETED|Washout||14
6247391|NCT00905606|7146653|FG000|NOT COMPLETED|Washout||1
6569624|NCT01846702|7492969|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6569625|NCT01846702|7492970|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6569626|NCT01846702|7492971|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6247392|NCT00905606|7146654|FG001|NOT COMPLETED|Washout||0
6247393|NCT00905606|7146653|FG000|STARTED|Period 2||14
6247394|NCT00905606|7146654|FG001|STARTED|Period 2||14
6247395|NCT00905606|7146653|FG000|COMPLETED|Period 2||14
6569627|NCT01846702|7492972|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
6569628|NCT01846702|7492973|FG005|Received at Least 1 Dose of Study Drug|Overall Study||6
6569629|NCT01846702|7492974|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
6569630|NCT01846702|7492968|FG000|COMPLETED|Overall Study||6
6247396|NCT00905606|7146654|FG001|COMPLETED|Period 2||14
6247397|NCT00905606|7146653|FG000|NOT COMPLETED|Period 2||0
6247398|NCT00905606|7146654|FG001|NOT COMPLETED|Period 2||0
6247399|NCT00905567|7146660|FG000|STARTED|Period 1||12
6247400|NCT00905567|7146661|FG001|STARTED|Period 1||12
6247401|NCT00905567|7146660|FG000|COMPLETED|Period 1||12
6247402|NCT00905567|7146661|FG001|COMPLETED|Period 1||12
6247403|NCT00905567|7146660|FG000|NOT COMPLETED|Period 1||0
6247404|NCT00905567|7146661|FG001|NOT COMPLETED|Period 1||0
6247405|NCT00905567|7146660|FG000|STARTED|Washout||12
6247406|NCT00905567|7146661|FG001|STARTED|Washout||12
6247407|NCT00905567|7146660|FG000|COMPLETED|Washout||12
6247408|NCT00905567|7146661|FG001|COMPLETED|Washout||11
6247409|NCT00905567|7146660|FG000|NOT COMPLETED|Washout||0
6247410|NCT00905567|7146661|FG001|NOT COMPLETED|Washout||1
6247411|NCT00905567|7146660|FG000|STARTED|Period 2||12
6247412|NCT00905567|7146661|FG001|STARTED|Period 2||11
6247413|NCT00905567|7146660|FG000|COMPLETED|Period 2||12
6247414|NCT00905567|7146661|FG001|COMPLETED|Period 2||11
6247415|NCT00905567|7146660|FG000|NOT COMPLETED|Period 2||0
6247416|NCT00905567|7146661|FG001|NOT COMPLETED|Period 2||0
6247417|NCT00905346|7146667|FG000|STARTED|Period 1||12
6247418|NCT00905346|7146668|FG001|STARTED|Period 1||12
6247419|NCT00905346|7146667|FG000|COMPLETED|Period 1||11
6247420|NCT00905346|7146668|FG001|COMPLETED|Period 1||12
6247421|NCT00905346|7146667|FG000|NOT COMPLETED|Period 1||1
6247422|NCT00905346|7146668|FG001|NOT COMPLETED|Period 1||0
6247423|NCT00905346|7146667|FG000|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
6247424|NCT00905346|7146668|FG001|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
6247425|NCT00905346|7146667|FG000|COMPLETED|Period 2||10
6247426|NCT00905346|7146668|FG001|COMPLETED|Period 2||11
6247427|NCT00905346|7146667|FG000|NOT COMPLETED|Period 2||0
6247428|NCT00905346|7146668|FG001|NOT COMPLETED|Period 2||0
6247429|NCT00905164|7146674|FG000|STARTED|Period 1||12
6247430|NCT00905164|7146675|FG001|STARTED|Period 1||12
6247431|NCT00905164|7146674|FG000|COMPLETED|Period 1||12
6247432|NCT00905164|7146675|FG001|COMPLETED|Period 1||11
6247433|NCT00905164|7146674|FG000|NOT COMPLETED|Period 1||0
6247434|NCT00905164|7146675|FG001|NOT COMPLETED|Period 1||1
6247435|NCT00905164|7146674|FG000|STARTED|Period 2||12
6247436|NCT00905164|7146675|FG001|STARTED|Period 2||11
6247437|NCT00905164|7146674|FG000|COMPLETED|Period 2||12
6247438|NCT00905164|7146675|FG001|COMPLETED|Period 2||11
6247439|NCT00905164|7146674|FG000|NOT COMPLETED|Period 2||0
6247440|NCT00905164|7146675|FG001|NOT COMPLETED|Period 2||0
6247441|NCT00904943|7146681|FG000|STARTED|Period 1||9
6247442|NCT00904943|7146682|FG001|STARTED|Period 1||9
6247443|NCT00904943|7146681|FG000|COMPLETED|Period 1||9
6247444|NCT00904943|7146682|FG001|COMPLETED|Period 1||9
6247445|NCT00904943|7146681|FG000|NOT COMPLETED|Period 1||0
6247446|NCT00904943|7146682|FG001|NOT COMPLETED|Period 1||0
6247447|NCT00904943|7146681|FG000|STARTED|Period 2||9
6247448|NCT00904943|7146682|FG001|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
6247449|NCT00904943|7146681|FG000|COMPLETED|Period 2||9
6247450|NCT00904943|7146682|FG001|COMPLETED|Period 2||8
6247451|NCT00904943|7146681|FG000|NOT COMPLETED|Period 2||0
6247452|NCT00904943|7146682|FG001|NOT COMPLETED|Period 2||0
6247453|NCT00890591|7146686|FG000|STARTED|Overall Study||144
6247454|NCT00890591|7146686|FG000|COMPLETED|Overall Study||124
6247455|NCT00890591|7146686|FG000|NOT COMPLETED|Overall Study||20
6247456|NCT00890409|7146694|FG000|STARTED|Overall Study||116
6247457|NCT00890409|7146695|FG001|STARTED|Overall Study||140
6247458|NCT00890409|7146694|FG000|COMPLETED|Overall Study||96
6247459|NCT00890409|7146695|FG001|COMPLETED|Overall Study||119
6247460|NCT00890409|7146694|FG000|NOT COMPLETED|Overall Study||20
6247461|NCT00890409|7146695|FG001|NOT COMPLETED|Overall Study||21
6247462|NCT00888355|7146703|FG000|STARTED|Overall Study||108
6247463|NCT00888355|7146704|FG001|STARTED|Overall Study||108
6247464|NCT00888355|7146705|FG002|STARTED|Overall Study||106
6247465|NCT00888355|7146706|FG003|STARTED|Overall Study||106
6247466|NCT00888355|7146703|FG000|COMPLETED|Overall Study||86
6247467|NCT00888355|7146704|FG001|COMPLETED|Overall Study||99
6247468|NCT00888355|7146705|FG002|COMPLETED|Overall Study||94
6247469|NCT00888355|7146706|FG003|COMPLETED|Overall Study||96
6247470|NCT00888355|7146703|FG000|NOT COMPLETED|Overall Study||22
6247471|NCT00888355|7146704|FG001|NOT COMPLETED|Overall Study||9
6247472|NCT00888355|7146705|FG002|NOT COMPLETED|Overall Study||12
6247473|NCT00888355|7146706|FG003|NOT COMPLETED|Overall Study||10
6247474|NCT00887250|7146715|FG000|STARTED|Overall Study||116
6505220|NCT01452191|7424387|FG001|STARTED|Overall Study||369
6505221|NCT01452191|7424388|FG002|STARTED|Overall Study||370
6505222|NCT01452191|7424386|FG000|COMPLETED|Overall Study||241
6505223|NCT01452191|7424387|FG001|COMPLETED|Overall Study||252
6505224|NCT01452191|7424388|FG002|COMPLETED|Overall Study||258
6505225|NCT01452191|7424386|FG000|NOT COMPLETED|Overall Study||132
6505226|NCT01452191|7424387|FG001|NOT COMPLETED|Overall Study||117
6505227|NCT01452191|7424388|FG002|NOT COMPLETED|Overall Study||112
6505228|NCT01452269|7424398|FG000|STARTED|Overall Study||48
6505229|NCT01452269|7424399|FG001|STARTED|Overall Study||56
6505230|NCT01452269|7424398|FG000|COMPLETED|Overall Study||47
6505231|NCT01452269|7424399|FG001|COMPLETED|Overall Study||51
6505232|NCT01452269|7424398|FG000|NOT COMPLETED|Overall Study||1
6505233|NCT01452269|7424399|FG001|NOT COMPLETED|Overall Study||5
6505234|NCT01452347|7424407|FG000|STARTED|Overall Study||168
6505235|NCT01452347|7424408|FG001|STARTED|Overall Study||84
6505236|NCT01452347|7424407|FG000|COMPLETED|Overall Study||151
6505237|NCT01452347|7424408|FG001|COMPLETED|Overall Study||77
6505238|NCT01452347|7424407|FG000|NOT COMPLETED|Overall Study||17
6505239|NCT01452347|7424408|FG001|NOT COMPLETED|Overall Study||7
6505240|NCT01452412|7424418|FG000|STARTED|Overall Study||74
6505241|NCT01452412|7424419|FG001|STARTED|Overall Study||75
6505242|NCT01452412|7424418|FG000|COMPLETED|Overall Study||46
6505243|NCT01452412|7424419|FG001|COMPLETED|Overall Study||58
6505244|NCT01452412|7424418|FG000|NOT COMPLETED|Overall Study||28
6505245|NCT01452412|7424419|FG001|NOT COMPLETED|Overall Study||17
6505246|NCT01452425|7424425|FG000|STARTED|Overall Study||10
6505247|NCT01452425|7424425|FG000|COMPLETED|Overall Study||10
6505248|NCT01452425|7424425|FG000|NOT COMPLETED|Overall Study||0
6505249|NCT01452529|7424432|FG000|STARTED|Run-in Period||905
6505250|NCT01452529|7424433|FG001|STARTED|Run-in Period||0
6505251|NCT01452529|7424434|FG002|STARTED|Run-in Period||0
6505252|NCT01452529|7424432|FG000|COMPLETED|Run-in Period||592
6505253|NCT01452529|7424433|FG001|COMPLETED|Run-in Period||0
6505254|NCT01452529|7424434|FG002|COMPLETED|Run-in Period||0
6247475|NCT00887250|7146716|FG001|STARTED|Overall Study||127
6505255|NCT01452529|7424432|FG000|NOT COMPLETED|Run-in Period||313
6505256|NCT01452529|7424433|FG001|NOT COMPLETED|Run-in Period||0
6505257|NCT01452529|7424434|FG002|NOT COMPLETED|Run-in Period||0
6505258|NCT01452529|7424432|FG000|STARTED|Double-blind (DB) Period||0
6247476|NCT00887250|7146717|FG002|STARTED|Overall Study||123
6247477|NCT00887250|7146715|FG000|COMPLETED|Overall Study||98
6247478|NCT00887250|7146716|FG001|COMPLETED|Overall Study||115
6247479|NCT00887250|7146717|FG002|COMPLETED|Overall Study||110
6247480|NCT00887250|7146715|FG000|NOT COMPLETED|Overall Study||18
6247481|NCT00887250|7146716|FG001|NOT COMPLETED|Overall Study||12
6505259|NCT01452529|7424433|FG001|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
6505260|NCT01452529|7424434|FG002|STARTED|Double-blind (DB) Period||292
6505261|NCT01452529|7424432|FG000|COMPLETED|Double-blind (DB) Period||0
6505262|NCT01452529|7424433|FG001|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
6505263|NCT01452529|7424434|FG002|COMPLETED|Double-blind (DB) Period||210
6505264|NCT01452529|7424432|FG000|NOT COMPLETED|Double-blind (DB) Period||0
6505265|NCT01452529|7424433|FG001|NOT COMPLETED|Double-blind (DB) Period||67
6505266|NCT01452529|7424434|FG002|NOT COMPLETED|Double-blind (DB) Period||82
6247482|NCT00887250|7146717|FG002|NOT COMPLETED|Overall Study||13
6247483|NCT00886600|7146726|FG000|STARTED|Double-blind Monotherapy||32
6247484|NCT00886600|7146727|FG001|STARTED|Double-blind Monotherapy||29
6247485|NCT00886600|7146728|FG002|STARTED|Double-blind Monotherapy||30
6247486|NCT00886600|7146729|FG003|STARTED|Double-blind Monotherapy||31
6247487|NCT00886600|7146726|FG000|COMPLETED|Double-blind Monotherapy||30
6247488|NCT00886600|7146727|FG001|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
6247489|NCT00886600|7146728|FG002|COMPLETED|Double-blind Monotherapy||29
6247490|NCT00886600|7146729|FG003|COMPLETED|Double-blind Monotherapy||29
6247491|NCT00886600|7146726|FG000|NOT COMPLETED|Double-blind Monotherapy||2
6247492|NCT00886600|7146727|FG001|NOT COMPLETED|Double-blind Monotherapy||1
6247493|NCT00886600|7146728|FG002|NOT COMPLETED|Double-blind Monotherapy||1
6247494|NCT00886600|7146729|FG003|NOT COMPLETED|Double-blind Monotherapy||2
6247495|NCT00886600|7146726|FG000|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
6247496|NCT00886600|7146727|FG001|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
6247497|NCT00886600|7146728|FG002|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
6247498|NCT00886600|7146729|FG003|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
6247499|NCT00886600|7146726|FG000|COMPLETED|Combination Therapy Period||28
6247500|NCT00886600|7146727|FG001|COMPLETED|Combination Therapy Period||21
6247501|NCT00886600|7146728|FG002|COMPLETED|Combination Therapy Period||19
6247502|NCT00886600|7146729|FG003|COMPLETED|Combination Therapy Period||23
6247503|NCT00886600|7146726|FG000|NOT COMPLETED|Combination Therapy Period||0
6247504|NCT00886600|7146727|FG001|NOT COMPLETED|Combination Therapy Period||0
6247505|NCT00886600|7146728|FG002|NOT COMPLETED|Combination Therapy Period||2
6247506|NCT00886600|7146729|FG003|NOT COMPLETED|Combination Therapy Period||0
6247507|NCT00882440|7146742|FG000|STARTED|Overall Study||78
6247508|NCT00882440|7146743|FG001|STARTED|Overall Study||80
6247509|NCT00882440|7146744|FG002|STARTED|Overall Study||82
6247510|NCT00882440|7146745|FG003|STARTED|Overall Study||79
6247511|NCT00882440|7146746|FG004|STARTED|Overall Study||90
6247512|NCT00882440|7146747|FG005|STARTED|Overall Study||84
6247513|NCT00882440|7146748|FG006|STARTED|Overall Study||83
6247514|NCT00882440|7146742|FG000|COMPLETED|Overall Study||67
6247515|NCT00882440|7146743|FG001|COMPLETED|Overall Study||72
6247516|NCT00882440|7146744|FG002|COMPLETED|Overall Study||75
6247517|NCT00882440|7146745|FG003|COMPLETED|Overall Study||76
6247518|NCT00882440|7146746|FG004|COMPLETED|Overall Study||80
6247519|NCT00882440|7146747|FG005|COMPLETED|Overall Study||77
6247520|NCT00882440|7146748|FG006|COMPLETED|Overall Study||79
6247521|NCT00882440|7146742|FG000|NOT COMPLETED|Overall Study||11
6247522|NCT00882440|7146743|FG001|NOT COMPLETED|Overall Study||8
6247523|NCT00882440|7146744|FG002|NOT COMPLETED|Overall Study||7
6569631|NCT01846702|7492969|FG001|COMPLETED|Overall Study||6
6569632|NCT01846702|7492970|FG002|COMPLETED|Overall Study||6
6569633|NCT01846702|7492971|FG003|COMPLETED|Overall Study||6
6569634|NCT01846702|7492972|FG004|COMPLETED|Overall Study||6
6569635|NCT01846702|7492973|FG005|COMPLETED|Overall Study||6
6569636|NCT01846702|7492974|FG006|COMPLETED|Overall Study||6
6569637|NCT01846702|7492968|FG000|NOT COMPLETED|Overall Study||0
6569638|NCT01846702|7492969|FG001|NOT COMPLETED|Overall Study||0
6569639|NCT01846702|7492970|FG002|NOT COMPLETED|Overall Study||1
6569640|NCT01846702|7492971|FG003|NOT COMPLETED|Overall Study||0
6505267|NCT01452789|7424443|FG000|STARTED|Overall Study||33
6569641|NCT01846702|7492972|FG004|NOT COMPLETED|Overall Study||0
6569642|NCT01846702|7492973|FG005|NOT COMPLETED|Overall Study||0
6505268|NCT01452789|7424444|FG001|STARTED|Overall Study||30
6505269|NCT01452789|7424443|FG000|COMPLETED|Overall Study||30
6505270|NCT01452789|7424444|FG001|COMPLETED|Overall Study||28
6247524|NCT00882440|7146745|FG003|NOT COMPLETED|Overall Study||3
6247525|NCT00882440|7146746|FG004|NOT COMPLETED|Overall Study||10
6247526|NCT00882440|7146747|FG005|NOT COMPLETED|Overall Study||7
6247527|NCT00882440|7146748|FG006|NOT COMPLETED|Overall Study||4
6247528|NCT00872430|7146759|FG000|STARTED|First Intervention||10
6247529|NCT00872430|7146760|FG001|STARTED|First Intervention||10
6247530|NCT00872430|7146759|FG000|COMPLETED|First Intervention||10
6247531|NCT00872430|7146760|FG001|COMPLETED|First Intervention||10
6247532|NCT00872430|7146759|FG000|NOT COMPLETED|First Intervention||0
6247533|NCT00872430|7146760|FG001|NOT COMPLETED|First Intervention||0
6569643|NCT01846702|7492974|FG006|NOT COMPLETED|Overall Study||0
6569644|NCT01846728|7492998|FG000|STARTED|Overall Study||6
6247534|NCT00872430|7146759|FG000|STARTED|Washout Period||10
6247535|NCT00872430|7146760|FG001|STARTED|Washout Period||10
6247536|NCT00872430|7146759|FG000|COMPLETED|Washout Period||10
6247537|NCT00872430|7146760|FG001|COMPLETED|Washout Period||10
6247538|NCT00872430|7146759|FG000|NOT COMPLETED|Washout Period||0
6247539|NCT00872430|7146760|FG001|NOT COMPLETED|Washout Period||0
6247540|NCT00872430|7146759|FG000|STARTED|Second Intervention||10
6247541|NCT00872430|7146760|FG001|STARTED|Second Intervention||10
6247542|NCT00872430|7146759|FG000|COMPLETED|Second Intervention||10
6247543|NCT00872430|7146760|FG001|COMPLETED|Second Intervention||10
6247544|NCT00872430|7146759|FG000|NOT COMPLETED|Second Intervention||0
6247545|NCT00872430|7146760|FG001|NOT COMPLETED|Second Intervention||0
6247546|NCT00870688|7146764|FG000|STARTED|Overall Study||82
6247547|NCT00870688|7146764|FG000|COMPLETED|Overall Study||78
6247548|NCT00870688|7146764|FG000|NOT COMPLETED|Overall Study||4
6247549|NCT00869128|7146767|FG000|STARTED|Overall Study||18
6247550|NCT00869128|7146768|FG001|STARTED|Overall Study||18
6247551|NCT00869128|7146767|FG000|COMPLETED|Overall Study||12
6247552|NCT00869128|7146768|FG001|COMPLETED|Overall Study||12
6247553|NCT00869128|7146767|FG000|NOT COMPLETED|Overall Study||6
6247554|NCT00869128|7146768|FG001|NOT COMPLETED|Overall Study||6
6247555|NCT00861705|7146776|FG000|STARTED|Overall Study||115
6247556|NCT00861705|7146777|FG001|STARTED|Overall Study||113
6247557|NCT00861705|7146778|FG002|STARTED|Overall Study||113
6247558|NCT00861705|7146779|FG003|STARTED|Overall Study||113
6247559|NCT00861705|7146776|FG000|COMPLETED|Overall Study||108
6247560|NCT00861705|7146777|FG001|COMPLETED|Overall Study||110
6247561|NCT00861705|7146778|FG002|COMPLETED|Overall Study||113
6247562|NCT00861705|7146779|FG003|COMPLETED|Overall Study||112
6247563|NCT00861705|7146776|FG000|NOT COMPLETED|Overall Study||7
6247564|NCT00861705|7146777|FG001|NOT COMPLETED|Overall Study||3
6247565|NCT00861705|7146778|FG002|NOT COMPLETED|Overall Study||0
6247566|NCT00861705|7146779|FG003|NOT COMPLETED|Overall Study||1
6247567|NCT00859521|7146799|FG000|STARTED|First Intervention||15
6247568|NCT00859521|7146800|FG001|STARTED|First Intervention||15
6247569|NCT00859521|7146799|FG000|COMPLETED|First Intervention||15
6247570|NCT00859521|7146800|FG001|COMPLETED|First Intervention||15
6247571|NCT00859521|7146799|FG000|NOT COMPLETED|First Intervention||0
6247572|NCT00859521|7146800|FG001|NOT COMPLETED|First Intervention||0
6247573|NCT00859521|7146799|FG000|STARTED|Washout||15
6247574|NCT00859521|7146800|FG001|STARTED|Washout||15
6247575|NCT00859521|7146799|FG000|COMPLETED|Washout||15
6247576|NCT00859521|7146800|FG001|COMPLETED|Washout||14
6247577|NCT00859521|7146799|FG000|NOT COMPLETED|Washout||0
6247578|NCT00859521|7146800|FG001|NOT COMPLETED|Washout||1
6247579|NCT00859521|7146799|FG000|STARTED|Second Intervention||15
6247580|NCT00859521|7146800|FG001|STARTED|Second Intervention||14
6247581|NCT00859521|7146799|FG000|COMPLETED|Second Intervention||15
6247582|NCT00859521|7146800|FG001|COMPLETED|Second Intervention||14
6247583|NCT00859521|7146799|FG000|NOT COMPLETED|Second Intervention||0
6247584|NCT00859521|7146800|FG001|NOT COMPLETED|Second Intervention||0
6247585|NCT00859430|7146806|FG000|STARTED|First Intervention||11
6247586|NCT00859430|7146807|FG001|STARTED|First Intervention||11
6247587|NCT00859430|7146806|FG000|COMPLETED|First Intervention||11
6247588|NCT00859430|7146807|FG001|COMPLETED|First Intervention||10
6247589|NCT00859430|7146806|FG000|NOT COMPLETED|First Intervention||0
6247590|NCT00859430|7146807|FG001|NOT COMPLETED|First Intervention||1
6569645|NCT01846728|7492998|FG000|COMPLETED|Overall Study||6
6247591|NCT00859430|7146806|FG000|STARTED|Second Intervention||11
6247592|NCT00859430|7146807|FG001|STARTED|Second Intervention||10
6569646|NCT01846728|7492998|FG000|NOT COMPLETED|Overall Study||0
6569647|NCT01846741|7493002|FG000|STARTED|Baseline Visit||22
6247593|NCT00859430|7146806|FG000|COMPLETED|Second Intervention||11
6247594|NCT00859430|7146807|FG001|COMPLETED|Second Intervention||10
6247595|NCT00859430|7146806|FG000|NOT COMPLETED|Second Intervention||0
6247596|NCT00859430|7146807|FG001|NOT COMPLETED|Second Intervention||0
6277012|NCT00123643|7176365|FG001|NOT COMPLETED|Overall Study||0
6277013|NCT00123682|7176375|FG000|STARTED|Overall Study||1069
6277014|NCT00123682|7176376|FG001|STARTED|Overall Study||934
6277015|NCT00123682|7176377|FG002|STARTED|Overall Study||592
6569648|NCT01846741|7493002|FG000|COMPLETED|Baseline Visit||20
6569649|NCT01846741|7493002|FG000|NOT COMPLETED|Baseline Visit||2
6247597|NCT00858702|7146813|FG000|STARTED|Overall Study||53
6247598|NCT00858702|7146814|FG001|STARTED|Overall Study||52
6247599|NCT00858702|7146813|FG000|COMPLETED|Overall Study||48
6247600|NCT00858702|7146814|FG001|COMPLETED|Overall Study||50
6247601|NCT00858702|7146813|FG000|NOT COMPLETED|Overall Study||5
6569650|NCT01846741|7493002|FG000|STARTED|Implantation to 18-Month/End of Study||20
6247602|NCT00858702|7146814|FG001|NOT COMPLETED|Overall Study||2
6569651|NCT01846741|7493002|FG000|COMPLETED|Implantation to 18-Month/End of Study||20
6247603|NCT00857285|7146822|FG000|STARTED|Overall Study||65
6569652|NCT01846741|7493002|FG000|NOT COMPLETED|Implantation to 18-Month/End of Study||0
6569653|NCT01846871|7493041|FG000|STARTED|Overall Study||10
6569654|NCT01846871|7493041|FG000|COMPLETED|Overall Study||10
6569655|NCT01846871|7493041|FG000|NOT COMPLETED|Overall Study||0
6569656|NCT01846988|7493052|FG000|STARTED|APAP Pressurize Comparison (4-8 Weeks)||15
6569657|NCT01846988|7493053|FG001|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
6569658|NCT01846988|7493054|FG002|STARTED|APAP Pressurize Comparison (4-8 Weeks)||0
6569659|NCT01846988|7493052|FG000|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||15
6657431|NCT02469389|7587768|FG001|NOT COMPLETED|Overall Study||8
6657432|NCT02469597|7587776|FG000|STARTED|Overall Study||22
6657433|NCT02469597|7587777|FG001|STARTED|Overall Study||24
6657434|NCT02469597|7587776|FG000|COMPLETED|Overall Study||22
6657435|NCT02469597|7587777|FG001|COMPLETED|Overall Study||24
6657436|NCT02469597|7587776|FG000|NOT COMPLETED|Overall Study||0
6657437|NCT02469597|7587777|FG001|NOT COMPLETED|Overall Study||0
6657438|NCT02469610|7587785|FG000|STARTED|Overall Study||34
6657439|NCT02469610|7587786|FG001|STARTED|Overall Study||31
6657440|NCT02469610|7587785|FG000|COMPLETED|Overall Study||30
6657441|NCT02469610|7587786|FG001|COMPLETED|Overall Study||30
6657442|NCT02469610|7587785|FG000|NOT COMPLETED|Overall Study||4
6657443|NCT02469610|7587786|FG001|NOT COMPLETED|Overall Study||1
6657444|NCT02469623|7587792|FG000|STARTED|Overall Study||85
6657445|NCT02469623|7587792|FG000|COMPLETED|Overall Study||72
6657446|NCT02469623|7587792|FG000|NOT COMPLETED|Overall Study||13
6657447|NCT02469701|7587797|FG000|STARTED|Overall Study||10
6657448|NCT02469701|7587797|FG000|COMPLETED|Overall Study||10
6657449|NCT02469701|7587797|FG000|NOT COMPLETED|Overall Study||0
6657450|NCT02469714|7587803|FG000|STARTED|Overall Study||55
6657451|NCT02469714|7587804|FG001|STARTED|Overall Study||55
6657452|NCT02469714|7587803|FG000|4 Month Follow-Up|Overall Study||50
6247604|NCT00857285|7146823|FG001|STARTED|Overall Study||65
6247605|NCT00857285|7146822|FG000|COMPLETED|Overall Study||53
6657453|NCT02469714|7587804|FG001|4 Month Follow-Up|Overall Study||51
6657454|NCT02469714|7587803|FG000|8 Month Follow-Up|Overall Study||49
6657455|NCT02469714|7587804|FG001|8 Month Follow-Up|Overall Study||50
6657456|NCT02469714|7587803|FG000|COMPLETED|Overall Study||47
6657457|NCT02469714|7587804|FG001|COMPLETED|Overall Study||50
6657458|NCT02469714|7587803|FG000|NOT COMPLETED|Overall Study||8
6657459|NCT02469714|7587804|FG001|NOT COMPLETED|Overall Study||5
6657460|NCT02469857|7587812|FG000|STARTED|Overall Study||143
6657461|NCT02469857|7587813|FG001|STARTED|Overall Study||147
6657462|NCT02469857|7587812|FG000|COMPLETED|Overall Study||118
6657463|NCT02469857|7587813|FG001|COMPLETED|Overall Study||115
6657464|NCT02469857|7587812|FG000|NOT COMPLETED|Overall Study||25
6657465|NCT02469857|7587813|FG001|NOT COMPLETED|Overall Study||32
6657466|NCT02469870|7587823|FG000|STARTED|Overall Study||77
6657467|NCT02469870|7587824|FG001|STARTED|Overall Study||79
6657468|NCT02469870|7587823|FG000|COMPLETED|Overall Study||73
6657469|NCT02469870|7587824|FG001|COMPLETED|Overall Study||72
6657470|NCT02469870|7587823|FG000|NOT COMPLETED|Overall Study||4
6657471|NCT02469870|7587824|FG001|NOT COMPLETED|Overall Study||7
6657472|NCT02469896|7587835|FG000|STARTED|Overall Study||8
6657473|NCT02469896|7587836|FG001|STARTED|Overall Study||14
6657474|NCT02469896|7587835|FG000|COMPLETED|Overall Study||6
6657475|NCT02469896|7587836|FG001|COMPLETED|Overall Study||14
6657476|NCT02469896|7587835|FG000|NOT COMPLETED|Overall Study||2
6657477|NCT02469896|7587836|FG001|NOT COMPLETED|Overall Study||0
6657478|NCT02469961|7587848|FG000|STARTED|Overall Study||25
6657479|NCT02469961|7587849|FG001|STARTED|Overall Study||25
6657480|NCT02469961|7587848|FG000|COMPLETED|Overall Study||21
6657481|NCT02469961|7587849|FG001|COMPLETED|Overall Study||24
6657482|NCT02469961|7587848|FG000|NOT COMPLETED|Overall Study||4
6657483|NCT02469961|7587849|FG001|NOT COMPLETED|Overall Study||1
6569660|NCT01846988|7493053|FG001|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
6569661|NCT01846988|7493054|FG002|COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
6569662|NCT01846988|7493052|FG000|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
6569663|NCT01846988|7493053|FG001|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
6569664|NCT01846988|7493054|FG002|NOT COMPLETED|APAP Pressurize Comparison (4-8 Weeks)||0
6569665|NCT01846988|7493052|FG000|STARTED|Intervention #1 - 4 Weeks||0
6569666|NCT01846988|7493053|FG001|STARTED|Intervention #1 - 4 Weeks|Only 10 of 15 participants completing Comparison period started periods 1 & 2|5
6569667|NCT01846988|7493054|FG002|STARTED|Intervention #1 - 4 Weeks||5
6569668|NCT01846988|7493052|FG000|COMPLETED|Intervention #1 - 4 Weeks||0
6569669|NCT01846988|7493053|FG001|COMPLETED|Intervention #1 - 4 Weeks||5
6569670|NCT01846988|7493054|FG002|COMPLETED|Intervention #1 - 4 Weeks||5
6569671|NCT01846988|7493052|FG000|NOT COMPLETED|Intervention #1 - 4 Weeks||0
6569672|NCT01846988|7493053|FG001|NOT COMPLETED|Intervention #1 - 4 Weeks||0
6569673|NCT01846988|7493054|FG002|NOT COMPLETED|Intervention #1 - 4 Weeks||0
6569674|NCT01846988|7493052|FG000|STARTED|Intervention #2 - 4 Weeks||0
6569675|NCT01846988|7493053|FG001|STARTED|Intervention #2 - 4 Weeks||5
6569676|NCT01846988|7493054|FG002|STARTED|Intervention #2 - 4 Weeks||5
6569677|NCT01846988|7493052|FG000|COMPLETED|Intervention #2 - 4 Weeks||0
6569678|NCT01846988|7493053|FG001|COMPLETED|Intervention #2 - 4 Weeks||5
6569679|NCT01846988|7493054|FG002|COMPLETED|Intervention #2 - 4 Weeks||5
6569680|NCT01846988|7493052|FG000|NOT COMPLETED|Intervention #2 - 4 Weeks||0
6569681|NCT01846988|7493053|FG001|NOT COMPLETED|Intervention #2 - 4 Weeks||0
6569682|NCT01846988|7493054|FG002|NOT COMPLETED|Intervention #2 - 4 Weeks||0
6569683|NCT01847001|7493071|FG000|STARTED|Overall Study||10
6247606|NCT00857285|7146823|FG001|COMPLETED|Overall Study||59
6247607|NCT00857285|7146822|FG000|NOT COMPLETED|Overall Study||12
6247608|NCT00857285|7146823|FG001|NOT COMPLETED|Overall Study||6
6247609|NCT00856934|7146830|FG000|STARTED|Overall Study||15
6247610|NCT00856934|7146831|FG001|STARTED|Overall Study||15
6247611|NCT00856934|7146832|FG002|STARTED|Overall Study||15
6247612|NCT00856934|7146830|FG000|COMPLETED|Overall Study||15
6247613|NCT00856934|7146831|FG001|COMPLETED|Overall Study||15
6247614|NCT00856934|7146832|FG002|COMPLETED|Overall Study||15
6247615|NCT00856934|7146830|FG000|NOT COMPLETED|Overall Study||0
6247616|NCT00856934|7146831|FG001|NOT COMPLETED|Overall Study||0
6247617|NCT00856934|7146832|FG002|NOT COMPLETED|Overall Study||0
6247618|NCT00850174|7146839|FG000|STARTED|First Intervention||30
6247619|NCT00850174|7146840|FG001|STARTED|First Intervention||30
6247620|NCT00850174|7146839|FG000|COMPLETED|First Intervention||30
6247621|NCT00850174|7146840|FG001|COMPLETED|First Intervention||30
6247622|NCT00850174|7146839|FG000|NOT COMPLETED|First Intervention||0
6247623|NCT00850174|7146840|FG001|NOT COMPLETED|First Intervention||0
6247624|NCT00850174|7146839|FG000|STARTED|Washout: One Week||30
6247625|NCT00850174|7146840|FG001|STARTED|Washout: One Week||30
6247626|NCT00850174|7146839|FG000|COMPLETED|Washout: One Week||30
6247627|NCT00850174|7146840|FG001|COMPLETED|Washout: One Week||28
6247628|NCT00850174|7146839|FG000|NOT COMPLETED|Washout: One Week||0
6247629|NCT00850174|7146840|FG001|NOT COMPLETED|Washout: One Week||2
6247630|NCT00850174|7146839|FG000|STARTED|Second Intervention||30
6247631|NCT00850174|7146840|FG001|STARTED|Second Intervention||28
6247632|NCT00850174|7146839|FG000|COMPLETED|Second Intervention||29
6247633|NCT00850174|7146840|FG001|COMPLETED|Second Intervention||28
6247634|NCT00850174|7146839|FG000|NOT COMPLETED|Second Intervention||1
6247635|NCT00850174|7146840|FG001|NOT COMPLETED|Second Intervention||0
6247636|NCT00849862|7146846|FG000|STARTED|First Intervention||11
6247637|NCT00849862|7146847|FG001|STARTED|First Intervention||11
6247638|NCT00849862|7146846|FG000|COMPLETED|First Intervention||11
6247639|NCT00849862|7146847|FG001|COMPLETED|First Intervention||11
6247640|NCT00849862|7146846|FG000|NOT COMPLETED|First Intervention||0
6247641|NCT00849862|7146847|FG001|NOT COMPLETED|First Intervention||0
6247642|NCT00849862|7146846|FG000|STARTED|Washout: 7 Days||11
6247643|NCT00849862|7146847|FG001|STARTED|Washout: 7 Days||11
6247644|NCT00849862|7146846|FG000|COMPLETED|Washout: 7 Days||11
6247645|NCT00849862|7146847|FG001|COMPLETED|Washout: 7 Days||11
6247646|NCT00849862|7146846|FG000|NOT COMPLETED|Washout: 7 Days||0
6247647|NCT00849862|7146847|FG001|NOT COMPLETED|Washout: 7 Days||0
6247648|NCT00849862|7146846|FG000|STARTED|Second Intervention||11
6247649|NCT00849862|7146847|FG001|STARTED|Second Intervention||11
6247650|NCT00849862|7146846|FG000|COMPLETED|Second Intervention||11
6247651|NCT00849862|7146847|FG001|COMPLETED|Second Intervention||11
6247652|NCT00849862|7146846|FG000|NOT COMPLETED|Second Intervention||0
6247653|NCT00849862|7146847|FG001|NOT COMPLETED|Second Intervention||0
6247654|NCT00849797|7146853|FG000|STARTED|First Intervention||60
6247655|NCT00849797|7146854|FG001|STARTED|First Intervention||60
6247656|NCT00849797|7146853|FG000|COMPLETED|First Intervention||59
6247657|NCT00849797|7146854|FG001|COMPLETED|First Intervention||59
6247658|NCT00849797|7146853|FG000|NOT COMPLETED|First Intervention||1
6247659|NCT00849797|7146854|FG001|NOT COMPLETED|First Intervention||1
6247660|NCT00849797|7146853|FG000|STARTED|Washout: One Week||59
6247661|NCT00849797|7146854|FG001|STARTED|Washout: One Week||59
6247662|NCT00849797|7146853|FG000|COMPLETED|Washout: One Week||59
6247663|NCT00849797|7146854|FG001|COMPLETED|Washout: One Week||57
6247664|NCT00849797|7146853|FG000|NOT COMPLETED|Washout: One Week||0
6247665|NCT00849797|7146854|FG001|NOT COMPLETED|Washout: One Week||2
6247666|NCT00849797|7146853|FG000|STARTED|Second Intervention||59
6247667|NCT00849797|7146854|FG001|STARTED|Second Intervention||57
6247668|NCT00849797|7146853|FG000|COMPLETED|Second Intervention||59
6247669|NCT00849797|7146854|FG001|COMPLETED|Second Intervention||57
6247670|NCT00849797|7146853|FG000|NOT COMPLETED|Second Intervention||0
6247671|NCT00849797|7146854|FG001|NOT COMPLETED|Second Intervention||0
6247672|NCT00849485|7146861|FG000|STARTED|First Intervention||11
6247673|NCT00849485|7146862|FG001|STARTED|First Intervention||11
6247674|NCT00849485|7146861|FG000|COMPLETED|First Intervention||11
6247675|NCT00849485|7146862|FG001|COMPLETED|First Intervention||11
6247676|NCT00849485|7146861|FG000|NOT COMPLETED|First Intervention||0
6247677|NCT00849485|7146862|FG001|NOT COMPLETED|First Intervention||0
6247678|NCT00849485|7146861|FG000|STARTED|Washout: 7 Days||11
6247679|NCT00849485|7146862|FG001|STARTED|Washout: 7 Days||11
6247680|NCT00849485|7146861|FG000|COMPLETED|Washout: 7 Days||11
6247681|NCT00849485|7146862|FG001|COMPLETED|Washout: 7 Days||11
6247682|NCT00849485|7146861|FG000|NOT COMPLETED|Washout: 7 Days||0
6247683|NCT00849485|7146862|FG001|NOT COMPLETED|Washout: 7 Days||0
6247684|NCT00849485|7146861|FG000|STARTED|Second Intervention||11
6247685|NCT00849485|7146862|FG001|STARTED|Second Intervention||11
6247686|NCT00849485|7146861|FG000|COMPLETED|Second Intervention||11
6247687|NCT00849485|7146862|FG001|COMPLETED|Second Intervention||11
6247688|NCT00849485|7146861|FG000|NOT COMPLETED|Second Intervention||0
6247689|NCT00849485|7146862|FG001|NOT COMPLETED|Second Intervention||0
6247690|NCT00847405|7146868|FG000|STARTED|First Intervention||14
6247691|NCT00847405|7146869|FG001|STARTED|First Intervention||14
6247692|NCT00847405|7146868|FG000|COMPLETED|First Intervention||14
6247693|NCT00847405|7146869|FG001|COMPLETED|First Intervention||13
6247694|NCT00847405|7146868|FG000|NOT COMPLETED|First Intervention||0
6247695|NCT00847405|7146869|FG001|NOT COMPLETED|First Intervention||1
6247696|NCT00847405|7146868|FG000|STARTED|Washout of 7 Days||14
6247697|NCT00847405|7146869|FG001|STARTED|Washout of 7 Days||13
6247698|NCT00847405|7146868|FG000|COMPLETED|Washout of 7 Days||13
6247699|NCT00847405|7146869|FG001|COMPLETED|Washout of 7 Days||13
6247700|NCT00847405|7146868|FG000|NOT COMPLETED|Washout of 7 Days||1
6247701|NCT00847405|7146869|FG001|NOT COMPLETED|Washout of 7 Days||0
6247702|NCT00847405|7146868|FG000|STARTED|Second Intervention||13
6247703|NCT00847405|7146869|FG001|STARTED|Second Intervention||13
6247704|NCT00847405|7146868|FG000|COMPLETED|Second Intervention||13
6247705|NCT00847405|7146869|FG001|COMPLETED|Second Intervention||13
6247706|NCT00847405|7146868|FG000|NOT COMPLETED|Second Intervention||0
6247707|NCT00847405|7146869|FG001|NOT COMPLETED|Second Intervention||0
6247708|NCT00846885|7146875|FG000|STARTED|First Intervention||14
6247709|NCT00846885|7146876|FG001|STARTED|First Intervention||14
6247710|NCT00846885|7146875|FG000|COMPLETED|First Intervention||14
6247711|NCT00846885|7146876|FG001|COMPLETED|First Intervention||14
6247712|NCT00846885|7146875|FG000|NOT COMPLETED|First Intervention||0
6247713|NCT00846885|7146876|FG001|NOT COMPLETED|First Intervention||0
6247714|NCT00846885|7146875|FG000|STARTED|Washout of 7 Days||14
6505271|NCT01452789|7424443|FG000|NOT COMPLETED|Overall Study||3
6505272|NCT01452789|7424444|FG001|NOT COMPLETED|Overall Study||2
6505273|NCT01452919|7424450|FG000|STARTED|Open-Label Treatment||123
6505274|NCT01452919|7424451|FG001|STARTED|Open-Label Treatment||0
6505275|NCT01452919|7424452|FG002|STARTED|Open-Label Treatment||0
6505276|NCT01452919|7424450|FG000|Received at Least 1 Dose of Study Drug|Open-Label Treatment||123
6505277|NCT01452919|7424451|FG001|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
6505278|NCT01452919|7424452|FG002|Received at Least 1 Dose of Study Drug|Open-Label Treatment||0
6505279|NCT01452919|7424450|FG000|COMPLETED|Open-Label Treatment||103
6505280|NCT01452919|7424451|FG001|COMPLETED|Open-Label Treatment||0
6505281|NCT01452919|7424452|FG002|COMPLETED|Open-Label Treatment||0
6505282|NCT01452919|7424450|FG000|NOT COMPLETED|Open-Label Treatment||20
6505283|NCT01452919|7424451|FG001|NOT COMPLETED|Open-Label Treatment||0
6505284|NCT01452919|7424452|FG002|NOT COMPLETED|Open-Label Treatment||0
6505285|NCT01452919|7424450|FG000|STARTED|Randomization Treatment||0
6505286|NCT01452919|7424451|FG001|STARTED|Randomization Treatment||50
6569684|NCT01847001|7493071|FG000|COMPLETED|Overall Study||10
6569685|NCT01847001|7493071|FG000|NOT COMPLETED|Overall Study||0
6569686|NCT01847014|7493076|FG000|STARTED|Baseline Extension Visit||4
6569687|NCT01847014|7493076|FG000|COMPLETED|Baseline Extension Visit||4
6569688|NCT01847014|7493076|FG000|NOT COMPLETED|Baseline Extension Visit||0
6569689|NCT01847014|7493076|FG000|STARTED|Completion of Extension Study||4
6569690|NCT01847014|7493076|FG000|COMPLETED|Completion of Extension Study||0
6569691|NCT01847014|7493076|FG000|NOT COMPLETED|Completion of Extension Study||4
6569692|NCT01847027|7493082|FG000|STARTED|Overall Study||11
6569693|NCT01847027|7493083|FG001|STARTED|Overall Study||12
6569694|NCT01847027|7493082|FG000|COMPLETED|Overall Study||10
6569695|NCT01847027|7493083|FG001|COMPLETED|Overall Study||10
6569696|NCT01847027|7493082|FG000|NOT COMPLETED|Overall Study||1
6569697|NCT01847027|7493083|FG001|NOT COMPLETED|Overall Study||2
6247715|NCT00846885|7146876|FG001|STARTED|Washout of 7 Days||14
6247716|NCT00846885|7146875|FG000|COMPLETED|Washout of 7 Days||14
6247717|NCT00846885|7146876|FG001|COMPLETED|Washout of 7 Days||14
6247718|NCT00846885|7146875|FG000|NOT COMPLETED|Washout of 7 Days||0
6247719|NCT00846885|7146876|FG001|NOT COMPLETED|Washout of 7 Days||0
6247720|NCT00846885|7146875|FG000|STARTED|Second Intervention||14
6247721|NCT00846885|7146876|FG001|STARTED|Second Intervention||14
6247722|NCT00846885|7146875|FG000|COMPLETED|Second Intervention||14
6247723|NCT00846885|7146876|FG001|COMPLETED|Second Intervention||14
6247724|NCT00846885|7146875|FG000|NOT COMPLETED|Second Intervention||0
6247725|NCT00846885|7146876|FG001|NOT COMPLETED|Second Intervention||0
6569698|NCT01847092|7493091|FG000|STARTED|Overall Study||77
6569699|NCT01847092|7493092|FG001|STARTED|Overall Study||77
6569700|NCT01847092|7493091|FG000|COMPLETED|Overall Study||51
6569701|NCT01847092|7493092|FG001|COMPLETED|Overall Study||66
6569702|NCT01847092|7493091|FG000|NOT COMPLETED|Overall Study||26
6277016|NCT00123682|7176378|FG003|STARTED|Overall Study||525
6277017|NCT00123682|7176375|FG000|COMPLETED|Overall Study||749
6505287|NCT01452919|7424452|FG002|STARTED|Randomization Treatment||53
6505288|NCT01452919|7424450|FG000|Received at Least 1 Dose of Study Drug|Randomization Treatment||0
6505289|NCT01452919|7424451|FG001|Received at Least 1 Dose of Study Drug|Randomization Treatment||50
6505290|NCT01452919|7424452|FG002|Received at Least 1 Dose of Study Drug|Randomization Treatment||53
6505291|NCT01452919|7424450|FG000|COMPLETED|Randomization Treatment||0
6505292|NCT01452919|7424451|FG001|COMPLETED|Randomization Treatment||47
6505293|NCT01452919|7424452|FG002|COMPLETED|Randomization Treatment||51
6505294|NCT01452919|7424450|FG000|NOT COMPLETED|Randomization Treatment||0
6505295|NCT01452919|7424451|FG001|NOT COMPLETED|Randomization Treatment||3
6505296|NCT01452919|7424452|FG002|NOT COMPLETED|Randomization Treatment||2
6505297|NCT01453023|7424462|FG000|STARTED|Treatment Period (TP) 1||13
6505298|NCT01453023|7424463|FG001|STARTED|Treatment Period (TP) 1||13
6505299|NCT01453023|7424462|FG000|COMPLETED|Treatment Period (TP) 1||12
6505300|NCT01453023|7424463|FG001|COMPLETED|Treatment Period (TP) 1||12
6505301|NCT01453023|7424462|FG000|NOT COMPLETED|Treatment Period (TP) 1||1
6505302|NCT01453023|7424463|FG001|NOT COMPLETED|Treatment Period (TP) 1||1
6505303|NCT01453023|7424462|FG000|STARTED|Washout Period||12
6505304|NCT01453023|7424463|FG001|STARTED|Washout Period||12
6505305|NCT01453023|7424462|FG000|COMPLETED|Washout Period||12
6505306|NCT01453023|7424463|FG001|COMPLETED|Washout Period||12
6505307|NCT01453023|7424462|FG000|NOT COMPLETED|Washout Period||0
6505308|NCT01453023|7424463|FG001|NOT COMPLETED|Washout Period||0
6505309|NCT01453023|7424462|FG000|STARTED|Treatment Period 2||12
6505310|NCT01453023|7424463|FG001|STARTED|Treatment Period 2||12
6505311|NCT01453023|7424462|FG000|COMPLETED|Treatment Period 2||12
6505312|NCT01453023|7424463|FG001|COMPLETED|Treatment Period 2||11
6505313|NCT01453023|7424462|FG000|NOT COMPLETED|Treatment Period 2||0
6505314|NCT01453023|7424463|FG001|NOT COMPLETED|Treatment Period 2||1
6569703|NCT01847092|7493092|FG001|NOT COMPLETED|Overall Study||11
6569704|NCT01847131|7493100|FG000|STARTED|Overall Study||25
6569705|NCT01847131|7493101|FG001|STARTED|Overall Study||25
6569706|NCT01847131|7493100|FG000|COMPLETED|Overall Study||25
6247756|NCT00841815|7146900|FG000|STARTED|Period 1||14
6247757|NCT00841815|7146901|FG001|STARTED|Period 1||14
6247758|NCT00841815|7146900|FG000|COMPLETED|Period 1||14
6247759|NCT00841815|7146901|FG001|COMPLETED|Period 1||14
6247760|NCT00841815|7146900|FG000|NOT COMPLETED|Period 1||0
6247761|NCT00841815|7146901|FG001|NOT COMPLETED|Period 1||0
6247762|NCT00841815|7146900|FG000|STARTED|Washout||14
6247763|NCT00841815|7146901|FG001|STARTED|Washout||14
6247764|NCT00841815|7146900|FG000|COMPLETED|Washout||14
6247765|NCT00841815|7146901|FG001|COMPLETED|Washout||13
6247766|NCT00841815|7146900|FG000|NOT COMPLETED|Washout||0
6247767|NCT00841815|7146901|FG001|NOT COMPLETED|Washout||1
6247768|NCT00841815|7146900|FG000|STARTED|Period 2||14
6247769|NCT00841815|7146901|FG001|STARTED|Period 2||13
6247770|NCT00841815|7146900|FG000|COMPLETED|Period 2||14
6247771|NCT00841815|7146901|FG001|COMPLETED|Period 2||13
6247772|NCT00841815|7146900|FG000|NOT COMPLETED|Period 2||0
6247773|NCT00841815|7146901|FG001|NOT COMPLETED|Period 2||0
6247774|NCT00841698|7146908|FG000|STARTED|First Intervention||25
6247775|NCT00841698|7146909|FG001|STARTED|First Intervention||25
6247776|NCT00841698|7146908|FG000|COMPLETED|First Intervention||24
6247777|NCT00841698|7146909|FG001|COMPLETED|First Intervention||25
6247778|NCT00841698|7146908|FG000|NOT COMPLETED|First Intervention||1
6247779|NCT00841698|7146909|FG001|NOT COMPLETED|First Intervention||0
6247780|NCT00841698|7146908|FG000|STARTED|Washout: 2 Weeks||24
6247781|NCT00841698|7146909|FG001|STARTED|Washout: 2 Weeks||25
6247782|NCT00841698|7146908|FG000|COMPLETED|Washout: 2 Weeks||24
6247783|NCT00841698|7146909|FG001|COMPLETED|Washout: 2 Weeks||25
6247784|NCT00841698|7146908|FG000|NOT COMPLETED|Washout: 2 Weeks||0
6247785|NCT00841698|7146909|FG001|NOT COMPLETED|Washout: 2 Weeks||0
6247786|NCT00841698|7146908|FG000|STARTED|Second Intervention||24
6247787|NCT00841698|7146909|FG001|STARTED|Second Intervention||25
6247788|NCT00841698|7146908|FG000|COMPLETED|Second Intervention||24
6247789|NCT00841698|7146909|FG001|COMPLETED|Second Intervention||25
6247790|NCT00841698|7146908|FG000|NOT COMPLETED|Second Intervention||0
6247791|NCT00841698|7146909|FG001|NOT COMPLETED|Second Intervention||0
6247792|NCT00841659|7146915|FG000|STARTED|First Intervention||12
6247793|NCT00841659|7146916|FG001|STARTED|First Intervention||12
6247794|NCT00841659|7146915|FG000|COMPLETED|First Intervention||12
6247795|NCT00841659|7146916|FG001|COMPLETED|First Intervention||12
6247796|NCT00841659|7146915|FG000|NOT COMPLETED|First Intervention||0
6247797|NCT00841659|7146916|FG001|NOT COMPLETED|First Intervention||0
6247798|NCT00841659|7146915|FG000|STARTED|Washout: 2 Weeks||12
6247799|NCT00841659|7146916|FG001|STARTED|Washout: 2 Weeks||12
6247800|NCT00841659|7146915|FG000|COMPLETED|Washout: 2 Weeks||11
6247801|NCT00841659|7146916|FG001|COMPLETED|Washout: 2 Weeks||12
6247802|NCT00841659|7146915|FG000|NOT COMPLETED|Washout: 2 Weeks||1
6247803|NCT00841659|7146916|FG001|NOT COMPLETED|Washout: 2 Weeks||0
6247804|NCT00841659|7146915|FG000|STARTED|Second Intervention||11
6247805|NCT00841659|7146916|FG001|STARTED|Second Intervention||12
6247806|NCT00841659|7146915|FG000|COMPLETED|Second Intervention||11
6247807|NCT00841659|7146916|FG001|COMPLETED|Second Intervention||12
6247808|NCT00841659|7146915|FG000|NOT COMPLETED|Second Intervention||0
6247809|NCT00841659|7146916|FG001|NOT COMPLETED|Second Intervention||0
6247810|NCT00841542|7146922|FG000|STARTED|Period 1||14
6247811|NCT00841542|7146923|FG001|STARTED|Period 1||14
6247812|NCT00841542|7146922|FG000|COMPLETED|Period 1||13
6247813|NCT00841542|7146923|FG001|COMPLETED|Period 1||14
6247814|NCT00841542|7146922|FG000|NOT COMPLETED|Period 1||1
6247815|NCT00841542|7146923|FG001|NOT COMPLETED|Period 1||0
6247816|NCT00841542|7146922|FG000|STARTED|Period 2||13
6247817|NCT00841542|7146923|FG001|STARTED|Period 2||14
6247818|NCT00841542|7146922|FG000|COMPLETED|Period 2||13
6247819|NCT00841542|7146923|FG001|COMPLETED|Period 2||14
6247820|NCT00841542|7146922|FG000|NOT COMPLETED|Period 2||0
6247821|NCT00841542|7146923|FG001|NOT COMPLETED|Period 2||0
6247822|NCT00840879|7146929|FG000|STARTED|First Intervention||14
6247823|NCT00840879|7146930|FG001|STARTED|First Intervention||14
6247824|NCT00840879|7146929|FG000|COMPLETED|First Intervention||14
6247825|NCT00840879|7146930|FG001|COMPLETED|First Intervention||14
6247826|NCT00840879|7146929|FG000|NOT COMPLETED|First Intervention||0
6247827|NCT00840879|7146930|FG001|NOT COMPLETED|First Intervention||0
6247828|NCT00840879|7146929|FG000|STARTED|Washout: 14 Days||14
6247829|NCT00840879|7146930|FG001|STARTED|Washout: 14 Days||14
6247830|NCT00840879|7146929|FG000|COMPLETED|Washout: 14 Days||14
6247831|NCT00840879|7146930|FG001|COMPLETED|Washout: 14 Days||14
6247832|NCT00840879|7146929|FG000|NOT COMPLETED|Washout: 14 Days||0
6247833|NCT00840879|7146930|FG001|NOT COMPLETED|Washout: 14 Days||0
6247834|NCT00840879|7146929|FG000|STARTED|Second Intervention||14
6247835|NCT00840879|7146930|FG001|STARTED|Second Intervention||14
6247836|NCT00840879|7146929|FG000|COMPLETED|Second Intervention||13
6247837|NCT00840879|7146930|FG001|COMPLETED|Second Intervention||14
6247838|NCT00840879|7146929|FG000|NOT COMPLETED|Second Intervention||1
6247839|NCT00840879|7146930|FG001|NOT COMPLETED|Second Intervention||0
6247840|NCT00840866|7146936|FG000|STARTED|First Intervention||20
6247841|NCT00840866|7146937|FG001|STARTED|First Intervention||19
6247842|NCT00840866|7146936|FG000|COMPLETED|First Intervention||20
6247843|NCT00840866|7146937|FG001|COMPLETED|First Intervention||19
6247844|NCT00840866|7146936|FG000|NOT COMPLETED|First Intervention||0
6247845|NCT00840866|7146937|FG001|NOT COMPLETED|First Intervention||0
6247846|NCT00840866|7146936|FG000|STARTED|Washout of 7 Days||20
6247847|NCT00840866|7146937|FG001|STARTED|Washout of 7 Days||19
6247848|NCT00840866|7146936|FG000|COMPLETED|Washout of 7 Days||20
6247849|NCT00840866|7146937|FG001|COMPLETED|Washout of 7 Days||19
6247850|NCT00840866|7146936|FG000|NOT COMPLETED|Washout of 7 Days||0
6247851|NCT00840866|7146937|FG001|NOT COMPLETED|Washout of 7 Days||0
6247852|NCT00840866|7146936|FG000|STARTED|Second Intervention||20
6247853|NCT00840866|7146937|FG001|STARTED|Second Intervention||19
6247854|NCT00840866|7146936|FG000|COMPLETED|Second Intervention||20
6247855|NCT00840866|7146937|FG001|COMPLETED|Second Intervention||19
6247856|NCT00840866|7146936|FG000|NOT COMPLETED|Second Intervention||0
6247857|NCT00840866|7146937|FG001|NOT COMPLETED|Second Intervention||0
6247858|NCT00840840|7146943|FG000|STARTED|Period 1||24
6247859|NCT00840840|7146944|FG001|STARTED|Period 1||24
6247860|NCT00840840|7146943|FG000|COMPLETED|Period 1||24
6247861|NCT00840840|7146944|FG001|COMPLETED|Period 1||24
6247862|NCT00840840|7146943|FG000|NOT COMPLETED|Period 1||0
6247863|NCT00840840|7146944|FG001|NOT COMPLETED|Period 1||0
6247864|NCT00840840|7146943|FG000|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
6247865|NCT00840840|7146944|FG001|STARTED|Period 2||24
6247866|NCT00840840|7146943|FG000|COMPLETED|Period 2||23
6247867|NCT00840840|7146944|FG001|COMPLETED|Period 2||24
6247868|NCT00840840|7146943|FG000|NOT COMPLETED|Period 2||0
6247869|NCT00840840|7146944|FG001|NOT COMPLETED|Period 2||0
6247870|NCT00840632|7146950|FG000|STARTED|First Intervention||20
6247871|NCT00840632|7146951|FG001|STARTED|First Intervention||20
6247872|NCT00840632|7146950|FG000|COMPLETED|First Intervention||20
6247873|NCT00840632|7146951|FG001|COMPLETED|First Intervention||19
6247874|NCT00840632|7146950|FG000|NOT COMPLETED|First Intervention||0
6247875|NCT00840632|7146951|FG001|NOT COMPLETED|First Intervention||1
6247876|NCT00840632|7146950|FG000|STARTED|Washout||20
6247877|NCT00840632|7146951|FG001|STARTED|Washout||19
6247878|NCT00840632|7146950|FG000|COMPLETED|Washout||19
6247879|NCT00840632|7146951|FG001|COMPLETED|Washout||18
6247880|NCT00840632|7146950|FG000|NOT COMPLETED|Washout||1
6569707|NCT01847131|7493101|FG001|COMPLETED|Overall Study||25
6569708|NCT01847131|7493100|FG000|NOT COMPLETED|Overall Study||0
6569709|NCT01847131|7493101|FG001|NOT COMPLETED|Overall Study||0
6247881|NCT00840632|7146951|FG001|NOT COMPLETED|Washout||1
6247882|NCT00840632|7146950|FG000|STARTED|Second Intervention||19
6247883|NCT00840632|7146951|FG001|STARTED|Second Intervention||18
6247884|NCT00840632|7146950|FG000|COMPLETED|Second Intervention||19
6247885|NCT00840632|7146951|FG001|COMPLETED|Second Intervention||18
6247886|NCT00840632|7146950|FG000|NOT COMPLETED|Second Intervention||0
6569710|NCT01847196|7493107|FG000|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
6569711|NCT01847196|7493107|FG000|COMPLETED|Overall Study||5
6247887|NCT00840632|7146951|FG001|NOT COMPLETED|Second Intervention||0
6247888|NCT00840476|7146957|FG000|STARTED|First Intervention||14
6247889|NCT00840476|7146958|FG001|STARTED|First Intervention||14
6247890|NCT00840476|7146957|FG000|COMPLETED|First Intervention||14
6247891|NCT00840476|7146958|FG001|COMPLETED|First Intervention||14
6247892|NCT00840476|7146957|FG000|NOT COMPLETED|First Intervention||0
6247893|NCT00840476|7146958|FG001|NOT COMPLETED|First Intervention||0
6247894|NCT00840476|7146957|FG000|STARTED|Washout: 14 Days||14
6247895|NCT00840476|7146958|FG001|STARTED|Washout: 14 Days||14
6247896|NCT00840476|7146957|FG000|COMPLETED|Washout: 14 Days||14
6247897|NCT00840476|7146958|FG001|COMPLETED|Washout: 14 Days||14
6247898|NCT00840476|7146957|FG000|NOT COMPLETED|Washout: 14 Days||0
6247899|NCT00840476|7146958|FG001|NOT COMPLETED|Washout: 14 Days||0
6247900|NCT00840476|7146957|FG000|STARTED|Second Intervention||14
6247901|NCT00840476|7146958|FG001|STARTED|Second Intervention||14
6247902|NCT00840476|7146957|FG000|COMPLETED|Second Intervention||14
6247903|NCT00840476|7146958|FG001|COMPLETED|Second Intervention||14
6247904|NCT00840476|7146957|FG000|NOT COMPLETED|Second Intervention||0
6247905|NCT00840476|7146958|FG001|NOT COMPLETED|Second Intervention||0
6247906|NCT00840411|7146964|FG000|STARTED|First Intervention||33
6247907|NCT00840411|7146965|FG001|STARTED|First Intervention||33
6247908|NCT00840411|7146964|FG000|COMPLETED|First Intervention||32
6247909|NCT00840411|7146965|FG001|COMPLETED|First Intervention||33
6247910|NCT00840411|7146964|FG000|NOT COMPLETED|First Intervention||1
6247911|NCT00840411|7146965|FG001|NOT COMPLETED|First Intervention||0
6247912|NCT00840411|7146964|FG000|STARTED|Washout||32
6247913|NCT00840411|7146965|FG001|STARTED|Washout||33
6247914|NCT00840411|7146964|FG000|COMPLETED|Washout||31
6247915|NCT00840411|7146965|FG001|COMPLETED|Washout||33
6247916|NCT00840411|7146964|FG000|NOT COMPLETED|Washout||1
6247917|NCT00840411|7146965|FG001|NOT COMPLETED|Washout||0
6247918|NCT00840411|7146964|FG000|STARTED|Second Intervention||31
6247919|NCT00840411|7146965|FG001|STARTED|Second Intervention||33
6247920|NCT00840411|7146964|FG000|COMPLETED|Second Intervention||31
6247921|NCT00840411|7146965|FG001|COMPLETED|Second Intervention||33
6247922|NCT00840411|7146964|FG000|NOT COMPLETED|Second Intervention||0
6247923|NCT00840411|7146965|FG001|NOT COMPLETED|Second Intervention||0
6247924|NCT00840281|7146971|FG000|STARTED|First Intervention||19
6247925|NCT00840281|7146972|FG001|STARTED|First Intervention||19
6247926|NCT00840281|7146971|FG000|COMPLETED|First Intervention||19
6247927|NCT00840281|7146972|FG001|COMPLETED|First Intervention||19
6247928|NCT00840281|7146971|FG000|NOT COMPLETED|First Intervention||0
6247929|NCT00840281|7146972|FG001|NOT COMPLETED|First Intervention||0
6247930|NCT00840281|7146971|FG000|STARTED|Washout of 7 Days||19
6247931|NCT00840281|7146972|FG001|STARTED|Washout of 7 Days||19
6247932|NCT00840281|7146971|FG000|COMPLETED|Washout of 7 Days||19
6247933|NCT00840281|7146972|FG001|COMPLETED|Washout of 7 Days||19
6247934|NCT00840281|7146971|FG000|NOT COMPLETED|Washout of 7 Days||0
6247935|NCT00840281|7146972|FG001|NOT COMPLETED|Washout of 7 Days||0
6247936|NCT00840281|7146971|FG000|STARTED|Second Intervention||19
6247937|NCT00840281|7146972|FG001|STARTED|Second Intervention||19
6247938|NCT00840281|7146971|FG000|COMPLETED|Second Intervention||19
6247939|NCT00840281|7146972|FG001|COMPLETED|Second Intervention||19
6247940|NCT00840281|7146971|FG000|NOT COMPLETED|Second Intervention||0
6247941|NCT00840281|7146972|FG001|NOT COMPLETED|Second Intervention||0
6247942|NCT00840216|7146978|FG000|STARTED|First Intervention||11
6247943|NCT00840216|7146979|FG001|STARTED|First Intervention||11
6247944|NCT00840216|7146978|FG000|COMPLETED|First Intervention||11
6247945|NCT00840216|7146979|FG001|COMPLETED|First Intervention||11
6247946|NCT00840216|7146978|FG000|NOT COMPLETED|First Intervention||0
6247947|NCT00840216|7146979|FG001|NOT COMPLETED|First Intervention||0
6247948|NCT00840216|7146978|FG000|STARTED|Washout: 7 Days||11
6247949|NCT00840216|7146979|FG001|STARTED|Washout: 7 Days||11
6247950|NCT00840216|7146978|FG000|COMPLETED|Washout: 7 Days||10
6247951|NCT00840216|7146979|FG001|COMPLETED|Washout: 7 Days||11
6247952|NCT00840216|7146978|FG000|NOT COMPLETED|Washout: 7 Days||1
6247953|NCT00840216|7146979|FG001|NOT COMPLETED|Washout: 7 Days||0
6247954|NCT00840216|7146978|FG000|STARTED|Second Intervention||10
6247955|NCT00840216|7146979|FG001|STARTED|Second Intervention||11
6247956|NCT00840216|7146978|FG000|COMPLETED|Second Intervention||10
6247957|NCT00840216|7146979|FG001|COMPLETED|Second Intervention||11
6247958|NCT00840216|7146978|FG000|NOT COMPLETED|Second Intervention||0
6247959|NCT00840216|7146979|FG001|NOT COMPLETED|Second Intervention||0
6247960|NCT00840203|7146985|FG000|STARTED|First Intervention||37
6569712|NCT01847196|7493107|FG000|NOT COMPLETED|Overall Study||0
6569713|NCT01847209|7493111|FG000|STARTED|Overall Study||25
6569714|NCT01847209|7493111|FG000|COMPLETED|Overall Study||23
6247961|NCT00840203|7146986|FG001|STARTED|First Intervention||35
6247962|NCT00840203|7146985|FG000|COMPLETED|First Intervention||36
6247963|NCT00840203|7146986|FG001|COMPLETED|First Intervention||34
6247964|NCT00840203|7146985|FG000|NOT COMPLETED|First Intervention||1
6247965|NCT00840203|7146986|FG001|NOT COMPLETED|First Intervention||1
6247966|NCT00840203|7146985|FG000|STARTED|Washout||36
6247967|NCT00840203|7146986|FG001|STARTED|Washout||34
6247968|NCT00840203|7146985|FG000|COMPLETED|Washout||35
6247969|NCT00840203|7146986|FG001|COMPLETED|Washout||34
6247970|NCT00840203|7146985|FG000|NOT COMPLETED|Washout||1
6247971|NCT00840203|7146986|FG001|NOT COMPLETED|Washout||0
6247972|NCT00840203|7146985|FG000|STARTED|Second Intervention||35
6247973|NCT00840203|7146986|FG001|STARTED|Second Intervention||34
6247974|NCT00840203|7146985|FG000|COMPLETED|Second Intervention||35
6247975|NCT00840203|7146986|FG001|COMPLETED|Second Intervention||34
6247976|NCT00840203|7146985|FG000|NOT COMPLETED|Second Intervention||0
6247977|NCT00840203|7146986|FG001|NOT COMPLETED|Second Intervention||0
6247978|NCT00840099|7146992|FG000|STARTED|Period 1||24
6247979|NCT00840099|7146993|FG001|STARTED|Period 1||24
6247980|NCT00840099|7146992|FG000|COMPLETED|Period 1||24
6247981|NCT00840099|7146993|FG001|COMPLETED|Period 1||24
6247982|NCT00840099|7146992|FG000|NOT COMPLETED|Period 1||0
6247983|NCT00840099|7146993|FG001|NOT COMPLETED|Period 1||0
6247984|NCT00840099|7146992|FG000|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
6247985|NCT00840099|7146993|FG001|STARTED|Period 2||24
6247986|NCT00840099|7146992|FG000|COMPLETED|Period 2||21
6247987|NCT00840099|7146993|FG001|COMPLETED|Period 2||24
6247988|NCT00840099|7146992|FG000|NOT COMPLETED|Period 2||0
6247989|NCT00840099|7146993|FG001|NOT COMPLETED|Period 2||0
6247990|NCT00840073|7146999|FG000|STARTED|First Intervention||25
6247991|NCT00840073|7147000|FG001|STARTED|First Intervention||25
6247992|NCT00840073|7146999|FG000|COMPLETED|First Intervention||25
6247993|NCT00840073|7147000|FG001|COMPLETED|First Intervention||25
6247994|NCT00840073|7146999|FG000|NOT COMPLETED|First Intervention||0
6247995|NCT00840073|7147000|FG001|NOT COMPLETED|First Intervention||0
6247996|NCT00840073|7146999|FG000|STARTED|Second Intervention||25
6247997|NCT00840073|7147000|FG001|STARTED|Second Intervention||25
6247998|NCT00840073|7146999|FG000|COMPLETED|Second Intervention||24
6247999|NCT00840073|7147000|FG001|COMPLETED|Second Intervention||24
6248000|NCT00840073|7146999|FG000|NOT COMPLETED|Second Intervention||1
6248001|NCT00840073|7147000|FG001|NOT COMPLETED|Second Intervention||1
6248002|NCT00839930|7147006|FG000|STARTED|First Intervention||15
6248003|NCT00839930|7147007|FG001|STARTED|First Intervention||15
6248004|NCT00839930|7147006|FG000|COMPLETED|First Intervention||15
6248005|NCT00839930|7147007|FG001|COMPLETED|First Intervention||15
6248006|NCT00839930|7147006|FG000|NOT COMPLETED|First Intervention||0
6248007|NCT00839930|7147007|FG001|NOT COMPLETED|First Intervention||0
6248008|NCT00839930|7147006|FG000|STARTED|Washout: 7 Days||15
6248009|NCT00839930|7147007|FG001|STARTED|Washout: 7 Days||15
6248010|NCT00839930|7147006|FG000|COMPLETED|Washout: 7 Days||15
6248011|NCT00839930|7147007|FG001|COMPLETED|Washout: 7 Days||15
6248012|NCT00839930|7147006|FG000|NOT COMPLETED|Washout: 7 Days||0
6569715|NCT01847209|7493111|FG000|NOT COMPLETED|Overall Study||2
6248013|NCT00839930|7147007|FG001|NOT COMPLETED|Washout: 7 Days||0
6248014|NCT00839930|7147006|FG000|STARTED|Second Intervention||15
6248015|NCT00839930|7147007|FG001|STARTED|Second Intervention||15
6248016|NCT00839930|7147006|FG000|COMPLETED|Second Intervention||15
6248017|NCT00839930|7147007|FG001|COMPLETED|Second Intervention||15
6248018|NCT00839930|7147006|FG000|NOT COMPLETED|Second Intervention||0
6248019|NCT00839930|7147007|FG001|NOT COMPLETED|Second Intervention||0
6248020|NCT00838630|7147013|FG000|STARTED|First Intervention||18
6248021|NCT00838630|7147014|FG001|STARTED|First Intervention||18
6248022|NCT00838630|7147013|FG000|COMPLETED|First Intervention||17
6248023|NCT00838630|7147014|FG001|COMPLETED|First Intervention||18
6248024|NCT00838630|7147013|FG000|NOT COMPLETED|First Intervention||1
6248025|NCT00838630|7147014|FG001|NOT COMPLETED|First Intervention||0
6248026|NCT00838630|7147013|FG000|STARTED|Washout: 7 Days||17
6248027|NCT00838630|7147014|FG001|STARTED|Washout: 7 Days||18
6248028|NCT00838630|7147013|FG000|COMPLETED|Washout: 7 Days||16
6248029|NCT00838630|7147014|FG001|COMPLETED|Washout: 7 Days||18
6248030|NCT00838630|7147013|FG000|NOT COMPLETED|Washout: 7 Days||1
6248031|NCT00838630|7147014|FG001|NOT COMPLETED|Washout: 7 Days||0
6248032|NCT00838630|7147013|FG000|STARTED|Second Intervention||16
6248033|NCT00838630|7147014|FG001|STARTED|Second Intervention||18
6248034|NCT00838630|7147013|FG000|COMPLETED|Second Intervention||16
6248035|NCT00838630|7147014|FG001|COMPLETED|Second Intervention||18
6248036|NCT00838630|7147013|FG000|NOT COMPLETED|Second Intervention||0
6248037|NCT00838630|7147014|FG001|NOT COMPLETED|Second Intervention||0
6248038|NCT00838279|7147020|FG000|STARTED|First Intervention||16
6248039|NCT00838279|7147021|FG001|STARTED|First Intervention||16
6505315|NCT01453036|7424472|FG000|STARTED|Overall Study||308
6505316|NCT01453036|7424473|FG001|STARTED|Overall Study||308
6505317|NCT01453036|7424474|FG002|STARTED|Overall Study||308
6505318|NCT01453036|7424472|FG000|COMPLETED|Overall Study||282
6505319|NCT01453036|7424473|FG001|COMPLETED|Overall Study||193
6505320|NCT01453036|7424474|FG002|COMPLETED|Overall Study||277
6505321|NCT01453036|7424472|FG000|NOT COMPLETED|Overall Study||26
6505322|NCT01453036|7424473|FG001|NOT COMPLETED|Overall Study||115
6505323|NCT01453036|7424474|FG002|NOT COMPLETED|Overall Study||31
6505324|NCT01453049|7424484|FG000|STARTED|Overall Study||42
6505325|NCT01453049|7424485|FG001|STARTED|Overall Study||44
6505326|NCT01453049|7424484|FG000|COMPLETED|Overall Study||1
6505327|NCT01453049|7424485|FG001|COMPLETED|Overall Study||2
6505328|NCT01453049|7424484|FG000|NOT COMPLETED|Overall Study||41
6505329|NCT01453049|7424485|FG001|NOT COMPLETED|Overall Study||42
6505330|NCT01453075|7424493|FG000|STARTED|Overall Study||16
6505331|NCT01453075|7424494|FG001|STARTED|Overall Study||15
6505332|NCT01453075|7424493|FG000|COMPLETED|Overall Study||11
6505333|NCT01453075|7424494|FG001|COMPLETED|Overall Study||14
6505334|NCT01453075|7424493|FG000|NOT COMPLETED|Overall Study||5
6505335|NCT01453075|7424494|FG001|NOT COMPLETED|Overall Study||1
6505336|NCT01453153|7424503|FG000|STARTED|Overall Study||4
6505337|NCT01453153|7424504|FG001|STARTED|Overall Study||4
6505338|NCT01453153|7424505|FG002|STARTED|Overall Study||20
6505339|NCT01453153|7424503|FG000|COMPLETED|Overall Study||0
6505340|NCT01453153|7424504|FG001|COMPLETED|Overall Study||0
6505341|NCT01453153|7424505|FG002|COMPLETED|Overall Study||0
6505342|NCT01453153|7424503|FG000|NOT COMPLETED|Overall Study||4
6505343|NCT01453153|7424504|FG001|NOT COMPLETED|Overall Study||4
6505344|NCT01453153|7424505|FG002|NOT COMPLETED|Overall Study||20
6505345|NCT01453166|7424520|FG000|STARTED|Overall Study||42
6505346|NCT01453166|7424521|FG001|STARTED|Overall Study||41
6505347|NCT01453166|7424522|FG002|STARTED|Overall Study||39
6505348|NCT01453166|7424520|FG000|COMPLETED|Overall Study||40
6505349|NCT01453166|7424521|FG001|COMPLETED|Overall Study||39
6505350|NCT01453166|7424522|FG002|COMPLETED|Overall Study||38
6248040|NCT00838279|7147020|FG000|COMPLETED|First Intervention||16
6248041|NCT00838279|7147021|FG001|COMPLETED|First Intervention||16
6248042|NCT00838279|7147020|FG000|NOT COMPLETED|First Intervention||0
6248043|NCT00838279|7147021|FG001|NOT COMPLETED|First Intervention||0
6248044|NCT00838279|7147020|FG000|STARTED|Washout||16
6248045|NCT00838279|7147021|FG001|STARTED|Washout||16
6569716|NCT01847313|7493117|FG000|STARTED|Overall Study||10
6569717|NCT01847313|7493118|FG001|STARTED|Overall Study||10
6569718|NCT01847313|7493117|FG000|COMPLETED|Overall Study||10
6569719|NCT01847313|7493118|FG001|COMPLETED|Overall Study||8
6569720|NCT01847313|7493117|FG000|NOT COMPLETED|Overall Study||0
6569721|NCT01847313|7493118|FG001|NOT COMPLETED|Overall Study||2
6569722|NCT01847430|7493124|FG000|STARTED|Overall Study||302
6569723|NCT01847430|7493124|FG000|COMPLETED|Overall Study||302
6569724|NCT01847430|7493124|FG000|NOT COMPLETED|Overall Study||0
6569725|NCT01847443|7493128|FG000|STARTED|Study Period 1||21
6569726|NCT01847443|7493129|FG001|STARTED|Study Period 1||21
6569727|NCT01847443|7493130|FG002|STARTED|Study Period 1||21
6569728|NCT01847443|7493131|FG003|STARTED|Study Period 1||21
6569729|NCT01847443|7493128|FG000|COMPLETED|Study Period 1||21
6569730|NCT01847443|7493129|FG001|COMPLETED|Study Period 1||20
6569731|NCT01847443|7493130|FG002|COMPLETED|Study Period 1||21
6569732|NCT01847443|7493131|FG003|COMPLETED|Study Period 1||21
6569733|NCT01847443|7493128|FG000|NOT COMPLETED|Study Period 1||0
6569734|NCT01847443|7493129|FG001|NOT COMPLETED|Study Period 1||1
6569735|NCT01847443|7493130|FG002|NOT COMPLETED|Study Period 1||0
6569736|NCT01847443|7493131|FG003|NOT COMPLETED|Study Period 1||0
6569737|NCT01847443|7493128|FG000|STARTED|Washout Period Before Study Period 2||21
6569738|NCT01847443|7493129|FG001|STARTED|Washout Period Before Study Period 2||20
6569739|NCT01847443|7493130|FG002|STARTED|Washout Period Before Study Period 2||21
6569740|NCT01847443|7493131|FG003|STARTED|Washout Period Before Study Period 2||21
6569741|NCT01847443|7493128|FG000|COMPLETED|Washout Period Before Study Period 2||19
6569742|NCT01847443|7493129|FG001|COMPLETED|Washout Period Before Study Period 2||19
6569743|NCT01847443|7493130|FG002|COMPLETED|Washout Period Before Study Period 2||21
6569744|NCT01847443|7493131|FG003|COMPLETED|Washout Period Before Study Period 2||21
6248046|NCT00838279|7147020|FG000|COMPLETED|Washout||15
6569745|NCT01847443|7493128|FG000|NOT COMPLETED|Washout Period Before Study Period 2||2
6569746|NCT01847443|7493129|FG001|NOT COMPLETED|Washout Period Before Study Period 2||1
6569747|NCT01847443|7493130|FG002|NOT COMPLETED|Washout Period Before Study Period 2||0
6569748|NCT01847443|7493131|FG003|NOT COMPLETED|Washout Period Before Study Period 2||0
6569749|NCT01847443|7493128|FG000|STARTED|Study Period 2||19
6569750|NCT01847443|7493129|FG001|STARTED|Study Period 2||19
6569751|NCT01847443|7493130|FG002|STARTED|Study Period 2||21
6569752|NCT01847443|7493131|FG003|STARTED|Study Period 2||21
6569753|NCT01847443|7493128|FG000|COMPLETED|Study Period 2||19
6569754|NCT01847443|7493129|FG001|COMPLETED|Study Period 2||19
6569755|NCT01847443|7493130|FG002|COMPLETED|Study Period 2||21
6569756|NCT01847443|7493131|FG003|COMPLETED|Study Period 2||21
6569757|NCT01847443|7493128|FG000|NOT COMPLETED|Study Period 2||0
6569758|NCT01847443|7493129|FG001|NOT COMPLETED|Study Period 2||0
6569759|NCT01847443|7493130|FG002|NOT COMPLETED|Study Period 2||0
6569760|NCT01847443|7493131|FG003|NOT COMPLETED|Study Period 2||0
6569761|NCT01847443|7493128|FG000|STARTED|Washout Period Before Study Period 3||19
6569762|NCT01847443|7493129|FG001|STARTED|Washout Period Before Study Period 3||19
6569763|NCT01847443|7493130|FG002|STARTED|Washout Period Before Study Period 3||21
6569764|NCT01847443|7493131|FG003|STARTED|Washout Period Before Study Period 3||21
6569765|NCT01847443|7493128|FG000|COMPLETED|Washout Period Before Study Period 3||18
6569766|NCT01847443|7493129|FG001|COMPLETED|Washout Period Before Study Period 3||19
6569767|NCT01847443|7493130|FG002|COMPLETED|Washout Period Before Study Period 3||21
6248047|NCT00838279|7147021|FG001|COMPLETED|Washout||15
6248048|NCT00838279|7147020|FG000|NOT COMPLETED|Washout||1
6248049|NCT00838279|7147021|FG001|NOT COMPLETED|Washout||1
6569768|NCT01847443|7493131|FG003|COMPLETED|Washout Period Before Study Period 3||21
6248050|NCT00838279|7147020|FG000|STARTED|Second Intervention||15
6248051|NCT00838279|7147021|FG001|STARTED|Second Intervention||15
6248052|NCT00838279|7147020|FG000|COMPLETED|Second Intervention||15
6248053|NCT00838279|7147021|FG001|COMPLETED|Second Intervention||15
6248054|NCT00838279|7147020|FG000|NOT COMPLETED|Second Intervention||0
6248055|NCT00838279|7147021|FG001|NOT COMPLETED|Second Intervention||0
6248056|NCT00838136|7147027|FG000|STARTED|First Intervention||16
6248057|NCT00838136|7147028|FG001|STARTED|First Intervention||16
6248058|NCT00838136|7147027|FG000|COMPLETED|First Intervention||16
6248059|NCT00838136|7147028|FG001|COMPLETED|First Intervention||16
6248060|NCT00838136|7147027|FG000|NOT COMPLETED|First Intervention||0
6248061|NCT00838136|7147028|FG001|NOT COMPLETED|First Intervention||0
6248062|NCT00838136|7147027|FG000|STARTED|Second Intervention||16
6248063|NCT00838136|7147028|FG001|STARTED|Second Intervention||16
6248064|NCT00838136|7147027|FG000|COMPLETED|Second Intervention||16
6248065|NCT00838136|7147028|FG001|COMPLETED|Second Intervention||15
6248066|NCT00838136|7147027|FG000|NOT COMPLETED|Second Intervention||0
6248067|NCT00838136|7147028|FG001|NOT COMPLETED|Second Intervention||1
6248068|NCT00836901|7147034|FG000|STARTED|First Intervention||24
6248069|NCT00836901|7147035|FG001|STARTED|First Intervention||28
6248070|NCT00836901|7147034|FG000|COMPLETED|First Intervention||23
6248071|NCT00836901|7147035|FG001|COMPLETED|First Intervention||28
6248072|NCT00836901|7147034|FG000|NOT COMPLETED|First Intervention||1
6248073|NCT00836901|7147035|FG001|NOT COMPLETED|First Intervention||0
6248074|NCT00836901|7147034|FG000|STARTED|Second Intervention||23
6248075|NCT00836901|7147035|FG001|STARTED|Second Intervention||28
6248076|NCT00836901|7147034|FG000|COMPLETED|Second Intervention||23
6248077|NCT00836901|7147035|FG001|COMPLETED|Second Intervention||28
6248078|NCT00836901|7147034|FG000|NOT COMPLETED|Second Intervention||0
6248079|NCT00836901|7147035|FG001|NOT COMPLETED|Second Intervention||0
6248080|NCT00836706|7147041|FG000|STARTED|First Intervention||11
6248081|NCT00836706|7147042|FG001|STARTED|First Intervention||12
6248082|NCT00836706|7147041|FG000|COMPLETED|First Intervention||11
6248083|NCT00836706|7147042|FG001|COMPLETED|First Intervention||12
6248084|NCT00836706|7147041|FG000|NOT COMPLETED|First Intervention||0
6248085|NCT00836706|7147042|FG001|NOT COMPLETED|First Intervention||0
6248086|NCT00836706|7147041|FG000|STARTED|Washout: 7 Days||11
6248087|NCT00836706|7147042|FG001|STARTED|Washout: 7 Days||12
6248088|NCT00836706|7147041|FG000|COMPLETED|Washout: 7 Days||11
6248089|NCT00836706|7147042|FG001|COMPLETED|Washout: 7 Days||11
6248090|NCT00836706|7147041|FG000|NOT COMPLETED|Washout: 7 Days||0
6248091|NCT00836706|7147042|FG001|NOT COMPLETED|Washout: 7 Days||1
6248092|NCT00836706|7147041|FG000|STARTED|Second Intervention||11
6248093|NCT00836706|7147042|FG001|STARTED|Second Intervention||11
6248094|NCT00836706|7147041|FG000|COMPLETED|Second Intervention||11
6248095|NCT00836706|7147042|FG001|COMPLETED|Second Intervention||11
6248096|NCT00836706|7147041|FG000|NOT COMPLETED|Second Intervention||0
6248097|NCT00836706|7147042|FG001|NOT COMPLETED|Second Intervention||0
6248098|NCT00836472|7147048|FG000|STARTED|First Intervention||30
6248099|NCT00836472|7147049|FG001|STARTED|First Intervention||30
6248100|NCT00836472|7147048|FG000|COMPLETED|First Intervention||30
6248101|NCT00836472|7147049|FG001|COMPLETED|First Intervention||30
6248102|NCT00836472|7147048|FG000|NOT COMPLETED|First Intervention||0
6248103|NCT00836472|7147049|FG001|NOT COMPLETED|First Intervention||0
6248104|NCT00836472|7147048|FG000|STARTED|Washout||30
6248105|NCT00836472|7147049|FG001|STARTED|Washout||30
6248106|NCT00836472|7147048|FG000|COMPLETED|Washout||28
6248107|NCT00836472|7147049|FG001|COMPLETED|Washout||27
6248108|NCT00836472|7147048|FG000|NOT COMPLETED|Washout||2
6248109|NCT00836472|7147049|FG001|NOT COMPLETED|Washout||3
6248110|NCT00836472|7147048|FG000|STARTED|Second Intervention||28
6248111|NCT00836472|7147049|FG001|STARTED|Second Intervention||27
6248112|NCT00836472|7147048|FG000|COMPLETED|Second Intervention||28
6248113|NCT00836472|7147049|FG001|COMPLETED|Second Intervention||27
6248114|NCT00836472|7147048|FG000|NOT COMPLETED|Second Intervention||0
6248115|NCT00836472|7147049|FG001|NOT COMPLETED|Second Intervention||0
6248116|NCT00836056|7147055|FG000|STARTED|First Intervention||12
6248117|NCT00836056|7147056|FG001|STARTED|First Intervention||12
6248118|NCT00836056|7147055|FG000|COMPLETED|First Intervention||11
6248119|NCT00836056|7147056|FG001|COMPLETED|First Intervention||12
6248120|NCT00836056|7147055|FG000|NOT COMPLETED|First Intervention||1
6248121|NCT00836056|7147056|FG001|NOT COMPLETED|First Intervention||0
6248122|NCT00836056|7147055|FG000|STARTED|Washout: 7 Days||11
6248123|NCT00836056|7147056|FG001|STARTED|Washout: 7 Days||12
6248124|NCT00836056|7147055|FG000|COMPLETED|Washout: 7 Days||11
6248125|NCT00836056|7147056|FG001|COMPLETED|Washout: 7 Days||12
6248126|NCT00836056|7147055|FG000|NOT COMPLETED|Washout: 7 Days||0
6248127|NCT00836056|7147056|FG001|NOT COMPLETED|Washout: 7 Days||0
6248128|NCT00836056|7147055|FG000|STARTED|Second Intervention||11
6248129|NCT00836056|7147056|FG001|STARTED|Second Intervention||12
6248130|NCT00836056|7147055|FG000|COMPLETED|Second Intervention||11
6248131|NCT00836056|7147056|FG001|COMPLETED|Second Intervention||12
6248132|NCT00836056|7147055|FG000|NOT COMPLETED|Second Intervention||0
6248133|NCT00836056|7147056|FG001|NOT COMPLETED|Second Intervention||0
6248134|NCT00836004|7147062|FG000|STARTED|First Intervention||12
6248135|NCT00836004|7147063|FG001|STARTED|First Intervention||12
6248136|NCT00836004|7147062|FG000|COMPLETED|First Intervention||12
6248137|NCT00836004|7147063|FG001|COMPLETED|First Intervention||12
6505351|NCT01453166|7424520|FG000|NOT COMPLETED|Overall Study||2
6505352|NCT01453166|7424521|FG001|NOT COMPLETED|Overall Study||2
6505353|NCT01453166|7424522|FG002|NOT COMPLETED|Overall Study||1
6505354|NCT01453205|7424533|FG000|STARTED|Overall Study||80
6505355|NCT01453205|7424534|FG001|STARTED|Overall Study||52
6505356|NCT01453205|7424535|FG002|STARTED|Overall Study||55
6248138|NCT00836004|7147062|FG000|NOT COMPLETED|First Intervention||0
6248139|NCT00836004|7147063|FG001|NOT COMPLETED|First Intervention||0
6248140|NCT00836004|7147062|FG000|STARTED|Washout: 7 Days||12
6248141|NCT00836004|7147063|FG001|STARTED|Washout: 7 Days||12
6248142|NCT00836004|7147062|FG000|COMPLETED|Washout: 7 Days||12
6248143|NCT00836004|7147063|FG001|COMPLETED|Washout: 7 Days||12
6248144|NCT00836004|7147062|FG000|NOT COMPLETED|Washout: 7 Days||0
6248145|NCT00836004|7147063|FG001|NOT COMPLETED|Washout: 7 Days||0
6248146|NCT00836004|7147062|FG000|STARTED|Second Intervention||12
6248147|NCT00836004|7147063|FG001|STARTED|Second Intervention||12
6248148|NCT00836004|7147062|FG000|COMPLETED|Second Intervention||12
6248149|NCT00836004|7147063|FG001|COMPLETED|Second Intervention||12
6248150|NCT00836004|7147062|FG000|NOT COMPLETED|Second Intervention||0
6248151|NCT00836004|7147063|FG001|NOT COMPLETED|Second Intervention||0
6248152|NCT00835991|7147069|FG000|STARTED|First Intervention||30
6248153|NCT00835991|7147070|FG001|STARTED|First Intervention||30
6248154|NCT00835991|7147069|FG000|COMPLETED|First Intervention||30
6248155|NCT00835991|7147070|FG001|COMPLETED|First Intervention||29
6248156|NCT00835991|7147069|FG000|NOT COMPLETED|First Intervention||0
6248157|NCT00835991|7147070|FG001|NOT COMPLETED|First Intervention||1
6248158|NCT00835991|7147069|FG000|STARTED|Washout||30
6248159|NCT00835991|7147070|FG001|STARTED|Washout||29
6248160|NCT00835991|7147069|FG000|COMPLETED|Washout||27
6248161|NCT00835991|7147070|FG001|COMPLETED|Washout||26
6248162|NCT00835991|7147069|FG000|NOT COMPLETED|Washout||3
6248163|NCT00835991|7147070|FG001|NOT COMPLETED|Washout||3
6248164|NCT00835991|7147069|FG000|STARTED|Second Intervention||27
6248165|NCT00835991|7147070|FG001|STARTED|Second Intervention||26
6248166|NCT00835991|7147069|FG000|COMPLETED|Second Intervention||27
6248167|NCT00835991|7147070|FG001|COMPLETED|Second Intervention||26
6248168|NCT00835991|7147069|FG000|NOT COMPLETED|Second Intervention||0
6248169|NCT00835991|7147070|FG001|NOT COMPLETED|Second Intervention||0
6248170|NCT00835796|7147076|FG000|STARTED|First Intervention||10
6248171|NCT00835796|7147077|FG001|STARTED|First Intervention||10
6248172|NCT00835796|7147076|FG000|COMPLETED|First Intervention||10
6248173|NCT00835796|7147077|FG001|COMPLETED|First Intervention||9
6248174|NCT00835796|7147076|FG000|NOT COMPLETED|First Intervention||0
6248175|NCT00835796|7147077|FG001|NOT COMPLETED|First Intervention||1
6248176|NCT00835796|7147076|FG000|STARTED|Washout||10
6248177|NCT00835796|7147077|FG001|STARTED|Washout||9
6248178|NCT00835796|7147076|FG000|COMPLETED|Washout||10
6248179|NCT00835796|7147077|FG001|COMPLETED|Washout||9
6248180|NCT00835796|7147076|FG000|NOT COMPLETED|Washout||0
6248181|NCT00835796|7147077|FG001|NOT COMPLETED|Washout||0
6248182|NCT00835796|7147076|FG000|STARTED|Second Intervention||10
6248183|NCT00835796|7147077|FG001|STARTED|Second Intervention||9
6248184|NCT00835796|7147076|FG000|COMPLETED|Second Intervention||10
6248185|NCT00835796|7147077|FG001|COMPLETED|Second Intervention||9
6248186|NCT00835796|7147076|FG000|NOT COMPLETED|Second Intervention||0
6248187|NCT00835796|7147077|FG001|NOT COMPLETED|Second Intervention||0
6248188|NCT00835705|7147083|FG000|STARTED|First Intervention||24
6248189|NCT00835705|7147084|FG001|STARTED|First Intervention||28
6248190|NCT00835705|7147083|FG000|COMPLETED|First Intervention||23
6248191|NCT00835705|7147084|FG001|COMPLETED|First Intervention||28
6248192|NCT00835705|7147083|FG000|NOT COMPLETED|First Intervention||1
6248193|NCT00835705|7147084|FG001|NOT COMPLETED|First Intervention||0
6248194|NCT00835705|7147083|FG000|STARTED|Second Intervention||23
6248195|NCT00835705|7147084|FG001|STARTED|Second Intervention||28
6248196|NCT00835705|7147083|FG000|COMPLETED|Second Intervention||22
6248197|NCT00835705|7147084|FG001|COMPLETED|Second Intervention||28
6248198|NCT00835705|7147083|FG000|NOT COMPLETED|Second Intervention||1
6248199|NCT00835705|7147084|FG001|NOT COMPLETED|Second Intervention||0
6505357|NCT01453205|7424533|FG000|COMPLETED|Overall Study||0
6505358|NCT01453205|7424534|FG001|COMPLETED|Overall Study||0
6505359|NCT01453205|7424535|FG002|COMPLETED|Overall Study||1
6248200|NCT00835692|7147090|FG000|STARTED|First Intervention||28
6248201|NCT00835692|7147091|FG001|STARTED|First Intervention||28
6248202|NCT00835692|7147090|FG000|COMPLETED|First Intervention||27
6248203|NCT00835692|7147091|FG001|COMPLETED|First Intervention||28
6248204|NCT00835692|7147090|FG000|NOT COMPLETED|First Intervention||1
6248205|NCT00835692|7147091|FG001|NOT COMPLETED|First Intervention||0
6248206|NCT00835692|7147090|FG000|STARTED|Washout||27
6248207|NCT00835692|7147091|FG001|STARTED|Washout||28
6248208|NCT00835692|7147090|FG000|COMPLETED|Washout||27
6248209|NCT00835692|7147091|FG001|COMPLETED|Washout||28
6248210|NCT00835692|7147090|FG000|NOT COMPLETED|Washout||0
6248211|NCT00835692|7147091|FG001|NOT COMPLETED|Washout||0
6248212|NCT00835692|7147090|FG000|STARTED|Second Intervention||27
6248213|NCT00835692|7147091|FG001|STARTED|Second Intervention||28
6248214|NCT00835692|7147090|FG000|COMPLETED|Second Intervention||27
6248215|NCT00835692|7147091|FG001|COMPLETED|Second Intervention||28
6248216|NCT00835692|7147090|FG000|NOT COMPLETED|Second Intervention||0
6248217|NCT00835692|7147091|FG001|NOT COMPLETED|Second Intervention||0
6248218|NCT00835666|7147097|FG000|STARTED|First Intervention||16
6248219|NCT00835666|7147098|FG001|STARTED|First Intervention||16
6248220|NCT00835666|7147097|FG000|COMPLETED|First Intervention||16
6248221|NCT00835666|7147098|FG001|COMPLETED|First Intervention||16
6248222|NCT00835666|7147097|FG000|NOT COMPLETED|First Intervention||0
6248223|NCT00835666|7147098|FG001|NOT COMPLETED|First Intervention||0
6248224|NCT00835666|7147097|FG000|STARTED|Washout||16
6248225|NCT00835666|7147098|FG001|STARTED|Washout||16
6248226|NCT00835666|7147097|FG000|COMPLETED|Washout||14
6248227|NCT00835666|7147098|FG001|COMPLETED|Washout||16
6248228|NCT00835666|7147097|FG000|NOT COMPLETED|Washout||2
6248229|NCT00835666|7147098|FG001|NOT COMPLETED|Washout||0
6248230|NCT00835666|7147097|FG000|STARTED|Second Intervention||14
6248231|NCT00835666|7147098|FG001|STARTED|Second Intervention||16
6248232|NCT00835666|7147097|FG000|COMPLETED|Second Intervention||14
6248233|NCT00835666|7147098|FG001|COMPLETED|Second Intervention||16
6248234|NCT00835666|7147097|FG000|NOT COMPLETED|Second Intervention||0
6248235|NCT00835666|7147098|FG001|NOT COMPLETED|Second Intervention||0
6248236|NCT00835640|7147104|FG000|STARTED|First Intervention||12
6248237|NCT00835640|7147105|FG001|STARTED|First Intervention||12
6248238|NCT00835640|7147104|FG000|COMPLETED|First Intervention||12
6248239|NCT00835640|7147105|FG001|COMPLETED|First Intervention||12
6248240|NCT00835640|7147104|FG000|NOT COMPLETED|First Intervention||0
6248241|NCT00835640|7147105|FG001|NOT COMPLETED|First Intervention||0
6248242|NCT00835640|7147104|FG000|STARTED|Washout of 7 Days||12
6248243|NCT00835640|7147105|FG001|STARTED|Washout of 7 Days||12
6248244|NCT00835640|7147104|FG000|COMPLETED|Washout of 7 Days||12
6248245|NCT00835640|7147105|FG001|COMPLETED|Washout of 7 Days||12
6248246|NCT00835640|7147104|FG000|NOT COMPLETED|Washout of 7 Days||0
6248247|NCT00835640|7147105|FG001|NOT COMPLETED|Washout of 7 Days||0
6248248|NCT00835640|7147104|FG000|STARTED|Second Intervention||12
6248249|NCT00835640|7147105|FG001|STARTED|Second Intervention||12
6505360|NCT01453205|7424533|FG000|NOT COMPLETED|Overall Study||80
6505361|NCT01453205|7424534|FG001|NOT COMPLETED|Overall Study||52
6505362|NCT01453205|7424535|FG002|NOT COMPLETED|Overall Study||54
6505363|NCT01453296|7424546|FG000|STARTED|Treatment Period 1||14
6505364|NCT01453296|7424547|FG001|STARTED|Treatment Period 1||14
6248250|NCT00835640|7147104|FG000|COMPLETED|Second Intervention||11
6248251|NCT00835640|7147105|FG001|COMPLETED|Second Intervention||12
6248252|NCT00835640|7147104|FG000|NOT COMPLETED|Second Intervention||1
6248253|NCT00835640|7147105|FG001|NOT COMPLETED|Second Intervention||0
6248254|NCT00835614|7147111|FG000|STARTED|First Intervention||13
6248255|NCT00835614|7147112|FG001|STARTED|First Intervention||13
6248256|NCT00835614|7147111|FG000|COMPLETED|First Intervention||13
6248257|NCT00835614|7147112|FG001|COMPLETED|First Intervention||13
6505365|NCT01453296|7424546|FG000|COMPLETED|Treatment Period 1||13
6248258|NCT00835614|7147111|FG000|NOT COMPLETED|First Intervention||0
6248259|NCT00835614|7147112|FG001|NOT COMPLETED|First Intervention||0
6248260|NCT00835614|7147111|FG000|STARTED|Washout of 7 Days||13
6248261|NCT00835614|7147112|FG001|STARTED|Washout of 7 Days||13
6248262|NCT00835614|7147111|FG000|COMPLETED|Washout of 7 Days||13
6248263|NCT00835614|7147112|FG001|COMPLETED|Washout of 7 Days||13
6248264|NCT00835614|7147111|FG000|NOT COMPLETED|Washout of 7 Days||0
6248265|NCT00835614|7147112|FG001|NOT COMPLETED|Washout of 7 Days||0
6248266|NCT00835614|7147111|FG000|STARTED|Second Intervention||13
6248267|NCT00835614|7147112|FG001|STARTED|Second Intervention||13
6248268|NCT00835614|7147111|FG000|COMPLETED|Second Intervention||13
6248269|NCT00835614|7147112|FG001|COMPLETED|Second Intervention||13
6248270|NCT00835614|7147111|FG000|NOT COMPLETED|Second Intervention||0
6248271|NCT00835614|7147112|FG001|NOT COMPLETED|Second Intervention||0
6248272|NCT00835588|7147118|FG000|STARTED|First Intervention||50
6248273|NCT00835588|7147119|FG001|STARTED|First Intervention||50
6248274|NCT00835588|7147118|FG000|COMPLETED|First Intervention||50
6248275|NCT00835588|7147119|FG001|COMPLETED|First Intervention||50
6248276|NCT00835588|7147118|FG000|NOT COMPLETED|First Intervention||0
6248277|NCT00835588|7147119|FG001|NOT COMPLETED|First Intervention||0
6248278|NCT00835588|7147118|FG000|STARTED|Washout: 5 Days||50
6248279|NCT00835588|7147119|FG001|STARTED|Washout: 5 Days||50
6248280|NCT00835588|7147118|FG000|COMPLETED|Washout: 5 Days||50
6248281|NCT00835588|7147119|FG001|COMPLETED|Washout: 5 Days||50
6248282|NCT00835588|7147118|FG000|NOT COMPLETED|Washout: 5 Days||0
6248283|NCT00835588|7147119|FG001|NOT COMPLETED|Washout: 5 Days||0
6248284|NCT00835588|7147118|FG000|STARTED|Second Intervention||50
6248285|NCT00835588|7147119|FG001|STARTED|Second Intervention||50
6248286|NCT00835588|7147118|FG000|COMPLETED|Second Intervention||50
6248287|NCT00835588|7147119|FG001|COMPLETED|Second Intervention||50
6248288|NCT00835588|7147118|FG000|NOT COMPLETED|Second Intervention||0
6248289|NCT00835588|7147119|FG001|NOT COMPLETED|Second Intervention||0
6248290|NCT00835575|7147125|FG000|STARTED|First Intervention||16
6248291|NCT00835575|7147126|FG001|STARTED|First Intervention||16
6248292|NCT00835575|7147125|FG000|COMPLETED|First Intervention||16
6248293|NCT00835575|7147126|FG001|COMPLETED|First Intervention||16
6248294|NCT00835575|7147125|FG000|NOT COMPLETED|First Intervention||0
6248295|NCT00835575|7147126|FG001|NOT COMPLETED|First Intervention||0
6248296|NCT00835575|7147125|FG000|STARTED|Washout of 14 Days||16
6248297|NCT00835575|7147126|FG001|STARTED|Washout of 14 Days||16
6248298|NCT00835575|7147125|FG000|COMPLETED|Washout of 14 Days||15
6248299|NCT00835575|7147126|FG001|COMPLETED|Washout of 14 Days||16
6248300|NCT00835575|7147125|FG000|NOT COMPLETED|Washout of 14 Days||1
6248301|NCT00835575|7147126|FG001|NOT COMPLETED|Washout of 14 Days||0
6569769|NCT01847443|7493128|FG000|NOT COMPLETED|Washout Period Before Study Period 3||1
6569770|NCT01847443|7493129|FG001|NOT COMPLETED|Washout Period Before Study Period 3||0
6569771|NCT01847443|7493130|FG002|NOT COMPLETED|Washout Period Before Study Period 3||0
6569772|NCT01847443|7493131|FG003|NOT COMPLETED|Washout Period Before Study Period 3||0
6569773|NCT01847443|7493128|FG000|STARTED|Study Period 3||18
6569774|NCT01847443|7493129|FG001|STARTED|Study Period 3||19
6569775|NCT01847443|7493130|FG002|STARTED|Study Period 3||21
6569776|NCT01847443|7493131|FG003|STARTED|Study Period 3||21
6569777|NCT01847443|7493128|FG000|COMPLETED|Study Period 3||18
6569778|NCT01847443|7493129|FG001|COMPLETED|Study Period 3||19
6569779|NCT01847443|7493130|FG002|COMPLETED|Study Period 3||21
6569780|NCT01847443|7493131|FG003|COMPLETED|Study Period 3||21
6248302|NCT00835575|7147125|FG000|STARTED|Second Intervention||15
6248303|NCT00835575|7147126|FG001|STARTED|Second Intervention||16
6248304|NCT00835575|7147125|FG000|COMPLETED|Second Intervention||15
6248305|NCT00835575|7147126|FG001|COMPLETED|Second Intervention||16
6248306|NCT00835575|7147125|FG000|NOT COMPLETED|Second Intervention||0
6248307|NCT00835575|7147126|FG001|NOT COMPLETED|Second Intervention||0
6248308|NCT00835549|7147132|FG000|STARTED|First Intervention||16
6248309|NCT00835549|7147133|FG001|STARTED|First Intervention||16
6248310|NCT00835549|7147132|FG000|COMPLETED|First Intervention||16
6248311|NCT00835549|7147133|FG001|COMPLETED|First Intervention||16
6248312|NCT00835549|7147132|FG000|NOT COMPLETED|First Intervention||0
6248313|NCT00835549|7147133|FG001|NOT COMPLETED|First Intervention||0
6248314|NCT00835549|7147132|FG000|STARTED|Washout of 7 Days||16
6248315|NCT00835549|7147133|FG001|STARTED|Washout of 7 Days||16
6248316|NCT00835549|7147132|FG000|COMPLETED|Washout of 7 Days||14
6248317|NCT00835549|7147133|FG001|COMPLETED|Washout of 7 Days||16
6248318|NCT00835549|7147132|FG000|NOT COMPLETED|Washout of 7 Days||2
6248319|NCT00835549|7147133|FG001|NOT COMPLETED|Washout of 7 Days||0
6248320|NCT00835549|7147132|FG000|STARTED|Second Intervention||14
6248321|NCT00835549|7147133|FG001|STARTED|Second Intervention||16
6248322|NCT00835549|7147132|FG000|COMPLETED|Second Intervention||14
6248323|NCT00835549|7147133|FG001|COMPLETED|Second Intervention||16
6248324|NCT00835549|7147132|FG000|NOT COMPLETED|Second Intervention||0
6248325|NCT00835549|7147133|FG001|NOT COMPLETED|Second Intervention||0
6248326|NCT00835536|7147139|FG000|STARTED|First Intervention||13
6248327|NCT00835536|7147140|FG001|STARTED|First Intervention||14
6248328|NCT00835536|7147139|FG000|COMPLETED|First Intervention||13
6248329|NCT00835536|7147140|FG001|COMPLETED|First Intervention||14
6248330|NCT00835536|7147139|FG000|NOT COMPLETED|First Intervention||0
6248331|NCT00835536|7147140|FG001|NOT COMPLETED|First Intervention||0
6248332|NCT00835536|7147139|FG000|STARTED|Washout of 5 Weeks||13
6248333|NCT00835536|7147140|FG001|STARTED|Washout of 5 Weeks||14
6248334|NCT00835536|7147139|FG000|COMPLETED|Washout of 5 Weeks||12
6248335|NCT00835536|7147140|FG001|COMPLETED|Washout of 5 Weeks||14
6248336|NCT00835536|7147139|FG000|NOT COMPLETED|Washout of 5 Weeks||1
6248337|NCT00835536|7147140|FG001|NOT COMPLETED|Washout of 5 Weeks||0
6248338|NCT00835536|7147139|FG000|STARTED|Second Intervention||12
6248339|NCT00835536|7147140|FG001|STARTED|Second Intervention||14
6248340|NCT00835536|7147139|FG000|COMPLETED|Second Intervention||12
6248341|NCT00835536|7147140|FG001|COMPLETED|Second Intervention||14
6248342|NCT00835536|7147139|FG000|NOT COMPLETED|Second Intervention||0
6248343|NCT00835536|7147140|FG001|NOT COMPLETED|Second Intervention||0
6248344|NCT00835497|7147146|FG000|STARTED|First Intervention||20
6248345|NCT00835497|7147147|FG001|STARTED|First Intervention||20
6248346|NCT00835497|7147146|FG000|COMPLETED|First Intervention||20
6248347|NCT00835497|7147147|FG001|COMPLETED|First Intervention||20
6248348|NCT00835497|7147146|FG000|NOT COMPLETED|First Intervention||0
6248349|NCT00835497|7147147|FG001|NOT COMPLETED|First Intervention||0
6248350|NCT00835497|7147146|FG000|STARTED|Washout: 7 Days||20
6248351|NCT00835497|7147147|FG001|STARTED|Washout: 7 Days||20
6248352|NCT00835497|7147146|FG000|COMPLETED|Washout: 7 Days||20
6248353|NCT00835497|7147147|FG001|COMPLETED|Washout: 7 Days||20
6248354|NCT00835497|7147146|FG000|NOT COMPLETED|Washout: 7 Days||0
6248355|NCT00835497|7147147|FG001|NOT COMPLETED|Washout: 7 Days||0
6248356|NCT00835497|7147146|FG000|STARTED|Second Intervention||20
6248357|NCT00835497|7147147|FG001|STARTED|Second Intervention||20
6248358|NCT00835497|7147146|FG000|COMPLETED|Second Intervention||20
6505366|NCT01453296|7424547|FG001|COMPLETED|Treatment Period 1||13
6505367|NCT01453296|7424546|FG000|NOT COMPLETED|Treatment Period 1||1
6505368|NCT01453296|7424547|FG001|NOT COMPLETED|Treatment Period 1||1
6505369|NCT01453296|7424546|FG000|STARTED|Washout Period||13
6505370|NCT01453296|7424547|FG001|STARTED|Washout Period||13
6505371|NCT01453296|7424546|FG000|COMPLETED|Washout Period||13
6505372|NCT01453296|7424547|FG001|COMPLETED|Washout Period||13
6505373|NCT01453296|7424546|FG000|NOT COMPLETED|Washout Period||0
6505374|NCT01453296|7424547|FG001|NOT COMPLETED|Washout Period||0
6505375|NCT01453296|7424546|FG000|STARTED|Treatment Period 2||13
6505376|NCT01453296|7424547|FG001|STARTED|Treatment Period 2||13
6505377|NCT01453296|7424546|FG000|COMPLETED|Treatment Period 2||11
6657492|NCT02470234|7587874|FG000|STARTED|Overall Study||5
6657493|NCT02470234|7587875|FG001|STARTED|Overall Study||3
6657494|NCT02470234|7587876|FG002|STARTED|Overall Study||2
6657495|NCT02470234|7587874|FG000|COMPLETED|Overall Study||5
6657496|NCT02470234|7587875|FG001|COMPLETED|Overall Study||3
6657497|NCT02470234|7587876|FG002|COMPLETED|Overall Study||2
6657498|NCT02470234|7587874|FG000|NOT COMPLETED|Overall Study||0
6657499|NCT02470234|7587875|FG001|NOT COMPLETED|Overall Study||0
6657500|NCT02470234|7587876|FG002|NOT COMPLETED|Overall Study||0
6657501|NCT02470312|7587891|FG000|STARTED|Overall Study||147
6248359|NCT00835497|7147147|FG001|COMPLETED|Second Intervention||20
6248360|NCT00835497|7147146|FG000|NOT COMPLETED|Second Intervention||0
6248361|NCT00835497|7147147|FG001|NOT COMPLETED|Second Intervention||0
6248362|NCT00835484|7147153|FG000|STARTED|First Intervention||16
6505378|NCT01453296|7424547|FG001|COMPLETED|Treatment Period 2||13
6505379|NCT01453296|7424546|FG000|NOT COMPLETED|Treatment Period 2||2
6505380|NCT01453296|7424547|FG001|NOT COMPLETED|Treatment Period 2||0
6248363|NCT00835484|7147154|FG001|STARTED|First Intervention||16
6248364|NCT00835484|7147153|FG000|COMPLETED|First Intervention||16
6248365|NCT00835484|7147154|FG001|COMPLETED|First Intervention||16
6248366|NCT00835484|7147153|FG000|NOT COMPLETED|First Intervention||0
6248367|NCT00835484|7147154|FG001|NOT COMPLETED|First Intervention||0
6248368|NCT00835484|7147153|FG000|STARTED|Washout of 7 Days||16
6248369|NCT00835484|7147154|FG001|STARTED|Washout of 7 Days||16
6248370|NCT00835484|7147153|FG000|COMPLETED|Washout of 7 Days||16
6248371|NCT00835484|7147154|FG001|COMPLETED|Washout of 7 Days||16
6248372|NCT00835484|7147153|FG000|NOT COMPLETED|Washout of 7 Days||0
6248373|NCT00835484|7147154|FG001|NOT COMPLETED|Washout of 7 Days||0
6248374|NCT00835484|7147153|FG000|STARTED|Second Intervention||16
6248375|NCT00835484|7147154|FG001|STARTED|Second Intervention||16
6248376|NCT00835484|7147153|FG000|COMPLETED|Second Intervention||16
6248377|NCT00835484|7147154|FG001|COMPLETED|Second Intervention||16
6248378|NCT00835484|7147153|FG000|NOT COMPLETED|Second Intervention||0
6248379|NCT00835484|7147154|FG001|NOT COMPLETED|Second Intervention||0
6248380|NCT00835406|7147160|FG000|STARTED|Period: First Intervention||70
6248381|NCT00835406|7147161|FG001|STARTED|Period: First Intervention||70
6248382|NCT00835406|7147160|FG000|COMPLETED|Period: First Intervention||68
6248383|NCT00835406|7147161|FG001|COMPLETED|Period: First Intervention||69
6248384|NCT00835406|7147160|FG000|NOT COMPLETED|Period: First Intervention||2
6248385|NCT00835406|7147161|FG001|NOT COMPLETED|Period: First Intervention||1
6248386|NCT00835406|7147160|FG000|STARTED|Period: Washout of 7 Days||68
6248387|NCT00835406|7147161|FG001|STARTED|Period: Washout of 7 Days||69
6248388|NCT00835406|7147160|FG000|COMPLETED|Period: Washout of 7 Days||68
6248389|NCT00835406|7147161|FG001|COMPLETED|Period: Washout of 7 Days||67
6248390|NCT00835406|7147160|FG000|NOT COMPLETED|Period: Washout of 7 Days||0
6248391|NCT00835406|7147161|FG001|NOT COMPLETED|Period: Washout of 7 Days||2
6248392|NCT00835406|7147160|FG000|STARTED|Period: Second Intervention||68
6248393|NCT00835406|7147161|FG001|STARTED|Period: Second Intervention||67
6248394|NCT00835406|7147160|FG000|COMPLETED|Period: Second Intervention||68
6248395|NCT00835406|7147161|FG001|COMPLETED|Period: Second Intervention||67
6248396|NCT00835406|7147160|FG000|NOT COMPLETED|Period: Second Intervention||0
6248397|NCT00835406|7147161|FG001|NOT COMPLETED|Period: Second Intervention||0
6248398|NCT00835367|7147167|FG000|STARTED|First Intervention||34
6248399|NCT00835367|7147168|FG001|STARTED|First Intervention||34
6248400|NCT00835367|7147167|FG000|COMPLETED|First Intervention||34
6248401|NCT00835367|7147168|FG001|COMPLETED|First Intervention||34
6248402|NCT00835367|7147167|FG000|NOT COMPLETED|First Intervention||0
6248403|NCT00835367|7147168|FG001|NOT COMPLETED|First Intervention||0
6248404|NCT00835367|7147167|FG000|STARTED|Washout||34
6248405|NCT00835367|7147168|FG001|STARTED|Washout||34
6248406|NCT00835367|7147167|FG000|COMPLETED|Washout||31
6248407|NCT00835367|7147168|FG001|COMPLETED|Washout||34
6248408|NCT00835367|7147167|FG000|NOT COMPLETED|Washout||3
6248409|NCT00835367|7147168|FG001|NOT COMPLETED|Washout||0
6248410|NCT00835367|7147167|FG000|STARTED|Second Intervention||31
6248411|NCT00835367|7147168|FG001|STARTED|Second Intervention||34
6248412|NCT00835367|7147167|FG000|COMPLETED|Second Intervention||30
6248413|NCT00835367|7147168|FG001|COMPLETED|Second Intervention||33
6248414|NCT00835367|7147167|FG000|NOT COMPLETED|Second Intervention||1
6248415|NCT00835367|7147168|FG001|NOT COMPLETED|Second Intervention||1
6248416|NCT00835354|7147174|FG000|STARTED|First Intervention||13
6248417|NCT00835354|7147175|FG001|STARTED|First Intervention||13
6248418|NCT00835354|7147174|FG000|COMPLETED|First Intervention||13
6248419|NCT00835354|7147175|FG001|COMPLETED|First Intervention||12
6248420|NCT00835354|7147174|FG000|NOT COMPLETED|First Intervention||0
6248421|NCT00835354|7147175|FG001|NOT COMPLETED|First Intervention||1
6248422|NCT00835354|7147174|FG000|STARTED|Washout of 7 Days||13
6248423|NCT00835354|7147175|FG001|STARTED|Washout of 7 Days||12
6248424|NCT00835354|7147174|FG000|COMPLETED|Washout of 7 Days||13
6248425|NCT00835354|7147175|FG001|COMPLETED|Washout of 7 Days||12
6657502|NCT02470312|7587892|FG001|STARTED|Overall Study||431
6657503|NCT02470312|7587891|FG000|COMPLETED|Overall Study||142
6657504|NCT02470312|7587892|FG001|COMPLETED|Overall Study||419
6657505|NCT02470312|7587891|FG000|NOT COMPLETED|Overall Study||5
6657506|NCT02470312|7587892|FG001|NOT COMPLETED|Overall Study||12
6657507|NCT02470390|7587900|FG000|STARTED|Overall Study||6
6657508|NCT02470390|7587901|FG001|STARTED|Overall Study||7
6657509|NCT02470390|7587900|FG000|COMPLETED|Overall Study||6
6657510|NCT02470390|7587901|FG001|COMPLETED|Overall Study||6
6657511|NCT02470390|7587900|FG000|NOT COMPLETED|Overall Study||0
6657512|NCT02470390|7587901|FG001|NOT COMPLETED|Overall Study||1
6248426|NCT00835354|7147174|FG000|NOT COMPLETED|Washout of 7 Days||0
6248427|NCT00835354|7147175|FG001|NOT COMPLETED|Washout of 7 Days||0
6248428|NCT00835354|7147174|FG000|STARTED|Second Intervention||13
6248429|NCT00835354|7147175|FG001|STARTED|Second Intervention||12
6505381|NCT01453348|7424556|FG000|STARTED|Overall Study||84
6505382|NCT01453348|7424557|FG001|STARTED|Overall Study||84
6505383|NCT01453348|7424558|FG002|STARTED|Overall Study||84
6505384|NCT01453348|7424556|FG000|COMPLETED|Overall Study||83
6505385|NCT01453348|7424557|FG001|COMPLETED|Overall Study||83
6505386|NCT01453348|7424558|FG002|COMPLETED|Overall Study||83
6505387|NCT01453348|7424556|FG000|NOT COMPLETED|Overall Study||1
6505388|NCT01453348|7424557|FG001|NOT COMPLETED|Overall Study||1
6505389|NCT01453348|7424558|FG002|NOT COMPLETED|Overall Study||1
6505390|NCT01453361|7424569|FG000|STARTED|Overall Study||18
6657513|NCT02470403|7587914|FG000|STARTED|Overall Study||44
6248430|NCT00835354|7147174|FG000|COMPLETED|Second Intervention||13
6248431|NCT00835354|7147175|FG001|COMPLETED|Second Intervention||12
6248432|NCT00835354|7147174|FG000|NOT COMPLETED|Second Intervention||0
6248433|NCT00835354|7147175|FG001|NOT COMPLETED|Second Intervention||0
6248434|NCT00835276|7147181|FG000|STARTED|First Intervention||24
6248435|NCT00835276|7147182|FG001|STARTED|First Intervention||24
6248436|NCT00835276|7147181|FG000|COMPLETED|First Intervention||24
6248437|NCT00835276|7147182|FG001|COMPLETED|First Intervention||24
6248438|NCT00835276|7147181|FG000|NOT COMPLETED|First Intervention||0
6248439|NCT00835276|7147182|FG001|NOT COMPLETED|First Intervention||0
6248440|NCT00835276|7147181|FG000|STARTED|Washout of 7 Days||24
6248441|NCT00835276|7147182|FG001|STARTED|Washout of 7 Days||24
6248442|NCT00835276|7147181|FG000|COMPLETED|Washout of 7 Days||24
6248443|NCT00835276|7147182|FG001|COMPLETED|Washout of 7 Days||24
6248444|NCT00835276|7147181|FG000|NOT COMPLETED|Washout of 7 Days||0
6248445|NCT00835276|7147182|FG001|NOT COMPLETED|Washout of 7 Days||0
6248446|NCT00835276|7147181|FG000|STARTED|Second Intervention||24
6248447|NCT00835276|7147182|FG001|STARTED|Second Intervention||24
6248448|NCT00835276|7147181|FG000|COMPLETED|Second Intervention||24
6248449|NCT00835276|7147182|FG001|COMPLETED|Second Intervention||24
6248450|NCT00835276|7147181|FG000|NOT COMPLETED|Second Intervention||0
6248451|NCT00835276|7147182|FG001|NOT COMPLETED|Second Intervention||0
6248452|NCT00835263|7147188|FG000|STARTED|First Intervention||16
6248453|NCT00835263|7147189|FG001|STARTED|First Intervention||16
6248454|NCT00835263|7147188|FG000|COMPLETED|First Intervention||16
6248455|NCT00835263|7147189|FG001|COMPLETED|First Intervention||16
6248456|NCT00835263|7147188|FG000|NOT COMPLETED|First Intervention||0
6248457|NCT00835263|7147189|FG001|NOT COMPLETED|First Intervention||0
6248458|NCT00835263|7147188|FG000|STARTED|Second Intervention||16
6248459|NCT00835263|7147189|FG001|STARTED|Second Intervention||16
6248460|NCT00835263|7147188|FG000|COMPLETED|Second Intervention||15
6248461|NCT00835263|7147189|FG001|COMPLETED|Second Intervention||16
6248462|NCT00835263|7147188|FG000|NOT COMPLETED|Second Intervention||1
6248463|NCT00835263|7147189|FG001|NOT COMPLETED|Second Intervention||0
6248464|NCT00835211|7147195|FG000|STARTED|First Intervention||24
6248465|NCT00835211|7147196|FG001|STARTED|First Intervention||24
6248466|NCT00835211|7147195|FG000|COMPLETED|First Intervention||24
6248467|NCT00835211|7147196|FG001|COMPLETED|First Intervention||23
6248468|NCT00835211|7147195|FG000|NOT COMPLETED|First Intervention||0
6248469|NCT00835211|7147196|FG001|NOT COMPLETED|First Intervention||1
6248470|NCT00835211|7147195|FG000|STARTED|Washout: 7 Days||24
6248471|NCT00835211|7147196|FG001|STARTED|Washout: 7 Days||23
6248472|NCT00835211|7147195|FG000|COMPLETED|Washout: 7 Days||21
6248473|NCT00835211|7147196|FG001|COMPLETED|Washout: 7 Days||22
6248474|NCT00835211|7147195|FG000|NOT COMPLETED|Washout: 7 Days||3
6248475|NCT00835211|7147196|FG001|NOT COMPLETED|Washout: 7 Days||1
6248476|NCT00835211|7147195|FG000|STARTED|Second Intervention||21
6248477|NCT00835211|7147196|FG001|STARTED|Second Intervention||22
6248478|NCT00835211|7147195|FG000|COMPLETED|Second Intervention||21
6248479|NCT00835211|7147196|FG001|COMPLETED|Second Intervention||22
6248480|NCT00835211|7147195|FG000|NOT COMPLETED|Second Intervention||0
6248481|NCT00835211|7147196|FG001|NOT COMPLETED|Second Intervention||0
6248482|NCT00835172|7147202|FG000|STARTED|First Intervention||16
6248483|NCT00835172|7147203|FG001|STARTED|First Intervention||16
6248484|NCT00835172|7147202|FG000|COMPLETED|First Intervention||16
6248485|NCT00835172|7147203|FG001|COMPLETED|First Intervention||16
6248486|NCT00835172|7147202|FG000|NOT COMPLETED|First Intervention||0
6248487|NCT00835172|7147203|FG001|NOT COMPLETED|First Intervention||0
6248488|NCT00835172|7147202|FG000|STARTED|Washout||16
6248489|NCT00835172|7147203|FG001|STARTED|Washout||16
6248490|NCT00835172|7147202|FG000|COMPLETED|Washout||16
6248491|NCT00835172|7147203|FG001|COMPLETED|Washout||15
6248492|NCT00835172|7147202|FG000|NOT COMPLETED|Washout||0
6248493|NCT00835172|7147203|FG001|NOT COMPLETED|Washout||1
6248494|NCT00835172|7147202|FG000|STARTED|Second Intervention||16
6248495|NCT00835172|7147203|FG001|STARTED|Second Intervention||15
6248496|NCT00835172|7147202|FG000|COMPLETED|Second Intervention||16
6248497|NCT00835172|7147203|FG001|COMPLETED|Second Intervention||15
6248498|NCT00835172|7147202|FG000|NOT COMPLETED|Second Intervention||0
6248499|NCT00835172|7147203|FG001|NOT COMPLETED|Second Intervention||0
6248500|NCT00835146|7147209|FG000|STARTED|First Intervention||14
6248501|NCT00835146|7147210|FG001|STARTED|First Intervention||14
6248502|NCT00835146|7147209|FG000|COMPLETED|First Intervention||14
6248503|NCT00835146|7147210|FG001|COMPLETED|First Intervention||14
6248504|NCT00835146|7147209|FG000|NOT COMPLETED|First Intervention||0
6248505|NCT00835146|7147210|FG001|NOT COMPLETED|First Intervention||0
6248506|NCT00835146|7147209|FG000|STARTED|Washout of 5 Weeks||14
6248507|NCT00835146|7147210|FG001|STARTED|Washout of 5 Weeks||14
6248508|NCT00835146|7147209|FG000|COMPLETED|Washout of 5 Weeks||14
6248509|NCT00835146|7147210|FG001|COMPLETED|Washout of 5 Weeks||14
6248510|NCT00835146|7147209|FG000|NOT COMPLETED|Washout of 5 Weeks||0
6248511|NCT00835146|7147210|FG001|NOT COMPLETED|Washout of 5 Weeks||0
6248512|NCT00835146|7147209|FG000|STARTED|Second Intervention||14
6248513|NCT00835146|7147210|FG001|STARTED|Second Intervention||14
6248514|NCT00835146|7147209|FG000|COMPLETED|Second Intervention||14
6248515|NCT00835146|7147210|FG001|COMPLETED|Second Intervention||14
6248516|NCT00835146|7147209|FG000|NOT COMPLETED|Second Intervention||0
6248517|NCT00835146|7147210|FG001|NOT COMPLETED|Second Intervention||0
6248518|NCT00835081|7147216|FG000|STARTED|First Intervention||13
6248519|NCT00835081|7147217|FG001|STARTED|First Intervention||13
6248520|NCT00835081|7147216|FG000|COMPLETED|First Intervention||13
6248521|NCT00835081|7147217|FG001|COMPLETED|First Intervention||13
6248522|NCT00835081|7147216|FG000|NOT COMPLETED|First Intervention||0
6248523|NCT00835081|7147217|FG001|NOT COMPLETED|First Intervention||0
6248524|NCT00835081|7147216|FG000|STARTED|Washout of 7 Days||13
6248525|NCT00835081|7147217|FG001|STARTED|Washout of 7 Days||13
6248526|NCT00835081|7147216|FG000|COMPLETED|Washout of 7 Days||12
6248527|NCT00835081|7147217|FG001|COMPLETED|Washout of 7 Days||13
6248528|NCT00835081|7147216|FG000|NOT COMPLETED|Washout of 7 Days||1
6248529|NCT00835081|7147217|FG001|NOT COMPLETED|Washout of 7 Days||0
6248530|NCT00835081|7147216|FG000|STARTED|Second Intervention||12
6248531|NCT00835081|7147217|FG001|STARTED|Second Intervention||13
6248532|NCT00835081|7147216|FG000|COMPLETED|Second Intervention||12
6248533|NCT00835081|7147217|FG001|COMPLETED|Second Intervention||13
6248534|NCT00835081|7147216|FG000|NOT COMPLETED|Second Intervention||0
6248535|NCT00835081|7147217|FG001|NOT COMPLETED|Second Intervention||0
6248536|NCT00835042|7147223|FG000|STARTED|First Intervention||30
6248537|NCT00835042|7147224|FG001|STARTED|First Intervention||28
6248538|NCT00835042|7147223|FG000|COMPLETED|First Intervention||26
6248539|NCT00835042|7147224|FG001|COMPLETED|First Intervention||26
6248540|NCT00835042|7147223|FG000|NOT COMPLETED|First Intervention||4
6248541|NCT00835042|7147224|FG001|NOT COMPLETED|First Intervention||2
6569781|NCT01847443|7493128|FG000|NOT COMPLETED|Study Period 3||0
6569782|NCT01847443|7493129|FG001|NOT COMPLETED|Study Period 3||0
6569783|NCT01847443|7493130|FG002|NOT COMPLETED|Study Period 3||0
6569784|NCT01847443|7493131|FG003|NOT COMPLETED|Study Period 3||0
6569785|NCT01847443|7493128|FG000|STARTED|Washout Period Before Study Period 4||18
6569786|NCT01847443|7493129|FG001|STARTED|Washout Period Before Study Period 4||19
6569787|NCT01847443|7493130|FG002|STARTED|Washout Period Before Study Period 4||21
6569788|NCT01847443|7493131|FG003|STARTED|Washout Period Before Study Period 4||21
6569789|NCT01847443|7493128|FG000|COMPLETED|Washout Period Before Study Period 4||16
6569790|NCT01847443|7493129|FG001|COMPLETED|Washout Period Before Study Period 4||19
6569791|NCT01847443|7493130|FG002|COMPLETED|Washout Period Before Study Period 4||21
6569792|NCT01847443|7493131|FG003|COMPLETED|Washout Period Before Study Period 4||21
6569793|NCT01847443|7493128|FG000|NOT COMPLETED|Washout Period Before Study Period 4||2
6569794|NCT01847443|7493129|FG001|NOT COMPLETED|Washout Period Before Study Period 4||0
6657514|NCT02470403|7587915|FG001|STARTED|Overall Study||44
6657515|NCT02470403|7587916|FG002|STARTED|Overall Study||40
6657516|NCT02470403|7587917|FG003|STARTED|Overall Study||43
6657517|NCT02470403|7587918|FG004|STARTED|Overall Study||10
6657518|NCT02470403|7587914|FG000|Dysglycemic|Overall Study||24
6657519|NCT02470403|7587915|FG001|Dysglycemic|Overall Study||24
6657520|NCT02470403|7587916|FG002|Dysglycemic|Overall Study||20
6657521|NCT02470403|7587917|FG003|Dysglycemic|Overall Study||20
6248542|NCT00835042|7147223|FG000|STARTED|Washout of 21 Days||26
6248543|NCT00835042|7147224|FG001|STARTED|Washout of 21 Days||26
6248544|NCT00835042|7147223|FG000|COMPLETED|Washout of 21 Days||26
6248545|NCT00835042|7147224|FG001|COMPLETED|Washout of 21 Days||24
6248546|NCT00835042|7147223|FG000|NOT COMPLETED|Washout of 21 Days||0
6248547|NCT00835042|7147224|FG001|NOT COMPLETED|Washout of 21 Days||2
6248548|NCT00835042|7147223|FG000|STARTED|Second Intervention||26
6248549|NCT00835042|7147224|FG001|STARTED|Second Intervention||24
6248550|NCT00835042|7147223|FG000|COMPLETED|Second Intervention||26
6248551|NCT00835042|7147224|FG001|COMPLETED|Second Intervention||24
6248552|NCT00835042|7147223|FG000|NOT COMPLETED|Second Intervention||0
6248553|NCT00835042|7147224|FG001|NOT COMPLETED|Second Intervention||0
6248554|NCT00834990|7147230|FG000|STARTED|First Intervention||12
6248555|NCT00834990|7147231|FG001|STARTED|First Intervention||11
6248556|NCT00834990|7147230|FG000|COMPLETED|First Intervention||12
6248557|NCT00834990|7147231|FG001|COMPLETED|First Intervention||11
6248558|NCT00834990|7147230|FG000|NOT COMPLETED|First Intervention||0
6248559|NCT00834990|7147231|FG001|NOT COMPLETED|First Intervention||0
6248560|NCT00834990|7147230|FG000|STARTED|Washout of 7 Days||12
6248561|NCT00834990|7147231|FG001|STARTED|Washout of 7 Days||11
6248562|NCT00834990|7147230|FG000|COMPLETED|Washout of 7 Days||12
6248563|NCT00834990|7147231|FG001|COMPLETED|Washout of 7 Days||11
6248564|NCT00834990|7147230|FG000|NOT COMPLETED|Washout of 7 Days||0
6248565|NCT00834990|7147231|FG001|NOT COMPLETED|Washout of 7 Days||0
6248566|NCT00834990|7147230|FG000|STARTED|Second Intervention||12
6248567|NCT00834990|7147231|FG001|STARTED|Second Intervention||11
6248568|NCT00834990|7147230|FG000|COMPLETED|Second Intervention||12
6248569|NCT00834990|7147231|FG001|COMPLETED|Second Intervention||11
6248570|NCT00834990|7147230|FG000|NOT COMPLETED|Second Intervention||0
6248571|NCT00834990|7147231|FG001|NOT COMPLETED|Second Intervention||0
6248572|NCT00834977|7147237|FG000|STARTED|First Intervention||24
6248573|NCT00834977|7147238|FG001|STARTED|First Intervention||24
6248574|NCT00834977|7147237|FG000|COMPLETED|First Intervention||24
6248575|NCT00834977|7147238|FG001|COMPLETED|First Intervention||24
6248576|NCT00834977|7147237|FG000|NOT COMPLETED|First Intervention||0
6248577|NCT00834977|7147238|FG001|NOT COMPLETED|First Intervention||0
6248578|NCT00834977|7147237|FG000|STARTED|Second Intervention||24
6248579|NCT00834977|7147238|FG001|STARTED|Second Intervention||24
6248580|NCT00834977|7147237|FG000|COMPLETED|Second Intervention||24
6248581|NCT00834977|7147238|FG001|COMPLETED|Second Intervention||24
6248582|NCT00834977|7147237|FG000|NOT COMPLETED|Second Intervention||0
6248583|NCT00834977|7147238|FG001|NOT COMPLETED|Second Intervention||0
6248584|NCT00834964|7147244|FG000|STARTED|First Intervention||15
6248585|NCT00834964|7147245|FG001|STARTED|First Intervention||15
6248586|NCT00834964|7147244|FG000|COMPLETED|First Intervention||15
6248587|NCT00834964|7147245|FG001|COMPLETED|First Intervention||15
6248588|NCT00834964|7147244|FG000|NOT COMPLETED|First Intervention||0
6248589|NCT00834964|7147245|FG001|NOT COMPLETED|First Intervention||0
6248590|NCT00834964|7147244|FG000|STARTED|Washout: 7 Days||15
6248591|NCT00834964|7147245|FG001|STARTED|Washout: 7 Days||15
6248592|NCT00834964|7147244|FG000|COMPLETED|Washout: 7 Days||15
6248593|NCT00834964|7147245|FG001|COMPLETED|Washout: 7 Days||15
6248594|NCT00834964|7147244|FG000|NOT COMPLETED|Washout: 7 Days||0
6248595|NCT00834964|7147245|FG001|NOT COMPLETED|Washout: 7 Days||0
6248596|NCT00834964|7147244|FG000|STARTED|Second Intervention||15
6248597|NCT00834964|7147245|FG001|STARTED|Second Intervention||15
6248598|NCT00834964|7147244|FG000|COMPLETED|Second Intervention||15
6248599|NCT00834964|7147245|FG001|COMPLETED|Second Intervention||15
6248600|NCT00834964|7147244|FG000|NOT COMPLETED|Second Intervention||0
6248601|NCT00834964|7147245|FG001|NOT COMPLETED|Second Intervention||0
6248602|NCT00834873|7147251|FG000|STARTED|First Intervention||12
6248603|NCT00834873|7147252|FG001|STARTED|First Intervention||12
6248604|NCT00834873|7147251|FG000|COMPLETED|First Intervention||12
6248605|NCT00834873|7147252|FG001|COMPLETED|First Intervention||11
6248606|NCT00834873|7147251|FG000|NOT COMPLETED|First Intervention||0
6248607|NCT00834873|7147252|FG001|NOT COMPLETED|First Intervention||1
6248608|NCT00834873|7147251|FG000|STARTED|Washout: 7 Days||12
6248609|NCT00834873|7147252|FG001|STARTED|Washout: 7 Days||11
6248610|NCT00834873|7147251|FG000|COMPLETED|Washout: 7 Days||12
6248611|NCT00834873|7147252|FG001|COMPLETED|Washout: 7 Days||11
6248612|NCT00834873|7147251|FG000|NOT COMPLETED|Washout: 7 Days||0
6248613|NCT00834873|7147252|FG001|NOT COMPLETED|Washout: 7 Days||0
6248614|NCT00834873|7147251|FG000|STARTED|Second Intervention||12
6248615|NCT00834873|7147252|FG001|STARTED|Second Intervention||11
6248616|NCT00834873|7147251|FG000|COMPLETED|Second Intervention||12
6505391|NCT01453361|7424569|FG000|COMPLETED|Overall Study||2
6505392|NCT01453361|7424569|FG000|NOT COMPLETED|Overall Study||16
6505393|NCT01453374|7424573|FG000|STARTED|Overall Study||27
6505394|NCT01453374|7424573|FG000|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
6505395|NCT01453374|7424573|FG000|NOT COMPLETED|Overall Study||18
6505396|NCT01453387|7424581|FG000|STARTED|Overall Study||21
6505397|NCT01453387|7424582|FG001|STARTED|Overall Study||7
6657522|NCT02470403|7587918|FG004|Dysglycemic|Overall Study||5
6657523|NCT02470403|7587914|FG000|Normoglycemic|Overall Study||20
6248617|NCT00834873|7147252|FG001|COMPLETED|Second Intervention||11
6248618|NCT00834873|7147251|FG000|NOT COMPLETED|Second Intervention||0
6248619|NCT00834873|7147252|FG001|NOT COMPLETED|Second Intervention||0
6248620|NCT00834795|7147258|FG000|STARTED|First Intervention||18
6248621|NCT00834795|7147259|FG001|STARTED|First Intervention||18
6248622|NCT00834795|7147258|FG000|COMPLETED|First Intervention||18
6248623|NCT00834795|7147259|FG001|COMPLETED|First Intervention||18
6248624|NCT00834795|7147258|FG000|NOT COMPLETED|First Intervention||0
6248625|NCT00834795|7147259|FG001|NOT COMPLETED|First Intervention||0
6248626|NCT00834795|7147258|FG000|STARTED|Washout: 7 Days||18
6248627|NCT00834795|7147259|FG001|STARTED|Washout: 7 Days||18
6248628|NCT00834795|7147258|FG000|COMPLETED|Washout: 7 Days||18
6248629|NCT00834795|7147259|FG001|COMPLETED|Washout: 7 Days||17
6248630|NCT00834795|7147258|FG000|NOT COMPLETED|Washout: 7 Days||0
6248631|NCT00834795|7147259|FG001|NOT COMPLETED|Washout: 7 Days||1
6248632|NCT00834795|7147258|FG000|STARTED|Second Intervention||18
6248633|NCT00834795|7147259|FG001|STARTED|Second Intervention||17
6248634|NCT00834795|7147258|FG000|COMPLETED|Second Intervention||17
6248635|NCT00834795|7147259|FG001|COMPLETED|Second Intervention||17
6248636|NCT00834795|7147258|FG000|NOT COMPLETED|Second Intervention||1
6248637|NCT00834795|7147259|FG001|NOT COMPLETED|Second Intervention||0
6248638|NCT00834756|7147265|FG000|STARTED|First Intervention||18
6248639|NCT00834756|7147266|FG001|STARTED|First Intervention||18
6248640|NCT00834756|7147265|FG000|COMPLETED|First Intervention||17
6248641|NCT00834756|7147266|FG001|COMPLETED|First Intervention||18
6248642|NCT00834756|7147265|FG000|NOT COMPLETED|First Intervention||1
6248643|NCT00834756|7147266|FG001|NOT COMPLETED|First Intervention||0
6248644|NCT00834756|7147265|FG000|STARTED|Washout: 21 Days||17
6248645|NCT00834756|7147266|FG001|STARTED|Washout: 21 Days||18
6248646|NCT00834756|7147265|FG000|COMPLETED|Washout: 21 Days||16
6248647|NCT00834756|7147266|FG001|COMPLETED|Washout: 21 Days||18
6248648|NCT00834756|7147265|FG000|NOT COMPLETED|Washout: 21 Days||1
6248649|NCT00834756|7147266|FG001|NOT COMPLETED|Washout: 21 Days||0
6248650|NCT00834756|7147265|FG000|STARTED|Second Intervention||16
6248651|NCT00834756|7147266|FG001|STARTED|Second Intervention||18
6248652|NCT00834756|7147265|FG000|COMPLETED|Second Intervention||16
6248653|NCT00834756|7147266|FG001|COMPLETED|Second Intervention||18
6248654|NCT00834756|7147265|FG000|NOT COMPLETED|Second Intervention||0
6248655|NCT00834756|7147266|FG001|NOT COMPLETED|Second Intervention||0
6248656|NCT00834743|7147272|FG000|STARTED|First Intervention||16
6248657|NCT00834743|7147273|FG001|STARTED|First Intervention||16
6248658|NCT00834743|7147272|FG000|COMPLETED|First Intervention||16
6248659|NCT00834743|7147273|FG001|COMPLETED|First Intervention||16
6248660|NCT00834743|7147272|FG000|NOT COMPLETED|First Intervention||0
6248661|NCT00834743|7147273|FG001|NOT COMPLETED|First Intervention||0
6248662|NCT00834743|7147272|FG000|STARTED|Washout of 7 Days||16
6248663|NCT00834743|7147273|FG001|STARTED|Washout of 7 Days||16
6248664|NCT00834743|7147272|FG000|COMPLETED|Washout of 7 Days||16
6248665|NCT00834743|7147273|FG001|COMPLETED|Washout of 7 Days||16
6248666|NCT00834743|7147272|FG000|NOT COMPLETED|Washout of 7 Days||0
6248667|NCT00834743|7147273|FG001|NOT COMPLETED|Washout of 7 Days||0
6248668|NCT00834743|7147272|FG000|STARTED|Second Intervention||16
6248669|NCT00834743|7147273|FG001|STARTED|Second Intervention||16
6248670|NCT00834743|7147272|FG000|COMPLETED|Second Intervention||15
6248671|NCT00834743|7147273|FG001|COMPLETED|Second Intervention||16
6248672|NCT00834743|7147272|FG000|NOT COMPLETED|Second Intervention||1
6248673|NCT00834743|7147273|FG001|NOT COMPLETED|Second Intervention||0
6248674|NCT00834717|7147279|FG000|STARTED|First Intervention||20
6248675|NCT00834717|7147280|FG001|STARTED|First Intervention||20
6248676|NCT00834717|7147279|FG000|COMPLETED|First Intervention||19
6248677|NCT00834717|7147280|FG001|COMPLETED|First Intervention||19
6248678|NCT00834717|7147279|FG000|NOT COMPLETED|First Intervention||1
6248679|NCT00834717|7147280|FG001|NOT COMPLETED|First Intervention||1
6248680|NCT00834717|7147279|FG000|STARTED|Second Intervention||19
6248681|NCT00834717|7147280|FG001|STARTED|Second Intervention||19
6248682|NCT00834717|7147279|FG000|COMPLETED|Second Intervention||19
6505398|NCT01453387|7424581|FG000|COMPLETED|Overall Study||21
6505399|NCT01453387|7424582|FG001|COMPLETED|Overall Study||7
6505400|NCT01453387|7424581|FG000|NOT COMPLETED|Overall Study||0
6505401|NCT01453387|7424582|FG001|NOT COMPLETED|Overall Study||0
6248683|NCT00834717|7147280|FG001|COMPLETED|Second Intervention||19
6248684|NCT00834717|7147279|FG000|NOT COMPLETED|Second Intervention||0
6248685|NCT00834717|7147280|FG001|NOT COMPLETED|Second Intervention||0
6248686|NCT00834639|7147286|FG000|STARTED|First Intervention||12
6248687|NCT00834639|7147287|FG001|STARTED|First Intervention||12
6248688|NCT00834639|7147286|FG000|COMPLETED|First Intervention||12
6248689|NCT00834639|7147287|FG001|COMPLETED|First Intervention||12
6248690|NCT00834639|7147286|FG000|NOT COMPLETED|First Intervention||0
6248691|NCT00834639|7147287|FG001|NOT COMPLETED|First Intervention||0
6248692|NCT00834639|7147286|FG000|STARTED|Washout of 7 Days||12
6248693|NCT00834639|7147287|FG001|STARTED|Washout of 7 Days||12
6248694|NCT00834639|7147286|FG000|COMPLETED|Washout of 7 Days||12
6248695|NCT00834639|7147287|FG001|COMPLETED|Washout of 7 Days||12
6248696|NCT00834639|7147286|FG000|NOT COMPLETED|Washout of 7 Days||0
6248697|NCT00834639|7147287|FG001|NOT COMPLETED|Washout of 7 Days||0
6248698|NCT00834639|7147286|FG000|STARTED|Second Intervention||12
6248699|NCT00834639|7147287|FG001|STARTED|Second Intervention||12
6248700|NCT00834639|7147286|FG000|COMPLETED|Second Intervention||12
6248701|NCT00834639|7147287|FG001|COMPLETED|Second Intervention||10
6248702|NCT00834639|7147286|FG000|NOT COMPLETED|Second Intervention||0
6248703|NCT00834639|7147287|FG001|NOT COMPLETED|Second Intervention||2
6248704|NCT00834613|7147293|FG000|STARTED|First Intervention||16
6248705|NCT00834613|7147294|FG001|STARTED|First Intervention||16
6248706|NCT00834613|7147293|FG000|COMPLETED|First Intervention||15
6248707|NCT00834613|7147294|FG001|COMPLETED|First Intervention||16
6248708|NCT00834613|7147293|FG000|NOT COMPLETED|First Intervention||1
6248709|NCT00834613|7147294|FG001|NOT COMPLETED|First Intervention||0
6248710|NCT00834613|7147293|FG000|STARTED|Washout of 7 Days||15
6248711|NCT00834613|7147294|FG001|STARTED|Washout of 7 Days||16
6248712|NCT00834613|7147293|FG000|COMPLETED|Washout of 7 Days||15
6248713|NCT00834613|7147294|FG001|COMPLETED|Washout of 7 Days||16
6248714|NCT00834613|7147293|FG000|NOT COMPLETED|Washout of 7 Days||0
6248715|NCT00834613|7147294|FG001|NOT COMPLETED|Washout of 7 Days||0
6248716|NCT00834613|7147293|FG000|STARTED|Second Intervention||15
6248717|NCT00834613|7147294|FG001|STARTED|Second Intervention||16
6248718|NCT00834613|7147293|FG000|COMPLETED|Second Intervention||15
6248719|NCT00834613|7147294|FG001|COMPLETED|Second Intervention||16
6248720|NCT00834613|7147293|FG000|NOT COMPLETED|Second Intervention||0
6248721|NCT00834613|7147294|FG001|NOT COMPLETED|Second Intervention||0
6569795|NCT01847443|7493130|FG002|NOT COMPLETED|Washout Period Before Study Period 4||0
6248722|NCT00834587|7147300|FG000|STARTED|First Intervention||20
6248723|NCT00834587|7147301|FG001|STARTED|First Intervention||20
6248724|NCT00834587|7147300|FG000|COMPLETED|First Intervention||20
6248725|NCT00834587|7147301|FG001|COMPLETED|First Intervention||20
6248726|NCT00834587|7147300|FG000|NOT COMPLETED|First Intervention||0
6248727|NCT00834587|7147301|FG001|NOT COMPLETED|First Intervention||0
6248728|NCT00834587|7147300|FG000|STARTED|Washout: 7 Days||20
6248729|NCT00834587|7147301|FG001|STARTED|Washout: 7 Days||20
6248730|NCT00834587|7147300|FG000|COMPLETED|Washout: 7 Days||19
6248731|NCT00834587|7147301|FG001|COMPLETED|Washout: 7 Days||20
6248732|NCT00834587|7147300|FG000|NOT COMPLETED|Washout: 7 Days||1
6248733|NCT00834587|7147301|FG001|NOT COMPLETED|Washout: 7 Days||0
6248734|NCT00834587|7147300|FG000|STARTED|Second Intervention||19
6248735|NCT00834587|7147301|FG001|STARTED|Second Intervention||20
6248736|NCT00834587|7147300|FG000|COMPLETED|Second Intervention||19
6248737|NCT00834587|7147301|FG001|COMPLETED|Second Intervention||20
6248738|NCT00834587|7147300|FG000|NOT COMPLETED|Second Intervention||0
6248739|NCT00834587|7147301|FG001|NOT COMPLETED|Second Intervention||0
6248740|NCT00834574|7147307|FG000|STARTED|First Intervention||16
6248741|NCT00834574|7147308|FG001|STARTED|First Intervention||16
6248742|NCT00834574|7147307|FG000|COMPLETED|First Intervention||16
6248743|NCT00834574|7147308|FG001|COMPLETED|First Intervention||16
6248744|NCT00834574|7147307|FG000|NOT COMPLETED|First Intervention||0
6248745|NCT00834574|7147308|FG001|NOT COMPLETED|First Intervention||0
6248746|NCT00834574|7147307|FG000|STARTED|Washout of 7 Days||16
6248747|NCT00834574|7147308|FG001|STARTED|Washout of 7 Days||16
6248748|NCT00834574|7147307|FG000|COMPLETED|Washout of 7 Days||16
6248749|NCT00834574|7147308|FG001|COMPLETED|Washout of 7 Days||16
6248750|NCT00834574|7147307|FG000|NOT COMPLETED|Washout of 7 Days||0
6248751|NCT00834574|7147308|FG001|NOT COMPLETED|Washout of 7 Days||0
6248752|NCT00834574|7147307|FG000|STARTED|Second Intervention||16
6248753|NCT00834574|7147308|FG001|STARTED|Second Intervention||16
6248754|NCT00834574|7147307|FG000|COMPLETED|Second Intervention||16
6248755|NCT00834574|7147308|FG001|COMPLETED|Second Intervention||16
6248756|NCT00834574|7147307|FG000|NOT COMPLETED|Second Intervention||0
6248757|NCT00834574|7147308|FG001|NOT COMPLETED|Second Intervention||0
6248758|NCT00834561|7147314|FG000|STARTED|First Intervention||16
6248759|NCT00834561|7147315|FG001|STARTED|First Intervention||16
6248760|NCT00834561|7147314|FG000|COMPLETED|First Intervention||16
6248761|NCT00834561|7147315|FG001|COMPLETED|First Intervention||16
6248762|NCT00834561|7147314|FG000|NOT COMPLETED|First Intervention||0
6505402|NCT01453413|7424605|FG000|STARTED|Overall Study||297
6505403|NCT01453413|7424605|FG000|COMPLETED|Overall Study||297
6505404|NCT01453413|7424605|FG000|NOT COMPLETED|Overall Study||0
6505405|NCT01453439|7424611|FG000|STARTED|Treatment Phase||61
6505406|NCT01453439|7424612|FG001|STARTED|Treatment Phase||59
6505407|NCT01453439|7424611|FG000|COMPLETED|Treatment Phase||44
6505408|NCT01453439|7424612|FG001|COMPLETED|Treatment Phase||48
6505409|NCT01453439|7424611|FG000|NOT COMPLETED|Treatment Phase||17
6505410|NCT01453439|7424612|FG001|NOT COMPLETED|Treatment Phase||11
6505411|NCT01453439|7424611|FG000|STARTED|Follow-up||44
6505412|NCT01453439|7424612|FG001|STARTED|Follow-up||48
6505413|NCT01453439|7424611|FG000|COMPLETED|Follow-up||39
6505414|NCT01453439|7424612|FG001|COMPLETED|Follow-up||37
6505415|NCT01453439|7424611|FG000|NOT COMPLETED|Follow-up||5
6505416|NCT01453439|7424612|FG001|NOT COMPLETED|Follow-up||11
6505417|NCT01453569|7424621|FG000|STARTED|Overall Study||86
6505418|NCT01453569|7424622|FG001|STARTED|Overall Study||84
6505419|NCT01453569|7424623|FG002|STARTED|Overall Study||85
6505420|NCT01453569|7424621|FG000|COMPLETED|Overall Study||75
6505421|NCT01453569|7424622|FG001|COMPLETED|Overall Study||70
6505422|NCT01453569|7424623|FG002|COMPLETED|Overall Study||78
6505423|NCT01453569|7424621|FG000|NOT COMPLETED|Overall Study||11
6505424|NCT01453569|7424622|FG001|NOT COMPLETED|Overall Study||14
6505425|NCT01453569|7424623|FG002|NOT COMPLETED|Overall Study||7
6505426|NCT01453595|7424634|FG000|STARTED|Overall Study||2
6505427|NCT01453595|7424635|FG001|STARTED|Overall Study||6
6505428|NCT01453595|7424636|FG002|STARTED|Overall Study||2
6505429|NCT01453595|7424634|FG000|COMPLETED|Overall Study||0
6505430|NCT01453595|7424635|FG001|COMPLETED|Overall Study||5
6505431|NCT01453595|7424636|FG002|COMPLETED|Overall Study||0
6505432|NCT01453595|7424634|FG000|NOT COMPLETED|Overall Study||2
6505433|NCT01453595|7424635|FG001|NOT COMPLETED|Overall Study||1
6505434|NCT01453595|7424636|FG002|NOT COMPLETED|Overall Study||2
6505435|NCT01453725|7424644|FG000|STARTED|Overall Study||98
6505436|NCT01453725|7424645|FG001|STARTED|Overall Study||100
6248763|NCT00834561|7147315|FG001|NOT COMPLETED|First Intervention||0
6248764|NCT00834561|7147314|FG000|STARTED|Second Intervention||16
6248765|NCT00834561|7147315|FG001|STARTED|Second Intervention||16
6248766|NCT00834561|7147314|FG000|COMPLETED|Second Intervention||16
6248767|NCT00834561|7147315|FG001|COMPLETED|Second Intervention||16
6248768|NCT00834561|7147314|FG000|NOT COMPLETED|Second Intervention||0
6248769|NCT00834561|7147315|FG001|NOT COMPLETED|Second Intervention||0
6248770|NCT00834535|7147321|FG000|STARTED|First Intervention||16
6248771|NCT00834535|7147322|FG001|STARTED|First Intervention||16
6248772|NCT00834535|7147321|FG000|COMPLETED|First Intervention||16
6248773|NCT00834535|7147322|FG001|COMPLETED|First Intervention||16
6657524|NCT02470403|7587915|FG001|Normoglycemic|Overall Study||20
6657525|NCT02470403|7587916|FG002|Normoglycemic|Overall Study||20
6657526|NCT02470403|7587917|FG003|Normoglycemic|Overall Study||23
6657527|NCT02470403|7587918|FG004|Normoglycemic|Overall Study||5
6657528|NCT02470403|7587914|FG000|COMPLETED|Overall Study||42
6657529|NCT02470403|7587915|FG001|COMPLETED|Overall Study||43
6657530|NCT02470403|7587916|FG002|COMPLETED|Overall Study||40
6657531|NCT02470403|7587917|FG003|COMPLETED|Overall Study||39
6657532|NCT02470403|7587918|FG004|COMPLETED|Overall Study||10
6657533|NCT02470403|7587914|FG000|NOT COMPLETED|Overall Study||2
6657534|NCT02470403|7587915|FG001|NOT COMPLETED|Overall Study||1
6657535|NCT02470403|7587916|FG002|NOT COMPLETED|Overall Study||0
6657536|NCT02470403|7587917|FG003|NOT COMPLETED|Overall Study||4
6657537|NCT02470403|7587918|FG004|NOT COMPLETED|Overall Study||0
6657538|NCT02470429|7587935|FG000|STARTED|Overall Study||50
6657539|NCT02470429|7587936|FG001|STARTED|Overall Study||49
6657540|NCT02470429|7587935|FG000|COMPLETED|Overall Study||48
6657541|NCT02470429|7587936|FG001|COMPLETED|Overall Study||49
6657542|NCT02470429|7587935|FG000|NOT COMPLETED|Overall Study||2
6657543|NCT02470429|7587936|FG001|NOT COMPLETED|Overall Study||0
6657544|NCT02470494|7587943|FG000|STARTED|Overall Study||46
6657545|NCT02470494|7587943|FG000|COMPLETED|Overall Study||41
6657546|NCT02470494|7587943|FG000|NOT COMPLETED|Overall Study||5
6657547|NCT02470585|7587950|FG000|STARTED|Overall Study||375
6657548|NCT02470585|7587951|FG001|STARTED|Overall Study||383
6657549|NCT02470585|7587952|FG002|STARTED|Overall Study||382
6657550|NCT02470585|7587950|FG000|Received Study Drug|Overall Study||371
6657551|NCT02470585|7587951|FG001|Received Study Drug|Overall Study||376
6657552|NCT02470585|7587952|FG002|Received Study Drug|Overall Study||377
6657553|NCT02470585|7587950|FG000|COMPLETED|Overall Study||268
6657554|NCT02470585|7587951|FG001|COMPLETED|Overall Study||266
6657555|NCT02470585|7587952|FG002|COMPLETED|Overall Study||257
6657556|NCT02470585|7587950|FG000|NOT COMPLETED|Overall Study||107
6657557|NCT02470585|7587951|FG001|NOT COMPLETED|Overall Study||117
6657558|NCT02470585|7587952|FG002|NOT COMPLETED|Overall Study||125
6657559|NCT02470741|7587962|FG000|STARTED|Overall Study||6
6657560|NCT02470741|7587963|FG001|STARTED|Overall Study||6
6657561|NCT02470741|7587962|FG000|COMPLETED|Overall Study||3
6657562|NCT02470741|7587963|FG001|COMPLETED|Overall Study||4
6657563|NCT02470741|7587962|FG000|NOT COMPLETED|Overall Study||3
6657564|NCT02470741|7587963|FG001|NOT COMPLETED|Overall Study||2
6657565|NCT02470754|7587969|FG000|STARTED|Overall Study||19
6657566|NCT02470754|7587970|FG001|STARTED|Overall Study||19
6657567|NCT02470754|7587969|FG000|COMPLETED|Overall Study||17
6657568|NCT02470754|7587970|FG001|COMPLETED|Overall Study||19
6657569|NCT02470754|7587969|FG000|NOT COMPLETED|Overall Study||2
6657570|NCT02470754|7587970|FG001|NOT COMPLETED|Overall Study||0
6657571|NCT02470806|7587978|FG000|STARTED|Overall Study||80
6657572|NCT02470806|7587979|FG001|STARTED|Overall Study|The Safety analysis included 164, ITT was 161, and Per Protocol was 115 subjects (total both arms).|84
6657573|NCT02470806|7587978|FG000|COMPLETED|Overall Study||62
6657574|NCT02470806|7587979|FG001|COMPLETED|Overall Study||42
6657575|NCT02470806|7587978|FG000|NOT COMPLETED|Overall Study||18
6657576|NCT02470806|7587979|FG001|NOT COMPLETED|Overall Study||42
6657577|NCT02470910|7587985|FG000|STARTED|Overall Study||15
6657578|NCT02470910|7587985|FG000|COMPLETED|Overall Study||15
6657579|NCT02470910|7587985|FG000|NOT COMPLETED|Overall Study||0
6657580|NCT02470949|7587992|FG000|STARTED|First Intervention||4
6657581|NCT02470949|7587993|FG001|STARTED|First Intervention||5
6657582|NCT02470949|7587992|FG000|COMPLETED|First Intervention||4
6657583|NCT02470949|7587993|FG001|COMPLETED|First Intervention||5
6657584|NCT02470949|7587992|FG000|NOT COMPLETED|First Intervention||0
6657585|NCT02470949|7587993|FG001|NOT COMPLETED|First Intervention||0
6657586|NCT02470949|7587992|FG000|STARTED|Washout Period for a Minimum of 4 Weeks||4
6657587|NCT02470949|7587993|FG001|STARTED|Washout Period for a Minimum of 4 Weeks||5
6657588|NCT02470949|7587992|FG000|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
6657589|NCT02470949|7587993|FG001|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
6657590|NCT02470949|7587992|FG000|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
6657591|NCT02470949|7587993|FG001|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
6657592|NCT02470949|7587992|FG000|STARTED|Second Intervention||4
6657593|NCT02470949|7587993|FG001|STARTED|Second Intervention||2
6657594|NCT02470949|7587992|FG000|COMPLETED|Second Intervention||4
6657595|NCT02470949|7587993|FG001|COMPLETED|Second Intervention||2
6657596|NCT02470949|7587992|FG000|NOT COMPLETED|Second Intervention||0
6657597|NCT02470949|7587993|FG001|NOT COMPLETED|Second Intervention||0
6569796|NCT01847443|7493131|FG003|NOT COMPLETED|Washout Period Before Study Period 4||0
6569797|NCT01847443|7493128|FG000|STARTED|Study Period 4||16
6569798|NCT01847443|7493129|FG001|STARTED|Study Period 4||19
6505437|NCT01453725|7424644|FG000|COMPLETED|Overall Study||85
6505438|NCT01453725|7424645|FG001|COMPLETED|Overall Study||89
6505439|NCT01453725|7424644|FG000|NOT COMPLETED|Overall Study||13
6505440|NCT01453725|7424645|FG001|NOT COMPLETED|Overall Study||11
6505441|NCT01453855|7424655|FG000|STARTED|Overall Study||442
6505442|NCT01453855|7424656|FG001|STARTED|Overall Study||422
6505443|NCT01453855|7424655|FG000|COMPLETED|Overall Study||432
6505444|NCT01453855|7424656|FG001|COMPLETED|Overall Study||408
6505445|NCT01453855|7424655|FG000|NOT COMPLETED|Overall Study||10
6505446|NCT01453855|7424656|FG001|NOT COMPLETED|Overall Study||14
6505447|NCT01453894|7424664|FG000|STARTED|Overall Study||225
6248774|NCT00834535|7147321|FG000|NOT COMPLETED|First Intervention||0
6248775|NCT00834535|7147322|FG001|NOT COMPLETED|First Intervention||0
6248776|NCT00834535|7147321|FG000|STARTED|Washout of 7 Days||16
6248777|NCT00834535|7147322|FG001|STARTED|Washout of 7 Days||16
6248778|NCT00834535|7147321|FG000|COMPLETED|Washout of 7 Days||16
6248779|NCT00834535|7147322|FG001|COMPLETED|Washout of 7 Days||16
6248780|NCT00834535|7147321|FG000|NOT COMPLETED|Washout of 7 Days||0
6248781|NCT00834535|7147322|FG001|NOT COMPLETED|Washout of 7 Days||0
6248782|NCT00834535|7147321|FG000|STARTED|Second Intervention||16
6248783|NCT00834535|7147322|FG001|STARTED|Second Intervention||16
6248784|NCT00834535|7147321|FG000|COMPLETED|Second Intervention||16
6248785|NCT00834535|7147322|FG001|COMPLETED|Second Intervention||16
6248786|NCT00834535|7147321|FG000|NOT COMPLETED|Second Intervention||0
6248787|NCT00834535|7147322|FG001|NOT COMPLETED|Second Intervention||0
6277018|NCT00123682|7176376|FG001|COMPLETED|Overall Study||731
6277019|NCT00123682|7176377|FG002|COMPLETED|Overall Study||438
6277020|NCT00123682|7176378|FG003|COMPLETED|Overall Study||430
6277021|NCT00123682|7176375|FG000|NOT COMPLETED|Overall Study||320
6277022|NCT00123682|7176376|FG001|NOT COMPLETED|Overall Study||203
6277023|NCT00123682|7176377|FG002|NOT COMPLETED|Overall Study||154
6277024|NCT00123682|7176378|FG003|NOT COMPLETED|Overall Study||95
6277025|NCT00123734|7176392|FG000|STARTED|Overall Study||82
6277026|NCT00123734|7176392|FG000|COMPLETED|Overall Study||74
6569799|NCT01847443|7493130|FG002|STARTED|Study Period 4||21
6569800|NCT01847443|7493131|FG003|STARTED|Study Period 4||21
6569801|NCT01847443|7493128|FG000|COMPLETED|Study Period 4||16
6569802|NCT01847443|7493129|FG001|COMPLETED|Study Period 4||19
6569803|NCT01847443|7493130|FG002|COMPLETED|Study Period 4||21
6569804|NCT01847443|7493131|FG003|COMPLETED|Study Period 4||21
6569805|NCT01847443|7493128|FG000|NOT COMPLETED|Study Period 4||0
6569806|NCT01847443|7493129|FG001|NOT COMPLETED|Study Period 4||0
6569807|NCT01847443|7493130|FG002|NOT COMPLETED|Study Period 4||0
6248788|NCT00834522|7147328|FG000|STARTED|First Intervention||40
6248789|NCT00834522|7147329|FG001|STARTED|First Intervention||40
6248790|NCT00834522|7147328|FG000|COMPLETED|First Intervention||40
6248791|NCT00834522|7147329|FG001|COMPLETED|First Intervention||40
6248792|NCT00834522|7147328|FG000|NOT COMPLETED|First Intervention||0
6569808|NCT01847443|7493131|FG003|NOT COMPLETED|Study Period 4||0
6569809|NCT01847469|7493145|FG000|STARTED|Overall Study||18
6569810|NCT01847469|7493146|FG001|STARTED|Overall Study||6
6569811|NCT01847469|7493145|FG000|COMPLETED|Overall Study||9
6569812|NCT01847469|7493146|FG001|COMPLETED|Overall Study||3
6569813|NCT01847469|7493145|FG000|NOT COMPLETED|Overall Study||9
6569814|NCT01847469|7493146|FG001|NOT COMPLETED|Overall Study||3
6569815|NCT01847547|7493154|FG000|STARTED|Overall Study||2991
6569816|NCT01847547|7493155|FG001|STARTED|Overall Study||2991
6569817|NCT01847547|7493154|FG000|COMPLETED|Overall Study||2991
6569818|NCT01847547|7493155|FG001|COMPLETED|Overall Study||2991
6569819|NCT01847547|7493154|FG000|NOT COMPLETED|Overall Study||0
6569820|NCT01847547|7493155|FG001|NOT COMPLETED|Overall Study||0
6569821|NCT01847560|7493172|FG000|STARTED|Overall Study||13464
6569822|NCT01847560|7493173|FG001|STARTED|Overall Study||19955
6569823|NCT01847560|7493174|FG002|STARTED|Overall Study||9731
6657598|NCT02471014|7588003|FG000|STARTED|Overall Study||25
6657599|NCT02471014|7588004|FG001|STARTED|Overall Study||25
6657600|NCT02471014|7588003|FG000|COMPLETED|Overall Study||23
6657601|NCT02471014|7588004|FG001|COMPLETED|Overall Study||23
6657602|NCT02471014|7588003|FG000|NOT COMPLETED|Overall Study||2
6657603|NCT02471014|7588004|FG001|NOT COMPLETED|Overall Study||2
6657604|NCT02471183|7588010|FG000|STARTED|Main Treatment Period||34
6657605|NCT02471183|7588010|FG000|COMPLETED|Main Treatment Period||32
6657606|NCT02471183|7588010|FG000|NOT COMPLETED|Main Treatment Period||2
6657607|NCT02471183|7588010|FG000|STARTED|Extended Treatment Period||32
6657608|NCT02471183|7588010|FG000|COMPLETED|Extended Treatment Period||31
6657609|NCT02471183|7588010|FG000|NOT COMPLETED|Extended Treatment Period||1
6657610|NCT02471313|7588014|FG000|STARTED|Overall Study||3
6657611|NCT02471313|7588014|FG000|COMPLETED|Overall Study||3
6657612|NCT02471313|7588014|FG000|NOT COMPLETED|Overall Study||0
6657613|NCT02471326|7588018|FG000|STARTED|Overall Study||10
6657614|NCT02471326|7588018|FG000|COMPLETED|Overall Study||9
6657615|NCT02471326|7588018|FG000|NOT COMPLETED|Overall Study||1
6657616|NCT02471404|7588025|FG000|STARTED|Overall Study||314
6657617|NCT02471404|7588026|FG001|STARTED|Overall Study||312
6657618|NCT02471404|7588027|FG002|STARTED|Overall Study||313
6657619|NCT02471404|7588025|FG000|COMPLETED|Overall Study||281
6657620|NCT02471404|7588026|FG001|COMPLETED|Overall Study||298
6657621|NCT02471404|7588027|FG002|COMPLETED|Overall Study||288
6657622|NCT02471404|7588025|FG000|NOT COMPLETED|Overall Study||33
6657623|NCT02471404|7588026|FG001|NOT COMPLETED|Overall Study||14
6657624|NCT02471404|7588027|FG002|NOT COMPLETED|Overall Study||25
6657625|NCT02471521|7588037|FG000|STARTED|Overall Study||60
6657626|NCT02471521|7588038|FG001|STARTED|Overall Study||60
6657627|NCT02471521|7588037|FG000|COMPLETED|Overall Study||60
6657628|NCT02471521|7588038|FG001|COMPLETED|Overall Study||52
6657629|NCT02471521|7588037|FG000|NOT COMPLETED|Overall Study||0
6657630|NCT02471521|7588038|FG001|NOT COMPLETED|Overall Study||8
6657631|NCT02471586|7588047|FG000|STARTED|Overall Study||158
6657632|NCT02471586|7588048|FG001|STARTED|Overall Study||146
6657633|NCT02471586|7588049|FG002|STARTED|Overall Study||146
6657634|NCT02471586|7588047|FG000|COMPLETED|Overall Study||153
6657635|NCT02471586|7588048|FG001|COMPLETED|Overall Study||136
6657636|NCT02471586|7588049|FG002|COMPLETED|Overall Study||142
6657637|NCT02471586|7588047|FG000|NOT COMPLETED|Overall Study||5
6657638|NCT02471586|7588048|FG001|NOT COMPLETED|Overall Study||10
6657639|NCT02471586|7588049|FG002|NOT COMPLETED|Overall Study||4
6737477|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Period 5(2 Days)||0
6737478|NCT03266172|7666732|FG000|STARTED|Part C Washout Period (7 Days)||0
6737479|NCT03266172|7666733|FG001|STARTED|Part C Washout Period (7 Days)||0
6737480|NCT03266172|7666734|FG002|STARTED|Part C Washout Period (7 Days)||15
6737481|NCT03266172|7666732|FG000|COMPLETED|Part C Washout Period (7 Days)||0
6737482|NCT03266172|7666733|FG001|COMPLETED|Part C Washout Period (7 Days)||0
6737483|NCT03266172|7666734|FG002|COMPLETED|Part C Washout Period (7 Days)||14
6737484|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737485|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737486|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||1
6737487|NCT03266172|7666732|FG000|STARTED|Part C Period 6(2 Days)||0
6737488|NCT03266172|7666733|FG001|STARTED|Part C Period 6(2 Days)||0
6737489|NCT03266172|7666734|FG002|STARTED|Part C Period 6(2 Days)||14
6737490|NCT03266172|7666732|FG000|COMPLETED|Part C Period 6(2 Days)||0
6737491|NCT03266172|7666733|FG001|COMPLETED|Part C Period 6(2 Days)||0
6737492|NCT03266172|7666734|FG002|COMPLETED|Part C Period 6(2 Days)||14
6737493|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Period 6(2 Days)||0
6737494|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Period 6(2 Days)||0
6737495|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Period 6(2 Days)||0
6737496|NCT03266419|7666786|FG000|STARTED|Overall Study||51
6737497|NCT03266419|7666787|FG001|STARTED|Overall Study||49
6737498|NCT03266419|7666786|FG000|COMPLETED|Overall Study||51
6569824|NCT01847560|7493175|FG003|STARTED|Overall Study||56655
6569825|NCT01847560|7493176|FG004|STARTED|Overall Study||27731
6248793|NCT00834522|7147329|FG001|NOT COMPLETED|First Intervention||0
6248794|NCT00834522|7147328|FG000|STARTED|Washout||40
6248795|NCT00834522|7147329|FG001|STARTED|Washout||40
6248796|NCT00834522|7147328|FG000|COMPLETED|Washout||37
6248797|NCT00834522|7147329|FG001|COMPLETED|Washout||39
6248798|NCT00834522|7147328|FG000|NOT COMPLETED|Washout||3
6248799|NCT00834522|7147329|FG001|NOT COMPLETED|Washout||1
6248800|NCT00834522|7147328|FG000|STARTED|Second Intervention||37
6248801|NCT00834522|7147329|FG001|STARTED|Second Intervention||39
6248802|NCT00834522|7147328|FG000|COMPLETED|Second Intervention||37
6248803|NCT00834522|7147329|FG001|COMPLETED|Second Intervention||39
6248804|NCT00834522|7147328|FG000|NOT COMPLETED|Second Intervention||0
6248805|NCT00834522|7147329|FG001|NOT COMPLETED|Second Intervention||0
6248806|NCT00834444|7147335|FG000|STARTED|First Intervention||18
6248807|NCT00834444|7147336|FG001|STARTED|First Intervention||18
6248808|NCT00834444|7147335|FG000|COMPLETED|First Intervention||17
6248809|NCT00834444|7147336|FG001|COMPLETED|First Intervention||17
6248810|NCT00834444|7147335|FG000|NOT COMPLETED|First Intervention||1
6248811|NCT00834444|7147336|FG001|NOT COMPLETED|First Intervention||1
6248812|NCT00834444|7147335|FG000|STARTED|Washout of 7 Days||17
6248813|NCT00834444|7147336|FG001|STARTED|Washout of 7 Days||17
6248814|NCT00834444|7147335|FG000|COMPLETED|Washout of 7 Days||17
6248815|NCT00834444|7147336|FG001|COMPLETED|Washout of 7 Days||16
6248816|NCT00834444|7147335|FG000|NOT COMPLETED|Washout of 7 Days||0
6248817|NCT00834444|7147336|FG001|NOT COMPLETED|Washout of 7 Days||1
6248818|NCT00834444|7147335|FG000|STARTED|Second Intervention||17
6248819|NCT00834444|7147336|FG001|STARTED|Second Intervention||16
6248820|NCT00834444|7147335|FG000|COMPLETED|Second Intervention||16
6248821|NCT00834444|7147336|FG001|COMPLETED|Second Intervention||16
6248822|NCT00834444|7147335|FG000|NOT COMPLETED|Second Intervention||1
6248823|NCT00834444|7147336|FG001|NOT COMPLETED|Second Intervention||0
6248824|NCT00834431|7147342|FG000|STARTED|First Intervention||18
6248825|NCT00834431|7147343|FG001|STARTED|First Intervention||18
6248826|NCT00834431|7147342|FG000|COMPLETED|First Intervention||18
6248827|NCT00834431|7147343|FG001|COMPLETED|First Intervention||17
6248828|NCT00834431|7147342|FG000|NOT COMPLETED|First Intervention||0
6248829|NCT00834431|7147343|FG001|NOT COMPLETED|First Intervention||1
6248830|NCT00834431|7147342|FG000|STARTED|Washout of 7 Days||18
6248831|NCT00834431|7147343|FG001|STARTED|Washout of 7 Days||17
6248832|NCT00834431|7147342|FG000|COMPLETED|Washout of 7 Days||18
6248833|NCT00834431|7147343|FG001|COMPLETED|Washout of 7 Days||16
6248834|NCT00834431|7147342|FG000|NOT COMPLETED|Washout of 7 Days||0
6248835|NCT00834431|7147343|FG001|NOT COMPLETED|Washout of 7 Days||1
6248836|NCT00834431|7147342|FG000|STARTED|Second Intervention||18
6248837|NCT00834431|7147343|FG001|STARTED|Second Intervention||16
6248838|NCT00834431|7147342|FG000|COMPLETED|Second Intervention||18
6248839|NCT00834431|7147343|FG001|COMPLETED|Second Intervention||16
6248840|NCT00834431|7147342|FG000|NOT COMPLETED|Second Intervention||0
6248841|NCT00834431|7147343|FG001|NOT COMPLETED|Second Intervention||0
6248842|NCT00834418|7147349|FG000|STARTED|Overall Study||42
6248843|NCT00834418|7147350|FG001|STARTED|Overall Study||42
6248844|NCT00834418|7147349|FG000|COMPLETED|Overall Study||42
6248845|NCT00834418|7147350|FG001|COMPLETED|Overall Study||40
6248846|NCT00834418|7147349|FG000|NOT COMPLETED|Overall Study||0
6248847|NCT00834418|7147350|FG001|NOT COMPLETED|Overall Study||2
6248848|NCT00834405|7147356|FG000|STARTED|Overall Study||20
6248849|NCT00834405|7147357|FG001|STARTED|Overall Study||17
6248850|NCT00834405|7147356|FG000|COMPLETED|Overall Study||20
6248851|NCT00834405|7147357|FG001|COMPLETED|Overall Study||17
6248852|NCT00834405|7147356|FG000|NOT COMPLETED|Overall Study||0
6248853|NCT00834405|7147357|FG001|NOT COMPLETED|Overall Study||0
6248854|NCT00834340|7147363|FG000|STARTED|First Intervention||16
6248855|NCT00834340|7147364|FG001|STARTED|First Intervention||16
6248856|NCT00834340|7147363|FG000|COMPLETED|First Intervention||16
6248857|NCT00834340|7147364|FG001|COMPLETED|First Intervention||16
6248858|NCT00834340|7147363|FG000|NOT COMPLETED|First Intervention||0
6248859|NCT00834340|7147364|FG001|NOT COMPLETED|First Intervention||0
6248860|NCT00834340|7147363|FG000|STARTED|Washout||16
6248861|NCT00834340|7147364|FG001|STARTED|Washout||16
6248862|NCT00834340|7147363|FG000|COMPLETED|Washout||14
6248863|NCT00834340|7147364|FG001|COMPLETED|Washout||16
6248864|NCT00834340|7147363|FG000|NOT COMPLETED|Washout||2
6248865|NCT00834340|7147364|FG001|NOT COMPLETED|Washout||0
6248866|NCT00834340|7147363|FG000|STARTED|Second Intervention||14
6248867|NCT00834340|7147364|FG001|STARTED|Second Intervention||16
6248868|NCT00834340|7147363|FG000|COMPLETED|Second Intervention||14
6248869|NCT00834340|7147364|FG001|COMPLETED|Second Intervention||16
6248870|NCT00834340|7147363|FG000|NOT COMPLETED|Second Intervention||0
6248871|NCT00834340|7147364|FG001|NOT COMPLETED|Second Intervention||0
6248872|NCT00834275|7147370|FG000|STARTED|First Intervention||13
6248873|NCT00834275|7147371|FG001|STARTED|First Intervention||13
6248874|NCT00834275|7147370|FG000|COMPLETED|First Intervention||13
6248875|NCT00834275|7147371|FG001|COMPLETED|First Intervention||13
6248876|NCT00834275|7147370|FG000|NOT COMPLETED|First Intervention||0
6505448|NCT01453894|7424665|FG001|STARTED|Overall Study||225
6505449|NCT01453894|7424664|FG000|COMPLETED|Overall Study||225
6657640|NCT02471612|7588059|FG000|STARTED|Overall Study||159
6657641|NCT02471612|7588059|FG000|COMPLETED|Overall Study||157
6657642|NCT02471612|7588059|FG000|NOT COMPLETED|Overall Study||2
6657643|NCT02471651|7588078|FG000|STARTED|Overall Study||20
6657644|NCT02471651|7588079|FG001|STARTED|Overall Study||20
6657645|NCT02471651|7588078|FG000|COMPLETED|Overall Study||15
6657646|NCT02471651|7588079|FG001|COMPLETED|Overall Study||15
6657647|NCT02471651|7588078|FG000|NOT COMPLETED|Overall Study||5
6657648|NCT02471651|7588079|FG001|NOT COMPLETED|Overall Study||5
6657649|NCT02471716|7588090|FG000|STARTED|Overall Study||3
6657650|NCT02471716|7588091|FG001|STARTED|Overall Study||3
6657651|NCT02471716|7588092|FG002|STARTED|Overall Study||3
6248877|NCT00834275|7147371|FG001|NOT COMPLETED|First Intervention||0
6248878|NCT00834275|7147370|FG000|STARTED|Washout of 7 Days||13
6248879|NCT00834275|7147371|FG001|STARTED|Washout of 7 Days||13
6248880|NCT00834275|7147370|FG000|COMPLETED|Washout of 7 Days||13
6248881|NCT00834275|7147371|FG001|COMPLETED|Washout of 7 Days||13
6248882|NCT00834275|7147370|FG000|NOT COMPLETED|Washout of 7 Days||0
6248883|NCT00834275|7147371|FG001|NOT COMPLETED|Washout of 7 Days||0
6248884|NCT00834275|7147370|FG000|STARTED|Second Intervention||13
6248885|NCT00834275|7147371|FG001|STARTED|Second Intervention||13
6248886|NCT00834275|7147370|FG000|COMPLETED|Second Intervention||13
6248887|NCT00834275|7147371|FG001|COMPLETED|Second Intervention||13
6248888|NCT00834275|7147370|FG000|NOT COMPLETED|Second Intervention||0
6248889|NCT00834275|7147371|FG001|NOT COMPLETED|Second Intervention||0
6248890|NCT00834249|7147377|FG000|STARTED|First Intervention||9
6248891|NCT00834249|7147378|FG001|STARTED|First Intervention||9
6248892|NCT00834249|7147377|FG000|COMPLETED|First Intervention||9
6248893|NCT00834249|7147378|FG001|COMPLETED|First Intervention||9
6248894|NCT00834249|7147377|FG000|NOT COMPLETED|First Intervention||0
6248895|NCT00834249|7147378|FG001|NOT COMPLETED|First Intervention||0
6248896|NCT00834249|7147377|FG000|STARTED|Washout: 7 Days||9
6248897|NCT00834249|7147378|FG001|STARTED|Washout: 7 Days||9
6248898|NCT00834249|7147377|FG000|COMPLETED|Washout: 7 Days||8
6248899|NCT00834249|7147378|FG001|COMPLETED|Washout: 7 Days||8
6248900|NCT00834249|7147377|FG000|NOT COMPLETED|Washout: 7 Days||1
6248901|NCT00834249|7147378|FG001|NOT COMPLETED|Washout: 7 Days||1
6248902|NCT00834249|7147377|FG000|STARTED|Second Intervention||8
6248903|NCT00834249|7147378|FG001|STARTED|Second Intervention||8
6248904|NCT00834249|7147377|FG000|COMPLETED|Second Intervention||7
6248905|NCT00834249|7147378|FG001|COMPLETED|Second Intervention||8
6248906|NCT00834249|7147377|FG000|NOT COMPLETED|Second Intervention||1
6248907|NCT00834249|7147378|FG001|NOT COMPLETED|Second Intervention||0
6248908|NCT00834197|7147384|FG000|STARTED|First Intervention||16
6248909|NCT00834197|7147385|FG001|STARTED|First Intervention||16
6248910|NCT00834197|7147384|FG000|COMPLETED|First Intervention||16
6248911|NCT00834197|7147385|FG001|COMPLETED|First Intervention||16
6248912|NCT00834197|7147384|FG000|NOT COMPLETED|First Intervention||0
6248913|NCT00834197|7147385|FG001|NOT COMPLETED|First Intervention||0
6248914|NCT00834197|7147384|FG000|STARTED|Washout of 14 Days||16
6248915|NCT00834197|7147385|FG001|STARTED|Washout of 14 Days||16
6248916|NCT00834197|7147384|FG000|COMPLETED|Washout of 14 Days||16
6248917|NCT00834197|7147385|FG001|COMPLETED|Washout of 14 Days||16
6248918|NCT00834197|7147384|FG000|NOT COMPLETED|Washout of 14 Days||0
6248919|NCT00834197|7147385|FG001|NOT COMPLETED|Washout of 14 Days||0
6248920|NCT00834197|7147384|FG000|STARTED|Second Intervention||16
6248921|NCT00834197|7147385|FG001|STARTED|Second Intervention||16
6248922|NCT00834197|7147384|FG000|COMPLETED|Second Intervention||16
6248923|NCT00834197|7147385|FG001|COMPLETED|Second Intervention||16
6248924|NCT00834197|7147384|FG000|NOT COMPLETED|Second Intervention||0
6248925|NCT00834197|7147385|FG001|NOT COMPLETED|Second Intervention||0
6248926|NCT00834132|7147391|FG000|STARTED|First Intervention||12
6248927|NCT00834132|7147392|FG001|STARTED|First Intervention||12
6248928|NCT00834132|7147391|FG000|COMPLETED|First Intervention||12
6248929|NCT00834132|7147392|FG001|COMPLETED|First Intervention||12
6248930|NCT00834132|7147391|FG000|NOT COMPLETED|First Intervention||0
6248931|NCT00834132|7147392|FG001|NOT COMPLETED|First Intervention||0
6248932|NCT00834132|7147391|FG000|STARTED|Washout: 21 Days||12
6248933|NCT00834132|7147392|FG001|STARTED|Washout: 21 Days||12
6248934|NCT00834132|7147391|FG000|COMPLETED|Washout: 21 Days||12
6248935|NCT00834132|7147392|FG001|COMPLETED|Washout: 21 Days||12
6248936|NCT00834132|7147391|FG000|NOT COMPLETED|Washout: 21 Days||0
6248937|NCT00834132|7147392|FG001|NOT COMPLETED|Washout: 21 Days||0
6248938|NCT00834132|7147391|FG000|STARTED|Second Intervention||12
6248939|NCT00834132|7147392|FG001|STARTED|Second Intervention||12
6248940|NCT00834132|7147391|FG000|COMPLETED|Second Intervention||12
6248941|NCT00834132|7147392|FG001|COMPLETED|Second Intervention||12
6248942|NCT00834132|7147391|FG000|NOT COMPLETED|Second Intervention||0
6248943|NCT00834132|7147392|FG001|NOT COMPLETED|Second Intervention||0
6248944|NCT00834067|7147398|FG000|STARTED|First Intervention||30
6248945|NCT00834067|7147399|FG001|STARTED|First Intervention||30
6248946|NCT00834067|7147398|FG000|COMPLETED|First Intervention||30
6248947|NCT00834067|7147399|FG001|COMPLETED|First Intervention||30
6248948|NCT00834067|7147398|FG000|NOT COMPLETED|First Intervention||0
6248949|NCT00834067|7147399|FG001|NOT COMPLETED|First Intervention||0
6248950|NCT00834067|7147398|FG000|STARTED|Washout of 21 Days||30
6248951|NCT00834067|7147399|FG001|STARTED|Washout of 21 Days||30
6248952|NCT00834067|7147398|FG000|COMPLETED|Washout of 21 Days||30
6248953|NCT00834067|7147399|FG001|COMPLETED|Washout of 21 Days||29
6248954|NCT00834067|7147398|FG000|NOT COMPLETED|Washout of 21 Days||0
6248955|NCT00834067|7147399|FG001|NOT COMPLETED|Washout of 21 Days||1
6248956|NCT00834067|7147398|FG000|STARTED|Second Intervention||30
6248957|NCT00834067|7147399|FG001|STARTED|Second Intervention||29
6248958|NCT00834067|7147398|FG000|COMPLETED|Second Intervention||30
6248959|NCT00834067|7147399|FG001|COMPLETED|Second Intervention||29
6248960|NCT00834067|7147398|FG000|NOT COMPLETED|Second Intervention||0
6248961|NCT00834067|7147399|FG001|NOT COMPLETED|Second Intervention||0
6248962|NCT00833937|7147405|FG000|STARTED|First Intervention||12
6248963|NCT00833937|7147406|FG001|STARTED|First Intervention||12
6248964|NCT00833937|7147405|FG000|COMPLETED|First Intervention||12
6248965|NCT00833937|7147406|FG001|COMPLETED|First Intervention||12
6248966|NCT00833937|7147405|FG000|NOT COMPLETED|First Intervention||0
6248967|NCT00833937|7147406|FG001|NOT COMPLETED|First Intervention||0
6248968|NCT00833937|7147405|FG000|STARTED|Washout||12
6248969|NCT00833937|7147406|FG001|STARTED|Washout||12
6248970|NCT00833937|7147405|FG000|COMPLETED|Washout||11
6569826|NCT01847560|7493177|FG005|STARTED|Overall Study||28343
6569827|NCT01847560|7493178|FG006|STARTED|Overall Study||40971
6248971|NCT00833937|7147406|FG001|COMPLETED|Washout||12
6248972|NCT00833937|7147405|FG000|NOT COMPLETED|Washout||1
6248973|NCT00833937|7147406|FG001|NOT COMPLETED|Washout||0
6248974|NCT00833937|7147405|FG000|STARTED|Second Intervention||11
6248975|NCT00833937|7147406|FG001|STARTED|Second Intervention||12
6248976|NCT00833937|7147405|FG000|COMPLETED|Second Intervention||11
6248977|NCT00833937|7147406|FG001|COMPLETED|Second Intervention||12
6248978|NCT00833937|7147405|FG000|NOT COMPLETED|Second Intervention||0
6248979|NCT00833937|7147406|FG001|NOT COMPLETED|Second Intervention||0
6248980|NCT00833664|7147412|FG000|STARTED|First Intervention||11
6248981|NCT00833664|7147413|FG001|STARTED|First Intervention||11
6248982|NCT00833664|7147412|FG000|COMPLETED|First Intervention||11
6248983|NCT00833664|7147413|FG001|COMPLETED|First Intervention||11
6248984|NCT00833664|7147412|FG000|NOT COMPLETED|First Intervention||0
6248985|NCT00833664|7147413|FG001|NOT COMPLETED|First Intervention||0
6248986|NCT00833664|7147412|FG000|STARTED|Washout: 14 Days||11
6248987|NCT00833664|7147413|FG001|STARTED|Washout: 14 Days||11
6248988|NCT00833664|7147412|FG000|COMPLETED|Washout: 14 Days||10
6569828|NCT01847560|7493179|FG007|STARTED|Overall Study||19829
6569829|NCT01847560|7493180|FG008|STARTED|Overall Study||77547
6248989|NCT00833664|7147413|FG001|COMPLETED|Washout: 14 Days||11
6248990|NCT00833664|7147412|FG000|NOT COMPLETED|Washout: 14 Days||1
6248991|NCT00833664|7147413|FG001|NOT COMPLETED|Washout: 14 Days||0
6248992|NCT00833664|7147412|FG000|STARTED|Second Intervention||10
6248993|NCT00833664|7147413|FG001|STARTED|Second Intervention||11
6248994|NCT00833664|7147412|FG000|COMPLETED|Second Intervention||10
6248995|NCT00833664|7147413|FG001|COMPLETED|Second Intervention||11
6248996|NCT00833664|7147412|FG000|NOT COMPLETED|Second Intervention||0
6248997|NCT00833664|7147413|FG001|NOT COMPLETED|Second Intervention||0
6248998|NCT00833586|7147419|FG000|STARTED|First Intervention||14
6248999|NCT00833586|7147420|FG001|STARTED|First Intervention||14
6505450|NCT01453894|7424665|FG001|COMPLETED|Overall Study||225
6505451|NCT01453894|7424664|FG000|NOT COMPLETED|Overall Study||0
6505452|NCT01453894|7424665|FG001|NOT COMPLETED|Overall Study||0
6505453|NCT01453998|7424674|FG000|STARTED|Before Protocol Amendment 2||85
6505454|NCT01453998|7424675|FG001|STARTED|Before Protocol Amendment 2||88
6505455|NCT01453998|7424676|FG002|STARTED|Before Protocol Amendment 2||99
6505456|NCT01453998|7424674|FG000|COMPLETED|Before Protocol Amendment 2||85
6657652|NCT02471716|7588093|FG003|STARTED|Overall Study||33
6657653|NCT02471716|7588094|FG004|STARTED|Overall Study||24
6657654|NCT02471716|7588090|FG000|COMPLETED|Overall Study||3
6657655|NCT02471716|7588091|FG001|COMPLETED|Overall Study||2
6657656|NCT02471716|7588092|FG002|COMPLETED|Overall Study||3
6657657|NCT02471716|7588093|FG003|COMPLETED|Overall Study||18
6657658|NCT02471716|7588094|FG004|COMPLETED|Overall Study||8
6657659|NCT02471716|7588090|FG000|NOT COMPLETED|Overall Study||0
6657660|NCT02471716|7588091|FG001|NOT COMPLETED|Overall Study||1
6657661|NCT02471716|7588092|FG002|NOT COMPLETED|Overall Study||0
6657662|NCT02471716|7588093|FG003|NOT COMPLETED|Overall Study||15
6505457|NCT01453998|7424675|FG001|COMPLETED|Before Protocol Amendment 2||88
6505458|NCT01453998|7424676|FG002|COMPLETED|Before Protocol Amendment 2||99
6505459|NCT01453998|7424674|FG000|NOT COMPLETED|Before Protocol Amendment 2||0
6505460|NCT01453998|7424675|FG001|NOT COMPLETED|Before Protocol Amendment 2||0
6505461|NCT01453998|7424676|FG002|NOT COMPLETED|Before Protocol Amendment 2||0
6505462|NCT01453998|7424674|FG000|STARTED|After Protocol Amendment 2.||131
6505463|NCT01453998|7424675|FG001|STARTED|After Protocol Amendment 2.||130
6505464|NCT01453998|7424676|FG002|STARTED|After Protocol Amendment 2.||124
6505465|NCT01453998|7424674|FG000|COMPLETED|After Protocol Amendment 2.||130
6505466|NCT01453998|7424675|FG001|COMPLETED|After Protocol Amendment 2.||130
6505467|NCT01453998|7424676|FG002|COMPLETED|After Protocol Amendment 2.||124
6505468|NCT01453998|7424674|FG000|NOT COMPLETED|After Protocol Amendment 2.||1
6657663|NCT02471716|7588094|FG004|NOT COMPLETED|Overall Study||16
6657664|NCT02471755|7588110|FG000|STARTED|Overall Study||45
6657665|NCT02471755|7588111|FG001|STARTED|Overall Study||45
6249000|NCT00833586|7147419|FG000|COMPLETED|First Intervention||14
6249001|NCT00833586|7147420|FG001|COMPLETED|First Intervention||14
6249002|NCT00833586|7147419|FG000|NOT COMPLETED|First Intervention||0
6505469|NCT01453998|7424675|FG001|NOT COMPLETED|After Protocol Amendment 2.||0
6249003|NCT00833586|7147420|FG001|NOT COMPLETED|First Intervention||0
6249004|NCT00833586|7147419|FG000|STARTED|Washout: 14 Days||14
6249005|NCT00833586|7147420|FG001|STARTED|Washout: 14 Days||14
6249006|NCT00833586|7147419|FG000|COMPLETED|Washout: 14 Days||14
6249007|NCT00833586|7147420|FG001|COMPLETED|Washout: 14 Days||14
6249008|NCT00833586|7147419|FG000|NOT COMPLETED|Washout: 14 Days||0
6249009|NCT00833586|7147420|FG001|NOT COMPLETED|Washout: 14 Days||0
6249010|NCT00833586|7147419|FG000|STARTED|Second Intervention||14
6249011|NCT00833586|7147420|FG001|STARTED|Second Intervention||14
6249012|NCT00833586|7147419|FG000|COMPLETED|Second Intervention||14
6249013|NCT00833586|7147420|FG001|COMPLETED|Second Intervention||14
6249014|NCT00833586|7147419|FG000|NOT COMPLETED|Second Intervention||0
6249015|NCT00833586|7147420|FG001|NOT COMPLETED|Second Intervention||0
6249016|NCT00833521|7147426|FG000|STARTED|First Intervention||19
6249017|NCT00833521|7147427|FG001|STARTED|First Intervention||19
6249018|NCT00833521|7147426|FG000|COMPLETED|First Intervention||19
6249019|NCT00833521|7147427|FG001|COMPLETED|First Intervention||19
6249020|NCT00833521|7147426|FG000|NOT COMPLETED|First Intervention||0
6249021|NCT00833521|7147427|FG001|NOT COMPLETED|First Intervention||0
6249022|NCT00833521|7147426|FG000|STARTED|Second Intervention||19
6249023|NCT00833521|7147427|FG001|STARTED|Second Intervention||19
6249024|NCT00833521|7147426|FG000|COMPLETED|Second Intervention||19
6249025|NCT00833521|7147427|FG001|COMPLETED|Second Intervention||19
6249026|NCT00833521|7147426|FG000|NOT COMPLETED|Second Intervention||0
6249027|NCT00833521|7147427|FG001|NOT COMPLETED|Second Intervention||0
6249028|NCT00830336|7147433|FG000|STARTED|First Intervention||40
6249029|NCT00830336|7147434|FG001|STARTED|First Intervention||40
6249030|NCT00830336|7147433|FG000|COMPLETED|First Intervention||40
6249031|NCT00830336|7147434|FG001|COMPLETED|First Intervention||40
6249032|NCT00830336|7147433|FG000|NOT COMPLETED|First Intervention||0
6249033|NCT00830336|7147434|FG001|NOT COMPLETED|First Intervention||0
6249034|NCT00830336|7147433|FG000|STARTED|Washout: 21 Days||40
6249035|NCT00830336|7147434|FG001|STARTED|Washout: 21 Days||40
6249036|NCT00830336|7147433|FG000|COMPLETED|Washout: 21 Days||39
6249037|NCT00830336|7147434|FG001|COMPLETED|Washout: 21 Days||40
6249038|NCT00830336|7147433|FG000|NOT COMPLETED|Washout: 21 Days||1
6249039|NCT00830336|7147434|FG001|NOT COMPLETED|Washout: 21 Days||0
6249040|NCT00830336|7147433|FG000|STARTED|Second Intervention||39
6249041|NCT00830336|7147434|FG001|STARTED|Second Intervention||40
6569830|NCT01847560|7493181|FG009|STARTED|Overall Study||39438
6569831|NCT01847560|7493172|FG000|COMPLETED|Overall Study||13464
6569832|NCT01847560|7493173|FG001|COMPLETED|Overall Study||19955
6569833|NCT01847560|7493174|FG002|COMPLETED|Overall Study||9731
6569834|NCT01847560|7493175|FG003|COMPLETED|Overall Study||56655
6249042|NCT00830336|7147433|FG000|COMPLETED|Second Intervention||39
6249043|NCT00830336|7147434|FG001|COMPLETED|Second Intervention||40
6249044|NCT00830336|7147433|FG000|NOT COMPLETED|Second Intervention||0
6249045|NCT00830336|7147434|FG001|NOT COMPLETED|Second Intervention||0
6249046|NCT00830258|7147440|FG000|STARTED|First Intervention||30
6249047|NCT00830258|7147441|FG001|STARTED|First Intervention||30
6249048|NCT00830258|7147440|FG000|COMPLETED|First Intervention||29
6249049|NCT00830258|7147441|FG001|COMPLETED|First Intervention||30
6249050|NCT00830258|7147440|FG000|NOT COMPLETED|First Intervention||1
6249051|NCT00830258|7147441|FG001|NOT COMPLETED|First Intervention||0
6249052|NCT00830258|7147440|FG000|STARTED|Washout: 7 Days||29
6249053|NCT00830258|7147441|FG001|STARTED|Washout: 7 Days||30
6249054|NCT00830258|7147440|FG000|COMPLETED|Washout: 7 Days||28
6249055|NCT00830258|7147441|FG001|COMPLETED|Washout: 7 Days||30
6249056|NCT00830258|7147440|FG000|NOT COMPLETED|Washout: 7 Days||1
6249057|NCT00830258|7147441|FG001|NOT COMPLETED|Washout: 7 Days||0
6249058|NCT00830258|7147440|FG000|STARTED|Second Intervention||28
6249059|NCT00830258|7147441|FG001|STARTED|Second Intervention||30
6249060|NCT00830258|7147440|FG000|COMPLETED|Second Intervention||28
6249061|NCT00830258|7147441|FG001|COMPLETED|Second Intervention||30
6249062|NCT00830258|7147440|FG000|NOT COMPLETED|Second Intervention||0
6249063|NCT00830258|7147441|FG001|NOT COMPLETED|Second Intervention||0
6569835|NCT01847560|7493176|FG004|COMPLETED|Overall Study||27731
6249064|NCT00830219|7147447|FG000|STARTED|First Intervention||23
6569836|NCT01847560|7493177|FG005|COMPLETED|Overall Study||28343
6249065|NCT00830219|7147448|FG001|STARTED|First Intervention||23
6249066|NCT00830219|7147447|FG000|COMPLETED|First Intervention||23
6249067|NCT00830219|7147448|FG001|COMPLETED|First Intervention||23
6249068|NCT00830219|7147447|FG000|NOT COMPLETED|First Intervention||0
6249069|NCT00830219|7147448|FG001|NOT COMPLETED|First Intervention||0
6249070|NCT00830219|7147447|FG000|STARTED|Washout of 7 Days||23
6249071|NCT00830219|7147448|FG001|STARTED|Washout of 7 Days||23
6249072|NCT00830219|7147447|FG000|COMPLETED|Washout of 7 Days||22
6249073|NCT00830219|7147448|FG001|COMPLETED|Washout of 7 Days||22
6249074|NCT00830219|7147447|FG000|NOT COMPLETED|Washout of 7 Days||1
6249075|NCT00830219|7147448|FG001|NOT COMPLETED|Washout of 7 Days||1
6249076|NCT00830219|7147447|FG000|STARTED|Second Intervention||22
6249077|NCT00830219|7147448|FG001|STARTED|Second Intervention||22
6249078|NCT00830219|7147447|FG000|COMPLETED|Second Intervention||22
6249079|NCT00830219|7147448|FG001|COMPLETED|Second Intervention||22
6249080|NCT00830219|7147447|FG000|NOT COMPLETED|Second Intervention||0
6249081|NCT00830219|7147448|FG001|NOT COMPLETED|Second Intervention||0
6249082|NCT00830206|7147454|FG000|STARTED|First Intervention||40
6249083|NCT00830206|7147455|FG001|STARTED|First Intervention||40
6249084|NCT00830206|7147454|FG000|COMPLETED|First Intervention||40
6249085|NCT00830206|7147455|FG001|COMPLETED|First Intervention||40
6249086|NCT00830206|7147454|FG000|NOT COMPLETED|First Intervention||0
6249087|NCT00830206|7147455|FG001|NOT COMPLETED|First Intervention||0
6249088|NCT00830206|7147454|FG000|STARTED|Washout: 21 Days||40
6249089|NCT00830206|7147455|FG001|STARTED|Washout: 21 Days||40
6249090|NCT00830206|7147454|FG000|COMPLETED|Washout: 21 Days||39
6249091|NCT00830206|7147455|FG001|COMPLETED|Washout: 21 Days||39
6249092|NCT00830206|7147454|FG000|NOT COMPLETED|Washout: 21 Days||1
6249093|NCT00830206|7147455|FG001|NOT COMPLETED|Washout: 21 Days||1
6249094|NCT00830206|7147454|FG000|STARTED|Second Intervention||39
6249095|NCT00830206|7147455|FG001|STARTED|Second Intervention||39
6249096|NCT00830206|7147454|FG000|COMPLETED|Second Intervention||39
6249097|NCT00830206|7147455|FG001|COMPLETED|Second Intervention||39
6249098|NCT00830206|7147454|FG000|NOT COMPLETED|Second Intervention||0
6249099|NCT00830206|7147455|FG001|NOT COMPLETED|Second Intervention||0
6249100|NCT00830024|7147461|FG000|STARTED|First Intervention||18
6249101|NCT00830024|7147462|FG001|STARTED|First Intervention||18
6249102|NCT00830024|7147461|FG000|COMPLETED|First Intervention||18
6249103|NCT00830024|7147462|FG001|COMPLETED|First Intervention||18
6249104|NCT00830024|7147461|FG000|NOT COMPLETED|First Intervention||0
6249105|NCT00830024|7147462|FG001|NOT COMPLETED|First Intervention||0
6249106|NCT00830024|7147461|FG000|STARTED|Washout: 7 Days||18
6249107|NCT00830024|7147462|FG001|STARTED|Washout: 7 Days||18
6249108|NCT00830024|7147461|FG000|COMPLETED|Washout: 7 Days||17
6249109|NCT00830024|7147462|FG001|COMPLETED|Washout: 7 Days||18
6249110|NCT00830024|7147461|FG000|NOT COMPLETED|Washout: 7 Days||1
6249111|NCT00830024|7147462|FG001|NOT COMPLETED|Washout: 7 Days||0
6249112|NCT00830024|7147461|FG000|STARTED|Second Intervention||17
6249113|NCT00830024|7147462|FG001|STARTED|Second Intervention||18
6249114|NCT00830024|7147461|FG000|COMPLETED|Second Intervention||17
6249115|NCT00830024|7147462|FG001|COMPLETED|Second Intervention||18
6249116|NCT00830024|7147461|FG000|NOT COMPLETED|Second Intervention||0
6249117|NCT00830024|7147462|FG001|NOT COMPLETED|Second Intervention||0
6249118|NCT00829998|7147468|FG000|STARTED|First Intervention||21
6249119|NCT00829998|7147469|FG001|STARTED|First Intervention||20
6657666|NCT02471755|7588110|FG000|COMPLETED|Overall Study||44
6657667|NCT02471755|7588111|FG001|COMPLETED|Overall Study||44
6657668|NCT02471755|7588110|FG000|NOT COMPLETED|Overall Study||1
6657669|NCT02471755|7588111|FG001|NOT COMPLETED|Overall Study||1
6657670|NCT02472145|7588120|FG000|STARTED|Overall Study||10
6657671|NCT02472145|7588121|FG001|STARTED|Overall Study||159
6657672|NCT02472145|7588122|FG002|STARTED|Overall Study||157
6657673|NCT02472145|7588120|FG000|Treated|Overall Study||10
6657674|NCT02472145|7588121|FG001|Treated|Overall Study||156
6657675|NCT02472145|7588122|FG002|Treated|Overall Study||156
6657676|NCT02472145|7588120|FG000|Safety|Overall Study||10
6657677|NCT02472145|7588121|FG001|Safety|Overall Study|9 participants who received decitabine,not JNJ-56022473 included,3 untreated participant excluded.|165
6657678|NCT02472145|7588122|FG002|Safety|Overall Study|1 participant who was not treated and 9 participants who received only decitabine were excluded.|147
6249120|NCT00829998|7147468|FG000|COMPLETED|First Intervention||21
6249121|NCT00829998|7147469|FG001|COMPLETED|First Intervention||20
6249122|NCT00829998|7147468|FG000|NOT COMPLETED|First Intervention||0
6249123|NCT00829998|7147469|FG001|NOT COMPLETED|First Intervention||0
6249124|NCT00829998|7147468|FG000|STARTED|Washout||21
6249125|NCT00829998|7147469|FG001|STARTED|Washout||20
6249126|NCT00829998|7147468|FG000|COMPLETED|Washout||21
6249127|NCT00829998|7147469|FG001|COMPLETED|Washout||19
6249128|NCT00829998|7147468|FG000|NOT COMPLETED|Washout||0
6249129|NCT00829998|7147469|FG001|NOT COMPLETED|Washout||1
6249130|NCT00829998|7147468|FG000|STARTED|Second Intervention||21
6249131|NCT00829998|7147469|FG001|STARTED|Second Intervention||19
6249132|NCT00829998|7147468|FG000|COMPLETED|Second Intervention||21
6249133|NCT00829998|7147469|FG001|COMPLETED|Second Intervention||19
6249134|NCT00829998|7147468|FG000|NOT COMPLETED|Second Intervention||0
6249135|NCT00829998|7147469|FG001|NOT COMPLETED|Second Intervention||0
6249136|NCT00829868|7147475|FG000|STARTED|First Intervention||21
6249137|NCT00829868|7147476|FG001|STARTED|First Intervention||21
6249138|NCT00829868|7147475|FG000|COMPLETED|First Intervention||21
6249139|NCT00829868|7147476|FG001|COMPLETED|First Intervention||21
6249140|NCT00829868|7147475|FG000|NOT COMPLETED|First Intervention||0
6249141|NCT00829868|7147476|FG001|NOT COMPLETED|First Intervention||0
6249142|NCT00829868|7147475|FG000|STARTED|Washout||21
6569837|NCT01847560|7493178|FG006|COMPLETED|Overall Study||40971
6569838|NCT01847560|7493179|FG007|COMPLETED|Overall Study||19829
6569839|NCT01847560|7493180|FG008|COMPLETED|Overall Study||77547
6569840|NCT01847560|7493181|FG009|COMPLETED|Overall Study||39438
6569841|NCT01847560|7493172|FG000|NOT COMPLETED|Overall Study||0
6569842|NCT01847560|7493173|FG001|NOT COMPLETED|Overall Study||0
6569843|NCT01847560|7493174|FG002|NOT COMPLETED|Overall Study||0
6569844|NCT01847560|7493175|FG003|NOT COMPLETED|Overall Study||0
6569845|NCT01847560|7493176|FG004|NOT COMPLETED|Overall Study||0
6569846|NCT01847560|7493177|FG005|NOT COMPLETED|Overall Study||0
6249143|NCT00829868|7147476|FG001|STARTED|Washout||21
6249144|NCT00829868|7147475|FG000|COMPLETED|Washout||20
6249145|NCT00829868|7147476|FG001|COMPLETED|Washout||21
6569847|NCT01847560|7493178|FG006|NOT COMPLETED|Overall Study||0
6249146|NCT00829868|7147475|FG000|NOT COMPLETED|Washout||1
6249147|NCT00829868|7147476|FG001|NOT COMPLETED|Washout||0
6249148|NCT00829868|7147475|FG000|STARTED|Second Intervention||20
6249149|NCT00829868|7147476|FG001|STARTED|Second Intervention||21
6249150|NCT00829868|7147475|FG000|COMPLETED|Second Intervention||20
6249151|NCT00829868|7147476|FG001|COMPLETED|Second Intervention||21
6249152|NCT00829868|7147475|FG000|NOT COMPLETED|Second Intervention||0
6249153|NCT00829868|7147476|FG001|NOT COMPLETED|Second Intervention||0
6249154|NCT00829790|7147482|FG000|STARTED|First Intervention||15
6249155|NCT00829790|7147483|FG001|STARTED|First Intervention||15
6249156|NCT00829790|7147482|FG000|COMPLETED|First Intervention||15
6249157|NCT00829790|7147483|FG001|COMPLETED|First Intervention||15
6249158|NCT00829790|7147482|FG000|NOT COMPLETED|First Intervention||0
6249159|NCT00829790|7147483|FG001|NOT COMPLETED|First Intervention||0
6249160|NCT00829790|7147482|FG000|STARTED|Washout of 14 Days||15
6249161|NCT00829790|7147483|FG001|STARTED|Washout of 14 Days||15
6249162|NCT00829790|7147482|FG000|COMPLETED|Washout of 14 Days||15
6249163|NCT00829790|7147483|FG001|COMPLETED|Washout of 14 Days||14
6249164|NCT00829790|7147482|FG000|NOT COMPLETED|Washout of 14 Days||0
6249165|NCT00829790|7147483|FG001|NOT COMPLETED|Washout of 14 Days||1
6249166|NCT00829790|7147482|FG000|STARTED|Second Intervention||15
6249167|NCT00829790|7147483|FG001|STARTED|Second Intervention||14
6249168|NCT00829790|7147482|FG000|COMPLETED|Second Intervention||15
6249169|NCT00829790|7147483|FG001|COMPLETED|Second Intervention||14
6249170|NCT00829790|7147482|FG000|NOT COMPLETED|Second Intervention||0
6249171|NCT00829790|7147483|FG001|NOT COMPLETED|Second Intervention||0
6249172|NCT00829764|7147489|FG000|STARTED|First Intervention||15
6249173|NCT00829764|7147490|FG001|STARTED|First Intervention||15
6249174|NCT00829764|7147489|FG000|COMPLETED|First Intervention||13
6249175|NCT00829764|7147490|FG001|COMPLETED|First Intervention||14
6249176|NCT00829764|7147489|FG000|NOT COMPLETED|First Intervention||2
6249177|NCT00829764|7147490|FG001|NOT COMPLETED|First Intervention||1
6249178|NCT00829764|7147489|FG000|STARTED|Washout of 14 Days||13
6249179|NCT00829764|7147490|FG001|STARTED|Washout of 14 Days||14
6249180|NCT00829764|7147489|FG000|COMPLETED|Washout of 14 Days||13
6249181|NCT00829764|7147490|FG001|COMPLETED|Washout of 14 Days||14
6505470|NCT01453998|7424676|FG002|NOT COMPLETED|After Protocol Amendment 2.||0
6505471|NCT01454063|7424689|FG000|STARTED|Randomized||202
6505472|NCT01454063|7424690|FG001|STARTED|Randomized||203
6505473|NCT01454063|7424689|FG000|COMPLETED|Randomized||201
6505474|NCT01454063|7424690|FG001|COMPLETED|Randomized||201
6505475|NCT01454063|7424689|FG000|NOT COMPLETED|Randomized||1
6505476|NCT01454063|7424690|FG001|NOT COMPLETED|Randomized||2
6505477|NCT01454063|7424689|FG000|STARTED|Treated||201
6569848|NCT01847560|7493179|FG007|NOT COMPLETED|Overall Study||0
6569849|NCT01847560|7493180|FG008|NOT COMPLETED|Overall Study||0
6569850|NCT01847560|7493181|FG009|NOT COMPLETED|Overall Study||0
6505478|NCT01454063|7424690|FG001|STARTED|Treated||201
6505479|NCT01454063|7424689|FG000|COMPLETED|Treated||199
6505480|NCT01454063|7424690|FG001|COMPLETED|Treated||201
6505481|NCT01454063|7424689|FG000|NOT COMPLETED|Treated||2
6505482|NCT01454063|7424690|FG001|NOT COMPLETED|Treated||0
6249182|NCT00829764|7147489|FG000|NOT COMPLETED|Washout of 14 Days||0
6249183|NCT00829764|7147490|FG001|NOT COMPLETED|Washout of 14 Days||0
6249184|NCT00829764|7147489|FG000|STARTED|Second Intervention||13
6249185|NCT00829764|7147490|FG001|STARTED|Second Intervention||14
6249186|NCT00829764|7147489|FG000|COMPLETED|Second Intervention||13
6249187|NCT00829764|7147490|FG001|COMPLETED|Second Intervention||14
6249188|NCT00829764|7147489|FG000|NOT COMPLETED|Second Intervention||0
6249189|NCT00829764|7147490|FG001|NOT COMPLETED|Second Intervention||0
6249190|NCT00829712|7147496|FG000|STARTED|First Intervention||12
6249191|NCT00829712|7147497|FG001|STARTED|First Intervention||12
6249192|NCT00829712|7147496|FG000|COMPLETED|First Intervention||12
6249193|NCT00829712|7147497|FG001|COMPLETED|First Intervention||12
6249194|NCT00829712|7147496|FG000|NOT COMPLETED|First Intervention||0
6249195|NCT00829712|7147497|FG001|NOT COMPLETED|First Intervention||0
6505483|NCT01454076|7424701|FG000|STARTED|Overall Study||29
6505484|NCT01454076|7424702|FG001|STARTED|Overall Study||20
6505485|NCT01454076|7424703|FG002|STARTED|Overall Study||24
6505486|NCT01454076|7424704|FG003|STARTED|Overall Study||18
6505487|NCT01454076|7424705|FG004|STARTED|Overall Study||21
6657679|NCT02472145|7588120|FG000|COMPLETED|Overall Study||0
6249196|NCT00829712|7147496|FG000|STARTED|Washout of 7 Days||12
6249197|NCT00829712|7147497|FG001|STARTED|Washout of 7 Days||12
6249198|NCT00829712|7147496|FG000|COMPLETED|Washout of 7 Days||12
6249199|NCT00829712|7147497|FG001|COMPLETED|Washout of 7 Days||11
6249200|NCT00829712|7147496|FG000|NOT COMPLETED|Washout of 7 Days||0
6249201|NCT00829712|7147497|FG001|NOT COMPLETED|Washout of 7 Days||1
6249202|NCT00829712|7147496|FG000|STARTED|Second Intervention||12
6249203|NCT00829712|7147497|FG001|STARTED|Second Intervention||11
6249204|NCT00829712|7147496|FG000|COMPLETED|Second Intervention||12
6249205|NCT00829712|7147497|FG001|COMPLETED|Second Intervention||11
6249206|NCT00829712|7147496|FG000|NOT COMPLETED|Second Intervention||0
6249207|NCT00829712|7147497|FG001|NOT COMPLETED|Second Intervention||0
6249208|NCT00829686|7147503|FG000|STARTED|Overall Study||13
6249209|NCT00829686|7147504|FG001|STARTED|Overall Study||18
6249210|NCT00829686|7147503|FG000|COMPLETED|Overall Study||13
6249211|NCT00829686|7147504|FG001|COMPLETED|Overall Study||18
6249212|NCT00829686|7147503|FG000|NOT COMPLETED|Overall Study||0
6249213|NCT00829686|7147504|FG001|NOT COMPLETED|Overall Study||0
6249214|NCT00829673|7147510|FG000|STARTED|First Intervention||12
6249215|NCT00829673|7147511|FG001|STARTED|First Intervention||12
6249216|NCT00829673|7147510|FG000|COMPLETED|First Intervention||12
6249217|NCT00829673|7147511|FG001|COMPLETED|First Intervention||12
6249218|NCT00829673|7147510|FG000|NOT COMPLETED|First Intervention||0
6249219|NCT00829673|7147511|FG001|NOT COMPLETED|First Intervention||0
6249220|NCT00829673|7147510|FG000|STARTED|Washout of 7 Days||12
6249221|NCT00829673|7147511|FG001|STARTED|Washout of 7 Days||12
6249222|NCT00829673|7147510|FG000|COMPLETED|Washout of 7 Days||11
6249223|NCT00829673|7147511|FG001|COMPLETED|Washout of 7 Days||12
6249224|NCT00829673|7147510|FG000|NOT COMPLETED|Washout of 7 Days||1
6249225|NCT00829673|7147511|FG001|NOT COMPLETED|Washout of 7 Days||0
6249226|NCT00829673|7147510|FG000|STARTED|Second Intervention||11
6249227|NCT00829673|7147511|FG001|STARTED|Second Intervention||12
6249228|NCT00829673|7147510|FG000|COMPLETED|Second Intervention||11
6249229|NCT00829673|7147511|FG001|COMPLETED|Second Intervention||12
6249230|NCT00829673|7147510|FG000|NOT COMPLETED|Second Intervention||0
6249231|NCT00829673|7147511|FG001|NOT COMPLETED|Second Intervention||0
6249232|NCT00829530|7147517|FG000|STARTED|First Intervention||20
6249233|NCT00829530|7147518|FG001|STARTED|First Intervention||20
6249234|NCT00829530|7147517|FG000|COMPLETED|First Intervention||20
6249235|NCT00829530|7147518|FG001|COMPLETED|First Intervention||18
6249236|NCT00829530|7147517|FG000|NOT COMPLETED|First Intervention||0
6249237|NCT00829530|7147518|FG001|NOT COMPLETED|First Intervention||2
6249238|NCT00829530|7147517|FG000|STARTED|Washout of 42 Days||20
6249239|NCT00829530|7147518|FG001|STARTED|Washout of 42 Days||18
6249240|NCT00829530|7147517|FG000|COMPLETED|Washout of 42 Days||20
6249241|NCT00829530|7147518|FG001|COMPLETED|Washout of 42 Days||18
6249242|NCT00829530|7147517|FG000|NOT COMPLETED|Washout of 42 Days||0
6249243|NCT00829530|7147518|FG001|NOT COMPLETED|Washout of 42 Days||0
6249244|NCT00829530|7147517|FG000|STARTED|Second Intervention||20
6249245|NCT00829530|7147518|FG001|STARTED|Second Intervention||18
6657680|NCT02472145|7588121|FG001|COMPLETED|Overall Study||0
6657681|NCT02472145|7588122|FG002|COMPLETED|Overall Study||0
6657682|NCT02472145|7588120|FG000|NOT COMPLETED|Overall Study||10
6657683|NCT02472145|7588121|FG001|NOT COMPLETED|Overall Study||159
6657684|NCT02472145|7588122|FG002|NOT COMPLETED|Overall Study||157
6657685|NCT02472223|7588131|FG000|STARTED|Overall Study||16
6657686|NCT02472223|7588132|FG001|STARTED|Overall Study||12
6657687|NCT02472223|7588131|FG000|COMPLETED|Overall Study||10
6657688|NCT02472223|7588132|FG001|COMPLETED|Overall Study||7
6657689|NCT02472223|7588131|FG000|NOT COMPLETED|Overall Study||6
6249246|NCT00829530|7147517|FG000|COMPLETED|Second Intervention||19
6249247|NCT00829530|7147518|FG001|COMPLETED|Second Intervention||18
6249248|NCT00829530|7147517|FG000|NOT COMPLETED|Second Intervention||1
6249249|NCT00829530|7147518|FG001|NOT COMPLETED|Second Intervention||0
6249250|NCT00829504|7147524|FG000|STARTED|First Intervention||22
6657690|NCT02472223|7588132|FG001|NOT COMPLETED|Overall Study||5
6657691|NCT02472262|7588141|FG000|STARTED|Overall Study||117
6657692|NCT02472262|7588142|FG001|STARTED|Overall Study||120
6505488|NCT01454076|7424701|FG000|COMPLETED|Overall Study||16
6657693|NCT02472262|7588143|FG002|STARTED|Overall Study||118
6505489|NCT01454076|7424702|FG001|COMPLETED|Overall Study||14
6505490|NCT01454076|7424703|FG002|COMPLETED|Overall Study||15
6505491|NCT01454076|7424704|FG003|COMPLETED|Overall Study||16
6505492|NCT01454076|7424705|FG004|COMPLETED|Overall Study||15
6505493|NCT01454076|7424701|FG000|NOT COMPLETED|Overall Study||13
6505494|NCT01454076|7424702|FG001|NOT COMPLETED|Overall Study||6
6249251|NCT00829504|7147525|FG001|STARTED|First Intervention||22
6249252|NCT00829504|7147524|FG000|COMPLETED|First Intervention||21
6249253|NCT00829504|7147525|FG001|COMPLETED|First Intervention||22
6249254|NCT00829504|7147524|FG000|NOT COMPLETED|First Intervention||1
6249255|NCT00829504|7147525|FG001|NOT COMPLETED|First Intervention||0
6249256|NCT00829504|7147524|FG000|STARTED|Washout of 7 Days||21
6249257|NCT00829504|7147525|FG001|STARTED|Washout of 7 Days||22
6249258|NCT00829504|7147524|FG000|COMPLETED|Washout of 7 Days||20
6249259|NCT00829504|7147525|FG001|COMPLETED|Washout of 7 Days||22
6249260|NCT00829504|7147524|FG000|NOT COMPLETED|Washout of 7 Days||1
6249261|NCT00829504|7147525|FG001|NOT COMPLETED|Washout of 7 Days||0
6249262|NCT00829504|7147524|FG000|STARTED|Second Intervention||20
6249263|NCT00829504|7147525|FG001|STARTED|Second Intervention||22
6249264|NCT00829504|7147524|FG000|COMPLETED|Second Intervention||19
6249265|NCT00829504|7147525|FG001|COMPLETED|Second Intervention||22
6249266|NCT00829504|7147524|FG000|NOT COMPLETED|Second Intervention||1
6249267|NCT00829504|7147525|FG001|NOT COMPLETED|Second Intervention||0
6249268|NCT00829452|7147531|FG000|STARTED|First Intervention||20
6249269|NCT00829452|7147532|FG001|STARTED|First Intervention||20
6249270|NCT00829452|7147531|FG000|COMPLETED|First Intervention||20
6505495|NCT01454076|7424703|FG002|NOT COMPLETED|Overall Study||9
6505496|NCT01454076|7424704|FG003|NOT COMPLETED|Overall Study||2
6505497|NCT01454076|7424705|FG004|NOT COMPLETED|Overall Study||6
6505498|NCT01454102|7424742|FG000|STARTED|Overall Study||12
6505499|NCT01454102|7424743|FG001|STARTED|Overall Study||15
6505500|NCT01454102|7424744|FG002|STARTED|Overall Study||15
6505501|NCT01454102|7424745|FG003|STARTED|Overall Study||12
6505502|NCT01454102|7424746|FG004|STARTED|Overall Study||21
6505503|NCT01454102|7424747|FG005|STARTED|Overall Study||52
6569851|NCT01847638|7493225|FG000|STARTED|Overall Study||25
6569852|NCT01847638|7493226|FG001|STARTED|Overall Study||25
6569853|NCT01847638|7493225|FG000|COMPLETED|Overall Study||25
6569854|NCT01847638|7493226|FG001|COMPLETED|Overall Study||25
6569855|NCT01847638|7493225|FG000|NOT COMPLETED|Overall Study||0
6249271|NCT00829452|7147532|FG001|COMPLETED|First Intervention||19
6569856|NCT01847638|7493226|FG001|NOT COMPLETED|Overall Study||0
6249272|NCT00829452|7147531|FG000|NOT COMPLETED|First Intervention||0
6249273|NCT00829452|7147532|FG001|NOT COMPLETED|First Intervention||1
6249274|NCT00829452|7147531|FG000|STARTED|Washout of 42 Days||20
6249275|NCT00829452|7147532|FG001|STARTED|Washout of 42 Days||19
6249276|NCT00829452|7147531|FG000|COMPLETED|Washout of 42 Days||20
6249277|NCT00829452|7147532|FG001|COMPLETED|Washout of 42 Days||18
6249278|NCT00829452|7147531|FG000|NOT COMPLETED|Washout of 42 Days||0
6249279|NCT00829452|7147532|FG001|NOT COMPLETED|Washout of 42 Days||1
6249280|NCT00829452|7147531|FG000|STARTED|Second Intervention||20
6249281|NCT00829452|7147532|FG001|STARTED|Second Intervention||18
6249282|NCT00829452|7147531|FG000|COMPLETED|Second Intervention||20
6249283|NCT00829452|7147532|FG001|COMPLETED|Second Intervention||17
6249284|NCT00829452|7147531|FG000|NOT COMPLETED|Second Intervention||0
6249285|NCT00829452|7147532|FG001|NOT COMPLETED|Second Intervention||1
6249286|NCT00829426|7147538|FG000|STARTED|First Intervention||16
6249287|NCT00829426|7147539|FG001|STARTED|First Intervention||16
6249288|NCT00829426|7147538|FG000|COMPLETED|First Intervention||16
6249289|NCT00829426|7147539|FG001|COMPLETED|First Intervention||16
6249290|NCT00829426|7147538|FG000|NOT COMPLETED|First Intervention||0
6249291|NCT00829426|7147539|FG001|NOT COMPLETED|First Intervention||0
6249292|NCT00829426|7147538|FG000|STARTED|Washout: 7 Days||16
6249293|NCT00829426|7147539|FG001|STARTED|Washout: 7 Days||16
6249294|NCT00829426|7147538|FG000|COMPLETED|Washout: 7 Days||15
6249295|NCT00829426|7147539|FG001|COMPLETED|Washout: 7 Days||16
6249296|NCT00829426|7147538|FG000|NOT COMPLETED|Washout: 7 Days||1
6249297|NCT00829426|7147539|FG001|NOT COMPLETED|Washout: 7 Days||0
6249298|NCT00829426|7147538|FG000|STARTED|Second Intervention||15
6249299|NCT00829426|7147539|FG001|STARTED|Second Intervention||16
6249300|NCT00829426|7147538|FG000|COMPLETED|Second Intervention||15
6249301|NCT00829426|7147539|FG001|COMPLETED|Second Intervention||16
6249302|NCT00829426|7147538|FG000|NOT COMPLETED|Second Intervention||0
6249303|NCT00829426|7147539|FG001|NOT COMPLETED|Second Intervention||0
6249304|NCT00829309|7147545|FG000|STARTED|First Intervention||8
6505504|NCT01454102|7424748|FG006|STARTED|Overall Study||24
6505505|NCT01454102|7424749|FG007|STARTED|Overall Study||25
6505506|NCT01454102|7424750|FG008|STARTED|Overall Study||13
6505507|NCT01454102|7424751|FG009|STARTED|Overall Study||13
6505508|NCT01454102|7424752|FG010|STARTED|Overall Study||12
6505509|NCT01454102|7424753|FG011|STARTED|Overall Study||31
6505510|NCT01454102|7424754|FG012|STARTED|Overall Study||40
6505511|NCT01454102|7424755|FG013|STARTED|Overall Study||38
6505512|NCT01454102|7424756|FG014|STARTED|Overall Study||39
6505513|NCT01454102|7424757|FG015|STARTED|Overall Study||14
6505514|NCT01454102|7424742|FG000|COMPLETED|Overall Study||12
6505515|NCT01454102|7424743|FG001|COMPLETED|Overall Study||15
6505516|NCT01454102|7424744|FG002|COMPLETED|Overall Study||15
6505517|NCT01454102|7424745|FG003|COMPLETED|Overall Study||12
6505518|NCT01454102|7424746|FG004|COMPLETED|Overall Study||18
6505519|NCT01454102|7424747|FG005|COMPLETED|Overall Study||49
6505520|NCT01454102|7424748|FG006|COMPLETED|Overall Study||22
6505521|NCT01454102|7424749|FG007|COMPLETED|Overall Study||25
6505522|NCT01454102|7424750|FG008|COMPLETED|Overall Study||12
6505523|NCT01454102|7424751|FG009|COMPLETED|Overall Study||13
6505524|NCT01454102|7424752|FG010|COMPLETED|Overall Study||12
6505525|NCT01454102|7424753|FG011|COMPLETED|Overall Study||27
6505526|NCT01454102|7424754|FG012|COMPLETED|Overall Study||33
6505527|NCT01454102|7424755|FG013|COMPLETED|Overall Study||34
6505528|NCT01454102|7424756|FG014|COMPLETED|Overall Study||36
6505529|NCT01454102|7424757|FG015|COMPLETED|Overall Study||13
6505530|NCT01454102|7424742|FG000|NOT COMPLETED|Overall Study||0
6505531|NCT01454102|7424743|FG001|NOT COMPLETED|Overall Study||0
6505532|NCT01454102|7424744|FG002|NOT COMPLETED|Overall Study||0
6505533|NCT01454102|7424745|FG003|NOT COMPLETED|Overall Study||0
6505534|NCT01454102|7424746|FG004|NOT COMPLETED|Overall Study||3
6505535|NCT01454102|7424747|FG005|NOT COMPLETED|Overall Study||3
6505536|NCT01454102|7424748|FG006|NOT COMPLETED|Overall Study||2
6505537|NCT01454102|7424749|FG007|NOT COMPLETED|Overall Study||0
6505538|NCT01454102|7424750|FG008|NOT COMPLETED|Overall Study||1
6505539|NCT01454102|7424751|FG009|NOT COMPLETED|Overall Study||0
6505540|NCT01454102|7424752|FG010|NOT COMPLETED|Overall Study||0
6505541|NCT01454102|7424753|FG011|NOT COMPLETED|Overall Study||4
6657694|NCT02472262|7588141|FG000|COMPLETED|Overall Study||99
6657695|NCT02472262|7588142|FG001|COMPLETED|Overall Study||99
6657696|NCT02472262|7588143|FG002|COMPLETED|Overall Study||93
6657697|NCT02472262|7588141|FG000|NOT COMPLETED|Overall Study||18
6657698|NCT02472262|7588142|FG001|NOT COMPLETED|Overall Study||21
6657699|NCT02472262|7588143|FG002|NOT COMPLETED|Overall Study||25
6657700|NCT02472314|7588153|FG000|STARTED|Overall Study||34
6657701|NCT02472314|7588154|FG001|STARTED|Overall Study||36
6657702|NCT02472314|7588153|FG000|COMPLETED|Overall Study||34
6657703|NCT02472314|7588154|FG001|COMPLETED|Overall Study||36
6249305|NCT00829309|7147546|FG001|STARTED|First Intervention||8
6249306|NCT00829309|7147545|FG000|COMPLETED|First Intervention||8
6249307|NCT00829309|7147546|FG001|COMPLETED|First Intervention||8
6505542|NCT01454102|7424754|FG012|NOT COMPLETED|Overall Study||7
6505543|NCT01454102|7424755|FG013|NOT COMPLETED|Overall Study||4
6505544|NCT01454102|7424756|FG014|NOT COMPLETED|Overall Study||3
6505545|NCT01454102|7424757|FG015|NOT COMPLETED|Overall Study||1
6657704|NCT02472314|7588153|FG000|NOT COMPLETED|Overall Study||0
6657705|NCT02472314|7588154|FG001|NOT COMPLETED|Overall Study||0
6657706|NCT02472353|7588162|FG000|STARTED|Overall Study||14
6249308|NCT00829309|7147545|FG000|NOT COMPLETED|First Intervention||0
6249309|NCT00829309|7147546|FG001|NOT COMPLETED|First Intervention||0
6249310|NCT00829309|7147545|FG000|STARTED|Washout: 7 Days||8
6249311|NCT00829309|7147546|FG001|STARTED|Washout: 7 Days||8
6249312|NCT00829309|7147545|FG000|COMPLETED|Washout: 7 Days||7
6569857|NCT01847755|7493232|FG000|STARTED|Overall Study||18
6569858|NCT01847755|7493232|FG000|COMPLETED|Overall Study||13
6569859|NCT01847755|7493232|FG000|NOT COMPLETED|Overall Study||5
6569860|NCT01847885|7493238|FG000|STARTED|Initial Enrollment (Consented)||88
6569861|NCT01847885|7493239|FG001|STARTED|Initial Enrollment (Consented)||0
6249313|NCT00829309|7147546|FG001|COMPLETED|Washout: 7 Days||8
6249314|NCT00829309|7147545|FG000|NOT COMPLETED|Washout: 7 Days||1
6249315|NCT00829309|7147546|FG001|NOT COMPLETED|Washout: 7 Days||0
6249316|NCT00829309|7147545|FG000|STARTED|Second Intervention||7
6249317|NCT00829309|7147546|FG001|STARTED|Second Intervention||8
6249318|NCT00829309|7147545|FG000|COMPLETED|Second Intervention||7
6249319|NCT00829309|7147546|FG001|COMPLETED|Second Intervention||8
6249320|NCT00829309|7147545|FG000|NOT COMPLETED|Second Intervention||0
6249321|NCT00829309|7147546|FG001|NOT COMPLETED|Second Intervention||0
6249322|NCT00828321|7147552|FG000|STARTED|First Intervention||20
6249323|NCT00828321|7147553|FG001|STARTED|First Intervention||20
6249324|NCT00828321|7147552|FG000|COMPLETED|First Intervention||20
6249325|NCT00828321|7147553|FG001|COMPLETED|First Intervention||20
6249326|NCT00828321|7147552|FG000|NOT COMPLETED|First Intervention||0
6249327|NCT00828321|7147553|FG001|NOT COMPLETED|First Intervention||0
6249328|NCT00828321|7147552|FG000|STARTED|Washout of 42 Days||20
6249329|NCT00828321|7147553|FG001|STARTED|Washout of 42 Days||20
6249330|NCT00828321|7147552|FG000|COMPLETED|Washout of 42 Days||18
6249331|NCT00828321|7147553|FG001|COMPLETED|Washout of 42 Days||20
6249332|NCT00828321|7147552|FG000|NOT COMPLETED|Washout of 42 Days||2
6249333|NCT00828321|7147553|FG001|NOT COMPLETED|Washout of 42 Days||0
6249334|NCT00828321|7147552|FG000|STARTED|Second Intervention||18
6249335|NCT00828321|7147553|FG001|STARTED|Second Intervention||20
6249336|NCT00828321|7147552|FG000|COMPLETED|Second Intervention||18
6249337|NCT00828321|7147553|FG001|COMPLETED|Second Intervention||19
6249338|NCT00828321|7147552|FG000|NOT COMPLETED|Second Intervention||0
6249339|NCT00828321|7147553|FG001|NOT COMPLETED|Second Intervention||1
6277027|NCT00123734|7176392|FG000|NOT COMPLETED|Overall Study||8
6277028|NCT00123955|7176401|FG000|STARTED|Overall Study||42
6277029|NCT00123955|7176402|FG001|STARTED|Overall Study||38
6277030|NCT00123955|7176401|FG000|COMPLETED|Overall Study||37
6277031|NCT00123955|7176402|FG001|COMPLETED|Overall Study||34
6277032|NCT00123955|7176401|FG000|NOT COMPLETED|Overall Study||5
6505546|NCT01454258|7424792|FG000|STARTED|Overall Study||10100
6505547|NCT01454258|7424792|FG000|COMPLETED|Overall Study||9103
6505548|NCT01454258|7424792|FG000|NOT COMPLETED|Overall Study||997
6505549|NCT01454284|7424800|FG000|STARTED|Overall Study||664
6505550|NCT01454284|7424801|FG001|STARTED|Overall Study||450
6505551|NCT01454284|7424800|FG000|Received at Least 1 Dose of Study Drug|Overall Study||663
6505552|NCT01454284|7424801|FG001|Received at Least 1 Dose of Study Drug|Overall Study||449
6505553|NCT01454284|7424800|FG000|COMPLETED|Overall Study||548
6505554|NCT01454284|7424801|FG001|COMPLETED|Overall Study||377
6505555|NCT01454284|7424800|FG000|NOT COMPLETED|Overall Study||116
6505556|NCT01454284|7424801|FG001|NOT COMPLETED|Overall Study||73
6505557|NCT01454362|7424809|FG000|STARTED|Overall Study||28
6505558|NCT01454362|7424810|FG001|STARTED|Overall Study||23
6569862|NCT01847885|7493240|FG002|STARTED|Initial Enrollment (Consented)||0
6569863|NCT01847885|7493238|FG000|Randomized|Initial Enrollment (Consented)||46
6569864|NCT01847885|7493239|FG001|Randomized|Initial Enrollment (Consented)||0
6569865|NCT01847885|7493240|FG002|Randomized|Initial Enrollment (Consented)||0
6569866|NCT01847885|7493238|FG000|Full Analysis Set|Initial Enrollment (Consented)||43
6569867|NCT01847885|7493239|FG001|Full Analysis Set|Initial Enrollment (Consented)||0
6657707|NCT02472353|7588163|FG001|STARTED|Overall Study||16
6657708|NCT02472353|7588162|FG000|COMPLETED|Overall Study||10
6657709|NCT02472353|7588163|FG001|COMPLETED|Overall Study||10
6657710|NCT02472353|7588162|FG000|NOT COMPLETED|Overall Study||4
6657711|NCT02472353|7588163|FG001|NOT COMPLETED|Overall Study||6
6657712|NCT02472366|7588171|FG000|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
6657713|NCT02472366|7588172|FG001|STARTED|Overall Study||10
6657714|NCT02472366|7588171|FG000|COMPLETED|Overall Study||5
6657715|NCT02472366|7588172|FG001|COMPLETED|Overall Study||10
6657716|NCT02472366|7588171|FG000|NOT COMPLETED|Overall Study||1
6657717|NCT02472366|7588172|FG001|NOT COMPLETED|Overall Study||0
6277033|NCT00123955|7176402|FG001|NOT COMPLETED|Overall Study||4
6277034|NCT00124020|7176410|FG000|STARTED|Overall Study||377
6277035|NCT00124020|7176411|FG001|STARTED|Overall Study||380
6277036|NCT00124020|7176410|FG000|COMPLETED|Overall Study||289
6277037|NCT00124020|7176411|FG001|COMPLETED|Overall Study||289
6277038|NCT00124020|7176410|FG000|NOT COMPLETED|Overall Study||88
6277039|NCT00124020|7176411|FG001|NOT COMPLETED|Overall Study||91
6277040|NCT00124072|7176421|FG000|STARTED|Overall Study||3017
6505559|NCT01454362|7424809|FG000|COMPLETED|Overall Study||28
6505560|NCT01454362|7424810|FG001|COMPLETED|Overall Study||23
6505561|NCT01454362|7424809|FG000|NOT COMPLETED|Overall Study||0
6569868|NCT01847885|7493240|FG002|Full Analysis Set|Initial Enrollment (Consented)||0
6569869|NCT01847885|7493238|FG000|Safety Set|Initial Enrollment (Consented)||41
6657718|NCT02472405|7588178|FG000|STARTED|Overall Study||18
6657719|NCT02472405|7588178|FG000|COMPLETED|Overall Study||8
6249340|NCT00806403|7147559|FG000|STARTED|Overall Study||104
6249341|NCT00806403|7147560|FG001|STARTED|Overall Study||101
6249342|NCT00806403|7147559|FG000|COMPLETED|Overall Study||100
6249343|NCT00806403|7147560|FG001|COMPLETED|Overall Study||98
6249344|NCT00806403|7147559|FG000|NOT COMPLETED|Overall Study||4
6249345|NCT00806403|7147560|FG001|NOT COMPLETED|Overall Study||3
6249346|NCT00803517|7147566|FG000|STARTED|Overall Study||12
6249347|NCT00803517|7147567|FG001|STARTED|Overall Study||12
6249348|NCT00803517|7147566|FG000|COMPLETED|Overall Study||12
6249349|NCT00803517|7147567|FG001|COMPLETED|Overall Study||12
6249350|NCT00803517|7147566|FG000|NOT COMPLETED|Overall Study||0
6249351|NCT00803517|7147567|FG001|NOT COMPLETED|Overall Study||0
6249352|NCT00803413|7147575|FG000|STARTED|Overall Period||28
6249353|NCT00803413|7147576|FG001|STARTED|Overall Period||32
6249354|NCT00803413|7147577|FG002|STARTED|Overall Period||29
6249355|NCT00803413|7147578|FG003|STARTED|Overall Period||30
6249356|NCT00803413|7147575|FG000|COMPLETED|Overall Period||28
6249357|NCT00803413|7147576|FG001|COMPLETED|Overall Period||32
6249358|NCT00803413|7147577|FG002|COMPLETED|Overall Period||29
6249359|NCT00803413|7147578|FG003|COMPLETED|Overall Period||30
6249360|NCT00803413|7147575|FG000|NOT COMPLETED|Overall Period||0
6249361|NCT00803413|7147576|FG001|NOT COMPLETED|Overall Period||0
6249362|NCT00803413|7147577|FG002|NOT COMPLETED|Overall Period||0
6505562|NCT01454362|7424810|FG001|NOT COMPLETED|Overall Study||0
6505563|NCT01454401|7424818|FG000|STARTED|Overall Study|ITT|44
6505564|NCT01454401|7424818|FG000|COMPLETED|Overall Study|Per Protocol (PP)|39
6505565|NCT01454401|7424818|FG000|NOT COMPLETED|Overall Study||5
6505566|NCT01454414|7424824|FG000|STARTED|Overall Study||79
6505567|NCT01454414|7424825|FG001|STARTED|Overall Study||80
6505568|NCT01454414|7424824|FG000|Baseline: Subjects That Sent Uniforms|Overall Study||67
6505569|NCT01454414|7424825|FG001|Baseline: Subjects That Sent Uniforms|Overall Study||66
6505570|NCT01454414|7424824|FG000|COMPLETED|Overall Study||66
6505571|NCT01454414|7424825|FG001|COMPLETED|Overall Study||64
6505572|NCT01454414|7424824|FG000|NOT COMPLETED|Overall Study||13
6505573|NCT01454414|7424825|FG001|NOT COMPLETED|Overall Study||16
6505574|NCT01454505|7424834|FG000|STARTED|Overall Study||35
6505575|NCT01454505|7424835|FG001|STARTED|Overall Study||15
6505576|NCT01454505|7424836|FG002|STARTED|Overall Study||40
6505577|NCT01454505|7424837|FG003|STARTED|Overall Study||20
6505578|NCT01454505|7424834|FG000|COMPLETED|Overall Study||35
6505579|NCT01454505|7424835|FG001|COMPLETED|Overall Study||15
6505580|NCT01454505|7424836|FG002|COMPLETED|Overall Study||40
6505581|NCT01454505|7424837|FG003|COMPLETED|Overall Study||20
6505582|NCT01454505|7424834|FG000|NOT COMPLETED|Overall Study||0
6505583|NCT01454505|7424835|FG001|NOT COMPLETED|Overall Study||0
6505584|NCT01454505|7424836|FG002|NOT COMPLETED|Overall Study||0
6505585|NCT01454505|7424837|FG003|NOT COMPLETED|Overall Study||0
6505586|NCT01454531|7424847|FG000|STARTED|Overall Study||196
6505587|NCT01454531|7424847|FG000|Subjects Treated|Overall Study||192
6505588|NCT01454531|7424847|FG000|COMPLETED|Overall Study||173
6505589|NCT01454531|7424847|FG000|NOT COMPLETED|Overall Study||23
6505590|NCT01454570|7424851|FG000|STARTED|Overall Study||19
6505591|NCT01454570|7424851|FG000|COMPLETED|Overall Study||10
6505592|NCT01454570|7424851|FG000|NOT COMPLETED|Overall Study||9
6505593|NCT01454583|7424858|FG000|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
6505594|NCT01454583|7424859|FG001|STARTED|1st Year||2696
6505595|NCT01454583|7424860|FG002|STARTED|1st Year||2113
6505596|NCT01454583|7424858|FG000|COMPLETED|1st Year||9120
6505597|NCT01454583|7424859|FG001|COMPLETED|1st Year||2378
6505598|NCT01454583|7424860|FG002|COMPLETED|1st Year||1933
6505599|NCT01454583|7424858|FG000|NOT COMPLETED|1st Year||1057
6505600|NCT01454583|7424859|FG001|NOT COMPLETED|1st Year||318
6505601|NCT01454583|7424860|FG002|NOT COMPLETED|1st Year||180
6505602|NCT01454583|7424858|FG000|STARTED|2nd Year||10177
6505603|NCT01454583|7424859|FG001|STARTED|2nd Year||2696
6505604|NCT01454583|7424860|FG002|STARTED|2nd Year||2113
6505605|NCT01454583|7424858|FG000|COMPLETED|2nd Year||6212
6505606|NCT01454583|7424859|FG001|COMPLETED|2nd Year||1647
6505607|NCT01454583|7424860|FG002|COMPLETED|2nd Year||1376
6505608|NCT01454583|7424858|FG000|NOT COMPLETED|2nd Year||3965
6505609|NCT01454583|7424859|FG001|NOT COMPLETED|2nd Year||1049
6505610|NCT01454583|7424860|FG002|NOT COMPLETED|2nd Year||737
6505611|NCT01454583|7424858|FG000|STARTED|3rd Year||3791
6505612|NCT01454583|7424859|FG001|STARTED|3rd Year||982
6505613|NCT01454583|7424860|FG002|STARTED|3rd Year||582
6505614|NCT01454583|7424858|FG000|COMPLETED|3rd Year||1832
6657720|NCT02472405|7588178|FG000|NOT COMPLETED|Overall Study||10
6657721|NCT02472457|7588186|FG000|STARTED|Overall Study|1 subject followed the Specific Carbohydrate Diet|8
6657722|NCT02472457|7588187|FG001|STARTED|Overall Study||11
6657723|NCT02472457|7588186|FG000|COMPLETED|Overall Study||8
6657724|NCT02472457|7588187|FG001|COMPLETED|Overall Study||10
6657725|NCT02472457|7588186|FG000|NOT COMPLETED|Overall Study||0
6657726|NCT02472457|7588187|FG001|NOT COMPLETED|Overall Study||1
6505615|NCT01454583|7424859|FG001|COMPLETED|3rd Year||470
6249363|NCT00803413|7147578|FG003|NOT COMPLETED|Overall Period||0
6249364|NCT00803114|7147586|FG000|STARTED|Overall Study||113
6249365|NCT00803114|7147587|FG001|STARTED|Overall Study||115
6249366|NCT00803114|7147586|FG000|COMPLETED|Overall Study||113
6249367|NCT00803114|7147587|FG001|COMPLETED|Overall Study||115
6249368|NCT00803114|7147586|FG000|NOT COMPLETED|Overall Study||0
6505616|NCT01454583|7424860|FG002|COMPLETED|3rd Year||285
6505617|NCT01454583|7424858|FG000|NOT COMPLETED|3rd Year||1959
6657727|NCT02472522|7588195|FG000|STARTED|Overall Study||50
6249369|NCT00803114|7147587|FG001|NOT COMPLETED|Overall Study||0
6249370|NCT00799292|7147593|FG000|STARTED|Overall Study||29
6249371|NCT00799292|7147594|FG001|STARTED|Overall Study||29
6249372|NCT00799292|7147593|FG000|COMPLETED|Overall Study||29
6249373|NCT00799292|7147594|FG001|COMPLETED|Overall Study||29
6249374|NCT00799292|7147593|FG000|NOT COMPLETED|Overall Study||0
6249375|NCT00799292|7147594|FG001|NOT COMPLETED|Overall Study||0
6249376|NCT00796523|7147600|FG000|STARTED|Overall Study||27
6249377|NCT00796523|7147601|FG001|STARTED|Overall Study||24
6249378|NCT00796523|7147600|FG000|COMPLETED|Overall Study||18
6249379|NCT00796523|7147601|FG001|COMPLETED|Overall Study||17
6249380|NCT00796523|7147600|FG000|NOT COMPLETED|Overall Study||9
6249381|NCT00796523|7147601|FG001|NOT COMPLETED|Overall Study||7
6249382|NCT00794924|7147607|FG000|STARTED|Overall Study|14 patients refused to start the study|174
6249383|NCT00794924|7147608|FG001|STARTED|Overall Study|14 patients refused to start the study|171
6249384|NCT00794924|7147607|FG000|COMPLETED|Overall Study||114
6249385|NCT00794924|7147608|FG001|COMPLETED|Overall Study||101
6249386|NCT00794924|7147607|FG000|NOT COMPLETED|Overall Study||60
6249387|NCT00794924|7147608|FG001|NOT COMPLETED|Overall Study||70
6249388|NCT00794677|7147614|FG000|STARTED|First Intervention||13
6249389|NCT00794677|7147615|FG001|STARTED|First Intervention||13
6249390|NCT00794677|7147614|FG000|COMPLETED|First Intervention||11
6249391|NCT00794677|7147615|FG001|COMPLETED|First Intervention||13
6249392|NCT00794677|7147614|FG000|NOT COMPLETED|First Intervention||2
6249393|NCT00794677|7147615|FG001|NOT COMPLETED|First Intervention||0
6249394|NCT00794677|7147614|FG000|STARTED|Second Intervention||11
6249395|NCT00794677|7147615|FG001|STARTED|Second Intervention||13
6249396|NCT00794677|7147614|FG000|COMPLETED|Second Intervention||11
6249397|NCT00794677|7147615|FG001|COMPLETED|Second Intervention||13
6249398|NCT00794677|7147614|FG000|NOT COMPLETED|Second Intervention||0
6249399|NCT00794677|7147615|FG001|NOT COMPLETED|Second Intervention||0
6277041|NCT00124072|7176422|FG001|STARTED|Overall Study||3016
6277042|NCT00124072|7176423|FG002|STARTED|Overall Study||3016
6277043|NCT00124072|7176424|FG003|STARTED|Overall Study||3015
6277044|NCT00124072|7176421|FG000|COMPLETED|Overall Study||2503
6277045|NCT00124072|7176422|FG001|COMPLETED|Overall Study||2504
6277046|NCT00124072|7176423|FG002|COMPLETED|Overall Study||2524
6277047|NCT00124072|7176424|FG003|COMPLETED|Overall Study||2515
6277048|NCT00124072|7176421|FG000|NOT COMPLETED|Overall Study||514
6277049|NCT00124072|7176422|FG001|NOT COMPLETED|Overall Study||512
6277050|NCT00124072|7176423|FG002|NOT COMPLETED|Overall Study||492
6277051|NCT00124072|7176424|FG003|NOT COMPLETED|Overall Study||500
6277052|NCT00124176|7176436|FG000|STARTED|Overall Study||40
6277053|NCT00124176|7176437|FG001|STARTED|Overall Study||41
6277054|NCT00124176|7176436|FG000|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
6277055|NCT00124176|7176437|FG001|Received Study Drug|Overall Study||41
6277056|NCT00124176|7176436|FG000|COMPLETED|Overall Study||40
6277057|NCT00124176|7176437|FG001|COMPLETED|Overall Study||41
6505618|NCT01454583|7424859|FG001|NOT COMPLETED|3rd Year||512
6505619|NCT01454583|7424860|FG002|NOT COMPLETED|3rd Year||297
6505620|NCT01454596|7424880|FG000|STARTED|Overall Study||1
6505621|NCT01454596|7424881|FG001|STARTED|Overall Study||1
6505622|NCT01454596|7424882|FG002|STARTED|Overall Study||1
6505623|NCT01454596|7424883|FG003|STARTED|Overall Study||1
6505624|NCT01454596|7424884|FG004|STARTED|Overall Study||1
6505625|NCT01454596|7424885|FG005|STARTED|Overall Study||1
6505626|NCT01454596|7424886|FG006|STARTED|Overall Study||1
6505627|NCT01454596|7424887|FG007|STARTED|Overall Study||3
6505628|NCT01454596|7424888|FG008|STARTED|Overall Study||3
6505629|NCT01454596|7424889|FG009|STARTED|Overall Study||3
6505630|NCT01454596|7424890|FG010|STARTED|Overall Study||1
6505631|NCT01454596|7424891|FG011|STARTED|Overall Study||1
6505632|NCT01454596|7424880|FG000|COMPLETED|Overall Study||1
6277058|NCT00124176|7176436|FG000|NOT COMPLETED|Overall Study||0
6277059|NCT00124176|7176437|FG001|NOT COMPLETED|Overall Study||0
6277060|NCT00124449|7176445|FG000|STARTED|6-month Double-Blind Treatment Period||28
6505633|NCT01454596|7424881|FG001|COMPLETED|Overall Study||1
6249400|NCT00792116|7147621|FG000|STARTED|Overall Study||53
6249401|NCT00792116|7147622|FG001|STARTED|Overall Study||55
6249402|NCT00792116|7147621|FG000|COMPLETED|Overall Study||52
6249403|NCT00792116|7147622|FG001|COMPLETED|Overall Study||54
6249404|NCT00792116|7147621|FG000|NOT COMPLETED|Overall Study||1
6249405|NCT00792116|7147622|FG001|NOT COMPLETED|Overall Study||1
6249406|NCT00758563|7147628|FG000|STARTED|Overall Study||7
6249407|NCT00758563|7147629|FG001|STARTED|Overall Study||8
6249408|NCT00758563|7147628|FG000|COMPLETED|Overall Study||7
6249409|NCT00758563|7147629|FG001|COMPLETED|Overall Study||8
6249410|NCT00758563|7147628|FG000|NOT COMPLETED|Overall Study||0
6249411|NCT00758563|7147629|FG001|NOT COMPLETED|Overall Study||0
6249412|NCT00758290|7147635|FG000|STARTED|Overall Study||11
6249413|NCT00758290|7147636|FG001|STARTED|Overall Study||12
6249414|NCT00758290|7147635|FG000|COMPLETED|Overall Study||11
6249415|NCT00758290|7147636|FG001|COMPLETED|Overall Study||12
6249416|NCT00758290|7147635|FG000|NOT COMPLETED|Overall Study||0
6249417|NCT00758290|7147636|FG001|NOT COMPLETED|Overall Study||0
6249418|NCT00756574|7147642|FG000|STARTED|Overall Study||225
6249419|NCT00756574|7147643|FG001|STARTED|Overall Study||221
6249420|NCT00756574|7147642|FG000|COMPLETED|Overall Study||212
6249421|NCT00756574|7147643|FG001|COMPLETED|Overall Study||210
6249422|NCT00756574|7147642|FG000|NOT COMPLETED|Overall Study||13
6249423|NCT00756574|7147643|FG001|NOT COMPLETED|Overall Study||11
6277061|NCT00124449|7176446|FG001|STARTED|6-month Double-Blind Treatment Period||28
6277062|NCT00124449|7176445|FG000|COMPLETED|6-month Double-Blind Treatment Period||22
6277063|NCT00124449|7176446|FG001|COMPLETED|6-month Double-Blind Treatment Period||17
6277064|NCT00124449|7176445|FG000|NOT COMPLETED|6-month Double-Blind Treatment Period||6
6277065|NCT00124449|7176446|FG001|NOT COMPLETED|6-month Double-Blind Treatment Period||11
6277066|NCT00124449|7176445|FG000|STARTED|18-Month Untreated Observation Period||22
6277067|NCT00124449|7176446|FG001|STARTED|18-Month Untreated Observation Period||17
6277068|NCT00124449|7176445|FG000|Completed Year 1 of Study|18-Month Untreated Observation Period||14
6277069|NCT00124449|7176446|FG001|Completed Year 1 of Study|18-Month Untreated Observation Period||9
6277070|NCT00124449|7176445|FG000|COMPLETED|18-Month Untreated Observation Period||7
6277071|NCT00124449|7176446|FG001|COMPLETED|18-Month Untreated Observation Period||4
6277072|NCT00124449|7176445|FG000|NOT COMPLETED|18-Month Untreated Observation Period||15
6277073|NCT00124449|7176446|FG001|NOT COMPLETED|18-Month Untreated Observation Period||13
6277074|NCT00124462|7176455|FG000|STARTED|Overall Study||40
6277075|NCT00124462|7176456|FG001|STARTED|Overall Study||40
6277076|NCT00124462|7176455|FG000|COMPLETED|Overall Study||29
6277077|NCT00124462|7176456|FG001|COMPLETED|Overall Study||27
6277078|NCT00124462|7176455|FG000|NOT COMPLETED|Overall Study||11
6277079|NCT00124462|7176456|FG001|NOT COMPLETED|Overall Study||13
6277080|NCT00124514|7176467|FG000|STARTED|Overall Study||6
6277081|NCT00124514|7176468|FG001|STARTED|Overall Study||9
6277082|NCT00124514|7176469|FG002|STARTED|Overall Study||8
6277083|NCT00124514|7176470|FG003|STARTED|Overall Study||6
6277084|NCT00124514|7176471|FG004|STARTED|Overall Study||2
6277085|NCT00124514|7176467|FG000|COMPLETED|Overall Study||2
6277086|NCT00124514|7176468|FG001|COMPLETED|Overall Study||7
6505634|NCT01454596|7424882|FG002|COMPLETED|Overall Study||1
6505635|NCT01454596|7424883|FG003|COMPLETED|Overall Study||1
6505636|NCT01454596|7424884|FG004|COMPLETED|Overall Study||1
6505637|NCT01454596|7424885|FG005|COMPLETED|Overall Study||1
6505638|NCT01454596|7424886|FG006|COMPLETED|Overall Study||1
6505639|NCT01454596|7424887|FG007|COMPLETED|Overall Study||3
6505640|NCT01454596|7424888|FG008|COMPLETED|Overall Study||3
6505641|NCT01454596|7424889|FG009|COMPLETED|Overall Study||2
6505642|NCT01454596|7424890|FG010|COMPLETED|Overall Study||0
6505643|NCT01454596|7424891|FG011|COMPLETED|Overall Study||1
6505644|NCT01454596|7424880|FG000|NOT COMPLETED|Overall Study||0
6505645|NCT01454596|7424881|FG001|NOT COMPLETED|Overall Study||0
6505646|NCT01454596|7424882|FG002|NOT COMPLETED|Overall Study||0
6505647|NCT01454596|7424883|FG003|NOT COMPLETED|Overall Study||0
6505648|NCT01454596|7424884|FG004|NOT COMPLETED|Overall Study||0
6505649|NCT01454596|7424885|FG005|NOT COMPLETED|Overall Study||0
6505650|NCT01454596|7424886|FG006|NOT COMPLETED|Overall Study||0
6505651|NCT01454596|7424887|FG007|NOT COMPLETED|Overall Study||0
6249424|NCT00740727|7147647|FG000|STARTED|Overall Study||18
6249425|NCT00740727|7147647|FG000|COMPLETED|Overall Study||18
6249426|NCT00740727|7147647|FG000|NOT COMPLETED|Overall Study||0
6249427|NCT00740480|7147650|FG000|STARTED|Overall Study||25
6249428|NCT00740480|7147650|FG000|COMPLETED|Overall Study||23
6249429|NCT00740480|7147650|FG000|NOT COMPLETED|Overall Study||2
6249430|NCT00724698|7147653|FG000|STARTED|Overall Study||3011
6249431|NCT00724698|7147653|FG000|COMPLETED|Overall Study||2921
6249432|NCT00724698|7147653|FG000|NOT COMPLETED|Overall Study||90
6249433|NCT00711555|7147656|FG000|STARTED|Overall Study||22
6249434|NCT00711555|7147656|FG000|COMPLETED|Overall Study||19
6249435|NCT00711555|7147656|FG000|NOT COMPLETED|Overall Study||3
6277087|NCT00124514|7176469|FG002|COMPLETED|Overall Study||7
6277088|NCT00124514|7176470|FG003|COMPLETED|Overall Study||5
6277089|NCT00124514|7176471|FG004|COMPLETED|Overall Study||1
6277090|NCT00124514|7176467|FG000|NOT COMPLETED|Overall Study||4
6277091|NCT00124514|7176468|FG001|NOT COMPLETED|Overall Study||2
6277092|NCT00124514|7176469|FG002|NOT COMPLETED|Overall Study||1
6277093|NCT00124514|7176470|FG003|NOT COMPLETED|Overall Study||1
6277094|NCT00124514|7176471|FG004|NOT COMPLETED|Overall Study||1
6277095|NCT00124579|7176478|FG000|STARTED|Induction||7
6277096|NCT00124579|7176478|FG000|COMPLETED|Induction||2
6277097|NCT00124579|7176478|FG000|NOT COMPLETED|Induction||5
6277098|NCT00124579|7176478|FG000|STARTED|Maintenance||2
6277099|NCT00124579|7176478|FG000|COMPLETED|Maintenance||0
6277100|NCT00124579|7176478|FG000|NOT COMPLETED|Maintenance||2
6277101|NCT00124618|7176483|FG000|STARTED|Overall Study||58
6277102|NCT00124618|7176483|FG000|COMPLETED|Overall Study||57
6277103|NCT00124618|7176483|FG000|NOT COMPLETED|Overall Study||1
6277104|NCT00124657|7176490|FG000|STARTED|Overall Study||18
6277105|NCT00124657|7176491|FG001|STARTED|Overall Study||5
6277106|NCT00124657|7176492|FG002|STARTED|Overall Study||39
6277107|NCT00124657|7176490|FG000|COMPLETED|Overall Study||2
6277108|NCT00124657|7176491|FG001|COMPLETED|Overall Study||0
6277109|NCT00124657|7176492|FG002|COMPLETED|Overall Study||7
6277110|NCT00124657|7176490|FG000|NOT COMPLETED|Overall Study||16
6277111|NCT00124657|7176491|FG001|NOT COMPLETED|Overall Study||5
6277112|NCT00124657|7176492|FG002|NOT COMPLETED|Overall Study||32
6277113|NCT00124709|7176515|FG000|STARTED|Overall Study||546
6277114|NCT00124709|7176516|FG001|STARTED|Overall Study||545
6277115|NCT00124709|7176515|FG000|Patients Who Received Study Medication|Overall Study||543
6277116|NCT00124709|7176516|FG001|Patients Who Received Study Medication|Overall Study||544
6277117|NCT00124709|7176515|FG000|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
6277118|NCT00124709|7176516|FG001|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
6277119|NCT00124709|7176515|FG000|NOT COMPLETED|Overall Study||255
6277120|NCT00124709|7176516|FG001|NOT COMPLETED|Overall Study||272
6277121|NCT00124735|7176532|FG000|STARTED|Overall Study||5
6277122|NCT00124735|7176533|FG001|STARTED|Overall Study||8
6277123|NCT00124735|7176534|FG002|STARTED|Overall Study||18
6277124|NCT00124735|7176535|FG003|STARTED|Overall Study||21
6277125|NCT00124735|7176536|FG004|STARTED|Overall Study||19
6277126|NCT00124735|7176537|FG005|STARTED|Overall Study||7
6277127|NCT00124735|7176538|FG006|STARTED|Overall Study||6
6277128|NCT00124735|7176539|FG007|STARTED|Overall Study||20
6277129|NCT00124735|7176540|FG008|STARTED|Overall Study||25
6277130|NCT00124735|7176541|FG009|STARTED|Overall Study||20
6277131|NCT00124735|7176532|FG000|COMPLETED|Overall Study||4
6277132|NCT00124735|7176533|FG001|COMPLETED|Overall Study||6
6277133|NCT00124735|7176534|FG002|COMPLETED|Overall Study||18
6277134|NCT00124735|7176535|FG003|COMPLETED|Overall Study||18
6277135|NCT00124735|7176536|FG004|COMPLETED|Overall Study||17
6277136|NCT00124735|7176537|FG005|COMPLETED|Overall Study||5
6277137|NCT00124735|7176538|FG006|COMPLETED|Overall Study||6
6277138|NCT00124735|7176539|FG007|COMPLETED|Overall Study||19
6277139|NCT00124735|7176540|FG008|COMPLETED|Overall Study||22
6277140|NCT00124735|7176541|FG009|COMPLETED|Overall Study||18
6277141|NCT00124735|7176532|FG000|NOT COMPLETED|Overall Study||1
6277142|NCT00124735|7176533|FG001|NOT COMPLETED|Overall Study||2
6277143|NCT00124735|7176534|FG002|NOT COMPLETED|Overall Study||0
6277144|NCT00124735|7176535|FG003|NOT COMPLETED|Overall Study||3
6277145|NCT00124735|7176536|FG004|NOT COMPLETED|Overall Study||2
6277146|NCT00124735|7176537|FG005|NOT COMPLETED|Overall Study||2
6277147|NCT00124735|7176538|FG006|NOT COMPLETED|Overall Study||0
6277148|NCT00124735|7176539|FG007|NOT COMPLETED|Overall Study||1
6277149|NCT00124735|7176540|FG008|NOT COMPLETED|Overall Study||3
6569870|NCT01847885|7493239|FG001|Safety Set|Initial Enrollment (Consented)||0
6569871|NCT01847885|7493240|FG002|Safety Set|Initial Enrollment (Consented)||0
6569872|NCT01847885|7493238|FG000|Per Protocol Set|Initial Enrollment (Consented)||40
6569873|NCT01847885|7493239|FG001|Per Protocol Set|Initial Enrollment (Consented)||0
6569874|NCT01847885|7493240|FG002|Per Protocol Set|Initial Enrollment (Consented)||0
6249436|NCT00676494|7147659|FG000|STARTED|Overall Study||172
6249437|NCT00676494|7147659|FG000|COMPLETED|Overall Study||158
6249438|NCT00676494|7147659|FG000|NOT COMPLETED|Overall Study||14
6249439|NCT00662389|7147662|FG000|STARTED|Overall Study||4
6249440|NCT00662389|7147662|FG000|COMPLETED|Overall Study||4
6249441|NCT00662389|7147662|FG000|NOT COMPLETED|Overall Study||0
6249442|NCT00659061|7147667|FG000|STARTED|Overall Study||308
6249443|NCT00659061|7147668|FG001|STARTED|Overall Study||302
6249444|NCT00659061|7147667|FG000|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
6249445|NCT00659061|7147668|FG001|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
6249446|NCT00659061|7147667|FG000|NOT COMPLETED|Overall Study||21
6249447|NCT00659061|7147668|FG001|NOT COMPLETED|Overall Study||15
6249448|NCT00654992|7147674|FG000|STARTED|Overall Study||36
6249449|NCT00654992|7147675|FG001|STARTED|Overall Study||35
6249450|NCT00654992|7147674|FG000|COMPLETED|Overall Study||36
6249451|NCT00654992|7147675|FG001|COMPLETED|Overall Study||35
6249452|NCT00654992|7147674|FG000|NOT COMPLETED|Overall Study||0
6249453|NCT00654992|7147675|FG001|NOT COMPLETED|Overall Study||0
6277150|NCT00124735|7176541|FG009|NOT COMPLETED|Overall Study||2
6277151|NCT00124748|7176557|FG000|STARTED|Overall Study||157
6277152|NCT00124748|7176558|FG001|STARTED|Overall Study||319
6277153|NCT00124748|7176557|FG000|Safety Population|Overall Study||157
6277154|NCT00124748|7176558|FG001|Safety Population|Overall Study||316
6277155|NCT00124748|7176557|FG000|COMPLETED|Overall Study||14
6277156|NCT00124748|7176558|FG001|COMPLETED|Overall Study||35
6277157|NCT00124748|7176557|FG000|NOT COMPLETED|Overall Study||143
6277158|NCT00124748|7176558|FG001|NOT COMPLETED|Overall Study||284
6505652|NCT01454596|7424888|FG008|NOT COMPLETED|Overall Study||0
6505653|NCT01454596|7424889|FG009|NOT COMPLETED|Overall Study||1
6505654|NCT01454596|7424890|FG010|NOT COMPLETED|Overall Study||1
6505655|NCT01454596|7424891|FG011|NOT COMPLETED|Overall Study||0
6505656|NCT01454726|7424919|FG000|STARTED|Overall Study||16
6505657|NCT01454726|7424920|FG001|STARTED|Overall Study||11
6505658|NCT01454726|7424919|FG000|COMPLETED|Overall Study||16
6505659|NCT01454726|7424920|FG001|COMPLETED|Overall Study||10
6505660|NCT01454726|7424919|FG000|NOT COMPLETED|Overall Study||0
6505661|NCT01454726|7424920|FG001|NOT COMPLETED|Overall Study||1
6505662|NCT01454739|7424928|FG000|STARTED|Overall Study|30 participants in <6 Years Old Age Cohort and 31 participants in 6 to <12 Years Old Age Cohort.|61
6505663|NCT01454739|7424929|FG001|STARTED|Overall Study||179
6505664|NCT01454739|7424928|FG000|Tailored Prophylaxis|Overall Study||59
6505665|NCT01454739|7424929|FG001|Tailored Prophylaxis|Overall Study||131
6505666|NCT01454739|7424928|FG000|Weekly Prophylaxis|Overall Study||0
6505667|NCT01454739|7424929|FG001|Weekly Prophylaxis|Overall Study||34
6505668|NCT01454739|7424928|FG000|Personalized Prophylaxis|Overall Study||3
6505669|NCT01454739|7424929|FG001|Personalized Prophylaxis|Overall Study||23
6505670|NCT01454739|7424928|FG000|Episodic|Overall Study||0
6505671|NCT01454739|7424929|FG001|Episodic|Overall Study||13
6505672|NCT01454739|7424928|FG000|Surgery Subgroup|Overall Study||2
6505673|NCT01454739|7424929|FG001|Surgery Subgroup|Overall Study||26
6277159|NCT00124917|7176564|FG000|STARTED|Overall Study||6
6277160|NCT00124917|7176564|FG000|COMPLETED|Overall Study||3
6277161|NCT00124917|7176564|FG000|NOT COMPLETED|Overall Study||3
6277162|NCT00124943|7176573|FG000|STARTED|Phase I||3
6277163|NCT00124943|7176574|FG001|STARTED|Phase I||3
6277164|NCT00124943|7176575|FG002|STARTED|Phase I||3
6277165|NCT00124943|7176576|FG003|STARTED|Phase I||3
6277166|NCT00124943|7176573|FG000|COMPLETED|Phase I||3
6277167|NCT00124943|7176574|FG001|COMPLETED|Phase I||3
6277168|NCT00124943|7176575|FG002|COMPLETED|Phase I||3
6505674|NCT01454739|7424928|FG000|COMPLETED|Overall Study||54
6505675|NCT01454739|7424929|FG001|COMPLETED|Overall Study||158
6249462|NCT00581477|7147688|FG000|STARTED|Overall Study|8 patients were enrolled|8
6249463|NCT00581477|7147688|FG000|Dose Selection Trial With Droxidopa|Overall Study|2 patients had been treated with droxidopa prior to enrollment and their data is not included. Since droxidopa restores the norepinephrine that is absent in untreated patients with DBH deficiency, we present only the results for naive patients.|6
6249464|NCT00581477|7147688|FG000|Droxidopa 25 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 25 mg of Droxidopa.|6
6249465|NCT00581477|7147688|FG000|Droxidopa 50 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 50 mg of Droxidopa.|6
6249466|NCT00581477|7147688|FG000|Droxidopa 100 mg|Overall Study|Because dosing was individualized for the participants, only 4 of the 6 patients were administered 100 mg of Droxidopa.|6
6249467|NCT00581477|7147688|FG000|Droxidopa 200 mg|Overall Study|Because dosing was individualized for the participants, only 5 of the 6 patients were administered 200 mg of Droxidopa.|6
6249468|NCT00581477|7147688|FG000|Droxidopa 250 mg|Overall Study|Because dosing was individualized for the participants, only 2 of the 6 patients were administered 250 mg of Droxidopa.|6
6249469|NCT00581477|7147688|FG000|Droxidopa 300 mg|Overall Study|Because dosing was individualized for the participants, only 1 of the 6 patients was administered 300 mg of Droxidopa.|6
6249470|NCT00581477|7147688|FG000|COMPLETED|Overall Study||6
6249471|NCT00581477|7147688|FG000|NOT COMPLETED|Overall Study||2
6249472|NCT00554294|7147704|FG000|STARTED|Overall Study||1469
6249473|NCT00554294|7147705|FG001|STARTED|Overall Study||1721
6249474|NCT00554294|7147704|FG000|COMPLETED|Overall Study||1309
6249475|NCT00554294|7147705|FG001|COMPLETED|Overall Study||1641
6249476|NCT00554294|7147704|FG000|NOT COMPLETED|Overall Study||160
6249477|NCT00554294|7147705|FG001|NOT COMPLETED|Overall Study||80
6249478|NCT00554190|7147709|FG000|STARTED|Overall Study|29 subjects treated.|29
6249479|NCT00554190|7147709|FG000|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
6249480|NCT00554190|7147709|FG000|NOT COMPLETED|Overall Study||10
6249481|NCT00546273|7147718|FG000|STARTED|I||4
6249482|NCT00546273|7147719|FG001|STARTED|I||0
6249483|NCT00546273|7147720|FG002|STARTED|I||0
6249484|NCT00546273|7147721|FG003|STARTED|I||0
6249485|NCT00546273|7147722|FG004|STARTED|I||2
6249486|NCT00546273|7147718|FG000|COMPLETED|I||4
6249487|NCT00546273|7147719|FG001|COMPLETED|I||0
6569875|NCT01847885|7493238|FG000|COMPLETED|Initial Enrollment (Consented)||40
6569876|NCT01847885|7493239|FG001|COMPLETED|Initial Enrollment (Consented)||0
6569877|NCT01847885|7493240|FG002|COMPLETED|Initial Enrollment (Consented)||0
6569878|NCT01847885|7493238|FG000|NOT COMPLETED|Initial Enrollment (Consented)||48
6249488|NCT00546273|7147720|FG002|COMPLETED|I||0
6249489|NCT00546273|7147721|FG003|COMPLETED|I||0
6249490|NCT00546273|7147722|FG004|COMPLETED|I||2
6249491|NCT00546273|7147718|FG000|NOT COMPLETED|I||0
6249492|NCT00546273|7147719|FG001|NOT COMPLETED|I||0
6249493|NCT00546273|7147720|FG002|NOT COMPLETED|I||0
6249494|NCT00546273|7147721|FG003|NOT COMPLETED|I||0
6249495|NCT00546273|7147722|FG004|NOT COMPLETED|I||0
6249496|NCT00546273|7147718|FG000|STARTED|II||0
6249497|NCT00546273|7147719|FG001|STARTED|II||4
6249498|NCT00546273|7147720|FG002|STARTED|II||0
6249499|NCT00546273|7147721|FG003|STARTED|II||0
6249500|NCT00546273|7147722|FG004|STARTED|II||2
6249501|NCT00546273|7147718|FG000|COMPLETED|II||0
6249502|NCT00546273|7147719|FG001|COMPLETED|II||4
6249503|NCT00546273|7147720|FG002|COMPLETED|II||0
6249504|NCT00546273|7147721|FG003|COMPLETED|II||0
6249505|NCT00546273|7147722|FG004|COMPLETED|II||2
6249506|NCT00546273|7147718|FG000|NOT COMPLETED|II||0
6249507|NCT00546273|7147719|FG001|NOT COMPLETED|II||0
6249508|NCT00546273|7147720|FG002|NOT COMPLETED|II||0
6249509|NCT00546273|7147721|FG003|NOT COMPLETED|II||0
6249510|NCT00546273|7147722|FG004|NOT COMPLETED|II||0
6249511|NCT00546273|7147718|FG000|STARTED|III||0
6249512|NCT00546273|7147719|FG001|STARTED|III||0
6249513|NCT00546273|7147720|FG002|STARTED|III||4
6249514|NCT00546273|7147721|FG003|STARTED|III||0
6249515|NCT00546273|7147722|FG004|STARTED|III||2
6249516|NCT00546273|7147718|FG000|COMPLETED|III||0
6249517|NCT00546273|7147719|FG001|COMPLETED|III||0
6249518|NCT00546273|7147720|FG002|COMPLETED|III||4
6249519|NCT00546273|7147721|FG003|COMPLETED|III||0
6249520|NCT00546273|7147722|FG004|COMPLETED|III||2
6249521|NCT00546273|7147718|FG000|NOT COMPLETED|III||0
6249522|NCT00546273|7147719|FG001|NOT COMPLETED|III||0
6249523|NCT00546273|7147720|FG002|NOT COMPLETED|III||0
6249524|NCT00546273|7147721|FG003|NOT COMPLETED|III||0
6249525|NCT00546273|7147722|FG004|NOT COMPLETED|III||0
6249526|NCT00546273|7147718|FG000|STARTED|IV||0
6505676|NCT01454739|7424928|FG000|NOT COMPLETED|Overall Study||7
6505677|NCT01454739|7424929|FG001|NOT COMPLETED|Overall Study||21
6505678|NCT01454778|7424942|FG000|STARTED|Overall Study||50
6249527|NCT00546273|7147719|FG001|STARTED|IV||0
6249528|NCT00546273|7147720|FG002|STARTED|IV||0
6249529|NCT00546273|7147721|FG003|STARTED|IV||4
6249530|NCT00546273|7147722|FG004|STARTED|IV||2
6249531|NCT00546273|7147718|FG000|COMPLETED|IV||0
6249532|NCT00546273|7147719|FG001|COMPLETED|IV||0
6249533|NCT00546273|7147720|FG002|COMPLETED|IV||0
6249534|NCT00546273|7147721|FG003|COMPLETED|IV||4
6249535|NCT00546273|7147722|FG004|COMPLETED|IV||2
6249536|NCT00546273|7147718|FG000|NOT COMPLETED|IV||0
6249537|NCT00546273|7147719|FG001|NOT COMPLETED|IV||0
6249538|NCT00546273|7147720|FG002|NOT COMPLETED|IV||0
6249539|NCT00546273|7147721|FG003|NOT COMPLETED|IV||0
6249540|NCT00546273|7147722|FG004|NOT COMPLETED|IV||0
6277169|NCT00124943|7176576|FG003|COMPLETED|Phase I||3
6277170|NCT00124943|7176573|FG000|NOT COMPLETED|Phase I||0
6277171|NCT00124943|7176574|FG001|NOT COMPLETED|Phase I||0
6277172|NCT00124943|7176575|FG002|NOT COMPLETED|Phase I||0
6277173|NCT00124943|7176576|FG003|NOT COMPLETED|Phase I||0
6277174|NCT00124943|7176573|FG000|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
6277175|NCT00124943|7176574|FG001|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
6277176|NCT00124943|7176575|FG002|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
6277177|NCT00124943|7176576|FG003|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
6277178|NCT00124943|7176573|FG000|COMPLETED|Phase II||3
6277179|NCT00124943|7176574|FG001|COMPLETED|Phase II||49
6277180|NCT00124943|7176575|FG002|COMPLETED|Phase II||3
6277181|NCT00124943|7176576|FG003|COMPLETED|Phase II||50
6277182|NCT00124943|7176573|FG000|NOT COMPLETED|Phase II||0
6277183|NCT00124943|7176574|FG001|NOT COMPLETED|Phase II||2
6277184|NCT00124943|7176575|FG002|NOT COMPLETED|Phase II||0
6277185|NCT00124943|7176576|FG003|NOT COMPLETED|Phase II||5
6277186|NCT00124982|7176588|FG000|STARTED|Short-term Period||449
6277187|NCT00124982|7176589|FG001|STARTED|Short-term Period||597
6277188|NCT00124982|7176590|FG002|STARTED|Short-term Period||0
6277189|NCT00124982|7176588|FG000|COMPLETED|Short-term Period||377
6277190|NCT00124982|7176589|FG001|COMPLETED|Short-term Period||483
6277191|NCT00124982|7176590|FG002|COMPLETED|Short-term Period||0
6277192|NCT00124982|7176588|FG000|NOT COMPLETED|Short-term Period||72
6277193|NCT00124982|7176589|FG001|NOT COMPLETED|Short-term Period||114
6277194|NCT00124982|7176590|FG002|NOT COMPLETED|Short-term Period||0
6277195|NCT00124982|7176588|FG000|STARTED|Long-term Period||0
6277196|NCT00124982|7176589|FG001|STARTED|Long-term Period||0
6277197|NCT00124982|7176590|FG002|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
6277198|NCT00124982|7176588|FG000|COMPLETED|Long-term Period||0
6277199|NCT00124982|7176589|FG001|COMPLETED|Long-term Period||0
6277200|NCT00124982|7176590|FG002|COMPLETED|Long-term Period||441
6277201|NCT00124982|7176588|FG000|NOT COMPLETED|Long-term Period||0
6277202|NCT00124982|7176589|FG001|NOT COMPLETED|Long-term Period||0
6277203|NCT00124982|7176590|FG002|NOT COMPLETED|Long-term Period||89
6277204|NCT00125034|7176601|FG000|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
6277205|NCT00125034|7176602|FG001|STARTED|Overall Study|Randomized & treated|168
6277206|NCT00125034|7176601|FG000|COMPLETED|Overall Study||170
6277207|NCT00125034|7176602|FG001|COMPLETED|Overall Study||168
6277208|NCT00125034|7176601|FG000|NOT COMPLETED|Overall Study||0
6277209|NCT00125034|7176602|FG001|NOT COMPLETED|Overall Study||0
6277210|NCT00125138|7176612|FG000|STARTED|Overall Study||15
6277211|NCT00125138|7176613|FG001|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
6277212|NCT00125138|7176614|FG002|STARTED|Overall Study||25
6277213|NCT00125138|7176615|FG003|STARTED|Overall Study||30
6277214|NCT00125138|7176612|FG000|COMPLETED|Overall Study||12
6277215|NCT00125138|7176613|FG001|COMPLETED|Overall Study||17
6277216|NCT00125138|7176614|FG002|COMPLETED|Overall Study||21
6277217|NCT00125138|7176615|FG003|COMPLETED|Overall Study||25
6277218|NCT00125138|7176612|FG000|NOT COMPLETED|Overall Study||3
6277219|NCT00125138|7176613|FG001|NOT COMPLETED|Overall Study||3
6505679|NCT01454778|7424942|FG000|COMPLETED|Overall Study||47
6505680|NCT01454778|7424942|FG000|NOT COMPLETED|Overall Study||3
6505681|NCT01454791|7424948|FG000|STARTED|Overall Study||20
6505682|NCT01454791|7424949|FG001|STARTED|Overall Study||20
6505683|NCT01454791|7424948|FG000|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
6505684|NCT01454791|7424949|FG001|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
6505685|NCT01454791|7424948|FG000|NOT COMPLETED|Overall Study||0
6505686|NCT01454791|7424949|FG001|NOT COMPLETED|Overall Study||0
6505687|NCT01454830|7424959|FG000|STARTED|Overall Study||61
6505688|NCT01454830|7424960|FG001|STARTED|Overall Study||57
6505689|NCT01454830|7424959|FG000|COMPLETED|Overall Study||30
6505690|NCT01454830|7424960|FG001|COMPLETED|Overall Study||30
6657728|NCT02472522|7588196|FG001|STARTED|Overall Study||50
6657729|NCT02472522|7588195|FG000|COMPLETED|Overall Study||50
6657730|NCT02472522|7588196|FG001|COMPLETED|Overall Study||50
6657731|NCT02472522|7588195|FG000|NOT COMPLETED|Overall Study||0
6657732|NCT02472522|7588196|FG001|NOT COMPLETED|Overall Study||0
6657733|NCT02472652|7588204|FG000|STARTED|Overall Study||2
6657734|NCT02472652|7588204|FG000|COMPLETED|Overall Study||1
6657735|NCT02472652|7588204|FG000|NOT COMPLETED|Overall Study||1
6657736|NCT02472730|7588210|FG000|STARTED|Overall Study||110
6657737|NCT02472730|7588211|FG001|STARTED|Overall Study||109
6657738|NCT02472730|7588210|FG000|COMPLETED|Overall Study||101
6657739|NCT02472730|7588211|FG001|COMPLETED|Overall Study||102
6277220|NCT00125138|7176614|FG002|NOT COMPLETED|Overall Study||4
6277221|NCT00125138|7176615|FG003|NOT COMPLETED|Overall Study||5
6277222|NCT00125164|7176629|FG000|STARTED|Overall Study||25
6657740|NCT02472730|7588210|FG000|NOT COMPLETED|Overall Study||9
6249541|NCT00529152|7147729|FG000|STARTED|Overall Study||100
6249542|NCT00529152|7147729|FG000|COMPLETED|Overall Study||95
6249543|NCT00529152|7147729|FG000|NOT COMPLETED|Overall Study||5
6249544|NCT00526227|7147732|FG000|STARTED|Overall Study||81
6249545|NCT00526227|7147732|FG000|COMPLETED|Overall Study||79
6249546|NCT00526227|7147732|FG000|NOT COMPLETED|Overall Study||2
6249547|NCT00513617|7147740|FG000|STARTED|Overall Study||36
6249548|NCT00513617|7147741|FG001|STARTED|Overall Study||35
6249549|NCT00513617|7147742|FG002|STARTED|Overall Study||38
6249550|NCT00513617|7147740|FG000|COMPLETED|Overall Study||25
6249551|NCT00513617|7147741|FG001|COMPLETED|Overall Study||25
6249552|NCT00513617|7147742|FG002|COMPLETED|Overall Study||30
6249553|NCT00513617|7147740|FG000|NOT COMPLETED|Overall Study||11
6249554|NCT00513617|7147741|FG001|NOT COMPLETED|Overall Study||10
6249555|NCT00513617|7147742|FG002|NOT COMPLETED|Overall Study||8
6505691|NCT01454830|7424959|FG000|NOT COMPLETED|Overall Study||31
6505692|NCT01454830|7424960|FG001|NOT COMPLETED|Overall Study||27
6505693|NCT01454934|7424968|FG000|STARTED|Overall Study||270
6505694|NCT01454934|7424969|FG001|STARTED|Overall Study||270
6505695|NCT01454934|7424968|FG000|COMPLETED|Overall Study||0
6505696|NCT01454934|7424969|FG001|COMPLETED|Overall Study||0
6505697|NCT01454934|7424968|FG000|NOT COMPLETED|Overall Study||270
6505698|NCT01454934|7424969|FG001|NOT COMPLETED|Overall Study||270
6505699|NCT01454947|7424983|FG000|STARTED|Overall Study||27
6505700|NCT01454947|7424984|FG001|STARTED|Overall Study||42
6505701|NCT01454947|7424985|FG002|STARTED|Overall Study||35
6505702|NCT01454947|7424986|FG003|STARTED|Overall Study||20
6505703|NCT01454947|7424987|FG004|STARTED|Overall Study||34
6505704|NCT01454947|7424988|FG005|STARTED|Overall Study||35
6505705|NCT01454947|7424989|FG006|STARTED|Overall Study||27
6505706|NCT01454947|7424990|FG007|STARTED|Overall Study||28
6505707|NCT01454947|7424983|FG000|COMPLETED|Overall Study||24
6505708|NCT01454947|7424984|FG001|COMPLETED|Overall Study||38
6505709|NCT01454947|7424985|FG002|COMPLETED|Overall Study||32
6505710|NCT01454947|7424986|FG003|COMPLETED|Overall Study||19
6505711|NCT01454947|7424987|FG004|COMPLETED|Overall Study||33
6505712|NCT01454947|7424988|FG005|COMPLETED|Overall Study||32
6505713|NCT01454947|7424989|FG006|COMPLETED|Overall Study||26
6505714|NCT01454947|7424990|FG007|COMPLETED|Overall Study||23
6505715|NCT01454947|7424983|FG000|NOT COMPLETED|Overall Study||3
6505716|NCT01454947|7424984|FG001|NOT COMPLETED|Overall Study||4
6505717|NCT01454947|7424985|FG002|NOT COMPLETED|Overall Study||3
6505718|NCT01454947|7424986|FG003|NOT COMPLETED|Overall Study||1
6505719|NCT01454947|7424987|FG004|NOT COMPLETED|Overall Study||1
6505720|NCT01454947|7424988|FG005|NOT COMPLETED|Overall Study||3
6505721|NCT01454947|7424989|FG006|NOT COMPLETED|Overall Study||1
6505722|NCT01454947|7424990|FG007|NOT COMPLETED|Overall Study||5
6505723|NCT01455012|7425010|FG000|STARTED|Overall Study||41
6505724|NCT01455012|7425011|FG001|STARTED|Overall Study||40
6505725|NCT01455012|7425010|FG000|COMPLETED|Overall Study||30
6505726|NCT01455012|7425011|FG001|COMPLETED|Overall Study||36
6505727|NCT01455012|7425010|FG000|NOT COMPLETED|Overall Study||11
6505728|NCT01455012|7425011|FG001|NOT COMPLETED|Overall Study||4
6657741|NCT02472730|7588211|FG001|NOT COMPLETED|Overall Study||7
6657742|NCT02472756|7588217|FG000|STARTED|Induction (Approximately 6 Months)||41
6657743|NCT02472756|7588217|FG000|Treated|Induction (Approximately 6 Months)||40
6657744|NCT02472756|7588217|FG000|COMPLETED|Induction (Approximately 6 Months)||39
6657745|NCT02472756|7588217|FG000|NOT COMPLETED|Induction (Approximately 6 Months)||2
6657746|NCT02472756|7588217|FG000|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
6657747|NCT02472756|7588217|FG000|COMPLETED|Maintenance (Approximately 2 Years)||10
6657748|NCT02472756|7588217|FG000|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
6657749|NCT02472795|7588226|FG000|STARTED|Overall Study||12
6249556|NCT00495222|7147747|FG000|STARTED|Overall Study||9
6249557|NCT00495222|7147747|FG000|COMPLETED|Overall Study||9
6249558|NCT00495222|7147747|FG000|NOT COMPLETED|Overall Study||0
6249559|NCT00495131|7147752|FG000|STARTED|Overall Study||154
6249560|NCT00495131|7147753|FG001|STARTED|Overall Study||154
6249561|NCT00495131|7147752|FG000|COMPLETED|Overall Study||147
6249562|NCT00495131|7147753|FG001|COMPLETED|Overall Study||148
6249563|NCT00495131|7147752|FG000|NOT COMPLETED|Overall Study||7
6249564|NCT00495131|7147753|FG001|NOT COMPLETED|Overall Study||6
6249565|NCT00491738|7147759|FG000|STARTED|Overall Study||7
6249566|NCT00491738|7147760|FG001|STARTED|Overall Study||9
6249567|NCT00491738|7147759|FG000|COMPLETED|Overall Study||7
6249568|NCT00491738|7147760|FG001|COMPLETED|Overall Study||9
6249569|NCT00491738|7147759|FG000|NOT COMPLETED|Overall Study||0
6249570|NCT00491738|7147760|FG001|NOT COMPLETED|Overall Study||0
6249571|NCT00484419|7147767|FG000|STARTED|Overall Study||57
6249572|NCT00484419|7147768|FG001|STARTED|Overall Study||56
6249573|NCT00484419|7147769|FG002|STARTED|Overall Study||56
6249574|NCT00484419|7147767|FG000|COMPLETED|Overall Study||45
6505729|NCT01455064|7425017|FG000|STARTED|Overall Study||31
6505730|NCT01455064|7425017|FG000|COMPLETED|Overall Study||30
6505731|NCT01455064|7425017|FG000|NOT COMPLETED|Overall Study||1
6505732|NCT01455181|7425021|FG000|STARTED|Overall Study||24
6505733|NCT01455181|7425021|FG000|COMPLETED|Overall Study||24
6249575|NCT00484419|7147768|FG001|COMPLETED|Overall Study||51
6505734|NCT01455181|7425021|FG000|NOT COMPLETED|Overall Study||0
6657750|NCT02472795|7588227|FG001|STARTED|Overall Study||12
6657751|NCT02472795|7588228|FG002|STARTED|Overall Study||13
6249576|NCT00484419|7147769|FG002|COMPLETED|Overall Study||45
6249577|NCT00484419|7147767|FG000|NOT COMPLETED|Overall Study||12
6249578|NCT00484419|7147768|FG001|NOT COMPLETED|Overall Study||5
6249579|NCT00484419|7147769|FG002|NOT COMPLETED|Overall Study||11
6277223|NCT00125164|7176630|FG001|STARTED|Overall Study||16
6277224|NCT00125164|7176631|FG002|STARTED|Overall Study||44
6277225|NCT00125164|7176632|FG003|STARTED|Overall Study||51
6277226|NCT00125164|7176629|FG000|COMPLETED|Overall Study||23
6277227|NCT00125164|7176630|FG001|COMPLETED|Overall Study||16
6277228|NCT00125164|7176631|FG002|COMPLETED|Overall Study||40
6277229|NCT00125164|7176632|FG003|COMPLETED|Overall Study||45
6277230|NCT00125164|7176629|FG000|NOT COMPLETED|Overall Study||2
6277231|NCT00125164|7176630|FG001|NOT COMPLETED|Overall Study||0
6277232|NCT00125164|7176631|FG002|NOT COMPLETED|Overall Study||4
6277233|NCT00125164|7176632|FG003|NOT COMPLETED|Overall Study||6
6277234|NCT00125190|7176642|FG000|STARTED|Overall Study||45
6277235|NCT00125190|7176642|FG000|Completed 34 Weeks of Study|Overall Study||43
6277236|NCT00125190|7176642|FG000|COMPLETED|Overall Study||30
6277237|NCT00125190|7176642|FG000|NOT COMPLETED|Overall Study||15
6277238|NCT00125242|7176649|FG000|STARTED|Overall Study||94
6277239|NCT00125242|7176650|FG001|STARTED|Overall Study||16
6277240|NCT00125242|7176649|FG000|COMPLETED|Overall Study||87
6277241|NCT00125242|7176650|FG001|COMPLETED|Overall Study||14
6657752|NCT02472795|7588229|FG003|STARTED|Overall Study||13
6569879|NCT01847885|7493239|FG001|NOT COMPLETED|Initial Enrollment (Consented)||0
6569880|NCT01847885|7493240|FG002|NOT COMPLETED|Initial Enrollment (Consented)||0
6569881|NCT01847885|7493238|FG000|STARTED|Randomization||0
6569882|NCT01847885|7493239|FG001|STARTED|Randomization||31
6569883|NCT01847885|7493240|FG002|STARTED|Randomization||15
6249580|NCT00479258|7147776|FG000|STARTED|Overall Study||0
6249581|NCT00479258|7147777|FG001|STARTED|Overall Study||0
6249582|NCT00479258|7147776|FG000|COMPLETED|Overall Study||0
6249583|NCT00479258|7147777|FG001|COMPLETED|Overall Study||0
6657753|NCT02472795|7588230|FG004|STARTED|Overall Study||17
6657754|NCT02472795|7588226|FG000|Pharmacodynamic Set|Overall Study||12
6657755|NCT02472795|7588227|FG001|Pharmacodynamic Set|Overall Study||10
6657756|NCT02472795|7588228|FG002|Pharmacodynamic Set|Overall Study||13
6657757|NCT02472795|7588229|FG003|Pharmacodynamic Set|Overall Study||13
6657758|NCT02472795|7588230|FG004|Pharmacodynamic Set|Overall Study||16
6657759|NCT02472795|7588226|FG000|Modified Pharmacodynamic Analysis Set|Overall Study||12
6657760|NCT02472795|7588227|FG001|Modified Pharmacodynamic Analysis Set|Overall Study||10
6657761|NCT02472795|7588228|FG002|Modified Pharmacodynamic Analysis Set|Overall Study||13
6657762|NCT02472795|7588229|FG003|Modified Pharmacodynamic Analysis Set|Overall Study||9
6657763|NCT02472795|7588230|FG004|Modified Pharmacodynamic Analysis Set|Overall Study||16
6657764|NCT02472795|7588226|FG000|COMPLETED|Overall Study||12
6657765|NCT02472795|7588227|FG001|COMPLETED|Overall Study||11
6657766|NCT02472795|7588228|FG002|COMPLETED|Overall Study||13
6657767|NCT02472795|7588229|FG003|COMPLETED|Overall Study||13
6657768|NCT02472795|7588230|FG004|COMPLETED|Overall Study||14
6657769|NCT02472795|7588226|FG000|NOT COMPLETED|Overall Study||0
6657770|NCT02472795|7588227|FG001|NOT COMPLETED|Overall Study||1
6657771|NCT02472795|7588228|FG002|NOT COMPLETED|Overall Study||0
6657772|NCT02472795|7588229|FG003|NOT COMPLETED|Overall Study||0
6657773|NCT02472795|7588230|FG004|NOT COMPLETED|Overall Study||3
6657774|NCT02472847|7588244|FG000|STARTED|Overall Study||24
6657775|NCT02472847|7588245|FG001|STARTED|Overall Study||26
6657776|NCT02472847|7588244|FG000|COMPLETED|Overall Study||23
6657777|NCT02472847|7588245|FG001|COMPLETED|Overall Study||21
6657778|NCT02472847|7588244|FG000|NOT COMPLETED|Overall Study||1
6657779|NCT02472847|7588245|FG001|NOT COMPLETED|Overall Study||5
6657780|NCT02472886|7588254|FG000|STARTED|Overall Study||67
6657781|NCT02472886|7588255|FG001|STARTED|Overall Study||59
6657782|NCT02472886|7588256|FG002|STARTED|Overall Study||27
6657783|NCT02472886|7588254|FG000|COMPLETED|Overall Study||67
6657784|NCT02472886|7588255|FG001|COMPLETED|Overall Study||57
6657785|NCT02472886|7588256|FG002|COMPLETED|Overall Study||26
6657786|NCT02472886|7588254|FG000|NOT COMPLETED|Overall Study||0
6657787|NCT02472886|7588255|FG001|NOT COMPLETED|Overall Study||2
6657788|NCT02472886|7588256|FG002|NOT COMPLETED|Overall Study||1
6657789|NCT02472977|7588272|FG000|STARTED|Overall Study||6
6657790|NCT02472977|7588273|FG001|STARTED|Overall Study||27
6657791|NCT02472977|7588274|FG002|STARTED|Overall Study||8
6657792|NCT02472977|7588272|FG000|COMPLETED|Overall Study||0
6657793|NCT02472977|7588273|FG001|COMPLETED|Overall Study||0
6657794|NCT02472977|7588274|FG002|COMPLETED|Overall Study||0
6657795|NCT02472977|7588272|FG000|NOT COMPLETED|Overall Study||6
6657796|NCT02472977|7588273|FG001|NOT COMPLETED|Overall Study||27
6657797|NCT02472977|7588274|FG002|NOT COMPLETED|Overall Study||8
6657798|NCT02473250|7588282|FG000|STARTED|Overall Study||40
6657799|NCT02473250|7588282|FG000|COMPLETED|Overall Study||20
6657800|NCT02473250|7588282|FG000|NOT COMPLETED|Overall Study||20
6657801|NCT02473289|7588289|FG000|STARTED|Overall Study||99
6657802|NCT02473289|7588290|FG001|STARTED|Overall Study||94
6657803|NCT02473289|7588289|FG000|COMPLETED|Overall Study||88
6657804|NCT02473289|7588290|FG001|COMPLETED|Overall Study||81
6657805|NCT02473289|7588289|FG000|NOT COMPLETED|Overall Study||11
6657806|NCT02473289|7588290|FG001|NOT COMPLETED|Overall Study||13
6657807|NCT02473367|7588296|FG000|STARTED|Period 1||20
6657808|NCT02473367|7588296|FG000|COMPLETED|Period 1||20
6657809|NCT02473367|7588296|FG000|NOT COMPLETED|Period 1||0
6657810|NCT02473367|7588296|FG000|STARTED|Wait 1||20
6657811|NCT02473367|7588296|FG000|COMPLETED|Wait 1||19
6657812|NCT02473367|7588296|FG000|NOT COMPLETED|Wait 1||1
6657813|NCT02473367|7588296|FG000|STARTED|Period 2||19
6657814|NCT02473367|7588296|FG000|COMPLETED|Period 2||19
6657815|NCT02473367|7588296|FG000|NOT COMPLETED|Period 2||0
6657816|NCT02473367|7588296|FG000|STARTED|Wait 2||19
6657817|NCT02473367|7588296|FG000|COMPLETED|Wait 2||19
6657818|NCT02473367|7588296|FG000|NOT COMPLETED|Wait 2||0
6657819|NCT02473367|7588296|FG000|STARTED|Period 3||19
6657820|NCT02473367|7588296|FG000|COMPLETED|Period 3||19
6657821|NCT02473367|7588296|FG000|NOT COMPLETED|Period 3||0
6657822|NCT02473367|7588296|FG000|STARTED|Wait 3||19
6657823|NCT02473367|7588296|FG000|COMPLETED|Wait 3||19
6657824|NCT02473367|7588296|FG000|NOT COMPLETED|Wait 3||0
6657825|NCT02473367|7588296|FG000|STARTED|Period 4||19
6657826|NCT02473367|7588296|FG000|COMPLETED|Period 4||18
6657827|NCT02473367|7588296|FG000|NOT COMPLETED|Period 4||1
6657828|NCT02473393|7588310|FG000|STARTED|Overall Study||5
6657829|NCT02473393|7588311|FG001|STARTED|Overall Study||12
6657830|NCT02473393|7588312|FG002|STARTED|Overall Study||13
6657831|NCT02473393|7588313|FG003|STARTED|Overall Study||13
6657832|NCT02473393|7588310|FG000|COMPLETED|Overall Study||5
6657833|NCT02473393|7588311|FG001|COMPLETED|Overall Study||12
6657834|NCT02473393|7588312|FG002|COMPLETED|Overall Study||11
6657835|NCT02473393|7588313|FG003|COMPLETED|Overall Study||12
6657836|NCT02473393|7588310|FG000|NOT COMPLETED|Overall Study||0
6657837|NCT02473393|7588311|FG001|NOT COMPLETED|Overall Study||0
6657838|NCT02473393|7588312|FG002|NOT COMPLETED|Overall Study||2
6657839|NCT02473393|7588313|FG003|NOT COMPLETED|Overall Study||1
6657840|NCT02473471|7588323|FG000|STARTED|Overall Study||35
6249584|NCT00479258|7147776|FG000|NOT COMPLETED|Overall Study||0
6249585|NCT00479258|7147777|FG001|NOT COMPLETED|Overall Study||0
6249586|NCT00474188|7147781|FG000|STARTED|Overall Study||26
6249587|NCT00474188|7147781|FG000|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
6249588|NCT00474188|7147781|FG000|NOT COMPLETED|Overall Study||6
6249589|NCT00440531|7147787|FG000|STARTED|Overall Study||185
6249590|NCT00440531|7147788|FG001|STARTED|Overall Study||183
6249591|NCT00440531|7147789|FG002|STARTED|Overall Study||172
6249592|NCT00440531|7147787|FG000|Vaccination 1|Overall Study||183
6249593|NCT00440531|7147788|FG001|Vaccination 1|Overall Study||183
6249594|NCT00440531|7147789|FG002|Vaccination 1|Overall Study||172
6249595|NCT00440531|7147787|FG000|Vaccination 2|Overall Study||181
6249596|NCT00440531|7147788|FG001|Vaccination 2|Overall Study||182
6249597|NCT00440531|7147789|FG002|Vaccination 2|Overall Study||171
6249598|NCT00440531|7147787|FG000|Vaccination 3|Overall Study||176
6657841|NCT02473471|7588323|FG000|Received Allocated Intervention|Overall Study||33
6657842|NCT02473471|7588323|FG000|Randomized Not Treated|Overall Study||2
6657843|NCT02473471|7588323|FG000|COMPLETED|Overall Study||32
6657844|NCT02473471|7588323|FG000|NOT COMPLETED|Overall Study||3
6657845|NCT02473510|7588335|FG000|STARTED|Overall Study||60
6657846|NCT02473510|7588336|FG001|STARTED|Overall Study||240
6657847|NCT02473510|7588335|FG000|COMPLETED|Overall Study||59
6657848|NCT02473510|7588336|FG001|COMPLETED|Overall Study||238
6657849|NCT02473510|7588335|FG000|NOT COMPLETED|Overall Study||1
6657850|NCT02473510|7588336|FG001|NOT COMPLETED|Overall Study||2
6657851|NCT02473614|7588342|FG000|STARTED|First Intervention (3 Weeks)||6
6657852|NCT02473614|7588343|FG001|STARTED|First Intervention (3 Weeks)||5
6657853|NCT02473614|7588342|FG000|COMPLETED|First Intervention (3 Weeks)||5
6657854|NCT02473614|7588343|FG001|COMPLETED|First Intervention (3 Weeks)||5
6657855|NCT02473614|7588342|FG000|NOT COMPLETED|First Intervention (3 Weeks)||1
6657856|NCT02473614|7588343|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
6657857|NCT02473614|7588342|FG000|STARTED|Wash Out Period (3 Weeks)||5
6657858|NCT02473614|7588343|FG001|STARTED|Wash Out Period (3 Weeks)||5
6657859|NCT02473614|7588342|FG000|COMPLETED|Wash Out Period (3 Weeks)||5
6657860|NCT02473614|7588343|FG001|COMPLETED|Wash Out Period (3 Weeks)||5
6657861|NCT02473614|7588342|FG000|NOT COMPLETED|Wash Out Period (3 Weeks)||0
6657862|NCT02473614|7588343|FG001|NOT COMPLETED|Wash Out Period (3 Weeks)||0
6657863|NCT02473614|7588342|FG000|STARTED|Second Intervention (3 Weeks)||5
6657864|NCT02473614|7588343|FG001|STARTED|Second Intervention (3 Weeks)||5
6657865|NCT02473614|7588342|FG000|COMPLETED|Second Intervention (3 Weeks)||5
6657866|NCT02473614|7588343|FG001|COMPLETED|Second Intervention (3 Weeks)||5
6657867|NCT02473614|7588342|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6657868|NCT02473614|7588343|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6657869|NCT02473640|7588350|FG000|STARTED|Treatment Period 1||15
6657870|NCT02473640|7588350|FG000|COMPLETED|Treatment Period 1||14
6657871|NCT02473640|7588350|FG000|NOT COMPLETED|Treatment Period 1||1
6657872|NCT02473640|7588350|FG000|STARTED|Run-in Phase||14
6657873|NCT02473640|7588350|FG000|COMPLETED|Run-in Phase||14
6657874|NCT02473640|7588350|FG000|NOT COMPLETED|Run-in Phase||0
6657875|NCT02473640|7588350|FG000|STARTED|Treatment Period 2||14
6657876|NCT02473640|7588350|FG000|COMPLETED|Treatment Period 2||14
6657877|NCT02473640|7588350|FG000|NOT COMPLETED|Treatment Period 2||0
6657878|NCT02473718|7588359|FG000|STARTED|Overall Study||41
6657879|NCT02473718|7588360|FG001|STARTED|Overall Study||41
6657880|NCT02473718|7588359|FG000|COMPLETED|Overall Study||41
6657881|NCT02473718|7588360|FG001|COMPLETED|Overall Study||41
6657882|NCT02473718|7588359|FG000|NOT COMPLETED|Overall Study||0
6657883|NCT02473718|7588360|FG001|NOT COMPLETED|Overall Study||0
6657884|NCT02473783|7588368|FG000|STARTED|Overall Study||20
6657885|NCT02473783|7588369|FG001|STARTED|Overall Study||17
6657886|NCT02473783|7588368|FG000|COMPLETED|Overall Study||20
6657887|NCT02473783|7588369|FG001|COMPLETED|Overall Study||17
6657888|NCT02473783|7588368|FG000|NOT COMPLETED|Overall Study||0
6657889|NCT02473783|7588369|FG001|NOT COMPLETED|Overall Study||0
6657890|NCT02473913|7588378|FG000|STARTED|Overall Study||11
6657891|NCT02473913|7588379|FG001|STARTED|Overall Study||11
6657892|NCT02473913|7588378|FG000|COMPLETED|Overall Study||8
6657893|NCT02473913|7588379|FG001|COMPLETED|Overall Study||8
6657894|NCT02473913|7588378|FG000|NOT COMPLETED|Overall Study||3
6657895|NCT02473913|7588379|FG001|NOT COMPLETED|Overall Study||3
6657896|NCT02473952|7588387|FG000|STARTED|Overall Study||30
6657897|NCT02473952|7588388|FG001|STARTED|Overall Study||32
6657898|NCT02473952|7588387|FG000|COMPLETED|Overall Study||28
6657899|NCT02473952|7588388|FG001|COMPLETED|Overall Study||24
6657900|NCT02473952|7588387|FG000|NOT COMPLETED|Overall Study||2
6657901|NCT02473952|7588388|FG001|NOT COMPLETED|Overall Study||8
6657902|NCT02473965|7588396|FG000|STARTED|Overall Study||30
6657903|NCT02473965|7588397|FG001|STARTED|Overall Study||30
6249599|NCT00440531|7147788|FG001|Vaccination 3|Overall Study||178
6249600|NCT00440531|7147789|FG002|Vaccination 3|Overall Study||166
6657904|NCT02473965|7588396|FG000|COMPLETED|Overall Study||18
6657905|NCT02473965|7588397|FG001|COMPLETED|Overall Study||20
6657906|NCT02473965|7588396|FG000|NOT COMPLETED|Overall Study||12
6657907|NCT02473965|7588397|FG001|NOT COMPLETED|Overall Study||10
6657908|NCT02473991|7588403|FG000|STARTED|Overall Study||395
6569884|NCT01847885|7493238|FG000|Full Analysis Set|Randomization||0
6569885|NCT01847885|7493239|FG001|Full Analysis Set|Randomization||28
6249601|NCT00440531|7147787|FG000|COMPLETED|Overall Study||175
6249602|NCT00440531|7147788|FG001|COMPLETED|Overall Study||178
6249603|NCT00440531|7147789|FG002|COMPLETED|Overall Study||165
6249604|NCT00440531|7147787|FG000|NOT COMPLETED|Overall Study||10
6249605|NCT00440531|7147788|FG001|NOT COMPLETED|Overall Study||5
6249606|NCT00440531|7147789|FG002|NOT COMPLETED|Overall Study||7
6249607|NCT00439738|7147797|FG000|STARTED|Overall Study||206
6249608|NCT00439738|7147798|FG001|STARTED|Overall Study||206
6249609|NCT00439738|7147797|FG000|COMPLETED|Overall Study||170
6249610|NCT00439738|7147798|FG001|COMPLETED|Overall Study||178
6249611|NCT00439738|7147797|FG000|NOT COMPLETED|Overall Study||36
6249612|NCT00439738|7147798|FG001|NOT COMPLETED|Overall Study||28
6249613|NCT00434226|7147804|FG000|STARTED|Overall Study||30
6249614|NCT00434226|7147805|FG001|STARTED|Overall Study||26
6249615|NCT00434226|7147804|FG000|COMPLETED|Overall Study||0
6249616|NCT00434226|7147805|FG001|COMPLETED|Overall Study||0
6249617|NCT00434226|7147804|FG000|NOT COMPLETED|Overall Study||30
6249618|NCT00434226|7147805|FG001|NOT COMPLETED|Overall Study||26
6277242|NCT00125242|7176649|FG000|NOT COMPLETED|Overall Study||7
6277243|NCT00125242|7176650|FG001|NOT COMPLETED|Overall Study||2
6277244|NCT00125359|7176655|FG000|STARTED|Overall Study||42
6277245|NCT00125359|7176655|FG000|COMPLETED|Overall Study||19
6505735|NCT01455194|7425028|FG000|STARTED|Overall Study||153
6505736|NCT01455194|7425029|FG001|STARTED|Overall Study||120
6505737|NCT01455194|7425030|FG002|STARTED|Overall Study||122
6505738|NCT01455194|7425031|FG003|STARTED|Overall Study||125
6505739|NCT01455194|7425028|FG000|COMPLETED|Overall Study||0
6505740|NCT01455194|7425029|FG001|COMPLETED|Overall Study||89
6505741|NCT01455194|7425030|FG002|COMPLETED|Overall Study||92
6505742|NCT01455194|7425031|FG003|COMPLETED|Overall Study||97
6505743|NCT01455194|7425028|FG000|NOT COMPLETED|Overall Study||153
6505744|NCT01455194|7425029|FG001|NOT COMPLETED|Overall Study||31
6505745|NCT01455194|7425030|FG002|NOT COMPLETED|Overall Study||30
6505746|NCT01455194|7425031|FG003|NOT COMPLETED|Overall Study||28
6505747|NCT01455220|7425044|FG000|STARTED|Overall Study||45
6505748|NCT01455220|7425044|FG000|COMPLETED|Overall Study||15
6505749|NCT01455220|7425044|FG000|NOT COMPLETED|Overall Study||30
6505750|NCT01455415|7425053|FG000|STARTED|Period 1|Started=Treated|154
6505751|NCT01455415|7425054|FG001|STARTED|Period 1|Started=Treated|147
6569886|NCT01847885|7493240|FG002|Full Analysis Set|Randomization||15
6569887|NCT01847885|7493238|FG000|Safety Set|Randomization||0
6569888|NCT01847885|7493239|FG001|Safety Set|Randomization||28
6569889|NCT01847885|7493240|FG002|Safety Set|Randomization||13
6657909|NCT02473991|7588403|FG000|COMPLETED|Overall Study||395
6505752|NCT01455415|7425053|FG000|COMPLETED|Period 1||135
6505753|NCT01455415|7425054|FG001|COMPLETED|Period 1||123
6505754|NCT01455415|7425053|FG000|NOT COMPLETED|Period 1||19
6569890|NCT01847885|7493238|FG000|Per Protocol Set|Randomization||0
6569891|NCT01847885|7493239|FG001|Per Protocol Set|Randomization||27
6569892|NCT01847885|7493240|FG002|Per Protocol Set|Randomization||13
6569893|NCT01847885|7493238|FG000|COMPLETED|Randomization||0
6569894|NCT01847885|7493239|FG001|COMPLETED|Randomization||27
6569895|NCT01847885|7493240|FG002|COMPLETED|Randomization||13
6657910|NCT02473991|7588403|FG000|NOT COMPLETED|Overall Study||0
6657911|NCT02474069|7588407|FG000|STARTED|Selection Phase (SP)||772
6657912|NCT02474069|7588408|FG001|STARTED|Selection Phase (SP)||0
6657913|NCT02474069|7588409|FG002|STARTED|Selection Phase (SP)||0
6657914|NCT02474069|7588407|FG000|COMPLETED|Selection Phase (SP)||749
6657915|NCT02474069|7588408|FG001|COMPLETED|Selection Phase (SP)||0
6657916|NCT02474069|7588409|FG002|COMPLETED|Selection Phase (SP)||0
6657917|NCT02474069|7588407|FG000|NOT COMPLETED|Selection Phase (SP)||23
6657918|NCT02474069|7588408|FG001|NOT COMPLETED|Selection Phase (SP)||0
6657919|NCT02474069|7588409|FG002|NOT COMPLETED|Selection Phase (SP)||0
6657920|NCT02474069|7588407|FG000|STARTED|Comparative Dosing Phase (CDP)||0
6657921|NCT02474069|7588408|FG001|STARTED|Comparative Dosing Phase (CDP)||162
6657922|NCT02474069|7588409|FG002|STARTED|Comparative Dosing Phase (CDP)||163
6657923|NCT02474069|7588407|FG000|COMPLETED|Comparative Dosing Phase (CDP)||0
6657924|NCT02474069|7588408|FG001|COMPLETED|Comparative Dosing Phase (CDP)||153
6657925|NCT02474069|7588409|FG002|COMPLETED|Comparative Dosing Phase (CDP)||157
6657926|NCT02474069|7588407|FG000|NOT COMPLETED|Comparative Dosing Phase (CDP)||0
6657927|NCT02474069|7588408|FG001|NOT COMPLETED|Comparative Dosing Phase (CDP)||9
6657928|NCT02474069|7588409|FG002|NOT COMPLETED|Comparative Dosing Phase (CDP)||6
6657929|NCT02474082|7588421|FG000|STARTED|Overall Study||105
6657930|NCT02474082|7588422|FG001|STARTED|Overall Study||97
6657931|NCT02474082|7588421|FG000|Full Analysis Set (FAS)|Overall Study||105
6657932|NCT02474082|7588422|FG001|Full Analysis Set (FAS)|Overall Study||95
6657933|NCT02474082|7588421|FG000|COMPLETED|Overall Study||99
6657934|NCT02474082|7588422|FG001|COMPLETED|Overall Study||43
6657935|NCT02474082|7588421|FG000|NOT COMPLETED|Overall Study||6
6657936|NCT02474082|7588422|FG001|NOT COMPLETED|Overall Study||54
6657937|NCT02474199|7588430|FG000|STARTED|Overall Study||5
6657938|NCT02474199|7588431|FG001|STARTED|Overall Study|Insufficient numbers of darTregs for infusion (4 of these 5 participants)|5
6657939|NCT02474199|7588432|FG002|STARTED|Overall Study||2
6657940|NCT02474199|7588433|FG003|STARTED|Overall Study||3
6657941|NCT02474199|7588430|FG000|COMPLETED|Overall Study||3
6657942|NCT02474199|7588431|FG001|COMPLETED|Overall Study||2
6569896|NCT01847885|7493238|FG000|NOT COMPLETED|Randomization||0
6569897|NCT01847885|7493239|FG001|NOT COMPLETED|Randomization||4
6569898|NCT01847885|7493240|FG002|NOT COMPLETED|Randomization||2
6569899|NCT01848041|7493255|FG000|STARTED|Overall Study||15
6569900|NCT01848041|7493256|FG001|STARTED|Overall Study||16
6569901|NCT01848041|7493257|FG002|STARTED|Overall Study||15
6569902|NCT01848041|7493255|FG000|COMPLETED|Overall Study||15
6569903|NCT01848041|7493256|FG001|COMPLETED|Overall Study||16
6569904|NCT01848041|7493257|FG002|COMPLETED|Overall Study||15
6569905|NCT01848041|7493255|FG000|NOT COMPLETED|Overall Study||0
6569906|NCT01848041|7493256|FG001|NOT COMPLETED|Overall Study||0
6569907|NCT01848041|7493257|FG002|NOT COMPLETED|Overall Study||0
6569908|NCT01848054|7493270|FG000|STARTED|Induction Phase||155
6569909|NCT01848054|7493271|FG001|STARTED|Induction Phase||155
6249646|NCT00430950|7147827|FG000|STARTED|Overall Study||502
6249647|NCT00430950|7147828|FG001|STARTED|Overall Study||508
6249648|NCT00430950|7147827|FG000|COMPLETED|Overall Study||489
6249649|NCT00430950|7147828|FG001|COMPLETED|Overall Study||495
6249650|NCT00430950|7147827|FG000|NOT COMPLETED|Overall Study||13
6249651|NCT00430950|7147828|FG001|NOT COMPLETED|Overall Study||13
6249652|NCT00430508|7147836|FG000|STARTED|Overall Study||140
6249653|NCT00430508|7147837|FG001|STARTED|Overall Study||278
6249654|NCT00430508|7147838|FG002|STARTED|Overall Study||279
6249655|NCT00430508|7147839|FG003|STARTED|Overall Study||274
6249656|NCT00430508|7147836|FG000|COMPLETED|Overall Study||137
6249657|NCT00430508|7147837|FG001|COMPLETED|Overall Study||272
6249658|NCT00430508|7147838|FG002|COMPLETED|Overall Study||266
6249659|NCT00430508|7147839|FG003|COMPLETED|Overall Study||269
6249660|NCT00430508|7147836|FG000|NOT COMPLETED|Overall Study||3
6249661|NCT00430508|7147837|FG001|NOT COMPLETED|Overall Study||6
6249662|NCT00430508|7147838|FG002|NOT COMPLETED|Overall Study||13
6249663|NCT00430508|7147839|FG003|NOT COMPLETED|Overall Study||5
6249664|NCT00430092|7147848|FG000|STARTED|Overall Study||54
6249665|NCT00430092|7147849|FG001|STARTED|Overall Study||52
6249666|NCT00430092|7147850|FG002|STARTED|Overall Study||113
6249667|NCT00430092|7147848|FG000|COMPLETED|Overall Study||48
6249668|NCT00430092|7147849|FG001|COMPLETED|Overall Study||48
6249669|NCT00430092|7147850|FG002|COMPLETED|Overall Study||56
6249670|NCT00430092|7147848|FG000|NOT COMPLETED|Overall Study||6
6249671|NCT00430092|7147849|FG001|NOT COMPLETED|Overall Study||4
6249672|NCT00430092|7147850|FG002|NOT COMPLETED|Overall Study||57
6249673|NCT00429923|7147858|FG000|STARTED|Overall Study||57
6249674|NCT00429923|7147859|FG001|STARTED|Overall Study||55
6249675|NCT00429923|7147860|FG002|STARTED|Overall Study||107
6249676|NCT00429923|7147858|FG000|COMPLETED|Overall Study||52
6249677|NCT00429923|7147859|FG001|COMPLETED|Overall Study||51
6249678|NCT00429923|7147860|FG002|COMPLETED|Overall Study||68
6249679|NCT00429923|7147858|FG000|NOT COMPLETED|Overall Study||5
6249680|NCT00429923|7147859|FG001|NOT COMPLETED|Overall Study||4
6249681|NCT00429923|7147860|FG002|NOT COMPLETED|Overall Study||39
6249682|NCT00425100|7147865|FG000|STARTED|Overall Study||516
6249683|NCT00425100|7147865|FG000|COMPLETED|Overall Study||463
6249684|NCT00425100|7147865|FG000|NOT COMPLETED|Overall Study||53
6249685|NCT00415623|7147872|FG000|STARTED|Overall Study||154
6249686|NCT00415623|7147873|FG001|STARTED|Overall Study||151
6249687|NCT00415623|7147872|FG000|COMPLETED|Overall Study||149
6249688|NCT00415623|7147873|FG001|COMPLETED|Overall Study||146
6249689|NCT00415623|7147872|FG000|NOT COMPLETED|Overall Study||5
6249690|NCT00415623|7147873|FG001|NOT COMPLETED|Overall Study||5
6249691|NCT00412932|7147880|FG000|STARTED|Olmesartan (Olm) 20 mg||178
6249692|NCT00412932|7147880|FG000|COMPLETED|Olmesartan (Olm) 20 mg||171
6569910|NCT01848054|7493270|FG000|COMPLETED|Induction Phase||132
6569911|NCT01848054|7493271|FG001|COMPLETED|Induction Phase||147
6569912|NCT01848054|7493270|FG000|NOT COMPLETED|Induction Phase||23
6249693|NCT00412932|7147880|FG000|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
6249694|NCT00412932|7147880|FG000|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
6249695|NCT00412932|7147880|FG000|COMPLETED|Olmesartan 40 mg||161
6249696|NCT00412932|7147880|FG000|NOT COMPLETED|Olmesartan 40 mg||8
6249697|NCT00412932|7147880|FG000|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
6249698|NCT00412932|7147880|FG000|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
6249699|NCT00412932|7147880|FG000|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
6249700|NCT00412932|7147880|FG000|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
6249701|NCT00412932|7147880|FG000|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
6249702|NCT00412932|7147880|FG000|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
6249703|NCT00397254|7147883|FG000|STARTED|Overall Study||79
6249704|NCT00397254|7147884|FG001|STARTED|Overall Study||76
6249705|NCT00397254|7147883|FG000|COMPLETED|Overall Study||77
6249706|NCT00397254|7147884|FG001|COMPLETED|Overall Study||74
6249707|NCT00397254|7147883|FG000|NOT COMPLETED|Overall Study||2
6249708|NCT00397254|7147884|FG001|NOT COMPLETED|Overall Study||2
6249709|NCT00393068|7147888|FG000|STARTED|Overall Study||62
6569913|NCT01848054|7493271|FG001|NOT COMPLETED|Induction Phase||8
6569914|NCT01848054|7493270|FG000|STARTED|Stabilization/Maintenance||132
6569915|NCT01848054|7493271|FG001|STARTED|Stabilization/Maintenance||147
6249710|NCT00393068|7147888|FG000|COMPLETED|Overall Study||44
6249711|NCT00393068|7147888|FG000|NOT COMPLETED|Overall Study||18
6249712|NCT00385515|7147894|FG000|STARTED|Overall Study||57
6249713|NCT00385515|7147895|FG001|STARTED|Overall Study||24
6249714|NCT00385515|7147894|FG000|COMPLETED|Overall Study||53
6249715|NCT00385515|7147895|FG001|COMPLETED|Overall Study||21
6249716|NCT00385515|7147894|FG000|NOT COMPLETED|Overall Study||4
6249717|NCT00385515|7147895|FG001|NOT COMPLETED|Overall Study||3
6277246|NCT00125359|7176655|FG000|NOT COMPLETED|Overall Study||23
6277247|NCT00125372|7176659|FG000|STARTED|Overall Study||12
6277248|NCT00125372|7176659|FG000|COMPLETED|Overall Study||10
6277249|NCT00125372|7176659|FG000|NOT COMPLETED|Overall Study||2
6277250|NCT00125515|7176666|FG000|STARTED|Overall Study||27
6277251|NCT00125515|7176667|FG001|STARTED|Overall Study||27
6277252|NCT00125515|7176668|FG002|STARTED|Overall Study||27
6277253|NCT00125515|7176666|FG000|COMPLETED|Overall Study||7
6277254|NCT00125515|7176667|FG001|COMPLETED|Overall Study||7
6277255|NCT00125515|7176668|FG002|COMPLETED|Overall Study||6
6277256|NCT00125515|7176666|FG000|NOT COMPLETED|Overall Study||20
6277257|NCT00125515|7176667|FG001|NOT COMPLETED|Overall Study||20
6277258|NCT00125515|7176668|FG002|NOT COMPLETED|Overall Study||21
6277259|NCT00125528|7176678|FG000|STARTED|Overall Study||20
6277260|NCT00125528|7176679|FG001|STARTED|Overall Study||21
6277261|NCT00125528|7176678|FG000|COMPLETED|Overall Study||18
6277262|NCT00125528|7176679|FG001|COMPLETED|Overall Study||20
6277263|NCT00125528|7176678|FG000|NOT COMPLETED|Overall Study||2
6277264|NCT00125528|7176679|FG001|NOT COMPLETED|Overall Study||1
6569916|NCT01848054|7493270|FG000|COMPLETED|Stabilization/Maintenance||92
6277265|NCT00125593|7176687|FG000|STARTED|Overall Study||4650
6249718|NCT00362401|7147902|FG000|STARTED|Overall Study||15
6249719|NCT00362401|7147903|FG001|STARTED|Overall Study||29
6249720|NCT00362401|7147904|FG002|STARTED|Overall Study||40
6249721|NCT00362401|7147902|FG000|COMPLETED|Overall Study||15
6249722|NCT00362401|7147903|FG001|COMPLETED|Overall Study||29
6249723|NCT00362401|7147904|FG002|COMPLETED|Overall Study||40
6249724|NCT00362401|7147902|FG000|NOT COMPLETED|Overall Study||0
6249725|NCT00362401|7147903|FG001|NOT COMPLETED|Overall Study||0
6249726|NCT00362401|7147904|FG002|NOT COMPLETED|Overall Study||0
6249727|NCT00338104|7147912|FG000|STARTED|Overall Study||25
6249728|NCT00338104|7147913|FG001|STARTED|Overall Study||25
6249729|NCT00338104|7147914|FG002|STARTED|Overall Study||25
6249730|NCT00338104|7147912|FG000|COMPLETED|Overall Study||23
6249731|NCT00338104|7147913|FG001|COMPLETED|Overall Study||24
6249732|NCT00338104|7147914|FG002|COMPLETED|Overall Study||22
6249733|NCT00338104|7147912|FG000|NOT COMPLETED|Overall Study||2
6249734|NCT00338104|7147913|FG001|NOT COMPLETED|Overall Study||1
6249735|NCT00338104|7147914|FG002|NOT COMPLETED|Overall Study||3
6249736|NCT00336973|7147919|FG000|STARTED|Overall Study||66
6249737|NCT00336973|7147919|FG000|COMPLETED|Overall Study||33
6249738|NCT00336973|7147919|FG000|NOT COMPLETED|Overall Study||33
6249739|NCT00326183|7147924|FG000|STARTED|Overall Study||1453
6249740|NCT00326183|7147925|FG001|STARTED|Overall Study||347
6249741|NCT00326183|7147924|FG000|Vaccination 1 + Safety Follow-up|Overall Study||1453
6249742|NCT00326183|7147925|FG001|Vaccination 1 + Safety Follow-up|Overall Study||347
6249743|NCT00326183|7147924|FG000|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
6249744|NCT00326183|7147925|FG001|Postvaccination 1 Post-safety Follow-up|Overall Study||325
6249745|NCT00326183|7147924|FG000|Vaccination 2 + Safety Follow-up|Overall Study||1301
6249746|NCT00326183|7147925|FG001|Vaccination 2 + Safety Follow-up|Overall Study||292
6249747|NCT00326183|7147924|FG000|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
6249748|NCT00326183|7147925|FG001|Postvaccination 2 Post-safety Follow-up|Overall Study||271
6249749|NCT00326183|7147924|FG000|COMPLETED|Overall Study||1253
6249750|NCT00326183|7147925|FG001|COMPLETED|Overall Study||264
6249751|NCT00326183|7147924|FG000|NOT COMPLETED|Overall Study||200
6249752|NCT00326183|7147925|FG001|NOT COMPLETED|Overall Study||83
6249753|NCT00323037|7147931|FG000|STARTED|Overall Study|Number randomized|165
6249754|NCT00323037|7147932|FG001|STARTED|Overall Study|Number randomized|153
6249755|NCT00323037|7147931|FG000|COMPLETED|Overall Study||132
6505755|NCT01455415|7425054|FG001|NOT COMPLETED|Period 1||24
6505756|NCT01455415|7425053|FG000|STARTED|Washout||135
6505757|NCT01455415|7425054|FG001|STARTED|Washout||123
6505758|NCT01455415|7425053|FG000|COMPLETED|Washout||127
6505759|NCT01455415|7425054|FG001|COMPLETED|Washout||116
6505760|NCT01455415|7425053|FG000|NOT COMPLETED|Washout||8
6505761|NCT01455415|7425054|FG001|NOT COMPLETED|Washout||7
6505762|NCT01455415|7425053|FG000|STARTED|Period 2||127
6505763|NCT01455415|7425054|FG001|STARTED|Period 2||116
6505764|NCT01455415|7425053|FG000|COMPLETED|Period 2||114
6505765|NCT01455415|7425054|FG001|COMPLETED|Period 2||106
6505766|NCT01455415|7425053|FG000|NOT COMPLETED|Period 2||13
6505767|NCT01455415|7425054|FG001|NOT COMPLETED|Period 2||10
6505768|NCT01455415|7425053|FG000|STARTED|Follow-up||114
6505769|NCT01455415|7425054|FG001|STARTED|Follow-up||106
6505770|NCT01455415|7425053|FG000|COMPLETED|Follow-up||111
6505771|NCT01455415|7425054|FG001|COMPLETED|Follow-up||104
6505772|NCT01455415|7425053|FG000|NOT COMPLETED|Follow-up||3
6505773|NCT01455415|7425054|FG001|NOT COMPLETED|Follow-up||2
6505774|NCT01455428|7425062|FG000|STARTED|Overall Study||112
6569917|NCT01848054|7493271|FG001|COMPLETED|Stabilization/Maintenance||107
6569918|NCT01848054|7493270|FG000|NOT COMPLETED|Stabilization/Maintenance||40
6569919|NCT01848054|7493271|FG001|NOT COMPLETED|Stabilization/Maintenance||40
6569920|NCT01848067|7493281|FG000|STARTED|Overall Study||9
6569921|NCT01848067|7493281|FG000|COMPLETED|Overall Study||9
6569922|NCT01848067|7493281|FG000|NOT COMPLETED|Overall Study||0
6569923|NCT01848145|7493285|FG000|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
6249756|NCT00323037|7147932|FG001|COMPLETED|Overall Study||126
6249757|NCT00323037|7147931|FG000|NOT COMPLETED|Overall Study||33
6249758|NCT00323037|7147932|FG001|NOT COMPLETED|Overall Study||27
6249759|NCT00318656|7147938|FG000|STARTED|Overall Study||12
6249760|NCT00318656|7147939|FG001|STARTED|Overall Study||11
6249761|NCT00318656|7147938|FG000|COMPLETED|Overall Study||12
6277266|NCT00125593|7176688|FG001|STARTED|Overall Study||4620
6277267|NCT00125593|7176687|FG000|COMPLETED|Overall Study||4549
6505775|NCT01455428|7425063|FG001|STARTED|Overall Study||110
6249762|NCT00318656|7147939|FG001|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
6249763|NCT00318656|7147938|FG000|NOT COMPLETED|Overall Study||0
6249764|NCT00318656|7147939|FG001|NOT COMPLETED|Overall Study||2
6277268|NCT00125593|7176688|FG001|COMPLETED|Overall Study||4517
6277269|NCT00125593|7176687|FG000|NOT COMPLETED|Overall Study||101
6277270|NCT00125593|7176688|FG001|NOT COMPLETED|Overall Study||103
6277271|NCT00125619|7176696|FG000|STARTED|Overall Study||8
6277272|NCT00125619|7176697|FG001|STARTED|Overall Study||8
6277273|NCT00125619|7176696|FG000|COMPLETED|Overall Study||8
6277274|NCT00125619|7176697|FG001|COMPLETED|Overall Study||8
6277275|NCT00125619|7176696|FG000|NOT COMPLETED|Overall Study||0
6277276|NCT00125619|7176697|FG001|NOT COMPLETED|Overall Study||0
6277277|NCT00125658|7176706|FG000|STARTED|Overall Study||8
6277278|NCT00125658|7176707|FG001|STARTED|Overall Study||6
6277279|NCT00125658|7176706|FG000|COMPLETED|Overall Study||8
6277280|NCT00125658|7176707|FG001|COMPLETED|Overall Study||6
6277281|NCT00125658|7176706|FG000|NOT COMPLETED|Overall Study||0
6277282|NCT00125658|7176707|FG001|NOT COMPLETED|Overall Study||0
6277283|NCT00125762|7176715|FG000|STARTED|Overall Study||907
6277284|NCT00125762|7176715|FG000|COMPLETED|Overall Study||748
6277285|NCT00125762|7176715|FG000|NOT COMPLETED|Overall Study||159
6277286|NCT00125788|7176721|FG000|STARTED|Overall Study||37
6277287|NCT00125788|7176722|FG001|STARTED|Overall Study||33
6277288|NCT00125788|7176721|FG000|COMPLETED|Overall Study||33
6277289|NCT00125788|7176722|FG001|COMPLETED|Overall Study||29
6277290|NCT00125788|7176721|FG000|NOT COMPLETED|Overall Study||4
6277291|NCT00125788|7176722|FG001|NOT COMPLETED|Overall Study||4
6277292|NCT00125853|7176728|FG000|STARTED|Wash-out (4 Weeks)||27
6277293|NCT00125853|7176729|FG001|STARTED|Wash-out (4 Weeks)||27
6277294|NCT00125853|7176728|FG000|COMPLETED|Wash-out (4 Weeks)||27
6277295|NCT00125853|7176729|FG001|COMPLETED|Wash-out (4 Weeks)||27
6277296|NCT00125853|7176728|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
6277297|NCT00125853|7176729|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
6277298|NCT00125853|7176728|FG000|STARTED|First Intervention (8 Weeks)||27
6277299|NCT00125853|7176729|FG001|STARTED|First Intervention (8 Weeks)||27
6277300|NCT00125853|7176728|FG000|COMPLETED|First Intervention (8 Weeks)||27
6277301|NCT00125853|7176729|FG001|COMPLETED|First Intervention (8 Weeks)||27
6277302|NCT00125853|7176728|FG000|NOT COMPLETED|First Intervention (8 Weeks)||0
6277303|NCT00125853|7176729|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
6277304|NCT00125853|7176728|FG000|STARTED|Wash-out (4 Weeks)||27
6277305|NCT00125853|7176729|FG001|STARTED|Wash-out (4 Weeks)||27
6277306|NCT00125853|7176728|FG000|COMPLETED|Wash-out (4 Weeks)||24
6277307|NCT00125853|7176729|FG001|COMPLETED|Wash-out (4 Weeks)||20
6277308|NCT00125853|7176728|FG000|NOT COMPLETED|Wash-out (4 Weeks)||3
6277309|NCT00125853|7176729|FG001|NOT COMPLETED|Wash-out (4 Weeks)||7
6277310|NCT00125853|7176728|FG000|STARTED|Second Intervention (8 Weeks)||24
6277311|NCT00125853|7176729|FG001|STARTED|Second Intervention (8 Weeks)||20
6277312|NCT00125853|7176728|FG000|COMPLETED|Second Intervention (8 Weeks)||24
6277313|NCT00125853|7176729|FG001|COMPLETED|Second Intervention (8 Weeks)||20
6277314|NCT00125853|7176728|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
6277315|NCT00125853|7176729|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
6277316|NCT00125931|7176735|FG000|STARTED|Overall Study||10
6277317|NCT00125931|7176735|FG000|COMPLETED|Overall Study||10
6277318|NCT00125931|7176735|FG000|NOT COMPLETED|Overall Study||0
6277319|NCT00125957|7176741|FG000|STARTED|First Intervention (3 Weeks)||15
6277320|NCT00125957|7176742|FG001|STARTED|First Intervention (3 Weeks)||17
6277321|NCT00125957|7176741|FG000|COMPLETED|First Intervention (3 Weeks)||15
6277322|NCT00125957|7176742|FG001|COMPLETED|First Intervention (3 Weeks)||17
6277323|NCT00125957|7176741|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
6277324|NCT00125957|7176742|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
6277325|NCT00125957|7176741|FG000|STARTED|Second Intervention (3 Weeks)||15
6277326|NCT00125957|7176742|FG001|STARTED|Second Intervention (3 Weeks)||17
6277327|NCT00125957|7176741|FG000|COMPLETED|Second Intervention (3 Weeks)||15
6277328|NCT00125957|7176742|FG001|COMPLETED|Second Intervention (3 Weeks)||17
6277329|NCT00125957|7176741|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6277330|NCT00125957|7176742|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6277331|NCT00126113|7176750|FG000|STARTED|Overall Study||37
6277332|NCT00126113|7176751|FG001|STARTED|Overall Study||37
6277333|NCT00126113|7176750|FG000|COMPLETED|Overall Study||34
6277334|NCT00126113|7176751|FG001|COMPLETED|Overall Study||35
6277335|NCT00126113|7176750|FG000|NOT COMPLETED|Overall Study||3
6277336|NCT00126113|7176751|FG001|NOT COMPLETED|Overall Study||2
6277337|NCT00126126|7176759|FG000|STARTED|Overall Study||9
6277338|NCT00126126|7176760|FG001|STARTED|Overall Study||9
6277339|NCT00126126|7176759|FG000|COMPLETED|Overall Study||9
6277340|NCT00126126|7176760|FG001|COMPLETED|Overall Study||7
6277341|NCT00126126|7176759|FG000|NOT COMPLETED|Overall Study||0
6277342|NCT00126126|7176760|FG001|NOT COMPLETED|Overall Study||2
6657943|NCT02474199|7588432|FG002|COMPLETED|Overall Study||0
6657944|NCT02474199|7588433|FG003|COMPLETED|Overall Study||0
6657945|NCT02474199|7588430|FG000|NOT COMPLETED|Overall Study||2
6657946|NCT02474199|7588431|FG001|NOT COMPLETED|Overall Study||3
6657947|NCT02474199|7588432|FG002|NOT COMPLETED|Overall Study||2
6277343|NCT00126191|7176768|FG000|STARTED|Overall Study||2
6277344|NCT00126191|7176769|FG001|STARTED|Overall Study||8
6277345|NCT00126191|7176768|FG000|COMPLETED|Overall Study||2
6657948|NCT02474199|7588433|FG003|NOT COMPLETED|Overall Study||3
6249765|NCT00301262|7147945|FG000|STARTED|Double Blind Phase (DB)||94
6249766|NCT00301262|7147946|FG001|STARTED|Double Blind Phase (DB)||82
6249767|NCT00301262|7147945|FG000|COMPLETED|Double Blind Phase (DB)||84
6249768|NCT00301262|7147946|FG001|COMPLETED|Double Blind Phase (DB)||69
6249769|NCT00301262|7147945|FG000|NOT COMPLETED|Double Blind Phase (DB)||10
6249770|NCT00301262|7147946|FG001|NOT COMPLETED|Double Blind Phase (DB)||13
6249771|NCT00301262|7147945|FG000|STARTED|Open Label Phase (OL)||83
6249772|NCT00301262|7147946|FG001|STARTED|Open Label Phase (OL)||69
6249773|NCT00301262|7147945|FG000|COMPLETED|Open Label Phase (OL)||79
6249774|NCT00301262|7147946|FG001|COMPLETED|Open Label Phase (OL)||67
6249775|NCT00301262|7147945|FG000|NOT COMPLETED|Open Label Phase (OL)||4
6249776|NCT00301262|7147946|FG001|NOT COMPLETED|Open Label Phase (OL)||2
6249777|NCT00283868|7147973|FG000|STARTED|Overall Study||111
6249778|NCT00283868|7147974|FG001|STARTED|Overall Study||111
6249779|NCT00283868|7147973|FG000|COMPLETED|Overall Study||104
6249780|NCT00283868|7147974|FG001|COMPLETED|Overall Study||103
6249781|NCT00283868|7147973|FG000|NOT COMPLETED|Overall Study||7
6249782|NCT00283868|7147974|FG001|NOT COMPLETED|Overall Study||8
6249783|NCT00282867|7147981|FG000|STARTED|Overall Study||24
6249784|NCT00282867|7147982|FG001|STARTED|Overall Study||25
6249785|NCT00282867|7147983|FG002|STARTED|Overall Study||25
6249786|NCT00282867|7147981|FG000|COMPLETED|Overall Study||23
6249787|NCT00282867|7147982|FG001|COMPLETED|Overall Study||24
6249788|NCT00282867|7147983|FG002|COMPLETED|Overall Study||25
6249789|NCT00282867|7147981|FG000|NOT COMPLETED|Overall Study||1
6249790|NCT00282867|7147982|FG001|NOT COMPLETED|Overall Study||1
6249791|NCT00282867|7147983|FG002|NOT COMPLETED|Overall Study||0
6249792|NCT00275340|7147990|FG000|STARTED|Overall Study||52
6249793|NCT00275340|7147991|FG001|STARTED|Overall Study||49
6249794|NCT00275340|7147990|FG000|COMPLETED|Overall Study||50
6249795|NCT00275340|7147991|FG001|COMPLETED|Overall Study||45
6249796|NCT00275340|7147990|FG000|NOT COMPLETED|Overall Study||2
6249797|NCT00275340|7147991|FG001|NOT COMPLETED|Overall Study||4
6249798|NCT00271544|7147995|FG000|STARTED|Overall Study|Total number of subjects enrolled.|190
6249799|NCT00271544|7147995|FG000|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
6249800|NCT00271544|7147995|FG000|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
6249801|NCT00271544|7147995|FG000|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
6249802|NCT00271544|7147995|FG000|NOT COMPLETED|Overall Study||20
6249803|NCT00240500|7148017|FG000|STARTED|Overall Study||17
6249804|NCT00240500|7148018|FG001|STARTED|Overall Study||20
6249805|NCT00240500|7148019|FG002|STARTED|Overall Study||17
6249806|NCT00240500|7148020|FG003|STARTED|Overall Study||23
6249807|NCT00240500|7148021|FG004|STARTED|Overall Study||29
6249808|NCT00240500|7148022|FG005|STARTED|Overall Study||3
6249809|NCT00240500|7148017|FG000|COMPLETED|Overall Study||16
6249810|NCT00240500|7148018|FG001|COMPLETED|Overall Study||17
6249811|NCT00240500|7148019|FG002|COMPLETED|Overall Study||14
6249812|NCT00240500|7148020|FG003|COMPLETED|Overall Study||19
6249813|NCT00240500|7148021|FG004|COMPLETED|Overall Study||26
6249814|NCT00240500|7148022|FG005|COMPLETED|Overall Study||2
6249815|NCT00240500|7148017|FG000|NOT COMPLETED|Overall Study||1
6249816|NCT00240500|7148018|FG001|NOT COMPLETED|Overall Study||3
6249817|NCT00240500|7148019|FG002|NOT COMPLETED|Overall Study||3
6249818|NCT00240500|7148020|FG003|NOT COMPLETED|Overall Study||4
6249819|NCT00240500|7148021|FG004|NOT COMPLETED|Overall Study||3
6249820|NCT00240500|7148022|FG005|NOT COMPLETED|Overall Study||1
6249821|NCT00235326|7148032|FG000|STARTED|Overall Study||1575
6249822|NCT00235326|7148033|FG001|STARTED|Overall Study||2986
6249823|NCT00235326|7148032|FG000|COMPLETED|Overall Study||829
6249824|NCT00235326|7148033|FG001|COMPLETED|Overall Study||1586
6249825|NCT00235326|7148032|FG000|NOT COMPLETED|Overall Study||746
6569924|NCT01848145|7493285|FG000|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
6569925|NCT01848145|7493285|FG000|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
6249826|NCT00235326|7148033|FG001|NOT COMPLETED|Overall Study||1400
6249827|NCT00232141|7148039|FG000|STARTED|Overall Study||151
6249828|NCT00232141|7148040|FG001|STARTED|Overall Study||151
6249829|NCT00232141|7148039|FG000|COMPLETED|Overall Study||120
6249830|NCT00232141|7148040|FG001|COMPLETED|Overall Study||125
6249831|NCT00232141|7148039|FG000|NOT COMPLETED|Overall Study||31
6249832|NCT00232141|7148040|FG001|NOT COMPLETED|Overall Study||26
6569926|NCT01848145|7493285|FG000|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
6569927|NCT01848145|7493285|FG000|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
6569928|NCT01848145|7493285|FG000|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
6569929|NCT01848145|7493285|FG000|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
6569930|NCT01848145|7493285|FG000|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
6569931|NCT01848145|7493285|FG000|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
6569932|NCT01848145|7493285|FG000|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
6569933|NCT01848145|7493285|FG000|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
6569934|NCT01848145|7493285|FG000|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
6249833|NCT00231153|7148046|FG000|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
6249834|NCT00231153|7148047|FG001|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
6249835|NCT00231153|7148046|FG000|COMPLETED|Overall Study||690
6249836|NCT00231153|7148047|FG001|COMPLETED|Overall Study||720
6249837|NCT00231153|7148046|FG000|NOT COMPLETED|Overall Study||217
6249838|NCT00231153|7148047|FG001|NOT COMPLETED|Overall Study||188
6249839|NCT00224003|7148051|FG000|STARTED|Overall Study|First patient in: April 2, 2003|23
6569935|NCT01848145|7493285|FG000|STARTED|Subsequent Infusions: Weeks 3-8||30
6569936|NCT01848145|7493285|FG000|COMPLETED|Subsequent Infusions: Weeks 3-8||20
6569937|NCT01848145|7493285|FG000|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
6569938|NCT01848158|7493291|FG000|STARTED|Overall Study||10
6569939|NCT01848158|7493292|FG001|STARTED|Overall Study||7
6569940|NCT01848158|7493291|FG000|COMPLETED|Overall Study||10
6569941|NCT01848158|7493292|FG001|COMPLETED|Overall Study||7
6569942|NCT01848158|7493291|FG000|NOT COMPLETED|Overall Study||0
6569943|NCT01848158|7493292|FG001|NOT COMPLETED|Overall Study||0
6569944|NCT01848184|7493298|FG000|STARTED|Overall Study||126
6569945|NCT01848184|7493298|FG000|COMPLETED|Overall Study||100
6249840|NCT00224003|7148051|FG000|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
6249841|NCT00224003|7148051|FG000|NOT COMPLETED|Overall Study||7
6277346|NCT00126191|7176769|FG001|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
6277347|NCT00126191|7176768|FG000|NOT COMPLETED|Overall Study||0
6277348|NCT00126191|7176769|FG001|NOT COMPLETED|Overall Study||2
6277349|NCT00126425|7176777|FG000|STARTED|Overall Study||539
6277350|NCT00126425|7176778|FG001|STARTED|Overall Study||48
6277351|NCT00126425|7176777|FG000|COMPLETED|Overall Study||498
6277352|NCT00126425|7176778|FG001|COMPLETED|Overall Study||37
6277353|NCT00126425|7176777|FG000|NOT COMPLETED|Overall Study||41
6505776|NCT01455428|7425062|FG000|Treated|Overall Study||111
6505777|NCT01455428|7425063|FG001|Treated|Overall Study||109
6505778|NCT01455428|7425062|FG000|COMPLETED|Overall Study||98
6569946|NCT01848184|7493298|FG000|NOT COMPLETED|Overall Study||26
6569947|NCT01848210|7493310|FG000|STARTED|Overall Study||411
6569948|NCT01848210|7493311|FG001|STARTED|Overall Study||418
6569949|NCT01848210|7493310|FG000|Safety Population-Received Study Drug|Overall Study||394
6569950|NCT01848210|7493311|FG001|Safety Population-Received Study Drug|Overall Study||398
6569951|NCT01848210|7493310|FG000|Intent-to-Treat (ITT) Population|Overall Study||383
6569952|NCT01848210|7493311|FG001|Intent-to-Treat (ITT) Population|Overall Study||388
6569953|NCT01848210|7493310|FG000|Per Protocol Population|Overall Study||222
6569954|NCT01848210|7493311|FG001|Per Protocol Population|Overall Study||245
6569955|NCT01848210|7493310|FG000|COMPLETED|Overall Study||323
6569956|NCT01848210|7493311|FG001|COMPLETED|Overall Study||340
6569957|NCT01848210|7493310|FG000|NOT COMPLETED|Overall Study||88
6569958|NCT01848210|7493311|FG001|NOT COMPLETED|Overall Study||78
6569959|NCT01848288|7493317|FG000|STARTED|Overall Study||100
6569960|NCT01848288|7493317|FG000|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
6569961|NCT01848288|7493317|FG000|NOT COMPLETED|Overall Study||3
6569962|NCT01848353|7493326|FG000|STARTED|Phase 1||38
6569963|NCT01848353|7493327|FG001|STARTED|Phase 1||43
6505779|NCT01455428|7425063|FG001|COMPLETED|Overall Study||92
6505780|NCT01455428|7425062|FG000|NOT COMPLETED|Overall Study||14
6505781|NCT01455428|7425063|FG001|NOT COMPLETED|Overall Study||18
6505782|NCT01455519|7425071|FG000|STARTED|Overall Study||12
6505783|NCT01455519|7425072|FG001|STARTED|Overall Study||23
6505784|NCT01455519|7425071|FG000|COMPLETED|Overall Study||8
6505785|NCT01455519|7425072|FG001|COMPLETED|Overall Study||18
6249842|NCT00162942|7148056|FG000|STARTED|Overall Study||157
6249843|NCT00162942|7148057|FG001|STARTED|Overall Study||78
6249844|NCT00162942|7148056|FG000|Week 12|Overall Study||127
6249845|NCT00162942|7148057|FG001|Week 12|Overall Study||61
6569964|NCT01848353|7493328|FG002|STARTED|Phase 1||20
6249846|NCT00162942|7148056|FG000|COMPLETED|Overall Study||51
6249847|NCT00162942|7148057|FG001|COMPLETED|Overall Study||26
6249848|NCT00162942|7148056|FG000|NOT COMPLETED|Overall Study||106
6249849|NCT00162942|7148057|FG001|NOT COMPLETED|Overall Study||52
6249850|NCT00147290|7148063|FG000|STARTED|Overall Study||266
6249851|NCT00147290|7148064|FG001|STARTED|Overall Study||260
6249852|NCT00147290|7148063|FG000|COMPLETED|Overall Study||266
6249853|NCT00147290|7148064|FG001|COMPLETED|Overall Study||260
6249854|NCT00147290|7148063|FG000|NOT COMPLETED|Overall Study||0
6249855|NCT00147290|7148064|FG001|NOT COMPLETED|Overall Study||0
6249856|NCT00147277|7148070|FG000|STARTED|Overall Study||475
6249857|NCT00147277|7148071|FG001|STARTED|Overall Study||450
6249858|NCT00147277|7148070|FG000|COMPLETED|Overall Study||475
6249859|NCT00147277|7148071|FG001|COMPLETED|Overall Study||450
6249860|NCT00147277|7148070|FG000|NOT COMPLETED|Overall Study||0
6249861|NCT00147277|7148071|FG001|NOT COMPLETED|Overall Study||0
6249862|NCT00126776|7148077|FG000|STARTED|Overall Study||372
6249863|NCT00126776|7148078|FG001|STARTED|Overall Study||371
6249864|NCT00126776|7148077|FG000|COMPLETED|Overall Study||372
6249865|NCT00126776|7148078|FG001|COMPLETED|Overall Study||371
6249866|NCT00126776|7148077|FG000|NOT COMPLETED|Overall Study||0
6249867|NCT00126776|7148078|FG001|NOT COMPLETED|Overall Study||0
6505786|NCT01455519|7425071|FG000|NOT COMPLETED|Overall Study||4
6505787|NCT01455519|7425072|FG001|NOT COMPLETED|Overall Study||5
6569965|NCT01848353|7493329|FG003|STARTED|Phase 1||19
6569966|NCT01848353|7493326|FG000|COMPLETED|Phase 1||35
6569967|NCT01848353|7493327|FG001|COMPLETED|Phase 1||42
6569968|NCT01848353|7493328|FG002|COMPLETED|Phase 1||20
6569969|NCT01848353|7493329|FG003|COMPLETED|Phase 1||19
6657949|NCT02474355|7588440|FG000|STARTED|Overall Study||3014
6657950|NCT02474355|7588440|FG000|COMPLETED|Overall Study||1386
6657951|NCT02474355|7588440|FG000|NOT COMPLETED|Overall Study||1628
6657952|NCT02474407|7588444|FG000|STARTED|First Intervention (14 Days)||39
6657953|NCT02474407|7588445|FG001|STARTED|First Intervention (14 Days)||39
6657954|NCT02474407|7588444|FG000|COMPLETED|First Intervention (14 Days)||39
6657955|NCT02474407|7588445|FG001|COMPLETED|First Intervention (14 Days)||39
6657956|NCT02474407|7588444|FG000|NOT COMPLETED|First Intervention (14 Days)||0
6657957|NCT02474407|7588445|FG001|NOT COMPLETED|First Intervention (14 Days)||0
6657958|NCT02474407|7588444|FG000|STARTED|Washout (14 Days)||39
6657959|NCT02474407|7588445|FG001|STARTED|Washout (14 Days)||39
6657960|NCT02474407|7588444|FG000|COMPLETED|Washout (14 Days)||39
6657961|NCT02474407|7588445|FG001|COMPLETED|Washout (14 Days)||39
6657962|NCT02474407|7588444|FG000|NOT COMPLETED|Washout (14 Days)||0
6657963|NCT02474407|7588445|FG001|NOT COMPLETED|Washout (14 Days)||0
6657964|NCT02474407|7588444|FG000|STARTED|Second Intervention (14 Days)||39
6657965|NCT02474407|7588445|FG001|STARTED|Second Intervention (14 Days)||39
6657966|NCT02474407|7588444|FG000|COMPLETED|Second Intervention (14 Days)||39
6657967|NCT02474407|7588445|FG001|COMPLETED|Second Intervention (14 Days)||39
6657968|NCT02474407|7588444|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
6657969|NCT02474407|7588445|FG001|NOT COMPLETED|Second Intervention (14 Days)||0
6657970|NCT02474498|7588474|FG000|STARTED|Overall Study||13
6657971|NCT02474498|7588475|FG001|STARTED|Overall Study||14
6657972|NCT02474498|7588476|FG002|STARTED|Overall Study||14
6657973|NCT02474498|7588474|FG000|COMPLETED|Overall Study||13
6657974|NCT02474498|7588475|FG001|COMPLETED|Overall Study||14
6657975|NCT02474498|7588476|FG002|COMPLETED|Overall Study||14
6657976|NCT02474498|7588474|FG000|NOT COMPLETED|Overall Study||0
6657977|NCT02474498|7588475|FG001|NOT COMPLETED|Overall Study||0
6657978|NCT02474498|7588476|FG002|NOT COMPLETED|Overall Study||0
6657979|NCT02474589|7588490|FG000|STARTED|Overall Study||359
6657980|NCT02474589|7588491|FG001|STARTED|Overall Study||90
6657981|NCT02474589|7588490|FG000|COMPLETED|Overall Study||334
6657982|NCT02474589|7588491|FG001|COMPLETED|Overall Study||85
6657983|NCT02474589|7588490|FG000|NOT COMPLETED|Overall Study||25
6657984|NCT02474589|7588491|FG001|NOT COMPLETED|Overall Study||5
6657985|NCT02474901|7588499|FG000|STARTED|Overall Study||45
6657986|NCT02474901|7588500|FG001|STARTED|Overall Study||56
6657987|NCT02474901|7588499|FG000|COMPLETED|Overall Study||44
6657988|NCT02474901|7588500|FG001|COMPLETED|Overall Study||56
6657989|NCT02474901|7588499|FG000|NOT COMPLETED|Overall Study||1
6657990|NCT02474901|7588500|FG001|NOT COMPLETED|Overall Study||0
6657991|NCT02475031|7588508|FG000|STARTED|Overall Study||35
6657992|NCT02475031|7588509|FG001|STARTED|Overall Study||35
6569970|NCT01848353|7493326|FG000|NOT COMPLETED|Phase 1||3
6569971|NCT01848353|7493327|FG001|NOT COMPLETED|Phase 1||1
6569972|NCT01848353|7493328|FG002|NOT COMPLETED|Phase 1||0
6569973|NCT01848353|7493329|FG003|NOT COMPLETED|Phase 1||0
6569974|NCT01848353|7493326|FG000|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|23
6569975|NCT01848353|7493327|FG001|STARTED|Phase 2|26 participants from Phase 1 intervention (both groups) withdrew and did not complete Phase 2|28
6569976|NCT01848353|7493328|FG002|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
6569977|NCT01848353|7493329|FG003|STARTED|Phase 2|Normal weight participants only completed baseline testing in Phase 1.|0
6569978|NCT01848353|7493326|FG000|COMPLETED|Phase 2||20
6569979|NCT01848353|7493327|FG001|COMPLETED|Phase 2||26
6569980|NCT01848353|7493328|FG002|COMPLETED|Phase 2||0
6569981|NCT01848353|7493329|FG003|COMPLETED|Phase 2||0
6249868|NCT00120042|7148085|FG000|STARTED|Overall Study||85
6249869|NCT00120042|7148086|FG001|STARTED|Overall Study||83
6249870|NCT00120042|7148087|FG002|STARTED|Overall Study||83
6505788|NCT01455545|7425078|FG000|STARTED|Overall Study||55
6505789|NCT01455545|7425079|FG001|STARTED|Overall Study||45
6505790|NCT01455545|7425078|FG000|COMPLETED|Overall Study||55
6505791|NCT01455545|7425079|FG001|COMPLETED|Overall Study||45
6505792|NCT01455545|7425078|FG000|NOT COMPLETED|Overall Study||0
6505793|NCT01455545|7425079|FG001|NOT COMPLETED|Overall Study||0
6505794|NCT01456000|7425096|FG000|STARTED|Overall Study||178
6505795|NCT01456000|7425097|FG001|STARTED|Overall Study||175
6249871|NCT00120042|7148085|FG000|COMPLETED|Overall Study||85
6249872|NCT00120042|7148086|FG001|COMPLETED|Overall Study||83
6249873|NCT00120042|7148087|FG002|COMPLETED|Overall Study||83
6249874|NCT00120042|7148085|FG000|NOT COMPLETED|Overall Study||0
6249875|NCT00120042|7148086|FG001|NOT COMPLETED|Overall Study||0
6249876|NCT00120042|7148087|FG002|NOT COMPLETED|Overall Study||0
6249877|NCT00106626|7148096|FG000|STARTED|Overall Study||13
6249878|NCT00106626|7148097|FG001|STARTED|Overall Study||9
6249879|NCT00106626|7148098|FG002|STARTED|Overall Study||14
6249880|NCT00106626|7148099|FG003|STARTED|Overall Study||16
6249881|NCT00106626|7148096|FG000|COMPLETED|Overall Study||3
6249882|NCT00106626|7148097|FG001|COMPLETED|Overall Study||3
6249883|NCT00106626|7148098|FG002|COMPLETED|Overall Study||2
6249884|NCT00106626|7148099|FG003|COMPLETED|Overall Study||3
6249885|NCT00106626|7148096|FG000|NOT COMPLETED|Overall Study||10
6249886|NCT00106626|7148097|FG001|NOT COMPLETED|Overall Study||6
6249887|NCT00106626|7148098|FG002|NOT COMPLETED|Overall Study||12
6249888|NCT00106626|7148099|FG003|NOT COMPLETED|Overall Study||13
6249889|NCT00089141|7148116|FG000|STARTED|Overall Study||74
6249890|NCT00089141|7148117|FG001|STARTED|Overall Study||77
6249891|NCT00089141|7148116|FG000|COMPLETED|Overall Study||56
6249892|NCT00089141|7148117|FG001|COMPLETED|Overall Study||53
6249893|NCT00089141|7148116|FG000|NOT COMPLETED|Overall Study||18
6249894|NCT00089141|7148117|FG001|NOT COMPLETED|Overall Study||24
6249895|NCT00083759|7148123|FG000|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
6249896|NCT00083759|7148124|FG001|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
6249897|NCT00083759|7148123|FG000|COMPLETED|Overall Study||66
6249898|NCT00083759|7148124|FG001|COMPLETED|Overall Study||66
6249899|NCT00083759|7148123|FG000|NOT COMPLETED|Overall Study||84
6249900|NCT00083759|7148124|FG001|NOT COMPLETED|Overall Study||83
6277354|NCT00126425|7176778|FG001|NOT COMPLETED|Overall Study||11
6277355|NCT00126438|7176786|FG000|STARTED|Overall Study||453
6277356|NCT00126438|7176787|FG001|STARTED|Overall Study||62
6277357|NCT00126438|7176786|FG000|COMPLETED|Overall Study||419
6277358|NCT00126438|7176787|FG001|COMPLETED|Overall Study||52
6277359|NCT00126438|7176786|FG000|NOT COMPLETED|Overall Study||34
6277360|NCT00126438|7176787|FG001|NOT COMPLETED|Overall Study||10
6277361|NCT00126490|7176793|FG000|STARTED|Overall Study||19
6277362|NCT00126490|7176793|FG000|COMPLETED|Overall Study||18
6277363|NCT00126490|7176793|FG000|NOT COMPLETED|Overall Study||1
6277364|NCT00126503|7176799|FG000|STARTED|Overall Study||48
6277365|NCT00126503|7176800|FG001|STARTED|Overall Study||21
6277366|NCT00126503|7176799|FG000|COMPLETED|Overall Study||1
6277367|NCT00126503|7176800|FG001|COMPLETED|Overall Study||0
6277368|NCT00126503|7176799|FG000|NOT COMPLETED|Overall Study||47
6277369|NCT00126503|7176800|FG001|NOT COMPLETED|Overall Study||21
6277370|NCT00126555|7176810|FG000|STARTED|Overall Study||23
6277371|NCT00126555|7176810|FG000|Stratum 1- Resectable|Overall Study|1 participant did not participate|18
6249901|NCT03513068|7148130|FG000|STARTED|Overall Study||54
6249902|NCT03513068|7148131|FG001|STARTED|Overall Study||54
6249903|NCT03513068|7148130|FG000|COMPLETED|Overall Study||49
6249904|NCT03513068|7148131|FG001|COMPLETED|Overall Study||48
6249905|NCT03513068|7148130|FG000|NOT COMPLETED|Overall Study||5
6249906|NCT03513068|7148131|FG001|NOT COMPLETED|Overall Study||6
6249907|NCT03502811|7148137|FG000|STARTED|Overall Study||1041
6249908|NCT03502811|7148137|FG000|COMPLETED|Overall Study||722
6249909|NCT03502811|7148137|FG000|NOT COMPLETED|Overall Study||319
6249910|NCT04604184|7148143|FG000|STARTED|Overall Study||67
6249911|NCT04604184|7148144|FG001|STARTED|Overall Study||66
6249912|NCT04604184|7148143|FG000|Treated|Overall Study||65
6249913|NCT04604184|7148144|FG001|Treated|Overall Study||64
6249914|NCT04604184|7148143|FG000|COMPLETED|Overall Study||47
6249915|NCT04604184|7148144|FG001|COMPLETED|Overall Study||47
6249916|NCT04604184|7148143|FG000|NOT COMPLETED|Overall Study||20
6249917|NCT04604184|7148144|FG001|NOT COMPLETED|Overall Study||19
6249918|NCT04368429|7148152|FG000|STARTED|Overall Study||180
6249919|NCT04368429|7148153|FG001|STARTED|Overall Study||180
6249920|NCT04368429|7148152|FG000|Safety Analysis Set|Overall Study||179
6249921|NCT04368429|7148153|FG001|Safety Analysis Set|Overall Study||180
6249922|NCT04368429|7148152|FG000|COMPLETED|Overall Study||179
6249923|NCT04368429|7148153|FG001|COMPLETED|Overall Study||180
6249924|NCT04368429|7148152|FG000|NOT COMPLETED|Overall Study||1
6249925|NCT04368429|7148153|FG001|NOT COMPLETED|Overall Study||0
6249926|NCT04267276|7148159|FG000|STARTED|Overall Study||7
6249927|NCT04267276|7148159|FG000|Treated|Overall Study||7
6249928|NCT04267276|7148159|FG000|COMPLETED|Overall Study||7
6249929|NCT04267276|7148159|FG000|NOT COMPLETED|Overall Study||0
6249930|NCT04266158|7148163|FG000|STARTED|Overall Study||0
6249931|NCT04266158|7148163|FG000|COMPLETED|Overall Study||0
6249932|NCT04266158|7148163|FG000|NOT COMPLETED|Overall Study||0
6249937|NCT03865316|7148171|FG000|COMPLETED|Overall Study||100
6249938|NCT03865316|7148171|FG000|NOT COMPLETED|Overall Study||8
6249939|NCT03688555|7148177|FG000|STARTED|Run-in Period||10
6249940|NCT03688555|7148178|FG001|STARTED|Run-in Period||0
6249941|NCT03688555|7148179|FG002|STARTED|Run-in Period||0
6249942|NCT03688555|7148177|FG000|COMPLETED|Run-in Period||10
6249943|NCT03688555|7148178|FG001|COMPLETED|Run-in Period||0
6249944|NCT03688555|7148179|FG002|COMPLETED|Run-in Period||0
6249945|NCT03688555|7148177|FG000|NOT COMPLETED|Run-in Period||0
6249946|NCT03688555|7148178|FG001|NOT COMPLETED|Run-in Period||0
6249947|NCT03688555|7148179|FG002|NOT COMPLETED|Run-in Period||0
6249948|NCT03688555|7148177|FG000|STARTED|Treatment Period|All 10 participants that completed the run-in period were eligible to be randomized to ACT-774312 or placebo.|0
6249949|NCT03688555|7148178|FG001|STARTED|Treatment Period||7
6249950|NCT03688555|7148179|FG002|STARTED|Treatment Period||3
6249951|NCT03688555|7148177|FG000|COMPLETED|Treatment Period||0
6249952|NCT03688555|7148178|FG001|COMPLETED|Treatment Period||7
6249953|NCT03688555|7148179|FG002|COMPLETED|Treatment Period||2
6249954|NCT03688555|7148177|FG000|NOT COMPLETED|Treatment Period||0
6249955|NCT03688555|7148178|FG001|NOT COMPLETED|Treatment Period||0
6249956|NCT03688555|7148179|FG002|NOT COMPLETED|Treatment Period||1
6249957|NCT03593213|7148189|FG000|STARTED|Open-label Treatment Period (18 Weeks)|Out of 162 participants who completed Open-label Treatment Period, 159 participants were randomized to Double-blind treatment Period.|587
6249958|NCT03593213|7148190|FG001|STARTED|Open-label Treatment Period (18 Weeks)||0
6249959|NCT03593213|7148191|FG002|STARTED|Open-label Treatment Period (18 Weeks)||0
6249960|NCT03593213|7148192|FG003|STARTED|Open-label Treatment Period (18 Weeks)||0
6249961|NCT03593213|7148189|FG000|COMPLETED|Open-label Treatment Period (18 Weeks)||162
6249962|NCT03593213|7148190|FG001|COMPLETED|Open-label Treatment Period (18 Weeks)||0
6249963|NCT03593213|7148191|FG002|COMPLETED|Open-label Treatment Period (18 Weeks)||0
6249964|NCT03593213|7148192|FG003|COMPLETED|Open-label Treatment Period (18 Weeks)||0
6249965|NCT03593213|7148189|FG000|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||425
6249966|NCT03593213|7148190|FG001|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
6249967|NCT03593213|7148191|FG002|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
6249968|NCT03593213|7148192|FG003|NOT COMPLETED|Open-label Treatment Period (18 Weeks)||0
6249969|NCT03593213|7148189|FG000|STARTED|Double-blind Treatment Period (26 Weeks)||0
6249970|NCT03593213|7148190|FG001|STARTED|Double-blind Treatment Period (26 Weeks)||54
6249971|NCT03593213|7148191|FG002|STARTED|Double-blind Treatment Period (26 Weeks)||49
6249972|NCT03593213|7148192|FG003|STARTED|Double-blind Treatment Period (26 Weeks)||56
6249973|NCT03593213|7148189|FG000|Safety Population|Double-blind Treatment Period (26 Weeks)||0
6249974|NCT03593213|7148190|FG001|Safety Population|Double-blind Treatment Period (26 Weeks)||53
6249975|NCT03593213|7148191|FG002|Safety Population|Double-blind Treatment Period (26 Weeks)||49
6249976|NCT03593213|7148192|FG003|Safety Population|Double-blind Treatment Period (26 Weeks)||54
6249977|NCT03593213|7148189|FG000|COMPLETED|Double-blind Treatment Period (26 Weeks)||0
6249978|NCT03593213|7148190|FG001|COMPLETED|Double-blind Treatment Period (26 Weeks)||14
6249979|NCT03593213|7148191|FG002|COMPLETED|Double-blind Treatment Period (26 Weeks)||16
6249980|NCT03593213|7148192|FG003|COMPLETED|Double-blind Treatment Period (26 Weeks)||21
6249981|NCT03593213|7148189|FG000|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||0
6569982|NCT01848353|7493326|FG000|NOT COMPLETED|Phase 2||3
6569983|NCT01848353|7493327|FG001|NOT COMPLETED|Phase 2||2
6249933|NCT04155840|7148167|FG000|STARTED|Overall Study||1
6249934|NCT04155840|7148167|FG000|COMPLETED|Overall Study||1
6249935|NCT04155840|7148167|FG000|NOT COMPLETED|Overall Study||0
6569984|NCT01848353|7493328|FG002|NOT COMPLETED|Phase 2||0
6249936|NCT03865316|7148171|FG000|STARTED|Overall Study||108
6569985|NCT01848353|7493329|FG003|NOT COMPLETED|Phase 2||0
6505796|NCT01456000|7425096|FG000|COMPLETED|Overall Study||170
6249982|NCT03593213|7148190|FG001|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||40
6249983|NCT03593213|7148191|FG002|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||33
6249984|NCT03593213|7148192|FG003|NOT COMPLETED|Double-blind Treatment Period (26 Weeks)||35
6277372|NCT00126555|7176810|FG000|Stratum 2- Unresectable|Overall Study||4
6277373|NCT00126555|7176810|FG000|COMPLETED|Overall Study||17
6277374|NCT00126555|7176810|FG000|NOT COMPLETED|Overall Study||6
6277375|NCT00126568|7176826|FG000|STARTED|Overall Study||20
6277376|NCT00126568|7176826|FG000|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
6277377|NCT00126568|7176826|FG000|NOT COMPLETED|Overall Study||2
6277378|NCT00126581|7176833|FG000|STARTED|Overall Study||81
6277379|NCT00126581|7176834|FG001|STARTED|Overall Study||100
6277380|NCT00126581|7176833|FG000|COMPLETED|Overall Study||68
6505797|NCT01456000|7425097|FG001|COMPLETED|Overall Study||172
6505798|NCT01456000|7425096|FG000|NOT COMPLETED|Overall Study||8
6569986|NCT01848353|7493326|FG000|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|5
6569987|NCT01848353|7493327|FG001|STARTED|Phase 3|31 participants from Phase 2 intervention (both groups) withdrew and did not complete Phase 3|10
6569988|NCT01848353|7493328|FG002|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
6569989|NCT01848353|7493329|FG003|STARTED|Phase 3|Normal weight participants only completed baseline testing in Phase 1.|0
6569990|NCT01848353|7493326|FG000|COMPLETED|Phase 3||4
6569991|NCT01848353|7493327|FG001|COMPLETED|Phase 3||9
6249985|NCT03349723|7148213|FG000|STARTED|Overall Study||6
6249986|NCT03349723|7148214|FG001|STARTED|Overall Study||6
6249987|NCT03349723|7148215|FG002|STARTED|Overall Study||6
6249988|NCT03349723|7148216|FG003|STARTED|Overall Study||6
6249989|NCT03349723|7148217|FG004|STARTED|Overall Study||6
6249990|NCT03349723|7148218|FG005|STARTED|Overall Study||6
6249991|NCT03349723|7148219|FG006|STARTED|Overall Study||6
6249992|NCT03349723|7148220|FG007|STARTED|Overall Study||14
6249993|NCT03349723|7148213|FG000|COMPLETED|Overall Study||6
6249994|NCT03349723|7148214|FG001|COMPLETED|Overall Study||6
6249995|NCT03349723|7148215|FG002|COMPLETED|Overall Study||6
6249996|NCT03349723|7148216|FG003|COMPLETED|Overall Study||6
6249997|NCT03349723|7148217|FG004|COMPLETED|Overall Study||6
6249998|NCT03349723|7148218|FG005|COMPLETED|Overall Study||6
6249999|NCT03349723|7148219|FG006|COMPLETED|Overall Study||6
6250000|NCT03349723|7148220|FG007|COMPLETED|Overall Study||14
6250001|NCT03349723|7148213|FG000|NOT COMPLETED|Overall Study||0
6250002|NCT03349723|7148214|FG001|NOT COMPLETED|Overall Study||0
6250003|NCT03349723|7148215|FG002|NOT COMPLETED|Overall Study||0
6250004|NCT03349723|7148216|FG003|NOT COMPLETED|Overall Study||0
6250005|NCT03349723|7148217|FG004|NOT COMPLETED|Overall Study||0
6250006|NCT03349723|7148218|FG005|NOT COMPLETED|Overall Study||0
6250007|NCT03349723|7148219|FG006|NOT COMPLETED|Overall Study||0
6250008|NCT03349723|7148220|FG007|NOT COMPLETED|Overall Study||0
6250009|NCT03248531|7148241|FG000|STARTED|Overall Study||22
6250010|NCT03248531|7148242|FG001|STARTED|Overall Study||22
6250011|NCT03248531|7148243|FG002|STARTED|Overall Study||46
6250012|NCT03248531|7148241|FG000|Completed Week 12|Overall Study||19
6250013|NCT03248531|7148242|FG001|Completed Week 12|Overall Study||18
6250014|NCT03248531|7148243|FG002|Completed Week 12|Overall Study||42
6250015|NCT03248531|7148241|FG000|COMPLETED|Overall Study||18
6569992|NCT01848353|7493328|FG002|COMPLETED|Phase 3||0
6569993|NCT01848353|7493329|FG003|COMPLETED|Phase 3||0
6569994|NCT01848353|7493326|FG000|NOT COMPLETED|Phase 3||1
6569995|NCT01848353|7493327|FG001|NOT COMPLETED|Phase 3||1
6569996|NCT01848353|7493328|FG002|NOT COMPLETED|Phase 3||0
6250016|NCT03248531|7148242|FG001|COMPLETED|Overall Study||17
6250017|NCT03248531|7148243|FG002|COMPLETED|Overall Study||38
6250018|NCT03248531|7148241|FG000|NOT COMPLETED|Overall Study||4
6250019|NCT03248531|7148242|FG001|NOT COMPLETED|Overall Study||5
6250020|NCT03248531|7148243|FG002|NOT COMPLETED|Overall Study||8
6250021|NCT03205605|7148258|FG000|STARTED|Overall Study||13
6250022|NCT03205605|7148258|FG000|COMPLETED|Overall Study||12
6250023|NCT03205605|7148258|FG000|NOT COMPLETED|Overall Study||1
6250024|NCT02556736|7148268|FG000|STARTED|Overall Study||14
6250025|NCT02556736|7148268|FG000|COMPLETED|Overall Study||14
6250026|NCT02556736|7148268|FG000|NOT COMPLETED|Overall Study||0
6250027|NCT02484456|7148274|FG000|STARTED|First Treatment Period: Week 1||10
6250028|NCT02484456|7148275|FG001|STARTED|First Treatment Period: Week 1||9
6250029|NCT02484456|7148274|FG000|COMPLETED|First Treatment Period: Week 1||10
6250030|NCT02484456|7148275|FG001|COMPLETED|First Treatment Period: Week 1||9
6250031|NCT02484456|7148274|FG000|NOT COMPLETED|First Treatment Period: Week 1||0
6569997|NCT01848353|7493329|FG003|NOT COMPLETED|Phase 3||0
6569998|NCT01848366|7493347|FG000|STARTED|Overall Study||8
6569999|NCT01848366|7493347|FG000|COMPLETED|Overall Study||8
6570000|NCT01848366|7493347|FG000|NOT COMPLETED|Overall Study||0
6570001|NCT01848457|7493355|FG000|STARTED|Overall Study||4
6570002|NCT01848457|7493356|FG001|STARTED|Overall Study||3
6570003|NCT01848457|7493357|FG002|STARTED|Overall Study||3
6570004|NCT01848457|7493358|FG003|STARTED|Overall Study||3
6570005|NCT01848457|7493355|FG000|Baseline|Overall Study||4
6570006|NCT01848457|7493356|FG001|Baseline|Overall Study||3
6570007|NCT01848457|7493357|FG002|Baseline|Overall Study||3
6570008|NCT01848457|7493358|FG003|Baseline|Overall Study||3
6570009|NCT01848457|7493355|FG000|Cycle 1|Overall Study||4
6570010|NCT01848457|7493356|FG001|Cycle 1|Overall Study||3
6570011|NCT01848457|7493357|FG002|Cycle 1|Overall Study||3
6570012|NCT01848457|7493358|FG003|Cycle 1|Overall Study||3
6570013|NCT01848457|7493355|FG000|Cycle 2|Overall Study||3
6570014|NCT01848457|7493356|FG001|Cycle 2|Overall Study||3
6570015|NCT01848457|7493357|FG002|Cycle 2|Overall Study||3
6570016|NCT01848457|7493358|FG003|Cycle 2|Overall Study||3
6570017|NCT01848457|7493355|FG000|Cycle 3|Overall Study||3
6570018|NCT01848457|7493356|FG001|Cycle 3|Overall Study||3
6250032|NCT02484456|7148275|FG001|NOT COMPLETED|First Treatment Period: Week 1||0
6250033|NCT02484456|7148274|FG000|STARTED|First Treatment Period: Week 2||10
6570019|NCT01848457|7493357|FG002|Cycle 3|Overall Study||3
6570020|NCT01848457|7493358|FG003|Cycle 3|Overall Study||3
6570021|NCT01848457|7493355|FG000|Cycle 4|Overall Study||3
6570022|NCT01848457|7493356|FG001|Cycle 4|Overall Study||3
6570023|NCT01848457|7493357|FG002|Cycle 4|Overall Study||3
6570024|NCT01848457|7493358|FG003|Cycle 4|Overall Study||3
6570025|NCT01848457|7493355|FG000|COMPLETED|Overall Study||3
6570026|NCT01848457|7493356|FG001|COMPLETED|Overall Study||3
6570027|NCT01848457|7493357|FG002|COMPLETED|Overall Study||3
6570028|NCT01848457|7493358|FG003|COMPLETED|Overall Study||3
6570029|NCT01848457|7493355|FG000|NOT COMPLETED|Overall Study||1
6570030|NCT01848457|7493356|FG001|NOT COMPLETED|Overall Study||0
6570031|NCT01848457|7493357|FG002|NOT COMPLETED|Overall Study||0
6570032|NCT01848457|7493358|FG003|NOT COMPLETED|Overall Study||0
6570033|NCT01848483|7493378|FG000|STARTED|Overall Study||61
6570034|NCT01848483|7493379|FG001|STARTED|Overall Study||60
6570035|NCT01848483|7493378|FG000|COMPLETED|Overall Study||50
6570036|NCT01848483|7493379|FG001|COMPLETED|Overall Study||49
6570037|NCT01848483|7493378|FG000|NOT COMPLETED|Overall Study||11
6570038|NCT01848483|7493379|FG001|NOT COMPLETED|Overall Study||11
6570039|NCT01848756|7493386|FG000|STARTED|Overall Study||15
6570040|NCT01848756|7493386|FG000|COMPLETED|Overall Study|Cycle 1|12
6570041|NCT01848756|7493386|FG000|NOT COMPLETED|Overall Study||3
6570042|NCT01848821|7493393|FG000|STARTED|Overall Study||7
6570043|NCT01848821|7493394|FG001|STARTED|Overall Study||7
6570044|NCT01848821|7493393|FG000|COMPLETED|Overall Study||7
6570045|NCT01848821|7493394|FG001|COMPLETED|Overall Study||7
6570046|NCT01848821|7493393|FG000|NOT COMPLETED|Overall Study||0
6570047|NCT01848821|7493394|FG001|NOT COMPLETED|Overall Study||0
6570048|NCT01848834|7493405|FG000|STARTED|Overall Study||32
6570049|NCT01848834|7493406|FG001|STARTED|Overall Study||61
6570050|NCT01848834|7493407|FG002|STARTED|Overall Study||33
6570051|NCT01848834|7493408|FG003|STARTED|Overall Study||39
6570052|NCT01848834|7493409|FG004|STARTED|Overall Study||132
6570053|NCT01848834|7493405|FG000|Treated|Overall Study||32
6570054|NCT01848834|7493406|FG001|Treated|Overall Study||60
6570055|NCT01848834|7493407|FG002|Treated|Overall Study||33
6570056|NCT01848834|7493408|FG003|Treated|Overall Study||39
6250034|NCT02484456|7148275|FG001|STARTED|First Treatment Period: Week 2||9
6250035|NCT02484456|7148274|FG000|COMPLETED|First Treatment Period: Week 2||10
6250036|NCT02484456|7148275|FG001|COMPLETED|First Treatment Period: Week 2||9
6570057|NCT01848834|7493409|FG004|Treated|Overall Study||132
6570058|NCT01848834|7493405|FG000|COMPLETED|Overall Study|Completed means two-year treatment completed|13
6570059|NCT01848834|7493406|FG001|COMPLETED|Overall Study|Completed means two-year treatment completed|13
6657993|NCT02475031|7588508|FG000|COMPLETED|Overall Study||35
6250037|NCT02484456|7148274|FG000|NOT COMPLETED|First Treatment Period: Week 2||0
6250038|NCT02484456|7148275|FG001|NOT COMPLETED|First Treatment Period: Week 2||0
6250039|NCT02484456|7148274|FG000|STARTED|Washout Period||10
6250040|NCT02484456|7148275|FG001|STARTED|Washout Period||9
6250041|NCT02484456|7148274|FG000|COMPLETED|Washout Period||10
6250042|NCT02484456|7148275|FG001|COMPLETED|Washout Period||8
6250043|NCT02484456|7148274|FG000|NOT COMPLETED|Washout Period||0
6250044|NCT02484456|7148275|FG001|NOT COMPLETED|Washout Period||1
6250045|NCT02484456|7148274|FG000|STARTED|Second Treatment Period: Week 1||10
6250046|NCT02484456|7148275|FG001|STARTED|Second Treatment Period: Week 1||8
6250047|NCT02484456|7148274|FG000|COMPLETED|Second Treatment Period: Week 1||9
6250048|NCT02484456|7148275|FG001|COMPLETED|Second Treatment Period: Week 1||7
6250049|NCT02484456|7148274|FG000|NOT COMPLETED|Second Treatment Period: Week 1||1
6250050|NCT02484456|7148275|FG001|NOT COMPLETED|Second Treatment Period: Week 1||1
6250051|NCT02484456|7148274|FG000|STARTED|Second Treatment Period: Week 2||9
6250052|NCT02484456|7148275|FG001|STARTED|Second Treatment Period: Week 2||7
6250053|NCT02484456|7148274|FG000|COMPLETED|Second Treatment Period: Week 2||9
6250054|NCT02484456|7148275|FG001|COMPLETED|Second Treatment Period: Week 2||6
6250055|NCT02484456|7148274|FG000|NOT COMPLETED|Second Treatment Period: Week 2||0
6250056|NCT02484456|7148275|FG001|NOT COMPLETED|Second Treatment Period: Week 2||1
6250057|NCT02481830|7148284|FG000|STARTED|Overall Study||284
6250058|NCT02481830|7148285|FG001|STARTED|Overall Study||285
6250059|NCT02481830|7148284|FG000|COMPLETED|Overall Study||282
6250060|NCT02481830|7148285|FG001|COMPLETED|Overall Study||265
6250061|NCT02481830|7148284|FG000|NOT COMPLETED|Overall Study||2
6250062|NCT02481830|7148285|FG001|NOT COMPLETED|Overall Study||20
6250063|NCT02234323|7148291|FG000|STARTED|All Enrolled||108
6250064|NCT02234323|7148291|FG000|COMPLETED|All Enrolled|These participants received at least one dose of study drug.|103
6250065|NCT02234323|7148291|FG000|NOT COMPLETED|All Enrolled||5
6250066|NCT02234323|7148291|FG000|STARTED|All Treated||103
6250067|NCT02234323|7148291|FG000|Episodic Treatment Regimen|All Treated|Participants were treated in more than one regimen and counted in all categories wherever applicable|81
6250068|NCT02234323|7148291|FG000|Prophylactic Treatment Regimen|All Treated|69 participants among the 81 who started in episodic regimen, switched to the prophylactic regimen.|89
6250069|NCT02234323|7148291|FG000|Immune Tolerance Induction (ITI)|All Treated|1/81 on episodic and 14/89 on prophylactic regimen had inhibitors and were switched directly to ITI.|15
6250070|NCT02234323|7148291|FG000|COMPLETED|All Treated||85
6250071|NCT02234323|7148291|FG000|NOT COMPLETED|All Treated||18
6250072|NCT02220855|7148297|FG000|STARTED|Overall Study||14
6250073|NCT02220855|7148297|FG000|COMPLETED|Overall Study||0
6250074|NCT02220855|7148297|FG000|NOT COMPLETED|Overall Study||14
6277381|NCT00126581|7176834|FG001|COMPLETED|Overall Study||80
6277382|NCT00126581|7176833|FG000|NOT COMPLETED|Overall Study||13
6277383|NCT00126581|7176834|FG001|NOT COMPLETED|Overall Study||20
6277384|NCT00126594|7176844|FG000|STARTED|Overall Study||40
6277385|NCT00126594|7176845|FG001|STARTED|Overall Study||40
6277386|NCT00126594|7176844|FG000|COMPLETED|Overall Study||1
6277387|NCT00126594|7176845|FG001|COMPLETED|Overall Study||3
6277388|NCT00126594|7176844|FG000|NOT COMPLETED|Overall Study||39
6277389|NCT00126594|7176845|FG001|NOT COMPLETED|Overall Study||37
6277390|NCT00126737|7176856|FG000|STARTED|Overall Study||28
6277391|NCT00126737|7176857|FG001|STARTED|Overall Study||27
6277392|NCT00126737|7176858|FG002|STARTED|Overall Study||30
6277393|NCT00126737|7176859|FG003|STARTED|Overall Study||25
6277394|NCT00126737|7176856|FG000|COMPLETED|Overall Study||22
6277395|NCT00126737|7176857|FG001|COMPLETED|Overall Study||24
6277396|NCT00126737|7176858|FG002|COMPLETED|Overall Study||24
6277397|NCT00126737|7176859|FG003|COMPLETED|Overall Study||18
6277398|NCT00126737|7176856|FG000|NOT COMPLETED|Overall Study||6
6277399|NCT00126737|7176857|FG001|NOT COMPLETED|Overall Study||3
6277400|NCT00126737|7176858|FG002|NOT COMPLETED|Overall Study||6
6277401|NCT00126737|7176859|FG003|NOT COMPLETED|Overall Study||7
6277402|NCT00126750|7176874|FG000|STARTED|Overall Study|Number of providers from 84 clinics|385
6277403|NCT00126750|7176875|FG001|STARTED|Overall Study|Number of providers from 84 clinics|462
6277404|NCT00126750|7176874|FG000|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
6277405|NCT00126750|7176875|FG001|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
6277406|NCT00126750|7176874|FG000|NOT COMPLETED|Overall Study||180
6277407|NCT00126750|7176875|FG001|NOT COMPLETED|Overall Study||266
6277408|NCT00127036|7176883|FG000|STARTED|Overall Study||34
6277409|NCT00127036|7176884|FG001|STARTED|Overall Study||31
6277410|NCT00127036|7176883|FG000|COMPLETED|Overall Study|26 Participants were evaluable.|26
6277411|NCT00127036|7176884|FG001|COMPLETED|Overall Study|20 Participants were evaluable.|20
6277412|NCT00127036|7176883|FG000|NOT COMPLETED|Overall Study||8
6277413|NCT00127036|7176884|FG001|NOT COMPLETED|Overall Study||11
6277414|NCT00127062|7176892|FG000|STARTED|First intervention_Oxford Street||31
6277415|NCT00127062|7176893|FG001|STARTED|First intervention_Oxford Street||29
6277416|NCT00127062|7176892|FG000|COMPLETED|First intervention_Oxford Street||31
6277417|NCT00127062|7176893|FG001|COMPLETED|First intervention_Oxford Street||29
6277418|NCT00127062|7176892|FG000|NOT COMPLETED|First intervention_Oxford Street||0
6277419|NCT00127062|7176893|FG001|NOT COMPLETED|First intervention_Oxford Street||0
6277420|NCT00127062|7176892|FG000|STARTED|Second intervention_Hyde Park||31
6277421|NCT00127062|7176893|FG001|STARTED|Second intervention_Hyde Park||29
6277422|NCT00127062|7176892|FG000|COMPLETED|Second intervention_Hyde Park||31
6277423|NCT00127062|7176893|FG001|COMPLETED|Second intervention_Hyde Park||29
6277424|NCT00127062|7176892|FG000|NOT COMPLETED|Second intervention_Hyde Park||0
6277425|NCT00127062|7176893|FG001|NOT COMPLETED|Second intervention_Hyde Park||0
6277426|NCT00127101|7176909|FG000|STARTED|Base Protocol||3
6277427|NCT00127101|7176910|FG001|STARTED|Base Protocol||5
6277428|NCT00127101|7176911|FG002|STARTED|Base Protocol||3
6277429|NCT00127101|7176912|FG003|STARTED|Base Protocol||3
6277430|NCT00127101|7176913|FG004|STARTED|Base Protocol||5
6277431|NCT00127101|7176914|FG005|STARTED|Base Protocol||4
6277432|NCT00127101|7176909|FG000|COMPLETED|Base Protocol||1
6277433|NCT00127101|7176910|FG001|COMPLETED|Base Protocol||1
6277434|NCT00127101|7176911|FG002|COMPLETED|Base Protocol||1
6657994|NCT02475031|7588509|FG001|COMPLETED|Overall Study||35
6657995|NCT02475031|7588508|FG000|NOT COMPLETED|Overall Study||0
6657996|NCT02475031|7588509|FG001|NOT COMPLETED|Overall Study||0
6657997|NCT02475070|7588519|FG000|STARTED|Overall Study||17
6657998|NCT02475070|7588520|FG001|STARTED|Overall Study||11
6657999|NCT02475070|7588519|FG000|COMPLETED|Overall Study||17
6250110|NCT01791595|7148349|FG000|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
6250111|NCT01791595|7148350|FG001|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250112|NCT01791595|7148351|FG002|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250113|NCT01791595|7148352|FG003|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250114|NCT01791595|7148353|FG004|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250115|NCT01791595|7148354|FG005|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250116|NCT01791595|7148355|FG006|STARTED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250117|NCT01791595|7148349|FG000|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250118|NCT01791595|7148350|FG001|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250119|NCT01791595|7148351|FG002|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250120|NCT01791595|7148352|FG003|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250121|NCT01791595|7148353|FG004|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250122|NCT01791595|7148354|FG005|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250123|NCT01791595|7148355|FG006|COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250124|NCT01791595|7148349|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||3
6250125|NCT01791595|7148350|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250126|NCT01791595|7148351|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250127|NCT01791595|7148352|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250128|NCT01791595|7148353|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250129|NCT01791595|7148354|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250130|NCT01791595|7148355|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 1 (5 mg OD)||0
6250131|NCT01791595|7148349|FG000|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250132|NCT01791595|7148350|FG001|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
6250133|NCT01791595|7148351|FG002|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250134|NCT01791595|7148352|FG003|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250135|NCT01791595|7148353|FG004|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250136|NCT01791595|7148354|FG005|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250137|NCT01791595|7148355|FG006|STARTED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250138|NCT01791595|7148349|FG000|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250139|NCT01791595|7148350|FG001|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250140|NCT01791595|7148351|FG002|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250141|NCT01791595|7148352|FG003|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250142|NCT01791595|7148353|FG004|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250143|NCT01791595|7148354|FG005|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250144|NCT01791595|7148355|FG006|COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250145|NCT01791595|7148349|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250146|NCT01791595|7148350|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||5
6250147|NCT01791595|7148351|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6570060|NCT01848834|7493407|FG002|COMPLETED|Overall Study|Completed means two-year treatment completed|9
6570061|NCT01848834|7493408|FG003|COMPLETED|Overall Study|Completed means two-year treatment completed|13
6570062|NCT01848834|7493409|FG004|COMPLETED|Overall Study|Completed means two-year treatment completed|38
6250148|NCT01791595|7148352|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250149|NCT01791595|7148353|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250150|NCT01791595|7148354|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250151|NCT01791595|7148355|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 2 (10 mg OD)||0
6250152|NCT01791595|7148349|FG000|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250153|NCT01791595|7148350|FG001|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250154|NCT01791595|7148351|FG002|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
6250155|NCT01791595|7148352|FG003|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250156|NCT01791595|7148353|FG004|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250157|NCT01791595|7148354|FG005|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250158|NCT01791595|7148355|FG006|STARTED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250159|NCT01791595|7148349|FG000|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250160|NCT01791595|7148350|FG001|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250161|NCT01791595|7148351|FG002|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250162|NCT01791595|7148352|FG003|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250163|NCT01791595|7148353|FG004|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250164|NCT01791595|7148354|FG005|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250165|NCT01791595|7148355|FG006|COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250166|NCT01791595|7148349|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250167|NCT01791595|7148350|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250168|NCT01791595|7148351|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||8
6250169|NCT01791595|7148352|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250170|NCT01791595|7148353|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250171|NCT01791595|7148354|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250172|NCT01791595|7148355|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 3 (20 mg OD)||0
6250173|NCT01791595|7148349|FG000|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250174|NCT01791595|7148350|FG001|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250175|NCT01791595|7148351|FG002|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250176|NCT01791595|7148352|FG003|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||5
6250177|NCT01791595|7148353|FG004|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250178|NCT01791595|7148354|FG005|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250179|NCT01791595|7148355|FG006|STARTED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6570063|NCT01848834|7493405|FG000|NOT COMPLETED|Overall Study||19
6277435|NCT00127101|7176912|FG003|COMPLETED|Base Protocol||3
6250180|NCT01791595|7148349|FG000|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6505799|NCT01456000|7425097|FG001|NOT COMPLETED|Overall Study||3
6505800|NCT01456039|7425106|FG000|STARTED|Phase 1 (First Step)||3
6505801|NCT01456039|7425107|FG001|STARTED|Phase 1 (First Step)||8
6505802|NCT01456039|7425108|FG002|STARTED|Phase 1 (First Step)||0
6505803|NCT01456039|7425106|FG000|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
6505804|NCT01456039|7425107|FG001|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
6505805|NCT01456039|7425108|FG002|COMPLETED|Phase 1 (First Step)||0
6505806|NCT01456039|7425106|FG000|NOT COMPLETED|Phase 1 (First Step)||2
6505807|NCT01456039|7425107|FG001|NOT COMPLETED|Phase 1 (First Step)||7
6505808|NCT01456039|7425108|FG002|NOT COMPLETED|Phase 1 (First Step)||0
6505809|NCT01456039|7425106|FG000|STARTED|Phase 2 (Second Step)||0
6505810|NCT01456039|7425107|FG001|STARTED|Phase 2 (Second Step)||0
6505811|NCT01456039|7425108|FG002|STARTED|Phase 2 (Second Step)||40
6505812|NCT01456039|7425106|FG000|COMPLETED|Phase 2 (Second Step)||0
6505813|NCT01456039|7425107|FG001|COMPLETED|Phase 2 (Second Step)||0
6505814|NCT01456039|7425108|FG002|COMPLETED|Phase 2 (Second Step)||7
6505815|NCT01456039|7425106|FG000|NOT COMPLETED|Phase 2 (Second Step)||0
6505816|NCT01456039|7425107|FG001|NOT COMPLETED|Phase 2 (Second Step)||0
6505817|NCT01456039|7425108|FG002|NOT COMPLETED|Phase 2 (Second Step)||33
6250181|NCT01791595|7148350|FG001|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250182|NCT01791595|7148351|FG002|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250183|NCT01791595|7148352|FG003|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||1
6250184|NCT01791595|7148353|FG004|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250185|NCT01791595|7148354|FG005|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250186|NCT01791595|7148355|FG006|COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250187|NCT01791595|7148349|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250188|NCT01791595|7148350|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250189|NCT01791595|7148351|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250190|NCT01791595|7148352|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||4
6250191|NCT01791595|7148353|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250192|NCT01791595|7148354|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250193|NCT01791595|7148355|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 4 (30 mg OD)||0
6250194|NCT01791595|7148349|FG000|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250195|NCT01791595|7148350|FG001|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250196|NCT01791595|7148351|FG002|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250197|NCT01791595|7148352|FG003|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250198|NCT01791595|7148353|FG004|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
6250199|NCT01791595|7148354|FG005|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250200|NCT01791595|7148355|FG006|STARTED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250201|NCT01791595|7148349|FG000|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250202|NCT01791595|7148350|FG001|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250203|NCT01791595|7148351|FG002|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250204|NCT01791595|7148352|FG003|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250205|NCT01791595|7148353|FG004|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250206|NCT01791595|7148354|FG005|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250207|NCT01791595|7148355|FG006|COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250208|NCT01791595|7148349|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250209|NCT01791595|7148350|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250210|NCT01791595|7148351|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250211|NCT01791595|7148352|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250212|NCT01791595|7148353|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||11
6250213|NCT01791595|7148354|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250214|NCT01791595|7148355|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 5 (15 mg BD)||0
6250215|NCT01791595|7148349|FG000|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250216|NCT01791595|7148350|FG001|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250217|NCT01791595|7148351|FG002|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250218|NCT01791595|7148352|FG003|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250219|NCT01791595|7148353|FG004|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250220|NCT01791595|7148354|FG005|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
6250221|NCT01791595|7148355|FG006|STARTED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250222|NCT01791595|7148349|FG000|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250223|NCT01791595|7148350|FG001|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250224|NCT01791595|7148351|FG002|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250225|NCT01791595|7148352|FG003|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250226|NCT01791595|7148353|FG004|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250227|NCT01791595|7148354|FG005|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250228|NCT01791595|7148355|FG006|COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250229|NCT01791595|7148349|FG000|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250230|NCT01791595|7148350|FG001|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250231|NCT01791595|7148351|FG002|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250232|NCT01791595|7148352|FG003|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250233|NCT01791595|7148353|FG004|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250234|NCT01791595|7148354|FG005|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||8
6250235|NCT01791595|7148355|FG006|NOT COMPLETED|Part 1 AZD3965 Cohort 6 (10 mg BD)||0
6250236|NCT01791595|7148349|FG000|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250237|NCT01791595|7148350|FG001|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250238|NCT01791595|7148351|FG002|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250239|NCT01791595|7148352|FG003|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250240|NCT01791595|7148353|FG004|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250241|NCT01791595|7148354|FG005|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250242|NCT01791595|7148355|FG006|STARTED|Part 2 AZD3965 Expansion (10 mg BD)||11
6250243|NCT01791595|7148349|FG000|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250244|NCT01791595|7148350|FG001|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6505818|NCT01456052|7425127|FG000|STARTED|Overall Study||10
6505819|NCT01456052|7425128|FG001|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
6505820|NCT01456052|7425129|FG002|STARTED|Overall Study||24
6505821|NCT01456052|7425127|FG000|COMPLETED|Overall Study||8
6505822|NCT01456052|7425128|FG001|COMPLETED|Overall Study||20
6505823|NCT01456052|7425129|FG002|COMPLETED|Overall Study||19
6505824|NCT01456052|7425127|FG000|NOT COMPLETED|Overall Study||2
6505825|NCT01456052|7425128|FG001|NOT COMPLETED|Overall Study||5
6505826|NCT01456052|7425129|FG002|NOT COMPLETED|Overall Study||5
6505827|NCT01456130|7425138|FG000|STARTED|Overall Study||67
6505828|NCT01456130|7425138|FG000|COMPLETED|Overall Study||57
6505829|NCT01456130|7425138|FG000|NOT COMPLETED|Overall Study||10
6505830|NCT01456143|7425142|FG000|STARTED|Overall Study||33
6505831|NCT01456143|7425142|FG000|COMPLETED|Overall Study||33
6505832|NCT01456143|7425142|FG000|NOT COMPLETED|Overall Study||0
6505833|NCT01456169|7425149|FG000|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
6505834|NCT01456169|7425150|FG001|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
6505835|NCT01456169|7425151|FG002|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
6505836|NCT01456169|7425149|FG000|COMPLETED|Overall Study||123
6505837|NCT01456169|7425150|FG001|COMPLETED|Overall Study||122
6505838|NCT01456169|7425151|FG002|COMPLETED|Overall Study||123
6505839|NCT01456169|7425149|FG000|NOT COMPLETED|Overall Study||10
6505840|NCT01456169|7425150|FG001|NOT COMPLETED|Overall Study||5
6505841|NCT01456169|7425151|FG002|NOT COMPLETED|Overall Study||12
6505842|NCT01456195|7425163|FG000|STARTED|Overall Study||143
6505843|NCT01456195|7425164|FG001|STARTED|Overall Study||137
6505844|NCT01456195|7425165|FG002|STARTED|Overall Study||141
6505845|NCT01456195|7425163|FG000|COMPLETED|Overall Study||132
6505846|NCT01456195|7425164|FG001|COMPLETED|Overall Study||127
6505847|NCT01456195|7425165|FG002|COMPLETED|Overall Study||127
6505848|NCT01456195|7425163|FG000|NOT COMPLETED|Overall Study||11
6505849|NCT01456195|7425164|FG001|NOT COMPLETED|Overall Study||10
6505850|NCT01456195|7425165|FG002|NOT COMPLETED|Overall Study||14
6505851|NCT01456221|7425175|FG000|STARTED|Overall Study||183
6505852|NCT01456221|7425176|FG001|STARTED|Overall Study||183
6505853|NCT01456221|7425175|FG000|COMPLETED|Overall Study||119
6505854|NCT01456221|7425176|FG001|COMPLETED|Overall Study||126
6505855|NCT01456221|7425175|FG000|NOT COMPLETED|Overall Study||64
6505856|NCT01456221|7425176|FG001|NOT COMPLETED|Overall Study||57
6505857|NCT01456299|7425185|FG000|STARTED|Overall Study||34
6505858|NCT01456299|7425186|FG001|STARTED|Overall Study||34
6505859|NCT01456299|7425187|FG002|STARTED|Overall Study||34
6505860|NCT01456299|7425185|FG000|COMPLETED|Overall Study||34
6505861|NCT01456299|7425186|FG001|COMPLETED|Overall Study||33
6505862|NCT01456299|7425187|FG002|COMPLETED|Overall Study||33
6505863|NCT01456299|7425185|FG000|NOT COMPLETED|Overall Study||0
6570064|NCT01848834|7493406|FG001|NOT COMPLETED|Overall Study||48
6570065|NCT01848834|7493407|FG002|NOT COMPLETED|Overall Study||24
6570066|NCT01848834|7493408|FG003|NOT COMPLETED|Overall Study||26
6570067|NCT01848834|7493409|FG004|NOT COMPLETED|Overall Study||94
6570068|NCT01848847|7493427|FG000|STARTED|Overall Study||51
6570069|NCT01848847|7493428|FG001|STARTED|Overall Study||51
6570070|NCT01848847|7493427|FG000|COMPLETED|Overall Study||49
6570071|NCT01848847|7493428|FG001|COMPLETED|Overall Study||48
6570072|NCT01848847|7493427|FG000|NOT COMPLETED|Overall Study||2
6570073|NCT01848847|7493428|FG001|NOT COMPLETED|Overall Study||3
6570074|NCT01848899|7493436|FG000|STARTED|Overall Study||50
6658000|NCT02475070|7588520|FG001|COMPLETED|Overall Study||11
6505864|NCT01456299|7425186|FG001|NOT COMPLETED|Overall Study||1
6505865|NCT01456299|7425187|FG002|NOT COMPLETED|Overall Study||1
6505866|NCT01456494|7425197|FG000|STARTED|Initial Inpatient Visit||24
6570075|NCT01848899|7493437|FG001|STARTED|Overall Study||50
6570076|NCT01848899|7493436|FG000|COMPLETED|Overall Study||50
6658001|NCT02475070|7588519|FG000|NOT COMPLETED|Overall Study||0
6658002|NCT02475070|7588520|FG001|NOT COMPLETED|Overall Study||0
6658003|NCT02475265|7588527|FG000|STARTED|Overall Study||11
6658004|NCT02475265|7588527|FG000|COMPLETED|Overall Study||8
6658005|NCT02475265|7588527|FG000|NOT COMPLETED|Overall Study||3
6658006|NCT02475278|7588531|FG000|STARTED|Overall Study||50
6658007|NCT02475278|7588531|FG000|COMPLETED|Overall Study||48
6658008|NCT02475278|7588531|FG000|NOT COMPLETED|Overall Study||2
6658009|NCT02475369|7588535|FG000|STARTED|Run-in Washout Period #1 (7 Days)||10
6658010|NCT02475369|7588536|FG001|STARTED|Run-in Washout Period #1 (7 Days)||11
6658011|NCT02475369|7588535|FG000|COMPLETED|Run-in Washout Period #1 (7 Days)||3
6658012|NCT02475369|7588536|FG001|COMPLETED|Run-in Washout Period #1 (7 Days)||9
6658013|NCT02475369|7588535|FG000|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||7
6658014|NCT02475369|7588536|FG001|NOT COMPLETED|Run-in Washout Period #1 (7 Days)||2
6658015|NCT02475369|7588535|FG000|STARTED|Treatment Period #1 (10 Days)||3
6658016|NCT02475369|7588536|FG001|STARTED|Treatment Period #1 (10 Days)||9
6505867|NCT01456494|7425198|FG001|STARTED|Initial Inpatient Visit||26
6505868|NCT01456494|7425197|FG000|COMPLETED|Initial Inpatient Visit||24
6505869|NCT01456494|7425198|FG001|COMPLETED|Initial Inpatient Visit||26
6505870|NCT01456494|7425197|FG000|NOT COMPLETED|Initial Inpatient Visit||0
6505871|NCT01456494|7425198|FG001|NOT COMPLETED|Initial Inpatient Visit||0
6570077|NCT01848899|7493437|FG001|COMPLETED|Overall Study||50
6570078|NCT01848899|7493436|FG000|NOT COMPLETED|Overall Study||0
6250245|NCT01791595|7148351|FG002|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250246|NCT01791595|7148352|FG003|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250247|NCT01791595|7148353|FG004|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250248|NCT01791595|7148354|FG005|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250249|NCT01791595|7148355|FG006|COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||1
6250250|NCT01791595|7148349|FG000|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250251|NCT01791595|7148350|FG001|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250252|NCT01791595|7148351|FG002|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250253|NCT01791595|7148352|FG003|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250254|NCT01791595|7148353|FG004|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250255|NCT01791595|7148354|FG005|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||0
6250256|NCT01791595|7148355|FG006|NOT COMPLETED|Part 2 AZD3965 Expansion (10 mg BD)||10
6250257|NCT01192776|7148379|FG000|STARTED|Overall Study||95
6250258|NCT01192776|7148380|FG001|STARTED|Overall Study||90
6250259|NCT01192776|7148381|FG002|STARTED|Overall Study||96
6250260|NCT01192776|7148382|FG003|STARTED|Overall Study||83
6250261|NCT01192776|7148379|FG000|Died Prior to Discharge|Overall Study||7
6250262|NCT01192776|7148380|FG001|Died Prior to Discharge|Overall Study||13
6250263|NCT01192776|7148381|FG002|Died Prior to Discharge|Overall Study||15
6250264|NCT01192776|7148382|FG003|Died Prior to Discharge|Overall Study||14
6250265|NCT01192776|7148379|FG000|Died After Discharge|Overall Study||1
6250266|NCT01192776|7148380|FG001|Died After Discharge|Overall Study||2
6250267|NCT01192776|7148381|FG002|Died After Discharge|Overall Study||3
6250268|NCT01192776|7148382|FG003|Died After Discharge|Overall Study||1
6250269|NCT01192776|7148379|FG000|COMPLETED|Overall Study||84
6250270|NCT01192776|7148380|FG001|COMPLETED|Overall Study||69
6250271|NCT01192776|7148381|FG002|COMPLETED|Overall Study||75
6250272|NCT01192776|7148382|FG003|COMPLETED|Overall Study||63
6250273|NCT01192776|7148379|FG000|NOT COMPLETED|Overall Study||11
6250274|NCT01192776|7148380|FG001|NOT COMPLETED|Overall Study||21
6250275|NCT01192776|7148381|FG002|NOT COMPLETED|Overall Study||21
6250276|NCT01192776|7148382|FG003|NOT COMPLETED|Overall Study||20
6250277|NCT01030575|7148398|FG000|STARTED|Overall Study||29
6250278|NCT01030575|7148399|FG001|STARTED|Overall Study||30
6250279|NCT01030575|7148400|FG002|STARTED|Overall Study||28
6250280|NCT01030575|7148401|FG003|STARTED|Overall Study||35
6250281|NCT01030575|7148398|FG000|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|29
6250282|NCT01030575|7148399|FG001|COMPLETED|Overall Study||30
6250283|NCT01030575|7148400|FG002|COMPLETED|Overall Study||28
6277436|NCT00127101|7176913|FG004|COMPLETED|Base Protocol||3
6277437|NCT00127101|7176914|FG005|COMPLETED|Base Protocol||3
6277438|NCT00127101|7176909|FG000|NOT COMPLETED|Base Protocol||2
6570079|NCT01848899|7493437|FG001|NOT COMPLETED|Overall Study||0
6570080|NCT01848938|7493445|FG000|STARTED|Overall Study||62
6570081|NCT01848938|7493446|FG001|STARTED|Overall Study||61
6250284|NCT01030575|7148401|FG003|COMPLETED|Overall Study|1 infant randomized to the placebo arm incorrectly received the low dose. The infant was included in the low dose arm for the pharmacokinetics analyses and as randomized to the placebo arm for all other analyzes.|35
6250285|NCT01030575|7148398|FG000|NOT COMPLETED|Overall Study||0
6250286|NCT01030575|7148399|FG001|NOT COMPLETED|Overall Study||0
6250287|NCT01030575|7148400|FG002|NOT COMPLETED|Overall Study||0
6250288|NCT01030575|7148401|FG003|NOT COMPLETED|Overall Study||0
6250289|NCT00089791|7148414|FG000|STARTED|Overall Study||3906
6250290|NCT00089791|7148415|FG001|STARTED|Overall Study||3902
6250291|NCT00089791|7148414|FG000|Received Study Medication|Overall Study||3883
6250292|NCT00089791|7148415|FG001|Received Study Medication|Overall Study||3879
6250293|NCT00089791|7148414|FG000|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
6250294|NCT00089791|7148415|FG001|Safety Analysis Set|Overall Study||3886
6250295|NCT00089791|7148414|FG000|COMPLETED|Overall Study||3206
6250296|NCT00089791|7148415|FG001|COMPLETED|Overall Study||3272
6250297|NCT00089791|7148414|FG000|NOT COMPLETED|Overall Study||700
6250298|NCT00089791|7148415|FG001|NOT COMPLETED|Overall Study||630
6277439|NCT00127101|7176910|FG001|NOT COMPLETED|Base Protocol||4
6277440|NCT00127101|7176911|FG002|NOT COMPLETED|Base Protocol||2
6277441|NCT00127101|7176912|FG003|NOT COMPLETED|Base Protocol||0
6277442|NCT00127101|7176913|FG004|NOT COMPLETED|Base Protocol||2
6277443|NCT00127101|7176914|FG005|NOT COMPLETED|Base Protocol||1
6277444|NCT00127101|7176909|FG000|STARTED|Continuation Phase||0
6277445|NCT00127101|7176910|FG001|STARTED|Continuation Phase||0
6277446|NCT00127101|7176911|FG002|STARTED|Continuation Phase||1
6277447|NCT00127101|7176912|FG003|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
6277448|NCT00127101|7176913|FG004|STARTED|Continuation Phase||3
6277449|NCT00127101|7176914|FG005|STARTED|Continuation Phase||3
6277450|NCT00127101|7176909|FG000|COMPLETED|Continuation Phase||0
6277451|NCT00127101|7176910|FG001|COMPLETED|Continuation Phase||0
6277452|NCT00127101|7176911|FG002|COMPLETED|Continuation Phase||0
6277453|NCT00127101|7176912|FG003|COMPLETED|Continuation Phase||0
6277454|NCT00127101|7176913|FG004|COMPLETED|Continuation Phase||0
6277455|NCT00127101|7176914|FG005|COMPLETED|Continuation Phase||0
6277456|NCT00127101|7176909|FG000|NOT COMPLETED|Continuation Phase||0
6277457|NCT00127101|7176910|FG001|NOT COMPLETED|Continuation Phase||0
6277458|NCT00127101|7176911|FG002|NOT COMPLETED|Continuation Phase||1
6277459|NCT00127101|7176912|FG003|NOT COMPLETED|Continuation Phase||0
6277460|NCT00127101|7176913|FG004|NOT COMPLETED|Continuation Phase||3
6277461|NCT00127101|7176914|FG005|NOT COMPLETED|Continuation Phase||3
6505872|NCT01456494|7425197|FG000|STARTED|Follow-Up Visit (Post 30-day Discharge)||24
6505873|NCT01456494|7425198|FG001|STARTED|Follow-Up Visit (Post 30-day Discharge)||26
6505874|NCT01456494|7425197|FG000|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||19
6505875|NCT01456494|7425198|FG001|COMPLETED|Follow-Up Visit (Post 30-day Discharge)||20
6505876|NCT01456494|7425197|FG000|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||5
6505877|NCT01456494|7425198|FG001|NOT COMPLETED|Follow-Up Visit (Post 30-day Discharge)||6
6505878|NCT01456780|7425207|FG000|STARTED|Overall Study||20
6277462|NCT00127166|7176930|FG000|STARTED|Period I||78
6277463|NCT00127166|7176931|FG001|STARTED|Period I||76
6277464|NCT00127166|7176930|FG000|COMPLETED|Period I||75
6277465|NCT00127166|7176931|FG001|COMPLETED|Period I||74
6277466|NCT00127166|7176930|FG000|NOT COMPLETED|Period I||3
6505879|NCT01456780|7425208|FG001|STARTED|Overall Study||20
6505880|NCT01456780|7425209|FG002|STARTED|Overall Study||20
6250299|NCT03376789|7148423|FG000|STARTED|Overall Study||108
6250300|NCT03376789|7148424|FG001|STARTED|Overall Study||111
6250301|NCT03376789|7148423|FG000|COMPLETED|Overall Study||103
6250302|NCT03376789|7148424|FG001|COMPLETED|Overall Study||102
6250303|NCT03376789|7148423|FG000|NOT COMPLETED|Overall Study||5
6250304|NCT03376789|7148424|FG001|NOT COMPLETED|Overall Study||9
6250305|NCT03342742|7148432|FG000|STARTED|Overall Study||15
6250306|NCT03342742|7148433|FG001|STARTED|Overall Study||13
6250307|NCT03342742|7148432|FG000|COMPLETED|Overall Study||13
6250308|NCT03342742|7148433|FG001|COMPLETED|Overall Study||11
6250309|NCT03342742|7148432|FG000|NOT COMPLETED|Overall Study||2
6250310|NCT03342742|7148433|FG001|NOT COMPLETED|Overall Study||2
6250311|NCT03333590|7148443|FG000|STARTED|Overall Study||1
6250312|NCT03333590|7148444|FG001|STARTED|Overall Study||1
6250313|NCT03333590|7148443|FG000|COMPLETED|Overall Study||1
6250314|NCT03333590|7148444|FG001|COMPLETED|Overall Study||1
6250315|NCT03333590|7148443|FG000|NOT COMPLETED|Overall Study||0
6250316|NCT03333590|7148444|FG001|NOT COMPLETED|Overall Study||0
6250317|NCT03290326|7148452|FG000|STARTED|Overall Study||10
6250318|NCT03290326|7148452|FG000|COMPLETED|Overall Study||10
6250319|NCT03290326|7148452|FG000|NOT COMPLETED|Overall Study||0
6250320|NCT03272711|7148460|FG000|STARTED|Overall Study||51
6250321|NCT03272711|7148461|FG001|STARTED|Overall Study||49
6250322|NCT03272711|7148460|FG000|COMPLETED|Overall Study||44
6250323|NCT03272711|7148461|FG001|COMPLETED|Overall Study||41
6250324|NCT03272711|7148460|FG000|NOT COMPLETED|Overall Study||7
6250325|NCT03272711|7148461|FG001|NOT COMPLETED|Overall Study||8
6250326|NCT03246789|7148469|FG000|STARTED|Overall Study||24
6250327|NCT03246789|7148470|FG001|STARTED|Overall Study||15
6250328|NCT03246789|7148469|FG000|COMPLETED|Overall Study||24
6250329|NCT03246789|7148470|FG001|COMPLETED|Overall Study||15
6250330|NCT03246789|7148469|FG000|NOT COMPLETED|Overall Study||0
6250331|NCT03246789|7148470|FG001|NOT COMPLETED|Overall Study||0
6250332|NCT03241225|7148478|FG000|STARTED|Overall Study||24
6250333|NCT03241225|7148479|FG001|STARTED|Overall Study||16
6250334|NCT03241225|7148478|FG000|COMPLETED|Overall Study||17
6250335|NCT03241225|7148479|FG001|COMPLETED|Overall Study||14
6250336|NCT03241225|7148478|FG000|NOT COMPLETED|Overall Study||7
6658017|NCT02475369|7588535|FG000|COMPLETED|Treatment Period #1 (10 Days)||3
6658018|NCT02475369|7588536|FG001|COMPLETED|Treatment Period #1 (10 Days)||9
6658019|NCT02475369|7588535|FG000|NOT COMPLETED|Treatment Period #1 (10 Days)||0
6658020|NCT02475369|7588536|FG001|NOT COMPLETED|Treatment Period #1 (10 Days)||0
6658021|NCT02475369|7588535|FG000|STARTED|Run-in Washout Period #2 (7 Days)||3
6250337|NCT03241225|7148479|FG001|NOT COMPLETED|Overall Study||2
6277467|NCT00127166|7176931|FG001|NOT COMPLETED|Period I||2
6277468|NCT00127166|7176930|FG000|STARTED|Washout Period||75
6277469|NCT00127166|7176931|FG001|STARTED|Washout Period||74
6277470|NCT00127166|7176930|FG000|COMPLETED|Washout Period||75
6277471|NCT00127166|7176931|FG001|COMPLETED|Washout Period||73
6277472|NCT00127166|7176930|FG000|NOT COMPLETED|Washout Period||0
6277473|NCT00127166|7176931|FG001|NOT COMPLETED|Washout Period||1
6277474|NCT00127166|7176930|FG000|STARTED|Period II||75
6277475|NCT00127166|7176931|FG001|STARTED|Period II||73
6277476|NCT00127166|7176930|FG000|COMPLETED|Period II||72
6277477|NCT00127166|7176931|FG001|COMPLETED|Period II||73
6277478|NCT00127166|7176930|FG000|NOT COMPLETED|Period II||3
6277479|NCT00127166|7176931|FG001|NOT COMPLETED|Period II||0
6277480|NCT00127192|7176942|FG000|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
6277481|NCT00127192|7176943|FG001|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
6277482|NCT00127192|7176944|FG002|STARTED|Overall Study|Study enrolled as per the target of N=70|70
6277483|NCT00127192|7176945|FG003|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
6277484|NCT00127192|7176946|FG004|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
6277485|NCT00127192|7176942|FG000|COMPLETED|Overall Study||77
6277486|NCT00127192|7176943|FG001|COMPLETED|Overall Study||71
6277487|NCT00127192|7176944|FG002|COMPLETED|Overall Study||68
6277488|NCT00127192|7176945|FG003|COMPLETED|Overall Study||67
6277489|NCT00127192|7176946|FG004|COMPLETED|Overall Study||68
6277490|NCT00127192|7176942|FG000|NOT COMPLETED|Overall Study||3
6277491|NCT00127192|7176943|FG001|NOT COMPLETED|Overall Study||1
6277492|NCT00127192|7176944|FG002|NOT COMPLETED|Overall Study||2
6277493|NCT00127192|7176945|FG003|NOT COMPLETED|Overall Study||1
6277494|NCT00127192|7176946|FG004|NOT COMPLETED|Overall Study||5
6277495|NCT00127205|7176961|FG000|STARTED|Overall Study||2262
6277496|NCT00127205|7176962|FG001|STARTED|Overall Study||2268
6277497|NCT00127205|7176963|FG002|STARTED|Overall Study||1567
6277498|NCT00127205|7176961|FG000|COMPLETED|Overall Study||1433
6277499|NCT00127205|7176962|FG001|COMPLETED|Overall Study||1295
6277500|NCT00127205|7176963|FG002|COMPLETED|Overall Study||955
6277501|NCT00127205|7176961|FG000|NOT COMPLETED|Overall Study||829
6277502|NCT00127205|7176962|FG001|NOT COMPLETED|Overall Study||973
6277503|NCT00127205|7176963|FG002|NOT COMPLETED|Overall Study||612
6277504|NCT00127218|7176975|FG000|STARTED|Overall Study||72
6277505|NCT00127218|7176976|FG001|STARTED|Overall Study||73
6277506|NCT00127218|7176975|FG000|COMPLETED|Overall Study||59
6277507|NCT00127218|7176976|FG001|COMPLETED|Overall Study||58
6277508|NCT00127218|7176975|FG000|NOT COMPLETED|Overall Study||13
6277509|NCT00127218|7176976|FG001|NOT COMPLETED|Overall Study||15
6277510|NCT00127231|7176986|FG000|STARTED|Overall Study||74
6277511|NCT00127231|7176987|FG001|STARTED|Overall Study||74
6277512|NCT00127231|7176986|FG000|COMPLETED|Overall Study||68
6277513|NCT00127231|7176987|FG001|COMPLETED|Overall Study||68
6277514|NCT00127231|7176986|FG000|NOT COMPLETED|Overall Study||6
6505881|NCT01456780|7425207|FG000|COMPLETED|Overall Study||17
6505882|NCT01456780|7425208|FG001|COMPLETED|Overall Study||17
6505883|NCT01456780|7425209|FG002|COMPLETED|Overall Study||20
6505884|NCT01456780|7425207|FG000|NOT COMPLETED|Overall Study||3
6505885|NCT01456780|7425208|FG001|NOT COMPLETED|Overall Study||3
6505886|NCT01456780|7425209|FG002|NOT COMPLETED|Overall Study||0
6505887|NCT01456897|7425219|FG000|STARTED|Overall Study||184
6505888|NCT01456897|7425220|FG001|STARTED|Overall Study||98
6505889|NCT01456897|7425219|FG000|COMPLETED|Overall Study||109
6505890|NCT01456897|7425220|FG001|COMPLETED|Overall Study||41
6250338|NCT03225846|7148492|FG000|STARTED|Overall Study||22
6250339|NCT03225846|7148493|FG001|STARTED|Overall Study||9
6250340|NCT03225846|7148494|FG002|STARTED|Overall Study||12
6250341|NCT03225846|7148495|FG003|STARTED|Overall Study||15
6250342|NCT03225846|7148496|FG004|STARTED|Overall Study||8
6250343|NCT03225846|7148497|FG005|STARTED|Overall Study||9
6250344|NCT03225846|7148498|FG006|STARTED|Overall Study||13
6250345|NCT03225846|7148492|FG000|Single Dose Period Only|Overall Study||6
6250346|NCT03225846|7148493|FG001|Single Dose Period Only|Overall Study||3
6505891|NCT01456897|7425219|FG000|NOT COMPLETED|Overall Study||75
6505892|NCT01456897|7425220|FG001|NOT COMPLETED|Overall Study||57
6505893|NCT01456936|7425230|FG000|STARTED|Overall Study||2037
6505894|NCT01456936|7425231|FG001|STARTED|Overall Study||2034
6505895|NCT01456936|7425232|FG002|STARTED|Overall Study||2038
6505896|NCT01456936|7425233|FG003|STARTED|Overall Study||2035
6505897|NCT01456936|7425230|FG000|Randomized and Treated|Overall Study||2016
6505898|NCT01456936|7425231|FG001|Randomized and Treated|Overall Study||2006
6505899|NCT01456936|7425232|FG002|Randomized and Treated|Overall Study||2022
6505900|NCT01456936|7425233|FG003|Randomized and Treated|Overall Study||2014
6505901|NCT01456936|7425230|FG000|COMPLETED|Overall Study||1598
6505902|NCT01456936|7425231|FG001|COMPLETED|Overall Study||1586
6505903|NCT01456936|7425232|FG002|COMPLETED|Overall Study||1557
6505904|NCT01456936|7425233|FG003|COMPLETED|Overall Study||1552
6505905|NCT01456936|7425230|FG000|NOT COMPLETED|Overall Study||439
6505906|NCT01456936|7425231|FG001|NOT COMPLETED|Overall Study||448
6505907|NCT01456936|7425232|FG002|NOT COMPLETED|Overall Study||481
6505908|NCT01456936|7425233|FG003|NOT COMPLETED|Overall Study||483
6505909|NCT01456949|7425243|FG000|STARTED|Enrollment||402
6505910|NCT01456949|7425243|FG000|Treated|Enrollment||359
6505911|NCT01456949|7425243|FG000|Modified Intent to Treat Group (mITT)|Enrollment||354
6505912|NCT01456949|7425243|FG000|COMPLETED|Enrollment|6 rollover subjects not included in final analysis. 359 treated; 354 treated & met all I/E criteria.|365
6505913|NCT01456949|7425243|FG000|NOT COMPLETED|Enrollment||37
6505914|NCT01456949|7425243|FG000|STARTED|Study Cryoablation Procedure & Follow-up||365
6505915|NCT01456949|7425243|FG000|3-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of 354 subjects who were treated and met all I/E criteria (mITT group).|344
6505916|NCT01456949|7425243|FG000|6-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|342
6505917|NCT01456949|7425243|FG000|12-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|325
6505918|NCT01456949|7425243|FG000|24-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|309
6505919|NCT01456949|7425243|FG000|36-month Follow-up Visit Completed|Study Cryoablation Procedure & Follow-up|Of mITT group.|298
6505920|NCT01456949|7425243|FG000|COMPLETED|Study Cryoablation Procedure & Follow-up|5 subjects completed at least 36 months of follow-up but did not complete a 36 month follow-up visit|303
6505921|NCT01456949|7425243|FG000|NOT COMPLETED|Study Cryoablation Procedure & Follow-up||62
6505922|NCT01456962|7425249|FG000|STARTED|Overall Study||16
6505923|NCT01456962|7425250|FG001|STARTED|Overall Study||20
6505924|NCT01456962|7425249|FG000|COMPLETED|Overall Study||14
6505925|NCT01456962|7425250|FG001|COMPLETED|Overall Study||19
6505926|NCT01456962|7425249|FG000|NOT COMPLETED|Overall Study||2
6505927|NCT01456962|7425250|FG001|NOT COMPLETED|Overall Study||1
6505928|NCT01457014|7425256|FG000|STARTED|First Night||74
6505929|NCT01457014|7425257|FG001|STARTED|First Night||0
6505930|NCT01457014|7425258|FG002|STARTED|First Night||0
6250347|NCT03225846|7148494|FG002|Single Dose Period Only|Overall Study||4
6250348|NCT03225846|7148495|FG003|Single Dose Period Only|Overall Study||7
6250349|NCT03225846|7148496|FG004|Single Dose Period Only|Overall Study||8
6250350|NCT03225846|7148497|FG005|Single Dose Period Only|Overall Study||0
6250351|NCT03225846|7148498|FG006|Single Dose Period Only|Overall Study||4
6250352|NCT03225846|7148492|FG000|Multiple Dose Period Only|Overall Study||3
6250353|NCT03225846|7148493|FG001|Multiple Dose Period Only|Overall Study||0
6250354|NCT03225846|7148494|FG002|Multiple Dose Period Only|Overall Study||3
6250355|NCT03225846|7148495|FG003|Multiple Dose Period Only|Overall Study||6
6570082|NCT01848938|7493445|FG000|COMPLETED|Overall Study||61
6570083|NCT01848938|7493446|FG001|COMPLETED|Overall Study||60
6570084|NCT01848938|7493445|FG000|NOT COMPLETED|Overall Study||1
6570085|NCT01848938|7493446|FG001|NOT COMPLETED|Overall Study||1
6570086|NCT01848977|7493452|FG000|STARTED|Overall Study||20
6570087|NCT01848977|7493452|FG000|COMPLETED|Overall Study||20
6570088|NCT01848977|7493452|FG000|NOT COMPLETED|Overall Study||0
6570089|NCT01848990|7493464|FG000|STARTED|Overall Study||227
6570090|NCT01848990|7493465|FG001|STARTED|Overall Study||115
6570091|NCT01848990|7493466|FG002|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
6570092|NCT01848990|7493464|FG000|Received at Least 1 Dose of Study Drug|Overall Study||227
6570093|NCT01848990|7493465|FG001|Received at Least 1 Dose of Study Drug|Overall Study||115
6570094|NCT01848990|7493466|FG002|Received at Least 1 Dose of Study Drug|Overall Study||113
6250356|NCT03225846|7148496|FG004|Multiple Dose Period Only|Overall Study||0
6250357|NCT03225846|7148497|FG005|Multiple Dose Period Only|Overall Study||0
6250358|NCT03225846|7148498|FG006|Multiple Dose Period Only|Overall Study||4
6250359|NCT03225846|7148492|FG000|Single Dose and Multiple Dose|Overall Study||13
6250360|NCT03225846|7148493|FG001|Single Dose and Multiple Dose|Overall Study||6
6250361|NCT03225846|7148494|FG002|Single Dose and Multiple Dose|Overall Study||5
6250362|NCT03225846|7148495|FG003|Single Dose and Multiple Dose|Overall Study||2
6250363|NCT03225846|7148496|FG004|Single Dose and Multiple Dose|Overall Study||0
6250364|NCT03225846|7148497|FG005|Single Dose and Multiple Dose|Overall Study||9
6250365|NCT03225846|7148498|FG006|Single Dose and Multiple Dose|Overall Study||5
6250366|NCT03225846|7148492|FG000|COMPLETED|Overall Study||22
6250367|NCT03225846|7148493|FG001|COMPLETED|Overall Study||7
6250368|NCT03225846|7148494|FG002|COMPLETED|Overall Study||11
6250369|NCT03225846|7148495|FG003|COMPLETED|Overall Study||15
6250370|NCT03225846|7148496|FG004|COMPLETED|Overall Study||8
6250371|NCT03225846|7148497|FG005|COMPLETED|Overall Study||9
6250372|NCT03225846|7148498|FG006|COMPLETED|Overall Study||6
6250373|NCT03225846|7148492|FG000|NOT COMPLETED|Overall Study||0
6250374|NCT03225846|7148493|FG001|NOT COMPLETED|Overall Study||2
6250375|NCT03225846|7148494|FG002|NOT COMPLETED|Overall Study||1
6250376|NCT03225846|7148495|FG003|NOT COMPLETED|Overall Study||0
6250377|NCT03225846|7148496|FG004|NOT COMPLETED|Overall Study||0
6250378|NCT03225846|7148497|FG005|NOT COMPLETED|Overall Study||0
6250379|NCT03225846|7148498|FG006|NOT COMPLETED|Overall Study||7
6277515|NCT00127231|7176987|FG001|NOT COMPLETED|Overall Study||6
6277516|NCT00127413|7176997|FG000|STARTED|Overall Study||12
6277517|NCT00127413|7176998|FG001|STARTED|Overall Study||10
6277518|NCT00127413|7176999|FG002|STARTED|Overall Study||13
6277519|NCT00127413|7177000|FG003|STARTED|Overall Study||7
6277520|NCT00127413|7176997|FG000|COMPLETED|Overall Study||6
6277521|NCT00127413|7176998|FG001|COMPLETED|Overall Study||6
6277522|NCT00127413|7176999|FG002|COMPLETED|Overall Study||5
6277523|NCT00127413|7177000|FG003|COMPLETED|Overall Study||5
6277524|NCT00127413|7176997|FG000|NOT COMPLETED|Overall Study||6
6277525|NCT00127413|7176998|FG001|NOT COMPLETED|Overall Study||4
6277526|NCT00127413|7176999|FG002|NOT COMPLETED|Overall Study||8
6277527|NCT00127413|7177000|FG003|NOT COMPLETED|Overall Study||2
6277528|NCT00127439|7177012|FG000|STARTED|Overall Study||9
6277529|NCT00127439|7177013|FG001|STARTED|Overall Study||10
6277530|NCT00127439|7177012|FG000|COMPLETED|Overall Study||9
6277531|NCT00127439|7177013|FG001|COMPLETED|Overall Study||10
6277532|NCT00127439|7177012|FG000|NOT COMPLETED|Overall Study||0
6505931|NCT01457014|7425259|FG003|STARTED|First Night||0
6505932|NCT01457014|7425256|FG000|COMPLETED|First Night||34
6505933|NCT01457014|7425257|FG001|COMPLETED|First Night||0
6505934|NCT01457014|7425258|FG002|COMPLETED|First Night||0
6505935|NCT01457014|7425259|FG003|COMPLETED|First Night||0
6505936|NCT01457014|7425256|FG000|NOT COMPLETED|First Night||40
6505937|NCT01457014|7425257|FG001|NOT COMPLETED|First Night||0
6505938|NCT01457014|7425258|FG002|NOT COMPLETED|First Night||0
6505939|NCT01457014|7425259|FG003|NOT COMPLETED|First Night||0
6505940|NCT01457014|7425256|FG000|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
6505941|NCT01457014|7425257|FG001|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
6505942|NCT01457014|7425258|FG002|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6505943|NCT01457014|7425259|FG003|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6505944|NCT01457014|7425256|FG000|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
6505945|NCT01457014|7425257|FG001|COMPLETED|Second Night||12
6505946|NCT01457014|7425258|FG002|COMPLETED|Second Night||11
6505947|NCT01457014|7425259|FG003|COMPLETED|Second Night||11
6505948|NCT01457014|7425256|FG000|NOT COMPLETED|Second Night||0
6505949|NCT01457014|7425257|FG001|NOT COMPLETED|Second Night||0
6505950|NCT01457014|7425258|FG002|NOT COMPLETED|Second Night||0
6505951|NCT01457014|7425259|FG003|NOT COMPLETED|Second Night||0
6505952|NCT01457014|7425256|FG000|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
6505953|NCT01457014|7425257|FG001|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6505954|NCT01457014|7425258|FG002|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6505955|NCT01457014|7425259|FG003|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
6505956|NCT01457014|7425256|FG000|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
6505957|NCT01457014|7425257|FG001|COMPLETED|Third Night||11
6505958|NCT01457014|7425258|FG002|COMPLETED|Third Night||11
6505959|NCT01457014|7425259|FG003|COMPLETED|Third Night||12
6505960|NCT01457014|7425256|FG000|NOT COMPLETED|Third Night||0
6505961|NCT01457014|7425257|FG001|NOT COMPLETED|Third Night||0
6505962|NCT01457014|7425258|FG002|NOT COMPLETED|Third Night||0
6505963|NCT01457014|7425259|FG003|NOT COMPLETED|Third Night||0
6505964|NCT01457014|7425256|FG000|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
6505965|NCT01457014|7425257|FG001|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6570095|NCT01848990|7493464|FG000|Completed Month 6|Overall Study||194
6570096|NCT01848990|7493465|FG001|Completed Month 6|Overall Study||106
6658022|NCT02475369|7588536|FG001|STARTED|Run-in Washout Period #2 (7 Days)||9
6658023|NCT02475369|7588535|FG000|COMPLETED|Run-in Washout Period #2 (7 Days)||3
6658024|NCT02475369|7588536|FG001|COMPLETED|Run-in Washout Period #2 (7 Days)||9
6658025|NCT02475369|7588535|FG000|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
6250380|NCT03221270|7148525|FG000|STARTED|Overall Study||8
6250381|NCT03221270|7148526|FG001|STARTED|Overall Study||6
6250382|NCT03221270|7148527|FG002|STARTED|Overall Study||5
6250383|NCT03221270|7148528|FG003|STARTED|Overall Study||6
6250384|NCT03221270|7148525|FG000|Completed 5-Day Treatment|Overall Study||8
6250385|NCT03221270|7148526|FG001|Completed 5-Day Treatment|Overall Study||6
6250386|NCT03221270|7148527|FG002|Completed 5-Day Treatment|Overall Study||5
6250387|NCT03221270|7148528|FG003|Completed 5-Day Treatment|Overall Study||6
6250388|NCT03221270|7148525|FG000|Completed 8-Week Maintenance|Overall Study||4
6250389|NCT03221270|7148526|FG001|Completed 8-Week Maintenance|Overall Study||6
6250390|NCT03221270|7148527|FG002|Completed 8-Week Maintenance|Overall Study||5
6250391|NCT03221270|7148528|FG003|Completed 8-Week Maintenance|Overall Study||5
6250392|NCT03221270|7148525|FG000|COMPLETED|Overall Study||4
6250393|NCT03221270|7148526|FG001|COMPLETED|Overall Study||6
6250394|NCT03221270|7148527|FG002|COMPLETED|Overall Study||5
6250395|NCT03221270|7148528|FG003|COMPLETED|Overall Study||5
6250396|NCT03221270|7148525|FG000|NOT COMPLETED|Overall Study||4
6250397|NCT03221270|7148526|FG001|NOT COMPLETED|Overall Study||0
6250398|NCT03221270|7148527|FG002|NOT COMPLETED|Overall Study||0
6250399|NCT03221270|7148528|FG003|NOT COMPLETED|Overall Study||1
6250400|NCT03203473|7148538|FG000|STARTED|Induction Phase||85
6250401|NCT03203473|7148539|FG001|STARTED|Induction Phase||0
6250402|NCT03203473|7148540|FG002|STARTED|Induction Phase||0
6250403|NCT03203473|7148538|FG000|COMPLETED|Induction Phase||69
6250404|NCT03203473|7148539|FG001|COMPLETED|Induction Phase||0
6250405|NCT03203473|7148540|FG002|COMPLETED|Induction Phase||0
6250406|NCT03203473|7148538|FG000|NOT COMPLETED|Induction Phase||16
6250407|NCT03203473|7148539|FG001|NOT COMPLETED|Induction Phase||0
6250408|NCT03203473|7148540|FG002|NOT COMPLETED|Induction Phase||0
6250409|NCT03203473|7148538|FG000|STARTED|Arm Allocation Phase||0
6250410|NCT03203473|7148539|FG001|STARTED|Arm Allocation Phase||12
6250411|NCT03203473|7148540|FG002|STARTED|Arm Allocation Phase||57
6250412|NCT03203473|7148538|FG000|COMPLETED|Arm Allocation Phase||0
6250413|NCT03203473|7148539|FG001|COMPLETED|Arm Allocation Phase||0
6250414|NCT03203473|7148540|FG002|COMPLETED|Arm Allocation Phase||0
6250415|NCT03203473|7148538|FG000|NOT COMPLETED|Arm Allocation Phase||0
6250416|NCT03203473|7148539|FG001|NOT COMPLETED|Arm Allocation Phase||12
6250417|NCT03203473|7148540|FG002|NOT COMPLETED|Arm Allocation Phase||57
6250418|NCT03191903|7148554|FG000|STARTED|Overall Study||251
6250419|NCT03191903|7148555|FG001|STARTED|Overall Study||251
6250420|NCT03191903|7148556|FG002|STARTED|Overall Study||74
6250421|NCT03191903|7148554|FG000|Intent to Treat Population|Overall Study||251
6250422|NCT03191903|7148555|FG001|Intent to Treat Population|Overall Study||251
6250423|NCT03191903|7148556|FG002|Intent to Treat Population|Overall Study||74
6250424|NCT03191903|7148554|FG000|COMPLETED|Overall Study||244
6505966|NCT01457014|7425258|FG002|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
6505967|NCT01457014|7425259|FG003|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
6505968|NCT01457014|7425256|FG000|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
6505969|NCT01457014|7425257|FG001|COMPLETED|Fourth Night||11
6505970|NCT01457014|7425258|FG002|COMPLETED|Fourth Night||12
6505971|NCT01457014|7425259|FG003|COMPLETED|Fourth Night||11
6505972|NCT01457014|7425256|FG000|NOT COMPLETED|Fourth Night||0
6505973|NCT01457014|7425257|FG001|NOT COMPLETED|Fourth Night||0
6505974|NCT01457014|7425258|FG002|NOT COMPLETED|Fourth Night||0
6505975|NCT01457014|7425259|FG003|NOT COMPLETED|Fourth Night||0
6505976|NCT01457118|7425271|FG000|STARTED|Overall Study||20
6505977|NCT01457118|7425272|FG001|STARTED|Overall Study||4
6505978|NCT01457118|7425273|FG002|STARTED|Overall Study||1
6505979|NCT01457118|7425274|FG003|STARTED|Overall Study||2
6505980|NCT01457118|7425271|FG000|COMPLETED|Overall Study||0
6505981|NCT01457118|7425272|FG001|COMPLETED|Overall Study||0
6505982|NCT01457118|7425273|FG002|COMPLETED|Overall Study||0
6505983|NCT01457118|7425274|FG003|COMPLETED|Overall Study||0
6505984|NCT01457118|7425271|FG000|NOT COMPLETED|Overall Study||20
6658026|NCT02475369|7588536|FG001|NOT COMPLETED|Run-in Washout Period #2 (7 Days)||0
6658027|NCT02475369|7588535|FG000|STARTED|Treatment Period #2 (10 Days)||3
6658028|NCT02475369|7588536|FG001|STARTED|Treatment Period #2 (10 Days)||9
6658029|NCT02475369|7588535|FG000|COMPLETED|Treatment Period #2 (10 Days)||3
6658030|NCT02475369|7588536|FG001|COMPLETED|Treatment Period #2 (10 Days)||9
6658031|NCT02475369|7588535|FG000|NOT COMPLETED|Treatment Period #2 (10 Days)||0
6658032|NCT02475369|7588536|FG001|NOT COMPLETED|Treatment Period #2 (10 Days)||0
6658033|NCT02475395|7588549|FG000|STARTED|Overall Study||258
6658034|NCT02475395|7588550|FG001|STARTED|Overall Study||14
6658035|NCT02475395|7588549|FG000|COMPLETED|Overall Study||228
6658036|NCT02475395|7588550|FG001|COMPLETED|Overall Study||11
6658037|NCT02475395|7588549|FG000|NOT COMPLETED|Overall Study||30
6658038|NCT02475395|7588550|FG001|NOT COMPLETED|Overall Study||3
6658039|NCT02475564|7588558|FG000|STARTED|Overall Study||22
6250425|NCT03191903|7148555|FG001|COMPLETED|Overall Study||246
6250426|NCT03191903|7148556|FG002|COMPLETED|Overall Study||70
6505985|NCT01457118|7425272|FG001|NOT COMPLETED|Overall Study||4
6505986|NCT01457118|7425273|FG002|NOT COMPLETED|Overall Study||1
6505987|NCT01457118|7425274|FG003|NOT COMPLETED|Overall Study||2
6658040|NCT02475564|7588559|FG001|STARTED|Overall Study||22
6658041|NCT02475564|7588558|FG000|COMPLETED|Overall Study||18
6658042|NCT02475564|7588559|FG001|COMPLETED|Overall Study||21
6250427|NCT03191903|7148554|FG000|NOT COMPLETED|Overall Study||7
6250428|NCT03191903|7148555|FG001|NOT COMPLETED|Overall Study||5
6250429|NCT03191903|7148556|FG002|NOT COMPLETED|Overall Study||4
6277533|NCT00127439|7177013|FG001|NOT COMPLETED|Overall Study||0
6277534|NCT00127530|7177024|FG000|STARTED|Overall Study||72
6277535|NCT00127530|7177025|FG001|STARTED|Overall Study||228
6277536|NCT00127530|7177024|FG000|COMPLETED|Overall Study||71
6277537|NCT00127530|7177025|FG001|COMPLETED|Overall Study||207
6277538|NCT00127530|7177024|FG000|NOT COMPLETED|Overall Study||1
6277539|NCT00127530|7177025|FG001|NOT COMPLETED|Overall Study||21
6280869|NCT00159419|7180685|FG000|NOT COMPLETED|Overall Study||0
6280870|NCT00159419|7180686|FG001|NOT COMPLETED|Overall Study||0
6280871|NCT00159432|7180692|FG000|STARTED|Overall Study||63
6280872|NCT00159432|7180692|FG000|COMPLETED|Overall Study||53
6280873|NCT00159432|7180692|FG000|NOT COMPLETED|Overall Study||10
6280874|NCT00159822|7180696|FG000|STARTED|Voriconazole Treatment Period||48
6280875|NCT00159822|7180696|FG000|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
6280876|NCT00159822|7180696|FG000|NOT COMPLETED|Voriconazole Treatment Period||22
6280877|NCT00159822|7180696|FG000|STARTED|Post-treatment Follow-up Period||26
6280878|NCT00159822|7180696|FG000|COMPLETED|Post-treatment Follow-up Period||23
6280879|NCT00159822|7180696|FG000|NOT COMPLETED|Post-treatment Follow-up Period||3
6280880|NCT00159861|7180702|FG000|STARTED|Core Study - 16 Weeks||133
6280881|NCT00159861|7180703|FG001|STARTED|Core Study - 16 Weeks||134
6280882|NCT00159861|7180702|FG000|Treated|Core Study - 16 Weeks||131
6280883|NCT00159861|7180703|FG001|Treated|Core Study - 16 Weeks||134
6280884|NCT00159861|7180702|FG000|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
6280885|NCT00159861|7180703|FG001|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
6280886|NCT00159861|7180702|FG000|NOT COMPLETED|Core Study - 16 Weeks||25
6280887|NCT00159861|7180703|FG001|NOT COMPLETED|Core Study - 16 Weeks||12
6280888|NCT00159861|7180702|FG000|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
6280889|NCT00159861|7180703|FG001|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
6280890|NCT00159861|7180702|FG000|Treated|Extension Study - up to 3 Years||115
6280891|NCT00159861|7180703|FG001|Treated|Extension Study - up to 3 Years||127
6280892|NCT00159861|7180702|FG000|COMPLETED|Extension Study - up to 3 Years||53
6280893|NCT00159861|7180703|FG001|COMPLETED|Extension Study - up to 3 Years||56
6280894|NCT00159861|7180702|FG000|NOT COMPLETED|Extension Study - up to 3 Years||62
6280895|NCT00159861|7180703|FG001|NOT COMPLETED|Extension Study - up to 3 Years||71
6280896|NCT00159874|7180721|FG000|STARTED|Overall Study||42
6280897|NCT00159874|7180722|FG001|STARTED|Overall Study||55
6280898|NCT00159874|7180723|FG002|STARTED|Overall Study||77
6280899|NCT00159874|7180724|FG003|STARTED|Overall Study||13
6280900|NCT00159874|7180725|FG004|STARTED|Overall Study||19
6280901|NCT00159874|7180726|FG005|STARTED|Overall Study||23
6280902|NCT00159874|7180727|FG006|STARTED|Overall Study||5
6280903|NCT00159874|7180721|FG000|Treated|Overall Study||42
6280904|NCT00159874|7180722|FG001|Treated|Overall Study||55
6280905|NCT00159874|7180723|FG002|Treated|Overall Study||77
6280906|NCT00159874|7180724|FG003|Treated|Overall Study||13
6280907|NCT00159874|7180725|FG004|Treated|Overall Study||19
6280908|NCT00159874|7180726|FG005|Treated|Overall Study||23
6280909|NCT00159874|7180727|FG006|Treated|Overall Study||5
6280910|NCT00159874|7180721|FG000|COMPLETED|Overall Study||22
6280911|NCT00159874|7180722|FG001|COMPLETED|Overall Study||25
6280912|NCT00159874|7180723|FG002|COMPLETED|Overall Study||34
6280913|NCT00159874|7180724|FG003|COMPLETED|Overall Study||7
6280914|NCT00159874|7180725|FG004|COMPLETED|Overall Study||11
6280915|NCT00159874|7180726|FG005|COMPLETED|Overall Study||11
6280916|NCT00159874|7180727|FG006|COMPLETED|Overall Study||0
6280917|NCT00159874|7180721|FG000|NOT COMPLETED|Overall Study||20
6280918|NCT00159874|7180722|FG001|NOT COMPLETED|Overall Study||30
6280919|NCT00159874|7180723|FG002|NOT COMPLETED|Overall Study||43
6280920|NCT00159874|7180724|FG003|NOT COMPLETED|Overall Study||6
6280921|NCT00159874|7180725|FG004|NOT COMPLETED|Overall Study||8
6280922|NCT00159874|7180726|FG005|NOT COMPLETED|Overall Study||12
6280923|NCT00159874|7180727|FG006|NOT COMPLETED|Overall Study||5
6280924|NCT00159913|7180747|FG000|STARTED|Overall Study||42
6280925|NCT00159913|7180748|FG001|STARTED|Overall Study||55
6280926|NCT00159913|7180749|FG002|STARTED|Overall Study||77
6280927|NCT00159913|7180750|FG003|STARTED|Overall Study||60
6280928|NCT00159913|7180747|FG000|COMPLETED|Overall Study||40
6280929|NCT00159913|7180748|FG001|COMPLETED|Overall Study||55
6280930|NCT00159913|7180749|FG002|COMPLETED|Overall Study||75
6280931|NCT00159913|7180750|FG003|COMPLETED|Overall Study||58
6280932|NCT00159913|7180747|FG000|NOT COMPLETED|Overall Study||2
6280933|NCT00159913|7180748|FG001|NOT COMPLETED|Overall Study||0
6280934|NCT00159913|7180749|FG002|NOT COMPLETED|Overall Study||2
6280935|NCT00159913|7180750|FG003|NOT COMPLETED|Overall Study||2
6658043|NCT02475564|7588558|FG000|NOT COMPLETED|Overall Study||4
6658044|NCT02475564|7588559|FG001|NOT COMPLETED|Overall Study||1
6658045|NCT02475629|7588565|FG000|STARTED|Overall Study||40
6280936|NCT00159965|7180764|FG000|STARTED|Overall Study||19
6280937|NCT00159965|7180765|FG001|STARTED|Overall Study||19
6280938|NCT00159965|7180764|FG000|COMPLETED|Overall Study||12
6280939|NCT00159965|7180765|FG001|COMPLETED|Overall Study||14
6658046|NCT02475629|7588565|FG000|COMPLETED|Overall Study||31
6658047|NCT02475629|7588565|FG000|NOT COMPLETED|Overall Study||9
6250430|NCT04289051|7148569|FG000|STARTED|Overall Study||13
6250431|NCT04289051|7148570|FG001|STARTED|Overall Study||13
6250432|NCT04289051|7148571|FG002|STARTED|Overall Study||13
6250433|NCT04289051|7148569|FG000|First Intervention (2 Weeks)|Overall Study||13
6250434|NCT04289051|7148570|FG001|First Intervention (2 Weeks)|Overall Study||13
6250435|NCT04289051|7148571|FG002|First Intervention (2 Weeks)|Overall Study||11
6250436|NCT04289051|7148569|FG000|Washout (1 Week)|Overall Study||13
6250437|NCT04289051|7148570|FG001|Washout (1 Week)|Overall Study||13
6250438|NCT04289051|7148571|FG002|Washout (1 Week)|Overall Study||11
6250439|NCT04289051|7148569|FG000|Second Intervention (2 Weeks)|Overall Study||13
6250440|NCT04289051|7148570|FG001|Second Intervention (2 Weeks)|Overall Study||13
6505988|NCT01457196|7425284|FG000|STARTED|Overall Study||2074
6505989|NCT01457196|7425284|FG000|COMPLETED|Overall Study||2074
6505990|NCT01457196|7425284|FG000|NOT COMPLETED|Overall Study||0
6505991|NCT01457339|7425292|FG000|STARTED|Period 1 (50 mg)||7
6505992|NCT01457339|7425293|FG001|STARTED|Period 1 (50 mg)||24
6505993|NCT01457339|7425292|FG000|COMPLETED|Period 1 (50 mg)||7
6505994|NCT01457339|7425293|FG001|COMPLETED|Period 1 (50 mg)||24
6505995|NCT01457339|7425292|FG000|NOT COMPLETED|Period 1 (50 mg)||0
6505996|NCT01457339|7425293|FG001|NOT COMPLETED|Period 1 (50 mg)||0
6505997|NCT01457339|7425292|FG000|STARTED|Period 2 (70 mg)||7
6505998|NCT01457339|7425293|FG001|STARTED|Period 2 (70 mg)||24
6505999|NCT01457339|7425292|FG000|COMPLETED|Period 2 (70 mg)||7
6506000|NCT01457339|7425293|FG001|COMPLETED|Period 2 (70 mg)||24
6506001|NCT01457339|7425292|FG000|NOT COMPLETED|Period 2 (70 mg)||0
6506002|NCT01457339|7425293|FG001|NOT COMPLETED|Period 2 (70 mg)||0
6506003|NCT01457339|7425292|FG000|STARTED|Period 3 (100 mg)||7
6506004|NCT01457339|7425293|FG001|STARTED|Period 3 (100 mg)||24
6506005|NCT01457339|7425292|FG000|COMPLETED|Period 3 (100 mg)||7
6506006|NCT01457339|7425293|FG001|COMPLETED|Period 3 (100 mg)||23
6506007|NCT01457339|7425292|FG000|NOT COMPLETED|Period 3 (100 mg)||0
6506008|NCT01457339|7425293|FG001|NOT COMPLETED|Period 3 (100 mg)||1
6506009|NCT01457339|7425292|FG000|STARTED|Period 4 (150 mg)||7
6506010|NCT01457339|7425293|FG001|STARTED|Period 4 (150 mg)||23
6506011|NCT01457339|7425292|FG000|COMPLETED|Period 4 (150 mg)||7
6506012|NCT01457339|7425293|FG001|COMPLETED|Period 4 (150 mg)||23
6506013|NCT01457339|7425292|FG000|NOT COMPLETED|Period 4 (150 mg)||0
6506014|NCT01457339|7425293|FG001|NOT COMPLETED|Period 4 (150 mg)||0
6506015|NCT01457339|7425292|FG000|STARTED|Period 5 (200 mg)||7
6506016|NCT01457339|7425293|FG001|STARTED|Period 5 (200 mg)||23
6506017|NCT01457339|7425292|FG000|COMPLETED|Period 5 (200 mg)||7
6506018|NCT01457339|7425293|FG001|COMPLETED|Period 5 (200 mg)||22
6506019|NCT01457339|7425292|FG000|NOT COMPLETED|Period 5 (200 mg)||0
6506020|NCT01457339|7425293|FG001|NOT COMPLETED|Period 5 (200 mg)||1
6506021|NCT01457339|7425292|FG000|STARTED|Period 6 (250 mg)||7
6506022|NCT01457339|7425293|FG001|STARTED|Period 6 (250 mg)||22
6506023|NCT01457339|7425292|FG000|COMPLETED|Period 6 (250 mg)||6
6506024|NCT01457339|7425293|FG001|COMPLETED|Period 6 (250 mg)||21
6506025|NCT01457339|7425292|FG000|NOT COMPLETED|Period 6 (250 mg)||1
6506026|NCT01457339|7425293|FG001|NOT COMPLETED|Period 6 (250 mg)||1
6506027|NCT01457352|7425318|FG000|STARTED|Period 1||392
6506028|NCT01457352|7425319|FG001|STARTED|Period 1||0
6506029|NCT01457352|7425318|FG000|COMPLETED|Period 1||376
6506030|NCT01457352|7425319|FG001|COMPLETED|Period 1||0
6506031|NCT01457352|7425318|FG000|NOT COMPLETED|Period 1||16
6506032|NCT01457352|7425319|FG001|NOT COMPLETED|Period 1||0
6506033|NCT01457352|7425318|FG000|STARTED|Period 2||376
6506034|NCT01457352|7425319|FG001|STARTED|Period 2||0
6506035|NCT01457352|7425318|FG000|COMPLETED|Period 2||296
6506036|NCT01457352|7425319|FG001|COMPLETED|Period 2||0
6506037|NCT01457352|7425318|FG000|NOT COMPLETED|Period 2||80
6506038|NCT01457352|7425319|FG001|NOT COMPLETED|Period 2||0
6506039|NCT01457352|7425318|FG000|STARTED|Period 3||147
6506040|NCT01457352|7425319|FG001|STARTED|Period 3||149
6506041|NCT01457352|7425318|FG000|Randomization|Period 3||147
6506042|NCT01457352|7425319|FG001|Randomization|Period 3||149
6506043|NCT01457352|7425318|FG000|COMPLETED|Period 3||146
6506044|NCT01457352|7425319|FG001|COMPLETED|Period 3||144
6506045|NCT01457352|7425318|FG000|NOT COMPLETED|Period 3||1
6506046|NCT01457352|7425319|FG001|NOT COMPLETED|Period 3||5
6506047|NCT01457417|7425334|FG000|STARTED|Overall Study||3
6506048|NCT01457417|7425335|FG001|STARTED|Overall Study||3
6506049|NCT01457417|7425336|FG002|STARTED|Overall Study||4
6506050|NCT01457417|7425337|FG003|STARTED|Overall Study||3
6506051|NCT01457417|7425338|FG004|STARTED|Overall Study||19
6658048|NCT02475655|7588571|FG000|STARTED|Overall Study||40
6658049|NCT02475655|7588572|FG001|STARTED|Overall Study||20
6658050|NCT02475655|7588571|FG000|COMPLETED|Overall Study||40
6658051|NCT02475655|7588572|FG001|COMPLETED|Overall Study||19
6658052|NCT02475655|7588571|FG000|NOT COMPLETED|Overall Study||0
6658053|NCT02475655|7588572|FG001|NOT COMPLETED|Overall Study||1
6658054|NCT02475733|7588580|FG000|STARTED|Overall Study||61
6658055|NCT02475733|7588581|FG001|STARTED|Overall Study||22
6506052|NCT01457417|7425334|FG000|COMPLETED|Overall Study||3
6506053|NCT01457417|7425335|FG001|COMPLETED|Overall Study||3
6658056|NCT02475733|7588580|FG000|COMPLETED|Overall Study||59
6658057|NCT02475733|7588581|FG001|COMPLETED|Overall Study||22
6658058|NCT02475733|7588580|FG000|NOT COMPLETED|Overall Study||2
6506054|NCT01457417|7425336|FG002|COMPLETED|Overall Study||4
6506055|NCT01457417|7425337|FG003|COMPLETED|Overall Study||3
6506056|NCT01457417|7425338|FG004|COMPLETED|Overall Study||19
6506057|NCT01457417|7425334|FG000|NOT COMPLETED|Overall Study||0
6506058|NCT01457417|7425335|FG001|NOT COMPLETED|Overall Study||0
6250441|NCT04289051|7148571|FG002|Second Intervention (2 Weeks)|Overall Study||11
6250442|NCT04289051|7148569|FG000|Washout (1 Week)|Overall Study||13
6250443|NCT04289051|7148570|FG001|Washout (1 Week)|Overall Study||13
6250444|NCT04289051|7148571|FG002|Washout (1 Week)|Overall Study||11
6250445|NCT04289051|7148569|FG000|Third Intervention (2 Weeks)|Overall Study||13
6250446|NCT04289051|7148570|FG001|Third Intervention (2 Weeks)|Overall Study||13
6250447|NCT04289051|7148571|FG002|Third Intervention (2 Weeks)|Overall Study||11
6250448|NCT04289051|7148569|FG000|COMPLETED|Overall Study||13
6250449|NCT04289051|7148570|FG001|COMPLETED|Overall Study||13
6250450|NCT04289051|7148571|FG002|COMPLETED|Overall Study||11
6250451|NCT04289051|7148569|FG000|NOT COMPLETED|Overall Study||0
6250452|NCT04289051|7148570|FG001|NOT COMPLETED|Overall Study||0
6250453|NCT04289051|7148571|FG002|NOT COMPLETED|Overall Study||2
6250454|NCT04210180|7148579|FG000|STARTED|Overall Study||25
6250455|NCT04210180|7148579|FG000|COMPLETED|Overall Study||23
6250456|NCT04210180|7148579|FG000|NOT COMPLETED|Overall Study||2
6250457|NCT04097223|7148583|FG000|STARTED|Overall Study||17464
6250458|NCT04097223|7148583|FG000|COMPLETED|Overall Study||17464
6250459|NCT04097223|7148583|FG000|NOT COMPLETED|Overall Study||0
6277540|NCT00127608|7177031|FG000|STARTED|Overall Study||36
6277541|NCT00127608|7177031|FG000|COMPLETED|Overall Study||35
6277542|NCT00127608|7177031|FG000|NOT COMPLETED|Overall Study||1
6277543|NCT00127660|7177039|FG000|STARTED|Overall Study||153
6277544|NCT00127660|7177040|FG001|STARTED|Overall Study||154
6277545|NCT00127660|7177041|FG002|STARTED|Overall Study||148
6277546|NCT00127660|7177042|FG003|STARTED|Overall Study||150
6277547|NCT00127660|7177039|FG000|COMPLETED|Overall Study||150
6277548|NCT00127660|7177040|FG001|COMPLETED|Overall Study||151
6277549|NCT00127660|7177041|FG002|COMPLETED|Overall Study||143
6277550|NCT00127660|7177042|FG003|COMPLETED|Overall Study||150
6277551|NCT00127660|7177039|FG000|NOT COMPLETED|Overall Study||3
6277552|NCT00127660|7177040|FG001|NOT COMPLETED|Overall Study||3
6277553|NCT00127660|7177041|FG002|NOT COMPLETED|Overall Study||5
6277554|NCT00127660|7177042|FG003|NOT COMPLETED|Overall Study||0
6277555|NCT00127712|7177054|FG000|STARTED|Overall Study||65
6277556|NCT00127712|7177055|FG001|STARTED|Overall Study||65
6277557|NCT00127712|7177054|FG000|COMPLETED|Overall Study||60
6277558|NCT00127712|7177055|FG001|COMPLETED|Overall Study||65
6277559|NCT00127712|7177054|FG000|NOT COMPLETED|Overall Study||5
6277560|NCT00127712|7177055|FG001|NOT COMPLETED|Overall Study||0
6277561|NCT00127790|7177065|FG000|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
6277562|NCT00127790|7177066|FG001|STARTED|Pre-Treatment||5
6277563|NCT00127790|7177067|FG002|STARTED|Pre-Treatment||6
6277564|NCT00127790|7177068|FG003|STARTED|Pre-Treatment||4
6277565|NCT00127790|7177065|FG000|COMPLETED|Pre-Treatment||6
6277566|NCT00127790|7177066|FG001|COMPLETED|Pre-Treatment||5
6277567|NCT00127790|7177067|FG002|COMPLETED|Pre-Treatment||6
6277568|NCT00127790|7177068|FG003|COMPLETED|Pre-Treatment||4
6277569|NCT00127790|7177065|FG000|NOT COMPLETED|Pre-Treatment||0
6277570|NCT00127790|7177066|FG001|NOT COMPLETED|Pre-Treatment||0
6277571|NCT00127790|7177067|FG002|NOT COMPLETED|Pre-Treatment||0
6277572|NCT00127790|7177068|FG003|NOT COMPLETED|Pre-Treatment||0
6277573|NCT00127790|7177065|FG000|STARTED|Post-Treatment||6
6277574|NCT00127790|7177066|FG001|STARTED|Post-Treatment||5
6277575|NCT00127790|7177067|FG002|STARTED|Post-Treatment||6
6277576|NCT00127790|7177068|FG003|STARTED|Post-Treatment||4
6277577|NCT00127790|7177065|FG000|COMPLETED|Post-Treatment||6
6277578|NCT00127790|7177066|FG001|COMPLETED|Post-Treatment||5
6277579|NCT00127790|7177067|FG002|COMPLETED|Post-Treatment||6
6277580|NCT00127790|7177068|FG003|COMPLETED|Post-Treatment||4
6277581|NCT00127790|7177065|FG000|NOT COMPLETED|Post-Treatment||0
6277582|NCT00127790|7177066|FG001|NOT COMPLETED|Post-Treatment||0
6277583|NCT00127790|7177067|FG002|NOT COMPLETED|Post-Treatment||0
6277584|NCT00127790|7177068|FG003|NOT COMPLETED|Post-Treatment||0
6277585|NCT00127803|7177082|FG000|STARTED|Overall Study||13
6277586|NCT00127803|7177083|FG001|STARTED|Overall Study||13
6277587|NCT00127803|7177084|FG002|STARTED|Overall Study||12
6277588|NCT00127803|7177085|FG003|STARTED|Overall Study||12
6277589|NCT00127803|7177082|FG000|COMPLETED|Overall Study||10
6277590|NCT00127803|7177083|FG001|COMPLETED|Overall Study||13
6277591|NCT00127803|7177084|FG002|COMPLETED|Overall Study||12
6506059|NCT01457417|7425336|FG002|NOT COMPLETED|Overall Study||0
6506060|NCT01457417|7425337|FG003|NOT COMPLETED|Overall Study||0
6506061|NCT01457417|7425338|FG004|NOT COMPLETED|Overall Study||0
6506062|NCT01457430|7425352|FG000|STARTED|Overall Study||19
6506063|NCT01457430|7425352|FG000|COMPLETED|Overall Study||19
6506064|NCT01457430|7425352|FG000|NOT COMPLETED|Overall Study||0
6506065|NCT01457521|7425359|FG000|STARTED|Overall Study||123
6506066|NCT01457521|7425360|FG001|STARTED|Overall Study||127
6506067|NCT01457521|7425359|FG000|COMPLETED|Overall Study||111
6506068|NCT01457521|7425360|FG001|COMPLETED|Overall Study||117
6506069|NCT01457521|7425359|FG000|NOT COMPLETED|Overall Study||12
6658059|NCT02475733|7588581|FG001|NOT COMPLETED|Overall Study||0
6658060|NCT02475837|7588589|FG000|STARTED|Overall Study||6
6506070|NCT01457521|7425360|FG001|NOT COMPLETED|Overall Study||10
6506071|NCT01457573|7425366|FG000|STARTED|Overall Study||10
6277592|NCT00127803|7177085|FG003|COMPLETED|Overall Study||11
6277593|NCT00127803|7177082|FG000|NOT COMPLETED|Overall Study||3
6277594|NCT00127803|7177083|FG001|NOT COMPLETED|Overall Study||0
6277595|NCT00127803|7177084|FG002|NOT COMPLETED|Overall Study||0
6277596|NCT00127803|7177085|FG003|NOT COMPLETED|Overall Study||1
6250460|NCT03675308|7148622|FG000|STARTED|Overall Study||481
6250461|NCT03675308|7148623|FG001|STARTED|Overall Study||483
6250462|NCT03675308|7148622|FG000|COMPLETED|Overall Study||467
6250463|NCT03675308|7148623|FG001|COMPLETED|Overall Study||473
6250464|NCT03675308|7148622|FG000|NOT COMPLETED|Overall Study||14
6250465|NCT03675308|7148623|FG001|NOT COMPLETED|Overall Study||10
6250466|NCT03573817|7148631|FG000|STARTED|Overall Study||63
6250467|NCT03573817|7148632|FG001|STARTED|Overall Study||59
6250468|NCT03573817|7148631|FG000|Randomized and Treated With Study Drug|Overall Study||63
6250469|NCT03573817|7148632|FG001|Randomized and Treated With Study Drug|Overall Study||59
6250470|NCT03573817|7148631|FG000|COMPLETED|Overall Study||62
6250471|NCT03573817|7148632|FG001|COMPLETED|Overall Study||55
6250472|NCT03573817|7148631|FG000|NOT COMPLETED|Overall Study||1
6250473|NCT03573817|7148632|FG001|NOT COMPLETED|Overall Study||4
6250474|NCT03318861|7148648|FG000|STARTED|Overall Study||3
6250475|NCT03318861|7148649|FG001|STARTED|Overall Study||4
6250476|NCT03318861|7148650|FG002|STARTED|Overall Study||3
6250477|NCT03318861|7148651|FG003|STARTED|Overall Study||4
6250478|NCT03318861|7148652|FG004|STARTED|Overall Study||3
6250479|NCT03318861|7148648|FG000|COMPLETED|Overall Study||0
6250480|NCT03318861|7148649|FG001|COMPLETED|Overall Study||0
6250481|NCT03318861|7148650|FG002|COMPLETED|Overall Study||0
6250482|NCT03318861|7148651|FG003|COMPLETED|Overall Study||0
6250483|NCT03318861|7148652|FG004|COMPLETED|Overall Study||0
6250484|NCT03318861|7148648|FG000|NOT COMPLETED|Overall Study||3
6250485|NCT03318861|7148649|FG001|NOT COMPLETED|Overall Study||4
6250486|NCT03318861|7148650|FG002|NOT COMPLETED|Overall Study||3
6250487|NCT03318861|7148651|FG003|NOT COMPLETED|Overall Study||4
6250488|NCT03318861|7148652|FG004|NOT COMPLETED|Overall Study||3
6250489|NCT03170349|7148664|FG000|STARTED|At 30 Days Follow-up||124
6250490|NCT03170349|7148664|FG000|COMPLETED|At 30 Days Follow-up||123
6250491|NCT03170349|7148664|FG000|NOT COMPLETED|At 30 Days Follow-up||1
6250492|NCT03170349|7148664|FG000|STARTED|At 6 Months Follow-up||123
6250493|NCT03170349|7148664|FG000|COMPLETED|At 6 Months Follow-up||114
6250494|NCT03170349|7148664|FG000|NOT COMPLETED|At 6 Months Follow-up||9
6250495|NCT03119064|7148670|FG000|STARTED|Overall Study||9
6250496|NCT03119064|7148671|FG001|STARTED|Overall Study||3
6250497|NCT03119064|7148672|FG002|STARTED|Overall Study||0
6250498|NCT03119064|7148670|FG000|COMPLETED|Overall Study||9
6250499|NCT03119064|7148671|FG001|COMPLETED|Overall Study||3
6250500|NCT03119064|7148672|FG002|COMPLETED|Overall Study||0
6250501|NCT03119064|7148670|FG000|NOT COMPLETED|Overall Study||0
6250502|NCT03119064|7148671|FG001|NOT COMPLETED|Overall Study||0
6250503|NCT03119064|7148672|FG002|NOT COMPLETED|Overall Study||0
6250504|NCT03097328|7148679|FG000|STARTED|Overall Study||39
6250505|NCT03097328|7148679|FG000|Treated|Overall Study||38
6250506|NCT03097328|7148679|FG000|COMPLETED|Overall Study||0
6250507|NCT03097328|7148679|FG000|NOT COMPLETED|Overall Study||39
6250508|NCT03095456|7148685|FG000|STARTED|Overall Study||103
6250509|NCT03095456|7148686|FG001|STARTED|Overall Study||104
6250510|NCT03095456|7148685|FG000|COMPLETED|Overall Study||99
6250511|NCT03095456|7148686|FG001|COMPLETED|Overall Study||96
6250512|NCT03095456|7148685|FG000|NOT COMPLETED|Overall Study||4
6250513|NCT03095456|7148686|FG001|NOT COMPLETED|Overall Study||8
6250514|NCT03064113|7148696|FG000|STARTED|Intervention 1 (2 Days)||8
6250515|NCT03064113|7148697|FG001|STARTED|Intervention 1 (2 Days)||8
6250516|NCT03064113|7148698|FG002|STARTED|Intervention 1 (2 Days)||8
6250517|NCT03064113|7148699|FG003|STARTED|Intervention 1 (2 Days)||8
6250518|NCT03064113|7148696|FG000|COMPLETED|Intervention 1 (2 Days)||8
6250519|NCT03064113|7148697|FG001|COMPLETED|Intervention 1 (2 Days)||8
6250520|NCT03064113|7148698|FG002|COMPLETED|Intervention 1 (2 Days)||8
6250521|NCT03064113|7148699|FG003|COMPLETED|Intervention 1 (2 Days)||8
6250522|NCT03064113|7148696|FG000|NOT COMPLETED|Intervention 1 (2 Days)||0
6250523|NCT03064113|7148697|FG001|NOT COMPLETED|Intervention 1 (2 Days)||0
6250524|NCT03064113|7148698|FG002|NOT COMPLETED|Intervention 1 (2 Days)||0
6250525|NCT03064113|7148699|FG003|NOT COMPLETED|Intervention 1 (2 Days)||0
6250526|NCT03064113|7148696|FG000|STARTED|Washout (7 Days)||8
6250527|NCT03064113|7148697|FG001|STARTED|Washout (7 Days)||8
6250528|NCT03064113|7148698|FG002|STARTED|Washout (7 Days)||8
6506072|NCT01457573|7425366|FG000|COMPLETED|Overall Study||10
6250529|NCT03064113|7148699|FG003|STARTED|Washout (7 Days)||8
6250530|NCT03064113|7148696|FG000|COMPLETED|Washout (7 Days)||8
6250531|NCT03064113|7148697|FG001|COMPLETED|Washout (7 Days)||8
6250532|NCT03064113|7148698|FG002|COMPLETED|Washout (7 Days)||8
6250533|NCT03064113|7148699|FG003|COMPLETED|Washout (7 Days)||8
6250534|NCT03064113|7148696|FG000|NOT COMPLETED|Washout (7 Days)||0
6250535|NCT03064113|7148697|FG001|NOT COMPLETED|Washout (7 Days)||0
6250536|NCT03064113|7148698|FG002|NOT COMPLETED|Washout (7 Days)||0
6250537|NCT03064113|7148699|FG003|NOT COMPLETED|Washout (7 Days)||0
6250538|NCT03064113|7148696|FG000|STARTED|Intervention 2 (2 Days)||8
6250539|NCT03064113|7148697|FG001|STARTED|Intervention 2 (2 Days)||8
6250540|NCT03064113|7148698|FG002|STARTED|Intervention 2 (2 Days)||8
6250541|NCT03064113|7148699|FG003|STARTED|Intervention 2 (2 Days)||8
6250542|NCT03064113|7148696|FG000|COMPLETED|Intervention 2 (2 Days)||8
6250543|NCT03064113|7148697|FG001|COMPLETED|Intervention 2 (2 Days)||8
6250544|NCT03064113|7148698|FG002|COMPLETED|Intervention 2 (2 Days)||8
6250545|NCT03064113|7148699|FG003|COMPLETED|Intervention 2 (2 Days)||8
6250546|NCT03064113|7148696|FG000|NOT COMPLETED|Intervention 2 (2 Days)||0
6250547|NCT03064113|7148697|FG001|NOT COMPLETED|Intervention 2 (2 Days)||0
6250548|NCT03064113|7148698|FG002|NOT COMPLETED|Intervention 2 (2 Days)||0
6250549|NCT03064113|7148699|FG003|NOT COMPLETED|Intervention 2 (2 Days)||0
6250550|NCT03064113|7148696|FG000|STARTED|Washout (7 Days)||8
6250551|NCT03064113|7148697|FG001|STARTED|Washout (7 Days)||8
6250552|NCT03064113|7148698|FG002|STARTED|Washout (7 Days)||8
6250553|NCT03064113|7148699|FG003|STARTED|Washout (7 Days)||8
6250554|NCT03064113|7148696|FG000|COMPLETED|Washout (7 Days)||8
6250555|NCT03064113|7148697|FG001|COMPLETED|Washout (7 Days)||8
6250556|NCT03064113|7148698|FG002|COMPLETED|Washout (7 Days)||8
6250557|NCT03064113|7148699|FG003|COMPLETED|Washout (7 Days)||8
6250558|NCT03064113|7148696|FG000|NOT COMPLETED|Washout (7 Days)||0
6250559|NCT03064113|7148697|FG001|NOT COMPLETED|Washout (7 Days)||0
6250560|NCT03064113|7148698|FG002|NOT COMPLETED|Washout (7 Days)||0
6250561|NCT03064113|7148699|FG003|NOT COMPLETED|Washout (7 Days)||0
6250562|NCT03064113|7148696|FG000|STARTED|Intervention 3 (2 Days)||8
6250563|NCT03064113|7148697|FG001|STARTED|Intervention 3 (2 Days)||8
6250564|NCT03064113|7148698|FG002|STARTED|Intervention 3 (2 Days)||8
6250565|NCT03064113|7148699|FG003|STARTED|Intervention 3 (2 Days)||8
6250566|NCT03064113|7148696|FG000|COMPLETED|Intervention 3 (2 Days)||8
6250567|NCT03064113|7148697|FG001|COMPLETED|Intervention 3 (2 Days)||8
6250568|NCT03064113|7148698|FG002|COMPLETED|Intervention 3 (2 Days)||8
6250569|NCT03064113|7148699|FG003|COMPLETED|Intervention 3 (2 Days)||8
6250570|NCT03064113|7148696|FG000|NOT COMPLETED|Intervention 3 (2 Days)||0
6250571|NCT03064113|7148697|FG001|NOT COMPLETED|Intervention 3 (2 Days)||0
6250572|NCT03064113|7148698|FG002|NOT COMPLETED|Intervention 3 (2 Days)||0
6250573|NCT03064113|7148699|FG003|NOT COMPLETED|Intervention 3 (2 Days)||0
6250574|NCT03064113|7148696|FG000|STARTED|Washout (7 Days)||8
6250575|NCT03064113|7148697|FG001|STARTED|Washout (7 Days)||8
6250576|NCT03064113|7148698|FG002|STARTED|Washout (7 Days)||8
6250577|NCT03064113|7148699|FG003|STARTED|Washout (7 Days)||8
6250578|NCT03064113|7148696|FG000|COMPLETED|Washout (7 Days)||8
6250579|NCT03064113|7148697|FG001|COMPLETED|Washout (7 Days)||8
6250580|NCT03064113|7148698|FG002|COMPLETED|Washout (7 Days)||8
6250581|NCT03064113|7148699|FG003|COMPLETED|Washout (7 Days)||8
6250582|NCT03064113|7148696|FG000|NOT COMPLETED|Washout (7 Days)||0
6250583|NCT03064113|7148697|FG001|NOT COMPLETED|Washout (7 Days)||0
6250584|NCT03064113|7148698|FG002|NOT COMPLETED|Washout (7 Days)||0
6250585|NCT03064113|7148699|FG003|NOT COMPLETED|Washout (7 Days)||0
6250586|NCT03064113|7148696|FG000|STARTED|Intervention 4 (2 Days)||8
6250587|NCT03064113|7148697|FG001|STARTED|Intervention 4 (2 Days)||8
6250588|NCT03064113|7148698|FG002|STARTED|Intervention 4 (2 Days)||8
6250589|NCT03064113|7148699|FG003|STARTED|Intervention 4 (2 Days)||8
6250590|NCT03064113|7148696|FG000|COMPLETED|Intervention 4 (2 Days)||8
6250591|NCT03064113|7148697|FG001|COMPLETED|Intervention 4 (2 Days)||8
6250592|NCT03064113|7148698|FG002|COMPLETED|Intervention 4 (2 Days)||8
6250593|NCT03064113|7148699|FG003|COMPLETED|Intervention 4 (2 Days)||8
6250594|NCT03064113|7148696|FG000|NOT COMPLETED|Intervention 4 (2 Days)||0
6250595|NCT03064113|7148697|FG001|NOT COMPLETED|Intervention 4 (2 Days)||0
6250596|NCT03064113|7148698|FG002|NOT COMPLETED|Intervention 4 (2 Days)||0
6250597|NCT03064113|7148699|FG003|NOT COMPLETED|Intervention 4 (2 Days)||0
6250598|NCT03064113|7148696|FG000|STARTED|Washout (7 Days)||8
6250599|NCT03064113|7148697|FG001|STARTED|Washout (7 Days)||8
6250600|NCT03064113|7148698|FG002|STARTED|Washout (7 Days)||8
6250601|NCT03064113|7148699|FG003|STARTED|Washout (7 Days)||8
6250602|NCT03064113|7148696|FG000|COMPLETED|Washout (7 Days)||8
6250603|NCT03064113|7148697|FG001|COMPLETED|Washout (7 Days)||8
6250604|NCT03064113|7148698|FG002|COMPLETED|Washout (7 Days)||8
6250605|NCT03064113|7148699|FG003|COMPLETED|Washout (7 Days)||8
6250606|NCT03064113|7148696|FG000|NOT COMPLETED|Washout (7 Days)||0
6250607|NCT03064113|7148697|FG001|NOT COMPLETED|Washout (7 Days)||0
6250608|NCT03064113|7148698|FG002|NOT COMPLETED|Washout (7 Days)||0
6250609|NCT03064113|7148699|FG003|NOT COMPLETED|Washout (7 Days)||0
6250610|NCT02938013|7148712|FG000|STARTED|Overall Study||5
6250611|NCT02938013|7148713|FG001|STARTED|Overall Study||5
6250612|NCT02938013|7148714|FG002|STARTED|Overall Study||5
6250613|NCT02938013|7148712|FG000|COMPLETED|Overall Study||5
6250614|NCT02938013|7148713|FG001|COMPLETED|Overall Study||5
6250615|NCT02938013|7148714|FG002|COMPLETED|Overall Study||5
6250616|NCT02938013|7148712|FG000|NOT COMPLETED|Overall Study||0
6506073|NCT01457573|7425366|FG000|NOT COMPLETED|Overall Study||0
6506074|NCT01457703|7425373|FG000|STARTED|Overall Study||29
6506075|NCT01457703|7425374|FG001|STARTED|Overall Study||33
6506076|NCT01457703|7425373|FG000|COMPLETED|Overall Study||23
6506077|NCT01457703|7425374|FG001|COMPLETED|Overall Study||22
6506078|NCT01457703|7425373|FG000|NOT COMPLETED|Overall Study||6
6506079|NCT01457703|7425374|FG001|NOT COMPLETED|Overall Study||11
6506080|NCT01457846|7425384|FG000|STARTED|Overall Study||41
6506081|NCT01457846|7425385|FG001|STARTED|Overall Study||30
6506082|NCT01457846|7425384|FG000|Received Treatment|Overall Study||40
6506083|NCT01457846|7425385|FG001|Received Treatment|Overall Study||27
6506084|NCT01457846|7425384|FG000|Did Not Receive Treatment|Overall Study||1
6506085|NCT01457846|7425385|FG001|Did Not Receive Treatment|Overall Study||3
6250617|NCT02938013|7148713|FG001|NOT COMPLETED|Overall Study||0
6250618|NCT02938013|7148714|FG002|NOT COMPLETED|Overall Study||0
6250619|NCT02919683|7148724|FG000|STARTED|Pre-Surgery Intervention||15
6250620|NCT02919683|7148725|FG001|STARTED|Pre-Surgery Intervention||15
6506086|NCT01457846|7425384|FG000|Ongoing Treatment at Data Cut-off|Overall Study||1
6506087|NCT01457846|7425385|FG001|Ongoing Treatment at Data Cut-off|Overall Study||1
6506088|NCT01457846|7425384|FG000|COMPLETED|Overall Study||0
6250621|NCT02919683|7148724|FG000|COMPLETED|Pre-Surgery Intervention||15
6250622|NCT02919683|7148725|FG001|COMPLETED|Pre-Surgery Intervention||15
6250623|NCT02919683|7148724|FG000|NOT COMPLETED|Pre-Surgery Intervention||0
6250624|NCT02919683|7148725|FG001|NOT COMPLETED|Pre-Surgery Intervention||0
6250625|NCT02919683|7148724|FG000|STARTED|Post-Surgery Follow-Up||15
6250626|NCT02919683|7148725|FG001|STARTED|Post-Surgery Follow-Up||15
6250627|NCT02919683|7148724|FG000|COMPLETED|Post-Surgery Follow-Up||12
6250628|NCT02919683|7148725|FG001|COMPLETED|Post-Surgery Follow-Up||13
6250629|NCT02919683|7148724|FG000|NOT COMPLETED|Post-Surgery Follow-Up||3
6506089|NCT01457846|7425385|FG001|COMPLETED|Overall Study||0
6506090|NCT01457846|7425384|FG000|NOT COMPLETED|Overall Study||41
6506091|NCT01457846|7425385|FG001|NOT COMPLETED|Overall Study||30
6506092|NCT01457885|7425391|FG000|STARTED|Overall Study||74
6506093|NCT01457885|7425391|FG000|COMPLETED|Overall Study||74
6506094|NCT01457885|7425391|FG000|NOT COMPLETED|Overall Study||0
6506095|NCT01457924|7425400|FG000|STARTED|Treatment Phase (Weeks 0-24)||67
6506096|NCT01457924|7425401|FG001|STARTED|Treatment Phase (Weeks 0-24)||34
6506097|NCT01457924|7425402|FG002|STARTED|Treatment Phase (Weeks 0-24)||32
6506098|NCT01457924|7425403|FG003|STARTED|Treatment Phase (Weeks 0-24)||34
6506099|NCT01457924|7425404|FG004|STARTED|Treatment Phase (Weeks 0-24)||64
6506100|NCT01457924|7425400|FG000|Completed to Week 12|Treatment Phase (Weeks 0-24)||65
6506101|NCT01457924|7425401|FG001|Completed to Week 12|Treatment Phase (Weeks 0-24)||31
6506102|NCT01457924|7425402|FG002|Completed to Week 12|Treatment Phase (Weeks 0-24)||30
6506103|NCT01457924|7425403|FG003|Completed to Week 12|Treatment Phase (Weeks 0-24)||33
6506104|NCT01457924|7425404|FG004|Completed to Week 12|Treatment Phase (Weeks 0-24)||60
6506105|NCT01457924|7425400|FG000|COMPLETED|Treatment Phase (Weeks 0-24)||64
6506106|NCT01457924|7425401|FG001|COMPLETED|Treatment Phase (Weeks 0-24)||29
6506107|NCT01457924|7425402|FG002|COMPLETED|Treatment Phase (Weeks 0-24)||30
6506108|NCT01457924|7425403|FG003|COMPLETED|Treatment Phase (Weeks 0-24)||33
6506109|NCT01457924|7425404|FG004|COMPLETED|Treatment Phase (Weeks 0-24)||58
6506110|NCT01457924|7425400|FG000|NOT COMPLETED|Treatment Phase (Weeks 0-24)||3
6506111|NCT01457924|7425401|FG001|NOT COMPLETED|Treatment Phase (Weeks 0-24)||5
6506112|NCT01457924|7425402|FG002|NOT COMPLETED|Treatment Phase (Weeks 0-24)||2
6506113|NCT01457924|7425403|FG003|NOT COMPLETED|Treatment Phase (Weeks 0-24)||1
6506114|NCT01457924|7425404|FG004|NOT COMPLETED|Treatment Phase (Weeks 0-24)||6
6506115|NCT01457924|7425400|FG000|STARTED|FUP (Weeks 24-48)||66
6506116|NCT01457924|7425401|FG001|STARTED|FUP (Weeks 24-48)||31
6506117|NCT01457924|7425402|FG002|STARTED|FUP (Weeks 24-48)||32
6506118|NCT01457924|7425403|FG003|STARTED|FUP (Weeks 24-48)||33
6506119|NCT01457924|7425404|FG004|STARTED|FUP (Weeks 24-48)||59
6506120|NCT01457924|7425400|FG000|COMPLETED|FUP (Weeks 24-48)||63
6506121|NCT01457924|7425401|FG001|COMPLETED|FUP (Weeks 24-48)||30
6506122|NCT01457924|7425402|FG002|COMPLETED|FUP (Weeks 24-48)||30
6506123|NCT01457924|7425403|FG003|COMPLETED|FUP (Weeks 24-48)||32
6506124|NCT01457924|7425404|FG004|COMPLETED|FUP (Weeks 24-48)||57
6506125|NCT01457924|7425400|FG000|NOT COMPLETED|FUP (Weeks 24-48)||3
6506126|NCT01457924|7425401|FG001|NOT COMPLETED|FUP (Weeks 24-48)||1
6506127|NCT01457924|7425402|FG002|NOT COMPLETED|FUP (Weeks 24-48)||2
6506128|NCT01457924|7425403|FG003|NOT COMPLETED|FUP (Weeks 24-48)||1
6506129|NCT01457924|7425404|FG004|NOT COMPLETED|FUP (Weeks 24-48)||2
6506130|NCT01457924|7425400|FG000|STARTED|Individualized FUP (Weeks 48+)||16
6506131|NCT01457924|7425401|FG001|STARTED|Individualized FUP (Weeks 48+)||18
6506132|NCT01457924|7425402|FG002|STARTED|Individualized FUP (Weeks 48+)||16
6506133|NCT01457924|7425403|FG003|STARTED|Individualized FUP (Weeks 48+)||20
6506134|NCT01457924|7425404|FG004|STARTED|Individualized FUP (Weeks 48+)||42
6506135|NCT01457924|7425400|FG000|COMPLETED|Individualized FUP (Weeks 48+)||11
6506136|NCT01457924|7425401|FG001|COMPLETED|Individualized FUP (Weeks 48+)||14
6506137|NCT01457924|7425402|FG002|COMPLETED|Individualized FUP (Weeks 48+)||12
6506138|NCT01457924|7425403|FG003|COMPLETED|Individualized FUP (Weeks 48+)||15
6506139|NCT01457924|7425404|FG004|COMPLETED|Individualized FUP (Weeks 48+)||36
6570097|NCT01848990|7493466|FG002|Completed Month 6|Overall Study||103
6570098|NCT01848990|7493464|FG000|COMPLETED|Overall Study||181
6570099|NCT01848990|7493465|FG001|COMPLETED|Overall Study||95
6570100|NCT01848990|7493466|FG002|COMPLETED|Overall Study||98
6570101|NCT01848990|7493464|FG000|NOT COMPLETED|Overall Study||46
6570102|NCT01848990|7493465|FG001|NOT COMPLETED|Overall Study||20
6570103|NCT01848990|7493466|FG002|NOT COMPLETED|Overall Study||16
6570104|NCT01849055|7493484|FG000|STARTED|Overall Study||8
6570105|NCT01849055|7493485|FG001|STARTED|Overall Study||8
6570106|NCT01849055|7493486|FG002|STARTED|Overall Study||8
6570107|NCT01849055|7493487|FG003|STARTED|Overall Study||8
6570108|NCT01849055|7493488|FG004|STARTED|Overall Study||8
6570109|NCT01849055|7493489|FG005|STARTED|Overall Study||8
6570110|NCT01849055|7493484|FG000|COMPLETED|Overall Study||8
6570111|NCT01849055|7493485|FG001|COMPLETED|Overall Study||8
6570112|NCT01849055|7493486|FG002|COMPLETED|Overall Study||7
6570113|NCT01849055|7493487|FG003|COMPLETED|Overall Study||8
6570114|NCT01849055|7493488|FG004|COMPLETED|Overall Study||8
6570115|NCT01849055|7493489|FG005|COMPLETED|Overall Study||8
6570116|NCT01849055|7493484|FG000|NOT COMPLETED|Overall Study||0
6570117|NCT01849055|7493485|FG001|NOT COMPLETED|Overall Study||0
6570118|NCT01849055|7493486|FG002|NOT COMPLETED|Overall Study||1
6250630|NCT02919683|7148725|FG001|NOT COMPLETED|Post-Surgery Follow-Up||2
6250631|NCT02901548|7148732|FG000|STARTED|Overall Study||17
6506140|NCT01457924|7425400|FG000|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
6570119|NCT01849055|7493487|FG003|NOT COMPLETED|Overall Study||0
6250632|NCT02901548|7148732|FG000|COMPLETED|Overall Study||13
6250633|NCT02901548|7148732|FG000|NOT COMPLETED|Overall Study||4
6250634|NCT02790138|7148738|FG000|STARTED|Overall Study||51
6250635|NCT02790138|7148739|FG001|STARTED|Overall Study||51
6250636|NCT02790138|7148738|FG000|COMPLETED|Overall Study||30
6250637|NCT02790138|7148739|FG001|COMPLETED|Overall Study||32
6250638|NCT02790138|7148738|FG000|NOT COMPLETED|Overall Study||21
6250639|NCT02790138|7148739|FG001|NOT COMPLETED|Overall Study||19
6250640|NCT02642315|7148746|FG000|STARTED|Overall Study||10
6250641|NCT02642315|7148746|FG000|COMPLETED|Overall Study||8
6250642|NCT02642315|7148746|FG000|NOT COMPLETED|Overall Study||2
6250643|NCT02518139|7148753|FG000|STARTED|Overall Study||364
6250644|NCT02518139|7148754|FG001|STARTED|Overall Study||335
6250645|NCT02518139|7148755|FG002|STARTED|Overall Study||356
6250646|NCT02518139|7148753|FG000|COMPLETED|Overall Study||219
6250647|NCT02518139|7148754|FG001|COMPLETED|Overall Study||191
6250648|NCT02518139|7148755|FG002|COMPLETED|Overall Study||262
6250649|NCT02518139|7148753|FG000|NOT COMPLETED|Overall Study||145
6250650|NCT02518139|7148754|FG001|NOT COMPLETED|Overall Study||144
6250651|NCT02518139|7148755|FG002|NOT COMPLETED|Overall Study||94
6250652|NCT02514239|7148773|FG000|STARTED|Overall Study||5
6250653|NCT02514239|7148774|FG001|STARTED|Overall Study||4
6250654|NCT02514239|7148775|FG002|STARTED|Overall Study||3
6250655|NCT02514239|7148776|FG003|STARTED|Overall Study||3
6250656|NCT02514239|7148777|FG004|STARTED|Overall Study||3
6250657|NCT02514239|7148778|FG005|STARTED|Overall Study||5
6250658|NCT02514239|7148779|FG006|STARTED|Overall Study||4
6250659|NCT02514239|7148780|FG007|STARTED|Overall Study||3
6250660|NCT02514239|7148781|FG008|STARTED|Overall Study||10
6250661|NCT02514239|7148782|FG009|STARTED|Overall Study||3
6250662|NCT02514239|7148773|FG000|Treated|Overall Study||5
6250663|NCT02514239|7148774|FG001|Treated|Overall Study||3
6250664|NCT02514239|7148775|FG002|Treated|Overall Study||3
6250665|NCT02514239|7148776|FG003|Treated|Overall Study||3
6250666|NCT02514239|7148777|FG004|Treated|Overall Study||3
6250667|NCT02514239|7148778|FG005|Treated|Overall Study||5
6250668|NCT02514239|7148779|FG006|Treated|Overall Study||4
6250669|NCT02514239|7148780|FG007|Treated|Overall Study||3
6250670|NCT02514239|7148781|FG008|Treated|Overall Study||10
6250671|NCT02514239|7148782|FG009|Treated|Overall Study||3
6250672|NCT02514239|7148773|FG000|COMPLETED|Overall Study||0
6250673|NCT02514239|7148774|FG001|COMPLETED|Overall Study||0
6250674|NCT02514239|7148775|FG002|COMPLETED|Overall Study||1
6250675|NCT02514239|7148776|FG003|COMPLETED|Overall Study||0
6250676|NCT02514239|7148777|FG004|COMPLETED|Overall Study||0
6250677|NCT02514239|7148778|FG005|COMPLETED|Overall Study||1
6250678|NCT02514239|7148779|FG006|COMPLETED|Overall Study||0
6250679|NCT02514239|7148780|FG007|COMPLETED|Overall Study||0
6250680|NCT02514239|7148781|FG008|COMPLETED|Overall Study||2
6250681|NCT02514239|7148782|FG009|COMPLETED|Overall Study||0
6250682|NCT02514239|7148773|FG000|NOT COMPLETED|Overall Study||5
6250683|NCT02514239|7148774|FG001|NOT COMPLETED|Overall Study||4
6250684|NCT02514239|7148775|FG002|NOT COMPLETED|Overall Study||2
6250685|NCT02514239|7148776|FG003|NOT COMPLETED|Overall Study||3
6250686|NCT02514239|7148777|FG004|NOT COMPLETED|Overall Study||3
6250687|NCT02514239|7148778|FG005|NOT COMPLETED|Overall Study||4
6250688|NCT02514239|7148779|FG006|NOT COMPLETED|Overall Study||4
6250689|NCT02514239|7148780|FG007|NOT COMPLETED|Overall Study||3
6250690|NCT02514239|7148781|FG008|NOT COMPLETED|Overall Study||8
6250691|NCT02514239|7148782|FG009|NOT COMPLETED|Overall Study||3
6250692|NCT02512510|7148825|FG000|STARTED|Overall Study||205
6250693|NCT02512510|7148826|FG001|STARTED|Overall Study||197
6250694|NCT02512510|7148827|FG002|STARTED|Overall Study||209
6250695|NCT02512510|7148825|FG000|COMPLETED|Overall Study||163
6250696|NCT02512510|7148826|FG001|COMPLETED|Overall Study||162
6250697|NCT02512510|7148827|FG002|COMPLETED|Overall Study||157
6250698|NCT02512510|7148825|FG000|NOT COMPLETED|Overall Study||42
6250699|NCT02512510|7148826|FG001|NOT COMPLETED|Overall Study||35
6250700|NCT02512510|7148827|FG002|NOT COMPLETED|Overall Study||52
6250701|NCT02459080|7148838|FG000|STARTED|Overall Study||212
6250702|NCT02459080|7148839|FG001|STARTED|Overall Study||198
6250703|NCT02459080|7148840|FG002|STARTED|Overall Study||209
6250704|NCT02459080|7148838|FG000|COMPLETED|Overall Study||168
6250705|NCT02459080|7148839|FG001|COMPLETED|Overall Study||158
6250706|NCT02459080|7148840|FG002|COMPLETED|Overall Study||151
6250707|NCT02459080|7148838|FG000|NOT COMPLETED|Overall Study||44
6250708|NCT02459080|7148839|FG001|NOT COMPLETED|Overall Study||40
6250709|NCT02459080|7148840|FG002|NOT COMPLETED|Overall Study||58
6250710|NCT02245672|7148851|FG000|STARTED|Overall Study||512
6250711|NCT02245672|7148852|FG001|STARTED|Overall Study||513
6250712|NCT02245672|7148853|FG002|STARTED|Overall Study||103
6250713|NCT02245672|7148851|FG000|COMPLETED|Overall Study||499
6250714|NCT02245672|7148852|FG001|COMPLETED|Overall Study||500
6250715|NCT02245672|7148853|FG002|COMPLETED|Overall Study||98
6250716|NCT02245672|7148851|FG000|NOT COMPLETED|Overall Study||13
6250717|NCT02245672|7148852|FG001|NOT COMPLETED|Overall Study||13
6250718|NCT02245672|7148853|FG002|NOT COMPLETED|Overall Study||5
6250719|NCT02109172|7148861|FG000|STARTED|Overall Study||11
6250720|NCT02109172|7148862|FG001|STARTED|Overall Study||11
6250721|NCT02109172|7148863|FG002|STARTED|Overall Study||10
6250722|NCT02109172|7148864|FG003|STARTED|Overall Study||11
6250723|NCT02109172|7148865|FG004|STARTED|Overall Study||10
6250724|NCT02109172|7148866|FG005|STARTED|Overall Study||11
6250725|NCT02109172|7148861|FG000|COMPLETED|Overall Study||10
6250726|NCT02109172|7148862|FG001|COMPLETED|Overall Study||11
6250727|NCT02109172|7148863|FG002|COMPLETED|Overall Study||9
6250728|NCT02109172|7148864|FG003|COMPLETED|Overall Study||10
6250729|NCT02109172|7148865|FG004|COMPLETED|Overall Study||9
6250730|NCT02109172|7148866|FG005|COMPLETED|Overall Study||10
6250731|NCT02109172|7148861|FG000|NOT COMPLETED|Overall Study||1
6250732|NCT02109172|7148862|FG001|NOT COMPLETED|Overall Study||0
6250733|NCT02109172|7148863|FG002|NOT COMPLETED|Overall Study||1
6250734|NCT02109172|7148864|FG003|NOT COMPLETED|Overall Study||1
6250735|NCT02109172|7148865|FG004|NOT COMPLETED|Overall Study||1
6250736|NCT02109172|7148866|FG005|NOT COMPLETED|Overall Study||1
6277597|NCT00127842|7177095|FG000|STARTED|Overall Study||110
6277598|NCT00127842|7177095|FG000|COMPLETED|Overall Study||71
6277599|NCT00127842|7177095|FG000|NOT COMPLETED|Overall Study||39
6277600|NCT00127855|7177104|FG000|STARTED|Primary Vaccination Course||82
6277601|NCT00127855|7177105|FG001|STARTED|Primary Vaccination Course||82
6277602|NCT00127855|7177106|FG002|STARTED|Primary Vaccination Course||80
6277603|NCT00127855|7177107|FG003|STARTED|Primary Vaccination Course||81
6277604|NCT00127855|7177108|FG004|STARTED|Primary Vaccination Course||82
6277605|NCT00127855|7177104|FG000|COMPLETED|Primary Vaccination Course||80
6277606|NCT00127855|7177105|FG001|COMPLETED|Primary Vaccination Course||81
6277607|NCT00127855|7177106|FG002|COMPLETED|Primary Vaccination Course||78
6277608|NCT00127855|7177107|FG003|COMPLETED|Primary Vaccination Course||81
6277609|NCT00127855|7177108|FG004|COMPLETED|Primary Vaccination Course||78
6277610|NCT00127855|7177104|FG000|NOT COMPLETED|Primary Vaccination Course||2
6277611|NCT00127855|7177105|FG001|NOT COMPLETED|Primary Vaccination Course||1
6277612|NCT00127855|7177106|FG002|NOT COMPLETED|Primary Vaccination Course||2
6277613|NCT00127855|7177107|FG003|NOT COMPLETED|Primary Vaccination Course||0
6277614|NCT00127855|7177108|FG004|NOT COMPLETED|Primary Vaccination Course||4
6277615|NCT00127855|7177104|FG000|STARTED|Polysaccharide Challenge Dose||80
6277616|NCT00127855|7177105|FG001|STARTED|Polysaccharide Challenge Dose||79
6277617|NCT00127855|7177106|FG002|STARTED|Polysaccharide Challenge Dose||77
6277618|NCT00127855|7177107|FG003|STARTED|Polysaccharide Challenge Dose||81
6277619|NCT00127855|7177108|FG004|STARTED|Polysaccharide Challenge Dose||77
6277620|NCT00127855|7177104|FG000|COMPLETED|Polysaccharide Challenge Dose||80
6277621|NCT00127855|7177105|FG001|COMPLETED|Polysaccharide Challenge Dose||79
6277622|NCT00127855|7177106|FG002|COMPLETED|Polysaccharide Challenge Dose||77
6277623|NCT00127855|7177107|FG003|COMPLETED|Polysaccharide Challenge Dose||81
6277624|NCT00127855|7177108|FG004|COMPLETED|Polysaccharide Challenge Dose||77
6277625|NCT00127855|7177104|FG000|NOT COMPLETED|Polysaccharide Challenge Dose||0
6277626|NCT00127855|7177105|FG001|NOT COMPLETED|Polysaccharide Challenge Dose||0
6277627|NCT00127855|7177106|FG002|NOT COMPLETED|Polysaccharide Challenge Dose||0
6277628|NCT00127855|7177107|FG003|NOT COMPLETED|Polysaccharide Challenge Dose||0
6277629|NCT00127855|7177108|FG004|NOT COMPLETED|Polysaccharide Challenge Dose||0
6277630|NCT00127933|7177122|FG000|STARTED|Overall Study||123
6277631|NCT00127933|7177123|FG001|STARTED|Overall Study||34
6277632|NCT00127933|7177122|FG000|Pathological Response|Overall Study||101
6277633|NCT00127933|7177123|FG001|Pathological Response|Overall Study||28
6277634|NCT00127933|7177122|FG000|Clinical Response|Overall Study||122
6277635|NCT00127933|7177123|FG001|Clinical Response|Overall Study||34
6277636|NCT00127933|7177122|FG000|Safety Population|Overall Study||122
6277637|NCT00127933|7177123|FG001|Safety Population|Overall Study||34
6277638|NCT00127933|7177122|FG000|Quality of Life Population|Overall Study||118
6277639|NCT00127933|7177123|FG001|Quality of Life Population|Overall Study||33
6570120|NCT01849055|7493488|FG004|NOT COMPLETED|Overall Study||0
6570121|NCT01849055|7493489|FG005|NOT COMPLETED|Overall Study||0
6570122|NCT01849068|7493509|FG000|STARTED|Overall Study||10
6570123|NCT01849068|7493510|FG001|STARTED|Overall Study||10
6570124|NCT01849068|7493509|FG000|COMPLETED|Overall Study||10
6570125|NCT01849068|7493510|FG001|COMPLETED|Overall Study||10
6570126|NCT01849068|7493509|FG000|NOT COMPLETED|Overall Study||0
6570127|NCT01849068|7493510|FG001|NOT COMPLETED|Overall Study||0
6570128|NCT01849172|7493518|FG000|STARTED|Overall Study||180
6570129|NCT01849172|7493519|FG001|STARTED|Overall Study||180
6570130|NCT01849172|7493518|FG000|COMPLETED|Overall Study||173
6570131|NCT01849172|7493519|FG001|COMPLETED|Overall Study||174
6570132|NCT01849172|7493518|FG000|NOT COMPLETED|Overall Study||7
6570133|NCT01849172|7493519|FG001|NOT COMPLETED|Overall Study||6
6570134|NCT01849276|7493525|FG000|STARTED|Registered to the Study||2
6277640|NCT00127933|7177122|FG000|Postoperative|Overall Study||98
6277641|NCT00127933|7177123|FG001|Postoperative|Overall Study||27
6277642|NCT00127933|7177122|FG000|COMPLETED|Overall Study||122
6277643|NCT00127933|7177123|FG001|COMPLETED|Overall Study||34
6277644|NCT00127933|7177122|FG000|NOT COMPLETED|Overall Study||1
6277645|NCT00127933|7177123|FG001|NOT COMPLETED|Overall Study||0
6277646|NCT00128102|7177131|FG000|STARTED|Overall Study||329
6277647|NCT00128102|7177132|FG001|STARTED|Overall Study||332
6277648|NCT00128102|7177131|FG000|Treated|Overall Study||329
6277649|NCT00128102|7177132|FG001|Treated|Overall Study||329
6277650|NCT00128102|7177131|FG000|COMPLETED|Overall Study||1
6277651|NCT00128102|7177132|FG001|COMPLETED|Overall Study||0
6277652|NCT00128102|7177131|FG000|NOT COMPLETED|Overall Study||328
6277653|NCT00128102|7177132|FG001|NOT COMPLETED|Overall Study||332
6277654|NCT00128180|7177140|FG000|STARTED|Overall Study||32
6277655|NCT00128180|7177141|FG001|STARTED|Overall Study||34
6277656|NCT00128180|7177140|FG000|COMPLETED|Overall Study||32
6570135|NCT01849276|7493525|FG000|COMPLETED|Registered to the Study||2
6250737|NCT02040792|7148879|FG000|STARTED|Overall Study||70
6250738|NCT02040792|7148880|FG001|STARTED|Overall Study||68
6250739|NCT02040792|7148881|FG002|STARTED|Overall Study||71
6250740|NCT02040792|7148882|FG003|STARTED|Overall Study||71
6250741|NCT02040792|7148883|FG004|STARTED|Overall Study||74
6250742|NCT02040792|7148879|FG000|COMPLETED|Overall Study||64
6250743|NCT02040792|7148880|FG001|COMPLETED|Overall Study||65
6250744|NCT02040792|7148881|FG002|COMPLETED|Overall Study||68
6250745|NCT02040792|7148882|FG003|COMPLETED|Overall Study||64
6250746|NCT02040792|7148883|FG004|COMPLETED|Overall Study||67
6250747|NCT02040792|7148879|FG000|NOT COMPLETED|Overall Study||6
6250748|NCT02040792|7148880|FG001|NOT COMPLETED|Overall Study||3
6250749|NCT02040792|7148881|FG002|NOT COMPLETED|Overall Study||3
6506141|NCT01457924|7425401|FG001|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
6506142|NCT01457924|7425402|FG002|NOT COMPLETED|Individualized FUP (Weeks 48+)||4
6506143|NCT01457924|7425403|FG003|NOT COMPLETED|Individualized FUP (Weeks 48+)||5
6506144|NCT01457924|7425404|FG004|NOT COMPLETED|Individualized FUP (Weeks 48+)||6
6506145|NCT01457950|7425418|FG000|STARTED|Double-Blind Phase||69
6506146|NCT01457950|7425419|FG001|STARTED|Double-Blind Phase||66
6506147|NCT01457950|7425420|FG002|STARTED|Double-Blind Phase||0
6506148|NCT01457950|7425421|FG003|STARTED|Double-Blind Phase||0
6506149|NCT01457950|7425418|FG000|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|62
6506150|NCT01457950|7425419|FG001|Completed the 6 Month Assessment|Double-Blind Phase|"Completed 6 month assessment refers to par. that completed at least one 6 month assessment."|64
6506151|NCT01457950|7425420|FG002|Completed the 6 Month Assessment|Double-Blind Phase||0
6506152|NCT01457950|7425421|FG003|Completed the 6 Month Assessment|Double-Blind Phase||0
6506153|NCT01457950|7425418|FG000|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|60
6506154|NCT01457950|7425419|FG001|COMPLETED|Double-Blind Phase|"Completed refers to par. that did not have a withdraw reason at the 6 month visit."|63
6506155|NCT01457950|7425420|FG002|COMPLETED|Double-Blind Phase||0
6506156|NCT01457950|7425421|FG003|COMPLETED|Double-Blind Phase||0
6506157|NCT01457950|7425418|FG000|NOT COMPLETED|Double-Blind Phase||9
6506158|NCT01457950|7425419|FG001|NOT COMPLETED|Double-Blind Phase||3
6506159|NCT01457950|7425420|FG002|NOT COMPLETED|Double-Blind Phase||0
6506160|NCT01457950|7425421|FG003|NOT COMPLETED|Double-Blind Phase||0
6506161|NCT01457950|7425418|FG000|STARTED|Open-Label Phase||0
6506162|NCT01457950|7425419|FG001|STARTED|Open-Label Phase||0
6506163|NCT01457950|7425420|FG002|STARTED|Open-Label Phase||60
6506164|NCT01457950|7425421|FG003|STARTED|Open-Label Phase||63
6506165|NCT01457950|7425418|FG000|COMPLETED|Open-Label Phase||0
6506166|NCT01457950|7425419|FG001|COMPLETED|Open-Label Phase||0
6506167|NCT01457950|7425420|FG002|COMPLETED|Open-Label Phase||58
6506168|NCT01457950|7425421|FG003|COMPLETED|Open-Label Phase||61
6506169|NCT01457950|7425418|FG000|NOT COMPLETED|Open-Label Phase||0
6506170|NCT01457950|7425419|FG001|NOT COMPLETED|Open-Label Phase||0
6506171|NCT01457950|7425420|FG002|NOT COMPLETED|Open-Label Phase||2
6506172|NCT01457950|7425421|FG003|NOT COMPLETED|Open-Label Phase||2
6506173|NCT01458106|7425434|FG000|STARTED|Overall Study||36
6506174|NCT01458106|7425435|FG001|STARTED|Overall Study||35
6506175|NCT01458106|7425434|FG000|PK Subgroup|Overall Study||25
6506176|NCT01458106|7425435|FG001|PK Subgroup|Overall Study||35
6506177|NCT01458106|7425434|FG000|Non-PK Subgroup|Overall Study||11
6506178|NCT01458106|7425435|FG001|Non-PK Subgroup|Overall Study||0
6506179|NCT01458106|7425434|FG000|COMPLETED|Overall Study||33
6506180|NCT01458106|7425435|FG001|COMPLETED|Overall Study||34
6506181|NCT01458106|7425434|FG000|NOT COMPLETED|Overall Study||3
6506182|NCT01458106|7425435|FG001|NOT COMPLETED|Overall Study||1
6506183|NCT01458119|7425444|FG000|STARTED|Overall Study||85
6506184|NCT01458119|7425444|FG000|Received at Least 1 Dose of Study Drug|Overall Study||85
6506185|NCT01458119|7425444|FG000|Safety Population|Overall Study||85
6506186|NCT01458119|7425444|FG000|Intent to Treat (ITT) Population|Overall Study||85
6506187|NCT01458119|7425444|FG000|ITT-Amenable Population|Overall Study||68
6506188|NCT01458119|7425444|FG000|COMPLETED|Overall Study||65
6506189|NCT01458119|7425444|FG000|NOT COMPLETED|Overall Study||20
6506190|NCT01458132|7425451|FG000|STARTED|Overall Study||15
6506191|NCT01458132|7425452|FG001|STARTED|Overall Study||4
6506192|NCT01458132|7425451|FG000|COMPLETED|Overall Study||0
6506193|NCT01458132|7425452|FG001|COMPLETED|Overall Study||1
6506194|NCT01458132|7425451|FG000|NOT COMPLETED|Overall Study||15
6506195|NCT01458132|7425452|FG001|NOT COMPLETED|Overall Study||3
6506196|NCT01458171|7425458|FG000|STARTED|Overall Study||23
6506197|NCT01458171|7425458|FG000|COMPLETED|Overall Study||22
6506198|NCT01458171|7425458|FG000|NOT COMPLETED|Overall Study||1
6506199|NCT01458210|7425464|FG000|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
6506200|NCT01458210|7425464|FG000|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
6506201|NCT01458210|7425464|FG000|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
6506202|NCT01458210|7425464|FG000|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
6506203|NCT01458210|7425464|FG000|STARTED|Ortho-Cyclen Alone (Period 1)||22
6506204|NCT01458210|7425464|FG000|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
6570136|NCT01849276|7493525|FG000|NOT COMPLETED|Registered to the Study||0
6250750|NCT02040792|7148882|FG003|NOT COMPLETED|Overall Study||7
6250751|NCT02040792|7148883|FG004|NOT COMPLETED|Overall Study||7
6250752|NCT01979003|7148895|FG000|STARTED|Overall Study||100
6250753|NCT01979003|7148895|FG000|COMPLETED|Overall Study||72
6250754|NCT01979003|7148895|FG000|NOT COMPLETED|Overall Study||28
6391714|NCT00837694|7303634|FG005|COMPLETED|Overall Study||10
6391715|NCT00837694|7303629|FG000|NOT COMPLETED|Overall Study||2
6391716|NCT00837694|7303630|FG001|NOT COMPLETED|Overall Study||0
6391717|NCT00837694|7303631|FG002|NOT COMPLETED|Overall Study||2
6391718|NCT00837694|7303632|FG003|NOT COMPLETED|Overall Study||1
6391719|NCT00837694|7303633|FG004|NOT COMPLETED|Overall Study||1
6391720|NCT00837694|7303634|FG005|NOT COMPLETED|Overall Study||1
6391721|NCT00837759|7303648|FG000|STARTED|Overall Study||7
6250763|NCT01704404|7148908|FG000|STARTED|Overall Study||11
6250764|NCT01704404|7148909|FG001|STARTED|Overall Study||10
6250765|NCT01704404|7148910|FG002|STARTED|Overall Study||10
6250766|NCT01704404|7148911|FG003|STARTED|Overall Study||11
6250767|NCT01704404|7148912|FG004|STARTED|Overall Study||11
6250768|NCT01704404|7148913|FG005|STARTED|Overall Study||9
6250769|NCT01704404|7148908|FG000|COMPLETED|Overall Study||10
6250770|NCT01704404|7148909|FG001|COMPLETED|Overall Study||9
6250771|NCT01704404|7148910|FG002|COMPLETED|Overall Study||9
6250772|NCT01704404|7148911|FG003|COMPLETED|Overall Study||8
6250773|NCT01704404|7148912|FG004|COMPLETED|Overall Study||10
6250774|NCT01704404|7148913|FG005|COMPLETED|Overall Study||9
6250775|NCT01704404|7148908|FG000|NOT COMPLETED|Overall Study||1
6250776|NCT01704404|7148909|FG001|NOT COMPLETED|Overall Study||1
6250777|NCT01704404|7148910|FG002|NOT COMPLETED|Overall Study||1
6250778|NCT01704404|7148911|FG003|NOT COMPLETED|Overall Study||3
6250779|NCT01704404|7148912|FG004|NOT COMPLETED|Overall Study||1
6250780|NCT01704404|7148913|FG005|NOT COMPLETED|Overall Study||0
6250781|NCT01307813|7148929|FG000|STARTED|Overall Study||4
6250782|NCT01307813|7148929|FG000|COMPLETED|Overall Study||4
6250783|NCT01307813|7148929|FG000|NOT COMPLETED|Overall Study||0
6250784|NCT00799396|7148933|FG000|STARTED|Clopidogrel Treatment||682
6250785|NCT00799396|7148933|FG000|COMPLETED|Clopidogrel Treatment||669
6506205|NCT01458210|7425464|FG000|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
6506206|NCT01458210|7425464|FG000|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
6506207|NCT01458210|7425464|FG000|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
6506208|NCT01458210|7425464|FG000|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
6506209|NCT01458249|7425473|FG000|STARTED|Overall Study||52
6506210|NCT01458249|7425473|FG000|Participants Treated|Overall Study||51
6506211|NCT01458249|7425473|FG000|COMPLETED|Overall Study||44
6506212|NCT01458249|7425473|FG000|NOT COMPLETED|Overall Study||8
6506213|NCT01458275|7425481|FG000|STARTED|Overall Study||283
6506214|NCT01458275|7425482|FG001|STARTED|Overall Study||282
6506215|NCT01458275|7425483|FG002|STARTED|Overall Study||282
6506216|NCT01458275|7425481|FG000|COMPLETED|Overall Study||269
6506217|NCT01458275|7425482|FG001|COMPLETED|Overall Study||269
6506218|NCT01458275|7425483|FG002|COMPLETED|Overall Study||273
6570137|NCT01849276|7493525|FG000|STARTED|Completed Treatment||2
6570138|NCT01849276|7493525|FG000|COMPLETED|Completed Treatment||2
6570139|NCT01849276|7493525|FG000|NOT COMPLETED|Completed Treatment||0
6250786|NCT00799396|7148933|FG000|NOT COMPLETED|Clopidogrel Treatment||13
6250787|NCT00799396|7148933|FG000|STARTED|Clopidogrel Plus Aspirin||669
6250788|NCT00799396|7148933|FG000|COMPLETED|Clopidogrel Plus Aspirin||663
6250789|NCT00799396|7148933|FG000|NOT COMPLETED|Clopidogrel Plus Aspirin||6
6250790|NCT00069238|7148937|FG000|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
6250791|NCT00069238|7148938|FG001|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6250792|NCT00069238|7148939|FG002|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6250793|NCT00069238|7148937|FG000|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
6250794|NCT00069238|7148938|FG001|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6250795|NCT00069238|7148939|FG002|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6250796|NCT00069238|7148937|FG000|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
6250797|NCT00069238|7148938|FG001|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6250798|NCT00069238|7148939|FG002|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
6250799|NCT00069238|7148937|FG000|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6250800|NCT00069238|7148938|FG001|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
6250801|NCT00069238|7148939|FG002|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6250802|NCT00069238|7148937|FG000|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6250803|NCT00069238|7148938|FG001|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
6250804|NCT00069238|7148939|FG002|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6250805|NCT00069238|7148937|FG000|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6250806|NCT00069238|7148938|FG001|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
6250807|NCT00069238|7148939|FG002|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
6250808|NCT00069238|7148937|FG000|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6250809|NCT00069238|7148938|FG001|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6250810|NCT00069238|7148939|FG002|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
6250811|NCT00069238|7148937|FG000|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6391722|NCT00837759|7303648|FG000|COMPLETED|Overall Study||3
6391723|NCT00837759|7303648|FG000|NOT COMPLETED|Overall Study||4
6391724|NCT00837811|7303655|FG000|STARTED|Overall Study||60
6391725|NCT00837811|7303656|FG001|STARTED|Overall Study||121
6391726|NCT00837811|7303657|FG002|STARTED|Overall Study||1
6391727|NCT00837811|7303655|FG000|Received Any Amount of Study Drug|Overall Study||60
6391728|NCT00837811|7303656|FG001|Received Any Amount of Study Drug|Overall Study||121
6391729|NCT00837811|7303657|FG002|Received Any Amount of Study Drug|Overall Study||1
6250812|NCT00069238|7148938|FG001|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6250813|NCT00069238|7148939|FG002|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
6250814|NCT00069238|7148937|FG000|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6250815|NCT00069238|7148938|FG001|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
6250816|NCT00069238|7148939|FG002|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
6277657|NCT00128180|7177141|FG001|COMPLETED|Overall Study||34
6277658|NCT00128180|7177140|FG000|NOT COMPLETED|Overall Study||0
6277659|NCT00128180|7177141|FG001|NOT COMPLETED|Overall Study||0
6277660|NCT00128193|7177159|FG000|STARTED|Overall Study||5
6277661|NCT00128193|7177160|FG001|STARTED|Overall Study||5
6277662|NCT00128193|7177161|FG002|STARTED|Overall Study||45
6277663|NCT00128193|7177162|FG003|STARTED|Overall Study||45
6277664|NCT00128193|7177163|FG004|STARTED|Overall Study||20
6277665|NCT00128193|7177164|FG005|STARTED|Overall Study||20
6277666|NCT00128193|7177165|FG006|STARTED|Overall Study||20
6277667|NCT00128193|7177166|FG007|STARTED|Overall Study||20
6277668|NCT00128193|7177167|FG008|STARTED|Overall Study||20
6277669|NCT00128193|7177168|FG009|STARTED|Overall Study||20
6277670|NCT00128193|7177169|FG010|STARTED|Overall Study||20
6277671|NCT00128193|7177170|FG011|STARTED|Overall Study||20
6277672|NCT00128193|7177159|FG000|COMPLETED|Overall Study||5
6277673|NCT00128193|7177160|FG001|COMPLETED|Overall Study||5
6277674|NCT00128193|7177161|FG002|COMPLETED|Overall Study||42
6277675|NCT00128193|7177162|FG003|COMPLETED|Overall Study||44
6277676|NCT00128193|7177163|FG004|COMPLETED|Overall Study||18
6277677|NCT00128193|7177164|FG005|COMPLETED|Overall Study||17
6277678|NCT00128193|7177165|FG006|COMPLETED|Overall Study||16
6277679|NCT00128193|7177166|FG007|COMPLETED|Overall Study||20
6277680|NCT00128193|7177167|FG008|COMPLETED|Overall Study||18
6277681|NCT00128193|7177168|FG009|COMPLETED|Overall Study||18
6277682|NCT00128193|7177169|FG010|COMPLETED|Overall Study||17
6277683|NCT00128193|7177170|FG011|COMPLETED|Overall Study||18
6277684|NCT00128193|7177159|FG000|NOT COMPLETED|Overall Study||0
6277685|NCT00128193|7177160|FG001|NOT COMPLETED|Overall Study||0
6277686|NCT00128193|7177161|FG002|NOT COMPLETED|Overall Study||3
6277687|NCT00128193|7177162|FG003|NOT COMPLETED|Overall Study||1
6277688|NCT00128193|7177163|FG004|NOT COMPLETED|Overall Study||2
6277689|NCT00128193|7177164|FG005|NOT COMPLETED|Overall Study||3
6277690|NCT00128193|7177165|FG006|NOT COMPLETED|Overall Study||4
6277691|NCT00128193|7177166|FG007|NOT COMPLETED|Overall Study||0
6277692|NCT00128193|7177167|FG008|NOT COMPLETED|Overall Study||2
6277693|NCT00128193|7177168|FG009|NOT COMPLETED|Overall Study||2
6277694|NCT00128193|7177169|FG010|NOT COMPLETED|Overall Study||3
6506219|NCT01458275|7425481|FG000|NOT COMPLETED|Overall Study||14
6506220|NCT01458275|7425482|FG001|NOT COMPLETED|Overall Study||13
6506221|NCT01458275|7425483|FG002|NOT COMPLETED|Overall Study||9
6506222|NCT01458288|7425493|FG000|STARTED|Overall Study||12
6506223|NCT01458288|7425493|FG000|COMPLETED|Overall Study||12
6506224|NCT01458288|7425493|FG000|NOT COMPLETED|Overall Study||0
6506225|NCT01458327|7425498|FG000|STARTED|Overall Study||3
6506226|NCT01458327|7425498|FG000|COMPLETED|Overall Study||3
6506227|NCT01458327|7425498|FG000|NOT COMPLETED|Overall Study||0
6506228|NCT01458366|7425508|FG000|STARTED|Period 1: 70mg/m^2||5
6506229|NCT01458366|7425509|FG001|STARTED|Period 1: 70mg/m^2||0
6506230|NCT01458366|7425510|FG002|STARTED|Period 1: 70mg/m^2||0
6506231|NCT01458366|7425511|FG003|STARTED|Period 1: 70mg/m^2||0
6506232|NCT01458366|7425512|FG004|STARTED|Period 1: 70mg/m^2||0
6506233|NCT01458366|7425508|FG000|COMPLETED|Period 1: 70mg/m^2||3
6506234|NCT01458366|7425509|FG001|COMPLETED|Period 1: 70mg/m^2||0
6506235|NCT01458366|7425510|FG002|COMPLETED|Period 1: 70mg/m^2||0
6277695|NCT00128193|7177170|FG011|NOT COMPLETED|Overall Study||2
6277696|NCT00128206|7177252|FG000|STARTED|Overall Study||184
6277697|NCT00128206|7177253|FG001|STARTED|Overall Study||180
6277698|NCT00128206|7177252|FG000|COMPLETED|Overall Study||47
6277699|NCT00128206|7177253|FG001|COMPLETED|Overall Study||60
6277700|NCT00128206|7177252|FG000|NOT COMPLETED|Overall Study||137
6277701|NCT00128206|7177253|FG001|NOT COMPLETED|Overall Study||120
6277702|NCT00128219|7177261|FG000|STARTED|Overall Study||333
6277703|NCT00128219|7177262|FG001|STARTED|Overall Study||334
6277704|NCT00128219|7177261|FG000|COMPLETED|Overall Study||264
6506236|NCT01458366|7425511|FG003|COMPLETED|Period 1: 70mg/m^2||0
6506237|NCT01458366|7425512|FG004|COMPLETED|Period 1: 70mg/m^2||0
6506238|NCT01458366|7425508|FG000|NOT COMPLETED|Period 1: 70mg/m^2||2
6506239|NCT01458366|7425509|FG001|NOT COMPLETED|Period 1: 70mg/m^2||0
6506240|NCT01458366|7425510|FG002|NOT COMPLETED|Period 1: 70mg/m^2||0
6506241|NCT01458366|7425511|FG003|NOT COMPLETED|Period 1: 70mg/m^2||0
6506242|NCT01458366|7425512|FG004|NOT COMPLETED|Period 1: 70mg/m^2||0
6506243|NCT01458366|7425508|FG000|STARTED|Period 2: 50mg/m^2||0
6506244|NCT01458366|7425509|FG001|STARTED|Period 2: 50mg/m^2||0
6506245|NCT01458366|7425510|FG002|STARTED|Period 2: 50mg/m^2||0
6506246|NCT01458366|7425511|FG003|STARTED|Period 2: 50mg/m^2||0
6506247|NCT01458366|7425512|FG004|STARTED|Period 2: 50mg/m^2||0
6506248|NCT01458366|7425508|FG000|COMPLETED|Period 2: 50mg/m^2||0
6277705|NCT00128219|7177262|FG001|COMPLETED|Overall Study||263
6277706|NCT00128219|7177261|FG000|NOT COMPLETED|Overall Study||69
6506249|NCT01458366|7425509|FG001|COMPLETED|Period 2: 50mg/m^2||0
6506250|NCT01458366|7425510|FG002|COMPLETED|Period 2: 50mg/m^2||0
6506251|NCT01458366|7425511|FG003|COMPLETED|Period 2: 50mg/m^2||0
6506252|NCT01458366|7425512|FG004|COMPLETED|Period 2: 50mg/m^2||0
6506253|NCT01458366|7425508|FG000|NOT COMPLETED|Period 2: 50mg/m^2||0
6250817|NCT03138499|7148946|FG000|STARTED|Overall Study||12
6250818|NCT03138499|7148947|FG001|STARTED|Overall Study||11
6250819|NCT03138499|7148946|FG000|COMPLETED|Overall Study||3
6250820|NCT03138499|7148947|FG001|COMPLETED|Overall Study||1
6250821|NCT03138499|7148946|FG000|NOT COMPLETED|Overall Study||9
6250822|NCT03138499|7148947|FG001|NOT COMPLETED|Overall Study||10
6250823|NCT03089281|7148956|FG000|STARTED|Overall Study||225
6250824|NCT03089281|7148957|FG001|STARTED|Overall Study||215
6250825|NCT03089281|7148956|FG000|COMPLETED|Overall Study||197
6506254|NCT01458366|7425509|FG001|NOT COMPLETED|Period 2: 50mg/m^2||0
6570140|NCT01849276|7493525|FG000|STARTED|Followed for Survival for 5 Years||2
6570141|NCT01849276|7493525|FG000|COMPLETED|Followed for Survival for 5 Years||0
6570142|NCT01849276|7493525|FG000|NOT COMPLETED|Followed for Survival for 5 Years||2
6570143|NCT01849289|7493531|FG000|STARTED|Overall Study||555
6570144|NCT01849289|7493532|FG001|STARTED|Overall Study||278
6570145|NCT01849289|7493531|FG000|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
6570146|NCT01849289|7493532|FG001|Exposed|Overall Study||278
6570147|NCT01849289|7493531|FG000|COMPLETED|Overall Study||523
6570148|NCT01849289|7493532|FG001|COMPLETED|Overall Study||254
6570149|NCT01849289|7493531|FG000|NOT COMPLETED|Overall Study||32
6570150|NCT01849289|7493532|FG001|NOT COMPLETED|Overall Study||24
6570151|NCT01849419|7493538|FG000|STARTED|Overall Study||65
6570152|NCT01849419|7493538|FG000|COMPLETED|Overall Study||65
6570153|NCT01849419|7493538|FG000|NOT COMPLETED|Overall Study||0
6570154|NCT01849458|7493543|FG000|STARTED|Overall Study||50
6570155|NCT01849458|7493543|FG000|6 Months Follow-up|Overall Study||50
6570156|NCT01849458|7493543|FG000|COMPLETED|Overall Study||46
6570157|NCT01849458|7493543|FG000|NOT COMPLETED|Overall Study||4
6570158|NCT01849497|7493549|FG000|STARTED|Overall Study||75
6570159|NCT01849497|7493550|FG001|STARTED|Overall Study||74
6570160|NCT01849497|7493549|FG000|Received Treatment|Overall Study||75
6570161|NCT01849497|7493550|FG001|Received Treatment|Overall Study||74
6570162|NCT01849497|7493549|FG000|COMPLETED|Overall Study||74
6570163|NCT01849497|7493550|FG001|COMPLETED|Overall Study||70
6570164|NCT01849497|7493549|FG000|NOT COMPLETED|Overall Study||1
6570165|NCT01849497|7493550|FG001|NOT COMPLETED|Overall Study||4
6570166|NCT01849562|7493559|FG000|STARTED|Overall Study||10
6570167|NCT01849562|7493560|FG001|STARTED|Overall Study||10
6570168|NCT01849562|7493561|FG002|STARTED|Overall Study||10
6570169|NCT01849562|7493559|FG000|COMPLETED|Overall Study||8
6570170|NCT01849562|7493560|FG001|COMPLETED|Overall Study||10
6570171|NCT01849562|7493561|FG002|COMPLETED|Overall Study||10
6570172|NCT01849562|7493559|FG000|NOT COMPLETED|Overall Study||2
6570173|NCT01849562|7493560|FG001|NOT COMPLETED|Overall Study||0
6570174|NCT01849562|7493561|FG002|NOT COMPLETED|Overall Study||0
6570175|NCT01849575|7493572|FG000|STARTED|Overall Study||1749
6570176|NCT01849575|7493573|FG001|STARTED|Overall Study||1783
6570177|NCT01849575|7493572|FG000|COMPLETED|Overall Study||1599
6570178|NCT01849575|7493573|FG001|COMPLETED|Overall Study||1576
6570179|NCT01849575|7493572|FG000|NOT COMPLETED|Overall Study||150
6570180|NCT01849575|7493573|FG001|NOT COMPLETED|Overall Study||207
6570181|NCT01849588|7493581|FG000|STARTED|Overall Study||3
6570182|NCT01849588|7493581|FG000|COMPLETED|Overall Study||0
6570183|NCT01849588|7493581|FG000|NOT COMPLETED|Overall Study||3
6570184|NCT01849692|7493587|FG000|STARTED|Overall Study||10
6570185|NCT01849692|7493588|FG001|STARTED|Overall Study||3
6570186|NCT01849692|7493589|FG002|STARTED|Overall Study||10
6570187|NCT01849692|7493590|FG003|STARTED|Overall Study||3
6570188|NCT01849692|7493591|FG004|STARTED|Overall Study||10
6570189|NCT01849692|7493592|FG005|STARTED|Overall Study||3
6570190|NCT01849692|7493593|FG006|STARTED|Overall Study||10
6570191|NCT01849692|7493594|FG007|STARTED|Overall Study||3
6570192|NCT01849692|7493587|FG000|COMPLETED|Overall Study||10
6570193|NCT01849692|7493588|FG001|COMPLETED|Overall Study||3
6570194|NCT01849692|7493589|FG002|COMPLETED|Overall Study||10
6570195|NCT01849692|7493590|FG003|COMPLETED|Overall Study||3
6250826|NCT03089281|7148957|FG001|COMPLETED|Overall Study||198
6506255|NCT01458366|7425510|FG002|NOT COMPLETED|Period 2: 50mg/m^2||0
6506256|NCT01458366|7425511|FG003|NOT COMPLETED|Period 2: 50mg/m^2||0
6506257|NCT01458366|7425512|FG004|NOT COMPLETED|Period 2: 50mg/m^2||0
6506258|NCT01458366|7425508|FG000|STARTED|Period 3: 90mg/m^2||0
6506259|NCT01458366|7425509|FG001|STARTED|Period 3: 90mg/m^2||0
6506260|NCT01458366|7425510|FG002|STARTED|Period 3: 90mg/m^2||3
6506261|NCT01458366|7425511|FG003|STARTED|Period 3: 90mg/m^2||0
6506262|NCT01458366|7425512|FG004|STARTED|Period 3: 90mg/m^2||0
6506263|NCT01458366|7425508|FG000|COMPLETED|Period 3: 90mg/m^2||0
6506264|NCT01458366|7425509|FG001|COMPLETED|Period 3: 90mg/m^2||0
6506265|NCT01458366|7425510|FG002|COMPLETED|Period 3: 90mg/m^2||3
6570196|NCT01849692|7493591|FG004|COMPLETED|Overall Study||10
6570197|NCT01849692|7493592|FG005|COMPLETED|Overall Study||3
6570198|NCT01849692|7493593|FG006|COMPLETED|Overall Study||10
6570199|NCT01849692|7493594|FG007|COMPLETED|Overall Study||3
6570200|NCT01849692|7493587|FG000|NOT COMPLETED|Overall Study||0
6570201|NCT01849692|7493588|FG001|NOT COMPLETED|Overall Study||0
6570202|NCT01849692|7493589|FG002|NOT COMPLETED|Overall Study||0
6570203|NCT01849692|7493590|FG003|NOT COMPLETED|Overall Study||0
6570204|NCT01849692|7493591|FG004|NOT COMPLETED|Overall Study||0
6250827|NCT03089281|7148956|FG000|NOT COMPLETED|Overall Study||28
6570205|NCT01849692|7493592|FG005|NOT COMPLETED|Overall Study||0
6570206|NCT01849692|7493593|FG006|NOT COMPLETED|Overall Study||0
6570207|NCT01849692|7493594|FG007|NOT COMPLETED|Overall Study||0
6250828|NCT03089281|7148957|FG001|NOT COMPLETED|Overall Study||17
6277707|NCT00128219|7177262|FG001|NOT COMPLETED|Overall Study||71
6277708|NCT00128401|7177270|FG000|STARTED|Overall Study||20
6277709|NCT00128401|7177271|FG001|STARTED|Overall Study||19
6277710|NCT00128401|7177270|FG000|COMPLETED|Overall Study||14
6277711|NCT00128401|7177271|FG001|COMPLETED|Overall Study||15
6277712|NCT00128401|7177270|FG000|NOT COMPLETED|Overall Study||6
6277713|NCT00128401|7177271|FG001|NOT COMPLETED|Overall Study||4
6277714|NCT00128492|7177280|FG000|STARTED|Overall Study||85
6277715|NCT00128492|7177281|FG001|STARTED|Overall Study||189
6277716|NCT00128492|7177280|FG000|COMPLETED|Overall Study||65
6277717|NCT00128492|7177281|FG001|COMPLETED|Overall Study||130
6277718|NCT00128492|7177280|FG000|NOT COMPLETED|Overall Study||20
6277719|NCT00128492|7177281|FG001|NOT COMPLETED|Overall Study||59
6277720|NCT00128661|7177289|FG000|STARTED|Overall Study||3727
6277721|NCT00128661|7177290|FG001|STARTED|Overall Study||3739
6277722|NCT00128661|7177289|FG000|COMPLETED|Overall Study||3453
6277723|NCT00128661|7177290|FG001|COMPLETED|Overall Study||3481
6277724|NCT00128661|7177289|FG000|NOT COMPLETED|Overall Study||274
6277725|NCT00128661|7177290|FG001|NOT COMPLETED|Overall Study||258
6277726|NCT00128713|7177299|FG000|STARTED|Overall Study||453
6277727|NCT00128713|7177300|FG001|STARTED|Overall Study||449
6277728|NCT00128713|7177301|FG002|STARTED|Overall Study||449
6277729|NCT00128713|7177299|FG000|COMPLETED|Overall Study||453
6277730|NCT00128713|7177300|FG001|COMPLETED|Overall Study||449
6277731|NCT00128713|7177301|FG002|COMPLETED|Overall Study||449
6277732|NCT00128713|7177299|FG000|NOT COMPLETED|Overall Study||0
6277733|NCT00128713|7177300|FG001|NOT COMPLETED|Overall Study||0
6277734|NCT00128713|7177301|FG002|NOT COMPLETED|Overall Study||0
6277735|NCT00128830|7177309|FG000|STARTED|Overall Study||211
6277736|NCT00128830|7177309|FG000|COMPLETED|Overall Study||139
6277737|NCT00128830|7177309|FG000|NOT COMPLETED|Overall Study||72
6277738|NCT00128921|7177318|FG000|STARTED|Overall Study||10
6277739|NCT00128921|7177319|FG001|STARTED|Overall Study||8
6277740|NCT00128921|7177320|FG002|STARTED|Overall Study||0
6277741|NCT00128921|7177318|FG000|Received Bortezomib|Overall Study||10
6277742|NCT00128921|7177319|FG001|Received Bortezomib|Overall Study||6
6277743|NCT00128921|7177320|FG002|Received Bortezomib|Overall Study||0
6277744|NCT00128921|7177318|FG000|COMPLETED|Overall Study||5
6277745|NCT00128921|7177319|FG001|COMPLETED|Overall Study||3
6277746|NCT00128921|7177320|FG002|COMPLETED|Overall Study||0
6277747|NCT00128921|7177318|FG000|NOT COMPLETED|Overall Study||5
6277748|NCT00128921|7177319|FG001|NOT COMPLETED|Overall Study||5
6277749|NCT00128921|7177320|FG002|NOT COMPLETED|Overall Study||0
6277750|NCT00129116|7177335|FG000|STARTED|Primary Phase||78
6277751|NCT00129116|7177336|FG001|STARTED|Primary Phase||77
6277752|NCT00129116|7177337|FG002|STARTED|Primary Phase||78
6277753|NCT00129116|7177338|FG003|STARTED|Primary Phase||78
6277754|NCT00129116|7177339|FG004|STARTED|Primary Phase||77
6277755|NCT00129116|7177335|FG000|COMPLETED|Primary Phase||76
6277756|NCT00129116|7177336|FG001|COMPLETED|Primary Phase||73
6277757|NCT00129116|7177337|FG002|COMPLETED|Primary Phase||77
6277758|NCT00129116|7177338|FG003|COMPLETED|Primary Phase||77
6277759|NCT00129116|7177339|FG004|COMPLETED|Primary Phase||76
6277760|NCT00129116|7177335|FG000|NOT COMPLETED|Primary Phase||2
6277761|NCT00129116|7177336|FG001|NOT COMPLETED|Primary Phase||4
6277762|NCT00129116|7177337|FG002|NOT COMPLETED|Primary Phase||1
6277763|NCT00129116|7177338|FG003|NOT COMPLETED|Primary Phase||1
6277764|NCT00129116|7177339|FG004|NOT COMPLETED|Primary Phase||1
6277765|NCT00129116|7177335|FG000|STARTED|Booster Phase||47
6277766|NCT00129116|7177336|FG001|STARTED|Booster Phase||42
6277767|NCT00129116|7177337|FG002|STARTED|Booster Phase||44
6277768|NCT00129116|7177338|FG003|STARTED|Booster Phase||44
6277769|NCT00129116|7177339|FG004|STARTED|Booster Phase||44
6277770|NCT00129116|7177335|FG000|COMPLETED|Booster Phase||45
6277771|NCT00129116|7177336|FG001|COMPLETED|Booster Phase||42
6277772|NCT00129116|7177337|FG002|COMPLETED|Booster Phase||44
6277773|NCT00129116|7177338|FG003|COMPLETED|Booster Phase||44
6277774|NCT00129116|7177339|FG004|COMPLETED|Booster Phase||43
6277775|NCT00129116|7177335|FG000|NOT COMPLETED|Booster Phase||2
6277776|NCT00129116|7177336|FG001|NOT COMPLETED|Booster Phase||0
6277777|NCT00129116|7177337|FG002|NOT COMPLETED|Booster Phase||0
6277778|NCT00129116|7177338|FG003|NOT COMPLETED|Booster Phase||0
6277779|NCT00129116|7177339|FG004|NOT COMPLETED|Booster Phase||1
6277780|NCT00129129|7177354|FG000|STARTED|Primary Phase||287
6277781|NCT00129129|7177355|FG001|STARTED|Primary Phase||319
6277782|NCT00129129|7177356|FG002|STARTED|Primary Phase||150
6277783|NCT00129129|7177357|FG003|STARTED|Primary Phase||0
6277784|NCT00129129|7177358|FG004|STARTED|Primary Phase||0
6277785|NCT00129129|7177354|FG000|COMPLETED|Primary Phase||262
6277786|NCT00129129|7177355|FG001|COMPLETED|Primary Phase||294
6277787|NCT00129129|7177356|FG002|COMPLETED|Primary Phase||150
6277788|NCT00129129|7177357|FG003|COMPLETED|Primary Phase||0
6277789|NCT00129129|7177358|FG004|COMPLETED|Primary Phase||0
6277790|NCT00129129|7177354|FG000|NOT COMPLETED|Primary Phase||25
6277791|NCT00129129|7177355|FG001|NOT COMPLETED|Primary Phase||25
6277792|NCT00129129|7177356|FG002|NOT COMPLETED|Primary Phase||0
6277793|NCT00129129|7177357|FG003|NOT COMPLETED|Primary Phase||0
6277794|NCT00129129|7177358|FG004|NOT COMPLETED|Primary Phase||0
6277795|NCT00129129|7177354|FG000|STARTED|Fourth Dose Phase||236
6277796|NCT00129129|7177355|FG001|STARTED|Fourth Dose Phase||0
6277797|NCT00129129|7177356|FG002|STARTED|Fourth Dose Phase||0
6277798|NCT00129129|7177357|FG003|STARTED|Fourth Dose Phase||132
6277799|NCT00129129|7177358|FG004|STARTED|Fourth Dose Phase||130
6250829|NCT03082898|7148965|FG000|STARTED|Overall Study||27
6250830|NCT03082898|7148966|FG001|STARTED|Overall Study||12
6250831|NCT03082898|7148965|FG000|COMPLETED|Overall Study||24
6506266|NCT01458366|7425511|FG003|COMPLETED|Period 3: 90mg/m^2||0
6506267|NCT01458366|7425512|FG004|COMPLETED|Period 3: 90mg/m^2||0
6506268|NCT01458366|7425508|FG000|NOT COMPLETED|Period 3: 90mg/m^2||0
6506269|NCT01458366|7425509|FG001|NOT COMPLETED|Period 3: 90mg/m^2||0
6506270|NCT01458366|7425510|FG002|NOT COMPLETED|Period 3: 90mg/m^2||0
6506271|NCT01458366|7425511|FG003|NOT COMPLETED|Period 3: 90mg/m^2||0
6506272|NCT01458366|7425512|FG004|NOT COMPLETED|Period 3: 90mg/m^2||0
6506273|NCT01458366|7425508|FG000|STARTED|Period 4: 120mg/m^2||0
6506274|NCT01458366|7425509|FG001|STARTED|Period 4: 120mg/m^2||0
6506275|NCT01458366|7425510|FG002|STARTED|Period 4: 120mg/m^2||0
6506276|NCT01458366|7425511|FG003|STARTED|Period 4: 120mg/m^2||3
6506277|NCT01458366|7425512|FG004|STARTED|Period 4: 120mg/m^2||0
6506278|NCT01458366|7425508|FG000|COMPLETED|Period 4: 120mg/m^2||0
6506279|NCT01458366|7425509|FG001|COMPLETED|Period 4: 120mg/m^2||0
6506280|NCT01458366|7425510|FG002|COMPLETED|Period 4: 120mg/m^2||0
6506281|NCT01458366|7425511|FG003|COMPLETED|Period 4: 120mg/m^2||3
6506282|NCT01458366|7425512|FG004|COMPLETED|Period 4: 120mg/m^2||0
6506283|NCT01458366|7425508|FG000|NOT COMPLETED|Period 4: 120mg/m^2||0
6506284|NCT01458366|7425509|FG001|NOT COMPLETED|Period 4: 120mg/m^2||0
6506285|NCT01458366|7425510|FG002|NOT COMPLETED|Period 4: 120mg/m^2||0
6506286|NCT01458366|7425511|FG003|NOT COMPLETED|Period 4: 120mg/m^2||0
6506287|NCT01458366|7425512|FG004|NOT COMPLETED|Period 4: 120mg/m^2||0
6506288|NCT01458366|7425508|FG000|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
6506289|NCT01458366|7425509|FG001|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
6506290|NCT01458366|7425510|FG002|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
6506291|NCT01458366|7425511|FG003|STARTED|Period 5: Maximum Tolerated Dose (MTD)||0
6506292|NCT01458366|7425512|FG004|STARTED|Period 5: Maximum Tolerated Dose (MTD)||27
6506293|NCT01458366|7425508|FG000|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6506294|NCT01458366|7425509|FG001|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6506295|NCT01458366|7425510|FG002|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6506296|NCT01458366|7425511|FG003|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6506297|NCT01458366|7425512|FG004|COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||26
6506298|NCT01458366|7425508|FG000|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6506299|NCT01458366|7425509|FG001|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6506300|NCT01458366|7425510|FG002|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6506301|NCT01458366|7425511|FG003|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||0
6506302|NCT01458366|7425512|FG004|NOT COMPLETED|Period 5: Maximum Tolerated Dose (MTD)||1
6506303|NCT01458392|7425523|FG000|STARTED|Overall Study||2
6506304|NCT01458392|7425524|FG001|STARTED|Overall Study||13
6506305|NCT01458392|7425525|FG002|STARTED|Overall Study||31
6506306|NCT01458392|7425523|FG000|COMPLETED|Overall Study||0
6506307|NCT01458392|7425524|FG001|COMPLETED|Overall Study||0
6506308|NCT01458392|7425525|FG002|COMPLETED|Overall Study||0
6506309|NCT01458392|7425523|FG000|NOT COMPLETED|Overall Study||2
6506310|NCT01458392|7425524|FG001|NOT COMPLETED|Overall Study||13
6506311|NCT01458392|7425525|FG002|NOT COMPLETED|Overall Study||31
6506312|NCT01458418|7425541|FG000|STARTED|Overall Study||0
6506313|NCT01458418|7425542|FG001|STARTED|Overall Study||0
6506314|NCT01458418|7425543|FG002|STARTED|Overall Study||0
6506315|NCT01458418|7425544|FG003|STARTED|Overall Study||4
6506316|NCT01458418|7425541|FG000|COMPLETED|Overall Study||0
6506317|NCT01458418|7425542|FG001|COMPLETED|Overall Study||0
6506318|NCT01458418|7425543|FG002|COMPLETED|Overall Study||0
6506319|NCT01458418|7425544|FG003|COMPLETED|Overall Study||4
6506320|NCT01458418|7425541|FG000|NOT COMPLETED|Overall Study||0
6506321|NCT01458418|7425542|FG001|NOT COMPLETED|Overall Study||0
6506322|NCT01458418|7425543|FG002|NOT COMPLETED|Overall Study||0
6506323|NCT01458418|7425544|FG003|NOT COMPLETED|Overall Study||0
6506324|NCT01458522|7425556|FG000|STARTED|Overall Study||37
6506325|NCT01458522|7425557|FG001|STARTED|Overall Study||37
6506326|NCT01458522|7425556|FG000|Received First Drug|Overall Study||35
6506327|NCT01458522|7425557|FG001|Received First Drug|Overall Study||35
6570208|NCT01849770|7493618|FG000|STARTED|Overall Study||20
6570209|NCT01849770|7493619|FG001|STARTED|Overall Study||19
6570210|NCT01849770|7493620|FG002|STARTED|Overall Study||20
6570211|NCT01849770|7493618|FG000|COMPLETED|Overall Study||20
6570212|NCT01849770|7493619|FG001|COMPLETED|Overall Study||15
6570213|NCT01849770|7493620|FG002|COMPLETED|Overall Study||19
6570214|NCT01849770|7493618|FG000|NOT COMPLETED|Overall Study||0
6570215|NCT01849770|7493619|FG001|NOT COMPLETED|Overall Study||4
6250832|NCT03082898|7148966|FG001|COMPLETED|Overall Study||11
6250833|NCT03082898|7148965|FG000|NOT COMPLETED|Overall Study||3
6250834|NCT03082898|7148966|FG001|NOT COMPLETED|Overall Study||1
6250835|NCT03082313|7148972|FG000|STARTED|Overall Study||12
6250836|NCT03082313|7148972|FG000|COMPLETED|Overall Study||12
6250837|NCT03082313|7148972|FG000|NOT COMPLETED|Overall Study||0
6250841|NCT03056443|7148982|FG000|STARTED|Overall Study||13
6250842|NCT03056443|7148982|FG000|COMPLETED|Overall Study||13
6506328|NCT01458522|7425556|FG000|Crossover to Second Drug|Overall Study||15
6506329|NCT01458522|7425557|FG001|Crossover to Second Drug|Overall Study||10
6506330|NCT01458522|7425556|FG000|COMPLETED|Overall Study||34
6506331|NCT01458522|7425557|FG001|COMPLETED|Overall Study||26
6506332|NCT01458522|7425556|FG000|NOT COMPLETED|Overall Study||3
6570216|NCT01849770|7493620|FG002|NOT COMPLETED|Overall Study||1
6570217|NCT01849822|7493630|FG000|STARTED|Overall Study||1
6250838|NCT03081767|7148976|FG000|STARTED|Overall Study||199
6250839|NCT03081767|7148976|FG000|COMPLETED|Overall Study||199
6250840|NCT03081767|7148976|FG000|NOT COMPLETED|Overall Study||0
6250843|NCT03056443|7148982|FG000|NOT COMPLETED|Overall Study||0
6277800|NCT00129129|7177354|FG000|COMPLETED|Fourth Dose Phase||232
6277801|NCT00129129|7177355|FG001|COMPLETED|Fourth Dose Phase||0
6277802|NCT00129129|7177356|FG002|COMPLETED|Fourth Dose Phase||0
6277803|NCT00129129|7177357|FG003|COMPLETED|Fourth Dose Phase||128
6277804|NCT00129129|7177358|FG004|COMPLETED|Fourth Dose Phase||124
6277805|NCT00129129|7177354|FG000|NOT COMPLETED|Fourth Dose Phase||4
6277806|NCT00129129|7177355|FG001|NOT COMPLETED|Fourth Dose Phase||0
6277807|NCT00129129|7177356|FG002|NOT COMPLETED|Fourth Dose Phase||0
6277808|NCT00129129|7177357|FG003|NOT COMPLETED|Fourth Dose Phase||4
6277809|NCT00129129|7177358|FG004|NOT COMPLETED|Fourth Dose Phase||6
6506333|NCT01458522|7425557|FG001|NOT COMPLETED|Overall Study||11
6506334|NCT01458535|7425575|FG000|STARTED|Overall Study||10
6506335|NCT01458535|7425576|FG001|STARTED|Overall Study||10
6506336|NCT01458535|7425577|FG002|STARTED|Overall Study||10
6506337|NCT01458535|7425578|FG003|STARTED|Overall Study||10
6506338|NCT01458535|7425579|FG004|STARTED|Overall Study||10
6506339|NCT01458535|7425580|FG005|STARTED|Overall Study||11
6506340|NCT01458535|7425575|FG000|COMPLETED|Overall Study||10
6506341|NCT01458535|7425576|FG001|COMPLETED|Overall Study||8
6506342|NCT01458535|7425577|FG002|COMPLETED|Overall Study||8
6506343|NCT01458535|7425578|FG003|COMPLETED|Overall Study||6
6506344|NCT01458535|7425579|FG004|COMPLETED|Overall Study||6
6506345|NCT01458535|7425580|FG005|COMPLETED|Overall Study||7
6506346|NCT01458535|7425575|FG000|NOT COMPLETED|Overall Study||0
6506347|NCT01458535|7425576|FG001|NOT COMPLETED|Overall Study||2
6506348|NCT01458535|7425577|FG002|NOT COMPLETED|Overall Study||2
6506349|NCT01458535|7425578|FG003|NOT COMPLETED|Overall Study||4
6506350|NCT01458535|7425579|FG004|NOT COMPLETED|Overall Study||4
6506351|NCT01458535|7425580|FG005|NOT COMPLETED|Overall Study||4
6506352|NCT01458561|7425596|FG000|STARTED|Overall Study||0
6506353|NCT01458561|7425597|FG001|STARTED|Overall Study||1
6506354|NCT01458561|7425596|FG000|COMPLETED|Overall Study||0
6506355|NCT01458561|7425597|FG001|COMPLETED|Overall Study||1
6506356|NCT01458561|7425596|FG000|NOT COMPLETED|Overall Study||0
6506357|NCT01458561|7425597|FG001|NOT COMPLETED|Overall Study||0
6506358|NCT01458574|7425636|FG000|STARTED|Overall Study||198
6506359|NCT01458574|7425637|FG001|STARTED|Overall Study||197
6506360|NCT01458574|7425638|FG002|STARTED|Overall Study||198
6506361|NCT01458574|7425636|FG000|Treated|Overall Study||198
6506362|NCT01458574|7425637|FG001|Treated|Overall Study||196
6506363|NCT01458574|7425638|FG002|Treated|Overall Study||198
6506364|NCT01458574|7425636|FG000|COMPLETED|Overall Study||111
6506365|NCT01458574|7425637|FG001|COMPLETED|Overall Study||126
6506366|NCT01458574|7425638|FG002|COMPLETED|Overall Study||53
6506367|NCT01458574|7425636|FG000|NOT COMPLETED|Overall Study||87
6506368|NCT01458574|7425637|FG001|NOT COMPLETED|Overall Study||71
6506369|NCT01458574|7425638|FG002|NOT COMPLETED|Overall Study||145
6506370|NCT01458587|7425648|FG000|STARTED|Overall Study||35
6506371|NCT01458587|7425649|FG001|STARTED|Overall Study||35
6506372|NCT01458587|7425648|FG000|COMPLETED|Overall Study||34
6506373|NCT01458587|7425649|FG001|COMPLETED|Overall Study||35
6506374|NCT01458587|7425648|FG000|NOT COMPLETED|Overall Study||1
6506375|NCT01458587|7425649|FG001|NOT COMPLETED|Overall Study||0
6506376|NCT01458639|7425657|FG000|STARTED|Overall Study||18
6506377|NCT01458639|7425657|FG000|COMPLETED|Overall Study||12
6506378|NCT01458639|7425657|FG000|NOT COMPLETED|Overall Study||6
6506379|NCT01458951|7425664|FG000|STARTED|Overall Study||429
6506380|NCT01458951|7425665|FG001|STARTED|Overall Study||6
6506381|NCT01458951|7425666|FG002|STARTED|Overall Study||112
6506382|NCT01458951|7425664|FG000|COMPLETED|Overall Study||397
6506383|NCT01458951|7425665|FG001|COMPLETED|Overall Study||5
6506384|NCT01458951|7425666|FG002|COMPLETED|Overall Study||97
6506385|NCT01458951|7425664|FG000|NOT COMPLETED|Overall Study||32
6506386|NCT01458951|7425665|FG001|NOT COMPLETED|Overall Study||1
6506387|NCT01458951|7425666|FG002|NOT COMPLETED|Overall Study||15
6506388|NCT01458990|7425675|FG000|STARTED|Overall Study||45
6506389|NCT01458990|7425676|FG001|STARTED|Overall Study||15
6506390|NCT01458990|7425675|FG000|COMPLETED|Overall Study||45
6506391|NCT01458990|7425676|FG001|COMPLETED|Overall Study||15
6506392|NCT01458990|7425675|FG000|NOT COMPLETED|Overall Study||0
6506393|NCT01458990|7425676|FG001|NOT COMPLETED|Overall Study||0
6506394|NCT01459016|7425684|FG000|STARTED|Overall Study||56
6506395|NCT01459016|7425684|FG000|COMPLETED|Overall Study||41
6506396|NCT01459016|7425684|FG000|NOT COMPLETED|Overall Study||15
6506397|NCT01459068|7425690|FG000|STARTED|Overall Study||165
6506398|NCT01459068|7425691|FG001|STARTED|Overall Study||182
6506399|NCT01459068|7425690|FG000|COMPLETED|Overall Study||126
6506400|NCT01459068|7425691|FG001|COMPLETED|Overall Study||148
6506401|NCT01459068|7425690|FG000|NOT COMPLETED|Overall Study||39
6506402|NCT01459068|7425691|FG001|NOT COMPLETED|Overall Study||34
6506403|NCT01459588|7425701|FG000|STARTED|Overall Study||105
6506404|NCT01459588|7425702|FG001|STARTED|Overall Study||51
6506405|NCT01459588|7425703|FG002|STARTED|Overall Study||103
6506406|NCT01459588|7425704|FG003|STARTED|Overall Study||56
6506407|NCT01459588|7425701|FG000|COMPLETED|Overall Study||104
6506408|NCT01459588|7425702|FG001|COMPLETED|Overall Study||49
6506409|NCT01459588|7425703|FG002|COMPLETED|Overall Study||102
6506410|NCT01459588|7425704|FG003|COMPLETED|Overall Study||55
6506411|NCT01459588|7425701|FG000|NOT COMPLETED|Overall Study||1
6250844|NCT03020225|7148989|FG000|STARTED|Overall Study||12
6250845|NCT03020225|7148990|FG001|STARTED|Overall Study||11
6250846|NCT03020225|7148991|FG002|STARTED|Overall Study||13
6250847|NCT03020225|7148989|FG000|COMPLETED|Overall Study||12
6250848|NCT03020225|7148990|FG001|COMPLETED|Overall Study||11
6506412|NCT01459588|7425702|FG001|NOT COMPLETED|Overall Study||2
6506413|NCT01459588|7425703|FG002|NOT COMPLETED|Overall Study||1
6506414|NCT01459588|7425704|FG003|NOT COMPLETED|Overall Study||1
6506415|NCT01459614|7425716|FG000|STARTED|Overall Study||29
6506416|NCT01459614|7425717|FG001|STARTED|Overall Study||10
6506417|NCT01459614|7425716|FG000|COMPLETED|Overall Study||28
6506418|NCT01459614|7425717|FG001|COMPLETED|Overall Study||10
6506419|NCT01459614|7425716|FG000|NOT COMPLETED|Overall Study||1
6506420|NCT01459614|7425717|FG001|NOT COMPLETED|Overall Study||0
6506421|NCT01459653|7425723|FG000|STARTED|Overall Study||1496
6506422|NCT01459653|7425723|FG000|COMPLETED|Overall Study||828
6506423|NCT01459653|7425723|FG000|NOT COMPLETED|Overall Study||668
6506424|NCT01459705|7425797|FG000|STARTED|Overall Study||54
6506425|NCT01459705|7425798|FG001|STARTED|Overall Study||54
6506426|NCT01459705|7425799|FG002|STARTED|Overall Study||54
6506427|NCT01459705|7425797|FG000|COMPLETED|Overall Study||32
6506428|NCT01459705|7425798|FG001|COMPLETED|Overall Study||30
6506429|NCT01459705|7425799|FG002|COMPLETED|Overall Study||47
6506430|NCT01459705|7425797|FG000|NOT COMPLETED|Overall Study||22
6506431|NCT01459705|7425798|FG001|NOT COMPLETED|Overall Study||24
6506432|NCT01459705|7425799|FG002|NOT COMPLETED|Overall Study||7
6506433|NCT01459718|7425807|FG000|STARTED|Overall Study||13
6506434|NCT01459718|7425807|FG000|Safety Analysis Set|Overall Study||13
6506435|NCT01459718|7425807|FG000|COMPLETED|Overall Study||10
6506436|NCT01459718|7425807|FG000|NOT COMPLETED|Overall Study||3
6506437|NCT01459783|7425813|FG000|STARTED|Baseline to 6 Months||71
6506438|NCT01459783|7425814|FG001|STARTED|Baseline to 6 Months||73
6506439|NCT01459783|7425813|FG000|COMPLETED|Baseline to 6 Months||39
6506440|NCT01459783|7425814|FG001|COMPLETED|Baseline to 6 Months||53
6506441|NCT01459783|7425813|FG000|NOT COMPLETED|Baseline to 6 Months||32
6506442|NCT01459783|7425814|FG001|NOT COMPLETED|Baseline to 6 Months||20
6506443|NCT01459783|7425813|FG000|STARTED|6 Months to 12 Months||39
6506444|NCT01459783|7425814|FG001|STARTED|6 Months to 12 Months||53
6506445|NCT01459783|7425813|FG000|COMPLETED|6 Months to 12 Months||20
6506446|NCT01459783|7425814|FG001|COMPLETED|6 Months to 12 Months||23
6506447|NCT01459783|7425813|FG000|NOT COMPLETED|6 Months to 12 Months||19
6506448|NCT01459783|7425814|FG001|NOT COMPLETED|6 Months to 12 Months||30
6570218|NCT01849822|7493630|FG000|COMPLETED|Overall Study||1
6570219|NCT01849822|7493630|FG000|NOT COMPLETED|Overall Study||0
6570220|NCT01849848|7493634|FG000|STARTED|Overall Study||17
6570221|NCT01849848|7493634|FG000|COMPLETED|Overall Study||13
6570222|NCT01849848|7493634|FG000|NOT COMPLETED|Overall Study||4
6570223|NCT01850030|7493640|FG000|STARTED|Overall Study||520
6570224|NCT01850030|7493641|FG001|STARTED|Overall Study||511
6570225|NCT01850030|7493640|FG000|COMPLETED|Overall Study||173
6570226|NCT01850030|7493641|FG001|COMPLETED|Overall Study||142
6570227|NCT01850030|7493640|FG000|NOT COMPLETED|Overall Study||347
6570228|NCT01850030|7493641|FG001|NOT COMPLETED|Overall Study||369
6570229|NCT01850394|7493650|FG000|STARTED|Overall Study||45
6570230|NCT01850394|7493651|FG001|STARTED|Overall Study||45
6570231|NCT01850394|7493652|FG002|STARTED|Overall Study||45
6570232|NCT01850394|7493650|FG000|COMPLETED|Overall Study||45
6570233|NCT01850394|7493651|FG001|COMPLETED|Overall Study||45
6570234|NCT01850394|7493652|FG002|COMPLETED|Overall Study||45
6570235|NCT01850394|7493650|FG000|NOT COMPLETED|Overall Study||0
6570236|NCT01850394|7493651|FG001|NOT COMPLETED|Overall Study||0
6570237|NCT01850394|7493652|FG002|NOT COMPLETED|Overall Study||0
6570238|NCT01850446|7493662|FG000|STARTED|Overall Study||92
6570239|NCT01850446|7493663|FG001|STARTED|Overall Study||92
6570240|NCT01850446|7493662|FG000|COMPLETED|Overall Study||87
6250849|NCT03020225|7148991|FG002|COMPLETED|Overall Study||13
6250850|NCT03020225|7148989|FG000|NOT COMPLETED|Overall Study||0
6250851|NCT03020225|7148990|FG001|NOT COMPLETED|Overall Study||0
6250852|NCT03020225|7148991|FG002|NOT COMPLETED|Overall Study||0
6250853|NCT05110014|7149025|FG000|STARTED|Overall Study||12239
6250854|NCT05110014|7149026|FG001|STARTED|Overall Study||10787
6250855|NCT05110014|7149025|FG000|COMPLETED|Overall Study||12239
6250856|NCT05110014|7149026|FG001|COMPLETED|Overall Study||10787
6250857|NCT05110014|7149025|FG000|NOT COMPLETED|Overall Study||0
6250858|NCT05110014|7149026|FG001|NOT COMPLETED|Overall Study||0
6250859|NCT04980040|7149034|FG000|STARTED|Overall Study||3623
6250860|NCT04980040|7149034|FG000|COMPLETED|Overall Study||3131
6250861|NCT04980040|7149034|FG000|NOT COMPLETED|Overall Study||492
6250862|NCT04218279|7149040|FG000|STARTED|Overall Study||316
6250863|NCT04218279|7149041|FG001|STARTED|Overall Study||362
6250864|NCT04218279|7149040|FG000|COMPLETED|Overall Study||211
6570241|NCT01850446|7493663|FG001|COMPLETED|Overall Study||90
6570242|NCT01850446|7493662|FG000|NOT COMPLETED|Overall Study||5
6570243|NCT01850446|7493663|FG001|NOT COMPLETED|Overall Study||2
6570244|NCT01850485|7493671|FG000|STARTED|Overall Study||9
6570245|NCT01850485|7493672|FG001|STARTED|Overall Study||13
6570246|NCT01850485|7493671|FG000|COMPLETED|Overall Study||9
6570247|NCT01850485|7493672|FG001|COMPLETED|Overall Study||13
6570248|NCT01850485|7493671|FG000|NOT COMPLETED|Overall Study||0
6570249|NCT01850485|7493672|FG001|NOT COMPLETED|Overall Study||0
6570250|NCT01850550|7493680|FG000|STARTED|Overall Study||40
6570251|NCT01850550|7493681|FG001|STARTED|Overall Study||40
6250865|NCT04218279|7149041|FG001|COMPLETED|Overall Study||225
6250866|NCT04218279|7149040|FG000|NOT COMPLETED|Overall Study||105
6250867|NCT04218279|7149041|FG001|NOT COMPLETED|Overall Study||137
6250868|NCT04167670|7149050|FG000|STARTED|Overall Study||349
6250869|NCT04167670|7149051|FG001|STARTED|Overall Study||349
6250870|NCT04167670|7149052|FG002|STARTED|Overall Study||348
6250871|NCT04167670|7149050|FG000|Received Study Drugs|Overall Study||348
6250872|NCT04167670|7149051|FG001|Received Study Drugs|Overall Study||346
6250873|NCT04167670|7149052|FG002|Received Study Drugs|Overall Study||345
6250874|NCT04167670|7149050|FG000|COMPLETED|Overall Study||334
6250875|NCT04167670|7149051|FG001|COMPLETED|Overall Study||331
6250876|NCT04167670|7149052|FG002|COMPLETED|Overall Study||334
6250877|NCT04167670|7149050|FG000|NOT COMPLETED|Overall Study||15
6250878|NCT04167670|7149051|FG001|NOT COMPLETED|Overall Study||18
6250879|NCT04167670|7149052|FG002|NOT COMPLETED|Overall Study||14
6570252|NCT01850550|7493680|FG000|COMPLETED|Overall Study||40
6570253|NCT01850550|7493681|FG001|COMPLETED|Overall Study||37
6570254|NCT01850550|7493680|FG000|NOT COMPLETED|Overall Study||0
6570255|NCT01850550|7493681|FG001|NOT COMPLETED|Overall Study||3
6623546|NCT02208050|7550678|FG001|COMPLETED|Washout Period 2: 2 Weeks Washout.||28
6623547|NCT02208050|7550677|FG000|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
6623548|NCT02208050|7550678|FG001|NOT COMPLETED|Washout Period 2: 2 Weeks Washout.||0
6623549|NCT02208063|7550700|FG000|STARTED|Overall Study||60
6623550|NCT02208063|7550701|FG001|STARTED|Overall Study||61
6506449|NCT01459796|7425822|FG000|STARTED|Overall Study||94
6506450|NCT01459796|7425823|FG001|STARTED|Overall Study||126
6506451|NCT01459796|7425822|FG000|COMPLETED|Overall Study||0
6506452|NCT01459796|7425823|FG001|COMPLETED|Overall Study||0
6506453|NCT01459796|7425822|FG000|NOT COMPLETED|Overall Study||94
6506454|NCT01459796|7425823|FG001|NOT COMPLETED|Overall Study||126
6250880|NCT04076917|7149060|FG000|STARTED|Overall Study||84
6250881|NCT04076917|7149060|FG000|COMPLETED|Overall Study||15
6250882|NCT04076917|7149060|FG000|NOT COMPLETED|Overall Study||69
6250883|NCT04000009|7149064|FG000|STARTED|Overall Study||235
6250884|NCT04000009|7149064|FG000|COMPLETED|Overall Study||70
6250885|NCT04000009|7149064|FG000|NOT COMPLETED|Overall Study||165
6250886|NCT03988335|7149070|FG000|STARTED|Overall Study||16
6250887|NCT03988335|7149071|FG001|STARTED|Overall Study||19
6250888|NCT03988335|7149070|FG000|COMPLETED|Overall Study||14
6250889|NCT03988335|7149071|FG001|COMPLETED|Overall Study||18
6250890|NCT03988335|7149070|FG000|NOT COMPLETED|Overall Study||2
6250891|NCT03988335|7149071|FG001|NOT COMPLETED|Overall Study||1
6277810|NCT00129220|7177381|FG000|STARTED|Study Period II||105
6277811|NCT00129220|7177382|FG001|STARTED|Study Period II||20
6277812|NCT00129220|7177383|FG002|STARTED|Study Period II||99
6277813|NCT00129220|7177381|FG000|Received at Least One Dose of Study Drug|Study Period II||104
6277814|NCT00129220|7177382|FG001|Received at Least One Dose of Study Drug|Study Period II||20
6277815|NCT00129220|7177383|FG002|Received at Least One Dose of Study Drug|Study Period II||97
6277816|NCT00129220|7177381|FG000|COMPLETED|Study Period II||72
6277817|NCT00129220|7177382|FG001|COMPLETED|Study Period II||8
6277818|NCT00129220|7177383|FG002|COMPLETED|Study Period II||52
6277819|NCT00129220|7177381|FG000|NOT COMPLETED|Study Period II||33
6277820|NCT00129220|7177382|FG001|NOT COMPLETED|Study Period II||12
6277821|NCT00129220|7177383|FG002|NOT COMPLETED|Study Period II||47
6277822|NCT00129220|7177381|FG000|STARTED|Study Period III||72
6277823|NCT00129220|7177382|FG001|STARTED|Study Period III||8
6277824|NCT00129220|7177383|FG002|STARTED|Study Period III||52
6277825|NCT00129220|7177381|FG000|COMPLETED|Study Period III||59
6277826|NCT00129220|7177382|FG001|COMPLETED|Study Period III||7
6277827|NCT00129220|7177383|FG002|COMPLETED|Study Period III||42
6277828|NCT00129220|7177381|FG000|NOT COMPLETED|Study Period III||13
6277829|NCT00129220|7177382|FG001|NOT COMPLETED|Study Period III||1
6277830|NCT00129220|7177383|FG002|NOT COMPLETED|Study Period III||10
6277831|NCT00129246|7177395|FG000|STARTED|Overall Study||20
6277832|NCT00129246|7177396|FG001|STARTED|Overall Study||20
6277833|NCT00129246|7177395|FG000|COMPLETED|Overall Study||20
6277834|NCT00129246|7177396|FG001|COMPLETED|Overall Study||20
6506455|NCT01459913|7425833|FG000|STARTED|Overall Study||106
6506456|NCT01459913|7425834|FG001|STARTED|Overall Study||52
6506457|NCT01459913|7425835|FG002|STARTED|Overall Study||19
6506458|NCT01459913|7425836|FG003|STARTED|Overall Study||62
6506459|NCT01459913|7425833|FG000|COMPLETED|Overall Study||65
6506460|NCT01459913|7425834|FG001|COMPLETED|Overall Study||32
6623551|NCT02208063|7550700|FG000|Randomized and Treated|Overall Study||58
6623552|NCT02208063|7550701|FG001|Randomized and Treated|Overall Study||60
6623553|NCT02208063|7550700|FG000|Microbiological All Treated|Overall Study||47
6623554|NCT02208063|7550701|FG001|Microbiological All Treated|Overall Study||52
6623555|NCT02208063|7550700|FG000|COMPLETED|Overall Study||48
6623556|NCT02208063|7550701|FG001|COMPLETED|Overall Study||50
6623557|NCT02208063|7550700|FG000|NOT COMPLETED|Overall Study||12
6623558|NCT02208063|7550701|FG001|NOT COMPLETED|Overall Study||11
6623559|NCT02208089|7550709|FG000|STARTED|Overall Study||47
6623560|NCT02208089|7550710|FG001|STARTED|Overall Study||47
6623561|NCT02208089|7550709|FG000|COMPLETED|Overall Study||40
6623562|NCT02208089|7550710|FG001|COMPLETED|Overall Study||47
6623563|NCT02208089|7550709|FG000|NOT COMPLETED|Overall Study||7
6623564|NCT02208089|7550710|FG001|NOT COMPLETED|Overall Study||0
6623565|NCT02208297|7550719|FG000|STARTED|Overall Study||163
6623566|NCT02208297|7550720|FG001|STARTED|Overall Study||163
6623567|NCT02208297|7550719|FG000|COMPLETED|Overall Study||141
6623568|NCT02208297|7550720|FG001|COMPLETED|Overall Study||107
6250892|NCT03792737|7149080|FG000|STARTED|Overall Study||166
6250893|NCT03792737|7149081|FG001|STARTED|Overall Study||167
6250894|NCT03792737|7149082|FG002|STARTED|Overall Study||167
6250895|NCT03792737|7149080|FG000|Safety Analysis Set|Overall Study||162
6250896|NCT03792737|7149081|FG001|Safety Analysis Set|Overall Study|one subject didn't participate screen visit or randomize, but receive IP treatment by mistake.|161
6250897|NCT03792737|7149082|FG002|Safety Analysis Set|Overall Study||162
6250898|NCT03792737|7149080|FG000|Full Analysis Set|Overall Study||162
6250899|NCT03792737|7149081|FG001|Full Analysis Set|Overall Study||160
6250900|NCT03792737|7149082|FG002|Full Analysis Set|Overall Study||162
6250901|NCT03792737|7149080|FG000|COMPLETED|Overall Study||160
6250902|NCT03792737|7149081|FG001|COMPLETED|Overall Study||159
6250903|NCT03792737|7149082|FG002|COMPLETED|Overall Study||158
6250904|NCT03792737|7149080|FG000|NOT COMPLETED|Overall Study||6
6250905|NCT03792737|7149081|FG001|NOT COMPLETED|Overall Study||8
6250906|NCT03792737|7149082|FG002|NOT COMPLETED|Overall Study||9
6250907|NCT03674112|7149092|FG000|STARTED|Overall Study||80
6250908|NCT03674112|7149093|FG001|STARTED|Overall Study||80
6250909|NCT03674112|7149092|FG000|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
6250910|NCT03674112|7149093|FG001|Completed Cross-Over Treatment (Cycles 1 to 6)|Overall Study||80
6250911|NCT03674112|7149092|FG000|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||34
6250912|NCT03674112|7149093|FG001|Completed Continuation Treatment (Cycles 7 up to 18 Total)|Overall Study||36
6250913|NCT03674112|7149092|FG000|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
6506461|NCT01459913|7425835|FG002|COMPLETED|Overall Study||6
6506462|NCT01459913|7425836|FG003|COMPLETED|Overall Study||29
6506463|NCT01459913|7425833|FG000|NOT COMPLETED|Overall Study||41
6506464|NCT01459913|7425834|FG001|NOT COMPLETED|Overall Study||20
6506465|NCT01459913|7425835|FG002|NOT COMPLETED|Overall Study||13
6506466|NCT01459913|7425836|FG003|NOT COMPLETED|Overall Study||33
6506467|NCT01460225|7425848|FG000|STARTED|Overall Study|January 2009.|19
6506468|NCT01460225|7425848|FG000|COMPLETED|Overall Study|November 2010|19
6506469|NCT01460225|7425848|FG000|NOT COMPLETED|Overall Study||0
6506470|NCT01460290|7425853|FG000|STARTED|Overall Study||15
6506471|NCT01460290|7425853|FG000|COMPLETED|Overall Study||11
6506472|NCT01460290|7425853|FG000|NOT COMPLETED|Overall Study||4
6506473|NCT01460303|7425860|FG000|STARTED|Overall Study||25
6506474|NCT01460303|7425861|FG001|STARTED|Overall Study||24
6506475|NCT01460303|7425860|FG000|COMPLETED|Overall Study||25
6506476|NCT01460303|7425861|FG001|COMPLETED|Overall Study||24
6506477|NCT01460303|7425860|FG000|NOT COMPLETED|Overall Study||0
6506478|NCT01460303|7425861|FG001|NOT COMPLETED|Overall Study||0
6506479|NCT01460342|7425869|FG000|STARTED|Overall Study||304
6506480|NCT01460342|7425870|FG001|STARTED|Overall Study||306
6506481|NCT01460342|7425869|FG000|Received at Least 1 Dose of Study Drug|Overall Study||304
6506482|NCT01460342|7425870|FG001|Received at Least 1 Dose of Study Drug|Overall Study||306
6506483|NCT01460342|7425869|FG000|COMPLETED|Overall Study||293
6506484|NCT01460342|7425870|FG001|COMPLETED|Overall Study||292
6506485|NCT01460342|7425869|FG000|NOT COMPLETED|Overall Study||11
6506486|NCT01460342|7425870|FG001|NOT COMPLETED|Overall Study||14
6506487|NCT01460368|7425878|FG000|STARTED|Part A||7
6506488|NCT01460368|7425879|FG001|STARTED|Part A||0
6506489|NCT01460368|7425880|FG002|STARTED|Part A||0
6506490|NCT01460368|7425881|FG003|STARTED|Part A||0
6506491|NCT01460368|7425882|FG004|STARTED|Part A||0
6506492|NCT01460368|7425883|FG005|STARTED|Part A||0
6506493|NCT01460368|7425884|FG006|STARTED|Part A||0
6506494|NCT01460368|7425878|FG000|Received at Least One Dose of Study Drug|Part A||7
6506495|NCT01460368|7425879|FG001|Received at Least One Dose of Study Drug|Part A||0
6506496|NCT01460368|7425880|FG002|Received at Least One Dose of Study Drug|Part A||0
6506497|NCT01460368|7425881|FG003|Received at Least One Dose of Study Drug|Part A||0
6506498|NCT01460368|7425882|FG004|Received at Least One Dose of Study Drug|Part A||0
6506499|NCT01460368|7425883|FG005|Received at Least One Dose of Study Drug|Part A||0
6506500|NCT01460368|7425884|FG006|Received at Least One Dose of Study Drug|Part A||0
6506501|NCT01460368|7425878|FG000|COMPLETED|Part A||7
6506502|NCT01460368|7425879|FG001|COMPLETED|Part A||0
6506503|NCT01460368|7425880|FG002|COMPLETED|Part A||0
6506504|NCT01460368|7425881|FG003|COMPLETED|Part A||0
6506505|NCT01460368|7425882|FG004|COMPLETED|Part A||0
6506506|NCT01460368|7425883|FG005|COMPLETED|Part A||0
6506507|NCT01460368|7425884|FG006|COMPLETED|Part A||0
6506508|NCT01460368|7425878|FG000|NOT COMPLETED|Part A||0
6506509|NCT01460368|7425879|FG001|NOT COMPLETED|Part A||0
6250914|NCT03674112|7149093|FG001|Completed Post-Treatment Follow-Up (Up to 3 Years)|Overall Study||0
6250915|NCT03674112|7149092|FG000|COMPLETED|Overall Study||0
6250916|NCT03674112|7149093|FG001|COMPLETED|Overall Study||0
6250917|NCT03674112|7149092|FG000|NOT COMPLETED|Overall Study||80
6250918|NCT03674112|7149093|FG001|NOT COMPLETED|Overall Study||80
6506510|NCT01460368|7425880|FG002|NOT COMPLETED|Part A||0
6506511|NCT01460368|7425881|FG003|NOT COMPLETED|Part A||0
6506512|NCT01460368|7425882|FG004|NOT COMPLETED|Part A||0
6506513|NCT01460368|7425883|FG005|NOT COMPLETED|Part A||0
6506514|NCT01460368|7425884|FG006|NOT COMPLETED|Part A||0
6506515|NCT01460368|7425878|FG000|STARTED|Part B: First Intervention (Period 1)||0
6506516|NCT01460368|7425879|FG001|STARTED|Part B: First Intervention (Period 1)||10
6506517|NCT01460368|7425880|FG002|STARTED|Part B: First Intervention (Period 1)||10
6250919|NCT03618641|7149119|FG000|STARTED|Overall Study||34
6250920|NCT03618641|7149119|FG000|COMPLETED|Overall Study||34
6250921|NCT03618641|7149119|FG000|NOT COMPLETED|Overall Study||0
6250922|NCT03584464|7149123|FG000|STARTED|Overall Study||205
6250923|NCT03584464|7149123|FG000|COMPLETED|Overall Study|Number of subjects that competed 1 year follow up or had a CEC event|204
6250924|NCT03584464|7149123|FG000|NOT COMPLETED|Overall Study||1
6250925|NCT03441477|7149127|FG000|STARTED|Overall Study||225
6250926|NCT03441477|7149127|FG000|COMPLETED|Overall Study||224
6250927|NCT03441477|7149127|FG000|NOT COMPLETED|Overall Study||1
6250928|NCT03205371|7149145|FG000|STARTED|Overall Study||107
6250929|NCT03205371|7149146|FG001|STARTED|Overall Study||53
6250930|NCT03205371|7149147|FG002|STARTED|Overall Study||53
6250931|NCT03205371|7149148|FG003|STARTED|Overall Study||86
6250932|NCT03205371|7149149|FG004|STARTED|Overall Study||42
6250933|NCT03205371|7149150|FG005|STARTED|Overall Study||42
6250934|NCT03205371|7149151|FG006|STARTED|Overall Study||200
6250935|NCT03205371|7149152|FG007|STARTED|Overall Study||100
6250936|NCT03205371|7149153|FG008|STARTED|Overall Study||100
6250937|NCT03205371|7149154|FG009|STARTED|Overall Study||200
6250938|NCT03205371|7149155|FG010|STARTED|Overall Study||100
6250939|NCT03205371|7149156|FG011|STARTED|Overall Study||100
6250940|NCT03205371|7149145|FG000|Safety Analysis Set (SafAS)|Overall Study||103
6250941|NCT03205371|7149146|FG001|Safety Analysis Set (SafAS)|Overall Study||52
6250942|NCT03205371|7149147|FG002|Safety Analysis Set (SafAS)|Overall Study||53
6250943|NCT03205371|7149148|FG003|Safety Analysis Set (SafAS)|Overall Study||86
6250944|NCT03205371|7149149|FG004|Safety Analysis Set (SafAS)|Overall Study||42
6250945|NCT03205371|7149150|FG005|Safety Analysis Set (SafAS)|Overall Study||42
6250946|NCT03205371|7149151|FG006|Safety Analysis Set (SafAS)|Overall Study||200
6250947|NCT03205371|7149152|FG007|Safety Analysis Set (SafAS)|Overall Study||100
6250948|NCT03205371|7149153|FG008|Safety Analysis Set (SafAS)|Overall Study||100
6250949|NCT03205371|7149154|FG009|Safety Analysis Set (SafAS)|Overall Study||200
6250950|NCT03205371|7149155|FG010|Safety Analysis Set (SafAS)|Overall Study||100
6250951|NCT03205371|7149156|FG011|Safety Analysis Set (SafAS)|Overall Study||99
6250952|NCT03205371|7149145|FG000|Per-protocol Analysis Set (PPAS)|Overall Study||92
6250953|NCT03205371|7149146|FG001|Per-protocol Analysis Set (PPAS)|Overall Study||45
6250954|NCT03205371|7149147|FG002|Per-protocol Analysis Set (PPAS)|Overall Study||50
6250955|NCT03205371|7149148|FG003|Per-protocol Analysis Set (PPAS)|Overall Study||85
6250956|NCT03205371|7149149|FG004|Per-protocol Analysis Set (PPAS)|Overall Study||42
6250957|NCT03205371|7149150|FG005|Per-protocol Analysis Set (PPAS)|Overall Study||42
6250958|NCT03205371|7149151|FG006|Per-protocol Analysis Set (PPAS)|Overall Study||155
6250959|NCT03205371|7149152|FG007|Per-protocol Analysis Set (PPAS)|Overall Study||79
6250960|NCT03205371|7149153|FG008|Per-protocol Analysis Set (PPAS)|Overall Study||68
6250961|NCT03205371|7149154|FG009|Per-protocol Analysis Set (PPAS)|Overall Study||196
6250962|NCT03205371|7149155|FG010|Per-protocol Analysis Set (PPAS)|Overall Study||96
6250963|NCT03205371|7149156|FG011|Per-protocol Analysis Set (PPAS)|Overall Study||92
6250964|NCT03205371|7149145|FG000|COMPLETED|Overall Study||103
6250965|NCT03205371|7149146|FG001|COMPLETED|Overall Study||52
6250966|NCT03205371|7149147|FG002|COMPLETED|Overall Study||53
6250967|NCT03205371|7149148|FG003|COMPLETED|Overall Study||86
6250968|NCT03205371|7149149|FG004|COMPLETED|Overall Study||42
6506518|NCT01460368|7425881|FG003|STARTED|Part B: First Intervention (Period 1)||10
6506519|NCT01460368|7425882|FG004|STARTED|Part B: First Intervention (Period 1)||10
6506520|NCT01460368|7425883|FG005|STARTED|Part B: First Intervention (Period 1)||10
6506521|NCT01460368|7425884|FG006|STARTED|Part B: First Intervention (Period 1)||10
6506522|NCT01460368|7425878|FG000|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||0
6506523|NCT01460368|7425879|FG001|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6506524|NCT01460368|7425880|FG002|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6506525|NCT01460368|7425881|FG003|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6506526|NCT01460368|7425882|FG004|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6506527|NCT01460368|7425883|FG005|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6506528|NCT01460368|7425884|FG006|Received at Least One Dose of Study Drug|Part B: First Intervention (Period 1)||10
6506529|NCT01460368|7425878|FG000|COMPLETED|Part B: First Intervention (Period 1)||0
6506530|NCT01460368|7425879|FG001|COMPLETED|Part B: First Intervention (Period 1)||10
6506531|NCT01460368|7425880|FG002|COMPLETED|Part B: First Intervention (Period 1)||10
6506532|NCT01460368|7425881|FG003|COMPLETED|Part B: First Intervention (Period 1)||10
6506533|NCT01460368|7425882|FG004|COMPLETED|Part B: First Intervention (Period 1)||9
6506534|NCT01460368|7425883|FG005|COMPLETED|Part B: First Intervention (Period 1)||10
6506535|NCT01460368|7425884|FG006|COMPLETED|Part B: First Intervention (Period 1)||10
6506536|NCT01460368|7425878|FG000|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6506537|NCT01460368|7425879|FG001|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6506538|NCT01460368|7425880|FG002|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6506539|NCT01460368|7425881|FG003|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6506540|NCT01460368|7425882|FG004|NOT COMPLETED|Part B: First Intervention (Period 1)||1
6506541|NCT01460368|7425883|FG005|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6506542|NCT01460368|7425884|FG006|NOT COMPLETED|Part B: First Intervention (Period 1)||0
6250969|NCT03205371|7149150|FG005|COMPLETED|Overall Study||42
6250970|NCT03205371|7149151|FG006|COMPLETED|Overall Study||190
6250971|NCT03205371|7149152|FG007|COMPLETED|Overall Study||97
6250972|NCT03205371|7149153|FG008|COMPLETED|Overall Study||95
6250973|NCT03205371|7149154|FG009|COMPLETED|Overall Study||200
6250974|NCT03205371|7149155|FG010|COMPLETED|Overall Study||100
6250975|NCT03205371|7149156|FG011|COMPLETED|Overall Study||99
6250976|NCT03205371|7149145|FG000|NOT COMPLETED|Overall Study||4
6250977|NCT03205371|7149146|FG001|NOT COMPLETED|Overall Study||1
6250978|NCT03205371|7149147|FG002|NOT COMPLETED|Overall Study||0
6250979|NCT03205371|7149148|FG003|NOT COMPLETED|Overall Study||0
6250980|NCT03205371|7149149|FG004|NOT COMPLETED|Overall Study||0
6250981|NCT03205371|7149150|FG005|NOT COMPLETED|Overall Study||0
6250982|NCT03205371|7149151|FG006|NOT COMPLETED|Overall Study||10
6250983|NCT03205371|7149152|FG007|NOT COMPLETED|Overall Study||3
6250984|NCT03205371|7149153|FG008|NOT COMPLETED|Overall Study||5
6250985|NCT03205371|7149154|FG009|NOT COMPLETED|Overall Study||0
6250986|NCT03205371|7149155|FG010|NOT COMPLETED|Overall Study||0
6250987|NCT03205371|7149156|FG011|NOT COMPLETED|Overall Study||1
6250988|NCT03165721|7149205|FG000|STARTED|Overall Study||7
6250989|NCT03165721|7149206|FG001|STARTED|Overall Study||1
6250990|NCT03165721|7149207|FG002|STARTED|Overall Study||1
6250991|NCT03165721|7149205|FG000|COMPLETED|Overall Study||3
6250992|NCT03165721|7149206|FG001|COMPLETED|Overall Study||1
6250993|NCT03165721|7149207|FG002|COMPLETED|Overall Study||1
6250994|NCT03165721|7149205|FG000|NOT COMPLETED|Overall Study||4
6250995|NCT03165721|7149206|FG001|NOT COMPLETED|Overall Study||0
6250996|NCT03165721|7149207|FG002|NOT COMPLETED|Overall Study||0
6250997|NCT03130959|7149227|FG000|STARTED|Treatment Period||23
6250998|NCT03130959|7149228|FG001|STARTED|Treatment Period||22
6250999|NCT03130959|7149229|FG002|STARTED|Treatment Period||16
6251000|NCT03130959|7149230|FG003|STARTED|Treatment Period||15
6251001|NCT03130959|7149231|FG004|STARTED|Treatment Period||15
6251002|NCT03130959|7149232|FG005|STARTED|Treatment Period||15
6251003|NCT03130959|7149233|FG006|STARTED|Treatment Period||12
6251004|NCT03130959|7149234|FG007|STARTED|Treatment Period||10
6251005|NCT03130959|7149235|FG008|STARTED|Treatment Period||19
6251006|NCT03130959|7149236|FG009|STARTED|Treatment Period||19
6251007|NCT03130959|7149227|FG000|COMPLETED|Treatment Period||2
6251008|NCT03130959|7149228|FG001|COMPLETED|Treatment Period||1
6251009|NCT03130959|7149229|FG002|COMPLETED|Treatment Period||1
6251010|NCT03130959|7149230|FG003|COMPLETED|Treatment Period||0
6251011|NCT03130959|7149231|FG004|COMPLETED|Treatment Period||0
6251012|NCT03130959|7149232|FG005|COMPLETED|Treatment Period||0
6251013|NCT03130959|7149233|FG006|COMPLETED|Treatment Period||0
6251014|NCT03130959|7149234|FG007|COMPLETED|Treatment Period||0
6251015|NCT03130959|7149235|FG008|COMPLETED|Treatment Period||0
6251016|NCT03130959|7149236|FG009|COMPLETED|Treatment Period||1
6251017|NCT03130959|7149227|FG000|NOT COMPLETED|Treatment Period||21
6251018|NCT03130959|7149228|FG001|NOT COMPLETED|Treatment Period||21
6251019|NCT03130959|7149229|FG002|NOT COMPLETED|Treatment Period||15
6251020|NCT03130959|7149230|FG003|NOT COMPLETED|Treatment Period||15
6251021|NCT03130959|7149231|FG004|NOT COMPLETED|Treatment Period||15
6251022|NCT03130959|7149232|FG005|NOT COMPLETED|Treatment Period||15
6251023|NCT03130959|7149233|FG006|NOT COMPLETED|Treatment Period||12
6251024|NCT03130959|7149234|FG007|NOT COMPLETED|Treatment Period||10
6251025|NCT03130959|7149235|FG008|NOT COMPLETED|Treatment Period||19
6251026|NCT03130959|7149236|FG009|NOT COMPLETED|Treatment Period||18
6251027|NCT03130959|7149227|FG000|STARTED|Follow-up Period||23
6251028|NCT03130959|7149228|FG001|STARTED|Follow-up Period||22
6251029|NCT03130959|7149229|FG002|STARTED|Follow-up Period||16
6251030|NCT03130959|7149230|FG003|STARTED|Follow-up Period||15
6251031|NCT03130959|7149231|FG004|STARTED|Follow-up Period||15
6251032|NCT03130959|7149232|FG005|STARTED|Follow-up Period||15
6251033|NCT03130959|7149233|FG006|STARTED|Follow-up Period||12
6251034|NCT03130959|7149234|FG007|STARTED|Follow-up Period||10
6251035|NCT03130959|7149235|FG008|STARTED|Follow-up Period||19
6251036|NCT03130959|7149236|FG009|STARTED|Follow-up Period||19
6251037|NCT03130959|7149227|FG000|COMPLETED|Follow-up Period||3
6251038|NCT03130959|7149228|FG001|COMPLETED|Follow-up Period||2
6251039|NCT03130959|7149229|FG002|COMPLETED|Follow-up Period||4
6251040|NCT03130959|7149230|FG003|COMPLETED|Follow-up Period||1
6251041|NCT03130959|7149231|FG004|COMPLETED|Follow-up Period||1
6251042|NCT03130959|7149232|FG005|COMPLETED|Follow-up Period||5
6251043|NCT03130959|7149233|FG006|COMPLETED|Follow-up Period||3
6251044|NCT03130959|7149234|FG007|COMPLETED|Follow-up Period||2
6251045|NCT03130959|7149235|FG008|COMPLETED|Follow-up Period||1
6251046|NCT03130959|7149236|FG009|COMPLETED|Follow-up Period||3
6251047|NCT03130959|7149227|FG000|NOT COMPLETED|Follow-up Period||20
6251048|NCT03130959|7149228|FG001|NOT COMPLETED|Follow-up Period||20
6251049|NCT03130959|7149229|FG002|NOT COMPLETED|Follow-up Period||12
6251050|NCT03130959|7149230|FG003|NOT COMPLETED|Follow-up Period||14
6251051|NCT03130959|7149231|FG004|NOT COMPLETED|Follow-up Period||14
6251052|NCT03130959|7149232|FG005|NOT COMPLETED|Follow-up Period||10
6251053|NCT03130959|7149233|FG006|NOT COMPLETED|Follow-up Period||9
6251054|NCT03130959|7149234|FG007|NOT COMPLETED|Follow-up Period||8
6251055|NCT03130959|7149235|FG008|NOT COMPLETED|Follow-up Period||18
6251056|NCT03130959|7149236|FG009|NOT COMPLETED|Follow-up Period||16
6251057|NCT02955797|7149275|FG000|STARTED|Overall Study||306
6251058|NCT02955797|7149276|FG001|STARTED|Overall Study||306
6251059|NCT02955797|7149277|FG002|STARTED|Overall Study||203
6251060|NCT02955797|7149278|FG003|STARTED|Overall Study||103
6251061|NCT02955797|7149275|FG000|Safety Analysis Set (SafAS)|Overall Study||303
6251062|NCT02955797|7149276|FG001|Safety Analysis Set (SafAS)|Overall Study||306
6251063|NCT02955797|7149277|FG002|Safety Analysis Set (SafAS)|Overall Study||203
6251064|NCT02955797|7149278|FG003|Safety Analysis Set (SafAS)|Overall Study||102
6251065|NCT02955797|7149275|FG000|Per Protocol Analysis Set (PPAS)|Overall Study||293
6251066|NCT02955797|7149276|FG001|Per Protocol Analysis Set (PPAS)|Overall Study||296
6251067|NCT02955797|7149277|FG002|Per Protocol Analysis Set (PPAS)|Overall Study||198
6251068|NCT02955797|7149278|FG003|Per Protocol Analysis Set (PPAS)|Overall Study||99
6251069|NCT02955797|7149275|FG000|COMPLETED|Overall Study||303
6251070|NCT02955797|7149276|FG001|COMPLETED|Overall Study||303
6251071|NCT02955797|7149277|FG002|COMPLETED|Overall Study||203
6251072|NCT02955797|7149278|FG003|COMPLETED|Overall Study||101
6251073|NCT02955797|7149275|FG000|NOT COMPLETED|Overall Study||3
6251074|NCT02955797|7149276|FG001|NOT COMPLETED|Overall Study||3
6251075|NCT02955797|7149277|FG002|NOT COMPLETED|Overall Study||0
6251076|NCT02955797|7149278|FG003|NOT COMPLETED|Overall Study||2
6251077|NCT02893930|7149291|FG000|STARTED|Overall Study||13
6251078|NCT02893930|7149291|FG000|Eligible and Treated|Overall Study||12
6251079|NCT02893930|7149291|FG000|COMPLETED|Overall Study||0
6251080|NCT02893930|7149291|FG000|NOT COMPLETED|Overall Study||13
6251081|NCT02859415|7149297|FG000|STARTED|Overall Study||1
6251082|NCT02859415|7149298|FG001|STARTED|Overall Study||2
6251083|NCT02859415|7149297|FG000|COMPLETED|Overall Study||0
6251084|NCT02859415|7149298|FG001|COMPLETED|Overall Study||1
6251085|NCT02859415|7149297|FG000|NOT COMPLETED|Overall Study||1
6251086|NCT02859415|7149298|FG001|NOT COMPLETED|Overall Study||1
6251087|NCT02842866|7149307|FG000|STARTED|Overall Study||451
6251088|NCT02842866|7149308|FG001|STARTED|Overall Study||455
6251089|NCT02842866|7149307|FG000|Vaccinated|Overall Study||448
6251090|NCT02842866|7149308|FG001|Vaccinated|Overall Study||453
6251091|NCT02842866|7149307|FG000|COMPLETED|Overall Study||444
6251092|NCT02842866|7149308|FG001|COMPLETED|Overall Study||452
6251093|NCT02842866|7149307|FG000|NOT COMPLETED|Overall Study||7
6251094|NCT02842866|7149308|FG001|NOT COMPLETED|Overall Study||3
6251095|NCT02842853|7149318|FG000|STARTED|Overall Study||902
6251096|NCT02842853|7149319|FG001|STARTED|Overall Study||895
6251097|NCT02842853|7149320|FG002|STARTED|Overall Study||906
6251098|NCT02842853|7149321|FG003|STARTED|Overall Study||641
6251099|NCT02842853|7149318|FG000|Vaccinated|Overall Study||895
6251100|NCT02842853|7149319|FG001|Vaccinated|Overall Study||886
6251101|NCT02842853|7149320|FG002|Vaccinated|Overall Study||900
6251102|NCT02842853|7149321|FG003|Vaccinated|Overall Study||636
6251103|NCT02842853|7149318|FG000|Safety Analysis Set (SafAS)|Overall Study||895
6251104|NCT02842853|7149319|FG001|Safety Analysis Set (SafAS)|Overall Study||883
6251105|NCT02842853|7149320|FG002|Safety Analysis Set (SafAS)|Overall Study||898
6251106|NCT02842853|7149321|FG003|Safety Analysis Set (SafAS)|Overall Study||635
6251107|NCT02842853|7149318|FG000|COMPLETED|Overall Study||879
6251108|NCT02842853|7149319|FG001|COMPLETED|Overall Study||861
6251109|NCT02842853|7149320|FG002|COMPLETED|Overall Study||885
6251110|NCT02842853|7149321|FG003|COMPLETED|Overall Study||617
6251111|NCT02842853|7149318|FG000|NOT COMPLETED|Overall Study||23
6251112|NCT02842853|7149319|FG001|NOT COMPLETED|Overall Study||34
6251113|NCT02842853|7149320|FG002|NOT COMPLETED|Overall Study||21
6251114|NCT02842853|7149321|FG003|NOT COMPLETED|Overall Study||24
6251115|NCT02759185|7149337|FG000|STARTED|Stage 1||20
6251116|NCT02759185|7149338|FG001|STARTED|Stage 1||20
6251117|NCT02759185|7149339|FG002|STARTED|Stage 1||20
6251118|NCT02759185|7149340|FG003|STARTED|Stage 1||20
6251119|NCT02759185|7149341|FG004|STARTED|Stage 1||0
6251120|NCT02759185|7149342|FG005|STARTED|Stage 1||0
6251121|NCT02759185|7149343|FG006|STARTED|Stage 1||0
6251122|NCT02759185|7149337|FG000|COMPLETED|Stage 1||19
6251123|NCT02759185|7149338|FG001|COMPLETED|Stage 1||19
6251124|NCT02759185|7149339|FG002|COMPLETED|Stage 1||17
6251125|NCT02759185|7149340|FG003|COMPLETED|Stage 1||20
6251126|NCT02759185|7149341|FG004|COMPLETED|Stage 1||0
6251127|NCT02759185|7149342|FG005|COMPLETED|Stage 1||0
6251128|NCT02759185|7149343|FG006|COMPLETED|Stage 1||0
6251129|NCT02759185|7149337|FG000|NOT COMPLETED|Stage 1||1
6251130|NCT02759185|7149338|FG001|NOT COMPLETED|Stage 1||1
6251131|NCT02759185|7149339|FG002|NOT COMPLETED|Stage 1||3
6251132|NCT02759185|7149340|FG003|NOT COMPLETED|Stage 1||0
6251133|NCT02759185|7149341|FG004|NOT COMPLETED|Stage 1||0
6251134|NCT02759185|7149342|FG005|NOT COMPLETED|Stage 1||0
6251135|NCT02759185|7149343|FG006|NOT COMPLETED|Stage 1||0
6251136|NCT02759185|7149337|FG000|STARTED|Stage 2||0
6251137|NCT02759185|7149338|FG001|STARTED|Stage 2||0
6506543|NCT01460368|7425878|FG000|STARTED|Part B: Washout (up to 15 Days)||0
6251138|NCT02759185|7149339|FG002|STARTED|Stage 2||0
6251139|NCT02759185|7149340|FG003|STARTED|Stage 2||0
6251140|NCT02759185|7149341|FG004|STARTED|Stage 2||29
6251141|NCT02759185|7149342|FG005|STARTED|Stage 2||27
6251142|NCT02759185|7149343|FG006|STARTED|Stage 2||18
6251143|NCT02759185|7149337|FG000|COMPLETED|Stage 2||0
6251144|NCT02759185|7149338|FG001|COMPLETED|Stage 2||0
6251145|NCT02759185|7149339|FG002|COMPLETED|Stage 2||0
6251146|NCT02759185|7149340|FG003|COMPLETED|Stage 2||0
6251147|NCT02759185|7149341|FG004|COMPLETED|Stage 2||27
6251148|NCT02759185|7149342|FG005|COMPLETED|Stage 2||24
6251149|NCT02759185|7149343|FG006|COMPLETED|Stage 2||17
6251150|NCT02759185|7149337|FG000|NOT COMPLETED|Stage 2||0
6251151|NCT02759185|7149338|FG001|NOT COMPLETED|Stage 2||0
6251152|NCT02759185|7149339|FG002|NOT COMPLETED|Stage 2||0
6251153|NCT02759185|7149340|FG003|NOT COMPLETED|Stage 2||0
6251154|NCT02759185|7149341|FG004|NOT COMPLETED|Stage 2||2
6251155|NCT02759185|7149342|FG005|NOT COMPLETED|Stage 2||3
6251156|NCT02759185|7149343|FG006|NOT COMPLETED|Stage 2||1
6251157|NCT02752906|7149363|FG000|STARTED|Overall Study||403
6251158|NCT02752906|7149364|FG001|STARTED|Overall Study||407
6251159|NCT02752906|7149363|FG000|Vaccinated|Overall Study||402
6251160|NCT02752906|7149364|FG001|Vaccinated|Overall Study||407
6251161|NCT02752906|7149363|FG000|COMPLETED|Overall Study||396
6251162|NCT02752906|7149364|FG001|COMPLETED|Overall Study||402
6251163|NCT02752906|7149363|FG000|NOT COMPLETED|Overall Study||7
6251164|NCT02752906|7149364|FG001|NOT COMPLETED|Overall Study||5
6251165|NCT02693691|7149370|FG000|STARTED|Primary Endpoint Analysis (First 12M)||234
6251166|NCT02693691|7149370|FG000|COMPLETED|Primary Endpoint Analysis (First 12M)||184
6251167|NCT02693691|7149370|FG000|NOT COMPLETED|Primary Endpoint Analysis (First 12M)||50
6251168|NCT02693691|7149370|FG000|STARTED|Extended Follow-Up (Until Last pt 12M)||184
6251169|NCT02693691|7149370|FG000|COMPLETED|Extended Follow-Up (Until Last pt 12M)||160
6251170|NCT02693691|7149370|FG000|NOT COMPLETED|Extended Follow-Up (Until Last pt 12M)||24
6277835|NCT00129246|7177395|FG000|NOT COMPLETED|Overall Study||0
6277836|NCT00129246|7177396|FG001|NOT COMPLETED|Overall Study||0
6277837|NCT00129259|7177404|FG000|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
6277838|NCT00129259|7177405|FG001|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
6277839|NCT00129259|7177404|FG000|Received All or Part of Cycle 1|Overall Study||52
6277840|NCT00129259|7177405|FG001|Received All or Part of Cycle 1|Overall Study||0
6277841|NCT00129259|7177404|FG000|Received All or Part of Cycle 2|Overall Study||40
6277842|NCT00129259|7177405|FG001|Received All or Part of Cycle 2|Overall Study||0
6277843|NCT00129259|7177404|FG000|COMPLETED|Overall Study||49
6277844|NCT00129259|7177405|FG001|COMPLETED|Overall Study||22
6277845|NCT00129259|7177404|FG000|NOT COMPLETED|Overall Study||3
6277846|NCT00129259|7177405|FG001|NOT COMPLETED|Overall Study||3
6506544|NCT01460368|7425879|FG001|STARTED|Part B: Washout (up to 15 Days)||10
6506545|NCT01460368|7425880|FG002|STARTED|Part B: Washout (up to 15 Days)||10
6506546|NCT01460368|7425881|FG003|STARTED|Part B: Washout (up to 15 Days)||10
6506547|NCT01460368|7425882|FG004|STARTED|Part B: Washout (up to 15 Days)||9
6506548|NCT01460368|7425883|FG005|STARTED|Part B: Washout (up to 15 Days)||10
6506549|NCT01460368|7425884|FG006|STARTED|Part B: Washout (up to 15 Days)||10
6506550|NCT01460368|7425878|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
6506551|NCT01460368|7425879|FG001|COMPLETED|Part B: Washout (up to 15 Days)||10
6506552|NCT01460368|7425880|FG002|COMPLETED|Part B: Washout (up to 15 Days)||10
6506553|NCT01460368|7425881|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
6506554|NCT01460368|7425882|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
6506555|NCT01460368|7425883|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
6506556|NCT01460368|7425884|FG006|COMPLETED|Part B: Washout (up to 15 Days)||10
6506557|NCT01460368|7425878|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506558|NCT01460368|7425879|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506559|NCT01460368|7425880|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506560|NCT01460368|7425881|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506561|NCT01460368|7425882|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506562|NCT01460368|7425883|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506563|NCT01460368|7425884|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506564|NCT01460368|7425878|FG000|STARTED|Part B: Second Intervention (Period 2)||0
6506565|NCT01460368|7425879|FG001|STARTED|Part B: Second Intervention (Period 2)||10
6506566|NCT01460368|7425880|FG002|STARTED|Part B: Second Intervention (Period 2)||10
6506567|NCT01460368|7425881|FG003|STARTED|Part B: Second Intervention (Period 2)||10
6506568|NCT01460368|7425882|FG004|STARTED|Part B: Second Intervention (Period 2)||9
6506569|NCT01460368|7425883|FG005|STARTED|Part B: Second Intervention (Period 2)||10
6506570|NCT01460368|7425884|FG006|STARTED|Part B: Second Intervention (Period 2)||10
6506571|NCT01460368|7425878|FG000|COMPLETED|Part B: Second Intervention (Period 2)||0
6506572|NCT01460368|7425879|FG001|COMPLETED|Part B: Second Intervention (Period 2)||8
6506573|NCT01460368|7425880|FG002|COMPLETED|Part B: Second Intervention (Period 2)||10
6506574|NCT01460368|7425881|FG003|COMPLETED|Part B: Second Intervention (Period 2)||10
6506575|NCT01460368|7425882|FG004|COMPLETED|Part B: Second Intervention (Period 2)||9
6506576|NCT01460368|7425883|FG005|COMPLETED|Part B: Second Intervention (Period 2)||10
6506577|NCT01460368|7425884|FG006|COMPLETED|Part B: Second Intervention (Period 2)||9
6506578|NCT01460368|7425878|FG000|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6506579|NCT01460368|7425879|FG001|NOT COMPLETED|Part B: Second Intervention (Period 2)||2
6506580|NCT01460368|7425880|FG002|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6506581|NCT01460368|7425881|FG003|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6506582|NCT01460368|7425882|FG004|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6506583|NCT01460368|7425883|FG005|NOT COMPLETED|Part B: Second Intervention (Period 2)||0
6506584|NCT01460368|7425884|FG006|NOT COMPLETED|Part B: Second Intervention (Period 2)||1
6506585|NCT01460368|7425878|FG000|STARTED|Part B: Washout (up to 15 Days)||0
6506586|NCT01460368|7425879|FG001|STARTED|Part B: Washout (up to 15 Days)||8
6506587|NCT01460368|7425880|FG002|STARTED|Part B: Washout (up to 15 Days)||10
6506588|NCT01460368|7425881|FG003|STARTED|Part B: Washout (up to 15 Days)||10
6506589|NCT01460368|7425882|FG004|STARTED|Part B: Washout (up to 15 Days)||9
6506590|NCT01460368|7425883|FG005|STARTED|Part B: Washout (up to 15 Days)||10
6506591|NCT01460368|7425884|FG006|STARTED|Part B: Washout (up to 15 Days)||9
6506592|NCT01460368|7425878|FG000|COMPLETED|Part B: Washout (up to 15 Days)||0
6506593|NCT01460368|7425879|FG001|COMPLETED|Part B: Washout (up to 15 Days)||8
6506594|NCT01460368|7425880|FG002|COMPLETED|Part B: Washout (up to 15 Days)||9
6506595|NCT01460368|7425881|FG003|COMPLETED|Part B: Washout (up to 15 Days)||10
6506596|NCT01460368|7425882|FG004|COMPLETED|Part B: Washout (up to 15 Days)||9
6506597|NCT01460368|7425883|FG005|COMPLETED|Part B: Washout (up to 15 Days)||10
6251171|NCT02540330|7149376|FG000|STARTED|Overall Study||2
6251172|NCT02540330|7149377|FG001|STARTED|Overall Study||1
6251173|NCT02540330|7149376|FG000|COMPLETED|Overall Study||2
6251174|NCT02540330|7149377|FG001|COMPLETED|Overall Study||1
6251175|NCT02540330|7149376|FG000|NOT COMPLETED|Overall Study||0
6251176|NCT02540330|7149377|FG001|NOT COMPLETED|Overall Study||0
6251177|NCT02417701|7149383|FG000|STARTED|Overall Study||34
6251178|NCT02417701|7149383|FG000|COMPLETED|Overall Study||34
6251179|NCT02417701|7149383|FG000|NOT COMPLETED|Overall Study||0
6251180|NCT02388906|7149392|FG000|STARTED|Pre-Treatment Period||453
6251181|NCT02388906|7149393|FG001|STARTED|Pre-Treatment Period||453
6251182|NCT02388906|7149392|FG000|COMPLETED|Pre-Treatment Period||452
6251183|NCT02388906|7149393|FG001|COMPLETED|Pre-Treatment Period||453
6251184|NCT02388906|7149392|FG000|NOT COMPLETED|Pre-Treatment Period||1
6251185|NCT02388906|7149393|FG001|NOT COMPLETED|Pre-Treatment Period||0
6251186|NCT02388906|7149392|FG000|STARTED|Treatment Period||452
6251187|NCT02388906|7149393|FG001|STARTED|Treatment Period||453
6251188|NCT02388906|7149392|FG000|COMPLETED|Treatment Period||275
6251189|NCT02388906|7149393|FG001|COMPLETED|Treatment Period||122
6251190|NCT02388906|7149392|FG000|NOT COMPLETED|Treatment Period||177
6251191|NCT02388906|7149393|FG001|NOT COMPLETED|Treatment Period||331
6251192|NCT02384993|7149401|FG000|STARTED|Overall Study||12
6251193|NCT02384993|7149402|FG001|STARTED|Overall Study||12
6251194|NCT02384993|7149401|FG000|COMPLETED|Overall Study||12
6251195|NCT02384993|7149402|FG001|COMPLETED|Overall Study||11
6251196|NCT02384993|7149401|FG000|NOT COMPLETED|Overall Study||0
6251197|NCT02384993|7149402|FG001|NOT COMPLETED|Overall Study||1
6251198|NCT02304302|7149411|FG000|STARTED|Overall Study||79
6251199|NCT02304302|7149412|FG001|STARTED|Overall Study||81
6251200|NCT02304302|7149411|FG000|COMPLETED|Overall Study||76
6251201|NCT02304302|7149412|FG001|COMPLETED|Overall Study||73
6251202|NCT02304302|7149411|FG000|NOT COMPLETED|Overall Study||3
6251203|NCT02304302|7149412|FG001|NOT COMPLETED|Overall Study||8
6251204|NCT02294461|7149424|FG000|STARTED|Double-blind Period (up to 29.4 Months)||202
6251205|NCT02294461|7149425|FG001|STARTED|Double-blind Period (up to 29.4 Months)||193
6251206|NCT02294461|7149424|FG000|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||202
6251207|NCT02294461|7149425|FG001|Treated/Received Study Drug|Double-blind Period (up to 29.4 Months)||193
6251208|NCT02294461|7149424|FG000|COMPLETED|Double-blind Period (up to 29.4 Months)||84
6251209|NCT02294461|7149425|FG001|COMPLETED|Double-blind Period (up to 29.4 Months)||1
6251210|NCT02294461|7149424|FG000|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||118
6251211|NCT02294461|7149425|FG001|NOT COMPLETED|Double-blind Period (up to 29.4 Months)||192
6251212|NCT02294461|7149424|FG000|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|85
6251213|NCT02294461|7149425|FG001|STARTED|Open-label Period (up to 54.3 Months)|Eligible participants who provided consent took part in open-label period.|51
6251214|NCT02294461|7149424|FG000|COMPLETED|Open-label Period (up to 54.3 Months)||0
6251215|NCT02294461|7149425|FG001|COMPLETED|Open-label Period (up to 54.3 Months)||0
6251216|NCT02294461|7149424|FG000|NOT COMPLETED|Open-label Period (up to 54.3 Months)||85
6251217|NCT02294461|7149425|FG001|NOT COMPLETED|Open-label Period (up to 54.3 Months)||51
6251218|NCT02269670|7149443|FG000|STARTED|Overall Study||3
6251219|NCT02269670|7149443|FG000|COMPLETED|Overall Study||0
6251220|NCT02269670|7149443|FG000|NOT COMPLETED|Overall Study||3
6251221|NCT02086175|7149447|FG000|STARTED|Overall Study||25
6251222|NCT02086175|7149447|FG000|COMPLETED|Overall Study||25
6251223|NCT02086175|7149447|FG000|NOT COMPLETED|Overall Study||0
6251224|NCT01860976|7149453|FG000|STARTED|Blinded Treatment||213
6251225|NCT01860976|7149454|FG001|STARTED|Blinded Treatment||211
6251226|NCT01860976|7149453|FG000|COMPLETED|Blinded Treatment||125
6251227|NCT01860976|7149454|FG001|COMPLETED|Blinded Treatment||98
6251228|NCT01860976|7149453|FG000|NOT COMPLETED|Blinded Treatment||88
6251229|NCT01860976|7149454|FG001|NOT COMPLETED|Blinded Treatment||113
6251230|NCT01860976|7149453|FG000|STARTED|Open-Label||197
6251231|NCT01860976|7149454|FG001|STARTED|Open-Label||185
6251232|NCT01860976|7149453|FG000|COMPLETED|Open-Label||169
6251233|NCT01860976|7149454|FG001|COMPLETED|Open-Label||166
6251234|NCT01860976|7149453|FG000|NOT COMPLETED|Open-Label||28
6251235|NCT01860976|7149454|FG001|NOT COMPLETED|Open-Label||19
6251236|NCT01860976|7149453|FG000|STARTED|Long Term Extension||106
6251237|NCT01860976|7149454|FG001|STARTED|Long Term Extension||0
6251238|NCT01860976|7149453|FG000|COMPLETED|Long Term Extension||81
6251239|NCT01860976|7149454|FG001|COMPLETED|Long Term Extension||0
6251240|NCT01860976|7149453|FG000|NOT COMPLETED|Long Term Extension||25
6251241|NCT01860976|7149454|FG001|NOT COMPLETED|Long Term Extension||0
6251242|NCT01761266|7149465|FG000|STARTED|Overall Study||478
6251243|NCT01761266|7149466|FG001|STARTED|Overall Study||476
6251244|NCT01761266|7149465|FG000|Treated|Overall Study||476
6251245|NCT01761266|7149466|FG001|Treated|Overall Study||475
6251246|NCT01761266|7149465|FG000|COMPLETED|Overall Study||0
6251247|NCT01761266|7149466|FG001|COMPLETED|Overall Study||0
6251248|NCT01761266|7149465|FG000|NOT COMPLETED|Overall Study||478
6251249|NCT01761266|7149466|FG001|NOT COMPLETED|Overall Study||476
6251250|NCT01550289|7149477|FG000|STARTED|Overall Study||128
6251251|NCT01550289|7149478|FG001|STARTED|Overall Study||61
6251252|NCT01550289|7149477|FG000|COMPLETED|Overall Study||115
6251253|NCT01550289|7149478|FG001|COMPLETED|Overall Study||57
6251254|NCT01550289|7149477|FG000|NOT COMPLETED|Overall Study||13
6251255|NCT01550289|7149478|FG001|NOT COMPLETED|Overall Study||4
6251256|NCT01346709|7149486|FG000|STARTED|Overall Study||5450
6251257|NCT01346709|7149486|FG000|COMPLETED|Overall Study||5099
6251258|NCT01346709|7149486|FG000|NOT COMPLETED|Overall Study||351
6251259|NCT01157091|7149490|FG000|STARTED|Overall Study||28
6251260|NCT01157091|7149490|FG000|COMPLETED|Overall Study||28
6251261|NCT01157091|7149490|FG000|NOT COMPLETED|Overall Study||0
6251262|NCT01081951|7149496|FG000|STARTED|Overall Study||81
6251263|NCT01081951|7149497|FG001|STARTED|Overall Study||81
6251264|NCT01081951|7149496|FG000|Received Study Treatment|Overall Study||81
6251265|NCT01081951|7149497|FG001|Received Study Treatment|Overall Study||75
6251266|NCT01081951|7149496|FG000|Entered Maintenance Phase|Overall Study||66
6251267|NCT01081951|7149497|FG001|Entered Maintenance Phase|Overall Study||55
6251268|NCT01081951|7149496|FG000|Ongoing Study Treatment at Data Cut-off|Overall Study||11
6506598|NCT01460368|7425884|FG006|COMPLETED|Part B: Washout (up to 15 Days)||9
6506599|NCT01460368|7425878|FG000|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506600|NCT01460368|7425879|FG001|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506601|NCT01460368|7425880|FG002|NOT COMPLETED|Part B: Washout (up to 15 Days)||1
6506602|NCT01460368|7425881|FG003|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506603|NCT01460368|7425882|FG004|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506604|NCT01460368|7425883|FG005|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506605|NCT01460368|7425884|FG006|NOT COMPLETED|Part B: Washout (up to 15 Days)||0
6506606|NCT01460368|7425878|FG000|STARTED|Part B: Third Interventions (Period 3)||0
6506607|NCT01460368|7425879|FG001|STARTED|Part B: Third Interventions (Period 3)||8
6506608|NCT01460368|7425880|FG002|STARTED|Part B: Third Interventions (Period 3)||9
6506609|NCT01460368|7425881|FG003|STARTED|Part B: Third Interventions (Period 3)||10
6506610|NCT01460368|7425882|FG004|STARTED|Part B: Third Interventions (Period 3)||9
6506611|NCT01460368|7425883|FG005|STARTED|Part B: Third Interventions (Period 3)||10
6506612|NCT01460368|7425884|FG006|STARTED|Part B: Third Interventions (Period 3)||9
6506613|NCT01460368|7425878|FG000|COMPLETED|Part B: Third Interventions (Period 3)||0
6506614|NCT01460368|7425879|FG001|COMPLETED|Part B: Third Interventions (Period 3)||8
6506615|NCT01460368|7425880|FG002|COMPLETED|Part B: Third Interventions (Period 3)||8
6506616|NCT01460368|7425881|FG003|COMPLETED|Part B: Third Interventions (Period 3)||9
6506617|NCT01460368|7425882|FG004|COMPLETED|Part B: Third Interventions (Period 3)||9
6506618|NCT01460368|7425883|FG005|COMPLETED|Part B: Third Interventions (Period 3)||9
6506619|NCT01460368|7425884|FG006|COMPLETED|Part B: Third Interventions (Period 3)||9
6506620|NCT01460368|7425878|FG000|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
6506621|NCT01460368|7425879|FG001|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
6506622|NCT01460368|7425880|FG002|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
6506623|NCT01460368|7425881|FG003|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
6506624|NCT01460368|7425882|FG004|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
6506625|NCT01460368|7425883|FG005|NOT COMPLETED|Part B: Third Interventions (Period 3)||1
6506626|NCT01460368|7425884|FG006|NOT COMPLETED|Part B: Third Interventions (Period 3)||0
6506627|NCT01460381|7425895|FG000|STARTED|Period 1 (Days 1-7)||7
6506628|NCT01460381|7425896|FG001|STARTED|Period 1 (Days 1-7)||11
6506629|NCT01460381|7425895|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||7
6506630|NCT01460381|7425896|FG001|Received at Least 1 Dose of Study Drug|Period 1 (Days 1-7)||11
6506631|NCT01460381|7425895|FG000|COMPLETED|Period 1 (Days 1-7)||7
6506632|NCT01460381|7425896|FG001|COMPLETED|Period 1 (Days 1-7)||11
6506633|NCT01460381|7425895|FG000|NOT COMPLETED|Period 1 (Days 1-7)||0
6506634|NCT01460381|7425896|FG001|NOT COMPLETED|Period 1 (Days 1-7)||0
6506635|NCT01460381|7425895|FG000|STARTED|Period 2 (Days 8-15)||7
6506636|NCT01460381|7425896|FG001|STARTED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2.|0
6506637|NCT01460381|7425895|FG000|COMPLETED|Period 2 (Days 8-15)|One participant was lost to follow-up after completing Period 2 and did not complete the study.|6
6506638|NCT01460381|7425896|FG001|COMPLETED|Period 2 (Days 8-15)|CYP2C19 extensive metabolizers did not participate in Period 2|0
6506639|NCT01460381|7425895|FG000|NOT COMPLETED|Period 2 (Days 8-15)||1
6506640|NCT01460381|7425896|FG001|NOT COMPLETED|Period 2 (Days 8-15)||0
6506641|NCT01460407|7425904|FG000|STARTED|Period 1: Day 1 to Day 5||14
6506642|NCT01460407|7425905|FG001|STARTED|Period 1: Day 1 to Day 5||0
6506643|NCT01460407|7425904|FG000|COMPLETED|Period 1: Day 1 to Day 5||14
6506644|NCT01460407|7425905|FG001|COMPLETED|Period 1: Day 1 to Day 5||0
6506645|NCT01460407|7425904|FG000|NOT COMPLETED|Period 1: Day 1 to Day 5||0
6506646|NCT01460407|7425905|FG001|NOT COMPLETED|Period 1: Day 1 to Day 5||0
6506647|NCT01460407|7425904|FG000|STARTED|Period 2: Day 6 to Day 14||0
6506648|NCT01460407|7425905|FG001|STARTED|Period 2: Day 6 to Day 14||14
6506649|NCT01460407|7425904|FG000|COMPLETED|Period 2: Day 6 to Day 14||0
6506650|NCT01460407|7425905|FG001|COMPLETED|Period 2: Day 6 to Day 14||13
6506651|NCT01460407|7425904|FG000|NOT COMPLETED|Period 2: Day 6 to Day 14||0
6506652|NCT01460407|7425905|FG001|NOT COMPLETED|Period 2: Day 6 to Day 14||1
6506653|NCT01460446|7425914|FG000|STARTED|Overall Study||105
6506654|NCT01460446|7425915|FG001|STARTED|Overall Study||113
6506655|NCT01460446|7425914|FG000|COMPLETED|Overall Study||100
6506656|NCT01460446|7425915|FG001|COMPLETED|Overall Study||93
6506657|NCT01460446|7425914|FG000|NOT COMPLETED|Overall Study||5
6506658|NCT01460446|7425915|FG001|NOT COMPLETED|Overall Study||20
6506659|NCT01460628|7425922|FG000|STARTED|Overall Study||25
6251269|NCT01081951|7149497|FG001|Ongoing Study Treatment at Data Cut-off|Overall Study||0
6251270|NCT01081951|7149496|FG000|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
6277847|NCT00129272|7177413|FG000|STARTED|Overall Study||71
6251271|NCT01081951|7149497|FG001|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
6251272|NCT01081951|7149496|FG000|NOT COMPLETED|Overall Study||56
6251273|NCT01081951|7149497|FG001|NOT COMPLETED|Overall Study||55
6251274|NCT01074190|7149506|FG000|STARTED|Overall Study||115
6251275|NCT01074190|7149507|FG001|STARTED|Overall Study||115
6251276|NCT01074190|7149508|FG002|STARTED|Overall Study||115
6251277|NCT01074190|7149506|FG000|COMPLETED|Overall Study||111
6251278|NCT01074190|7149507|FG001|COMPLETED|Overall Study||109
6251279|NCT01074190|7149508|FG002|COMPLETED|Overall Study||112
6251280|NCT01074190|7149506|FG000|NOT COMPLETED|Overall Study||4
6251281|NCT01074190|7149507|FG001|NOT COMPLETED|Overall Study||6
6251282|NCT01074190|7149508|FG002|NOT COMPLETED|Overall Study||3
6251283|NCT00893516|7149521|FG000|STARTED|Overall Study||0
6251284|NCT00893516|7149522|FG001|STARTED|Overall Study||0
6251285|NCT00893516|7149521|FG000|COMPLETED|Overall Study||0
6251286|NCT00893516|7149522|FG001|COMPLETED|Overall Study||0
6251287|NCT00893516|7149521|FG000|NOT COMPLETED|Overall Study||0
6251288|NCT00893516|7149522|FG001|NOT COMPLETED|Overall Study||0
6251289|NCT00875524|7149528|FG000|STARTED|Overall Study||120
6251290|NCT00875524|7149529|FG001|STARTED|Overall Study||60
6251291|NCT00875524|7149528|FG000|Received Vaccination 1|Overall Study||120
6251292|NCT00875524|7149529|FG001|Received Vaccination 1|Overall Study||60
6251293|NCT00875524|7149528|FG000|Received Vaccination 2|Overall Study||116
6251294|NCT00875524|7149529|FG001|Received Vaccination 2|Overall Study||58
6251295|NCT00875524|7149528|FG000|Received Vaccination 3|Overall Study||114
6251296|NCT00875524|7149529|FG001|Received Vaccination 3|Overall Study||58
6251297|NCT00875524|7149528|FG000|COMPLETED|Overall Study||112
6251298|NCT00875524|7149529|FG001|COMPLETED|Overall Study||54
6251299|NCT00875524|7149528|FG000|NOT COMPLETED|Overall Study||8
6251300|NCT00875524|7149529|FG001|NOT COMPLETED|Overall Study||6
6251301|NCT00842530|7149537|FG000|STARTED|Overall Study||2669
6251302|NCT00842530|7149538|FG001|STARTED|Overall Study||1333
6251303|NCT00842530|7149537|FG000|Received Vaccination 1|Overall Study||2666
6251304|NCT00842530|7149538|FG001|Received Vaccination 1|Overall Study||1331
6251305|NCT00842530|7149537|FG000|Received Vaccination 2|Overall Study||2584
6251306|NCT00842530|7149538|FG001|Received Vaccination 2|Overall Study||1300
6251307|NCT00842530|7149537|FG000|Received Vaccination 3|Overall Study||2557
6251308|NCT00842530|7149538|FG001|Received Vaccination 3|Overall Study||1282
6251309|NCT00842530|7149537|FG000|COMPLETED|Overall Study||2552
6251310|NCT00842530|7149538|FG001|COMPLETED|Overall Study||1276
6251311|NCT00842530|7149537|FG000|NOT COMPLETED|Overall Study||117
6251312|NCT00842530|7149538|FG001|NOT COMPLETED|Overall Study||57
6251313|NCT00788151|7149547|FG000|STARTED|Overall Study||200
6251314|NCT00788151|7149548|FG001|STARTED|Overall Study||100
6251315|NCT00788151|7149547|FG000|Received Vaccination 1|Overall Study||199
6251316|NCT00788151|7149548|FG001|Received Vaccination 1|Overall Study||99
6251317|NCT00788151|7149547|FG000|Received Vaccination 2|Overall Study||188
6251318|NCT00788151|7149548|FG001|Received Vaccination 2|Overall Study||92
6251319|NCT00788151|7149547|FG000|Received Vaccination 3|Overall Study||186
6251320|NCT00788151|7149548|FG001|Received Vaccination 3|Overall Study||90
6251321|NCT00788151|7149547|FG000|COMPLETED|Overall Study||186
6251322|NCT00788151|7149548|FG001|COMPLETED|Overall Study||90
6251323|NCT00788151|7149547|FG000|NOT COMPLETED|Overall Study||14
6251324|NCT00788151|7149548|FG001|NOT COMPLETED|Overall Study||10
6251325|NCT00539591|7149557|FG000|STARTED|Overall Study||23
6251326|NCT00539591|7149558|FG001|STARTED|Overall Study||2
6251327|NCT00539591|7149559|FG002|STARTED|Overall Study||4
6251328|NCT00539591|7149557|FG000|COMPLETED|Overall Study||18
6251329|NCT00539591|7149558|FG001|COMPLETED|Overall Study||0
6251330|NCT00539591|7149559|FG002|COMPLETED|Overall Study||1
6570256|NCT01850589|7493689|FG000|STARTED|Overall Study||22
6570257|NCT01850589|7493690|FG001|STARTED|Overall Study||22
6570258|NCT01850589|7493689|FG000|COMPLETED|Overall Study||14
6251331|NCT00539591|7149557|FG000|NOT COMPLETED|Overall Study||5
6251332|NCT00539591|7149558|FG001|NOT COMPLETED|Overall Study||2
6251333|NCT00539591|7149559|FG002|NOT COMPLETED|Overall Study||3
6277848|NCT00129272|7177414|FG001|STARTED|Overall Study||73
6277849|NCT00129272|7177413|FG000|COMPLETED|Overall Study||54
6277850|NCT00129272|7177414|FG001|COMPLETED|Overall Study||51
6277851|NCT00129272|7177413|FG000|NOT COMPLETED|Overall Study||17
6277852|NCT00129272|7177414|FG001|NOT COMPLETED|Overall Study||22
6277853|NCT00129285|7177423|FG000|STARTED|Overall Study||65
6277854|NCT00129285|7177424|FG001|STARTED|Overall Study||70
6277855|NCT00129285|7177425|FG002|STARTED|Overall Study||75
6277856|NCT00129285|7177423|FG000|COMPLETED|Overall Study||40
6277857|NCT00129285|7177424|FG001|COMPLETED|Overall Study||43
6277858|NCT00129285|7177425|FG002|COMPLETED|Overall Study||37
6277859|NCT00129285|7177423|FG000|NOT COMPLETED|Overall Study||25
6277860|NCT00129285|7177424|FG001|NOT COMPLETED|Overall Study||27
6277861|NCT00129285|7177425|FG002|NOT COMPLETED|Overall Study||38
6277862|NCT00129311|7177439|FG000|STARTED|Overall Study||51
6277863|NCT00129311|7177440|FG001|STARTED|Overall Study||50
6277864|NCT00129311|7177439|FG000|COMPLETED|Overall Study||39
6277865|NCT00129311|7177440|FG001|COMPLETED|Overall Study||31
6277866|NCT00129311|7177439|FG000|NOT COMPLETED|Overall Study||12
6277867|NCT00129311|7177440|FG001|NOT COMPLETED|Overall Study||19
6277868|NCT00129376|7177446|FG000|STARTED|Overall Study||63
6277869|NCT00129376|7177446|FG000|COMPLETED|Overall Study||61
6570259|NCT01850589|7493690|FG001|COMPLETED|Overall Study||22
6251334|NCT02892955|7149595|FG000|STARTED|Overall Study||1685
6251335|NCT02892955|7149595|FG000|COMPLETED|Overall Study||1685
6251336|NCT02892955|7149595|FG000|NOT COMPLETED|Overall Study||0
6251337|NCT02883673|7149599|FG000|STARTED|Overall Study||107
6251338|NCT02883673|7149599|FG000|COMPLETED|Overall Study||107
6251339|NCT02883673|7149599|FG000|NOT COMPLETED|Overall Study||0
6251340|NCT04748783|7149609|FG000|STARTED|Overall Study||0
6251341|NCT04748783|7149610|FG001|STARTED|Overall Study||1
6251342|NCT04748783|7149611|FG002|STARTED|Overall Study||0
6251343|NCT04748783|7149612|FG003|STARTED|Overall Study||0
6251344|NCT04748783|7149613|FG004|STARTED|Overall Study||1
6251345|NCT04748783|7149609|FG000|COMPLETED|Overall Study||0
6251346|NCT04748783|7149610|FG001|COMPLETED|Overall Study||1
6251347|NCT04748783|7149611|FG002|COMPLETED|Overall Study||0
6251348|NCT04748783|7149612|FG003|COMPLETED|Overall Study||0
6251349|NCT04748783|7149613|FG004|COMPLETED|Overall Study||1
6251350|NCT04748783|7149609|FG000|NOT COMPLETED|Overall Study||0
6251351|NCT04748783|7149610|FG001|NOT COMPLETED|Overall Study||0
6251352|NCT04748783|7149611|FG002|NOT COMPLETED|Overall Study||0
6251353|NCT04748783|7149612|FG003|NOT COMPLETED|Overall Study||0
6251354|NCT04748783|7149613|FG004|NOT COMPLETED|Overall Study||0
6251355|NCT04482647|7149626|FG000|STARTED|Overall Study||100
6251356|NCT04482647|7149626|FG000|COMPLETED|Overall Study||88
6251357|NCT04482647|7149626|FG000|NOT COMPLETED|Overall Study||12
6251358|NCT04405570|7149634|FG000|STARTED|Overall Study||23
6251359|NCT04405570|7149635|FG001|STARTED|Overall Study||64
6251360|NCT04405570|7149636|FG002|STARTED|Overall Study||55
6251361|NCT04405570|7149637|FG003|STARTED|Overall Study||62
6251362|NCT04405570|7149634|FG000|Number of Subjects Randomized Not Dosed|Overall Study||0
6251363|NCT04405570|7149635|FG001|Number of Subjects Randomized Not Dosed|Overall Study||2
6251364|NCT04405570|7149636|FG002|Number of Subjects Randomized Not Dosed|Overall Study||0
6251365|NCT04405570|7149637|FG003|Number of Subjects Randomized Not Dosed|Overall Study||0
6251366|NCT04405570|7149634|FG000|Number of Subjects in the Safety Population|Overall Study||23
6251367|NCT04405570|7149635|FG001|Number of Subjects in the Safety Population|Overall Study||62
6251368|NCT04405570|7149636|FG002|Number of Subjects in the Safety Population|Overall Study||55
6251369|NCT04405570|7149637|FG003|Number of Subjects in the Safety Population|Overall Study||62
6251370|NCT04405570|7149634|FG000|Number of Subjects in the mITT Population|Overall Study||23
6251371|NCT04405570|7149635|FG001|Number of Subjects in the mITT Population|Overall Study||61
6251372|NCT04405570|7149636|FG002|Number of Subjects in the mITT Population|Overall Study||53
6251373|NCT04405570|7149637|FG003|Number of Subjects in the mITT Population|Overall Study||61
6251374|NCT04405570|7149634|FG000|COMPLETED|Overall Study||23
6251375|NCT04405570|7149635|FG001|COMPLETED|Overall Study||59
6251376|NCT04405570|7149636|FG002|COMPLETED|Overall Study||52
6251377|NCT04405570|7149637|FG003|COMPLETED|Overall Study||61
6251378|NCT04405570|7149634|FG000|NOT COMPLETED|Overall Study||0
6251379|NCT04405570|7149635|FG001|NOT COMPLETED|Overall Study||5
6251380|NCT04405570|7149636|FG002|NOT COMPLETED|Overall Study||3
6251381|NCT04405570|7149637|FG003|NOT COMPLETED|Overall Study||1
6251382|NCT04135937|7149650|FG000|STARTED|Overall Study||12
6251383|NCT04135937|7149650|FG000|COMPLETED|Overall Study||9
6506660|NCT01460628|7425922|FG000|COMPLETED|Overall Study||20
6506661|NCT01460628|7425922|FG000|NOT COMPLETED|Overall Study||5
6506662|NCT01460719|7425926|FG000|STARTED|Overall Study||80
6506663|NCT01460719|7425926|FG000|Vaccination 1 (Day 1)|Overall Study||80
6506664|NCT01460719|7425926|FG000|Vaccination 2 (~Day 30)|Overall Study||78
6506665|NCT01460719|7425926|FG000|Vaccination 3 (~Day 60)|Overall Study||78
6506666|NCT01460719|7425926|FG000|Vaccination 4 (~Day 90)|Overall Study||78
6506667|NCT01460719|7425926|FG000|COMPLETED|Overall Study||78
6506668|NCT01460719|7425926|FG000|NOT COMPLETED|Overall Study||2
6506669|NCT01460732|7425930|FG000|STARTED|Overall Study||81
6506670|NCT01460732|7425930|FG000|COMPLETED|Overall Study||81
6506671|NCT01460732|7425930|FG000|NOT COMPLETED|Overall Study||0
6506672|NCT01460875|7425936|FG000|STARTED|Overall Study||34
6506673|NCT01460875|7425936|FG000|COMPLETED|Overall Study||34
6506674|NCT01460875|7425936|FG000|NOT COMPLETED|Overall Study||0
6506675|NCT01460901|7425940|FG000|STARTED|Overall Study|First enrollment|5
6506676|NCT01460901|7425940|FG000|tV-CTL Infusion|Overall Study||3
6506677|NCT01460901|7425940|FG000|COMPLETED|Overall Study|Follow-up completed|3
6506678|NCT01460901|7425940|FG000|NOT COMPLETED|Overall Study||2
6506679|NCT01460927|7425947|FG000|STARTED|Overall Study||25
6506680|NCT01460927|7425947|FG000|COMPLETED|Overall Study||25
6506681|NCT01460927|7425947|FG000|NOT COMPLETED|Overall Study||0
6506682|NCT01460940|7425955|FG000|STARTED|Overall Study||24
6506683|NCT01460940|7425955|FG000|COMPLETED|Overall Study||24
6506684|NCT01460940|7425955|FG000|NOT COMPLETED|Overall Study||0
6506685|NCT01461005|7425959|FG000|STARTED|Overall Study||1
6506686|NCT01461005|7425959|FG000|COMPLETED|Overall Study||0
6506687|NCT01461005|7425959|FG000|NOT COMPLETED|Overall Study||1
6506688|NCT01461044|7425966|FG000|STARTED|Overall Study||150
6506689|NCT01461044|7425967|FG001|STARTED|Overall Study||77
6506690|NCT01461044|7425966|FG000|Participants Alive at Inclusion|Overall Study||127
6506691|NCT01461044|7425967|FG001|Participants Alive at Inclusion|Overall Study||58
6506692|NCT01461044|7425966|FG000|COMPLETED|Overall Study||80
6506693|NCT01461044|7425967|FG001|COMPLETED|Overall Study||37
6251384|NCT04135937|7149650|FG000|NOT COMPLETED|Overall Study||3
6251385|NCT03989232|7149656|FG000|STARTED|Overall Study||481
6251386|NCT03989232|7149657|FG001|STARTED|Overall Study||480
6506694|NCT01461044|7425966|FG000|NOT COMPLETED|Overall Study||70
6251387|NCT03989232|7149656|FG000|Exposed|Overall Study||480
6251388|NCT03989232|7149657|FG001|Exposed|Overall Study||479
6251389|NCT03989232|7149656|FG000|Safety Analysis Set (SAS)|Overall Study||480
6251390|NCT03989232|7149657|FG001|Safety Analysis Set (SAS)|Overall Study||479
6251391|NCT03989232|7149656|FG000|Full Analysis Set (FAS)|Overall Study||481
6251392|NCT03989232|7149657|FG001|Full Analysis Set (FAS)|Overall Study||480
6251393|NCT03989232|7149656|FG000|COMPLETED|Overall Study||471
6251394|NCT03989232|7149657|FG001|COMPLETED|Overall Study||462
6251395|NCT03989232|7149656|FG000|NOT COMPLETED|Overall Study||10
6251396|NCT03989232|7149657|FG001|NOT COMPLETED|Overall Study||18
6277870|NCT00129376|7177446|FG000|NOT COMPLETED|Overall Study||2
6277871|NCT00129389|7177452|FG000|STARTED|Overall Study||974
6277872|NCT00129389|7177453|FG001|STARTED|Overall Study||951
6277873|NCT00129389|7177452|FG000|COMPLETED|Overall Study|1 patient was crossed from arm A to B by error. 16 patients were crossed from arm B, to A by error.|941
6277874|NCT00129389|7177453|FG001|COMPLETED|Overall Study|16 patients were crossed from arm B to A by error. 1 patient was crossed from arm A to B by error.|811
6277875|NCT00129389|7177452|FG000|NOT COMPLETED|Overall Study||33
6277876|NCT00129389|7177453|FG001|NOT COMPLETED|Overall Study||140
6277877|NCT00129441|7177461|FG000|STARTED|Overall Study||9
6277878|NCT00129441|7177462|FG001|STARTED|Overall Study||6
6277879|NCT00129441|7177461|FG000|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
6277880|NCT00129441|7177462|FG001|Baseline, Visit 1|Overall Study||6
6277881|NCT00129441|7177461|FG000|Week 1, Visit 2|Overall Study||9
6277882|NCT00129441|7177462|FG001|Week 1, Visit 2|Overall Study||6
6277883|NCT00129441|7177461|FG000|Week 2, Visit 3|Overall Study||9
6277884|NCT00129441|7177462|FG001|Week 2, Visit 3|Overall Study||6
6277885|NCT00129441|7177461|FG000|Week 3, Visit 4|Overall Study||9
6277886|NCT00129441|7177462|FG001|Week 3, Visit 4|Overall Study||6
6277887|NCT00129441|7177461|FG000|Week 4, Visit 5|Overall Study||9
6277888|NCT00129441|7177462|FG001|Week 4, Visit 5|Overall Study||6
6277889|NCT00129441|7177461|FG000|Week 5, Visit 6|Overall Study||9
6277890|NCT00129441|7177462|FG001|Week 5, Visit 6|Overall Study||6
6277891|NCT00129441|7177461|FG000|Week 26, Visit 7|Overall Study||9
6277892|NCT00129441|7177462|FG001|Week 26, Visit 7|Overall Study||6
6277893|NCT00129441|7177461|FG000|Year 1, Visit 8|Overall Study||9
6277894|NCT00129441|7177462|FG001|Year 1, Visit 8|Overall Study||6
6277895|NCT00129441|7177461|FG000|COMPLETED|Overall Study||9
6277896|NCT00129441|7177462|FG001|COMPLETED|Overall Study||6
6277897|NCT00129441|7177461|FG000|NOT COMPLETED|Overall Study||0
6277898|NCT00129441|7177462|FG001|NOT COMPLETED|Overall Study||0
6277899|NCT00129467|7177470|FG000|STARTED|Received Intervention||15
6277900|NCT00129467|7177471|FG001|STARTED|Received Intervention||17
6277901|NCT00129467|7177470|FG000|COMPLETED|Received Intervention||9
6277902|NCT00129467|7177471|FG001|COMPLETED|Received Intervention||13
6277903|NCT00129467|7177470|FG000|NOT COMPLETED|Received Intervention||6
6277904|NCT00129467|7177471|FG001|NOT COMPLETED|Received Intervention||4
6277905|NCT00129467|7177470|FG000|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
6277906|NCT00129467|7177471|FG001|STARTED|Open Label for SSRI+Methylphenidate Arm||0
6277907|NCT00129467|7177470|FG000|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
6277908|NCT00129467|7177471|FG001|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
6277909|NCT00129467|7177470|FG000|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
6277910|NCT00129467|7177471|FG001|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
6277911|NCT00129480|7177479|FG000|STARTED|Overall Study||187
6277912|NCT00129480|7177480|FG001|STARTED|Overall Study||214
6277913|NCT00129480|7177479|FG000|COMPLETED|Overall Study||187
6277914|NCT00129480|7177480|FG001|COMPLETED|Overall Study||214
6277915|NCT00129480|7177479|FG000|NOT COMPLETED|Overall Study||0
6277916|NCT00129480|7177480|FG001|NOT COMPLETED|Overall Study||0
6277917|NCT00129545|7177489|FG000|STARTED|Overall Study||93
6277918|NCT00129545|7177490|FG001|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
6277919|NCT00129545|7177491|FG002|STARTED|Overall Study||244
6277920|NCT00129545|7177489|FG000|COMPLETED|Overall Study||67
6277921|NCT00129545|7177490|FG001|COMPLETED|Overall Study||299
6277922|NCT00129545|7177491|FG002|COMPLETED|Overall Study||133
6277923|NCT00129545|7177489|FG000|NOT COMPLETED|Overall Study||26
6277924|NCT00129545|7177490|FG001|NOT COMPLETED|Overall Study||164
6277925|NCT00129545|7177491|FG002|NOT COMPLETED|Overall Study||111
6277926|NCT00129623|7177501|FG000|STARTED|Overall Study||83
6277927|NCT00129623|7177502|FG001|STARTED|Overall Study||77
6277928|NCT00129623|7177501|FG000|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
6277929|NCT00129623|7177502|FG001|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
6277930|NCT00129623|7177501|FG000|COMPLETED|Overall Study||73
6277931|NCT00129623|7177502|FG001|COMPLETED|Overall Study||65
6277932|NCT00129623|7177501|FG000|NOT COMPLETED|Overall Study||10
6277933|NCT00129623|7177502|FG001|NOT COMPLETED|Overall Study||12
6277934|NCT00129649|7177512|FG000|STARTED|Overall Study||258
6277935|NCT00129649|7177513|FG001|STARTED|Overall Study||246
6277936|NCT00129649|7177512|FG000|COMPLETED|Overall Study||182
6277937|NCT00129649|7177513|FG001|COMPLETED|Overall Study||181
6277938|NCT00129649|7177512|FG000|NOT COMPLETED|Overall Study||76
6277939|NCT00129649|7177513|FG001|NOT COMPLETED|Overall Study||65
6277940|NCT00129701|7177519|FG000|STARTED|Overall Study||104
6277941|NCT00129701|7177519|FG000|COMPLETED|Overall Study||71
6277942|NCT00129701|7177519|FG000|NOT COMPLETED|Overall Study||33
6277943|NCT00129727|7177526|FG000|STARTED|Overall Study||62
6506695|NCT01461044|7425967|FG001|NOT COMPLETED|Overall Study||40
6506696|NCT01461057|7425978|FG000|STARTED|Overall Study||15
6506697|NCT01461057|7425979|FG001|STARTED|Overall Study||15
6506698|NCT01461057|7425978|FG000|COMPLETED|Overall Study||0
6506699|NCT01461057|7425979|FG001|COMPLETED|Overall Study||0
6506700|NCT01461057|7425978|FG000|NOT COMPLETED|Overall Study||15
6506701|NCT01461057|7425979|FG001|NOT COMPLETED|Overall Study||15
6506702|NCT01461096|7425987|FG000|STARTED|Overall Study||288
6506703|NCT01461096|7425988|FG001|STARTED|Overall Study||287
6506704|NCT01461096|7425987|FG000|Did Not Start Treatment|Overall Study||0
6506705|NCT01461096|7425988|FG001|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
6506706|NCT01461096|7425987|FG000|COMPLETED|Overall Study||226
6506707|NCT01461096|7425988|FG001|COMPLETED|Overall Study||226
6506708|NCT01461096|7425987|FG000|NOT COMPLETED|Overall Study||62
6506709|NCT01461096|7425988|FG001|NOT COMPLETED|Overall Study||61
6506710|NCT01461369|7425998|FG000|STARTED|Overall Study||104
6506711|NCT01461369|7425999|FG001|STARTED|Overall Study||98
6506712|NCT01461369|7426000|FG002|STARTED|Overall Study||103
6506713|NCT01461369|7425998|FG000|COMPLETED|Overall Study||91
6506714|NCT01461369|7425999|FG001|COMPLETED|Overall Study||81
6506715|NCT01461369|7426000|FG002|COMPLETED|Overall Study||86
6506716|NCT01461369|7425998|FG000|NOT COMPLETED|Overall Study||13
6506717|NCT01461369|7425999|FG001|NOT COMPLETED|Overall Study||17
6506718|NCT01461369|7426000|FG002|NOT COMPLETED|Overall Study||17
6506719|NCT01461473|7426010|FG000|STARTED|Overall Study||72
6506720|NCT01461473|7426011|FG001|STARTED|Overall Study||59
6506721|NCT01461473|7426010|FG000|COMPLETED|Overall Study||67
6506722|NCT01461473|7426011|FG001|COMPLETED|Overall Study||55
6506723|NCT01461473|7426010|FG000|NOT COMPLETED|Overall Study||5
6506724|NCT01461473|7426011|FG001|NOT COMPLETED|Overall Study||4
6506725|NCT01461499|7426019|FG000|STARTED|Overall Study||119
6506726|NCT01461499|7426020|FG001|STARTED|Overall Study||118
6506727|NCT01461499|7426019|FG000|COMPLETED|Overall Study||111
6506728|NCT01461499|7426020|FG001|COMPLETED|Overall Study||114
6506729|NCT01461499|7426019|FG000|NOT COMPLETED|Overall Study||8
6506730|NCT01461499|7426020|FG001|NOT COMPLETED|Overall Study||4
6506731|NCT01461538|7426031|FG000|STARTED|Overall Study||46
6506732|NCT01461538|7426032|FG001|STARTED|Overall Study||28
6506733|NCT01461538|7426033|FG002|STARTED|Overall Study||9
6506734|NCT01461538|7426031|FG000|COMPLETED|Overall Study||28
6506735|NCT01461538|7426032|FG001|COMPLETED|Overall Study||20
6506736|NCT01461538|7426033|FG002|COMPLETED|Overall Study||7
6506737|NCT01461538|7426031|FG000|NOT COMPLETED|Overall Study||18
6506738|NCT01461538|7426032|FG001|NOT COMPLETED|Overall Study||8
6506739|NCT01461538|7426033|FG002|NOT COMPLETED|Overall Study||2
6506740|NCT01461551|7426046|FG000|STARTED|Overall Study||35
6506741|NCT01461551|7426047|FG001|STARTED|Overall Study||35
6506742|NCT01461551|7426048|FG002|STARTED|Overall Study||35
6506743|NCT01461551|7426046|FG000|COMPLETED|Overall Study||33
6506744|NCT01461551|7426047|FG001|COMPLETED|Overall Study||34
6506745|NCT01461551|7426048|FG002|COMPLETED|Overall Study||33
6506746|NCT01461551|7426046|FG000|NOT COMPLETED|Overall Study||2
6251439|NCT03896295|7149698|FG000|STARTED|Overall Study||7
6251440|NCT03896295|7149699|FG001|STARTED|Overall Study||30
6251441|NCT03896295|7149698|FG000|COMPLETED|Overall Study||0
6251442|NCT03896295|7149699|FG001|COMPLETED|Overall Study||0
6251443|NCT03896295|7149698|FG000|NOT COMPLETED|Overall Study||7
6251444|NCT03896295|7149699|FG001|NOT COMPLETED|Overall Study||30
6251445|NCT03213457|7149713|FG000|STARTED|Overall Study||194
6251446|NCT03213457|7149714|FG001|STARTED|Overall Study||98
6251447|NCT03213457|7149715|FG002|STARTED|Overall Study||389
6251448|NCT03213457|7149713|FG000|Randomized and Treated|Overall Study||193
6251449|NCT03213457|7149714|FG001|Randomized and Treated|Overall Study||97
6251450|NCT03213457|7149715|FG002|Randomized and Treated|Overall Study||389
6570260|NCT01850589|7493689|FG000|NOT COMPLETED|Overall Study||8
6570261|NCT01850589|7493690|FG001|NOT COMPLETED|Overall Study||0
6570262|NCT01850602|7493698|FG000|STARTED|Overall Study||108
6251451|NCT03213457|7149713|FG000|COMPLETED|Overall Study||106
6251452|NCT03213457|7149714|FG001|COMPLETED|Overall Study||59
6251453|NCT03213457|7149715|FG002|COMPLETED|Overall Study||215
6251454|NCT03213457|7149713|FG000|NOT COMPLETED|Overall Study||88
6251455|NCT03213457|7149714|FG001|NOT COMPLETED|Overall Study||39
6251456|NCT03213457|7149715|FG002|NOT COMPLETED|Overall Study||174
6251457|NCT02982720|7149723|FG000|STARTED|Overall Study||4
6251458|NCT02982720|7149723|FG000|COMPLETED|Overall Study||0
6251459|NCT02982720|7149723|FG000|NOT COMPLETED|Overall Study||4
6251460|NCT02548754|7149729|FG000|STARTED|Overall Study||26
6251461|NCT02548754|7149730|FG001|STARTED|Overall Study||27
6251462|NCT02548754|7149729|FG000|COMPLETED|Overall Study||24
6251463|NCT02548754|7149730|FG001|COMPLETED|Overall Study||23
6251464|NCT02548754|7149729|FG000|NOT COMPLETED|Overall Study||2
6251465|NCT02548754|7149730|FG001|NOT COMPLETED|Overall Study||4
6251466|NCT02375672|7149736|FG000|STARTED|Overall Study||30
6251467|NCT02375672|7149736|FG000|COMPLETED|Overall Study||10
6251468|NCT02375672|7149736|FG000|NOT COMPLETED|Overall Study||20
6251469|NCT02329327|7149742|FG000|STARTED|Overall Study||477
6251470|NCT02329327|7149743|FG001|STARTED|Overall Study||2
6251471|NCT02329327|7149742|FG000|Received At Least 1 Dose of Study Drug|Overall Study||477
6251472|NCT02329327|7149743|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
6251473|NCT02329327|7149742|FG000|Efficacy Population|Overall Study||347
6251474|NCT02329327|7149743|FG001|Efficacy Population|Overall Study||2
6251475|NCT02329327|7149742|FG000|Death|Overall Study||3
6251476|NCT02329327|7149743|FG001|Death|Overall Study||0
6251477|NCT02329327|7149742|FG000|COMPLETED|Overall Study||392
6251478|NCT02329327|7149743|FG001|COMPLETED|Overall Study||2
6251479|NCT02329327|7149742|FG000|NOT COMPLETED|Overall Study||85
6251480|NCT02329327|7149743|FG001|NOT COMPLETED|Overall Study||0
6251481|NCT02153645|7149765|FG000|STARTED|Overall Study||30
6251482|NCT02153645|7149766|FG001|STARTED|Overall Study||29
6251483|NCT02153645|7149767|FG002|STARTED|Overall Study||28
6251484|NCT02153645|7149765|FG000|COMPLETED|Overall Study||17
6570263|NCT01850602|7493699|FG001|STARTED|Overall Study||105
6251485|NCT02153645|7149766|FG001|COMPLETED|Overall Study||19
6251486|NCT02153645|7149767|FG002|COMPLETED|Overall Study||18
6251487|NCT02153645|7149765|FG000|NOT COMPLETED|Overall Study||13
6251488|NCT02153645|7149766|FG001|NOT COMPLETED|Overall Study||10
6251489|NCT02153645|7149767|FG002|NOT COMPLETED|Overall Study||10
6251490|NCT02153632|7149778|FG000|STARTED|Overall Study||45
6251491|NCT02153632|7149779|FG001|STARTED|Overall Study||46
6251492|NCT02153632|7149780|FG002|STARTED|Overall Study||44
6251493|NCT02153632|7149778|FG000|COMPLETED|Overall Study||27
6251494|NCT02153632|7149779|FG001|COMPLETED|Overall Study||27
6251495|NCT02153632|7149780|FG002|COMPLETED|Overall Study||25
6251496|NCT02153632|7149778|FG000|NOT COMPLETED|Overall Study||18
6251497|NCT02153632|7149779|FG001|NOT COMPLETED|Overall Study||19
6251498|NCT02153632|7149780|FG002|NOT COMPLETED|Overall Study||19
6251499|NCT02063724|7149788|FG000|STARTED|Overall Study||15
6251500|NCT02063724|7149788|FG000|COMPLETED|Overall Study||14
6251501|NCT02063724|7149788|FG000|NOT COMPLETED|Overall Study||1
6251502|NCT01942135|7149794|FG000|STARTED|Overall Study||347
6251503|NCT01942135|7149795|FG001|STARTED|Overall Study||174
6251504|NCT01942135|7149794|FG000|COMPLETED|Overall Study||0
6251505|NCT01942135|7149795|FG001|COMPLETED|Overall Study||0
6251506|NCT01942135|7149794|FG000|NOT COMPLETED|Overall Study||347
6251507|NCT01942135|7149795|FG001|NOT COMPLETED|Overall Study||174
6277944|NCT00129727|7177526|FG000|COMPLETED|Overall Study||57
6277945|NCT00129727|7177526|FG000|NOT COMPLETED|Overall Study||5
6277946|NCT00129740|7177530|FG000|STARTED|Overall Study||148
6277947|NCT00129740|7177530|FG000|COMPLETED|Overall Study||148
6506747|NCT01461551|7426047|FG001|NOT COMPLETED|Overall Study||1
6506748|NCT01461551|7426048|FG002|NOT COMPLETED|Overall Study||2
6506749|NCT01461655|7426056|FG000|STARTED|Overall Study||40
6506750|NCT01461655|7426056|FG000|COMPLETED|Overall Study||40
6506751|NCT01461655|7426056|FG000|NOT COMPLETED|Overall Study||0
6506752|NCT01461668|7426063|FG000|STARTED|Overall Study||27
6506753|NCT01461668|7426064|FG001|STARTED|Overall Study||26
6506754|NCT01461668|7426063|FG000|COMPLETED|Overall Study||25
6506755|NCT01461668|7426064|FG001|COMPLETED|Overall Study||25
6570264|NCT01850602|7493698|FG000|COMPLETED|Overall Study||94
6570265|NCT01850602|7493699|FG001|COMPLETED|Overall Study||87
6570266|NCT01850602|7493698|FG000|NOT COMPLETED|Overall Study||14
6570267|NCT01850602|7493699|FG001|NOT COMPLETED|Overall Study||18
6570268|NCT01850615|7493707|FG000|STARTED|Overall Study||116
6570269|NCT01850615|7493708|FG001|STARTED|Overall Study||120
6570270|NCT01850615|7493707|FG000|Exposed|Overall Study||115
6506756|NCT01461668|7426063|FG000|NOT COMPLETED|Overall Study||2
6506757|NCT01461668|7426064|FG001|NOT COMPLETED|Overall Study||1
6506758|NCT01461707|7426072|FG000|STARTED|Overall Study||15
6506759|NCT01461707|7426073|FG001|STARTED|Overall Study||15
6506760|NCT01461707|7426072|FG000|COMPLETED|Overall Study||14
6506761|NCT01461707|7426073|FG001|COMPLETED|Overall Study||15
6506762|NCT01461707|7426072|FG000|NOT COMPLETED|Overall Study||1
6506763|NCT01461707|7426073|FG001|NOT COMPLETED|Overall Study||0
6506764|NCT01461733|7426081|FG000|STARTED|Overall Study||12
6506765|NCT01461733|7426082|FG001|STARTED|Overall Study||12
6506766|NCT01461733|7426081|FG000|COMPLETED|Overall Study||8
6506767|NCT01461733|7426082|FG001|COMPLETED|Overall Study||8
6506768|NCT01461733|7426081|FG000|NOT COMPLETED|Overall Study||4
6506769|NCT01461733|7426082|FG001|NOT COMPLETED|Overall Study||4
6506770|NCT01461811|7426090|FG000|STARTED|Overall Study||95
6506771|NCT01461811|7426091|FG001|STARTED|Overall Study||49
6506772|NCT01461811|7426090|FG000|COMPLETED|Overall Study||91
6506773|NCT01461811|7426091|FG001|COMPLETED|Overall Study||46
6506774|NCT01461811|7426090|FG000|NOT COMPLETED|Overall Study||4
6506775|NCT01461811|7426091|FG001|NOT COMPLETED|Overall Study||3
6506776|NCT01461824|7426100|FG000|STARTED|Overall Study||12
6506777|NCT01461824|7426101|FG001|STARTED|Overall Study||11
6506778|NCT01461824|7426102|FG002|STARTED|Overall Study||11
6506779|NCT01461824|7426100|FG000|COMPLETED|Overall Study||10
6506780|NCT01461824|7426101|FG001|COMPLETED|Overall Study||7
6506781|NCT01461824|7426102|FG002|COMPLETED|Overall Study||8
6506782|NCT01461824|7426100|FG000|NOT COMPLETED|Overall Study||2
6506783|NCT01461824|7426101|FG001|NOT COMPLETED|Overall Study||4
6506784|NCT01461824|7426102|FG002|NOT COMPLETED|Overall Study||3
6506785|NCT01461863|7426112|FG000|STARTED|Overall Study||48
6506786|NCT01461863|7426113|FG001|STARTED|Overall Study||48
6506787|NCT01461863|7426112|FG000|COMPLETED|Overall Study||48
6506788|NCT01461863|7426113|FG001|COMPLETED|Overall Study||48
6506789|NCT01461863|7426112|FG000|NOT COMPLETED|Overall Study||0
6506790|NCT01461863|7426113|FG001|NOT COMPLETED|Overall Study||0
6506791|NCT01461928|7426121|FG000|STARTED|Induction (up to 8 Months)||692
6506792|NCT01461928|7426122|FG001|STARTED|Induction (up to 8 Months)||0
6506793|NCT01461928|7426123|FG002|STARTED|Induction (up to 8 Months)||0
6506794|NCT01461928|7426121|FG000|COMPLETED|Induction (up to 8 Months)||494
6277948|NCT00129740|7177530|FG000|NOT COMPLETED|Overall Study||0
6277949|NCT00129766|7177536|FG000|STARTED|Overall Study||3306
6277950|NCT00129766|7177537|FG001|STARTED|Overall Study||3329
6277951|NCT00129766|7177536|FG000|COMPLETED|Overall Study||3246
6506795|NCT01461928|7426122|FG001|COMPLETED|Induction (up to 8 Months)||0
6506796|NCT01461928|7426123|FG002|COMPLETED|Induction (up to 8 Months)||0
6506797|NCT01461928|7426121|FG000|NOT COMPLETED|Induction (up to 8 Months)||198
6506798|NCT01461928|7426122|FG001|NOT COMPLETED|Induction (up to 8 Months)||0
6506799|NCT01461928|7426123|FG002|NOT COMPLETED|Induction (up to 8 Months)||0
6506800|NCT01461928|7426121|FG000|STARTED|Maintenance I (24 Months)||494
6506801|NCT01461928|7426122|FG001|STARTED|Maintenance I (24 Months)||0
6506802|NCT01461928|7426123|FG002|STARTED|Maintenance I (24 Months)||0
6506803|NCT01461928|7426121|FG000|COMPLETED|Maintenance I (24 Months)|Responders during 2 yrs Maint I treatment|276
6506804|NCT01461928|7426122|FG001|COMPLETED|Maintenance I (24 Months)||0
6506805|NCT01461928|7426123|FG002|COMPLETED|Maintenance I (24 Months)||0
6506806|NCT01461928|7426121|FG000|NOT COMPLETED|Maintenance I (24 Months)||218
6251508|NCT01689909|7149803|FG000|STARTED|Overall Study||51
6251509|NCT01689909|7149804|FG001|STARTED|Overall Study||52
6251510|NCT01689909|7149803|FG000|COMPLETED|Overall Study||51
6251511|NCT01689909|7149804|FG001|COMPLETED|Overall Study||52
6251512|NCT01689909|7149803|FG000|NOT COMPLETED|Overall Study||0
6251513|NCT01689909|7149804|FG001|NOT COMPLETED|Overall Study||0
6251514|NCT01566149|7149814|FG000|STARTED|Overall Study||24
6251515|NCT01566149|7149815|FG001|STARTED|Overall Study||25
6251516|NCT01566149|7149814|FG000|COMPLETED|Overall Study||21
6251517|NCT01566149|7149815|FG001|COMPLETED|Overall Study||23
6251518|NCT01566149|7149814|FG000|NOT COMPLETED|Overall Study||3
6251519|NCT01566149|7149815|FG001|NOT COMPLETED|Overall Study||2
6251520|NCT01481935|7149823|FG000|STARTED|Overall Study||97
6251521|NCT01481935|7149824|FG001|STARTED|Overall Study||93
6251522|NCT01481935|7149823|FG000|COMPLETED|Overall Study||97
6251523|NCT01481935|7149824|FG001|COMPLETED|Overall Study||93
6251524|NCT01481935|7149823|FG000|NOT COMPLETED|Overall Study||0
6251525|NCT01481935|7149824|FG001|NOT COMPLETED|Overall Study||0
6251526|NCT01386125|7149832|FG000|STARTED|Overall Study||375
6251527|NCT01386125|7149833|FG001|STARTED|Overall Study||373
6251528|NCT01386125|7149832|FG000|COMPLETED|Overall Study||350
6251529|NCT01386125|7149833|FG001|COMPLETED|Overall Study||336
6251530|NCT01386125|7149832|FG000|NOT COMPLETED|Overall Study||25
6251531|NCT01386125|7149833|FG001|NOT COMPLETED|Overall Study||37
6251532|NCT01257568|7149839|FG000|STARTED|Overall Study||40
6251533|NCT01257568|7149839|FG000|COMPLETED|Overall Study||7
6251534|NCT01257568|7149839|FG000|NOT COMPLETED|Overall Study||33
6251535|NCT01165424|7149845|FG000|STARTED|Overall Study||80
6251536|NCT01165424|7149845|FG000|COMPLETED|Overall Study||76
6251537|NCT01165424|7149845|FG000|NOT COMPLETED|Overall Study||4
6251538|NCT01135134|7149851|FG000|STARTED|Overall Study||220
6251539|NCT01135134|7149852|FG001|STARTED|Overall Study||113
6251540|NCT01135134|7149851|FG000|COMPLETED|Overall Study||218
6251541|NCT01135134|7149852|FG001|COMPLETED|Overall Study||112
6251542|NCT01135134|7149851|FG000|NOT COMPLETED|Overall Study||2
6251543|NCT01135134|7149852|FG001|NOT COMPLETED|Overall Study||1
6506807|NCT01461928|7426122|FG001|NOT COMPLETED|Maintenance I (24 Months)||0
6506808|NCT01461928|7426123|FG002|NOT COMPLETED|Maintenance I (24 Months)||0
6506809|NCT01461928|7426121|FG000|STARTED|Maintenance II (15 Months)||0
6506810|NCT01461928|7426122|FG001|STARTED|Maintenance II (15 Months)||138
6506811|NCT01461928|7426123|FG002|STARTED|Maintenance II (15 Months)||138
6506812|NCT01461928|7426121|FG000|COMPLETED|Maintenance II (15 Months)||0
6506813|NCT01461928|7426122|FG001|COMPLETED|Maintenance II (15 Months)|6 participants did not receive treatment|115
6506814|NCT01461928|7426123|FG002|COMPLETED|Maintenance II (15 Months)||111
6506815|NCT01461928|7426121|FG000|NOT COMPLETED|Maintenance II (15 Months)||0
6506816|NCT01461928|7426122|FG001|NOT COMPLETED|Maintenance II (15 Months)||23
6506817|NCT01461928|7426123|FG002|NOT COMPLETED|Maintenance II (15 Months)||27
6506818|NCT01461980|7426137|FG000|STARTED|Overall Study||888
6506819|NCT01461980|7426138|FG001|STARTED|Overall Study||878
6506820|NCT01461980|7426139|FG002|STARTED|Overall Study||882
6506821|NCT01461980|7426137|FG000|Vaccination 1|Overall Study||884
6506822|NCT01461980|7426138|FG001|Vaccination 1|Overall Study||870
6506823|NCT01461980|7426139|FG002|Vaccination 1|Overall Study||875
6506824|NCT01461980|7426137|FG000|Vaccination 2|Overall Study||802
6506825|NCT01461980|7426138|FG001|Vaccination 2|Overall Study||819
6506826|NCT01461980|7426139|FG002|Vaccination 2|Overall Study||799
6506827|NCT01461980|7426137|FG000|Vaccination 3|Overall Study||757
6506828|NCT01461980|7426138|FG001|Vaccination 3|Overall Study||777
6506829|NCT01461980|7426139|FG002|Vaccination 3|Overall Study||748
6506830|NCT01461980|7426137|FG000|COMPLETED|Overall Study||722
6506831|NCT01461980|7426138|FG001|COMPLETED|Overall Study||733
6506832|NCT01461980|7426139|FG002|COMPLETED|Overall Study||717
6506833|NCT01461980|7426137|FG000|NOT COMPLETED|Overall Study||166
6506834|NCT01461980|7426138|FG001|NOT COMPLETED|Overall Study||145
6506835|NCT01461980|7426139|FG002|NOT COMPLETED|Overall Study||165
6506836|NCT01461993|7426151|FG000|STARTED|Overall Study||999
6506837|NCT01461993|7426152|FG001|STARTED|Overall Study||998
6506838|NCT01461993|7426153|FG002|STARTED|Overall Study||502
6506839|NCT01461993|7426151|FG000|COMPLETED|Overall Study||848
6506840|NCT01461993|7426152|FG001|COMPLETED|Overall Study||841
6251544|NCT00867165|7149860|FG000|STARTED|Overall Study||93
6251545|NCT00867165|7149861|FG001|STARTED|Overall Study||45
6251546|NCT00867165|7149860|FG000|COMPLETED|Overall Study||89
6251547|NCT00867165|7149861|FG001|COMPLETED|Overall Study||45
6251548|NCT00867165|7149860|FG000|NOT COMPLETED|Overall Study||4
6251549|NCT00867165|7149861|FG001|NOT COMPLETED|Overall Study||0
6506841|NCT01461993|7426153|FG002|COMPLETED|Overall Study||438
6506842|NCT01461993|7426151|FG000|NOT COMPLETED|Overall Study||151
6506843|NCT01461993|7426152|FG001|NOT COMPLETED|Overall Study||157
6506844|NCT01461993|7426153|FG002|NOT COMPLETED|Overall Study||64
6506845|NCT01462045|7426165|FG000|STARTED|Overall Study||11
6506846|NCT01462045|7426166|FG001|STARTED|Overall Study||11
6506847|NCT01462045|7426167|FG002|STARTED|Overall Study||7
6251550|NCT00733005|7149869|FG000|STARTED|Overall Study||162
6251551|NCT00733005|7149870|FG001|STARTED|Overall Study||162
6251552|NCT00733005|7149869|FG000|COMPLETED|Overall Study||160
6251553|NCT00733005|7149870|FG001|COMPLETED|Overall Study||159
6251554|NCT00733005|7149869|FG000|NOT COMPLETED|Overall Study||2
6506848|NCT01462045|7426165|FG000|COMPLETED|Overall Study||11
6506849|NCT01462045|7426166|FG001|COMPLETED|Overall Study||10
6506850|NCT01462045|7426167|FG002|COMPLETED|Overall Study||7
6251555|NCT00733005|7149870|FG001|NOT COMPLETED|Overall Study||3
6251556|NCT00732381|7149878|FG000|STARTED|Overall Study||176
6251557|NCT00732381|7149879|FG001|STARTED|Overall Study||175
6506851|NCT01462045|7426165|FG000|NOT COMPLETED|Overall Study||0
6506852|NCT01462045|7426166|FG001|NOT COMPLETED|Overall Study||1
6506853|NCT01462045|7426167|FG002|NOT COMPLETED|Overall Study||0
6570271|NCT01850615|7493708|FG001|Exposed|Overall Study||120
6570272|NCT01850615|7493707|FG000|COMPLETED|Overall Study||107
6570273|NCT01850615|7493708|FG001|COMPLETED|Overall Study||115
6570274|NCT01850615|7493707|FG000|NOT COMPLETED|Overall Study||9
6570275|NCT01850615|7493708|FG001|NOT COMPLETED|Overall Study||5
6570276|NCT01850641|7493714|FG000|STARTED|Overall Study||35
6570277|NCT01850641|7493714|FG000|COMPLETED|Overall Study||30
6570278|NCT01850641|7493714|FG000|NOT COMPLETED|Overall Study||5
6570279|NCT01850745|7493721|FG000|STARTED|Overall Study||147
6570280|NCT01850745|7493722|FG001|STARTED|Overall Study||169
6570281|NCT01850745|7493723|FG002|STARTED|Overall Study||131
6570282|NCT01850745|7493721|FG000|COMPLETED|Overall Study||147
6570283|NCT01850745|7493722|FG001|COMPLETED|Overall Study||169
6570284|NCT01850745|7493723|FG002|COMPLETED|Overall Study||131
6570285|NCT01850745|7493721|FG000|NOT COMPLETED|Overall Study||0
6570286|NCT01850745|7493722|FG001|NOT COMPLETED|Overall Study||0
6570287|NCT01850745|7493723|FG002|NOT COMPLETED|Overall Study||0
6570288|NCT01850823|7493734|FG000|STARTED|Overall Study||175
6570289|NCT01850823|7493735|FG001|STARTED|Overall Study||350
6570290|NCT01850823|7493736|FG002|STARTED|Overall Study||355
6570291|NCT01850823|7493734|FG000|COMPLETED|Overall Study||172
6570292|NCT01850823|7493735|FG001|COMPLETED|Overall Study||347
6570293|NCT01850823|7493736|FG002|COMPLETED|Overall Study||345
6570294|NCT01850823|7493734|FG000|NOT COMPLETED|Overall Study||3
6570295|NCT01850823|7493735|FG001|NOT COMPLETED|Overall Study||3
6570296|NCT01850823|7493736|FG002|NOT COMPLETED|Overall Study||10
6570297|NCT01851330|7493749|FG000|STARTED|Overall Study||215
6570298|NCT01851330|7493750|FG001|STARTED|Overall Study||216
6570299|NCT01851330|7493751|FG002|STARTED|Overall Study||216
6570300|NCT01851330|7493749|FG000|COMPLETED|Overall Study||202
6570301|NCT01851330|7493750|FG001|COMPLETED|Overall Study||200
6570302|NCT01851330|7493751|FG002|COMPLETED|Overall Study||204
6570303|NCT01851330|7493749|FG000|NOT COMPLETED|Overall Study||13
6570304|NCT01851330|7493750|FG001|NOT COMPLETED|Overall Study||16
6570305|NCT01851330|7493751|FG002|NOT COMPLETED|Overall Study||12
6570306|NCT01851590|7493762|FG000|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
6570307|NCT01851590|7493763|FG001|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
6570308|NCT01851590|7493764|FG002|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
6570309|NCT01851590|7493762|FG000|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
6570310|NCT01851590|7493763|FG001|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
6570311|NCT01851590|7493764|FG002|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
6570312|NCT01851590|7493762|FG000|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
6570313|NCT01851590|7493763|FG001|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
6570314|NCT01851590|7493764|FG002|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
6570315|NCT01851590|7493762|FG000|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
6570316|NCT01851590|7493763|FG001|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
6570317|NCT01851590|7493764|FG002|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
6570318|NCT01851590|7493762|FG000|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
6570319|NCT01851590|7493763|FG001|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
6570320|NCT01851590|7493764|FG002|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
6570321|NCT01851590|7493762|FG000|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
6570322|NCT01851590|7493763|FG001|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
6570323|NCT01851590|7493764|FG002|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
6570324|NCT01851590|7493762|FG000|NOT COMPLETED|Overall Study||0
6570325|NCT01851590|7493763|FG001|NOT COMPLETED|Overall Study||1
6570326|NCT01851590|7493764|FG002|NOT COMPLETED|Overall Study||3
6570327|NCT01851655|7493778|FG000|STARTED|Overall Study||12
6570328|NCT01851655|7493779|FG001|STARTED|Overall Study||12
6570329|NCT01851655|7493778|FG000|COMPLETED|Overall Study||12
6570330|NCT01851655|7493779|FG001|COMPLETED|Overall Study||12
6570331|NCT01851655|7493778|FG000|NOT COMPLETED|Overall Study||0
6570332|NCT01851655|7493779|FG001|NOT COMPLETED|Overall Study||0
6570333|NCT01851720|7493787|FG000|STARTED|Overall Study||0
6570334|NCT01851720|7493788|FG001|STARTED|Overall Study||1
6251558|NCT00732381|7149878|FG000|COMPLETED|Overall Study||174
6251559|NCT00732381|7149879|FG001|COMPLETED|Overall Study||174
6251560|NCT00732381|7149878|FG000|NOT COMPLETED|Overall Study||2
6251561|NCT00732381|7149879|FG001|NOT COMPLETED|Overall Study||1
6251562|NCT00654095|7149885|FG000|STARTED|Overall Study||146
6251563|NCT00654095|7149885|FG000|COMPLETED|Overall Study||114
6251564|NCT00654095|7149885|FG000|NOT COMPLETED|Overall Study||32
6251565|NCT00653523|7149889|FG000|STARTED|Overall Study||151
6251566|NCT00653523|7149889|FG000|COMPLETED|Overall Study||132
6251567|NCT00653523|7149889|FG000|NOT COMPLETED|Overall Study||19
6251568|NCT00599027|7149895|FG000|STARTED|Overall Study||26
6251569|NCT00599027|7149896|FG001|STARTED|Overall Study||25
6251570|NCT00599027|7149895|FG000|COMPLETED|Overall Study||25
6251571|NCT00599027|7149896|FG001|COMPLETED|Overall Study||22
6251572|NCT00599027|7149895|FG000|NOT COMPLETED|Overall Study||1
6251573|NCT00599027|7149896|FG001|NOT COMPLETED|Overall Study||3
6251574|NCT00552032|7149904|FG000|STARTED|Overall Study||66
6251575|NCT00552032|7149905|FG001|STARTED|Overall Study||66
6251576|NCT00552032|7149904|FG000|COMPLETED|Overall Study||49
6251577|NCT00552032|7149905|FG001|COMPLETED|Overall Study||47
6251578|NCT00552032|7149904|FG000|NOT COMPLETED|Overall Study||17
6251579|NCT00552032|7149905|FG001|NOT COMPLETED|Overall Study||19
6251580|NCT00546052|7149911|FG000|STARTED|Overall Study||1738
6251581|NCT00546052|7149911|FG000|Week 4|Overall Study||1714
6251582|NCT00546052|7149911|FG000|Week 8|Overall Study||1680
6251583|NCT00546052|7149911|FG000|Week 12|Overall Study||1650
6251584|NCT00546052|7149911|FG000|Week 32|Overall Study||1583
6251585|NCT00546052|7149911|FG000|Week 52|Overall Study||1511
6251586|NCT00546052|7149911|FG000|COMPLETED|Overall Study||1511
6251587|NCT00546052|7149911|FG000|NOT COMPLETED|Overall Study||227
6251588|NCT00442117|7149920|FG000|STARTED|Overall Study||85
6251589|NCT00442117|7149921|FG001|STARTED|Overall Study||87
6251590|NCT00442117|7149920|FG000|COMPLETED|Overall Study||47
6251591|NCT00442117|7149921|FG001|COMPLETED|Overall Study||49
6251592|NCT00442117|7149920|FG000|NOT COMPLETED|Overall Study||38
6251593|NCT00442117|7149921|FG001|NOT COMPLETED|Overall Study||38
6251594|NCT00424008|7149929|FG000|STARTED|Overall Study||371
6251595|NCT00424008|7149930|FG001|STARTED|Overall Study||351
6251596|NCT00424008|7149929|FG000|COMPLETED|Overall Study||22
6251597|NCT00424008|7149930|FG001|COMPLETED|Overall Study||16
6251598|NCT00424008|7149929|FG000|NOT COMPLETED|Overall Study||349
6251599|NCT00424008|7149930|FG001|NOT COMPLETED|Overall Study||335
6251600|NCT00423176|7149939|FG000|STARTED|Overall Study||114
6251601|NCT00423176|7149940|FG001|STARTED|Overall Study||123
6251602|NCT00423176|7149939|FG000|COMPLETED|Overall Study||98
6251603|NCT00423176|7149940|FG001|COMPLETED|Overall Study||94
6251604|NCT00423176|7149939|FG000|NOT COMPLETED|Overall Study||16
6251605|NCT00423176|7149940|FG001|NOT COMPLETED|Overall Study||29
6251606|NCT00383240|7149950|FG000|STARTED|Overall Study||191
6251607|NCT00383240|7149951|FG001|STARTED|Overall Study||192
6251608|NCT00383240|7149952|FG002|STARTED|Overall Study||202
6251609|NCT00383240|7149953|FG003|STARTED|Overall Study||196
6251610|NCT00383240|7149950|FG000|COMPLETED|Overall Study||156
6251611|NCT00383240|7149951|FG001|COMPLETED|Overall Study||159
6251612|NCT00383240|7149952|FG002|COMPLETED|Overall Study||117
6251613|NCT00383240|7149953|FG003|COMPLETED|Overall Study||119
6251614|NCT00383240|7149950|FG000|NOT COMPLETED|Overall Study||35
6251615|NCT00383240|7149951|FG001|NOT COMPLETED|Overall Study||33
6251616|NCT00383240|7149952|FG002|NOT COMPLETED|Overall Study||85
6251617|NCT00383240|7149953|FG003|NOT COMPLETED|Overall Study||77
6277952|NCT00129766|7177537|FG001|COMPLETED|Overall Study||3270
6277953|NCT00129766|7177536|FG000|NOT COMPLETED|Overall Study||60
6277954|NCT00129766|7177537|FG001|NOT COMPLETED|Overall Study||59
6277955|NCT00129935|7177546|FG000|STARTED|Overall Study||669
6277956|NCT00129935|7177547|FG001|STARTED|Overall Study||715
6277957|NCT00129935|7177546|FG000|COMPLETED|Overall Study|2 patients crossed from arm A to B by error, and 1 patient received other treatment by error.|633
6277958|NCT00129935|7177547|FG001|COMPLETED|Overall Study|1 patient crossed from arm B to A by error.|623
6277959|NCT00129935|7177546|FG000|NOT COMPLETED|Overall Study||36
6277960|NCT00129935|7177547|FG001|NOT COMPLETED|Overall Study||92
6277961|NCT00129961|7177555|FG000|STARTED|Overall Study||39
6277962|NCT00129961|7177556|FG001|STARTED|Overall Study||47
6277963|NCT00129961|7177555|FG000|COMPLETED|Overall Study||20
6277964|NCT00129961|7177556|FG001|COMPLETED|Overall Study||24
6277965|NCT00129961|7177555|FG000|NOT COMPLETED|Overall Study||19
6277966|NCT00129961|7177556|FG001|NOT COMPLETED|Overall Study||23
6277967|NCT00129987|7177564|FG000|STARTED|1st Educational Session||287
6277968|NCT00129987|7177565|FG001|STARTED|1st Educational Session||280
6277969|NCT00129987|7177564|FG000|COMPLETED|1st Educational Session||146
6277970|NCT00129987|7177565|FG001|COMPLETED|1st Educational Session||171
6277971|NCT00129987|7177564|FG000|NOT COMPLETED|1st Educational Session||141
6277972|NCT00129987|7177565|FG001|NOT COMPLETED|1st Educational Session||109
6277973|NCT00129987|7177564|FG000|STARTED|1 Year||146
6277974|NCT00129987|7177565|FG001|STARTED|1 Year||171
6277975|NCT00129987|7177564|FG000|COMPLETED|1 Year||114
6277976|NCT00129987|7177565|FG001|COMPLETED|1 Year||150
6277977|NCT00129987|7177564|FG000|NOT COMPLETED|1 Year||32
6277978|NCT00129987|7177565|FG001|NOT COMPLETED|1 Year||21
6277979|NCT00130039|7177573|FG000|STARTED|Overall Study||232
6277980|NCT00130039|7177574|FG001|STARTED|Overall Study||225
6277981|NCT00130039|7177573|FG000|COMPLETED|Overall Study|full analysis set|202
6277982|NCT00130039|7177574|FG001|COMPLETED|Overall Study|full analysis set|207
6277983|NCT00130039|7177573|FG000|NOT COMPLETED|Overall Study||30
6277984|NCT00130039|7177574|FG001|NOT COMPLETED|Overall Study||18
6251618|NCT02787499|7149966|FG000|STARTED|Overall Study||423
6251619|NCT02787499|7149967|FG001|STARTED|Overall Study||417
6251620|NCT02787499|7149966|FG000|COMPLETED|Overall Study||423
6251621|NCT02787499|7149967|FG001|COMPLETED|Overall Study||417
6251622|NCT02787499|7149966|FG000|NOT COMPLETED|Overall Study||0
6251623|NCT02787499|7149967|FG001|NOT COMPLETED|Overall Study||0
6251624|NCT02765399|7149975|FG000|STARTED|Overall Study||16
6251625|NCT02765399|7149976|FG001|STARTED|Overall Study||7
6251626|NCT02765399|7149975|FG000|COMPLETED|Overall Study||15
6251627|NCT02765399|7149976|FG001|COMPLETED|Overall Study||7
6251628|NCT02765399|7149975|FG000|NOT COMPLETED|Overall Study||1
6251629|NCT02765399|7149976|FG001|NOT COMPLETED|Overall Study||0
6251630|NCT04539262|7149990|FG000|STARTED|Overall Study||12
6251631|NCT04539262|7149991|FG001|STARTED|Overall Study||13
6251632|NCT04539262|7149992|FG002|STARTED|Overall Study||12
6251633|NCT04539262|7149993|FG003|STARTED|Overall Study||12
6251634|NCT04539262|7149994|FG004|STARTED|Overall Study||12
6251635|NCT04539262|7149995|FG005|STARTED|Overall Study||13
6251636|NCT04539262|7149996|FG006|STARTED|Overall Study||62
6251637|NCT04539262|7149997|FG007|STARTED|Overall Study||20
6251638|NCT04539262|7149990|FG000|COMPLETED|Overall Study||12
6251639|NCT04539262|7149991|FG001|COMPLETED|Overall Study||12
6570335|NCT01851720|7493787|FG000|COMPLETED|Overall Study||0
6570336|NCT01851720|7493788|FG001|COMPLETED|Overall Study||0
6570337|NCT01851720|7493787|FG000|NOT COMPLETED|Overall Study||0
6570338|NCT01851720|7493788|FG001|NOT COMPLETED|Overall Study||1
6570339|NCT01851772|7493794|FG000|STARTED|Overall Study||3
6570340|NCT01851772|7493794|FG000|COMPLETED|Overall Study||3
6570341|NCT01851772|7493794|FG000|NOT COMPLETED|Overall Study||0
6570342|NCT01851863|7493802|FG000|STARTED|Overall Study||65
6570343|NCT01851863|7493803|FG001|STARTED|Overall Study||66
6251640|NCT04539262|7149992|FG002|COMPLETED|Overall Study||11
6251641|NCT04539262|7149993|FG003|COMPLETED|Overall Study||11
6251642|NCT04539262|7149994|FG004|COMPLETED|Overall Study||12
6251643|NCT04539262|7149995|FG005|COMPLETED|Overall Study||13
6251644|NCT04539262|7149996|FG006|COMPLETED|Overall Study||61
6251645|NCT04539262|7149997|FG007|COMPLETED|Overall Study||20
6251646|NCT04539262|7149990|FG000|NOT COMPLETED|Overall Study||0
6251647|NCT04539262|7149991|FG001|NOT COMPLETED|Overall Study||1
6251648|NCT04539262|7149992|FG002|NOT COMPLETED|Overall Study||1
6251649|NCT04539262|7149993|FG003|NOT COMPLETED|Overall Study||1
6251650|NCT04539262|7149994|FG004|NOT COMPLETED|Overall Study||0
6251651|NCT04539262|7149995|FG005|NOT COMPLETED|Overall Study||0
6251652|NCT04539262|7149996|FG006|NOT COMPLETED|Overall Study||1
6251653|NCT04539262|7149997|FG007|NOT COMPLETED|Overall Study||0
6251654|NCT04482439|7150018|FG000|STARTED|Overall Study||35
6251655|NCT04482439|7150018|FG000|COMPLETED|Overall Study||33
6251656|NCT04482439|7150018|FG000|NOT COMPLETED|Overall Study||2
6277985|NCT00130117|7177582|FG000|STARTED|Overall Study||11
6277986|NCT00130117|7177583|FG001|STARTED|Overall Study||9
6277987|NCT00130117|7177582|FG000|COMPLETED|Overall Study||7
6277988|NCT00130117|7177583|FG001|COMPLETED|Overall Study||6
6277989|NCT00130117|7177582|FG000|NOT COMPLETED|Overall Study||4
6277990|NCT00130117|7177583|FG001|NOT COMPLETED|Overall Study||3
6277991|NCT00130208|7177592|FG000|STARTED|Maintenance Period (26 Weeks)||524
6277992|NCT00130208|7177593|FG001|STARTED|Maintenance Period (26 Weeks)||532
6277993|NCT00130208|7177592|FG000|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||492
6277994|NCT00130208|7177593|FG001|Valid Albumin Creatinine Ratio|Maintenance Period (26 Weeks)||494
6277995|NCT00130208|7177592|FG000|COMPLETED|Maintenance Period (26 Weeks)||500
6277996|NCT00130208|7177593|FG001|COMPLETED|Maintenance Period (26 Weeks)||502
6277997|NCT00130208|7177592|FG000|NOT COMPLETED|Maintenance Period (26 Weeks)||24
6277998|NCT00130208|7177593|FG001|NOT COMPLETED|Maintenance Period (26 Weeks)||30
6277999|NCT00130208|7177592|FG000|STARTED|Washout Period (8 Weeks)||500
6278000|NCT00130208|7177593|FG001|STARTED|Washout Period (8 Weeks)||502
6278001|NCT00130208|7177592|FG000|COMPLETED|Washout Period (8 Weeks)||494
6278002|NCT00130208|7177593|FG001|COMPLETED|Washout Period (8 Weeks)||490
6278003|NCT00130208|7177592|FG000|NOT COMPLETED|Washout Period (8 Weeks)||6
6278004|NCT00130208|7177593|FG001|NOT COMPLETED|Washout Period (8 Weeks)||12
6278005|NCT00130247|7177601|FG000|STARTED|Overall Study||196
6278006|NCT00130247|7177602|FG001|STARTED|Overall Study||198
6278007|NCT00130247|7177601|FG000|COMPLETED|Overall Study||194
6278008|NCT00130247|7177602|FG001|COMPLETED|Overall Study||194
6570344|NCT01851863|7493804|FG002|STARTED|Overall Study||65
6570345|NCT01851863|7493805|FG003|STARTED|Overall Study||66
6658061|NCT02475837|7588590|FG001|STARTED|Overall Study||7
6658062|NCT02475837|7588589|FG000|COMPLETED|Overall Study||6
6658063|NCT02475837|7588590|FG001|COMPLETED|Overall Study||7
6658064|NCT02475837|7588589|FG000|NOT COMPLETED|Overall Study||0
6658065|NCT02475837|7588590|FG001|NOT COMPLETED|Overall Study||0
6658066|NCT02475850|7588598|FG000|STARTED|Overall Study||2802
6278009|NCT00130247|7177601|FG000|NOT COMPLETED|Overall Study||2
6278010|NCT00130247|7177602|FG001|NOT COMPLETED|Overall Study||4
6278011|NCT00130286|7177612|FG000|STARTED|Overall Study||22
6278012|NCT00130286|7177613|FG001|STARTED|Overall Study||19
6278013|NCT00130286|7177614|FG002|STARTED|Overall Study||17
6278014|NCT00130286|7177615|FG003|STARTED|Overall Study||19
6278015|NCT00130286|7177612|FG000|COMPLETED|Overall Study||22
6278016|NCT00130286|7177613|FG001|COMPLETED|Overall Study||16
6278017|NCT00130286|7177614|FG002|COMPLETED|Overall Study||13
6278018|NCT00130286|7177615|FG003|COMPLETED|Overall Study||17
6570346|NCT01851863|7493802|FG000|COMPLETED|Overall Study||60
6251657|NCT04465162|7150023|FG000|STARTED|Overall Study||73
6251658|NCT04465162|7150023|FG000|COMPLETED|Overall Study||73
6251659|NCT04465162|7150023|FG000|NOT COMPLETED|Overall Study||0
6251660|NCT04404725|7150027|FG000|STARTED|First Intervention||32
6251661|NCT04404725|7150028|FG001|STARTED|First Intervention||31
6251662|NCT04404725|7150027|FG000|COMPLETED|First Intervention||32
6251663|NCT04404725|7150028|FG001|COMPLETED|First Intervention||29
6251664|NCT04404725|7150027|FG000|NOT COMPLETED|First Intervention||0
6251665|NCT04404725|7150028|FG001|NOT COMPLETED|First Intervention||2
6251666|NCT04404725|7150027|FG000|STARTED|Second Intervention||32
6251667|NCT04404725|7150028|FG001|STARTED|Second Intervention||29
6251668|NCT04404725|7150027|FG000|COMPLETED|Second Intervention||31
6251669|NCT04404725|7150028|FG001|COMPLETED|Second Intervention||27
6251670|NCT04404725|7150027|FG000|NOT COMPLETED|Second Intervention||1
6251671|NCT04404725|7150028|FG001|NOT COMPLETED|Second Intervention||2
6251672|NCT04382586|7150036|FG000|STARTED|Overall Study||30
6506854|NCT01462084|7426175|FG000|STARTED|Overall Study||11
6506855|NCT01462084|7426176|FG001|STARTED|Overall Study||10
6506856|NCT01462084|7426175|FG000|Included for Analysis|Overall Study||9
6506857|NCT01462084|7426176|FG001|Included for Analysis|Overall Study||9
6506858|NCT01462084|7426175|FG000|COMPLETED|Overall Study||9
6506859|NCT01462084|7426176|FG001|COMPLETED|Overall Study||9
6506860|NCT01462084|7426175|FG000|NOT COMPLETED|Overall Study||2
6506861|NCT01462084|7426176|FG001|NOT COMPLETED|Overall Study||1
6506862|NCT01462110|7426185|FG000|STARTED|Overall Study||44
6506863|NCT01462110|7426186|FG001|STARTED|Overall Study||43
6506864|NCT01462110|7426185|FG000|COMPLETED|Overall Study||43
6506865|NCT01462110|7426186|FG001|COMPLETED|Overall Study||43
6506866|NCT01462110|7426185|FG000|NOT COMPLETED|Overall Study||1
6506867|NCT01462110|7426186|FG001|NOT COMPLETED|Overall Study||0
6506868|NCT01462162|7426192|FG000|STARTED|Overall Study||120
6506869|NCT01462162|7426192|FG000|COMPLETED|Overall Study||108
6506870|NCT01462162|7426192|FG000|NOT COMPLETED|Overall Study||12
6506871|NCT01462227|7426199|FG000|STARTED|First Assignment||4
6506872|NCT01462227|7426200|FG001|STARTED|First Assignment||2
6506873|NCT01462227|7426201|FG002|STARTED|First Assignment||6
6506874|NCT01462227|7426202|FG003|STARTED|First Assignment||5
6506875|NCT01462227|7426199|FG000|COMPLETED|First Assignment||4
6506876|NCT01462227|7426200|FG001|COMPLETED|First Assignment||2
6506877|NCT01462227|7426201|FG002|COMPLETED|First Assignment||6
6506878|NCT01462227|7426202|FG003|COMPLETED|First Assignment||5
6506879|NCT01462227|7426199|FG000|NOT COMPLETED|First Assignment||0
6506880|NCT01462227|7426200|FG001|NOT COMPLETED|First Assignment||0
6506881|NCT01462227|7426201|FG002|NOT COMPLETED|First Assignment||0
6506882|NCT01462227|7426202|FG003|NOT COMPLETED|First Assignment||0
6506883|NCT01462227|7426199|FG000|STARTED|Second Assignment||4
6506884|NCT01462227|7426200|FG001|STARTED|Second Assignment||2
6506885|NCT01462227|7426201|FG002|STARTED|Second Assignment||6
6506886|NCT01462227|7426202|FG003|STARTED|Second Assignment||5
6506887|NCT01462227|7426199|FG000|COMPLETED|Second Assignment||3
6506888|NCT01462227|7426200|FG001|COMPLETED|Second Assignment||1
6506889|NCT01462227|7426201|FG002|COMPLETED|Second Assignment||5
6506890|NCT01462227|7426202|FG003|COMPLETED|Second Assignment||5
6506891|NCT01462227|7426199|FG000|NOT COMPLETED|Second Assignment||1
6506892|NCT01462227|7426200|FG001|NOT COMPLETED|Second Assignment||1
6506893|NCT01462227|7426201|FG002|NOT COMPLETED|Second Assignment||1
6506894|NCT01462227|7426202|FG003|NOT COMPLETED|Second Assignment||0
6506895|NCT01462253|7426210|FG000|STARTED|Overall Study||35
6506896|NCT01462253|7426210|FG000|COMPLETED|Overall Study||27
6506897|NCT01462253|7426210|FG000|NOT COMPLETED|Overall Study||8
6506898|NCT01462266|7426216|FG000|STARTED|Overall Study||330
6506899|NCT01462266|7426217|FG001|STARTED|Overall Study||330
6506900|NCT01462266|7426216|FG000|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
6506901|NCT01462266|7426217|FG001|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
6506902|NCT01462266|7426216|FG000|COMPLETED|Overall Study||295
6506903|NCT01462266|7426217|FG001|COMPLETED|Overall Study||303
6506904|NCT01462266|7426216|FG000|NOT COMPLETED|Overall Study||35
6506905|NCT01462266|7426217|FG001|NOT COMPLETED|Overall Study||27
6506906|NCT01462279|7426223|FG000|STARTED|Overall Study||20
6251673|NCT04382586|7150037|FG001|STARTED|Overall Study||33
6506907|NCT01462279|7426223|FG000|COMPLETED|Overall Study||17
6506908|NCT01462279|7426223|FG000|NOT COMPLETED|Overall Study||3
6506909|NCT01462292|7426230|FG000|STARTED|Overall Study||16
6506910|NCT01462292|7426231|FG001|STARTED|Overall Study||17
6506911|NCT01462292|7426232|FG002|STARTED|Overall Study||18
6506912|NCT01462292|7426230|FG000|COMPLETED|Overall Study||16
6506913|NCT01462292|7426231|FG001|COMPLETED|Overall Study||17
6506914|NCT01462292|7426232|FG002|COMPLETED|Overall Study||18
6506915|NCT01462292|7426230|FG000|NOT COMPLETED|Overall Study||0
6506916|NCT01462292|7426231|FG001|NOT COMPLETED|Overall Study||0
6506917|NCT01462292|7426232|FG002|NOT COMPLETED|Overall Study||0
6506918|NCT01462305|7426245|FG000|STARTED|Overall Study||18
6251674|NCT04382586|7150036|FG000|COMPLETED|Overall Study||13
6506919|NCT01462305|7426246|FG001|STARTED|Overall Study||17
6506920|NCT01462305|7426245|FG000|COMPLETED|Overall Study||16
6506921|NCT01462305|7426246|FG001|COMPLETED|Overall Study||13
6506922|NCT01462305|7426245|FG000|NOT COMPLETED|Overall Study||2
6506923|NCT01462305|7426246|FG001|NOT COMPLETED|Overall Study||4
6506924|NCT01462318|7426254|FG000|STARTED|Main Study / TP-DI Study||113
6506925|NCT01462318|7426255|FG001|STARTED|Main Study / TP-DI Study||20
6251675|NCT04382586|7150037|FG001|COMPLETED|Overall Study||17
6251676|NCT04382586|7150036|FG000|NOT COMPLETED|Overall Study||17
6251677|NCT04382586|7150037|FG001|NOT COMPLETED|Overall Study||16
6251678|NCT04348656|7150045|FG000|STARTED|Overall Study||627
6251679|NCT04348656|7150046|FG001|STARTED|Overall Study||313
6251680|NCT04348656|7150045|FG000|Baseline Population|Overall Study||625
6251681|NCT04348656|7150046|FG001|Baseline Population|Overall Study||313
6251682|NCT04348656|7150045|FG000|Intention to Treat Analysis|Overall Study||614
6251683|NCT04348656|7150046|FG001|Intention to Treat Analysis|Overall Study||307
6251684|NCT04348656|7150045|FG000|Per Protocol Analysis|Overall Study||548
6251685|NCT04348656|7150046|FG001|Per Protocol Analysis|Overall Study||303
6251686|NCT04348656|7150045|FG000|COMPLETED|Overall Study||614
6251687|NCT04348656|7150046|FG001|COMPLETED|Overall Study||307
6251688|NCT04348656|7150045|FG000|NOT COMPLETED|Overall Study||13
6251689|NCT04348656|7150046|FG001|NOT COMPLETED|Overall Study||6
6251690|NCT04283253|7150052|FG000|STARTED|Overall Study||1
6251691|NCT04283253|7150052|FG000|COMPLETED|Overall Study||1
6251692|NCT04283253|7150052|FG000|NOT COMPLETED|Overall Study||0
6278019|NCT00130286|7177612|FG000|NOT COMPLETED|Overall Study||0
6278020|NCT00130286|7177613|FG001|NOT COMPLETED|Overall Study||3
6278021|NCT00130286|7177614|FG002|NOT COMPLETED|Overall Study||4
6278022|NCT00130286|7177615|FG003|NOT COMPLETED|Overall Study||2
6278023|NCT00130442|7177627|FG000|STARTED|Overall Study||66
6278024|NCT00130442|7177628|FG001|STARTED|Overall Study||68
6278025|NCT00130442|7177627|FG000|COMPLETED|Overall Study||65
6278026|NCT00130442|7177628|FG001|COMPLETED|Overall Study||66
6278027|NCT00130442|7177627|FG000|NOT COMPLETED|Overall Study||1
6278028|NCT00130442|7177628|FG001|NOT COMPLETED|Overall Study||2
6278029|NCT00130520|7177636|FG000|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
6278030|NCT00130520|7177636|FG000|Completion of at Least One Cycle|Overall Study||39
6278031|NCT00130520|7177636|FG000|COMPLETED|Overall Study||1
6278032|NCT00130520|7177636|FG000|NOT COMPLETED|Overall Study||39
6278033|NCT00130533|7177642|FG000|STARTED|Overall Study||448
6278034|NCT00130533|7177643|FG001|STARTED|Overall Study||428
6278035|NCT00130533|7177642|FG000|COMPLETED|Overall Study||337
6278036|NCT00130533|7177643|FG001|COMPLETED|Overall Study||398
6278037|NCT00130533|7177642|FG000|NOT COMPLETED|Overall Study||111
6278038|NCT00130533|7177643|FG001|NOT COMPLETED|Overall Study||30
6278039|NCT00130637|7177649|FG000|STARTED|Overall Study||6
6278040|NCT00130637|7177649|FG000|COMPLETED|Overall Study||3
6278041|NCT00130637|7177649|FG000|NOT COMPLETED|Overall Study||3
6278042|NCT00130689|7177653|FG000|STARTED|Overall Study||43
6278043|NCT00130689|7177653|FG000|Eligible|Overall Study||37
6278044|NCT00130689|7177653|FG000|Treated|Overall Study||35
6278045|NCT00130689|7177653|FG000|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
6278046|NCT00130689|7177653|FG000|NOT COMPLETED|Overall Study||43
6278047|NCT00130728|7177659|FG000|STARTED|Overall Study||319
6278048|NCT00130728|7177660|FG001|STARTED|Overall Study||317
6278049|NCT00130728|7177659|FG000|Received Study Drug (Safety Population)|Overall Study||313
6278050|NCT00130728|7177660|FG001|Received Study Drug (Safety Population)|Overall Study||313
6278051|NCT00130728|7177659|FG000|COMPLETED|Overall Study||57
6278052|NCT00130728|7177660|FG001|COMPLETED|Overall Study||57
6278053|NCT00130728|7177659|FG000|NOT COMPLETED|Overall Study||262
6278054|NCT00130728|7177660|FG001|NOT COMPLETED|Overall Study||260
6278055|NCT00130780|7177668|FG000|STARTED|Overall Study||51
6278056|NCT00130780|7177669|FG001|STARTED|Overall Study||20
6278057|NCT00130780|7177668|FG000|COMPLETED|Overall Study||51
6278058|NCT00130780|7177669|FG001|COMPLETED|Overall Study||20
6278059|NCT00130780|7177668|FG000|NOT COMPLETED|Overall Study||0
6278060|NCT00130780|7177669|FG001|NOT COMPLETED|Overall Study||0
6278061|NCT00130793|7177677|FG000|STARTED|Overall Study||183
6278062|NCT00130793|7177678|FG001|STARTED|Overall Study||185
6278063|NCT00130793|7177677|FG000|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
6278064|NCT00130793|7177678|FG001|Vaccinated|Overall Study||185
6278065|NCT00130793|7177677|FG000|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
6278066|NCT00130793|7177678|FG001|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
6278067|NCT00130793|7177677|FG000|NOT COMPLETED|Overall Study||3
6278068|NCT00130793|7177678|FG001|NOT COMPLETED|Overall Study||4
6278069|NCT00130832|7177687|FG000|STARTED|Overall Study||372
6278070|NCT00130832|7177688|FG001|STARTED|Overall Study||363
6278071|NCT00130832|7177687|FG000|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
6278072|NCT00130832|7177688|FG001|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
6278073|NCT00130832|7177687|FG000|NOT COMPLETED|Overall Study||16
6278074|NCT00130832|7177688|FG001|NOT COMPLETED|Overall Study||17
6278075|NCT00130923|7177696|FG000|STARTED|Overall Study||49
6506926|NCT01462318|7426256|FG002|STARTED|Main Study / TP-DI Study||0
6506927|NCT01462318|7426254|FG000|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
6506928|NCT01462318|7426255|FG001|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
6506929|NCT01462318|7426256|FG002|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
6506930|NCT01462318|7426254|FG000|COMPLETED|Main Study / TP-DI Study||105
6506931|NCT01462318|7426255|FG001|COMPLETED|Main Study / TP-DI Study||20
6278076|NCT00130923|7177697|FG001|STARTED|Overall Study||46
6278077|NCT00130923|7177696|FG000|COMPLETED|Overall Study||36
6251693|NCT04246541|7150058|FG000|STARTED|Overall Study||25
6251694|NCT04246541|7150059|FG001|STARTED|Overall Study||23
6251695|NCT04246541|7150058|FG000|COMPLETED|Overall Study||22
6251696|NCT04246541|7150059|FG001|COMPLETED|Overall Study||20
6251697|NCT04246541|7150058|FG000|NOT COMPLETED|Overall Study||3
6251698|NCT04246541|7150059|FG001|NOT COMPLETED|Overall Study||3
6251699|NCT04079881|7150067|FG000|STARTED|Overall Study||1
6251700|NCT04079881|7150068|FG001|STARTED|Overall Study||0
6251701|NCT04079881|7150067|FG000|COMPLETED|Overall Study||1
6251702|NCT04079881|7150068|FG001|COMPLETED|Overall Study||0
6251703|NCT04079881|7150067|FG000|NOT COMPLETED|Overall Study||0
6251704|NCT04079881|7150068|FG001|NOT COMPLETED|Overall Study||0
6251705|NCT03950674|7150077|FG000|STARTED|Overall Study||25
6251706|NCT03950674|7150078|FG001|STARTED|Overall Study||15
6251707|NCT03950674|7150077|FG000|Treated|Overall Study||25
6251708|NCT03950674|7150078|FG001|Treated|Overall Study||15
6251709|NCT03950674|7150077|FG000|Switched to Pembrolizumab|Overall Study||0
6251710|NCT03950674|7150078|FG001|Switched to Pembrolizumab|Overall Study||4
6251711|NCT03950674|7150077|FG000|COMPLETED|Overall Study||0
6251712|NCT03950674|7150078|FG001|COMPLETED|Overall Study||0
6251713|NCT03950674|7150077|FG000|NOT COMPLETED|Overall Study||25
6251714|NCT03950674|7150078|FG001|NOT COMPLETED|Overall Study||15
6251715|NCT03868839|7150085|FG000|STARTED|Overall Study||6
6251716|NCT03868839|7150085|FG000|COMPLETED|Overall Study||5
6251717|NCT03868839|7150085|FG000|NOT COMPLETED|Overall Study||1
6251718|NCT03847974|7150089|FG000|STARTED|Overall Study||32
6251719|NCT03847974|7150089|FG000|COMPLETED|Overall Study||26
6251720|NCT03847974|7150089|FG000|NOT COMPLETED|Overall Study||6
6251721|NCT03846427|7150093|FG000|STARTED|Overall Study||68
6251722|NCT03846427|7150093|FG000|COMPLETED|Overall Study||0
6251723|NCT03846427|7150093|FG000|NOT COMPLETED|Overall Study||68
6251724|NCT03787095|7150099|FG000|STARTED|Overall Study||4
6251725|NCT03787095|7150100|FG001|STARTED|Overall Study||1
6251726|NCT03787095|7150099|FG000|COMPLETED|Overall Study||4
6251727|NCT03787095|7150100|FG001|COMPLETED|Overall Study|Participant had final visit at study week 7 in accordance with decision from team after the study was closed.|1
6251728|NCT03787095|7150099|FG000|NOT COMPLETED|Overall Study||0
6506932|NCT01462318|7426256|FG002|COMPLETED|Main Study / TP-DI Study||0
6506933|NCT01462318|7426254|FG000|NOT COMPLETED|Main Study / TP-DI Study||8
6506934|NCT01462318|7426255|FG001|NOT COMPLETED|Main Study / TP-DI Study||0
6506935|NCT01462318|7426256|FG002|NOT COMPLETED|Main Study / TP-DI Study||0
6506936|NCT01462318|7426254|FG000|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
6506937|NCT01462318|7426255|FG001|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
6506938|NCT01462318|7426256|FG002|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
6506939|NCT01462318|7426254|FG000|COMPLETED|Extension Phase||0
6506940|NCT01462318|7426255|FG001|COMPLETED|Extension Phase||0
6506941|NCT01462318|7426256|FG002|COMPLETED|Extension Phase||70
6506942|NCT01462318|7426254|FG000|NOT COMPLETED|Extension Phase||0
6506943|NCT01462318|7426255|FG001|NOT COMPLETED|Extension Phase||0
6506944|NCT01462318|7426256|FG002|NOT COMPLETED|Extension Phase||45
6506945|NCT01462344|7426263|FG000|STARTED|Overall Study||3107
6506946|NCT01462344|7426264|FG001|STARTED|Overall Study||3101
6506947|NCT01462344|7426263|FG000|COMPLETED|Overall Study||2724
6506948|NCT01462344|7426264|FG001|COMPLETED|Overall Study||2751
6506949|NCT01462344|7426263|FG000|NOT COMPLETED|Overall Study||383
6506950|NCT01462344|7426264|FG001|NOT COMPLETED|Overall Study||350
6506951|NCT01462357|7426273|FG000|STARTED|Overall Study||359
6506952|NCT01462357|7426274|FG001|STARTED|Overall Study||358
6506953|NCT01462357|7426275|FG002|STARTED|Overall Study||358
6506954|NCT01462357|7426273|FG000|COMPLETED|Overall Study||351
6506955|NCT01462357|7426274|FG001|COMPLETED|Overall Study||339
6506956|NCT01462357|7426275|FG002|COMPLETED|Overall Study||346
6506957|NCT01462357|7426273|FG000|NOT COMPLETED|Overall Study||8
6506958|NCT01462357|7426274|FG001|NOT COMPLETED|Overall Study||19
6506959|NCT01462357|7426275|FG002|NOT COMPLETED|Overall Study||12
6506960|NCT01462435|7426287|FG000|STARTED|Overall Study||106
6506961|NCT01462435|7426288|FG001|STARTED|Overall Study||109
6506962|NCT01462435|7426289|FG002|STARTED|Overall Study||107
6506963|NCT01462435|7426290|FG003|STARTED|Overall Study||106
6506964|NCT01462435|7426287|FG000|COMPLETED|Overall Study||105
6506965|NCT01462435|7426288|FG001|COMPLETED|Overall Study||109
6506966|NCT01462435|7426289|FG002|COMPLETED|Overall Study||106
6506967|NCT01462435|7426290|FG003|COMPLETED|Overall Study||101
6506968|NCT01462435|7426287|FG000|NOT COMPLETED|Overall Study||1
6506969|NCT01462435|7426288|FG001|NOT COMPLETED|Overall Study||0
6506970|NCT01462435|7426289|FG002|NOT COMPLETED|Overall Study||1
6506971|NCT01462435|7426290|FG003|NOT COMPLETED|Overall Study||5
6506972|NCT01462565|7426300|FG000|STARTED|Overall Study||16
6251729|NCT03787095|7150100|FG001|NOT COMPLETED|Overall Study||0
6251730|NCT03746951|7150109|FG000|STARTED|Overall Study||8
6251731|NCT03746951|7150110|FG001|STARTED|Overall Study||7
6251732|NCT03746951|7150109|FG000|COMPLETED|Overall Study||8
6251733|NCT03746951|7150110|FG001|COMPLETED|Overall Study||7
6251734|NCT03746951|7150109|FG000|NOT COMPLETED|Overall Study||0
6251735|NCT03746951|7150110|FG001|NOT COMPLETED|Overall Study||0
6251736|NCT03685747|7150116|FG000|STARTED|Overall Study||4
6506973|NCT01462565|7426300|FG000|COMPLETED|Overall Study||16
6506974|NCT01462565|7426300|FG000|NOT COMPLETED|Overall Study||0
6506975|NCT01462695|7426306|FG000|STARTED|Overall Study||17
6506976|NCT01462695|7426307|FG001|STARTED|Overall Study||13
6251737|NCT03685747|7150116|FG000|COMPLETED|Overall Study||4
6251738|NCT03685747|7150116|FG000|NOT COMPLETED|Overall Study||0
6251739|NCT03671148|7150122|FG000|STARTED|Overall Study||220
6251740|NCT03671148|7150123|FG001|STARTED|Overall Study||224
6251741|NCT03671148|7150122|FG000|Received Study Drug|Overall Study||219
6251742|NCT03671148|7150123|FG001|Received Study Drug|Overall Study||224
6251743|NCT03671148|7150122|FG000|COMPLETED|Overall Study||199
6251744|NCT03671148|7150123|FG001|COMPLETED|Overall Study||215
6251745|NCT03671148|7150122|FG000|NOT COMPLETED|Overall Study||21
6251746|NCT03671148|7150123|FG001|NOT COMPLETED|Overall Study||9
6506977|NCT01462695|7426306|FG000|COMPLETED|Overall Study||0
6506978|NCT01462695|7426307|FG001|COMPLETED|Overall Study||0
6506979|NCT01462695|7426306|FG000|NOT COMPLETED|Overall Study||17
6506980|NCT01462695|7426307|FG001|NOT COMPLETED|Overall Study||13
6506981|NCT01462773|7426313|FG000|STARTED|Overall Study||16
6506982|NCT01462773|7426313|FG000|COMPLETED|Overall Study||16
6506983|NCT01462773|7426313|FG000|NOT COMPLETED|Overall Study||0
6506984|NCT01462812|7426320|FG000|STARTED|Overall Study||111
6506985|NCT01462812|7426321|FG001|STARTED|Overall Study||112
6506986|NCT01462812|7426320|FG000|COMPLETED|Overall Study||111
6506987|NCT01462812|7426321|FG001|COMPLETED|Overall Study||111
6506988|NCT01462812|7426320|FG000|NOT COMPLETED|Overall Study||0
6506989|NCT01462812|7426321|FG001|NOT COMPLETED|Overall Study||1
6506990|NCT01462877|7426327|FG000|STARTED|Overall Study||506
6506991|NCT01462877|7426327|FG000|Safety Set|Overall Study||492
6506992|NCT01462877|7426327|FG000|Full Analysis Set|Overall Study||468
6506993|NCT01462877|7426327|FG000|Per-protocol Set|Overall Study||364
6506994|NCT01462877|7426327|FG000|COMPLETED|Overall Study||435
6506995|NCT01462877|7426327|FG000|NOT COMPLETED|Overall Study||71
6506996|NCT01462929|7426334|FG000|STARTED|Overall Study||171
6506997|NCT01462929|7426335|FG001|STARTED|Overall Study||158
6506998|NCT01462929|7426336|FG002|STARTED|Overall Study||85
6506999|NCT01462929|7426334|FG000|COMPLETED|Overall Study||166
6507000|NCT01462929|7426335|FG001|COMPLETED|Overall Study||154
6507001|NCT01462929|7426336|FG002|COMPLETED|Overall Study||80
6507002|NCT01462929|7426334|FG000|NOT COMPLETED|Overall Study||5
6507003|NCT01462929|7426335|FG001|NOT COMPLETED|Overall Study||4
6507004|NCT01462929|7426336|FG002|NOT COMPLETED|Overall Study||5
6507005|NCT01462942|7426349|FG000|STARTED|Overall Study||194
6507006|NCT01462942|7426350|FG001|STARTED|Overall Study||385
6507007|NCT01462942|7426351|FG002|STARTED|Overall Study||381
6507008|NCT01462942|7426352|FG003|STARTED|Overall Study||385
6507009|NCT01462942|7426353|FG004|STARTED|Overall Study||384
6507010|NCT01462942|7426349|FG000|COMPLETED|Overall Study||160
6507011|NCT01462942|7426350|FG001|COMPLETED|Overall Study||351
6507012|NCT01462942|7426351|FG002|COMPLETED|Overall Study||341
6507013|NCT01462942|7426352|FG003|COMPLETED|Overall Study||335
6507014|NCT01462942|7426353|FG004|COMPLETED|Overall Study||339
6507015|NCT01462942|7426349|FG000|NOT COMPLETED|Overall Study||34
6507016|NCT01462942|7426350|FG001|NOT COMPLETED|Overall Study||34
6507017|NCT01462942|7426351|FG002|NOT COMPLETED|Overall Study||40
6507018|NCT01462942|7426352|FG003|NOT COMPLETED|Overall Study||50
6507019|NCT01462942|7426353|FG004|NOT COMPLETED|Overall Study||45
6507020|NCT01463007|7426365|FG000|STARTED|Overall Study||41
6507021|NCT01463007|7426365|FG000|COMPLETED|Overall Study||40
6507022|NCT01463007|7426365|FG000|NOT COMPLETED|Overall Study||1
6507023|NCT01463033|7426372|FG000|STARTED|Overall Study||66
6507024|NCT01463033|7426373|FG001|STARTED|Overall Study||60
6507025|NCT01463033|7426372|FG000|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
6507026|NCT01463033|7426373|FG001|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
6507027|NCT01463033|7426372|FG000|NOT COMPLETED|Overall Study||7
6507028|NCT01463033|7426373|FG001|NOT COMPLETED|Overall Study||6
6507029|NCT01463098|7426394|FG000|STARTED|Part A (11 Days)||16
6507030|NCT01463098|7426395|FG001|STARTED|Part A (11 Days)||6
6507031|NCT01463098|7426396|FG002|STARTED|Part A (11 Days)||6
6507032|NCT01463098|7426397|FG003|STARTED|Part A (11 Days)||6
6507033|NCT01463098|7426398|FG004|STARTED|Part A (11 Days)||6
6507034|NCT01463098|7426399|FG005|STARTED|Part A (11 Days)||6
6507035|NCT01463098|7426400|FG006|STARTED|Part A (11 Days)||6
6507036|NCT01463098|7426401|FG007|STARTED|Part A (11 Days)||6
6507037|NCT01463098|7426402|FG008|STARTED|Part A (11 Days)||6
6507038|NCT01463098|7426403|FG009|STARTED|Part A (11 Days)||0
6507039|NCT01463098|7426404|FG010|STARTED|Part A (11 Days)||0
6507040|NCT01463098|7426405|FG011|STARTED|Part A (11 Days)||0
6507041|NCT01463098|7426406|FG012|STARTED|Part A (11 Days)||0
6507042|NCT01463098|7426407|FG013|STARTED|Part A (11 Days)||0
6507043|NCT01463098|7426394|FG000|COMPLETED|Part A (11 Days)||14
6507044|NCT01463098|7426395|FG001|COMPLETED|Part A (11 Days)||6
6251747|NCT03640949|7150131|FG000|STARTED|Overall Study||237
6251748|NCT03640949|7150132|FG001|STARTED|Overall Study||264
6251749|NCT03640949|7150131|FG000|COMPLETED|Overall Study||237
6507045|NCT01463098|7426396|FG002|COMPLETED|Part A (11 Days)||6
6507046|NCT01463098|7426397|FG003|COMPLETED|Part A (11 Days)||6
6507047|NCT01463098|7426398|FG004|COMPLETED|Part A (11 Days)||5
6507048|NCT01463098|7426399|FG005|COMPLETED|Part A (11 Days)||6
6507049|NCT01463098|7426400|FG006|COMPLETED|Part A (11 Days)||6
6507050|NCT01463098|7426401|FG007|COMPLETED|Part A (11 Days)||6
6507051|NCT01463098|7426402|FG008|COMPLETED|Part A (11 Days)||5
6507052|NCT01463098|7426403|FG009|COMPLETED|Part A (11 Days)||0
6507053|NCT01463098|7426404|FG010|COMPLETED|Part A (11 Days)||0
6507054|NCT01463098|7426405|FG011|COMPLETED|Part A (11 Days)||0
6507055|NCT01463098|7426406|FG012|COMPLETED|Part A (11 Days)||0
6251750|NCT03640949|7150132|FG001|COMPLETED|Overall Study||264
6251751|NCT03640949|7150131|FG000|NOT COMPLETED|Overall Study||0
6251752|NCT03640949|7150132|FG001|NOT COMPLETED|Overall Study||0
6251753|NCT03615508|7150138|FG000|STARTED|Overall Study||1
6251754|NCT03615508|7150138|FG000|COMPLETED|Overall Study||1
6251755|NCT03615508|7150138|FG000|NOT COMPLETED|Overall Study||0
6251756|NCT03612856|7150145|FG000|STARTED|Pre-dose Period||8
6251757|NCT03612856|7150146|FG001|STARTED|Pre-dose Period||10
6251758|NCT03612856|7150147|FG002|STARTED|Pre-dose Period||9
6251759|NCT03612856|7150145|FG000|COMPLETED|Pre-dose Period||8
6251760|NCT03612856|7150146|FG001|COMPLETED|Pre-dose Period||8
6251761|NCT03612856|7150147|FG002|COMPLETED|Pre-dose Period||8
6251762|NCT03612856|7150145|FG000|NOT COMPLETED|Pre-dose Period||0
6251763|NCT03612856|7150146|FG001|NOT COMPLETED|Pre-dose Period||2
6251764|NCT03612856|7150147|FG002|NOT COMPLETED|Pre-dose Period||1
6251765|NCT03612856|7150145|FG000|STARTED|Post-dose Period||8
6251766|NCT03612856|7150146|FG001|STARTED|Post-dose Period||8
6251767|NCT03612856|7150147|FG002|STARTED|Post-dose Period||8
6251768|NCT03612856|7150145|FG000|COMPLETED|Post-dose Period||8
6251769|NCT03612856|7150146|FG001|COMPLETED|Post-dose Period||8
6251770|NCT03612856|7150147|FG002|COMPLETED|Post-dose Period||8
6251771|NCT03612856|7150145|FG000|NOT COMPLETED|Post-dose Period||0
6251772|NCT03612856|7150146|FG001|NOT COMPLETED|Post-dose Period||0
6251773|NCT03612856|7150147|FG002|NOT COMPLETED|Post-dose Period||0
6251774|NCT03607487|7150159|FG000|STARTED|Overall Study||9
6251775|NCT03607487|7150160|FG001|STARTED|Overall Study||9
6251776|NCT03607487|7150161|FG002|STARTED|Overall Study||9
6251777|NCT03607487|7150162|FG003|STARTED|Overall Study||8
6251778|NCT03607487|7150159|FG000|COMPLETED|Overall Study||7
6251779|NCT03607487|7150160|FG001|COMPLETED|Overall Study||9
6251780|NCT03607487|7150161|FG002|COMPLETED|Overall Study||9
6251781|NCT03607487|7150162|FG003|COMPLETED|Overall Study||7
6251782|NCT03607487|7150159|FG000|NOT COMPLETED|Overall Study||2
6251783|NCT03607487|7150160|FG001|NOT COMPLETED|Overall Study||0
6251784|NCT03607487|7150161|FG002|NOT COMPLETED|Overall Study||0
6251785|NCT03607487|7150162|FG003|NOT COMPLETED|Overall Study||1
6251786|NCT03586687|7150177|FG000|STARTED|Overall Study||6
6251787|NCT03586687|7150178|FG001|STARTED|Overall Study||9
6251788|NCT03586687|7150179|FG002|STARTED|Overall Study||4
6251789|NCT03586687|7150177|FG000|COMPLETED|Overall Study||6
6251790|NCT03586687|7150178|FG001|COMPLETED|Overall Study||9
6251791|NCT03586687|7150179|FG002|COMPLETED|Overall Study||4
6570347|NCT01851863|7493803|FG001|COMPLETED|Overall Study||57
6570348|NCT01851863|7493804|FG002|COMPLETED|Overall Study||60
6570349|NCT01851863|7493805|FG003|COMPLETED|Overall Study||63
6570350|NCT01851863|7493802|FG000|NOT COMPLETED|Overall Study||5
6570351|NCT01851863|7493803|FG001|NOT COMPLETED|Overall Study||9
6570352|NCT01851863|7493804|FG002|NOT COMPLETED|Overall Study||5
6570353|NCT01851863|7493805|FG003|NOT COMPLETED|Overall Study||3
6570354|NCT01851876|7493820|FG000|STARTED|Overall Study||56
6570355|NCT01851876|7493821|FG001|STARTED|Overall Study||62
6570356|NCT01851876|7493820|FG000|COMPLETED|Overall Study||56
6570357|NCT01851876|7493821|FG001|COMPLETED|Overall Study||62
6570358|NCT01851876|7493820|FG000|NOT COMPLETED|Overall Study||0
6570359|NCT01851876|7493821|FG001|NOT COMPLETED|Overall Study||0
6570360|NCT01852019|7493829|FG000|STARTED|Day 1||3
6570361|NCT01852019|7493830|FG001|STARTED|Day 1||3
6570362|NCT01852019|7493831|FG002|STARTED|Day 1||6
6570363|NCT01852019|7493832|FG003|STARTED|Day 1||0
6570364|NCT01852019|7493833|FG004|STARTED|Day 1||0
6570365|NCT01852019|7493829|FG000|COMPLETED|Day 1||3
6570366|NCT01852019|7493830|FG001|COMPLETED|Day 1||3
6570367|NCT01852019|7493831|FG002|COMPLETED|Day 1||6
6570368|NCT01852019|7493832|FG003|COMPLETED|Day 1||0
6570369|NCT01852019|7493833|FG004|COMPLETED|Day 1||0
6658067|NCT02475850|7588599|FG001|STARTED|Overall Study||2649
6658068|NCT02475850|7588598|FG000|COMPLETED|Overall Study||2209
6658069|NCT02475850|7588599|FG001|COMPLETED|Overall Study||2165
6658070|NCT02475850|7588598|FG000|NOT COMPLETED|Overall Study||593
6658071|NCT02475850|7588599|FG001|NOT COMPLETED|Overall Study||484
6658072|NCT02475954|7588608|FG000|STARTED|Overall Study||87
6658073|NCT02475954|7588609|FG001|STARTED|Overall Study||87
6251792|NCT03586687|7150177|FG000|NOT COMPLETED|Overall Study||0
6251793|NCT03586687|7150178|FG001|NOT COMPLETED|Overall Study||0
6251794|NCT03586687|7150179|FG002|NOT COMPLETED|Overall Study||0
6251795|NCT03529773|7150227|FG000|STARTED|Overall Study||12
6658074|NCT02475954|7588608|FG000|COMPLETED|Overall Study||73
6658075|NCT02475954|7588609|FG001|COMPLETED|Overall Study||75
6658076|NCT02475954|7588608|FG000|NOT COMPLETED|Overall Study||14
6658077|NCT02475954|7588609|FG001|NOT COMPLETED|Overall Study||12
6658078|NCT02475980|7588616|FG000|STARTED|Overall Study||13
6658079|NCT02475980|7588616|FG000|COMPLETED|Overall Study||8
6251796|NCT03529773|7150228|FG001|STARTED|Overall Study||12
6251797|NCT03529773|7150229|FG002|STARTED|Overall Study||12
6251798|NCT03529773|7150230|FG003|STARTED|Overall Study||12
6251799|NCT03529773|7150231|FG004|STARTED|Overall Study||12
6658080|NCT02475980|7588616|FG000|NOT COMPLETED|Overall Study||5
6251800|NCT03529773|7150232|FG005|STARTED|Overall Study||12
6251801|NCT03529773|7150233|FG006|STARTED|Overall Study||12
6251802|NCT03529773|7150234|FG007|STARTED|Overall Study||12
6251803|NCT03529773|7150235|FG008|STARTED|Overall Study||12
6570370|NCT01852019|7493829|FG000|NOT COMPLETED|Day 1||0
6570371|NCT01852019|7493830|FG001|NOT COMPLETED|Day 1||0
6570372|NCT01852019|7493831|FG002|NOT COMPLETED|Day 1||0
6658081|NCT02476032|7588623|FG000|STARTED|Overall Study||20
6251804|NCT03529773|7150236|FG009|STARTED|Overall Study||12
6251805|NCT03529773|7150237|FG010|STARTED|Overall Study||12
6251806|NCT03529773|7150238|FG011|STARTED|Overall Study||12
6251807|NCT03529773|7150239|FG012|STARTED|Overall Study||12
6251808|NCT03529773|7150240|FG013|STARTED|Overall Study||12
6251809|NCT03529773|7150241|FG014|STARTED|Overall Study||41
6251810|NCT03529773|7150242|FG015|STARTED|Overall Study||42
6251811|NCT03529773|7150243|FG016|STARTED|Overall Study||41
6251812|NCT03529773|7150244|FG017|STARTED|Overall Study||41
6251813|NCT03529773|7150245|FG018|STARTED|Overall Study||41
6251814|NCT03529773|7150246|FG019|STARTED|Overall Study||41
6251815|NCT03529773|7150247|FG020|STARTED|Overall Study||41
6251816|NCT03529773|7150248|FG021|STARTED|Overall Study||41
6251817|NCT03529773|7150249|FG022|STARTED|Overall Study||41
6251818|NCT03529773|7150250|FG023|STARTED|Overall Study||41
6251819|NCT03529773|7150251|FG024|STARTED|Overall Study||41
6251820|NCT03529773|7150252|FG025|STARTED|Overall Study||41
6251821|NCT03529773|7150253|FG026|STARTED|Overall Study||41
6251822|NCT03529773|7150254|FG027|STARTED|Overall Study||41
6251823|NCT03529773|7150255|FG028|STARTED|Overall Study||41
6251824|NCT03529773|7150256|FG029|STARTED|Overall Study||40
6251825|NCT03529773|7150257|FG030|STARTED|Overall Study||42
6251826|NCT03529773|7150258|FG031|STARTED|Overall Study||40
6251827|NCT03529773|7150259|FG032|STARTED|Overall Study||40
6251828|NCT03529773|7150260|FG033|STARTED|Overall Study||41
6251829|NCT03529773|7150261|FG034|STARTED|Overall Study||41
6251830|NCT03529773|7150262|FG035|STARTED|Overall Study||40
6251831|NCT03529773|7150263|FG036|STARTED|Overall Study||41
6251832|NCT03529773|7150264|FG037|STARTED|Overall Study||42
6251833|NCT03529773|7150265|FG038|STARTED|Overall Study||43
6251834|NCT03529773|7150266|FG039|STARTED|Overall Study||41
6251835|NCT03529773|7150227|FG000|COMPLETED|Overall Study||12
6251836|NCT03529773|7150228|FG001|COMPLETED|Overall Study||12
6251837|NCT03529773|7150229|FG002|COMPLETED|Overall Study||11
6251838|NCT03529773|7150230|FG003|COMPLETED|Overall Study||12
6251839|NCT03529773|7150231|FG004|COMPLETED|Overall Study||11
6251840|NCT03529773|7150232|FG005|COMPLETED|Overall Study||11
6251841|NCT03529773|7150233|FG006|COMPLETED|Overall Study||12
6251842|NCT03529773|7150234|FG007|COMPLETED|Overall Study||11
6251843|NCT03529773|7150235|FG008|COMPLETED|Overall Study||12
6251844|NCT03529773|7150236|FG009|COMPLETED|Overall Study||11
6251845|NCT03529773|7150237|FG010|COMPLETED|Overall Study||11
6251846|NCT03529773|7150238|FG011|COMPLETED|Overall Study||12
6251847|NCT03529773|7150239|FG012|COMPLETED|Overall Study||10
6251848|NCT03529773|7150240|FG013|COMPLETED|Overall Study||11
6251849|NCT03529773|7150241|FG014|COMPLETED|Overall Study||35
6251850|NCT03529773|7150242|FG015|COMPLETED|Overall Study||38
6251851|NCT03529773|7150243|FG016|COMPLETED|Overall Study||40
6251852|NCT03529773|7150244|FG017|COMPLETED|Overall Study||35
6251853|NCT03529773|7150245|FG018|COMPLETED|Overall Study||37
6251854|NCT03529773|7150246|FG019|COMPLETED|Overall Study||37
6251855|NCT03529773|7150247|FG020|COMPLETED|Overall Study||34
6251856|NCT03529773|7150248|FG021|COMPLETED|Overall Study||36
6251857|NCT03529773|7150249|FG022|COMPLETED|Overall Study||34
6251858|NCT03529773|7150250|FG023|COMPLETED|Overall Study||35
6251859|NCT03529773|7150251|FG024|COMPLETED|Overall Study||33
6251860|NCT03529773|7150252|FG025|COMPLETED|Overall Study||30
6251861|NCT03529773|7150253|FG026|COMPLETED|Overall Study||32
6251862|NCT03529773|7150254|FG027|COMPLETED|Overall Study||39
6251863|NCT03529773|7150255|FG028|COMPLETED|Overall Study||40
6251864|NCT03529773|7150256|FG029|COMPLETED|Overall Study||40
6251865|NCT03529773|7150257|FG030|COMPLETED|Overall Study||39
6251866|NCT03529773|7150258|FG031|COMPLETED|Overall Study||40
6251867|NCT03529773|7150259|FG032|COMPLETED|Overall Study||40
6251868|NCT03529773|7150260|FG033|COMPLETED|Overall Study||39
6251869|NCT03529773|7150261|FG034|COMPLETED|Overall Study||37
6251870|NCT03529773|7150262|FG035|COMPLETED|Overall Study||36
6251871|NCT03529773|7150263|FG036|COMPLETED|Overall Study||39
6251872|NCT03529773|7150264|FG037|COMPLETED|Overall Study||36
6251873|NCT03529773|7150265|FG038|COMPLETED|Overall Study||39
6251874|NCT03529773|7150266|FG039|COMPLETED|Overall Study||37
6251875|NCT03529773|7150227|FG000|NOT COMPLETED|Overall Study||0
6251876|NCT03529773|7150228|FG001|NOT COMPLETED|Overall Study||0
6251877|NCT03529773|7150229|FG002|NOT COMPLETED|Overall Study||1
6251878|NCT03529773|7150230|FG003|NOT COMPLETED|Overall Study||0
6251879|NCT03529773|7150231|FG004|NOT COMPLETED|Overall Study||1
6251880|NCT03529773|7150232|FG005|NOT COMPLETED|Overall Study||1
6251881|NCT03529773|7150233|FG006|NOT COMPLETED|Overall Study||0
6251882|NCT03529773|7150234|FG007|NOT COMPLETED|Overall Study||1
6251883|NCT03529773|7150235|FG008|NOT COMPLETED|Overall Study||0
6251884|NCT03529773|7150236|FG009|NOT COMPLETED|Overall Study||1
6251885|NCT03529773|7150237|FG010|NOT COMPLETED|Overall Study||1
6251886|NCT03529773|7150238|FG011|NOT COMPLETED|Overall Study||0
6251887|NCT03529773|7150239|FG012|NOT COMPLETED|Overall Study||2
6251888|NCT03529773|7150240|FG013|NOT COMPLETED|Overall Study||1
6251889|NCT03529773|7150241|FG014|NOT COMPLETED|Overall Study||6
6251890|NCT03529773|7150242|FG015|NOT COMPLETED|Overall Study||4
6251891|NCT03529773|7150243|FG016|NOT COMPLETED|Overall Study||1
6251892|NCT03529773|7150244|FG017|NOT COMPLETED|Overall Study||6
6251893|NCT03529773|7150245|FG018|NOT COMPLETED|Overall Study||4
6251894|NCT03529773|7150246|FG019|NOT COMPLETED|Overall Study||4
6251895|NCT03529773|7150247|FG020|NOT COMPLETED|Overall Study||7
6251896|NCT03529773|7150248|FG021|NOT COMPLETED|Overall Study||5
6251897|NCT03529773|7150249|FG022|NOT COMPLETED|Overall Study||7
6251898|NCT03529773|7150250|FG023|NOT COMPLETED|Overall Study||6
6251899|NCT03529773|7150251|FG024|NOT COMPLETED|Overall Study||8
6251900|NCT03529773|7150252|FG025|NOT COMPLETED|Overall Study||11
6251901|NCT03529773|7150253|FG026|NOT COMPLETED|Overall Study||9
6251902|NCT03529773|7150254|FG027|NOT COMPLETED|Overall Study||2
6507056|NCT01463098|7426407|FG013|COMPLETED|Part A (11 Days)||0
6507057|NCT01463098|7426394|FG000|NOT COMPLETED|Part A (11 Days)||2
6507058|NCT01463098|7426395|FG001|NOT COMPLETED|Part A (11 Days)||0
6507059|NCT01463098|7426396|FG002|NOT COMPLETED|Part A (11 Days)||0
6507060|NCT01463098|7426397|FG003|NOT COMPLETED|Part A (11 Days)||0
6507061|NCT01463098|7426398|FG004|NOT COMPLETED|Part A (11 Days)||1
6507062|NCT01463098|7426399|FG005|NOT COMPLETED|Part A (11 Days)||0
6507063|NCT01463098|7426400|FG006|NOT COMPLETED|Part A (11 Days)||0
6507064|NCT01463098|7426401|FG007|NOT COMPLETED|Part A (11 Days)||0
6507065|NCT01463098|7426402|FG008|NOT COMPLETED|Part A (11 Days)||1
6507066|NCT01463098|7426403|FG009|NOT COMPLETED|Part A (11 Days)||0
6507067|NCT01463098|7426404|FG010|NOT COMPLETED|Part A (11 Days)||0
6507068|NCT01463098|7426405|FG011|NOT COMPLETED|Part A (11 Days)||0
6507069|NCT01463098|7426406|FG012|NOT COMPLETED|Part A (11 Days)||0
6507070|NCT01463098|7426407|FG013|NOT COMPLETED|Part A (11 Days)||0
6507071|NCT01463098|7426394|FG000|STARTED|Part B (11 Days)||0
6507072|NCT01463098|7426395|FG001|STARTED|Part B (11 Days)||0
6507073|NCT01463098|7426396|FG002|STARTED|Part B (11 Days)||0
6507074|NCT01463098|7426397|FG003|STARTED|Part B (11 Days)||0
6507075|NCT01463098|7426398|FG004|STARTED|Part B (11 Days)||0
6507076|NCT01463098|7426399|FG005|STARTED|Part B (11 Days)||0
6507077|NCT01463098|7426400|FG006|STARTED|Part B (11 Days)||0
6507078|NCT01463098|7426401|FG007|STARTED|Part B (11 Days)||0
6507079|NCT01463098|7426402|FG008|STARTED|Part B (11 Days)||0
6507080|NCT01463098|7426403|FG009|STARTED|Part B (11 Days)||12
6507081|NCT01463098|7426404|FG010|STARTED|Part B (11 Days)||11
6507082|NCT01463098|7426405|FG011|STARTED|Part B (11 Days)||13
6507083|NCT01463098|7426406|FG012|STARTED|Part B (11 Days)||10
6507084|NCT01463098|7426407|FG013|STARTED|Part B (11 Days)||12
6507085|NCT01463098|7426394|FG000|COMPLETED|Part B (11 Days)||0
6507086|NCT01463098|7426395|FG001|COMPLETED|Part B (11 Days)||0
6507087|NCT01463098|7426396|FG002|COMPLETED|Part B (11 Days)||0
6507088|NCT01463098|7426397|FG003|COMPLETED|Part B (11 Days)||0
6507089|NCT01463098|7426398|FG004|COMPLETED|Part B (11 Days)||0
6507090|NCT01463098|7426399|FG005|COMPLETED|Part B (11 Days)||0
6507091|NCT01463098|7426400|FG006|COMPLETED|Part B (11 Days)||0
6507092|NCT01463098|7426401|FG007|COMPLETED|Part B (11 Days)||0
6507093|NCT01463098|7426402|FG008|COMPLETED|Part B (11 Days)||0
6507094|NCT01463098|7426403|FG009|COMPLETED|Part B (11 Days)||12
6507095|NCT01463098|7426404|FG010|COMPLETED|Part B (11 Days)||11
6507096|NCT01463098|7426405|FG011|COMPLETED|Part B (11 Days)||12
6507097|NCT01463098|7426406|FG012|COMPLETED|Part B (11 Days)||10
6507098|NCT01463098|7426407|FG013|COMPLETED|Part B (11 Days)||12
6507099|NCT01463098|7426394|FG000|NOT COMPLETED|Part B (11 Days)||0
6507100|NCT01463098|7426395|FG001|NOT COMPLETED|Part B (11 Days)||0
6507101|NCT01463098|7426396|FG002|NOT COMPLETED|Part B (11 Days)||0
6507102|NCT01463098|7426397|FG003|NOT COMPLETED|Part B (11 Days)||0
6507103|NCT01463098|7426398|FG004|NOT COMPLETED|Part B (11 Days)||0
6507104|NCT01463098|7426399|FG005|NOT COMPLETED|Part B (11 Days)||0
6507105|NCT01463098|7426400|FG006|NOT COMPLETED|Part B (11 Days)||0
6507106|NCT01463098|7426401|FG007|NOT COMPLETED|Part B (11 Days)||0
6507107|NCT01463098|7426402|FG008|NOT COMPLETED|Part B (11 Days)||0
6507108|NCT01463098|7426403|FG009|NOT COMPLETED|Part B (11 Days)||0
6507109|NCT01463098|7426404|FG010|NOT COMPLETED|Part B (11 Days)||0
6507110|NCT01463098|7426405|FG011|NOT COMPLETED|Part B (11 Days)||1
6507111|NCT01463098|7426406|FG012|NOT COMPLETED|Part B (11 Days)||0
6507112|NCT01463098|7426407|FG013|NOT COMPLETED|Part B (11 Days)||0
6507113|NCT01463111|7426456|FG000|STARTED|Overall Study||26
6507114|NCT01463111|7426456|FG000|COMPLETED|Overall Study||17
6507115|NCT01463111|7426456|FG000|NOT COMPLETED|Overall Study||9
6507116|NCT01463202|7426462|FG000|STARTED|Overall Study||79
6507117|NCT01463202|7426463|FG001|STARTED|Overall Study||78
6507118|NCT01463202|7426462|FG000|COMPLETED|Overall Study||79
6507119|NCT01463202|7426463|FG001|COMPLETED|Overall Study||78
6507120|NCT01463202|7426462|FG000|NOT COMPLETED|Overall Study||0
6507121|NCT01463202|7426463|FG001|NOT COMPLETED|Overall Study||0
6507122|NCT01463267|7426473|FG000|STARTED|Overall Study||15
6507123|NCT01463267|7426474|FG001|STARTED|Overall Study||15
6507124|NCT01463267|7426475|FG002|STARTED|Overall Study||15
6507125|NCT01463267|7426476|FG003|STARTED|Overall Study||15
6251903|NCT03529773|7150255|FG028|NOT COMPLETED|Overall Study||1
6251904|NCT03529773|7150256|FG029|NOT COMPLETED|Overall Study||0
6251905|NCT03529773|7150257|FG030|NOT COMPLETED|Overall Study||3
6251906|NCT03529773|7150258|FG031|NOT COMPLETED|Overall Study||0
6251907|NCT03529773|7150259|FG032|NOT COMPLETED|Overall Study||0
6251908|NCT03529773|7150260|FG033|NOT COMPLETED|Overall Study||2
6251909|NCT03529773|7150261|FG034|NOT COMPLETED|Overall Study||4
6507126|NCT01463267|7426473|FG000|COMPLETED|Overall Study||14
6507127|NCT01463267|7426474|FG001|COMPLETED|Overall Study||15
6507128|NCT01463267|7426475|FG002|COMPLETED|Overall Study||13
6507129|NCT01463267|7426476|FG003|COMPLETED|Overall Study||13
6507130|NCT01463267|7426473|FG000|NOT COMPLETED|Overall Study||1
6507131|NCT01463267|7426474|FG001|NOT COMPLETED|Overall Study||0
6507132|NCT01463267|7426475|FG002|NOT COMPLETED|Overall Study||2
6507133|NCT01463267|7426476|FG003|NOT COMPLETED|Overall Study||2
6507134|NCT01463306|7426489|FG000|STARTED|Overall Study||384
6251910|NCT03529773|7150262|FG035|NOT COMPLETED|Overall Study||4
6251911|NCT03529773|7150263|FG036|NOT COMPLETED|Overall Study||2
6251912|NCT03529773|7150264|FG037|NOT COMPLETED|Overall Study||6
6251913|NCT03529773|7150265|FG038|NOT COMPLETED|Overall Study||4
6251914|NCT03529773|7150266|FG039|NOT COMPLETED|Overall Study||4
6251915|NCT03502070|7150369|FG000|STARTED|Overall Study||47
6251916|NCT03502070|7150369|FG000|COMPLETED|Overall Study||45
6251917|NCT03502070|7150369|FG000|NOT COMPLETED|Overall Study||2
6251918|NCT03485911|7150376|FG000|STARTED|Overall Study||41
6251919|NCT03485911|7150377|FG001|STARTED|Overall Study||40
6251920|NCT03485911|7150378|FG002|STARTED|Overall Study||40
6251921|NCT03485911|7150376|FG000|COMPLETED|Overall Study||40
6251922|NCT03485911|7150377|FG001|COMPLETED|Overall Study||38
6251923|NCT03485911|7150378|FG002|COMPLETED|Overall Study||36
6570373|NCT01852019|7493832|FG003|NOT COMPLETED|Day 1||0
6570374|NCT01852019|7493833|FG004|NOT COMPLETED|Day 1||0
6570375|NCT01852019|7493829|FG000|STARTED|Day 8||0
6251924|NCT03485911|7150376|FG000|NOT COMPLETED|Overall Study||1
6251925|NCT03485911|7150377|FG001|NOT COMPLETED|Overall Study||2
6251926|NCT03485911|7150378|FG002|NOT COMPLETED|Overall Study||4
6251927|NCT03403634|7150386|FG000|STARTED|Overall Study|19 patients were accrued and completed consent.|19
6251928|NCT03403634|7150386|FG000|Treated|Overall Study|4 patients became ineligible prior to the start of treatment.|15
6251929|NCT03403634|7150386|FG000|COMPLETED|Overall Study||12
6251930|NCT03403634|7150386|FG000|NOT COMPLETED|Overall Study||7
6251931|NCT03382041|7150392|FG000|STARTED|Overall Study||7
6251932|NCT03382041|7150393|FG001|STARTED|Overall Study||13
6251933|NCT03382041|7150392|FG000|COMPLETED|Overall Study||3
6251934|NCT03382041|7150393|FG001|COMPLETED|Overall Study||4
6507135|NCT01463306|7426490|FG001|STARTED|Overall Study||210
6507136|NCT01463306|7426491|FG002|STARTED|Overall Study||11
6507137|NCT01463306|7426489|FG000|COMPLETED|Overall Study||298
6507138|NCT01463306|7426490|FG001|COMPLETED|Overall Study||158
6507139|NCT01463306|7426491|FG002|COMPLETED|Overall Study||6
6507140|NCT01463306|7426489|FG000|NOT COMPLETED|Overall Study||86
6507141|NCT01463306|7426490|FG001|NOT COMPLETED|Overall Study||52
6507142|NCT01463306|7426491|FG002|NOT COMPLETED|Overall Study||5
6507143|NCT01463358|7426501|FG000|STARTED|Overall Study||49
6507144|NCT01463358|7426502|FG001|STARTED|Overall Study||52
6507145|NCT01463358|7426501|FG000|COMPLETED|Overall Study||46
6507146|NCT01463358|7426502|FG001|COMPLETED|Overall Study||47
6507147|NCT01463358|7426501|FG000|NOT COMPLETED|Overall Study||3
6507148|NCT01463358|7426502|FG001|NOT COMPLETED|Overall Study||5
6507149|NCT01463384|7426508|FG000|STARTED|Overall Study||13
6507150|NCT01463384|7426508|FG000|COMPLETED|Overall Study||13
6507151|NCT01463384|7426508|FG000|NOT COMPLETED|Overall Study||0
6507152|NCT01463527|7426516|FG000|STARTED|Overall Study||83
6507153|NCT01463527|7426517|FG001|STARTED|Overall Study||84
6507154|NCT01463527|7426516|FG000|COMPLETED|Overall Study||77
6507155|NCT01463527|7426517|FG001|COMPLETED|Overall Study||77
6507156|NCT01463527|7426516|FG000|NOT COMPLETED|Overall Study||6
6507157|NCT01463527|7426517|FG001|NOT COMPLETED|Overall Study||7
6507158|NCT01463631|7426527|FG000|STARTED|Overall Study||3
6507159|NCT01463631|7426528|FG001|STARTED|Overall Study||4
6507160|NCT01463631|7426529|FG002|STARTED|Overall Study||5
6507161|NCT01463631|7426530|FG003|STARTED|Overall Study||15
6507162|NCT01463631|7426527|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6507163|NCT01463631|7426528|FG001|Received at Least One Dose of Study Drug|Overall Study||4
6507164|NCT01463631|7426529|FG002|Received at Least One Dose of Study Drug|Overall Study||5
6507165|NCT01463631|7426530|FG003|Received at Least One Dose of Study Drug|Overall Study||15
6507166|NCT01463631|7426527|FG000|COMPLETED|Overall Study||3
6507167|NCT01463631|7426528|FG001|COMPLETED|Overall Study||4
6507168|NCT01463631|7426529|FG002|COMPLETED|Overall Study||4
6507169|NCT01463631|7426530|FG003|COMPLETED|Overall Study||9
6507170|NCT01463631|7426527|FG000|NOT COMPLETED|Overall Study||0
6507171|NCT01463631|7426528|FG001|NOT COMPLETED|Overall Study||0
6507172|NCT01463631|7426529|FG002|NOT COMPLETED|Overall Study||1
6507173|NCT01463631|7426530|FG003|NOT COMPLETED|Overall Study||6
6507174|NCT01463683|7426545|FG000|STARTED|Overall Study||309
6507175|NCT01463683|7426546|FG001|STARTED|Overall Study||309
6507176|NCT01463683|7426547|FG002|STARTED|Overall Study||104
6507177|NCT01463683|7426545|FG000|Received Vaccination 1 (Day 1)|Overall Study||309
6507178|NCT01463683|7426546|FG001|Received Vaccination 1 (Day 1)|Overall Study||308
6507179|NCT01463683|7426547|FG002|Received Vaccination 1 (Day 1)|Overall Study||104
6507180|NCT01463683|7426545|FG000|Received Vaccination 2 (Month 1)|Overall Study||302
6507181|NCT01463683|7426546|FG001|Received Vaccination 2 (Month 1)|Overall Study||300
6507182|NCT01463683|7426547|FG002|Received Vaccination 2 (Month 1)|Overall Study||103
6507183|NCT01463683|7426545|FG000|Received Vaccination 3 (Month 6)|Overall Study||290
6507184|NCT01463683|7426546|FG001|Received Vaccination 3 (Month 6)|Overall Study||281
6507185|NCT01463683|7426547|FG002|Received Vaccination 3 (Month 6)|Overall Study||93
6507186|NCT01463683|7426545|FG000|COMPLETED|Overall Study||290
6251935|NCT03382041|7150392|FG000|NOT COMPLETED|Overall Study||4
6251936|NCT03382041|7150393|FG001|NOT COMPLETED|Overall Study||9
6507187|NCT01463683|7426546|FG001|COMPLETED|Overall Study||278
6507188|NCT01463683|7426547|FG002|COMPLETED|Overall Study||93
6507189|NCT01463683|7426545|FG000|NOT COMPLETED|Overall Study||19
6507190|NCT01463683|7426546|FG001|NOT COMPLETED|Overall Study||31
6507191|NCT01463683|7426547|FG002|NOT COMPLETED|Overall Study||11
6507192|NCT01463696|7426563|FG000|STARTED|Overall Study||1
6570376|NCT01852019|7493830|FG001|STARTED|Day 8||0
6251937|NCT03332095|7150401|FG000|STARTED|Overall Study||10
6251938|NCT03332095|7150402|FG001|STARTED|Overall Study||45
6251939|NCT03332095|7150401|FG000|Received at Least One Dose of Study Treatment|Overall Study||9
6251940|NCT03332095|7150402|FG001|Received at Least One Dose of Study Treatment|Overall Study||45
6251941|NCT03332095|7150401|FG000|COMPLETED|Overall Study||9
6251942|NCT03332095|7150402|FG001|COMPLETED|Overall Study||44
6251943|NCT03332095|7150401|FG000|NOT COMPLETED|Overall Study||1
6507193|NCT01463696|7426564|FG001|STARTED|Overall Study||6
6507194|NCT01463696|7426565|FG002|STARTED|Overall Study||3
6507195|NCT01463696|7426566|FG003|STARTED|Overall Study||7
6507196|NCT01463696|7426567|FG004|STARTED|Overall Study||3
6507197|NCT01463696|7426568|FG005|STARTED|Overall Study||6
6507198|NCT01463696|7426569|FG006|STARTED|Overall Study||16
6507199|NCT01463696|7426570|FG007|STARTED|Overall Study||6
6507200|NCT01463696|7426563|FG000|Treated|Overall Study||1
6507201|NCT01463696|7426564|FG001|Treated|Overall Study||6
6507202|NCT01463696|7426565|FG002|Treated|Overall Study||3
6507203|NCT01463696|7426566|FG003|Treated|Overall Study||7
6507204|NCT01463696|7426567|FG004|Treated|Overall Study||3
6507205|NCT01463696|7426568|FG005|Treated|Overall Study||6
6507206|NCT01463696|7426569|FG006|Treated|Overall Study||15
6507207|NCT01463696|7426570|FG007|Treated|Overall Study||6
6507208|NCT01463696|7426563|FG000|COMPLETED|Overall Study||1
6507209|NCT01463696|7426564|FG001|COMPLETED|Overall Study||4
6507210|NCT01463696|7426565|FG002|COMPLETED|Overall Study||2
6507211|NCT01463696|7426566|FG003|COMPLETED|Overall Study||3
6507212|NCT01463696|7426567|FG004|COMPLETED|Overall Study||2
6507213|NCT01463696|7426568|FG005|COMPLETED|Overall Study||3
6507214|NCT01463696|7426569|FG006|COMPLETED|Overall Study||6
6507215|NCT01463696|7426570|FG007|COMPLETED|Overall Study||2
6507216|NCT01463696|7426563|FG000|NOT COMPLETED|Overall Study||0
6507217|NCT01463696|7426564|FG001|NOT COMPLETED|Overall Study||2
6507218|NCT01463696|7426565|FG002|NOT COMPLETED|Overall Study||1
6507219|NCT01463696|7426566|FG003|NOT COMPLETED|Overall Study||4
6507220|NCT01463696|7426567|FG004|NOT COMPLETED|Overall Study||1
6570377|NCT01852019|7493831|FG002|STARTED|Day 8||0
6570378|NCT01852019|7493832|FG003|STARTED|Day 8||6
6570379|NCT01852019|7493833|FG004|STARTED|Day 8||6
6507221|NCT01463696|7426568|FG005|NOT COMPLETED|Overall Study||3
6507222|NCT01463696|7426569|FG006|NOT COMPLETED|Overall Study||10
6507223|NCT01463696|7426570|FG007|NOT COMPLETED|Overall Study||4
6507224|NCT01463878|7426590|FG000|STARTED|Overall Study||9
6507225|NCT01463878|7426591|FG001|STARTED|Overall Study||9
6507226|NCT01463878|7426590|FG000|COMPLETED|Overall Study||7
6507227|NCT01463878|7426591|FG001|COMPLETED|Overall Study||7
6507228|NCT01463878|7426590|FG000|NOT COMPLETED|Overall Study||2
6507229|NCT01463878|7426591|FG001|NOT COMPLETED|Overall Study||2
6507230|NCT01463982|7426601|FG000|STARTED|Overall Study||3
6507231|NCT01463982|7426602|FG001|STARTED|Overall Study||8
6507232|NCT01463982|7426603|FG002|STARTED|Overall Study||4
6507233|NCT01463982|7426604|FG003|STARTED|Overall Study||6
6507234|NCT01463982|7426601|FG000|COMPLETED|Overall Study||3
6507235|NCT01463982|7426602|FG001|COMPLETED|Overall Study||7
6507236|NCT01463982|7426603|FG002|COMPLETED|Overall Study||2
6507237|NCT01463982|7426604|FG003|COMPLETED|Overall Study||6
6507238|NCT01463982|7426601|FG000|NOT COMPLETED|Overall Study||0
6507239|NCT01463982|7426602|FG001|NOT COMPLETED|Overall Study||1
6251944|NCT03332095|7150402|FG001|NOT COMPLETED|Overall Study||1
6251945|NCT03201419|7150417|FG000|STARTED|Overall Study||60
6251946|NCT03201419|7150418|FG001|STARTED|Overall Study||27
6251947|NCT03201419|7150419|FG002|STARTED|Overall Study||24
6251948|NCT03201419|7150420|FG003|STARTED|Overall Study||14
6251949|NCT03201419|7150421|FG004|STARTED|Overall Study||13
6251950|NCT03201419|7150422|FG005|STARTED|Overall Study||34
6251951|NCT03201419|7150423|FG006|STARTED|Overall Study||87
6251952|NCT03201419|7150424|FG007|STARTED|Overall Study||26
6251953|NCT03201419|7150425|FG008|STARTED|Overall Study||17
6251954|NCT03201419|7150417|FG000|COMPLETED|Overall Study||52
6251955|NCT03201419|7150418|FG001|COMPLETED|Overall Study||24
6251956|NCT03201419|7150419|FG002|COMPLETED|Overall Study||22
6251957|NCT03201419|7150420|FG003|COMPLETED|Overall Study||14
6251958|NCT03201419|7150421|FG004|COMPLETED|Overall Study||12
6251959|NCT03201419|7150422|FG005|COMPLETED|Overall Study||33
6251960|NCT03201419|7150423|FG006|COMPLETED|Overall Study||81
6251961|NCT03201419|7150424|FG007|COMPLETED|Overall Study||25
6251962|NCT03201419|7150425|FG008|COMPLETED|Overall Study||15
6251963|NCT03201419|7150417|FG000|NOT COMPLETED|Overall Study||8
6507240|NCT01463982|7426603|FG002|NOT COMPLETED|Overall Study||2
6507241|NCT01463982|7426604|FG003|NOT COMPLETED|Overall Study||0
6507242|NCT01464021|7426614|FG000|STARTED|Overall Study||26
6507243|NCT01464021|7426614|FG000|COMPLETED|Overall Study||0
6570380|NCT01852019|7493829|FG000|COMPLETED|Day 8||0
6570381|NCT01852019|7493830|FG001|COMPLETED|Day 8||0
6251964|NCT03201419|7150418|FG001|NOT COMPLETED|Overall Study||3
6507244|NCT01464021|7426614|FG000|NOT COMPLETED|Overall Study||26
6251965|NCT03201419|7150419|FG002|NOT COMPLETED|Overall Study||2
6251966|NCT03201419|7150420|FG003|NOT COMPLETED|Overall Study||0
6507245|NCT01464190|7426620|FG000|STARTED|Overall Study||391
6507246|NCT01464190|7426621|FG001|STARTED|Overall Study||268
6507247|NCT01464190|7426620|FG000|COMPLETED|Overall Study||322
6507248|NCT01464190|7426621|FG001|COMPLETED|Overall Study||227
6507249|NCT01464190|7426620|FG000|NOT COMPLETED|Overall Study||69
6507250|NCT01464190|7426621|FG001|NOT COMPLETED|Overall Study||41
6570382|NCT01852019|7493831|FG002|COMPLETED|Day 8||0
6251967|NCT03201419|7150421|FG004|NOT COMPLETED|Overall Study||1
6251968|NCT03201419|7150422|FG005|NOT COMPLETED|Overall Study||1
6251969|NCT03201419|7150423|FG006|NOT COMPLETED|Overall Study||6
6251970|NCT03201419|7150424|FG007|NOT COMPLETED|Overall Study||1
6251971|NCT03201419|7150425|FG008|NOT COMPLETED|Overall Study||2
6251972|NCT03197766|7150461|FG000|STARTED|Overall Study||60
6251973|NCT03197766|7150462|FG001|STARTED|Overall Study||61
6251974|NCT03197766|7150461|FG000|COMPLETED|Overall Study||58
6251975|NCT03197766|7150462|FG001|COMPLETED|Overall Study||61
6251976|NCT03197766|7150461|FG000|NOT COMPLETED|Overall Study||2
6251977|NCT03197766|7150462|FG001|NOT COMPLETED|Overall Study||0
6278078|NCT00130923|7177697|FG001|COMPLETED|Overall Study||32
6278079|NCT00130923|7177696|FG000|NOT COMPLETED|Overall Study||13
6278080|NCT00130923|7177697|FG001|NOT COMPLETED|Overall Study||14
6278081|NCT00131248|7177704|FG000|STARTED|Intervention 1 (3-day Course)||9
6278082|NCT00131248|7177705|FG001|STARTED|Intervention 1 (3-day Course)||9
6278083|NCT00131248|7177704|FG000|COMPLETED|Intervention 1 (3-day Course)||8
6278084|NCT00131248|7177705|FG001|COMPLETED|Intervention 1 (3-day Course)||9
6278085|NCT00131248|7177704|FG000|NOT COMPLETED|Intervention 1 (3-day Course)||1
6278086|NCT00131248|7177705|FG001|NOT COMPLETED|Intervention 1 (3-day Course)||0
6278087|NCT00131248|7177704|FG000|STARTED|Washout (24 Hour)||8
6278088|NCT00131248|7177705|FG001|STARTED|Washout (24 Hour)||9
6278089|NCT00131248|7177704|FG000|COMPLETED|Washout (24 Hour)||8
6278090|NCT00131248|7177705|FG001|COMPLETED|Washout (24 Hour)||9
6278091|NCT00131248|7177704|FG000|NOT COMPLETED|Washout (24 Hour)||0
6278092|NCT00131248|7177705|FG001|NOT COMPLETED|Washout (24 Hour)||0
6278093|NCT00131248|7177704|FG000|STARTED|Intervention 2 (7-day Course)||8
6278094|NCT00131248|7177705|FG001|STARTED|Intervention 2 (7-day Course)||9
6278095|NCT00131248|7177704|FG000|COMPLETED|Intervention 2 (7-day Course)||8
6278096|NCT00131248|7177705|FG001|COMPLETED|Intervention 2 (7-day Course)||9
6278097|NCT00131248|7177704|FG000|NOT COMPLETED|Intervention 2 (7-day Course)||0
6278098|NCT00131248|7177705|FG001|NOT COMPLETED|Intervention 2 (7-day Course)||0
6278099|NCT00131248|7177704|FG000|STARTED|Washout 2 (24 Hours)||8
6278100|NCT00131248|7177705|FG001|STARTED|Washout 2 (24 Hours)||9
6278101|NCT00131248|7177704|FG000|COMPLETED|Washout 2 (24 Hours)||8
6278102|NCT00131248|7177705|FG001|COMPLETED|Washout 2 (24 Hours)||9
6278103|NCT00131248|7177704|FG000|NOT COMPLETED|Washout 2 (24 Hours)||0
6278104|NCT00131248|7177705|FG001|NOT COMPLETED|Washout 2 (24 Hours)||0
6278105|NCT00131248|7177704|FG000|STARTED|Intervention 3 (4-day Course)||8
6278106|NCT00131248|7177705|FG001|STARTED|Intervention 3 (4-day Course)||9
6278107|NCT00131248|7177704|FG000|COMPLETED|Intervention 3 (4-day Course)||8
6278108|NCT00131248|7177705|FG001|COMPLETED|Intervention 3 (4-day Course)||9
6278109|NCT00131248|7177704|FG000|NOT COMPLETED|Intervention 3 (4-day Course)||0
6278110|NCT00131248|7177705|FG001|NOT COMPLETED|Intervention 3 (4-day Course)||0
6278111|NCT00131352|7177713|FG000|STARTED|Initial Treatment Period|Safety population|123
6278112|NCT00131352|7177714|FG001|STARTED|Initial Treatment Period|Safety population|130
6278113|NCT00131352|7177713|FG000|Intent to Treat Population|Initial Treatment Period||124
6278114|NCT00131352|7177714|FG001|Intent to Treat Population|Initial Treatment Period||129
6278115|NCT00131352|7177713|FG000|COMPLETED|Initial Treatment Period||114
6278116|NCT00131352|7177714|FG001|COMPLETED|Initial Treatment Period||118
6278117|NCT00131352|7177713|FG000|NOT COMPLETED|Initial Treatment Period||9
6278118|NCT00131352|7177714|FG001|NOT COMPLETED|Initial Treatment Period||12
6278119|NCT00131352|7177713|FG000|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
6278120|NCT00131352|7177714|FG001|STARTED|Repeat Treatment Period||0
6278121|NCT00131352|7177713|FG000|COMPLETED|Repeat Treatment Period||158
6278122|NCT00131352|7177714|FG001|COMPLETED|Repeat Treatment Period||0
6278123|NCT00131352|7177713|FG000|NOT COMPLETED|Repeat Treatment Period||2
6278124|NCT00131352|7177714|FG001|NOT COMPLETED|Repeat Treatment Period||0
6278125|NCT00131365|7177722|FG000|STARTED|Overall Study|Only safety data was reported due to early closure of the study due to device obsolescence.|9
6278126|NCT00131365|7177722|FG000|COMPLETED|Overall Study||5
6278127|NCT00131365|7177722|FG000|NOT COMPLETED|Overall Study||4
6278128|NCT00131378|7177731|FG000|STARTED|Overall Study||40
6278129|NCT00131378|7177732|FG001|STARTED|Overall Study||40
6278130|NCT00131378|7177733|FG002|STARTED|Overall Study||32
6278131|NCT00131378|7177734|FG003|STARTED|Overall Study||30
6278132|NCT00131378|7177731|FG000|COMPLETED|Overall Study||29
6278133|NCT00131378|7177732|FG001|COMPLETED|Overall Study||22
6278134|NCT00131378|7177733|FG002|COMPLETED|Overall Study||22
6278135|NCT00131378|7177734|FG003|COMPLETED|Overall Study||21
6278136|NCT00131378|7177731|FG000|NOT COMPLETED|Overall Study||11
6278137|NCT00131378|7177732|FG001|NOT COMPLETED|Overall Study||18
6278138|NCT00131378|7177733|FG002|NOT COMPLETED|Overall Study||10
6278139|NCT00131378|7177734|FG003|NOT COMPLETED|Overall Study||9
6278140|NCT00131456|7177748|FG000|STARTED|Overall Study||52
6278141|NCT00131456|7177749|FG001|STARTED|Overall Study||51
6278142|NCT00131456|7177748|FG000|COMPLETED|Overall Study||33
6278143|NCT00131456|7177749|FG001|COMPLETED|Overall Study||31
6278144|NCT00131456|7177748|FG000|NOT COMPLETED|Overall Study||19
6278145|NCT00131456|7177749|FG001|NOT COMPLETED|Overall Study||20
6278146|NCT00131469|7177757|FG000|STARTED|Overall Study||38
6278147|NCT00131469|7177758|FG001|STARTED|Overall Study||40
6278148|NCT00131469|7177757|FG000|COMPLETED|Overall Study||29
6278149|NCT00131469|7177758|FG001|COMPLETED|Overall Study||27
6278150|NCT00131469|7177757|FG000|NOT COMPLETED|Overall Study||9
6251978|NCT05143801|7150468|FG000|STARTED|Overall Study||10
6251979|NCT05143801|7150468|FG000|COMPLETED|Overall Study||10
6251980|NCT05143801|7150468|FG000|NOT COMPLETED|Overall Study||0
6251981|NCT04516759|7150480|FG000|STARTED|Overall Study|excluding 2 subjects who were randomized but did not start treatment|80
6251982|NCT04516759|7150481|FG001|STARTED|Overall Study|excluding 1 subject who was randomized but did not start treatment|73
6251983|NCT04516759|7150480|FG000|COMPLETED|Overall Study||79
6251984|NCT04516759|7150481|FG001|COMPLETED|Overall Study||71
6251985|NCT04516759|7150480|FG000|NOT COMPLETED|Overall Study||1
6251986|NCT04516759|7150481|FG001|NOT COMPLETED|Overall Study||2
6251987|NCT03930446|7150489|FG000|STARTED|Overall Study||40
6251988|NCT03930446|7150490|FG001|STARTED|Overall Study||40
6251989|NCT03930446|7150489|FG000|COMPLETED|Overall Study||40
6251990|NCT03930446|7150490|FG001|COMPLETED|Overall Study||40
6251991|NCT03930446|7150489|FG000|NOT COMPLETED|Overall Study||0
6251992|NCT03930446|7150490|FG001|NOT COMPLETED|Overall Study||0
6251993|NCT03892642|7150496|FG000|STARTED|Overall Study||18
6251994|NCT03892642|7150496|FG000|COMPLETED|Overall Study||18
6251995|NCT03892642|7150496|FG000|NOT COMPLETED|Overall Study||0
6251996|NCT03492099|7150500|FG000|STARTED|Overall Study||47
6251997|NCT03492099|7150500|FG000|COMPLETED|Overall Study||43
6251998|NCT03492099|7150500|FG000|NOT COMPLETED|Overall Study||4
6251999|NCT03409276|7150510|FG000|STARTED|Overall Study||2
6252000|NCT03409276|7150511|FG001|STARTED|Overall Study||10
6507251|NCT01464229|7426629|FG000|STARTED|Overall Study||10
6507252|NCT01464229|7426630|FG001|STARTED|Overall Study||10
6507253|NCT01464229|7426629|FG000|COMPLETED|Overall Study||5
6507254|NCT01464229|7426630|FG001|COMPLETED|Overall Study||8
6507255|NCT01464229|7426629|FG000|NOT COMPLETED|Overall Study||5
6507256|NCT01464229|7426630|FG001|NOT COMPLETED|Overall Study||2
6507257|NCT01464255|7426638|FG000|STARTED|Overall Study||25
6507258|NCT01464255|7426639|FG001|STARTED|Overall Study||25
6507259|NCT01464255|7426638|FG000|COMPLETED|Overall Study||25
6507260|NCT01464255|7426639|FG001|COMPLETED|Overall Study||24
6507261|NCT01464255|7426638|FG000|NOT COMPLETED|Overall Study||0
6507262|NCT01464255|7426639|FG001|NOT COMPLETED|Overall Study||1
6507263|NCT01464307|7426648|FG000|STARTED|Main Period||144
6507264|NCT01464307|7426649|FG001|STARTED|Main Period||145
6507265|NCT01464307|7426648|FG000|Treated|Main Period||144
6507266|NCT01464307|7426649|FG001|Treated|Main Period||145
6507267|NCT01464307|7426648|FG000|COMPLETED|Main Period||129
6507268|NCT01464307|7426649|FG001|COMPLETED|Main Period||140
6507269|NCT01464307|7426648|FG000|NOT COMPLETED|Main Period||15
6507270|NCT01464307|7426649|FG001|NOT COMPLETED|Main Period||5
6507271|NCT01464307|7426648|FG000|STARTED|Open-Label Extension Period||269
6507272|NCT01464307|7426649|FG001|STARTED|Open-Label Extension Period||0
6507273|NCT01464307|7426648|FG000|Treated|Open-Label Extension Period||269
6507274|NCT01464307|7426649|FG001|Treated|Open-Label Extension Period||0
6507275|NCT01464307|7426648|FG000|COMPLETED|Open-Label Extension Period||218
6507276|NCT01464307|7426649|FG001|COMPLETED|Open-Label Extension Period||0
6507277|NCT01464307|7426648|FG000|NOT COMPLETED|Open-Label Extension Period||51
6507278|NCT01464307|7426649|FG001|NOT COMPLETED|Open-Label Extension Period||0
6507279|NCT01464333|7426656|FG000|STARTED|Overall Study||389
6507280|NCT01464333|7426656|FG000|COMPLETED|Overall Study||226
6507281|NCT01464333|7426656|FG000|NOT COMPLETED|Overall Study||163
6507282|NCT01464346|7426660|FG000|STARTED|Overall Study||29
6507283|NCT01464346|7426661|FG001|STARTED|Overall Study||32
6507284|NCT01464346|7426662|FG002|STARTED|Overall Study||29
6507285|NCT01464346|7426660|FG000|COMPLETED|Overall Study||29
6507286|NCT01464346|7426661|FG001|COMPLETED|Overall Study||32
6507287|NCT01464346|7426662|FG002|COMPLETED|Overall Study||28
6507288|NCT01464346|7426660|FG000|NOT COMPLETED|Overall Study||0
6507289|NCT01464346|7426661|FG001|NOT COMPLETED|Overall Study||0
6507290|NCT01464346|7426662|FG002|NOT COMPLETED|Overall Study||1
6507291|NCT01464359|7426670|FG000|STARTED|Overall Study||3
6507292|NCT01464359|7426670|FG000|COMPLETED|Overall Study||3
6507293|NCT01464359|7426670|FG000|NOT COMPLETED|Overall Study||0
6507294|NCT01464424|7426674|FG000|STARTED|Period 1, First 6 Weeks||42
6507295|NCT01464424|7426675|FG001|STARTED|Period 1, First 6 Weeks||42
6507296|NCT01464424|7426674|FG000|COMPLETED|Period 1, First 6 Weeks||42
6507297|NCT01464424|7426675|FG001|COMPLETED|Period 1, First 6 Weeks||41
6507298|NCT01464424|7426674|FG000|NOT COMPLETED|Period 1, First 6 Weeks||0
6507299|NCT01464424|7426675|FG001|NOT COMPLETED|Period 1, First 6 Weeks||1
6507300|NCT01464424|7426674|FG000|STARTED|Period 2, Second 6 Weeks||42
6507301|NCT01464424|7426675|FG001|STARTED|Period 2, Second 6 Weeks||41
6507302|NCT01464424|7426674|FG000|COMPLETED|Period 2, Second 6 Weeks||42
6507303|NCT01464424|7426675|FG001|COMPLETED|Period 2, Second 6 Weeks||41
6507304|NCT01464424|7426674|FG000|NOT COMPLETED|Period 2, Second 6 Weeks||0
6507305|NCT01464424|7426675|FG001|NOT COMPLETED|Period 2, Second 6 Weeks||0
6507306|NCT01464619|7426683|FG000|STARTED|Overall Study||32
6507307|NCT01464619|7426684|FG001|STARTED|Overall Study||29
6507308|NCT01464619|7426683|FG000|COMPLETED|Overall Study||29
6507309|NCT01464619|7426684|FG001|COMPLETED|Overall Study||25
6507310|NCT01464619|7426683|FG000|NOT COMPLETED|Overall Study||3
6507311|NCT01464619|7426684|FG001|NOT COMPLETED|Overall Study||4
6252001|NCT03409276|7150512|FG002|STARTED|Overall Study||6
6252002|NCT03409276|7150513|FG003|STARTED|Overall Study||21
6507312|NCT01464697|7426694|FG000|STARTED|Overall Study||93
6507313|NCT01464697|7426695|FG001|STARTED|Overall Study||96
6252003|NCT03409276|7150514|FG004|STARTED|Overall Study||21
6507314|NCT01464697|7426694|FG000|COMPLETED|Overall Study||90
6252004|NCT03409276|7150510|FG000|Month 2.5 Immunogenicity Cohort|Overall Study||2
6252005|NCT03409276|7150511|FG001|Month 2.5 Immunogenicity Cohort|Overall Study||10
6252006|NCT03409276|7150512|FG002|Month 2.5 Immunogenicity Cohort|Overall Study||0
6252007|NCT03409276|7150513|FG003|Month 2.5 Immunogenicity Cohort|Overall Study||0
6252008|NCT03409276|7150514|FG004|Month 2.5 Immunogenicity Cohort|Overall Study||0
6252009|NCT03409276|7150510|FG000|Month 8.5 Immunogenicity Cohort|Overall Study||0
6252010|NCT03409276|7150511|FG001|Month 8.5 Immunogenicity Cohort|Overall Study||0
6252011|NCT03409276|7150512|FG002|Month 8.5 Immunogenicity Cohort|Overall Study||6
6252012|NCT03409276|7150513|FG003|Month 8.5 Immunogenicity Cohort|Overall Study||19
6252013|NCT03409276|7150514|FG004|Month 8.5 Immunogenicity Cohort|Overall Study||16
6252014|NCT03409276|7150510|FG000|COMPLETED|Overall Study||2
6252015|NCT03409276|7150511|FG001|COMPLETED|Overall Study||10
6252016|NCT03409276|7150512|FG002|COMPLETED|Overall Study||6
6252017|NCT03409276|7150513|FG003|COMPLETED|Overall Study||19
6252018|NCT03409276|7150514|FG004|COMPLETED|Overall Study||18
6252019|NCT03409276|7150510|FG000|NOT COMPLETED|Overall Study||0
6252020|NCT03409276|7150511|FG001|NOT COMPLETED|Overall Study||0
6252021|NCT03409276|7150512|FG002|NOT COMPLETED|Overall Study||0
6252022|NCT03409276|7150513|FG003|NOT COMPLETED|Overall Study||2
6252023|NCT03409276|7150514|FG004|NOT COMPLETED|Overall Study||3
6252024|NCT03360396|7150532|FG000|STARTED|Overall Study||80
6252025|NCT03360396|7150533|FG001|STARTED|Overall Study||40
6252026|NCT03360396|7150532|FG000|COMPLETED|Overall Study||0
6252027|NCT03360396|7150533|FG001|COMPLETED|Overall Study||0
6252028|NCT03360396|7150532|FG000|NOT COMPLETED|Overall Study||80
6252029|NCT03360396|7150533|FG001|NOT COMPLETED|Overall Study||40
6252030|NCT03312907|7150542|FG000|STARTED|Overall Study||72
6252031|NCT03312907|7150543|FG001|STARTED|Overall Study||144
6252032|NCT03312907|7150544|FG002|STARTED|Overall Study||76
6252033|NCT03312907|7150542|FG000|COMPLETED|Overall Study||55
6252034|NCT03312907|7150543|FG001|COMPLETED|Overall Study||114
6252035|NCT03312907|7150544|FG002|COMPLETED|Overall Study||57
6252036|NCT03312907|7150542|FG000|NOT COMPLETED|Overall Study||17
6252037|NCT03312907|7150543|FG001|NOT COMPLETED|Overall Study||30
6252038|NCT03312907|7150544|FG002|NOT COMPLETED|Overall Study||19
6252039|NCT03148756|7150554|FG000|STARTED|Overall Study||0
6252040|NCT03148756|7150555|FG001|STARTED|Overall Study||2
6252041|NCT03148756|7150554|FG000|COMPLETED|Overall Study||0
6252042|NCT03148756|7150555|FG001|COMPLETED|Overall Study||1
6252043|NCT03148756|7150554|FG000|NOT COMPLETED|Overall Study||0
6252044|NCT03148756|7150555|FG001|NOT COMPLETED|Overall Study||1
6252045|NCT03079102|7150563|FG000|STARTED|Overall Study||30
6252046|NCT03079102|7150564|FG001|STARTED|Overall Study||27
6252047|NCT03079102|7150563|FG000|COMPLETED|Overall Study||30
6252048|NCT03079102|7150564|FG001|COMPLETED|Overall Study|One subject had study drug discontinued by the PI after 3h of therapy due to progressive hemodynamic deterioration (worsening hypotension and shock). Discontinuation of study drug did not impact this deterioration.|26
6252049|NCT03079102|7150563|FG000|NOT COMPLETED|Overall Study||0
6252050|NCT03079102|7150564|FG001|NOT COMPLETED|Overall Study||1
6252051|NCT03064126|7150574|FG000|STARTED|Overall Study||278
6252052|NCT03064126|7150575|FG001|STARTED|Overall Study||98
6252053|NCT03064126|7150576|FG002|STARTED|Overall Study||52
6507315|NCT01464697|7426695|FG001|COMPLETED|Overall Study||86
6507316|NCT01464697|7426694|FG000|NOT COMPLETED|Overall Study||3
6507317|NCT01464697|7426695|FG001|NOT COMPLETED|Overall Study||10
6507318|NCT01464775|7426703|FG000|STARTED|Overall Study||123
6507319|NCT01464775|7426704|FG001|STARTED|Overall Study||44
6507320|NCT01464775|7426703|FG000|COMPLETED|Overall Study||112
6507321|NCT01464775|7426704|FG001|COMPLETED|Overall Study||38
6507322|NCT01464775|7426703|FG000|NOT COMPLETED|Overall Study||11
6507323|NCT01464775|7426704|FG001|NOT COMPLETED|Overall Study||6
6507324|NCT01464788|7426715|FG000|STARTED|Overall Study||30
6507325|NCT01464788|7426716|FG001|STARTED|Overall Study||31
6507326|NCT01464788|7426717|FG002|STARTED|Overall Study||29
6507327|NCT01464788|7426715|FG000|COMPLETED|Overall Study||30
6507328|NCT01464788|7426716|FG001|COMPLETED|Overall Study||29
6507329|NCT01464788|7426717|FG002|COMPLETED|Overall Study||29
6507330|NCT01464788|7426715|FG000|NOT COMPLETED|Overall Study||0
6507331|NCT01464788|7426716|FG001|NOT COMPLETED|Overall Study||2
6507332|NCT01464788|7426717|FG002|NOT COMPLETED|Overall Study||0
6507333|NCT01464827|7426741|FG000|STARTED|Overall Study||80
6507334|NCT01464827|7426742|FG001|STARTED|Overall Study||43
6507335|NCT01464827|7426743|FG002|STARTED|Overall Study||39
6507336|NCT01464827|7426744|FG003|STARTED|Overall Study||40
6507337|NCT01464827|7426745|FG004|STARTED|Overall Study||80
6507338|NCT01464827|7426746|FG005|STARTED|Overall Study||39
6507339|NCT01464827|7426747|FG006|STARTED|Overall Study||41
6507340|NCT01464827|7426748|FG007|STARTED|Overall Study||40
6507341|NCT01464827|7426749|FG008|STARTED|Overall Study||40
6507342|NCT01464827|7426750|FG009|STARTED|Overall Study||47
6507343|NCT01464827|7426751|FG010|STARTED|Overall Study||23
6507344|NCT01464827|7426752|FG011|STARTED|Overall Study||23
6507345|NCT01464827|7426753|FG012|STARTED|Overall Study||23
6507346|NCT01464827|7426754|FG013|STARTED|Overall Study||22
6507347|NCT01464827|7426741|FG000|Treated|Overall Study||80
6507348|NCT01464827|7426742|FG001|Treated|Overall Study||41
6507349|NCT01464827|7426743|FG002|Treated|Overall Study||39
6507350|NCT01464827|7426744|FG003|Treated|Overall Study||40
6507351|NCT01464827|7426745|FG004|Treated|Overall Study||79
6507352|NCT01464827|7426746|FG005|Treated|Overall Study||39
6507353|NCT01464827|7426747|FG006|Treated|Overall Study||40
6252054|NCT03064126|7150577|FG003|STARTED|Overall Study||12
6252055|NCT03064126|7150574|FG000|COMPLETED|Overall Study||252
6252056|NCT03064126|7150575|FG001|COMPLETED|Overall Study||91
6252057|NCT03064126|7150576|FG002|COMPLETED|Overall Study||49
6252058|NCT03064126|7150577|FG003|COMPLETED|Overall Study||11
6252059|NCT03064126|7150574|FG000|NOT COMPLETED|Overall Study||26
6252060|NCT03064126|7150575|FG001|NOT COMPLETED|Overall Study||7
6252061|NCT03064126|7150576|FG002|NOT COMPLETED|Overall Study||3
6252062|NCT03064126|7150577|FG003|NOT COMPLETED|Overall Study||1
6252063|NCT02944513|7150590|FG000|STARTED|Overall Study||35
6252064|NCT02944513|7150591|FG001|STARTED|Overall Study||33
6252065|NCT02944513|7150590|FG000|COMPLETED|Overall Study||31
6252066|NCT02944513|7150591|FG001|COMPLETED|Overall Study||32
6252067|NCT02944513|7150590|FG000|NOT COMPLETED|Overall Study||4
6252068|NCT02944513|7150591|FG001|NOT COMPLETED|Overall Study||1
6252069|NCT02913222|7150599|FG000|STARTED|Overall Study||23
6252070|NCT02913222|7150600|FG001|STARTED|Overall Study||23
6252071|NCT02913222|7150599|FG000|COMPLETED|Overall Study||22
6252072|NCT02913222|7150600|FG001|COMPLETED|Overall Study||21
6252073|NCT02913222|7150599|FG000|NOT COMPLETED|Overall Study||1
6252074|NCT02913222|7150600|FG001|NOT COMPLETED|Overall Study||2
6252075|NCT02734433|7150608|FG000|STARTED|Overall Study||3
6252076|NCT02734433|7150609|FG001|STARTED|Overall Study||8
6252077|NCT02734433|7150608|FG000|COMPLETED|Overall Study||1
6252078|NCT02734433|7150609|FG001|COMPLETED|Overall Study||0
6252079|NCT02734433|7150608|FG000|NOT COMPLETED|Overall Study||2
6252080|NCT02734433|7150609|FG001|NOT COMPLETED|Overall Study||8
6252081|NCT02474927|7150615|FG000|STARTED|Overall Study||22
6252082|NCT02474927|7150615|FG000|COMPLETED|Overall Study||22
6252083|NCT02474927|7150615|FG000|NOT COMPLETED|Overall Study||0
6252084|NCT02386839|7150621|FG000|STARTED|Overall Study||36
6252085|NCT02386839|7150622|FG001|STARTED|Overall Study||40
6252086|NCT02386839|7150621|FG000|COMPLETED|Overall Study||20
6252087|NCT02386839|7150622|FG001|COMPLETED|Overall Study||25
6252088|NCT02386839|7150621|FG000|NOT COMPLETED|Overall Study||16
6252089|NCT02386839|7150622|FG001|NOT COMPLETED|Overall Study||15
6252090|NCT02145507|7150634|FG000|STARTED|First Donation||82
6252091|NCT02145507|7150635|FG001|STARTED|First Donation||88
6252092|NCT02145507|7150634|FG000|Randomized to Have Blood Processed With SOLX (IP)|First Donation||52
6252093|NCT02145507|7150635|FG001|Randomized to Have Blood Processed With SOLX (IP)|First Donation||51
6252094|NCT02145507|7150634|FG000|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||30
6252095|NCT02145507|7150635|FG001|Randomized to Have Blood Processed With AS-3 (CP)|First Donation||37
6252096|NCT02145507|7150634|FG000|COMPLETED|First Donation||70
6252097|NCT02145507|7150635|FG001|COMPLETED|First Donation||67
6252098|NCT02145507|7150634|FG000|NOT COMPLETED|First Donation||12
6252099|NCT02145507|7150635|FG001|NOT COMPLETED|First Donation||21
6252100|NCT02145507|7150634|FG000|STARTED|Second Donation||65
6252101|NCT02145507|7150635|FG001|STARTED|Second Donation|Note: Of the 65 participants who started the second period in Arm 2, there were 3 screen failures, therefore only n=62 participants received their alternate procedure.|65
6252102|NCT02145507|7150634|FG000|Blood Processed With AS-3 (CP)|Second Donation||39
6252103|NCT02145507|7150635|FG001|Blood Processed With AS-3 (CP)|Second Donation||35
6252104|NCT02145507|7150634|FG000|Blood Processed With SOLX (IP)|Second Donation||26
6252105|NCT02145507|7150635|FG001|Blood Processed With SOLX (IP)|Second Donation||27
6252106|NCT02145507|7150634|FG000|COMPLETED|Second Donation||63
6252107|NCT02145507|7150635|FG001|COMPLETED|Second Donation||60
6252108|NCT02145507|7150634|FG000|NOT COMPLETED|Second Donation||2
6252109|NCT02145507|7150635|FG001|NOT COMPLETED|Second Donation||5
6252110|NCT02120469|7150649|FG000|STARTED|Overall Study||13
6252111|NCT02120469|7150650|FG001|STARTED|Overall Study||10
6252112|NCT02120469|7150651|FG002|STARTED|Overall Study||4
6252113|NCT02120469|7150649|FG000|COMPLETED|Overall Study||12
6252114|NCT02120469|7150650|FG001|COMPLETED|Overall Study||10
6252115|NCT02120469|7150651|FG002|COMPLETED|Overall Study||3
6252116|NCT02120469|7150649|FG000|NOT COMPLETED|Overall Study||1
6252117|NCT02120469|7150650|FG001|NOT COMPLETED|Overall Study||0
6252118|NCT02120469|7150651|FG002|NOT COMPLETED|Overall Study||1
6252119|NCT02091960|7150661|FG000|STARTED|Overall Study||103
6252120|NCT02091960|7150661|FG000|Received Treatment|Overall Study||103
6252121|NCT02091960|7150661|FG000|COMPLETED|Overall Study|Completed indicates participants with disease progression|52
6252122|NCT02091960|7150661|FG000|NOT COMPLETED|Overall Study||51
6252123|NCT02048722|7150665|FG000|STARTED|2 Cycles of Treatment||31
6252124|NCT02048722|7150665|FG000|Attempted 1st Cycle|2 Cycles of Treatment||31
6252125|NCT02048722|7150665|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||23
6252126|NCT02048722|7150665|FG000|COMPLETED|2 Cycles of Treatment||23
6252127|NCT02048722|7150665|FG000|NOT COMPLETED|2 Cycles of Treatment||8
6252128|NCT02048722|7150665|FG000|STARTED|Reached 1st Response/Continued Treatment||23
6252129|NCT02048722|7150665|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||23
6252130|NCT02048722|7150665|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||13
6252131|NCT02048722|7150665|FG000|COMPLETED|Reached 1st Response/Continued Treatment||13
6252132|NCT02048722|7150665|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||10
6252133|NCT02048722|7150665|FG000|STARTED|Follow up 5 Years or Cut of Timepoint||31
6252134|NCT02048722|7150665|FG000|COMPLETED|Follow up 5 Years or Cut of Timepoint||4
6252135|NCT02048722|7150665|FG000|NOT COMPLETED|Follow up 5 Years or Cut of Timepoint||27
6252136|NCT01896102|7150669|FG000|STARTED|Overall Study||32
6252137|NCT01896102|7150669|FG000|COMPLETED|Overall Study||29
6252138|NCT01896102|7150669|FG000|NOT COMPLETED|Overall Study||3
6252139|NCT01885078|7150682|FG000|STARTED|Treatment Period||451
6252140|NCT01885078|7150683|FG001|STARTED|Treatment Period||1091
6252141|NCT01885078|7150684|FG002|STARTED|Treatment Period||180
6252142|NCT01885078|7150685|FG003|STARTED|Treatment Period||403
6507354|NCT01464827|7426748|FG007|Treated|Overall Study||40
6507355|NCT01464827|7426749|FG008|Treated|Overall Study||40
6507356|NCT01464827|7426750|FG009|Treated|Overall Study||45
6507357|NCT01464827|7426751|FG010|Treated|Overall Study||23
6507358|NCT01464827|7426752|FG011|Treated|Overall Study||22
6507359|NCT01464827|7426753|FG012|Treated|Overall Study||23
6507360|NCT01464827|7426754|FG013|Treated|Overall Study||20
6507361|NCT01464827|7426741|FG000|COMPLETED|Overall Study||77
6507362|NCT01464827|7426742|FG001|COMPLETED|Overall Study||36
6507363|NCT01464827|7426743|FG002|COMPLETED|Overall Study||39
6507364|NCT01464827|7426744|FG003|COMPLETED|Overall Study||36
6507365|NCT01464827|7426745|FG004|COMPLETED|Overall Study||72
6507366|NCT01464827|7426746|FG005|COMPLETED|Overall Study||38
6507367|NCT01464827|7426747|FG006|COMPLETED|Overall Study||37
6507368|NCT01464827|7426748|FG007|COMPLETED|Overall Study||37
6507369|NCT01464827|7426749|FG008|COMPLETED|Overall Study||37
6507370|NCT01464827|7426750|FG009|COMPLETED|Overall Study||44
6507371|NCT01464827|7426751|FG010|COMPLETED|Overall Study||21
6507372|NCT01464827|7426752|FG011|COMPLETED|Overall Study||21
6507373|NCT01464827|7426753|FG012|COMPLETED|Overall Study||21
6507374|NCT01464827|7426754|FG013|COMPLETED|Overall Study||19
6507375|NCT01464827|7426741|FG000|NOT COMPLETED|Overall Study||3
6507376|NCT01464827|7426742|FG001|NOT COMPLETED|Overall Study||7
6507377|NCT01464827|7426743|FG002|NOT COMPLETED|Overall Study||0
6507378|NCT01464827|7426744|FG003|NOT COMPLETED|Overall Study||4
6507379|NCT01464827|7426745|FG004|NOT COMPLETED|Overall Study||8
6507380|NCT01464827|7426746|FG005|NOT COMPLETED|Overall Study||1
6507381|NCT01464827|7426747|FG006|NOT COMPLETED|Overall Study||4
6507382|NCT01464827|7426748|FG007|NOT COMPLETED|Overall Study||3
6507383|NCT01464827|7426749|FG008|NOT COMPLETED|Overall Study||3
6507384|NCT01464827|7426750|FG009|NOT COMPLETED|Overall Study||3
6507385|NCT01464827|7426751|FG010|NOT COMPLETED|Overall Study||2
6507386|NCT01464827|7426752|FG011|NOT COMPLETED|Overall Study||2
6507387|NCT01464827|7426753|FG012|NOT COMPLETED|Overall Study||2
6507388|NCT01464827|7426754|FG013|NOT COMPLETED|Overall Study||3
6507389|NCT01464840|7426798|FG000|STARTED|Overall Study||10
6507390|NCT01464840|7426799|FG001|STARTED|Overall Study||10
6507391|NCT01464840|7426800|FG002|STARTED|Overall Study||10
6507392|NCT01464840|7426798|FG000|COMPLETED|Overall Study||10
6507393|NCT01464840|7426799|FG001|COMPLETED|Overall Study||10
6507394|NCT01464840|7426800|FG002|COMPLETED|Overall Study||10
6507395|NCT01464840|7426798|FG000|NOT COMPLETED|Overall Study||0
6507396|NCT01464840|7426799|FG001|NOT COMPLETED|Overall Study||0
6507397|NCT01464840|7426800|FG002|NOT COMPLETED|Overall Study||0
6507398|NCT01464879|7426808|FG000|STARTED|Overall Study||20
6507399|NCT01464879|7426808|FG000|Hand Application (2.50 mL)|Overall Study||20
6507400|NCT01464879|7426808|FG000|Washout Period|Overall Study||20
6507401|NCT01464879|7426808|FG000|Applicator Application (1.25 mL)|Overall Study|One subject discontinued due to non-compliance.|19
6507402|NCT01464879|7426808|FG000|Applicator Application (2.50 mL)|Overall Study|One subject discontinued due to physician's decision.|18
6507403|NCT01464879|7426808|FG000|Applicator Application (3.75 mL)|Overall Study||18
6507404|NCT01464879|7426808|FG000|COMPLETED|Overall Study||18
6507405|NCT01464879|7426808|FG000|NOT COMPLETED|Overall Study||2
6507406|NCT01464931|7426820|FG000|STARTED|Overall Study||16
6507407|NCT01464931|7426821|FG001|STARTED|Overall Study||16
6507408|NCT01464931|7426820|FG000|COMPLETED|Overall Study||15
6507409|NCT01464931|7426821|FG001|COMPLETED|Overall Study||16
6507410|NCT01464931|7426820|FG000|NOT COMPLETED|Overall Study||1
6507411|NCT01464931|7426821|FG001|NOT COMPLETED|Overall Study||0
6507412|NCT01464996|7426834|FG000|STARTED|Overall Study||24
6507413|NCT01464996|7426834|FG000|OptiBond XTR|Overall Study||23
6507414|NCT01464996|7426834|FG000|OptiBond FL|Overall Study||24
6507415|NCT01464996|7426834|FG000|COMPLETED|Overall Study||24
6507416|NCT01464996|7426834|FG000|NOT COMPLETED|Overall Study||0
6507417|NCT01465022|7426843|FG000|STARTED|Overall Study||64
6507418|NCT01465022|7426844|FG001|STARTED|Overall Study||63
6507419|NCT01465022|7426845|FG002|STARTED|Overall Study||70
6507420|NCT01465022|7426843|FG000|COMPLETED|Overall Study||41
6507421|NCT01465022|7426844|FG001|COMPLETED|Overall Study||40
6658082|NCT02476032|7588624|FG001|STARTED|Overall Study||20
6507422|NCT01465022|7426845|FG002|COMPLETED|Overall Study||0
6507423|NCT01465022|7426843|FG000|NOT COMPLETED|Overall Study||23
6507424|NCT01465022|7426844|FG001|NOT COMPLETED|Overall Study||23
6507425|NCT01465022|7426845|FG002|NOT COMPLETED|Overall Study||70
6507426|NCT01465048|7426854|FG000|STARTED|Overall Study||6
6570383|NCT01852019|7493832|FG003|COMPLETED|Day 8||6
6507427|NCT01465048|7426855|FG001|STARTED|Overall Study||6
6507428|NCT01465048|7426856|FG002|STARTED|Overall Study||6
6507429|NCT01465048|7426854|FG000|COMPLETED|Overall Study||6
6507430|NCT01465048|7426855|FG001|COMPLETED|Overall Study||6
6507431|NCT01465048|7426856|FG002|COMPLETED|Overall Study||6
6570384|NCT01852019|7493833|FG004|COMPLETED|Day 8||6
6570385|NCT01852019|7493829|FG000|NOT COMPLETED|Day 8||0
6570386|NCT01852019|7493830|FG001|NOT COMPLETED|Day 8||0
6570387|NCT01852019|7493831|FG002|NOT COMPLETED|Day 8||0
6507432|NCT01465048|7426854|FG000|NOT COMPLETED|Overall Study||0
6658083|NCT02476032|7588625|FG002|STARTED|Overall Study||20
6252143|NCT01885078|7150686|FG004|STARTED|Treatment Period||117
6252144|NCT01885078|7150687|FG005|STARTED|Treatment Period||331
6252145|NCT01885078|7150688|FG006|STARTED|Treatment Period||221
6252146|NCT01885078|7150689|FG007|STARTED|Treatment Period||83
6252147|NCT01885078|7150690|FG008|STARTED|Treatment Period||0
6252148|NCT01885078|7150691|FG009|STARTED|Treatment Period||0
6252149|NCT01885078|7150682|FG000|Received at Least Once Dose of Study Drug|Treatment Period||451
6252150|NCT01885078|7150683|FG001|Received at Least Once Dose of Study Drug|Treatment Period||1090
6252151|NCT01885078|7150684|FG002|Received at Least Once Dose of Study Drug|Treatment Period||180
6252152|NCT01885078|7150685|FG003|Received at Least Once Dose of Study Drug|Treatment Period||403
6252153|NCT01885078|7150686|FG004|Received at Least Once Dose of Study Drug|Treatment Period||117
6252154|NCT01885078|7150687|FG005|Received at Least Once Dose of Study Drug|Treatment Period||331
6252155|NCT01885078|7150688|FG006|Received at Least Once Dose of Study Drug|Treatment Period||221
6252156|NCT01885078|7150689|FG007|Received at Least Once Dose of Study Drug|Treatment Period||83
6252157|NCT01885078|7150690|FG008|Received at Least Once Dose of Study Drug|Treatment Period||0
6252158|NCT01885078|7150691|FG009|Received at Least Once Dose of Study Drug|Treatment Period||0
6252159|NCT01885078|7150682|FG000|COMPLETED|Treatment Period||19
6252160|NCT01885078|7150683|FG001|COMPLETED|Treatment Period||64
6252161|NCT01885078|7150684|FG002|COMPLETED|Treatment Period||49
6252162|NCT01885078|7150685|FG003|COMPLETED|Treatment Period||120
6252163|NCT01885078|7150686|FG004|COMPLETED|Treatment Period||27
6252164|NCT01885078|7150687|FG005|COMPLETED|Treatment Period||81
6252165|NCT01885078|7150688|FG006|COMPLETED|Treatment Period||0
6252166|NCT01885078|7150689|FG007|COMPLETED|Treatment Period||55
6252167|NCT01885078|7150690|FG008|COMPLETED|Treatment Period||0
6252168|NCT01885078|7150691|FG009|COMPLETED|Treatment Period||0
6252169|NCT01885078|7150682|FG000|NOT COMPLETED|Treatment Period||432
6252170|NCT01885078|7150683|FG001|NOT COMPLETED|Treatment Period||1027
6252171|NCT01885078|7150684|FG002|NOT COMPLETED|Treatment Period||131
6252172|NCT01885078|7150685|FG003|NOT COMPLETED|Treatment Period||283
6252173|NCT01885078|7150686|FG004|NOT COMPLETED|Treatment Period||90
6252174|NCT01885078|7150687|FG005|NOT COMPLETED|Treatment Period||250
6252175|NCT01885078|7150688|FG006|NOT COMPLETED|Treatment Period||221
6252176|NCT01885078|7150689|FG007|NOT COMPLETED|Treatment Period||28
6252177|NCT01885078|7150690|FG008|NOT COMPLETED|Treatment Period||0
6252178|NCT01885078|7150691|FG009|NOT COMPLETED|Treatment Period||0
6252179|NCT01885078|7150682|FG000|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
6252180|NCT01885078|7150683|FG001|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
6252181|NCT01885078|7150684|FG002|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
6252182|NCT01885078|7150685|FG003|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
6252183|NCT01885078|7150686|FG004|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
6252184|NCT01885078|7150687|FG005|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
6252185|NCT01885078|7150688|FG006|STARTED|Step-down Period||0
6252186|NCT01885078|7150689|FG007|STARTED|Step-down Period|Not all participants were eligible to enter the Step-Down Period.|0
6252187|NCT01885078|7150690|FG008|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|592
6252188|NCT01885078|7150691|FG009|STARTED|Step-down Period|Eligible participants were offered the option of participating in the Step-Down Period.|594
6252189|NCT01885078|7150682|FG000|Complete Through Week 96|Step-down Period||0
6252190|NCT01885078|7150683|FG001|Complete Through Week 96|Step-down Period||0
6252191|NCT01885078|7150684|FG002|Complete Through Week 96|Step-down Period||0
6252192|NCT01885078|7150685|FG003|Complete Through Week 96|Step-down Period||0
6252193|NCT01885078|7150686|FG004|Complete Through Week 96|Step-down Period||0
6252194|NCT01885078|7150687|FG005|Complete Through Week 96|Step-down Period||0
6252195|NCT01885078|7150688|FG006|Complete Through Week 96|Step-down Period||0
6252196|NCT01885078|7150689|FG007|Complete Through Week 96|Step-down Period||0
6252197|NCT01885078|7150690|FG008|Complete Through Week 96|Step-down Period||407
6252198|NCT01885078|7150691|FG009|Complete Through Week 96|Step-down Period||455
6252199|NCT01885078|7150682|FG000|COMPLETED|Step-down Period||0
6252200|NCT01885078|7150683|FG001|COMPLETED|Step-down Period||0
6252201|NCT01885078|7150684|FG002|COMPLETED|Step-down Period||0
6252202|NCT01885078|7150685|FG003|COMPLETED|Step-down Period||0
6252203|NCT01885078|7150686|FG004|COMPLETED|Step-down Period||0
6252204|NCT01885078|7150687|FG005|COMPLETED|Step-down Period||0
6252205|NCT01885078|7150688|FG006|COMPLETED|Step-down Period||0
6252206|NCT01885078|7150689|FG007|COMPLETED|Step-down Period||0
6252207|NCT01885078|7150690|FG008|COMPLETED|Step-down Period||523
6252208|NCT01885078|7150691|FG009|COMPLETED|Step-down Period||533
6252209|NCT01885078|7150682|FG000|NOT COMPLETED|Step-down Period||0
6252210|NCT01885078|7150683|FG001|NOT COMPLETED|Step-down Period||0
6252211|NCT01885078|7150684|FG002|NOT COMPLETED|Step-down Period||0
6252212|NCT01885078|7150685|FG003|NOT COMPLETED|Step-down Period||0
6252213|NCT01885078|7150686|FG004|NOT COMPLETED|Step-down Period||0
6252214|NCT01885078|7150687|FG005|NOT COMPLETED|Step-down Period||0
6252215|NCT01885078|7150688|FG006|NOT COMPLETED|Step-down Period||0
6252216|NCT01885078|7150689|FG007|NOT COMPLETED|Step-down Period||0
6252217|NCT01885078|7150690|FG008|NOT COMPLETED|Step-down Period||69
6252218|NCT01885078|7150691|FG009|NOT COMPLETED|Step-down Period||61
6252219|NCT01047683|7150715|FG000|STARTED|Overall Study||76
6252220|NCT01047683|7150716|FG001|STARTED|Overall Study||76
6252221|NCT01047683|7150717|FG002|STARTED|Overall Study||77
6252222|NCT01047683|7150715|FG000|COMPLETED|Overall Study||71
6252223|NCT01047683|7150716|FG001|COMPLETED|Overall Study||70
6252224|NCT01047683|7150717|FG002|COMPLETED|Overall Study||74
6252225|NCT01047683|7150715|FG000|NOT COMPLETED|Overall Study||5
6252226|NCT01047683|7150716|FG001|NOT COMPLETED|Overall Study||6
6252227|NCT01047683|7150717|FG002|NOT COMPLETED|Overall Study||3
6252228|NCT01047501|7150728|FG000|STARTED|Overall Study||233
6252229|NCT01047501|7150729|FG001|STARTED|Overall Study||236
6252230|NCT01047501|7150730|FG002|STARTED|Overall Study||233
6252231|NCT01047501|7150728|FG000|COMPLETED|Overall Study||217
6252232|NCT01047501|7150729|FG001|COMPLETED|Overall Study||225
6252233|NCT01047501|7150730|FG002|COMPLETED|Overall Study||221
6252234|NCT01047501|7150728|FG000|NOT COMPLETED|Overall Study||16
6252235|NCT01047501|7150729|FG001|NOT COMPLETED|Overall Study||11
6252236|NCT01047501|7150730|FG002|NOT COMPLETED|Overall Study||12
6252237|NCT00981656|7150738|FG000|STARTED|Overall Study||37
6252238|NCT00981656|7150738|FG000|Eligible and Started Study Treatment|Overall Study||34
6252239|NCT00981656|7150738|FG000|COMPLETED|Overall Study||34
6252240|NCT00981656|7150738|FG000|NOT COMPLETED|Overall Study||3
6252241|NCT00838526|7150744|FG000|STARTED|Overall Study|Treated|59
6252242|NCT00838526|7150745|FG001|STARTED|Overall Study|Treated|176
6252243|NCT00838526|7150744|FG000|COMPLETED|Overall Study||35
6252244|NCT00838526|7150745|FG001|COMPLETED|Overall Study||137
6252245|NCT00838526|7150744|FG000|NOT COMPLETED|Overall Study||24
6252246|NCT00838526|7150745|FG001|NOT COMPLETED|Overall Study||39
6252247|NCT00126672|7150751|FG000|STARTED|Overall Study||36
6252248|NCT00126672|7150751|FG000|COMPLETED|Overall Study||28
6252249|NCT00126672|7150751|FG000|NOT COMPLETED|Overall Study||8
6278151|NCT00131469|7177758|FG001|NOT COMPLETED|Overall Study||13
6278152|NCT00131508|7177766|FG000|STARTED|Overall Study||12
6278153|NCT00131508|7177767|FG001|STARTED|Overall Study||13
6278154|NCT00131508|7177766|FG000|COMPLETED|Overall Study||9
6278155|NCT00131508|7177767|FG001|COMPLETED|Overall Study||5
6278156|NCT00131508|7177766|FG000|NOT COMPLETED|Overall Study||3
6278157|NCT00131508|7177767|FG001|NOT COMPLETED|Overall Study||8
6278158|NCT00131573|7177775|FG000|STARTED|Overall Study||46
6278159|NCT00131573|7177776|FG001|STARTED|Overall Study||39
6278160|NCT00131573|7177775|FG000|COMPLETED|Overall Study||13
6278161|NCT00131573|7177776|FG001|COMPLETED|Overall Study||13
6507433|NCT01465048|7426855|FG001|NOT COMPLETED|Overall Study||0
6507434|NCT01465048|7426856|FG002|NOT COMPLETED|Overall Study||0
6507435|NCT01465178|7426866|FG000|STARTED|Overall Study||31
6507436|NCT01465178|7426867|FG001|STARTED|Overall Study||31
6507437|NCT01465178|7426866|FG000|COMPLETED|Overall Study||30
6507438|NCT01465178|7426867|FG001|COMPLETED|Overall Study||31
6507439|NCT01465178|7426866|FG000|NOT COMPLETED|Overall Study||1
6507440|NCT01465178|7426867|FG001|NOT COMPLETED|Overall Study||0
6507441|NCT01465191|7426876|FG000|STARTED|Overall Study||56
6507442|NCT01465191|7426877|FG001|STARTED|Overall Study||63
6507443|NCT01465191|7426878|FG002|STARTED|Overall Study||50
6507444|NCT01465191|7426876|FG000|COMPLETED|Overall Study||47
6507445|NCT01465191|7426877|FG001|COMPLETED|Overall Study||54
6507446|NCT01465191|7426878|FG002|COMPLETED|Overall Study||43
6507447|NCT01465191|7426876|FG000|NOT COMPLETED|Overall Study||9
6507448|NCT01465191|7426877|FG001|NOT COMPLETED|Overall Study||9
6507449|NCT01465191|7426878|FG002|NOT COMPLETED|Overall Study||7
6507450|NCT01465334|7426891|FG000|STARTED|Overall Study||15
6507451|NCT01465334|7426892|FG001|STARTED|Overall Study||15
6507452|NCT01465334|7426891|FG000|Complete Part A Induction|Overall Study||12
6507453|NCT01465334|7426892|FG001|Complete Part A Induction|Overall Study||15
6507454|NCT01465334|7426891|FG000|Complete Part B Induction|Overall Study||7
6507455|NCT01465334|7426892|FG001|Complete Part B Induction|Overall Study||15
6507456|NCT01465334|7426891|FG000|Eligible for Allogeneic Transplant|Overall Study||9
6507457|NCT01465334|7426892|FG001|Eligible for Allogeneic Transplant|Overall Study||9
6507458|NCT01465334|7426891|FG000|COMPLETED|Overall Study||13
6507459|NCT01465334|7426892|FG001|COMPLETED|Overall Study||9
6507460|NCT01465334|7426891|FG000|NOT COMPLETED|Overall Study||2
6507461|NCT01465334|7426892|FG001|NOT COMPLETED|Overall Study||6
6507462|NCT01465347|7426898|FG000|STARTED|Overall Study||3
6507463|NCT01465347|7426899|FG001|STARTED|Overall Study||56
6507464|NCT01465347|7426898|FG000|COMPLETED|Overall Study||2
6507465|NCT01465347|7426899|FG001|COMPLETED|Overall Study||53
6507466|NCT01465347|7426898|FG000|NOT COMPLETED|Overall Study||1
6507467|NCT01465347|7426899|FG001|NOT COMPLETED|Overall Study||3
6507468|NCT01465386|7426908|FG000|STARTED|Overall Study||6
6507469|NCT01465386|7426908|FG000|COMPLETED|Overall Study||2
6507470|NCT01465386|7426908|FG000|NOT COMPLETED|Overall Study||4
6570388|NCT01852019|7493832|FG003|NOT COMPLETED|Day 8||0
6278162|NCT00131573|7177775|FG000|NOT COMPLETED|Overall Study||33
6507471|NCT01465412|7426916|FG000|STARTED|Overall Study||12
6507472|NCT01465412|7426917|FG001|STARTED|Overall Study||12
6507473|NCT01465412|7426918|FG002|STARTED|Overall Study||9
6507474|NCT01465412|7426919|FG003|STARTED|Overall Study||9
6507475|NCT01465412|7426916|FG000|COMPLETED|Overall Study||12
6507476|NCT01465412|7426917|FG001|COMPLETED|Overall Study||12
6507477|NCT01465412|7426918|FG002|COMPLETED|Overall Study||9
6507478|NCT01465412|7426919|FG003|COMPLETED|Overall Study||9
6507479|NCT01465412|7426916|FG000|NOT COMPLETED|Overall Study||0
6507480|NCT01465412|7426917|FG001|NOT COMPLETED|Overall Study||0
6570389|NCT01852019|7493833|FG004|NOT COMPLETED|Day 8||0
6507481|NCT01465412|7426918|FG002|NOT COMPLETED|Overall Study||0
6252250|NCT03172780|7150758|FG000|STARTED|Overall Study||406
6252251|NCT03172780|7150759|FG001|STARTED|Overall Study||409
6507482|NCT01465412|7426919|FG003|NOT COMPLETED|Overall Study||0
6507483|NCT01465464|7426931|FG000|STARTED|Overall Study||444
6507484|NCT01465464|7426932|FG001|STARTED|Overall Study||444
6507485|NCT01465464|7426931|FG000|COMPLETED|Overall Study||0
6507486|NCT01465464|7426932|FG001|COMPLETED|Overall Study||0
6507487|NCT01465464|7426931|FG000|NOT COMPLETED|Overall Study||444
6507488|NCT01465464|7426932|FG001|NOT COMPLETED|Overall Study||444
6507489|NCT01465659|7426942|FG000|STARTED|Completed 1 Cycle of Treatment||7
6507490|NCT01465659|7426943|FG001|STARTED|Completed 1 Cycle of Treatment||5
6507491|NCT01465659|7426944|FG002|STARTED|Completed 1 Cycle of Treatment||6
6507492|NCT01465659|7426945|FG003|STARTED|Completed 1 Cycle of Treatment||11
6507493|NCT01465659|7426942|FG000|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||7
6507494|NCT01465659|7426943|FG001|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||4
6507495|NCT01465659|7426944|FG002|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||6
6507496|NCT01465659|7426945|FG003|Completed 1 Cycle of Treatment|Completed 1 Cycle of Treatment||11
6507497|NCT01465659|7426942|FG000|COMPLETED|Completed 1 Cycle of Treatment||7
6507498|NCT01465659|7426943|FG001|COMPLETED|Completed 1 Cycle of Treatment||4
6507499|NCT01465659|7426944|FG002|COMPLETED|Completed 1 Cycle of Treatment||6
6507500|NCT01465659|7426945|FG003|COMPLETED|Completed 1 Cycle of Treatment||10
6507501|NCT01465659|7426942|FG000|NOT COMPLETED|Completed 1 Cycle of Treatment||0
6507502|NCT01465659|7426943|FG001|NOT COMPLETED|Completed 1 Cycle of Treatment||1
6507503|NCT01465659|7426944|FG002|NOT COMPLETED|Completed 1 Cycle of Treatment||0
6507504|NCT01465659|7426945|FG003|NOT COMPLETED|Completed 1 Cycle of Treatment||1
6507505|NCT01465659|7426942|FG000|STARTED|Completed 2 Cycles/Reached 1st Response||7
6507506|NCT01465659|7426943|FG001|STARTED|Completed 2 Cycles/Reached 1st Response||4
6507507|NCT01465659|7426944|FG002|STARTED|Completed 2 Cycles/Reached 1st Response||6
6507508|NCT01465659|7426945|FG003|STARTED|Completed 2 Cycles/Reached 1st Response||10
6507509|NCT01465659|7426942|FG000|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||7
6507510|NCT01465659|7426943|FG001|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||4
6507511|NCT01465659|7426944|FG002|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||6
6507512|NCT01465659|7426945|FG003|Attempted 2 Cycles of Treatment|Completed 2 Cycles/Reached 1st Response||10
6507513|NCT01465659|7426942|FG000|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||7
6507514|NCT01465659|7426943|FG001|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||4
6507515|NCT01465659|7426944|FG002|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||6
6507516|NCT01465659|7426945|FG003|Reached 1st Response|Completed 2 Cycles/Reached 1st Response||10
6507517|NCT01465659|7426942|FG000|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||7
6507518|NCT01465659|7426943|FG001|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
6507519|NCT01465659|7426944|FG002|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||4
6507520|NCT01465659|7426945|FG003|Assessed to Move on to Next Cycle|Completed 2 Cycles/Reached 1st Response||10
6507521|NCT01465659|7426942|FG000|COMPLETED|Completed 2 Cycles/Reached 1st Response||5
6507522|NCT01465659|7426943|FG001|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
6570390|NCT01852032|7493846|FG000|STARTED|Overall Study||23
6570391|NCT01852032|7493846|FG000|COMPLETED|Overall Study||23
6570392|NCT01852032|7493846|FG000|NOT COMPLETED|Overall Study||0
6570393|NCT01852045|7493853|FG000|STARTED|Overall Study||39
6570394|NCT01852045|7493854|FG001|STARTED|Overall Study||45
6570395|NCT01852045|7493855|FG002|STARTED|Overall Study||30
6570396|NCT01852045|7493853|FG000|mITT Population|Overall Study||38
6570397|NCT01852045|7493854|FG001|mITT Population|Overall Study||45
6570398|NCT01852045|7493855|FG002|mITT Population|Overall Study||30
6570399|NCT01852045|7493853|FG000|Safety Population|Overall Study||38
6507523|NCT01465659|7426944|FG002|COMPLETED|Completed 2 Cycles/Reached 1st Response||4
6507524|NCT01465659|7426945|FG003|COMPLETED|Completed 2 Cycles/Reached 1st Response||9
6507525|NCT01465659|7426942|FG000|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
6507526|NCT01465659|7426943|FG001|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||0
6507527|NCT01465659|7426944|FG002|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||2
6507528|NCT01465659|7426945|FG003|NOT COMPLETED|Completed 2 Cycles/Reached 1st Response||1
6507529|NCT01465659|7426942|FG000|STARTED|Went on to Cycle 3 and Beyond||5
6507530|NCT01465659|7426943|FG001|STARTED|Went on to Cycle 3 and Beyond||4
6507531|NCT01465659|7426944|FG002|STARTED|Went on to Cycle 3 and Beyond||4
6507532|NCT01465659|7426945|FG003|STARTED|Went on to Cycle 3 and Beyond||9
6507533|NCT01465659|7426942|FG000|COMPLETED|Went on to Cycle 3 and Beyond||5
6507534|NCT01465659|7426943|FG001|COMPLETED|Went on to Cycle 3 and Beyond||4
6507535|NCT01465659|7426944|FG002|COMPLETED|Went on to Cycle 3 and Beyond||4
6507536|NCT01465659|7426945|FG003|COMPLETED|Went on to Cycle 3 and Beyond||9
6507537|NCT01465659|7426942|FG000|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
6507538|NCT01465659|7426943|FG001|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
6507539|NCT01465659|7426944|FG002|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
6507540|NCT01465659|7426945|FG003|NOT COMPLETED|Went on to Cycle 3 and Beyond||0
6507541|NCT01465659|7426942|FG000|STARTED|Completed Follow for 1 Year||7
6507542|NCT01465659|7426943|FG001|STARTED|Completed Follow for 1 Year||4
6507543|NCT01465659|7426944|FG002|STARTED|Completed Follow for 1 Year||6
6570400|NCT01852045|7493854|FG001|Safety Population|Overall Study||45
6570401|NCT01852045|7493855|FG002|Safety Population|Overall Study||30
6570402|NCT01852045|7493853|FG000|COMPLETED|Overall Study||33
6252252|NCT03172780|7150760|FG002|STARTED|Overall Study||405
6252253|NCT03172780|7150758|FG000|COMPLETED|Overall Study||388
6252254|NCT03172780|7150759|FG001|COMPLETED|Overall Study||389
6252255|NCT03172780|7150760|FG002|COMPLETED|Overall Study||389
6252256|NCT03172780|7150758|FG000|NOT COMPLETED|Overall Study||18
6252257|NCT03172780|7150759|FG001|NOT COMPLETED|Overall Study||20
6252258|NCT03172780|7150760|FG002|NOT COMPLETED|Overall Study||16
6252259|NCT03151304|7150768|FG000|STARTED|Overall Study||64
6252260|NCT03151304|7150768|FG000|COMPLETED|Overall Study||0
6252261|NCT03151304|7150768|FG000|NOT COMPLETED|Overall Study||64
6252262|NCT03113409|7150772|FG000|STARTED|Overall Study||10
6252263|NCT03113409|7150773|FG001|STARTED|Overall Study|Study procedure was never started|0
6252264|NCT03113409|7150774|FG002|STARTED|Overall Study|Study procedure was never started|0
6252265|NCT03113409|7150772|FG000|COMPLETED|Overall Study||5
6252266|NCT03113409|7150773|FG001|COMPLETED|Overall Study||0
6252267|NCT03113409|7150774|FG002|COMPLETED|Overall Study||0
6252268|NCT03113409|7150772|FG000|NOT COMPLETED|Overall Study||5
6252269|NCT03113409|7150773|FG001|NOT COMPLETED|Overall Study||0
6252270|NCT03113409|7150774|FG002|NOT COMPLETED|Overall Study||0
6252271|NCT03084471|7150778|FG000|STARTED|Overall Study||867
6252272|NCT03084471|7150778|FG000|COMPLETED|Overall Study||0
6252273|NCT03084471|7150778|FG000|NOT COMPLETED|Overall Study||867
6252274|NCT03007979|7150785|FG000|STARTED|Overall Study||55
6252275|NCT03007979|7150785|FG000|COMPLETED|Overall Study||54
6252276|NCT03007979|7150785|FG000|NOT COMPLETED|Overall Study||1
6252277|NCT02953340|7150791|FG000|STARTED|Overall Study||118
6252278|NCT02953340|7150792|FG001|STARTED|Overall Study||119
6252279|NCT02953340|7150791|FG000|Safety Population|Overall Study||117
6252280|NCT02953340|7150792|FG001|Safety Population|Overall Study||118
6252281|NCT02953340|7150791|FG000|Entered Safety Follow-up Period|Overall Study||117
6252282|NCT02953340|7150792|FG001|Entered Safety Follow-up Period|Overall Study||118
6252283|NCT02953340|7150791|FG000|COMPLETED|Overall Study||96
6252284|NCT02953340|7150792|FG001|COMPLETED|Overall Study||85
6252285|NCT02953340|7150791|FG000|NOT COMPLETED|Overall Study||22
6252286|NCT02953340|7150792|FG001|NOT COMPLETED|Overall Study||34
6252287|NCT02870920|7150806|FG000|STARTED|Overall Study||61
6252288|NCT02870920|7150807|FG001|STARTED|Overall Study||119
6252289|NCT02870920|7150806|FG000|COMPLETED|Overall Study||61
6252290|NCT02870920|7150807|FG001|COMPLETED|Overall Study||119
6252291|NCT02870920|7150806|FG000|NOT COMPLETED|Overall Study||0
6252292|NCT02870920|7150807|FG001|NOT COMPLETED|Overall Study||0
6252293|NCT02855944|7150815|FG000|STARTED|Period 1: Treatment||233
6252294|NCT02855944|7150816|FG001|STARTED|Period 1: Treatment||116
6252295|NCT02855944|7150815|FG000|COMPLETED|Period 1: Treatment||188
6252296|NCT02855944|7150816|FG001|COMPLETED|Period 1: Treatment||108
6252297|NCT02855944|7150815|FG000|NOT COMPLETED|Period 1: Treatment||45
6252298|NCT02855944|7150816|FG001|NOT COMPLETED|Period 1: Treatment||8
6252299|NCT02855944|7150815|FG000|STARTED|Period 2: Crossover to Rucaparib||0
6252300|NCT02855944|7150816|FG001|STARTED|Period 2: Crossover to Rucaparib||74
6252301|NCT02855944|7150815|FG000|COMPLETED|Period 2: Crossover to Rucaparib||0
6252302|NCT02855944|7150816|FG001|COMPLETED|Period 2: Crossover to Rucaparib||47
6507544|NCT01465659|7426945|FG003|STARTED|Completed Follow for 1 Year||11
6507545|NCT01465659|7426942|FG000|COMPLETED|Completed Follow for 1 Year||1
6507546|NCT01465659|7426943|FG001|COMPLETED|Completed Follow for 1 Year||1
6507547|NCT01465659|7426944|FG002|COMPLETED|Completed Follow for 1 Year||4
6507548|NCT01465659|7426945|FG003|COMPLETED|Completed Follow for 1 Year||7
6507549|NCT01465659|7426942|FG000|NOT COMPLETED|Completed Follow for 1 Year||6
6507550|NCT01465659|7426943|FG001|NOT COMPLETED|Completed Follow for 1 Year||3
6507551|NCT01465659|7426944|FG002|NOT COMPLETED|Completed Follow for 1 Year||2
6507552|NCT01465659|7426945|FG003|NOT COMPLETED|Completed Follow for 1 Year||4
6507553|NCT01465763|7426961|FG000|STARTED|Overall Study||476
6507554|NCT01465763|7426962|FG001|STARTED|Overall Study||16
6507555|NCT01465763|7426963|FG002|STARTED|Overall Study||122
6507556|NCT01465763|7426961|FG000|COMPLETED|Overall Study||445
6507557|NCT01465763|7426962|FG001|COMPLETED|Overall Study||15
6507558|NCT01465763|7426963|FG002|COMPLETED|Overall Study||118
6507559|NCT01465763|7426961|FG000|NOT COMPLETED|Overall Study||31
6507560|NCT01465763|7426962|FG001|NOT COMPLETED|Overall Study||1
6507561|NCT01465763|7426963|FG002|NOT COMPLETED|Overall Study||4
6252303|NCT02855944|7150815|FG000|NOT COMPLETED|Period 2: Crossover to Rucaparib||0
6252304|NCT02855944|7150816|FG001|NOT COMPLETED|Period 2: Crossover to Rucaparib||27
6252305|NCT02851407|7150825|FG000|STARTED|Overall Study||190
6252306|NCT02851407|7150826|FG001|STARTED|Overall Study||182
6252307|NCT02851407|7150825|FG000|COMPLETED|Overall Study||120
6252308|NCT02851407|7150826|FG001|COMPLETED|Overall Study||121
6252309|NCT02851407|7150825|FG000|NOT COMPLETED|Overall Study||70
6252310|NCT02851407|7150826|FG001|NOT COMPLETED|Overall Study||61
6252311|NCT02717611|7150832|FG000|STARTED|Overall Study||60
6252312|NCT02717611|7150832|FG000|COMPLETED|Overall Study||0
6252313|NCT02717611|7150832|FG000|NOT COMPLETED|Overall Study||60
6252314|NCT02707276|7150840|FG000|STARTED|Overall Study||3
6252315|NCT02707276|7150841|FG001|STARTED|Overall Study||5
6252316|NCT02707276|7150842|FG002|STARTED|Overall Study||3
6252317|NCT02707276|7150843|FG003|STARTED|Overall Study||2
6252318|NCT02707276|7150840|FG000|COMPLETED|Overall Study||3
6252319|NCT02707276|7150841|FG001|COMPLETED|Overall Study||5
6252320|NCT02707276|7150842|FG002|COMPLETED|Overall Study||3
6252321|NCT02707276|7150843|FG003|COMPLETED|Overall Study||2
6252322|NCT02707276|7150840|FG000|NOT COMPLETED|Overall Study||0
6252323|NCT02707276|7150841|FG001|NOT COMPLETED|Overall Study||0
6252324|NCT02707276|7150842|FG002|NOT COMPLETED|Overall Study||0
6252325|NCT02707276|7150843|FG003|NOT COMPLETED|Overall Study||0
6252326|NCT02666430|7150855|FG000|STARTED|Baseline||64
6252327|NCT02666430|7150856|FG001|STARTED|Baseline||63
6252328|NCT02666430|7150855|FG000|COMPLETED|Baseline||64
6252329|NCT02666430|7150856|FG001|COMPLETED|Baseline||63
6252330|NCT02666430|7150855|FG000|NOT COMPLETED|Baseline||0
6252331|NCT02666430|7150856|FG001|NOT COMPLETED|Baseline||0
6252332|NCT02666430|7150855|FG000|STARTED|Period 1||64
6252333|NCT02666430|7150856|FG001|STARTED|Period 1||63
6252334|NCT02666430|7150855|FG000|COMPLETED|Period 1||63
6252335|NCT02666430|7150856|FG001|COMPLETED|Period 1||62
6252336|NCT02666430|7150855|FG000|NOT COMPLETED|Period 1||1
6252337|NCT02666430|7150856|FG001|NOT COMPLETED|Period 1||1
6252338|NCT02666430|7150855|FG000|STARTED|Period 2||63
6252339|NCT02666430|7150856|FG001|STARTED|Period 2||62
6252340|NCT02666430|7150855|FG000|COMPLETED|Period 2||62
6252341|NCT02666430|7150856|FG001|COMPLETED|Period 2||58
6252342|NCT02666430|7150855|FG000|NOT COMPLETED|Period 2||1
6252343|NCT02666430|7150856|FG001|NOT COMPLETED|Period 2||4
6252344|NCT02666430|7150855|FG000|STARTED|Period 3||62
6252345|NCT02666430|7150856|FG001|STARTED|Period 3||58
6252346|NCT02666430|7150855|FG000|COMPLETED|Period 3||61
6252347|NCT02666430|7150856|FG001|COMPLETED|Period 3||58
6252348|NCT02666430|7150855|FG000|NOT COMPLETED|Period 3||1
6252349|NCT02666430|7150856|FG001|NOT COMPLETED|Period 3||0
6252350|NCT02643420|7150864|FG000|STARTED|Overall Study||196
6252351|NCT02643420|7150865|FG001|STARTED|Overall Study||210
6252352|NCT02643420|7150864|FG000|Safety Population|Overall Study|One participant was randomized to the Arm 2: Pegfilgrastim and TC but was inadvertently administered SPI-2012 on Cycle 1, Day 2 and was included in the Arm 1: SPI-2012 and TC for the Safety Population.|197
6252353|NCT02643420|7150865|FG001|Safety Population|Overall Study||208
6252354|NCT02643420|7150864|FG000|COMPLETED|Overall Study||142
6252355|NCT02643420|7150865|FG001|COMPLETED|Overall Study||145
6252356|NCT02643420|7150864|FG000|NOT COMPLETED|Overall Study||54
6252357|NCT02643420|7150865|FG001|NOT COMPLETED|Overall Study||65
6252358|NCT02639559|7150879|FG000|STARTED|Overall Study||25
6252359|NCT02639559|7150880|FG001|STARTED|Overall Study||25
6252360|NCT02639559|7150879|FG000|COMPLETED|Overall Study||24
6252361|NCT02639559|7150880|FG001|COMPLETED|Overall Study||22
6252362|NCT02639559|7150879|FG000|NOT COMPLETED|Overall Study||1
6252363|NCT02639559|7150880|FG001|NOT COMPLETED|Overall Study||3
6252364|NCT02569476|7150886|FG000|STARTED|Overall Study||119
6252365|NCT02569476|7150886|FG000|COMPLETED|Overall Study||0
6252366|NCT02569476|7150886|FG000|NOT COMPLETED|Overall Study||119
6252367|NCT02549209|7150896|FG000|STARTED|Overall Study||46
6252368|NCT02549209|7150896|FG000|COMPLETED|Overall Study||46
6252369|NCT02549209|7150896|FG000|NOT COMPLETED|Overall Study||0
6252370|NCT02496676|7150902|FG000|STARTED|Phase 1 - Period 1||2
6252371|NCT02496676|7150903|FG001|STARTED|Phase 1 - Period 1||3
6252372|NCT02496676|7150902|FG000|COMPLETED|Phase 1 - Period 1||2
6252373|NCT02496676|7150903|FG001|COMPLETED|Phase 1 - Period 1||2
6252374|NCT02496676|7150902|FG000|NOT COMPLETED|Phase 1 - Period 1||0
6252375|NCT02496676|7150903|FG001|NOT COMPLETED|Phase 1 - Period 1||1
6252376|NCT02496676|7150902|FG000|STARTED|Phase 1 - Period 2||2
6252377|NCT02496676|7150903|FG001|STARTED|Phase 1 - Period 2||2
6252378|NCT02496676|7150902|FG000|COMPLETED|Phase 1 - Period 2||2
6252379|NCT02496676|7150903|FG001|COMPLETED|Phase 1 - Period 2||2
6252380|NCT02496676|7150902|FG000|NOT COMPLETED|Phase 1 - Period 2||0
6252381|NCT02496676|7150903|FG001|NOT COMPLETED|Phase 1 - Period 2||0
6252382|NCT02496676|7150902|FG000|STARTED|Washout Period||2
6252383|NCT02496676|7150903|FG001|STARTED|Washout Period||2
6252384|NCT02496676|7150902|FG000|COMPLETED|Washout Period||2
6252385|NCT02496676|7150903|FG001|COMPLETED|Washout Period||2
6252386|NCT02496676|7150902|FG000|NOT COMPLETED|Washout Period||0
6252387|NCT02496676|7150903|FG001|NOT COMPLETED|Washout Period||0
6252388|NCT02496676|7150902|FG000|STARTED|Phase 2 - IV MgSO4||2
6252389|NCT02496676|7150903|FG001|STARTED|Phase 2 - IV MgSO4||2
6252390|NCT02496676|7150902|FG000|COMPLETED|Phase 2 - IV MgSO4||2
6252391|NCT02496676|7150903|FG001|COMPLETED|Phase 2 - IV MgSO4||1
6252392|NCT02496676|7150902|FG000|NOT COMPLETED|Phase 2 - IV MgSO4||0
6252393|NCT02496676|7150903|FG001|NOT COMPLETED|Phase 2 - IV MgSO4||1
6252394|NCT02496676|7150902|FG000|STARTED|Phase 2 - Oral Magnesium||2
6252395|NCT02496676|7150903|FG001|STARTED|Phase 2 - Oral Magnesium||1
6252396|NCT02496676|7150902|FG000|COMPLETED|Phase 2 - Oral Magnesium||2
6252397|NCT02496676|7150903|FG001|COMPLETED|Phase 2 - Oral Magnesium||1
6252398|NCT02496676|7150902|FG000|NOT COMPLETED|Phase 2 - Oral Magnesium||0
6252399|NCT02496676|7150903|FG001|NOT COMPLETED|Phase 2 - Oral Magnesium||0
6252400|NCT02494141|7150919|FG000|STARTED|Overall Study||34
6252401|NCT02494141|7150920|FG001|STARTED|Overall Study||34
6252402|NCT02494141|7150919|FG000|COMPLETED|Overall Study||28
6252403|NCT02494141|7150920|FG001|COMPLETED|Overall Study||29
6252404|NCT02494141|7150919|FG000|NOT COMPLETED|Overall Study||6
6252405|NCT02494141|7150920|FG001|NOT COMPLETED|Overall Study||5
6252406|NCT02412618|7150928|FG000|STARTED|Overall Study||50
6252407|NCT02412618|7150929|FG001|STARTED|Overall Study||50
6252408|NCT02412618|7150928|FG000|COMPLETED|Overall Study||48
6252409|NCT02412618|7150929|FG001|COMPLETED|Overall Study||48
6252410|NCT02412618|7150928|FG000|NOT COMPLETED|Overall Study||2
6252411|NCT02412618|7150929|FG001|NOT COMPLETED|Overall Study||2
6252412|NCT02373683|7150937|FG000|STARTED|Overall Study||6
6252413|NCT02373683|7150938|FG001|STARTED|Overall Study||4
6252414|NCT02373683|7150937|FG000|COMPLETED|Overall Study||6
6252415|NCT02373683|7150938|FG001|COMPLETED|Overall Study||4
6252416|NCT02373683|7150937|FG000|NOT COMPLETED|Overall Study||0
6252417|NCT02373683|7150938|FG001|NOT COMPLETED|Overall Study||0
6252418|NCT02351180|7150946|FG000|STARTED|Overall Study||8
6252419|NCT02351180|7150947|FG001|STARTED|Overall Study||8
6252420|NCT02351180|7150946|FG000|COMPLETED|Overall Study||7
6252421|NCT02351180|7150947|FG001|COMPLETED|Overall Study||8
6252422|NCT02351180|7150946|FG000|NOT COMPLETED|Overall Study||1
6252423|NCT02351180|7150947|FG001|NOT COMPLETED|Overall Study||0
6252424|NCT02337764|7150953|FG000|STARTED|Overall Study||222
6252425|NCT02337764|7150953|FG000|COMPLETED|Overall Study||162
6252426|NCT02337764|7150953|FG000|NOT COMPLETED|Overall Study||60
6252427|NCT02337738|7150960|FG000|STARTED|Overall Study||141
6252428|NCT02337738|7150961|FG001|STARTED|Overall Study||134
6252429|NCT02337738|7150962|FG002|STARTED|Overall Study||129
6252430|NCT02337738|7150960|FG000|COMPLETED|Overall Study||119
6252431|NCT02337738|7150961|FG001|COMPLETED|Overall Study||104
6252432|NCT02337738|7150962|FG002|COMPLETED|Overall Study||103
6252433|NCT02337738|7150960|FG000|NOT COMPLETED|Overall Study||22
6252434|NCT02337738|7150961|FG001|NOT COMPLETED|Overall Study||30
6252435|NCT02337738|7150962|FG002|NOT COMPLETED|Overall Study||26
6252436|NCT02332187|7150972|FG000|STARTED|Overall Study||5
6252437|NCT02332187|7150973|FG001|STARTED|Overall Study||10
6252438|NCT02332187|7150972|FG000|COMPLETED|Overall Study||3
6252439|NCT02332187|7150973|FG001|COMPLETED|Overall Study||7
6252440|NCT02332187|7150972|FG000|NOT COMPLETED|Overall Study||2
6252441|NCT02332187|7150973|FG001|NOT COMPLETED|Overall Study||3
6278163|NCT00131573|7177776|FG001|NOT COMPLETED|Overall Study||26
6278164|NCT00131664|7177786|FG000|STARTED|First Period (First 6 Months)||136
6278165|NCT00131664|7177787|FG001|STARTED|First Period (First 6 Months)||135
6507562|NCT01465802|7426975|FG000|STARTED|Overall Study||66
6507563|NCT01465802|7426976|FG001|STARTED|Overall Study||66
6507564|NCT01465802|7426977|FG002|STARTED|Overall Study||7
6507565|NCT01465802|7426978|FG003|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
6507566|NCT01465802|7426979|FG004|STARTED|Overall Study||25
6507567|NCT01465802|7426975|FG000|COMPLETED|Overall Study||33
6507568|NCT01465802|7426976|FG001|COMPLETED|Overall Study||42
6507569|NCT01465802|7426977|FG002|COMPLETED|Overall Study||7
6507570|NCT01465802|7426978|FG003|COMPLETED|Overall Study||38
6507571|NCT01465802|7426979|FG004|COMPLETED|Overall Study||13
6507572|NCT01465802|7426975|FG000|NOT COMPLETED|Overall Study||33
6507573|NCT01465802|7426976|FG001|NOT COMPLETED|Overall Study||24
6507574|NCT01465802|7426977|FG002|NOT COMPLETED|Overall Study||0
6507575|NCT01465802|7426978|FG003|NOT COMPLETED|Overall Study||29
6507576|NCT01465802|7426979|FG004|NOT COMPLETED|Overall Study||12
6507577|NCT01465841|7426993|FG000|STARTED|Overall Study||517
6507578|NCT01465841|7426993|FG000|COMPLETED|Overall Study||449
6507579|NCT01465841|7426993|FG000|NOT COMPLETED|Overall Study||68
6507580|NCT01465958|7426997|FG000|STARTED|Run-in Phase||11
6507581|NCT01465958|7426998|FG001|STARTED|Run-in Phase||0
6507582|NCT01465958|7426997|FG000|COMPLETED|Run-in Phase||10
6507583|NCT01465958|7426998|FG001|COMPLETED|Run-in Phase||0
6507584|NCT01465958|7426997|FG000|NOT COMPLETED|Run-in Phase||1
6507585|NCT01465958|7426998|FG001|NOT COMPLETED|Run-in Phase||0
6507586|NCT01465958|7426997|FG000|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
6507587|NCT01465958|7426998|FG001|STARTED|Intravenous (IV) Phase||0
6507588|NCT01465958|7426997|FG000|COMPLETED|Intravenous (IV) Phase||11
6507589|NCT01465958|7426998|FG001|COMPLETED|Intravenous (IV) Phase||0
6507590|NCT01465958|7426997|FG000|NOT COMPLETED|Intravenous (IV) Phase||0
6507591|NCT01465958|7426998|FG001|NOT COMPLETED|Intravenous (IV) Phase||0
6507592|NCT01465958|7426997|FG000|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
6507593|NCT01465958|7426998|FG001|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
6278166|NCT00131664|7177788|FG002|STARTED|First Period (First 6 Months)||120
6278167|NCT00131664|7177789|FG003|STARTED|First Period (First 6 Months)||0
6278168|NCT00131664|7177790|FG004|STARTED|First Period (First 6 Months)||0
6278169|NCT00131664|7177791|FG005|STARTED|First Period (First 6 Months)||0
6278170|NCT00131664|7177786|FG000|COMPLETED|First Period (First 6 Months)||111
6252442|NCT02296125|7150981|FG000|STARTED|Overall Study||279
6252443|NCT02296125|7150982|FG001|STARTED|Overall Study|183 participant received gefitinib and 93 participants received erlotinib.|277
6252444|NCT02296125|7150983|FG002|STARTED|Overall Study|There were 12 participants who were in both the Global and China Extension Osimertinib Arm.|71
6252445|NCT02296125|7150984|FG003|STARTED|Overall Study|There were 7 participants who were in both the Global and China Extension SoC EGFR-TKI Arm.|65
6252446|NCT02296125|7150981|FG000|COMPLETED|Overall Study||61
6252447|NCT02296125|7150982|FG001|COMPLETED|Overall Study||13
6252448|NCT02296125|7150983|FG002|COMPLETED|Overall Study||15
6252449|NCT02296125|7150984|FG003|COMPLETED|Overall Study||3
6252450|NCT02296125|7150981|FG000|NOT COMPLETED|Overall Study||218
6252451|NCT02296125|7150982|FG001|NOT COMPLETED|Overall Study||264
6252452|NCT02296125|7150983|FG002|NOT COMPLETED|Overall Study||56
6252453|NCT02296125|7150984|FG003|NOT COMPLETED|Overall Study||62
6252454|NCT02227875|7150997|FG000|STARTED|Overall Study||277
6252455|NCT02227875|7150998|FG001|STARTED|Overall Study||283
6252456|NCT02227875|7150997|FG000|COMPLETED|Overall Study||240
6252457|NCT02227875|7150998|FG001|COMPLETED|Overall Study||250
6252458|NCT02227875|7150997|FG000|NOT COMPLETED|Overall Study||37
6252459|NCT02227875|7150998|FG001|NOT COMPLETED|Overall Study||33
6252460|NCT02227862|7151006|FG000|STARTED|Overall Study||280
6252461|NCT02227862|7151007|FG001|STARTED|Overall Study||278
6252462|NCT02227862|7151006|FG000|Week 24|Overall Study||269
6252463|NCT02227862|7151007|FG001|Week 24|Overall Study||263
6252464|NCT02227862|7151006|FG000|COMPLETED|Overall Study||261
6252465|NCT02227862|7151007|FG001|COMPLETED|Overall Study||256
6252466|NCT02227862|7151006|FG000|NOT COMPLETED|Overall Study||19
6252467|NCT02227862|7151007|FG001|NOT COMPLETED|Overall Study||22
6252468|NCT02200939|7151015|FG000|STARTED|Overall Study||33
6252469|NCT02200939|7151016|FG001|STARTED|Overall Study||115
6252470|NCT02200939|7151015|FG000|COMPLETED|Overall Study||31
6252471|NCT02200939|7151016|FG001|COMPLETED|Overall Study||104
6252472|NCT02200939|7151015|FG000|NOT COMPLETED|Overall Study||2
6252473|NCT02200939|7151016|FG001|NOT COMPLETED|Overall Study||11
6252474|NCT02108964|7151034|FG000|STARTED|Overall Study||17
6252475|NCT02108964|7151035|FG001|STARTED|Overall Study||38
6252476|NCT02108964|7151036|FG002|STARTED|Overall Study||73
6252477|NCT02108964|7151037|FG003|STARTED|Overall Study||8
6252478|NCT02108964|7151038|FG004|STARTED|Overall Study||28
6252479|NCT02108964|7151039|FG005|STARTED|Overall Study||5
6252480|NCT02108964|7151040|FG006|STARTED|Overall Study||11
6252481|NCT02108964|7151041|FG007|STARTED|Overall Study||45
6252482|NCT02108964|7151034|FG000|COMPLETED|Overall Study||3
6252483|NCT02108964|7151035|FG001|COMPLETED|Overall Study||6
6252484|NCT02108964|7151036|FG002|COMPLETED|Overall Study||8
6252485|NCT02108964|7151037|FG003|COMPLETED|Overall Study||2
6252486|NCT02108964|7151038|FG004|COMPLETED|Overall Study||3
6252487|NCT02108964|7151039|FG005|COMPLETED|Overall Study||0
6252488|NCT02108964|7151040|FG006|COMPLETED|Overall Study||0
6252489|NCT02108964|7151041|FG007|COMPLETED|Overall Study||33
6252490|NCT02108964|7151034|FG000|NOT COMPLETED|Overall Study||14
6252491|NCT02108964|7151035|FG001|NOT COMPLETED|Overall Study||32
6252492|NCT02108964|7151036|FG002|NOT COMPLETED|Overall Study||65
6252493|NCT02108964|7151037|FG003|NOT COMPLETED|Overall Study||6
6252494|NCT02108964|7151038|FG004|NOT COMPLETED|Overall Study||25
6252495|NCT02108964|7151039|FG005|NOT COMPLETED|Overall Study||5
6252496|NCT02108964|7151040|FG006|NOT COMPLETED|Overall Study||11
6252497|NCT02108964|7151041|FG007|NOT COMPLETED|Overall Study||12
6252498|NCT02022566|7151062|FG000|STARTED|Overall Study||227
6252499|NCT02022566|7151063|FG001|STARTED|Overall Study||90
6252500|NCT02022566|7151062|FG000|COMPLETED|Overall Study||169
6252501|NCT02022566|7151063|FG001|COMPLETED|Overall Study||49
6252502|NCT02022566|7151062|FG000|NOT COMPLETED|Overall Study||58
6252503|NCT02022566|7151063|FG001|NOT COMPLETED|Overall Study||41
6252504|NCT01989598|7151069|FG000|STARTED|Overall Study|Includes pts receiving Single agent Trametinib and pts who are receiving Trametinib with AKT Inhibitor GSK2141795|25
6252505|NCT01989598|7151069|FG000|Dual Therapy With Trametinib and GSK2141795|Overall Study|Patients with progressive disease or who achieve less than PR after 4 courses also received Akt inhibitor GSK2141795 PO daily on days 1-28 along with Tremetinib|12
6252506|NCT01989598|7151069|FG000|COMPLETED|Overall Study|Note: 25 patients enrolled, however, one patient unevaluable was not included in analysis|25
6252507|NCT01989598|7151069|FG000|NOT COMPLETED|Overall Study||0
6252508|NCT01939275|7151078|FG000|STARTED|Overall Study||8
6252509|NCT01939275|7151078|FG000|COMPLETED|Overall Study||8
6252510|NCT01939275|7151078|FG000|NOT COMPLETED|Overall Study||0
6252511|NCT01922895|7151084|FG000|STARTED|Overall Study||24
6252512|NCT01922895|7151085|FG001|STARTED|Overall Study||21
6252513|NCT01922895|7151084|FG000|COMPLETED|Overall Study||18
6252514|NCT01922895|7151085|FG001|COMPLETED|Overall Study||7
6252515|NCT01922895|7151084|FG000|NOT COMPLETED|Overall Study||6
6252516|NCT01922895|7151085|FG001|NOT COMPLETED|Overall Study||14
6252517|NCT01901289|7151091|FG000|STARTED|Overall Study||200
6252518|NCT01901289|7151091|FG000|12-Month Follow-up|Overall Study||194
6252519|NCT01901289|7151091|FG000|COMPLETED|Overall Study||115
6252520|NCT01901289|7151091|FG000|NOT COMPLETED|Overall Study||85
6252521|NCT01831895|7151095|FG000|STARTED|Overall Study||17
6252522|NCT01831895|7151095|FG000|COMPLETED|Overall Study||15
6252523|NCT01831895|7151095|FG000|NOT COMPLETED|Overall Study||2
6252524|NCT01831076|7151101|FG000|STARTED|Overall Study||31
6252525|NCT01831076|7151102|FG001|STARTED|Overall Study||5
6252526|NCT01831076|7151101|FG000|COMPLETED|Overall Study||30
6252527|NCT01831076|7151102|FG001|COMPLETED|Overall Study||4
6252528|NCT01831076|7151101|FG000|NOT COMPLETED|Overall Study||1
6252529|NCT01831076|7151102|FG001|NOT COMPLETED|Overall Study||1
6252530|NCT01595581|7151110|FG000|STARTED|Overall Study||7
6252531|NCT01595581|7151111|FG001|STARTED|Overall Study||7
6252532|NCT01595581|7151110|FG000|COMPLETED|Overall Study||6
6252533|NCT01595581|7151111|FG001|COMPLETED|Overall Study||7
6252534|NCT01595581|7151110|FG000|NOT COMPLETED|Overall Study||1
6252535|NCT01595581|7151111|FG001|NOT COMPLETED|Overall Study||0
6252536|NCT01514682|7151121|FG000|STARTED|Overall Study||19
6252537|NCT01514682|7151122|FG001|STARTED|Overall Study||20
6252538|NCT01514682|7151121|FG000|COMPLETED|Overall Study||13
6252539|NCT01514682|7151122|FG001|COMPLETED|Overall Study||14
6252540|NCT01514682|7151121|FG000|NOT COMPLETED|Overall Study||6
6252541|NCT01514682|7151122|FG001|NOT COMPLETED|Overall Study||6
6252542|NCT01453140|7151128|FG000|STARTED|Overall Study|3 patients were enrolled|3
6252543|NCT01453140|7151128|FG000|COMPLETED|Overall Study|All three patients experienced grade 4 limiting toxicities (possible treatment related)|0
6252544|NCT01453140|7151128|FG000|NOT COMPLETED|Overall Study||3
6252545|NCT01408641|7151138|FG000|STARTED|Overall Study||1
6252546|NCT01408641|7151139|FG001|STARTED|Overall Study||0
6507594|NCT01465958|7426997|FG000|COMPLETED|Subcutaneous (SC) Phase||0
6507595|NCT01465958|7426998|FG001|COMPLETED|Subcutaneous (SC) Phase||10
6507596|NCT01465958|7426997|FG000|NOT COMPLETED|Subcutaneous (SC) Phase||0
6507597|NCT01465958|7426998|FG001|NOT COMPLETED|Subcutaneous (SC) Phase||1
6507598|NCT01465997|7427007|FG000|STARTED|Overall Study||279
6507599|NCT01465997|7427008|FG001|STARTED|Overall Study||269
6507600|NCT01465997|7427007|FG000|COMPLETED|Overall Study||211
6507601|NCT01465997|7427008|FG001|COMPLETED|Overall Study||180
6507602|NCT01465997|7427007|FG000|NOT COMPLETED|Overall Study||68
6507603|NCT01465997|7427008|FG001|NOT COMPLETED|Overall Study||89
6507604|NCT01466062|7427016|FG000|STARTED|Overall Study||28
6507605|NCT01466062|7427016|FG000|COMPLETED|Overall Study||26
6507606|NCT01466062|7427016|FG000|NOT COMPLETED|Overall Study||2
6507607|NCT01466075|7427020|FG000|STARTED|Overall Study||207
6658084|NCT02476032|7588623|FG000|COMPLETED|Overall Study||20
6252547|NCT01408641|7151138|FG000|COMPLETED|Overall Study||0
6507608|NCT01466075|7427020|FG000|COMPLETED|Overall Study||207
6507609|NCT01466075|7427020|FG000|NOT COMPLETED|Overall Study||0
6507610|NCT01466127|7427026|FG000|STARTED|Overall Study||30
6507611|NCT01466127|7427027|FG001|STARTED|Overall Study||30
6507612|NCT01466127|7427026|FG000|COMPLETED|Overall Study||16
6507613|NCT01466127|7427027|FG001|COMPLETED|Overall Study||14
6507614|NCT01466127|7427026|FG000|NOT COMPLETED|Overall Study||14
6507615|NCT01466127|7427027|FG001|NOT COMPLETED|Overall Study||16
6507616|NCT01466153|7427036|FG000|STARTED|Overall Study||62
6507617|NCT01466153|7427037|FG001|STARTED|Overall Study||36
6507618|NCT01466153|7427038|FG002|STARTED|Overall Study||61
6507619|NCT01466153|7427036|FG000|COMPLETED|Overall Study||33
6507620|NCT01466153|7427037|FG001|COMPLETED|Overall Study||12
6507621|NCT01466153|7427038|FG002|COMPLETED|Overall Study||36
6507622|NCT01466153|7427036|FG000|NOT COMPLETED|Overall Study||29
6507623|NCT01466153|7427037|FG001|NOT COMPLETED|Overall Study||24
6507624|NCT01466153|7427038|FG002|NOT COMPLETED|Overall Study||25
6570403|NCT01852045|7493854|FG001|COMPLETED|Overall Study||41
6570404|NCT01852045|7493855|FG002|COMPLETED|Overall Study||26
6570405|NCT01852045|7493853|FG000|NOT COMPLETED|Overall Study||6
6570406|NCT01852045|7493854|FG001|NOT COMPLETED|Overall Study||4
6570407|NCT01852045|7493855|FG002|NOT COMPLETED|Overall Study||4
6507625|NCT01466166|7427048|FG000|STARTED|Overall Study||188
6507626|NCT01466166|7427048|FG000|Received Treatment|Overall Study||188
6507627|NCT01466166|7427048|FG000|Completed 24 Weeks of Treatment|Overall Study||55
6507628|NCT01466166|7427048|FG000|COMPLETED|Overall Study||25
6507629|NCT01466166|7427048|FG000|NOT COMPLETED|Overall Study||163
6507630|NCT01466179|7427052|FG000|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
6507631|NCT01466179|7427052|FG000|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
6507632|NCT01466179|7427052|FG000|NOT COMPLETED|Overall Study||179
6507633|NCT01466192|7427059|FG000|STARTED|Overall Study||108
6507634|NCT01466192|7427059|FG000|COMPLETED|Overall Study||104
6507635|NCT01466192|7427059|FG000|NOT COMPLETED|Overall Study||4
6507636|NCT01466270|7427065|FG000|STARTED|Overall Study||31
6507637|NCT01466270|7427066|FG001|STARTED|Overall Study||31
6507638|NCT01466270|7427065|FG000|COMPLETED|Overall Study||19
6507639|NCT01466270|7427066|FG001|COMPLETED|Overall Study||25
6507640|NCT01466270|7427065|FG000|NOT COMPLETED|Overall Study||12
6252548|NCT01408641|7151139|FG001|COMPLETED|Overall Study||0
6252549|NCT01408641|7151138|FG000|NOT COMPLETED|Overall Study||1
6507641|NCT01466270|7427066|FG001|NOT COMPLETED|Overall Study||6
6507642|NCT01466348|7427074|FG000|STARTED|Period I - First Intervention||36
6507643|NCT01466348|7427075|FG001|STARTED|Period I - First Intervention||36
6507644|NCT01466348|7427074|FG000|Intent To Treat (ITT) Population|Period I - First Intervention||36
6570408|NCT01852058|7493866|FG000|STARTED|Treatment Cycle 1, Occurred in Study 120||31
6658085|NCT02476032|7588624|FG001|COMPLETED|Overall Study||19
6252550|NCT01408641|7151139|FG001|NOT COMPLETED|Overall Study||0
6252551|NCT01032265|7151147|FG000|STARTED|Overall Study||126
6252552|NCT01032265|7151148|FG001|STARTED|Overall Study||124
6252553|NCT01032265|7151147|FG000|COMPLETED|Overall Study||113
6252554|NCT01032265|7151148|FG001|COMPLETED|Overall Study||107
6252555|NCT01032265|7151147|FG000|NOT COMPLETED|Overall Study||13
6252556|NCT01032265|7151148|FG001|NOT COMPLETED|Overall Study||17
6252557|NCT00679783|7151161|FG000|STARTED|Overall Study|Gave Informed consent and passed screening|4
6252558|NCT00679783|7151162|FG001|STARTED|Overall Study|Gave Informed consent and passed screening|13
6252559|NCT00679783|7151163|FG002|STARTED|Overall Study|Gave Informed consent and passed screening|3
6252560|NCT00679783|7151164|FG003|STARTED|Overall Study|Gave Informed consent and passed screening|45
6252561|NCT00679783|7151165|FG004|STARTED|Overall Study|Gave Informed consent and passed screening|5
6252562|NCT00679783|7151166|FG005|STARTED|Overall Study|Gave Informed consent and passed screening|5
6252563|NCT00679783|7151167|FG006|STARTED|Overall Study|Gave Informed consent and passed screening|16
6252564|NCT00679783|7151161|FG000|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
6252565|NCT00679783|7151162|FG001|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
6252566|NCT00679783|7151163|FG002|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
6252567|NCT00679783|7151164|FG003|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
6252568|NCT00679783|7151165|FG004|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
6252569|NCT00679783|7151166|FG005|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
6252570|NCT00679783|7151167|FG006|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
6252571|NCT00679783|7151161|FG000|NOT COMPLETED|Overall Study||2
6252572|NCT00679783|7151162|FG001|NOT COMPLETED|Overall Study||3
6252573|NCT00679783|7151163|FG002|NOT COMPLETED|Overall Study||1
6252574|NCT00679783|7151164|FG003|NOT COMPLETED|Overall Study||20
6252575|NCT00679783|7151165|FG004|NOT COMPLETED|Overall Study||1
6252576|NCT00679783|7151166|FG005|NOT COMPLETED|Overall Study||0
6252577|NCT00679783|7151167|FG006|NOT COMPLETED|Overall Study||1
6252578|NCT00653068|7151187|FG000|STARTED|Overall Study||70
6252579|NCT00653068|7151187|FG000|COMPLETED|Overall Study||20
6252580|NCT00653068|7151187|FG000|NOT COMPLETED|Overall Study||50
6252581|NCT00601900|7151196|FG000|STARTED|Overall Study||195
6252582|NCT00601900|7151197|FG001|STARTED|Overall Study||199
6252583|NCT00601900|7151196|FG000|COMPLETED|Overall Study||195
6252584|NCT00601900|7151197|FG001|COMPLETED|Overall Study||196
6252585|NCT00601900|7151196|FG000|NOT COMPLETED|Overall Study||0
6252586|NCT00601900|7151197|FG001|NOT COMPLETED|Overall Study||3
6252587|NCT00193479|7151203|FG000|STARTED|Induction Chemotherapy||51
6252588|NCT00193479|7151203|FG000|COMPLETED|Induction Chemotherapy||48
6252589|NCT00193479|7151203|FG000|NOT COMPLETED|Induction Chemotherapy||3
6252590|NCT00193479|7151203|FG000|STARTED|Maintenance Rituximab||48
6252591|NCT00193479|7151203|FG000|COMPLETED|Maintenance Rituximab||44
6252592|NCT00193479|7151203|FG000|NOT COMPLETED|Maintenance Rituximab||4
6252593|NCT00193427|7151207|FG000|STARTED|Overall Study||75
6252594|NCT00193427|7151207|FG000|COMPLETED|Overall Study||26
6252595|NCT00193427|7151207|FG000|NOT COMPLETED|Overall Study||49
6252596|NCT00193414|7151212|FG000|STARTED|Overall Study||72
6252597|NCT00193414|7151212|FG000|COMPLETED|Overall Study||14
6252598|NCT00193414|7151212|FG000|NOT COMPLETED|Overall Study||58
6252599|NCT00085735|7151222|FG000|STARTED|Overall Study||64
6252600|NCT00085735|7151223|FG001|STARTED|Overall Study||64
6252601|NCT00085735|7151224|FG002|STARTED|Overall Study||63
6252602|NCT00085735|7151225|FG003|STARTED|Overall Study||65
6252603|NCT00085735|7151226|FG004|STARTED|Overall Study||147
6252604|NCT00085735|7151227|FG005|STARTED|Overall Study||146
6252605|NCT00085735|7151222|FG000|COMPLETED|Overall Study||52
6252606|NCT00085735|7151223|FG001|COMPLETED|Overall Study||54
6252607|NCT00085735|7151224|FG002|COMPLETED|Overall Study||46
6252608|NCT00085735|7151225|FG003|COMPLETED|Overall Study||46
6252609|NCT00085735|7151226|FG004|COMPLETED|Overall Study||105
6252610|NCT00085735|7151227|FG005|COMPLETED|Overall Study||115
6252611|NCT00085735|7151222|FG000|NOT COMPLETED|Overall Study||12
6252612|NCT00085735|7151223|FG001|NOT COMPLETED|Overall Study||10
6252613|NCT00085735|7151224|FG002|NOT COMPLETED|Overall Study||17
6252614|NCT00085735|7151225|FG003|NOT COMPLETED|Overall Study||19
6252615|NCT00085735|7151226|FG004|NOT COMPLETED|Overall Study||42
6252616|NCT00085735|7151227|FG005|NOT COMPLETED|Overall Study||31
6252617|NCT00003042|7151256|FG000|STARTED|Overall Study||14
6252618|NCT00003042|7151257|FG001|STARTED|Overall Study||27
6252619|NCT00003042|7151256|FG000|COMPLETED|Overall Study||14
6252620|NCT00003042|7151257|FG001|COMPLETED|Overall Study||27
6252621|NCT00003042|7151256|FG000|NOT COMPLETED|Overall Study||0
6507645|NCT01466348|7427075|FG001|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
6507646|NCT01466348|7427074|FG000|COMPLETED|Period I - First Intervention||36
6507647|NCT01466348|7427075|FG001|COMPLETED|Period I - First Intervention||35
6507648|NCT01466348|7427074|FG000|NOT COMPLETED|Period I - First Intervention||0
6507649|NCT01466348|7427075|FG001|NOT COMPLETED|Period I - First Intervention||1
6507650|NCT01466348|7427074|FG000|STARTED|Period II - Second Intervention||35
6507651|NCT01466348|7427075|FG001|STARTED|Period II - Second Intervention||36
6507652|NCT01466348|7427074|FG000|COMPLETED|Period II - Second Intervention||35
6507653|NCT01466348|7427075|FG001|COMPLETED|Period II - Second Intervention||36
6507654|NCT01466348|7427074|FG000|NOT COMPLETED|Period II - Second Intervention||0
6507655|NCT01466348|7427075|FG001|NOT COMPLETED|Period II - Second Intervention||0
6507656|NCT01466361|7427087|FG000|STARTED|Overall Study||52
6507657|NCT01466361|7427088|FG001|STARTED|Overall Study||34
6507658|NCT01466361|7427089|FG002|STARTED|Overall Study||60
6507659|NCT01466361|7427090|FG003|STARTED|Overall Study||41
6507660|NCT01466361|7427087|FG000|COMPLETED|Overall Study||52
6252622|NCT00003042|7151257|FG001|NOT COMPLETED|Overall Study||0
6252623|NCT00002874|7151265|FG000|STARTED|Overall Study||421
6252624|NCT00002874|7151266|FG001|STARTED|Overall Study||419
6252625|NCT00002874|7151265|FG000|COMPLETED|Overall Study||376
6252626|NCT00002874|7151266|FG001|COMPLETED|Overall Study||384
6252627|NCT00002874|7151265|FG000|NOT COMPLETED|Overall Study||45
6252628|NCT00002874|7151266|FG001|NOT COMPLETED|Overall Study||35
6278171|NCT00131664|7177787|FG001|COMPLETED|First Period (First 6 Months)||117
6278172|NCT00131664|7177788|FG002|COMPLETED|First Period (First 6 Months)||104
6278173|NCT00131664|7177789|FG003|COMPLETED|First Period (First 6 Months)||0
6278174|NCT00131664|7177790|FG004|COMPLETED|First Period (First 6 Months)||0
6278175|NCT00131664|7177791|FG005|COMPLETED|First Period (First 6 Months)||0
6278176|NCT00131664|7177786|FG000|NOT COMPLETED|First Period (First 6 Months)||25
6278177|NCT00131664|7177787|FG001|NOT COMPLETED|First Period (First 6 Months)||18
6278178|NCT00131664|7177788|FG002|NOT COMPLETED|First Period (First 6 Months)||16
6278179|NCT00131664|7177789|FG003|NOT COMPLETED|First Period (First 6 Months)||0
6278180|NCT00131664|7177790|FG004|NOT COMPLETED|First Period (First 6 Months)||0
6278181|NCT00131664|7177791|FG005|NOT COMPLETED|First Period (First 6 Months)||0
6278182|NCT00131664|7177786|FG000|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
6278183|NCT00131664|7177787|FG001|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
6278184|NCT00131664|7177788|FG002|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
6278185|NCT00131664|7177789|FG003|STARTED|Second Period (Additional Drug Added)||21
6278186|NCT00131664|7177790|FG004|STARTED|Second Period (Additional Drug Added)||16
6278187|NCT00131664|7177791|FG005|STARTED|Second Period (Additional Drug Added)||25
6278188|NCT00131664|7177786|FG000|COMPLETED|Second Period (Additional Drug Added)||81
6278189|NCT00131664|7177787|FG001|COMPLETED|Second Period (Additional Drug Added)||97
6278190|NCT00131664|7177788|FG002|COMPLETED|Second Period (Additional Drug Added)||76
6278191|NCT00131664|7177789|FG003|COMPLETED|Second Period (Additional Drug Added)||19
6278192|NCT00131664|7177790|FG004|COMPLETED|Second Period (Additional Drug Added)||15
6278193|NCT00131664|7177791|FG005|COMPLETED|Second Period (Additional Drug Added)||22
6278194|NCT00131664|7177786|FG000|NOT COMPLETED|Second Period (Additional Drug Added)||9
6278195|NCT00131664|7177787|FG001|NOT COMPLETED|Second Period (Additional Drug Added)||4
6278196|NCT00131664|7177788|FG002|NOT COMPLETED|Second Period (Additional Drug Added)||3
6278197|NCT00131664|7177789|FG003|NOT COMPLETED|Second Period (Additional Drug Added)||2
6278198|NCT00131664|7177790|FG004|NOT COMPLETED|Second Period (Additional Drug Added)||1
6278199|NCT00131664|7177791|FG005|NOT COMPLETED|Second Period (Additional Drug Added)||3
6278200|NCT00131677|7177804|FG000|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
6278201|NCT00131677|7177805|FG001|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
6278202|NCT00131677|7177804|FG000|COMPLETED|Overall Study||171
6278203|NCT00131677|7177805|FG001|COMPLETED|Overall Study||160
6278204|NCT00131677|7177804|FG000|NOT COMPLETED|Overall Study||30
6278205|NCT00131677|7177805|FG001|NOT COMPLETED|Overall Study||39
6278206|NCT00131885|7177820|FG000|STARTED|Time 1: First Intervention||9
6278207|NCT00131885|7177821|FG001|STARTED|Time 1: First Intervention||9
6278208|NCT00131885|7177822|FG002|STARTED|Time 1: First Intervention||9
6278209|NCT00131885|7177823|FG003|STARTED|Time 1: First Intervention||9
6278210|NCT00131885|7177820|FG000|COMPLETED|Time 1: First Intervention||9
6278211|NCT00131885|7177821|FG001|COMPLETED|Time 1: First Intervention||9
6278212|NCT00131885|7177822|FG002|COMPLETED|Time 1: First Intervention||9
6278213|NCT00131885|7177823|FG003|COMPLETED|Time 1: First Intervention||9
6278214|NCT00131885|7177820|FG000|NOT COMPLETED|Time 1: First Intervention||0
6278215|NCT00131885|7177821|FG001|NOT COMPLETED|Time 1: First Intervention||0
6278216|NCT00131885|7177822|FG002|NOT COMPLETED|Time 1: First Intervention||0
6278217|NCT00131885|7177823|FG003|NOT COMPLETED|Time 1: First Intervention||0
6507661|NCT01466361|7427088|FG001|COMPLETED|Overall Study||34
6507662|NCT01466361|7427089|FG002|COMPLETED|Overall Study||60
6507663|NCT01466361|7427090|FG003|COMPLETED|Overall Study||41
6507664|NCT01466361|7427087|FG000|NOT COMPLETED|Overall Study||0
6507665|NCT01466361|7427088|FG001|NOT COMPLETED|Overall Study||0
6507666|NCT01466361|7427089|FG002|NOT COMPLETED|Overall Study||0
6507667|NCT01466361|7427090|FG003|NOT COMPLETED|Overall Study||0
6507668|NCT01466387|7427111|FG000|STARTED|Overall Study||101
6507669|NCT01466387|7427112|FG001|STARTED|Overall Study||100
6507670|NCT01466387|7427113|FG002|STARTED|Overall Study||99
6507671|NCT01466387|7427114|FG003|STARTED|Overall Study||101
6507672|NCT01466387|7427115|FG004|STARTED|Overall Study||51
6507673|NCT01466387|7427116|FG005|STARTED|Overall Study||100
6507674|NCT01466387|7427111|FG000|COMPLETED|Overall Study||100
6507675|NCT01466387|7427112|FG001|COMPLETED|Overall Study||100
6507676|NCT01466387|7427113|FG002|COMPLETED|Overall Study||98
6507677|NCT01466387|7427114|FG003|COMPLETED|Overall Study||99
6507678|NCT01466387|7427115|FG004|COMPLETED|Overall Study||51
6507679|NCT01466387|7427116|FG005|COMPLETED|Overall Study||99
6507680|NCT01466387|7427111|FG000|NOT COMPLETED|Overall Study||1
6507681|NCT01466387|7427112|FG001|NOT COMPLETED|Overall Study||0
6507682|NCT01466387|7427113|FG002|NOT COMPLETED|Overall Study||1
6507683|NCT01466387|7427114|FG003|NOT COMPLETED|Overall Study||2
6507684|NCT01466387|7427115|FG004|NOT COMPLETED|Overall Study||0
6507685|NCT01466387|7427116|FG005|NOT COMPLETED|Overall Study||1
6507686|NCT01466491|7427143|FG000|STARTED|Overall Study||83
6507687|NCT01466491|7427144|FG001|STARTED|Overall Study||83
6252629|NCT04399356|7151274|FG000|STARTED|Overall Study||36
6252630|NCT04399356|7151275|FG001|STARTED|Overall Study||37
6252631|NCT04399356|7151274|FG000|COMPLETED|Overall Study||33
6252632|NCT04399356|7151275|FG001|COMPLETED|Overall Study||34
6252633|NCT04399356|7151274|FG000|NOT COMPLETED|Overall Study||3
6507688|NCT01466491|7427145|FG002|STARTED|Overall Study||83
6507689|NCT01466491|7427146|FG003|STARTED|Overall Study||83
6507690|NCT01466491|7427143|FG000|COMPLETED|Overall Study||83
6507691|NCT01466491|7427144|FG001|COMPLETED|Overall Study||80
6507692|NCT01466491|7427145|FG002|COMPLETED|Overall Study||80
6507693|NCT01466491|7427146|FG003|COMPLETED|Overall Study||83
6507694|NCT01466491|7427143|FG000|NOT COMPLETED|Overall Study||0
6507695|NCT01466491|7427144|FG001|NOT COMPLETED|Overall Study||3
6507696|NCT01466491|7427145|FG002|NOT COMPLETED|Overall Study||3
6507697|NCT01466491|7427146|FG003|NOT COMPLETED|Overall Study||0
6507698|NCT01466595|7427158|FG000|STARTED|Overall Study||49
6507699|NCT01466595|7427159|FG001|STARTED|Overall Study||24
6507700|NCT01466595|7427158|FG000|COMPLETED|Overall Study||49
6507701|NCT01466595|7427159|FG001|COMPLETED|Overall Study||23
6507702|NCT01466595|7427158|FG000|NOT COMPLETED|Overall Study||0
6507703|NCT01466595|7427159|FG001|NOT COMPLETED|Overall Study||1
6507704|NCT01466660|7427167|FG000|STARTED|Overall Study||160
6507705|NCT01466660|7427168|FG001|STARTED|Overall Study||159
6507706|NCT01466660|7427167|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
6507707|NCT01466660|7427168|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12 April 2019|0
6507708|NCT01466660|7427167|FG000|NOT COMPLETED|Overall Study||160
6507709|NCT01466660|7427168|FG001|NOT COMPLETED|Overall Study||159
6507710|NCT01466673|7427176|FG000|STARTED|Overall Study||100
6507711|NCT01466673|7427177|FG001|STARTED|Overall Study||101
6507712|NCT01466673|7427176|FG000|COMPLETED|Overall Study||93
6507713|NCT01466673|7427177|FG001|COMPLETED|Overall Study||95
6507714|NCT01466673|7427176|FG000|NOT COMPLETED|Overall Study||7
6507715|NCT01466673|7427177|FG001|NOT COMPLETED|Overall Study||6
6507716|NCT01466751|7427185|FG000|STARTED|Overall Study||14
6507717|NCT01466751|7427186|FG001|STARTED|Overall Study||14
6507718|NCT01466751|7427185|FG000|COMPLETED|Overall Study||13
6507719|NCT01466751|7427186|FG001|COMPLETED|Overall Study||14
6507720|NCT01466751|7427185|FG000|NOT COMPLETED|Overall Study||1
6507721|NCT01466751|7427186|FG001|NOT COMPLETED|Overall Study||0
6507722|NCT01466764|7427196|FG000|STARTED|Overall Study||5
6507723|NCT01466764|7427197|FG001|STARTED|Overall Study||5
6507724|NCT01466764|7427196|FG000|COMPLETED|Overall Study||5
6507725|NCT01466764|7427197|FG001|COMPLETED|Overall Study||5
6507726|NCT01466764|7427196|FG000|NOT COMPLETED|Overall Study||0
6507727|NCT01466764|7427197|FG001|NOT COMPLETED|Overall Study||0
6507728|NCT01466790|7427211|FG000|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
6507729|NCT01466790|7427212|FG001|STARTED|Overall Study||15
6507730|NCT01466790|7427213|FG002|STARTED|Overall Study||27
6507731|NCT01466790|7427214|FG003|STARTED|Overall Study||14
6507732|NCT01466790|7427215|FG004|STARTED|Overall Study||30
6507733|NCT01466790|7427216|FG005|STARTED|Overall Study||16
6507734|NCT01466790|7427217|FG006|STARTED|Overall Study||27
6507735|NCT01466790|7427218|FG007|STARTED|Overall Study||14
6507736|NCT01466790|7427211|FG000|COMPLETED|Overall Study||20
6507737|NCT01466790|7427212|FG001|COMPLETED|Overall Study||14
6507738|NCT01466790|7427213|FG002|COMPLETED|Overall Study||27
6507739|NCT01466790|7427214|FG003|COMPLETED|Overall Study||14
6507740|NCT01466790|7427215|FG004|COMPLETED|Overall Study||27
6507741|NCT01466790|7427216|FG005|COMPLETED|Overall Study||16
6507742|NCT01466790|7427217|FG006|COMPLETED|Overall Study||26
6507743|NCT01466790|7427218|FG007|COMPLETED|Overall Study||13
6507744|NCT01466790|7427211|FG000|NOT COMPLETED|Overall Study||4
6507745|NCT01466790|7427212|FG001|NOT COMPLETED|Overall Study||1
6507746|NCT01466790|7427213|FG002|NOT COMPLETED|Overall Study||0
6507747|NCT01466790|7427214|FG003|NOT COMPLETED|Overall Study||0
6507748|NCT01466790|7427215|FG004|NOT COMPLETED|Overall Study||3
6252634|NCT04399356|7151275|FG001|NOT COMPLETED|Overall Study||3
6252686|NCT03933449|7151333|FG000|STARTED|Overall Study||62
6252687|NCT03933449|7151334|FG001|STARTED|Overall Study||61
6252688|NCT03933449|7151333|FG000|Treated|Overall Study||62
6252689|NCT03933449|7151334|FG001|Treated|Overall Study||59
6252690|NCT03933449|7151333|FG000|COMPLETED|Overall Study||0
6252691|NCT03933449|7151334|FG001|COMPLETED|Overall Study||0
6252692|NCT03933449|7151333|FG000|NOT COMPLETED|Overall Study||62
6252693|NCT03933449|7151334|FG001|NOT COMPLETED|Overall Study||61
6252694|NCT03826667|7151340|FG000|STARTED|Overall Study||464
6252695|NCT03826667|7151340|FG000|HEALICOIL™ PK Preloaded Suture Anchors|Overall Study||193
6252696|NCT03826667|7151340|FG000|BIORAPTOR™ 2.3 PK Suture Anchors/BIORAPTOR™ Curved 2.3 PK Suture Anchors|Overall Study||41
6252697|NCT03826667|7151340|FG000|MULTIFIX™ S Ultra Knotless Fixation System|Overall Study||78
6252698|NCT03826667|7151340|FG000|FOOTPRINT™ Ultra PK Suture Anchors|Overall Study||136
6252699|NCT03826667|7151340|FG000|TWINFIX™ Ultra PK Suture Anchors/TWINFIX™ Ultra Preloaded and With Needles|Overall Study||57
6252700|NCT03826667|7151340|FG000|SPEEDSCREW™ Knotless Fixation System|Overall Study||59
6252701|NCT03826667|7151340|FG000|SpeedLock Knotless Fixation Device|Overall Study||18
6252702|NCT03826667|7151340|FG000|COMPLETED|Overall Study||443
6507749|NCT01466790|7427216|FG005|NOT COMPLETED|Overall Study||0
6507750|NCT01466790|7427217|FG006|NOT COMPLETED|Overall Study||1
6507751|NCT01466790|7427218|FG007|NOT COMPLETED|Overall Study||1
6507752|NCT01466881|7427232|FG000|STARTED|Overall Study||42
6252635|NCT04350905|7151281|FG000|STARTED|Overall Study||42
6252636|NCT04350905|7151281|FG000|COMPLETED|Overall Study||41
6252637|NCT04350905|7151281|FG000|NOT COMPLETED|Overall Study||1
6252638|NCT04236635|7151285|FG000|STARTED|Overall Study||2
6252639|NCT04236635|7151286|FG001|STARTED|Overall Study||1
6252640|NCT04236635|7151287|FG002|STARTED|Overall Study||1
6252641|NCT04236635|7151288|FG003|STARTED|Overall Study||4
6252642|NCT04236635|7151289|FG004|STARTED|Overall Study||1
6252643|NCT04236635|7151290|FG005|STARTED|Overall Study||1
6252644|NCT04236635|7151285|FG000|Safety Population|Overall Study||2
6252645|NCT04236635|7151286|FG001|Safety Population|Overall Study||1
6252646|NCT04236635|7151287|FG002|Safety Population|Overall Study||1
6252647|NCT04236635|7151288|FG003|Safety Population|Overall Study||4
6252648|NCT04236635|7151289|FG004|Safety Population|Overall Study||1
6252649|NCT04236635|7151290|FG005|Safety Population|Overall Study||1
6252650|NCT04236635|7151285|FG000|Evaluable Population|Overall Study||2
6252651|NCT04236635|7151286|FG001|Evaluable Population|Overall Study||1
6252652|NCT04236635|7151287|FG002|Evaluable Population|Overall Study||1
6252653|NCT04236635|7151288|FG003|Evaluable Population|Overall Study||2
6252654|NCT04236635|7151289|FG004|Evaluable Population|Overall Study||1
6252655|NCT04236635|7151290|FG005|Evaluable Population|Overall Study||1
6252656|NCT04236635|7151285|FG000|COMPLETED|Overall Study||2
6252657|NCT04236635|7151286|FG001|COMPLETED|Overall Study||1
6252658|NCT04236635|7151287|FG002|COMPLETED|Overall Study||1
6252659|NCT04236635|7151288|FG003|COMPLETED|Overall Study||4
6252660|NCT04236635|7151289|FG004|COMPLETED|Overall Study||1
6252661|NCT04236635|7151290|FG005|COMPLETED|Overall Study||1
6252662|NCT04236635|7151285|FG000|NOT COMPLETED|Overall Study||0
6252663|NCT04236635|7151286|FG001|NOT COMPLETED|Overall Study||0
6252664|NCT04236635|7151287|FG002|NOT COMPLETED|Overall Study||0
6252665|NCT04236635|7151288|FG003|NOT COMPLETED|Overall Study||0
6252666|NCT04236635|7151289|FG004|NOT COMPLETED|Overall Study||0
6252667|NCT04236635|7151290|FG005|NOT COMPLETED|Overall Study||0
6252668|NCT04156399|7151305|FG000|STARTED|Overall Study||6
6252669|NCT04156399|7151305|FG000|COMPLETED|Overall Study|Of the six participants who started the study, two completed all 10 acupuncture sessions, two completed 9 sessions, and one completed 8 sessions. The three who completed 8 or 9 sessions were unable to complete due to the COVID-19 lockdowns, however, we were able to collect post-test measures for them. Finally, one participant was hospitalized (unrelated to acupuncture) and could not complete the study nor provide post-test measures.|2
6252670|NCT04156399|7151305|FG000|NOT COMPLETED|Overall Study||4
6252671|NCT04148521|7151311|FG000|STARTED|Overall Study||534
6252672|NCT04148521|7151312|FG001|STARTED|Overall Study||555
6252673|NCT04148521|7151311|FG000|COMPLETED|Overall Study||534
6252674|NCT04148521|7151312|FG001|COMPLETED|Overall Study||555
6252675|NCT04148521|7151311|FG000|NOT COMPLETED|Overall Study||0
6252676|NCT04148521|7151312|FG001|NOT COMPLETED|Overall Study||0
6252677|NCT04115228|7151318|FG000|STARTED|Overall Study||10
6252678|NCT04115228|7151318|FG000|COMPLETED|Overall Study||10
6252679|NCT04115228|7151318|FG000|NOT COMPLETED|Overall Study||0
6252680|NCT04052620|7151324|FG000|STARTED|Overall Study||150
6252681|NCT04052620|7151325|FG001|STARTED|Overall Study||152
6252682|NCT04052620|7151324|FG000|COMPLETED|Overall Study||143
6252683|NCT04052620|7151325|FG001|COMPLETED|Overall Study||145
6252684|NCT04052620|7151324|FG000|NOT COMPLETED|Overall Study||7
6252685|NCT04052620|7151325|FG001|NOT COMPLETED|Overall Study||7
6252703|NCT03826667|7151340|FG000|NOT COMPLETED|Overall Study||21
6278218|NCT00131885|7177820|FG000|STARTED|Time 2: Second Intervention||9
6278219|NCT00131885|7177821|FG001|STARTED|Time 2: Second Intervention||9
6278220|NCT00131885|7177822|FG002|STARTED|Time 2: Second Intervention||9
6278221|NCT00131885|7177823|FG003|STARTED|Time 2: Second Intervention||9
6278222|NCT00131885|7177820|FG000|COMPLETED|Time 2: Second Intervention||9
6278223|NCT00131885|7177821|FG001|COMPLETED|Time 2: Second Intervention||9
6278224|NCT00131885|7177822|FG002|COMPLETED|Time 2: Second Intervention||9
6278225|NCT00131885|7177823|FG003|COMPLETED|Time 2: Second Intervention||9
6278226|NCT00131885|7177820|FG000|NOT COMPLETED|Time 2: Second Intervention||0
6278227|NCT00131885|7177821|FG001|NOT COMPLETED|Time 2: Second Intervention||0
6278228|NCT00131885|7177822|FG002|NOT COMPLETED|Time 2: Second Intervention||0
6278229|NCT00131885|7177823|FG003|NOT COMPLETED|Time 2: Second Intervention||0
6278230|NCT00131911|7177835|FG000|STARTED|Overall Study||51
6278231|NCT00131911|7177836|FG001|STARTED|Overall Study||42
6278232|NCT00131911|7177835|FG000|COMPLETED|Overall Study||50
6278233|NCT00131911|7177836|FG001|COMPLETED|Overall Study||42
6278234|NCT00131911|7177835|FG000|NOT COMPLETED|Overall Study||1
6278235|NCT00131911|7177836|FG001|NOT COMPLETED|Overall Study||0
6278236|NCT00131937|7177841|FG000|STARTED|Overall Study||14
6278237|NCT00131937|7177841|FG000|COMPLETED|Overall Study||0
6278238|NCT00131937|7177841|FG000|NOT COMPLETED|Overall Study||14
6278239|NCT00132002|7177845|FG000|STARTED|Overall Study||14
6278240|NCT00132002|7177845|FG000|COMPLETED|Overall Study||14
6278241|NCT00132002|7177845|FG000|NOT COMPLETED|Overall Study||0
6278242|NCT00132028|7177849|FG000|STARTED|Overall Study||27
6278243|NCT00132028|7177849|FG000|Eligible|Overall Study||25
6278244|NCT00132028|7177849|FG000|Eligible and Began Protocol Therapy|Overall Study||25
6278245|NCT00132028|7177849|FG000|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
6278246|NCT00132028|7177849|FG000|NOT COMPLETED|Overall Study||27
6278247|NCT00132041|7177853|FG000|STARTED|Baseline||51
6278248|NCT00132041|7177853|FG000|Eligible|Baseline||45
6278249|NCT00132041|7177853|FG000|COMPLETED|Baseline||45
6252704|NCT03600909|7151353|FG000|STARTED|Overall Study||0
6252705|NCT03600909|7151354|FG001|STARTED|Overall Study||3
6252706|NCT03600909|7151355|FG002|STARTED|Overall Study||0
6252707|NCT03600909|7151353|FG000|COMPLETED|Overall Study||0
6252708|NCT03600909|7151354|FG001|COMPLETED|Overall Study||0
6252709|NCT03600909|7151355|FG002|COMPLETED|Overall Study||0
6252710|NCT03600909|7151353|FG000|NOT COMPLETED|Overall Study||0
6252711|NCT03600909|7151354|FG001|NOT COMPLETED|Overall Study||3
6252712|NCT03600909|7151355|FG002|NOT COMPLETED|Overall Study||0
6252713|NCT03368781|7151363|FG000|STARTED|Overall Study||128
6252714|NCT03368781|7151363|FG000|COMPLETED|Overall Study||103
6252715|NCT03368781|7151363|FG000|NOT COMPLETED|Overall Study||25
6252716|NCT03366428|7151371|FG000|STARTED|Overall Study||51
6252717|NCT03366428|7151371|FG000|COMPLETED|Overall Study||0
6252718|NCT03366428|7151371|FG000|NOT COMPLETED|Overall Study||51
6252719|NCT03221660|7151377|FG000|STARTED|Overall Study||50
6252720|NCT03221660|7151377|FG000|COMPLETED|Overall Study||50
6252721|NCT03221660|7151377|FG000|NOT COMPLETED|Overall Study||0
6252722|NCT03131219|7151383|FG000|STARTED|Initial Evaluation Period||21
6252723|NCT03131219|7151384|FG001|STARTED|Initial Evaluation Period||10
6252724|NCT03131219|7151383|FG000|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||21
6252725|NCT03131219|7151384|FG001|Received At Least 1 Dose of Study Drug|Initial Evaluation Period||10
6252726|NCT03131219|7151383|FG000|COMPLETED|Initial Evaluation Period||17
6252727|NCT03131219|7151384|FG001|COMPLETED|Initial Evaluation Period||10
6507753|NCT01466881|7427232|FG000|Eligible and Treated|Overall Study||37
6507754|NCT01466881|7427232|FG000|COMPLETED|Overall Study||2
6507755|NCT01466881|7427232|FG000|NOT COMPLETED|Overall Study||40
6507756|NCT01466972|7427238|FG000|STARTED|Overall Study||30
6507757|NCT01466972|7427238|FG000|COMPLETED|Overall Study||30
6507758|NCT01466972|7427238|FG000|NOT COMPLETED|Overall Study||0
6507759|NCT01466985|7427245|FG000|STARTED|Overall Study||6
6507760|NCT01466985|7427246|FG001|STARTED|Overall Study||6
6507761|NCT01466985|7427247|FG002|STARTED|Overall Study||6
6507762|NCT01466985|7427245|FG000|COMPLETED|Overall Study||6
6507763|NCT01466985|7427246|FG001|COMPLETED|Overall Study||6
6507764|NCT01466985|7427247|FG002|COMPLETED|Overall Study||6
6507765|NCT01466985|7427245|FG000|NOT COMPLETED|Overall Study||0
6507766|NCT01466985|7427246|FG001|NOT COMPLETED|Overall Study||0
6507767|NCT01466985|7427247|FG002|NOT COMPLETED|Overall Study||0
6507768|NCT01467037|7427258|FG000|STARTED|Overall Study||374
6507769|NCT01467037|7427258|FG000|COMPLETED|Overall Study||374
6507770|NCT01467037|7427258|FG000|NOT COMPLETED|Overall Study||0
6507771|NCT01467063|7427265|FG000|STARTED|Overall Study||6
6507772|NCT01467063|7427266|FG001|STARTED|Overall Study||7
6507773|NCT01467063|7427265|FG000|COMPLETED|Overall Study||5
6507774|NCT01467063|7427266|FG001|COMPLETED|Overall Study||7
6507775|NCT01467063|7427265|FG000|NOT COMPLETED|Overall Study||1
6507776|NCT01467063|7427266|FG001|NOT COMPLETED|Overall Study||0
6507777|NCT01467076|7427275|FG000|STARTED|Overall Study||3
6507778|NCT01467076|7427276|FG001|STARTED|Overall Study||2
6507779|NCT01467076|7427277|FG002|STARTED|Overall Study||2
6507780|NCT01467076|7427275|FG000|COMPLETED|Overall Study||2
6507781|NCT01467076|7427276|FG001|COMPLETED|Overall Study||2
6507782|NCT01467076|7427277|FG002|COMPLETED|Overall Study||2
6507783|NCT01467076|7427275|FG000|NOT COMPLETED|Overall Study||1
6507784|NCT01467076|7427276|FG001|NOT COMPLETED|Overall Study||0
6507785|NCT01467076|7427277|FG002|NOT COMPLETED|Overall Study||0
6507786|NCT01467271|7427285|FG000|STARTED|Overall Study||540
6507787|NCT01467271|7427285|FG000|COMPLETED|Overall Study||338
6507788|NCT01467271|7427285|FG000|NOT COMPLETED|Overall Study||202
6507789|NCT01467427|7427291|FG000|STARTED|Overall Study||12
6507790|NCT01467427|7427292|FG001|STARTED|Overall Study||13
6507791|NCT01467427|7427291|FG000|Completed Main Phase|Overall Study||11
6507792|NCT01467427|7427292|FG001|Completed Main Phase|Overall Study||13
6570409|NCT01852058|7493867|FG001|STARTED|Treatment Cycle 1, Occurred in Study 120||39
6570410|NCT01852058|7493868|FG002|STARTED|Treatment Cycle 1, Occurred in Study 120||25
6570411|NCT01852058|7493869|FG003|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6570412|NCT01852058|7493870|FG004|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6570413|NCT01852058|7493871|FG005|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6570414|NCT01852058|7493872|FG006|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6570415|NCT01852058|7493873|FG007|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6570416|NCT01852058|7493874|FG008|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6252728|NCT03131219|7151383|FG000|NOT COMPLETED|Initial Evaluation Period||4
6507793|NCT01467427|7427291|FG000|COMPLETED|Overall Study||0
6507794|NCT01467427|7427292|FG001|COMPLETED|Overall Study||0
6507795|NCT01467427|7427291|FG000|NOT COMPLETED|Overall Study||12
6507796|NCT01467427|7427292|FG001|NOT COMPLETED|Overall Study||13
6507797|NCT01467466|7427302|FG000|STARTED|Overall Study||1300
6507798|NCT01467466|7427303|FG001|STARTED|Overall Study||1292
6507799|NCT01467466|7427304|FG002|STARTED|Overall Study||1294
6507800|NCT01467466|7427305|FG003|STARTED|Overall Study||1291
6507801|NCT01467466|7427302|FG000|COMPLETED|Overall Study||1191
6507802|NCT01467466|7427303|FG001|COMPLETED|Overall Study||1188
6507803|NCT01467466|7427304|FG002|COMPLETED|Overall Study||1190
6507804|NCT01467466|7427305|FG003|COMPLETED|Overall Study||1203
6507805|NCT01467466|7427302|FG000|NOT COMPLETED|Overall Study||109
6507806|NCT01467466|7427303|FG001|NOT COMPLETED|Overall Study||104
6507807|NCT01467466|7427304|FG002|NOT COMPLETED|Overall Study||104
6507808|NCT01467466|7427305|FG003|NOT COMPLETED|Overall Study||88
6252729|NCT03131219|7151384|FG001|NOT COMPLETED|Initial Evaluation Period||0
6252730|NCT03131219|7151383|FG000|STARTED|Extension Period||17
6252731|NCT03131219|7151384|FG001|STARTED|Extension Period||10
6252732|NCT03131219|7151383|FG000|Received At Least 1 Dose of Study Drug|Extension Period||17
6252733|NCT03131219|7151384|FG001|Received At Least 1 Dose of Study Drug|Extension Period||10
6252734|NCT03131219|7151383|FG000|Ongoing|Extension Period||16
6252735|NCT03131219|7151384|FG001|Ongoing|Extension Period||10
6252736|NCT03131219|7151383|FG000|COMPLETED|Extension Period||0
6252737|NCT03131219|7151384|FG001|COMPLETED|Extension Period||0
6252738|NCT03131219|7151383|FG000|NOT COMPLETED|Extension Period||17
6252739|NCT03131219|7151384|FG001|NOT COMPLETED|Extension Period||10
6658086|NCT02476032|7588625|FG002|COMPLETED|Overall Study||19
6658087|NCT02476032|7588623|FG000|NOT COMPLETED|Overall Study||0
6658088|NCT02476032|7588624|FG001|NOT COMPLETED|Overall Study||1
6658089|NCT02476032|7588625|FG002|NOT COMPLETED|Overall Study||1
6658090|NCT02476175|7588636|FG000|STARTED|Overall Study||35
6658091|NCT02476175|7588636|FG000|COMPLETED|Overall Study||33
6658092|NCT02476175|7588636|FG000|NOT COMPLETED|Overall Study||2
6658093|NCT02476357|7588642|FG000|STARTED|Overall Study||40
6252740|NCT03075527|7151390|FG000|STARTED|Overall Study||19
6252741|NCT03075527|7151390|FG000|COMPLETED|Overall Study||17
6252742|NCT03075527|7151390|FG000|NOT COMPLETED|Overall Study||2
6252743|NCT02756611|7151394|FG000|STARTED|Overall Study||258
6252744|NCT02756611|7151394|FG000|COMPLETED|Overall Study||2
6252745|NCT02756611|7151394|FG000|NOT COMPLETED|Overall Study||256
6252746|NCT02724878|7151398|FG000|STARTED|Overall Study||65
6252747|NCT02724878|7151398|FG000|Treated|Overall Study||60
6252748|NCT02724878|7151398|FG000|Responders|Overall Study||20
6252749|NCT02724878|7151398|FG000|COMPLETED|Overall Study||0
6252750|NCT02724878|7151398|FG000|NOT COMPLETED|Overall Study||65
6252751|NCT02605993|7151406|FG000|STARTED|Treatment Period||6
6252752|NCT02605993|7151407|FG001|STARTED|Treatment Period||6
6252753|NCT02605993|7151408|FG002|STARTED|Treatment Period||7
6252754|NCT02605993|7151409|FG003|STARTED|Treatment Period||7
6252755|NCT02605993|7151406|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||6
6252756|NCT02605993|7151407|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||6
6252757|NCT02605993|7151408|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||7
6252758|NCT02605993|7151409|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||7
6252759|NCT02605993|7151406|FG000|COMPLETED|Treatment Period||6
6252760|NCT02605993|7151407|FG001|COMPLETED|Treatment Period||6
6252761|NCT02605993|7151408|FG002|COMPLETED|Treatment Period||7
6252762|NCT02605993|7151409|FG003|COMPLETED|Treatment Period||7
6252763|NCT02605993|7151406|FG000|NOT COMPLETED|Treatment Period||0
6252764|NCT02605993|7151407|FG001|NOT COMPLETED|Treatment Period||0
6252765|NCT02605993|7151408|FG002|NOT COMPLETED|Treatment Period||0
6252766|NCT02605993|7151409|FG003|NOT COMPLETED|Treatment Period||0
6252767|NCT02605993|7151406|FG000|STARTED|Extension Period||6
6252768|NCT02605993|7151407|FG001|STARTED|Extension Period||6
6252769|NCT02605993|7151408|FG002|STARTED|Extension Period||7
6252770|NCT02605993|7151409|FG003|STARTED|Extension Period||7
6252771|NCT02605993|7151406|FG000|COMPLETED|Extension Period||0
6252772|NCT02605993|7151407|FG001|COMPLETED|Extension Period||0
6252773|NCT02605993|7151408|FG002|COMPLETED|Extension Period||0
6252774|NCT02605993|7151409|FG003|COMPLETED|Extension Period||0
6252775|NCT02605993|7151406|FG000|NOT COMPLETED|Extension Period||6
6252776|NCT02605993|7151407|FG001|NOT COMPLETED|Extension Period||6
6252777|NCT02605993|7151408|FG002|NOT COMPLETED|Extension Period||7
6252778|NCT02605993|7151409|FG003|NOT COMPLETED|Extension Period||7
6278250|NCT00132041|7177853|FG000|NOT COMPLETED|Baseline||6
6278251|NCT00132041|7177853|FG000|STARTED|3 Months Post Ablation||45
6278252|NCT00132041|7177853|FG000|COMPLETED|3 Months Post Ablation||42
6278253|NCT00132041|7177853|FG000|NOT COMPLETED|3 Months Post Ablation||3
6278254|NCT00132041|7177853|FG000|STARTED|6 Months Post Ablation||42
6278255|NCT00132041|7177853|FG000|COMPLETED|6 Months Post Ablation||32
6278256|NCT00132041|7177853|FG000|NOT COMPLETED|6 Months Post Ablation||10
6278257|NCT00132041|7177853|FG000|STARTED|9 Months Post Ablation||32
6278258|NCT00132041|7177853|FG000|COMPLETED|9 Months Post Ablation||30
6278259|NCT00132041|7177853|FG000|NOT COMPLETED|9 Months Post Ablation||2
6278260|NCT00132041|7177853|FG000|STARTED|12 Months Post Ablation||30
6278261|NCT00132041|7177853|FG000|COMPLETED|12 Months Post Ablation||26
6278262|NCT00132041|7177853|FG000|NOT COMPLETED|12 Months Post Ablation||4
6278263|NCT00132041|7177853|FG000|STARTED|15 Months Post Ablation||26
6278264|NCT00132041|7177853|FG000|COMPLETED|15 Months Post Ablation||18
6278265|NCT00132041|7177853|FG000|NOT COMPLETED|15 Months Post Ablation||8
6278266|NCT00132041|7177853|FG000|STARTED|18 Months Post Ablation||18
6278267|NCT00132041|7177853|FG000|COMPLETED|18 Months Post Ablation||12
6658094|NCT02476357|7588643|FG001|STARTED|Overall Study||40
6658095|NCT02476357|7588642|FG000|COMPLETED|Overall Study||40
6252779|NCT02562235|7151419|FG000|STARTED|Overall Study||24
6252780|NCT02562235|7151419|FG000|COMPLETED|Overall Study||21
6252781|NCT02562235|7151419|FG000|NOT COMPLETED|Overall Study||3
6252782|NCT02522715|7151430|FG000|STARTED|Overall Study||3
6252783|NCT02522715|7151431|FG001|STARTED|Overall Study|+1 early withdrawal|33
6252784|NCT02522715|7151430|FG000|COMPLETED|Overall Study||3
6252785|NCT02522715|7151431|FG001|COMPLETED|Overall Study||33
6252786|NCT02522715|7151430|FG000|NOT COMPLETED|Overall Study||0
6252787|NCT02522715|7151431|FG001|NOT COMPLETED|Overall Study||0
6252788|NCT02487095|7151442|FG000|STARTED|Phase I Dose Escalation||6
6252789|NCT02487095|7151443|FG001|STARTED|Phase I Dose Escalation||6
6252790|NCT02487095|7151444|FG002|STARTED|Phase I Dose Escalation||3
6252791|NCT02487095|7151445|FG003|STARTED|Phase I Dose Escalation||6
6252792|NCT02487095|7151446|FG004|STARTED|Phase I Dose Escalation||0
6507809|NCT01467479|7427318|FG000|STARTED|Overall Study||55
6507810|NCT01467479|7427319|FG001|STARTED|Overall Study||69
6507811|NCT01467479|7427320|FG002|STARTED|Overall Study||61
6507812|NCT01467479|7427318|FG000|Treated|Overall Study||54
6507813|NCT01467479|7427319|FG001|Treated|Overall Study||69
6507814|NCT01467479|7427320|FG002|Treated|Overall Study||59
6507815|NCT01467479|7427318|FG000|COMPLETED|Overall Study||46
6507816|NCT01467479|7427319|FG001|COMPLETED|Overall Study||52
6570417|NCT01852058|7493875|FG009|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6570418|NCT01852058|7493876|FG010|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6570419|NCT01852058|7493877|FG011|STARTED|Treatment Cycle 1, Occurred in Study 120||0
6507817|NCT01467479|7427320|FG002|COMPLETED|Overall Study||45
6507818|NCT01467479|7427318|FG000|NOT COMPLETED|Overall Study||9
6507819|NCT01467479|7427319|FG001|NOT COMPLETED|Overall Study||17
6507820|NCT01467479|7427320|FG002|NOT COMPLETED|Overall Study||16
6507821|NCT01467492|7427331|FG000|STARTED|Overall Study||83
6507822|NCT01467492|7427332|FG001|STARTED|Overall Study||38
6507823|NCT01467492|7427331|FG000|COMPLETED|Overall Study||61
6507824|NCT01467492|7427332|FG001|COMPLETED|Overall Study||25
6507825|NCT01467492|7427331|FG000|NOT COMPLETED|Overall Study||22
6507826|NCT01467492|7427332|FG001|NOT COMPLETED|Overall Study||13
6507827|NCT01467505|7427341|FG000|STARTED|Overall Study||51
6507828|NCT01467505|7427342|FG001|STARTED|Overall Study||10
6507829|NCT01467505|7427341|FG000|COMPLETED|Overall Study||18
6507830|NCT01467505|7427342|FG001|COMPLETED|Overall Study||7
6507831|NCT01467505|7427341|FG000|NOT COMPLETED|Overall Study||33
6507832|NCT01467505|7427342|FG001|NOT COMPLETED|Overall Study||3
6507833|NCT01467557|7427350|FG000|STARTED|Overall Study||601
6507834|NCT01467557|7427351|FG001|STARTED|Overall Study||570
6507835|NCT01467557|7427350|FG000|2 Week Survey Completed|Overall Study||551
6507836|NCT01467557|7427351|FG001|2 Week Survey Completed|Overall Study||522
6507837|NCT01467557|7427350|FG000|4 Month Survey Completed|Overall Study||533
6507838|NCT01467557|7427351|FG001|4 Month Survey Completed|Overall Study||493
6507839|NCT01467557|7427350|FG000|12 Month Survey Completed|Overall Study||502
6507840|NCT01467557|7427351|FG001|12 Month Survey Completed|Overall Study||463
6507841|NCT01467557|7427350|FG000|COMPLETED|Overall Study||502
6507842|NCT01467557|7427351|FG001|COMPLETED|Overall Study||463
6507843|NCT01467557|7427350|FG000|NOT COMPLETED|Overall Study||99
6507844|NCT01467557|7427351|FG001|NOT COMPLETED|Overall Study||107
6507845|NCT01467570|7427359|FG000|STARTED|Overall Study||75
6507846|NCT01467570|7427360|FG001|STARTED|Overall Study||72
6507847|NCT01467570|7427359|FG000|COMPLETED|Overall Study||67
6507848|NCT01467570|7427360|FG001|COMPLETED|Overall Study||63
6507849|NCT01467570|7427359|FG000|NOT COMPLETED|Overall Study||8
6507850|NCT01467570|7427360|FG001|NOT COMPLETED|Overall Study||9
6570420|NCT01852058|7493866|FG000|COMPLETED|Treatment Cycle 1, Occurred in Study 120||30
6570421|NCT01852058|7493867|FG001|COMPLETED|Treatment Cycle 1, Occurred in Study 120||39
6570422|NCT01852058|7493868|FG002|COMPLETED|Treatment Cycle 1, Occurred in Study 120||25
6570423|NCT01852058|7493869|FG003|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570424|NCT01852058|7493870|FG004|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570425|NCT01852058|7493871|FG005|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570426|NCT01852058|7493872|FG006|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570427|NCT01852058|7493873|FG007|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570428|NCT01852058|7493874|FG008|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570429|NCT01852058|7493875|FG009|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570430|NCT01852058|7493876|FG010|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570431|NCT01852058|7493877|FG011|COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570432|NCT01852058|7493866|FG000|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||1
6570433|NCT01852058|7493867|FG001|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570434|NCT01852058|7493868|FG002|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570435|NCT01852058|7493869|FG003|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570436|NCT01852058|7493870|FG004|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570437|NCT01852058|7493871|FG005|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570438|NCT01852058|7493872|FG006|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570439|NCT01852058|7493873|FG007|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570440|NCT01852058|7493874|FG008|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570441|NCT01852058|7493875|FG009|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570442|NCT01852058|7493876|FG010|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6570443|NCT01852058|7493877|FG011|NOT COMPLETED|Treatment Cycle 1, Occurred in Study 120||0
6252793|NCT02487095|7151442|FG000|COMPLETED|Phase I Dose Escalation||6
6252794|NCT02487095|7151443|FG001|COMPLETED|Phase I Dose Escalation||6
6252795|NCT02487095|7151444|FG002|COMPLETED|Phase I Dose Escalation||3
6252796|NCT02487095|7151445|FG003|COMPLETED|Phase I Dose Escalation||6
6252797|NCT02487095|7151446|FG004|COMPLETED|Phase I Dose Escalation||0
6252798|NCT02487095|7151442|FG000|NOT COMPLETED|Phase I Dose Escalation||0
6252799|NCT02487095|7151443|FG001|NOT COMPLETED|Phase I Dose Escalation||0
6252800|NCT02487095|7151444|FG002|NOT COMPLETED|Phase I Dose Escalation||0
6252801|NCT02487095|7151445|FG003|NOT COMPLETED|Phase I Dose Escalation||0
6252802|NCT02487095|7151446|FG004|NOT COMPLETED|Phase I Dose Escalation||0
6252803|NCT02487095|7151442|FG000|STARTED|Dose Expansion||0
6252804|NCT02487095|7151443|FG001|STARTED|Dose Expansion||0
6252805|NCT02487095|7151444|FG002|STARTED|Dose Expansion||0
6252806|NCT02487095|7151445|FG003|STARTED|Dose Expansion||0
6252807|NCT02487095|7151446|FG004|STARTED|Dose Expansion||41
6252808|NCT02487095|7151442|FG000|COMPLETED|Dose Expansion||0
6252809|NCT02487095|7151443|FG001|COMPLETED|Dose Expansion||0
6252810|NCT02487095|7151444|FG002|COMPLETED|Dose Expansion||0
6252811|NCT02487095|7151445|FG003|COMPLETED|Dose Expansion||0
6252812|NCT02487095|7151446|FG004|COMPLETED|Dose Expansion||40
6252813|NCT02487095|7151442|FG000|NOT COMPLETED|Dose Expansion||0
6252814|NCT02487095|7151443|FG001|NOT COMPLETED|Dose Expansion||0
6252815|NCT02487095|7151444|FG002|NOT COMPLETED|Dose Expansion||0
6252816|NCT02487095|7151445|FG003|NOT COMPLETED|Dose Expansion||0
6252817|NCT02487095|7151446|FG004|NOT COMPLETED|Dose Expansion||1
6391730|NCT00837811|7303655|FG000|Had at Least 1 Efficacy Assessment|Overall Study||59
6391731|NCT00837811|7303656|FG001|Had at Least 1 Efficacy Assessment|Overall Study||121
6391732|NCT00837811|7303657|FG002|Had at Least 1 Efficacy Assessment|Overall Study||1
6391733|NCT00837811|7303655|FG000|Included in Efficacy Analyses|Overall Study||59
6391734|NCT00837811|7303656|FG001|Included in Efficacy Analyses|Overall Study|Excludes participant from site with Good Clinical Practice (GCP) violations.|120
6507851|NCT01467583|7427371|FG000|STARTED|Overall Study||16
6507852|NCT01467583|7427372|FG001|STARTED|Overall Study||4
6507853|NCT01467583|7427373|FG002|STARTED|Overall Study||12
6252826|NCT02347917|7151477|FG000|STARTED|Overall Study||4
6252827|NCT02347917|7151478|FG001|STARTED|Overall Study||24
6252828|NCT02347917|7151477|FG000|Discontinued beforeBBI608 Administration|Overall Study||0
6252829|NCT02347917|7151478|FG001|Discontinued beforeBBI608 Administration|Overall Study||0
6252830|NCT02347917|7151477|FG000|Start BBI608 Administration|Overall Study||4
6252831|NCT02347917|7151478|FG001|Start BBI608 Administration|Overall Study||24
6252832|NCT02347917|7151477|FG000|Discontinued in DLT Evaluation Period|Overall Study||1
6252833|NCT02347917|7151478|FG001|Discontinued in DLT Evaluation Period|Overall Study||0
6252834|NCT02347917|7151477|FG000|Complete DLT Evaluation Period|Overall Study||3
6252835|NCT02347917|7151478|FG001|Complete DLT Evaluation Period|Overall Study||0
6252836|NCT02347917|7151477|FG000|Discontinued After BBI608 Administration|Overall Study||4
6252837|NCT02347917|7151478|FG001|Discontinued After BBI608 Administration|Overall Study||24
6252838|NCT02347917|7151477|FG000|Discontinued Before Survival Observation|Overall Study||0
6252839|NCT02347917|7151478|FG001|Discontinued Before Survival Observation|Overall Study||1
6252840|NCT02347917|7151477|FG000|COMPLETED|Overall Study||4
6252841|NCT02347917|7151478|FG001|COMPLETED|Overall Study||23
6252842|NCT02347917|7151477|FG000|NOT COMPLETED|Overall Study||0
6252843|NCT02347917|7151478|FG001|NOT COMPLETED|Overall Study||1
6252844|NCT02344108|7151492|FG000|STARTED|Overall Study||42
6252845|NCT02344108|7151492|FG000|COMPLETED|Overall Study||42
6252846|NCT02344108|7151492|FG000|NOT COMPLETED|Overall Study||0
6252847|NCT02335658|7151502|FG000|STARTED|Overall Study|97 subjects in Cohort 1 and 103 subjects in Cohort 2 started to receive DSP-5423P.|97
6252848|NCT02335658|7151503|FG001|STARTED|Overall Study||103
6252849|NCT02335658|7151502|FG000|COMPLETED|Overall Study|57 subjects in Cohort 1 and 59 subjects in Cohort 2 completed the study.|57
6252850|NCT02335658|7151503|FG001|COMPLETED|Overall Study||59
6252851|NCT02335658|7151502|FG000|NOT COMPLETED|Overall Study||40
6252852|NCT02335658|7151503|FG001|NOT COMPLETED|Overall Study||44
6252853|NCT02287584|7151514|FG000|STARTED|the Double-blind Phase||190
6252854|NCT02287584|7151515|FG001|STARTED|the Double-blind Phase||196
6252855|NCT02287584|7151516|FG002|STARTED|the Double-blind Phase||194
6252856|NCT02287584|7151517|FG003|STARTED|the Double-blind Phase||0
6252857|NCT02287584|7151518|FG004|STARTED|the Double-blind Phase||0
6252858|NCT02287584|7151519|FG005|STARTED|the Double-blind Phase||0
6252859|NCT02287584|7151514|FG000|COMPLETED|the Double-blind Phase||138
6252860|NCT02287584|7151515|FG001|COMPLETED|the Double-blind Phase||149
6252861|NCT02287584|7151516|FG002|COMPLETED|the Double-blind Phase||161
6252862|NCT02287584|7151517|FG003|COMPLETED|the Double-blind Phase||0
6252863|NCT02287584|7151518|FG004|COMPLETED|the Double-blind Phase||0
6252864|NCT02287584|7151519|FG005|COMPLETED|the Double-blind Phase||0
6252865|NCT02287584|7151514|FG000|NOT COMPLETED|the Double-blind Phase||52
6252866|NCT02287584|7151515|FG001|NOT COMPLETED|the Double-blind Phase||47
6252867|NCT02287584|7151516|FG002|NOT COMPLETED|the Double-blind Phase||33
6507854|NCT01467583|7427371|FG000|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
6507855|NCT01467583|7427372|FG001|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
6507856|NCT01467583|7427373|FG002|COMPLETED|Overall Study||10
6507857|NCT01467583|7427371|FG000|NOT COMPLETED|Overall Study||2
6507858|NCT01467583|7427372|FG001|NOT COMPLETED|Overall Study||1
6507859|NCT01467583|7427373|FG002|NOT COMPLETED|Overall Study||2
6507860|NCT01467661|7427384|FG000|STARTED|Overall Study||53
6252868|NCT02287584|7151517|FG003|NOT COMPLETED|the Double-blind Phase||0
6252869|NCT02287584|7151518|FG004|NOT COMPLETED|the Double-blind Phase||0
6252870|NCT02287584|7151519|FG005|NOT COMPLETED|the Double-blind Phase||0
6252871|NCT02287584|7151514|FG000|STARTED|the Open-label Phase||0
6252872|NCT02287584|7151515|FG001|STARTED|the Open-label Phase||0
6252873|NCT02287584|7151516|FG002|STARTED|the Open-label Phase||0
6252874|NCT02287584|7151517|FG003|STARTED|the Open-label Phase||138
6252875|NCT02287584|7151518|FG004|STARTED|the Open-label Phase||149
6252876|NCT02287584|7151519|FG005|STARTED|the Open-label Phase||161
6252877|NCT02287584|7151514|FG000|Treated|the Open-label Phase||0
6252878|NCT02287584|7151515|FG001|Treated|the Open-label Phase||0
6252879|NCT02287584|7151516|FG002|Treated|the Open-label Phase||0
6252880|NCT02287584|7151517|FG003|Treated|the Open-label Phase||131
6252881|NCT02287584|7151518|FG004|Treated|the Open-label Phase||143
6252882|NCT02287584|7151519|FG005|Treated|the Open-label Phase||157
6252883|NCT02287584|7151514|FG000|COMPLETED|the Open-label Phase||0
6252884|NCT02287584|7151515|FG001|COMPLETED|the Open-label Phase||0
6252885|NCT02287584|7151516|FG002|COMPLETED|the Open-label Phase||0
6252886|NCT02287584|7151517|FG003|COMPLETED|the Open-label Phase||81
6252887|NCT02287584|7151518|FG004|COMPLETED|the Open-label Phase||87
6252888|NCT02287584|7151519|FG005|COMPLETED|the Open-label Phase||104
6252889|NCT02287584|7151514|FG000|NOT COMPLETED|the Open-label Phase||0
6252890|NCT02287584|7151515|FG001|NOT COMPLETED|the Open-label Phase||0
6252891|NCT02287584|7151516|FG002|NOT COMPLETED|the Open-label Phase||0
6252892|NCT02287584|7151517|FG003|NOT COMPLETED|the Open-label Phase||57
6252893|NCT02287584|7151518|FG004|NOT COMPLETED|the Open-label Phase||62
6252894|NCT02287584|7151519|FG005|NOT COMPLETED|the Open-label Phase||57
6252895|NCT02178566|7151535|FG000|STARTED|Overall Study||0
6252896|NCT02178566|7151536|FG001|STARTED|Overall Study|no data available|1
6252897|NCT02178566|7151535|FG000|COMPLETED|Overall Study||0
6507861|NCT01467661|7427384|FG000|Completed SPD422-308 (NCT01214915)|Overall Study||42
6507862|NCT01467661|7427384|FG000|Started SPD422-309 (NCT01467661)|Overall Study||41
6507863|NCT01467661|7427384|FG000|Started Post Marketing Trial|Overall Study||33
6507864|NCT01467661|7427384|FG000|COMPLETED|Overall Study||32
6507865|NCT01467661|7427384|FG000|NOT COMPLETED|Overall Study||21
6507866|NCT01467700|7427394|FG000|STARTED|Overall Study||115
6507867|NCT01467700|7427395|FG001|STARTED|Overall Study||128
6507868|NCT01467700|7427396|FG002|STARTED|Overall Study||124
6507869|NCT01467700|7427397|FG003|STARTED|Overall Study||123
6507870|NCT01467700|7427394|FG000|Safety Set - Received Treatment|Overall Study||115
6507871|NCT01467700|7427395|FG001|Safety Set - Received Treatment|Overall Study||127
6507872|NCT01467700|7427396|FG002|Safety Set - Received Treatment|Overall Study||124
6507873|NCT01467700|7427397|FG003|Safety Set - Received Treatment|Overall Study||123
6507874|NCT01467700|7427394|FG000|COMPLETED|Overall Study||86
6507875|NCT01467700|7427395|FG001|COMPLETED|Overall Study||100
6507876|NCT01467700|7427396|FG002|COMPLETED|Overall Study||97
6507877|NCT01467700|7427397|FG003|COMPLETED|Overall Study||96
6507878|NCT01467700|7427394|FG000|NOT COMPLETED|Overall Study||29
6507879|NCT01467700|7427395|FG001|NOT COMPLETED|Overall Study||28
6507880|NCT01467700|7427396|FG002|NOT COMPLETED|Overall Study||27
6507881|NCT01467700|7427397|FG003|NOT COMPLETED|Overall Study||27
6507882|NCT01467713|7427411|FG000|STARTED|Overall Study||164
6507883|NCT01467713|7427412|FG001|STARTED|Overall Study||164
6507884|NCT01467713|7427413|FG002|STARTED|Overall Study||160
6507885|NCT01467713|7427414|FG003|STARTED|Overall Study||154
6507886|NCT01467713|7427411|FG000|Safety Analysis Set: Received Treatment|Overall Study||163
6507887|NCT01467713|7427412|FG001|Safety Analysis Set: Received Treatment|Overall Study||164
6507888|NCT01467713|7427413|FG002|Safety Analysis Set: Received Treatment|Overall Study||159
6507889|NCT01467713|7427414|FG003|Safety Analysis Set: Received Treatment|Overall Study||154
6507890|NCT01467713|7427411|FG000|COMPLETED|Overall Study||62
6507891|NCT01467713|7427412|FG001|COMPLETED|Overall Study||60
6507892|NCT01467713|7427413|FG002|COMPLETED|Overall Study||58
6507893|NCT01467713|7427414|FG003|COMPLETED|Overall Study||45
6507894|NCT01467713|7427411|FG000|NOT COMPLETED|Overall Study||102
6507895|NCT01467713|7427412|FG001|NOT COMPLETED|Overall Study||104
6507896|NCT01467713|7427413|FG002|NOT COMPLETED|Overall Study||102
6507897|NCT01467713|7427414|FG003|NOT COMPLETED|Overall Study||109
6507898|NCT01467882|7427424|FG000|STARTED|Overall Study||44
6507899|NCT01467882|7427424|FG000|COMPLETED|Overall Study||44
6507900|NCT01467882|7427424|FG000|NOT COMPLETED|Overall Study||0
6507901|NCT01467934|7427438|FG000|STARTED|Overall Study||208
6507902|NCT01467934|7427439|FG001|STARTED|Overall Study||212
6507903|NCT01467934|7427440|FG002|STARTED|Overall Study||110
6507904|NCT01467934|7427438|FG000|COMPLETED|Overall Study||208
6507905|NCT01467934|7427439|FG001|COMPLETED|Overall Study||212
6507906|NCT01467934|7427440|FG002|COMPLETED|Overall Study||110
6507907|NCT01467934|7427438|FG000|NOT COMPLETED|Overall Study||0
6507908|NCT01467934|7427439|FG001|NOT COMPLETED|Overall Study||0
6507909|NCT01467934|7427440|FG002|NOT COMPLETED|Overall Study||0
6507910|NCT01467947|7427448|FG000|STARTED|Overall Study||46
6507911|NCT01467947|7427448|FG000|COMPLETED|Overall Study||46
6252898|NCT02178566|7151536|FG001|COMPLETED|Overall Study|no data available|0
6252899|NCT02178566|7151535|FG000|NOT COMPLETED|Overall Study||0
6252900|NCT02178566|7151536|FG001|NOT COMPLETED|Overall Study||1
6252901|NCT02173301|7151546|FG000|STARTED|Overall Study||49
6252902|NCT02173301|7151547|FG001|STARTED|Overall Study||55
6252903|NCT02173301|7151548|FG002|STARTED|Overall Study||48
6507912|NCT01467947|7427448|FG000|NOT COMPLETED|Overall Study||0
6252904|NCT02173301|7151549|FG003|STARTED|Overall Study||48
6252905|NCT02173301|7151546|FG000|COMPLETED|Overall Study||29
6252906|NCT02173301|7151547|FG001|COMPLETED|Overall Study||32
6252907|NCT02173301|7151548|FG002|COMPLETED|Overall Study||28
6252908|NCT02173301|7151549|FG003|COMPLETED|Overall Study||33
6252909|NCT02173301|7151546|FG000|NOT COMPLETED|Overall Study||20
6252910|NCT02173301|7151547|FG001|NOT COMPLETED|Overall Study||23
6252911|NCT02173301|7151548|FG002|NOT COMPLETED|Overall Study||20
6252912|NCT02173301|7151549|FG003|NOT COMPLETED|Overall Study||15
6252913|NCT02043678|7151561|FG000|STARTED|Overall Study||401
6252914|NCT02043678|7151562|FG001|STARTED|Overall Study||405
6252915|NCT02043678|7151561|FG000|Treated|Overall Study||390
6252916|NCT02043678|7151562|FG001|Treated|Overall Study||396
6252917|NCT02043678|7151561|FG000|COMPLETED|Overall Study||0
6252918|NCT02043678|7151562|FG001|COMPLETED|Overall Study||0
6252919|NCT02043678|7151561|FG000|NOT COMPLETED|Overall Study||401
6252920|NCT02043678|7151562|FG001|NOT COMPLETED|Overall Study||405
6252921|NCT01986114|7151568|FG000|STARTED|Overall Study||495
6252922|NCT01986114|7151568|FG000|COMPLETED|Overall Study||339
6252923|NCT01986114|7151568|FG000|NOT COMPLETED|Overall Study||156
6252924|NCT01986101|7151577|FG000|STARTED|Overall Study||172
6252925|NCT01986101|7151578|FG001|STARTED|Overall Study||184
6252926|NCT01986101|7151579|FG002|STARTED|Overall Study||169
6252927|NCT01986101|7151577|FG000|Intent-to-Treat Population|Overall Study||171
6252928|NCT01986101|7151578|FG001|Intent-to-Treat Population|Overall Study||182
6252929|NCT01986101|7151579|FG002|Intent-to-Treat Population|Overall Study||169
6252930|NCT01986101|7151577|FG000|Safety Population|Overall Study||172
6252931|NCT01986101|7151578|FG001|Safety Population|Overall Study||184
6252932|NCT01986101|7151579|FG002|Safety Population|Overall Study||169
6252933|NCT01986101|7151577|FG000|COMPLETED|Overall Study||139
6252934|NCT01986101|7151578|FG001|COMPLETED|Overall Study||157
6252935|NCT01986101|7151579|FG002|COMPLETED|Overall Study||137
6570444|NCT01852058|7493866|FG000|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6570445|NCT01852058|7493867|FG001|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6570446|NCT01852058|7493868|FG002|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6252936|NCT01986101|7151577|FG000|NOT COMPLETED|Overall Study||33
6252937|NCT01986101|7151578|FG001|NOT COMPLETED|Overall Study||27
6252938|NCT01986101|7151579|FG002|NOT COMPLETED|Overall Study||32
6252939|NCT01972035|7151592|FG000|STARTED|Overall Study||66
6252940|NCT01972035|7151593|FG001|STARTED|Overall Study||71
6252941|NCT01972035|7151592|FG000|COMPLETED|Overall Study||27
6252942|NCT01972035|7151593|FG001|COMPLETED|Overall Study||44
6252943|NCT01972035|7151592|FG000|NOT COMPLETED|Overall Study||39
6252944|NCT01972035|7151593|FG001|NOT COMPLETED|Overall Study||27
6252945|NCT01955980|7151601|FG000|STARTED|Overall Study||10
6252946|NCT01955980|7151602|FG001|STARTED|Overall Study||9
6252947|NCT01955980|7151601|FG000|COMPLETED|Overall Study||10
6252948|NCT01955980|7151602|FG001|COMPLETED|Overall Study||9
6252949|NCT01955980|7151601|FG000|NOT COMPLETED|Overall Study||0
6252950|NCT01955980|7151602|FG001|NOT COMPLETED|Overall Study||0
6252951|NCT01946711|7151611|FG000|STARTED|Overall Study||8
6252952|NCT01946711|7151612|FG001|STARTED|Overall Study||6
6252953|NCT01946711|7151611|FG000|COMPLETED|Overall Study||8
6252954|NCT01946711|7151612|FG001|COMPLETED|Overall Study||6
6252955|NCT01946711|7151611|FG000|NOT COMPLETED|Overall Study||0
6252956|NCT01946711|7151612|FG001|NOT COMPLETED|Overall Study||0
6252957|NCT01891994|7151618|FG000|STARTED|Overall Study||40
6252958|NCT01891994|7151618|FG000|COMPLETED|Overall Study||40
6252959|NCT01891994|7151618|FG000|NOT COMPLETED|Overall Study||0
6252960|NCT01839396|7151624|FG000|STARTED|Overall Study||121
6252961|NCT01839396|7151625|FG001|STARTED|Overall Study||39
6252962|NCT01839396|7151624|FG000|COMPLETED|Overall Study||121
6252963|NCT01839396|7151625|FG001|COMPLETED|Overall Study||39
6252964|NCT01839396|7151624|FG000|NOT COMPLETED|Overall Study||0
6252965|NCT01839396|7151625|FG001|NOT COMPLETED|Overall Study||0
6252966|NCT01813305|7151633|FG000|STARTED|Overall Study||98
6252967|NCT01813305|7151634|FG001|STARTED|Overall Study||26
6252968|NCT01813305|7151633|FG000|COMPLETED|Overall Study||63
6252969|NCT01813305|7151634|FG001|COMPLETED|Overall Study||18
6252970|NCT01813305|7151633|FG000|NOT COMPLETED|Overall Study||35
6252971|NCT01813305|7151634|FG001|NOT COMPLETED|Overall Study||8
6252972|NCT01740427|7151644|FG000|STARTED|Overall Study||444
6252973|NCT01740427|7151645|FG001|STARTED|Overall Study||222
6252974|NCT01740427|7151644|FG000|COMPLETED|Overall Study||0
6252975|NCT01740427|7151645|FG001|COMPLETED|Overall Study||0
6252976|NCT01740427|7151644|FG000|NOT COMPLETED|Overall Study||444
6252977|NCT01740427|7151645|FG001|NOT COMPLETED|Overall Study||222
6570447|NCT01852058|7493869|FG003|STARTED|Treatment Cycle2:Retreatment 1,Study 121||9
6570448|NCT01852058|7493870|FG004|STARTED|Treatment Cycle2:Retreatment 1,Study 121||45
6252978|NCT01680965|7151655|FG000|STARTED|Overall Study||3
6252979|NCT01680965|7151656|FG001|STARTED|Overall Study||3
6252980|NCT01680965|7151657|FG002|STARTED|Overall Study||6
6252981|NCT01680965|7151658|FG003|STARTED|Overall Study||32
6252982|NCT01680965|7151655|FG000|COMPLETED|Overall Study||3
6252983|NCT01680965|7151656|FG001|COMPLETED|Overall Study||3
6252984|NCT01680965|7151657|FG002|COMPLETED|Overall Study||6
6252985|NCT01680965|7151658|FG003|COMPLETED|Overall Study||26
6252986|NCT01680965|7151655|FG000|NOT COMPLETED|Overall Study||0
6252987|NCT01680965|7151656|FG001|NOT COMPLETED|Overall Study||0
6252988|NCT01680965|7151657|FG002|NOT COMPLETED|Overall Study||0
6252989|NCT01680965|7151658|FG003|NOT COMPLETED|Overall Study||6
6252990|NCT01614912|7151666|FG000|STARTED|Overall Study||284
6252991|NCT01614912|7151666|FG000|COMPLETED|Overall Study||159
6252992|NCT01614912|7151666|FG000|NOT COMPLETED|Overall Study||125
6252993|NCT01614899|7151673|FG000|STARTED|Overall Study||150
6252994|NCT01614899|7151674|FG001|STARTED|Overall Study||155
6252995|NCT01614899|7151675|FG002|STARTED|Overall Study||152
6252996|NCT01614899|7151673|FG000|COMPLETED|Overall Study||106
6252997|NCT01614899|7151674|FG001|COMPLETED|Overall Study||116
6252998|NCT01614899|7151675|FG002|COMPLETED|Overall Study||110
6252999|NCT01614899|7151673|FG000|NOT COMPLETED|Overall Study||44
6253000|NCT01614899|7151674|FG001|NOT COMPLETED|Overall Study||39
6253001|NCT01614899|7151675|FG002|NOT COMPLETED|Overall Study||42
6253002|NCT01592370|7151690|FG000|STARTED|Overall Study||105
6253003|NCT01592370|7151691|FG001|STARTED|Overall Study||65
6253004|NCT01592370|7151692|FG002|STARTED|Overall Study||72
6253005|NCT01592370|7151693|FG003|STARTED|Overall Study||6
6253006|NCT01592370|7151694|FG004|STARTED|Overall Study||5
6253007|NCT01592370|7151695|FG005|STARTED|Overall Study||41
6253008|NCT01592370|7151696|FG006|STARTED|Overall Study||22
6253009|NCT01592370|7151690|FG000|COMPLETED|Overall Study||1
6253010|NCT01592370|7151691|FG001|COMPLETED|Overall Study||40
6253011|NCT01592370|7151692|FG002|COMPLETED|Overall Study||0
6253012|NCT01592370|7151693|FG003|COMPLETED|Overall Study||1
6253013|NCT01592370|7151694|FG004|COMPLETED|Overall Study||1
6570449|NCT01852058|7493871|FG005|STARTED|Treatment Cycle2:Retreatment 1,Study 121||36
6570450|NCT01852058|7493872|FG006|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6570451|NCT01852058|7493873|FG007|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6253014|NCT01592370|7151695|FG005|COMPLETED|Overall Study||7
6253015|NCT01592370|7151696|FG006|COMPLETED|Overall Study||6
6253016|NCT01592370|7151690|FG000|NOT COMPLETED|Overall Study||104
6253017|NCT01592370|7151691|FG001|NOT COMPLETED|Overall Study||25
6253018|NCT01592370|7151692|FG002|NOT COMPLETED|Overall Study||72
6253019|NCT01592370|7151693|FG003|NOT COMPLETED|Overall Study||5
6253020|NCT01592370|7151694|FG004|NOT COMPLETED|Overall Study||4
6253021|NCT01592370|7151695|FG005|NOT COMPLETED|Overall Study||34
6253022|NCT01592370|7151696|FG006|NOT COMPLETED|Overall Study||16
6507913|NCT01467960|7427458|FG000|STARTED|Overall Study||30
6507914|NCT01467960|7427459|FG001|STARTED|Overall Study||30
6507915|NCT01467960|7427460|FG002|STARTED|Overall Study||30
6507916|NCT01467960|7427461|FG003|STARTED|Overall Study||30
6507917|NCT01467960|7427462|FG004|STARTED|Overall Study||30
6507918|NCT01467960|7427463|FG005|STARTED|Overall Study||30
6507919|NCT01467960|7427458|FG000|COMPLETED|Overall Study||30
6507920|NCT01467960|7427459|FG001|COMPLETED|Overall Study||30
6507921|NCT01467960|7427460|FG002|COMPLETED|Overall Study||30
6507922|NCT01467960|7427461|FG003|COMPLETED|Overall Study||0
6507923|NCT01467960|7427462|FG004|COMPLETED|Overall Study||0
6507924|NCT01467960|7427463|FG005|COMPLETED|Overall Study||0
6570452|NCT01852058|7493874|FG008|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6570453|NCT01852058|7493875|FG009|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6570454|NCT01852058|7493876|FG010|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6570455|NCT01852058|7493877|FG011|STARTED|Treatment Cycle2:Retreatment 1,Study 121||0
6278268|NCT00132041|7177853|FG000|NOT COMPLETED|18 Months Post Ablation||6
6507925|NCT01467960|7427458|FG000|NOT COMPLETED|Overall Study||0
6507926|NCT01467960|7427459|FG001|NOT COMPLETED|Overall Study||0
6507927|NCT01467960|7427460|FG002|NOT COMPLETED|Overall Study||0
6507928|NCT01467960|7427461|FG003|NOT COMPLETED|Overall Study||30
6507929|NCT01467960|7427462|FG004|NOT COMPLETED|Overall Study||30
6507930|NCT01467960|7427463|FG005|NOT COMPLETED|Overall Study||30
6507931|NCT01467999|7427477|FG000|STARTED|Overall Study||22
6507932|NCT01467999|7427477|FG000|COMPLETED|Overall Study||9
6507933|NCT01467999|7427477|FG000|NOT COMPLETED|Overall Study||13
6507934|NCT01468012|7427484|FG000|STARTED|Overall Study||9
6507935|NCT01468012|7427485|FG001|STARTED|Overall Study||10
6507936|NCT01468012|7427486|FG002|STARTED|Overall Study||4
6507937|NCT01468012|7427484|FG000|COMPLETED|Overall Study||7
6507938|NCT01468012|7427485|FG001|COMPLETED|Overall Study||9
6507939|NCT01468012|7427486|FG002|COMPLETED|Overall Study||0
6507940|NCT01468012|7427484|FG000|NOT COMPLETED|Overall Study||2
6507941|NCT01468012|7427485|FG001|NOT COMPLETED|Overall Study||1
6507942|NCT01468012|7427486|FG002|NOT COMPLETED|Overall Study||4
6507943|NCT01468077|7427497|FG000|STARTED|Overall Study||22
6507944|NCT01468077|7427498|FG001|STARTED|Overall Study||25
6507945|NCT01468077|7427497|FG000|COMPLETED|Overall Study||18
6507946|NCT01468077|7427498|FG001|COMPLETED|Overall Study||22
6507947|NCT01468077|7427497|FG000|NOT COMPLETED|Overall Study||4
6507948|NCT01468077|7427498|FG001|NOT COMPLETED|Overall Study||3
6507949|NCT01468181|7427509|FG000|STARTED|Overall Study||131
6507950|NCT01468181|7427510|FG001|STARTED|Overall Study||61
6507951|NCT01468181|7427511|FG002|STARTED|Overall Study||65
6507952|NCT01468181|7427512|FG003|STARTED|Overall Study||66
6507953|NCT01468181|7427513|FG004|STARTED|Overall Study||71
6507954|NCT01468181|7427509|FG000|Received at Least 1 Dose of Study Drug|Overall Study||131
6507955|NCT01468181|7427510|FG001|Received at Least 1 Dose of Study Drug|Overall Study||61
6507956|NCT01468181|7427511|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
6507957|NCT01468181|7427512|FG003|Received at Least 1 Dose of Study Drug|Overall Study||66
6507958|NCT01468181|7427513|FG004|Received at Least 1 Dose of Study Drug|Overall Study||71
6507959|NCT01468181|7427509|FG000|COMPLETED|Overall Study||121
6507960|NCT01468181|7427510|FG001|COMPLETED|Overall Study||59
6507961|NCT01468181|7427511|FG002|COMPLETED|Overall Study||57
6253023|NCT00711269|7151720|FG000|STARTED|Overall Study||131
6253024|NCT00711269|7151721|FG001|STARTED|Overall Study||131
6253025|NCT00711269|7151722|FG002|STARTED|Overall Study||133
6253026|NCT00711269|7151723|FG003|STARTED|Overall Study||65
6253027|NCT00711269|7151720|FG000|COMPLETED|Overall Study||87
6253028|NCT00711269|7151721|FG001|COMPLETED|Overall Study||83
6253029|NCT00711269|7151722|FG002|COMPLETED|Overall Study||83
6253030|NCT00711269|7151723|FG003|COMPLETED|Overall Study||51
6253031|NCT00711269|7151720|FG000|NOT COMPLETED|Overall Study||44
6253032|NCT00711269|7151721|FG001|NOT COMPLETED|Overall Study||48
6253033|NCT00711269|7151722|FG002|NOT COMPLETED|Overall Study||50
6253034|NCT00711269|7151723|FG003|NOT COMPLETED|Overall Study||14
6253035|NCT00152477|7151737|FG000|STARTED|Chemotherapy Period||50
6253036|NCT00152477|7151738|FG001|STARTED|Chemotherapy Period||56
6253037|NCT00152477|7151739|FG002|STARTED|Chemotherapy Period||59
6253038|NCT00152477|7151737|FG000|Part II|Chemotherapy Period||50
6253039|NCT00152477|7151738|FG001|Part II|Chemotherapy Period||53
6253040|NCT00152477|7151739|FG002|Part II|Chemotherapy Period||53
6253041|NCT00152477|7151737|FG000|COMPLETED|Chemotherapy Period||22
6253042|NCT00152477|7151738|FG001|COMPLETED|Chemotherapy Period||34
6253043|NCT00152477|7151739|FG002|COMPLETED|Chemotherapy Period||39
6253044|NCT00152477|7151737|FG000|NOT COMPLETED|Chemotherapy Period||28
6253045|NCT00152477|7151738|FG001|NOT COMPLETED|Chemotherapy Period||22
6253046|NCT00152477|7151739|FG002|NOT COMPLETED|Chemotherapy Period||20
6253047|NCT00152477|7151737|FG000|STARTED|Monotherapy Period|7 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|15
6253048|NCT00152477|7151738|FG001|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|29
6253049|NCT00152477|7151739|FG002|STARTED|Monotherapy Period|5 subjects completed the Chemotherapy period but did not enter the Monotherapy period.|34
6253050|NCT00152477|7151737|FG000|Part II|Monotherapy Period||13
6253051|NCT00152477|7151738|FG001|Part II|Monotherapy Period||26
6253052|NCT00152477|7151739|FG002|Part II|Monotherapy Period||29
6253053|NCT00152477|7151737|FG000|COMPLETED|Monotherapy Period||0
6253054|NCT00152477|7151738|FG001|COMPLETED|Monotherapy Period||0
6253055|NCT00152477|7151739|FG002|COMPLETED|Monotherapy Period||0
6253056|NCT00152477|7151737|FG000|NOT COMPLETED|Monotherapy Period||15
6253057|NCT00152477|7151738|FG001|NOT COMPLETED|Monotherapy Period||29
6253058|NCT00152477|7151739|FG002|NOT COMPLETED|Monotherapy Period||34
6253059|NCT04471935|7151750|FG000|STARTED|Overall Study||10
6253060|NCT04471935|7151750|FG000|COMPLETED|Overall Study||8
6253061|NCT04471935|7151750|FG000|NOT COMPLETED|Overall Study||2
6253062|NCT04439344|7151754|FG000|STARTED|Overall Study||53
6253063|NCT04439344|7151754|FG000|Started Protocol Therapy|Overall Study||50
6253064|NCT04439344|7151754|FG000|Eligible|Overall Study||47
6253065|NCT04439344|7151754|FG000|COMPLETED|Overall Study||0
6253066|NCT04439344|7151754|FG000|NOT COMPLETED|Overall Study||53
6253067|NCT04439279|7151758|FG000|STARTED|Overall Study||35
6253068|NCT04439279|7151758|FG000|Started Protocol Therapy|Overall Study||35
6253069|NCT04439279|7151758|FG000|Eligible|Overall Study||33
6253070|NCT04439279|7151758|FG000|Reported Adverse Events Data|Overall Study|Adverse event was not assessed on one patient before discontinuing therapy due to withdraw/refusal|34
6253071|NCT04439279|7151758|FG000|COMPLETED|Overall Study|Treatment continued until disease progression or intolerability.|0
6253072|NCT04439279|7151758|FG000|NOT COMPLETED|Overall Study||35
6253073|NCT04439123|7151762|FG000|STARTED|Overall Study|All 35 patients enrolled were eligible and treated in the arm|35
6253074|NCT04439123|7151762|FG000|COMPLETED|Overall Study||0
6253075|NCT04439123|7151762|FG000|NOT COMPLETED|Overall Study||35
6253076|NCT04439110|7151766|FG000|STARTED|Overall Study||38
6253077|NCT04439110|7151766|FG000|Eligible|Overall Study||36
6253078|NCT04439110|7151766|FG000|COMPLETED|Overall Study||0
6253079|NCT04439110|7151766|FG000|NOT COMPLETED|Overall Study||38
6253089|NCT04697693|7151783|FG000|STARTED|Overall Study|Actual date on which the first participant was enrolled.|1
6253090|NCT04697693|7151783|FG000|COMPLETED|Overall Study||1
6253091|NCT04697693|7151783|FG000|NOT COMPLETED|Overall Study||0
6253092|NCT04551677|7151790|FG000|STARTED|Overall Study||29
6253093|NCT04551677|7151791|FG001|STARTED|Overall Study||31
6253094|NCT04551677|7151792|FG002|STARTED|Overall Study||30
6253095|NCT04551677|7151790|FG000|Vaccinated|Overall Study||29
6253096|NCT04551677|7151791|FG001|Vaccinated|Overall Study||31
6253097|NCT04551677|7151792|FG002|Vaccinated|Overall Study||30
6253098|NCT04551677|7151790|FG000|COMPLETED|Overall Study||29
6253099|NCT04551677|7151791|FG001|COMPLETED|Overall Study||31
6253100|NCT04551677|7151792|FG002|COMPLETED|Overall Study||30
6253101|NCT04551677|7151790|FG000|NOT COMPLETED|Overall Study||0
6253102|NCT04551677|7151791|FG001|NOT COMPLETED|Overall Study||0
6253103|NCT04551677|7151792|FG002|NOT COMPLETED|Overall Study||0
6253104|NCT04498832|7151802|FG000|STARTED|Overall Study||1049
6253105|NCT04498832|7151803|FG001|STARTED|Overall Study||1051
6253106|NCT04498832|7151802|FG000|COMPLETED|Overall Study||1048
6253107|NCT04498832|7151803|FG001|COMPLETED|Overall Study||1047
6253108|NCT04498832|7151802|FG000|NOT COMPLETED|Overall Study||1
6253109|NCT04498832|7151803|FG001|NOT COMPLETED|Overall Study||4
6253110|NCT04109222|7151812|FG000|STARTED|Overall Study||30
6253111|NCT04109222|7151813|FG001|STARTED|Overall Study||30
6253112|NCT04109222|7151814|FG002|STARTED|Overall Study||30
6253113|NCT04109222|7151812|FG000|COMPLETED|Overall Study||29
6253114|NCT04109222|7151813|FG001|COMPLETED|Overall Study||30
6253115|NCT04109222|7151814|FG002|COMPLETED|Overall Study||30
6253116|NCT04109222|7151812|FG000|NOT COMPLETED|Overall Study||1
6253117|NCT04109222|7151813|FG001|NOT COMPLETED|Overall Study||0
6253080|NCT04180540|7151772|FG000|STARTED|Overall Study||55
6253081|NCT04180540|7151773|FG001|STARTED|Overall Study||54
6253082|NCT04180540|7151772|FG000|COMPLETED|Overall Study||53
6253083|NCT04180540|7151773|FG001|COMPLETED|Overall Study||54
6253084|NCT04180540|7151772|FG000|NOT COMPLETED|Overall Study||2
6253085|NCT04180540|7151773|FG001|NOT COMPLETED|Overall Study||0
6253086|NCT03912298|7151779|FG000|STARTED|Overall Study||7
6253087|NCT03912298|7151779|FG000|COMPLETED|Overall Study||7
6253088|NCT03912298|7151779|FG000|NOT COMPLETED|Overall Study||0
6253118|NCT04109222|7151814|FG002|NOT COMPLETED|Overall Study||0
6253119|NCT04046939|7151826|FG000|STARTED|Screening Period||534
6253120|NCT04046939|7151827|FG001|STARTED|Screening Period||0
6253121|NCT04046939|7151828|FG002|STARTED|Screening Period||0
6253122|NCT04046939|7151829|FG003|STARTED|Screening Period||0
6253123|NCT04046939|7151826|FG000|Received Placebo During Run-In Period|Screening Period||144
6253124|NCT04046939|7151827|FG001|Received Placebo During Run-In Period|Screening Period||0
6253125|NCT04046939|7151828|FG002|Received Placebo During Run-In Period|Screening Period||0
6253126|NCT04046939|7151829|FG003|Received Placebo During Run-In Period|Screening Period||0
6253127|NCT04046939|7151826|FG000|COMPLETED|Screening Period||103
6253128|NCT04046939|7151827|FG001|COMPLETED|Screening Period||0
6253129|NCT04046939|7151828|FG002|COMPLETED|Screening Period||0
6253130|NCT04046939|7151829|FG003|COMPLETED|Screening Period||0
6253131|NCT04046939|7151826|FG000|NOT COMPLETED|Screening Period||431
6253132|NCT04046939|7151827|FG001|NOT COMPLETED|Screening Period||0
6253133|NCT04046939|7151828|FG002|NOT COMPLETED|Screening Period||0
6253134|NCT04046939|7151829|FG003|NOT COMPLETED|Screening Period||0
6253135|NCT04046939|7151826|FG000|STARTED|Primary Assessment Period||27
6253136|NCT04046939|7151827|FG001|STARTED|Primary Assessment Period||22
6253137|NCT04046939|7151828|FG002|STARTED|Primary Assessment Period||26
6253138|NCT04046939|7151829|FG003|STARTED|Primary Assessment Period||28
6253139|NCT04046939|7151826|FG000|COMPLETED|Primary Assessment Period||25
6253140|NCT04046939|7151827|FG001|COMPLETED|Primary Assessment Period||22
6507962|NCT01468181|7427512|FG003|COMPLETED|Overall Study||63
6507963|NCT01468181|7427513|FG004|COMPLETED|Overall Study||66
6507964|NCT01468181|7427509|FG000|NOT COMPLETED|Overall Study||10
6507965|NCT01468181|7427510|FG001|NOT COMPLETED|Overall Study||2
6507966|NCT01468181|7427511|FG002|NOT COMPLETED|Overall Study||8
6507967|NCT01468181|7427512|FG003|NOT COMPLETED|Overall Study||3
6507968|NCT01468181|7427513|FG004|NOT COMPLETED|Overall Study||5
6507969|NCT01468207|7427527|FG000|STARTED|Treatment Period 1||154
6507970|NCT01468207|7427528|FG001|STARTED|Treatment Period 1||153
6507971|NCT01468207|7427529|FG002|STARTED|Treatment Period 1||0
6507972|NCT01468207|7427530|FG003|STARTED|Treatment Period 1||0
6507973|NCT01468207|7427531|FG004|STARTED|Treatment Period 1||0
6507974|NCT01468207|7427532|FG005|STARTED|Treatment Period 1||0
6507975|NCT01468207|7427527|FG000|Received Study Drug|Treatment Period 1||152
6507976|NCT01468207|7427528|FG001|Received Study Drug|Treatment Period 1||153
6507977|NCT01468207|7427529|FG002|Received Study Drug|Treatment Period 1||0
6507978|NCT01468207|7427530|FG003|Received Study Drug|Treatment Period 1||0
6507979|NCT01468207|7427531|FG004|Received Study Drug|Treatment Period 1||0
6507980|NCT01468207|7427532|FG005|Received Study Drug|Treatment Period 1||0
6507981|NCT01468207|7427527|FG000|COMPLETED|Treatment Period 1||145
6507982|NCT01468207|7427528|FG001|COMPLETED|Treatment Period 1||145
6507983|NCT01468207|7427529|FG002|COMPLETED|Treatment Period 1||0
6507984|NCT01468207|7427530|FG003|COMPLETED|Treatment Period 1||0
6507985|NCT01468207|7427531|FG004|COMPLETED|Treatment Period 1||0
6507986|NCT01468207|7427532|FG005|COMPLETED|Treatment Period 1||0
6507987|NCT01468207|7427527|FG000|NOT COMPLETED|Treatment Period 1||9
6507988|NCT01468207|7427528|FG001|NOT COMPLETED|Treatment Period 1||8
6507989|NCT01468207|7427529|FG002|NOT COMPLETED|Treatment Period 1||0
6507990|NCT01468207|7427530|FG003|NOT COMPLETED|Treatment Period 1||0
6507991|NCT01468207|7427531|FG004|NOT COMPLETED|Treatment Period 1||0
6507992|NCT01468207|7427532|FG005|NOT COMPLETED|Treatment Period 1||0
6507993|NCT01468207|7427527|FG000|STARTED|Treatment Period 2||0
6507994|NCT01468207|7427528|FG001|STARTED|Treatment Period 2||0
6507995|NCT01468207|7427529|FG002|STARTED|Treatment Period 2||145
6507996|NCT01468207|7427530|FG003|STARTED|Treatment Period 2||49
6507997|NCT01468207|7427531|FG004|STARTED|Treatment Period 2||48
6507998|NCT01468207|7427532|FG005|STARTED|Treatment Period 2||48
6507999|NCT01468207|7427527|FG000|COMPLETED|Treatment Period 2||0
6508000|NCT01468207|7427528|FG001|COMPLETED|Treatment Period 2||0
6508001|NCT01468207|7427529|FG002|COMPLETED|Treatment Period 2||93
6508002|NCT01468207|7427530|FG003|COMPLETED|Treatment Period 2||22
6508003|NCT01468207|7427531|FG004|COMPLETED|Treatment Period 2||27
6253141|NCT04046939|7151828|FG002|COMPLETED|Primary Assessment Period||24
6253142|NCT04046939|7151829|FG003|COMPLETED|Primary Assessment Period||28
6253143|NCT04046939|7151826|FG000|NOT COMPLETED|Primary Assessment Period||2
6508004|NCT01468207|7427532|FG005|COMPLETED|Treatment Period 2||28
6508005|NCT01468207|7427527|FG000|NOT COMPLETED|Treatment Period 2||0
6508006|NCT01468207|7427528|FG001|NOT COMPLETED|Treatment Period 2||0
6508007|NCT01468207|7427529|FG002|NOT COMPLETED|Treatment Period 2||52
6508008|NCT01468207|7427530|FG003|NOT COMPLETED|Treatment Period 2||27
6508009|NCT01468207|7427531|FG004|NOT COMPLETED|Treatment Period 2||21
6508010|NCT01468207|7427532|FG005|NOT COMPLETED|Treatment Period 2||20
6508011|NCT01468233|7427552|FG000|STARTED|Treatment Period 1||163
6508012|NCT01468233|7427553|FG001|STARTED|Treatment Period 1||163
6508013|NCT01468233|7427554|FG002|STARTED|Treatment Period 1||0
6253144|NCT04046939|7151827|FG001|NOT COMPLETED|Primary Assessment Period||0
6253145|NCT04046939|7151828|FG002|NOT COMPLETED|Primary Assessment Period||2
6508014|NCT01468233|7427555|FG003|STARTED|Treatment Period 1||0
6508015|NCT01468233|7427556|FG004|STARTED|Treatment Period 1||0
6508016|NCT01468233|7427557|FG005|STARTED|Treatment Period 1||0
6508017|NCT01468233|7427552|FG000|COMPLETED|Treatment Period 1||151
6508018|NCT01468233|7427553|FG001|COMPLETED|Treatment Period 1||155
6508019|NCT01468233|7427554|FG002|COMPLETED|Treatment Period 1||0
6508020|NCT01468233|7427555|FG003|COMPLETED|Treatment Period 1||0
6508021|NCT01468233|7427556|FG004|COMPLETED|Treatment Period 1||0
6508022|NCT01468233|7427557|FG005|COMPLETED|Treatment Period 1||0
6508023|NCT01468233|7427552|FG000|NOT COMPLETED|Treatment Period 1||12
6508024|NCT01468233|7427553|FG001|NOT COMPLETED|Treatment Period 1||8
6508025|NCT01468233|7427554|FG002|NOT COMPLETED|Treatment Period 1||0
6508026|NCT01468233|7427555|FG003|NOT COMPLETED|Treatment Period 1||0
6508027|NCT01468233|7427556|FG004|NOT COMPLETED|Treatment Period 1||0
6508028|NCT01468233|7427557|FG005|NOT COMPLETED|Treatment Period 1||0
6508029|NCT01468233|7427552|FG000|STARTED|Treatment Period 2||0
6508030|NCT01468233|7427553|FG001|STARTED|Treatment Period 2||0
6508031|NCT01468233|7427554|FG002|STARTED|Treatment Period 2||151
6508032|NCT01468233|7427555|FG003|STARTED|Treatment Period 2||51
6508033|NCT01468233|7427556|FG004|STARTED|Treatment Period 2||53
6508034|NCT01468233|7427557|FG005|STARTED|Treatment Period 2||51
6508035|NCT01468233|7427552|FG000|COMPLETED|Treatment Period 2||0
6508036|NCT01468233|7427553|FG001|COMPLETED|Treatment Period 2||0
6508037|NCT01468233|7427554|FG002|COMPLETED|Treatment Period 2||40
6508038|NCT01468233|7427555|FG003|COMPLETED|Treatment Period 2||23
6508039|NCT01468233|7427556|FG004|COMPLETED|Treatment Period 2||25
6508040|NCT01468233|7427557|FG005|COMPLETED|Treatment Period 2||28
6508041|NCT01468233|7427552|FG000|NOT COMPLETED|Treatment Period 2||0
6508042|NCT01468233|7427553|FG001|NOT COMPLETED|Treatment Period 2||0
6508043|NCT01468233|7427554|FG002|NOT COMPLETED|Treatment Period 2||111
6508044|NCT01468233|7427555|FG003|NOT COMPLETED|Treatment Period 2||28
6508045|NCT01468233|7427556|FG004|NOT COMPLETED|Treatment Period 2||28
6508046|NCT01468233|7427557|FG005|NOT COMPLETED|Treatment Period 2||23
6508047|NCT01468311|7427575|FG000|STARTED|Overall Study||6
6508048|NCT01468311|7427575|FG000|COMPLETED|Overall Study||4
6508049|NCT01468311|7427575|FG000|NOT COMPLETED|Overall Study||2
6508050|NCT01468337|7427579|FG000|STARTED|Overall Study||5
6508051|NCT01468337|7427579|FG000|Week 2|Overall Study||5
6508052|NCT01468337|7427579|FG000|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
6508053|NCT01468337|7427579|FG000|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
6508054|NCT01468337|7427579|FG000|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
6508055|NCT01468337|7427579|FG000|COMPLETED|Overall Study||5
6508056|NCT01468337|7427579|FG000|NOT COMPLETED|Overall Study||0
6508057|NCT01468350|7427587|FG000|STARTED|(PART A) Day 1, Day 3||6
6508058|NCT01468350|7427588|FG001|STARTED|(PART A) Day 1, Day 3||5
6508059|NCT01468350|7427589|FG002|STARTED|(PART A) Day 1, Day 3||0
6508060|NCT01468350|7427590|FG003|STARTED|(PART A) Day 1, Day 3||0
6508061|NCT01468350|7427587|FG000|COMPLETED|(PART A) Day 1, Day 3||6
6508062|NCT01468350|7427588|FG001|COMPLETED|(PART A) Day 1, Day 3||5
6508063|NCT01468350|7427589|FG002|COMPLETED|(PART A) Day 1, Day 3||0
6508064|NCT01468350|7427590|FG003|COMPLETED|(PART A) Day 1, Day 3||0
6508065|NCT01468350|7427587|FG000|NOT COMPLETED|(PART A) Day 1, Day 3||0
6508066|NCT01468350|7427588|FG001|NOT COMPLETED|(PART A) Day 1, Day 3||0
6508067|NCT01468350|7427589|FG002|NOT COMPLETED|(PART A) Day 1, Day 3||0
6508068|NCT01468350|7427590|FG003|NOT COMPLETED|(PART A) Day 1, Day 3||0
6508069|NCT01468350|7427587|FG000|STARTED|(PART B) Day 1, Day 15||0
6508070|NCT01468350|7427588|FG001|STARTED|(PART B) Day 1, Day 15||0
6508071|NCT01468350|7427589|FG002|STARTED|(PART B) Day 1, Day 15||12
6508072|NCT01468350|7427590|FG003|STARTED|(PART B) Day 1, Day 15||12
6508073|NCT01468350|7427587|FG000|COMPLETED|(PART B) Day 1, Day 15||0
6508074|NCT01468350|7427588|FG001|COMPLETED|(PART B) Day 1, Day 15||0
6508075|NCT01468350|7427589|FG002|COMPLETED|(PART B) Day 1, Day 15||12
6508076|NCT01468350|7427590|FG003|COMPLETED|(PART B) Day 1, Day 15||12
6508077|NCT01468350|7427587|FG000|NOT COMPLETED|(PART B) Day 1, Day 15||0
6508078|NCT01468350|7427588|FG001|NOT COMPLETED|(PART B) Day 1, Day 15||0
6508079|NCT01468350|7427589|FG002|NOT COMPLETED|(PART B) Day 1, Day 15||0
6508080|NCT01468350|7427590|FG003|NOT COMPLETED|(PART B) Day 1, Day 15||0
6508081|NCT01468454|7427600|FG000|STARTED|Overall Study||128
6508082|NCT01468454|7427600|FG000|PETs Completed|Overall Study||128
6508083|NCT01468454|7427600|FG000|Had Both PET and Surgery|Overall Study||119
6508084|NCT01468454|7427600|FG000|COMPLETED|Overall Study||119
6508085|NCT01468454|7427600|FG000|NOT COMPLETED|Overall Study||9
6508086|NCT01468532|7427605|FG000|STARTED|Overall Study||18
6508087|NCT01468532|7427605|FG000|COMPLETED|Overall Study||18
6508088|NCT01468532|7427605|FG000|NOT COMPLETED|Overall Study||0
6508089|NCT01468558|7427609|FG000|STARTED|Overall Study||24
6508090|NCT01468558|7427609|FG000|COMPLETED|Overall Study||22
6508091|NCT01468558|7427609|FG000|NOT COMPLETED|Overall Study||2
6508092|NCT01468584|7427617|FG000|STARTED|Overall Study||10
6508093|NCT01468584|7427617|FG000|COMPLETED|Overall Study||10
6508094|NCT01468584|7427617|FG000|NOT COMPLETED|Overall Study||0
6508095|NCT01468597|7427621|FG000|STARTED|Overall Study||184
6508096|NCT01468597|7427621|FG000|COMPLETED|Overall Study||149
6253146|NCT04046939|7151829|FG003|NOT COMPLETED|Primary Assessment Period||0
6253147|NCT04046939|7151826|FG000|STARTED|Eosinophil Recovery Period||25
6253148|NCT04046939|7151827|FG001|STARTED|Eosinophil Recovery Period||22
6253149|NCT04046939|7151828|FG002|STARTED|Eosinophil Recovery Period||24
6253150|NCT04046939|7151829|FG003|STARTED|Eosinophil Recovery Period||28
6253151|NCT04046939|7151826|FG000|COMPLETED|Eosinophil Recovery Period||24
6253152|NCT04046939|7151827|FG001|COMPLETED|Eosinophil Recovery Period||22
6253153|NCT04046939|7151828|FG002|COMPLETED|Eosinophil Recovery Period||24
6253154|NCT04046939|7151829|FG003|COMPLETED|Eosinophil Recovery Period||27
6253155|NCT04046939|7151826|FG000|NOT COMPLETED|Eosinophil Recovery Period||1
6253156|NCT04046939|7151827|FG001|NOT COMPLETED|Eosinophil Recovery Period||0
6253157|NCT04046939|7151828|FG002|NOT COMPLETED|Eosinophil Recovery Period||0
6253158|NCT04046939|7151829|FG003|NOT COMPLETED|Eosinophil Recovery Period||1
6253159|NCT03912259|7151847|FG000|STARTED|Overall Study||83
6508097|NCT01468597|7427621|FG000|NOT COMPLETED|Overall Study||35
6508098|NCT01468675|7427627|FG000|STARTED|Overall Study||2699
6508099|NCT01468675|7427628|FG001|STARTED|Overall Study||3376
6508100|NCT01468675|7427627|FG000|COMPLETED|Overall Study||1699
6508101|NCT01468675|7427628|FG001|COMPLETED|Overall Study||2004
6508102|NCT01468675|7427627|FG000|NOT COMPLETED|Overall Study||1000
6508103|NCT01468675|7427628|FG001|NOT COMPLETED|Overall Study||1372
6508104|NCT01468701|7427651|FG000|STARTED|Overall Study||4964
6508105|NCT01468701|7427652|FG001|STARTED|Overall Study||5103
6508106|NCT01468701|7427653|FG002|STARTED|Overall Study||1784
6508107|NCT01468701|7427654|FG003|STARTED|Overall Study||715
6508108|NCT01468701|7427655|FG004|STARTED|Overall Study||1736
6508109|NCT01468701|7427656|FG005|STARTED|Overall Study||128
6508110|NCT01468701|7427657|FG006|STARTED|Overall Study||1209
6570456|NCT01852058|7493866|FG000|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570457|NCT01852058|7493867|FG001|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6253160|NCT03912259|7151848|FG001|STARTED|Overall Study||82
6253161|NCT03912259|7151847|FG000|COMPLETED|Overall Study||66
6253162|NCT03912259|7151848|FG001|COMPLETED|Overall Study||76
6508111|NCT01468701|7427658|FG007|STARTED|Overall Study||5
6508112|NCT01468701|7427659|FG008|STARTED|Overall Study||3879
6508113|NCT01468701|7427660|FG009|STARTED|Overall Study||4962
6508114|NCT01468701|7427661|FG010|STARTED|Overall Study||4054
6508115|NCT01468701|7427662|FG011|STARTED|Overall Study||4538
6508116|NCT01468701|7427663|FG012|STARTED|Overall Study||333
6508117|NCT01468701|7427664|FG013|STARTED|Overall Study||2182
6508118|NCT01468701|7427665|FG014|STARTED|Overall Study||214
6508119|NCT01468701|7427666|FG015|STARTED|Overall Study||1418
6508120|NCT01468701|7427667|FG016|STARTED|Overall Study||11
6508121|NCT01468701|7427651|FG000|All Eligible Patient|Overall Study||4873
6508122|NCT01468701|7427652|FG001|All Eligible Patient|Overall Study||4963
6508123|NCT01468701|7427653|FG002|All Eligible Patient|Overall Study||1755
6508124|NCT01468701|7427654|FG003|All Eligible Patient|Overall Study||703
6508125|NCT01468701|7427655|FG004|All Eligible Patient|Overall Study||1714
6508126|NCT01468701|7427656|FG005|All Eligible Patient|Overall Study||126
6508127|NCT01468701|7427657|FG006|All Eligible Patient|Overall Study||1170
6508128|NCT01468701|7427658|FG007|All Eligible Patient|Overall Study||4
6508129|NCT01468701|7427659|FG008|All Eligible Patient|Overall Study||3839
6508130|NCT01468701|7427660|FG009|All Eligible Patient|Overall Study||4836
6508131|NCT01468701|7427661|FG010|All Eligible Patient|Overall Study||4015
6508132|NCT01468701|7427662|FG011|All Eligible Patient|Overall Study||4505
6508133|NCT01468701|7427663|FG012|All Eligible Patient|Overall Study||332
6508134|NCT01468701|7427664|FG013|All Eligible Patient|Overall Study||2163
6508135|NCT01468701|7427665|FG014|All Eligible Patient|Overall Study||213
6508136|NCT01468701|7427666|FG015|All Eligible Patient|Overall Study||1386
6508137|NCT01468701|7427667|FG016|All Eligible Patient|Overall Study||11
6508138|NCT01468701|7427651|FG000|COMPLETED|Overall Study||3965
6508139|NCT01468701|7427652|FG001|COMPLETED|Overall Study||0
6508140|NCT01468701|7427653|FG002|COMPLETED|Overall Study||0
6508141|NCT01468701|7427654|FG003|COMPLETED|Overall Study||0
6508142|NCT01468701|7427655|FG004|COMPLETED|Overall Study||0
6508143|NCT01468701|7427656|FG005|COMPLETED|Overall Study||0
6508144|NCT01468701|7427657|FG006|COMPLETED|Overall Study||0
6508145|NCT01468701|7427658|FG007|COMPLETED|Overall Study||0
6508146|NCT01468701|7427659|FG008|COMPLETED|Overall Study||3219
6508147|NCT01468701|7427660|FG009|COMPLETED|Overall Study||3780
6508148|NCT01468701|7427661|FG010|COMPLETED|Overall Study||3256
6508149|NCT01468701|7427662|FG011|COMPLETED|Overall Study||3672
6508150|NCT01468701|7427663|FG012|COMPLETED|Overall Study||284
6508151|NCT01468701|7427664|FG013|COMPLETED|Overall Study||1712
6508152|NCT01468701|7427665|FG014|COMPLETED|Overall Study||151
6508153|NCT01468701|7427666|FG015|COMPLETED|Overall Study||1056
6508154|NCT01468701|7427667|FG016|COMPLETED|Overall Study||10
6508155|NCT01468701|7427651|FG000|NOT COMPLETED|Overall Study||999
6508156|NCT01468701|7427652|FG001|NOT COMPLETED|Overall Study||5103
6508157|NCT01468701|7427653|FG002|NOT COMPLETED|Overall Study||1784
6508158|NCT01468701|7427654|FG003|NOT COMPLETED|Overall Study||715
6508159|NCT01468701|7427655|FG004|NOT COMPLETED|Overall Study||1736
6508160|NCT01468701|7427656|FG005|NOT COMPLETED|Overall Study||128
6508161|NCT01468701|7427657|FG006|NOT COMPLETED|Overall Study||1209
6508162|NCT01468701|7427658|FG007|NOT COMPLETED|Overall Study||5
6508163|NCT01468701|7427659|FG008|NOT COMPLETED|Overall Study||660
6508164|NCT01468701|7427660|FG009|NOT COMPLETED|Overall Study||1182
6253163|NCT03912259|7151847|FG000|NOT COMPLETED|Overall Study||17
6253164|NCT03912259|7151848|FG001|NOT COMPLETED|Overall Study||6
6253165|NCT03890367|7151858|FG000|STARTED|Overall Study||232
6253166|NCT03890367|7151859|FG001|STARTED|Overall Study||235
6253167|NCT03890367|7151860|FG002|STARTED|Overall Study||240
6253168|NCT03890367|7151858|FG000|Safety Analysis Set|Overall Study||230
6253169|NCT03890367|7151859|FG001|Safety Analysis Set|Overall Study||232
6253170|NCT03890367|7151860|FG002|Safety Analysis Set|Overall Study||239
6253171|NCT03890367|7151858|FG000|COMPLETED|Overall Study||228
6253172|NCT03890367|7151859|FG001|COMPLETED|Overall Study||229
6253173|NCT03890367|7151860|FG002|COMPLETED|Overall Study||239
6253174|NCT03890367|7151858|FG000|NOT COMPLETED|Overall Study||4
6253175|NCT03890367|7151859|FG001|NOT COMPLETED|Overall Study||6
6253176|NCT03890367|7151860|FG002|NOT COMPLETED|Overall Study||1
6253177|NCT03784898|7151868|FG000|STARTED|Overall Study||13
6253178|NCT03784898|7151868|FG000|COMPLETED|Overall Study||13
6253179|NCT03784898|7151868|FG000|NOT COMPLETED|Overall Study||0
6278269|NCT00132132|7177865|FG000|STARTED|Overall Study||15
6278270|NCT00132132|7177866|FG001|STARTED|Overall Study||15
6278271|NCT00132132|7177865|FG000|COMPLETED|Overall Study||8
6278272|NCT00132132|7177866|FG001|COMPLETED|Overall Study||13
6278273|NCT00132132|7177865|FG000|NOT COMPLETED|Overall Study||7
6278274|NCT00132132|7177866|FG001|NOT COMPLETED|Overall Study||2
6278275|NCT00132301|7177874|FG000|STARTED|Overall Study||141
6278276|NCT00132301|7177875|FG001|STARTED|Overall Study||157
6278277|NCT00132301|7177874|FG000|COMPLETED|Overall Study||121
6278278|NCT00132301|7177875|FG001|COMPLETED|Overall Study||144
6278279|NCT00132301|7177874|FG000|NOT COMPLETED|Overall Study||20
6278280|NCT00132301|7177875|FG001|NOT COMPLETED|Overall Study||13
6278281|NCT00132314|7177883|FG000|STARTED|Overall Study||190
6278282|NCT00132314|7177884|FG001|STARTED|Overall Study||192
6278283|NCT00132314|7177883|FG000|Received Treatment|Overall Study||188
6278284|NCT00132314|7177884|FG001|Received Treatment|Overall Study||185
6278285|NCT00132314|7177883|FG000|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
6278286|NCT00132314|7177884|FG001|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
6278287|NCT00132314|7177883|FG000|COMPLETED|Overall Study||117
6278288|NCT00132314|7177884|FG001|COMPLETED|Overall Study||120
6278289|NCT00132314|7177883|FG000|NOT COMPLETED|Overall Study||73
6278290|NCT00132314|7177884|FG001|NOT COMPLETED|Overall Study||72
6278291|NCT00132496|7177892|FG000|STARTED|Overall Study||54
6278292|NCT00132496|7177893|FG001|STARTED|Overall Study||57
6278293|NCT00132496|7177892|FG000|COMPLETED|Overall Study||52
6278294|NCT00132496|7177893|FG001|COMPLETED|Overall Study||55
6278295|NCT00132496|7177892|FG000|NOT COMPLETED|Overall Study||2
6278296|NCT00132496|7177893|FG001|NOT COMPLETED|Overall Study||2
6278297|NCT00132678|7177901|FG000|STARTED|Period II (Open-Label Oral Risperidone)||0
6278298|NCT00132678|7177902|FG001|STARTED|Period II (Open-Label Oral Risperidone)||0
6278299|NCT00132678|7177903|FG002|STARTED|Period II (Open-Label Oral Risperidone)||440
6278300|NCT00132678|7177901|FG000|COMPLETED|Period II (Open-Label Oral Risperidone)||0
6278301|NCT00132678|7177902|FG001|COMPLETED|Period II (Open-Label Oral Risperidone)||0
6278302|NCT00132678|7177903|FG002|COMPLETED|Period II (Open-Label Oral Risperidone)||382
6278303|NCT00132678|7177901|FG000|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
6278304|NCT00132678|7177902|FG001|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
6278305|NCT00132678|7177903|FG002|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
6278306|NCT00132678|7177901|FG000|STARTED|Period III (Open-Label Stabilization)||501
6508165|NCT01468701|7427661|FG010|NOT COMPLETED|Overall Study||798
6508166|NCT01468701|7427662|FG011|NOT COMPLETED|Overall Study||866
6508167|NCT01468701|7427663|FG012|NOT COMPLETED|Overall Study||49
6508168|NCT01468701|7427664|FG013|NOT COMPLETED|Overall Study||470
6508169|NCT01468701|7427665|FG014|NOT COMPLETED|Overall Study||63
6508170|NCT01468701|7427666|FG015|NOT COMPLETED|Overall Study||362
6508171|NCT01468701|7427667|FG016|NOT COMPLETED|Overall Study||1
6508172|NCT01468818|7427680|FG000|STARTED|Overall Study||18
6508173|NCT01468818|7427680|FG000|COMPLETED|Overall Study||16
6508174|NCT01468818|7427680|FG000|NOT COMPLETED|Overall Study||2
6508175|NCT01468844|7427686|FG000|STARTED|Overall Study||4
6508176|NCT01468844|7427687|FG001|STARTED|Overall Study||2
6508177|NCT01468844|7427686|FG000|COMPLETED|Overall Study||2
6508178|NCT01468844|7427687|FG001|COMPLETED|Overall Study||2
6508179|NCT01468844|7427686|FG000|NOT COMPLETED|Overall Study||2
6508180|NCT01468844|7427687|FG001|NOT COMPLETED|Overall Study||0
6508181|NCT01468909|7427698|FG000|STARTED|Overall Study||52
6508182|NCT01468909|7427699|FG001|STARTED|Overall Study||54
6508183|NCT01468909|7427698|FG000|COMPLETED|Overall Study||50
6508184|NCT01468909|7427699|FG001|COMPLETED|Overall Study||52
6508185|NCT01468909|7427698|FG000|NOT COMPLETED|Overall Study||2
6508186|NCT01468909|7427699|FG001|NOT COMPLETED|Overall Study||2
6508187|NCT01468974|7427705|FG000|STARTED|1 Month Follow-up|Intent-to-treat (ITT) population|35
6508188|NCT01468974|7427705|FG000|COMPLETED|1 Month Follow-up||34
6508189|NCT01468974|7427705|FG000|NOT COMPLETED|1 Month Follow-up||1
6508190|NCT01468974|7427705|FG000|STARTED|6 Months Follow-up||34
6508191|NCT01468974|7427705|FG000|COMPLETED|6 Months Follow-up||34
6508192|NCT01468974|7427705|FG000|NOT COMPLETED|6 Months Follow-up||0
6278307|NCT00132678|7177902|FG001|STARTED|Period III (Open-Label Stabilization)||0
6278308|NCT00132678|7177903|FG002|STARTED|Period III (Open-Label Stabilization)||0
6278309|NCT00132678|7177901|FG000|COMPLETED|Period III (Open-Label Stabilization)||303
6278310|NCT00132678|7177902|FG001|COMPLETED|Period III (Open-Label Stabilization)||0
6253180|NCT03607422|7151878|FG000|STARTED|Overall Study||242
6253181|NCT03607422|7151879|FG001|STARTED|Overall Study||243
6253182|NCT03607422|7151880|FG002|STARTED|Overall Study||247
6253183|NCT03607422|7151881|FG003|STARTED|Overall Study||60
6253184|NCT03607422|7151882|FG004|STARTED|Overall Study||58
6253185|NCT03607422|7151883|FG005|STARTED|Overall Study||62
6253186|NCT03607422|7151878|FG000|COMPLETED|Overall Study||204
6253187|NCT03607422|7151879|FG001|COMPLETED|Overall Study||233
6253188|NCT03607422|7151880|FG002|COMPLETED|Overall Study||235
6253189|NCT03607422|7151881|FG003|COMPLETED|Overall Study||55
6253190|NCT03607422|7151882|FG004|COMPLETED|Overall Study||55
6253191|NCT03607422|7151883|FG005|COMPLETED|Overall Study||59
6253192|NCT03607422|7151878|FG000|NOT COMPLETED|Overall Study||38
6253193|NCT03607422|7151879|FG001|NOT COMPLETED|Overall Study||10
6253194|NCT03607422|7151880|FG002|NOT COMPLETED|Overall Study||12
6253195|NCT03607422|7151881|FG003|NOT COMPLETED|Overall Study||5
6253196|NCT03607422|7151882|FG004|NOT COMPLETED|Overall Study||3
6253197|NCT03607422|7151883|FG005|NOT COMPLETED|Overall Study||3
6253198|NCT03600805|7151901|FG000|STARTED|Overall Study||28
6253199|NCT03600805|7151902|FG001|STARTED|Overall Study||14
6253200|NCT03600805|7151903|FG002|STARTED|Overall Study||14
6253201|NCT03600805|7151904|FG003|STARTED|Overall Study||27
6253202|NCT03600805|7151901|FG000|Week 52 Analysis Set Population|Overall Study||10
6253203|NCT03600805|7151902|FG001|Week 52 Analysis Set Population|Overall Study||6
6253204|NCT03600805|7151903|FG002|Week 52 Analysis Set Population|Overall Study||7
6253205|NCT03600805|7151904|FG003|Week 52 Analysis Set Population|Overall Study||13
6253206|NCT03600805|7151901|FG000|COMPLETED|Overall Study||9
6253207|NCT03600805|7151902|FG001|COMPLETED|Overall Study||6
6253208|NCT03600805|7151903|FG002|COMPLETED|Overall Study||6
6253209|NCT03600805|7151904|FG003|COMPLETED|Overall Study||8
6253210|NCT03600805|7151901|FG000|NOT COMPLETED|Overall Study||19
6253211|NCT03600805|7151902|FG001|NOT COMPLETED|Overall Study||8
6253212|NCT03600805|7151903|FG002|NOT COMPLETED|Overall Study||8
6253213|NCT03600805|7151904|FG003|NOT COMPLETED|Overall Study||19
6253214|NCT03584724|7151918|FG000|STARTED|Overall Study||25
6253215|NCT03584724|7151919|FG001|STARTED|Overall Study||24
6253216|NCT03584724|7151918|FG000|COMPLETED|Overall Study||18
6253217|NCT03584724|7151919|FG001|COMPLETED|Overall Study||23
6253218|NCT03584724|7151918|FG000|NOT COMPLETED|Overall Study||7
6253219|NCT03584724|7151919|FG001|NOT COMPLETED|Overall Study||1
6253220|NCT03434119|7151927|FG000|STARTED|Overall Study||116
6253221|NCT03434119|7151928|FG001|STARTED|Overall Study||125
6253222|NCT03434119|7151927|FG000|Treated|Overall Study||115
6253223|NCT03434119|7151928|FG001|Treated|Overall Study||125
6253224|NCT03434119|7151927|FG000|COMPLETED|Overall Study||9
6253225|NCT03434119|7151928|FG001|COMPLETED|Overall Study||12
6253226|NCT03434119|7151927|FG000|NOT COMPLETED|Overall Study||107
6253227|NCT03434119|7151928|FG001|NOT COMPLETED|Overall Study||113
6253228|NCT03417245|7151936|FG000|STARTED|Overall Study||40
6253229|NCT03417245|7151937|FG001|STARTED|Overall Study||80
6253230|NCT03417245|7151936|FG000|Treated|Overall Study||40
6253231|NCT03417245|7151937|FG001|Treated|Overall Study||79
6253232|NCT03417245|7151936|FG000|COMPLETED|Overall Study||37
6253233|NCT03417245|7151937|FG001|COMPLETED|Overall Study||79
6253234|NCT03417245|7151936|FG000|NOT COMPLETED|Overall Study||3
6253235|NCT03417245|7151937|FG001|NOT COMPLETED|Overall Study||1
6253236|NCT03417102|7151945|FG000|STARTED|Overall Study||19
6253237|NCT03417102|7151946|FG001|STARTED|Overall Study||38
6253238|NCT03417102|7151945|FG000|Safety Analysis Set|Overall Study||19
6253239|NCT03417102|7151946|FG001|Safety Analysis Set|Overall Study|3 participants were non-randomized but treated with Fitusiran considered in this arm for safety.|41
6253240|NCT03417102|7151945|FG000|COMPLETED|Overall Study||19
6253241|NCT03417102|7151946|FG001|COMPLETED|Overall Study||33
6253242|NCT03417102|7151945|FG000|NOT COMPLETED|Overall Study||0
6253243|NCT03417102|7151946|FG001|NOT COMPLETED|Overall Study||5
6253244|NCT03402230|7151952|FG000|STARTED|Overall Study||25
6253245|NCT03402230|7151953|FG001|STARTED|Overall Study||24
6253246|NCT03402230|7151952|FG000|COMPLETED|Overall Study||25
6253247|NCT03402230|7151953|FG001|COMPLETED|Overall Study||23
6253248|NCT03402230|7151952|FG000|NOT COMPLETED|Overall Study||0
6508193|NCT01468974|7427705|FG000|STARTED|1 Year Follow-up||34
6508194|NCT01468974|7427705|FG000|COMPLETED|1 Year Follow-up||34
6508195|NCT01468974|7427705|FG000|NOT COMPLETED|1 Year Follow-up||0
6508196|NCT01468974|7427705|FG000|STARTED|2 Years Follow-up||34
6508197|NCT01468974|7427705|FG000|COMPLETED|2 Years Follow-up||32
6508198|NCT01468974|7427705|FG000|NOT COMPLETED|2 Years Follow-up||2
6253249|NCT03402230|7151953|FG001|NOT COMPLETED|Overall Study||1
6253250|NCT03278626|7151958|FG000|STARTED|Overall Study||12
6253251|NCT03278626|7151958|FG000|COMPLETED|Overall Study||7
6253252|NCT03278626|7151958|FG000|NOT COMPLETED|Overall Study||5
6253253|NCT03211858|7151964|FG000|STARTED|Overall Study||301
6253254|NCT03211858|7151965|FG001|STARTED|Overall Study||296
6253255|NCT03211858|7151964|FG000|Treated|Overall Study||301
6253256|NCT03211858|7151965|FG001|Treated|Overall Study||296
6253257|NCT03211858|7151964|FG000|COMPLETED|Overall Study||264
6253258|NCT03211858|7151965|FG001|COMPLETED|Overall Study||263
6253259|NCT03211858|7151964|FG000|NOT COMPLETED|Overall Study||37
6253260|NCT03211858|7151965|FG001|NOT COMPLETED|Overall Study||33
6253261|NCT03093480|7151975|FG000|STARTED|Overall Study||16
6253262|NCT03093480|7151975|FG000|Tapering Period|Overall Study||10
6253263|NCT03093480|7151975|FG000|Follow-up Period|Overall Study||10
6253264|NCT03093480|7151975|FG000|COMPLETED|Overall Study||16
6253265|NCT03093480|7151975|FG000|NOT COMPLETED|Overall Study||0
6253266|NCT03077438|7151981|FG000|STARTED|Overall Study||499
6253267|NCT03077438|7151982|FG001|STARTED|Overall Study||501
6658096|NCT02476357|7588643|FG001|COMPLETED|Overall Study||40
6658097|NCT02476357|7588642|FG000|NOT COMPLETED|Overall Study||0
6658098|NCT02476357|7588643|FG001|NOT COMPLETED|Overall Study||0
6508199|NCT01468974|7427705|FG000|STARTED|3 Years Follow-up||32
6508200|NCT01468974|7427705|FG000|COMPLETED|3 Years Follow-up||26
6508201|NCT01468974|7427705|FG000|NOT COMPLETED|3 Years Follow-up||6
6508202|NCT01468987|7427711|FG000|STARTED|Overall Study||691
6508203|NCT01468987|7427712|FG001|STARTED|Overall Study||678
6508204|NCT01468987|7427711|FG000|Received at Least 1 Dose of Study Drug|Overall Study||691
6508205|NCT01468987|7427712|FG001|Received at Least 1 Dose of Study Drug|Overall Study||677
6508206|NCT01468987|7427711|FG000|COMPLETED|Overall Study||620
6508207|NCT01468987|7427712|FG001|COMPLETED|Overall Study||618
6508208|NCT01468987|7427711|FG000|NOT COMPLETED|Overall Study||71
6508209|NCT01468987|7427712|FG001|NOT COMPLETED|Overall Study||60
6508210|NCT01469000|7427722|FG000|STARTED|Overall Study||129
6508211|NCT01469000|7427723|FG001|STARTED|Overall Study||66
6508212|NCT01469000|7427722|FG000|Received at Least 1 Dose of Study Drug|Overall Study||126
6508213|NCT01469000|7427723|FG001|Received at Least 1 Dose of Study Drug|Overall Study||65
6508214|NCT01469000|7427722|FG000|COMPLETED|Overall Study||109
6508215|NCT01469000|7427723|FG001|COMPLETED|Overall Study||62
6508216|NCT01469000|7427722|FG000|NOT COMPLETED|Overall Study||20
6508217|NCT01469000|7427723|FG001|NOT COMPLETED|Overall Study||4
6508218|NCT01469013|7427734|FG000|STARTED|Part A (Treatment Period)||24
6508219|NCT01469013|7427735|FG001|STARTED|Part A (Treatment Period)||24
6508220|NCT01469013|7427736|FG002|STARTED|Part A (Treatment Period)||24
6508221|NCT01469013|7427737|FG003|STARTED|Part A (Treatment Period)||24
6508222|NCT01469013|7427738|FG004|STARTED|Part A (Treatment Period)||49
6508223|NCT01469013|7427739|FG005|STARTED|Part A (Treatment Period)||0
6570458|NCT01852058|7493868|FG002|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570459|NCT01852058|7493869|FG003|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||8
6570460|NCT01852058|7493870|FG004|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||38
6570461|NCT01852058|7493871|FG005|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||27
6570462|NCT01852058|7493872|FG006|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570463|NCT01852058|7493873|FG007|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570464|NCT01852058|7493874|FG008|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570465|NCT01852058|7493875|FG009|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570466|NCT01852058|7493876|FG010|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570467|NCT01852058|7493877|FG011|COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570468|NCT01852058|7493866|FG000|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570469|NCT01852058|7493867|FG001|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570470|NCT01852058|7493868|FG002|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570471|NCT01852058|7493869|FG003|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||1
6570472|NCT01852058|7493870|FG004|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||7
6570473|NCT01852058|7493871|FG005|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||9
6570474|NCT01852058|7493872|FG006|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570475|NCT01852058|7493873|FG007|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570476|NCT01852058|7493874|FG008|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570477|NCT01852058|7493875|FG009|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570478|NCT01852058|7493876|FG010|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570479|NCT01852058|7493877|FG011|NOT COMPLETED|Treatment Cycle2:Retreatment 1,Study 121||0
6570480|NCT01852058|7493866|FG000|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570481|NCT01852058|7493867|FG001|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570482|NCT01852058|7493868|FG002|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570483|NCT01852058|7493869|FG003|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570484|NCT01852058|7493870|FG004|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570485|NCT01852058|7493871|FG005|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570486|NCT01852058|7493872|FG006|STARTED|Treatment Cycle3:Retreatment 2,Study 121||5
6570487|NCT01852058|7493873|FG007|STARTED|Treatment Cycle3:Retreatment 2,Study 121||16
6570488|NCT01852058|7493874|FG008|STARTED|Treatment Cycle3:Retreatment 2,Study 121||34
6570489|NCT01852058|7493875|FG009|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570490|NCT01852058|7493876|FG010|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570491|NCT01852058|7493877|FG011|STARTED|Treatment Cycle3:Retreatment 2,Study 121||0
6570492|NCT01852058|7493866|FG000|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570493|NCT01852058|7493867|FG001|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570494|NCT01852058|7493868|FG002|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6658099|NCT02476422|7588653|FG000|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
6658100|NCT02476422|7588654|FG001|STARTED|Overall Study||162
6658101|NCT02476422|7588653|FG000|COMPLETED|Overall Study||166
6253268|NCT03077438|7151981|FG000|Safety Analysis Set (SafAS)|Overall Study||498
6253269|NCT03077438|7151982|FG001|Safety Analysis Set (SafAS)|Overall Study||494
6253270|NCT03077438|7151981|FG000|COMPLETED|Overall Study||487
6253271|NCT03077438|7151982|FG001|COMPLETED|Overall Study||487
6253272|NCT03077438|7151981|FG000|NOT COMPLETED|Overall Study||12
6253273|NCT03077438|7151982|FG001|NOT COMPLETED|Overall Study||14
6253274|NCT03045653|7151992|FG000|STARTED|Overall Study||30
6253275|NCT03045653|7151992|FG000|COMPLETED|Overall Study||30
6253276|NCT03045653|7151992|FG000|NOT COMPLETED|Overall Study||0
6253277|NCT02948959|7151998|FG000|STARTED|52 Weeks Treatment Period||135
6253278|NCT02948959|7151999|FG001|STARTED|52 Weeks Treatment Period||273
6253279|NCT02948959|7151998|FG000|Treated|52 Weeks Treatment Period||135
6253280|NCT02948959|7151999|FG001|Treated|52 Weeks Treatment Period||270
6253281|NCT02948959|7151998|FG000|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|134
6253282|NCT02948959|7151999|FG001|Safety Population|52 Weeks Treatment Period|1 participant randomized to placebo received dupilumab; counted in dupilumab arm for safety analysis.|271
6253283|NCT02948959|7151998|FG000|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||114
6253284|NCT02948959|7151999|FG001|Type 2 Inflammatory Asthma Phenotype Population|52 Weeks Treatment Period||236
6253285|NCT02948959|7151998|FG000|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||84
6253286|NCT02948959|7151999|FG001|Baseline Blood Eosinophils Count >=300 Cells Per Microlitre Population|52 Weeks Treatment Period||175
6253287|NCT02948959|7151998|FG000|COMPLETED|52 Weeks Treatment Period||130
6253288|NCT02948959|7151999|FG001|COMPLETED|52 Weeks Treatment Period||248
6253289|NCT02948959|7151998|FG000|NOT COMPLETED|52 Weeks Treatment Period||5
6253290|NCT02948959|7151999|FG001|NOT COMPLETED|52 Weeks Treatment Period||25
6508224|NCT01469013|7427740|FG006|STARTED|Part A (Treatment Period)||0
6508225|NCT01469013|7427741|FG007|STARTED|Part A (Treatment Period)||0
6508226|NCT01469013|7427742|FG008|STARTED|Part A (Treatment Period)||0
6508227|NCT01469013|7427743|FG009|STARTED|Part A (Treatment Period)||0
6508228|NCT01469013|7427744|FG010|STARTED|Part A (Treatment Period)||0
6508229|NCT01469013|7427745|FG011|STARTED|Part A (Treatment Period)||0
6508230|NCT01469013|7427746|FG012|STARTED|Part A (Treatment Period)||0
6508231|NCT01469013|7427734|FG000|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
6508232|NCT01469013|7427735|FG001|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
6508233|NCT01469013|7427736|FG002|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
6508234|NCT01469013|7427737|FG003|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||24
6508235|NCT01469013|7427738|FG004|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||49
6508236|NCT01469013|7427739|FG005|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6508237|NCT01469013|7427740|FG006|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6508238|NCT01469013|7427741|FG007|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6508239|NCT01469013|7427742|FG008|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6508240|NCT01469013|7427743|FG009|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6508241|NCT01469013|7427744|FG010|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6508242|NCT01469013|7427745|FG011|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6508243|NCT01469013|7427746|FG012|Received at Least 1 Dose of Study Drug|Part A (Treatment Period)||0
6508244|NCT01469013|7427734|FG000|COMPLETED|Part A (Treatment Period)||23
6508245|NCT01469013|7427735|FG001|COMPLETED|Part A (Treatment Period)||24
6508246|NCT01469013|7427736|FG002|COMPLETED|Part A (Treatment Period)||23
6508247|NCT01469013|7427737|FG003|COMPLETED|Part A (Treatment Period)||24
6508248|NCT01469013|7427738|FG004|COMPLETED|Part A (Treatment Period)||48
6508249|NCT01469013|7427739|FG005|COMPLETED|Part A (Treatment Period)||0
6508250|NCT01469013|7427740|FG006|COMPLETED|Part A (Treatment Period)||0
6508251|NCT01469013|7427741|FG007|COMPLETED|Part A (Treatment Period)||0
6570495|NCT01852058|7493869|FG003|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570496|NCT01852058|7493870|FG004|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570497|NCT01852058|7493871|FG005|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570498|NCT01852058|7493872|FG006|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||5
6570499|NCT01852058|7493873|FG007|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||15
6570500|NCT01852058|7493874|FG008|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||33
6570501|NCT01852058|7493875|FG009|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570502|NCT01852058|7493876|FG010|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570503|NCT01852058|7493877|FG011|COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570504|NCT01852058|7493866|FG000|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570505|NCT01852058|7493867|FG001|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570506|NCT01852058|7493868|FG002|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570507|NCT01852058|7493869|FG003|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570508|NCT01852058|7493870|FG004|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570509|NCT01852058|7493871|FG005|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570510|NCT01852058|7493872|FG006|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570511|NCT01852058|7493873|FG007|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
6570512|NCT01852058|7493874|FG008|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||1
6570513|NCT01852058|7493875|FG009|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570514|NCT01852058|7493876|FG010|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570515|NCT01852058|7493877|FG011|NOT COMPLETED|Treatment Cycle3:Retreatment 2,Study 121||0
6570516|NCT01852058|7493866|FG000|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6570517|NCT01852058|7493867|FG001|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6570518|NCT01852058|7493868|FG002|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6570519|NCT01852058|7493869|FG003|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6570520|NCT01852058|7493870|FG004|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6570521|NCT01852058|7493871|FG005|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6253291|NCT02948959|7151998|FG000|STARTED|12 Weeks Follow-up Period||9
6253292|NCT02948959|7151999|FG001|STARTED|12 Weeks Follow-up Period||31
6253293|NCT02948959|7151998|FG000|COMPLETED|12 Weeks Follow-up Period||4
6253294|NCT02948959|7151999|FG001|COMPLETED|12 Weeks Follow-up Period||19
6253295|NCT02948959|7151998|FG000|NOT COMPLETED|12 Weeks Follow-up Period||5
6253296|NCT02948959|7151999|FG001|NOT COMPLETED|12 Weeks Follow-up Period||12
6253297|NCT02878603|7152015|FG000|STARTED|Overall Study||29
6253298|NCT02878603|7152016|FG001|STARTED|Overall Study||75
6253299|NCT02878603|7152015|FG000|COMPLETED|Overall Study||23
6253300|NCT02878603|7152016|FG001|COMPLETED|Overall Study||70
6253301|NCT02878603|7152015|FG000|NOT COMPLETED|Overall Study||6
6253302|NCT02878603|7152016|FG001|NOT COMPLETED|Overall Study||5
6253303|NCT02864407|7152022|FG000|STARTED|Overall Study||3223
6253304|NCT02864407|7152022|FG000|Effectiveness Analysis Set|Overall Study||2105
6253305|NCT02864407|7152022|FG000|Long-term Safety Analysis Set|Overall Study||813
6253306|NCT02864407|7152022|FG000|Long-term Effectiveness Analysis Set|Overall Study||767
6253307|NCT02864407|7152022|FG000|COMPLETED|Overall Study||3100
6253308|NCT02864407|7152022|FG000|NOT COMPLETED|Overall Study||123
6253309|NCT02846532|7152029|FG000|STARTED|Overall Study||12
6253310|NCT02846532|7152030|FG001|STARTED|Overall Study||66
6253311|NCT02846532|7152031|FG002|STARTED|Overall Study||34
6253312|NCT02846532|7152029|FG000|COMPLETED|Overall Study||11
6253313|NCT02846532|7152030|FG001|COMPLETED|Overall Study||63
6253314|NCT02846532|7152031|FG002|COMPLETED|Overall Study||33
6253315|NCT02846532|7152029|FG000|NOT COMPLETED|Overall Study||1
6253316|NCT02846532|7152030|FG001|NOT COMPLETED|Overall Study||3
6253317|NCT02846532|7152031|FG002|NOT COMPLETED|Overall Study||1
6253318|NCT02688933|7152041|FG000|STARTED|Overall Study||320
6253319|NCT02688933|7152042|FG001|STARTED|Overall Study||318
6253320|NCT02688933|7152041|FG000|COMPLETED|Overall Study||291
6253321|NCT02688933|7152042|FG001|COMPLETED|Overall Study||281
6253322|NCT02688933|7152041|FG000|NOT COMPLETED|Overall Study||29
6253323|NCT02688933|7152042|FG001|NOT COMPLETED|Overall Study||37
6278311|NCT00132678|7177903|FG002|COMPLETED|Period III (Open-Label Stabilization)||0
6278312|NCT00132678|7177901|FG000|NOT COMPLETED|Period III (Open-Label Stabilization)||198
6278313|NCT00132678|7177902|FG001|NOT COMPLETED|Period III (Open-Label Stabilization)||0
6278314|NCT00132678|7177903|FG002|NOT COMPLETED|Period III (Open-Label Stabilization)||0
6278315|NCT00132678|7177901|FG000|STARTED|Period IV (Double-Blind Treatment)||154
6278316|NCT00132678|7177902|FG001|STARTED|Period IV (Double-Blind Treatment)||149
6278317|NCT00132678|7177903|FG002|STARTED|Period IV (Double-Blind Treatment)||0
6278318|NCT00132678|7177901|FG000|COMPLETED|Period IV (Double-Blind Treatment)||117
6278319|NCT00132678|7177902|FG001|COMPLETED|Period IV (Double-Blind Treatment)||109
6570522|NCT01852058|7493872|FG006|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6570523|NCT01852058|7493873|FG007|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6278320|NCT00132678|7177903|FG002|COMPLETED|Period IV (Double-Blind Treatment)||0
6278321|NCT00132678|7177901|FG000|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
6278322|NCT00132678|7177902|FG001|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
6278323|NCT00132678|7177903|FG002|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
6278324|NCT00132691|7177913|FG000|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
6278325|NCT00132691|7177914|FG001|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
6278326|NCT00132691|7177913|FG000|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
6278327|NCT00132691|7177914|FG001|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
6278328|NCT00132691|7177913|FG000|NOT COMPLETED|Overall Study||11
6278329|NCT00132691|7177914|FG001|NOT COMPLETED|Overall Study||12
6278330|NCT00132730|7177929|FG000|STARTED|Period I - Placebo Run-in (Base)||150
6278331|NCT00132730|7177930|FG001|STARTED|Period I - Placebo Run-in (Base)||148
6278332|NCT00132730|7177931|FG002|STARTED|Period I - Placebo Run-in (Base)||153
6278333|NCT00132730|7177932|FG003|STARTED|Period I - Placebo Run-in (Base)||153
6278334|NCT00132730|7177933|FG004|STARTED|Period I - Placebo Run-in (Base)||0
6278335|NCT00132730|7177934|FG005|STARTED|Period I - Placebo Run-in (Base)||0
6278336|NCT00132730|7177929|FG000|COMPLETED|Period I - Placebo Run-in (Base)||150
6278337|NCT00132730|7177930|FG001|COMPLETED|Period I - Placebo Run-in (Base)||148
6278338|NCT00132730|7177931|FG002|COMPLETED|Period I - Placebo Run-in (Base)||153
6278339|NCT00132730|7177932|FG003|COMPLETED|Period I - Placebo Run-in (Base)||153
6278340|NCT00132730|7177933|FG004|COMPLETED|Period I - Placebo Run-in (Base)||0
6278341|NCT00132730|7177934|FG005|COMPLETED|Period I - Placebo Run-in (Base)||0
6278342|NCT00132730|7177929|FG000|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6278343|NCT00132730|7177930|FG001|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6278344|NCT00132730|7177931|FG002|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6278345|NCT00132730|7177932|FG003|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6278346|NCT00132730|7177933|FG004|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6278347|NCT00132730|7177934|FG005|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
6278348|NCT00132730|7177929|FG000|STARTED|Period II - 12-week Treatment (Base)||150
6278349|NCT00132730|7177930|FG001|STARTED|Period II - 12-week Treatment (Base)||148
6278350|NCT00132730|7177931|FG002|STARTED|Period II - 12-week Treatment (Base)||153
6278351|NCT00132730|7177932|FG003|STARTED|Period II - 12-week Treatment (Base)||153
6278352|NCT00132730|7177933|FG004|STARTED|Period II - 12-week Treatment (Base)||0
6570524|NCT01852058|7493874|FG008|STARTED|Treatment Cycle4:Retreatment 3,Study 121||0
6570525|NCT01852058|7493875|FG009|STARTED|Treatment Cycle4:Retreatment 3,Study 121||3
6253324|NCT02550197|7152050|FG000|STARTED|Overall Study||200
6253325|NCT02550197|7152051|FG001|STARTED|Overall Study||100
6253326|NCT02550197|7152050|FG000|COMPLETED|Overall Study||200
6253327|NCT02550197|7152051|FG001|COMPLETED|Overall Study||100
6253328|NCT02550197|7152050|FG000|NOT COMPLETED|Overall Study||0
6253329|NCT02550197|7152051|FG001|NOT COMPLETED|Overall Study||0
6253330|NCT02492165|7152061|FG000|STARTED|Overall Study||100
6253331|NCT02492165|7152062|FG001|STARTED|Overall Study||60
6253332|NCT02492165|7152063|FG002|STARTED|Overall Study||60
6253333|NCT02492165|7152064|FG003|STARTED|Overall Study||30
6253334|NCT02492165|7152061|FG000|COMPLETED|Overall Study||100
6253335|NCT02492165|7152062|FG001|COMPLETED|Overall Study||59
6253336|NCT02492165|7152063|FG002|COMPLETED|Overall Study||60
6253337|NCT02492165|7152064|FG003|COMPLETED|Overall Study||30
6253338|NCT02492165|7152061|FG000|NOT COMPLETED|Overall Study||0
6253339|NCT02492165|7152062|FG001|NOT COMPLETED|Overall Study||1
6253340|NCT02492165|7152063|FG002|NOT COMPLETED|Overall Study||0
6253341|NCT02492165|7152064|FG003|NOT COMPLETED|Overall Study||0
6253342|NCT02476006|7152074|FG000|STARTED|Overall Study||998
6253343|NCT02476006|7152074|FG000|Treated|Overall Study||994
6253344|NCT02476006|7152074|FG000|COMPLETED|Overall Study||878
6253345|NCT02476006|7152074|FG000|NOT COMPLETED|Overall Study||120
6253346|NCT02468414|7152080|FG000|STARTED|Overall Study||3
6253347|NCT02468414|7152081|FG001|STARTED|Overall Study||0
6253348|NCT02468414|7152080|FG000|Successfully Screened|Overall Study||2
6253349|NCT02468414|7152081|FG001|Successfully Screened|Overall Study||0
6253350|NCT02468414|7152080|FG000|Harvesting|Overall Study||1
6253351|NCT02468414|7152081|FG001|Harvesting|Overall Study||0
6253352|NCT02468414|7152080|FG000|Implantation|Overall Study||1
6253353|NCT02468414|7152081|FG001|Implantation|Overall Study||0
6253354|NCT02468414|7152080|FG000|Safety Follow-up|Overall Study||0
6253355|NCT02468414|7152081|FG001|Safety Follow-up|Overall Study||0
6253356|NCT02468414|7152080|FG000|COMPLETED|Overall Study||0
6253357|NCT02468414|7152081|FG001|COMPLETED|Overall Study||0
6253358|NCT02468414|7152080|FG000|NOT COMPLETED|Overall Study||3
6253359|NCT02468414|7152081|FG001|NOT COMPLETED|Overall Study||0
6253360|NCT02462876|7152087|FG000|STARTED|Overall Study||60
6508252|NCT01469013|7427742|FG008|COMPLETED|Part A (Treatment Period)||0
6508253|NCT01469013|7427743|FG009|COMPLETED|Part A (Treatment Period)||0
6508254|NCT01469013|7427744|FG010|COMPLETED|Part A (Treatment Period)||0
6508255|NCT01469013|7427745|FG011|COMPLETED|Part A (Treatment Period)||0
6508256|NCT01469013|7427746|FG012|COMPLETED|Part A (Treatment Period)||0
6508257|NCT01469013|7427734|FG000|NOT COMPLETED|Part A (Treatment Period)||1
6508258|NCT01469013|7427735|FG001|NOT COMPLETED|Part A (Treatment Period)||0
6508259|NCT01469013|7427736|FG002|NOT COMPLETED|Part A (Treatment Period)||1
6508260|NCT01469013|7427737|FG003|NOT COMPLETED|Part A (Treatment Period)||0
6508261|NCT01469013|7427738|FG004|NOT COMPLETED|Part A (Treatment Period)||1
6508262|NCT01469013|7427739|FG005|NOT COMPLETED|Part A (Treatment Period)||0
6508263|NCT01469013|7427740|FG006|NOT COMPLETED|Part A (Treatment Period)||0
6508264|NCT01469013|7427741|FG007|NOT COMPLETED|Part A (Treatment Period)||0
6508265|NCT01469013|7427742|FG008|NOT COMPLETED|Part A (Treatment Period)||0
6508266|NCT01469013|7427743|FG009|NOT COMPLETED|Part A (Treatment Period)||0
6508267|NCT01469013|7427744|FG010|NOT COMPLETED|Part A (Treatment Period)||0
6508268|NCT01469013|7427745|FG011|NOT COMPLETED|Part A (Treatment Period)||0
6508269|NCT01469013|7427746|FG012|NOT COMPLETED|Part A (Treatment Period)||0
6508270|NCT01469013|7427734|FG000|STARTED|Part B (Extension Period)||0
6508271|NCT01469013|7427735|FG001|STARTED|Part B (Extension Period)||0
6508272|NCT01469013|7427736|FG002|STARTED|Part B (Extension Period)||0
6508273|NCT01469013|7427737|FG003|STARTED|Part B (Extension Period)||0
6508274|NCT01469013|7427738|FG004|STARTED|Part B (Extension Period)||0
6508275|NCT01469013|7427739|FG005|STARTED|Part B (Extension Period)||12
6508276|NCT01469013|7427740|FG006|STARTED|Part B (Extension Period)||12
6508277|NCT01469013|7427741|FG007|STARTED|Part B (Extension Period)||23
6508278|NCT01469013|7427742|FG008|STARTED|Part B (Extension Period)||24
6508279|NCT01469013|7427743|FG009|STARTED|Part B (Extension Period)||11
6508280|NCT01469013|7427744|FG010|STARTED|Part B (Extension Period)||12
6508281|NCT01469013|7427745|FG011|STARTED|Part B (Extension Period)||24
6508282|NCT01469013|7427746|FG012|STARTED|Part B (Extension Period)||24
6508283|NCT01469013|7427734|FG000|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6508284|NCT01469013|7427735|FG001|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6508285|NCT01469013|7427736|FG002|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6508286|NCT01469013|7427737|FG003|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6508287|NCT01469013|7427738|FG004|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||0
6508288|NCT01469013|7427739|FG005|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
6508289|NCT01469013|7427740|FG006|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
6253361|NCT02462876|7152087|FG000|COMPLETED|Overall Study||33
6253362|NCT02462876|7152087|FG000|NOT COMPLETED|Overall Study||27
6253363|NCT02332590|7152093|FG000|STARTED|DB Period (up to 24 Weeks)||185
6253364|NCT02332590|7152094|FG001|STARTED|DB Period (up to 24 Weeks)||184
6253365|NCT02332590|7152093|FG000|Treated|DB Period (up to 24 Weeks)||184
6253366|NCT02332590|7152094|FG001|Treated|DB Period (up to 24 Weeks)||184
6253367|NCT02332590|7152093|FG000|COMPLETED|DB Period (up to 24 Weeks)|155 participants entered OLE period and 1 did not enroll.|156
6253368|NCT02332590|7152094|FG001|COMPLETED|DB Period (up to 24 Weeks)||165
6253369|NCT02332590|7152093|FG000|NOT COMPLETED|DB Period (up to 24 Weeks)||29
6253370|NCT02332590|7152094|FG001|NOT COMPLETED|DB Period (up to 24 Weeks)||19
6253371|NCT02332590|7152093|FG000|STARTED|OLE Period (Week 24 up to Week 300)||155
6253372|NCT02332590|7152094|FG001|STARTED|OLE Period (Week 24 up to Week 300)||165
6253373|NCT02332590|7152093|FG000|COMPLETED|OLE Period (Week 24 up to Week 300)||108
6253374|NCT02332590|7152094|FG001|COMPLETED|OLE Period (Week 24 up to Week 300)||120
6253375|NCT02332590|7152093|FG000|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||47
6253376|NCT02332590|7152094|FG001|NOT COMPLETED|OLE Period (Week 24 up to Week 300)||45
6253377|NCT02255656|7152102|FG000|STARTED|Overall Study||1062
6253378|NCT02255656|7152102|FG000|COMPLETED|Overall Study||592
6253379|NCT02255656|7152102|FG000|NOT COMPLETED|Overall Study||470
6253380|NCT02134028|7152121|FG000|STARTED|Overall Study||111
6253381|NCT02134028|7152122|FG001|STARTED|Overall Study||421
6253382|NCT02134028|7152123|FG002|STARTED|Overall Study||517
6253383|NCT02134028|7152124|FG003|STARTED|Overall Study||1013
6253384|NCT02134028|7152125|FG004|STARTED|Overall Study||97
6253385|NCT02134028|7152126|FG005|STARTED|Overall Study||90
6253386|NCT02134028|7152127|FG006|STARTED|Overall Study||19
6253387|NCT02134028|7152128|FG007|STARTED|Overall Study||14
6253388|NCT02134028|7152121|FG000|COMPLETED|Overall Study||102
6253389|NCT02134028|7152122|FG001|COMPLETED|Overall Study||379
6253390|NCT02134028|7152123|FG002|COMPLETED|Overall Study||465
6253391|NCT02134028|7152124|FG003|COMPLETED|Overall Study||908
6253392|NCT02134028|7152125|FG004|COMPLETED|Overall Study||83
6253393|NCT02134028|7152126|FG005|COMPLETED|Overall Study||76
6253394|NCT02134028|7152127|FG006|COMPLETED|Overall Study||15
6253395|NCT02134028|7152128|FG007|COMPLETED|Overall Study||11
6253396|NCT02134028|7152121|FG000|NOT COMPLETED|Overall Study||9
6253397|NCT02134028|7152122|FG001|NOT COMPLETED|Overall Study||42
6253398|NCT02134028|7152123|FG002|NOT COMPLETED|Overall Study||52
6253399|NCT02134028|7152124|FG003|NOT COMPLETED|Overall Study||105
6253400|NCT02134028|7152125|FG004|NOT COMPLETED|Overall Study||14
6253401|NCT02134028|7152126|FG005|NOT COMPLETED|Overall Study||14
6253402|NCT02134028|7152127|FG006|NOT COMPLETED|Overall Study||4
6253403|NCT02134028|7152128|FG007|NOT COMPLETED|Overall Study||3
6253404|NCT02037620|7152148|FG000|STARTED|Overall Study||5
6253405|NCT02037620|7152148|FG000|COMPLETED|Overall Study||4
6253406|NCT02037620|7152148|FG000|NOT COMPLETED|Overall Study||1
6253407|NCT01902173|7152158|FG000|STARTED|Phase 1 Doublet Regimen Cohort 1||3
6253408|NCT01902173|7152159|FG001|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6253409|NCT01902173|7152160|FG002|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6253410|NCT01902173|7152161|FG003|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6253411|NCT01902173|7152162|FG004|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6253412|NCT01902173|7152163|FG005|STARTED|Phase 1 Doublet Regimen Cohort 1||0
6253413|NCT01902173|7152158|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253414|NCT01902173|7152159|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253415|NCT01902173|7152160|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253416|NCT01902173|7152161|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253417|NCT01902173|7152162|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253418|NCT01902173|7152163|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253419|NCT01902173|7152158|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||3
6253420|NCT01902173|7152159|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253421|NCT01902173|7152160|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253422|NCT01902173|7152161|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253423|NCT01902173|7152162|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253424|NCT01902173|7152163|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 1||0
6253425|NCT01902173|7152158|FG000|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6253426|NCT01902173|7152159|FG001|STARTED|Phase 1 Doublet Regimen Cohort 2||9
6253427|NCT01902173|7152160|FG002|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6253428|NCT01902173|7152161|FG003|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6253429|NCT01902173|7152162|FG004|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6253430|NCT01902173|7152163|FG005|STARTED|Phase 1 Doublet Regimen Cohort 2||0
6253431|NCT01902173|7152158|FG000|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253432|NCT01902173|7152159|FG001|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253433|NCT01902173|7152160|FG002|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253434|NCT01902173|7152161|FG003|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253435|NCT01902173|7152162|FG004|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253436|NCT01902173|7152163|FG005|COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253437|NCT01902173|7152158|FG000|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253438|NCT01902173|7152159|FG001|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||9
6253439|NCT01902173|7152160|FG002|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253440|NCT01902173|7152161|FG003|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253441|NCT01902173|7152162|FG004|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253442|NCT01902173|7152163|FG005|NOT COMPLETED|Phase 1 Doublet Regimen Cohort 2||0
6253443|NCT01902173|7152158|FG000|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6253444|NCT01902173|7152159|FG001|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6253445|NCT01902173|7152160|FG002|STARTED|Phase 1 Triplet Regimen Cohort 1||4
6253446|NCT01902173|7152161|FG003|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6253447|NCT01902173|7152162|FG004|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6253448|NCT01902173|7152163|FG005|STARTED|Phase 1 Triplet Regimen Cohort 1||0
6253449|NCT01902173|7152158|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253450|NCT01902173|7152159|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253451|NCT01902173|7152160|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253452|NCT01902173|7152161|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253453|NCT01902173|7152162|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253454|NCT01902173|7152163|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253455|NCT01902173|7152158|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253456|NCT01902173|7152159|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253457|NCT01902173|7152160|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||4
6253458|NCT01902173|7152161|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253459|NCT01902173|7152162|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253460|NCT01902173|7152163|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 1||0
6253461|NCT01902173|7152158|FG000|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6253462|NCT01902173|7152159|FG001|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6253463|NCT01902173|7152160|FG002|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6253464|NCT01902173|7152161|FG003|STARTED|Phase 1 Triplet Regimen Cohort 2||3
6253465|NCT01902173|7152162|FG004|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6253466|NCT01902173|7152163|FG005|STARTED|Phase 1 Triplet Regimen Cohort 2||0
6253467|NCT01902173|7152158|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253468|NCT01902173|7152159|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253469|NCT01902173|7152160|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6508290|NCT01469013|7427741|FG007|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||23
6508291|NCT01469013|7427742|FG008|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
6508292|NCT01469013|7427743|FG009|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||11
6508293|NCT01469013|7427744|FG010|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||12
6508294|NCT01469013|7427745|FG011|Received at Least 1 Dose of Study Drug|Part B (Extension Period)||24
6508295|NCT01469013|7427746|FG012|Received at Least 1 Dose of Study Drug|Part B (Extension Period)|1 participant discontinued prior to receiving study drug|23
6508296|NCT01469013|7427734|FG000|COMPLETED|Part B (Extension Period)||0
6508297|NCT01469013|7427735|FG001|COMPLETED|Part B (Extension Period)||0
6508298|NCT01469013|7427736|FG002|COMPLETED|Part B (Extension Period)||0
6508299|NCT01469013|7427737|FG003|COMPLETED|Part B (Extension Period)||0
6508300|NCT01469013|7427738|FG004|COMPLETED|Part B (Extension Period)||0
6508301|NCT01469013|7427739|FG005|COMPLETED|Part B (Extension Period)||10
6508302|NCT01469013|7427740|FG006|COMPLETED|Part B (Extension Period)||7
6508303|NCT01469013|7427741|FG007|COMPLETED|Part B (Extension Period)||18
6508304|NCT01469013|7427742|FG008|COMPLETED|Part B (Extension Period)||20
6508305|NCT01469013|7427743|FG009|COMPLETED|Part B (Extension Period)||8
6508306|NCT01469013|7427744|FG010|COMPLETED|Part B (Extension Period)||10
6508307|NCT01469013|7427745|FG011|COMPLETED|Part B (Extension Period)||18
6508308|NCT01469013|7427746|FG012|COMPLETED|Part B (Extension Period)||18
6508309|NCT01469013|7427734|FG000|NOT COMPLETED|Part B (Extension Period)||0
6508310|NCT01469013|7427735|FG001|NOT COMPLETED|Part B (Extension Period)||0
6508311|NCT01469013|7427736|FG002|NOT COMPLETED|Part B (Extension Period)||0
6508312|NCT01469013|7427737|FG003|NOT COMPLETED|Part B (Extension Period)||0
6508313|NCT01469013|7427738|FG004|NOT COMPLETED|Part B (Extension Period)||0
6508314|NCT01469013|7427739|FG005|NOT COMPLETED|Part B (Extension Period)||2
6508315|NCT01469013|7427740|FG006|NOT COMPLETED|Part B (Extension Period)||5
6508316|NCT01469013|7427741|FG007|NOT COMPLETED|Part B (Extension Period)||5
6508317|NCT01469013|7427742|FG008|NOT COMPLETED|Part B (Extension Period)||4
6508318|NCT01469013|7427743|FG009|NOT COMPLETED|Part B (Extension Period)||3
6508319|NCT01469013|7427744|FG010|NOT COMPLETED|Part B (Extension Period)||2
6508320|NCT01469013|7427745|FG011|NOT COMPLETED|Part B (Extension Period)||6
6508321|NCT01469013|7427746|FG012|NOT COMPLETED|Part B (Extension Period)||6
6508322|NCT01469039|7427776|FG000|STARTED|Overall Study||207
6508323|NCT01469039|7427777|FG001|STARTED|Overall Study||208
6508324|NCT01469039|7427778|FG002|STARTED|Overall Study||208
6508325|NCT01469039|7427776|FG000|COMPLETED|Overall Study||130
6508326|NCT01469039|7427777|FG001|COMPLETED|Overall Study||135
6508327|NCT01469039|7427778|FG002|COMPLETED|Overall Study||95
6508328|NCT01469039|7427776|FG000|NOT COMPLETED|Overall Study||77
6508329|NCT01469039|7427777|FG001|NOT COMPLETED|Overall Study||73
6508330|NCT01469039|7427778|FG002|NOT COMPLETED|Overall Study||113
6508331|NCT01469052|7427792|FG000|STARTED|Overall Study||6
6508332|NCT01469052|7427793|FG001|STARTED|Overall Study||4
6508333|NCT01469052|7427794|FG002|STARTED|Overall Study||6
6508334|NCT01469052|7427795|FG003|STARTED|Overall Study||6
6508335|NCT01469052|7427796|FG004|STARTED|Overall Study||8
6508336|NCT01469052|7427797|FG005|STARTED|Overall Study||6
6508337|NCT01469052|7427792|FG000|COMPLETED|Overall Study||0
6508338|NCT01469052|7427793|FG001|COMPLETED|Overall Study||0
6508339|NCT01469052|7427794|FG002|COMPLETED|Overall Study||0
6508340|NCT01469052|7427795|FG003|COMPLETED|Overall Study||1
6508341|NCT01469052|7427796|FG004|COMPLETED|Overall Study||0
6508342|NCT01469052|7427797|FG005|COMPLETED|Overall Study||0
6508343|NCT01469052|7427792|FG000|NOT COMPLETED|Overall Study||6
6508344|NCT01469052|7427793|FG001|NOT COMPLETED|Overall Study||4
6508345|NCT01469052|7427794|FG002|NOT COMPLETED|Overall Study||6
6508346|NCT01469052|7427795|FG003|NOT COMPLETED|Overall Study||5
6508347|NCT01469052|7427796|FG004|NOT COMPLETED|Overall Study||8
6508348|NCT01469052|7427797|FG005|NOT COMPLETED|Overall Study||6
6508349|NCT01469065|7427814|FG000|STARTED|Overall Study||16
6508350|NCT01469065|7427815|FG001|STARTED|Overall Study||17
6508351|NCT01469065|7427816|FG002|STARTED|Overall Study||16
6508352|NCT01469065|7427817|FG003|STARTED|Overall Study||16
6508353|NCT01469065|7427818|FG004|STARTED|Overall Study||17
6253470|NCT01902173|7152161|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253471|NCT01902173|7152162|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253472|NCT01902173|7152163|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253473|NCT01902173|7152158|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253474|NCT01902173|7152159|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253475|NCT01902173|7152160|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253476|NCT01902173|7152161|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||3
6253477|NCT01902173|7152162|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253478|NCT01902173|7152163|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 2||0
6253479|NCT01902173|7152158|FG000|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6253480|NCT01902173|7152159|FG001|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6253481|NCT01902173|7152160|FG002|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6253482|NCT01902173|7152161|FG003|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6253483|NCT01902173|7152162|FG004|STARTED|Phase 1 Triplet Regimen Cohort 3||3
6253484|NCT01902173|7152163|FG005|STARTED|Phase 1 Triplet Regimen Cohort 3||0
6253485|NCT01902173|7152158|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253486|NCT01902173|7152159|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253487|NCT01902173|7152160|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253488|NCT01902173|7152161|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253489|NCT01902173|7152162|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253490|NCT01902173|7152163|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253491|NCT01902173|7152158|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253492|NCT01902173|7152159|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253493|NCT01902173|7152160|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253494|NCT01902173|7152161|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253495|NCT01902173|7152162|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||3
6253496|NCT01902173|7152163|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 3||0
6253497|NCT01902173|7152158|FG000|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6253498|NCT01902173|7152159|FG001|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6253499|NCT01902173|7152160|FG002|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6253500|NCT01902173|7152161|FG003|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6253501|NCT01902173|7152162|FG004|STARTED|Phase 1 Triplet Regimen Cohort 4||0
6253502|NCT01902173|7152163|FG005|STARTED|Phase 1 Triplet Regimen Cohort 4||5
6253503|NCT01902173|7152158|FG000|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253504|NCT01902173|7152159|FG001|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253505|NCT01902173|7152160|FG002|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253506|NCT01902173|7152161|FG003|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253507|NCT01902173|7152162|FG004|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253508|NCT01902173|7152163|FG005|COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253509|NCT01902173|7152158|FG000|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253510|NCT01902173|7152159|FG001|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253511|NCT01902173|7152160|FG002|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253512|NCT01902173|7152161|FG003|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253513|NCT01902173|7152162|FG004|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||0
6253514|NCT01902173|7152163|FG005|NOT COMPLETED|Phase 1 Triplet Regimen Cohort 4||5
6253515|NCT01902173|7152158|FG000|STARTED|Phase II||0
6253516|NCT01902173|7152159|FG001|STARTED|Phase II||0
6253517|NCT01902173|7152160|FG002|STARTED|Phase II||0
6253518|NCT01902173|7152161|FG003|STARTED|Phase II||0
6253519|NCT01902173|7152162|FG004|STARTED|Phase II||0
6253520|NCT01902173|7152163|FG005|STARTED|Phase II||0
6253521|NCT01902173|7152158|FG000|COMPLETED|Phase II||0
6253522|NCT01902173|7152159|FG001|COMPLETED|Phase II||0
6253523|NCT01902173|7152160|FG002|COMPLETED|Phase II||0
6253524|NCT01902173|7152161|FG003|COMPLETED|Phase II||0
6253525|NCT01902173|7152162|FG004|COMPLETED|Phase II||0
6508354|NCT01469065|7427814|FG000|COMPLETED|Overall Study||16
6508355|NCT01469065|7427815|FG001|COMPLETED|Overall Study||16
6508356|NCT01469065|7427816|FG002|COMPLETED|Overall Study||16
6508357|NCT01469065|7427817|FG003|COMPLETED|Overall Study||16
6508358|NCT01469065|7427818|FG004|COMPLETED|Overall Study||16
6508359|NCT01469065|7427814|FG000|NOT COMPLETED|Overall Study||0
6508360|NCT01469065|7427815|FG001|NOT COMPLETED|Overall Study||1
6508361|NCT01469065|7427816|FG002|NOT COMPLETED|Overall Study||0
6508362|NCT01469065|7427817|FG003|NOT COMPLETED|Overall Study||0
6508363|NCT01469065|7427818|FG004|NOT COMPLETED|Overall Study||1
6508364|NCT01469182|7427836|FG000|STARTED|Overall Study||610
6508365|NCT01469182|7427837|FG001|STARTED|Overall Study||304
6508366|NCT01469182|7427836|FG000|Treated|Overall Study||609
6508367|NCT01469182|7427837|FG001|Treated|Overall Study||304
6508368|NCT01469182|7427836|FG000|COMPLETED|Overall Study||575
6508369|NCT01469182|7427837|FG001|COMPLETED|Overall Study||298
6508370|NCT01469182|7427836|FG000|NOT COMPLETED|Overall Study||35
6508371|NCT01469182|7427837|FG001|NOT COMPLETED|Overall Study||6
6508372|NCT01469221|7427845|FG000|STARTED|Open Label Phase||0
6508373|NCT01469221|7427846|FG001|STARTED|Open Label Phase||0
6508374|NCT01469221|7427847|FG002|STARTED|Open Label Phase||47
6508375|NCT01469221|7427845|FG000|COMPLETED|Open Label Phase||0
6508376|NCT01469221|7427846|FG001|COMPLETED|Open Label Phase||0
6508377|NCT01469221|7427847|FG002|COMPLETED|Open Label Phase||44
6508378|NCT01469221|7427845|FG000|NOT COMPLETED|Open Label Phase||0
6508379|NCT01469221|7427846|FG001|NOT COMPLETED|Open Label Phase||0
6508380|NCT01469221|7427847|FG002|NOT COMPLETED|Open Label Phase||3
6508381|NCT01469221|7427845|FG000|STARTED|Double Blind Phase||14
6253526|NCT01902173|7152163|FG005|COMPLETED|Phase II||0
6253527|NCT01902173|7152158|FG000|NOT COMPLETED|Phase II||0
6253528|NCT01902173|7152159|FG001|NOT COMPLETED|Phase II||0
6253529|NCT01902173|7152160|FG002|NOT COMPLETED|Phase II||0
6253530|NCT01902173|7152161|FG003|NOT COMPLETED|Phase II||0
6253531|NCT01902173|7152162|FG004|NOT COMPLETED|Phase II||0
6253532|NCT01902173|7152163|FG005|NOT COMPLETED|Phase II||0
6253533|NCT01900444|7152180|FG000|STARTED|Overall Study||119
6253534|NCT01900444|7152180|FG000|COMPLETED|Overall Study||116
6253535|NCT01900444|7152180|FG000|NOT COMPLETED|Overall Study||3
6253536|NCT01887912|7152186|FG000|STARTED|Overall Study||6201
6253537|NCT01887912|7152187|FG001|STARTED|Overall Study||3101
6253538|NCT01887912|7152186|FG000|Safety Population|Overall Study||6113
6253539|NCT01887912|7152187|FG001|Safety Population|Overall Study||3057
6253540|NCT01887912|7152186|FG000|COMPLETED|Overall Study||4809
6253541|NCT01887912|7152187|FG001|COMPLETED|Overall Study||2370
6253542|NCT01887912|7152186|FG000|NOT COMPLETED|Overall Study||1392
6253543|NCT01887912|7152187|FG001|NOT COMPLETED|Overall Study||731
6253544|NCT01886872|7152196|FG000|STARTED|Overall Study||183
6253545|NCT01886872|7152197|FG001|STARTED|Overall Study||182
6253546|NCT01886872|7152198|FG002|STARTED|Overall Study||182
6253547|NCT01886872|7152196|FG000|Evaluable for Secondary Endpoints|Overall Study||183
6253548|NCT01886872|7152197|FG001|Evaluable for Secondary Endpoints|Overall Study||182
6253549|NCT01886872|7152198|FG002|Evaluable for Secondary Endpoints|Overall Study||182
6253550|NCT01886872|7152196|FG000|Evaluable for Adverse Events|Overall Study||176
6253551|NCT01886872|7152197|FG001|Evaluable for Adverse Events|Overall Study||180
6253552|NCT01886872|7152198|FG002|Evaluable for Adverse Events|Overall Study||181
6253553|NCT01886872|7152196|FG000|Crossover Cohort|Overall Study||30
6253554|NCT01886872|7152197|FG001|Crossover Cohort|Overall Study||0
6253555|NCT01886872|7152198|FG002|Crossover Cohort|Overall Study||0
6253556|NCT01886872|7152196|FG000|COMPLETED|Overall Study||176
6253557|NCT01886872|7152197|FG001|COMPLETED|Overall Study||178
6253558|NCT01886872|7152198|FG002|COMPLETED|Overall Study||170
6253559|NCT01886872|7152196|FG000|NOT COMPLETED|Overall Study||7
6253560|NCT01886872|7152197|FG001|NOT COMPLETED|Overall Study||4
6253561|NCT01886872|7152198|FG002|NOT COMPLETED|Overall Study||12
6253562|NCT01835145|7152209|FG000|STARTED|Overall Study||32
6253563|NCT01835145|7152210|FG001|STARTED|Overall Study||15
6253564|NCT01835145|7152209|FG000|COMPLETED|Overall Study||31
6253565|NCT01835145|7152210|FG001|COMPLETED|Overall Study||15
6253566|NCT01835145|7152209|FG000|NOT COMPLETED|Overall Study||1
6253567|NCT01835145|7152210|FG001|NOT COMPLETED|Overall Study||0
6253568|NCT01751126|7152221|FG000|STARTED|Period I||57
6253569|NCT01751126|7152222|FG001|STARTED|Period I||54
6253570|NCT01751126|7152223|FG002|STARTED|Period I||58
6508382|NCT01469221|7427846|FG001|STARTED|Double Blind Phase||17
6508383|NCT01469221|7427847|FG002|STARTED|Double Blind Phase||0
6508384|NCT01469221|7427845|FG000|COMPLETED|Double Blind Phase||0
6508385|NCT01469221|7427846|FG001|COMPLETED|Double Blind Phase||0
6508386|NCT01469221|7427847|FG002|COMPLETED|Double Blind Phase||0
6508387|NCT01469221|7427845|FG000|NOT COMPLETED|Double Blind Phase||14
6508388|NCT01469221|7427846|FG001|NOT COMPLETED|Double Blind Phase||17
6508389|NCT01469221|7427847|FG002|NOT COMPLETED|Double Blind Phase||0
6508390|NCT01469234|7427857|FG000|STARTED|Overall Study||85
6508391|NCT01469234|7427858|FG001|STARTED|Overall Study||85
6508392|NCT01469234|7427859|FG002|STARTED|Overall Study||85
6508393|NCT01469234|7427857|FG000|COMPLETED|Overall Study||85
6508394|NCT01469234|7427858|FG001|COMPLETED|Overall Study||85
6508395|NCT01469234|7427859|FG002|COMPLETED|Overall Study||85
6508396|NCT01469234|7427857|FG000|NOT COMPLETED|Overall Study||0
6508397|NCT01469234|7427858|FG001|NOT COMPLETED|Overall Study||0
6508398|NCT01469234|7427859|FG002|NOT COMPLETED|Overall Study||0
6508399|NCT01469364|7427867|FG000|STARTED|Overall Study||30
6508400|NCT01469364|7427867|FG000|COMPLETED|Overall Study||28
6508401|NCT01469364|7427867|FG000|NOT COMPLETED|Overall Study||2
6508402|NCT01469377|7427874|FG000|STARTED|Overall Study||269
6508403|NCT01469377|7427875|FG001|STARTED|Overall Study||274
6508404|NCT01469377|7427876|FG002|STARTED|Overall Study||276
6508405|NCT01469377|7427874|FG000|COMPLETED|Overall Study||234
6508406|NCT01469377|7427875|FG001|COMPLETED|Overall Study||226
6508407|NCT01469377|7427876|FG002|COMPLETED|Overall Study||210
6508408|NCT01469377|7427874|FG000|NOT COMPLETED|Overall Study||35
6508409|NCT01469377|7427875|FG001|NOT COMPLETED|Overall Study||48
6508410|NCT01469377|7427876|FG002|NOT COMPLETED|Overall Study||66
6508411|NCT01469546|7427884|FG000|STARTED|Received 5 mg Dose||42
6508412|NCT01469546|7427884|FG000|Completed First Cycle|Received 5 mg Dose||30
6508413|NCT01469546|7427884|FG000|COMPLETED|Received 5 mg Dose||19
6508414|NCT01469546|7427884|FG000|NOT COMPLETED|Received 5 mg Dose||23
6508415|NCT01469546|7427884|FG000|STARTED|Dose Escalation to 10 mg||19
6508416|NCT01469546|7427884|FG000|COMPLETED|Dose Escalation to 10 mg||19
6508417|NCT01469546|7427884|FG000|NOT COMPLETED|Dose Escalation to 10 mg||0
6508418|NCT01469585|7427890|FG000|STARTED|Overall Study||11
6253571|NCT01751126|7152221|FG000|COMPLETED|Period I||51
6253572|NCT01751126|7152222|FG001|COMPLETED|Period I||43
6253573|NCT01751126|7152223|FG002|COMPLETED|Period I||49
6253574|NCT01751126|7152221|FG000|NOT COMPLETED|Period I||6
6253575|NCT01751126|7152222|FG001|NOT COMPLETED|Period I||11
6253576|NCT01751126|7152223|FG002|NOT COMPLETED|Period I||9
6253577|NCT01751126|7152221|FG000|STARTED|Period II||72
6508419|NCT01469585|7427891|FG001|STARTED|Overall Study||9
6508420|NCT01469585|7427890|FG000|COMPLETED|Overall Study||4
6508421|NCT01469585|7427891|FG001|COMPLETED|Overall Study||6
6253578|NCT01751126|7152222|FG001|STARTED|Period II||70
6253579|NCT01751126|7152223|FG002|STARTED|Period II|Following completion of the first period of the trial, all patients were to be administered NOVA22007 (High or Low dose) for a safety 8-month follow-up period.|0
6253580|NCT01751126|7152221|FG000|COMPLETED|Period II||72
6253581|NCT01751126|7152222|FG001|COMPLETED|Period II||70
6253582|NCT01751126|7152223|FG002|COMPLETED|Period II||0
6253583|NCT01751126|7152221|FG000|NOT COMPLETED|Period II||0
6253584|NCT01751126|7152222|FG001|NOT COMPLETED|Period II||0
6253585|NCT01751126|7152223|FG002|NOT COMPLETED|Period II||0
6253586|NCT01468896|7152247|FG000|STARTED|Overall Study||6
6253587|NCT01468896|7152248|FG001|STARTED|Overall Study||17
6253588|NCT01468896|7152247|FG000|COMPLETED|Overall Study||6
6253589|NCT01468896|7152248|FG001|COMPLETED|Overall Study||17
6253590|NCT01468896|7152247|FG000|NOT COMPLETED|Overall Study||0
6253591|NCT01468896|7152248|FG001|NOT COMPLETED|Overall Study||0
6253592|NCT01437423|7152255|FG000|STARTED|Overall Study||662
6253593|NCT01437423|7152255|FG000|COMPLETED|Overall Study||647
6253594|NCT01437423|7152255|FG000|NOT COMPLETED|Overall Study||15
6253595|NCT01410890|7152261|FG000|STARTED|Overall Study||10
6253596|NCT01410890|7152262|FG001|STARTED|Overall Study||11
6253597|NCT01410890|7152261|FG000|Treated|Overall Study||10
6253598|NCT01410890|7152262|FG001|Treated|Overall Study||10
6253599|NCT01410890|7152261|FG000|COMPLETED|Overall Study||10
6253600|NCT01410890|7152262|FG001|COMPLETED|Overall Study||10
6253601|NCT01410890|7152261|FG000|NOT COMPLETED|Overall Study||0
6253602|NCT01410890|7152262|FG001|NOT COMPLETED|Overall Study||1
6253603|NCT01251861|7152272|FG000|STARTED|Overall Study||54
6253604|NCT01251861|7152273|FG001|STARTED|Overall Study||54
6253605|NCT01251861|7152272|FG000|Pts Who Received Protocol Therapy|Overall Study||50
6253606|NCT01251861|7152273|FG001|Pts Who Received Protocol Therapy|Overall Study||53
6253607|NCT01251861|7152272|FG000|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||49
6253608|NCT01251861|7152273|FG001|Pts w/ Follow-up PSA Lower Than Baseline|Overall Study||47
6253609|NCT01251861|7152272|FG000|Pts With PSA Response|Overall Study||44
6253610|NCT01251861|7152273|FG001|Pts With PSA Response|Overall Study||36
6253611|NCT01251861|7152272|FG000|COMPLETED|Overall Study||36
6253612|NCT01251861|7152273|FG001|COMPLETED|Overall Study||26
6253613|NCT01251861|7152272|FG000|NOT COMPLETED|Overall Study||18
6253614|NCT01251861|7152273|FG001|NOT COMPLETED|Overall Study||28
6508422|NCT01469585|7427890|FG000|NOT COMPLETED|Overall Study||7
6508423|NCT01469585|7427891|FG001|NOT COMPLETED|Overall Study||3
6508424|NCT01469637|7427901|FG000|STARTED|First Intervention||22
6508425|NCT01469637|7427902|FG001|STARTED|First Intervention||22
6508426|NCT01469637|7427901|FG000|COMPLETED|First Intervention||22
6508427|NCT01469637|7427902|FG001|COMPLETED|First Intervention||21
6508428|NCT01469637|7427901|FG000|NOT COMPLETED|First Intervention||0
6508429|NCT01469637|7427902|FG001|NOT COMPLETED|First Intervention||1
6508430|NCT01469637|7427901|FG000|STARTED|Second Intervention||22
6508431|NCT01469637|7427902|FG001|STARTED|Second Intervention||21
6508432|NCT01469637|7427901|FG000|COMPLETED|Second Intervention||21
6508433|NCT01469637|7427902|FG001|COMPLETED|Second Intervention||21
6508434|NCT01469637|7427901|FG000|NOT COMPLETED|Second Intervention||1
6508435|NCT01469637|7427902|FG001|NOT COMPLETED|Second Intervention||0
6508436|NCT01469715|7427908|FG000|STARTED|Overall Study||16
6508437|NCT01469715|7427908|FG000|COMPLETED|Overall Study||16
6508438|NCT01469715|7427908|FG000|NOT COMPLETED|Overall Study||0
6508439|NCT01469767|7427912|FG000|STARTED|Overall Study||10
6508440|NCT01469767|7427912|FG000|COMPLETED|Overall Study||10
6508441|NCT01469767|7427912|FG000|NOT COMPLETED|Overall Study||0
6508442|NCT01469819|7427916|FG000|STARTED|Overall Study||37
6508443|NCT01469819|7427916|FG000|COMPLETED|Overall Study||29
6508444|NCT01469819|7427916|FG000|NOT COMPLETED|Overall Study||8
6508445|NCT01470001|7427928|FG000|STARTED|Overall Study||58
6508446|NCT01470001|7427929|FG001|STARTED|Overall Study||60
6508447|NCT01470001|7427928|FG000|COMPLETED|Overall Study||53
6508448|NCT01470001|7427929|FG001|COMPLETED|Overall Study||58
6508449|NCT01470001|7427928|FG000|NOT COMPLETED|Overall Study||5
6253633|NCT01190228|7152303|FG000|STARTED|Overall Study||349
6253634|NCT01190228|7152304|FG001|STARTED|Overall Study||46
6253635|NCT01190228|7152305|FG002|STARTED|Overall Study||59
6253636|NCT01190228|7152303|FG000|COMPLETED|Overall Study||344
6253637|NCT01190228|7152304|FG001|COMPLETED|Overall Study||46
6253638|NCT01190228|7152305|FG002|COMPLETED|Overall Study||59
6253639|NCT01190228|7152303|FG000|NOT COMPLETED|Overall Study||5
6253640|NCT01190228|7152304|FG001|NOT COMPLETED|Overall Study||0
6253641|NCT01190228|7152305|FG002|NOT COMPLETED|Overall Study||0
6253642|NCT01146652|7152317|FG000|STARTED|Overall Study||1912
6253643|NCT01146652|7152318|FG001|STARTED|Overall Study||111
6253644|NCT01146652|7152317|FG000|Treated|Overall Study||1910
6253645|NCT01146652|7152318|FG001|Treated|Overall Study||111
6253646|NCT01146652|7152317|FG000|Enrolled in the Sub-study|Overall Study||110
6253647|NCT01146652|7152318|FG001|Enrolled in the Sub-study|Overall Study||14
6253648|NCT01146652|7152317|FG000|Discontinued From the Sub-study|Overall Study||1
6253649|NCT01146652|7152318|FG001|Discontinued From the Sub-study|Overall Study||2
6253650|NCT01146652|7152317|FG000|Switched Back to Main Study|Overall Study||108
6253651|NCT01146652|7152318|FG001|Switched Back to Main Study|Overall Study||13
6253652|NCT01146652|7152317|FG000|COMPLETED|Overall Study||961
6253653|NCT01146652|7152318|FG001|COMPLETED|Overall Study||66
6253654|NCT01146652|7152317|FG000|NOT COMPLETED|Overall Study||951
6253655|NCT01146652|7152318|FG001|NOT COMPLETED|Overall Study||45
6253656|NCT01049035|7152338|FG000|STARTED|Overall Study||107
6253657|NCT01049035|7152339|FG001|STARTED|Overall Study||108
6253658|NCT01049035|7152340|FG002|STARTED|Overall Study||107
6253659|NCT01049035|7152341|FG003|STARTED|Overall Study||75
6253660|NCT01049035|7152342|FG004|STARTED|Overall Study||75
6253661|NCT01049035|7152343|FG005|STARTED|Overall Study||54
6253662|NCT01049035|7152344|FG006|STARTED|Overall Study||54
6253663|NCT01049035|7152338|FG000|Safety Population|Overall Study||104
6253664|NCT01049035|7152339|FG001|Safety Population|Overall Study||102
6253665|NCT01049035|7152340|FG002|Safety Population|Overall Study||100
6253666|NCT01049035|7152341|FG003|Safety Population|Overall Study||74
6253667|NCT01049035|7152342|FG004|Safety Population|Overall Study||70
6253668|NCT01049035|7152343|FG005|Safety Population|Overall Study||52
6253669|NCT01049035|7152344|FG006|Safety Population|Overall Study||49
6253670|NCT01049035|7152338|FG000|COMPLETED|Overall Study||74
6253671|NCT01049035|7152339|FG001|COMPLETED|Overall Study||87
6253672|NCT01049035|7152340|FG002|COMPLETED|Overall Study||80
6253673|NCT01049035|7152341|FG003|COMPLETED|Overall Study||64
6253674|NCT01049035|7152342|FG004|COMPLETED|Overall Study||71
6253675|NCT01049035|7152343|FG005|COMPLETED|Overall Study||42
6253676|NCT01049035|7152344|FG006|COMPLETED|Overall Study||39
6253677|NCT01049035|7152338|FG000|NOT COMPLETED|Overall Study||33
6253678|NCT01049035|7152339|FG001|NOT COMPLETED|Overall Study||21
6253679|NCT01049035|7152340|FG002|NOT COMPLETED|Overall Study||27
6253680|NCT01049035|7152341|FG003|NOT COMPLETED|Overall Study||11
6253681|NCT01049035|7152342|FG004|NOT COMPLETED|Overall Study||4
6253682|NCT01049035|7152343|FG005|NOT COMPLETED|Overall Study||12
6253683|NCT01049035|7152344|FG006|NOT COMPLETED|Overall Study||15
6253684|NCT00728884|7152370|FG000|STARTED|Implant Placement Surgery||162
6253685|NCT00728884|7152370|FG000|COMPLETED|Implant Placement Surgery||162
6253686|NCT00728884|7152370|FG000|NOT COMPLETED|Implant Placement Surgery||0
6253687|NCT00728884|7152370|FG000|STARTED|Permanent Prosthesis Placement||162
6253688|NCT00728884|7152370|FG000|COMPLETED|Permanent Prosthesis Placement||149
6570526|NCT01852058|7493876|FG010|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
6658102|NCT02476422|7588654|FG001|COMPLETED|Overall Study||161
6253689|NCT00728884|7152370|FG000|NOT COMPLETED|Permanent Prosthesis Placement||13
6253690|NCT00728884|7152370|FG000|STARTED|One Year Post Placement Follow-up||149
6253691|NCT00728884|7152370|FG000|COMPLETED|One Year Post Placement Follow-up||145
6253692|NCT00728884|7152370|FG000|NOT COMPLETED|One Year Post Placement Follow-up||4
6253693|NCT00728884|7152370|FG000|STARTED|Two Year Post Placement Follow-up||145
6253694|NCT00728884|7152370|FG000|COMPLETED|Two Year Post Placement Follow-up||145
6253695|NCT00728884|7152370|FG000|NOT COMPLETED|Two Year Post Placement Follow-up||0
6253696|NCT00727090|7152376|FG000|STARTED|Overall Study||3
6253697|NCT00727090|7152377|FG001|STARTED|Overall Study||3
6253698|NCT00727090|7152376|FG000|COMPLETED|Overall Study||3
6253699|NCT00727090|7152377|FG001|COMPLETED|Overall Study||3
6253700|NCT00727090|7152376|FG000|NOT COMPLETED|Overall Study||0
6253701|NCT00727090|7152377|FG001|NOT COMPLETED|Overall Study||0
6253702|NCT00726063|7152387|FG000|STARTED|Overall Study|Number of implants= 239|122
6253703|NCT00726063|7152388|FG001|STARTED|Overall Study|Number of implants= 246|119
6253704|NCT00726063|7152387|FG000|COMPLETED|Overall Study|Number of implants =230|113
6253705|NCT00726063|7152388|FG001|COMPLETED|Overall Study|Number of implants = 239|112
6253706|NCT00726063|7152387|FG000|NOT COMPLETED|Overall Study||9
6253707|NCT00726063|7152388|FG001|NOT COMPLETED|Overall Study||7
6253708|NCT00725049|7152396|FG000|STARTED|Overall Study||17
6253709|NCT00725049|7152397|FG001|STARTED|Overall Study||20
6253710|NCT00725049|7152396|FG000|COMPLETED|Overall Study||17
6253711|NCT00725049|7152397|FG001|COMPLETED|Overall Study||20
6658103|NCT02476422|7588653|FG000|NOT COMPLETED|Overall Study||0
6253712|NCT00725049|7152396|FG000|NOT COMPLETED|Overall Study||0
6253713|NCT00725049|7152397|FG001|NOT COMPLETED|Overall Study||0
6253714|NCT00713206|7152405|FG000|STARTED|Overall Study||65
6253715|NCT00713206|7152406|FG001|STARTED|Overall Study||57
6253716|NCT00713206|7152405|FG000|COMPLETED|Overall Study||60
6253717|NCT00713206|7152406|FG001|COMPLETED|Overall Study||53
6253718|NCT00713206|7152405|FG000|NOT COMPLETED|Overall Study||5
6253719|NCT00713206|7152406|FG001|NOT COMPLETED|Overall Study||4
6253720|NCT00658814|7152414|FG000|STARTED|Remission Induction Chemotherapy||83
6253721|NCT00658814|7152415|FG001|STARTED|Remission Induction Chemotherapy||59
6253722|NCT00658814|7152414|FG000|Eligible|Remission Induction Chemotherapy||82
6253723|NCT00658814|7152415|FG001|Eligible|Remission Induction Chemotherapy||57
6253724|NCT00658814|7152414|FG000|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
6253725|NCT00658814|7152415|FG001|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
6253726|NCT00658814|7152414|FG000|COMPLETED|Remission Induction Chemotherapy||75
6253727|NCT00658814|7152415|FG001|COMPLETED|Remission Induction Chemotherapy||41
6253728|NCT00658814|7152414|FG000|NOT COMPLETED|Remission Induction Chemotherapy||8
6253729|NCT00658814|7152415|FG001|NOT COMPLETED|Remission Induction Chemotherapy||18
6253730|NCT00658814|7152414|FG000|STARTED|Consolidation Therapy||24
6253731|NCT00658814|7152415|FG001|STARTED|Consolidation Therapy||13
6253732|NCT00658814|7152414|FG000|Eligible|Consolidation Therapy||22
6253733|NCT00658814|7152415|FG001|Eligible|Consolidation Therapy||11
6253734|NCT00658814|7152414|FG000|COMPLETED|Consolidation Therapy||22
6253735|NCT00658814|7152415|FG001|COMPLETED|Consolidation Therapy||10
6253736|NCT00658814|7152414|FG000|NOT COMPLETED|Consolidation Therapy||2
6253737|NCT00658814|7152415|FG001|NOT COMPLETED|Consolidation Therapy||3
6253738|NCT00658814|7152414|FG000|STARTED|Maintenance Therapy||20
6253739|NCT00658814|7152415|FG001|STARTED|Maintenance Therapy||8
6253740|NCT00658814|7152414|FG000|Eligible|Maintenance Therapy||19
6253741|NCT00658814|7152415|FG001|Eligible|Maintenance Therapy||8
6253742|NCT00658814|7152414|FG000|COMPLETED|Maintenance Therapy||17
6253743|NCT00658814|7152415|FG001|COMPLETED|Maintenance Therapy||7
6253744|NCT00658814|7152414|FG000|NOT COMPLETED|Maintenance Therapy||3
6253745|NCT00658814|7152415|FG001|NOT COMPLETED|Maintenance Therapy||1
6508450|NCT01470001|7427929|FG001|NOT COMPLETED|Overall Study||2
6508451|NCT01470027|7427941|FG000|STARTED|Overall Study||16
6508452|NCT01470027|7427942|FG001|STARTED|Overall Study||15
6570527|NCT01852058|7493877|FG011|STARTED|Treatment Cycle4:Retreatment 3,Study 121||4
6570528|NCT01852058|7493866|FG000|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570529|NCT01852058|7493867|FG001|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570530|NCT01852058|7493868|FG002|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570531|NCT01852058|7493869|FG003|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570532|NCT01852058|7493870|FG004|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570533|NCT01852058|7493871|FG005|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570534|NCT01852058|7493872|FG006|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570535|NCT01852058|7493873|FG007|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570536|NCT01852058|7493874|FG008|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570537|NCT01852058|7493875|FG009|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||3
6570538|NCT01852058|7493876|FG010|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
6570539|NCT01852058|7493877|FG011|COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||4
6570540|NCT01852058|7493866|FG000|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6623569|NCT02208297|7550719|FG000|NOT COMPLETED|Overall Study||22
6508453|NCT01470027|7427943|FG002|STARTED|Overall Study||16
6508454|NCT01470027|7427941|FG000|COMPLETED|Overall Study||15
6508455|NCT01470027|7427942|FG001|COMPLETED|Overall Study||14
6508456|NCT01470027|7427943|FG002|COMPLETED|Overall Study||15
6508457|NCT01470027|7427941|FG000|NOT COMPLETED|Overall Study||1
6508458|NCT01470027|7427942|FG001|NOT COMPLETED|Overall Study||1
6508459|NCT01470027|7427943|FG002|NOT COMPLETED|Overall Study||1
6508460|NCT01470118|7427960|FG000|STARTED|Overall Study||43
6508461|NCT01470118|7427961|FG001|STARTED|Overall Study||43
6508462|NCT01470118|7427962|FG002|STARTED|Overall Study||41
6508463|NCT01470118|7427960|FG000|COMPLETED|Overall Study||38
6508464|NCT01470118|7427961|FG001|COMPLETED|Overall Study||38
6508465|NCT01470118|7427962|FG002|COMPLETED|Overall Study||39
6508466|NCT01470118|7427960|FG000|NOT COMPLETED|Overall Study||5
6508467|NCT01470118|7427961|FG001|NOT COMPLETED|Overall Study||5
6508468|NCT01470118|7427962|FG002|NOT COMPLETED|Overall Study||2
6508469|NCT01470144|7427970|FG000|STARTED|Overall Study||41
6508470|NCT01470144|7427970|FG000|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
6508471|NCT01470144|7427970|FG000|NOT COMPLETED|Overall Study||10
6508472|NCT01470170|7427979|FG000|STARTED|Overall Study||34
6508473|NCT01470170|7427980|FG001|STARTED|Overall Study||35
6508474|NCT01470170|7427981|FG002|STARTED|Overall Study||34
6508475|NCT01470170|7427982|FG003|STARTED|Overall Study||36
6508476|NCT01470170|7427983|FG004|STARTED|Overall Study||34
6508477|NCT01470170|7427979|FG000|COMPLETED|Overall Study||34
6508478|NCT01470170|7427980|FG001|COMPLETED|Overall Study||35
6508479|NCT01470170|7427981|FG002|COMPLETED|Overall Study||34
6508480|NCT01470170|7427982|FG003|COMPLETED|Overall Study||36
6508481|NCT01470170|7427983|FG004|COMPLETED|Overall Study||34
6508482|NCT01470170|7427979|FG000|NOT COMPLETED|Overall Study||0
6508483|NCT01470170|7427980|FG001|NOT COMPLETED|Overall Study||0
6508484|NCT01470170|7427981|FG002|NOT COMPLETED|Overall Study||0
6508485|NCT01470170|7427982|FG003|NOT COMPLETED|Overall Study||0
6508486|NCT01470170|7427983|FG004|NOT COMPLETED|Overall Study||0
6508487|NCT01470196|7427995|FG000|STARTED|Overall Study||31
6508488|NCT01470196|7427995|FG000|COMPLETED|Overall Study||31
6508489|NCT01470196|7427995|FG000|NOT COMPLETED|Overall Study||0
6508490|NCT01470248|7427999|FG000|STARTED|Overall Study||20
6508491|NCT01470248|7427999|FG000|COMPLETED|Overall Study||19
6508492|NCT01470248|7427999|FG000|NOT COMPLETED|Overall Study||1
6508493|NCT01470417|7428005|FG000|STARTED|Overall Study||3
6508494|NCT01470417|7428006|FG001|STARTED|Overall Study||7
6508495|NCT01470417|7428005|FG000|COMPLETED|Overall Study||3
6508496|NCT01470417|7428006|FG001|COMPLETED|Overall Study||5
6508497|NCT01470417|7428005|FG000|NOT COMPLETED|Overall Study||0
6508498|NCT01470417|7428006|FG001|NOT COMPLETED|Overall Study||2
6508499|NCT01470469|7428014|FG000|STARTED|Overall Study||21
6508500|NCT01470469|7428015|FG001|STARTED|Overall Study||62
6508501|NCT01470469|7428014|FG000|COMPLETED|Overall Study||11
6508502|NCT01470469|7428015|FG001|COMPLETED|Overall Study||38
6508503|NCT01470469|7428014|FG000|NOT COMPLETED|Overall Study||10
6508504|NCT01470469|7428015|FG001|NOT COMPLETED|Overall Study||24
6508505|NCT01470599|7428023|FG000|STARTED|Overall Study||62
6508506|NCT01470599|7428024|FG001|STARTED|Overall Study||88
6508507|NCT01470599|7428023|FG000|COMPLETED|Overall Study||43
6508508|NCT01470599|7428024|FG001|COMPLETED|Overall Study||45
6508509|NCT01470599|7428023|FG000|NOT COMPLETED|Overall Study||19
6508510|NCT01470599|7428024|FG001|NOT COMPLETED|Overall Study||43
6508511|NCT01470612|7428032|FG000|STARTED|Overall Study||175
6508512|NCT01470612|7428033|FG001|STARTED|Overall Study||769
6508513|NCT01470612|7428032|FG000|COMPLETED|Overall Study||91
6508514|NCT01470612|7428033|FG001|COMPLETED|Overall Study||104
6508515|NCT01470612|7428032|FG000|NOT COMPLETED|Overall Study||84
6508516|NCT01470612|7428033|FG001|NOT COMPLETED|Overall Study||665
6508517|NCT01470651|7428041|FG000|STARTED|Overall Study||13
6508518|NCT01470651|7428042|FG001|STARTED|Overall Study||13
6508519|NCT01470651|7428041|FG000|COMPLETED|Overall Study||6
6508520|NCT01470651|7428042|FG001|COMPLETED|Overall Study||10
6508521|NCT01470651|7428041|FG000|NOT COMPLETED|Overall Study||7
6508522|NCT01470651|7428042|FG001|NOT COMPLETED|Overall Study||3
6508523|NCT01470781|7428050|FG000|STARTED|Overall Study||39
6508524|NCT01470781|7428051|FG001|STARTED|Overall Study||33
6508525|NCT01470781|7428050|FG000|Midpoint Assessment|Overall Study||30
6508526|NCT01470781|7428051|FG001|Midpoint Assessment|Overall Study||30
6508527|NCT01470781|7428050|FG000|Post-Treatment Assessment|Overall Study||22
6508528|NCT01470781|7428051|FG001|Post-Treatment Assessment|Overall Study||23
6508529|NCT01470781|7428050|FG000|COMPLETED|Overall Study||21
6508530|NCT01470781|7428051|FG001|COMPLETED|Overall Study||21
6508531|NCT01470781|7428050|FG000|NOT COMPLETED|Overall Study||18
6508532|NCT01470781|7428051|FG001|NOT COMPLETED|Overall Study||12
6508533|NCT01470859|7428060|FG000|STARTED|Overall Study||15
6508534|NCT01470859|7428061|FG001|STARTED|Overall Study||15
6508535|NCT01470859|7428060|FG000|COMPLETED|Overall Study||14
6508536|NCT01470859|7428061|FG001|COMPLETED|Overall Study||15
6508537|NCT01470859|7428060|FG000|NOT COMPLETED|Overall Study||1
6508538|NCT01470859|7428061|FG001|NOT COMPLETED|Overall Study||0
6508539|NCT01470989|7428069|FG000|STARTED|Overall Study||227
6508540|NCT01470989|7428070|FG001|STARTED|Overall Study||229
6508541|NCT01470989|7428069|FG000|Completed Core Study|Overall Study||208
6508542|NCT01470989|7428070|FG001|Completed Core Study|Overall Study||208
6508543|NCT01470989|7428069|FG000|Entered Extension 1 Study|Overall Study||174
6508544|NCT01470989|7428070|FG001|Entered Extension 1 Study|Overall Study||161
6508545|NCT01470989|7428069|FG000|Completed Extension 1 Study|Overall Study||165
6508546|NCT01470989|7428070|FG001|Completed Extension 1 Study|Overall Study||152
6508547|NCT01470989|7428069|FG000|Entered Extension 2 Study|Overall Study||141
6508548|NCT01470989|7428070|FG001|Entered Extension 2 Study|Overall Study||131
6508549|NCT01470989|7428069|FG000|Completed Extension 2 Study|Overall Study||132
6508550|NCT01470989|7428070|FG001|Completed Extension 2 Study|Overall Study||117
6508551|NCT01470989|7428069|FG000|Entered Extension 3|Overall Study||87
6508552|NCT01470989|7428070|FG001|Entered Extension 3|Overall Study||49
6508553|NCT01470989|7428069|FG000|COMPLETED|Overall Study||79
6508554|NCT01470989|7428070|FG001|COMPLETED|Overall Study||43
6508555|NCT01470989|7428069|FG000|NOT COMPLETED|Overall Study||148
6508556|NCT01470989|7428070|FG001|NOT COMPLETED|Overall Study||186
6508557|NCT01471015|7428081|FG000|STARTED|Overall Study||10
6508558|NCT01471015|7428082|FG001|STARTED|Overall Study||10
6508559|NCT01471015|7428083|FG002|STARTED|Overall Study||10
6508560|NCT01471015|7428081|FG000|COMPLETED|Overall Study||10
6508561|NCT01471015|7428082|FG001|COMPLETED|Overall Study||9
6508562|NCT01471015|7428083|FG002|COMPLETED|Overall Study||9
6508563|NCT01471015|7428081|FG000|NOT COMPLETED|Overall Study||0
6508564|NCT01471015|7428082|FG001|NOT COMPLETED|Overall Study||1
6508565|NCT01471015|7428083|FG002|NOT COMPLETED|Overall Study||1
6508566|NCT01471028|7428093|FG000|STARTED|VTI-208||96
6508567|NCT01471028|7428094|FG001|STARTED|VTI-208||107
6253766|NCT00569127|7152436|FG000|STARTED|Overall Study||214
6253767|NCT00569127|7152437|FG001|STARTED|Overall Study||213
6253768|NCT00569127|7152436|FG000|Eligible|Overall Study||200
6508568|NCT01471028|7428093|FG000|COMPLETED|VTI-208||56
6508569|NCT01471028|7428094|FG001|COMPLETED|VTI-208||63
6508570|NCT01471028|7428093|FG000|NOT COMPLETED|VTI-208||40
6508571|NCT01471028|7428094|FG001|NOT COMPLETED|VTI-208||44
6508572|NCT01471028|7428093|FG000|STARTED|VTI-208E||56
6508573|NCT01471028|7428094|FG001|STARTED|VTI-208E||63
6508574|NCT01471028|7428093|FG000|Database Lock, 31 July 2015|VTI-208E||56
6508575|NCT01471028|7428094|FG001|Database Lock, 31 July 2015|VTI-208E||63
6508576|NCT01471028|7428093|FG000|COMPLETED|VTI-208E||48
6508577|NCT01471028|7428094|FG001|COMPLETED|VTI-208E||51
6508578|NCT01471028|7428093|FG000|NOT COMPLETED|VTI-208E||8
6508579|NCT01471028|7428094|FG001|NOT COMPLETED|VTI-208E||12
6508580|NCT01471041|7428103|FG000|STARTED|Overall Study||54
6508581|NCT01471041|7428103|FG000|COMPLETED|Overall Study||47
6508582|NCT01471041|7428103|FG000|NOT COMPLETED|Overall Study||7
6508583|NCT01471054|7428109|FG000|STARTED|Overall Study||5
6508584|NCT01471054|7428110|FG001|STARTED|Overall Study||1
6508585|NCT01471054|7428109|FG000|COMPLETED|Overall Study||1
6508586|NCT01471054|7428110|FG001|COMPLETED|Overall Study||1
6508587|NCT01471054|7428109|FG000|NOT COMPLETED|Overall Study||4
6508588|NCT01471054|7428110|FG001|NOT COMPLETED|Overall Study||0
6508589|NCT01471093|7428128|FG000|STARTED|Overall Study||25
6508590|NCT01471093|7428129|FG001|STARTED|Overall Study||25
6508591|NCT01471093|7428130|FG002|STARTED|Overall Study||25
6508592|NCT01471093|7428131|FG003|STARTED|Overall Study||25
6508593|NCT01471093|7428128|FG000|COMPLETED|Overall Study||24
6508594|NCT01471093|7428129|FG001|COMPLETED|Overall Study||25
6508595|NCT01471093|7428130|FG002|COMPLETED|Overall Study||25
6508596|NCT01471093|7428131|FG003|COMPLETED|Overall Study||25
6508597|NCT01471093|7428128|FG000|NOT COMPLETED|Overall Study||1
6508598|NCT01471093|7428129|FG001|NOT COMPLETED|Overall Study||0
6508599|NCT01471093|7428130|FG002|NOT COMPLETED|Overall Study||0
6508600|NCT01471093|7428131|FG003|NOT COMPLETED|Overall Study||0
6508601|NCT01471171|7428137|FG000|STARTED|Treatment Period 1||57
6508602|NCT01471171|7428138|FG001|STARTED|Treatment Period 1||55
6508603|NCT01471171|7428137|FG000|COMPLETED|Treatment Period 1||53
6508604|NCT01471171|7428138|FG001|COMPLETED|Treatment Period 1||54
6508605|NCT01471171|7428137|FG000|NOT COMPLETED|Treatment Period 1||4
6508606|NCT01471171|7428138|FG001|NOT COMPLETED|Treatment Period 1||1
6508607|NCT01471171|7428137|FG000|STARTED|Treatment Period 2||53
6508608|NCT01471171|7428138|FG001|STARTED|Treatment Period 2||54
6508609|NCT01471171|7428137|FG000|COMPLETED|Treatment Period 2||52
6508610|NCT01471171|7428138|FG001|COMPLETED|Treatment Period 2||54
6508611|NCT01471171|7428137|FG000|NOT COMPLETED|Treatment Period 2||1
6508612|NCT01471171|7428138|FG001|NOT COMPLETED|Treatment Period 2||0
6508613|NCT01471197|7428146|FG000|STARTED|Overall Study||6
6508614|NCT01471197|7428147|FG001|STARTED|Overall Study||2
6508615|NCT01471197|7428146|FG000|COMPLETED|Overall Study||0
6508616|NCT01471197|7428147|FG001|COMPLETED|Overall Study||0
6508617|NCT01471197|7428146|FG000|NOT COMPLETED|Overall Study||6
6508618|NCT01471197|7428147|FG001|NOT COMPLETED|Overall Study||2
6508619|NCT01471353|7428153|FG000|STARTED|Overall Study||42
6508620|NCT01471353|7428153|FG000|COMPLETED|Overall Study||39
6508621|NCT01471353|7428153|FG000|NOT COMPLETED|Overall Study||3
6508622|NCT01471379|7428160|FG000|STARTED|Overall Study||1
6508623|NCT01471379|7428161|FG001|STARTED|Overall Study||1
6508624|NCT01471379|7428162|FG002|STARTED|Overall Study||0
6508625|NCT01471379|7428160|FG000|COMPLETED|Overall Study||0
6508626|NCT01471379|7428161|FG001|COMPLETED|Overall Study||0
6508627|NCT01471379|7428162|FG002|COMPLETED|Overall Study||0
6508628|NCT01471379|7428160|FG000|NOT COMPLETED|Overall Study||1
6508629|NCT01471379|7428161|FG001|NOT COMPLETED|Overall Study||1
6508630|NCT01471379|7428162|FG002|NOT COMPLETED|Overall Study||0
6508631|NCT01471457|7428173|FG000|STARTED|Overall Study||92
6508632|NCT01471457|7428174|FG001|STARTED|Overall Study||92
6508633|NCT01471457|7428173|FG000|COMPLETED|Overall Study||73
6508634|NCT01471457|7428174|FG001|COMPLETED|Overall Study||74
6508635|NCT01471457|7428173|FG000|NOT COMPLETED|Overall Study||19
6508636|NCT01471457|7428174|FG001|NOT COMPLETED|Overall Study||18
6253769|NCT00569127|7152437|FG001|Eligible|Overall Study||202
6253770|NCT00569127|7152436|FG000|COMPLETED|Overall Study||0
6253771|NCT00569127|7152437|FG001|COMPLETED|Overall Study||0
6253772|NCT00569127|7152436|FG000|NOT COMPLETED|Overall Study||214
6253773|NCT00569127|7152437|FG001|NOT COMPLETED|Overall Study||213
6508637|NCT01471522|7428182|FG000|STARTED|Overall Study||2588
6508638|NCT01471522|7428183|FG001|STARTED|Overall Study||2591
6508639|NCT01471522|7428182|FG000|COMPLETED|Overall Study||2524
6508640|NCT01471522|7428183|FG001|COMPLETED|Overall Study||2543
6508641|NCT01471522|7428182|FG000|NOT COMPLETED|Overall Study||64
6508642|NCT01471522|7428183|FG001|NOT COMPLETED|Overall Study||48
6508643|NCT01471574|7428194|FG000|STARTED|Treatment Period||132
6508644|NCT01471574|7428195|FG001|STARTED|Treatment Period||39
6508645|NCT01471574|7428196|FG002|STARTED|Treatment Period||106
6508646|NCT01471574|7428197|FG003|STARTED|Treatment Period||24
6278353|NCT00132730|7177934|FG005|STARTED|Period II - 12-week Treatment (Base)||0
6278354|NCT00132730|7177929|FG000|COMPLETED|Period II - 12-week Treatment (Base)||127
6278355|NCT00132730|7177930|FG001|COMPLETED|Period II - 12-week Treatment (Base)||133
6278356|NCT00132730|7177931|FG002|COMPLETED|Period II - 12-week Treatment (Base)||135
6278357|NCT00132730|7177932|FG003|COMPLETED|Period II - 12-week Treatment (Base)||131
6278358|NCT00132730|7177933|FG004|COMPLETED|Period II - 12-week Treatment (Base)||0
6278359|NCT00132730|7177934|FG005|COMPLETED|Period II - 12-week Treatment (Base)||0
6278360|NCT00132730|7177929|FG000|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
6278361|NCT00132730|7177930|FG001|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
6278362|NCT00132730|7177931|FG002|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
6278363|NCT00132730|7177932|FG003|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
6278364|NCT00132730|7177933|FG004|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
6278365|NCT00132730|7177934|FG005|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
6278366|NCT00132730|7177929|FG000|STARTED|Period III - Blinded Extension (EXT1)||0
6278367|NCT00132730|7177930|FG001|STARTED|Period III - Blinded Extension (EXT1)||0
6278368|NCT00132730|7177931|FG002|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
6278369|NCT00132730|7177932|FG003|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
6278370|NCT00132730|7177933|FG004|STARTED|Period III - Blinded Extension (EXT1)||0
6278371|NCT00132730|7177934|FG005|STARTED|Period III - Blinded Extension (EXT1)||0
6278372|NCT00132730|7177929|FG000|COMPLETED|Period III - Blinded Extension (EXT1)||0
6278373|NCT00132730|7177930|FG001|COMPLETED|Period III - Blinded Extension (EXT1)||0
6278374|NCT00132730|7177931|FG002|COMPLETED|Period III - Blinded Extension (EXT1)||235
6508647|NCT01471574|7428194|FG000|COMPLETED|Treatment Period||101
6508648|NCT01471574|7428195|FG001|COMPLETED|Treatment Period||29
6508649|NCT01471574|7428196|FG002|COMPLETED|Treatment Period||82
6278375|NCT00132730|7177932|FG003|COMPLETED|Period III - Blinded Extension (EXT1)||82
6278376|NCT00132730|7177933|FG004|COMPLETED|Period III - Blinded Extension (EXT1)||0
6278377|NCT00132730|7177934|FG005|COMPLETED|Period III - Blinded Extension (EXT1)||0
6278378|NCT00132730|7177929|FG000|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
6278379|NCT00132730|7177930|FG001|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
6278380|NCT00132730|7177931|FG002|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
6278381|NCT00132730|7177932|FG003|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
6278382|NCT00132730|7177933|FG004|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
6278383|NCT00132730|7177934|FG005|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
6278384|NCT00132730|7177929|FG000|STARTED|Period IV - Open-label Extension (EXT2)||0
6278385|NCT00132730|7177930|FG001|STARTED|Period IV - Open-label Extension (EXT2)||0
6278386|NCT00132730|7177931|FG002|STARTED|Period IV - Open-label Extension (EXT2)||0
6278387|NCT00132730|7177932|FG003|STARTED|Period IV - Open-label Extension (EXT2)||0
6278388|NCT00132730|7177933|FG004|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
6278389|NCT00132730|7177934|FG005|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
6278390|NCT00132730|7177929|FG000|COMPLETED|Period IV - Open-label Extension (EXT2)||0
6278391|NCT00132730|7177930|FG001|COMPLETED|Period IV - Open-label Extension (EXT2)||0
6278392|NCT00132730|7177931|FG002|COMPLETED|Period IV - Open-label Extension (EXT2)||0
6278393|NCT00132730|7177932|FG003|COMPLETED|Period IV - Open-label Extension (EXT2)||0
6278394|NCT00132730|7177933|FG004|COMPLETED|Period IV - Open-label Extension (EXT2)||8
6278395|NCT00132730|7177934|FG005|COMPLETED|Period IV - Open-label Extension (EXT2)||3
6278396|NCT00132730|7177929|FG000|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
6278397|NCT00132730|7177930|FG001|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
6278398|NCT00132730|7177931|FG002|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
6278399|NCT00132730|7177932|FG003|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
6278400|NCT00132730|7177933|FG004|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
6278401|NCT00132730|7177934|FG005|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
6278402|NCT00132730|7177929|FG000|STARTED|Period V - Open-label Extension (EXT2)||0
6278403|NCT00132730|7177930|FG001|STARTED|Period V - Open-label Extension (EXT2)||0
6508650|NCT01471574|7428197|FG003|COMPLETED|Treatment Period||21
6508651|NCT01471574|7428194|FG000|NOT COMPLETED|Treatment Period||31
6508652|NCT01471574|7428195|FG001|NOT COMPLETED|Treatment Period||10
6508653|NCT01471574|7428196|FG002|NOT COMPLETED|Treatment Period||24
6508654|NCT01471574|7428197|FG003|NOT COMPLETED|Treatment Period||3
6508655|NCT01471574|7428194|FG000|STARTED|Follow-up Period||121
6508656|NCT01471574|7428195|FG001|STARTED|Follow-up Period||34
6508657|NCT01471574|7428196|FG002|STARTED|Follow-up Period||102
6508658|NCT01471574|7428197|FG003|STARTED|Follow-up Period||24
6508659|NCT01471574|7428194|FG000|COMPLETED|Follow-up Period||114
6508660|NCT01471574|7428195|FG001|COMPLETED|Follow-up Period||32
6508661|NCT01471574|7428196|FG002|COMPLETED|Follow-up Period||95
6508662|NCT01471574|7428197|FG003|COMPLETED|Follow-up Period||21
6508663|NCT01471574|7428194|FG000|NOT COMPLETED|Follow-up Period||7
6508664|NCT01471574|7428195|FG001|NOT COMPLETED|Follow-up Period||2
6508665|NCT01471574|7428196|FG002|NOT COMPLETED|Follow-up Period||7
6253780|NCT04654351|7152456|FG000|STARTED|Overall Study||2
6253781|NCT04654351|7152456|FG000|COMPLETED|Overall Study||2
6253782|NCT04654351|7152456|FG000|NOT COMPLETED|Overall Study||0
6253783|NCT04422990|7152463|FG000|STARTED|Overall Study||50
6253784|NCT04422990|7152464|FG001|STARTED|Overall Study||97
6253785|NCT04422990|7152463|FG000|COMPLETED|Overall Study||47
6253786|NCT04422990|7152464|FG001|COMPLETED|Overall Study||96
6253787|NCT04422990|7152463|FG000|NOT COMPLETED|Overall Study||3
6253788|NCT04422990|7152464|FG001|NOT COMPLETED|Overall Study||1
6253789|NCT04388319|7152473|FG000|STARTED|Enrolled in Study||26
6253790|NCT04388319|7152473|FG000|COMPLETED|Enrolled in Study||24
6253791|NCT04388319|7152473|FG000|NOT COMPLETED|Enrolled in Study||2
6253792|NCT04388319|7152473|FG000|STARTED|Treatment Period||24
6253793|NCT04388319|7152473|FG000|COMPLETED|Treatment Period||23
6253794|NCT04388319|7152473|FG000|NOT COMPLETED|Treatment Period||1
6253795|NCT04358549|7152479|FG000|STARTED|Overall Study||25
6253796|NCT04358549|7152480|FG001|STARTED|Overall Study||25
6253797|NCT04358549|7152479|FG000|ITT Population (Randomized Subjects)|Overall Study||25
6253798|NCT04358549|7152480|FG001|ITT Population (Randomized Subjects)|Overall Study||25
6253799|NCT04358549|7152479|FG000|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||24
6253800|NCT04358549|7152480|FG001|Safety Population (Patients Who Received Either Favipiravir + SOC or SOC Alone)|Overall Study||25
6253801|NCT04358549|7152479|FG000|COMPLETED|Overall Study||15
6253802|NCT04358549|7152480|FG001|COMPLETED|Overall Study||17
6253803|NCT04358549|7152479|FG000|NOT COMPLETED|Overall Study||10
6253804|NCT04358549|7152480|FG001|NOT COMPLETED|Overall Study||8
6253805|NCT04229888|7152486|FG000|STARTED|Overall Study||14
6253806|NCT04229888|7152486|FG000|COMPLETED|Overall Study||14
6253807|NCT04229888|7152486|FG000|NOT COMPLETED|Overall Study||0
6253808|NCT04221828|7152493|FG000|STARTED|Overall Study||1
6253809|NCT04221828|7152493|FG000|COMPLETED|Overall Study||1
6253810|NCT04221828|7152493|FG000|NOT COMPLETED|Overall Study||0
6253811|NCT04095416|7152499|FG000|STARTED|Overall Study||13
6253812|NCT04095416|7152500|FG001|STARTED|Overall Study||19
6253813|NCT04095416|7152499|FG000|COMPLETED|Overall Study||10
6253814|NCT04095416|7152500|FG001|COMPLETED|Overall Study||19
6253815|NCT04095416|7152499|FG000|NOT COMPLETED|Overall Study||3
6253816|NCT04095416|7152500|FG001|NOT COMPLETED|Overall Study||0
6253817|NCT04018612|7152509|FG000|STARTED|Overall Study||44
6253818|NCT04018612|7152510|FG001|STARTED|Overall Study||44
6253819|NCT04018612|7152511|FG002|STARTED|Overall Study||22
6253820|NCT04018612|7152509|FG000|COMPLETED|Overall Study||43
6253821|NCT04018612|7152510|FG001|COMPLETED|Overall Study||44
6253822|NCT04018612|7152511|FG002|COMPLETED|Overall Study||21
6253823|NCT04018612|7152509|FG000|NOT COMPLETED|Overall Study||1
6253824|NCT04018612|7152510|FG001|NOT COMPLETED|Overall Study||0
6253825|NCT04018612|7152511|FG002|NOT COMPLETED|Overall Study||1
6253826|NCT03976648|7152521|FG000|STARTED|Overall Study||21
6253827|NCT03976648|7152522|FG001|STARTED|Overall Study||10
6253828|NCT03976648|7152521|FG000|COMPLETED|Overall Study||0
6253829|NCT03976648|7152522|FG001|COMPLETED|Overall Study||0
6253830|NCT03976648|7152521|FG000|NOT COMPLETED|Overall Study||21
6253831|NCT03976648|7152522|FG001|NOT COMPLETED|Overall Study||10
6253832|NCT03944486|7152528|FG000|STARTED|Overall Study||24
6253833|NCT03944486|7152528|FG000|COMPLETED|Overall Study||12
6253834|NCT03944486|7152528|FG000|NOT COMPLETED|Overall Study||12
6253835|NCT03895840|7152532|FG000|STARTED|Overall Study||70
6253836|NCT03895840|7152532|FG000|6-Week Follow-Up|Overall Study||70
6253837|NCT03895840|7152532|FG000|12-Week Follow-Up|Overall Study||65
6253838|NCT03895840|7152532|FG000|24-Week Follow-Up|Overall Study||49
6253839|NCT03895840|7152532|FG000|COMPLETED|Overall Study||49
6253840|NCT03895840|7152532|FG000|NOT COMPLETED|Overall Study||21
6253841|NCT03619902|7152536|FG000|STARTED|Overall Study||8
6253842|NCT03619902|7152536|FG000|COMPLETED|Overall Study||6
6253843|NCT03619902|7152536|FG000|NOT COMPLETED|Overall Study||2
6253844|NCT03617523|7152545|FG000|STARTED|Overall Study||30
6253845|NCT03617523|7152546|FG001|STARTED|Overall Study||30
6253846|NCT03617523|7152547|FG002|STARTED|Overall Study||61
6253847|NCT03617523|7152548|FG003|STARTED|Overall Study||59
6253848|NCT03617523|7152549|FG004|STARTED|Overall Study||60
6253849|NCT03617523|7152545|FG000|COMPLETED|Overall Study||30
6253850|NCT03617523|7152546|FG001|COMPLETED|Overall Study||30
6253851|NCT03617523|7152547|FG002|COMPLETED|Overall Study||61
6253852|NCT03617523|7152548|FG003|COMPLETED|Overall Study||59
6253853|NCT03617523|7152549|FG004|COMPLETED|Overall Study||60
6253854|NCT03617523|7152545|FG000|NOT COMPLETED|Overall Study||0
6253855|NCT03617523|7152546|FG001|NOT COMPLETED|Overall Study||0
6253856|NCT03617523|7152547|FG002|NOT COMPLETED|Overall Study||0
6253857|NCT03617523|7152548|FG003|NOT COMPLETED|Overall Study||0
6253858|NCT03617523|7152549|FG004|NOT COMPLETED|Overall Study||0
6253859|NCT03546192|7152568|FG000|STARTED|Overall Study||60
6570541|NCT01852058|7493867|FG001|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6253860|NCT03546192|7152569|FG001|STARTED|Overall Study||60
6253861|NCT03546192|7152568|FG000|COMPLETED|Overall Study||60
6253862|NCT03546192|7152569|FG001|COMPLETED|Overall Study||60
6253863|NCT03546192|7152568|FG000|NOT COMPLETED|Overall Study||0
6253864|NCT03546192|7152569|FG001|NOT COMPLETED|Overall Study||0
6253865|NCT03517449|7152577|FG000|STARTED|Overall Study||411
6253866|NCT03517449|7152578|FG001|STARTED|Overall Study||416
6253867|NCT03517449|7152577|FG000|Treated|Overall Study||406
6253868|NCT03517449|7152578|FG001|Treated|Overall Study||388
6253869|NCT03517449|7152577|FG000|COMPLETED|Overall Study||0
6253870|NCT03517449|7152578|FG001|COMPLETED|Overall Study||0
6253871|NCT03517449|7152577|FG000|NOT COMPLETED|Overall Study||411
6253872|NCT03517449|7152578|FG001|NOT COMPLETED|Overall Study||416
6278404|NCT00132730|7177931|FG002|STARTED|Period V - Open-label Extension (EXT2)||0
6278405|NCT00132730|7177932|FG003|STARTED|Period V - Open-label Extension (EXT2)||0
6278406|NCT00132730|7177933|FG004|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
6278407|NCT00132730|7177934|FG005|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
6278408|NCT00132730|7177929|FG000|COMPLETED|Period V - Open-label Extension (EXT2)||0
6278409|NCT00132730|7177930|FG001|COMPLETED|Period V - Open-label Extension (EXT2)||0
6278410|NCT00132730|7177931|FG002|COMPLETED|Period V - Open-label Extension (EXT2)||0
6278411|NCT00132730|7177932|FG003|COMPLETED|Period V - Open-label Extension (EXT2)||0
6278412|NCT00132730|7177933|FG004|COMPLETED|Period V - Open-label Extension (EXT2)||0
6278413|NCT00132730|7177934|FG005|COMPLETED|Period V - Open-label Extension (EXT2)||0
6278414|NCT00132730|7177929|FG000|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
6278415|NCT00132730|7177930|FG001|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
6278416|NCT00132730|7177931|FG002|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
6278417|NCT00132730|7177932|FG003|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
6278418|NCT00132730|7177933|FG004|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
6278419|NCT00132730|7177934|FG005|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
6278420|NCT00132769|7177950|FG000|STARTED|Overall Study||53
6278421|NCT00132769|7177951|FG001|STARTED|Overall Study||53
6278422|NCT00132769|7177950|FG000|COMPLETED|Overall Study||42
6278423|NCT00132769|7177951|FG001|COMPLETED|Overall Study||42
6278424|NCT00132769|7177950|FG000|NOT COMPLETED|Overall Study||11
6278425|NCT00132769|7177951|FG001|NOT COMPLETED|Overall Study||11
6278426|NCT00132808|7177960|FG000|STARTED|Stratum I||77
6278427|NCT00132808|7177961|FG001|STARTED|Stratum I||70
6278428|NCT00132808|7177962|FG002|STARTED|Stratum I||77
6278429|NCT00132808|7177960|FG000|COMPLETED|Stratum I||68
6278430|NCT00132808|7177961|FG001|COMPLETED|Stratum I||58
6278431|NCT00132808|7177962|FG002|COMPLETED|Stratum I||72
6278432|NCT00132808|7177960|FG000|NOT COMPLETED|Stratum I||9
6278433|NCT00132808|7177961|FG001|NOT COMPLETED|Stratum I||12
6278434|NCT00132808|7177962|FG002|NOT COMPLETED|Stratum I||5
6278435|NCT00132808|7177960|FG000|STARTED|Stratum II||121
6278436|NCT00132808|7177961|FG001|STARTED|Stratum II||111
6278437|NCT00132808|7177962|FG002|STARTED|Stratum II||125
6278438|NCT00132808|7177960|FG000|COMPLETED|Stratum II||113
6278439|NCT00132808|7177961|FG001|COMPLETED|Stratum II||96
6278440|NCT00132808|7177962|FG002|COMPLETED|Stratum II||116
6278441|NCT00132808|7177960|FG000|NOT COMPLETED|Stratum II||8
6278442|NCT00132808|7177961|FG001|NOT COMPLETED|Stratum II||15
6278443|NCT00132808|7177962|FG002|NOT COMPLETED|Stratum II||9
6280940|NCT00159965|7180764|FG000|NOT COMPLETED|Overall Study||7
6280941|NCT00159965|7180765|FG001|NOT COMPLETED|Overall Study||5
6280942|NCT00160199|7180773|FG000|STARTED|Overall Study||122
6280943|NCT00160199|7180774|FG001|STARTED|Overall Study||118
6280944|NCT00160199|7180773|FG000|COMPLETED|Overall Study||98
6280945|NCT00160199|7180774|FG001|COMPLETED|Overall Study||81
6280946|NCT00160199|7180773|FG000|NOT COMPLETED|Overall Study||24
6280947|NCT00160199|7180774|FG001|NOT COMPLETED|Overall Study||37
6280948|NCT00160251|7180786|FG000|STARTED|Prior to Amendment 2||15
6280949|NCT00160251|7180787|FG001|STARTED|Prior to Amendment 2||34
6280950|NCT00160251|7180788|FG002|STARTED|Prior to Amendment 2||48
6280951|NCT00160251|7180789|FG003|STARTED|Prior to Amendment 2||49
6280952|NCT00160251|7180790|FG004|STARTED|Prior to Amendment 2||49
6280953|NCT00160251|7180791|FG005|STARTED|Prior to Amendment 2||97
6280954|NCT00160251|7180792|FG006|STARTED|Prior to Amendment 2||65
6280955|NCT00160251|7180793|FG007|STARTED|Prior to Amendment 2||0
6280956|NCT00160251|7180786|FG000|COMPLETED|Prior to Amendment 2||6
6280957|NCT00160251|7180787|FG001|COMPLETED|Prior to Amendment 2||28
6508666|NCT01471574|7428197|FG003|NOT COMPLETED|Follow-up Period||3
6508667|NCT01471626|7428213|FG000|STARTED|Overall Study||21
6508668|NCT01471626|7428213|FG000|COMPLETED|Overall Study||21
6508669|NCT01471626|7428213|FG000|NOT COMPLETED|Overall Study||0
6508670|NCT01471639|7428217|FG000|STARTED|Overall Study||37
6508671|NCT01471639|7428217|FG000|COMPLETED|Overall Study||37
6508672|NCT01471639|7428217|FG000|NOT COMPLETED|Overall Study||0
6508673|NCT01471691|7428223|FG000|STARTED|Overall Study||8
6508674|NCT01471691|7428224|FG001|STARTED|Overall Study||6
6508675|NCT01471691|7428223|FG000|COMPLETED|Overall Study||8
6508676|NCT01471691|7428224|FG001|COMPLETED|Overall Study||5
6280958|NCT00160251|7180788|FG002|COMPLETED|Prior to Amendment 2||4
6280959|NCT00160251|7180789|FG003|COMPLETED|Prior to Amendment 2||9
6280960|NCT00160251|7180790|FG004|COMPLETED|Prior to Amendment 2||21
6280961|NCT00160251|7180791|FG005|COMPLETED|Prior to Amendment 2||14
6280962|NCT00160251|7180792|FG006|COMPLETED|Prior to Amendment 2||61
6280963|NCT00160251|7180793|FG007|COMPLETED|Prior to Amendment 2||0
6280964|NCT00160251|7180786|FG000|NOT COMPLETED|Prior to Amendment 2||9
6280965|NCT00160251|7180787|FG001|NOT COMPLETED|Prior to Amendment 2||6
6508677|NCT01471691|7428223|FG000|NOT COMPLETED|Overall Study||0
6280966|NCT00160251|7180788|FG002|NOT COMPLETED|Prior to Amendment 2||44
6280967|NCT00160251|7180789|FG003|NOT COMPLETED|Prior to Amendment 2||40
6280968|NCT00160251|7180790|FG004|NOT COMPLETED|Prior to Amendment 2||28
6508678|NCT01471691|7428224|FG001|NOT COMPLETED|Overall Study||1
6508679|NCT01471782|7428236|FG000|STARTED|Overall Study||5
6253873|NCT03470922|7152586|FG000|STARTED|Overall Study||355
6253874|NCT03470922|7152587|FG001|STARTED|Overall Study||359
6253875|NCT03470922|7152586|FG000|COMPLETED|Overall Study||237
6253876|NCT03470922|7152587|FG001|COMPLETED|Overall Study||227
6253877|NCT03470922|7152586|FG000|NOT COMPLETED|Overall Study||118
6253878|NCT03470922|7152587|FG001|NOT COMPLETED|Overall Study||132
6253879|NCT03387852|7152597|FG000|STARTED|Overall Study||74
6253880|NCT03387852|7152598|FG001|STARTED|Overall Study||73
6253881|NCT03387852|7152599|FG002|STARTED|Overall Study||74
6253882|NCT03387852|7152600|FG003|STARTED|Overall Study||75
6253883|NCT03387852|7152597|FG000|Treated|Overall Study||74
6253884|NCT03387852|7152598|FG001|Treated|Overall Study||73
6253885|NCT03387852|7152599|FG002|Treated|Overall Study||74
6253886|NCT03387852|7152600|FG003|Treated|Overall Study||74
6253887|NCT03387852|7152597|FG000|COMPLETED|Overall Study||41
6253888|NCT03387852|7152598|FG001|COMPLETED|Overall Study||55
6253889|NCT03387852|7152599|FG002|COMPLETED|Overall Study||47
6253890|NCT03387852|7152600|FG003|COMPLETED|Overall Study||56
6253891|NCT03387852|7152597|FG000|NOT COMPLETED|Overall Study||33
6253892|NCT03387852|7152598|FG001|NOT COMPLETED|Overall Study||18
6253893|NCT03387852|7152599|FG002|NOT COMPLETED|Overall Study||27
6253894|NCT03387852|7152600|FG003|NOT COMPLETED|Overall Study||19
6253895|NCT03308825|7152615|FG000|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|59
6253896|NCT03308825|7152616|FG001|STARTED|Overall Study|1 child in Group 1 received a 0.5mL dose instead of a 0.25 mL dose and is included in Group 2.|61
6253897|NCT03308825|7152617|FG002|STARTED|Overall Study||60
6253898|NCT03308825|7152618|FG003|STARTED|Overall Study||60
6253899|NCT03308825|7152615|FG000|COMPLETED|Overall Study||57
6253900|NCT03308825|7152616|FG001|COMPLETED|Overall Study||57
6253901|NCT03308825|7152617|FG002|COMPLETED|Overall Study||59
6253902|NCT03308825|7152618|FG003|COMPLETED|Overall Study||60
6253903|NCT03308825|7152615|FG000|NOT COMPLETED|Overall Study||2
6253904|NCT03308825|7152616|FG001|NOT COMPLETED|Overall Study||4
6253905|NCT03308825|7152617|FG002|NOT COMPLETED|Overall Study||1
6253906|NCT03308825|7152618|FG003|NOT COMPLETED|Overall Study||0
6253907|NCT02915302|7152634|FG000|STARTED|Overall Study||955
6253908|NCT02915302|7152635|FG001|STARTED|Overall Study||995
6253909|NCT02915302|7152634|FG000|Vaccinated (Safety Analysis Set)|Overall Study||949
6253910|NCT02915302|7152635|FG001|Vaccinated (Safety Analysis Set)|Overall Study||992
6253911|NCT02915302|7152634|FG000|COMPLETED|Overall Study||890
6253912|NCT02915302|7152635|FG001|COMPLETED|Overall Study||917
6253913|NCT02915302|7152634|FG000|NOT COMPLETED|Overall Study||65
6253914|NCT02915302|7152635|FG001|NOT COMPLETED|Overall Study||78
6253915|NCT02908269|7152644|FG000|STARTED|Overall Study||60
6253916|NCT02908269|7152645|FG001|STARTED|Overall Study||60
6253917|NCT02908269|7152646|FG002|STARTED|Overall Study||60
6253918|NCT02908269|7152644|FG000|COMPLETED|Overall Study||60
6253919|NCT02908269|7152645|FG001|COMPLETED|Overall Study||60
6253920|NCT02908269|7152646|FG002|COMPLETED|Overall Study||60
6253921|NCT02908269|7152644|FG000|NOT COMPLETED|Overall Study||0
6253922|NCT02908269|7152645|FG001|NOT COMPLETED|Overall Study||0
6253923|NCT02908269|7152646|FG002|NOT COMPLETED|Overall Study||0
6253924|NCT02744040|7152658|FG000|STARTED|Overall Study||28
6253925|NCT02744040|7152659|FG001|STARTED|Overall Study||51
6253926|NCT02744040|7152660|FG002|STARTED|Overall Study||72
6253927|NCT02744040|7152658|FG000|COMPLETED|Overall Study||22
6253928|NCT02744040|7152659|FG001|COMPLETED|Overall Study||40
6570542|NCT01852058|7493868|FG002|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570543|NCT01852058|7493869|FG003|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570544|NCT01852058|7493870|FG004|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570545|NCT01852058|7493871|FG005|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570546|NCT01852058|7493872|FG006|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6253929|NCT02744040|7152660|FG002|COMPLETED|Overall Study||50
6253930|NCT02744040|7152658|FG000|NOT COMPLETED|Overall Study||6
6253931|NCT02744040|7152659|FG001|NOT COMPLETED|Overall Study||11
6253932|NCT02744040|7152660|FG002|NOT COMPLETED|Overall Study||22
6253933|NCT02698826|7152668|FG000|STARTED|Overall Study||16
6508680|NCT01471782|7428237|FG001|STARTED|Overall Study||7
6508681|NCT01471782|7428238|FG002|STARTED|Overall Study||5
6508682|NCT01471782|7428239|FG003|STARTED|Overall Study||6
6508683|NCT01471782|7428240|FG004|STARTED|Overall Study||26
6508684|NCT01471782|7428241|FG005|STARTED|Overall Study||44
6508685|NCT01471782|7428236|FG000|COMPLETED|Overall Study|Completed 5 cycles|0
6508686|NCT01471782|7428237|FG001|COMPLETED|Overall Study|Completed 5 cycles|1
6508687|NCT01471782|7428238|FG002|COMPLETED|Overall Study|Completed 5 cycles|0
6508688|NCT01471782|7428239|FG003|COMPLETED|Overall Study|Completed 5 cycles|1
6570547|NCT01852058|7493873|FG007|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6623570|NCT02208297|7550720|FG001|NOT COMPLETED|Overall Study||56
6253934|NCT02698826|7152668|FG000|COMPLETED|Overall Study||2
6253935|NCT02698826|7152668|FG000|NOT COMPLETED|Overall Study||14
6253936|NCT02617589|7152676|FG000|STARTED|All Randomized||280
6253937|NCT02617589|7152677|FG001|STARTED|All Randomized||280
6253938|NCT02617589|7152676|FG000|COMPLETED|All Randomized||278
6253939|NCT02617589|7152677|FG001|COMPLETED|All Randomized||275
6253940|NCT02617589|7152676|FG000|NOT COMPLETED|All Randomized||2
6253941|NCT02617589|7152677|FG001|NOT COMPLETED|All Randomized||5
6253942|NCT02617589|7152676|FG000|STARTED|Treatment Period||278
6508689|NCT01471782|7428240|FG004|COMPLETED|Overall Study|Completed 5 cycles|0
6253943|NCT02617589|7152677|FG001|STARTED|Treatment Period||275
6253944|NCT02617589|7152676|FG000|COMPLETED|Treatment Period||4
6253945|NCT02617589|7152677|FG001|COMPLETED|Treatment Period||1
6253946|NCT02617589|7152676|FG000|NOT COMPLETED|Treatment Period||274
6253947|NCT02617589|7152677|FG001|NOT COMPLETED|Treatment Period||274
6253948|NCT02614859|7152685|FG000|STARTED|Overall Study||9
6253949|NCT02614859|7152686|FG001|STARTED|Overall Study||20
6253950|NCT02614859|7152685|FG000|COMPLETED|Overall Study||9
6253951|NCT02614859|7152686|FG001|COMPLETED|Overall Study||19
6253952|NCT02614859|7152685|FG000|NOT COMPLETED|Overall Study||0
6253953|NCT02614859|7152686|FG001|NOT COMPLETED|Overall Study||1
6278444|NCT00132873|7177970|FG000|STARTED|Overall Study||59
6278445|NCT00132873|7177970|FG000|COMPLETED|Overall Study||50
6278446|NCT00132873|7177970|FG000|NOT COMPLETED|Overall Study||9
6278447|NCT00132964|7177976|FG000|STARTED|Overall Study||54
6278448|NCT00132964|7177977|FG001|STARTED|Overall Study||57
6278449|NCT00132964|7177976|FG000|COMPLETED|Overall Study||50
6278450|NCT00132964|7177977|FG001|COMPLETED|Overall Study||54
6278451|NCT00132964|7177976|FG000|NOT COMPLETED|Overall Study||4
6278452|NCT00132964|7177977|FG001|NOT COMPLETED|Overall Study||3
6278453|NCT00133575|7177990|FG000|STARTED|Overall Study||10
6278454|NCT00133575|7177991|FG001|STARTED|Overall Study||10
6278455|NCT00133575|7177992|FG002|STARTED|Overall Study||10
6278456|NCT00133575|7177993|FG003|STARTED|Overall Study||10
6278457|NCT00133575|7177994|FG004|STARTED|Overall Study||10
6278458|NCT00133575|7177995|FG005|STARTED|Overall Study||10
6278459|NCT00133575|7177996|FG006|STARTED|Overall Study||12
6278460|NCT00133575|7177990|FG000|COMPLETED|Overall Study||10
6278461|NCT00133575|7177991|FG001|COMPLETED|Overall Study||10
6278462|NCT00133575|7177992|FG002|COMPLETED|Overall Study||8
6278463|NCT00133575|7177993|FG003|COMPLETED|Overall Study||9
6278464|NCT00133575|7177994|FG004|COMPLETED|Overall Study||6
6278465|NCT00133575|7177995|FG005|COMPLETED|Overall Study||9
6278466|NCT00133575|7177996|FG006|COMPLETED|Overall Study||9
6278467|NCT00133575|7177990|FG000|NOT COMPLETED|Overall Study||0
6278468|NCT00133575|7177991|FG001|NOT COMPLETED|Overall Study||0
6278469|NCT00133575|7177992|FG002|NOT COMPLETED|Overall Study||2
6278470|NCT00133575|7177993|FG003|NOT COMPLETED|Overall Study||1
6278471|NCT00133575|7177994|FG004|NOT COMPLETED|Overall Study||4
6278472|NCT00133575|7177995|FG005|NOT COMPLETED|Overall Study||1
6278473|NCT00133575|7177996|FG006|NOT COMPLETED|Overall Study||3
6278474|NCT00133705|7178014|FG000|STARTED|Overall Study||22
6278475|NCT00133705|7178015|FG001|STARTED|Overall Study||20
6278476|NCT00133705|7178014|FG000|COMPLETED|Overall Study||20
6278477|NCT00133705|7178015|FG001|COMPLETED|Overall Study||17
6278478|NCT00133705|7178014|FG000|NOT COMPLETED|Overall Study||2
6278479|NCT00133705|7178015|FG001|NOT COMPLETED|Overall Study||3
6278480|NCT00133809|7178021|FG000|STARTED|Overall Study||8
6278481|NCT00133809|7178021|FG000|COMPLETED|Overall Study||8
6278482|NCT00133809|7178021|FG000|NOT COMPLETED|Overall Study||0
6508690|NCT01471782|7428241|FG005|COMPLETED|Overall Study|Completed 5 cycles|3
6508691|NCT01471782|7428236|FG000|NOT COMPLETED|Overall Study||5
6508692|NCT01471782|7428237|FG001|NOT COMPLETED|Overall Study||6
6508693|NCT01471782|7428238|FG002|NOT COMPLETED|Overall Study||5
6508694|NCT01471782|7428239|FG003|NOT COMPLETED|Overall Study||5
6508695|NCT01471782|7428240|FG004|NOT COMPLETED|Overall Study||26
6508696|NCT01471782|7428241|FG005|NOT COMPLETED|Overall Study||41
6508697|NCT01472185|7428268|FG000|STARTED|Overall Study||232
6508698|NCT01472185|7428269|FG001|STARTED|Overall Study||233
6508699|NCT01472185|7428268|FG000|COMPLETED|Overall Study||198
6508700|NCT01472185|7428269|FG001|COMPLETED|Overall Study||199
6508701|NCT01472185|7428268|FG000|NOT COMPLETED|Overall Study||34
6508702|NCT01472185|7428269|FG001|NOT COMPLETED|Overall Study||34
6508703|NCT01472289|7428275|FG000|STARTED|Overall Study||17
6508704|NCT01472289|7428275|FG000|COMPLETED|Overall Study||15
6508705|NCT01472289|7428275|FG000|NOT COMPLETED|Overall Study||2
6508706|NCT01472341|7428279|FG000|STARTED|Overall Study||507
6508707|NCT01472341|7428279|FG000|COMPLETED|Overall Study||235
6508708|NCT01472341|7428279|FG000|NOT COMPLETED|Overall Study||272
6508709|NCT01472380|7428283|FG000|STARTED|Efavirenz Alone||30
6508710|NCT01472380|7428283|FG000|COMPLETED|Efavirenz Alone||29
6508711|NCT01472380|7428283|FG000|NOT COMPLETED|Efavirenz Alone||1
6508712|NCT01472380|7428283|FG000|STARTED|Fenofibric Acid (FFA) Alone||29
6508713|NCT01472380|7428283|FG000|COMPLETED|Fenofibric Acid (FFA) Alone||29
6508714|NCT01472380|7428283|FG000|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
6508715|NCT01472380|7428283|FG000|STARTED|1 Day Period Between Dosing||29
6508716|NCT01472380|7428283|FG000|COMPLETED|1 Day Period Between Dosing||28
6508717|NCT01472380|7428283|FG000|NOT COMPLETED|1 Day Period Between Dosing||1
6508718|NCT01472380|7428283|FG000|STARTED|Efavirenz and FFA||28
6508719|NCT01472380|7428283|FG000|COMPLETED|Efavirenz and FFA||28
6508720|NCT01472380|7428283|FG000|NOT COMPLETED|Efavirenz and FFA||0
6508721|NCT01472432|7428292|FG000|STARTED|Overall Study||53
6508722|NCT01472432|7428293|FG001|STARTED|Overall Study||53
6508723|NCT01472432|7428292|FG000|Ulcer Reduction|Overall Study||13
6508724|NCT01472432|7428293|FG001|Ulcer Reduction|Overall Study||33
6508725|NCT01472432|7428292|FG000|COMPLETED|Overall Study||53
6508726|NCT01472432|7428293|FG001|COMPLETED|Overall Study||53
6508727|NCT01472432|7428292|FG000|NOT COMPLETED|Overall Study||0
6508728|NCT01472432|7428293|FG001|NOT COMPLETED|Overall Study||0
6278483|NCT00133952|7178027|FG000|STARTED|Overall Study||157
6278484|NCT00133952|7178028|FG001|STARTED|Overall Study||152
6508729|NCT01472445|7428303|FG000|STARTED|Overall Study||25
6508730|NCT01472445|7428304|FG001|STARTED|Overall Study||16
6253954|NCT02614066|7152698|FG000|STARTED|Overall Study||6
6253955|NCT02614066|7152699|FG001|STARTED|Overall Study||28
6253956|NCT02614066|7152700|FG002|STARTED|Overall Study||20
6253957|NCT02614066|7152701|FG003|STARTED|Overall Study||71
6253958|NCT02614066|7152698|FG000|COMPLETED|Overall Study||0
6253959|NCT02614066|7152699|FG001|COMPLETED|Overall Study||0
6253960|NCT02614066|7152700|FG002|COMPLETED|Overall Study||0
6253961|NCT02614066|7152701|FG003|COMPLETED|Overall Study||0
6253962|NCT02614066|7152698|FG000|NOT COMPLETED|Overall Study||6
6253963|NCT02614066|7152699|FG001|NOT COMPLETED|Overall Study||28
6253964|NCT02614066|7152700|FG002|NOT COMPLETED|Overall Study||20
6570548|NCT01852058|7493874|FG008|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570549|NCT01852058|7493875|FG009|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6253965|NCT02614066|7152701|FG003|NOT COMPLETED|Overall Study||71
6253966|NCT02558634|7152709|FG000|STARTED|Blinded: First Intervention (3 Months)||4
6253967|NCT02558634|7152710|FG001|STARTED|Blinded: First Intervention (3 Months)||2
6253968|NCT02558634|7152709|FG000|COMPLETED|Blinded: First Intervention (3 Months)||4
6253969|NCT02558634|7152710|FG001|COMPLETED|Blinded: First Intervention (3 Months)||2
6253970|NCT02558634|7152709|FG000|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
6253971|NCT02558634|7152710|FG001|NOT COMPLETED|Blinded: First Intervention (3 Months)||0
6253972|NCT02558634|7152709|FG000|STARTED|Blinded: Second Intervention (3 Months)||4
6253973|NCT02558634|7152710|FG001|STARTED|Blinded: Second Intervention (3 Months)||2
6253974|NCT02558634|7152709|FG000|COMPLETED|Blinded: Second Intervention (3 Months)|Assessed after 2 weeks - 1 participant requested to have their DBS 'on'|3
6253975|NCT02558634|7152710|FG001|COMPLETED|Blinded: Second Intervention (3 Months)||2
6253976|NCT02558634|7152709|FG000|NOT COMPLETED|Blinded: Second Intervention (3 Months)||1
6253977|NCT02558634|7152710|FG001|NOT COMPLETED|Blinded: Second Intervention (3 Months)||0
6253978|NCT02558634|7152709|FG000|STARTED|Unblinded: DBS on (6 Months)||4
6508731|NCT01472445|7428303|FG000|COMPLETED|Overall Study||25
6508732|NCT01472445|7428304|FG001|COMPLETED|Overall Study||16
6508733|NCT01472445|7428303|FG000|NOT COMPLETED|Overall Study||0
6508734|NCT01472445|7428304|FG001|NOT COMPLETED|Overall Study||0
6508735|NCT01472549|7428314|FG000|STARTED|Overall Study||572
6508736|NCT01472549|7428315|FG001|STARTED|Overall Study||575
6508737|NCT01472549|7428314|FG000|COMPLETED|Overall Study||572
6508738|NCT01472549|7428315|FG001|COMPLETED|Overall Study||575
6508739|NCT01472549|7428314|FG000|NOT COMPLETED|Overall Study||0
6508740|NCT01472549|7428315|FG001|NOT COMPLETED|Overall Study||0
6508741|NCT01472718|7428323|FG000|STARTED|Overall Study||104
6508742|NCT01472718|7428324|FG001|STARTED|Overall Study||104
6508743|NCT01472718|7428323|FG000|COMPLETED|Overall Study||98
6508744|NCT01472718|7428324|FG001|COMPLETED|Overall Study||97
6508745|NCT01472718|7428323|FG000|NOT COMPLETED|Overall Study||6
6508746|NCT01472718|7428324|FG001|NOT COMPLETED|Overall Study||7
6508747|NCT01472757|7428334|FG000|STARTED|Overall Study||91
6508748|NCT01472757|7428335|FG001|STARTED|Overall Study||93
6570550|NCT01852058|7493876|FG010|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570551|NCT01852058|7493877|FG011|NOT COMPLETED|Treatment Cycle4:Retreatment 3,Study 121||0
6570552|NCT01852071|7493914|FG000|STARTED|Overall Study||20
6570553|NCT01852071|7493915|FG001|STARTED|Overall Study||26
6570554|NCT01852071|7493914|FG000|COMPLETED|Overall Study||20
6570555|NCT01852071|7493915|FG001|COMPLETED|Overall Study||26
6570556|NCT01852071|7493914|FG000|NOT COMPLETED|Overall Study||0
6570557|NCT01852071|7493915|FG001|NOT COMPLETED|Overall Study||0
6570558|NCT01852084|7493931|FG000|STARTED|Overall Study||79
6570559|NCT01852084|7493932|FG001|STARTED|Overall Study||80
6570560|NCT01852084|7493933|FG002|STARTED|Overall Study||20
6570561|NCT01852084|7493934|FG003|STARTED|Overall Study||12
6570562|NCT01852084|7493931|FG000|COMPLETED|Overall Study||79
6570563|NCT01852084|7493932|FG001|COMPLETED|Overall Study||80
6570564|NCT01852084|7493933|FG002|COMPLETED|Overall Study||18
6570565|NCT01852084|7493934|FG003|COMPLETED|Overall Study||12
6570566|NCT01852084|7493931|FG000|NOT COMPLETED|Overall Study||0
6570567|NCT01852084|7493932|FG001|NOT COMPLETED|Overall Study||0
6570568|NCT01852084|7493933|FG002|NOT COMPLETED|Overall Study||2
6570569|NCT01852084|7493934|FG003|NOT COMPLETED|Overall Study||0
6570570|NCT01852110|7493946|FG000|STARTED|Overall Study||120
6570571|NCT01852110|7493947|FG001|STARTED|Overall Study||120
6570572|NCT01852110|7493948|FG002|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6508749|NCT01472757|7428336|FG002|STARTED|Overall Study||95
6508750|NCT01472757|7428337|FG003|STARTED|Overall Study||94
6508751|NCT01472757|7428334|FG000|Full Analysis Set|Overall Study||91
6570573|NCT01852110|7493949|FG003|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6570574|NCT01852110|7493950|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6570575|NCT01852110|7493951|FG005|STARTED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6253979|NCT02558634|7152710|FG001|STARTED|Unblinded: DBS on (6 Months)||2
6253980|NCT02558634|7152709|FG000|COMPLETED|Unblinded: DBS on (6 Months)||4
6253981|NCT02558634|7152710|FG001|COMPLETED|Unblinded: DBS on (6 Months)||2
6253982|NCT02558634|7152709|FG000|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
6253983|NCT02558634|7152710|FG001|NOT COMPLETED|Unblinded: DBS on (6 Months)||0
6508752|NCT01472757|7428335|FG001|Full Analysis Set|Overall Study||93
6508753|NCT01472757|7428336|FG002|Full Analysis Set|Overall Study||92
6508754|NCT01472757|7428337|FG003|Full Analysis Set|Overall Study||92
6508755|NCT01472757|7428334|FG000|COMPLETED|Overall Study||61
6508756|NCT01472757|7428335|FG001|COMPLETED|Overall Study||80
6253984|NCT02519348|7152729|FG000|STARTED|Overall Study||40
6253985|NCT02519348|7152730|FG001|STARTED|Overall Study||104
6253986|NCT02519348|7152731|FG002|STARTED|Overall Study||75
6253987|NCT02519348|7152732|FG003|STARTED|Overall Study||69
6253988|NCT02519348|7152733|FG004|STARTED|Overall Study||84
6253989|NCT02519348|7152734|FG005|STARTED|Overall Study||47
6253990|NCT02519348|7152735|FG006|STARTED|Overall Study||3
6253991|NCT02519348|7152736|FG007|STARTED|Overall Study||5
6253992|NCT02519348|7152737|FG008|STARTED|Overall Study||6
6253993|NCT02519348|7152729|FG000|Treated|Overall Study||40
6253994|NCT02519348|7152730|FG001|Treated|Overall Study||101
6253995|NCT02519348|7152731|FG002|Treated|Overall Study||74
6253996|NCT02519348|7152732|FG003|Treated|Overall Study||69
6253997|NCT02519348|7152733|FG004|Treated|Overall Study||82
6253998|NCT02519348|7152734|FG005|Treated|Overall Study||47
6253999|NCT02519348|7152735|FG006|Treated|Overall Study||3
6254000|NCT02519348|7152736|FG007|Treated|Overall Study||5
6254001|NCT02519348|7152737|FG008|Treated|Overall Study||5
6254002|NCT02519348|7152729|FG000|COMPLETED|Overall Study||0
6254003|NCT02519348|7152730|FG001|COMPLETED|Overall Study||0
6254004|NCT02519348|7152731|FG002|COMPLETED|Overall Study||0
6254005|NCT02519348|7152732|FG003|COMPLETED|Overall Study||0
6254006|NCT02519348|7152733|FG004|COMPLETED|Overall Study||0
6254007|NCT02519348|7152734|FG005|COMPLETED|Overall Study||0
6254008|NCT02519348|7152735|FG006|COMPLETED|Overall Study||0
6254009|NCT02519348|7152736|FG007|COMPLETED|Overall Study||0
6254010|NCT02519348|7152737|FG008|COMPLETED|Overall Study||0
6254011|NCT02519348|7152729|FG000|NOT COMPLETED|Overall Study||40
6254012|NCT02519348|7152730|FG001|NOT COMPLETED|Overall Study||104
6254013|NCT02519348|7152731|FG002|NOT COMPLETED|Overall Study||75
6254014|NCT02519348|7152732|FG003|NOT COMPLETED|Overall Study||69
6254015|NCT02519348|7152733|FG004|NOT COMPLETED|Overall Study||84
6254016|NCT02519348|7152734|FG005|NOT COMPLETED|Overall Study||47
6254017|NCT02519348|7152735|FG006|NOT COMPLETED|Overall Study||3
6254018|NCT02519348|7152736|FG007|NOT COMPLETED|Overall Study||5
6254019|NCT02519348|7152737|FG008|NOT COMPLETED|Overall Study||6
6254020|NCT02429414|7152760|FG000|STARTED|Overall Study||42
6254021|NCT02429414|7152761|FG001|STARTED|Overall Study||38
6254022|NCT02429414|7152760|FG000|COMPLETED|Overall Study||42
6254023|NCT02429414|7152761|FG001|COMPLETED|Overall Study||37
6254024|NCT02429414|7152760|FG000|NOT COMPLETED|Overall Study||0
6254025|NCT02429414|7152761|FG001|NOT COMPLETED|Overall Study||1
6508757|NCT01472757|7428336|FG002|COMPLETED|Overall Study||76
6508758|NCT01472757|7428337|FG003|COMPLETED|Overall Study||75
6508759|NCT01472757|7428334|FG000|NOT COMPLETED|Overall Study||30
6508760|NCT01472757|7428335|FG001|NOT COMPLETED|Overall Study||13
6508761|NCT01472757|7428336|FG002|NOT COMPLETED|Overall Study||19
6508762|NCT01472757|7428337|FG003|NOT COMPLETED|Overall Study||19
6508763|NCT01472822|7428349|FG000|STARTED|Overall Study||30
6508764|NCT01472822|7428350|FG001|STARTED|Overall Study||30
6508765|NCT01472822|7428349|FG000|COMPLETED|Overall Study||28
6508766|NCT01472822|7428350|FG001|COMPLETED|Overall Study||28
6508767|NCT01472822|7428349|FG000|NOT COMPLETED|Overall Study||2
6508768|NCT01472822|7428350|FG001|NOT COMPLETED|Overall Study||2
6508769|NCT01472835|7428358|FG000|STARTED|Overall Study||37
6508770|NCT01472835|7428359|FG001|STARTED|Overall Study||36
6508771|NCT01472835|7428358|FG000|COMPLETED|Overall Study||35
6508772|NCT01472835|7428359|FG001|COMPLETED|Overall Study||36
6508773|NCT01472835|7428358|FG000|NOT COMPLETED|Overall Study||2
6508774|NCT01472835|7428359|FG001|NOT COMPLETED|Overall Study||0
6508775|NCT01472874|7428368|FG000|STARTED|Overall Study||8
6508776|NCT01472874|7428368|FG000|COMPLETED|Overall Study||8
6508777|NCT01472874|7428368|FG000|NOT COMPLETED|Overall Study||0
6508778|NCT01472939|7428376|FG000|STARTED|Overall Study||123
6508779|NCT01472939|7428377|FG001|STARTED|Overall Study||119
6508780|NCT01472939|7428378|FG002|STARTED|Overall Study||119
6508781|NCT01472939|7428379|FG003|STARTED|Overall Study||119
6508782|NCT01472939|7428376|FG000|COMPLETED|Overall Study||103
6508783|NCT01472939|7428377|FG001|COMPLETED|Overall Study||105
6570576|NCT01852110|7493946|FG000|Treated|Overall Study||119
6570577|NCT01852110|7493947|FG001|Treated|Overall Study||120
6570578|NCT01852110|7493948|FG002|Treated|Overall Study||0
6570579|NCT01852110|7493949|FG003|Treated|Overall Study||0
6508784|NCT01472939|7428378|FG002|COMPLETED|Overall Study||108
6570580|NCT01852110|7493950|FG004|Treated|Overall Study||0
6508785|NCT01472939|7428379|FG003|COMPLETED|Overall Study||99
6508786|NCT01472939|7428376|FG000|NOT COMPLETED|Overall Study||20
6508787|NCT01472939|7428377|FG001|NOT COMPLETED|Overall Study||14
6508788|NCT01472939|7428378|FG002|NOT COMPLETED|Overall Study||11
6508789|NCT01472939|7428379|FG003|NOT COMPLETED|Overall Study||20
6508790|NCT01472965|7428394|FG000|STARTED|Overall Study||49
6508791|NCT01472965|7428395|FG001|STARTED|Overall Study||46
6508792|NCT01472965|7428394|FG000|COMPLETED|Overall Study||48
6508793|NCT01472965|7428395|FG001|COMPLETED|Overall Study||46
6508794|NCT01472965|7428394|FG000|NOT COMPLETED|Overall Study||1
6508795|NCT01472965|7428395|FG001|NOT COMPLETED|Overall Study||0
6508796|NCT01473160|7428401|FG000|STARTED|Overall Study||9
6570581|NCT01852110|7493951|FG005|Treated|Overall Study||0
6570582|NCT01852110|7493946|FG000|COMPLETED|Overall Study||70
6570583|NCT01852110|7493947|FG001|COMPLETED|Overall Study||74
6570584|NCT01852110|7493948|FG002|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6570585|NCT01852110|7493949|FG003|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6570586|NCT01852110|7493950|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6570587|NCT01852110|7493951|FG005|COMPLETED|Overall Study|Study terminated prior to participant recruitment for Stage 2|0
6570588|NCT01852110|7493946|FG000|NOT COMPLETED|Overall Study||50
6570589|NCT01852110|7493947|FG001|NOT COMPLETED|Overall Study||46
6254034|NCT02267603|7152776|FG000|STARTED|Overall Study||50
6254035|NCT02267603|7152776|FG000|COMPLETED|Overall Study||6
6254036|NCT02267603|7152776|FG000|NOT COMPLETED|Overall Study||44
6254037|NCT02258659|7152780|FG000|STARTED|Overall Study||62
6254038|NCT02258659|7152780|FG000|COMPLETED|Overall Study||61
6254039|NCT02258659|7152780|FG000|NOT COMPLETED|Overall Study||1
6254040|NCT02111850|7152795|FG000|STARTED|Phase 1 Dose Escalation||1
6254041|NCT02111850|7152796|FG001|STARTED|Phase 1 Dose Escalation||1
6254042|NCT02111850|7152797|FG002|STARTED|Phase 1 Dose Escalation||1
6254043|NCT02111850|7152798|FG003|STARTED|Phase 1 Dose Escalation||1
6254044|NCT02111850|7152799|FG004|STARTED|Phase 1 Dose Escalation||2
6254045|NCT02111850|7152800|FG005|STARTED|Phase 1 Dose Escalation||1
6254046|NCT02111850|7152801|FG006|STARTED|Phase 1 Dose Escalation||1
6254047|NCT02111850|7152802|FG007|STARTED|Phase 1 Dose Escalation||1
6254048|NCT02111850|7152803|FG008|STARTED|Phase 1 Dose Escalation||6
6254049|NCT02111850|7152804|FG009|STARTED|Phase 1 Dose Escalation||0
6254050|NCT02111850|7152805|FG010|STARTED|Phase 1 Dose Escalation||0
6254051|NCT02111850|7152795|FG000|COMPLETED|Phase 1 Dose Escalation||1
6254052|NCT02111850|7152796|FG001|COMPLETED|Phase 1 Dose Escalation||1
6254053|NCT02111850|7152797|FG002|COMPLETED|Phase 1 Dose Escalation||1
6254054|NCT02111850|7152798|FG003|COMPLETED|Phase 1 Dose Escalation||1
6254055|NCT02111850|7152799|FG004|COMPLETED|Phase 1 Dose Escalation||1
6254056|NCT02111850|7152800|FG005|COMPLETED|Phase 1 Dose Escalation||1
6254057|NCT02111850|7152801|FG006|COMPLETED|Phase 1 Dose Escalation||1
6254058|NCT02111850|7152802|FG007|COMPLETED|Phase 1 Dose Escalation||1
6254059|NCT02111850|7152803|FG008|COMPLETED|Phase 1 Dose Escalation||6
6254060|NCT02111850|7152804|FG009|COMPLETED|Phase 1 Dose Escalation||0
6254061|NCT02111850|7152805|FG010|COMPLETED|Phase 1 Dose Escalation||0
6508797|NCT01473160|7428401|FG000|COMPLETED|Overall Study||9
6508798|NCT01473160|7428401|FG000|NOT COMPLETED|Overall Study||0
6508799|NCT01473355|7428407|FG000|STARTED|Overall Study||45
6508800|NCT01473355|7428407|FG000|COMPLETED|Overall Study||39
6508801|NCT01473355|7428407|FG000|NOT COMPLETED|Overall Study||6
6508802|NCT01473368|7428415|FG000|STARTED|Overall Study||14
6508803|NCT01473368|7428416|FG001|STARTED|Overall Study||12
6508804|NCT01473368|7428417|FG002|STARTED|Overall Study||15
6508805|NCT01473368|7428418|FG003|STARTED|Overall Study||12
6508806|NCT01473368|7428415|FG000|COMPLETED|Overall Study||13
6508807|NCT01473368|7428416|FG001|COMPLETED|Overall Study||12
6508808|NCT01473368|7428417|FG002|COMPLETED|Overall Study||12
6508809|NCT01473368|7428418|FG003|COMPLETED|Overall Study||12
6508810|NCT01473368|7428415|FG000|NOT COMPLETED|Overall Study||1
6508811|NCT01473368|7428416|FG001|NOT COMPLETED|Overall Study||0
6508812|NCT01473368|7428417|FG002|NOT COMPLETED|Overall Study||3
6508813|NCT01473368|7428418|FG003|NOT COMPLETED|Overall Study||0
6508814|NCT01473381|7428448|FG000|STARTED|Overall Study||290
6508815|NCT01473381|7428449|FG001|STARTED|Overall Study||292
6508816|NCT01473381|7428450|FG002|STARTED|Overall Study||291
6508817|NCT01473381|7428451|FG003|STARTED|Overall Study||289
6508818|NCT01473381|7428448|FG000|Safety Population|Overall Study||281
6508819|NCT01473381|7428449|FG001|Safety Population|Overall Study||288
6508820|NCT01473381|7428450|FG002|Safety Population|Overall Study||287
6508821|NCT01473381|7428451|FG003|Safety Population|Overall Study||282
6508822|NCT01473381|7428448|FG000|COMPLETED|Overall Study||210
6508823|NCT01473381|7428449|FG001|COMPLETED|Overall Study||199
6508824|NCT01473381|7428450|FG002|COMPLETED|Overall Study||189
6508825|NCT01473381|7428451|FG003|COMPLETED|Overall Study||200
6508826|NCT01473381|7428448|FG000|NOT COMPLETED|Overall Study||80
6508827|NCT01473381|7428449|FG001|NOT COMPLETED|Overall Study||93
6508828|NCT01473381|7428450|FG002|NOT COMPLETED|Overall Study||102
6508829|NCT01473381|7428451|FG003|NOT COMPLETED|Overall Study||89
6508830|NCT01473394|7428464|FG000|STARTED|Overall Study||253
6508831|NCT01473394|7428465|FG001|STARTED|Overall Study||255
6508832|NCT01473394|7428464|FG000|COMPLETED|Overall Study||208
6508833|NCT01473394|7428465|FG001|COMPLETED|Overall Study||212
6508834|NCT01473394|7428464|FG000|NOT COMPLETED|Overall Study||45
6508835|NCT01473394|7428465|FG001|NOT COMPLETED|Overall Study||43
6508836|NCT01473407|7428473|FG000|STARTED|Overall Study||306
6508837|NCT01473407|7428474|FG001|STARTED|Overall Study||306
6508838|NCT01473407|7428473|FG000|COMPLETED|Overall Study||252
6508839|NCT01473407|7428474|FG001|COMPLETED|Overall Study||259
6508840|NCT01473407|7428473|FG000|NOT COMPLETED|Overall Study||54
6570590|NCT01852110|7493948|FG002|NOT COMPLETED|Overall Study||0
6658104|NCT02476422|7588654|FG001|NOT COMPLETED|Overall Study||1
6508841|NCT01473407|7428474|FG001|NOT COMPLETED|Overall Study||47
6508842|NCT01473420|7428482|FG000|STARTED|Titration Period (18 Weeks)||160
6508843|NCT01473420|7428483|FG001|STARTED|Titration Period (18 Weeks)||160
6508844|NCT01473420|7428482|FG000|Treated|Titration Period (18 Weeks)||80
6254062|NCT02111850|7152795|FG000|NOT COMPLETED|Phase 1 Dose Escalation||0
6508845|NCT01473420|7428483|FG001|Treated|Titration Period (18 Weeks)||86
6508846|NCT01473420|7428482|FG000|COMPLETED|Titration Period (18 Weeks)||124
6508847|NCT01473420|7428483|FG001|COMPLETED|Titration Period (18 Weeks)||122
6508848|NCT01473420|7428482|FG000|NOT COMPLETED|Titration Period (18 Weeks)||36
6508849|NCT01473420|7428483|FG001|NOT COMPLETED|Titration Period (18 Weeks)||38
6508850|NCT01473420|7428482|FG000|STARTED|Maintenance Period (16 Weeks)||124
6508851|NCT01473420|7428483|FG001|STARTED|Maintenance Period (16 Weeks)||122
6508852|NCT01473420|7428482|FG000|COMPLETED|Maintenance Period (16 Weeks)||106
6508853|NCT01473420|7428483|FG001|COMPLETED|Maintenance Period (16 Weeks)||105
6508854|NCT01473420|7428482|FG000|NOT COMPLETED|Maintenance Period (16 Weeks)||18
6508855|NCT01473420|7428483|FG001|NOT COMPLETED|Maintenance Period (16 Weeks)||17
6508856|NCT01473524|7428498|FG000|STARTED|DB Phase||71
6508857|NCT01473524|7428499|FG001|STARTED|DB Phase||73
6508858|NCT01473524|7428500|FG002|STARTED|DB Phase||73
6508859|NCT01473524|7428501|FG003|STARTED|DB Phase||0
6508860|NCT01473524|7428502|FG004|STARTED|DB Phase||0
6508861|NCT01473524|7428503|FG005|STARTED|DB Phase||0
6508862|NCT01473524|7428498|FG000|Received at Least 1 Dose of Study Drug|DB Phase||70
6508863|NCT01473524|7428499|FG001|Received at Least 1 Dose of Study Drug|DB Phase||73
6508864|NCT01473524|7428500|FG002|Received at Least 1 Dose of Study Drug|DB Phase||73
6508865|NCT01473524|7428501|FG003|Received at Least 1 Dose of Study Drug|DB Phase||0
6508866|NCT01473524|7428502|FG004|Received at Least 1 Dose of Study Drug|DB Phase||0
6508867|NCT01473524|7428503|FG005|Received at Least 1 Dose of Study Drug|DB Phase||0
6508868|NCT01473524|7428498|FG000|COMPLETED|DB Phase||64
6508869|NCT01473524|7428499|FG001|COMPLETED|DB Phase||64
6508870|NCT01473524|7428500|FG002|COMPLETED|DB Phase||70
6508871|NCT01473524|7428501|FG003|COMPLETED|DB Phase||0
6508872|NCT01473524|7428502|FG004|COMPLETED|DB Phase||0
6508873|NCT01473524|7428503|FG005|COMPLETED|DB Phase||0
6508874|NCT01473524|7428498|FG000|NOT COMPLETED|DB Phase||7
6508875|NCT01473524|7428499|FG001|NOT COMPLETED|DB Phase||9
6508876|NCT01473524|7428500|FG002|NOT COMPLETED|DB Phase||3
6508877|NCT01473524|7428501|FG003|NOT COMPLETED|DB Phase||0
6508878|NCT01473524|7428502|FG004|NOT COMPLETED|DB Phase||0
6508879|NCT01473524|7428503|FG005|NOT COMPLETED|DB Phase||0
6508880|NCT01473524|7428498|FG000|STARTED|LTSE Phase||0
6508881|NCT01473524|7428499|FG001|STARTED|LTSE Phase||0
6508882|NCT01473524|7428500|FG002|STARTED|LTSE Phase||0
6508883|NCT01473524|7428501|FG003|STARTED|LTSE Phase|One participant in the double-blind OCA 5-10 mg group did not enroll in the LTSE phase.|63
6508884|NCT01473524|7428502|FG004|STARTED|LTSE Phase||64
6508885|NCT01473524|7428503|FG005|STARTED|LTSE Phase|Four participants in the double-blind placebo group did not enroll in the LTSE phase.|66
6508886|NCT01473524|7428498|FG000|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
6508887|NCT01473524|7428499|FG001|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
6508888|NCT01473524|7428500|FG002|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||0
6508889|NCT01473524|7428501|FG003|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||63
6508890|NCT01473524|7428502|FG004|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||64
6508891|NCT01473524|7428503|FG005|Received at Least 1 Dose of OCA in LTSE|LTSE Phase||66
6508892|NCT01473524|7428498|FG000|COMPLETED|LTSE Phase||0
6508893|NCT01473524|7428499|FG001|COMPLETED|LTSE Phase||0
6508894|NCT01473524|7428500|FG002|COMPLETED|LTSE Phase||0
6508895|NCT01473524|7428501|FG003|COMPLETED|LTSE Phase||54
6508896|NCT01473524|7428502|FG004|COMPLETED|LTSE Phase||47
6508897|NCT01473524|7428503|FG005|COMPLETED|LTSE Phase||45
6508898|NCT01473524|7428498|FG000|NOT COMPLETED|LTSE Phase||0
6508899|NCT01473524|7428499|FG001|NOT COMPLETED|LTSE Phase||0
6508900|NCT01473524|7428500|FG002|NOT COMPLETED|LTSE Phase||0
6508901|NCT01473524|7428501|FG003|NOT COMPLETED|LTSE Phase||9
6508902|NCT01473524|7428502|FG004|NOT COMPLETED|LTSE Phase||17
6508903|NCT01473524|7428503|FG005|NOT COMPLETED|LTSE Phase||21
6508904|NCT01473563|7428525|FG000|STARTED|Overall Study||52
6508905|NCT01473563|7428525|FG000|Received at Least 1 Dose of Study Drug|Overall Study||52
6508906|NCT01473563|7428525|FG000|COMPLETED|Overall Study||51
6508907|NCT01473563|7428525|FG000|NOT COMPLETED|Overall Study||1
6508908|NCT01473589|7428531|FG000|STARTED|Overall Study||60
6508909|NCT01473589|7428532|FG001|STARTED|Overall Study||62
6508910|NCT01473589|7428531|FG000|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
6508911|NCT01473589|7428532|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
6508912|NCT01473589|7428531|FG000|Completed 6 Months|Overall Study||51
6508913|NCT01473589|7428532|FG001|Completed 6 Months|Overall Study||54
6254063|NCT02111850|7152796|FG001|NOT COMPLETED|Phase 1 Dose Escalation||0
6254064|NCT02111850|7152797|FG002|NOT COMPLETED|Phase 1 Dose Escalation||0
6254065|NCT02111850|7152798|FG003|NOT COMPLETED|Phase 1 Dose Escalation||0
6254066|NCT02111850|7152799|FG004|NOT COMPLETED|Phase 1 Dose Escalation||1
6254067|NCT02111850|7152800|FG005|NOT COMPLETED|Phase 1 Dose Escalation||0
6254068|NCT02111850|7152801|FG006|NOT COMPLETED|Phase 1 Dose Escalation||0
6254069|NCT02111850|7152802|FG007|NOT COMPLETED|Phase 1 Dose Escalation||0
6254070|NCT02111850|7152803|FG008|NOT COMPLETED|Phase 1 Dose Escalation||0
6254071|NCT02111850|7152804|FG009|NOT COMPLETED|Phase 1 Dose Escalation||0
6508914|NCT01473589|7428531|FG000|Completed 12 Months|Overall Study||49
6508915|NCT01473589|7428532|FG001|Completed 12 Months|Overall Study||48
6508916|NCT01473589|7428531|FG000|COMPLETED|Overall Study||49
6508917|NCT01473589|7428532|FG001|COMPLETED|Overall Study||46
6254072|NCT02111850|7152805|FG010|NOT COMPLETED|Phase 1 Dose Escalation||0
6254073|NCT02111850|7152795|FG000|STARTED|Phase 2 Maximum Tolerated Dose||0
6508918|NCT01473589|7428531|FG000|NOT COMPLETED|Overall Study||11
6508919|NCT01473589|7428532|FG001|NOT COMPLETED|Overall Study||16
6570591|NCT01852110|7493949|FG003|NOT COMPLETED|Overall Study||0
6570592|NCT01852110|7493950|FG004|NOT COMPLETED|Overall Study||0
6570593|NCT01852110|7493951|FG005|NOT COMPLETED|Overall Study||0
6570594|NCT01852162|7493967|FG000|STARTED|Overall Study||18
6570595|NCT01852162|7493968|FG001|STARTED|Overall Study||17
6570596|NCT01852162|7493967|FG000|COMPLETED|Overall Study||14
6570597|NCT01852162|7493968|FG001|COMPLETED|Overall Study||16
6570598|NCT01852162|7493967|FG000|NOT COMPLETED|Overall Study||4
6570599|NCT01852162|7493968|FG001|NOT COMPLETED|Overall Study||1
6570600|NCT01852175|7493976|FG000|STARTED|Overall Study||55
6570601|NCT01852175|7493977|FG001|STARTED|Overall Study||55
6570602|NCT01852175|7493976|FG000|COMPLETED|Overall Study||55
6570603|NCT01852175|7493977|FG001|COMPLETED|Overall Study||55
6570604|NCT01852175|7493976|FG000|NOT COMPLETED|Overall Study||0
6570605|NCT01852175|7493977|FG001|NOT COMPLETED|Overall Study||0
6570606|NCT01852201|7493985|FG000|STARTED|Overall Study||21
6570607|NCT01852201|7493986|FG001|STARTED|Overall Study||12
6570608|NCT01852201|7493985|FG000|COMPLETED|Overall Study||21
6570609|NCT01852201|7493986|FG001|COMPLETED|Overall Study||12
6570610|NCT01852201|7493985|FG000|NOT COMPLETED|Overall Study||0
6570611|NCT01852201|7493986|FG001|NOT COMPLETED|Overall Study||0
6570612|NCT01852214|7493993|FG000|STARTED|Period 1||26
6570613|NCT01852214|7493994|FG001|STARTED|Period 1||24
6570614|NCT01852214|7493993|FG000|COMPLETED|Period 1||25
6570615|NCT01852214|7493994|FG001|COMPLETED|Period 1||21
6570616|NCT01852214|7493993|FG000|NOT COMPLETED|Period 1||1
6570617|NCT01852214|7493994|FG001|NOT COMPLETED|Period 1||3
6570618|NCT01852214|7493993|FG000|STARTED|Washout Period||25
6570619|NCT01852214|7493994|FG001|STARTED|Washout Period||21
6570620|NCT01852214|7493993|FG000|COMPLETED|Washout Period||25
6570621|NCT01852214|7493994|FG001|COMPLETED|Washout Period||20
6570622|NCT01852214|7493993|FG000|NOT COMPLETED|Washout Period||0
6570623|NCT01852214|7493994|FG001|NOT COMPLETED|Washout Period||1
6570624|NCT01852214|7493993|FG000|STARTED|Period 2||25
6570625|NCT01852214|7493994|FG001|STARTED|Period 2||20
6570626|NCT01852214|7493993|FG000|COMPLETED|Period 2||25
6570627|NCT01852214|7493994|FG001|COMPLETED|Period 2||20
6570628|NCT01852214|7493993|FG000|NOT COMPLETED|Period 2||0
6570629|NCT01852214|7493994|FG001|NOT COMPLETED|Period 2||0
6570630|NCT01852292|7494003|FG000|STARTED|Overall Study||79
6570631|NCT01852292|7494004|FG001|STARTED|Overall Study||79
6570632|NCT01852292|7494003|FG000|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
6570633|NCT01852292|7494004|FG001|COMPLETED|Overall Study|Completed = participants who were ongoing and did not discontinue study treatment per protocol|0
6570634|NCT01852292|7494003|FG000|NOT COMPLETED|Overall Study||79
6570635|NCT01852292|7494004|FG001|NOT COMPLETED|Overall Study||79
6570636|NCT01852344|7494014|FG000|STARTED|Overall Study||27
6570637|NCT01852344|7494015|FG001|STARTED|Overall Study||27
6570638|NCT01852344|7494016|FG002|STARTED|Overall Study||27
6570639|NCT01852344|7494017|FG003|STARTED|Overall Study||27
6570640|NCT01852344|7494014|FG000|Actual Participation in First Assignment|Overall Study||27
6570641|NCT01852344|7494015|FG001|Actual Participation in First Assignment|Overall Study||27
6570642|NCT01852344|7494016|FG002|Actual Participation in First Assignment|Overall Study||27
6570643|NCT01852344|7494017|FG003|Actual Participation in First Assignment|Overall Study||27
6570644|NCT01852344|7494014|FG000|COMPLETED|Overall Study||27
6570645|NCT01852344|7494015|FG001|COMPLETED|Overall Study||27
6570646|NCT01852344|7494016|FG002|COMPLETED|Overall Study||27
6570647|NCT01852344|7494017|FG003|COMPLETED|Overall Study||27
6570648|NCT01852344|7494014|FG000|NOT COMPLETED|Overall Study||0
6570649|NCT01852344|7494015|FG001|NOT COMPLETED|Overall Study||0
6570650|NCT01852344|7494016|FG002|NOT COMPLETED|Overall Study||0
6570651|NCT01852344|7494017|FG003|NOT COMPLETED|Overall Study||0
6570652|NCT01852383|7494028|FG000|STARTED|Overall Study||30
6570653|NCT01852383|7494028|FG000|COMPLETED|Overall Study||19
6570654|NCT01852383|7494028|FG000|NOT COMPLETED|Overall Study||11
6570655|NCT01852513|7494035|FG000|STARTED|Overall Study||20
6570656|NCT01852513|7494036|FG001|STARTED|Overall Study||19
6254074|NCT02111850|7152796|FG001|STARTED|Phase 2 Maximum Tolerated Dose||0
6254075|NCT02111850|7152797|FG002|STARTED|Phase 2 Maximum Tolerated Dose||0
6254076|NCT02111850|7152798|FG003|STARTED|Phase 2 Maximum Tolerated Dose||0
6254077|NCT02111850|7152799|FG004|STARTED|Phase 2 Maximum Tolerated Dose||0
6254078|NCT02111850|7152800|FG005|STARTED|Phase 2 Maximum Tolerated Dose||0
6254079|NCT02111850|7152801|FG006|STARTED|Phase 2 Maximum Tolerated Dose||0
6254080|NCT02111850|7152802|FG007|STARTED|Phase 2 Maximum Tolerated Dose||0
6570657|NCT01852513|7494035|FG000|COMPLETED|Overall Study||20
6570658|NCT01852513|7494036|FG001|COMPLETED|Overall Study||19
6570659|NCT01852513|7494035|FG000|NOT COMPLETED|Overall Study||0
6570660|NCT01852513|7494036|FG001|NOT COMPLETED|Overall Study||0
6570661|NCT01852591|7494042|FG000|STARTED|Overall Study||8
6570662|NCT01852591|7494042|FG000|COMPLETED|Overall Study||5
6570663|NCT01852591|7494042|FG000|NOT COMPLETED|Overall Study||3
6570664|NCT01852669|7494048|FG000|STARTED|Overall Study||71
6570665|NCT01852669|7494049|FG001|STARTED|Overall Study||69
6570666|NCT01852669|7494048|FG000|COMPLETED|Overall Study||71
6570667|NCT01852669|7494049|FG001|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
6254081|NCT02111850|7152803|FG008|STARTED|Phase 2 Maximum Tolerated Dose||0
6254082|NCT02111850|7152804|FG009|STARTED|Phase 2 Maximum Tolerated Dose||5
6254083|NCT02111850|7152805|FG010|STARTED|Phase 2 Maximum Tolerated Dose||1
6254084|NCT02111850|7152795|FG000|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254085|NCT02111850|7152796|FG001|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254086|NCT02111850|7152797|FG002|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254087|NCT02111850|7152798|FG003|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254088|NCT02111850|7152799|FG004|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6508920|NCT01473602|7428542|FG000|STARTED|Overall Study||18
6508921|NCT01473602|7428543|FG001|STARTED|Overall Study||21
6508922|NCT01473602|7428542|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
6508923|NCT01473602|7428543|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
6508924|NCT01473602|7428542|FG000|Completed 6 Months|Overall Study||12
6508925|NCT01473602|7428543|FG001|Completed 6 Months|Overall Study||15
6508926|NCT01473602|7428542|FG000|Completed 12 Months|Overall Study||10
6508927|NCT01473602|7428543|FG001|Completed 12 Months|Overall Study||13
6508928|NCT01473602|7428542|FG000|COMPLETED|Overall Study||10
6508929|NCT01473602|7428543|FG001|COMPLETED|Overall Study||13
6508930|NCT01473602|7428542|FG000|NOT COMPLETED|Overall Study||8
6508931|NCT01473602|7428543|FG001|NOT COMPLETED|Overall Study||8
6508932|NCT01473745|7428553|FG000|STARTED|Overall Study||24
6508933|NCT01473745|7428554|FG001|STARTED|Overall Study||24
6508934|NCT01473745|7428553|FG000|COMPLETED|Overall Study||24
6508935|NCT01473745|7428554|FG001|COMPLETED|Overall Study||24
6508936|NCT01473745|7428553|FG000|NOT COMPLETED|Overall Study||0
6508937|NCT01473745|7428554|FG001|NOT COMPLETED|Overall Study||0
6508938|NCT01473758|7428562|FG000|STARTED|Cycle 1||38
6508939|NCT01473758|7428563|FG001|STARTED|Cycle 1||43
6508940|NCT01473758|7428564|FG002|STARTED|Cycle 1||0
6508941|NCT01473758|7428565|FG003|STARTED|Cycle 1||0
6508942|NCT01473758|7428562|FG000|COMPLETED|Cycle 1||27
6508943|NCT01473758|7428563|FG001|COMPLETED|Cycle 1||40
6508944|NCT01473758|7428564|FG002|COMPLETED|Cycle 1||0
6508945|NCT01473758|7428565|FG003|COMPLETED|Cycle 1||0
6508946|NCT01473758|7428562|FG000|NOT COMPLETED|Cycle 1||11
6508947|NCT01473758|7428563|FG001|NOT COMPLETED|Cycle 1||3
6508948|NCT01473758|7428564|FG002|NOT COMPLETED|Cycle 1||0
6508949|NCT01473758|7428565|FG003|NOT COMPLETED|Cycle 1||0
6508950|NCT01473758|7428562|FG000|STARTED|Cycle 2||0
6508951|NCT01473758|7428563|FG001|STARTED|Cycle 2||0
6508952|NCT01473758|7428564|FG002|STARTED|Cycle 2||10
6508953|NCT01473758|7428565|FG003|STARTED|Cycle 2||4
6508954|NCT01473758|7428562|FG000|COMPLETED|Cycle 2||0
6508955|NCT01473758|7428563|FG001|COMPLETED|Cycle 2||0
6508956|NCT01473758|7428564|FG002|COMPLETED|Cycle 2||5
6508957|NCT01473758|7428565|FG003|COMPLETED|Cycle 2||4
6508958|NCT01473758|7428562|FG000|NOT COMPLETED|Cycle 2||0
6508959|NCT01473758|7428563|FG001|NOT COMPLETED|Cycle 2||0
6508960|NCT01473758|7428564|FG002|NOT COMPLETED|Cycle 2||5
6508961|NCT01473758|7428565|FG003|NOT COMPLETED|Cycle 2||0
6508962|NCT01473836|7428573|FG000|STARTED|Overall Study||38
6508963|NCT01473836|7428573|FG000|COMPLETED|Overall Study||32
6508964|NCT01473836|7428573|FG000|NOT COMPLETED|Overall Study||6
6508965|NCT01473940|7428581|FG000|STARTED|Induction Therapy||3
6508966|NCT01473940|7428582|FG001|STARTED|Induction Therapy||4
6508967|NCT01473940|7428583|FG002|STARTED|Induction Therapy||6
6508968|NCT01473940|7428584|FG003|STARTED|Induction Therapy||8
6508969|NCT01473940|7428581|FG000|Started Treatment|Induction Therapy||3
6508970|NCT01473940|7428582|FG001|Started Treatment|Induction Therapy||4
6508971|NCT01473940|7428583|FG002|Started Treatment|Induction Therapy||6
6508972|NCT01473940|7428584|FG003|Started Treatment|Induction Therapy||8
6508973|NCT01473940|7428581|FG000|Completed Induction- 12 Weeks|Induction Therapy||3
6508974|NCT01473940|7428582|FG001|Completed Induction- 12 Weeks|Induction Therapy||3
6508975|NCT01473940|7428583|FG002|Completed Induction- 12 Weeks|Induction Therapy||4
6508976|NCT01473940|7428584|FG003|Completed Induction- 12 Weeks|Induction Therapy||7
6508977|NCT01473940|7428581|FG000|COMPLETED|Induction Therapy||3
6508978|NCT01473940|7428582|FG001|COMPLETED|Induction Therapy||3
6508979|NCT01473940|7428583|FG002|COMPLETED|Induction Therapy||4
6508980|NCT01473940|7428584|FG003|COMPLETED|Induction Therapy||7
6508981|NCT01473940|7428581|FG000|NOT COMPLETED|Induction Therapy||0
6508982|NCT01473940|7428582|FG001|NOT COMPLETED|Induction Therapy||1
6254089|NCT02111850|7152800|FG005|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254090|NCT02111850|7152801|FG006|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254091|NCT02111850|7152802|FG007|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254092|NCT02111850|7152803|FG008|COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254093|NCT02111850|7152804|FG009|COMPLETED|Phase 2 Maximum Tolerated Dose||5
6254094|NCT02111850|7152805|FG010|COMPLETED|Phase 2 Maximum Tolerated Dose||1
6254095|NCT02111850|7152795|FG000|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254096|NCT02111850|7152796|FG001|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254097|NCT02111850|7152797|FG002|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6508983|NCT01473940|7428583|FG002|NOT COMPLETED|Induction Therapy||2
6508984|NCT01473940|7428584|FG003|NOT COMPLETED|Induction Therapy||1
6508985|NCT01473940|7428581|FG000|STARTED|Maintenance Therapy||3
6508986|NCT01473940|7428582|FG001|STARTED|Maintenance Therapy||3
6508987|NCT01473940|7428583|FG002|STARTED|Maintenance Therapy||4
6508988|NCT01473940|7428584|FG003|STARTED|Maintenance Therapy||7
6508989|NCT01473940|7428581|FG000|Evaluated for Response|Maintenance Therapy||3
6508990|NCT01473940|7428582|FG001|Evaluated for Response|Maintenance Therapy||3
6508991|NCT01473940|7428583|FG002|Evaluated for Response|Maintenance Therapy||4
6254098|NCT02111850|7152798|FG003|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254099|NCT02111850|7152799|FG004|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254100|NCT02111850|7152800|FG005|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254101|NCT02111850|7152801|FG006|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254102|NCT02111850|7152802|FG007|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254103|NCT02111850|7152803|FG008|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254104|NCT02111850|7152804|FG009|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254105|NCT02111850|7152805|FG010|NOT COMPLETED|Phase 2 Maximum Tolerated Dose||0
6254106|NCT01983553|7152833|FG000|STARTED|Overall Study||2131
6254107|NCT01983553|7152834|FG001|STARTED|Overall Study||1072
6254108|NCT01983553|7152833|FG000|COMPLETED|Overall Study||2131
6254109|NCT01983553|7152834|FG001|COMPLETED|Overall Study||1072
6254110|NCT01983553|7152833|FG000|NOT COMPLETED|Overall Study||0
6254111|NCT01983553|7152834|FG001|NOT COMPLETED|Overall Study||0
6254112|NCT01935934|7152842|FG000|STARTED|Overall Study||70
6254113|NCT01935934|7152843|FG001|STARTED|Overall Study||32
6254114|NCT01935934|7152842|FG000|COMPLETED|Overall Study||70
6254115|NCT01935934|7152843|FG001|COMPLETED|Overall Study||32
6254116|NCT01935934|7152842|FG000|NOT COMPLETED|Overall Study||0
6254117|NCT01935934|7152843|FG001|NOT COMPLETED|Overall Study||0
6254118|NCT01760291|7152852|FG000|STARTED|Overall Study||576
6254119|NCT01760291|7152852|FG000|COMPLETED|Overall Study||340
6254120|NCT01760291|7152852|FG000|NOT COMPLETED|Overall Study||236
6254121|NCT01483027|7152858|FG000|STARTED|Overall Study||215
6254122|NCT01483027|7152859|FG001|STARTED|Overall Study||213
6254123|NCT01483027|7152858|FG000|COMPLETED|Overall Study||169
6254124|NCT01483027|7152859|FG001|COMPLETED|Overall Study||153
6254125|NCT01483027|7152858|FG000|NOT COMPLETED|Overall Study||46
6254126|NCT01483027|7152859|FG001|NOT COMPLETED|Overall Study||60
6254127|NCT01472562|7152865|FG000|STARTED|Induction Phase (Week 1- 48)||38
6254128|NCT01472562|7152865|FG000|COMPLETED|Induction Phase (Week 1- 48)||27
6254129|NCT01472562|7152865|FG000|NOT COMPLETED|Induction Phase (Week 1- 48)||11
6254130|NCT01472562|7152865|FG000|STARTED|Maintenance Phase (Week 49 to PD)||27
6254131|NCT01472562|7152865|FG000|COMPLETED|Maintenance Phase (Week 49 to PD)||4
6254132|NCT01472562|7152865|FG000|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
6254133|NCT01379781|7152871|FG000|STARTED|Overall Study||27
6254134|NCT01379781|7152872|FG001|STARTED|Overall Study||27
6254135|NCT01379781|7152871|FG000|COMPLETED|Overall Study||16
6254136|NCT01379781|7152872|FG001|COMPLETED|Overall Study||19
6254137|NCT01379781|7152871|FG000|NOT COMPLETED|Overall Study||11
6254138|NCT01379781|7152872|FG001|NOT COMPLETED|Overall Study||8
6254139|NCT01065454|7152882|FG000|STARTED|Treatment||67
6254140|NCT01065454|7152883|FG001|STARTED|Treatment||33
6254141|NCT01065454|7152884|FG002|STARTED|Treatment||32
6254142|NCT01065454|7152885|FG003|STARTED|Treatment||69
6254143|NCT01065454|7152882|FG000|COMPLETED|Treatment||54
6254144|NCT01065454|7152883|FG001|COMPLETED|Treatment||28
6254145|NCT01065454|7152884|FG002|COMPLETED|Treatment||23
6254146|NCT01065454|7152885|FG003|COMPLETED|Treatment||57
6254147|NCT01065454|7152882|FG000|NOT COMPLETED|Treatment||13
6254148|NCT01065454|7152883|FG001|NOT COMPLETED|Treatment||5
6254149|NCT01065454|7152884|FG002|NOT COMPLETED|Treatment||9
6254150|NCT01065454|7152885|FG003|NOT COMPLETED|Treatment||12
6254151|NCT01065454|7152882|FG000|STARTED|Follow up||54
6254152|NCT01065454|7152883|FG001|STARTED|Follow up||28
6254153|NCT01065454|7152884|FG002|STARTED|Follow up||23
6254154|NCT01065454|7152885|FG003|STARTED|Follow up||57
6254155|NCT01065454|7152882|FG000|Entering Follow-up|Follow up||49
6254156|NCT01065454|7152883|FG001|Entering Follow-up|Follow up||27
6254157|NCT01065454|7152884|FG002|Entering Follow-up|Follow up||23
6254158|NCT01065454|7152885|FG003|Entering Follow-up|Follow up||51
6254159|NCT01065454|7152882|FG000|COMPLETED|Follow up||15
6254160|NCT01065454|7152883|FG001|COMPLETED|Follow up||4
6254161|NCT01065454|7152884|FG002|COMPLETED|Follow up||6
6254162|NCT01065454|7152885|FG003|COMPLETED|Follow up||13
6254163|NCT01065454|7152882|FG000|NOT COMPLETED|Follow up||39
6254164|NCT01065454|7152883|FG001|NOT COMPLETED|Follow up||24
6254165|NCT01065454|7152884|FG002|NOT COMPLETED|Follow up||17
6254166|NCT01065454|7152885|FG003|NOT COMPLETED|Follow up||44
6254167|NCT00180414|7152897|FG000|STARTED|Overall Study||4
6254168|NCT00180414|7152898|FG001|STARTED|Overall Study||4
6254169|NCT00180414|7152897|FG000|COMPLETED|Overall Study||0
6254170|NCT00180414|7152898|FG001|COMPLETED|Overall Study||0
6254171|NCT00180414|7152897|FG000|NOT COMPLETED|Overall Study||4
6254172|NCT00180414|7152898|FG001|NOT COMPLETED|Overall Study||4
6254173|NCT00135200|7152904|FG000|STARTED|Overall Study||16
6254174|NCT00135200|7152904|FG000|COMPLETED|Overall Study||16
6254175|NCT00135200|7152904|FG000|NOT COMPLETED|Overall Study||0
6278485|NCT00133952|7178027|FG000|Received at Least One Dose of Study Drug|Overall Study||153
6278486|NCT00133952|7178028|FG001|Received at Least One Dose of Study Drug|Overall Study||149
6278487|NCT00133952|7178027|FG000|COMPLETED|Overall Study||115
6278488|NCT00133952|7178028|FG001|COMPLETED|Overall Study||124
6278489|NCT00133952|7178027|FG000|NOT COMPLETED|Overall Study||42
6278490|NCT00133952|7178028|FG001|NOT COMPLETED|Overall Study||28
6278491|NCT00133978|7178038|FG000|STARTED|Overall Study||303
6278492|NCT00133978|7178039|FG001|STARTED|Overall Study||308
6278493|NCT00133978|7178040|FG002|STARTED|Overall Study||310
6278494|NCT00133978|7178041|FG003|STARTED|Overall Study||302
6278495|NCT00133978|7178038|FG000|COMPLETED|Overall Study||301
6278496|NCT00133978|7178039|FG001|COMPLETED|Overall Study||307
6278497|NCT00133978|7178040|FG002|COMPLETED|Overall Study||310
6254176|NCT02513394|7152910|FG000|STARTED|Overall Study||2896
6254177|NCT02513394|7152911|FG001|STARTED|Overall Study||2900
6254178|NCT02513394|7152910|FG000|COMPLETED|Overall Study||2884
6508992|NCT01473940|7428584|FG003|Evaluated for Response|Maintenance Therapy||7
6508993|NCT01473940|7428581|FG000|Went on to Start Maintenance Therapy|Maintenance Therapy||2
6508994|NCT01473940|7428582|FG001|Went on to Start Maintenance Therapy|Maintenance Therapy||1
6508995|NCT01473940|7428583|FG002|Went on to Start Maintenance Therapy|Maintenance Therapy||3
6508996|NCT01473940|7428584|FG003|Went on to Start Maintenance Therapy|Maintenance Therapy||3
6508997|NCT01473940|7428581|FG000|COMPLETED|Maintenance Therapy||2
6508998|NCT01473940|7428582|FG001|COMPLETED|Maintenance Therapy||1
6508999|NCT01473940|7428583|FG002|COMPLETED|Maintenance Therapy||3
6509000|NCT01473940|7428584|FG003|COMPLETED|Maintenance Therapy||3
6509001|NCT01473940|7428581|FG000|NOT COMPLETED|Maintenance Therapy||1
6509002|NCT01473940|7428582|FG001|NOT COMPLETED|Maintenance Therapy||2
6509003|NCT01473940|7428583|FG002|NOT COMPLETED|Maintenance Therapy||1
6509004|NCT01473940|7428584|FG003|NOT COMPLETED|Maintenance Therapy||4
6509005|NCT01473940|7428581|FG000|STARTED|Follow-up Until Death||3
6509006|NCT01473940|7428582|FG001|STARTED|Follow-up Until Death||4
6509007|NCT01473940|7428583|FG002|STARTED|Follow-up Until Death||5
6509008|NCT01473940|7428584|FG003|STARTED|Follow-up Until Death||7
6509009|NCT01473940|7428581|FG000|COMPLETED|Follow-up Until Death||3
6509010|NCT01473940|7428582|FG001|COMPLETED|Follow-up Until Death||4
6509011|NCT01473940|7428583|FG002|COMPLETED|Follow-up Until Death||5
6509012|NCT01473940|7428584|FG003|COMPLETED|Follow-up Until Death||7
6509013|NCT01473940|7428581|FG000|NOT COMPLETED|Follow-up Until Death||0
6509014|NCT01473940|7428582|FG001|NOT COMPLETED|Follow-up Until Death||0
6509015|NCT01473940|7428583|FG002|NOT COMPLETED|Follow-up Until Death||0
6509016|NCT01473940|7428584|FG003|NOT COMPLETED|Follow-up Until Death||0
6509017|NCT01473953|7428602|FG000|STARTED|Overall Study||6
6509018|NCT01473953|7428603|FG001|STARTED|Overall Study||6
6509019|NCT01473953|7428604|FG002|STARTED|Overall Study||6
6509020|NCT01473953|7428605|FG003|STARTED|Overall Study||5
6509021|NCT01473953|7428606|FG004|STARTED|Overall Study||8
6509022|NCT01473953|7428602|FG000|COMPLETED|Overall Study||5
6509023|NCT01473953|7428603|FG001|COMPLETED|Overall Study||6
6509024|NCT01473953|7428604|FG002|COMPLETED|Overall Study||6
6509025|NCT01473953|7428605|FG003|COMPLETED|Overall Study||5
6509026|NCT01473953|7428606|FG004|COMPLETED|Overall Study||8
6509027|NCT01473953|7428602|FG000|NOT COMPLETED|Overall Study||1
6509028|NCT01473953|7428603|FG001|NOT COMPLETED|Overall Study||0
6509029|NCT01473953|7428604|FG002|NOT COMPLETED|Overall Study||0
6509030|NCT01473953|7428605|FG003|NOT COMPLETED|Overall Study||0
6509031|NCT01473953|7428606|FG004|NOT COMPLETED|Overall Study||0
6509032|NCT01473992|7428620|FG000|STARTED|Overall Study||10
6509033|NCT01473992|7428621|FG001|STARTED|Overall Study||10
6509034|NCT01473992|7428622|FG002|STARTED|Overall Study||5
6509035|NCT01473992|7428620|FG000|COMPLETED|Overall Study||10
6509036|NCT01473992|7428621|FG001|COMPLETED|Overall Study||10
6509037|NCT01473992|7428622|FG002|COMPLETED|Overall Study||5
6509038|NCT01473992|7428620|FG000|NOT COMPLETED|Overall Study||0
6509039|NCT01473992|7428621|FG001|NOT COMPLETED|Overall Study||0
6509040|NCT01473992|7428622|FG002|NOT COMPLETED|Overall Study||0
6509041|NCT01474018|7428632|FG000|STARTED|Overall Study||5
6509042|NCT01474018|7428633|FG001|STARTED|Overall Study||10
6509043|NCT01474018|7428632|FG000|COMPLETED|Overall Study|Writing paper|5
6509044|NCT01474018|7428633|FG001|COMPLETED|Overall Study||7
6509045|NCT01474018|7428632|FG000|NOT COMPLETED|Overall Study||0
6509046|NCT01474018|7428633|FG001|NOT COMPLETED|Overall Study||3
6509047|NCT01474109|7428642|FG000|STARTED|Period 1: Baseline to Week 16||95
6509048|NCT01474109|7428643|FG001|STARTED|Period 1: Baseline to Week 16||97
6509049|NCT01474109|7428644|FG002|STARTED|Period 1: Baseline to Week 16||97
6509050|NCT01474109|7428642|FG000|COMPLETED|Period 1: Baseline to Week 16||88
6509051|NCT01474109|7428643|FG001|COMPLETED|Period 1: Baseline to Week 16||91
6509052|NCT01474109|7428644|FG002|COMPLETED|Period 1: Baseline to Week 16||95
6509053|NCT01474109|7428642|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||7
6509054|NCT01474109|7428643|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||6
6509055|NCT01474109|7428644|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||2
6509056|NCT01474109|7428642|FG000|STARTED|Period 2: Week 16 to End of Study||88
6509057|NCT01474109|7428643|FG001|STARTED|Period 2: Week 16 to End of Study||91
6509058|NCT01474109|7428644|FG002|STARTED|Period 2: Week 16 to End of Study||95
6509059|NCT01474109|7428642|FG000|COMPLETED|Period 2: Week 16 to End of Study||70
6509060|NCT01474109|7428643|FG001|COMPLETED|Period 2: Week 16 to End of Study||73
6509061|NCT01474109|7428644|FG002|COMPLETED|Period 2: Week 16 to End of Study||83
6509062|NCT01474109|7428642|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||18
6254179|NCT02513394|7152911|FG001|COMPLETED|Overall Study||2877
6254180|NCT02513394|7152910|FG000|NOT COMPLETED|Overall Study||12
6254181|NCT02513394|7152911|FG001|NOT COMPLETED|Overall Study||23
6254182|NCT02498132|7152920|FG000|STARTED|Overall Study||24
6254183|NCT02498132|7152921|FG001|STARTED|Overall Study||19
6254184|NCT02498132|7152922|FG002|STARTED|Overall Study||9
6254185|NCT02498132|7152920|FG000|COMPLETED|Overall Study||22
6254186|NCT02498132|7152921|FG001|COMPLETED|Overall Study||18
6254187|NCT02498132|7152922|FG002|COMPLETED|Overall Study||9
6254188|NCT02498132|7152920|FG000|NOT COMPLETED|Overall Study||2
6254189|NCT02498132|7152921|FG001|NOT COMPLETED|Overall Study||1
6254190|NCT02498132|7152922|FG002|NOT COMPLETED|Overall Study||0
6254191|NCT02450760|7152932|FG000|STARTED|Overall Study||15
6254192|NCT02450760|7152933|FG001|STARTED|Overall Study||18
6254193|NCT02450760|7152932|FG000|COMPLETED|Overall Study||15
6254194|NCT02450760|7152933|FG001|COMPLETED|Overall Study||18
6254195|NCT02450760|7152932|FG000|NOT COMPLETED|Overall Study||0
6254196|NCT02450760|7152933|FG001|NOT COMPLETED|Overall Study||0
6278498|NCT00133978|7178041|FG003|COMPLETED|Overall Study||300
6278499|NCT00133978|7178038|FG000|NOT COMPLETED|Overall Study||2
6278500|NCT00133978|7178039|FG001|NOT COMPLETED|Overall Study||1
6278501|NCT00133978|7178040|FG002|NOT COMPLETED|Overall Study||0
6278502|NCT00133978|7178041|FG003|NOT COMPLETED|Overall Study||2
6278503|NCT00133991|7178055|FG000|STARTED|Overall Study||21
6278504|NCT00133991|7178055|FG000|COMPLETED|Overall Study||17
6278505|NCT00133991|7178055|FG000|NOT COMPLETED|Overall Study||4
6278506|NCT00134004|7178059|FG000|STARTED|Overall Study||210
6278507|NCT00134004|7178059|FG000|COMPLETED|Overall Study||210
6278508|NCT00134004|7178059|FG000|NOT COMPLETED|Overall Study||0
6278509|NCT00134017|7178063|FG000|STARTED|Overall Study||142
6278510|NCT00134017|7178063|FG000|COMPLETED|Overall Study||142
6278511|NCT00134017|7178063|FG000|NOT COMPLETED|Overall Study||0
6278512|NCT00134043|7178069|FG000|STARTED|Overall Study||16
6278513|NCT00134043|7178070|FG001|STARTED|Overall Study||3
6278514|NCT00134043|7178069|FG000|COMPLETED|Overall Study||16
6278515|NCT00134043|7178070|FG001|COMPLETED|Overall Study||3
6278516|NCT00134043|7178069|FG000|NOT COMPLETED|Overall Study||0
6278517|NCT00134043|7178070|FG001|NOT COMPLETED|Overall Study||0
6278518|NCT00134056|7178077|FG000|STARTED|Randomization||518
6278519|NCT00134056|7178078|FG001|STARTED|Randomization||520
6278520|NCT00134056|7178077|FG000|COMPLETED|Randomization||496
6278521|NCT00134056|7178078|FG001|COMPLETED|Randomization||500
6278522|NCT00134056|7178077|FG000|NOT COMPLETED|Randomization||22
6278523|NCT00134056|7178078|FG001|NOT COMPLETED|Randomization||20
6278524|NCT00134056|7178077|FG000|STARTED|Eligible for Protocol Assigned Treatment||496
6278525|NCT00134056|7178078|FG001|STARTED|Eligible for Protocol Assigned Treatment||500
6278526|NCT00134056|7178077|FG000|COMPLETED|Eligible for Protocol Assigned Treatment||169
6278527|NCT00134056|7178078|FG001|COMPLETED|Eligible for Protocol Assigned Treatment||185
6278528|NCT00134056|7178077|FG000|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
6278529|NCT00134056|7178078|FG001|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
6278530|NCT00134082|7178087|FG000|STARTED|Overall Study||30
6278531|NCT00134082|7178087|FG000|COMPLETED|Overall Study||27
6278532|NCT00134082|7178087|FG000|NOT COMPLETED|Overall Study||3
6278533|NCT00134381|7178091|FG000|STARTED|Overall Study||1
6278534|NCT00134381|7178092|FG001|STARTED|Overall Study||2
6278535|NCT00134381|7178093|FG002|STARTED|Overall Study||1
6278536|NCT00134381|7178094|FG003|STARTED|Overall Study||2
6278537|NCT00134381|7178095|FG004|STARTED|Overall Study||31
6278538|NCT00134381|7178096|FG005|STARTED|Overall Study||31
6278539|NCT00134381|7178091|FG000|COMPLETED|Overall Study||1
6278540|NCT00134381|7178092|FG001|COMPLETED|Overall Study||2
6278541|NCT00134381|7178093|FG002|COMPLETED|Overall Study||1
6278542|NCT00134381|7178094|FG003|COMPLETED|Overall Study||2
6278543|NCT00134381|7178095|FG004|COMPLETED|Overall Study||31
6278544|NCT00134381|7178096|FG005|COMPLETED|Overall Study||29
6278545|NCT00134381|7178091|FG000|NOT COMPLETED|Overall Study||0
6278546|NCT00134381|7178092|FG001|NOT COMPLETED|Overall Study||0
6278547|NCT00134381|7178093|FG002|NOT COMPLETED|Overall Study||0
6570668|NCT01852669|7494048|FG000|NOT COMPLETED|Overall Study||0
6570669|NCT01852669|7494049|FG001|NOT COMPLETED|Overall Study||1
6570670|NCT01852799|7494055|FG000|STARTED|Overall Study||18
6570671|NCT01852799|7494055|FG000|COMPLETED|Overall Study||0
6570672|NCT01852799|7494055|FG000|NOT COMPLETED|Overall Study||18
6278548|NCT00134381|7178094|FG003|NOT COMPLETED|Overall Study||0
6278549|NCT00134381|7178095|FG004|NOT COMPLETED|Overall Study||0
6278550|NCT00134381|7178096|FG005|NOT COMPLETED|Overall Study||2
6278551|NCT00134563|7178116|FG000|STARTED|Overall Study|Randomized|363
6278552|NCT00134563|7178117|FG001|STARTED|Overall Study|Randomized|366
6278553|NCT00134563|7178118|FG002|STARTED|Overall Study|Randomized|359
6278554|NCT00134563|7178116|FG000|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
6278555|NCT00134563|7178117|FG001|Treated|Overall Study||365
6278556|NCT00134563|7178118|FG002|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
6278557|NCT00134563|7178116|FG000|COMPLETED|Overall Study|completed treatment period|259
6278558|NCT00134563|7178117|FG001|COMPLETED|Overall Study|completed treatment period|274
6278559|NCT00134563|7178118|FG002|COMPLETED|Overall Study|completed treatment period|263
6278560|NCT00134563|7178116|FG000|NOT COMPLETED|Overall Study||104
6278561|NCT00134563|7178117|FG001|NOT COMPLETED|Overall Study||92
6278562|NCT00134563|7178118|FG002|NOT COMPLETED|Overall Study||96
6278563|NCT00134719|7178129|FG000|STARTED|Primary Vaccination Phase||661
6278564|NCT00134719|7178130|FG001|STARTED|Primary Vaccination Phase||221
6278565|NCT00134719|7178131|FG002|STARTED|Primary Vaccination Phase||221
6278566|NCT00134719|7178129|FG000|COMPLETED|Primary Vaccination Phase||647
6278567|NCT00134719|7178130|FG001|COMPLETED|Primary Vaccination Phase||215
6278568|NCT00134719|7178131|FG002|COMPLETED|Primary Vaccination Phase||216
6278569|NCT00134719|7178129|FG000|NOT COMPLETED|Primary Vaccination Phase||14
6570673|NCT01852825|7494062|FG000|STARTED|Overall Study||16
6278570|NCT00134719|7178130|FG001|NOT COMPLETED|Primary Vaccination Phase||6
6278571|NCT00134719|7178131|FG002|NOT COMPLETED|Primary Vaccination Phase||5
6570674|NCT01852825|7494063|FG001|STARTED|Overall Study||7
6254197|NCT03618056|7152944|FG000|STARTED|Overall Study||1
6254198|NCT03618056|7152944|FG000|COMPLETED|Overall Study||1
6254199|NCT03618056|7152944|FG000|NOT COMPLETED|Overall Study||0
6254200|NCT03503617|7152950|FG000|STARTED|Overall Study||14
6254201|NCT03503617|7152951|FG001|STARTED|Overall Study||13
6254202|NCT03503617|7152950|FG000|COMPLETED|Overall Study||14
6254203|NCT03503617|7152951|FG001|COMPLETED|Overall Study||10
6254204|NCT03503617|7152950|FG000|NOT COMPLETED|Overall Study||0
6254205|NCT03503617|7152951|FG001|NOT COMPLETED|Overall Study||3
6278572|NCT00134719|7178129|FG000|STARTED|Fourth Dose Vaccination Phase||625
6278573|NCT00134719|7178130|FG001|STARTED|Fourth Dose Vaccination Phase||206
6278574|NCT00134719|7178131|FG002|STARTED|Fourth Dose Vaccination Phase||204
6278575|NCT00134719|7178129|FG000|COMPLETED|Fourth Dose Vaccination Phase||623
6278576|NCT00134719|7178130|FG001|COMPLETED|Fourth Dose Vaccination Phase||203
6278577|NCT00134719|7178131|FG002|COMPLETED|Fourth Dose Vaccination Phase||203
6278578|NCT00134719|7178129|FG000|NOT COMPLETED|Fourth Dose Vaccination Phase||2
6278579|NCT00134719|7178130|FG001|NOT COMPLETED|Fourth Dose Vaccination Phase||3
6278580|NCT00134719|7178131|FG002|NOT COMPLETED|Fourth Dose Vaccination Phase||1
6278581|NCT00134784|7178143|FG000|STARTED|Overall Study||29
6278582|NCT00134784|7178144|FG001|STARTED|Overall Study||38
6278583|NCT00134784|7178145|FG002|STARTED|Overall Study||37
6278584|NCT00134784|7178146|FG003|STARTED|Overall Study||38
6278585|NCT00134784|7178143|FG000|COMPLETED|Overall Study||27
6278586|NCT00134784|7178144|FG001|COMPLETED|Overall Study||36
6278587|NCT00134784|7178145|FG002|COMPLETED|Overall Study||35
6278588|NCT00134784|7178146|FG003|COMPLETED|Overall Study||37
6278589|NCT00134784|7178143|FG000|NOT COMPLETED|Overall Study||2
6278590|NCT00134784|7178144|FG001|NOT COMPLETED|Overall Study||2
6278591|NCT00134784|7178145|FG002|NOT COMPLETED|Overall Study||2
6278592|NCT00134784|7178146|FG003|NOT COMPLETED|Overall Study||1
6278593|NCT00134901|7178155|FG000|STARTED|Overall Study||39
6278594|NCT00134901|7178156|FG001|STARTED|Overall Study||42
6278595|NCT00134901|7178155|FG000|COMPLETED|Overall Study||22
6278596|NCT00134901|7178156|FG001|COMPLETED|Overall Study||27
6278597|NCT00134901|7178155|FG000|NOT COMPLETED|Overall Study||17
6278598|NCT00134901|7178156|FG001|NOT COMPLETED|Overall Study||15
6280969|NCT00160251|7180791|FG005|NOT COMPLETED|Prior to Amendment 2||83
6280970|NCT00160251|7180792|FG006|NOT COMPLETED|Prior to Amendment 2||4
6280971|NCT00160251|7180793|FG007|NOT COMPLETED|Prior to Amendment 2||0
6280972|NCT00160251|7180786|FG000|STARTED|Post-amendment 2||0
6280973|NCT00160251|7180787|FG001|STARTED|Post-amendment 2||0
6280974|NCT00160251|7180788|FG002|STARTED|Post-amendment 2||0
6280975|NCT00160251|7180789|FG003|STARTED|Post-amendment 2||0
6280976|NCT00160251|7180790|FG004|STARTED|Post-amendment 2||0
6280977|NCT00160251|7180791|FG005|STARTED|Post-amendment 2||0
6280978|NCT00160251|7180792|FG006|STARTED|Post-amendment 2||0
6280979|NCT00160251|7180793|FG007|STARTED|Post-amendment 2||143
6280980|NCT00160251|7180786|FG000|COMPLETED|Post-amendment 2||0
6280981|NCT00160251|7180787|FG001|COMPLETED|Post-amendment 2||0
6280982|NCT00160251|7180788|FG002|COMPLETED|Post-amendment 2||0
6280983|NCT00160251|7180789|FG003|COMPLETED|Post-amendment 2||0
6280984|NCT00160251|7180790|FG004|COMPLETED|Post-amendment 2||0
6280985|NCT00160251|7180791|FG005|COMPLETED|Post-amendment 2||0
6280986|NCT00160251|7180792|FG006|COMPLETED|Post-amendment 2||0
6280987|NCT00160251|7180793|FG007|COMPLETED|Post-amendment 2||88
6280988|NCT00160251|7180786|FG000|NOT COMPLETED|Post-amendment 2||0
6280989|NCT00160251|7180787|FG001|NOT COMPLETED|Post-amendment 2||0
6280990|NCT00160251|7180788|FG002|NOT COMPLETED|Post-amendment 2||0
6280991|NCT00160251|7180789|FG003|NOT COMPLETED|Post-amendment 2||0
6280992|NCT00160251|7180790|FG004|NOT COMPLETED|Post-amendment 2||0
6280993|NCT00160251|7180791|FG005|NOT COMPLETED|Post-amendment 2||0
6280994|NCT00160251|7180792|FG006|NOT COMPLETED|Post-amendment 2||0
6280995|NCT00160251|7180793|FG007|NOT COMPLETED|Post-amendment 2||55
6280996|NCT00160524|7180850|FG000|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
6280997|NCT00160524|7180850|FG000|COMPLETED|Overall Study||117
6280998|NCT00160524|7180850|FG000|NOT COMPLETED|Overall Study||478
6280999|NCT00160615|7180856|FG000|STARTED|Overall Study||50
6281000|NCT00160615|7180857|FG001|STARTED|Overall Study||101
6281001|NCT00160615|7180856|FG000|COMPLETED|Overall Study||32
6281002|NCT00160615|7180857|FG001|COMPLETED|Overall Study||56
6281003|NCT00160615|7180856|FG000|NOT COMPLETED|Overall Study||18
6281004|NCT00160615|7180857|FG001|NOT COMPLETED|Overall Study||45
6281005|NCT00160641|7180865|FG000|STARTED|Overall Study||567
6281006|NCT00160641|7180865|FG000|COMPLETED|Overall Study||346
6281007|NCT00160641|7180865|FG000|NOT COMPLETED|Overall Study||221
6281008|NCT00160654|7180869|FG000|STARTED|Overall Study||251
6281009|NCT00160654|7180869|FG000|COMPLETED|Overall Study||218
6281010|NCT00160654|7180869|FG000|NOT COMPLETED|Overall Study||33
6281011|NCT00160667|7180876|FG000|STARTED|Overall Study||50
6281012|NCT00160667|7180877|FG001|STARTED|Overall Study||51
6281013|NCT00160667|7180878|FG002|STARTED|Overall Study||51
6281014|NCT00160667|7180876|FG000|COMPLETED|Overall Study||45
6281015|NCT00160667|7180877|FG001|COMPLETED|Overall Study||48
6281016|NCT00160667|7180878|FG002|COMPLETED|Overall Study||45
6281017|NCT00160667|7180876|FG000|NOT COMPLETED|Overall Study||5
6281018|NCT00160667|7180877|FG001|NOT COMPLETED|Overall Study||3
6281019|NCT00160667|7180878|FG002|NOT COMPLETED|Overall Study||6
6281020|NCT00160680|7180889|FG000|STARTED|Overall Study||31
6281021|NCT00160680|7180890|FG001|STARTED|Overall Study||31
6281022|NCT00160680|7180889|FG000|COMPLETED|Overall Study||22
6254206|NCT03298867|7152959|FG000|STARTED|Double-Masked 24-Week Treatment Period||42
6254207|NCT03298867|7152960|FG001|STARTED|Double-Masked 24-Week Treatment Period||41
6254208|NCT03298867|7152959|FG000|COMPLETED|Double-Masked 24-Week Treatment Period|36 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|40
6254209|NCT03298867|7152960|FG001|COMPLETED|Double-Masked 24-Week Treatment Period|3 participants who completed the double-masked treatment period as nonresponders chose to enroll in the OPTIC-X open-label extension study (NCT03461211).|39
6254210|NCT03298867|7152959|FG000|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
6254211|NCT03298867|7152960|FG001|NOT COMPLETED|Double-Masked 24-Week Treatment Period||2
6254212|NCT03298867|7152959|FG000|STARTED|48-Week Follow-Up Period (Weeks 24-72)||4
6254213|NCT03298867|7152960|FG001|STARTED|48-Week Follow-Up Period (Weeks 24-72)||36
6254214|NCT03298867|7152959|FG000|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||3
6254215|NCT03298867|7152960|FG001|COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||20
6254216|NCT03298867|7152959|FG000|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||1
6254217|NCT03298867|7152960|FG001|NOT COMPLETED|48-Week Follow-Up Period (Weeks 24-72)||16
6254218|NCT03298867|7152959|FG000|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||3
6254219|NCT03298867|7152960|FG001|STARTED|48-Week Follow-Up Contact (Weeks 96-120)||20
6254220|NCT03298867|7152959|FG000|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||3
6254221|NCT03298867|7152960|FG001|COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||19
6254222|NCT03298867|7152959|FG000|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||0
6254223|NCT03298867|7152960|FG001|NOT COMPLETED|48-Week Follow-Up Contact (Weeks 96-120)||1
6254224|NCT03227224|7152970|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||138
6254225|NCT03227224|7152971|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||33
6254226|NCT03227224|7152972|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||63
6570675|NCT01852825|7494064|FG002|STARTED|Overall Study||3
6570676|NCT01852825|7494062|FG000|COMPLETED|Overall Study||14
6570677|NCT01852825|7494063|FG001|COMPLETED|Overall Study||7
6570678|NCT01852825|7494064|FG002|COMPLETED|Overall Study||3
6570679|NCT01852825|7494062|FG000|NOT COMPLETED|Overall Study||2
6254227|NCT03227224|7152973|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||53
6254228|NCT03227224|7152970|FG000|Treated|Double-blind Treatment Period (6 Weeks)||137
6254229|NCT03227224|7152971|FG001|Treated|Double-blind Treatment Period (6 Weeks)||33
6254230|NCT03227224|7152972|FG002|Treated|Double-blind Treatment Period (6 Weeks)||61
6254231|NCT03227224|7152973|FG003|Treated|Double-blind Treatment Period (6 Weeks)||52
6254232|NCT03227224|7152970|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||123
6254233|NCT03227224|7152971|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||27
6254234|NCT03227224|7152972|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||55
6254235|NCT03227224|7152973|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||46
6254236|NCT03227224|7152970|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||15
6254237|NCT03227224|7152971|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||6
6254238|NCT03227224|7152972|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||8
6254239|NCT03227224|7152973|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||7
6254240|NCT03227224|7152970|FG000|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|138
6254241|NCT03227224|7152971|FG001|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|33
6254242|NCT03227224|7152972|FG002|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|63
6254243|NCT03227224|7152973|FG003|STARTED|Follow-up Phase (2 Weeks)|All participants that started the double-blind period were followed-up for follow-up phase.|53
6254244|NCT03227224|7152970|FG000|COMPLETED|Follow-up Phase (2 Weeks)||134
6254245|NCT03227224|7152971|FG001|COMPLETED|Follow-up Phase (2 Weeks)||29
6254246|NCT03227224|7152972|FG002|COMPLETED|Follow-up Phase (2 Weeks)||57
6254247|NCT03227224|7152973|FG003|COMPLETED|Follow-up Phase (2 Weeks)||50
6254248|NCT03227224|7152970|FG000|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
6254249|NCT03227224|7152971|FG001|NOT COMPLETED|Follow-up Phase (2 Weeks)||4
6254250|NCT03227224|7152972|FG002|NOT COMPLETED|Follow-up Phase (2 Weeks)||6
6254251|NCT03227224|7152973|FG003|NOT COMPLETED|Follow-up Phase (2 Weeks)||3
6254252|NCT03220581|7152992|FG000|STARTED|Overall Study||28
6254253|NCT03220581|7152993|FG001|STARTED|Overall Study||32
6254254|NCT03220581|7152992|FG000|COMPLETED|Overall Study||25
6254255|NCT03220581|7152993|FG001|COMPLETED|Overall Study||25
6254256|NCT03220581|7152992|FG000|NOT COMPLETED|Overall Study||3
6254257|NCT03220581|7152993|FG001|NOT COMPLETED|Overall Study||7
6254258|NCT03099486|7153001|FG000|STARTED|Overall Study||2
6254259|NCT03099486|7153001|FG000|COMPLETED|Overall Study||2
6254260|NCT03099486|7153001|FG000|NOT COMPLETED|Overall Study||0
6254261|NCT02991482|7153007|FG000|STARTED|Overall Study||73
6254262|NCT02991482|7153008|FG001|STARTED|Overall Study||71
6254263|NCT02991482|7153007|FG000|Crossed-over to Pembrolizumab at Progression|Overall Study||0
6254264|NCT02991482|7153008|FG001|Crossed-over to Pembrolizumab at Progression|Overall Study||45
6254265|NCT02991482|7153007|FG000|COMPLETED|Overall Study||8
6254266|NCT02991482|7153008|FG001|COMPLETED|Overall Study||5
6254267|NCT02991482|7153007|FG000|NOT COMPLETED|Overall Study||65
6254268|NCT02991482|7153008|FG001|NOT COMPLETED|Overall Study||66
6254269|NCT02768870|7153014|FG000|STARTED|Overall Study||26
6570680|NCT01852825|7494063|FG001|NOT COMPLETED|Overall Study||0
6570681|NCT01852825|7494064|FG002|NOT COMPLETED|Overall Study||0
6570682|NCT01852942|7494074|FG000|STARTED|Overall Study||25
6254270|NCT02768870|7153014|FG000|Implanted With Device|Overall Study||24
6254271|NCT02768870|7153014|FG000|COMPLETED|Overall Study||0
6254272|NCT02768870|7153014|FG000|NOT COMPLETED|Overall Study||26
6254273|NCT02648698|7153020|FG000|STARTED|Overall Study||60
6254274|NCT02648698|7153021|FG001|STARTED|Overall Study||60
6254275|NCT02648698|7153020|FG000|COMPLETED|Overall Study||59
6254276|NCT02648698|7153021|FG001|COMPLETED|Overall Study||55
6254277|NCT02648698|7153020|FG000|NOT COMPLETED|Overall Study||1
6254278|NCT02648698|7153021|FG001|NOT COMPLETED|Overall Study||5
6254279|NCT02432196|7153027|FG000|STARTED|Overall Study||26
6254280|NCT02432196|7153027|FG000|Implanted With Device|Overall Study||25
6254281|NCT02432196|7153027|FG000|COMPLETED|Overall Study||0
6254282|NCT02432196|7153027|FG000|NOT COMPLETED|Overall Study||26
6254283|NCT02340676|7153031|FG000|STARTED|Overall Study||25
6254284|NCT02340676|7153031|FG000|COMPLETED|Overall Study||25
6254285|NCT02340676|7153031|FG000|NOT COMPLETED|Overall Study||0
6254286|NCT02000882|7153035|FG000|STARTED|Overall Study||10
6254287|NCT02000882|7153035|FG000|COMPLETED|Overall Study||4
6254288|NCT02000882|7153035|FG000|NOT COMPLETED|Overall Study||6
6254289|NCT01654315|7153042|FG000|STARTED|Overall Study||15
6254290|NCT01654315|7153043|FG001|STARTED|Overall Study||10
6254291|NCT01654315|7153044|FG002|STARTED|Overall Study||9
6254292|NCT01654315|7153042|FG000|COMPLETED|Overall Study||15
6254293|NCT01654315|7153043|FG001|COMPLETED|Overall Study||10
6254294|NCT01654315|7153044|FG002|COMPLETED|Overall Study||9
6254295|NCT01654315|7153042|FG000|NOT COMPLETED|Overall Study||0
6254296|NCT01654315|7153043|FG001|NOT COMPLETED|Overall Study||0
6254297|NCT01654315|7153044|FG002|NOT COMPLETED|Overall Study||0
6254298|NCT01642004|7153054|FG000|STARTED|Randomization||135
6570683|NCT01852942|7494075|FG001|STARTED|Overall Study||27
6570684|NCT01852942|7494074|FG000|COMPLETED|Overall Study||20
6570685|NCT01852942|7494075|FG001|COMPLETED|Overall Study||21
6570686|NCT01852942|7494074|FG000|NOT COMPLETED|Overall Study||5
6570687|NCT01852942|7494075|FG001|NOT COMPLETED|Overall Study||6
6570688|NCT01852955|7494084|FG000|STARTED|Overall Study||35
6570689|NCT01852955|7494085|FG001|STARTED|Overall Study||35
6570690|NCT01852955|7494084|FG000|COMPLETED|Overall Study||33
6570691|NCT01852955|7494085|FG001|COMPLETED|Overall Study||32
6570692|NCT01852955|7494084|FG000|NOT COMPLETED|Overall Study||2
6570693|NCT01852955|7494085|FG001|NOT COMPLETED|Overall Study||3
6570694|NCT01853046|7494093|FG000|STARTED|Overall Study||18
6570695|NCT01853046|7494094|FG001|STARTED|Overall Study||6
6570696|NCT01853046|7494093|FG000|Received Treatment|Overall Study||18
6254299|NCT01642004|7153055|FG001|STARTED|Randomization||137
6254300|NCT01642004|7153054|FG000|COMPLETED|Randomization||131
6254301|NCT01642004|7153055|FG001|COMPLETED|Randomization||129
6254302|NCT01642004|7153054|FG000|NOT COMPLETED|Randomization||4
6254303|NCT01642004|7153055|FG001|NOT COMPLETED|Randomization||8
6254304|NCT01642004|7153054|FG000|STARTED|Treatment||131
6254305|NCT01642004|7153055|FG001|STARTED|Treatment||129
6254306|NCT01642004|7153054|FG000|COMPLETED|Treatment||21
6254307|NCT01642004|7153055|FG001|COMPLETED|Treatment||2
6254308|NCT01642004|7153054|FG000|NOT COMPLETED|Treatment||110
6254309|NCT01642004|7153055|FG001|NOT COMPLETED|Treatment||127
6254310|NCT01366092|7153061|FG000|STARTED|Overall Study||35
6254311|NCT01366092|7153061|FG000|COMPLETED|Overall Study||31
6254312|NCT01366092|7153061|FG000|NOT COMPLETED|Overall Study||4
6254313|NCT01326104|7153067|FG000|STARTED|Overall Study||7
6254314|NCT01326104|7153068|FG001|STARTED|Overall Study||19
6254315|NCT01326104|7153067|FG000|COMPLETED|Overall Study||7
6254316|NCT01326104|7153068|FG001|COMPLETED|Overall Study||15
6254317|NCT01326104|7153067|FG000|NOT COMPLETED|Overall Study||0
6254318|NCT01326104|7153068|FG001|NOT COMPLETED|Overall Study||4
6254319|NCT01244815|7153078|FG000|STARTED|Overall Study|Randomized|101
6254320|NCT01244815|7153079|FG001|STARTED|Overall Study|Randomized|105
6254321|NCT01244815|7153080|FG002|STARTED|Overall Study|Randomized|99
6254322|NCT01244815|7153081|FG003|STARTED|Overall Study|Randomized|99
6254323|NCT01244815|7153078|FG000|Treated|Overall Study||101
6254324|NCT01244815|7153079|FG001|Treated|Overall Study||104
6254325|NCT01244815|7153080|FG002|Treated|Overall Study||99
6254326|NCT01244815|7153081|FG003|Treated|Overall Study||99
6254327|NCT01244815|7153078|FG000|COMPLETED|Overall Study||87
6254328|NCT01244815|7153079|FG001|COMPLETED|Overall Study||88
6254329|NCT01244815|7153080|FG002|COMPLETED|Overall Study||88
6254330|NCT01244815|7153081|FG003|COMPLETED|Overall Study||87
6570697|NCT01853046|7494094|FG001|Received Treatment|Overall Study||6
6570698|NCT01853046|7494093|FG000|COMPLETED|Overall Study||0
6570699|NCT01853046|7494094|FG001|COMPLETED|Overall Study||0
6570700|NCT01853046|7494093|FG000|NOT COMPLETED|Overall Study||18
6570701|NCT01853046|7494094|FG001|NOT COMPLETED|Overall Study||6
6254331|NCT01244815|7153078|FG000|NOT COMPLETED|Overall Study||14
6254332|NCT01244815|7153079|FG001|NOT COMPLETED|Overall Study||17
6254333|NCT01244815|7153080|FG002|NOT COMPLETED|Overall Study||11
6254334|NCT01244815|7153081|FG003|NOT COMPLETED|Overall Study||12
6254335|NCT01142596|7153093|FG000|STARTED|Overall Study||44
6254336|NCT01142596|7153094|FG001|STARTED|Overall Study||157
6254337|NCT01142596|7153093|FG000|COMPLETED|Overall Study||15
6254338|NCT01142596|7153094|FG001|COMPLETED|Overall Study||71
6254339|NCT01142596|7153093|FG000|NOT COMPLETED|Overall Study||29
6254340|NCT01142596|7153094|FG001|NOT COMPLETED|Overall Study||86
6254341|NCT01098110|7153103|FG000|STARTED|Overall Study|Randomized participants|176
6570702|NCT01853072|7494103|FG000|STARTED|Overall Study||308
6570703|NCT01853072|7494104|FG001|STARTED|Overall Study||307
6254342|NCT01098110|7153104|FG001|STARTED|Overall Study|Randomized participants|182
6254343|NCT01098110|7153105|FG002|STARTED|Overall Study|Randomized participants|174
6509063|NCT01474109|7428643|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||18
6509064|NCT01474109|7428644|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||12
6509065|NCT01474122|7428655|FG000|STARTED|Period 1: Baseline to Week 16||88
6509066|NCT01474122|7428656|FG001|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
6509067|NCT01474122|7428657|FG002|STARTED|Period 1: Baseline to Week 16||89
6509068|NCT01474122|7428655|FG000|COMPLETED|Period 1: Baseline to Week 16||87
6509069|NCT01474122|7428656|FG001|COMPLETED|Period 1: Baseline to Week 16||86
6509070|NCT01474122|7428657|FG002|COMPLETED|Period 1: Baseline to Week 16||88
6509071|NCT01474122|7428655|FG000|NOT COMPLETED|Period 1: Baseline to Week 16||1
6509072|NCT01474122|7428656|FG001|NOT COMPLETED|Period 1: Baseline to Week 16||2
6509073|NCT01474122|7428657|FG002|NOT COMPLETED|Period 1: Baseline to Week 16||1
6509074|NCT01474122|7428655|FG000|STARTED|Period 2: Week 16 to End of Study||87
6509075|NCT01474122|7428656|FG001|STARTED|Period 2: Week 16 to End of Study||86
6509076|NCT01474122|7428657|FG002|STARTED|Period 2: Week 16 to End of Study||88
6570704|NCT01853072|7494103|FG000|Randomized|Overall Study||308
6570705|NCT01853072|7494104|FG001|Randomized|Overall Study||307
6570706|NCT01853072|7494103|FG000|Treated (Safety Analysis Set)|Overall Study||301
6570707|NCT01853072|7494104|FG001|Treated (Safety Analysis Set)|Overall Study||302
6570708|NCT01853072|7494103|FG000|Full Analysis Set|Overall Study||298
6570709|NCT01853072|7494104|FG001|Full Analysis Set|Overall Study||300
6570710|NCT01853072|7494103|FG000|COMPLETED|Overall Study||296
6570711|NCT01853072|7494104|FG001|COMPLETED|Overall Study||286
6570712|NCT01853072|7494103|FG000|NOT COMPLETED|Overall Study||12
6570713|NCT01853072|7494104|FG001|NOT COMPLETED|Overall Study||21
6570714|NCT01853085|7494112|FG000|STARTED|Overall Study||1830
6570715|NCT01853085|7494112|FG000|COMPLETED|Overall Study||1595
6570716|NCT01853085|7494112|FG000|NOT COMPLETED|Overall Study||235
6570717|NCT01853137|7494118|FG000|STARTED|Overall Study||25
6570718|NCT01853137|7494119|FG001|STARTED|Overall Study||18
6570719|NCT01853137|7494118|FG000|COMPLETED|Overall Study||21
6570720|NCT01853137|7494119|FG001|COMPLETED|Overall Study||17
6570721|NCT01853137|7494118|FG000|NOT COMPLETED|Overall Study||4
6391735|NCT00837811|7303657|FG002|Included in Efficacy Analyses|Overall Study||1
6391736|NCT00837811|7303655|FG000|COMPLETED|Overall Study||53
6391737|NCT00837811|7303656|FG001|COMPLETED|Overall Study||87
6391738|NCT00837811|7303657|FG002|COMPLETED|Overall Study||0
6391739|NCT00837811|7303655|FG000|NOT COMPLETED|Overall Study||7
6391740|NCT00837811|7303656|FG001|NOT COMPLETED|Overall Study||34
6570722|NCT01853137|7494119|FG001|NOT COMPLETED|Overall Study||1
6570723|NCT01853215|7494126|FG000|STARTED|Overall Study||24
6570724|NCT01853215|7494126|FG000|COMPLETED|Overall Study||24
6570725|NCT01853215|7494126|FG000|NOT COMPLETED|Overall Study||0
6570726|NCT01853228|7494131|FG000|STARTED|Phase 1||9
6570727|NCT01853228|7494132|FG001|STARTED|Phase 1||7
6570728|NCT01853228|7494131|FG000|COMPLETED|Phase 1||0
6570729|NCT01853228|7494132|FG001|COMPLETED|Phase 1|Participants who completed Phase 1 moved to Phase 2.|7
6570730|NCT01853228|7494131|FG000|NOT COMPLETED|Phase 1||9
6570731|NCT01853228|7494132|FG001|NOT COMPLETED|Phase 1||0
6570732|NCT01853228|7494131|FG000|STARTED|Phase 2||0
6570733|NCT01853228|7494132|FG001|STARTED|Phase 2|1 additional participant was enrolled, making total of 8 participants evaluable in Phase 2.|8
6570734|NCT01853228|7494131|FG000|COMPLETED|Phase 2||0
6570735|NCT01853228|7494132|FG001|COMPLETED|Phase 2||0
6570736|NCT01853228|7494131|FG000|NOT COMPLETED|Phase 2||0
6570737|NCT01853228|7494132|FG001|NOT COMPLETED|Phase 2||8
6570738|NCT01853254|7494137|FG000|STARTED|Overall Study||272
6570739|NCT01853254|7494137|FG000|COMPLETED|Overall Study||168
6570740|NCT01853254|7494137|FG000|NOT COMPLETED|Overall Study||104
6570741|NCT01853280|7494143|FG000|STARTED|Overall Study||22
6570742|NCT01853280|7494144|FG001|STARTED|Overall Study||22
6570743|NCT01853280|7494143|FG000|COMPLETED|Overall Study||20
6570744|NCT01853280|7494144|FG001|COMPLETED|Overall Study||16
6570745|NCT01853280|7494143|FG000|NOT COMPLETED|Overall Study||2
6570746|NCT01853280|7494144|FG001|NOT COMPLETED|Overall Study||6
6570747|NCT01853332|7494150|FG000|STARTED|Overall Study||210
6570748|NCT01853332|7494150|FG000|COMPLETED|Overall Study||151
6570749|NCT01853332|7494150|FG000|NOT COMPLETED|Overall Study||59
6254344|NCT01098110|7153103|FG000|Treated|Overall Study|Received at least one dose of trial medication|175
6254345|NCT01098110|7153104|FG001|Treated|Overall Study|Received at least one dose of trial medication|181
6254346|NCT01098110|7153105|FG002|Treated|Overall Study|Received at least one dose of trial medication|174
6254347|NCT01098110|7153103|FG000|COMPLETED|Overall Study||114
6254348|NCT01098110|7153104|FG001|COMPLETED|Overall Study||109
6254349|NCT01098110|7153105|FG002|COMPLETED|Overall Study||80
6570750|NCT01853371|7494157|FG000|STARTED|Overall Study||10
6570751|NCT01853371|7494158|FG001|STARTED|Overall Study||10
6570752|NCT01853371|7494157|FG000|COMPLETED|Overall Study||10
6570753|NCT01853371|7494158|FG001|COMPLETED|Overall Study||8
6570754|NCT01853371|7494157|FG000|NOT COMPLETED|Overall Study||0
6570755|NCT01853371|7494158|FG001|NOT COMPLETED|Overall Study||2
6570756|NCT01853384|7494166|FG000|STARTED|Randomized||131
6570757|NCT01853384|7494167|FG001|STARTED|Randomized||121
6570758|NCT01853384|7494166|FG000|COMPLETED|Randomized||69
6570759|NCT01853384|7494167|FG001|COMPLETED|Randomized||75
6570760|NCT01853384|7494166|FG000|NOT COMPLETED|Randomized||62
6570761|NCT01853384|7494167|FG001|NOT COMPLETED|Randomized||46
6254350|NCT01098110|7153103|FG000|NOT COMPLETED|Overall Study||62
6254351|NCT01098110|7153104|FG001|NOT COMPLETED|Overall Study||73
6254352|NCT01098110|7153105|FG002|NOT COMPLETED|Overall Study||94
6254353|NCT01006265|7153117|FG000|STARTED|Overall Study||119
6254354|NCT01006265|7153118|FG001|STARTED|Overall Study||116
6254355|NCT01006265|7153119|FG002|STARTED|Overall Study||108
6254356|NCT01006265|7153120|FG003|STARTED|Overall Study||121
6254357|NCT01006265|7153117|FG000|Treated|Overall Study||119
6254358|NCT01006265|7153118|FG001|Treated|Overall Study||114
6254359|NCT01006265|7153119|FG002|Treated|Overall Study||108
6254360|NCT01006265|7153120|FG003|Treated|Overall Study||121
6254361|NCT01006265|7153117|FG000|COMPLETED|Overall Study||113
6254362|NCT01006265|7153118|FG001|COMPLETED|Overall Study||107
6254363|NCT01006265|7153119|FG002|COMPLETED|Overall Study||99
6254364|NCT01006265|7153120|FG003|COMPLETED|Overall Study||116
6254365|NCT01006265|7153117|FG000|NOT COMPLETED|Overall Study||6
6254366|NCT01006265|7153118|FG001|NOT COMPLETED|Overall Study||9
6254367|NCT01006265|7153119|FG002|NOT COMPLETED|Overall Study||9
6254368|NCT01006265|7153120|FG003|NOT COMPLETED|Overall Study||5
6278599|NCT00135226|7178168|FG000|STARTED|Overall Study||3870
6278600|NCT00135226|7178169|FG001|STARTED|Overall Study||3870
6278601|NCT00135226|7178170|FG002|STARTED|Overall Study||3870
6278602|NCT00135226|7178171|FG003|STARTED|Overall Study||3870
6278603|NCT00135226|7178168|FG000|COMPLETED|Overall Study||3836
6278604|NCT00135226|7178169|FG001|COMPLETED|Overall Study||3835
6278605|NCT00135226|7178170|FG002|COMPLETED|Overall Study||3836
6278606|NCT00135226|7178171|FG003|COMPLETED|Overall Study||3834
6278607|NCT00135226|7178168|FG000|NOT COMPLETED|Overall Study||34
6278608|NCT00135226|7178169|FG001|NOT COMPLETED|Overall Study||35
6278609|NCT00135226|7178170|FG002|NOT COMPLETED|Overall Study||34
6278610|NCT00135226|7178171|FG003|NOT COMPLETED|Overall Study||36
6278611|NCT00135330|7178186|FG000|STARTED|Overall Study||45
6278612|NCT00135330|7178187|FG001|STARTED|Overall Study||47
6278613|NCT00135330|7178188|FG002|STARTED|Overall Study||45
6278614|NCT00135330|7178186|FG000|COMPLETED|Overall Study||33
6278615|NCT00135330|7178187|FG001|COMPLETED|Overall Study||34
6278616|NCT00135330|7178188|FG002|COMPLETED|Overall Study||34
6278617|NCT00135330|7178186|FG000|NOT COMPLETED|Overall Study||12
6278618|NCT00135330|7178187|FG001|NOT COMPLETED|Overall Study||13
6278619|NCT00135330|7178188|FG002|NOT COMPLETED|Overall Study||11
6278620|NCT00135356|7178198|FG000|STARTED|Overall Study|Number randomized and treated|131
6278621|NCT00135356|7178199|FG001|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
6278622|NCT00135356|7178198|FG000|Discontinued Prior to Week 96 Visit|Overall Study||16
6278623|NCT00135356|7178199|FG001|Discontinued Prior to Week 96 Visit|Overall Study||9
6278624|NCT00135356|7178198|FG000|Discontinued on or After Week 96 Visit|Overall Study||1
6278625|NCT00135356|7178199|FG001|Discontinued on or After Week 96 Visit|Overall Study||0
6278626|NCT00135356|7178198|FG000|COMPLETED|Overall Study||114
6278627|NCT00135356|7178199|FG001|COMPLETED|Overall Study||60
6278628|NCT00135356|7178198|FG000|NOT COMPLETED|Overall Study||17
6278629|NCT00135356|7178199|FG001|NOT COMPLETED|Overall Study||9
6278630|NCT00135512|7178205|FG000|STARTED|Overall Study||234
6278631|NCT00135512|7178205|FG000|COMPLETED|Overall Study||111
6278632|NCT00135512|7178205|FG000|NOT COMPLETED|Overall Study||123
6278633|NCT00135694|7178212|FG000|STARTED|Overall Study||180
6278634|NCT00135694|7178213|FG001|STARTED|Overall Study||77
6278635|NCT00135694|7178214|FG002|STARTED|Overall Study||18
6278636|NCT00135694|7178212|FG000|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
6278637|NCT00135694|7178213|FG001|COMPLETED|Overall Study||56
6278638|NCT00135694|7178214|FG002|COMPLETED|Overall Study||11
6278639|NCT00135694|7178212|FG000|NOT COMPLETED|Overall Study||180
6278640|NCT00135694|7178213|FG001|NOT COMPLETED|Overall Study||21
6278641|NCT00135694|7178214|FG002|NOT COMPLETED|Overall Study||7
6278642|NCT00135707|7178224|FG000|STARTED|Overall Study||5088
6278643|NCT00135707|7178225|FG001|STARTED|Overall Study||5066
6278644|NCT00135707|7178224|FG000|COMPLETED|Overall Study||4993
6278645|NCT00135707|7178225|FG001|COMPLETED|Overall Study||4976
6278646|NCT00135707|7178224|FG000|NOT COMPLETED|Overall Study||95
6278647|NCT00135707|7178225|FG001|NOT COMPLETED|Overall Study||90
6278648|NCT00135798|7178238|FG000|STARTED|Overall Study||16
6278649|NCT00135798|7178239|FG001|STARTED|Overall Study||31
6278650|NCT00135798|7178240|FG002|STARTED|Overall Study||32
6278651|NCT00135798|7178238|FG000|COMPLETED|Overall Study||16
6278652|NCT00135798|7178239|FG001|COMPLETED|Overall Study||31
6278653|NCT00135798|7178240|FG002|COMPLETED|Overall Study||32
6278654|NCT00135798|7178238|FG000|NOT COMPLETED|Overall Study||0
6278655|NCT00135798|7178239|FG001|NOT COMPLETED|Overall Study||0
6278656|NCT00135798|7178240|FG002|NOT COMPLETED|Overall Study||0
6278657|NCT00136084|7178249|FG000|STARTED|Overall Study||109
6278658|NCT00136084|7178250|FG001|STARTED|Overall Study||114
6278659|NCT00136084|7178249|FG000|COMPLETED|Overall Study||61
6278660|NCT00136084|7178250|FG001|COMPLETED|Overall Study||72
6278661|NCT00136084|7178249|FG000|NOT COMPLETED|Overall Study||48
6278662|NCT00136084|7178250|FG001|NOT COMPLETED|Overall Study||42
6278663|NCT00136214|7178264|FG000|STARTED|Overall Study||15
6278664|NCT00136214|7178265|FG001|STARTED|Overall Study||7
6278665|NCT00136214|7178264|FG000|COMPLETED|Overall Study||15
6278666|NCT00136214|7178265|FG001|COMPLETED|Overall Study||7
6278667|NCT00136214|7178264|FG000|NOT COMPLETED|Overall Study||0
6278668|NCT00136214|7178265|FG001|NOT COMPLETED|Overall Study||0
6281023|NCT00160680|7180890|FG001|COMPLETED|Overall Study||18
6254369|NCT00591227|7153132|FG000|STARTED|Overall Study||89
6254370|NCT00591227|7153133|FG001|STARTED|Overall Study||87
6254371|NCT00591227|7153132|FG000|COMPLETED|Overall Study||89
6254372|NCT00591227|7153133|FG001|COMPLETED|Overall Study||87
6254373|NCT00591227|7153132|FG000|NOT COMPLETED|Overall Study||0
6254374|NCT00591227|7153133|FG001|NOT COMPLETED|Overall Study||0
6509077|NCT01474122|7428655|FG000|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
6509078|NCT01474122|7428656|FG001|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
6509079|NCT01474122|7428657|FG002|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
6509080|NCT01474122|7428655|FG000|NOT COMPLETED|Period 2: Week 16 to End of Study||17
6509081|NCT01474122|7428656|FG001|NOT COMPLETED|Period 2: Week 16 to End of Study||13
6509082|NCT01474122|7428657|FG002|NOT COMPLETED|Period 2: Week 16 to End of Study||15
6509083|NCT01474200|7428669|FG000|STARTED|Overall Study||110
6509084|NCT01474200|7428670|FG001|STARTED|Overall Study||114
6509085|NCT01474200|7428669|FG000|COMPLETED|Overall Study||81
6509086|NCT01474200|7428670|FG001|COMPLETED|Overall Study||84
6509087|NCT01474200|7428669|FG000|NOT COMPLETED|Overall Study||29
6509088|NCT01474200|7428670|FG001|NOT COMPLETED|Overall Study||30
6509089|NCT01474213|7428678|FG000|STARTED|Overall Study||20
6509090|NCT01474213|7428679|FG001|STARTED|Overall Study||20
6509091|NCT01474213|7428678|FG000|COMPLETED|Overall Study||20
6509092|NCT01474213|7428679|FG001|COMPLETED|Overall Study||20
6509093|NCT01474213|7428678|FG000|NOT COMPLETED|Overall Study||0
6509094|NCT01474213|7428679|FG001|NOT COMPLETED|Overall Study||0
6509095|NCT01474239|7428691|FG000|STARTED|Overall Study||59
6509096|NCT01474239|7428692|FG001|STARTED|Overall Study||32
6509097|NCT01474239|7428691|FG000|COMPLETED|Overall Study||0
6570762|NCT01853384|7494166|FG000|STARTED|Enrolled in Follow up Period||96
6570763|NCT01853384|7494167|FG001|STARTED|Enrolled in Follow up Period||94
6509098|NCT01474239|7428692|FG001|COMPLETED|Overall Study||0
6509099|NCT01474239|7428691|FG000|NOT COMPLETED|Overall Study||59
6509100|NCT01474239|7428692|FG001|NOT COMPLETED|Overall Study||32
6509101|NCT01474291|7428700|FG000|STARTED|Overall Study||603
6509102|NCT01474291|7428700|FG000|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
6509103|NCT01474291|7428700|FG000|COMPLETED|Overall Study||383
6509104|NCT01474291|7428700|FG000|NOT COMPLETED|Overall Study||220
6509105|NCT01474317|7428707|FG000|STARTED|Overall Study||226
6509106|NCT01474317|7428707|FG000|COMPLETED|Overall Study||224
6509107|NCT01474317|7428707|FG000|NOT COMPLETED|Overall Study||2
6509108|NCT01474434|7428715|FG000|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
6509109|NCT01474434|7428716|FG001|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
6509110|NCT01474434|7428717|FG002|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
6509111|NCT01474434|7428718|FG003|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
6509112|NCT01474434|7428715|FG000|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
6509113|NCT01474434|7428716|FG001|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
6509114|NCT01474434|7428717|FG002|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
6509115|NCT01474434|7428718|FG003|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
6509116|NCT01474434|7428715|FG000|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
6509117|NCT01474434|7428716|FG001|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
6509118|NCT01474434|7428717|FG002|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
6509119|NCT01474434|7428718|FG003|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
6509120|NCT01474434|7428715|FG000|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
6509121|NCT01474434|7428716|FG001|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
6509122|NCT01474434|7428717|FG002|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
6509123|NCT01474434|7428718|FG003|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
6509124|NCT01474434|7428715|FG000|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
6509125|NCT01474434|7428716|FG001|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
6509126|NCT01474434|7428717|FG002|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
6509127|NCT01474434|7428718|FG003|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
6509128|NCT01474434|7428715|FG000|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
6509129|NCT01474434|7428716|FG001|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
6509130|NCT01474434|7428717|FG002|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
6509131|NCT01474434|7428718|FG003|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
6509132|NCT01474486|7428732|FG000|STARTED|Overall Study||28
6509133|NCT01474486|7428732|FG000|Treated|Overall Study||22
6509134|NCT01474486|7428732|FG000|COMPLETED|Overall Study||20
6509135|NCT01474486|7428732|FG000|NOT COMPLETED|Overall Study||8
6509136|NCT01474512|7428743|FG000|STARTED|Induction Period||431
6509137|NCT01474512|7428744|FG001|STARTED|Induction Period||432
6509138|NCT01474512|7428745|FG002|STARTED|Induction Period||433
6509139|NCT01474512|7428746|FG003|STARTED|Induction Period||0
6254375|NCT00534976|7153142|FG000|STARTED|Period 1: Placebo Run-in||33
6254376|NCT00534976|7153143|FG001|STARTED|Period 1: Placebo Run-in||33
6254377|NCT00534976|7153142|FG000|COMPLETED|Period 1: Placebo Run-in||33
6254378|NCT00534976|7153143|FG001|COMPLETED|Period 1: Placebo Run-in||33
6254379|NCT00534976|7153142|FG000|NOT COMPLETED|Period 1: Placebo Run-in||0
6254380|NCT00534976|7153143|FG001|NOT COMPLETED|Period 1: Placebo Run-in||0
6509140|NCT01474512|7428747|FG004|STARTED|Induction Period||0
6509141|NCT01474512|7428748|FG005|STARTED|Induction Period||0
6509142|NCT01474512|7428749|FG006|STARTED|Induction Period||0
6737499|NCT03266419|7666787|FG001|COMPLETED|Overall Study||49
6254381|NCT00534976|7153142|FG000|STARTED|Period 2: Treatment Montelukast/ Placebo||33
6254382|NCT00534976|7153143|FG001|STARTED|Period 2: Treatment Montelukast/ Placebo||33
6254383|NCT00534976|7153142|FG000|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
6254384|NCT00534976|7153143|FG001|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
6254385|NCT00534976|7153142|FG000|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
6254386|NCT00534976|7153143|FG001|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
6254387|NCT00534976|7153142|FG000|STARTED|Period 3: Crossover Placebo/ Montelukast||33
6254388|NCT00534976|7153143|FG001|STARTED|Period 3: Crossover Placebo/ Montelukast||32
6254389|NCT00534976|7153142|FG000|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
6254390|NCT00534976|7153143|FG001|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
6254391|NCT00534976|7153142|FG000|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
6254392|NCT00534976|7153143|FG001|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
6254393|NCT00337675|7153152|FG000|STARTED|Overall Study||589
6254394|NCT00337675|7153153|FG001|STARTED|Overall Study||591
6254395|NCT00337675|7153154|FG002|STARTED|Overall Study||591
6254396|NCT00337675|7153152|FG000|COMPLETED|Overall Study||492
6254397|NCT00337675|7153153|FG001|COMPLETED|Overall Study||488
6254398|NCT00337675|7153154|FG002|COMPLETED|Overall Study||492
6254399|NCT00337675|7153152|FG000|NOT COMPLETED|Overall Study||97
6254400|NCT00337675|7153153|FG001|NOT COMPLETED|Overall Study||103
6254401|NCT00337675|7153154|FG002|NOT COMPLETED|Overall Study||99
6254402|NCT00317772|7153166|FG000|STARTED|Overall Study||3
6254403|NCT00317772|7153167|FG001|STARTED|Overall Study||3
6254404|NCT00317772|7153168|FG002|STARTED|Overall Study||3
6254405|NCT00317772|7153169|FG003|STARTED|Overall Study||10
6254406|NCT00317772|7153166|FG000|COMPLETED|Overall Study||1
6254407|NCT00317772|7153167|FG001|COMPLETED|Overall Study||1
6254408|NCT00317772|7153168|FG002|COMPLETED|Overall Study||2
6254409|NCT00317772|7153169|FG003|COMPLETED|Overall Study||1
6254410|NCT00317772|7153166|FG000|NOT COMPLETED|Overall Study||2
6254411|NCT00317772|7153167|FG001|NOT COMPLETED|Overall Study||2
6254412|NCT00317772|7153168|FG002|NOT COMPLETED|Overall Study||1
6254413|NCT00317772|7153169|FG003|NOT COMPLETED|Overall Study||9
6254414|NCT00291486|7153185|FG000|STARTED|Overall Study||3
6254415|NCT00291486|7153186|FG001|STARTED|Overall Study||6
6254416|NCT00291486|7153187|FG002|STARTED|Overall Study||3
6254417|NCT00291486|7153188|FG003|STARTED|Overall Study||3
6254418|NCT00291486|7153189|FG004|STARTED|Overall Study||4
6254419|NCT00291486|7153185|FG000|COMPLETED|Overall Study||2
6254420|NCT00291486|7153186|FG001|COMPLETED|Overall Study||3
6254421|NCT00291486|7153187|FG002|COMPLETED|Overall Study||2
6254422|NCT00291486|7153188|FG003|COMPLETED|Overall Study||2
6254423|NCT00291486|7153189|FG004|COMPLETED|Overall Study||3
6254424|NCT00291486|7153185|FG000|NOT COMPLETED|Overall Study||1
6254425|NCT00291486|7153186|FG001|NOT COMPLETED|Overall Study||3
6254426|NCT00291486|7153187|FG002|NOT COMPLETED|Overall Study||1
6254427|NCT00291486|7153188|FG003|NOT COMPLETED|Overall Study||1
6254428|NCT00291486|7153189|FG004|NOT COMPLETED|Overall Study||1
6254429|NCT00284856|7153213|FG000|STARTED|Overall Study||347
6254430|NCT00284856|7153214|FG001|STARTED|Overall Study||336
6509143|NCT01474512|7428750|FG007|STARTED|Induction Period||0
6509144|NCT01474512|7428751|FG008|STARTED|Induction Period||0
6509145|NCT01474512|7428752|FG009|STARTED|Induction Period||0
6509146|NCT01474512|7428753|FG010|STARTED|Induction Period||0
6509147|NCT01474512|7428754|FG011|STARTED|Induction Period||0
6509148|NCT01474512|7428755|FG012|STARTED|Induction Period||0
6509149|NCT01474512|7428756|FG013|STARTED|Induction Period||0
6509150|NCT01474512|7428757|FG014|STARTED|Induction Period||0
6509151|NCT01474512|7428758|FG015|STARTED|Induction Period||0
6509152|NCT01474512|7428759|FG016|STARTED|Induction Period||0
6509153|NCT01474512|7428760|FG017|STARTED|Induction Period||0
6509154|NCT01474512|7428743|FG000|Received Study Drug|Induction Period||431
6509155|NCT01474512|7428744|FG001|Received Study Drug|Induction Period||432
6509156|NCT01474512|7428745|FG002|Received Study Drug|Induction Period||433
6509157|NCT01474512|7428746|FG003|Received Study Drug|Induction Period||0
6509158|NCT01474512|7428747|FG004|Received Study Drug|Induction Period||0
6509159|NCT01474512|7428748|FG005|Received Study Drug|Induction Period||0
6509160|NCT01474512|7428749|FG006|Received Study Drug|Induction Period||0
6509161|NCT01474512|7428750|FG007|Received Study Drug|Induction Period||0
6509162|NCT01474512|7428751|FG008|Received Study Drug|Induction Period||0
6254431|NCT00284856|7153215|FG002|STARTED|Overall Study||336
6254432|NCT00284856|7153213|FG000|COMPLETED|Overall Study||296
6254433|NCT00284856|7153214|FG001|COMPLETED|Overall Study||286
6254434|NCT00284856|7153215|FG002|COMPLETED|Overall Study||276
6254435|NCT00284856|7153213|FG000|NOT COMPLETED|Overall Study||51
6254436|NCT00284856|7153214|FG001|NOT COMPLETED|Overall Study||50
6254437|NCT00284856|7153215|FG002|NOT COMPLETED|Overall Study||60
6254438|NCT00070707|7153225|FG000|STARTED|Overall Study||113
6254439|NCT00070707|7153226|FG001|STARTED|Overall Study||75
6254440|NCT00070707|7153225|FG000|COMPLETED|Overall Study||99
6254441|NCT00070707|7153226|FG001|COMPLETED|Overall Study||68
6254442|NCT00070707|7153225|FG000|NOT COMPLETED|Overall Study||14
6509163|NCT01474512|7428752|FG009|Received Study Drug|Induction Period||0
6509164|NCT01474512|7428753|FG010|Received Study Drug|Induction Period||0
6509165|NCT01474512|7428754|FG011|Received Study Drug|Induction Period||0
6509166|NCT01474512|7428755|FG012|Received Study Drug|Induction Period||0
6509167|NCT01474512|7428756|FG013|Received Study Drug|Induction Period||0
6509168|NCT01474512|7428757|FG014|Received Study Drug|Induction Period||0
6254443|NCT00070707|7153226|FG001|NOT COMPLETED|Overall Study||7
6278669|NCT00136318|7178275|FG000|STARTED|Overall Study|Took first dose of study medication|90
6278670|NCT00136318|7178276|FG001|STARTED|Overall Study|Took first dose of study medication|91
6278671|NCT00136318|7178275|FG000|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
6278672|NCT00136318|7178276|FG001|COMPLETED|Overall Study||84
6278673|NCT00136318|7178275|FG000|NOT COMPLETED|Overall Study||7
6278674|NCT00136318|7178276|FG001|NOT COMPLETED|Overall Study||7
6278675|NCT00136357|7178285|FG000|STARTED|Overall Study||41
6278676|NCT00136357|7178286|FG001|STARTED|Overall Study||41
6509169|NCT01474512|7428758|FG015|Received Study Drug|Induction Period||0
6509170|NCT01474512|7428759|FG016|Received Study Drug|Induction Period||0
6509171|NCT01474512|7428760|FG017|Received Study Drug|Induction Period||0
6509172|NCT01474512|7428743|FG000|COMPLETED|Induction Period||407
6509173|NCT01474512|7428744|FG001|COMPLETED|Induction Period||408
6509174|NCT01474512|7428745|FG002|COMPLETED|Induction Period||415
6509175|NCT01474512|7428746|FG003|COMPLETED|Induction Period||0
6509176|NCT01474512|7428747|FG004|COMPLETED|Induction Period||0
6509177|NCT01474512|7428748|FG005|COMPLETED|Induction Period||0
6509178|NCT01474512|7428749|FG006|COMPLETED|Induction Period||0
6509179|NCT01474512|7428750|FG007|COMPLETED|Induction Period||0
6509180|NCT01474512|7428751|FG008|COMPLETED|Induction Period||0
6509181|NCT01474512|7428752|FG009|COMPLETED|Induction Period||0
6509182|NCT01474512|7428753|FG010|COMPLETED|Induction Period||0
6509183|NCT01474512|7428754|FG011|COMPLETED|Induction Period||0
6509184|NCT01474512|7428755|FG012|COMPLETED|Induction Period||0
6509185|NCT01474512|7428756|FG013|COMPLETED|Induction Period||0
6509186|NCT01474512|7428757|FG014|COMPLETED|Induction Period||0
6509187|NCT01474512|7428758|FG015|COMPLETED|Induction Period||0
6509188|NCT01474512|7428759|FG016|COMPLETED|Induction Period||0
6509189|NCT01474512|7428760|FG017|COMPLETED|Induction Period||0
6509190|NCT01474512|7428743|FG000|NOT COMPLETED|Induction Period||24
6509191|NCT01474512|7428744|FG001|NOT COMPLETED|Induction Period||24
6509192|NCT01474512|7428745|FG002|NOT COMPLETED|Induction Period||18
6509193|NCT01474512|7428746|FG003|NOT COMPLETED|Induction Period||0
6509194|NCT01474512|7428747|FG004|NOT COMPLETED|Induction Period||0
6509195|NCT01474512|7428748|FG005|NOT COMPLETED|Induction Period||0
6509196|NCT01474512|7428749|FG006|NOT COMPLETED|Induction Period||0
6509197|NCT01474512|7428750|FG007|NOT COMPLETED|Induction Period||0
6509198|NCT01474512|7428751|FG008|NOT COMPLETED|Induction Period||0
6509199|NCT01474512|7428752|FG009|NOT COMPLETED|Induction Period||0
6509200|NCT01474512|7428753|FG010|NOT COMPLETED|Induction Period||0
6509201|NCT01474512|7428754|FG011|NOT COMPLETED|Induction Period||0
6509202|NCT01474512|7428755|FG012|NOT COMPLETED|Induction Period||0
6509203|NCT01474512|7428756|FG013|NOT COMPLETED|Induction Period||0
6509204|NCT01474512|7428757|FG014|NOT COMPLETED|Induction Period||0
6509205|NCT01474512|7428758|FG015|NOT COMPLETED|Induction Period||0
6509206|NCT01474512|7428759|FG016|NOT COMPLETED|Induction Period||0
6509207|NCT01474512|7428760|FG017|NOT COMPLETED|Induction Period||0
6509208|NCT01474512|7428743|FG000|STARTED|Maintenance Period||0
6509209|NCT01474512|7428744|FG001|STARTED|Maintenance Period||0
6509210|NCT01474512|7428745|FG002|STARTED|Maintenance Period||0
6509211|NCT01474512|7428746|FG003|STARTED|Maintenance Period||226
6509212|NCT01474512|7428747|FG004|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
6509213|NCT01474512|7428748|FG005|STARTED|Maintenance Period||229
6509214|NCT01474512|7428749|FG006|STARTED|Maintenance Period||16
6278677|NCT00136357|7178285|FG000|COMPLETED|Overall Study||38
6278678|NCT00136357|7178286|FG001|COMPLETED|Overall Study||39
6278679|NCT00136357|7178285|FG000|NOT COMPLETED|Overall Study||3
6278680|NCT00136357|7178286|FG001|NOT COMPLETED|Overall Study||2
6278681|NCT00136604|7178297|FG000|STARTED|Overall Study||249
6278682|NCT00136604|7178298|FG001|STARTED|Overall Study||123
6278683|NCT00136604|7178299|FG002|STARTED|Overall Study||79
6278684|NCT00136604|7178300|FG003|STARTED|Overall Study||41
6278685|NCT00136604|7178301|FG004|STARTED|Overall Study||125
6278686|NCT00136604|7178297|FG000|COMPLETED|Overall Study||248
6278687|NCT00136604|7178298|FG001|COMPLETED|Overall Study||122
6278688|NCT00136604|7178299|FG002|COMPLETED|Overall Study||79
6278689|NCT00136604|7178300|FG003|COMPLETED|Overall Study||41
6278690|NCT00136604|7178301|FG004|COMPLETED|Overall Study||124
6278691|NCT00136604|7178297|FG000|NOT COMPLETED|Overall Study||1
6278692|NCT00136604|7178298|FG001|NOT COMPLETED|Overall Study||1
6278693|NCT00136604|7178299|FG002|NOT COMPLETED|Overall Study||0
6278694|NCT00136604|7178300|FG003|NOT COMPLETED|Overall Study||0
6278695|NCT00136604|7178301|FG004|NOT COMPLETED|Overall Study||1
6278696|NCT00136695|7178319|FG000|STARTED|Overall Study||45
6278697|NCT00136695|7178320|FG001|STARTED|Overall Study||43
6278698|NCT00136695|7178319|FG000|COMPLETED|Overall Study||34
6278699|NCT00136695|7178320|FG001|COMPLETED|Overall Study||35
6278700|NCT00136695|7178319|FG000|NOT COMPLETED|Overall Study||11
6278701|NCT00136695|7178320|FG001|NOT COMPLETED|Overall Study||8
6278702|NCT00136760|7178330|FG000|STARTED|Overall Study||12
6278703|NCT00136760|7178331|FG001|STARTED|Overall Study||16
6278704|NCT00136760|7178332|FG002|STARTED|Overall Study||11
6278705|NCT00136760|7178333|FG003|STARTED|Overall Study||13
6278706|NCT00136760|7178330|FG000|COMPLETED|Overall Study||12
6509215|NCT01474512|7428750|FG007|STARTED|Maintenance Period||391
6509216|NCT01474512|7428751|FG008|STARTED|Maintenance Period||78
6254444|NCT02358993|7153234|FG000|STARTED|Overall Study||105
6254445|NCT02358993|7153235|FG001|STARTED|Overall Study||96
6254446|NCT02358993|7153234|FG000|COMPLETED|Overall Study||103
6570764|NCT01853384|7494166|FG000|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
6570765|NCT01853384|7494167|FG001|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
6570766|NCT01853384|7494166|FG000|COMPLETED|Enrolled in Follow up Period||96
6570767|NCT01853384|7494167|FG001|COMPLETED|Enrolled in Follow up Period||94
6570768|NCT01853384|7494166|FG000|NOT COMPLETED|Enrolled in Follow up Period||0
6570769|NCT01853384|7494167|FG001|NOT COMPLETED|Enrolled in Follow up Period||0
6570770|NCT01853384|7494166|FG000|STARTED|Completed Follow up Visit 1||96
6570771|NCT01853384|7494167|FG001|STARTED|Completed Follow up Visit 1||94
6570772|NCT01853384|7494166|FG000|COMPLETED|Completed Follow up Visit 1||82
6570773|NCT01853384|7494167|FG001|COMPLETED|Completed Follow up Visit 1||85
6570774|NCT01853384|7494166|FG000|NOT COMPLETED|Completed Follow up Visit 1||14
6570775|NCT01853384|7494167|FG001|NOT COMPLETED|Completed Follow up Visit 1||9
6254447|NCT02358993|7153235|FG001|COMPLETED|Overall Study||94
6254448|NCT02358993|7153234|FG000|NOT COMPLETED|Overall Study||2
6254449|NCT02358993|7153235|FG001|NOT COMPLETED|Overall Study||2
6254450|NCT03566199|7153241|FG000|STARTED|Overall Study||1
6254451|NCT03566199|7153242|FG001|STARTED|Overall Study||0
6509217|NCT01474512|7428752|FG009|STARTED|Maintenance Period||62
6509218|NCT01474512|7428753|FG010|STARTED|Maintenance Period||0
6509219|NCT01474512|7428754|FG011|STARTED|Maintenance Period||0
6509220|NCT01474512|7428755|FG012|STARTED|Maintenance Period||0
6509221|NCT01474512|7428756|FG013|STARTED|Maintenance Period||0
6509222|NCT01474512|7428757|FG014|STARTED|Maintenance Period||0
6509223|NCT01474512|7428758|FG015|STARTED|Maintenance Period||0
6509224|NCT01474512|7428759|FG016|STARTED|Maintenance Period||0
6509225|NCT01474512|7428760|FG017|STARTED|Maintenance Period||0
6509226|NCT01474512|7428743|FG000|Received Study Drug|Maintenance Period||0
6509227|NCT01474512|7428744|FG001|Received Study Drug|Maintenance Period||0
6509228|NCT01474512|7428745|FG002|Received Study Drug|Maintenance Period||0
6509229|NCT01474512|7428746|FG003|Received Study Drug|Maintenance Period||226
6509230|NCT01474512|7428747|FG004|Received Study Drug|Maintenance Period||227
6509231|NCT01474512|7428748|FG005|Received Study Drug|Maintenance Period||229
6509232|NCT01474512|7428749|FG006|Received Study Drug|Maintenance Period||16
6509233|NCT01474512|7428750|FG007|Received Study Drug|Maintenance Period||391
6509234|NCT01474512|7428751|FG008|Received Study Drug|Maintenance Period||78
6509235|NCT01474512|7428752|FG009|Received Study Drug|Maintenance Period||62
6509236|NCT01474512|7428753|FG010|Received Study Drug|Maintenance Period||0
6509237|NCT01474512|7428754|FG011|Received Study Drug|Maintenance Period||0
6509238|NCT01474512|7428755|FG012|Received Study Drug|Maintenance Period||0
6509239|NCT01474512|7428756|FG013|Received Study Drug|Maintenance Period||0
6509240|NCT01474512|7428757|FG014|Received Study Drug|Maintenance Period||0
6509241|NCT01474512|7428758|FG015|Received Study Drug|Maintenance Period||0
6509242|NCT01474512|7428759|FG016|Received Study Drug|Maintenance Period||0
6509243|NCT01474512|7428760|FG017|Received Study Drug|Maintenance Period||0
6509244|NCT01474512|7428743|FG000|Relapsed Population Received Drug|Maintenance Period||0
6509245|NCT01474512|7428744|FG001|Relapsed Population Received Drug|Maintenance Period||0
6509246|NCT01474512|7428745|FG002|Relapsed Population Received Drug|Maintenance Period||0
6509247|NCT01474512|7428746|FG003|Relapsed Population Received Drug|Maintenance Period||0
6509248|NCT01474512|7428747|FG004|Relapsed Population Received Drug|Maintenance Period||0
6509249|NCT01474512|7428748|FG005|Relapsed Population Received Drug|Maintenance Period||0
6509250|NCT01474512|7428749|FG006|Relapsed Population Received Drug|Maintenance Period||0
6509251|NCT01474512|7428750|FG007|Relapsed Population Received Drug|Maintenance Period||0
6509252|NCT01474512|7428751|FG008|Relapsed Population Received Drug|Maintenance Period||0
6509253|NCT01474512|7428752|FG009|Relapsed Population Received Drug|Maintenance Period||0
6509254|NCT01474512|7428753|FG010|Relapsed Population Received Drug|Maintenance Period||348
6509255|NCT01474512|7428754|FG011|Relapsed Population Received Drug|Maintenance Period||0
6509256|NCT01474512|7428755|FG012|Relapsed Population Received Drug|Maintenance Period||0
6509257|NCT01474512|7428756|FG013|Relapsed Population Received Drug|Maintenance Period||0
6509258|NCT01474512|7428757|FG014|Relapsed Population Received Drug|Maintenance Period||0
6509259|NCT01474512|7428758|FG015|Relapsed Population Received Drug|Maintenance Period||0
6509260|NCT01474512|7428759|FG016|Relapsed Population Received Drug|Maintenance Period||0
6509261|NCT01474512|7428760|FG017|Relapsed Population Received Drug|Maintenance Period||0
6509262|NCT01474512|7428743|FG000|Relapsed Population Completers|Maintenance Period||0
6509263|NCT01474512|7428744|FG001|Relapsed Population Completers|Maintenance Period||0
6509264|NCT01474512|7428745|FG002|Relapsed Population Completers|Maintenance Period||0
6509265|NCT01474512|7428746|FG003|Relapsed Population Completers|Maintenance Period||0
6509266|NCT01474512|7428747|FG004|Relapsed Population Completers|Maintenance Period||0
6509267|NCT01474512|7428748|FG005|Relapsed Population Completers|Maintenance Period||0
6509268|NCT01474512|7428749|FG006|Relapsed Population Completers|Maintenance Period||0
6509269|NCT01474512|7428750|FG007|Relapsed Population Completers|Maintenance Period||0
6570776|NCT01853384|7494166|FG000|STARTED|Completed Follow up Visit 2||96
6570777|NCT01853384|7494167|FG001|STARTED|Completed Follow up Visit 2||94
6570778|NCT01853384|7494166|FG000|COMPLETED|Completed Follow up Visit 2||93
6570779|NCT01853384|7494167|FG001|COMPLETED|Completed Follow up Visit 2||91
6254452|NCT03566199|7153243|FG002|STARTED|Overall Study||1
6254453|NCT03566199|7153244|FG003|STARTED|Overall Study||0
6254454|NCT03566199|7153245|FG004|STARTED|Overall Study||1
6254455|NCT03566199|7153246|FG005|STARTED|Overall Study||0
6254456|NCT03566199|7153247|FG006|STARTED|Overall Study||4
6254457|NCT03566199|7153248|FG007|STARTED|Overall Study||0
6254458|NCT03566199|7153241|FG000|COMPLETED|Overall Study||1
6254459|NCT03566199|7153242|FG001|COMPLETED|Overall Study||0
6254460|NCT03566199|7153243|FG002|COMPLETED|Overall Study||1
6254461|NCT03566199|7153244|FG003|COMPLETED|Overall Study||0
6254462|NCT03566199|7153245|FG004|COMPLETED|Overall Study||1
6254463|NCT03566199|7153246|FG005|COMPLETED|Overall Study||0
6254464|NCT03566199|7153247|FG006|COMPLETED|Overall Study||4
6254465|NCT03566199|7153248|FG007|COMPLETED|Overall Study||0
6254466|NCT03566199|7153241|FG000|NOT COMPLETED|Overall Study||0
6254467|NCT03566199|7153242|FG001|NOT COMPLETED|Overall Study||0
6254468|NCT03566199|7153243|FG002|NOT COMPLETED|Overall Study||0
6254469|NCT03566199|7153244|FG003|NOT COMPLETED|Overall Study||0
6254470|NCT03566199|7153245|FG004|NOT COMPLETED|Overall Study||0
6254471|NCT03566199|7153246|FG005|NOT COMPLETED|Overall Study||0
6254472|NCT03566199|7153247|FG006|NOT COMPLETED|Overall Study||0
6254473|NCT03566199|7153248|FG007|NOT COMPLETED|Overall Study||0
6278707|NCT00136760|7178331|FG001|COMPLETED|Overall Study||16
6278708|NCT00136760|7178332|FG002|COMPLETED|Overall Study||11
6278709|NCT00136760|7178333|FG003|COMPLETED|Overall Study||13
6278710|NCT00136760|7178330|FG000|NOT COMPLETED|Overall Study||0
6278711|NCT00136760|7178331|FG001|NOT COMPLETED|Overall Study||0
6278712|NCT00136760|7178332|FG002|NOT COMPLETED|Overall Study||0
6278713|NCT00136760|7178333|FG003|NOT COMPLETED|Overall Study||0
6278714|NCT00136812|7178345|FG000|STARTED|Overall Study||111
6278715|NCT00136812|7178346|FG001|STARTED|Overall Study||113
6278716|NCT00136812|7178345|FG000|COMPLETED|Overall Study||111
6278717|NCT00136812|7178346|FG001|COMPLETED|Overall Study||113
6278718|NCT00136812|7178345|FG000|NOT COMPLETED|Overall Study||0
6278719|NCT00136812|7178346|FG001|NOT COMPLETED|Overall Study||0
6278720|NCT00136838|7178352|FG000|STARTED|First Intervention ( 5 Days)||6
6278721|NCT00136838|7178353|FG001|STARTED|First Intervention ( 5 Days)||6
6278722|NCT00136838|7178352|FG000|COMPLETED|First Intervention ( 5 Days)||6
6278723|NCT00136838|7178353|FG001|COMPLETED|First Intervention ( 5 Days)||6
6278724|NCT00136838|7178352|FG000|NOT COMPLETED|First Intervention ( 5 Days)||0
6278725|NCT00136838|7178353|FG001|NOT COMPLETED|First Intervention ( 5 Days)||0
6278726|NCT00136838|7178352|FG000|STARTED|Second Intervention ( 5 Days)||6
6278727|NCT00136838|7178353|FG001|STARTED|Second Intervention ( 5 Days)||6
6278728|NCT00136838|7178352|FG000|COMPLETED|Second Intervention ( 5 Days)||6
6278729|NCT00136838|7178353|FG001|COMPLETED|Second Intervention ( 5 Days)||6
6278730|NCT00136838|7178352|FG000|NOT COMPLETED|Second Intervention ( 5 Days)||0
6278731|NCT00136838|7178353|FG001|NOT COMPLETED|Second Intervention ( 5 Days)||0
6278732|NCT00136916|7178363|FG000|STARTED|Overall Study||319
6278733|NCT00136916|7178364|FG001|STARTED|Overall Study||316
6278734|NCT00136916|7178363|FG000|Received Treatment|Overall Study||316
6278735|NCT00136916|7178364|FG001|Received Treatment|Overall Study||311
6278736|NCT00136916|7178363|FG000|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
6278737|NCT00136916|7178364|FG001|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
6278738|NCT00136916|7178363|FG000|NOT COMPLETED|Overall Study||125
6278739|NCT00136916|7178364|FG001|NOT COMPLETED|Overall Study||104
6278740|NCT00136955|7178372|FG000|STARTED|Overall Study||41
6278741|NCT00136955|7178372|FG000|COMPLETED|Overall Study||18
6278742|NCT00136955|7178372|FG000|NOT COMPLETED|Overall Study||23
6278743|NCT00137046|7178378|FG000|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
6278744|NCT00137046|7178379|FG001|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
6278745|NCT00137046|7178378|FG000|Received Study Treatment|Overall Study||290
6278746|NCT00137046|7178379|FG001|Received Study Treatment|Overall Study||290
6278747|NCT00137046|7178378|FG000|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
6278748|NCT00137046|7178379|FG001|COMPLETED|Overall Study||198
6278749|NCT00137046|7178378|FG000|NOT COMPLETED|Overall Study||99
6278750|NCT00137046|7178379|FG001|NOT COMPLETED|Overall Study||93
6278751|NCT00137111|7178393|FG000|STARTED|Window Therapy||0
6278752|NCT00137111|7178394|FG001|STARTED|Window Therapy||176
6278753|NCT00137111|7178395|FG002|STARTED|Window Therapy||180
6278754|NCT00137111|7178396|FG003|STARTED|Window Therapy||142
6278755|NCT00137111|7178393|FG000|COMPLETED|Window Therapy||0
6278756|NCT00137111|7178394|FG001|COMPLETED|Window Therapy||176
6278757|NCT00137111|7178395|FG002|COMPLETED|Window Therapy||180
6278758|NCT00137111|7178396|FG003|COMPLETED|Window Therapy||142
6278759|NCT00137111|7178393|FG000|NOT COMPLETED|Window Therapy||0
6278760|NCT00137111|7178394|FG001|NOT COMPLETED|Window Therapy||0
6278761|NCT00137111|7178395|FG002|NOT COMPLETED|Window Therapy||0
6509270|NCT01474512|7428751|FG008|Relapsed Population Completers|Maintenance Period||0
6509271|NCT01474512|7428752|FG009|Relapsed Population Completers|Maintenance Period||0
6509272|NCT01474512|7428753|FG010|Relapsed Population Completers|Maintenance Period||321
6278762|NCT00137111|7178396|FG003|NOT COMPLETED|Window Therapy||0
6278763|NCT00137111|7178393|FG000|STARTED|Total Therapy||498
6278764|NCT00137111|7178394|FG001|STARTED|Total Therapy||0
6278765|NCT00137111|7178395|FG002|STARTED|Total Therapy||0
6278766|NCT00137111|7178396|FG003|STARTED|Total Therapy||0
6278767|NCT00137111|7178393|FG000|COMPLETED|Total Therapy||458
6278768|NCT00137111|7178394|FG001|COMPLETED|Total Therapy||0
6254474|NCT05096312|7153254|FG000|STARTED|Overall Study||11
6254475|NCT05096312|7153255|FG001|STARTED|Overall Study||12
6254476|NCT05096312|7153254|FG000|COMPLETED|Overall Study||8
6254477|NCT05096312|7153255|FG001|COMPLETED|Overall Study||8
6254478|NCT05096312|7153254|FG000|NOT COMPLETED|Overall Study||3
6254479|NCT05096312|7153255|FG001|NOT COMPLETED|Overall Study||4
6254480|NCT03560258|7153264|FG000|STARTED|Overall Study||22
6254481|NCT03560258|7153265|FG001|STARTED|Overall Study||11
6254482|NCT03560258|7153266|FG002|STARTED|Overall Study||12
6254483|NCT03560258|7153264|FG000|Received at Least 1 Dose of Treatment|Overall Study||22
6254484|NCT03560258|7153265|FG001|Received at Least 1 Dose of Treatment|Overall Study||10
6254485|NCT03560258|7153266|FG002|Received at Least 1 Dose of Treatment|Overall Study||12
6254486|NCT03560258|7153264|FG000|COMPLETED|Overall Study||19
6254487|NCT03560258|7153265|FG001|COMPLETED|Overall Study||10
6254488|NCT03560258|7153266|FG002|COMPLETED|Overall Study||11
6254489|NCT03560258|7153264|FG000|NOT COMPLETED|Overall Study||3
6254490|NCT03560258|7153265|FG001|NOT COMPLETED|Overall Study||1
6254491|NCT03560258|7153266|FG002|NOT COMPLETED|Overall Study||1
6254492|NCT03275168|7153276|FG000|STARTED|Overall Study||34
6254493|NCT03275168|7153277|FG001|STARTED|Overall Study||34
6254494|NCT03275168|7153276|FG000|COMPLETED|Overall Study||27
6254495|NCT03275168|7153277|FG001|COMPLETED|Overall Study||25
6254496|NCT03275168|7153276|FG000|NOT COMPLETED|Overall Study||7
6254497|NCT03275168|7153277|FG001|NOT COMPLETED|Overall Study||9
6254498|NCT04528641|7153289|FG000|STARTED|Overall Study||15
6254499|NCT04528641|7153290|FG001|STARTED|Overall Study||15
6254500|NCT04528641|7153291|FG002|STARTED|Overall Study||15
6254501|NCT04528641|7153292|FG003|STARTED|Overall Study||16
6254502|NCT04528641|7153293|FG004|STARTED|Overall Study||15
6254503|NCT04528641|7153294|FG005|STARTED|Overall Study||15
6254504|NCT04528641|7153289|FG000|COMPLETED|Overall Study||15
6254505|NCT04528641|7153290|FG001|COMPLETED|Overall Study||15
6254506|NCT04528641|7153291|FG002|COMPLETED|Overall Study||15
6254507|NCT04528641|7153292|FG003|COMPLETED|Overall Study||15
6254508|NCT04528641|7153293|FG004|COMPLETED|Overall Study||15
6254509|NCT04528641|7153294|FG005|COMPLETED|Overall Study||14
6254510|NCT04528641|7153289|FG000|NOT COMPLETED|Overall Study||0
6254511|NCT04528641|7153290|FG001|NOT COMPLETED|Overall Study||0
6254512|NCT04528641|7153291|FG002|NOT COMPLETED|Overall Study||0
6254513|NCT04528641|7153292|FG003|NOT COMPLETED|Overall Study||1
6509273|NCT01474512|7428754|FG011|Relapsed Population Completers|Maintenance Period||0
6509274|NCT01474512|7428755|FG012|Relapsed Population Completers|Maintenance Period||0
6509275|NCT01474512|7428756|FG013|Relapsed Population Completers|Maintenance Period||0
6509276|NCT01474512|7428757|FG014|Relapsed Population Completers|Maintenance Period||0
6509277|NCT01474512|7428758|FG015|Relapsed Population Completers|Maintenance Period||0
6509278|NCT01474512|7428759|FG016|Relapsed Population Completers|Maintenance Period||0
6509279|NCT01474512|7428760|FG017|Relapsed Population Completers|Maintenance Period||0
6509280|NCT01474512|7428743|FG000|COMPLETED|Maintenance Period||0
6509281|NCT01474512|7428744|FG001|COMPLETED|Maintenance Period||0
6509282|NCT01474512|7428745|FG002|COMPLETED|Maintenance Period||0
6509283|NCT01474512|7428746|FG003|COMPLETED|Maintenance Period||24
6509284|NCT01474512|7428747|FG004|COMPLETED|Maintenance Period||108
6509285|NCT01474512|7428748|FG005|COMPLETED|Maintenance Period||177
6509286|NCT01474512|7428749|FG006|COMPLETED|Maintenance Period||6
6509287|NCT01474512|7428750|FG007|COMPLETED|Maintenance Period||350
6509288|NCT01474512|7428751|FG008|COMPLETED|Maintenance Period||62
6509289|NCT01474512|7428752|FG009|COMPLETED|Maintenance Period||44
6509290|NCT01474512|7428753|FG010|COMPLETED|Maintenance Period||0
6509291|NCT01474512|7428754|FG011|COMPLETED|Maintenance Period||0
6509292|NCT01474512|7428755|FG012|COMPLETED|Maintenance Period||0
6509293|NCT01474512|7428756|FG013|COMPLETED|Maintenance Period||0
6509294|NCT01474512|7428757|FG014|COMPLETED|Maintenance Period||0
6509295|NCT01474512|7428758|FG015|COMPLETED|Maintenance Period||0
6509296|NCT01474512|7428759|FG016|COMPLETED|Maintenance Period||0
6509297|NCT01474512|7428760|FG017|COMPLETED|Maintenance Period||0
6509298|NCT01474512|7428743|FG000|NOT COMPLETED|Maintenance Period||0
6509299|NCT01474512|7428744|FG001|NOT COMPLETED|Maintenance Period||0
6509300|NCT01474512|7428745|FG002|NOT COMPLETED|Maintenance Period||0
6509301|NCT01474512|7428746|FG003|NOT COMPLETED|Maintenance Period||202
6509302|NCT01474512|7428747|FG004|NOT COMPLETED|Maintenance Period||119
6509303|NCT01474512|7428748|FG005|NOT COMPLETED|Maintenance Period||52
6509304|NCT01474512|7428749|FG006|NOT COMPLETED|Maintenance Period||10
6509305|NCT01474512|7428750|FG007|NOT COMPLETED|Maintenance Period||41
6509306|NCT01474512|7428751|FG008|NOT COMPLETED|Maintenance Period||16
6509307|NCT01474512|7428752|FG009|NOT COMPLETED|Maintenance Period||18
6509308|NCT01474512|7428753|FG010|NOT COMPLETED|Maintenance Period||0
6509309|NCT01474512|7428754|FG011|NOT COMPLETED|Maintenance Period||0
6509310|NCT01474512|7428755|FG012|NOT COMPLETED|Maintenance Period||0
6509311|NCT01474512|7428756|FG013|NOT COMPLETED|Maintenance Period||0
6509312|NCT01474512|7428757|FG014|NOT COMPLETED|Maintenance Period||0
6254514|NCT04528641|7153293|FG004|NOT COMPLETED|Overall Study||0
6254515|NCT04528641|7153294|FG005|NOT COMPLETED|Overall Study||1
6254516|NCT04497883|7153313|FG000|STARTED|Treatment Period 1 (2 Days)||12
6254517|NCT04497883|7153314|FG001|STARTED|Treatment Period 1 (2 Days)||12
6509313|NCT01474512|7428758|FG015|NOT COMPLETED|Maintenance Period||0
6509314|NCT01474512|7428759|FG016|NOT COMPLETED|Maintenance Period||0
6509315|NCT01474512|7428760|FG017|NOT COMPLETED|Maintenance Period||0
6509316|NCT01474512|7428743|FG000|STARTED|Long-Term Extension Period||0
6254518|NCT04497883|7153315|FG002|STARTED|Treatment Period 1 (2 Days)||0
6254519|NCT04497883|7153316|FG003|STARTED|Treatment Period 1 (2 Days)||0
6254520|NCT04497883|7153313|FG000|COMPLETED|Treatment Period 1 (2 Days)||12
6254521|NCT04497883|7153314|FG001|COMPLETED|Treatment Period 1 (2 Days)||12
6254522|NCT04497883|7153315|FG002|COMPLETED|Treatment Period 1 (2 Days)||0
6254523|NCT04497883|7153316|FG003|COMPLETED|Treatment Period 1 (2 Days)||0
6254524|NCT04497883|7153313|FG000|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6254525|NCT04497883|7153314|FG001|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6254526|NCT04497883|7153315|FG002|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6254527|NCT04497883|7153316|FG003|NOT COMPLETED|Treatment Period 1 (2 Days)||0
6254528|NCT04497883|7153313|FG000|STARTED|Washout Period 1 (72 Hours)||12
6254529|NCT04497883|7153314|FG001|STARTED|Washout Period 1 (72 Hours)||12
6254530|NCT04497883|7153315|FG002|STARTED|Washout Period 1 (72 Hours)||0
6254531|NCT04497883|7153316|FG003|STARTED|Washout Period 1 (72 Hours)||0
6254532|NCT04497883|7153313|FG000|COMPLETED|Washout Period 1 (72 Hours)||12
6254533|NCT04497883|7153314|FG001|COMPLETED|Washout Period 1 (72 Hours)||12
6254534|NCT04497883|7153315|FG002|COMPLETED|Washout Period 1 (72 Hours)||0
6254535|NCT04497883|7153316|FG003|COMPLETED|Washout Period 1 (72 Hours)||0
6254536|NCT04497883|7153313|FG000|NOT COMPLETED|Washout Period 1 (72 Hours)||0
6254537|NCT04497883|7153314|FG001|NOT COMPLETED|Washout Period 1 (72 Hours)||0
6254538|NCT04497883|7153315|FG002|NOT COMPLETED|Washout Period 1 (72 Hours)||0
6254539|NCT04497883|7153316|FG003|NOT COMPLETED|Washout Period 1 (72 Hours)||0
6254540|NCT04497883|7153313|FG000|STARTED|Treatment Period 2 (2 Days)||0
6254541|NCT04497883|7153314|FG001|STARTED|Treatment Period 2 (2 Days)||0
6254542|NCT04497883|7153315|FG002|STARTED|Treatment Period 2 (2 Days)||6
6254543|NCT04497883|7153316|FG003|STARTED|Treatment Period 2 (2 Days)||6
6254544|NCT04497883|7153313|FG000|COMPLETED|Treatment Period 2 (2 Days)||0
6254545|NCT04497883|7153314|FG001|COMPLETED|Treatment Period 2 (2 Days)||0
6254546|NCT04497883|7153315|FG002|COMPLETED|Treatment Period 2 (2 Days)||6
6254547|NCT04497883|7153316|FG003|COMPLETED|Treatment Period 2 (2 Days)||6
6254548|NCT04497883|7153313|FG000|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6254549|NCT04497883|7153314|FG001|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6254550|NCT04497883|7153315|FG002|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6254551|NCT04497883|7153316|FG003|NOT COMPLETED|Treatment Period 2 (2 Days)||0
6254552|NCT04497883|7153313|FG000|STARTED|Washout Period 2 (72 Hours)||0
6254553|NCT04497883|7153314|FG001|STARTED|Washout Period 2 (72 Hours)||0
6254554|NCT04497883|7153315|FG002|STARTED|Washout Period 2 (72 Hours)||6
6254555|NCT04497883|7153316|FG003|STARTED|Washout Period 2 (72 Hours)||6
6254556|NCT04497883|7153313|FG000|COMPLETED|Washout Period 2 (72 Hours)||0
6254557|NCT04497883|7153314|FG001|COMPLETED|Washout Period 2 (72 Hours)||0
6254558|NCT04497883|7153315|FG002|COMPLETED|Washout Period 2 (72 Hours)||6
6254559|NCT04497883|7153316|FG003|COMPLETED|Washout Period 2 (72 Hours)||6
6254560|NCT04497883|7153313|FG000|NOT COMPLETED|Washout Period 2 (72 Hours)||0
6254561|NCT04497883|7153314|FG001|NOT COMPLETED|Washout Period 2 (72 Hours)||0
6254562|NCT04497883|7153315|FG002|NOT COMPLETED|Washout Period 2 (72 Hours)||0
6254563|NCT04497883|7153316|FG003|NOT COMPLETED|Washout Period 2 (72 Hours)||0
6254564|NCT04497883|7153313|FG000|STARTED|Treatment Period 3 (2 Days)||0
6570780|NCT01853384|7494166|FG000|NOT COMPLETED|Completed Follow up Visit 2||3
6570781|NCT01853384|7494167|FG001|NOT COMPLETED|Completed Follow up Visit 2||3
6570782|NCT01853397|7494177|FG000|STARTED|Overall Study||18
6737500|NCT03266419|7666786|FG000|NOT COMPLETED|Overall Study||0
6254565|NCT04497883|7153314|FG001|STARTED|Treatment Period 3 (2 Days)||0
6254566|NCT04497883|7153315|FG002|STARTED|Treatment Period 3 (2 Days)||6
6254567|NCT04497883|7153316|FG003|STARTED|Treatment Period 3 (2 Days)||6
6254568|NCT04497883|7153313|FG000|COMPLETED|Treatment Period 3 (2 Days)||0
6254569|NCT04497883|7153314|FG001|COMPLETED|Treatment Period 3 (2 Days)||0
6509317|NCT01474512|7428744|FG001|STARTED|Long-Term Extension Period||0
6509318|NCT01474512|7428745|FG002|STARTED|Long-Term Extension Period||0
6509319|NCT01474512|7428746|FG003|STARTED|Long-Term Extension Period||0
6509320|NCT01474512|7428747|FG004|STARTED|Long-Term Extension Period||0
6509321|NCT01474512|7428748|FG005|STARTED|Long-Term Extension Period||0
6509322|NCT01474512|7428749|FG006|STARTED|Long-Term Extension Period||0
6509323|NCT01474512|7428750|FG007|STARTED|Long-Term Extension Period||0
6509324|NCT01474512|7428751|FG008|STARTED|Long-Term Extension Period||0
6509325|NCT01474512|7428752|FG009|STARTED|Long-Term Extension Period||0
6509326|NCT01474512|7428753|FG010|STARTED|Long-Term Extension Period||0
6509327|NCT01474512|7428754|FG011|STARTED|Long-Term Extension Period|9 participants did not start the long-term extension period.|26
6509328|NCT01474512|7428755|FG012|STARTED|Long-Term Extension Period|Participants received Ixe alone at the start of long-term extension.|1054
6509329|NCT01474512|7428756|FG013|STARTED|Long-Term Extension Period|Participants received Ixe in all dosing regimens, including participants who switched PBO to Ixe.|1075
6509330|NCT01474512|7428757|FG014|STARTED|Long-Term Extension Period||0
6509331|NCT01474512|7428758|FG015|STARTED|Long-Term Extension Period||0
6509332|NCT01474512|7428759|FG016|STARTED|Long-Term Extension Period||0
6509333|NCT01474512|7428760|FG017|STARTED|Long-Term Extension Period||0
6509334|NCT01474512|7428743|FG000|COMPLETED|Long-Term Extension Period||0
6509335|NCT01474512|7428744|FG001|COMPLETED|Long-Term Extension Period||0
6509336|NCT01474512|7428745|FG002|COMPLETED|Long-Term Extension Period||0
6509337|NCT01474512|7428746|FG003|COMPLETED|Long-Term Extension Period||0
6570783|NCT01853397|7494178|FG001|STARTED|Overall Study||20
6570784|NCT01853397|7494179|FG002|STARTED|Overall Study||17
6254570|NCT04497883|7153315|FG002|COMPLETED|Treatment Period 3 (2 Days)||6
6254571|NCT04497883|7153316|FG003|COMPLETED|Treatment Period 3 (2 Days)||6
6254572|NCT04497883|7153313|FG000|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6254573|NCT04497883|7153314|FG001|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6254574|NCT04497883|7153315|FG002|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6254575|NCT04497883|7153316|FG003|NOT COMPLETED|Treatment Period 3 (2 Days)||0
6278769|NCT00137111|7178395|FG002|COMPLETED|Total Therapy||0
6278770|NCT00137111|7178396|FG003|COMPLETED|Total Therapy||0
6509338|NCT01474512|7428747|FG004|COMPLETED|Long-Term Extension Period||0
6509339|NCT01474512|7428748|FG005|COMPLETED|Long-Term Extension Period||0
6509340|NCT01474512|7428749|FG006|COMPLETED|Long-Term Extension Period||0
6509341|NCT01474512|7428750|FG007|COMPLETED|Long-Term Extension Period||0
6509342|NCT01474512|7428751|FG008|COMPLETED|Long-Term Extension Period||0
6509343|NCT01474512|7428752|FG009|COMPLETED|Long-Term Extension Period||0
6509344|NCT01474512|7428753|FG010|COMPLETED|Long-Term Extension Period||0
6509345|NCT01474512|7428754|FG011|COMPLETED|Long-Term Extension Period||0
6509346|NCT01474512|7428755|FG012|COMPLETED|Long-Term Extension Period||836
6509347|NCT01474512|7428756|FG013|COMPLETED|Long-Term Extension Period||855
6509348|NCT01474512|7428757|FG014|COMPLETED|Long-Term Extension Period||0
6509349|NCT01474512|7428758|FG015|COMPLETED|Long-Term Extension Period||0
6509350|NCT01474512|7428759|FG016|COMPLETED|Long-Term Extension Period||0
6509351|NCT01474512|7428760|FG017|COMPLETED|Long-Term Extension Period||0
6509352|NCT01474512|7428743|FG000|NOT COMPLETED|Long-Term Extension Period||0
6509353|NCT01474512|7428744|FG001|NOT COMPLETED|Long-Term Extension Period||0
6509354|NCT01474512|7428745|FG002|NOT COMPLETED|Long-Term Extension Period||0
6509355|NCT01474512|7428746|FG003|NOT COMPLETED|Long-Term Extension Period||0
6509356|NCT01474512|7428747|FG004|NOT COMPLETED|Long-Term Extension Period||0
6509357|NCT01474512|7428748|FG005|NOT COMPLETED|Long-Term Extension Period||0
6509358|NCT01474512|7428749|FG006|NOT COMPLETED|Long-Term Extension Period||0
6509359|NCT01474512|7428750|FG007|NOT COMPLETED|Long-Term Extension Period||0
6509360|NCT01474512|7428751|FG008|NOT COMPLETED|Long-Term Extension Period||0
6509361|NCT01474512|7428752|FG009|NOT COMPLETED|Long-Term Extension Period||0
6509362|NCT01474512|7428753|FG010|NOT COMPLETED|Long-Term Extension Period||0
6509363|NCT01474512|7428754|FG011|NOT COMPLETED|Long-Term Extension Period||26
6509364|NCT01474512|7428755|FG012|NOT COMPLETED|Long-Term Extension Period||218
6509365|NCT01474512|7428756|FG013|NOT COMPLETED|Long-Term Extension Period||220
6509366|NCT01474512|7428757|FG014|NOT COMPLETED|Long-Term Extension Period||0
6509367|NCT01474512|7428758|FG015|NOT COMPLETED|Long-Term Extension Period||0
6509368|NCT01474512|7428759|FG016|NOT COMPLETED|Long-Term Extension Period||0
6509369|NCT01474512|7428760|FG017|NOT COMPLETED|Long-Term Extension Period||0
6509370|NCT01474512|7428743|FG000|STARTED|Post-Treatment Follow-Up||0
6509371|NCT01474512|7428744|FG001|STARTED|Post-Treatment Follow-Up||0
6509372|NCT01474512|7428745|FG002|STARTED|Post-Treatment Follow-Up||0
6509373|NCT01474512|7428746|FG003|STARTED|Post-Treatment Follow-Up||0
6509374|NCT01474512|7428747|FG004|STARTED|Post-Treatment Follow-Up||0
6509375|NCT01474512|7428748|FG005|STARTED|Post-Treatment Follow-Up||0
6509376|NCT01474512|7428749|FG006|STARTED|Post-Treatment Follow-Up||0
6509377|NCT01474512|7428750|FG007|STARTED|Post-Treatment Follow-Up||0
6509378|NCT01474512|7428751|FG008|STARTED|Post-Treatment Follow-Up||0
6509379|NCT01474512|7428752|FG009|STARTED|Post-Treatment Follow-Up||0
6509380|NCT01474512|7428753|FG010|STARTED|Post-Treatment Follow-Up||0
6278771|NCT00137111|7178393|FG000|NOT COMPLETED|Total Therapy||40
6509381|NCT01474512|7428754|FG011|STARTED|Post-Treatment Follow-Up||0
6509382|NCT01474512|7428755|FG012|STARTED|Post-Treatment Follow-Up||0
6509383|NCT01474512|7428756|FG013|STARTED|Post-Treatment Follow-Up||0
6509384|NCT01474512|7428757|FG014|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|18
6509385|NCT01474512|7428758|FG015|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|25
6509386|NCT01474512|7428759|FG016|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|700
6509387|NCT01474512|7428760|FG017|STARTED|Post-Treatment Follow-Up|Includes participants who started the post treatment follow-up period.|285
6509388|NCT01474512|7428743|FG000|COMPLETED|Post-Treatment Follow-Up||0
6509389|NCT01474512|7428744|FG001|COMPLETED|Post-Treatment Follow-Up||0
6509390|NCT01474512|7428745|FG002|COMPLETED|Post-Treatment Follow-Up||0
6509391|NCT01474512|7428746|FG003|COMPLETED|Post-Treatment Follow-Up||0
6509392|NCT01474512|7428747|FG004|COMPLETED|Post-Treatment Follow-Up||0
6509393|NCT01474512|7428748|FG005|COMPLETED|Post-Treatment Follow-Up||0
6570785|NCT01853397|7494180|FG003|STARTED|Overall Study||17
6570786|NCT01853397|7494177|FG000|COMPLETED|Overall Study||18
6570787|NCT01853397|7494178|FG001|COMPLETED|Overall Study||20
6570788|NCT01853397|7494179|FG002|COMPLETED|Overall Study||17
6570789|NCT01853397|7494180|FG003|COMPLETED|Overall Study||15
6570790|NCT01853397|7494177|FG000|NOT COMPLETED|Overall Study||0
6570791|NCT01853397|7494178|FG001|NOT COMPLETED|Overall Study||0
6570792|NCT01853397|7494179|FG002|NOT COMPLETED|Overall Study||0
6570793|NCT01853397|7494180|FG003|NOT COMPLETED|Overall Study||2
6570794|NCT01853462|7494192|FG000|STARTED|Overall Study||11
6570795|NCT01853462|7494193|FG001|STARTED|Overall Study||11
6570796|NCT01853462|7494192|FG000|COMPLETED|Overall Study||10
6570797|NCT01853462|7494193|FG001|COMPLETED|Overall Study||10
6570798|NCT01853462|7494192|FG000|NOT COMPLETED|Overall Study||1
6278772|NCT00137111|7178394|FG001|NOT COMPLETED|Total Therapy||0
6278773|NCT00137111|7178395|FG002|NOT COMPLETED|Total Therapy||0
6278774|NCT00137111|7178396|FG003|NOT COMPLETED|Total Therapy||0
6254576|NCT04034238|7153330|FG000|STARTED|Dose Escalation Phase||7
6254577|NCT04034238|7153331|FG001|STARTED|Dose Escalation Phase||3
6254578|NCT04034238|7153332|FG002|STARTED|Dose Escalation Phase||0
6509394|NCT01474512|7428749|FG006|COMPLETED|Post-Treatment Follow-Up||0
6509395|NCT01474512|7428750|FG007|COMPLETED|Post-Treatment Follow-Up||0
6509396|NCT01474512|7428751|FG008|COMPLETED|Post-Treatment Follow-Up||0
6509397|NCT01474512|7428752|FG009|COMPLETED|Post-Treatment Follow-Up||0
6509398|NCT01474512|7428753|FG010|COMPLETED|Post-Treatment Follow-Up||0
6509399|NCT01474512|7428754|FG011|COMPLETED|Post-Treatment Follow-Up||0
6509400|NCT01474512|7428755|FG012|COMPLETED|Post-Treatment Follow-Up||0
6509401|NCT01474512|7428756|FG013|COMPLETED|Post-Treatment Follow-Up||0
6509402|NCT01474512|7428757|FG014|COMPLETED|Post-Treatment Follow-Up||0
6509403|NCT01474512|7428758|FG015|COMPLETED|Post-Treatment Follow-Up||17
6509404|NCT01474512|7428759|FG016|COMPLETED|Post-Treatment Follow-Up||544
6509405|NCT01474512|7428760|FG017|COMPLETED|Post-Treatment Follow-Up||239
6509406|NCT01474512|7428743|FG000|NOT COMPLETED|Post-Treatment Follow-Up||0
6509407|NCT01474512|7428744|FG001|NOT COMPLETED|Post-Treatment Follow-Up||0
6509408|NCT01474512|7428745|FG002|NOT COMPLETED|Post-Treatment Follow-Up||0
6509409|NCT01474512|7428746|FG003|NOT COMPLETED|Post-Treatment Follow-Up||0
6509410|NCT01474512|7428747|FG004|NOT COMPLETED|Post-Treatment Follow-Up||0
6509411|NCT01474512|7428748|FG005|NOT COMPLETED|Post-Treatment Follow-Up||0
6509412|NCT01474512|7428749|FG006|NOT COMPLETED|Post-Treatment Follow-Up||0
6509413|NCT01474512|7428750|FG007|NOT COMPLETED|Post-Treatment Follow-Up||0
6509414|NCT01474512|7428751|FG008|NOT COMPLETED|Post-Treatment Follow-Up||0
6509415|NCT01474512|7428752|FG009|NOT COMPLETED|Post-Treatment Follow-Up||0
6509416|NCT01474512|7428753|FG010|NOT COMPLETED|Post-Treatment Follow-Up||0
6509417|NCT01474512|7428754|FG011|NOT COMPLETED|Post-Treatment Follow-Up||0
6509418|NCT01474512|7428755|FG012|NOT COMPLETED|Post-Treatment Follow-Up||0
6509419|NCT01474512|7428756|FG013|NOT COMPLETED|Post-Treatment Follow-Up||0
6509420|NCT01474512|7428757|FG014|NOT COMPLETED|Post-Treatment Follow-Up||18
6509421|NCT01474512|7428758|FG015|NOT COMPLETED|Post-Treatment Follow-Up||8
6509422|NCT01474512|7428759|FG016|NOT COMPLETED|Post-Treatment Follow-Up||156
6509423|NCT01474512|7428760|FG017|NOT COMPLETED|Post-Treatment Follow-Up||46
6509424|NCT01474538|7428792|FG000|STARTED|Treatment Period 1||60
6509425|NCT01474538|7428793|FG001|STARTED|Treatment Period 1||62
6509426|NCT01474538|7428792|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
6509427|NCT01474538|7428793|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
6509428|NCT01474538|7428792|FG000|COMPLETED|Treatment Period 1||57
6509429|NCT01474538|7428793|FG001|COMPLETED|Treatment Period 1||58
6509430|NCT01474538|7428792|FG000|NOT COMPLETED|Treatment Period 1||3
6509431|NCT01474538|7428793|FG001|NOT COMPLETED|Treatment Period 1||4
6509432|NCT01474538|7428792|FG000|STARTED|Treatment Period 2||57
6509433|NCT01474538|7428793|FG001|STARTED|Treatment Period 2||58
6509434|NCT01474538|7428792|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
6509435|NCT01474538|7428793|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
6509436|NCT01474538|7428792|FG000|COMPLETED|Treatment Period 2||51
6509437|NCT01474538|7428793|FG001|COMPLETED|Treatment Period 2||56
6509438|NCT01474538|7428792|FG000|NOT COMPLETED|Treatment Period 2||6
6509439|NCT01474538|7428793|FG001|NOT COMPLETED|Treatment Period 2||2
6509440|NCT01474551|7428799|FG000|STARTED|Overall Study||2
6509441|NCT01474551|7428799|FG000|COMPLETED|Overall Study||1
6509442|NCT01474551|7428799|FG000|NOT COMPLETED|Overall Study||1
6509443|NCT01474590|7428805|FG000|STARTED|Overall Study||133
6509444|NCT01474590|7428806|FG001|STARTED|Overall Study||133
6509445|NCT01474590|7428805|FG000|COMPLETED|Overall Study||105
6509446|NCT01474590|7428806|FG001|COMPLETED|Overall Study||116
6509447|NCT01474590|7428805|FG000|NOT COMPLETED|Overall Study||28
6509448|NCT01474590|7428806|FG001|NOT COMPLETED|Overall Study||17
6509449|NCT01474681|7428814|FG000|STARTED|Overall Study||1
6509450|NCT01474681|7428815|FG001|STARTED|Overall Study||8
6509451|NCT01474681|7428816|FG002|STARTED|Overall Study||3
6509452|NCT01474681|7428817|FG003|STARTED|Overall Study||15
6509453|NCT01474681|7428814|FG000|COMPLETED|Overall Study||1
6509454|NCT01474681|7428815|FG001|COMPLETED|Overall Study||5
6509455|NCT01474681|7428816|FG002|COMPLETED|Overall Study||1
6509456|NCT01474681|7428817|FG003|COMPLETED|Overall Study||9
6509457|NCT01474681|7428814|FG000|NOT COMPLETED|Overall Study||0
6509458|NCT01474681|7428815|FG001|NOT COMPLETED|Overall Study||3
6509459|NCT01474681|7428816|FG002|NOT COMPLETED|Overall Study||2
6509460|NCT01474681|7428817|FG003|NOT COMPLETED|Overall Study||6
6509461|NCT01474746|7428833|FG000|STARTED|Overall Study||30
6509462|NCT01474746|7428834|FG001|STARTED|Overall Study||27
6509463|NCT01474746|7428833|FG000|COMPLETED|Overall Study||27
6509464|NCT01474746|7428834|FG001|COMPLETED|Overall Study||25
6509465|NCT01474746|7428833|FG000|NOT COMPLETED|Overall Study||3
6509466|NCT01474746|7428834|FG001|NOT COMPLETED|Overall Study||2
6509467|NCT01474772|7428842|FG000|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
6509468|NCT01474772|7428843|FG001|STARTED|Period 1|STARTED=treated|102
6509469|NCT01474772|7428842|FG000|COMPLETED|Period 1||89
6509470|NCT01474772|7428843|FG001|COMPLETED|Period 1||99
6509471|NCT01474772|7428842|FG000|NOT COMPLETED|Period 1||12
6509472|NCT01474772|7428843|FG001|NOT COMPLETED|Period 1||3
6509473|NCT01474772|7428842|FG000|STARTED|Washout||89
6509474|NCT01474772|7428843|FG001|STARTED|Washout||99
6509475|NCT01474772|7428842|FG000|COMPLETED|Washout||86
6509476|NCT01474772|7428843|FG001|COMPLETED|Washout||97
6254579|NCT04034238|7153333|FG003|STARTED|Dose Escalation Phase||2
6254580|NCT04034238|7153330|FG000|COMPLETED|Dose Escalation Phase||6
6254581|NCT04034238|7153331|FG001|COMPLETED|Dose Escalation Phase||3
6254582|NCT04034238|7153332|FG002|COMPLETED|Dose Escalation Phase||0
6254583|NCT04034238|7153333|FG003|COMPLETED|Dose Escalation Phase||0
6254584|NCT04034238|7153330|FG000|NOT COMPLETED|Dose Escalation Phase||1
6254585|NCT04034238|7153331|FG001|NOT COMPLETED|Dose Escalation Phase||0
6254586|NCT04034238|7153332|FG002|NOT COMPLETED|Dose Escalation Phase||0
6254587|NCT04034238|7153333|FG003|NOT COMPLETED|Dose Escalation Phase||2
6254588|NCT04034238|7153330|FG000|STARTED|Dose Expansion Phase||0
6254589|NCT04034238|7153331|FG001|STARTED|Dose Expansion Phase||0
6254590|NCT04034238|7153332|FG002|STARTED|Dose Expansion Phase||6
6254591|NCT04034238|7153333|FG003|STARTED|Dose Expansion Phase||1
6254592|NCT04034238|7153330|FG000|COMPLETED|Dose Expansion Phase||0
6254593|NCT04034238|7153331|FG001|COMPLETED|Dose Expansion Phase||0
6254594|NCT04034238|7153332|FG002|COMPLETED|Dose Expansion Phase||5
6254595|NCT04034238|7153333|FG003|COMPLETED|Dose Expansion Phase||0
6509477|NCT01474772|7428842|FG000|NOT COMPLETED|Washout||3
6509478|NCT01474772|7428843|FG001|NOT COMPLETED|Washout||2
6509479|NCT01474772|7428842|FG000|STARTED|Period 2||86
6509480|NCT01474772|7428843|FG001|STARTED|Period 2||97
6509481|NCT01474772|7428842|FG000|COMPLETED|Period 2||77
6509482|NCT01474772|7428843|FG001|COMPLETED|Period 2||87
6509483|NCT01474772|7428842|FG000|NOT COMPLETED|Period 2||9
6509484|NCT01474772|7428843|FG001|NOT COMPLETED|Period 2||10
6509485|NCT01474772|7428842|FG000|STARTED|Follow-up||77
6509486|NCT01474772|7428843|FG001|STARTED|Follow-up||87
6509487|NCT01474772|7428842|FG000|COMPLETED|Follow-up||77
6509488|NCT01474772|7428843|FG001|COMPLETED|Follow-up||86
6509489|NCT01474772|7428842|FG000|NOT COMPLETED|Follow-up||0
6509490|NCT01474772|7428843|FG001|NOT COMPLETED|Follow-up||1
6509491|NCT01474863|7428852|FG000|STARTED|Overall Study||26
6509492|NCT01474863|7428853|FG001|STARTED|Overall Study||22
6509493|NCT01474863|7428854|FG002|STARTED|Overall Study||24
6509494|NCT01474863|7428852|FG000|COMPLETED|Overall Study||26
6509495|NCT01474863|7428853|FG001|COMPLETED|Overall Study||22
6509496|NCT01474863|7428854|FG002|COMPLETED|Overall Study||24
6509497|NCT01474863|7428852|FG000|NOT COMPLETED|Overall Study||0
6509498|NCT01474863|7428853|FG001|NOT COMPLETED|Overall Study||0
6509499|NCT01474863|7428854|FG002|NOT COMPLETED|Overall Study||0
6509500|NCT01474876|7428865|FG000|STARTED|Overall Study||403
6509501|NCT01474876|7428866|FG001|STARTED|Overall Study||151
6509502|NCT01474876|7428867|FG002|STARTED|Overall Study||1
6509503|NCT01474876|7428865|FG000|COMPLETED|Overall Study||337
6509504|NCT01474876|7428866|FG001|COMPLETED|Overall Study||128
6509505|NCT01474876|7428867|FG002|COMPLETED|Overall Study||1
6509506|NCT01474876|7428865|FG000|NOT COMPLETED|Overall Study||66
6509507|NCT01474876|7428866|FG001|NOT COMPLETED|Overall Study||23
6509508|NCT01474876|7428867|FG002|NOT COMPLETED|Overall Study||0
6509509|NCT01474915|7428875|FG000|STARTED|Overall Study||60
6509510|NCT01474915|7428876|FG001|STARTED|Overall Study||61
6509511|NCT01474915|7428875|FG000|COMPLETED|Overall Study||50
6509512|NCT01474915|7428876|FG001|COMPLETED|Overall Study||51
6509513|NCT01474915|7428875|FG000|NOT COMPLETED|Overall Study||10
6509514|NCT01474915|7428876|FG001|NOT COMPLETED|Overall Study||10
6509515|NCT01474993|7428885|FG000|STARTED|Overall Study||15
6509516|NCT01474993|7428886|FG001|STARTED|Overall Study||29
6509517|NCT01474993|7428885|FG000|COMPLETED|Overall Study||14
6509518|NCT01474993|7428886|FG001|COMPLETED|Overall Study||26
6509519|NCT01474993|7428885|FG000|NOT COMPLETED|Overall Study||1
6509520|NCT01474993|7428886|FG001|NOT COMPLETED|Overall Study||3
6509521|NCT01475071|7428894|FG000|STARTED|Overall Study||100
6509522|NCT01475071|7428894|FG000|COMPLETED|Overall Study||92
6509523|NCT01475071|7428894|FG000|NOT COMPLETED|Overall Study||8
6509524|NCT01475097|7428902|FG000|STARTED|Overall Study||128
6509525|NCT01475097|7428903|FG001|STARTED|Overall Study||127
6509526|NCT01475097|7428902|FG000|COMPLETED|Overall Study||127
6509527|NCT01475097|7428903|FG001|COMPLETED|Overall Study||126
6509528|NCT01475097|7428902|FG000|NOT COMPLETED|Overall Study||1
6509529|NCT01475097|7428903|FG001|NOT COMPLETED|Overall Study||1
6509530|NCT01475136|7428913|FG000|STARTED|Overall Study||7
6509531|NCT01475136|7428914|FG001|STARTED|Overall Study||9
6509532|NCT01475136|7428915|FG002|STARTED|Overall Study||9
6509533|NCT01475136|7428916|FG003|STARTED|Overall Study||12
6509534|NCT01475136|7428913|FG000|Received 1 Dose of Study Drug|Overall Study||7
6509535|NCT01475136|7428914|FG001|Received 1 Dose of Study Drug|Overall Study||6
6509536|NCT01475136|7428915|FG002|Received 1 Dose of Study Drug|Overall Study||6
6509537|NCT01475136|7428916|FG003|Received 1 Dose of Study Drug|Overall Study||7
6509538|NCT01475136|7428913|FG000|COMPLETED|Overall Study||6
6509539|NCT01475136|7428914|FG001|COMPLETED|Overall Study||6
6509540|NCT01475136|7428915|FG002|COMPLETED|Overall Study||6
6509541|NCT01475136|7428916|FG003|COMPLETED|Overall Study||7
6509542|NCT01475136|7428913|FG000|NOT COMPLETED|Overall Study||1
6254596|NCT04034238|7153330|FG000|NOT COMPLETED|Dose Expansion Phase||0
6254597|NCT04034238|7153331|FG001|NOT COMPLETED|Dose Expansion Phase||0
6254598|NCT04034238|7153332|FG002|NOT COMPLETED|Dose Expansion Phase||1
6254599|NCT04034238|7153333|FG003|NOT COMPLETED|Dose Expansion Phase||1
6254600|NCT03984305|7153346|FG000|STARTED|Overall Study||23
6254601|NCT03984305|7153347|FG001|STARTED|Overall Study||18
6254602|NCT03984305|7153346|FG000|COMPLETED|Overall Study||0
6254603|NCT03984305|7153347|FG001|COMPLETED|Overall Study||0
6254604|NCT03984305|7153346|FG000|NOT COMPLETED|Overall Study||23
6254605|NCT03984305|7153347|FG001|NOT COMPLETED|Overall Study||18
6254606|NCT03982368|7153356|FG000|STARTED|Overall Study||87
6254607|NCT03982368|7153357|FG001|STARTED|Overall Study||86
6254608|NCT03982368|7153358|FG002|STARTED|Overall Study||88
6254609|NCT03982368|7153356|FG000|FAS Popuation|Overall Study||81
6254610|NCT03982368|7153357|FG001|FAS Popuation|Overall Study||82
6254611|NCT03982368|7153358|FG002|FAS Popuation|Overall Study||84
6254612|NCT03982368|7153356|FG000|PP Population|Overall Study||72
6254613|NCT03982368|7153357|FG001|PP Population|Overall Study||71
6254614|NCT03982368|7153358|FG002|PP Population|Overall Study||80
6254615|NCT03982368|7153356|FG000|COMPLETED|Overall Study||74
6254616|NCT03982368|7153357|FG001|COMPLETED|Overall Study||79
6254617|NCT03982368|7153358|FG002|COMPLETED|Overall Study||83
6254618|NCT03982368|7153356|FG000|NOT COMPLETED|Overall Study||13
6254619|NCT03982368|7153357|FG001|NOT COMPLETED|Overall Study||7
6254620|NCT03982368|7153358|FG002|NOT COMPLETED|Overall Study||5
6254621|NCT03952143|7153371|FG000|STARTED|Lead-In Period||628
6254622|NCT03952143|7153372|FG001|STARTED|Lead-In Period||0
6254623|NCT03952143|7153373|FG002|STARTED|Lead-In Period||0
6254624|NCT03952143|7153371|FG000|Participants Who Received at Least One Dose|Lead-In Period||628
6254625|NCT03952143|7153372|FG001|Participants Who Received at Least One Dose|Lead-In Period||0
6254626|NCT03952143|7153373|FG002|Participants Who Received at Least One Dose|Lead-In Period||0
6254627|NCT03952143|7153371|FG000|COMPLETED|Lead-In Period||595
6254628|NCT03952143|7153372|FG001|COMPLETED|Lead-In Period||0
6254629|NCT03952143|7153373|FG002|COMPLETED|Lead-In Period||0
6254630|NCT03952143|7153371|FG000|NOT COMPLETED|Lead-In Period||33
6254631|NCT03952143|7153372|FG001|NOT COMPLETED|Lead-In Period||0
6254632|NCT03952143|7153373|FG002|NOT COMPLETED|Lead-In Period||0
6254633|NCT03952143|7153371|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period|0
6254634|NCT03952143|7153372|FG001|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|200
6254635|NCT03952143|7153373|FG002|STARTED|Treatment Period|Participants were randomized to either Insulin lispro or LY900014 in Treatment Period.|395
6254636|NCT03952143|7153371|FG000|Participants Who Received at Least One Dose|Treatment Period||0
6254637|NCT03952143|7153372|FG001|Participants Who Received at Least One Dose|Treatment Period||200
6254638|NCT03952143|7153373|FG002|Participants Who Received at Least One Dose|Treatment Period||395
6254639|NCT03952143|7153371|FG000|COMPLETED|Treatment Period||0
6254640|NCT03952143|7153372|FG001|COMPLETED|Treatment Period||191
6254641|NCT03952143|7153373|FG002|COMPLETED|Treatment Period||359
6254642|NCT03952143|7153371|FG000|NOT COMPLETED|Treatment Period||0
6254643|NCT03952143|7153372|FG001|NOT COMPLETED|Treatment Period||9
6254644|NCT03952143|7153373|FG002|NOT COMPLETED|Treatment Period||36
6254645|NCT03924752|7153380|FG000|STARTED|Overall Study||10
6254646|NCT03924752|7153380|FG000|COMPLETED|Overall Study||10
6254647|NCT03924752|7153380|FG000|NOT COMPLETED|Overall Study||0
6278775|NCT00137267|7178405|FG000|STARTED|Overall Study||55
6278776|NCT00137267|7178406|FG001|STARTED|Overall Study||47
6278777|NCT00137267|7178405|FG000|COMPLETED|Overall Study||40
6278778|NCT00137267|7178406|FG001|COMPLETED|Overall Study||26
6278779|NCT00137267|7178405|FG000|NOT COMPLETED|Overall Study||15
6278780|NCT00137267|7178406|FG001|NOT COMPLETED|Overall Study||21
6570799|NCT01853462|7494193|FG001|NOT COMPLETED|Overall Study||1
6570800|NCT01853475|7494204|FG000|STARTED|Overall Study||8
6570801|NCT01853475|7494205|FG001|STARTED|Overall Study||8
6570802|NCT01853475|7494206|FG002|STARTED|Overall Study||8
6570803|NCT01853475|7494204|FG000|COMPLETED|Overall Study||8
6278781|NCT00137280|7178414|FG000|STARTED|Overall Study||389
6278782|NCT00137280|7178415|FG001|STARTED|Overall Study||412
6278783|NCT00137280|7178414|FG000|COMPLETED|Overall Study||305
6278784|NCT00137280|7178415|FG001|COMPLETED|Overall Study||357
6278785|NCT00137280|7178414|FG000|NOT COMPLETED|Overall Study||84
6278786|NCT00137280|7178415|FG001|NOT COMPLETED|Overall Study||55
6278787|NCT00137423|7178423|FG000|STARTED|Overall Study||54
6278788|NCT00137423|7178424|FG001|STARTED|Overall Study||53
6509543|NCT01475136|7428914|FG001|NOT COMPLETED|Overall Study||3
6509544|NCT01475136|7428915|FG002|NOT COMPLETED|Overall Study||3
6509545|NCT01475136|7428916|FG003|NOT COMPLETED|Overall Study||5
6509546|NCT01475162|7428926|FG000|STARTED|Overall Study||14
6509547|NCT01475162|7428926|FG000|COMPLETED|Overall Study||0
6509548|NCT01475162|7428926|FG000|NOT COMPLETED|Overall Study||14
6509549|NCT01475175|7428931|FG000|STARTED|Overall Study||12
6509550|NCT01475175|7428931|FG000|COMPLETED|Overall Study||12
6509551|NCT01475175|7428931|FG000|NOT COMPLETED|Overall Study||0
6278789|NCT00137423|7178423|FG000|COMPLETED|Overall Study||15
6278790|NCT00137423|7178424|FG001|COMPLETED|Overall Study||9
6509552|NCT01475214|7428938|FG000|STARTED|Overall Study||84
6278791|NCT00137423|7178423|FG000|NOT COMPLETED|Overall Study||39
6278792|NCT00137423|7178424|FG001|NOT COMPLETED|Overall Study||44
6278793|NCT00137436|7178434|FG000|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
6254648|NCT03829514|7153384|FG000|STARTED|Overall Study||10
6254649|NCT03829514|7153384|FG000|COMPLETED|Overall Study||10
6254650|NCT03829514|7153384|FG000|NOT COMPLETED|Overall Study||0
6254651|NCT03691428|7153390|FG000|STARTED|Overall Study||48
6254652|NCT03691428|7153391|FG001|STARTED|Overall Study||42
6254653|NCT03691428|7153390|FG000|COMPLETED|Overall Study||42
6254654|NCT03691428|7153391|FG001|COMPLETED|Overall Study||34
6254655|NCT03691428|7153390|FG000|NOT COMPLETED|Overall Study||6
6254656|NCT03691428|7153391|FG001|NOT COMPLETED|Overall Study||8
6254657|NCT03685708|7153400|FG000|STARTED|Overall Study||14
6254658|NCT03685708|7153401|FG001|STARTED|Overall Study||18
6254659|NCT03685708|7153402|FG002|STARTED|Overall Study||46
6254660|NCT03685708|7153400|FG000|COMPLETED|Overall Study||13
6254661|NCT03685708|7153401|FG001|COMPLETED|Overall Study||16
6254662|NCT03685708|7153402|FG002|COMPLETED|Overall Study||37
6254663|NCT03685708|7153400|FG000|NOT COMPLETED|Overall Study||1
6254664|NCT03685708|7153401|FG001|NOT COMPLETED|Overall Study||2
6254665|NCT03685708|7153402|FG002|NOT COMPLETED|Overall Study||9
6254666|NCT03669588|7153412|FG000|STARTED|Overall Study||84
6254667|NCT03669588|7153413|FG001|STARTED|Overall Study||83
6254668|NCT03669588|7153412|FG000|COMPLETED|Overall Study||80
6254669|NCT03669588|7153413|FG001|COMPLETED|Overall Study||76
6254670|NCT03669588|7153412|FG000|NOT COMPLETED|Overall Study||4
6254671|NCT03669588|7153413|FG001|NOT COMPLETED|Overall Study||7
6254672|NCT03531632|7153422|FG000|STARTED|Overall Study||5
6254673|NCT03531632|7153423|FG001|STARTED|Overall Study||3
6254674|NCT03531632|7153424|FG002|STARTED|Overall Study||28
6254675|NCT03531632|7153422|FG000|Safety Population|Overall Study|At least 1 dose of study drug|5
6254676|NCT03531632|7153423|FG001|Safety Population|Overall Study||3
6254677|NCT03531632|7153424|FG002|Safety Population|Overall Study||28
6254678|NCT03531632|7153422|FG000|Response Evaluable Population|Overall Study|All patients who received at least one dose of any study drug, had baseline measurable disease, and had at least one post-baseline radiographic tumor assessment or discontinued treatment due to clearly documented, clinically progressive disease or death.|5
6254679|NCT03531632|7153423|FG001|Response Evaluable Population|Overall Study||3
6254680|NCT03531632|7153424|FG002|Response Evaluable Population|Overall Study||24
6254681|NCT03531632|7153422|FG000|COMPLETED|Overall Study||0
6254682|NCT03531632|7153423|FG001|COMPLETED|Overall Study||0
6254683|NCT03531632|7153424|FG002|COMPLETED|Overall Study||2
6254684|NCT03531632|7153422|FG000|NOT COMPLETED|Overall Study||5
6254685|NCT03531632|7153423|FG001|NOT COMPLETED|Overall Study||3
6254686|NCT03531632|7153424|FG002|NOT COMPLETED|Overall Study||26
6254687|NCT03488030|7153435|FG000|STARTED|Overall Study||101
6254688|NCT03488030|7153436|FG001|STARTED|Overall Study||145
6254689|NCT03488030|7153435|FG000|COMPLETED|Overall Study||101
6254690|NCT03488030|7153436|FG001|COMPLETED|Overall Study||145
6254691|NCT03488030|7153435|FG000|NOT COMPLETED|Overall Study||0
6254692|NCT03488030|7153436|FG001|NOT COMPLETED|Overall Study||0
6254693|NCT03412604|7153447|FG000|STARTED|Overall Study||5
6254694|NCT03412604|7153447|FG000|COMPLETED|Overall Study||4
6254695|NCT03412604|7153447|FG000|NOT COMPLETED|Overall Study||1
6254696|NCT03206073|7153455|FG000|STARTED|Overall Study||4
6254697|NCT03206073|7153456|FG001|STARTED|Overall Study||12
6254698|NCT03206073|7153457|FG002|STARTED|Overall Study||4
6254699|NCT03206073|7153458|FG003|STARTED|Overall Study||14
6254700|NCT03206073|7153455|FG000|COMPLETED|Overall Study||3
6254701|NCT03206073|7153456|FG001|COMPLETED|Overall Study||11
6254702|NCT03206073|7153457|FG002|COMPLETED|Overall Study||0
6254703|NCT03206073|7153458|FG003|COMPLETED|Overall Study||14
6254704|NCT03206073|7153455|FG000|NOT COMPLETED|Overall Study||1
6254705|NCT03206073|7153456|FG001|NOT COMPLETED|Overall Study||1
6254706|NCT03206073|7153457|FG002|NOT COMPLETED|Overall Study||4
6254707|NCT03206073|7153458|FG003|NOT COMPLETED|Overall Study||0
6254708|NCT03195127|7153470|FG000|STARTED|Overall Study||15
6254709|NCT03195127|7153471|FG001|STARTED|Overall Study||18
6254710|NCT03195127|7153470|FG000|COMPLETED|Overall Study||15
6254711|NCT03195127|7153471|FG001|COMPLETED|Overall Study||17
6254712|NCT03195127|7153470|FG000|NOT COMPLETED|Overall Study||0
6254713|NCT03195127|7153471|FG001|NOT COMPLETED|Overall Study||1
6254714|NCT03102034|7153483|FG000|STARTED|Overall Study||21
6254715|NCT03102034|7153484|FG001|STARTED|Overall Study||11
6254716|NCT03102034|7153483|FG000|COMPLETED|Overall Study||20
6254717|NCT03102034|7153484|FG001|COMPLETED|Overall Study||11
6254718|NCT03102034|7153483|FG000|NOT COMPLETED|Overall Study||1
6254719|NCT03102034|7153484|FG001|NOT COMPLETED|Overall Study||0
6254720|NCT03076164|7153490|FG000|STARTED|Overall Study||24
6254721|NCT03076164|7153490|FG000|COMPLETED|Overall Study||24
6254722|NCT03076164|7153490|FG000|NOT COMPLETED|Overall Study||0
6278794|NCT00137436|7178434|FG000|COMPLETED|Overall Study||12
6278795|NCT00137436|7178434|FG000|NOT COMPLETED|Overall Study||43
6278796|NCT00137449|7178440|FG000|STARTED|Overall Study||30
6278797|NCT00137449|7178441|FG001|STARTED|Overall Study||30
6278798|NCT00137449|7178440|FG000|COMPLETED|Overall Study||14
6509553|NCT01475214|7428939|FG001|STARTED|Overall Study||79
6278799|NCT00137449|7178441|FG001|COMPLETED|Overall Study||12
6278800|NCT00137449|7178440|FG000|NOT COMPLETED|Overall Study||16
6278801|NCT00137449|7178441|FG001|NOT COMPLETED|Overall Study||18
6278802|NCT00137631|7178450|FG000|STARTED|Overall Study||164
6278803|NCT00137631|7178451|FG001|STARTED|Overall Study||174
6278804|NCT00137631|7178450|FG000|Complete 3-month Follow-up|Overall Study||120
6278805|NCT00137631|7178451|FG001|Complete 3-month Follow-up|Overall Study||125
6281024|NCT00160680|7180889|FG000|NOT COMPLETED|Overall Study||9
6254723|NCT02723864|7153501|FG000|STARTED|Overall Study||3
6254724|NCT02723864|7153502|FG001|STARTED|Overall Study||3
6254725|NCT02723864|7153503|FG002|STARTED|Overall Study||6
6254726|NCT02723864|7153504|FG003|STARTED|Overall Study||7
6254727|NCT02723864|7153505|FG004|STARTED|Overall Study||3
6509554|NCT01475214|7428940|FG002|STARTED|Overall Study||81
6509555|NCT01475214|7428938|FG000|COMPLETED|Overall Study||79
6509556|NCT01475214|7428939|FG001|COMPLETED|Overall Study||75
6509557|NCT01475214|7428940|FG002|COMPLETED|Overall Study||79
6509558|NCT01475214|7428938|FG000|NOT COMPLETED|Overall Study||5
6509559|NCT01475214|7428939|FG001|NOT COMPLETED|Overall Study||4
6509560|NCT01475214|7428940|FG002|NOT COMPLETED|Overall Study||2
6509561|NCT01475253|7428952|FG000|STARTED|Randomized, Blinded Study||47
6509562|NCT01475253|7428953|FG001|STARTED|Randomized, Blinded Study||46
6509563|NCT01475253|7428954|FG002|STARTED|Randomized, Blinded Study||11
6509564|NCT01475253|7428955|FG003|STARTED|Randomized, Blinded Study||0
6509565|NCT01475253|7428952|FG000|COMPLETED|Randomized, Blinded Study||45
6509566|NCT01475253|7428953|FG001|COMPLETED|Randomized, Blinded Study||45
6509567|NCT01475253|7428954|FG002|COMPLETED|Randomized, Blinded Study||11
6509568|NCT01475253|7428955|FG003|COMPLETED|Randomized, Blinded Study||0
6509569|NCT01475253|7428952|FG000|NOT COMPLETED|Randomized, Blinded Study||2
6509570|NCT01475253|7428953|FG001|NOT COMPLETED|Randomized, Blinded Study||1
6509571|NCT01475253|7428954|FG002|NOT COMPLETED|Randomized, Blinded Study||0
6509572|NCT01475253|7428955|FG003|NOT COMPLETED|Randomized, Blinded Study||0
6509573|NCT01475253|7428952|FG000|STARTED|Open Label Extension||0
6509574|NCT01475253|7428953|FG001|STARTED|Open Label Extension||0
6509575|NCT01475253|7428954|FG002|STARTED|Open Label Extension||0
6509576|NCT01475253|7428955|FG003|STARTED|Open Label Extension||56
6509577|NCT01475253|7428952|FG000|COMPLETED|Open Label Extension||0
6509578|NCT01475253|7428953|FG001|COMPLETED|Open Label Extension||0
6509579|NCT01475253|7428954|FG002|COMPLETED|Open Label Extension||0
6509580|NCT01475253|7428955|FG003|COMPLETED|Open Label Extension||56
6509581|NCT01475253|7428952|FG000|NOT COMPLETED|Open Label Extension||0
6509582|NCT01475253|7428953|FG001|NOT COMPLETED|Open Label Extension||0
6509583|NCT01475253|7428954|FG002|NOT COMPLETED|Open Label Extension||0
6509584|NCT01475253|7428955|FG003|NOT COMPLETED|Open Label Extension||0
6509585|NCT01475305|7428965|FG000|STARTED|Overall Study||4
6509586|NCT01475305|7428966|FG001|STARTED|Overall Study||3
6509587|NCT01475305|7428965|FG000|End of Quarantine, Day 15|Overall Study||4
6509588|NCT01475305|7428966|FG001|End of Quarantine, Day 15|Overall Study||3
6509589|NCT01475305|7428965|FG000|COMPLETED|Overall Study||4
6509590|NCT01475305|7428966|FG001|COMPLETED|Overall Study||3
6509591|NCT01475305|7428965|FG000|NOT COMPLETED|Overall Study||0
6509592|NCT01475305|7428966|FG001|NOT COMPLETED|Overall Study||0
6509593|NCT01475331|7428975|FG000|STARTED|Overall Study||23
6570804|NCT01853475|7494205|FG001|COMPLETED|Overall Study||7
6570805|NCT01853475|7494206|FG002|COMPLETED|Overall Study||8
6570806|NCT01853475|7494204|FG000|NOT COMPLETED|Overall Study||0
6570807|NCT01853475|7494205|FG001|NOT COMPLETED|Overall Study||1
6570808|NCT01853475|7494206|FG002|NOT COMPLETED|Overall Study||0
6570809|NCT01853553|7494216|FG000|STARTED|Overall Study||29
6570810|NCT01853553|7494217|FG001|STARTED|Overall Study||32
6254728|NCT02723864|7153506|FG005|STARTED|Overall Study||25
6254729|NCT02723864|7153507|FG006|STARTED|Overall Study||6
6254730|NCT02723864|7153501|FG000|COMPLETED|Overall Study||2
6254731|NCT02723864|7153502|FG001|COMPLETED|Overall Study||2
6254732|NCT02723864|7153503|FG002|COMPLETED|Overall Study||5
6254733|NCT02723864|7153504|FG003|COMPLETED|Overall Study||7
6254734|NCT02723864|7153505|FG004|COMPLETED|Overall Study||2
6254735|NCT02723864|7153506|FG005|COMPLETED|Overall Study||14
6254736|NCT02723864|7153507|FG006|COMPLETED|Overall Study||4
6254737|NCT02723864|7153501|FG000|NOT COMPLETED|Overall Study||1
6254738|NCT02723864|7153502|FG001|NOT COMPLETED|Overall Study||1
6254739|NCT02723864|7153503|FG002|NOT COMPLETED|Overall Study||1
6254740|NCT02723864|7153504|FG003|NOT COMPLETED|Overall Study||0
6254741|NCT02723864|7153505|FG004|NOT COMPLETED|Overall Study||1
6254742|NCT02723864|7153506|FG005|NOT COMPLETED|Overall Study||11
6254743|NCT02723864|7153507|FG006|NOT COMPLETED|Overall Study||2
6254744|NCT02701556|7153546|FG000|STARTED|Overall Study||198
6254745|NCT02701556|7153547|FG001|STARTED|Overall Study||198
6254746|NCT02701556|7153546|FG000|COMPLETED|Overall Study||175
6254747|NCT02701556|7153547|FG001|COMPLETED|Overall Study||178
6254748|NCT02701556|7153546|FG000|NOT COMPLETED|Overall Study||23
6254749|NCT02701556|7153547|FG001|NOT COMPLETED|Overall Study||20
6254750|NCT02691013|7153555|FG000|STARTED|Overall Study||61
6254751|NCT02691013|7153556|FG001|STARTED|Overall Study||59
6254752|NCT02691013|7153555|FG000|COMPLETED|Overall Study||58
6254753|NCT02691013|7153556|FG001|COMPLETED|Overall Study||59
6254754|NCT02691013|7153555|FG000|NOT COMPLETED|Overall Study||3
6254755|NCT02691013|7153556|FG001|NOT COMPLETED|Overall Study||0
6254756|NCT02597062|7153564|FG000|STARTED|Overall Study||76
6254757|NCT02597062|7153564|FG000|COMPLETED|Overall Study||75
6254758|NCT02597062|7153564|FG000|NOT COMPLETED|Overall Study||1
6254759|NCT02130882|7153570|FG000|STARTED|Overall Study||10
6254760|NCT02130882|7153571|FG001|STARTED|Overall Study||10
6254761|NCT02130882|7153570|FG000|COMPLETED|Overall Study||10
6254762|NCT02130882|7153571|FG001|COMPLETED|Overall Study||9
6254763|NCT02130882|7153570|FG000|NOT COMPLETED|Overall Study||0
6254764|NCT02130882|7153571|FG001|NOT COMPLETED|Overall Study||1
6254765|NCT01920932|7153577|FG000|STARTED|Overall Study||77
6254766|NCT01920932|7153577|FG000|COMPLETED|Overall Study||75
6254767|NCT01920932|7153577|FG000|NOT COMPLETED|Overall Study||2
6254768|NCT01850563|7153600|FG000|STARTED|Overall Study||22
6254769|NCT01850563|7153601|FG001|STARTED|Overall Study||19
6254770|NCT01850563|7153600|FG000|HBO Treatment Completed|Overall Study||19
6254771|NCT01850563|7153601|FG001|HBO Treatment Completed|Overall Study||0
6254772|NCT01850563|7153600|FG000|COMPLETED|Overall Study||19
6254773|NCT01850563|7153601|FG001|COMPLETED|Overall Study||19
6254774|NCT01850563|7153600|FG000|NOT COMPLETED|Overall Study||3
6254775|NCT01850563|7153601|FG001|NOT COMPLETED|Overall Study||0
6254776|NCT01827111|7153608|FG000|STARTED|Overall Study||19
6254777|NCT01827111|7153608|FG000|COMPLETED|Overall Study||18
6570811|NCT01853553|7494216|FG000|COMPLETED|Overall Study||28
6254778|NCT01827111|7153608|FG000|NOT COMPLETED|Overall Study||1
6254785|NCT01437111|7153621|FG000|STARTED|Overall Study||200
6254786|NCT01437111|7153621|FG000|Treated Participants|Overall Study||198
6254787|NCT01437111|7153621|FG000|COMPLETED|Overall Study||182
6254788|NCT01437111|7153621|FG000|NOT COMPLETED|Overall Study||18
6254789|NCT01057121|7153630|FG000|STARTED|Phase I: 10 mg/Day Lenalidomide||3
6254790|NCT01057121|7153631|FG001|STARTED|Phase I: 10 mg/Day Lenalidomide||0
6254791|NCT01057121|7153632|FG002|STARTED|Phase I: 10 mg/Day Lenalidomide||0
6254792|NCT01057121|7153633|FG003|STARTED|Phase I: 10 mg/Day Lenalidomide||0
6254793|NCT01057121|7153634|FG004|STARTED|Phase I: 10 mg/Day Lenalidomide||0
6254794|NCT01057121|7153630|FG000|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
6254795|NCT01057121|7153631|FG001|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254796|NCT01057121|7153632|FG002|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254797|NCT01057121|7153633|FG003|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254798|NCT01057121|7153634|FG004|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254799|NCT01057121|7153630|FG000|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254800|NCT01057121|7153631|FG001|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254801|NCT01057121|7153632|FG002|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254802|NCT01057121|7153633|FG003|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254803|NCT01057121|7153634|FG004|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
6254804|NCT01057121|7153630|FG000|STARTED|Phase I: 15 mg/Day Lenolidomide||0
6254805|NCT01057121|7153631|FG001|STARTED|Phase I: 15 mg/Day Lenolidomide||3
6254806|NCT01057121|7153632|FG002|STARTED|Phase I: 15 mg/Day Lenolidomide||0
6254807|NCT01057121|7153633|FG003|STARTED|Phase I: 15 mg/Day Lenolidomide||0
6254808|NCT01057121|7153634|FG004|STARTED|Phase I: 15 mg/Day Lenolidomide||0
6254809|NCT01057121|7153630|FG000|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254810|NCT01057121|7153631|FG001|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
6254811|NCT01057121|7153632|FG002|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254812|NCT01057121|7153633|FG003|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254813|NCT01057121|7153634|FG004|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254814|NCT01057121|7153630|FG000|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254815|NCT01057121|7153631|FG001|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254816|NCT01057121|7153632|FG002|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254817|NCT01057121|7153633|FG003|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254818|NCT01057121|7153634|FG004|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
6254819|NCT01057121|7153630|FG000|STARTED|Phase I: 20 mg/Day Lenalidomide||0
6254820|NCT01057121|7153631|FG001|STARTED|Phase I: 20 mg/Day Lenalidomide||0
6254821|NCT01057121|7153632|FG002|STARTED|Phase I: 20 mg/Day Lenalidomide||3
6254822|NCT01057121|7153633|FG003|STARTED|Phase I: 20 mg/Day Lenalidomide||0
6254823|NCT01057121|7153634|FG004|STARTED|Phase I: 20 mg/Day Lenalidomide||0
6254824|NCT01057121|7153630|FG000|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254825|NCT01057121|7153631|FG001|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254826|NCT01057121|7153632|FG002|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
6254827|NCT01057121|7153633|FG003|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254828|NCT01057121|7153634|FG004|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254829|NCT01057121|7153630|FG000|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254830|NCT01057121|7153631|FG001|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254831|NCT01057121|7153632|FG002|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254832|NCT01057121|7153633|FG003|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254833|NCT01057121|7153634|FG004|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
6254834|NCT01057121|7153630|FG000|STARTED|Phase I: 25 mg/Day Lenalidomide||0
6254835|NCT01057121|7153631|FG001|STARTED|Phase I: 25 mg/Day Lenalidomide||0
6254836|NCT01057121|7153632|FG002|STARTED|Phase I: 25 mg/Day Lenalidomide||0
6509594|NCT01475331|7428976|FG001|STARTED|Overall Study||23
6509595|NCT01475331|7428975|FG000|COMPLETED|Overall Study||18
6509596|NCT01475331|7428976|FG001|COMPLETED|Overall Study||21
6509597|NCT01475331|7428975|FG000|NOT COMPLETED|Overall Study||5
6509598|NCT01475331|7428976|FG001|NOT COMPLETED|Overall Study||2
6509599|NCT01475370|7428985|FG000|STARTED|Overall Study||3
6509600|NCT01475370|7428986|FG001|STARTED|Overall Study||3
6509601|NCT01475370|7428987|FG002|STARTED|Overall Study||3
6509602|NCT01475370|7428985|FG000|COMPLETED|Overall Study||0
6509603|NCT01475370|7428986|FG001|COMPLETED|Overall Study||0
6509604|NCT01475370|7428987|FG002|COMPLETED|Overall Study||0
6254837|NCT01057121|7153633|FG003|STARTED|Phase I: 25 mg/Day Lenalidomide||6
6254838|NCT01057121|7153634|FG004|STARTED|Phase I: 25 mg/Day Lenalidomide||0
6254839|NCT01057121|7153630|FG000|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254840|NCT01057121|7153631|FG001|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254841|NCT01057121|7153632|FG002|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254842|NCT01057121|7153633|FG003|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
6254843|NCT01057121|7153634|FG004|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254844|NCT01057121|7153630|FG000|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254845|NCT01057121|7153631|FG001|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254846|NCT01057121|7153632|FG002|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254847|NCT01057121|7153633|FG003|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254848|NCT01057121|7153634|FG004|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
6254849|NCT01057121|7153630|FG000|STARTED|Phase II: 25 mg/Day Lenalidomide||0
6254850|NCT01057121|7153631|FG001|STARTED|Phase II: 25 mg/Day Lenalidomide||0
6254851|NCT01057121|7153632|FG002|STARTED|Phase II: 25 mg/Day Lenalidomide||0
6254852|NCT01057121|7153633|FG003|STARTED|Phase II: 25 mg/Day Lenalidomide||0
6254853|NCT01057121|7153634|FG004|STARTED|Phase II: 25 mg/Day Lenalidomide||23
6254854|NCT01057121|7153630|FG000|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254855|NCT01057121|7153631|FG001|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254856|NCT01057121|7153632|FG002|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254857|NCT01057121|7153633|FG003|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254858|NCT01057121|7153634|FG004|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
6254859|NCT01057121|7153630|FG000|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254860|NCT01057121|7153631|FG001|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254861|NCT01057121|7153632|FG002|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254862|NCT01057121|7153633|FG003|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254863|NCT01057121|7153634|FG004|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
6254864|NCT01004263|7153658|FG000|STARTED|Overall Study|Participants who took study drug|606
6254865|NCT01004263|7153658|FG000|COMPLETED|Overall Study||427
6254866|NCT01004263|7153658|FG000|NOT COMPLETED|Overall Study||179
6254867|NCT01001234|7153667|FG000|STARTED|Overall Study|Participants who were randomized to study drug|492
6254868|NCT01001234|7153668|FG001|STARTED|Overall Study|Participants who were randomized to study drug|31
6254869|NCT01001234|7153669|FG002|STARTED|Overall Study|Participants who were randomized to study drug|409
6254870|NCT01001234|7153670|FG003|STARTED|Overall Study|Participants who were randomized to study drug|410
6254871|NCT01001234|7153671|FG004|STARTED|Overall Study|Participants who were randomized to study drug|40
6254872|NCT01001234|7153667|FG000|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
6254873|NCT01001234|7153668|FG001|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
6254874|NCT01001234|7153669|FG002|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
6254875|NCT01001234|7153670|FG003|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
6254876|NCT01001234|7153671|FG004|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
6254877|NCT01001234|7153667|FG000|Participants Not Treated|Overall Study|Participants who did not take study drug|368
6254878|NCT01001234|7153668|FG001|Participants Not Treated|Overall Study|Participants who did not take study drug|23
6254879|NCT01001234|7153669|FG002|Participants Not Treated|Overall Study|Participants who did not take study drug|9
6254880|NCT01001234|7153670|FG003|Participants Not Treated|Overall Study|Participants who did not take study drug|5
6254881|NCT01001234|7153671|FG004|Participants Not Treated|Overall Study|Participants who did not take study drug|0
6254882|NCT01001234|7153667|FG000|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
6254883|NCT01001234|7153668|FG001|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
6254884|NCT01001234|7153669|FG002|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
6254885|NCT01001234|7153670|FG003|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
6254886|NCT01001234|7153671|FG004|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
6254887|NCT01001234|7153667|FG000|NOT COMPLETED|Overall Study||405
6254888|NCT01001234|7153668|FG001|NOT COMPLETED|Overall Study||26
6254889|NCT01001234|7153669|FG002|NOT COMPLETED|Overall Study||32
6254890|NCT01001234|7153670|FG003|NOT COMPLETED|Overall Study||25
6254891|NCT01001234|7153671|FG004|NOT COMPLETED|Overall Study||0
6254892|NCT00924170|7153679|FG000|STARTED|Overall Study||10
6254893|NCT00924170|7153680|FG001|STARTED|Overall Study||8
6254894|NCT00924170|7153679|FG000|COMPLETED|Overall Study||3
6254895|NCT00924170|7153680|FG001|COMPLETED|Overall Study||0
6254896|NCT00924170|7153679|FG000|NOT COMPLETED|Overall Study||7
6254897|NCT00924170|7153680|FG001|NOT COMPLETED|Overall Study||8
6254898|NCT00894556|7153695|FG000|STARTED|Baseline Phase||0
6254899|NCT00894556|7153696|FG001|STARTED|Baseline Phase||0
6254900|NCT00894556|7153697|FG002|STARTED|Baseline Phase||0
6254901|NCT00894556|7153698|FG003|STARTED|Baseline Phase||194
6254902|NCT00894556|7153695|FG000|COMPLETED|Baseline Phase||0
6254903|NCT00894556|7153696|FG001|COMPLETED|Baseline Phase||0
6254904|NCT00894556|7153697|FG002|COMPLETED|Baseline Phase||0
6254905|NCT00894556|7153698|FG003|COMPLETED|Baseline Phase||109
6254906|NCT00894556|7153695|FG000|NOT COMPLETED|Baseline Phase||0
6254907|NCT00894556|7153696|FG001|NOT COMPLETED|Baseline Phase||0
6570812|NCT01853553|7494217|FG001|COMPLETED|Overall Study||32
6254908|NCT00894556|7153697|FG002|NOT COMPLETED|Baseline Phase||0
6254909|NCT00894556|7153698|FG003|NOT COMPLETED|Baseline Phase||85
6254910|NCT00894556|7153695|FG000|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
6254911|NCT00894556|7153696|FG001|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
6254912|NCT00894556|7153697|FG002|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
6254913|NCT00894556|7153698|FG003|STARTED|Treatment Phase||0
6254914|NCT00894556|7153695|FG000|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
6254915|NCT00894556|7153696|FG001|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
6254916|NCT00894556|7153697|FG002|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
6254917|NCT00894556|7153698|FG003|COMPLETED|Treatment Phase||0
6254918|NCT00894556|7153695|FG000|NOT COMPLETED|Treatment Phase||4
6254919|NCT00894556|7153696|FG001|NOT COMPLETED|Treatment Phase||4
6509605|NCT01475370|7428985|FG000|NOT COMPLETED|Overall Study||3
6509606|NCT01475370|7428986|FG001|NOT COMPLETED|Overall Study||3
6509607|NCT01475370|7428987|FG002|NOT COMPLETED|Overall Study||3
6509608|NCT01475461|7429001|FG000|STARTED|Run-in Period||376
6509609|NCT01475461|7429002|FG001|STARTED|Run-in Period||0
6509610|NCT01475461|7429003|FG002|STARTED|Run-in Period||0
6509611|NCT01475461|7429004|FG003|STARTED|Run-in Period||0
6509612|NCT01475461|7429005|FG004|STARTED|Run-in Period||0
6509613|NCT01475461|7429006|FG005|STARTED|Run-in Period||0
6509614|NCT01475461|7429007|FG006|STARTED|Run-in Period||0
6509615|NCT01475461|7429001|FG000|COMPLETED|Run-in Period||335
6509616|NCT01475461|7429002|FG001|COMPLETED|Run-in Period||0
6509617|NCT01475461|7429003|FG002|COMPLETED|Run-in Period||0
6509618|NCT01475461|7429004|FG003|COMPLETED|Run-in Period||0
6509619|NCT01475461|7429005|FG004|COMPLETED|Run-in Period||0
6509620|NCT01475461|7429006|FG005|COMPLETED|Run-in Period||0
6509621|NCT01475461|7429007|FG006|COMPLETED|Run-in Period||0
6509622|NCT01475461|7429001|FG000|NOT COMPLETED|Run-in Period||41
6509623|NCT01475461|7429002|FG001|NOT COMPLETED|Run-in Period||0
6509624|NCT01475461|7429003|FG002|NOT COMPLETED|Run-in Period||0
6509625|NCT01475461|7429004|FG003|NOT COMPLETED|Run-in Period||0
6509626|NCT01475461|7429005|FG004|NOT COMPLETED|Run-in Period||0
6509627|NCT01475461|7429006|FG005|NOT COMPLETED|Run-in Period||0
6509628|NCT01475461|7429007|FG006|NOT COMPLETED|Run-in Period||0
6509629|NCT01475461|7429001|FG000|STARTED|Treatment Period||0
6509630|NCT01475461|7429002|FG001|STARTED|Treatment Period||57
6509631|NCT01475461|7429003|FG002|STARTED|Treatment Period||57
6509632|NCT01475461|7429004|FG003|STARTED|Treatment Period||54
6509633|NCT01475461|7429005|FG004|STARTED|Treatment Period||56
6509634|NCT01475461|7429006|FG005|STARTED|Treatment Period||56
6509635|NCT01475461|7429007|FG006|STARTED|Treatment Period||55
6509636|NCT01475461|7429001|FG000|COMPLETED|Treatment Period||0
6509637|NCT01475461|7429002|FG001|COMPLETED|Treatment Period||48
6509638|NCT01475461|7429003|FG002|COMPLETED|Treatment Period||53
6509639|NCT01475461|7429004|FG003|COMPLETED|Treatment Period||46
6509640|NCT01475461|7429005|FG004|COMPLETED|Treatment Period||52
6509641|NCT01475461|7429006|FG005|COMPLETED|Treatment Period||51
6509642|NCT01475461|7429007|FG006|COMPLETED|Treatment Period||53
6509643|NCT01475461|7429001|FG000|NOT COMPLETED|Treatment Period||0
6509644|NCT01475461|7429002|FG001|NOT COMPLETED|Treatment Period||9
6509645|NCT01475461|7429003|FG002|NOT COMPLETED|Treatment Period||4
6509646|NCT01475461|7429004|FG003|NOT COMPLETED|Treatment Period||8
6509647|NCT01475461|7429005|FG004|NOT COMPLETED|Treatment Period||4
6509648|NCT01475461|7429006|FG005|NOT COMPLETED|Treatment Period||5
6509649|NCT01475461|7429007|FG006|NOT COMPLETED|Treatment Period||2
6509650|NCT01475474|7429040|FG000|STARTED|Baseline Period - 4 Weeks||97
6509651|NCT01475474|7429040|FG000|COMPLETED|Baseline Period - 4 Weeks||91
6509652|NCT01475474|7429040|FG000|NOT COMPLETED|Baseline Period - 4 Weeks||6
6509653|NCT01475474|7429040|FG000|STARTED|Treatment Period - 12 Weeks||91
6509654|NCT01475474|7429040|FG000|COMPLETED|Treatment Period - 12 Weeks||73
6509655|NCT01475474|7429040|FG000|NOT COMPLETED|Treatment Period - 12 Weeks||18
6509656|NCT01475474|7429040|FG000|STARTED|Return to Baseline Period - 4 Weeks||73
6509657|NCT01475474|7429040|FG000|COMPLETED|Return to Baseline Period - 4 Weeks||71
6509658|NCT01475474|7429040|FG000|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
6509659|NCT01475487|7429047|FG000|STARTED|Overall Study||25
6509660|NCT01475487|7429048|FG001|STARTED|Overall Study||25
6509661|NCT01475487|7429047|FG000|COMPLETED|Overall Study||23
6509662|NCT01475487|7429048|FG001|COMPLETED|Overall Study||24
6509663|NCT01475487|7429047|FG000|NOT COMPLETED|Overall Study||2
6509664|NCT01475487|7429048|FG001|NOT COMPLETED|Overall Study||1
6509665|NCT01475513|7429056|FG000|STARTED|Overall Study||20
6509666|NCT01475513|7429057|FG001|STARTED|Overall Study||26
6509667|NCT01475513|7429056|FG000|COMPLETED|Overall Study||17
6509668|NCT01475513|7429057|FG001|COMPLETED|Overall Study||16
6509669|NCT01475513|7429056|FG000|NOT COMPLETED|Overall Study||3
6570813|NCT01853553|7494216|FG000|NOT COMPLETED|Overall Study||1
6509670|NCT01475513|7429057|FG001|NOT COMPLETED|Overall Study||10
6509671|NCT01475643|7429067|FG000|STARTED|Overall Study|53 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|54
6509672|NCT01475643|7429068|FG001|STARTED|Overall Study|52 included in Intent-to-treat (ITT) population, due to no post-treatment assessment.|53
6509673|NCT01475643|7429067|FG000|COMPLETED|Overall Study||40
6509674|NCT01475643|7429068|FG001|COMPLETED|Overall Study||43
6254920|NCT00894556|7153697|FG002|NOT COMPLETED|Treatment Phase||1
6254921|NCT00894556|7153698|FG003|NOT COMPLETED|Treatment Phase||0
6254922|NCT00840177|7153708|FG000|STARTED|Overall Study||36
6254923|NCT00840177|7153709|FG001|STARTED|Overall Study||29
6254924|NCT00840177|7153710|FG002|STARTED|Overall Study||50
6254925|NCT00840177|7153708|FG000|Treated|Overall Study||36
6254926|NCT00840177|7153709|FG001|Treated|Overall Study||29
6254927|NCT00840177|7153710|FG002|Treated|Overall Study||46
6254928|NCT00840177|7153708|FG000|Assessed for AEs|Overall Study||35
6254929|NCT00840177|7153709|FG001|Assessed for AEs|Overall Study||29
6254930|NCT00840177|7153710|FG002|Assessed for AEs|Overall Study||46
6254931|NCT00840177|7153708|FG000|COMPLETED|Overall Study||18
6254932|NCT00840177|7153709|FG001|COMPLETED|Overall Study||20
6254933|NCT00840177|7153710|FG002|COMPLETED|Overall Study||39
6254934|NCT00840177|7153708|FG000|NOT COMPLETED|Overall Study||18
6254935|NCT00840177|7153709|FG001|NOT COMPLETED|Overall Study||9
6254936|NCT00840177|7153710|FG002|NOT COMPLETED|Overall Study||11
6254937|NCT00820950|7153723|FG000|STARTED|Overall Study||6
6254938|NCT00820950|7153724|FG001|STARTED|Overall Study||6
6254939|NCT00820950|7153725|FG002|STARTED|Overall Study||6
6254940|NCT00820950|7153726|FG003|STARTED|Overall Study||6
6254941|NCT00820950|7153727|FG004|STARTED|Overall Study||6
6254942|NCT00820950|7153728|FG005|STARTED|Overall Study||6
6254943|NCT00820950|7153729|FG006|STARTED|Overall Study||6
6254944|NCT00820950|7153730|FG007|STARTED|Overall Study||6
6254945|NCT00820950|7153731|FG008|STARTED|Overall Study||5
6254946|NCT00820950|7153732|FG009|STARTED|Overall Study||5
6254947|NCT00820950|7153723|FG000|COMPLETED|Overall Study||5
6254948|NCT00820950|7153724|FG001|COMPLETED|Overall Study||5
6254949|NCT00820950|7153725|FG002|COMPLETED|Overall Study||6
6254950|NCT00820950|7153726|FG003|COMPLETED|Overall Study||6
6254951|NCT00820950|7153727|FG004|COMPLETED|Overall Study||6
6254952|NCT00820950|7153728|FG005|COMPLETED|Overall Study||6
6254953|NCT00820950|7153729|FG006|COMPLETED|Overall Study||5
6254954|NCT00820950|7153730|FG007|COMPLETED|Overall Study||5
6254955|NCT00820950|7153731|FG008|COMPLETED|Overall Study||5
6254956|NCT00820950|7153732|FG009|COMPLETED|Overall Study||5
6254957|NCT00820950|7153723|FG000|NOT COMPLETED|Overall Study||1
6254958|NCT00820950|7153724|FG001|NOT COMPLETED|Overall Study||1
6254959|NCT00820950|7153725|FG002|NOT COMPLETED|Overall Study||0
6254960|NCT00820950|7153726|FG003|NOT COMPLETED|Overall Study||0
6254961|NCT00820950|7153727|FG004|NOT COMPLETED|Overall Study||0
6254962|NCT00820950|7153728|FG005|NOT COMPLETED|Overall Study||0
6254963|NCT00820950|7153729|FG006|NOT COMPLETED|Overall Study||1
6254964|NCT00820950|7153730|FG007|NOT COMPLETED|Overall Study||1
6254965|NCT00820950|7153731|FG008|NOT COMPLETED|Overall Study||0
6254966|NCT00820950|7153732|FG009|NOT COMPLETED|Overall Study||0
6254967|NCT00806416|7153774|FG000|STARTED|Period 1 - Part I||107
6254968|NCT00806416|7153775|FG001|STARTED|Period 1 - Part I||107
6254969|NCT00806416|7153776|FG002|STARTED|Period 1 - Part I||0
6254970|NCT00806416|7153777|FG003|STARTED|Period 1 - Part I||0
6254971|NCT00806416|7153774|FG000|COMPLETED|Period 1 - Part I||104
6254972|NCT00806416|7153775|FG001|COMPLETED|Period 1 - Part I||103
6254973|NCT00806416|7153776|FG002|COMPLETED|Period 1 - Part I||0
6254974|NCT00806416|7153777|FG003|COMPLETED|Period 1 - Part I||0
6254975|NCT00806416|7153774|FG000|NOT COMPLETED|Period 1 - Part I||3
6254976|NCT00806416|7153775|FG001|NOT COMPLETED|Period 1 - Part I||4
6254977|NCT00806416|7153776|FG002|NOT COMPLETED|Period 1 - Part I||0
6254978|NCT00806416|7153777|FG003|NOT COMPLETED|Period 1 - Part I||0
6254979|NCT00806416|7153774|FG000|STARTED|Period 2 - Part I||104
6254980|NCT00806416|7153775|FG001|STARTED|Period 2 - Part I||103
6254981|NCT00806416|7153776|FG002|STARTED|Period 2 - Part I||0
6254982|NCT00806416|7153777|FG003|STARTED|Period 2 - Part I||0
6254983|NCT00806416|7153774|FG000|COMPLETED|Period 2 - Part I||104
6254984|NCT00806416|7153775|FG001|COMPLETED|Period 2 - Part I||103
6254985|NCT00806416|7153776|FG002|COMPLETED|Period 2 - Part I||0
6254986|NCT00806416|7153777|FG003|COMPLETED|Period 2 - Part I||0
6254987|NCT00806416|7153774|FG000|NOT COMPLETED|Period 2 - Part I||0
6254988|NCT00806416|7153775|FG001|NOT COMPLETED|Period 2 - Part I||0
6254989|NCT00806416|7153776|FG002|NOT COMPLETED|Period 2 - Part I||0
6254990|NCT00806416|7153777|FG003|NOT COMPLETED|Period 2 - Part I||0
6254991|NCT00806416|7153774|FG000|STARTED|Period 1 - Part II||0
6254992|NCT00806416|7153775|FG001|STARTED|Period 1 - Part II||0
6254993|NCT00806416|7153776|FG002|STARTED|Period 1 - Part II||14
6254994|NCT00806416|7153777|FG003|STARTED|Period 1 - Part II||16
6254995|NCT00806416|7153774|FG000|COMPLETED|Period 1 - Part II||0
6254996|NCT00806416|7153775|FG001|COMPLETED|Period 1 - Part II||0
6254997|NCT00806416|7153776|FG002|COMPLETED|Period 1 - Part II||14
6254998|NCT00806416|7153777|FG003|COMPLETED|Period 1 - Part II||14
6254999|NCT00806416|7153774|FG000|NOT COMPLETED|Period 1 - Part II||0
6255000|NCT00806416|7153775|FG001|NOT COMPLETED|Period 1 - Part II||0
6255001|NCT00806416|7153776|FG002|NOT COMPLETED|Period 1 - Part II||0
6255002|NCT00806416|7153777|FG003|NOT COMPLETED|Period 1 - Part II||2
6255003|NCT00806416|7153774|FG000|STARTED|Period 2 - Part II||0
6255004|NCT00806416|7153775|FG001|STARTED|Period 2 - Part II||0
6255005|NCT00806416|7153776|FG002|STARTED|Period 2 - Part II||14
6255006|NCT00806416|7153777|FG003|STARTED|Period 2 - Part II||14
6255007|NCT00806416|7153774|FG000|COMPLETED|Period 2 - Part II||0
6255008|NCT00806416|7153775|FG001|COMPLETED|Period 2 - Part II||0
6255009|NCT00806416|7153776|FG002|COMPLETED|Period 2 - Part II||14
6255010|NCT00806416|7153777|FG003|COMPLETED|Period 2 - Part II||14
6255011|NCT00806416|7153774|FG000|NOT COMPLETED|Period 2 - Part II||0
6255012|NCT00806416|7153775|FG001|NOT COMPLETED|Period 2 - Part II||0
6255013|NCT00806416|7153776|FG002|NOT COMPLETED|Period 2 - Part II||0
6255014|NCT00806416|7153777|FG003|NOT COMPLETED|Period 2 - Part II||0
6255015|NCT00729651|7153787|FG000|STARTED|Overall Study||173
6255016|NCT00729651|7153788|FG001|STARTED|Overall Study||170
6255017|NCT00729651|7153787|FG000|COMPLETED|Overall Study||154
6255018|NCT00729651|7153788|FG001|COMPLETED|Overall Study||152
6255019|NCT00729651|7153787|FG000|NOT COMPLETED|Overall Study||19
6255020|NCT00729651|7153788|FG001|NOT COMPLETED|Overall Study||18
6255021|NCT00698815|7153797|FG000|STARTED|Overall Study||42
6255022|NCT00698815|7153798|FG001|STARTED|Overall Study||47
6255023|NCT00698815|7153799|FG002|STARTED|Overall Study||41
6255024|NCT00698815|7153797|FG000|COMPLETED|Overall Study||32
6255025|NCT00698815|7153798|FG001|COMPLETED|Overall Study||33
6255026|NCT00698815|7153799|FG002|COMPLETED|Overall Study||31
6255027|NCT00698815|7153797|FG000|NOT COMPLETED|Overall Study||10
6255028|NCT00698815|7153798|FG001|NOT COMPLETED|Overall Study||14
6255029|NCT00698815|7153799|FG002|NOT COMPLETED|Overall Study||10
6255030|NCT00698022|7153810|FG000|STARTED|Overall Study||30
6255031|NCT00698022|7153811|FG001|STARTED|Overall Study||30
6255032|NCT00698022|7153812|FG002|STARTED|Overall Study||16
6255033|NCT00698022|7153810|FG000|COMPLETED|Overall Study||14
6255034|NCT00698022|7153811|FG001|COMPLETED|Overall Study||20
6255035|NCT00698022|7153812|FG002|COMPLETED|Overall Study||14
6255036|NCT00698022|7153810|FG000|NOT COMPLETED|Overall Study||16
6255037|NCT00698022|7153811|FG001|NOT COMPLETED|Overall Study||10
6255038|NCT00698022|7153812|FG002|NOT COMPLETED|Overall Study||2
6255039|NCT00692913|7153822|FG000|STARTED|Overall Study||257
6255040|NCT00692913|7153823|FG001|STARTED|Overall Study||258
6255041|NCT00692913|7153822|FG000|COMPLETED|Overall Study||228
6255042|NCT00692913|7153823|FG001|COMPLETED|Overall Study||228
6255043|NCT00692913|7153822|FG000|NOT COMPLETED|Overall Study||29
6255044|NCT00692913|7153823|FG001|NOT COMPLETED|Overall Study||30
6255045|NCT00617994|7153834|FG000|STARTED|Overall Study||5
6509675|NCT01475643|7429067|FG000|NOT COMPLETED|Overall Study||14
6509676|NCT01475643|7429068|FG001|NOT COMPLETED|Overall Study||10
6509677|NCT01475721|7429076|FG000|STARTED|Overall Study||5834
6509678|NCT01475721|7429077|FG001|STARTED|Overall Study||5845
6509679|NCT01475721|7429076|FG000|COMPLETED|Overall Study||5823
6509680|NCT01475721|7429077|FG001|COMPLETED|Overall Study||5831
6509681|NCT01475721|7429076|FG000|NOT COMPLETED|Overall Study||11
6509682|NCT01475721|7429077|FG001|NOT COMPLETED|Overall Study||14
6509683|NCT01475734|7429085|FG000|STARTED|Overall Study||22
6509684|NCT01475734|7429086|FG001|STARTED|Overall Study||22
6509685|NCT01475734|7429085|FG000|COMPLETED|Overall Study||20
6509686|NCT01475734|7429086|FG001|COMPLETED|Overall Study||21
6509687|NCT01475734|7429085|FG000|NOT COMPLETED|Overall Study||2
6509688|NCT01475734|7429086|FG001|NOT COMPLETED|Overall Study||1
6509689|NCT01475825|7429096|FG000|STARTED|Overall Study||104
6509690|NCT01475825|7429097|FG001|STARTED|Overall Study||51
6509691|NCT01475825|7429098|FG002|STARTED|Overall Study||102
6509692|NCT01475825|7429099|FG003|STARTED|Overall Study||52
6509693|NCT01475825|7429096|FG000|Randomized and Treated|Overall Study||104
6509694|NCT01475825|7429097|FG001|Randomized and Treated|Overall Study||51
6509695|NCT01475825|7429098|FG002|Randomized and Treated|Overall Study||102
6509696|NCT01475825|7429099|FG003|Randomized and Treated|Overall Study||52
6509697|NCT01475825|7429096|FG000|Completed Blinded Treatment Period|Overall Study||60
6509698|NCT01475825|7429097|FG001|Completed Blinded Treatment Period|Overall Study||42
6509699|NCT01475825|7429098|FG002|Completed Blinded Treatment Period|Overall Study||59
6509700|NCT01475825|7429099|FG003|Completed Blinded Treatment Period|Overall Study||40
6509701|NCT01475825|7429096|FG000|Entered Open-Label Continuation|Overall Study||45
6509702|NCT01475825|7429097|FG001|Entered Open-Label Continuation|Overall Study||31
6509703|NCT01475825|7429098|FG002|Entered Open-Label Continuation|Overall Study||44
6509704|NCT01475825|7429099|FG003|Entered Open-Label Continuation|Overall Study||29
6509705|NCT01475825|7429096|FG000|Completed Open-Label Continuation|Overall Study||37
6509706|NCT01475825|7429097|FG001|Completed Open-Label Continuation|Overall Study||19
6509707|NCT01475825|7429098|FG002|Completed Open-Label Continuation|Overall Study||38
6509708|NCT01475825|7429099|FG003|Completed Open-Label Continuation|Overall Study||22
6509709|NCT01475825|7429096|FG000|COMPLETED|Overall Study||37
6509710|NCT01475825|7429097|FG001|COMPLETED|Overall Study||19
6509711|NCT01475825|7429098|FG002|COMPLETED|Overall Study||38
6509712|NCT01475825|7429099|FG003|COMPLETED|Overall Study||22
6255046|NCT00617994|7153835|FG001|STARTED|Overall Study||5
6255047|NCT00617994|7153836|FG002|STARTED|Overall Study||5
6255048|NCT00617994|7153837|FG003|STARTED|Overall Study||5
6255049|NCT00617994|7153838|FG004|STARTED|Overall Study||5
6255050|NCT00617994|7153834|FG000|COMPLETED|Overall Study||5
6255051|NCT00617994|7153835|FG001|COMPLETED|Overall Study||5
6255052|NCT00617994|7153836|FG002|COMPLETED|Overall Study||5
6255053|NCT00617994|7153837|FG003|COMPLETED|Overall Study||5
6255054|NCT00617994|7153838|FG004|COMPLETED|Overall Study||5
6255055|NCT00617994|7153834|FG000|NOT COMPLETED|Overall Study||0
6509713|NCT01475825|7429096|FG000|NOT COMPLETED|Overall Study||67
6509714|NCT01475825|7429097|FG001|NOT COMPLETED|Overall Study||32
6509715|NCT01475825|7429098|FG002|NOT COMPLETED|Overall Study||64
6509716|NCT01475825|7429099|FG003|NOT COMPLETED|Overall Study||30
6509717|NCT01475838|7429111|FG000|STARTED|Randomized Phase||293
6509718|NCT01475838|7429112|FG001|STARTED|Randomized Phase||145
6509719|NCT01475838|7429111|FG000|COMPLETED|Randomized Phase||263
6255056|NCT00617994|7153835|FG001|NOT COMPLETED|Overall Study||0
6255057|NCT00617994|7153836|FG002|NOT COMPLETED|Overall Study||0
6255058|NCT00617994|7153837|FG003|NOT COMPLETED|Overall Study||0
6255059|NCT00617994|7153838|FG004|NOT COMPLETED|Overall Study||0
6255060|NCT00617708|7153869|FG000|STARTED|Overall Study||10
6255061|NCT00617708|7153870|FG001|STARTED|Overall Study||60
6255062|NCT00617708|7153871|FG002|STARTED|Overall Study||64
6255063|NCT00617708|7153869|FG000|Eligible and Began Protocol Therapy|Overall Study||9
6255064|NCT00617708|7153870|FG001|Eligible and Began Protocol Therapy|Overall Study||57
6255065|NCT00617708|7153871|FG002|Eligible and Began Protocol Therapy|Overall Study||59
6255066|NCT00617708|7153869|FG000|COMPLETED|Overall Study||0
6255067|NCT00617708|7153870|FG001|COMPLETED|Overall Study||0
6255068|NCT00617708|7153871|FG002|COMPLETED|Overall Study||0
6255069|NCT00617708|7153869|FG000|NOT COMPLETED|Overall Study||10
6255070|NCT00617708|7153870|FG001|NOT COMPLETED|Overall Study||60
6255071|NCT00617708|7153871|FG002|NOT COMPLETED|Overall Study||64
6255072|NCT00516737|7153883|FG000|STARTED|Overall Study||103
6255073|NCT00516737|7153884|FG001|STARTED|Overall Study||104
6255074|NCT00516737|7153883|FG000|COMPLETED|Overall Study||92
6255075|NCT00516737|7153884|FG001|COMPLETED|Overall Study||96
6255076|NCT00516737|7153883|FG000|NOT COMPLETED|Overall Study||11
6255077|NCT00516737|7153884|FG001|NOT COMPLETED|Overall Study||8
6255078|NCT00358527|7153892|FG000|STARTED|Overall Study||267
6255079|NCT00358527|7153893|FG001|STARTED|Overall Study||134
6255080|NCT00358527|7153892|FG000|COMPLETED|Overall Study||254
6255081|NCT00358527|7153893|FG001|COMPLETED|Overall Study||131
6255082|NCT00358527|7153892|FG000|NOT COMPLETED|Overall Study||13
6255083|NCT00358527|7153893|FG001|NOT COMPLETED|Overall Study||3
6255084|NCT00326898|7153902|FG000|STARTED|Overall Study||647
6255085|NCT00326898|7153903|FG001|STARTED|Overall Study||649
6255086|NCT00326898|7153904|FG002|STARTED|Overall Study||647
6255087|NCT00326898|7153902|FG000|Patients With Toxicity Data|Overall Study||625
6255088|NCT00326898|7153903|FG001|Patients With Toxicity Data|Overall Study||628
6255089|NCT00326898|7153904|FG002|Patients With Toxicity Data|Overall Study||626
6255090|NCT00326898|7153902|FG000|Patients With Clear Cell Histology|Overall Study||542
6255091|NCT00326898|7153903|FG001|Patients With Clear Cell Histology|Overall Study||540
6255092|NCT00326898|7153904|FG002|Patients With Clear Cell Histology|Overall Study||540
6255093|NCT00326898|7153902|FG000|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
6255094|NCT00326898|7153903|FG001|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
6255095|NCT00326898|7153904|FG002|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
6255096|NCT00326898|7153902|FG000|COMPLETED|Overall Study||296
6255097|NCT00326898|7153903|FG001|COMPLETED|Overall Study||306
6255098|NCT00326898|7153904|FG002|COMPLETED|Overall Study||444
6255099|NCT00326898|7153902|FG000|NOT COMPLETED|Overall Study||351
6255100|NCT00326898|7153903|FG001|NOT COMPLETED|Overall Study||343
6255101|NCT00326898|7153904|FG002|NOT COMPLETED|Overall Study||203
6255102|NCT00156065|7153915|FG000|STARTED|Overall Study||51
6255103|NCT00156065|7153916|FG001|STARTED|Overall Study||93
6255104|NCT00156065|7153917|FG002|STARTED|Overall Study||43
6255105|NCT00156065|7153915|FG000|COMPLETED|Overall Study||20
6255106|NCT00156065|7153916|FG001|COMPLETED|Overall Study||30
6255107|NCT00156065|7153917|FG002|COMPLETED|Overall Study||16
6255108|NCT00156065|7153915|FG000|NOT COMPLETED|Overall Study||31
6255109|NCT00156065|7153916|FG001|NOT COMPLETED|Overall Study||63
6255110|NCT00156065|7153917|FG002|NOT COMPLETED|Overall Study||27
6255111|NCT00150176|7153927|FG000|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
6255112|NCT00150176|7153928|FG001|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
6255113|NCT00150176|7153927|FG000|COMPLETED|Overall Study||135
6255114|NCT00150176|7153928|FG001|COMPLETED|Overall Study||72
6255115|NCT00150176|7153927|FG000|NOT COMPLETED|Overall Study||59
6255116|NCT00150176|7153928|FG001|NOT COMPLETED|Overall Study||120
6255117|NCT00145509|7153937|FG000|STARTED|Overall Study||41
6255118|NCT00145509|7153938|FG001|STARTED|Overall Study||36
6255119|NCT00145509|7153937|FG000|COMPLETED|Overall Study||19
6255120|NCT00145509|7153938|FG001|COMPLETED|Overall Study||15
6255121|NCT00145509|7153937|FG000|NOT COMPLETED|Overall Study||22
6255122|NCT00145509|7153938|FG001|NOT COMPLETED|Overall Study||21
6255123|NCT00145496|7153946|FG000|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
6255124|NCT00145496|7153947|FG001|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
6509720|NCT01475838|7429112|FG001|COMPLETED|Randomized Phase||109
6509721|NCT01475838|7429111|FG000|NOT COMPLETED|Randomized Phase||30
6509722|NCT01475838|7429112|FG001|NOT COMPLETED|Randomized Phase||36
6509723|NCT01475838|7429111|FG000|STARTED|Extension Phase||42
6509724|NCT01475838|7429112|FG001|STARTED|Extension Phase||20
6509725|NCT01475838|7429111|FG000|COMPLETED|Extension Phase||41
6509726|NCT01475838|7429112|FG001|COMPLETED|Extension Phase||20
6509727|NCT01475838|7429111|FG000|NOT COMPLETED|Extension Phase||1
6509728|NCT01475838|7429112|FG001|NOT COMPLETED|Extension Phase||0
6509729|NCT01475851|7429121|FG000|STARTED|Overall Study||13
6255125|NCT00145496|7153946|FG000|COMPLETED|Overall Study||121
6255126|NCT00145496|7153947|FG001|COMPLETED|Overall Study||143
6509730|NCT01475851|7429122|FG001|STARTED|Overall Study||21
6509731|NCT01475851|7429121|FG000|COMPLETED|Overall Study||12
6509732|NCT01475851|7429122|FG001|COMPLETED|Overall Study||21
6509733|NCT01475851|7429121|FG000|NOT COMPLETED|Overall Study||1
6509734|NCT01475851|7429122|FG001|NOT COMPLETED|Overall Study||0
6255127|NCT00145496|7153946|FG000|NOT COMPLETED|Overall Study||123
6255128|NCT00145496|7153947|FG001|NOT COMPLETED|Overall Study||81
6255129|NCT00145470|7153955|FG000|STARTED|Overall Study||167
6255130|NCT00145470|7153956|FG001|STARTED|Overall Study||159
6255131|NCT00145470|7153955|FG000|Treated|Overall Study||166
6255132|NCT00145470|7153956|FG001|Treated|Overall Study||158
6255133|NCT00145470|7153955|FG000|COMPLETED|Overall Study||55
6255134|NCT00145470|7153956|FG001|COMPLETED|Overall Study||61
6255135|NCT00145470|7153955|FG000|NOT COMPLETED|Overall Study||112
6255136|NCT00145470|7153956|FG001|NOT COMPLETED|Overall Study||98
6255137|NCT00129402|7153964|FG000|STARTED|Start Period1 to End Period1 (Week 1-6)||43
6255138|NCT00129402|7153965|FG001|STARTED|Start Period1 to End Period1 (Week 1-6)||40
6255139|NCT00129402|7153966|FG002|STARTED|Start Period1 to End Period1 (Week 1-6)||43
6255140|NCT00129402|7153967|FG003|STARTED|Start Period1 to End Period1 (Week 1-6)||40
6255141|NCT00129402|7153968|FG004|STARTED|Start Period1 to End Period1 (Week 1-6)||40
6255142|NCT00129402|7153969|FG005|STARTED|Start Period1 to End Period1 (Week 1-6)||42
6255143|NCT00129402|7153970|FG006|STARTED|Start Period1 to End Period1 (Week 1-6)||0
6255144|NCT00129402|7153964|FG000|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
6255145|NCT00129402|7153965|FG001|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
6255146|NCT00129402|7153966|FG002|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
6255147|NCT00129402|7153967|FG003|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
6255148|NCT00129402|7153968|FG004|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
6255149|NCT00129402|7153969|FG005|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
6255150|NCT00129402|7153970|FG006|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
6255151|NCT00129402|7153964|FG000|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
6255152|NCT00129402|7153965|FG001|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
6255153|NCT00129402|7153966|FG002|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
6255154|NCT00129402|7153967|FG003|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
6255155|NCT00129402|7153968|FG004|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
6255156|NCT00129402|7153969|FG005|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
6255157|NCT00129402|7153970|FG006|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
6255158|NCT00129402|7153964|FG000|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6255159|NCT00129402|7153965|FG001|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6255160|NCT00129402|7153966|FG002|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
6255161|NCT00129402|7153967|FG003|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6255162|NCT00129402|7153968|FG004|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6255163|NCT00129402|7153969|FG005|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
6255164|NCT00129402|7153970|FG006|STARTED|Start Period2 to End Period2 (Week 7-33)||0
6255165|NCT00129402|7153964|FG000|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255166|NCT00129402|7153965|FG001|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255167|NCT00129402|7153966|FG002|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
6255168|NCT00129402|7153967|FG003|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255169|NCT00129402|7153968|FG004|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255170|NCT00129402|7153969|FG005|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
6255171|NCT00129402|7153970|FG006|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255172|NCT00129402|7153964|FG000|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255173|NCT00129402|7153965|FG001|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255174|NCT00129402|7153966|FG002|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
6255175|NCT00129402|7153967|FG003|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255176|NCT00129402|7153968|FG004|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255177|NCT00129402|7153969|FG005|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
6255178|NCT00129402|7153970|FG006|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
6255179|NCT00129402|7153964|FG000|STARTED|Start Period3 to End Period3(Week 34-53)||0
6255180|NCT00129402|7153965|FG001|STARTED|Start Period3 to End Period3(Week 34-53)||0
6255181|NCT00129402|7153966|FG002|STARTED|Start Period3 to End Period3(Week 34-53)||0
6255182|NCT00129402|7153967|FG003|STARTED|Start Period3 to End Period3(Week 34-53)||0
6255183|NCT00129402|7153968|FG004|STARTED|Start Period3 to End Period3(Week 34-53)||0
6255184|NCT00129402|7153969|FG005|STARTED|Start Period3 to End Period3(Week 34-53)||0
6255185|NCT00129402|7153970|FG006|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
6255186|NCT00129402|7153964|FG000|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255187|NCT00129402|7153965|FG001|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255188|NCT00129402|7153966|FG002|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255189|NCT00129402|7153967|FG003|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255190|NCT00129402|7153968|FG004|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255191|NCT00129402|7153969|FG005|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255192|NCT00129402|7153970|FG006|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
6255193|NCT00129402|7153964|FG000|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255194|NCT00129402|7153965|FG001|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6281025|NCT00160680|7180890|FG001|NOT COMPLETED|Overall Study||13
6255195|NCT00129402|7153966|FG002|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255196|NCT00129402|7153967|FG003|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255197|NCT00129402|7153968|FG004|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255198|NCT00129402|7153969|FG005|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
6255199|NCT00129402|7153970|FG006|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
6255200|NCT00101439|7153980|FG000|STARTED|Period 1||28
6255201|NCT00101439|7153981|FG001|STARTED|Period 1||30
6255202|NCT00101439|7153980|FG000|COMPLETED|Period 1||28
6255203|NCT00101439|7153981|FG001|COMPLETED|Period 1||30
6255204|NCT00101439|7153980|FG000|NOT COMPLETED|Period 1||0
6255205|NCT00101439|7153981|FG001|NOT COMPLETED|Period 1||0
6255206|NCT00101439|7153980|FG000|STARTED|Period 2||28
6255207|NCT00101439|7153981|FG001|STARTED|Period 2||30
6255208|NCT00101439|7153980|FG000|COMPLETED|Period 2||28
6255209|NCT00101439|7153981|FG001|COMPLETED|Period 2||28
6255210|NCT00101439|7153980|FG000|NOT COMPLETED|Period 2||0
6255211|NCT00101439|7153981|FG001|NOT COMPLETED|Period 2||2
6255212|NCT00096200|7153990|FG000|STARTED|Overall Study||9
6255213|NCT00096200|7153991|FG001|STARTED|Overall Study||30
6255214|NCT00096200|7153992|FG002|STARTED|Overall Study||5
6255215|NCT00096200|7153990|FG000|COMPLETED|Overall Study||8
6255216|NCT00096200|7153991|FG001|COMPLETED|Overall Study||23
6255217|NCT00096200|7153992|FG002|COMPLETED|Overall Study||5
6255218|NCT00096200|7153990|FG000|NOT COMPLETED|Overall Study||1
6255219|NCT00096200|7153991|FG001|NOT COMPLETED|Overall Study||7
6255220|NCT00096200|7153992|FG002|NOT COMPLETED|Overall Study||0
6278806|NCT00137631|7178450|FG000|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
6278807|NCT00137631|7178451|FG001|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
6278808|NCT00137631|7178450|FG000|COMPLETED|Overall Study||127
6278809|NCT00137631|7178451|FG001|COMPLETED|Overall Study||133
6278810|NCT00137631|7178450|FG000|NOT COMPLETED|Overall Study||37
6278811|NCT00137631|7178451|FG001|NOT COMPLETED|Overall Study||41
6278812|NCT00137839|7178457|FG000|STARTED|Overall Study||84
6278813|NCT00137839|7178457|FG000|Treated|Overall Study||83
6278814|NCT00137839|7178457|FG000|COMPLETED|Overall Study|Data on Reason Not Completed reflects Reason Off-Study|0
6278815|NCT00137839|7178457|FG000|NOT COMPLETED|Overall Study||84
6278816|NCT00137969|7178466|FG000|STARTED|Overall Study||174
6278817|NCT00137969|7178467|FG001|STARTED|Overall Study||88
6278818|NCT00137969|7178466|FG000|Received Study Drug|Overall Study||169
6278819|NCT00137969|7178467|FG001|Received Study Drug|Overall Study||88
6278820|NCT00137969|7178466|FG000|COMPLETED|Overall Study||107
6278821|NCT00137969|7178467|FG001|COMPLETED|Overall Study||67
6278822|NCT00137969|7178466|FG000|NOT COMPLETED|Overall Study||67
6509735|NCT01475955|7429133|FG000|STARTED|Overall Study||48
6509736|NCT01475955|7429134|FG001|STARTED|Overall Study||48
6509737|NCT01475955|7429135|FG002|STARTED|Overall Study||47
6509738|NCT01475955|7429136|FG003|STARTED|Overall Study||46
6509739|NCT01475955|7429137|FG004|STARTED|Overall Study||46
6509740|NCT01475955|7429133|FG000|COMPLETED|Overall Study||47
6509741|NCT01475955|7429134|FG001|COMPLETED|Overall Study||48
6509742|NCT01475955|7429135|FG002|COMPLETED|Overall Study||44
6509743|NCT01475955|7429136|FG003|COMPLETED|Overall Study||46
6509744|NCT01475955|7429137|FG004|COMPLETED|Overall Study||46
6509745|NCT01475955|7429133|FG000|NOT COMPLETED|Overall Study||1
6509746|NCT01475955|7429134|FG001|NOT COMPLETED|Overall Study||0
6509747|NCT01475955|7429135|FG002|NOT COMPLETED|Overall Study||3
6509748|NCT01475955|7429136|FG003|NOT COMPLETED|Overall Study||0
6509749|NCT01475955|7429137|FG004|NOT COMPLETED|Overall Study||0
6509750|NCT01476202|7429171|FG000|STARTED|Overall Study||40
6509751|NCT01476202|7429172|FG001|STARTED|Overall Study||40
6509752|NCT01476202|7429173|FG002|STARTED|Overall Study||40
6509753|NCT01476202|7429171|FG000|COMPLETED|Overall Study||40
6509754|NCT01476202|7429172|FG001|COMPLETED|Overall Study||40
6509755|NCT01476202|7429173|FG002|COMPLETED|Overall Study||40
6509756|NCT01476202|7429171|FG000|NOT COMPLETED|Overall Study||0
6509757|NCT01476202|7429172|FG001|NOT COMPLETED|Overall Study||0
6509758|NCT01476202|7429173|FG002|NOT COMPLETED|Overall Study||0
6509759|NCT01476267|7429184|FG000|STARTED|Overall Study||6
6509760|NCT01476267|7429184|FG000|COMPLETED|Overall Study||6
6509761|NCT01476267|7429184|FG000|NOT COMPLETED|Overall Study||0
6509762|NCT01476345|7429188|FG000|STARTED|Period 1||40
6509763|NCT01476345|7429189|FG001|STARTED|Period 1||40
6509764|NCT01476345|7429188|FG000|Received at Least 1 Dose of Study Drug|Period 1||40
6509765|NCT01476345|7429189|FG001|Received at Least 1 Dose of Study Drug|Period 1||40
6509766|NCT01476345|7429188|FG000|COMPLETED|Period 1||40
6509767|NCT01476345|7429189|FG001|COMPLETED|Period 1||40
6278823|NCT00137969|7178467|FG001|NOT COMPLETED|Overall Study||21
6278824|NCT00138034|7178475|FG000|STARTED|Overall Study||26
6278825|NCT00138034|7178476|FG001|STARTED|Overall Study||23
6278826|NCT00138034|7178475|FG000|COMPLETED|Overall Study||23
6509768|NCT01476345|7429188|FG000|NOT COMPLETED|Period 1||0
6509769|NCT01476345|7429189|FG001|NOT COMPLETED|Period 1||0
6509770|NCT01476345|7429188|FG000|STARTED|Period 2||40
6509771|NCT01476345|7429189|FG001|STARTED|Period 2||40
6509772|NCT01476345|7429188|FG000|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
6509773|NCT01476345|7429189|FG001|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
6509774|NCT01476345|7429188|FG000|NOT COMPLETED|Period 2||0
6509775|NCT01476345|7429189|FG001|NOT COMPLETED|Period 2||0
6509776|NCT01476345|7429188|FG000|STARTED|Period 3||39
6255221|NCT03257267|7154002|FG000|STARTED|Overall Study||304
6255222|NCT03257267|7154003|FG001|STARTED|Overall Study||304
6255223|NCT03257267|7154002|FG000|Full Analysis Set (FAS)|Overall Study||304
6255224|NCT03257267|7154003|FG001|Full Analysis Set (FAS)|Overall Study||304
6255225|NCT03257267|7154002|FG000|Safety Analysis Set (SAF)|Overall Study||300
6255226|NCT03257267|7154003|FG001|Safety Analysis Set (SAF)|Overall Study||290
6255227|NCT03257267|7154002|FG000|Completed Treatment|Overall Study||13
6255228|NCT03257267|7154003|FG001|Completed Treatment|Overall Study||0
6255229|NCT03257267|7154002|FG000|COMPLETED|Overall Study||7
6255230|NCT03257267|7154003|FG001|COMPLETED|Overall Study||0
6255231|NCT03257267|7154002|FG000|NOT COMPLETED|Overall Study||297
6255232|NCT03257267|7154003|FG001|NOT COMPLETED|Overall Study||304
6255233|NCT04581811|7154011|FG000|STARTED|Overall Study||26
6255234|NCT04581811|7154012|FG001|STARTED|Overall Study||26
6509777|NCT01476345|7429189|FG001|STARTED|Period 3||39
6509778|NCT01476345|7429188|FG000|COMPLETED|Period 3||39
6509779|NCT01476345|7429189|FG001|COMPLETED|Period 3||39
6509780|NCT01476345|7429188|FG000|NOT COMPLETED|Period 3||0
6509781|NCT01476345|7429189|FG001|NOT COMPLETED|Period 3||0
6509782|NCT01476345|7429188|FG000|STARTED|Period 4||39
6509783|NCT01476345|7429189|FG001|STARTED|Period 4||39
6509784|NCT01476345|7429188|FG000|COMPLETED|Period 4||39
6509785|NCT01476345|7429189|FG001|COMPLETED|Period 4||39
6509786|NCT01476345|7429188|FG000|NOT COMPLETED|Period 4||0
6509787|NCT01476345|7429189|FG001|NOT COMPLETED|Period 4||0
6509788|NCT01476449|7429197|FG000|STARTED|Overall Study||10
6509789|NCT01476449|7429198|FG001|STARTED|Overall Study||10
6509790|NCT01476449|7429197|FG000|COMPLETED|Overall Study||8
6509791|NCT01476449|7429198|FG001|COMPLETED|Overall Study||8
6509792|NCT01476449|7429197|FG000|NOT COMPLETED|Overall Study||2
6509793|NCT01476449|7429198|FG001|NOT COMPLETED|Overall Study||2
6509794|NCT01476475|7429206|FG000|STARTED|Overall Study||161
6509795|NCT01476475|7429207|FG001|STARTED|Overall Study||162
6509796|NCT01476475|7429206|FG000|COMPLETED|Overall Study||150
6509797|NCT01476475|7429207|FG001|COMPLETED|Overall Study||159
6509798|NCT01476475|7429206|FG000|NOT COMPLETED|Overall Study||11
6509799|NCT01476475|7429207|FG001|NOT COMPLETED|Overall Study||3
6509800|NCT01476644|7429214|FG000|STARTED|Overall Study||161
6509801|NCT01476644|7429214|FG000|COMPLETED|Overall Study||122
6509802|NCT01476644|7429214|FG000|NOT COMPLETED|Overall Study||39
6509803|NCT01476696|7429219|FG000|STARTED|Overall Study||15
6509804|NCT01476696|7429220|FG001|STARTED|Overall Study||9
6509805|NCT01476696|7429221|FG002|STARTED|Overall Study||9
6509806|NCT01476696|7429219|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
6509807|NCT01476696|7429220|FG001|Received at Least 1 Dose of Study Drug|Overall Study||9
6509808|NCT01476696|7429221|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
6509809|NCT01476696|7429219|FG000|COMPLETED|Overall Study||12
6509810|NCT01476696|7429220|FG001|COMPLETED|Overall Study||8
6509811|NCT01476696|7429221|FG002|COMPLETED|Overall Study||9
6509812|NCT01476696|7429219|FG000|NOT COMPLETED|Overall Study||3
6509813|NCT01476696|7429220|FG001|NOT COMPLETED|Overall Study||1
6509814|NCT01476696|7429221|FG002|NOT COMPLETED|Overall Study||0
6509815|NCT01476722|7429234|FG000|STARTED|Overall Study||125
6509816|NCT01476722|7429234|FG000|COMPLETED|Overall Study||124
6509817|NCT01476722|7429234|FG000|NOT COMPLETED|Overall Study||1
6509818|NCT01476748|7429241|FG000|STARTED|Overall Study||5
6509819|NCT01476748|7429242|FG001|STARTED|Overall Study||5
6509820|NCT01476748|7429243|FG002|STARTED|Overall Study||5
6509821|NCT01476748|7429241|FG000|COMPLETED|Overall Study||5
6509822|NCT01476748|7429242|FG001|COMPLETED|Overall Study||5
6509823|NCT01476748|7429243|FG002|COMPLETED|Overall Study||5
6509824|NCT01476748|7429241|FG000|NOT COMPLETED|Overall Study||0
6509825|NCT01476748|7429242|FG001|NOT COMPLETED|Overall Study||0
6509826|NCT01476748|7429243|FG002|NOT COMPLETED|Overall Study||0
6509827|NCT01477320|7429253|FG000|STARTED|Overall Study||62
6509828|NCT01477320|7429254|FG001|STARTED|Overall Study||62
6509829|NCT01477320|7429253|FG000|COMPLETED|Overall Study||55
6509830|NCT01477320|7429254|FG001|COMPLETED|Overall Study||47
6509831|NCT01477320|7429253|FG000|NOT COMPLETED|Overall Study||7
6509832|NCT01477320|7429254|FG001|NOT COMPLETED|Overall Study||15
6509833|NCT01477333|7429260|FG000|STARTED|Overall Study||18
6509834|NCT01477333|7429260|FG000|COMPLETED|Overall Study||15
6509835|NCT01477333|7429260|FG000|NOT COMPLETED|Overall Study||3
6509836|NCT01477450|7429271|FG000|STARTED|Overall Study||10
6509837|NCT01477450|7429272|FG001|STARTED|Overall Study||10
6509838|NCT01477450|7429273|FG002|STARTED|Overall Study||10
6509839|NCT01477450|7429271|FG000|COMPLETED|Overall Study||10
6509840|NCT01477450|7429272|FG001|COMPLETED|Overall Study||10
6509841|NCT01477450|7429273|FG002|COMPLETED|Overall Study||10
6509842|NCT01477450|7429271|FG000|NOT COMPLETED|Overall Study||0
6509843|NCT01477450|7429272|FG001|NOT COMPLETED|Overall Study||0
6255235|NCT04581811|7154011|FG000|COMPLETED|Overall Study||26
6509844|NCT01477450|7429273|FG002|NOT COMPLETED|Overall Study||0
6509845|NCT01477463|7429283|FG000|STARTED|Overall Study||18
6509846|NCT01477463|7429284|FG001|STARTED|Overall Study||6
6255236|NCT04581811|7154012|FG001|COMPLETED|Overall Study||26
6509847|NCT01477463|7429283|FG000|COMPLETED|Overall Study||18
6509848|NCT01477463|7429284|FG001|COMPLETED|Overall Study||6
6509849|NCT01477463|7429283|FG000|NOT COMPLETED|Overall Study||0
6509850|NCT01477463|7429284|FG001|NOT COMPLETED|Overall Study||0
6509851|NCT01477567|7429299|FG000|STARTED|Overall Study||5
6509852|NCT01477567|7429300|FG001|STARTED|Overall Study||6
6509853|NCT01477567|7429301|FG002|STARTED|Overall Study||6
6255237|NCT04581811|7154011|FG000|NOT COMPLETED|Overall Study||0
6255238|NCT04581811|7154012|FG001|NOT COMPLETED|Overall Study||0
6278827|NCT00138034|7178476|FG001|COMPLETED|Overall Study||20
6278828|NCT00138034|7178475|FG000|NOT COMPLETED|Overall Study||3
6278829|NCT00138034|7178476|FG001|NOT COMPLETED|Overall Study||3
6278830|NCT00138125|7178482|FG000|STARTED|Overall Study||2
6278831|NCT00138125|7178482|FG000|COMPLETED|Overall Study||2
6278832|NCT00138125|7178482|FG000|NOT COMPLETED|Overall Study||0
6278833|NCT00138203|7178487|FG000|STARTED|Overall Study||16
6278834|NCT00138203|7178487|FG000|COMPLETED|Overall Study||16
6278835|NCT00138203|7178487|FG000|NOT COMPLETED|Overall Study||0
6278836|NCT00138294|7178492|FG000|STARTED|Overall Study||29255
6278837|NCT00138294|7178492|FG000|COMPLETED|Overall Study||29255
6278838|NCT00138294|7178492|FG000|NOT COMPLETED|Overall Study||0
6278839|NCT00138424|7178502|FG000|STARTED|Overall Study||9
6278840|NCT00138424|7178503|FG001|STARTED|Overall Study||5
6278841|NCT00138424|7178504|FG002|STARTED|Overall Study||5
6278842|NCT00138424|7178505|FG003|STARTED|Overall Study||3
6278843|NCT00138424|7178502|FG000|COMPLETED|Overall Study||9
6278844|NCT00138424|7178503|FG001|COMPLETED|Overall Study||4
6278845|NCT00138424|7178504|FG002|COMPLETED|Overall Study||5
6278846|NCT00138424|7178505|FG003|COMPLETED|Overall Study||3
6278847|NCT00138424|7178502|FG000|NOT COMPLETED|Overall Study||0
6278848|NCT00138424|7178503|FG001|NOT COMPLETED|Overall Study||1
6278849|NCT00138424|7178504|FG002|NOT COMPLETED|Overall Study||0
6278850|NCT00138424|7178505|FG003|NOT COMPLETED|Overall Study||0
6278851|NCT00138645|7178519|FG000|STARTED|Overall Study||30
6278852|NCT00138645|7178520|FG001|STARTED|Overall Study||30
6278853|NCT00138645|7178519|FG000|COMPLETED|Overall Study||24
6278854|NCT00138645|7178520|FG001|COMPLETED|Overall Study||23
6278855|NCT00138645|7178519|FG000|NOT COMPLETED|Overall Study||6
6278856|NCT00138645|7178520|FG001|NOT COMPLETED|Overall Study||7
6278857|NCT00138658|7178526|FG000|STARTED|Overall Study||81
6278858|NCT00138658|7178526|FG000|COMPLETED|Overall Study||20
6278859|NCT00138658|7178526|FG000|NOT COMPLETED|Overall Study||61
6278860|NCT00138671|7178534|FG000|STARTED|Overall Study||59
6278861|NCT00138671|7178535|FG001|STARTED|Overall Study||46
6278862|NCT00138671|7178534|FG000|COMPLETED|Overall Study||46
6278863|NCT00138671|7178535|FG001|COMPLETED|Overall Study||30
6278864|NCT00138671|7178534|FG000|NOT COMPLETED|Overall Study||13
6278865|NCT00138671|7178535|FG001|NOT COMPLETED|Overall Study||16
6278866|NCT00139399|7178545|FG000|STARTED|Overall Study||60
6278867|NCT00139399|7178546|FG001|STARTED|Overall Study||82
6278868|NCT00139399|7178545|FG000|COMPLETED|Overall Study||44
6278869|NCT00139399|7178546|FG001|COMPLETED|Overall Study||59
6278870|NCT00139399|7178545|FG000|NOT COMPLETED|Overall Study||16
6278871|NCT00139399|7178546|FG001|NOT COMPLETED|Overall Study||23
6278872|NCT00139477|7178554|FG000|STARTED|First Intervention -Baseline to 6Months||31
6278873|NCT00139477|7178555|FG001|STARTED|First Intervention -Baseline to 6Months||35
6278874|NCT00139477|7178554|FG000|COMPLETED|First Intervention -Baseline to 6Months||19
6278875|NCT00139477|7178555|FG001|COMPLETED|First Intervention -Baseline to 6Months||23
6278876|NCT00139477|7178554|FG000|NOT COMPLETED|First Intervention -Baseline to 6Months||12
6278877|NCT00139477|7178555|FG001|NOT COMPLETED|First Intervention -Baseline to 6Months||12
6278878|NCT00139477|7178554|FG000|STARTED|Second Intervention -6Months to 12Months||19
6278879|NCT00139477|7178555|FG001|STARTED|Second Intervention -6Months to 12Months||23
6278880|NCT00139477|7178554|FG000|COMPLETED|Second Intervention -6Months to 12Months||14
6278881|NCT00139477|7178555|FG001|COMPLETED|Second Intervention -6Months to 12Months||18
6278882|NCT00139477|7178554|FG000|NOT COMPLETED|Second Intervention -6Months to 12Months||5
6278883|NCT00139477|7178555|FG001|NOT COMPLETED|Second Intervention -6Months to 12Months||5
6278884|NCT00139659|7178565|FG000|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
6278885|NCT00139659|7178566|FG001|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
6278886|NCT00139659|7178565|FG000|COMPLETED|Overall Study||106
6278887|NCT00139659|7178566|FG001|COMPLETED|Overall Study||123
6278888|NCT00139659|7178565|FG000|NOT COMPLETED|Overall Study||40
6278889|NCT00139659|7178566|FG001|NOT COMPLETED|Overall Study||18
6278890|NCT00139737|7178576|FG000|STARTED|Overall Study||344
6278891|NCT00139737|7178576|FG000|Received Treatment|Overall Study||331
6278892|NCT00139737|7178576|FG000|COMPLETED|Overall Study||3
6278893|NCT00139737|7178576|FG000|NOT COMPLETED|Overall Study||341
6278894|NCT00139776|7178582|FG000|STARTED|Period I||1772
6255239|NCT04456959|7154018|FG000|STARTED|Overall Study||28
6255240|NCT04456959|7154018|FG000|COMPLETED|Overall Study||28
6255241|NCT04456959|7154018|FG000|NOT COMPLETED|Overall Study||0
6255242|NCT04263987|7154024|FG000|STARTED|Overall Study||30
6255243|NCT04263987|7154025|FG001|STARTED|Overall Study||30
6255244|NCT04263987|7154024|FG000|COMPLETED|Overall Study||30
6255245|NCT04263987|7154025|FG001|COMPLETED|Overall Study||30
6255246|NCT04263987|7154024|FG000|NOT COMPLETED|Overall Study||0
6255247|NCT04263987|7154025|FG001|NOT COMPLETED|Overall Study||0
6255248|NCT04223830|7154031|FG000|STARTED|Overall Study||200
6255249|NCT04223830|7154031|FG000|COMPLETED|Overall Study||190
6255250|NCT04223830|7154031|FG000|NOT COMPLETED|Overall Study||10
6255302|NCT03990766|7154106|FG000|STARTED|Overall Study||14
6255303|NCT03990766|7154107|FG001|STARTED|Overall Study||13
6255304|NCT03990766|7154106|FG000|COMPLETED|Overall Study||12
6255305|NCT03990766|7154107|FG001|COMPLETED|Overall Study||10
6255306|NCT03990766|7154106|FG000|NOT COMPLETED|Overall Study||2
6255307|NCT03990766|7154107|FG001|NOT COMPLETED|Overall Study||3
6255308|NCT03947333|7154115|FG000|STARTED|Overall Study||135
6255309|NCT03947333|7154116|FG001|STARTED|Overall Study||135
6255310|NCT03947333|7154115|FG000|COMPLETED|Overall Study||135
6255311|NCT03947333|7154116|FG001|COMPLETED|Overall Study||135
6255312|NCT03947333|7154115|FG000|NOT COMPLETED|Overall Study||0
6255313|NCT03947333|7154116|FG001|NOT COMPLETED|Overall Study||0
6255314|NCT03886220|7154125|FG000|STARTED|Treatment Period||28
6255315|NCT03886220|7154126|FG001|STARTED|Treatment Period||54
6255316|NCT03886220|7154125|FG000|COMPLETED|Treatment Period||23
6255317|NCT03886220|7154126|FG001|COMPLETED|Treatment Period||42
6255318|NCT03886220|7154125|FG000|NOT COMPLETED|Treatment Period||5
6255319|NCT03886220|7154126|FG001|NOT COMPLETED|Treatment Period||12
6255320|NCT03886220|7154125|FG000|STARTED|Post-Treatment Follow-Up Period||25
6255321|NCT03886220|7154126|FG001|STARTED|Post-Treatment Follow-Up Period||41
6509854|NCT01477567|7429302|FG003|STARTED|Overall Study||6
6509855|NCT01477567|7429303|FG004|STARTED|Overall Study||6
6509856|NCT01477567|7429304|FG005|STARTED|Overall Study||5
6509857|NCT01477567|7429305|FG006|STARTED|Overall Study||6
6509858|NCT01477567|7429299|FG000|Received at Least 1 Dose of Study Drug|Overall Study||5
6509859|NCT01477567|7429300|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6509860|NCT01477567|7429301|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6509861|NCT01477567|7429302|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6509862|NCT01477567|7429303|FG004|Received at Least 1 Dose of Study Drug|Overall Study||6
6509863|NCT01477567|7429304|FG005|Received at Least 1 Dose of Study Drug|Overall Study||5
6509864|NCT01477567|7429305|FG006|Received at Least 1 Dose of Study Drug|Overall Study||6
6509865|NCT01477567|7429299|FG000|COMPLETED|Overall Study||5
6509866|NCT01477567|7429300|FG001|COMPLETED|Overall Study||6
6509867|NCT01477567|7429301|FG002|COMPLETED|Overall Study||6
6509868|NCT01477567|7429302|FG003|COMPLETED|Overall Study||6
6509869|NCT01477567|7429303|FG004|COMPLETED|Overall Study||6
6509870|NCT01477567|7429304|FG005|COMPLETED|Overall Study||5
6509871|NCT01477567|7429305|FG006|COMPLETED|Overall Study||6
6509872|NCT01477567|7429299|FG000|NOT COMPLETED|Overall Study||0
6509873|NCT01477567|7429300|FG001|NOT COMPLETED|Overall Study||0
6509874|NCT01477567|7429301|FG002|NOT COMPLETED|Overall Study||0
6509875|NCT01477567|7429302|FG003|NOT COMPLETED|Overall Study||0
6509876|NCT01477567|7429303|FG004|NOT COMPLETED|Overall Study||0
6509877|NCT01477567|7429304|FG005|NOT COMPLETED|Overall Study||0
6509878|NCT01477567|7429305|FG006|NOT COMPLETED|Overall Study||0
6509879|NCT01477710|7429326|FG000|STARTED|Overall Study||30
6509880|NCT01477710|7429326|FG000|COMPLETED|Overall Study||30
6509881|NCT01477710|7429326|FG000|NOT COMPLETED|Overall Study||0
6255322|NCT03886220|7154125|FG000|COMPLETED|Post-Treatment Follow-Up Period||23
6255323|NCT03886220|7154126|FG001|COMPLETED|Post-Treatment Follow-Up Period||39
6255324|NCT03886220|7154125|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||2
6255325|NCT03886220|7154126|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||2
6255326|NCT03800979|7154132|FG000|STARTED|Overall Study||19
6255327|NCT03800979|7154132|FG000|COMPLETED|Overall Study||19
6255328|NCT03800979|7154132|FG000|NOT COMPLETED|Overall Study||0
6255329|NCT03794661|7154136|FG000|STARTED|Overall Study||8
6509882|NCT01477749|7429334|FG000|STARTED|Overall Study||47
6509883|NCT01477749|7429334|FG000|COMPLETED|Overall Study||43
6509884|NCT01477749|7429334|FG000|NOT COMPLETED|Overall Study||4
6255251|NCT04153435|7154038|FG000|STARTED|Overall Study||197
6255252|NCT04153435|7154039|FG001|STARTED|Overall Study||200
6255253|NCT04153435|7154038|FG000|COMPLETED|Overall Study||197
6255254|NCT04153435|7154039|FG001|COMPLETED|Overall Study||200
6255255|NCT04153435|7154038|FG000|NOT COMPLETED|Overall Study||0
6255256|NCT04153435|7154039|FG001|NOT COMPLETED|Overall Study||0
6255257|NCT04153188|7154047|FG000|STARTED|Overall Study||17
6255258|NCT04153188|7154048|FG001|STARTED|Overall Study||13
6255259|NCT04153188|7154047|FG000|COMPLETED|Overall Study||14
6255260|NCT04153188|7154048|FG001|COMPLETED|Overall Study||11
6255261|NCT04153188|7154047|FG000|NOT COMPLETED|Overall Study||3
6255262|NCT04153188|7154048|FG001|NOT COMPLETED|Overall Study||2
6255263|NCT04118270|7154056|FG000|STARTED|Overall Study||37
6255264|NCT04118270|7154057|FG001|STARTED|Overall Study||13
6255265|NCT04118270|7154056|FG000|COMPLETED|Overall Study||37
6255266|NCT04118270|7154057|FG001|COMPLETED|Overall Study||13
6255267|NCT04118270|7154056|FG000|NOT COMPLETED|Overall Study||0
6255268|NCT04118270|7154057|FG001|NOT COMPLETED|Overall Study||0
6255269|NCT04110314|7154071|FG000|STARTED|Overall Study||71781
6255270|NCT04110314|7154072|FG001|STARTED|Overall Study||71492
6255271|NCT04110314|7154073|FG002|STARTED|Overall Study||72177
6255272|NCT04110314|7154074|FG003|STARTED|Overall Study||71512
6255273|NCT04110314|7154075|FG004|STARTED|Overall Study||71536
6255274|NCT04110314|7154076|FG005|STARTED|Overall Study||72138
6255275|NCT04110314|7154071|FG000|Patients Who Met Inclusion|Overall Study||36526
6255276|NCT04110314|7154072|FG001|Patients Who Met Inclusion|Overall Study||36388
6255277|NCT04110314|7154073|FG002|Patients Who Met Inclusion|Overall Study||36541
6255278|NCT04110314|7154074|FG003|Patients Who Met Inclusion|Overall Study||36377
6255279|NCT04110314|7154075|FG004|Patients Who Met Inclusion|Overall Study||36289
6255280|NCT04110314|7154076|FG005|Patients Who Met Inclusion|Overall Study||36411
6255281|NCT04110314|7154071|FG000|COMPLETED|Overall Study||36526
6255282|NCT04110314|7154072|FG001|COMPLETED|Overall Study||36388
6255283|NCT04110314|7154073|FG002|COMPLETED|Overall Study||36541
6255284|NCT04110314|7154074|FG003|COMPLETED|Overall Study||36377
6255285|NCT04110314|7154075|FG004|COMPLETED|Overall Study||36289
6255286|NCT04110314|7154076|FG005|COMPLETED|Overall Study||36411
6255287|NCT04110314|7154071|FG000|NOT COMPLETED|Overall Study||35255
6255288|NCT04110314|7154072|FG001|NOT COMPLETED|Overall Study||35104
6255289|NCT04110314|7154073|FG002|NOT COMPLETED|Overall Study||35636
6255290|NCT04110314|7154074|FG003|NOT COMPLETED|Overall Study||35135
6255291|NCT04110314|7154075|FG004|NOT COMPLETED|Overall Study||35247
6255292|NCT04110314|7154076|FG005|NOT COMPLETED|Overall Study||35727
6255293|NCT04108429|7154088|FG000|STARTED|Overall Study||117
6255294|NCT04108429|7154088|FG000|COMPLETED|Overall Study||117
6255295|NCT04108429|7154088|FG000|NOT COMPLETED|Overall Study||0
6255296|NCT04061915|7154096|FG000|STARTED|Overall Study||161
6255297|NCT04061915|7154097|FG001|STARTED|Overall Study||161
6255298|NCT04061915|7154096|FG000|COMPLETED|Overall Study||161
6255299|NCT04061915|7154097|FG001|COMPLETED|Overall Study||161
6255300|NCT04061915|7154096|FG000|NOT COMPLETED|Overall Study||0
6255301|NCT04061915|7154097|FG001|NOT COMPLETED|Overall Study||0
6255330|NCT03794661|7154136|FG000|COMPLETED|Overall Study||8
6255331|NCT03794661|7154136|FG000|NOT COMPLETED|Overall Study||0
6255332|NCT03691909|7154140|FG000|STARTED|Overall Study||15
6255333|NCT03691909|7154140|FG000|Per Protocol Population Day 1|Overall Study||15
6255334|NCT03691909|7154140|FG000|Per Protocol Population Week 1|Overall Study||15
6255335|NCT03691909|7154140|FG000|Per Protocol Population Week 4|Overall Study||14
6255336|NCT03691909|7154140|FG000|Per Protocol Population Week 8|Overall Study||13
6255337|NCT03691909|7154140|FG000|Per Protocol Population Week 12|Overall Study||15
6255338|NCT03691909|7154140|FG000|Per Protocol Population Week 26|Overall Study||14
6255339|NCT03691909|7154140|FG000|Per Protocol Population Week 52|Overall Study||13
6255340|NCT03691909|7154140|FG000|COMPLETED|Overall Study||15
6255341|NCT03691909|7154140|FG000|NOT COMPLETED|Overall Study||0
6255342|NCT03627091|7154148|FG000|STARTED|Overall Study||19
6255343|NCT03627091|7154149|FG001|STARTED|Overall Study||10
6255344|NCT03627091|7154150|FG002|STARTED|Overall Study||11
6255345|NCT03627091|7154148|FG000|COMPLETED|Overall Study||7
6255346|NCT03627091|7154149|FG001|COMPLETED|Overall Study||4
6255347|NCT03627091|7154150|FG002|COMPLETED|Overall Study||6
6255348|NCT03627091|7154148|FG000|NOT COMPLETED|Overall Study||12
6255349|NCT03627091|7154149|FG001|NOT COMPLETED|Overall Study||6
6255350|NCT03627091|7154150|FG002|NOT COMPLETED|Overall Study||5
6255351|NCT03574129|7154161|FG000|STARTED|Overall Study||578
6255352|NCT03574129|7154162|FG001|STARTED|Overall Study||488
6255353|NCT03574129|7154161|FG000|COMPLETED|Overall Study||506
6255354|NCT03574129|7154162|FG001|COMPLETED|Overall Study||440
6255355|NCT03574129|7154161|FG000|NOT COMPLETED|Overall Study||72
6255356|NCT03574129|7154162|FG001|NOT COMPLETED|Overall Study||48
6278895|NCT00139776|7178583|FG001|STARTED|Period I||0
6278896|NCT00139776|7178584|FG002|STARTED|Period I||0
6278897|NCT00139776|7178585|FG003|STARTED|Period I||0
6278898|NCT00139776|7178582|FG000|COMPLETED|Period I||1197
6278899|NCT00139776|7178583|FG001|COMPLETED|Period I||0
6278900|NCT00139776|7178584|FG002|COMPLETED|Period I||0
6278901|NCT00139776|7178585|FG003|COMPLETED|Period I||0
6278902|NCT00139776|7178582|FG000|NOT COMPLETED|Period I||575
6278903|NCT00139776|7178583|FG001|NOT COMPLETED|Period I||0
6278904|NCT00139776|7178584|FG002|NOT COMPLETED|Period I||0
6278905|NCT00139776|7178585|FG003|NOT COMPLETED|Period I||0
6278906|NCT00139776|7178582|FG000|STARTED|Period II||0
6278907|NCT00139776|7178583|FG001|STARTED|Period II||1197
6278908|NCT00139776|7178584|FG002|STARTED|Period II||0
6509885|NCT01477762|7429342|FG000|STARTED|Overall Study||25
6509886|NCT01477762|7429343|FG001|STARTED|Overall Study||33
6509887|NCT01477762|7429344|FG002|STARTED|Overall Study||20
6509888|NCT01477762|7429345|FG003|STARTED|Overall Study||13
6509889|NCT01477762|7429342|FG000|COMPLETED|Overall Study||16
6509890|NCT01477762|7429343|FG001|COMPLETED|Overall Study||20
6509891|NCT01477762|7429344|FG002|COMPLETED|Overall Study||16
6509892|NCT01477762|7429345|FG003|COMPLETED|Overall Study||11
6509893|NCT01477762|7429342|FG000|NOT COMPLETED|Overall Study||9
6509894|NCT01477762|7429343|FG001|NOT COMPLETED|Overall Study||13
6509895|NCT01477762|7429344|FG002|NOT COMPLETED|Overall Study||4
6509896|NCT01477762|7429345|FG003|NOT COMPLETED|Overall Study||2
6509897|NCT01477853|7429358|FG000|STARTED|Phase A||55
6509898|NCT01477853|7429359|FG001|STARTED|Phase A||56
6509899|NCT01477853|7429360|FG002|STARTED|Phase A||55
6509900|NCT01477853|7429358|FG000|COMPLETED|Phase A||12
6509901|NCT01477853|7429359|FG001|COMPLETED|Phase A||11
6509902|NCT01477853|7429360|FG002|COMPLETED|Phase A||11
6509903|NCT01477853|7429358|FG000|NOT COMPLETED|Phase A||43
6509904|NCT01477853|7429359|FG001|NOT COMPLETED|Phase A||45
6509905|NCT01477853|7429360|FG002|NOT COMPLETED|Phase A||44
6509906|NCT01477853|7429358|FG000|STARTED|Phase B||12
6509907|NCT01477853|7429359|FG001|STARTED|Phase B||11
6509908|NCT01477853|7429360|FG002|STARTED|Phase B||11
6509909|NCT01477853|7429358|FG000|COMPLETED|Phase B||0
6509910|NCT01477853|7429359|FG001|COMPLETED|Phase B||0
6509911|NCT01477853|7429360|FG002|COMPLETED|Phase B||0
6509912|NCT01477853|7429358|FG000|NOT COMPLETED|Phase B||12
6509913|NCT01477853|7429359|FG001|NOT COMPLETED|Phase B||11
6509914|NCT01477853|7429360|FG002|NOT COMPLETED|Phase B||11
6509915|NCT01477892|7429370|FG000|STARTED|Overall Study||7
6509916|NCT01477892|7429371|FG001|STARTED|Overall Study||7
6509917|NCT01477892|7429370|FG000|COMPLETED|Overall Study||7
6509918|NCT01477892|7429371|FG001|COMPLETED|Overall Study||5
6509919|NCT01477892|7429370|FG000|NOT COMPLETED|Overall Study||0
6509920|NCT01477892|7429371|FG001|NOT COMPLETED|Overall Study||2
6509921|NCT01478009|7429379|FG000|STARTED|Overall Study||50
6509922|NCT01478009|7429380|FG001|STARTED|Overall Study||50
6509923|NCT01478009|7429379|FG000|COMPLETED|Overall Study||49
6509924|NCT01478009|7429380|FG001|COMPLETED|Overall Study||49
6509925|NCT01478009|7429379|FG000|NOT COMPLETED|Overall Study||1
6509926|NCT01478009|7429380|FG001|NOT COMPLETED|Overall Study||1
6509927|NCT01478048|7429388|FG000|STARTED|Overall Study||77
6509928|NCT01478048|7429389|FG001|STARTED|Overall Study||75
6509929|NCT01478048|7429388|FG000|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|76
6509930|NCT01478048|7429389|FG001|Received Treatment|Overall Study|1 randomized to E-Bd but received Bd. Included in E-Bd group for efficacy and Bd group for safety|74
6509931|NCT01478048|7429388|FG000|COMPLETED|Overall Study||0
6509932|NCT01478048|7429389|FG001|COMPLETED|Overall Study||0
6509933|NCT01478048|7429388|FG000|NOT COMPLETED|Overall Study||77
6509934|NCT01478048|7429389|FG001|NOT COMPLETED|Overall Study||75
6509935|NCT01478087|7429395|FG000|STARTED|Overall Study||3
6509936|NCT01478087|7429395|FG000|COMPLETED|Overall Study||2
6509937|NCT01478087|7429395|FG000|NOT COMPLETED|Overall Study||1
6509938|NCT01478256|7429401|FG000|STARTED|Overall Study||15
6509939|NCT01478256|7429402|FG001|STARTED|Overall Study||15
6509940|NCT01478256|7429401|FG000|COMPLETED|Overall Study||15
6509941|NCT01478256|7429402|FG001|COMPLETED|Overall Study||15
6509942|NCT01478256|7429401|FG000|NOT COMPLETED|Overall Study||0
6509943|NCT01478256|7429402|FG001|NOT COMPLETED|Overall Study||0
6509944|NCT01478321|7429410|FG000|STARTED|Concurrent Therapy (5 Weeks)||54
6509945|NCT01478321|7429410|FG000|COMPLETED|Concurrent Therapy (5 Weeks)||38
6509946|NCT01478321|7429410|FG000|NOT COMPLETED|Concurrent Therapy (5 Weeks)||16
6509947|NCT01478321|7429410|FG000|STARTED|Started Adjuvant Therapy||38
6509948|NCT01478321|7429410|FG000|Completed First Cycle|Started Adjuvant Therapy||37
6509949|NCT01478321|7429410|FG000|COMPLETED|Started Adjuvant Therapy||37
6509950|NCT01478321|7429410|FG000|NOT COMPLETED|Started Adjuvant Therapy||1
6509951|NCT01478321|7429410|FG000|STARTED|Adjuvant Therapy Until PD or Toxicity||37
6509952|NCT01478321|7429410|FG000|Went on to Cycle 2 +|Adjuvant Therapy Until PD or Toxicity||27
6509953|NCT01478321|7429410|FG000|COMPLETED|Adjuvant Therapy Until PD or Toxicity||27
6509954|NCT01478321|7429410|FG000|NOT COMPLETED|Adjuvant Therapy Until PD or Toxicity||10
6509955|NCT01478321|7429410|FG000|STARTED|Follow-up Until Death or 12.31.18 Occurs||54
6509956|NCT01478321|7429410|FG000|COMPLETED|Follow-up Until Death or 12.31.18 Occurs||54
6509957|NCT01478321|7429410|FG000|NOT COMPLETED|Follow-up Until Death or 12.31.18 Occurs||0
6509958|NCT01478347|7429414|FG000|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
6509959|NCT01478347|7429414|FG000|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
6509960|NCT01478347|7429414|FG000|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
6509961|NCT01478347|7429414|FG000|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
6509962|NCT01478347|7429414|FG000|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
6509963|NCT01478347|7429414|FG000|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
6509964|NCT01478360|7429420|FG000|STARTED|Overall Study||31
6509965|NCT01478360|7429421|FG001|STARTED|Overall Study||15
6509966|NCT01478360|7429420|FG000|PD (Pharmacodynamic) Analysis Set|Overall Study||31
6509967|NCT01478360|7429421|FG001|PD (Pharmacodynamic) Analysis Set|Overall Study||15
6509968|NCT01478360|7429420|FG000|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
6509969|NCT01478360|7429421|FG001|PK (Pharmacokinetics) Analysis Set|Overall Study||0
6509970|NCT01478360|7429420|FG000|COMPLETED|Overall Study||29
6255357|NCT03568318|7154186|FG000|STARTED|Overall Study||264
6255358|NCT03568318|7154187|FG001|STARTED|Overall Study||261
6255359|NCT03568318|7154188|FG002|STARTED|Overall Study||260
6255360|NCT03568318|7154189|FG003|STARTED|Overall Study||63
6255361|NCT03568318|7154190|FG004|STARTED|Overall Study||60
6255362|NCT03568318|7154191|FG005|STARTED|Overall Study||60
6255363|NCT03568318|7154186|FG000|Received Study Drug|Overall Study||264
6255364|NCT03568318|7154187|FG001|Received Study Drug|Overall Study||261
6255365|NCT03568318|7154188|FG002|Received Study Drug|Overall Study||260
6255366|NCT03568318|7154189|FG003|Received Study Drug|Overall Study||62
6255367|NCT03568318|7154190|FG004|Received Study Drug|Overall Study||60
6255368|NCT03568318|7154191|FG005|Received Study Drug|Overall Study||60
6255369|NCT03568318|7154186|FG000|COMPLETED|Overall Study||244
6255370|NCT03568318|7154187|FG001|COMPLETED|Overall Study||249
6255371|NCT03568318|7154188|FG002|COMPLETED|Overall Study||250
6255372|NCT03568318|7154189|FG003|COMPLETED|Overall Study||59
6255373|NCT03568318|7154190|FG004|COMPLETED|Overall Study||58
6255374|NCT03568318|7154191|FG005|COMPLETED|Overall Study||60
6255375|NCT03568318|7154186|FG000|NOT COMPLETED|Overall Study||20
6255376|NCT03568318|7154187|FG001|NOT COMPLETED|Overall Study||12
6255377|NCT03568318|7154188|FG002|NOT COMPLETED|Overall Study||10
6255378|NCT03568318|7154189|FG003|NOT COMPLETED|Overall Study||4
6255379|NCT03568318|7154190|FG004|NOT COMPLETED|Overall Study||2
6255380|NCT03568318|7154191|FG005|NOT COMPLETED|Overall Study||0
6255381|NCT03525678|7154208|FG000|STARTED|Overall Study||97
6255382|NCT03525678|7154209|FG001|STARTED|Overall Study||99
6255383|NCT03525678|7154210|FG002|STARTED|Overall Study||25
6255384|NCT03525678|7154208|FG000|Received Study Treatment|Overall Study||95
6255385|NCT03525678|7154209|FG001|Received Study Treatment|Overall Study||99
6255386|NCT03525678|7154210|FG002|Received Study Treatment|Overall Study||24
6255387|NCT03525678|7154208|FG000|COMPLETED|Overall Study||0
6255388|NCT03525678|7154209|FG001|COMPLETED|Overall Study||0
6255389|NCT03525678|7154210|FG002|COMPLETED|Overall Study||0
6255390|NCT03525678|7154208|FG000|NOT COMPLETED|Overall Study||97
6255391|NCT03525678|7154209|FG001|NOT COMPLETED|Overall Study||99
6255392|NCT03525678|7154210|FG002|NOT COMPLETED|Overall Study||25
6255393|NCT03498560|7154218|FG000|STARTED|Overall Study||38
6255394|NCT03498560|7154218|FG000|Completed Baseline Assessment|Overall Study||32
6255395|NCT03498560|7154218|FG000|Completed PSG|Overall Study||25
6255396|NCT03498560|7154218|FG000|COMPLETED|Overall Study||17
6255397|NCT03498560|7154218|FG000|NOT COMPLETED|Overall Study||21
6255398|NCT03441360|7154226|FG000|STARTED|Overall Study||8
6255399|NCT03441360|7154227|FG001|STARTED|Overall Study||8
6509971|NCT01478360|7429421|FG001|COMPLETED|Overall Study||12
6509972|NCT01478360|7429420|FG000|NOT COMPLETED|Overall Study||2
6509973|NCT01478360|7429421|FG001|NOT COMPLETED|Overall Study||3
6509974|NCT01478373|7429427|FG000|STARTED|Treatment Phase||39
6509975|NCT01478373|7429427|FG000|COMPLETED|Treatment Phase||38
6509976|NCT01478373|7429427|FG000|NOT COMPLETED|Treatment Phase||1
6509977|NCT01478373|7429427|FG000|STARTED|Survival Phase||38
6509978|NCT01478373|7429427|FG000|COMPLETED|Survival Phase||0
6509979|NCT01478373|7429427|FG000|NOT COMPLETED|Survival Phase||38
6570814|NCT01853553|7494217|FG001|NOT COMPLETED|Overall Study||0
6570815|NCT01853605|7494227|FG000|STARTED|Overall Study||1939
6570816|NCT01853605|7494228|FG001|STARTED|Overall Study||693
6570817|NCT01853605|7494229|FG002|STARTED|Overall Study||751
6570818|NCT01853605|7494230|FG003|STARTED|Overall Study||428
6570819|NCT01853605|7494227|FG000|COMPLETED|Overall Study||1939
6570820|NCT01853605|7494228|FG001|COMPLETED|Overall Study||693
6570821|NCT01853605|7494229|FG002|COMPLETED|Overall Study||751
6570822|NCT01853605|7494230|FG003|COMPLETED|Overall Study||428
6570823|NCT01853605|7494227|FG000|NOT COMPLETED|Overall Study||0
6570824|NCT01853605|7494228|FG001|NOT COMPLETED|Overall Study||0
6570825|NCT01853605|7494229|FG002|NOT COMPLETED|Overall Study||0
6570826|NCT01853605|7494230|FG003|NOT COMPLETED|Overall Study||0
6570827|NCT01853618|7494245|FG000|STARTED|Overall Study||8
6570828|NCT01853618|7494246|FG001|STARTED|Overall Study||12
6570829|NCT01853618|7494247|FG002|STARTED|Overall Study||12
6570830|NCT01853618|7494248|FG003|STARTED|Overall Study||9
6570831|NCT01853618|7494249|FG004|STARTED|Overall Study||20
6570832|NCT01853618|7494245|FG000|COMPLETED|Overall Study||6
6570833|NCT01853618|7494246|FG001|COMPLETED|Overall Study||10
6570834|NCT01853618|7494247|FG002|COMPLETED|Overall Study||10
6570835|NCT01853618|7494248|FG003|COMPLETED|Overall Study||8
6570836|NCT01853618|7494249|FG004|COMPLETED|Overall Study||17
6570837|NCT01853618|7494245|FG000|NOT COMPLETED|Overall Study||2
6570838|NCT01853618|7494246|FG001|NOT COMPLETED|Overall Study||2
6255400|NCT03441360|7154228|FG002|STARTED|Overall Study||5
6255401|NCT03441360|7154226|FG000|COMPLETED|Overall Study||0
6255402|NCT03441360|7154227|FG001|COMPLETED|Overall Study||0
6255403|NCT03441360|7154228|FG002|COMPLETED|Overall Study||0
6255404|NCT03441360|7154226|FG000|NOT COMPLETED|Overall Study||8
6255405|NCT03441360|7154227|FG001|NOT COMPLETED|Overall Study||8
6255406|NCT03441360|7154228|FG002|NOT COMPLETED|Overall Study||5
6255407|NCT03434379|7154238|FG000|STARTED|Global Period||165
6255408|NCT03434379|7154239|FG001|STARTED|Global Period||336
6255409|NCT03434379|7154240|FG002|STARTED|Global Period||0
6255410|NCT03434379|7154241|FG003|STARTED|Global Period||0
6570839|NCT01853618|7494247|FG002|NOT COMPLETED|Overall Study||2
6570840|NCT01853618|7494248|FG003|NOT COMPLETED|Overall Study||1
6570841|NCT01853618|7494249|FG004|NOT COMPLETED|Overall Study||3
6570842|NCT01853644|7494262|FG000|STARTED|Registration and Treatment Start||31
6255411|NCT03434379|7154238|FG000|COMPLETED|Global Period||0
6570843|NCT01853644|7494262|FG000|Registered|Registration and Treatment Start||31
6570844|NCT01853644|7494262|FG000|Started Treatment|Registration and Treatment Start||30
6570845|NCT01853644|7494262|FG000|COMPLETED|Registration and Treatment Start||30
6570846|NCT01853644|7494262|FG000|NOT COMPLETED|Registration and Treatment Start||1
6570847|NCT01853644|7494262|FG000|STARTED|Reached First Response/Complete 2 Cycles||30
6570848|NCT01853644|7494262|FG000|COMPLETED|Reached First Response/Complete 2 Cycles||24
6570849|NCT01853644|7494262|FG000|NOT COMPLETED|Reached First Response/Complete 2 Cycles||6
6570850|NCT01853644|7494262|FG000|STARTED|Continued Treatment After First Response||24
6570851|NCT01853644|7494262|FG000|COMPLETED|Continued Treatment After First Response||12
6570852|NCT01853644|7494262|FG000|NOT COMPLETED|Continued Treatment After First Response||12
6570853|NCT01853644|7494262|FG000|STARTED|Follow up for 3 Years or Until Death|All patients that are treated on the study go into the follow up period|30
6570854|NCT01853644|7494262|FG000|COMPLETED|Follow up for 3 Years or Until Death||30
6570855|NCT01853644|7494262|FG000|NOT COMPLETED|Follow up for 3 Years or Until Death||0
6570856|NCT01853696|7494268|FG000|STARTED|Overall Study||84
6570857|NCT01853696|7494269|FG001|STARTED|Overall Study||83
6570858|NCT01853696|7494268|FG000|COMPLETED|Overall Study||78
6570859|NCT01853696|7494269|FG001|COMPLETED|Overall Study||78
6570860|NCT01853696|7494268|FG000|NOT COMPLETED|Overall Study||6
6570861|NCT01853696|7494269|FG001|NOT COMPLETED|Overall Study||5
6570862|NCT01853774|7494277|FG000|STARTED|Overall Study||257
6570863|NCT01853774|7494278|FG001|STARTED|Overall Study||162
6570864|NCT01853774|7494277|FG000|COMPLETED|Overall Study||211
6570865|NCT01853774|7494278|FG001|COMPLETED|Overall Study||134
6570866|NCT01853774|7494277|FG000|NOT COMPLETED|Overall Study||46
6570867|NCT01853774|7494278|FG001|NOT COMPLETED|Overall Study||28
6570868|NCT01853839|7494286|FG000|STARTED|Overall Study||2092
6570869|NCT01853839|7494286|FG000|COMPLETED|Overall Study||1663
6570870|NCT01853839|7494286|FG000|NOT COMPLETED|Overall Study||429
6570871|NCT01853878|7494296|FG000|STARTED|Overall Study||86
6570872|NCT01853878|7494297|FG001|STARTED|Overall Study||47
6570873|NCT01853878|7494296|FG000|COMPLETED|Overall Study||23
6570874|NCT01853878|7494297|FG001|COMPLETED|Overall Study||3
6570875|NCT01853878|7494296|FG000|NOT COMPLETED|Overall Study||63
6570876|NCT01853878|7494297|FG001|NOT COMPLETED|Overall Study||44
6570877|NCT01853930|7494305|FG000|STARTED|Overall Study||25
6570878|NCT01853930|7494306|FG001|STARTED|Overall Study||8
6570879|NCT01853930|7494305|FG000|COMPLETED|Overall Study||25
6570880|NCT01853930|7494306|FG001|COMPLETED|Overall Study||8
6570881|NCT01853930|7494305|FG000|NOT COMPLETED|Overall Study||0
6570882|NCT01853930|7494306|FG001|NOT COMPLETED|Overall Study||0
6570883|NCT01854034|7494312|FG000|STARTED|Overall Study||29
6570884|NCT01854034|7494312|FG000|COMPLETED|Overall Study||29
6570885|NCT01854034|7494312|FG000|NOT COMPLETED|Overall Study||0
6570886|NCT01854047|7494321|FG000|STARTED|Overall Study||158
6570887|NCT01854047|7494322|FG001|STARTED|Overall Study||157
6570888|NCT01854047|7494323|FG002|STARTED|Overall Study||150
6570889|NCT01854047|7494324|FG003|STARTED|Overall Study||157
6570890|NCT01854047|7494325|FG004|STARTED|Overall Study||154
6570891|NCT01854047|7494321|FG000|Treated|Overall Study||158
6570892|NCT01854047|7494322|FG001|Treated|Overall Study||156
6570893|NCT01854047|7494323|FG002|Treated|Overall Study||148
6570894|NCT01854047|7494324|FG003|Treated|Overall Study||157
6570895|NCT01854047|7494325|FG004|Treated|Overall Study||150
6570896|NCT01854047|7494321|FG000|Completed 12-week Study Treatment|Overall Study||153
6570897|NCT01854047|7494322|FG001|Completed 12-week Study Treatment|Overall Study||149
6570898|NCT01854047|7494323|FG002|Completed 12-week Study Treatment|Overall Study||141
6570899|NCT01854047|7494324|FG003|Completed 12-week Study Treatment|Overall Study||146
6570900|NCT01854047|7494325|FG004|Completed 12-week Study Treatment|Overall Study||143
6570901|NCT01854047|7494321|FG000|COMPLETED|Overall Study||146
6570902|NCT01854047|7494322|FG001|COMPLETED|Overall Study||149
6570903|NCT01854047|7494323|FG002|COMPLETED|Overall Study||137
6570904|NCT01854047|7494324|FG003|COMPLETED|Overall Study||142
6570905|NCT01854047|7494325|FG004|COMPLETED|Overall Study||135
6570906|NCT01854047|7494321|FG000|NOT COMPLETED|Overall Study||12
6570907|NCT01854047|7494322|FG001|NOT COMPLETED|Overall Study||8
6570908|NCT01854047|7494323|FG002|NOT COMPLETED|Overall Study||13
6570909|NCT01854047|7494324|FG003|NOT COMPLETED|Overall Study||15
6570910|NCT01854047|7494325|FG004|NOT COMPLETED|Overall Study||19
6570911|NCT01854138|7494339|FG000|STARTED|Overall Study|historical control with waiver of authorization; no informed consent signed|400
6570912|NCT01854138|7494340|FG001|STARTED|Overall Study||248
6570913|NCT01854138|7494339|FG000|COMPLETED|Overall Study||400
6570914|NCT01854138|7494340|FG001|COMPLETED|Overall Study||196
6570915|NCT01854138|7494339|FG000|NOT COMPLETED|Overall Study||0
6570916|NCT01854138|7494340|FG001|NOT COMPLETED|Overall Study||52
6570917|NCT01854177|7494347|FG000|STARTED|Overall Study||10
6570918|NCT01854177|7494347|FG000|COMPLETED|Overall Study||10
6255412|NCT03434379|7154239|FG001|COMPLETED|Global Period||0
6570919|NCT01854177|7494347|FG000|NOT COMPLETED|Overall Study||0
6570920|NCT01854242|7494353|FG000|STARTED|Overall Study||50
6570921|NCT01854242|7494353|FG000|COMPLETED|Overall Study||50
6570922|NCT01854242|7494353|FG000|NOT COMPLETED|Overall Study||0
6570923|NCT01854281|7494361|FG000|STARTED|Overall Study||15
6570924|NCT01854281|7494362|FG001|STARTED|Overall Study||19
6255413|NCT03434379|7154240|FG002|COMPLETED|Global Period||0
6570925|NCT01854281|7494363|FG002|STARTED|Overall Study||5
6570926|NCT01854281|7494364|FG003|STARTED|Overall Study||8
6255414|NCT03434379|7154241|FG003|COMPLETED|Global Period||0
6255415|NCT03434379|7154238|FG000|NOT COMPLETED|Global Period||165
6255416|NCT03434379|7154239|FG001|NOT COMPLETED|Global Period||336
6255417|NCT03434379|7154240|FG002|NOT COMPLETED|Global Period||0
6255418|NCT03434379|7154241|FG003|NOT COMPLETED|Global Period||0
6255419|NCT03434379|7154238|FG000|STARTED|China Extension Period||0
6255420|NCT03434379|7154239|FG001|STARTED|China Extension Period||0
6255421|NCT03434379|7154240|FG002|STARTED|China Extension Period|n=43 Chinese participants from the sorafenib Global population are included in the China population.|61
6255422|NCT03434379|7154241|FG003|STARTED|China Extension Period|n=94 Chinese participants from the Atezolizumab + Bevacizumab Global population are included in the China population.|133
6255423|NCT03434379|7154238|FG000|COMPLETED|China Extension Period||0
6255424|NCT03434379|7154239|FG001|COMPLETED|China Extension Period||0
6255425|NCT03434379|7154240|FG002|COMPLETED|China Extension Period||0
6255426|NCT03434379|7154241|FG003|COMPLETED|China Extension Period||0
6255427|NCT03434379|7154238|FG000|NOT COMPLETED|China Extension Period||0
6255428|NCT03434379|7154239|FG001|NOT COMPLETED|China Extension Period||0
6255429|NCT03434379|7154240|FG002|NOT COMPLETED|China Extension Period||61
6255430|NCT03434379|7154241|FG003|NOT COMPLETED|China Extension Period||133
6255431|NCT03368170|7154255|FG000|STARTED|Overall Study||39
6255432|NCT03368170|7154256|FG001|STARTED|Overall Study||36
6255433|NCT03368170|7154255|FG000|COMPLETED|Overall Study||37
6255434|NCT03368170|7154256|FG001|COMPLETED|Overall Study||35
6255435|NCT03368170|7154255|FG000|NOT COMPLETED|Overall Study||2
6255436|NCT03368170|7154256|FG001|NOT COMPLETED|Overall Study||1
6255437|NCT03336528|7154264|FG000|STARTED|Overall Study||92
6255438|NCT03336528|7154265|FG001|STARTED|Overall Study||88
6255439|NCT03336528|7154264|FG000|Participated in Optional Outpatient Study|Overall Study||72
6255440|NCT03336528|7154265|FG001|Participated in Optional Outpatient Study|Overall Study||59
6255441|NCT03336528|7154264|FG000|COMPLETED|Overall Study||82
6255442|NCT03336528|7154265|FG001|COMPLETED|Overall Study||79
6255443|NCT03336528|7154264|FG000|NOT COMPLETED|Overall Study||10
6255444|NCT03336528|7154265|FG001|NOT COMPLETED|Overall Study||9
6255445|NCT03334409|7154275|FG000|STARTED|Overall Study||2
6255446|NCT03334409|7154276|FG001|STARTED|Overall Study||3
6255447|NCT03334409|7154275|FG000|COMPLETED|Overall Study||1
6255448|NCT03334409|7154276|FG001|COMPLETED|Overall Study||3
6255449|NCT03334409|7154275|FG000|NOT COMPLETED|Overall Study||1
6255450|NCT03334409|7154276|FG001|NOT COMPLETED|Overall Study||0
6255451|NCT03332498|7154285|FG000|STARTED|Overall Study||4
6255452|NCT03332498|7154286|FG001|STARTED|Overall Study||4
6255453|NCT03332498|7154287|FG002|STARTED|Overall Study||32
6255454|NCT03332498|7154285|FG000|COMPLETED|Overall Study||4
6255455|NCT03332498|7154286|FG001|COMPLETED|Overall Study||4
6255456|NCT03332498|7154287|FG002|COMPLETED|Overall Study||30
6255457|NCT03332498|7154285|FG000|NOT COMPLETED|Overall Study||0
6255458|NCT03332498|7154286|FG001|NOT COMPLETED|Overall Study||0
6255459|NCT03332498|7154287|FG002|NOT COMPLETED|Overall Study||2
6278909|NCT00139776|7178585|FG003|STARTED|Period II||0
6278910|NCT00139776|7178582|FG000|COMPLETED|Period II||0
6278911|NCT00139776|7178583|FG001|COMPLETED|Period II||875
6278912|NCT00139776|7178584|FG002|COMPLETED|Period II||0
6278913|NCT00139776|7178585|FG003|COMPLETED|Period II||0
6278914|NCT00139776|7178582|FG000|NOT COMPLETED|Period II||0
6278915|NCT00139776|7178583|FG001|NOT COMPLETED|Period II||322
6278916|NCT00139776|7178584|FG002|NOT COMPLETED|Period II||0
6278917|NCT00139776|7178585|FG003|NOT COMPLETED|Period II||0
6570927|NCT01854281|7494361|FG000|COMPLETED|Overall Study||15
6570928|NCT01854281|7494362|FG001|COMPLETED|Overall Study||19
6570929|NCT01854281|7494363|FG002|COMPLETED|Overall Study||5
6570930|NCT01854281|7494364|FG003|COMPLETED|Overall Study||8
6570931|NCT01854281|7494361|FG000|NOT COMPLETED|Overall Study||0
6278918|NCT00139776|7178582|FG000|STARTED|Period III||0
6278919|NCT00139776|7178583|FG001|STARTED|Period III||0
6278920|NCT00139776|7178584|FG002|STARTED|Period III|Randomized 440: 9 participants not treated|431
6278921|NCT00139776|7178585|FG003|STARTED|Period III|Randomized 435: 8 participants not treated|427
6278922|NCT00139776|7178582|FG000|COMPLETED|Period III||0
6278923|NCT00139776|7178583|FG001|COMPLETED|Period III||0
6278924|NCT00139776|7178584|FG002|COMPLETED|Period III||355
6278925|NCT00139776|7178585|FG003|COMPLETED|Period III||321
6278926|NCT00139776|7178582|FG000|NOT COMPLETED|Period III||0
6278927|NCT00139776|7178583|FG001|NOT COMPLETED|Period III||0
6278928|NCT00139776|7178584|FG002|NOT COMPLETED|Period III||76
6278929|NCT00139776|7178585|FG003|NOT COMPLETED|Period III||106
6278930|NCT00139997|7178594|FG000|STARTED|Overall Study||15
6278931|NCT00139997|7178595|FG001|STARTED|Overall Study||11
6278932|NCT00139997|7178594|FG000|COMPLETED|Overall Study||14
6278933|NCT00139997|7178595|FG001|COMPLETED|Overall Study||9
6278934|NCT00139997|7178594|FG000|NOT COMPLETED|Overall Study||1
6278935|NCT00139997|7178595|FG001|NOT COMPLETED|Overall Study||2
6278936|NCT00140140|7178604|FG000|STARTED|Overall Study||4
6278937|NCT00140140|7178605|FG001|STARTED|Overall Study||6
6278938|NCT00140140|7178606|FG002|STARTED|Overall Study||6
6278939|NCT00140140|7178604|FG000|COMPLETED|Overall Study|Progressive disease|2
6278940|NCT00140140|7178605|FG001|COMPLETED|Overall Study|Progressive disease|4
6278941|NCT00140140|7178606|FG002|COMPLETED|Overall Study|Progressive disease|4
6278942|NCT00140140|7178604|FG000|NOT COMPLETED|Overall Study||2
6278943|NCT00140140|7178605|FG001|NOT COMPLETED|Overall Study||2
6278944|NCT00140140|7178606|FG002|NOT COMPLETED|Overall Study||2
6570932|NCT01854281|7494362|FG001|NOT COMPLETED|Overall Study||0
6255460|NCT03287843|7154296|FG000|STARTED|Overall Study||175
6255461|NCT03287843|7154297|FG001|STARTED|Overall Study||175
6255462|NCT03287843|7154296|FG000|Excluded|Overall Study|No surgery n=5 R2 resection n=5 Stage IV n=2|12
6255463|NCT03287843|7154297|FG001|Excluded|Overall Study|No surgery n=4 R2 resection n=2 Stage IV n=2|8
6255464|NCT03287843|7154296|FG000|Lost to Follow up|Overall Study||3
6255465|NCT03287843|7154297|FG001|Lost to Follow up|Overall Study||0
6255466|NCT03287843|7154296|FG000|COMPLETED|Overall Study||160
6255467|NCT03287843|7154297|FG001|COMPLETED|Overall Study||167
6255468|NCT03287843|7154296|FG000|NOT COMPLETED|Overall Study||15
6255469|NCT03287843|7154297|FG001|NOT COMPLETED|Overall Study||8
6255470|NCT03230292|7154303|FG000|STARTED|Overall Study||43
6255471|NCT03230292|7154303|FG000|COMPLETED|Overall Study||37
6255472|NCT03230292|7154303|FG000|NOT COMPLETED|Overall Study||6
6255473|NCT03226067|7154312|FG000|STARTED|Overall Study||36
6255474|NCT03226067|7154313|FG001|STARTED|Overall Study||38
6255475|NCT03226067|7154314|FG002|STARTED|Overall Study||37
6255476|NCT03226067|7154312|FG000|COMPLETED|Overall Study||36
6255477|NCT03226067|7154313|FG001|COMPLETED|Overall Study||38
6255478|NCT03226067|7154314|FG002|COMPLETED|Overall Study||37
6255479|NCT03226067|7154312|FG000|NOT COMPLETED|Overall Study||0
6255480|NCT03226067|7154313|FG001|NOT COMPLETED|Overall Study||0
6255481|NCT03226067|7154314|FG002|NOT COMPLETED|Overall Study||0
6255482|NCT03131960|7154324|FG000|STARTED|Overall Study|1 participant missed the day one visit (V5) but remained in the study and returned for the day 90 assessment (V7).|53
6255483|NCT03131960|7154325|FG001|STARTED|Overall Study|1 discontinued treatment due to adverse event and inability to tolerate rehabilitation.|55
6255484|NCT03131960|7154324|FG000|COMPLETED|Overall Study||53
6255485|NCT03131960|7154325|FG001|COMPLETED|Overall Study||54
6255486|NCT03131960|7154324|FG000|NOT COMPLETED|Overall Study||0
6255487|NCT03131960|7154325|FG001|NOT COMPLETED|Overall Study||1
6255488|NCT03084536|7154334|FG000|STARTED|Overall Study||53
6255489|NCT03084536|7154335|FG001|STARTED|Overall Study||54
6255490|NCT03084536|7154336|FG002|STARTED|Overall Study||27
6255491|NCT03084536|7154334|FG000|COMPLETED|Overall Study||53
6255492|NCT03084536|7154335|FG001|COMPLETED|Overall Study||54
6255493|NCT03084536|7154336|FG002|COMPLETED|Overall Study||0
6255494|NCT03084536|7154334|FG000|NOT COMPLETED|Overall Study||0
6255495|NCT03084536|7154335|FG001|NOT COMPLETED|Overall Study||0
6255496|NCT03084536|7154336|FG002|NOT COMPLETED|Overall Study||27
6255497|NCT02996305|7154346|FG000|STARTED|Overall Study||29
6255498|NCT02996305|7154347|FG001|STARTED|Overall Study||29
6255499|NCT02996305|7154348|FG002|STARTED|Overall Study||30
6255500|NCT02996305|7154346|FG000|COMPLETED|Overall Study||26
6255501|NCT02996305|7154347|FG001|COMPLETED|Overall Study||27
6255502|NCT02996305|7154348|FG002|COMPLETED|Overall Study||25
6255503|NCT02996305|7154346|FG000|NOT COMPLETED|Overall Study||3
6255504|NCT02996305|7154347|FG001|NOT COMPLETED|Overall Study||2
6255505|NCT02996305|7154348|FG002|NOT COMPLETED|Overall Study||5
6255506|NCT02992119|7154363|FG000|STARTED|Overall Study||21
6255507|NCT02992119|7154364|FG001|STARTED|Overall Study||21
6255508|NCT02992119|7154365|FG002|STARTED|Overall Study||30
6255509|NCT02992119|7154366|FG003|STARTED|Overall Study||30
6255510|NCT02992119|7154367|FG004|STARTED|Overall Study||30
6255511|NCT02992119|7154368|FG005|STARTED|Overall Study||30
6255512|NCT02992119|7154369|FG006|STARTED|Overall Study||31
6255513|NCT02992119|7154363|FG000|COMPLETED|Overall Study||19
6255514|NCT02992119|7154364|FG001|COMPLETED|Overall Study||20
6255515|NCT02992119|7154365|FG002|COMPLETED|Overall Study||29
6255516|NCT02992119|7154366|FG003|COMPLETED|Overall Study||30
6255517|NCT02992119|7154367|FG004|COMPLETED|Overall Study||30
6570933|NCT01854281|7494363|FG002|NOT COMPLETED|Overall Study||0
6570934|NCT01854281|7494364|FG003|NOT COMPLETED|Overall Study||0
6570935|NCT01854359|7494376|FG000|STARTED|Overall Study||31
6570936|NCT01854359|7494377|FG001|STARTED|Overall Study||30
6570937|NCT01854359|7494376|FG000|COMPLETED|Overall Study||26
6570938|NCT01854359|7494377|FG001|COMPLETED|Overall Study||22
6570939|NCT01854359|7494376|FG000|NOT COMPLETED|Overall Study||5
6570940|NCT01854359|7494377|FG001|NOT COMPLETED|Overall Study||8
6570941|NCT01854528|7494393|FG000|STARTED|Overall Study||101
6570942|NCT01854528|7494394|FG001|STARTED|Overall Study||47
6570943|NCT01854528|7494393|FG000|COMPLETED|Overall Study||101
6570944|NCT01854528|7494394|FG001|COMPLETED|Overall Study||32
6570945|NCT01854528|7494393|FG000|NOT COMPLETED|Overall Study||0
6570946|NCT01854528|7494394|FG001|NOT COMPLETED|Overall Study||15
6570947|NCT01854593|7494402|FG000|STARTED|Overall Study||34
6570948|NCT01854593|7494403|FG001|STARTED|Overall Study||35
6570949|NCT01854593|7494402|FG000|COMPLETED|Overall Study||32
6255518|NCT02992119|7154368|FG005|COMPLETED|Overall Study||30
6255519|NCT02992119|7154369|FG006|COMPLETED|Overall Study||28
6255520|NCT02992119|7154363|FG000|NOT COMPLETED|Overall Study||2
6255521|NCT02992119|7154364|FG001|NOT COMPLETED|Overall Study||1
6255522|NCT02992119|7154365|FG002|NOT COMPLETED|Overall Study||1
6255523|NCT02992119|7154366|FG003|NOT COMPLETED|Overall Study||0
6255524|NCT02992119|7154367|FG004|NOT COMPLETED|Overall Study||0
6570950|NCT01854593|7494403|FG001|COMPLETED|Overall Study||34
6570951|NCT01854593|7494402|FG000|NOT COMPLETED|Overall Study||2
6570952|NCT01854593|7494403|FG001|NOT COMPLETED|Overall Study||1
6570953|NCT01854632|7494412|FG000|STARTED|Overall Study||1174
6570954|NCT01854632|7494413|FG001|STARTED|Overall Study||587
6570955|NCT01854632|7494412|FG000|COMPLETED|Overall Study||1148
6570956|NCT01854632|7494413|FG001|COMPLETED|Overall Study||574
6570957|NCT01854632|7494412|FG000|NOT COMPLETED|Overall Study||26
6255525|NCT02992119|7154368|FG005|NOT COMPLETED|Overall Study||0
6255526|NCT02992119|7154369|FG006|NOT COMPLETED|Overall Study||3
6255527|NCT02988661|7154388|FG000|STARTED|Overall Study||168
6255528|NCT02988661|7154389|FG001|STARTED|Overall Study||531
6255529|NCT02988661|7154388|FG000|COMPLETED|Overall Study||165
6255530|NCT02988661|7154389|FG001|COMPLETED|Overall Study||447
6255531|NCT02988661|7154388|FG000|NOT COMPLETED|Overall Study||3
6255532|NCT02988661|7154389|FG001|NOT COMPLETED|Overall Study||84
6255533|NCT02951767|7154395|FG000|STARTED|Overall Study||119
6255534|NCT02951767|7154395|FG000|COMPLETED|Overall Study||0
6255535|NCT02951767|7154395|FG000|NOT COMPLETED|Overall Study||119
6255536|NCT02951052|7154401|FG000|STARTED|Overall Study||308
6255537|NCT02951052|7154402|FG001|STARTED|Overall Study||308
6570958|NCT01854632|7494413|FG001|NOT COMPLETED|Overall Study||13
6570959|NCT01854645|7494424|FG000|STARTED|Overall Study||527
6570960|NCT01854645|7494425|FG001|STARTED|Overall Study||451
6570961|NCT01854645|7494426|FG002|STARTED|Overall Study||452
6570962|NCT01854645|7494427|FG003|STARTED|Overall Study||453
6570963|NCT01854645|7494428|FG004|STARTED|Overall Study||220
6570964|NCT01854645|7494424|FG000|COMPLETED|Overall Study||429
6570965|NCT01854645|7494425|FG001|COMPLETED|Overall Study||345
6570966|NCT01854645|7494426|FG002|COMPLETED|Overall Study||370
6570967|NCT01854645|7494427|FG003|COMPLETED|Overall Study||391
6570968|NCT01854645|7494428|FG004|COMPLETED|Overall Study||160
6570969|NCT01854645|7494424|FG000|NOT COMPLETED|Overall Study||98
6570970|NCT01854645|7494425|FG001|NOT COMPLETED|Overall Study||106
6570971|NCT01854645|7494426|FG002|NOT COMPLETED|Overall Study||82
6570972|NCT01854645|7494427|FG003|NOT COMPLETED|Overall Study||62
6570973|NCT01854645|7494428|FG004|NOT COMPLETED|Overall Study||60
6570974|NCT01854658|7494444|FG000|STARTED|Overall Study||439
6570975|NCT01854658|7494445|FG001|STARTED|Overall Study||440
6570976|NCT01854658|7494446|FG002|STARTED|Overall Study||512
6570977|NCT01854658|7494447|FG003|STARTED|Overall Study||224
6570978|NCT01854658|7494444|FG000|COMPLETED|Overall Study||346
6570979|NCT01854658|7494445|FG001|COMPLETED|Overall Study||365
6570980|NCT01854658|7494446|FG002|COMPLETED|Overall Study||432
6570981|NCT01854658|7494447|FG003|COMPLETED|Overall Study||165
6570982|NCT01854658|7494444|FG000|NOT COMPLETED|Overall Study||93
6570983|NCT01854658|7494445|FG001|NOT COMPLETED|Overall Study||75
6570984|NCT01854658|7494446|FG002|NOT COMPLETED|Overall Study||80
6570985|NCT01854658|7494447|FG003|NOT COMPLETED|Overall Study||59
6570986|NCT01854697|7494462|FG000|STARTED|Overall Study||69
6570987|NCT01854697|7494463|FG001|STARTED|Overall Study||34
6570988|NCT01854697|7494464|FG002|STARTED|Overall Study||84
6570989|NCT01854697|7494465|FG003|STARTED|Overall Study||83
6570990|NCT01854697|7494466|FG004|STARTED|Overall Study||41
6570991|NCT01854697|7494462|FG000|COMPLETED|Overall Study||63
6570992|NCT01854697|7494463|FG001|COMPLETED|Overall Study||31
6570993|NCT01854697|7494464|FG002|COMPLETED|Overall Study||82
6570994|NCT01854697|7494465|FG003|COMPLETED|Overall Study||80
6570995|NCT01854697|7494466|FG004|COMPLETED|Overall Study||39
6570996|NCT01854697|7494462|FG000|NOT COMPLETED|Overall Study||6
6570997|NCT01854697|7494463|FG001|NOT COMPLETED|Overall Study||3
6570998|NCT01854697|7494464|FG002|NOT COMPLETED|Overall Study||2
6570999|NCT01854697|7494465|FG003|NOT COMPLETED|Overall Study||3
6571000|NCT01854697|7494466|FG004|NOT COMPLETED|Overall Study||2
6571001|NCT01854710|7494476|FG000|STARTED|Overall Study||10
6571002|NCT01854710|7494477|FG001|STARTED|Overall Study||10
6571003|NCT01854710|7494478|FG002|STARTED|Overall Study||10
6571004|NCT01854710|7494479|FG003|STARTED|Overall Study||10
6571005|NCT01854710|7494480|FG004|STARTED|Overall Study||10
6571006|NCT01854710|7494481|FG005|STARTED|Overall Study||10
6571007|NCT01854710|7494476|FG000|COMPLETED|Overall Study||6
6571008|NCT01854710|7494477|FG001|COMPLETED|Overall Study||7
6571009|NCT01854710|7494478|FG002|COMPLETED|Overall Study||8
6571010|NCT01854710|7494479|FG003|COMPLETED|Overall Study||8
6571011|NCT01854710|7494480|FG004|COMPLETED|Overall Study||8
6571012|NCT01854710|7494481|FG005|COMPLETED|Overall Study||8
6571013|NCT01854710|7494476|FG000|NOT COMPLETED|Overall Study||4
6571014|NCT01854710|7494477|FG001|NOT COMPLETED|Overall Study||3
6571015|NCT01854710|7494478|FG002|NOT COMPLETED|Overall Study||2
6571016|NCT01854710|7494479|FG003|NOT COMPLETED|Overall Study||2
6571017|NCT01854710|7494480|FG004|NOT COMPLETED|Overall Study||2
6571018|NCT01854710|7494481|FG005|NOT COMPLETED|Overall Study||2
6571019|NCT01854775|7494494|FG000|STARTED|Treatment Phase (48 Weeks)||50
6571020|NCT01854775|7494495|FG001|STARTED|Treatment Phase (48 Weeks)||52
6255538|NCT02951052|7154401|FG000|COMPLETED|Overall Study||281
6255539|NCT02951052|7154402|FG001|COMPLETED|Overall Study||290
6571021|NCT01854775|7494496|FG002|STARTED|Treatment Phase (48 Weeks)||27
6571022|NCT01854775|7494494|FG000|COMPLETED|Treatment Phase (48 Weeks)||48
6255540|NCT02951052|7154401|FG000|NOT COMPLETED|Overall Study||27
6255541|NCT02951052|7154402|FG001|NOT COMPLETED|Overall Study||18
6571023|NCT01854775|7494495|FG001|COMPLETED|Treatment Phase (48 Weeks)||51
6571024|NCT01854775|7494496|FG002|COMPLETED|Treatment Phase (48 Weeks)||18
6571025|NCT01854775|7494494|FG000|NOT COMPLETED|Treatment Phase (48 Weeks)||2
6571026|NCT01854775|7494495|FG001|NOT COMPLETED|Treatment Phase (48 Weeks)||1
6571027|NCT01854775|7494496|FG002|NOT COMPLETED|Treatment Phase (48 Weeks)||9
6571028|NCT01854775|7494494|FG000|STARTED|Extension Phase||48
6571029|NCT01854775|7494495|FG001|STARTED|Extension Phase||50
6571030|NCT01854775|7494496|FG002|STARTED|Extension Phase||18
6571031|NCT01854775|7494494|FG000|COMPLETED|Extension Phase||9
6571032|NCT01854775|7494495|FG001|COMPLETED|Extension Phase||3
6255542|NCT02921776|7154418|FG000|STARTED|Overall Study||13
6255543|NCT02921776|7154419|FG001|STARTED|Overall Study||23
6255544|NCT02921776|7154420|FG002|STARTED|Overall Study||7
6255545|NCT02921776|7154421|FG003|STARTED|Overall Study||31
6255546|NCT02921776|7154422|FG004|STARTED|Overall Study||32
6255547|NCT02921776|7154423|FG005|STARTED|Overall Study||7
6255548|NCT02921776|7154424|FG006|STARTED|Overall Study||18
6255549|NCT02921776|7154425|FG007|STARTED|Overall Study||16
6255550|NCT02921776|7154418|FG000|COMPLETED|Overall Study||11
6255551|NCT02921776|7154419|FG001|COMPLETED|Overall Study||15
6255552|NCT02921776|7154420|FG002|COMPLETED|Overall Study||7
6255553|NCT02921776|7154421|FG003|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 23|23
6255554|NCT02921776|7154422|FG004|COMPLETED|Overall Study|Completed Primary outcome (daily measures) = 27 Completed Secondary outcomes (@ICU discharge) = 26|26
6255555|NCT02921776|7154423|FG005|COMPLETED|Overall Study||5
6255556|NCT02921776|7154424|FG006|COMPLETED|Overall Study|"At discharge/ extubation =11~1-mos post-discharge = 8 3-mos post-discharge = 8"|7
6255557|NCT02921776|7154425|FG007|COMPLETED|Overall Study|"At discharge/ extubation =15~1-mos post-discharge = 12 3-mos post-discharge = 11"|9
6255558|NCT02921776|7154418|FG000|NOT COMPLETED|Overall Study||2
6255559|NCT02921776|7154419|FG001|NOT COMPLETED|Overall Study||8
6255560|NCT02921776|7154420|FG002|NOT COMPLETED|Overall Study||0
6255561|NCT02921776|7154421|FG003|NOT COMPLETED|Overall Study||8
6255562|NCT02921776|7154422|FG004|NOT COMPLETED|Overall Study||6
6255563|NCT02921776|7154423|FG005|NOT COMPLETED|Overall Study||2
6255564|NCT02921776|7154424|FG006|NOT COMPLETED|Overall Study||11
6255565|NCT02921776|7154425|FG007|NOT COMPLETED|Overall Study||7
6255566|NCT02898259|7154454|FG000|STARTED|Overall Study||3
6255567|NCT02898259|7154455|FG001|STARTED|Overall Study||3
6255568|NCT02898259|7154456|FG002|STARTED|Overall Study||6
6255569|NCT02898259|7154457|FG003|STARTED|Overall Study||7
6255570|NCT02898259|7154458|FG004|STARTED|Overall Study||0
6255571|NCT02898259|7154454|FG000|COMPLETED|Overall Study||2
6255572|NCT02898259|7154455|FG001|COMPLETED|Overall Study||2
6255573|NCT02898259|7154456|FG002|COMPLETED|Overall Study||1
6255574|NCT02898259|7154457|FG003|COMPLETED|Overall Study||6
6255575|NCT02898259|7154458|FG004|COMPLETED|Overall Study||0
6255576|NCT02898259|7154454|FG000|NOT COMPLETED|Overall Study||1
6255577|NCT02898259|7154455|FG001|NOT COMPLETED|Overall Study||1
6255578|NCT02898259|7154456|FG002|NOT COMPLETED|Overall Study||5
6255579|NCT02898259|7154457|FG003|NOT COMPLETED|Overall Study||1
6571033|NCT01854775|7494496|FG002|COMPLETED|Extension Phase||0
6571034|NCT01854775|7494494|FG000|NOT COMPLETED|Extension Phase||39
6571035|NCT01854775|7494495|FG001|NOT COMPLETED|Extension Phase||47
6571036|NCT01854775|7494496|FG002|NOT COMPLETED|Extension Phase||18
6571037|NCT01854827|7494504|FG000|STARTED|Overall Study||30
6571038|NCT01854827|7494504|FG000|COMPLETED|Overall Study||29
6571039|NCT01854827|7494504|FG000|NOT COMPLETED|Overall Study||1
6571040|NCT01854879|7494508|FG000|STARTED|Overall Study|97 consented|97
6571041|NCT01854879|7494508|FG000|COMPLETED|Overall Study|92 had matched endpoint data|92
6571042|NCT01854879|7494508|FG000|NOT COMPLETED|Overall Study||5
6571043|NCT01854905|7494512|FG000|STARTED|Overall Study||400
6571044|NCT01854905|7494512|FG000|COMPLETED|Overall Study||400
6571045|NCT01854905|7494512|FG000|NOT COMPLETED|Overall Study||0
6571046|NCT01854918|7494518|FG000|STARTED|SOC-controlled Period (Year 1)||1227
6571047|NCT01854918|7494519|FG001|STARTED|SOC-controlled Period (Year 1)||2454
6571048|NCT01854918|7494518|FG000|Received Evolocumab|SOC-controlled Period (Year 1)|5 participants received evolocumab in error|5
6571049|NCT01854918|7494519|FG001|Received Evolocumab|SOC-controlled Period (Year 1)||2452
6571050|NCT01854918|7494518|FG000|COMPLETED|SOC-controlled Period (Year 1)||1197
6571051|NCT01854918|7494519|FG001|COMPLETED|SOC-controlled Period (Year 1)||2391
6571052|NCT01854918|7494518|FG000|NOT COMPLETED|SOC-controlled Period (Year 1)||30
6571053|NCT01854918|7494519|FG001|NOT COMPLETED|SOC-controlled Period (Year 1)||63
6571054|NCT01854918|7494518|FG000|STARTED|All-IP Period (Years 2 and 3)||1197
6571055|NCT01854918|7494519|FG001|STARTED|All-IP Period (Years 2 and 3)||2391
6571056|NCT01854918|7494518|FG000|Received Evolocumab|All-IP Period (Years 2 and 3)||1152
6571057|NCT01854918|7494519|FG001|Received Evolocumab|All-IP Period (Years 2 and 3)||2291
6571058|NCT01854918|7494518|FG000|COMPLETED|All-IP Period (Years 2 and 3)||1079
6571059|NCT01854918|7494519|FG001|COMPLETED|All-IP Period (Years 2 and 3)||2196
6571060|NCT01854918|7494518|FG000|NOT COMPLETED|All-IP Period (Years 2 and 3)||118
6571061|NCT01854918|7494519|FG001|NOT COMPLETED|All-IP Period (Years 2 and 3)||195
6571062|NCT01854944|7494535|FG000|STARTED|Overall Study||4
6571063|NCT01854944|7494536|FG001|STARTED|Overall Study||4
6571064|NCT01854944|7494537|FG002|STARTED|Overall Study||4
6571065|NCT01854944|7494535|FG000|COMPLETED|Overall Study||4
6571066|NCT01854944|7494536|FG001|COMPLETED|Overall Study||4
6571067|NCT01854944|7494537|FG002|COMPLETED|Overall Study||3
6571068|NCT01854944|7494535|FG000|NOT COMPLETED|Overall Study||0
6571069|NCT01854944|7494536|FG001|NOT COMPLETED|Overall Study||0
6571070|NCT01854944|7494537|FG002|NOT COMPLETED|Overall Study||1
6571071|NCT01855048|7494565|FG000|STARTED|Overall Study||9
6571072|NCT01855048|7494566|FG001|STARTED|Overall Study||3
6571073|NCT01855048|7494567|FG002|STARTED|Overall Study||6
6571074|NCT01855048|7494568|FG003|STARTED|Overall Study||6
6571075|NCT01855048|7494569|FG004|STARTED|Overall Study||6
6571076|NCT01855048|7494570|FG005|STARTED|Overall Study||6
6571077|NCT01855048|7494565|FG000|COMPLETED|Overall Study||9
6571078|NCT01855048|7494566|FG001|COMPLETED|Overall Study||2
6571079|NCT01855048|7494567|FG002|COMPLETED|Overall Study||6
6255580|NCT02898259|7154458|FG004|NOT COMPLETED|Overall Study||0
6278945|NCT00140205|7178616|FG000|STARTED|Overall Study||5
6278946|NCT00140205|7178617|FG001|STARTED|Overall Study||5
6278947|NCT00140205|7178618|FG002|STARTED|Overall Study||5
6278948|NCT00140205|7178616|FG000|COMPLETED|Overall Study||5
6278949|NCT00140205|7178617|FG001|COMPLETED|Overall Study||5
6278950|NCT00140205|7178618|FG002|COMPLETED|Overall Study||5
6278951|NCT00140205|7178616|FG000|NOT COMPLETED|Overall Study||0
6278952|NCT00140205|7178617|FG001|NOT COMPLETED|Overall Study||0
6278953|NCT00140205|7178618|FG002|NOT COMPLETED|Overall Study||0
6278954|NCT00140231|7178649|FG000|STARTED|Fed State 1 Day- day5||7
6571080|NCT01855048|7494568|FG003|COMPLETED|Overall Study||6
6571081|NCT01855048|7494569|FG004|COMPLETED|Overall Study||5
6571082|NCT01855048|7494570|FG005|COMPLETED|Overall Study||6
6571083|NCT01855048|7494565|FG000|NOT COMPLETED|Overall Study||0
6571084|NCT01855048|7494566|FG001|NOT COMPLETED|Overall Study||1
6571085|NCT01855048|7494567|FG002|NOT COMPLETED|Overall Study||0
6571086|NCT01855048|7494568|FG003|NOT COMPLETED|Overall Study||0
6571087|NCT01855048|7494569|FG004|NOT COMPLETED|Overall Study||1
6571088|NCT01855048|7494570|FG005|NOT COMPLETED|Overall Study||0
6571089|NCT01855074|7494594|FG000|STARTED|Overall Study||80
6571090|NCT01855074|7494594|FG000|Treated|Overall Study||79
6571091|NCT01855074|7494594|FG000|COMPLETED|Overall Study||66
6571092|NCT01855074|7494594|FG000|NOT COMPLETED|Overall Study||14
6571093|NCT01855126|7494600|FG000|STARTED|First Intervention (8 Weeks)||24
6571094|NCT01855126|7494601|FG001|STARTED|First Intervention (8 Weeks)||22
6571095|NCT01855126|7494600|FG000|COMPLETED|First Intervention (8 Weeks)||20
6571096|NCT01855126|7494601|FG001|COMPLETED|First Intervention (8 Weeks)||16
6571097|NCT01855126|7494600|FG000|NOT COMPLETED|First Intervention (8 Weeks)||4
6571098|NCT01855126|7494601|FG001|NOT COMPLETED|First Intervention (8 Weeks)||6
6571099|NCT01855126|7494600|FG000|STARTED|Washout Period (2 Weeks)||20
6571100|NCT01855126|7494601|FG001|STARTED|Washout Period (2 Weeks)||16
6571101|NCT01855126|7494600|FG000|COMPLETED|Washout Period (2 Weeks)||20
6571102|NCT01855126|7494601|FG001|COMPLETED|Washout Period (2 Weeks)||16
6571103|NCT01855126|7494600|FG000|NOT COMPLETED|Washout Period (2 Weeks)||0
6571104|NCT01855126|7494601|FG001|NOT COMPLETED|Washout Period (2 Weeks)||0
6571105|NCT01855126|7494600|FG000|STARTED|Second Intervention (8 Weeks)||20
6571106|NCT01855126|7494601|FG001|STARTED|Second Intervention (8 Weeks)||16
6571107|NCT01855126|7494600|FG000|COMPLETED|Second Intervention (8 Weeks)||18
6571108|NCT01855126|7494601|FG001|COMPLETED|Second Intervention (8 Weeks)||14
6571109|NCT01855126|7494600|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
6571110|NCT01855126|7494601|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||2
6571111|NCT01855243|7494614|FG000|STARTED|Overall Study||20
6571112|NCT01855243|7494615|FG001|STARTED|Overall Study||21
6571113|NCT01855243|7494616|FG002|STARTED|Overall Study||22
6571114|NCT01855243|7494614|FG000|COMPLETED|Overall Study||19
6571115|NCT01855243|7494615|FG001|COMPLETED|Overall Study||21
6571116|NCT01855243|7494616|FG002|COMPLETED|Overall Study||22
6571117|NCT01855243|7494614|FG000|NOT COMPLETED|Overall Study||1
6571118|NCT01855243|7494615|FG001|NOT COMPLETED|Overall Study||0
6571119|NCT01855243|7494616|FG002|NOT COMPLETED|Overall Study||0
6571120|NCT01855360|7494624|FG000|STARTED|Overall Study||40
6571121|NCT01855360|7494624|FG000|COMPLETED|Overall Study||30
6571122|NCT01855360|7494624|FG000|NOT COMPLETED|Overall Study||10
6571123|NCT01855399|7494630|FG000|STARTED|6 Month||146
6571124|NCT01855399|7494631|FG001|STARTED|6 Month||144
6571125|NCT01855399|7494630|FG000|COMPLETED|6 Month||126
6571126|NCT01855399|7494631|FG001|COMPLETED|6 Month||129
6571127|NCT01855399|7494630|FG000|NOT COMPLETED|6 Month||20
6571128|NCT01855399|7494631|FG001|NOT COMPLETED|6 Month||15
6571129|NCT01855399|7494630|FG000|STARTED|12 Month||126
6571130|NCT01855399|7494631|FG001|STARTED|12 Month||129
6571131|NCT01855399|7494630|FG000|COMPLETED|12 Month||119
6571132|NCT01855399|7494631|FG001|COMPLETED|12 Month||118
6571133|NCT01855399|7494630|FG000|NOT COMPLETED|12 Month||7
6571134|NCT01855399|7494631|FG001|NOT COMPLETED|12 Month||11
6571135|NCT01855412|7494640|FG000|STARTED|Overall Study||501
6571136|NCT01855412|7494641|FG001|STARTED|Overall Study||603
6571137|NCT01855412|7494642|FG002|STARTED|Overall Study||100
6571138|NCT01855412|7494640|FG000|COMPLETED|Overall Study||289
6571139|NCT01855412|7494641|FG001|COMPLETED|Overall Study||260
6571140|NCT01855412|7494642|FG002|COMPLETED|Overall Study||24
6571141|NCT01855412|7494640|FG000|NOT COMPLETED|Overall Study||212
6571142|NCT01855412|7494641|FG001|NOT COMPLETED|Overall Study||343
6571143|NCT01855412|7494642|FG002|NOT COMPLETED|Overall Study||76
6571144|NCT01855425|7494656|FG000|STARTED|Overall Study||96
6571145|NCT01855425|7494656|FG000|COMPLETED|Overall Study||76
6571146|NCT01855425|7494656|FG000|NOT COMPLETED|Overall Study||20
6571147|NCT01855750|7494662|FG000|STARTED|Overall Study||419
6571148|NCT01855750|7494663|FG001|STARTED|Overall Study||419
6737501|NCT03266419|7666787|FG001|NOT COMPLETED|Overall Study||0
6571149|NCT01855750|7494662|FG000|Treated|Overall Study|3 participants not treated:2 withdrew consent and 1 not treated per Sponsor/investigator's decision.|416
6571150|NCT01855750|7494663|FG001|Treated|Overall Study|1 participant not treated: withdrew consent.|418
6571151|NCT01855750|7494662|FG000|COMPLETED|Overall Study||0
6571152|NCT01855750|7494663|FG001|COMPLETED|Overall Study||0
6571153|NCT01855750|7494662|FG000|NOT COMPLETED|Overall Study||419
6571154|NCT01855750|7494663|FG001|NOT COMPLETED|Overall Study||419
6278955|NCT00140231|7178650|FG001|STARTED|Fed State 1 Day- day5||6
6278956|NCT00140231|7178649|FG000|COMPLETED|Fed State 1 Day- day5||7
6255581|NCT02870348|7154471|FG000|STARTED|Overall Study||4
6255582|NCT02870348|7154471|FG000|COMPLETED|Overall Study||0
6255583|NCT02870348|7154471|FG000|NOT COMPLETED|Overall Study||4
6255584|NCT02841280|7154477|FG000|STARTED|Overall Study||81
6255585|NCT02841280|7154478|FG001|STARTED|Overall Study||79
6255586|NCT02841280|7154477|FG000|COMPLETED|Overall Study||67
6255587|NCT02841280|7154478|FG001|COMPLETED|Overall Study||73
6255588|NCT02841280|7154477|FG000|NOT COMPLETED|Overall Study||14
6255589|NCT02841280|7154478|FG001|NOT COMPLETED|Overall Study||6
6255590|NCT02786498|7154488|FG000|STARTED|Overall Study||27
6255591|NCT02786498|7154489|FG001|STARTED|Overall Study||24
6255592|NCT02786498|7154490|FG002|STARTED|Overall Study||24
6255593|NCT02786498|7154491|FG003|STARTED|Overall Study||27
6255594|NCT02786498|7154488|FG000|COMPLETED|Overall Study||25
6255595|NCT02786498|7154489|FG001|COMPLETED|Overall Study||24
6255596|NCT02786498|7154490|FG002|COMPLETED|Overall Study||24
6255597|NCT02786498|7154491|FG003|COMPLETED|Overall Study||26
6255598|NCT02786498|7154488|FG000|NOT COMPLETED|Overall Study||2
6255599|NCT02786498|7154489|FG001|NOT COMPLETED|Overall Study||0
6255600|NCT02786498|7154490|FG002|NOT COMPLETED|Overall Study||0
6255601|NCT02786498|7154491|FG003|NOT COMPLETED|Overall Study||1
6255602|NCT02771275|7154501|FG000|STARTED|Overall Study||13
6255603|NCT02771275|7154501|FG000|COMPLETED|Overall Study||0
6255604|NCT02771275|7154501|FG000|NOT COMPLETED|Overall Study||13
6255605|NCT02675426|7154508|FG000|STARTED|Overall Study||221
6255606|NCT02675426|7154509|FG001|STARTED|Overall Study||221
6255607|NCT02675426|7154510|FG002|STARTED|Overall Study||219
6255608|NCT02675426|7154508|FG000|Treated|Overall Study||221
6255609|NCT02675426|7154509|FG001|Treated|Overall Study||221
6255610|NCT02675426|7154510|FG002|Treated|Overall Study||219
6255611|NCT02675426|7154508|FG000|COMPLETED|Overall Study||208
6255612|NCT02675426|7154509|FG001|COMPLETED|Overall Study||213
6255613|NCT02675426|7154510|FG002|COMPLETED|Overall Study||201
6255614|NCT02675426|7154508|FG000|NOT COMPLETED|Overall Study||13
6255615|NCT02675426|7154509|FG001|NOT COMPLETED|Overall Study||8
6255616|NCT02675426|7154510|FG002|NOT COMPLETED|Overall Study||18
6255617|NCT02639546|7154526|FG000|STARTED|Overall Study||6
6255618|NCT02639546|7154527|FG001|STARTED|Overall Study||6
6255619|NCT02639546|7154528|FG002|STARTED|Overall Study||6
6255620|NCT02639546|7154529|FG003|STARTED|Overall Study||6
6255621|NCT02639546|7154530|FG004|STARTED|Overall Study||7
6255622|NCT02639546|7154531|FG005|STARTED|Overall Study||8
6255623|NCT02639546|7154532|FG006|STARTED|Overall Study||5
6571155|NCT01855789|7494669|FG000|STARTED|1) Baseline up to Week 24||718
6571156|NCT01855789|7494670|FG001|STARTED|1) Baseline up to Week 24||0
6571157|NCT01855789|7494671|FG002|STARTED|1) Baseline up to Week 24||0
6571158|NCT01855789|7494672|FG003|STARTED|1) Baseline up to Week 24||0
6571159|NCT01855789|7494669|FG000|COMPLETED|1) Baseline up to Week 24||602
6571160|NCT01855789|7494670|FG001|COMPLETED|1) Baseline up to Week 24||0
6571161|NCT01855789|7494671|FG002|COMPLETED|1) Baseline up to Week 24||0
6571162|NCT01855789|7494672|FG003|COMPLETED|1) Baseline up to Week 24||0
6571163|NCT01855789|7494669|FG000|NOT COMPLETED|1) Baseline up to Week 24||116
6571164|NCT01855789|7494670|FG001|NOT COMPLETED|1) Baseline up to Week 24||0
6571165|NCT01855789|7494671|FG002|NOT COMPLETED|1) Baseline up to Week 24||0
6571166|NCT01855789|7494672|FG003|NOT COMPLETED|1) Baseline up to Week 24||0
6571167|NCT01855789|7494669|FG000|STARTED|2) Week 24 up to End of Study||0
6571168|NCT01855789|7494670|FG001|STARTED|2) Week 24 up to End of Study||147
6571169|NCT01855789|7494671|FG002|STARTED|2) Week 24 up to End of Study||147
6571170|NCT01855789|7494672|FG003|STARTED|2) Week 24 up to End of Study||308
6571171|NCT01855789|7494669|FG000|COMPLETED|2) Week 24 up to End of Study||0
6571172|NCT01855789|7494670|FG001|COMPLETED|2) Week 24 up to End of Study||132
6571173|NCT01855789|7494671|FG002|COMPLETED|2) Week 24 up to End of Study||129
6571174|NCT01855789|7494672|FG003|COMPLETED|2) Week 24 up to End of Study||250
6571175|NCT01855789|7494669|FG000|NOT COMPLETED|2) Week 24 up to End of Study||0
6571176|NCT01855789|7494670|FG001|NOT COMPLETED|2) Week 24 up to End of Study||15
6571177|NCT01855789|7494671|FG002|NOT COMPLETED|2) Week 24 up to End of Study||18
6571178|NCT01855789|7494672|FG003|NOT COMPLETED|2) Week 24 up to End of Study||58
6571179|NCT01855828|7494678|FG000|STARTED|Overall Study||50
6571180|NCT01855828|7494678|FG000|COMPLETED|Overall Study||48
6571181|NCT01855828|7494678|FG000|NOT COMPLETED|Overall Study||2
6571182|NCT01855919|7494689|FG000|STARTED|Overall Study||232
6571183|NCT01855919|7494690|FG001|STARTED|Overall Study||226
6571184|NCT01855919|7494689|FG000|Received at Least 1 Dose of Study Drug|Overall Study||232
6571185|NCT01855919|7494690|FG001|Received at Least 1 Dose of Study Drug|Overall Study||226
6571186|NCT01855919|7494689|FG000|COMPLETED|Overall Study||209
6571187|NCT01855919|7494690|FG001|COMPLETED|Overall Study||200
6571188|NCT01855919|7494689|FG000|NOT COMPLETED|Overall Study||23
6571189|NCT01855919|7494690|FG001|NOT COMPLETED|Overall Study||26
6571190|NCT01855945|7494709|FG000|STARTED|Overall Study||54
6571191|NCT01855945|7494710|FG001|STARTED|Overall Study||55
6571192|NCT01855945|7494711|FG002|STARTED|Overall Study||51
6571193|NCT01855945|7494712|FG003|STARTED|Overall Study||53
6571194|NCT01855945|7494713|FG004|STARTED|Overall Study||51
6255624|NCT02639546|7154533|FG007|STARTED|Overall Study||12
6255625|NCT02639546|7154526|FG000|Tumor Type - Neuroblastoma|Overall Study||0
6255626|NCT02639546|7154527|FG001|Tumor Type - Neuroblastoma|Overall Study||0
6255627|NCT02639546|7154528|FG002|Tumor Type - Neuroblastoma|Overall Study||1
6571195|NCT01855945|7494714|FG005|STARTED|Overall Study||53
6255628|NCT02639546|7154529|FG003|Tumor Type - Neuroblastoma|Overall Study||0
6571196|NCT01855945|7494715|FG006|STARTED|Overall Study||53
6571197|NCT01855945|7494716|FG007|STARTED|Overall Study||55
6571198|NCT01855945|7494717|FG008|STARTED|Overall Study||48
6571199|NCT01855945|7494718|FG009|STARTED|Overall Study||51
6571200|NCT01855945|7494719|FG010|STARTED|Overall Study||51
6571201|NCT01855945|7494720|FG011|STARTED|Overall Study||52
6571202|NCT01855945|7494709|FG000|COMPLETED|Overall Study||38
6571203|NCT01855945|7494710|FG001|COMPLETED|Overall Study||44
6571204|NCT01855945|7494711|FG002|COMPLETED|Overall Study||39
6571205|NCT01855945|7494712|FG003|COMPLETED|Overall Study||49
6571206|NCT01855945|7494713|FG004|COMPLETED|Overall Study||50
6571207|NCT01855945|7494714|FG005|COMPLETED|Overall Study||50
6571208|NCT01855945|7494715|FG006|COMPLETED|Overall Study||43
6571209|NCT01855945|7494716|FG007|COMPLETED|Overall Study||47
6571210|NCT01855945|7494717|FG008|COMPLETED|Overall Study||46
6571211|NCT01855945|7494718|FG009|COMPLETED|Overall Study||49
6571212|NCT01855945|7494719|FG010|COMPLETED|Overall Study||46
6571213|NCT01855945|7494720|FG011|COMPLETED|Overall Study||49
6571214|NCT01855945|7494709|FG000|NOT COMPLETED|Overall Study||16
6571215|NCT01855945|7494710|FG001|NOT COMPLETED|Overall Study||11
6571216|NCT01855945|7494711|FG002|NOT COMPLETED|Overall Study||12
6571217|NCT01855945|7494712|FG003|NOT COMPLETED|Overall Study||4
6571218|NCT01855945|7494713|FG004|NOT COMPLETED|Overall Study||1
6571219|NCT01855945|7494714|FG005|NOT COMPLETED|Overall Study||3
6571220|NCT01855945|7494715|FG006|NOT COMPLETED|Overall Study||10
6571221|NCT01855945|7494716|FG007|NOT COMPLETED|Overall Study||8
6571222|NCT01855945|7494717|FG008|NOT COMPLETED|Overall Study||2
6571223|NCT01855945|7494718|FG009|NOT COMPLETED|Overall Study||2
6571224|NCT01855945|7494719|FG010|NOT COMPLETED|Overall Study||5
6571225|NCT01855945|7494720|FG011|NOT COMPLETED|Overall Study||3
6571226|NCT01855958|7494785|FG000|STARTED|Overall Study||13
6571227|NCT01855958|7494786|FG001|STARTED|Overall Study||13
6571228|NCT01855958|7494785|FG000|COMPLETED|Overall Study||12
6571229|NCT01855958|7494786|FG001|COMPLETED|Overall Study||13
6571230|NCT01855958|7494785|FG000|NOT COMPLETED|Overall Study||1
6571231|NCT01855958|7494786|FG001|NOT COMPLETED|Overall Study||0
6571232|NCT01855997|7494794|FG000|STARTED|Overall Study||1669
6571233|NCT01855997|7494794|FG000|COMPLETED|Overall Study||1669
6571234|NCT01855997|7494794|FG000|NOT COMPLETED|Overall Study||0
6571235|NCT01856114|7494808|FG000|STARTED|Overall Study||11
6571236|NCT01856114|7494809|FG001|STARTED|Overall Study||11
6571237|NCT01856114|7494808|FG000|COMPLETED|Overall Study||9
6571238|NCT01856114|7494809|FG001|COMPLETED|Overall Study||11
6571239|NCT01856114|7494808|FG000|NOT COMPLETED|Overall Study||2
6571240|NCT01856114|7494809|FG001|NOT COMPLETED|Overall Study||0
6571241|NCT01856218|7494815|FG000|STARTED|First Phase||3
6571242|NCT01856218|7494815|FG000|COMPLETED|First Phase||3
6571243|NCT01856218|7494815|FG000|NOT COMPLETED|First Phase||0
6571244|NCT01856218|7494815|FG000|STARTED|Long-Term Extension Phase||3
6571245|NCT01856218|7494815|FG000|COMPLETED|Long-Term Extension Phase||3
6571246|NCT01856218|7494815|FG000|NOT COMPLETED|Long-Term Extension Phase||0
6571247|NCT01856257|7494822|FG000|STARTED|Overall Study||29
6571248|NCT01856257|7494823|FG001|STARTED|Overall Study||29
6571249|NCT01856257|7494824|FG002|STARTED|Overall Study||11
6571250|NCT01856257|7494825|FG003|STARTED|Overall Study||2
6571251|NCT01856257|7494822|FG000|COMPLETED|Overall Study||26
6571252|NCT01856257|7494823|FG001|COMPLETED|Overall Study||28
6571253|NCT01856257|7494824|FG002|COMPLETED|Overall Study||11
6571254|NCT01856257|7494825|FG003|COMPLETED|Overall Study||0
6571255|NCT01856257|7494822|FG000|NOT COMPLETED|Overall Study||3
6571256|NCT01856257|7494823|FG001|NOT COMPLETED|Overall Study||1
6571257|NCT01856257|7494824|FG002|NOT COMPLETED|Overall Study||0
6571258|NCT01856257|7494825|FG003|NOT COMPLETED|Overall Study||2
6571259|NCT01856309|7494838|FG000|STARTED|Overall Study||305
6571260|NCT01856309|7494839|FG001|STARTED|Overall Study||291
6571261|NCT01856309|7494840|FG002|STARTED|Overall Study||606
6571262|NCT01856309|7494841|FG003|STARTED|Overall Study||618
6571263|NCT01856309|7494838|FG000|Participants From Study CNTO136ARA3002|Overall Study||197
6571264|NCT01856309|7494839|FG001|Participants From Study CNTO136ARA3002|Overall Study||187
6571265|NCT01856309|7494840|FG002|Participants From Study CNTO136ARA3002|Overall Study||405
6571266|NCT01856309|7494841|FG003|Participants From Study CNTO136ARA3002|Overall Study||412
6571267|NCT01856309|7494838|FG000|Participants From Study CNTO136ARA3003|Overall Study||108
6571268|NCT01856309|7494839|FG001|Participants From Study CNTO136ARA3003|Overall Study||104
6571269|NCT01856309|7494840|FG002|Participants From Study CNTO136ARA3003|Overall Study||201
6571270|NCT01856309|7494841|FG003|Participants From Study CNTO136ARA3003|Overall Study||206
6571271|NCT01856309|7494838|FG000|Treated Partcipants|Overall Study||305
6571272|NCT01856309|7494839|FG001|Treated Partcipants|Overall Study||290
6571273|NCT01856309|7494840|FG002|Treated Partcipants|Overall Study||605
6571274|NCT01856309|7494841|FG003|Treated Partcipants|Overall Study||618
6571275|NCT01856309|7494838|FG000|COMPLETED|Overall Study||6
6571276|NCT01856309|7494839|FG001|COMPLETED|Overall Study||3
6571277|NCT01856309|7494840|FG002|COMPLETED|Overall Study||11
6571278|NCT01856309|7494841|FG003|COMPLETED|Overall Study||9
6571279|NCT01856309|7494838|FG000|NOT COMPLETED|Overall Study||299
6571280|NCT01856309|7494839|FG001|NOT COMPLETED|Overall Study||288
6571281|NCT01856309|7494840|FG002|NOT COMPLETED|Overall Study||595
6571282|NCT01856309|7494841|FG003|NOT COMPLETED|Overall Study||609
6571283|NCT01856491|7494851|FG000|STARTED|Overall Study||167
6571284|NCT01856491|7494851|FG000|COMPLETED|Overall Study||152
6571285|NCT01856491|7494851|FG000|NOT COMPLETED|Overall Study||15
6571286|NCT01856530|7494857|FG000|STARTED|Overall Study||27
6571287|NCT01856530|7494858|FG001|STARTED|Overall Study||27
6571288|NCT01856530|7494857|FG000|COMPLETED|Overall Study||27
6571289|NCT01856530|7494858|FG001|COMPLETED|Overall Study||27
6571290|NCT01856530|7494857|FG000|NOT COMPLETED|Overall Study||0
6571291|NCT01856530|7494858|FG001|NOT COMPLETED|Overall Study||0
6571292|NCT01856543|7494866|FG000|STARTED|Overall Study||73
6571293|NCT01856543|7494867|FG001|STARTED|Overall Study||70
6571294|NCT01856543|7494866|FG000|COMPLETED|Overall Study||60
6571295|NCT01856543|7494867|FG001|COMPLETED|Overall Study||64
6571296|NCT01856543|7494866|FG000|NOT COMPLETED|Overall Study||13
6571297|NCT01856543|7494867|FG001|NOT COMPLETED|Overall Study||6
6571298|NCT01856569|7494874|FG000|STARTED|Overall Study||152
6571299|NCT01856569|7494874|FG000|Full Analysis Set|Overall Study||144
6571300|NCT01856569|7494874|FG000|COMPLETED|Overall Study||139
6571301|NCT01856569|7494874|FG000|NOT COMPLETED|Overall Study||13
6623571|NCT02208310|7550728|FG000|STARTED|Overall Study||6
6623572|NCT02208310|7550729|FG001|STARTED|Overall Study||5
6623573|NCT02208310|7550728|FG000|Day 180|Overall Study||0
6623574|NCT02208310|7550729|FG001|Day 180|Overall Study||1
6623575|NCT02208310|7550728|FG000|COMPLETED|Overall Study||0
6623576|NCT02208310|7550729|FG001|COMPLETED|Overall Study||0
6623577|NCT02208310|7550728|FG000|NOT COMPLETED|Overall Study||6
6623578|NCT02208310|7550729|FG001|NOT COMPLETED|Overall Study||5
6623579|NCT02208349|7550737|FG000|STARTED|Initial 6 Months||16
6623580|NCT02208349|7550738|FG001|STARTED|Initial 6 Months||9
6623581|NCT02208349|7550737|FG000|COMPLETED|Initial 6 Months||16
6623582|NCT02208349|7550738|FG001|COMPLETED|Initial 6 Months||9
6623583|NCT02208349|7550737|FG000|NOT COMPLETED|Initial 6 Months||0
6623584|NCT02208349|7550738|FG001|NOT COMPLETED|Initial 6 Months||0
6623585|NCT02208349|7550737|FG000|STARTED|Second 6 Months||11
6623586|NCT02208349|7550738|FG001|STARTED|Second 6 Months||7
6623587|NCT02208349|7550737|FG000|COMPLETED|Second 6 Months||11
6623588|NCT02208349|7550738|FG001|COMPLETED|Second 6 Months||7
6623589|NCT02208349|7550737|FG000|NOT COMPLETED|Second 6 Months||0
6623590|NCT02208349|7550738|FG001|NOT COMPLETED|Second 6 Months||0
6623591|NCT02208349|7550737|FG000|STARTED|Third 6 Month||6
6623592|NCT02208349|7550738|FG001|STARTED|Third 6 Month||3
6623593|NCT02208349|7550737|FG000|COMPLETED|Third 6 Month||6
6623594|NCT02208349|7550738|FG001|COMPLETED|Third 6 Month||3
6623595|NCT02208349|7550737|FG000|NOT COMPLETED|Third 6 Month||0
6623596|NCT02208349|7550738|FG001|NOT COMPLETED|Third 6 Month||0
6623597|NCT02208349|7550737|FG000|STARTED|Fourth 6 Month||14
6623598|NCT02208349|7550738|FG001|STARTED|Fourth 6 Month||2
6623599|NCT02208349|7550737|FG000|COMPLETED|Fourth 6 Month||14
6623600|NCT02208349|7550738|FG001|COMPLETED|Fourth 6 Month||2
6623601|NCT02208349|7550737|FG000|NOT COMPLETED|Fourth 6 Month||0
6623602|NCT02208349|7550738|FG001|NOT COMPLETED|Fourth 6 Month||0
6623603|NCT02208349|7550737|FG000|STARTED|Fifth 6 Month||7
6623604|NCT02208349|7550738|FG001|STARTED|Fifth 6 Month||2
6623605|NCT02208349|7550737|FG000|COMPLETED|Fifth 6 Month||7
6623606|NCT02208349|7550738|FG001|COMPLETED|Fifth 6 Month||2
6623607|NCT02208349|7550737|FG000|NOT COMPLETED|Fifth 6 Month||0
6623608|NCT02208349|7550738|FG001|NOT COMPLETED|Fifth 6 Month||0
6623609|NCT02208349|7550737|FG000|STARTED|Sixth 6 Month||3
6623610|NCT02208349|7550738|FG001|STARTED|Sixth 6 Month||2
6623611|NCT02208349|7550737|FG000|COMPLETED|Sixth 6 Month||3
6623612|NCT02208349|7550738|FG001|COMPLETED|Sixth 6 Month||2
6623613|NCT02208349|7550737|FG000|NOT COMPLETED|Sixth 6 Month||0
6623614|NCT02208349|7550738|FG001|NOT COMPLETED|Sixth 6 Month||0
6623615|NCT02208466|7550749|FG000|STARTED|Overall Study||9
6623616|NCT02208466|7550750|FG001|STARTED|Overall Study||10
6623617|NCT02208466|7550751|FG002|STARTED|Overall Study||8
6623618|NCT02208466|7550749|FG000|COMPLETED|Overall Study||9
6623619|NCT02208466|7550750|FG001|COMPLETED|Overall Study||10
6623620|NCT02208466|7550751|FG002|COMPLETED|Overall Study||8
6623621|NCT02208466|7550749|FG000|NOT COMPLETED|Overall Study||0
6623622|NCT02208466|7550750|FG001|NOT COMPLETED|Overall Study||0
6623623|NCT02208466|7550751|FG002|NOT COMPLETED|Overall Study||0
6623624|NCT02208843|7550759|FG000|STARTED|Overall Study||60
6623625|NCT02208843|7550759|FG000|COMPLETED|Overall Study||0
6623626|NCT02208843|7550759|FG000|NOT COMPLETED|Overall Study||60
6623627|NCT02208999|7550765|FG000|STARTED|Overall Study||106
6623628|NCT02208999|7550765|FG000|COMPLETED|Overall Study||105
6623629|NCT02208999|7550765|FG000|NOT COMPLETED|Overall Study||1
6623630|NCT02209064|7550784|FG000|STARTED|Overall Study||25
6623631|NCT02209064|7550784|FG000|COMPLETED|Overall Study||25
6623632|NCT02209064|7550784|FG000|NOT COMPLETED|Overall Study||0
6623633|NCT02209181|7550793|FG000|STARTED|Overall Study||67
6623634|NCT02209181|7550794|FG001|STARTED|Overall Study||67
6623635|NCT02209181|7550795|FG002|STARTED|Overall Study||69
6623636|NCT02209181|7550796|FG003|STARTED|Overall Study||66
6623637|NCT02209181|7550793|FG000|COMPLETED|Overall Study||66
6623638|NCT02209181|7550794|FG001|COMPLETED|Overall Study||66
6623639|NCT02209181|7550795|FG002|COMPLETED|Overall Study||68
6623640|NCT02209181|7550796|FG003|COMPLETED|Overall Study||66
6623641|NCT02209181|7550793|FG000|NOT COMPLETED|Overall Study||1
6623642|NCT02209181|7550794|FG001|NOT COMPLETED|Overall Study||1
6623643|NCT02209181|7550795|FG002|NOT COMPLETED|Overall Study||1
6623644|NCT02209181|7550796|FG003|NOT COMPLETED|Overall Study||0
6623645|NCT02209259|7550809|FG000|STARTED|Overall Study||56
6623646|NCT02209259|7550810|FG001|STARTED|Overall Study||56
6623647|NCT02209259|7550811|FG002|STARTED|Overall Study||56
6623648|NCT02209259|7550809|FG000|COMPLETED|Overall Study||56
6571302|NCT01856582|7494878|FG000|STARTED|Overall Study||23
6571303|NCT01856582|7494878|FG000|COMPLETED|Overall Study||22
6571304|NCT01856582|7494878|FG000|NOT COMPLETED|Overall Study||1
6571305|NCT01856595|7494891|FG000|STARTED|Overall Study||18
6571306|NCT01856595|7494892|FG001|STARTED|Overall Study||12
6571307|NCT01856595|7494893|FG002|STARTED|Overall Study||12
6571308|NCT01856595|7494894|FG003|STARTED|Overall Study||12
6571309|NCT01856595|7494895|FG004|STARTED|Overall Study||14
6571310|NCT01856595|7494896|FG005|STARTED|Overall Study||12
6571311|NCT01856595|7494897|FG006|STARTED|Overall Study||13
6571312|NCT01856595|7494898|FG007|STARTED|Overall Study||10
6571313|NCT01856595|7494899|FG008|STARTED|Overall Study||14
6571314|NCT01856595|7494891|FG000|COMPLETED|Overall Study||18
6571315|NCT01856595|7494892|FG001|COMPLETED|Overall Study||11
6571316|NCT01856595|7494893|FG002|COMPLETED|Overall Study||12
6571317|NCT01856595|7494894|FG003|COMPLETED|Overall Study||12
6571318|NCT01856595|7494895|FG004|COMPLETED|Overall Study||14
6571319|NCT01856595|7494896|FG005|COMPLETED|Overall Study||12
6571320|NCT01856595|7494897|FG006|COMPLETED|Overall Study||12
6571321|NCT01856595|7494898|FG007|COMPLETED|Overall Study||10
6571322|NCT01856595|7494899|FG008|COMPLETED|Overall Study||14
6571323|NCT01856595|7494891|FG000|NOT COMPLETED|Overall Study||0
6571324|NCT01856595|7494892|FG001|NOT COMPLETED|Overall Study||1
6571325|NCT01856595|7494893|FG002|NOT COMPLETED|Overall Study||0
6571326|NCT01856595|7494894|FG003|NOT COMPLETED|Overall Study||0
6571327|NCT01856595|7494895|FG004|NOT COMPLETED|Overall Study||0
6571328|NCT01856595|7494896|FG005|NOT COMPLETED|Overall Study||0
6571329|NCT01856595|7494897|FG006|NOT COMPLETED|Overall Study||1
6571330|NCT01856595|7494898|FG007|NOT COMPLETED|Overall Study||0
6571331|NCT01856595|7494899|FG008|NOT COMPLETED|Overall Study||0
6571332|NCT01856673|7494937|FG000|STARTED|Overall Study||175
6571333|NCT01856673|7494938|FG001|STARTED|Overall Study||175
6571334|NCT01856673|7494939|FG002|STARTED|Overall Study||171
6571335|NCT01856673|7494937|FG000|Buenaventura Participants|Overall Study||92
6571336|NCT01856673|7494938|FG001|Buenaventura Participants|Overall Study||89
6571337|NCT01856673|7494939|FG002|Buenaventura Participants|Overall Study||88
6571338|NCT01856673|7494937|FG000|Quibdó Participants|Overall Study||83
6571339|NCT01856673|7494938|FG001|Quibdó Participants|Overall Study||86
6571340|NCT01856673|7494939|FG002|Quibdó Participants|Overall Study||83
6571341|NCT01856673|7494937|FG000|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|80
6571342|NCT01856673|7494938|FG001|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
6571343|NCT01856673|7494939|FG002|COMPLETED|Overall Study||137
6571344|NCT01856673|7494937|FG000|NOT COMPLETED|Overall Study||95
6571345|NCT01856673|7494938|FG001|NOT COMPLETED|Overall Study||85
6571346|NCT01856673|7494939|FG002|NOT COMPLETED|Overall Study||34
6571347|NCT01856686|7494949|FG000|STARTED|Overall Study||31
6255629|NCT02639546|7154530|FG004|Tumor Type - Neuroblastoma|Overall Study||0
6255630|NCT02639546|7154531|FG005|Tumor Type - Neuroblastoma|Overall Study||0
6255631|NCT02639546|7154532|FG006|Tumor Type - Neuroblastoma|Overall Study||0
6255632|NCT02639546|7154533|FG007|Tumor Type - Neuroblastoma|Overall Study||0
6571348|NCT01856686|7494950|FG001|STARTED|Overall Study||33
6571349|NCT01856686|7494949|FG000|COMPLETED|Overall Study||26
6571350|NCT01856686|7494950|FG001|COMPLETED|Overall Study||22
6571351|NCT01856686|7494949|FG000|NOT COMPLETED|Overall Study||5
6571352|NCT01856686|7494950|FG001|NOT COMPLETED|Overall Study||11
6571353|NCT01856712|7494958|FG000|STARTED|Overall Study||23
6571354|NCT01856712|7494959|FG001|STARTED|Overall Study|1 received oral in error thus randomized.|22
6571355|NCT01856712|7494958|FG000|Lost to 14 Day Follow up|Overall Study||6
6571356|NCT01856712|7494959|FG001|Lost to 14 Day Follow up|Overall Study||2
6571357|NCT01856712|7494958|FG000|Lost to 45 Day Follow up|Overall Study||1
6571358|NCT01856712|7494959|FG001|Lost to 45 Day Follow up|Overall Study||1
6571359|NCT01856712|7494958|FG000|COMPLETED|Overall Study||16
6571360|NCT01856712|7494959|FG001|COMPLETED|Overall Study||19
6571361|NCT01856712|7494958|FG000|NOT COMPLETED|Overall Study||7
6571362|NCT01856712|7494959|FG001|NOT COMPLETED|Overall Study||3
6571363|NCT01856764|7494971|FG000|STARTED|Overall Study||20
6571364|NCT01856764|7494972|FG001|STARTED|Overall Study||20
6571365|NCT01856764|7494971|FG000|COMPLETED|Overall Study||20
6571366|NCT01856764|7494972|FG001|COMPLETED|Overall Study||20
6571367|NCT01856764|7494971|FG000|NOT COMPLETED|Overall Study||0
6571368|NCT01856764|7494972|FG001|NOT COMPLETED|Overall Study||0
6571369|NCT01856790|7494978|FG000|STARTED|Closed Loop Control||15
6571370|NCT01856790|7494978|FG000|COMPLETED|Closed Loop Control||13
6571371|NCT01856790|7494978|FG000|NOT COMPLETED|Closed Loop Control||2
6571372|NCT01856790|7494978|FG000|STARTED|Closed Loop Control + Liraglutide||13
6571373|NCT01856790|7494978|FG000|COMPLETED|Closed Loop Control + Liraglutide||11
6571374|NCT01856790|7494978|FG000|NOT COMPLETED|Closed Loop Control + Liraglutide||2
6571375|NCT01856907|7494992|FG000|STARTED|Overall Study||12
6571376|NCT01856907|7494993|FG001|STARTED|Overall Study||12
6571377|NCT01856907|7494994|FG002|STARTED|Overall Study||12
6571378|NCT01856907|7494992|FG000|COMPLETED|Overall Study||12
6571379|NCT01856907|7494993|FG001|COMPLETED|Overall Study||9
6571380|NCT01856907|7494994|FG002|COMPLETED|Overall Study||12
6571381|NCT01856907|7494992|FG000|NOT COMPLETED|Overall Study||0
6571382|NCT01856907|7494993|FG001|NOT COMPLETED|Overall Study||3
6571383|NCT01856907|7494994|FG002|NOT COMPLETED|Overall Study||0
6571384|NCT01856933|7495005|FG000|STARTED|Overall Study||6
6571385|NCT01856933|7495005|FG000|COMPLETED|Overall Study||6
6571386|NCT01856933|7495005|FG000|NOT COMPLETED|Overall Study||0
6571387|NCT01857102|7495009|FG000|STARTED|Period 1||58
6571388|NCT01857102|7495010|FG001|STARTED|Period 1||56
6571389|NCT01857102|7495009|FG000|Habitual Users|Period 1||51
6571390|NCT01857102|7495010|FG001|Habitual Users|Period 1||52
6571391|NCT01857102|7495009|FG000|Neophtyes|Period 1||7
6571392|NCT01857102|7495010|FG001|Neophtyes|Period 1||4
6571393|NCT01857102|7495009|FG000|COMPLETED|Period 1||55
6255633|NCT02639546|7154526|FG000|Tumor Type - High-Grade Glioma|Overall Study||3
6255634|NCT02639546|7154527|FG001|Tumor Type - High-Grade Glioma|Overall Study||1
6255635|NCT02639546|7154528|FG002|Tumor Type - High-Grade Glioma|Overall Study||0
6571394|NCT01857102|7495010|FG001|COMPLETED|Period 1||51
6571395|NCT01857102|7495009|FG000|NOT COMPLETED|Period 1||3
6571396|NCT01857102|7495010|FG001|NOT COMPLETED|Period 1||5
6571397|NCT01857102|7495009|FG000|STARTED|Period 2||55
6571398|NCT01857102|7495010|FG001|STARTED|Period 2||51
6571399|NCT01857102|7495009|FG000|Habitual Users|Period 2||48
6571400|NCT01857102|7495010|FG001|Habitual Users|Period 2||47
6571401|NCT01857102|7495009|FG000|Neophytes|Period 2||7
6571402|NCT01857102|7495010|FG001|Neophytes|Period 2||4
6571403|NCT01857102|7495009|FG000|COMPLETED|Period 2||53
6571404|NCT01857102|7495010|FG001|COMPLETED|Period 2||51
6571405|NCT01857102|7495009|FG000|NOT COMPLETED|Period 2||2
6571406|NCT01857102|7495010|FG001|NOT COMPLETED|Period 2||0
6571407|NCT01857206|7495020|FG000|STARTED|Overall Study||1372
6571408|NCT01857206|7495021|FG001|STARTED|Overall Study||683
6571409|NCT01857206|7495020|FG000|COMPLETED|Overall Study||1359
6571410|NCT01857206|7495021|FG001|COMPLETED|Overall Study||673
6571411|NCT01857206|7495020|FG000|NOT COMPLETED|Overall Study||13
6571412|NCT01857206|7495021|FG001|NOT COMPLETED|Overall Study||10
6571413|NCT01857232|7495036|FG000|STARTED|Overall Study||69
6571414|NCT01857232|7495037|FG001|STARTED|Overall Study||67
6571415|NCT01857232|7495038|FG002|STARTED|Overall Study||67
6571416|NCT01857232|7495039|FG003|STARTED|Overall Study||70
6571417|NCT01857232|7495040|FG004|STARTED|Overall Study||69
6571418|NCT01857232|7495036|FG000|Evaluable ITT|Overall Study||66
6571419|NCT01857232|7495037|FG001|Evaluable ITT|Overall Study||66
6571420|NCT01857232|7495038|FG002|Evaluable ITT|Overall Study||63
6571421|NCT01857232|7495039|FG003|Evaluable ITT|Overall Study||68
6571422|NCT01857232|7495040|FG004|Evaluable ITT|Overall Study||65
6571423|NCT01857232|7495036|FG000|COMPLETED|Overall Study||61
6571424|NCT01857232|7495037|FG001|COMPLETED|Overall Study||65
6571425|NCT01857232|7495038|FG002|COMPLETED|Overall Study||63
6571426|NCT01857232|7495039|FG003|COMPLETED|Overall Study||68
6571427|NCT01857232|7495040|FG004|COMPLETED|Overall Study||63
6571428|NCT01857232|7495036|FG000|NOT COMPLETED|Overall Study||8
6571429|NCT01857232|7495037|FG001|NOT COMPLETED|Overall Study||2
6571430|NCT01857232|7495038|FG002|NOT COMPLETED|Overall Study||4
6571431|NCT01857232|7495039|FG003|NOT COMPLETED|Overall Study||2
6571432|NCT01857232|7495040|FG004|NOT COMPLETED|Overall Study||6
6571433|NCT01857258|7495055|FG000|STARTED|First Intervention (3 h Postprandially)||8
6571434|NCT01857258|7495056|FG001|STARTED|First Intervention (3 h Postprandially)||7
6571435|NCT01857258|7495055|FG000|COMPLETED|First Intervention (3 h Postprandially)||8
6571436|NCT01857258|7495056|FG001|COMPLETED|First Intervention (3 h Postprandially)||7
6571437|NCT01857258|7495055|FG000|NOT COMPLETED|First Intervention (3 h Postprandially)||0
6571438|NCT01857258|7495056|FG001|NOT COMPLETED|First Intervention (3 h Postprandially)||0
6571439|NCT01857258|7495055|FG000|STARTED|Wash-out Period (7 Days)||8
6571440|NCT01857258|7495056|FG001|STARTED|Wash-out Period (7 Days)||7
6571441|NCT01857258|7495055|FG000|COMPLETED|Wash-out Period (7 Days)||8
6571442|NCT01857258|7495056|FG001|COMPLETED|Wash-out Period (7 Days)||7
6571443|NCT01857258|7495055|FG000|NOT COMPLETED|Wash-out Period (7 Days)||0
6571444|NCT01857258|7495056|FG001|NOT COMPLETED|Wash-out Period (7 Days)||0
6571445|NCT01857258|7495055|FG000|STARTED|Second Intervention (3 h Postprandially)||8
6571446|NCT01857258|7495056|FG001|STARTED|Second Intervention (3 h Postprandially)||7
6571447|NCT01857258|7495055|FG000|COMPLETED|Second Intervention (3 h Postprandially)||8
6571448|NCT01857258|7495056|FG001|COMPLETED|Second Intervention (3 h Postprandially)||7
6571449|NCT01857258|7495055|FG000|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
6571450|NCT01857258|7495056|FG001|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
6571451|NCT01857297|7495066|FG000|STARTED|Overall Study||60
6571452|NCT01857297|7495067|FG001|STARTED|Overall Study||60
6571453|NCT01857297|7495066|FG000|COMPLETED|Overall Study||60
6571454|NCT01857297|7495067|FG001|COMPLETED|Overall Study||60
6571455|NCT01857297|7495066|FG000|NOT COMPLETED|Overall Study||0
6571456|NCT01857297|7495067|FG001|NOT COMPLETED|Overall Study||0
6571457|NCT01857310|7495075|FG000|STARTED|Primary Analysis: Live Birth|Male partner|1185
6571458|NCT01857310|7495076|FG001|STARTED|Primary Analysis: Live Birth|Male partner|1185
6571459|NCT01857310|7495075|FG000|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
6571460|NCT01857310|7495076|FG001|COMPLETED|Primary Analysis: Live Birth|Chart abstraction of whether live birth occurred|1185
6571461|NCT01857310|7495075|FG000|NOT COMPLETED|Primary Analysis: Live Birth||0
6571462|NCT01857310|7495076|FG001|NOT COMPLETED|Primary Analysis: Live Birth||0
6571463|NCT01857310|7495075|FG000|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
6571464|NCT01857310|7495076|FG001|STARTED|Secondary Analysis: Semen Quality at 6m|Male partner|1185
6571465|NCT01857310|7495075|FG000|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|870
6623649|NCT02209259|7550810|FG001|COMPLETED|Overall Study||56
6571466|NCT01857310|7495076|FG001|COMPLETED|Secondary Analysis: Semen Quality at 6m|Completed 6-month study visit|903
6571467|NCT01857310|7495075|FG000|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||315
6571468|NCT01857310|7495076|FG001|NOT COMPLETED|Secondary Analysis: Semen Quality at 6m||282
6571469|NCT01857323|7495082|FG000|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
6571470|NCT01857323|7495082|FG000|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
6571471|NCT01857323|7495082|FG000|COMPLETED|Overall Study||253
6571472|NCT01857323|7495082|FG000|NOT COMPLETED|Overall Study||64
6571473|NCT01857362|7495086|FG000|STARTED|Overall Study||6
6571474|NCT01857362|7495087|FG001|STARTED|Overall Study||6
6571475|NCT01857362|7495086|FG000|COMPLETED|Overall Study||6
6571476|NCT01857362|7495087|FG001|COMPLETED|Overall Study||6
6571477|NCT01857362|7495086|FG000|NOT COMPLETED|Overall Study||0
6571478|NCT01857362|7495087|FG001|NOT COMPLETED|Overall Study||0
6571479|NCT01857531|7495093|FG000|STARTED|Overall Study||16
6571480|NCT01857531|7495093|FG000|COMPLETED|Overall Study||12
6571481|NCT01857531|7495093|FG000|NOT COMPLETED|Overall Study||4
6571482|NCT01857583|7495101|FG000|STARTED|Overall Study||30
6571483|NCT01857583|7495102|FG001|STARTED|Overall Study||7
6571484|NCT01857583|7495103|FG002|STARTED|Overall Study||22
6571485|NCT01857583|7495104|FG003|STARTED|Overall Study||21
6571486|NCT01857583|7495101|FG000|Safety Analysis Population|Overall Study||30
6571487|NCT01857583|7495102|FG001|Safety Analysis Population|Overall Study||7
6571488|NCT01857583|7495103|FG002|Safety Analysis Population|Overall Study||22
6571489|NCT01857583|7495104|FG003|Safety Analysis Population|Overall Study||20
6571490|NCT01857583|7495101|FG000|COMPLETED|Overall Study||29
6571491|NCT01857583|7495102|FG001|COMPLETED|Overall Study||6
6571492|NCT01857583|7495103|FG002|COMPLETED|Overall Study||19
6571493|NCT01857583|7495104|FG003|COMPLETED|Overall Study||17
6571494|NCT01857583|7495101|FG000|NOT COMPLETED|Overall Study||1
6571495|NCT01857583|7495102|FG001|NOT COMPLETED|Overall Study||1
6571496|NCT01857583|7495103|FG002|NOT COMPLETED|Overall Study||3
6571497|NCT01857583|7495104|FG003|NOT COMPLETED|Overall Study||4
6571498|NCT01857622|7495117|FG000|STARTED|Overall Study||50
6571499|NCT01857622|7495118|FG001|STARTED|Overall Study||22
6571500|NCT01857622|7495119|FG002|STARTED|Overall Study||21
6571501|NCT01857622|7495117|FG000|COMPLETED|Overall Study||39
6571502|NCT01857622|7495118|FG001|COMPLETED|Overall Study||21
6571503|NCT01857622|7495119|FG002|COMPLETED|Overall Study||19
6571504|NCT01857622|7495117|FG000|NOT COMPLETED|Overall Study||11
6571505|NCT01857622|7495118|FG001|NOT COMPLETED|Overall Study||1
6571506|NCT01857622|7495119|FG002|NOT COMPLETED|Overall Study||2
6571507|NCT01857713|7495127|FG000|STARTED|Overall Study||95
6571508|NCT01857713|7495127|FG000|COMPLETED|Overall Study||89
6571509|NCT01857713|7495127|FG000|NOT COMPLETED|Overall Study||6
6571510|NCT01857869|7495143|FG000|STARTED|Primary/Challenge Phase||34
6571511|NCT01857869|7495144|FG001|STARTED|Primary/Challenge Phase||17
6571512|NCT01857869|7495145|FG002|STARTED|Primary/Challenge Phase||12
6571513|NCT01857869|7495146|FG003|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571514|NCT01857869|7495147|FG004|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571515|NCT01857869|7495148|FG005|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571516|NCT01857869|7495149|FG006|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571517|NCT01857869|7495150|FG007|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571518|NCT01857869|7495151|FG008|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571519|NCT01857869|7495152|FG009|STARTED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571520|NCT01857869|7495143|FG000|COMPLETED|Primary/Challenge Phase||29
6571521|NCT01857869|7495144|FG001|COMPLETED|Primary/Challenge Phase||16
6571522|NCT01857869|7495145|FG002|COMPLETED|Primary/Challenge Phase||12
6571523|NCT01857869|7495146|FG003|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571524|NCT01857869|7495147|FG004|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571525|NCT01857869|7495148|FG005|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571526|NCT01857869|7495149|FG006|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571527|NCT01857869|7495150|FG007|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571528|NCT01857869|7495151|FG008|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571529|NCT01857869|7495152|FG009|COMPLETED|Primary/Challenge Phase|Only GSK257049-0,1,7M,GSK257049-0,1,2M and Infectivity Control Groups were included in Primary phase|0
6571530|NCT01857869|7495143|FG000|NOT COMPLETED|Primary/Challenge Phase||5
6571531|NCT01857869|7495144|FG001|NOT COMPLETED|Primary/Challenge Phase||1
6571532|NCT01857869|7495145|FG002|NOT COMPLETED|Primary/Challenge Phase||0
6571533|NCT01857869|7495146|FG003|NOT COMPLETED|Primary/Challenge Phase||0
6571534|NCT01857869|7495147|FG004|NOT COMPLETED|Primary/Challenge Phase||0
6571535|NCT01857869|7495148|FG005|NOT COMPLETED|Primary/Challenge Phase||0
6571536|NCT01857869|7495149|FG006|NOT COMPLETED|Primary/Challenge Phase||0
6571537|NCT01857869|7495150|FG007|NOT COMPLETED|Primary/Challenge Phase||0
6571538|NCT01857869|7495151|FG008|NOT COMPLETED|Primary/Challenge Phase||0
6571539|NCT01857869|7495152|FG009|NOT COMPLETED|Primary/Challenge Phase||0
6571540|NCT01857869|7495143|FG000|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6571541|NCT01857869|7495144|FG001|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6571542|NCT01857869|7495145|FG002|STARTED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6571543|NCT01857869|7495146|FG003|STARTED|Booster/Rechallenge Phase||9
6571544|NCT01857869|7495147|FG004|STARTED|Booster/Rechallenge Phase||10
6571545|NCT01857869|7495148|FG005|STARTED|Booster/Rechallenge Phase||2
6571546|NCT01857869|7495149|FG006|STARTED|Booster/Rechallenge Phase||5
6571547|NCT01857869|7495150|FG007|STARTED|Booster/Rechallenge Phase||4
6571548|NCT01857869|7495151|FG008|STARTED|Booster/Rechallenge Phase||3
6571549|NCT01857869|7495152|FG009|STARTED|Booster/Rechallenge Phase||6
6571550|NCT01857869|7495143|FG000|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6571551|NCT01857869|7495144|FG001|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6571552|NCT01857869|7495145|FG002|COMPLETED|Booster/Rechallenge Phase|GSK257049-0,1,7M, GSK257049-0,1,2M and Infectivity Control Groups were not included in Booster phase|0
6571553|NCT01857869|7495146|FG003|COMPLETED|Booster/Rechallenge Phase||7
6571554|NCT01857869|7495147|FG004|COMPLETED|Booster/Rechallenge Phase||10
6571555|NCT01857869|7495148|FG005|COMPLETED|Booster/Rechallenge Phase||2
6571556|NCT01857869|7495149|FG006|COMPLETED|Booster/Rechallenge Phase||5
6571557|NCT01857869|7495150|FG007|COMPLETED|Booster/Rechallenge Phase||4
6571558|NCT01857869|7495151|FG008|COMPLETED|Booster/Rechallenge Phase||3
6571559|NCT01857869|7495152|FG009|COMPLETED|Booster/Rechallenge Phase||6
6571560|NCT01857869|7495143|FG000|NOT COMPLETED|Booster/Rechallenge Phase||0
6571561|NCT01857869|7495144|FG001|NOT COMPLETED|Booster/Rechallenge Phase||0
6571562|NCT01857869|7495145|FG002|NOT COMPLETED|Booster/Rechallenge Phase||0
6571563|NCT01857869|7495146|FG003|NOT COMPLETED|Booster/Rechallenge Phase||2
6571564|NCT01857869|7495147|FG004|NOT COMPLETED|Booster/Rechallenge Phase||0
6571565|NCT01857869|7495148|FG005|NOT COMPLETED|Booster/Rechallenge Phase||0
6571566|NCT01857869|7495149|FG006|NOT COMPLETED|Booster/Rechallenge Phase||0
6571567|NCT01857869|7495150|FG007|NOT COMPLETED|Booster/Rechallenge Phase||0
6571568|NCT01857869|7495151|FG008|NOT COMPLETED|Booster/Rechallenge Phase||0
6571569|NCT01857869|7495152|FG009|NOT COMPLETED|Booster/Rechallenge Phase||0
6571570|NCT01857882|7495177|FG000|STARTED|Overall Study||21
6571571|NCT01857882|7495178|FG001|STARTED|Overall Study||20
6571572|NCT01857882|7495177|FG000|COMPLETED|Overall Study||21
6571573|NCT01857882|7495178|FG001|COMPLETED|Overall Study||20
6571574|NCT01857882|7495177|FG000|NOT COMPLETED|Overall Study||0
6571575|NCT01857882|7495178|FG001|NOT COMPLETED|Overall Study||0
6571576|NCT01857973|7495184|FG000|STARTED|Overall Study||78
6571577|NCT01857973|7495184|FG000|Exploratory A Phase|Overall Study||9
6571578|NCT01857973|7495184|FG000|Xploratory B Phase|Overall Study||9
6571579|NCT01857973|7495184|FG000|Phase 1|Overall Study||17
6571580|NCT01857973|7495184|FG000|Phase 2|Overall Study||14
6571581|NCT01857973|7495184|FG000|Phase 3|Overall Study||10
6571582|NCT01857973|7495184|FG000|Phase 4|Overall Study||10
6571583|NCT01857973|7495184|FG000|Phase 6|Overall Study||4
6571584|NCT01857973|7495184|FG000|Phase 7|Overall Study||4
6571585|NCT01857973|7495184|FG000|COMPLETED|Overall Study||73
6571586|NCT01857973|7495184|FG000|NOT COMPLETED|Overall Study||5
6571587|NCT01857986|7495190|FG000|STARTED|Overall Study||39
6571588|NCT01857986|7495191|FG001|STARTED|Overall Study||37
6571589|NCT01857986|7495190|FG000|COMPLETED|Overall Study||34
6571590|NCT01857986|7495191|FG001|COMPLETED|Overall Study||30
6571591|NCT01857986|7495190|FG000|NOT COMPLETED|Overall Study||5
6571592|NCT01857986|7495191|FG001|NOT COMPLETED|Overall Study||7
6571593|NCT01858194|7495199|FG000|STARTED|Overall Study||8
6571594|NCT01858194|7495200|FG001|STARTED|Overall Study||9
6571595|NCT01858194|7495199|FG000|COMPLETED|Overall Study|All patients in Control arm completed.|8
6571596|NCT01858194|7495200|FG001|COMPLETED|Overall Study||7
6571597|NCT01858194|7495199|FG000|NOT COMPLETED|Overall Study||0
6571598|NCT01858194|7495200|FG001|NOT COMPLETED|Overall Study||2
6571599|NCT01858363|7495210|FG000|STARTED|Overall Study||222
6571600|NCT01858363|7495211|FG001|STARTED|Overall Study||72
6571601|NCT01858363|7495210|FG000|Pre-discharge Visit|Overall Study||219
6571602|NCT01858363|7495211|FG001|Pre-discharge Visit|Overall Study||72
6571603|NCT01858363|7495210|FG000|1-month Visit|Overall Study||214
6571604|NCT01858363|7495211|FG001|1-month Visit|Overall Study||68
6571605|NCT01858363|7495210|FG000|6-month Visit|Overall Study||208
6571606|NCT01858363|7495211|FG001|6-month Visit|Overall Study||64
6571607|NCT01858363|7495210|FG000|12-month Vist|Overall Study||205
6571608|NCT01858363|7495211|FG001|12-month Vist|Overall Study||61
6571609|NCT01858363|7495210|FG000|24-month Visit|Overall Study||184
6571610|NCT01858363|7495211|FG001|24-month Visit|Overall Study||58
6571611|NCT01858363|7495210|FG000|36-month Visit|Overall Study||169
6571612|NCT01858363|7495211|FG001|36-month Visit|Overall Study||53
6571613|NCT01858363|7495210|FG000|48-month Visit|Overall Study||157
6571614|NCT01858363|7495211|FG001|48-month Visit|Overall Study||53
6571615|NCT01858363|7495210|FG000|COMPLETED|Overall Study||146
6571616|NCT01858363|7495211|FG001|COMPLETED|Overall Study||46
6571617|NCT01858363|7495210|FG000|NOT COMPLETED|Overall Study||76
6571618|NCT01858363|7495211|FG001|NOT COMPLETED|Overall Study||26
6571619|NCT01858376|7495217|FG000|STARTED|Overall Study||24
6571620|NCT01858376|7495217|FG000|COMPLETED|Overall Study||20
6571621|NCT01858376|7495217|FG000|NOT COMPLETED|Overall Study||4
6571622|NCT01858389|7495223|FG000|STARTED|Overall Study|Enrolled|16
6571623|NCT01858389|7495224|FG001|STARTED|Overall Study|Enrolled|25
6571624|NCT01858389|7495223|FG000|Received Treatment|Overall Study||16
6571625|NCT01858389|7495224|FG001|Received Treatment|Overall Study||22
6571626|NCT01858389|7495223|FG000|COMPLETED|Overall Study||0
6571627|NCT01858389|7495224|FG001|COMPLETED|Overall Study||0
6571628|NCT01858389|7495223|FG000|NOT COMPLETED|Overall Study||16
6571629|NCT01858389|7495224|FG001|NOT COMPLETED|Overall Study||25
6571630|NCT01858428|7495234|FG000|STARTED|Overall Study|EverCross™ Balloon Catheter now a product of Medtronic|100
6571631|NCT01858428|7495235|FG001|STARTED|Overall Study||200
6571632|NCT01858428|7495234|FG000|COMPLETED|Overall Study||99
6571633|NCT01858428|7495235|FG001|COMPLETED|Overall Study||190
6571634|NCT01858428|7495234|FG000|NOT COMPLETED|Overall Study||1
6658105|NCT02476448|7588664|FG000|STARTED|Overall Study|one given phenazopyridine pre-op and was analyzed in her randomization group per intention to treat|44
6658106|NCT02476448|7588665|FG001|STARTED|Overall Study||44
6658107|NCT02476448|7588666|FG002|STARTED|Overall Study||44
6571635|NCT01858428|7495235|FG001|NOT COMPLETED|Overall Study||10
6571636|NCT01858532|7495245|FG000|STARTED|Overall Study||1325
6571637|NCT01858532|7495246|FG001|STARTED|Overall Study||1323
6571638|NCT01858532|7495247|FG002|STARTED|Overall Study||509
6571639|NCT01858532|7495248|FG003|STARTED|Overall Study||511
6571640|NCT01858532|7495245|FG000|COMPLETED|Overall Study||1144
6571641|NCT01858532|7495246|FG001|COMPLETED|Overall Study||1131
6571642|NCT01858532|7495247|FG002|COMPLETED|Overall Study||411
6571643|NCT01858532|7495248|FG003|COMPLETED|Overall Study||418
6571644|NCT01858532|7495245|FG000|NOT COMPLETED|Overall Study||181
6571645|NCT01858532|7495246|FG001|NOT COMPLETED|Overall Study||192
6571646|NCT01858532|7495247|FG002|NOT COMPLETED|Overall Study||98
6571647|NCT01858532|7495248|FG003|NOT COMPLETED|Overall Study||93
6571648|NCT01858545|7495260|FG000|STARTED|Overall Study||27
6571649|NCT01858545|7495261|FG001|STARTED|Overall Study||29
6571650|NCT01858545|7495260|FG000|COMPLETED|Overall Study||23
6571651|NCT01858545|7495261|FG001|COMPLETED|Overall Study||23
6571652|NCT01858545|7495260|FG000|NOT COMPLETED|Overall Study||4
6571653|NCT01858545|7495261|FG001|NOT COMPLETED|Overall Study||6
6571654|NCT01858558|7495269|FG000|STARTED|Overall Study||70
6571655|NCT01858558|7495270|FG001|STARTED|Overall Study||31
6571656|NCT01858558|7495269|FG000|COMPLETED|Overall Study||61
6571657|NCT01858558|7495270|FG001|COMPLETED|Overall Study||29
6571658|NCT01858558|7495269|FG000|NOT COMPLETED|Overall Study||9
6571659|NCT01858558|7495270|FG001|NOT COMPLETED|Overall Study||2
6571660|NCT01858636|7495276|FG000|STARTED|Overall Study|Subjects consented|235
6571661|NCT01858636|7495276|FG000|Device Deployment|Overall Study||211
6571662|NCT01858636|7495276|FG000|COMPLETED|Overall Study||207
6571663|NCT01858636|7495276|FG000|NOT COMPLETED|Overall Study||28
6571664|NCT01858701|7495281|FG000|STARTED|Period 1, First 30 Days of Wear||20
6571665|NCT01858701|7495282|FG001|STARTED|Period 1, First 30 Days of Wear||20
6571666|NCT01858701|7495281|FG000|COMPLETED|Period 1, First 30 Days of Wear||20
6571667|NCT01858701|7495282|FG001|COMPLETED|Period 1, First 30 Days of Wear||19
6571668|NCT01858701|7495281|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
6571669|NCT01858701|7495282|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
6571670|NCT01858701|7495281|FG000|STARTED|Washout Period, 1-13 Days||20
6571671|NCT01858701|7495282|FG001|STARTED|Washout Period, 1-13 Days||19
6571672|NCT01858701|7495281|FG000|COMPLETED|Washout Period, 1-13 Days||18
6571673|NCT01858701|7495282|FG001|COMPLETED|Washout Period, 1-13 Days||17
6571674|NCT01858701|7495281|FG000|NOT COMPLETED|Washout Period, 1-13 Days||2
6571675|NCT01858701|7495282|FG001|NOT COMPLETED|Washout Period, 1-13 Days||2
6571676|NCT01858701|7495281|FG000|STARTED|Period 2, Second 30 Days of Wear||18
6571677|NCT01858701|7495282|FG001|STARTED|Period 2, Second 30 Days of Wear||17
6571678|NCT01858701|7495281|FG000|COMPLETED|Period 2, Second 30 Days of Wear||18
6571679|NCT01858701|7495282|FG001|COMPLETED|Period 2, Second 30 Days of Wear||16
6571680|NCT01858701|7495281|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
6571681|NCT01858701|7495282|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
6571682|NCT01858753|7495290|FG000|STARTED|Overall Study||5
6571683|NCT01858753|7495291|FG001|STARTED|Overall Study||0
6571684|NCT01858753|7495290|FG000|COMPLETED|Overall Study||0
6571685|NCT01858753|7495291|FG001|COMPLETED|Overall Study||0
6571686|NCT01858753|7495290|FG000|NOT COMPLETED|Overall Study||5
6571687|NCT01858753|7495291|FG001|NOT COMPLETED|Overall Study||0
6571688|NCT01858766|7495316|FG000|STARTED|Overall Study||27
6571689|NCT01858766|7495317|FG001|STARTED|Overall Study||28
6571690|NCT01858766|7495318|FG002|STARTED|Overall Study||11
6571691|NCT01858766|7495319|FG003|STARTED|Overall Study||10
6571692|NCT01858766|7495320|FG004|STARTED|Overall Study||27
6571693|NCT01858766|7495321|FG005|STARTED|Overall Study||28
6571694|NCT01858766|7495322|FG006|STARTED|Overall Study||7
6571695|NCT01858766|7495323|FG007|STARTED|Overall Study||7
6571696|NCT01858766|7495324|FG008|STARTED|Overall Study||1
6658108|NCT02476448|7588667|FG003|STARTED|Overall Study||44
6658109|NCT02476448|7588664|FG000|COMPLETED|Overall Study||44
6571697|NCT01858766|7495325|FG009|STARTED|Overall Study||4
6571698|NCT01858766|7495326|FG010|STARTED|Overall Study||5
6571699|NCT01858766|7495327|FG011|STARTED|Overall Study||30
6571700|NCT01858766|7495328|FG012|STARTED|Overall Study||30
6571701|NCT01858766|7495329|FG013|STARTED|Overall Study||29
6571702|NCT01858766|7495330|FG014|STARTED|Overall Study||31
6571703|NCT01858766|7495331|FG015|STARTED|Overall Study||26
6571704|NCT01858766|7495332|FG016|STARTED|Overall Study||25
6571705|NCT01858766|7495333|FG017|STARTED|Overall Study||27
6571706|NCT01858766|7495334|FG018|STARTED|Overall Study||26
6571707|NCT01858766|7495316|FG000|COMPLETED|Overall Study||26
6571708|NCT01858766|7495317|FG001|COMPLETED|Overall Study||28
6571709|NCT01858766|7495318|FG002|COMPLETED|Overall Study||10
6571710|NCT01858766|7495319|FG003|COMPLETED|Overall Study||10
6571711|NCT01858766|7495320|FG004|COMPLETED|Overall Study||26
6571712|NCT01858766|7495321|FG005|COMPLETED|Overall Study||24
6571713|NCT01858766|7495322|FG006|COMPLETED|Overall Study||7
6571714|NCT01858766|7495323|FG007|COMPLETED|Overall Study||5
6571715|NCT01858766|7495324|FG008|COMPLETED|Overall Study||1
6571716|NCT01858766|7495325|FG009|COMPLETED|Overall Study||4
6255636|NCT02639546|7154529|FG003|Tumor Type - High-Grade Glioma|Overall Study||0
6255637|NCT02639546|7154530|FG004|Tumor Type - High-Grade Glioma|Overall Study||1
6255638|NCT02639546|7154531|FG005|Tumor Type - High-Grade Glioma|Overall Study||0
6255639|NCT02639546|7154532|FG006|Tumor Type - High-Grade Glioma|Overall Study||0
6255640|NCT02639546|7154533|FG007|Tumor Type - High-Grade Glioma|Overall Study||0
6255641|NCT02639546|7154526|FG000|Tumor Type - Low-Grade Glioma|Overall Study||1
6255642|NCT02639546|7154527|FG001|Tumor Type - Low-Grade Glioma|Overall Study||2
6255643|NCT02639546|7154528|FG002|Tumor Type - Low-Grade Glioma|Overall Study||4
6255644|NCT02639546|7154529|FG003|Tumor Type - Low-Grade Glioma|Overall Study||5
6255645|NCT02639546|7154530|FG004|Tumor Type - Low-Grade Glioma|Overall Study||3
6255646|NCT02639546|7154531|FG005|Tumor Type - Low-Grade Glioma|Overall Study||2
6255647|NCT02639546|7154532|FG006|Tumor Type - Low-Grade Glioma|Overall Study||3
6255648|NCT02639546|7154533|FG007|Tumor Type - Low-Grade Glioma|Overall Study||12
6255649|NCT02639546|7154526|FG000|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255650|NCT02639546|7154527|FG001|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255651|NCT02639546|7154528|FG002|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255652|NCT02639546|7154529|FG003|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6571717|NCT01858766|7495326|FG010|COMPLETED|Overall Study||5
6571718|NCT01858766|7495327|FG011|COMPLETED|Overall Study||25
6571719|NCT01858766|7495328|FG012|COMPLETED|Overall Study||25
6571720|NCT01858766|7495329|FG013|COMPLETED|Overall Study||26
6571721|NCT01858766|7495330|FG014|COMPLETED|Overall Study||23
6571722|NCT01858766|7495331|FG015|COMPLETED|Overall Study||20
6571723|NCT01858766|7495332|FG016|COMPLETED|Overall Study||22
6571724|NCT01858766|7495333|FG017|COMPLETED|Overall Study||23
6571725|NCT01858766|7495334|FG018|COMPLETED|Overall Study||22
6571726|NCT01858766|7495316|FG000|NOT COMPLETED|Overall Study||1
6571727|NCT01858766|7495317|FG001|NOT COMPLETED|Overall Study||0
6571728|NCT01858766|7495318|FG002|NOT COMPLETED|Overall Study||1
6571729|NCT01858766|7495319|FG003|NOT COMPLETED|Overall Study||0
6571730|NCT01858766|7495320|FG004|NOT COMPLETED|Overall Study||1
6571731|NCT01858766|7495321|FG005|NOT COMPLETED|Overall Study||4
6571732|NCT01858766|7495322|FG006|NOT COMPLETED|Overall Study||0
6571733|NCT01858766|7495323|FG007|NOT COMPLETED|Overall Study||2
6571734|NCT01858766|7495324|FG008|NOT COMPLETED|Overall Study||0
6571735|NCT01858766|7495325|FG009|NOT COMPLETED|Overall Study||0
6571736|NCT01858766|7495326|FG010|NOT COMPLETED|Overall Study||0
6571737|NCT01858766|7495327|FG011|NOT COMPLETED|Overall Study||5
6571738|NCT01858766|7495328|FG012|NOT COMPLETED|Overall Study||5
6571739|NCT01858766|7495329|FG013|NOT COMPLETED|Overall Study||3
6571740|NCT01858766|7495330|FG014|NOT COMPLETED|Overall Study||8
6571741|NCT01858766|7495331|FG015|NOT COMPLETED|Overall Study||6
6571742|NCT01858766|7495332|FG016|NOT COMPLETED|Overall Study||3
6571743|NCT01858766|7495333|FG017|NOT COMPLETED|Overall Study||4
6571744|NCT01858766|7495334|FG018|NOT COMPLETED|Overall Study||4
6571745|NCT01859013|7495369|FG000|STARTED|Overall Study||16
6571746|NCT01859013|7495370|FG001|STARTED|Overall Study||14
6571747|NCT01859013|7495369|FG000|COMPLETED|Overall Study||12
6571748|NCT01859013|7495370|FG001|COMPLETED|Overall Study||9
6571749|NCT01859013|7495369|FG000|NOT COMPLETED|Overall Study||4
6571750|NCT01859013|7495370|FG001|NOT COMPLETED|Overall Study||5
6571751|NCT01859078|7495376|FG000|STARTED|Overall Study||28
6571752|NCT01859078|7495376|FG000|COMPLETED|Overall Study||28
6571753|NCT01859078|7495376|FG000|NOT COMPLETED|Overall Study||0
6571754|NCT01859143|7495384|FG000|STARTED|Overall Study||240
6571755|NCT01859143|7495385|FG001|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
6571756|NCT01859143|7495384|FG000|COMPLETED|Overall Study||238
6571757|NCT01859143|7495385|FG001|COMPLETED|Overall Study||60
6571758|NCT01859143|7495384|FG000|NOT COMPLETED|Overall Study||2
6571759|NCT01859143|7495385|FG001|NOT COMPLETED|Overall Study||0
6571760|NCT01859195|7495394|FG000|STARTED|Overall Study||24
6571761|NCT01859195|7495395|FG001|STARTED|Overall Study||12
6571762|NCT01859195|7495394|FG000|COMPLETED|Overall Study||24
6571763|NCT01859195|7495395|FG001|COMPLETED|Overall Study||12
6571764|NCT01859195|7495394|FG000|NOT COMPLETED|Overall Study||0
6571765|NCT01859195|7495395|FG001|NOT COMPLETED|Overall Study||0
6255653|NCT02639546|7154530|FG004|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255654|NCT02639546|7154531|FG005|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255655|NCT02639546|7154532|FG006|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
6255656|NCT02639546|7154533|FG007|Tumor Type - Dnet In Noonan's Syndrome Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255657|NCT02639546|7154526|FG000|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
6255658|NCT02639546|7154527|FG001|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
6255659|NCT02639546|7154528|FG002|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
6255660|NCT02639546|7154529|FG003|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
6255661|NCT02639546|7154530|FG004|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
6255662|NCT02639546|7154531|FG005|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||1
6255663|NCT02639546|7154532|FG006|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
6255664|NCT02639546|7154533|FG007|Tumor Type - Malignant Peripheral Nerve Sheath Tumor|Overall Study||0
6255665|NCT02639546|7154526|FG000|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||1
6255666|NCT02639546|7154527|FG001|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255667|NCT02639546|7154528|FG002|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255668|NCT02639546|7154529|FG003|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255669|NCT02639546|7154530|FG004|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255670|NCT02639546|7154531|FG005|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255671|NCT02639546|7154532|FG006|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255672|NCT02639546|7154533|FG007|Tumor Type - Metastatic Mediastinal Yolksac Tumor With RAS/RAF/MEK/ERK Pathway Activation|Overall Study||0
6255673|NCT02639546|7154526|FG000|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
6255674|NCT02639546|7154527|FG001|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||1
6255675|NCT02639546|7154528|FG002|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
6255676|NCT02639546|7154529|FG003|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
6255677|NCT02639546|7154530|FG004|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
6255678|NCT02639546|7154531|FG005|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
6255679|NCT02639546|7154532|FG006|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
6255680|NCT02639546|7154533|FG007|Tumor Type - Non-Rhabdomyosarcoma Soft Tissue Sarcoma|Overall Study||0
6255681|NCT02639546|7154526|FG000|Tumor Type - Plexiform Neurofibroma|Overall Study||1
6255682|NCT02639546|7154527|FG001|Tumor Type - Plexiform Neurofibroma|Overall Study||2
6255683|NCT02639546|7154528|FG002|Tumor Type - Plexiform Neurofibroma|Overall Study||1
6255684|NCT02639546|7154529|FG003|Tumor Type - Plexiform Neurofibroma|Overall Study||1
6255685|NCT02639546|7154530|FG004|Tumor Type - Plexiform Neurofibroma|Overall Study||2
6255686|NCT02639546|7154531|FG005|Tumor Type - Plexiform Neurofibroma|Overall Study||4
6255687|NCT02639546|7154532|FG006|Tumor Type - Plexiform Neurofibroma|Overall Study||1
6255688|NCT02639546|7154533|FG007|Tumor Type - Plexiform Neurofibroma|Overall Study||0
6255689|NCT02639546|7154526|FG000|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
6255690|NCT02639546|7154527|FG001|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
6255691|NCT02639546|7154528|FG002|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
6255692|NCT02639546|7154529|FG003|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
6255693|NCT02639546|7154530|FG004|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
6571766|NCT01859247|7495411|FG000|STARTED|Overall Study||1
6571767|NCT01859247|7495412|FG001|STARTED|Overall Study||1
6571768|NCT01859247|7495413|FG002|STARTED|Overall Study||1
6571769|NCT01859247|7495414|FG003|STARTED|Overall Study||1
6571770|NCT01859247|7495415|FG004|STARTED|Overall Study||1
6571771|NCT01859247|7495416|FG005|STARTED|Overall Study||1
6571772|NCT01859247|7495417|FG006|STARTED|Overall Study||1
6571773|NCT01859247|7495418|FG007|STARTED|Overall Study||1
6571774|NCT01859247|7495411|FG000|COMPLETED|Overall Study||1
6571775|NCT01859247|7495412|FG001|COMPLETED|Overall Study||1
6255694|NCT02639546|7154531|FG005|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||1
6255695|NCT02639546|7154532|FG006|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
6255696|NCT02639546|7154533|FG007|Tumor Type - Rhabdoid Tumor/ATRT|Overall Study||0
6255697|NCT02639546|7154526|FG000|COMPLETED|Overall Study||0
6255698|NCT02639546|7154527|FG001|COMPLETED|Overall Study||0
6255699|NCT02639546|7154528|FG002|COMPLETED|Overall Study||0
6255700|NCT02639546|7154529|FG003|COMPLETED|Overall Study||0
6255701|NCT02639546|7154530|FG004|COMPLETED|Overall Study||0
6255702|NCT02639546|7154531|FG005|COMPLETED|Overall Study||0
6255703|NCT02639546|7154532|FG006|COMPLETED|Overall Study||0
6255704|NCT02639546|7154533|FG007|COMPLETED|Overall Study||0
6255705|NCT02639546|7154526|FG000|NOT COMPLETED|Overall Study||6
6255706|NCT02639546|7154527|FG001|NOT COMPLETED|Overall Study||6
6255707|NCT02639546|7154528|FG002|NOT COMPLETED|Overall Study||6
6255708|NCT02639546|7154529|FG003|NOT COMPLETED|Overall Study||6
6255709|NCT02639546|7154530|FG004|NOT COMPLETED|Overall Study||7
6571776|NCT01859247|7495413|FG002|COMPLETED|Overall Study||1
6571777|NCT01859247|7495414|FG003|COMPLETED|Overall Study||1
6658110|NCT02476448|7588665|FG001|COMPLETED|Overall Study||44
6255710|NCT02639546|7154531|FG005|NOT COMPLETED|Overall Study||8
6255711|NCT02639546|7154532|FG006|NOT COMPLETED|Overall Study||5
6255712|NCT02639546|7154533|FG007|NOT COMPLETED|Overall Study||12
6255713|NCT02575339|7154568|FG000|STARTED|Study Treatment||7
6255714|NCT02575339|7154569|FG001|STARTED|Study Treatment|This study was terminated at Phase I.|4
6571778|NCT01859247|7495415|FG004|COMPLETED|Overall Study||1
6571779|NCT01859247|7495416|FG005|COMPLETED|Overall Study||1
6571780|NCT01859247|7495417|FG006|COMPLETED|Overall Study||1
6571781|NCT01859247|7495418|FG007|COMPLETED|Overall Study||1
6571782|NCT01859247|7495411|FG000|NOT COMPLETED|Overall Study||0
6571783|NCT01859247|7495412|FG001|NOT COMPLETED|Overall Study||0
6571784|NCT01859247|7495413|FG002|NOT COMPLETED|Overall Study||0
6571785|NCT01859247|7495414|FG003|NOT COMPLETED|Overall Study||0
6571786|NCT01859247|7495415|FG004|NOT COMPLETED|Overall Study||0
6571787|NCT01859247|7495416|FG005|NOT COMPLETED|Overall Study||0
6571788|NCT01859247|7495417|FG006|NOT COMPLETED|Overall Study||0
6571789|NCT01859247|7495418|FG007|NOT COMPLETED|Overall Study||0
6571790|NCT01859312|7495437|FG000|STARTED|Overall Study||8
6571791|NCT01859312|7495437|FG000|COMPLETED|Overall Study|Based on medication & supply accountability, one participant was found to be partially non-compliant|8
6571792|NCT01859312|7495437|FG000|NOT COMPLETED|Overall Study||0
6571793|NCT01859325|7495444|FG000|STARTED|Overall Study||15
6571794|NCT01859325|7495445|FG001|STARTED|Overall Study||16
6571795|NCT01859325|7495446|FG002|STARTED|Overall Study||2
6571796|NCT01859325|7495444|FG000|COMPLETED|Overall Study||12
6571797|NCT01859325|7495445|FG001|COMPLETED|Overall Study||12
6571798|NCT01859325|7495446|FG002|COMPLETED|Overall Study||2
6571799|NCT01859325|7495444|FG000|NOT COMPLETED|Overall Study||3
6571800|NCT01859325|7495445|FG001|NOT COMPLETED|Overall Study||4
6571801|NCT01859325|7495446|FG002|NOT COMPLETED|Overall Study||0
6571802|NCT01859390|7495454|FG000|STARTED|Overall Study||36
6571803|NCT01859390|7495455|FG001|STARTED|Overall Study||37
6571804|NCT01859390|7495454|FG000|Withdrawals|Overall Study||2
6571805|NCT01859390|7495455|FG001|Withdrawals|Overall Study||2
6571806|NCT01859390|7495454|FG000|COMPLETED|Overall Study||35
6571807|NCT01859390|7495455|FG001|COMPLETED|Overall Study||30
6571808|NCT01859390|7495454|FG000|NOT COMPLETED|Overall Study||1
6571809|NCT01859390|7495455|FG001|NOT COMPLETED|Overall Study||7
6571810|NCT01859403|7495463|FG000|STARTED|Primary Endpoint Measure||21
6571811|NCT01859403|7495464|FG001|STARTED|Primary Endpoint Measure||30
6571812|NCT01859403|7495463|FG000|COMPLETED|Primary Endpoint Measure||20
6571813|NCT01859403|7495464|FG001|COMPLETED|Primary Endpoint Measure||26
6571814|NCT01859403|7495463|FG000|NOT COMPLETED|Primary Endpoint Measure||1
6571815|NCT01859403|7495464|FG001|NOT COMPLETED|Primary Endpoint Measure||4
6571816|NCT01859403|7495463|FG000|STARTED|Secondary Endpoint Measure||20
6571817|NCT01859403|7495464|FG001|STARTED|Secondary Endpoint Measure||26
6571818|NCT01859403|7495463|FG000|COMPLETED|Secondary Endpoint Measure||14
6571819|NCT01859403|7495464|FG001|COMPLETED|Secondary Endpoint Measure||18
6571820|NCT01859403|7495463|FG000|NOT COMPLETED|Secondary Endpoint Measure||6
6571821|NCT01859403|7495464|FG001|NOT COMPLETED|Secondary Endpoint Measure||8
6571822|NCT01859494|7495470|FG000|STARTED|Overall Study||219
6571823|NCT01859494|7495470|FG000|COMPLETED|Overall Study||218
6571824|NCT01859494|7495470|FG000|NOT COMPLETED|Overall Study||1
6571825|NCT01859507|7495474|FG000|STARTED|Overall Study||32
6571826|NCT01859507|7495474|FG000|COMPLETED|Overall Study||28
6571827|NCT01859507|7495474|FG000|NOT COMPLETED|Overall Study||4
6571828|NCT01859598|7495479|FG000|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
6571829|NCT01859598|7495479|FG000|COMPLETED|Visit 2 at 3 Months||17253
6571830|NCT01859598|7495479|FG000|NOT COMPLETED|Visit 2 at 3 Months||1742
6571831|NCT01859598|7495479|FG000|STARTED|Visit 3 at 6 Months||17253
6571832|NCT01859598|7495479|FG000|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
6571833|NCT01859598|7495479|FG000|NOT COMPLETED|Visit 3 at 6 Months||912
6571834|NCT01859611|7495485|FG000|STARTED|Overall Study||51
6571835|NCT01859611|7495485|FG000|COMPLETED|Overall Study||43
6571836|NCT01859611|7495485|FG000|NOT COMPLETED|Overall Study||8
6571837|NCT01859637|7495489|FG000|STARTED|Overall Study||6
6571838|NCT01859637|7495489|FG000|COMPLETED|Overall Study||6
6571839|NCT01859637|7495489|FG000|NOT COMPLETED|Overall Study||0
6571840|NCT01859702|7495493|FG000|STARTED|Overall Study||36
6571841|NCT01859702|7495493|FG000|COMPLETED|Overall Study||31
6571842|NCT01859702|7495493|FG000|NOT COMPLETED|Overall Study||5
6571843|NCT01859715|7495500|FG000|STARTED|Overall Study||141
6571844|NCT01859715|7495501|FG001|STARTED|Overall Study||91
6571845|NCT01859715|7495502|FG002|STARTED|Overall Study||116
6255715|NCT02575339|7154570|FG002|STARTED|Study Treatment|This study was terminated at Phase I.|0
6255716|NCT02575339|7154568|FG000|COMPLETED|Study Treatment||0
6255717|NCT02575339|7154569|FG001|COMPLETED|Study Treatment||0
6255718|NCT02575339|7154570|FG002|COMPLETED|Study Treatment||0
6571846|NCT01859715|7495500|FG000|COMPLETED|Overall Study||125
6571847|NCT01859715|7495501|FG001|COMPLETED|Overall Study||83
6571848|NCT01859715|7495502|FG002|COMPLETED|Overall Study||93
6571849|NCT01859715|7495500|FG000|NOT COMPLETED|Overall Study||16
6571850|NCT01859715|7495501|FG001|NOT COMPLETED|Overall Study||8
6571851|NCT01859715|7495502|FG002|NOT COMPLETED|Overall Study||23
6571852|NCT01859741|7495520|FG000|STARTED|Overall Study||3
6571853|NCT01859741|7495521|FG001|STARTED|Overall Study||3
6571854|NCT01859741|7495522|FG002|STARTED|Overall Study||6
6571855|NCT01859741|7495523|FG003|STARTED|Overall Study||3
6571856|NCT01859741|7495524|FG004|STARTED|Overall Study||6
6255719|NCT02575339|7154568|FG000|NOT COMPLETED|Study Treatment||7
6255720|NCT02575339|7154569|FG001|NOT COMPLETED|Study Treatment||4
6255721|NCT02575339|7154570|FG002|NOT COMPLETED|Study Treatment||0
6255722|NCT02575339|7154568|FG000|STARTED|Follow up||7
6255723|NCT02575339|7154569|FG001|STARTED|Follow up||4
6255724|NCT02575339|7154570|FG002|STARTED|Follow up||0
6255725|NCT02575339|7154568|FG000|COMPLETED|Follow up||0
6255726|NCT02575339|7154569|FG001|COMPLETED|Follow up||0
6255727|NCT02575339|7154570|FG002|COMPLETED|Follow up||0
6255728|NCT02575339|7154568|FG000|NOT COMPLETED|Follow up||7
6255729|NCT02575339|7154569|FG001|NOT COMPLETED|Follow up||4
6255730|NCT02575339|7154570|FG002|NOT COMPLETED|Follow up||0
6255731|NCT02542267|7154580|FG000|STARTED|Overall Study||108
6255732|NCT02542267|7154580|FG000|COMPLETED|Overall Study||53
6255733|NCT02542267|7154580|FG000|NOT COMPLETED|Overall Study||55
6255734|NCT02498444|7154586|FG000|STARTED|Overall Study||16
6255735|NCT02498444|7154587|FG001|STARTED|Overall Study||18
6255736|NCT02498444|7154586|FG000|COMPLETED|Overall Study||12
6255737|NCT02498444|7154587|FG001|COMPLETED|Overall Study||18
6255738|NCT02498444|7154586|FG000|NOT COMPLETED|Overall Study||4
6255739|NCT02498444|7154587|FG001|NOT COMPLETED|Overall Study||0
6255740|NCT02487108|7154597|FG000|STARTED|Overall Study||142
6255741|NCT02487108|7154598|FG001|STARTED|Overall Study||142
6255742|NCT02487108|7154599|FG002|STARTED|Overall Study||143
6255743|NCT02487108|7154600|FG003|STARTED|Overall Study||142
6255744|NCT02487108|7154597|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
6255745|NCT02487108|7154598|FG001|Received at Least 1 Dose of Study Drug|Overall Study||142
6255746|NCT02487108|7154599|FG002|Received at Least 1 Dose of Study Drug|Overall Study||141
6255747|NCT02487108|7154600|FG003|Received at Least 1 Dose of Study Drug|Overall Study||142
6255748|NCT02487108|7154597|FG000|COMPLETED|Overall Study||126
6255749|NCT02487108|7154598|FG001|COMPLETED|Overall Study||126
6255750|NCT02487108|7154599|FG002|COMPLETED|Overall Study||117
6255751|NCT02487108|7154600|FG003|COMPLETED|Overall Study||131
6255752|NCT02487108|7154597|FG000|NOT COMPLETED|Overall Study||16
6571857|NCT01859741|7495525|FG005|STARTED|Overall Study||6
6571858|NCT01859741|7495526|FG006|STARTED|Overall Study||72
6571859|NCT01859741|7495527|FG007|STARTED|Overall Study||73
6571860|NCT01859741|7495520|FG000|COMPLETED|Overall Study||0
6571861|NCT01859741|7495521|FG001|COMPLETED|Overall Study||0
6571862|NCT01859741|7495522|FG002|COMPLETED|Overall Study||0
6571863|NCT01859741|7495523|FG003|COMPLETED|Overall Study||0
6571864|NCT01859741|7495524|FG004|COMPLETED|Overall Study||0
6571865|NCT01859741|7495525|FG005|COMPLETED|Overall Study||0
6571866|NCT01859741|7495526|FG006|COMPLETED|Overall Study||2
6571867|NCT01859741|7495527|FG007|COMPLETED|Overall Study||3
6571868|NCT01859741|7495520|FG000|NOT COMPLETED|Overall Study||3
6571869|NCT01859741|7495521|FG001|NOT COMPLETED|Overall Study||3
6571870|NCT01859741|7495522|FG002|NOT COMPLETED|Overall Study||6
6571871|NCT01859741|7495523|FG003|NOT COMPLETED|Overall Study||3
6571872|NCT01859741|7495524|FG004|NOT COMPLETED|Overall Study||6
6571873|NCT01859741|7495525|FG005|NOT COMPLETED|Overall Study||6
6571874|NCT01859741|7495526|FG006|NOT COMPLETED|Overall Study||70
6571875|NCT01859741|7495527|FG007|NOT COMPLETED|Overall Study||70
6571876|NCT01859793|7495547|FG000|STARTED|First Intervention (8 Weeks)||20
6571877|NCT01859793|7495548|FG001|STARTED|First Intervention (8 Weeks)||18
6571878|NCT01859793|7495547|FG000|COMPLETED|First Intervention (8 Weeks)||15
6571879|NCT01859793|7495548|FG001|COMPLETED|First Intervention (8 Weeks)||17
6571880|NCT01859793|7495547|FG000|NOT COMPLETED|First Intervention (8 Weeks)||5
6658111|NCT02476448|7588666|FG002|COMPLETED|Overall Study||44
6658112|NCT02476448|7588667|FG003|COMPLETED|Overall Study||44
6658113|NCT02476448|7588664|FG000|NOT COMPLETED|Overall Study||0
6658114|NCT02476448|7588665|FG001|NOT COMPLETED|Overall Study||0
6658115|NCT02476448|7588666|FG002|NOT COMPLETED|Overall Study||0
6658116|NCT02476448|7588667|FG003|NOT COMPLETED|Overall Study||0
6255753|NCT02487108|7154598|FG001|NOT COMPLETED|Overall Study||16
6255754|NCT02487108|7154599|FG002|NOT COMPLETED|Overall Study||26
6255755|NCT02487108|7154600|FG003|NOT COMPLETED|Overall Study||11
6255756|NCT02455557|7154610|FG000|STARTED|Overall Study||66
6255757|NCT02455557|7154610|FG000|COMPLETED|Overall Study||64
6255758|NCT02455557|7154610|FG000|NOT COMPLETED|Overall Study||2
6255759|NCT02435849|7154614|FG000|STARTED|Overall Study||97
6255760|NCT02435849|7154614|FG000|Enrolled and Infused|Overall Study||79
6255761|NCT02435849|7154614|FG000|Enrolled But Not Infused|Overall Study||18
6658117|NCT02476565|7588679|FG000|STARTED|Overall Study||20
6658118|NCT02476565|7588680|FG001|STARTED|Overall Study||19
6658119|NCT02476565|7588679|FG000|COMPLETED|Overall Study||20
6255762|NCT02435849|7154614|FG000|Discontinued Study Follow-up|Overall Study||34
6255763|NCT02435849|7154614|FG000|COMPLETED|Overall Study||0
6255764|NCT02435849|7154614|FG000|NOT COMPLETED|Overall Study||97
6255765|NCT02393690|7154620|FG000|STARTED|Overall Study||29
6255766|NCT02393690|7154621|FG001|STARTED|Overall Study||31
6255767|NCT02393690|7154620|FG000|COMPLETED|Overall Study||29
6255768|NCT02393690|7154621|FG001|COMPLETED|Overall Study||31
6255769|NCT02393690|7154620|FG000|NOT COMPLETED|Overall Study||0
6571881|NCT01859793|7495548|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
6571882|NCT01859793|7495547|FG000|STARTED|Washout Period (4 Weeks)||15
6571883|NCT01859793|7495548|FG001|STARTED|Washout Period (4 Weeks)||17
6571884|NCT01859793|7495547|FG000|COMPLETED|Washout Period (4 Weeks)||14
6571885|NCT01859793|7495548|FG001|COMPLETED|Washout Period (4 Weeks)||16
6658120|NCT02476565|7588680|FG001|COMPLETED|Overall Study||19
6255770|NCT02393690|7154621|FG001|NOT COMPLETED|Overall Study||0
6255771|NCT02387996|7154627|FG000|STARTED|Overall Study||270
6255772|NCT02387996|7154627|FG000|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
6255773|NCT02387996|7154627|FG000|NOT COMPLETED|Overall Study||204
6255774|NCT02363010|7154634|FG000|STARTED|Overall Study||110
6255775|NCT02363010|7154635|FG001|STARTED|Overall Study||105
6255776|NCT02363010|7154636|FG002|STARTED|Overall Study||105
6255777|NCT02363010|7154634|FG000|COMPLETED|Overall Study||88
6255778|NCT02363010|7154635|FG001|COMPLETED|Overall Study||94
6255779|NCT02363010|7154636|FG002|COMPLETED|Overall Study||89
6255780|NCT02363010|7154634|FG000|NOT COMPLETED|Overall Study||22
6255781|NCT02363010|7154635|FG001|NOT COMPLETED|Overall Study||11
6255782|NCT02363010|7154636|FG002|NOT COMPLETED|Overall Study||16
6255783|NCT02351856|7154644|FG000|STARTED|Overall Study||8
6255784|NCT02351856|7154644|FG000|COMPLETED|Overall Study||0
6255785|NCT02351856|7154644|FG000|NOT COMPLETED|Overall Study||8
6255786|NCT02349386|7154652|FG000|STARTED|24-Week Double-Blind Main Study||9
6255787|NCT02349386|7154653|FG001|STARTED|24-Week Double-Blind Main Study||8
6255788|NCT02349386|7154654|FG002|STARTED|24-Week Double-Blind Main Study||9
6255789|NCT02349386|7154655|FG003|STARTED|24-Week Double-Blind Main Study||8
6255790|NCT02349386|7154652|FG000|COMPLETED|24-Week Double-Blind Main Study||3
6255791|NCT02349386|7154653|FG001|COMPLETED|24-Week Double-Blind Main Study||2
6255792|NCT02349386|7154654|FG002|COMPLETED|24-Week Double-Blind Main Study||4
6255793|NCT02349386|7154655|FG003|COMPLETED|24-Week Double-Blind Main Study||0
6255794|NCT02349386|7154652|FG000|NOT COMPLETED|24-Week Double-Blind Main Study||6
6255795|NCT02349386|7154653|FG001|NOT COMPLETED|24-Week Double-Blind Main Study||6
6255796|NCT02349386|7154654|FG002|NOT COMPLETED|24-Week Double-Blind Main Study||5
6255797|NCT02349386|7154655|FG003|NOT COMPLETED|24-Week Double-Blind Main Study||8
6255798|NCT02349386|7154652|FG000|STARTED|28-Week Double-Blind Optional Extension||3
6255799|NCT02349386|7154653|FG001|STARTED|28-Week Double-Blind Optional Extension||2
6571886|NCT01859793|7495547|FG000|NOT COMPLETED|Washout Period (4 Weeks)||1
6571887|NCT01859793|7495548|FG001|NOT COMPLETED|Washout Period (4 Weeks)||1
6571888|NCT01859793|7495547|FG000|STARTED|2nd Intervention Period||14
6571889|NCT01859793|7495548|FG001|STARTED|2nd Intervention Period||16
6571890|NCT01859793|7495547|FG000|COMPLETED|2nd Intervention Period||14
6571891|NCT01859793|7495548|FG001|COMPLETED|2nd Intervention Period||16
6571892|NCT01859793|7495547|FG000|NOT COMPLETED|2nd Intervention Period||0
6571893|NCT01859793|7495548|FG001|NOT COMPLETED|2nd Intervention Period||0
6571894|NCT01859923|7495558|FG000|STARTED|Overall Study||7
6571895|NCT01859923|7495559|FG001|STARTED|Overall Study||6
6571896|NCT01859923|7495560|FG002|STARTED|Overall Study||12
6571897|NCT01859923|7495561|FG003|STARTED|Overall Study||12
6571898|NCT01859923|7495558|FG000|COMPLETED|Overall Study||7
6571899|NCT01859923|7495559|FG001|COMPLETED|Overall Study||6
6571900|NCT01859923|7495560|FG002|COMPLETED|Overall Study||11
6571901|NCT01859923|7495561|FG003|COMPLETED|Overall Study||11
6571902|NCT01859923|7495558|FG000|NOT COMPLETED|Overall Study||0
6571903|NCT01859923|7495559|FG001|NOT COMPLETED|Overall Study||0
6571904|NCT01859923|7495560|FG002|NOT COMPLETED|Overall Study||1
6571905|NCT01859923|7495561|FG003|NOT COMPLETED|Overall Study||1
6571906|NCT01859949|7495576|FG000|STARTED|Overall Study|Treated participants|29
6571907|NCT01859949|7495577|FG001|STARTED|Overall Study|Treated participants|32
6571908|NCT01859949|7495576|FG000|COMPLETED|Overall Study||15
6571909|NCT01859949|7495577|FG001|COMPLETED|Overall Study||15
6571910|NCT01859949|7495576|FG000|NOT COMPLETED|Overall Study||14
6571911|NCT01859949|7495577|FG001|NOT COMPLETED|Overall Study||17
6571912|NCT01859988|7495589|FG000|STARTED|Overall Study||63
6571913|NCT01859988|7495590|FG001|STARTED|Overall Study||64
6571914|NCT01859988|7495591|FG002|STARTED|Overall Study||62
6571915|NCT01859988|7495592|FG003|STARTED|Overall Study||65
6571916|NCT01859988|7495593|FG004|STARTED|Overall Study||65
6571917|NCT01859988|7495594|FG005|STARTED|Overall Study||61
6255800|NCT02349386|7154654|FG002|STARTED|28-Week Double-Blind Optional Extension||4
6255801|NCT02349386|7154655|FG003|STARTED|28-Week Double-Blind Optional Extension||0
6255802|NCT02349386|7154652|FG000|COMPLETED|28-Week Double-Blind Optional Extension||1
6255803|NCT02349386|7154653|FG001|COMPLETED|28-Week Double-Blind Optional Extension||2
6255804|NCT02349386|7154654|FG002|COMPLETED|28-Week Double-Blind Optional Extension||1
6255805|NCT02349386|7154655|FG003|COMPLETED|28-Week Double-Blind Optional Extension||0
6255806|NCT02349386|7154652|FG000|NOT COMPLETED|28-Week Double-Blind Optional Extension||2
6255807|NCT02349386|7154653|FG001|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
6255808|NCT02349386|7154654|FG002|NOT COMPLETED|28-Week Double-Blind Optional Extension||3
6255809|NCT02349386|7154655|FG003|NOT COMPLETED|28-Week Double-Blind Optional Extension||0
6278957|NCT00140231|7178650|FG001|COMPLETED|Fed State 1 Day- day5||6
6278958|NCT00140231|7178649|FG000|NOT COMPLETED|Fed State 1 Day- day5||0
6278959|NCT00140231|7178650|FG001|NOT COMPLETED|Fed State 1 Day- day5||0
6278960|NCT00140231|7178649|FG000|STARTED|Washout 8weeks||7
6278961|NCT00140231|7178650|FG001|STARTED|Washout 8weeks||6
6571918|NCT01859988|7495589|FG000|Treated|Overall Study||63
6571919|NCT01859988|7495590|FG001|Treated|Overall Study||64
6571920|NCT01859988|7495591|FG002|Treated|Overall Study||61
6571921|NCT01859988|7495592|FG003|Treated|Overall Study||65
6571922|NCT01859988|7495593|FG004|Treated|Overall Study||65
6571923|NCT01859988|7495594|FG005|Treated|Overall Study||61
6571924|NCT01859988|7495589|FG000|COMPLETED|Overall Study||52
6571925|NCT01859988|7495590|FG001|COMPLETED|Overall Study||52
6571926|NCT01859988|7495591|FG002|COMPLETED|Overall Study||34
6571927|NCT01859988|7495592|FG003|COMPLETED|Overall Study||55
6571928|NCT01859988|7495593|FG004|COMPLETED|Overall Study||42
6571929|NCT01859988|7495594|FG005|COMPLETED|Overall Study||42
6571930|NCT01859988|7495589|FG000|NOT COMPLETED|Overall Study||11
6571931|NCT01859988|7495590|FG001|NOT COMPLETED|Overall Study||12
6571932|NCT01859988|7495591|FG002|NOT COMPLETED|Overall Study||28
6571933|NCT01859988|7495592|FG003|NOT COMPLETED|Overall Study||10
6571934|NCT01859988|7495593|FG004|NOT COMPLETED|Overall Study||23
6571935|NCT01859988|7495594|FG005|NOT COMPLETED|Overall Study||19
6571936|NCT01860079|7495610|FG000|STARTED|Overall Study||384
6571937|NCT01860079|7495611|FG001|STARTED|Overall Study||385
6571938|NCT01860079|7495610|FG000|COMPLETED|Overall Study||370
6571939|NCT01860079|7495611|FG001|COMPLETED|Overall Study||363
6571940|NCT01860079|7495610|FG000|NOT COMPLETED|Overall Study||14
6571941|NCT01860079|7495611|FG001|NOT COMPLETED|Overall Study||22
6571942|NCT01860170|7495620|FG000|STARTED|Overall Study||3
6571943|NCT01860170|7495621|FG001|STARTED|Overall Study||3
6571944|NCT01860170|7495622|FG002|STARTED|Overall Study||22
6571945|NCT01860170|7495620|FG000|COMPLETED|Overall Study||3
6571946|NCT01860170|7495621|FG001|COMPLETED|Overall Study||3
6571947|NCT01860170|7495622|FG002|COMPLETED|Overall Study||22
6571948|NCT01860170|7495620|FG000|NOT COMPLETED|Overall Study||0
6571949|NCT01860170|7495621|FG001|NOT COMPLETED|Overall Study||0
6571950|NCT01860170|7495622|FG002|NOT COMPLETED|Overall Study||0
6571951|NCT01860287|7495633|FG000|STARTED|Overall Study||18
6571952|NCT01860287|7495634|FG001|STARTED|Overall Study||15
6571953|NCT01860287|7495635|FG002|STARTED|Overall Study||15
6571954|NCT01860287|7495633|FG000|COMPLETED|Overall Study||18
6571955|NCT01860287|7495634|FG001|COMPLETED|Overall Study||15
6571956|NCT01860287|7495635|FG002|COMPLETED|Overall Study||15
6571957|NCT01860287|7495633|FG000|NOT COMPLETED|Overall Study||0
6571958|NCT01860287|7495634|FG001|NOT COMPLETED|Overall Study||0
6571959|NCT01860287|7495635|FG002|NOT COMPLETED|Overall Study||0
6571960|NCT01860521|7495645|FG000|STARTED|Overall Study|September 2011|52
6571961|NCT01860521|7495646|FG001|STARTED|Overall Study|September 2011|52
6571962|NCT01860521|7495645|FG000|COMPLETED|Overall Study|June 2013|52
6571963|NCT01860521|7495646|FG001|COMPLETED|Overall Study|June 2013|52
6571964|NCT01860521|7495645|FG000|NOT COMPLETED|Overall Study||0
6571965|NCT01860521|7495646|FG001|NOT COMPLETED|Overall Study||0
6571966|NCT01860534|7495654|FG000|STARTED|ROP #1||14
6571967|NCT01860534|7495655|FG001|STARTED|ROP #1||14
6571968|NCT01860534|7495654|FG000|COMPLETED|ROP #1||14
6571969|NCT01860534|7495655|FG001|COMPLETED|ROP #1||13
6571970|NCT01860534|7495654|FG000|NOT COMPLETED|ROP #1||0
6571971|NCT01860534|7495655|FG001|NOT COMPLETED|ROP #1||1
6571972|NCT01860534|7495654|FG000|STARTED|ROP #2||14
6571973|NCT01860534|7495655|FG001|STARTED|ROP #2||13
6571974|NCT01860534|7495654|FG000|COMPLETED|ROP #2||13
6571975|NCT01860534|7495655|FG001|COMPLETED|ROP #2||13
6571976|NCT01860534|7495654|FG000|NOT COMPLETED|ROP #2||1
6571977|NCT01860534|7495655|FG001|NOT COMPLETED|ROP #2||0
6571978|NCT01860573|7495665|FG000|STARTED|Overall Study||83
6571979|NCT01860573|7495666|FG001|STARTED|Overall Study||85
6571980|NCT01860573|7495665|FG000|COMPLETED|Overall Study||83
6571981|NCT01860573|7495666|FG001|COMPLETED|Overall Study||85
6571982|NCT01860573|7495665|FG000|NOT COMPLETED|Overall Study||0
6571983|NCT01860573|7495666|FG001|NOT COMPLETED|Overall Study||0
6571984|NCT01860586|7495672|FG000|STARTED|Overall Study||20
6571985|NCT01860586|7495672|FG000|COMPLETED|Overall Study||20
6571986|NCT01860586|7495672|FG000|NOT COMPLETED|Overall Study||0
6571987|NCT01860651|7495679|FG000|STARTED|Overall Study||56
6571988|NCT01860651|7495680|FG001|STARTED|Overall Study||47
6571989|NCT01860651|7495679|FG000|COMPLETED|Overall Study||31
6571990|NCT01860651|7495680|FG001|COMPLETED|Overall Study||39
6571991|NCT01860651|7495679|FG000|NOT COMPLETED|Overall Study||25
6571992|NCT01860651|7495680|FG001|NOT COMPLETED|Overall Study||8
6571993|NCT01860677|7495692|FG000|STARTED|First Intervention (1 Day)||8
6571994|NCT01860677|7495693|FG001|STARTED|First Intervention (1 Day)||0
6571995|NCT01860677|7495692|FG000|COMPLETED|First Intervention (1 Day)||8
6571996|NCT01860677|7495693|FG001|COMPLETED|First Intervention (1 Day)||0
6571997|NCT01860677|7495692|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6571998|NCT01860677|7495693|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6571999|NCT01860677|7495692|FG000|STARTED|Second Intervention (1 Day)||8
6572000|NCT01860677|7495693|FG001|STARTED|Second Intervention (1 Day)||0
6572001|NCT01860677|7495692|FG000|COMPLETED|Second Intervention (1 Day)||1
6572002|NCT01860677|7495693|FG001|COMPLETED|Second Intervention (1 Day)||0
6572003|NCT01860677|7495692|FG000|NOT COMPLETED|Second Intervention (1 Day)||7
6572004|NCT01860677|7495693|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6572005|NCT01860703|7495700|FG000|STARTED|Overall Study||13
6572006|NCT01860703|7495701|FG001|STARTED|Overall Study||13
6572007|NCT01860703|7495702|FG002|STARTED|Overall Study||12
6572008|NCT01860703|7495703|FG003|STARTED|Overall Study||12
6572009|NCT01860703|7495700|FG000|COMPLETED|Overall Study||11
6572010|NCT01860703|7495701|FG001|COMPLETED|Overall Study||8
6572011|NCT01860703|7495702|FG002|COMPLETED|Overall Study||11
6572012|NCT01860703|7495703|FG003|COMPLETED|Overall Study||10
6572013|NCT01860703|7495700|FG000|NOT COMPLETED|Overall Study||2
6572014|NCT01860703|7495701|FG001|NOT COMPLETED|Overall Study||5
6572015|NCT01860703|7495702|FG002|NOT COMPLETED|Overall Study||1
6572016|NCT01860703|7495703|FG003|NOT COMPLETED|Overall Study||2
6572017|NCT01860807|7495721|FG000|STARTED|Overall Study||64
6572018|NCT01860807|7495722|FG001|STARTED|Overall Study||61
6572019|NCT01860807|7495721|FG000|COMPLETED|Overall Study||34
6572020|NCT01860807|7495722|FG001|COMPLETED|Overall Study||32
6572021|NCT01860807|7495721|FG000|NOT COMPLETED|Overall Study||30
6572022|NCT01860807|7495722|FG001|NOT COMPLETED|Overall Study||29
6572023|NCT01860846|7495728|FG000|STARTED|Overall Study||106
6572024|NCT01860846|7495728|FG000|Month 1|Overall Study||97
6572025|NCT01860846|7495728|FG000|Month 2|Overall Study||83
6572026|NCT01860846|7495728|FG000|Month 4|Overall Study||82
6572027|NCT01860846|7495728|FG000|Month 6|Overall Study||85
6572028|NCT01860846|7495728|FG000|Month 12|Overall Study||73
6572029|NCT01860846|7495728|FG000|COMPLETED|Overall Study||73
6572030|NCT01860846|7495728|FG000|NOT COMPLETED|Overall Study||33
6572031|NCT01860950|7495738|FG000|STARTED|Overall Study||14
6572032|NCT01860950|7495739|FG001|STARTED|Overall Study||15
6572033|NCT01860950|7495740|FG002|STARTED|Overall Study||10
6572034|NCT01860950|7495741|FG003|STARTED|Overall Study||13
6572035|NCT01860950|7495742|FG004|STARTED|Overall Study||14
6572036|NCT01860950|7495743|FG005|STARTED|Overall Study||13
6572037|NCT01860950|7495738|FG000|COMPLETED|Overall Study||14
6572038|NCT01860950|7495739|FG001|COMPLETED|Overall Study||15
6572039|NCT01860950|7495740|FG002|COMPLETED|Overall Study||10
6572040|NCT01860950|7495741|FG003|COMPLETED|Overall Study||13
6572041|NCT01860950|7495742|FG004|COMPLETED|Overall Study||14
6572042|NCT01860950|7495743|FG005|COMPLETED|Overall Study||13
6572043|NCT01860950|7495738|FG000|NOT COMPLETED|Overall Study||0
6572044|NCT01860950|7495739|FG001|NOT COMPLETED|Overall Study||0
6572045|NCT01860950|7495740|FG002|NOT COMPLETED|Overall Study||0
6572046|NCT01860950|7495741|FG003|NOT COMPLETED|Overall Study||0
6572047|NCT01860950|7495742|FG004|NOT COMPLETED|Overall Study||0
6572048|NCT01860950|7495743|FG005|NOT COMPLETED|Overall Study||0
6572049|NCT01860989|7495758|FG000|STARTED|Overall Study||11
6572050|NCT01860989|7495758|FG000|COMPLETED|Overall Study||6
6572051|NCT01860989|7495758|FG000|NOT COMPLETED|Overall Study||5
6572052|NCT01861002|7495762|FG000|STARTED|Overall Study||15
6572053|NCT01861002|7495762|FG000|COMPLETED|Overall Study||14
6572054|NCT01861002|7495762|FG000|NOT COMPLETED|Overall Study||1
6572055|NCT01861028|7495770|FG000|STARTED|Overall Study||44
6572056|NCT01861028|7495770|FG000|COMPLETED|Overall Study||44
6572057|NCT01861028|7495770|FG000|NOT COMPLETED|Overall Study||0
6572058|NCT01861054|7495777|FG000|STARTED|Overall Study||18
6572059|NCT01861054|7495778|FG001|STARTED|Overall Study||2
6572060|NCT01861054|7495777|FG000|Safety Population|Overall Study||18
6572061|NCT01861054|7495778|FG001|Safety Population|Overall Study||2
6572062|NCT01861054|7495777|FG000|PK Population|Overall Study||4
6572063|NCT01861054|7495778|FG001|PK Population|Overall Study||2
6572064|NCT01861054|7495777|FG000|COMPLETED|Overall Study||18
6572065|NCT01861054|7495778|FG001|COMPLETED|Overall Study||2
6572066|NCT01861054|7495777|FG000|NOT COMPLETED|Overall Study||0
6572067|NCT01861054|7495778|FG001|NOT COMPLETED|Overall Study||0
6572068|NCT01861301|7495787|FG000|STARTED|Overall Study||18
6572069|NCT01861301|7495787|FG000|COMPLETED|Overall Study||18
6572070|NCT01861301|7495787|FG000|NOT COMPLETED|Overall Study||0
6572071|NCT01861457|7495794|FG000|STARTED|Overall Study||20
6572072|NCT01861457|7495795|FG001|STARTED|Overall Study||19
6572073|NCT01861457|7495794|FG000|COMPLETED|Overall Study||20
6572074|NCT01861457|7495795|FG001|COMPLETED|Overall Study||19
6572075|NCT01861457|7495794|FG000|NOT COMPLETED|Overall Study||0
6572076|NCT01861457|7495795|FG001|NOT COMPLETED|Overall Study||0
6572077|NCT01861522|7495803|FG000|STARTED|Overall Study||240
6572078|NCT01861522|7495804|FG001|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
6572079|NCT01861522|7495803|FG000|COMPLETED|Overall Study||237
6572080|NCT01861522|7495804|FG001|COMPLETED|Overall Study||232
6572081|NCT01861522|7495803|FG000|NOT COMPLETED|Overall Study||3
6572082|NCT01861522|7495804|FG001|NOT COMPLETED|Overall Study||0
6572083|NCT01861574|7495814|FG000|STARTED|Overall Study||28
6572084|NCT01861574|7495815|FG001|STARTED|Overall Study||25
6572085|NCT01861574|7495816|FG002|STARTED|Overall Study||27
6572086|NCT01861574|7495817|FG003|STARTED|Overall Study||28
6572087|NCT01861574|7495814|FG000|COMPLETED|Overall Study||28
6572088|NCT01861574|7495815|FG001|COMPLETED|Overall Study||25
6572089|NCT01861574|7495816|FG002|COMPLETED|Overall Study||27
6572090|NCT01861574|7495817|FG003|COMPLETED|Overall Study||28
6572091|NCT01861574|7495814|FG000|NOT COMPLETED|Overall Study||0
6572092|NCT01861574|7495815|FG001|NOT COMPLETED|Overall Study||0
6572093|NCT01861574|7495816|FG002|NOT COMPLETED|Overall Study||0
6572094|NCT01861574|7495817|FG003|NOT COMPLETED|Overall Study||0
6572095|NCT01861587|7495832|FG000|STARTED|Overall Study||14
6572096|NCT01861587|7495833|FG001|STARTED|Overall Study||13
6572097|NCT01861587|7495832|FG000|COMPLETED|Overall Study||14
6572098|NCT01861587|7495833|FG001|COMPLETED|Overall Study||13
6572099|NCT01861587|7495832|FG000|NOT COMPLETED|Overall Study||0
6572100|NCT01861587|7495833|FG001|NOT COMPLETED|Overall Study||0
6572101|NCT01861665|7495845|FG000|STARTED|Overall Study||10
6572102|NCT01861665|7495846|FG001|STARTED|Overall Study||17
6572103|NCT01861665|7495845|FG000|COMPLETED|Overall Study||10
6572104|NCT01861665|7495846|FG001|COMPLETED|Overall Study||17
6572105|NCT01861665|7495845|FG000|NOT COMPLETED|Overall Study||0
6572106|NCT01861665|7495846|FG001|NOT COMPLETED|Overall Study||0
6572107|NCT01861704|7495854|FG000|STARTED|Overall Study||70
6572108|NCT01861704|7495855|FG001|STARTED|Overall Study||107
6572109|NCT01861704|7495854|FG000|COMPLETED|Overall Study||67
6572110|NCT01861704|7495855|FG001|COMPLETED|Overall Study||104
6572111|NCT01861704|7495854|FG000|NOT COMPLETED|Overall Study||3
6572112|NCT01861704|7495855|FG001|NOT COMPLETED|Overall Study||3
6572113|NCT01861756|7495863|FG000|STARTED|Overall Study||101
6572114|NCT01861756|7495864|FG001|STARTED|Overall Study||103
6572115|NCT01861756|7495863|FG000|COMPLETED|Overall Study||88
6572116|NCT01861756|7495864|FG001|COMPLETED|Overall Study||85
6572117|NCT01861756|7495863|FG000|NOT COMPLETED|Overall Study||13
6572118|NCT01861756|7495864|FG001|NOT COMPLETED|Overall Study||18
6572119|NCT01861925|7495873|FG000|STARTED|Overall Study||34
6572120|NCT01861925|7495874|FG001|STARTED|Overall Study||8
6572121|NCT01861925|7495875|FG002|STARTED|Overall Study||8
6572122|NCT01861925|7495873|FG000|COMPLETED|Overall Study||34
6572123|NCT01861925|7495874|FG001|COMPLETED|Overall Study||8
6572124|NCT01861925|7495875|FG002|COMPLETED|Overall Study||8
6572125|NCT01861925|7495873|FG000|NOT COMPLETED|Overall Study||0
6572126|NCT01861925|7495874|FG001|NOT COMPLETED|Overall Study||0
6572127|NCT01861925|7495875|FG002|NOT COMPLETED|Overall Study||0
6572128|NCT01862029|7495884|FG000|STARTED|Overall Study||9
6572129|NCT01862029|7495884|FG000|COMPLETED|Overall Study||8
6572130|NCT01862029|7495884|FG000|NOT COMPLETED|Overall Study||1
6572131|NCT01862133|7495889|FG000|STARTED|Overall Study||105
6572132|NCT01862133|7495890|FG001|STARTED|Overall Study||31
6572133|NCT01862133|7495889|FG000|Returned During 6 mo Study|Overall Study||92
6572134|NCT01862133|7495890|FG001|Returned During 6 mo Study|Overall Study||31
6572135|NCT01862133|7495889|FG000|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
6572136|NCT01862133|7495890|FG001|COMPLETED|Overall Study||31
6572137|NCT01862133|7495889|FG000|NOT COMPLETED|Overall Study||0
6572138|NCT01862133|7495890|FG001|NOT COMPLETED|Overall Study||0
6572139|NCT01862159|7495896|FG000|STARTED|Overall Study||25038
6572140|NCT01862159|7495896|FG000|COMPLETED|Overall Study||25038
6572141|NCT01862159|7495896|FG000|NOT COMPLETED|Overall Study||0
6572142|NCT01862250|7495900|FG000|STARTED|Overall Study||12
6572143|NCT01862250|7495900|FG000|COMPLETED|Overall Study||8
6572144|NCT01862250|7495900|FG000|NOT COMPLETED|Overall Study||4
6572145|NCT01862328|7495911|FG000|STARTED|Overall Study||4
6572146|NCT01862328|7495912|FG001|STARTED|Overall Study||18
6572147|NCT01862328|7495913|FG002|STARTED|Overall Study||6
6572148|NCT01862328|7495914|FG003|STARTED|Overall Study||7
6572149|NCT01862328|7495915|FG004|STARTED|Overall Study||12
6572150|NCT01862328|7495916|FG005|STARTED|Overall Study||7
6572151|NCT01862328|7495917|FG006|STARTED|Overall Study||10
6572152|NCT01862328|7495911|FG000|COMPLETED|Overall Study||0
6572153|NCT01862328|7495912|FG001|COMPLETED|Overall Study||0
6572154|NCT01862328|7495913|FG002|COMPLETED|Overall Study||0
6572155|NCT01862328|7495914|FG003|COMPLETED|Overall Study||0
6572156|NCT01862328|7495915|FG004|COMPLETED|Overall Study||0
6572157|NCT01862328|7495916|FG005|COMPLETED|Overall Study||0
6572158|NCT01862328|7495917|FG006|COMPLETED|Overall Study||0
6572159|NCT01862328|7495911|FG000|NOT COMPLETED|Overall Study||4
6572160|NCT01862328|7495912|FG001|NOT COMPLETED|Overall Study||18
6572161|NCT01862328|7495913|FG002|NOT COMPLETED|Overall Study||6
6572162|NCT01862328|7495914|FG003|NOT COMPLETED|Overall Study||7
6572163|NCT01862328|7495915|FG004|NOT COMPLETED|Overall Study||12
6572164|NCT01862328|7495916|FG005|NOT COMPLETED|Overall Study||7
6572165|NCT01862328|7495917|FG006|NOT COMPLETED|Overall Study||10
6572166|NCT01862419|7495941|FG000|STARTED|Overall Study||1201
6572167|NCT01862419|7495942|FG001|STARTED|Overall Study||1192
6572168|NCT01862419|7495941|FG000|COMPLETED|Overall Study||1201
6572169|NCT01862419|7495942|FG001|COMPLETED|Overall Study||1192
6572170|NCT01862419|7495941|FG000|NOT COMPLETED|Overall Study||0
6572171|NCT01862419|7495942|FG001|NOT COMPLETED|Overall Study||0
6572172|NCT01862484|7495950|FG000|STARTED|Overall Study||15
6572173|NCT01862484|7495951|FG001|STARTED|Overall Study||14
6572174|NCT01862484|7495950|FG000|COMPLETED|Overall Study||13
6572175|NCT01862484|7495951|FG001|COMPLETED|Overall Study||6
6572176|NCT01862484|7495950|FG000|NOT COMPLETED|Overall Study||2
6572177|NCT01862484|7495951|FG001|NOT COMPLETED|Overall Study||8
6572178|NCT01862536|7495959|FG000|STARTED|Overall Study||13
6572179|NCT01862536|7495960|FG001|STARTED|Overall Study||23
6572180|NCT01862536|7495959|FG000|COMPLETED|Overall Study||10
6572181|NCT01862536|7495960|FG001|COMPLETED|Overall Study||16
6572182|NCT01862536|7495959|FG000|NOT COMPLETED|Overall Study||3
6572183|NCT01862536|7495960|FG001|NOT COMPLETED|Overall Study||7
6572184|NCT01862614|7495968|FG000|STARTED|First Appointment.|Received articaine injection at first appointment.|40
6572185|NCT01862614|7495969|FG001|STARTED|First Appointment.|Received buffered articaine at first appointment.|40
6572186|NCT01862614|7495968|FG000|COMPLETED|First Appointment.||40
6572187|NCT01862614|7495969|FG001|COMPLETED|First Appointment.||40
6572188|NCT01862614|7495968|FG000|NOT COMPLETED|First Appointment.||0
6572189|NCT01862614|7495969|FG001|NOT COMPLETED|First Appointment.||0
6572190|NCT01862614|7495968|FG000|STARTED|2 Week Washout Period.||40
6572191|NCT01862614|7495969|FG001|STARTED|2 Week Washout Period.||40
6572192|NCT01862614|7495968|FG000|COMPLETED|2 Week Washout Period.||40
6658121|NCT02476565|7588679|FG000|NOT COMPLETED|Overall Study||0
6658122|NCT02476565|7588680|FG001|NOT COMPLETED|Overall Study||0
6572193|NCT01862614|7495969|FG001|COMPLETED|2 Week Washout Period.||40
6572194|NCT01862614|7495968|FG000|NOT COMPLETED|2 Week Washout Period.||0
6572195|NCT01862614|7495969|FG001|NOT COMPLETED|2 Week Washout Period.||0
6572196|NCT01862614|7495968|FG000|STARTED|Second Appointment.|Received buffered articaine at second appointment.|40
6572197|NCT01862614|7495969|FG001|STARTED|Second Appointment.|Received articaine at second appointment.|40
6572198|NCT01862614|7495968|FG000|COMPLETED|Second Appointment.||40
6572199|NCT01862614|7495969|FG001|COMPLETED|Second Appointment.||40
6572200|NCT01862614|7495968|FG000|NOT COMPLETED|Second Appointment.||0
6658123|NCT02476578|7588688|FG000|STARTED|Overall Study||4310
6572201|NCT01862614|7495969|FG001|NOT COMPLETED|Second Appointment.||0
6572202|NCT01862640|7495979|FG000|STARTED|Overall Study||20
6572203|NCT01862640|7495980|FG001|STARTED|Overall Study||137
6572204|NCT01862640|7495981|FG002|STARTED|Overall Study||140
6572205|NCT01862640|7495982|FG003|STARTED|Overall Study||136
6572206|NCT01862640|7495979|FG000|COMPLETED|Overall Study||13
6572207|NCT01862640|7495980|FG001|COMPLETED|Overall Study||121
6572208|NCT01862640|7495981|FG002|COMPLETED|Overall Study||122
6572209|NCT01862640|7495982|FG003|COMPLETED|Overall Study||121
6572210|NCT01862640|7495979|FG000|NOT COMPLETED|Overall Study||7
6572211|NCT01862640|7495980|FG001|NOT COMPLETED|Overall Study||16
6572212|NCT01862640|7495981|FG002|NOT COMPLETED|Overall Study||18
6572213|NCT01862640|7495982|FG003|NOT COMPLETED|Overall Study||15
6572214|NCT01862796|7495994|FG000|STARTED|Overall Study||19
6572215|NCT01862796|7495995|FG001|STARTED|Overall Study||18
6572216|NCT01862796|7495996|FG002|STARTED|Overall Study||24
6572217|NCT01862796|7495994|FG000|COMPLETED|Overall Study||19
6572218|NCT01862796|7495995|FG001|COMPLETED|Overall Study||18
6572219|NCT01862796|7495996|FG002|COMPLETED|Overall Study||23
6572220|NCT01862796|7495994|FG000|NOT COMPLETED|Overall Study||0
6572221|NCT01862796|7495995|FG001|NOT COMPLETED|Overall Study||0
6572222|NCT01862796|7495996|FG002|NOT COMPLETED|Overall Study||1
6572223|NCT01862874|7496006|FG000|STARTED|Overall Study|Randomized participants|562
6572224|NCT01862874|7496007|FG001|STARTED|Overall Study|Randomized participants|562
6572225|NCT01862874|7496006|FG000|Vaccination 1|Overall Study||561
6572226|NCT01862874|7496007|FG001|Vaccination 1|Overall Study||562
6572227|NCT01862874|7496006|FG000|Vaccination 2|Overall Study||539
6572228|NCT01862874|7496007|FG001|Vaccination 2|Overall Study||542
6572229|NCT01862874|7496006|FG000|Vaccination 3|Overall Study||530
6572230|NCT01862874|7496007|FG001|Vaccination 3|Overall Study||532
6572231|NCT01862874|7496006|FG000|COMPLETED|Overall Study||483
6572232|NCT01862874|7496007|FG001|COMPLETED|Overall Study||485
6572233|NCT01862874|7496006|FG000|NOT COMPLETED|Overall Study||79
6572234|NCT01862874|7496007|FG001|NOT COMPLETED|Overall Study||77
6572235|NCT01862991|7496016|FG000|STARTED|Overall Study||24
6572236|NCT01862991|7496017|FG001|STARTED|Overall Study||28
6572237|NCT01862991|7496018|FG002|STARTED|Overall Study||28
6572238|NCT01862991|7496016|FG000|COMPLETED|Overall Study||21
6572239|NCT01862991|7496017|FG001|COMPLETED|Overall Study||27
6572240|NCT01862991|7496018|FG002|COMPLETED|Overall Study||27
6572241|NCT01862991|7496016|FG000|NOT COMPLETED|Overall Study||3
6572242|NCT01862991|7496017|FG001|NOT COMPLETED|Overall Study||1
6572243|NCT01862991|7496018|FG002|NOT COMPLETED|Overall Study||1
6572244|NCT01863017|7496028|FG000|STARTED|Overall Study||12
6572245|NCT01863017|7496029|FG001|STARTED|Overall Study||19
6572246|NCT01863017|7496028|FG000|Normal Weight Participants|Overall Study||5
6572247|NCT01863017|7496029|FG001|Normal Weight Participants|Overall Study||5
6572248|NCT01863017|7496028|FG000|Obese Participants|Overall Study||4
6572249|NCT01863017|7496029|FG001|Obese Participants|Overall Study||7
6572250|NCT01863017|7496028|FG000|Participants With PWS|Overall Study||3
6572251|NCT01863017|7496029|FG001|Participants With PWS|Overall Study||7
6572252|NCT01863017|7496028|FG000|COMPLETED|Overall Study||12
6572253|NCT01863017|7496029|FG001|COMPLETED|Overall Study||19
6572254|NCT01863017|7496028|FG000|NOT COMPLETED|Overall Study||0
6572255|NCT01863017|7496029|FG001|NOT COMPLETED|Overall Study||0
6572256|NCT01863030|7496035|FG000|STARTED|Baseline||31
6572257|NCT01863030|7496035|FG000|COMPLETED|Baseline||31
6572258|NCT01863030|7496035|FG000|NOT COMPLETED|Baseline||0
6572259|NCT01863030|7496035|FG000|STARTED|Follow up||31
6572260|NCT01863030|7496035|FG000|2 Weeks|Follow up||31
6572261|NCT01863030|7496035|FG000|3 Months|Follow up||28
6572262|NCT01863030|7496035|FG000|6 Months|Follow up||29
6572263|NCT01863030|7496035|FG000|12 Months|Follow up||26
6572264|NCT01863030|7496035|FG000|24 Months|Follow up||13
6572265|NCT01863030|7496035|FG000|COMPLETED|Follow up||13
6572266|NCT01863030|7496035|FG000|NOT COMPLETED|Follow up||18
6572267|NCT01863134|7496042|FG000|STARTED|Overall Study||72
6572268|NCT01863134|7496043|FG001|STARTED|Overall Study||68
6572269|NCT01863134|7496042|FG000|COMPLETED|Overall Study||72
6572270|NCT01863134|7496043|FG001|COMPLETED|Overall Study||68
6572271|NCT01863134|7496042|FG000|NOT COMPLETED|Overall Study||0
6572272|NCT01863134|7496043|FG001|NOT COMPLETED|Overall Study||0
6623650|NCT02209259|7550811|FG002|COMPLETED|Overall Study||56
6623651|NCT02209259|7550809|FG000|NOT COMPLETED|Overall Study||0
6623652|NCT02209259|7550810|FG001|NOT COMPLETED|Overall Study||0
6623653|NCT02209259|7550811|FG002|NOT COMPLETED|Overall Study||0
6623654|NCT02209272|7550821|FG000|STARTED|Overall Study||32
6623655|NCT02209272|7550822|FG001|STARTED|Overall Study||36
6623656|NCT02209272|7550821|FG000|COMPLETED|Overall Study||32
6623657|NCT02209272|7550822|FG001|COMPLETED|Overall Study||36
6623658|NCT02209272|7550821|FG000|NOT COMPLETED|Overall Study||0
6623659|NCT02209272|7550822|FG001|NOT COMPLETED|Overall Study||0
6623660|NCT02209454|7550828|FG000|STARTED|First Period||13
6623661|NCT02209454|7550829|FG001|STARTED|First Period||13
6623662|NCT02209454|7550828|FG000|COMPLETED|First Period||13
6623663|NCT02209454|7550829|FG001|COMPLETED|First Period||13
6623664|NCT02209454|7550828|FG000|NOT COMPLETED|First Period||0
6623665|NCT02209454|7550829|FG001|NOT COMPLETED|First Period||0
6572273|NCT01863368|7496051|FG000|STARTED|Phase I, Day 0 to Day 35||46
6572274|NCT01863368|7496052|FG001|STARTED|Phase I, Day 0 to Day 35||48
6572275|NCT01863368|7496051|FG000|Treated|Phase I, Day 0 to Day 35||46
6572276|NCT01863368|7496052|FG001|Treated|Phase I, Day 0 to Day 35||47
6572277|NCT01863368|7496051|FG000|COMPLETED|Phase I, Day 0 to Day 35||43
6572278|NCT01863368|7496052|FG001|COMPLETED|Phase I, Day 0 to Day 35||41
6572279|NCT01863368|7496051|FG000|NOT COMPLETED|Phase I, Day 0 to Day 35||3
6572280|NCT01863368|7496052|FG001|NOT COMPLETED|Phase I, Day 0 to Day 35||7
6572281|NCT01863368|7496051|FG000|STARTED|Phase II, Day 35 to Day 90||43
6572282|NCT01863368|7496052|FG001|STARTED|Phase II, Day 35 to Day 90||41
6572283|NCT01863368|7496051|FG000|COMPLETED|Phase II, Day 35 to Day 90||41
6572284|NCT01863368|7496052|FG001|COMPLETED|Phase II, Day 35 to Day 90||41
6572285|NCT01863368|7496051|FG000|NOT COMPLETED|Phase II, Day 35 to Day 90||2
6572286|NCT01863368|7496052|FG001|NOT COMPLETED|Phase II, Day 35 to Day 90||0
6572287|NCT01863433|7496059|FG000|STARTED|Overall Study||120
6572288|NCT01863433|7496059|FG000|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
6572289|NCT01863433|7496059|FG000|NOT COMPLETED|Overall Study||1
6572290|NCT01863498|7496065|FG000|STARTED|Overall Study||33
6572291|NCT01863498|7496066|FG001|STARTED|Overall Study||32
6572292|NCT01863498|7496065|FG000|COMPLETED|Overall Study||33
6572293|NCT01863498|7496066|FG001|COMPLETED|Overall Study||32
6572294|NCT01863498|7496065|FG000|NOT COMPLETED|Overall Study||0
6572295|NCT01863498|7496066|FG001|NOT COMPLETED|Overall Study||0
6572296|NCT01863563|7496072|FG000|STARTED|Overall Study||100
6572297|NCT01863563|7496072|FG000|COMPLETED|Overall Study||100
6572298|NCT01863563|7496072|FG000|NOT COMPLETED|Overall Study||0
6572299|NCT01863667|7496078|FG000|STARTED|Overall Study||33
6572300|NCT01863667|7496079|FG001|STARTED|Overall Study||32
6572301|NCT01863667|7496078|FG000|COMPLETED|Overall Study||0
6572302|NCT01863667|7496079|FG001|COMPLETED|Overall Study||0
6572303|NCT01863667|7496078|FG000|NOT COMPLETED|Overall Study||33
6572304|NCT01863667|7496079|FG001|NOT COMPLETED|Overall Study||32
6572305|NCT01863680|7496085|FG000|STARTED|Overall Study||178
6572306|NCT01863680|7496085|FG000|Subjects Started COS Treatment|Overall Study||169
6572307|NCT01863680|7496085|FG000|Subjects Received hCG Injection|Overall Study||162
6572308|NCT01863680|7496085|FG000|Subjects Received Study Drug|Overall Study||149
6572309|NCT01863680|7496085|FG000|Subjects Who Have Undergone IVF/ET|Overall Study||123
6572310|NCT01863680|7496085|FG000|COMPLETED|Overall Study||121
6572311|NCT01863680|7496085|FG000|NOT COMPLETED|Overall Study||57
6572312|NCT01863732|7496093|FG000|STARTED|Overall Study||100
6572313|NCT01863732|7496094|FG001|STARTED|Overall Study||87
6572314|NCT01863732|7496095|FG002|STARTED|Overall Study||46
6572315|NCT01863732|7496096|FG003|STARTED|Overall Study||41
6572316|NCT01863732|7496093|FG000|COMPLETED|Overall Study||87
6572317|NCT01863732|7496094|FG001|COMPLETED|Overall Study||75
6572318|NCT01863732|7496095|FG002|COMPLETED|Overall Study||35
6572319|NCT01863732|7496096|FG003|COMPLETED|Overall Study||33
6572320|NCT01863732|7496093|FG000|NOT COMPLETED|Overall Study||13
6572321|NCT01863732|7496094|FG001|NOT COMPLETED|Overall Study||12
6572322|NCT01863732|7496095|FG002|NOT COMPLETED|Overall Study||11
6572323|NCT01863732|7496096|FG003|NOT COMPLETED|Overall Study||8
6572324|NCT01863758|7496105|FG000|STARTED|Pharmacokinetic Assessment||66
6572325|NCT01863758|7496105|FG000|COMPLETED|Pharmacokinetic Assessment||66
6572326|NCT01863758|7496105|FG000|NOT COMPLETED|Pharmacokinetic Assessment||0
6572327|NCT01863758|7496105|FG000|STARTED|Prophylactic Treatment-Phase I||66
6572328|NCT01863758|7496105|FG000|COMPLETED|Prophylactic Treatment-Phase I||66
6572329|NCT01863758|7496105|FG000|NOT COMPLETED|Prophylactic Treatment-Phase I||0
6572330|NCT01863758|7496105|FG000|STARTED|Prophylactic Treatment-Phase II||66
6572331|NCT01863758|7496105|FG000|COMPLETED|Prophylactic Treatment-Phase II||64
6572332|NCT01863758|7496105|FG000|NOT COMPLETED|Prophylactic Treatment-Phase II||2
6572333|NCT01863771|7496109|FG000|STARTED|Induction Phase||144
6572334|NCT01863771|7496110|FG001|STARTED|Induction Phase||0
6572335|NCT01863771|7496111|FG002|STARTED|Induction Phase||0
6572336|NCT01863771|7496112|FG003|STARTED|Induction Phase||0
6572337|NCT01863771|7496109|FG000|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
6572338|NCT01863771|7496110|FG001|COMPLETED|Induction Phase||0
6572339|NCT01863771|7496111|FG002|COMPLETED|Induction Phase||0
6572340|NCT01863771|7496112|FG003|COMPLETED|Induction Phase||0
6572341|NCT01863771|7496109|FG000|NOT COMPLETED|Induction Phase||21
6572342|NCT01863771|7496110|FG001|NOT COMPLETED|Induction Phase||0
6572343|NCT01863771|7496111|FG002|NOT COMPLETED|Induction Phase||0
6572344|NCT01863771|7496112|FG003|NOT COMPLETED|Induction Phase||0
6572345|NCT01863771|7496109|FG000|STARTED|Maintenance Phase||0
6572346|NCT01863771|7496110|FG001|STARTED|Maintenance Phase||32
6572347|NCT01863771|7496111|FG002|STARTED|Maintenance Phase||31
6572348|NCT01863771|7496112|FG003|STARTED|Maintenance Phase||60
6572349|NCT01863771|7496109|FG000|COMPLETED|Maintenance Phase||0
6572350|NCT01863771|7496110|FG001|COMPLETED|Maintenance Phase||27
6572351|NCT01863771|7496111|FG002|COMPLETED|Maintenance Phase||19
6572352|NCT01863771|7496112|FG003|COMPLETED|Maintenance Phase||17
6572353|NCT01863771|7496109|FG000|NOT COMPLETED|Maintenance Phase||0
6572354|NCT01863771|7496110|FG001|NOT COMPLETED|Maintenance Phase||5
6572355|NCT01863771|7496111|FG002|NOT COMPLETED|Maintenance Phase||12
6572356|NCT01863771|7496112|FG003|NOT COMPLETED|Maintenance Phase||43
6572357|NCT01863849|7496122|FG000|STARTED|Overall Study||60
6572358|NCT01863849|7496123|FG001|STARTED|Overall Study||60
6572359|NCT01863849|7496122|FG000|COMPLETED|Overall Study||59
6572360|NCT01863849|7496123|FG001|COMPLETED|Overall Study||60
6572361|NCT01863849|7496122|FG000|NOT COMPLETED|Overall Study||1
6572362|NCT01863849|7496123|FG001|NOT COMPLETED|Overall Study||0
6572363|NCT01863953|7496133|FG000|STARTED|Overall Study||38
6572364|NCT01863953|7496134|FG001|STARTED|Overall Study||36
6572365|NCT01863953|7496135|FG002|STARTED|Overall Study||38
6572366|NCT01863953|7496133|FG000|COMPLETED|Overall Study||38
6572367|NCT01863953|7496134|FG001|COMPLETED|Overall Study||36
6572368|NCT01863953|7496135|FG002|COMPLETED|Overall Study||37
6572369|NCT01863953|7496133|FG000|NOT COMPLETED|Overall Study||0
6572370|NCT01863953|7496134|FG001|NOT COMPLETED|Overall Study||0
6572371|NCT01863953|7496135|FG002|NOT COMPLETED|Overall Study||1
6572372|NCT01864005|7496145|FG000|STARTED|Overall Study||29
6572373|NCT01864005|7496146|FG001|STARTED|Overall Study||31
6572374|NCT01864005|7496145|FG000|COMPLETED|Overall Study||26
6572375|NCT01864005|7496146|FG001|COMPLETED|Overall Study||25
6572376|NCT01864005|7496145|FG000|NOT COMPLETED|Overall Study||3
6572377|NCT01864005|7496146|FG001|NOT COMPLETED|Overall Study||6
6572378|NCT01864148|7496157|FG000|STARTED|Overall Study||93
6572379|NCT01864148|7496158|FG001|STARTED|Overall Study||45
6572380|NCT01864148|7496159|FG002|STARTED|Overall Study||95
6572381|NCT01864148|7496160|FG003|STARTED|Overall Study||94
6572382|NCT01864148|7496161|FG004|STARTED|Overall Study||92
6572383|NCT01864148|7496157|FG000|Randomized and Dosed|Overall Study||93
6572384|NCT01864148|7496158|FG001|Randomized and Dosed|Overall Study||45
6572385|NCT01864148|7496159|FG002|Randomized and Dosed|Overall Study||95
6572386|NCT01864148|7496160|FG003|Randomized and Dosed|Overall Study||93
6572387|NCT01864148|7496161|FG004|Randomized and Dosed|Overall Study||92
6572388|NCT01864148|7496157|FG000|COMPLETED|Overall Study||73
6572389|NCT01864148|7496158|FG001|COMPLETED|Overall Study||40
6572390|NCT01864148|7496159|FG002|COMPLETED|Overall Study||84
6572391|NCT01864148|7496160|FG003|COMPLETED|Overall Study||68
6572392|NCT01864148|7496161|FG004|COMPLETED|Overall Study||69
6572393|NCT01864148|7496157|FG000|NOT COMPLETED|Overall Study||20
6572394|NCT01864148|7496158|FG001|NOT COMPLETED|Overall Study||5
6572395|NCT01864148|7496159|FG002|NOT COMPLETED|Overall Study||11
6572396|NCT01864148|7496160|FG003|NOT COMPLETED|Overall Study||26
6572397|NCT01864148|7496161|FG004|NOT COMPLETED|Overall Study||23
6572398|NCT01864174|7496180|FG000|STARTED|Double Blind Treatment - All Treated||283
6572399|NCT01864174|7496181|FG001|STARTED|Double Blind Treatment - All Treated||285
6572400|NCT01864174|7496180|FG000|COMPLETED|Double Blind Treatment - All Treated||268
6572401|NCT01864174|7496181|FG001|COMPLETED|Double Blind Treatment - All Treated||271
6572402|NCT01864174|7496180|FG000|NOT COMPLETED|Double Blind Treatment - All Treated||15
6572403|NCT01864174|7496181|FG001|NOT COMPLETED|Double Blind Treatment - All Treated||14
6572404|NCT01864174|7496180|FG000|STARTED|Double Blind - Compliant Randomized||268
6572405|NCT01864174|7496181|FG001|STARTED|Double Blind - Compliant Randomized||271
6572406|NCT01864174|7496180|FG000|COMPLETED|Double Blind - Compliant Randomized||245
6572407|NCT01864174|7496181|FG001|COMPLETED|Double Blind - Compliant Randomized||245
6572408|NCT01864174|7496180|FG000|NOT COMPLETED|Double Blind - Compliant Randomized||23
6572409|NCT01864174|7496181|FG001|NOT COMPLETED|Double Blind - Compliant Randomized||26
6572410|NCT01864174|7496180|FG000|STARTED|Off Treatment Follow-Up||9
6572411|NCT01864174|7496181|FG001|STARTED|Off Treatment Follow-Up||1
6572412|NCT01864174|7496180|FG000|COMPLETED|Off Treatment Follow-Up||6
6572413|NCT01864174|7496181|FG001|COMPLETED|Off Treatment Follow-Up||1
6572414|NCT01864174|7496180|FG000|NOT COMPLETED|Off Treatment Follow-Up||3
6572415|NCT01864174|7496181|FG001|NOT COMPLETED|Off Treatment Follow-Up||0
6572416|NCT01864200|7496189|FG000|STARTED|Overall Study||45
6572417|NCT01864200|7496190|FG001|STARTED|Overall Study||29
6572418|NCT01864200|7496189|FG000|COMPLETED|Overall Study||43
6572419|NCT01864200|7496190|FG001|COMPLETED|Overall Study||26
6572420|NCT01864200|7496189|FG000|NOT COMPLETED|Overall Study||2
6572421|NCT01864200|7496190|FG001|NOT COMPLETED|Overall Study||3
6572422|NCT01864291|7496196|FG000|STARTED|Overall Study||9
6572423|NCT01864291|7496196|FG000|COMPLETED|Overall Study|7/9 subjects had a minimum of one year followup since enrollment.|7
6572424|NCT01864291|7496196|FG000|NOT COMPLETED|Overall Study||2
6572425|NCT01864434|7496202|FG000|STARTED|Overall Study||25
6572426|NCT01864434|7496203|FG001|STARTED|Overall Study||25
6572427|NCT01864434|7496202|FG000|COMPLETED|Overall Study||25
6572428|NCT01864434|7496203|FG001|COMPLETED|Overall Study||25
6572429|NCT01864434|7496202|FG000|NOT COMPLETED|Overall Study||0
6572430|NCT01864434|7496203|FG001|NOT COMPLETED|Overall Study||0
6572431|NCT01864525|7496211|FG000|STARTED|Overall Study||10
6572432|NCT01864525|7496212|FG001|STARTED|Overall Study||7
6572433|NCT01864525|7496211|FG000|COMPLETED|Overall Study||9
6572434|NCT01864525|7496212|FG001|COMPLETED|Overall Study||7
6572435|NCT01864525|7496211|FG000|NOT COMPLETED|Overall Study||1
6572436|NCT01864525|7496212|FG001|NOT COMPLETED|Overall Study||0
6572437|NCT01864538|7496218|FG000|STARTED|Overall Study||11
6572438|NCT01864538|7496218|FG000|COMPLETED|Overall Study||0
6572439|NCT01864538|7496218|FG000|NOT COMPLETED|Overall Study||11
6572440|NCT01864564|7496224|FG000|STARTED|Overall Study||480
6572441|NCT01864564|7496225|FG001|STARTED|Overall Study||482
6572442|NCT01864564|7496224|FG000|COMPLETED|Overall Study||443
6572443|NCT01864564|7496225|FG001|COMPLETED|Overall Study||387
6572444|NCT01864564|7496224|FG000|NOT COMPLETED|Overall Study||37
6572445|NCT01864564|7496225|FG001|NOT COMPLETED|Overall Study||95
6572446|NCT01865084|7496234|FG000|STARTED|Double Blind Period (DB)||116
6572447|NCT01865084|7496235|FG001|STARTED|Double Blind Period (DB)||102
6572448|NCT01865084|7496236|FG002|STARTED|Double Blind Period (DB)||113
6572449|NCT01865084|7496234|FG000|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
6572450|NCT01865084|7496235|FG001|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
6572451|NCT01865084|7496236|FG002|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
6572452|NCT01865084|7496234|FG000|COMPLETED|Double Blind Period (DB)||111
6572453|NCT01865084|7496235|FG001|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
6572454|NCT01865084|7496236|FG002|COMPLETED|Double Blind Period (DB)||107
6572455|NCT01865084|7496234|FG000|NOT COMPLETED|Double Blind Period (DB)||5
6572456|NCT01865084|7496235|FG001|NOT COMPLETED|Double Blind Period (DB)||4
6572457|NCT01865084|7496236|FG002|NOT COMPLETED|Double Blind Period (DB)||6
6572458|NCT01865084|7496234|FG000|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
6572459|NCT01865084|7496235|FG001|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
6572460|NCT01865084|7496236|FG002|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
6572461|NCT01865084|7496234|FG000|COMPLETED|Open Label Extension (OLE) Period||0
6572462|NCT01865084|7496235|FG001|COMPLETED|Open Label Extension (OLE) Period||139
6572463|NCT01865084|7496236|FG002|COMPLETED|Open Label Extension (OLE) Period||158
6572464|NCT01865084|7496234|FG000|NOT COMPLETED|Open Label Extension (OLE) Period||0
6572465|NCT01865084|7496235|FG001|NOT COMPLETED|Open Label Extension (OLE) Period||11
6572466|NCT01865084|7496236|FG002|NOT COMPLETED|Open Label Extension (OLE) Period||7
6572467|NCT01865448|7496250|FG000|STARTED|Overall Study||17
6572468|NCT01865448|7496251|FG001|STARTED|Overall Study||17
6572469|NCT01865448|7496250|FG000|COMPLETED|Overall Study||15
6572470|NCT01865448|7496251|FG001|COMPLETED|Overall Study||14
6572471|NCT01865448|7496250|FG000|NOT COMPLETED|Overall Study||2
6572472|NCT01865448|7496251|FG001|NOT COMPLETED|Overall Study||3
6572473|NCT01865487|7496264|FG000|STARTED|Overall Study||15
6572474|NCT01865487|7496265|FG001|STARTED|Overall Study||15
6572475|NCT01865487|7496266|FG002|STARTED|Overall Study||15
6572476|NCT01865487|7496267|FG003|STARTED|Overall Study||5
6572477|NCT01865487|7496268|FG004|STARTED|Overall Study||12
6572478|NCT01865487|7496269|FG005|STARTED|Overall Study||4
6572479|NCT01865487|7496270|FG006|STARTED|Overall Study||12
6572480|NCT01865487|7496271|FG007|STARTED|Overall Study||4
6572481|NCT01865487|7496272|FG008|STARTED|Overall Study||12
6572482|NCT01865487|7496273|FG009|STARTED|Overall Study||4
6572483|NCT01865487|7496264|FG000|COMPLETED|Overall Study||15
6572484|NCT01865487|7496265|FG001|COMPLETED|Overall Study||15
6572485|NCT01865487|7496266|FG002|COMPLETED|Overall Study||15
6572486|NCT01865487|7496267|FG003|COMPLETED|Overall Study||4
6572487|NCT01865487|7496268|FG004|COMPLETED|Overall Study||11
6572488|NCT01865487|7496269|FG005|COMPLETED|Overall Study||4
6572489|NCT01865487|7496270|FG006|COMPLETED|Overall Study||11
6572490|NCT01865487|7496271|FG007|COMPLETED|Overall Study||4
6572491|NCT01865487|7496272|FG008|COMPLETED|Overall Study||12
6572492|NCT01865487|7496273|FG009|COMPLETED|Overall Study||4
6572493|NCT01865487|7496264|FG000|NOT COMPLETED|Overall Study||0
6572494|NCT01865487|7496265|FG001|NOT COMPLETED|Overall Study||0
6572495|NCT01865487|7496266|FG002|NOT COMPLETED|Overall Study||0
6572496|NCT01865487|7496267|FG003|NOT COMPLETED|Overall Study||1
6572497|NCT01865487|7496268|FG004|NOT COMPLETED|Overall Study||1
6572498|NCT01865487|7496269|FG005|NOT COMPLETED|Overall Study||0
6572499|NCT01865487|7496270|FG006|NOT COMPLETED|Overall Study||1
6572500|NCT01865487|7496271|FG007|NOT COMPLETED|Overall Study||0
6572501|NCT01865487|7496272|FG008|NOT COMPLETED|Overall Study||0
6572502|NCT01865487|7496273|FG009|NOT COMPLETED|Overall Study||0
6572503|NCT01865552|7496307|FG000|STARTED|Period 1||23
6572504|NCT01865552|7496308|FG001|STARTED|Period 1||23
6572505|NCT01865552|7496309|FG002|STARTED|Period 1||23
6572506|NCT01865552|7496310|FG003|STARTED|Period 1||23
6572507|NCT01865552|7496311|FG004|STARTED|Period 1||23
6572508|NCT01865552|7496312|FG005|STARTED|Period 1||23
6572509|NCT01865552|7496307|FG000|Discontinued From Period 1|Period 1||1
6572510|NCT01865552|7496308|FG001|Discontinued From Period 1|Period 1||0
6572511|NCT01865552|7496309|FG002|Discontinued From Period 1|Period 1||0
6572512|NCT01865552|7496310|FG003|Discontinued From Period 1|Period 1||1
6572513|NCT01865552|7496311|FG004|Discontinued From Period 1|Period 1||3
6572514|NCT01865552|7496312|FG005|Discontinued From Period 1|Period 1||1
6572515|NCT01865552|7496307|FG000|COMPLETED|Period 1||22
6572516|NCT01865552|7496308|FG001|COMPLETED|Period 1||23
6572517|NCT01865552|7496309|FG002|COMPLETED|Period 1||23
6572518|NCT01865552|7496310|FG003|COMPLETED|Period 1||22
6572519|NCT01865552|7496311|FG004|COMPLETED|Period 1||20
6572520|NCT01865552|7496312|FG005|COMPLETED|Period 1||22
6572521|NCT01865552|7496307|FG000|NOT COMPLETED|Period 1||1
6572522|NCT01865552|7496308|FG001|NOT COMPLETED|Period 1||0
6572523|NCT01865552|7496309|FG002|NOT COMPLETED|Period 1||0
6572524|NCT01865552|7496310|FG003|NOT COMPLETED|Period 1||1
6572525|NCT01865552|7496311|FG004|NOT COMPLETED|Period 1||3
6572526|NCT01865552|7496312|FG005|NOT COMPLETED|Period 1||1
6572527|NCT01865552|7496307|FG000|STARTED|Period 2||22
6572528|NCT01865552|7496308|FG001|STARTED|Period 2||23
6572529|NCT01865552|7496309|FG002|STARTED|Period 2||23
6572530|NCT01865552|7496310|FG003|STARTED|Period 2||22
6572531|NCT01865552|7496311|FG004|STARTED|Period 2||20
6572532|NCT01865552|7496312|FG005|STARTED|Period 2||22
6572533|NCT01865552|7496307|FG000|COMPLETED|Period 2||22
6572534|NCT01865552|7496308|FG001|COMPLETED|Period 2||23
6572535|NCT01865552|7496309|FG002|COMPLETED|Period 2||23
6572536|NCT01865552|7496310|FG003|COMPLETED|Period 2||22
6572537|NCT01865552|7496311|FG004|COMPLETED|Period 2||20
6572538|NCT01865552|7496312|FG005|COMPLETED|Period 2||22
6572539|NCT01865552|7496307|FG000|NOT COMPLETED|Period 2||0
6572540|NCT01865552|7496308|FG001|NOT COMPLETED|Period 2||0
6572541|NCT01865552|7496309|FG002|NOT COMPLETED|Period 2||0
6572542|NCT01865552|7496310|FG003|NOT COMPLETED|Period 2||0
6572543|NCT01865552|7496311|FG004|NOT COMPLETED|Period 2||0
6572544|NCT01865552|7496312|FG005|NOT COMPLETED|Period 2||0
6572545|NCT01865708|7496326|FG000|STARTED|Overall Study||10
6572546|NCT01865708|7496326|FG000|COMPLETED|Overall Study||10
6572547|NCT01865708|7496326|FG000|NOT COMPLETED|Overall Study||0
6572548|NCT01865747|7496332|FG000|STARTED|Overall Study (ITT)||330
6572549|NCT01865747|7496333|FG001|STARTED|Overall Study (ITT)||328
6572550|NCT01865747|7496332|FG000|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
6572551|NCT01865747|7496333|FG001|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
6572552|NCT01865747|7496332|FG000|NOT COMPLETED|Overall Study (ITT)||198
6572553|NCT01865747|7496333|FG001|NOT COMPLETED|Overall Study (ITT)||255
6572554|NCT01865747|7496332|FG000|STARTED|Primary Intent to Treat (PITT)||187
6572555|NCT01865747|7496333|FG001|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
6572556|NCT01865747|7496332|FG000|COMPLETED|Primary Intent to Treat (PITT)||56
6572557|NCT01865747|7496333|FG001|COMPLETED|Primary Intent to Treat (PITT)||36
6572558|NCT01865747|7496332|FG000|NOT COMPLETED|Primary Intent to Treat (PITT)||131
6572559|NCT01865747|7496333|FG001|NOT COMPLETED|Primary Intent to Treat (PITT)||152
6572560|NCT01865812|7496339|FG000|STARTED|Overall Study||26
6572561|NCT01865812|7496339|FG000|COMPLETED|Overall Study||24
6572562|NCT01865812|7496339|FG000|NOT COMPLETED|Overall Study||2
6572563|NCT01866098|7496346|FG000|STARTED|Overall Study||51
6572564|NCT01866098|7496347|FG001|STARTED|Overall Study||47
6572565|NCT01866098|7496348|FG002|STARTED|Overall Study||46
6572566|NCT01866098|7496346|FG000|COMPLETED|Overall Study||32
6572567|NCT01866098|7496347|FG001|COMPLETED|Overall Study||20
6572568|NCT01866098|7496348|FG002|COMPLETED|Overall Study||25
6572569|NCT01866098|7496346|FG000|NOT COMPLETED|Overall Study||19
6572570|NCT01866098|7496347|FG001|NOT COMPLETED|Overall Study||27
6572571|NCT01866098|7496348|FG002|NOT COMPLETED|Overall Study||21
6572572|NCT01866150|7496356|FG000|STARTED|Overall Study||450
6572573|NCT01866150|7496356|FG000|COMPLETED|Overall Study||450
6572574|NCT01866150|7496356|FG000|NOT COMPLETED|Overall Study||0
6572575|NCT01866163|7496365|FG000|STARTED|Overall Study||323
6572576|NCT01866163|7496366|FG001|STARTED|Overall Study||103
6572577|NCT01866163|7496365|FG000|COMPLETED|Overall Study||313
6572578|NCT01866163|7496366|FG001|COMPLETED|Overall Study||99
6572579|NCT01866163|7496365|FG000|NOT COMPLETED|Overall Study||10
6572580|NCT01866163|7496366|FG001|NOT COMPLETED|Overall Study||4
6572581|NCT01866293|7496372|FG000|STARTED|Overall Study||11
6572582|NCT01866293|7496372|FG000|COMPLETED|Overall Study||9
6572583|NCT01866293|7496372|FG000|NOT COMPLETED|Overall Study||2
6572584|NCT01866306|7496383|FG000|STARTED|Overall Study||6
6572585|NCT01866306|7496384|FG001|STARTED|Overall Study||6
6572586|NCT01866306|7496385|FG002|STARTED|Overall Study||6
6572587|NCT01866306|7496386|FG003|STARTED|Overall Study||6
6572588|NCT01866306|7496387|FG004|STARTED|Overall Study||6
6572589|NCT01866306|7496388|FG005|STARTED|Overall Study||6
6572590|NCT01866306|7496389|FG006|STARTED|Overall Study||23
6572591|NCT01866306|7496383|FG000|COMPLETED|Overall Study||6
6572592|NCT01866306|7496384|FG001|COMPLETED|Overall Study||6
6572593|NCT01866306|7496385|FG002|COMPLETED|Overall Study||6
6572594|NCT01866306|7496386|FG003|COMPLETED|Overall Study||6
6572595|NCT01866306|7496387|FG004|COMPLETED|Overall Study||6
6572596|NCT01866306|7496388|FG005|COMPLETED|Overall Study||6
6572597|NCT01866306|7496389|FG006|COMPLETED|Overall Study||23
6572598|NCT01866306|7496383|FG000|NOT COMPLETED|Overall Study||0
6572599|NCT01866306|7496384|FG001|NOT COMPLETED|Overall Study||0
6572600|NCT01866306|7496385|FG002|NOT COMPLETED|Overall Study||0
6572601|NCT01866306|7496386|FG003|NOT COMPLETED|Overall Study||0
6572602|NCT01866306|7496387|FG004|NOT COMPLETED|Overall Study||0
6572603|NCT01866306|7496388|FG005|NOT COMPLETED|Overall Study||0
6572604|NCT01866306|7496389|FG006|NOT COMPLETED|Overall Study||0
6572605|NCT01866319|7496408|FG000|STARTED|Overall Study||278
6572606|NCT01866319|7496409|FG001|STARTED|Overall Study||279
6572607|NCT01866319|7496410|FG002|STARTED|Overall Study||277
6572608|NCT01866319|7496408|FG000|Treated|Overall Study||256
6572609|NCT01866319|7496409|FG001|Treated|Overall Study||278
6572610|NCT01866319|7496410|FG002|Treated|Overall Study||277
6572611|NCT01866319|7496408|FG000|COMPLETED|Overall Study||71
6572612|NCT01866319|7496409|FG001|COMPLETED|Overall Study||101
6572613|NCT01866319|7496410|FG002|COMPLETED|Overall Study||97
6572614|NCT01866319|7496408|FG000|NOT COMPLETED|Overall Study||207
6572615|NCT01866319|7496409|FG001|NOT COMPLETED|Overall Study||178
6572616|NCT01866319|7496410|FG002|NOT COMPLETED|Overall Study||180
6572617|NCT01866410|7496418|FG000|STARTED|Overall Study||37
6572618|NCT01866410|7496418|FG000|COMPLETED|Overall Study||37
6572619|NCT01866410|7496418|FG000|NOT COMPLETED|Overall Study||0
6572620|NCT01866423|7496425|FG000|STARTED|Overall Study||4
6572621|NCT01866423|7496425|FG000|COMPLETED|Overall Study||0
6572622|NCT01866423|7496425|FG000|NOT COMPLETED|Overall Study||4
6572623|NCT01866592|7496429|FG000|STARTED|Overall Study||81
6572624|NCT01866592|7496429|FG000|COMPLETED|Overall Study||58
6572625|NCT01866592|7496429|FG000|NOT COMPLETED|Overall Study||23
6572626|NCT01866826|7496433|FG000|STARTED|Phase I -Initial Randomization - 4 Weeks||23
6572627|NCT01866826|7496434|FG001|STARTED|Phase I -Initial Randomization - 4 Weeks||23
6572628|NCT01866826|7496433|FG000|COMPLETED|Phase I -Initial Randomization - 4 Weeks||22
6572629|NCT01866826|7496434|FG001|COMPLETED|Phase I -Initial Randomization - 4 Weeks||23
6572630|NCT01866826|7496433|FG000|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||1
6572631|NCT01866826|7496434|FG001|NOT COMPLETED|Phase I -Initial Randomization - 4 Weeks||0
6572632|NCT01866826|7496433|FG000|STARTED|Wash-Out Period - 4 -6 Weeks||22
6572633|NCT01866826|7496434|FG001|STARTED|Wash-Out Period - 4 -6 Weeks||23
6572634|NCT01866826|7496433|FG000|COMPLETED|Wash-Out Period - 4 -6 Weeks||22
6572635|NCT01866826|7496434|FG001|COMPLETED|Wash-Out Period - 4 -6 Weeks||20
6572636|NCT01866826|7496433|FG000|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||0
6572637|NCT01866826|7496434|FG001|NOT COMPLETED|Wash-Out Period - 4 -6 Weeks||3
6572638|NCT01866826|7496433|FG000|STARTED|Second Intervention - 4 Weeks||22
6572639|NCT01866826|7496434|FG001|STARTED|Second Intervention - 4 Weeks||20
6572640|NCT01866826|7496433|FG000|COMPLETED|Second Intervention - 4 Weeks||22
6572641|NCT01866826|7496434|FG001|COMPLETED|Second Intervention - 4 Weeks||20
6572642|NCT01866826|7496433|FG000|NOT COMPLETED|Second Intervention - 4 Weeks||0
6572643|NCT01866826|7496434|FG001|NOT COMPLETED|Second Intervention - 4 Weeks||0
6572644|NCT01866839|7496440|FG000|STARTED|Overall Study||40
6572645|NCT01866839|7496440|FG000|COMPLETED|Overall Study||30
6572646|NCT01866839|7496440|FG000|NOT COMPLETED|Overall Study||10
6572647|NCT01866917|7496446|FG000|STARTED|Overall Study||17
6572648|NCT01866917|7496447|FG001|STARTED|Overall Study||18
6572649|NCT01866917|7496446|FG000|COMPLETED|Overall Study||13
6572650|NCT01866917|7496447|FG001|COMPLETED|Overall Study||12
6572651|NCT01866917|7496446|FG000|NOT COMPLETED|Overall Study||4
6572652|NCT01866917|7496447|FG001|NOT COMPLETED|Overall Study||6
6572653|NCT01866943|7496455|FG000|STARTED|Overall Study||19
6572654|NCT01866943|7496456|FG001|STARTED|Overall Study||22
6572655|NCT01866943|7496455|FG000|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
6572656|NCT01866943|7496456|FG001|COMPLETED|Overall Study|Unknown - the only spreadsheet available is de-identified and blinded.|0
6572657|NCT01866943|7496455|FG000|NOT COMPLETED|Overall Study||19
6572658|NCT01866943|7496456|FG001|NOT COMPLETED|Overall Study||22
6572659|NCT01867008|7496465|FG000|STARTED|Overall Study||55
6572660|NCT01867008|7496465|FG000|COMPLETED|Overall Study||54
6572661|NCT01867008|7496465|FG000|NOT COMPLETED|Overall Study||1
6572662|NCT01867021|7496471|FG000|STARTED|Overall Study||1452
6572663|NCT01867021|7496472|FG001|STARTED|Overall Study||1450
6572664|NCT01867021|7496471|FG000|COMPLETED|Overall Study||1450
6572665|NCT01867021|7496472|FG001|COMPLETED|Overall Study||1440
6572666|NCT01867021|7496471|FG000|NOT COMPLETED|Overall Study||2
6572667|NCT01867021|7496472|FG001|NOT COMPLETED|Overall Study||10
6572668|NCT01867047|7496485|FG000|STARTED|Overall Study||31
6572669|NCT01867047|7496486|FG001|STARTED|Overall Study||28
6572670|NCT01867047|7496485|FG000|COMPLETED|Overall Study||23
6572671|NCT01867047|7496486|FG001|COMPLETED|Overall Study||23
6572672|NCT01867047|7496485|FG000|NOT COMPLETED|Overall Study||8
6572673|NCT01867047|7496486|FG001|NOT COMPLETED|Overall Study||5
6572674|NCT01867086|7496496|FG000|STARTED|Overall Study||1
6572675|NCT01867086|7496496|FG000|COMPLETED|Overall Study|"Completed means subject had been given all manufactured doses."|0
6572676|NCT01867086|7496496|FG000|NOT COMPLETED|Overall Study||1
6572677|NCT01867164|7496502|FG000|STARTED|Overall Study||81
6572678|NCT01867164|7496503|FG001|STARTED|Overall Study||79
6572679|NCT01867164|7496502|FG000|COMPLETED|Overall Study||81
6572680|NCT01867164|7496503|FG001|COMPLETED|Overall Study||79
6572681|NCT01867164|7496502|FG000|NOT COMPLETED|Overall Study||0
6572682|NCT01867164|7496503|FG001|NOT COMPLETED|Overall Study||0
6572683|NCT01867216|7496516|FG000|STARTED|Overall Study||16
6572684|NCT01867216|7496517|FG001|STARTED|Overall Study||8
6572685|NCT01867216|7496518|FG002|STARTED|Overall Study||8
6572686|NCT01867216|7496519|FG003|STARTED|Overall Study||8
6572687|NCT01867216|7496520|FG004|STARTED|Overall Study||9
6572688|NCT01867216|7496521|FG005|STARTED|Overall Study||8
6572689|NCT01867216|7496522|FG006|STARTED|Overall Study||9
6572690|NCT01867216|7496516|FG000|Received Study Drug|Overall Study||14
6572691|NCT01867216|7496517|FG001|Received Study Drug|Overall Study||8
6572692|NCT01867216|7496518|FG002|Received Study Drug|Overall Study||8
6572693|NCT01867216|7496519|FG003|Received Study Drug|Overall Study||8
6572694|NCT01867216|7496520|FG004|Received Study Drug|Overall Study||9
6572695|NCT01867216|7496521|FG005|Received Study Drug|Overall Study||8
6572696|NCT01867216|7496522|FG006|Received Study Drug|Overall Study||9
6572697|NCT01867216|7496516|FG000|COMPLETED|Overall Study||12
6572698|NCT01867216|7496517|FG001|COMPLETED|Overall Study||8
6572699|NCT01867216|7496518|FG002|COMPLETED|Overall Study||8
6572700|NCT01867216|7496519|FG003|COMPLETED|Overall Study||8
6572701|NCT01867216|7496520|FG004|COMPLETED|Overall Study||8
6572702|NCT01867216|7496521|FG005|COMPLETED|Overall Study||8
6572703|NCT01867216|7496522|FG006|COMPLETED|Overall Study||8
6572704|NCT01867216|7496516|FG000|NOT COMPLETED|Overall Study||4
6572705|NCT01867216|7496517|FG001|NOT COMPLETED|Overall Study||0
6572706|NCT01867216|7496518|FG002|NOT COMPLETED|Overall Study||0
6572707|NCT01867216|7496519|FG003|NOT COMPLETED|Overall Study||0
6572708|NCT01867216|7496520|FG004|NOT COMPLETED|Overall Study||1
6572709|NCT01867216|7496521|FG005|NOT COMPLETED|Overall Study||0
6572710|NCT01867216|7496522|FG006|NOT COMPLETED|Overall Study||1
6572711|NCT01867294|7496548|FG000|STARTED|Overall Study||9
6572712|NCT01867294|7496549|FG001|STARTED|Overall Study||10
6572713|NCT01867294|7496550|FG002|STARTED|Overall Study||0
6572714|NCT01867294|7496551|FG003|STARTED|Overall Study||0
6572715|NCT01867294|7496548|FG000|COMPLETED|Overall Study||8
6572716|NCT01867294|7496549|FG001|COMPLETED|Overall Study||9
6572717|NCT01867294|7496550|FG002|COMPLETED|Overall Study||0
6572718|NCT01867294|7496551|FG003|COMPLETED|Overall Study||0
6572719|NCT01867294|7496548|FG000|NOT COMPLETED|Overall Study||1
6572720|NCT01867294|7496549|FG001|NOT COMPLETED|Overall Study||1
6572721|NCT01867294|7496550|FG002|NOT COMPLETED|Overall Study||0
6572722|NCT01867294|7496551|FG003|NOT COMPLETED|Overall Study||0
6572723|NCT01867307|7496561|FG000|STARTED|Overall Study|Started are the treated patients|18
6572724|NCT01867307|7496562|FG001|STARTED|Overall Study|Started are the treated patients|19
6572725|NCT01867307|7496561|FG000|COMPLETED|Overall Study||15
6572726|NCT01867307|7496562|FG001|COMPLETED|Overall Study||16
6572727|NCT01867307|7496561|FG000|NOT COMPLETED|Overall Study||3
6572728|NCT01867307|7496562|FG001|NOT COMPLETED|Overall Study||3
6572729|NCT01867424|7496570|FG000|STARTED|Overall Study||12
6572730|NCT01867424|7496571|FG001|STARTED|Overall Study||12
6572731|NCT01867424|7496570|FG000|COMPLETED|Overall Study||10
6572732|NCT01867424|7496571|FG001|COMPLETED|Overall Study||11
6572733|NCT01867424|7496570|FG000|NOT COMPLETED|Overall Study||2
6572734|NCT01867424|7496571|FG001|NOT COMPLETED|Overall Study||1
6572735|NCT01867515|7496580|FG000|STARTED|Overall Study||13
6572736|NCT01867515|7496581|FG001|STARTED|Overall Study||12
6572737|NCT01867515|7496582|FG002|STARTED|Overall Study||25
6572738|NCT01867515|7496580|FG000|COMPLETED|Overall Study||13
6572739|NCT01867515|7496581|FG001|COMPLETED|Overall Study||11
6572740|NCT01867515|7496582|FG002|COMPLETED|Overall Study||14
6572741|NCT01867515|7496580|FG000|NOT COMPLETED|Overall Study||0
6572742|NCT01867515|7496581|FG001|NOT COMPLETED|Overall Study||1
6572743|NCT01867515|7496582|FG002|NOT COMPLETED|Overall Study||11
6572744|NCT01867580|7496592|FG000|STARTED|Overall Study||93
6572745|NCT01867580|7496593|FG001|STARTED|Overall Study||88
6572746|NCT01867580|7496592|FG000|COMPLETED|Overall Study||65
6572747|NCT01867580|7496593|FG001|COMPLETED|Overall Study||64
6572748|NCT01867580|7496592|FG000|NOT COMPLETED|Overall Study||28
6572749|NCT01867580|7496593|FG001|NOT COMPLETED|Overall Study||24
6572750|NCT01867632|7496601|FG000|STARTED|Overall Study||65
6572751|NCT01867632|7496602|FG001|STARTED|Overall Study||66
6572752|NCT01867632|7496601|FG000|COMPLETED|Overall Study||65
6572753|NCT01867632|7496602|FG001|COMPLETED|Overall Study||66
6572754|NCT01867632|7496601|FG000|NOT COMPLETED|Overall Study||0
6572755|NCT01867632|7496602|FG001|NOT COMPLETED|Overall Study||0
6572756|NCT01867658|7496608|FG000|STARTED|Overall Study||112
6572757|NCT01867658|7496608|FG000|COMPLETED|Overall Study||103
6572758|NCT01867658|7496608|FG000|NOT COMPLETED|Overall Study||9
6572759|NCT01867671|7496614|FG000|STARTED|Overall Study||96
6572760|NCT01867671|7496615|FG001|STARTED|Overall Study||50
6572761|NCT01867671|7496614|FG000|COMPLETED|Overall Study||67
6572762|NCT01867671|7496615|FG001|COMPLETED|Overall Study||22
6572763|NCT01867671|7496614|FG000|NOT COMPLETED|Overall Study||29
6572764|NCT01867671|7496615|FG001|NOT COMPLETED|Overall Study||28
6572765|NCT01867710|7496625|FG000|STARTED|Overall Study||41
6572766|NCT01867710|7496626|FG001|STARTED|Overall Study||41
6572767|NCT01867710|7496627|FG002|STARTED|Overall Study||40
6572768|NCT01867710|7496628|FG003|STARTED|Overall Study||42
6572769|NCT01867710|7496625|FG000|Treated|Overall Study||41
6572770|NCT01867710|7496626|FG001|Treated|Overall Study||41
6572771|NCT01867710|7496627|FG002|Treated|Overall Study||39
6572772|NCT01867710|7496628|FG003|Treated|Overall Study||42
6572773|NCT01867710|7496625|FG000|COMPLETED|Overall Study||0
6572774|NCT01867710|7496626|FG001|COMPLETED|Overall Study||0
6572775|NCT01867710|7496627|FG002|COMPLETED|Overall Study||0
6572776|NCT01867710|7496628|FG003|COMPLETED|Overall Study||0
6572777|NCT01867710|7496625|FG000|NOT COMPLETED|Overall Study||41
6572778|NCT01867710|7496626|FG001|NOT COMPLETED|Overall Study||41
6572779|NCT01867710|7496627|FG002|NOT COMPLETED|Overall Study||40
6572780|NCT01867710|7496628|FG003|NOT COMPLETED|Overall Study||42
6572781|NCT01868009|7496638|FG000|STARTED|Period 1 (5-9 Days)||143
6572782|NCT01868009|7496639|FG001|STARTED|Period 1 (5-9 Days)||144
6572783|NCT01868009|7496638|FG000|COMPLETED|Period 1 (5-9 Days)||143
6572784|NCT01868009|7496639|FG001|COMPLETED|Period 1 (5-9 Days)||142
6572785|NCT01868009|7496638|FG000|NOT COMPLETED|Period 1 (5-9 Days)||0
6572786|NCT01868009|7496639|FG001|NOT COMPLETED|Period 1 (5-9 Days)||2
6572787|NCT01868009|7496638|FG000|STARTED|Period 2 (5-9 Days)||143
6572788|NCT01868009|7496639|FG001|STARTED|Period 2 (5-9 Days)||142
6572789|NCT01868009|7496638|FG000|COMPLETED|Period 2 (5-9 Days)||141
6572790|NCT01868009|7496639|FG001|COMPLETED|Period 2 (5-9 Days)||142
6572791|NCT01868009|7496638|FG000|NOT COMPLETED|Period 2 (5-9 Days)||2
6572792|NCT01868009|7496639|FG001|NOT COMPLETED|Period 2 (5-9 Days)||0
6572793|NCT01868022|7496654|FG000|STARTED|Overall Study||3
6572794|NCT01868022|7496655|FG001|STARTED|Overall Study||3
6572795|NCT01868022|7496656|FG002|STARTED|Overall Study||14
6572796|NCT01868022|7496657|FG003|STARTED|Overall Study||3
6572797|NCT01868022|7496658|FG004|STARTED|Overall Study||3
6572798|NCT01868022|7496659|FG005|STARTED|Overall Study||3
6572799|NCT01868022|7496660|FG006|STARTED|Overall Study||3
6572800|NCT01868022|7496661|FG007|STARTED|Overall Study||25
6572801|NCT01868022|7496662|FG008|STARTED|Overall Study||8
6572802|NCT01868022|7496654|FG000|COMPLETED|Overall Study||3
6572803|NCT01868022|7496655|FG001|COMPLETED|Overall Study||3
6572804|NCT01868022|7496656|FG002|COMPLETED|Overall Study||13
6572805|NCT01868022|7496657|FG003|COMPLETED|Overall Study||2
6572806|NCT01868022|7496658|FG004|COMPLETED|Overall Study||1
6572807|NCT01868022|7496659|FG005|COMPLETED|Overall Study||2
6572808|NCT01868022|7496660|FG006|COMPLETED|Overall Study||3
6572809|NCT01868022|7496661|FG007|COMPLETED|Overall Study||16
6572810|NCT01868022|7496662|FG008|COMPLETED|Overall Study||6
6572811|NCT01868022|7496654|FG000|NOT COMPLETED|Overall Study||0
6572812|NCT01868022|7496655|FG001|NOT COMPLETED|Overall Study||0
6572813|NCT01868022|7496656|FG002|NOT COMPLETED|Overall Study||1
6572814|NCT01868022|7496657|FG003|NOT COMPLETED|Overall Study||1
6572815|NCT01868022|7496658|FG004|NOT COMPLETED|Overall Study||2
6572816|NCT01868022|7496659|FG005|NOT COMPLETED|Overall Study||1
6572817|NCT01868022|7496660|FG006|NOT COMPLETED|Overall Study||0
6572818|NCT01868022|7496661|FG007|NOT COMPLETED|Overall Study||9
6572819|NCT01868022|7496662|FG008|NOT COMPLETED|Overall Study||2
6572820|NCT01868035|7496688|FG000|STARTED|Overall Study||15
6572821|NCT01868035|7496688|FG000|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
6572822|NCT01868035|7496688|FG000|NOT COMPLETED|Overall Study||7
6572823|NCT01868074|7496694|FG000|STARTED|Overall Study||36
6572824|NCT01868074|7496695|FG001|STARTED|Overall Study||36
6572825|NCT01868074|7496694|FG000|COMPLETED|Overall Study||29
6572826|NCT01868074|7496695|FG001|COMPLETED|Overall Study||32
6572827|NCT01868074|7496694|FG000|NOT COMPLETED|Overall Study||7
6572828|NCT01868074|7496695|FG001|NOT COMPLETED|Overall Study||4
6572829|NCT01868165|7496701|FG000|STARTED|Overall Study||337
6572830|NCT01868165|7496701|FG000|COMPLETED|Overall Study||292
6572831|NCT01868165|7496701|FG000|NOT COMPLETED|Overall Study||45
6572832|NCT01868243|7496707|FG000|STARTED|Overall Study||15
6572833|NCT01868243|7496708|FG001|STARTED|Overall Study||12
6572834|NCT01868243|7496707|FG000|COMPLETED|Overall Study||15
6572835|NCT01868243|7496708|FG001|COMPLETED|Overall Study||11
6572836|NCT01868243|7496707|FG000|NOT COMPLETED|Overall Study||0
6572837|NCT01868243|7496708|FG001|NOT COMPLETED|Overall Study||1
6572838|NCT01868334|7496718|FG000|STARTED|Year 1 RCCT Study||13186
6572839|NCT01868334|7496719|FG001|STARTED|Year 1 RCCT Study||17185
6572840|NCT01868334|7496720|FG002|STARTED|Year 1 RCCT Study||19274
6572841|NCT01868334|7496721|FG003|STARTED|Year 1 RCCT Study||20904
6572842|NCT01868334|7496718|FG000|COMPLETED|Year 1 RCCT Study||13186
6572843|NCT01868334|7496719|FG001|COMPLETED|Year 1 RCCT Study||17185
6572844|NCT01868334|7496720|FG002|COMPLETED|Year 1 RCCT Study||19274
6572845|NCT01868334|7496721|FG003|COMPLETED|Year 1 RCCT Study||20904
6572846|NCT01868334|7496718|FG000|NOT COMPLETED|Year 1 RCCT Study||0
6572847|NCT01868334|7496719|FG001|NOT COMPLETED|Year 1 RCCT Study||0
6572848|NCT01868334|7496720|FG002|NOT COMPLETED|Year 1 RCCT Study||0
6572849|NCT01868334|7496721|FG003|NOT COMPLETED|Year 1 RCCT Study||0
6572850|NCT01868334|7496718|FG000|STARTED|Year 2 Pre-post Study|Reflects: control sites from Year 1 (N=8) and Year 1 Intervention sites who continued in Y2 (N=4)|22324
6572851|NCT01868334|7496719|FG001|STARTED|Year 2 Pre-post Study|Reflects: the six Year 1 Intervention sites who chose not to actively engage Year 2|8047
6572852|NCT01868334|7496720|FG002|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Control sites who became active in the intervention during Year 2|20904
6572853|NCT01868334|7496721|FG003|STARTED|Year 2 Pre-post Study|Reflects: Year 1 Intervention sites who chose not to actively engage Year 2|19274
6572854|NCT01868334|7496718|FG000|COMPLETED|Year 2 Pre-post Study||22324
6572855|NCT01868334|7496719|FG001|COMPLETED|Year 2 Pre-post Study||8047
6572856|NCT01868334|7496720|FG002|COMPLETED|Year 2 Pre-post Study||20904
6572857|NCT01868334|7496721|FG003|COMPLETED|Year 2 Pre-post Study||19274
6572858|NCT01868334|7496718|FG000|NOT COMPLETED|Year 2 Pre-post Study||0
6572859|NCT01868334|7496719|FG001|NOT COMPLETED|Year 2 Pre-post Study||0
6572860|NCT01868334|7496720|FG002|NOT COMPLETED|Year 2 Pre-post Study||0
6572861|NCT01868334|7496721|FG003|NOT COMPLETED|Year 2 Pre-post Study||0
6572862|NCT01868425|7496761|FG000|STARTED|Overall Study||55
6572863|NCT01868425|7496762|FG001|STARTED|Overall Study||57
6572864|NCT01868425|7496761|FG000|COMPLETED|Overall Study||55
6572865|NCT01868425|7496762|FG001|COMPLETED|Overall Study||57
6572866|NCT01868425|7496761|FG000|NOT COMPLETED|Overall Study||0
6572867|NCT01868425|7496762|FG001|NOT COMPLETED|Overall Study||0
6572868|NCT01868477|7496770|FG000|STARTED|Overall Study||12
6572869|NCT01868477|7496771|FG001|STARTED|Overall Study||11
6572870|NCT01868477|7496770|FG000|Switched to EPO+DFX|Overall Study||5
6572871|NCT01868477|7496771|FG001|Switched to EPO+DFX|Overall Study||0
6572872|NCT01868477|7496770|FG000|Not Switched to EPO+DFX|Overall Study||7
6572873|NCT01868477|7496771|FG001|Not Switched to EPO+DFX|Overall Study||0
6572874|NCT01868477|7496770|FG000|COMPLETED|Overall Study||8
6572875|NCT01868477|7496771|FG001|COMPLETED|Overall Study||6
6572876|NCT01868477|7496770|FG000|NOT COMPLETED|Overall Study||4
6572877|NCT01868477|7496771|FG001|NOT COMPLETED|Overall Study||5
6572878|NCT01868503|7496784|FG000|STARTED|Overall Study||7
6572879|NCT01868503|7496784|FG000|COMPLETED|Overall Study||5
6572880|NCT01868503|7496784|FG000|NOT COMPLETED|Overall Study||2
6572881|NCT01868542|7496792|FG000|STARTED|Overall Study||23
6572882|NCT01868542|7496793|FG001|STARTED|Overall Study||23
6572883|NCT01868542|7496792|FG000|COMPLETED|Overall Study||23
6572884|NCT01868542|7496793|FG001|COMPLETED|Overall Study||21
6572885|NCT01868542|7496792|FG000|NOT COMPLETED|Overall Study||0
6572886|NCT01868542|7496793|FG001|NOT COMPLETED|Overall Study||2
6572887|NCT01868594|7496801|FG000|STARTED|Overall Study||76
6572888|NCT01868594|7496802|FG001|STARTED|Overall Study||75
6572889|NCT01868594|7496801|FG000|COMPLETED|Overall Study||72
6572890|NCT01868594|7496802|FG001|COMPLETED|Overall Study||72
6572891|NCT01868594|7496801|FG000|NOT COMPLETED|Overall Study||4
6572892|NCT01868594|7496802|FG001|NOT COMPLETED|Overall Study||3
6572893|NCT01868633|7496812|FG000|STARTED|Overall Study||26
6572894|NCT01868633|7496813|FG001|STARTED|Overall Study||26
6572895|NCT01868633|7496812|FG000|COMPLETED|Overall Study||26
6572896|NCT01868633|7496813|FG001|COMPLETED|Overall Study||26
6572897|NCT01868633|7496812|FG000|NOT COMPLETED|Overall Study||0
6572898|NCT01868633|7496813|FG001|NOT COMPLETED|Overall Study||0
6572899|NCT01868646|7496821|FG000|STARTED|Overall Study||76
6572900|NCT01868646|7496822|FG001|STARTED|Overall Study||72
6572901|NCT01868646|7496821|FG000|COMPLETED|Overall Study||73
6572902|NCT01868646|7496822|FG001|COMPLETED|Overall Study||67
6572903|NCT01868646|7496821|FG000|NOT COMPLETED|Overall Study||3
6572904|NCT01868646|7496822|FG001|NOT COMPLETED|Overall Study||5
6572905|NCT01868776|7496830|FG000|STARTED|Overall Study||50
6572906|NCT01868776|7496831|FG001|STARTED|Overall Study||50
6572907|NCT01868776|7496830|FG000|COMPLETED|Overall Study||50
6572908|NCT01868776|7496831|FG001|COMPLETED|Overall Study||50
6572909|NCT01868776|7496830|FG000|NOT COMPLETED|Overall Study||0
6572910|NCT01868776|7496831|FG001|NOT COMPLETED|Overall Study||0
6572911|NCT01868789|7496839|FG000|STARTED|Overall Study||9
6391741|NCT00837811|7303657|FG002|NOT COMPLETED|Overall Study||1
6391742|NCT00837824|7303676|FG000|STARTED|Overall Study||11
6391743|NCT00837824|7303677|FG001|STARTED|Overall Study||9
6391744|NCT00837824|7303676|FG000|COMPLETED|Overall Study||11
6391745|NCT00837824|7303677|FG001|COMPLETED|Overall Study||9
6391746|NCT00837824|7303676|FG000|NOT COMPLETED|Overall Study||0
6391747|NCT00837824|7303677|FG001|NOT COMPLETED|Overall Study||0
6391748|NCT00837876|7303684|FG000|STARTED|Overall Study||37
6391749|NCT00837876|7303684|FG000|COMPLETED|Overall Study||0
6391750|NCT00837876|7303684|FG000|NOT COMPLETED|Overall Study||37
6391751|NCT00837902|7303690|FG000|STARTED|Overall Study||85
6391752|NCT00837902|7303691|FG001|STARTED|Overall Study||69
6391753|NCT00837902|7303690|FG000|COMPLETED|Overall Study||85
6391754|NCT00837902|7303691|FG001|COMPLETED|Overall Study||69
6391755|NCT00837902|7303690|FG000|NOT COMPLETED|Overall Study||0
6391756|NCT00837902|7303691|FG001|NOT COMPLETED|Overall Study||0
6391757|NCT00837967|7303698|FG000|STARTED|First Intervention||13
6391758|NCT00837967|7303699|FG001|STARTED|First Intervention||12
6572912|NCT01868789|7496840|FG001|STARTED|Overall Study||14
6572913|NCT01868789|7496839|FG000|COMPLETED|Overall Study||7
6572914|NCT01868789|7496840|FG001|COMPLETED|Overall Study||12
6572915|NCT01868789|7496839|FG000|NOT COMPLETED|Overall Study||2
6572916|NCT01868789|7496840|FG001|NOT COMPLETED|Overall Study||2
6572917|NCT01868893|7496846|FG000|STARTED|Overall Study||20
6572918|NCT01868893|7496846|FG000|COMPLETED|Overall Study||0
6572919|NCT01868893|7496846|FG000|NOT COMPLETED|Overall Study||20
6572920|NCT01868997|7496854|FG000|STARTED|Overall Study|randomized and treated|45
6572921|NCT01868997|7496855|FG001|STARTED|Overall Study|randomized and treated|42
6572922|NCT01868997|7496854|FG000|COMPLETED|Overall Study||38
6572923|NCT01868997|7496855|FG001|COMPLETED|Overall Study||36
6572924|NCT01868997|7496854|FG000|NOT COMPLETED|Overall Study||7
6572925|NCT01868997|7496855|FG001|NOT COMPLETED|Overall Study||6
6572926|NCT01869075|7496867|FG000|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
6572927|NCT01869075|7496868|FG001|STARTED|Phase 0 (Baseline)||418
6572928|NCT01869075|7496869|FG002|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
6572929|NCT01869075|7496870|FG003|STARTED|Phase 0 (Baseline)||416
6572930|NCT01869075|7496871|FG004|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
6572931|NCT01869075|7496872|FG005|STARTED|Phase 0 (Baseline)||341
6572932|NCT01869075|7496867|FG000|COMPLETED|Phase 0 (Baseline)||0
6572933|NCT01869075|7496868|FG001|COMPLETED|Phase 0 (Baseline)||418
6572934|NCT01869075|7496869|FG002|COMPLETED|Phase 0 (Baseline)||0
6572935|NCT01869075|7496870|FG003|COMPLETED|Phase 0 (Baseline)||416
6572936|NCT01869075|7496871|FG004|COMPLETED|Phase 0 (Baseline)||0
6572937|NCT01869075|7496872|FG005|COMPLETED|Phase 0 (Baseline)||341
6572938|NCT01869075|7496867|FG000|NOT COMPLETED|Phase 0 (Baseline)||0
6572939|NCT01869075|7496868|FG001|NOT COMPLETED|Phase 0 (Baseline)||0
6572940|NCT01869075|7496869|FG002|NOT COMPLETED|Phase 0 (Baseline)||0
6572941|NCT01869075|7496870|FG003|NOT COMPLETED|Phase 0 (Baseline)||0
6572942|NCT01869075|7496871|FG004|NOT COMPLETED|Phase 0 (Baseline)||0
6572943|NCT01869075|7496872|FG005|NOT COMPLETED|Phase 0 (Baseline)||0
6572944|NCT01869075|7496867|FG000|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
6572945|NCT01869075|7496868|FG001|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
6391759|NCT00837967|7303698|FG000|COMPLETED|First Intervention||13
6391760|NCT00837967|7303699|FG001|COMPLETED|First Intervention||12
6391761|NCT00837967|7303698|FG000|NOT COMPLETED|First Intervention||0
6572946|NCT01869075|7496869|FG002|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
6572947|NCT01869075|7496870|FG003|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
6572948|NCT01869075|7496871|FG004|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
6572949|NCT01869075|7496872|FG005|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
6572950|NCT01869075|7496867|FG000|COMPLETED|Phase 1||45
6572951|NCT01869075|7496868|FG001|COMPLETED|Phase 1||75
6572952|NCT01869075|7496869|FG002|COMPLETED|Phase 1||45
6572953|NCT01869075|7496870|FG003|COMPLETED|Phase 1||75
6572954|NCT01869075|7496871|FG004|COMPLETED|Phase 1||30
6572955|NCT01869075|7496872|FG005|COMPLETED|Phase 1||90
6572956|NCT01869075|7496867|FG000|NOT COMPLETED|Phase 1||0
6572957|NCT01869075|7496868|FG001|NOT COMPLETED|Phase 1||0
6572958|NCT01869075|7496869|FG002|NOT COMPLETED|Phase 1||0
6572959|NCT01869075|7496870|FG003|NOT COMPLETED|Phase 1||0
6572960|NCT01869075|7496871|FG004|NOT COMPLETED|Phase 1||0
6572961|NCT01869075|7496872|FG005|NOT COMPLETED|Phase 1||0
6572962|NCT01869075|7496867|FG000|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
6572963|NCT01869075|7496868|FG001|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
6572964|NCT01869075|7496869|FG002|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
6572965|NCT01869075|7496870|FG003|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
6572966|NCT01869075|7496871|FG004|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
6572967|NCT01869075|7496872|FG005|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
6572968|NCT01869075|7496867|FG000|COMPLETED|Phase 2||90
6572969|NCT01869075|7496868|FG001|COMPLETED|Phase 2||30
6572970|NCT01869075|7496869|FG002|COMPLETED|Phase 2||75
6572971|NCT01869075|7496870|FG003|COMPLETED|Phase 2||45
6572972|NCT01869075|7496871|FG004|COMPLETED|Phase 2||75
6572973|NCT01869075|7496872|FG005|COMPLETED|Phase 2||45
6572974|NCT01869075|7496867|FG000|NOT COMPLETED|Phase 2||0
6572975|NCT01869075|7496868|FG001|NOT COMPLETED|Phase 2||0
6572976|NCT01869075|7496869|FG002|NOT COMPLETED|Phase 2||0
6572977|NCT01869075|7496870|FG003|NOT COMPLETED|Phase 2||0
6572978|NCT01869075|7496871|FG004|NOT COMPLETED|Phase 2||0
6572979|NCT01869075|7496872|FG005|NOT COMPLETED|Phase 2||0
6572980|NCT01869192|7496888|FG000|STARTED|Preoperative Chemotherapy to Surgery||37
6572981|NCT01869192|7496889|FG001|STARTED|Preoperative Chemotherapy to Surgery||35
6572982|NCT01869192|7496888|FG000|COMPLETED|Preoperative Chemotherapy to Surgery||35
6572983|NCT01869192|7496889|FG001|COMPLETED|Preoperative Chemotherapy to Surgery|one never got treatment on study|34
6572984|NCT01869192|7496888|FG000|NOT COMPLETED|Preoperative Chemotherapy to Surgery||2
6572985|NCT01869192|7496889|FG001|NOT COMPLETED|Preoperative Chemotherapy to Surgery||1
6572986|NCT01869192|7496888|FG000|STARTED|Postoperative Chemotherapy|3 did not start postop chemotherapy|32
6572987|NCT01869192|7496889|FG001|STARTED|Postoperative Chemotherapy||33
6572988|NCT01869192|7496888|FG000|COMPLETED|Postoperative Chemotherapy||32
6572989|NCT01869192|7496889|FG001|COMPLETED|Postoperative Chemotherapy||31
6572990|NCT01869192|7496888|FG000|NOT COMPLETED|Postoperative Chemotherapy||0
6572991|NCT01869192|7496889|FG001|NOT COMPLETED|Postoperative Chemotherapy||2
6572992|NCT01869348|7496897|FG000|STARTED|Overall Study||20
6572993|NCT01869348|7496898|FG001|STARTED|Overall Study||20
6572994|NCT01869348|7496897|FG000|COMPLETED|Overall Study||19
6572995|NCT01869348|7496898|FG001|COMPLETED|Overall Study||19
6572996|NCT01869348|7496897|FG000|NOT COMPLETED|Overall Study||1
6572997|NCT01869348|7496898|FG001|NOT COMPLETED|Overall Study||1
6572998|NCT01869374|7496906|FG000|STARTED|Overall Study||9
6572999|NCT01869374|7496907|FG001|STARTED|Overall Study||9
6573000|NCT01869374|7496906|FG000|COMPLETED|Overall Study||9
6573001|NCT01869374|7496907|FG001|COMPLETED|Overall Study||8
6573002|NCT01869374|7496906|FG000|NOT COMPLETED|Overall Study||0
6573003|NCT01869374|7496907|FG001|NOT COMPLETED|Overall Study||1
6573004|NCT01869439|7496913|FG000|STARTED|Overall Study||40
6573005|NCT01869439|7496913|FG000|COMPLETED|Overall Study||40
6573006|NCT01869439|7496913|FG000|NOT COMPLETED|Overall Study||0
6573007|NCT01869634|7496919|FG000|STARTED|Overall Study||20
6573008|NCT01869634|7496920|FG001|STARTED|Overall Study||17
6573009|NCT01869634|7496919|FG000|COMPLETED|Overall Study||18
6573010|NCT01869634|7496920|FG001|COMPLETED|Overall Study||17
6573011|NCT01869634|7496919|FG000|NOT COMPLETED|Overall Study||2
6573012|NCT01869634|7496920|FG001|NOT COMPLETED|Overall Study||0
6573013|NCT01869647|7496929|FG000|STARTED|Overall Study||66
6573014|NCT01869647|7496930|FG001|STARTED|Overall Study||136
6573015|NCT01869647|7496931|FG002|STARTED|Overall Study||62
6573016|NCT01869647|7496929|FG000|COMPLETED|Overall Study||65
6573017|NCT01869647|7496930|FG001|COMPLETED|Overall Study||130
6573018|NCT01869647|7496931|FG002|COMPLETED|Overall Study||62
6573019|NCT01869647|7496929|FG000|NOT COMPLETED|Overall Study||1
6573020|NCT01869647|7496930|FG001|NOT COMPLETED|Overall Study||6
6573021|NCT01869647|7496931|FG002|NOT COMPLETED|Overall Study||0
6573022|NCT01869686|7496939|FG000|STARTED|Overall Study||12
6573023|NCT01869686|7496939|FG000|COMPLETED|Overall Study||12
6573024|NCT01869686|7496939|FG000|NOT COMPLETED|Overall Study||0
6573025|NCT01869699|7496945|FG000|STARTED|Overall Study||21
6573026|NCT01869699|7496946|FG001|STARTED|Overall Study||20
6573027|NCT01869699|7496945|FG000|COMPLETED|Overall Study||20
6573028|NCT01869699|7496946|FG001|COMPLETED|Overall Study||20
6573029|NCT01869699|7496945|FG000|NOT COMPLETED|Overall Study||1
6573030|NCT01869699|7496946|FG001|NOT COMPLETED|Overall Study||0
6573031|NCT01869725|7496952|FG000|STARTED|Overall Study||68
6573032|NCT01869725|7496952|FG000|COMPLETED|Overall Study||64
6573033|NCT01869725|7496952|FG000|NOT COMPLETED|Overall Study||4
6573034|NCT01869764|7496958|FG000|STARTED|Overall Study||28
6573035|NCT01869764|7496959|FG001|STARTED|Overall Study||29
6573036|NCT01869764|7496958|FG000|COMPLETED|Overall Study||28
6573037|NCT01869764|7496959|FG001|COMPLETED|Overall Study||27
6573038|NCT01869764|7496958|FG000|NOT COMPLETED|Overall Study||0
6573039|NCT01869764|7496959|FG001|NOT COMPLETED|Overall Study||2
6573040|NCT01869777|7496965|FG000|STARTED|Overall Study||102
6573041|NCT01869777|7496965|FG000|COMPLETED|Overall Study||101
6573042|NCT01869777|7496965|FG000|NOT COMPLETED|Overall Study||1
6573043|NCT01869959|7496973|FG000|STARTED|Randomization Period||0
6573044|NCT01869959|7496974|FG001|STARTED|Randomization Period||0
6573045|NCT01869959|7496975|FG002|STARTED|Randomization Period||0
6573046|NCT01869959|7496976|FG003|STARTED|Randomization Period||0
6573047|NCT01869959|7496977|FG004|STARTED|Randomization Period||47
6573048|NCT01869959|7496973|FG000|COMPLETED|Randomization Period||0
6573049|NCT01869959|7496974|FG001|COMPLETED|Randomization Period||0
6573050|NCT01869959|7496975|FG002|COMPLETED|Randomization Period||0
6573051|NCT01869959|7496976|FG003|COMPLETED|Randomization Period||0
6573052|NCT01869959|7496977|FG004|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
6573053|NCT01869959|7496973|FG000|NOT COMPLETED|Randomization Period||0
6573054|NCT01869959|7496974|FG001|NOT COMPLETED|Randomization Period||0
6573055|NCT01869959|7496975|FG002|NOT COMPLETED|Randomization Period||0
6573056|NCT01869959|7496976|FG003|NOT COMPLETED|Randomization Period||0
6573057|NCT01869959|7496977|FG004|NOT COMPLETED|Randomization Period||1
6573058|NCT01869959|7496973|FG000|STARTED|Treatment Period||11
6573059|NCT01869959|7496974|FG001|STARTED|Treatment Period||10
6573060|NCT01869959|7496975|FG002|STARTED|Treatment Period||15
6573061|NCT01869959|7496976|FG003|STARTED|Treatment Period||10
6573062|NCT01869959|7496977|FG004|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
6573063|NCT01869959|7496973|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||11
6573064|NCT01869959|7496974|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||10
6573065|NCT01869959|7496975|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||15
6573066|NCT01869959|7496976|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||10
6573067|NCT01869959|7496977|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||0
6573068|NCT01869959|7496973|FG000|COMPLETED|Treatment Period||10
6573069|NCT01869959|7496974|FG001|COMPLETED|Treatment Period||8
6573070|NCT01869959|7496975|FG002|COMPLETED|Treatment Period||12
6573071|NCT01869959|7496976|FG003|COMPLETED|Treatment Period||8
6573072|NCT01869959|7496977|FG004|COMPLETED|Treatment Period||0
6573073|NCT01869959|7496973|FG000|NOT COMPLETED|Treatment Period||1
6573074|NCT01869959|7496974|FG001|NOT COMPLETED|Treatment Period||2
6573075|NCT01869959|7496975|FG002|NOT COMPLETED|Treatment Period||3
6573076|NCT01869959|7496976|FG003|NOT COMPLETED|Treatment Period||2
6573077|NCT01869959|7496977|FG004|NOT COMPLETED|Treatment Period||0
6573078|NCT01870076|7496991|FG000|STARTED|Overall Study||10
6573079|NCT01870076|7496992|FG001|STARTED|Overall Study||12
6573080|NCT01870076|7496993|FG002|STARTED|Overall Study||8
6573081|NCT01870076|7496994|FG003|STARTED|Overall Study||11
6573082|NCT01870076|7496991|FG000|COMPLETED|Overall Study||9
6573083|NCT01870076|7496992|FG001|COMPLETED|Overall Study||12
6573084|NCT01870076|7496993|FG002|COMPLETED|Overall Study||7
6573085|NCT01870076|7496994|FG003|COMPLETED|Overall Study||11
6573086|NCT01870076|7496991|FG000|NOT COMPLETED|Overall Study||1
6573087|NCT01870076|7496992|FG001|NOT COMPLETED|Overall Study||0
6573088|NCT01870076|7496993|FG002|NOT COMPLETED|Overall Study||1
6573089|NCT01870076|7496994|FG003|NOT COMPLETED|Overall Study||0
6573090|NCT01870297|7497011|FG000|STARTED|Overall Study||11
6573091|NCT01870297|7497012|FG001|STARTED|Overall Study||15
6573092|NCT01870297|7497013|FG002|STARTED|Overall Study||8
6573093|NCT01870297|7497014|FG003|STARTED|Overall Study||9
6573094|NCT01870297|7497015|FG004|STARTED|Overall Study||10
6573095|NCT01870297|7497016|FG005|STARTED|Overall Study||9
6573096|NCT01870297|7497017|FG006|STARTED|Overall Study||10
6573097|NCT01870297|7497011|FG000|COMPLETED|Overall Study||11
6573098|NCT01870297|7497012|FG001|COMPLETED|Overall Study||8
6573099|NCT01870297|7497013|FG002|COMPLETED|Overall Study||7
6573100|NCT01870297|7497014|FG003|COMPLETED|Overall Study||9
6573101|NCT01870297|7497015|FG004|COMPLETED|Overall Study||7
6573102|NCT01870297|7497016|FG005|COMPLETED|Overall Study||8
6573103|NCT01870297|7497017|FG006|COMPLETED|Overall Study||8
6573104|NCT01870297|7497011|FG000|NOT COMPLETED|Overall Study||0
6573105|NCT01870297|7497012|FG001|NOT COMPLETED|Overall Study||7
6573106|NCT01870297|7497013|FG002|NOT COMPLETED|Overall Study||1
6573107|NCT01870297|7497014|FG003|NOT COMPLETED|Overall Study||0
6573108|NCT01870297|7497015|FG004|NOT COMPLETED|Overall Study||3
6573109|NCT01870297|7497016|FG005|NOT COMPLETED|Overall Study||1
6573110|NCT01870297|7497017|FG006|NOT COMPLETED|Overall Study||2
6573111|NCT01870388|7497044|FG000|STARTED|Overall Study||8
6573112|NCT01870388|7497045|FG001|STARTED|Overall Study||8
6573113|NCT01870388|7497044|FG000|Received 1 Dose of Study Drug|Overall Study||8
6573114|NCT01870388|7497045|FG001|Received 1 Dose of Study Drug|Overall Study||8
6573115|NCT01870388|7497044|FG000|COMPLETED|Overall Study||8
6573116|NCT01870388|7497045|FG001|COMPLETED|Overall Study||8
6573117|NCT01870388|7497044|FG000|NOT COMPLETED|Overall Study||0
6573118|NCT01870388|7497045|FG001|NOT COMPLETED|Overall Study||0
6573119|NCT01870583|7497056|FG000|STARTED|Overall Study||467
6573120|NCT01870583|7497057|FG001|STARTED|Overall Study||474
6573121|NCT01870583|7497058|FG002|STARTED|Overall Study||463
6573122|NCT01870583|7497056|FG000|COMPLETED|Overall Study||456
6573123|NCT01870583|7497057|FG001|COMPLETED|Overall Study||456
6573124|NCT01870583|7497058|FG002|COMPLETED|Overall Study||455
6573125|NCT01870583|7497056|FG000|NOT COMPLETED|Overall Study||11
6573126|NCT01870583|7497057|FG001|NOT COMPLETED|Overall Study||18
6573127|NCT01870583|7497058|FG002|NOT COMPLETED|Overall Study||8
6573128|NCT01870596|7497068|FG000|STARTED|Overall Study||14
6573129|NCT01870596|7497069|FG001|STARTED|Overall Study||18
6573130|NCT01870596|7497068|FG000|COMPLETED|Overall Study||14
6573131|NCT01870596|7497069|FG001|COMPLETED|Overall Study||18
6573132|NCT01870596|7497068|FG000|NOT COMPLETED|Overall Study||0
6573133|NCT01870596|7497069|FG001|NOT COMPLETED|Overall Study||0
6573134|NCT01870726|7497082|FG000|STARTED|Overall Study||5
6573135|NCT01870726|7497083|FG001|STARTED|Overall Study||6
6573136|NCT01870726|7497084|FG002|STARTED|Overall Study||4
6573137|NCT01870726|7497085|FG003|STARTED|Overall Study||6
6573138|NCT01870726|7497086|FG004|STARTED|Overall Study||7
6573139|NCT01870726|7497087|FG005|STARTED|Overall Study||5
6573140|NCT01870726|7497088|FG006|STARTED|Overall Study||10
6573141|NCT01870726|7497082|FG000|COMPLETED|Overall Study||0
6573142|NCT01870726|7497083|FG001|COMPLETED|Overall Study||0
6573143|NCT01870726|7497084|FG002|COMPLETED|Overall Study||0
6573144|NCT01870726|7497085|FG003|COMPLETED|Overall Study||0
6573145|NCT01870726|7497086|FG004|COMPLETED|Overall Study||0
6573146|NCT01870726|7497087|FG005|COMPLETED|Overall Study||0
6573147|NCT01870726|7497088|FG006|COMPLETED|Overall Study||0
6573148|NCT01870726|7497082|FG000|NOT COMPLETED|Overall Study||5
6573149|NCT01870726|7497083|FG001|NOT COMPLETED|Overall Study||6
6573150|NCT01870726|7497084|FG002|NOT COMPLETED|Overall Study||4
6573151|NCT01870726|7497085|FG003|NOT COMPLETED|Overall Study||6
6573152|NCT01870726|7497086|FG004|NOT COMPLETED|Overall Study||7
6573153|NCT01870726|7497087|FG005|NOT COMPLETED|Overall Study||5
6573154|NCT01870726|7497088|FG006|NOT COMPLETED|Overall Study||10
6573155|NCT01870739|7497115|FG000|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
6573156|NCT01870739|7497116|FG001|STARTED|Single Drug Treatment (12 Weeks)||57
6573157|NCT01870739|7497115|FG000|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
6573158|NCT01870739|7497116|FG001|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
6573159|NCT01870739|7497115|FG000|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
6573160|NCT01870739|7497116|FG001|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
6573161|NCT01870739|7497115|FG000|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
6573162|NCT01870739|7497116|FG001|COMPLETED|Single Drug Treatment (12 Weeks)||53
6573163|NCT01870739|7497115|FG000|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
6573164|NCT01870739|7497116|FG001|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
6573165|NCT01870739|7497115|FG000|STARTED|Add-on Period (40 Weeks)||54
6573166|NCT01870739|7497116|FG001|STARTED|Add-on Period (40 Weeks)||53
6573167|NCT01870739|7497115|FG000|COMPLETED|Add-on Period (40 Weeks)||51
6573168|NCT01870739|7497116|FG001|COMPLETED|Add-on Period (40 Weeks)||51
6573169|NCT01870739|7497115|FG000|NOT COMPLETED|Add-on Period (40 Weeks)||3
6573170|NCT01870739|7497116|FG001|NOT COMPLETED|Add-on Period (40 Weeks)||2
6573171|NCT01870778|7497134|FG000|STARTED|Overall Study||3274
6573172|NCT01870778|7497135|FG001|STARTED|Overall Study||3271
6573173|NCT01870778|7497134|FG000|Safety Set|Overall Study||3257
6573174|NCT01870778|7497135|FG001|Safety Set|Overall Study||3248
6573175|NCT01870778|7497134|FG000|Full Analysis Set|Overall Study||3274
6573176|NCT01870778|7497135|FG001|Full Analysis Set|Overall Study||3271
6573177|NCT01870778|7497134|FG000|Biomarker Analysis Set|Overall Study||521
6573178|NCT01870778|7497135|FG001|Biomarker Analysis Set|Overall Study||510
6573179|NCT01870778|7497134|FG000|COMPLETED|Overall Study||3266
6573180|NCT01870778|7497135|FG001|COMPLETED|Overall Study||3262
6573181|NCT01870778|7497134|FG000|NOT COMPLETED|Overall Study||8
6573182|NCT01870778|7497135|FG001|NOT COMPLETED|Overall Study||9
6573183|NCT01870843|7497141|FG000|STARTED|Overall Study||261
6573184|NCT01870843|7497141|FG000|COMPLETED|Overall Study||208
6573185|NCT01870843|7497141|FG000|NOT COMPLETED|Overall Study||53
6573186|NCT01870856|7497147|FG000|STARTED|Overall Study||25
6573187|NCT01870856|7497148|FG001|STARTED|Overall Study||27
6573188|NCT01870856|7497147|FG000|COMPLETED|Overall Study||25
6573189|NCT01870856|7497148|FG001|COMPLETED|Overall Study||27
6573190|NCT01870856|7497147|FG000|NOT COMPLETED|Overall Study||0
6573191|NCT01870856|7497148|FG001|NOT COMPLETED|Overall Study||0
6573192|NCT01870869|7497160|FG000|STARTED|Overall Study||288
6573193|NCT01870869|7497161|FG001|STARTED|Overall Study||206
6573194|NCT01870869|7497162|FG002|STARTED|Overall Study||1222
6573195|NCT01870869|7497163|FG003|STARTED|Overall Study||235
6573196|NCT01870869|7497160|FG000|COMPLETED|Overall Study||260
6573197|NCT01870869|7497161|FG001|COMPLETED|Overall Study||192
6573198|NCT01870869|7497162|FG002|COMPLETED|Overall Study||1092
6573199|NCT01870869|7497163|FG003|COMPLETED|Overall Study||205
6573200|NCT01870869|7497160|FG000|NOT COMPLETED|Overall Study||28
6573201|NCT01870869|7497161|FG001|NOT COMPLETED|Overall Study||14
6573202|NCT01870869|7497162|FG002|NOT COMPLETED|Overall Study||130
6573203|NCT01870869|7497163|FG003|NOT COMPLETED|Overall Study||30
6573204|NCT01870921|7497173|FG000|STARTED|Overall Study||2004
6573205|NCT01870921|7497173|FG000|COMPLETED|Overall Study||1914
6573206|NCT01870921|7497173|FG000|NOT COMPLETED|Overall Study||90
6573207|NCT01870973|7497179|FG000|STARTED|Overall Study||56
6573208|NCT01870973|7497180|FG001|STARTED|Overall Study||52
6573209|NCT01870973|7497179|FG000|COMPLETED|Overall Study||46
6573210|NCT01870973|7497180|FG001|COMPLETED|Overall Study||49
6573211|NCT01870973|7497179|FG000|NOT COMPLETED|Overall Study||10
6573212|NCT01870973|7497180|FG001|NOT COMPLETED|Overall Study||3
6573213|NCT01870999|7497189|FG000|STARTED|Overall Study||14
6573214|NCT01870999|7497190|FG001|STARTED|Overall Study||16
6573215|NCT01870999|7497191|FG002|STARTED|Overall Study||11
6573216|NCT01870999|7497189|FG000|Safety Population; Received Study Drug|Overall Study||14
6573217|NCT01870999|7497190|FG001|Safety Population; Received Study Drug|Overall Study||15
6573218|NCT01870999|7497191|FG002|Safety Population; Received Study Drug|Overall Study||10
6573219|NCT01870999|7497189|FG000|COMPLETED|Overall Study||10
6573220|NCT01870999|7497190|FG001|COMPLETED|Overall Study||8
6573221|NCT01870999|7497191|FG002|COMPLETED|Overall Study||4
6573222|NCT01870999|7497189|FG000|NOT COMPLETED|Overall Study||4
6573223|NCT01870999|7497190|FG001|NOT COMPLETED|Overall Study||8
6573224|NCT01870999|7497191|FG002|NOT COMPLETED|Overall Study||7
6623666|NCT02209454|7550828|FG000|STARTED|Washout Period a Minimum of a 7 Day||13
6623667|NCT02209454|7550829|FG001|STARTED|Washout Period a Minimum of a 7 Day||13
6623668|NCT02209454|7550828|FG000|COMPLETED|Washout Period a Minimum of a 7 Day||13
6623669|NCT02209454|7550829|FG001|COMPLETED|Washout Period a Minimum of a 7 Day||13
6623670|NCT02209454|7550828|FG000|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
6623671|NCT02209454|7550829|FG001|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
6623672|NCT02209454|7550828|FG000|STARTED|Second Period||13
6623673|NCT02209454|7550829|FG001|STARTED|Second Period||13
6623674|NCT02209454|7550828|FG000|COMPLETED|Second Period||12
6623675|NCT02209454|7550829|FG001|COMPLETED|Second Period||13
6623676|NCT02209454|7550828|FG000|NOT COMPLETED|Second Period||1
6623677|NCT02209454|7550829|FG001|NOT COMPLETED|Second Period||0
6623678|NCT02209506|7550840|FG000|STARTED|Overall Study||3
6623679|NCT02209506|7550841|FG001|STARTED|Overall Study||6
6623680|NCT02209506|7550842|FG002|STARTED|Overall Study||6
6623681|NCT02209506|7550843|FG003|STARTED|Overall Study||2
6623682|NCT02209506|7550844|FG004|STARTED|Overall Study||6
6623683|NCT02209506|7550840|FG000|COMPLETED|Overall Study||3
6623684|NCT02209506|7550841|FG001|COMPLETED|Overall Study||6
6623685|NCT02209506|7550842|FG002|COMPLETED|Overall Study||6
6623686|NCT02209506|7550843|FG003|COMPLETED|Overall Study||2
6623687|NCT02209506|7550844|FG004|COMPLETED|Overall Study||5
6623688|NCT02209506|7550840|FG000|NOT COMPLETED|Overall Study||0
6623689|NCT02209506|7550841|FG001|NOT COMPLETED|Overall Study||0
6623690|NCT02209506|7550842|FG002|NOT COMPLETED|Overall Study||0
6623691|NCT02209506|7550843|FG003|NOT COMPLETED|Overall Study||0
6623692|NCT02209506|7550844|FG004|NOT COMPLETED|Overall Study||1
6623693|NCT02209519|7550861|FG000|STARTED|Overall Study||107
6623694|NCT02209519|7550862|FG001|STARTED|Overall Study||107
6623695|NCT02209519|7550861|FG000|COMPLETED|Overall Study||107
6623696|NCT02209519|7550862|FG001|COMPLETED|Overall Study||107
6623697|NCT02209519|7550861|FG000|NOT COMPLETED|Overall Study||0
6623698|NCT02209519|7550862|FG001|NOT COMPLETED|Overall Study||0
6623699|NCT02209532|7550871|FG000|STARTED|Overall Study||90
6623700|NCT02209532|7550872|FG001|STARTED|Overall Study||90
6623701|NCT02209532|7550871|FG000|COMPLETED|Overall Study||87
6623702|NCT02209532|7550872|FG001|COMPLETED|Overall Study||89
6623703|NCT02209532|7550871|FG000|NOT COMPLETED|Overall Study||3
6623704|NCT02209532|7550872|FG001|NOT COMPLETED|Overall Study||1
6623705|NCT02209597|7550879|FG000|STARTED|Phase 1 Current Tx (Non-randomized)||74
6623706|NCT02209597|7550879|FG000|COMPLETED|Phase 1 Current Tx (Non-randomized)||71
6623707|NCT02209597|7550879|FG000|NOT COMPLETED|Phase 1 Current Tx (Non-randomized)||3
6623708|NCT02209597|7550879|FG000|STARTED|Phase 2 (Randomized: 1 Brand, 3 Generic)||71
6623709|NCT02209597|7550879|FG000|COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||67
6623710|NCT02209597|7550879|FG000|NOT COMPLETED|Phase 2 (Randomized: 1 Brand, 3 Generic)||4
6623711|NCT02209597|7550879|FG000|STARTED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
6623712|NCT02209597|7550879|FG000|COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||67
6623713|NCT02209597|7550879|FG000|NOT COMPLETED|Phase 3 (Randomized: 1 Brand, 3 Generic)||0
6623714|NCT02209597|7550879|FG000|STARTED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
6623715|NCT02209597|7550879|FG000|COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||67
6623716|NCT02209597|7550879|FG000|NOT COMPLETED|Phase 4 (Randomized: 1 Brand, 3 Generic)||0
6623717|NCT02209610|7550891|FG000|STARTED|Overall Study||16
6623718|NCT02209610|7550892|FG001|STARTED|Overall Study||16
6623719|NCT02209610|7550891|FG000|COMPLETED|Overall Study||16
6623720|NCT02209610|7550892|FG001|COMPLETED|Overall Study||16
6623721|NCT02209610|7550891|FG000|NOT COMPLETED|Overall Study||0
6623722|NCT02209610|7550892|FG001|NOT COMPLETED|Overall Study||0
6623723|NCT02209766|7550903|FG000|STARTED|Overall Study||6
6623724|NCT02209766|7550904|FG001|STARTED|Overall Study||3
6623725|NCT02209766|7550905|FG002|STARTED|Overall Study||6
6623726|NCT02209766|7550906|FG003|STARTED|Overall Study||3
6623727|NCT02209766|7550907|FG004|STARTED|Overall Study||6
6623728|NCT02209766|7550903|FG000|COMPLETED|Overall Study||6
6623729|NCT02209766|7550904|FG001|COMPLETED|Overall Study||3
6623730|NCT02209766|7550905|FG002|COMPLETED|Overall Study||6
6623731|NCT02209766|7550906|FG003|COMPLETED|Overall Study||2
6623732|NCT02209766|7550907|FG004|COMPLETED|Overall Study||6
6623733|NCT02209766|7550903|FG000|NOT COMPLETED|Overall Study||0
6623734|NCT02209766|7550904|FG001|NOT COMPLETED|Overall Study||0
6623735|NCT02209766|7550905|FG002|NOT COMPLETED|Overall Study||0
6623736|NCT02209766|7550906|FG003|NOT COMPLETED|Overall Study||1
6623737|NCT02209766|7550907|FG004|NOT COMPLETED|Overall Study||0
6623738|NCT02209948|7550919|FG000|STARTED|Overall Study||80
6623739|NCT02209948|7550920|FG001|STARTED|Overall Study||79
6623740|NCT02209948|7550919|FG000|Recieved Alocated Intervention|Overall Study||80
6623741|NCT02209948|7550920|FG001|Recieved Alocated Intervention|Overall Study||79
6623742|NCT02209948|7550919|FG000|Lost to Follow up|Overall Study||0
6623743|NCT02209948|7550920|FG001|Lost to Follow up|Overall Study||1
6623744|NCT02209948|7550919|FG000|Discontinued Due to Progression|Overall Study||31
6573225|NCT01871077|7497199|FG000|STARTED|Overall Study||30
6573226|NCT01871077|7497199|FG000|COMPLETED|Overall Study||30
6573227|NCT01871077|7497199|FG000|NOT COMPLETED|Overall Study||0
6573228|NCT01871090|7497205|FG000|STARTED|Overall Study||35
6573229|NCT01871090|7497206|FG001|STARTED|Overall Study||48
6573230|NCT01871090|7497205|FG000|COMPLETED|Overall Study||33
6573231|NCT01871090|7497206|FG001|COMPLETED|Overall Study||25
6573232|NCT01871090|7497205|FG000|NOT COMPLETED|Overall Study||2
6573233|NCT01871090|7497206|FG001|NOT COMPLETED|Overall Study||23
6573234|NCT01871142|7497212|FG000|STARTED|Overall Study||12
6573235|NCT01871142|7497212|FG000|Received Placebo + Normoixa|Overall Study||11
6573236|NCT01871142|7497212|FG000|Received Placebo + Hypoxia|Overall Study||12
6573237|NCT01871142|7497212|FG000|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
6573238|NCT01871142|7497212|FG000|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
6573239|NCT01871142|7497212|FG000|COMPLETED|Overall Study||11
6573240|NCT01871142|7497212|FG000|NOT COMPLETED|Overall Study||1
6573241|NCT01871285|7497228|FG000|STARTED|First Intervention (1 Day)||18
6573242|NCT01871285|7497229|FG001|STARTED|First Intervention (1 Day)||15
6573243|NCT01871285|7497230|FG002|STARTED|First Intervention (1 Day)||4
6573244|NCT01871285|7497231|FG003|STARTED|First Intervention (1 Day)||2
6573245|NCT01871285|7497228|FG000|COMPLETED|First Intervention (1 Day)||17
6573246|NCT01871285|7497229|FG001|COMPLETED|First Intervention (1 Day)||14
6573247|NCT01871285|7497230|FG002|COMPLETED|First Intervention (1 Day)||3
6573248|NCT01871285|7497231|FG003|COMPLETED|First Intervention (1 Day)||2
6573249|NCT01871285|7497228|FG000|NOT COMPLETED|First Intervention (1 Day)||1
6573250|NCT01871285|7497229|FG001|NOT COMPLETED|First Intervention (1 Day)||1
6573251|NCT01871285|7497230|FG002|NOT COMPLETED|First Intervention (1 Day)||1
6573252|NCT01871285|7497231|FG003|NOT COMPLETED|First Intervention (1 Day)||0
6573253|NCT01871285|7497228|FG000|STARTED|Second Intervention (1 Day)||17
6573254|NCT01871285|7497229|FG001|STARTED|Second Intervention (1 Day)||14
6573255|NCT01871285|7497230|FG002|STARTED|Second Intervention (1 Day)||3
6573256|NCT01871285|7497231|FG003|STARTED|Second Intervention (1 Day)||2
6573257|NCT01871285|7497228|FG000|COMPLETED|Second Intervention (1 Day)||17
6573258|NCT01871285|7497229|FG001|COMPLETED|Second Intervention (1 Day)||14
6573259|NCT01871285|7497230|FG002|COMPLETED|Second Intervention (1 Day)||3
6573260|NCT01871285|7497231|FG003|COMPLETED|Second Intervention (1 Day)||2
6573261|NCT01871285|7497228|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6573262|NCT01871285|7497229|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6573263|NCT01871285|7497230|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6573264|NCT01871285|7497231|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6573265|NCT01871402|7497243|FG000|STARTED|Overall Study||110
6573266|NCT01871402|7497244|FG001|STARTED|Overall Study||111
6573267|NCT01871402|7497243|FG000|COMPLETED|Overall Study||109
6573268|NCT01871402|7497244|FG001|COMPLETED|Overall Study||108
6573269|NCT01871402|7497243|FG000|NOT COMPLETED|Overall Study||1
6573270|NCT01871402|7497244|FG001|NOT COMPLETED|Overall Study||3
6573271|NCT01871441|7497250|FG000|STARTED|Overall Study||4
6573272|NCT01871441|7497250|FG000|COMPLETED|Overall Study||4
6573273|NCT01871441|7497250|FG000|NOT COMPLETED|Overall Study||0
6573274|NCT01871506|7497257|FG000|STARTED|Overall Study||150
6573275|NCT01871506|7497258|FG001|STARTED|Overall Study||153
6573276|NCT01871506|7497257|FG000|COMPLETED|Overall Study||150
6573277|NCT01871506|7497258|FG001|COMPLETED|Overall Study||153
6573278|NCT01871506|7497257|FG000|NOT COMPLETED|Overall Study||0
6573279|NCT01871506|7497258|FG001|NOT COMPLETED|Overall Study||0
6573280|NCT01871519|7497277|FG000|STARTED|Overall Study||350
6573281|NCT01871519|7497277|FG000|COMPLETED|Overall Study||260
6573282|NCT01871519|7497277|FG000|NOT COMPLETED|Overall Study||90
6573283|NCT01871532|7497284|FG000|STARTED|Overall Study||12
6573284|NCT01871532|7497285|FG001|STARTED|Overall Study||12
6573285|NCT01871532|7497284|FG000|Subjects Received hCG Treatment|Overall Study||11
6573286|NCT01871532|7497285|FG001|Subjects Received hCG Treatment|Overall Study||9
6573287|NCT01871532|7497284|FG000|COMPLETED|Overall Study||11
6573288|NCT01871532|7497285|FG001|COMPLETED|Overall Study||10
6573289|NCT01871532|7497284|FG000|NOT COMPLETED|Overall Study||1
6573290|NCT01871532|7497285|FG001|NOT COMPLETED|Overall Study||2
6573291|NCT01871545|7497293|FG000|STARTED|Overall Study||73
6573292|NCT01871545|7497294|FG001|STARTED|Overall Study||11
6573293|NCT01871545|7497293|FG000|COMPLETED|Overall Study||56
6573294|NCT01871545|7497294|FG001|COMPLETED|Overall Study||8
6573295|NCT01871545|7497293|FG000|NOT COMPLETED|Overall Study||17
6573296|NCT01871545|7497294|FG001|NOT COMPLETED|Overall Study||3
6573297|NCT01871558|7497305|FG000|STARTED|Overall Study||21
6573298|NCT01871558|7497306|FG001|STARTED|Overall Study||21
6573299|NCT01871558|7497305|FG000|COMPLETED|Overall Study||18
6573300|NCT01871558|7497306|FG001|COMPLETED|Overall Study||19
6573301|NCT01871558|7497305|FG000|NOT COMPLETED|Overall Study||3
6573302|NCT01871558|7497306|FG001|NOT COMPLETED|Overall Study||2
6573303|NCT01871805|7497318|FG000|STARTED|Phase I||7
6573304|NCT01871805|7497319|FG001|STARTED|Phase I||7
6573305|NCT01871805|7497320|FG002|STARTED|Phase I||13
6573306|NCT01871805|7497321|FG003|STARTED|Phase I||7
6573307|NCT01871805|7497322|FG004|STARTED|Phase I||13
6573308|NCT01871805|7497323|FG005|STARTED|Phase I||0
6573309|NCT01871805|7497318|FG000|COMPLETED|Phase I||0
6573310|NCT01871805|7497319|FG001|COMPLETED|Phase I||0
6573311|NCT01871805|7497320|FG002|COMPLETED|Phase I||0
6573312|NCT01871805|7497321|FG003|COMPLETED|Phase I||0
6573313|NCT01871805|7497322|FG004|COMPLETED|Phase I||0
6573314|NCT01871805|7497323|FG005|COMPLETED|Phase I||0
6573315|NCT01871805|7497318|FG000|NOT COMPLETED|Phase I||7
6573316|NCT01871805|7497319|FG001|NOT COMPLETED|Phase I||7
6573317|NCT01871805|7497320|FG002|NOT COMPLETED|Phase I||13
6573318|NCT01871805|7497321|FG003|NOT COMPLETED|Phase I||7
6573319|NCT01871805|7497322|FG004|NOT COMPLETED|Phase I||13
6573320|NCT01871805|7497323|FG005|NOT COMPLETED|Phase I||0
6573321|NCT01871805|7497318|FG000|STARTED|Phase II||0
6573322|NCT01871805|7497319|FG001|STARTED|Phase II||0
6573323|NCT01871805|7497320|FG002|STARTED|Phase II||0
6573324|NCT01871805|7497321|FG003|STARTED|Phase II||0
6573325|NCT01871805|7497322|FG004|STARTED|Phase II||0
6573326|NCT01871805|7497323|FG005|STARTED|Phase II||87
6573327|NCT01871805|7497318|FG000|COMPLETED|Phase II||0
6573328|NCT01871805|7497319|FG001|COMPLETED|Phase II||0
6573329|NCT01871805|7497320|FG002|COMPLETED|Phase II||0
6573330|NCT01871805|7497321|FG003|COMPLETED|Phase II||0
6573331|NCT01871805|7497322|FG004|COMPLETED|Phase II||0
6573332|NCT01871805|7497323|FG005|COMPLETED|Phase II||0
6573333|NCT01871805|7497318|FG000|NOT COMPLETED|Phase II||0
6573334|NCT01871805|7497319|FG001|NOT COMPLETED|Phase II||0
6573335|NCT01871805|7497320|FG002|NOT COMPLETED|Phase II||0
6573336|NCT01871805|7497321|FG003|NOT COMPLETED|Phase II||0
6573337|NCT01871805|7497322|FG004|NOT COMPLETED|Phase II||0
6573338|NCT01871805|7497323|FG005|NOT COMPLETED|Phase II||87
6573339|NCT01871870|7497354|FG000|STARTED|Overall Study||20
6573340|NCT01871870|7497354|FG000|COMPLETED|Overall Study||11
6573341|NCT01871870|7497354|FG000|NOT COMPLETED|Overall Study||9
6573342|NCT01872078|7497362|FG000|STARTED|Overall Study||16
6573343|NCT01872078|7497363|FG001|STARTED|Overall Study||15
6573344|NCT01872078|7497364|FG002|STARTED|Overall Study||17
6573345|NCT01872078|7497365|FG003|STARTED|Overall Study||17
6573346|NCT01872078|7497362|FG000|COMPLETED|Overall Study||16
6573347|NCT01872078|7497363|FG001|COMPLETED|Overall Study||15
6573348|NCT01872078|7497364|FG002|COMPLETED|Overall Study||14
6573349|NCT01872078|7497365|FG003|COMPLETED|Overall Study||15
6573350|NCT01872078|7497362|FG000|NOT COMPLETED|Overall Study||0
6573351|NCT01872078|7497363|FG001|NOT COMPLETED|Overall Study||0
6573352|NCT01872078|7497364|FG002|NOT COMPLETED|Overall Study||3
6573353|NCT01872078|7497365|FG003|NOT COMPLETED|Overall Study||2
6573354|NCT01872325|7497377|FG000|STARTED|Overall Study||689
6573355|NCT01872325|7497378|FG001|STARTED|Overall Study||387
6573356|NCT01872325|7497377|FG000|COMPLETED|Overall Study||689
6573357|NCT01872325|7497378|FG001|COMPLETED|Overall Study||387
6573358|NCT01872325|7497377|FG000|NOT COMPLETED|Overall Study||0
6573359|NCT01872325|7497378|FG001|NOT COMPLETED|Overall Study||0
6573360|NCT01872338|7497386|FG000|STARTED|Overall Study||66
6573361|NCT01872338|7497387|FG001|STARTED|Overall Study||69
6573362|NCT01872338|7497386|FG000|COMPLETED|Overall Study||46
6573363|NCT01872338|7497387|FG001|COMPLETED|Overall Study||69
6573364|NCT01872338|7497386|FG000|NOT COMPLETED|Overall Study||20
6573365|NCT01872338|7497387|FG001|NOT COMPLETED|Overall Study||0
6573366|NCT01872611|7497395|FG000|STARTED|Overall Study||301
6573367|NCT01872611|7497396|FG001|STARTED|Overall Study||304
6573368|NCT01872611|7497395|FG000|Randomized|Overall Study||301
6573369|NCT01872611|7497396|FG001|Randomized|Overall Study||304
6573370|NCT01872611|7497395|FG000|Treated (Safety Analysis Set)|Overall Study||293
6573371|NCT01872611|7497396|FG001|Treated (Safety Analysis Set)|Overall Study||295
6573372|NCT01872611|7497395|FG000|Full Analysis Set|Overall Study||289
6573373|NCT01872611|7497396|FG001|Full Analysis Set|Overall Study||293
6573374|NCT01872611|7497395|FG000|COMPLETED|Overall Study||277
6573375|NCT01872611|7497396|FG001|COMPLETED|Overall Study||292
6573376|NCT01872611|7497395|FG000|NOT COMPLETED|Overall Study||24
6573377|NCT01872611|7497396|FG001|NOT COMPLETED|Overall Study||12
6573378|NCT01872689|7497408|FG000|STARTED|Double-Blind/Placebo-Controlled Period||76
6573379|NCT01872689|7497409|FG001|STARTED|Double-Blind/Placebo-Controlled Period||78
6573380|NCT01872689|7497410|FG002|STARTED|Double-Blind/Placebo-Controlled Period||177
6573381|NCT01872689|7497411|FG003|STARTED|Double-Blind/Placebo-Controlled Period||174
6573382|NCT01872689|7497408|FG000|COMPLETED|Double-Blind/Placebo-Controlled Period||56
6573383|NCT01872689|7497409|FG001|COMPLETED|Double-Blind/Placebo-Controlled Period||58
6573384|NCT01872689|7497410|FG002|COMPLETED|Double-Blind/Placebo-Controlled Period||129
6573385|NCT01872689|7497411|FG003|COMPLETED|Double-Blind/Placebo-Controlled Period||136
6573386|NCT01872689|7497408|FG000|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
6573387|NCT01872689|7497409|FG001|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||20
6573388|NCT01872689|7497410|FG002|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||48
6573389|NCT01872689|7497411|FG003|NOT COMPLETED|Double-Blind/Placebo-Controlled Period||38
6573390|NCT01872689|7497408|FG000|STARTED|Open-Label Period (Only For Monotherapy)|Of the 56 participants who completed Period 1, only 52 started Period 2.|52
6573391|NCT01872689|7497409|FG001|STARTED|Open-Label Period (Only For Monotherapy)|Of the 58 participants who completed Period 1, only 56 started Period 2.|56
6573392|NCT01872689|7497410|FG002|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
6573393|NCT01872689|7497411|FG003|STARTED|Open-Label Period (Only For Monotherapy)|As per study design, Period 2 was not intended for this arm.|0
6573394|NCT01872689|7497408|FG000|COMPLETED|Open-Label Period (Only For Monotherapy)||31
6573395|NCT01872689|7497409|FG001|COMPLETED|Open-Label Period (Only For Monotherapy)||33
6573396|NCT01872689|7497410|FG002|COMPLETED|Open-Label Period (Only For Monotherapy)||0
6573397|NCT01872689|7497411|FG003|COMPLETED|Open-Label Period (Only For Monotherapy)||0
6573398|NCT01872689|7497408|FG000|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||21
6573399|NCT01872689|7497409|FG001|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||23
6573400|NCT01872689|7497410|FG002|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
6573401|NCT01872689|7497411|FG003|NOT COMPLETED|Open-Label Period (Only For Monotherapy)||0
6573402|NCT01872715|7497424|FG000|STARTED|Overall Study||24
6573403|NCT01872715|7497424|FG000|COMPLETED|Overall Study||20
6573404|NCT01872715|7497424|FG000|NOT COMPLETED|Overall Study||4
6573405|NCT01872819|7497438|FG000|STARTED|Overall Study||14
6573406|NCT01872819|7497438|FG000|COMPLETED|Overall Study||14
6573407|NCT01872819|7497438|FG000|NOT COMPLETED|Overall Study||0
6573408|NCT01872910|7497449|FG000|STARTED|Overall Study||30
6573409|NCT01872910|7497450|FG001|STARTED|Overall Study||31
6573410|NCT01872910|7497451|FG002|STARTED|Overall Study||30
6573411|NCT01872910|7497452|FG003|STARTED|Overall Study||15
6573412|NCT01872910|7497453|FG004|STARTED|Overall Study||15
6573413|NCT01872910|7497454|FG005|STARTED|Overall Study||3
6573414|NCT01872910|7497449|FG000|Received Any Study Drug|Overall Study||30
6573415|NCT01872910|7497450|FG001|Received Any Study Drug|Overall Study||31
6573416|NCT01872910|7497451|FG002|Received Any Study Drug|Overall Study||30
6573417|NCT01872910|7497452|FG003|Received Any Study Drug|Overall Study||15
6573418|NCT01872910|7497453|FG004|Received Any Study Drug|Overall Study||15
6573419|NCT01872910|7497454|FG005|Received Any Study Drug|Overall Study||3
6573420|NCT01872910|7497449|FG000|COMPLETED|Overall Study||28
6573421|NCT01872910|7497450|FG001|COMPLETED|Overall Study||31
6573422|NCT01872910|7497451|FG002|COMPLETED|Overall Study||28
6573423|NCT01872910|7497452|FG003|COMPLETED|Overall Study||15
6573424|NCT01872910|7497453|FG004|COMPLETED|Overall Study||15
6573425|NCT01872910|7497454|FG005|COMPLETED|Overall Study||3
6573426|NCT01872910|7497449|FG000|NOT COMPLETED|Overall Study||2
6573427|NCT01872910|7497450|FG001|NOT COMPLETED|Overall Study||0
6573428|NCT01872910|7497451|FG002|NOT COMPLETED|Overall Study||2
6573429|NCT01872910|7497452|FG003|NOT COMPLETED|Overall Study||0
6573430|NCT01872910|7497453|FG004|NOT COMPLETED|Overall Study||0
6573431|NCT01872910|7497454|FG005|NOT COMPLETED|Overall Study||0
6573432|NCT01873287|7497469|FG000|STARTED|Overall Study||2006
6573433|NCT01873287|7497470|FG001|STARTED|Overall Study||1057
6573434|NCT01873287|7497469|FG000|COMPLETED|Overall Study||1701
6573435|NCT01873287|7497470|FG001|COMPLETED|Overall Study||883
6573436|NCT01873287|7497469|FG000|NOT COMPLETED|Overall Study||305
6573437|NCT01873287|7497470|FG001|NOT COMPLETED|Overall Study||174
6573438|NCT01873417|7497478|FG000|STARTED|Overall Study||237
6573439|NCT01873417|7497478|FG000|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
6573440|NCT01873417|7497478|FG000|COMPLETED|Overall Study||202
6573441|NCT01873417|7497478|FG000|NOT COMPLETED|Overall Study||35
6573442|NCT01873495|7497482|FG000|STARTED|Overall Study||7
6573443|NCT01873495|7497482|FG000|COMPLETED|Overall Study||0
6573444|NCT01873495|7497482|FG000|NOT COMPLETED|Overall Study||7
6573445|NCT01873586|7497486|FG000|STARTED|Overall Study||29
6573446|NCT01873586|7497486|FG000|COMPLETED|Overall Study||26
6573447|NCT01873586|7497486|FG000|NOT COMPLETED|Overall Study||3
6573448|NCT01873729|7497493|FG000|STARTED|Overall Study||3
6573449|NCT01873729|7497493|FG000|COMPLETED|Overall Study||2
6573450|NCT01873729|7497493|FG000|NOT COMPLETED|Overall Study||1
6573451|NCT01873742|7497499|FG000|STARTED|Overall Study||165
6573452|NCT01873742|7497500|FG001|STARTED|Overall Study||163
6573453|NCT01873742|7497499|FG000|COMPLETED|Overall Study||97
6573454|NCT01873742|7497500|FG001|COMPLETED|Overall Study||87
6573455|NCT01873742|7497499|FG000|NOT COMPLETED|Overall Study||68
6573456|NCT01873742|7497500|FG001|NOT COMPLETED|Overall Study||76
6573457|NCT01873846|7497506|FG000|STARTED|Overall Study||400
6573458|NCT01873846|7497506|FG000|Eligble Participants Dispensed Lenses|Overall Study||396
6573459|NCT01873846|7497506|FG000|COMPLETED|Overall Study||388
6573460|NCT01873846|7497506|FG000|NOT COMPLETED|Overall Study||12
6573461|NCT01873859|7497512|FG000|STARTED|Overall Study||83
6573462|NCT01873859|7497513|FG001|STARTED|Overall Study||83
6573463|NCT01873859|7497512|FG000|COMPLETED|Overall Study||83
6573464|NCT01873859|7497513|FG001|COMPLETED|Overall Study||79
6573465|NCT01873859|7497512|FG000|NOT COMPLETED|Overall Study||0
6573466|NCT01873859|7497513|FG001|NOT COMPLETED|Overall Study||4
6573467|NCT01873950|7497520|FG000|STARTED|Period 1||5
6573468|NCT01873950|7497521|FG001|STARTED|Period 1||4
6573469|NCT01873950|7497522|FG002|STARTED|Period 1||5
6573470|NCT01873950|7497523|FG003|STARTED|Period 1||4
6573471|NCT01873950|7497524|FG004|STARTED|Period 1||4
6573472|NCT01873950|7497520|FG000|COMPLETED|Period 1||5
6573473|NCT01873950|7497521|FG001|COMPLETED|Period 1||4
6573474|NCT01873950|7497522|FG002|COMPLETED|Period 1||5
6573475|NCT01873950|7497523|FG003|COMPLETED|Period 1||4
6573476|NCT01873950|7497524|FG004|COMPLETED|Period 1||4
6573477|NCT01873950|7497520|FG000|NOT COMPLETED|Period 1||0
6573478|NCT01873950|7497521|FG001|NOT COMPLETED|Period 1||0
6573479|NCT01873950|7497522|FG002|NOT COMPLETED|Period 1||0
6573480|NCT01873950|7497523|FG003|NOT COMPLETED|Period 1||0
6573481|NCT01873950|7497524|FG004|NOT COMPLETED|Period 1||0
6573482|NCT01873950|7497520|FG000|STARTED|Period 2||5
6573483|NCT01873950|7497521|FG001|STARTED|Period 2||4
6573484|NCT01873950|7497522|FG002|STARTED|Period 2||4
6573485|NCT01873950|7497523|FG003|STARTED|Period 2||4
6573486|NCT01873950|7497524|FG004|STARTED|Period 2||5
6573487|NCT01873950|7497520|FG000|COMPLETED|Period 2||5
6573488|NCT01873950|7497521|FG001|COMPLETED|Period 2||4
6573489|NCT01873950|7497522|FG002|COMPLETED|Period 2||4
6573490|NCT01873950|7497523|FG003|COMPLETED|Period 2||4
6573491|NCT01873950|7497524|FG004|COMPLETED|Period 2||5
6573492|NCT01873950|7497520|FG000|NOT COMPLETED|Period 2||0
6573493|NCT01873950|7497521|FG001|NOT COMPLETED|Period 2||0
6573494|NCT01873950|7497522|FG002|NOT COMPLETED|Period 2||0
6573495|NCT01873950|7497523|FG003|NOT COMPLETED|Period 2||0
6573496|NCT01873950|7497524|FG004|NOT COMPLETED|Period 2||0
6573497|NCT01873950|7497520|FG000|STARTED|Period 3||4
6573498|NCT01873950|7497521|FG001|STARTED|Period 3||4
6573499|NCT01873950|7497522|FG002|STARTED|Period 3||5
6573500|NCT01873950|7497523|FG003|STARTED|Period 3||5
6573501|NCT01873950|7497524|FG004|STARTED|Period 3||4
6573502|NCT01873950|7497520|FG000|COMPLETED|Period 3||4
6573503|NCT01873950|7497521|FG001|COMPLETED|Period 3||4
6573504|NCT01873950|7497522|FG002|COMPLETED|Period 3||5
6573505|NCT01873950|7497523|FG003|COMPLETED|Period 3||5
6573506|NCT01873950|7497524|FG004|COMPLETED|Period 3||4
6573507|NCT01873950|7497520|FG000|NOT COMPLETED|Period 3||0
6573508|NCT01873950|7497521|FG001|NOT COMPLETED|Period 3||0
6573509|NCT01873950|7497522|FG002|NOT COMPLETED|Period 3||0
6573510|NCT01873950|7497523|FG003|NOT COMPLETED|Period 3||0
6573511|NCT01873950|7497524|FG004|NOT COMPLETED|Period 3||0
6573512|NCT01873950|7497520|FG000|STARTED|Period 4||4
6573513|NCT01873950|7497521|FG001|STARTED|Period 4||5
6573514|NCT01873950|7497522|FG002|STARTED|Period 4||4
6573515|NCT01873950|7497523|FG003|STARTED|Period 4||4
6573516|NCT01873950|7497524|FG004|STARTED|Period 4||5
6573517|NCT01873950|7497520|FG000|COMPLETED|Period 4||4
6573518|NCT01873950|7497521|FG001|COMPLETED|Period 4||5
6573519|NCT01873950|7497522|FG002|COMPLETED|Period 4||4
6573520|NCT01873950|7497523|FG003|COMPLETED|Period 4||4
6573521|NCT01873950|7497524|FG004|COMPLETED|Period 4||5
6573522|NCT01873950|7497520|FG000|NOT COMPLETED|Period 4||0
6573523|NCT01873950|7497521|FG001|NOT COMPLETED|Period 4||0
6573524|NCT01873950|7497522|FG002|NOT COMPLETED|Period 4||0
6573525|NCT01873950|7497523|FG003|NOT COMPLETED|Period 4||0
6573526|NCT01873950|7497524|FG004|NOT COMPLETED|Period 4||0
6573527|NCT01873950|7497520|FG000|STARTED|Period 5||4
6573528|NCT01873950|7497521|FG001|STARTED|Period 5||5
6573529|NCT01873950|7497522|FG002|STARTED|Period 5||4
6573530|NCT01873950|7497523|FG003|STARTED|Period 5||4
6573531|NCT01873950|7497524|FG004|STARTED|Period 5||4
6573532|NCT01873950|7497520|FG000|COMPLETED|Period 5||4
6573533|NCT01873950|7497521|FG001|COMPLETED|Period 5||5
6573534|NCT01873950|7497522|FG002|COMPLETED|Period 5||4
6573535|NCT01873950|7497523|FG003|COMPLETED|Period 5||3
6573536|NCT01873950|7497524|FG004|COMPLETED|Period 5||4
6573537|NCT01873950|7497520|FG000|NOT COMPLETED|Period 5||0
6573538|NCT01873950|7497521|FG001|NOT COMPLETED|Period 5||0
6573539|NCT01873950|7497522|FG002|NOT COMPLETED|Period 5||0
6573540|NCT01873950|7497523|FG003|NOT COMPLETED|Period 5||1
6573541|NCT01873950|7497524|FG004|NOT COMPLETED|Period 5||0
6573542|NCT01873989|7497540|FG000|STARTED|Overall Study||8
6573543|NCT01873989|7497541|FG001|STARTED|Overall Study||7
6573544|NCT01873989|7497540|FG000|COMPLETED|Overall Study||7
6573545|NCT01873989|7497541|FG001|COMPLETED|Overall Study||6
6573546|NCT01873989|7497540|FG000|NOT COMPLETED|Overall Study||1
6573547|NCT01873989|7497541|FG001|NOT COMPLETED|Overall Study||1
6573548|NCT01874054|7497547|FG000|STARTED|Overall Study||55
6573549|NCT01874054|7497547|FG000|Completed ≥2 Cycles of Combo Treatment|Overall Study||53
6573550|NCT01874054|7497547|FG000|Completed 16 Cycles of BV Treatment|Overall Study||17
6573551|NCT01874054|7497547|FG000|COMPLETED|Overall Study||0
6573552|NCT01874054|7497547|FG000|NOT COMPLETED|Overall Study||55
6573553|NCT01874119|7497551|FG000|STARTED|First Intervention (6 Days)||8
6573554|NCT01874119|7497552|FG001|STARTED|First Intervention (6 Days)||5
6573555|NCT01874119|7497551|FG000|COMPLETED|First Intervention (6 Days)||7
6573556|NCT01874119|7497552|FG001|COMPLETED|First Intervention (6 Days)||5
6573557|NCT01874119|7497551|FG000|NOT COMPLETED|First Intervention (6 Days)||1
6573558|NCT01874119|7497552|FG001|NOT COMPLETED|First Intervention (6 Days)||0
6573559|NCT01874119|7497551|FG000|STARTED|Washout (7 Days)||7
6573560|NCT01874119|7497552|FG001|STARTED|Washout (7 Days)||5
6573561|NCT01874119|7497551|FG000|COMPLETED|Washout (7 Days)||4
6573562|NCT01874119|7497552|FG001|COMPLETED|Washout (7 Days)||3
6573563|NCT01874119|7497551|FG000|NOT COMPLETED|Washout (7 Days)||3
6573564|NCT01874119|7497552|FG001|NOT COMPLETED|Washout (7 Days)||2
6573565|NCT01874119|7497551|FG000|STARTED|Second Intervention (6 Days)||4
6573566|NCT01874119|7497552|FG001|STARTED|Second Intervention (6 Days)||3
6573567|NCT01874119|7497551|FG000|COMPLETED|Second Intervention (6 Days)||4
6573568|NCT01874119|7497552|FG001|COMPLETED|Second Intervention (6 Days)||3
6573569|NCT01874119|7497551|FG000|NOT COMPLETED|Second Intervention (6 Days)||0
6573570|NCT01874119|7497552|FG001|NOT COMPLETED|Second Intervention (6 Days)||0
6573571|NCT01874132|7497561|FG000|STARTED|Overall Study||22
6573572|NCT01874132|7497562|FG001|STARTED|Overall Study||22
6573573|NCT01874132|7497563|FG002|STARTED|Overall Study||22
6573574|NCT01874132|7497561|FG000|COMPLETED|Overall Study||18
6573575|NCT01874132|7497562|FG001|COMPLETED|Overall Study||18
6573576|NCT01874132|7497563|FG002|COMPLETED|Overall Study||19
6573577|NCT01874132|7497561|FG000|NOT COMPLETED|Overall Study||4
6573578|NCT01874132|7497562|FG001|NOT COMPLETED|Overall Study||4
6573579|NCT01874132|7497563|FG002|NOT COMPLETED|Overall Study||3
6573580|NCT01874145|7497573|FG000|STARTED|Core Period||101
6573581|NCT01874145|7497574|FG001|STARTED|Core Period||108
6573582|NCT01874145|7497573|FG000|Full Analysis Set|Core Period||100
6573583|NCT01874145|7497574|FG001|Full Analysis Set|Core Period||108
6573584|NCT01874145|7497573|FG000|COMPLETED|Core Period||98
6573585|NCT01874145|7497574|FG001|COMPLETED|Core Period||101
6573586|NCT01874145|7497573|FG000|NOT COMPLETED|Core Period||3
6573587|NCT01874145|7497574|FG001|NOT COMPLETED|Core Period||7
6573588|NCT01874145|7497573|FG000|STARTED|Extension Period|Switchers|97
6573589|NCT01874145|7497574|FG001|STARTED|Extension Period|Non-Switchers|101
6573590|NCT01874145|7497573|FG000|Full Analysis Set|Extension Period||95
6573591|NCT01874145|7497574|FG001|Full Analysis Set|Extension Period||101
6573592|NCT01874145|7497573|FG000|COMPLETED|Extension Period||91
6573593|NCT01874145|7497574|FG001|COMPLETED|Extension Period||97
6573594|NCT01874145|7497573|FG000|NOT COMPLETED|Extension Period||6
6573595|NCT01874145|7497574|FG001|NOT COMPLETED|Extension Period||4
6573596|NCT01874262|7497586|FG000|STARTED|Overall Study||91
6573597|NCT01874262|7497587|FG001|STARTED|Overall Study||83
6573598|NCT01874262|7497586|FG000|Not Correctly Randomised|Overall Study||2
6573599|NCT01874262|7497587|FG001|Not Correctly Randomised|Overall Study||0
6573600|NCT01874262|7497586|FG000|Not Included Due to Tehnical Issues|Overall Study||3
6573601|NCT01874262|7497587|FG001|Not Included Due to Tehnical Issues|Overall Study||3
6573602|NCT01874262|7497586|FG000|COMPLETED|Overall Study||86
6573603|NCT01874262|7497587|FG001|COMPLETED|Overall Study||80
6573604|NCT01874262|7497586|FG000|NOT COMPLETED|Overall Study||5
6573605|NCT01874262|7497587|FG001|NOT COMPLETED|Overall Study||3
6573606|NCT01874275|7497595|FG000|STARTED|Overall Study||4
6573607|NCT01874275|7497596|FG001|STARTED|Overall Study||2
6573608|NCT01874275|7497595|FG000|COMPLETED|Overall Study||3
6573609|NCT01874275|7497596|FG001|COMPLETED|Overall Study||2
6573610|NCT01874275|7497595|FG000|NOT COMPLETED|Overall Study||1
6573611|NCT01874275|7497596|FG001|NOT COMPLETED|Overall Study||0
6573612|NCT01874288|7497613|FG000|STARTED|Overall Study||3
6573613|NCT01874288|7497614|FG001|STARTED|Overall Study||3
6573614|NCT01874288|7497615|FG002|STARTED|Overall Study||9
6573615|NCT01874288|7497616|FG003|STARTED|Overall Study||7
6573616|NCT01874288|7497617|FG004|STARTED|Overall Study||2
6573617|NCT01874288|7497613|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6573618|NCT01874288|7497614|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6573619|NCT01874288|7497615|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
6573620|NCT01874288|7497616|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
6573621|NCT01874288|7497617|FG004|Received at Least 1 Dose of Study Drug|Overall Study||2
6573622|NCT01874288|7497613|FG000|COMPLETED|Overall Study||0
6573623|NCT01874288|7497614|FG001|COMPLETED|Overall Study||3
6573624|NCT01874288|7497615|FG002|COMPLETED|Overall Study||4
6573625|NCT01874288|7497616|FG003|COMPLETED|Overall Study||0
6573626|NCT01874288|7497617|FG004|COMPLETED|Overall Study||0
6573627|NCT01874288|7497613|FG000|NOT COMPLETED|Overall Study||3
6573628|NCT01874288|7497614|FG001|NOT COMPLETED|Overall Study||0
6573629|NCT01874288|7497615|FG002|NOT COMPLETED|Overall Study||5
6573630|NCT01874288|7497616|FG003|NOT COMPLETED|Overall Study||7
6573631|NCT01874288|7497617|FG004|NOT COMPLETED|Overall Study||2
6573632|NCT01874340|7497634|FG000|STARTED|Overall Study||6
6573633|NCT01874340|7497635|FG001|STARTED|Overall Study||8
6573634|NCT01874340|7497636|FG002|STARTED|Overall Study||8
6573635|NCT01874340|7497637|FG003|STARTED|Overall Study||6
6573636|NCT01874340|7497634|FG000|COMPLETED|Overall Study||0
6573637|NCT01874340|7497635|FG001|COMPLETED|Overall Study||0
6573638|NCT01874340|7497636|FG002|COMPLETED|Overall Study||0
6573639|NCT01874340|7497637|FG003|COMPLETED|Overall Study||1
6573640|NCT01874340|7497634|FG000|NOT COMPLETED|Overall Study||6
6573641|NCT01874340|7497635|FG001|NOT COMPLETED|Overall Study||8
6573642|NCT01874340|7497636|FG002|NOT COMPLETED|Overall Study||8
6573643|NCT01874340|7497637|FG003|NOT COMPLETED|Overall Study||5
6573644|NCT01874392|7497647|FG000|STARTED|Overall Study||9
6573645|NCT01874392|7497647|FG000|COMPLETED|Overall Study||9
6573646|NCT01874392|7497647|FG000|NOT COMPLETED|Overall Study||0
6573647|NCT01874431|7497659|FG000|STARTED|Overall Study||96
6573648|NCT01874431|7497660|FG001|STARTED|Overall Study||92
6573649|NCT01874431|7497661|FG002|STARTED|Overall Study||100
6573650|NCT01874431|7497662|FG003|STARTED|Overall Study||98
6573651|NCT01874431|7497663|FG004|STARTED|Overall Study||98
6573652|NCT01874431|7497664|FG005|STARTED|Overall Study||125
6573653|NCT01874431|7497665|FG006|STARTED|Overall Study||120
6573654|NCT01874431|7497666|FG007|STARTED|Overall Study||94
6573655|NCT01874431|7497659|FG000|Participants Received Treatment|Overall Study||96
6573656|NCT01874431|7497660|FG001|Participants Received Treatment|Overall Study||92
6573657|NCT01874431|7497661|FG002|Participants Received Treatment|Overall Study||100
6573658|NCT01874431|7497662|FG003|Participants Received Treatment|Overall Study||97
6573659|NCT01874431|7497663|FG004|Participants Received Treatment|Overall Study||98
6573660|NCT01874431|7497664|FG005|Participants Received Treatment|Overall Study||125
6573661|NCT01874431|7497665|FG006|Participants Received Treatment|Overall Study||119
6573662|NCT01874431|7497666|FG007|Participants Received Treatment|Overall Study||94
6573663|NCT01874431|7497659|FG000|COMPLETED|Overall Study||90
6573664|NCT01874431|7497660|FG001|COMPLETED|Overall Study||87
6573665|NCT01874431|7497661|FG002|COMPLETED|Overall Study||90
6573666|NCT01874431|7497662|FG003|COMPLETED|Overall Study||91
6573667|NCT01874431|7497663|FG004|COMPLETED|Overall Study||90
6573668|NCT01874431|7497664|FG005|COMPLETED|Overall Study||114
6573669|NCT01874431|7497665|FG006|COMPLETED|Overall Study||112
6573670|NCT01874431|7497666|FG007|COMPLETED|Overall Study||90
6573671|NCT01874431|7497659|FG000|NOT COMPLETED|Overall Study||6
6573672|NCT01874431|7497660|FG001|NOT COMPLETED|Overall Study||5
6573673|NCT01874431|7497661|FG002|NOT COMPLETED|Overall Study||10
6573674|NCT01874431|7497662|FG003|NOT COMPLETED|Overall Study||7
6573675|NCT01874431|7497663|FG004|NOT COMPLETED|Overall Study||8
6573676|NCT01874431|7497664|FG005|NOT COMPLETED|Overall Study||11
6573677|NCT01874431|7497665|FG006|NOT COMPLETED|Overall Study||8
6573678|NCT01874431|7497666|FG007|NOT COMPLETED|Overall Study||4
6573679|NCT01874535|7497686|FG000|STARTED|Overall Study||207
6573680|NCT01874535|7497687|FG001|STARTED|Overall Study||201
6573681|NCT01874535|7497686|FG000|COMPLETED|Overall Study||152
6573682|NCT01874535|7497687|FG001|COMPLETED|Overall Study||157
6573683|NCT01874535|7497686|FG000|NOT COMPLETED|Overall Study||55
6573684|NCT01874535|7497687|FG001|NOT COMPLETED|Overall Study||44
6573685|NCT01874665|7497695|FG000|STARTED|Overall Study||30
6573686|NCT01874665|7497696|FG001|STARTED|Overall Study||15
6573687|NCT01874665|7497695|FG000|COMPLETED|Overall Study||0
6573688|NCT01874665|7497696|FG001|COMPLETED|Overall Study||0
6573689|NCT01874665|7497695|FG000|NOT COMPLETED|Overall Study||30
6573690|NCT01874665|7497696|FG001|NOT COMPLETED|Overall Study||15
6573691|NCT01874756|7497707|FG000|STARTED|Overall Study||29
6573692|NCT01874756|7497708|FG001|STARTED|Overall Study||10
6573693|NCT01874756|7497709|FG002|STARTED|Overall Study||29
6573694|NCT01874756|7497710|FG003|STARTED|Overall Study||27
6573695|NCT01874756|7497707|FG000|COMPLETED|Overall Study||28
6573696|NCT01874756|7497708|FG001|COMPLETED|Overall Study||10
6573697|NCT01874756|7497709|FG002|COMPLETED|Overall Study||27
6573698|NCT01874756|7497710|FG003|COMPLETED|Overall Study||21
6573699|NCT01874756|7497707|FG000|NOT COMPLETED|Overall Study||1
6573700|NCT01874756|7497708|FG001|NOT COMPLETED|Overall Study||0
6573701|NCT01874756|7497709|FG002|NOT COMPLETED|Overall Study||2
6573702|NCT01874756|7497710|FG003|NOT COMPLETED|Overall Study||6
6573703|NCT01874951|7497722|FG000|STARTED|Overall Study||6
6573704|NCT01874951|7497723|FG001|STARTED|Overall Study||6
6573705|NCT01874951|7497722|FG000|COMPLETED|Overall Study||6
6573706|NCT01874951|7497723|FG001|COMPLETED|Overall Study||6
6573707|NCT01874951|7497722|FG000|NOT COMPLETED|Overall Study||0
6573708|NCT01874951|7497723|FG001|NOT COMPLETED|Overall Study||0
6573709|NCT01875159|7497734|FG000|STARTED|Overall Study||45
6573710|NCT01875159|7497735|FG001|STARTED|Overall Study||53
6573711|NCT01875159|7497734|FG000|COMPLETED|Overall Study||42
6573712|NCT01875159|7497735|FG001|COMPLETED|Overall Study||53
6573713|NCT01875159|7497734|FG000|NOT COMPLETED|Overall Study||3
6573714|NCT01875159|7497735|FG001|NOT COMPLETED|Overall Study||0
6573715|NCT01875237|7497743|FG000|STARTED|Overall Study||2
6573716|NCT01875237|7497744|FG001|STARTED|Overall Study||1
6573717|NCT01875237|7497743|FG000|COMPLETED|Overall Study||0
6573718|NCT01875237|7497744|FG001|COMPLETED|Overall Study||1
6573719|NCT01875237|7497743|FG000|NOT COMPLETED|Overall Study||2
6573720|NCT01875237|7497744|FG001|NOT COMPLETED|Overall Study||0
6573721|NCT01875250|7497754|FG000|STARTED|Overall Study||19
6573722|NCT01875250|7497755|FG001|STARTED|Overall Study||19
6573723|NCT01875250|7497754|FG000|COMPLETED|Overall Study||17
6573724|NCT01875250|7497755|FG001|COMPLETED|Overall Study||19
6573725|NCT01875250|7497754|FG000|NOT COMPLETED|Overall Study||2
6573726|NCT01875250|7497755|FG001|NOT COMPLETED|Overall Study||0
6573727|NCT01875367|7497765|FG000|STARTED|Overall Study||81
6573728|NCT01875367|7497766|FG001|STARTED|Overall Study||85
6573729|NCT01875367|7497765|FG000|COMPLETED|Overall Study||76
6573730|NCT01875367|7497766|FG001|COMPLETED|Overall Study||83
6573731|NCT01875367|7497765|FG000|NOT COMPLETED|Overall Study||5
6573732|NCT01875367|7497766|FG001|NOT COMPLETED|Overall Study||2
6573733|NCT01875445|7497778|FG000|STARTED|Overall Study||19
6573734|NCT01875445|7497779|FG001|STARTED|Overall Study||19
6573735|NCT01875445|7497778|FG000|COMPLETED|Overall Study||12
6573736|NCT01875445|7497779|FG001|COMPLETED|Overall Study||19
6573737|NCT01875445|7497778|FG000|NOT COMPLETED|Overall Study||7
6573738|NCT01875445|7497779|FG001|NOT COMPLETED|Overall Study||0
6573739|NCT01875471|7497787|FG000|STARTED|Overall Study||137
6573740|NCT01875471|7497788|FG001|STARTED|Overall Study||138
6573741|NCT01875471|7497787|FG000|Completed Per Protocol|Overall Study||127
6573742|NCT01875471|7497788|FG001|Completed Per Protocol|Overall Study||123
6573743|NCT01875471|7497787|FG000|COMPLETED|Overall Study||136
6573744|NCT01875471|7497788|FG001|COMPLETED|Overall Study||137
6573745|NCT01875471|7497787|FG000|NOT COMPLETED|Overall Study||1
6573746|NCT01875471|7497788|FG001|NOT COMPLETED|Overall Study||1
6573747|NCT01875510|7497796|FG000|STARTED|Overall Study||40
6573748|NCT01875510|7497797|FG001|STARTED|Overall Study||40
6573749|NCT01875510|7497796|FG000|COMPLETED|Overall Study||40
6573750|NCT01875510|7497797|FG001|COMPLETED|Overall Study||40
6573751|NCT01875510|7497796|FG000|NOT COMPLETED|Overall Study||0
6573752|NCT01875510|7497797|FG001|NOT COMPLETED|Overall Study||0
6573753|NCT01875731|7497805|FG000|STARTED|Overall Study||34
6573754|NCT01875731|7497806|FG001|STARTED|Overall Study||32
6573755|NCT01875731|7497805|FG000|COMPLETED|Overall Study||33
6573756|NCT01875731|7497806|FG001|COMPLETED|Overall Study||32
6573757|NCT01875731|7497805|FG000|NOT COMPLETED|Overall Study||1
6573758|NCT01875731|7497806|FG001|NOT COMPLETED|Overall Study||0
6573759|NCT01875783|7497812|FG000|STARTED|Overall Study||385
6573760|NCT01875783|7497812|FG000|COMPLETED|Overall Study||385
6573761|NCT01875783|7497812|FG000|NOT COMPLETED|Overall Study||0
6573762|NCT01875848|7497820|FG000|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
6573763|NCT01875848|7497821|FG001|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
6573764|NCT01875848|7497820|FG000|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
6573765|NCT01875848|7497821|FG001|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
6573766|NCT01875848|7497820|FG000|NOT COMPLETED|Overall Study||2
6573767|NCT01875848|7497821|FG001|NOT COMPLETED|Overall Study||0
6573768|NCT01875861|7497829|FG000|STARTED|Pre-implementation||4779
6573769|NCT01875861|7497830|FG001|STARTED|Pre-implementation||3714
6573770|NCT01875861|7497829|FG000|COMPLETED|Pre-implementation||4779
6573771|NCT01875861|7497830|FG001|COMPLETED|Pre-implementation||3714
6573772|NCT01875861|7497829|FG000|NOT COMPLETED|Pre-implementation||0
6573773|NCT01875861|7497830|FG001|NOT COMPLETED|Pre-implementation||0
6573774|NCT01875861|7497829|FG000|STARTED|Implementation||4546
6573775|NCT01875861|7497830|FG001|STARTED|Implementation||3444
6573776|NCT01875861|7497829|FG000|COMPLETED|Implementation||4546
6573777|NCT01875861|7497830|FG001|COMPLETED|Implementation||3444
6573778|NCT01875861|7497829|FG000|NOT COMPLETED|Implementation||0
6573779|NCT01875861|7497830|FG001|NOT COMPLETED|Implementation||0
6573780|NCT01875861|7497829|FG000|STARTED|Sustainability||4306
6573781|NCT01875861|7497830|FG001|STARTED|Sustainability||3444
6573782|NCT01875861|7497829|FG000|COMPLETED|Sustainability||4306
6573783|NCT01875861|7497830|FG001|COMPLETED|Sustainability||3444
6573784|NCT01875861|7497829|FG000|NOT COMPLETED|Sustainability||0
6573785|NCT01875861|7497830|FG001|NOT COMPLETED|Sustainability||0
6573786|NCT01875874|7497837|FG000|STARTED|Overall Study||8
6573787|NCT01875874|7497837|FG000|COMPLETED|Overall Study||5
6573788|NCT01875874|7497837|FG000|NOT COMPLETED|Overall Study||3
6573789|NCT01875978|7497844|FG000|STARTED|Study 4weeks||20
6573790|NCT01875978|7497845|FG001|STARTED|Study 4weeks||20
6573791|NCT01875978|7497844|FG000|COMPLETED|Study 4weeks||20
6573792|NCT01875978|7497845|FG001|COMPLETED|Study 4weeks||20
6573793|NCT01875978|7497844|FG000|NOT COMPLETED|Study 4weeks||0
6573794|NCT01875978|7497845|FG001|NOT COMPLETED|Study 4weeks||0
6573795|NCT01875978|7497844|FG000|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
6573796|NCT01875978|7497845|FG001|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
6573797|NCT01875978|7497844|FG000|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
6573798|NCT01875978|7497845|FG001|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
6573799|NCT01875978|7497844|FG000|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
6573800|NCT01875978|7497845|FG001|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
6573801|NCT01875991|7497855|FG000|STARTED|Overall Study||108
6573802|NCT01875991|7497856|FG001|STARTED|Overall Study||109
6573803|NCT01875991|7497855|FG000|Received Etanercept in Period 1|Overall Study||108
6573804|NCT01875991|7497856|FG001|Received Etanercept in Period 1|Overall Study||108
6573805|NCT01875991|7497855|FG000|Received Etanercept in Period 2|Overall Study||102
6573806|NCT01875991|7497856|FG001|Received Etanercept in Period 2|Overall Study||103
6573807|NCT01875991|7497855|FG000|COMPLETED|Overall Study||101
6573808|NCT01875991|7497856|FG001|COMPLETED|Overall Study||103
6573809|NCT01875991|7497855|FG000|NOT COMPLETED|Overall Study||7
6573810|NCT01875991|7497856|FG001|NOT COMPLETED|Overall Study||6
6573811|NCT01876043|7497865|FG000|STARTED|Overall Study||24
6573812|NCT01876043|7497865|FG000|Interim Analysis Population|Overall Study||17
6573813|NCT01876043|7497865|FG000|COMPLETED|Overall Study||22
6573814|NCT01876043|7497865|FG000|NOT COMPLETED|Overall Study||2
6573815|NCT01876082|7497871|FG000|STARTED|Overall Study||48
6573816|NCT01876082|7497872|FG001|STARTED|Overall Study||24
6573817|NCT01876082|7497871|FG000|Safety Population|Overall Study||48
6573818|NCT01876082|7497872|FG001|Safety Population|Overall Study|2 patients did not start control treatment|22
6573819|NCT01876082|7497871|FG000|COMPLETED|Overall Study||46
6573820|NCT01876082|7497872|FG001|COMPLETED|Overall Study||20
6573821|NCT01876082|7497871|FG000|NOT COMPLETED|Overall Study||2
6573822|NCT01876082|7497872|FG001|NOT COMPLETED|Overall Study||4
6573823|NCT01876212|7497880|FG000|STARTED|Overall Study||9
6573824|NCT01876212|7497881|FG001|STARTED|Overall Study||6
6573825|NCT01876212|7497880|FG000|COMPLETED|Overall Study||9
6573826|NCT01876212|7497881|FG001|COMPLETED|Overall Study||6
6573827|NCT01876212|7497880|FG000|NOT COMPLETED|Overall Study||0
6573828|NCT01876212|7497881|FG001|NOT COMPLETED|Overall Study||0
6573829|NCT01876251|7497890|FG000|STARTED|Overall Study||15
6573830|NCT01876251|7497891|FG001|STARTED|Overall Study||3
6573831|NCT01876251|7497892|FG002|STARTED|Overall Study||11
6573832|NCT01876251|7497890|FG000|COMPLETED|Overall Study||0
6573833|NCT01876251|7497891|FG001|COMPLETED|Overall Study||0
6573834|NCT01876251|7497892|FG002|COMPLETED|Overall Study||0
6573835|NCT01876251|7497890|FG000|NOT COMPLETED|Overall Study||15
6573836|NCT01876251|7497891|FG001|NOT COMPLETED|Overall Study||3
6573837|NCT01876251|7497892|FG002|NOT COMPLETED|Overall Study||11
6573838|NCT01876329|7497904|FG000|STARTED|Overall Study||45
6573839|NCT01876329|7497905|FG001|STARTED|Overall Study||36
6573840|NCT01876329|7497906|FG002|STARTED|Overall Study||44
6573841|NCT01876329|7497904|FG000|COMPLETED|Overall Study||45
6573842|NCT01876329|7497905|FG001|COMPLETED|Overall Study||36
6573843|NCT01876329|7497906|FG002|COMPLETED|Overall Study||44
6573844|NCT01876329|7497904|FG000|NOT COMPLETED|Overall Study||0
6573845|NCT01876329|7497905|FG001|NOT COMPLETED|Overall Study||0
6573846|NCT01876329|7497906|FG002|NOT COMPLETED|Overall Study||0
6573847|NCT01876368|7497916|FG000|STARTED|Overall Study||188
6573848|NCT01876368|7497917|FG001|STARTED|Overall Study||188
6573849|NCT01876368|7497916|FG000|Full Analysis Set (FAS)|Overall Study||188
6573850|NCT01876368|7497917|FG001|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
6573851|NCT01876368|7497916|FG000|Safety Set (SAF)|Overall Study||188
6573852|NCT01876368|7497917|FG001|Safety Set (SAF)|Overall Study||187
6573853|NCT01876368|7497916|FG000|COMPLETED|Overall Study||179
6573854|NCT01876368|7497917|FG001|COMPLETED|Overall Study||175
6573855|NCT01876368|7497916|FG000|NOT COMPLETED|Overall Study||9
6573856|NCT01876368|7497917|FG001|NOT COMPLETED|Overall Study||13
6573857|NCT01876381|7497923|FG000|STARTED|Overall Study||23
6573858|NCT01876381|7497923|FG000|COMPLETED|Overall Study||16
6573859|NCT01876381|7497923|FG000|NOT COMPLETED|Overall Study||7
6573860|NCT01876420|7497927|FG000|STARTED|Overall Study||60
6573861|NCT01876420|7497927|FG000|COMPLETED|Overall Study||59
6573862|NCT01876420|7497927|FG000|NOT COMPLETED|Overall Study||1
6573863|NCT01876446|7497933|FG000|STARTED|Overall Study||20
6573864|NCT01876446|7497934|FG001|STARTED|Overall Study||18
6573865|NCT01876446|7497933|FG000|COMPLETED|Overall Study||18
6573866|NCT01876446|7497934|FG001|COMPLETED|Overall Study||12
6573867|NCT01876446|7497933|FG000|NOT COMPLETED|Overall Study||2
6573868|NCT01876446|7497934|FG001|NOT COMPLETED|Overall Study||6
6573869|NCT01876485|7497942|FG000|STARTED|Overall Study||140
6573870|NCT01876485|7497943|FG001|STARTED|Overall Study||140
6573871|NCT01876485|7497942|FG000|Post-Intervention|Overall Study||125
6573872|NCT01876485|7497943|FG001|Post-Intervention|Overall Study||129
6573873|NCT01876485|7497942|FG000|Maintenance|Overall Study||116
6573874|NCT01876485|7497943|FG001|Maintenance|Overall Study||114
6573875|NCT01876485|7497942|FG000|COMPLETED|Overall Study||116
6573876|NCT01876485|7497943|FG001|COMPLETED|Overall Study||114
6573877|NCT01876485|7497942|FG000|NOT COMPLETED|Overall Study||24
6573878|NCT01876485|7497943|FG001|NOT COMPLETED|Overall Study||26
6573879|NCT01876511|7497952|FG000|STARTED|Overall Study||41
6573880|NCT01876511|7497953|FG001|STARTED|Overall Study||25
6573881|NCT01876511|7497954|FG002|STARTED|Overall Study||47
6573882|NCT01876511|7497952|FG000|Stages 1 and 2|Overall Study||24
6573883|NCT01876511|7497953|FG001|Stages 1 and 2|Overall Study||25
6573884|NCT01876511|7497954|FG002|Stages 1 and 2|Overall Study||21
6573885|NCT01876511|7497952|FG000|COMPLETED|Overall Study||18
6573886|NCT01876511|7497953|FG001|COMPLETED|Overall Study||0
6573887|NCT01876511|7497954|FG002|COMPLETED|Overall Study||16
6573888|NCT01876511|7497952|FG000|NOT COMPLETED|Overall Study||23
6573889|NCT01876511|7497953|FG001|NOT COMPLETED|Overall Study||25
6573890|NCT01876511|7497954|FG002|NOT COMPLETED|Overall Study||31
6573891|NCT01876706|7497964|FG000|STARTED|Overall Study||51
6573892|NCT01876706|7497964|FG000|1 Month|Overall Study||51
6573893|NCT01876706|7497964|FG000|3 Months|Overall Study||51
6573894|NCT01876706|7497964|FG000|6 Months|Overall Study||46
6573895|NCT01876706|7497964|FG000|12 Months|Overall Study||42
6573896|NCT01876706|7497964|FG000|24 Months|Overall Study||35
6573897|NCT01876706|7497964|FG000|36 Months|Overall Study||32
6573898|NCT01876706|7497964|FG000|48 Months|Overall Study||31
6573899|NCT01876706|7497964|FG000|60 Months|Overall Study||26
6573900|NCT01876706|7497964|FG000|COMPLETED|Overall Study||26
6573901|NCT01876706|7497964|FG000|NOT COMPLETED|Overall Study||25
6573902|NCT01876732|7497968|FG000|STARTED|Overall Study||132
6573903|NCT01876732|7497968|FG000|COMPLETED|Overall Study||57
6573904|NCT01876732|7497968|FG000|NOT COMPLETED|Overall Study||75
6573905|NCT01876784|7497975|FG000|STARTED|Overall Study||119
6573906|NCT01876784|7497976|FG001|STARTED|Overall Study||119
6573907|NCT01876784|7497975|FG000|Treated|Overall Study||117
6573908|NCT01876784|7497976|FG001|Treated|Overall Study||118
6573909|NCT01876784|7497975|FG000|COMPLETED|Overall Study||0
6573910|NCT01876784|7497976|FG001|COMPLETED|Overall Study||0
6573911|NCT01876784|7497975|FG000|NOT COMPLETED|Overall Study||119
6573912|NCT01876784|7497976|FG001|NOT COMPLETED|Overall Study||119
6573913|NCT01876810|7497982|FG000|STARTED|Overall Study||14
6573914|NCT01876810|7497983|FG001|STARTED|Overall Study||14
6573915|NCT01876810|7497982|FG000|COMPLETED|Overall Study||14
6573916|NCT01876810|7497983|FG001|COMPLETED|Overall Study||13
6573917|NCT01876810|7497982|FG000|NOT COMPLETED|Overall Study||0
6573918|NCT01876810|7497983|FG001|NOT COMPLETED|Overall Study||1
6573919|NCT01876823|7497992|FG000|STARTED|Overall Study||35
6573920|NCT01876823|7497992|FG000|COMPLETED|Overall Study||26
6573921|NCT01876823|7497992|FG000|NOT COMPLETED|Overall Study||9
6573922|NCT01876901|7497998|FG000|STARTED|Overall Study||65
6573923|NCT01876901|7497999|FG001|STARTED|Overall Study||59
6573924|NCT01876901|7497998|FG000|COMPLETED|Overall Study||48
6573925|NCT01876901|7497999|FG001|COMPLETED|Overall Study||52
6573926|NCT01876901|7497998|FG000|NOT COMPLETED|Overall Study||17
6573927|NCT01876901|7497999|FG001|NOT COMPLETED|Overall Study||7
6573928|NCT01876979|7498008|FG000|STARTED|Overall Study||2
6573929|NCT01876979|7498009|FG001|STARTED|Overall Study||3
6573930|NCT01876979|7498008|FG000|COMPLETED|Overall Study||0
6573931|NCT01876979|7498009|FG001|COMPLETED|Overall Study||0
6573932|NCT01876979|7498008|FG000|NOT COMPLETED|Overall Study||2
6573933|NCT01876979|7498009|FG001|NOT COMPLETED|Overall Study||3
6573934|NCT01876992|7498017|FG000|STARTED|Overall Study||5
6573935|NCT01876992|7498018|FG001|STARTED|Overall Study||5
6573936|NCT01876992|7498017|FG000|COMPLETED|Overall Study||5
6573937|NCT01876992|7498018|FG001|COMPLETED|Overall Study||5
6573938|NCT01876992|7498017|FG000|NOT COMPLETED|Overall Study||0
6573939|NCT01876992|7498018|FG001|NOT COMPLETED|Overall Study||0
6573940|NCT01877083|7498025|FG000|STARTED|Treatment Phase||25
6573941|NCT01877083|7498025|FG000|COMPLETED|Treatment Phase||5
6573942|NCT01877083|7498025|FG000|NOT COMPLETED|Treatment Phase||20
6573943|NCT01877083|7498025|FG000|STARTED|Extension Phase||5
6573944|NCT01877083|7498025|FG000|COMPLETED|Extension Phase||0
6573945|NCT01877083|7498025|FG000|NOT COMPLETED|Extension Phase||5
6573946|NCT01877148|7498031|FG000|STARTED|Overall Study||6
6573947|NCT01877148|7498032|FG001|STARTED|Overall Study||6
6573948|NCT01877148|7498031|FG000|COMPLETED|Overall Study||5
6573949|NCT01877148|7498032|FG001|COMPLETED|Overall Study||5
6573950|NCT01877148|7498031|FG000|NOT COMPLETED|Overall Study||1
6573951|NCT01877148|7498032|FG001|NOT COMPLETED|Overall Study||1
6573952|NCT01877161|7498038|FG000|STARTED|First Session of Stimulation||12
6573953|NCT01877161|7498038|FG000|COMPLETED|First Session of Stimulation||12
6573954|NCT01877161|7498038|FG000|NOT COMPLETED|First Session of Stimulation||0
6573955|NCT01877161|7498038|FG000|STARTED|Washout (at Least 3 Days)||12
6573956|NCT01877161|7498038|FG000|COMPLETED|Washout (at Least 3 Days)||12
6573957|NCT01877161|7498038|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
6573958|NCT01877161|7498038|FG000|STARTED|Second Session of Stimulation||12
6573959|NCT01877161|7498038|FG000|COMPLETED|Second Session of Stimulation||12
6573960|NCT01877161|7498038|FG000|NOT COMPLETED|Second Session of Stimulation||0
6573961|NCT01877161|7498038|FG000|STARTED|Washout (at Least 3 Days)||12
6573962|NCT01877161|7498038|FG000|COMPLETED|Washout (at Least 3 Days)||12
6573963|NCT01877161|7498038|FG000|NOT COMPLETED|Washout (at Least 3 Days)||0
6573964|NCT01877161|7498038|FG000|STARTED|Third Session of Stimulation||12
6573965|NCT01877161|7498038|FG000|COMPLETED|Third Session of Stimulation||12
6573966|NCT01877161|7498038|FG000|NOT COMPLETED|Third Session of Stimulation||0
6573967|NCT01877187|7498046|FG000|STARTED|Overall Study|21 HCC, 18 non-HCC|39
6573968|NCT01877187|7498046|FG000|Completed 30 Day f/u|Overall Study|18 HCC, 17 non-HCC|35
6573969|NCT01877187|7498046|FG000|Completed 90 Day f/u|Overall Study|11 HCC, 9 non-HCC|20
6573970|NCT01877187|7498046|FG000|COMPLETED|Overall Study|10 HCC, 7 non-HCC|17
6573971|NCT01877187|7498046|FG000|NOT COMPLETED|Overall Study||22
6573972|NCT01877239|7498053|FG000|STARTED|Overall Study||111
6573973|NCT01877239|7498053|FG000|Treated|Overall Study||76
6573974|NCT01877239|7498053|FG000|COMPLETED|Overall Study||61
6573975|NCT01877239|7498053|FG000|NOT COMPLETED|Overall Study||50
6573976|NCT01877265|7498057|FG000|STARTED|Treatment Period 1||3
6573977|NCT01877265|7498058|FG001|STARTED|Treatment Period 1||3
6573978|NCT01877265|7498059|FG002|STARTED|Treatment Period 1||3
6573979|NCT01877265|7498060|FG003|STARTED|Treatment Period 1||3
6573980|NCT01877265|7498061|FG004|STARTED|Treatment Period 1||3
6573981|NCT01877265|7498062|FG005|STARTED|Treatment Period 1||3
6573982|NCT01877265|7498057|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||3
6573983|NCT01877265|7498058|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||3
6573984|NCT01877265|7498059|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||3
6573985|NCT01877265|7498060|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||3
6573986|NCT01877265|7498061|FG004|Received at Least One Dose of Study Drug|Treatment Period 1||3
6573987|NCT01877265|7498062|FG005|Received at Least One Dose of Study Drug|Treatment Period 1||3
6573988|NCT01877265|7498057|FG000|COMPLETED|Treatment Period 1||3
6573989|NCT01877265|7498058|FG001|COMPLETED|Treatment Period 1||3
6573990|NCT01877265|7498059|FG002|COMPLETED|Treatment Period 1||2
6573991|NCT01877265|7498060|FG003|COMPLETED|Treatment Period 1||3
6573992|NCT01877265|7498061|FG004|COMPLETED|Treatment Period 1||3
6573993|NCT01877265|7498062|FG005|COMPLETED|Treatment Period 1||3
6573994|NCT01877265|7498057|FG000|NOT COMPLETED|Treatment Period 1||0
6573995|NCT01877265|7498058|FG001|NOT COMPLETED|Treatment Period 1||0
6573996|NCT01877265|7498059|FG002|NOT COMPLETED|Treatment Period 1||1
6573997|NCT01877265|7498060|FG003|NOT COMPLETED|Treatment Period 1||0
6573998|NCT01877265|7498061|FG004|NOT COMPLETED|Treatment Period 1||0
6573999|NCT01877265|7498062|FG005|NOT COMPLETED|Treatment Period 1||0
6574000|NCT01877265|7498057|FG000|STARTED|Washout Period 1 (at Least 14 Days)||3
6574001|NCT01877265|7498058|FG001|STARTED|Washout Period 1 (at Least 14 Days)||3
6574002|NCT01877265|7498059|FG002|STARTED|Washout Period 1 (at Least 14 Days)||2
6574003|NCT01877265|7498060|FG003|STARTED|Washout Period 1 (at Least 14 Days)||3
6574004|NCT01877265|7498061|FG004|STARTED|Washout Period 1 (at Least 14 Days)||3
6574005|NCT01877265|7498062|FG005|STARTED|Washout Period 1 (at Least 14 Days)||3
6574006|NCT01877265|7498057|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6574007|NCT01877265|7498058|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6574008|NCT01877265|7498059|FG002|COMPLETED|Washout Period 1 (at Least 14 Days)||2
6574009|NCT01877265|7498060|FG003|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6574010|NCT01877265|7498061|FG004|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6574011|NCT01877265|7498062|FG005|COMPLETED|Washout Period 1 (at Least 14 Days)||3
6574012|NCT01877265|7498057|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6574013|NCT01877265|7498058|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6574014|NCT01877265|7498059|FG002|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6574015|NCT01877265|7498060|FG003|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6574016|NCT01877265|7498061|FG004|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6574017|NCT01877265|7498062|FG005|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6574018|NCT01877265|7498057|FG000|STARTED|Treatment Period 2||3
6574019|NCT01877265|7498058|FG001|STARTED|Treatment Period 2||3
6574020|NCT01877265|7498059|FG002|STARTED|Treatment Period 2||2
6574021|NCT01877265|7498060|FG003|STARTED|Treatment Period 2||3
6574022|NCT01877265|7498061|FG004|STARTED|Treatment Period 2||3
6574023|NCT01877265|7498062|FG005|STARTED|Treatment Period 2||3
6574024|NCT01877265|7498057|FG000|Received at Least One Dose of Study Drug|Treatment Period 2||3
6574025|NCT01877265|7498058|FG001|Received at Least One Dose of Study Drug|Treatment Period 2||3
6574026|NCT01877265|7498059|FG002|Received at Least One Dose of Study Drug|Treatment Period 2||2
6574027|NCT01877265|7498060|FG003|Received at Least One Dose of Study Drug|Treatment Period 2||3
6574028|NCT01877265|7498061|FG004|Received at Least One Dose of Study Drug|Treatment Period 2||3
6574029|NCT01877265|7498062|FG005|Received at Least One Dose of Study Drug|Treatment Period 2||3
6574030|NCT01877265|7498057|FG000|COMPLETED|Treatment Period 2||3
6574031|NCT01877265|7498058|FG001|COMPLETED|Treatment Period 2||3
6574032|NCT01877265|7498059|FG002|COMPLETED|Treatment Period 2||2
6574033|NCT01877265|7498060|FG003|COMPLETED|Treatment Period 2||3
6574034|NCT01877265|7498061|FG004|COMPLETED|Treatment Period 2||3
6574035|NCT01877265|7498062|FG005|COMPLETED|Treatment Period 2||3
6574036|NCT01877265|7498057|FG000|NOT COMPLETED|Treatment Period 2||0
6574037|NCT01877265|7498058|FG001|NOT COMPLETED|Treatment Period 2||0
6574038|NCT01877265|7498059|FG002|NOT COMPLETED|Treatment Period 2||0
6574039|NCT01877265|7498060|FG003|NOT COMPLETED|Treatment Period 2||0
6574040|NCT01877265|7498061|FG004|NOT COMPLETED|Treatment Period 2||0
6574041|NCT01877265|7498062|FG005|NOT COMPLETED|Treatment Period 2||0
6574042|NCT01877265|7498057|FG000|STARTED|Washout Period 2 (at Least 14 Days)||3
6574043|NCT01877265|7498058|FG001|STARTED|Washout Period 2 (at Least 14 Days)||3
6574044|NCT01877265|7498059|FG002|STARTED|Washout Period 2 (at Least 14 Days)||2
6574045|NCT01877265|7498060|FG003|STARTED|Washout Period 2 (at Least 14 Days)||3
6574046|NCT01877265|7498061|FG004|STARTED|Washout Period 2 (at Least 14 Days)||3
6574047|NCT01877265|7498062|FG005|STARTED|Washout Period 2 (at Least 14 Days)||3
6574048|NCT01877265|7498057|FG000|COMPLETED|Washout Period 2 (at Least 14 Days)||3
6574049|NCT01877265|7498058|FG001|COMPLETED|Washout Period 2 (at Least 14 Days)||3
6574050|NCT01877265|7498059|FG002|COMPLETED|Washout Period 2 (at Least 14 Days)||2
6574051|NCT01877265|7498060|FG003|COMPLETED|Washout Period 2 (at Least 14 Days)||3
6574052|NCT01877265|7498061|FG004|COMPLETED|Washout Period 2 (at Least 14 Days)||3
6574053|NCT01877265|7498062|FG005|COMPLETED|Washout Period 2 (at Least 14 Days)||2
6574054|NCT01877265|7498057|FG000|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6574055|NCT01877265|7498058|FG001|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6574056|NCT01877265|7498059|FG002|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6574057|NCT01877265|7498060|FG003|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6574058|NCT01877265|7498061|FG004|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||0
6574059|NCT01877265|7498062|FG005|NOT COMPLETED|Washout Period 2 (at Least 14 Days)||1
6574060|NCT01877265|7498057|FG000|STARTED|Treatment Period 3||3
6574061|NCT01877265|7498058|FG001|STARTED|Treatment Period 3||3
6574062|NCT01877265|7498059|FG002|STARTED|Treatment Period 3||2
6574063|NCT01877265|7498060|FG003|STARTED|Treatment Period 3||3
6574064|NCT01877265|7498061|FG004|STARTED|Treatment Period 3||3
6574065|NCT01877265|7498062|FG005|STARTED|Treatment Period 3||2
6574066|NCT01877265|7498057|FG000|Received at Least One Dose of Study Drug|Treatment Period 3||3
6574067|NCT01877265|7498058|FG001|Received at Least One Dose of Study Drug|Treatment Period 3||3
6574068|NCT01877265|7498059|FG002|Received at Least One Dose of Study Drug|Treatment Period 3||2
6255810|NCT02328014|7154669|FG000|STARTED|Overall Study||6
6255811|NCT02328014|7154670|FG001|STARTED|Overall Study||6
6255812|NCT02328014|7154671|FG002|STARTED|Overall Study||6
6255813|NCT02328014|7154672|FG003|STARTED|Overall Study||22
6255814|NCT02328014|7154669|FG000|COMPLETED|Overall Study||0
6255815|NCT02328014|7154670|FG001|COMPLETED|Overall Study||0
6255816|NCT02328014|7154671|FG002|COMPLETED|Overall Study||0
6255817|NCT02328014|7154672|FG003|COMPLETED|Overall Study||0
6255818|NCT02328014|7154669|FG000|NOT COMPLETED|Overall Study||6
6255819|NCT02328014|7154670|FG001|NOT COMPLETED|Overall Study||6
6255820|NCT02328014|7154671|FG002|NOT COMPLETED|Overall Study||6
6255821|NCT02328014|7154672|FG003|NOT COMPLETED|Overall Study||22
6255822|NCT02281500|7154682|FG000|STARTED|Overall Study||22
6255823|NCT02281500|7154682|FG000|COMPLETED|Overall Study||22
6255824|NCT02281500|7154682|FG000|NOT COMPLETED|Overall Study||0
6255825|NCT02243020|7154688|FG000|STARTED|Overall Study||8
6574069|NCT01877265|7498060|FG003|Received at Least One Dose of Study Drug|Treatment Period 3||3
6574070|NCT01877265|7498061|FG004|Received at Least One Dose of Study Drug|Treatment Period 3||3
6574071|NCT01877265|7498062|FG005|Received at Least One Dose of Study Drug|Treatment Period 3||2
6574072|NCT01877265|7498057|FG000|COMPLETED|Treatment Period 3||2
6574073|NCT01877265|7498058|FG001|COMPLETED|Treatment Period 3||3
6574074|NCT01877265|7498059|FG002|COMPLETED|Treatment Period 3||2
6574075|NCT01877265|7498060|FG003|COMPLETED|Treatment Period 3||3
6574076|NCT01877265|7498061|FG004|COMPLETED|Treatment Period 3||3
6574077|NCT01877265|7498062|FG005|COMPLETED|Treatment Period 3||2
6574078|NCT01877265|7498057|FG000|NOT COMPLETED|Treatment Period 3||1
6574079|NCT01877265|7498058|FG001|NOT COMPLETED|Treatment Period 3||0
6574080|NCT01877265|7498059|FG002|NOT COMPLETED|Treatment Period 3||0
6574081|NCT01877265|7498060|FG003|NOT COMPLETED|Treatment Period 3||0
6574082|NCT01877265|7498061|FG004|NOT COMPLETED|Treatment Period 3||0
6574083|NCT01877265|7498062|FG005|NOT COMPLETED|Treatment Period 3||0
6574084|NCT01877278|7498075|FG000|STARTED|Overall Study||33
6574085|NCT01877278|7498076|FG001|STARTED|Overall Study||33
6574086|NCT01877278|7498075|FG000|COMPLETED|Overall Study||30
6574087|NCT01877278|7498076|FG001|COMPLETED|Overall Study||30
6255826|NCT02243020|7154689|FG001|STARTED|Overall Study||9
6255827|NCT02243020|7154688|FG000|COMPLETED|Overall Study||8
6574088|NCT01877278|7498075|FG000|NOT COMPLETED|Overall Study||3
6574089|NCT01877278|7498076|FG001|NOT COMPLETED|Overall Study||3
6574090|NCT01877408|7498084|FG000|STARTED|Overall Study||50
6574091|NCT01877408|7498085|FG001|STARTED|Overall Study||100
6574092|NCT01877408|7498084|FG000|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
6574093|NCT01877408|7498085|FG001|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
6574094|NCT01877408|7498084|FG000|NOT COMPLETED|Overall Study||0
6574095|NCT01877408|7498085|FG001|NOT COMPLETED|Overall Study||2
6574096|NCT01877421|7498124|FG000|STARTED|Phase 1||2
6574097|NCT01877421|7498125|FG001|STARTED|Phase 1||1
6574098|NCT01877421|7498126|FG002|STARTED|Phase 1||4
6574099|NCT01877421|7498127|FG003|STARTED|Phase 1||2
6574100|NCT01877421|7498128|FG004|STARTED|Phase 1||4
6574101|NCT01877421|7498129|FG005|STARTED|Phase 1||2
6574102|NCT01877421|7498130|FG006|STARTED|Phase 1||4
6574103|NCT01877421|7498131|FG007|STARTED|Phase 1||2
6574104|NCT01877421|7498132|FG008|STARTED|Phase 1||7
6574105|NCT01877421|7498133|FG009|STARTED|Phase 1||3
6574106|NCT01877421|7498134|FG010|STARTED|Phase 1||7
6574107|NCT01877421|7498135|FG011|STARTED|Phase 1||3
6574108|NCT01877421|7498136|FG012|STARTED|Phase 1||7
6574109|NCT01877421|7498137|FG013|STARTED|Phase 1||3
6574110|NCT01877421|7498138|FG014|STARTED|Phase 1||7
6574111|NCT01877421|7498139|FG015|STARTED|Phase 1||3
6574112|NCT01877421|7498140|FG016|STARTED|Phase 1||7
6574113|NCT01877421|7498141|FG017|STARTED|Phase 1||3
6574114|NCT01877421|7498124|FG000|COMPLETED|Phase 1||2
6574115|NCT01877421|7498125|FG001|COMPLETED|Phase 1||1
6574116|NCT01877421|7498126|FG002|COMPLETED|Phase 1||4
6574117|NCT01877421|7498127|FG003|COMPLETED|Phase 1||2
6574118|NCT01877421|7498128|FG004|COMPLETED|Phase 1||4
6574119|NCT01877421|7498129|FG005|COMPLETED|Phase 1||2
6574120|NCT01877421|7498130|FG006|COMPLETED|Phase 1||4
6574121|NCT01877421|7498131|FG007|COMPLETED|Phase 1||2
6574122|NCT01877421|7498132|FG008|COMPLETED|Phase 1||7
6574123|NCT01877421|7498133|FG009|COMPLETED|Phase 1||3
6574124|NCT01877421|7498134|FG010|COMPLETED|Phase 1||7
6574125|NCT01877421|7498135|FG011|COMPLETED|Phase 1||3
6574126|NCT01877421|7498136|FG012|COMPLETED|Phase 1||7
6574127|NCT01877421|7498137|FG013|COMPLETED|Phase 1||3
6574128|NCT01877421|7498138|FG014|COMPLETED|Phase 1||7
6574129|NCT01877421|7498139|FG015|COMPLETED|Phase 1||3
6574130|NCT01877421|7498140|FG016|COMPLETED|Phase 1||7
6574131|NCT01877421|7498141|FG017|COMPLETED|Phase 1||3
6574132|NCT01877421|7498124|FG000|NOT COMPLETED|Phase 1||0
6574133|NCT01877421|7498125|FG001|NOT COMPLETED|Phase 1||0
6574134|NCT01877421|7498126|FG002|NOT COMPLETED|Phase 1||0
6574135|NCT01877421|7498127|FG003|NOT COMPLETED|Phase 1||0
6574136|NCT01877421|7498128|FG004|NOT COMPLETED|Phase 1||0
6574137|NCT01877421|7498129|FG005|NOT COMPLETED|Phase 1||0
6574138|NCT01877421|7498130|FG006|NOT COMPLETED|Phase 1||0
6574139|NCT01877421|7498131|FG007|NOT COMPLETED|Phase 1||0
6574140|NCT01877421|7498132|FG008|NOT COMPLETED|Phase 1||0
6574141|NCT01877421|7498133|FG009|NOT COMPLETED|Phase 1||0
6574142|NCT01877421|7498134|FG010|NOT COMPLETED|Phase 1||0
6574143|NCT01877421|7498135|FG011|NOT COMPLETED|Phase 1||0
6574144|NCT01877421|7498136|FG012|NOT COMPLETED|Phase 1||0
6574145|NCT01877421|7498137|FG013|NOT COMPLETED|Phase 1||0
6574146|NCT01877421|7498138|FG014|NOT COMPLETED|Phase 1||0
6574147|NCT01877421|7498139|FG015|NOT COMPLETED|Phase 1||0
6574148|NCT01877421|7498140|FG016|NOT COMPLETED|Phase 1||0
6574149|NCT01877421|7498141|FG017|NOT COMPLETED|Phase 1||0
6574150|NCT01877421|7498124|FG000|STARTED|Phase 2||0
6574151|NCT01877421|7498125|FG001|STARTED|Phase 2||0
6574152|NCT01877421|7498126|FG002|STARTED|Phase 2||4
6574153|NCT01877421|7498127|FG003|STARTED|Phase 2||2
6574154|NCT01877421|7498128|FG004|STARTED|Phase 2||7
6574155|NCT01877421|7498129|FG005|STARTED|Phase 2||3
6574156|NCT01877421|7498130|FG006|STARTED|Phase 2||7
6574157|NCT01877421|7498131|FG007|STARTED|Phase 2||2
6574158|NCT01877421|7498132|FG008|STARTED|Phase 2||6
6574159|NCT01877421|7498133|FG009|STARTED|Phase 2||3
6574160|NCT01877421|7498134|FG010|STARTED|Phase 2||7
6574161|NCT01877421|7498135|FG011|STARTED|Phase 2||3
6574162|NCT01877421|7498136|FG012|STARTED|Phase 2||7
6574163|NCT01877421|7498137|FG013|STARTED|Phase 2||3
6574164|NCT01877421|7498138|FG014|STARTED|Phase 2||7
6574165|NCT01877421|7498139|FG015|STARTED|Phase 2||3
6574166|NCT01877421|7498140|FG016|STARTED|Phase 2||0
6574167|NCT01877421|7498141|FG017|STARTED|Phase 2||0
6574168|NCT01877421|7498124|FG000|COMPLETED|Phase 2||0
6574169|NCT01877421|7498125|FG001|COMPLETED|Phase 2||0
6574170|NCT01877421|7498126|FG002|COMPLETED|Phase 2||4
6574171|NCT01877421|7498127|FG003|COMPLETED|Phase 2||2
6574172|NCT01877421|7498128|FG004|COMPLETED|Phase 2||7
6574173|NCT01877421|7498129|FG005|COMPLETED|Phase 2||3
6574174|NCT01877421|7498130|FG006|COMPLETED|Phase 2||6
6574175|NCT01877421|7498131|FG007|COMPLETED|Phase 2||2
6574176|NCT01877421|7498132|FG008|COMPLETED|Phase 2||5
6574177|NCT01877421|7498133|FG009|COMPLETED|Phase 2||3
6574178|NCT01877421|7498134|FG010|COMPLETED|Phase 2||5
6574179|NCT01877421|7498135|FG011|COMPLETED|Phase 2||3
6574180|NCT01877421|7498136|FG012|COMPLETED|Phase 2||6
6574181|NCT01877421|7498137|FG013|COMPLETED|Phase 2||3
6574182|NCT01877421|7498138|FG014|COMPLETED|Phase 2||7
6574183|NCT01877421|7498139|FG015|COMPLETED|Phase 2||2
6574184|NCT01877421|7498140|FG016|COMPLETED|Phase 2||0
6574185|NCT01877421|7498141|FG017|COMPLETED|Phase 2||0
6574186|NCT01877421|7498124|FG000|NOT COMPLETED|Phase 2||0
6574187|NCT01877421|7498125|FG001|NOT COMPLETED|Phase 2||0
6574188|NCT01877421|7498126|FG002|NOT COMPLETED|Phase 2||0
6574189|NCT01877421|7498127|FG003|NOT COMPLETED|Phase 2||0
6574190|NCT01877421|7498128|FG004|NOT COMPLETED|Phase 2||0
6574191|NCT01877421|7498129|FG005|NOT COMPLETED|Phase 2||0
6574192|NCT01877421|7498130|FG006|NOT COMPLETED|Phase 2||1
6574193|NCT01877421|7498131|FG007|NOT COMPLETED|Phase 2||0
6574194|NCT01877421|7498132|FG008|NOT COMPLETED|Phase 2||1
6574195|NCT01877421|7498133|FG009|NOT COMPLETED|Phase 2||0
6574196|NCT01877421|7498134|FG010|NOT COMPLETED|Phase 2||2
6574197|NCT01877421|7498135|FG011|NOT COMPLETED|Phase 2||0
6574198|NCT01877421|7498136|FG012|NOT COMPLETED|Phase 2||1
6574199|NCT01877421|7498137|FG013|NOT COMPLETED|Phase 2||0
6574200|NCT01877421|7498138|FG014|NOT COMPLETED|Phase 2||0
6574201|NCT01877421|7498139|FG015|NOT COMPLETED|Phase 2||1
6574202|NCT01877421|7498140|FG016|NOT COMPLETED|Phase 2||0
6574203|NCT01877421|7498141|FG017|NOT COMPLETED|Phase 2||0
6574204|NCT01877538|7498221|FG000|STARTED|Overall Study||7
6574205|NCT01877538|7498221|FG000|COMPLETED|Overall Study||7
6574206|NCT01877538|7498221|FG000|NOT COMPLETED|Overall Study||0
6574207|NCT01877551|7498227|FG000|STARTED|Overall Study||13
6574208|NCT01877551|7498228|FG001|STARTED|Overall Study||14
6574209|NCT01877551|7498227|FG000|COMPLETED|Overall Study||13
6574210|NCT01877551|7498228|FG001|COMPLETED|Overall Study||13
6574211|NCT01877551|7498227|FG000|NOT COMPLETED|Overall Study||0
6574212|NCT01877551|7498228|FG001|NOT COMPLETED|Overall Study||1
6574213|NCT01877642|7498236|FG000|STARTED|Overall Study||4
6574214|NCT01877642|7498237|FG001|STARTED|Overall Study||3
6574215|NCT01877642|7498238|FG002|STARTED|Overall Study||3
6574216|NCT01877642|7498239|FG003|STARTED|Overall Study||3
6574217|NCT01877642|7498240|FG004|STARTED|Overall Study||3
6574218|NCT01877642|7498241|FG005|STARTED|Overall Study||3
6574219|NCT01877642|7498242|FG006|STARTED|Overall Study||3
6574220|NCT01877642|7498236|FG000|COMPLETED|Overall Study||4
6574221|NCT01877642|7498237|FG001|COMPLETED|Overall Study||3
6574222|NCT01877642|7498238|FG002|COMPLETED|Overall Study||3
6574223|NCT01877642|7498239|FG003|COMPLETED|Overall Study||3
6574224|NCT01877642|7498240|FG004|COMPLETED|Overall Study||3
6574225|NCT01877642|7498241|FG005|COMPLETED|Overall Study||3
6574226|NCT01877642|7498242|FG006|COMPLETED|Overall Study||3
6574227|NCT01877642|7498236|FG000|NOT COMPLETED|Overall Study||0
6574228|NCT01877642|7498237|FG001|NOT COMPLETED|Overall Study||0
6574229|NCT01877642|7498238|FG002|NOT COMPLETED|Overall Study||0
6574230|NCT01877642|7498239|FG003|NOT COMPLETED|Overall Study||0
6574231|NCT01877642|7498240|FG004|NOT COMPLETED|Overall Study||0
6574232|NCT01877642|7498241|FG005|NOT COMPLETED|Overall Study||0
6574233|NCT01877642|7498242|FG006|NOT COMPLETED|Overall Study||0
6574234|NCT01877668|7498256|FG000|STARTED|Overall Study|Received treatment|107
6574235|NCT01877668|7498257|FG001|STARTED|Overall Study|Received treatment|104
6574236|NCT01877668|7498258|FG002|STARTED|Overall Study|Received treatment|106
6574237|NCT01877668|7498259|FG003|STARTED|Overall Study|Received treatment|52
6574238|NCT01877668|7498260|FG004|STARTED|Overall Study|Received treatment|53
6574239|NCT01877668|7498256|FG000|COMPLETED|Overall Study||96
6574240|NCT01877668|7498257|FG001|COMPLETED|Overall Study||96
6574241|NCT01877668|7498258|FG002|COMPLETED|Overall Study||94
6574242|NCT01877668|7498259|FG003|COMPLETED|Overall Study||44
6574243|NCT01877668|7498260|FG004|COMPLETED|Overall Study||43
6574244|NCT01877668|7498256|FG000|NOT COMPLETED|Overall Study||11
6574245|NCT01877668|7498257|FG001|NOT COMPLETED|Overall Study||8
6574246|NCT01877668|7498258|FG002|NOT COMPLETED|Overall Study||12
6574247|NCT01877668|7498259|FG003|NOT COMPLETED|Overall Study||8
6574248|NCT01877668|7498260|FG004|NOT COMPLETED|Overall Study||10
6574249|NCT01877720|7498276|FG000|STARTED|Overall Study||8
6574250|NCT01877720|7498277|FG001|STARTED|Overall Study||8
6574251|NCT01877720|7498276|FG000|1st Intervention|Overall Study||7
6574252|NCT01877720|7498277|FG001|1st Intervention|Overall Study||8
6574253|NCT01877720|7498276|FG000|2nd Intervention|Overall Study||7
6574254|NCT01877720|7498277|FG001|2nd Intervention|Overall Study||8
6574255|NCT01877720|7498276|FG000|COMPLETED|Overall Study||7
6574256|NCT01877720|7498277|FG001|COMPLETED|Overall Study||8
6574257|NCT01877720|7498276|FG000|NOT COMPLETED|Overall Study||1
6574258|NCT01877720|7498277|FG001|NOT COMPLETED|Overall Study||0
6574259|NCT01877915|7498285|FG000|STARTED|Overall Study||2507
6574260|NCT01877915|7498286|FG001|STARTED|Overall Study||2515
6574261|NCT01877915|7498285|FG000|COMPLETED|Overall Study||2453
6574262|NCT01877915|7498286|FG001|COMPLETED|Overall Study||2447
6574263|NCT01877915|7498285|FG000|NOT COMPLETED|Overall Study||54
6574264|NCT01877915|7498286|FG001|NOT COMPLETED|Overall Study||68
6574265|NCT01877941|7498292|FG000|STARTED|Overall Study||39
6574266|NCT01877941|7498292|FG000|COMPLETED|Overall Study||39
6574267|NCT01877941|7498292|FG000|NOT COMPLETED|Overall Study||0
6574268|NCT01878006|7498297|FG000|STARTED|Study Session 1||5
6574269|NCT01878006|7498298|FG001|STARTED|Study Session 1||5
6574270|NCT01878006|7498297|FG000|COMPLETED|Study Session 1||5
6574271|NCT01878006|7498298|FG001|COMPLETED|Study Session 1||5
6574272|NCT01878006|7498297|FG000|NOT COMPLETED|Study Session 1||0
6574273|NCT01878006|7498298|FG001|NOT COMPLETED|Study Session 1||0
6574274|NCT01878006|7498297|FG000|STARTED|Study Session 2||5
6574275|NCT01878006|7498298|FG001|STARTED|Study Session 2||5
6574276|NCT01878006|7498297|FG000|COMPLETED|Study Session 2||5
6574277|NCT01878006|7498298|FG001|COMPLETED|Study Session 2||5
6574278|NCT01878006|7498297|FG000|NOT COMPLETED|Study Session 2||0
6574279|NCT01878006|7498298|FG001|NOT COMPLETED|Study Session 2||0
6574280|NCT01878084|7498304|FG000|STARTED|Overall Study||9
6574281|NCT01878084|7498304|FG000|Test(Received TAMP Bioglass) s|Overall Study||7
6574282|NCT01878084|7498304|FG000|Control (Sockets Were Left Empty)|Overall Study||7
6574283|NCT01878084|7498304|FG000|COMPLETED|Overall Study||7
6574284|NCT01878084|7498304|FG000|NOT COMPLETED|Overall Study||2
6574285|NCT01878097|7498311|FG000|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
6574286|NCT01878097|7498312|FG001|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
6574287|NCT01878097|7498311|FG000|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
6574288|NCT01878097|7498312|FG001|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
6574289|NCT01878097|7498311|FG000|NOT COMPLETED|Baseline||2497
6574290|NCT01878097|7498312|FG001|NOT COMPLETED|Baseline||1800
6574291|NCT01878097|7498311|FG000|STARTED|Implementation Year 1||11742
6574292|NCT01878097|7498312|FG001|STARTED|Implementation Year 1||9866
6574293|NCT01878097|7498311|FG000|COMPLETED|Implementation Year 1||8540
6574294|NCT01878097|7498312|FG001|COMPLETED|Implementation Year 1||7317
6574295|NCT01878097|7498311|FG000|NOT COMPLETED|Implementation Year 1||3202
6574296|NCT01878097|7498312|FG001|NOT COMPLETED|Implementation Year 1||2549
6574297|NCT01878097|7498311|FG000|STARTED|Implementation Year 2||11567
6574298|NCT01878097|7498312|FG001|STARTED|Implementation Year 2||9611
6574299|NCT01878097|7498311|FG000|COMPLETED|Implementation Year 2||8286
6574300|NCT01878097|7498312|FG001|COMPLETED|Implementation Year 2||6770
6574301|NCT01878097|7498311|FG000|NOT COMPLETED|Implementation Year 2||3281
6574302|NCT01878097|7498312|FG001|NOT COMPLETED|Implementation Year 2||2841
6574303|NCT01878097|7498311|FG000|STARTED|Implementation Year 3||10540
6574304|NCT01878097|7498312|FG001|STARTED|Implementation Year 3||9750
6574305|NCT01878097|7498311|FG000|COMPLETED|Implementation Year 3||7046
6574306|NCT01878097|7498312|FG001|COMPLETED|Implementation Year 3||6770
6574307|NCT01878097|7498311|FG000|NOT COMPLETED|Implementation Year 3||3494
6574308|NCT01878097|7498312|FG001|NOT COMPLETED|Implementation Year 3||2980
6574309|NCT01878097|7498311|FG000|STARTED|Implementation Year 4||10585
6574310|NCT01878097|7498312|FG001|STARTED|Implementation Year 4||9614
6574311|NCT01878097|7498311|FG000|COMPLETED|Implementation Year 4||6981
6574312|NCT01878097|7498312|FG001|COMPLETED|Implementation Year 4||6607
6574313|NCT01878097|7498311|FG000|NOT COMPLETED|Implementation Year 4||3604
6574314|NCT01878097|7498312|FG001|NOT COMPLETED|Implementation Year 4||3007
6574315|NCT01878149|7498320|FG000|STARTED|Overall Study||21
6574316|NCT01878149|7498321|FG001|STARTED|Overall Study||17
6574317|NCT01878149|7498320|FG000|COMPLETED|Overall Study||19
6574318|NCT01878149|7498321|FG001|COMPLETED|Overall Study||15
6574319|NCT01878149|7498320|FG000|NOT COMPLETED|Overall Study||2
6574320|NCT01878149|7498321|FG001|NOT COMPLETED|Overall Study||2
6574321|NCT01878175|7498327|FG000|STARTED|Overall Study||15
6574322|NCT01878175|7498327|FG000|COMPLETED|Overall Study||13
6574323|NCT01878175|7498327|FG000|NOT COMPLETED|Overall Study||2
6574324|NCT01878214|7498334|FG000|STARTED|Overall Study||223
6574325|NCT01878214|7498335|FG001|STARTED|Overall Study||219
6574326|NCT01878214|7498334|FG000|COMPLETED|Overall Study||170
6574327|NCT01878214|7498335|FG001|COMPLETED|Overall Study||175
6574328|NCT01878214|7498334|FG000|NOT COMPLETED|Overall Study||53
6574329|NCT01878214|7498335|FG001|NOT COMPLETED|Overall Study||44
6623745|NCT02209948|7550920|FG001|Discontinued Due to Progression|Overall Study||39
6623746|NCT02209948|7550919|FG000|COMPLETED|Overall Study||80
6623747|NCT02209948|7550920|FG001|COMPLETED|Overall Study||79
6623748|NCT02209948|7550919|FG000|NOT COMPLETED|Overall Study||0
6623749|NCT02209948|7550920|FG001|NOT COMPLETED|Overall Study||0
6623750|NCT02210000|7550928|FG000|STARTED|Overall Study||57
6623751|NCT02210000|7550929|FG001|STARTED|Overall Study||57
6623752|NCT02210000|7550928|FG000|COMPLETED|Overall Study||38
6623753|NCT02210000|7550929|FG001|COMPLETED|Overall Study||36
6623754|NCT02210000|7550928|FG000|NOT COMPLETED|Overall Study||19
6623755|NCT02210000|7550929|FG001|NOT COMPLETED|Overall Study||21
6623756|NCT02210039|7550935|FG000|STARTED|Overall Study||6
6623757|NCT02210039|7550935|FG000|COMPLETED|Overall Study||6
6623758|NCT02210039|7550935|FG000|NOT COMPLETED|Overall Study||0
6623759|NCT02210052|7550939|FG000|STARTED|Overall Study||6
6623760|NCT02210052|7550939|FG000|COMPLETED|Overall Study||6
6623761|NCT02210052|7550939|FG000|NOT COMPLETED|Overall Study||0
6623762|NCT02210065|7550943|FG000|STARTED|Overall Study||1
6623763|NCT02210065|7550943|FG000|COMPLETED|Overall Study||1
6623764|NCT02210065|7550943|FG000|NOT COMPLETED|Overall Study||0
6623765|NCT02210091|7550949|FG000|STARTED|Overall Study||32
6623766|NCT02210091|7550950|FG001|STARTED|Overall Study||34
6623767|NCT02210091|7550949|FG000|COMPLETED|Overall Study||32
6623768|NCT02210091|7550950|FG001|COMPLETED|Overall Study||32
6623769|NCT02210091|7550949|FG000|NOT COMPLETED|Overall Study||0
6623770|NCT02210091|7550950|FG001|NOT COMPLETED|Overall Study||2
6623771|NCT02210195|7550974|FG000|STARTED|Overall Study||10
6623772|NCT02210195|7550975|FG001|STARTED|Overall Study||10
6623773|NCT02210195|7550974|FG000|COMPLETED|Overall Study||6
6623774|NCT02210195|7550975|FG001|COMPLETED|Overall Study||10
6623775|NCT02210195|7550974|FG000|NOT COMPLETED|Overall Study||4
6623776|NCT02210195|7550975|FG001|NOT COMPLETED|Overall Study||0
6623777|NCT02210208|7550981|FG000|STARTED|Period A (Graft Site)||25
6623778|NCT02210208|7550981|FG000|COMPLETED|Period A (Graft Site)||23
6623779|NCT02210208|7550981|FG000|NOT COMPLETED|Period A (Graft Site)||2
6658124|NCT02476578|7588689|FG001|STARTED|Overall Study||4274
6574330|NCT01878253|7498341|FG000|STARTED|Overall Study||95
6574331|NCT01878253|7498341|FG000|Pre-Operative|Overall Study||95
6574332|NCT01878253|7498341|FG000|6 Weeks|Overall Study||95
6574333|NCT01878253|7498341|FG000|6 Months|Overall Study||90
6574334|NCT01878253|7498341|FG000|1 Year|Overall Study||88
6574335|NCT01878253|7498341|FG000|2 Year|Overall Study||86
6574336|NCT01878253|7498341|FG000|COMPLETED|Overall Study||86
6574337|NCT01878253|7498341|FG000|NOT COMPLETED|Overall Study||9
6574338|NCT01878292|7498353|FG000|STARTED|Randomized||174
6574339|NCT01878292|7498354|FG001|STARTED|Randomized||175
6574340|NCT01878292|7498355|FG002|STARTED|Randomized||180
6574341|NCT01878292|7498353|FG000|COMPLETED|Randomized||171
6574342|NCT01878292|7498354|FG001|COMPLETED|Randomized||175
6574343|NCT01878292|7498355|FG002|COMPLETED|Randomized||180
6574344|NCT01878292|7498353|FG000|NOT COMPLETED|Randomized||3
6574345|NCT01878292|7498354|FG001|NOT COMPLETED|Randomized||0
6574346|NCT01878292|7498355|FG002|NOT COMPLETED|Randomized||0
6574347|NCT01878292|7498353|FG000|STARTED|Double-blind Treatment Period||171
6574348|NCT01878292|7498354|FG001|STARTED|Double-blind Treatment Period||175
6574349|NCT01878292|7498355|FG002|STARTED|Double-blind Treatment Period||180
6574350|NCT01878292|7498353|FG000|COMPLETED|Double-blind Treatment Period||142
6574351|NCT01878292|7498354|FG001|COMPLETED|Double-blind Treatment Period||149
6574352|NCT01878292|7498355|FG002|COMPLETED|Double-blind Treatment Period||161
6574353|NCT01878292|7498353|FG000|NOT COMPLETED|Double-blind Treatment Period||29
6574354|NCT01878292|7498354|FG001|NOT COMPLETED|Double-blind Treatment Period||26
6574355|NCT01878292|7498355|FG002|NOT COMPLETED|Double-blind Treatment Period||19
6574356|NCT01878292|7498353|FG000|STARTED|Double-blind Down-Taper Period||127
6574357|NCT01878292|7498354|FG001|STARTED|Double-blind Down-Taper Period||140
6574358|NCT01878292|7498355|FG002|STARTED|Double-blind Down-Taper Period||146
6574359|NCT01878292|7498353|FG000|COMPLETED|Double-blind Down-Taper Period||122
6574360|NCT01878292|7498354|FG001|COMPLETED|Double-blind Down-Taper Period||132
6574361|NCT01878292|7498355|FG002|COMPLETED|Double-blind Down-Taper Period||142
6574362|NCT01878292|7498353|FG000|NOT COMPLETED|Double-blind Down-Taper Period||5
6574363|NCT01878292|7498354|FG001|NOT COMPLETED|Double-blind Down-Taper Period||8
6574364|NCT01878292|7498355|FG002|NOT COMPLETED|Double-blind Down-Taper Period||4
6574365|NCT01878383|7498365|FG000|STARTED|Overall Study||50
6574366|NCT01878383|7498366|FG001|STARTED|Overall Study||12500
6574367|NCT01878383|7498365|FG000|COMPLETED|Overall Study||50
6574368|NCT01878383|7498366|FG001|COMPLETED|Overall Study||11001
6574369|NCT01878383|7498365|FG000|NOT COMPLETED|Overall Study||0
6574370|NCT01878383|7498366|FG001|NOT COMPLETED|Overall Study||1499
6574371|NCT01878526|7498374|FG000|STARTED|Overall Study||40
6574372|NCT01878526|7498375|FG001|STARTED|Overall Study||40
6574373|NCT01878526|7498374|FG000|COMPLETED|Overall Study||37
6574374|NCT01878526|7498375|FG001|COMPLETED|Overall Study||38
6574375|NCT01878526|7498374|FG000|NOT COMPLETED|Overall Study||3
6574376|NCT01878526|7498375|FG001|NOT COMPLETED|Overall Study||2
6574377|NCT01878604|7498382|FG000|STARTED|Overall Study||5
6574378|NCT01878604|7498382|FG000|COMPLETED|Overall Study||5
6574379|NCT01878604|7498382|FG000|NOT COMPLETED|Overall Study||0
6574380|NCT01878656|7498389|FG000|STARTED|Overall Study||72
6574381|NCT01878656|7498390|FG001|STARTED|Overall Study||72
6574382|NCT01878656|7498389|FG000|COMPLETED|Overall Study||72
6574383|NCT01878656|7498390|FG001|COMPLETED|Overall Study||72
6574384|NCT01878656|7498389|FG000|NOT COMPLETED|Overall Study||0
6574385|NCT01878656|7498390|FG001|NOT COMPLETED|Overall Study||0
6574386|NCT01878799|7498398|FG000|STARTED|Overall Study||37
6574387|NCT01878799|7498399|FG001|STARTED|Overall Study||13
6574388|NCT01878799|7498398|FG000|COMPLETED|Overall Study||36
6574389|NCT01878799|7498399|FG001|COMPLETED|Overall Study||13
6574390|NCT01878799|7498398|FG000|NOT COMPLETED|Overall Study||1
6574391|NCT01878799|7498399|FG001|NOT COMPLETED|Overall Study||0
6574392|NCT01878812|7498407|FG000|STARTED|Overall Study||60
6574393|NCT01878812|7498408|FG001|STARTED|Overall Study||57
6574394|NCT01878812|7498407|FG000|COMPLETED|Overall Study||60
6574395|NCT01878812|7498408|FG001|COMPLETED|Overall Study||57
6574396|NCT01878812|7498407|FG000|NOT COMPLETED|Overall Study||0
6574397|NCT01878812|7498408|FG001|NOT COMPLETED|Overall Study||0
6574398|NCT01878825|7498416|FG000|STARTED|Overall Study||60
6574399|NCT01878825|7498417|FG001|STARTED|Overall Study||60
6574400|NCT01878825|7498416|FG000|COMPLETED|Overall Study||60
6574401|NCT01878825|7498417|FG001|COMPLETED|Overall Study||60
6574402|NCT01878825|7498416|FG000|NOT COMPLETED|Overall Study||0
6574403|NCT01878825|7498417|FG001|NOT COMPLETED|Overall Study||0
6574404|NCT01878890|7498436|FG000|STARTED|Overall Study||5
6574405|NCT01878890|7498437|FG001|STARTED|Overall Study||11
6574406|NCT01878890|7498438|FG002|STARTED|Overall Study||4
6574407|NCT01878890|7498439|FG003|STARTED|Overall Study||5
6574408|NCT01878890|7498436|FG000|COMPLETED|Overall Study||5
6574409|NCT01878890|7498437|FG001|COMPLETED|Overall Study||10
6574410|NCT01878890|7498438|FG002|COMPLETED|Overall Study||4
6574411|NCT01878890|7498439|FG003|COMPLETED|Overall Study||5
6574412|NCT01878890|7498436|FG000|NOT COMPLETED|Overall Study||0
6574413|NCT01878890|7498437|FG001|NOT COMPLETED|Overall Study||1
6574414|NCT01878890|7498438|FG002|NOT COMPLETED|Overall Study||0
6574415|NCT01878890|7498439|FG003|NOT COMPLETED|Overall Study||0
6574416|NCT01879059|7498450|FG000|STARTED|Overall Study||13
6574417|NCT01879059|7498450|FG000|COMPLETED|Overall Study||13
6574418|NCT01879059|7498450|FG000|NOT COMPLETED|Overall Study||0
6574419|NCT01879072|7498454|FG000|STARTED|Overall Study||1860
6574420|NCT01879072|7498454|FG000|COMPLETED|Overall Study||1709
6574421|NCT01879072|7498454|FG000|NOT COMPLETED|Overall Study||151
6574422|NCT01879176|7498460|FG000|STARTED|Overall Study||24
6574423|NCT01879176|7498461|FG001|STARTED|Overall Study||22
6574424|NCT01879176|7498460|FG000|COMPLETED|Overall Study||16
6574425|NCT01879176|7498461|FG001|COMPLETED|Overall Study||16
6574426|NCT01879176|7498460|FG000|NOT COMPLETED|Overall Study||8
6574427|NCT01879176|7498461|FG001|NOT COMPLETED|Overall Study||6
6574428|NCT01879319|7498469|FG000|STARTED|Overall Study||82
6574429|NCT01879319|7498470|FG001|STARTED|Overall Study||82
6574430|NCT01879319|7498469|FG000|Received Treatment|Overall Study||82
6574431|NCT01879319|7498470|FG001|Received Treatment|Overall Study||82
6574432|NCT01879319|7498469|FG000|COMPLETED|Overall Study||80
6574433|NCT01879319|7498470|FG001|COMPLETED|Overall Study||77
6574434|NCT01879319|7498469|FG000|NOT COMPLETED|Overall Study||2
6574435|NCT01879319|7498470|FG001|NOT COMPLETED|Overall Study||5
6574436|NCT01879332|7498479|FG000|STARTED|Overall Study||6
6574437|NCT01879332|7498480|FG001|STARTED|Overall Study||6
6574438|NCT01879332|7498481|FG002|STARTED|Overall Study||4
6574439|NCT01879332|7498479|FG000|COMPLETED|Overall Study||0
6574440|NCT01879332|7498480|FG001|COMPLETED|Overall Study||0
6574441|NCT01879332|7498481|FG002|COMPLETED|Overall Study||0
6574442|NCT01879332|7498479|FG000|NOT COMPLETED|Overall Study||6
6574443|NCT01879332|7498480|FG001|NOT COMPLETED|Overall Study||6
6574444|NCT01879332|7498481|FG002|NOT COMPLETED|Overall Study||4
6574445|NCT01879345|7498492|FG000|STARTED|Single-dose Period||6
6574446|NCT01879345|7498493|FG001|STARTED|Single-dose Period||6
6574447|NCT01879345|7498494|FG002|STARTED|Single-dose Period||6
6574448|NCT01879345|7498492|FG000|COMPLETED|Single-dose Period||6
6574449|NCT01879345|7498493|FG001|COMPLETED|Single-dose Period||6
6574450|NCT01879345|7498494|FG002|COMPLETED|Single-dose Period||6
6574451|NCT01879345|7498492|FG000|NOT COMPLETED|Single-dose Period||0
6574452|NCT01879345|7498493|FG001|NOT COMPLETED|Single-dose Period||0
6574453|NCT01879345|7498494|FG002|NOT COMPLETED|Single-dose Period||0
6574454|NCT01879345|7498492|FG000|STARTED|7-day Multiple-dose Period||6
6574455|NCT01879345|7498493|FG001|STARTED|7-day Multiple-dose Period||6
6574456|NCT01879345|7498494|FG002|STARTED|7-day Multiple-dose Period||6
6574457|NCT01879345|7498492|FG000|COMPLETED|7-day Multiple-dose Period||6
6574458|NCT01879345|7498493|FG001|COMPLETED|7-day Multiple-dose Period||6
6574459|NCT01879345|7498494|FG002|COMPLETED|7-day Multiple-dose Period||6
6574460|NCT01879345|7498492|FG000|NOT COMPLETED|7-day Multiple-dose Period||0
6574461|NCT01879345|7498493|FG001|NOT COMPLETED|7-day Multiple-dose Period||0
6574462|NCT01879345|7498494|FG002|NOT COMPLETED|7-day Multiple-dose Period||0
6574463|NCT01879371|7498510|FG000|STARTED|Overall Study||6
6574464|NCT01879371|7498511|FG001|STARTED|Overall Study||6
6574465|NCT01879371|7498512|FG002|STARTED|Overall Study||6
6574466|NCT01879371|7498513|FG003|STARTED|Overall Study||6
6574467|NCT01879371|7498514|FG004|STARTED|Overall Study||6
6574468|NCT01879371|7498515|FG005|STARTED|Overall Study||6
6574469|NCT01879371|7498510|FG000|COMPLETED|Overall Study||6
6574470|NCT01879371|7498511|FG001|COMPLETED|Overall Study||6
6574471|NCT01879371|7498512|FG002|COMPLETED|Overall Study||6
6574472|NCT01879371|7498513|FG003|COMPLETED|Overall Study||6
6574473|NCT01879371|7498514|FG004|COMPLETED|Overall Study||6
6574474|NCT01879371|7498515|FG005|COMPLETED|Overall Study||6
6574475|NCT01879371|7498510|FG000|NOT COMPLETED|Overall Study||0
6574476|NCT01879371|7498511|FG001|NOT COMPLETED|Overall Study||0
6574477|NCT01879371|7498512|FG002|NOT COMPLETED|Overall Study||0
6574478|NCT01879371|7498513|FG003|NOT COMPLETED|Overall Study||0
6574479|NCT01879371|7498514|FG004|NOT COMPLETED|Overall Study||0
6574480|NCT01879371|7498515|FG005|NOT COMPLETED|Overall Study||0
6574481|NCT01879410|7498525|FG000|STARTED|Overall Study||350
6574482|NCT01879410|7498526|FG001|STARTED|Overall Study||350
6574483|NCT01879410|7498525|FG000|Intent-to-Treat Population|Overall Study||349
6574484|NCT01879410|7498526|FG001|Intent-to-Treat Population|Overall Study||348
6574485|NCT01879410|7498525|FG000|COMPLETED|Overall Study||326
6574486|NCT01879410|7498526|FG001|COMPLETED|Overall Study||312
6574487|NCT01879410|7498525|FG000|NOT COMPLETED|Overall Study||24
6574488|NCT01879410|7498526|FG001|NOT COMPLETED|Overall Study||38
6574489|NCT01879540|7498532|FG000|STARTED|Overall Study||63
6574490|NCT01879540|7498532|FG000|COMPLETED|Overall Study||63
6574491|NCT01879540|7498532|FG000|NOT COMPLETED|Overall Study||0
6574492|NCT01879553|7498538|FG000|STARTED|Overall Study||63
6574493|NCT01879553|7498539|FG001|STARTED|Overall Study||63
6574494|NCT01879553|7498538|FG000|COMPLETED|Overall Study||62
6574495|NCT01879553|7498539|FG001|COMPLETED|Overall Study||63
6574496|NCT01879553|7498538|FG000|NOT COMPLETED|Overall Study||1
6574497|NCT01879553|7498539|FG001|NOT COMPLETED|Overall Study||0
6574498|NCT01879579|7498548|FG000|STARTED|Overall Study||33
6574499|NCT01879579|7498549|FG001|STARTED|Overall Study||28
6574500|NCT01879579|7498548|FG000|COMPLETED|Overall Study||28
6574501|NCT01879579|7498549|FG001|COMPLETED|Overall Study||26
6574502|NCT01879579|7498548|FG000|NOT COMPLETED|Overall Study||5
6574503|NCT01879579|7498549|FG001|NOT COMPLETED|Overall Study||2
6574504|NCT01879618|7498558|FG000|STARTED|Overall Study||152
6574505|NCT01879618|7498558|FG000|COMPLETED|Overall Study||131
6574506|NCT01879618|7498558|FG000|NOT COMPLETED|Overall Study||21
6574507|NCT01879683|7498562|FG000|STARTED|Overall Study||10
6574508|NCT01879683|7498562|FG000|COMPLETED|Overall Study||9
6574509|NCT01879683|7498562|FG000|NOT COMPLETED|Overall Study||1
6574510|NCT01879722|7498576|FG000|STARTED|Overall Study||7
6574511|NCT01879722|7498577|FG001|STARTED|Overall Study||8
6574512|NCT01879722|7498578|FG002|STARTED|Overall Study||7
6574513|NCT01879722|7498579|FG003|STARTED|Overall Study||8
6574514|NCT01879722|7498580|FG004|STARTED|Overall Study||8
6574515|NCT01879722|7498581|FG005|STARTED|Overall Study||9
6574516|NCT01879722|7498582|FG006|STARTED|Overall Study||8
6574517|NCT01879722|7498583|FG007|STARTED|Overall Study||8
6574518|NCT01879722|7498584|FG008|STARTED|Overall Study||8
6574519|NCT01879722|7498585|FG009|STARTED|Overall Study||6
6574520|NCT01879722|7498576|FG000|COMPLETED|Overall Study||7
6574521|NCT01879722|7498577|FG001|COMPLETED|Overall Study||7
6574522|NCT01879722|7498578|FG002|COMPLETED|Overall Study||7
6574523|NCT01879722|7498579|FG003|COMPLETED|Overall Study||7
6574524|NCT01879722|7498580|FG004|COMPLETED|Overall Study||7
6574525|NCT01879722|7498581|FG005|COMPLETED|Overall Study||9
6574526|NCT01879722|7498582|FG006|COMPLETED|Overall Study||8
6574527|NCT01879722|7498583|FG007|COMPLETED|Overall Study||7
6574528|NCT01879722|7498584|FG008|COMPLETED|Overall Study||6
6574529|NCT01879722|7498585|FG009|COMPLETED|Overall Study||6
6574530|NCT01879722|7498576|FG000|NOT COMPLETED|Overall Study||0
6574531|NCT01879722|7498577|FG001|NOT COMPLETED|Overall Study||1
6574532|NCT01879722|7498578|FG002|NOT COMPLETED|Overall Study||0
6574533|NCT01879722|7498579|FG003|NOT COMPLETED|Overall Study||1
6574534|NCT01879722|7498580|FG004|NOT COMPLETED|Overall Study||1
6574535|NCT01879722|7498581|FG005|NOT COMPLETED|Overall Study||0
6574536|NCT01879722|7498582|FG006|NOT COMPLETED|Overall Study||0
6574537|NCT01879722|7498583|FG007|NOT COMPLETED|Overall Study||1
6574538|NCT01879722|7498584|FG008|NOT COMPLETED|Overall Study||2
6574539|NCT01879722|7498585|FG009|NOT COMPLETED|Overall Study||0
6623780|NCT02210208|7550981|FG000|STARTED|Period B (Donor Site)|6 subjects was decided by the Physician not to be included in the Part B.|19
6623781|NCT02210208|7550981|FG000|COMPLETED|Period B (Donor Site)||12
6623782|NCT02210208|7550981|FG000|NOT COMPLETED|Period B (Donor Site)||7
6623783|NCT02210221|7550987|FG000|STARTED|Overall Study||4559
6623784|NCT02210221|7550987|FG000|COMPLETED|Overall Study||4509
6623785|NCT02210221|7550987|FG000|NOT COMPLETED|Overall Study||50
6623786|NCT02210247|7551001|FG000|STARTED|Overall Study||12
6623787|NCT02210247|7551002|FG001|STARTED|Overall Study||12
6623788|NCT02210247|7551003|FG002|STARTED|Overall Study||12
6623789|NCT02210247|7551004|FG003|STARTED|Overall Study||12
6623790|NCT02210247|7551005|FG004|STARTED|Overall Study||12
6623791|NCT02210247|7551001|FG000|COMPLETED|Overall Study||12
6623792|NCT02210247|7551002|FG001|COMPLETED|Overall Study||12
6623793|NCT02210247|7551003|FG002|COMPLETED|Overall Study||12
6623794|NCT02210247|7551004|FG003|COMPLETED|Overall Study||12
6623795|NCT02210247|7551005|FG004|COMPLETED|Overall Study||12
6623796|NCT02210247|7551001|FG000|NOT COMPLETED|Overall Study||0
6623797|NCT02210247|7551002|FG001|NOT COMPLETED|Overall Study||0
6623798|NCT02210247|7551003|FG002|NOT COMPLETED|Overall Study||0
6623799|NCT02210247|7551004|FG003|NOT COMPLETED|Overall Study||0
6623800|NCT02210247|7551005|FG004|NOT COMPLETED|Overall Study||0
6623801|NCT02210286|7551022|FG000|STARTED|Overall Study||17
6623802|NCT02210286|7551022|FG000|COMPLETED|Overall Study||15
6623803|NCT02210286|7551022|FG000|NOT COMPLETED|Overall Study||2
6623804|NCT02210689|7551033|FG000|STARTED|Overall Study||242
6623805|NCT02210689|7551034|FG001|STARTED|Overall Study||240
6623806|NCT02210689|7551035|FG002|STARTED|Overall Study||122
6623807|NCT02210689|7551033|FG000|Safety Population|Overall Study||233
6623808|NCT02210689|7551034|FG001|Safety Population|Overall Study||236
6623809|NCT02210689|7551035|FG002|Safety Population|Overall Study||122
6623810|NCT02210689|7551033|FG000|mITT Population|Overall Study||199
6623811|NCT02210689|7551034|FG001|mITT Population|Overall Study||207
6623812|NCT02210689|7551035|FG002|mITT Population|Overall Study||107
6623813|NCT02210689|7551033|FG000|PP Population|Overall Study||164
6623814|NCT02210689|7551034|FG001|PP Population|Overall Study||169
6623815|NCT02210689|7551035|FG002|PP Population|Overall Study||84
6623816|NCT02210689|7551033|FG000|COMPLETED|Overall Study||190
6623817|NCT02210689|7551034|FG001|COMPLETED|Overall Study||193
6623818|NCT02210689|7551035|FG002|COMPLETED|Overall Study||99
6623819|NCT02210689|7551033|FG000|NOT COMPLETED|Overall Study||52
6623820|NCT02210689|7551034|FG001|NOT COMPLETED|Overall Study||47
6623821|NCT02210689|7551035|FG002|NOT COMPLETED|Overall Study||23
6623822|NCT02210780|7551045|FG000|STARTED|Overall Study||97
6623823|NCT02210780|7551046|FG001|STARTED|Overall Study||97
6623824|NCT02210780|7551045|FG000|COMPLETED|Overall Study||92
6623825|NCT02210780|7551046|FG001|COMPLETED|Overall Study||89
6623826|NCT02210780|7551045|FG000|NOT COMPLETED|Overall Study||5
6623827|NCT02210780|7551046|FG001|NOT COMPLETED|Overall Study||8
6623828|NCT02211014|7551054|FG000|STARTED|Overall Study||13
6623829|NCT02211014|7551055|FG001|STARTED|Overall Study||14
6623830|NCT02211014|7551054|FG000|COMPLETED|Overall Study||11
6623831|NCT02211014|7551055|FG001|COMPLETED|Overall Study||8
6623832|NCT02211014|7551054|FG000|NOT COMPLETED|Overall Study||2
6623833|NCT02211014|7551055|FG001|NOT COMPLETED|Overall Study||6
6623834|NCT02211261|7551088|FG000|STARTED|Overall Study||9
6623835|NCT02211261|7551089|FG001|STARTED|Overall Study||6
6623836|NCT02211261|7551090|FG002|STARTED|Overall Study||6
6623837|NCT02211261|7551091|FG003|STARTED|Overall Study||6
6623838|NCT02211261|7551092|FG004|STARTED|Overall Study||9
6623839|NCT02211261|7551093|FG005|STARTED|Overall Study||2
6623840|NCT02211261|7551094|FG006|STARTED|Overall Study||6
6623841|NCT02211261|7551095|FG007|STARTED|Overall Study||8
6623842|NCT02211261|7551096|FG008|STARTED|Overall Study||8
6574540|NCT04838054|7498612|FG000|STARTED|Overall Study||29
6574541|NCT04838054|7498613|FG001|STARTED|Overall Study||28
6574542|NCT04838054|7498612|FG000|COMPLETED|Overall Study||27
6574543|NCT04838054|7498613|FG001|COMPLETED|Overall Study||28
6574544|NCT04838054|7498612|FG000|NOT COMPLETED|Overall Study||2
6574545|NCT04838054|7498613|FG001|NOT COMPLETED|Overall Study||0
6574546|NCT04495829|7498619|FG000|STARTED|Overall Study||70
6574547|NCT04495829|7498619|FG000|COMPLETED|Overall Study||65
6574548|NCT04495829|7498619|FG000|NOT COMPLETED|Overall Study||5
6574549|NCT03861052|7498627|FG000|STARTED|Overall Study||159
6574550|NCT03861052|7498628|FG001|STARTED|Overall Study||158
6574551|NCT03861052|7498629|FG002|STARTED|Overall Study||160
6574552|NCT03861052|7498630|FG003|STARTED|Overall Study||159
6574553|NCT03861052|7498627|FG000|Received at Least One Dose of Study Drug|Overall Study||159
6574554|NCT03861052|7498628|FG001|Received at Least One Dose of Study Drug|Overall Study||158
6574555|NCT03861052|7498629|FG002|Received at Least One Dose of Study Drug|Overall Study||160
6574556|NCT03861052|7498630|FG003|Received at Least One Dose of Study Drug|Overall Study||159
6574557|NCT03861052|7498627|FG000|COMPLETED|Overall Study||155
6574558|NCT03861052|7498628|FG001|COMPLETED|Overall Study||151
6574559|NCT03861052|7498629|FG002|COMPLETED|Overall Study||155
6574560|NCT03861052|7498630|FG003|COMPLETED|Overall Study||154
6574561|NCT03861052|7498627|FG000|NOT COMPLETED|Overall Study||4
6574562|NCT03861052|7498628|FG001|NOT COMPLETED|Overall Study||7
6574563|NCT03861052|7498629|FG002|NOT COMPLETED|Overall Study||5
6574564|NCT03861052|7498630|FG003|NOT COMPLETED|Overall Study||5
6574565|NCT03846453|7498647|FG000|STARTED|Placebo Run-in (14 Days)||1108
6574566|NCT03846453|7498648|FG001|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
6574567|NCT03846453|7498649|FG002|STARTED|Placebo Run-in (14 Days)|Participants in this group were randomized after they completed the placebo run-in period.|0
6574568|NCT03846453|7498647|FG000|COMPLETED|Placebo Run-in (14 Days)||637
6574569|NCT03846453|7498648|FG001|COMPLETED|Placebo Run-in (14 Days)||0
6574570|NCT03846453|7498649|FG002|COMPLETED|Placebo Run-in (14 Days)||0
6574571|NCT03846453|7498647|FG000|NOT COMPLETED|Placebo Run-in (14 Days)||471
6574572|NCT03846453|7498648|FG001|NOT COMPLETED|Placebo Run-in (14 Days)||0
6574573|NCT03846453|7498649|FG002|NOT COMPLETED|Placebo Run-in (14 Days)||0
6574574|NCT03846453|7498647|FG000|STARTED|Randomized Treatment Period (Days 57±3)|All participants who completed the placebo run-in period and qualified were randomized to either 0.25% HL036 Ophthalmic Solution group or placebo group.|0
6574575|NCT03846453|7498648|FG001|STARTED|Randomized Treatment Period (Days 57±3)||318
6574576|NCT03846453|7498649|FG002|STARTED|Randomized Treatment Period (Days 57±3)||319
6574577|NCT03846453|7498647|FG000|COMPLETED|Randomized Treatment Period (Days 57±3)||0
6574578|NCT03846453|7498648|FG001|COMPLETED|Randomized Treatment Period (Days 57±3)||291
6574579|NCT03846453|7498649|FG002|COMPLETED|Randomized Treatment Period (Days 57±3)||294
6574580|NCT03846453|7498647|FG000|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||0
6574581|NCT03846453|7498648|FG001|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||27
6574582|NCT03846453|7498649|FG002|NOT COMPLETED|Randomized Treatment Period (Days 57±3)||25
6574647|NCT03041701|7498758|FG000|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||7
6574648|NCT03041701|7498759|FG001|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||6
6574649|NCT03041701|7498760|FG002|STARTED|Ph I: Dose Level 1 and 2 Dose Escalation||0
6574650|NCT03041701|7498758|FG000|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||6
6574651|NCT03041701|7498759|FG001|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||5
6574652|NCT03041701|7498760|FG002|COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
6574653|NCT03041701|7498758|FG000|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
6574654|NCT03041701|7498759|FG001|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||1
6574655|NCT03041701|7498760|FG002|NOT COMPLETED|Ph I: Dose Level 1 and 2 Dose Escalation||0
6574656|NCT03041701|7498758|FG000|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
6574657|NCT03041701|7498759|FG001|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
6574658|NCT03041701|7498760|FG002|STARTED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
6574659|NCT03041701|7498758|FG000|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
6574660|NCT03041701|7498759|FG001|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
6574661|NCT03041701|7498760|FG002|COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
6574662|NCT03041701|7498758|FG000|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
6574663|NCT03041701|7498759|FG001|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||0
6574664|NCT03041701|7498760|FG002|NOT COMPLETED|Ph 2:Dose Level 1 Maximum Tolerated Dose||1
6574665|NCT03000179|7498771|FG000|STARTED|Overall Study||8
6574666|NCT03000179|7498771|FG000|COMPLETED|Overall Study||6
6574667|NCT03000179|7498771|FG000|NOT COMPLETED|Overall Study||2
6574668|NCT02876835|7498777|FG000|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1937
6574669|NCT02876835|7498778|FG001|STARTED|Run-in Period: Placebo (Week-4 to Day 1)||1935
6574670|NCT02876835|7498777|FG000|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1937
6574671|NCT02876835|7498778|FG001|COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||1935
6574672|NCT02876835|7498777|FG000|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
6574673|NCT02876835|7498778|FG001|NOT COMPLETED|Run-in Period: Placebo (Week-4 to Day 1)||0
6574674|NCT02876835|7498777|FG000|STARTED|Treatment Period (51.1 Month)||1937
6574675|NCT02876835|7498778|FG001|STARTED|Treatment Period (51.1 Month)||1935
6574676|NCT02876835|7498777|FG000|COMPLETED|Treatment Period (51.1 Month)||1873
6658125|NCT02476578|7588688|FG000|Died Before Email Was Sent|Overall Study||35
6574583|NCT03607994|7498659|FG000|STARTED|Overall Study||10
6574584|NCT03607994|7498660|FG001|STARTED|Overall Study||12
6574585|NCT03607994|7498659|FG000|COMPLETED|Overall Study||9
6574586|NCT03607994|7498660|FG001|COMPLETED|Overall Study||11
6574587|NCT03607994|7498659|FG000|NOT COMPLETED|Overall Study||1
6574588|NCT03607994|7498660|FG001|NOT COMPLETED|Overall Study||1
6574589|NCT03605862|7498668|FG000|STARTED|Overall Study||872
6574590|NCT03605862|7498669|FG001|STARTED|Overall Study||884
6574591|NCT03605862|7498668|FG000|COMPLETED|Overall Study||844
6574592|NCT03605862|7498669|FG001|COMPLETED|Overall Study||858
6574593|NCT03605862|7498668|FG000|NOT COMPLETED|Overall Study||28
6574594|NCT03605862|7498669|FG001|NOT COMPLETED|Overall Study||26
6574595|NCT03541252|7498676|FG000|STARTED|Overall Study||20
6574596|NCT03541252|7498676|FG000|COMPLETED|Overall Study||19
6574597|NCT03541252|7498676|FG000|NOT COMPLETED|Overall Study||1
6574598|NCT03401112|7498685|FG000|STARTED|Overall Study||15
6574599|NCT03401112|7498686|FG001|STARTED|Overall Study||26
6574600|NCT03401112|7498687|FG002|STARTED|Overall Study||22
6574601|NCT03401112|7498688|FG003|STARTED|Overall Study||27
6574602|NCT03401112|7498689|FG004|STARTED|Overall Study||10
6574603|NCT03401112|7498685|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
6574604|NCT03401112|7498686|FG001|Received at Least 1 Dose of Study Drug|Overall Study||26
6574605|NCT03401112|7498687|FG002|Received at Least 1 Dose of Study Drug|Overall Study||20
6574606|NCT03401112|7498688|FG003|Received at Least 1 Dose of Study Drug|Overall Study||25
6574607|NCT03401112|7498689|FG004|Received at Least 1 Dose of Study Drug|Overall Study||10
6574608|NCT03401112|7498685|FG000|COMPLETED|Overall Study||10
6574609|NCT03401112|7498686|FG001|COMPLETED|Overall Study||19
6574610|NCT03401112|7498687|FG002|COMPLETED|Overall Study||11
6574611|NCT03401112|7498688|FG003|COMPLETED|Overall Study||21
6574612|NCT03401112|7498689|FG004|COMPLETED|Overall Study||10
6574613|NCT03401112|7498685|FG000|NOT COMPLETED|Overall Study||5
6574614|NCT03401112|7498686|FG001|NOT COMPLETED|Overall Study||7
6574615|NCT03401112|7498687|FG002|NOT COMPLETED|Overall Study||11
6574616|NCT03401112|7498688|FG003|NOT COMPLETED|Overall Study||6
6574617|NCT03401112|7498689|FG004|NOT COMPLETED|Overall Study||0
6574618|NCT03391232|7498718|FG000|STARTED|Part A - First Dose (1-12weeks)||5
6574619|NCT03391232|7498719|FG001|STARTED|Part A - First Dose (1-12weeks)||6
6574620|NCT03391232|7498718|FG000|COMPLETED|Part A - First Dose (1-12weeks)|This cohort finished the trial here after 12 weeks.|5
6574621|NCT03391232|7498719|FG001|COMPLETED|Part A - First Dose (1-12weeks)|After interim analysis this cohort continued the trial.|6
6574622|NCT03391232|7498718|FG000|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
6574623|NCT03391232|7498719|FG001|NOT COMPLETED|Part A - First Dose (1-12weeks)||0
6574624|NCT03391232|7498718|FG000|STARTED|Part B - Additional 2 Doses (13-38weeks)||0
6574625|NCT03391232|7498719|FG001|STARTED|Part B - Additional 2 Doses (13-38weeks)||6
6574626|NCT03391232|7498718|FG000|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
6574627|NCT03391232|7498719|FG001|COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
6574628|NCT03391232|7498718|FG000|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||0
6574629|NCT03391232|7498719|FG001|NOT COMPLETED|Part B - Additional 2 Doses (13-38weeks)||3
6574630|NCT03383666|7498727|FG000|STARTED|Overall Study||21
6574631|NCT03383666|7498727|FG000|Implanted With Pulse Rider|Overall Study||18
6574632|NCT03383666|7498727|FG000|Attempted But Unsuccessful Implantation|Overall Study||3
6574633|NCT03383666|7498727|FG000|COMPLETED|Overall Study||17
6574634|NCT03383666|7498727|FG000|NOT COMPLETED|Overall Study||4
6574635|NCT03362112|7498731|FG000|STARTED|Overall Study||1713
6574636|NCT03362112|7498731|FG000|COMPLETED|Overall Study||1622
6574637|NCT03362112|7498731|FG000|NOT COMPLETED|Overall Study||91
6574638|NCT03299049|7498737|FG000|STARTED|Overall Study||522
6574639|NCT03299049|7498738|FG001|STARTED|Overall Study||523
6574640|NCT03299049|7498737|FG000|COMPLETED|Overall Study||0
6574641|NCT03299049|7498738|FG001|COMPLETED|Overall Study||0
6574642|NCT03299049|7498737|FG000|NOT COMPLETED|Overall Study||522
6574643|NCT03299049|7498738|FG001|NOT COMPLETED|Overall Study||523
6574644|NCT03158298|7498751|FG000|STARTED|Overall Study||82
6574645|NCT03158298|7498751|FG000|COMPLETED|Overall Study||82
6574646|NCT03158298|7498751|FG000|NOT COMPLETED|Overall Study||0
6574677|NCT02876835|7498778|FG001|COMPLETED|Treatment Period (51.1 Month)||1870
6574678|NCT02876835|7498777|FG000|NOT COMPLETED|Treatment Period (51.1 Month)||64
6574679|NCT02876835|7498778|FG001|NOT COMPLETED|Treatment Period (51.1 Month)||65
6574680|NCT02860039|7498787|FG000|STARTED|Overall Study||84
6574681|NCT02860039|7498788|FG001|STARTED|Overall Study||86
6574682|NCT02860039|7498787|FG000|Visit 1|Overall Study||84
6574683|NCT02860039|7498788|FG001|Visit 1|Overall Study||86
6574684|NCT02860039|7498787|FG000|Visit 2|Overall Study||83
6574685|NCT02860039|7498788|FG001|Visit 2|Overall Study||84
6574686|NCT02860039|7498787|FG000|Visit 3|Overall Study||77
6574687|NCT02860039|7498788|FG001|Visit 3|Overall Study||84
6574688|NCT02860039|7498787|FG000|Visit 4|Overall Study||73
6574689|NCT02860039|7498788|FG001|Visit 4|Overall Study||82
6574690|NCT02860039|7498787|FG000|Visit 1 Repeat|Overall Study||31
6574691|NCT02860039|7498788|FG001|Visit 1 Repeat|Overall Study||35
6574692|NCT02860039|7498787|FG000|Visit 2 Repeat|Overall Study||30
6574693|NCT02860039|7498788|FG001|Visit 2 Repeat|Overall Study||35
6574694|NCT02860039|7498787|FG000|Visit 3 Repeat|Overall Study||29
6574695|NCT02860039|7498788|FG001|Visit 3 Repeat|Overall Study||35
6574696|NCT02860039|7498787|FG000|Visit 4 Repeat|Overall Study||26
6574697|NCT02860039|7498788|FG001|Visit 4 Repeat|Overall Study||22
6574698|NCT02860039|7498787|FG000|COMPLETED|Overall Study||73
6658126|NCT02476578|7588689|FG001|Died Before Email Was Sent|Overall Study||43
6658127|NCT02476578|7588688|FG000|Left Before End of Trial|Overall Study||6
6658128|NCT02476578|7588689|FG001|Left Before End of Trial|Overall Study||13
6658129|NCT02476578|7588688|FG000|COMPLETED|Overall Study||4269
6658130|NCT02476578|7588689|FG001|COMPLETED|Overall Study||4218
6658131|NCT02476578|7588688|FG000|NOT COMPLETED|Overall Study||41
6658132|NCT02476578|7588689|FG001|NOT COMPLETED|Overall Study||56
6658133|NCT02476617|7588695|FG000|STARTED|Overall Study||25
6658134|NCT02476617|7588695|FG000|COMPLETED|Overall Study||23
6658135|NCT02476617|7588695|FG000|NOT COMPLETED|Overall Study||2
6658136|NCT02476890|7588703|FG000|STARTED|Overall Study|Crossover study|6
6658137|NCT02476890|7588704|FG001|STARTED|Overall Study|Crossover study|6
6658138|NCT02476890|7588705|FG002|STARTED|Overall Study|Crossover study|12
6658139|NCT02476890|7588706|FG003|STARTED|Overall Study|Crossover study|12
6658140|NCT02476890|7588703|FG000|Washout|Overall Study||6
6658141|NCT02476890|7588704|FG001|Washout|Overall Study||6
6658142|NCT02476890|7588705|FG002|Washout|Overall Study||12
6658143|NCT02476890|7588706|FG003|Washout|Overall Study||12
6658144|NCT02476890|7588703|FG000|COMPLETED|Overall Study||6
6658145|NCT02476890|7588704|FG001|COMPLETED|Overall Study||6
6658146|NCT02476890|7588705|FG002|COMPLETED|Overall Study||12
6658147|NCT02476890|7588706|FG003|COMPLETED|Overall Study||12
6658148|NCT02476890|7588703|FG000|NOT COMPLETED|Overall Study||0
6658149|NCT02476890|7588704|FG001|NOT COMPLETED|Overall Study||0
6658150|NCT02476890|7588705|FG002|NOT COMPLETED|Overall Study||0
6658151|NCT02476890|7588706|FG003|NOT COMPLETED|Overall Study||0
6658152|NCT02477020|7588720|FG000|STARTED|Overall Study||81
6658153|NCT02477020|7588721|FG001|STARTED|Overall Study||83
6658154|NCT02477020|7588720|FG000|COMPLETED|Overall Study|Completed = participants who completed study treatment.|51
6658155|NCT02477020|7588721|FG001|COMPLETED|Overall Study|Completed = participants who completed study treatment.|55
6658156|NCT02477020|7588720|FG000|NOT COMPLETED|Overall Study||30
6658157|NCT02477020|7588721|FG001|NOT COMPLETED|Overall Study||28
6658158|NCT02477111|7588727|FG000|STARTED|Overall Study||150
6658159|NCT02477111|7588727|FG000|COMPLETED|Overall Study|All participants who were assessed for one year|139
6658160|NCT02477111|7588727|FG000|NOT COMPLETED|Overall Study||11
6658161|NCT02477215|7588737|FG000|STARTED|Dose Escalation Phase||4
6658162|NCT02477215|7588738|FG001|STARTED|Dose Escalation Phase||8
6658163|NCT02477215|7588739|FG002|STARTED|Dose Escalation Phase||6
6658164|NCT02477215|7588737|FG000|COMPLETED|Dose Escalation Phase||3
6658165|NCT02477215|7588738|FG001|COMPLETED|Dose Escalation Phase||6
6658166|NCT02477215|7588739|FG002|COMPLETED|Dose Escalation Phase||6
6658167|NCT02477215|7588737|FG000|NOT COMPLETED|Dose Escalation Phase||1
6658168|NCT02477215|7588738|FG001|NOT COMPLETED|Dose Escalation Phase||2
6658169|NCT02477215|7588739|FG002|NOT COMPLETED|Dose Escalation Phase||0
6658170|NCT02477215|7588737|FG000|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
6658171|NCT02477215|7588738|FG001|STARTED|Fixed Dose Phase|Subjects in Period 1 did not continue into Period 2. This is a new subject population.|20
6658172|NCT02477215|7588739|FG002|STARTED|Fixed Dose Phase|No subjects were started in this group as it was not the optimal dose.|0
6658173|NCT02477215|7588737|FG000|COMPLETED|Fixed Dose Phase||0
6658174|NCT02477215|7588738|FG001|COMPLETED|Fixed Dose Phase||13
6658175|NCT02477215|7588739|FG002|COMPLETED|Fixed Dose Phase||0
6658176|NCT02477215|7588737|FG000|NOT COMPLETED|Fixed Dose Phase||0
6658177|NCT02477215|7588738|FG001|NOT COMPLETED|Fixed Dose Phase||7
6658178|NCT02477215|7588739|FG002|NOT COMPLETED|Fixed Dose Phase||0
6658179|NCT02477319|7588754|FG000|STARTED|Overall Study||55
6658180|NCT02477319|7588755|FG001|STARTED|Overall Study||40
6658181|NCT02477319|7588756|FG002|STARTED|Overall Study||164
6658182|NCT02477319|7588757|FG003|STARTED|Overall Study||193
6658183|NCT02477319|7588754|FG000|COMPLETED|Overall Study||55
6658184|NCT02477319|7588755|FG001|COMPLETED|Overall Study||37
6658185|NCT02477319|7588756|FG002|COMPLETED|Overall Study||149
6658186|NCT02477319|7588757|FG003|COMPLETED|Overall Study||171
6658187|NCT02477319|7588754|FG000|NOT COMPLETED|Overall Study||0
6574699|NCT02860039|7498788|FG001|COMPLETED|Overall Study||82
6574700|NCT02860039|7498787|FG000|NOT COMPLETED|Overall Study||11
6574701|NCT02860039|7498788|FG001|NOT COMPLETED|Overall Study||4
6574702|NCT02743728|7498794|FG000|STARTED|Overall Study||20
6574703|NCT02743728|7498794|FG000|COMPLETED|Overall Study||20
6574704|NCT02743728|7498794|FG000|NOT COMPLETED|Overall Study||0
6574705|NCT02482389|7498798|FG000|STARTED|Overall Study||3
6574706|NCT02482389|7498798|FG000|COMPLETED|Overall Study||3
6574707|NCT02482389|7498798|FG000|NOT COMPLETED|Overall Study||0
6574708|NCT02362503|7498805|FG000|STARTED|Double-blind Period-Up to 8 Days||69
6574709|NCT02362503|7498806|FG001|STARTED|Double-blind Period-Up to 8 Days||203
6574710|NCT02362503|7498807|FG002|STARTED|Double-blind Period-Up to 8 Days||0
6574711|NCT02362503|7498805|FG000|COMPLETED|Double-blind Period-Up to 8 Days||68
6574712|NCT02362503|7498806|FG001|COMPLETED|Double-blind Period-Up to 8 Days||199
6574713|NCT02362503|7498807|FG002|COMPLETED|Double-blind Period-Up to 8 Days||0
6574714|NCT02362503|7498805|FG000|NOT COMPLETED|Double-blind Period-Up to 8 Days||1
6574715|NCT02362503|7498806|FG001|NOT COMPLETED|Double-blind Period-Up to 8 Days||4
6574716|NCT02362503|7498807|FG002|NOT COMPLETED|Double-blind Period-Up to 8 Days||0
6574717|NCT02362503|7498805|FG000|STARTED|Open Label Period-Up to 96 Weeks||68
6574718|NCT02362503|7498806|FG001|STARTED|Open Label Period-Up to 96 Weeks||199
6574719|NCT02362503|7498807|FG002|STARTED|Open Label Period-Up to 96 Weeks||99
6574720|NCT02362503|7498805|FG000|COMPLETED|Open Label Period-Up to 96 Weeks||0
6574721|NCT02362503|7498806|FG001|COMPLETED|Open Label Period-Up to 96 Weeks||0
6574722|NCT02362503|7498807|FG002|COMPLETED|Open Label Period-Up to 96 Weeks||0
6574723|NCT02362503|7498805|FG000|NOT COMPLETED|Open Label Period-Up to 96 Weeks||68
6574724|NCT02362503|7498806|FG001|NOT COMPLETED|Open Label Period-Up to 96 Weeks||199
6574725|NCT02362503|7498807|FG002|NOT COMPLETED|Open Label Period-Up to 96 Weeks||99
6574726|NCT02288247|7498818|FG000|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||688
6574727|NCT02288247|7498819|FG001|STARTED|Period 1: OL Treatment (Max: 315 Weeks)||0
6574728|NCT02288247|7498818|FG000|Treated|Period 1: OL Treatment (Max: 315 Weeks)||687
6574729|NCT02288247|7498819|FG001|Treated|Period 1: OL Treatment (Max: 315 Weeks)||0
6574730|NCT02288247|7498818|FG000|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||41
6574731|NCT02288247|7498819|FG001|COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
6574732|NCT02288247|7498818|FG000|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||647
6574733|NCT02288247|7498819|FG001|NOT COMPLETED|Period 1: OL Treatment (Max: 315 Weeks)||0
6574734|NCT02288247|7498818|FG000|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|137 participants from period 1 were randomized to period 2.|137
6574735|NCT02288247|7498819|FG001|STARTED|Period 2: DB Treatment (Max: 180 Weeks)|136 participants from period 1 were randomized to period 2.|136
6574736|NCT02288247|7498818|FG000|Treated|Period 2: DB Treatment (Max: 180 Weeks)||136
6574737|NCT02288247|7498819|FG001|Treated|Period 2: DB Treatment (Max: 180 Weeks)||135
6574738|NCT02288247|7498818|FG000|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
6574739|NCT02288247|7498819|FG001|COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||1
6574740|NCT02288247|7498818|FG000|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||136
6574741|NCT02288247|7498819|FG001|NOT COMPLETED|Period 2: DB Treatment (Max: 180 Weeks)||135
6574742|NCT02232282|7498829|FG000|STARTED|Overall Study||10
6574743|NCT02232282|7498830|FG001|STARTED|Overall Study||12
6574744|NCT02232282|7498829|FG000|COMPLETED|Overall Study||10
6574745|NCT02232282|7498830|FG001|COMPLETED|Overall Study||11
6574746|NCT02232282|7498829|FG000|NOT COMPLETED|Overall Study||0
6574747|NCT02232282|7498830|FG001|NOT COMPLETED|Overall Study||1
6623843|NCT02211261|7551097|FG009|STARTED|Overall Study||16
6623844|NCT02211261|7551098|FG010|STARTED|Overall Study||8
6623845|NCT02211261|7551088|FG000|COMPLETED|Overall Study||9
6623846|NCT02211261|7551089|FG001|COMPLETED|Overall Study||6
6623847|NCT02211261|7551090|FG002|COMPLETED|Overall Study||5
6623848|NCT02211261|7551091|FG003|COMPLETED|Overall Study||6
6623849|NCT02211261|7551092|FG004|COMPLETED|Overall Study||7
6623850|NCT02211261|7551093|FG005|COMPLETED|Overall Study||1
6623851|NCT02211261|7551094|FG006|COMPLETED|Overall Study||6
6623852|NCT02211261|7551095|FG007|COMPLETED|Overall Study||7
6623853|NCT02211261|7551096|FG008|COMPLETED|Overall Study||8
6623854|NCT02211261|7551097|FG009|COMPLETED|Overall Study||14
6623855|NCT02211261|7551098|FG010|COMPLETED|Overall Study||8
6623856|NCT02211261|7551088|FG000|NOT COMPLETED|Overall Study||0
6623857|NCT02211261|7551089|FG001|NOT COMPLETED|Overall Study||0
6623858|NCT02211261|7551090|FG002|NOT COMPLETED|Overall Study||1
6623859|NCT02211261|7551091|FG003|NOT COMPLETED|Overall Study||0
6623860|NCT02211261|7551092|FG004|NOT COMPLETED|Overall Study||2
6623861|NCT02211261|7551093|FG005|NOT COMPLETED|Overall Study||1
6623862|NCT02211261|7551094|FG006|NOT COMPLETED|Overall Study||0
6623863|NCT02211261|7551095|FG007|NOT COMPLETED|Overall Study||1
6623864|NCT02211261|7551096|FG008|NOT COMPLETED|Overall Study||0
6623865|NCT02211261|7551097|FG009|NOT COMPLETED|Overall Study||2
6623866|NCT02211261|7551098|FG010|NOT COMPLETED|Overall Study||0
6623867|NCT02211313|7551133|FG000|STARTED|Overall Study||18
6623868|NCT02211313|7551134|FG001|STARTED|Overall Study||23
6623869|NCT02211313|7551133|FG000|COMPLETED|Overall Study||12
6623870|NCT02211313|7551134|FG001|COMPLETED|Overall Study||20
6623871|NCT02211313|7551133|FG000|NOT COMPLETED|Overall Study||6
6623872|NCT02211313|7551134|FG001|NOT COMPLETED|Overall Study||3
6623873|NCT02211456|7551140|FG000|STARTED|Overall Study||15
6623874|NCT02211456|7551140|FG000|COMPLETED|Overall Study||15
6623875|NCT02211456|7551140|FG000|NOT COMPLETED|Overall Study||0
6623876|NCT02211495|7551146|FG000|STARTED|Overall Study||4
6623877|NCT02211495|7551147|FG001|STARTED|Overall Study||4
6623878|NCT02211495|7551146|FG000|COMPLETED|Overall Study||4
6623879|NCT02211495|7551147|FG001|COMPLETED|Overall Study||4
6623880|NCT02211495|7551146|FG000|NOT COMPLETED|Overall Study||0
6623881|NCT02211495|7551147|FG001|NOT COMPLETED|Overall Study||0
6623882|NCT02211534|7551159|FG000|STARTED|Overall Study||24
6623883|NCT02211534|7551160|FG001|STARTED|Overall Study||11
6623884|NCT02211534|7551159|FG000|COMPLETED|Overall Study||11
6623885|NCT02211534|7551160|FG001|COMPLETED|Overall Study||6
6623886|NCT02211534|7551159|FG000|NOT COMPLETED|Overall Study||13
6623887|NCT02211534|7551160|FG001|NOT COMPLETED|Overall Study||5
6623888|NCT02211638|7551166|FG000|STARTED|Overall Study||18113
6623889|NCT02211638|7551166|FG000|COMPLETED|Overall Study||17130
6623890|NCT02211638|7551166|FG000|NOT COMPLETED|Overall Study||983
6623891|NCT02212028|7551172|FG000|STARTED|Overall Study||26
6623892|NCT02212028|7551173|FG001|STARTED|Overall Study||26
6623893|NCT02212028|7551172|FG000|COMPLETED|Overall Study||26
6623894|NCT02212028|7551173|FG001|COMPLETED|Overall Study||26
6623895|NCT02212028|7551172|FG000|NOT COMPLETED|Overall Study||0
6623896|NCT02212028|7551173|FG001|NOT COMPLETED|Overall Study||0
6623897|NCT02212106|7551181|FG000|STARTED|Overall Study||302
6623898|NCT02212106|7551182|FG001|STARTED|Overall Study||100
6623899|NCT02212106|7551181|FG000|COMPLETED|Overall Study||292
6574748|NCT01492361|7498842|FG000|STARTED|Overall Study||4089
6574749|NCT01492361|7498843|FG001|STARTED|Overall Study||4090
6574750|NCT01492361|7498842|FG000|Completed Final Visit|Overall Study||3419
6574751|NCT01492361|7498843|FG001|Completed Final Visit|Overall Study||3335
6574752|NCT01492361|7498842|FG000|Death Before Final Visit|Overall Study||265
6574753|NCT01492361|7498843|FG001|Death Before Final Visit|Overall Study||295
6574754|NCT01492361|7498842|FG000|COMPLETED|Overall Study||3684
6574755|NCT01492361|7498843|FG001|COMPLETED|Overall Study||3630
6574756|NCT01492361|7498842|FG000|NOT COMPLETED|Overall Study||405
6574757|NCT01492361|7498843|FG001|NOT COMPLETED|Overall Study||460
6574758|NCT01296711|7498857|FG000|STARTED|Overall Study||20
6574759|NCT01296711|7498858|FG001|STARTED|Overall Study||20
6574760|NCT01296711|7498859|FG002|STARTED|Overall Study||21
6574761|NCT01296711|7498860|FG003|STARTED|Overall Study||20
6574762|NCT01296711|7498861|FG004|STARTED|Overall Study||17
6574763|NCT01296711|7498862|FG005|STARTED|Overall Study||16
6574764|NCT01296711|7498863|FG006|STARTED|Overall Study||40
6574765|NCT01296711|7498864|FG007|STARTED|Overall Study||36
6574766|NCT01296711|7498857|FG000|COMPLETED|Overall Study||4
6574767|NCT01296711|7498858|FG001|COMPLETED|Overall Study||12
6574768|NCT01296711|7498859|FG002|COMPLETED|Overall Study||8
6574769|NCT01296711|7498860|FG003|COMPLETED|Overall Study||7
6574770|NCT01296711|7498861|FG004|COMPLETED|Overall Study||7
6574771|NCT01296711|7498862|FG005|COMPLETED|Overall Study||5
6574772|NCT01296711|7498863|FG006|COMPLETED|Overall Study||9
6574773|NCT01296711|7498864|FG007|COMPLETED|Overall Study||15
6574774|NCT01296711|7498857|FG000|NOT COMPLETED|Overall Study||16
6574775|NCT01296711|7498858|FG001|NOT COMPLETED|Overall Study||8
6574776|NCT01296711|7498859|FG002|NOT COMPLETED|Overall Study||13
6574777|NCT01296711|7498860|FG003|NOT COMPLETED|Overall Study||13
6574778|NCT01296711|7498861|FG004|NOT COMPLETED|Overall Study||10
6574779|NCT01296711|7498862|FG005|NOT COMPLETED|Overall Study||11
6574780|NCT01296711|7498863|FG006|NOT COMPLETED|Overall Study||31
6574781|NCT01296711|7498864|FG007|NOT COMPLETED|Overall Study||21
6574782|NCT00084656|7498885|FG000|STARTED|Overall Study||25
6574783|NCT00084656|7498886|FG001|STARTED|Overall Study||25
6574784|NCT00084656|7498887|FG002|STARTED|Overall Study||26
6574785|NCT00084656|7498885|FG000|COMPLETED|Overall Study||0
6574786|NCT00084656|7498886|FG001|COMPLETED|Overall Study||0
6574787|NCT00084656|7498887|FG002|COMPLETED|Overall Study||0
6574788|NCT00084656|7498885|FG000|NOT COMPLETED|Overall Study||25
6574789|NCT00084656|7498886|FG001|NOT COMPLETED|Overall Study||25
6574790|NCT00084656|7498887|FG002|NOT COMPLETED|Overall Study||26
6574791|NCT01879735|7498899|FG000|STARTED|Overall Study||6
6574792|NCT01879735|7498900|FG001|STARTED|Overall Study||16
6574793|NCT01879735|7498899|FG000|COMPLETED|Overall Study||6
6574794|NCT01879735|7498900|FG001|COMPLETED|Overall Study||16
6574795|NCT01879735|7498899|FG000|NOT COMPLETED|Overall Study||0
6574796|NCT01879735|7498900|FG001|NOT COMPLETED|Overall Study||0
6574797|NCT01879800|7498908|FG000|STARTED|Overall Study||14
6574798|NCT01879800|7498909|FG001|STARTED|Overall Study||30
6574799|NCT01879800|7498908|FG000|COMPLETED|Overall Study||14
6574800|NCT01879800|7498909|FG001|COMPLETED|Overall Study||26
6574801|NCT01879800|7498908|FG000|NOT COMPLETED|Overall Study||0
6574802|NCT01879800|7498909|FG001|NOT COMPLETED|Overall Study||4
6574803|NCT01879826|7498917|FG000|STARTED|Overall Study||41
6574804|NCT01879826|7498918|FG001|STARTED|Overall Study||40
6574805|NCT01879826|7498917|FG000|COMPLETED|Overall Study||41
6574806|NCT01879826|7498918|FG001|COMPLETED|Overall Study||40
6574807|NCT01879826|7498917|FG000|NOT COMPLETED|Overall Study||0
6574808|NCT01879826|7498918|FG001|NOT COMPLETED|Overall Study||0
6574809|NCT01879852|7498926|FG000|STARTED|Overall Study||14
6574810|NCT01879852|7498927|FG001|STARTED|Overall Study||13
6574811|NCT01879852|7498926|FG000|COMPLETED|Overall Study||12
6574812|NCT01879852|7498927|FG001|COMPLETED|Overall Study||13
6574813|NCT01879852|7498926|FG000|NOT COMPLETED|Overall Study||2
6574814|NCT01879852|7498927|FG001|NOT COMPLETED|Overall Study||0
6574815|NCT01880047|7498937|FG000|STARTED|Weeks 0-2||17
6574816|NCT01880047|7498938|FG001|STARTED|Weeks 0-2||9
6574817|NCT01880047|7498939|FG002|STARTED|Weeks 0-2||5
6574818|NCT01880047|7498940|FG003|STARTED|Weeks 0-2||3
6574819|NCT01880047|7498937|FG000|COMPLETED|Weeks 0-2||17
6574820|NCT01880047|7498938|FG001|COMPLETED|Weeks 0-2||8
6574821|NCT01880047|7498939|FG002|COMPLETED|Weeks 0-2||4
6574822|NCT01880047|7498940|FG003|COMPLETED|Weeks 0-2||2
6574823|NCT01880047|7498937|FG000|NOT COMPLETED|Weeks 0-2||0
6574824|NCT01880047|7498938|FG001|NOT COMPLETED|Weeks 0-2||1
6574825|NCT01880047|7498939|FG002|NOT COMPLETED|Weeks 0-2||1
6574826|NCT01880047|7498940|FG003|NOT COMPLETED|Weeks 0-2||1
6574827|NCT01880047|7498937|FG000|STARTED|Weeks 3-4||17
6574828|NCT01880047|7498938|FG001|STARTED|Weeks 3-4||8
6574829|NCT01880047|7498939|FG002|STARTED|Weeks 3-4||4
6574830|NCT01880047|7498940|FG003|STARTED|Weeks 3-4||2
6574831|NCT01880047|7498937|FG000|COMPLETED|Weeks 3-4||17
6574832|NCT01880047|7498938|FG001|COMPLETED|Weeks 3-4||7
6574833|NCT01880047|7498939|FG002|COMPLETED|Weeks 3-4||4
6574834|NCT01880047|7498940|FG003|COMPLETED|Weeks 3-4||2
6574835|NCT01880047|7498937|FG000|NOT COMPLETED|Weeks 3-4||0
6574836|NCT01880047|7498938|FG001|NOT COMPLETED|Weeks 3-4||1
6574837|NCT01880047|7498939|FG002|NOT COMPLETED|Weeks 3-4||0
6574838|NCT01880047|7498940|FG003|NOT COMPLETED|Weeks 3-4||0
6574839|NCT01880047|7498937|FG000|STARTED|Weeks 5-8||17
6574840|NCT01880047|7498938|FG001|STARTED|Weeks 5-8||7
6574841|NCT01880047|7498939|FG002|STARTED|Weeks 5-8||4
6574842|NCT01880047|7498940|FG003|STARTED|Weeks 5-8||2
6574843|NCT01880047|7498937|FG000|COMPLETED|Weeks 5-8||15
6574844|NCT01880047|7498938|FG001|COMPLETED|Weeks 5-8||6
6574845|NCT01880047|7498939|FG002|COMPLETED|Weeks 5-8||4
6574846|NCT01880047|7498940|FG003|COMPLETED|Weeks 5-8||2
6574847|NCT01880047|7498937|FG000|NOT COMPLETED|Weeks 5-8||2
6574848|NCT01880047|7498938|FG001|NOT COMPLETED|Weeks 5-8||1
6574849|NCT01880047|7498939|FG002|NOT COMPLETED|Weeks 5-8||0
6574850|NCT01880047|7498940|FG003|NOT COMPLETED|Weeks 5-8||0
6574851|NCT01880047|7498937|FG000|STARTED|Extension Phase - 18 Months|15 subjects went into extension phase, were followed for variable periods of time|15
6574852|NCT01880047|7498938|FG001|STARTED|Extension Phase - 18 Months|6 subjects went into extension phase, were followed for variable periods of time|6
6574853|NCT01880047|7498939|FG002|STARTED|Extension Phase - 18 Months|4 subjects went into extension phase, were followed for variable periods of time|4
6574854|NCT01880047|7498940|FG003|STARTED|Extension Phase - 18 Months|2 subjects went into extension phase, were followed for variable periods of time|2
6574855|NCT01880047|7498937|FG000|COMPLETED|Extension Phase - 18 Months||6
6574856|NCT01880047|7498938|FG001|COMPLETED|Extension Phase - 18 Months||3
6574857|NCT01880047|7498939|FG002|COMPLETED|Extension Phase - 18 Months||3
6574858|NCT01880047|7498940|FG003|COMPLETED|Extension Phase - 18 Months||0
6574859|NCT01880047|7498937|FG000|NOT COMPLETED|Extension Phase - 18 Months||9
6574860|NCT01880047|7498938|FG001|NOT COMPLETED|Extension Phase - 18 Months||3
6574861|NCT01880047|7498939|FG002|NOT COMPLETED|Extension Phase - 18 Months||1
6574862|NCT01880047|7498940|FG003|NOT COMPLETED|Extension Phase - 18 Months||2
6574863|NCT01880073|7498957|FG000|STARTED|Overall Study||24
6574864|NCT01880073|7498957|FG000|COMPLETED|Overall Study||24
6574865|NCT01880073|7498957|FG000|NOT COMPLETED|Overall Study||0
6574866|NCT01880086|7498963|FG000|STARTED|Overall Study||6
6574867|NCT01880086|7498964|FG001|STARTED|Overall Study||7
6574868|NCT01880086|7498963|FG000|COMPLETED|Overall Study||5
6574869|NCT01880086|7498964|FG001|COMPLETED|Overall Study||6
6574870|NCT01880086|7498963|FG000|NOT COMPLETED|Overall Study||1
6574871|NCT01880086|7498964|FG001|NOT COMPLETED|Overall Study||1
6574872|NCT01880099|7498973|FG000|STARTED|Overall Study||17
6574873|NCT01880099|7498974|FG001|STARTED|Overall Study||21
6574874|NCT01880099|7498975|FG002|STARTED|Overall Study||22
6574875|NCT01880099|7498973|FG000|COMPLETED|Overall Study||9
6574876|NCT01880099|7498974|FG001|COMPLETED|Overall Study||11
6574877|NCT01880099|7498975|FG002|COMPLETED|Overall Study||15
6574878|NCT01880099|7498973|FG000|NOT COMPLETED|Overall Study||8
6574879|NCT01880099|7498974|FG001|NOT COMPLETED|Overall Study||10
6574880|NCT01880099|7498975|FG002|NOT COMPLETED|Overall Study||7
6574881|NCT01880320|7498986|FG000|STARTED|Overall Study||217
6574882|NCT01880320|7498987|FG001|STARTED|Overall Study||217
6574883|NCT01880320|7498988|FG002|STARTED|Overall Study||69
6574884|NCT01880320|7498986|FG000|COMPLETED|Overall Study||197
6574885|NCT01880320|7498987|FG001|COMPLETED|Overall Study||192
6574886|NCT01880320|7498988|FG002|COMPLETED|Overall Study||61
6574887|NCT01880320|7498986|FG000|NOT COMPLETED|Overall Study||20
6574888|NCT01880320|7498987|FG001|NOT COMPLETED|Overall Study||25
6574889|NCT01880320|7498988|FG002|NOT COMPLETED|Overall Study||8
6574890|NCT01880424|7498998|FG000|STARTED|Overall Study||417
6574891|NCT01880424|7498999|FG001|STARTED|Overall Study||422
6574892|NCT01880424|7498998|FG000|COMPLETED|Overall Study||384
6574893|NCT01880424|7498999|FG001|COMPLETED|Overall Study||367
6574894|NCT01880424|7498998|FG000|NOT COMPLETED|Overall Study||33
6574895|NCT01880424|7498999|FG001|NOT COMPLETED|Overall Study||55
6574896|NCT01880437|7499008|FG000|STARTED|Overall Study||15
6574897|NCT01880437|7499009|FG001|STARTED|Overall Study||4
6574898|NCT01880437|7499010|FG002|STARTED|Overall Study||19
6574899|NCT01880437|7499008|FG000|COMPLETED|Overall Study||0
6574900|NCT01880437|7499009|FG001|COMPLETED|Overall Study||0
6574901|NCT01880437|7499010|FG002|COMPLETED|Overall Study||0
6574902|NCT01880437|7499008|FG000|NOT COMPLETED|Overall Study||15
6574903|NCT01880437|7499009|FG001|NOT COMPLETED|Overall Study||4
6574904|NCT01880437|7499010|FG002|NOT COMPLETED|Overall Study||19
6574905|NCT01880515|7499022|FG000|STARTED|Overall Study||53
6574906|NCT01880515|7499023|FG001|STARTED|Overall Study||54
6574907|NCT01880515|7499022|FG000|COMPLETED|Overall Study||45
6574908|NCT01880515|7499023|FG001|COMPLETED|Overall Study||45
6574909|NCT01880515|7499022|FG000|NOT COMPLETED|Overall Study||8
6574910|NCT01880515|7499023|FG001|NOT COMPLETED|Overall Study||9
6574911|NCT01880528|7499032|FG000|STARTED|Overall Study||12
6574912|NCT01880528|7499033|FG001|STARTED|Overall Study||11
6574913|NCT01880528|7499032|FG000|COMPLETED|Overall Study||11
6574914|NCT01880528|7499033|FG001|COMPLETED|Overall Study||10
6574915|NCT01880528|7499032|FG000|NOT COMPLETED|Overall Study||1
6574916|NCT01880528|7499033|FG001|NOT COMPLETED|Overall Study||1
6574917|NCT01880554|7499039|FG000|STARTED|Overall Study|Patients enrolled in the study|68
6574918|NCT01880554|7499039|FG000|Population Eligible|Overall Study||58
6574919|NCT01880554|7499039|FG000|Population Eligible and Assessable|Overall Study||54
6574920|NCT01880554|7499039|FG000|COMPLETED|Overall Study|Patients eligible and assessable according to two-stage Simon's design (primary outcome)|52
6574921|NCT01880554|7499039|FG000|NOT COMPLETED|Overall Study||16
6574922|NCT01880593|7499046|FG000|STARTED|Overall Study||18
6574923|NCT01880593|7499047|FG001|STARTED|Overall Study||16
6574924|NCT01880593|7499046|FG000|COMPLETED|Overall Study||10
6574925|NCT01880593|7499047|FG001|COMPLETED|Overall Study||10
6574926|NCT01880593|7499046|FG000|NOT COMPLETED|Overall Study||8
6574927|NCT01880593|7499047|FG001|NOT COMPLETED|Overall Study||6
6574928|NCT01880697|7499055|FG000|STARTED|Overall Study||63
6574929|NCT01880697|7499056|FG001|STARTED|Overall Study||63
6574930|NCT01880697|7499055|FG000|COMPLETED|Overall Study||63
6574931|NCT01880697|7499056|FG001|COMPLETED|Overall Study||62
6574932|NCT01880697|7499055|FG000|NOT COMPLETED|Overall Study||0
6574933|NCT01880697|7499056|FG001|NOT COMPLETED|Overall Study||1
6574934|NCT01880723|7499064|FG000|STARTED|Overall Study||16
6574935|NCT01880723|7499065|FG001|STARTED|Overall Study||16
6574936|NCT01880723|7499064|FG000|COMPLETED|Overall Study||16
6574937|NCT01880723|7499065|FG001|COMPLETED|Overall Study||16
6574938|NCT01880723|7499064|FG000|NOT COMPLETED|Overall Study||0
6574939|NCT01880723|7499065|FG001|NOT COMPLETED|Overall Study||0
6574940|NCT01880736|7499075|FG000|STARTED|Overall Study||114
6574941|NCT01880736|7499076|FG001|STARTED|Overall Study||115
6574942|NCT01880736|7499077|FG002|STARTED|Overall Study||115
6574943|NCT01880736|7499078|FG003|STARTED|Overall Study||114
6574944|NCT01880736|7499075|FG000|COMPLETED|Overall Study||113
6574945|NCT01880736|7499076|FG001|COMPLETED|Overall Study||113
6574946|NCT01880736|7499077|FG002|COMPLETED|Overall Study||114
6574947|NCT01880736|7499078|FG003|COMPLETED|Overall Study||108
6574948|NCT01880736|7499075|FG000|NOT COMPLETED|Overall Study||1
6574949|NCT01880736|7499076|FG001|NOT COMPLETED|Overall Study||2
6574950|NCT01880736|7499077|FG002|NOT COMPLETED|Overall Study||1
6574951|NCT01880736|7499078|FG003|NOT COMPLETED|Overall Study||6
6574952|NCT01880840|7499090|FG000|STARTED|Overall Study||95
6574953|NCT01880840|7499091|FG001|STARTED|Overall Study||96
6574954|NCT01880840|7499090|FG000|COMPLETED|Overall Study||87
6574955|NCT01880840|7499091|FG001|COMPLETED|Overall Study||91
6574956|NCT01880840|7499090|FG000|NOT COMPLETED|Overall Study||8
6574957|NCT01880840|7499091|FG001|NOT COMPLETED|Overall Study||5
6574958|NCT01881009|7499099|FG000|STARTED|Inpatient Safety Testing (22 Hours)||16
6574959|NCT01881009|7499100|FG001|STARTED|Inpatient Safety Testing (22 Hours)||0
6574960|NCT01881009|7499099|FG000|COMPLETED|Inpatient Safety Testing (22 Hours)||16
6574961|NCT01881009|7499100|FG001|COMPLETED|Inpatient Safety Testing (22 Hours)||0
6574962|NCT01881009|7499099|FG000|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
6574963|NCT01881009|7499100|FG001|NOT COMPLETED|Inpatient Safety Testing (22 Hours)||0
6574964|NCT01881009|7499099|FG000|STARTED|Summer Camp Session (6 Days)||0
6574965|NCT01881009|7499100|FG001|STARTED|Summer Camp Session (6 Days)||22
6574966|NCT01881009|7499099|FG000|COMPLETED|Summer Camp Session (6 Days)||0
6574967|NCT01881009|7499100|FG001|COMPLETED|Summer Camp Session (6 Days)||21
6574968|NCT01881009|7499099|FG000|NOT COMPLETED|Summer Camp Session (6 Days)||0
6574969|NCT01881009|7499100|FG001|NOT COMPLETED|Summer Camp Session (6 Days)||1
6574970|NCT01881087|7499110|FG000|STARTED|Overall Study||60
6574971|NCT01881087|7499111|FG001|STARTED|Overall Study||61
6574972|NCT01881087|7499112|FG002|STARTED|Overall Study||62
6574973|NCT01881087|7499110|FG000|COMPLETED|Overall Study||59
6574974|NCT01881087|7499111|FG001|COMPLETED|Overall Study||61
6574975|NCT01881087|7499112|FG002|COMPLETED|Overall Study||60
6574976|NCT01881087|7499110|FG000|NOT COMPLETED|Overall Study||1
6574977|NCT01881087|7499111|FG001|NOT COMPLETED|Overall Study||0
6574978|NCT01881087|7499112|FG002|NOT COMPLETED|Overall Study||2
6574979|NCT01881113|7499122|FG000|STARTED|Overall Study||51
6574980|NCT01881113|7499123|FG001|STARTED|Overall Study||50
6574981|NCT01881113|7499122|FG000|COMPLETED|Overall Study||43
6574982|NCT01881113|7499123|FG001|COMPLETED|Overall Study||44
6574983|NCT01881113|7499122|FG000|NOT COMPLETED|Overall Study||8
6574984|NCT01881113|7499123|FG001|NOT COMPLETED|Overall Study||6
6574985|NCT01881126|7499131|FG000|STARTED|Overall Study||47
6574986|NCT01881126|7499132|FG001|STARTED|Overall Study||46
6574987|NCT01881126|7499131|FG000|COMPLETED|Overall Study||46
6574988|NCT01881126|7499132|FG001|COMPLETED|Overall Study||44
6574989|NCT01881126|7499131|FG000|NOT COMPLETED|Overall Study||1
6574990|NCT01881126|7499132|FG001|NOT COMPLETED|Overall Study||2
6574991|NCT01881230|7499141|FG000|STARTED|Overall Study||61
6574992|NCT01881230|7499142|FG001|STARTED|Overall Study||64
6574993|NCT01881230|7499143|FG002|STARTED|Overall Study||66
6574994|NCT01881230|7499141|FG000|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of Investigational Product (IP)|60
6574995|NCT01881230|7499142|FG001|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
6574996|NCT01881230|7499143|FG002|Safety Population|Overall Study|Safety Population = randomized who received at least 1 dose of IP|64
6574997|NCT01881230|7499141|FG000|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|60
6574998|NCT01881230|7499142|FG001|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
6574999|NCT01881230|7499143|FG002|Treatment Discontinued|Overall Study|Treatment Duration=PD, toxicity, radiation/removal of lesions, consent withdrawal, doctor decision|64
6575000|NCT01881230|7499141|FG000|COMPLETED|Overall Study|Not applicable according to the study design|0
6575001|NCT01881230|7499142|FG001|COMPLETED|Overall Study|Not applicable according to the study design|0
6575002|NCT01881230|7499143|FG002|COMPLETED|Overall Study|Not applicable according to the study design|0
6575003|NCT01881230|7499141|FG000|NOT COMPLETED|Overall Study||61
6575004|NCT01881230|7499142|FG001|NOT COMPLETED|Overall Study||64
6575005|NCT01881230|7499143|FG002|NOT COMPLETED|Overall Study||66
6575006|NCT01881373|7499154|FG000|STARTED|Baseline|Cross-sectional sample|1517
6575007|NCT01881373|7499155|FG001|STARTED|Baseline|Cross-sectional sample|1491
6575008|NCT01881373|7499156|FG002|STARTED|Baseline|Cross-sectional sample|1321
6575009|NCT01881373|7499154|FG000|COMPLETED|Baseline|Cross-sectional sample|1517
6575010|NCT01881373|7499155|FG001|COMPLETED|Baseline|Cross-sectional sample|1491
6575011|NCT01881373|7499156|FG002|COMPLETED|Baseline|Cross-sectional sample|1321
6575012|NCT01881373|7499154|FG000|NOT COMPLETED|Baseline||0
6575013|NCT01881373|7499155|FG001|NOT COMPLETED|Baseline||0
6575014|NCT01881373|7499156|FG002|NOT COMPLETED|Baseline||0
6575015|NCT01881373|7499154|FG000|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
6575016|NCT01881373|7499155|FG001|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
6575017|NCT01881373|7499156|FG002|STARTED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
6575018|NCT01881373|7499154|FG000|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1342
6575019|NCT01881373|7499155|FG001|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1295
6575020|NCT01881373|7499156|FG002|COMPLETED|24 Months|Cross-sectional sample, independent of sample at baseline|1405
6575021|NCT01881373|7499154|FG000|NOT COMPLETED|24 Months||0
6575022|NCT01881373|7499155|FG001|NOT COMPLETED|24 Months||0
6575023|NCT01881373|7499156|FG002|NOT COMPLETED|24 Months||0
6575024|NCT01881412|7499170|FG000|STARTED|Overall Study||59
6575025|NCT01881412|7499171|FG001|STARTED|Overall Study||59
6575026|NCT01881412|7499170|FG000|COMPLETED|Overall Study||49
6575027|NCT01881412|7499171|FG001|COMPLETED|Overall Study||57
6575028|NCT01881412|7499170|FG000|NOT COMPLETED|Overall Study||10
6575029|NCT01881412|7499171|FG001|NOT COMPLETED|Overall Study||2
6575030|NCT01881620|7499177|FG000|STARTED|Overall Study||109
6575031|NCT01881620|7499177|FG000|COMPLETED|Overall Study|Eligible patients with PET-CT scanner performed AND interpretation of 2 pairs of observors available|105
6575032|NCT01881620|7499177|FG000|NOT COMPLETED|Overall Study||4
6575033|NCT01881737|7499181|FG000|STARTED|Overall Study|This is a pilot study|15
6575034|NCT01881737|7499181|FG000|Number Screened|Overall Study||15
6575035|NCT01881737|7499181|FG000|COMPLETED|Overall Study||10
6575036|NCT01881737|7499181|FG000|NOT COMPLETED|Overall Study||5
6575037|NCT01881750|7499189|FG000|STARTED|Overall Study||27
6575038|NCT01881750|7499190|FG001|STARTED|Overall Study||26
6575039|NCT01881750|7499189|FG000|COMPLETED|Overall Study||25
6575040|NCT01881750|7499190|FG001|COMPLETED|Overall Study||22
6575041|NCT01881750|7499189|FG000|NOT COMPLETED|Overall Study||2
6575042|NCT01881750|7499190|FG001|NOT COMPLETED|Overall Study||4
6575043|NCT01881776|7499201|FG000|STARTED|Overall Study||24
6575044|NCT01881776|7499202|FG001|STARTED|Overall Study||24
6575045|NCT01881776|7499203|FG002|STARTED|Overall Study||22
6575046|NCT01881776|7499201|FG000|COMPLETED|Overall Study||23
6575047|NCT01881776|7499202|FG001|COMPLETED|Overall Study||20
6575048|NCT01881776|7499203|FG002|COMPLETED|Overall Study||20
6575049|NCT01881776|7499201|FG000|NOT COMPLETED|Overall Study||1
6575050|NCT01881776|7499202|FG001|NOT COMPLETED|Overall Study||4
6575051|NCT01881776|7499203|FG002|NOT COMPLETED|Overall Study||2
6575052|NCT01881789|7499217|FG000|STARTED|Overall Study||3
6575053|NCT01881789|7499218|FG001|STARTED|Overall Study||7
6575054|NCT01881789|7499219|FG002|STARTED|Overall Study||3
6575055|NCT01881789|7499220|FG003|STARTED|Overall Study||3
6575056|NCT01881789|7499221|FG004|STARTED|Overall Study||2
6575057|NCT01881789|7499222|FG005|STARTED|Overall Study||3
6575058|NCT01881789|7499217|FG000|COMPLETED|Overall Study||0
6575059|NCT01881789|7499218|FG001|COMPLETED|Overall Study||0
6575060|NCT01881789|7499219|FG002|COMPLETED|Overall Study||0
6575061|NCT01881789|7499220|FG003|COMPLETED|Overall Study||0
6575062|NCT01881789|7499221|FG004|COMPLETED|Overall Study||0
6575063|NCT01881789|7499222|FG005|COMPLETED|Overall Study||0
6575064|NCT01881789|7499217|FG000|NOT COMPLETED|Overall Study||3
6575065|NCT01881789|7499218|FG001|NOT COMPLETED|Overall Study||7
6575066|NCT01881789|7499219|FG002|NOT COMPLETED|Overall Study||3
6575067|NCT01881789|7499220|FG003|NOT COMPLETED|Overall Study||3
6575068|NCT01881789|7499221|FG004|NOT COMPLETED|Overall Study||2
6575069|NCT01881789|7499222|FG005|NOT COMPLETED|Overall Study||3
6575070|NCT01881828|7499239|FG000|STARTED|Overall Study|23 excluded at randomization from enrollment|71
6575071|NCT01881828|7499240|FG001|STARTED|Overall Study|23 excluded from randomization from enrollment|69
6575072|NCT01881828|7499239|FG000|COMPLETED|Overall Study||71
6575073|NCT01881828|7499240|FG001|COMPLETED|Overall Study||69
6575074|NCT01881828|7499239|FG000|NOT COMPLETED|Overall Study||0
6575075|NCT01881828|7499240|FG001|NOT COMPLETED|Overall Study||0
6575076|NCT01881867|7499248|FG000|STARTED|Overall Study||26
6575077|NCT01881867|7499249|FG001|STARTED|Overall Study||28
6575078|NCT01881867|7499248|FG000|COMPLETED|Overall Study||14
6575079|NCT01881867|7499249|FG001|COMPLETED|Overall Study||15
6575080|NCT01881867|7499248|FG000|NOT COMPLETED|Overall Study||12
6575081|NCT01881867|7499249|FG001|NOT COMPLETED|Overall Study||13
6575082|NCT01882062|7499257|FG000|STARTED|Overall Study|16th of may 2013|10
6575083|NCT01882062|7499257|FG000|COMPLETED|Overall Study|18th of july 2013|10
6575084|NCT01882062|7499257|FG000|NOT COMPLETED|Overall Study||0
6575085|NCT01882088|7499261|FG000|STARTED|Overall Study|35 patients were provided with psyllium in 5.0 sachets, 3 sachets per day for 10 days|35
6575086|NCT01882088|7499261|FG000|COMPLETED|Overall Study||30
6575087|NCT01882088|7499261|FG000|NOT COMPLETED|Overall Study||5
6575088|NCT01882257|7499268|FG000|STARTED|Study Origination to Beginning Therapy||11
6575089|NCT01882257|7499269|FG001|STARTED|Study Origination to Beginning Therapy||40
6575090|NCT01882257|7499270|FG002|STARTED|Study Origination to Beginning Therapy||23
6575091|NCT01882257|7499268|FG000|Started Therapy Using Device|Study Origination to Beginning Therapy||11
6575092|NCT01882257|7499269|FG001|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
6623900|NCT02212106|7551182|FG001|COMPLETED|Overall Study||96
6575093|NCT01882257|7499270|FG002|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
6575094|NCT01882257|7499268|FG000|COMPLETED|Study Origination to Beginning Therapy||11
6575095|NCT01882257|7499269|FG001|COMPLETED|Study Origination to Beginning Therapy||38
6575096|NCT01882257|7499270|FG002|COMPLETED|Study Origination to Beginning Therapy||22
6575097|NCT01882257|7499268|FG000|NOT COMPLETED|Study Origination to Beginning Therapy||0
6575098|NCT01882257|7499269|FG001|NOT COMPLETED|Study Origination to Beginning Therapy||2
6575099|NCT01882257|7499270|FG002|NOT COMPLETED|Study Origination to Beginning Therapy||1
6575100|NCT01882257|7499268|FG000|STARTED|Therapy Portion of Study (12 Months)||11
6575101|NCT01882257|7499269|FG001|STARTED|Therapy Portion of Study (12 Months)||38
6575102|NCT01882257|7499270|FG002|STARTED|Therapy Portion of Study (12 Months)||22
6575103|NCT01882257|7499268|FG000|COMPLETED|Therapy Portion of Study (12 Months)||11
6575104|NCT01882257|7499269|FG001|COMPLETED|Therapy Portion of Study (12 Months)||27
6575105|NCT01882257|7499270|FG002|COMPLETED|Therapy Portion of Study (12 Months)||18
6575106|NCT01882257|7499268|FG000|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
6575107|NCT01882257|7499269|FG001|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
6575108|NCT01882257|7499270|FG002|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
6575109|NCT01882413|7499277|FG000|STARTED|Overall Study||204
6575110|NCT01882413|7499277|FG000|COMPLETED|Overall Study||204
6575111|NCT01882413|7499277|FG000|NOT COMPLETED|Overall Study||0
6575112|NCT01882439|7499285|FG000|STARTED|Overall Study|Received treatment|131
6575113|NCT01882439|7499286|FG001|STARTED|Overall Study|Received treatment|132
6575114|NCT01882439|7499287|FG002|STARTED|Overall Study|Received treatment|66
6575115|NCT01882439|7499288|FG003|STARTED|Overall Study|Received treatment|65
6575116|NCT01882439|7499285|FG000|COMPLETED|Overall Study||122
6575117|NCT01882439|7499286|FG001|COMPLETED|Overall Study||111
6575118|NCT01882439|7499287|FG002|COMPLETED|Overall Study||56
6575119|NCT01882439|7499288|FG003|COMPLETED|Overall Study||56
6575120|NCT01882439|7499285|FG000|NOT COMPLETED|Overall Study||9
6575121|NCT01882439|7499286|FG001|NOT COMPLETED|Overall Study||21
6575122|NCT01882439|7499287|FG002|NOT COMPLETED|Overall Study||10
6575123|NCT01882439|7499288|FG003|NOT COMPLETED|Overall Study||9
6575124|NCT01882465|7499303|FG000|STARTED|Period 1||6
6575125|NCT01882465|7499304|FG001|STARTED|Period 1||6
6575126|NCT01882465|7499305|FG002|STARTED|Period 1||5
6575127|NCT01882465|7499306|FG003|STARTED|Period 1||6
6575128|NCT01882465|7499307|FG004|STARTED|Period 1||5
6575129|NCT01882465|7499308|FG005|STARTED|Period 1||5
6575130|NCT01882465|7499309|FG006|STARTED|Period 1||1
6575131|NCT01882465|7499303|FG000|COMPLETED|Period 1||6
6575132|NCT01882465|7499304|FG001|COMPLETED|Period 1||6
6575133|NCT01882465|7499305|FG002|COMPLETED|Period 1||5
6575134|NCT01882465|7499306|FG003|COMPLETED|Period 1||5
6575135|NCT01882465|7499307|FG004|COMPLETED|Period 1||5
6575136|NCT01882465|7499308|FG005|COMPLETED|Period 1||5
6575137|NCT01882465|7499309|FG006|COMPLETED|Period 1||0
6575138|NCT01882465|7499303|FG000|NOT COMPLETED|Period 1||0
6575139|NCT01882465|7499304|FG001|NOT COMPLETED|Period 1||0
6575140|NCT01882465|7499305|FG002|NOT COMPLETED|Period 1||0
6575141|NCT01882465|7499306|FG003|NOT COMPLETED|Period 1||1
6575142|NCT01882465|7499307|FG004|NOT COMPLETED|Period 1||0
6575143|NCT01882465|7499308|FG005|NOT COMPLETED|Period 1||0
6575144|NCT01882465|7499309|FG006|NOT COMPLETED|Period 1||1
6575145|NCT01882465|7499303|FG000|STARTED|Period 2||6
6575146|NCT01882465|7499304|FG001|STARTED|Period 2||6
6575147|NCT01882465|7499305|FG002|STARTED|Period 2||5
6575148|NCT01882465|7499306|FG003|STARTED|Period 2||5
6575149|NCT01882465|7499307|FG004|STARTED|Period 2||5
6575150|NCT01882465|7499308|FG005|STARTED|Period 2||5
6575151|NCT01882465|7499309|FG006|STARTED|Period 2||0
6575152|NCT01882465|7499303|FG000|COMPLETED|Period 2||6
6575153|NCT01882465|7499304|FG001|COMPLETED|Period 2||6
6575154|NCT01882465|7499305|FG002|COMPLETED|Period 2||5
6575155|NCT01882465|7499306|FG003|COMPLETED|Period 2||5
6575156|NCT01882465|7499307|FG004|COMPLETED|Period 2||4
6575157|NCT01882465|7499308|FG005|COMPLETED|Period 2||5
6575158|NCT01882465|7499309|FG006|COMPLETED|Period 2||0
6575159|NCT01882465|7499303|FG000|NOT COMPLETED|Period 2||0
6575160|NCT01882465|7499304|FG001|NOT COMPLETED|Period 2||0
6575161|NCT01882465|7499305|FG002|NOT COMPLETED|Period 2||0
6575162|NCT01882465|7499306|FG003|NOT COMPLETED|Period 2||0
6575163|NCT01882465|7499307|FG004|NOT COMPLETED|Period 2||1
6575164|NCT01882465|7499308|FG005|NOT COMPLETED|Period 2||0
6575165|NCT01882465|7499309|FG006|NOT COMPLETED|Period 2||0
6575166|NCT01882465|7499303|FG000|STARTED|Period 3||6
6575167|NCT01882465|7499304|FG001|STARTED|Period 3||6
6575168|NCT01882465|7499305|FG002|STARTED|Period 3||5
6575169|NCT01882465|7499306|FG003|STARTED|Period 3||5
6575170|NCT01882465|7499307|FG004|STARTED|Period 3||4
6575171|NCT01882465|7499308|FG005|STARTED|Period 3||5
6575172|NCT01882465|7499309|FG006|STARTED|Period 3||0
6575173|NCT01882465|7499303|FG000|COMPLETED|Period 3||6
6575174|NCT01882465|7499304|FG001|COMPLETED|Period 3||6
6575175|NCT01882465|7499305|FG002|COMPLETED|Period 3||5
6575176|NCT01882465|7499306|FG003|COMPLETED|Period 3||5
6575177|NCT01882465|7499307|FG004|COMPLETED|Period 3||4
6575178|NCT01882465|7499308|FG005|COMPLETED|Period 3||5
6575179|NCT01882465|7499309|FG006|COMPLETED|Period 3||0
6575180|NCT01882465|7499303|FG000|NOT COMPLETED|Period 3||0
6575181|NCT01882465|7499304|FG001|NOT COMPLETED|Period 3||0
6575182|NCT01882465|7499305|FG002|NOT COMPLETED|Period 3||0
6575183|NCT01882465|7499306|FG003|NOT COMPLETED|Period 3||0
6575184|NCT01882465|7499307|FG004|NOT COMPLETED|Period 3||0
6575185|NCT01882465|7499308|FG005|NOT COMPLETED|Period 3||0
6575186|NCT01882465|7499309|FG006|NOT COMPLETED|Period 3||0
6575187|NCT01882543|7499319|FG000|STARTED|Overall Study||37
6575188|NCT01882543|7499320|FG001|STARTED|Overall Study||32
6575189|NCT01882543|7499319|FG000|COMPLETED|Overall Study||33
6575190|NCT01882543|7499320|FG001|COMPLETED|Overall Study||29
6575191|NCT01882543|7499319|FG000|NOT COMPLETED|Overall Study||4
6575192|NCT01882543|7499320|FG001|NOT COMPLETED|Overall Study||3
6575193|NCT01882647|7499329|FG000|STARTED|Overall Study||110
6575194|NCT01882647|7499330|FG001|STARTED|Overall Study||112
6575195|NCT01882647|7499329|FG000|COMPLETED|Overall Study||108
6575196|NCT01882647|7499330|FG001|COMPLETED|Overall Study||106
6575197|NCT01882647|7499329|FG000|NOT COMPLETED|Overall Study||2
6575198|NCT01882647|7499330|FG001|NOT COMPLETED|Overall Study||6
6575199|NCT01882725|7499336|FG000|STARTED|Overall Study||14
6575200|NCT01882725|7499336|FG000|COMPLETED|Overall Study||14
6575201|NCT01882725|7499336|FG000|NOT COMPLETED|Overall Study||0
6575202|NCT01882764|7499342|FG000|STARTED|Overall Study||47
6575203|NCT01882764|7499343|FG001|STARTED|Overall Study||19
6575204|NCT01882764|7499342|FG000|COMPLETED|Overall Study||0
6575205|NCT01882764|7499343|FG001|COMPLETED|Overall Study||1
6575206|NCT01882764|7499342|FG000|NOT COMPLETED|Overall Study||47
6575207|NCT01882764|7499343|FG001|NOT COMPLETED|Overall Study||18
6575208|NCT01882803|7499349|FG000|STARTED|Overall Study||129
6575209|NCT01882803|7499349|FG000|COMPLETED|Overall Study|Subject received treatment in 28-day cycles until disease progression or unacceptable toxicity.|35
6575210|NCT01882803|7499349|FG000|NOT COMPLETED|Overall Study||94
6575211|NCT01882829|7499354|FG000|STARTED|Overall Study||20
6575212|NCT01882829|7499354|FG000|COMPLETED|Overall Study||14
6575213|NCT01882829|7499354|FG000|NOT COMPLETED|Overall Study||6
6575214|NCT01882868|7499358|FG000|STARTED|Overall Study||62
6575215|NCT01882868|7499358|FG000|COMPLETED|Overall Study||62
6575216|NCT01882868|7499358|FG000|NOT COMPLETED|Overall Study||0
6575217|NCT01882907|7499364|FG000|STARTED|Overall Study||117
6575218|NCT01882907|7499365|FG001|STARTED|Overall Study||111
6575219|NCT01882907|7499364|FG000|COMPLETED|Overall Study||103
6575220|NCT01882907|7499365|FG001|COMPLETED|Overall Study||83
6575221|NCT01882907|7499364|FG000|NOT COMPLETED|Overall Study||14
6575222|NCT01882907|7499365|FG001|NOT COMPLETED|Overall Study||28
6575223|NCT01882985|7499373|FG000|STARTED|Overall Study||14
6575224|NCT01882985|7499373|FG000|COMPLETED|Overall Study||12
6575225|NCT01882985|7499373|FG000|NOT COMPLETED|Overall Study||2
6575226|NCT01883141|7499377|FG000|STARTED|Overall Study||31
6575227|NCT01883141|7499377|FG000|Passing Eligibility|Overall Study||30
6575228|NCT01883141|7499377|FG000|EP Study Performed|Overall Study||30
6575229|NCT01883141|7499377|FG000|Usable EP Data|Overall Study||26
6575230|NCT01883141|7499377|FG000|BiV Pacing-Distal|Overall Study||24
6575231|NCT01883141|7499377|FG000|BiV Pacing-Mid|Overall Study||25
6575232|NCT01883141|7499377|FG000|BiV Pacing-Standard Therapy|Overall Study||26
6575233|NCT01883141|7499377|FG000|Multispot-pacing|Overall Study||24
6575234|NCT01883141|7499377|FG000|BiV Pacing-Anterior|Overall Study||23
6575235|NCT01883141|7499377|FG000|Biv Pacing-Posterior|Overall Study||22
6575236|NCT01883141|7499377|FG000|Multivein|Overall Study||23
6575237|NCT01883141|7499377|FG000|COMPLETED|Overall Study|Exit form with exit reason available|31
6575238|NCT01883141|7499377|FG000|NOT COMPLETED|Overall Study||0
6575239|NCT01883362|7499383|FG000|STARTED|Treatment||30
6575240|NCT01883362|7499384|FG001|STARTED|Treatment||30
6575241|NCT01883362|7499383|FG000|COMPLETED|Treatment||14
6575242|NCT01883362|7499384|FG001|COMPLETED|Treatment||16
6575243|NCT01883362|7499383|FG000|NOT COMPLETED|Treatment||16
6575244|NCT01883362|7499384|FG001|NOT COMPLETED|Treatment||14
6575245|NCT01883362|7499383|FG000|STARTED|Post Treatment Follow-up||26
6575246|NCT01883362|7499384|FG001|STARTED|Post Treatment Follow-up||27
6575247|NCT01883362|7499383|FG000|COMPLETED|Post Treatment Follow-up||10
6575248|NCT01883362|7499384|FG001|COMPLETED|Post Treatment Follow-up||13
6575249|NCT01883362|7499383|FG000|NOT COMPLETED|Post Treatment Follow-up||16
6575250|NCT01883362|7499384|FG001|NOT COMPLETED|Post Treatment Follow-up||14
6575251|NCT01883427|7499396|FG000|STARTED|Overall Study||20
6575252|NCT01883427|7499397|FG001|STARTED|Overall Study||20
6575253|NCT01883427|7499396|FG000|COMPLETED|Overall Study||20
6575254|NCT01883427|7499397|FG001|COMPLETED|Overall Study||20
6575255|NCT01883427|7499396|FG000|NOT COMPLETED|Overall Study||0
6575256|NCT01883427|7499397|FG001|NOT COMPLETED|Overall Study||0
6575257|NCT01883440|7499405|FG000|STARTED|Overall Study||45
6575258|NCT01883440|7499406|FG001|STARTED|Overall Study||45
6575259|NCT01883440|7499405|FG000|COMPLETED|Overall Study||42
6575260|NCT01883440|7499406|FG001|COMPLETED|Overall Study||45
6575261|NCT01883440|7499405|FG000|NOT COMPLETED|Overall Study||3
6575262|NCT01883440|7499406|FG001|NOT COMPLETED|Overall Study||0
6575263|NCT01883453|7499415|FG000|STARTED|Overall Study||73
6575264|NCT01883453|7499416|FG001|STARTED|Overall Study||73
6575265|NCT01883453|7499415|FG000|COMPLETED|Overall Study||48
6575266|NCT01883453|7499416|FG001|COMPLETED|Overall Study||50
6575267|NCT01883453|7499415|FG000|NOT COMPLETED|Overall Study||25
6658188|NCT02477319|7588755|FG001|NOT COMPLETED|Overall Study||3
6575268|NCT01883453|7499416|FG001|NOT COMPLETED|Overall Study||23
6575269|NCT01883492|7499424|FG000|STARTED|Overall Study||75
6575270|NCT01883492|7499425|FG001|STARTED|Overall Study||78
6575271|NCT01883492|7499424|FG000|COMPLETED|Overall Study||62
6575272|NCT01883492|7499425|FG001|COMPLETED|Overall Study||67
6575273|NCT01883492|7499424|FG000|NOT COMPLETED|Overall Study||13
6575274|NCT01883492|7499425|FG001|NOT COMPLETED|Overall Study||11
6575275|NCT01883635|7499433|FG000|STARTED|Overall Study||24
6575276|NCT01883635|7499434|FG001|STARTED|Overall Study||20
6575277|NCT01883635|7499433|FG000|COMPLETED|Overall Study||20
6575278|NCT01883635|7499434|FG001|COMPLETED|Overall Study||20
6575279|NCT01883635|7499433|FG000|NOT COMPLETED|Overall Study||4
6575280|NCT01883635|7499434|FG001|NOT COMPLETED|Overall Study||0
6575281|NCT01883856|7499444|FG000|STARTED|Overall Study||26
6575282|NCT01883856|7499445|FG001|STARTED|Overall Study||26
6575283|NCT01883856|7499444|FG000|COMPLETED|Overall Study||26
6575284|NCT01883856|7499445|FG001|COMPLETED|Overall Study||26
6575285|NCT01883856|7499444|FG000|NOT COMPLETED|Overall Study||0
6575286|NCT01883856|7499445|FG001|NOT COMPLETED|Overall Study||0
6575287|NCT01883895|7499451|FG000|STARTED|Overall Study||34
6575288|NCT01883895|7499451|FG000|COMPLETED|Overall Study||32
6575289|NCT01883895|7499451|FG000|NOT COMPLETED|Overall Study||2
6575290|NCT01883986|7499457|FG000|STARTED|Overall Study|Allocated to intervention arm|20
6575291|NCT01883986|7499458|FG001|STARTED|Overall Study|Allocated to usual care arm|20
6575292|NCT01883986|7499457|FG000|Did Not Complete Study|Overall Study||3
6575293|NCT01883986|7499458|FG001|Did Not Complete Study|Overall Study|Did not completed study|1
6575294|NCT01883986|7499457|FG000|COMPLETED|Overall Study|Received allocated intervention|17
6575295|NCT01883986|7499458|FG001|COMPLETED|Overall Study|Completed study|19
6575296|NCT01883986|7499457|FG000|NOT COMPLETED|Overall Study||3
6575297|NCT01883986|7499458|FG001|NOT COMPLETED|Overall Study||1
6575298|NCT01883999|7499464|FG000|STARTED|Overall Study||64
6575299|NCT01883999|7499464|FG000|COMPLETED|Overall Study||61
6575300|NCT01883999|7499464|FG000|NOT COMPLETED|Overall Study||3
6575301|NCT01884025|7499470|FG000|STARTED|Overall Study||13
6575302|NCT01884025|7499471|FG001|STARTED|Overall Study||14
6575303|NCT01884025|7499470|FG000|COMPLETED|Overall Study||10
6575304|NCT01884025|7499471|FG001|COMPLETED|Overall Study||10
6575305|NCT01884025|7499470|FG000|NOT COMPLETED|Overall Study||3
6575306|NCT01884025|7499471|FG001|NOT COMPLETED|Overall Study||4
6575307|NCT01884064|7499479|FG000|STARTED|Overall Study||12
6575308|NCT01884064|7499480|FG001|STARTED|Overall Study||5
6575309|NCT01884064|7499479|FG000|COMPLETED|Overall Study||12
6575310|NCT01884064|7499480|FG001|COMPLETED|Overall Study||5
6575311|NCT01884064|7499479|FG000|NOT COMPLETED|Overall Study||0
6575312|NCT01884064|7499480|FG001|NOT COMPLETED|Overall Study||0
6575313|NCT01884311|7499486|FG000|STARTED|Overall Study||38
6575314|NCT01884311|7499486|FG000|COMPLETED|Overall Study||33
6575315|NCT01884311|7499486|FG000|NOT COMPLETED|Overall Study||5
6575316|NCT01884337|7499495|FG000|STARTED|Treatment||326
6575317|NCT01884337|7499496|FG001|STARTED|Treatment||172
6575318|NCT01884337|7499495|FG000|Continuing Into Follow-up Period|Treatment||324
6575319|NCT01884337|7499496|FG001|Continuing Into Follow-up Period|Treatment||171
6575320|NCT01884337|7499495|FG000|COMPLETED|Treatment||322
6575321|NCT01884337|7499496|FG001|COMPLETED|Treatment||170
6575322|NCT01884337|7499495|FG000|NOT COMPLETED|Treatment||4
6575323|NCT01884337|7499496|FG001|NOT COMPLETED|Treatment||2
6575324|NCT01884337|7499495|FG000|STARTED|Follow-up Period||324
6575325|NCT01884337|7499496|FG001|STARTED|Follow-up Period||171
6575326|NCT01884337|7499495|FG000|COMPLETED|Follow-up Period||323
6575327|NCT01884337|7499496|FG001|COMPLETED|Follow-up Period||170
6575328|NCT01884337|7499495|FG000|NOT COMPLETED|Follow-up Period||1
6575329|NCT01884337|7499496|FG001|NOT COMPLETED|Follow-up Period||1
6575330|NCT01884350|7499504|FG000|STARTED|Primary Efficacy Analysis Set (24 Weeks)||583
6575331|NCT01884350|7499505|FG001|STARTED|Primary Efficacy Analysis Set (24 Weeks)||579
6575332|NCT01884350|7499506|FG002|STARTED|Primary Efficacy Analysis Set (24 Weeks)|Participants were not randomized to this arm until after initial 24-week period|0
6575333|NCT01884350|7499504|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||604
6575334|NCT01884350|7499505|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||558
6575335|NCT01884350|7499506|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (24 Weeks)||0
6575336|NCT01884350|7499504|FG000|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||529
6575337|NCT01884350|7499505|FG001|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||525
6575338|NCT01884350|7499506|FG002|COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
6575339|NCT01884350|7499504|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
6575340|NCT01884350|7499505|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||54
6575341|NCT01884350|7499506|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (24 Weeks)||0
6575342|NCT01884350|7499504|FG000|STARTED|Primary Efficacy Analysis Set (48 Weeks)||583
6575343|NCT01884350|7499505|FG001|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|263
6575344|NCT01884350|7499506|FG002|STARTED|Primary Efficacy Analysis Set (48 Weeks)|After 24 weeks participants were randomized to continue AEP or stop AEP and revert to SOC.|261
6575345|NCT01884350|7499504|FG000|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||604
6575346|NCT01884350|7499505|FG001|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||308
6575347|NCT01884350|7499506|FG002|Safety Analysis Set|Primary Efficacy Analysis Set (48 Weeks)||223
6575348|NCT01884350|7499504|FG000|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||503
6575349|NCT01884350|7499505|FG001|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
6575350|NCT01884350|7499506|FG002|COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||250
6575351|NCT01884350|7499504|FG000|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||80
6575352|NCT01884350|7499505|FG001|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||13
6575353|NCT01884350|7499506|FG002|NOT COMPLETED|Primary Efficacy Analysis Set (48 Weeks)||11
6575354|NCT01884519|7499518|FG000|STARTED|Overall Study||60
6575355|NCT01884519|7499519|FG001|STARTED|Overall Study||60
6575356|NCT01884519|7499518|FG000|COMPLETED|Overall Study||60
6575357|NCT01884519|7499519|FG001|COMPLETED|Overall Study||60
6575358|NCT01884519|7499518|FG000|NOT COMPLETED|Overall Study||0
6575359|NCT01884519|7499519|FG001|NOT COMPLETED|Overall Study||0
6575360|NCT01884545|7499537|FG000|STARTED|Overall Study||50
6575361|NCT01884545|7499538|FG001|STARTED|Overall Study||49
6575362|NCT01884545|7499539|FG002|STARTED|Overall Study||49
6575363|NCT01884545|7499540|FG003|STARTED|Overall Study||52
6575364|NCT01884545|7499537|FG000|COMPLETED|Overall Study||37
6575365|NCT01884545|7499538|FG001|COMPLETED|Overall Study||31
6575366|NCT01884545|7499539|FG002|COMPLETED|Overall Study||35
6575367|NCT01884545|7499540|FG003|COMPLETED|Overall Study||43
6575368|NCT01884545|7499537|FG000|NOT COMPLETED|Overall Study||13
6575369|NCT01884545|7499538|FG001|NOT COMPLETED|Overall Study||18
6575370|NCT01884545|7499539|FG002|NOT COMPLETED|Overall Study||14
6575371|NCT01884545|7499540|FG003|NOT COMPLETED|Overall Study||9
6575372|NCT01884571|7499550|FG000|STARTED|Overall Study||31
6575373|NCT01884571|7499550|FG000|COMPLETED|Overall Study||23
6575374|NCT01884571|7499550|FG000|NOT COMPLETED|Overall Study||8
6575375|NCT01884597|7499557|FG000|STARTED|Overall Study||5
6575376|NCT01884597|7499558|FG001|STARTED|Overall Study||3
6575377|NCT01884597|7499559|FG002|STARTED|Overall Study||16
6575378|NCT01884597|7499557|FG000|COMPLETED|Overall Study||4
6575379|NCT01884597|7499558|FG001|COMPLETED|Overall Study||2
6575380|NCT01884597|7499559|FG002|COMPLETED|Overall Study||15
6575381|NCT01884597|7499557|FG000|NOT COMPLETED|Overall Study||1
6575382|NCT01884597|7499558|FG001|NOT COMPLETED|Overall Study||1
6575383|NCT01884597|7499559|FG002|NOT COMPLETED|Overall Study||1
6575384|NCT01884675|7499575|FG000|STARTED|Overall Study||16
6575385|NCT01884675|7499576|FG001|STARTED|Overall Study||17
6575386|NCT01884675|7499575|FG000|COMPLETED|Overall Study||13
6575387|NCT01884675|7499576|FG001|COMPLETED|Overall Study||15
6575388|NCT01884675|7499575|FG000|NOT COMPLETED|Overall Study||3
6575389|NCT01884675|7499576|FG001|NOT COMPLETED|Overall Study||2
6575390|NCT01884688|7499584|FG000|STARTED|Overall Study||3
6575391|NCT01884688|7499584|FG000|COMPLETED|Overall Study||1
6575392|NCT01884688|7499584|FG000|NOT COMPLETED|Overall Study||2
6575393|NCT01884844|7499590|FG000|STARTED|Overall Study||16
6575394|NCT01884844|7499591|FG001|STARTED|Overall Study||17
6575395|NCT01884844|7499590|FG000|COMPLETED|Overall Study||13
6575396|NCT01884844|7499591|FG001|COMPLETED|Overall Study||12
6575397|NCT01884844|7499590|FG000|NOT COMPLETED|Overall Study||3
6575398|NCT01884844|7499591|FG001|NOT COMPLETED|Overall Study||5
6575399|NCT01885000|7499599|FG000|STARTED|Overall Study||48
6575400|NCT01885000|7499600|FG001|STARTED|Overall Study||44
6575401|NCT01885000|7499599|FG000|COMPLETED|Overall Study||46
6575402|NCT01885000|7499600|FG001|COMPLETED|Overall Study||42
6575403|NCT01885000|7499599|FG000|NOT COMPLETED|Overall Study||2
6575404|NCT01885000|7499600|FG001|NOT COMPLETED|Overall Study||2
6575405|NCT01885104|7499608|FG000|STARTED|Overall Study||31
6575406|NCT01885104|7499609|FG001|STARTED|Overall Study||34
6575407|NCT01885104|7499608|FG000|COMPLETED|Overall Study||29
6575408|NCT01885104|7499609|FG001|COMPLETED|Overall Study||33
6575409|NCT01885104|7499608|FG000|NOT COMPLETED|Overall Study||2
6575410|NCT01885104|7499609|FG001|NOT COMPLETED|Overall Study||1
6575411|NCT01885117|7499617|FG000|STARTED|Overall Study||61
6575412|NCT01885117|7499618|FG001|STARTED|Overall Study||64
6575413|NCT01885117|7499617|FG000|COMPLETED|Overall Study||61
6575414|NCT01885117|7499618|FG001|COMPLETED|Overall Study||64
6575415|NCT01885117|7499617|FG000|NOT COMPLETED|Overall Study||0
6575416|NCT01885117|7499618|FG001|NOT COMPLETED|Overall Study||0
6575417|NCT01885182|7499626|FG000|STARTED|Overall Study||117
6575418|NCT01885182|7499627|FG001|STARTED|Overall Study||115
6575419|NCT01885182|7499626|FG000|Safety Population|Overall Study||114
6575420|NCT01885182|7499627|FG001|Safety Population|Overall Study||111
6575421|NCT01885182|7499626|FG000|FAP Population|Overall Study||107
6575422|NCT01885182|7499627|FG001|FAP Population|Overall Study||106
6575423|NCT01885182|7499626|FG000|COMPLETED|Overall Study||83
6575424|NCT01885182|7499627|FG001|COMPLETED|Overall Study||93
6575425|NCT01885182|7499626|FG000|NOT COMPLETED|Overall Study||34
6575426|NCT01885182|7499627|FG001|NOT COMPLETED|Overall Study||22
6575427|NCT01885195|7499635|FG000|STARTED|Overall Study||110
6575428|NCT01885195|7499635|FG000|COMPLETED|Overall Study||0
6575429|NCT01885195|7499635|FG000|NOT COMPLETED|Overall Study||110
6575430|NCT01885208|7499641|FG000|STARTED|Overall Study||406
6575431|NCT01885208|7499642|FG001|STARTED|Overall Study||407
6575432|NCT01885208|7499641|FG000|Exposed|Overall Study||404
6575433|NCT01885208|7499642|FG001|Exposed|Overall Study||405
6575434|NCT01885208|7499641|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|82
6575435|NCT01885208|7499642|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects who prematurely discontinued treatment were allowed to continue participation in the trial.|85
6575436|NCT01885208|7499641|FG000|COMPLETED|Overall Study||374
6575437|NCT01885208|7499642|FG001|COMPLETED|Overall Study||369
6575438|NCT01885208|7499641|FG000|NOT COMPLETED|Overall Study||32
6575439|NCT01885208|7499642|FG001|NOT COMPLETED|Overall Study||38
6575440|NCT01885559|7499650|FG000|STARTED|Overall Study||242
6575441|NCT01885559|7499651|FG001|STARTED|Overall Study||244
6575442|NCT01885559|7499650|FG000|COMPLETED|Overall Study||218
6575443|NCT01885559|7499651|FG001|COMPLETED|Overall Study||208
6575444|NCT01885559|7499650|FG000|NOT COMPLETED|Overall Study||24
6575445|NCT01885559|7499651|FG001|NOT COMPLETED|Overall Study||36
6575446|NCT01885871|7499657|FG000|STARTED|Overall Study||20
6575447|NCT01885871|7499657|FG000|COMPLETED|Overall Study||20
6575448|NCT01885871|7499657|FG000|NOT COMPLETED|Overall Study||0
6575449|NCT01885897|7499667|FG000|STARTED|Overall Study||6
6575450|NCT01885897|7499668|FG001|STARTED|Overall Study||3
6575451|NCT01885897|7499669|FG002|STARTED|Overall Study||4
6575452|NCT01885897|7499670|FG003|STARTED|Overall Study||3
6575453|NCT01885897|7499671|FG004|STARTED|Overall Study||8
6575454|NCT01885897|7499672|FG005|STARTED|Overall Study||9
6658189|NCT02477319|7588756|FG002|NOT COMPLETED|Overall Study||15
6658190|NCT02477319|7588757|FG003|NOT COMPLETED|Overall Study||22
6658191|NCT02477332|7588770|FG000|STARTED|Overall Study||43
6658192|NCT02477332|7588771|FG001|STARTED|Overall Study||84
6658193|NCT02477332|7588772|FG002|STARTED|Overall Study||85
6658194|NCT02477332|7588773|FG003|STARTED|Overall Study||85
6658195|NCT02477332|7588774|FG004|STARTED|Overall Study||43
6658196|NCT02477332|7588775|FG005|STARTED|Overall Study||42
6658197|NCT02477332|7588770|FG000|COMPLETED|Overall Study||40
6658198|NCT02477332|7588771|FG001|COMPLETED|Overall Study||77
6658199|NCT02477332|7588772|FG002|COMPLETED|Overall Study||73
6658200|NCT02477332|7588773|FG003|COMPLETED|Overall Study||72
6658201|NCT02477332|7588774|FG004|COMPLETED|Overall Study||39
6658202|NCT02477332|7588775|FG005|COMPLETED|Overall Study||37
6658203|NCT02477332|7588770|FG000|NOT COMPLETED|Overall Study||3
6658204|NCT02477332|7588771|FG001|NOT COMPLETED|Overall Study||7
6658205|NCT02477332|7588772|FG002|NOT COMPLETED|Overall Study||12
6658206|NCT02477332|7588773|FG003|NOT COMPLETED|Overall Study||13
6658207|NCT02477332|7588774|FG004|NOT COMPLETED|Overall Study||4
6658208|NCT02477332|7588775|FG005|NOT COMPLETED|Overall Study||5
6658209|NCT02477423|7588793|FG000|STARTED|Overall Study||12
6658210|NCT02477423|7588794|FG001|STARTED|Overall Study||15
6658211|NCT02477423|7588793|FG000|COMPLETED|Overall Study||11
6658212|NCT02477423|7588794|FG001|COMPLETED|Overall Study||11
6658213|NCT02477423|7588793|FG000|NOT COMPLETED|Overall Study||1
6658214|NCT02477423|7588794|FG001|NOT COMPLETED|Overall Study||4
6658215|NCT02477527|7588800|FG000|STARTED|Overall Study||27
6658216|NCT02477527|7588800|FG000|COMPLETED|Overall Study||21
6658217|NCT02477527|7588800|FG000|NOT COMPLETED|Overall Study||6
6658218|NCT02477553|7588806|FG000|STARTED|Overall Study||364
6658219|NCT02477553|7588807|FG001|STARTED|Overall Study||364
6658220|NCT02477553|7588806|FG000|COMPLETED|Overall Study||344
6658221|NCT02477553|7588807|FG001|COMPLETED|Overall Study||344
6658222|NCT02477553|7588806|FG000|NOT COMPLETED|Overall Study||20
6658223|NCT02477553|7588807|FG001|NOT COMPLETED|Overall Study||20
6658224|NCT02477605|7588815|FG000|STARTED|Overall Study||68
6658225|NCT02477605|7588816|FG001|STARTED|Overall Study||68
6658226|NCT02477605|7588815|FG000|Randomized and Treated|Overall Study||67
6658227|NCT02477605|7588816|FG001|Randomized and Treated|Overall Study||68
6658228|NCT02477605|7588815|FG000|COMPLETED|Overall Study||67
6658229|NCT02477605|7588816|FG001|COMPLETED|Overall Study||64
6658230|NCT02477605|7588815|FG000|NOT COMPLETED|Overall Study||1
6658231|NCT02477605|7588816|FG001|NOT COMPLETED|Overall Study||4
6658232|NCT02477670|7588828|FG000|STARTED|Stage 1||47
6658233|NCT02477670|7588829|FG001|STARTED|Stage 1||80
6658234|NCT02477670|7588830|FG002|STARTED|Stage 1||0
6658235|NCT02477670|7588831|FG003|STARTED|Stage 1||0
6658236|NCT02477670|7588832|FG004|STARTED|Stage 1||0
6658237|NCT02477670|7588833|FG005|STARTED|Stage 1||0
6658238|NCT02477670|7588834|FG006|STARTED|Stage 1||0
6658239|NCT02477670|7588828|FG000|COMPLETED|Stage 1||43
6658240|NCT02477670|7588829|FG001|COMPLETED|Stage 1||67
6658241|NCT02477670|7588830|FG002|COMPLETED|Stage 1||0
6658242|NCT02477670|7588831|FG003|COMPLETED|Stage 1||0
6658243|NCT02477670|7588832|FG004|COMPLETED|Stage 1||0
6658244|NCT02477670|7588833|FG005|COMPLETED|Stage 1||0
6658245|NCT02477670|7588834|FG006|COMPLETED|Stage 1||0
6658246|NCT02477670|7588828|FG000|NOT COMPLETED|Stage 1||4
6658247|NCT02477670|7588829|FG001|NOT COMPLETED|Stage 1||13
6658248|NCT02477670|7588830|FG002|NOT COMPLETED|Stage 1||0
6658249|NCT02477670|7588831|FG003|NOT COMPLETED|Stage 1||0
6658250|NCT02477670|7588832|FG004|NOT COMPLETED|Stage 1||0
6658251|NCT02477670|7588833|FG005|NOT COMPLETED|Stage 1||0
6658252|NCT02477670|7588834|FG006|NOT COMPLETED|Stage 1||0
6658253|NCT02477670|7588828|FG000|STARTED|Stage 2||0
6658254|NCT02477670|7588829|FG001|STARTED|Stage 2||0
6658255|NCT02477670|7588830|FG002|STARTED|Stage 2||30
6658256|NCT02477670|7588831|FG003|STARTED|Stage 2||33
6658257|NCT02477670|7588832|FG004|STARTED|Stage 2||2
6658258|NCT02477670|7588833|FG005|STARTED|Stage 2||1
6575455|NCT01885897|7499667|FG000|COMPLETED|Overall Study||6
6575456|NCT01885897|7499668|FG001|COMPLETED|Overall Study||3
6575457|NCT01885897|7499669|FG002|COMPLETED|Overall Study||4
6575458|NCT01885897|7499670|FG003|COMPLETED|Overall Study||3
6658259|NCT02477670|7588834|FG006|STARTED|Stage 2||42
6658260|NCT02477670|7588828|FG000|COMPLETED|Stage 2||0
6658261|NCT02477670|7588829|FG001|COMPLETED|Stage 2||0
6658262|NCT02477670|7588830|FG002|COMPLETED|Stage 2||28
6658263|NCT02477670|7588831|FG003|COMPLETED|Stage 2||32
6658264|NCT02477670|7588832|FG004|COMPLETED|Stage 2||2
6658265|NCT02477670|7588833|FG005|COMPLETED|Stage 2||1
6658266|NCT02477670|7588834|FG006|COMPLETED|Stage 2||42
6658267|NCT02477670|7588828|FG000|NOT COMPLETED|Stage 2||0
6658268|NCT02477670|7588829|FG001|NOT COMPLETED|Stage 2||0
6658269|NCT02477670|7588830|FG002|NOT COMPLETED|Stage 2||2
6658270|NCT02477670|7588831|FG003|NOT COMPLETED|Stage 2||1
6658271|NCT02477670|7588832|FG004|NOT COMPLETED|Stage 2||0
6575459|NCT01885897|7499671|FG004|COMPLETED|Overall Study||8
6575460|NCT01885897|7499672|FG005|COMPLETED|Overall Study||9
6575461|NCT01885897|7499667|FG000|NOT COMPLETED|Overall Study||0
6575462|NCT01885897|7499668|FG001|NOT COMPLETED|Overall Study||0
6575463|NCT01885897|7499669|FG002|NOT COMPLETED|Overall Study||0
6575464|NCT01885897|7499670|FG003|NOT COMPLETED|Overall Study||0
6575465|NCT01885897|7499671|FG004|NOT COMPLETED|Overall Study||0
6575466|NCT01885897|7499672|FG005|NOT COMPLETED|Overall Study||0
6575467|NCT01885910|7499686|FG000|STARTED|Overall Study||32
6575468|NCT01885910|7499686|FG000|COMPLETED|Overall Study||24
6575469|NCT01885910|7499686|FG000|NOT COMPLETED|Overall Study||8
6575470|NCT01885936|7499694|FG000|STARTED|Overall Study||8
6575471|NCT01885936|7499695|FG001|STARTED|Overall Study||5
6575472|NCT01885936|7499694|FG000|COMPLETED|Overall Study||7
6575473|NCT01885936|7499695|FG001|COMPLETED|Overall Study||5
6575474|NCT01885936|7499694|FG000|NOT COMPLETED|Overall Study||1
6575475|NCT01885936|7499695|FG001|NOT COMPLETED|Overall Study||0
6575476|NCT01886105|7499701|FG000|STARTED|Overall Study||4
6575477|NCT01886105|7499701|FG000|COMPLETED|Overall Study||1
6575478|NCT01886105|7499701|FG000|NOT COMPLETED|Overall Study||3
6575479|NCT01886235|7499706|FG000|STARTED|Overall Study||10
6575480|NCT01886235|7499706|FG000|COMPLETED|Overall Study||10
6575481|NCT01886235|7499706|FG000|NOT COMPLETED|Overall Study||0
6575482|NCT01886287|7499710|FG000|STARTED|Overall Study||2
6575483|NCT01886287|7499710|FG000|COMPLETED|Overall Study||0
6575484|NCT01886287|7499710|FG000|NOT COMPLETED|Overall Study||2
6575485|NCT01886300|7499714|FG000|STARTED|Overall Study||16
6575486|NCT01886300|7499714|FG000|COMPLETED|Overall Study||0
6575487|NCT01886300|7499714|FG000|NOT COMPLETED|Overall Study||16
6623901|NCT02212106|7551181|FG000|NOT COMPLETED|Overall Study||10
6623902|NCT02212106|7551182|FG001|NOT COMPLETED|Overall Study||4
6623903|NCT02212197|7551192|FG000|STARTED|Overall Study||19
6623904|NCT02212197|7551193|FG001|STARTED|Overall Study||15
6623905|NCT02212197|7551194|FG002|STARTED|Overall Study||17
6623906|NCT02212197|7551192|FG000|COMPLETED|Overall Study||18
6623907|NCT02212197|7551193|FG001|COMPLETED|Overall Study||15
6623908|NCT02212197|7551194|FG002|COMPLETED|Overall Study||17
6623909|NCT02212197|7551192|FG000|NOT COMPLETED|Overall Study||1
6623910|NCT02212197|7551193|FG001|NOT COMPLETED|Overall Study||0
6623911|NCT02212197|7551194|FG002|NOT COMPLETED|Overall Study||0
6623912|NCT02212301|7551202|FG000|STARTED|Period 1||21
6623913|NCT02212301|7551203|FG001|STARTED|Period 1||22
6623914|NCT02212301|7551202|FG000|COMPLETED|Period 1||21
6623915|NCT02212301|7551203|FG001|COMPLETED|Period 1||21
6623916|NCT02212301|7551202|FG000|NOT COMPLETED|Period 1||0
6623917|NCT02212301|7551203|FG001|NOT COMPLETED|Period 1||1
6623918|NCT02212301|7551202|FG000|STARTED|Period 2||21
6623919|NCT02212301|7551203|FG001|STARTED|Period 2||21
6623920|NCT02212301|7551202|FG000|COMPLETED|Period 2||21
6623921|NCT02212301|7551203|FG001|COMPLETED|Period 2||21
6623922|NCT02212301|7551202|FG000|NOT COMPLETED|Period 2||0
6623923|NCT02212301|7551203|FG001|NOT COMPLETED|Period 2||0
6623924|NCT02212379|7551210|FG000|STARTED|From Baseline to Week 48||165
6623925|NCT02212379|7551210|FG000|COMPLETED|From Baseline to Week 48||156
6623926|NCT02212379|7551210|FG000|NOT COMPLETED|From Baseline to Week 48||9
6623927|NCT02212379|7551210|FG000|STARTED|From Week 48 to Week 96||156
6623928|NCT02212379|7551210|FG000|COMPLETED|From Week 48 to Week 96||152
6623929|NCT02212379|7551210|FG000|NOT COMPLETED|From Week 48 to Week 96||4
6623930|NCT02212457|7551223|FG000|STARTED|Overall Study||228
6623931|NCT02212457|7551224|FG001|STARTED|Overall Study||232
6623932|NCT02212457|7551225|FG002|STARTED|Overall Study||157
6623933|NCT02212457|7551226|FG003|STARTED|Overall Study||134
6623934|NCT02212457|7551227|FG004|STARTED|Overall Study||152
6623935|NCT02212457|7551228|FG005|STARTED|Overall Study||160
6623936|NCT02212457|7551223|FG000|COMPLETED|Overall Study||209
6623937|NCT02212457|7551224|FG001|COMPLETED|Overall Study||211
6623938|NCT02212457|7551225|FG002|COMPLETED|Overall Study||141
6623939|NCT02212457|7551226|FG003|COMPLETED|Overall Study||123
6623940|NCT02212457|7551227|FG004|COMPLETED|Overall Study||137
6623941|NCT02212457|7551228|FG005|COMPLETED|Overall Study||147
6623942|NCT02212457|7551223|FG000|NOT COMPLETED|Overall Study||19
6623943|NCT02212457|7551224|FG001|NOT COMPLETED|Overall Study||21
6623944|NCT02212457|7551225|FG002|NOT COMPLETED|Overall Study||16
6623945|NCT02212457|7551226|FG003|NOT COMPLETED|Overall Study||11
6623946|NCT02212457|7551227|FG004|NOT COMPLETED|Overall Study||15
6623947|NCT02212457|7551228|FG005|NOT COMPLETED|Overall Study||13
6623948|NCT02212587|7551249|FG000|STARTED|Overall Study||10
6623949|NCT02212587|7551249|FG000|COMPLETED|Overall Study||9
6623950|NCT02212587|7551249|FG000|NOT COMPLETED|Overall Study||1
6623951|NCT02212678|7551253|FG000|STARTED|Overall Study||8
6623952|NCT02212678|7551253|FG000|COMPLETED|Overall Study||7
6623953|NCT02212678|7551253|FG000|NOT COMPLETED|Overall Study||1
6623954|NCT02212730|7551259|FG000|STARTED|Overall Study||6
6623955|NCT02212730|7551260|FG001|STARTED|Overall Study||4
6658272|NCT02477670|7588833|FG005|NOT COMPLETED|Stage 2||0
6623956|NCT02212730|7551259|FG000|Received Neoadjuvant Pembrolizumab|Overall Study||4
6623957|NCT02212730|7551260|FG001|Received Neoadjuvant Pembrolizumab|Overall Study||0
6623958|NCT02212730|7551259|FG000|Underwent RCC|Overall Study||4
6623959|NCT02212730|7551260|FG001|Underwent RCC|Overall Study||3
6623960|NCT02212730|7551259|FG000|Received Post-RCC Pembrolizumab|Overall Study||1
6623961|NCT02212730|7551260|FG001|Received Post-RCC Pembrolizumab|Overall Study||1
6623962|NCT02212730|7551259|FG000|COMPLETED|Overall Study||4
6575488|NCT01886313|7499720|FG000|STARTED|Overall Study||6
6575489|NCT01886313|7499721|FG001|STARTED|Overall Study||5
6575490|NCT01886313|7499720|FG000|COMPLETED|Overall Study||5
6575491|NCT01886313|7499721|FG001|COMPLETED|Overall Study||4
6575492|NCT01886313|7499720|FG000|NOT COMPLETED|Overall Study||1
6575493|NCT01886313|7499721|FG001|NOT COMPLETED|Overall Study||1
6575494|NCT01886378|7499727|FG000|STARTED|Overall Study||29
6575495|NCT01886378|7499727|FG000|Completed 24 Weeks of UX007 Treatment|Overall Study||25
6575496|NCT01886378|7499727|FG000|COMPLETED|Overall Study||24
6575497|NCT01886378|7499727|FG000|NOT COMPLETED|Overall Study||5
6575498|NCT01886690|7499733|FG000|STARTED|Overall Study||75
6575499|NCT01886690|7499734|FG001|STARTED|Overall Study||73
6575500|NCT01886690|7499733|FG000|COMPLETED|Overall Study||75
6575501|NCT01886690|7499734|FG001|COMPLETED|Overall Study||71
6575502|NCT01886690|7499733|FG000|NOT COMPLETED|Overall Study||0
6575503|NCT01886690|7499734|FG001|NOT COMPLETED|Overall Study||2
6575504|NCT01886716|7499744|FG000|STARTED|Week 1||24
6575505|NCT01886716|7499745|FG001|STARTED|Week 1||20
6575506|NCT01886716|7499746|FG002|STARTED|Week 1||22
6575507|NCT01886716|7499747|FG003|STARTED|Week 1||20
6575508|NCT01886716|7499744|FG000|COMPLETED|Week 1||24
6575509|NCT01886716|7499745|FG001|COMPLETED|Week 1||20
6575510|NCT01886716|7499746|FG002|COMPLETED|Week 1||20
6575511|NCT01886716|7499747|FG003|COMPLETED|Week 1||18
6575512|NCT01886716|7499744|FG000|NOT COMPLETED|Week 1||0
6575513|NCT01886716|7499745|FG001|NOT COMPLETED|Week 1||0
6575514|NCT01886716|7499746|FG002|NOT COMPLETED|Week 1||2
6575515|NCT01886716|7499747|FG003|NOT COMPLETED|Week 1||2
6575516|NCT01886716|7499744|FG000|STARTED|Week 2||24
6575517|NCT01886716|7499745|FG001|STARTED|Week 2||20
6575518|NCT01886716|7499746|FG002|STARTED|Week 2||20
6575519|NCT01886716|7499747|FG003|STARTED|Week 2||18
6575520|NCT01886716|7499744|FG000|COMPLETED|Week 2||21
6575521|NCT01886716|7499745|FG001|COMPLETED|Week 2||18
6575522|NCT01886716|7499746|FG002|COMPLETED|Week 2||19
6575523|NCT01886716|7499747|FG003|COMPLETED|Week 2||15
6575524|NCT01886716|7499744|FG000|NOT COMPLETED|Week 2||3
6575525|NCT01886716|7499745|FG001|NOT COMPLETED|Week 2||2
6575526|NCT01886716|7499746|FG002|NOT COMPLETED|Week 2||1
6575527|NCT01886716|7499747|FG003|NOT COMPLETED|Week 2||3
6575528|NCT01886716|7499744|FG000|STARTED|Week 3||21
6575529|NCT01886716|7499745|FG001|STARTED|Week 3||18
6575530|NCT01886716|7499746|FG002|STARTED|Week 3||19
6575531|NCT01886716|7499747|FG003|STARTED|Week 3||15
6575532|NCT01886716|7499744|FG000|COMPLETED|Week 3||20
6575533|NCT01886716|7499745|FG001|COMPLETED|Week 3||17
6575534|NCT01886716|7499746|FG002|COMPLETED|Week 3||19
6575535|NCT01886716|7499747|FG003|COMPLETED|Week 3||14
6575536|NCT01886716|7499744|FG000|NOT COMPLETED|Week 3||1
6575537|NCT01886716|7499745|FG001|NOT COMPLETED|Week 3||1
6575538|NCT01886716|7499746|FG002|NOT COMPLETED|Week 3||0
6575539|NCT01886716|7499747|FG003|NOT COMPLETED|Week 3||1
6575540|NCT01886716|7499744|FG000|STARTED|Week 4||20
6575541|NCT01886716|7499745|FG001|STARTED|Week 4||17
6575542|NCT01886716|7499746|FG002|STARTED|Week 4||19
6575543|NCT01886716|7499747|FG003|STARTED|Week 4||14
6575544|NCT01886716|7499744|FG000|COMPLETED|Week 4||20
6575545|NCT01886716|7499745|FG001|COMPLETED|Week 4||17
6575546|NCT01886716|7499746|FG002|COMPLETED|Week 4||19
6575547|NCT01886716|7499747|FG003|COMPLETED|Week 4||14
6575548|NCT01886716|7499744|FG000|NOT COMPLETED|Week 4||0
6575549|NCT01886716|7499745|FG001|NOT COMPLETED|Week 4||0
6575550|NCT01886716|7499746|FG002|NOT COMPLETED|Week 4||0
6575551|NCT01886716|7499747|FG003|NOT COMPLETED|Week 4||0
6575552|NCT01886716|7499744|FG000|STARTED|1-Week Post Follow-Up||20
6575553|NCT01886716|7499745|FG001|STARTED|1-Week Post Follow-Up||17
6575554|NCT01886716|7499746|FG002|STARTED|1-Week Post Follow-Up||19
6575555|NCT01886716|7499747|FG003|STARTED|1-Week Post Follow-Up||14
6575556|NCT01886716|7499744|FG000|COMPLETED|1-Week Post Follow-Up||20
6575557|NCT01886716|7499745|FG001|COMPLETED|1-Week Post Follow-Up||17
6575558|NCT01886716|7499746|FG002|COMPLETED|1-Week Post Follow-Up||19
6575559|NCT01886716|7499747|FG003|COMPLETED|1-Week Post Follow-Up||14
6575560|NCT01886716|7499744|FG000|NOT COMPLETED|1-Week Post Follow-Up||0
6575561|NCT01886716|7499745|FG001|NOT COMPLETED|1-Week Post Follow-Up||0
6575562|NCT01886716|7499746|FG002|NOT COMPLETED|1-Week Post Follow-Up||0
6575563|NCT01886716|7499747|FG003|NOT COMPLETED|1-Week Post Follow-Up||0
6575564|NCT01886716|7499744|FG000|STARTED|1-Month Post Follow-Up||20
6575565|NCT01886716|7499745|FG001|STARTED|1-Month Post Follow-Up||17
6575566|NCT01886716|7499746|FG002|STARTED|1-Month Post Follow-Up||19
6575567|NCT01886716|7499747|FG003|STARTED|1-Month Post Follow-Up||14
6575568|NCT01886716|7499744|FG000|COMPLETED|1-Month Post Follow-Up||20
6575569|NCT01886716|7499745|FG001|COMPLETED|1-Month Post Follow-Up||17
6575570|NCT01886716|7499746|FG002|COMPLETED|1-Month Post Follow-Up||19
6575571|NCT01886716|7499747|FG003|COMPLETED|1-Month Post Follow-Up||14
6575572|NCT01886716|7499744|FG000|NOT COMPLETED|1-Month Post Follow-Up||0
6575573|NCT01886716|7499745|FG001|NOT COMPLETED|1-Month Post Follow-Up||0
6575574|NCT01886716|7499746|FG002|NOT COMPLETED|1-Month Post Follow-Up||0
6575575|NCT01886716|7499747|FG003|NOT COMPLETED|1-Month Post Follow-Up||0
6575576|NCT01886781|7499759|FG000|STARTED|Overall Study||54
6575577|NCT01886781|7499760|FG001|STARTED|Overall Study||27
6575578|NCT01886781|7499759|FG000|COMPLETED|Overall Study||40
6575579|NCT01886781|7499760|FG001|COMPLETED|Overall Study||25
6575580|NCT01886781|7499759|FG000|NOT COMPLETED|Overall Study||14
6575581|NCT01886781|7499760|FG001|NOT COMPLETED|Overall Study||2
6575582|NCT01886807|7499769|FG000|STARTED|Overall Study||164
6575583|NCT01886807|7499770|FG001|STARTED|Overall Study||155
6575584|NCT01886807|7499771|FG002|STARTED|Overall Study||163
6575585|NCT01886807|7499769|FG000|COMPLETED|Overall Study||159
6575586|NCT01886807|7499770|FG001|COMPLETED|Overall Study||145
6575587|NCT01886807|7499771|FG002|COMPLETED|Overall Study||153
6575588|NCT01886807|7499769|FG000|NOT COMPLETED|Overall Study||5
6575589|NCT01886807|7499770|FG001|NOT COMPLETED|Overall Study||10
6575590|NCT01886807|7499771|FG002|NOT COMPLETED|Overall Study||10
6575591|NCT01886833|7499782|FG000|STARTED|Overall Study||420
6575592|NCT01886833|7499782|FG000|COMPLETED|Overall Study||216
6575593|NCT01886833|7499782|FG000|NOT COMPLETED|Overall Study||204
6575594|NCT01886937|7499791|FG000|STARTED|Overall Study||7
6575595|NCT01886937|7499792|FG001|STARTED|Overall Study||6
6575596|NCT01886937|7499791|FG000|COMPLETED|Overall Study||7
6575597|NCT01886937|7499792|FG001|COMPLETED|Overall Study||6
6575598|NCT01886937|7499791|FG000|NOT COMPLETED|Overall Study||0
6575599|NCT01886937|7499792|FG001|NOT COMPLETED|Overall Study||0
6575600|NCT01887132|7499798|FG000|STARTED|Overall Study||4
6575601|NCT01887132|7499798|FG000|COMPLETED|Overall Study||4
6575602|NCT01887132|7499798|FG000|NOT COMPLETED|Overall Study||0
6575603|NCT01887171|7499804|FG000|STARTED|Overall Study||43
6575604|NCT01887171|7499805|FG001|STARTED|Overall Study||43
6575605|NCT01887171|7499804|FG000|COMPLETED|Overall Study||43
6575606|NCT01887171|7499805|FG001|COMPLETED|Overall Study||43
6575607|NCT01887171|7499804|FG000|NOT COMPLETED|Overall Study||0
6575608|NCT01887171|7499805|FG001|NOT COMPLETED|Overall Study||0
6575609|NCT01887210|7499813|FG000|STARTED|Overall Study||33
6575610|NCT01887210|7499814|FG001|STARTED|Overall Study||33
6575611|NCT01887210|7499813|FG000|COMPLETED|Overall Study||32
6575612|NCT01887210|7499814|FG001|COMPLETED|Overall Study||29
6575613|NCT01887210|7499813|FG000|NOT COMPLETED|Overall Study||1
6575614|NCT01887210|7499814|FG001|NOT COMPLETED|Overall Study||4
6575615|NCT01887327|7499823|FG000|STARTED|Overall Study||30
6575616|NCT01887327|7499824|FG001|STARTED|Overall Study||31
6575617|NCT01887327|7499825|FG002|STARTED|Overall Study||30
6575618|NCT01887327|7499823|FG000|COMPLETED|Overall Study||29
6575619|NCT01887327|7499824|FG001|COMPLETED|Overall Study||27
6575620|NCT01887327|7499825|FG002|COMPLETED|Overall Study||27
6575621|NCT01887327|7499823|FG000|NOT COMPLETED|Overall Study||1
6575622|NCT01887327|7499824|FG001|NOT COMPLETED|Overall Study||4
6575623|NCT01887327|7499825|FG002|NOT COMPLETED|Overall Study||3
6575624|NCT01887353|7499836|FG000|STARTED|Overall Study||4
6575625|NCT01887353|7499837|FG001|STARTED|Overall Study||4
6575626|NCT01887353|7499836|FG000|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
6575627|NCT01887353|7499837|FG001|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
6575628|NCT01887353|7499836|FG000|NOT COMPLETED|Overall Study||4
6575629|NCT01887353|7499837|FG001|NOT COMPLETED|Overall Study||3
6575630|NCT01887418|7499846|FG000|STARTED|Overall Study||15
6575631|NCT01887418|7499847|FG001|STARTED|Overall Study||14
6575632|NCT01887418|7499848|FG002|STARTED|Overall Study||10
6575633|NCT01887418|7499846|FG000|COMPLETED|Overall Study||15
6575634|NCT01887418|7499847|FG001|COMPLETED|Overall Study||14
6575635|NCT01887418|7499848|FG002|COMPLETED|Overall Study||9
6575636|NCT01887418|7499846|FG000|NOT COMPLETED|Overall Study||0
6575637|NCT01887418|7499847|FG001|NOT COMPLETED|Overall Study||0
6575638|NCT01887418|7499848|FG002|NOT COMPLETED|Overall Study||1
6575639|NCT01887470|7499860|FG000|STARTED|Overall Study||10
6575640|NCT01887470|7499861|FG001|STARTED|Overall Study||10
6575641|NCT01887470|7499862|FG002|STARTED|Overall Study||10
6575642|NCT01887470|7499863|FG003|STARTED|Overall Study||10
6575643|NCT01887470|7499860|FG000|COMPLETED|Overall Study||10
6575644|NCT01887470|7499861|FG001|COMPLETED|Overall Study||10
6575645|NCT01887470|7499862|FG002|COMPLETED|Overall Study||10
6575646|NCT01887470|7499863|FG003|COMPLETED|Overall Study||10
6575647|NCT01887470|7499860|FG000|NOT COMPLETED|Overall Study||0
6575648|NCT01887470|7499861|FG001|NOT COMPLETED|Overall Study||0
6575649|NCT01887470|7499862|FG002|NOT COMPLETED|Overall Study||0
6575650|NCT01887470|7499863|FG003|NOT COMPLETED|Overall Study||0
6575651|NCT01887587|7499873|FG000|STARTED|Overall Study||5
6575652|NCT01887587|7499873|FG000|COMPLETED|Overall Study||5
6575653|NCT01887587|7499873|FG000|NOT COMPLETED|Overall Study||0
6575654|NCT01887600|7499880|FG000|STARTED|Overall Study||391
6575655|NCT01887600|7499881|FG001|STARTED|Overall Study||203
6575656|NCT01887600|7499880|FG000|Treatment Received|Overall Study||391
6575657|NCT01887600|7499881|FG001|Treatment Received|Overall Study||203
6575658|NCT01887600|7499880|FG000|COMPLETED|Overall Study||245
6575659|NCT01887600|7499881|FG001|COMPLETED|Overall Study||89
6575660|NCT01887600|7499880|FG000|NOT COMPLETED|Overall Study||146
6575661|NCT01887600|7499881|FG001|NOT COMPLETED|Overall Study||114
6575662|NCT01887678|7499890|FG000|STARTED|Overall Study||119
6575663|NCT01887678|7499891|FG001|STARTED|Overall Study||113
6575664|NCT01887678|7499890|FG000|COMPLETED|Overall Study||102
6575665|NCT01887678|7499891|FG001|COMPLETED|Overall Study||85
6575666|NCT01887678|7499890|FG000|NOT COMPLETED|Overall Study||17
6575667|NCT01887678|7499891|FG001|NOT COMPLETED|Overall Study||28
6575668|NCT01887717|7499899|FG000|STARTED|Overall Study||17
6575669|NCT01887717|7499900|FG001|STARTED|Overall Study||19
6575670|NCT01887717|7499899|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
6575671|NCT01887717|7499900|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
6575672|NCT01887717|7499899|FG000|COMPLETED|Overall Study||11
6575673|NCT01887717|7499900|FG001|COMPLETED|Overall Study||8
6575674|NCT01887717|7499899|FG000|NOT COMPLETED|Overall Study||6
6575675|NCT01887717|7499900|FG001|NOT COMPLETED|Overall Study||11
6575676|NCT01887990|7499910|FG000|STARTED|Overall Study||7
6575677|NCT01887990|7499911|FG001|STARTED|Overall Study||7
6575678|NCT01887990|7499912|FG002|STARTED|Overall Study||2
6575679|NCT01887990|7499913|FG003|STARTED|Overall Study||2
6575680|NCT01887990|7499910|FG000|COMPLETED|Overall Study||7
6575681|NCT01887990|7499911|FG001|COMPLETED|Overall Study||7
6575682|NCT01887990|7499912|FG002|COMPLETED|Overall Study||2
6575683|NCT01887990|7499913|FG003|COMPLETED|Overall Study||2
6575684|NCT01887990|7499910|FG000|NOT COMPLETED|Overall Study||0
6575685|NCT01887990|7499911|FG001|NOT COMPLETED|Overall Study||0
6575686|NCT01887990|7499912|FG002|NOT COMPLETED|Overall Study||0
6575687|NCT01887990|7499913|FG003|NOT COMPLETED|Overall Study||0
6575688|NCT01888003|7499928|FG000|STARTED|Overall Study||5
6575689|NCT01888003|7499929|FG001|STARTED|Overall Study||6
6575690|NCT01888003|7499930|FG002|STARTED|Overall Study||40
6575691|NCT01888003|7499928|FG000|COMPLETED|Overall Study||0
6575692|NCT01888003|7499929|FG001|COMPLETED|Overall Study||0
6575693|NCT01888003|7499930|FG002|COMPLETED|Overall Study||0
6575694|NCT01888003|7499928|FG000|NOT COMPLETED|Overall Study||5
6575695|NCT01888003|7499929|FG001|NOT COMPLETED|Overall Study||6
6575696|NCT01888003|7499930|FG002|NOT COMPLETED|Overall Study||40
6575697|NCT01888367|7499941|FG000|STARTED|Overall Study||296
6575698|NCT01888367|7499942|FG001|STARTED|Overall Study||71
6575699|NCT01888367|7499943|FG002|STARTED|Overall Study||78
6575700|NCT01888367|7499941|FG000|COMPLETED|Overall Study||288
6575701|NCT01888367|7499942|FG001|COMPLETED|Overall Study||66
6575702|NCT01888367|7499943|FG002|COMPLETED|Overall Study||73
6575703|NCT01888367|7499941|FG000|NOT COMPLETED|Overall Study||8
6575704|NCT01888367|7499942|FG001|NOT COMPLETED|Overall Study||5
6575705|NCT01888367|7499943|FG002|NOT COMPLETED|Overall Study||5
6575706|NCT01888432|7499953|FG000|STARTED|12-month Analysis (FAS)||142
6575707|NCT01888432|7499954|FG001|STARTED|12-month Analysis (FAS)||142
6575708|NCT01888432|7499953|FG000|COMPLETED|12-month Analysis (FAS)||131
6575709|NCT01888432|7499954|FG001|COMPLETED|12-month Analysis (FAS)||133
6575710|NCT01888432|7499953|FG000|NOT COMPLETED|12-month Analysis (FAS)||11
6575711|NCT01888432|7499954|FG001|NOT COMPLETED|12-month Analysis (FAS)||9
6575712|NCT01888432|7499953|FG000|STARTED|24-month Analysis (FAS)||142
6575713|NCT01888432|7499954|FG001|STARTED|24-month Analysis (FAS)||142
6575714|NCT01888432|7499953|FG000|COMPLETED|24-month Analysis (FAS)||125
6575715|NCT01888432|7499954|FG001|COMPLETED|24-month Analysis (FAS)||125
6575716|NCT01888432|7499953|FG000|NOT COMPLETED|24-month Analysis (FAS)||17
6575717|NCT01888432|7499954|FG001|NOT COMPLETED|24-month Analysis (FAS)||17
6575718|NCT01888432|7499953|FG000|STARTED|36-month Analysis (Extension)||13
6575719|NCT01888432|7499954|FG001|STARTED|36-month Analysis (Extension)||5
6575720|NCT01888432|7499953|FG000|COMPLETED|36-month Analysis (Extension)||12
6575721|NCT01888432|7499954|FG001|COMPLETED|36-month Analysis (Extension)||5
6575722|NCT01888432|7499953|FG000|NOT COMPLETED|36-month Analysis (Extension)||1
6575723|NCT01888432|7499954|FG001|NOT COMPLETED|36-month Analysis (Extension)||0
6575724|NCT01888484|7499962|FG000|STARTED|Overall Study||12
6575725|NCT01888484|7499963|FG001|STARTED|Overall Study||14
6575726|NCT01888484|7499964|FG002|STARTED|Overall Study||12
6575727|NCT01888484|7499965|FG003|STARTED|Overall Study||37
6575728|NCT01888484|7499962|FG000|COMPLETED|Overall Study||12
6575729|NCT01888484|7499963|FG001|COMPLETED|Overall Study||14
6575730|NCT01888484|7499964|FG002|COMPLETED|Overall Study||8
6575731|NCT01888484|7499965|FG003|COMPLETED|Overall Study||34
6575732|NCT01888484|7499962|FG000|NOT COMPLETED|Overall Study||0
6575733|NCT01888484|7499963|FG001|NOT COMPLETED|Overall Study||0
6575734|NCT01888484|7499964|FG002|NOT COMPLETED|Overall Study||4
6575735|NCT01888484|7499965|FG003|NOT COMPLETED|Overall Study||3
6575736|NCT01888497|7499970|FG000|STARTED|First Intervention Period||13
6575737|NCT01888497|7499971|FG001|STARTED|First Intervention Period||14
6575738|NCT01888497|7499972|FG002|STARTED|First Intervention Period||15
6575739|NCT01888497|7499973|FG003|STARTED|First Intervention Period||17
6575740|NCT01888497|7499970|FG000|COMPLETED|First Intervention Period||13
6575741|NCT01888497|7499971|FG001|COMPLETED|First Intervention Period||14
6575742|NCT01888497|7499972|FG002|COMPLETED|First Intervention Period||15
6575743|NCT01888497|7499973|FG003|COMPLETED|First Intervention Period||17
6575744|NCT01888497|7499970|FG000|NOT COMPLETED|First Intervention Period||0
6575745|NCT01888497|7499971|FG001|NOT COMPLETED|First Intervention Period||0
6575746|NCT01888497|7499972|FG002|NOT COMPLETED|First Intervention Period||0
6575747|NCT01888497|7499973|FG003|NOT COMPLETED|First Intervention Period||0
6575748|NCT01888497|7499970|FG000|STARTED|Washout Period 1||13
6575749|NCT01888497|7499971|FG001|STARTED|Washout Period 1||14
6575750|NCT01888497|7499972|FG002|STARTED|Washout Period 1||15
6575751|NCT01888497|7499973|FG003|STARTED|Washout Period 1||17
6575752|NCT01888497|7499970|FG000|COMPLETED|Washout Period 1||13
6575753|NCT01888497|7499971|FG001|COMPLETED|Washout Period 1||14
6575754|NCT01888497|7499972|FG002|COMPLETED|Washout Period 1||14
6575755|NCT01888497|7499973|FG003|COMPLETED|Washout Period 1||16
6575756|NCT01888497|7499970|FG000|NOT COMPLETED|Washout Period 1||0
6575757|NCT01888497|7499971|FG001|NOT COMPLETED|Washout Period 1||0
6575758|NCT01888497|7499972|FG002|NOT COMPLETED|Washout Period 1||1
6575759|NCT01888497|7499973|FG003|NOT COMPLETED|Washout Period 1||1
6575760|NCT01888497|7499970|FG000|STARTED|Second Intervention Period||13
6575761|NCT01888497|7499971|FG001|STARTED|Second Intervention Period||14
6575762|NCT01888497|7499972|FG002|STARTED|Second Intervention Period||14
6575763|NCT01888497|7499973|FG003|STARTED|Second Intervention Period||16
6575764|NCT01888497|7499970|FG000|COMPLETED|Second Intervention Period||13
6575765|NCT01888497|7499971|FG001|COMPLETED|Second Intervention Period||14
6575766|NCT01888497|7499972|FG002|COMPLETED|Second Intervention Period||14
6575767|NCT01888497|7499973|FG003|COMPLETED|Second Intervention Period||16
6575768|NCT01888497|7499970|FG000|NOT COMPLETED|Second Intervention Period||0
6575769|NCT01888497|7499971|FG001|NOT COMPLETED|Second Intervention Period||0
6575770|NCT01888497|7499972|FG002|NOT COMPLETED|Second Intervention Period||0
6575771|NCT01888497|7499973|FG003|NOT COMPLETED|Second Intervention Period||0
6575772|NCT01888497|7499970|FG000|STARTED|Washout Period 2||13
6575773|NCT01888497|7499971|FG001|STARTED|Washout Period 2||14
6575774|NCT01888497|7499972|FG002|STARTED|Washout Period 2||14
6575775|NCT01888497|7499973|FG003|STARTED|Washout Period 2||16
6575776|NCT01888497|7499970|FG000|COMPLETED|Washout Period 2||13
6575777|NCT01888497|7499971|FG001|COMPLETED|Washout Period 2||14
6575778|NCT01888497|7499972|FG002|COMPLETED|Washout Period 2||14
6575779|NCT01888497|7499973|FG003|COMPLETED|Washout Period 2||14
6575780|NCT01888497|7499970|FG000|NOT COMPLETED|Washout Period 2||0
6575781|NCT01888497|7499971|FG001|NOT COMPLETED|Washout Period 2||0
6575782|NCT01888497|7499972|FG002|NOT COMPLETED|Washout Period 2||0
6575783|NCT01888497|7499973|FG003|NOT COMPLETED|Washout Period 2||2
6575784|NCT01888497|7499970|FG000|STARTED|Third Intervention Period||13
6575785|NCT01888497|7499971|FG001|STARTED|Third Intervention Period||14
6575786|NCT01888497|7499972|FG002|STARTED|Third Intervention Period||14
6575787|NCT01888497|7499973|FG003|STARTED|Third Intervention Period||14
6575788|NCT01888497|7499970|FG000|COMPLETED|Third Intervention Period||13
6575789|NCT01888497|7499971|FG001|COMPLETED|Third Intervention Period||14
6575790|NCT01888497|7499972|FG002|COMPLETED|Third Intervention Period||14
6575791|NCT01888497|7499973|FG003|COMPLETED|Third Intervention Period||14
6575792|NCT01888497|7499970|FG000|NOT COMPLETED|Third Intervention Period||0
6575793|NCT01888497|7499971|FG001|NOT COMPLETED|Third Intervention Period||0
6575794|NCT01888497|7499972|FG002|NOT COMPLETED|Third Intervention Period||0
6575795|NCT01888497|7499973|FG003|NOT COMPLETED|Third Intervention Period||0
6575796|NCT01888497|7499970|FG000|STARTED|Washout Period 3||13
6575797|NCT01888497|7499971|FG001|STARTED|Washout Period 3||14
6575798|NCT01888497|7499972|FG002|STARTED|Washout Period 3||14
6575799|NCT01888497|7499973|FG003|STARTED|Washout Period 3||14
6575800|NCT01888497|7499970|FG000|COMPLETED|Washout Period 3||13
6575801|NCT01888497|7499971|FG001|COMPLETED|Washout Period 3||14
6575802|NCT01888497|7499972|FG002|COMPLETED|Washout Period 3||14
6575803|NCT01888497|7499973|FG003|COMPLETED|Washout Period 3||14
6575804|NCT01888497|7499970|FG000|NOT COMPLETED|Washout Period 3||0
6575805|NCT01888497|7499971|FG001|NOT COMPLETED|Washout Period 3||0
6575806|NCT01888497|7499972|FG002|NOT COMPLETED|Washout Period 3||0
6575807|NCT01888497|7499973|FG003|NOT COMPLETED|Washout Period 3||0
6575808|NCT01888497|7499970|FG000|STARTED|Fourth Intervention Period||13
6575809|NCT01888497|7499971|FG001|STARTED|Fourth Intervention Period||14
6575810|NCT01888497|7499972|FG002|STARTED|Fourth Intervention Period||14
6575811|NCT01888497|7499973|FG003|STARTED|Fourth Intervention Period||14
6575812|NCT01888497|7499970|FG000|COMPLETED|Fourth Intervention Period||13
6575813|NCT01888497|7499971|FG001|COMPLETED|Fourth Intervention Period||14
6575814|NCT01888497|7499972|FG002|COMPLETED|Fourth Intervention Period||14
6575815|NCT01888497|7499973|FG003|COMPLETED|Fourth Intervention Period||14
6575816|NCT01888497|7499970|FG000|NOT COMPLETED|Fourth Intervention Period||0
6575817|NCT01888497|7499971|FG001|NOT COMPLETED|Fourth Intervention Period||0
6575818|NCT01888497|7499972|FG002|NOT COMPLETED|Fourth Intervention Period||0
6575819|NCT01888497|7499973|FG003|NOT COMPLETED|Fourth Intervention Period||0
6575820|NCT01888640|7499986|FG000|STARTED|Overall Study||103
6575821|NCT01888640|7499987|FG001|STARTED|Overall Study||99
6575822|NCT01888640|7499988|FG002|STARTED|Overall Study||99
6575823|NCT01888640|7499986|FG000|COMPLETED|Overall Study||76
6575824|NCT01888640|7499987|FG001|COMPLETED|Overall Study||68
6575825|NCT01888640|7499988|FG002|COMPLETED|Overall Study||94
6575826|NCT01888640|7499986|FG000|NOT COMPLETED|Overall Study||27
6575827|NCT01888640|7499987|FG001|NOT COMPLETED|Overall Study||31
6575828|NCT01888640|7499988|FG002|NOT COMPLETED|Overall Study||5
6575829|NCT01888874|7500006|FG000|STARTED|Period 1 (Baseline up to Week 12)||86
6575830|NCT01888874|7500007|FG001|STARTED|Period 1 (Baseline up to Week 12)||82
6575831|NCT01888874|7500008|FG002|STARTED|Period 1 (Baseline up to Week 12)||85
6575832|NCT01888874|7500009|FG003|STARTED|Period 1 (Baseline up to Week 12)||86
6575833|NCT01888874|7500010|FG004|STARTED|Period 1 (Baseline up to Week 12)||86
6575834|NCT01888874|7500011|FG005|STARTED|Period 1 (Baseline up to Week 12)||85
6575835|NCT01888874|7500012|FG006|STARTED|Period 1 (Baseline up to Week 12)||84
6575836|NCT01888874|7500006|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||83
6575837|NCT01888874|7500007|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||76
6575838|NCT01888874|7500008|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||78
6575839|NCT01888874|7500009|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||80
6575840|NCT01888874|7500010|FG004|COMPLETED|Period 1 (Baseline up to Week 12)||77
6575841|NCT01888874|7500011|FG005|COMPLETED|Period 1 (Baseline up to Week 12)||80
6575842|NCT01888874|7500012|FG006|COMPLETED|Period 1 (Baseline up to Week 12)||83
6575843|NCT01888874|7500006|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
6575844|NCT01888874|7500007|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
6575845|NCT01888874|7500008|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
6575846|NCT01888874|7500009|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||6
6575847|NCT01888874|7500010|FG004|NOT COMPLETED|Period 1 (Baseline up to Week 12)||9
6575848|NCT01888874|7500011|FG005|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
6575849|NCT01888874|7500012|FG006|NOT COMPLETED|Period 1 (Baseline up to Week 12)||1
6575850|NCT01888874|7500006|FG000|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo group moved to 100 mg QD(15 participants) and 50 mg BID(15 participants).|53
6575851|NCT01888874|7500007|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (19 participants).|57
6575852|NCT01888874|7500008|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 50 mg QD (19 participants) moved to 100 mg QD group.|112
6575853|NCT01888874|7500009|FG003|STARTED|Period 2 (Week 13 to Week 24)||80
6575854|NCT01888874|7500010|FG004|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 25 mg BID group moved to 50 mg BID group (17 participants).|60
6575855|NCT01888874|7500011|FG005|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(15 participants) and 25 mg BID(17 participants) moved to 50 mg BID group.|112
6575856|NCT01888874|7500012|FG006|STARTED|Period 2 (Week 13 to Week 24)||83
6575857|NCT01888874|7500006|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||50
6575858|NCT01888874|7500007|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||55
6575859|NCT01888874|7500008|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||104
6575860|NCT01888874|7500009|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||78
6575861|NCT01888874|7500010|FG004|COMPLETED|Period 2 (Week 13 to Week 24)||57
6575862|NCT01888874|7500011|FG005|COMPLETED|Period 2 (Week 13 to Week 24)||109
6575863|NCT01888874|7500012|FG006|COMPLETED|Period 2 (Week 13 to Week 24)||80
6575864|NCT01888874|7500006|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
6575865|NCT01888874|7500007|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
6575866|NCT01888874|7500008|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||8
6575867|NCT01888874|7500009|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
6575868|NCT01888874|7500010|FG004|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
6575869|NCT01888874|7500011|FG005|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
6575870|NCT01888874|7500012|FG006|NOT COMPLETED|Period 2 (Week 13 to Week 24)||3
6575871|NCT01888900|7500031|FG000|STARTED|Overall Study||22
6575872|NCT01888900|7500032|FG001|STARTED|Overall Study||13
6575873|NCT01888900|7500031|FG000|COMPLETED|Overall Study||22
6575874|NCT01888900|7500032|FG001|COMPLETED|Overall Study||11
6575875|NCT01888900|7500031|FG000|NOT COMPLETED|Overall Study||0
6575876|NCT01888900|7500032|FG001|NOT COMPLETED|Overall Study||2
6575877|NCT01888952|7500040|FG000|STARTED|Overall Study||10
6575878|NCT01888952|7500040|FG000|COMPLETED|Overall Study||10
6575879|NCT01888952|7500040|FG000|NOT COMPLETED|Overall Study||0
6575880|NCT01888965|7500044|FG000|STARTED|Overall Study||9
6575881|NCT01888965|7500044|FG000|COMPLETED|Overall Study||0
6575882|NCT01888965|7500044|FG000|NOT COMPLETED|Overall Study||9
6575883|NCT01889069|7500050|FG000|STARTED|Overall Study||158
6575884|NCT01889069|7500050|FG000|COMPLETED|Overall Study||113
6575885|NCT01889069|7500050|FG000|NOT COMPLETED|Overall Study||45
6575886|NCT01889238|7500060|FG000|STARTED|Overall Study||118
6575887|NCT01889238|7500060|FG000|COMPLETED|Overall Study|DP, AE, death, treatment withdrawal were considered completed (defined in protocol).|109
6575888|NCT01889238|7500060|FG000|NOT COMPLETED|Overall Study||9
6575889|NCT01889251|7500066|FG000|STARTED|Overall Study||115
6575890|NCT01889251|7500067|FG001|STARTED|Overall Study||57
6575891|NCT01889251|7500066|FG000|COMPLETED|Overall Study||114
6575892|NCT01889251|7500067|FG001|COMPLETED|Overall Study||57
6575893|NCT01889251|7500066|FG000|NOT COMPLETED|Overall Study||1
6575894|NCT01889251|7500067|FG001|NOT COMPLETED|Overall Study||0
6575895|NCT01889355|7500073|FG000|STARTED|Overall Study||115
6575896|NCT01889355|7500073|FG000|COMPLETED|Overall Study||113
6575897|NCT01889355|7500073|FG000|NOT COMPLETED|Overall Study||2
6575898|NCT01889563|7500079|FG000|STARTED|Overall Study||17
6575899|NCT01889563|7500080|FG001|STARTED|Overall Study||15
6575900|NCT01889563|7500079|FG000|COMPLETED|Overall Study||10
6575901|NCT01889563|7500080|FG001|COMPLETED|Overall Study||10
6575902|NCT01889563|7500079|FG000|NOT COMPLETED|Overall Study||7
6575903|NCT01889563|7500080|FG001|NOT COMPLETED|Overall Study||5
6575904|NCT01889602|7500089|FG000|STARTED|First Intervention||20
6575905|NCT01889602|7500090|FG001|STARTED|First Intervention||20
6575906|NCT01889602|7500091|FG002|STARTED|First Intervention||20
6575907|NCT01889602|7500089|FG000|COMPLETED|First Intervention||19
6575908|NCT01889602|7500090|FG001|COMPLETED|First Intervention||17
6575909|NCT01889602|7500091|FG002|COMPLETED|First Intervention||18
6575910|NCT01889602|7500089|FG000|NOT COMPLETED|First Intervention||1
6575911|NCT01889602|7500090|FG001|NOT COMPLETED|First Intervention||3
6575912|NCT01889602|7500091|FG002|NOT COMPLETED|First Intervention||2
6575913|NCT01889602|7500089|FG000|STARTED|First Washout Period of at Least 2 Weeks||19
6575914|NCT01889602|7500090|FG001|STARTED|First Washout Period of at Least 2 Weeks||17
6575915|NCT01889602|7500091|FG002|STARTED|First Washout Period of at Least 2 Weeks||18
6575916|NCT01889602|7500089|FG000|COMPLETED|First Washout Period of at Least 2 Weeks||19
6575917|NCT01889602|7500090|FG001|COMPLETED|First Washout Period of at Least 2 Weeks||17
6575918|NCT01889602|7500091|FG002|COMPLETED|First Washout Period of at Least 2 Weeks||18
6575919|NCT01889602|7500089|FG000|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
6575920|NCT01889602|7500090|FG001|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
6575921|NCT01889602|7500091|FG002|NOT COMPLETED|First Washout Period of at Least 2 Weeks||0
6575922|NCT01889602|7500089|FG000|STARTED|Second Intervention||19
6575923|NCT01889602|7500090|FG001|STARTED|Second Intervention||17
6575924|NCT01889602|7500091|FG002|STARTED|Second Intervention||18
6575925|NCT01889602|7500089|FG000|COMPLETED|Second Intervention||18
6575926|NCT01889602|7500090|FG001|COMPLETED|Second Intervention||17
6575927|NCT01889602|7500091|FG002|COMPLETED|Second Intervention||16
6575928|NCT01889602|7500089|FG000|NOT COMPLETED|Second Intervention||1
6575929|NCT01889602|7500090|FG001|NOT COMPLETED|Second Intervention||0
6575930|NCT01889602|7500091|FG002|NOT COMPLETED|Second Intervention||2
6575931|NCT01889602|7500089|FG000|STARTED|Second Washout Period of at Least 2 Week||18
6575932|NCT01889602|7500090|FG001|STARTED|Second Washout Period of at Least 2 Week||17
6575933|NCT01889602|7500091|FG002|STARTED|Second Washout Period of at Least 2 Week||16
6575934|NCT01889602|7500089|FG000|COMPLETED|Second Washout Period of at Least 2 Week||18
6575935|NCT01889602|7500090|FG001|COMPLETED|Second Washout Period of at Least 2 Week||17
6575936|NCT01889602|7500091|FG002|COMPLETED|Second Washout Period of at Least 2 Week||16
6575937|NCT01889602|7500089|FG000|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
6575938|NCT01889602|7500090|FG001|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
6575939|NCT01889602|7500091|FG002|NOT COMPLETED|Second Washout Period of at Least 2 Week||0
6575940|NCT01889602|7500089|FG000|STARTED|Third Intervention||18
6575941|NCT01889602|7500090|FG001|STARTED|Third Intervention||17
6575942|NCT01889602|7500091|FG002|STARTED|Third Intervention||16
6575943|NCT01889602|7500089|FG000|COMPLETED|Third Intervention||15
6575944|NCT01889602|7500090|FG001|COMPLETED|Third Intervention||15
6575945|NCT01889602|7500091|FG002|COMPLETED|Third Intervention||16
6575946|NCT01889602|7500089|FG000|NOT COMPLETED|Third Intervention||3
6575947|NCT01889602|7500090|FG001|NOT COMPLETED|Third Intervention||2
6575948|NCT01889602|7500091|FG002|NOT COMPLETED|Third Intervention||0
6575949|NCT01889602|7500089|FG000|STARTED|Third Washout Period of at Least 2 Weeks||15
6575950|NCT01889602|7500090|FG001|STARTED|Third Washout Period of at Least 2 Weeks||15
6575951|NCT01889602|7500091|FG002|STARTED|Third Washout Period of at Least 2 Weeks||16
6575952|NCT01889602|7500089|FG000|COMPLETED|Third Washout Period of at Least 2 Weeks||15
6575953|NCT01889602|7500090|FG001|COMPLETED|Third Washout Period of at Least 2 Weeks||15
6575954|NCT01889602|7500091|FG002|COMPLETED|Third Washout Period of at Least 2 Weeks||16
6575955|NCT01889602|7500089|FG000|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
6575956|NCT01889602|7500090|FG001|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
6658273|NCT02477670|7588834|FG006|NOT COMPLETED|Stage 2||0
6658274|NCT02477709|7588845|FG000|STARTED|Overall Study||6
6658275|NCT02477709|7588845|FG000|COMPLETED|Overall Study||6
6658276|NCT02477709|7588845|FG000|NOT COMPLETED|Overall Study||0
6658277|NCT02477800|7588852|FG000|STARTED|Placebo-Controlled Period||545
6658278|NCT02477800|7588853|FG001|STARTED|Placebo-Controlled Period||547
6658279|NCT02477800|7588854|FG002|STARTED|Placebo-Controlled Period||555
6658280|NCT02477800|7588855|FG003|STARTED|Placebo-Controlled Period||0
6658281|NCT02477800|7588856|FG004|STARTED|Placebo-Controlled Period||0
6658282|NCT02477800|7588857|FG005|STARTED|Placebo-Controlled Period||0
6658283|NCT02477800|7588858|FG006|STARTED|Placebo-Controlled Period||0
6658284|NCT02477800|7588852|FG000|COMPLETED|Placebo-Controlled Period||325
6658285|NCT02477800|7588853|FG001|COMPLETED|Placebo-Controlled Period||325
6658286|NCT02477800|7588854|FG002|COMPLETED|Placebo-Controlled Period||288
6658287|NCT02477800|7588855|FG003|COMPLETED|Placebo-Controlled Period||0
6658288|NCT02477800|7588856|FG004|COMPLETED|Placebo-Controlled Period||0
6658289|NCT02477800|7588857|FG005|COMPLETED|Placebo-Controlled Period||0
6658290|NCT02477800|7588858|FG006|COMPLETED|Placebo-Controlled Period||0
6658291|NCT02477800|7588852|FG000|NOT COMPLETED|Placebo-Controlled Period||220
6658292|NCT02477800|7588853|FG001|NOT COMPLETED|Placebo-Controlled Period||222
6658293|NCT02477800|7588854|FG002|NOT COMPLETED|Placebo-Controlled Period||267
6658294|NCT02477800|7588855|FG003|NOT COMPLETED|Placebo-Controlled Period||0
6658295|NCT02477800|7588856|FG004|NOT COMPLETED|Placebo-Controlled Period||0
6658296|NCT02477800|7588857|FG005|NOT COMPLETED|Placebo-Controlled Period||0
6658297|NCT02477800|7588858|FG006|NOT COMPLETED|Placebo-Controlled Period||0
6658298|NCT02477800|7588852|FG000|STARTED|Long Term Extension Period||0
6658299|NCT02477800|7588853|FG001|STARTED|Long Term Extension Period||0
6658300|NCT02477800|7588854|FG002|STARTED|Long Term Extension Period||0
6658301|NCT02477800|7588855|FG003|STARTED|Long Term Extension Period|12 PC completers did not enter LTE.|150
6658302|NCT02477800|7588856|FG004|STARTED|Long Term Extension Period|11 PC completers did not enter LTE.|152
6658303|NCT02477800|7588857|FG005|STARTED|Long Term Extension Period|26 PC completers did not enter LTE.|299
6658304|NCT02477800|7588858|FG006|STARTED|Long Term Extension Period|37 PC completers did not enter LTE.|251
6658305|NCT02477800|7588852|FG000|COMPLETED|Long Term Extension Period||0
6658306|NCT02477800|7588853|FG001|COMPLETED|Long Term Extension Period||0
6658307|NCT02477800|7588854|FG002|COMPLETED|Long Term Extension Period||0
6658308|NCT02477800|7588855|FG003|COMPLETED|Long Term Extension Period||0
6658309|NCT02477800|7588856|FG004|COMPLETED|Long Term Extension Period||0
6658310|NCT02477800|7588857|FG005|COMPLETED|Long Term Extension Period||0
6658311|NCT02477800|7588858|FG006|COMPLETED|Long Term Extension Period||0
6658312|NCT02477800|7588852|FG000|NOT COMPLETED|Long Term Extension Period||0
6658313|NCT02477800|7588853|FG001|NOT COMPLETED|Long Term Extension Period||0
6658314|NCT02477800|7588854|FG002|NOT COMPLETED|Long Term Extension Period||0
6658315|NCT02477800|7588855|FG003|NOT COMPLETED|Long Term Extension Period||150
6658316|NCT02477800|7588856|FG004|NOT COMPLETED|Long Term Extension Period||152
6658317|NCT02477800|7588857|FG005|NOT COMPLETED|Long Term Extension Period||299
6658318|NCT02477800|7588858|FG006|NOT COMPLETED|Long Term Extension Period||251
6658319|NCT02477839|7588872|FG000|STARTED|Overall Study||127
6575957|NCT01889602|7500091|FG002|NOT COMPLETED|Third Washout Period of at Least 2 Weeks||0
6575958|NCT01889667|7500110|FG000|STARTED|Overall Study||10
6575959|NCT01889667|7500111|FG001|STARTED|Overall Study||10
6575960|NCT01889667|7500112|FG002|STARTED|Overall Study||10
6575961|NCT01889667|7500110|FG000|COMPLETED|Overall Study||10
6575962|NCT01889667|7500111|FG001|COMPLETED|Overall Study||10
6575963|NCT01889667|7500112|FG002|COMPLETED|Overall Study||10
6575964|NCT01889667|7500110|FG000|NOT COMPLETED|Overall Study||0
6575965|NCT01889667|7500111|FG001|NOT COMPLETED|Overall Study||0
6575966|NCT01889667|7500112|FG002|NOT COMPLETED|Overall Study||0
6575967|NCT01889797|7500124|FG000|STARTED|Overall Study||16
6575968|NCT01889797|7500125|FG001|STARTED|Overall Study||16
6575969|NCT01889797|7500124|FG000|COMPLETED|Overall Study||16
6575970|NCT01889797|7500125|FG001|COMPLETED|Overall Study||16
6575971|NCT01889797|7500124|FG000|NOT COMPLETED|Overall Study||0
6575972|NCT01889797|7500125|FG001|NOT COMPLETED|Overall Study||0
6575973|NCT01889862|7500131|FG000|STARTED|Part 1 (Up to 13 Weeks)||86
6575974|NCT01889862|7500132|FG001|STARTED|Part 1 (Up to 13 Weeks)||0
6575975|NCT01889862|7500133|FG002|STARTED|Part 1 (Up to 13 Weeks)||78
6575976|NCT01889862|7500134|FG003|STARTED|Part 1 (Up to 13 Weeks)||0
6575977|NCT01889862|7500135|FG004|STARTED|Part 1 (Up to 13 Weeks)||0
6575978|NCT01889862|7500131|FG000|COMPLETED|Part 1 (Up to 13 Weeks)|Out of 164, total 12 subjects have not completed Part 1.|74
6575979|NCT01889862|7500132|FG001|COMPLETED|Part 1 (Up to 13 Weeks)||0
6575980|NCT01889862|7500133|FG002|COMPLETED|Part 1 (Up to 13 Weeks)||78
6575981|NCT01889862|7500134|FG003|COMPLETED|Part 1 (Up to 13 Weeks)||0
6575982|NCT01889862|7500135|FG004|COMPLETED|Part 1 (Up to 13 Weeks)||0
6575983|NCT01889862|7500131|FG000|NOT COMPLETED|Part 1 (Up to 13 Weeks)||12
6575984|NCT01889862|7500132|FG001|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
6575985|NCT01889862|7500133|FG002|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
6575986|NCT01889862|7500134|FG003|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
6575987|NCT01889862|7500135|FG004|NOT COMPLETED|Part 1 (Up to 13 Weeks)||0
6575988|NCT01889862|7500131|FG000|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|34
6575989|NCT01889862|7500132|FG001|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|15
6575990|NCT01889862|7500133|FG002|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|32
6575991|NCT01889862|7500134|FG003|STARTED|Part 2 (8 Weeks)|Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.|14
6575992|NCT01889862|7500135|FG004|STARTED|Part 2 (8 Weeks)||0
6575993|NCT01889862|7500131|FG000|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
6575994|NCT01889862|7500132|FG001|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
6575995|NCT01889862|7500133|FG002|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||29
6575996|NCT01889862|7500134|FG003|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||14
6575997|NCT01889862|7500135|FG004|Per Amendment #2 of the Protocol|Part 2 (8 Weeks)||0
6575998|NCT01889862|7500131|FG000|COMPLETED|Part 2 (8 Weeks)||34
6575999|NCT01889862|7500132|FG001|COMPLETED|Part 2 (8 Weeks)||15
6576000|NCT01889862|7500133|FG002|COMPLETED|Part 2 (8 Weeks)||31
6576001|NCT01889862|7500134|FG003|COMPLETED|Part 2 (8 Weeks)||14
6576002|NCT01889862|7500135|FG004|COMPLETED|Part 2 (8 Weeks)||0
6576003|NCT01889862|7500131|FG000|NOT COMPLETED|Part 2 (8 Weeks)||0
6576004|NCT01889862|7500132|FG001|NOT COMPLETED|Part 2 (8 Weeks)||0
6576005|NCT01889862|7500133|FG002|NOT COMPLETED|Part 2 (8 Weeks)||1
6576006|NCT01889862|7500134|FG003|NOT COMPLETED|Part 2 (8 Weeks)||0
6576007|NCT01889862|7500135|FG004|NOT COMPLETED|Part 2 (8 Weeks)||0
6576008|NCT01889862|7500131|FG000|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|48
6576009|NCT01889862|7500132|FG001|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 20mg/kg.|0
6576010|NCT01889862|7500133|FG002|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|41
6576011|NCT01889862|7500134|FG003|STARTED|Part 3A/B (6 Week)|Subjects switch from placebo to active 40mg/kg.|0
6576012|NCT01889862|7500135|FG004|STARTED|Part 3A/B (6 Week)||0
6576013|NCT01889862|7500131|FG000|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||34
6576014|NCT01889862|7500132|FG001|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
6576015|NCT01889862|7500133|FG002|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||26
6576016|NCT01889862|7500134|FG003|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
6576017|NCT01889862|7500135|FG004|Per Amendment #2 of the Protocol|Part 3A/B (6 Week)||0
6576018|NCT01889862|7500131|FG000|COMPLETED|Part 3A/B (6 Week)||48
6576019|NCT01889862|7500132|FG001|COMPLETED|Part 3A/B (6 Week)||0
6576020|NCT01889862|7500133|FG002|COMPLETED|Part 3A/B (6 Week)||41
6576021|NCT01889862|7500134|FG003|COMPLETED|Part 3A/B (6 Week)||0
6576022|NCT01889862|7500135|FG004|COMPLETED|Part 3A/B (6 Week)||0
6576023|NCT01889862|7500131|FG000|NOT COMPLETED|Part 3A/B (6 Week)||0
6576024|NCT01889862|7500132|FG001|NOT COMPLETED|Part 3A/B (6 Week)||0
6576025|NCT01889862|7500133|FG002|NOT COMPLETED|Part 3A/B (6 Week)||0
6576026|NCT01889862|7500134|FG003|NOT COMPLETED|Part 3A/B (6 Week)||0
6576027|NCT01889862|7500135|FG004|NOT COMPLETED|Part 3A/B (6 Week)||0
6576028|NCT01889862|7500131|FG000|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
6576029|NCT01889862|7500132|FG001|STARTED|Part 4 (Up to 274 Weeks)||0
6576030|NCT01889862|7500133|FG002|STARTED|Part 4 (Up to 274 Weeks)|51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 & 3 entered 165-302 Part 4 respectively.|0
6576031|NCT01889862|7500134|FG003|STARTED|Part 4 (Up to 274 Weeks)||0
6623963|NCT02212730|7551260|FG001|COMPLETED|Overall Study||3
6576032|NCT01889862|7500135|FG004|STARTED|Part 4 (Up to 274 Weeks)|Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.|202
6576033|NCT01889862|7500131|FG000|COMPLETED|Part 4 (Up to 274 Weeks)||0
6576034|NCT01889862|7500132|FG001|COMPLETED|Part 4 (Up to 274 Weeks)||0
6576035|NCT01889862|7500133|FG002|COMPLETED|Part 4 (Up to 274 Weeks)||0
6576036|NCT01889862|7500134|FG003|COMPLETED|Part 4 (Up to 274 Weeks)||0
6576037|NCT01889862|7500135|FG004|COMPLETED|Part 4 (Up to 274 Weeks)||172
6576038|NCT01889862|7500131|FG000|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
6576039|NCT01889862|7500132|FG001|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
6576040|NCT01889862|7500133|FG002|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
6576041|NCT01889862|7500134|FG003|NOT COMPLETED|Part 4 (Up to 274 Weeks)||0
6576042|NCT01889862|7500135|FG004|NOT COMPLETED|Part 4 (Up to 274 Weeks)||30
6576043|NCT01890031|7500165|FG000|STARTED|Overall Study||50
6576044|NCT01890031|7500166|FG001|STARTED|Overall Study||50
6576045|NCT01890031|7500167|FG002|STARTED|Overall Study||12
6576046|NCT01890031|7500168|FG003|STARTED|Overall Study||11
6576047|NCT01890031|7500169|FG004|STARTED|Overall Study||8
6576048|NCT01890031|7500165|FG000|COMPLETED|Overall Study||50
6576049|NCT01890031|7500166|FG001|COMPLETED|Overall Study||50
6576050|NCT01890031|7500167|FG002|COMPLETED|Overall Study||12
6576051|NCT01890031|7500168|FG003|COMPLETED|Overall Study||11
6576052|NCT01890031|7500169|FG004|COMPLETED|Overall Study||8
6576053|NCT01890031|7500165|FG000|NOT COMPLETED|Overall Study||0
6576054|NCT01890031|7500166|FG001|NOT COMPLETED|Overall Study||0
6576055|NCT01890031|7500167|FG002|NOT COMPLETED|Overall Study||0
6576056|NCT01890031|7500168|FG003|NOT COMPLETED|Overall Study||0
6576057|NCT01890031|7500169|FG004|NOT COMPLETED|Overall Study||0
6576058|NCT01890109|7500183|FG000|STARTED|Overall Study||52
6576059|NCT01890109|7500184|FG001|STARTED|Overall Study||51
6576060|NCT01890109|7500183|FG000|Received Study Treatment|Overall Study||52
6576061|NCT01890109|7500184|FG001|Received Study Treatment|Overall Study||50
6576062|NCT01890109|7500183|FG000|COMPLETED|Overall Study||51
6576063|NCT01890109|7500184|FG001|COMPLETED|Overall Study||46
6576064|NCT01890109|7500183|FG000|NOT COMPLETED|Overall Study||1
6576065|NCT01890109|7500184|FG001|NOT COMPLETED|Overall Study||5
6576066|NCT01890122|7500195|FG000|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
6576067|NCT01890122|7500196|FG001|STARTED|Overall Study||163
6576068|NCT01890122|7500197|FG002|STARTED|Overall Study||159
6576069|NCT01890122|7500198|FG003|STARTED|Overall Study||163
6576070|NCT01890122|7500195|FG000|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
6576071|NCT01890122|7500196|FG001|Treated|Overall Study||162
6576072|NCT01890122|7500197|FG002|Treated|Overall Study||159
6576073|NCT01890122|7500198|FG003|Treated|Overall Study||163
6576074|NCT01890122|7500195|FG000|COMPLETED|Overall Study||135
6576075|NCT01890122|7500196|FG001|COMPLETED|Overall Study||126
6576076|NCT01890122|7500197|FG002|COMPLETED|Overall Study||146
6576077|NCT01890122|7500198|FG003|COMPLETED|Overall Study||104
6576078|NCT01890122|7500195|FG000|NOT COMPLETED|Overall Study||27
6576079|NCT01890122|7500196|FG001|NOT COMPLETED|Overall Study||37
6576080|NCT01890122|7500197|FG002|NOT COMPLETED|Overall Study||13
6576081|NCT01890122|7500198|FG003|NOT COMPLETED|Overall Study||59
6576082|NCT01890148|7500208|FG000|STARTED|Overall Study||5
6576083|NCT01890148|7500208|FG000|COMPLETED|Overall Study||4
6576084|NCT01890148|7500208|FG000|NOT COMPLETED|Overall Study||1
6576085|NCT01890226|7500214|FG000|STARTED|Overall Study||155
6576086|NCT01890226|7500215|FG001|STARTED|Overall Study||156
6576087|NCT01890226|7500214|FG000|COMPLETED|Overall Study||155
6576088|NCT01890226|7500215|FG001|COMPLETED|Overall Study||156
6576089|NCT01890226|7500214|FG000|NOT COMPLETED|Overall Study||0
6576090|NCT01890226|7500215|FG001|NOT COMPLETED|Overall Study||0
6576091|NCT01890265|7500227|FG000|STARTED|Overall Study||50
6576092|NCT01890265|7500228|FG001|STARTED|Overall Study||53
6576093|NCT01890265|7500229|FG002|STARTED|Overall Study||24
6576094|NCT01890265|7500230|FG003|STARTED|Overall Study||12
6576095|NCT01890265|7500231|FG004|STARTED|Overall Study||15
6576096|NCT01890265|7500232|FG005|STARTED|Overall Study||6
6576097|NCT01890265|7500227|FG000|Safety Population|Overall Study||50
6576098|NCT01890265|7500228|FG001|Safety Population|Overall Study||53
6576099|NCT01890265|7500229|FG002|Safety Population|Overall Study||24
6576100|NCT01890265|7500230|FG003|Safety Population|Overall Study||12
6576101|NCT01890265|7500231|FG004|Safety Population|Overall Study||15
6576102|NCT01890265|7500232|FG005|Safety Population|Overall Study||6
6576103|NCT01890265|7500227|FG000|Intent-to-Treat (ITT) Population|Overall Study||50
6576104|NCT01890265|7500228|FG001|Intent-to-Treat (ITT) Population|Overall Study||51
6576105|NCT01890265|7500229|FG002|Intent-to-Treat (ITT) Population|Overall Study||24
6576106|NCT01890265|7500230|FG003|Intent-to-Treat (ITT) Population|Overall Study||12
6576107|NCT01890265|7500231|FG004|Intent-to-Treat (ITT) Population|Overall Study||15
6576108|NCT01890265|7500232|FG005|Intent-to-Treat (ITT) Population|Overall Study||6
6576109|NCT01890265|7500227|FG000|COMPLETED|Overall Study||40
6576110|NCT01890265|7500228|FG001|COMPLETED|Overall Study||40
6576111|NCT01890265|7500229|FG002|COMPLETED|Overall Study||20
6576112|NCT01890265|7500230|FG003|COMPLETED|Overall Study||12
6576113|NCT01890265|7500231|FG004|COMPLETED|Overall Study||13
6576114|NCT01890265|7500232|FG005|COMPLETED|Overall Study||6
6576115|NCT01890265|7500227|FG000|NOT COMPLETED|Overall Study||10
6576116|NCT01890265|7500228|FG001|NOT COMPLETED|Overall Study||13
6576117|NCT01890265|7500229|FG002|NOT COMPLETED|Overall Study||4
6576118|NCT01890265|7500230|FG003|NOT COMPLETED|Overall Study||0
6576119|NCT01890265|7500231|FG004|NOT COMPLETED|Overall Study||2
6576120|NCT01890265|7500232|FG005|NOT COMPLETED|Overall Study||0
6576121|NCT01890343|7500245|FG000|STARTED|Overall Study||8
6576122|NCT01890343|7500246|FG001|STARTED|Overall Study||10
6576123|NCT01890343|7500247|FG002|STARTED|Overall Study||10
6576124|NCT01890343|7500245|FG000|COMPLETED|Overall Study||8
6576125|NCT01890343|7500246|FG001|COMPLETED|Overall Study||10
6576126|NCT01890343|7500247|FG002|COMPLETED|Overall Study||10
6576127|NCT01890343|7500245|FG000|NOT COMPLETED|Overall Study||0
6576128|NCT01890343|7500246|FG001|NOT COMPLETED|Overall Study||0
6576129|NCT01890343|7500247|FG002|NOT COMPLETED|Overall Study||0
6576130|NCT01890421|7500255|FG000|STARTED|Overall Study||426
6576131|NCT01890421|7500255|FG000|COMPLETED|Overall Study||415
6576132|NCT01890421|7500255|FG000|NOT COMPLETED|Overall Study||11
6576133|NCT01890434|7500259|FG000|STARTED|Overall Study||478
6576134|NCT01890434|7500259|FG000|Evaluated for Efficacy|Overall Study||389
6576135|NCT01890434|7500259|FG000|COMPLETED|Overall Study||458
6576136|NCT01890434|7500259|FG000|NOT COMPLETED|Overall Study||20
6576137|NCT01890473|7500265|FG000|STARTED|Overall Study||111
6576138|NCT01890473|7500266|FG001|STARTED|Overall Study||113
6576139|NCT01890473|7500265|FG000|COMPLETED|Overall Study||109
6576140|NCT01890473|7500266|FG001|COMPLETED|Overall Study||113
6576141|NCT01890473|7500265|FG000|NOT COMPLETED|Overall Study||2
6576142|NCT01890473|7500266|FG001|NOT COMPLETED|Overall Study||0
6576143|NCT01890512|7500274|FG000|STARTED|Overall Study||20
6576144|NCT01890512|7500274|FG000|COMPLETED|Overall Study||17
6576145|NCT01890512|7500274|FG000|NOT COMPLETED|Overall Study||3
6576146|NCT01890642|7500281|FG000|STARTED|Overall Study||56
6576147|NCT01890642|7500282|FG001|STARTED|Overall Study||53
6576148|NCT01890642|7500283|FG002|STARTED|Overall Study||96
6576149|NCT01890642|7500281|FG000|COMPLETED|Overall Study||56
6576150|NCT01890642|7500282|FG001|COMPLETED|Overall Study||53
6576151|NCT01890642|7500283|FG002|COMPLETED|Overall Study||96
6576152|NCT01890642|7500281|FG000|NOT COMPLETED|Overall Study||0
6576153|NCT01890642|7500282|FG001|NOT COMPLETED|Overall Study||0
6576154|NCT01890642|7500283|FG002|NOT COMPLETED|Overall Study||0
6576155|NCT01890707|7500293|FG000|STARTED|Overall Study||11
6576156|NCT01890707|7500294|FG001|STARTED|Overall Study||8
6576157|NCT01890707|7500293|FG000|COMPLETED|Overall Study||10
6576158|NCT01890707|7500294|FG001|COMPLETED|Overall Study||7
6576159|NCT01890707|7500293|FG000|NOT COMPLETED|Overall Study||1
6576160|NCT01890707|7500294|FG001|NOT COMPLETED|Overall Study||1
6576161|NCT01890746|7500302|FG000|STARTED|Overall Study||74
6576162|NCT01890746|7500303|FG001|STARTED|Overall Study||74
6576163|NCT01890746|7500302|FG000|COMPLETED|Overall Study||22
6576164|NCT01890746|7500303|FG001|COMPLETED|Overall Study||33
6576165|NCT01890746|7500302|FG000|NOT COMPLETED|Overall Study||52
6576166|NCT01890746|7500303|FG001|NOT COMPLETED|Overall Study||41
6576167|NCT01890785|7500315|FG000|STARTED|First Intervention||5
6576168|NCT01890785|7500316|FG001|STARTED|First Intervention||5
6576169|NCT01890785|7500317|FG002|STARTED|First Intervention||5
6576170|NCT01890785|7500318|FG003|STARTED|First Intervention||5
6576171|NCT01890785|7500319|FG004|STARTED|First Intervention||5
6576172|NCT01890785|7500320|FG005|STARTED|First Intervention||5
6576173|NCT01890785|7500315|FG000|COMPLETED|First Intervention||5
6576174|NCT01890785|7500316|FG001|COMPLETED|First Intervention||5
6576175|NCT01890785|7500317|FG002|COMPLETED|First Intervention||5
6576176|NCT01890785|7500318|FG003|COMPLETED|First Intervention||5
6576177|NCT01890785|7500319|FG004|COMPLETED|First Intervention||5
6576178|NCT01890785|7500320|FG005|COMPLETED|First Intervention||5
6576179|NCT01890785|7500315|FG000|NOT COMPLETED|First Intervention||0
6576180|NCT01890785|7500316|FG001|NOT COMPLETED|First Intervention||0
6576181|NCT01890785|7500317|FG002|NOT COMPLETED|First Intervention||0
6576182|NCT01890785|7500318|FG003|NOT COMPLETED|First Intervention||0
6576183|NCT01890785|7500319|FG004|NOT COMPLETED|First Intervention||0
6576184|NCT01890785|7500320|FG005|NOT COMPLETED|First Intervention||0
6576185|NCT01890785|7500315|FG000|STARTED|Second Intervention||5
6576186|NCT01890785|7500316|FG001|STARTED|Second Intervention||5
6576187|NCT01890785|7500317|FG002|STARTED|Second Intervention||5
6576188|NCT01890785|7500318|FG003|STARTED|Second Intervention||5
6576189|NCT01890785|7500319|FG004|STARTED|Second Intervention||5
6576190|NCT01890785|7500320|FG005|STARTED|Second Intervention||5
6576191|NCT01890785|7500315|FG000|COMPLETED|Second Intervention||5
6576192|NCT01890785|7500316|FG001|COMPLETED|Second Intervention||5
6576193|NCT01890785|7500317|FG002|COMPLETED|Second Intervention||5
6576194|NCT01890785|7500318|FG003|COMPLETED|Second Intervention||5
6576195|NCT01890785|7500319|FG004|COMPLETED|Second Intervention||5
6576196|NCT01890785|7500320|FG005|COMPLETED|Second Intervention||5
6576197|NCT01890785|7500315|FG000|NOT COMPLETED|Second Intervention||0
6576198|NCT01890785|7500316|FG001|NOT COMPLETED|Second Intervention||0
6576199|NCT01890785|7500317|FG002|NOT COMPLETED|Second Intervention||0
6576200|NCT01890785|7500318|FG003|NOT COMPLETED|Second Intervention||0
6576201|NCT01890785|7500319|FG004|NOT COMPLETED|Second Intervention||0
6576202|NCT01890785|7500320|FG005|NOT COMPLETED|Second Intervention||0
6576203|NCT01890785|7500315|FG000|STARTED|Third Intervention||5
6576204|NCT01890785|7500316|FG001|STARTED|Third Intervention||5
6576205|NCT01890785|7500317|FG002|STARTED|Third Intervention||5
6576206|NCT01890785|7500318|FG003|STARTED|Third Intervention||5
6576207|NCT01890785|7500319|FG004|STARTED|Third Intervention||5
6576208|NCT01890785|7500320|FG005|STARTED|Third Intervention||5
6576209|NCT01890785|7500315|FG000|COMPLETED|Third Intervention||5
6576210|NCT01890785|7500316|FG001|COMPLETED|Third Intervention||4
6576211|NCT01890785|7500317|FG002|COMPLETED|Third Intervention||5
6576212|NCT01890785|7500318|FG003|COMPLETED|Third Intervention||5
6576213|NCT01890785|7500319|FG004|COMPLETED|Third Intervention||5
6576214|NCT01890785|7500320|FG005|COMPLETED|Third Intervention||5
6576215|NCT01890785|7500315|FG000|NOT COMPLETED|Third Intervention||0
6576216|NCT01890785|7500316|FG001|NOT COMPLETED|Third Intervention||1
6576217|NCT01890785|7500317|FG002|NOT COMPLETED|Third Intervention||0
6576218|NCT01890785|7500318|FG003|NOT COMPLETED|Third Intervention||0
6576219|NCT01890785|7500319|FG004|NOT COMPLETED|Third Intervention||0
6576220|NCT01890785|7500320|FG005|NOT COMPLETED|Third Intervention||0
6576221|NCT01890915|7500331|FG000|STARTED|Overall Study||11
6576222|NCT01890915|7500332|FG001|STARTED|Overall Study||10
6576223|NCT01890915|7500331|FG000|COMPLETED|Overall Study||8
6576224|NCT01890915|7500332|FG001|COMPLETED|Overall Study||9
6576225|NCT01890915|7500331|FG000|NOT COMPLETED|Overall Study||3
6576226|NCT01890915|7500332|FG001|NOT COMPLETED|Overall Study||1
6576227|NCT01890954|7500340|FG000|STARTED|Overall Study||9
6576228|NCT01890954|7500341|FG001|STARTED|Overall Study||8
6576229|NCT01890954|7500340|FG000|COMPLETED|Overall Study||8
6576230|NCT01890954|7500341|FG001|COMPLETED|Overall Study||8
6576231|NCT01890954|7500340|FG000|NOT COMPLETED|Overall Study||1
6576232|NCT01890954|7500341|FG001|NOT COMPLETED|Overall Study||0
6576233|NCT01890967|7500353|FG000|STARTED|Overall Study||88
6576234|NCT01890967|7500354|FG001|STARTED|Overall Study||88
6576235|NCT01890967|7500355|FG002|STARTED|Overall Study||88
6576236|NCT01890967|7500356|FG003|STARTED|Overall Study||88
6576237|NCT01890967|7500357|FG004|STARTED|Overall Study||87
6576238|NCT01890967|7500358|FG005|STARTED|Overall Study||88
6576239|NCT01890967|7500353|FG000|Received at Least One Dose of Study Drug|Overall Study||87
6576240|NCT01890967|7500354|FG001|Received at Least One Dose of Study Drug|Overall Study||87
6576241|NCT01890967|7500355|FG002|Received at Least One Dose of Study Drug|Overall Study||86
6576242|NCT01890967|7500356|FG003|Received at Least One Dose of Study Drug|Overall Study||86
6576243|NCT01890967|7500357|FG004|Received at Least One Dose of Study Drug|Overall Study||86
6576244|NCT01890967|7500358|FG005|Received at Least One Dose of Study Drug|Overall Study||87
6576245|NCT01890967|7500353|FG000|COMPLETED|Overall Study||78
6576246|NCT01890967|7500354|FG001|COMPLETED|Overall Study||77
6576247|NCT01890967|7500355|FG002|COMPLETED|Overall Study||78
6576248|NCT01890967|7500356|FG003|COMPLETED|Overall Study||77
6576249|NCT01890967|7500357|FG004|COMPLETED|Overall Study||77
6576250|NCT01890967|7500358|FG005|COMPLETED|Overall Study||75
6576251|NCT01890967|7500353|FG000|NOT COMPLETED|Overall Study||10
6576252|NCT01890967|7500354|FG001|NOT COMPLETED|Overall Study||11
6576253|NCT01890967|7500355|FG002|NOT COMPLETED|Overall Study||10
6576254|NCT01890967|7500356|FG003|NOT COMPLETED|Overall Study||11
6576255|NCT01890967|7500357|FG004|NOT COMPLETED|Overall Study||10
6576256|NCT01890967|7500358|FG005|NOT COMPLETED|Overall Study||13
6576257|NCT01891305|7500381|FG000|STARTED|Overall Study||12
6576258|NCT01891305|7500382|FG001|STARTED|Overall Study||12
6576259|NCT01891305|7500383|FG002|STARTED|Overall Study||14
6576260|NCT01891305|7500384|FG003|STARTED|Overall Study||12
6576261|NCT01891305|7500381|FG000|COMPLETED|Overall Study||9
6576262|NCT01891305|7500382|FG001|COMPLETED|Overall Study||11
6576263|NCT01891305|7500383|FG002|COMPLETED|Overall Study||11
6576264|NCT01891305|7500384|FG003|COMPLETED|Overall Study||12
6576265|NCT01891305|7500381|FG000|NOT COMPLETED|Overall Study||3
6576266|NCT01891305|7500382|FG001|NOT COMPLETED|Overall Study||1
6576267|NCT01891305|7500383|FG002|NOT COMPLETED|Overall Study||3
6576268|NCT01891305|7500384|FG003|NOT COMPLETED|Overall Study||0
6576269|NCT01891331|7500398|FG000|STARTED|Overall Study||14
6576270|NCT01891331|7500399|FG001|STARTED|Overall Study||12
6576271|NCT01891331|7500400|FG002|STARTED|Overall Study||14
6576272|NCT01891331|7500401|FG003|STARTED|Overall Study||15
6576273|NCT01891331|7500398|FG000|COMPLETED|Overall Study||12
6576274|NCT01891331|7500399|FG001|COMPLETED|Overall Study||10
6576275|NCT01891331|7500400|FG002|COMPLETED|Overall Study||13
6576276|NCT01891331|7500401|FG003|COMPLETED|Overall Study||13
6576277|NCT01891331|7500398|FG000|NOT COMPLETED|Overall Study||2
6576278|NCT01891331|7500399|FG001|NOT COMPLETED|Overall Study||2
6576279|NCT01891331|7500400|FG002|NOT COMPLETED|Overall Study||1
6576280|NCT01891331|7500401|FG003|NOT COMPLETED|Overall Study||2
6576281|NCT01891357|7500411|FG000|STARTED|Overall Study||64
6576282|NCT01891357|7500411|FG000|COMPLETED|Overall Study||61
6576283|NCT01891357|7500411|FG000|NOT COMPLETED|Overall Study||3
6576284|NCT01891669|7500425|FG000|STARTED|Overall Study||2
6576285|NCT01891669|7500426|FG001|STARTED|Overall Study||2
6576286|NCT01891669|7500427|FG002|STARTED|Overall Study||2
6576287|NCT01891669|7500428|FG003|STARTED|Overall Study||2
6576288|NCT01891669|7500429|FG004|STARTED|Overall Study||2
6576289|NCT01891669|7500430|FG005|STARTED|Overall Study||2
6576290|NCT01891669|7500431|FG006|STARTED|Overall Study||2
6576291|NCT01891669|7500432|FG007|STARTED|Overall Study||6
6576292|NCT01891669|7500433|FG008|STARTED|Overall Study||3
6576293|NCT01891669|7500434|FG009|STARTED|Overall Study||3
6576294|NCT01891669|7500425|FG000|COMPLETED|Overall Study||0
6576295|NCT01891669|7500426|FG001|COMPLETED|Overall Study||1
6576296|NCT01891669|7500427|FG002|COMPLETED|Overall Study||2
6576297|NCT01891669|7500428|FG003|COMPLETED|Overall Study||2
6576298|NCT01891669|7500429|FG004|COMPLETED|Overall Study||2
6576299|NCT01891669|7500430|FG005|COMPLETED|Overall Study||2
6576300|NCT01891669|7500431|FG006|COMPLETED|Overall Study||1
6576301|NCT01891669|7500432|FG007|COMPLETED|Overall Study||2
6576302|NCT01891669|7500433|FG008|COMPLETED|Overall Study||2
6576303|NCT01891669|7500434|FG009|COMPLETED|Overall Study||1
6576304|NCT01891669|7500425|FG000|NOT COMPLETED|Overall Study||2
6576305|NCT01891669|7500426|FG001|NOT COMPLETED|Overall Study||1
6576306|NCT01891669|7500427|FG002|NOT COMPLETED|Overall Study||0
6576307|NCT01891669|7500428|FG003|NOT COMPLETED|Overall Study||0
6576308|NCT01891669|7500429|FG004|NOT COMPLETED|Overall Study||0
6576309|NCT01891669|7500430|FG005|NOT COMPLETED|Overall Study||0
6576310|NCT01891669|7500431|FG006|NOT COMPLETED|Overall Study||1
6576311|NCT01891669|7500432|FG007|NOT COMPLETED|Overall Study||4
6576312|NCT01891669|7500433|FG008|NOT COMPLETED|Overall Study||1
6576313|NCT01891669|7500434|FG009|NOT COMPLETED|Overall Study||2
6576314|NCT01891721|7500468|FG000|STARTED|Overall Study||39
6576315|NCT01891721|7500469|FG001|STARTED|Overall Study||40
6576316|NCT01891721|7500470|FG002|STARTED|Overall Study||20
6576317|NCT01891721|7500468|FG000|COMPLETED|Overall Study||29
6576318|NCT01891721|7500469|FG001|COMPLETED|Overall Study||35
6576319|NCT01891721|7500470|FG002|COMPLETED|Overall Study||19
6576320|NCT01891721|7500468|FG000|NOT COMPLETED|Overall Study||10
6576321|NCT01891721|7500469|FG001|NOT COMPLETED|Overall Study||5
6576322|NCT01891721|7500470|FG002|NOT COMPLETED|Overall Study||1
6576323|NCT01891734|7500480|FG000|STARTED|Overall Study||17
6576324|NCT01891734|7500481|FG001|STARTED|Overall Study||16
6576325|NCT01891734|7500480|FG000|COMPLETED|Overall Study||14
6576326|NCT01891734|7500481|FG001|COMPLETED|Overall Study||13
6576327|NCT01891734|7500480|FG000|NOT COMPLETED|Overall Study||3
6576328|NCT01891734|7500481|FG001|NOT COMPLETED|Overall Study||3
6576329|NCT01891864|7500491|FG000|STARTED|Treatment Period 1||264
6576330|NCT01891864|7500492|FG001|STARTED|Treatment Period 1||267
6576331|NCT01891864|7500493|FG002|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6576332|NCT01891864|7500494|FG003|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6576333|NCT01891864|7500495|FG004|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6576334|NCT01891864|7500496|FG005|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6576335|NCT01891864|7500491|FG000|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
6576336|NCT01891864|7500492|FG001|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
6576337|NCT01891864|7500493|FG002|COMPLETED|Treatment Period 1||0
6576338|NCT01891864|7500494|FG003|COMPLETED|Treatment Period 1||0
6576339|NCT01891864|7500495|FG004|COMPLETED|Treatment Period 1||0
6576340|NCT01891864|7500496|FG005|COMPLETED|Treatment Period 1||0
6576341|NCT01891864|7500491|FG000|NOT COMPLETED|Treatment Period 1||8
6576342|NCT01891864|7500492|FG001|NOT COMPLETED|Treatment Period 1||12
6576343|NCT01891864|7500493|FG002|NOT COMPLETED|Treatment Period 1||0
6576344|NCT01891864|7500494|FG003|NOT COMPLETED|Treatment Period 1||0
6576345|NCT01891864|7500495|FG004|NOT COMPLETED|Treatment Period 1||0
6576346|NCT01891864|7500496|FG005|NOT COMPLETED|Treatment Period 1||0
6576347|NCT01891864|7500491|FG000|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
6576348|NCT01891864|7500492|FG001|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
6576349|NCT01891864|7500493|FG002|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
6576350|NCT01891864|7500494|FG003|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
6576351|NCT01891864|7500495|FG004|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
6576352|NCT01891864|7500496|FG005|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
6576353|NCT01891864|7500491|FG000|COMPLETED|Treatment Period 2||0
6576354|NCT01891864|7500492|FG001|COMPLETED|Treatment Period 2||0
6576355|NCT01891864|7500493|FG002|COMPLETED|Treatment Period 2||143
6576356|NCT01891864|7500494|FG003|COMPLETED|Treatment Period 2||142
6576357|NCT01891864|7500495|FG004|COMPLETED|Treatment Period 2||96
6576358|NCT01891864|7500496|FG005|COMPLETED|Treatment Period 2||91
6576359|NCT01891864|7500491|FG000|NOT COMPLETED|Treatment Period 2||0
6576360|NCT01891864|7500492|FG001|NOT COMPLETED|Treatment Period 2||0
6576361|NCT01891864|7500493|FG002|NOT COMPLETED|Treatment Period 2||7
6576362|NCT01891864|7500494|FG003|NOT COMPLETED|Treatment Period 2||9
6576363|NCT01891864|7500495|FG004|NOT COMPLETED|Treatment Period 2||4
6576364|NCT01891864|7500496|FG005|NOT COMPLETED|Treatment Period 2||5
6576365|NCT01891864|7500491|FG000|STARTED|Extension Period||0
6576366|NCT01891864|7500492|FG001|STARTED|Extension Period||0
6576367|NCT01891864|7500493|FG002|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
6576368|NCT01891864|7500494|FG003|STARTED|Extension Period||142
6576369|NCT01891864|7500495|FG004|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
6576370|NCT01891864|7500496|FG005|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
6576371|NCT01891864|7500491|FG000|COMPLETED|Extension Period||0
6576372|NCT01891864|7500492|FG001|COMPLETED|Extension Period||0
6576373|NCT01891864|7500493|FG002|COMPLETED|Extension Period||132
6576374|NCT01891864|7500494|FG003|COMPLETED|Extension Period||137
6576375|NCT01891864|7500495|FG004|COMPLETED|Extension Period||88
6576376|NCT01891864|7500496|FG005|COMPLETED|Extension Period||90
6576377|NCT01891864|7500491|FG000|NOT COMPLETED|Extension Period||0
6576378|NCT01891864|7500492|FG001|NOT COMPLETED|Extension Period||0
6576379|NCT01891864|7500493|FG002|NOT COMPLETED|Extension Period||8
6576380|NCT01891864|7500494|FG003|NOT COMPLETED|Extension Period||5
6576381|NCT01891864|7500495|FG004|NOT COMPLETED|Extension Period||7
6576382|NCT01891864|7500496|FG005|NOT COMPLETED|Extension Period||0
6576383|NCT01891890|7500511|FG000|STARTED|Overall Study||24
6576384|NCT01891890|7500512|FG001|STARTED|Overall Study||27
6576385|NCT01891890|7500513|FG002|STARTED|Overall Study||21
6576386|NCT01891890|7500511|FG000|COMPLETED|Overall Study||17
6576387|NCT01891890|7500512|FG001|COMPLETED|Overall Study||24
6576388|NCT01891890|7500513|FG002|COMPLETED|Overall Study||14
6576389|NCT01891890|7500511|FG000|NOT COMPLETED|Overall Study||7
6576390|NCT01891890|7500512|FG001|NOT COMPLETED|Overall Study||3
6576391|NCT01891890|7500513|FG002|NOT COMPLETED|Overall Study||7
6576392|NCT01891968|7500521|FG000|STARTED|Overall Study||15
6576393|NCT01891968|7500521|FG000|COMPLETED|Overall Study||15
6576394|NCT01891968|7500521|FG000|NOT COMPLETED|Overall Study||0
6576395|NCT01892007|7500527|FG000|STARTED|Overall Study||27
6576396|NCT01892007|7500528|FG001|STARTED|Overall Study||30
6576397|NCT01892007|7500527|FG000|COMPLETED|Overall Study||27
6576398|NCT01892007|7500528|FG001|COMPLETED|Overall Study||30
6576399|NCT01892007|7500527|FG000|NOT COMPLETED|Overall Study||0
6576400|NCT01892007|7500528|FG001|NOT COMPLETED|Overall Study||0
6576401|NCT01892020|7500534|FG000|STARTED|Period 1||81
6576402|NCT01892020|7500535|FG001|STARTED|Period 1||80
6576403|NCT01892020|7500534|FG000|COMPLETED|Period 1||78
6576404|NCT01892020|7500535|FG001|COMPLETED|Period 1||74
6576405|NCT01892020|7500534|FG000|NOT COMPLETED|Period 1||3
6576406|NCT01892020|7500535|FG001|NOT COMPLETED|Period 1||6
6576407|NCT01892020|7500534|FG000|STARTED|Period 2||78
6576408|NCT01892020|7500535|FG001|STARTED|Period 2||74
6576409|NCT01892020|7500534|FG000|COMPLETED|Period 2||77
6576410|NCT01892020|7500535|FG001|COMPLETED|Period 2||74
6576411|NCT01892020|7500534|FG000|NOT COMPLETED|Period 2||1
6576412|NCT01892020|7500535|FG001|NOT COMPLETED|Period 2||0
6576413|NCT01892163|7500543|FG000|STARTED|Overall Study||50
6576414|NCT01892163|7500544|FG001|STARTED|Overall Study||50
6576415|NCT01892163|7500543|FG000|COMPLETED|Overall Study||48
6576416|NCT01892163|7500544|FG001|COMPLETED|Overall Study||49
6576417|NCT01892163|7500543|FG000|NOT COMPLETED|Overall Study||2
6576418|NCT01892163|7500544|FG001|NOT COMPLETED|Overall Study||1
6576419|NCT01892189|7500559|FG000|STARTED|First Intervention Period (1 Day)||3
6576420|NCT01892189|7500560|FG001|STARTED|First Intervention Period (1 Day)||3
6576421|NCT01892189|7500561|FG002|STARTED|First Intervention Period (1 Day)||3
6576422|NCT01892189|7500562|FG003|STARTED|First Intervention Period (1 Day)||3
6576423|NCT01892189|7500563|FG004|STARTED|First Intervention Period (1 Day)||3
6576424|NCT01892189|7500564|FG005|STARTED|First Intervention Period (1 Day)||3
6576425|NCT01892189|7500565|FG006|STARTED|First Intervention Period (1 Day)||3
6576426|NCT01892189|7500566|FG007|STARTED|First Intervention Period (1 Day)||3
6576427|NCT01892189|7500567|FG008|STARTED|First Intervention Period (1 Day)||3
6576428|NCT01892189|7500559|FG000|COMPLETED|First Intervention Period (1 Day)||3
6576429|NCT01892189|7500560|FG001|COMPLETED|First Intervention Period (1 Day)||3
6576430|NCT01892189|7500561|FG002|COMPLETED|First Intervention Period (1 Day)||3
6576431|NCT01892189|7500562|FG003|COMPLETED|First Intervention Period (1 Day)||3
6576432|NCT01892189|7500563|FG004|COMPLETED|First Intervention Period (1 Day)||3
6576433|NCT01892189|7500564|FG005|COMPLETED|First Intervention Period (1 Day)||3
6576434|NCT01892189|7500565|FG006|COMPLETED|First Intervention Period (1 Day)||3
6576435|NCT01892189|7500566|FG007|COMPLETED|First Intervention Period (1 Day)||3
6576436|NCT01892189|7500567|FG008|COMPLETED|First Intervention Period (1 Day)||3
6576437|NCT01892189|7500559|FG000|NOT COMPLETED|First Intervention Period (1 Day)||0
6576438|NCT01892189|7500560|FG001|NOT COMPLETED|First Intervention Period (1 Day)||0
6576439|NCT01892189|7500561|FG002|NOT COMPLETED|First Intervention Period (1 Day)||0
6576440|NCT01892189|7500562|FG003|NOT COMPLETED|First Intervention Period (1 Day)||0
6576441|NCT01892189|7500563|FG004|NOT COMPLETED|First Intervention Period (1 Day)||0
6576442|NCT01892189|7500564|FG005|NOT COMPLETED|First Intervention Period (1 Day)||0
6576443|NCT01892189|7500565|FG006|NOT COMPLETED|First Intervention Period (1 Day)||0
6576444|NCT01892189|7500566|FG007|NOT COMPLETED|First Intervention Period (1 Day)||0
6576445|NCT01892189|7500567|FG008|NOT COMPLETED|First Intervention Period (1 Day)||0
6576446|NCT01892189|7500559|FG000|STARTED|Washout Period 1 (7 Days)||3
6576447|NCT01892189|7500560|FG001|STARTED|Washout Period 1 (7 Days)||3
6576448|NCT01892189|7500561|FG002|STARTED|Washout Period 1 (7 Days)||3
6576449|NCT01892189|7500562|FG003|STARTED|Washout Period 1 (7 Days)||3
6576450|NCT01892189|7500563|FG004|STARTED|Washout Period 1 (7 Days)||3
6576451|NCT01892189|7500564|FG005|STARTED|Washout Period 1 (7 Days)||3
6658320|NCT02477839|7588873|FG001|STARTED|Overall Study||128
6576452|NCT01892189|7500565|FG006|STARTED|Washout Period 1 (7 Days)||3
6576453|NCT01892189|7500566|FG007|STARTED|Washout Period 1 (7 Days)||3
6576454|NCT01892189|7500567|FG008|STARTED|Washout Period 1 (7 Days)||3
6576455|NCT01892189|7500559|FG000|COMPLETED|Washout Period 1 (7 Days)||3
6576456|NCT01892189|7500560|FG001|COMPLETED|Washout Period 1 (7 Days)||3
6576457|NCT01892189|7500561|FG002|COMPLETED|Washout Period 1 (7 Days)||1
6576458|NCT01892189|7500562|FG003|COMPLETED|Washout Period 1 (7 Days)||2
6576459|NCT01892189|7500563|FG004|COMPLETED|Washout Period 1 (7 Days)||3
6576460|NCT01892189|7500564|FG005|COMPLETED|Washout Period 1 (7 Days)||2
6576461|NCT01892189|7500565|FG006|COMPLETED|Washout Period 1 (7 Days)||2
6576462|NCT01892189|7500566|FG007|COMPLETED|Washout Period 1 (7 Days)||3
6576463|NCT01892189|7500567|FG008|COMPLETED|Washout Period 1 (7 Days)||1
6576464|NCT01892189|7500559|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6576465|NCT01892189|7500560|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6576466|NCT01892189|7500561|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||2
6576467|NCT01892189|7500562|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
6576468|NCT01892189|7500563|FG004|NOT COMPLETED|Washout Period 1 (7 Days)||0
6576469|NCT01892189|7500564|FG005|NOT COMPLETED|Washout Period 1 (7 Days)||1
6576470|NCT01892189|7500565|FG006|NOT COMPLETED|Washout Period 1 (7 Days)||1
6576471|NCT01892189|7500566|FG007|NOT COMPLETED|Washout Period 1 (7 Days)||0
6576472|NCT01892189|7500567|FG008|NOT COMPLETED|Washout Period 1 (7 Days)||2
6576473|NCT01892189|7500559|FG000|STARTED|Second Intervention Period (1 Day)||3
6576474|NCT01892189|7500560|FG001|STARTED|Second Intervention Period (1 Day)||3
6576475|NCT01892189|7500561|FG002|STARTED|Second Intervention Period (1 Day)||1
6576476|NCT01892189|7500562|FG003|STARTED|Second Intervention Period (1 Day)||2
6576477|NCT01892189|7500563|FG004|STARTED|Second Intervention Period (1 Day)||3
6576478|NCT01892189|7500564|FG005|STARTED|Second Intervention Period (1 Day)||2
6576479|NCT01892189|7500565|FG006|STARTED|Second Intervention Period (1 Day)||2
6576480|NCT01892189|7500566|FG007|STARTED|Second Intervention Period (1 Day)||3
6576481|NCT01892189|7500567|FG008|STARTED|Second Intervention Period (1 Day)||1
6576482|NCT01892189|7500559|FG000|COMPLETED|Second Intervention Period (1 Day)||3
6576483|NCT01892189|7500560|FG001|COMPLETED|Second Intervention Period (1 Day)||3
6576484|NCT01892189|7500561|FG002|COMPLETED|Second Intervention Period (1 Day)||1
6576485|NCT01892189|7500562|FG003|COMPLETED|Second Intervention Period (1 Day)||2
6576486|NCT01892189|7500563|FG004|COMPLETED|Second Intervention Period (1 Day)||3
6576487|NCT01892189|7500564|FG005|COMPLETED|Second Intervention Period (1 Day)||2
6576488|NCT01892189|7500565|FG006|COMPLETED|Second Intervention Period (1 Day)||2
6576489|NCT01892189|7500566|FG007|COMPLETED|Second Intervention Period (1 Day)||3
6576490|NCT01892189|7500567|FG008|COMPLETED|Second Intervention Period (1 Day)||1
6576491|NCT01892189|7500559|FG000|NOT COMPLETED|Second Intervention Period (1 Day)||0
6658321|NCT02477839|7588872|FG000|Completed Transition Period|Overall Study||124
6658322|NCT02477839|7588873|FG001|Completed Transition Period|Overall Study||117
6658323|NCT02477839|7588872|FG000|Completed Taper After Maintenance|Overall Study||0
6658324|NCT02477839|7588873|FG001|Completed Taper After Maintenance|Overall Study||1
6658325|NCT02477839|7588872|FG000|COMPLETED|Overall Study||124
6658326|NCT02477839|7588873|FG001|COMPLETED|Overall Study||118
6658327|NCT02477839|7588872|FG000|NOT COMPLETED|Overall Study||3
6658328|NCT02477839|7588873|FG001|NOT COMPLETED|Overall Study||10
6658329|NCT02478164|7588881|FG000|STARTED|Overall Study|17 participants enrolled. 15 of 17 received ponatinib as 2 participants withdrew prior to ponatinib.|15
6658330|NCT02478164|7588881|FG000|COMPLETED|Overall Study||0
6658331|NCT02478164|7588881|FG000|NOT COMPLETED|Overall Study||15
6658332|NCT02478359|7588887|FG000|STARTED|Overall Study||1349
6658333|NCT02478359|7588888|FG001|STARTED|Overall Study||1358
6658334|NCT02478359|7588887|FG000|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 106|1243
6658335|NCT02478359|7588888|FG001|Intention-to-treat Population Month 12|Overall Study|Disenrolled from health plan: 65|1293
6658336|NCT02478359|7588887|FG000|COMPLETED|Overall Study||1243
6658337|NCT02478359|7588888|FG001|COMPLETED|Overall Study||1293
6658338|NCT02478359|7588887|FG000|NOT COMPLETED|Overall Study||106
6658339|NCT02478359|7588888|FG001|NOT COMPLETED|Overall Study||65
6658340|NCT02478372|7588898|FG000|STARTED|Overall Study||121
6658341|NCT02478372|7588899|FG001|STARTED|Overall Study||121
6658342|NCT02478372|7588898|FG000|Recieved Allocation Intervention|Overall Study||109
6658343|NCT02478372|7588899|FG001|Recieved Allocation Intervention|Overall Study||113
6658344|NCT02478372|7588898|FG000|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
6658345|NCT02478372|7588899|FG001|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
6658346|NCT02478372|7588898|FG000|Reviewed at One Year|Overall Study|Routine follow up at one year|108
6658347|NCT02478372|7588899|FG001|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
6658348|NCT02478372|7588898|FG000|COMPLETED|Overall Study||108
6658349|NCT02478372|7588899|FG001|COMPLETED|Overall Study||107
6658350|NCT02478372|7588898|FG000|NOT COMPLETED|Overall Study||13
6658351|NCT02478372|7588899|FG001|NOT COMPLETED|Overall Study||14
6658352|NCT02478398|7588907|FG000|STARTED|Overall Study||513
6658353|NCT02478398|7588908|FG001|STARTED|Overall Study||512
6658354|NCT02478398|7588907|FG000|Treated|Overall Study||512
6658355|NCT02478398|7588908|FG001|Treated|Overall Study||510
6658356|NCT02478398|7588907|FG000|COMPLETED|Overall Study||461
6658357|NCT02478398|7588908|FG001|COMPLETED|Overall Study||491
6658358|NCT02478398|7588907|FG000|NOT COMPLETED|Overall Study||52
6658359|NCT02478398|7588908|FG001|NOT COMPLETED|Overall Study||21
6658360|NCT02478463|7588915|FG000|STARTED|Treatment Period 1 (Up to Day 29)||19
6658361|NCT02478463|7588915|FG000|COMPLETED|Treatment Period 1 (Up to Day 29)||18
6658362|NCT02478463|7588915|FG000|NOT COMPLETED|Treatment Period 1 (Up to Day 29)||1
6658363|NCT02478463|7588915|FG000|STARTED|Washout Period (Up to 42 Days)||18
6658364|NCT02478463|7588915|FG000|COMPLETED|Washout Period (Up to 42 Days)||17
6576492|NCT01892189|7500560|FG001|NOT COMPLETED|Second Intervention Period (1 Day)||0
6576493|NCT01892189|7500561|FG002|NOT COMPLETED|Second Intervention Period (1 Day)||0
6576494|NCT01892189|7500562|FG003|NOT COMPLETED|Second Intervention Period (1 Day)||0
6576495|NCT01892189|7500563|FG004|NOT COMPLETED|Second Intervention Period (1 Day)||0
6576496|NCT01892189|7500564|FG005|NOT COMPLETED|Second Intervention Period (1 Day)||0
6576497|NCT01892189|7500565|FG006|NOT COMPLETED|Second Intervention Period (1 Day)||0
6576498|NCT01892189|7500566|FG007|NOT COMPLETED|Second Intervention Period (1 Day)||0
6576499|NCT01892189|7500567|FG008|NOT COMPLETED|Second Intervention Period (1 Day)||0
6576500|NCT01892189|7500559|FG000|STARTED|Washout Period 2 (7 Days)||3
6576501|NCT01892189|7500560|FG001|STARTED|Washout Period 2 (7 Days)||3
6576502|NCT01892189|7500561|FG002|STARTED|Washout Period 2 (7 Days)||1
6576503|NCT01892189|7500562|FG003|STARTED|Washout Period 2 (7 Days)||2
6576504|NCT01892189|7500563|FG004|STARTED|Washout Period 2 (7 Days)||3
6576505|NCT01892189|7500564|FG005|STARTED|Washout Period 2 (7 Days)||2
6576506|NCT01892189|7500565|FG006|STARTED|Washout Period 2 (7 Days)||2
6576507|NCT01892189|7500566|FG007|STARTED|Washout Period 2 (7 Days)||3
6576508|NCT01892189|7500567|FG008|STARTED|Washout Period 2 (7 Days)||1
6576509|NCT01892189|7500559|FG000|COMPLETED|Washout Period 2 (7 Days)||3
6576510|NCT01892189|7500560|FG001|COMPLETED|Washout Period 2 (7 Days)||3
6576511|NCT01892189|7500561|FG002|COMPLETED|Washout Period 2 (7 Days)||1
6576512|NCT01892189|7500562|FG003|COMPLETED|Washout Period 2 (7 Days)||2
6576513|NCT01892189|7500563|FG004|COMPLETED|Washout Period 2 (7 Days)||3
6576514|NCT01892189|7500564|FG005|COMPLETED|Washout Period 2 (7 Days)||2
6576515|NCT01892189|7500565|FG006|COMPLETED|Washout Period 2 (7 Days)||2
6576516|NCT01892189|7500566|FG007|COMPLETED|Washout Period 2 (7 Days)||3
6576517|NCT01892189|7500567|FG008|COMPLETED|Washout Period 2 (7 Days)||1
6576518|NCT01892189|7500559|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576519|NCT01892189|7500560|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576520|NCT01892189|7500561|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576521|NCT01892189|7500562|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576522|NCT01892189|7500563|FG004|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576523|NCT01892189|7500564|FG005|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576524|NCT01892189|7500565|FG006|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576525|NCT01892189|7500566|FG007|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576526|NCT01892189|7500567|FG008|NOT COMPLETED|Washout Period 2 (7 Days)||0
6576527|NCT01892189|7500559|FG000|STARTED|Third Intervention Period (1 Day)||3
6576528|NCT01892189|7500560|FG001|STARTED|Third Intervention Period (1 Day)||3
6576529|NCT01892189|7500561|FG002|STARTED|Third Intervention Period (1 Day)||1
6576530|NCT01892189|7500562|FG003|STARTED|Third Intervention Period (1 Day)||2
6576531|NCT01892189|7500563|FG004|STARTED|Third Intervention Period (1 Day)||3
6576532|NCT01892189|7500564|FG005|STARTED|Third Intervention Period (1 Day)||2
6576533|NCT01892189|7500565|FG006|STARTED|Third Intervention Period (1 Day)||2
6576534|NCT01892189|7500566|FG007|STARTED|Third Intervention Period (1 Day)||3
6576535|NCT01892189|7500567|FG008|STARTED|Third Intervention Period (1 Day)||1
6576536|NCT01892189|7500559|FG000|COMPLETED|Third Intervention Period (1 Day)||3
6576537|NCT01892189|7500560|FG001|COMPLETED|Third Intervention Period (1 Day)||3
6576538|NCT01892189|7500561|FG002|COMPLETED|Third Intervention Period (1 Day)||1
6576539|NCT01892189|7500562|FG003|COMPLETED|Third Intervention Period (1 Day)||2
6576540|NCT01892189|7500563|FG004|COMPLETED|Third Intervention Period (1 Day)||3
6576541|NCT01892189|7500564|FG005|COMPLETED|Third Intervention Period (1 Day)||2
6576542|NCT01892189|7500565|FG006|COMPLETED|Third Intervention Period (1 Day)||2
6576543|NCT01892189|7500566|FG007|COMPLETED|Third Intervention Period (1 Day)||3
6576544|NCT01892189|7500567|FG008|COMPLETED|Third Intervention Period (1 Day)||1
6576545|NCT01892189|7500559|FG000|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576546|NCT01892189|7500560|FG001|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576547|NCT01892189|7500561|FG002|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576548|NCT01892189|7500562|FG003|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576549|NCT01892189|7500563|FG004|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576550|NCT01892189|7500564|FG005|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576551|NCT01892189|7500565|FG006|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576552|NCT01892189|7500566|FG007|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576553|NCT01892189|7500567|FG008|NOT COMPLETED|Third Intervention Period (1 Day)||0
6576554|NCT01892267|7500584|FG000|STARTED|Overall Study||9
6576555|NCT01892267|7500585|FG001|STARTED|Overall Study||10
6576556|NCT01892267|7500584|FG000|COMPLETED|Overall Study||9
6576557|NCT01892267|7500585|FG001|COMPLETED|Overall Study||10
6576558|NCT01892267|7500584|FG000|NOT COMPLETED|Overall Study||0
6576559|NCT01892267|7500585|FG001|NOT COMPLETED|Overall Study||0
6576560|NCT01892293|7500591|FG000|STARTED|Overall Study||6
6576561|NCT01892293|7500591|FG000|Received T-cell|Overall Study||2
6576562|NCT01892293|7500591|FG000|COMPLETED|Overall Study||2
6576563|NCT01892293|7500591|FG000|NOT COMPLETED|Overall Study||4
6576564|NCT01892306|7500597|FG000|STARTED|Overall Study||13
6576565|NCT01892306|7500598|FG001|STARTED|Overall Study||16
6576566|NCT01892306|7500597|FG000|COMPLETED|Overall Study||8
6576567|NCT01892306|7500598|FG001|COMPLETED|Overall Study||10
6576568|NCT01892306|7500597|FG000|NOT COMPLETED|Overall Study||5
6576569|NCT01892306|7500598|FG001|NOT COMPLETED|Overall Study||6
6576570|NCT01892345|7500606|FG000|STARTED|Overall Study||96
6576571|NCT01892345|7500607|FG001|STARTED|Overall Study||47
6576572|NCT01892345|7500606|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||96
6576573|NCT01892345|7500607|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||47
6576574|NCT01892345|7500606|FG000|COMPLETED|Overall Study||80
6576575|NCT01892345|7500607|FG001|COMPLETED|Overall Study||44
6576576|NCT01892345|7500606|FG000|NOT COMPLETED|Overall Study||16
6576577|NCT01892345|7500607|FG001|NOT COMPLETED|Overall Study||3
6576578|NCT01892436|7500617|FG000|STARTED|Overall Study||147
6576579|NCT01892436|7500618|FG001|STARTED|Overall Study||161
6576580|NCT01892436|7500619|FG002|STARTED|Overall Study||74
6576581|NCT01892436|7500620|FG003|STARTED|Overall Study||75
6576582|NCT01892436|7500617|FG000|COMPLETED|Overall Study||124
6576583|NCT01892436|7500618|FG001|COMPLETED|Overall Study||132
6576584|NCT01892436|7500619|FG002|COMPLETED|Overall Study||63
6576585|NCT01892436|7500620|FG003|COMPLETED|Overall Study||61
6576586|NCT01892436|7500617|FG000|NOT COMPLETED|Overall Study||23
6576587|NCT01892436|7500618|FG001|NOT COMPLETED|Overall Study||29
6576588|NCT01892436|7500619|FG002|NOT COMPLETED|Overall Study||11
6576589|NCT01892436|7500620|FG003|NOT COMPLETED|Overall Study||14
6576590|NCT01892501|7500630|FG000|STARTED|Overall Study||75
6576591|NCT01892501|7500630|FG000|Group A : Biopsy Surgically Possible|Overall Study||72
6576592|NCT01892501|7500630|FG000|Group B : Biopsy Not Surgically Possible|Overall Study||3
6576593|NCT01892501|7500630|FG000|COMPLETED|Overall Study||47
6576594|NCT01892501|7500630|FG000|NOT COMPLETED|Overall Study||28
6576595|NCT01892540|7500637|FG000|STARTED|Overall Study||15
6576596|NCT01892540|7500638|FG001|STARTED|Overall Study||0
6576597|NCT01892540|7500639|FG002|STARTED|Overall Study||28
6576598|NCT01892540|7500637|FG000|COMPLETED|Overall Study||15
6576599|NCT01892540|7500638|FG001|COMPLETED|Overall Study||0
6576600|NCT01892540|7500639|FG002|COMPLETED|Overall Study||25
6576601|NCT01892540|7500637|FG000|NOT COMPLETED|Overall Study||0
6576602|NCT01892540|7500638|FG001|NOT COMPLETED|Overall Study||0
6576603|NCT01892540|7500639|FG002|NOT COMPLETED|Overall Study||3
6576604|NCT01892657|7500647|FG000|STARTED|Overall Study||128
6576605|NCT01892657|7500647|FG000|COMPLETED|Overall Study||110
6576606|NCT01892657|7500647|FG000|NOT COMPLETED|Overall Study||18
6576607|NCT01892709|7500663|FG000|STARTED|Overall Study||215
6576608|NCT01892709|7500663|FG000|COMPLETED|Overall Study||215
6576609|NCT01892709|7500663|FG000|NOT COMPLETED|Overall Study||0
6576610|NCT01892865|7500673|FG000|STARTED|Overall Study|107 operative days scheduled with the Historical Means method were included|356
6576611|NCT01892865|7500674|FG001|STARTED|Overall Study|100 operative days scheduled with the Predictive Modeling System method were included|379
6576612|NCT01892865|7500673|FG000|COMPLETED|Overall Study||356
6576613|NCT01892865|7500674|FG001|COMPLETED|Overall Study||379
6576614|NCT01892865|7500673|FG000|NOT COMPLETED|Overall Study||0
6576615|NCT01892865|7500674|FG001|NOT COMPLETED|Overall Study||0
6576616|NCT01893203|7500680|FG000|STARTED|Overall Study||14
6576617|NCT01893203|7500680|FG000|COMPLETED|Overall Study||13
6576618|NCT01893203|7500680|FG000|NOT COMPLETED|Overall Study||1
6576619|NCT01893281|7500684|FG000|STARTED|Overall Study||78
6576620|NCT01893281|7500684|FG000|Received at Least 1 Dose of Study Drug|Overall Study||78
6576621|NCT01893281|7500684|FG000|COMPLETED|Overall Study||75
6576622|NCT01893281|7500684|FG000|NOT COMPLETED|Overall Study||3
6576623|NCT01893346|7500692|FG000|STARTED|Overall Study||11
6576624|NCT01893346|7500693|FG001|STARTED|Overall Study||8
6576625|NCT01893346|7500694|FG002|STARTED|Overall Study||8
6576626|NCT01893346|7500695|FG003|STARTED|Overall Study||8
6576627|NCT01893346|7500692|FG000|Patients Who Received Full Infusion|Overall Study||8
6576628|NCT01893346|7500693|FG001|Patients Who Received Full Infusion|Overall Study||8
6576629|NCT01893346|7500694|FG002|Patients Who Received Full Infusion|Overall Study||8
6576630|NCT01893346|7500695|FG003|Patients Who Received Full Infusion|Overall Study||8
6576631|NCT01893346|7500692|FG000|COMPLETED|Overall Study||8
6576632|NCT01893346|7500693|FG001|COMPLETED|Overall Study||7
6576633|NCT01893346|7500694|FG002|COMPLETED|Overall Study||8
6576634|NCT01893346|7500695|FG003|COMPLETED|Overall Study||8
6576635|NCT01893346|7500692|FG000|NOT COMPLETED|Overall Study||3
6576636|NCT01893346|7500693|FG001|NOT COMPLETED|Overall Study||1
6576637|NCT01893346|7500694|FG002|NOT COMPLETED|Overall Study||0
6576638|NCT01893346|7500695|FG003|NOT COMPLETED|Overall Study||0
6576639|NCT01893372|7500707|FG000|STARTED|Overall Study||7
6576640|NCT01893372|7500708|FG001|STARTED|Overall Study||22
6576641|NCT01893372|7500707|FG000|COMPLETED|Overall Study||7
6576642|NCT01893372|7500708|FG001|COMPLETED|Overall Study||22
6576643|NCT01893372|7500707|FG000|NOT COMPLETED|Overall Study||0
6576644|NCT01893372|7500708|FG001|NOT COMPLETED|Overall Study||0
6576645|NCT01893411|7500717|FG000|STARTED|Overall Study||156
6576646|NCT01893411|7500718|FG001|STARTED|Overall Study||77
6576647|NCT01893411|7500719|FG002|STARTED|Overall Study||78
6576648|NCT01893411|7500717|FG000|COMPLETED|Overall Study||139
6576649|NCT01893411|7500718|FG001|COMPLETED|Overall Study||70
6576650|NCT01893411|7500719|FG002|COMPLETED|Overall Study||69
6576651|NCT01893411|7500717|FG000|NOT COMPLETED|Overall Study||17
6576652|NCT01893411|7500718|FG001|NOT COMPLETED|Overall Study||7
6576653|NCT01893411|7500719|FG002|NOT COMPLETED|Overall Study||9
6576654|NCT01893567|7500727|FG000|STARTED|Overall Study||28
6576655|NCT01893567|7500727|FG000|COMPLETED|Overall Study||28
6576656|NCT01893567|7500727|FG000|NOT COMPLETED|Overall Study||0
6576657|NCT01893632|7500733|FG000|STARTED|Overall Study||1
6576658|NCT01893632|7500734|FG001|STARTED|Overall Study||1
6576659|NCT01893632|7500733|FG000|COMPLETED|Overall Study||1
6576660|NCT01893632|7500734|FG001|COMPLETED|Overall Study||1
6576661|NCT01893632|7500733|FG000|NOT COMPLETED|Overall Study||0
6576662|NCT01893632|7500734|FG001|NOT COMPLETED|Overall Study||0
6576663|NCT01893801|7500740|FG000|STARTED|Overall Study||25
6576664|NCT01893801|7500740|FG000|COMPLETED|Overall Study||25
6576665|NCT01893801|7500740|FG000|NOT COMPLETED|Overall Study||0
6576666|NCT01893827|7500748|FG000|STARTED|Overall Study||117
6576667|NCT01893827|7500749|FG001|STARTED|Overall Study||120
6576668|NCT01893827|7500748|FG000|COMPLETED|Overall Study||98
6576669|NCT01893827|7500749|FG001|COMPLETED|Overall Study||94
6576670|NCT01893827|7500748|FG000|NOT COMPLETED|Overall Study||19
6576671|NCT01893827|7500749|FG001|NOT COMPLETED|Overall Study||26
6576672|NCT01893879|7500757|FG000|STARTED|Overall Study||7
6576673|NCT01893879|7500758|FG001|STARTED|Overall Study||7
6576674|NCT01893879|7500757|FG000|COMPLETED|Overall Study||5
6576675|NCT01893879|7500758|FG001|COMPLETED|Overall Study||4
6576676|NCT01893879|7500757|FG000|NOT COMPLETED|Overall Study||2
6576677|NCT01893879|7500758|FG001|NOT COMPLETED|Overall Study||3
6576678|NCT01893905|7500766|FG000|STARTED|Overall Study||80
6576679|NCT01893905|7500767|FG001|STARTED|Overall Study||78
6576680|NCT01893905|7500766|FG000|COMPLETED|Overall Study||55
6576681|NCT01893905|7500767|FG001|COMPLETED|Overall Study||64
6576682|NCT01893905|7500766|FG000|NOT COMPLETED|Overall Study||25
6576683|NCT01893905|7500767|FG001|NOT COMPLETED|Overall Study||14
6576684|NCT01893983|7500775|FG000|STARTED|Overall Study||140
6576685|NCT01893983|7500776|FG001|STARTED|Overall Study||140
6576686|NCT01893983|7500775|FG000|COMPLETED|Overall Study||130
6576687|NCT01893983|7500776|FG001|COMPLETED|Overall Study||134
6576688|NCT01893983|7500775|FG000|NOT COMPLETED|Overall Study||10
6576689|NCT01893983|7500776|FG001|NOT COMPLETED|Overall Study||6
6576690|NCT01894022|7500784|FG000|STARTED|Overall Study||9
6576691|NCT01894022|7500785|FG001|STARTED|Overall Study||10
6576692|NCT01894022|7500784|FG000|COMPLETED|Overall Study||0
6576693|NCT01894022|7500785|FG001|COMPLETED|Overall Study||0
6576694|NCT01894022|7500784|FG000|NOT COMPLETED|Overall Study||9
6576695|NCT01894022|7500785|FG001|NOT COMPLETED|Overall Study||10
6576696|NCT01894087|7500794|FG000|STARTED|Overall Study||102
6576697|NCT01894087|7500795|FG001|STARTED|Overall Study||102
6576698|NCT01894087|7500794|FG000|COMPLETED|Overall Study||96
6576699|NCT01894087|7500795|FG001|COMPLETED|Overall Study||102
6576700|NCT01894087|7500794|FG000|NOT COMPLETED|Overall Study||6
6576701|NCT01894087|7500795|FG001|NOT COMPLETED|Overall Study||0
6576702|NCT01894100|7500803|FG000|STARTED|Overall Study||15
6576703|NCT01894100|7500804|FG001|STARTED|Overall Study||15
6576704|NCT01894100|7500803|FG000|COMPLETED|Overall Study||12
6576705|NCT01894100|7500804|FG001|COMPLETED|Overall Study||14
6576706|NCT01894100|7500803|FG000|NOT COMPLETED|Overall Study||3
6576707|NCT01894100|7500804|FG001|NOT COMPLETED|Overall Study||1
6576708|NCT01894152|7500810|FG000|STARTED|Overall Study||2002
6576709|NCT01894152|7500810|FG000|COMPLETED|Overall Study||1851
6576710|NCT01894152|7500810|FG000|NOT COMPLETED|Overall Study||151
6576711|NCT01894178|7500816|FG000|STARTED|Overall Study||30
6576712|NCT01894178|7500817|FG001|STARTED|Overall Study||30
6576713|NCT01894178|7500816|FG000|COMPLETED|Overall Study||30
6576714|NCT01894178|7500817|FG001|COMPLETED|Overall Study||30
6576715|NCT01894178|7500816|FG000|NOT COMPLETED|Overall Study||0
6576716|NCT01894178|7500817|FG001|NOT COMPLETED|Overall Study||0
6576717|NCT01894230|7500825|FG000|STARTED|Overall Study||83
6576718|NCT01894230|7500826|FG001|STARTED|Overall Study||76
6576719|NCT01894230|7500825|FG000|COMPLETED|Overall Study||76
6576720|NCT01894230|7500826|FG001|COMPLETED|Overall Study||69
6576721|NCT01894230|7500825|FG000|NOT COMPLETED|Overall Study||7
6576722|NCT01894230|7500826|FG001|NOT COMPLETED|Overall Study||7
6576723|NCT01894243|7500835|FG000|STARTED|Overall Study||13
6576724|NCT01894243|7500836|FG001|STARTED|Overall Study||10
6576725|NCT01894243|7500837|FG002|STARTED|Overall Study||8
6576726|NCT01894243|7500835|FG000|Completed Treatment in Part A|Overall Study||13
6576727|NCT01894243|7500836|FG001|Completed Treatment in Part A|Overall Study||10
6576728|NCT01894243|7500837|FG002|Completed Treatment in Part A|Overall Study||8
6576729|NCT01894243|7500835|FG000|Ongoing Into Part B|Overall Study||13
6576730|NCT01894243|7500836|FG001|Ongoing Into Part B|Overall Study||10
6576731|NCT01894243|7500837|FG002|Ongoing Into Part B|Overall Study||8
6576732|NCT01894243|7500835|FG000|COMPLETED|Overall Study||0
6576733|NCT01894243|7500836|FG001|COMPLETED|Overall Study||0
6576734|NCT01894243|7500837|FG002|COMPLETED|Overall Study||0
6576735|NCT01894243|7500835|FG000|NOT COMPLETED|Overall Study||13
6576736|NCT01894243|7500836|FG001|NOT COMPLETED|Overall Study||10
6576737|NCT01894243|7500837|FG002|NOT COMPLETED|Overall Study||8
6576738|NCT01894256|7500855|FG000|STARTED|Part A||15
6576739|NCT01894256|7500856|FG001|STARTED|Part A||15
6576740|NCT01894256|7500857|FG002|STARTED|Part A||14
6576741|NCT01894256|7500855|FG000|COMPLETED|Part A||15
6576742|NCT01894256|7500856|FG001|COMPLETED|Part A||14
6576743|NCT01894256|7500857|FG002|COMPLETED|Part A||14
6576744|NCT01894256|7500855|FG000|NOT COMPLETED|Part A||0
6576745|NCT01894256|7500856|FG001|NOT COMPLETED|Part A||1
6576746|NCT01894256|7500857|FG002|NOT COMPLETED|Part A||0
6576747|NCT01894256|7500855|FG000|STARTED|Part B||15
6576748|NCT01894256|7500856|FG001|STARTED|Part B||14
6576749|NCT01894256|7500857|FG002|STARTED|Part B||14
6576750|NCT01894256|7500855|FG000|COMPLETED|Part B||0
6576751|NCT01894256|7500856|FG001|COMPLETED|Part B||0
6576752|NCT01894256|7500857|FG002|COMPLETED|Part B||0
6576753|NCT01894256|7500855|FG000|NOT COMPLETED|Part B||15
6576754|NCT01894256|7500856|FG001|NOT COMPLETED|Part B||14
6576755|NCT01894256|7500857|FG002|NOT COMPLETED|Part B||14
6623964|NCT02212730|7551259|FG000|NOT COMPLETED|Overall Study||2
6623965|NCT02212730|7551260|FG001|NOT COMPLETED|Overall Study||1
6623966|NCT02212834|7551270|FG000|STARTED|Overall Study||33938
6623967|NCT02212834|7551271|FG001|STARTED|Overall Study||2506
6623968|NCT02212834|7551270|FG000|COMPLETED|Overall Study||33938
6623969|NCT02212834|7551271|FG001|COMPLETED|Overall Study||2506
6623970|NCT02212834|7551270|FG000|NOT COMPLETED|Overall Study||0
6623971|NCT02212834|7551271|FG001|NOT COMPLETED|Overall Study||0
6623972|NCT02212977|7551279|FG000|STARTED|Overall Study||55
6623973|NCT02212977|7551280|FG001|STARTED|Overall Study||54
6623974|NCT02212977|7551279|FG000|COMPLETED|Overall Study||50
6623975|NCT02212977|7551280|FG001|COMPLETED|Overall Study||48
6623976|NCT02212977|7551279|FG000|NOT COMPLETED|Overall Study||5
6623977|NCT02212977|7551280|FG001|NOT COMPLETED|Overall Study||6
6623978|NCT02213042|7551289|FG000|STARTED|Overall Study||17
6623979|NCT02213042|7551290|FG001|STARTED|Overall Study||15
6623980|NCT02213042|7551291|FG002|STARTED|Overall Study||10
6623981|NCT02213042|7551289|FG000|Total Deaths|Overall Study||11
6623982|NCT02213042|7551290|FG001|Total Deaths|Overall Study||9
6623983|NCT02213042|7551291|FG002|Total Deaths|Overall Study||6
6623984|NCT02213042|7551289|FG000|COMPLETED|Overall Study||0
6623985|NCT02213042|7551290|FG001|COMPLETED|Overall Study||0
6623986|NCT02213042|7551291|FG002|COMPLETED|Overall Study||0
6623987|NCT02213042|7551289|FG000|NOT COMPLETED|Overall Study||17
6623988|NCT02213042|7551290|FG001|NOT COMPLETED|Overall Study||15
6623989|NCT02213042|7551291|FG002|NOT COMPLETED|Overall Study||10
6623990|NCT02213055|7551303|FG000|STARTED|Overall Study||97
6623991|NCT02213055|7551304|FG001|STARTED|Overall Study||0
6623992|NCT02213055|7551303|FG000|COMPLETED|Overall Study||58
6623993|NCT02213055|7551304|FG001|COMPLETED|Overall Study||0
6623994|NCT02213055|7551303|FG000|NOT COMPLETED|Overall Study||39
6623995|NCT02213055|7551304|FG001|NOT COMPLETED|Overall Study||0
6623996|NCT02213068|7551313|FG000|STARTED|Overall Study||9
6623997|NCT02213068|7551314|FG001|STARTED|Overall Study||8
6623998|NCT02213068|7551315|FG002|STARTED|Overall Study||10
6623999|NCT02213068|7551313|FG000|COMPLETED|Overall Study||9
6624000|NCT02213068|7551314|FG001|COMPLETED|Overall Study||8
6624001|NCT02213068|7551315|FG002|COMPLETED|Overall Study||10
6624002|NCT02213068|7551313|FG000|NOT COMPLETED|Overall Study||0
6624003|NCT02213068|7551314|FG001|NOT COMPLETED|Overall Study||0
6624004|NCT02213068|7551315|FG002|NOT COMPLETED|Overall Study||0
6624005|NCT02213094|7551325|FG000|STARTED|Overall Study||5
6624006|NCT02213094|7551326|FG001|STARTED|Overall Study||5
6624007|NCT02213094|7551325|FG000|COMPLETED|Overall Study|One subject stopped study agent early because of elevation in LFTs > 3x ULN|4
6624008|NCT02213094|7551326|FG001|COMPLETED|Overall Study||5
6624009|NCT02213094|7551325|FG000|NOT COMPLETED|Overall Study||1
6624010|NCT02213094|7551326|FG001|NOT COMPLETED|Overall Study||0
6624011|NCT02213133|7551335|FG000|STARTED|Overall Study||37
6624012|NCT02213133|7551336|FG001|STARTED|Overall Study||5
6624013|NCT02213133|7551337|FG002|STARTED|Overall Study||3
6624014|NCT02213133|7551335|FG000|Treated|Overall Study||33
6624015|NCT02213133|7551336|FG001|Treated|Overall Study||4
6624016|NCT02213133|7551337|FG002|Treated|Overall Study||1
6624017|NCT02213133|7551335|FG000|COMPLETED|Overall Study||0
6624018|NCT02213133|7551336|FG001|COMPLETED|Overall Study||0
6624019|NCT02213133|7551337|FG002|COMPLETED|Overall Study||0
6624020|NCT02213133|7551335|FG000|NOT COMPLETED|Overall Study||37
6624021|NCT02213133|7551336|FG001|NOT COMPLETED|Overall Study||5
6624022|NCT02213133|7551337|FG002|NOT COMPLETED|Overall Study||3
6624023|NCT02213198|7551348|FG000|STARTED|Baseline||306
6624024|NCT02213198|7551349|FG001|STARTED|Baseline||159
6624025|NCT02213198|7551348|FG000|COMPLETED|Baseline||218
6624026|NCT02213198|7551349|FG001|COMPLETED|Baseline||108
6624027|NCT02213198|7551348|FG000|NOT COMPLETED|Baseline||88
6624028|NCT02213198|7551349|FG001|NOT COMPLETED|Baseline||51
6624029|NCT02213198|7551348|FG000|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
6624030|NCT02213198|7551349|FG001|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
6624031|NCT02213198|7551348|FG000|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
6624032|NCT02213198|7551349|FG001|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
6624033|NCT02213198|7551348|FG000|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
6624034|NCT02213198|7551349|FG001|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
6624035|NCT02213198|7551348|FG000|STARTED|Follow up 2 6 Months Post TCC Treatment||125
6624036|NCT02213198|7551349|FG001|STARTED|Follow up 2 6 Months Post TCC Treatment||67
6624037|NCT02213198|7551348|FG000|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
6624038|NCT02213198|7551349|FG001|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
6624039|NCT02213198|7551348|FG000|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
6624040|NCT02213198|7551349|FG001|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
6624041|NCT02213250|7551355|FG000|STARTED|Overall Study||4
6624042|NCT02213250|7551356|FG001|STARTED|Overall Study||8
6624043|NCT02213250|7551355|FG000|COMPLETED|Overall Study||4
6624044|NCT02213250|7551356|FG001|COMPLETED|Overall Study||8
6624045|NCT02213250|7551355|FG000|NOT COMPLETED|Overall Study||0
6624046|NCT02213250|7551356|FG001|NOT COMPLETED|Overall Study||0
6624047|NCT02213263|7551365|FG000|STARTED|Overall Study||198
6624048|NCT02213263|7551366|FG001|STARTED|Overall Study||196
6624049|NCT02213263|7551365|FG000|Treated|Overall Study||197
6576756|NCT01894477|7500870|FG000|STARTED|Overall Study||35
6576757|NCT01894477|7500871|FG001|STARTED|Overall Study||67
6576758|NCT01894477|7500870|FG000|COMPLETED|Overall Study||35
6576759|NCT01894477|7500871|FG001|COMPLETED|Overall Study||65
6576760|NCT01894477|7500870|FG000|NOT COMPLETED|Overall Study||0
6576761|NCT01894477|7500871|FG001|NOT COMPLETED|Overall Study||2
6576762|NCT01894503|7500877|FG000|STARTED|Overall Study||5
6576763|NCT01894503|7500877|FG000|COMPLETED|Overall Study||5
6576764|NCT01894503|7500877|FG000|NOT COMPLETED|Overall Study||0
6576765|NCT01894516|7500886|FG000|STARTED|Period 1 (Baseline up to Week 12)||72
6576766|NCT01894516|7500887|FG001|STARTED|Period 1 (Baseline up to Week 12)||72
6576767|NCT01894516|7500888|FG002|STARTED|Period 1 (Baseline up to Week 12)||70
6576768|NCT01894516|7500889|FG003|STARTED|Period 1 (Baseline up to Week 12)||69
6576769|NCT01894516|7500886|FG000|COMPLETED|Period 1 (Baseline up to Week 12)||65
6576770|NCT01894516|7500887|FG001|COMPLETED|Period 1 (Baseline up to Week 12)||67
6576771|NCT01894516|7500888|FG002|COMPLETED|Period 1 (Baseline up to Week 12)||67
6576772|NCT01894516|7500889|FG003|COMPLETED|Period 1 (Baseline up to Week 12)||66
6576773|NCT01894516|7500886|FG000|NOT COMPLETED|Period 1 (Baseline up to Week 12)||7
6576774|NCT01894516|7500887|FG001|NOT COMPLETED|Period 1 (Baseline up to Week 12)||5
6576775|NCT01894516|7500888|FG002|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
6576776|NCT01894516|7500889|FG003|NOT COMPLETED|Period 1 (Baseline up to Week 12)||3
6576777|NCT01894516|7500886|FG000|STARTED|Period 2 (Week 13 to Week 24)|All participants from Placebo moved to 100 mg QD (65 participants) group.|0
6576778|NCT01894516|7500887|FG001|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from 50 mg QD group moved to 100 mg QD group (15 participants).|52
6576779|NCT01894516|7500888|FG002|STARTED|Period 2 (Week 13 to Week 24)|Nonresponders from Placebo(65 participants) and 50 mg QD (15 participants) moved to 100 mg QD group.|147
6576780|NCT01894516|7500889|FG003|STARTED|Period 2 (Week 13 to Week 24)||66
6576781|NCT01894516|7500886|FG000|COMPLETED|Period 2 (Week 13 to Week 24)||0
6576782|NCT01894516|7500887|FG001|COMPLETED|Period 2 (Week 13 to Week 24)||50
6576783|NCT01894516|7500888|FG002|COMPLETED|Period 2 (Week 13 to Week 24)||142
6576784|NCT01894516|7500889|FG003|COMPLETED|Period 2 (Week 13 to Week 24)||65
6576785|NCT01894516|7500886|FG000|NOT COMPLETED|Period 2 (Week 13 to Week 24)||0
6576786|NCT01894516|7500887|FG001|NOT COMPLETED|Period 2 (Week 13 to Week 24)||2
6576787|NCT01894516|7500888|FG002|NOT COMPLETED|Period 2 (Week 13 to Week 24)||5
6576788|NCT01894516|7500889|FG003|NOT COMPLETED|Period 2 (Week 13 to Week 24)||1
6576789|NCT01894555|7500903|FG000|STARTED|Overall Study||33
6576790|NCT01894555|7500903|FG000|COMPLETED|Overall Study||33
6576791|NCT01894555|7500903|FG000|NOT COMPLETED|Overall Study||0
6576792|NCT01894568|7500909|FG000|STARTED|Overall Study||192
6576793|NCT01894568|7500910|FG001|STARTED|Overall Study||196
6576794|NCT01894568|7500909|FG000|Received at Least 1 Dose of Study Drug|Overall Study||192
6576795|NCT01894568|7500910|FG001|Received at Least 1 Dose of Study Drug|Overall Study||196
6576796|NCT01894568|7500909|FG000|COMPLETED|Overall Study||182
6576797|NCT01894568|7500910|FG001|COMPLETED|Overall Study||186
6576798|NCT01894568|7500909|FG000|NOT COMPLETED|Overall Study||10
6576799|NCT01894568|7500910|FG001|NOT COMPLETED|Overall Study||10
6576800|NCT01894581|7500919|FG000|STARTED|Overall Study||20
6576801|NCT01894581|7500920|FG001|STARTED|Overall Study||19
6576802|NCT01894581|7500919|FG000|COMPLETED|Overall Study||15
6576803|NCT01894581|7500920|FG001|COMPLETED|Overall Study||12
6576804|NCT01894581|7500919|FG000|NOT COMPLETED|Overall Study||5
6576805|NCT01894581|7500920|FG001|NOT COMPLETED|Overall Study||7
6576806|NCT01894607|7500926|FG000|STARTED|Overall Study||11
6576807|NCT01894607|7500926|FG000|COMPLETED|Overall Study||10
6576808|NCT01894607|7500926|FG000|NOT COMPLETED|Overall Study||1
6576809|NCT01894620|7500932|FG000|STARTED|Overall Study||6
6576810|NCT01894620|7500933|FG001|STARTED|Overall Study||5
6576811|NCT01894620|7500932|FG000|COMPLETED|Overall Study||6
6576812|NCT01894620|7500933|FG001|COMPLETED|Overall Study||4
6576813|NCT01894620|7500932|FG000|NOT COMPLETED|Overall Study||0
6576814|NCT01894620|7500933|FG001|NOT COMPLETED|Overall Study||1
6658365|NCT02478463|7588915|FG000|NOT COMPLETED|Washout Period (Up to 42 Days)||1
6658366|NCT02478463|7588915|FG000|STARTED|Treatment Period 2 (Up to 52 Weeks)||17
6658367|NCT02478463|7588915|FG000|COMPLETED|Treatment Period 2 (Up to 52 Weeks)||16
6658368|NCT02478463|7588915|FG000|NOT COMPLETED|Treatment Period 2 (Up to 52 Weeks)||1
6658369|NCT02478489|7588923|FG000|STARTED|Overall Study||123
6658370|NCT02478489|7588924|FG001|STARTED|Overall Study||125
6658371|NCT02478489|7588923|FG000|COMPLETED|Overall Study||108
6658372|NCT02478489|7588924|FG001|COMPLETED|Overall Study||109
6658373|NCT02478489|7588923|FG000|NOT COMPLETED|Overall Study||15
6658374|NCT02478489|7588924|FG001|NOT COMPLETED|Overall Study||16
6658375|NCT02478580|7588932|FG000|STARTED|Overall Study||34
6658376|NCT02478580|7588933|FG001|STARTED|Overall Study||33
6658377|NCT02478580|7588932|FG000|COMPLETED|Overall Study||34
6658378|NCT02478580|7588933|FG001|COMPLETED|Overall Study||33
6658379|NCT02478580|7588932|FG000|NOT COMPLETED|Overall Study||0
6658380|NCT02478580|7588933|FG001|NOT COMPLETED|Overall Study||0
6658381|NCT02478632|7588943|FG000|STARTED|Early Switch Phase (Up to Week 52)||53
6658382|NCT02478632|7588944|FG001|STARTED|Early Switch Phase (Up to Week 52)||49
6658383|NCT02478632|7588943|FG000|COMPLETED|Early Switch Phase (Up to Week 52)||49
6658384|NCT02478632|7588944|FG001|COMPLETED|Early Switch Phase (Up to Week 52)||44
6658385|NCT02478632|7588943|FG000|NOT COMPLETED|Early Switch Phase (Up to Week 52)||4
6658386|NCT02478632|7588944|FG001|NOT COMPLETED|Early Switch Phase (Up to Week 52)||5
6658387|NCT02478632|7588943|FG000|STARTED|Late Switch Phase (Week 52 to Week 148)||49
6576815|NCT01894672|7500941|FG000|STARTED|Overall Study||7
6576816|NCT01894672|7500941|FG000|COMPLETED|Overall Study||7
6576817|NCT01894672|7500941|FG000|NOT COMPLETED|Overall Study||0
6576818|NCT01894776|7500946|FG000|STARTED|Overall Study||15
6576819|NCT01894776|7500946|FG000|COMPLETED|Overall Study||14
6576820|NCT01894776|7500946|FG000|NOT COMPLETED|Overall Study||1
6576821|NCT01894841|7500952|FG000|STARTED|Overall Study||52
6576822|NCT01894841|7500953|FG001|STARTED|Overall Study||53
6576823|NCT01894841|7500952|FG000|COMPLETED|Overall Study||34
6576824|NCT01894841|7500953|FG001|COMPLETED|Overall Study||44
6576825|NCT01894841|7500952|FG000|NOT COMPLETED|Overall Study||18
6576826|NCT01894841|7500953|FG001|NOT COMPLETED|Overall Study||9
6576827|NCT01894906|7500965|FG000|STARTED|Overall Study||6
6576828|NCT01894906|7500966|FG001|STARTED|Overall Study||6
6255828|NCT02243020|7154689|FG001|COMPLETED|Overall Study||9
6255829|NCT02243020|7154688|FG000|NOT COMPLETED|Overall Study||0
6255830|NCT02243020|7154689|FG001|NOT COMPLETED|Overall Study||0
6255831|NCT02108652|7154695|FG000|STARTED|Overall Study||310
6255832|NCT02108652|7154695|FG000|COMPLETED|Overall Study||0
6255833|NCT02108652|7154695|FG000|NOT COMPLETED|Overall Study||310
6255834|NCT01905384|7154701|FG000|STARTED|Overall Study||3
6576829|NCT01894906|7500965|FG000|Treatment A|Overall Study||6
6576830|NCT01894906|7500966|FG001|Treatment A|Overall Study||6
6576831|NCT01894906|7500965|FG000|Treatment B|Overall Study||6
6576832|NCT01894906|7500966|FG001|Treatment B|Overall Study||6
6576833|NCT01894906|7500965|FG000|Treatment C|Overall Study||6
6576834|NCT01894906|7500966|FG001|Treatment C|Overall Study||6
6576835|NCT01894906|7500965|FG000|Treatment D|Overall Study||6
6576836|NCT01894906|7500966|FG001|Treatment D|Overall Study||6
6576837|NCT01894906|7500965|FG000|Treatment E|Overall Study||6
6576838|NCT01894906|7500966|FG001|Treatment E|Overall Study||6
6576839|NCT01894906|7500965|FG000|Treatment F|Overall Study||6
6576840|NCT01894906|7500966|FG001|Treatment F|Overall Study||6
6576841|NCT01894906|7500965|FG000|COMPLETED|Overall Study||6
6576842|NCT01894906|7500966|FG001|COMPLETED|Overall Study||6
6576843|NCT01894906|7500965|FG000|NOT COMPLETED|Overall Study||0
6576844|NCT01894906|7500966|FG001|NOT COMPLETED|Overall Study||0
6576845|NCT01894919|7500997|FG000|STARTED|Overall Study||98
6576846|NCT01894919|7500998|FG001|STARTED|Overall Study||47
6576847|NCT01894919|7500999|FG002|STARTED|Overall Study||89
6576848|NCT01894919|7501000|FG003|STARTED|Overall Study||43
6576849|NCT01894919|7501001|FG004|STARTED|Overall Study||81
6576850|NCT01894919|7501002|FG005|STARTED|Overall Study||39
6576851|NCT01894919|7501003|FG006|STARTED|Overall Study||32
6576852|NCT01894919|7501004|FG007|STARTED|Overall Study||36
6576853|NCT01894919|7501005|FG008|STARTED|Overall Study||91
6576854|NCT01894919|7501006|FG009|STARTED|Overall Study||90
6576855|NCT01894919|7501007|FG010|STARTED|Overall Study||100
6576856|NCT01894919|7501008|FG011|STARTED|Overall Study||55
6576857|NCT01894919|7501009|FG012|STARTED|Overall Study||50
6576858|NCT01894919|7500997|FG000|COMPLETED|Overall Study||96
6576859|NCT01894919|7500998|FG001|COMPLETED|Overall Study||47
6576860|NCT01894919|7500999|FG002|COMPLETED|Overall Study||89
6576861|NCT01894919|7501000|FG003|COMPLETED|Overall Study||43
6576862|NCT01894919|7501001|FG004|COMPLETED|Overall Study||78
6576863|NCT01894919|7501002|FG005|COMPLETED|Overall Study||39
6576864|NCT01894919|7501003|FG006|COMPLETED|Overall Study||32
6576865|NCT01894919|7501004|FG007|COMPLETED|Overall Study||36
6576866|NCT01894919|7501005|FG008|COMPLETED|Overall Study||91
6576867|NCT01894919|7501006|FG009|COMPLETED|Overall Study||89
6576868|NCT01894919|7501007|FG010|COMPLETED|Overall Study||98
6576869|NCT01894919|7501008|FG011|COMPLETED|Overall Study||55
6576870|NCT01894919|7501009|FG012|COMPLETED|Overall Study||50
6576871|NCT01894919|7500997|FG000|NOT COMPLETED|Overall Study||2
6576872|NCT01894919|7500998|FG001|NOT COMPLETED|Overall Study||0
6576873|NCT01894919|7500999|FG002|NOT COMPLETED|Overall Study||0
6576874|NCT01894919|7501000|FG003|NOT COMPLETED|Overall Study||0
6576875|NCT01894919|7501001|FG004|NOT COMPLETED|Overall Study||3
6576876|NCT01894919|7501002|FG005|NOT COMPLETED|Overall Study||0
6576877|NCT01894919|7501003|FG006|NOT COMPLETED|Overall Study||0
6576878|NCT01894919|7501004|FG007|NOT COMPLETED|Overall Study||0
6576879|NCT01894919|7501005|FG008|NOT COMPLETED|Overall Study||0
6576880|NCT01894919|7501006|FG009|NOT COMPLETED|Overall Study||1
6576881|NCT01894919|7501007|FG010|NOT COMPLETED|Overall Study||2
6576882|NCT01894919|7501008|FG011|NOT COMPLETED|Overall Study||0
6576883|NCT01894919|7501009|FG012|NOT COMPLETED|Overall Study||0
6576884|NCT01894984|7501053|FG000|STARTED|Overall Study||396
6576885|NCT01894984|7501054|FG001|STARTED|Overall Study||244
6255835|NCT01905384|7154702|FG001|STARTED|Overall Study||3
6576886|NCT01894984|7501053|FG000|COMPLETED|Overall Study||82
6576887|NCT01894984|7501054|FG001|COMPLETED|Overall Study||69
6576888|NCT01894984|7501053|FG000|NOT COMPLETED|Overall Study||314
6576889|NCT01894984|7501054|FG001|NOT COMPLETED|Overall Study||175
6576890|NCT01895036|7501060|FG000|STARTED|Overall Study||6
6576891|NCT01895036|7501060|FG000|COMPLETED|Overall Study||6
6576892|NCT01895036|7501060|FG000|NOT COMPLETED|Overall Study||0
6576893|NCT01895062|7501066|FG000|STARTED|Overall Study||30
6576894|NCT01895062|7501067|FG001|STARTED|Overall Study||24
6576895|NCT01895062|7501066|FG000|COMPLETED|Overall Study||30
6576896|NCT01895062|7501067|FG001|COMPLETED|Overall Study||24
6576897|NCT01895062|7501066|FG000|NOT COMPLETED|Overall Study||0
6576898|NCT01895062|7501067|FG001|NOT COMPLETED|Overall Study||0
6576899|NCT01895088|7501073|FG000|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
6576900|NCT01895088|7501073|FG000|COMPLETED|Overall Study||253
6576901|NCT01895088|7501073|FG000|NOT COMPLETED|Overall Study||18
6576902|NCT01895101|7501080|FG000|STARTED|Overall Study||250
6576903|NCT01895101|7501081|FG001|STARTED|Overall Study||250
6576904|NCT01895101|7501082|FG002|STARTED|Overall Study||250
6576905|NCT01895101|7501080|FG000|COMPLETED|Overall Study||249
6576906|NCT01895101|7501081|FG001|COMPLETED|Overall Study||245
6576907|NCT01895101|7501082|FG002|COMPLETED|Overall Study||245
6576908|NCT01895101|7501080|FG000|NOT COMPLETED|Overall Study||1
6576909|NCT01895101|7501081|FG001|NOT COMPLETED|Overall Study||5
6576910|NCT01895101|7501082|FG002|NOT COMPLETED|Overall Study||5
6576911|NCT01895127|7501092|FG000|STARTED|Screening||4
6576912|NCT01895127|7501093|FG001|STARTED|Screening||7
6576913|NCT01895127|7501092|FG000|COMPLETED|Screening|One subject was found to be pregnant at screening so was withdrawn from the study prior to treatment|4
6576914|NCT01895127|7501093|FG001|COMPLETED|Screening||7
6576915|NCT01895127|7501092|FG000|NOT COMPLETED|Screening||0
6576916|NCT01895127|7501093|FG001|NOT COMPLETED|Screening||0
6576917|NCT01895127|7501092|FG000|STARTED|Treatment Period (Week 0-Month 3)||3
6576918|NCT01895127|7501093|FG001|STARTED|Treatment Period (Week 0-Month 3)||7
6576919|NCT01895127|7501092|FG000|COMPLETED|Treatment Period (Week 0-Month 3)||3
6576920|NCT01895127|7501093|FG001|COMPLETED|Treatment Period (Week 0-Month 3)||7
6576921|NCT01895127|7501092|FG000|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
6576922|NCT01895127|7501093|FG001|NOT COMPLETED|Treatment Period (Week 0-Month 3)||0
6576923|NCT01895127|7501092|FG000|STARTED|Month 3 Follow-up & Biopsy||3
6576924|NCT01895127|7501093|FG001|STARTED|Month 3 Follow-up & Biopsy||7
6576925|NCT01895127|7501092|FG000|COMPLETED|Month 3 Follow-up & Biopsy||3
6576926|NCT01895127|7501093|FG001|COMPLETED|Month 3 Follow-up & Biopsy||7
6576927|NCT01895127|7501092|FG000|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
6576928|NCT01895127|7501093|FG001|NOT COMPLETED|Month 3 Follow-up & Biopsy||0
6576929|NCT01895127|7501092|FG000|STARTED|Long Term Follow-up (Month 3-12)||3
6576930|NCT01895127|7501093|FG001|STARTED|Long Term Follow-up (Month 3-12)||7
6576931|NCT01895127|7501092|FG000|COMPLETED|Long Term Follow-up (Month 3-12)||1
6576932|NCT01895127|7501093|FG001|COMPLETED|Long Term Follow-up (Month 3-12)||4
6658388|NCT02478632|7588944|FG001|STARTED|Late Switch Phase (Week 52 to Week 148)||44
6658389|NCT02478632|7588943|FG000|COMPLETED|Late Switch Phase (Week 52 to Week 148)||42
6658390|NCT02478632|7588944|FG001|COMPLETED|Late Switch Phase (Week 52 to Week 148)||40
6658391|NCT02478632|7588943|FG000|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||7
6658392|NCT02478632|7588944|FG001|NOT COMPLETED|Late Switch Phase (Week 52 to Week 148)||4
6658393|NCT02478671|7588953|FG000|STARTED|Overall Study||4
6658394|NCT02478671|7588953|FG000|COMPLETED|Overall Study||4
6658395|NCT02478671|7588953|FG000|NOT COMPLETED|Overall Study||0
6658396|NCT02479139|7588964|FG000|STARTED|Overall Study||27
6658397|NCT02479139|7588965|FG001|STARTED|Overall Study||22
6658398|NCT02479139|7588966|FG002|STARTED|Overall Study||28
6658399|NCT02479139|7588967|FG003|STARTED|Overall Study||21
6658400|NCT02479139|7588968|FG004|STARTED|Overall Study||22
6658401|NCT02479139|7588969|FG005|STARTED|Overall Study||25
6658402|NCT02479139|7588964|FG000|COMPLETED|Overall Study||19
6658403|NCT02479139|7588965|FG001|COMPLETED|Overall Study||12
6658404|NCT02479139|7588966|FG002|COMPLETED|Overall Study||21
6658405|NCT02479139|7588967|FG003|COMPLETED|Overall Study||14
6658406|NCT02479139|7588968|FG004|COMPLETED|Overall Study||17
6658407|NCT02479139|7588969|FG005|COMPLETED|Overall Study||19
6658408|NCT02479139|7588964|FG000|NOT COMPLETED|Overall Study||8
6658409|NCT02479139|7588965|FG001|NOT COMPLETED|Overall Study||10
6576933|NCT01895127|7501092|FG000|NOT COMPLETED|Long Term Follow-up (Month 3-12)||2
6576934|NCT01895127|7501093|FG001|NOT COMPLETED|Long Term Follow-up (Month 3-12)||3
6576935|NCT01895270|7501102|FG000|STARTED|Study Medications Induction (W1-4)||11
6576936|NCT01895270|7501103|FG001|STARTED|Study Medications Induction (W1-4)||14
6576937|NCT01895270|7501102|FG000|COMPLETED|Study Medications Induction (W1-4)||5
6576938|NCT01895270|7501103|FG001|COMPLETED|Study Medications Induction (W1-4)||8
6576939|NCT01895270|7501102|FG000|NOT COMPLETED|Study Medications Induction (W1-4)||6
6576940|NCT01895270|7501103|FG001|NOT COMPLETED|Study Medications Induction (W1-4)||6
6576941|NCT01895270|7501102|FG000|STARTED|Buprenorphine Taper (W5 to W6D3)||5
6624050|NCT02213263|7551366|FG001|Treated|Overall Study||196
6658410|NCT02479139|7588966|FG002|NOT COMPLETED|Overall Study||7
6658411|NCT02479139|7588967|FG003|NOT COMPLETED|Overall Study||7
6658412|NCT02479139|7588968|FG004|NOT COMPLETED|Overall Study||5
6658413|NCT02479139|7588969|FG005|NOT COMPLETED|Overall Study||6
6576942|NCT01895270|7501103|FG001|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
6576943|NCT01895270|7501102|FG000|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
6576944|NCT01895270|7501103|FG001|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
6576945|NCT01895270|7501102|FG000|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
6576946|NCT01895270|7501103|FG001|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
6576947|NCT01895270|7501102|FG000|STARTED|Isradipine Taper (W7-8)||2
6576948|NCT01895270|7501103|FG001|STARTED|Isradipine Taper (W7-8)||2
6576949|NCT01895270|7501102|FG000|COMPLETED|Isradipine Taper (W7-8)||2
6576950|NCT01895270|7501103|FG001|COMPLETED|Isradipine Taper (W7-8)||0
6576951|NCT01895270|7501102|FG000|NOT COMPLETED|Isradipine Taper (W7-8)||0
6576952|NCT01895270|7501103|FG001|NOT COMPLETED|Isradipine Taper (W7-8)||2
6576953|NCT01895309|7501111|FG000|STARTED|Overall Study||299
6576954|NCT01895309|7501112|FG001|STARTED|Overall Study||297
6576955|NCT01895309|7501111|FG000|COMPLETED|Overall Study||259
6576956|NCT01895309|7501112|FG001|COMPLETED|Overall Study||246
6576957|NCT01895309|7501111|FG000|NOT COMPLETED|Overall Study||40
6576958|NCT01895309|7501112|FG001|NOT COMPLETED|Overall Study||51
6576959|NCT01895322|7501122|FG000|STARTED|Overall Study||20
6576960|NCT01895322|7501122|FG000|COMPLETED|Overall Study||7
6576961|NCT01895322|7501122|FG000|NOT COMPLETED|Overall Study||13
6576962|NCT01895335|7501127|FG000|STARTED|Overall Study||1001
6576963|NCT01895335|7501127|FG000|Treated|Overall Study||1000
6576964|NCT01895335|7501127|FG000|COMPLETED|Overall Study||786
6576965|NCT01895335|7501127|FG000|NOT COMPLETED|Overall Study||215
6576966|NCT01895361|7501134|FG000|STARTED|Overall Study||67
6576967|NCT01895361|7501135|FG001|STARTED|Overall Study||66
6576968|NCT01895361|7501136|FG002|STARTED|Overall Study||65
6576969|NCT01895361|7501134|FG000|COMPLETED|Overall Study||43
6576970|NCT01895361|7501135|FG001|COMPLETED|Overall Study||45
6576971|NCT01895361|7501136|FG002|COMPLETED|Overall Study||41
6576972|NCT01895361|7501134|FG000|NOT COMPLETED|Overall Study||24
6576973|NCT01895361|7501135|FG001|NOT COMPLETED|Overall Study||21
6576974|NCT01895361|7501136|FG002|NOT COMPLETED|Overall Study||24
6576975|NCT01895452|7501146|FG000|STARTED|Overall Study||65
6576976|NCT01895452|7501147|FG001|STARTED|Overall Study||226
6576977|NCT01895452|7501146|FG000|COMPLETED|Overall Study||61
6576978|NCT01895452|7501147|FG001|COMPLETED|Overall Study||198
6576979|NCT01895452|7501146|FG000|NOT COMPLETED|Overall Study||4
6576980|NCT01895452|7501147|FG001|NOT COMPLETED|Overall Study||28
6576981|NCT01895543|7501153|FG000|STARTED|Overall Study||411
6576982|NCT01895543|7501153|FG000|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
6576983|NCT01895543|7501153|FG000|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
6576984|NCT01895543|7501153|FG000|COMPLETED|Overall Study||282
6576985|NCT01895543|7501153|FG000|NOT COMPLETED|Overall Study||129
6576986|NCT01895608|7501161|FG000|STARTED|Overall Study||10
6576987|NCT01895608|7501162|FG001|STARTED|Overall Study||7
6576988|NCT01895608|7501163|FG002|STARTED|Overall Study||11
6576989|NCT01895608|7501164|FG003|STARTED|Overall Study||6
6576990|NCT01895608|7501161|FG000|COMPLETED|Overall Study||10
6576991|NCT01895608|7501162|FG001|COMPLETED|Overall Study||6
6576992|NCT01895608|7501163|FG002|COMPLETED|Overall Study||8
6576993|NCT01895608|7501164|FG003|COMPLETED|Overall Study||6
6576994|NCT01895608|7501161|FG000|NOT COMPLETED|Overall Study||0
6576995|NCT01895608|7501162|FG001|NOT COMPLETED|Overall Study||1
6576996|NCT01895608|7501163|FG002|NOT COMPLETED|Overall Study||3
6576997|NCT01895608|7501164|FG003|NOT COMPLETED|Overall Study||0
6576998|NCT01895634|7501174|FG000|STARTED|Overall Study||49
6576999|NCT01895634|7501174|FG000|COMPLETED|Overall Study||46
6577000|NCT01895634|7501174|FG000|NOT COMPLETED|Overall Study||3
6577001|NCT01895647|7501181|FG000|STARTED|Overall Study||8
6577002|NCT01895647|7501182|FG001|STARTED|Overall Study||10
6577003|NCT01895647|7501183|FG002|STARTED|Overall Study||7
6577004|NCT01895647|7501181|FG000|COMPLETED|Overall Study||8
6577005|NCT01895647|7501182|FG001|COMPLETED|Overall Study||10
6577006|NCT01895647|7501183|FG002|COMPLETED|Overall Study||7
6577007|NCT01895647|7501181|FG000|NOT COMPLETED|Overall Study||0
6577008|NCT01895647|7501182|FG001|NOT COMPLETED|Overall Study||0
6577009|NCT01895647|7501183|FG002|NOT COMPLETED|Overall Study||0
6577010|NCT01895777|7501193|FG000|STARTED|Overall Study||177
6577011|NCT01895777|7501194|FG001|STARTED|Overall Study||90
6577012|NCT01895777|7501193|FG000|Treated|Overall Study||176
6577013|NCT01895777|7501194|FG001|Treated|Overall Study||90
6577014|NCT01895777|7501193|FG000|COMPLETED|Overall Study||168
6577015|NCT01895777|7501194|FG001|COMPLETED|Overall Study||85
6577016|NCT01895777|7501193|FG000|NOT COMPLETED|Overall Study||9
6577017|NCT01895777|7501194|FG001|NOT COMPLETED|Overall Study||5
6577018|NCT01895855|7501205|FG000|STARTED|Overall Study||95
6577019|NCT01895855|7501206|FG001|STARTED|Overall Study||102
6577020|NCT01895855|7501205|FG000|COMPLETED|Overall Study||95
6577021|NCT01895855|7501206|FG001|COMPLETED|Overall Study||102
6577022|NCT01895855|7501205|FG000|NOT COMPLETED|Overall Study||0
6577023|NCT01895855|7501206|FG001|NOT COMPLETED|Overall Study||0
6577024|NCT01895946|7501218|FG000|STARTED|Overall Study||18
6577025|NCT01895946|7501219|FG001|STARTED|Overall Study||12
6577026|NCT01895946|7501218|FG000|COMPLETED|Overall Study||18
6577027|NCT01895946|7501219|FG001|COMPLETED|Overall Study||12
6577028|NCT01895946|7501218|FG000|NOT COMPLETED|Overall Study||0
6577029|NCT01895946|7501219|FG001|NOT COMPLETED|Overall Study||0
6577030|NCT01895972|7501225|FG000|STARTED|Overall Study||130
6577031|NCT01895972|7501225|FG000|COMPLETED|Overall Study||121
6577032|NCT01895972|7501225|FG000|NOT COMPLETED|Overall Study||9
6577033|NCT01896050|7501231|FG000|STARTED|Overall Study||93
6577034|NCT01896050|7501232|FG001|STARTED|Overall Study||22
6577035|NCT01896050|7501231|FG000|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
6577036|NCT01896050|7501232|FG001|COMPLETED|Overall Study||20
6577037|NCT01896050|7501231|FG000|NOT COMPLETED|Overall Study||38
6577038|NCT01896050|7501232|FG001|NOT COMPLETED|Overall Study||2
6577039|NCT01896115|7501242|FG000|STARTED|Overall Study||16
6577040|NCT01896115|7501243|FG001|STARTED|Overall Study||24
6577041|NCT01896115|7501242|FG000|Phase 1 Short PW|Overall Study||15
6577042|NCT01896115|7501243|FG001|Phase 1 Short PW|Overall Study||0
6577043|NCT01896115|7501242|FG000|Phase 1 Conventional PW|Overall Study||15
6577044|NCT01896115|7501243|FG001|Phase 1 Conventional PW|Overall Study||0
6577045|NCT01896115|7501242|FG000|Phase 1 Dorsal Steering|Overall Study||15
6577046|NCT01896115|7501243|FG001|Phase 1 Dorsal Steering|Overall Study||0
6577047|NCT01896115|7501242|FG000|Phase 1 Ventral Steering|Overall Study||15
6577048|NCT01896115|7501243|FG001|Phase 1 Ventral Steering|Overall Study||0
6577049|NCT01896115|7501242|FG000|Phase 2 Single Contact|Overall Study||0
6577050|NCT01896115|7501243|FG001|Phase 2 Single Contact|Overall Study||24
6577051|NCT01896115|7501242|FG000|Phase 2 Steering|Overall Study||0
6577052|NCT01896115|7501243|FG001|Phase 2 Steering|Overall Study||24
6577053|NCT01896115|7501242|FG000|COMPLETED|Overall Study||15
6577054|NCT01896115|7501243|FG001|COMPLETED|Overall Study||24
6577055|NCT01896115|7501242|FG000|NOT COMPLETED|Overall Study||1
6577056|NCT01896115|7501243|FG001|NOT COMPLETED|Overall Study||0
6577057|NCT01896128|7501256|FG000|STARTED|Overall Study||8
6577058|NCT01896128|7501257|FG001|STARTED|Overall Study||11
6577059|NCT01896128|7501256|FG000|COMPLETED|Overall Study||5
6577060|NCT01896128|7501257|FG001|COMPLETED|Overall Study||8
6577061|NCT01896128|7501256|FG000|NOT COMPLETED|Overall Study||3
6577062|NCT01896128|7501257|FG001|NOT COMPLETED|Overall Study||3
6577063|NCT01896193|7501267|FG000|STARTED|Overall Study||62
6577064|NCT01896193|7501268|FG001|STARTED|Overall Study||65
6577065|NCT01896193|7501267|FG000|COMPLETED|Overall Study||41
6577066|NCT01896193|7501268|FG001|COMPLETED|Overall Study||53
6577067|NCT01896193|7501267|FG000|NOT COMPLETED|Overall Study||21
6577068|NCT01896193|7501268|FG001|NOT COMPLETED|Overall Study||12
6577069|NCT01896206|7501276|FG000|STARTED|Overall Study||21
6577070|NCT01896206|7501276|FG000|COMPLETED|Overall Study||21
6577071|NCT01896206|7501276|FG000|NOT COMPLETED|Overall Study||0
6577072|NCT01896232|7501282|FG000|STARTED|Overall Study||343
6577073|NCT01896232|7501283|FG001|STARTED|Overall Study||340
6577074|NCT01896232|7501282|FG000|Received Treatment|Overall Study||341
6577075|NCT01896232|7501283|FG001|Received Treatment|Overall Study||338
6577076|NCT01896232|7501282|FG000|COMPLETED|Overall Study||294
6577077|NCT01896232|7501283|FG001|COMPLETED|Overall Study||287
6577078|NCT01896232|7501282|FG000|NOT COMPLETED|Overall Study||49
6577079|NCT01896232|7501283|FG001|NOT COMPLETED|Overall Study||53
6577080|NCT01896271|7501289|FG000|STARTED|Overall Study||30
6577081|NCT01896271|7501289|FG000|COMPLETED|Overall Study||20
6577082|NCT01896271|7501289|FG000|NOT COMPLETED|Overall Study||10
6577083|NCT01896297|7501293|FG000|STARTED|Overall Study||60
6577084|NCT01896297|7501293|FG000|COMPLETED|Overall Study||59
6577085|NCT01896297|7501293|FG000|NOT COMPLETED|Overall Study||1
6577086|NCT01896544|7501300|FG000|STARTED|Overall Study||10
6577087|NCT01896544|7501301|FG001|STARTED|Overall Study||10
6577088|NCT01896544|7501302|FG002|STARTED|Overall Study||10
6577089|NCT01896544|7501300|FG000|COMPLETED|Overall Study||10
6577090|NCT01896544|7501301|FG001|COMPLETED|Overall Study||10
6577091|NCT01896544|7501302|FG002|COMPLETED|Overall Study||10
6577092|NCT01896544|7501300|FG000|NOT COMPLETED|Overall Study||0
6577093|NCT01896544|7501301|FG001|NOT COMPLETED|Overall Study||0
6577094|NCT01896544|7501302|FG002|NOT COMPLETED|Overall Study||0
6577095|NCT01896557|7501315|FG000|STARTED|Clopidogrel Alone||44
6577096|NCT01896557|7501316|FG001|STARTED|Clopidogrel Alone||48
6577097|NCT01896557|7501315|FG000|COMPLETED|Clopidogrel Alone||43
6577098|NCT01896557|7501316|FG001|COMPLETED|Clopidogrel Alone||48
6577099|NCT01896557|7501315|FG000|NOT COMPLETED|Clopidogrel Alone||1
6577100|NCT01896557|7501316|FG001|NOT COMPLETED|Clopidogrel Alone||0
6658414|NCT02479412|7588992|FG000|STARTED|Overall Study||6
6577101|NCT01896557|7501315|FG000|STARTED|Clopidogrel + GI Protector||43
6577102|NCT01896557|7501316|FG001|STARTED|Clopidogrel + GI Protector||48
6577103|NCT01896557|7501315|FG000|COMPLETED|Clopidogrel + GI Protector||41
6577104|NCT01896557|7501316|FG001|COMPLETED|Clopidogrel + GI Protector||44
6577105|NCT01896557|7501315|FG000|NOT COMPLETED|Clopidogrel + GI Protector||2
6577106|NCT01896557|7501316|FG001|NOT COMPLETED|Clopidogrel + GI Protector||4
6577107|NCT01896687|7501324|FG000|STARTED|Overall Study||15
6577108|NCT01896687|7501325|FG001|STARTED|Overall Study||15
6577109|NCT01896687|7501324|FG000|COMPLETED|Overall Study||15
6577110|NCT01896687|7501325|FG001|COMPLETED|Overall Study||15
6577111|NCT01896687|7501324|FG000|NOT COMPLETED|Overall Study||0
6577112|NCT01896687|7501325|FG001|NOT COMPLETED|Overall Study||0
6577113|NCT01896700|7501333|FG000|STARTED|Overall Study||12
6577114|NCT01896700|7501334|FG001|STARTED|Overall Study||12
6658415|NCT02479412|7588993|FG001|STARTED|Overall Study||6
6577115|NCT01896700|7501333|FG000|COMPLETED|Overall Study||8
6577116|NCT01896700|7501334|FG001|COMPLETED|Overall Study||6
6577117|NCT01896700|7501333|FG000|NOT COMPLETED|Overall Study||4
6577118|NCT01896700|7501334|FG001|NOT COMPLETED|Overall Study||6
6577119|NCT01896726|7501340|FG000|STARTED|Treatment Period 1 (Days 1-22)||20
6577120|NCT01896726|7501340|FG000|Received Microgynon|Treatment Period 1 (Days 1-22)||20
6577121|NCT01896726|7501340|FG000|COMPLETED|Treatment Period 1 (Days 1-22)||20
6577122|NCT01896726|7501340|FG000|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
6577123|NCT01896726|7501340|FG000|STARTED|Treatment Period 2 (Days 23-31)||20
6577124|NCT01896726|7501340|FG000|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
6577125|NCT01896726|7501340|FG000|Received Microgynon|Treatment Period 2 (Days 23-31)||18
6577126|NCT01896726|7501340|FG000|COMPLETED|Treatment Period 2 (Days 23-31)||18
6577127|NCT01896726|7501340|FG000|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
6577128|NCT01896856|7501353|FG000|STARTED|Overall Study||6
6577129|NCT01896856|7501354|FG001|STARTED|Overall Study||3
6577130|NCT01896856|7501355|FG002|STARTED|Overall Study||7
6577131|NCT01896856|7501356|FG003|STARTED|Overall Study||6
6577132|NCT01896856|7501357|FG004|STARTED|Overall Study||62
6577133|NCT01896856|7501358|FG005|STARTED|Overall Study||34
6577134|NCT01896856|7501353|FG000|COMPLETED|Overall Study||6
6577135|NCT01896856|7501354|FG001|COMPLETED|Overall Study||3
6577136|NCT01896856|7501355|FG002|COMPLETED|Overall Study||6
6577137|NCT01896856|7501356|FG003|COMPLETED|Overall Study||6
6577138|NCT01896856|7501357|FG004|COMPLETED|Overall Study||62
6577139|NCT01896856|7501358|FG005|COMPLETED|Overall Study||34
6577140|NCT01896856|7501353|FG000|NOT COMPLETED|Overall Study||0
6577141|NCT01896856|7501354|FG001|NOT COMPLETED|Overall Study||0
6577142|NCT01896856|7501355|FG002|NOT COMPLETED|Overall Study||1
6577143|NCT01896856|7501356|FG003|NOT COMPLETED|Overall Study||0
6577144|NCT01896856|7501357|FG004|NOT COMPLETED|Overall Study||0
6577145|NCT01896856|7501358|FG005|NOT COMPLETED|Overall Study||0
6577146|NCT01896869|7501375|FG000|STARTED|Overall Study||41
6577147|NCT01896869|7501376|FG001|STARTED|Overall Study||42
6577148|NCT01896869|7501375|FG000|COMPLETED|Overall Study||40
6577149|NCT01896869|7501376|FG001|COMPLETED|Overall Study||36
6577150|NCT01896869|7501375|FG000|NOT COMPLETED|Overall Study||1
6577151|NCT01896869|7501376|FG001|NOT COMPLETED|Overall Study||6
6577152|NCT01896895|7501387|FG000|STARTED|Double-blind MP||20
6577153|NCT01896895|7501388|FG001|STARTED|Double-blind MP||22
6577154|NCT01896895|7501389|FG002|STARTED|Double-blind MP||19
6577155|NCT01896895|7501390|FG003|STARTED|Double-blind MP||0
6577156|NCT01896895|7501387|FG000|COMPLETED|Double-blind MP||19
6577157|NCT01896895|7501388|FG001|COMPLETED|Double-blind MP||20
6577158|NCT01896895|7501389|FG002|COMPLETED|Double-blind MP||16
6577159|NCT01896895|7501390|FG003|COMPLETED|Double-blind MP||0
6577160|NCT01896895|7501387|FG000|NOT COMPLETED|Double-blind MP||1
6577161|NCT01896895|7501388|FG001|NOT COMPLETED|Double-blind MP||2
6577162|NCT01896895|7501389|FG002|NOT COMPLETED|Double-blind MP||3
6577163|NCT01896895|7501390|FG003|NOT COMPLETED|Double-blind MP||0
6577164|NCT01896895|7501387|FG000|STARTED|OLEX Period||0
6577165|NCT01896895|7501388|FG001|STARTED|OLEX Period||0
6577166|NCT01896895|7501389|FG002|STARTED|OLEX Period||0
6577167|NCT01896895|7501390|FG003|STARTED|OLEX Period|Not all participants who completed double-blind MP fulfilled the inclusion criteria for OLEX period.|39
6577168|NCT01896895|7501387|FG000|COMPLETED|OLEX Period||0
6577169|NCT01896895|7501388|FG001|COMPLETED|OLEX Period||0
6658416|NCT02479412|7588994|FG002|STARTED|Overall Study||6
6577170|NCT01896895|7501389|FG002|COMPLETED|OLEX Period||0
6577171|NCT01896895|7501390|FG003|COMPLETED|OLEX Period||39
6577172|NCT01896895|7501387|FG000|NOT COMPLETED|OLEX Period||0
6577173|NCT01896895|7501388|FG001|NOT COMPLETED|OLEX Period||0
6577174|NCT01896895|7501389|FG002|NOT COMPLETED|OLEX Period||0
6577175|NCT01896895|7501390|FG003|NOT COMPLETED|OLEX Period||0
6577176|NCT01896921|7501399|FG000|STARTED|Overall Study||7
6577177|NCT01896921|7501399|FG000|COMPLETED|Overall Study||5
6577178|NCT01896921|7501399|FG000|NOT COMPLETED|Overall Study||2
6577179|NCT01896934|7501403|FG000|STARTED|Overall Study||21
6577180|NCT01896934|7501403|FG000|COMPLETED|Overall Study||19
6577181|NCT01896934|7501403|FG000|NOT COMPLETED|Overall Study||2
6577182|NCT01896986|7501409|FG000|STARTED|Overall Study||14
6577183|NCT01896986|7501410|FG001|STARTED|Overall Study||23
6577184|NCT01896986|7501409|FG000|COMPLETED|Overall Study||0
6577185|NCT01896986|7501410|FG001|COMPLETED|Overall Study||0
6577186|NCT01896986|7501409|FG000|NOT COMPLETED|Overall Study||14
6577187|NCT01896986|7501410|FG001|NOT COMPLETED|Overall Study||23
6577188|NCT01897025|7501418|FG000|STARTED|Overall Study||10
6577189|NCT01897025|7501419|FG001|STARTED|Overall Study||9
6577190|NCT01897025|7501418|FG000|COMPLETED|Overall Study||10
6577191|NCT01897025|7501419|FG001|COMPLETED|Overall Study||9
6577192|NCT01897025|7501418|FG000|NOT COMPLETED|Overall Study||0
6577193|NCT01897025|7501419|FG001|NOT COMPLETED|Overall Study||0
6577194|NCT01897077|7501427|FG000|STARTED|Overall Study||0
6577195|NCT01897077|7501428|FG001|STARTED|Overall Study||5
6577196|NCT01897077|7501427|FG000|COMPLETED|Overall Study||0
6577197|NCT01897077|7501428|FG001|COMPLETED|Overall Study||5
6577198|NCT01897077|7501427|FG000|NOT COMPLETED|Overall Study||0
6577199|NCT01897077|7501428|FG001|NOT COMPLETED|Overall Study||0
6577200|NCT01897233|7501434|FG000|STARTED|Part A (14 Days)||10
6577201|NCT01897233|7501434|FG000|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
6624051|NCT02213263|7551365|FG000|COMPLETED|Overall Study||170
6624052|NCT02213263|7551366|FG001|COMPLETED|Overall Study||170
6577202|NCT01897233|7501434|FG000|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
6577203|NCT01897233|7501434|FG000|COMPLETED|Part A (14 Days)||10
6577204|NCT01897233|7501434|FG000|NOT COMPLETED|Part A (14 Days)||0
6577205|NCT01897233|7501434|FG000|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
6577206|NCT01897233|7501434|FG000|COMPLETED|Part B (24 Weeks)||54
6577207|NCT01897233|7501434|FG000|NOT COMPLETED|Part B (24 Weeks)||4
6577208|NCT01897285|7501442|FG000|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
6577209|NCT01897285|7501442|FG000|COMPLETED|Overall Study||20
6577210|NCT01897285|7501442|FG000|NOT COMPLETED|Overall Study||0
6577211|NCT01897402|7501450|FG000|STARTED|Overall Study||265
6577212|NCT01897402|7501451|FG001|STARTED|Overall Study||260
6577213|NCT01897402|7501450|FG000|COMPLETED|Overall Study||246
6577214|NCT01897402|7501451|FG001|COMPLETED|Overall Study||244
6577215|NCT01897402|7501450|FG000|NOT COMPLETED|Overall Study||19
6577216|NCT01897402|7501451|FG001|NOT COMPLETED|Overall Study||16
6577217|NCT01897493|7501463|FG000|STARTED|Period 1 (Day 1 Through Day 6 Predose)||16
6577218|NCT01897493|7501463|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Day 1 Through Day 6 Predose)||16
6577219|NCT01897493|7501463|FG000|COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||15
6577220|NCT01897493|7501463|FG000|NOT COMPLETED|Period 1 (Day 1 Through Day 6 Predose)||1
6577221|NCT01897493|7501463|FG000|STARTED|Period 2 (Day 6 Postdose Through Day 20)||15
6577222|NCT01897493|7501463|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Day 6 Postdose Through Day 20)||15
6577223|NCT01897493|7501463|FG000|COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||15
6577224|NCT01897493|7501463|FG000|NOT COMPLETED|Period 2 (Day 6 Postdose Through Day 20)||0
6577225|NCT01897532|7501472|FG000|STARTED|Discontinuation From Treatment||3492
6577226|NCT01897532|7501473|FG001|STARTED|Discontinuation From Treatment||3499
6577227|NCT01897532|7501472|FG000|Treated|Discontinuation From Treatment||3485
6577228|NCT01897532|7501473|FG001|Treated|Discontinuation From Treatment||3494
6577229|NCT01897532|7501472|FG000|COMPLETED|Discontinuation From Treatment||2530
6577230|NCT01897532|7501473|FG001|COMPLETED|Discontinuation From Treatment||2660
6577231|NCT01897532|7501472|FG000|NOT COMPLETED|Discontinuation From Treatment||962
6577232|NCT01897532|7501473|FG001|NOT COMPLETED|Discontinuation From Treatment||839
6577233|NCT01897532|7501472|FG000|STARTED|Discontinuation From Trial||3492
6577234|NCT01897532|7501473|FG001|STARTED|Discontinuation From Trial||3499
6577235|NCT01897532|7501472|FG000|Treated|Discontinuation From Trial||3485
6577236|NCT01897532|7501473|FG001|Treated|Discontinuation From Trial||3494
6577237|NCT01897532|7501472|FG000|COMPLETED|Discontinuation From Trial||3430
6577238|NCT01897532|7501473|FG001|COMPLETED|Discontinuation From Trial||3458
6255836|NCT01905384|7154701|FG000|COMPLETED|Overall Study||3
6255837|NCT01905384|7154702|FG001|COMPLETED|Overall Study||3
6255838|NCT01905384|7154701|FG000|NOT COMPLETED|Overall Study||0
6255839|NCT01905384|7154702|FG001|NOT COMPLETED|Overall Study||0
6577239|NCT01897532|7501472|FG000|NOT COMPLETED|Discontinuation From Trial||62
6577240|NCT01897532|7501473|FG001|NOT COMPLETED|Discontinuation From Trial||41
6577241|NCT01897714|7501485|FG000|STARTED|Phase I (Dose Escalation)||4
6577242|NCT01897714|7501486|FG001|STARTED|Phase I (Dose Escalation)||7
6577243|NCT01897714|7501487|FG002|STARTED|Phase I (Dose Escalation)||6
6577244|NCT01897714|7501488|FG003|STARTED|Phase I (Dose Escalation)||6
6577245|NCT01897714|7501489|FG004|STARTED|Phase I (Dose Escalation)||0
6577246|NCT01897714|7501490|FG005|STARTED|Phase I (Dose Escalation)||0
6577247|NCT01897714|7501485|FG000|COMPLETED|Phase I (Dose Escalation)||1
6577248|NCT01897714|7501486|FG001|COMPLETED|Phase I (Dose Escalation)||0
6577249|NCT01897714|7501487|FG002|COMPLETED|Phase I (Dose Escalation)||1
6577250|NCT01897714|7501488|FG003|COMPLETED|Phase I (Dose Escalation)||0
6577251|NCT01897714|7501489|FG004|COMPLETED|Phase I (Dose Escalation)||0
6577252|NCT01897714|7501490|FG005|COMPLETED|Phase I (Dose Escalation)||0
6577253|NCT01897714|7501485|FG000|NOT COMPLETED|Phase I (Dose Escalation)||3
6577254|NCT01897714|7501486|FG001|NOT COMPLETED|Phase I (Dose Escalation)||7
6577255|NCT01897714|7501487|FG002|NOT COMPLETED|Phase I (Dose Escalation)||5
6577256|NCT01897714|7501488|FG003|NOT COMPLETED|Phase I (Dose Escalation)||6
6577257|NCT01897714|7501489|FG004|NOT COMPLETED|Phase I (Dose Escalation)||0
6577258|NCT01897714|7501490|FG005|NOT COMPLETED|Phase I (Dose Escalation)||0
6577259|NCT01897714|7501485|FG000|STARTED|Phase II (MTD)||0
6577260|NCT01897714|7501486|FG001|STARTED|Phase II (MTD)||0
6577261|NCT01897714|7501487|FG002|STARTED|Phase II (MTD)||0
6577262|NCT01897714|7501488|FG003|STARTED|Phase II (MTD)||0
6577263|NCT01897714|7501489|FG004|STARTED|Phase II (MTD)|6 patients were entered from the Phase I: Melflufen 40 mg + Dexamethasone arm.|45
6577264|NCT01897714|7501490|FG005|STARTED|Phase II (MTD)||13
6577265|NCT01897714|7501485|FG000|COMPLETED|Phase II (MTD)||0
6255840|NCT01904032|7154710|FG000|STARTED|Overall Study||64
6255841|NCT01904032|7154711|FG001|STARTED|Overall Study||65
6577266|NCT01897714|7501486|FG001|COMPLETED|Phase II (MTD)||0
6577267|NCT01897714|7501487|FG002|COMPLETED|Phase II (MTD)||0
6577268|NCT01897714|7501488|FG003|COMPLETED|Phase II (MTD)||0
6577269|NCT01897714|7501489|FG004|COMPLETED|Phase II (MTD)||15
6577270|NCT01897714|7501490|FG005|COMPLETED|Phase II (MTD)||2
6577271|NCT01897714|7501485|FG000|NOT COMPLETED|Phase II (MTD)||0
6577272|NCT01897714|7501486|FG001|NOT COMPLETED|Phase II (MTD)||0
6577273|NCT01897714|7501487|FG002|NOT COMPLETED|Phase II (MTD)||0
6577274|NCT01897714|7501488|FG003|NOT COMPLETED|Phase II (MTD)||0
6577275|NCT01897714|7501489|FG004|NOT COMPLETED|Phase II (MTD)||30
6577276|NCT01897714|7501490|FG005|NOT COMPLETED|Phase II (MTD)||11
6577277|NCT01897727|7501508|FG000|STARTED|Overall Study||8
6577278|NCT01897727|7501509|FG001|STARTED|Overall Study||9
6577279|NCT01897727|7501508|FG000|COMPLETED|Overall Study||8
6577280|NCT01897727|7501509|FG001|COMPLETED|Overall Study||8
6577281|NCT01897727|7501508|FG000|NOT COMPLETED|Overall Study||0
6577282|NCT01897727|7501509|FG001|NOT COMPLETED|Overall Study||1
6577283|NCT01897766|7501515|FG000|STARTED|Overall Study||482
6577284|NCT01897766|7501515|FG000|COMPLETED|Overall Study||482
6577285|NCT01897766|7501515|FG000|NOT COMPLETED|Overall Study||0
6577286|NCT01897792|7501521|FG000|STARTED|Overall Study||6
6577287|NCT01897792|7501522|FG001|STARTED|Overall Study||5
6577288|NCT01897792|7501521|FG000|COMPLETED|Overall Study||6
6577289|NCT01897792|7501522|FG001|COMPLETED|Overall Study||5
6577290|NCT01897792|7501521|FG000|NOT COMPLETED|Overall Study||0
6577291|NCT01897792|7501522|FG001|NOT COMPLETED|Overall Study||0
6577292|NCT01897896|7501534|FG000|STARTED|Overall Study||82
6577293|NCT01897896|7501535|FG001|STARTED|Overall Study||37
6577294|NCT01897896|7501534|FG000|COMPLETED|Overall Study||56
6577295|NCT01897896|7501535|FG001|COMPLETED|Overall Study||25
6577296|NCT01897896|7501534|FG000|NOT COMPLETED|Overall Study||26
6577297|NCT01897896|7501535|FG001|NOT COMPLETED|Overall Study||12
6577298|NCT01898013|7501545|FG000|STARTED|Visit 3 (Randomization Visit)||45
6577299|NCT01898013|7501546|FG001|STARTED|Visit 3 (Randomization Visit)||49
6577300|NCT01898013|7501545|FG000|COMPLETED|Visit 3 (Randomization Visit)||45
6577301|NCT01898013|7501546|FG001|COMPLETED|Visit 3 (Randomization Visit)||49
6577302|NCT01898013|7501545|FG000|NOT COMPLETED|Visit 3 (Randomization Visit)||0
6577303|NCT01898013|7501546|FG001|NOT COMPLETED|Visit 3 (Randomization Visit)||0
6577304|NCT01898013|7501545|FG000|STARTED|Visit 4||45
6577305|NCT01898013|7501546|FG001|STARTED|Visit 4||49
6577306|NCT01898013|7501545|FG000|COMPLETED|Visit 4||45
6577307|NCT01898013|7501546|FG001|COMPLETED|Visit 4||48
6577308|NCT01898013|7501545|FG000|NOT COMPLETED|Visit 4||0
6577309|NCT01898013|7501546|FG001|NOT COMPLETED|Visit 4||1
6577310|NCT01898013|7501545|FG000|STARTED|Visit 5||45
6577311|NCT01898013|7501546|FG001|STARTED|Visit 5||48
6577312|NCT01898013|7501545|FG000|COMPLETED|Visit 5||44
6577313|NCT01898013|7501546|FG001|COMPLETED|Visit 5||47
6577314|NCT01898013|7501545|FG000|NOT COMPLETED|Visit 5||1
6577315|NCT01898013|7501546|FG001|NOT COMPLETED|Visit 5||1
6577316|NCT01898013|7501545|FG000|STARTED|Visit 6||44
6577317|NCT01898013|7501546|FG001|STARTED|Visit 6||47
6577318|NCT01898013|7501545|FG000|COMPLETED|Visit 6||41
6577319|NCT01898013|7501546|FG001|COMPLETED|Visit 6||42
6577320|NCT01898013|7501545|FG000|NOT COMPLETED|Visit 6||3
6577321|NCT01898013|7501546|FG001|NOT COMPLETED|Visit 6||5
6577322|NCT01898078|7501554|FG000|STARTED|Overall Study||13
6577323|NCT01898078|7501555|FG001|STARTED|Overall Study||13
6577324|NCT01898078|7501554|FG000|COMPLETED|Overall Study|Completed treatment|7
6577325|NCT01898078|7501555|FG001|COMPLETED|Overall Study|Completed treatment|5
6577326|NCT01898078|7501554|FG000|NOT COMPLETED|Overall Study||6
6577327|NCT01898078|7501555|FG001|NOT COMPLETED|Overall Study||8
6577328|NCT01898091|7501565|FG000|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
6577329|NCT01898091|7501566|FG001|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
6577330|NCT01898091|7501565|FG000|COMPLETED|Overall Study||23
6577331|NCT01898091|7501566|FG001|COMPLETED|Overall Study||19
6577332|NCT01898091|7501565|FG000|NOT COMPLETED|Overall Study||2
6577333|NCT01898091|7501566|FG001|NOT COMPLETED|Overall Study||6
6577334|NCT01898130|7501572|FG000|STARTED|Treatment||27
6577335|NCT01898130|7501572|FG000|Reached 1st Response/2 Cycles|Treatment||24
6577336|NCT01898130|7501572|FG000|Went on to Start Cycle 3|Treatment||21
6577337|NCT01898130|7501572|FG000|COMPLETED|Treatment||21
6577338|NCT01898130|7501572|FG000|NOT COMPLETED|Treatment||6
6577339|NCT01898130|7501572|FG000|STARTED|Follow up Until PD or Death|All patients treated on study go into follow up period for survival data.|27
6577340|NCT01898130|7501572|FG000|COMPLETED|Follow up Until PD or Death||26
6577341|NCT01898130|7501572|FG000|NOT COMPLETED|Follow up Until PD or Death||1
6577342|NCT01898195|7501579|FG000|STARTED|Varenicline Adherence||53
6577343|NCT01898195|7501580|FG001|STARTED|Varenicline Adherence||54
6577344|NCT01898195|7501581|FG002|STARTED|Varenicline Adherence||51
6577345|NCT01898195|7501579|FG000|COMPLETED|Varenicline Adherence||18
6577346|NCT01898195|7501580|FG001|COMPLETED|Varenicline Adherence||16
6577347|NCT01898195|7501581|FG002|COMPLETED|Varenicline Adherence||15
6577348|NCT01898195|7501579|FG000|NOT COMPLETED|Varenicline Adherence||35
6577349|NCT01898195|7501580|FG001|NOT COMPLETED|Varenicline Adherence||38
6577350|NCT01898195|7501581|FG002|NOT COMPLETED|Varenicline Adherence||36
6577351|NCT01898195|7501579|FG000|STARTED|Smoking Abstinence||53
6577352|NCT01898195|7501580|FG001|STARTED|Smoking Abstinence||54
6577353|NCT01898195|7501581|FG002|STARTED|Smoking Abstinence||51
6577354|NCT01898195|7501579|FG000|COMPLETED|Smoking Abstinence||18
6577355|NCT01898195|7501580|FG001|COMPLETED|Smoking Abstinence||16
6577356|NCT01898195|7501581|FG002|COMPLETED|Smoking Abstinence||15
6577357|NCT01898195|7501579|FG000|NOT COMPLETED|Smoking Abstinence||35
6577358|NCT01898195|7501580|FG001|NOT COMPLETED|Smoking Abstinence||38
6577359|NCT01898195|7501581|FG002|NOT COMPLETED|Smoking Abstinence||36
6577360|NCT01898208|7501592|FG000|STARTED|Overall Study||247
6577361|NCT01898208|7501593|FG001|STARTED|Overall Study||247
6577362|NCT01898208|7501594|FG002|STARTED|Overall Study||249
6577363|NCT01898208|7501592|FG000|COMPLETED|Overall Study||207
6577364|NCT01898208|7501593|FG001|COMPLETED|Overall Study||198
6577365|NCT01898208|7501594|FG002|COMPLETED|Overall Study||212
6577366|NCT01898208|7501592|FG000|NOT COMPLETED|Overall Study||40
6577367|NCT01898208|7501593|FG001|NOT COMPLETED|Overall Study||49
6577368|NCT01898208|7501594|FG002|NOT COMPLETED|Overall Study||37
6577369|NCT01898286|7501602|FG000|STARTED|Overall Study||38
6577370|NCT01898286|7501602|FG000|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
6577371|NCT01898286|7501602|FG000|NOT COMPLETED|Overall Study||3
6577372|NCT01898299|7501608|FG000|STARTED|Post Treatment (One Week)||47
6577373|NCT01898299|7501609|FG001|STARTED|Post Treatment (One Week)||42
6577374|NCT01898299|7501608|FG000|COMPLETED|Post Treatment (One Week)||47
6577375|NCT01898299|7501609|FG001|COMPLETED|Post Treatment (One Week)||42
6577376|NCT01898299|7501608|FG000|NOT COMPLETED|Post Treatment (One Week)||0
6577377|NCT01898299|7501609|FG001|NOT COMPLETED|Post Treatment (One Week)||0
6577378|NCT01898299|7501608|FG000|STARTED|Post Treatment (One Month)||47
6577379|NCT01898299|7501609|FG001|STARTED|Post Treatment (One Month)||42
6577380|NCT01898299|7501608|FG000|COMPLETED|Post Treatment (One Month)||44
6577381|NCT01898299|7501609|FG001|COMPLETED|Post Treatment (One Month)||38
6577382|NCT01898299|7501608|FG000|NOT COMPLETED|Post Treatment (One Month)||3
6577383|NCT01898299|7501609|FG001|NOT COMPLETED|Post Treatment (One Month)||4
6577384|NCT01898403|7501615|FG000|STARTED|Overall Study||50
6577385|NCT01898403|7501615|FG000|COMPLETED|Overall Study||50
6577386|NCT01898403|7501615|FG000|NOT COMPLETED|Overall Study||0
6577387|NCT01898429|7501621|FG000|STARTED|Phase 1||5
6577388|NCT01898429|7501622|FG001|STARTED|Phase 1||0
6577389|NCT01898429|7501623|FG002|STARTED|Phase 1||0
6577390|NCT01898429|7501621|FG000|COMPLETED|Phase 1||5
6577391|NCT01898429|7501622|FG001|COMPLETED|Phase 1||0
6577392|NCT01898429|7501623|FG002|COMPLETED|Phase 1||0
6577393|NCT01898429|7501621|FG000|NOT COMPLETED|Phase 1||0
6577394|NCT01898429|7501622|FG001|NOT COMPLETED|Phase 1||0
6577395|NCT01898429|7501623|FG002|NOT COMPLETED|Phase 1||0
6577396|NCT01898429|7501621|FG000|STARTED|Phase 2||0
6577397|NCT01898429|7501622|FG001|STARTED|Phase 2||5
6577398|NCT01898429|7501623|FG002|STARTED|Phase 2||0
6577399|NCT01898429|7501621|FG000|COMPLETED|Phase 2||0
6577400|NCT01898429|7501622|FG001|COMPLETED|Phase 2||5
6577401|NCT01898429|7501623|FG002|COMPLETED|Phase 2||0
6577402|NCT01898429|7501621|FG000|NOT COMPLETED|Phase 2||0
6577403|NCT01898429|7501622|FG001|NOT COMPLETED|Phase 2||0
6577404|NCT01898429|7501623|FG002|NOT COMPLETED|Phase 2||0
6577405|NCT01898429|7501621|FG000|STARTED|Phase 3||0
6577406|NCT01898429|7501622|FG001|STARTED|Phase 3||0
6577407|NCT01898429|7501623|FG002|STARTED|Phase 3||5
6577408|NCT01898429|7501621|FG000|COMPLETED|Phase 3||0
6577409|NCT01898429|7501622|FG001|COMPLETED|Phase 3||0
6577410|NCT01898429|7501623|FG002|COMPLETED|Phase 3||5
6577411|NCT01898429|7501621|FG000|NOT COMPLETED|Phase 3||0
6577412|NCT01898429|7501622|FG001|NOT COMPLETED|Phase 3||0
6577413|NCT01898429|7501623|FG002|NOT COMPLETED|Phase 3||0
6577414|NCT01898442|7501630|FG000|STARTED|Overall Study||17
6577415|NCT01898442|7501631|FG001|STARTED|Overall Study||17
6577416|NCT01898442|7501632|FG002|STARTED|Overall Study||18
6577417|NCT01898442|7501630|FG000|COMPLETED|Overall Study||16
6577418|NCT01898442|7501631|FG001|COMPLETED|Overall Study||15
6577419|NCT01898442|7501632|FG002|COMPLETED|Overall Study||15
6577420|NCT01898442|7501630|FG000|NOT COMPLETED|Overall Study||1
6577421|NCT01898442|7501631|FG001|NOT COMPLETED|Overall Study||2
6577422|NCT01898442|7501632|FG002|NOT COMPLETED|Overall Study||3
6577423|NCT01898598|7501642|FG000|STARTED|Overall Study||12
6577424|NCT01898598|7501643|FG001|STARTED|Overall Study||6
6577425|NCT01898598|7501642|FG000|Treated|Overall Study||11
6577426|NCT01898598|7501643|FG001|Treated|Overall Study||5
6577427|NCT01898598|7501642|FG000|COMPLETED|Overall Study||8
6577428|NCT01898598|7501643|FG001|COMPLETED|Overall Study||4
6577429|NCT01898598|7501642|FG000|NOT COMPLETED|Overall Study||4
6577430|NCT01898598|7501643|FG001|NOT COMPLETED|Overall Study||2
6577431|NCT01898611|7501651|FG000|STARTED|Overall Study||5
6577432|NCT01898611|7501652|FG001|STARTED|Overall Study||11
6577433|NCT01898611|7501651|FG000|COMPLETED|Overall Study||5
6577434|NCT01898611|7501652|FG001|COMPLETED|Overall Study||10
6577435|NCT01898611|7501651|FG000|NOT COMPLETED|Overall Study||0
6577436|NCT01898611|7501652|FG001|NOT COMPLETED|Overall Study||1
6577437|NCT01898689|7501660|FG000|STARTED|Overall Study||10
6577438|NCT01898689|7501661|FG001|STARTED|Overall Study||14
6577439|NCT01898689|7501660|FG000|COMPLETED|Overall Study||10
6577440|NCT01898689|7501661|FG001|COMPLETED|Overall Study||14
6577441|NCT01898689|7501660|FG000|NOT COMPLETED|Overall Study||0
6577442|NCT01898689|7501661|FG001|NOT COMPLETED|Overall Study||0
6577443|NCT01898754|7501671|FG000|STARTED|Overall Study||494
6577444|NCT01898754|7501672|FG001|STARTED|Overall Study||497
6577445|NCT01898754|7501671|FG000|COMPLETED|Overall Study||400
6577446|NCT01898754|7501672|FG001|COMPLETED|Overall Study||403
6577447|NCT01898754|7501671|FG000|NOT COMPLETED|Overall Study||94
6577448|NCT01898754|7501672|FG001|NOT COMPLETED|Overall Study||94
6577449|NCT01898806|7501678|FG000|STARTED|Overall Study||11
6577450|NCT01898806|7501678|FG000|COMPLETED|Overall Study||8
6577451|NCT01898806|7501678|FG000|NOT COMPLETED|Overall Study||3
6577452|NCT01898884|7501687|FG000|STARTED|Single Dose Period||8
6577453|NCT01898884|7501688|FG001|STARTED|Single Dose Period||6
6577454|NCT01898884|7501689|FG002|STARTED|Single Dose Period||6
6577455|NCT01898884|7501690|FG003|STARTED|Single Dose Period||6
6577456|NCT01898884|7501691|FG004|STARTED|Single Dose Period||6
6577457|NCT01898884|7501692|FG005|STARTED|Single Dose Period||0
6577458|NCT01898884|7501693|FG006|STARTED|Single Dose Period||0
6577459|NCT01898884|7501694|FG007|STARTED|Single Dose Period||0
6577460|NCT01898884|7501695|FG008|STARTED|Single Dose Period||0
6577461|NCT01898884|7501687|FG000|COMPLETED|Single Dose Period||8
6577462|NCT01898884|7501688|FG001|COMPLETED|Single Dose Period||6
6577463|NCT01898884|7501689|FG002|COMPLETED|Single Dose Period||6
6577464|NCT01898884|7501690|FG003|COMPLETED|Single Dose Period||6
6577465|NCT01898884|7501691|FG004|COMPLETED|Single Dose Period||6
6577466|NCT01898884|7501692|FG005|COMPLETED|Single Dose Period||0
6577467|NCT01898884|7501693|FG006|COMPLETED|Single Dose Period||0
6577468|NCT01898884|7501694|FG007|COMPLETED|Single Dose Period||0
6577469|NCT01898884|7501695|FG008|COMPLETED|Single Dose Period||0
6577470|NCT01898884|7501687|FG000|NOT COMPLETED|Single Dose Period||0
6577471|NCT01898884|7501688|FG001|NOT COMPLETED|Single Dose Period||0
6577472|NCT01898884|7501689|FG002|NOT COMPLETED|Single Dose Period||0
6577473|NCT01898884|7501690|FG003|NOT COMPLETED|Single Dose Period||0
6577474|NCT01898884|7501691|FG004|NOT COMPLETED|Single Dose Period||0
6577475|NCT01898884|7501692|FG005|NOT COMPLETED|Single Dose Period||0
6577476|NCT01898884|7501693|FG006|NOT COMPLETED|Single Dose Period||0
6577477|NCT01898884|7501694|FG007|NOT COMPLETED|Single Dose Period||0
6577478|NCT01898884|7501695|FG008|NOT COMPLETED|Single Dose Period||0
6577479|NCT01898884|7501687|FG000|STARTED|Multiple Dose Period||0
6577480|NCT01898884|7501688|FG001|STARTED|Multiple Dose Period||0
6577481|NCT01898884|7501689|FG002|STARTED|Multiple Dose Period||0
6577482|NCT01898884|7501690|FG003|STARTED|Multiple Dose Period||0
6577483|NCT01898884|7501691|FG004|STARTED|Multiple Dose Period||0
6577484|NCT01898884|7501692|FG005|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
6577485|NCT01898884|7501693|FG006|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
6577486|NCT01898884|7501694|FG007|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
6577487|NCT01898884|7501695|FG008|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
6577488|NCT01898884|7501687|FG000|Treated|Multiple Dose Period||0
6577489|NCT01898884|7501688|FG001|Treated|Multiple Dose Period||0
6577490|NCT01898884|7501689|FG002|Treated|Multiple Dose Period||0
6577491|NCT01898884|7501690|FG003|Treated|Multiple Dose Period||0
6577492|NCT01898884|7501691|FG004|Treated|Multiple Dose Period||0
6577493|NCT01898884|7501692|FG005|Treated|Multiple Dose Period||6
6577494|NCT01898884|7501693|FG006|Treated|Multiple Dose Period||6
6577495|NCT01898884|7501694|FG007|Treated|Multiple Dose Period||6
6577496|NCT01898884|7501695|FG008|Treated|Multiple Dose Period||5
6577497|NCT01898884|7501687|FG000|COMPLETED|Multiple Dose Period||0
6577498|NCT01898884|7501688|FG001|COMPLETED|Multiple Dose Period||0
6577499|NCT01898884|7501689|FG002|COMPLETED|Multiple Dose Period||0
6577500|NCT01898884|7501690|FG003|COMPLETED|Multiple Dose Period||0
6577501|NCT01898884|7501691|FG004|COMPLETED|Multiple Dose Period||0
6577502|NCT01898884|7501692|FG005|COMPLETED|Multiple Dose Period||6
6577503|NCT01898884|7501693|FG006|COMPLETED|Multiple Dose Period||5
6577504|NCT01898884|7501694|FG007|COMPLETED|Multiple Dose Period||6
6577505|NCT01898884|7501695|FG008|COMPLETED|Multiple Dose Period||5
6577506|NCT01898884|7501687|FG000|NOT COMPLETED|Multiple Dose Period||0
6577507|NCT01898884|7501688|FG001|NOT COMPLETED|Multiple Dose Period||0
6577508|NCT01898884|7501689|FG002|NOT COMPLETED|Multiple Dose Period||0
6577509|NCT01898884|7501690|FG003|NOT COMPLETED|Multiple Dose Period||0
6577510|NCT01898884|7501691|FG004|NOT COMPLETED|Multiple Dose Period||0
6577511|NCT01898884|7501692|FG005|NOT COMPLETED|Multiple Dose Period||0
6577512|NCT01898884|7501693|FG006|NOT COMPLETED|Multiple Dose Period||1
6577513|NCT01898884|7501694|FG007|NOT COMPLETED|Multiple Dose Period||0
6577514|NCT01898884|7501695|FG008|NOT COMPLETED|Multiple Dose Period||1
6577515|NCT01898923|7501733|FG000|STARTED|Overall Study||122
6577516|NCT01898923|7501734|FG001|STARTED|Overall Study||114
6577517|NCT01898923|7501733|FG000|COMPLETED|Overall Study||106
6577518|NCT01898923|7501734|FG001|COMPLETED|Overall Study||93
6577519|NCT01898923|7501733|FG000|NOT COMPLETED|Overall Study||16
6577520|NCT01898923|7501734|FG001|NOT COMPLETED|Overall Study||21
6577521|NCT01899053|7501754|FG000|STARTED|Overall Study||7
6577522|NCT01899053|7501755|FG001|STARTED|Overall Study||3
6577523|NCT01899053|7501756|FG002|STARTED|Overall Study||7
6577524|NCT01899053|7501757|FG003|STARTED|Overall Study||3
6577525|NCT01899053|7501758|FG004|STARTED|Overall Study||6
6577526|NCT01899053|7501759|FG005|STARTED|Overall Study||3
6577527|NCT01899053|7501760|FG006|STARTED|Overall Study||3
6577528|NCT01899053|7501761|FG007|STARTED|Overall Study||3
6577529|NCT01899053|7501762|FG008|STARTED|Overall Study||6
6577530|NCT01899053|7501763|FG009|STARTED|Overall Study||3
6577531|NCT01899053|7501764|FG010|STARTED|Overall Study||16
6577532|NCT01899053|7501765|FG011|STARTED|Overall Study||7
6577533|NCT01899053|7501766|FG012|STARTED|Overall Study||14
6577534|NCT01899053|7501767|FG013|STARTED|Overall Study||20
6577535|NCT01899053|7501754|FG000|COMPLETED|Overall Study||0
6577536|NCT01899053|7501755|FG001|COMPLETED|Overall Study||0
6577537|NCT01899053|7501756|FG002|COMPLETED|Overall Study||0
6577538|NCT01899053|7501757|FG003|COMPLETED|Overall Study||0
6577539|NCT01899053|7501758|FG004|COMPLETED|Overall Study||0
6577540|NCT01899053|7501759|FG005|COMPLETED|Overall Study||0
6577541|NCT01899053|7501760|FG006|COMPLETED|Overall Study||0
6658417|NCT02479412|7588995|FG003|STARTED|Overall Study||7
6577542|NCT01899053|7501761|FG007|COMPLETED|Overall Study||0
6577543|NCT01899053|7501762|FG008|COMPLETED|Overall Study||0
6577544|NCT01899053|7501763|FG009|COMPLETED|Overall Study||0
6577545|NCT01899053|7501764|FG010|COMPLETED|Overall Study||0
6577546|NCT01899053|7501765|FG011|COMPLETED|Overall Study||0
6577547|NCT01899053|7501766|FG012|COMPLETED|Overall Study||0
6577548|NCT01899053|7501767|FG013|COMPLETED|Overall Study||0
6577549|NCT01899053|7501754|FG000|NOT COMPLETED|Overall Study||7
6577550|NCT01899053|7501755|FG001|NOT COMPLETED|Overall Study||3
6577551|NCT01899053|7501756|FG002|NOT COMPLETED|Overall Study||7
6577552|NCT01899053|7501757|FG003|NOT COMPLETED|Overall Study||3
6577553|NCT01899053|7501758|FG004|NOT COMPLETED|Overall Study||6
6577554|NCT01899053|7501759|FG005|NOT COMPLETED|Overall Study||3
6577555|NCT01899053|7501760|FG006|NOT COMPLETED|Overall Study||3
6577556|NCT01899053|7501761|FG007|NOT COMPLETED|Overall Study||3
6577557|NCT01899053|7501762|FG008|NOT COMPLETED|Overall Study||6
6577558|NCT01899053|7501763|FG009|NOT COMPLETED|Overall Study||3
6577559|NCT01899053|7501764|FG010|NOT COMPLETED|Overall Study||16
6577560|NCT01899053|7501765|FG011|NOT COMPLETED|Overall Study||7
6577561|NCT01899053|7501766|FG012|NOT COMPLETED|Overall Study||14
6577562|NCT01899053|7501767|FG013|NOT COMPLETED|Overall Study||20
6577563|NCT01899300|7501799|FG000|STARTED|Overall Study||1
6577564|NCT01899300|7501800|FG001|STARTED|Overall Study||0
6577565|NCT01899300|7501799|FG000|COMPLETED|Overall Study||1
6577566|NCT01899300|7501800|FG001|COMPLETED|Overall Study||0
6577567|NCT01899300|7501799|FG000|NOT COMPLETED|Overall Study||0
6577568|NCT01899300|7501800|FG001|NOT COMPLETED|Overall Study||0
6577569|NCT01899677|7501808|FG000|STARTED|Overall Study||35
6577570|NCT01899677|7501809|FG001|STARTED|Overall Study||35
6577571|NCT01899677|7501808|FG000|COMPLETED|Overall Study||25
6577572|NCT01899677|7501809|FG001|COMPLETED|Overall Study||28
6577573|NCT01899677|7501808|FG000|NOT COMPLETED|Overall Study||10
6577574|NCT01899677|7501809|FG001|NOT COMPLETED|Overall Study||7
6577575|NCT01899742|7501817|FG000|STARTED|Overall Study||247
6577576|NCT01899742|7501818|FG001|STARTED|Overall Study||247
6577577|NCT01899742|7501817|FG000|COMPLETED|Overall Study||230
6577578|NCT01899742|7501818|FG001|COMPLETED|Overall Study||231
6577579|NCT01899742|7501817|FG000|NOT COMPLETED|Overall Study||17
6577580|NCT01899742|7501818|FG001|NOT COMPLETED|Overall Study||16
6577581|NCT01899768|7501824|FG000|STARTED|Part A||16
6577582|NCT01899768|7501824|FG000|COMPLETED|Part A||13
6577583|NCT01899768|7501824|FG000|NOT COMPLETED|Part A||3
6577584|NCT01899768|7501824|FG000|STARTED|Part B||13
6577585|NCT01899768|7501824|FG000|COMPLETED|Part B||11
6577586|NCT01899768|7501824|FG000|NOT COMPLETED|Part B||2
6577587|NCT01899768|7501824|FG000|STARTED|Part C||11
6577588|NCT01899768|7501824|FG000|COMPLETED|Part C||11
6577589|NCT01899768|7501824|FG000|NOT COMPLETED|Part C||0
6577590|NCT01899911|7501832|FG000|STARTED|Overall Study||12
6577591|NCT01899911|7501832|FG000|COMPLETED|Overall Study||12
6577592|NCT01899911|7501832|FG000|NOT COMPLETED|Overall Study||0
6577593|NCT01900054|7501836|FG000|STARTED|Overall Study||58
6577594|NCT01900054|7501836|FG000|COMPLETED|Overall Study||56
6577595|NCT01900054|7501836|FG000|NOT COMPLETED|Overall Study||2
6577596|NCT01900067|7501842|FG000|STARTED|Overall Study||134
6577597|NCT01900067|7501843|FG001|STARTED|Overall Study||137
6577598|NCT01900067|7501842|FG000|COMPLETED|Overall Study||122
6577599|NCT01900067|7501843|FG001|COMPLETED|Overall Study||124
6577600|NCT01900067|7501842|FG000|NOT COMPLETED|Overall Study||12
6577601|NCT01900067|7501843|FG001|NOT COMPLETED|Overall Study||13
6577602|NCT01900249|7501852|FG000|STARTED|Overall Study||67
6577603|NCT01900249|7501853|FG001|STARTED|Overall Study||68
6577604|NCT01900249|7501854|FG002|STARTED|Overall Study||69
6577605|NCT01900249|7501852|FG000|COMPLETED|Overall Study||64
6577606|NCT01900249|7501853|FG001|COMPLETED|Overall Study||63
6577607|NCT01900249|7501854|FG002|COMPLETED|Overall Study||65
6577608|NCT01900249|7501852|FG000|NOT COMPLETED|Overall Study||3
6577609|NCT01900249|7501853|FG001|NOT COMPLETED|Overall Study||5
6577610|NCT01900249|7501854|FG002|NOT COMPLETED|Overall Study||4
6577611|NCT01900314|7501864|FG000|STARTED|Overall Study||20
6577612|NCT01900314|7501865|FG001|STARTED|Overall Study||20
6577613|NCT01900314|7501864|FG000|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
6577614|NCT01900314|7501865|FG001|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
6577615|NCT01900314|7501864|FG000|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
6577616|NCT01900314|7501865|FG001|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
6577617|NCT01900314|7501864|FG000|NOT COMPLETED|Overall Study||4
6577618|NCT01900314|7501865|FG001|NOT COMPLETED|Overall Study||4
6577619|NCT01900392|7501875|FG000|STARTED|Overall Study||39
6577620|NCT01900392|7501876|FG001|STARTED|Overall Study||75
6577621|NCT01900392|7501877|FG002|STARTED|Overall Study||77
6577622|NCT01900392|7501875|FG000|COMPLETED|Overall Study||38
6577623|NCT01900392|7501876|FG001|COMPLETED|Overall Study||74
6577624|NCT01900392|7501877|FG002|COMPLETED|Overall Study||77
6577625|NCT01900392|7501875|FG000|NOT COMPLETED|Overall Study||1
6577626|NCT01900392|7501876|FG001|NOT COMPLETED|Overall Study||1
6577627|NCT01900392|7501877|FG002|NOT COMPLETED|Overall Study||0
6577628|NCT01900431|7501887|FG000|STARTED|Principal Treatment Period (Part A)||20
6577629|NCT01900431|7501888|FG001|STARTED|Principal Treatment Period (Part A)||38
6577630|NCT01900431|7501889|FG002|STARTED|Principal Treatment Period (Part A)||0
6624053|NCT02213263|7551365|FG000|NOT COMPLETED|Overall Study||28
6577631|NCT01900431|7501887|FG000|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
6577632|NCT01900431|7501888|FG001|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
6577633|NCT01900431|7501889|FG002|COMPLETED|Principal Treatment Period (Part A)||0
6577634|NCT01900431|7501887|FG000|NOT COMPLETED|Principal Treatment Period (Part A)||7
6577635|NCT01900431|7501888|FG001|NOT COMPLETED|Principal Treatment Period (Part A)||10
6577636|NCT01900431|7501889|FG002|NOT COMPLETED|Principal Treatment Period (Part A)||0
6577637|NCT01900431|7501887|FG000|STARTED|Extended Treatment Period (Part B)||8
6577638|NCT01900431|7501888|FG001|STARTED|Extended Treatment Period (Part B)||22
6577639|NCT01900431|7501889|FG002|STARTED|Extended Treatment Period (Part B)||0
6577640|NCT01900431|7501887|FG000|COMPLETED|Extended Treatment Period (Part B)||7
6577641|NCT01900431|7501888|FG001|COMPLETED|Extended Treatment Period (Part B)||12
6577642|NCT01900431|7501889|FG002|COMPLETED|Extended Treatment Period (Part B)||0
6577643|NCT01900431|7501887|FG000|NOT COMPLETED|Extended Treatment Period (Part B)||1
6577644|NCT01900431|7501888|FG001|NOT COMPLETED|Extended Treatment Period (Part B)||10
6577645|NCT01900431|7501889|FG002|NOT COMPLETED|Extended Treatment Period (Part B)||0
6577646|NCT01900431|7501887|FG000|STARTED|Open-Label Treatment Period (Part C)||0
6577647|NCT01900431|7501888|FG001|STARTED|Open-Label Treatment Period (Part C)||0
6577648|NCT01900431|7501889|FG002|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
6577649|NCT01900431|7501887|FG000|COMPLETED|Open-Label Treatment Period (Part C)||0
6577650|NCT01900431|7501888|FG001|COMPLETED|Open-Label Treatment Period (Part C)||0
6577651|NCT01900431|7501889|FG002|COMPLETED|Open-Label Treatment Period (Part C)||13
6577652|NCT01900431|7501887|FG000|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
6577653|NCT01900431|7501888|FG001|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
6577654|NCT01900431|7501889|FG002|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
6577655|NCT01900561|7501899|FG000|STARTED|Overall Study||278
6577656|NCT01900561|7501900|FG001|STARTED|Overall Study||278
6577657|NCT01900561|7501899|FG000|COMPLETED|Overall Study||261
6577658|NCT01900561|7501900|FG001|COMPLETED|Overall Study||269
6577659|NCT01900561|7501899|FG000|NOT COMPLETED|Overall Study||17
6577660|NCT01900561|7501900|FG001|NOT COMPLETED|Overall Study||9
6577661|NCT01900652|7501908|FG000|STARTED|Overall Study||83
6577662|NCT01900652|7501909|FG001|STARTED|Overall Study||28
6577663|NCT01900652|7501908|FG000|Post-Erlotinib Progression Tumor Sample|Overall Study||66
6577664|NCT01900652|7501909|FG001|Post-Erlotinib Progression Tumor Sample|Overall Study||23
6577665|NCT01900652|7501908|FG000|COMPLETED|Overall Study||75
6577666|NCT01900652|7501909|FG001|COMPLETED|Overall Study||25
6577667|NCT01900652|7501908|FG000|NOT COMPLETED|Overall Study||8
6577668|NCT01900652|7501909|FG001|NOT COMPLETED|Overall Study||3
6577669|NCT01900665|7501922|FG000|STARTED|Placebo Controlled Period||1057
6577670|NCT01900665|7501923|FG001|STARTED|Placebo Controlled Period||1072
6577671|NCT01900665|7501922|FG000|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1054
6577672|NCT01900665|7501923|FG001|Received at Least 1 Dose of Study Drug|Placebo Controlled Period||1067
6577673|NCT01900665|7501922|FG000|COMPLETED|Placebo Controlled Period||914
6577674|NCT01900665|7501923|FG001|COMPLETED|Placebo Controlled Period||908
6577675|NCT01900665|7501922|FG000|NOT COMPLETED|Placebo Controlled Period||143
6577676|NCT01900665|7501923|FG001|NOT COMPLETED|Placebo Controlled Period||164
6577677|NCT01900665|7501922|FG000|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|881
6577678|NCT01900665|7501923|FG001|STARTED|Open Label Period|Patients from Placebo Controlled Period were not required to enter into Open Label Period.|859
6577679|NCT01900665|7501922|FG000|COMPLETED|Open Label Period||0
6577680|NCT01900665|7501923|FG001|COMPLETED|Open Label Period||0
6577681|NCT01900665|7501922|FG000|NOT COMPLETED|Open Label Period||881
6577682|NCT01900665|7501923|FG001|NOT COMPLETED|Open Label Period||859
6577683|NCT01900704|7501935|FG000|STARTED|Overall Study||270
6577684|NCT01900704|7501936|FG001|STARTED|Overall Study||270
6577685|NCT01900704|7501937|FG002|STARTED|Overall Study||270
6577686|NCT01900704|7501935|FG000|COMPLETED|Overall Study||229
6577687|NCT01900704|7501936|FG001|COMPLETED|Overall Study||235
6577688|NCT01900704|7501937|FG002|COMPLETED|Overall Study||237
6577689|NCT01900704|7501935|FG000|NOT COMPLETED|Overall Study||41
6577690|NCT01900704|7501936|FG001|NOT COMPLETED|Overall Study||35
6577691|NCT01900704|7501937|FG002|NOT COMPLETED|Overall Study||33
6577692|NCT01900899|7501948|FG000|STARTED|Overall Study||159
6577693|NCT01900899|7501949|FG001|STARTED|Overall Study||25
6577694|NCT01900899|7501948|FG000|COMPLETED|Overall Study||150
6577695|NCT01900899|7501949|FG001|COMPLETED|Overall Study||24
6577696|NCT01900899|7501948|FG000|NOT COMPLETED|Overall Study||9
6577697|NCT01900899|7501949|FG001|NOT COMPLETED|Overall Study||1
6577698|NCT01901055|7501957|FG000|STARTED|Randomization But Not Titrated||49
6577699|NCT01901055|7501958|FG001|STARTED|Randomization But Not Titrated||49
6577700|NCT01901055|7501957|FG000|COMPLETED|Randomization But Not Titrated||48
6577701|NCT01901055|7501958|FG001|COMPLETED|Randomization But Not Titrated||47
6577702|NCT01901055|7501957|FG000|NOT COMPLETED|Randomization But Not Titrated||1
6577703|NCT01901055|7501958|FG001|NOT COMPLETED|Randomization But Not Titrated||2
6577704|NCT01901055|7501957|FG000|STARTED|Started Protocol to Week 6||48
6577705|NCT01901055|7501958|FG001|STARTED|Started Protocol to Week 6||47
6577706|NCT01901055|7501957|FG000|COMPLETED|Started Protocol to Week 6||45
6577707|NCT01901055|7501958|FG001|COMPLETED|Started Protocol to Week 6||43
6577708|NCT01901055|7501957|FG000|NOT COMPLETED|Started Protocol to Week 6||3
6577709|NCT01901055|7501958|FG001|NOT COMPLETED|Started Protocol to Week 6||4
6577710|NCT01901055|7501957|FG000|STARTED|Week 12 Assessment||45
6577711|NCT01901055|7501958|FG001|STARTED|Week 12 Assessment||43
6577712|NCT01901055|7501957|FG000|COMPLETED|Week 12 Assessment||44
6577713|NCT01901055|7501958|FG001|COMPLETED|Week 12 Assessment||39
6577714|NCT01901055|7501957|FG000|NOT COMPLETED|Week 12 Assessment||1
6577715|NCT01901055|7501958|FG001|NOT COMPLETED|Week 12 Assessment||4
6577716|NCT01901055|7501957|FG000|STARTED|Week 24||44
6577717|NCT01901055|7501958|FG001|STARTED|Week 24||39
6577718|NCT01901055|7501957|FG000|COMPLETED|Week 24||30
6577719|NCT01901055|7501958|FG001|COMPLETED|Week 24||20
6577720|NCT01901055|7501957|FG000|NOT COMPLETED|Week 24||14
6577721|NCT01901055|7501958|FG001|NOT COMPLETED|Week 24||19
6577722|NCT01901055|7501957|FG000|STARTED|Week 36||30
6577723|NCT01901055|7501958|FG001|STARTED|Week 36||20
6577724|NCT01901055|7501957|FG000|COMPLETED|Week 36||30
6577725|NCT01901055|7501958|FG001|COMPLETED|Week 36||15
6577726|NCT01901055|7501957|FG000|NOT COMPLETED|Week 36||0
6577727|NCT01901055|7501958|FG001|NOT COMPLETED|Week 36||5
6624054|NCT02213263|7551366|FG001|NOT COMPLETED|Overall Study||26
6624055|NCT02213289|7551374|FG000|STARTED|Overall Study||68
6624056|NCT02213289|7551375|FG001|STARTED|Overall Study||12
6624057|NCT02213289|7551374|FG000|Immuno-oncology|Overall Study||5
6624058|NCT02213289|7551375|FG001|Immuno-oncology|Overall Study||0
6624059|NCT02213289|7551374|FG000|HER2 Amplified|Overall Study||16
6624060|NCT02213289|7551375|FG001|HER2 Amplified|Overall Study||0
6624061|NCT02213289|7551374|FG000|EGFR Amplified|Overall Study||8
6624062|NCT02213289|7551375|FG001|EGFR Amplified|Overall Study||0
6624063|NCT02213289|7551374|FG000|FGFR2 Amplified|Overall Study||1
6624064|NCT02213289|7551375|FG001|FGFR2 Amplified|Overall Study||0
6624065|NCT02213289|7551374|FG000|MAPK/PIK3CA Aberrant|Overall Study||20
6624066|NCT02213289|7551375|FG001|MAPK/PIK3CA Aberrant|Overall Study||0
6624067|NCT02213289|7551374|FG000|EGFR Expressing|Overall Study||9
6624068|NCT02213289|7551375|FG001|EGFR Expressing|Overall Study||0
6624069|NCT02213289|7551374|FG000|All Negative|Overall Study||9
6624070|NCT02213289|7551375|FG001|All Negative|Overall Study||0
6624071|NCT02213289|7551374|FG000|Other (Non-ITT)|Overall Study||0
6624072|NCT02213289|7551375|FG001|Other (Non-ITT)|Overall Study||12
6624073|NCT02213289|7551374|FG000|COMPLETED|Overall Study||68
6624074|NCT02213289|7551375|FG001|COMPLETED|Overall Study||12
6624075|NCT02213289|7551374|FG000|NOT COMPLETED|Overall Study||0
6624076|NCT02213289|7551375|FG001|NOT COMPLETED|Overall Study||0
6624077|NCT02213380|7551387|FG000|STARTED|Underwent Randomization||476
6624078|NCT02213380|7551388|FG001|STARTED|Underwent Randomization||474
6624079|NCT02213380|7551387|FG000|COMPLETED|Underwent Randomization||471
6624080|NCT02213380|7551388|FG001|COMPLETED|Underwent Randomization||471
6624081|NCT02213380|7551387|FG000|NOT COMPLETED|Underwent Randomization||5
6624082|NCT02213380|7551388|FG001|NOT COMPLETED|Underwent Randomization||3
6624083|NCT02213380|7551387|FG000|STARTED|Per-protocol Analysis||471
6624084|NCT02213380|7551388|FG001|STARTED|Per-protocol Analysis||471
6624085|NCT02213380|7551387|FG000|COMPLETED|Per-protocol Analysis||439
6624086|NCT02213380|7551388|FG001|COMPLETED|Per-protocol Analysis||435
6624087|NCT02213380|7551387|FG000|NOT COMPLETED|Per-protocol Analysis||32
6624088|NCT02213380|7551388|FG001|NOT COMPLETED|Per-protocol Analysis||36
6624089|NCT02213458|7551396|FG000|STARTED|Overall Study||1024
6624090|NCT02213458|7551397|FG001|STARTED|Overall Study||536
6624091|NCT02213458|7551396|FG000|COMPLETED|Overall Study||970
6624092|NCT02213458|7551397|FG001|COMPLETED|Overall Study||526
6624093|NCT02213458|7551396|FG000|NOT COMPLETED|Overall Study||54
6658418|NCT02479412|7588996|FG004|STARTED|Overall Study||6
6658419|NCT02479412|7588997|FG005|STARTED|Overall Study||5
6658420|NCT02479412|7588998|FG006|STARTED|Overall Study||6
6658421|NCT02479412|7588999|FG007|STARTED|Overall Study||5
6658422|NCT02479412|7589000|FG008|STARTED|Overall Study||7
6658423|NCT02479412|7588992|FG000|COMPLETED|Overall Study||6
6658424|NCT02479412|7588993|FG001|COMPLETED|Overall Study||6
6658425|NCT02479412|7588994|FG002|COMPLETED|Overall Study||4
6658426|NCT02479412|7588995|FG003|COMPLETED|Overall Study||6
6658427|NCT02479412|7588996|FG004|COMPLETED|Overall Study||5
6658428|NCT02479412|7588997|FG005|COMPLETED|Overall Study||5
6658429|NCT02479412|7588998|FG006|COMPLETED|Overall Study||6
6658430|NCT02479412|7588999|FG007|COMPLETED|Overall Study||4
6658431|NCT02479412|7589000|FG008|COMPLETED|Overall Study||6
6658432|NCT02479412|7588992|FG000|NOT COMPLETED|Overall Study||0
6658433|NCT02479412|7588993|FG001|NOT COMPLETED|Overall Study||0
6658434|NCT02479412|7588994|FG002|NOT COMPLETED|Overall Study||2
6658435|NCT02479412|7588995|FG003|NOT COMPLETED|Overall Study||1
6658436|NCT02479412|7588996|FG004|NOT COMPLETED|Overall Study||1
6658437|NCT02479412|7588997|FG005|NOT COMPLETED|Overall Study||0
6624094|NCT02213458|7551397|FG001|NOT COMPLETED|Overall Study||10
6624095|NCT02213510|7551405|FG000|STARTED|Overall Study||21
6624096|NCT02213510|7551406|FG001|STARTED|Overall Study||19
6624097|NCT02213510|7551405|FG000|COMPLETED|Overall Study||20
6624098|NCT02213510|7551406|FG001|COMPLETED|Overall Study||18
6624099|NCT02213510|7551405|FG000|NOT COMPLETED|Overall Study||1
6624100|NCT02213510|7551406|FG001|NOT COMPLETED|Overall Study||1
6658438|NCT02479412|7588998|FG006|NOT COMPLETED|Overall Study||0
6658439|NCT02479412|7588999|FG007|NOT COMPLETED|Overall Study||1
6658440|NCT02479412|7589000|FG008|NOT COMPLETED|Overall Study||1
6658441|NCT02479763|7589018|FG000|STARTED|Overall Study||53
6658442|NCT02479763|7589019|FG001|STARTED|Overall Study||53
6577728|NCT01901146|7501969|FG000|STARTED|Neoadjuvant Phase||364
6577729|NCT01901146|7501970|FG001|STARTED|Neoadjuvant Phase||361
6577730|NCT01901146|7501971|FG002|STARTED|Neoadjuvant Phase||0
6577731|NCT01901146|7501972|FG003|STARTED|Neoadjuvant Phase||0
6577732|NCT01901146|7501973|FG004|STARTED|Neoadjuvant Phase||0
6577733|NCT01901146|7501969|FG000|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|358
6577734|NCT01901146|7501970|FG001|COMPLETED|Neoadjuvant Phase|Indicates participants who completed surgery|347
6577735|NCT01901146|7501971|FG002|COMPLETED|Neoadjuvant Phase||0
6577736|NCT01901146|7501972|FG003|COMPLETED|Neoadjuvant Phase||0
6577737|NCT01901146|7501973|FG004|COMPLETED|Neoadjuvant Phase||0
6577738|NCT01901146|7501969|FG000|NOT COMPLETED|Neoadjuvant Phase||6
6577739|NCT01901146|7501970|FG001|NOT COMPLETED|Neoadjuvant Phase||14
6577740|NCT01901146|7501971|FG002|NOT COMPLETED|Neoadjuvant Phase||0
6577741|NCT01901146|7501972|FG003|NOT COMPLETED|Neoadjuvant Phase||0
6577742|NCT01901146|7501973|FG004|NOT COMPLETED|Neoadjuvant Phase||0
6577743|NCT01901146|7501969|FG000|STARTED|Adjuvant Phase||0
6577744|NCT01901146|7501970|FG001|STARTED|Adjuvant Phase||0
6577745|NCT01901146|7501971|FG002|STARTED|Adjuvant Phase|Nine participants discontinued the study after surgery but before entering adjuvant phase.|349
6577746|NCT01901146|7501972|FG003|STARTED|Adjuvant Phase|Two participants discontinued the study after surgery but before entering adjuvant phase.|171
6577747|NCT01901146|7501973|FG004|STARTED|Adjuvant Phase|Three participants discontinued the study after surgery but before entering adjuvant phase.|171
6577748|NCT01901146|7501969|FG000|COMPLETED|Adjuvant Phase||0
6577749|NCT01901146|7501970|FG001|COMPLETED|Adjuvant Phase||0
6577750|NCT01901146|7501971|FG002|COMPLETED|Adjuvant Phase||323
6577751|NCT01901146|7501972|FG003|COMPLETED|Adjuvant Phase||164
6577752|NCT01901146|7501973|FG004|COMPLETED|Adjuvant Phase||157
6577753|NCT01901146|7501969|FG000|NOT COMPLETED|Adjuvant Phase||0
6577754|NCT01901146|7501970|FG001|NOT COMPLETED|Adjuvant Phase||0
6577755|NCT01901146|7501971|FG002|NOT COMPLETED|Adjuvant Phase||26
6577756|NCT01901146|7501972|FG003|NOT COMPLETED|Adjuvant Phase||7
6577757|NCT01901146|7501973|FG004|NOT COMPLETED|Adjuvant Phase||14
6577758|NCT01901185|7501982|FG000|STARTED|Overall Study||77
6577759|NCT01901185|7501982|FG000|Received Etanercept With Autoinjector A|Overall Study||75
6577760|NCT01901185|7501982|FG000|COMPLETED|Overall Study||75
6577761|NCT01901185|7501982|FG000|NOT COMPLETED|Overall Study||2
6577762|NCT01901211|7501988|FG000|STARTED|First Ten-week Period||6
6577763|NCT01901211|7501989|FG001|STARTED|First Ten-week Period||5
6577764|NCT01901211|7501988|FG000|COMPLETED|First Ten-week Period||6
6577765|NCT01901211|7501989|FG001|COMPLETED|First Ten-week Period||5
6577766|NCT01901211|7501988|FG000|NOT COMPLETED|First Ten-week Period||0
6577767|NCT01901211|7501989|FG001|NOT COMPLETED|First Ten-week Period||0
6577768|NCT01901211|7501988|FG000|STARTED|Washout (6 Weeks)||6
6577769|NCT01901211|7501989|FG001|STARTED|Washout (6 Weeks)||5
6577770|NCT01901211|7501988|FG000|COMPLETED|Washout (6 Weeks)||6
6577771|NCT01901211|7501989|FG001|COMPLETED|Washout (6 Weeks)||5
6577772|NCT01901211|7501988|FG000|NOT COMPLETED|Washout (6 Weeks)||0
6577773|NCT01901211|7501989|FG001|NOT COMPLETED|Washout (6 Weeks)||0
6577774|NCT01901211|7501988|FG000|STARTED|Second Ten-week Period||6
6577775|NCT01901211|7501989|FG001|STARTED|Second Ten-week Period||5
6577776|NCT01901211|7501988|FG000|COMPLETED|Second Ten-week Period||6
6577777|NCT01901211|7501989|FG001|COMPLETED|Second Ten-week Period||5
6577778|NCT01901211|7501988|FG000|NOT COMPLETED|Second Ten-week Period||0
6577779|NCT01901211|7501989|FG001|NOT COMPLETED|Second Ten-week Period||0
6577780|NCT01901250|7501997|FG000|STARTED|Overall Study||260
6577781|NCT01901250|7501998|FG001|STARTED|Overall Study||265
6577782|NCT01901250|7501997|FG000|End of Kidergarten|Overall Study||215
6577783|NCT01901250|7501998|FG001|End of Kidergarten|Overall Study||212
6577784|NCT01901250|7501997|FG000|Start of 1st Grade|Overall Study||173
6577785|NCT01901250|7501998|FG001|Start of 1st Grade|Overall Study||176
6577786|NCT01901250|7501997|FG000|End of 1st Grade|Overall Study||143
6577787|NCT01901250|7501998|FG001|End of 1st Grade|Overall Study||151
6577788|NCT01901250|7501997|FG000|COMPLETED|Overall Study||122
6577789|NCT01901250|7501998|FG001|COMPLETED|Overall Study||139
6577790|NCT01901250|7501997|FG000|NOT COMPLETED|Overall Study||138
6577791|NCT01901250|7501998|FG001|NOT COMPLETED|Overall Study||126
6577792|NCT01901302|7502006|FG000|STARTED|Overall Study||31
6577793|NCT01901302|7502007|FG001|STARTED|Overall Study||30
6577794|NCT01901302|7502006|FG000|Received at Least 1 Dose of Study Drug|Overall Study||31
6577795|NCT01901302|7502007|FG001|Received at Least 1 Dose of Study Drug|Overall Study||30
6577796|NCT01901302|7502006|FG000|COMPLETED|Overall Study||4
6577797|NCT01901302|7502007|FG001|COMPLETED|Overall Study||7
6577798|NCT01901302|7502006|FG000|NOT COMPLETED|Overall Study||27
6577799|NCT01901302|7502007|FG001|NOT COMPLETED|Overall Study||23
6577800|NCT01901328|7502015|FG000|STARTED|Overall Study||26
6577801|NCT01901328|7502016|FG001|STARTED|Overall Study||23
6577802|NCT01901328|7502015|FG000|Received at Least 1 Dose of Study Drug|Overall Study||26
6577803|NCT01901328|7502016|FG001|Received at Least 1 Dose of Study Drug|Overall Study||23
6577804|NCT01901328|7502015|FG000|COMPLETED|Overall Study||4
6577805|NCT01901328|7502016|FG001|COMPLETED|Overall Study||2
6577806|NCT01901328|7502015|FG000|NOT COMPLETED|Overall Study||22
6577807|NCT01901328|7502016|FG001|NOT COMPLETED|Overall Study||21
6577808|NCT01901341|7502025|FG000|STARTED|Overall Study||22
6577809|NCT01901341|7502026|FG001|STARTED|Overall Study||22
6577810|NCT01901341|7502025|FG000|Received at Least 1 Dose of Study Drug|Overall Study||22
6577811|NCT01901341|7502026|FG001|Received at Least 1 Dose of Study Drug|Overall Study||22
6577812|NCT01901341|7502025|FG000|COMPLETED|Overall Study||2
6577813|NCT01901341|7502026|FG001|COMPLETED|Overall Study||1
6577814|NCT01901341|7502025|FG000|NOT COMPLETED|Overall Study||20
6577815|NCT01901341|7502026|FG001|NOT COMPLETED|Overall Study||21
6577816|NCT01901393|7502035|FG000|STARTED|Overall Study||51
6577817|NCT01901393|7502036|FG001|STARTED|Overall Study||49
6577818|NCT01901393|7502035|FG000|COMPLETED|Overall Study||50
6577819|NCT01901393|7502036|FG001|COMPLETED|Overall Study||49
6577820|NCT01901393|7502035|FG000|NOT COMPLETED|Overall Study||1
6577821|NCT01901393|7502036|FG001|NOT COMPLETED|Overall Study||0
6577822|NCT01901419|7502044|FG000|STARTED|Overall Study||40
6577823|NCT01901419|7502045|FG001|STARTED|Overall Study||40
6577824|NCT01901419|7502044|FG000|COMPLETED|Overall Study||32
6577825|NCT01901419|7502045|FG001|COMPLETED|Overall Study||31
6577826|NCT01901419|7502044|FG000|NOT COMPLETED|Overall Study||8
6577827|NCT01901419|7502045|FG001|NOT COMPLETED|Overall Study||9
6577828|NCT01901575|7502051|FG000|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
6577829|NCT01901575|7502051|FG000|COMPLETED|Overall Study||16
6577830|NCT01901575|7502051|FG000|NOT COMPLETED|Overall Study||0
6577831|NCT01901588|7502058|FG000|STARTED|Overall Study||32
6577832|NCT01901588|7502059|FG001|STARTED|Overall Study||31
6577833|NCT01901588|7502058|FG000|COMPLETED|Overall Study||32
6577834|NCT01901588|7502059|FG001|COMPLETED|Overall Study||31
6577835|NCT01901588|7502058|FG000|NOT COMPLETED|Overall Study||0
6577836|NCT01901588|7502059|FG001|NOT COMPLETED|Overall Study||0
6577837|NCT01901614|7502067|FG000|STARTED|Overall Study||3
6577838|NCT01901614|7502068|FG001|STARTED|Overall Study||2
6577839|NCT01901614|7502067|FG000|COMPLETED|Overall Study||1
6577840|NCT01901614|7502068|FG001|COMPLETED|Overall Study||1
6577841|NCT01901614|7502067|FG000|NOT COMPLETED|Overall Study||2
6577842|NCT01901614|7502068|FG001|NOT COMPLETED|Overall Study||1
6577843|NCT01901653|7502087|FG000|STARTED|Overall Study||3
6577844|NCT01901653|7502088|FG001|STARTED|Overall Study||1
6577845|NCT01901653|7502089|FG002|STARTED|Overall Study||11
6577846|NCT01901653|7502090|FG003|STARTED|Overall Study||3
6577847|NCT01901653|7502091|FG004|STARTED|Overall Study||2
6577848|NCT01901653|7502092|FG005|STARTED|Overall Study||3
6577849|NCT01901653|7502093|FG006|STARTED|Overall Study||7
6577850|NCT01901653|7502094|FG007|STARTED|Overall Study||10
6577851|NCT01901653|7502095|FG008|STARTED|Overall Study||1
6577852|NCT01901653|7502096|FG009|STARTED|Overall Study||18
6577853|NCT01901653|7502097|FG010|STARTED|Overall Study||2
6577854|NCT01901653|7502098|FG011|STARTED|Overall Study||16
6577855|NCT01901653|7502099|FG012|STARTED|Overall Study||5
6577856|NCT01901653|7502087|FG000|COMPLETED|Overall Study||0
6577857|NCT01901653|7502088|FG001|COMPLETED|Overall Study||0
6577858|NCT01901653|7502089|FG002|COMPLETED|Overall Study||0
6577859|NCT01901653|7502090|FG003|COMPLETED|Overall Study||0
6577860|NCT01901653|7502091|FG004|COMPLETED|Overall Study||0
6577861|NCT01901653|7502092|FG005|COMPLETED|Overall Study||0
6577862|NCT01901653|7502093|FG006|COMPLETED|Overall Study||0
6577863|NCT01901653|7502094|FG007|COMPLETED|Overall Study||0
6577864|NCT01901653|7502095|FG008|COMPLETED|Overall Study||0
6577865|NCT01901653|7502096|FG009|COMPLETED|Overall Study||0
6577866|NCT01901653|7502097|FG010|COMPLETED|Overall Study||0
6577867|NCT01901653|7502098|FG011|COMPLETED|Overall Study||0
6577868|NCT01901653|7502099|FG012|COMPLETED|Overall Study||0
6577869|NCT01901653|7502087|FG000|NOT COMPLETED|Overall Study||3
6577870|NCT01901653|7502088|FG001|NOT COMPLETED|Overall Study||1
6577871|NCT01901653|7502089|FG002|NOT COMPLETED|Overall Study||11
6577872|NCT01901653|7502090|FG003|NOT COMPLETED|Overall Study||3
6577873|NCT01901653|7502091|FG004|NOT COMPLETED|Overall Study||2
6577874|NCT01901653|7502092|FG005|NOT COMPLETED|Overall Study||3
6577875|NCT01901653|7502093|FG006|NOT COMPLETED|Overall Study||7
6577876|NCT01901653|7502094|FG007|NOT COMPLETED|Overall Study||10
6577877|NCT01901653|7502095|FG008|NOT COMPLETED|Overall Study||1
6577878|NCT01901653|7502096|FG009|NOT COMPLETED|Overall Study||18
6577879|NCT01901653|7502097|FG010|NOT COMPLETED|Overall Study||2
6577880|NCT01901653|7502098|FG011|NOT COMPLETED|Overall Study||16
6577881|NCT01901653|7502099|FG012|NOT COMPLETED|Overall Study||5
6577882|NCT01901809|7502129|FG000|STARTED|Overall Study||19
6577883|NCT01901809|7502130|FG001|STARTED|Overall Study||23
6577884|NCT01901809|7502131|FG002|STARTED|Overall Study||24
6577885|NCT01901809|7502132|FG003|STARTED|Overall Study||24
6577886|NCT01901809|7502129|FG000|COMPLETED|Overall Study||19
6577887|NCT01901809|7502130|FG001|COMPLETED|Overall Study||23
6577888|NCT01901809|7502131|FG002|COMPLETED|Overall Study||21
6577889|NCT01901809|7502132|FG003|COMPLETED|Overall Study||22
6577890|NCT01901809|7502129|FG000|NOT COMPLETED|Overall Study||0
6577891|NCT01901809|7502130|FG001|NOT COMPLETED|Overall Study||0
6577892|NCT01901809|7502131|FG002|NOT COMPLETED|Overall Study||3
6577893|NCT01901809|7502132|FG003|NOT COMPLETED|Overall Study||2
6577894|NCT01901848|7502148|FG000|STARTED|Randomized and Treated||25
6577895|NCT01901848|7502149|FG001|STARTED|Randomized and Treated||25
6577896|NCT01901848|7502148|FG000|COMPLETED|Randomized and Treated|Ten cases were practice cases used to establish fidelity to CPT, and were removed from analyses.|22
6577897|NCT01901848|7502149|FG001|COMPLETED|Randomized and Treated||19
6577898|NCT01901848|7502148|FG000|NOT COMPLETED|Randomized and Treated||3
6577899|NCT01901848|7502149|FG001|NOT COMPLETED|Randomized and Treated||6
6577900|NCT01901848|7502148|FG000|STARTED|Removed From Analyses||22
6577901|NCT01901848|7502149|FG001|STARTED|Removed From Analyses||19
6577902|NCT01901848|7502148|FG000|COMPLETED|Removed From Analyses||12
6577903|NCT01901848|7502149|FG001|COMPLETED|Removed From Analyses||19
6577904|NCT01901848|7502148|FG000|NOT COMPLETED|Removed From Analyses||10
6577905|NCT01901848|7502149|FG001|NOT COMPLETED|Removed From Analyses||0
6577906|NCT01901874|7502155|FG000|STARTED|Procedure||312
6577907|NCT01901874|7502155|FG000|COMPLETED|Procedure||312
6577908|NCT01901874|7502155|FG000|NOT COMPLETED|Procedure||0
6577909|NCT01901874|7502155|FG000|STARTED|Screening Committee Retrospective Review||312
6577910|NCT01901874|7502155|FG000|COMPLETED|Screening Committee Retrospective Review||265
6577911|NCT01901874|7502155|FG000|NOT COMPLETED|Screening Committee Retrospective Review||47
6577912|NCT01901874|7502155|FG000|STARTED|30-Day MAE Evaluation||265
6577913|NCT01901874|7502155|FG000|COMPLETED|30-Day MAE Evaluation||264
6577914|NCT01901874|7502155|FG000|NOT COMPLETED|30-Day MAE Evaluation||1
6577915|NCT01901874|7502155|FG000|STARTED|1-Year (365-Day) MAE Evaluation||264
6577916|NCT01901874|7502155|FG000|COMPLETED|1-Year (365-Day) MAE Evaluation||244
6577917|NCT01901874|7502155|FG000|NOT COMPLETED|1-Year (365-Day) MAE Evaluation||20
6577918|NCT01902004|7502161|FG000|STARTED|Overall Study||48
6577919|NCT01902004|7502162|FG001|STARTED|Overall Study||47
6577920|NCT01902004|7502161|FG000|COMPLETED|Overall Study||33
6577921|NCT01902004|7502162|FG001|COMPLETED|Overall Study||29
6577922|NCT01902004|7502161|FG000|NOT COMPLETED|Overall Study||15
6577923|NCT01902004|7502162|FG001|NOT COMPLETED|Overall Study||18
6577924|NCT01902134|7502174|FG000|STARTED|Overall Study||159
6577925|NCT01902134|7502175|FG001|STARTED|Overall Study||161
6577926|NCT01902134|7502176|FG002|STARTED|Overall Study||160
6577927|NCT01902134|7502177|FG003|STARTED|Overall Study||54
6577928|NCT01902134|7502178|FG004|STARTED|Overall Study||53
6577929|NCT01902134|7502179|FG005|STARTED|Overall Study||54
6577930|NCT01902134|7502174|FG000|Single-dose Phase|Overall Study||159
6577931|NCT01902134|7502175|FG001|Single-dose Phase|Overall Study||161
6577932|NCT01902134|7502176|FG002|Single-dose Phase|Overall Study||160
6577933|NCT01902134|7502177|FG003|Single-dose Phase|Overall Study||54
6577934|NCT01902134|7502178|FG004|Single-dose Phase|Overall Study||53
6577935|NCT01902134|7502179|FG005|Single-dose Phase|Overall Study||54
6577936|NCT01902134|7502174|FG000|Multiple-dose Phase|Overall Study||159
6577937|NCT01902134|7502175|FG001|Multiple-dose Phase|Overall Study||160
6577938|NCT01902134|7502176|FG002|Multiple-dose Phase|Overall Study||160
6577939|NCT01902134|7502177|FG003|Multiple-dose Phase|Overall Study||54
6577940|NCT01902134|7502178|FG004|Multiple-dose Phase|Overall Study||53
6577941|NCT01902134|7502179|FG005|Multiple-dose Phase|Overall Study||52
6577942|NCT01902134|7502174|FG000|COMPLETED|Overall Study||151
6577943|NCT01902134|7502175|FG001|COMPLETED|Overall Study||150
6577944|NCT01902134|7502176|FG002|COMPLETED|Overall Study||145
6577945|NCT01902134|7502177|FG003|COMPLETED|Overall Study||52
6577946|NCT01902134|7502178|FG004|COMPLETED|Overall Study||46
6577947|NCT01902134|7502179|FG005|COMPLETED|Overall Study||45
6577948|NCT01902134|7502174|FG000|NOT COMPLETED|Overall Study||8
6577949|NCT01902134|7502175|FG001|NOT COMPLETED|Overall Study||11
6577950|NCT01902134|7502176|FG002|NOT COMPLETED|Overall Study||15
6577951|NCT01902134|7502177|FG003|NOT COMPLETED|Overall Study||2
6577952|NCT01902134|7502178|FG004|NOT COMPLETED|Overall Study||7
6577953|NCT01902134|7502179|FG005|NOT COMPLETED|Overall Study||9
6577954|NCT01902303|7502197|FG000|STARTED|Overall Study|Allocated to placebo|77
6577955|NCT01902303|7502198|FG001|STARTED|Overall Study|Allocated to active treatment|81
6577956|NCT01902303|7502197|FG000|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
6577957|NCT01902303|7502198|FG001|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
6577958|NCT01902303|7502197|FG000|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
6577959|NCT01902303|7502198|FG001|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
6577960|NCT01902303|7502197|FG000|NOT COMPLETED|Overall Study||23
6577961|NCT01902303|7502198|FG001|NOT COMPLETED|Overall Study||24
6577962|NCT01902459|7502208|FG000|STARTED|Overall Study||75
6577963|NCT01902459|7502209|FG001|STARTED|Overall Study||75
6577964|NCT01902459|7502208|FG000|COMPLETED|Overall Study||75
6577965|NCT01902459|7502209|FG001|COMPLETED|Overall Study||75
6577966|NCT01902459|7502208|FG000|NOT COMPLETED|Overall Study||0
6577967|NCT01902459|7502209|FG001|NOT COMPLETED|Overall Study||0
6577968|NCT01902628|7502215|FG000|STARTED|Overall Study||437
6577969|NCT01902628|7502215|FG000|COMPLETED|Overall Study||354
6577970|NCT01902628|7502215|FG000|NOT COMPLETED|Overall Study||83
6577971|NCT01902758|7502221|FG000|STARTED|Overall Study||14
6577972|NCT01902758|7502222|FG001|STARTED|Overall Study||14
6577973|NCT01902758|7502221|FG000|COMPLETED|Overall Study||14
6577974|NCT01902758|7502222|FG001|COMPLETED|Overall Study||14
6577975|NCT01902758|7502221|FG000|NOT COMPLETED|Overall Study||0
6577976|NCT01902758|7502222|FG001|NOT COMPLETED|Overall Study||0
6577977|NCT01902901|7502230|FG000|STARTED|Overall Study||180
6577978|NCT01902901|7502231|FG001|STARTED|Overall Study||203
6577979|NCT01902901|7502230|FG000|COMPLETED|Overall Study||180
6577980|NCT01902901|7502231|FG001|COMPLETED|Overall Study||201
6577981|NCT01902901|7502230|FG000|NOT COMPLETED|Overall Study||0
6577982|NCT01902901|7502231|FG001|NOT COMPLETED|Overall Study||2
6577983|NCT01902953|7502237|FG000|STARTED|Overall Study||16
6577984|NCT01902953|7502237|FG000|COMPLETED|Overall Study||16
6577985|NCT01902953|7502237|FG000|NOT COMPLETED|Overall Study||0
6577986|NCT01903005|7502243|FG000|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
6577987|NCT01903005|7502243|FG000|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
6577988|NCT01903005|7502243|FG000|NOT COMPLETED|Overall Study||373
6577989|NCT01903031|7502251|FG000|STARTED|Overall Study||27
6577990|NCT01903031|7502252|FG001|STARTED|Overall Study||28
6577991|NCT01903031|7502253|FG002|STARTED|Overall Study||29
6577992|NCT01903031|7502251|FG000|COMPLETED|Overall Study||25
6577993|NCT01903031|7502252|FG001|COMPLETED|Overall Study||25
6577994|NCT01903031|7502253|FG002|COMPLETED|Overall Study||24
6577995|NCT01903031|7502251|FG000|NOT COMPLETED|Overall Study||2
6577996|NCT01903031|7502252|FG001|NOT COMPLETED|Overall Study||3
6577997|NCT01903031|7502253|FG002|NOT COMPLETED|Overall Study||5
6577998|NCT01903148|7502266|FG000|STARTED|Overall Study||441
6577999|NCT01903148|7502266|FG000|COMPLETED|Overall Study||441
6578000|NCT01903148|7502266|FG000|NOT COMPLETED|Overall Study||0
6578001|NCT01903187|7502274|FG000|STARTED|Procedure||2
6578002|NCT01903187|7502275|FG001|STARTED|Procedure||2
6658443|NCT02479763|7589018|FG000|COMPLETED|Overall Study||50
6658444|NCT02479763|7589019|FG001|COMPLETED|Overall Study||50
6658445|NCT02479763|7589018|FG000|NOT COMPLETED|Overall Study||3
6658446|NCT02479763|7589019|FG001|NOT COMPLETED|Overall Study||3
6658447|NCT02479802|7589025|FG000|STARTED|Overall Study||13
6658448|NCT02479802|7589025|FG000|COMPLETED|Overall Study||11
6658449|NCT02479802|7589025|FG000|NOT COMPLETED|Overall Study||2
6658450|NCT02479880|7589031|FG000|STARTED|Overall Study||15
6658451|NCT02479880|7589032|FG001|STARTED|Overall Study||15
6658452|NCT02479880|7589031|FG000|COMPLETED|Overall Study||2
6658453|NCT02479880|7589032|FG001|COMPLETED|Overall Study||2
6658454|NCT02479880|7589031|FG000|NOT COMPLETED|Overall Study||13
6658455|NCT02479880|7589032|FG001|NOT COMPLETED|Overall Study||13
6658456|NCT02480010|7589040|FG000|STARTED|Overall Study||35
6658457|NCT02480010|7589041|FG001|STARTED|Overall Study||33
6658458|NCT02480010|7589040|FG000|COMPLETED|Overall Study||0
6658459|NCT02480010|7589041|FG001|COMPLETED|Overall Study||0
6658460|NCT02480010|7589040|FG000|NOT COMPLETED|Overall Study||35
6658461|NCT02480010|7589041|FG001|NOT COMPLETED|Overall Study||33
6658462|NCT02480114|7589049|FG000|STARTED|Overall Study||41
6658463|NCT02480114|7589050|FG001|STARTED|Overall Study||38
6658464|NCT02480114|7589049|FG000|COMPLETED|Overall Study||32
6658465|NCT02480114|7589050|FG001|COMPLETED|Overall Study||30
6658466|NCT02480114|7589049|FG000|NOT COMPLETED|Overall Study||9
6658467|NCT02480114|7589050|FG001|NOT COMPLETED|Overall Study||8
6658468|NCT02480153|7589058|FG000|STARTED|Period 1: First Dose to Week 26 Pre-dose||297
6658469|NCT02480153|7589059|FG001|STARTED|Period 1: First Dose to Week 26 Pre-dose||300
6658470|NCT02480153|7589060|FG002|STARTED|Period 1: First Dose to Week 26 Pre-dose||0
6658471|NCT02480153|7589058|FG000|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||297
6658472|NCT02480153|7589059|FG001|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||299
6658473|NCT02480153|7589060|FG002|Received Treatment|Period 1: First Dose to Week 26 Pre-dose||0
6658474|NCT02480153|7589058|FG000|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||293
6658475|NCT02480153|7589059|FG001|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||284
6658476|NCT02480153|7589060|FG002|COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
6658477|NCT02480153|7589058|FG000|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||4
6658478|NCT02480153|7589059|FG001|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||16
6658479|NCT02480153|7589060|FG002|NOT COMPLETED|Period 1: First Dose to Week 26 Pre-dose||0
6658480|NCT02480153|7589058|FG000|STARTED|Period 2: Week 26 to Week 52 Pre-dose||283
6658481|NCT02480153|7589059|FG001|STARTED|Period 2: Week 26 to Week 52 Pre-dose||135
6658482|NCT02480153|7589060|FG002|STARTED|Period 2: Week 26 to Week 52 Pre-dose||134
6658483|NCT02480153|7589058|FG000|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||283
6658484|NCT02480153|7589059|FG001|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||135
6658485|NCT02480153|7589060|FG002|Received Treatment|Period 2: Week 26 to Week 52 Pre-dose||133
6658486|NCT02480153|7589058|FG000|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||263
6658487|NCT02480153|7589059|FG001|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||122
6658488|NCT02480153|7589060|FG002|COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||127
6658489|NCT02480153|7589058|FG000|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||20
6658490|NCT02480153|7589059|FG001|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||13
6658491|NCT02480153|7589060|FG002|NOT COMPLETED|Period 2: Week 26 to Week 52 Pre-dose||7
6658492|NCT02480153|7589058|FG000|STARTED|Period 3: Week 52 Dosing to Week 78||259
6658493|NCT02480153|7589059|FG001|STARTED|Period 3: Week 52 Dosing to Week 78||121
6658494|NCT02480153|7589060|FG002|STARTED|Period 3: Week 52 Dosing to Week 78||127
6658495|NCT02480153|7589058|FG000|Received Treatment|Period 3: Week 52 Dosing to Week 78||258
6658496|NCT02480153|7589059|FG001|Received Treatment|Period 3: Week 52 Dosing to Week 78||120
6658497|NCT02480153|7589060|FG002|Received Treatment|Period 3: Week 52 Dosing to Week 78||127
6658498|NCT02480153|7589058|FG000|COMPLETED|Period 3: Week 52 Dosing to Week 78||252
6658499|NCT02480153|7589059|FG001|COMPLETED|Period 3: Week 52 Dosing to Week 78||118
6658500|NCT02480153|7589060|FG002|COMPLETED|Period 3: Week 52 Dosing to Week 78||123
6658501|NCT02480153|7589058|FG000|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||7
6658502|NCT02480153|7589059|FG001|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||3
6658503|NCT02480153|7589060|FG002|NOT COMPLETED|Period 3: Week 52 Dosing to Week 78||4
6658504|NCT02480166|7589086|FG000|STARTED|Overall Study||20
6658505|NCT02480166|7589087|FG001|STARTED|Overall Study||36
6658506|NCT02480166|7589088|FG002|STARTED|Overall Study||4
6658507|NCT02480166|7589086|FG000|COMPLETED|Overall Study||20
6658508|NCT02480166|7589087|FG001|COMPLETED|Overall Study||36
6658509|NCT02480166|7589088|FG002|COMPLETED|Overall Study||4
6658510|NCT02480166|7589086|FG000|NOT COMPLETED|Overall Study||0
6578003|NCT01903187|7502274|FG000|COMPLETED|Procedure||2
6578004|NCT01903187|7502275|FG001|COMPLETED|Procedure||2
6578005|NCT01903187|7502274|FG000|NOT COMPLETED|Procedure||0
6578006|NCT01903187|7502275|FG001|NOT COMPLETED|Procedure||0
6578007|NCT01903187|7502274|FG000|STARTED|1 Month||2
6578008|NCT01903187|7502275|FG001|STARTED|1 Month||2
6578009|NCT01903187|7502274|FG000|COMPLETED|1 Month||2
6578010|NCT01903187|7502275|FG001|COMPLETED|1 Month||2
6658511|NCT02480166|7589087|FG001|NOT COMPLETED|Overall Study||0
6658512|NCT02480166|7589088|FG002|NOT COMPLETED|Overall Study||0
6658513|NCT02480439|7589100|FG000|STARTED|Treatment Period 1||8
6658514|NCT02480439|7589101|FG001|STARTED|Treatment Period 1||8
6658515|NCT02480439|7589102|FG002|STARTED|Treatment Period 1||8
6658516|NCT02480439|7589100|FG000|COMPLETED|Treatment Period 1||8
6658517|NCT02480439|7589101|FG001|COMPLETED|Treatment Period 1||8
6658518|NCT02480439|7589102|FG002|COMPLETED|Treatment Period 1||8
6658519|NCT02480439|7589100|FG000|NOT COMPLETED|Treatment Period 1||0
6658520|NCT02480439|7589101|FG001|NOT COMPLETED|Treatment Period 1||0
6658521|NCT02480439|7589102|FG002|NOT COMPLETED|Treatment Period 1||0
6658522|NCT02480439|7589100|FG000|STARTED|Treatment Period 2||8
6658523|NCT02480439|7589101|FG001|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
6658524|NCT02480439|7589102|FG002|STARTED|Treatment Period 2||8
6658525|NCT02480439|7589100|FG000|COMPLETED|Treatment Period 2||8
6658526|NCT02480439|7589101|FG001|COMPLETED|Treatment Period 2||7
6658527|NCT02480439|7589102|FG002|COMPLETED|Treatment Period 2||8
6658528|NCT02480439|7589100|FG000|NOT COMPLETED|Treatment Period 2||0
6658529|NCT02480439|7589101|FG001|NOT COMPLETED|Treatment Period 2||0
6658530|NCT02480439|7589102|FG002|NOT COMPLETED|Treatment Period 2||0
6658531|NCT02480439|7589100|FG000|STARTED|Treatment Period 3||8
6658532|NCT02480439|7589101|FG001|STARTED|Treatment Period 3||7
6658533|NCT02480439|7589102|FG002|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
6658534|NCT02480439|7589100|FG000|COMPLETED|Treatment Period 3||8
6658535|NCT02480439|7589101|FG001|COMPLETED|Treatment Period 3||7
6658536|NCT02480439|7589102|FG002|COMPLETED|Treatment Period 3||7
6658537|NCT02480439|7589100|FG000|NOT COMPLETED|Treatment Period 3||0
6658538|NCT02480439|7589101|FG001|NOT COMPLETED|Treatment Period 3||0
6658539|NCT02480439|7589102|FG002|NOT COMPLETED|Treatment Period 3||0
6658540|NCT02480582|7589110|FG000|STARTED|Overall Study||7
6658541|NCT02480582|7589111|FG001|STARTED|Overall Study||7
6658542|NCT02480582|7589112|FG002|STARTED|Overall Study||7
6658543|NCT02480582|7589113|FG003|STARTED|Overall Study||7
6578011|NCT01903187|7502274|FG000|NOT COMPLETED|1 Month||0
6578012|NCT01903187|7502275|FG001|NOT COMPLETED|1 Month||0
6578013|NCT01903187|7502274|FG000|STARTED|3 Month||2
6578014|NCT01903187|7502275|FG001|STARTED|3 Month||0
6578015|NCT01903187|7502274|FG000|COMPLETED|3 Month||2
6578016|NCT01903187|7502275|FG001|COMPLETED|3 Month||0
6578017|NCT01903187|7502274|FG000|NOT COMPLETED|3 Month||0
6578018|NCT01903187|7502275|FG001|NOT COMPLETED|3 Month||0
6578019|NCT01903187|7502274|FG000|STARTED|6 Month||2
6578020|NCT01903187|7502275|FG001|STARTED|6 Month||0
6578021|NCT01903187|7502274|FG000|COMPLETED|6 Month||2
6578022|NCT01903187|7502275|FG001|COMPLETED|6 Month||0
6578023|NCT01903187|7502274|FG000|NOT COMPLETED|6 Month||0
6578024|NCT01903187|7502275|FG001|NOT COMPLETED|6 Month||0
6578025|NCT01903187|7502274|FG000|STARTED|12 Month||2
6578026|NCT01903187|7502275|FG001|STARTED|12 Month||0
6578027|NCT01903187|7502274|FG000|COMPLETED|12 Month||2
6578028|NCT01903187|7502275|FG001|COMPLETED|12 Month||0
6578029|NCT01903187|7502274|FG000|NOT COMPLETED|12 Month||0
6578030|NCT01903187|7502275|FG001|NOT COMPLETED|12 Month||0
6578031|NCT01903252|7502284|FG000|STARTED|Double-Blind Induction||409
6578032|NCT01903252|7502285|FG001|STARTED|Double-Blind Induction||408
6578033|NCT01903252|7502286|FG002|STARTED|Double-Blind Induction||0
6578034|NCT01903252|7502287|FG003|STARTED|Double-Blind Induction||0
6578035|NCT01903252|7502288|FG004|STARTED|Double-Blind Induction||0
6578036|NCT01903252|7502289|FG005|STARTED|Double-Blind Induction||0
6578037|NCT01903252|7502284|FG000|COMPLETED|Double-Blind Induction||370
6578038|NCT01903252|7502285|FG001|COMPLETED|Double-Blind Induction||367
6578039|NCT01903252|7502286|FG002|COMPLETED|Double-Blind Induction||0
6578040|NCT01903252|7502287|FG003|COMPLETED|Double-Blind Induction||0
6578041|NCT01903252|7502288|FG004|COMPLETED|Double-Blind Induction||0
6578042|NCT01903252|7502289|FG005|COMPLETED|Double-Blind Induction||0
6578043|NCT01903252|7502284|FG000|NOT COMPLETED|Double-Blind Induction||39
6578044|NCT01903252|7502285|FG001|NOT COMPLETED|Double-Blind Induction||41
6578045|NCT01903252|7502286|FG002|NOT COMPLETED|Double-Blind Induction||0
6578046|NCT01903252|7502287|FG003|NOT COMPLETED|Double-Blind Induction||0
6578047|NCT01903252|7502288|FG004|NOT COMPLETED|Double-Blind Induction||0
6578048|NCT01903252|7502289|FG005|NOT COMPLETED|Double-Blind Induction||0
6578049|NCT01903252|7502284|FG000|STARTED|Extended Induction, Open-Label||0
6578050|NCT01903252|7502285|FG001|STARTED|Extended Induction, Open-Label|This treatment arm was only used in Period 1, double-blind induction phase.|0
6578051|NCT01903252|7502286|FG002|STARTED|Extended Induction, Open-Label|The subjects in this phase were non-responders at week 8 and discontinued the double-blind phase.|243
6578052|NCT01903252|7502287|FG003|STARTED|Extended Induction, Open-Label||0
6578053|NCT01903252|7502288|FG004|STARTED|Extended Induction, Open-Label||0
6578054|NCT01903252|7502289|FG005|STARTED|Extended Induction, Open-Label||0
6578055|NCT01903252|7502284|FG000|COMPLETED|Extended Induction, Open-Label||0
6578056|NCT01903252|7502285|FG001|COMPLETED|Extended Induction, Open-Label||0
6578057|NCT01903252|7502286|FG002|COMPLETED|Extended Induction, Open-Label||220
6578058|NCT01903252|7502287|FG003|COMPLETED|Extended Induction, Open-Label||0
6578059|NCT01903252|7502288|FG004|COMPLETED|Extended Induction, Open-Label||0
6578060|NCT01903252|7502289|FG005|COMPLETED|Extended Induction, Open-Label||0
6578061|NCT01903252|7502284|FG000|NOT COMPLETED|Extended Induction, Open-Label||0
6578062|NCT01903252|7502285|FG001|NOT COMPLETED|Extended Induction, Open-Label||0
6578063|NCT01903252|7502286|FG002|NOT COMPLETED|Extended Induction, Open-Label||23
6578064|NCT01903252|7502287|FG003|NOT COMPLETED|Extended Induction, Open-Label||0
6578065|NCT01903252|7502288|FG004|NOT COMPLETED|Extended Induction, Open-Label||0
6578066|NCT01903252|7502289|FG005|NOT COMPLETED|Extended Induction, Open-Label||0
6578067|NCT01903252|7502284|FG000|STARTED|Maintenance, Open-Label||0
6578068|NCT01903252|7502285|FG001|STARTED|Maintenance, Open-Label||0
6578069|NCT01903252|7502286|FG002|STARTED|Maintenance, Open-Label|Period 2 (extended induction) is completed, subjects are newly allocated to Period 3, maintenance.|0
6578070|NCT01903252|7502287|FG003|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|202
6578071|NCT01903252|7502288|FG004|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|274
6578072|NCT01903252|7502289|FG005|STARTED|Maintenance, Open-Label|This is period 3, Open-Label Maintenance following on from period 1, the double-blind induction.|199
6578073|NCT01903252|7502284|FG000|COMPLETED|Maintenance, Open-Label||0
6578074|NCT01903252|7502285|FG001|COMPLETED|Maintenance, Open-Label||0
6578075|NCT01903252|7502286|FG002|COMPLETED|Maintenance, Open-Label||0
6578076|NCT01903252|7502287|FG003|COMPLETED|Maintenance, Open-Label||196
6578077|NCT01903252|7502288|FG004|COMPLETED|Maintenance, Open-Label||253
6578078|NCT01903252|7502289|FG005|COMPLETED|Maintenance, Open-Label||181
6578079|NCT01903252|7502284|FG000|NOT COMPLETED|Maintenance, Open-Label||0
6578080|NCT01903252|7502285|FG001|NOT COMPLETED|Maintenance, Open-Label||0
6578081|NCT01903252|7502286|FG002|NOT COMPLETED|Maintenance, Open-Label||0
6578082|NCT01903252|7502287|FG003|NOT COMPLETED|Maintenance, Open-Label||6
6578083|NCT01903252|7502288|FG004|NOT COMPLETED|Maintenance, Open-Label||21
6578084|NCT01903252|7502289|FG005|NOT COMPLETED|Maintenance, Open-Label||18
6578085|NCT01903265|7502309|FG000|STARTED|Overall Study||103
6578086|NCT01903265|7502310|FG001|STARTED|Overall Study||102
6578087|NCT01903265|7502309|FG000|COMPLETED|Overall Study||89
6578088|NCT01903265|7502310|FG001|COMPLETED|Overall Study||85
6578089|NCT01903265|7502309|FG000|NOT COMPLETED|Overall Study||14
6578090|NCT01903265|7502310|FG001|NOT COMPLETED|Overall Study||17
6578091|NCT01903356|7502316|FG000|STARTED|Overall Study||724
6578092|NCT01903356|7502316|FG000|COMPLETED|Overall Study||709
6578093|NCT01903356|7502316|FG000|NOT COMPLETED|Overall Study||15
6578094|NCT01903434|7502320|FG000|STARTED|Treatment Period 1||30
6578095|NCT01903434|7502321|FG001|STARTED|Treatment Period 1||30
6578096|NCT01903434|7502320|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
6578097|NCT01903434|7502321|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 1||30
6578098|NCT01903434|7502320|FG000|COMPLETED|Treatment Period 1||30
6578099|NCT01903434|7502321|FG001|COMPLETED|Treatment Period 1||30
6578100|NCT01903434|7502320|FG000|NOT COMPLETED|Treatment Period 1||0
6578101|NCT01903434|7502321|FG001|NOT COMPLETED|Treatment Period 1||0
6578102|NCT01903434|7502320|FG000|STARTED|Washout Period 1 (at Least 14 Days)||30
6578103|NCT01903434|7502321|FG001|STARTED|Washout Period 1 (at Least 14 Days)||30
6578104|NCT01903434|7502320|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
6578105|NCT01903434|7502321|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
6578106|NCT01903434|7502320|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||1
6578107|NCT01903434|7502321|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||2
6578108|NCT01903434|7502320|FG000|STARTED|Treatment Period 2||29
6578109|NCT01903434|7502321|FG001|STARTED|Treatment Period 2||28
6578110|NCT01903434|7502320|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 2||29
6578111|NCT01903434|7502321|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 2||28
6578112|NCT01903434|7502320|FG000|COMPLETED|Treatment Period 2||29
6578113|NCT01903434|7502321|FG001|COMPLETED|Treatment Period 2||28
6578114|NCT01903434|7502320|FG000|NOT COMPLETED|Treatment Period 2||0
6578115|NCT01903434|7502321|FG001|NOT COMPLETED|Treatment Period 2||0
6578116|NCT01903434|7502320|FG000|STARTED|Washout Period 1 (at Least 14 Days)||29
6578117|NCT01903434|7502321|FG001|STARTED|Washout Period 1 (at Least 14 Days)||28
6578118|NCT01903434|7502320|FG000|COMPLETED|Washout Period 1 (at Least 14 Days)||29
6578119|NCT01903434|7502321|FG001|COMPLETED|Washout Period 1 (at Least 14 Days)||28
6578120|NCT01903434|7502320|FG000|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6578121|NCT01903434|7502321|FG001|NOT COMPLETED|Washout Period 1 (at Least 14 Days)||0
6578122|NCT01903434|7502320|FG000|STARTED|Treatment Period 3||29
6578123|NCT01903434|7502321|FG001|STARTED|Treatment Period 3||28
6578124|NCT01903434|7502320|FG000|Received at Least 1 Dose of Study Drug|Treatment Period 3||29
6578125|NCT01903434|7502321|FG001|Received at Least 1 Dose of Study Drug|Treatment Period 3||28
6578126|NCT01903434|7502320|FG000|COMPLETED|Treatment Period 3||29
6578127|NCT01903434|7502321|FG001|COMPLETED|Treatment Period 3||28
6578128|NCT01903434|7502320|FG000|NOT COMPLETED|Treatment Period 3||0
6578129|NCT01903434|7502321|FG001|NOT COMPLETED|Treatment Period 3||0
6578130|NCT01903460|7502331|FG000|STARTED|Overall Study||6
6578131|NCT01903460|7502332|FG001|STARTED|Overall Study||8
6578132|NCT01903460|7502333|FG002|STARTED|Overall Study||3
6578133|NCT01903460|7502334|FG003|STARTED|Overall Study||3
6578134|NCT01903460|7502331|FG000|COMPLETED|Overall Study||6
6578135|NCT01903460|7502332|FG001|COMPLETED|Overall Study||8
6578136|NCT01903460|7502333|FG002|COMPLETED|Overall Study||3
6578137|NCT01903460|7502334|FG003|COMPLETED|Overall Study||2
6578138|NCT01903460|7502331|FG000|NOT COMPLETED|Overall Study||0
6578139|NCT01903460|7502332|FG001|NOT COMPLETED|Overall Study||0
6578140|NCT01903460|7502333|FG002|NOT COMPLETED|Overall Study||0
6578141|NCT01903460|7502334|FG003|NOT COMPLETED|Overall Study||1
6578142|NCT01903525|7502345|FG000|STARTED|Overall Study||20
6578143|NCT01903525|7502346|FG001|STARTED|Overall Study||20
6578144|NCT01903525|7502345|FG000|COMPLETED|Overall Study||15
6578145|NCT01903525|7502346|FG001|COMPLETED|Overall Study||10
6578146|NCT01903525|7502345|FG000|NOT COMPLETED|Overall Study||5
6578147|NCT01903525|7502346|FG001|NOT COMPLETED|Overall Study||10
6578148|NCT01903564|7502354|FG000|STARTED|Overall Study||10
6578149|NCT01903564|7502355|FG001|STARTED|Overall Study||29
6578150|NCT01903564|7502354|FG000|COMPLETED|Overall Study||10
6578151|NCT01903564|7502355|FG001|COMPLETED|Overall Study||29
6578152|NCT01903564|7502354|FG000|NOT COMPLETED|Overall Study||0
6578153|NCT01903564|7502355|FG001|NOT COMPLETED|Overall Study||0
6578154|NCT01903720|7502361|FG000|STARTED|Overall Study||71
6578155|NCT01903720|7502361|FG000|COMPLETED|Overall Study||59
6578156|NCT01903720|7502361|FG000|NOT COMPLETED|Overall Study||12
6578157|NCT01903733|7502369|FG000|STARTED|Overall Study||250
6578158|NCT01903733|7502370|FG001|STARTED|Overall Study||284
6578159|NCT01903733|7502371|FG002|STARTED|Overall Study||119
6578160|NCT01903733|7502372|FG003|STARTED|Overall Study||167
6578161|NCT01903733|7502369|FG000|Full Analysis Set|Overall Study||250
6578162|NCT01903733|7502370|FG001|Full Analysis Set|Overall Study||284
6578163|NCT01903733|7502371|FG002|Full Analysis Set|Overall Study||119
6578164|NCT01903733|7502372|FG003|Full Analysis Set|Overall Study||167
6578165|NCT01903733|7502369|FG000|Safety Analysis Set|Overall Study||248
6578166|NCT01903733|7502370|FG001|Safety Analysis Set|Overall Study||284
6578167|NCT01903733|7502371|FG002|Safety Analysis Set|Overall Study||119
6578168|NCT01903733|7502372|FG003|Safety Analysis Set|Overall Study||167
6578169|NCT01903733|7502369|FG000|Enrolled in B1871040|Overall Study||124
6578170|NCT01903733|7502370|FG001|Enrolled in B1871040|Overall Study||90
6578171|NCT01903733|7502371|FG002|Enrolled in B1871040|Overall Study||28
6578172|NCT01903733|7502372|FG003|Enrolled in B1871040|Overall Study||18
6578173|NCT01903733|7502369|FG000|Treated in B1871040|Overall Study||98
6578174|NCT01903733|7502370|FG001|Treated in B1871040|Overall Study||69
6578175|NCT01903733|7502371|FG002|Treated in B1871040|Overall Study||13
6578176|NCT01903733|7502372|FG003|Treated in B1871040|Overall Study||8
6578177|NCT01903733|7502369|FG000|COMPLETED|Overall Study||144
6578178|NCT01903733|7502370|FG001|COMPLETED|Overall Study||158
6578179|NCT01903733|7502371|FG002|COMPLETED|Overall Study||58
6578180|NCT01903733|7502372|FG003|COMPLETED|Overall Study||48
6578181|NCT01903733|7502369|FG000|NOT COMPLETED|Overall Study||106
6578182|NCT01903733|7502370|FG001|NOT COMPLETED|Overall Study||126
6578183|NCT01903733|7502371|FG002|NOT COMPLETED|Overall Study||61
6578184|NCT01903733|7502372|FG003|NOT COMPLETED|Overall Study||119
6578185|NCT01903798|7502396|FG000|STARTED|Overall Study||2
6578186|NCT01903798|7502397|FG001|STARTED|Overall Study||0
6578187|NCT01903798|7502398|FG002|STARTED|Overall Study||1
6578188|NCT01903798|7502399|FG003|STARTED|Overall Study||1
6578189|NCT01903798|7502396|FG000|COMPLETED|Overall Study||2
6578190|NCT01903798|7502397|FG001|COMPLETED|Overall Study||0
6578191|NCT01903798|7502398|FG002|COMPLETED|Overall Study||1
6578192|NCT01903798|7502399|FG003|COMPLETED|Overall Study||1
6578193|NCT01903798|7502396|FG000|NOT COMPLETED|Overall Study||0
6578194|NCT01903798|7502397|FG001|NOT COMPLETED|Overall Study||0
6578195|NCT01903798|7502398|FG002|NOT COMPLETED|Overall Study||0
6578196|NCT01903798|7502399|FG003|NOT COMPLETED|Overall Study||0
6578197|NCT01903811|7502411|FG000|STARTED|Overall Study||72
6578198|NCT01903811|7502412|FG001|STARTED|Overall Study||71
6578199|NCT01903811|7502411|FG000|Crossover to Arm II|Overall Study|Following disease progression on Arm I. Note: these patients are also counted in 'Completed'.|16
6578200|NCT01903811|7502412|FG001|Crossover to Arm II|Overall Study||0
6578201|NCT01903811|7502411|FG000|COMPLETED|Overall Study||64
6578202|NCT01903811|7502412|FG001|COMPLETED|Overall Study||57
6578203|NCT01903811|7502411|FG000|NOT COMPLETED|Overall Study||8
6578204|NCT01903811|7502412|FG001|NOT COMPLETED|Overall Study||14
6578205|NCT01903837|7502425|FG000|STARTED|Part A||75
6578206|NCT01903837|7502426|FG001|STARTED|Part A||80
6578207|NCT01903837|7502427|FG002|STARTED|Part A||86
6578208|NCT01903837|7502428|FG003|STARTED|Part A||68
6578209|NCT01903837|7502425|FG000|COMPLETED|Part A||56
6578210|NCT01903837|7502426|FG001|COMPLETED|Part A||52
6578211|NCT01903837|7502427|FG002|COMPLETED|Part A||58
6578212|NCT01903837|7502428|FG003|COMPLETED|Part A||55
6578213|NCT01903837|7502425|FG000|NOT COMPLETED|Part A||19
6578214|NCT01903837|7502426|FG001|NOT COMPLETED|Part A||28
6578215|NCT01903837|7502427|FG002|NOT COMPLETED|Part A||28
6578216|NCT01903837|7502428|FG003|NOT COMPLETED|Part A||13
6578217|NCT01903837|7502425|FG000|STARTED|Part B||54
6578218|NCT01903837|7502426|FG001|STARTED|Part B||52
6578219|NCT01903837|7502427|FG002|STARTED|Part B||57
6578220|NCT01903837|7502428|FG003|STARTED|Part B||55
6578221|NCT01903837|7502425|FG000|COMPLETED|Part B||45
6578222|NCT01903837|7502426|FG001|COMPLETED|Part B||46
6578223|NCT01903837|7502427|FG002|COMPLETED|Part B||52
6578224|NCT01903837|7502428|FG003|COMPLETED|Part B||44
6578225|NCT01903837|7502425|FG000|NOT COMPLETED|Part B||9
6578226|NCT01903837|7502426|FG001|NOT COMPLETED|Part B||6
6578227|NCT01903837|7502427|FG002|NOT COMPLETED|Part B||5
6578228|NCT01903837|7502428|FG003|NOT COMPLETED|Part B||11
6578229|NCT01903863|7502461|FG000|STARTED|Overall Study||15
6578230|NCT01903863|7502462|FG001|STARTED|Overall Study||16
6578231|NCT01903863|7502461|FG000|COMPLETED|Overall Study||13
6578232|NCT01903863|7502462|FG001|COMPLETED|Overall Study||16
6578233|NCT01903863|7502461|FG000|NOT COMPLETED|Overall Study||2
6578234|NCT01903863|7502462|FG001|NOT COMPLETED|Overall Study||0
6578235|NCT01903876|7502470|FG000|STARTED|Baseline to Post-Intervention Period||367
6578236|NCT01903876|7502471|FG001|STARTED|Baseline to Post-Intervention Period||376
6578237|NCT01903876|7502470|FG000|COMPLETED|Baseline to Post-Intervention Period||183
6578238|NCT01903876|7502471|FG001|COMPLETED|Baseline to Post-Intervention Period||268
6578239|NCT01903876|7502470|FG000|NOT COMPLETED|Baseline to Post-Intervention Period||184
6578240|NCT01903876|7502471|FG001|NOT COMPLETED|Baseline to Post-Intervention Period||108
6578241|NCT01903876|7502470|FG000|STARTED|Six-Month Follow-up Period||183
6578242|NCT01903876|7502471|FG001|STARTED|Six-Month Follow-up Period||268
6578243|NCT01903876|7502470|FG000|COMPLETED|Six-Month Follow-up Period||92
6578244|NCT01903876|7502471|FG001|COMPLETED|Six-Month Follow-up Period||123
6578245|NCT01903876|7502470|FG000|NOT COMPLETED|Six-Month Follow-up Period||91
6578246|NCT01903876|7502471|FG001|NOT COMPLETED|Six-Month Follow-up Period||145
6578247|NCT01903993|7502479|FG000|STARTED|Overall Study||143
6578248|NCT01903993|7502480|FG001|STARTED|Overall Study||144
6578249|NCT01903993|7502479|FG000|Received Treatment|Overall Study||135
6578250|NCT01903993|7502480|FG001|Received Treatment|Overall Study||142
6578251|NCT01903993|7502479|FG000|COMPLETED|Overall Study||0
6578252|NCT01903993|7502480|FG001|COMPLETED|Overall Study||0
6578253|NCT01903993|7502479|FG000|NOT COMPLETED|Overall Study||143
6578254|NCT01903993|7502480|FG001|NOT COMPLETED|Overall Study||144
6578255|NCT01904019|7502487|FG000|STARTED|Pre-operative||95
6578256|NCT01904019|7502487|FG000|COMPLETED|Pre-operative||95
6578257|NCT01904019|7502487|FG000|NOT COMPLETED|Pre-operative||0
6578258|NCT01904019|7502487|FG000|STARTED|1 Year Follow-up||95
6578259|NCT01904019|7502487|FG000|COMPLETED|1 Year Follow-up||86
6578260|NCT01904019|7502487|FG000|NOT COMPLETED|1 Year Follow-up||9
6578261|NCT01904019|7502487|FG000|STARTED|3 Year Follow-up||86
6578262|NCT01904019|7502487|FG000|COMPLETED|3 Year Follow-up||71
6578263|NCT01904019|7502487|FG000|NOT COMPLETED|3 Year Follow-up||15
6578264|NCT01904019|7502487|FG000|STARTED|5 Year Follow-up||71
6578265|NCT01904019|7502487|FG000|COMPLETED|5 Year Follow-up||65
6578266|NCT01904019|7502487|FG000|NOT COMPLETED|5 Year Follow-up||6
6578267|NCT01904058|7502495|FG000|STARTED|Overall Study||21
6578268|NCT01904058|7502496|FG001|STARTED|Overall Study||21
6578269|NCT01904058|7502497|FG002|STARTED|Overall Study||11
6578270|NCT01904058|7502498|FG003|STARTED|Overall Study||13
6578271|NCT01904058|7502495|FG000|COMPLETED|Overall Study||18
6578272|NCT01904058|7502496|FG001|COMPLETED|Overall Study||21
6578273|NCT01904058|7502497|FG002|COMPLETED|Overall Study||10
6578274|NCT01904058|7502498|FG003|COMPLETED|Overall Study||12
6578275|NCT01904058|7502495|FG000|NOT COMPLETED|Overall Study||3
6578276|NCT01904058|7502496|FG001|NOT COMPLETED|Overall Study||0
6578277|NCT01904058|7502497|FG002|NOT COMPLETED|Overall Study||1
6578278|NCT01904058|7502498|FG003|NOT COMPLETED|Overall Study||1
6578279|NCT01904071|7502517|FG000|STARTED|Overall Study||24
6578280|NCT01904071|7502518|FG001|STARTED|Overall Study||20
6578281|NCT01904071|7502519|FG002|STARTED|Overall Study||20
6578282|NCT01904071|7502517|FG000|COMPLETED|Overall Study||24
6578283|NCT01904071|7502518|FG001|COMPLETED|Overall Study||20
6578284|NCT01904071|7502519|FG002|COMPLETED|Overall Study||20
6578285|NCT01904071|7502517|FG000|NOT COMPLETED|Overall Study||0
6578286|NCT01904071|7502518|FG001|NOT COMPLETED|Overall Study||0
6578287|NCT01904071|7502519|FG002|NOT COMPLETED|Overall Study||0
6578288|NCT01904149|7502533|FG000|STARTED|Overall Study||152
6578289|NCT01904149|7502534|FG001|STARTED|Overall Study||151
6578290|NCT01904149|7502535|FG002|STARTED|Overall Study||150
6578291|NCT01904149|7502536|FG003|STARTED|Overall Study||51
6578292|NCT01904149|7502537|FG004|STARTED|Overall Study||51
6578293|NCT01904149|7502538|FG005|STARTED|Overall Study||51
6578294|NCT01904149|7502533|FG000|Single-dose Phase|Overall Study||152
6578295|NCT01904149|7502534|FG001|Single-dose Phase|Overall Study||151
6578296|NCT01904149|7502535|FG002|Single-dose Phase|Overall Study||150
6578297|NCT01904149|7502536|FG003|Single-dose Phase|Overall Study||51
6578298|NCT01904149|7502537|FG004|Single-dose Phase|Overall Study||51
6578299|NCT01904149|7502538|FG005|Single-dose Phase|Overall Study||51
6578300|NCT01904149|7502533|FG000|Multiple-dose Phase|Overall Study||150
6578301|NCT01904149|7502534|FG001|Multiple-dose Phase|Overall Study||146
6578302|NCT01904149|7502535|FG002|Multiple-dose Phase|Overall Study||149
6578303|NCT01904149|7502536|FG003|Multiple-dose Phase|Overall Study||48
6578304|NCT01904149|7502537|FG004|Multiple-dose Phase|Overall Study||48
6578305|NCT01904149|7502538|FG005|Multiple-dose Phase|Overall Study||49
6578306|NCT01904149|7502533|FG000|COMPLETED|Overall Study||147
6578307|NCT01904149|7502534|FG001|COMPLETED|Overall Study||140
6658544|NCT02480582|7589114|FG004|STARTED|Overall Study||7
6578308|NCT01904149|7502535|FG002|COMPLETED|Overall Study||148
6578309|NCT01904149|7502536|FG003|COMPLETED|Overall Study||47
6578310|NCT01904149|7502537|FG004|COMPLETED|Overall Study||46
6578311|NCT01904149|7502538|FG005|COMPLETED|Overall Study||48
6578312|NCT01904149|7502533|FG000|NOT COMPLETED|Overall Study||5
6578313|NCT01904149|7502534|FG001|NOT COMPLETED|Overall Study||11
6578314|NCT01904149|7502535|FG002|NOT COMPLETED|Overall Study||2
6578315|NCT01904149|7502536|FG003|NOT COMPLETED|Overall Study||4
6578316|NCT01904149|7502537|FG004|NOT COMPLETED|Overall Study||5
6578317|NCT01904149|7502538|FG005|NOT COMPLETED|Overall Study||3
6578318|NCT01904383|7502554|FG000|STARTED|Overall Study||4057
6578319|NCT01904383|7502554|FG000|Treated|Overall Study||3940
6578320|NCT01904383|7502554|FG000|COMPLETED|Overall Study||2283
6578321|NCT01904383|7502554|FG000|NOT COMPLETED|Overall Study||1774
6578322|NCT01904448|7502558|FG000|STARTED|Overall Study||5
6578323|NCT01904448|7502558|FG000|COMPLETED|Overall Study||5
6578324|NCT01904448|7502558|FG000|NOT COMPLETED|Overall Study||0
6578325|NCT01904526|7502563|FG000|STARTED|Overall Study||5
6578326|NCT01904526|7502563|FG000|COMPLETED|Overall Study||5
6578327|NCT01904526|7502563|FG000|NOT COMPLETED|Overall Study||0
6578328|NCT01904604|7502574|FG000|STARTED|Overall Study||25
6578329|NCT01904604|7502575|FG001|STARTED|Overall Study||25
6578330|NCT01904604|7502576|FG002|STARTED|Overall Study||25
6578331|NCT01904604|7502574|FG000|Completed Week 52 OFC|Overall Study||22
6578332|NCT01904604|7502575|FG001|Completed Week 52 OFC|Overall Study||21
6578333|NCT01904604|7502576|FG002|Completed Week 52 OFC|Overall Study||25
6578334|NCT01904604|7502574|FG000|Began Crossover Treatment|Overall Study|2 participants who completed the Week 52 OFC did not crossover; 1 passed the OFC and 1 relocated.|20
6578335|NCT01904604|7502575|FG001|Began Crossover Treatment|Overall Study||21
6578336|NCT01904604|7502576|FG002|Began Crossover Treatment|Overall Study|Per protocol, this treatment group did not crossover.|0
6578337|NCT01904604|7502574|FG000|Completed Week 130 OFC|Overall Study||18
6578338|NCT01904604|7502575|FG001|Completed Week 130 OFC|Overall Study||18
6578339|NCT01904604|7502576|FG002|Completed Week 130 OFC|Overall Study||23
6578340|NCT01904604|7502574|FG000|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
6578341|NCT01904604|7502575|FG001|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|18
6578342|NCT01904604|7502576|FG002|COMPLETED|Overall Study|COMPLETED: Completed the Week 130 Oral Food Challenge (OFC).|23
6578343|NCT01904604|7502574|FG000|NOT COMPLETED|Overall Study||7
6578344|NCT01904604|7502575|FG001|NOT COMPLETED|Overall Study||7
6578345|NCT01904604|7502576|FG002|NOT COMPLETED|Overall Study||2
6578346|NCT01904721|7502594|FG000|STARTED|Overall Study||13
6578347|NCT01904721|7502595|FG001|STARTED|Overall Study||13
6578348|NCT01904721|7502596|FG002|STARTED|Overall Study||12
6578349|NCT01904721|7502597|FG003|STARTED|Overall Study||12
6578350|NCT01904721|7502598|FG004|STARTED|Overall Study||65
6578351|NCT01904721|7502599|FG005|STARTED|Overall Study||65
6578352|NCT01904721|7502600|FG006|STARTED|Overall Study||64
6578353|NCT01904721|7502594|FG000|COMPLETED|Overall Study||13
6578354|NCT01904721|7502595|FG001|COMPLETED|Overall Study||13
6578355|NCT01904721|7502596|FG002|COMPLETED|Overall Study||11
6578356|NCT01904721|7502597|FG003|COMPLETED|Overall Study||11
6578357|NCT01904721|7502598|FG004|COMPLETED|Overall Study||57
6578358|NCT01904721|7502599|FG005|COMPLETED|Overall Study||56
6578359|NCT01904721|7502600|FG006|COMPLETED|Overall Study||57
6578360|NCT01904721|7502594|FG000|NOT COMPLETED|Overall Study||0
6578361|NCT01904721|7502595|FG001|NOT COMPLETED|Overall Study||0
6578362|NCT01904721|7502596|FG002|NOT COMPLETED|Overall Study||1
6578363|NCT01904721|7502597|FG003|NOT COMPLETED|Overall Study||1
6578364|NCT01904721|7502598|FG004|NOT COMPLETED|Overall Study||8
6578365|NCT01904721|7502599|FG005|NOT COMPLETED|Overall Study||9
6578366|NCT01904721|7502600|FG006|NOT COMPLETED|Overall Study||7
6578367|NCT01904760|7502614|FG000|STARTED|Overall Study||40
6578368|NCT01904760|7502615|FG001|STARTED|Overall Study||40
6578369|NCT01904760|7502614|FG000|COMPLETED|Overall Study||39
6578370|NCT01904760|7502615|FG001|COMPLETED|Overall Study||40
6578371|NCT01904760|7502614|FG000|NOT COMPLETED|Overall Study||1
6578372|NCT01904760|7502615|FG001|NOT COMPLETED|Overall Study||0
6578373|NCT01904773|7502621|FG000|STARTED|Screen||28
6578374|NCT01904773|7502622|FG001|STARTED|Screen||0
6578375|NCT01904773|7502623|FG002|STARTED|Screen||0
6578376|NCT01904773|7502624|FG003|STARTED|Screen||0
6578377|NCT01904773|7502625|FG004|STARTED|Screen||0
6578378|NCT01904773|7502626|FG005|STARTED|Screen||0
6578379|NCT01904773|7502627|FG006|STARTED|Screen||0
6578380|NCT01904773|7502628|FG007|STARTED|Screen||0
6578381|NCT01904773|7502629|FG008|STARTED|Screen||0
6578382|NCT01904773|7502621|FG000|COMPLETED|Screen||24
6578383|NCT01904773|7502622|FG001|COMPLETED|Screen||0
6578384|NCT01904773|7502623|FG002|COMPLETED|Screen||0
6578385|NCT01904773|7502624|FG003|COMPLETED|Screen||0
6578386|NCT01904773|7502625|FG004|COMPLETED|Screen||0
6578387|NCT01904773|7502626|FG005|COMPLETED|Screen||0
6578388|NCT01904773|7502627|FG006|COMPLETED|Screen||0
6578389|NCT01904773|7502628|FG007|COMPLETED|Screen||0
6578390|NCT01904773|7502629|FG008|COMPLETED|Screen||0
6578391|NCT01904773|7502621|FG000|NOT COMPLETED|Screen||4
6578392|NCT01904773|7502622|FG001|NOT COMPLETED|Screen||0
6578393|NCT01904773|7502623|FG002|NOT COMPLETED|Screen||0
6578394|NCT01904773|7502624|FG003|NOT COMPLETED|Screen||0
6578395|NCT01904773|7502625|FG004|NOT COMPLETED|Screen||0
6578396|NCT01904773|7502626|FG005|NOT COMPLETED|Screen||0
6578397|NCT01904773|7502627|FG006|NOT COMPLETED|Screen||0
6578398|NCT01904773|7502628|FG007|NOT COMPLETED|Screen||0
6578399|NCT01904773|7502629|FG008|NOT COMPLETED|Screen||0
6578400|NCT01904773|7502621|FG000|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
6578401|NCT01904773|7502622|FG001|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578402|NCT01904773|7502623|FG002|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578403|NCT01904773|7502624|FG003|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578404|NCT01904773|7502625|FG004|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578405|NCT01904773|7502626|FG005|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578406|NCT01904773|7502627|FG006|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578407|NCT01904773|7502628|FG007|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578408|NCT01904773|7502629|FG008|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578409|NCT01904773|7502621|FG000|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
6578410|NCT01904773|7502622|FG001|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578411|NCT01904773|7502623|FG002|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578412|NCT01904773|7502624|FG003|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578413|NCT01904773|7502625|FG004|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578414|NCT01904773|7502626|FG005|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578415|NCT01904773|7502627|FG006|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578416|NCT01904773|7502628|FG007|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578417|NCT01904773|7502629|FG008|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578418|NCT01904773|7502621|FG000|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578419|NCT01904773|7502622|FG001|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578420|NCT01904773|7502623|FG002|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578421|NCT01904773|7502624|FG003|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578422|NCT01904773|7502625|FG004|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578423|NCT01904773|7502626|FG005|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578424|NCT01904773|7502627|FG006|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578425|NCT01904773|7502628|FG007|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578426|NCT01904773|7502629|FG008|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
6578427|NCT01904773|7502621|FG000|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
6578428|NCT01904773|7502622|FG001|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578429|NCT01904773|7502623|FG002|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578430|NCT01904773|7502624|FG003|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578431|NCT01904773|7502625|FG004|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578432|NCT01904773|7502626|FG005|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578433|NCT01904773|7502627|FG006|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578434|NCT01904773|7502628|FG007|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578435|NCT01904773|7502629|FG008|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578436|NCT01904773|7502621|FG000|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
6578437|NCT01904773|7502622|FG001|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578438|NCT01904773|7502623|FG002|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578439|NCT01904773|7502624|FG003|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578440|NCT01904773|7502625|FG004|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578441|NCT01904773|7502626|FG005|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578442|NCT01904773|7502627|FG006|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578443|NCT01904773|7502628|FG007|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578444|NCT01904773|7502629|FG008|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578445|NCT01904773|7502621|FG000|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
6578446|NCT01904773|7502622|FG001|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578447|NCT01904773|7502623|FG002|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578448|NCT01904773|7502624|FG003|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578449|NCT01904773|7502625|FG004|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578450|NCT01904773|7502626|FG005|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578451|NCT01904773|7502627|FG006|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578452|NCT01904773|7502628|FG007|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578453|NCT01904773|7502629|FG008|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578454|NCT01904773|7502621|FG000|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
6578455|NCT01904773|7502622|FG001|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578456|NCT01904773|7502623|FG002|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578457|NCT01904773|7502624|FG003|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578458|NCT01904773|7502625|FG004|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578459|NCT01904773|7502626|FG005|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578460|NCT01904773|7502627|FG006|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578461|NCT01904773|7502628|FG007|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578462|NCT01904773|7502629|FG008|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578463|NCT01904773|7502621|FG000|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
6578464|NCT01904773|7502622|FG001|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578465|NCT01904773|7502623|FG002|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578466|NCT01904773|7502624|FG003|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578467|NCT01904773|7502625|FG004|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578468|NCT01904773|7502626|FG005|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578469|NCT01904773|7502627|FG006|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578470|NCT01904773|7502628|FG007|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578471|NCT01904773|7502629|FG008|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
6578472|NCT01904773|7502621|FG000|STARTED|First Intervention||0
6578473|NCT01904773|7502622|FG001|STARTED|First Intervention||2
6578474|NCT01904773|7502623|FG002|STARTED|First Intervention||1
6578475|NCT01904773|7502624|FG003|STARTED|First Intervention||2
6578476|NCT01904773|7502625|FG004|STARTED|First Intervention||3
6578477|NCT01904773|7502626|FG005|STARTED|First Intervention||4
6578478|NCT01904773|7502627|FG006|STARTED|First Intervention||4
6578479|NCT01904773|7502628|FG007|STARTED|First Intervention||3
6578480|NCT01904773|7502629|FG008|STARTED|First Intervention||4
6578481|NCT01904773|7502621|FG000|COMPLETED|First Intervention||0
6578482|NCT01904773|7502622|FG001|COMPLETED|First Intervention||2
6578483|NCT01904773|7502623|FG002|COMPLETED|First Intervention||1
6578484|NCT01904773|7502624|FG003|COMPLETED|First Intervention||2
6578485|NCT01904773|7502625|FG004|COMPLETED|First Intervention||3
6578486|NCT01904773|7502626|FG005|COMPLETED|First Intervention||4
6578487|NCT01904773|7502627|FG006|COMPLETED|First Intervention||3
6578488|NCT01904773|7502628|FG007|COMPLETED|First Intervention||3
6578489|NCT01904773|7502629|FG008|COMPLETED|First Intervention||4
6578490|NCT01904773|7502621|FG000|NOT COMPLETED|First Intervention||0
6578491|NCT01904773|7502622|FG001|NOT COMPLETED|First Intervention||0
6578492|NCT01904773|7502623|FG002|NOT COMPLETED|First Intervention||0
6578493|NCT01904773|7502624|FG003|NOT COMPLETED|First Intervention||0
6578494|NCT01904773|7502625|FG004|NOT COMPLETED|First Intervention||0
6578495|NCT01904773|7502626|FG005|NOT COMPLETED|First Intervention||0
6578496|NCT01904773|7502627|FG006|NOT COMPLETED|First Intervention||1
6578497|NCT01904773|7502628|FG007|NOT COMPLETED|First Intervention||0
6578498|NCT01904773|7502629|FG008|NOT COMPLETED|First Intervention||0
6578499|NCT01904773|7502621|FG000|STARTED|Placebo Washout First Intervention||0
6578500|NCT01904773|7502622|FG001|STARTED|Placebo Washout First Intervention||2
6578501|NCT01904773|7502623|FG002|STARTED|Placebo Washout First Intervention||1
6578502|NCT01904773|7502624|FG003|STARTED|Placebo Washout First Intervention||2
6578503|NCT01904773|7502625|FG004|STARTED|Placebo Washout First Intervention||3
6578504|NCT01904773|7502626|FG005|STARTED|Placebo Washout First Intervention||4
6578505|NCT01904773|7502627|FG006|STARTED|Placebo Washout First Intervention||3
6578506|NCT01904773|7502628|FG007|STARTED|Placebo Washout First Intervention||3
6578507|NCT01904773|7502629|FG008|STARTED|Placebo Washout First Intervention||4
6578508|NCT01904773|7502621|FG000|COMPLETED|Placebo Washout First Intervention||0
6578509|NCT01904773|7502622|FG001|COMPLETED|Placebo Washout First Intervention||1
6578510|NCT01904773|7502623|FG002|COMPLETED|Placebo Washout First Intervention||1
6578511|NCT01904773|7502624|FG003|COMPLETED|Placebo Washout First Intervention||2
6578512|NCT01904773|7502625|FG004|COMPLETED|Placebo Washout First Intervention||3
6578513|NCT01904773|7502626|FG005|COMPLETED|Placebo Washout First Intervention||4
6578514|NCT01904773|7502627|FG006|COMPLETED|Placebo Washout First Intervention||3
6578515|NCT01904773|7502628|FG007|COMPLETED|Placebo Washout First Intervention||3
6578516|NCT01904773|7502629|FG008|COMPLETED|Placebo Washout First Intervention||4
6578517|NCT01904773|7502621|FG000|NOT COMPLETED|Placebo Washout First Intervention||0
6578518|NCT01904773|7502622|FG001|NOT COMPLETED|Placebo Washout First Intervention||1
6578519|NCT01904773|7502623|FG002|NOT COMPLETED|Placebo Washout First Intervention||0
6578520|NCT01904773|7502624|FG003|NOT COMPLETED|Placebo Washout First Intervention||0
6578521|NCT01904773|7502625|FG004|NOT COMPLETED|Placebo Washout First Intervention||0
6578522|NCT01904773|7502626|FG005|NOT COMPLETED|Placebo Washout First Intervention||0
6578523|NCT01904773|7502627|FG006|NOT COMPLETED|Placebo Washout First Intervention||0
6578524|NCT01904773|7502628|FG007|NOT COMPLETED|Placebo Washout First Intervention||0
6578525|NCT01904773|7502629|FG008|NOT COMPLETED|Placebo Washout First Intervention||0
6578526|NCT01904773|7502621|FG000|STARTED|Second Intervention||0
6578527|NCT01904773|7502622|FG001|STARTED|Second Intervention||1
6578528|NCT01904773|7502623|FG002|STARTED|Second Intervention||1
6578529|NCT01904773|7502624|FG003|STARTED|Second Intervention||2
6578530|NCT01904773|7502625|FG004|STARTED|Second Intervention||3
6578531|NCT01904773|7502626|FG005|STARTED|Second Intervention||4
6578532|NCT01904773|7502627|FG006|STARTED|Second Intervention||3
6578533|NCT01904773|7502628|FG007|STARTED|Second Intervention||3
6578534|NCT01904773|7502629|FG008|STARTED|Second Intervention||4
6578535|NCT01904773|7502621|FG000|COMPLETED|Second Intervention||0
6578536|NCT01904773|7502622|FG001|COMPLETED|Second Intervention||1
6578537|NCT01904773|7502623|FG002|COMPLETED|Second Intervention||1
6578538|NCT01904773|7502624|FG003|COMPLETED|Second Intervention||2
6578539|NCT01904773|7502625|FG004|COMPLETED|Second Intervention||3
6578540|NCT01904773|7502626|FG005|COMPLETED|Second Intervention||4
6578541|NCT01904773|7502627|FG006|COMPLETED|Second Intervention||3
6578542|NCT01904773|7502628|FG007|COMPLETED|Second Intervention||3
6578543|NCT01904773|7502629|FG008|COMPLETED|Second Intervention||4
6578544|NCT01904773|7502621|FG000|NOT COMPLETED|Second Intervention||0
6578545|NCT01904773|7502622|FG001|NOT COMPLETED|Second Intervention||0
6578546|NCT01904773|7502623|FG002|NOT COMPLETED|Second Intervention||0
6578547|NCT01904773|7502624|FG003|NOT COMPLETED|Second Intervention||0
6578548|NCT01904773|7502625|FG004|NOT COMPLETED|Second Intervention||0
6578549|NCT01904773|7502626|FG005|NOT COMPLETED|Second Intervention||0
6578550|NCT01904773|7502627|FG006|NOT COMPLETED|Second Intervention||0
6578551|NCT01904773|7502628|FG007|NOT COMPLETED|Second Intervention||0
6578552|NCT01904773|7502629|FG008|NOT COMPLETED|Second Intervention||0
6578553|NCT01904773|7502621|FG000|STARTED|Placebo Washout Second Intervention||0
6578554|NCT01904773|7502622|FG001|STARTED|Placebo Washout Second Intervention||1
6578555|NCT01904773|7502623|FG002|STARTED|Placebo Washout Second Intervention||1
6578556|NCT01904773|7502624|FG003|STARTED|Placebo Washout Second Intervention||2
6578557|NCT01904773|7502625|FG004|STARTED|Placebo Washout Second Intervention||3
6578558|NCT01904773|7502626|FG005|STARTED|Placebo Washout Second Intervention||4
6578559|NCT01904773|7502627|FG006|STARTED|Placebo Washout Second Intervention||3
6578560|NCT01904773|7502628|FG007|STARTED|Placebo Washout Second Intervention||3
6578561|NCT01904773|7502629|FG008|STARTED|Placebo Washout Second Intervention||4
6578562|NCT01904773|7502621|FG000|COMPLETED|Placebo Washout Second Intervention||0
6578563|NCT01904773|7502622|FG001|COMPLETED|Placebo Washout Second Intervention||1
6578564|NCT01904773|7502623|FG002|COMPLETED|Placebo Washout Second Intervention||1
6578565|NCT01904773|7502624|FG003|COMPLETED|Placebo Washout Second Intervention||2
6578566|NCT01904773|7502625|FG004|COMPLETED|Placebo Washout Second Intervention||3
6578567|NCT01904773|7502626|FG005|COMPLETED|Placebo Washout Second Intervention||4
6578568|NCT01904773|7502627|FG006|COMPLETED|Placebo Washout Second Intervention||3
6578569|NCT01904773|7502628|FG007|COMPLETED|Placebo Washout Second Intervention||3
6578570|NCT01904773|7502629|FG008|COMPLETED|Placebo Washout Second Intervention||4
6578571|NCT01904773|7502621|FG000|NOT COMPLETED|Placebo Washout Second Intervention||0
6578572|NCT01904773|7502622|FG001|NOT COMPLETED|Placebo Washout Second Intervention||0
6578573|NCT01904773|7502623|FG002|NOT COMPLETED|Placebo Washout Second Intervention||0
6578574|NCT01904773|7502624|FG003|NOT COMPLETED|Placebo Washout Second Intervention||0
6578575|NCT01904773|7502625|FG004|NOT COMPLETED|Placebo Washout Second Intervention||0
6578576|NCT01904773|7502626|FG005|NOT COMPLETED|Placebo Washout Second Intervention||0
6578577|NCT01904773|7502627|FG006|NOT COMPLETED|Placebo Washout Second Intervention||0
6578578|NCT01904773|7502628|FG007|NOT COMPLETED|Placebo Washout Second Intervention||0
6578579|NCT01904773|7502629|FG008|NOT COMPLETED|Placebo Washout Second Intervention||0
6578580|NCT01904773|7502621|FG000|STARTED|Third Intervention||0
6578581|NCT01904773|7502622|FG001|STARTED|Third Intervention||1
6578582|NCT01904773|7502623|FG002|STARTED|Third Intervention||1
6578583|NCT01904773|7502624|FG003|STARTED|Third Intervention||2
6578584|NCT01904773|7502625|FG004|STARTED|Third Intervention||3
6578585|NCT01904773|7502626|FG005|STARTED|Third Intervention||4
6578586|NCT01904773|7502627|FG006|STARTED|Third Intervention||3
6578587|NCT01904773|7502628|FG007|STARTED|Third Intervention||3
6578588|NCT01904773|7502629|FG008|STARTED|Third Intervention||4
6578589|NCT01904773|7502621|FG000|COMPLETED|Third Intervention||0
6578590|NCT01904773|7502622|FG001|COMPLETED|Third Intervention||1
6578591|NCT01904773|7502623|FG002|COMPLETED|Third Intervention||1
6578592|NCT01904773|7502624|FG003|COMPLETED|Third Intervention||2
6578593|NCT01904773|7502625|FG004|COMPLETED|Third Intervention||3
6578594|NCT01904773|7502626|FG005|COMPLETED|Third Intervention||4
6578595|NCT01904773|7502627|FG006|COMPLETED|Third Intervention||3
6578596|NCT01904773|7502628|FG007|COMPLETED|Third Intervention||3
6578597|NCT01904773|7502629|FG008|COMPLETED|Third Intervention||4
6578598|NCT01904773|7502621|FG000|NOT COMPLETED|Third Intervention||0
6578599|NCT01904773|7502622|FG001|NOT COMPLETED|Third Intervention||0
6578600|NCT01904773|7502623|FG002|NOT COMPLETED|Third Intervention||0
6578601|NCT01904773|7502624|FG003|NOT COMPLETED|Third Intervention||0
6578602|NCT01904773|7502625|FG004|NOT COMPLETED|Third Intervention||0
6578603|NCT01904773|7502626|FG005|NOT COMPLETED|Third Intervention||0
6578604|NCT01904773|7502627|FG006|NOT COMPLETED|Third Intervention||0
6658545|NCT02480582|7589115|FG005|STARTED|Overall Study||7
6658546|NCT02480582|7589110|FG000|COMPLETED|Overall Study||7
6658547|NCT02480582|7589111|FG001|COMPLETED|Overall Study||7
6658548|NCT02480582|7589112|FG002|COMPLETED|Overall Study||7
6658549|NCT02480582|7589113|FG003|COMPLETED|Overall Study||7
6658550|NCT02480582|7589114|FG004|COMPLETED|Overall Study||7
6658551|NCT02480582|7589115|FG005|COMPLETED|Overall Study||7
6658552|NCT02480582|7589110|FG000|NOT COMPLETED|Overall Study||0
6658553|NCT02480582|7589111|FG001|NOT COMPLETED|Overall Study||0
6658554|NCT02480582|7589112|FG002|NOT COMPLETED|Overall Study||0
6658555|NCT02480582|7589113|FG003|NOT COMPLETED|Overall Study||0
6658556|NCT02480582|7589114|FG004|NOT COMPLETED|Overall Study||0
6658557|NCT02480582|7589115|FG005|NOT COMPLETED|Overall Study||0
6658558|NCT02480621|7589130|FG000|STARTED|Randomization||44
6658559|NCT02480621|7589131|FG001|STARTED|Randomization||40
6658560|NCT02480621|7589130|FG000|COMPLETED|Randomization||43
6658561|NCT02480621|7589131|FG001|COMPLETED|Randomization||39
6658562|NCT02480621|7589130|FG000|NOT COMPLETED|Randomization||1
6658563|NCT02480621|7589131|FG001|NOT COMPLETED|Randomization||1
6658564|NCT02480621|7589130|FG000|STARTED|Follow Up||43
6658565|NCT02480621|7589131|FG001|STARTED|Follow Up||39
6658566|NCT02480621|7589130|FG000|COMPLETED|Follow Up||39
6658567|NCT02480621|7589131|FG001|COMPLETED|Follow Up||37
6658568|NCT02480621|7589130|FG000|NOT COMPLETED|Follow Up||4
6658569|NCT02480621|7589131|FG001|NOT COMPLETED|Follow Up||2
6658570|NCT02480712|7589137|FG000|STARTED|Overall Study||107
6658571|NCT02480712|7589137|FG000|COMPLETED|Overall Study||96
6658572|NCT02480712|7589137|FG000|NOT COMPLETED|Overall Study||11
6737502|NCT03266588|7666796|FG000|STARTED|Observational Period||1605
6737503|NCT03266588|7666797|FG001|STARTED|Observational Period||786
6737504|NCT03266588|7666798|FG002|STARTED|Observational Period||476
6737505|NCT03266588|7666796|FG000|COMPLETED|Observational Period||1089
6737506|NCT03266588|7666797|FG001|COMPLETED|Observational Period||511
6737507|NCT03266588|7666798|FG002|COMPLETED|Observational Period||308
6737508|NCT03266588|7666796|FG000|NOT COMPLETED|Observational Period||516
6737509|NCT03266588|7666797|FG001|NOT COMPLETED|Observational Period||275
6737510|NCT03266588|7666798|FG002|NOT COMPLETED|Observational Period||168
6737511|NCT03266588|7666796|FG000|STARTED|Long-term Treatment Period||1089
6737512|NCT03266588|7666797|FG001|STARTED|Long-term Treatment Period||511
6737513|NCT03266588|7666798|FG002|STARTED|Long-term Treatment Period||308
6578605|NCT01904773|7502628|FG007|NOT COMPLETED|Third Intervention||0
6578606|NCT01904773|7502629|FG008|NOT COMPLETED|Third Intervention||0
6578607|NCT01904773|7502621|FG000|STARTED|Placebo Washout Third Intervention||0
6578608|NCT01904773|7502622|FG001|STARTED|Placebo Washout Third Intervention||1
6578609|NCT01904773|7502623|FG002|STARTED|Placebo Washout Third Intervention||1
6578610|NCT01904773|7502624|FG003|STARTED|Placebo Washout Third Intervention||2
6578611|NCT01904773|7502625|FG004|STARTED|Placebo Washout Third Intervention||3
6578612|NCT01904773|7502626|FG005|STARTED|Placebo Washout Third Intervention||4
6578613|NCT01904773|7502627|FG006|STARTED|Placebo Washout Third Intervention||3
6578614|NCT01904773|7502628|FG007|STARTED|Placebo Washout Third Intervention||3
6578615|NCT01904773|7502629|FG008|STARTED|Placebo Washout Third Intervention||4
6578616|NCT01904773|7502621|FG000|COMPLETED|Placebo Washout Third Intervention||0
6578617|NCT01904773|7502622|FG001|COMPLETED|Placebo Washout Third Intervention||1
6578618|NCT01904773|7502623|FG002|COMPLETED|Placebo Washout Third Intervention||1
6578619|NCT01904773|7502624|FG003|COMPLETED|Placebo Washout Third Intervention||2
6578620|NCT01904773|7502625|FG004|COMPLETED|Placebo Washout Third Intervention||3
6578621|NCT01904773|7502626|FG005|COMPLETED|Placebo Washout Third Intervention||4
6578622|NCT01904773|7502627|FG006|COMPLETED|Placebo Washout Third Intervention||3
6578623|NCT01904773|7502628|FG007|COMPLETED|Placebo Washout Third Intervention||3
6578624|NCT01904773|7502629|FG008|COMPLETED|Placebo Washout Third Intervention||4
6578625|NCT01904773|7502621|FG000|NOT COMPLETED|Placebo Washout Third Intervention||0
6578626|NCT01904773|7502622|FG001|NOT COMPLETED|Placebo Washout Third Intervention||0
6578627|NCT01904773|7502623|FG002|NOT COMPLETED|Placebo Washout Third Intervention||0
6578628|NCT01904773|7502624|FG003|NOT COMPLETED|Placebo Washout Third Intervention||0
6578629|NCT01904773|7502625|FG004|NOT COMPLETED|Placebo Washout Third Intervention||0
6578630|NCT01904773|7502626|FG005|NOT COMPLETED|Placebo Washout Third Intervention||0
6578631|NCT01904773|7502627|FG006|NOT COMPLETED|Placebo Washout Third Intervention||0
6578632|NCT01904773|7502628|FG007|NOT COMPLETED|Placebo Washout Third Intervention||0
6578633|NCT01904773|7502629|FG008|NOT COMPLETED|Placebo Washout Third Intervention||0
6578634|NCT01904773|7502621|FG000|STARTED|Fourth Intervention||0
6578635|NCT01904773|7502622|FG001|STARTED|Fourth Intervention||1
6578636|NCT01904773|7502623|FG002|STARTED|Fourth Intervention||1
6578637|NCT01904773|7502624|FG003|STARTED|Fourth Intervention||2
6578638|NCT01904773|7502625|FG004|STARTED|Fourth Intervention||3
6578639|NCT01904773|7502626|FG005|STARTED|Fourth Intervention||4
6578640|NCT01904773|7502627|FG006|STARTED|Fourth Intervention||3
6578641|NCT01904773|7502628|FG007|STARTED|Fourth Intervention||3
6578642|NCT01904773|7502629|FG008|STARTED|Fourth Intervention||4
6578643|NCT01904773|7502621|FG000|COMPLETED|Fourth Intervention||0
6578644|NCT01904773|7502622|FG001|COMPLETED|Fourth Intervention||1
6578645|NCT01904773|7502623|FG002|COMPLETED|Fourth Intervention||1
6578646|NCT01904773|7502624|FG003|COMPLETED|Fourth Intervention||2
6578647|NCT01904773|7502625|FG004|COMPLETED|Fourth Intervention||3
6578648|NCT01904773|7502626|FG005|COMPLETED|Fourth Intervention||4
6578649|NCT01904773|7502627|FG006|COMPLETED|Fourth Intervention||3
6578650|NCT01904773|7502628|FG007|COMPLETED|Fourth Intervention||3
6578651|NCT01904773|7502629|FG008|COMPLETED|Fourth Intervention||4
6578652|NCT01904773|7502621|FG000|NOT COMPLETED|Fourth Intervention||0
6578653|NCT01904773|7502622|FG001|NOT COMPLETED|Fourth Intervention||0
6578654|NCT01904773|7502623|FG002|NOT COMPLETED|Fourth Intervention||0
6578655|NCT01904773|7502624|FG003|NOT COMPLETED|Fourth Intervention||0
6578656|NCT01904773|7502625|FG004|NOT COMPLETED|Fourth Intervention||0
6578657|NCT01904773|7502626|FG005|NOT COMPLETED|Fourth Intervention||0
6578658|NCT01904773|7502627|FG006|NOT COMPLETED|Fourth Intervention||0
6578659|NCT01904773|7502628|FG007|NOT COMPLETED|Fourth Intervention||0
6578660|NCT01904773|7502629|FG008|NOT COMPLETED|Fourth Intervention||0
6578661|NCT01904773|7502621|FG000|STARTED|Placebo Washout Fourth Intervention||0
6578662|NCT01904773|7502622|FG001|STARTED|Placebo Washout Fourth Intervention||1
6578663|NCT01904773|7502623|FG002|STARTED|Placebo Washout Fourth Intervention||1
6578664|NCT01904773|7502624|FG003|STARTED|Placebo Washout Fourth Intervention||2
6578665|NCT01904773|7502625|FG004|STARTED|Placebo Washout Fourth Intervention||3
6578666|NCT01904773|7502626|FG005|STARTED|Placebo Washout Fourth Intervention||4
6578667|NCT01904773|7502627|FG006|STARTED|Placebo Washout Fourth Intervention||3
6578668|NCT01904773|7502628|FG007|STARTED|Placebo Washout Fourth Intervention||3
6578669|NCT01904773|7502629|FG008|STARTED|Placebo Washout Fourth Intervention||4
6578670|NCT01904773|7502621|FG000|COMPLETED|Placebo Washout Fourth Intervention||0
6578671|NCT01904773|7502622|FG001|COMPLETED|Placebo Washout Fourth Intervention||1
6578672|NCT01904773|7502623|FG002|COMPLETED|Placebo Washout Fourth Intervention||1
6578673|NCT01904773|7502624|FG003|COMPLETED|Placebo Washout Fourth Intervention||2
6578674|NCT01904773|7502625|FG004|COMPLETED|Placebo Washout Fourth Intervention||3
6578675|NCT01904773|7502626|FG005|COMPLETED|Placebo Washout Fourth Intervention||4
6578676|NCT01904773|7502627|FG006|COMPLETED|Placebo Washout Fourth Intervention||3
6578677|NCT01904773|7502628|FG007|COMPLETED|Placebo Washout Fourth Intervention||3
6578678|NCT01904773|7502629|FG008|COMPLETED|Placebo Washout Fourth Intervention||4
6578679|NCT01904773|7502621|FG000|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578680|NCT01904773|7502622|FG001|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578681|NCT01904773|7502623|FG002|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578682|NCT01904773|7502624|FG003|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578683|NCT01904773|7502625|FG004|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578684|NCT01904773|7502626|FG005|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578685|NCT01904773|7502627|FG006|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578686|NCT01904773|7502628|FG007|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578687|NCT01904773|7502629|FG008|NOT COMPLETED|Placebo Washout Fourth Intervention||0
6578688|NCT01904773|7502621|FG000|STARTED|Fifth Intervention||0
6578689|NCT01904773|7502622|FG001|STARTED|Fifth Intervention||1
6578690|NCT01904773|7502623|FG002|STARTED|Fifth Intervention||1
6578691|NCT01904773|7502624|FG003|STARTED|Fifth Intervention||2
6578692|NCT01904773|7502625|FG004|STARTED|Fifth Intervention||3
6578693|NCT01904773|7502626|FG005|STARTED|Fifth Intervention||4
6578694|NCT01904773|7502627|FG006|STARTED|Fifth Intervention||3
6578695|NCT01904773|7502628|FG007|STARTED|Fifth Intervention||3
6578696|NCT01904773|7502629|FG008|STARTED|Fifth Intervention||4
6578697|NCT01904773|7502621|FG000|COMPLETED|Fifth Intervention||0
6578698|NCT01904773|7502622|FG001|COMPLETED|Fifth Intervention||1
6578699|NCT01904773|7502623|FG002|COMPLETED|Fifth Intervention||1
6578700|NCT01904773|7502624|FG003|COMPLETED|Fifth Intervention||2
6578701|NCT01904773|7502625|FG004|COMPLETED|Fifth Intervention||3
6578702|NCT01904773|7502626|FG005|COMPLETED|Fifth Intervention||4
6578703|NCT01904773|7502627|FG006|COMPLETED|Fifth Intervention||3
6578704|NCT01904773|7502628|FG007|COMPLETED|Fifth Intervention||2
6578705|NCT01904773|7502629|FG008|COMPLETED|Fifth Intervention||4
6578706|NCT01904773|7502621|FG000|NOT COMPLETED|Fifth Intervention||0
6578707|NCT01904773|7502622|FG001|NOT COMPLETED|Fifth Intervention||0
6578708|NCT01904773|7502623|FG002|NOT COMPLETED|Fifth Intervention||0
6578709|NCT01904773|7502624|FG003|NOT COMPLETED|Fifth Intervention||0
6578710|NCT01904773|7502625|FG004|NOT COMPLETED|Fifth Intervention||0
6578711|NCT01904773|7502626|FG005|NOT COMPLETED|Fifth Intervention||0
6578712|NCT01904773|7502627|FG006|NOT COMPLETED|Fifth Intervention||0
6578713|NCT01904773|7502628|FG007|NOT COMPLETED|Fifth Intervention||1
6578714|NCT01904773|7502629|FG008|NOT COMPLETED|Fifth Intervention||0
6578715|NCT01904773|7502621|FG000|STARTED|Placebo Washout Fifth Intervention||0
6578716|NCT01904773|7502622|FG001|STARTED|Placebo Washout Fifth Intervention||1
6578717|NCT01904773|7502623|FG002|STARTED|Placebo Washout Fifth Intervention||1
6578718|NCT01904773|7502624|FG003|STARTED|Placebo Washout Fifth Intervention||2
6578719|NCT01904773|7502625|FG004|STARTED|Placebo Washout Fifth Intervention||3
6578720|NCT01904773|7502626|FG005|STARTED|Placebo Washout Fifth Intervention||4
6578721|NCT01904773|7502627|FG006|STARTED|Placebo Washout Fifth Intervention||3
6578722|NCT01904773|7502628|FG007|STARTED|Placebo Washout Fifth Intervention||2
6578723|NCT01904773|7502629|FG008|STARTED|Placebo Washout Fifth Intervention||4
6578724|NCT01904773|7502621|FG000|COMPLETED|Placebo Washout Fifth Intervention||0
6578725|NCT01904773|7502622|FG001|COMPLETED|Placebo Washout Fifth Intervention||0
6578726|NCT01904773|7502623|FG002|COMPLETED|Placebo Washout Fifth Intervention||1
6578727|NCT01904773|7502624|FG003|COMPLETED|Placebo Washout Fifth Intervention||2
6578728|NCT01904773|7502625|FG004|COMPLETED|Placebo Washout Fifth Intervention||3
6578729|NCT01904773|7502626|FG005|COMPLETED|Placebo Washout Fifth Intervention||4
6578730|NCT01904773|7502627|FG006|COMPLETED|Placebo Washout Fifth Intervention||3
6578731|NCT01904773|7502628|FG007|COMPLETED|Placebo Washout Fifth Intervention||2
6578732|NCT01904773|7502629|FG008|COMPLETED|Placebo Washout Fifth Intervention||4
6578733|NCT01904773|7502621|FG000|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6578734|NCT01904773|7502622|FG001|NOT COMPLETED|Placebo Washout Fifth Intervention||1
6578735|NCT01904773|7502623|FG002|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6578736|NCT01904773|7502624|FG003|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6578737|NCT01904773|7502625|FG004|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6578738|NCT01904773|7502626|FG005|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6578739|NCT01904773|7502627|FG006|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6578740|NCT01904773|7502628|FG007|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6578741|NCT01904773|7502629|FG008|NOT COMPLETED|Placebo Washout Fifth Intervention||0
6578742|NCT01904773|7502621|FG000|STARTED|Sixth Intervention||0
6578743|NCT01904773|7502622|FG001|STARTED|Sixth Intervention||0
6578744|NCT01904773|7502623|FG002|STARTED|Sixth Intervention||1
6578745|NCT01904773|7502624|FG003|STARTED|Sixth Intervention||2
6578746|NCT01904773|7502625|FG004|STARTED|Sixth Intervention||3
6578747|NCT01904773|7502626|FG005|STARTED|Sixth Intervention||4
6578748|NCT01904773|7502627|FG006|STARTED|Sixth Intervention||3
6578749|NCT01904773|7502628|FG007|STARTED|Sixth Intervention||2
6578750|NCT01904773|7502629|FG008|STARTED|Sixth Intervention||4
6578751|NCT01904773|7502621|FG000|COMPLETED|Sixth Intervention||0
6578752|NCT01904773|7502622|FG001|COMPLETED|Sixth Intervention||0
6578753|NCT01904773|7502623|FG002|COMPLETED|Sixth Intervention||1
6578754|NCT01904773|7502624|FG003|COMPLETED|Sixth Intervention||2
6578755|NCT01904773|7502625|FG004|COMPLETED|Sixth Intervention||3
6578756|NCT01904773|7502626|FG005|COMPLETED|Sixth Intervention||4
6578757|NCT01904773|7502627|FG006|COMPLETED|Sixth Intervention||3
6578758|NCT01904773|7502628|FG007|COMPLETED|Sixth Intervention||2
6578759|NCT01904773|7502629|FG008|COMPLETED|Sixth Intervention||4
6578760|NCT01904773|7502621|FG000|NOT COMPLETED|Sixth Intervention||0
6578761|NCT01904773|7502622|FG001|NOT COMPLETED|Sixth Intervention||0
6578762|NCT01904773|7502623|FG002|NOT COMPLETED|Sixth Intervention||0
6578763|NCT01904773|7502624|FG003|NOT COMPLETED|Sixth Intervention||0
6578764|NCT01904773|7502625|FG004|NOT COMPLETED|Sixth Intervention||0
6578765|NCT01904773|7502626|FG005|NOT COMPLETED|Sixth Intervention||0
6578766|NCT01904773|7502627|FG006|NOT COMPLETED|Sixth Intervention||0
6578767|NCT01904773|7502628|FG007|NOT COMPLETED|Sixth Intervention||0
6578768|NCT01904773|7502629|FG008|NOT COMPLETED|Sixth Intervention||0
6578769|NCT01904864|7502643|FG000|STARTED|Overall Study||40
6578770|NCT01904864|7502644|FG001|STARTED|Overall Study||40
6578771|NCT01904864|7502643|FG000|COMPLETED|Overall Study||31
6578772|NCT01904864|7502644|FG001|COMPLETED|Overall Study||28
6578773|NCT01904864|7502643|FG000|NOT COMPLETED|Overall Study||9
6578774|NCT01904864|7502644|FG001|NOT COMPLETED|Overall Study||12
6578775|NCT01904903|7502650|FG000|STARTED|Overall Study||31
6578776|NCT01904903|7502650|FG000|COMPLETED|Overall Study||30
6578777|NCT01904903|7502650|FG000|NOT COMPLETED|Overall Study||1
6578778|NCT01905241|7502654|FG000|STARTED|Overall Study||20
6578779|NCT01905241|7502654|FG000|COMPLETED|Overall Study||20
6578780|NCT01905241|7502654|FG000|NOT COMPLETED|Overall Study||0
6578781|NCT01905254|7502658|FG000|STARTED|Overall Study||34
6578782|NCT01905254|7502658|FG000|COMPLETED|Overall Study||34
6578783|NCT01905254|7502658|FG000|NOT COMPLETED|Overall Study||0
6578784|NCT01905267|7502664|FG000|STARTED|Overall Study||17
6578785|NCT01905267|7502665|FG001|STARTED|Overall Study||16
6578786|NCT01905267|7502664|FG000|COMPLETED|Overall Study||15
6578787|NCT01905267|7502665|FG001|COMPLETED|Overall Study||14
6578788|NCT01905267|7502664|FG000|NOT COMPLETED|Overall Study||2
6578789|NCT01905267|7502665|FG001|NOT COMPLETED|Overall Study||2
6578790|NCT01905423|7502676|FG000|STARTED|Overall Study||4456
6578791|NCT01905423|7502677|FG001|STARTED|Overall Study||3297
6578792|NCT01905423|7502678|FG002|STARTED|Overall Study||4111
6578793|NCT01905423|7502679|FG003|STARTED|Overall Study||2757
6578794|NCT01905423|7502680|FG004|STARTED|Overall Study||2487
6578795|NCT01905423|7502676|FG000|Baseline|Overall Study||1443
6578796|NCT01905423|7502677|FG001|Baseline|Overall Study||722
6578797|NCT01905423|7502678|FG002|Baseline|Overall Study||1033
6578798|NCT01905423|7502679|FG003|Baseline|Overall Study||1482
6578799|NCT01905423|7502680|FG004|Baseline|Overall Study||1326
6578800|NCT01905423|7502676|FG000|Year 1 Follow-up|Overall Study||994
6578801|NCT01905423|7502677|FG001|Year 1 Follow-up|Overall Study||846
6578802|NCT01905423|7502678|FG002|Year 1 Follow-up|Overall Study||1007
6578803|NCT01905423|7502679|FG003|Year 1 Follow-up|Overall Study||1275
6578804|NCT01905423|7502680|FG004|Year 1 Follow-up|Overall Study||1161
6578805|NCT01905423|7502676|FG000|Year 2 Follow-up|Overall Study||1114
6578806|NCT01905423|7502677|FG001|Year 2 Follow-up|Overall Study||858
6578807|NCT01905423|7502678|FG002|Year 2 Follow-up|Overall Study||1043
6578808|NCT01905423|7502679|FG003|Year 2 Follow-up|Overall Study||0
6578809|NCT01905423|7502680|FG004|Year 2 Follow-up|Overall Study||0
6578810|NCT01905423|7502676|FG000|Year 3 Follow-up|Overall Study||905
6578811|NCT01905423|7502677|FG001|Year 3 Follow-up|Overall Study||871
6578812|NCT01905423|7502678|FG002|Year 3 Follow-up|Overall Study||1028
6578813|NCT01905423|7502679|FG003|Year 3 Follow-up|Overall Study||0
6578814|NCT01905423|7502680|FG004|Year 3 Follow-up|Overall Study||0
6578815|NCT01905423|7502676|FG000|COMPLETED|Overall Study||4456
6578816|NCT01905423|7502677|FG001|COMPLETED|Overall Study||3297
6578817|NCT01905423|7502678|FG002|COMPLETED|Overall Study||4111
6578818|NCT01905423|7502679|FG003|COMPLETED|Overall Study||2757
6578819|NCT01905423|7502680|FG004|COMPLETED|Overall Study||2487
6578820|NCT01905423|7502676|FG000|NOT COMPLETED|Overall Study||0
6578821|NCT01905423|7502677|FG001|NOT COMPLETED|Overall Study||0
6578822|NCT01905423|7502678|FG002|NOT COMPLETED|Overall Study||0
6578823|NCT01905423|7502679|FG003|NOT COMPLETED|Overall Study||0
6578824|NCT01905423|7502680|FG004|NOT COMPLETED|Overall Study||0
6578825|NCT01905540|7502696|FG000|STARTED|Period 1||7
6578826|NCT01905540|7502697|FG001|STARTED|Period 1||7
6578827|NCT01905540|7502698|FG002|STARTED|Period 1||7
6578828|NCT01905540|7502699|FG003|STARTED|Period 1||7
6578829|NCT01905540|7502696|FG000|COMPLETED|Period 1||7
6578830|NCT01905540|7502697|FG001|COMPLETED|Period 1||7
6578831|NCT01905540|7502698|FG002|COMPLETED|Period 1||7
6578832|NCT01905540|7502699|FG003|COMPLETED|Period 1||7
6578833|NCT01905540|7502696|FG000|NOT COMPLETED|Period 1||0
6578834|NCT01905540|7502697|FG001|NOT COMPLETED|Period 1||0
6578835|NCT01905540|7502698|FG002|NOT COMPLETED|Period 1||0
6578836|NCT01905540|7502699|FG003|NOT COMPLETED|Period 1||0
6578837|NCT01905540|7502696|FG000|STARTED|Period 2||7
6578838|NCT01905540|7502697|FG001|STARTED|Period 2||7
6578839|NCT01905540|7502698|FG002|STARTED|Period 2||7
6578840|NCT01905540|7502699|FG003|STARTED|Period 2||7
6578841|NCT01905540|7502696|FG000|COMPLETED|Period 2||7
6578842|NCT01905540|7502697|FG001|COMPLETED|Period 2||7
6578843|NCT01905540|7502698|FG002|COMPLETED|Period 2||7
6578844|NCT01905540|7502699|FG003|COMPLETED|Period 2||7
6578845|NCT01905540|7502696|FG000|NOT COMPLETED|Period 2||0
6578846|NCT01905540|7502697|FG001|NOT COMPLETED|Period 2||0
6578847|NCT01905540|7502698|FG002|NOT COMPLETED|Period 2||0
6578848|NCT01905540|7502699|FG003|NOT COMPLETED|Period 2||0
6578849|NCT01905540|7502696|FG000|STARTED|Period 3||7
6578850|NCT01905540|7502697|FG001|STARTED|Period 3||7
6578851|NCT01905540|7502698|FG002|STARTED|Period 3||7
6578852|NCT01905540|7502699|FG003|STARTED|Period 3||7
6578853|NCT01905540|7502696|FG000|COMPLETED|Period 3||6
6578854|NCT01905540|7502697|FG001|COMPLETED|Period 3||7
6578855|NCT01905540|7502698|FG002|COMPLETED|Period 3||6
6578856|NCT01905540|7502699|FG003|COMPLETED|Period 3||6
6578857|NCT01905540|7502696|FG000|NOT COMPLETED|Period 3||1
6578858|NCT01905540|7502697|FG001|NOT COMPLETED|Period 3||0
6578859|NCT01905540|7502698|FG002|NOT COMPLETED|Period 3||1
6578860|NCT01905540|7502699|FG003|NOT COMPLETED|Period 3||1
6578861|NCT01905553|7502711|FG000|STARTED|Period 1||5
6578862|NCT01905553|7502712|FG001|STARTED|Period 1||4
6578863|NCT01905553|7502711|FG000|COMPLETED|Period 1||5
6578864|NCT01905553|7502712|FG001|COMPLETED|Period 1||4
6578865|NCT01905553|7502711|FG000|NOT COMPLETED|Period 1||0
6578866|NCT01905553|7502712|FG001|NOT COMPLETED|Period 1||0
6578867|NCT01905553|7502711|FG000|STARTED|Period 2||5
6578868|NCT01905553|7502712|FG001|STARTED|Period 2||4
6578869|NCT01905553|7502711|FG000|COMPLETED|Period 2||4
6578870|NCT01905553|7502712|FG001|COMPLETED|Period 2||4
6578871|NCT01905553|7502711|FG000|NOT COMPLETED|Period 2||1
6578872|NCT01905553|7502712|FG001|NOT COMPLETED|Period 2||0
6578873|NCT01905592|7502720|FG000|STARTED|Overall Study||71
6578874|NCT01905592|7502721|FG001|STARTED|Overall Study||135
6578875|NCT01905592|7502720|FG000|COMPLETED|Overall Study||0
6578876|NCT01905592|7502721|FG001|COMPLETED|Overall Study||0
6578877|NCT01905592|7502720|FG000|NOT COMPLETED|Overall Study||71
6578878|NCT01905592|7502721|FG001|NOT COMPLETED|Overall Study||135
6578879|NCT01905657|7502730|FG000|STARTED|Overall Study||345
6578880|NCT01905657|7502731|FG001|STARTED|Overall Study||346
6578881|NCT01905657|7502732|FG002|STARTED|Overall Study||343
6578882|NCT01905657|7502730|FG000|Treated|Overall Study||339
6578883|NCT01905657|7502731|FG001|Treated|Overall Study||343
6578884|NCT01905657|7502732|FG002|Treated|Overall Study||309
6578885|NCT01905657|7502730|FG000|Received Second Course of Pembrolizumab|Overall Study||14
6578886|NCT01905657|7502731|FG001|Received Second Course of Pembrolizumab|Overall Study||7
6578887|NCT01905657|7502732|FG002|Received Second Course of Pembrolizumab|Overall Study||0
6578888|NCT01905657|7502730|FG000|Switched Over to Pembrolizumab|Overall Study||0
6578889|NCT01905657|7502731|FG001|Switched Over to Pembrolizumab|Overall Study||0
6578890|NCT01905657|7502732|FG002|Switched Over to Pembrolizumab|Overall Study||8
6578891|NCT01905657|7502730|FG000|COMPLETED|Overall Study||142
6578892|NCT01905657|7502731|FG001|COMPLETED|Overall Study||159
6578893|NCT01905657|7502732|FG002|COMPLETED|Overall Study||143
6578894|NCT01905657|7502730|FG000|NOT COMPLETED|Overall Study||203
6578895|NCT01905657|7502731|FG001|NOT COMPLETED|Overall Study||187
6578896|NCT01905657|7502732|FG002|NOT COMPLETED|Overall Study||200
6578897|NCT01905683|7502743|FG000|STARTED|Overall Study||370
6578898|NCT01905683|7502743|FG000|COMPLETED|Overall Study||319
6578899|NCT01905683|7502743|FG000|NOT COMPLETED|Overall Study||51
6578900|NCT01905943|7502747|FG000|STARTED|Overall Study||972
6578901|NCT01905943|7502747|FG000|COMPLETED|Overall Study|All patients provide reason at final analysis|658
6578902|NCT01905943|7502747|FG000|NOT COMPLETED|Overall Study||314
6578903|NCT01905956|7502768|FG000|STARTED|Overall Study|Randomized|60
6578904|NCT01905956|7502769|FG001|STARTED|Overall Study|Randomized|59
6578905|NCT01905956|7502768|FG000|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
6578906|NCT01905956|7502769|FG001|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
6578907|NCT01905956|7502768|FG000|COMPLETED|Overall Study|Per-protocol population|54
6578908|NCT01905956|7502769|FG001|COMPLETED|Overall Study|Per-protocol population|48
6578909|NCT01905956|7502768|FG000|NOT COMPLETED|Overall Study||6
6578910|NCT01905956|7502769|FG001|NOT COMPLETED|Overall Study||11
6578911|NCT01906008|7502777|FG000|STARTED|Overall Study||59
6578912|NCT01906008|7502778|FG001|STARTED|Overall Study||61
6578913|NCT01906008|7502777|FG000|COMPLETED|Overall Study||32
6578914|NCT01906008|7502778|FG001|COMPLETED|Overall Study||34
6578915|NCT01906008|7502777|FG000|NOT COMPLETED|Overall Study||27
6578916|NCT01906008|7502778|FG001|NOT COMPLETED|Overall Study||27
6578917|NCT01906346|7502784|FG000|STARTED|Overall Study||9
6578918|NCT01906346|7502784|FG000|COMPLETED|Overall Study||8
6578919|NCT01906346|7502784|FG000|NOT COMPLETED|Overall Study||1
6578920|NCT01906372|7502790|FG000|STARTED|Overall Study||12
6578921|NCT01906372|7502790|FG000|Visit 7: Treatment Phase Completed|Overall Study||10
6578922|NCT01906372|7502790|FG000|Visit 10: Follow up Phase Completed|Overall Study||8
6578923|NCT01906372|7502790|FG000|COMPLETED|Overall Study||10
6578924|NCT01906372|7502790|FG000|NOT COMPLETED|Overall Study||2
6578925|NCT01906476|7502797|FG000|STARTED|Overall Study||157
6578926|NCT01906476|7502798|FG001|STARTED|Overall Study||155
6578927|NCT01906476|7502797|FG000|COMPLETED|Overall Study||140
6578928|NCT01906476|7502798|FG001|COMPLETED|Overall Study||139
6578929|NCT01906476|7502797|FG000|NOT COMPLETED|Overall Study||17
6578930|NCT01906476|7502798|FG001|NOT COMPLETED|Overall Study||16
6578931|NCT01906515|7502806|FG000|STARTED|Overall Study||45
6578932|NCT01906515|7502807|FG001|STARTED|Overall Study||61
6578933|NCT01906515|7502806|FG000|COMPLETED|Overall Study||45
6578934|NCT01906515|7502807|FG001|COMPLETED|Overall Study||61
6578935|NCT01906515|7502806|FG000|NOT COMPLETED|Overall Study||0
6578936|NCT01906515|7502807|FG001|NOT COMPLETED|Overall Study||0
6578937|NCT01906658|7502818|FG000|STARTED|Overall Study||11
6578938|NCT01906658|7502819|FG001|STARTED|Overall Study||11
6578939|NCT01906658|7502820|FG002|STARTED|Overall Study||10
6578940|NCT01906658|7502821|FG003|STARTED|Overall Study||11
6578941|NCT01906658|7502818|FG000|COMPLETED|Overall Study||9
6578942|NCT01906658|7502819|FG001|COMPLETED|Overall Study||10
6578943|NCT01906658|7502820|FG002|COMPLETED|Overall Study||7
6578944|NCT01906658|7502821|FG003|COMPLETED|Overall Study||11
6578945|NCT01906658|7502818|FG000|NOT COMPLETED|Overall Study||2
6578946|NCT01906658|7502819|FG001|NOT COMPLETED|Overall Study||1
6578947|NCT01906658|7502820|FG002|NOT COMPLETED|Overall Study||3
6578948|NCT01906658|7502821|FG003|NOT COMPLETED|Overall Study||0
6578949|NCT01906866|7502833|FG000|STARTED|Overall Study||60
6578950|NCT01906866|7502834|FG001|STARTED|Overall Study||65
6578951|NCT01906866|7502833|FG000|COMPLETED|Overall Study||51
6578952|NCT01906866|7502834|FG001|COMPLETED|Overall Study||44
6578953|NCT01906866|7502833|FG000|NOT COMPLETED|Overall Study||9
6578954|NCT01906866|7502834|FG001|NOT COMPLETED|Overall Study||21
6578955|NCT01907087|7502843|FG000|STARTED|Overall Study||24
6578956|NCT01907087|7502843|FG000|COMPLETED|Overall Study||23
6578957|NCT01907087|7502843|FG000|NOT COMPLETED|Overall Study||1
6578958|NCT01907100|7502851|FG000|STARTED|Overall Study||43
6578959|NCT01907100|7502852|FG001|STARTED|Overall Study||44
6578960|NCT01907100|7502853|FG002|STARTED|Overall Study||229
6578961|NCT01907100|7502854|FG003|STARTED|Overall Study||229
6578962|NCT01907100|7502851|FG000|Treated Patients|Overall Study||41
6578963|NCT01907100|7502852|FG001|Treated Patients|Overall Study||44
6578964|NCT01907100|7502853|FG002|Treated Patients|Overall Study||228
6578965|NCT01907100|7502854|FG003|Treated Patients|Overall Study||227
6578966|NCT01907100|7502851|FG000|COMPLETED|Overall Study||1
6578967|NCT01907100|7502852|FG001|COMPLETED|Overall Study||4
6578968|NCT01907100|7502853|FG002|COMPLETED|Overall Study||82
6578969|NCT01907100|7502854|FG003|COMPLETED|Overall Study||83
6578970|NCT01907100|7502851|FG000|NOT COMPLETED|Overall Study||42
6578971|NCT01907100|7502852|FG001|NOT COMPLETED|Overall Study||40
6578972|NCT01907100|7502853|FG002|NOT COMPLETED|Overall Study||147
6578973|NCT01907100|7502854|FG003|NOT COMPLETED|Overall Study||146
6578974|NCT01907113|7502867|FG000|STARTED|Overall Study||8
6578975|NCT01907113|7502868|FG001|STARTED|Overall Study||9
6578976|NCT01907113|7502869|FG002|STARTED|Overall Study||7
6578977|NCT01907113|7502870|FG003|STARTED|Overall Study||8
6578978|NCT01907113|7502871|FG004|STARTED|Overall Study||8
6578979|NCT01907113|7502867|FG000|COMPLETED|Overall Study||8
6578980|NCT01907113|7502868|FG001|COMPLETED|Overall Study||9
6578981|NCT01907113|7502869|FG002|COMPLETED|Overall Study||7
6578982|NCT01907113|7502870|FG003|COMPLETED|Overall Study||8
6578983|NCT01907113|7502871|FG004|COMPLETED|Overall Study||8
6578984|NCT01907113|7502867|FG000|NOT COMPLETED|Overall Study||0
6578985|NCT01907113|7502868|FG001|NOT COMPLETED|Overall Study||0
6578986|NCT01907113|7502869|FG002|NOT COMPLETED|Overall Study||0
6578987|NCT01907113|7502870|FG003|NOT COMPLETED|Overall Study||0
6578988|NCT01907113|7502871|FG004|NOT COMPLETED|Overall Study||0
6578989|NCT01907217|7502885|FG000|STARTED|Overall Study||69
6578990|NCT01907217|7502886|FG001|STARTED|Overall Study||69
6578991|NCT01907217|7502885|FG000|COMPLETED|Overall Study||69
6578992|NCT01907217|7502886|FG001|COMPLETED|Overall Study||67
6578993|NCT01907217|7502885|FG000|NOT COMPLETED|Overall Study||0
6578994|NCT01907217|7502886|FG001|NOT COMPLETED|Overall Study||2
6578995|NCT01907269|7502896|FG000|STARTED|6 Month Outcome Measures Post-interventi||1342
6578996|NCT01907269|7502897|FG001|STARTED|6 Month Outcome Measures Post-interventi||1342
6578997|NCT01907269|7502896|FG000|COMPLETED|6 Month Outcome Measures Post-interventi||953
6578998|NCT01907269|7502897|FG001|COMPLETED|6 Month Outcome Measures Post-interventi||1053
6578999|NCT01907269|7502896|FG000|NOT COMPLETED|6 Month Outcome Measures Post-interventi||389
6579000|NCT01907269|7502897|FG001|NOT COMPLETED|6 Month Outcome Measures Post-interventi||289
6579001|NCT01907269|7502896|FG000|STARTED|18 Month Outcome Measures Post-intervent||1178
6579002|NCT01907269|7502897|FG001|STARTED|18 Month Outcome Measures Post-intervent||1250
6579003|NCT01907269|7502896|FG000|COMPLETED|18 Month Outcome Measures Post-intervent||859
6579004|NCT01907269|7502897|FG001|COMPLETED|18 Month Outcome Measures Post-intervent||970
6579005|NCT01907269|7502896|FG000|NOT COMPLETED|18 Month Outcome Measures Post-intervent||319
6579006|NCT01907269|7502897|FG001|NOT COMPLETED|18 Month Outcome Measures Post-intervent||280
6579007|NCT01907321|7502903|FG000|STARTED|Overall Study||14
6579008|NCT01907321|7502903|FG000|COMPLETED|Overall Study||12
6579009|NCT01907321|7502903|FG000|NOT COMPLETED|Overall Study||2
6579010|NCT01907334|7502907|FG000|STARTED|Overall Study||6
6579011|NCT01907334|7502908|FG001|STARTED|Overall Study||4
6579012|NCT01907334|7502907|FG000|COMPLETED|Overall Study||6
6579013|NCT01907334|7502908|FG001|COMPLETED|Overall Study||4
6579014|NCT01907334|7502907|FG000|NOT COMPLETED|Overall Study||0
6658573|NCT02480764|7589150|FG000|STARTED|Overall Study||199
6658574|NCT02480764|7589151|FG001|STARTED|Overall Study||209
6658575|NCT02480764|7589152|FG002|STARTED|Overall Study||204
6658576|NCT02480764|7589150|FG000|COMPLETED|Overall Study||189
6658577|NCT02480764|7589151|FG001|COMPLETED|Overall Study||189
6658578|NCT02480764|7589152|FG002|COMPLETED|Overall Study||183
6658579|NCT02480764|7589150|FG000|NOT COMPLETED|Overall Study||10
6658580|NCT02480764|7589151|FG001|NOT COMPLETED|Overall Study||20
6658581|NCT02480764|7589152|FG002|NOT COMPLETED|Overall Study||21
6658582|NCT02480920|7589160|FG000|STARTED|Overall Study||2738
6658583|NCT02480920|7589160|FG000|COMPLETED|Overall Study||2738
6658584|NCT02480920|7589160|FG000|NOT COMPLETED|Overall Study||0
6658585|NCT02480998|7589166|FG000|STARTED|Overall Study||56
6658586|NCT02480998|7589167|FG001|STARTED|Overall Study||28
6658587|NCT02480998|7589166|FG000|COMPLETED|Overall Study||56
6658588|NCT02480998|7589167|FG001|COMPLETED|Overall Study||28
6658589|NCT02480998|7589166|FG000|NOT COMPLETED|Overall Study||0
6658590|NCT02480998|7589167|FG001|NOT COMPLETED|Overall Study||0
6658591|NCT02481050|7589175|FG000|STARTED|Overall Study||58
6658592|NCT02481050|7589175|FG000|COMPLETED|Overall Study||0
6658593|NCT02481050|7589175|FG000|NOT COMPLETED|Overall Study||58
6658594|NCT02481141|7589181|FG000|STARTED|Overall Study||35
6658595|NCT02481141|7589182|FG001|STARTED|Overall Study||18
6658596|NCT02481141|7589181|FG000|COMPLETED|Overall Study||26
6658597|NCT02481141|7589182|FG001|COMPLETED|Overall Study||13
6658598|NCT02481141|7589181|FG000|NOT COMPLETED|Overall Study||9
6579015|NCT01907334|7502908|FG001|NOT COMPLETED|Overall Study||0
6579016|NCT01907490|7502913|FG000|STARTED|Overall Study||38
6579017|NCT01907490|7502913|FG000|COMPLETED|Overall Study||38
6579018|NCT01907490|7502913|FG000|NOT COMPLETED|Overall Study||0
6579019|NCT01907516|7502920|FG000|STARTED|First Intervention (3 Weeks)||50
6579020|NCT01907516|7502921|FG001|STARTED|First Intervention (3 Weeks)||50
6579021|NCT01907516|7502920|FG000|COMPLETED|First Intervention (3 Weeks)||40
6579022|NCT01907516|7502921|FG001|COMPLETED|First Intervention (3 Weeks)||34
6579023|NCT01907516|7502920|FG000|NOT COMPLETED|First Intervention (3 Weeks)||10
6579024|NCT01907516|7502921|FG001|NOT COMPLETED|First Intervention (3 Weeks)||16
6579025|NCT01907516|7502920|FG000|STARTED|Second Intervention (3 Weeks)||40
6579026|NCT01907516|7502921|FG001|STARTED|Second Intervention (3 Weeks)||34
6579027|NCT01907516|7502920|FG000|COMPLETED|Second Intervention (3 Weeks)||40
6579028|NCT01907516|7502921|FG001|COMPLETED|Second Intervention (3 Weeks)||34
6579029|NCT01907516|7502920|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6579030|NCT01907516|7502921|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6579031|NCT01907607|7502928|FG000|STARTED|Overall Study||29
6579032|NCT01907607|7502928|FG000|COMPLETED|Overall Study||29
6579033|NCT01907607|7502928|FG000|NOT COMPLETED|Overall Study||0
6579034|NCT01907737|7502932|FG000|STARTED|Overall Study||22
6579035|NCT01907737|7502932|FG000|COMPLETED|Overall Study||21
6579036|NCT01907737|7502932|FG000|NOT COMPLETED|Overall Study||1
6579037|NCT01907815|7502944|FG000|STARTED|Overall Study||17
6579038|NCT01907815|7502945|FG001|STARTED|Overall Study||7
6579039|NCT01907815|7502944|FG000|COMPLETED|Overall Study||16
6579040|NCT01907815|7502945|FG001|COMPLETED|Overall Study||7
6579041|NCT01907815|7502944|FG000|NOT COMPLETED|Overall Study||1
6579042|NCT01907815|7502945|FG001|NOT COMPLETED|Overall Study||0
6579043|NCT01907828|7502955|FG000|STARTED|Overall Study||39
6579044|NCT01907828|7502956|FG001|STARTED|Overall Study||22
6579045|NCT01907828|7502955|FG000|Underwent Procedure|Overall Study||39
6579046|NCT01907828|7502956|FG001|Underwent Procedure|Overall Study|2 participants terminated early|20
6579047|NCT01907828|7502955|FG000|1-month Follow-up|Overall Study|2 participants terminated early|37
6579048|NCT01907828|7502956|FG001|1-month Follow-up|Overall Study|3 participants terminated early|17
6579049|NCT01907828|7502955|FG000|3-month Follow-up|Overall Study|1 participant terminated early|36
6579050|NCT01907828|7502956|FG001|3-month Follow-up|Overall Study|1 participant terminated early|16
6579051|NCT01907828|7502955|FG000|6-month Follow-up|Overall Study|1 participant terminated early|35
6579052|NCT01907828|7502956|FG001|6-month Follow-up|Overall Study||16
6579053|NCT01907828|7502955|FG000|12-month Follow-up|Overall Study|1 participant terminated early|34
6579054|NCT01907828|7502956|FG001|12-month Follow-up|Overall Study||16
6579055|NCT01907828|7502955|FG000|24-month Follow-up|Overall Study|2 participants terminated early|32
6579056|NCT01907828|7502956|FG001|24-month Follow-up|Overall Study||16
6579057|NCT01907828|7502955|FG000|COMPLETED|Overall Study||32
6579058|NCT01907828|7502956|FG001|COMPLETED|Overall Study||16
6579059|NCT01907828|7502955|FG000|NOT COMPLETED|Overall Study||7
6579060|NCT01907828|7502956|FG001|NOT COMPLETED|Overall Study||6
6579061|NCT01907854|7502964|FG000|STARTED|Overall Study||203
6579062|NCT01907854|7502965|FG001|STARTED|Overall Study||204
6579063|NCT01907854|7502964|FG000|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
6579064|NCT01907854|7502965|FG001|Exposed|Overall Study||204
6579065|NCT01907854|7502964|FG000|COMPLETED|Overall Study||187
6579066|NCT01907854|7502965|FG001|COMPLETED|Overall Study||191
6579067|NCT01907854|7502964|FG000|NOT COMPLETED|Overall Study||16
6579068|NCT01907854|7502965|FG001|NOT COMPLETED|Overall Study||13
6579069|NCT01907906|7502973|FG000|STARTED|Overall Study||16
6579070|NCT01907906|7502974|FG001|STARTED|Overall Study||13
6579071|NCT01907906|7502973|FG000|COMPLETED|Overall Study||12
6579072|NCT01907906|7502974|FG001|COMPLETED|Overall Study||12
6579073|NCT01907906|7502973|FG000|NOT COMPLETED|Overall Study||4
6579074|NCT01907906|7502974|FG001|NOT COMPLETED|Overall Study||1
6579075|NCT01908062|7502984|FG000|STARTED|Overall Study||26
6579076|NCT01908062|7502985|FG001|STARTED|Overall Study||25
6579077|NCT01908062|7502984|FG000|COMPLETED|Overall Study||24
6579078|NCT01908062|7502985|FG001|COMPLETED|Overall Study||22
6579079|NCT01908062|7502984|FG000|NOT COMPLETED|Overall Study||2
6579080|NCT01908062|7502985|FG001|NOT COMPLETED|Overall Study||3
6579081|NCT01908101|7502994|FG000|STARTED|Overall Study||68
6579082|NCT01908101|7502994|FG000|COMPLETED|Overall Study||59
6579083|NCT01908101|7502994|FG000|NOT COMPLETED|Overall Study||9
6579084|NCT01908127|7503000|FG000|STARTED|Overall Study||23
6579085|NCT01908127|7503001|FG001|STARTED|Overall Study||23
6579086|NCT01908127|7503000|FG000|COMPLETED|Overall Study||22
6579087|NCT01908127|7503001|FG001|COMPLETED|Overall Study||23
6579088|NCT01908127|7503000|FG000|NOT COMPLETED|Overall Study||1
6579089|NCT01908127|7503001|FG001|NOT COMPLETED|Overall Study||0
6579090|NCT01908140|7503009|FG000|STARTED|Overall Study||468
6579091|NCT01908140|7503010|FG001|STARTED|Overall Study||465
6579092|NCT01908140|7503009|FG000|COMPLETED|Overall Study||402
6579093|NCT01908140|7503010|FG001|COMPLETED|Overall Study||386
6579094|NCT01908140|7503009|FG000|NOT COMPLETED|Overall Study||66
6579095|NCT01908140|7503010|FG001|NOT COMPLETED|Overall Study||79
6579096|NCT01908205|7503018|FG000|STARTED|Overall Study||30
6579097|NCT01908205|7503019|FG001|STARTED|Overall Study||30
6579098|NCT01908205|7503018|FG000|COMPLETED|Overall Study||25
6579099|NCT01908205|7503019|FG001|COMPLETED|Overall Study||29
6579100|NCT01908205|7503018|FG000|NOT COMPLETED|Overall Study||5
6579101|NCT01908205|7503019|FG001|NOT COMPLETED|Overall Study||1
6579102|NCT01908426|7503040|FG000|STARTED|Overall Study||470
6579103|NCT01908426|7503041|FG001|STARTED|Overall Study||237
6579104|NCT01908426|7503040|FG000|COMPLETED|Overall Study||73
6579105|NCT01908426|7503041|FG001|COMPLETED|Overall Study||26
6579106|NCT01908426|7503040|FG000|NOT COMPLETED|Overall Study||397
6579107|NCT01908426|7503041|FG001|NOT COMPLETED|Overall Study||211
6579108|NCT01908530|7503050|FG000|STARTED|Overall Study||8
6579109|NCT01908530|7503051|FG001|STARTED|Overall Study||8
6579110|NCT01908530|7503052|FG002|STARTED|Overall Study||10
6579111|NCT01908530|7503050|FG000|COMPLETED|Overall Study||8
6579112|NCT01908530|7503051|FG001|COMPLETED|Overall Study||8
6579113|NCT01908530|7503052|FG002|COMPLETED|Overall Study||10
6579114|NCT01908530|7503050|FG000|NOT COMPLETED|Overall Study||0
6579115|NCT01908530|7503051|FG001|NOT COMPLETED|Overall Study||0
6579116|NCT01908530|7503052|FG002|NOT COMPLETED|Overall Study||0
6579117|NCT01908582|7503063|FG000|STARTED|Period 1||26
6579118|NCT01908582|7503063|FG000|Received at Least One Dose of Study Drug|Period 1||26
6579119|NCT01908582|7503063|FG000|COMPLETED|Period 1||26
6579120|NCT01908582|7503063|FG000|NOT COMPLETED|Period 1||0
6579121|NCT01908582|7503063|FG000|STARTED|Period 2||26
6579122|NCT01908582|7503063|FG000|COMPLETED|Period 2||24
6579123|NCT01908582|7503063|FG000|NOT COMPLETED|Period 2||2
6579124|NCT01908634|7503070|FG000|STARTED|Milk-based Strawberry Beverage With Meal||10
6579125|NCT01908634|7503070|FG000|COMPLETED|Milk-based Strawberry Beverage With Meal||10
6579126|NCT01908634|7503070|FG000|NOT COMPLETED|Milk-based Strawberry Beverage With Meal||0
6579127|NCT01908634|7503070|FG000|STARTED|Water-based Strawberry Beverage Wit Meal||10
6579128|NCT01908634|7503070|FG000|COMPLETED|Water-based Strawberry Beverage Wit Meal||9
6579129|NCT01908634|7503070|FG000|NOT COMPLETED|Water-based Strawberry Beverage Wit Meal||1
6579130|NCT01908634|7503070|FG000|STARTED|Milk-based Strawberry Beverage w/o Meal||9
6579131|NCT01908634|7503070|FG000|COMPLETED|Milk-based Strawberry Beverage w/o Meal||4
6579132|NCT01908634|7503070|FG000|NOT COMPLETED|Milk-based Strawberry Beverage w/o Meal||5
6579133|NCT01908634|7503070|FG000|STARTED|Water-based Strawberry Beverage w/o Meal||4
6579134|NCT01908634|7503070|FG000|COMPLETED|Water-based Strawberry Beverage w/o Meal||4
6579135|NCT01908634|7503070|FG000|NOT COMPLETED|Water-based Strawberry Beverage w/o Meal||0
6579136|NCT01908699|7503080|FG000|STARTED|Overall Study||137
6579137|NCT01908699|7503081|FG001|STARTED|Overall Study||136
6579138|NCT01908699|7503080|FG000|Received at Least 1 Dose of Study Drug|Overall Study||136
6579139|NCT01908699|7503081|FG001|Received at Least 1 Dose of Study Drug|Overall Study||135
6579140|NCT01908699|7503080|FG000|COMPLETED|Overall Study||62
6579141|NCT01908699|7503081|FG001|COMPLETED|Overall Study||58
6579142|NCT01908699|7503080|FG000|NOT COMPLETED|Overall Study||75
6579143|NCT01908699|7503081|FG001|NOT COMPLETED|Overall Study||78
6579144|NCT01908751|7503091|FG000|STARTED|Overall Study||22
6579145|NCT01908751|7503092|FG001|STARTED|Overall Study||23
6579146|NCT01908751|7503093|FG002|STARTED|Overall Study||21
6579147|NCT01908751|7503094|FG003|STARTED|Overall Study||20
6579148|NCT01908751|7503091|FG000|COMPLETED|Overall Study||17
6579149|NCT01908751|7503092|FG001|COMPLETED|Overall Study||18
6579150|NCT01908751|7503093|FG002|COMPLETED|Overall Study||16
6579151|NCT01908751|7503094|FG003|COMPLETED|Overall Study||16
6579152|NCT01908751|7503091|FG000|NOT COMPLETED|Overall Study||5
6579153|NCT01908751|7503092|FG001|NOT COMPLETED|Overall Study||5
6579154|NCT01908751|7503093|FG002|NOT COMPLETED|Overall Study||5
6579155|NCT01908751|7503094|FG003|NOT COMPLETED|Overall Study||4
6624101|NCT02213666|7551412|FG000|STARTED|Overall Study||72
6624102|NCT02213666|7551412|FG000|COMPLETED|Overall Study||71
6624103|NCT02213666|7551412|FG000|NOT COMPLETED|Overall Study||1
6624104|NCT02213900|7551418|FG000|STARTED|Overall Study||68
6624105|NCT02213900|7551419|FG001|STARTED|Overall Study||67
6624106|NCT02213900|7551418|FG000|COMPLETED|Overall Study||68
6624107|NCT02213900|7551419|FG001|COMPLETED|Overall Study||67
6624108|NCT02213900|7551418|FG000|NOT COMPLETED|Overall Study||0
6624109|NCT02213900|7551419|FG001|NOT COMPLETED|Overall Study||0
6624110|NCT02214017|7551427|FG000|STARTED|Overall Study||22
6624111|NCT02214017|7551428|FG001|STARTED|Overall Study||18
6624112|NCT02214017|7551427|FG000|COMPLETED|Overall Study||22
6624113|NCT02214017|7551428|FG001|COMPLETED|Overall Study||18
6624114|NCT02214017|7551427|FG000|NOT COMPLETED|Overall Study||0
6624115|NCT02214017|7551428|FG001|NOT COMPLETED|Overall Study||0
6624116|NCT02214121|7551437|FG000|STARTED|Part A||46
6624117|NCT02214121|7551438|FG001|STARTED|Part A||0
6624118|NCT02214121|7551439|FG002|STARTED|Part A||0
6624119|NCT02214121|7551437|FG000|COMPLETED|Part A||39
6624120|NCT02214121|7551438|FG001|COMPLETED|Part A||0
6624121|NCT02214121|7551439|FG002|COMPLETED|Part A||0
6624122|NCT02214121|7551437|FG000|NOT COMPLETED|Part A||7
6624123|NCT02214121|7551438|FG001|NOT COMPLETED|Part A||0
6624124|NCT02214121|7551439|FG002|NOT COMPLETED|Part A||0
6624125|NCT02214121|7551437|FG000|STARTED|Part B||0
6624126|NCT02214121|7551438|FG001|STARTED|Part B||17
6624127|NCT02214121|7551439|FG002|STARTED|Part B||8
6624128|NCT02214121|7551437|FG000|COMPLETED|Part B||0
6624129|NCT02214121|7551438|FG001|COMPLETED|Part B||14
6624130|NCT02214121|7551439|FG002|COMPLETED|Part B||7
6624131|NCT02214121|7551437|FG000|NOT COMPLETED|Part B||0
6624132|NCT02214121|7551438|FG001|NOT COMPLETED|Part B||3
6624133|NCT02214121|7551439|FG002|NOT COMPLETED|Part B||1
6624134|NCT02214147|7551462|FG000|STARTED|Overall Study||16
6624135|NCT02214147|7551463|FG001|STARTED|Overall Study||12
6624136|NCT02214147|7551464|FG002|STARTED|Overall Study||8
6624137|NCT02214147|7551462|FG000|COMPLETED|Overall Study||16
6579156|NCT01908803|7503106|FG000|STARTED|Overall Study||46
6579157|NCT01908803|7503107|FG001|STARTED|Overall Study||24
6579158|NCT01908803|7503106|FG000|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
6579159|NCT01908803|7503107|FG001|Treated|Overall Study||24
6579160|NCT01908803|7503106|FG000|COMPLETED|Overall Study||42
6579161|NCT01908803|7503107|FG001|COMPLETED|Overall Study||23
6579162|NCT01908803|7503106|FG000|NOT COMPLETED|Overall Study||4
6579163|NCT01908803|7503107|FG001|NOT COMPLETED|Overall Study||1
6579164|NCT01908816|7503118|FG000|STARTED|Overall Study||93
6579165|NCT01908816|7503119|FG001|STARTED|Overall Study||84
6579166|NCT01908816|7503120|FG002|STARTED|Overall Study||58
6579167|NCT01908816|7503121|FG003|STARTED|Overall Study||35
6579168|NCT01908816|7503118|FG000|COMPLETED|Overall Study||0
6579169|NCT01908816|7503119|FG001|COMPLETED|Overall Study||0
6579170|NCT01908816|7503120|FG002|COMPLETED|Overall Study||0
6579171|NCT01908816|7503121|FG003|COMPLETED|Overall Study||0
6579172|NCT01908816|7503118|FG000|NOT COMPLETED|Overall Study||93
6579173|NCT01908816|7503119|FG001|NOT COMPLETED|Overall Study||84
6579174|NCT01908816|7503120|FG002|NOT COMPLETED|Overall Study||58
6579175|NCT01908816|7503121|FG003|NOT COMPLETED|Overall Study||35
6579176|NCT01908829|7503137|FG000|STARTED|Overall Study||727
6579177|NCT01908829|7503138|FG001|STARTED|Overall Study||728
6579178|NCT01908829|7503139|FG002|STARTED|Overall Study||719
6579179|NCT01908829|7503137|FG000|Treated With Double-blind Drug|Overall Study||725
6579180|NCT01908829|7503138|FG001|Treated With Double-blind Drug|Overall Study||728
6579181|NCT01908829|7503139|FG002|Treated With Double-blind Drug|Overall Study||719
6579182|NCT01908829|7503137|FG000|COMPLETED|Overall Study||678
6579183|NCT01908829|7503138|FG001|COMPLETED|Overall Study||679
6579184|NCT01908829|7503139|FG002|COMPLETED|Overall Study||680
6579185|NCT01908829|7503137|FG000|NOT COMPLETED|Overall Study||49
6579186|NCT01908829|7503138|FG001|NOT COMPLETED|Overall Study||49
6579187|NCT01908829|7503139|FG002|NOT COMPLETED|Overall Study||39
6579188|NCT01908842|7503149|FG000|STARTED|Induction||383
6579189|NCT01908842|7503150|FG001|STARTED|Induction||375
6579190|NCT01908842|7503149|FG000|COMPLETED|Induction||357
6579191|NCT01908842|7503150|FG001|COMPLETED|Induction||344
6579192|NCT01908842|7503149|FG000|NOT COMPLETED|Induction||26
6579193|NCT01908842|7503150|FG001|NOT COMPLETED|Induction||31
6579194|NCT01908842|7503149|FG000|STARTED|Switch to Other BNX Formulation (Day 15)||357
6579195|NCT01908842|7503150|FG001|STARTED|Switch to Other BNX Formulation (Day 15)||344
6579196|NCT01908842|7503149|FG000|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
6579197|NCT01908842|7503150|FG001|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
6579198|NCT01908842|7503149|FG000|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
6579199|NCT01908842|7503150|FG001|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
6579200|NCT01908842|7503149|FG000|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
6579201|NCT01908842|7503150|FG001|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
6579202|NCT01908842|7503149|FG000|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
6579203|NCT01908842|7503150|FG001|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
6579204|NCT01908842|7503149|FG000|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
6579205|NCT01908842|7503150|FG001|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
6579206|NCT01908907|7503158|FG000|STARTED|Overall Study||31
6579207|NCT01908907|7503159|FG001|STARTED|Overall Study||29
6579208|NCT01908907|7503158|FG000|COMPLETED|Overall Study||29
6579209|NCT01908907|7503159|FG001|COMPLETED|Overall Study||29
6579210|NCT01908907|7503158|FG000|NOT COMPLETED|Overall Study||2
6579211|NCT01908907|7503159|FG001|NOT COMPLETED|Overall Study||0
6579212|NCT01908972|7503171|FG000|STARTED|Overall Study||17
6579213|NCT01908972|7503172|FG001|STARTED|Overall Study||17
6579214|NCT01908972|7503171|FG000|COMPLETED|Overall Study||15
6579215|NCT01908972|7503172|FG001|COMPLETED|Overall Study||17
6579216|NCT01908972|7503171|FG000|NOT COMPLETED|Overall Study||2
6579217|NCT01908972|7503172|FG001|NOT COMPLETED|Overall Study||0
6579218|NCT01909011|7503180|FG000|STARTED|Overall Study||7
6579219|NCT01909011|7503181|FG001|STARTED|Overall Study||9
6579220|NCT01909011|7503180|FG000|COMPLETED|Overall Study||7
6579221|NCT01909011|7503181|FG001|COMPLETED|Overall Study||9
6579222|NCT01909011|7503180|FG000|NOT COMPLETED|Overall Study||0
6579223|NCT01909011|7503181|FG001|NOT COMPLETED|Overall Study||0
6579224|NCT01909141|7503189|FG000|STARTED|Overall Study||50
6579225|NCT01909141|7503190|FG001|STARTED|Overall Study||50
6579226|NCT01909141|7503189|FG000|COMPLETED|Overall Study||50
6579227|NCT01909141|7503190|FG001|COMPLETED|Overall Study||50
6579228|NCT01909141|7503189|FG000|NOT COMPLETED|Overall Study||0
6579229|NCT01909141|7503190|FG001|NOT COMPLETED|Overall Study||0
6579230|NCT01909154|7503198|FG000|STARTED|Overall Study||12
6579231|NCT01909154|7503198|FG000|COMPLETED|Overall Study||12
6579232|NCT01909154|7503198|FG000|NOT COMPLETED|Overall Study||0
6579233|NCT01909180|7503202|FG000|STARTED|Overall Study||49
6579234|NCT01909180|7503202|FG000|COMPLETED|Overall Study||49
6579235|NCT01909180|7503202|FG000|NOT COMPLETED|Overall Study||0
6579236|NCT01909336|7503211|FG000|STARTED|Overall Study||53
6579237|NCT01909336|7503212|FG001|STARTED|Overall Study||53
6579238|NCT01909336|7503213|FG002|STARTED|Overall Study||55
6579239|NCT01909336|7503211|FG000|COMPLETED|Overall Study||49
6579240|NCT01909336|7503212|FG001|COMPLETED|Overall Study||50
6579241|NCT01909336|7503213|FG002|COMPLETED|Overall Study||52
6579242|NCT01909336|7503211|FG000|NOT COMPLETED|Overall Study||4
6579243|NCT01909336|7503212|FG001|NOT COMPLETED|Overall Study||3
6579244|NCT01909336|7503213|FG002|NOT COMPLETED|Overall Study||3
6579245|NCT01909466|7503221|FG000|STARTED|Overall Study||68
6579246|NCT01909466|7503222|FG001|STARTED|Overall Study||73
6579247|NCT01909466|7503221|FG000|COMPLETED|Overall Study||46
6579248|NCT01909466|7503222|FG001|COMPLETED|Overall Study||50
6579249|NCT01909466|7503221|FG000|NOT COMPLETED|Overall Study||22
6579250|NCT01909466|7503222|FG001|NOT COMPLETED|Overall Study||23
6579251|NCT01909674|7503228|FG000|STARTED|Overall Study||12
6579252|NCT01909674|7503229|FG001|STARTED|Overall Study||9
6579253|NCT01909674|7503228|FG000|COMPLETED|Overall Study||7
6579254|NCT01909674|7503229|FG001|COMPLETED|Overall Study||7
6579255|NCT01909674|7503228|FG000|NOT COMPLETED|Overall Study||5
6579256|NCT01909674|7503229|FG001|NOT COMPLETED|Overall Study||2
6579257|NCT01909713|7503235|FG000|STARTED|Overall Study||35
6579258|NCT01909713|7503235|FG000|COMPLETED|Overall Study||35
6579259|NCT01909713|7503235|FG000|NOT COMPLETED|Overall Study||0
6579260|NCT01909778|7503260|FG000|STARTED|Overall Study||2
6579261|NCT01909778|7503260|FG000|COMPLETED|Overall Study||1
6579262|NCT01909778|7503260|FG000|NOT COMPLETED|Overall Study||1
6579263|NCT01909791|7503269|FG000|STARTED|Overall Study||226
6579264|NCT01909791|7503270|FG001|STARTED|Overall Study||240
6579265|NCT01909791|7503271|FG002|STARTED|Overall Study||236
6579266|NCT01909791|7503269|FG000|COMPLETED|Overall Study||205
6579267|NCT01909791|7503270|FG001|COMPLETED|Overall Study||212
6579268|NCT01909791|7503271|FG002|COMPLETED|Overall Study||208
6579269|NCT01909791|7503269|FG000|NOT COMPLETED|Overall Study||21
6579270|NCT01909791|7503270|FG001|NOT COMPLETED|Overall Study||28
6579271|NCT01909791|7503271|FG002|NOT COMPLETED|Overall Study||28
6579272|NCT01909804|7503296|FG000|STARTED|Overall Study||26
6579273|NCT01909804|7503297|FG001|STARTED|Overall Study||28
6579274|NCT01909804|7503298|FG002|STARTED|Overall Study||27
6579275|NCT01909804|7503299|FG003|STARTED|Overall Study||26
6579276|NCT01909804|7503300|FG004|STARTED|Overall Study||26
6579277|NCT01909804|7503301|FG005|STARTED|Overall Study||25
6579278|NCT01909804|7503302|FG006|STARTED|Overall Study||27
6579279|NCT01909804|7503303|FG007|STARTED|Overall Study||26
6579280|NCT01909804|7503304|FG008|STARTED|Overall Study||27
6579281|NCT01909804|7503305|FG009|STARTED|Overall Study||29
6579282|NCT01909804|7503306|FG010|STARTED|Overall Study||27
6579283|NCT01909804|7503307|FG011|STARTED|Overall Study||29
6579284|NCT01909804|7503296|FG000|COMPLETED|Overall Study||22
6579285|NCT01909804|7503297|FG001|COMPLETED|Overall Study||27
6579286|NCT01909804|7503298|FG002|COMPLETED|Overall Study||27
6579287|NCT01909804|7503299|FG003|COMPLETED|Overall Study||26
6579288|NCT01909804|7503300|FG004|COMPLETED|Overall Study||18
6579289|NCT01909804|7503301|FG005|COMPLETED|Overall Study||21
6579290|NCT01909804|7503302|FG006|COMPLETED|Overall Study||25
6579291|NCT01909804|7503303|FG007|COMPLETED|Overall Study||25
6579292|NCT01909804|7503304|FG008|COMPLETED|Overall Study||27
6579293|NCT01909804|7503305|FG009|COMPLETED|Overall Study||28
6579294|NCT01909804|7503306|FG010|COMPLETED|Overall Study||26
6579295|NCT01909804|7503307|FG011|COMPLETED|Overall Study||26
6579296|NCT01909804|7503296|FG000|NOT COMPLETED|Overall Study||4
6579297|NCT01909804|7503297|FG001|NOT COMPLETED|Overall Study||1
6579298|NCT01909804|7503298|FG002|NOT COMPLETED|Overall Study||0
6579299|NCT01909804|7503299|FG003|NOT COMPLETED|Overall Study||0
6579300|NCT01909804|7503300|FG004|NOT COMPLETED|Overall Study||8
6579301|NCT01909804|7503301|FG005|NOT COMPLETED|Overall Study||4
6579302|NCT01909804|7503302|FG006|NOT COMPLETED|Overall Study||2
6579303|NCT01909804|7503303|FG007|NOT COMPLETED|Overall Study||1
6579304|NCT01909804|7503304|FG008|NOT COMPLETED|Overall Study||0
6579305|NCT01909804|7503305|FG009|NOT COMPLETED|Overall Study||1
6579306|NCT01909804|7503306|FG010|NOT COMPLETED|Overall Study||1
6579307|NCT01909804|7503307|FG011|NOT COMPLETED|Overall Study||3
6579308|NCT01909973|7503331|FG000|STARTED|Overall Study||8
6579309|NCT01909973|7503332|FG001|STARTED|Overall Study||7
6579310|NCT01909973|7503331|FG000|COMPLETED|Overall Study||7
6579311|NCT01909973|7503332|FG001|COMPLETED|Overall Study||7
6579312|NCT01909973|7503331|FG000|NOT COMPLETED|Overall Study||1
6579313|NCT01909973|7503332|FG001|NOT COMPLETED|Overall Study||0
6579314|NCT01910064|7503338|FG000|STARTED|Overall Study||436
6579315|NCT01910064|7503338|FG000|COMPLETED|Overall Study||391
6579316|NCT01910064|7503338|FG000|NOT COMPLETED|Overall Study||45
6579317|NCT01910116|7503344|FG000|STARTED|Overall Study||110
6579318|NCT01910116|7503345|FG001|STARTED|Overall Study||110
6579319|NCT01910116|7503344|FG000|Week 4|Overall Study||106
6579320|NCT01910116|7503345|FG001|Week 4|Overall Study||102
6658599|NCT02481141|7589182|FG001|NOT COMPLETED|Overall Study||5
6658600|NCT02481206|7589211|FG000|STARTED|Overall Study||34
6658601|NCT02481206|7589212|FG001|STARTED|Overall Study||32
6579321|NCT01910116|7503344|FG000|Week 8|Overall Study||98
6579322|NCT01910116|7503345|FG001|Week 8|Overall Study||99
6579323|NCT01910116|7503344|FG000|Week 12|Overall Study||97
6579324|NCT01910116|7503345|FG001|Week 12|Overall Study||96
6579325|NCT01910116|7503344|FG000|Week 16|Overall Study||96
6579326|NCT01910116|7503345|FG001|Week 16|Overall Study||94
6579327|NCT01910116|7503344|FG000|COMPLETED|Overall Study||96
6579328|NCT01910116|7503345|FG001|COMPLETED|Overall Study||94
6579329|NCT01910116|7503344|FG000|NOT COMPLETED|Overall Study||14
6579330|NCT01910116|7503345|FG001|NOT COMPLETED|Overall Study||16
6579331|NCT01910129|7503353|FG000|STARTED|Run-in Period Phase 1||0
6579332|NCT01910129|7503354|FG001|STARTED|Run-in Period Phase 1||0
6579333|NCT01910129|7503355|FG002|STARTED|Run-in Period Phase 1||13
6579334|NCT01910129|7503353|FG000|COMPLETED|Run-in Period Phase 1||0
6658602|NCT02481206|7589211|FG000|COMPLETED|Overall Study||29
6579335|NCT01910129|7503354|FG001|COMPLETED|Run-in Period Phase 1||0
6579336|NCT01910129|7503355|FG002|COMPLETED|Run-in Period Phase 1||13
6579337|NCT01910129|7503353|FG000|NOT COMPLETED|Run-in Period Phase 1||0
6579338|NCT01910129|7503354|FG001|NOT COMPLETED|Run-in Period Phase 1||0
6579339|NCT01910129|7503355|FG002|NOT COMPLETED|Run-in Period Phase 1||0
6579340|NCT01910129|7503353|FG000|STARTED|Randomized Phase 2||7
6579341|NCT01910129|7503354|FG001|STARTED|Randomized Phase 2||6
6579342|NCT01910129|7503355|FG002|STARTED|Randomized Phase 2||0
6579343|NCT01910129|7503353|FG000|COMPLETED|Randomized Phase 2||5
6579344|NCT01910129|7503354|FG001|COMPLETED|Randomized Phase 2||5
6579345|NCT01910129|7503355|FG002|COMPLETED|Randomized Phase 2||0
6579346|NCT01910129|7503353|FG000|NOT COMPLETED|Randomized Phase 2||2
6579347|NCT01910129|7503354|FG001|NOT COMPLETED|Randomized Phase 2||1
6579348|NCT01910129|7503355|FG002|NOT COMPLETED|Randomized Phase 2||0
6579349|NCT01910129|7503353|FG000|STARTED|Randomized Phase 3||5
6579350|NCT01910129|7503354|FG001|STARTED|Randomized Phase 3||5
6579351|NCT01910129|7503355|FG002|STARTED|Randomized Phase 3||0
6579352|NCT01910129|7503353|FG000|COMPLETED|Randomized Phase 3||5
6579353|NCT01910129|7503354|FG001|COMPLETED|Randomized Phase 3||4
6579354|NCT01910129|7503355|FG002|COMPLETED|Randomized Phase 3||0
6579355|NCT01910129|7503353|FG000|NOT COMPLETED|Randomized Phase 3||0
6579356|NCT01910129|7503354|FG001|NOT COMPLETED|Randomized Phase 3||1
6579357|NCT01910129|7503355|FG002|NOT COMPLETED|Randomized Phase 3||0
6579358|NCT01910181|7503373|FG000|STARTED|Overall Study||46
6579359|NCT01910181|7503373|FG000|PK Cohort|Overall Study||20
6579360|NCT01910181|7503373|FG000|Expansion Cohort|Overall Study||26
6579361|NCT01910181|7503373|FG000|COMPLETED|Overall Study||0
6579362|NCT01910181|7503373|FG000|NOT COMPLETED|Overall Study||46
6579363|NCT01910298|7503380|FG000|STARTED|Overall Study||76
6579364|NCT01910298|7503381|FG001|STARTED|Overall Study||55
6579365|NCT01910298|7503380|FG000|Safety Set|Overall Study||76
6579366|NCT01910298|7503381|FG001|Safety Set|Overall Study|4 participants did not have first surgery date and were not included in Safety Set.|51
6579367|NCT01910298|7503380|FG000|COMPLETED|Overall Study||71
6579368|NCT01910298|7503381|FG001|COMPLETED|Overall Study||23
6579369|NCT01910298|7503380|FG000|NOT COMPLETED|Overall Study||5
6579370|NCT01910298|7503381|FG001|NOT COMPLETED|Overall Study||32
6579371|NCT01910311|7503387|FG000|STARTED|Period 1 (Days 1-2)||18
6579372|NCT01910311|7503387|FG000|Received Baricitinib|Period 1 (Days 1-2)||18
6579373|NCT01910311|7503387|FG000|COMPLETED|Period 1 (Days 1-2)||18
6579374|NCT01910311|7503387|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
6579375|NCT01910311|7503387|FG000|STARTED|Period 2 (Days 3-32)||18
6579376|NCT01910311|7503387|FG000|Received Baricitinib|Period 2 (Days 3-32)||18
6579377|NCT01910311|7503387|FG000|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
6579378|NCT01910311|7503387|FG000|COMPLETED|Period 2 (Days 3-32)||18
6579379|NCT01910311|7503387|FG000|NOT COMPLETED|Period 2 (Days 3-32)||0
6579380|NCT01910519|7503397|FG000|STARTED|Overall Study||35
6579381|NCT01910519|7503398|FG001|STARTED|Overall Study||15
6579382|NCT01910519|7503397|FG000|COMPLETED|Overall Study||31
6579383|NCT01910519|7503398|FG001|COMPLETED|Overall Study||15
6579384|NCT01910519|7503397|FG000|NOT COMPLETED|Overall Study||4
6579385|NCT01910519|7503398|FG001|NOT COMPLETED|Overall Study||0
6579386|NCT01910636|7503406|FG000|STARTED|Overall Study||90
6579387|NCT01910636|7503407|FG001|STARTED|Overall Study||63
6579388|NCT01910636|7503406|FG000|COMPLETED|Overall Study||90
6579389|NCT01910636|7503407|FG001|COMPLETED|Overall Study||63
6579390|NCT01910636|7503406|FG000|NOT COMPLETED|Overall Study||0
6579391|NCT01910636|7503407|FG001|NOT COMPLETED|Overall Study||0
6579392|NCT01910688|7503413|FG000|STARTED|Overall Study||25
6579393|NCT01910688|7503413|FG000|3.5month|Overall Study||25
6579394|NCT01910688|7503413|FG000|2nd RFA Treatment|Overall Study||22
6579395|NCT01910688|7503413|FG000|7.5months|Overall Study||24
6579396|NCT01910688|7503413|FG000|3rd RFA Treatment|Overall Study||18
6579397|NCT01910688|7503413|FG000|12months|Overall Study||22
6579398|NCT01910688|7503413|FG000|COMPLETED|Overall Study||20
6579399|NCT01910688|7503413|FG000|NOT COMPLETED|Overall Study||5
6579400|NCT01910792|7503419|FG000|STARTED|Overall Study||9
6579401|NCT01910792|7503420|FG001|STARTED|Overall Study||10
6579402|NCT01910792|7503419|FG000|COMPLETED|Overall Study||9
6579403|NCT01910792|7503420|FG001|COMPLETED|Overall Study||10
6579404|NCT01910792|7503419|FG000|NOT COMPLETED|Overall Study||0
6579405|NCT01910792|7503420|FG001|NOT COMPLETED|Overall Study||0
6579406|NCT01910831|7503426|FG000|STARTED|Overall Study||20
6579407|NCT01910831|7503426|FG000|COMPLETED|Overall Study||19
6579408|NCT01910831|7503426|FG000|NOT COMPLETED|Overall Study||1
6579409|NCT01911065|7503433|FG000|STARTED|Overall Study||45
6579410|NCT01911065|7503434|FG001|STARTED|Overall Study||9
6579411|NCT01911065|7503433|FG000|COMPLETED|Overall Study||45
6579412|NCT01911065|7503434|FG001|COMPLETED|Overall Study||9
6579413|NCT01911065|7503433|FG000|NOT COMPLETED|Overall Study||0
6579414|NCT01911065|7503434|FG001|NOT COMPLETED|Overall Study||0
6579415|NCT01911169|7503442|FG000|STARTED|Overall Study||6
6579416|NCT01911169|7503443|FG001|STARTED|Overall Study||3
6579417|NCT01911169|7503442|FG000|COMPLETED|Overall Study||6
6579418|NCT01911169|7503443|FG001|COMPLETED|Overall Study||3
6579419|NCT01911169|7503442|FG000|NOT COMPLETED|Overall Study||0
6579420|NCT01911169|7503443|FG001|NOT COMPLETED|Overall Study||0
6579421|NCT01911221|7503449|FG000|STARTED|Overall Study||13
6579422|NCT01911221|7503449|FG000|COMPLETED|Overall Study||13
6579423|NCT01911221|7503449|FG000|NOT COMPLETED|Overall Study||0
6579424|NCT01911260|7503457|FG000|STARTED|Supplementation Period||50
6579425|NCT01911260|7503458|FG001|STARTED|Supplementation Period||50
6579426|NCT01911260|7503459|FG002|STARTED|Supplementation Period||49
6579427|NCT01911260|7503460|FG003|STARTED|Supplementation Period||50
6579428|NCT01911260|7503457|FG000|COMPLETED|Supplementation Period||40
6579429|NCT01911260|7503458|FG001|COMPLETED|Supplementation Period||38
6579430|NCT01911260|7503459|FG002|COMPLETED|Supplementation Period||39
6579431|NCT01911260|7503460|FG003|COMPLETED|Supplementation Period||42
6579432|NCT01911260|7503457|FG000|NOT COMPLETED|Supplementation Period||10
6579433|NCT01911260|7503458|FG001|NOT COMPLETED|Supplementation Period||12
6579434|NCT01911260|7503459|FG002|NOT COMPLETED|Supplementation Period||10
6579435|NCT01911260|7503460|FG003|NOT COMPLETED|Supplementation Period||8
6579436|NCT01911260|7503457|FG000|STARTED|Follow-up Period||40
6579437|NCT01911260|7503458|FG001|STARTED|Follow-up Period||38
6579438|NCT01911260|7503459|FG002|STARTED|Follow-up Period||39
6579439|NCT01911260|7503460|FG003|STARTED|Follow-up Period||42
6579440|NCT01911260|7503457|FG000|COMPLETED|Follow-up Period||27
6579441|NCT01911260|7503458|FG001|COMPLETED|Follow-up Period||18
6579442|NCT01911260|7503459|FG002|COMPLETED|Follow-up Period||24
6579443|NCT01911260|7503460|FG003|COMPLETED|Follow-up Period||30
6579444|NCT01911260|7503457|FG000|NOT COMPLETED|Follow-up Period||13
6579445|NCT01911260|7503458|FG001|NOT COMPLETED|Follow-up Period||20
6579446|NCT01911260|7503459|FG002|NOT COMPLETED|Follow-up Period||15
6579447|NCT01911260|7503460|FG003|NOT COMPLETED|Follow-up Period||12
6579448|NCT01911273|7503472|FG000|STARTED|Overall Study||1
6579449|NCT01911273|7503473|FG001|STARTED|Overall Study||2
6579450|NCT01911273|7503472|FG000|COMPLETED|Overall Study||0
6579451|NCT01911273|7503473|FG001|COMPLETED|Overall Study||0
6579452|NCT01911273|7503472|FG000|NOT COMPLETED|Overall Study||1
6579453|NCT01911273|7503473|FG001|NOT COMPLETED|Overall Study||2
6579454|NCT01911351|7503481|FG000|STARTED|Overall Study||39
6579455|NCT01911351|7503482|FG001|STARTED|Overall Study||43
6579456|NCT01911351|7503481|FG000|COMPLETED|Overall Study||39
6579457|NCT01911351|7503482|FG001|COMPLETED|Overall Study||43
6579458|NCT01911351|7503481|FG000|NOT COMPLETED|Overall Study||0
6579459|NCT01911351|7503482|FG001|NOT COMPLETED|Overall Study||0
6579460|NCT01911390|7503492|FG000|STARTED|Overall Study||10
6579461|NCT01911390|7503493|FG001|STARTED|Overall Study||10
6579462|NCT01911390|7503494|FG002|STARTED|Overall Study||10
6579463|NCT01911390|7503495|FG003|STARTED|Overall Study||11
6579464|NCT01911390|7503492|FG000|COMPLETED|Overall Study||9
6579465|NCT01911390|7503493|FG001|COMPLETED|Overall Study||10
6579466|NCT01911390|7503494|FG002|COMPLETED|Overall Study||9
6579467|NCT01911390|7503495|FG003|COMPLETED|Overall Study||10
6579468|NCT01911390|7503492|FG000|NOT COMPLETED|Overall Study||1
6579469|NCT01911390|7503493|FG001|NOT COMPLETED|Overall Study||0
6658603|NCT02481206|7589212|FG001|COMPLETED|Overall Study||31
6658604|NCT02481206|7589211|FG000|NOT COMPLETED|Overall Study||5
6658605|NCT02481206|7589212|FG001|NOT COMPLETED|Overall Study||1
6658606|NCT02481219|7589222|FG000|STARTED|Overall Study||60
6658607|NCT02481219|7589223|FG001|STARTED|Overall Study||62
6658608|NCT02481219|7589222|FG000|COMPLETED|Overall Study||58
6658609|NCT02481219|7589223|FG001|COMPLETED|Overall Study||61
6658610|NCT02481219|7589222|FG000|NOT COMPLETED|Overall Study||2
6658611|NCT02481219|7589223|FG001|NOT COMPLETED|Overall Study||1
6658612|NCT02481258|7589235|FG000|STARTED|Overall Study||12
6658613|NCT02481258|7589236|FG001|STARTED|Overall Study||11
6658614|NCT02481258|7589235|FG000|COMPLETED|Overall Study||12
6658615|NCT02481258|7589236|FG001|COMPLETED|Overall Study||11
6658616|NCT02481258|7589235|FG000|NOT COMPLETED|Overall Study||0
6658617|NCT02481258|7589236|FG001|NOT COMPLETED|Overall Study||0
6658618|NCT02481297|7589246|FG000|STARTED|Overall Study||1
6658619|NCT02481297|7589247|FG001|STARTED|Overall Study||6
6658620|NCT02481297|7589246|FG000|COMPLETED|Overall Study||1
6658621|NCT02481297|7589247|FG001|COMPLETED|Overall Study||6
6658622|NCT02481297|7589246|FG000|NOT COMPLETED|Overall Study||0
6658623|NCT02481297|7589247|FG001|NOT COMPLETED|Overall Study||0
6658624|NCT02481375|7589257|FG000|STARTED|Overall Study||206
6658625|NCT02481375|7589258|FG001|STARTED|Overall Study||202
6658626|NCT02481375|7589259|FG002|STARTED|Overall Study||201
6658627|NCT02481375|7589260|FG003|STARTED|Overall Study||200
6658628|NCT02481375|7589257|FG000|COMPLETED|Overall Study||192
6658629|NCT02481375|7589258|FG001|COMPLETED|Overall Study||191
6658630|NCT02481375|7589259|FG002|COMPLETED|Overall Study||191
6658631|NCT02481375|7589260|FG003|COMPLETED|Overall Study||186
6658632|NCT02481375|7589257|FG000|NOT COMPLETED|Overall Study||14
6658633|NCT02481375|7589258|FG001|NOT COMPLETED|Overall Study||11
6658634|NCT02481375|7589259|FG002|NOT COMPLETED|Overall Study||10
6658635|NCT02481375|7589260|FG003|NOT COMPLETED|Overall Study||14
6658636|NCT02481440|7589270|FG000|STARTED|Overall Study||102
6658637|NCT02481440|7589270|FG000|COMPLETED|Overall Study||41
6658638|NCT02481440|7589270|FG000|NOT COMPLETED|Overall Study||61
6658639|NCT02481505|7589277|FG000|STARTED|Overall Study||15
6658640|NCT02481505|7589278|FG001|STARTED|Overall Study||15
6658641|NCT02481505|7589279|FG002|STARTED|Overall Study||15
6658642|NCT02481505|7589277|FG000|COMPLETED|Overall Study||15
6658643|NCT02481505|7589278|FG001|COMPLETED|Overall Study||15
6579470|NCT01911390|7503494|FG002|NOT COMPLETED|Overall Study||1
6658644|NCT02481505|7589279|FG002|COMPLETED|Overall Study||15
6658645|NCT02481505|7589277|FG000|NOT COMPLETED|Overall Study||0
6658646|NCT02481505|7589278|FG001|NOT COMPLETED|Overall Study||0
6658647|NCT02481505|7589279|FG002|NOT COMPLETED|Overall Study||0
6658648|NCT02481557|7589289|FG000|STARTED|Overall Study||17
6579471|NCT01911390|7503495|FG003|NOT COMPLETED|Overall Study||1
6579472|NCT01911403|7503507|FG000|STARTED|Overall Study||61
6579473|NCT01911403|7503508|FG001|STARTED|Overall Study||62
6579474|NCT01911403|7503507|FG000|COMPLETED|Overall Study||52
6579475|NCT01911403|7503508|FG001|COMPLETED|Overall Study||59
6579476|NCT01911403|7503507|FG000|NOT COMPLETED|Overall Study||9
6658649|NCT02481557|7589290|FG001|STARTED|Overall Study||19
6658650|NCT02481557|7589289|FG000|COMPLETED|Overall Study||17
6658651|NCT02481557|7589290|FG001|COMPLETED|Overall Study||19
6658652|NCT02481557|7589289|FG000|NOT COMPLETED|Overall Study||0
6658653|NCT02481557|7589290|FG001|NOT COMPLETED|Overall Study||0
6658654|NCT02481596|7589299|FG000|STARTED|Overall Study||126
6658655|NCT02481596|7589300|FG001|STARTED|Overall Study||127
6658656|NCT02481596|7589301|FG002|STARTED|Overall Study||253
6658657|NCT02481596|7589299|FG000|COMPLETED|Overall Study||123
6658658|NCT02481596|7589300|FG001|COMPLETED|Overall Study||126
6658659|NCT02481596|7589301|FG002|COMPLETED|Overall Study||245
6658660|NCT02481596|7589299|FG000|NOT COMPLETED|Overall Study||3
6658661|NCT02481596|7589300|FG001|NOT COMPLETED|Overall Study||1
6658662|NCT02481596|7589301|FG002|NOT COMPLETED|Overall Study||8
6658663|NCT02481713|7589311|FG000|STARTED|Overall Study||56
6658664|NCT02481713|7589312|FG001|STARTED|Overall Study||58
6658665|NCT02481713|7589311|FG000|COMPLETED|Overall Study||40
6658666|NCT02481713|7589312|FG001|COMPLETED|Overall Study||42
6658667|NCT02481713|7589311|FG000|NOT COMPLETED|Overall Study||16
6658668|NCT02481713|7589312|FG001|NOT COMPLETED|Overall Study||16
6658669|NCT02481869|7589320|FG000|STARTED|Overall Study||5
6658670|NCT02481869|7589321|FG001|STARTED|Overall Study||6
6658671|NCT02481869|7589320|FG000|COMPLETED|Overall Study||0
6658672|NCT02481869|7589321|FG001|COMPLETED|Overall Study||2
6658673|NCT02481869|7589320|FG000|NOT COMPLETED|Overall Study||5
6658674|NCT02481869|7589321|FG001|NOT COMPLETED|Overall Study||4
6658675|NCT02481934|7589328|FG000|STARTED|Overall Study||5
6658676|NCT02481934|7589328|FG000|COMPLETED|Overall Study||3
6658677|NCT02481934|7589328|FG000|NOT COMPLETED|Overall Study||2
6658678|NCT02481947|7589334|FG000|STARTED|Overall Study||230
6658679|NCT02481947|7589335|FG001|STARTED|Overall Study||229
6658680|NCT02481947|7589334|FG000|COMPLETED|Overall Study||184
6658681|NCT02481947|7589335|FG001|COMPLETED|Overall Study||193
6658682|NCT02481947|7589334|FG000|NOT COMPLETED|Overall Study||46
6658683|NCT02481947|7589335|FG001|NOT COMPLETED|Overall Study||36
6658684|NCT02482025|7589343|FG000|STARTED|Overall Study||122
6658685|NCT02482025|7589344|FG001|STARTED|Overall Study||118
6579477|NCT01911403|7503508|FG001|NOT COMPLETED|Overall Study||3
6579478|NCT01911429|7503517|FG000|STARTED|Overall Study||108
6579479|NCT01911429|7503518|FG001|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
6579480|NCT01911429|7503519|FG002|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
6579481|NCT01911429|7503517|FG000|COMPLETED|Overall Study||96
6579482|NCT01911429|7503518|FG001|COMPLETED|Overall Study||96
6579483|NCT01911429|7503519|FG002|COMPLETED|Overall Study||93
6579484|NCT01911429|7503517|FG000|NOT COMPLETED|Overall Study||12
6579485|NCT01911429|7503518|FG001|NOT COMPLETED|Overall Study||10
6579486|NCT01911429|7503519|FG002|NOT COMPLETED|Overall Study||20
6579487|NCT01911442|7503530|FG000|STARTED|Overall Study||49
6579488|NCT01911442|7503531|FG001|STARTED|Overall Study||51
6579489|NCT01911442|7503532|FG002|STARTED|Overall Study||50
6579490|NCT01911442|7503530|FG000|COMPLETED|Overall Study||43
6579491|NCT01911442|7503531|FG001|COMPLETED|Overall Study||47
6579492|NCT01911442|7503532|FG002|COMPLETED|Overall Study||38
6579493|NCT01911442|7503530|FG000|NOT COMPLETED|Overall Study||6
6579494|NCT01911442|7503531|FG001|NOT COMPLETED|Overall Study||4
6579495|NCT01911442|7503532|FG002|NOT COMPLETED|Overall Study||12
6579496|NCT01911546|7503544|FG000|STARTED|Overall Study||20
6579497|NCT01911546|7503544|FG000|COMPLETED|Overall Study||14
6579498|NCT01911546|7503544|FG000|NOT COMPLETED|Overall Study||6
6579499|NCT01911689|7503550|FG000|STARTED|Overall Study||117
6579500|NCT01911689|7503551|FG001|STARTED|Overall Study||51
6579501|NCT01911689|7503550|FG000|COMPLETED|Overall Study||117
6579502|NCT01911689|7503551|FG001|COMPLETED|Overall Study||51
6579503|NCT01911689|7503550|FG000|NOT COMPLETED|Overall Study||0
6579504|NCT01911689|7503551|FG001|NOT COMPLETED|Overall Study||0
6579505|NCT01911780|7503566|FG000|STARTED|Double-blind Period (8 Weeks)||68
6579506|NCT01911780|7503567|FG001|STARTED|Double-blind Period (8 Weeks)||64
6579507|NCT01911780|7503566|FG000|COMPLETED|Double-blind Period (8 Weeks)||65
6579508|NCT01911780|7503567|FG001|COMPLETED|Double-blind Period (8 Weeks)||61
6579509|NCT01911780|7503566|FG000|NOT COMPLETED|Double-blind Period (8 Weeks)||3
6579510|NCT01911780|7503567|FG001|NOT COMPLETED|Double-blind Period (8 Weeks)||3
6579511|NCT01911780|7503566|FG000|STARTED|Extension Period (52 Weeks)||65
6579512|NCT01911780|7503567|FG001|STARTED|Extension Period (52 Weeks)||61
6579513|NCT01911780|7503566|FG000|COMPLETED|Extension Period (52 Weeks)||61
6579514|NCT01911780|7503567|FG001|COMPLETED|Extension Period (52 Weeks)||58
6658686|NCT02482025|7589343|FG000|COMPLETED|Overall Study||122
6658687|NCT02482025|7589344|FG001|COMPLETED|Overall Study||118
6658688|NCT02482025|7589343|FG000|NOT COMPLETED|Overall Study||0
6658689|NCT02482025|7589344|FG001|NOT COMPLETED|Overall Study||0
6658690|NCT02482129|7589352|FG000|STARTED|Overall Study||32
6658691|NCT02482129|7589353|FG001|STARTED|Overall Study||11
6658692|NCT02482129|7589352|FG000|Treated, as Randomized|Overall Study||30
6658693|NCT02482129|7589353|FG001|Treated, as Randomized|Overall Study||9
6579515|NCT01911780|7503566|FG000|NOT COMPLETED|Extension Period (52 Weeks)||4
6579516|NCT01911780|7503567|FG001|NOT COMPLETED|Extension Period (52 Weeks)||3
6579517|NCT01911819|7503580|FG000|STARTED|Overall Study||10
6579518|NCT01911819|7503581|FG001|STARTED|Overall Study|One of 10 sinuses was replaced to another sinus due to infection.|11
6579519|NCT01911819|7503582|FG002|STARTED|Overall Study||10
6579520|NCT01911819|7503580|FG000|COMPLETED|Overall Study||9
6579521|NCT01911819|7503581|FG001|COMPLETED|Overall Study||9
6579522|NCT01911819|7503582|FG002|COMPLETED|Overall Study||10
6579523|NCT01911819|7503580|FG000|NOT COMPLETED|Overall Study||1
6579524|NCT01911819|7503581|FG001|NOT COMPLETED|Overall Study||2
6579525|NCT01911819|7503582|FG002|NOT COMPLETED|Overall Study||0
6579526|NCT01911845|7503590|FG000|STARTED|Overall Study||38
6579527|NCT01911845|7503590|FG000|Completed Study Drug|Overall Study||37
6579528|NCT01911845|7503590|FG000|COMPLETED|Overall Study||32
6579529|NCT01911845|7503590|FG000|NOT COMPLETED|Overall Study||6
6579530|NCT01911910|7503598|FG000|STARTED|Overall Study||197
6579531|NCT01911910|7503599|FG001|STARTED|Overall Study||205
6579532|NCT01911910|7503598|FG000|COMPLETED|Overall Study||184
6579533|NCT01911910|7503599|FG001|COMPLETED|Overall Study||194
6579534|NCT01911910|7503598|FG000|NOT COMPLETED|Overall Study||13
6579535|NCT01911910|7503599|FG001|NOT COMPLETED|Overall Study||11
6579536|NCT01912222|7503608|FG000|STARTED|Part A: Pharmacokinetic Period||13
6579537|NCT01912222|7503609|FG001|STARTED|Part A: Pharmacokinetic Period||15
6579538|NCT01912222|7503610|FG002|STARTED|Part A: Pharmacokinetic Period||20
6579539|NCT01912222|7503608|FG000|COMPLETED|Part A: Pharmacokinetic Period||12
6579540|NCT01912222|7503609|FG001|COMPLETED|Part A: Pharmacokinetic Period||13
6579541|NCT01912222|7503610|FG002|COMPLETED|Part A: Pharmacokinetic Period||18
6579542|NCT01912222|7503608|FG000|NOT COMPLETED|Part A: Pharmacokinetic Period||1
6579543|NCT01912222|7503609|FG001|NOT COMPLETED|Part A: Pharmacokinetic Period||2
6579544|NCT01912222|7503610|FG002|NOT COMPLETED|Part A: Pharmacokinetic Period||2
6579545|NCT01912222|7503608|FG000|STARTED|Part B: Treatment Period||13
6579546|NCT01912222|7503609|FG001|STARTED|Part B: Treatment Period||15
6579547|NCT01912222|7503610|FG002|STARTED|Part B: Treatment Period||20
6579548|NCT01912222|7503608|FG000|COMPLETED|Part B: Treatment Period||0
6579549|NCT01912222|7503609|FG001|COMPLETED|Part B: Treatment Period||0
6579550|NCT01912222|7503610|FG002|COMPLETED|Part B: Treatment Period||0
6579551|NCT01912222|7503608|FG000|NOT COMPLETED|Part B: Treatment Period||13
6579552|NCT01912222|7503609|FG001|NOT COMPLETED|Part B: Treatment Period||15
6579553|NCT01912222|7503610|FG002|NOT COMPLETED|Part B: Treatment Period||20
6579554|NCT01912274|7503619|FG000|STARTED|Overall Study||50
6579555|NCT01912274|7503619|FG000|COMPLETED|Overall Study||50
6579556|NCT01912274|7503619|FG000|NOT COMPLETED|Overall Study||0
6579557|NCT01912287|7503626|FG000|STARTED|Overall Study||93
6579558|NCT01912287|7503627|FG001|STARTED|Overall Study||90
6579559|NCT01912287|7503628|FG002|STARTED|Overall Study||43
6579560|NCT01912287|7503626|FG000|COMPLETED|Overall Study||60
6579561|NCT01912287|7503627|FG001|COMPLETED|Overall Study||67
6579562|NCT01912287|7503628|FG002|COMPLETED|Overall Study||28
6579563|NCT01912287|7503626|FG000|NOT COMPLETED|Overall Study||33
6579564|NCT01912287|7503627|FG001|NOT COMPLETED|Overall Study||23
6579565|NCT01912287|7503628|FG002|NOT COMPLETED|Overall Study||15
6579566|NCT01912339|7503638|FG000|STARTED|Blinded (0 to 3 Months)||136
6579567|NCT01912339|7503639|FG001|STARTED|Blinded (0 to 3 Months)||61
6579568|NCT01912339|7503640|FG002|STARTED|Blinded (0 to 3 Months)||0
6579569|NCT01912339|7503638|FG000|COMPLETED|Blinded (0 to 3 Months)||134
6579570|NCT01912339|7503639|FG001|COMPLETED|Blinded (0 to 3 Months)||61
6579571|NCT01912339|7503640|FG002|COMPLETED|Blinded (0 to 3 Months)||0
6579572|NCT01912339|7503638|FG000|NOT COMPLETED|Blinded (0 to 3 Months)||2
6579573|NCT01912339|7503639|FG001|NOT COMPLETED|Blinded (0 to 3 Months)||0
6579574|NCT01912339|7503640|FG002|NOT COMPLETED|Blinded (0 to 3 Months)||0
6579575|NCT01912339|7503638|FG000|STARTED|Unblinded (3 to 6 Months/Crossover)||134
6579576|NCT01912339|7503639|FG001|STARTED|Unblinded (3 to 6 Months/Crossover)||61
6579577|NCT01912339|7503640|FG002|STARTED|Unblinded (3 to 6 Months/Crossover)||0
6579578|NCT01912339|7503638|FG000|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
6579579|NCT01912339|7503639|FG001|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
6579580|NCT01912339|7503640|FG002|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
6579581|NCT01912339|7503638|FG000|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
6579582|NCT01912339|7503639|FG001|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
6579583|NCT01912339|7503640|FG002|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
6579584|NCT01912339|7503638|FG000|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
6579585|NCT01912339|7503639|FG001|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
6579586|NCT01912339|7503640|FG002|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
6579587|NCT01912339|7503638|FG000|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
6579588|NCT01912339|7503639|FG001|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
6579589|NCT01912339|7503640|FG002|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
6579590|NCT01912339|7503638|FG000|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
6579591|NCT01912339|7503639|FG001|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
6579592|NCT01912339|7503640|FG002|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
6579593|NCT01912352|7503646|FG000|STARTED|Overall Study||83
6579594|NCT01912352|7503646|FG000|COMPLETED|Overall Study||78
6579595|NCT01912352|7503646|FG000|NOT COMPLETED|Overall Study||5
6579596|NCT01912456|7503652|FG000|STARTED|Period 1||22
6579597|NCT01912456|7503653|FG001|STARTED|Period 1||23
6579598|NCT01912456|7503654|FG002|STARTED|Period 1||23
6579599|NCT01912456|7503655|FG003|STARTED|Period 1||22
6579600|NCT01912456|7503652|FG000|COMPLETED|Period 1||20
6579601|NCT01912456|7503653|FG001|COMPLETED|Period 1||22
6579602|NCT01912456|7503654|FG002|COMPLETED|Period 1||21
6579603|NCT01912456|7503655|FG003|COMPLETED|Period 1||19
6579604|NCT01912456|7503652|FG000|NOT COMPLETED|Period 1||2
6579605|NCT01912456|7503653|FG001|NOT COMPLETED|Period 1||1
6579606|NCT01912456|7503654|FG002|NOT COMPLETED|Period 1||2
6579607|NCT01912456|7503655|FG003|NOT COMPLETED|Period 1||3
6579608|NCT01912456|7503652|FG000|STARTED|Period 2||20
6579609|NCT01912456|7503653|FG001|STARTED|Period 2||22
6579610|NCT01912456|7503654|FG002|STARTED|Period 2||21
6579611|NCT01912456|7503655|FG003|STARTED|Period 2||19
6579612|NCT01912456|7503652|FG000|COMPLETED|Period 2||20
6579613|NCT01912456|7503653|FG001|COMPLETED|Period 2||20
6579614|NCT01912456|7503654|FG002|COMPLETED|Period 2||21
6579615|NCT01912456|7503655|FG003|COMPLETED|Period 2||18
6579616|NCT01912456|7503652|FG000|NOT COMPLETED|Period 2||0
6579617|NCT01912456|7503653|FG001|NOT COMPLETED|Period 2||2
6579618|NCT01912456|7503654|FG002|NOT COMPLETED|Period 2||0
6579619|NCT01912456|7503655|FG003|NOT COMPLETED|Period 2||1
6579620|NCT01912495|7503665|FG000|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
6579621|NCT01912495|7503665|FG000|COMPLETED|Overall Study||57
6579622|NCT01912495|7503665|FG000|NOT COMPLETED|Overall Study||0
6579623|NCT01912599|7503674|FG000|STARTED|Overall Study||20
6579624|NCT01912599|7503675|FG001|STARTED|Overall Study||16
6579625|NCT01912599|7503674|FG000|COMPLETED|Overall Study||20
6579626|NCT01912599|7503675|FG001|COMPLETED|Overall Study||15
6579627|NCT01912599|7503674|FG000|NOT COMPLETED|Overall Study||0
6579628|NCT01912599|7503675|FG001|NOT COMPLETED|Overall Study||1
6579629|NCT01912612|7503683|FG000|STARTED|Overall Study||36
6579630|NCT01912612|7503684|FG001|STARTED|Overall Study||40
6579631|NCT01912612|7503685|FG002|STARTED|Overall Study||3
6579632|NCT01912612|7503683|FG000|COMPLETED|Overall Study||31
6579633|NCT01912612|7503684|FG001|COMPLETED|Overall Study||40
6579634|NCT01912612|7503685|FG002|COMPLETED|Overall Study||0
6579635|NCT01912612|7503683|FG000|NOT COMPLETED|Overall Study||5
6579636|NCT01912612|7503684|FG001|NOT COMPLETED|Overall Study||0
6579637|NCT01912612|7503685|FG002|NOT COMPLETED|Overall Study||3
6579638|NCT01912716|7503693|FG000|STARTED|Overall Study|receipt of 1st dose of indomethacin|522
6579639|NCT01912716|7503694|FG001|STARTED|Overall Study||515
6579640|NCT01912716|7503693|FG000|Receipt of 2nd Dose|Overall Study||511
6579641|NCT01912716|7503694|FG001|Receipt of 2nd Dose|Overall Study||503
6579642|NCT01912716|7503693|FG000|5-day Follow-up|Overall Study||522
6579643|NCT01912716|7503694|FG001|5-day Follow-up|Overall Study||515
6579644|NCT01912716|7503693|FG000|3-day Follow-up|Overall Study||521
6579645|NCT01912716|7503694|FG001|3-day Follow-up|Overall Study||513
6579646|NCT01912716|7503693|FG000|COMPLETED|Overall Study||522
6579647|NCT01912716|7503694|FG001|COMPLETED|Overall Study||515
6579648|NCT01912716|7503693|FG000|NOT COMPLETED|Overall Study||0
6579649|NCT01912716|7503694|FG001|NOT COMPLETED|Overall Study||0
6579650|NCT01912729|7503704|FG000|STARTED|Overall Study||20
6579651|NCT01912729|7503705|FG001|STARTED|Overall Study||20
6579652|NCT01912729|7503704|FG000|COMPLETED|Overall Study||20
6579653|NCT01912729|7503705|FG001|COMPLETED|Overall Study||19
6579654|NCT01912729|7503704|FG000|NOT COMPLETED|Overall Study||0
6579655|NCT01912729|7503705|FG001|NOT COMPLETED|Overall Study||1
6579656|NCT01912768|7503713|FG000|STARTED|Overall Study||239
6579657|NCT01912768|7503714|FG001|STARTED|Overall Study||113
6579658|NCT01912768|7503713|FG000|COMPLETED|Overall Study||229
6579659|NCT01912768|7503714|FG001|COMPLETED|Overall Study||109
6579660|NCT01912768|7503713|FG000|NOT COMPLETED|Overall Study||10
6579661|NCT01912768|7503714|FG001|NOT COMPLETED|Overall Study||4
6579662|NCT01912781|7503723|FG000|STARTED|Overall Study||71
6579663|NCT01912781|7503724|FG001|STARTED|Overall Study||35
6579664|NCT01912781|7503723|FG000|COMPLETED|Overall Study||69
6579665|NCT01912781|7503724|FG001|COMPLETED|Overall Study||35
6579666|NCT01912781|7503723|FG000|NOT COMPLETED|Overall Study||2
6579667|NCT01912781|7503724|FG001|NOT COMPLETED|Overall Study||0
6579668|NCT01912807|7503733|FG000|STARTED|Overall Study|Enrolment phase: Recruiting of participants started December 11, 2013|150
6579669|NCT01912807|7503734|FG001|STARTED|Overall Study|Enrolment phase: Recruitment of participants started December 11, 2013|150
6579670|NCT01912807|7503733|FG000|Randomized|Overall Study||144
6579671|NCT01912807|7503734|FG001|Randomized|Overall Study||146
6579672|NCT01912807|7503733|FG000|COMPLETED|Overall Study|"n=108 completed study and immediate follow up~n=36 participants were lost to follow up at 24 hr"|108
6579673|NCT01912807|7503734|FG001|COMPLETED|Overall Study|"n=109 completed study and immediate follow up~n=37 participants were lost to follow up at 24 hr"|109
6579674|NCT01912807|7503733|FG000|NOT COMPLETED|Overall Study||42
6579675|NCT01912807|7503734|FG001|NOT COMPLETED|Overall Study||41
6579676|NCT01912872|7503744|FG000|STARTED|Overall Study||16
6579677|NCT01912872|7503745|FG001|STARTED|Overall Study||17
6579678|NCT01912872|7503746|FG002|STARTED|Overall Study||40
6579679|NCT01912872|7503747|FG003|STARTED|Overall Study||39
6579680|NCT01912872|7503744|FG000|Completed Study Treatment at Month 12|Overall Study||11
6579681|NCT01912872|7503745|FG001|Completed Study Treatment at Month 12|Overall Study||13
6579682|NCT01912872|7503746|FG002|Completed Study Treatment at Month 12|Overall Study||30
6579683|NCT01912872|7503747|FG003|Completed Study Treatment at Month 12|Overall Study||27
6579684|NCT01912872|7503744|FG000|Discontinued Treatment Prior to Month 12|Overall Study||5
6579685|NCT01912872|7503745|FG001|Discontinued Treatment Prior to Month 12|Overall Study||4
6579686|NCT01912872|7503746|FG002|Discontinued Treatment Prior to Month 12|Overall Study||10
6579687|NCT01912872|7503747|FG003|Discontinued Treatment Prior to Month 12|Overall Study||11
6579688|NCT01912872|7503744|FG000|COMPLETED|Overall Study||11
6579689|NCT01912872|7503745|FG001|COMPLETED|Overall Study||13
6579690|NCT01912872|7503746|FG002|COMPLETED|Overall Study||30
6579691|NCT01912872|7503747|FG003|COMPLETED|Overall Study||27
6579692|NCT01912872|7503744|FG000|NOT COMPLETED|Overall Study||5
6579693|NCT01912872|7503745|FG001|NOT COMPLETED|Overall Study||4
6579694|NCT01912872|7503746|FG002|NOT COMPLETED|Overall Study||10
6579695|NCT01912872|7503747|FG003|NOT COMPLETED|Overall Study||12
6579696|NCT01912963|7503761|FG000|STARTED|Overall Study||6
6579697|NCT01912963|7503762|FG001|STARTED|Overall Study||19
6579698|NCT01912963|7503763|FG002|STARTED|Overall Study||7
6579699|NCT01912963|7503761|FG000|COMPLETED|Overall Study||0
6579700|NCT01912963|7503762|FG001|COMPLETED|Overall Study||0
6579701|NCT01912963|7503763|FG002|COMPLETED|Overall Study||0
6579702|NCT01912963|7503761|FG000|NOT COMPLETED|Overall Study||6
6579703|NCT01912963|7503762|FG001|NOT COMPLETED|Overall Study||19
6579704|NCT01912963|7503763|FG002|NOT COMPLETED|Overall Study||7
6579705|NCT01913041|7503771|FG000|STARTED|Overall Study||869
6579706|NCT01913041|7503771|FG000|COMPLETED|Overall Study||830
6579707|NCT01913041|7503771|FG000|NOT COMPLETED|Overall Study||39
6579708|NCT01913314|7503775|FG000|STARTED|Overall Study||6
6579709|NCT01913314|7503775|FG000|Received Study Drug|Overall Study||6
6579710|NCT01913314|7503775|FG000|COMPLETED|Overall Study||6
6579711|NCT01913314|7503775|FG000|NOT COMPLETED|Overall Study||0
6579712|NCT01913340|7503781|FG000|STARTED|Overall Study|22 (92%) received all 5 doses, 1 (4%) received 4 doses, and 1 (4%) only received 1 dose.|24
6579713|NCT01913340|7503782|FG001|STARTED|Overall Study||26
6579714|NCT01913340|7503781|FG000|COMPLETED|Overall Study||21
6579715|NCT01913340|7503782|FG001|COMPLETED|Overall Study||20
6579716|NCT01913340|7503781|FG000|NOT COMPLETED|Overall Study||3
6579717|NCT01913340|7503782|FG001|NOT COMPLETED|Overall Study||6
6579718|NCT01913353|7503790|FG000|STARTED|Overall Study||221
6579719|NCT01913353|7503791|FG001|STARTED|Overall Study||219
6579720|NCT01913353|7503790|FG000|COMPLETED|Overall Study||189
6579721|NCT01913353|7503791|FG001|COMPLETED|Overall Study||204
6579722|NCT01913353|7503790|FG000|NOT COMPLETED|Overall Study||32
6579723|NCT01913353|7503791|FG001|NOT COMPLETED|Overall Study||15
6579724|NCT01913405|7503804|FG000|STARTED|Overall Study||22
6579725|NCT01913405|7503804|FG000|COMPLETED|Overall Study||20
6579726|NCT01913405|7503804|FG000|NOT COMPLETED|Overall Study||2
6579727|NCT01913470|7503823|FG000|STARTED|Overall Study||5
6579728|NCT01913470|7503824|FG001|STARTED|Overall Study||7
6579729|NCT01913470|7503823|FG000|COMPLETED|Overall Study||5
6579730|NCT01913470|7503824|FG001|COMPLETED|Overall Study||4
6579731|NCT01913470|7503823|FG000|NOT COMPLETED|Overall Study||0
6579732|NCT01913470|7503824|FG001|NOT COMPLETED|Overall Study||3
6579733|NCT01913483|7503833|FG000|STARTED|Overall Study||367
6579734|NCT01913483|7503834|FG001|STARTED|Overall Study||365
6579735|NCT01913483|7503833|FG000|Received at Least 1 Dose of Study Drug|Overall Study||335
6579736|NCT01913483|7503834|FG001|Received at Least 1 Dose of Study Drug|Overall Study||321
6579737|NCT01913483|7503833|FG000|COMPLETED|Overall Study||346
6579738|NCT01913483|7503834|FG001|COMPLETED|Overall Study||343
6579739|NCT01913483|7503833|FG000|NOT COMPLETED|Overall Study||21
6579740|NCT01913483|7503834|FG001|NOT COMPLETED|Overall Study||22
6579741|NCT01913535|7503845|FG000|STARTED|Phase 1 (Days 0-2)||2
6579742|NCT01913535|7503846|FG001|STARTED|Phase 1 (Days 0-2)||2
6579743|NCT01913535|7503847|FG002|STARTED|Phase 1 (Days 0-2)||1
6579744|NCT01913535|7503848|FG003|STARTED|Phase 1 (Days 0-2)||2
6579745|NCT01913535|7503849|FG004|STARTED|Phase 1 (Days 0-2)||1
6579746|NCT01913535|7503845|FG000|COMPLETED|Phase 1 (Days 0-2)||2
6579747|NCT01913535|7503846|FG001|COMPLETED|Phase 1 (Days 0-2)||2
6579748|NCT01913535|7503847|FG002|COMPLETED|Phase 1 (Days 0-2)||1
6579749|NCT01913535|7503848|FG003|COMPLETED|Phase 1 (Days 0-2)||2
6579750|NCT01913535|7503849|FG004|COMPLETED|Phase 1 (Days 0-2)||1
6579751|NCT01913535|7503845|FG000|NOT COMPLETED|Phase 1 (Days 0-2)||0
6579752|NCT01913535|7503846|FG001|NOT COMPLETED|Phase 1 (Days 0-2)||0
6579753|NCT01913535|7503847|FG002|NOT COMPLETED|Phase 1 (Days 0-2)||0
6579754|NCT01913535|7503848|FG003|NOT COMPLETED|Phase 1 (Days 0-2)||0
6579755|NCT01913535|7503849|FG004|NOT COMPLETED|Phase 1 (Days 0-2)||0
6579756|NCT01913535|7503845|FG000|STARTED|Phase 2 (Days 3-5)||2
6579757|NCT01913535|7503846|FG001|STARTED|Phase 2 (Days 3-5)||2
6579758|NCT01913535|7503847|FG002|STARTED|Phase 2 (Days 3-5)||1
6579759|NCT01913535|7503848|FG003|STARTED|Phase 2 (Days 3-5)||2
6579760|NCT01913535|7503849|FG004|STARTED|Phase 2 (Days 3-5)||1
6579761|NCT01913535|7503845|FG000|COMPLETED|Phase 2 (Days 3-5)||2
6579762|NCT01913535|7503846|FG001|COMPLETED|Phase 2 (Days 3-5)||2
6579763|NCT01913535|7503847|FG002|COMPLETED|Phase 2 (Days 3-5)||1
6579764|NCT01913535|7503848|FG003|COMPLETED|Phase 2 (Days 3-5)||2
6579765|NCT01913535|7503849|FG004|COMPLETED|Phase 2 (Days 3-5)||1
6579766|NCT01913535|7503845|FG000|NOT COMPLETED|Phase 2 (Days 3-5)||0
6579767|NCT01913535|7503846|FG001|NOT COMPLETED|Phase 2 (Days 3-5)||0
6579768|NCT01913535|7503847|FG002|NOT COMPLETED|Phase 2 (Days 3-5)||0
6579769|NCT01913535|7503848|FG003|NOT COMPLETED|Phase 2 (Days 3-5)||0
6579770|NCT01913535|7503849|FG004|NOT COMPLETED|Phase 2 (Days 3-5)||0
6579771|NCT01913600|7503862|FG000|STARTED|Overall Study||56
6579772|NCT01913600|7503862|FG000|COMPLETED|Overall Study||55
6579773|NCT01913600|7503862|FG000|NOT COMPLETED|Overall Study||1
6579774|NCT01913639|7503866|FG000|STARTED|Overall Study||39
6579775|NCT01913639|7503866|FG000|COMPLETED|Overall Study||36
6579776|NCT01913639|7503866|FG000|NOT COMPLETED|Overall Study||3
6579777|NCT01913795|7503874|FG000|STARTED|Overall Study||4
6579778|NCT01913795|7503875|FG001|STARTED|Overall Study||10
6579779|NCT01913795|7503876|FG002|STARTED|Overall Study||9
6579780|NCT01913795|7503877|FG003|STARTED|Overall Study||6
6579781|NCT01913795|7503874|FG000|COMPLETED|Overall Study||4
6579782|NCT01913795|7503875|FG001|COMPLETED|Overall Study||7
6579783|NCT01913795|7503876|FG002|COMPLETED|Overall Study||9
6579784|NCT01913795|7503877|FG003|COMPLETED|Overall Study||5
6579785|NCT01913795|7503874|FG000|NOT COMPLETED|Overall Study||0
6579786|NCT01913795|7503875|FG001|NOT COMPLETED|Overall Study||3
6579787|NCT01913795|7503876|FG002|NOT COMPLETED|Overall Study||0
6579788|NCT01913795|7503877|FG003|NOT COMPLETED|Overall Study||1
6579789|NCT01914003|7503889|FG000|STARTED|Overall Study||27
6579790|NCT01914003|7503890|FG001|STARTED|Overall Study||26
6579791|NCT01914003|7503889|FG000|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
6579792|NCT01914003|7503890|FG001|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
6579793|NCT01914003|7503889|FG000|NOT COMPLETED|Overall Study||8
6579794|NCT01914003|7503890|FG001|NOT COMPLETED|Overall Study||12
6579795|NCT01914159|7503896|FG000|STARTED|Overall Study||24
6579796|NCT01914159|7503896|FG000|COMPLETED|Overall Study||21
6579797|NCT01914159|7503896|FG000|NOT COMPLETED|Overall Study||3
6579798|NCT01914393|7503903|FG000|STARTED|Overall Study||271
6579799|NCT01914393|7503904|FG001|STARTED|Overall Study||125
6579800|NCT01914393|7503905|FG002|STARTED|Overall Study||306
6579801|NCT01914393|7503903|FG000|COMPLETED|Overall Study||156
6579802|NCT01914393|7503904|FG001|COMPLETED|Overall Study||54
6579803|NCT01914393|7503905|FG002|COMPLETED|Overall Study||168
6579804|NCT01914393|7503903|FG000|NOT COMPLETED|Overall Study||115
6579805|NCT01914393|7503904|FG001|NOT COMPLETED|Overall Study||71
6579806|NCT01914393|7503905|FG002|NOT COMPLETED|Overall Study||138
6579807|NCT01914510|7503917|FG000|STARTED|Overall Study||40
6579808|NCT01914510|7503917|FG000|COMPLETED|Overall Study||38
6579809|NCT01914510|7503917|FG000|NOT COMPLETED|Overall Study||2
6579810|NCT01914666|7503925|FG000|STARTED|Treatment Period||68
6579811|NCT01914666|7503926|FG001|STARTED|Treatment Period||42
6579812|NCT01914666|7503927|FG002|STARTED|Treatment Period||41
6579813|NCT01914666|7503925|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||68
6579814|NCT01914666|7503926|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||42
6579815|NCT01914666|7503927|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||41
6579816|NCT01914666|7503925|FG000|COMPLETED|Treatment Period||55
6579817|NCT01914666|7503926|FG001|COMPLETED|Treatment Period||36
6579818|NCT01914666|7503927|FG002|COMPLETED|Treatment Period||33
6579819|NCT01914666|7503925|FG000|NOT COMPLETED|Treatment Period||13
6579820|NCT01914666|7503926|FG001|NOT COMPLETED|Treatment Period||6
6579821|NCT01914666|7503927|FG002|NOT COMPLETED|Treatment Period||8
6579822|NCT01914666|7503925|FG000|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
6579823|NCT01914666|7503926|FG001|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
6579824|NCT01914666|7503927|FG002|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
6579825|NCT01914666|7503925|FG000|COMPLETED|Tapering Period||59
6579826|NCT01914666|7503926|FG001|COMPLETED|Tapering Period||39
6579827|NCT01914666|7503927|FG002|COMPLETED|Tapering Period||40
6579828|NCT01914666|7503925|FG000|NOT COMPLETED|Tapering Period||0
6579829|NCT01914666|7503926|FG001|NOT COMPLETED|Tapering Period||0
6579830|NCT01914666|7503927|FG002|NOT COMPLETED|Tapering Period||0
6579831|NCT01914679|7503933|FG000|STARTED|Overall Study||17
6579832|NCT01914679|7503933|FG000|Began 12 Week Actual RINCE Treatment|Overall Study||17
6579833|NCT01914679|7503933|FG000|COMPLETED|Overall Study||12
6579834|NCT01914679|7503933|FG000|NOT COMPLETED|Overall Study||5
6579835|NCT01914757|7503940|FG000|STARTED|Overall Study||425
6579836|NCT01914757|7503941|FG001|STARTED|Overall Study||441
6579837|NCT01914757|7503942|FG002|STARTED|Overall Study||440
6579838|NCT01914757|7503940|FG000|COMPLETED|Overall Study||389
6579839|NCT01914757|7503941|FG001|COMPLETED|Overall Study||390
6579840|NCT01914757|7503942|FG002|COMPLETED|Overall Study||402
6579841|NCT01914757|7503940|FG000|NOT COMPLETED|Overall Study||36
6579842|NCT01914757|7503941|FG001|NOT COMPLETED|Overall Study||51
6579843|NCT01914757|7503942|FG002|NOT COMPLETED|Overall Study||38
6579844|NCT01914926|7503952|FG000|STARTED|Overall Study||29
6579845|NCT01914926|7503953|FG001|STARTED|Overall Study||25
6579846|NCT01914926|7503952|FG000|COMPLETED|Overall Study||28
6579847|NCT01914926|7503953|FG001|COMPLETED|Overall Study||24
6579848|NCT01914926|7503952|FG000|NOT COMPLETED|Overall Study||1
6579849|NCT01914926|7503953|FG001|NOT COMPLETED|Overall Study||1
6579850|NCT01915095|7503966|FG000|STARTED|Overall Study||10
6579851|NCT01915095|7503967|FG001|STARTED|Overall Study||10
6579852|NCT01915095|7503968|FG002|STARTED|Overall Study||5
6579853|NCT01915095|7503969|FG003|STARTED|Overall Study||8
6579854|NCT01915095|7503970|FG004|STARTED|Overall Study||9
6579855|NCT01915095|7503966|FG000|SCI|Overall Study||5
6579856|NCT01915095|7503967|FG001|SCI|Overall Study||5
6579857|NCT01915095|7503968|FG002|SCI|Overall Study||5
6579858|NCT01915095|7503969|FG003|SCI|Overall Study||8
6579859|NCT01915095|7503970|FG004|SCI|Overall Study||9
6579860|NCT01915095|7503966|FG000|Control|Overall Study||5
6579861|NCT01915095|7503967|FG001|Control|Overall Study||5
6579862|NCT01915095|7503968|FG002|Control|Overall Study||0
6579863|NCT01915095|7503969|FG003|Control|Overall Study||0
6579864|NCT01915095|7503970|FG004|Control|Overall Study||0
6579865|NCT01915095|7503966|FG000|COMPLETED|Overall Study||10
6579866|NCT01915095|7503967|FG001|COMPLETED|Overall Study||10
6579867|NCT01915095|7503968|FG002|COMPLETED|Overall Study||5
6579868|NCT01915095|7503969|FG003|COMPLETED|Overall Study||4
6579869|NCT01915095|7503970|FG004|COMPLETED|Overall Study||3
6579870|NCT01915095|7503966|FG000|NOT COMPLETED|Overall Study||0
6579871|NCT01915095|7503967|FG001|NOT COMPLETED|Overall Study||0
6579872|NCT01915095|7503968|FG002|NOT COMPLETED|Overall Study||0
6579873|NCT01915095|7503969|FG003|NOT COMPLETED|Overall Study||4
6579874|NCT01915095|7503970|FG004|NOT COMPLETED|Overall Study||6
6579875|NCT01915108|7503995|FG000|STARTED|Overall Study||32
6579876|NCT01915108|7503996|FG001|STARTED|Overall Study||32
6579877|NCT01915108|7503997|FG002|STARTED|Overall Study||32
6579878|NCT01915108|7503998|FG003|STARTED|Overall Study||32
6579879|NCT01915108|7503995|FG000|COMPLETED|Overall Study|two patients were excluded from the study|30
6579880|NCT01915108|7503996|FG001|COMPLETED|Overall Study|three patients were excluded from the study|29
6579881|NCT01915108|7503997|FG002|COMPLETED|Overall Study|one patients were excluded from the study|31
6579882|NCT01915108|7503998|FG003|COMPLETED|Overall Study|two patients were excluded from the study|30
6579883|NCT01915108|7503995|FG000|NOT COMPLETED|Overall Study||2
6579884|NCT01915108|7503996|FG001|NOT COMPLETED|Overall Study||3
6579885|NCT01915108|7503997|FG002|NOT COMPLETED|Overall Study||1
6579886|NCT01915108|7503998|FG003|NOT COMPLETED|Overall Study||2
6579887|NCT01915173|7504012|FG000|STARTED|Overall Study||6
6579888|NCT01915173|7504013|FG001|STARTED|Overall Study||6
6579889|NCT01915173|7504014|FG002|STARTED|Overall Study||6
6579890|NCT01915173|7504015|FG003|STARTED|Overall Study||6
6579891|NCT01915173|7504012|FG000|COMPLETED|Overall Study||6
6579892|NCT01915173|7504013|FG001|COMPLETED|Overall Study||6
6579893|NCT01915173|7504014|FG002|COMPLETED|Overall Study||6
6579894|NCT01915173|7504015|FG003|COMPLETED|Overall Study||6
6579895|NCT01915173|7504012|FG000|NOT COMPLETED|Overall Study||0
6579896|NCT01915173|7504013|FG001|NOT COMPLETED|Overall Study||0
6579897|NCT01915173|7504014|FG002|NOT COMPLETED|Overall Study||0
6579898|NCT01915173|7504015|FG003|NOT COMPLETED|Overall Study||0
6579899|NCT01915303|7504025|FG000|STARTED|Core Phase||68
6579900|NCT01915303|7504025|FG000|COMPLETED|Core Phase||52
6579901|NCT01915303|7504025|FG000|NOT COMPLETED|Core Phase||16
6579902|NCT01915303|7504025|FG000|STARTED|Extension Phase||29
6579903|NCT01915303|7504025|FG000|COMPLETED|Extension Phase||12
6579904|NCT01915303|7504025|FG000|NOT COMPLETED|Extension Phase||17
6579905|NCT01915563|7504031|FG000|STARTED|Overall Study||243
6579906|NCT01915563|7504032|FG001|STARTED|Overall Study||227
6579907|NCT01915563|7504031|FG000|COMPLETED|Overall Study||243
6579908|NCT01915563|7504032|FG001|COMPLETED|Overall Study||227
6579909|NCT01915563|7504031|FG000|NOT COMPLETED|Overall Study||0
6579910|NCT01915563|7504032|FG001|NOT COMPLETED|Overall Study||0
6579911|NCT01915732|7504040|FG000|STARTED|Overall Study||500
6579912|NCT01915732|7504041|FG001|STARTED|Overall Study||516
6579913|NCT01915732|7504040|FG000|COMPLETED|Overall Study||430
6579914|NCT01915732|7504041|FG001|COMPLETED|Overall Study||445
6579915|NCT01915732|7504040|FG000|NOT COMPLETED|Overall Study||70
6579916|NCT01915732|7504041|FG001|NOT COMPLETED|Overall Study||71
6579917|NCT01915771|7504047|FG000|STARTED|Day 1||15
6579918|NCT01915771|7504047|FG000|COMPLETED|Day 1||14
6579919|NCT01915771|7504047|FG000|NOT COMPLETED|Day 1||1
6579920|NCT01915771|7504047|FG000|STARTED|Day 15||14
6579921|NCT01915771|7504047|FG000|COMPLETED|Day 15||13
6579922|NCT01915771|7504047|FG000|NOT COMPLETED|Day 15||1
6579923|NCT01915823|7504057|FG000|STARTED|Overall Study||173
6579924|NCT01915823|7504058|FG001|STARTED|Overall Study||175
6579925|NCT01915823|7504057|FG000|COMPLETED|Overall Study||171
6579926|NCT01915823|7504058|FG001|COMPLETED|Overall Study||173
6579927|NCT01915823|7504057|FG000|NOT COMPLETED|Overall Study||2
6579928|NCT01915823|7504058|FG001|NOT COMPLETED|Overall Study||2
6579929|NCT01915849|7504068|FG000|STARTED|Treatment Period 1 (4 Days)||5
6579930|NCT01915849|7504069|FG001|STARTED|Treatment Period 1 (4 Days)||3
6579931|NCT01915849|7504070|FG002|STARTED|Treatment Period 1 (4 Days)||3
6579932|NCT01915849|7504071|FG003|STARTED|Treatment Period 1 (4 Days)||3
6579933|NCT01915849|7504068|FG000|COMPLETED|Treatment Period 1 (4 Days)||3
6579934|NCT01915849|7504069|FG001|COMPLETED|Treatment Period 1 (4 Days)||3
6579935|NCT01915849|7504070|FG002|COMPLETED|Treatment Period 1 (4 Days)||3
6579936|NCT01915849|7504071|FG003|COMPLETED|Treatment Period 1 (4 Days)||3
6579937|NCT01915849|7504068|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||2
6579938|NCT01915849|7504069|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6579939|NCT01915849|7504070|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6579940|NCT01915849|7504071|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6579941|NCT01915849|7504068|FG000|STARTED|Treatment Period 2 (4 Days)||3
6579942|NCT01915849|7504069|FG001|STARTED|Treatment Period 2 (4 Days)||3
6579943|NCT01915849|7504070|FG002|STARTED|Treatment Period 2 (4 Days)||3
6579944|NCT01915849|7504071|FG003|STARTED|Treatment Period 2 (4 Days)||3
6579945|NCT01915849|7504068|FG000|COMPLETED|Treatment Period 2 (4 Days)||3
6579946|NCT01915849|7504069|FG001|COMPLETED|Treatment Period 2 (4 Days)||3
6579947|NCT01915849|7504070|FG002|COMPLETED|Treatment Period 2 (4 Days)||3
6579948|NCT01915849|7504071|FG003|COMPLETED|Treatment Period 2 (4 Days)||3
6579949|NCT01915849|7504068|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6579950|NCT01915849|7504069|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6579951|NCT01915849|7504070|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6579952|NCT01915849|7504071|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6579953|NCT01915849|7504068|FG000|STARTED|Treatment Period 3 (4 Days)||3
6579954|NCT01915849|7504069|FG001|STARTED|Treatment Period 3 (4 Days)||3
6579955|NCT01915849|7504070|FG002|STARTED|Treatment Period 3 (4 Days)||3
6579956|NCT01915849|7504071|FG003|STARTED|Treatment Period 3 (4 Days)||3
6579957|NCT01915849|7504068|FG000|COMPLETED|Treatment Period 3 (4 Days)||3
6579958|NCT01915849|7504069|FG001|COMPLETED|Treatment Period 3 (4 Days)||3
6579959|NCT01915849|7504070|FG002|COMPLETED|Treatment Period 3 (4 Days)||3
6579960|NCT01915849|7504071|FG003|COMPLETED|Treatment Period 3 (4 Days)||3
6579961|NCT01915849|7504068|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6579962|NCT01915849|7504069|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6579963|NCT01915849|7504070|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6579964|NCT01915849|7504071|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6579965|NCT01915849|7504068|FG000|STARTED|Treatment Period 4 (4 Days)||3
6579966|NCT01915849|7504069|FG001|STARTED|Treatment Period 4 (4 Days)||3
6579967|NCT01915849|7504070|FG002|STARTED|Treatment Period 4 (4 Days)||3
6579968|NCT01915849|7504071|FG003|STARTED|Treatment Period 4 (4 Days)||3
6579969|NCT01915849|7504068|FG000|COMPLETED|Treatment Period 4 (4 Days)||3
6579970|NCT01915849|7504069|FG001|COMPLETED|Treatment Period 4 (4 Days)||3
6579971|NCT01915849|7504070|FG002|COMPLETED|Treatment Period 4 (4 Days)||3
6579972|NCT01915849|7504071|FG003|COMPLETED|Treatment Period 4 (4 Days)||3
6579973|NCT01915849|7504068|FG000|NOT COMPLETED|Treatment Period 4 (4 Days)||0
6579974|NCT01915849|7504069|FG001|NOT COMPLETED|Treatment Period 4 (4 Days)||0
6579975|NCT01915849|7504070|FG002|NOT COMPLETED|Treatment Period 4 (4 Days)||0
6579976|NCT01915849|7504071|FG003|NOT COMPLETED|Treatment Period 4 (4 Days)||0
6579977|NCT01915914|7504081|FG000|STARTED|Acute Phase||123
6579978|NCT01915914|7504082|FG001|STARTED|Acute Phase||0
6579979|NCT01915914|7504083|FG002|STARTED|Acute Phase||0
6579980|NCT01915914|7504084|FG003|STARTED|Acute Phase||0
6579981|NCT01915914|7504081|FG000|Completed-Not Entered Maintenance Phase|Acute Phase||4
6579982|NCT01915914|7504082|FG001|Completed-Not Entered Maintenance Phase|Acute Phase||0
6579983|NCT01915914|7504083|FG002|Completed-Not Entered Maintenance Phase|Acute Phase||0
6579984|NCT01915914|7504084|FG003|Completed-Not Entered Maintenance Phase|Acute Phase||0
6579985|NCT01915914|7504081|FG000|COMPLETED|Acute Phase||111
6579986|NCT01915914|7504082|FG001|COMPLETED|Acute Phase||0
6579987|NCT01915914|7504083|FG002|COMPLETED|Acute Phase||0
6579988|NCT01915914|7504084|FG003|COMPLETED|Acute Phase||0
6579989|NCT01915914|7504081|FG000|NOT COMPLETED|Acute Phase||12
6579990|NCT01915914|7504082|FG001|NOT COMPLETED|Acute Phase||0
6579991|NCT01915914|7504083|FG002|NOT COMPLETED|Acute Phase||0
6579992|NCT01915914|7504084|FG003|NOT COMPLETED|Acute Phase||0
6579993|NCT01915914|7504081|FG000|STARTED|Maintenance Phase||0
6579994|NCT01915914|7504082|FG001|STARTED|Maintenance Phase||54
6579995|NCT01915914|7504083|FG002|STARTED|Maintenance Phase||53
6579996|NCT01915914|7504084|FG003|STARTED|Maintenance Phase||0
6579997|NCT01915914|7504081|FG000|COMPLETED|Maintenance Phase||0
6579998|NCT01915914|7504082|FG001|COMPLETED|Maintenance Phase||48
6579999|NCT01915914|7504083|FG002|COMPLETED|Maintenance Phase||51
6580000|NCT01915914|7504084|FG003|COMPLETED|Maintenance Phase||0
6580001|NCT01915914|7504081|FG000|NOT COMPLETED|Maintenance Phase||0
6580002|NCT01915914|7504082|FG001|NOT COMPLETED|Maintenance Phase||6
6580003|NCT01915914|7504083|FG002|NOT COMPLETED|Maintenance Phase||2
6580004|NCT01915914|7504084|FG003|NOT COMPLETED|Maintenance Phase||0
6580005|NCT01915914|7504081|FG000|STARTED|Follow-up Phase||0
6580006|NCT01915914|7504082|FG001|STARTED|Follow-up Phase||0
6580007|NCT01915914|7504083|FG002|STARTED|Follow-up Phase||0
6580008|NCT01915914|7504084|FG003|STARTED|Follow-up Phase||66
6580009|NCT01915914|7504081|FG000|COMPLETED|Follow-up Phase||0
6580010|NCT01915914|7504082|FG001|COMPLETED|Follow-up Phase||0
6580011|NCT01915914|7504083|FG002|COMPLETED|Follow-up Phase||0
6580012|NCT01915914|7504084|FG003|COMPLETED|Follow-up Phase||64
6580013|NCT01915914|7504081|FG000|NOT COMPLETED|Follow-up Phase||0
6580014|NCT01915914|7504082|FG001|NOT COMPLETED|Follow-up Phase||0
6580015|NCT01915914|7504083|FG002|NOT COMPLETED|Follow-up Phase||0
6580016|NCT01915914|7504084|FG003|NOT COMPLETED|Follow-up Phase||2
6580017|NCT01915940|7504104|FG000|STARTED|Pre-randomization Washout Period||169
6580018|NCT01915940|7504105|FG001|STARTED|Pre-randomization Washout Period||0
6580019|NCT01915940|7504106|FG002|STARTED|Pre-randomization Washout Period||0
6580020|NCT01915940|7504104|FG000|COMPLETED|Pre-randomization Washout Period||130
6580021|NCT01915940|7504105|FG001|COMPLETED|Pre-randomization Washout Period||0
6580022|NCT01915940|7504106|FG002|COMPLETED|Pre-randomization Washout Period||0
6580023|NCT01915940|7504104|FG000|NOT COMPLETED|Pre-randomization Washout Period||39
6580024|NCT01915940|7504105|FG001|NOT COMPLETED|Pre-randomization Washout Period||0
6580025|NCT01915940|7504106|FG002|NOT COMPLETED|Pre-randomization Washout Period||0
6580026|NCT01915940|7504104|FG000|STARTED|Treatment Period||0
6580027|NCT01915940|7504105|FG001|STARTED|Treatment Period||64
6580028|NCT01915940|7504106|FG002|STARTED|Treatment Period||66
6580029|NCT01915940|7504104|FG000|COMPLETED|Treatment Period||0
6580030|NCT01915940|7504105|FG001|COMPLETED|Treatment Period||53
6580031|NCT01915940|7504106|FG002|COMPLETED|Treatment Period||62
6580032|NCT01915940|7504104|FG000|NOT COMPLETED|Treatment Period||0
6580033|NCT01915940|7504105|FG001|NOT COMPLETED|Treatment Period||11
6580034|NCT01915940|7504106|FG002|NOT COMPLETED|Treatment Period||4
6580035|NCT01916109|7504112|FG000|STARTED|Overall Study||4
6580036|NCT01916109|7504112|FG000|COMPLETED|Overall Study||3
6580037|NCT01916109|7504112|FG000|NOT COMPLETED|Overall Study||1
6580038|NCT01916226|7504120|FG000|STARTED|Overall Study||170
6580039|NCT01916226|7504121|FG001|STARTED|Overall Study||170
6580040|NCT01916226|7504122|FG002|STARTED|Overall Study||171
6580041|NCT01916226|7504123|FG003|STARTED|Overall Study||171
6580042|NCT01916226|7504120|FG000|COMPLETED|Overall Study||169
6580043|NCT01916226|7504121|FG001|COMPLETED|Overall Study||169
6580044|NCT01916226|7504122|FG002|COMPLETED|Overall Study||168
6580045|NCT01916226|7504123|FG003|COMPLETED|Overall Study||167
6580046|NCT01916226|7504120|FG000|NOT COMPLETED|Overall Study||1
6580047|NCT01916226|7504121|FG001|NOT COMPLETED|Overall Study||1
6580048|NCT01916226|7504122|FG002|NOT COMPLETED|Overall Study||3
6580049|NCT01916226|7504123|FG003|NOT COMPLETED|Overall Study||4
6580050|NCT01916304|7504134|FG000|STARTED|Overall Study||101
6580051|NCT01916304|7504134|FG000|Safety Set|Overall Study||101
6580052|NCT01916304|7504134|FG000|Intent-to-Treat Set|Overall Study||84
6580053|NCT01916304|7504134|FG000|COMPLETED|Overall Study||84
6580054|NCT01916304|7504134|FG000|NOT COMPLETED|Overall Study||17
6580055|NCT01916629|7504140|FG000|STARTED|Overall Study||7
6580056|NCT01916629|7504141|FG001|STARTED|Overall Study||5
6580057|NCT01916629|7504140|FG000|COMPLETED|Overall Study||7
6580058|NCT01916629|7504141|FG001|COMPLETED|Overall Study||5
6580059|NCT01916629|7504140|FG000|NOT COMPLETED|Overall Study||0
6580060|NCT01916629|7504141|FG001|NOT COMPLETED|Overall Study||0
6580061|NCT01916655|7504150|FG000|STARTED|Overall Study||131
6580062|NCT01916655|7504151|FG001|STARTED|Overall Study||109
6580063|NCT01916655|7504152|FG002|STARTED|Overall Study||120
6580064|NCT01916655|7504150|FG000|COMPLETED|Overall Study||116
6580065|NCT01916655|7504151|FG001|COMPLETED|Overall Study||89
6580066|NCT01916655|7504152|FG002|COMPLETED|Overall Study||91
6580067|NCT01916655|7504150|FG000|NOT COMPLETED|Overall Study||15
6580068|NCT01916655|7504151|FG001|NOT COMPLETED|Overall Study||20
6580069|NCT01916655|7504152|FG002|NOT COMPLETED|Overall Study||29
6580070|NCT01916681|7504164|FG000|STARTED|Overall Study||123
6580071|NCT01916681|7504165|FG001|STARTED|Overall Study||120
6580072|NCT01916681|7504166|FG002|STARTED|Overall Study||123
6580073|NCT01916681|7504167|FG003|STARTED|Overall Study||125
6580074|NCT01916681|7504164|FG000|COMPLETED|Overall Study||123
6580075|NCT01916681|7504165|FG001|COMPLETED|Overall Study||120
6580076|NCT01916681|7504166|FG002|COMPLETED|Overall Study||123
6580077|NCT01916681|7504167|FG003|COMPLETED|Overall Study||125
6580078|NCT01916681|7504164|FG000|NOT COMPLETED|Overall Study||0
6580079|NCT01916681|7504165|FG001|NOT COMPLETED|Overall Study||0
6580080|NCT01916681|7504166|FG002|NOT COMPLETED|Overall Study||0
6580081|NCT01916681|7504167|FG003|NOT COMPLETED|Overall Study||0
6580082|NCT01916824|7504180|FG000|STARTED|Overall Study||24
6580083|NCT01916824|7504181|FG001|STARTED|Overall Study||29
6580084|NCT01916824|7504180|FG000|COMPLETED|Overall Study||17
6580085|NCT01916824|7504181|FG001|COMPLETED|Overall Study||20
6580086|NCT01916824|7504180|FG000|NOT COMPLETED|Overall Study||7
6580087|NCT01916824|7504181|FG001|NOT COMPLETED|Overall Study||9
6580088|NCT01916928|7504187|FG000|STARTED|Overall Study||50
6580089|NCT01916928|7504187|FG000|COMPLETED|Overall Study||50
6580090|NCT01916928|7504187|FG000|NOT COMPLETED|Overall Study||0
6580091|NCT01916941|7504193|FG000|STARTED|Overall Study||18
6580092|NCT01916941|7504194|FG001|STARTED|Overall Study||18
6580093|NCT01916941|7504193|FG000|COMPLETED|Overall Study||13
6580094|NCT01916941|7504194|FG001|COMPLETED|Overall Study||14
6580095|NCT01916941|7504193|FG000|NOT COMPLETED|Overall Study||5
6580096|NCT01916941|7504194|FG001|NOT COMPLETED|Overall Study||4
6624138|NCT02214147|7551463|FG001|COMPLETED|Overall Study||12
6624139|NCT02214147|7551464|FG002|COMPLETED|Overall Study||8
6624140|NCT02214147|7551462|FG000|NOT COMPLETED|Overall Study||0
6624141|NCT02214147|7551463|FG001|NOT COMPLETED|Overall Study||0
6624142|NCT02214147|7551464|FG002|NOT COMPLETED|Overall Study||0
6624143|NCT02214186|7551474|FG000|STARTED|Overall Study||23
6624144|NCT02214186|7551475|FG001|STARTED|Overall Study||23
6624145|NCT02214186|7551474|FG000|COMPLETED|Overall Study||21
6624146|NCT02214186|7551475|FG001|COMPLETED|Overall Study||21
6624147|NCT02214186|7551474|FG000|NOT COMPLETED|Overall Study||2
6624148|NCT02214186|7551475|FG001|NOT COMPLETED|Overall Study||2
6624149|NCT02214212|7551483|FG000|STARTED|Overall Study||66
6624150|NCT02214212|7551484|FG001|STARTED|Overall Study||65
6624151|NCT02214212|7551483|FG000|COMPLETED|Overall Study||57
6624152|NCT02214212|7551484|FG001|COMPLETED|Overall Study||59
6624153|NCT02214212|7551483|FG000|NOT COMPLETED|Overall Study||9
6624154|NCT02214212|7551484|FG001|NOT COMPLETED|Overall Study||6
6624155|NCT02214225|7551498|FG000|STARTED|Overall Study||1741
6624156|NCT02214225|7551499|FG001|STARTED|Overall Study||871
6624157|NCT02214225|7551500|FG002|STARTED|Overall Study||872
6624158|NCT02214225|7551498|FG000|COMPLETED|Overall Study||1686
6624159|NCT02214225|7551499|FG001|COMPLETED|Overall Study||852
6624160|NCT02214225|7551500|FG002|COMPLETED|Overall Study||850
6624161|NCT02214225|7551498|FG000|NOT COMPLETED|Overall Study||55
6624162|NCT02214225|7551499|FG001|NOT COMPLETED|Overall Study||19
6624163|NCT02214225|7551500|FG002|NOT COMPLETED|Overall Study||22
6624164|NCT02214238|7551533|FG000|STARTED|Overall Study||26
6624165|NCT02214238|7551534|FG001|STARTED|Overall Study||23
6624166|NCT02214238|7551533|FG000|COMPLETED|Overall Study||20
6624167|NCT02214238|7551534|FG001|COMPLETED|Overall Study||17
6624168|NCT02214238|7551533|FG000|NOT COMPLETED|Overall Study||6
6624169|NCT02214238|7551534|FG001|NOT COMPLETED|Overall Study||6
6580097|NCT01917006|7504207|FG000|STARTED|Randomized-treatment Period||5
6580098|NCT01917006|7504208|FG001|STARTED|Randomized-treatment Period||7
6580099|NCT01917006|7504209|FG002|STARTED|Randomized-treatment Period||8
6580100|NCT01917006|7504210|FG003|STARTED|Randomized-treatment Period||8
6580101|NCT01917006|7504211|FG004|STARTED|Randomized-treatment Period||8
6580102|NCT01917006|7504212|FG005|STARTED|Randomized-treatment Period||8
6580103|NCT01917006|7504213|FG006|STARTED|Randomized-treatment Period||15
6580104|NCT01917006|7504214|FG007|STARTED|Randomized-treatment Period||0
6580105|NCT01917006|7504207|FG000|COMPLETED|Randomized-treatment Period||3
6580106|NCT01917006|7504208|FG001|COMPLETED|Randomized-treatment Period||7
6580107|NCT01917006|7504209|FG002|COMPLETED|Randomized-treatment Period||8
6658694|NCT02482129|7589352|FG000|COMPLETED|Overall Study||26
6658695|NCT02482129|7589353|FG001|COMPLETED|Overall Study||9
6658696|NCT02482129|7589352|FG000|NOT COMPLETED|Overall Study||6
6658697|NCT02482129|7589353|FG001|NOT COMPLETED|Overall Study||2
6658698|NCT02482298|7589364|FG000|STARTED|Overall Study||30
6658699|NCT02482298|7589365|FG001|STARTED|Overall Study||27
6658700|NCT02482298|7589366|FG002|STARTED|Overall Study||30
6658701|NCT02482298|7589364|FG000|COMPLETED|Overall Study||28
6658702|NCT02482298|7589365|FG001|COMPLETED|Overall Study||24
6255842|NCT01904032|7154710|FG000|COMPLETED|Overall Study||57
6255843|NCT01904032|7154711|FG001|COMPLETED|Overall Study||62
6255844|NCT01904032|7154710|FG000|NOT COMPLETED|Overall Study||7
6580108|NCT01917006|7504210|FG003|COMPLETED|Randomized-treatment Period||7
6580109|NCT01917006|7504211|FG004|COMPLETED|Randomized-treatment Period||8
6580110|NCT01917006|7504212|FG005|COMPLETED|Randomized-treatment Period||7
6580111|NCT01917006|7504213|FG006|COMPLETED|Randomized-treatment Period||14
6580112|NCT01917006|7504214|FG007|COMPLETED|Randomized-treatment Period||0
6580113|NCT01917006|7504207|FG000|NOT COMPLETED|Randomized-treatment Period||2
6580114|NCT01917006|7504208|FG001|NOT COMPLETED|Randomized-treatment Period||0
6580115|NCT01917006|7504209|FG002|NOT COMPLETED|Randomized-treatment Period||0
6580116|NCT01917006|7504210|FG003|NOT COMPLETED|Randomized-treatment Period||1
6580117|NCT01917006|7504211|FG004|NOT COMPLETED|Randomized-treatment Period||0
6580118|NCT01917006|7504212|FG005|NOT COMPLETED|Randomized-treatment Period||1
6580119|NCT01917006|7504213|FG006|NOT COMPLETED|Randomized-treatment Period||1
6580120|NCT01917006|7504214|FG007|NOT COMPLETED|Randomized-treatment Period||0
6658703|NCT02482298|7589366|FG002|COMPLETED|Overall Study||27
6658704|NCT02482298|7589364|FG000|NOT COMPLETED|Overall Study||2
6658705|NCT02482298|7589365|FG001|NOT COMPLETED|Overall Study||3
6658706|NCT02482298|7589366|FG002|NOT COMPLETED|Overall Study||3
6658707|NCT02482428|7589379|FG000|STARTED|Overall Study||24
6658708|NCT02482428|7589380|FG001|STARTED|Overall Study||22
6658709|NCT02482428|7589381|FG002|STARTED|Overall Study||10
6658710|NCT02482428|7589382|FG003|STARTED|Overall Study||10
6658711|NCT02482428|7589383|FG004|STARTED|Overall Study||22
6658712|NCT02482428|7589379|FG000|COMPLETED|Overall Study||15
6658713|NCT02482428|7589380|FG001|COMPLETED|Overall Study||10
6658714|NCT02482428|7589381|FG002|COMPLETED|Overall Study||9
6658715|NCT02482428|7589382|FG003|COMPLETED|Overall Study||8
6658716|NCT02482428|7589383|FG004|COMPLETED|Overall Study||15
6658717|NCT02482428|7589379|FG000|NOT COMPLETED|Overall Study||9
6658718|NCT02482428|7589380|FG001|NOT COMPLETED|Overall Study||12
6658719|NCT02482428|7589381|FG002|NOT COMPLETED|Overall Study||1
6658720|NCT02482428|7589382|FG003|NOT COMPLETED|Overall Study||2
6658721|NCT02482428|7589383|FG004|NOT COMPLETED|Overall Study||7
6658722|NCT02482571|7589397|FG000|STARTED|Overall Study||25
6658723|NCT02482571|7589397|FG000|COMPLETED|Overall Study||17
6658724|NCT02482571|7589397|FG000|NOT COMPLETED|Overall Study||8
6658725|NCT02482610|7589402|FG000|STARTED|Overall Study||4
6658726|NCT02482610|7589403|FG001|STARTED|Overall Study||5
6658727|NCT02482610|7589404|FG002|STARTED|Overall Study||2
6658728|NCT02482610|7589405|FG003|STARTED|Overall Study||3
6658729|NCT02482610|7589406|FG004|STARTED|Overall Study||3
6658730|NCT02482610|7589407|FG005|STARTED|Overall Study||5
6658731|NCT02482610|7589402|FG000|COMPLETED|Overall Study||4
6658732|NCT02482610|7589403|FG001|COMPLETED|Overall Study||5
6658733|NCT02482610|7589404|FG002|COMPLETED|Overall Study||2
6658734|NCT02482610|7589405|FG003|COMPLETED|Overall Study||3
6658735|NCT02482610|7589406|FG004|COMPLETED|Overall Study||3
6658736|NCT02482610|7589407|FG005|COMPLETED|Overall Study||5
6658737|NCT02482610|7589402|FG000|NOT COMPLETED|Overall Study||0
6658738|NCT02482610|7589403|FG001|NOT COMPLETED|Overall Study||0
6658739|NCT02482610|7589404|FG002|NOT COMPLETED|Overall Study||0
6658740|NCT02482610|7589405|FG003|NOT COMPLETED|Overall Study||0
6658741|NCT02482610|7589406|FG004|NOT COMPLETED|Overall Study||0
6658742|NCT02482610|7589407|FG005|NOT COMPLETED|Overall Study||0
6658743|NCT02482675|7589418|FG000|STARTED|Overall Study||1
6658744|NCT02482675|7589419|FG001|STARTED|Overall Study||1
6658745|NCT02482675|7589420|FG002|STARTED|Overall Study||1
6255845|NCT01904032|7154711|FG001|NOT COMPLETED|Overall Study||3
6255846|NCT01876953|7154719|FG000|STARTED|Overall Study||17
6658746|NCT02482675|7589421|FG003|STARTED|Overall Study||1
6658747|NCT02482675|7589422|FG004|STARTED|Overall Study||1
6658748|NCT02482675|7589423|FG005|STARTED|Overall Study||1
6658749|NCT02482675|7589424|FG006|STARTED|Overall Study||1
6658750|NCT02482675|7589425|FG007|STARTED|Overall Study||1
6658751|NCT02482675|7589426|FG008|STARTED|Overall Study||1
6658752|NCT02482675|7589427|FG009|STARTED|Overall Study||1
6658753|NCT02482675|7589428|FG010|STARTED|Overall Study||1
6658754|NCT02482675|7589429|FG011|STARTED|Overall Study||1
6580121|NCT01917006|7504207|FG000|STARTED|Open-label Period||0
6580122|NCT01917006|7504208|FG001|STARTED|Open-label Period||0
6580123|NCT01917006|7504209|FG002|STARTED|Open-label Period||0
6580124|NCT01917006|7504210|FG003|STARTED|Open-label Period||0
6580125|NCT01917006|7504211|FG004|STARTED|Open-label Period||0
6580126|NCT01917006|7504212|FG005|STARTED|Open-label Period||0
6580127|NCT01917006|7504213|FG006|STARTED|Open-label Period||0
6580128|NCT01917006|7504214|FG007|STARTED|Open-label Period||8
6580129|NCT01917006|7504207|FG000|COMPLETED|Open-label Period||0
6580130|NCT01917006|7504208|FG001|COMPLETED|Open-label Period||0
6580131|NCT01917006|7504209|FG002|COMPLETED|Open-label Period||0
6580132|NCT01917006|7504210|FG003|COMPLETED|Open-label Period||0
6580133|NCT01917006|7504211|FG004|COMPLETED|Open-label Period||0
6580134|NCT01917006|7504212|FG005|COMPLETED|Open-label Period||0
6580135|NCT01917006|7504213|FG006|COMPLETED|Open-label Period||0
6580136|NCT01917006|7504214|FG007|COMPLETED|Open-label Period||6
6580137|NCT01917006|7504207|FG000|NOT COMPLETED|Open-label Period||0
6580138|NCT01917006|7504208|FG001|NOT COMPLETED|Open-label Period||0
6580139|NCT01917006|7504209|FG002|NOT COMPLETED|Open-label Period||0
6580140|NCT01917006|7504210|FG003|NOT COMPLETED|Open-label Period||0
6580141|NCT01917006|7504211|FG004|NOT COMPLETED|Open-label Period||0
6580142|NCT01917006|7504212|FG005|NOT COMPLETED|Open-label Period||0
6580143|NCT01917006|7504213|FG006|NOT COMPLETED|Open-label Period||0
6580144|NCT01917006|7504214|FG007|NOT COMPLETED|Open-label Period||2
6580145|NCT01917084|7504231|FG000|STARTED|Overall Study||20
6580146|NCT01917084|7504231|FG000|COMPLETED|Overall Study||19
6580147|NCT01917084|7504231|FG000|NOT COMPLETED|Overall Study||1
6580148|NCT01917136|7504235|FG000|STARTED|Overall Study||21
6580149|NCT01917136|7504235|FG000|COMPLETED|Overall Study||21
6580150|NCT01917136|7504235|FG000|NOT COMPLETED|Overall Study||0
6580151|NCT01917188|7504242|FG000|STARTED|Overall Study||29
6580152|NCT01917188|7504243|FG001|STARTED|Overall Study||23
6580153|NCT01917188|7504244|FG002|STARTED|Overall Study||20
6580154|NCT01917188|7504242|FG000|COMPLETED|Overall Study||17
6580155|NCT01917188|7504243|FG001|COMPLETED|Overall Study||17
6580156|NCT01917188|7504244|FG002|COMPLETED|Overall Study||11
6580157|NCT01917188|7504242|FG000|NOT COMPLETED|Overall Study||12
6580158|NCT01917188|7504243|FG001|NOT COMPLETED|Overall Study||6
6580159|NCT01917188|7504244|FG002|NOT COMPLETED|Overall Study||9
6580160|NCT01917214|7504252|FG000|STARTED|Overall Study||212
6580161|NCT01917214|7504252|FG000|COMPLETED|Overall Study||212
6580162|NCT01917214|7504252|FG000|NOT COMPLETED|Overall Study||0
6580163|NCT01917344|7504257|FG000|STARTED|Overall Study||10
6580164|NCT01917344|7504257|FG000|COMPLETED|Overall Study||9
6580165|NCT01917344|7504257|FG000|NOT COMPLETED|Overall Study||1
6580166|NCT01917513|7504263|FG000|STARTED|Overall Study||502
6580167|NCT01917513|7504264|FG001|STARTED|Overall Study||498
6580168|NCT01917513|7504263|FG000|COMPLETED|Overall Study||407
6580169|NCT01917513|7504264|FG001|COMPLETED|Overall Study||396
6580170|NCT01917513|7504263|FG000|NOT COMPLETED|Overall Study||95
6580171|NCT01917513|7504264|FG001|NOT COMPLETED|Overall Study||102
6580172|NCT01917526|7504272|FG000|STARTED|Overall Study||250
6580173|NCT01917526|7504273|FG001|STARTED|Overall Study||250
6580174|NCT01917526|7504272|FG000|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
6580175|NCT01917526|7504273|FG001|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
6580176|NCT01917526|7504272|FG000|NOT COMPLETED|Overall Study||1
6580177|NCT01917526|7504273|FG001|NOT COMPLETED|Overall Study||1
6580178|NCT01917656|7504281|FG000|STARTED|Overall Study||172
6580179|NCT01917656|7504282|FG001|STARTED|Overall Study||171
6580180|NCT01917656|7504281|FG000|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
6580181|NCT01917656|7504282|FG001|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
6580182|NCT01917656|7504281|FG000|Exposed During Ramadan (Fasting)|Overall Study||152
6580183|NCT01917656|7504282|FG001|Exposed During Ramadan (Fasting)|Overall Study||163
6580184|NCT01917656|7504281|FG000|COMPLETED|Overall Study||146
6580185|NCT01917656|7504282|FG001|COMPLETED|Overall Study||147
6580186|NCT01917656|7504281|FG000|NOT COMPLETED|Overall Study||26
6580187|NCT01917656|7504282|FG001|NOT COMPLETED|Overall Study||24
6580188|NCT01917682|7504288|FG000|STARTED|Overall Study||754
6580189|NCT01917682|7504288|FG000|COMPLETED|Overall Study||754
6580190|NCT01917682|7504288|FG000|NOT COMPLETED|Overall Study||0
6580191|NCT01917747|7504295|FG000|STARTED|Overall Study||60
6580192|NCT01917747|7504296|FG001|STARTED|Overall Study||46
6580193|NCT01917747|7504295|FG000|COMPLETED|Overall Study||41
6580194|NCT01917747|7504296|FG001|COMPLETED|Overall Study||35
6580195|NCT01917747|7504295|FG000|NOT COMPLETED|Overall Study||19
6580196|NCT01917747|7504296|FG001|NOT COMPLETED|Overall Study||11
6580197|NCT01917773|7504306|FG000|STARTED|Overall Study||13
6580198|NCT01917773|7504306|FG000|COMPLETED|Overall Study||13
6580199|NCT01917773|7504306|FG000|NOT COMPLETED|Overall Study||0
6580200|NCT01917812|7504315|FG000|STARTED|Overall Study||16
6580201|NCT01917812|7504316|FG001|STARTED|Overall Study||16
6580202|NCT01917812|7504317|FG002|STARTED|Overall Study||16
6580203|NCT01917812|7504315|FG000|COMPLETED|Overall Study||15
6580204|NCT01917812|7504316|FG001|COMPLETED|Overall Study||16
6580205|NCT01917812|7504317|FG002|COMPLETED|Overall Study||16
6580206|NCT01917812|7504315|FG000|NOT COMPLETED|Overall Study||1
6580207|NCT01917812|7504316|FG001|NOT COMPLETED|Overall Study||0
6580208|NCT01917812|7504317|FG002|NOT COMPLETED|Overall Study||0
6580209|NCT01917968|7504327|FG000|STARTED|Overall Study||225
6580210|NCT01917968|7504328|FG001|STARTED|Overall Study||485
6580211|NCT01917968|7504327|FG000|COMPLETED|Overall Study||171
6580212|NCT01917968|7504328|FG001|COMPLETED|Overall Study||401
6391762|NCT00837967|7303699|FG001|NOT COMPLETED|First Intervention||0
6391763|NCT00837967|7303698|FG000|STARTED|Washout Period of 7 - 14 Days||13
6391764|NCT00837967|7303699|FG001|STARTED|Washout Period of 7 - 14 Days||12
6391765|NCT00837967|7303698|FG000|COMPLETED|Washout Period of 7 - 14 Days||11
6391766|NCT00837967|7303699|FG001|COMPLETED|Washout Period of 7 - 14 Days||12
6580213|NCT01917968|7504327|FG000|NOT COMPLETED|Overall Study||54
6580214|NCT01917968|7504328|FG001|NOT COMPLETED|Overall Study||84
6580215|NCT01918072|7504341|FG000|STARTED|Controlled Trial Step One - Six Months||11
6580216|NCT01918072|7504342|FG001|STARTED|Controlled Trial Step One - Six Months||0
6580217|NCT01918072|7504343|FG002|STARTED|Controlled Trial Step One - Six Months||0
6580218|NCT01918072|7504341|FG000|Intervention|Controlled Trial Step One - Six Months||1
6580219|NCT01918072|7504342|FG001|Intervention|Controlled Trial Step One - Six Months||0
6580220|NCT01918072|7504343|FG002|Intervention|Controlled Trial Step One - Six Months||0
6580221|NCT01918072|7504341|FG000|Control|Controlled Trial Step One - Six Months||10
6580222|NCT01918072|7504342|FG001|Control|Controlled Trial Step One - Six Months||0
6580223|NCT01918072|7504343|FG002|Control|Controlled Trial Step One - Six Months||0
6580224|NCT01918072|7504341|FG000|COMPLETED|Controlled Trial Step One - Six Months||11
6580225|NCT01918072|7504342|FG001|COMPLETED|Controlled Trial Step One - Six Months||0
6580226|NCT01918072|7504343|FG002|COMPLETED|Controlled Trial Step One - Six Months||0
6580227|NCT01918072|7504341|FG000|NOT COMPLETED|Controlled Trial Step One - Six Months||0
6580228|NCT01918072|7504342|FG001|NOT COMPLETED|Controlled Trial Step One - Six Months||0
6580229|NCT01918072|7504343|FG002|NOT COMPLETED|Controlled Trial Step One - Six Months||0
6580230|NCT01918072|7504341|FG000|STARTED|Controlled Trial Step Two - Six Months||11
6580231|NCT01918072|7504342|FG001|STARTED|Controlled Trial Step Two - Six Months||0
6580232|NCT01918072|7504343|FG002|STARTED|Controlled Trial Step Two - Six Months||0
6580233|NCT01918072|7504341|FG000|Intervention|Controlled Trial Step Two - Six Months||7
6580234|NCT01918072|7504342|FG001|Intervention|Controlled Trial Step Two - Six Months||0
6580235|NCT01918072|7504343|FG002|Intervention|Controlled Trial Step Two - Six Months||0
6580236|NCT01918072|7504341|FG000|Control|Controlled Trial Step Two - Six Months||4
6580237|NCT01918072|7504342|FG001|Control|Controlled Trial Step Two - Six Months||0
6580238|NCT01918072|7504343|FG002|Control|Controlled Trial Step Two - Six Months||0
6580239|NCT01918072|7504341|FG000|COMPLETED|Controlled Trial Step Two - Six Months||11
6580240|NCT01918072|7504342|FG001|COMPLETED|Controlled Trial Step Two - Six Months||0
6580241|NCT01918072|7504343|FG002|COMPLETED|Controlled Trial Step Two - Six Months||0
6580242|NCT01918072|7504341|FG000|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
6580243|NCT01918072|7504342|FG001|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
6580244|NCT01918072|7504343|FG002|NOT COMPLETED|Controlled Trial Step Two - Six Months||0
6580245|NCT01918072|7504341|FG000|STARTED|Controlled Trial Step Three - Six Months||11
6580246|NCT01918072|7504342|FG001|STARTED|Controlled Trial Step Three - Six Months||0
6580247|NCT01918072|7504343|FG002|STARTED|Controlled Trial Step Three - Six Months||0
6580248|NCT01918072|7504341|FG000|Intervention|Controlled Trial Step Three - Six Months||9
6580249|NCT01918072|7504342|FG001|Intervention|Controlled Trial Step Three - Six Months||0
6580250|NCT01918072|7504343|FG002|Intervention|Controlled Trial Step Three - Six Months||0
6580251|NCT01918072|7504341|FG000|Control|Controlled Trial Step Three - Six Months||2
6580252|NCT01918072|7504342|FG001|Control|Controlled Trial Step Three - Six Months||0
6580253|NCT01918072|7504343|FG002|Control|Controlled Trial Step Three - Six Months||0
6580254|NCT01918072|7504341|FG000|COMPLETED|Controlled Trial Step Three - Six Months||11
6580255|NCT01918072|7504342|FG001|COMPLETED|Controlled Trial Step Three - Six Months||0
6580256|NCT01918072|7504343|FG002|COMPLETED|Controlled Trial Step Three - Six Months||0
6580257|NCT01918072|7504341|FG000|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
6580258|NCT01918072|7504342|FG001|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
6580259|NCT01918072|7504343|FG002|NOT COMPLETED|Controlled Trial Step Three - Six Months||0
6580260|NCT01918072|7504341|FG000|STARTED|Controlled Trial Step Four - Six Months||11
6580261|NCT01918072|7504342|FG001|STARTED|Controlled Trial Step Four - Six Months||0
6580262|NCT01918072|7504343|FG002|STARTED|Controlled Trial Step Four - Six Months||0
6580263|NCT01918072|7504341|FG000|Intervention|Controlled Trial Step Four - Six Months||11
6580264|NCT01918072|7504342|FG001|Intervention|Controlled Trial Step Four - Six Months||0
6580265|NCT01918072|7504343|FG002|Intervention|Controlled Trial Step Four - Six Months||0
6580266|NCT01918072|7504341|FG000|Control|Controlled Trial Step Four - Six Months||0
6580267|NCT01918072|7504342|FG001|Control|Controlled Trial Step Four - Six Months||0
6580268|NCT01918072|7504343|FG002|Control|Controlled Trial Step Four - Six Months||0
6580269|NCT01918072|7504341|FG000|COMPLETED|Controlled Trial Step Four - Six Months||11
6580270|NCT01918072|7504342|FG001|COMPLETED|Controlled Trial Step Four - Six Months||0
6580271|NCT01918072|7504343|FG002|COMPLETED|Controlled Trial Step Four - Six Months||0
6580272|NCT01918072|7504341|FG000|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
6580273|NCT01918072|7504342|FG001|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
6580274|NCT01918072|7504343|FG002|NOT COMPLETED|Controlled Trial Step Four - Six Months||0
6580275|NCT01918072|7504341|FG000|STARTED|Controlled Trial Step Five - Four Months||11
6580276|NCT01918072|7504342|FG001|STARTED|Controlled Trial Step Five - Four Months||0
6580277|NCT01918072|7504343|FG002|STARTED|Controlled Trial Step Five - Four Months||0
6580278|NCT01918072|7504341|FG000|Intervention|Controlled Trial Step Five - Four Months||11
6580279|NCT01918072|7504342|FG001|Intervention|Controlled Trial Step Five - Four Months||0
6580280|NCT01918072|7504343|FG002|Intervention|Controlled Trial Step Five - Four Months||0
6580281|NCT01918072|7504341|FG000|Control|Controlled Trial Step Five - Four Months||0
6580282|NCT01918072|7504342|FG001|Control|Controlled Trial Step Five - Four Months||0
6580283|NCT01918072|7504343|FG002|Control|Controlled Trial Step Five - Four Months||0
6580284|NCT01918072|7504341|FG000|COMPLETED|Controlled Trial Step Five - Four Months||11
6580285|NCT01918072|7504342|FG001|COMPLETED|Controlled Trial Step Five - Four Months||0
6580286|NCT01918072|7504343|FG002|COMPLETED|Controlled Trial Step Five - Four Months||0
6580287|NCT01918072|7504341|FG000|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
6580288|NCT01918072|7504342|FG001|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
6580289|NCT01918072|7504343|FG002|NOT COMPLETED|Controlled Trial Step Five - Four Months||0
6580290|NCT01918072|7504341|FG000|STARTED|E-consult Assessment Period||0
6580291|NCT01918072|7504342|FG001|STARTED|E-consult Assessment Period||42
6580292|NCT01918072|7504343|FG002|STARTED|E-consult Assessment Period||0
6580293|NCT01918072|7504341|FG000|COMPLETED|E-consult Assessment Period||0
6580294|NCT01918072|7504342|FG001|COMPLETED|E-consult Assessment Period||42
6580295|NCT01918072|7504343|FG002|COMPLETED|E-consult Assessment Period||0
6580296|NCT01918072|7504341|FG000|NOT COMPLETED|E-consult Assessment Period||0
6580297|NCT01918072|7504342|FG001|NOT COMPLETED|E-consult Assessment Period||0
6580298|NCT01918072|7504343|FG002|NOT COMPLETED|E-consult Assessment Period||0
6580299|NCT01918072|7504341|FG000|STARTED|Quality Assessment Period||0
6580300|NCT01918072|7504342|FG001|STARTED|Quality Assessment Period||0
6580301|NCT01918072|7504343|FG002|STARTED|Quality Assessment Period||202
6580302|NCT01918072|7504341|FG000|COMPLETED|Quality Assessment Period||0
6580303|NCT01918072|7504342|FG001|COMPLETED|Quality Assessment Period||0
6580304|NCT01918072|7504343|FG002|COMPLETED|Quality Assessment Period||202
6580305|NCT01918072|7504341|FG000|NOT COMPLETED|Quality Assessment Period||0
6580306|NCT01918072|7504342|FG001|NOT COMPLETED|Quality Assessment Period||0
6580307|NCT01918072|7504343|FG002|NOT COMPLETED|Quality Assessment Period||0
6580308|NCT01918085|7504355|FG000|STARTED|Test Period 1: Strata Strip||10
6580309|NCT01918085|7504356|FG001|STARTED|Test Period 1: Strata Strip||12
6580310|NCT01918085|7504355|FG000|COMPLETED|Test Period 1: Strata Strip||10
6580311|NCT01918085|7504356|FG001|COMPLETED|Test Period 1: Strata Strip||11
6580312|NCT01918085|7504355|FG000|NOT COMPLETED|Test Period 1: Strata Strip||0
6580313|NCT01918085|7504356|FG001|NOT COMPLETED|Test Period 1: Strata Strip||1
6580314|NCT01918085|7504355|FG000|STARTED|Test Period 1: Hydrocolloid Strip||10
6580315|NCT01918085|7504356|FG001|STARTED|Test Period 1: Hydrocolloid Strip||11
6580316|NCT01918085|7504355|FG000|COMPLETED|Test Period 1: Hydrocolloid Strip||10
6580317|NCT01918085|7504356|FG001|COMPLETED|Test Period 1: Hydrocolloid Strip||11
6580318|NCT01918085|7504355|FG000|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
6580319|NCT01918085|7504356|FG001|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
6580320|NCT01918085|7504355|FG000|STARTED|Test Period 2: Strata Strip||10
6580321|NCT01918085|7504356|FG001|STARTED|Test Period 2: Strata Strip||11
6580322|NCT01918085|7504355|FG000|COMPLETED|Test Period 2: Strata Strip||10
6580323|NCT01918085|7504356|FG001|COMPLETED|Test Period 2: Strata Strip||11
6580324|NCT01918085|7504355|FG000|NOT COMPLETED|Test Period 2: Strata Strip||0
6580325|NCT01918085|7504356|FG001|NOT COMPLETED|Test Period 2: Strata Strip||0
6580326|NCT01918085|7504355|FG000|STARTED|Test Period 2: Hydrocolloid Strip||10
6580327|NCT01918085|7504356|FG001|STARTED|Test Period 2: Hydrocolloid Strip||11
6580328|NCT01918085|7504355|FG000|COMPLETED|Test Period 2: Hydrocolloid Strip||10
6580329|NCT01918085|7504356|FG001|COMPLETED|Test Period 2: Hydrocolloid Strip||11
6580330|NCT01918085|7504355|FG000|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
6580331|NCT01918085|7504356|FG001|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
6580332|NCT01918189|7504364|FG000|STARTED|Overall Study||59
6580333|NCT01918189|7504364|FG000|Completed Baseline Assessment|Overall Study||58
6580334|NCT01918189|7504364|FG000|Completed Follow-up Assessment|Overall Study||41
6580335|NCT01918189|7504364|FG000|COMPLETED|Overall Study||41
6580336|NCT01918189|7504364|FG000|NOT COMPLETED|Overall Study||18
6580337|NCT01918306|7504371|FG000|STARTED|Overall Study||6
6580338|NCT01918306|7504372|FG001|STARTED|Overall Study|No patients enrolled|0
6580339|NCT01918306|7504373|FG002|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
6580340|NCT01918306|7504374|FG003|STARTED|Overall Study||3
6580341|NCT01918306|7504371|FG000|COMPLETED|Overall Study||0
6580342|NCT01918306|7504372|FG001|COMPLETED|Overall Study||0
6580343|NCT01918306|7504373|FG002|COMPLETED|Overall Study||0
6580344|NCT01918306|7504374|FG003|COMPLETED|Overall Study||0
6580345|NCT01918306|7504371|FG000|NOT COMPLETED|Overall Study||6
6580346|NCT01918306|7504372|FG001|NOT COMPLETED|Overall Study||0
6580347|NCT01918306|7504373|FG002|NOT COMPLETED|Overall Study||2
6580348|NCT01918306|7504374|FG003|NOT COMPLETED|Overall Study||3
6580349|NCT01918332|7504398|FG000|STARTED|Overall Study||43
6580350|NCT01918332|7504399|FG001|STARTED|Overall Study||41
6580351|NCT01918332|7504400|FG002|STARTED|Overall Study||39
6580352|NCT01918332|7504401|FG003|STARTED|Overall Study||45
6580353|NCT01918332|7504398|FG000|COMPLETED|Overall Study||35
6580354|NCT01918332|7504399|FG001|COMPLETED|Overall Study||36
6580355|NCT01918332|7504400|FG002|COMPLETED|Overall Study||30
6580356|NCT01918332|7504401|FG003|COMPLETED|Overall Study||38
6580357|NCT01918332|7504398|FG000|NOT COMPLETED|Overall Study||8
6580358|NCT01918332|7504399|FG001|NOT COMPLETED|Overall Study||5
6580359|NCT01918332|7504400|FG002|NOT COMPLETED|Overall Study||9
6580360|NCT01918332|7504401|FG003|NOT COMPLETED|Overall Study||7
6658755|NCT02482675|7589430|FG012|STARTED|Overall Study||1
6658756|NCT02482675|7589431|FG013|STARTED|Overall Study||1
6658757|NCT02482675|7589432|FG014|STARTED|Overall Study||1
6658758|NCT02482675|7589433|FG015|STARTED|Overall Study||1
6658759|NCT02482675|7589434|FG016|STARTED|Overall Study||1
6658760|NCT02482675|7589435|FG017|STARTED|Overall Study||1
6658761|NCT02482675|7589436|FG018|STARTED|Overall Study||1
6658762|NCT02482675|7589437|FG019|STARTED|Overall Study||1
6658763|NCT02482675|7589438|FG020|STARTED|Overall Study||1
6580361|NCT01918371|7504413|FG000|STARTED|Overall Study||166
6580362|NCT01918371|7504414|FG001|STARTED|Overall Study||157
6580363|NCT01918371|7504413|FG000|Participants With Complete Data|Overall Study||165
6580364|NCT01918371|7504414|FG001|Participants With Complete Data|Overall Study||156
6580365|NCT01918371|7504413|FG000|COMPLETED|Overall Study||165
6580366|NCT01918371|7504414|FG001|COMPLETED|Overall Study||156
6580367|NCT01918371|7504413|FG000|NOT COMPLETED|Overall Study||1
6580368|NCT01918371|7504414|FG001|NOT COMPLETED|Overall Study||1
6580369|NCT01918761|7504420|FG000|STARTED|Overall Study||5
6580370|NCT01918761|7504420|FG000|COMPLETED|Overall Study||5
6580371|NCT01918761|7504420|FG000|NOT COMPLETED|Overall Study||0
6580372|NCT01918774|7504424|FG000|STARTED|Overall Study||57
6580373|NCT01918774|7504424|FG000|COMPLETED|Overall Study||52
6580374|NCT01918774|7504424|FG000|NOT COMPLETED|Overall Study||5
6580375|NCT01918800|7504430|FG000|STARTED|Overall Study||109
6580376|NCT01918800|7504431|FG001|STARTED|Overall Study||109
6580377|NCT01918800|7504430|FG000|COMPLETED|Overall Study||100
6580378|NCT01918800|7504431|FG001|COMPLETED|Overall Study||104
6580379|NCT01918800|7504430|FG000|NOT COMPLETED|Overall Study||9
6580380|NCT01918800|7504431|FG001|NOT COMPLETED|Overall Study||5
6580381|NCT01919112|7504440|FG000|STARTED|Primary Analysis-day 5 of Intervention||14
6580382|NCT01919112|7504441|FG001|STARTED|Primary Analysis-day 5 of Intervention||13
6580383|NCT01919112|7504442|FG002|STARTED|Primary Analysis-day 5 of Intervention||15
6580384|NCT01919112|7504440|FG000|COMPLETED|Primary Analysis-day 5 of Intervention||14
6580385|NCT01919112|7504441|FG001|COMPLETED|Primary Analysis-day 5 of Intervention||13
6580386|NCT01919112|7504442|FG002|COMPLETED|Primary Analysis-day 5 of Intervention||15
6580387|NCT01919112|7504440|FG000|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
6580388|NCT01919112|7504441|FG001|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
6580389|NCT01919112|7504442|FG002|NOT COMPLETED|Primary Analysis-day 5 of Intervention||0
6580390|NCT01919112|7504440|FG000|STARTED|Secondary Analysis-day 30||14
6580391|NCT01919112|7504441|FG001|STARTED|Secondary Analysis-day 30||13
6580392|NCT01919112|7504442|FG002|STARTED|Secondary Analysis-day 30||15
6580393|NCT01919112|7504440|FG000|COMPLETED|Secondary Analysis-day 30||12
6580394|NCT01919112|7504441|FG001|COMPLETED|Secondary Analysis-day 30||12
6580395|NCT01919112|7504442|FG002|COMPLETED|Secondary Analysis-day 30||14
6580396|NCT01919112|7504440|FG000|NOT COMPLETED|Secondary Analysis-day 30||2
6580397|NCT01919112|7504441|FG001|NOT COMPLETED|Secondary Analysis-day 30||1
6580398|NCT01919112|7504442|FG002|NOT COMPLETED|Secondary Analysis-day 30||1
6580399|NCT01919164|7504455|FG000|STARTED|Overall Study||108
6580400|NCT01919164|7504456|FG001|STARTED|Overall Study||110
6580401|NCT01919164|7504457|FG002|STARTED|Overall Study||111
6580402|NCT01919164|7504458|FG003|STARTED|Overall Study||110
6580403|NCT01919164|7504459|FG004|STARTED|Overall Study||110
6580404|NCT01919164|7504455|FG000|Safety Analysis Set|Overall Study||107
6580405|NCT01919164|7504456|FG001|Safety Analysis Set|Overall Study|1 participant assigned to Placebo arm who inadvertently received 30 mcg was included in this arm.|109
6580406|NCT01919164|7504457|FG002|Safety Analysis Set|Overall Study||111
6580407|NCT01919164|7504458|FG003|Safety Analysis Set|Overall Study|1 participant in Sprifermin2 Cycles arm who inadvertently received 100 mcg was included in this arm.|111
6580408|NCT01919164|7504459|FG004|Safety Analysis Set|Overall Study||109
6580409|NCT01919164|7504455|FG000|COMPLETED|Overall Study||65
6580410|NCT01919164|7504456|FG001|COMPLETED|Overall Study||80
6580411|NCT01919164|7504457|FG002|COMPLETED|Overall Study||74
6580412|NCT01919164|7504458|FG003|COMPLETED|Overall Study||82
6580413|NCT01919164|7504459|FG004|COMPLETED|Overall Study||77
6580414|NCT01919164|7504455|FG000|NOT COMPLETED|Overall Study||43
6580415|NCT01919164|7504456|FG001|NOT COMPLETED|Overall Study||30
6580416|NCT01919164|7504457|FG002|NOT COMPLETED|Overall Study||37
6580417|NCT01919164|7504458|FG003|NOT COMPLETED|Overall Study||28
6580418|NCT01919164|7504459|FG004|NOT COMPLETED|Overall Study||33
6580419|NCT01919190|7504473|FG000|STARTED|Overall Study|Met eligibility criteria|33
6580420|NCT01919190|7504474|FG001|STARTED|Overall Study|Met eligibility criteria|34
6580421|NCT01919190|7504473|FG000|COMPLETED|Overall Study||30
6580422|NCT01919190|7504474|FG001|COMPLETED|Overall Study||34
6580423|NCT01919190|7504473|FG000|NOT COMPLETED|Overall Study||3
6580424|NCT01919190|7504474|FG001|NOT COMPLETED|Overall Study||0
6580425|NCT01919216|7504484|FG000|STARTED|Overall Study||28
6580426|NCT01919216|7504485|FG001|STARTED|Overall Study||21
6580427|NCT01919216|7504486|FG002|STARTED|Overall Study||5
6580428|NCT01919216|7504484|FG000|COMPLETED|Overall Study||26
6580429|NCT01919216|7504485|FG001|COMPLETED|Overall Study||20
6580430|NCT01919216|7504486|FG002|COMPLETED|Overall Study||4
6580431|NCT01919216|7504484|FG000|NOT COMPLETED|Overall Study||2
6580432|NCT01919216|7504485|FG001|NOT COMPLETED|Overall Study||1
6580433|NCT01919216|7504486|FG002|NOT COMPLETED|Overall Study||1
6580434|NCT01919229|7504497|FG000|STARTED|Overall Study||4
6658764|NCT02482675|7589439|FG021|STARTED|Overall Study||1
6658765|NCT02482675|7589440|FG022|STARTED|Overall Study||1
6658766|NCT02482675|7589418|FG000|COMPLETED|Overall Study||1
6580435|NCT01919229|7504498|FG001|STARTED|Overall Study||6
6580436|NCT01919229|7504499|FG002|STARTED|Overall Study||4
6580437|NCT01919229|7504497|FG000|COMPLETED|Overall Study||4
6580438|NCT01919229|7504498|FG001|COMPLETED|Overall Study||6
6580439|NCT01919229|7504499|FG002|COMPLETED|Overall Study||3
6580440|NCT01919229|7504497|FG000|NOT COMPLETED|Overall Study||0
6580441|NCT01919229|7504498|FG001|NOT COMPLETED|Overall Study||0
6580442|NCT01919229|7504499|FG002|NOT COMPLETED|Overall Study||1
6580443|NCT01919307|7504507|FG000|STARTED|Overall Study||29
6580444|NCT01919307|7504507|FG000|COMPLETED|Overall Study||20
6580445|NCT01919307|7504507|FG000|NOT COMPLETED|Overall Study||9
6580446|NCT01919398|7504514|FG000|STARTED|Overall Study||3
6580447|NCT01919398|7504515|FG001|STARTED|Overall Study||3
6580448|NCT01919398|7504516|FG002|STARTED|Overall Study||13
6580449|NCT01919398|7504514|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6580450|NCT01919398|7504515|FG001|Received at Least One Dose of Study Drug|Overall Study||3
6580451|NCT01919398|7504516|FG002|Received at Least One Dose of Study Drug|Overall Study||13
6580452|NCT01919398|7504514|FG000|COMPLETED|Overall Study||3
6580453|NCT01919398|7504515|FG001|COMPLETED|Overall Study||3
6580454|NCT01919398|7504516|FG002|COMPLETED|Overall Study||9
6580455|NCT01919398|7504514|FG000|NOT COMPLETED|Overall Study||0
6580456|NCT01919398|7504515|FG001|NOT COMPLETED|Overall Study||0
6580457|NCT01919398|7504516|FG002|NOT COMPLETED|Overall Study||4
6580458|NCT01919411|7504526|FG000|STARTED|Overall Study||43
6580459|NCT01919411|7504527|FG001|STARTED|Overall Study||46
6580460|NCT01919411|7504526|FG000|COMPLETED|Overall Study||38
6580461|NCT01919411|7504527|FG001|COMPLETED|Overall Study||41
6580462|NCT01919411|7504526|FG000|NOT COMPLETED|Overall Study||5
6580463|NCT01919411|7504527|FG001|NOT COMPLETED|Overall Study||5
6580464|NCT01919450|7504537|FG000|STARTED|Overall Study||20
6580465|NCT01919450|7504538|FG001|STARTED|Overall Study||20
6580466|NCT01919450|7504539|FG002|STARTED|Overall Study||20
6580467|NCT01919450|7504540|FG003|STARTED|Overall Study||20
6580468|NCT01919450|7504537|FG000|COMPLETED|Overall Study||20
6580469|NCT01919450|7504538|FG001|COMPLETED|Overall Study||20
6580470|NCT01919450|7504539|FG002|COMPLETED|Overall Study||20
6580471|NCT01919450|7504540|FG003|COMPLETED|Overall Study||19
6580472|NCT01919450|7504537|FG000|NOT COMPLETED|Overall Study||0
6580473|NCT01919450|7504538|FG001|NOT COMPLETED|Overall Study||0
6580474|NCT01919450|7504539|FG002|NOT COMPLETED|Overall Study||0
6580475|NCT01919450|7504540|FG003|NOT COMPLETED|Overall Study||1
6580476|NCT01919489|7504552|FG000|STARTED|Overall Study||136
6580477|NCT01919489|7504553|FG001|STARTED|Overall Study||137
6580478|NCT01919489|7504552|FG000|COMPLETED|Overall Study||80
6580479|NCT01919489|7504553|FG001|COMPLETED|Overall Study||93
6580480|NCT01919489|7504552|FG000|NOT COMPLETED|Overall Study||56
6580481|NCT01919489|7504553|FG001|NOT COMPLETED|Overall Study||44
6580482|NCT01919606|7504561|FG000|STARTED|Overall Study||1
6580483|NCT01919606|7504562|FG001|STARTED|Overall Study||0
6580484|NCT01919606|7504561|FG000|COMPLETED|Overall Study||1
6580485|NCT01919606|7504562|FG001|COMPLETED|Overall Study||0
6580486|NCT01919606|7504561|FG000|NOT COMPLETED|Overall Study||0
6580487|NCT01919606|7504562|FG001|NOT COMPLETED|Overall Study||0
6580488|NCT01919697|7504570|FG000|STARTED|Overall Study||224
6580489|NCT01919697|7504571|FG001|STARTED|Overall Study||2146
6580490|NCT01919697|7504570|FG000|COMPLETED|Overall Study||171
6580491|NCT01919697|7504571|FG001|COMPLETED|Overall Study||1761
6580492|NCT01919697|7504570|FG000|NOT COMPLETED|Overall Study||53
6580493|NCT01919697|7504571|FG001|NOT COMPLETED|Overall Study||385
6580494|NCT01919723|7504580|FG000|STARTED|Overall Study||35
6580495|NCT01919723|7504581|FG001|STARTED|Overall Study||35
6580496|NCT01919723|7504580|FG000|COMPLETED|Overall Study||33
6580497|NCT01919723|7504581|FG001|COMPLETED|Overall Study||33
6580498|NCT01919723|7504580|FG000|NOT COMPLETED|Overall Study||2
6580499|NCT01919723|7504581|FG001|NOT COMPLETED|Overall Study||2
6580500|NCT01919801|7504589|FG000|STARTED|Overall Study||61
6580501|NCT01919801|7504590|FG001|STARTED|Overall Study||60
6580502|NCT01919801|7504589|FG000|COMPLETED|Overall Study||60
6580503|NCT01919801|7504590|FG001|COMPLETED|Overall Study||57
6580504|NCT01919801|7504589|FG000|NOT COMPLETED|Overall Study||1
6580505|NCT01919801|7504590|FG001|NOT COMPLETED|Overall Study||3
6580506|NCT01919814|7504596|FG000|STARTED|Overall Study||30
6580507|NCT01919814|7504597|FG001|STARTED|Overall Study||30
6580508|NCT01919814|7504596|FG000|COMPLETED|Overall Study||27
6580509|NCT01919814|7504597|FG001|COMPLETED|Overall Study||30
6580510|NCT01919814|7504596|FG000|NOT COMPLETED|Overall Study||3
6580511|NCT01919814|7504597|FG001|NOT COMPLETED|Overall Study||0
6580512|NCT01919970|7504605|FG000|STARTED|Overall Study||14
6580513|NCT01919970|7504606|FG001|STARTED|Overall Study||18
6580514|NCT01919970|7504605|FG000|COMPLETED|Overall Study||11
6580515|NCT01919970|7504606|FG001|COMPLETED|Overall Study||18
6580516|NCT01919970|7504605|FG000|NOT COMPLETED|Overall Study||3
6580517|NCT01919970|7504606|FG001|NOT COMPLETED|Overall Study||0
6580518|NCT01919996|7504612|FG000|STARTED|Overall Study||8
6580519|NCT01919996|7504612|FG000|COMPLETED|Overall Study||8
6580520|NCT01919996|7504612|FG000|NOT COMPLETED|Overall Study||0
6580521|NCT01920061|7504636|FG000|STARTED|Overall Study||4
6580522|NCT01920061|7504637|FG001|STARTED|Overall Study||5
6580523|NCT01920061|7504638|FG002|STARTED|Overall Study||3
6580524|NCT01920061|7504639|FG003|STARTED|Overall Study||4
6580525|NCT01920061|7504640|FG004|STARTED|Overall Study||5
6580526|NCT01920061|7504641|FG005|STARTED|Overall Study||4
6580527|NCT01920061|7504642|FG006|STARTED|Overall Study||3
6580528|NCT01920061|7504643|FG007|STARTED|Overall Study||3
6580529|NCT01920061|7504644|FG008|STARTED|Overall Study||3
6580530|NCT01920061|7504645|FG009|STARTED|Overall Study||3
6580531|NCT01920061|7504646|FG010|STARTED|Overall Study||10
6580532|NCT01920061|7504647|FG011|STARTED|Overall Study||5
6580533|NCT01920061|7504648|FG012|STARTED|Overall Study||3
6580534|NCT01920061|7504649|FG013|STARTED|Overall Study||16
6580535|NCT01920061|7504650|FG014|STARTED|Overall Study||4
6580536|NCT01920061|7504651|FG015|STARTED|Overall Study||7
6580537|NCT01920061|7504652|FG016|STARTED|Overall Study||3
6580538|NCT01920061|7504653|FG017|STARTED|Overall Study||3
6580539|NCT01920061|7504654|FG018|STARTED|Overall Study||10
6580540|NCT01920061|7504655|FG019|STARTED|Overall Study||12
6580541|NCT01920061|7504636|FG000|Received Treatment|Overall Study||4
6580542|NCT01920061|7504637|FG001|Received Treatment|Overall Study||5
6580543|NCT01920061|7504638|FG002|Received Treatment|Overall Study||3
6580544|NCT01920061|7504639|FG003|Received Treatment|Overall Study||3
6580545|NCT01920061|7504640|FG004|Received Treatment|Overall Study||5
6580546|NCT01920061|7504641|FG005|Received Treatment|Overall Study||4
6580547|NCT01920061|7504642|FG006|Received Treatment|Overall Study||3
6580548|NCT01920061|7504643|FG007|Received Treatment|Overall Study||3
6580549|NCT01920061|7504644|FG008|Received Treatment|Overall Study||3
6580550|NCT01920061|7504645|FG009|Received Treatment|Overall Study||3
6580551|NCT01920061|7504646|FG010|Received Treatment|Overall Study||10
6580552|NCT01920061|7504647|FG011|Received Treatment|Overall Study||5
6580553|NCT01920061|7504648|FG012|Received Treatment|Overall Study||2
6580554|NCT01920061|7504649|FG013|Received Treatment|Overall Study||15
6580555|NCT01920061|7504650|FG014|Received Treatment|Overall Study||4
6580556|NCT01920061|7504651|FG015|Received Treatment|Overall Study||7
6580557|NCT01920061|7504652|FG016|Received Treatment|Overall Study||3
6580558|NCT01920061|7504653|FG017|Received Treatment|Overall Study||3
6580559|NCT01920061|7504654|FG018|Received Treatment|Overall Study||10
6580560|NCT01920061|7504655|FG019|Received Treatment|Overall Study||12
6580561|NCT01920061|7504636|FG000|COMPLETED|Overall Study||2
6580562|NCT01920061|7504637|FG001|COMPLETED|Overall Study||1
6580563|NCT01920061|7504638|FG002|COMPLETED|Overall Study||1
6580564|NCT01920061|7504639|FG003|COMPLETED|Overall Study||2
6580565|NCT01920061|7504640|FG004|COMPLETED|Overall Study||3
6580566|NCT01920061|7504641|FG005|COMPLETED|Overall Study||2
6580567|NCT01920061|7504642|FG006|COMPLETED|Overall Study||2
6580568|NCT01920061|7504643|FG007|COMPLETED|Overall Study||2
6580569|NCT01920061|7504644|FG008|COMPLETED|Overall Study||2
6580570|NCT01920061|7504645|FG009|COMPLETED|Overall Study||1
6580571|NCT01920061|7504646|FG010|COMPLETED|Overall Study||5
6580572|NCT01920061|7504647|FG011|COMPLETED|Overall Study||2
6580573|NCT01920061|7504648|FG012|COMPLETED|Overall Study||1
6580574|NCT01920061|7504649|FG013|COMPLETED|Overall Study||10
6580575|NCT01920061|7504650|FG014|COMPLETED|Overall Study||3
6580576|NCT01920061|7504651|FG015|COMPLETED|Overall Study||4
6580577|NCT01920061|7504652|FG016|COMPLETED|Overall Study||1
6580578|NCT01920061|7504653|FG017|COMPLETED|Overall Study||1
6580579|NCT01920061|7504654|FG018|COMPLETED|Overall Study||4
6580580|NCT01920061|7504655|FG019|COMPLETED|Overall Study||8
6580581|NCT01920061|7504636|FG000|NOT COMPLETED|Overall Study||2
6580582|NCT01920061|7504637|FG001|NOT COMPLETED|Overall Study||4
6580583|NCT01920061|7504638|FG002|NOT COMPLETED|Overall Study||2
6580584|NCT01920061|7504639|FG003|NOT COMPLETED|Overall Study||2
6580585|NCT01920061|7504640|FG004|NOT COMPLETED|Overall Study||2
6580586|NCT01920061|7504641|FG005|NOT COMPLETED|Overall Study||2
6580587|NCT01920061|7504642|FG006|NOT COMPLETED|Overall Study||1
6658767|NCT02482675|7589419|FG001|COMPLETED|Overall Study||1
6658768|NCT02482675|7589420|FG002|COMPLETED|Overall Study||1
6658769|NCT02482675|7589421|FG003|COMPLETED|Overall Study||1
6658770|NCT02482675|7589422|FG004|COMPLETED|Overall Study||1
6658771|NCT02482675|7589423|FG005|COMPLETED|Overall Study||1
6658772|NCT02482675|7589424|FG006|COMPLETED|Overall Study||1
6658773|NCT02482675|7589425|FG007|COMPLETED|Overall Study||1
6658774|NCT02482675|7589426|FG008|COMPLETED|Overall Study||1
6658775|NCT02482675|7589427|FG009|COMPLETED|Overall Study||1
6658776|NCT02482675|7589428|FG010|COMPLETED|Overall Study||1
6658777|NCT02482675|7589429|FG011|COMPLETED|Overall Study||1
6658778|NCT02482675|7589430|FG012|COMPLETED|Overall Study||1
6658779|NCT02482675|7589431|FG013|COMPLETED|Overall Study||1
6658780|NCT02482675|7589432|FG014|COMPLETED|Overall Study||1
6658781|NCT02482675|7589433|FG015|COMPLETED|Overall Study||1
6658782|NCT02482675|7589434|FG016|COMPLETED|Overall Study||1
6658783|NCT02482675|7589435|FG017|COMPLETED|Overall Study||1
6658784|NCT02482675|7589436|FG018|COMPLETED|Overall Study||1
6658785|NCT02482675|7589437|FG019|COMPLETED|Overall Study||1
6658786|NCT02482675|7589438|FG020|COMPLETED|Overall Study||1
6658787|NCT02482675|7589439|FG021|COMPLETED|Overall Study||1
6658788|NCT02482675|7589440|FG022|COMPLETED|Overall Study||1
6658789|NCT02482675|7589418|FG000|NOT COMPLETED|Overall Study||0
6658790|NCT02482675|7589419|FG001|NOT COMPLETED|Overall Study||0
6658791|NCT02482675|7589420|FG002|NOT COMPLETED|Overall Study||0
6658792|NCT02482675|7589421|FG003|NOT COMPLETED|Overall Study||0
6658793|NCT02482675|7589422|FG004|NOT COMPLETED|Overall Study||0
6658794|NCT02482675|7589423|FG005|NOT COMPLETED|Overall Study||0
6658795|NCT02482675|7589424|FG006|NOT COMPLETED|Overall Study||0
6580588|NCT01920061|7504643|FG007|NOT COMPLETED|Overall Study||1
6580589|NCT01920061|7504644|FG008|NOT COMPLETED|Overall Study||1
6658796|NCT02482675|7589425|FG007|NOT COMPLETED|Overall Study||0
6658797|NCT02482675|7589426|FG008|NOT COMPLETED|Overall Study||0
6580590|NCT01920061|7504645|FG009|NOT COMPLETED|Overall Study||2
6580591|NCT01920061|7504646|FG010|NOT COMPLETED|Overall Study||5
6580592|NCT01920061|7504647|FG011|NOT COMPLETED|Overall Study||3
6580593|NCT01920061|7504648|FG012|NOT COMPLETED|Overall Study||2
6580594|NCT01920061|7504649|FG013|NOT COMPLETED|Overall Study||6
6580595|NCT01920061|7504650|FG014|NOT COMPLETED|Overall Study||1
6580596|NCT01920061|7504651|FG015|NOT COMPLETED|Overall Study||3
6580597|NCT01920061|7504652|FG016|NOT COMPLETED|Overall Study||2
6580598|NCT01920061|7504653|FG017|NOT COMPLETED|Overall Study||2
6580599|NCT01920061|7504654|FG018|NOT COMPLETED|Overall Study||6
6580600|NCT01920061|7504655|FG019|NOT COMPLETED|Overall Study||4
6580601|NCT01920152|7504720|FG000|STARTED|Overall Study||19
6580602|NCT01920152|7504721|FG001|STARTED|Overall Study||15
6580603|NCT01920152|7504720|FG000|COMPLETED|Overall Study||18
6580604|NCT01920152|7504721|FG001|COMPLETED|Overall Study||13
6580605|NCT01920152|7504720|FG000|NOT COMPLETED|Overall Study||1
6580606|NCT01920152|7504721|FG001|NOT COMPLETED|Overall Study||2
6580607|NCT01920178|7504729|FG000|STARTED|Overall Study||5
6580608|NCT01920178|7504730|FG001|STARTED|Overall Study||2
6580609|NCT01920178|7504729|FG000|COMPLETED|Overall Study||3
6580610|NCT01920178|7504730|FG001|COMPLETED|Overall Study||1
6580611|NCT01920178|7504729|FG000|NOT COMPLETED|Overall Study||2
6580612|NCT01920178|7504730|FG001|NOT COMPLETED|Overall Study||1
6580613|NCT01920282|7504739|FG000|STARTED|Overall Study||15
6580614|NCT01920282|7504740|FG001|STARTED|Overall Study||15
6580615|NCT01920282|7504741|FG002|STARTED|Overall Study||15
6580616|NCT01920282|7504739|FG000|COMPLETED|Overall Study||15
6580617|NCT01920282|7504740|FG001|COMPLETED|Overall Study||15
6580618|NCT01920282|7504741|FG002|COMPLETED|Overall Study||15
6580619|NCT01920282|7504739|FG000|NOT COMPLETED|Overall Study||0
6580620|NCT01920282|7504740|FG001|NOT COMPLETED|Overall Study||0
6580621|NCT01920282|7504741|FG002|NOT COMPLETED|Overall Study||0
6580622|NCT01920477|7504751|FG000|STARTED|Overall Study||17
6580623|NCT01920477|7504752|FG001|STARTED|Overall Study||18
6580624|NCT01920477|7504751|FG000|Requiried Individualized Follow-up|Overall Study||1
6580625|NCT01920477|7504752|FG001|Requiried Individualized Follow-up|Overall Study||0
6580626|NCT01920477|7504751|FG000|COMPLETED|Overall Study||2
6580627|NCT01920477|7504752|FG001|COMPLETED|Overall Study||1
6580628|NCT01920477|7504751|FG000|NOT COMPLETED|Overall Study||15
6580629|NCT01920477|7504752|FG001|NOT COMPLETED|Overall Study||17
6580630|NCT01920555|7504763|FG000|STARTED|Overall Study||18
6580631|NCT01920555|7504764|FG001|STARTED|Overall Study||20
6580632|NCT01920555|7504765|FG002|STARTED|Overall Study||22
6580633|NCT01920555|7504766|FG003|STARTED|Overall Study||20
6580634|NCT01920555|7504767|FG004|STARTED|Overall Study||19
6580635|NCT01920555|7504763|FG000|COMPLETED|Overall Study||14
6580636|NCT01920555|7504764|FG001|COMPLETED|Overall Study||16
6580637|NCT01920555|7504765|FG002|COMPLETED|Overall Study||21
6580638|NCT01920555|7504766|FG003|COMPLETED|Overall Study||17
6580639|NCT01920555|7504767|FG004|COMPLETED|Overall Study||18
6580640|NCT01920555|7504763|FG000|NOT COMPLETED|Overall Study||4
6580641|NCT01920555|7504764|FG001|NOT COMPLETED|Overall Study||4
6580642|NCT01920555|7504765|FG002|NOT COMPLETED|Overall Study||1
6580643|NCT01920555|7504766|FG003|NOT COMPLETED|Overall Study||3
6580644|NCT01920555|7504767|FG004|NOT COMPLETED|Overall Study||1
6580645|NCT01920568|7504781|FG000|STARTED|Overall Study||326
6580646|NCT01920568|7504782|FG001|STARTED|Overall Study||159
6580647|NCT01920568|7504781|FG000|COMPLETED|Overall Study||175
6580648|NCT01920568|7504782|FG001|COMPLETED|Overall Study||75
6580649|NCT01920568|7504781|FG000|NOT COMPLETED|Overall Study||151
6580650|NCT01920568|7504782|FG001|NOT COMPLETED|Overall Study||84
6580651|NCT01920594|7504791|FG000|STARTED|Overall Study||27
6580652|NCT01920594|7504792|FG001|STARTED|Overall Study||28
6580653|NCT01920594|7504791|FG000|COMPLETED|Overall Study||20
6580654|NCT01920594|7504792|FG001|COMPLETED|Overall Study||25
6580655|NCT01920594|7504791|FG000|NOT COMPLETED|Overall Study||7
6580656|NCT01920594|7504792|FG001|NOT COMPLETED|Overall Study||3
6580657|NCT01920711|7504800|FG000|STARTED|Overall Study||2419
6580658|NCT01920711|7504801|FG001|STARTED|Overall Study||2403
6580659|NCT01920711|7504800|FG000|COMPLETED|Overall Study||2055
6580660|NCT01920711|7504801|FG001|COMPLETED|Overall Study||2030
6580661|NCT01920711|7504800|FG000|NOT COMPLETED|Overall Study||364
6580662|NCT01920711|7504801|FG001|NOT COMPLETED|Overall Study||373
6580663|NCT01920802|7504811|FG000|STARTED|Overall Study||11
6580664|NCT01920802|7504812|FG001|STARTED|Overall Study||9
6580665|NCT01920802|7504813|FG002|STARTED|Overall Study||11
6580666|NCT01920802|7504811|FG000|COMPLETED|Overall Study||7
6580667|NCT01920802|7504812|FG001|COMPLETED|Overall Study||7
6580668|NCT01920802|7504813|FG002|COMPLETED|Overall Study||10
6580669|NCT01920802|7504811|FG000|NOT COMPLETED|Overall Study||4
6580670|NCT01920802|7504812|FG001|NOT COMPLETED|Overall Study||2
6580671|NCT01920802|7504813|FG002|NOT COMPLETED|Overall Study||1
6580672|NCT01920854|7504828|FG000|STARTED|Overall Study||12
6580673|NCT01920854|7504829|FG001|STARTED|Overall Study||6
6580674|NCT01920854|7504830|FG002|STARTED|Overall Study||6
6580675|NCT01920854|7504831|FG003|STARTED|Overall Study||6
6580676|NCT01920854|7504832|FG004|STARTED|Overall Study||6
6580677|NCT01920854|7504833|FG005|STARTED|Overall Study||6
6580678|NCT01920854|7504834|FG006|STARTED|Overall Study||6
6580679|NCT01920854|7504828|FG000|COMPLETED|Overall Study||11
6580680|NCT01920854|7504829|FG001|COMPLETED|Overall Study||6
6580681|NCT01920854|7504830|FG002|COMPLETED|Overall Study||6
6580682|NCT01920854|7504831|FG003|COMPLETED|Overall Study||6
6580683|NCT01920854|7504832|FG004|COMPLETED|Overall Study||5
6580684|NCT01920854|7504833|FG005|COMPLETED|Overall Study||6
6580685|NCT01920854|7504834|FG006|COMPLETED|Overall Study||5
6580686|NCT01920854|7504828|FG000|NOT COMPLETED|Overall Study||1
6580687|NCT01920854|7504829|FG001|NOT COMPLETED|Overall Study||0
6580688|NCT01920854|7504830|FG002|NOT COMPLETED|Overall Study||0
6580689|NCT01920854|7504831|FG003|NOT COMPLETED|Overall Study||0
6580690|NCT01920854|7504832|FG004|NOT COMPLETED|Overall Study||1
6580691|NCT01920854|7504833|FG005|NOT COMPLETED|Overall Study||0
6580692|NCT01920854|7504834|FG006|NOT COMPLETED|Overall Study||1
6580693|NCT01920893|7504871|FG000|STARTED|Overall Study||30
6580694|NCT01920893|7504872|FG001|STARTED|Overall Study||30
6580695|NCT01920893|7504871|FG000|Treated (Safety Population)|Overall Study||30
6580696|NCT01920893|7504872|FG001|Treated (Safety Population)|Overall Study||30
6580697|NCT01920893|7504871|FG000|COMPLETED|Overall Study||23
6580698|NCT01920893|7504872|FG001|COMPLETED|Overall Study||28
6580699|NCT01920893|7504871|FG000|NOT COMPLETED|Overall Study||7
6580700|NCT01920893|7504872|FG001|NOT COMPLETED|Overall Study||2
6580701|NCT01920958|7504879|FG000|STARTED|Overall Study||233
6580702|NCT01920958|7504879|FG000|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
6580703|NCT01920958|7504879|FG000|NOT COMPLETED|Overall Study||5
6580704|NCT01921101|7504885|FG000|STARTED|Overall Study||40
6580705|NCT01921101|7504886|FG001|STARTED|Overall Study||38
6580706|NCT01921101|7504885|FG000|COMPLETED|Overall Study||24
6580707|NCT01921101|7504886|FG001|COMPLETED|Overall Study||32
6580708|NCT01921101|7504885|FG000|NOT COMPLETED|Overall Study||16
6580709|NCT01921101|7504886|FG001|NOT COMPLETED|Overall Study||6
6580710|NCT01921179|7504894|FG000|STARTED|5 Week Randomized GOALS vs EDU Training||24
6580711|NCT01921179|7504895|FG001|STARTED|5 Week Randomized GOALS vs EDU Training||22
6580712|NCT01921179|7504894|FG000|COMPLETED|5 Week Randomized GOALS vs EDU Training||21
6580713|NCT01921179|7504895|FG001|COMPLETED|5 Week Randomized GOALS vs EDU Training||19
6580714|NCT01921179|7504894|FG000|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
6580715|NCT01921179|7504895|FG001|NOT COMPLETED|5 Week Randomized GOALS vs EDU Training||3
6580716|NCT01921179|7504894|FG000|STARTED|Long Term Follow-up After GOALS Training||34
6580717|NCT01921179|7504895|FG001|STARTED|Long Term Follow-up After GOALS Training|13 out of 19 participants who completed EDU, also completed GOALS training|0
6580718|NCT01921179|7504894|FG000|COMPLETED|Long Term Follow-up After GOALS Training||32
6580719|NCT01921179|7504895|FG001|COMPLETED|Long Term Follow-up After GOALS Training||0
6580720|NCT01921179|7504894|FG000|NOT COMPLETED|Long Term Follow-up After GOALS Training||2
6580721|NCT01921179|7504895|FG001|NOT COMPLETED|Long Term Follow-up After GOALS Training||0
6580722|NCT01921205|7504904|FG000|STARTED|Overall Study||172
6580723|NCT01921205|7504905|FG001|STARTED|Overall Study||171
6580724|NCT01921205|7504904|FG000|COMPLETED|Overall Study||151
6580725|NCT01921205|7504905|FG001|COMPLETED|Overall Study||151
6580726|NCT01921205|7504904|FG000|NOT COMPLETED|Overall Study||21
6580727|NCT01921205|7504905|FG001|NOT COMPLETED|Overall Study||20
6580728|NCT01921257|7504911|FG000|STARTED|Overall Study||16
6580729|NCT01921257|7504911|FG000|Placebo run-in|Overall Study||16
6580730|NCT01921257|7504911|FG000|Active Treatment|Overall Study||13
6580731|NCT01921257|7504911|FG000|COMPLETED|Overall Study||13
6580732|NCT01921257|7504911|FG000|NOT COMPLETED|Overall Study||3
6580733|NCT01921270|7504916|FG000|STARTED|Overall Study||18
6580734|NCT01921270|7504916|FG000|COMPLETED|Overall Study||17
6580735|NCT01921270|7504916|FG000|NOT COMPLETED|Overall Study||1
6580736|NCT01921296|7504920|FG000|STARTED|Overall Study||2
6580737|NCT01921296|7504920|FG000|COMPLETED|Overall Study||2
6580738|NCT01921296|7504920|FG000|NOT COMPLETED|Overall Study||0
6580739|NCT01921322|7504926|FG000|STARTED|Overall Study||57
6580740|NCT01921322|7504927|FG001|STARTED|Overall Study||61
6580741|NCT01921322|7504926|FG000|COMPLETED|Overall Study||42
6580742|NCT01921322|7504927|FG001|COMPLETED|Overall Study||44
6580743|NCT01921322|7504926|FG000|NOT COMPLETED|Overall Study||15
6580744|NCT01921322|7504927|FG001|NOT COMPLETED|Overall Study||17
6580745|NCT01921348|7504935|FG000|STARTED|Overall Study||9
6580746|NCT01921348|7504936|FG001|STARTED|Overall Study||9
6580747|NCT01921348|7504935|FG000|COMPLETED|Overall Study||8
6580748|NCT01921348|7504936|FG001|COMPLETED|Overall Study||7
6580749|NCT01921348|7504935|FG000|NOT COMPLETED|Overall Study||1
6580750|NCT01921348|7504936|FG001|NOT COMPLETED|Overall Study||2
6580751|NCT01921387|7504942|FG000|STARTED|Overall Study||20
6580752|NCT01921387|7504942|FG000|COMPLETED|Overall Study||19
6580753|NCT01921387|7504942|FG000|NOT COMPLETED|Overall Study||1
6580754|NCT01921452|7504946|FG000|STARTED|Overall Study||283
6580755|NCT01921452|7504946|FG000|COMPLETED|Overall Study||283
6580756|NCT01921452|7504946|FG000|NOT COMPLETED|Overall Study||0
6580757|NCT01921517|7504953|FG000|STARTED|Overall Study||42
6580758|NCT01921517|7504954|FG001|STARTED|Overall Study||38
6580759|NCT01921517|7504953|FG000|COMPLETED|Overall Study||27
6580760|NCT01921517|7504954|FG001|COMPLETED|Overall Study||29
6580761|NCT01921517|7504953|FG000|NOT COMPLETED|Overall Study||15
6580762|NCT01921517|7504954|FG001|NOT COMPLETED|Overall Study||9
6580763|NCT01921634|7504960|FG000|STARTED|Overall Study||300
6580764|NCT01921634|7504960|FG000|COMPLETED|Overall Study||300
6580765|NCT01921634|7504960|FG000|NOT COMPLETED|Overall Study||0
6580766|NCT01921751|7504968|FG000|STARTED|Overall Study||4
6580767|NCT01921751|7504969|FG001|STARTED|Overall Study||4
6580768|NCT01921751|7504970|FG002|STARTED|Overall Study||5
6580769|NCT01921751|7504968|FG000|COMPLETED|Overall Study|All randomized patients are reported here.|4
6580770|NCT01921751|7504969|FG001|COMPLETED|Overall Study|All randomized patients are reported here.|4
6580771|NCT01921751|7504970|FG002|COMPLETED|Overall Study|All randomized patients are reported here.|5
6580772|NCT01921751|7504968|FG000|NOT COMPLETED|Overall Study||0
6580773|NCT01921751|7504969|FG001|NOT COMPLETED|Overall Study||0
6580774|NCT01921751|7504970|FG002|NOT COMPLETED|Overall Study||0
6580775|NCT01921829|7504981|FG000|STARTED|Overall Study||10
6580776|NCT01921829|7504982|FG001|STARTED|Overall Study||9
6580777|NCT01921829|7504981|FG000|COMPLETED|Overall Study||10
6580778|NCT01921829|7504982|FG001|COMPLETED|Overall Study||8
6580779|NCT01921829|7504981|FG000|NOT COMPLETED|Overall Study||0
6580780|NCT01921829|7504982|FG001|NOT COMPLETED|Overall Study||1
6580781|NCT01921894|7504991|FG000|STARTED|Overall Study||8
6580782|NCT01921894|7504992|FG001|STARTED|Overall Study||8
6580783|NCT01921894|7504993|FG002|STARTED|Overall Study||8
6580784|NCT01921894|7504991|FG000|COMPLETED|Overall Study||8
6580785|NCT01921894|7504992|FG001|COMPLETED|Overall Study||8
6580786|NCT01921894|7504993|FG002|COMPLETED|Overall Study||8
6580787|NCT01921894|7504991|FG000|NOT COMPLETED|Overall Study||0
6580788|NCT01921894|7504992|FG001|NOT COMPLETED|Overall Study||0
6580789|NCT01921894|7504993|FG002|NOT COMPLETED|Overall Study||0
6580790|NCT01922011|7505015|FG000|STARTED|Overall Study|Randomized participants|75
6580791|NCT01922011|7505016|FG001|STARTED|Overall Study|Randomized participants|74
6580792|NCT01922011|7505015|FG000|Treated|Overall Study|Treated Participants|73
6580793|NCT01922011|7505016|FG001|Treated|Overall Study|Treated Participants|73
6580794|NCT01922011|7505015|FG000|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
6580795|NCT01922011|7505016|FG001|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
6580796|NCT01922011|7505015|FG000|COMPLETED|Overall Study||69
6580797|NCT01922011|7505016|FG001|COMPLETED|Overall Study||69
6580798|NCT01922011|7505015|FG000|NOT COMPLETED|Overall Study||6
6580799|NCT01922011|7505016|FG001|NOT COMPLETED|Overall Study||5
6580800|NCT01922024|7505030|FG000|STARTED|Overall Study||1653
6580801|NCT01922024|7505031|FG001|STARTED|Overall Study||471
6580802|NCT01922024|7505030|FG000|COMPLETED|Overall Study||1653
6580803|NCT01922024|7505031|FG001|COMPLETED|Overall Study||471
6580804|NCT01922024|7505030|FG000|NOT COMPLETED|Overall Study||0
6580805|NCT01922024|7505031|FG001|NOT COMPLETED|Overall Study||0
6580806|NCT01922037|7505039|FG000|STARTED|Overall Study||69
6580807|NCT01922037|7505040|FG001|STARTED|Overall Study||737
6580808|NCT01922037|7505039|FG000|Treated|Overall Study||69
6580809|NCT01922037|7505040|FG001|Treated|Overall Study||732
6580810|NCT01922037|7505039|FG000|COMPLETED|Overall Study||59
6580811|NCT01922037|7505040|FG001|COMPLETED|Overall Study||563
6580812|NCT01922037|7505039|FG000|NOT COMPLETED|Overall Study||10
6580813|NCT01922037|7505040|FG001|NOT COMPLETED|Overall Study||174
6580814|NCT01922050|7505062|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||3
6580815|NCT01922050|7505063|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||3
6580816|NCT01922050|7505064|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||6
6580817|NCT01922050|7505065|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||6
6580818|NCT01922050|7505066|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||17
6580819|NCT01922050|7505067|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||18
6580820|NCT01922050|7505068|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||3
6580821|NCT01922050|7505069|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||3
6580822|NCT01922050|7505070|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||6
6580823|NCT01922050|7505071|FG009|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6580824|NCT01922050|7505072|FG010|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6580825|NCT01922050|7505073|FG011|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6580826|NCT01922050|7505074|FG012|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6580827|NCT01922050|7505075|FG013|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6580828|NCT01922050|7505062|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
6580829|NCT01922050|7505063|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
6580830|NCT01922050|7505064|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
6580831|NCT01922050|7505065|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
6580832|NCT01922050|7505066|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||17
6580833|NCT01922050|7505067|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||18
6580834|NCT01922050|7505068|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
6580835|NCT01922050|7505069|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||3
6580836|NCT01922050|7505070|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||6
6580837|NCT01922050|7505071|FG009|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6580838|NCT01922050|7505072|FG010|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580839|NCT01922050|7505073|FG011|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580840|NCT01922050|7505074|FG012|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580841|NCT01922050|7505075|FG013|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580842|NCT01922050|7505062|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580843|NCT01922050|7505063|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580844|NCT01922050|7505064|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580845|NCT01922050|7505065|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580846|NCT01922050|7505066|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580847|NCT01922050|7505067|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580848|NCT01922050|7505068|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580849|NCT01922050|7505069|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580850|NCT01922050|7505070|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580851|NCT01922050|7505071|FG009|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580852|NCT01922050|7505072|FG010|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580853|NCT01922050|7505073|FG011|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580854|NCT01922050|7505074|FG012|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580855|NCT01922050|7505075|FG013|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6580856|NCT01922050|7505062|FG000|STARTED|Part 2 Double-blind Phase||0
6580857|NCT01922050|7505063|FG001|STARTED|Part 2 Double-blind Phase||0
6580858|NCT01922050|7505064|FG002|STARTED|Part 2 Double-blind Phase||0
6580859|NCT01922050|7505065|FG003|STARTED|Part 2 Double-blind Phase||0
6580860|NCT01922050|7505066|FG004|STARTED|Part 2 Double-blind Phase||0
6580861|NCT01922050|7505067|FG005|STARTED|Part 2 Double-blind Phase||0
6580862|NCT01922050|7505068|FG006|STARTED|Part 2 Double-blind Phase||0
6580863|NCT01922050|7505069|FG007|STARTED|Part 2 Double-blind Phase||0
6580864|NCT01922050|7505070|FG008|STARTED|Part 2 Double-blind Phase||0
6580865|NCT01922050|7505071|FG009|STARTED|Part 2 Double-blind Phase||0
6580866|NCT01922050|7505072|FG010|STARTED|Part 2 Double-blind Phase||62
6580867|NCT01922050|7505073|FG011|STARTED|Part 2 Double-blind Phase||60
6580868|NCT01922050|7505074|FG012|STARTED|Part 2 Double-blind Phase||62
6580869|NCT01922050|7505075|FG013|STARTED|Part 2 Double-blind Phase||59
6580870|NCT01922050|7505062|FG000|COMPLETED|Part 2 Double-blind Phase||0
6580871|NCT01922050|7505063|FG001|COMPLETED|Part 2 Double-blind Phase||0
6580872|NCT01922050|7505064|FG002|COMPLETED|Part 2 Double-blind Phase||0
6580873|NCT01922050|7505065|FG003|COMPLETED|Part 2 Double-blind Phase||0
6580874|NCT01922050|7505066|FG004|COMPLETED|Part 2 Double-blind Phase||0
6580875|NCT01922050|7505067|FG005|COMPLETED|Part 2 Double-blind Phase||0
6580876|NCT01922050|7505068|FG006|COMPLETED|Part 2 Double-blind Phase||0
6580877|NCT01922050|7505069|FG007|COMPLETED|Part 2 Double-blind Phase||0
6580878|NCT01922050|7505070|FG008|COMPLETED|Part 2 Double-blind Phase||0
6580879|NCT01922050|7505071|FG009|COMPLETED|Part 2 Double-blind Phase||0
6580880|NCT01922050|7505072|FG010|COMPLETED|Part 2 Double-blind Phase||61
6580881|NCT01922050|7505073|FG011|COMPLETED|Part 2 Double-blind Phase||58
6580882|NCT01922050|7505074|FG012|COMPLETED|Part 2 Double-blind Phase||62
6580883|NCT01922050|7505075|FG013|COMPLETED|Part 2 Double-blind Phase||56
6580884|NCT01922050|7505062|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
6580885|NCT01922050|7505063|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
6580886|NCT01922050|7505064|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
6580887|NCT01922050|7505065|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
6580888|NCT01922050|7505066|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
6580889|NCT01922050|7505067|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
6580890|NCT01922050|7505068|FG006|NOT COMPLETED|Part 2 Double-blind Phase||0
6580891|NCT01922050|7505069|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
6580892|NCT01922050|7505070|FG008|NOT COMPLETED|Part 2 Double-blind Phase||0
6580893|NCT01922050|7505071|FG009|NOT COMPLETED|Part 2 Double-blind Phase||0
6580894|NCT01922050|7505072|FG010|NOT COMPLETED|Part 2 Double-blind Phase||1
6580895|NCT01922050|7505073|FG011|NOT COMPLETED|Part 2 Double-blind Phase||2
6580896|NCT01922050|7505074|FG012|NOT COMPLETED|Part 2 Double-blind Phase||0
6580897|NCT01922050|7505075|FG013|NOT COMPLETED|Part 2 Double-blind Phase||3
6580898|NCT01922089|7505107|FG000|STARTED|Overall Study||247
6580899|NCT01922089|7505108|FG001|STARTED|Overall Study||251
6580900|NCT01922089|7505107|FG000|Safety Set|Overall Study||246
6580901|NCT01922089|7505108|FG001|Safety Set|Overall Study||251
6580902|NCT01922089|7505107|FG000|COMPLETED|Overall Study||208
6580903|NCT01922089|7505108|FG001|COMPLETED|Overall Study||221
6580904|NCT01922089|7505107|FG000|NOT COMPLETED|Overall Study||39
6580905|NCT01922089|7505108|FG001|NOT COMPLETED|Overall Study||30
6580906|NCT01922102|7505117|FG000|STARTED|Overall Study||182
6580907|NCT01922102|7505118|FG001|STARTED|Overall Study||184
6580908|NCT01922102|7505119|FG002|STARTED|Overall Study||91
6580909|NCT01922102|7505117|FG000|COMPLETED|Overall Study||173
6580910|NCT01922102|7505118|FG001|COMPLETED|Overall Study||175
6580911|NCT01922102|7505119|FG002|COMPLETED|Overall Study||83
6580912|NCT01922102|7505117|FG000|NOT COMPLETED|Overall Study||9
6580913|NCT01922102|7505118|FG001|NOT COMPLETED|Overall Study||9
6580914|NCT01922102|7505119|FG002|NOT COMPLETED|Overall Study||8
6580915|NCT01922115|7505133|FG000|STARTED|Overall Study||28
6580916|NCT01922115|7505134|FG001|STARTED|Overall Study||31
6580917|NCT01922115|7505133|FG000|COMPLETED|Overall Study||21
6580918|NCT01922115|7505134|FG001|COMPLETED|Overall Study||24
6580919|NCT01922115|7505133|FG000|NOT COMPLETED|Overall Study||7
6580920|NCT01922115|7505134|FG001|NOT COMPLETED|Overall Study||7
6580921|NCT01922219|7505140|FG000|STARTED|Overall Study||37
6580922|NCT01922219|7505140|FG000|COMPLETED|Overall Study||28
6580923|NCT01922219|7505140|FG000|NOT COMPLETED|Overall Study||9
6580924|NCT01922258|7505146|FG000|STARTED|Overall Study||133
6580925|NCT01922258|7505147|FG001|STARTED|Overall Study||137
6580926|NCT01922258|7505146|FG000|COMPLETED|Overall Study||117
6580927|NCT01922258|7505147|FG001|COMPLETED|Overall Study||121
6580928|NCT01922258|7505146|FG000|NOT COMPLETED|Overall Study||16
6580929|NCT01922258|7505147|FG001|NOT COMPLETED|Overall Study||16
6580930|NCT01922271|7505155|FG000|STARTED|PERIOD 1||76
6580931|NCT01922271|7505156|FG001|STARTED|PERIOD 1||76
6580932|NCT01922271|7505155|FG000|COMPLETED|PERIOD 1||76
6580933|NCT01922271|7505156|FG001|COMPLETED|PERIOD 1||76
6580934|NCT01922271|7505155|FG000|NOT COMPLETED|PERIOD 1||0
6580935|NCT01922271|7505156|FG001|NOT COMPLETED|PERIOD 1||0
6580936|NCT01922271|7505155|FG000|STARTED|WASHOUT Period||76
6580937|NCT01922271|7505156|FG001|STARTED|WASHOUT Period||76
6580938|NCT01922271|7505155|FG000|COMPLETED|WASHOUT Period||75
6580939|NCT01922271|7505156|FG001|COMPLETED|WASHOUT Period||76
6580940|NCT01922271|7505155|FG000|NOT COMPLETED|WASHOUT Period||1
6580941|NCT01922271|7505156|FG001|NOT COMPLETED|WASHOUT Period||0
6580942|NCT01922271|7505155|FG000|STARTED|PERIOD 2||75
6580943|NCT01922271|7505156|FG001|STARTED|PERIOD 2||76
6580944|NCT01922271|7505155|FG000|COMPLETED|PERIOD 2||75
6580945|NCT01922271|7505156|FG001|COMPLETED|PERIOD 2||76
6580946|NCT01922271|7505155|FG000|NOT COMPLETED|PERIOD 2||0
6580947|NCT01922271|7505156|FG001|NOT COMPLETED|PERIOD 2||0
6580948|NCT01922336|7505165|FG000|STARTED|Overall Study||53
6580949|NCT01922336|7505166|FG001|STARTED|Overall Study||53
6580950|NCT01922336|7505167|FG002|STARTED|Overall Study||53
6580951|NCT01922336|7505165|FG000|COMPLETED|Overall Study||53
6580952|NCT01922336|7505166|FG001|COMPLETED|Overall Study||53
6580953|NCT01922336|7505167|FG002|COMPLETED|Overall Study||53
6580954|NCT01922336|7505165|FG000|NOT COMPLETED|Overall Study||0
6580955|NCT01922336|7505166|FG001|NOT COMPLETED|Overall Study||0
6580956|NCT01922336|7505167|FG002|NOT COMPLETED|Overall Study||0
6580957|NCT01922349|7505179|FG000|STARTED|Single Rising Dose (SRD) Period||25
6580958|NCT01922349|7505180|FG001|STARTED|Single Rising Dose (SRD) Period||27
6580959|NCT01922349|7505181|FG002|STARTED|Single Rising Dose (SRD) Period||18
6580960|NCT01922349|7505182|FG003|STARTED|Single Rising Dose (SRD) Period||27
6580961|NCT01922349|7505179|FG000|COMPLETED|Single Rising Dose (SRD) Period||25
6580962|NCT01922349|7505180|FG001|COMPLETED|Single Rising Dose (SRD) Period||27
6580963|NCT01922349|7505181|FG002|COMPLETED|Single Rising Dose (SRD) Period||18
6580964|NCT01922349|7505182|FG003|COMPLETED|Single Rising Dose (SRD) Period||27
6580965|NCT01922349|7505179|FG000|NOT COMPLETED|Single Rising Dose (SRD) Period||0
6580966|NCT01922349|7505180|FG001|NOT COMPLETED|Single Rising Dose (SRD) Period||0
6580967|NCT01922349|7505181|FG002|NOT COMPLETED|Single Rising Dose (SRD) Period||0
6580968|NCT01922349|7505182|FG003|NOT COMPLETED|Single Rising Dose (SRD) Period||0
6580969|NCT01922349|7505179|FG000|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
6580970|NCT01922349|7505180|FG001|STARTED|Multiple Rising Dose (MRD) Period||27
6580971|NCT01922349|7505181|FG002|STARTED|Multiple Rising Dose (MRD) Period||18
6580972|NCT01922349|7505182|FG003|STARTED|Multiple Rising Dose (MRD) Period||27
6580973|NCT01922349|7505179|FG000|COMPLETED|Multiple Rising Dose (MRD) Period||24
6580974|NCT01922349|7505180|FG001|COMPLETED|Multiple Rising Dose (MRD) Period||27
6580975|NCT01922349|7505181|FG002|COMPLETED|Multiple Rising Dose (MRD) Period||18
6580976|NCT01922349|7505182|FG003|COMPLETED|Multiple Rising Dose (MRD) Period||26
6658798|NCT02482675|7589427|FG009|NOT COMPLETED|Overall Study||0
6658799|NCT02482675|7589428|FG010|NOT COMPLETED|Overall Study||0
6658800|NCT02482675|7589429|FG011|NOT COMPLETED|Overall Study||0
6658801|NCT02482675|7589430|FG012|NOT COMPLETED|Overall Study||0
6658802|NCT02482675|7589431|FG013|NOT COMPLETED|Overall Study||0
6658803|NCT02482675|7589432|FG014|NOT COMPLETED|Overall Study||0
6658804|NCT02482675|7589433|FG015|NOT COMPLETED|Overall Study||0
6658805|NCT02482675|7589434|FG016|NOT COMPLETED|Overall Study||0
6658806|NCT02482675|7589435|FG017|NOT COMPLETED|Overall Study||0
6658807|NCT02482675|7589436|FG018|NOT COMPLETED|Overall Study||0
6658808|NCT02482675|7589437|FG019|NOT COMPLETED|Overall Study||0
6658809|NCT02482675|7589438|FG020|NOT COMPLETED|Overall Study||0
6658810|NCT02482675|7589439|FG021|NOT COMPLETED|Overall Study||0
6658811|NCT02482675|7589440|FG022|NOT COMPLETED|Overall Study||0
6658812|NCT02482805|7589453|FG000|STARTED|Overall Study||26
6658813|NCT02482805|7589454|FG001|STARTED|Overall Study||27
6658814|NCT02482805|7589455|FG002|STARTED|Overall Study||20
6658815|NCT02482805|7589453|FG000|COMPLETED|Overall Study||22
6658816|NCT02482805|7589454|FG001|COMPLETED|Overall Study||23
6658817|NCT02482805|7589455|FG002|COMPLETED|Overall Study||20
6658818|NCT02482805|7589453|FG000|NOT COMPLETED|Overall Study||4
6658819|NCT02482805|7589454|FG001|NOT COMPLETED|Overall Study||4
6658820|NCT02482805|7589455|FG002|NOT COMPLETED|Overall Study||0
6658821|NCT02482870|7589463|FG000|STARTED|Period 1 - First 60 Patients||30
6658822|NCT02482870|7589464|FG001|STARTED|Period 1 - First 60 Patients||30
6658823|NCT02482870|7589463|FG000|COMPLETED|Period 1 - First 60 Patients||30
6658824|NCT02482870|7589464|FG001|COMPLETED|Period 1 - First 60 Patients||30
6658825|NCT02482870|7589463|FG000|NOT COMPLETED|Period 1 - First 60 Patients||0
6658826|NCT02482870|7589464|FG001|NOT COMPLETED|Period 1 - First 60 Patients||0
6658827|NCT02482870|7589463|FG000|STARTED|Period 2 - Rest of the Study||186
6658828|NCT02482870|7589464|FG001|STARTED|Period 2 - Rest of the Study||202
6658829|NCT02482870|7589463|FG000|COMPLETED|Period 2 - Rest of the Study||186
6658830|NCT02482870|7589464|FG001|COMPLETED|Period 2 - Rest of the Study||202
6658831|NCT02482870|7589463|FG000|NOT COMPLETED|Period 2 - Rest of the Study||0
6580977|NCT01922349|7505179|FG000|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
6580978|NCT01922349|7505180|FG001|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
6580979|NCT01922349|7505181|FG002|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
6580980|NCT01922349|7505182|FG003|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
6580981|NCT01922739|7505218|FG000|STARTED|Titration/Adjustment Period||182
6580982|NCT01922739|7505218|FG000|Safety Analysis Set|Titration/Adjustment Period||182
6580983|NCT01922739|7505218|FG000|COMPLETED|Titration/Adjustment Period||170
6580984|NCT01922739|7505218|FG000|NOT COMPLETED|Titration/Adjustment Period||12
6580985|NCT01922739|7505218|FG000|STARTED|Open-label Treatment Period||170
6580986|NCT01922739|7505218|FG000|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
6580987|NCT01922739|7505218|FG000|COMPLETED|Open-label Treatment Period||136
6580988|NCT01922739|7505218|FG000|NOT COMPLETED|Open-label Treatment Period||34
6580989|NCT01922934|7505236|FG000|STARTED|Eligible Patients||428
6580990|NCT01922934|7505237|FG001|STARTED|Eligible Patients||4302
6580991|NCT01922934|7505236|FG000|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
6580992|NCT01922934|7505237|FG001|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
6580993|NCT01922934|7505236|FG000|NOT COMPLETED|Eligible Patients||53
6580994|NCT01922934|7505237|FG001|NOT COMPLETED|Eligible Patients||88
6580995|NCT01922934|7505236|FG000|STARTED|Visit 0 - Patient Contacted & Consented||375
6580996|NCT01922934|7505237|FG001|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
6580997|NCT01922934|7505236|FG000|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
6580998|NCT01922934|7505237|FG001|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
6580999|NCT01922934|7505236|FG000|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
6581000|NCT01922934|7505237|FG001|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
6581001|NCT01922934|7505236|FG000|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
6581002|NCT01922934|7505237|FG001|STARTED|Visit 1- Weight Measured||4214
6581003|NCT01922934|7505236|FG000|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
6581004|NCT01922934|7505237|FG001|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
6581005|NCT01922934|7505236|FG000|NOT COMPLETED|Visit 1- Weight Measured||21
6581006|NCT01922934|7505237|FG001|NOT COMPLETED|Visit 1- Weight Measured||1284
6581007|NCT01922934|7505236|FG000|STARTED|Visit 12 / Final Visits||119
6581008|NCT01922934|7505237|FG001|STARTED|Visit 12 / Final Visits||2930
6581009|NCT01922934|7505236|FG000|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
6581010|NCT01922934|7505237|FG001|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
6581011|NCT01922934|7505236|FG000|NOT COMPLETED|Visit 12 / Final Visits||6
6581012|NCT01922934|7505237|FG001|NOT COMPLETED|Visit 12 / Final Visits||290
6581013|NCT01922986|7505247|FG000|STARTED|Overall Study||2
6581014|NCT01922986|7505248|FG001|STARTED|Overall Study||2
6581015|NCT01922986|7505247|FG000|COMPLETED|Overall Study||2
6581016|NCT01922986|7505248|FG001|COMPLETED|Overall Study||2
6581017|NCT01922986|7505247|FG000|NOT COMPLETED|Overall Study||0
6581018|NCT01922986|7505248|FG001|NOT COMPLETED|Overall Study||0
6581019|NCT01923129|7505256|FG000|STARTED|Overall Study||71
6581020|NCT01923129|7505257|FG001|STARTED|Overall Study||71
6581021|NCT01923129|7505256|FG000|COMPLETED|Overall Study||71
6581022|NCT01923129|7505257|FG001|COMPLETED|Overall Study||71
6581023|NCT01923129|7505256|FG000|NOT COMPLETED|Overall Study||0
6581024|NCT01923129|7505257|FG001|NOT COMPLETED|Overall Study||0
6581025|NCT01923181|7505272|FG000|STARTED|Overall Study||70
6581026|NCT01923181|7505273|FG001|STARTED|Overall Study||70
6581027|NCT01923181|7505274|FG002|STARTED|Overall Study||69
6581028|NCT01923181|7505275|FG003|STARTED|Overall Study||70
6581029|NCT01923181|7505276|FG004|STARTED|Overall Study||71
6581030|NCT01923181|7505277|FG005|STARTED|Overall Study||70
6581031|NCT01923181|7505278|FG006|STARTED|Overall Study||70
6581032|NCT01923181|7505279|FG007|STARTED|Overall Study||69
6581033|NCT01923181|7505280|FG008|STARTED|Overall Study||71
6581034|NCT01923181|7505272|FG000|Full Analysis Set (FAS)|Overall Study||70
6581035|NCT01923181|7505273|FG001|Full Analysis Set (FAS)|Overall Study||70
6581036|NCT01923181|7505274|FG002|Full Analysis Set (FAS)|Overall Study||69
6581037|NCT01923181|7505275|FG003|Full Analysis Set (FAS)|Overall Study||70
6581038|NCT01923181|7505276|FG004|Full Analysis Set (FAS)|Overall Study||71
6581039|NCT01923181|7505277|FG005|Full Analysis Set (FAS)|Overall Study||70
6581040|NCT01923181|7505278|FG006|Full Analysis Set (FAS)|Overall Study||70
6581041|NCT01923181|7505279|FG007|Full Analysis Set (FAS)|Overall Study||69
6581042|NCT01923181|7505280|FG008|Full Analysis Set (FAS)|Overall Study||71
6581043|NCT01923181|7505272|FG000|Safety Analysis Set (SAS)|Overall Study||70
6581044|NCT01923181|7505273|FG001|Safety Analysis Set (SAS)|Overall Study||70
6581045|NCT01923181|7505274|FG002|Safety Analysis Set (SAS)|Overall Study||69
6581046|NCT01923181|7505275|FG003|Safety Analysis Set (SAS)|Overall Study||70
6581047|NCT01923181|7505276|FG004|Safety Analysis Set (SAS)|Overall Study||71
6581048|NCT01923181|7505277|FG005|Safety Analysis Set (SAS)|Overall Study||70
6581049|NCT01923181|7505278|FG006|Safety Analysis Set (SAS)|Overall Study||70
6581050|NCT01923181|7505279|FG007|Safety Analysis Set (SAS)|Overall Study||69
6581051|NCT01923181|7505280|FG008|Safety Analysis Set (SAS)|Overall Study||71
6581052|NCT01923181|7505272|FG000|COMPLETED|Overall Study||67
6581053|NCT01923181|7505273|FG001|COMPLETED|Overall Study||64
6581054|NCT01923181|7505274|FG002|COMPLETED|Overall Study||67
6581055|NCT01923181|7505275|FG003|COMPLETED|Overall Study||65
6581056|NCT01923181|7505276|FG004|COMPLETED|Overall Study||63
6581057|NCT01923181|7505277|FG005|COMPLETED|Overall Study||66
6581058|NCT01923181|7505278|FG006|COMPLETED|Overall Study||62
6581059|NCT01923181|7505279|FG007|COMPLETED|Overall Study||61
6581060|NCT01923181|7505280|FG008|COMPLETED|Overall Study||68
6581061|NCT01923181|7505272|FG000|NOT COMPLETED|Overall Study||3
6581062|NCT01923181|7505273|FG001|NOT COMPLETED|Overall Study||6
6581063|NCT01923181|7505274|FG002|NOT COMPLETED|Overall Study||2
6581064|NCT01923181|7505275|FG003|NOT COMPLETED|Overall Study||5
6581065|NCT01923181|7505276|FG004|NOT COMPLETED|Overall Study||8
6581066|NCT01923181|7505277|FG005|NOT COMPLETED|Overall Study||4
6581067|NCT01923181|7505278|FG006|NOT COMPLETED|Overall Study||8
6581068|NCT01923181|7505279|FG007|NOT COMPLETED|Overall Study||8
6581069|NCT01923181|7505280|FG008|NOT COMPLETED|Overall Study||3
6581070|NCT01923285|7505305|FG000|STARTED|Overall Study||76
6581071|NCT01923285|7505306|FG001|STARTED|Overall Study||76
6581072|NCT01923285|7505305|FG000|Modified Intent-to-treat|Overall Study||73
6581073|NCT01923285|7505306|FG001|Modified Intent-to-treat|Overall Study||73
6581074|NCT01923285|7505305|FG000|COMPLETED|Overall Study||69
6581075|NCT01923285|7505306|FG001|COMPLETED|Overall Study||70
6581076|NCT01923285|7505305|FG000|NOT COMPLETED|Overall Study||7
6581077|NCT01923285|7505306|FG001|NOT COMPLETED|Overall Study||6
6581078|NCT01923311|7505314|FG000|STARTED|Overall Study||17
6581079|NCT01923311|7505315|FG001|STARTED|Overall Study||14
6581080|NCT01923311|7505314|FG000|COMPLETED|Overall Study||0
6581081|NCT01923311|7505315|FG001|COMPLETED|Overall Study||13
6581082|NCT01923311|7505314|FG000|NOT COMPLETED|Overall Study||17
6581083|NCT01923311|7505315|FG001|NOT COMPLETED|Overall Study||1
6581084|NCT01923363|7505322|FG000|STARTED|Overall Study||29
6581085|NCT01923363|7505322|FG000|COMPLETED|Overall Study||28
6581086|NCT01923363|7505322|FG000|NOT COMPLETED|Overall Study||1
6581087|NCT01923389|7505328|FG000|STARTED|Overall Study||2
6581088|NCT01923389|7505329|FG001|STARTED|Overall Study||2
6581089|NCT01923389|7505328|FG000|COMPLETED|Overall Study||1
6581090|NCT01923389|7505329|FG001|COMPLETED|Overall Study||2
6581091|NCT01923389|7505328|FG000|NOT COMPLETED|Overall Study||1
6581092|NCT01923389|7505329|FG001|NOT COMPLETED|Overall Study||0
6581093|NCT01923428|7505340|FG000|STARTED|Overall Study||88
6581094|NCT01923428|7505341|FG001|STARTED|Overall Study||89
6581095|NCT01923428|7505342|FG002|STARTED|Overall Study||89
6581096|NCT01923428|7505343|FG003|STARTED|Overall Study||90
6581097|NCT01923428|7505340|FG000|COMPLETED|Overall Study||69
6581098|NCT01923428|7505341|FG001|COMPLETED|Overall Study||77
6581099|NCT01923428|7505342|FG002|COMPLETED|Overall Study||78
6581100|NCT01923428|7505343|FG003|COMPLETED|Overall Study||80
6581101|NCT01923428|7505340|FG000|NOT COMPLETED|Overall Study||19
6581102|NCT01923428|7505341|FG001|NOT COMPLETED|Overall Study||12
6581103|NCT01923428|7505342|FG002|NOT COMPLETED|Overall Study||11
6581104|NCT01923428|7505343|FG003|NOT COMPLETED|Overall Study||10
6581105|NCT01923467|7505353|FG000|STARTED|Overall Study|Offered stop smoking program|767
6581106|NCT01923467|7505353|FG000|Baseline Completed, Enrolled|Overall Study||288
6581107|NCT01923467|7505353|FG000|COMPLETED|Overall Study|Completed 3-month follow up survey|226
6581108|NCT01923467|7505353|FG000|NOT COMPLETED|Overall Study||541
6581109|NCT01923740|7505359|FG000|STARTED|Overall Study||227
6581110|NCT01923740|7505360|FG001|STARTED|Overall Study||232
6581111|NCT01923740|7505359|FG000|COMPLETED|Overall Study||221
6581112|NCT01923740|7505360|FG001|COMPLETED|Overall Study||223
6581113|NCT01923740|7505359|FG000|NOT COMPLETED|Overall Study||6
6581114|NCT01923740|7505360|FG001|NOT COMPLETED|Overall Study||9
6581115|NCT01923805|7505368|FG000|STARTED|Overall Study|early termination|3
6581116|NCT01923805|7505369|FG001|STARTED|Overall Study|early termination|5
6581117|NCT01923805|7505368|FG000|COMPLETED|Overall Study||0
6581118|NCT01923805|7505369|FG001|COMPLETED|Overall Study||0
6581119|NCT01923805|7505368|FG000|NOT COMPLETED|Overall Study||3
6581120|NCT01923805|7505369|FG001|NOT COMPLETED|Overall Study||5
6581121|NCT01923896|7505377|FG000|STARTED|Overall Study||8
6581122|NCT01923896|7505378|FG001|STARTED|Overall Study||8
6581123|NCT01923896|7505377|FG000|COMPLETED|Overall Study||7
6581124|NCT01923896|7505378|FG001|COMPLETED|Overall Study||8
6581125|NCT01923896|7505377|FG000|NOT COMPLETED|Overall Study||1
6581126|NCT01923896|7505378|FG001|NOT COMPLETED|Overall Study||0
6581127|NCT01923961|7505387|FG000|STARTED|First Intervention||3
6581128|NCT01923961|7505388|FG001|STARTED|First Intervention||3
6581129|NCT01923961|7505389|FG002|STARTED|First Intervention||2
6581130|NCT01923961|7505387|FG000|COMPLETED|First Intervention||3
6581131|NCT01923961|7505388|FG001|COMPLETED|First Intervention||3
6581132|NCT01923961|7505389|FG002|COMPLETED|First Intervention||2
6581133|NCT01923961|7505387|FG000|NOT COMPLETED|First Intervention||0
6581134|NCT01923961|7505388|FG001|NOT COMPLETED|First Intervention||0
6581135|NCT01923961|7505389|FG002|NOT COMPLETED|First Intervention||0
6581136|NCT01923961|7505387|FG000|STARTED|Washout (1 Week)||3
6581137|NCT01923961|7505388|FG001|STARTED|Washout (1 Week)||3
6581138|NCT01923961|7505389|FG002|STARTED|Washout (1 Week)||2
6581139|NCT01923961|7505387|FG000|COMPLETED|Washout (1 Week)||3
6581140|NCT01923961|7505388|FG001|COMPLETED|Washout (1 Week)||3
6581141|NCT01923961|7505389|FG002|COMPLETED|Washout (1 Week)||2
6581142|NCT01923961|7505387|FG000|NOT COMPLETED|Washout (1 Week)||0
6581143|NCT01923961|7505388|FG001|NOT COMPLETED|Washout (1 Week)||0
6581144|NCT01923961|7505389|FG002|NOT COMPLETED|Washout (1 Week)||0
6581145|NCT01923961|7505387|FG000|STARTED|Second Intervention||3
6581146|NCT01923961|7505388|FG001|STARTED|Second Intervention||3
6581147|NCT01923961|7505389|FG002|STARTED|Second Intervention||2
6581148|NCT01923961|7505387|FG000|COMPLETED|Second Intervention||3
6581149|NCT01923961|7505388|FG001|COMPLETED|Second Intervention||3
6581150|NCT01923961|7505389|FG002|COMPLETED|Second Intervention||2
6581151|NCT01923961|7505387|FG000|NOT COMPLETED|Second Intervention||0
6581152|NCT01923961|7505388|FG001|NOT COMPLETED|Second Intervention||0
6581153|NCT01923961|7505389|FG002|NOT COMPLETED|Second Intervention||0
6581154|NCT01923961|7505387|FG000|STARTED|Washout (1 Week)||3
6581155|NCT01923961|7505388|FG001|STARTED|Washout (1 Week)||3
6581156|NCT01923961|7505389|FG002|STARTED|Washout (1 Week)||2
6581157|NCT01923961|7505387|FG000|COMPLETED|Washout (1 Week)||3
6581158|NCT01923961|7505388|FG001|COMPLETED|Washout (1 Week)||3
6581159|NCT01923961|7505389|FG002|COMPLETED|Washout (1 Week)||2
6581160|NCT01923961|7505387|FG000|NOT COMPLETED|Washout (1 Week)||0
6581161|NCT01923961|7505388|FG001|NOT COMPLETED|Washout (1 Week)||0
6581162|NCT01923961|7505389|FG002|NOT COMPLETED|Washout (1 Week)||0
6581163|NCT01923961|7505387|FG000|STARTED|Third Intervention||3
6581164|NCT01923961|7505388|FG001|STARTED|Third Intervention||3
6581165|NCT01923961|7505389|FG002|STARTED|Third Intervention||2
6581166|NCT01923961|7505387|FG000|COMPLETED|Third Intervention||3
6581167|NCT01923961|7505388|FG001|COMPLETED|Third Intervention||3
6581168|NCT01923961|7505389|FG002|COMPLETED|Third Intervention||2
6581169|NCT01923961|7505387|FG000|NOT COMPLETED|Third Intervention||0
6581170|NCT01923961|7505388|FG001|NOT COMPLETED|Third Intervention||0
6581171|NCT01923961|7505389|FG002|NOT COMPLETED|Third Intervention||0
6581172|NCT01924169|7505397|FG000|STARTED|Overall Study||3
6581173|NCT01924169|7505397|FG000|COMPLETED|Overall Study||3
6581174|NCT01924169|7505397|FG000|NOT COMPLETED|Overall Study||0
6581175|NCT01924182|7505403|FG000|STARTED|Overall Study||3
6581176|NCT01924182|7505404|FG001|STARTED|Overall Study||0
6581177|NCT01924182|7505403|FG000|COMPLETED|Overall Study||2
6581178|NCT01924182|7505404|FG001|COMPLETED|Overall Study||0
6581179|NCT01924182|7505403|FG000|NOT COMPLETED|Overall Study||1
6581180|NCT01924182|7505404|FG001|NOT COMPLETED|Overall Study||0
6581181|NCT01924299|7505412|FG000|STARTED|Period 1||18
6581182|NCT01924299|7505413|FG001|STARTED|Period 1||18
6581183|NCT01924299|7505412|FG000|Received Baricitinib|Period 1||18
6581184|NCT01924299|7505413|FG001|Received Baricitinib|Period 1||18
6581185|NCT01924299|7505412|FG000|COMPLETED|Period 1||18
6581186|NCT01924299|7505413|FG001|COMPLETED|Period 1||18
6581187|NCT01924299|7505412|FG000|NOT COMPLETED|Period 1||0
6581188|NCT01924299|7505413|FG001|NOT COMPLETED|Period 1||0
6581189|NCT01924299|7505412|FG000|STARTED|Period 2||18
6581190|NCT01924299|7505413|FG001|STARTED|Period 2||18
6581191|NCT01924299|7505412|FG000|Received at Least 1 Dose of Study Drug|Period 2||18
6581192|NCT01924299|7505413|FG001|Received at Least 1 Dose of Study Drug|Period 2||18
6581193|NCT01924299|7505412|FG000|Received Baricitinib|Period 2||17
6581194|NCT01924299|7505413|FG001|Received Baricitinib|Period 2||17
6581195|NCT01924299|7505412|FG000|COMPLETED|Period 2||17
6581196|NCT01924299|7505413|FG001|COMPLETED|Period 2||17
6581197|NCT01924299|7505412|FG000|NOT COMPLETED|Period 2||1
6581198|NCT01924299|7505413|FG001|NOT COMPLETED|Period 2||1
6581199|NCT01924364|7505425|FG000|STARTED|Overall Study||7
6581200|NCT01924364|7505425|FG000|COMPLETED|Overall Study||4
6581201|NCT01924364|7505425|FG000|NOT COMPLETED|Overall Study||3
6581202|NCT01924390|7505442|FG000|STARTED|Overall Study||22
6581203|NCT01924390|7505443|FG001|STARTED|Overall Study||22
6581204|NCT01924390|7505442|FG000|COMPLETED|Overall Study||21
6581205|NCT01924390|7505443|FG001|COMPLETED|Overall Study||21
6581206|NCT01924390|7505442|FG000|NOT COMPLETED|Overall Study||1
6581207|NCT01924390|7505443|FG001|NOT COMPLETED|Overall Study||1
6624170|NCT02214277|7551543|FG000|STARTED|Overall Study||123
6624171|NCT02214277|7551544|FG001|STARTED|Overall Study||121
6624172|NCT02214277|7551545|FG002|STARTED|Overall Study||119
6624173|NCT02214277|7551543|FG000|COMPLETED|Overall Study||104
6624174|NCT02214277|7551544|FG001|COMPLETED|Overall Study||96
6624175|NCT02214277|7551545|FG002|COMPLETED|Overall Study||85
6624176|NCT02214277|7551543|FG000|NOT COMPLETED|Overall Study||19
6624177|NCT02214277|7551544|FG001|NOT COMPLETED|Overall Study||25
6624178|NCT02214277|7551545|FG002|NOT COMPLETED|Overall Study||34
6624179|NCT02214290|7551552|FG000|STARTED|First Intervention (7 Days)||8
6624180|NCT02214290|7551553|FG001|STARTED|First Intervention (7 Days)||8
6624181|NCT02214290|7551552|FG000|COMPLETED|First Intervention (7 Days)||8
6624182|NCT02214290|7551553|FG001|COMPLETED|First Intervention (7 Days)||8
6624183|NCT02214290|7551552|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6624184|NCT02214290|7551553|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6624185|NCT02214290|7551552|FG000|STARTED|Washout (14 Days)||8
6624186|NCT02214290|7551553|FG001|STARTED|Washout (14 Days)||8
6624187|NCT02214290|7551552|FG000|COMPLETED|Washout (14 Days)||8
6624188|NCT02214290|7551553|FG001|COMPLETED|Washout (14 Days)||8
6624189|NCT02214290|7551552|FG000|NOT COMPLETED|Washout (14 Days)||0
6624190|NCT02214290|7551553|FG001|NOT COMPLETED|Washout (14 Days)||0
6624191|NCT02214290|7551552|FG000|STARTED|Second Intervention (7 Days)||8
6624192|NCT02214290|7551553|FG001|STARTED|Second Intervention (7 Days)||8
6624193|NCT02214290|7551552|FG000|COMPLETED|Second Intervention (7 Days)||8
6624194|NCT02214290|7551553|FG001|COMPLETED|Second Intervention (7 Days)||8
6624195|NCT02214290|7551552|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6624196|NCT02214290|7551553|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6624197|NCT02214420|7551564|FG000|STARTED|Overall Study||14
6624198|NCT02214420|7551565|FG001|STARTED|Overall Study||10
6624199|NCT02214420|7551564|FG000|COMPLETED|Overall Study||13
6624200|NCT02214420|7551565|FG001|COMPLETED|Overall Study||10
6581208|NCT01924429|7505451|FG000|STARTED|Period 1 - First Intervention (4 Weeks)||17
6581209|NCT01924429|7505452|FG001|STARTED|Period 1 - First Intervention (4 Weeks)||13
6581210|NCT01924429|7505451|FG000|COMPLETED|Period 1 - First Intervention (4 Weeks)||17
6581211|NCT01924429|7505452|FG001|COMPLETED|Period 1 - First Intervention (4 Weeks)||13
6581212|NCT01924429|7505451|FG000|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
6581213|NCT01924429|7505452|FG001|NOT COMPLETED|Period 1 - First Intervention (4 Weeks)||0
6581214|NCT01924429|7505451|FG000|STARTED|Washout Period (2 Weeks)||17
6581215|NCT01924429|7505452|FG001|STARTED|Washout Period (2 Weeks)||13
6581216|NCT01924429|7505451|FG000|COMPLETED|Washout Period (2 Weeks)||14
6581217|NCT01924429|7505452|FG001|COMPLETED|Washout Period (2 Weeks)||11
6581218|NCT01924429|7505451|FG000|NOT COMPLETED|Washout Period (2 Weeks)||3
6581219|NCT01924429|7505452|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
6581220|NCT01924429|7505451|FG000|STARTED|Period 2 - Second Intervention (4 Weeks)||14
6581221|NCT01924429|7505452|FG001|STARTED|Period 2 - Second Intervention (4 Weeks)||11
6581222|NCT01924429|7505451|FG000|COMPLETED|Period 2 - Second Intervention (4 Weeks)||14
6581223|NCT01924429|7505452|FG001|COMPLETED|Period 2 - Second Intervention (4 Weeks)||11
6581224|NCT01924429|7505451|FG000|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
6581225|NCT01924429|7505452|FG001|NOT COMPLETED|Period 2 - Second Intervention (4 Weeks)||0
6581226|NCT01924442|7505462|FG000|STARTED|Overall Study||1099
6581227|NCT01924442|7505463|FG001|STARTED|Overall Study||1104
6581228|NCT01924442|7505462|FG000|COMPLETED|Overall Study||1059
6581229|NCT01924442|7505463|FG001|COMPLETED|Overall Study||967
6581230|NCT01924442|7505462|FG000|NOT COMPLETED|Overall Study||40
6581231|NCT01924442|7505463|FG001|NOT COMPLETED|Overall Study||137
6581232|NCT01924559|7505469|FG000|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
6581233|NCT01924559|7505469|FG000|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
6581234|NCT01924559|7505469|FG000|NOT COMPLETED|Overall Study||0
6581235|NCT01924689|7505489|FG000|STARTED|Overall Study||3
6581236|NCT01924689|7505490|FG001|STARTED|Overall Study||3
6581237|NCT01924689|7505491|FG002|STARTED|Overall Study||4
6581238|NCT01924689|7505492|FG003|STARTED|Overall Study||6
6581239|NCT01924689|7505493|FG004|STARTED|Overall Study||6
6581240|NCT01924689|7505494|FG005|STARTED|Overall Study||2
6581241|NCT01924689|7505489|FG000|COMPLETED|Overall Study||0
6581242|NCT01924689|7505490|FG001|COMPLETED|Overall Study||0
6581243|NCT01924689|7505491|FG002|COMPLETED|Overall Study||0
6581244|NCT01924689|7505492|FG003|COMPLETED|Overall Study||0
6581245|NCT01924689|7505493|FG004|COMPLETED|Overall Study||0
6581246|NCT01924689|7505494|FG005|COMPLETED|Overall Study||0
6581247|NCT01924689|7505489|FG000|NOT COMPLETED|Overall Study||3
6581248|NCT01924689|7505490|FG001|NOT COMPLETED|Overall Study||3
6581249|NCT01924689|7505491|FG002|NOT COMPLETED|Overall Study||4
6581250|NCT01924689|7505492|FG003|NOT COMPLETED|Overall Study||6
6581251|NCT01924689|7505493|FG004|NOT COMPLETED|Overall Study||6
6581252|NCT01924689|7505494|FG005|NOT COMPLETED|Overall Study||2
6581253|NCT01924754|7505515|FG000|STARTED|Overall Study||50
6581254|NCT01924754|7505516|FG001|STARTED|Overall Study||50
6581255|NCT01924754|7505517|FG002|STARTED|Overall Study||50
6581256|NCT01924754|7505515|FG000|COMPLETED|Overall Study||49
6581257|NCT01924754|7505516|FG001|COMPLETED|Overall Study||47
6581258|NCT01924754|7505517|FG002|COMPLETED|Overall Study||47
6581259|NCT01924754|7505515|FG000|NOT COMPLETED|Overall Study||1
6581260|NCT01924754|7505516|FG001|NOT COMPLETED|Overall Study||3
6581261|NCT01924754|7505517|FG002|NOT COMPLETED|Overall Study||3
6581262|NCT01924767|7505533|FG000|STARTED|Overall Study||12
6581263|NCT01924767|7505534|FG001|STARTED|Overall Study||9
6581264|NCT01924767|7505535|FG002|STARTED|Overall Study||9
6581265|NCT01924767|7505536|FG003|STARTED|Overall Study||9
6581266|NCT01924767|7505537|FG004|STARTED|Overall Study||9
6581267|NCT01924767|7505533|FG000|COMPLETED|Overall Study||11
6581268|NCT01924767|7505534|FG001|COMPLETED|Overall Study||9
6581269|NCT01924767|7505535|FG002|COMPLETED|Overall Study||8
6581270|NCT01924767|7505536|FG003|COMPLETED|Overall Study||9
6581271|NCT01924767|7505537|FG004|COMPLETED|Overall Study||9
6581272|NCT01924767|7505533|FG000|NOT COMPLETED|Overall Study||1
6581273|NCT01924767|7505534|FG001|NOT COMPLETED|Overall Study||0
6581274|NCT01924767|7505535|FG002|NOT COMPLETED|Overall Study||1
6581275|NCT01924767|7505536|FG003|NOT COMPLETED|Overall Study||0
6581276|NCT01924767|7505537|FG004|NOT COMPLETED|Overall Study||0
6581277|NCT01924806|7505556|FG000|STARTED|Overall Study||5
6581278|NCT01924806|7505557|FG001|STARTED|Overall Study||4
6581279|NCT01924806|7505556|FG000|COMPLETED|Overall Study||3
6581280|NCT01924806|7505557|FG001|COMPLETED|Overall Study||3
6581281|NCT01924806|7505556|FG000|NOT COMPLETED|Overall Study||2
6581282|NCT01924806|7505557|FG001|NOT COMPLETED|Overall Study||1
6581283|NCT01924845|7505563|FG000|STARTED|Overall Study||24
6581284|NCT01924845|7505563|FG000|COMPLETED|Overall Study||18
6581285|NCT01924845|7505563|FG000|NOT COMPLETED|Overall Study||6
6581286|NCT01924871|7505569|FG000|STARTED|Overall Study||31
6581287|NCT01924871|7505570|FG001|STARTED|Overall Study||31
6581288|NCT01924871|7505569|FG000|COMPLETED|Overall Study||25
6581289|NCT01924871|7505570|FG001|COMPLETED|Overall Study||29
6581290|NCT01924871|7505569|FG000|NOT COMPLETED|Overall Study||6
6581291|NCT01924871|7505570|FG001|NOT COMPLETED|Overall Study||2
6581292|NCT01924949|7505576|FG000|STARTED|Overall Study||5
6581293|NCT01924949|7505576|FG000|COMPLETED|Overall Study||5
6581294|NCT01924949|7505576|FG000|NOT COMPLETED|Overall Study||0
6581295|NCT01924975|7505582|FG000|STARTED|Overall Study||51
6581296|NCT01924975|7505583|FG001|STARTED|Overall Study||51
6581297|NCT01924975|7505582|FG000|COMPLETED|Overall Study||51
6581298|NCT01924975|7505583|FG001|COMPLETED|Overall Study||51
6581299|NCT01924975|7505582|FG000|NOT COMPLETED|Overall Study||0
6581300|NCT01924975|7505583|FG001|NOT COMPLETED|Overall Study||0
6581301|NCT01924988|7505589|FG000|STARTED|Overall Study||15
6581302|NCT01924988|7505589|FG000|COMPLETED|Overall Study||15
6581303|NCT01924988|7505589|FG000|NOT COMPLETED|Overall Study||0
6581304|NCT01925014|7505598|FG000|STARTED|Overall Study||1535
6581305|NCT01925014|7505599|FG001|STARTED|Overall Study||1539
6581306|NCT01925014|7505598|FG000|COMPLETED|Overall Study||1526
6581307|NCT01925014|7505599|FG001|COMPLETED|Overall Study||1520
6581308|NCT01925014|7505598|FG000|NOT COMPLETED|Overall Study||9
6581309|NCT01925014|7505599|FG001|NOT COMPLETED|Overall Study||19
6581310|NCT01925144|7505605|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
6581311|NCT01925144|7505605|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
6581312|NCT01925144|7505605|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
6581313|NCT01925144|7505605|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
6581314|NCT01925144|7505605|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
6581315|NCT01925144|7505605|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
6581316|NCT01925144|7505605|FG000|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
6581317|NCT01925144|7505605|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
6581318|NCT01925144|7505605|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
6658832|NCT02482870|7589464|FG001|NOT COMPLETED|Period 2 - Rest of the Study||0
6658833|NCT02482935|7589478|FG000|STARTED|Period 1||15
6658834|NCT02482935|7589479|FG001|STARTED|Period 1||15
6658835|NCT02482935|7589478|FG000|Received Abemaciclib|Period 1||15
6658836|NCT02482935|7589479|FG001|Received Abemaciclib|Period 1||15
6658837|NCT02482935|7589478|FG000|Washout|Period 1||15
6658838|NCT02482935|7589479|FG001|Washout|Period 1||15
6658839|NCT02482935|7589478|FG000|COMPLETED|Period 1||14
6658840|NCT02482935|7589479|FG001|COMPLETED|Period 1||15
6658841|NCT02482935|7589478|FG000|NOT COMPLETED|Period 1||1
6658842|NCT02482935|7589479|FG001|NOT COMPLETED|Period 1||0
6658843|NCT02482935|7589478|FG000|STARTED|Period 2||14
6658844|NCT02482935|7589479|FG001|STARTED|Period 2||15
6658845|NCT02482935|7589478|FG000|Received Abemaciclib|Period 2||14
6658846|NCT02482935|7589479|FG001|Received Abemaciclib|Period 2||15
6658847|NCT02482935|7589478|FG000|Follow-up|Period 2||14
6658848|NCT02482935|7589479|FG001|Follow-up|Period 2||15
6658849|NCT02482935|7589478|FG000|COMPLETED|Period 2||14
6658850|NCT02482935|7589479|FG001|COMPLETED|Period 2||15
6658851|NCT02482935|7589478|FG000|NOT COMPLETED|Period 2||0
6658852|NCT02482935|7589479|FG001|NOT COMPLETED|Period 2||0
6658853|NCT02483000|7589485|FG000|STARTED|Overall Study||3
6658854|NCT02483000|7589485|FG000|COMPLETED|Overall Study||3
6658855|NCT02483000|7589485|FG000|NOT COMPLETED|Overall Study||0
6658856|NCT02483416|7589494|FG000|STARTED|Overall Study||21
6658857|NCT02483416|7589495|FG001|STARTED|Overall Study||7
6658858|NCT02483416|7589494|FG000|COMPLETED|Overall Study||18
6658859|NCT02483416|7589495|FG001|COMPLETED|Overall Study||6
6658860|NCT02483416|7589494|FG000|NOT COMPLETED|Overall Study||3
6658861|NCT02483416|7589495|FG001|NOT COMPLETED|Overall Study||1
6658862|NCT02483520|7589504|FG000|STARTED|Overall Study||92
6658863|NCT02483520|7589505|FG001|STARTED|Overall Study||97
6658864|NCT02483520|7589504|FG000|Caregivers|Overall Study||50
6658865|NCT02483520|7589505|FG001|Caregivers|Overall Study||56
6658866|NCT02483520|7589504|FG000|Persons With Dementia|Overall Study||42
6658867|NCT02483520|7589505|FG001|Persons With Dementia|Overall Study||41
6658868|NCT02483520|7589504|FG000|COMPLETED|Overall Study||81
6658869|NCT02483520|7589505|FG001|COMPLETED|Overall Study||73
6658870|NCT02483520|7589504|FG000|NOT COMPLETED|Overall Study||11
6658871|NCT02483520|7589505|FG001|NOT COMPLETED|Overall Study||24
6658872|NCT02483572|7589513|FG000|STARTED|Overall Study||2
6658873|NCT02483572|7589514|FG001|STARTED|Overall Study||2
6658874|NCT02483572|7589513|FG000|COMPLETED|Overall Study||0
6658875|NCT02483572|7589514|FG001|COMPLETED|Overall Study||1
6658876|NCT02483572|7589513|FG000|NOT COMPLETED|Overall Study||2
6658877|NCT02483572|7589514|FG001|NOT COMPLETED|Overall Study||1
6658878|NCT02483585|7589522|FG000|STARTED|Double-blind Treatment Phase||291
6658879|NCT02483585|7589523|FG001|STARTED|Double-blind Treatment Phase||286
6658880|NCT02483585|7589522|FG000|Received Treatment|Double-blind Treatment Phase||289
6658881|NCT02483585|7589523|FG001|Received Treatment|Double-blind Treatment Phase||283
6658882|NCT02483585|7589522|FG000|COMPLETED|Double-blind Treatment Phase||275
6658883|NCT02483585|7589523|FG001|COMPLETED|Double-blind Treatment Phase||271
6658884|NCT02483585|7589522|FG000|NOT COMPLETED|Double-blind Treatment Phase||16
6658885|NCT02483585|7589523|FG001|NOT COMPLETED|Double-blind Treatment Phase||15
6658886|NCT02483585|7589522|FG000|STARTED|Open-label Treatment Phase|Five participants who completed the double-blind phase did not enter the open-label treatment phase|270
6658887|NCT02483585|7589523|FG001|STARTED|Open-label Treatment Phase|Three participants who completed the double-blind phase did not enter the open-label treatment phase|268
6658888|NCT02483585|7589522|FG000|COMPLETED|Open-label Treatment Phase||243
6658889|NCT02483585|7589523|FG001|COMPLETED|Open-label Treatment Phase||243
6658890|NCT02483585|7589522|FG000|NOT COMPLETED|Open-label Treatment Phase||27
6658891|NCT02483585|7589523|FG001|NOT COMPLETED|Open-label Treatment Phase||25
6658892|NCT02483611|7589536|FG000|STARTED|Overall Study||16
6658893|NCT02483611|7589537|FG001|STARTED|Overall Study||16
6581319|NCT01925170|7505612|FG000|STARTED|Overall Study||1638
6581320|NCT01925170|7505612|FG000|COMPLETED|Overall Study||1585
6581321|NCT01925170|7505612|FG000|NOT COMPLETED|Overall Study||53
6581322|NCT01925183|7505620|FG000|STARTED|Overall Study||3
6581323|NCT01925183|7505621|FG001|STARTED|Overall Study||3
6581324|NCT01925183|7505620|FG000|COMPLETED|Overall Study||2
6581325|NCT01925183|7505621|FG001|COMPLETED|Overall Study||3
6581326|NCT01925183|7505620|FG000|NOT COMPLETED|Overall Study||1
6581327|NCT01925183|7505621|FG001|NOT COMPLETED|Overall Study||0
6581328|NCT01925209|7505631|FG000|STARTED|Treatment Epoch||63
6581329|NCT01925209|7505632|FG001|STARTED|Treatment Epoch||63
6581330|NCT01925209|7505633|FG002|STARTED|Treatment Epoch||63
6581331|NCT01925209|7505634|FG003|STARTED|Treatment Epoch||62
6581332|NCT01925209|7505631|FG000|Full Analysis Set|Treatment Epoch||63
6581333|NCT01925209|7505632|FG001|Full Analysis Set|Treatment Epoch||63
6581334|NCT01925209|7505633|FG002|Full Analysis Set|Treatment Epoch||63
6581335|NCT01925209|7505634|FG003|Full Analysis Set|Treatment Epoch||62
6581336|NCT01925209|7505631|FG000|COMPLETED|Treatment Epoch||54
6581337|NCT01925209|7505632|FG001|COMPLETED|Treatment Epoch||55
6581338|NCT01925209|7505633|FG002|COMPLETED|Treatment Epoch||56
6581339|NCT01925209|7505634|FG003|COMPLETED|Treatment Epoch||57
6581340|NCT01925209|7505631|FG000|NOT COMPLETED|Treatment Epoch||9
6581341|NCT01925209|7505632|FG001|NOT COMPLETED|Treatment Epoch||8
6581342|NCT01925209|7505633|FG002|NOT COMPLETED|Treatment Epoch||7
6581343|NCT01925209|7505634|FG003|NOT COMPLETED|Treatment Epoch||5
6581344|NCT01925209|7505631|FG000|STARTED|Maintenance Treatment Epoch||49
6581345|NCT01925209|7505632|FG001|STARTED|Maintenance Treatment Epoch||46
6581346|NCT01925209|7505633|FG002|STARTED|Maintenance Treatment Epoch||52
6581347|NCT01925209|7505634|FG003|STARTED|Maintenance Treatment Epoch||50
6581348|NCT01925209|7505631|FG000|COMPLETED|Maintenance Treatment Epoch||49
6581349|NCT01925209|7505632|FG001|COMPLETED|Maintenance Treatment Epoch||45
6581350|NCT01925209|7505633|FG002|COMPLETED|Maintenance Treatment Epoch||50
6581351|NCT01925209|7505634|FG003|COMPLETED|Maintenance Treatment Epoch||48
6581352|NCT01925209|7505631|FG000|NOT COMPLETED|Maintenance Treatment Epoch||0
6581353|NCT01925209|7505632|FG001|NOT COMPLETED|Maintenance Treatment Epoch||1
6581354|NCT01925209|7505633|FG002|NOT COMPLETED|Maintenance Treatment Epoch||2
6581355|NCT01925209|7505634|FG003|NOT COMPLETED|Maintenance Treatment Epoch||2
6581356|NCT01925209|7505631|FG000|STARTED|Follow-up||57
6581357|NCT01925209|7505632|FG001|STARTED|Follow-up||61
6581358|NCT01925209|7505633|FG002|STARTED|Follow-up||56
6581359|NCT01925209|7505634|FG003|STARTED|Follow-up||58
6581360|NCT01925209|7505631|FG000|COMPLETED|Follow-up||56
6581361|NCT01925209|7505632|FG001|COMPLETED|Follow-up||55
6581362|NCT01925209|7505633|FG002|COMPLETED|Follow-up||55
6581363|NCT01925209|7505634|FG003|COMPLETED|Follow-up||54
6581364|NCT01925209|7505631|FG000|NOT COMPLETED|Follow-up||1
6581365|NCT01925209|7505632|FG001|NOT COMPLETED|Follow-up||6
6581366|NCT01925209|7505633|FG002|NOT COMPLETED|Follow-up||1
6581367|NCT01925209|7505634|FG003|NOT COMPLETED|Follow-up||4
6581368|NCT01925274|7505647|FG000|STARTED|Overall Study||7
6581369|NCT01925274|7505648|FG001|STARTED|Overall Study||6
6581370|NCT01925274|7505649|FG002|STARTED|Overall Study||6
6581371|NCT01925274|7505647|FG000|COMPLETED|Overall Study||0
6581372|NCT01925274|7505648|FG001|COMPLETED|Overall Study||0
6581373|NCT01925274|7505649|FG002|COMPLETED|Overall Study||0
6581374|NCT01925274|7505647|FG000|NOT COMPLETED|Overall Study||7
6581375|NCT01925274|7505648|FG001|NOT COMPLETED|Overall Study||6
6581376|NCT01925274|7505649|FG002|NOT COMPLETED|Overall Study||6
6581377|NCT01925339|7505661|FG000|STARTED|Overall Study||20
6581378|NCT01925339|7505662|FG001|STARTED|Overall Study||20
6581379|NCT01925339|7505661|FG000|COMPLETED|Overall Study||18
6581380|NCT01925339|7505662|FG001|COMPLETED|Overall Study||20
6581381|NCT01925339|7505661|FG000|NOT COMPLETED|Overall Study||2
6581382|NCT01925339|7505662|FG001|NOT COMPLETED|Overall Study||0
6581383|NCT01925404|7505672|FG000|STARTED|Overall Study|"The primary outcome of this study is at the level of a park.~The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users"|
6581384|NCT01925404|7505673|FG001|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
6581385|NCT01925404|7505674|FG002|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
6581386|NCT01925404|7505675|FG003|STARTED|Overall Study|The park is the unit of analysis. We did not recruit participants, but had measure of park use by counting observed users|
6581387|NCT01925404|7505672|FG000|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
6581388|NCT01925404|7505673|FG001|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
6581389|NCT01925404|7505674|FG002|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
6581390|NCT01925404|7505675|FG003|COMPLETED|Overall Study|We did not recruit participants or follow the same park users over time. The follow up numbers of users are greater than at baseline, and this generates an error message.|
6581391|NCT01925404|7505672|FG000|NOT COMPLETED|Overall Study||
6581392|NCT01925404|7505673|FG001|NOT COMPLETED|Overall Study||
6581393|NCT01925404|7505674|FG002|NOT COMPLETED|Overall Study||
6581394|NCT01925404|7505675|FG003|NOT COMPLETED|Overall Study||
6581395|NCT01925417|7505685|FG000|STARTED|Overall Study||34
6581396|NCT01925417|7505685|FG000|COMPLETED|Overall Study||31
6581397|NCT01925417|7505685|FG000|NOT COMPLETED|Overall Study||3
6581398|NCT01925469|7505692|FG000|STARTED|Overall Study||15
6581399|NCT01925469|7505693|FG001|STARTED|Overall Study||15
6581400|NCT01925469|7505692|FG000|COMPLETED|Overall Study||14
6581401|NCT01925469|7505693|FG001|COMPLETED|Overall Study||15
6581402|NCT01925469|7505692|FG000|NOT COMPLETED|Overall Study||1
6581403|NCT01925469|7505693|FG001|NOT COMPLETED|Overall Study||0
6581404|NCT01925612|7505704|FG000|STARTED|Overall Study||29
6581405|NCT01925612|7505705|FG001|STARTED|Overall Study||22
6581406|NCT01925612|7505706|FG002|STARTED|Overall Study||11
6581407|NCT01925612|7505707|FG003|STARTED|Overall Study||11
6581408|NCT01925612|7505708|FG004|STARTED|Overall Study||12
6581409|NCT01925612|7505704|FG000|COMPLETED|Overall Study||25
6581410|NCT01925612|7505705|FG001|COMPLETED|Overall Study||18
6581411|NCT01925612|7505706|FG002|COMPLETED|Overall Study||10
6581412|NCT01925612|7505707|FG003|COMPLETED|Overall Study||10
6581413|NCT01925612|7505708|FG004|COMPLETED|Overall Study||10
6581414|NCT01925612|7505704|FG000|NOT COMPLETED|Overall Study||4
6581415|NCT01925612|7505705|FG001|NOT COMPLETED|Overall Study||4
6581416|NCT01925612|7505706|FG002|NOT COMPLETED|Overall Study||1
6581417|NCT01925612|7505707|FG003|NOT COMPLETED|Overall Study||1
6581418|NCT01925612|7505708|FG004|NOT COMPLETED|Overall Study||2
6581419|NCT01925677|7505720|FG000|STARTED|Overall Study||3
6581420|NCT01925677|7505720|FG000|COMPLETED|Overall Study||3
6581421|NCT01925677|7505720|FG000|NOT COMPLETED|Overall Study||0
6581422|NCT01925703|7505724|FG000|STARTED|Overall Study||13
6581423|NCT01925703|7505724|FG000|Dosing Regimen Completed|Overall Study||12
6581424|NCT01925703|7505724|FG000|Full Iron Repletion Achieved|Overall Study||11
6581425|NCT01925703|7505724|FG000|Follow-up Completed|Overall Study||9
6581426|NCT01925703|7505724|FG000|COMPLETED|Overall Study||9
6581427|NCT01925703|7505724|FG000|NOT COMPLETED|Overall Study||4
6581428|NCT01925768|7505730|FG000|STARTED|Placebo-controlled Phase (Week 0 - 24)||109
6581429|NCT01925768|7505731|FG001|STARTED|Placebo-controlled Phase (Week 0 - 24)||110
6581430|NCT01925768|7505730|FG000|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
6581431|NCT01925768|7505731|FG001|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||109
6581432|NCT01925768|7505730|FG000|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||101
6581433|NCT01925768|7505731|FG001|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||91
6581434|NCT01925768|7505730|FG000|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||35
6581435|NCT01925768|7505731|FG001|Escaped Early (EE)|Placebo-controlled Phase (Week 0 - 24)||13
6581436|NCT01925768|7505730|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|3 participants who completed Week 24 did not enter the active treatment phase|98
6581437|NCT01925768|7505731|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|2 participants who completed Week 24 did not enter the active treatment phase|87
6581438|NCT01925768|7505730|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||11
6581439|NCT01925768|7505731|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
6581440|NCT01925768|7505730|FG000|STARTED|ActiveTreatment/Extension (Weeks 24-104)||95
6581441|NCT01925768|7505731|FG001|STARTED|ActiveTreatment/Extension (Weeks 24-104)||85
6581442|NCT01925768|7505730|FG000|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||75
6581443|NCT01925768|7505731|FG001|COMPLETED|ActiveTreatment/Extension (Weeks 24-104)|Completed Apremilast treatment at Week 104|67
6581444|NCT01925768|7505730|FG000|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||20
6581445|NCT01925768|7505731|FG001|NOT COMPLETED|ActiveTreatment/Extension (Weeks 24-104)||18
6581446|NCT01925781|7505743|FG000|STARTED|Overall Study||5
6581447|NCT01925781|7505744|FG001|STARTED|Overall Study||5
6581448|NCT01925781|7505743|FG000|COMPLETED|Overall Study||3
6581449|NCT01925781|7505744|FG001|COMPLETED|Overall Study||1
6581450|NCT01925781|7505743|FG000|NOT COMPLETED|Overall Study||2
6581451|NCT01925781|7505744|FG001|NOT COMPLETED|Overall Study||4
6581452|NCT01925950|7505752|FG000|STARTED|Part 1||1
6581453|NCT01925950|7505753|FG001|STARTED|Part 1||1
6581454|NCT01925950|7505752|FG000|COMPLETED|Part 1||1
6581455|NCT01925950|7505753|FG001|COMPLETED|Part 1||1
6581456|NCT01925950|7505752|FG000|NOT COMPLETED|Part 1||0
6581457|NCT01925950|7505753|FG001|NOT COMPLETED|Part 1||0
6581458|NCT01925950|7505752|FG000|STARTED|Part 2||1
6581459|NCT01925950|7505753|FG001|STARTED|Part 2|The 1 orBec subject completed Part 1 but did not meet the criteria of a CR to continue to Part 2|0
6581460|NCT01925950|7505752|FG000|COMPLETED|Part 2||0
6581461|NCT01925950|7505753|FG001|COMPLETED|Part 2||0
6581462|NCT01925950|7505752|FG000|NOT COMPLETED|Part 2||1
6581463|NCT01925950|7505753|FG001|NOT COMPLETED|Part 2||0
6581464|NCT01925989|7505761|FG000|STARTED|Period 1||7
6581465|NCT01925989|7505762|FG001|STARTED|Period 1||8
6581466|NCT01925989|7505763|FG002|STARTED|Period 1||12
6581467|NCT01925989|7505761|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
6581468|NCT01925989|7505762|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
6581469|NCT01925989|7505763|FG002|Received at Least 1 Dose of Study Drug|Period 1||0
6581470|NCT01925989|7505761|FG000|COMPLETED|Period 1||6
6581471|NCT01925989|7505762|FG001|COMPLETED|Period 1||6
6581472|NCT01925989|7505763|FG002|COMPLETED|Period 1||12
6581473|NCT01925989|7505761|FG000|NOT COMPLETED|Period 1||1
6581474|NCT01925989|7505762|FG001|NOT COMPLETED|Period 1||2
6581475|NCT01925989|7505763|FG002|NOT COMPLETED|Period 1||0
6581476|NCT01925989|7505761|FG000|STARTED|Period 2||6
6581477|NCT01925989|7505762|FG001|STARTED|Period 2||6
6581478|NCT01925989|7505763|FG002|STARTED|Period 2||12
6581479|NCT01925989|7505761|FG000|COMPLETED|Period 2||6
6581480|NCT01925989|7505762|FG001|COMPLETED|Period 2||6
6581481|NCT01925989|7505763|FG002|COMPLETED|Period 2||12
6581482|NCT01925989|7505761|FG000|NOT COMPLETED|Period 2||0
6581483|NCT01925989|7505762|FG001|NOT COMPLETED|Period 2||0
6581484|NCT01925989|7505763|FG002|NOT COMPLETED|Period 2||0
6581485|NCT01926015|7505777|FG000|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
6581486|NCT01926015|7505778|FG001|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
6581487|NCT01926015|7505777|FG000|Received >=1 Vaccination|Overall Study||94
6581488|NCT01926015|7505778|FG001|Received >=1 Vaccination|Overall Study||96
6581489|NCT01926015|7505777|FG000|COMPLETED|Overall Study||94
6581490|NCT01926015|7505778|FG001|COMPLETED|Overall Study||95
6581491|NCT01926015|7505777|FG000|NOT COMPLETED|Overall Study||2
6581492|NCT01926015|7505778|FG001|NOT COMPLETED|Overall Study||1
6581493|NCT01926028|7505787|FG000|STARTED|Overall Study||85
6581494|NCT01926028|7505788|FG001|STARTED|Overall Study||89
6581495|NCT01926028|7505789|FG002|STARTED|Overall Study||14
6581496|NCT01926028|7505787|FG000|COMPLETED|Overall Study||64
6581497|NCT01926028|7505788|FG001|COMPLETED|Overall Study||67
6581498|NCT01926028|7505789|FG002|COMPLETED|Overall Study||12
6581499|NCT01926028|7505787|FG000|NOT COMPLETED|Overall Study||21
6581500|NCT01926028|7505788|FG001|NOT COMPLETED|Overall Study||22
6581501|NCT01926028|7505789|FG002|NOT COMPLETED|Overall Study||2
6581502|NCT01926119|7505798|FG000|STARTED|Overall Study||4
6581503|NCT01926119|7505798|FG000|COMPLETED|Overall Study||3
6581504|NCT01926119|7505798|FG000|NOT COMPLETED|Overall Study||1
6581505|NCT01926444|7505806|FG000|STARTED|Overall Study||56
6581506|NCT01926444|7505807|FG001|STARTED|Overall Study||52
6581507|NCT01926444|7505808|FG002|STARTED|Overall Study||57
6581508|NCT01926444|7505809|FG003|STARTED|Overall Study||103
6581509|NCT01926444|7505806|FG000|COMPLETED|Overall Study||56
6581510|NCT01926444|7505807|FG001|COMPLETED|Overall Study||52
6581511|NCT01926444|7505808|FG002|COMPLETED|Overall Study||53
6581512|NCT01926444|7505809|FG003|COMPLETED|Overall Study||101
6581513|NCT01926444|7505806|FG000|NOT COMPLETED|Overall Study||0
6581514|NCT01926444|7505807|FG001|NOT COMPLETED|Overall Study||0
6581515|NCT01926444|7505808|FG002|NOT COMPLETED|Overall Study||4
6581516|NCT01926444|7505809|FG003|NOT COMPLETED|Overall Study||2
6581517|NCT01926496|7505821|FG000|STARTED|Overall Study||240
6581518|NCT01926496|7505822|FG001|STARTED|Overall Study||245
6581519|NCT01926496|7505821|FG000|COMPLETED|Overall Study||203
6581520|NCT01926496|7505822|FG001|COMPLETED|Overall Study||197
6581521|NCT01926496|7505821|FG000|NOT COMPLETED|Overall Study||37
6581522|NCT01926496|7505822|FG001|NOT COMPLETED|Overall Study||48
6581523|NCT01926509|7505836|FG000|STARTED|Overall Study||6
6581524|NCT01926509|7505837|FG001|STARTED|Overall Study||6
6581525|NCT01926509|7505838|FG002|STARTED|Overall Study||5
6581526|NCT01926509|7505839|FG003|STARTED|Overall Study||6
6581527|NCT01926509|7505836|FG000|COMPLETED|Overall Study||5
6581528|NCT01926509|7505837|FG001|COMPLETED|Overall Study||6
6581529|NCT01926509|7505838|FG002|COMPLETED|Overall Study||5
6581530|NCT01926509|7505839|FG003|COMPLETED|Overall Study||6
6581531|NCT01926509|7505836|FG000|NOT COMPLETED|Overall Study||1
6581532|NCT01926509|7505837|FG001|NOT COMPLETED|Overall Study||0
6581533|NCT01926509|7505838|FG002|NOT COMPLETED|Overall Study||0
6581534|NCT01926509|7505839|FG003|NOT COMPLETED|Overall Study||0
6581535|NCT01926626|7505849|FG000|STARTED|Overall Study||38
6581536|NCT01926626|7505849|FG000|Received Moclobemide|Overall Study||37
6581537|NCT01926626|7505849|FG000|COMPLETED|Overall Study||16
6581538|NCT01926626|7505849|FG000|NOT COMPLETED|Overall Study||22
6581539|NCT01926782|7505859|FG000|STARTED|Overall Study||157
6581540|NCT01926782|7505860|FG001|STARTED|Overall Study||78
6581541|NCT01926782|7505861|FG002|STARTED|Overall Study||312
6581542|NCT01926782|7505862|FG003|STARTED|Overall Study||73
6581543|NCT01926782|7505863|FG004|STARTED|Overall Study||37
6581544|NCT01926782|7505864|FG005|STARTED|Overall Study||146
6581545|NCT01926782|7505859|FG000|Treated|Overall Study||157
6581546|NCT01926782|7505860|FG001|Treated|Overall Study||78
6581547|NCT01926782|7505861|FG002|Treated|Overall Study||312
6581548|NCT01926782|7505862|FG003|Treated|Overall Study||72
6581549|NCT01926782|7505863|FG004|Treated|Overall Study||37
6581550|NCT01926782|7505864|FG005|Treated|Overall Study||146
6581551|NCT01926782|7505859|FG000|Completed 24 Weeks Treatment Period|Overall Study||137
6581552|NCT01926782|7505860|FG001|Completed 24 Weeks Treatment Period|Overall Study||68
6581553|NCT01926782|7505861|FG002|Completed 24 Weeks Treatment Period|Overall Study||285
6581554|NCT01926782|7505862|FG003|Completed 24 Weeks Treatment Period|Overall Study||58
6581555|NCT01926782|7505863|FG004|Completed 24 Weeks Treatment Period|Overall Study||31
6581556|NCT01926782|7505864|FG005|Completed 24 Weeks Treatment Period|Overall Study||120
6581557|NCT01926782|7505859|FG000|COMPLETED|Overall Study||129
6581558|NCT01926782|7505860|FG001|COMPLETED|Overall Study||65
6581559|NCT01926782|7505861|FG002|COMPLETED|Overall Study||272
6581560|NCT01926782|7505862|FG003|COMPLETED|Overall Study||53
6581561|NCT01926782|7505863|FG004|COMPLETED|Overall Study||29
6581562|NCT01926782|7505864|FG005|COMPLETED|Overall Study||105
6581563|NCT01926782|7505859|FG000|NOT COMPLETED|Overall Study||28
6581564|NCT01926782|7505860|FG001|NOT COMPLETED|Overall Study||13
6581565|NCT01926782|7505861|FG002|NOT COMPLETED|Overall Study||40
6581566|NCT01926782|7505862|FG003|NOT COMPLETED|Overall Study||20
6581567|NCT01926782|7505863|FG004|NOT COMPLETED|Overall Study||8
6581568|NCT01926782|7505864|FG005|NOT COMPLETED|Overall Study||41
6581569|NCT01926886|7505879|FG000|STARTED|Overall Study||102
6581570|NCT01926886|7505880|FG001|STARTED|Overall Study|HCPs were not enrolled in the study. No baseline data were collected for these participants.|21
6581571|NCT01926886|7505879|FG000|Received at Least 1 Dose of Study Drug|Overall Study||101
6581572|NCT01926886|7505880|FG001|Received at Least 1 Dose of Study Drug|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|0
6581573|NCT01926886|7505879|FG000|COMPLETED|Overall Study||70
6581574|NCT01926886|7505880|FG001|COMPLETED|Overall Study|Partcipants were HCPs included for polling purposes. HCPs were not enrolled in the study.|21
6581575|NCT01926886|7505879|FG000|NOT COMPLETED|Overall Study||32
6581576|NCT01926886|7505880|FG001|NOT COMPLETED|Overall Study||0
6581577|NCT01926977|7505888|FG000|STARTED|Overall Study||47
6581578|NCT01926977|7505889|FG001|STARTED|Overall Study||53
6581579|NCT01926977|7505888|FG000|COMPLETED|Overall Study||47
6581580|NCT01926977|7505889|FG001|COMPLETED|Overall Study||53
6581581|NCT01926977|7505888|FG000|NOT COMPLETED|Overall Study||0
6658894|NCT02483611|7589538|FG002|STARTED|Overall Study||16
6658895|NCT02483611|7589536|FG000|COMPLETED|Overall Study||16
6658896|NCT02483611|7589537|FG001|COMPLETED|Overall Study||16
6658897|NCT02483611|7589538|FG002|COMPLETED|Overall Study|One patient required decurarization|15
6658898|NCT02483611|7589536|FG000|NOT COMPLETED|Overall Study||0
6658899|NCT02483611|7589537|FG001|NOT COMPLETED|Overall Study||0
6658900|NCT02483611|7589538|FG002|NOT COMPLETED|Overall Study||1
6658901|NCT02483676|7589548|FG000|STARTED|Overall Study||23
6658902|NCT02483676|7589549|FG001|STARTED|Overall Study||22
6658903|NCT02483676|7589548|FG000|COMPLETED|Overall Study||17
6658904|NCT02483676|7589549|FG001|COMPLETED|Overall Study||17
6658905|NCT02483676|7589548|FG000|NOT COMPLETED|Overall Study||6
6658906|NCT02483676|7589549|FG001|NOT COMPLETED|Overall Study||5
6658907|NCT02483975|7589557|FG000|STARTED|Overall Study||56
6658908|NCT02483975|7589558|FG001|STARTED|Overall Study||55
6658909|NCT02483975|7589557|FG000|COMPLETED|Overall Study||54
6658910|NCT02483975|7589558|FG001|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
6658911|NCT02483975|7589557|FG000|NOT COMPLETED|Overall Study||2
6658912|NCT02483975|7589558|FG001|NOT COMPLETED|Overall Study||2
6658913|NCT02484092|7589567|FG000|STARTED|Overall Study||15
6658914|NCT02484092|7589567|FG000|COMPLETED|Overall Study||15
6658915|NCT02484092|7589567|FG000|NOT COMPLETED|Overall Study||0
6658916|NCT02484222|7589571|FG000|STARTED|Overall Study||80
6658917|NCT02484222|7589571|FG000|COMPLETED|Overall Study||77
6658918|NCT02484222|7589571|FG000|NOT COMPLETED|Overall Study||3
6658919|NCT02484547|7589580|FG000|STARTED|Placebo-Controlled Period||548
6658920|NCT02484547|7589581|FG001|STARTED|Placebo-Controlled Period||543
6658921|NCT02484547|7589582|FG002|STARTED|Placebo-Controlled Period||547
6658922|NCT02484547|7589583|FG003|STARTED|Placebo-Controlled Period||0
6658923|NCT02484547|7589584|FG004|STARTED|Placebo-Controlled Period||0
6658924|NCT02484547|7589585|FG005|STARTED|Placebo-Controlled Period||0
6658925|NCT02484547|7589586|FG006|STARTED|Placebo-Controlled Period||0
6658926|NCT02484547|7589580|FG000|COMPLETED|Placebo-Controlled Period||288
6658927|NCT02484547|7589581|FG001|COMPLETED|Placebo-Controlled Period||291
6658928|NCT02484547|7589582|FG002|COMPLETED|Placebo-Controlled Period||295
6658929|NCT02484547|7589583|FG003|COMPLETED|Placebo-Controlled Period||0
6658930|NCT02484547|7589584|FG004|COMPLETED|Placebo-Controlled Period||0
6658931|NCT02484547|7589585|FG005|COMPLETED|Placebo-Controlled Period||0
6658932|NCT02484547|7589586|FG006|COMPLETED|Placebo-Controlled Period||0
6658933|NCT02484547|7589580|FG000|NOT COMPLETED|Placebo-Controlled Period||260
6658934|NCT02484547|7589581|FG001|NOT COMPLETED|Placebo-Controlled Period||252
6658935|NCT02484547|7589582|FG002|NOT COMPLETED|Placebo-Controlled Period||252
6658936|NCT02484547|7589583|FG003|NOT COMPLETED|Placebo-Controlled Period||0
6658937|NCT02484547|7589584|FG004|NOT COMPLETED|Placebo-Controlled Period||0
6658938|NCT02484547|7589585|FG005|NOT COMPLETED|Placebo-Controlled Period||0
6658939|NCT02484547|7589586|FG006|NOT COMPLETED|Placebo-Controlled Period||0
6658940|NCT02484547|7589580|FG000|STARTED|Long-Term Extension Period||0
6658941|NCT02484547|7589581|FG001|STARTED|Long-Term Extension Period||0
6658942|NCT02484547|7589582|FG002|STARTED|Long-Term Extension Period||0
6658943|NCT02484547|7589583|FG003|STARTED|Long-Term Extension Period|11 PC completers did not enter LTE.|131
6658944|NCT02484547|7589584|FG004|STARTED|Long-Term Extension Period|14 PC completers did not enter LTE.|132
6658945|NCT02484547|7589585|FG005|STARTED|Long-Term Extension Period|40 PC completers did not enter LTE.|251
6658946|NCT02484547|7589586|FG006|STARTED|Long-Term Extension Period|38 PC completers did not enter LTE.|257
6658947|NCT02484547|7589580|FG000|COMPLETED|Long-Term Extension Period||0
6658948|NCT02484547|7589581|FG001|COMPLETED|Long-Term Extension Period||0
6658949|NCT02484547|7589582|FG002|COMPLETED|Long-Term Extension Period||0
6658950|NCT02484547|7589583|FG003|COMPLETED|Long-Term Extension Period||0
6658951|NCT02484547|7589584|FG004|COMPLETED|Long-Term Extension Period||0
6658952|NCT02484547|7589585|FG005|COMPLETED|Long-Term Extension Period||0
6658953|NCT02484547|7589586|FG006|COMPLETED|Long-Term Extension Period||0
6658954|NCT02484547|7589580|FG000|NOT COMPLETED|Long-Term Extension Period||0
6658955|NCT02484547|7589581|FG001|NOT COMPLETED|Long-Term Extension Period||0
6581582|NCT01926977|7505889|FG001|NOT COMPLETED|Overall Study||0
6581583|NCT01927055|7505898|FG000|STARTED|Open-label||61
6581584|NCT01927055|7505899|FG001|STARTED|Open-label||0
6581585|NCT01927055|7505900|FG002|STARTED|Open-label||0
6581586|NCT01927055|7505898|FG000|COMPLETED|Open-label||45
6581587|NCT01927055|7505899|FG001|COMPLETED|Open-label||0
6581588|NCT01927055|7505900|FG002|COMPLETED|Open-label||0
6581589|NCT01927055|7505898|FG000|NOT COMPLETED|Open-label||16
6581590|NCT01927055|7505899|FG001|NOT COMPLETED|Open-label||0
6581591|NCT01927055|7505900|FG002|NOT COMPLETED|Open-label||0
6581592|NCT01927055|7505898|FG000|STARTED|Double-Blind||0
6581593|NCT01927055|7505899|FG001|STARTED|Double-Blind||22
6581594|NCT01927055|7505900|FG002|STARTED|Double-Blind||23
6581595|NCT01927055|7505898|FG000|COMPLETED|Double-Blind||0
6581596|NCT01927055|7505899|FG001|COMPLETED|Double-Blind||11
6581597|NCT01927055|7505900|FG002|COMPLETED|Double-Blind||10
6581598|NCT01927055|7505898|FG000|NOT COMPLETED|Double-Blind||0
6581599|NCT01927055|7505899|FG001|NOT COMPLETED|Double-Blind||11
6581600|NCT01927055|7505900|FG002|NOT COMPLETED|Double-Blind||13
6581601|NCT01927120|7505907|FG000|STARTED|Overall Study||20
6581602|NCT01927120|7505907|FG000|COMPLETED|Overall Study||10
6581603|NCT01927120|7505907|FG000|NOT COMPLETED|Overall Study||10
6581604|NCT01927341|7505916|FG000|STARTED|Phase 1b||10
6581605|NCT01927341|7505917|FG001|STARTED|Phase 1b||0
6581606|NCT01927341|7505918|FG002|STARTED|Phase 1b||0
6581607|NCT01927341|7505919|FG003|STARTED|Phase 1b||0
6581608|NCT01927341|7505920|FG004|STARTED|Phase 1b||0
6581609|NCT01927341|7505916|FG000|COMPLETED|Phase 1b||0
6581610|NCT01927341|7505917|FG001|COMPLETED|Phase 1b||0
6581611|NCT01927341|7505918|FG002|COMPLETED|Phase 1b||0
6581612|NCT01927341|7505919|FG003|COMPLETED|Phase 1b||0
6581613|NCT01927341|7505920|FG004|COMPLETED|Phase 1b||0
6581614|NCT01927341|7505916|FG000|NOT COMPLETED|Phase 1b||10
6581615|NCT01927341|7505917|FG001|NOT COMPLETED|Phase 1b||0
6581616|NCT01927341|7505918|FG002|NOT COMPLETED|Phase 1b||0
6581617|NCT01927341|7505919|FG003|NOT COMPLETED|Phase 1b||0
6581618|NCT01927341|7505920|FG004|NOT COMPLETED|Phase 1b||0
6581619|NCT01927341|7505916|FG000|STARTED|Phase 2||0
6581620|NCT01927341|7505917|FG001|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
6581621|NCT01927341|7505918|FG002|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|5
6581622|NCT01927341|7505919|FG003|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|15
6581623|NCT01927341|7505920|FG004|STARTED|Phase 2|Participants of phase 2 enrolled after enrollment of participants of phase 1b.|8
6581624|NCT01927341|7505916|FG000|COMPLETED|Phase 2||0
6581625|NCT01927341|7505917|FG001|COMPLETED|Phase 2||0
6581626|NCT01927341|7505918|FG002|COMPLETED|Phase 2||0
6581627|NCT01927341|7505919|FG003|COMPLETED|Phase 2||0
6581628|NCT01927341|7505920|FG004|COMPLETED|Phase 2||0
6581629|NCT01927341|7505916|FG000|NOT COMPLETED|Phase 2||0
6581630|NCT01927341|7505917|FG001|NOT COMPLETED|Phase 2||15
6581631|NCT01927341|7505918|FG002|NOT COMPLETED|Phase 2||5
6581632|NCT01927341|7505919|FG003|NOT COMPLETED|Phase 2||15
6581633|NCT01927341|7505920|FG004|NOT COMPLETED|Phase 2||8
6581634|NCT01927367|7505938|FG000|STARTED|Overall Study||597
6581635|NCT01927367|7505939|FG001|STARTED|Overall Study||548
6581636|NCT01927367|7505938|FG000|COMPLETED|Overall Study||590
6581637|NCT01927367|7505939|FG001|COMPLETED|Overall Study||543
6581638|NCT01927367|7505938|FG000|NOT COMPLETED|Overall Study||7
6581639|NCT01927367|7505939|FG001|NOT COMPLETED|Overall Study||5
6581640|NCT01927497|7505947|FG000|STARTED|Overall Study||50
6581641|NCT01927497|7505948|FG001|STARTED|Overall Study||54
6581642|NCT01927497|7505947|FG000|COMPLETED|Overall Study||48
6581643|NCT01927497|7505948|FG001|COMPLETED|Overall Study||53
6581644|NCT01927497|7505947|FG000|NOT COMPLETED|Overall Study||2
6581645|NCT01927497|7505948|FG001|NOT COMPLETED|Overall Study||1
6581646|NCT01927562|7505954|FG000|STARTED|Overall Study||57
6581647|NCT01927562|7505954|FG000|COMPLETED|Overall Study|5 at M24, 2 at M30,12 at M36 due to two protocol changes moving followups from M24 to M30 to M36|19
6581648|NCT01927562|7505954|FG000|NOT COMPLETED|Overall Study||38
6581649|NCT01927575|7505958|FG000|STARTED|Overall Study||1
6581650|NCT01927575|7505958|FG000|COMPLETED|Overall Study||1
6581651|NCT01927575|7505958|FG000|NOT COMPLETED|Overall Study||0
6581652|NCT01927627|7505966|FG000|STARTED|Overall Study||42
6581653|NCT01927627|7505966|FG000|COMPLETED|Overall Study||37
6581654|NCT01927627|7505966|FG000|NOT COMPLETED|Overall Study||5
6581655|NCT01927718|7505970|FG000|STARTED|Overall Study||10
6581656|NCT01927718|7505970|FG000|COMPLETED|Overall Study||10
6581657|NCT01927718|7505970|FG000|NOT COMPLETED|Overall Study||0
6581658|NCT01927757|7505974|FG000|STARTED|Overall Study||90
6581659|NCT01927757|7505974|FG000|Received Etanercept|Overall Study||88
6581660|NCT01927757|7505974|FG000|COMPLETED|Overall Study||67
6581661|NCT01927757|7505974|FG000|NOT COMPLETED|Overall Study||23
6581662|NCT01927861|7505984|FG000|STARTED|Pivotal Phase (104 Weeks)||25
6581663|NCT01927861|7505985|FG001|STARTED|Pivotal Phase (104 Weeks)||26
6581664|NCT01927861|7505984|FG000|COMPLETED|Pivotal Phase (104 Weeks)||25
6581665|NCT01927861|7505985|FG001|COMPLETED|Pivotal Phase (104 Weeks)||26
6581666|NCT01927861|7505984|FG000|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
6581667|NCT01927861|7505985|FG001|NOT COMPLETED|Pivotal Phase (104 Weeks)||0
6581668|NCT01927861|7505984|FG000|STARTED|Extension Phase (104 Weeks)||25
6581669|NCT01927861|7505985|FG001|STARTED|Extension Phase (104 Weeks)||26
6581670|NCT01927861|7505984|FG000|COMPLETED|Extension Phase (104 Weeks)||25
6581671|NCT01927861|7505985|FG001|COMPLETED|Extension Phase (104 Weeks)||23
6581672|NCT01927861|7505984|FG000|NOT COMPLETED|Extension Phase (104 Weeks)||0
6581673|NCT01927861|7505985|FG001|NOT COMPLETED|Extension Phase (104 Weeks)||3
6581674|NCT01927861|7505984|FG000|STARTED|Extended Treatment Phase (26 Weeks)|15 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|15
6581675|NCT01927861|7505985|FG001|STARTED|Extended Treatment Phase (26 Weeks)|14 participants agreed to continue the treatment for 26 weeks in the extended treatment phase.|14
6581676|NCT01927861|7505984|FG000|COMPLETED|Extended Treatment Phase (26 Weeks)||15
6581677|NCT01927861|7505985|FG001|COMPLETED|Extended Treatment Phase (26 Weeks)||14
6581678|NCT01927861|7505984|FG000|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
6581679|NCT01927861|7505985|FG001|NOT COMPLETED|Extended Treatment Phase (26 Weeks)||0
6581680|NCT01927887|7505991|FG000|STARTED|Overall Study||12
6581681|NCT01927887|7505991|FG000|COMPLETED|Overall Study||12
6581682|NCT01927887|7505991|FG000|NOT COMPLETED|Overall Study||0
6581683|NCT01928030|7505996|FG000|STARTED|Overall Study||3
6581684|NCT01928030|7505997|FG001|STARTED|Overall Study||0
6581685|NCT01928030|7505998|FG002|STARTED|Overall Study||0
6581686|NCT01928030|7505996|FG000|COMPLETED|Overall Study||3
6581687|NCT01928030|7505997|FG001|COMPLETED|Overall Study||0
6581688|NCT01928030|7505998|FG002|COMPLETED|Overall Study||0
6581689|NCT01928030|7505996|FG000|NOT COMPLETED|Overall Study||0
6581690|NCT01928030|7505997|FG001|NOT COMPLETED|Overall Study||0
6581691|NCT01928030|7505998|FG002|NOT COMPLETED|Overall Study||0
6581692|NCT01928186|7506005|FG000|STARTED|Overall Study||28
6581693|NCT01928186|7506005|FG000|COMPLETED|Overall Study||28
6581694|NCT01928186|7506005|FG000|NOT COMPLETED|Overall Study||0
6581695|NCT01928199|7506011|FG000|STARTED|Overall Study||32
6581696|NCT01928199|7506012|FG001|STARTED|Overall Study||29
6581697|NCT01928199|7506011|FG000|COMPLETED|Overall Study||32
6581698|NCT01928199|7506012|FG001|COMPLETED|Overall Study||29
6581699|NCT01928199|7506011|FG000|NOT COMPLETED|Overall Study||0
6581700|NCT01928199|7506012|FG001|NOT COMPLETED|Overall Study||0
6581701|NCT01928225|7506020|FG000|STARTED|Overall Study||90
6581702|NCT01928225|7506021|FG001|STARTED|Overall Study||90
6581703|NCT01928225|7506020|FG000|COMPLETED|Overall Study||87
6581704|NCT01928225|7506021|FG001|COMPLETED|Overall Study||87
6581705|NCT01928225|7506020|FG000|NOT COMPLETED|Overall Study||3
6581706|NCT01928225|7506021|FG001|NOT COMPLETED|Overall Study||3
6581707|NCT01928290|7506030|FG000|STARTED|Overall Study||41
6581708|NCT01928290|7506031|FG001|STARTED|Overall Study||26
6581709|NCT01928290|7506030|FG000|COMPLETED|Overall Study||41
6581710|NCT01928290|7506031|FG001|COMPLETED|Overall Study||26
6581711|NCT01928290|7506030|FG000|NOT COMPLETED|Overall Study||0
6581712|NCT01928290|7506031|FG001|NOT COMPLETED|Overall Study||0
6581713|NCT01928329|7506039|FG000|STARTED|Overall Study||40
6581714|NCT01928329|7506040|FG001|STARTED|Overall Study||39
6581715|NCT01928329|7506039|FG000|COMPLETED|Overall Study||28
6581716|NCT01928329|7506040|FG001|COMPLETED|Overall Study||25
6581717|NCT01928329|7506039|FG000|NOT COMPLETED|Overall Study||12
6581718|NCT01928329|7506040|FG001|NOT COMPLETED|Overall Study||14
6581719|NCT01928381|7506046|FG000|STARTED|Screening for Pain Training||143
6581720|NCT01928381|7506047|FG001|STARTED|Screening for Pain Training||0
6581721|NCT01928381|7506048|FG002|STARTED|Screening for Pain Training||0
6581722|NCT01928381|7506049|FG003|STARTED|Screening for Pain Training||0
6581723|NCT01928381|7506050|FG004|STARTED|Screening for Pain Training||0
6581724|NCT01928381|7506051|FG005|STARTED|Screening for Pain Training||0
6581725|NCT01928381|7506052|FG006|STARTED|Screening for Pain Training||0
6581726|NCT01928381|7506046|FG000|COMPLETED|Screening for Pain Training||83
6581727|NCT01928381|7506047|FG001|COMPLETED|Screening for Pain Training||0
6581728|NCT01928381|7506048|FG002|COMPLETED|Screening for Pain Training||0
6581729|NCT01928381|7506049|FG003|COMPLETED|Screening for Pain Training||0
6581730|NCT01928381|7506050|FG004|COMPLETED|Screening for Pain Training||0
6581731|NCT01928381|7506051|FG005|COMPLETED|Screening for Pain Training||0
6581732|NCT01928381|7506052|FG006|COMPLETED|Screening for Pain Training||0
6581733|NCT01928381|7506046|FG000|NOT COMPLETED|Screening for Pain Training||60
6581734|NCT01928381|7506047|FG001|NOT COMPLETED|Screening for Pain Training||0
6581735|NCT01928381|7506048|FG002|NOT COMPLETED|Screening for Pain Training||0
6581736|NCT01928381|7506049|FG003|NOT COMPLETED|Screening for Pain Training||0
6581737|NCT01928381|7506050|FG004|NOT COMPLETED|Screening for Pain Training||0
6581738|NCT01928381|7506051|FG005|NOT COMPLETED|Screening for Pain Training||0
6581739|NCT01928381|7506052|FG006|NOT COMPLETED|Screening for Pain Training||0
6581740|NCT01928381|7506046|FG000|STARTED|Part 1 - Pain Training||83
6581741|NCT01928381|7506047|FG001|STARTED|Part 1 - Pain Training||0
6581742|NCT01928381|7506048|FG002|STARTED|Part 1 - Pain Training||0
6581743|NCT01928381|7506049|FG003|STARTED|Part 1 - Pain Training||0
6581744|NCT01928381|7506050|FG004|STARTED|Part 1 - Pain Training||0
6581745|NCT01928381|7506051|FG005|STARTED|Part 1 - Pain Training||0
6581746|NCT01928381|7506052|FG006|STARTED|Part 1 - Pain Training||0
6581747|NCT01928381|7506046|FG000|COMPLETED|Part 1 - Pain Training||48
6581748|NCT01928381|7506047|FG001|COMPLETED|Part 1 - Pain Training||0
6581749|NCT01928381|7506048|FG002|COMPLETED|Part 1 - Pain Training||0
6581750|NCT01928381|7506049|FG003|COMPLETED|Part 1 - Pain Training||0
6581751|NCT01928381|7506050|FG004|COMPLETED|Part 1 - Pain Training||0
6581752|NCT01928381|7506051|FG005|COMPLETED|Part 1 - Pain Training||0
6581753|NCT01928381|7506052|FG006|COMPLETED|Part 1 - Pain Training||0
6581754|NCT01928381|7506046|FG000|NOT COMPLETED|Part 1 - Pain Training||35
6581755|NCT01928381|7506047|FG001|NOT COMPLETED|Part 1 - Pain Training||0
6581756|NCT01928381|7506048|FG002|NOT COMPLETED|Part 1 - Pain Training||0
6581757|NCT01928381|7506049|FG003|NOT COMPLETED|Part 1 - Pain Training||0
6581758|NCT01928381|7506050|FG004|NOT COMPLETED|Part 1 - Pain Training||0
6581759|NCT01928381|7506051|FG005|NOT COMPLETED|Part 1 - Pain Training||0
6581760|NCT01928381|7506052|FG006|NOT COMPLETED|Part 1 - Pain Training||0
6581761|NCT01928381|7506046|FG000|STARTED|Placebo run-in & Part 2 Eligibility||48
6581762|NCT01928381|7506047|FG001|STARTED|Placebo run-in & Part 2 Eligibility||0
6581763|NCT01928381|7506048|FG002|STARTED|Placebo run-in & Part 2 Eligibility||0
6581764|NCT01928381|7506049|FG003|STARTED|Placebo run-in & Part 2 Eligibility||0
6581765|NCT01928381|7506050|FG004|STARTED|Placebo run-in & Part 2 Eligibility||0
6581766|NCT01928381|7506051|FG005|STARTED|Placebo run-in & Part 2 Eligibility||0
6581767|NCT01928381|7506052|FG006|STARTED|Placebo run-in & Part 2 Eligibility||0
6581768|NCT01928381|7506046|FG000|COMPLETED|Placebo run-in & Part 2 Eligibility||34
6581769|NCT01928381|7506047|FG001|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581770|NCT01928381|7506048|FG002|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581771|NCT01928381|7506049|FG003|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581772|NCT01928381|7506050|FG004|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581773|NCT01928381|7506051|FG005|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581774|NCT01928381|7506052|FG006|COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581775|NCT01928381|7506046|FG000|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
6581776|NCT01928381|7506047|FG001|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581777|NCT01928381|7506048|FG002|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581778|NCT01928381|7506049|FG003|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581779|NCT01928381|7506050|FG004|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581780|NCT01928381|7506051|FG005|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581781|NCT01928381|7506052|FG006|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
6581782|NCT01928381|7506046|FG000|STARTED|Part 2 - First Intervention||0
6581783|NCT01928381|7506047|FG001|STARTED|Part 2 - First Intervention||6
6581784|NCT01928381|7506048|FG002|STARTED|Part 2 - First Intervention||6
6581785|NCT01928381|7506049|FG003|STARTED|Part 2 - First Intervention||6
6581786|NCT01928381|7506050|FG004|STARTED|Part 2 - First Intervention||4
6581787|NCT01928381|7506051|FG005|STARTED|Part 2 - First Intervention||6
6581788|NCT01928381|7506052|FG006|STARTED|Part 2 - First Intervention||6
6581789|NCT01928381|7506046|FG000|COMPLETED|Part 2 - First Intervention||0
6581790|NCT01928381|7506047|FG001|COMPLETED|Part 2 - First Intervention||6
6581791|NCT01928381|7506048|FG002|COMPLETED|Part 2 - First Intervention||4
6581792|NCT01928381|7506049|FG003|COMPLETED|Part 2 - First Intervention||5
6581793|NCT01928381|7506050|FG004|COMPLETED|Part 2 - First Intervention||4
6581794|NCT01928381|7506051|FG005|COMPLETED|Part 2 - First Intervention||5
6581795|NCT01928381|7506052|FG006|COMPLETED|Part 2 - First Intervention||5
6581796|NCT01928381|7506046|FG000|NOT COMPLETED|Part 2 - First Intervention||0
6581797|NCT01928381|7506047|FG001|NOT COMPLETED|Part 2 - First Intervention||0
6581798|NCT01928381|7506048|FG002|NOT COMPLETED|Part 2 - First Intervention||2
6391767|NCT00837967|7303698|FG000|NOT COMPLETED|Washout Period of 7 - 14 Days||2
6391768|NCT00837967|7303699|FG001|NOT COMPLETED|Washout Period of 7 - 14 Days||0
6391769|NCT00837967|7303698|FG000|STARTED|Second Intervention||11
6391770|NCT00837967|7303699|FG001|STARTED|Second Intervention||12
6391771|NCT00837967|7303698|FG000|COMPLETED|Second Intervention||11
6391772|NCT00837967|7303699|FG001|COMPLETED|Second Intervention||12
6391773|NCT00837967|7303698|FG000|NOT COMPLETED|Second Intervention||0
6391774|NCT00837967|7303699|FG001|NOT COMPLETED|Second Intervention||0
6391775|NCT00838006|7303708|FG000|STARTED|Overall Study||102
6391776|NCT00838006|7303709|FG001|STARTED|Overall Study||98
6391777|NCT00838006|7303710|FG002|STARTED|Overall Study||142
6391778|NCT00838006|7303708|FG000|3-month Post-deployment Follow-up|Overall Study||92
6391779|NCT00838006|7303709|FG001|3-month Post-deployment Follow-up|Overall Study||80
6391780|NCT00838006|7303710|FG002|3-month Post-deployment Follow-up|Overall Study||135
6391781|NCT00838006|7303708|FG000|COMPLETED|Overall Study||68
6391782|NCT00838006|7303709|FG001|COMPLETED|Overall Study||72
6391783|NCT00838006|7303710|FG002|COMPLETED|Overall Study||94
6391784|NCT00838006|7303708|FG000|NOT COMPLETED|Overall Study||34
6391785|NCT00838006|7303709|FG001|NOT COMPLETED|Overall Study||26
6391786|NCT00838006|7303710|FG002|NOT COMPLETED|Overall Study||48
6391787|NCT00838097|7303720|FG000|STARTED|Overall Study||321
6391788|NCT00838097|7303720|FG000|Received Darbepoetin Alfa|Overall Study||319
6391789|NCT00838097|7303720|FG000|COMPLETED|Overall Study||145
6391790|NCT00838097|7303720|FG000|NOT COMPLETED|Overall Study||176
6391791|NCT00838110|7303726|FG000|STARTED|Overall Study||127
6391792|NCT00838110|7303727|FG001|STARTED|Overall Study||128
6391793|NCT00838110|7303728|FG002|STARTED|Overall Study||243
6391794|NCT00838110|7303729|FG003|STARTED|Overall Study||244
6391795|NCT00838110|7303726|FG000|Treated|Overall Study||127
6391796|NCT00838110|7303727|FG001|Treated|Overall Study||127
6581799|NCT01928381|7506049|FG003|NOT COMPLETED|Part 2 - First Intervention||1
6581800|NCT01928381|7506050|FG004|NOT COMPLETED|Part 2 - First Intervention||0
6581801|NCT01928381|7506051|FG005|NOT COMPLETED|Part 2 - First Intervention||1
6581802|NCT01928381|7506052|FG006|NOT COMPLETED|Part 2 - First Intervention||1
6581803|NCT01928381|7506046|FG000|STARTED|Washout First Intervention||0
6581804|NCT01928381|7506047|FG001|STARTED|Washout First Intervention||6
6581805|NCT01928381|7506048|FG002|STARTED|Washout First Intervention||4
6581806|NCT01928381|7506049|FG003|STARTED|Washout First Intervention||5
6581807|NCT01928381|7506050|FG004|STARTED|Washout First Intervention||4
6581808|NCT01928381|7506051|FG005|STARTED|Washout First Intervention||5
6581809|NCT01928381|7506052|FG006|STARTED|Washout First Intervention||5
6581810|NCT01928381|7506046|FG000|COMPLETED|Washout First Intervention||0
6581811|NCT01928381|7506047|FG001|COMPLETED|Washout First Intervention||6
6581812|NCT01928381|7506048|FG002|COMPLETED|Washout First Intervention||4
6581813|NCT01928381|7506049|FG003|COMPLETED|Washout First Intervention||5
6581814|NCT01928381|7506050|FG004|COMPLETED|Washout First Intervention||3
6391797|NCT00838110|7303728|FG002|Treated|Overall Study||243
6581815|NCT01928381|7506051|FG005|COMPLETED|Washout First Intervention||5
6581816|NCT01928381|7506052|FG006|COMPLETED|Washout First Intervention||5
6581817|NCT01928381|7506046|FG000|NOT COMPLETED|Washout First Intervention||0
6581818|NCT01928381|7506047|FG001|NOT COMPLETED|Washout First Intervention||0
6581819|NCT01928381|7506048|FG002|NOT COMPLETED|Washout First Intervention||0
6581820|NCT01928381|7506049|FG003|NOT COMPLETED|Washout First Intervention||0
6581821|NCT01928381|7506050|FG004|NOT COMPLETED|Washout First Intervention||1
6581822|NCT01928381|7506051|FG005|NOT COMPLETED|Washout First Intervention||0
6581823|NCT01928381|7506052|FG006|NOT COMPLETED|Washout First Intervention||0
6581824|NCT01928381|7506046|FG000|STARTED|Part 2 - Second Intervention||0
6581825|NCT01928381|7506047|FG001|STARTED|Part 2 - Second Intervention||6
6581826|NCT01928381|7506048|FG002|STARTED|Part 2 - Second Intervention||4
6581827|NCT01928381|7506049|FG003|STARTED|Part 2 - Second Intervention||5
6581828|NCT01928381|7506050|FG004|STARTED|Part 2 - Second Intervention||3
6581829|NCT01928381|7506051|FG005|STARTED|Part 2 - Second Intervention||5
6581830|NCT01928381|7506052|FG006|STARTED|Part 2 - Second Intervention||5
6581831|NCT01928381|7506046|FG000|COMPLETED|Part 2 - Second Intervention||0
6581832|NCT01928381|7506047|FG001|COMPLETED|Part 2 - Second Intervention||5
6581833|NCT01928381|7506048|FG002|COMPLETED|Part 2 - Second Intervention||4
6581834|NCT01928381|7506049|FG003|COMPLETED|Part 2 - Second Intervention||4
6581835|NCT01928381|7506050|FG004|COMPLETED|Part 2 - Second Intervention||3
6581836|NCT01928381|7506051|FG005|COMPLETED|Part 2 - Second Intervention||5
6581837|NCT01928381|7506052|FG006|COMPLETED|Part 2 - Second Intervention||5
6581838|NCT01928381|7506046|FG000|NOT COMPLETED|Part 2 - Second Intervention||0
6581839|NCT01928381|7506047|FG001|NOT COMPLETED|Part 2 - Second Intervention||1
6581840|NCT01928381|7506048|FG002|NOT COMPLETED|Part 2 - Second Intervention||0
6581841|NCT01928381|7506049|FG003|NOT COMPLETED|Part 2 - Second Intervention||1
6581842|NCT01928381|7506050|FG004|NOT COMPLETED|Part 2 - Second Intervention||0
6581843|NCT01928381|7506051|FG005|NOT COMPLETED|Part 2 - Second Intervention||0
6581844|NCT01928381|7506052|FG006|NOT COMPLETED|Part 2 - Second Intervention||0
6581845|NCT01928381|7506046|FG000|STARTED|Washout Second Intervention||0
6581846|NCT01928381|7506047|FG001|STARTED|Washout Second Intervention||5
6581847|NCT01928381|7506048|FG002|STARTED|Washout Second Intervention||4
6581848|NCT01928381|7506049|FG003|STARTED|Washout Second Intervention||4
6581849|NCT01928381|7506050|FG004|STARTED|Washout Second Intervention||3
6581850|NCT01928381|7506051|FG005|STARTED|Washout Second Intervention||5
6581851|NCT01928381|7506052|FG006|STARTED|Washout Second Intervention||5
6581852|NCT01928381|7506046|FG000|COMPLETED|Washout Second Intervention||0
6581853|NCT01928381|7506047|FG001|COMPLETED|Washout Second Intervention||5
6581854|NCT01928381|7506048|FG002|COMPLETED|Washout Second Intervention||4
6581855|NCT01928381|7506049|FG003|COMPLETED|Washout Second Intervention||4
6581856|NCT01928381|7506050|FG004|COMPLETED|Washout Second Intervention||3
6581857|NCT01928381|7506051|FG005|COMPLETED|Washout Second Intervention||5
6581858|NCT01928381|7506052|FG006|COMPLETED|Washout Second Intervention||5
6581859|NCT01928381|7506046|FG000|NOT COMPLETED|Washout Second Intervention||0
6581860|NCT01928381|7506047|FG001|NOT COMPLETED|Washout Second Intervention||0
6581861|NCT01928381|7506048|FG002|NOT COMPLETED|Washout Second Intervention||0
6581862|NCT01928381|7506049|FG003|NOT COMPLETED|Washout Second Intervention||0
6581863|NCT01928381|7506050|FG004|NOT COMPLETED|Washout Second Intervention||0
6581864|NCT01928381|7506051|FG005|NOT COMPLETED|Washout Second Intervention||0
6581865|NCT01928381|7506052|FG006|NOT COMPLETED|Washout Second Intervention||0
6581866|NCT01928381|7506046|FG000|STARTED|Part 2 - Third Intervention||0
6581867|NCT01928381|7506047|FG001|STARTED|Part 2 - Third Intervention||5
6581868|NCT01928381|7506048|FG002|STARTED|Part 2 - Third Intervention||4
6581869|NCT01928381|7506049|FG003|STARTED|Part 2 - Third Intervention||4
6581870|NCT01928381|7506050|FG004|STARTED|Part 2 - Third Intervention||3
6581871|NCT01928381|7506051|FG005|STARTED|Part 2 - Third Intervention||5
6581872|NCT01928381|7506052|FG006|STARTED|Part 2 - Third Intervention||5
6581873|NCT01928381|7506046|FG000|COMPLETED|Part 2 - Third Intervention||0
6581874|NCT01928381|7506047|FG001|COMPLETED|Part 2 - Third Intervention||5
6581875|NCT01928381|7506048|FG002|COMPLETED|Part 2 - Third Intervention||4
6581876|NCT01928381|7506049|FG003|COMPLETED|Part 2 - Third Intervention||4
6581877|NCT01928381|7506050|FG004|COMPLETED|Part 2 - Third Intervention||3
6581878|NCT01928381|7506051|FG005|COMPLETED|Part 2 - Third Intervention||5
6581879|NCT01928381|7506052|FG006|COMPLETED|Part 2 - Third Intervention||5
6581880|NCT01928381|7506046|FG000|NOT COMPLETED|Part 2 - Third Intervention||0
6581881|NCT01928381|7506047|FG001|NOT COMPLETED|Part 2 - Third Intervention||0
6581882|NCT01928381|7506048|FG002|NOT COMPLETED|Part 2 - Third Intervention||0
6581883|NCT01928381|7506049|FG003|NOT COMPLETED|Part 2 - Third Intervention||0
6581884|NCT01928381|7506050|FG004|NOT COMPLETED|Part 2 - Third Intervention||0
6581885|NCT01928381|7506051|FG005|NOT COMPLETED|Part 2 - Third Intervention||0
6581886|NCT01928381|7506052|FG006|NOT COMPLETED|Part 2 - Third Intervention||0
6581887|NCT01928381|7506046|FG000|STARTED|Part 2 - Post Third Intervention||0
6581888|NCT01928381|7506047|FG001|STARTED|Part 2 - Post Third Intervention||5
6581889|NCT01928381|7506048|FG002|STARTED|Part 2 - Post Third Intervention||4
6581890|NCT01928381|7506049|FG003|STARTED|Part 2 - Post Third Intervention||4
6581891|NCT01928381|7506050|FG004|STARTED|Part 2 - Post Third Intervention||3
6581892|NCT01928381|7506051|FG005|STARTED|Part 2 - Post Third Intervention||5
6581893|NCT01928381|7506052|FG006|STARTED|Part 2 - Post Third Intervention||5
6581894|NCT01928381|7506046|FG000|COMPLETED|Part 2 - Post Third Intervention||0
6581895|NCT01928381|7506047|FG001|COMPLETED|Part 2 - Post Third Intervention||5
6581896|NCT01928381|7506048|FG002|COMPLETED|Part 2 - Post Third Intervention||3
6581897|NCT01928381|7506049|FG003|COMPLETED|Part 2 - Post Third Intervention||4
6581898|NCT01928381|7506050|FG004|COMPLETED|Part 2 - Post Third Intervention||3
6581899|NCT01928381|7506051|FG005|COMPLETED|Part 2 - Post Third Intervention||5
6581900|NCT01928381|7506052|FG006|COMPLETED|Part 2 - Post Third Intervention||5
6581901|NCT01928381|7506046|FG000|NOT COMPLETED|Part 2 - Post Third Intervention||0
6581902|NCT01928381|7506047|FG001|NOT COMPLETED|Part 2 - Post Third Intervention||0
6581903|NCT01928381|7506048|FG002|NOT COMPLETED|Part 2 - Post Third Intervention||1
6581904|NCT01928381|7506049|FG003|NOT COMPLETED|Part 2 - Post Third Intervention||0
6581905|NCT01928381|7506050|FG004|NOT COMPLETED|Part 2 - Post Third Intervention||0
6581906|NCT01928381|7506051|FG005|NOT COMPLETED|Part 2 - Post Third Intervention||0
6581907|NCT01928381|7506052|FG006|NOT COMPLETED|Part 2 - Post Third Intervention||0
6581908|NCT01928433|7506065|FG000|STARTED|Overall Study||76
6581909|NCT01928433|7506066|FG001|STARTED|Overall Study||75
6581910|NCT01928433|7506067|FG002|STARTED|Overall Study||74
6581911|NCT01928433|7506065|FG000|COMPLETED|Overall Study||56
6581912|NCT01928433|7506066|FG001|COMPLETED|Overall Study||54
6581913|NCT01928433|7506067|FG002|COMPLETED|Overall Study||46
6581914|NCT01928433|7506065|FG000|NOT COMPLETED|Overall Study||20
6581915|NCT01928433|7506066|FG001|NOT COMPLETED|Overall Study||21
6581916|NCT01928433|7506067|FG002|NOT COMPLETED|Overall Study||28
6581917|NCT01928446|7506080|FG000|STARTED|Overall Study||255
6581918|NCT01928446|7506081|FG001|STARTED|Overall Study||264
6581919|NCT01928446|7506080|FG000|COMPLETED|Overall Study|39 subjects stopped study drug but continued with followup|144
6581920|NCT01928446|7506081|FG001|COMPLETED|Overall Study|23 subjects stopped study drug but continued with followup|125
6581921|NCT01928446|7506080|FG000|NOT COMPLETED|Overall Study||111
6581922|NCT01928446|7506081|FG001|NOT COMPLETED|Overall Study||139
6581923|NCT01928472|7506093|FG000|STARTED|Overall Study||98
6581924|NCT01928472|7506094|FG001|STARTED|Overall Study||104
6581925|NCT01928472|7506095|FG002|STARTED|Overall Study||98
6581926|NCT01928472|7506096|FG003|STARTED|Overall Study||102
6581927|NCT01928472|7506093|FG000|COMPLETED|Overall Study||90
6581928|NCT01928472|7506094|FG001|COMPLETED|Overall Study||96
6581929|NCT01928472|7506095|FG002|COMPLETED|Overall Study||91
6581930|NCT01928472|7506096|FG003|COMPLETED|Overall Study||100
6581931|NCT01928472|7506093|FG000|NOT COMPLETED|Overall Study||8
6581932|NCT01928472|7506094|FG001|NOT COMPLETED|Overall Study||8
6581933|NCT01928472|7506095|FG002|NOT COMPLETED|Overall Study||7
6581934|NCT01928472|7506096|FG003|NOT COMPLETED|Overall Study||2
6581935|NCT01928485|7506109|FG000|STARTED|Overall Study||4
6581936|NCT01928485|7506110|FG001|STARTED|Overall Study||2
6581937|NCT01928485|7506109|FG000|COMPLETED|Overall Study||4
6581938|NCT01928485|7506110|FG001|COMPLETED|Overall Study||1
6581939|NCT01928485|7506109|FG000|NOT COMPLETED|Overall Study||0
6581940|NCT01928485|7506110|FG001|NOT COMPLETED|Overall Study||1
6581941|NCT01928524|7506123|FG000|STARTED|Overall Study||3
6581942|NCT01928524|7506124|FG001|STARTED|Overall Study||3
6255847|NCT01876953|7154720|FG001|STARTED|Overall Study||3
6255848|NCT01876953|7154719|FG000|COMPLETED|Overall Study||17
6255849|NCT01876953|7154720|FG001|COMPLETED|Overall Study||3
6255850|NCT01876953|7154719|FG000|NOT COMPLETED|Overall Study||0
6581943|NCT01928524|7506125|FG002|STARTED|Overall Study||6
6581944|NCT01928524|7506126|FG003|STARTED|Overall Study||6
6581945|NCT01928524|7506127|FG004|STARTED|Overall Study||3
6581946|NCT01928524|7506128|FG005|STARTED|Overall Study||8
6255851|NCT01876953|7154720|FG001|NOT COMPLETED|Overall Study||0
6255852|NCT01772472|7154728|FG000|STARTED|Overall Study||743
6581947|NCT01928524|7506129|FG006|STARTED|Overall Study||5
6581948|NCT01928524|7506123|FG000|COMPLETED|Overall Study||3
6581949|NCT01928524|7506124|FG001|COMPLETED|Overall Study||3
6581950|NCT01928524|7506125|FG002|COMPLETED|Overall Study||6
6581951|NCT01928524|7506126|FG003|COMPLETED|Overall Study||6
6581952|NCT01928524|7506127|FG004|COMPLETED|Overall Study||3
6581953|NCT01928524|7506128|FG005|COMPLETED|Overall Study||8
6581954|NCT01928524|7506129|FG006|COMPLETED|Overall Study||5
6581955|NCT01928524|7506123|FG000|NOT COMPLETED|Overall Study||0
6581956|NCT01928524|7506124|FG001|NOT COMPLETED|Overall Study||0
6581957|NCT01928524|7506125|FG002|NOT COMPLETED|Overall Study||0
6581958|NCT01928524|7506126|FG003|NOT COMPLETED|Overall Study||0
6581959|NCT01928524|7506127|FG004|NOT COMPLETED|Overall Study||0
6581960|NCT01928524|7506128|FG005|NOT COMPLETED|Overall Study||0
6581961|NCT01928524|7506129|FG006|NOT COMPLETED|Overall Study||0
6581962|NCT01928680|7506145|FG000|STARTED|Overall Study||33
6581963|NCT01928680|7506145|FG000|COMPLETED|Overall Study||33
6581964|NCT01928680|7506145|FG000|NOT COMPLETED|Overall Study||0
6581965|NCT01928693|7506152|FG000|STARTED|Overall Study||0
6581966|NCT01928693|7506153|FG001|STARTED|Overall Study||1
6581967|NCT01928693|7506154|FG002|STARTED|Overall Study||1
6581968|NCT01928693|7506152|FG000|COMPLETED|Overall Study||0
6581969|NCT01928693|7506153|FG001|COMPLETED|Overall Study||1
6581970|NCT01928693|7506154|FG002|COMPLETED|Overall Study||1
6581971|NCT01928693|7506152|FG000|NOT COMPLETED|Overall Study||0
6581972|NCT01928693|7506153|FG001|NOT COMPLETED|Overall Study||0
6581973|NCT01928693|7506154|FG002|NOT COMPLETED|Overall Study||0
6581974|NCT01928719|7506164|FG000|STARTED|Overall Study||122
6581975|NCT01928719|7506165|FG001|STARTED|Overall Study||123
6581976|NCT01928719|7506164|FG000|COMPLETED|Overall Study||70
6581977|NCT01928719|7506165|FG001|COMPLETED|Overall Study||104
6581978|NCT01928719|7506164|FG000|NOT COMPLETED|Overall Study||52
6581979|NCT01928719|7506165|FG001|NOT COMPLETED|Overall Study||19
6581980|NCT01928758|7506175|FG000|STARTED|Overall Study||94
6581981|NCT01928758|7506176|FG001|STARTED|Overall Study||94
6581982|NCT01928758|7506175|FG000|COMPLETED|Overall Study||69
6581983|NCT01928758|7506176|FG001|COMPLETED|Overall Study||74
6581984|NCT01928758|7506175|FG000|NOT COMPLETED|Overall Study||25
6581985|NCT01928758|7506176|FG001|NOT COMPLETED|Overall Study||20
6581986|NCT01928771|7506186|FG000|STARTED|Overall Study||400
6581987|NCT01928771|7506187|FG001|STARTED|Overall Study||398
6581988|NCT01928771|7506188|FG002|STARTED|Overall Study||407
6581989|NCT01928771|7506186|FG000|Received Treatment|Overall Study||399
6581990|NCT01928771|7506187|FG001|Received Treatment|Overall Study||398
6581991|NCT01928771|7506188|FG002|Received Treatment|Overall Study||407
6581992|NCT01928771|7506186|FG000|COMPLETED|Overall Study||354
6581993|NCT01928771|7506187|FG001|COMPLETED|Overall Study||358
6581994|NCT01928771|7506188|FG002|COMPLETED|Overall Study||367
6581995|NCT01928771|7506186|FG000|NOT COMPLETED|Overall Study||46
6581996|NCT01928771|7506187|FG001|NOT COMPLETED|Overall Study||40
6581997|NCT01928771|7506188|FG002|NOT COMPLETED|Overall Study||40
6581998|NCT01928797|7506198|FG000|STARTED|Overall Study||30
6581999|NCT01928797|7506199|FG001|STARTED|Overall Study||30
6582000|NCT01928797|7506198|FG000|COMPLETED|Overall Study||30
6582001|NCT01928797|7506199|FG001|COMPLETED|Overall Study||30
6582002|NCT01928797|7506198|FG000|NOT COMPLETED|Overall Study||0
6582003|NCT01928797|7506199|FG001|NOT COMPLETED|Overall Study||0
6582004|NCT01928849|7506209|FG000|STARTED|Overall Study||66
6582005|NCT01928849|7506210|FG001|STARTED|Overall Study||62
6582006|NCT01928849|7506209|FG000|COMPLETED|Overall Study||52
6582007|NCT01928849|7506210|FG001|COMPLETED|Overall Study||55
6582008|NCT01928849|7506209|FG000|NOT COMPLETED|Overall Study||14
6582009|NCT01928849|7506210|FG001|NOT COMPLETED|Overall Study||7
6582010|NCT01928862|7506221|FG000|STARTED|Overall Study||16
6582011|NCT01928862|7506222|FG001|STARTED|Overall Study||16
6582012|NCT01928862|7506223|FG002|STARTED|Overall Study||16
6582013|NCT01928862|7506224|FG003|STARTED|Overall Study||16
6582014|NCT01928862|7506225|FG004|STARTED|Overall Study||14
6582015|NCT01928862|7506221|FG000|COMPLETED|Overall Study||15
6582016|NCT01928862|7506222|FG001|COMPLETED|Overall Study||16
6582017|NCT01928862|7506223|FG002|COMPLETED|Overall Study||16
6582018|NCT01928862|7506224|FG003|COMPLETED|Overall Study||16
6582019|NCT01928862|7506225|FG004|COMPLETED|Overall Study||13
6582020|NCT01928862|7506221|FG000|NOT COMPLETED|Overall Study||1
6582021|NCT01928862|7506222|FG001|NOT COMPLETED|Overall Study||0
6582022|NCT01928862|7506223|FG002|NOT COMPLETED|Overall Study||0
6582023|NCT01928862|7506224|FG003|NOT COMPLETED|Overall Study||0
6582024|NCT01928862|7506225|FG004|NOT COMPLETED|Overall Study||1
6582025|NCT01928927|7506240|FG000|STARTED|Overall Study||29
6582026|NCT01928927|7506241|FG001|STARTED|Overall Study||15
6582027|NCT01928927|7506240|FG000|COMPLETED|Overall Study||27
6582028|NCT01928927|7506241|FG001|COMPLETED|Overall Study||14
6582029|NCT01928927|7506240|FG000|NOT COMPLETED|Overall Study||2
6582030|NCT01928927|7506241|FG001|NOT COMPLETED|Overall Study||1
6582031|NCT01928940|7506253|FG000|STARTED|Overall Study||6
6582032|NCT01928940|7506254|FG001|STARTED|Overall Study||6
6582033|NCT01928940|7506253|FG000|COMPLETED|Overall Study||6
6582034|NCT01928940|7506254|FG001|COMPLETED|Overall Study||5
6582035|NCT01928940|7506253|FG000|NOT COMPLETED|Overall Study||0
6582036|NCT01928940|7506254|FG001|NOT COMPLETED|Overall Study||1
6582037|NCT01929018|7506263|FG000|STARTED|Overall Study||19
6582038|NCT01929018|7506264|FG001|STARTED|Overall Study||19
6582039|NCT01929018|7506263|FG000|COMPLETED|Overall Study||18
6582040|NCT01929018|7506264|FG001|COMPLETED|Overall Study||18
6582041|NCT01929018|7506263|FG000|NOT COMPLETED|Overall Study||1
6582042|NCT01929018|7506264|FG001|NOT COMPLETED|Overall Study||1
6582043|NCT01929031|7506274|FG000|STARTED|Overall Study||213
6582044|NCT01929031|7506275|FG001|STARTED|Overall Study||209
6582045|NCT01929031|7506276|FG002|STARTED|Overall Study||35
6582046|NCT01929031|7506277|FG003|STARTED|Overall Study||35
6582047|NCT01929031|7506278|FG004|STARTED|Overall Study||34
6582048|NCT01929031|7506279|FG005|STARTED|Overall Study||36
6582049|NCT01929031|7506274|FG000|COMPLETED|Overall Study||209
6582050|NCT01929031|7506275|FG001|COMPLETED|Overall Study||207
6582051|NCT01929031|7506276|FG002|COMPLETED|Overall Study||34
6582052|NCT01929031|7506277|FG003|COMPLETED|Overall Study||35
6582053|NCT01929031|7506278|FG004|COMPLETED|Overall Study||33
6582054|NCT01929031|7506279|FG005|COMPLETED|Overall Study||35
6582055|NCT01929031|7506274|FG000|NOT COMPLETED|Overall Study||4
6582056|NCT01929031|7506275|FG001|NOT COMPLETED|Overall Study||2
6582057|NCT01929031|7506276|FG002|NOT COMPLETED|Overall Study||1
6582058|NCT01929031|7506277|FG003|NOT COMPLETED|Overall Study||0
6582059|NCT01929031|7506278|FG004|NOT COMPLETED|Overall Study||1
6582060|NCT01929031|7506279|FG005|NOT COMPLETED|Overall Study||1
6582061|NCT01929044|7506291|FG000|STARTED|Overall Study||153
6582062|NCT01929044|7506292|FG001|STARTED|Overall Study||146
6582063|NCT01929044|7506291|FG000|COMPLETED|Overall Study||142
6582064|NCT01929044|7506292|FG001|COMPLETED|Overall Study||129
6582065|NCT01929044|7506291|FG000|NOT COMPLETED|Overall Study||11
6582066|NCT01929044|7506292|FG001|NOT COMPLETED|Overall Study||17
6582067|NCT01929057|7506300|FG000|STARTED|Overall Study||31
6582068|NCT01929057|7506301|FG001|STARTED|Overall Study||3
6582069|NCT01929057|7506300|FG000|COMPLETED|Overall Study||31
6582070|NCT01929057|7506301|FG001|COMPLETED|Overall Study||3
6582071|NCT01929057|7506300|FG000|NOT COMPLETED|Overall Study||0
6582072|NCT01929057|7506301|FG001|NOT COMPLETED|Overall Study||0
6582073|NCT01929083|7506309|FG000|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
6582074|NCT01929083|7506310|FG001|STARTED|Intervention 1||9
6582075|NCT01929083|7506309|FG000|Returned for 1st Ibutilide Administratio|Intervention 1||7
6582076|NCT01929083|7506310|FG001|Returned for 1st Ibutilide Administratio|Intervention 1||9
6582077|NCT01929083|7506309|FG000|COMPLETED|Intervention 1||7
6582078|NCT01929083|7506310|FG001|COMPLETED|Intervention 1||9
6582079|NCT01929083|7506309|FG000|NOT COMPLETED|Intervention 1||3
6582080|NCT01929083|7506310|FG001|NOT COMPLETED|Intervention 1||0
6582081|NCT01929083|7506309|FG000|STARTED|Intervention 2||7
6582082|NCT01929083|7506310|FG001|STARTED|Intervention 2||9
6582083|NCT01929083|7506309|FG000|Returned for 2nd Ibutilide Administratio|Intervention 2||7
6582084|NCT01929083|7506310|FG001|Returned for 2nd Ibutilide Administratio|Intervention 2||8
6582085|NCT01929083|7506309|FG000|COMPLETED|Intervention 2||7
6582086|NCT01929083|7506310|FG001|COMPLETED|Intervention 2||8
6582087|NCT01929083|7506309|FG000|NOT COMPLETED|Intervention 2||0
6582088|NCT01929083|7506310|FG001|NOT COMPLETED|Intervention 2||1
6582089|NCT01929109|7506321|FG000|STARTED|Period 1 (All Groups)||14
6582090|NCT01929109|7506322|FG001|STARTED|Period 1 (All Groups)||8
6582091|NCT01929109|7506323|FG002|STARTED|Period 1 (All Groups)||9
6582092|NCT01929109|7506324|FG003|STARTED|Period 1 (All Groups)||8
6582093|NCT01929109|7506325|FG004|STARTED|Period 1 (All Groups)||8
6582094|NCT01929109|7506321|FG000|COMPLETED|Period 1 (All Groups)||14
6582095|NCT01929109|7506322|FG001|COMPLETED|Period 1 (All Groups)||8
6582096|NCT01929109|7506323|FG002|COMPLETED|Period 1 (All Groups)||8
6582097|NCT01929109|7506324|FG003|COMPLETED|Period 1 (All Groups)||8
6582098|NCT01929109|7506325|FG004|COMPLETED|Period 1 (All Groups)||8
6582099|NCT01929109|7506321|FG000|NOT COMPLETED|Period 1 (All Groups)||0
6582100|NCT01929109|7506322|FG001|NOT COMPLETED|Period 1 (All Groups)||0
6582101|NCT01929109|7506323|FG002|NOT COMPLETED|Period 1 (All Groups)||1
6582102|NCT01929109|7506324|FG003|NOT COMPLETED|Period 1 (All Groups)||0
6582103|NCT01929109|7506325|FG004|NOT COMPLETED|Period 1 (All Groups)||0
6582104|NCT01929109|7506321|FG000|STARTED|Period 2 (End Stage Renal Disease Only)||0
6582105|NCT01929109|7506322|FG001|STARTED|Period 2 (End Stage Renal Disease Only)||0
6582106|NCT01929109|7506323|FG002|STARTED|Period 2 (End Stage Renal Disease Only)||0
6582107|NCT01929109|7506324|FG003|STARTED|Period 2 (End Stage Renal Disease Only)||0
6582108|NCT01929109|7506325|FG004|STARTED|Period 2 (End Stage Renal Disease Only)||8
6582109|NCT01929109|7506321|FG000|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582110|NCT01929109|7506322|FG001|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582111|NCT01929109|7506323|FG002|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582112|NCT01929109|7506324|FG003|COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582113|NCT01929109|7506325|FG004|COMPLETED|Period 2 (End Stage Renal Disease Only)||8
6582114|NCT01929109|7506321|FG000|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582115|NCT01929109|7506322|FG001|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582116|NCT01929109|7506323|FG002|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582117|NCT01929109|7506324|FG003|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582118|NCT01929109|7506325|FG004|NOT COMPLETED|Period 2 (End Stage Renal Disease Only)||0
6582119|NCT01929135|7506342|FG000|STARTED|Overall Study||19
6582120|NCT01929135|7506343|FG001|STARTED|Overall Study||19
6582121|NCT01929135|7506342|FG000|COMPLETED|Overall Study||18
6582122|NCT01929135|7506343|FG001|COMPLETED|Overall Study||18
6582123|NCT01929135|7506342|FG000|NOT COMPLETED|Overall Study||1
6582124|NCT01929135|7506343|FG001|NOT COMPLETED|Overall Study||1
6582125|NCT01929226|7506353|FG000|STARTED|Overall Study||210
6582126|NCT01929226|7506354|FG001|STARTED|Overall Study||70
6582127|NCT01929226|7506353|FG000|COMPLETED|Overall Study||205
6582128|NCT01929226|7506354|FG001|COMPLETED|Overall Study||69
6582129|NCT01929226|7506353|FG000|NOT COMPLETED|Overall Study||5
6582130|NCT01929226|7506354|FG001|NOT COMPLETED|Overall Study||1
6582131|NCT01929291|7506361|FG000|STARTED|Overall Study||672
6582132|NCT01929291|7506361|FG000|COMPLETED|Overall Study||672
6582133|NCT01929291|7506361|FG000|NOT COMPLETED|Overall Study||0
6582134|NCT01929317|7506367|FG000|STARTED|Dose Increase Effect Verification Phase||61
6582135|NCT01929317|7506368|FG001|STARTED|Dose Increase Effect Verification Phase||20
6582136|NCT01929317|7506367|FG000|COMPLETED|Dose Increase Effect Verification Phase||52
6582137|NCT01929317|7506368|FG001|COMPLETED|Dose Increase Effect Verification Phase||19
6582138|NCT01929317|7506367|FG000|NOT COMPLETED|Dose Increase Effect Verification Phase||9
6582139|NCT01929317|7506368|FG001|NOT COMPLETED|Dose Increase Effect Verification Phase||1
6582140|NCT01929317|7506367|FG000|STARTED|Long-term Phase||44
6582141|NCT01929317|7506368|FG001|STARTED|Long-term Phase||18
6582142|NCT01929317|7506367|FG000|COMPLETED|Long-term Phase||25
6582143|NCT01929317|7506368|FG001|COMPLETED|Long-term Phase||14
6582144|NCT01929317|7506367|FG000|NOT COMPLETED|Long-term Phase||19
6582145|NCT01929317|7506368|FG001|NOT COMPLETED|Long-term Phase||4
6582146|NCT01929343|7506383|FG000|STARTED|Overall Study||12
6582147|NCT01929343|7506384|FG001|STARTED|Overall Study||9
6582148|NCT01929343|7506385|FG002|STARTED|Overall Study||12
6582149|NCT01929343|7506383|FG000|COMPLETED|Overall Study||11
6582150|NCT01929343|7506384|FG001|COMPLETED|Overall Study||7
6582151|NCT01929343|7506385|FG002|COMPLETED|Overall Study||12
6582152|NCT01929343|7506383|FG000|NOT COMPLETED|Overall Study||1
6582153|NCT01929343|7506384|FG001|NOT COMPLETED|Overall Study||2
6582154|NCT01929343|7506385|FG002|NOT COMPLETED|Overall Study||0
6582155|NCT01929395|7506396|FG000|STARTED|Overall Study||19
6582156|NCT01929395|7506397|FG001|STARTED|Overall Study||70
6582157|NCT01929395|7506398|FG002|STARTED|Overall Study||70
6582158|NCT01929395|7506396|FG000|COMPLETED|Overall Study||18
6582159|NCT01929395|7506397|FG001|COMPLETED|Overall Study||69
6582160|NCT01929395|7506398|FG002|COMPLETED|Overall Study||69
6582161|NCT01929395|7506396|FG000|NOT COMPLETED|Overall Study||1
6582162|NCT01929395|7506397|FG001|NOT COMPLETED|Overall Study||1
6582163|NCT01929395|7506398|FG002|NOT COMPLETED|Overall Study||1
6582164|NCT01929408|7506406|FG000|STARTED|Overall Study||703
6582165|NCT01929408|7506406|FG000|COMPLETED|Overall Study||695
6658956|NCT02484547|7589582|FG002|NOT COMPLETED|Long-Term Extension Period||0
6658957|NCT02484547|7589583|FG003|NOT COMPLETED|Long-Term Extension Period||131
6658958|NCT02484547|7589584|FG004|NOT COMPLETED|Long-Term Extension Period||132
6582166|NCT01929408|7506406|FG000|NOT COMPLETED|Overall Study||8
6582167|NCT01929460|7506412|FG000|STARTED|Overall Study||13
6582168|NCT01929460|7506413|FG001|STARTED|Overall Study||13
6582169|NCT01929460|7506412|FG000|COMPLETED|Overall Study||13
6582170|NCT01929460|7506413|FG001|COMPLETED|Overall Study||13
6582171|NCT01929460|7506412|FG000|NOT COMPLETED|Overall Study||0
6255853|NCT01772472|7154729|FG001|STARTED|Overall Study||743
6255854|NCT01772472|7154728|FG000|COMPLETED|Overall Study||0
6255855|NCT01772472|7154729|FG001|COMPLETED|Overall Study||0
6255856|NCT01772472|7154728|FG000|NOT COMPLETED|Overall Study||743
6255857|NCT01772472|7154729|FG001|NOT COMPLETED|Overall Study||743
6255858|NCT01764711|7154737|FG000|STARTED|Overall Study||8
6255859|NCT01764711|7154738|FG001|STARTED|Overall Study||5
6255860|NCT01764711|7154737|FG000|COMPLETED|Overall Study||8
6255861|NCT01764711|7154738|FG001|COMPLETED|Overall Study||5
6582172|NCT01929460|7506413|FG001|NOT COMPLETED|Overall Study||0
6582173|NCT01929473|7506419|FG000|STARTED|Overall Study|0 day|3830
6582174|NCT01929473|7506419|FG000|365 Day|Overall Study||3589
6582175|NCT01929473|7506419|FG000|COMPLETED|Overall Study||3243
6582176|NCT01929473|7506419|FG000|NOT COMPLETED|Overall Study||587
6582177|NCT01929642|7506423|FG000|STARTED|Overall Study||3
6582178|NCT01929642|7506423|FG000|COMPLETED|Overall Study||1
6582179|NCT01929642|7506423|FG000|NOT COMPLETED|Overall Study||2
6582180|NCT01929681|7506431|FG000|STARTED|Overall Study||28
6582181|NCT01929681|7506432|FG001|STARTED|Overall Study||25
6582182|NCT01929681|7506431|FG000|COMPLETED|Overall Study||26
6582183|NCT01929681|7506432|FG001|COMPLETED|Overall Study||24
6582184|NCT01929681|7506431|FG000|NOT COMPLETED|Overall Study||2
6582185|NCT01929681|7506432|FG001|NOT COMPLETED|Overall Study||1
6582186|NCT01929707|7506438|FG000|STARTED|Intervention Period 1||6
6582187|NCT01929707|7506439|FG001|STARTED|Intervention Period 1||8
6582188|NCT01929707|7506440|FG002|STARTED|Intervention Period 1||12
6582189|NCT01929707|7506441|FG003|STARTED|Intervention Period 1||10
6582190|NCT01929707|7506442|FG004|STARTED|Intervention Period 1||0
6582191|NCT01929707|7506443|FG005|STARTED|Intervention Period 1||0
6582192|NCT01929707|7506444|FG006|STARTED|Intervention Period 1||0
6658959|NCT02484547|7589585|FG005|NOT COMPLETED|Long-Term Extension Period||251
6658960|NCT02484547|7589586|FG006|NOT COMPLETED|Long-Term Extension Period||257
6255862|NCT01764711|7154737|FG000|NOT COMPLETED|Overall Study||0
6582193|NCT01929707|7506445|FG007|STARTED|Intervention Period 1||0
6582194|NCT01929707|7506438|FG000|Received at Least 1 Dose of Study Drug|Intervention Period 1||6
6582195|NCT01929707|7506439|FG001|Received at Least 1 Dose of Study Drug|Intervention Period 1||8
6582196|NCT01929707|7506440|FG002|Received at Least 1 Dose of Study Drug|Intervention Period 1||12
6582197|NCT01929707|7506441|FG003|Received at Least 1 Dose of Study Drug|Intervention Period 1||10
6582198|NCT01929707|7506442|FG004|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
6582199|NCT01929707|7506443|FG005|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
6582200|NCT01929707|7506444|FG006|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
6582201|NCT01929707|7506445|FG007|Received at Least 1 Dose of Study Drug|Intervention Period 1||0
6582202|NCT01929707|7506438|FG000|COMPLETED|Intervention Period 1||6
6582203|NCT01929707|7506439|FG001|COMPLETED|Intervention Period 1||8
6582204|NCT01929707|7506440|FG002|COMPLETED|Intervention Period 1||12
6582205|NCT01929707|7506441|FG003|COMPLETED|Intervention Period 1|Two discontinued participants were replaced in Period 2|7
6582206|NCT01929707|7506442|FG004|COMPLETED|Intervention Period 1||0
6582207|NCT01929707|7506443|FG005|COMPLETED|Intervention Period 1||0
6582208|NCT01929707|7506444|FG006|COMPLETED|Intervention Period 1||0
6582209|NCT01929707|7506445|FG007|COMPLETED|Intervention Period 1||0
6582210|NCT01929707|7506438|FG000|NOT COMPLETED|Intervention Period 1||0
6582211|NCT01929707|7506439|FG001|NOT COMPLETED|Intervention Period 1||0
6582212|NCT01929707|7506440|FG002|NOT COMPLETED|Intervention Period 1||0
6582213|NCT01929707|7506441|FG003|NOT COMPLETED|Intervention Period 1||3
6582214|NCT01929707|7506442|FG004|NOT COMPLETED|Intervention Period 1||0
6582215|NCT01929707|7506443|FG005|NOT COMPLETED|Intervention Period 1||0
6582216|NCT01929707|7506444|FG006|NOT COMPLETED|Intervention Period 1||0
6582217|NCT01929707|7506445|FG007|NOT COMPLETED|Intervention Period 1||0
6582218|NCT01929707|7506438|FG000|STARTED|Washout Period ≥7 Days||6
6582219|NCT01929707|7506439|FG001|STARTED|Washout Period ≥7 Days||8
6582220|NCT01929707|7506440|FG002|STARTED|Washout Period ≥7 Days||12
6582221|NCT01929707|7506441|FG003|STARTED|Washout Period ≥7 Days||7
6582222|NCT01929707|7506442|FG004|STARTED|Washout Period ≥7 Days||0
6582223|NCT01929707|7506443|FG005|STARTED|Washout Period ≥7 Days||0
6582224|NCT01929707|7506444|FG006|STARTED|Washout Period ≥7 Days||0
6582225|NCT01929707|7506445|FG007|STARTED|Washout Period ≥7 Days||0
6582226|NCT01929707|7506438|FG000|COMPLETED|Washout Period ≥7 Days||6
6582227|NCT01929707|7506439|FG001|COMPLETED|Washout Period ≥7 Days||8
6582228|NCT01929707|7506440|FG002|COMPLETED|Washout Period ≥7 Days||12
6582229|NCT01929707|7506441|FG003|COMPLETED|Washout Period ≥7 Days||7
6582230|NCT01929707|7506442|FG004|COMPLETED|Washout Period ≥7 Days||0
6582231|NCT01929707|7506443|FG005|COMPLETED|Washout Period ≥7 Days||0
6582232|NCT01929707|7506444|FG006|COMPLETED|Washout Period ≥7 Days||0
6582233|NCT01929707|7506445|FG007|COMPLETED|Washout Period ≥7 Days||0
6582234|NCT01929707|7506438|FG000|NOT COMPLETED|Washout Period ≥7 Days||0
6582235|NCT01929707|7506439|FG001|NOT COMPLETED|Washout Period ≥7 Days||0
6582236|NCT01929707|7506440|FG002|NOT COMPLETED|Washout Period ≥7 Days||0
6582237|NCT01929707|7506441|FG003|NOT COMPLETED|Washout Period ≥7 Days||0
6582238|NCT01929707|7506442|FG004|NOT COMPLETED|Washout Period ≥7 Days||0
6582239|NCT01929707|7506443|FG005|NOT COMPLETED|Washout Period ≥7 Days||0
6582240|NCT01929707|7506444|FG006|NOT COMPLETED|Washout Period ≥7 Days||0
6582241|NCT01929707|7506445|FG007|NOT COMPLETED|Washout Period ≥7 Days||0
6582242|NCT01929707|7506438|FG000|STARTED|Intervention Period 2|Incomplete-crossover design|0
6582243|NCT01929707|7506439|FG001|STARTED|Intervention Period 2|Incomplete-crossover design|0
6582244|NCT01929707|7506440|FG002|STARTED|Intervention Period 2|Incomplete-crossover design|0
6582245|NCT01929707|7506441|FG003|STARTED|Intervention Period 2|Incomplete-crossover design|5
6582246|NCT01929707|7506442|FG004|STARTED|Intervention Period 2|Incomplete-crossover design|6
6582247|NCT01929707|7506443|FG005|STARTED|Intervention Period 2|Incomplete-crossover design|8
6582248|NCT01929707|7506444|FG006|STARTED|Intervention Period 2|Incomplete-crossover design|12
6582249|NCT01929707|7506445|FG007|STARTED|Intervention Period 2|Incomplete-crossover design|4
6582250|NCT01929707|7506438|FG000|COMPLETED|Intervention Period 2||0
6582251|NCT01929707|7506439|FG001|COMPLETED|Intervention Period 2||0
6582252|NCT01929707|7506440|FG002|COMPLETED|Intervention Period 2||0
6582253|NCT01929707|7506441|FG003|COMPLETED|Intervention Period 2||5
6582254|NCT01929707|7506442|FG004|COMPLETED|Intervention Period 2||6
6582255|NCT01929707|7506443|FG005|COMPLETED|Intervention Period 2||6
6582256|NCT01929707|7506444|FG006|COMPLETED|Intervention Period 2||12
6582257|NCT01929707|7506445|FG007|COMPLETED|Intervention Period 2||4
6582258|NCT01929707|7506438|FG000|NOT COMPLETED|Intervention Period 2||0
6582259|NCT01929707|7506439|FG001|NOT COMPLETED|Intervention Period 2||0
6582260|NCT01929707|7506440|FG002|NOT COMPLETED|Intervention Period 2||0
6582261|NCT01929707|7506441|FG003|NOT COMPLETED|Intervention Period 2||0
6582262|NCT01929707|7506442|FG004|NOT COMPLETED|Intervention Period 2||0
6582263|NCT01929707|7506443|FG005|NOT COMPLETED|Intervention Period 2||2
6582264|NCT01929707|7506444|FG006|NOT COMPLETED|Intervention Period 2||0
6582265|NCT01929707|7506445|FG007|NOT COMPLETED|Intervention Period 2||0
6582266|NCT01929759|7506466|FG000|STARTED|Overall Study||10
6582267|NCT01929759|7506466|FG000|COMPLETED|Overall Study||10
6582268|NCT01929759|7506466|FG000|NOT COMPLETED|Overall Study||0
6582269|NCT01929863|7506470|FG000|STARTED|Period 1:Intervention Period 1 (7 Days)||7
6582270|NCT01929863|7506471|FG001|STARTED|Period 1:Intervention Period 1 (7 Days)||8
6582271|NCT01929863|7506470|FG000|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
6582272|NCT01929863|7506471|FG001|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
6582273|NCT01929863|7506470|FG000|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
6582274|NCT01929863|7506471|FG001|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
6582275|NCT01929863|7506470|FG000|STARTED|Period 2:Washout Period (13-15 Days)||6
6582276|NCT01929863|7506471|FG001|STARTED|Period 2:Washout Period (13-15 Days)||7
6582277|NCT01929863|7506470|FG000|COMPLETED|Period 2:Washout Period (13-15 Days)||6
6582278|NCT01929863|7506471|FG001|COMPLETED|Period 2:Washout Period (13-15 Days)||7
6658961|NCT02484651|7589600|FG000|STARTED|Overall Study|35 patients were randomized|35
6658962|NCT02484651|7589601|FG001|STARTED|Overall Study|35 patients were randomized|35
6658963|NCT02484651|7589600|FG000|End of Clinical Study|Overall Study||35
6658964|NCT02484651|7589601|FG001|End of Clinical Study|Overall Study||35
6658965|NCT02484651|7589600|FG000|Data Analysis|Overall Study||32
6658966|NCT02484651|7589601|FG001|Data Analysis|Overall Study||31
6582279|NCT01929863|7506470|FG000|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
6582280|NCT01929863|7506471|FG001|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
6582281|NCT01929863|7506470|FG000|STARTED|Period 3:Intervention Period 2 (7 Days)||6
6582282|NCT01929863|7506471|FG001|STARTED|Period 3:Intervention Period 2 (7 Days)||7
6582283|NCT01929863|7506470|FG000|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
6582284|NCT01929863|7506471|FG001|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
6582285|NCT01929863|7506470|FG000|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
6582286|NCT01929863|7506471|FG001|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
6582287|NCT01929863|7506470|FG000|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
6582288|NCT01929863|7506471|FG001|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
6582289|NCT01929863|7506470|FG000|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
6582290|NCT01929863|7506471|FG001|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
6582291|NCT01929863|7506470|FG000|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
6582292|NCT01929863|7506471|FG001|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
6582293|NCT01929876|7506482|FG000|STARTED|Period 1||16
6582294|NCT01929876|7506482|FG000|COMPLETED|Period 1||16
6582295|NCT01929876|7506482|FG000|NOT COMPLETED|Period 1||0
6582296|NCT01929876|7506482|FG000|STARTED|Period 2||16
6582297|NCT01929876|7506482|FG000|COMPLETED|Period 2||15
6582298|NCT01929876|7506482|FG000|NOT COMPLETED|Period 2||1
6582299|NCT01929889|7506486|FG000|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
6582300|NCT01929889|7506486|FG000|COMPLETED|Overall Study|3 subjects completed the study.|3
6582301|NCT01929889|7506486|FG000|NOT COMPLETED|Overall Study||5
6582302|NCT01929980|7506490|FG000|STARTED|Overall Study||4
6582303|NCT01929980|7506490|FG000|COMPLETED|Overall Study||3
6582304|NCT01929980|7506490|FG000|NOT COMPLETED|Overall Study||1
6582305|NCT01929993|7506496|FG000|STARTED|Overall Study||82
6582306|NCT01929993|7506497|FG001|STARTED|Overall Study||82
6582307|NCT01929993|7506496|FG000|COMPLETED|Overall Study||52
6582308|NCT01929993|7506497|FG001|COMPLETED|Overall Study||54
6582309|NCT01929993|7506496|FG000|NOT COMPLETED|Overall Study||30
6582310|NCT01929993|7506497|FG001|NOT COMPLETED|Overall Study||28
6582311|NCT01930045|7506503|FG000|STARTED|Part 1 - Period 1||3
6582312|NCT01930045|7506504|FG001|STARTED|Part 1 - Period 1||3
6582313|NCT01930045|7506505|FG002|STARTED|Part 1 - Period 1||3
6582314|NCT01930045|7506506|FG003|STARTED|Part 1 - Period 1||3
6582315|NCT01930045|7506507|FG004|STARTED|Part 1 - Period 1||3
6582316|NCT01930045|7506508|FG005|STARTED|Part 1 - Period 1||3
6582317|NCT01930045|7506503|FG000|COMPLETED|Part 1 - Period 1||3
6582318|NCT01930045|7506504|FG001|COMPLETED|Part 1 - Period 1||3
6582319|NCT01930045|7506505|FG002|COMPLETED|Part 1 - Period 1||3
6582320|NCT01930045|7506506|FG003|COMPLETED|Part 1 - Period 1||3
6582321|NCT01930045|7506507|FG004|COMPLETED|Part 1 - Period 1||3
6582322|NCT01930045|7506508|FG005|COMPLETED|Part 1 - Period 1||3
6582323|NCT01930045|7506503|FG000|NOT COMPLETED|Part 1 - Period 1||0
6582324|NCT01930045|7506504|FG001|NOT COMPLETED|Part 1 - Period 1||0
6582325|NCT01930045|7506505|FG002|NOT COMPLETED|Part 1 - Period 1||0
6582326|NCT01930045|7506506|FG003|NOT COMPLETED|Part 1 - Period 1||0
6582327|NCT01930045|7506507|FG004|NOT COMPLETED|Part 1 - Period 1||0
6582328|NCT01930045|7506508|FG005|NOT COMPLETED|Part 1 - Period 1||0
6582329|NCT01930045|7506503|FG000|STARTED|Part 1 - Period 2||3
6582330|NCT01930045|7506504|FG001|STARTED|Part 1 - Period 2||3
6582331|NCT01930045|7506505|FG002|STARTED|Part 1 - Period 2||3
6582332|NCT01930045|7506506|FG003|STARTED|Part 1 - Period 2||3
6582333|NCT01930045|7506507|FG004|STARTED|Part 1 - Period 2||3
6582334|NCT01930045|7506508|FG005|STARTED|Part 1 - Period 2||3
6582335|NCT01930045|7506503|FG000|COMPLETED|Part 1 - Period 2||3
6582336|NCT01930045|7506504|FG001|COMPLETED|Part 1 - Period 2||3
6582337|NCT01930045|7506505|FG002|COMPLETED|Part 1 - Period 2||3
6582338|NCT01930045|7506506|FG003|COMPLETED|Part 1 - Period 2||3
6582339|NCT01930045|7506507|FG004|COMPLETED|Part 1 - Period 2||3
6582340|NCT01930045|7506508|FG005|COMPLETED|Part 1 - Period 2||3
6582341|NCT01930045|7506503|FG000|NOT COMPLETED|Part 1 - Period 2||0
6582342|NCT01930045|7506504|FG001|NOT COMPLETED|Part 1 - Period 2||0
6582343|NCT01930045|7506505|FG002|NOT COMPLETED|Part 1 - Period 2||0
6582344|NCT01930045|7506506|FG003|NOT COMPLETED|Part 1 - Period 2||0
6582345|NCT01930045|7506507|FG004|NOT COMPLETED|Part 1 - Period 2||0
6582346|NCT01930045|7506508|FG005|NOT COMPLETED|Part 1 - Period 2||0
6582347|NCT01930045|7506503|FG000|STARTED|Part 1 - Period 3||3
6582348|NCT01930045|7506504|FG001|STARTED|Part 1 - Period 3||3
6582349|NCT01930045|7506505|FG002|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
6582350|NCT01930045|7506506|FG003|STARTED|Part 1 - Period 3||3
6582351|NCT01930045|7506507|FG004|STARTED|Part 1 - Period 3||3
6582352|NCT01930045|7506508|FG005|STARTED|Part 1 - Period 3||3
6582353|NCT01930045|7506503|FG000|COMPLETED|Part 1 - Period 3||3
6582354|NCT01930045|7506504|FG001|COMPLETED|Part 1 - Period 3||3
6582355|NCT01930045|7506505|FG002|COMPLETED|Part 1 - Period 3||2
6582356|NCT01930045|7506506|FG003|COMPLETED|Part 1 - Period 3||3
6582357|NCT01930045|7506507|FG004|COMPLETED|Part 1 - Period 3||3
6582358|NCT01930045|7506508|FG005|COMPLETED|Part 1 - Period 3||3
6582359|NCT01930045|7506503|FG000|NOT COMPLETED|Part 1 - Period 3||0
6582360|NCT01930045|7506504|FG001|NOT COMPLETED|Part 1 - Period 3||0
6582361|NCT01930045|7506505|FG002|NOT COMPLETED|Part 1 - Period 3||0
6582362|NCT01930045|7506506|FG003|NOT COMPLETED|Part 1 - Period 3||0
6582363|NCT01930045|7506507|FG004|NOT COMPLETED|Part 1 - Period 3||0
6582364|NCT01930045|7506508|FG005|NOT COMPLETED|Part 1 - Period 3||0
6582365|NCT01930045|7506503|FG000|STARTED|Pause (up to 37 Days)||3
6582366|NCT01930045|7506504|FG001|STARTED|Pause (up to 37 Days)||3
6582367|NCT01930045|7506505|FG002|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
6582368|NCT01930045|7506506|FG003|STARTED|Pause (up to 37 Days)||3
6582369|NCT01930045|7506507|FG004|STARTED|Pause (up to 37 Days)||3
6582370|NCT01930045|7506508|FG005|STARTED|Pause (up to 37 Days)||3
6582371|NCT01930045|7506503|FG000|COMPLETED|Pause (up to 37 Days)||3
6582372|NCT01930045|7506504|FG001|COMPLETED|Pause (up to 37 Days)||3
6582373|NCT01930045|7506505|FG002|COMPLETED|Pause (up to 37 Days)||3
6582374|NCT01930045|7506506|FG003|COMPLETED|Pause (up to 37 Days)||3
6582375|NCT01930045|7506507|FG004|COMPLETED|Pause (up to 37 Days)||3
6582376|NCT01930045|7506508|FG005|COMPLETED|Pause (up to 37 Days)||1
6582377|NCT01930045|7506503|FG000|NOT COMPLETED|Pause (up to 37 Days)||0
6582378|NCT01930045|7506504|FG001|NOT COMPLETED|Pause (up to 37 Days)||0
6582379|NCT01930045|7506505|FG002|NOT COMPLETED|Pause (up to 37 Days)||0
6582380|NCT01930045|7506506|FG003|NOT COMPLETED|Pause (up to 37 Days)||0
6582381|NCT01930045|7506507|FG004|NOT COMPLETED|Pause (up to 37 Days)||0
6582382|NCT01930045|7506508|FG005|NOT COMPLETED|Pause (up to 37 Days)||2
6582383|NCT01930045|7506503|FG000|STARTED|Part 2 - Period 4||3
6658967|NCT02484651|7589600|FG000|COMPLETED|Overall Study||32
6658968|NCT02484651|7589601|FG001|COMPLETED|Overall Study||31
6658969|NCT02484651|7589600|FG000|NOT COMPLETED|Overall Study||3
6658970|NCT02484651|7589601|FG001|NOT COMPLETED|Overall Study||4
6658971|NCT02484690|7589613|FG000|STARTED|Overall Study||68
6658972|NCT02484690|7589614|FG001|STARTED|Overall Study||46
6658973|NCT02484690|7589615|FG002|STARTED|Overall Study||39
6658974|NCT02484690|7589616|FG003|STARTED|Overall Study||46
6658975|NCT02484690|7589617|FG004|STARTED|Overall Study||64
6658976|NCT02484690|7589613|FG000|Received at Least One Dose of Study Drug|Overall Study||67
6658977|NCT02484690|7589614|FG001|Received at Least One Dose of Study Drug|Overall Study||46
6658978|NCT02484690|7589615|FG002|Received at Least One Dose of Study Drug|Overall Study||39
6658979|NCT02484690|7589616|FG003|Received at Least One Dose of Study Drug|Overall Study||46
6658980|NCT02484690|7589617|FG004|Received at Least One Dose of Study Drug|Overall Study||64
6658981|NCT02484690|7589613|FG000|COMPLETED|Overall Study||64
6658982|NCT02484690|7589614|FG001|COMPLETED|Overall Study||40
6658983|NCT02484690|7589615|FG002|COMPLETED|Overall Study||36
6658984|NCT02484690|7589616|FG003|COMPLETED|Overall Study||44
6658985|NCT02484690|7589617|FG004|COMPLETED|Overall Study||58
6658986|NCT02484690|7589613|FG000|NOT COMPLETED|Overall Study||4
6658987|NCT02484690|7589614|FG001|NOT COMPLETED|Overall Study||6
6658988|NCT02484690|7589615|FG002|NOT COMPLETED|Overall Study||3
6658989|NCT02484690|7589616|FG003|NOT COMPLETED|Overall Study||2
6658990|NCT02484690|7589617|FG004|NOT COMPLETED|Overall Study||6
6658991|NCT02484729|7589640|FG000|STARTED|Overall Study||16
6658992|NCT02484729|7589641|FG001|STARTED|Overall Study||6
6658993|NCT02484729|7589642|FG002|STARTED|Overall Study||6
6658994|NCT02484729|7589643|FG003|STARTED|Overall Study||6
6658995|NCT02484729|7589644|FG004|STARTED|Overall Study||5
6658996|NCT02484729|7589645|FG005|STARTED|Overall Study||6
6658997|NCT02484729|7589646|FG006|STARTED|Overall Study||5
6658998|NCT02484729|7589647|FG007|STARTED|Overall Study||6
6658999|NCT02484729|7589648|FG008|STARTED|Overall Study||6
6659000|NCT02484729|7589649|FG009|STARTED|Overall Study||8
6659001|NCT02484729|7589640|FG000|COMPLETED|Overall Study||16
6659002|NCT02484729|7589641|FG001|COMPLETED|Overall Study||6
6659003|NCT02484729|7589642|FG002|COMPLETED|Overall Study||6
6659004|NCT02484729|7589643|FG003|COMPLETED|Overall Study||6
6659005|NCT02484729|7589644|FG004|COMPLETED|Overall Study||5
6659006|NCT02484729|7589645|FG005|COMPLETED|Overall Study||6
6659007|NCT02484729|7589646|FG006|COMPLETED|Overall Study||5
6659008|NCT02484729|7589647|FG007|COMPLETED|Overall Study||6
6659009|NCT02484729|7589648|FG008|COMPLETED|Overall Study||6
6659010|NCT02484729|7589649|FG009|COMPLETED|Overall Study||7
6659011|NCT02484729|7589640|FG000|NOT COMPLETED|Overall Study||0
6659012|NCT02484729|7589641|FG001|NOT COMPLETED|Overall Study||0
6659013|NCT02484729|7589642|FG002|NOT COMPLETED|Overall Study||0
6659014|NCT02484729|7589643|FG003|NOT COMPLETED|Overall Study||0
6659015|NCT02484729|7589644|FG004|NOT COMPLETED|Overall Study||0
6659016|NCT02484729|7589645|FG005|NOT COMPLETED|Overall Study||0
6659017|NCT02484729|7589646|FG006|NOT COMPLETED|Overall Study||0
6659018|NCT02484729|7589647|FG007|NOT COMPLETED|Overall Study||0
6659019|NCT02484729|7589648|FG008|NOT COMPLETED|Overall Study||0
6659020|NCT02484729|7589649|FG009|NOT COMPLETED|Overall Study||1
6659021|NCT02484807|7589689|FG000|STARTED|Overall Study||39
6659022|NCT02484807|7589690|FG001|STARTED|Overall Study||7
6659023|NCT02484807|7589691|FG002|STARTED|Overall Study||19
6659024|NCT02484807|7589692|FG003|STARTED|Overall Study||21
6659025|NCT02484807|7589693|FG004|STARTED|Overall Study||33
6582384|NCT01930045|7506504|FG001|STARTED|Part 2 - Period 4||3
6659026|NCT02484807|7589694|FG005|STARTED|Overall Study||6
6659027|NCT02484807|7589689|FG000|COMPLETED|Overall Study||39
6659028|NCT02484807|7589690|FG001|COMPLETED|Overall Study||7
6659029|NCT02484807|7589691|FG002|COMPLETED|Overall Study||19
6659030|NCT02484807|7589692|FG003|COMPLETED|Overall Study||21
6659031|NCT02484807|7589693|FG004|COMPLETED|Overall Study||33
6659032|NCT02484807|7589694|FG005|COMPLETED|Overall Study||6
6659033|NCT02484807|7589689|FG000|NOT COMPLETED|Overall Study||0
6659034|NCT02484807|7589690|FG001|NOT COMPLETED|Overall Study||0
6659035|NCT02484807|7589691|FG002|NOT COMPLETED|Overall Study||0
6659036|NCT02484807|7589692|FG003|NOT COMPLETED|Overall Study||0
6582385|NCT01930045|7506505|FG002|STARTED|Part 2 - Period 4||3
6582386|NCT01930045|7506506|FG003|STARTED|Part 2 - Period 4||3
6582387|NCT01930045|7506507|FG004|STARTED|Part 2 - Period 4||3
6582388|NCT01930045|7506508|FG005|STARTED|Part 2 - Period 4||1
6582389|NCT01930045|7506503|FG000|COMPLETED|Part 2 - Period 4||3
6582390|NCT01930045|7506504|FG001|COMPLETED|Part 2 - Period 4||3
6582391|NCT01930045|7506505|FG002|COMPLETED|Part 2 - Period 4||3
6582392|NCT01930045|7506506|FG003|COMPLETED|Part 2 - Period 4||3
6582393|NCT01930045|7506507|FG004|COMPLETED|Part 2 - Period 4||3
6582394|NCT01930045|7506508|FG005|COMPLETED|Part 2 - Period 4||1
6582395|NCT01930045|7506503|FG000|NOT COMPLETED|Part 2 - Period 4||0
6582396|NCT01930045|7506504|FG001|NOT COMPLETED|Part 2 - Period 4||0
6582397|NCT01930045|7506505|FG002|NOT COMPLETED|Part 2 - Period 4||0
6582398|NCT01930045|7506506|FG003|NOT COMPLETED|Part 2 - Period 4||0
6582399|NCT01930045|7506507|FG004|NOT COMPLETED|Part 2 - Period 4||0
6582400|NCT01930045|7506508|FG005|NOT COMPLETED|Part 2 - Period 4||0
6582401|NCT01930045|7506503|FG000|STARTED|Part 2 - Period 5||3
6582402|NCT01930045|7506504|FG001|STARTED|Part 2 - Period 5||3
6582403|NCT01930045|7506505|FG002|STARTED|Part 2 - Period 5||3
6582404|NCT01930045|7506506|FG003|STARTED|Part 2 - Period 5||3
6582405|NCT01930045|7506507|FG004|STARTED|Part 2 - Period 5||3
6582406|NCT01930045|7506508|FG005|STARTED|Part 2 - Period 5||1
6582407|NCT01930045|7506503|FG000|COMPLETED|Part 2 - Period 5||3
6582408|NCT01930045|7506504|FG001|COMPLETED|Part 2 - Period 5||3
6582409|NCT01930045|7506505|FG002|COMPLETED|Part 2 - Period 5||3
6582410|NCT01930045|7506506|FG003|COMPLETED|Part 2 - Period 5||3
6582411|NCT01930045|7506507|FG004|COMPLETED|Part 2 - Period 5||3
6582412|NCT01930045|7506508|FG005|COMPLETED|Part 2 - Period 5||1
6582413|NCT01930045|7506503|FG000|NOT COMPLETED|Part 2 - Period 5||0
6582414|NCT01930045|7506504|FG001|NOT COMPLETED|Part 2 - Period 5||0
6582415|NCT01930045|7506505|FG002|NOT COMPLETED|Part 2 - Period 5||0
6582416|NCT01930045|7506506|FG003|NOT COMPLETED|Part 2 - Period 5||0
6582417|NCT01930045|7506507|FG004|NOT COMPLETED|Part 2 - Period 5||0
6582418|NCT01930045|7506508|FG005|NOT COMPLETED|Part 2 - Period 5||0
6582419|NCT01930058|7506523|FG000|STARTED|Overall Study||3
6582420|NCT01930058|7506524|FG001|STARTED|Overall Study||3
6582421|NCT01930058|7506525|FG002|STARTED|Overall Study||3
6582422|NCT01930058|7506523|FG000|COMPLETED|Overall Study||3
6582423|NCT01930058|7506524|FG001|COMPLETED|Overall Study||3
6582424|NCT01930058|7506525|FG002|COMPLETED|Overall Study||3
6582425|NCT01930058|7506523|FG000|NOT COMPLETED|Overall Study||0
6582426|NCT01930058|7506524|FG001|NOT COMPLETED|Overall Study||0
6582427|NCT01930058|7506525|FG002|NOT COMPLETED|Overall Study||0
6582428|NCT01930162|7506532|FG000|STARTED|Overall Study||9
6582429|NCT01930162|7506532|FG000|COMPLETED|Overall Study||4
6582430|NCT01930162|7506532|FG000|NOT COMPLETED|Overall Study||5
6624201|NCT02214420|7551564|FG000|NOT COMPLETED|Overall Study||1
6624202|NCT02214420|7551565|FG001|NOT COMPLETED|Overall Study||0
6624203|NCT02214615|7551573|FG000|STARTED|First Intervention||1
6624204|NCT02214615|7551574|FG001|STARTED|First Intervention||1
6624205|NCT02214615|7551573|FG000|COMPLETED|First Intervention||1
6624206|NCT02214615|7551574|FG001|COMPLETED|First Intervention||1
6624207|NCT02214615|7551573|FG000|NOT COMPLETED|First Intervention||0
6624208|NCT02214615|7551574|FG001|NOT COMPLETED|First Intervention||0
6624209|NCT02214615|7551573|FG000|STARTED|Washout||1
6624210|NCT02214615|7551574|FG001|STARTED|Washout||1
6624211|NCT02214615|7551573|FG000|COMPLETED|Washout||1
6624212|NCT02214615|7551574|FG001|COMPLETED|Washout||1
6624213|NCT02214615|7551573|FG000|NOT COMPLETED|Washout||0
6624214|NCT02214615|7551574|FG001|NOT COMPLETED|Washout||0
6624215|NCT02214615|7551573|FG000|STARTED|Second Intervention||1
6624216|NCT02214615|7551574|FG001|STARTED|Second Intervention||1
6624217|NCT02214615|7551573|FG000|COMPLETED|Second Intervention||1
6624218|NCT02214615|7551574|FG001|COMPLETED|Second Intervention||1
6624219|NCT02214615|7551573|FG000|NOT COMPLETED|Second Intervention||0
6624220|NCT02214615|7551574|FG001|NOT COMPLETED|Second Intervention||0
6624221|NCT02214628|7551582|FG000|STARTED|Overall Study||63
6624222|NCT02214628|7551583|FG001|STARTED|Overall Study||38
6624223|NCT02214628|7551582|FG000|COMPLETED|Overall Study||36
6624224|NCT02214628|7551583|FG001|COMPLETED|Overall Study||9
6624225|NCT02214628|7551582|FG000|NOT COMPLETED|Overall Study||27
6624226|NCT02214628|7551583|FG001|NOT COMPLETED|Overall Study||29
6624227|NCT02215070|7551593|FG000|STARTED|Overall Study||26
6624228|NCT02215070|7551594|FG001|STARTED|Overall Study||52
6624229|NCT02215070|7551593|FG000|COMPLETED|Overall Study||20
6624230|NCT02215070|7551594|FG001|COMPLETED|Overall Study||52
6624231|NCT02215070|7551593|FG000|NOT COMPLETED|Overall Study||6
6624232|NCT02215070|7551594|FG001|NOT COMPLETED|Overall Study||0
6624233|NCT02215161|7551600|FG000|STARTED|Overall Study||14
6624234|NCT02215161|7551600|FG000|COMPLETED|Overall Study||14
6624235|NCT02215161|7551600|FG000|NOT COMPLETED|Overall Study||0
6624236|NCT02215200|7551615|FG000|STARTED|Overall Study||29
6624237|NCT02215200|7551616|FG001|STARTED|Overall Study||29
6624238|NCT02215200|7551617|FG002|STARTED|Overall Study||31
6624239|NCT02215200|7551615|FG000|COMPLETED|Overall Study||29
6624240|NCT02215200|7551616|FG001|COMPLETED|Overall Study||28
6624241|NCT02215200|7551617|FG002|COMPLETED|Overall Study||30
6624242|NCT02215200|7551615|FG000|NOT COMPLETED|Overall Study||0
6624243|NCT02215200|7551616|FG001|NOT COMPLETED|Overall Study||1
6624244|NCT02215200|7551617|FG002|NOT COMPLETED|Overall Study||1
6624245|NCT02215252|7551628|FG000|STARTED|Overall Study||44
6624246|NCT02215252|7551629|FG001|STARTED|Overall Study||46
6582431|NCT01930175|7506540|FG000|STARTED|Core Study||7
6582432|NCT01930175|7506541|FG001|STARTED|Core Study||2
6582433|NCT01930175|7506542|FG002|STARTED|Core Study||4
6582434|NCT01930175|7506540|FG000|Safety Analysis Set|Core Study||7
6582435|NCT01930175|7506541|FG001|Safety Analysis Set|Core Study||2
6582436|NCT01930175|7506542|FG002|Safety Analysis Set|Core Study||4
6582437|NCT01930175|7506540|FG000|Pharmacokinetics (PK) Analysis Set|Core Study||7
6582438|NCT01930175|7506541|FG001|Pharmacokinetics (PK) Analysis Set|Core Study||2
6582439|NCT01930175|7506542|FG002|Pharmacokinetics (PK) Analysis Set|Core Study|Placebo patients were excluded from the PK analyses|0
6582440|NCT01930175|7506540|FG000|COMPLETED|Core Study||7
6582441|NCT01930175|7506541|FG001|COMPLETED|Core Study||1
6582442|NCT01930175|7506542|FG002|COMPLETED|Core Study||3
6582443|NCT01930175|7506540|FG000|NOT COMPLETED|Core Study||0
6582444|NCT01930175|7506541|FG001|NOT COMPLETED|Core Study||1
6582445|NCT01930175|7506542|FG002|NOT COMPLETED|Core Study||1
6582446|NCT01930175|7506540|FG000|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
6582447|NCT01930175|7506541|FG001|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|0
6582448|NCT01930175|7506542|FG002|STARTED|Open Label VAY736 10 mg/kg at Week 24|Only patients originally randomized to Placebo were allowed to enter this Period.|3
6582449|NCT01930175|7506540|FG000|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6582450|NCT01930175|7506541|FG001|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6582451|NCT01930175|7506542|FG002|COMPLETED|Open Label VAY736 10 mg/kg at Week 24||3
6582452|NCT01930175|7506540|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6582453|NCT01930175|7506541|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6582454|NCT01930175|7506542|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg at Week 24||0
6582455|NCT01930188|7506554|FG000|STARTED|Overall Study||409
6582456|NCT01930188|7506555|FG001|STARTED|Overall Study||409
6582457|NCT01930188|7506556|FG002|STARTED|Overall Study||407
6582458|NCT01930188|7506554|FG000|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|53
6582459|NCT01930188|7506555|FG001|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|61
6582460|NCT01930188|7506556|FG002|Premature Discontinuation of Treatment|Overall Study|Subjects prematurely discontinued treatment were allowed to continue participation in the trial.|32
6582461|NCT01930188|7506554|FG000|COMPLETED|Overall Study||387
6582462|NCT01930188|7506555|FG001|COMPLETED|Overall Study||388
6582463|NCT01930188|7506556|FG002|COMPLETED|Overall Study||388
6582464|NCT01930188|7506554|FG000|NOT COMPLETED|Overall Study||22
6582465|NCT01930188|7506555|FG001|NOT COMPLETED|Overall Study||21
6582466|NCT01930188|7506556|FG002|NOT COMPLETED|Overall Study||19
6582467|NCT01930214|7506568|FG000|STARTED|Overall Study||100
6582468|NCT01930214|7506569|FG001|STARTED|Overall Study||117
6582469|NCT01930214|7506570|FG002|STARTED|Overall Study||133
6582470|NCT01930214|7506568|FG000|COMPLETED|Overall Study||80
6582471|NCT01930214|7506569|FG001|COMPLETED|Overall Study||96
6582472|NCT01930214|7506570|FG002|COMPLETED|Overall Study||108
6582473|NCT01930214|7506568|FG000|NOT COMPLETED|Overall Study||20
6582474|NCT01930214|7506569|FG001|NOT COMPLETED|Overall Study||21
6582475|NCT01930214|7506570|FG002|NOT COMPLETED|Overall Study||25
6582476|NCT01930435|7506578|FG000|STARTED|Overall Study||20
6582477|NCT01930435|7506578|FG000|COMPLETED|Overall Study||20
6582478|NCT01930435|7506578|FG000|NOT COMPLETED|Overall Study||0
6582479|NCT01930487|7506583|FG000|STARTED|First Intervention (30 Days)||21
6582480|NCT01930487|7506584|FG001|STARTED|First Intervention (30 Days)||25
6582481|NCT01930487|7506583|FG000|COMPLETED|First Intervention (30 Days)||19
6582482|NCT01930487|7506584|FG001|COMPLETED|First Intervention (30 Days)||23
6582483|NCT01930487|7506583|FG000|NOT COMPLETED|First Intervention (30 Days)||2
6582484|NCT01930487|7506584|FG001|NOT COMPLETED|First Intervention (30 Days)||2
6582485|NCT01930487|7506583|FG000|STARTED|Washout Period (3 Weeks)||19
6582486|NCT01930487|7506584|FG001|STARTED|Washout Period (3 Weeks)||23
6582487|NCT01930487|7506583|FG000|COMPLETED|Washout Period (3 Weeks)||19
6582488|NCT01930487|7506584|FG001|COMPLETED|Washout Period (3 Weeks)||23
6582489|NCT01930487|7506583|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
6582490|NCT01930487|7506584|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
6582491|NCT01930487|7506583|FG000|STARTED|Second Intervention (30 Days)||19
6582492|NCT01930487|7506584|FG001|STARTED|Second Intervention (30 Days)||23
6582493|NCT01930487|7506583|FG000|COMPLETED|Second Intervention (30 Days)||19
6582494|NCT01930487|7506584|FG001|COMPLETED|Second Intervention (30 Days)||23
6582495|NCT01930487|7506583|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
6582496|NCT01930487|7506584|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
6582497|NCT01930643|7506592|FG000|STARTED|Overall Study||7
6582498|NCT01930643|7506593|FG001|STARTED|Overall Study||6
6582499|NCT01930643|7506592|FG000|COMPLETED|Overall Study||7
6582500|NCT01930643|7506593|FG001|COMPLETED|Overall Study||6
6582501|NCT01930643|7506592|FG000|NOT COMPLETED|Overall Study||0
6582502|NCT01930643|7506593|FG001|NOT COMPLETED|Overall Study||0
6582503|NCT01930747|7506602|FG000|STARTED|Overall Study||16
6582504|NCT01930747|7506603|FG001|STARTED|Overall Study||14
6582505|NCT01930747|7506604|FG002|STARTED|Overall Study||12
6582506|NCT01930747|7506602|FG000|COMPLETED|Overall Study||16
6582507|NCT01930747|7506603|FG001|COMPLETED|Overall Study||14
6582508|NCT01930747|7506604|FG002|COMPLETED|Overall Study||12
6582509|NCT01930747|7506602|FG000|NOT COMPLETED|Overall Study||0
6582510|NCT01930747|7506603|FG001|NOT COMPLETED|Overall Study||0
6582511|NCT01930747|7506604|FG002|NOT COMPLETED|Overall Study||0
6582512|NCT01930799|7506612|FG000|STARTED|Overall Study||120
6582513|NCT01930799|7506612|FG000|COMPLETED|Overall Study||112
6582514|NCT01930799|7506612|FG000|NOT COMPLETED|Overall Study||8
6582515|NCT01930890|7506620|FG000|STARTED|Overall Study||14
6582516|NCT01930890|7506621|FG001|STARTED|Overall Study||33
6582517|NCT01930890|7506622|FG002|STARTED|Overall Study||13
6582518|NCT01930890|7506623|FG003|STARTED|Overall Study||27
6582519|NCT01930890|7506620|FG000|COMPLETED|Overall Study||0
6582520|NCT01930890|7506621|FG001|COMPLETED|Overall Study||0
6582521|NCT01930890|7506622|FG002|COMPLETED|Overall Study||0
6582522|NCT01930890|7506623|FG003|COMPLETED|Overall Study||0
6582523|NCT01930890|7506620|FG000|NOT COMPLETED|Overall Study||14
6582524|NCT01930890|7506621|FG001|NOT COMPLETED|Overall Study||33
6582525|NCT01930890|7506622|FG002|NOT COMPLETED|Overall Study||13
6582526|NCT01930890|7506623|FG003|NOT COMPLETED|Overall Study||27
6582527|NCT01931059|7506635|FG000|STARTED|Day 1||6
6582528|NCT01931059|7506636|FG001|STARTED|Day 1||5
6582529|NCT01931059|7506635|FG000|COMPLETED|Day 1||6
6582530|NCT01931059|7506636|FG001|COMPLETED|Day 1||4
6582531|NCT01931059|7506635|FG000|NOT COMPLETED|Day 1||0
6582532|NCT01931059|7506636|FG001|NOT COMPLETED|Day 1||1
6582533|NCT01931059|7506635|FG000|STARTED|Day2||6
6582534|NCT01931059|7506636|FG001|STARTED|Day2||4
6582535|NCT01931059|7506635|FG000|COMPLETED|Day2||6
6582536|NCT01931059|7506636|FG001|COMPLETED|Day2||4
6582537|NCT01931059|7506635|FG000|NOT COMPLETED|Day2||0
6582538|NCT01931059|7506636|FG001|NOT COMPLETED|Day2||0
6582539|NCT01931059|7506635|FG000|STARTED|Day3||6
6582540|NCT01931059|7506636|FG001|STARTED|Day3||4
6582541|NCT01931059|7506635|FG000|COMPLETED|Day3||5
6582542|NCT01931059|7506636|FG001|COMPLETED|Day3||4
6582543|NCT01931059|7506635|FG000|NOT COMPLETED|Day3||1
6582544|NCT01931059|7506636|FG001|NOT COMPLETED|Day3||0
6582545|NCT01931150|7506650|FG000|STARTED|Overall Study||5
6582546|NCT01931150|7506651|FG001|STARTED|Overall Study||6
6582547|NCT01931150|7506650|FG000|COMPLETED|Overall Study||4
6582548|NCT01931150|7506651|FG001|COMPLETED|Overall Study||4
6582549|NCT01931150|7506650|FG000|NOT COMPLETED|Overall Study||1
6582550|NCT01931150|7506651|FG001|NOT COMPLETED|Overall Study||2
6582551|NCT01931163|7506657|FG000|STARTED|Overall Study||22
6582552|NCT01931163|7506657|FG000|COMPLETED|Overall Study||22
6582553|NCT01931163|7506657|FG000|NOT COMPLETED|Overall Study||0
6582554|NCT01931202|7506664|FG000|STARTED|Overall Study||8
6582555|NCT01931202|7506665|FG001|STARTED|Overall Study||51
6582556|NCT01931202|7506666|FG002|STARTED|Overall Study||49
6582557|NCT01931202|7506664|FG000|COMPLETED|Overall Study||8
6582558|NCT01931202|7506665|FG001|COMPLETED|Overall Study||46
6582559|NCT01931202|7506666|FG002|COMPLETED|Overall Study||45
6582560|NCT01931202|7506664|FG000|NOT COMPLETED|Overall Study||0
6582561|NCT01931202|7506665|FG001|NOT COMPLETED|Overall Study||5
6582562|NCT01931202|7506666|FG002|NOT COMPLETED|Overall Study||4
6582563|NCT01931397|7506677|FG000|STARTED|Overall Study||30
6582564|NCT01931397|7506677|FG000|COMPLETED|Overall Study||19
6582565|NCT01931397|7506677|FG000|NOT COMPLETED|Overall Study||11
6582566|NCT01931462|7506685|FG000|STARTED|Overall Study||2
6582567|NCT01931462|7506685|FG000|COMPLETED|Overall Study||1
6582568|NCT01931462|7506685|FG000|NOT COMPLETED|Overall Study||1
6582569|NCT01931475|7506691|FG000|STARTED|Period 1: Double-Blind Treatment Phase||205
6582570|NCT01931475|7506692|FG001|STARTED|Period 1: Double-Blind Treatment Phase||202
6659037|NCT02484807|7589693|FG004|NOT COMPLETED|Overall Study||0
6659038|NCT02484807|7589694|FG005|NOT COMPLETED|Overall Study||0
6582571|NCT01931475|7506691|FG000|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
6582572|NCT01931475|7506692|FG001|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
6582573|NCT01931475|7506691|FG000|COMPLETED|Period 1: Double-Blind Treatment Phase||166
6582574|NCT01931475|7506692|FG001|COMPLETED|Period 1: Double-Blind Treatment Phase||176
6582575|NCT01931475|7506691|FG000|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
6582576|NCT01931475|7506692|FG001|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
6582577|NCT01931475|7506691|FG000|STARTED|Period 2: Extension Treatment Phase||166
6582578|NCT01931475|7506692|FG001|STARTED|Period 2: Extension Treatment Phase||176
6582579|NCT01931475|7506691|FG000|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
6582580|NCT01931475|7506692|FG001|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
6582581|NCT01931475|7506691|FG000|COMPLETED|Period 2: Extension Treatment Phase||162
6582582|NCT01931475|7506692|FG001|COMPLETED|Period 2: Extension Treatment Phase||157
6582583|NCT01931475|7506691|FG000|NOT COMPLETED|Period 2: Extension Treatment Phase||4
6582584|NCT01931475|7506692|FG001|NOT COMPLETED|Period 2: Extension Treatment Phase||19
6582585|NCT01931527|7506705|FG000|STARTED|Overall Study||16
6582586|NCT01931527|7506706|FG001|STARTED|Overall Study||15
6582587|NCT01931527|7506705|FG000|COMPLETED|Overall Study||16
6582588|NCT01931527|7506706|FG001|COMPLETED|Overall Study||15
6582589|NCT01931527|7506705|FG000|NOT COMPLETED|Overall Study||0
6582590|NCT01931527|7506706|FG001|NOT COMPLETED|Overall Study||0
6582591|NCT01931566|7506719|FG000|STARTED|Overall Study||433
6582592|NCT01931566|7506720|FG001|STARTED|Overall Study||1516
6582593|NCT01931566|7506721|FG002|STARTED|Overall Study||1545
6582594|NCT01931566|7506719|FG000|Treated|Overall Study||427
6582595|NCT01931566|7506720|FG001|Treated|Overall Study||1507
6582596|NCT01931566|7506721|FG002|Treated|Overall Study||1531
6659039|NCT02484859|7589711|FG000|STARTED|Overall Study||44
6659040|NCT02484859|7589712|FG001|STARTED|Overall Study||44
6659041|NCT02484859|7589711|FG000|COMPLETED|Overall Study||44
6659042|NCT02484859|7589712|FG001|COMPLETED|Overall Study||44
6659043|NCT02484859|7589711|FG000|NOT COMPLETED|Overall Study||0
6659044|NCT02484859|7589712|FG001|NOT COMPLETED|Overall Study||0
6659045|NCT02484898|7589720|FG000|STARTED|Overall Study||200
6582597|NCT01931566|7506719|FG000|COMPLETED|Overall Study||4
6582598|NCT01931566|7506720|FG001|COMPLETED|Overall Study||40
6582599|NCT01931566|7506721|FG002|COMPLETED|Overall Study||39
6582600|NCT01931566|7506719|FG000|NOT COMPLETED|Overall Study||429
6582601|NCT01931566|7506720|FG001|NOT COMPLETED|Overall Study||1476
6582602|NCT01931566|7506721|FG002|NOT COMPLETED|Overall Study||1506
6582603|NCT01931670|7506733|FG000|STARTED|Treatment Period||360
6582604|NCT01931670|7506734|FG001|STARTED|Treatment Period||226
6582605|NCT01931670|7506735|FG002|STARTED|Treatment Period||229
6582606|NCT01931670|7506733|FG000|COMPLETED|Treatment Period||270
6582607|NCT01931670|7506734|FG001|COMPLETED|Treatment Period||178
6582608|NCT01931670|7506735|FG002|COMPLETED|Treatment Period||184
6582609|NCT01931670|7506733|FG000|NOT COMPLETED|Treatment Period||90
6582610|NCT01931670|7506734|FG001|NOT COMPLETED|Treatment Period||48
6582611|NCT01931670|7506735|FG002|NOT COMPLETED|Treatment Period||45
6582612|NCT01931670|7506733|FG000|STARTED|Post-Treatment Follow-Up (PTFU) Period||61
6582613|NCT01931670|7506734|FG001|STARTED|Post-Treatment Follow-Up (PTFU) Period||40
6582614|NCT01931670|7506735|FG002|STARTED|Post-Treatment Follow-Up (PTFU) Period||54
6582615|NCT01931670|7506733|FG000|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||42
6582616|NCT01931670|7506734|FG001|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||24
6582617|NCT01931670|7506735|FG002|Completed PTFU Month 6|Post-Treatment Follow-Up (PTFU) Period||18
6582618|NCT01931670|7506733|FG000|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||0
6582619|NCT01931670|7506734|FG001|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||4
6582620|NCT01931670|7506735|FG002|Completed PTFU Month 12|Post-Treatment Follow-Up (PTFU) Period||15
6582621|NCT01931670|7506733|FG000|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||42
6582622|NCT01931670|7506734|FG001|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||28
6582623|NCT01931670|7506735|FG002|COMPLETED|Post-Treatment Follow-Up (PTFU) Period||33
6582624|NCT01931670|7506733|FG000|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||19
6582625|NCT01931670|7506734|FG001|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||12
6582626|NCT01931670|7506735|FG002|NOT COMPLETED|Post-Treatment Follow-Up (PTFU) Period||21
6582627|NCT01931709|7506743|FG000|STARTED|Overall Study||35
6582628|NCT01931709|7506743|FG000|COMPLETED|Overall Study||35
6582629|NCT01931709|7506743|FG000|NOT COMPLETED|Overall Study||0
6582630|NCT01931735|7506753|FG000|STARTED|Randomized Phase||4
6582631|NCT01931735|7506754|FG001|STARTED|Randomized Phase||3
6582632|NCT01931735|7506755|FG002|STARTED|Randomized Phase||9
6582633|NCT01931735|7506756|FG003|STARTED|Randomized Phase||0
6582634|NCT01931735|7506753|FG000|COMPLETED|Randomized Phase||2
6582635|NCT01931735|7506754|FG001|COMPLETED|Randomized Phase||1
6582636|NCT01931735|7506755|FG002|COMPLETED|Randomized Phase||4
6582637|NCT01931735|7506756|FG003|COMPLETED|Randomized Phase||0
6582638|NCT01931735|7506753|FG000|NOT COMPLETED|Randomized Phase||2
6582639|NCT01931735|7506754|FG001|NOT COMPLETED|Randomized Phase||2
6582640|NCT01931735|7506755|FG002|NOT COMPLETED|Randomized Phase||5
6582641|NCT01931735|7506756|FG003|NOT COMPLETED|Randomized Phase||0
6582642|NCT01931735|7506753|FG000|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|2
6582643|NCT01931735|7506754|FG001|STARTED|Observational Non-Randomized Phase|Participants continued from the randomized phase|1
6582644|NCT01931735|7506755|FG002|STARTED|Observational Non-Randomized Phase||0
6582645|NCT01931735|7506756|FG003|STARTED|Observational Non-Randomized Phase|Participants recruited post-amendment|11
6582646|NCT01931735|7506753|FG000|COMPLETED|Observational Non-Randomized Phase||2
6582647|NCT01931735|7506754|FG001|COMPLETED|Observational Non-Randomized Phase||1
6582648|NCT01931735|7506755|FG002|COMPLETED|Observational Non-Randomized Phase||0
6582649|NCT01931735|7506756|FG003|COMPLETED|Observational Non-Randomized Phase||9
6582650|NCT01931735|7506753|FG000|NOT COMPLETED|Observational Non-Randomized Phase||0
6582651|NCT01931735|7506754|FG001|NOT COMPLETED|Observational Non-Randomized Phase||0
6582652|NCT01931735|7506755|FG002|NOT COMPLETED|Observational Non-Randomized Phase||0
6582653|NCT01931735|7506756|FG003|NOT COMPLETED|Observational Non-Randomized Phase||2
6582654|NCT01931839|7506773|FG000|STARTED|Overall Study||335
6582655|NCT01931839|7506774|FG001|STARTED|Overall Study||178
6582656|NCT01931839|7506775|FG002|STARTED|Overall Study||340
6582657|NCT01931839|7506776|FG003|STARTED|Overall Study||176
6582658|NCT01931839|7506777|FG004|STARTED|Overall Study||19
6582659|NCT01931839|7506778|FG005|STARTED|Overall Study||55
6582660|NCT01931839|7506779|FG006|STARTED|Overall Study||60
6582661|NCT01931839|7506773|FG000|Full Analysis Set (As Randomized)|Overall Study||334
6582662|NCT01931839|7506774|FG001|Full Analysis Set (As Randomized)|Overall Study||179
6582663|NCT01931839|7506775|FG002|Full Analysis Set (As Randomized)|Overall Study||340
6582664|NCT01931839|7506776|FG003|Full Analysis Set (As Randomized)|Overall Study||176
6582665|NCT01931839|7506777|FG004|Full Analysis Set (As Randomized)|Overall Study||19
6582666|NCT01931839|7506778|FG005|Full Analysis Set (As Randomized)|Overall Study||55
6582667|NCT01931839|7506779|FG006|Full Analysis Set (As Randomized)|Overall Study||60
6582668|NCT01931839|7506773|FG000|Safety Analysis Set (As Dosed)|Overall Study||335
6582669|NCT01931839|7506774|FG001|Safety Analysis Set (As Dosed)|Overall Study||178
6582670|NCT01931839|7506775|FG002|Safety Analysis Set (As Dosed)|Overall Study||340
6659046|NCT02484898|7589720|FG000|COMPLETED|Overall Study||182
6582671|NCT01931839|7506776|FG003|Safety Analysis Set (As Dosed)|Overall Study||176
6582672|NCT01931839|7506777|FG004|Safety Analysis Set (As Dosed)|Overall Study||19
6582673|NCT01931839|7506778|FG005|Safety Analysis Set (As Dosed)|Overall Study||55
6582674|NCT01931839|7506779|FG006|Safety Analysis Set (As Dosed)|Overall Study||60
6582675|NCT01931839|7506773|FG000|COMPLETED|Overall Study||294
6582676|NCT01931839|7506774|FG001|COMPLETED|Overall Study||152
6582677|NCT01931839|7506775|FG002|COMPLETED|Overall Study||301
6582678|NCT01931839|7506776|FG003|COMPLETED|Overall Study||162
6582679|NCT01931839|7506777|FG004|COMPLETED|Overall Study||18
6582680|NCT01931839|7506778|FG005|COMPLETED|Overall Study||50
6582681|NCT01931839|7506779|FG006|COMPLETED|Overall Study||56
6582682|NCT01931839|7506773|FG000|NOT COMPLETED|Overall Study||41
6582683|NCT01931839|7506774|FG001|NOT COMPLETED|Overall Study||26
6582684|NCT01931839|7506775|FG002|NOT COMPLETED|Overall Study||39
6582685|NCT01931839|7506776|FG003|NOT COMPLETED|Overall Study||14
6582686|NCT01931839|7506777|FG004|NOT COMPLETED|Overall Study||1
6582687|NCT01931839|7506778|FG005|NOT COMPLETED|Overall Study||5
6582688|NCT01931839|7506779|FG006|NOT COMPLETED|Overall Study||4
6582689|NCT01931865|7506799|FG000|STARTED|Overall Study||12
6582690|NCT01931865|7506799|FG000|COMPLETED|Overall Study||8
6582691|NCT01931865|7506799|FG000|NOT COMPLETED|Overall Study||4
6582692|NCT01931878|7506804|FG000|STARTED|First Intervention||10
6582693|NCT01931878|7506805|FG001|STARTED|First Intervention||14
6582694|NCT01931878|7506804|FG000|COMPLETED|First Intervention||9
6582695|NCT01931878|7506805|FG001|COMPLETED|First Intervention||14
6582696|NCT01931878|7506804|FG000|NOT COMPLETED|First Intervention||1
6582697|NCT01931878|7506805|FG001|NOT COMPLETED|First Intervention||0
6582698|NCT01931878|7506804|FG000|STARTED|Second Intervention (After 3 Months)||9
6582699|NCT01931878|7506805|FG001|STARTED|Second Intervention (After 3 Months)||14
6582700|NCT01931878|7506804|FG000|COMPLETED|Second Intervention (After 3 Months)||9
6582701|NCT01931878|7506805|FG001|COMPLETED|Second Intervention (After 3 Months)||12
6582702|NCT01931878|7506804|FG000|NOT COMPLETED|Second Intervention (After 3 Months)||0
6582703|NCT01931878|7506805|FG001|NOT COMPLETED|Second Intervention (After 3 Months)||2
6582704|NCT01931956|7506819|FG000|STARTED|Overall Study||59
6582705|NCT01931956|7506820|FG001|STARTED|Overall Study||7
6582706|NCT01931956|7506821|FG002|STARTED|Overall Study||628
6582707|NCT01931956|7506822|FG003|STARTED|Overall Study||271
6582708|NCT01931956|7506819|FG000|COMPLETED|Overall Study||8
6582709|NCT01931956|7506820|FG001|COMPLETED|Overall Study||0
6582710|NCT01931956|7506821|FG002|COMPLETED|Overall Study||141
6582711|NCT01931956|7506822|FG003|COMPLETED|Overall Study||138
6582712|NCT01931956|7506819|FG000|NOT COMPLETED|Overall Study||51
6582713|NCT01931956|7506820|FG001|NOT COMPLETED|Overall Study||7
6582714|NCT01931956|7506821|FG002|NOT COMPLETED|Overall Study||487
6582715|NCT01931956|7506822|FG003|NOT COMPLETED|Overall Study||133
6582716|NCT01931995|7506847|FG000|STARTED|First Intervention (1 Day)||23
6582717|NCT01931995|7506848|FG001|STARTED|First Intervention (1 Day)||22
6582718|NCT01931995|7506847|FG000|COMPLETED|First Intervention (1 Day)||19
6582719|NCT01931995|7506848|FG001|COMPLETED|First Intervention (1 Day)||18
6582720|NCT01931995|7506847|FG000|NOT COMPLETED|First Intervention (1 Day)||4
6582721|NCT01931995|7506848|FG001|NOT COMPLETED|First Intervention (1 Day)||4
6582722|NCT01931995|7506847|FG000|STARTED|Washout (at Least 6 Days)||19
6582723|NCT01931995|7506848|FG001|STARTED|Washout (at Least 6 Days)||18
6582724|NCT01931995|7506847|FG000|COMPLETED|Washout (at Least 6 Days)||19
6582725|NCT01931995|7506848|FG001|COMPLETED|Washout (at Least 6 Days)||18
6582726|NCT01931995|7506847|FG000|NOT COMPLETED|Washout (at Least 6 Days)||0
6582727|NCT01931995|7506848|FG001|NOT COMPLETED|Washout (at Least 6 Days)||0
6582728|NCT01931995|7506847|FG000|STARTED|Second Intervention (1 Day)||18
6582729|NCT01931995|7506848|FG001|STARTED|Second Intervention (1 Day)||19
6582730|NCT01931995|7506847|FG000|COMPLETED|Second Intervention (1 Day)||18
6582731|NCT01931995|7506848|FG001|COMPLETED|Second Intervention (1 Day)||19
6582732|NCT01931995|7506847|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6582733|NCT01931995|7506848|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6582734|NCT01932060|7506856|FG000|STARTED|Overall Study||27
6582735|NCT01932060|7506857|FG001|STARTED|Overall Study||24
6582736|NCT01932060|7506856|FG000|COMPLETED|Overall Study||27
6582737|NCT01932060|7506857|FG001|COMPLETED|Overall Study||24
6582738|NCT01932060|7506856|FG000|NOT COMPLETED|Overall Study||0
6582739|NCT01932060|7506857|FG001|NOT COMPLETED|Overall Study||0
6582740|NCT01932112|7506863|FG000|STARTED|Overall Study||378
6582741|NCT01932112|7506863|FG000|COMPLETED|Overall Study||378
6582742|NCT01932112|7506863|FG000|NOT COMPLETED|Overall Study||0
6582743|NCT01932164|7506867|FG000|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
6582744|NCT01932164|7506867|FG000|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
6582745|NCT01932164|7506867|FG000|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
6582746|NCT01932164|7506867|FG000|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
6582747|NCT01932164|7506867|FG000|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
6582748|NCT01932164|7506867|FG000|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
6582749|NCT01932164|7506867|FG000|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
6582750|NCT01932164|7506867|FG000|NOT COMPLETED|Overall Study||0
6582751|NCT01932242|7506873|FG000|STARTED|Overall Study||35
6582752|NCT01932242|7506874|FG001|STARTED|Overall Study||35
6582753|NCT01932242|7506873|FG000|COMPLETED|Overall Study||30
6582754|NCT01932242|7506874|FG001|COMPLETED|Overall Study||30
6582755|NCT01932242|7506873|FG000|NOT COMPLETED|Overall Study||5
6582756|NCT01932242|7506874|FG001|NOT COMPLETED|Overall Study||5
6582757|NCT01932294|7506880|FG000|STARTED|Overall Study||171
6582758|NCT01932294|7506880|FG000|COMPLETED|Overall Study||72
6582759|NCT01932294|7506880|FG000|NOT COMPLETED|Overall Study||99
6582760|NCT01932437|7506887|FG000|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
6582761|NCT01932437|7506888|FG001|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
6582762|NCT01932437|7506889|FG002|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582763|NCT01932437|7506890|FG003|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582764|NCT01932437|7506891|FG004|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582765|NCT01932437|7506892|FG005|STARTED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582766|NCT01932437|7506887|FG000|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||1
6582767|NCT01932437|7506888|FG001|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||3
6582768|NCT01932437|7506889|FG002|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582769|NCT01932437|7506890|FG003|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582770|NCT01932437|7506891|FG004|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582771|NCT01932437|7506892|FG005|COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582772|NCT01932437|7506887|FG000|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582773|NCT01932437|7506888|FG001|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582774|NCT01932437|7506889|FG002|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582775|NCT01932437|7506890|FG003|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582776|NCT01932437|7506891|FG004|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582777|NCT01932437|7506892|FG005|NOT COMPLETED|Cohort 1 - ETI-204 4 mg/kg or Placebo||0
6582778|NCT01932437|7506887|FG000|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
6582779|NCT01932437|7506888|FG001|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582780|NCT01932437|7506889|FG002|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
6582781|NCT01932437|7506890|FG003|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582782|NCT01932437|7506891|FG004|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582783|NCT01932437|7506892|FG005|STARTED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582784|NCT01932437|7506887|FG000|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||2
6582785|NCT01932437|7506888|FG001|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582786|NCT01932437|7506889|FG002|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||6
6582787|NCT01932437|7506890|FG003|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582788|NCT01932437|7506891|FG004|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582789|NCT01932437|7506892|FG005|COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582790|NCT01932437|7506887|FG000|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582791|NCT01932437|7506888|FG001|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582792|NCT01932437|7506889|FG002|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582793|NCT01932437|7506890|FG003|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582794|NCT01932437|7506891|FG004|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582795|NCT01932437|7506892|FG005|NOT COMPLETED|Cohort 2 - ETI-204 8 mg/kg or Placebo||0
6582796|NCT01932437|7506887|FG000|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
6582797|NCT01932437|7506888|FG001|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582798|NCT01932437|7506889|FG002|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582799|NCT01932437|7506890|FG003|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
6582800|NCT01932437|7506891|FG004|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582801|NCT01932437|7506892|FG005|STARTED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582802|NCT01932437|7506887|FG000|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||2
6582803|NCT01932437|7506888|FG001|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582804|NCT01932437|7506889|FG002|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582805|NCT01932437|7506890|FG003|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||6
6582806|NCT01932437|7506891|FG004|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582807|NCT01932437|7506892|FG005|COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582808|NCT01932437|7506887|FG000|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582809|NCT01932437|7506888|FG001|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582810|NCT01932437|7506889|FG002|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582811|NCT01932437|7506890|FG003|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582812|NCT01932437|7506891|FG004|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582813|NCT01932437|7506892|FG005|NOT COMPLETED|Cohort 3 - ETI-204 16 mg/kg or Placebo||0
6582814|NCT01932437|7506887|FG000|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
6582815|NCT01932437|7506888|FG001|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582816|NCT01932437|7506889|FG002|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582817|NCT01932437|7506890|FG003|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582818|NCT01932437|7506891|FG004|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
6582819|NCT01932437|7506892|FG005|STARTED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582820|NCT01932437|7506887|FG000|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||2
6582821|NCT01932437|7506888|FG001|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582822|NCT01932437|7506889|FG002|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582823|NCT01932437|7506890|FG003|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582824|NCT01932437|7506891|FG004|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||6
6582825|NCT01932437|7506892|FG005|COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582826|NCT01932437|7506887|FG000|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582827|NCT01932437|7506888|FG001|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582828|NCT01932437|7506889|FG002|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582829|NCT01932437|7506890|FG003|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582830|NCT01932437|7506891|FG004|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582831|NCT01932437|7506892|FG005|NOT COMPLETED|Cohort 4 - ETI-204 20 mg/kg or Placebo||0
6582832|NCT01932437|7506887|FG000|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
6582833|NCT01932437|7506888|FG001|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582834|NCT01932437|7506889|FG002|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582835|NCT01932437|7506890|FG003|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582836|NCT01932437|7506891|FG004|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582837|NCT01932437|7506892|FG005|STARTED|Cohort 5 - ETI-204 24 mg/kg or Placebo||6
6582838|NCT01932437|7506887|FG000|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||2
6582839|NCT01932437|7506888|FG001|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582840|NCT01932437|7506889|FG002|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582841|NCT01932437|7506890|FG003|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582842|NCT01932437|7506891|FG004|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582843|NCT01932437|7506892|FG005|COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||5
6582844|NCT01932437|7506887|FG000|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582845|NCT01932437|7506888|FG001|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582846|NCT01932437|7506889|FG002|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582847|NCT01932437|7506890|FG003|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582848|NCT01932437|7506891|FG004|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||0
6582849|NCT01932437|7506892|FG005|NOT COMPLETED|Cohort 5 - ETI-204 24 mg/kg or Placebo||1
6582850|NCT01932606|7506915|FG000|STARTED|Overall Study||14
6582851|NCT01932606|7506916|FG001|STARTED|Overall Study||14
6582852|NCT01932606|7506915|FG000|COMPLETED|Overall Study||14
6582853|NCT01932606|7506916|FG001|COMPLETED|Overall Study||14
6582854|NCT01932606|7506915|FG000|NOT COMPLETED|Overall Study||0
6582855|NCT01932606|7506916|FG001|NOT COMPLETED|Overall Study||0
6582856|NCT01932697|7506924|FG000|STARTED|Overall Study||38
6582857|NCT01932697|7506925|FG001|STARTED|Overall Study||43
6582858|NCT01932697|7506924|FG000|COMPLETED|Overall Study||36
6582859|NCT01932697|7506925|FG001|COMPLETED|Overall Study||43
6582860|NCT01932697|7506924|FG000|NOT COMPLETED|Overall Study||2
6582861|NCT01932697|7506925|FG001|NOT COMPLETED|Overall Study||0
6582862|NCT01932762|7506937|FG000|STARTED|Overall Study||30
6582863|NCT01932762|7506938|FG001|STARTED|Overall Study||30
6582864|NCT01932762|7506939|FG002|STARTED|Overall Study||19
6582865|NCT01932762|7506940|FG003|STARTED|Overall Study||19
6582866|NCT01932762|7506937|FG000|COMPLETED|Overall Study||24
6582867|NCT01932762|7506938|FG001|COMPLETED|Overall Study||28
6582868|NCT01932762|7506939|FG002|COMPLETED|Overall Study||19
6582869|NCT01932762|7506940|FG003|COMPLETED|Overall Study||18
6582870|NCT01932762|7506937|FG000|NOT COMPLETED|Overall Study||6
6582871|NCT01932762|7506938|FG001|NOT COMPLETED|Overall Study||2
6582872|NCT01932762|7506939|FG002|NOT COMPLETED|Overall Study||0
6582873|NCT01932762|7506940|FG003|NOT COMPLETED|Overall Study||1
6582874|NCT01932788|7506952|FG000|STARTED|Overall Study||173
6582875|NCT01932788|7506953|FG001|STARTED|Overall Study||169
6582876|NCT01932788|7506952|FG000|COMPLETED|Overall Study||135
6582877|NCT01932788|7506953|FG001|COMPLETED|Overall Study||118
6582878|NCT01932788|7506952|FG000|NOT COMPLETED|Overall Study||38
6582879|NCT01932788|7506953|FG001|NOT COMPLETED|Overall Study||51
6582880|NCT01932970|7506959|FG000|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
6582881|NCT01932970|7506959|FG000|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
6582882|NCT01932970|7506959|FG000|COMPLETED|Overall Study||140
6582883|NCT01932970|7506959|FG000|NOT COMPLETED|Overall Study||18
6582884|NCT01932996|7506965|FG000|STARTED|Overall Study||172
6582885|NCT01932996|7506966|FG001|STARTED|Overall Study||180
6582886|NCT01932996|7506965|FG000|COMPLETED|Overall Study||170
6582887|NCT01932996|7506966|FG001|COMPLETED|Overall Study||180
6582888|NCT01932996|7506965|FG000|NOT COMPLETED|Overall Study||2
6582889|NCT01932996|7506966|FG001|NOT COMPLETED|Overall Study||0
6582890|NCT01933048|7506974|FG000|STARTED|Overall Study||548
6582891|NCT01933048|7506975|FG001|STARTED|Overall Study||529
6582892|NCT01933048|7506974|FG000|COMPLETED|Overall Study||523
6582893|NCT01933048|7506975|FG001|COMPLETED|Overall Study||501
6582894|NCT01933048|7506974|FG000|NOT COMPLETED|Overall Study||25
6582895|NCT01933048|7506975|FG001|NOT COMPLETED|Overall Study||28
6582896|NCT01933113|7506984|FG000|STARTED|Overall Study||3
6582897|NCT01933113|7506984|FG000|COMPLETED|Overall Study||2
6582898|NCT01933113|7506984|FG000|NOT COMPLETED|Overall Study||1
6582899|NCT01933217|7506990|FG000|STARTED|Randomization (4 Weeks)||12
6582900|NCT01933217|7506991|FG001|STARTED|Randomization (4 Weeks)||14
6582901|NCT01933217|7506990|FG000|COMPLETED|Randomization (4 Weeks)||10
6582902|NCT01933217|7506991|FG001|COMPLETED|Randomization (4 Weeks)||10
6582903|NCT01933217|7506990|FG000|NOT COMPLETED|Randomization (4 Weeks)||2
6582904|NCT01933217|7506991|FG001|NOT COMPLETED|Randomization (4 Weeks)||4
6582905|NCT01933217|7506990|FG000|STARTED|Crossover (4 Weeks)||10
6582906|NCT01933217|7506991|FG001|STARTED|Crossover (4 Weeks)||10
6582907|NCT01933217|7506990|FG000|COMPLETED|Crossover (4 Weeks)||10
6582908|NCT01933217|7506991|FG001|COMPLETED|Crossover (4 Weeks)||10
6582909|NCT01933217|7506990|FG000|NOT COMPLETED|Crossover (4 Weeks)||0
6582910|NCT01933217|7506991|FG001|NOT COMPLETED|Crossover (4 Weeks)||0
6582911|NCT01933230|7506999|FG000|STARTED|Overall Study||2
6582912|NCT01933230|7506999|FG000|COMPLETED|Overall Study||2
6582913|NCT01933230|7506999|FG000|NOT COMPLETED|Overall Study||0
6582914|NCT01933243|7507005|FG000|STARTED|Overall Study||12
6582915|NCT01933243|7507006|FG001|STARTED|Overall Study||12
6582916|NCT01933243|7507005|FG000|COMPLETED|Overall Study||10
6582917|NCT01933243|7507006|FG001|COMPLETED|Overall Study||8
6582918|NCT01933243|7507005|FG000|NOT COMPLETED|Overall Study||2
6582919|NCT01933243|7507006|FG001|NOT COMPLETED|Overall Study||4
6582920|NCT01933334|7507014|FG000|STARTED|Overall Study||32
6582921|NCT01933334|7507015|FG001|STARTED|Overall Study||31
6582922|NCT01933334|7507014|FG000|COMPLETED|Overall Study||27
6582923|NCT01933334|7507015|FG001|COMPLETED|Overall Study||29
6582924|NCT01933334|7507014|FG000|NOT COMPLETED|Overall Study||5
6582925|NCT01933334|7507015|FG001|NOT COMPLETED|Overall Study||2
6582926|NCT01933399|7507024|FG000|STARTED|Overall Study||29
6582927|NCT01933399|7507025|FG001|STARTED|Overall Study||32
6582928|NCT01933399|7507026|FG002|STARTED|Overall Study||37
6582929|NCT01933399|7507024|FG000|COMPLETED|Overall Study||29
6582930|NCT01933399|7507025|FG001|COMPLETED|Overall Study||32
6582931|NCT01933399|7507026|FG002|COMPLETED|Overall Study||37
6582932|NCT01933399|7507024|FG000|NOT COMPLETED|Overall Study||0
6582933|NCT01933399|7507025|FG001|NOT COMPLETED|Overall Study||0
6582934|NCT01933399|7507026|FG002|NOT COMPLETED|Overall Study||0
6582935|NCT01933425|7507034|FG000|STARTED|Overall Study||7
6582936|NCT01933425|7507035|FG001|STARTED|Overall Study||7
6582937|NCT01933425|7507034|FG000|COMPLETED|Overall Study||7
6582938|NCT01933425|7507035|FG001|COMPLETED|Overall Study||7
6582939|NCT01933425|7507034|FG000|NOT COMPLETED|Overall Study||0
6582940|NCT01933425|7507035|FG001|NOT COMPLETED|Overall Study||0
6582941|NCT01933464|7507045|FG000|STARTED|Overall Study||5
6582942|NCT01933464|7507046|FG001|STARTED|Overall Study||5
6582943|NCT01933464|7507045|FG000|COMPLETED|Overall Study||5
6582944|NCT01933464|7507046|FG001|COMPLETED|Overall Study||5
6582945|NCT01933464|7507045|FG000|NOT COMPLETED|Overall Study||0
6582946|NCT01933464|7507046|FG001|NOT COMPLETED|Overall Study||0
6582947|NCT01933594|7507058|FG000|STARTED|Overall Study||12
6582948|NCT01933594|7507059|FG001|STARTED|Overall Study||12
6255863|NCT01764711|7154738|FG001|NOT COMPLETED|Overall Study||0
6255864|NCT01632878|7154746|FG000|STARTED|Screening||1531
6255865|NCT01632878|7154746|FG000|COMPLETED|Screening||1263
6255866|NCT01632878|7154746|FG000|NOT COMPLETED|Screening||268
6255867|NCT01632878|7154746|FG000|STARTED|Treatment||1263
6255868|NCT01632878|7154746|FG000|COMPLETED|Treatment||1105
6255869|NCT01632878|7154746|FG000|NOT COMPLETED|Treatment||158
6255870|NCT01275846|7154750|FG000|STARTED|Overall Study||26
6582949|NCT01933594|7507060|FG002|STARTED|Overall Study||12
6582950|NCT01933594|7507061|FG003|STARTED|Overall Study||7
6582951|NCT01933594|7507062|FG004|STARTED|Overall Study||13
6582952|NCT01933594|7507063|FG005|STARTED|Overall Study||3
6582953|NCT01933594|7507058|FG000|COMPLETED|Overall Study||11
6582954|NCT01933594|7507059|FG001|COMPLETED|Overall Study||12
6582955|NCT01933594|7507060|FG002|COMPLETED|Overall Study||12
6582956|NCT01933594|7507061|FG003|COMPLETED|Overall Study||7
6582957|NCT01933594|7507062|FG004|COMPLETED|Overall Study||11
6582958|NCT01933594|7507063|FG005|COMPLETED|Overall Study||3
6582959|NCT01933594|7507058|FG000|NOT COMPLETED|Overall Study||1
6582960|NCT01933594|7507059|FG001|NOT COMPLETED|Overall Study||0
6582961|NCT01933594|7507060|FG002|NOT COMPLETED|Overall Study||0
6582962|NCT01933594|7507061|FG003|NOT COMPLETED|Overall Study||0
6582963|NCT01933594|7507062|FG004|NOT COMPLETED|Overall Study||2
6582964|NCT01933594|7507063|FG005|NOT COMPLETED|Overall Study||0
6582965|NCT01933672|7507081|FG000|STARTED|Metformin Run-in Period||43
6582966|NCT01933672|7507082|FG001|STARTED|Metformin Run-in Period||0
6582967|NCT01933672|7507083|FG002|STARTED|Metformin Run-in Period||0
6582968|NCT01933672|7507084|FG003|STARTED|Metformin Run-in Period||0
6582969|NCT01933672|7507085|FG004|STARTED|Metformin Run-in Period||0
6582970|NCT01933672|7507086|FG005|STARTED|Metformin Run-in Period||0
6582971|NCT01933672|7507087|FG006|STARTED|Metformin Run-in Period||0
6582972|NCT01933672|7507081|FG000|Received Treatment|Metformin Run-in Period||43
6582973|NCT01933672|7507082|FG001|Received Treatment|Metformin Run-in Period||0
6582974|NCT01933672|7507083|FG002|Received Treatment|Metformin Run-in Period||0
6582975|NCT01933672|7507084|FG003|Received Treatment|Metformin Run-in Period||0
6582976|NCT01933672|7507085|FG004|Received Treatment|Metformin Run-in Period||0
6582977|NCT01933672|7507086|FG005|Received Treatment|Metformin Run-in Period||0
6582978|NCT01933672|7507087|FG006|Received Treatment|Metformin Run-in Period||0
6582979|NCT01933672|7507081|FG000|COMPLETED|Metformin Run-in Period||33
6659047|NCT02484898|7589720|FG000|NOT COMPLETED|Overall Study||18
6659048|NCT02484911|7589726|FG000|STARTED|Overall Study||60
6659049|NCT02484911|7589727|FG001|STARTED|Overall Study||60
6255871|NCT01275846|7154750|FG000|COMPLETED|Overall Study||25
6582980|NCT01933672|7507082|FG001|COMPLETED|Metformin Run-in Period||0
6582981|NCT01933672|7507083|FG002|COMPLETED|Metformin Run-in Period||0
6582982|NCT01933672|7507084|FG003|COMPLETED|Metformin Run-in Period||0
6582983|NCT01933672|7507085|FG004|COMPLETED|Metformin Run-in Period||0
6582984|NCT01933672|7507086|FG005|COMPLETED|Metformin Run-in Period||0
6582985|NCT01933672|7507087|FG006|COMPLETED|Metformin Run-in Period||0
6582986|NCT01933672|7507081|FG000|NOT COMPLETED|Metformin Run-in Period||10
6582987|NCT01933672|7507082|FG001|NOT COMPLETED|Metformin Run-in Period||0
6582988|NCT01933672|7507083|FG002|NOT COMPLETED|Metformin Run-in Period||0
6582989|NCT01933672|7507084|FG003|NOT COMPLETED|Metformin Run-in Period||0
6582990|NCT01933672|7507085|FG004|NOT COMPLETED|Metformin Run-in Period||0
6582991|NCT01933672|7507086|FG005|NOT COMPLETED|Metformin Run-in Period||0
6582992|NCT01933672|7507087|FG006|NOT COMPLETED|Metformin Run-in Period||0
6582993|NCT01933672|7507081|FG000|STARTED|First Intervention Period (12-16 Days)||0
6582994|NCT01933672|7507082|FG001|STARTED|First Intervention Period (12-16 Days)||7
6582995|NCT01933672|7507083|FG002|STARTED|First Intervention Period (12-16 Days)||3
6582996|NCT01933672|7507084|FG003|STARTED|First Intervention Period (12-16 Days)||5
6582997|NCT01933672|7507085|FG004|STARTED|First Intervention Period (12-16 Days)||7
6582998|NCT01933672|7507086|FG005|STARTED|First Intervention Period (12-16 Days)||5
6582999|NCT01933672|7507087|FG006|STARTED|First Intervention Period (12-16 Days)||6
6583000|NCT01933672|7507081|FG000|COMPLETED|First Intervention Period (12-16 Days)||0
6583001|NCT01933672|7507082|FG001|COMPLETED|First Intervention Period (12-16 Days)||7
6583002|NCT01933672|7507083|FG002|COMPLETED|First Intervention Period (12-16 Days)||2
6583003|NCT01933672|7507084|FG003|COMPLETED|First Intervention Period (12-16 Days)||5
6583004|NCT01933672|7507085|FG004|COMPLETED|First Intervention Period (12-16 Days)||6
6583005|NCT01933672|7507086|FG005|COMPLETED|First Intervention Period (12-16 Days)||4
6583006|NCT01933672|7507087|FG006|COMPLETED|First Intervention Period (12-16 Days)||6
6583007|NCT01933672|7507081|FG000|NOT COMPLETED|First Intervention Period (12-16 Days)||0
6583008|NCT01933672|7507082|FG001|NOT COMPLETED|First Intervention Period (12-16 Days)||0
6583009|NCT01933672|7507083|FG002|NOT COMPLETED|First Intervention Period (12-16 Days)||1
6583010|NCT01933672|7507084|FG003|NOT COMPLETED|First Intervention Period (12-16 Days)||0
6583011|NCT01933672|7507085|FG004|NOT COMPLETED|First Intervention Period (12-16 Days)||1
6583012|NCT01933672|7507086|FG005|NOT COMPLETED|First Intervention Period (12-16 Days)||1
6583013|NCT01933672|7507087|FG006|NOT COMPLETED|First Intervention Period (12-16 Days)||0
6583014|NCT01933672|7507081|FG000|STARTED|First Washout Period (7-14 Days)||0
6583015|NCT01933672|7507082|FG001|STARTED|First Washout Period (7-14 Days)||7
6583016|NCT01933672|7507083|FG002|STARTED|First Washout Period (7-14 Days)||2
6583017|NCT01933672|7507084|FG003|STARTED|First Washout Period (7-14 Days)||5
6583018|NCT01933672|7507085|FG004|STARTED|First Washout Period (7-14 Days)||6
6583019|NCT01933672|7507086|FG005|STARTED|First Washout Period (7-14 Days)||4
6583020|NCT01933672|7507087|FG006|STARTED|First Washout Period (7-14 Days)||6
6583021|NCT01933672|7507081|FG000|COMPLETED|First Washout Period (7-14 Days)||0
6583022|NCT01933672|7507082|FG001|COMPLETED|First Washout Period (7-14 Days)||7
6583023|NCT01933672|7507083|FG002|COMPLETED|First Washout Period (7-14 Days)||2
6583024|NCT01933672|7507084|FG003|COMPLETED|First Washout Period (7-14 Days)||5
6583025|NCT01933672|7507085|FG004|COMPLETED|First Washout Period (7-14 Days)||6
6583026|NCT01933672|7507086|FG005|COMPLETED|First Washout Period (7-14 Days)||4
6583027|NCT01933672|7507087|FG006|COMPLETED|First Washout Period (7-14 Days)||6
6583028|NCT01933672|7507081|FG000|NOT COMPLETED|First Washout Period (7-14 Days)||0
6583029|NCT01933672|7507082|FG001|NOT COMPLETED|First Washout Period (7-14 Days)||0
6583030|NCT01933672|7507083|FG002|NOT COMPLETED|First Washout Period (7-14 Days)||0
6583031|NCT01933672|7507084|FG003|NOT COMPLETED|First Washout Period (7-14 Days)||0
6583032|NCT01933672|7507085|FG004|NOT COMPLETED|First Washout Period (7-14 Days)||0
6583033|NCT01933672|7507086|FG005|NOT COMPLETED|First Washout Period (7-14 Days)||0
6583034|NCT01933672|7507087|FG006|NOT COMPLETED|First Washout Period (7-14 Days)||0
6583035|NCT01933672|7507081|FG000|STARTED|Second Intervention Period (12-16 Days)||0
6583036|NCT01933672|7507082|FG001|STARTED|Second Intervention Period (12-16 Days)||7
6583037|NCT01933672|7507083|FG002|STARTED|Second Intervention Period (12-16 Days)||2
6583038|NCT01933672|7507084|FG003|STARTED|Second Intervention Period (12-16 Days)||5
6583039|NCT01933672|7507085|FG004|STARTED|Second Intervention Period (12-16 Days)||6
6583040|NCT01933672|7507086|FG005|STARTED|Second Intervention Period (12-16 Days)||4
6583041|NCT01933672|7507087|FG006|STARTED|Second Intervention Period (12-16 Days)||6
6583042|NCT01933672|7507081|FG000|COMPLETED|Second Intervention Period (12-16 Days)||0
6583043|NCT01933672|7507082|FG001|COMPLETED|Second Intervention Period (12-16 Days)||6
6583044|NCT01933672|7507083|FG002|COMPLETED|Second Intervention Period (12-16 Days)||1
6583045|NCT01933672|7507084|FG003|COMPLETED|Second Intervention Period (12-16 Days)||5
6583046|NCT01933672|7507085|FG004|COMPLETED|Second Intervention Period (12-16 Days)||6
6583047|NCT01933672|7507086|FG005|COMPLETED|Second Intervention Period (12-16 Days)||4
6583048|NCT01933672|7507087|FG006|COMPLETED|Second Intervention Period (12-16 Days)||6
6583049|NCT01933672|7507081|FG000|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6583050|NCT01933672|7507082|FG001|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
6583051|NCT01933672|7507083|FG002|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
6583052|NCT01933672|7507084|FG003|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6583053|NCT01933672|7507085|FG004|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6583054|NCT01933672|7507086|FG005|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6583055|NCT01933672|7507087|FG006|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
6583056|NCT01933672|7507081|FG000|STARTED|Second Washout Period (7-14 Days)||0
6583057|NCT01933672|7507082|FG001|STARTED|Second Washout Period (7-14 Days)||6
6583058|NCT01933672|7507083|FG002|STARTED|Second Washout Period (7-14 Days)||1
6583059|NCT01933672|7507084|FG003|STARTED|Second Washout Period (7-14 Days)||5
6583060|NCT01933672|7507085|FG004|STARTED|Second Washout Period (7-14 Days)||6
6583061|NCT01933672|7507086|FG005|STARTED|Second Washout Period (7-14 Days)||4
6583062|NCT01933672|7507087|FG006|STARTED|Second Washout Period (7-14 Days)||6
6583063|NCT01933672|7507081|FG000|COMPLETED|Second Washout Period (7-14 Days)||0
6583064|NCT01933672|7507082|FG001|COMPLETED|Second Washout Period (7-14 Days)||6
6583065|NCT01933672|7507083|FG002|COMPLETED|Second Washout Period (7-14 Days)||1
6583066|NCT01933672|7507084|FG003|COMPLETED|Second Washout Period (7-14 Days)||5
6583067|NCT01933672|7507085|FG004|COMPLETED|Second Washout Period (7-14 Days)||6
6583068|NCT01933672|7507086|FG005|COMPLETED|Second Washout Period (7-14 Days)||4
6583069|NCT01933672|7507087|FG006|COMPLETED|Second Washout Period (7-14 Days)||6
6583070|NCT01933672|7507081|FG000|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6583071|NCT01933672|7507082|FG001|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6583072|NCT01933672|7507083|FG002|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6583073|NCT01933672|7507084|FG003|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6583074|NCT01933672|7507085|FG004|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6583075|NCT01933672|7507086|FG005|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6583076|NCT01933672|7507087|FG006|NOT COMPLETED|Second Washout Period (7-14 Days)||0
6583077|NCT01933672|7507081|FG000|STARTED|Third Intervention Period (12-16 Days)||0
6583078|NCT01933672|7507082|FG001|STARTED|Third Intervention Period (12-16 Days)||6
6583079|NCT01933672|7507083|FG002|STARTED|Third Intervention Period (12-16 Days)||1
6583080|NCT01933672|7507084|FG003|STARTED|Third Intervention Period (12-16 Days)||5
6583081|NCT01933672|7507085|FG004|STARTED|Third Intervention Period (12-16 Days)||6
6583082|NCT01933672|7507086|FG005|STARTED|Third Intervention Period (12-16 Days)||4
6583083|NCT01933672|7507087|FG006|STARTED|Third Intervention Period (12-16 Days)||6
6583084|NCT01933672|7507081|FG000|COMPLETED|Third Intervention Period (12-16 Days)||0
6583085|NCT01933672|7507082|FG001|COMPLETED|Third Intervention Period (12-16 Days)||5
6583086|NCT01933672|7507083|FG002|COMPLETED|Third Intervention Period (12-16 Days)||1
6583087|NCT01933672|7507084|FG003|COMPLETED|Third Intervention Period (12-16 Days)||4
6583088|NCT01933672|7507085|FG004|COMPLETED|Third Intervention Period (12-16 Days)||6
6583089|NCT01933672|7507086|FG005|COMPLETED|Third Intervention Period (12-16 Days)||4
6583090|NCT01933672|7507087|FG006|COMPLETED|Third Intervention Period (12-16 Days)||6
6583091|NCT01933672|7507081|FG000|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6583092|NCT01933672|7507082|FG001|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
6583093|NCT01933672|7507083|FG002|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6583094|NCT01933672|7507084|FG003|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
6583095|NCT01933672|7507085|FG004|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6583096|NCT01933672|7507086|FG005|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6583097|NCT01933672|7507087|FG006|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
6583098|NCT01933776|7507102|FG000|STARTED|Overall Study||20
6583099|NCT01933776|7507103|FG001|STARTED|Overall Study||20
6583100|NCT01933776|7507102|FG000|COMPLETED|Overall Study||20
6583101|NCT01933776|7507103|FG001|COMPLETED|Overall Study||20
6583102|NCT01933776|7507102|FG000|NOT COMPLETED|Overall Study||0
6583103|NCT01933776|7507103|FG001|NOT COMPLETED|Overall Study||0
6583104|NCT01933789|7507118|FG000|STARTED|Overall Study||65
6583105|NCT01933789|7507119|FG001|STARTED|Overall Study||67
6583106|NCT01933789|7507120|FG002|STARTED|Overall Study||2
6583107|NCT01933789|7507121|FG003|STARTED|Overall Study||2
6583108|NCT01933789|7507122|FG004|STARTED|Overall Study||249
6583109|NCT01933789|7507123|FG005|STARTED|Overall Study||288
6583110|NCT01933789|7507124|FG006|STARTED|Overall Study||58
6583111|NCT01933789|7507125|FG007|STARTED|Overall Study||61
6583112|NCT01933789|7507126|FG008|STARTED|Overall Study||25
6583113|NCT01933789|7507118|FG000|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|61
6583114|NCT01933789|7507119|FG001|Had Target Visit|Overall Study|Had target visit(s) completed before clinician or patient withdrawal|65
6583115|NCT01933789|7507120|FG002|Had Target Visit|Overall Study||2
6583116|NCT01933789|7507121|FG003|Had Target Visit|Overall Study||2
6583117|NCT01933789|7507122|FG004|Had Target Visit|Overall Study||228
6583118|NCT01933789|7507123|FG005|Had Target Visit|Overall Study||266
6583119|NCT01933789|7507124|FG006|Had Target Visit|Overall Study||0
6583120|NCT01933789|7507125|FG007|Had Target Visit|Overall Study||0
6583121|NCT01933789|7507126|FG008|Had Target Visit|Overall Study||0
6583122|NCT01933789|7507118|FG000|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|57
6583123|NCT01933789|7507119|FG001|Completed After-visit Survey|Overall Study|Number reflects individual clinicians who returned surveys for up to 6 enrolled patients|64
6583124|NCT01933789|7507120|FG002|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|2
6624247|NCT02215252|7551630|FG002|STARTED|Overall Study||45
6659050|NCT02484911|7589726|FG000|COMPLETED|Overall Study||56
6659051|NCT02484911|7589727|FG001|COMPLETED|Overall Study||58
6659052|NCT02484911|7589726|FG000|NOT COMPLETED|Overall Study||4
6659053|NCT02484911|7589727|FG001|NOT COMPLETED|Overall Study||2
6659054|NCT02485158|7589734|FG000|STARTED|Overall Study||28
6659055|NCT02485158|7589734|FG000|COMPLETED|Overall Study||24
6659056|NCT02485158|7589734|FG000|NOT COMPLETED|Overall Study||4
6659057|NCT02485301|7589745|FG000|STARTED|Overall Study||1509
6659058|NCT02485301|7589746|FG001|STARTED|Overall Study||1504
6659059|NCT02485301|7589745|FG000|COMPLETED|Overall Study||1471
6659060|NCT02485301|7589746|FG001|COMPLETED|Overall Study||1455
6659061|NCT02485301|7589745|FG000|NOT COMPLETED|Overall Study||38
6659062|NCT02485301|7589746|FG001|NOT COMPLETED|Overall Study||49
6659063|NCT02485353|7589752|FG000|STARTED|Overall Study||2
6659064|NCT02485353|7589752|FG000|COMPLETED|Overall Study||0
6583125|NCT01933789|7507121|FG003|Completed After-visit Survey|Overall Study|Number reflects individual IP Team members who returned surveys for up to 6 enrolled patients|1
6583126|NCT01933789|7507122|FG004|Completed After-visit Survey|Overall Study||0
6583127|NCT01933789|7507123|FG005|Completed After-visit Survey|Overall Study||0
6583128|NCT01933789|7507124|FG006|Completed After-visit Survey|Overall Study||0
6583129|NCT01933789|7507125|FG007|Completed After-visit Survey|Overall Study||0
6583130|NCT01933789|7507126|FG008|Completed After-visit Survey|Overall Study||0
6583131|NCT01933789|7507118|FG000|Completed 2-Week Survey|Overall Study||0
6583132|NCT01933789|7507119|FG001|Completed 2-Week Survey|Overall Study||0
6583133|NCT01933789|7507120|FG002|Completed 2-Week Survey|Overall Study||0
6583134|NCT01933789|7507121|FG003|Completed 2-Week Survey|Overall Study||0
6583135|NCT01933789|7507122|FG004|Completed 2-Week Survey|Overall Study||184
6583136|NCT01933789|7507123|FG005|Completed 2-Week Survey|Overall Study||215
6583137|NCT01933789|7507124|FG006|Completed 2-Week Survey|Overall Study||0
6583138|NCT01933789|7507125|FG007|Completed 2-Week Survey|Overall Study||0
6583139|NCT01933789|7507126|FG008|Completed 2-Week Survey|Overall Study||0
6583140|NCT01933789|7507118|FG000|Completed 3-Month Survey|Overall Study||0
6583141|NCT01933789|7507119|FG001|Completed 3-Month Survey|Overall Study||0
6583142|NCT01933789|7507120|FG002|Completed 3-Month Survey|Overall Study||0
6583143|NCT01933789|7507121|FG003|Completed 3-Month Survey|Overall Study||0
6583144|NCT01933789|7507122|FG004|Completed 3-Month Survey|Overall Study||176
6583145|NCT01933789|7507123|FG005|Completed 3-Month Survey|Overall Study||211
6583146|NCT01933789|7507124|FG006|Completed 3-Month Survey|Overall Study||37
6583147|NCT01933789|7507125|FG007|Completed 3-Month Survey|Overall Study||43
6583148|NCT01933789|7507126|FG008|Completed 3-Month Survey|Overall Study||0
6583149|NCT01933789|7507118|FG000|Completed 6-Month Survey|Overall Study||0
6583150|NCT01933789|7507119|FG001|Completed 6-Month Survey|Overall Study||0
6583151|NCT01933789|7507120|FG002|Completed 6-Month Survey|Overall Study||0
6583152|NCT01933789|7507121|FG003|Completed 6-Month Survey|Overall Study||0
6583153|NCT01933789|7507122|FG004|Completed 6-Month Survey|Overall Study||160
6583154|NCT01933789|7507123|FG005|Completed 6-Month Survey|Overall Study||188
6583155|NCT01933789|7507124|FG006|Completed 6-Month Survey|Overall Study||35
6583156|NCT01933789|7507125|FG007|Completed 6-Month Survey|Overall Study||40
6583157|NCT01933789|7507126|FG008|Completed 6-Month Survey|Overall Study||0
6583158|NCT01933789|7507118|FG000|Qualitative Interviews|Overall Study||0
6583159|NCT01933789|7507119|FG001|Qualitative Interviews|Overall Study||0
6583160|NCT01933789|7507120|FG002|Qualitative Interviews|Overall Study||0
6583161|NCT01933789|7507121|FG003|Qualitative Interviews|Overall Study||0
6583162|NCT01933789|7507122|FG004|Qualitative Interviews|Overall Study||0
6583163|NCT01933789|7507123|FG005|Qualitative Interviews|Overall Study||0
6583164|NCT01933789|7507124|FG006|Qualitative Interviews|Overall Study||0
6583165|NCT01933789|7507125|FG007|Qualitative Interviews|Overall Study||0
6583166|NCT01933789|7507126|FG008|Qualitative Interviews|Overall Study||25
6583167|NCT01933789|7507118|FG000|COMPLETED|Overall Study||59
6583168|NCT01933789|7507119|FG001|COMPLETED|Overall Study||66
6583169|NCT01933789|7507120|FG002|COMPLETED|Overall Study||2
6583170|NCT01933789|7507121|FG003|COMPLETED|Overall Study||1
6583171|NCT01933789|7507122|FG004|COMPLETED|Overall Study||190
6583172|NCT01933789|7507123|FG005|COMPLETED|Overall Study||221
6583173|NCT01933789|7507124|FG006|COMPLETED|Overall Study||43
6583174|NCT01933789|7507125|FG007|COMPLETED|Overall Study||47
6583175|NCT01933789|7507126|FG008|COMPLETED|Overall Study||25
6583176|NCT01933789|7507118|FG000|NOT COMPLETED|Overall Study||6
6583177|NCT01933789|7507119|FG001|NOT COMPLETED|Overall Study||1
6583178|NCT01933789|7507120|FG002|NOT COMPLETED|Overall Study||0
6583179|NCT01933789|7507121|FG003|NOT COMPLETED|Overall Study||1
6583180|NCT01933789|7507122|FG004|NOT COMPLETED|Overall Study||59
6583181|NCT01933789|7507123|FG005|NOT COMPLETED|Overall Study||67
6583182|NCT01933789|7507124|FG006|NOT COMPLETED|Overall Study||15
6583183|NCT01933789|7507125|FG007|NOT COMPLETED|Overall Study||14
6583184|NCT01933789|7507126|FG008|NOT COMPLETED|Overall Study||0
6583185|NCT01933880|7507148|FG000|STARTED|Overall Study||153
6583186|NCT01933880|7507149|FG001|STARTED|Overall Study||41
6583187|NCT01933880|7507148|FG000|COMPLETED|Overall Study||123
6583188|NCT01933880|7507149|FG001|COMPLETED|Overall Study||40
6583189|NCT01933880|7507148|FG000|NOT COMPLETED|Overall Study||30
6583190|NCT01933880|7507149|FG001|NOT COMPLETED|Overall Study||1
6583191|NCT01933919|7507162|FG000|STARTED|Double-blind Placebo-controlled Phase||19
6583192|NCT01933919|7507163|FG001|STARTED|Double-blind Placebo-controlled Phase||19
6583193|NCT01933919|7507162|FG000|Received Study Drug|Double-blind Placebo-controlled Phase||19
6583194|NCT01933919|7507163|FG001|Received Study Drug|Double-blind Placebo-controlled Phase||19
6583195|NCT01933919|7507162|FG000|COMPLETED|Double-blind Placebo-controlled Phase||19
6583196|NCT01933919|7507163|FG001|COMPLETED|Double-blind Placebo-controlled Phase||15
6583197|NCT01933919|7507162|FG000|NOT COMPLETED|Double-blind Placebo-controlled Phase||0
6583198|NCT01933919|7507163|FG001|NOT COMPLETED|Double-blind Placebo-controlled Phase||4
6583199|NCT01933919|7507162|FG000|STARTED|Open-label Long-term Phase||19
6583200|NCT01933919|7507163|FG001|STARTED|Open-label Long-term Phase||15
6583201|NCT01933919|7507162|FG000|COMPLETED|Open-label Long-term Phase||12
6583202|NCT01933919|7507163|FG001|COMPLETED|Open-label Long-term Phase||9
6583203|NCT01933919|7507162|FG000|NOT COMPLETED|Open-label Long-term Phase||7
6583204|NCT01933919|7507163|FG001|NOT COMPLETED|Open-label Long-term Phase||6
6583205|NCT01933984|7507183|FG000|STARTED|Overall Study||26
6583206|NCT01933984|7507184|FG001|STARTED|Overall Study||25
6583207|NCT01933984|7507183|FG000|COMPLETED|Overall Study||26
6583208|NCT01933984|7507184|FG001|COMPLETED|Overall Study||25
6583209|NCT01933984|7507183|FG000|NOT COMPLETED|Overall Study||0
6583210|NCT01933984|7507184|FG001|NOT COMPLETED|Overall Study||0
6583211|NCT01934010|7507197|FG000|STARTED|Overall Study||114
6583212|NCT01934010|7507198|FG001|STARTED|Overall Study||67
6583213|NCT01934010|7507199|FG002|STARTED|Overall Study||76
6583214|NCT01934010|7507197|FG000|COMPLETED|Overall Study||91
6583215|NCT01934010|7507198|FG001|COMPLETED|Overall Study||56
6583216|NCT01934010|7507199|FG002|COMPLETED|Overall Study||74
6583217|NCT01934010|7507197|FG000|NOT COMPLETED|Overall Study||23
6583218|NCT01934010|7507198|FG001|NOT COMPLETED|Overall Study||11
6583219|NCT01934010|7507199|FG002|NOT COMPLETED|Overall Study||2
6583220|NCT01934140|7507218|FG000|STARTED|Persistence Phase (Year 6-10)||235
6583221|NCT01934140|7507219|FG001|STARTED|Persistence Phase (Year 6-10)||76
6583222|NCT01934140|7507218|FG000|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|152
6583223|NCT01934140|7507219|FG001|COMPLETED|Persistence Phase (Year 6-10)|Participants completed all persistence phase visits|51
6583224|NCT01934140|7507218|FG000|NOT COMPLETED|Persistence Phase (Year 6-10)||83
6583225|NCT01934140|7507219|FG001|NOT COMPLETED|Persistence Phase (Year 6-10)||25
6583226|NCT01934140|7507218|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|164
6583227|NCT01934140|7507219|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent, were enrolled in booster phase.|56
6583228|NCT01934140|7507218|FG000|Vaccinated|Booster Phase (6 Months)||164
6583229|NCT01934140|7507219|FG001|Vaccinated|Booster Phase (6 Months)||56
6583230|NCT01934140|7507218|FG000|COMPLETED|Booster Phase (6 Months)||159
6583231|NCT01934140|7507219|FG001|COMPLETED|Booster Phase (6 Months)||53
6583232|NCT01934140|7507218|FG000|NOT COMPLETED|Booster Phase (6 Months)||5
6583233|NCT01934140|7507219|FG001|NOT COMPLETED|Booster Phase (6 Months)||3
6583234|NCT01934192|7507231|FG000|STARTED|Overall Study||40
6583235|NCT01934192|7507232|FG001|STARTED|Overall Study||44
6583236|NCT01934192|7507233|FG002|STARTED|Overall Study||4
6583237|NCT01934192|7507234|FG003|STARTED|Overall Study||4
6583238|NCT01934192|7507231|FG000|COMPLETED|Overall Study||31
6583239|NCT01934192|7507232|FG001|COMPLETED|Overall Study||37
6583240|NCT01934192|7507233|FG002|COMPLETED|Overall Study||3
6583241|NCT01934192|7507234|FG003|COMPLETED|Overall Study||3
6583242|NCT01934192|7507231|FG000|NOT COMPLETED|Overall Study||9
6583243|NCT01934192|7507232|FG001|NOT COMPLETED|Overall Study||7
6583244|NCT01934192|7507233|FG002|NOT COMPLETED|Overall Study||1
6583245|NCT01934192|7507234|FG003|NOT COMPLETED|Overall Study||1
6583246|NCT01934218|7507257|FG000|STARTED|Double-blind Phase||404
6583247|NCT01934218|7507258|FG001|STARTED|Double-blind Phase||410
6583248|NCT01934218|7507257|FG000|Analyzed Participants|Double-blind Phase||402
6583249|NCT01934218|7507258|FG001|Analyzed Participants|Double-blind Phase||407
6583250|NCT01934218|7507257|FG000|COMPLETED|Double-blind Phase||356
6583251|NCT01934218|7507258|FG001|COMPLETED|Double-blind Phase||356
6583252|NCT01934218|7507257|FG000|NOT COMPLETED|Double-blind Phase||48
6583253|NCT01934218|7507258|FG001|NOT COMPLETED|Double-blind Phase||54
6583254|NCT01934218|7507257|FG000|STARTED|Open-Label Phase||316
6583255|NCT01934218|7507258|FG001|STARTED|Open-Label Phase||328
6583256|NCT01934218|7507257|FG000|COMPLETED|Open-Label Phase||290
6583257|NCT01934218|7507258|FG001|COMPLETED|Open-Label Phase||304
6583258|NCT01934218|7507257|FG000|NOT COMPLETED|Open-Label Phase||26
6583259|NCT01934218|7507258|FG001|NOT COMPLETED|Open-Label Phase||24
6583260|NCT01934231|7507264|FG000|STARTED|Overall Study||27
6583261|NCT01934231|7507264|FG000|COMPLETED|Overall Study||27
6583262|NCT01934231|7507264|FG000|NOT COMPLETED|Overall Study||0
6583263|NCT01934335|7507270|FG000|STARTED|Overall Study||7
6583264|NCT01934335|7507271|FG001|STARTED|Overall Study||5
6583265|NCT01934335|7507270|FG000|COMPLETED|Overall Study||6
6583266|NCT01934335|7507271|FG001|COMPLETED|Overall Study||4
6583267|NCT01934335|7507270|FG000|NOT COMPLETED|Overall Study||1
6659065|NCT02485353|7589752|FG000|NOT COMPLETED|Overall Study||2
6659066|NCT02485483|7589758|FG000|STARTED|Overall Study||277
6659067|NCT02485483|7589759|FG001|STARTED|Overall Study||1015
6659068|NCT02485483|7589758|FG000|COMPLETED|Overall Study||223
6659069|NCT02485483|7589759|FG001|COMPLETED|Overall Study||1015
6659070|NCT02485483|7589758|FG000|NOT COMPLETED|Overall Study||54
6659071|NCT02485483|7589759|FG001|NOT COMPLETED|Overall Study||0
6659072|NCT02485561|7589768|FG000|STARTED|Overall Study||161
6659073|NCT02485561|7589769|FG001|STARTED|Overall Study||157
6659074|NCT02485561|7589770|FG002|STARTED|Overall Study||159
6659075|NCT02485561|7589768|FG000|Completed 1 mo Survey|Overall Study||145
6659076|NCT02485561|7589769|FG001|Completed 1 mo Survey|Overall Study||138
6659077|NCT02485561|7589770|FG002|Completed 1 mo Survey|Overall Study||144
6659078|NCT02485561|7589768|FG000|COMPLETED|Overall Study||133
6659079|NCT02485561|7589769|FG001|COMPLETED|Overall Study||118
6659080|NCT02485561|7589770|FG002|COMPLETED|Overall Study||136
6659081|NCT02485561|7589768|FG000|NOT COMPLETED|Overall Study||28
6659082|NCT02485561|7589769|FG001|NOT COMPLETED|Overall Study||39
6583268|NCT01934335|7507271|FG001|NOT COMPLETED|Overall Study||1
6583269|NCT01934517|7507277|FG000|STARTED|Overall Study||25
6583270|NCT01934517|7507277|FG000|COMPLETED|Overall Study||25
6583271|NCT01934517|7507277|FG000|NOT COMPLETED|Overall Study||0
6583272|NCT01934556|7507288|FG000|STARTED|Overall Study||30
6659083|NCT02485561|7589770|FG002|NOT COMPLETED|Overall Study||23
6583273|NCT01934556|7507289|FG001|STARTED|Overall Study||60
6583274|NCT01934556|7507290|FG002|STARTED|Overall Study||60
6583275|NCT01934556|7507288|FG000|COMPLETED|Overall Study||25
6583276|NCT01934556|7507289|FG001|COMPLETED|Overall Study||44
6583277|NCT01934556|7507290|FG002|COMPLETED|Overall Study||50
6583278|NCT01934556|7507288|FG000|NOT COMPLETED|Overall Study||5
6583279|NCT01934556|7507289|FG001|NOT COMPLETED|Overall Study||16
6583280|NCT01934556|7507290|FG002|NOT COMPLETED|Overall Study||10
6583281|NCT01934582|7507298|FG000|STARTED|Overall Study||13
6583282|NCT01934582|7507298|FG000|COMPLETED|Overall Study||13
6583283|NCT01934582|7507298|FG000|NOT COMPLETED|Overall Study||0
6583284|NCT01934790|7507304|FG000|STARTED|Treatment|Eligible for treatment|45
6583285|NCT01934790|7507304|FG000|Participants Received Study Treatment|Treatment||44
6583286|NCT01934790|7507304|FG000|COMPLETED|Treatment||29
6583287|NCT01934790|7507304|FG000|NOT COMPLETED|Treatment||16
6583288|NCT01934790|7507304|FG000|STARTED|Active Follow up||34
6583289|NCT01934790|7507304|FG000|COMPLETED|Active Follow up||10
6583290|NCT01934790|7507304|FG000|NOT COMPLETED|Active Follow up||24
6583291|NCT01934790|7507304|FG000|STARTED|Long Term Follow up||12
6583292|NCT01934790|7507304|FG000|COMPLETED|Long Term Follow up||12
6583293|NCT01934790|7507304|FG000|NOT COMPLETED|Long Term Follow up||0
6583294|NCT01934894|7507310|FG000|STARTED|Overall Study||6
6583295|NCT01934894|7507311|FG001|STARTED|Overall Study||5
6583296|NCT01934894|7507310|FG000|COMPLETED|Overall Study||0
6583297|NCT01934894|7507311|FG001|COMPLETED|Overall Study||0
6583298|NCT01934894|7507310|FG000|NOT COMPLETED|Overall Study||6
6583299|NCT01934894|7507311|FG001|NOT COMPLETED|Overall Study||5
6583300|NCT01934972|7507322|FG000|STARTED|Overall Study||13
6583301|NCT01934972|7507323|FG001|STARTED|Overall Study||11
6583302|NCT01934972|7507322|FG000|COMPLETED|Overall Study||4
6583303|NCT01934972|7507323|FG001|COMPLETED|Overall Study||5
6583304|NCT01934972|7507322|FG000|NOT COMPLETED|Overall Study||9
6583305|NCT01934972|7507323|FG001|NOT COMPLETED|Overall Study||6
6583306|NCT01935180|7507331|FG000|STARTED|Overall Study||573
6583307|NCT01935180|7507332|FG001|STARTED|Overall Study||575
6583308|NCT01935180|7507331|FG000|COMPLETED|Overall Study||552
6583309|NCT01935180|7507332|FG001|COMPLETED|Overall Study||561
6583310|NCT01935180|7507331|FG000|NOT COMPLETED|Overall Study||21
6583311|NCT01935180|7507332|FG001|NOT COMPLETED|Overall Study||14
6583312|NCT01935622|7507341|FG000|STARTED|Overall Study||3
6583313|NCT01935622|7507342|FG001|STARTED|Overall Study||3
6583314|NCT01935622|7507343|FG002|STARTED|Overall Study||4
6583315|NCT01935622|7507341|FG000|COMPLETED|Overall Study||1
6583316|NCT01935622|7507342|FG001|COMPLETED|Overall Study||1
6583317|NCT01935622|7507343|FG002|COMPLETED|Overall Study||4
6583318|NCT01935622|7507341|FG000|NOT COMPLETED|Overall Study||2
6583319|NCT01935622|7507342|FG001|NOT COMPLETED|Overall Study||2
6583320|NCT01935622|7507343|FG002|NOT COMPLETED|Overall Study||0
6583321|NCT01935700|7507353|FG000|STARTED|Overall Study||14
6583322|NCT01935700|7507354|FG001|STARTED|Overall Study||86
6583323|NCT01935700|7507353|FG000|COMPLETED|Overall Study||9
6583324|NCT01935700|7507354|FG001|COMPLETED|Overall Study||86
6583325|NCT01935700|7507353|FG000|NOT COMPLETED|Overall Study||5
6583326|NCT01935700|7507354|FG001|NOT COMPLETED|Overall Study||0
6583327|NCT01935791|7507362|FG000|STARTED|Period 1||4
6583328|NCT01935791|7507363|FG001|STARTED|Period 1||4
6583329|NCT01935791|7507364|FG002|STARTED|Period 1||3
6583330|NCT01935791|7507365|FG003|STARTED|Period 1||0
6583331|NCT01935791|7507366|FG004|STARTED|Period 1||0
6583332|NCT01935791|7507367|FG005|STARTED|Period 1||0
6583333|NCT01935791|7507368|FG006|STARTED|Period 1||0
6583334|NCT01935791|7507369|FG007|STARTED|Period 1||0
6583335|NCT01935791|7507370|FG008|STARTED|Period 1||0
6583336|NCT01935791|7507362|FG000|COMPLETED|Period 1||4
6583337|NCT01935791|7507363|FG001|COMPLETED|Period 1||4
6583338|NCT01935791|7507364|FG002|COMPLETED|Period 1||3
6583339|NCT01935791|7507365|FG003|COMPLETED|Period 1||0
6583340|NCT01935791|7507366|FG004|COMPLETED|Period 1||0
6583341|NCT01935791|7507367|FG005|COMPLETED|Period 1||0
6583342|NCT01935791|7507368|FG006|COMPLETED|Period 1||0
6583343|NCT01935791|7507369|FG007|COMPLETED|Period 1||0
6583344|NCT01935791|7507370|FG008|COMPLETED|Period 1||0
6583345|NCT01935791|7507362|FG000|NOT COMPLETED|Period 1||0
6583346|NCT01935791|7507363|FG001|NOT COMPLETED|Period 1||0
6583347|NCT01935791|7507364|FG002|NOT COMPLETED|Period 1||0
6583348|NCT01935791|7507365|FG003|NOT COMPLETED|Period 1||0
6583349|NCT01935791|7507366|FG004|NOT COMPLETED|Period 1||0
6583350|NCT01935791|7507367|FG005|NOT COMPLETED|Period 1||0
6583351|NCT01935791|7507368|FG006|NOT COMPLETED|Period 1||0
6583352|NCT01935791|7507369|FG007|NOT COMPLETED|Period 1||0
6583353|NCT01935791|7507370|FG008|NOT COMPLETED|Period 1||0
6583354|NCT01935791|7507362|FG000|STARTED|Period 2||0
6583355|NCT01935791|7507363|FG001|STARTED|Period 2||0
6583356|NCT01935791|7507364|FG002|STARTED|Period 2||0
6583357|NCT01935791|7507365|FG003|STARTED|Period 2||2
6583358|NCT01935791|7507366|FG004|STARTED|Period 2||3
6583359|NCT01935791|7507367|FG005|STARTED|Period 2||1
6583360|NCT01935791|7507368|FG006|STARTED|Period 2||1
6583361|NCT01935791|7507369|FG007|STARTED|Period 2||3
6583362|NCT01935791|7507370|FG008|STARTED|Period 2||1
6583363|NCT01935791|7507362|FG000|COMPLETED|Period 2||0
6583364|NCT01935791|7507363|FG001|COMPLETED|Period 2||0
6583365|NCT01935791|7507364|FG002|COMPLETED|Period 2||0
6583366|NCT01935791|7507365|FG003|COMPLETED|Period 2||2
6583367|NCT01935791|7507366|FG004|COMPLETED|Period 2||3
6583368|NCT01935791|7507367|FG005|COMPLETED|Period 2||1
6583369|NCT01935791|7507368|FG006|COMPLETED|Period 2||1
6583370|NCT01935791|7507369|FG007|COMPLETED|Period 2||3
6583371|NCT01935791|7507370|FG008|COMPLETED|Period 2||1
6583372|NCT01935791|7507362|FG000|NOT COMPLETED|Period 2||0
6583373|NCT01935791|7507363|FG001|NOT COMPLETED|Period 2||0
6583374|NCT01935791|7507364|FG002|NOT COMPLETED|Period 2||0
6583375|NCT01935791|7507365|FG003|NOT COMPLETED|Period 2||0
6583376|NCT01935791|7507366|FG004|NOT COMPLETED|Period 2||0
6583377|NCT01935791|7507367|FG005|NOT COMPLETED|Period 2||0
6583378|NCT01935791|7507368|FG006|NOT COMPLETED|Period 2||0
6583379|NCT01935791|7507369|FG007|NOT COMPLETED|Period 2||0
6583380|NCT01935791|7507370|FG008|NOT COMPLETED|Period 2||0
6583381|NCT01936181|7507386|FG000|STARTED|Randomised, Double-blind||291
6583382|NCT01936181|7507387|FG001|STARTED|Randomised, Double-blind||293
6583383|NCT01936181|7507388|FG002|STARTED|Randomised, Double-blind||0
6583384|NCT01936181|7507389|FG003|STARTED|Randomised, Double-blind||0
6583385|NCT01936181|7507386|FG000|COMPLETED|Randomised, Double-blind||227
6583386|NCT01936181|7507387|FG001|COMPLETED|Randomised, Double-blind||225
6583387|NCT01936181|7507388|FG002|COMPLETED|Randomised, Double-blind||0
6583388|NCT01936181|7507389|FG003|COMPLETED|Randomised, Double-blind||0
6583389|NCT01936181|7507386|FG000|NOT COMPLETED|Randomised, Double-blind||64
6583390|NCT01936181|7507387|FG001|NOT COMPLETED|Randomised, Double-blind||68
6583391|NCT01936181|7507388|FG002|NOT COMPLETED|Randomised, Double-blind||0
6583392|NCT01936181|7507389|FG003|NOT COMPLETED|Randomised, Double-blind||0
6583393|NCT01936181|7507386|FG000|STARTED|Transition-extension||201
6583394|NCT01936181|7507387|FG001|STARTED|Transition-extension||0
6583395|NCT01936181|7507388|FG002|STARTED|Transition-extension||94
6583396|NCT01936181|7507389|FG003|STARTED|Transition-extension||101
6583397|NCT01936181|7507386|FG000|COMPLETED|Transition-extension||186
6583398|NCT01936181|7507387|FG001|COMPLETED|Transition-extension||0
6583399|NCT01936181|7507388|FG002|COMPLETED|Transition-extension||88
6583400|NCT01936181|7507389|FG003|COMPLETED|Transition-extension||96
6583401|NCT01936181|7507386|FG000|NOT COMPLETED|Transition-extension||15
6583402|NCT01936181|7507387|FG001|NOT COMPLETED|Transition-extension||0
6583403|NCT01936181|7507388|FG002|NOT COMPLETED|Transition-extension||6
6583404|NCT01936181|7507389|FG003|NOT COMPLETED|Transition-extension||5
6583405|NCT01936259|7507402|FG000|STARTED|Overall Study||130
6583406|NCT01936259|7507403|FG001|STARTED|Overall Study||131
6583407|NCT01936259|7507402|FG000|COMPLETED|Overall Study||118
6583408|NCT01936259|7507403|FG001|COMPLETED|Overall Study||111
6583409|NCT01936259|7507402|FG000|NOT COMPLETED|Overall Study||12
6583410|NCT01936259|7507403|FG001|NOT COMPLETED|Overall Study||20
6583411|NCT01936324|7507412|FG000|STARTED|Overall Study||6
6583412|NCT01936324|7507413|FG001|STARTED|Overall Study||53
6583413|NCT01936324|7507414|FG002|STARTED|Overall Study||55
6583414|NCT01936324|7507412|FG000|COMPLETED|Overall Study||6
6583415|NCT01936324|7507413|FG001|COMPLETED|Overall Study||47
6583416|NCT01936324|7507414|FG002|COMPLETED|Overall Study||50
6583417|NCT01936324|7507412|FG000|NOT COMPLETED|Overall Study||0
6583418|NCT01936324|7507413|FG001|NOT COMPLETED|Overall Study||6
6583419|NCT01936324|7507414|FG002|NOT COMPLETED|Overall Study||5
6583420|NCT01936363|7507423|FG000|STARTED|Overall Study||32
6583421|NCT01936363|7507424|FG001|STARTED|Overall Study||33
6583422|NCT01936363|7507423|FG000|COMPLETED|Overall Study||32
6583423|NCT01936363|7507424|FG001|COMPLETED|Overall Study||33
6583424|NCT01936363|7507423|FG000|NOT COMPLETED|Overall Study||0
6583425|NCT01936363|7507424|FG001|NOT COMPLETED|Overall Study||0
6583426|NCT01936389|7507432|FG000|STARTED|Overall Study||5
6583427|NCT01936389|7507433|FG001|STARTED|Overall Study||5
6583428|NCT01936389|7507432|FG000|COMPLETED|Overall Study||4
6583429|NCT01936389|7507433|FG001|COMPLETED|Overall Study||5
6583430|NCT01936389|7507432|FG000|NOT COMPLETED|Overall Study||1
6583431|NCT01936389|7507433|FG001|NOT COMPLETED|Overall Study||0
6583432|NCT01936467|7507441|FG000|STARTED|Overall Study||60
6583433|NCT01936467|7507442|FG001|STARTED|Overall Study||61
6583434|NCT01936467|7507441|FG000|COMPLETED|Overall Study||60
6583435|NCT01936467|7507442|FG001|COMPLETED|Overall Study||61
6583436|NCT01936467|7507441|FG000|NOT COMPLETED|Overall Study||0
6583437|NCT01936467|7507442|FG001|NOT COMPLETED|Overall Study||0
6583438|NCT01936519|7507454|FG000|STARTED|Overall Study||12
6583439|NCT01936519|7507455|FG001|STARTED|Overall Study||12
6583440|NCT01936519|7507454|FG000|COMPLETED|Overall Study||11
6583441|NCT01936519|7507455|FG001|COMPLETED|Overall Study||8
6583442|NCT01936519|7507454|FG000|NOT COMPLETED|Overall Study||1
6583443|NCT01936519|7507455|FG001|NOT COMPLETED|Overall Study||4
6583444|NCT01936623|7507466|FG000|STARTED|Overall Study||40
6583445|NCT01936623|7507467|FG001|STARTED|Overall Study||40
6583446|NCT01936623|7507466|FG000|COMPLETED|Overall Study||40
6583447|NCT01936623|7507467|FG001|COMPLETED|Overall Study||35
6583448|NCT01936623|7507466|FG000|NOT COMPLETED|Overall Study||0
6583449|NCT01936623|7507467|FG001|NOT COMPLETED|Overall Study||5
6583450|NCT01936649|7507473|FG000|STARTED|Overall Study||63
6583451|NCT01936649|7507473|FG000|Treated|Overall Study||51
6583452|NCT01936649|7507473|FG000|COMPLETED|Overall Study||50
6583453|NCT01936649|7507473|FG000|NOT COMPLETED|Overall Study||13
6583454|NCT01936662|7507479|FG000|STARTED|Overall Study||42
6583455|NCT01936662|7507480|FG001|STARTED|Overall Study||42
6583456|NCT01936662|7507479|FG000|COMPLETED|Overall Study||42
6583457|NCT01936662|7507480|FG001|COMPLETED|Overall Study||42
6583458|NCT01936662|7507479|FG000|NOT COMPLETED|Overall Study||0
6583459|NCT01936662|7507480|FG001|NOT COMPLETED|Overall Study||0
6583460|NCT01936844|7507490|FG000|STARTED|Overall Study||15
6583461|NCT01936844|7507491|FG001|STARTED|Overall Study||15
6583462|NCT01936844|7507490|FG000|COMPLETED|Overall Study||9
6583463|NCT01936844|7507491|FG001|COMPLETED|Overall Study||8
6583464|NCT01936844|7507490|FG000|NOT COMPLETED|Overall Study||6
6583465|NCT01936844|7507491|FG001|NOT COMPLETED|Overall Study||7
6583466|NCT01936857|7507499|FG000|STARTED|Overall Study||141
6583467|NCT01936857|7507500|FG001|STARTED|Overall Study||140
6583468|NCT01936857|7507499|FG000|COMPLETED|Overall Study||107
6583469|NCT01936857|7507500|FG001|COMPLETED|Overall Study||115
6583470|NCT01936857|7507499|FG000|NOT COMPLETED|Overall Study||34
6583471|NCT01936857|7507500|FG001|NOT COMPLETED|Overall Study||25
6583472|NCT01936870|7507506|FG000|STARTED|Overall Study||2492
6583473|NCT01936870|7507506|FG000|COMPLETED|Overall Study||2303
6583474|NCT01936870|7507506|FG000|NOT COMPLETED|Overall Study||189
6583475|NCT01936896|7507510|FG000|STARTED|Overall Study||10
6583476|NCT01936896|7507510|FG000|COMPLETED|Overall Study||10
6583477|NCT01936896|7507510|FG000|NOT COMPLETED|Overall Study||0
6583478|NCT01936909|7507517|FG000|STARTED|Overall Study||20
6583479|NCT01936909|7507518|FG001|STARTED|Overall Study||20
6583480|NCT01936909|7507519|FG002|STARTED|Overall Study||20
6583481|NCT01936909|7507517|FG000|COMPLETED|Overall Study||10
6583482|NCT01936909|7507518|FG001|COMPLETED|Overall Study||12
6583483|NCT01936909|7507519|FG002|COMPLETED|Overall Study||14
6583484|NCT01936909|7507517|FG000|NOT COMPLETED|Overall Study||10
6583485|NCT01936909|7507518|FG001|NOT COMPLETED|Overall Study||8
6583486|NCT01936909|7507519|FG002|NOT COMPLETED|Overall Study||6
6583487|NCT01936948|7507531|FG000|STARTED|Overall Study||227
6583488|NCT01936948|7507532|FG001|STARTED|Overall Study||231
6583489|NCT01936948|7507533|FG002|STARTED|Overall Study||237
6583490|NCT01936948|7507534|FG003|STARTED|Overall Study||233
6583491|NCT01936948|7507531|FG000|Crossover|Overall Study||31
6583492|NCT01936948|7507532|FG001|Crossover|Overall Study||27
6583493|NCT01936948|7507533|FG002|Crossover|Overall Study||22
6583494|NCT01936948|7507534|FG003|Crossover|Overall Study||25
6583495|NCT01936948|7507531|FG000|COMPLETED|Overall Study||227
6583496|NCT01936948|7507532|FG001|COMPLETED|Overall Study||228
6583497|NCT01936948|7507533|FG002|COMPLETED|Overall Study||234
6583498|NCT01936948|7507534|FG003|COMPLETED|Overall Study||230
6583499|NCT01936948|7507531|FG000|NOT COMPLETED|Overall Study||0
6583500|NCT01936948|7507532|FG001|NOT COMPLETED|Overall Study||3
6583501|NCT01936948|7507533|FG002|NOT COMPLETED|Overall Study||3
6583502|NCT01936948|7507534|FG003|NOT COMPLETED|Overall Study||3
6583503|NCT01937026|7507542|FG000|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
6583504|NCT01937026|7507542|FG000|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
6583505|NCT01937026|7507542|FG000|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
6583506|NCT01937026|7507542|FG000|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
6583507|NCT01937026|7507542|FG000|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
6583508|NCT01937026|7507542|FG000|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
6583509|NCT01937026|7507542|FG000|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
6583510|NCT01937026|7507542|FG000|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
6583511|NCT01937026|7507542|FG000|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
6583512|NCT01937117|7507549|FG000|STARTED|Overall Study||88
6583513|NCT01937117|7507549|FG000|COMPLETED|Overall Study||75
6583514|NCT01937117|7507549|FG000|NOT COMPLETED|Overall Study||13
6583515|NCT01937130|7507557|FG000|STARTED|Overall Study||5
6583516|NCT01937130|7507558|FG001|STARTED|Overall Study||7
6583517|NCT01937130|7507559|FG002|STARTED|Overall Study||5
6583518|NCT01937130|7507560|FG003|STARTED|Overall Study||4
6583519|NCT01937130|7507557|FG000|COMPLETED|Overall Study||0
6583520|NCT01937130|7507558|FG001|COMPLETED|Overall Study||3
6583521|NCT01937130|7507559|FG002|COMPLETED|Overall Study||2
6583522|NCT01937130|7507560|FG003|COMPLETED|Overall Study||2
6583523|NCT01937130|7507557|FG000|NOT COMPLETED|Overall Study||5
6583524|NCT01937130|7507558|FG001|NOT COMPLETED|Overall Study||4
6583525|NCT01937130|7507559|FG002|NOT COMPLETED|Overall Study||3
6583526|NCT01937130|7507560|FG003|NOT COMPLETED|Overall Study||2
6583527|NCT01937195|7507570|FG000|STARTED|Overall Study||95
6583528|NCT01937195|7507570|FG000|COMPLETED|Overall Study||95
6583529|NCT01937195|7507570|FG000|NOT COMPLETED|Overall Study||0
6583530|NCT01937260|7507576|FG000|STARTED|Overall Study||21
6583531|NCT01937260|7507577|FG001|STARTED|Overall Study||10
6583532|NCT01937260|7507576|FG000|COMPLETED|Overall Study||20
6583533|NCT01937260|7507577|FG001|COMPLETED|Overall Study||10
6583534|NCT01937260|7507576|FG000|NOT COMPLETED|Overall Study||1
6583535|NCT01937260|7507577|FG001|NOT COMPLETED|Overall Study||0
6583536|NCT01937299|7507585|FG000|STARTED|Overall Study||117
6583537|NCT01937299|7507586|FG001|STARTED|Overall Study||116
6583538|NCT01937299|7507585|FG000|COMPLETED|Overall Study||103
6583539|NCT01937299|7507586|FG001|COMPLETED|Overall Study||112
6583540|NCT01937299|7507585|FG000|NOT COMPLETED|Overall Study||14
6583541|NCT01937299|7507586|FG001|NOT COMPLETED|Overall Study||4
6583542|NCT01937312|7507595|FG000|STARTED|Overall Study||94
6583543|NCT01937312|7507596|FG001|STARTED|Overall Study||95
6583544|NCT01937312|7507595|FG000|Treated|Overall Study||93
6583545|NCT01937312|7507596|FG001|Treated|Overall Study||95
6583546|NCT01937312|7507595|FG000|COMPLETED|Overall Study||83
6583547|NCT01937312|7507596|FG001|COMPLETED|Overall Study||92
6583548|NCT01937312|7507595|FG000|NOT COMPLETED|Overall Study||11
6583549|NCT01937312|7507596|FG001|NOT COMPLETED|Overall Study||3
6583550|NCT01937351|7507605|FG000|STARTED|Overall Study||134
6583551|NCT01937351|7507606|FG001|STARTED|Overall Study||28
6583552|NCT01937351|7507605|FG000|Treated w Study Device|Overall Study||130
6583553|NCT01937351|7507606|FG001|Treated w Study Device|Overall Study||28
6583554|NCT01937351|7507605|FG000|30-Day Follow-up|Overall Study||128
6583555|NCT01937351|7507606|FG001|30-Day Follow-up|Overall Study||27
6583556|NCT01937351|7507605|FG000|6-Month Follow-up|Overall Study||125
6583557|NCT01937351|7507606|FG001|6-Month Follow-up|Overall Study||26
6583558|NCT01937351|7507605|FG000|COMPLETED|Overall Study||125
6583559|NCT01937351|7507606|FG001|COMPLETED|Overall Study||26
6583560|NCT01937351|7507605|FG000|NOT COMPLETED|Overall Study||9
6583561|NCT01937351|7507606|FG001|NOT COMPLETED|Overall Study||2
6583562|NCT01937364|7507613|FG000|STARTED|Overall Study||9
6583563|NCT01937364|7507614|FG001|STARTED|Overall Study||8
6583564|NCT01937364|7507613|FG000|COMPLETED|Overall Study||7
6583565|NCT01937364|7507614|FG001|COMPLETED|Overall Study||7
6583566|NCT01937364|7507613|FG000|NOT COMPLETED|Overall Study||2
6583567|NCT01937364|7507614|FG001|NOT COMPLETED|Overall Study||1
6583568|NCT01937390|7507620|FG000|STARTED|Overall Study||585
6583569|NCT01937390|7507620|FG000|COMPLETED|Overall Study||550
6583570|NCT01937390|7507620|FG000|NOT COMPLETED|Overall Study||35
6583571|NCT01937520|7507626|FG000|STARTED|Overall Study||11
6583572|NCT01937520|7507627|FG001|STARTED|Overall Study||9
6583573|NCT01937520|7507626|FG000|COMPLETED|Overall Study||11
6583574|NCT01937520|7507627|FG001|COMPLETED|Overall Study||9
6583575|NCT01937520|7507626|FG000|NOT COMPLETED|Overall Study||0
6583576|NCT01937520|7507627|FG001|NOT COMPLETED|Overall Study||0
6583577|NCT01937559|7507637|FG000|STARTED|Overall Study||61
6583578|NCT01937559|7507638|FG001|STARTED|Overall Study||61
6583579|NCT01937559|7507639|FG002|STARTED|Overall Study||66
6583580|NCT01937559|7507637|FG000|COMPLETED|Overall Study||50
6583581|NCT01937559|7507638|FG001|COMPLETED|Overall Study||50
6583582|NCT01937559|7507639|FG002|COMPLETED|Overall Study||66
6583583|NCT01937559|7507637|FG000|NOT COMPLETED|Overall Study||11
6583584|NCT01937559|7507638|FG001|NOT COMPLETED|Overall Study||11
6583585|NCT01937559|7507639|FG002|NOT COMPLETED|Overall Study||0
6583586|NCT01937598|7507651|FG000|STARTED|Overall Study||8
6583587|NCT01937598|7507652|FG001|STARTED|Overall Study||8
6583588|NCT01937598|7507651|FG000|COMPLETED|Overall Study||8
6583589|NCT01937598|7507652|FG001|COMPLETED|Overall Study||8
6583590|NCT01937598|7507651|FG000|NOT COMPLETED|Overall Study||0
6583591|NCT01937598|7507652|FG001|NOT COMPLETED|Overall Study||0
6583592|NCT01937624|7507658|FG000|STARTED|Overall Study||51
6583593|NCT01937624|7507658|FG000|COMPLETED|Overall Study||51
6583594|NCT01937624|7507658|FG000|NOT COMPLETED|Overall Study||0
6624248|NCT02215252|7551628|FG000|COMPLETED|Overall Study||42
6624249|NCT02215252|7551629|FG001|COMPLETED|Overall Study||38
6624250|NCT02215252|7551630|FG002|COMPLETED|Overall Study||41
6624251|NCT02215252|7551628|FG000|NOT COMPLETED|Overall Study||2
6624252|NCT02215252|7551629|FG001|NOT COMPLETED|Overall Study||8
6624253|NCT02215252|7551630|FG002|NOT COMPLETED|Overall Study||4
6624254|NCT02215369|7551638|FG000|STARTED|Overall Study||112
6624255|NCT02215369|7551638|FG000|COMPLETED|Overall Study||70
6624256|NCT02215369|7551638|FG000|NOT COMPLETED|Overall Study||42
6624257|NCT02215616|7551646|FG000|STARTED|Overall Study||108
6624258|NCT02215616|7551647|FG001|STARTED|Overall Study||107
6624259|NCT02215616|7551648|FG002|STARTED|Overall Study||107
6624260|NCT02215616|7551649|FG003|STARTED|Overall Study||30
6624261|NCT02215616|7551646|FG000|Received at Least 1 Dose of Study Drug|Overall Study||108
6624262|NCT02215616|7551647|FG001|Received at Least 1 Dose of Study Drug|Overall Study||107
6624263|NCT02215616|7551648|FG002|Received at Least 1 Dose of Study Drug|Overall Study||106
6624264|NCT02215616|7551649|FG003|Received at Least 1 Dose of Study Drug|Overall Study||29
6624265|NCT02215616|7551646|FG000|COMPLETED|Overall Study||97
6624266|NCT02215616|7551647|FG001|COMPLETED|Overall Study||90
6624267|NCT02215616|7551648|FG002|COMPLETED|Overall Study||93
6624268|NCT02215616|7551649|FG003|COMPLETED|Overall Study||17
6624269|NCT02215616|7551646|FG000|NOT COMPLETED|Overall Study||11
6624270|NCT02215616|7551647|FG001|NOT COMPLETED|Overall Study||17
6624271|NCT02215616|7551648|FG002|NOT COMPLETED|Overall Study||14
6624272|NCT02215616|7551649|FG003|NOT COMPLETED|Overall Study||13
6624273|NCT02215954|7551662|FG000|STARTED|Overall Study||214
6624274|NCT02215954|7551663|FG001|STARTED|Overall Study||212
6624275|NCT02215954|7551664|FG002|STARTED|Overall Study||211
6624276|NCT02215954|7551662|FG000|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
6624277|NCT02215954|7551663|FG001|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
6624278|NCT02215954|7551664|FG002|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
6624279|NCT02215954|7551662|FG000|Per Protocol (PP) Analysis Set|Overall Study||212
6624280|NCT02215954|7551663|FG001|Per Protocol (PP) Analysis Set|Overall Study||208
6624281|NCT02215954|7551664|FG002|Per Protocol (PP) Analysis Set|Overall Study||205
6624282|NCT02215954|7551662|FG000|Safety Analysis Set|Overall Study||213
6624283|NCT02215954|7551663|FG001|Safety Analysis Set|Overall Study||211
6624284|NCT02215954|7551664|FG002|Safety Analysis Set|Overall Study||208
6624285|NCT02215954|7551662|FG000|COMPLETED|Overall Study||213
6624286|NCT02215954|7551663|FG001|COMPLETED|Overall Study||211
6624287|NCT02215954|7551664|FG002|COMPLETED|Overall Study||205
6624288|NCT02215954|7551662|FG000|NOT COMPLETED|Overall Study||1
6624289|NCT02215954|7551663|FG001|NOT COMPLETED|Overall Study||1
6624290|NCT02215954|7551664|FG002|NOT COMPLETED|Overall Study||6
6624291|NCT02215967|7551677|FG000|STARTED|Overall Study||3
6624292|NCT02215967|7551678|FG001|STARTED|Overall Study||3
6624293|NCT02215967|7551679|FG002|STARTED|Overall Study||5
6624294|NCT02215967|7551680|FG003|STARTED|Overall Study||19
6583595|NCT01937715|7507667|FG000|STARTED|Overall Study||3
6583596|NCT01937715|7507668|FG001|STARTED|Overall Study||4
6583597|NCT01937715|7507669|FG002|STARTED|Overall Study||3
6583598|NCT01937715|7507670|FG003|STARTED|Overall Study||5
6583599|NCT01937715|7507671|FG004|STARTED|Overall Study||3
6583600|NCT01937715|7507667|FG000|COMPLETED|Overall Study||3
6583601|NCT01937715|7507668|FG001|COMPLETED|Overall Study||3
6583602|NCT01937715|7507669|FG002|COMPLETED|Overall Study||3
6583603|NCT01937715|7507670|FG003|COMPLETED|Overall Study||1
6583604|NCT01937715|7507671|FG004|COMPLETED|Overall Study||1
6583605|NCT01937715|7507667|FG000|NOT COMPLETED|Overall Study||0
6583606|NCT01937715|7507668|FG001|NOT COMPLETED|Overall Study||1
6583607|NCT01937715|7507669|FG002|NOT COMPLETED|Overall Study||0
6583608|NCT01937715|7507670|FG003|NOT COMPLETED|Overall Study||4
6583609|NCT01937715|7507671|FG004|NOT COMPLETED|Overall Study||2
6583610|NCT01937871|7507686|FG000|STARTED|Overall Study||361
6583611|NCT01937871|7507687|FG001|STARTED|Overall Study||363
6583612|NCT01937871|7507688|FG002|STARTED|Overall Study||185
6583613|NCT01937871|7507686|FG000|Received at Least One Dose of Study Drug|Overall Study||361
6583614|NCT01937871|7507687|FG001|Received at Least One Dose of Study Drug|Overall Study||362
6583615|NCT01937871|7507688|FG002|Received at Least One Dose of Study Drug|Overall Study||185
6583616|NCT01937871|7507686|FG000|COMPLETED|Overall Study||337
6583617|NCT01937871|7507687|FG001|COMPLETED|Overall Study||346
6583618|NCT01937871|7507688|FG002|COMPLETED|Overall Study||174
6583619|NCT01937871|7507686|FG000|NOT COMPLETED|Overall Study||24
6583620|NCT01937871|7507687|FG001|NOT COMPLETED|Overall Study||17
6583621|NCT01937871|7507688|FG002|NOT COMPLETED|Overall Study||11
6583622|NCT01937884|7507701|FG000|STARTED|Overall Study||7
6583623|NCT01937884|7507702|FG001|STARTED|Overall Study||11
6583624|NCT01937884|7507701|FG000|COMPLETED|Overall Study||6
6583625|NCT01937884|7507702|FG001|COMPLETED|Overall Study||11
6583626|NCT01937884|7507701|FG000|NOT COMPLETED|Overall Study||1
6583627|NCT01937884|7507702|FG001|NOT COMPLETED|Overall Study||0
6583628|NCT01937975|7507713|FG000|STARTED|Overall Study||8
6583629|NCT01937975|7507714|FG001|STARTED|Overall Study||8
6583630|NCT01937975|7507715|FG002|STARTED|Overall Study||8
6583631|NCT01937975|7507713|FG000|COMPLETED|Overall Study||8
6583632|NCT01937975|7507714|FG001|COMPLETED|Overall Study||8
6583633|NCT01937975|7507715|FG002|COMPLETED|Overall Study||8
6583634|NCT01937975|7507713|FG000|NOT COMPLETED|Overall Study||0
6583635|NCT01937975|7507714|FG001|NOT COMPLETED|Overall Study||0
6583636|NCT01937975|7507715|FG002|NOT COMPLETED|Overall Study||0
6583637|NCT01938001|7507729|FG000|STARTED|Overall Study||178
6583638|NCT01938001|7507730|FG001|STARTED|Overall Study||180
6583639|NCT01938001|7507729|FG000|Participants Received Treatment|Overall Study||176
6583640|NCT01938001|7507730|FG001|Participants Received Treatment|Overall Study||180
6583641|NCT01938001|7507729|FG000|Completed Treatment|Overall Study||124
6583642|NCT01938001|7507730|FG001|Completed Treatment|Overall Study||110
6583643|NCT01938001|7507729|FG000|COMPLETED|Overall Study||135
6583644|NCT01938001|7507730|FG001|COMPLETED|Overall Study||133
6583645|NCT01938001|7507729|FG000|NOT COMPLETED|Overall Study||43
6583646|NCT01938001|7507730|FG001|NOT COMPLETED|Overall Study||47
6583647|NCT01938040|7507738|FG000|STARTED|Overall Study||28
6583648|NCT01938040|7507739|FG001|STARTED|Overall Study||27
6583649|NCT01938040|7507738|FG000|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
6583650|NCT01938040|7507739|FG001|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
6583651|NCT01938040|7507738|FG000|Behavior Metrics|Overall Study||28
6583652|NCT01938040|7507739|FG001|Behavior Metrics|Overall Study||27
6583653|NCT01938040|7507738|FG000|COMPLETED|Overall Study||28
6583654|NCT01938040|7507739|FG001|COMPLETED|Overall Study||27
6583655|NCT01938040|7507738|FG000|NOT COMPLETED|Overall Study||0
6583656|NCT01938040|7507739|FG001|NOT COMPLETED|Overall Study||0
6583657|NCT01938066|7507753|FG000|STARTED|Overall Study||15
6583658|NCT01938066|7507754|FG001|STARTED|Overall Study||15
6583659|NCT01938066|7507753|FG000|COMPLETED|Overall Study||14
6583660|NCT01938066|7507754|FG001|COMPLETED|Overall Study||13
6583661|NCT01938066|7507753|FG000|NOT COMPLETED|Overall Study||1
6583662|NCT01938066|7507754|FG001|NOT COMPLETED|Overall Study||2
6583663|NCT01938079|7507762|FG000|STARTED|Overall Study||10
6583664|NCT01938079|7507763|FG001|STARTED|Overall Study||10
6583665|NCT01938079|7507762|FG000|COMPLETED|Overall Study||10
6583666|NCT01938079|7507763|FG001|COMPLETED|Overall Study||10
6583667|NCT01938079|7507762|FG000|NOT COMPLETED|Overall Study||0
6583668|NCT01938079|7507763|FG001|NOT COMPLETED|Overall Study||0
6583669|NCT01938170|7507769|FG000|STARTED|Overall Study||41
6583670|NCT01938170|7507769|FG000|COMPLETED|Overall Study||41
6583671|NCT01938170|7507769|FG000|NOT COMPLETED|Overall Study||0
6583672|NCT01938378|7507776|FG000|STARTED|Overall Study||41
6583673|NCT01938378|7507776|FG000|COMPLETED|Overall Study||41
6583674|NCT01938378|7507776|FG000|NOT COMPLETED|Overall Study||0
6583675|NCT01938391|7507794|FG000|STARTED|Baseline||25
6583676|NCT01938391|7507794|FG000|COMPLETED|Baseline||25
6583677|NCT01938391|7507794|FG000|NOT COMPLETED|Baseline||0
6583678|NCT01938391|7507794|FG000|STARTED|2 Week Follow up||25
6583679|NCT01938391|7507794|FG000|COMPLETED|2 Week Follow up||25
6583680|NCT01938391|7507794|FG000|NOT COMPLETED|2 Week Follow up||0
6583681|NCT01938391|7507794|FG000|STARTED|6 Month Follow up||25
6583682|NCT01938391|7507794|FG000|COMPLETED|6 Month Follow up||24
6583683|NCT01938391|7507794|FG000|NOT COMPLETED|6 Month Follow up||1
6583684|NCT01938391|7507794|FG000|STARTED|12 Month Follow up||24
6583685|NCT01938391|7507794|FG000|COMPLETED|12 Month Follow up||22
6583686|NCT01938391|7507794|FG000|NOT COMPLETED|12 Month Follow up||2
6583687|NCT01938430|7507812|FG000|STARTED|Overall Study||30
6583688|NCT01938430|7507813|FG001|STARTED|Overall Study||29
6583689|NCT01938430|7507814|FG002|STARTED|Overall Study||23
6583690|NCT01938430|7507815|FG003|STARTED|Overall Study||26
6583691|NCT01938430|7507816|FG004|STARTED|Overall Study||55
6583692|NCT01938430|7507817|FG005|STARTED|Overall Study||56
6583693|NCT01938430|7507818|FG006|STARTED|Overall Study||26
6583694|NCT01938430|7507819|FG007|STARTED|Overall Study||25
6583695|NCT01938430|7507820|FG008|STARTED|Overall Study||26
6583696|NCT01938430|7507821|FG009|STARTED|Overall Study||26
6583697|NCT01938430|7507822|FG010|STARTED|Overall Study||6
6583698|NCT01938430|7507823|FG011|STARTED|Overall Study||4
6583699|NCT01938430|7507824|FG012|STARTED|Overall Study||4
6583700|NCT01938430|7507825|FG013|STARTED|Overall Study||3
6583701|NCT01938430|7507812|FG000|COMPLETED|Overall Study||26
6583702|NCT01938430|7507813|FG001|COMPLETED|Overall Study||26
6583703|NCT01938430|7507814|FG002|COMPLETED|Overall Study||18
6583704|NCT01938430|7507815|FG003|COMPLETED|Overall Study||24
6583705|NCT01938430|7507816|FG004|COMPLETED|Overall Study||55
6583706|NCT01938430|7507817|FG005|COMPLETED|Overall Study||55
6583707|NCT01938430|7507818|FG006|COMPLETED|Overall Study||24
6583708|NCT01938430|7507819|FG007|COMPLETED|Overall Study||24
6583709|NCT01938430|7507820|FG008|COMPLETED|Overall Study||22
6583710|NCT01938430|7507821|FG009|COMPLETED|Overall Study||23
6583711|NCT01938430|7507822|FG010|COMPLETED|Overall Study||3
6583712|NCT01938430|7507823|FG011|COMPLETED|Overall Study||3
6583713|NCT01938430|7507824|FG012|COMPLETED|Overall Study||4
6583714|NCT01938430|7507825|FG013|COMPLETED|Overall Study||2
6583715|NCT01938430|7507812|FG000|NOT COMPLETED|Overall Study||4
6583716|NCT01938430|7507813|FG001|NOT COMPLETED|Overall Study||3
6583717|NCT01938430|7507814|FG002|NOT COMPLETED|Overall Study||5
6583718|NCT01938430|7507815|FG003|NOT COMPLETED|Overall Study||2
6583719|NCT01938430|7507816|FG004|NOT COMPLETED|Overall Study||0
6583720|NCT01938430|7507817|FG005|NOT COMPLETED|Overall Study||1
6583721|NCT01938430|7507818|FG006|NOT COMPLETED|Overall Study||2
6583722|NCT01938430|7507819|FG007|NOT COMPLETED|Overall Study||1
6583723|NCT01938430|7507820|FG008|NOT COMPLETED|Overall Study||4
6583724|NCT01938430|7507821|FG009|NOT COMPLETED|Overall Study||3
6583725|NCT01938430|7507822|FG010|NOT COMPLETED|Overall Study||3
6583726|NCT01938430|7507823|FG011|NOT COMPLETED|Overall Study||1
6583727|NCT01938430|7507824|FG012|NOT COMPLETED|Overall Study||0
6583728|NCT01938430|7507825|FG013|NOT COMPLETED|Overall Study||1
6583729|NCT01938573|7507880|FG000|STARTED|Overall Study||15
6583730|NCT01938573|7507881|FG001|STARTED|Overall Study||6
6583731|NCT01938573|7507880|FG000|COMPLETED|Overall Study||13
6583732|NCT01938573|7507881|FG001|COMPLETED|Overall Study||6
6583733|NCT01938573|7507880|FG000|NOT COMPLETED|Overall Study||2
6583734|NCT01938573|7507881|FG001|NOT COMPLETED|Overall Study||0
6583735|NCT01938625|7507888|FG000|STARTED|Overall Study||10
6583736|NCT01938625|7507889|FG001|STARTED|Overall Study||25
6583737|NCT01938625|7507888|FG000|COMPLETED|Overall Study||10
6583738|NCT01938625|7507889|FG001|COMPLETED|Overall Study||23
6583739|NCT01938625|7507888|FG000|NOT COMPLETED|Overall Study||0
6583740|NCT01938625|7507889|FG001|NOT COMPLETED|Overall Study||2
6583741|NCT01938664|7507897|FG000|STARTED|Overall Study||20
6583742|NCT01938664|7507898|FG001|STARTED|Overall Study||10
6583743|NCT01938664|7507897|FG000|COMPLETED|Overall Study||5
6583744|NCT01938664|7507898|FG001|COMPLETED|Overall Study||0
6583745|NCT01938664|7507897|FG000|NOT COMPLETED|Overall Study||15
6583746|NCT01938664|7507898|FG001|NOT COMPLETED|Overall Study||10
6583747|NCT01938846|7507907|FG000|STARTED|Overall Study||41
6583748|NCT01938846|7507908|FG001|STARTED|Overall Study||25
6583749|NCT01938846|7507909|FG002|STARTED|Overall Study||24
6583750|NCT01938846|7507907|FG000|COMPLETED|Overall Study||0
6583751|NCT01938846|7507908|FG001|COMPLETED|Overall Study||0
6583752|NCT01938846|7507909|FG002|COMPLETED|Overall Study||0
6583753|NCT01938846|7507907|FG000|NOT COMPLETED|Overall Study||41
6583754|NCT01938846|7507908|FG001|NOT COMPLETED|Overall Study||25
6583755|NCT01938846|7507909|FG002|NOT COMPLETED|Overall Study||24
6583756|NCT01938989|7507950|FG000|STARTED|Overall Study||77
6583757|NCT01938989|7507951|FG001|STARTED|Overall Study||77
6583758|NCT01938989|7507950|FG000|COMPLETED|Overall Study||77
6583759|NCT01938989|7507951|FG001|COMPLETED|Overall Study||77
6583760|NCT01938989|7507950|FG000|NOT COMPLETED|Overall Study||0
6583761|NCT01938989|7507951|FG001|NOT COMPLETED|Overall Study||0
6583762|NCT01939002|7507959|FG000|STARTED|Overall Study||103
6583763|NCT01939002|7507960|FG001|STARTED|Overall Study||98
6583764|NCT01939002|7507959|FG000|COMPLETED|Overall Study||84
6583765|NCT01939002|7507960|FG001|COMPLETED|Overall Study||80
6583766|NCT01939002|7507959|FG000|NOT COMPLETED|Overall Study||19
6583767|NCT01939002|7507960|FG001|NOT COMPLETED|Overall Study||18
6583768|NCT01939028|7507971|FG000|STARTED|Overall Study||58
6583769|NCT01939028|7507971|FG000|COMPLETED|Overall Study||46
6583770|NCT01939028|7507971|FG000|NOT COMPLETED|Overall Study||12
6583771|NCT01939145|7507977|FG000|STARTED|Overall Study||49
6583772|NCT01939145|7507978|FG001|STARTED|Overall Study||51
6583773|NCT01939145|7507977|FG000|COMPLETED|Overall Study||47
6583774|NCT01939145|7507978|FG001|COMPLETED|Overall Study||44
6583775|NCT01939145|7507977|FG000|NOT COMPLETED|Overall Study||2
6583776|NCT01939145|7507978|FG001|NOT COMPLETED|Overall Study||7
6583777|NCT01939158|7507988|FG000|STARTED|Overall Study||203
6583778|NCT01939158|7507989|FG001|STARTED|Overall Study||198
6583779|NCT01939158|7507990|FG002|STARTED|Overall Study||201
6583780|NCT01939158|7507991|FG003|STARTED|Overall Study||201
6583781|NCT01939158|7507988|FG000|Vaccinated|Overall Study||203
6583782|NCT01939158|7507989|FG001|Vaccinated|Overall Study||197
6583783|NCT01939158|7507990|FG002|Vaccinated|Overall Study||201
6583784|NCT01939158|7507991|FG003|Vaccinated|Overall Study||201
6583785|NCT01939158|7507988|FG000|COMPLETED|Overall Study||156
6583786|NCT01939158|7507989|FG001|COMPLETED|Overall Study||146
6583787|NCT01939158|7507990|FG002|COMPLETED|Overall Study||160
6583788|NCT01939158|7507991|FG003|COMPLETED|Overall Study||157
6583789|NCT01939158|7507988|FG000|NOT COMPLETED|Overall Study||47
6583790|NCT01939158|7507989|FG001|NOT COMPLETED|Overall Study||52
6583791|NCT01939158|7507990|FG002|NOT COMPLETED|Overall Study||41
6583792|NCT01939158|7507991|FG003|NOT COMPLETED|Overall Study||44
6583793|NCT01939197|7508012|FG000|STARTED|Overall Study||31
6583794|NCT01939197|7508013|FG001|STARTED|Overall Study||32
6583795|NCT01939197|7508014|FG002|STARTED|Overall Study||10
6583796|NCT01939197|7508015|FG003|STARTED|Overall Study||12
6583797|NCT01939197|7508016|FG004|STARTED|Overall Study||200
6583798|NCT01939197|7508017|FG005|STARTED|Overall Study||5
6583799|NCT01939197|7508018|FG006|STARTED|Overall Study||28
6583800|NCT01939197|7508012|FG000|COMPLETED|Overall Study||30
6583801|NCT01939197|7508013|FG001|COMPLETED|Overall Study||31
6583802|NCT01939197|7508014|FG002|COMPLETED|Overall Study||10
6583803|NCT01939197|7508015|FG003|COMPLETED|Overall Study||11
6583804|NCT01939197|7508016|FG004|COMPLETED|Overall Study||196
6583805|NCT01939197|7508017|FG005|COMPLETED|Overall Study||4
6583806|NCT01939197|7508018|FG006|COMPLETED|Overall Study||26
6583807|NCT01939197|7508012|FG000|NOT COMPLETED|Overall Study||1
6583808|NCT01939197|7508013|FG001|NOT COMPLETED|Overall Study||1
6583809|NCT01939197|7508014|FG002|NOT COMPLETED|Overall Study||0
6583810|NCT01939197|7508015|FG003|NOT COMPLETED|Overall Study||1
6583811|NCT01939197|7508016|FG004|NOT COMPLETED|Overall Study||4
6583812|NCT01939197|7508017|FG005|NOT COMPLETED|Overall Study||1
6583813|NCT01939197|7508018|FG006|NOT COMPLETED|Overall Study||2
6583814|NCT01939288|7508050|FG000|STARTED|Overall Study||5
6583815|NCT01939288|7508051|FG001|STARTED|Overall Study||5
6583816|NCT01939288|7508050|FG000|COMPLETED|Overall Study||5
6583817|NCT01939288|7508051|FG001|COMPLETED|Overall Study||5
6583818|NCT01939288|7508050|FG000|NOT COMPLETED|Overall Study||0
6583819|NCT01939288|7508051|FG001|NOT COMPLETED|Overall Study||0
6583820|NCT01939301|7508058|FG000|STARTED|Overall Study||39
6583821|NCT01939301|7508059|FG001|STARTED|Overall Study||39
6583822|NCT01939301|7508058|FG000|COMPLETED|Overall Study||38
6583823|NCT01939301|7508059|FG001|COMPLETED|Overall Study||38
6583824|NCT01939301|7508058|FG000|NOT COMPLETED|Overall Study||1
6583825|NCT01939301|7508059|FG001|NOT COMPLETED|Overall Study||1
6583826|NCT01939314|7508067|FG000|STARTED|Overall Study||45
6583827|NCT01939314|7508068|FG001|STARTED|Overall Study||48
6583828|NCT01939314|7508067|FG000|15 Minute Endpoint|Overall Study||41
6583829|NCT01939314|7508068|FG001|15 Minute Endpoint|Overall Study||46
6583830|NCT01939314|7508067|FG000|24 Hour Endpoint|Overall Study||36
6583831|NCT01939314|7508068|FG001|24 Hour Endpoint|Overall Study||40
6583832|NCT01939314|7508067|FG000|COMPLETED|Overall Study||36
6583833|NCT01939314|7508068|FG001|COMPLETED|Overall Study||40
6583834|NCT01939314|7508067|FG000|NOT COMPLETED|Overall Study||9
6583835|NCT01939314|7508068|FG001|NOT COMPLETED|Overall Study||8
6583836|NCT01939353|7508076|FG000|STARTED|Placebo Run-in (1 Week)||45
6583837|NCT01939353|7508076|FG000|COMPLETED|Placebo Run-in (1 Week)||41
6583838|NCT01939353|7508076|FG000|NOT COMPLETED|Placebo Run-in (1 Week)||4
6583839|NCT01939353|7508076|FG000|STARTED|CTN SR Treatment Phase (4 Weeks)||41
6583840|NCT01939353|7508076|FG000|COMPLETED|CTN SR Treatment Phase (4 Weeks)||37
6583841|NCT01939353|7508076|FG000|NOT COMPLETED|CTN SR Treatment Phase (4 Weeks)||4
6583842|NCT01939366|7508085|FG000|STARTED|Overall Study||66
6583843|NCT01939366|7508086|FG001|STARTED|Overall Study||64
6583844|NCT01939366|7508087|FG002|STARTED|Overall Study||65
6583845|NCT01939366|7508088|FG003|STARTED|Overall Study||68
6583846|NCT01939366|7508089|FG004|STARTED|Overall Study||66
6583847|NCT01939366|7508085|FG000|Allocated Set Excl. Non-compliant Sites|Overall Study||64
6583848|NCT01939366|7508086|FG001|Allocated Set Excl. Non-compliant Sites|Overall Study||61
6583849|NCT01939366|7508087|FG002|Allocated Set Excl. Non-compliant Sites|Overall Study||63
6583850|NCT01939366|7508088|FG003|Allocated Set Excl. Non-compliant Sites|Overall Study||65
6583851|NCT01939366|7508089|FG004|Allocated Set Excl. Non-compliant Sites|Overall Study||63
6583852|NCT01939366|7508085|FG000|Safety Set|Overall Study||64
6583853|NCT01939366|7508086|FG001|Safety Set|Overall Study||61
6583854|NCT01939366|7508087|FG002|Safety Set|Overall Study||62
6583855|NCT01939366|7508088|FG003|Safety Set|Overall Study||65
6583856|NCT01939366|7508089|FG004|Safety Set|Overall Study||62
6583857|NCT01939366|7508085|FG000|Full Analysis Set|Overall Study||64
6583858|NCT01939366|7508086|FG001|Full Analysis Set|Overall Study||60
6583859|NCT01939366|7508087|FG002|Full Analysis Set|Overall Study||61
6583860|NCT01939366|7508088|FG003|Full Analysis Set|Overall Study||65
6583861|NCT01939366|7508089|FG004|Full Analysis Set|Overall Study||62
6583862|NCT01939366|7508085|FG000|Per Protocol Set|Overall Study||58
6583863|NCT01939366|7508086|FG001|Per Protocol Set|Overall Study||55
6583864|NCT01939366|7508087|FG002|Per Protocol Set|Overall Study||50
6583865|NCT01939366|7508088|FG003|Per Protocol Set|Overall Study||51
6583866|NCT01939366|7508089|FG004|Per Protocol Set|Overall Study||49
6583867|NCT01939366|7508085|FG000|COMPLETED|Overall Study||52
6583868|NCT01939366|7508086|FG001|COMPLETED|Overall Study||41
6583869|NCT01939366|7508087|FG002|COMPLETED|Overall Study||27
6583870|NCT01939366|7508088|FG003|COMPLETED|Overall Study||51
6583871|NCT01939366|7508089|FG004|COMPLETED|Overall Study||48
6583872|NCT01939366|7508085|FG000|NOT COMPLETED|Overall Study||14
6583873|NCT01939366|7508086|FG001|NOT COMPLETED|Overall Study||23
6583874|NCT01939366|7508087|FG002|NOT COMPLETED|Overall Study||38
6583875|NCT01939366|7508088|FG003|NOT COMPLETED|Overall Study||17
6583876|NCT01939366|7508089|FG004|NOT COMPLETED|Overall Study||18
6583877|NCT01939405|7508103|FG000|STARTED|Overall Study||30
6583878|NCT01939405|7508104|FG001|STARTED|Overall Study||30
6583879|NCT01939405|7508103|FG000|COMPLETED|Overall Study||27
6583880|NCT01939405|7508104|FG001|COMPLETED|Overall Study||28
6583881|NCT01939405|7508103|FG000|NOT COMPLETED|Overall Study||3
6583882|NCT01939405|7508104|FG001|NOT COMPLETED|Overall Study||2
6583883|NCT01939496|7508113|FG000|STARTED|Overall Study||56
6583884|NCT01939496|7508114|FG001|STARTED|Overall Study||57
6583885|NCT01939496|7508115|FG002|STARTED|Overall Study||56
6583886|NCT01939496|7508113|FG000|COMPLETED|Overall Study||47
6583887|NCT01939496|7508114|FG001|COMPLETED|Overall Study||54
6583888|NCT01939496|7508115|FG002|COMPLETED|Overall Study||54
6583889|NCT01939496|7508113|FG000|NOT COMPLETED|Overall Study||9
6583890|NCT01939496|7508114|FG001|NOT COMPLETED|Overall Study||3
6583891|NCT01939496|7508115|FG002|NOT COMPLETED|Overall Study||2
6583892|NCT01939548|7508126|FG000|STARTED|Overall Study||78
6583893|NCT01939548|7508127|FG001|STARTED|Overall Study||82
6583894|NCT01939548|7508128|FG002|STARTED|Overall Study||80
6583895|NCT01939548|7508126|FG000|COMPLETED|Overall Study||41
6583896|NCT01939548|7508127|FG001|COMPLETED|Overall Study||33
6583897|NCT01939548|7508128|FG002|COMPLETED|Overall Study||50
6583898|NCT01939548|7508126|FG000|NOT COMPLETED|Overall Study||37
6583899|NCT01939548|7508127|FG001|NOT COMPLETED|Overall Study||49
6583900|NCT01939548|7508128|FG002|NOT COMPLETED|Overall Study||30
6583901|NCT01939899|7508141|FG000|STARTED|Lead-in Dose Finding Phase||3
6583902|NCT01939899|7508142|FG001|STARTED|Lead-in Dose Finding Phase||7
6583903|NCT01939899|7508143|FG002|STARTED|Lead-in Dose Finding Phase||6
6583904|NCT01939899|7508144|FG003|STARTED|Lead-in Dose Finding Phase||0
6583905|NCT01939899|7508145|FG004|STARTED|Lead-in Dose Finding Phase||0
6583906|NCT01939899|7508141|FG000|COMPLETED|Lead-in Dose Finding Phase||1
6583907|NCT01939899|7508142|FG001|COMPLETED|Lead-in Dose Finding Phase||0
6583908|NCT01939899|7508143|FG002|COMPLETED|Lead-in Dose Finding Phase||1
6583909|NCT01939899|7508144|FG003|COMPLETED|Lead-in Dose Finding Phase||0
6583910|NCT01939899|7508145|FG004|COMPLETED|Lead-in Dose Finding Phase||0
6583911|NCT01939899|7508141|FG000|NOT COMPLETED|Lead-in Dose Finding Phase||2
6583912|NCT01939899|7508142|FG001|NOT COMPLETED|Lead-in Dose Finding Phase||7
6583913|NCT01939899|7508143|FG002|NOT COMPLETED|Lead-in Dose Finding Phase||5
6583914|NCT01939899|7508144|FG003|NOT COMPLETED|Lead-in Dose Finding Phase||0
6583915|NCT01939899|7508145|FG004|NOT COMPLETED|Lead-in Dose Finding Phase||0
6583916|NCT01939899|7508141|FG000|STARTED|Phase 2||0
6583917|NCT01939899|7508142|FG001|STARTED|Phase 2||0
6583918|NCT01939899|7508143|FG002|STARTED|Phase 2||0
6583919|NCT01939899|7508144|FG003|STARTED|Phase 2||12
6583920|NCT01939899|7508145|FG004|STARTED|Phase 2||1
6583921|NCT01939899|7508141|FG000|COMPLETED|Phase 2||0
6583922|NCT01939899|7508142|FG001|COMPLETED|Phase 2||0
6583923|NCT01939899|7508143|FG002|COMPLETED|Phase 2||0
6583924|NCT01939899|7508144|FG003|COMPLETED|Phase 2||1
6583925|NCT01939899|7508145|FG004|COMPLETED|Phase 2||0
6583926|NCT01939899|7508141|FG000|NOT COMPLETED|Phase 2||0
6583927|NCT01939899|7508142|FG001|NOT COMPLETED|Phase 2||0
6583928|NCT01939899|7508143|FG002|NOT COMPLETED|Phase 2||0
6583929|NCT01939899|7508144|FG003|NOT COMPLETED|Phase 2||11
6583930|NCT01939899|7508145|FG004|NOT COMPLETED|Phase 2||1
6583931|NCT01939938|7508163|FG000|STARTED|Overall Study||10
6583932|NCT01939938|7508163|FG000|COMPLETED|Overall Study||10
6583933|NCT01939938|7508163|FG000|NOT COMPLETED|Overall Study||0
6583934|NCT01939977|7508171|FG000|STARTED|Overall Study||46
6583935|NCT01939977|7508172|FG001|STARTED|Overall Study|48 patients randomized but 1 did not meet inclusion criteria. 47 patients analyzed.|48
6583936|NCT01939977|7508171|FG000|COMPLETED|Overall Study||37
6583937|NCT01939977|7508172|FG001|COMPLETED|Overall Study||41
6583938|NCT01939977|7508171|FG000|NOT COMPLETED|Overall Study||9
6583939|NCT01939977|7508172|FG001|NOT COMPLETED|Overall Study||7
6583940|NCT01940120|7508178|FG000|STARTED|Overall Study||78
6583941|NCT01940120|7508178|FG000|COMPLETED|Overall Study||30
6583942|NCT01940120|7508178|FG000|NOT COMPLETED|Overall Study||48
6583943|NCT01940146|7508187|FG000|STARTED|Overall Study||56
6583944|NCT01940146|7508188|FG001|STARTED|Overall Study||55
6583945|NCT01940146|7508189|FG002|STARTED|Overall Study||56
6583946|NCT01940146|7508190|FG003|STARTED|Overall Study||55
6583947|NCT01940146|7508187|FG000|COMPLETED|Overall Study||55
6583948|NCT01940146|7508188|FG001|COMPLETED|Overall Study||55
6583949|NCT01940146|7508189|FG002|COMPLETED|Overall Study||55
6583950|NCT01940146|7508190|FG003|COMPLETED|Overall Study||53
6583951|NCT01940146|7508187|FG000|NOT COMPLETED|Overall Study||1
6583952|NCT01940146|7508188|FG001|NOT COMPLETED|Overall Study||0
6583953|NCT01940146|7508189|FG002|NOT COMPLETED|Overall Study||1
6583954|NCT01940146|7508190|FG003|NOT COMPLETED|Overall Study||2
6583955|NCT01940276|7508202|FG000|STARTED|Overall Study||50
6583956|NCT01940276|7508203|FG001|STARTED|Overall Study||50
6583957|NCT01940276|7508202|FG000|COMPLETED|Overall Study||50
6583958|NCT01940276|7508203|FG001|COMPLETED|Overall Study||50
6583959|NCT01940276|7508202|FG000|NOT COMPLETED|Overall Study||0
6583960|NCT01940276|7508203|FG001|NOT COMPLETED|Overall Study||0
6583961|NCT01940354|7508211|FG000|STARTED|Overall Study||110
6583962|NCT01940354|7508212|FG001|STARTED|Overall Study||110
6583963|NCT01940354|7508211|FG000|COMPLETED|Overall Study||106
6583964|NCT01940354|7508212|FG001|COMPLETED|Overall Study||108
6583965|NCT01940354|7508211|FG000|NOT COMPLETED|Overall Study||4
6583966|NCT01940354|7508212|FG001|NOT COMPLETED|Overall Study||2
6583967|NCT01940484|7508218|FG000|STARTED|Overall Study||98
6583968|NCT01940484|7508218|FG000|COMPLETED|Overall Study||88
6583969|NCT01940484|7508218|FG000|NOT COMPLETED|Overall Study||10
6583970|NCT01940497|7508224|FG000|STARTED|Overall Study||121
6583971|NCT01940497|7508225|FG001|STARTED|Overall Study||119
6583972|NCT01940497|7508224|FG000|Treated|Overall Study||115
6583973|NCT01940497|7508225|FG001|Treated|Overall Study||113
6583974|NCT01940497|7508224|FG000|Treated: Adjuvant|Overall Study||95
6583975|NCT01940497|7508225|FG001|Treated: Adjuvant|Overall Study||92
6583976|NCT01940497|7508224|FG000|Treated: Neoadjuvant|Overall Study||20
6583977|NCT01940497|7508225|FG001|Treated: Neoadjuvant|Overall Study||21
6583978|NCT01940497|7508224|FG000|COMPLETED|Overall Study||100
6583979|NCT01940497|7508225|FG001|COMPLETED|Overall Study||101
6583980|NCT01940497|7508224|FG000|NOT COMPLETED|Overall Study||21
6583981|NCT01940497|7508225|FG001|NOT COMPLETED|Overall Study||18
6583982|NCT01940510|7508242|FG000|STARTED|Overall Study||24
6583983|NCT01940510|7508242|FG000|COMPLETED|Overall Study||24
6583984|NCT01940510|7508242|FG000|NOT COMPLETED|Overall Study||0
6583985|NCT01940523|7508251|FG000|STARTED|Overall Study||320
6583986|NCT01940523|7508252|FG001|STARTED|Overall Study||320
6583987|NCT01940523|7508251|FG000|COMPLETED|Overall Study||320
6583988|NCT01940523|7508252|FG001|COMPLETED|Overall Study||320
6583989|NCT01940523|7508251|FG000|NOT COMPLETED|Overall Study||0
6583990|NCT01940523|7508252|FG001|NOT COMPLETED|Overall Study||0
6583991|NCT01940705|7508264|FG000|STARTED|Overall Study||66
6583992|NCT01940705|7508265|FG001|STARTED|Overall Study||67
6583993|NCT01940705|7508266|FG002|STARTED|Overall Study||69
6583994|NCT01940705|7508267|FG003|STARTED|Overall Study||67
6583995|NCT01940705|7508264|FG000|COMPLETED|Overall Study||62
6583996|NCT01940705|7508265|FG001|COMPLETED|Overall Study||59
6583997|NCT01940705|7508266|FG002|COMPLETED|Overall Study||61
6583998|NCT01940705|7508267|FG003|COMPLETED|Overall Study||63
6583999|NCT01940705|7508264|FG000|NOT COMPLETED|Overall Study||4
6584000|NCT01940705|7508265|FG001|NOT COMPLETED|Overall Study||8
6584001|NCT01940705|7508266|FG002|NOT COMPLETED|Overall Study||8
6584002|NCT01940705|7508267|FG003|NOT COMPLETED|Overall Study||4
6584003|NCT01940887|7508282|FG000|STARTED|Year 1||322
6584004|NCT01940887|7508283|FG001|STARTED|Year 1||320
6584005|NCT01940887|7508282|FG000|COMPLETED|Year 1||283
6584006|NCT01940887|7508283|FG001|COMPLETED|Year 1||297
6584007|NCT01940887|7508282|FG000|NOT COMPLETED|Year 1||39
6584008|NCT01940887|7508283|FG001|NOT COMPLETED|Year 1||23
6584009|NCT01940887|7508282|FG000|STARTED|Year 2||283
6584010|NCT01940887|7508283|FG001|STARTED|Year 2||297
6584011|NCT01940887|7508282|FG000|COMPLETED|Year 2||66
6584012|NCT01940887|7508283|FG001|COMPLETED|Year 2||75
6584013|NCT01940887|7508282|FG000|NOT COMPLETED|Year 2||217
6584014|NCT01940887|7508283|FG001|NOT COMPLETED|Year 2||222
6584015|NCT01940900|7508291|FG000|STARTED|Overall Study||311
6584016|NCT01940900|7508292|FG001|STARTED|Overall Study||315
6584017|NCT01940900|7508291|FG000|COMPLETED|Overall Study||282
6584018|NCT01940900|7508292|FG001|COMPLETED|Overall Study||284
6584019|NCT01940900|7508291|FG000|NOT COMPLETED|Overall Study||29
6584020|NCT01940900|7508292|FG001|NOT COMPLETED|Overall Study||31
6584021|NCT01940939|7508300|FG000|STARTED|Overall Study||35
6584022|NCT01940939|7508301|FG001|STARTED|Overall Study||35
6584023|NCT01940939|7508300|FG000|COMPLETED|Overall Study||33
6584024|NCT01940939|7508301|FG001|COMPLETED|Overall Study||27
6584025|NCT01940939|7508300|FG000|NOT COMPLETED|Overall Study||2
6584026|NCT01940939|7508301|FG001|NOT COMPLETED|Overall Study||8
6584027|NCT01941030|7508309|FG000|STARTED|Overall Study||25
6584028|NCT01941030|7508310|FG001|STARTED|Overall Study||26
6584029|NCT01941030|7508309|FG000|COMPLETED|Overall Study||12
6584030|NCT01941030|7508310|FG001|COMPLETED|Overall Study||13
6584031|NCT01941030|7508309|FG000|NOT COMPLETED|Overall Study||13
6584032|NCT01941030|7508310|FG001|NOT COMPLETED|Overall Study||13
6584033|NCT01941095|7508316|FG000|STARTED|Overall Study||97
6584034|NCT01941095|7508316|FG000|COMPLETED|Overall Study||41
6584035|NCT01941095|7508316|FG000|NOT COMPLETED|Overall Study||56
6584036|NCT01941186|7508323|FG000|STARTED|Randomization/Allocation to Study Group||31
6584037|NCT01941186|7508324|FG001|STARTED|Randomization/Allocation to Study Group||33
6584038|NCT01941186|7508323|FG000|COMPLETED|Randomization/Allocation to Study Group||31
6584039|NCT01941186|7508324|FG001|COMPLETED|Randomization/Allocation to Study Group||33
6584040|NCT01941186|7508323|FG000|NOT COMPLETED|Randomization/Allocation to Study Group||0
6584041|NCT01941186|7508324|FG001|NOT COMPLETED|Randomization/Allocation to Study Group||0
6584042|NCT01941186|7508323|FG000|STARTED|Follow-up||31
6584043|NCT01941186|7508324|FG001|STARTED|Follow-up||33
6584044|NCT01941186|7508323|FG000|COMPLETED|Follow-up||30
6584045|NCT01941186|7508324|FG001|COMPLETED|Follow-up||33
6584046|NCT01941186|7508323|FG000|NOT COMPLETED|Follow-up||1
6584047|NCT01941186|7508324|FG001|NOT COMPLETED|Follow-up||0
6584048|NCT01941472|7508343|FG000|STARTED|Overall Study||40
6584049|NCT01941472|7508343|FG000|COMPLETED|Overall Study||40
6584050|NCT01941472|7508343|FG000|NOT COMPLETED|Overall Study||0
6584051|NCT01941485|7508347|FG000|STARTED|Overall Study||59
6584052|NCT01941485|7508347|FG000|COMPLETED|Overall Study||59
6584053|NCT01941485|7508347|FG000|NOT COMPLETED|Overall Study||0
6584054|NCT01941498|7508369|FG000|STARTED|Overall Study||97
6584055|NCT01941498|7508369|FG000|COMPLETED|Overall Study||96
6584056|NCT01941498|7508369|FG000|NOT COMPLETED|Overall Study||1
6584057|NCT01941537|7508390|FG000|STARTED|Overall Study||40
6584058|NCT01941537|7508391|FG001|STARTED|Overall Study||20
6584059|NCT01941537|7508390|FG000|COMPLETED|Overall Study||36
6584060|NCT01941537|7508391|FG001|COMPLETED|Overall Study||17
6584061|NCT01941537|7508390|FG000|NOT COMPLETED|Overall Study||4
6584062|NCT01941537|7508391|FG001|NOT COMPLETED|Overall Study||3
6584063|NCT01941628|7508400|FG000|STARTED|Overall Study||46
6584064|NCT01941628|7508401|FG001|STARTED|Overall Study||45
6584065|NCT01941628|7508400|FG000|COMPLETED|Overall Study||45
6584066|NCT01941628|7508401|FG001|COMPLETED|Overall Study||45
6584067|NCT01941628|7508400|FG000|NOT COMPLETED|Overall Study||1
6584068|NCT01941628|7508401|FG001|NOT COMPLETED|Overall Study||0
6584069|NCT01941745|7508411|FG000|STARTED|Overall Study||22
6584070|NCT01941745|7508412|FG001|STARTED|Overall Study||22
6584071|NCT01941745|7508413|FG002|STARTED|Overall Study||21
6584072|NCT01941745|7508414|FG003|STARTED|Overall Study||23
6584073|NCT01941745|7508411|FG000|COMPLETED|Overall Study||22
6584074|NCT01941745|7508412|FG001|COMPLETED|Overall Study||22
6584075|NCT01941745|7508413|FG002|COMPLETED|Overall Study||21
6584076|NCT01941745|7508414|FG003|COMPLETED|Overall Study||23
6584077|NCT01941745|7508411|FG000|NOT COMPLETED|Overall Study||0
6584078|NCT01941745|7508412|FG001|NOT COMPLETED|Overall Study||0
6584079|NCT01941745|7508413|FG002|NOT COMPLETED|Overall Study||0
6584080|NCT01941745|7508414|FG003|NOT COMPLETED|Overall Study||0
6584081|NCT01941927|7508429|FG000|STARTED|Overall Study||10
6584082|NCT01941927|7508430|FG001|STARTED|Overall Study||10
6584083|NCT01941927|7508429|FG000|COMPLETED|Overall Study||10
6584084|NCT01941927|7508430|FG001|COMPLETED|Overall Study||10
6584085|NCT01941927|7508429|FG000|NOT COMPLETED|Overall Study||0
6584086|NCT01941927|7508430|FG001|NOT COMPLETED|Overall Study||0
6584087|NCT01941940|7508436|FG000|STARTED|Overall Study||227
6584088|NCT01941940|7508436|FG000|COMPLETED|Overall Study||194
6584089|NCT01941940|7508436|FG000|NOT COMPLETED|Overall Study||33
6584090|NCT01942148|7508440|FG000|STARTED|Overall Study||68
6584091|NCT01942148|7508440|FG000|COMPLETED|Overall Study||41
6584092|NCT01942148|7508440|FG000|NOT COMPLETED|Overall Study||27
6584093|NCT01942161|7508447|FG000|STARTED|Overall Study||35
6584094|NCT01942161|7508448|FG001|STARTED|Overall Study||30
6584095|NCT01942161|7508449|FG002|STARTED|Overall Study||41
6584096|NCT01942161|7508447|FG000|COMPLETED|Overall Study||27
6584097|NCT01942161|7508448|FG001|COMPLETED|Overall Study||24
6584098|NCT01942161|7508449|FG002|COMPLETED|Overall Study||35
6584099|NCT01942161|7508447|FG000|NOT COMPLETED|Overall Study||8
6584100|NCT01942161|7508448|FG001|NOT COMPLETED|Overall Study||6
6584101|NCT01942161|7508449|FG002|NOT COMPLETED|Overall Study||6
6584102|NCT01942486|7508457|FG000|STARTED|Overall Study||35
6584103|NCT01942486|7508457|FG000|COMPLETED|Overall Study||8
6584104|NCT01942486|7508457|FG000|NOT COMPLETED|Overall Study||27
6584105|NCT01942590|7508463|FG000|STARTED|Overall Study||8
6584106|NCT01942590|7508464|FG001|STARTED|Overall Study||5
6659084|NCT02485704|7589780|FG000|STARTED|Overall Study||154
6659085|NCT02485704|7589781|FG001|STARTED|Overall Study||126
6659086|NCT02485704|7589780|FG000|COMPLETED|Overall Study||149
6659087|NCT02485704|7589781|FG001|COMPLETED|Overall Study||118
6659088|NCT02485704|7589780|FG000|NOT COMPLETED|Overall Study||5
6659089|NCT02485704|7589781|FG001|NOT COMPLETED|Overall Study||8
6659090|NCT02485717|7589790|FG000|STARTED|Overall Study||142
6659091|NCT02485717|7589791|FG001|STARTED|Overall Study||129
6659092|NCT02485717|7589792|FG002|STARTED|Overall Study||20
6659093|NCT02485717|7589790|FG000|COMPLETED|Overall Study||136
6659094|NCT02485717|7589791|FG001|COMPLETED|Overall Study||127
6659095|NCT02485717|7589792|FG002|COMPLETED|Overall Study||19
6659096|NCT02485717|7589790|FG000|NOT COMPLETED|Overall Study||6
6659097|NCT02485717|7589791|FG001|NOT COMPLETED|Overall Study||2
6659098|NCT02485717|7589792|FG002|NOT COMPLETED|Overall Study||1
6659099|NCT02485834|7589800|FG000|STARTED|Overall Study||3
6659100|NCT02485834|7589801|FG001|STARTED|Overall Study||2
6659101|NCT02485834|7589800|FG000|COMPLETED|Overall Study||3
6659102|NCT02485834|7589801|FG001|COMPLETED|Overall Study||2
6659103|NCT02485834|7589800|FG000|NOT COMPLETED|Overall Study||0
6659104|NCT02485834|7589801|FG001|NOT COMPLETED|Overall Study||0
6659105|NCT02485912|7589808|FG000|STARTED|Overall Study||20
6659106|NCT02485912|7589809|FG001|STARTED|Overall Study||20
6659107|NCT02485912|7589808|FG000|COMPLETED|Overall Study||20
6659108|NCT02485912|7589809|FG001|COMPLETED|Overall Study||20
6659109|NCT02485912|7589808|FG000|NOT COMPLETED|Overall Study||0
6659110|NCT02485912|7589809|FG001|NOT COMPLETED|Overall Study||0
6659111|NCT02485925|7589815|FG000|STARTED|Overall Study||200
6659112|NCT02485925|7589815|FG000|Safety Population|Overall Study||200
6659113|NCT02485925|7589815|FG000|Intent to Treat (ITT) Population|Overall Study||193
6659114|NCT02485925|7589815|FG000|Per-Protocol Population|Overall Study||166
6659115|NCT02485925|7589815|FG000|COMPLETED|Overall Study||185
6659116|NCT02485925|7589815|FG000|NOT COMPLETED|Overall Study||15
6659117|NCT02485964|7589819|FG000|STARTED|Overall Study||10
6659118|NCT02485964|7589819|FG000|COMPLETED|Overall Study||10
6659119|NCT02485964|7589819|FG000|NOT COMPLETED|Overall Study||0
6584107|NCT01942590|7508463|FG000|COMPLETED|Overall Study||7
6584108|NCT01942590|7508464|FG001|COMPLETED|Overall Study||4
6584109|NCT01942590|7508463|FG000|NOT COMPLETED|Overall Study||1
6737514|NCT03266588|7666796|FG000|Treated|Long-term Treatment Period||1033
6584110|NCT01942590|7508464|FG001|NOT COMPLETED|Overall Study||1
6584111|NCT01942668|7508476|FG000|STARTED|Overall Study||418
6584112|NCT01942668|7508477|FG001|STARTED|Overall Study||426
6584113|NCT01942668|7508478|FG002|STARTED|Overall Study||422
6584114|NCT01942668|7508479|FG003|STARTED|Overall Study||427
6584115|NCT01942668|7508480|FG004|STARTED|Overall Study||152
6584116|NCT01942668|7508476|FG000|COMPLETED|Overall Study||284
6584117|NCT01942668|7508477|FG001|COMPLETED|Overall Study||305
6584118|NCT01942668|7508478|FG002|COMPLETED|Overall Study||312
6584119|NCT01942668|7508479|FG003|COMPLETED|Overall Study||281
6584120|NCT01942668|7508480|FG004|COMPLETED|Overall Study||93
6584121|NCT01942668|7508476|FG000|NOT COMPLETED|Overall Study||134
6584122|NCT01942668|7508477|FG001|NOT COMPLETED|Overall Study||121
6584123|NCT01942668|7508478|FG002|NOT COMPLETED|Overall Study||110
6584124|NCT01942668|7508479|FG003|NOT COMPLETED|Overall Study||146
6584125|NCT01942668|7508480|FG004|NOT COMPLETED|Overall Study||59
6584126|NCT01942694|7508499|FG000|STARTED|Overall Study||1212
6584127|NCT01942694|7508500|FG001|STARTED|Overall Study||1211
6584128|NCT01942694|7508499|FG000|COMPLETED|Overall Study||1211
6584129|NCT01942694|7508500|FG001|COMPLETED|Overall Study||1211
6584130|NCT01942694|7508499|FG000|NOT COMPLETED|Overall Study||1
6584131|NCT01942694|7508500|FG001|NOT COMPLETED|Overall Study||0
6584132|NCT01942707|7508508|FG000|STARTED|Overall Study||23
6659120|NCT02486016|7589823|FG000|STARTED|Overall Study|Same 10 volunteers completed Apotex, Duragesic and Mylan arms of the study; crossover study.|10
6659121|NCT02486016|7589823|FG000|COMPLETED|Overall Study||10
6659122|NCT02486016|7589823|FG000|NOT COMPLETED|Overall Study||0
6659123|NCT02486211|7589833|FG000|STARTED|Overall Study||7
6659124|NCT02486211|7589834|FG001|STARTED|Overall Study||7
6659125|NCT02486211|7589833|FG000|COMPLETED|Overall Study||6
6659126|NCT02486211|7589834|FG001|COMPLETED|Overall Study||7
6659127|NCT02486211|7589833|FG000|NOT COMPLETED|Overall Study||1
6659128|NCT02486211|7589834|FG001|NOT COMPLETED|Overall Study||0
6659129|NCT02486263|7589843|FG000|STARTED|Overall Study||40
6659130|NCT02486263|7589844|FG001|STARTED|Overall Study||36
6659131|NCT02486263|7589843|FG000|COMPLETED|Overall Study||37
6659132|NCT02486263|7589844|FG001|COMPLETED|Overall Study||35
6659133|NCT02486263|7589843|FG000|NOT COMPLETED|Overall Study||3
6659134|NCT02486263|7589844|FG001|NOT COMPLETED|Overall Study||1
6659135|NCT02486302|7589852|FG000|STARTED|Overall Study||1534
6659136|NCT02486302|7589852|FG000|Treated|Overall Study||1523
6659137|NCT02486302|7589852|FG000|COMPLETED|Overall Study||858
6659138|NCT02486302|7589852|FG000|NOT COMPLETED|Overall Study||676
6659139|NCT02486328|7589867|FG000|STARTED|Overall Study||52
6659140|NCT02486328|7589868|FG001|STARTED|Overall Study||51
6659141|NCT02486328|7589867|FG000|COMPLETED|Overall Study||50
6659142|NCT02486328|7589868|FG001|COMPLETED|Overall Study||50
6659143|NCT02486328|7589867|FG000|NOT COMPLETED|Overall Study||2
6659144|NCT02486328|7589868|FG001|NOT COMPLETED|Overall Study||1
6659145|NCT02486406|7589878|FG000|STARTED|Overall Study||12
6659146|NCT02486406|7589879|FG001|STARTED|Overall Study||26
6659147|NCT02486406|7589880|FG002|STARTED|Overall Study||12
6659148|NCT02486406|7589881|FG003|STARTED|Overall Study||14
6659149|NCT02486406|7589878|FG000|COMPLETED|Overall Study||10
6659150|NCT02486406|7589879|FG001|COMPLETED|Overall Study||23
6659151|NCT02486406|7589880|FG002|COMPLETED|Overall Study||10
6659152|NCT02486406|7589881|FG003|COMPLETED|Overall Study||10
6659153|NCT02486406|7589878|FG000|NOT COMPLETED|Overall Study||2
6659154|NCT02486406|7589879|FG001|NOT COMPLETED|Overall Study||3
6659155|NCT02486406|7589880|FG002|NOT COMPLETED|Overall Study||2
6659156|NCT02486406|7589881|FG003|NOT COMPLETED|Overall Study||4
6659157|NCT02486588|7589919|FG000|STARTED|Overall Study||1188
6659158|NCT02486588|7589920|FG001|STARTED|Overall Study||1252
6659159|NCT02486588|7589921|FG002|STARTED|Overall Study||1220
6659160|NCT02486588|7589922|FG003|STARTED|Overall Study||1206
6659161|NCT02486588|7589923|FG004|STARTED|Overall Study||1243
6659162|NCT02486588|7589924|FG005|STARTED|Overall Study||1205
6659163|NCT02486588|7589919|FG000|COMPLETED|Overall Study||450
6659164|NCT02486588|7589920|FG001|COMPLETED|Overall Study||502
6659165|NCT02486588|7589921|FG002|COMPLETED|Overall Study||465
6659166|NCT02486588|7589922|FG003|COMPLETED|Overall Study||468
6659167|NCT02486588|7589923|FG004|COMPLETED|Overall Study||497
6659168|NCT02486588|7589924|FG005|COMPLETED|Overall Study||459
6659169|NCT02486588|7589919|FG000|NOT COMPLETED|Overall Study||738
6659170|NCT02486588|7589920|FG001|NOT COMPLETED|Overall Study||750
6659171|NCT02486588|7589921|FG002|NOT COMPLETED|Overall Study||755
6659172|NCT02486588|7589922|FG003|NOT COMPLETED|Overall Study||738
6659173|NCT02486588|7589923|FG004|NOT COMPLETED|Overall Study||746
6659174|NCT02486588|7589924|FG005|NOT COMPLETED|Overall Study||746
6659175|NCT02486627|7589945|FG000|STARTED|Overall Study||306
6659176|NCT02486627|7589946|FG001|STARTED|Overall Study||303
6659177|NCT02486627|7589945|FG000|COMPLETED|Overall Study||299
6659178|NCT02486627|7589946|FG001|COMPLETED|Overall Study||294
6659179|NCT02486627|7589945|FG000|NOT COMPLETED|Overall Study||7
6659180|NCT02486627|7589946|FG001|NOT COMPLETED|Overall Study||9
6659181|NCT02486653|7589954|FG000|STARTED|Overall Study||76
6659182|NCT02486653|7589955|FG001|STARTED|Overall Study||75
6659183|NCT02486653|7589954|FG000|COMPLETED|Overall Study||70
6659184|NCT02486653|7589955|FG001|COMPLETED|Overall Study||71
6659185|NCT02486653|7589954|FG000|NOT COMPLETED|Overall Study||6
6659186|NCT02486653|7589955|FG001|NOT COMPLETED|Overall Study||4
6659187|NCT02486692|7589963|FG000|STARTED|Overall Study||30
6659188|NCT02486692|7589964|FG001|STARTED|Overall Study||30
6659189|NCT02486692|7589963|FG000|COMPLETED|Overall Study||26
6584133|NCT01942707|7508509|FG001|STARTED|Overall Study||23
6584134|NCT01942707|7508508|FG000|COMPLETED|Overall Study||23
6584135|NCT01942707|7508509|FG001|COMPLETED|Overall Study||23
6584136|NCT01942707|7508508|FG000|NOT COMPLETED|Overall Study||0
6584137|NCT01942707|7508509|FG001|NOT COMPLETED|Overall Study||0
6584138|NCT01942720|7508515|FG000|STARTED|Overall Study||74
6584139|NCT01942720|7508515|FG000|COMPLETED|Overall Study||53
6584140|NCT01942720|7508515|FG000|NOT COMPLETED|Overall Study||21
6584141|NCT01942733|7508519|FG000|STARTED|Overall Study||44
6584142|NCT01942733|7508519|FG000|COMPLETED|Overall Study||41
6584143|NCT01942733|7508519|FG000|NOT COMPLETED|Overall Study||3
6584144|NCT01942785|7508523|FG000|STARTED|Overall Study||54
6584145|NCT01942785|7508523|FG000|COMPLETED|Overall Study||50
6584146|NCT01942785|7508523|FG000|NOT COMPLETED|Overall Study||4
6584147|NCT01942993|7508529|FG000|STARTED|Overall Study||3
6659190|NCT02486692|7589964|FG001|COMPLETED|Overall Study||23
6659191|NCT02486692|7589963|FG000|NOT COMPLETED|Overall Study||4
6659192|NCT02486692|7589964|FG001|NOT COMPLETED|Overall Study||7
6659193|NCT02486757|7589970|FG000|STARTED|Overall Study||6
6659194|NCT02486757|7589970|FG000|COMPLETED|Overall Study||5
6659195|NCT02486757|7589970|FG000|NOT COMPLETED|Overall Study||1
6659196|NCT02486796|7589976|FG000|STARTED|Overall Study||3
6659197|NCT02486796|7589977|FG001|STARTED|Overall Study||2
6659198|NCT02486796|7589976|FG000|COMPLETED|Overall Study||1
6584148|NCT01942993|7508529|FG000|COMPLETED|Overall Study||1
6584149|NCT01942993|7508529|FG000|NOT COMPLETED|Overall Study||2
6584150|NCT01943110|7508533|FG000|STARTED|Overall Study||30
6584151|NCT01943110|7508533|FG000|COMPLETED|Overall Study||30
6584152|NCT01943110|7508533|FG000|NOT COMPLETED|Overall Study||0
6584153|NCT01943227|7508551|FG000|STARTED|Overall Study||10
6584154|NCT01943227|7508552|FG001|STARTED|Overall Study||10
6584155|NCT01943227|7508551|FG000|COMPLETED|Overall Study||10
6584156|NCT01943227|7508552|FG001|COMPLETED|Overall Study||10
6584157|NCT01943227|7508551|FG000|NOT COMPLETED|Overall Study||0
6584158|NCT01943227|7508552|FG001|NOT COMPLETED|Overall Study||0
6584159|NCT01943292|7508561|FG000|STARTED|Overall Study||3
6659199|NCT02486796|7589977|FG001|COMPLETED|Overall Study||1
6659200|NCT02486796|7589976|FG000|NOT COMPLETED|Overall Study||2
6659201|NCT02486796|7589977|FG001|NOT COMPLETED|Overall Study||1
6659202|NCT02486939|7589985|FG000|STARTED|Overall Study||225
6659203|NCT02486939|7589986|FG001|STARTED|Overall Study||134
6659204|NCT02486939|7589985|FG000|COMPLETED|Overall Study||224
6659205|NCT02486939|7589986|FG001|COMPLETED|Overall Study||132
6659206|NCT02486939|7589985|FG000|NOT COMPLETED|Overall Study||1
6584160|NCT01943292|7508562|FG001|STARTED|Overall Study||3
6584161|NCT01943292|7508563|FG002|STARTED|Overall Study||3
6584162|NCT01943292|7508561|FG000|Completed Cycle 1|Overall Study||3
6584163|NCT01943292|7508562|FG001|Completed Cycle 1|Overall Study||3
6584164|NCT01943292|7508563|FG002|Completed Cycle 1|Overall Study||3
6584165|NCT01943292|7508561|FG000|Completed Treatment|Overall Study||3
6584166|NCT01943292|7508562|FG001|Completed Treatment|Overall Study||3
6584167|NCT01943292|7508563|FG002|Completed Treatment|Overall Study||3
6584168|NCT01943292|7508561|FG000|Completed Follow-Up|Overall Study||2
6584169|NCT01943292|7508562|FG001|Completed Follow-Up|Overall Study||3
6584170|NCT01943292|7508563|FG002|Completed Follow-Up|Overall Study||3
6584171|NCT01943292|7508561|FG000|COMPLETED|Overall Study||2
6584172|NCT01943292|7508562|FG001|COMPLETED|Overall Study||3
6584173|NCT01943292|7508563|FG002|COMPLETED|Overall Study||3
6584174|NCT01943292|7508561|FG000|NOT COMPLETED|Overall Study||1
6584175|NCT01943292|7508562|FG001|NOT COMPLETED|Overall Study||0
6584176|NCT01943292|7508563|FG002|NOT COMPLETED|Overall Study||0
6584177|NCT01943344|7508571|FG000|STARTED|Overall Study||12
6584178|NCT01943344|7508571|FG000|COMPLETED|Overall Study||9
6584179|NCT01943344|7508571|FG000|NOT COMPLETED|Overall Study||3
6584180|NCT01943435|7508580|FG000|STARTED|Baseline Eligibility and Randomization||88
6584181|NCT01943435|7508581|FG001|STARTED|Baseline Eligibility and Randomization||84
6584182|NCT01943435|7508582|FG002|STARTED|Baseline Eligibility and Randomization||87
6584183|NCT01943435|7508580|FG000|COMPLETED|Baseline Eligibility and Randomization||84
6584184|NCT01943435|7508581|FG001|COMPLETED|Baseline Eligibility and Randomization||72
6584185|NCT01943435|7508582|FG002|COMPLETED|Baseline Eligibility and Randomization||84
6584186|NCT01943435|7508580|FG000|NOT COMPLETED|Baseline Eligibility and Randomization||4
6584187|NCT01943435|7508581|FG001|NOT COMPLETED|Baseline Eligibility and Randomization||12
6584188|NCT01943435|7508582|FG002|NOT COMPLETED|Baseline Eligibility and Randomization||3
6584189|NCT01943435|7508580|FG000|STARTED|Intervention Period||84
6584190|NCT01943435|7508581|FG001|STARTED|Intervention Period||72
6584191|NCT01943435|7508582|FG002|STARTED|Intervention Period||84
6584192|NCT01943435|7508580|FG000|COMPLETED|Intervention Period||81
6584193|NCT01943435|7508581|FG001|COMPLETED|Intervention Period||69
6584194|NCT01943435|7508582|FG002|COMPLETED|Intervention Period||80
6584195|NCT01943435|7508580|FG000|NOT COMPLETED|Intervention Period||3
6584196|NCT01943435|7508581|FG001|NOT COMPLETED|Intervention Period||3
6584197|NCT01943435|7508582|FG002|NOT COMPLETED|Intervention Period||4
6659207|NCT02486939|7589986|FG001|NOT COMPLETED|Overall Study||2
6659208|NCT02486952|7589992|FG000|STARTED|Overall Study||154
6659209|NCT02486952|7589992|FG000|Started Induction Therapy|Overall Study||151
6584198|NCT01943435|7508580|FG000|STARTED|2 Month Follow up||81
6584199|NCT01943435|7508581|FG001|STARTED|2 Month Follow up||69
6584200|NCT01943435|7508582|FG002|STARTED|2 Month Follow up||80
6584201|NCT01943435|7508580|FG000|COMPLETED|2 Month Follow up||79
6584202|NCT01943435|7508581|FG001|COMPLETED|2 Month Follow up||66
6584203|NCT01943435|7508582|FG002|COMPLETED|2 Month Follow up||80
6584204|NCT01943435|7508580|FG000|NOT COMPLETED|2 Month Follow up||2
6584205|NCT01943435|7508581|FG001|NOT COMPLETED|2 Month Follow up||3
6584206|NCT01943435|7508582|FG002|NOT COMPLETED|2 Month Follow up||0
6584207|NCT01943435|7508580|FG000|STARTED|6 Month Follow up||79
6584208|NCT01943435|7508581|FG001|STARTED|6 Month Follow up||66
6584209|NCT01943435|7508582|FG002|STARTED|6 Month Follow up||80
6584210|NCT01943435|7508580|FG000|COMPLETED|6 Month Follow up||67
6584211|NCT01943435|7508581|FG001|COMPLETED|6 Month Follow up||59
6584212|NCT01943435|7508582|FG002|COMPLETED|6 Month Follow up||65
6584213|NCT01943435|7508580|FG000|NOT COMPLETED|6 Month Follow up||12
6584214|NCT01943435|7508581|FG001|NOT COMPLETED|6 Month Follow up||7
6584215|NCT01943435|7508582|FG002|NOT COMPLETED|6 Month Follow up||15
6584216|NCT01943461|7508594|FG000|STARTED|Overall Study||5
6584217|NCT01943461|7508595|FG001|STARTED|Overall Study||6
6584218|NCT01943461|7508596|FG002|STARTED|Overall Study||6
6584219|NCT01943461|7508597|FG003|STARTED|Overall Study||40
6584220|NCT01943461|7508594|FG000|COMPLETED|Overall Study||5
6584221|NCT01943461|7508595|FG001|COMPLETED|Overall Study||6
6584222|NCT01943461|7508596|FG002|COMPLETED|Overall Study||6
6584223|NCT01943461|7508597|FG003|COMPLETED|Overall Study||40
6584224|NCT01943461|7508594|FG000|NOT COMPLETED|Overall Study||0
6584225|NCT01943461|7508595|FG001|NOT COMPLETED|Overall Study||0
6584226|NCT01943461|7508596|FG002|NOT COMPLETED|Overall Study||0
6584227|NCT01943461|7508597|FG003|NOT COMPLETED|Overall Study||0
6584228|NCT01943474|7508609|FG000|STARTED|Overall Study||123
6584229|NCT01943474|7508610|FG001|STARTED|Overall Study||125
6584230|NCT01943474|7508609|FG000|COMPLETED|Overall Study||123
6584231|NCT01943474|7508610|FG001|COMPLETED|Overall Study||125
6584232|NCT01943474|7508609|FG000|NOT COMPLETED|Overall Study||0
6584233|NCT01943474|7508610|FG001|NOT COMPLETED|Overall Study||0
6584234|NCT01943539|7508616|FG000|STARTED|Overall Study||44
6584235|NCT01943539|7508617|FG001|STARTED|Overall Study||40
6584236|NCT01943539|7508616|FG000|COMPLETED|Overall Study||40
6584237|NCT01943539|7508617|FG001|COMPLETED|Overall Study||40
6584238|NCT01943539|7508616|FG000|NOT COMPLETED|Overall Study||4
6584239|NCT01943539|7508617|FG001|NOT COMPLETED|Overall Study||0
6584240|NCT01943552|7508626|FG000|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
6584241|NCT01943552|7508627|FG001|STARTED|Overall Study||94
6584242|NCT01943552|7508626|FG000|COMPLETED|Overall Study||71
6584243|NCT01943552|7508627|FG001|COMPLETED|Overall Study||69
6584244|NCT01943552|7508626|FG000|NOT COMPLETED|Overall Study||25
6584245|NCT01943552|7508627|FG001|NOT COMPLETED|Overall Study||25
6584246|NCT01943565|7508636|FG000|STARTED|Overall Study||11
6584247|NCT01943565|7508637|FG001|STARTED|Overall Study||9
6584248|NCT01943565|7508638|FG002|STARTED|Overall Study||9
6584249|NCT01943565|7508636|FG000|COMPLETED|Overall Study||11
6584250|NCT01943565|7508637|FG001|COMPLETED|Overall Study||9
6584251|NCT01943565|7508638|FG002|COMPLETED|Overall Study||9
6584252|NCT01943565|7508636|FG000|NOT COMPLETED|Overall Study||0
6584253|NCT01943565|7508637|FG001|NOT COMPLETED|Overall Study||0
6584254|NCT01943565|7508638|FG002|NOT COMPLETED|Overall Study||0
6584255|NCT01943591|7508648|FG000|STARTED|Overall Study||104
6584256|NCT01943591|7508649|FG001|STARTED|Overall Study||106
6584257|NCT01943591|7508648|FG000|COMPLETED|Overall Study||99
6584258|NCT01943591|7508649|FG001|COMPLETED|Overall Study||95
6584259|NCT01943591|7508648|FG000|NOT COMPLETED|Overall Study||5
6584260|NCT01943591|7508649|FG001|NOT COMPLETED|Overall Study||11
6584261|NCT01943799|7508659|FG000|STARTED|Overall Study||27
6584262|NCT01943799|7508660|FG001|STARTED|Overall Study||50
6584263|NCT01943799|7508661|FG002|STARTED|Overall Study|1 participant was randomized to OAV + GS-4774 2 YU but received OAV + GS-4774 10 YU.|51
6584264|NCT01943799|7508662|FG003|STARTED|Overall Study||50
6584265|NCT01943799|7508659|FG000|COMPLETED|Overall Study||22
6584266|NCT01943799|7508660|FG001|COMPLETED|Overall Study||47
6584267|NCT01943799|7508661|FG002|COMPLETED|Overall Study||49
6584268|NCT01943799|7508662|FG003|COMPLETED|Overall Study||50
6584269|NCT01943799|7508659|FG000|NOT COMPLETED|Overall Study||5
6584270|NCT01943799|7508660|FG001|NOT COMPLETED|Overall Study||3
6584271|NCT01943799|7508661|FG002|NOT COMPLETED|Overall Study||2
6584272|NCT01943799|7508662|FG003|NOT COMPLETED|Overall Study||0
6584273|NCT01943851|7508690|FG000|STARTED|Part 1 (Up to 86.9 Weeks)||1
6584274|NCT01943851|7508691|FG001|STARTED|Part 1 (Up to 86.9 Weeks)||1
6584275|NCT01943851|7508692|FG002|STARTED|Part 1 (Up to 86.9 Weeks)||1
6584276|NCT01943851|7508693|FG003|STARTED|Part 1 (Up to 86.9 Weeks)||5
6584277|NCT01943851|7508694|FG004|STARTED|Part 1 (Up to 86.9 Weeks)||1
6584278|NCT01943851|7508695|FG005|STARTED|Part 1 (Up to 86.9 Weeks)||4
6584279|NCT01943851|7508696|FG006|STARTED|Part 1 (Up to 86.9 Weeks)||8
6584280|NCT01943851|7508697|FG007|STARTED|Part 1 (Up to 86.9 Weeks)||18
6584281|NCT01943851|7508698|FG008|STARTED|Part 1 (Up to 86.9 Weeks)||3
6584282|NCT01943851|7508699|FG009|STARTED|Part 1 (Up to 86.9 Weeks)||8
6584283|NCT01943851|7508700|FG010|STARTED|Part 1 (Up to 86.9 Weeks)||1
6584284|NCT01943851|7508701|FG011|STARTED|Part 1 (Up to 86.9 Weeks)||7
6584285|NCT01943851|7508702|FG012|STARTED|Part 1 (Up to 86.9 Weeks)||7
6584286|NCT01943851|7508703|FG013|STARTED|Part 1 (Up to 86.9 Weeks)||16
6584287|NCT01943851|7508704|FG014|STARTED|Part 1 (Up to 86.9 Weeks)||6
6584288|NCT01943851|7508705|FG015|STARTED|Part 1 (Up to 86.9 Weeks)||0
6584289|NCT01943851|7508706|FG016|STARTED|Part 1 (Up to 86.9 Weeks)||0
6584290|NCT01943851|7508707|FG017|STARTED|Part 1 (Up to 86.9 Weeks)||0
6584291|NCT01943851|7508690|FG000|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584292|NCT01943851|7508691|FG001|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584293|NCT01943851|7508692|FG002|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584294|NCT01943851|7508693|FG003|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
6584295|NCT01943851|7508694|FG004|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584296|NCT01943851|7508695|FG005|COMPLETED|Part 1 (Up to 86.9 Weeks)||4
6584297|NCT01943851|7508696|FG006|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
6584298|NCT01943851|7508697|FG007|COMPLETED|Part 1 (Up to 86.9 Weeks)||16
6584299|NCT01943851|7508698|FG008|COMPLETED|Part 1 (Up to 86.9 Weeks)||2
6584300|NCT01943851|7508699|FG009|COMPLETED|Part 1 (Up to 86.9 Weeks)||8
6584301|NCT01943851|7508700|FG010|COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584302|NCT01943851|7508701|FG011|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
6584303|NCT01943851|7508702|FG012|COMPLETED|Part 1 (Up to 86.9 Weeks)||7
6584304|NCT01943851|7508703|FG013|COMPLETED|Part 1 (Up to 86.9 Weeks)||15
6584305|NCT01943851|7508704|FG014|COMPLETED|Part 1 (Up to 86.9 Weeks)||6
6584306|NCT01943851|7508705|FG015|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584307|NCT01943851|7508706|FG016|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584308|NCT01943851|7508707|FG017|COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584309|NCT01943851|7508690|FG000|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584310|NCT01943851|7508691|FG001|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584311|NCT01943851|7508692|FG002|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584312|NCT01943851|7508693|FG003|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584313|NCT01943851|7508694|FG004|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584314|NCT01943851|7508695|FG005|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584315|NCT01943851|7508696|FG006|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584316|NCT01943851|7508697|FG007|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||2
6584317|NCT01943851|7508698|FG008|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584318|NCT01943851|7508699|FG009|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584319|NCT01943851|7508700|FG010|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584320|NCT01943851|7508701|FG011|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584321|NCT01943851|7508702|FG012|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584322|NCT01943851|7508703|FG013|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||1
6584323|NCT01943851|7508704|FG014|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584324|NCT01943851|7508705|FG015|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584325|NCT01943851|7508706|FG016|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584326|NCT01943851|7508707|FG017|NOT COMPLETED|Part 1 (Up to 86.9 Weeks)||0
6584327|NCT01943851|7508690|FG000|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584328|NCT01943851|7508691|FG001|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584329|NCT01943851|7508692|FG002|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584330|NCT01943851|7508693|FG003|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584331|NCT01943851|7508694|FG004|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584332|NCT01943851|7508695|FG005|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584333|NCT01943851|7508696|FG006|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584334|NCT01943851|7508697|FG007|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584335|NCT01943851|7508698|FG008|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584336|NCT01943851|7508699|FG009|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584337|NCT01943851|7508700|FG010|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584338|NCT01943851|7508701|FG011|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584339|NCT01943851|7508702|FG012|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584340|NCT01943851|7508703|FG013|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584341|NCT01943851|7508704|FG014|STARTED|Part 2 (Up to 36.4 Weeks)||0
6584342|NCT01943851|7508705|FG015|STARTED|Part 2 (Up to 36.4 Weeks)||7
6584343|NCT01943851|7508706|FG016|STARTED|Part 2 (Up to 36.4 Weeks)||16
6584344|NCT01943851|7508707|FG017|STARTED|Part 2 (Up to 36.4 Weeks)||1
6584345|NCT01943851|7508690|FG000|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584346|NCT01943851|7508691|FG001|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584347|NCT01943851|7508692|FG002|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584348|NCT01943851|7508693|FG003|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584349|NCT01943851|7508694|FG004|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584350|NCT01943851|7508695|FG005|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584351|NCT01943851|7508696|FG006|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584352|NCT01943851|7508697|FG007|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584353|NCT01943851|7508698|FG008|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584354|NCT01943851|7508699|FG009|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584355|NCT01943851|7508700|FG010|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584356|NCT01943851|7508701|FG011|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584357|NCT01943851|7508702|FG012|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584358|NCT01943851|7508703|FG013|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584359|NCT01943851|7508704|FG014|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584360|NCT01943851|7508705|FG015|COMPLETED|Part 2 (Up to 36.4 Weeks)||1
6584361|NCT01943851|7508706|FG016|COMPLETED|Part 2 (Up to 36.4 Weeks)||13
6584362|NCT01943851|7508707|FG017|COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584363|NCT01943851|7508690|FG000|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584364|NCT01943851|7508691|FG001|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584365|NCT01943851|7508692|FG002|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584366|NCT01943851|7508693|FG003|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584367|NCT01943851|7508694|FG004|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584368|NCT01943851|7508695|FG005|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584369|NCT01943851|7508696|FG006|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584370|NCT01943851|7508697|FG007|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584371|NCT01943851|7508698|FG008|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584372|NCT01943851|7508699|FG009|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584373|NCT01943851|7508700|FG010|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584374|NCT01943851|7508701|FG011|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584375|NCT01943851|7508702|FG012|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584376|NCT01943851|7508703|FG013|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584377|NCT01943851|7508704|FG014|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||0
6584378|NCT01943851|7508705|FG015|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||6
6584379|NCT01943851|7508706|FG016|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||3
6584380|NCT01943851|7508707|FG017|NOT COMPLETED|Part 2 (Up to 36.4 Weeks)||1
6584381|NCT01943864|7508748|FG000|STARTED|Overall Study||20
6584382|NCT01943864|7508748|FG000|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
6584383|NCT01943864|7508748|FG000|NOT COMPLETED|Overall Study||0
6584384|NCT01943916|7508752|FG000|STARTED|Overall Study||2105
6584385|NCT01943916|7508752|FG000|COMPLETED|Overall Study||1739
6584386|NCT01943916|7508752|FG000|NOT COMPLETED|Overall Study||366
6584387|NCT01944046|7508763|FG000|STARTED|Randomized to DB||146
6584388|NCT01944046|7508764|FG001|STARTED|Randomized to DB||144
6584389|NCT01944046|7508763|FG000|COMPLETED|Randomized to DB||125
6584390|NCT01944046|7508764|FG001|COMPLETED|Randomized to DB||125
6584391|NCT01944046|7508763|FG000|NOT COMPLETED|Randomized to DB||21
6584392|NCT01944046|7508764|FG001|NOT COMPLETED|Randomized to DB||19
6584393|NCT01944046|7508763|FG000|STARTED|Open Label Eligible and Consented||124
6584394|NCT01944046|7508764|FG001|STARTED|Open Label Eligible and Consented||124
6584395|NCT01944046|7508763|FG000|COMPLETED|Open Label Eligible and Consented||110
6584396|NCT01944046|7508764|FG001|COMPLETED|Open Label Eligible and Consented||116
6584397|NCT01944046|7508763|FG000|NOT COMPLETED|Open Label Eligible and Consented||14
6584398|NCT01944046|7508764|FG001|NOT COMPLETED|Open Label Eligible and Consented||8
6584399|NCT01944098|7508776|FG000|STARTED|Overall Study||10
6584400|NCT01944098|7508777|FG001|STARTED|Overall Study||10
6584401|NCT01944098|7508776|FG000|COMPLETED|Overall Study||9
6584402|NCT01944098|7508777|FG001|COMPLETED|Overall Study||10
6584403|NCT01944098|7508776|FG000|NOT COMPLETED|Overall Study||1
6584404|NCT01944098|7508777|FG001|NOT COMPLETED|Overall Study||0
6584405|NCT01944293|7508785|FG000|STARTED|Overall Study||7
6584406|NCT01944293|7508786|FG001|STARTED|Overall Study||9
6584407|NCT01944293|7508785|FG000|COMPLETED|Overall Study||7
6584408|NCT01944293|7508786|FG001|COMPLETED|Overall Study||9
6584409|NCT01944293|7508785|FG000|NOT COMPLETED|Overall Study||0
6584410|NCT01944293|7508786|FG001|NOT COMPLETED|Overall Study||0
6584411|NCT01944319|7508794|FG000|STARTED|Overall Study||40
6584412|NCT01944319|7508795|FG001|STARTED|Overall Study||39
6584413|NCT01944319|7508794|FG000|COMPLETED|Overall Study||40
6584414|NCT01944319|7508795|FG001|COMPLETED|Overall Study||39
6584415|NCT01944319|7508794|FG000|NOT COMPLETED|Overall Study||0
6584416|NCT01944319|7508795|FG001|NOT COMPLETED|Overall Study||0
6584417|NCT01944345|7508802|FG000|STARTED|Overall Study||69
6584418|NCT01944345|7508802|FG000|COMPLETED|Overall Study||69
6584419|NCT01944345|7508802|FG000|NOT COMPLETED|Overall Study||0
6584420|NCT01944371|7508809|FG000|STARTED|Overall Study||10
6584421|NCT01944371|7508810|FG001|STARTED|Overall Study||10
6584422|NCT01944371|7508811|FG002|STARTED|Overall Study||10
6584423|NCT01944371|7508809|FG000|COMPLETED|Overall Study||10
6584424|NCT01944371|7508810|FG001|COMPLETED|Overall Study||10
6584425|NCT01944371|7508811|FG002|COMPLETED|Overall Study||10
6584426|NCT01944371|7508809|FG000|NOT COMPLETED|Overall Study||0
6584427|NCT01944371|7508810|FG001|NOT COMPLETED|Overall Study||0
6584428|NCT01944371|7508811|FG002|NOT COMPLETED|Overall Study||0
6584429|NCT01944423|7508821|FG000|STARTED|Overall Study||27
6584430|NCT01944423|7508822|FG001|STARTED|Overall Study||26
6584431|NCT01944423|7508821|FG000|End of Treatment|Overall Study||21
6584432|NCT01944423|7508822|FG001|End of Treatment|Overall Study||20
6584433|NCT01944423|7508821|FG000|1-month Follow-up|Overall Study||22
6584434|NCT01944423|7508822|FG001|1-month Follow-up|Overall Study||19
6584435|NCT01944423|7508821|FG000|4-month Follow-up|Overall Study||19
6584436|NCT01944423|7508822|FG001|4-month Follow-up|Overall Study||16
6584437|NCT01944423|7508821|FG000|COMPLETED|Overall Study|6-month follow-up|19
6584438|NCT01944423|7508822|FG001|COMPLETED|Overall Study|6-month follow-up|17
6584439|NCT01944423|7508821|FG000|NOT COMPLETED|Overall Study||8
6584440|NCT01944423|7508822|FG001|NOT COMPLETED|Overall Study||9
6584441|NCT01944462|7508828|FG000|STARTED|PPPP Educational Program||203
6584442|NCT01944462|7508828|FG000|Baseline|PPPP Educational Program||203
6584443|NCT01944462|7508828|FG000|Post-Test|PPPP Educational Program||187
6584444|NCT01944462|7508828|FG000|3 Month Follow-Up|PPPP Educational Program||143
6584445|NCT01944462|7508828|FG000|COMPLETED|PPPP Educational Program||143
6584446|NCT01944462|7508828|FG000|NOT COMPLETED|PPPP Educational Program||60
6584447|NCT01944462|7508828|FG000|STARTED|Optional Vaccination||20
6584448|NCT01944462|7508828|FG000|COMPLETED|Optional Vaccination||20
6584449|NCT01944462|7508828|FG000|NOT COMPLETED|Optional Vaccination||0
6584450|NCT01944631|7508835|FG000|STARTED|Overall Study||100
6584451|NCT01944631|7508836|FG001|STARTED|Overall Study||100
6584452|NCT01944631|7508835|FG000|COMPLETED|Overall Study||96
6584453|NCT01944631|7508836|FG001|COMPLETED|Overall Study||98
6584454|NCT01944631|7508835|FG000|NOT COMPLETED|Overall Study||4
6584455|NCT01944631|7508836|FG001|NOT COMPLETED|Overall Study||2
6584456|NCT01944644|7508844|FG000|STARTED|Overall Study||34
6584457|NCT01944644|7508845|FG001|STARTED|Overall Study||32
6584458|NCT01944644|7508844|FG000|COMPLETED|Overall Study||34
6584459|NCT01944644|7508845|FG001|COMPLETED|Overall Study||32
6584460|NCT01944644|7508844|FG000|NOT COMPLETED|Overall Study||0
6584461|NCT01944644|7508845|FG001|NOT COMPLETED|Overall Study||0
6584462|NCT01944670|7508851|FG000|STARTED|Overall Study||26
6584463|NCT01944670|7508851|FG000|COMPLETED|Overall Study||24
6584464|NCT01944670|7508851|FG000|NOT COMPLETED|Overall Study||2
6584465|NCT01944722|7508857|FG000|STARTED|Overall Study||33858
6584466|NCT01944722|7508857|FG000|COMPLETED|Overall Study||24343
6584467|NCT01944722|7508857|FG000|NOT COMPLETED|Overall Study||9515
6584468|NCT01944774|7508869|FG000|STARTED|Overall Study||69
6584469|NCT01944774|7508870|FG001|STARTED|Overall Study||68
6584470|NCT01944774|7508871|FG002|STARTED|Overall Study||70
6584471|NCT01944774|7508869|FG000|Received Treatment|Overall Study||68
6584472|NCT01944774|7508870|FG001|Received Treatment|Overall Study||67
6584473|NCT01944774|7508871|FG002|Received Treatment|Overall Study||70
6584474|NCT01944774|7508869|FG000|COMPLETED|Overall Study||63
6584475|NCT01944774|7508870|FG001|COMPLETED|Overall Study||60
6584476|NCT01944774|7508871|FG002|COMPLETED|Overall Study||62
6584477|NCT01944774|7508869|FG000|NOT COMPLETED|Overall Study||6
6584478|NCT01944774|7508870|FG001|NOT COMPLETED|Overall Study||8
6584479|NCT01944774|7508871|FG002|NOT COMPLETED|Overall Study||8
6584480|NCT01944839|7508884|FG000|STARTED|Overall Study||309
6584481|NCT01944839|7508885|FG001|STARTED|Overall Study||310
6584482|NCT01944839|7508884|FG000|COMPLETED|Overall Study||287
6584483|NCT01944839|7508885|FG001|COMPLETED|Overall Study||282
6584484|NCT01944839|7508884|FG000|NOT COMPLETED|Overall Study||22
6584485|NCT01944839|7508885|FG001|NOT COMPLETED|Overall Study||28
6584486|NCT01944878|7508893|FG000|STARTED|Overall Study||127
6584487|NCT01944878|7508894|FG001|STARTED|Overall Study||328
6584488|NCT01944878|7508893|FG000|COMPLETED|Overall Study||127
6584489|NCT01944878|7508894|FG001|COMPLETED|Overall Study||328
6584490|NCT01944878|7508893|FG000|NOT COMPLETED|Overall Study||0
6584491|NCT01944878|7508894|FG001|NOT COMPLETED|Overall Study||0
6584492|NCT01944930|7508904|FG000|STARTED|Overall Study||12
6584493|NCT01944930|7508905|FG001|STARTED|Overall Study||11
6584494|NCT01944930|7508904|FG000|COMPLETED|Overall Study||10
6584495|NCT01944930|7508905|FG001|COMPLETED|Overall Study||10
6584496|NCT01944930|7508904|FG000|NOT COMPLETED|Overall Study||2
6584497|NCT01944930|7508905|FG001|NOT COMPLETED|Overall Study||1
6584498|NCT01944969|7508911|FG000|STARTED|Overall Study||26
6584499|NCT01944969|7508911|FG000|COMPLETED|Overall Study||0
6584500|NCT01944969|7508911|FG000|NOT COMPLETED|Overall Study||26
6584501|NCT01945034|7508920|FG000|STARTED|Overall Study||67
6584502|NCT01945034|7508921|FG001|STARTED|Overall Study||85
6584503|NCT01945034|7508922|FG002|STARTED|Overall Study||152
6584504|NCT01945034|7508920|FG000|COMPLETED|Overall Study||66
6584505|NCT01945034|7508921|FG001|COMPLETED|Overall Study||80
6584506|NCT01945034|7508922|FG002|COMPLETED|Overall Study||145
6584507|NCT01945034|7508920|FG000|NOT COMPLETED|Overall Study||1
6584508|NCT01945034|7508921|FG001|NOT COMPLETED|Overall Study||5
6584509|NCT01945034|7508922|FG002|NOT COMPLETED|Overall Study||7
6624295|NCT02215967|7551677|FG000|COMPLETED|Overall Study||3
6624296|NCT02215967|7551678|FG001|COMPLETED|Overall Study||3
6624297|NCT02215967|7551679|FG002|COMPLETED|Overall Study||4
6624298|NCT02215967|7551680|FG003|COMPLETED|Overall Study||16
6624299|NCT02215967|7551677|FG000|NOT COMPLETED|Overall Study||0
6624300|NCT02215967|7551678|FG001|NOT COMPLETED|Overall Study||0
6624301|NCT02215967|7551679|FG002|NOT COMPLETED|Overall Study||1
6624302|NCT02215967|7551680|FG003|NOT COMPLETED|Overall Study||3
6624303|NCT02216071|7551692|FG000|STARTED|Overall Study||254
6624304|NCT02216071|7551693|FG001|STARTED|Overall Study||245
6624305|NCT02216071|7551692|FG000|COMPLETED|Overall Study||239
6624306|NCT02216071|7551693|FG001|COMPLETED|Overall Study||233
6624307|NCT02216071|7551692|FG000|NOT COMPLETED|Overall Study||15
6624308|NCT02216071|7551693|FG001|NOT COMPLETED|Overall Study||12
6624309|NCT02216097|7551701|FG000|STARTED|Overall Study||8
6624310|NCT02216097|7551702|FG001|STARTED|Overall Study||6
6624311|NCT02216097|7551701|FG000|COMPLETED|Overall Study||8
6624312|NCT02216097|7551702|FG001|COMPLETED|Overall Study||6
6624313|NCT02216097|7551701|FG000|NOT COMPLETED|Overall Study||0
6624314|NCT02216097|7551702|FG001|NOT COMPLETED|Overall Study||0
6624315|NCT02216123|7551710|FG000|STARTED|Overall Study||166
6624316|NCT02216123|7551711|FG001|STARTED|Overall Study||85
6624317|NCT02216123|7551710|FG000|COMPLETED|Overall Study||160
6624318|NCT02216123|7551711|FG001|COMPLETED|Overall Study||83
6624319|NCT02216123|7551710|FG000|NOT COMPLETED|Overall Study||6
6624320|NCT02216123|7551711|FG001|NOT COMPLETED|Overall Study||2
6624321|NCT02216136|7551724|FG000|STARTED|Overall Study||72
6624322|NCT02216136|7551725|FG001|STARTED|Overall Study||90
6624323|NCT02216136|7551726|FG002|STARTED|Overall Study||0
6624324|NCT02216136|7551724|FG000|COMPLETED|Overall Study||72
6624325|NCT02216136|7551725|FG001|COMPLETED|Overall Study||90
6624326|NCT02216136|7551726|FG002|COMPLETED|Overall Study||0
6624327|NCT02216136|7551724|FG000|NOT COMPLETED|Overall Study||0
6624328|NCT02216136|7551725|FG001|NOT COMPLETED|Overall Study||0
6624329|NCT02216136|7551726|FG002|NOT COMPLETED|Overall Study||0
6624330|NCT02216214|7551736|FG000|STARTED|Overall Study||443
6624331|NCT02216214|7551737|FG001|STARTED|Overall Study||445
6624332|NCT02216214|7551736|FG000|Treated|Overall Study||442
6624333|NCT02216214|7551737|FG001|Treated|Overall Study||445
6624334|NCT02216214|7551736|FG000|COMPLETED|Overall Study||400
6624335|NCT02216214|7551737|FG001|COMPLETED|Overall Study||409
6624336|NCT02216214|7551736|FG000|NOT COMPLETED|Overall Study||43
6624337|NCT02216214|7551737|FG001|NOT COMPLETED|Overall Study||36
6624338|NCT02216357|7551745|FG000|STARTED|Overall Study||14
6624339|NCT02216357|7551746|FG001|STARTED|Overall Study||5
6584510|NCT01945086|7508933|FG000|STARTED|Overall Study||27
6584511|NCT01945086|7508934|FG001|STARTED|Overall Study||24
6584512|NCT01945086|7508935|FG002|STARTED|Overall Study||28
6584513|NCT01945086|7508933|FG000|COMPLETED|Overall Study||26
6584514|NCT01945086|7508934|FG001|COMPLETED|Overall Study||24
6584515|NCT01945086|7508935|FG002|COMPLETED|Overall Study||26
6584516|NCT01945086|7508933|FG000|NOT COMPLETED|Overall Study||1
6584517|NCT01945086|7508934|FG001|NOT COMPLETED|Overall Study||0
6584518|NCT01945086|7508935|FG002|NOT COMPLETED|Overall Study||2
6584519|NCT01945112|7508943|FG000|STARTED|Overall Study|total number of sites where tape was applied|77
6584520|NCT01945112|7508944|FG001|STARTED|Overall Study|total number of sites where tape was applied|51
6584521|NCT01945112|7508943|FG000|COMPLETED|Overall Study||77
6584522|NCT01945112|7508944|FG001|COMPLETED|Overall Study||51
6584523|NCT01945112|7508943|FG000|NOT COMPLETED|Overall Study||0
6584524|NCT01945112|7508944|FG001|NOT COMPLETED|Overall Study||0
6584525|NCT01945138|7508951|FG000|STARTED|Overall Study||7
6584526|NCT01945138|7508952|FG001|STARTED|Overall Study||7
6584527|NCT01945138|7508951|FG000|COMPLETED|Overall Study||7
6584528|NCT01945138|7508952|FG001|COMPLETED|Overall Study||7
6584529|NCT01945138|7508951|FG000|NOT COMPLETED|Overall Study||0
6584530|NCT01945138|7508952|FG001|NOT COMPLETED|Overall Study||0
6584531|NCT01945216|7508961|FG000|STARTED|Overall Study||3317
6584532|NCT01945216|7508961|FG000|COMPLETED|Overall Study||3218
6584533|NCT01945216|7508961|FG000|NOT COMPLETED|Overall Study||99
6584534|NCT01945242|7508971|FG000|STARTED|Overall Study||1251
6584535|NCT01945242|7508972|FG001|STARTED|Overall Study||123
6584536|NCT01945242|7508971|FG000|COMPLETED|Overall Study||1248
6584537|NCT01945242|7508972|FG001|COMPLETED|Overall Study||120
6584538|NCT01945242|7508971|FG000|NOT COMPLETED|Overall Study||3
6584539|NCT01945242|7508972|FG001|NOT COMPLETED|Overall Study||3
6584540|NCT01945281|7508981|FG000|STARTED|Overall Study||34
6584541|NCT01945281|7508982|FG001|STARTED|Overall Study||17
6584542|NCT01945281|7508981|FG000|Treated|Overall Study||33
6584543|NCT01945281|7508982|FG001|Treated|Overall Study||16
6584544|NCT01945281|7508981|FG000|COMPLETED|Overall Study||28
6584545|NCT01945281|7508982|FG001|COMPLETED|Overall Study||13
6584546|NCT01945281|7508981|FG000|NOT COMPLETED|Overall Study||6
6584547|NCT01945281|7508982|FG001|NOT COMPLETED|Overall Study||4
6584548|NCT01945294|7508991|FG000|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
6584549|NCT01945294|7508992|FG001|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
6584550|NCT01945294|7508993|FG002|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
6584551|NCT01945294|7508994|FG003|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
6584552|NCT01945294|7508991|FG000|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
6584553|NCT01945294|7508992|FG001|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6584554|NCT01945294|7508993|FG002|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6584555|NCT01945294|7508994|FG003|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6584556|NCT01945294|7508991|FG000|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
6584557|NCT01945294|7508992|FG001|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6584558|NCT01945294|7508993|FG002|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6584559|NCT01945294|7508994|FG003|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
6584560|NCT01945294|7508991|FG000|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
6584561|NCT01945294|7508992|FG001|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
6584562|NCT01945294|7508993|FG002|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
6584563|NCT01945294|7508994|FG003|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
6584564|NCT01945294|7508991|FG000|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
6584565|NCT01945294|7508992|FG001|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
6584566|NCT01945294|7508993|FG002|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
6584567|NCT01945294|7508994|FG003|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
6584568|NCT01945294|7508991|FG000|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
6584569|NCT01945294|7508992|FG001|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
6584570|NCT01945294|7508993|FG002|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
6584571|NCT01945294|7508994|FG003|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
6584572|NCT01945489|7509005|FG000|STARTED|Cycle 1||129
6584573|NCT01945489|7509006|FG001|STARTED|Cycle 1||125
6584574|NCT01945489|7509005|FG000|COMPLETED|Cycle 1||116
6584575|NCT01945489|7509006|FG001|COMPLETED|Cycle 1||121
6584576|NCT01945489|7509005|FG000|NOT COMPLETED|Cycle 1||13
6584577|NCT01945489|7509006|FG001|NOT COMPLETED|Cycle 1||4
6584578|NCT01945489|7509005|FG000|STARTED|Cycle 2|Not all participants participated in Cycle 2.|88
6584579|NCT01945489|7509006|FG001|STARTED|Cycle 2||107
6584580|NCT01945489|7509005|FG000|COMPLETED|Cycle 2||87
6584581|NCT01945489|7509006|FG001|COMPLETED|Cycle 2||106
6584582|NCT01945489|7509005|FG000|NOT COMPLETED|Cycle 2||1
6584583|NCT01945489|7509006|FG001|NOT COMPLETED|Cycle 2||1
6584584|NCT01945580|7509015|FG000|STARTED|Overall Study||228
6584585|NCT01945580|7509016|FG001|STARTED|Overall Study||485
6584586|NCT01945580|7509015|FG000|COMPLETED|Overall Study||176
6584587|NCT01945580|7509016|FG001|COMPLETED|Overall Study||401
6584588|NCT01945580|7509015|FG000|NOT COMPLETED|Overall Study||52
6584589|NCT01945580|7509016|FG001|NOT COMPLETED|Overall Study||84
6584590|NCT01945593|7509030|FG000|STARTED|Overall Study||3
6584591|NCT01945593|7509031|FG001|STARTED|Overall Study||64
6584592|NCT01945593|7509032|FG002|STARTED|Overall Study||26
6584593|NCT01945593|7509033|FG003|STARTED|Overall Study||125
6584594|NCT01945593|7509030|FG000|COMPLETED|Overall Study||3
6584595|NCT01945593|7509031|FG001|COMPLETED|Overall Study||56
6584596|NCT01945593|7509032|FG002|COMPLETED|Overall Study||23
6584597|NCT01945593|7509033|FG003|COMPLETED|Overall Study||105
6584598|NCT01945593|7509030|FG000|NOT COMPLETED|Overall Study||0
6584599|NCT01945593|7509031|FG001|NOT COMPLETED|Overall Study||8
6584600|NCT01945593|7509032|FG002|NOT COMPLETED|Overall Study||3
6584601|NCT01945593|7509033|FG003|NOT COMPLETED|Overall Study||20
6584602|NCT01945710|7509055|FG000|STARTED|Overall Study||7
6584603|NCT01945710|7509056|FG001|STARTED|Overall Study||6
6584604|NCT01945710|7509057|FG002|STARTED|Overall Study||7
6584605|NCT01945710|7509058|FG003|STARTED|Overall Study||3
6584606|NCT01945710|7509059|FG004|STARTED|Overall Study||9
6584607|NCT01945710|7509060|FG005|STARTED|Overall Study||3
6584608|NCT01945710|7509061|FG006|STARTED|Overall Study||23
6584609|NCT01945710|7509055|FG000|COMPLETED|Overall Study||0
6584610|NCT01945710|7509056|FG001|COMPLETED|Overall Study||0
6584611|NCT01945710|7509057|FG002|COMPLETED|Overall Study||0
6584612|NCT01945710|7509058|FG003|COMPLETED|Overall Study||0
6584613|NCT01945710|7509059|FG004|COMPLETED|Overall Study||0
6584614|NCT01945710|7509060|FG005|COMPLETED|Overall Study||0
6584615|NCT01945710|7509061|FG006|COMPLETED|Overall Study||0
6584616|NCT01945710|7509055|FG000|NOT COMPLETED|Overall Study||7
6584617|NCT01945710|7509056|FG001|NOT COMPLETED|Overall Study||6
6584618|NCT01945710|7509057|FG002|NOT COMPLETED|Overall Study||7
6584619|NCT01945710|7509058|FG003|NOT COMPLETED|Overall Study||3
6584620|NCT01945710|7509059|FG004|NOT COMPLETED|Overall Study||9
6584621|NCT01945710|7509060|FG005|NOT COMPLETED|Overall Study||3
6584622|NCT01945710|7509061|FG006|NOT COMPLETED|Overall Study||23
6584623|NCT01945866|7509081|FG000|STARTED|Overall Study||65
6584624|NCT01945866|7509082|FG001|STARTED|Overall Study||64
6584625|NCT01945866|7509081|FG000|COMPLETED|Overall Study||63
6584626|NCT01945866|7509082|FG001|COMPLETED|Overall Study||64
6584627|NCT01945866|7509081|FG000|NOT COMPLETED|Overall Study||2
6584628|NCT01945866|7509082|FG001|NOT COMPLETED|Overall Study||0
6584629|NCT01945944|7509091|FG000|STARTED|Overall Study||9
6584630|NCT01945944|7509092|FG001|STARTED|Overall Study||9
6584631|NCT01945944|7509091|FG000|COMPLETED|Overall Study||8
6584632|NCT01945944|7509092|FG001|COMPLETED|Overall Study||6
6584633|NCT01945944|7509091|FG000|NOT COMPLETED|Overall Study||1
6584634|NCT01945944|7509092|FG001|NOT COMPLETED|Overall Study||3
6584635|NCT01945970|7509100|FG000|STARTED|Overall Study||5
6584636|NCT01945970|7509101|FG001|STARTED|Overall Study||5
6584637|NCT01945970|7509102|FG002|STARTED|Overall Study||5
6584638|NCT01945970|7509103|FG003|STARTED|Overall Study||5
6584639|NCT01945970|7509104|FG004|STARTED|Overall Study||5
6584640|NCT01945970|7509105|FG005|STARTED|Overall Study||5
6584641|NCT01945970|7509100|FG000|COMPLETED|Overall Study||5
6584642|NCT01945970|7509101|FG001|COMPLETED|Overall Study||5
6584643|NCT01945970|7509102|FG002|COMPLETED|Overall Study||5
6584644|NCT01945970|7509103|FG003|COMPLETED|Overall Study||5
6584645|NCT01945970|7509104|FG004|COMPLETED|Overall Study||5
6584646|NCT01945970|7509105|FG005|COMPLETED|Overall Study||5
6584647|NCT01945970|7509100|FG000|NOT COMPLETED|Overall Study||0
6584648|NCT01945970|7509101|FG001|NOT COMPLETED|Overall Study||0
6584649|NCT01945970|7509102|FG002|NOT COMPLETED|Overall Study||0
6584650|NCT01945970|7509103|FG003|NOT COMPLETED|Overall Study||0
6584651|NCT01945970|7509104|FG004|NOT COMPLETED|Overall Study||0
6584652|NCT01945970|7509105|FG005|NOT COMPLETED|Overall Study||0
6584653|NCT01945996|7509117|FG000|STARTED|Overall Study||22
6584654|NCT01945996|7509118|FG001|STARTED|Overall Study||22
6584655|NCT01945996|7509117|FG000|COMPLETED|Overall Study||19
6584656|NCT01945996|7509118|FG001|COMPLETED|Overall Study||17
6584657|NCT01945996|7509117|FG000|NOT COMPLETED|Overall Study||3
6584658|NCT01945996|7509118|FG001|NOT COMPLETED|Overall Study||5
6584659|NCT01946126|7509128|FG000|STARTED|Overall Study||184
6584660|NCT01946126|7509129|FG001|STARTED|Overall Study||275
6584661|NCT01946126|7509128|FG000|COMPLETED|Overall Study||184
6584662|NCT01946126|7509129|FG001|COMPLETED|Overall Study||275
6584663|NCT01946126|7509128|FG000|NOT COMPLETED|Overall Study||0
6584664|NCT01946126|7509129|FG001|NOT COMPLETED|Overall Study||0
6584665|NCT01946152|7509139|FG000|STARTED|Overall Study||3
6584666|NCT01946152|7509140|FG001|STARTED|Overall Study||3
6584667|NCT01946152|7509141|FG002|STARTED|Overall Study||6
6584668|NCT01946152|7509142|FG003|STARTED|Overall Study||8
6584669|NCT01946152|7509139|FG000|COMPLETED|Overall Study||2
6584670|NCT01946152|7509140|FG001|COMPLETED|Overall Study||0
6584671|NCT01946152|7509141|FG002|COMPLETED|Overall Study||0
6584672|NCT01946152|7509142|FG003|COMPLETED|Overall Study||0
6584673|NCT01946152|7509139|FG000|NOT COMPLETED|Overall Study||1
6659210|NCT02486952|7589992|FG000|COMPLETED|Overall Study||104
6659211|NCT02486952|7589992|FG000|NOT COMPLETED|Overall Study||50
6584674|NCT01946152|7509140|FG001|NOT COMPLETED|Overall Study||3
6584675|NCT01946152|7509141|FG002|NOT COMPLETED|Overall Study||6
6584676|NCT01946152|7509142|FG003|NOT COMPLETED|Overall Study||8
6584677|NCT01946165|7509156|FG000|STARTED|Overall Study||45
6584678|NCT01946165|7509157|FG001|STARTED|Overall Study||23
6584679|NCT01946165|7509156|FG000|COMPLETED|Overall Study||43
6584680|NCT01946165|7509157|FG001|COMPLETED|Overall Study||21
6584681|NCT01946165|7509156|FG000|NOT COMPLETED|Overall Study||2
6584682|NCT01946165|7509157|FG001|NOT COMPLETED|Overall Study||2
6584683|NCT01946178|7509164|FG000|STARTED|Overall Study||73
6584684|NCT01946178|7509164|FG000|COMPLETED|Overall Study||71
6584685|NCT01946178|7509164|FG000|NOT COMPLETED|Overall Study||2
6584686|NCT01946191|7509174|FG000|STARTED|Allocation||98
6584687|NCT01946191|7509175|FG001|STARTED|Allocation||96
6584688|NCT01946191|7509174|FG000|COMPLETED|Allocation||97
6584689|NCT01946191|7509175|FG001|COMPLETED|Allocation||95
6584690|NCT01946191|7509174|FG000|NOT COMPLETED|Allocation||1
6584691|NCT01946191|7509175|FG001|NOT COMPLETED|Allocation||1
6584692|NCT01946191|7509174|FG000|STARTED|Follow-Up, 24-mo Endpoint||97
6584693|NCT01946191|7509175|FG001|STARTED|Follow-Up, 24-mo Endpoint||95
6584694|NCT01946191|7509174|FG000|COMPLETED|Follow-Up, 24-mo Endpoint||80
6584695|NCT01946191|7509175|FG001|COMPLETED|Follow-Up, 24-mo Endpoint||77
6584696|NCT01946191|7509174|FG000|NOT COMPLETED|Follow-Up, 24-mo Endpoint||17
6584697|NCT01946191|7509175|FG001|NOT COMPLETED|Follow-Up, 24-mo Endpoint||18
6584698|NCT01946191|7509174|FG000|STARTED|Primary Outcome Analysis||98
6584699|NCT01946191|7509175|FG001|STARTED|Primary Outcome Analysis||95
6584700|NCT01946191|7509174|FG000|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|80
6584701|NCT01946191|7509175|FG001|COMPLETED|Primary Outcome Analysis|Weight data at 24 months|77
6584702|NCT01946191|7509174|FG000|NOT COMPLETED|Primary Outcome Analysis||18
6584703|NCT01946191|7509175|FG001|NOT COMPLETED|Primary Outcome Analysis||18
6584704|NCT01946243|7509182|FG000|STARTED|Overall Study||96
6584705|NCT01946243|7509182|FG000|COMPLETED|Overall Study||96
6584706|NCT01946243|7509182|FG000|NOT COMPLETED|Overall Study||0
6584707|NCT01946282|7509191|FG000|STARTED|Year 1||6565
6584708|NCT01946282|7509192|FG001|STARTED|Year 1||1000
6584709|NCT01946282|7509193|FG002|STARTED|Year 1||1000
6584710|NCT01946282|7509191|FG000|COMPLETED|Year 1||2379
6584711|NCT01946282|7509192|FG001|COMPLETED|Year 1||392
6584712|NCT01946282|7509193|FG002|COMPLETED|Year 1||346
6584713|NCT01946282|7509191|FG000|NOT COMPLETED|Year 1||4186
6584714|NCT01946282|7509192|FG001|NOT COMPLETED|Year 1||608
6584715|NCT01946282|7509193|FG002|NOT COMPLETED|Year 1||654
6584716|NCT01946282|7509191|FG000|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|2051
6584717|NCT01946282|7509192|FG001|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|341
6584718|NCT01946282|7509193|FG002|STARTED|Year 2|Patients are those with Year 1 negative FIT results, or no longer met inclusion criteria.|299
6584719|NCT01946282|7509191|FG000|COMPLETED|Year 2||1248
6584720|NCT01946282|7509192|FG001|COMPLETED|Year 2||210
6584721|NCT01946282|7509193|FG002|COMPLETED|Year 2||184
6584722|NCT01946282|7509191|FG000|NOT COMPLETED|Year 2||803
6584723|NCT01946282|7509192|FG001|NOT COMPLETED|Year 2||131
6584724|NCT01946282|7509193|FG002|NOT COMPLETED|Year 2||115
6584725|NCT01946282|7509191|FG000|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|1144
6584726|NCT01946282|7509192|FG001|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|184
6584727|NCT01946282|7509193|FG002|STARTED|Year 3|Patients are those with Year 2 negative FIT results, or no longer met inclusion criteria.|170
6584728|NCT01946282|7509191|FG000|COMPLETED|Year 3||856
6584729|NCT01946282|7509192|FG001|COMPLETED|Year 3||141
6584730|NCT01946282|7509193|FG002|COMPLETED|Year 3||140
6584731|NCT01946282|7509191|FG000|NOT COMPLETED|Year 3||288
6584732|NCT01946282|7509192|FG001|NOT COMPLETED|Year 3||43
6584733|NCT01946282|7509193|FG002|NOT COMPLETED|Year 3||30
6584734|NCT01946412|7509203|FG000|STARTED|Overall Study||33
6584735|NCT01946412|7509203|FG000|COMPLETED|Overall Study||28
6584736|NCT01946412|7509203|FG000|NOT COMPLETED|Overall Study||5
6584737|NCT01946425|7509211|FG000|STARTED|Overall Study||30
6659212|NCT02487030|7590003|FG000|STARTED|Overall Study||43
6659213|NCT02487030|7590004|FG001|STARTED|Overall Study||42
6659214|NCT02487030|7590005|FG002|STARTED|Overall Study||43
6584738|NCT01946425|7509212|FG001|STARTED|Overall Study||30
6584739|NCT01946425|7509211|FG000|COMPLETED|Overall Study||28
6584740|NCT01946425|7509212|FG001|COMPLETED|Overall Study||30
6584741|NCT01946425|7509211|FG000|NOT COMPLETED|Overall Study||2
6584742|NCT01946425|7509212|FG001|NOT COMPLETED|Overall Study||0
6584743|NCT01946438|7509223|FG000|STARTED|Overall Study||52
6584744|NCT01946438|7509224|FG001|STARTED|Overall Study||52
6584745|NCT01946438|7509225|FG002|STARTED|Overall Study||52
6584746|NCT01946438|7509226|FG003|STARTED|Overall Study||52
6584747|NCT01946438|7509223|FG000|COMPLETED|Overall Study||50
6584748|NCT01946438|7509224|FG001|COMPLETED|Overall Study||52
6584749|NCT01946438|7509225|FG002|COMPLETED|Overall Study||51
6584750|NCT01946438|7509226|FG003|COMPLETED|Overall Study||51
6584751|NCT01946438|7509223|FG000|NOT COMPLETED|Overall Study||2
6584752|NCT01946438|7509224|FG001|NOT COMPLETED|Overall Study||0
6584753|NCT01946438|7509225|FG002|NOT COMPLETED|Overall Study||1
6584754|NCT01946438|7509226|FG003|NOT COMPLETED|Overall Study||1
6584755|NCT01946529|7509245|FG000|STARTED|End of Window Therapy (2 Courses)||1
6584756|NCT01946529|7509246|FG001|STARTED|End of Window Therapy (2 Courses)||17
6584757|NCT01946529|7509247|FG002|STARTED|End of Window Therapy (2 Courses)||6
6584758|NCT01946529|7509245|FG000|COMPLETED|End of Window Therapy (2 Courses)||1
6584759|NCT01946529|7509246|FG001|COMPLETED|End of Window Therapy (2 Courses)||16
6584760|NCT01946529|7509247|FG002|COMPLETED|End of Window Therapy (2 Courses)||6
6584761|NCT01946529|7509245|FG000|NOT COMPLETED|End of Window Therapy (2 Courses)||0
6584762|NCT01946529|7509246|FG001|NOT COMPLETED|End of Window Therapy (2 Courses)||1
6584763|NCT01946529|7509247|FG002|NOT COMPLETED|End of Window Therapy (2 Courses)||0
6584764|NCT01946529|7509245|FG000|STARTED|Completion of All Therapy||1
6584765|NCT01946529|7509246|FG001|STARTED|Completion of All Therapy||16
6584766|NCT01946529|7509247|FG002|STARTED|Completion of All Therapy||6
6659215|NCT02487030|7590006|FG003|STARTED|Overall Study||42
6584767|NCT01946529|7509245|FG000|COMPLETED|Completion of All Therapy||0
6584768|NCT01946529|7509246|FG001|COMPLETED|Completion of All Therapy||0
6584769|NCT01946529|7509247|FG002|COMPLETED|Completion of All Therapy||0
6584770|NCT01946529|7509245|FG000|NOT COMPLETED|Completion of All Therapy||1
6584771|NCT01946529|7509246|FG001|NOT COMPLETED|Completion of All Therapy||16
6584772|NCT01946529|7509247|FG002|NOT COMPLETED|Completion of All Therapy||6
6584773|NCT01946802|7509254|FG000|STARTED|Overall Study||44
6584774|NCT01946802|7509254|FG000|COMPLETED|Overall Study||39
6584775|NCT01946802|7509254|FG000|NOT COMPLETED|Overall Study||5
6584776|NCT01946880|7509260|FG000|STARTED|Overall Study||50
6584777|NCT01946880|7509261|FG001|STARTED|Overall Study||52
6584778|NCT01946880|7509260|FG000|COMPLETED|Overall Study||43
6584779|NCT01946880|7509261|FG001|COMPLETED|Overall Study||49
6584780|NCT01946880|7509260|FG000|NOT COMPLETED|Overall Study||7
6584781|NCT01946880|7509261|FG001|NOT COMPLETED|Overall Study||3
6584782|NCT01947127|7509269|FG000|STARTED|Overall Study||166
6584783|NCT01947127|7509270|FG001|STARTED|Overall Study||292
6584784|NCT01947127|7509269|FG000|COMPLETED|Overall Study||143
6584785|NCT01947127|7509270|FG001|COMPLETED|Overall Study||249
6584786|NCT01947127|7509269|FG000|NOT COMPLETED|Overall Study||23
6584787|NCT01947127|7509270|FG001|NOT COMPLETED|Overall Study||43
6584788|NCT01947153|7509276|FG000|STARTED|Test Period 1||18
6584789|NCT01947153|7509277|FG001|STARTED|Test Period 1||18
6584790|NCT01947153|7509276|FG000|COMPLETED|Test Period 1||18
6584791|NCT01947153|7509277|FG001|COMPLETED|Test Period 1||18
6584792|NCT01947153|7509276|FG000|NOT COMPLETED|Test Period 1||0
6584793|NCT01947153|7509277|FG001|NOT COMPLETED|Test Period 1||0
6584794|NCT01947153|7509276|FG000|STARTED|Test Period 2||18
6584795|NCT01947153|7509277|FG001|STARTED|Test Period 2||18
6584796|NCT01947153|7509276|FG000|COMPLETED|Test Period 2||18
6584797|NCT01947153|7509277|FG001|COMPLETED|Test Period 2||18
6584798|NCT01947153|7509276|FG000|NOT COMPLETED|Test Period 2||0
6584799|NCT01947153|7509277|FG001|NOT COMPLETED|Test Period 2||0
6584800|NCT01947283|7509290|FG000|STARTED|Overall Study||89
6584801|NCT01947283|7509291|FG001|STARTED|Overall Study||68
6584802|NCT01947283|7509292|FG002|STARTED|Overall Study||83
6584803|NCT01947283|7509293|FG003|STARTED|Overall Study||72
6584804|NCT01947283|7509294|FG004|STARTED|Overall Study||95
6584805|NCT01947283|7509295|FG005|STARTED|Overall Study||34
6584806|NCT01947283|7509296|FG006|STARTED|Overall Study||40
6584807|NCT01947283|7509290|FG000|Baseline Assessment|Overall Study||89
6584808|NCT01947283|7509291|FG001|Baseline Assessment|Overall Study||68
6584809|NCT01947283|7509292|FG002|Baseline Assessment|Overall Study||83
6584810|NCT01947283|7509293|FG003|Baseline Assessment|Overall Study||72
6584811|NCT01947283|7509294|FG004|Baseline Assessment|Overall Study||0
6584812|NCT01947283|7509295|FG005|Baseline Assessment|Overall Study||34
6584813|NCT01947283|7509296|FG006|Baseline Assessment|Overall Study||40
6584814|NCT01947283|7509290|FG000|Follow-up Assessment|Overall Study||64
6584815|NCT01947283|7509291|FG001|Follow-up Assessment|Overall Study||51
6584816|NCT01947283|7509292|FG002|Follow-up Assessment|Overall Study||65
6584817|NCT01947283|7509293|FG003|Follow-up Assessment|Overall Study||59
6584818|NCT01947283|7509294|FG004|Follow-up Assessment|Overall Study||0
6584819|NCT01947283|7509295|FG005|Follow-up Assessment|Overall Study||27
6584820|NCT01947283|7509296|FG006|Follow-up Assessment|Overall Study||36
6584821|NCT01947283|7509290|FG000|Clinical Recording|Overall Study||65
6584822|NCT01947283|7509291|FG001|Clinical Recording|Overall Study||54
6584823|NCT01947283|7509292|FG002|Clinical Recording|Overall Study||68
6584824|NCT01947283|7509293|FG003|Clinical Recording|Overall Study||57
6584825|NCT01947283|7509294|FG004|Clinical Recording|Overall Study||0
6584826|NCT01947283|7509295|FG005|Clinical Recording|Overall Study||0
6584827|NCT01947283|7509296|FG006|Clinical Recording|Overall Study||0
6584828|NCT01947283|7509290|FG000|End-of-Intervention Assessment|Overall Study||74
6584829|NCT01947283|7509291|FG001|End-of-Intervention Assessment|Overall Study||53
6584830|NCT01947283|7509292|FG002|End-of-Intervention Assessment|Overall Study||73
6584831|NCT01947283|7509293|FG003|End-of-Intervention Assessment|Overall Study||66
6584832|NCT01947283|7509294|FG004|End-of-Intervention Assessment|Overall Study||0
6584833|NCT01947283|7509295|FG005|End-of-Intervention Assessment|Overall Study||32
6584834|NCT01947283|7509296|FG006|End-of-Intervention Assessment|Overall Study||33
6584835|NCT01947283|7509290|FG000|In Analysis|Overall Study||89
6584836|NCT01947283|7509291|FG001|In Analysis|Overall Study||68
6584837|NCT01947283|7509292|FG002|In Analysis|Overall Study||83
6584838|NCT01947283|7509293|FG003|In Analysis|Overall Study||72
6584839|NCT01947283|7509294|FG004|In Analysis|Overall Study||95
6584840|NCT01947283|7509295|FG005|In Analysis|Overall Study||30
6584841|NCT01947283|7509296|FG006|In Analysis|Overall Study||38
6584842|NCT01947283|7509290|FG000|Completed NRCT Baseline Assessment|Overall Study||0
6584843|NCT01947283|7509291|FG001|Completed NRCT Baseline Assessment|Overall Study||0
6584844|NCT01947283|7509292|FG002|Completed NRCT Baseline Assessment|Overall Study||0
6584845|NCT01947283|7509293|FG003|Completed NRCT Baseline Assessment|Overall Study||0
6584846|NCT01947283|7509294|FG004|Completed NRCT Baseline Assessment|Overall Study||95
6584847|NCT01947283|7509295|FG005|Completed NRCT Baseline Assessment|Overall Study||0
6584848|NCT01947283|7509296|FG006|Completed NRCT Baseline Assessment|Overall Study||0
6584849|NCT01947283|7509290|FG000|COMPLETED|Overall Study||60
6584850|NCT01947283|7509291|FG001|COMPLETED|Overall Study||45
6584851|NCT01947283|7509292|FG002|COMPLETED|Overall Study||62
6584852|NCT01947283|7509293|FG003|COMPLETED|Overall Study||55
6584853|NCT01947283|7509294|FG004|COMPLETED|Overall Study||95
6584854|NCT01947283|7509295|FG005|COMPLETED|Overall Study||27
6584855|NCT01947283|7509296|FG006|COMPLETED|Overall Study||32
6584856|NCT01947283|7509290|FG000|NOT COMPLETED|Overall Study||29
6584857|NCT01947283|7509291|FG001|NOT COMPLETED|Overall Study||23
6584858|NCT01947283|7509292|FG002|NOT COMPLETED|Overall Study||21
6584859|NCT01947283|7509293|FG003|NOT COMPLETED|Overall Study||17
6584860|NCT01947283|7509294|FG004|NOT COMPLETED|Overall Study||0
6584861|NCT01947283|7509295|FG005|NOT COMPLETED|Overall Study||7
6584862|NCT01947283|7509296|FG006|NOT COMPLETED|Overall Study||8
6584863|NCT01947335|7509315|FG000|STARTED|Overall Study||42
6584864|NCT01947335|7509316|FG001|STARTED|Overall Study||41
6584865|NCT01947335|7509315|FG000|COMPLETED|Overall Study||42
6584866|NCT01947335|7509316|FG001|COMPLETED|Overall Study||41
6584867|NCT01947335|7509315|FG000|NOT COMPLETED|Overall Study||0
6584868|NCT01947335|7509316|FG001|NOT COMPLETED|Overall Study||0
6584869|NCT01947491|7509326|FG000|STARTED|Overall Study||174
6584870|NCT01947491|7509327|FG001|STARTED|Overall Study||87
6255872|NCT01275846|7154750|FG000|NOT COMPLETED|Overall Study||1
6255873|NCT01097005|7154754|FG000|STARTED|Overall Study|number of participants who were enrolled for this study.|466
6255874|NCT01097005|7154754|FG000|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
6255875|NCT01097005|7154754|FG000|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
6255876|NCT01097005|7154754|FG000|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
6255877|NCT01097005|7154754|FG000|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
6255878|NCT01097005|7154754|FG000|COMPLETED|Overall Study||101
6255879|NCT01097005|7154754|FG000|NOT COMPLETED|Overall Study||365
6584871|NCT01947491|7509328|FG002|STARTED|Overall Study||90
6584872|NCT01947491|7509329|FG003|STARTED|Overall Study||43
6584873|NCT01947491|7509326|FG000|COMPLETED|Overall Study||166
6584874|NCT01947491|7509327|FG001|COMPLETED|Overall Study||81
6584875|NCT01947491|7509328|FG002|COMPLETED|Overall Study||88
6584876|NCT01947491|7509329|FG003|COMPLETED|Overall Study||38
6584877|NCT01947491|7509326|FG000|NOT COMPLETED|Overall Study||8
6584878|NCT01947491|7509327|FG001|NOT COMPLETED|Overall Study||6
6584879|NCT01947491|7509328|FG002|NOT COMPLETED|Overall Study||2
6584880|NCT01947491|7509329|FG003|NOT COMPLETED|Overall Study||5
6584881|NCT01947517|7509341|FG000|STARTED|Overall Study||26
6584882|NCT01947517|7509342|FG001|STARTED|Overall Study||26
6584883|NCT01947517|7509341|FG000|COMPLETED|Overall Study||25
6584884|NCT01947517|7509342|FG001|COMPLETED|Overall Study||25
6584885|NCT01947517|7509341|FG000|NOT COMPLETED|Overall Study||1
6584886|NCT01947517|7509342|FG001|NOT COMPLETED|Overall Study||1
6584887|NCT01947582|7509348|FG000|STARTED|Overall Study||2
6584888|NCT01947582|7509348|FG000|COMPLETED|Overall Study||1
6584889|NCT01947582|7509348|FG000|NOT COMPLETED|Overall Study||1
6584890|NCT01947647|7509354|FG000|STARTED|Treatment Phase||46
6584891|NCT01947647|7509355|FG001|STARTED|Treatment Phase||47
6584892|NCT01947647|7509354|FG000|COMPLETED|Treatment Phase||29
6584893|NCT01947647|7509355|FG001|COMPLETED|Treatment Phase||21
6584894|NCT01947647|7509354|FG000|NOT COMPLETED|Treatment Phase||17
6584895|NCT01947647|7509355|FG001|NOT COMPLETED|Treatment Phase||26
6584896|NCT01947647|7509354|FG000|STARTED|6-month Followup Phase||29
6584897|NCT01947647|7509355|FG001|STARTED|6-month Followup Phase||21
6584898|NCT01947647|7509354|FG000|COMPLETED|6-month Followup Phase||20
6584899|NCT01947647|7509355|FG001|COMPLETED|6-month Followup Phase||13
6584900|NCT01947647|7509354|FG000|NOT COMPLETED|6-month Followup Phase||9
6584901|NCT01947647|7509355|FG001|NOT COMPLETED|6-month Followup Phase||8
6584902|NCT01947816|7509361|FG000|STARTED|Overall Study||1593
6584903|NCT01947816|7509361|FG000|COMPLETED|Overall Study||1523
6584904|NCT01947816|7509361|FG000|NOT COMPLETED|Overall Study||70
6584905|NCT01947855|7509368|FG000|STARTED|Overall Study||21
6584906|NCT01947855|7509369|FG001|STARTED|Overall Study||20
6584907|NCT01947855|7509370|FG002|STARTED|Overall Study||19
6584908|NCT01947855|7509368|FG000|COMPLETED|Overall Study||20
6584909|NCT01947855|7509369|FG001|COMPLETED|Overall Study||20
6584910|NCT01947855|7509370|FG002|COMPLETED|Overall Study||19
6584911|NCT01947855|7509368|FG000|NOT COMPLETED|Overall Study||1
6584912|NCT01947855|7509369|FG001|NOT COMPLETED|Overall Study||0
6584913|NCT01947855|7509370|FG002|NOT COMPLETED|Overall Study||0
6584914|NCT01947894|7509381|FG000|STARTED|Overall Study||247
6584915|NCT01947894|7509382|FG001|STARTED|Overall Study||42
6584916|NCT01947894|7509383|FG002|STARTED|Overall Study||88
6584917|NCT01947894|7509381|FG000|Treated|Overall Study||246
6584918|NCT01947894|7509382|FG001|Treated|Overall Study||41
6584919|NCT01947894|7509383|FG002|Treated|Overall Study||87
6584920|NCT01947894|7509381|FG000|COMPLETED|Overall Study||160
6584921|NCT01947894|7509382|FG001|COMPLETED|Overall Study||24
6584922|NCT01947894|7509383|FG002|COMPLETED|Overall Study||61
6584923|NCT01947894|7509381|FG000|NOT COMPLETED|Overall Study||87
6584924|NCT01947894|7509382|FG001|NOT COMPLETED|Overall Study||18
6584925|NCT01947894|7509383|FG002|NOT COMPLETED|Overall Study||27
6584926|NCT01947907|7509395|FG000|STARTED|Overall Study||12
6584927|NCT01947907|7509396|FG001|STARTED|Overall Study||14
6255880|NCT01072682|7154760|FG000|STARTED|Overall Study||35
6255881|NCT01072682|7154760|FG000|COMPLETED|Overall Study||35
6255882|NCT01072682|7154760|FG000|NOT COMPLETED|Overall Study||0
6255883|NCT00931255|7154766|FG000|STARTED|Overall Study||17
6255884|NCT00931255|7154767|FG001|STARTED|Overall Study||15
6255885|NCT00931255|7154766|FG000|COMPLETED|Overall Study||15
6255886|NCT00931255|7154767|FG001|COMPLETED|Overall Study||12
6255887|NCT00931255|7154766|FG000|NOT COMPLETED|Overall Study||2
6584928|NCT01947907|7509397|FG002|STARTED|Overall Study||14
6584929|NCT01947907|7509398|FG003|STARTED|Overall Study||13
6584930|NCT01947907|7509395|FG000|COMPLETED|Overall Study||12
6584931|NCT01947907|7509396|FG001|COMPLETED|Overall Study||14
6584932|NCT01947907|7509397|FG002|COMPLETED|Overall Study||14
6584933|NCT01947907|7509398|FG003|COMPLETED|Overall Study||13
6584934|NCT01947907|7509395|FG000|NOT COMPLETED|Overall Study||0
6584935|NCT01947907|7509396|FG001|NOT COMPLETED|Overall Study||0
6584936|NCT01947907|7509397|FG002|NOT COMPLETED|Overall Study||0
6584937|NCT01947907|7509398|FG003|NOT COMPLETED|Overall Study||0
6584938|NCT01947946|7509411|FG000|STARTED|Overall Study||3
6584939|NCT01947946|7509412|FG001|STARTED|Overall Study||5
6584940|NCT01947946|7509413|FG002|STARTED|Overall Study||5
6584941|NCT01947946|7509411|FG000|COMPLETED|Overall Study|Study Stopped|0
6584942|NCT01947946|7509412|FG001|COMPLETED|Overall Study||0
6584943|NCT01947946|7509413|FG002|COMPLETED|Overall Study||0
6584944|NCT01947946|7509411|FG000|NOT COMPLETED|Overall Study||3
6584945|NCT01947946|7509412|FG001|NOT COMPLETED|Overall Study||5
6584946|NCT01947946|7509413|FG002|NOT COMPLETED|Overall Study||5
6584947|NCT01948050|7509423|FG000|STARTED|Overall Study||16
6584948|NCT01948050|7509424|FG001|STARTED|Overall Study||8
6584949|NCT01948050|7509423|FG000|COMPLETED|Overall Study||16
6584950|NCT01948050|7509424|FG001|COMPLETED|Overall Study||7
6584951|NCT01948050|7509423|FG000|NOT COMPLETED|Overall Study||0
6584952|NCT01948050|7509424|FG001|NOT COMPLETED|Overall Study||1
6584953|NCT01948063|7509432|FG000|STARTED|Overall Study||20
6584954|NCT01948063|7509433|FG001|STARTED|Overall Study||21
6584955|NCT01948063|7509432|FG000|COMPLETED|Overall Study||19
6584956|NCT01948063|7509433|FG001|COMPLETED|Overall Study||19
6584957|NCT01948063|7509432|FG000|NOT COMPLETED|Overall Study||1
6584958|NCT01948063|7509433|FG001|NOT COMPLETED|Overall Study||2
6584959|NCT01948076|7509441|FG000|STARTED|Overall Study||20
6584960|NCT01948076|7509442|FG001|STARTED|Overall Study||20
6584961|NCT01948076|7509441|FG000|COMPLETED|Overall Study||20
6584962|NCT01948076|7509442|FG001|COMPLETED|Overall Study||19
6584963|NCT01948076|7509441|FG000|NOT COMPLETED|Overall Study||0
6584964|NCT01948076|7509442|FG001|NOT COMPLETED|Overall Study||1
6584965|NCT01948141|7509450|FG000|STARTED|Overall Study||6
6584966|NCT01948141|7509450|FG000|COMPLETED|Overall Study||6
6584967|NCT01948141|7509450|FG000|NOT COMPLETED|Overall Study||0
6584968|NCT01948193|7509454|FG000|STARTED|Overall Study||177
6584969|NCT01948193|7509454|FG000|COMPLETED|Overall Study||168
6584970|NCT01948193|7509454|FG000|NOT COMPLETED|Overall Study||9
6584971|NCT01948258|7509459|FG000|STARTED|Overall Study||395
6584972|NCT01948258|7509459|FG000|COMPLETED|Overall Study||233
6584973|NCT01948258|7509459|FG000|NOT COMPLETED|Overall Study||162
6584974|NCT01948310|7509465|FG000|STARTED|Overall Study||19
6584975|NCT01948310|7509466|FG001|STARTED|Overall Study||18
6584976|NCT01948310|7509465|FG000|COMPLETED|Overall Study||16
6584977|NCT01948310|7509466|FG001|COMPLETED|Overall Study||13
6584978|NCT01948310|7509465|FG000|NOT COMPLETED|Overall Study||3
6584979|NCT01948310|7509466|FG001|NOT COMPLETED|Overall Study||5
6584980|NCT01948375|7509474|FG000|STARTED|Overall Study||30
6584981|NCT01948375|7509475|FG001|STARTED|Overall Study||30
6584982|NCT01948375|7509474|FG000|COMPLETED|Overall Study||30
6584983|NCT01948375|7509475|FG001|COMPLETED|Overall Study||30
6584984|NCT01948375|7509474|FG000|NOT COMPLETED|Overall Study||0
6584985|NCT01948375|7509475|FG001|NOT COMPLETED|Overall Study||0
6584986|NCT01948388|7509485|FG000|STARTED|Overall Study||10
6584987|NCT01948388|7509486|FG001|STARTED|Overall Study||10
6584988|NCT01948388|7509485|FG000|COMPLETED|Overall Study||8
6584989|NCT01948388|7509486|FG001|COMPLETED|Overall Study||9
6584990|NCT01948388|7509485|FG000|NOT COMPLETED|Overall Study||2
6584991|NCT01948388|7509486|FG001|NOT COMPLETED|Overall Study||1
6584992|NCT01948427|7509499|FG000|STARTED|Overall Study||49
6584993|NCT01948427|7509500|FG001|STARTED|Overall Study||89
6584994|NCT01948427|7509501|FG002|STARTED|Overall Study||4
6584995|NCT01948427|7509502|FG003|STARTED|Overall Study||1
6584996|NCT01948427|7509503|FG004|STARTED|Overall Study||60
6584997|NCT01948427|7509499|FG000|COMPLETED|Overall Study||42
6584998|NCT01948427|7509500|FG001|COMPLETED|Overall Study||72
6584999|NCT01948427|7509501|FG002|COMPLETED|Overall Study||4
6585000|NCT01948427|7509502|FG003|COMPLETED|Overall Study||1
6585001|NCT01948427|7509503|FG004|COMPLETED|Overall Study||46
6585002|NCT01948427|7509499|FG000|NOT COMPLETED|Overall Study||7
6585003|NCT01948427|7509500|FG001|NOT COMPLETED|Overall Study||17
6585004|NCT01948427|7509501|FG002|NOT COMPLETED|Overall Study||0
6585005|NCT01948427|7509502|FG003|NOT COMPLETED|Overall Study||0
6585006|NCT01948427|7509503|FG004|NOT COMPLETED|Overall Study||14
6585007|NCT01948518|7509520|FG000|STARTED|Overall Study||15
6585008|NCT01948518|7509520|FG000|COMPLETED|Overall Study||15
6585009|NCT01948518|7509520|FG000|NOT COMPLETED|Overall Study||0
6585010|NCT01948739|7509524|FG000|STARTED|Overall Study||18
6585011|NCT01948739|7509524|FG000|Received Intervention|Overall Study||10
6585012|NCT01948739|7509524|FG000|COMPLETED|Overall Study||10
6585013|NCT01948739|7509524|FG000|NOT COMPLETED|Overall Study||8
6585014|NCT01948791|7509528|FG000|STARTED|Overall Study||222
6585015|NCT01948791|7509528|FG000|COMPLETED|Overall Study||151
6585016|NCT01948791|7509528|FG000|NOT COMPLETED|Overall Study||71
6585017|NCT01948830|7509534|FG000|STARTED|Overall Study||323
6585018|NCT01948830|7509535|FG001|STARTED|Overall Study||327
6585019|NCT01948830|7509534|FG000|Safety Set|Overall Study||323
6585020|NCT01948830|7509535|FG001|Safety Set|Overall Study||326
6585021|NCT01948830|7509534|FG000|COMPLETED|Overall Study||290
6585022|NCT01948830|7509535|FG001|COMPLETED|Overall Study||295
6585023|NCT01948830|7509534|FG000|NOT COMPLETED|Overall Study||33
6585024|NCT01948830|7509535|FG001|NOT COMPLETED|Overall Study||32
6585025|NCT01948908|7509544|FG000|STARTED|Overall Study||33
6585026|NCT01948908|7509545|FG001|STARTED|Overall Study||33
6585027|NCT01948908|7509546|FG002|STARTED|Overall Study||33
6585028|NCT01948908|7509544|FG000|COMPLETED|Overall Study||32
6585029|NCT01948908|7509545|FG001|COMPLETED|Overall Study||33
6585030|NCT01948908|7509546|FG002|COMPLETED|Overall Study||31
6585031|NCT01948908|7509544|FG000|NOT COMPLETED|Overall Study||1
6585032|NCT01948908|7509545|FG001|NOT COMPLETED|Overall Study||0
6585033|NCT01948908|7509546|FG002|NOT COMPLETED|Overall Study||2
6585034|NCT01948947|7509556|FG000|STARTED|Overall Study||14
6585035|NCT01948947|7509557|FG001|STARTED|Overall Study||15
6585036|NCT01948947|7509556|FG000|COMPLETED|Overall Study||14
6585037|NCT01948947|7509557|FG001|COMPLETED|Overall Study||15
6585038|NCT01948947|7509556|FG000|NOT COMPLETED|Overall Study||0
6585039|NCT01948947|7509557|FG001|NOT COMPLETED|Overall Study||0
6585040|NCT01948986|7509568|FG000|STARTED|Overall Study||6
6585041|NCT01948986|7509569|FG001|STARTED|Overall Study||8
6585042|NCT01948986|7509570|FG002|STARTED|Overall Study||8
6585043|NCT01948986|7509571|FG003|STARTED|Overall Study||6
6585044|NCT01948986|7509572|FG004|STARTED|Overall Study||8
6585045|NCT01948986|7509568|FG000|COMPLETED|Overall Study||6
6585046|NCT01948986|7509569|FG001|COMPLETED|Overall Study||8
6585047|NCT01948986|7509570|FG002|COMPLETED|Overall Study||8
6585048|NCT01948986|7509571|FG003|COMPLETED|Overall Study||6
6585049|NCT01948986|7509572|FG004|COMPLETED|Overall Study||8
6585050|NCT01948986|7509568|FG000|NOT COMPLETED|Overall Study||0
6585051|NCT01948986|7509569|FG001|NOT COMPLETED|Overall Study||0
6585052|NCT01948986|7509570|FG002|NOT COMPLETED|Overall Study||0
6585053|NCT01948986|7509571|FG003|NOT COMPLETED|Overall Study||0
6585054|NCT01948986|7509572|FG004|NOT COMPLETED|Overall Study||0
6585055|NCT01949051|7509584|FG000|STARTED|Treatment Period 1 (7 Days)||13
6585056|NCT01949051|7509585|FG001|STARTED|Treatment Period 1 (7 Days)||13
6585057|NCT01949051|7509586|FG002|STARTED|Treatment Period 1 (7 Days)||13
6585058|NCT01949051|7509587|FG003|STARTED|Treatment Period 1 (7 Days)||13
6585059|NCT01949051|7509588|FG004|STARTED|Treatment Period 1 (7 Days)||13
6585060|NCT01949051|7509589|FG005|STARTED|Treatment Period 1 (7 Days)||13
6585061|NCT01949051|7509584|FG000|COMPLETED|Treatment Period 1 (7 Days)||11
6585062|NCT01949051|7509585|FG001|COMPLETED|Treatment Period 1 (7 Days)||13
6585063|NCT01949051|7509586|FG002|COMPLETED|Treatment Period 1 (7 Days)||13
6585064|NCT01949051|7509587|FG003|COMPLETED|Treatment Period 1 (7 Days)||12
6585065|NCT01949051|7509588|FG004|COMPLETED|Treatment Period 1 (7 Days)||13
6585066|NCT01949051|7509589|FG005|COMPLETED|Treatment Period 1 (7 Days)||13
6585067|NCT01949051|7509584|FG000|NOT COMPLETED|Treatment Period 1 (7 Days)||2
6585068|NCT01949051|7509585|FG001|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6585069|NCT01949051|7509586|FG002|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6585070|NCT01949051|7509587|FG003|NOT COMPLETED|Treatment Period 1 (7 Days)||1
6585071|NCT01949051|7509588|FG004|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6585072|NCT01949051|7509589|FG005|NOT COMPLETED|Treatment Period 1 (7 Days)||0
6585073|NCT01949051|7509584|FG000|STARTED|Washout Period 1 (14 to 20 Days)||11
6585074|NCT01949051|7509585|FG001|STARTED|Washout Period 1 (14 to 20 Days)||13
6585075|NCT01949051|7509586|FG002|STARTED|Washout Period 1 (14 to 20 Days)||13
6585076|NCT01949051|7509587|FG003|STARTED|Washout Period 1 (14 to 20 Days)||12
6585077|NCT01949051|7509588|FG004|STARTED|Washout Period 1 (14 to 20 Days)||13
6585078|NCT01949051|7509589|FG005|STARTED|Washout Period 1 (14 to 20 Days)||13
6659216|NCT02487030|7590007|FG004|STARTED|Overall Study||36
6659217|NCT02487030|7590008|FG005|STARTED|Overall Study||38
6659218|NCT02487030|7590009|FG006|STARTED|Overall Study||11
6659219|NCT02487030|7590003|FG000|COMPLETED|Overall Study||41
6659220|NCT02487030|7590004|FG001|COMPLETED|Overall Study||38
6659221|NCT02487030|7590005|FG002|COMPLETED|Overall Study||41
6659222|NCT02487030|7590006|FG003|COMPLETED|Overall Study||40
6659223|NCT02487030|7590007|FG004|COMPLETED|Overall Study||34
6659224|NCT02487030|7590008|FG005|COMPLETED|Overall Study||37
6659225|NCT02487030|7590009|FG006|COMPLETED|Overall Study||11
6659226|NCT02487030|7590003|FG000|NOT COMPLETED|Overall Study||2
6659227|NCT02487030|7590004|FG001|NOT COMPLETED|Overall Study||4
6659228|NCT02487030|7590005|FG002|NOT COMPLETED|Overall Study||2
6659229|NCT02487030|7590006|FG003|NOT COMPLETED|Overall Study||2
6659230|NCT02487030|7590007|FG004|NOT COMPLETED|Overall Study||2
6659231|NCT02487030|7590008|FG005|NOT COMPLETED|Overall Study||1
6659232|NCT02487030|7590009|FG006|NOT COMPLETED|Overall Study||0
6659233|NCT02487056|7590026|FG000|STARTED|Overall Study||1622
6659234|NCT02487056|7590026|FG000|COMPLETED|Overall Study||1606
6659235|NCT02487056|7590026|FG000|NOT COMPLETED|Overall Study||16
6659236|NCT02487199|7590033|FG000|STARTED|Overall Study||13
6659237|NCT02487199|7590034|FG001|STARTED|Overall Study||5
6659238|NCT02487199|7590033|FG000|COMPLETED|Overall Study||13
6659239|NCT02487199|7590034|FG001|COMPLETED|Overall Study||4
6659240|NCT02487199|7590033|FG000|NOT COMPLETED|Overall Study||0
6659241|NCT02487199|7590034|FG001|NOT COMPLETED|Overall Study||1
6659242|NCT02487225|7590042|FG000|STARTED|Overall Study||45
6659243|NCT02487225|7590043|FG001|STARTED|Overall Study||38
6659244|NCT02487225|7590042|FG000|COMPLETED|Overall Study||18
6659245|NCT02487225|7590043|FG001|COMPLETED|Overall Study||8
6659246|NCT02487225|7590042|FG000|NOT COMPLETED|Overall Study||27
6659247|NCT02487225|7590043|FG001|NOT COMPLETED|Overall Study||30
6585079|NCT01949051|7509584|FG000|COMPLETED|Washout Period 1 (14 to 20 Days)||11
6585080|NCT01949051|7509585|FG001|COMPLETED|Washout Period 1 (14 to 20 Days)||13
6585081|NCT01949051|7509586|FG002|COMPLETED|Washout Period 1 (14 to 20 Days)||13
6585082|NCT01949051|7509587|FG003|COMPLETED|Washout Period 1 (14 to 20 Days)||12
6585083|NCT01949051|7509588|FG004|COMPLETED|Washout Period 1 (14 to 20 Days)||13
6585084|NCT01949051|7509589|FG005|COMPLETED|Washout Period 1 (14 to 20 Days)||13
6585085|NCT01949051|7509584|FG000|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6585086|NCT01949051|7509585|FG001|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6585087|NCT01949051|7509586|FG002|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6585088|NCT01949051|7509587|FG003|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6585089|NCT01949051|7509588|FG004|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6585090|NCT01949051|7509589|FG005|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
6585091|NCT01949051|7509584|FG000|STARTED|Treatment Period 2 (7 Days)||11
6585092|NCT01949051|7509585|FG001|STARTED|Treatment Period 2 (7 Days)||13
6585093|NCT01949051|7509586|FG002|STARTED|Treatment Period 2 (7 Days)||13
6585094|NCT01949051|7509587|FG003|STARTED|Treatment Period 2 (7 Days)||12
6585095|NCT01949051|7509588|FG004|STARTED|Treatment Period 2 (7 Days)||13
6585096|NCT01949051|7509589|FG005|STARTED|Treatment Period 2 (7 Days)||13
6585097|NCT01949051|7509584|FG000|COMPLETED|Treatment Period 2 (7 Days)||11
6585098|NCT01949051|7509585|FG001|COMPLETED|Treatment Period 2 (7 Days)||12
6585099|NCT01949051|7509586|FG002|COMPLETED|Treatment Period 2 (7 Days)||12
6585100|NCT01949051|7509587|FG003|COMPLETED|Treatment Period 2 (7 Days)||12
6585101|NCT01949051|7509588|FG004|COMPLETED|Treatment Period 2 (7 Days)||13
6585102|NCT01949051|7509589|FG005|COMPLETED|Treatment Period 2 (7 Days)||12
6585103|NCT01949051|7509584|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6585104|NCT01949051|7509585|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||1
6585105|NCT01949051|7509586|FG002|NOT COMPLETED|Treatment Period 2 (7 Days)||1
6585106|NCT01949051|7509587|FG003|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6585107|NCT01949051|7509588|FG004|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6585108|NCT01949051|7509589|FG005|NOT COMPLETED|Treatment Period 2 (7 Days)||1
6585109|NCT01949051|7509584|FG000|STARTED|Washout Period 2 (14 to 20 Days)||11
6585110|NCT01949051|7509585|FG001|STARTED|Washout Period 2 (14 to 20 Days)||12
6585111|NCT01949051|7509586|FG002|STARTED|Washout Period 2 (14 to 20 Days)||12
6585112|NCT01949051|7509587|FG003|STARTED|Washout Period 2 (14 to 20 Days)||12
6585113|NCT01949051|7509588|FG004|STARTED|Washout Period 2 (14 to 20 Days)||13
6585114|NCT01949051|7509589|FG005|STARTED|Washout Period 2 (14 to 20 Days)||12
6585115|NCT01949051|7509584|FG000|COMPLETED|Washout Period 2 (14 to 20 Days)||11
6585116|NCT01949051|7509585|FG001|COMPLETED|Washout Period 2 (14 to 20 Days)||12
6585117|NCT01949051|7509586|FG002|COMPLETED|Washout Period 2 (14 to 20 Days)||12
6585118|NCT01949051|7509587|FG003|COMPLETED|Washout Period 2 (14 to 20 Days)||12
6585119|NCT01949051|7509588|FG004|COMPLETED|Washout Period 2 (14 to 20 Days)||13
6585120|NCT01949051|7509589|FG005|COMPLETED|Washout Period 2 (14 to 20 Days)||12
6585121|NCT01949051|7509584|FG000|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6585122|NCT01949051|7509585|FG001|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6585123|NCT01949051|7509586|FG002|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6585124|NCT01949051|7509587|FG003|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6585125|NCT01949051|7509588|FG004|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6585126|NCT01949051|7509589|FG005|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
6585127|NCT01949051|7509584|FG000|STARTED|Treatment Period 3 (7 Days)||11
6585128|NCT01949051|7509585|FG001|STARTED|Treatment Period 3 (7 Days)||12
6585129|NCT01949051|7509586|FG002|STARTED|Treatment Period 3 (7 Days)||12
6585130|NCT01949051|7509587|FG003|STARTED|Treatment Period 3 (7 Days)||12
6585131|NCT01949051|7509588|FG004|STARTED|Treatment Period 3 (7 Days)||13
6585132|NCT01949051|7509589|FG005|STARTED|Treatment Period 3 (7 Days)||12
6585133|NCT01949051|7509584|FG000|COMPLETED|Treatment Period 3 (7 Days)||11
6585134|NCT01949051|7509585|FG001|COMPLETED|Treatment Period 3 (7 Days)||12
6585135|NCT01949051|7509586|FG002|COMPLETED|Treatment Period 3 (7 Days)||12
6585136|NCT01949051|7509587|FG003|COMPLETED|Treatment Period 3 (7 Days)||12
6659248|NCT02487303|7590052|FG000|STARTED|Overall Study||49
6659249|NCT02487303|7590053|FG001|STARTED|Overall Study||51
6659250|NCT02487303|7590054|FG002|STARTED|Overall Study||48
6659251|NCT02487303|7590052|FG000|COMPLETED|Overall Study||47
6659252|NCT02487303|7590053|FG001|COMPLETED|Overall Study||47
6659253|NCT02487303|7590054|FG002|COMPLETED|Overall Study||47
6659254|NCT02487303|7590052|FG000|NOT COMPLETED|Overall Study||2
6659255|NCT02487303|7590053|FG001|NOT COMPLETED|Overall Study||4
6659256|NCT02487303|7590054|FG002|NOT COMPLETED|Overall Study||1
6659257|NCT02487446|7590065|FG000|STARTED|Period 1||178
6659258|NCT02487446|7590066|FG001|STARTED|Period 1||179
6659259|NCT02487446|7590065|FG000|COMPLETED|Period 1||165
6659260|NCT02487446|7590066|FG001|COMPLETED|Period 1||171
6659261|NCT02487446|7590065|FG000|NOT COMPLETED|Period 1||13
6659262|NCT02487446|7590066|FG001|NOT COMPLETED|Period 1||8
6659263|NCT02487446|7590065|FG000|STARTED|Washout||165
6659264|NCT02487446|7590066|FG001|STARTED|Washout||171
6659265|NCT02487446|7590065|FG000|COMPLETED|Washout||162
6659266|NCT02487446|7590066|FG001|COMPLETED|Washout||163
6659267|NCT02487446|7590065|FG000|NOT COMPLETED|Washout||3
6659268|NCT02487446|7590066|FG001|NOT COMPLETED|Washout||8
6659269|NCT02487446|7590065|FG000|STARTED|Period 2||162
6659270|NCT02487446|7590066|FG001|STARTED|Period 2||163
6659271|NCT02487446|7590065|FG000|COMPLETED|Period 2||154
6659272|NCT02487446|7590066|FG001|COMPLETED|Period 2||158
6585137|NCT01949051|7509588|FG004|COMPLETED|Treatment Period 3 (7 Days)||13
6585138|NCT01949051|7509589|FG005|COMPLETED|Treatment Period 3 (7 Days)||12
6585139|NCT01949051|7509584|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6585140|NCT01949051|7509585|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6585141|NCT01949051|7509586|FG002|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6585142|NCT01949051|7509587|FG003|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6585143|NCT01949051|7509588|FG004|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6585144|NCT01949051|7509589|FG005|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6585145|NCT01949090|7509602|FG000|STARTED|Overall Study||60
6585146|NCT01949090|7509603|FG001|STARTED|Overall Study||60
6585147|NCT01949090|7509604|FG002|STARTED|Overall Study||60
6585148|NCT01949090|7509605|FG003|STARTED|Overall Study||60
6585149|NCT01949090|7509606|FG004|STARTED|Overall Study||120
6585150|NCT01949090|7509602|FG000|COMPLETED|Overall Study||56
6585151|NCT01949090|7509603|FG001|COMPLETED|Overall Study||58
6585152|NCT01949090|7509604|FG002|COMPLETED|Overall Study||58
6585153|NCT01949090|7509605|FG003|COMPLETED|Overall Study||59
6585154|NCT01949090|7509606|FG004|COMPLETED|Overall Study||116
6585155|NCT01949090|7509602|FG000|NOT COMPLETED|Overall Study||4
6585156|NCT01949090|7509603|FG001|NOT COMPLETED|Overall Study||2
6585157|NCT01949090|7509604|FG002|NOT COMPLETED|Overall Study||2
6585158|NCT01949090|7509605|FG003|NOT COMPLETED|Overall Study||1
6585159|NCT01949090|7509606|FG004|NOT COMPLETED|Overall Study||4
6585160|NCT01949116|7509621|FG000|STARTED|Overall Study||86
6585161|NCT01949116|7509622|FG001|STARTED|Overall Study||90
6585162|NCT01949116|7509621|FG000|COMPLETED|Overall Study||78
6585163|NCT01949116|7509622|FG001|COMPLETED|Overall Study||84
6585164|NCT01949116|7509621|FG000|NOT COMPLETED|Overall Study||8
6585165|NCT01949116|7509622|FG001|NOT COMPLETED|Overall Study||6
6585166|NCT01949142|7509634|FG000|STARTED|Overall Study||179
6585167|NCT01949142|7509635|FG001|STARTED|Overall Study||87
6585168|NCT01949142|7509634|FG000|COMPLETED|Overall Study||176
6585169|NCT01949142|7509635|FG001|COMPLETED|Overall Study||86
6585170|NCT01949142|7509634|FG000|NOT COMPLETED|Overall Study||3
6585171|NCT01949142|7509635|FG001|NOT COMPLETED|Overall Study||1
6585172|NCT01949155|7509644|FG000|STARTED|Overall Study||178
6585173|NCT01949155|7509645|FG001|STARTED|Overall Study||88
6585174|NCT01949155|7509644|FG000|COMPLETED|Overall Study||176
6585175|NCT01949155|7509645|FG001|COMPLETED|Overall Study||88
6585176|NCT01949155|7509644|FG000|NOT COMPLETED|Overall Study||2
6585177|NCT01949155|7509645|FG001|NOT COMPLETED|Overall Study||0
6585178|NCT01949337|7509654|FG000|STARTED|Overall Study||657
6585179|NCT01949337|7509655|FG001|STARTED|Overall Study||654
6585180|NCT01949337|7509654|FG000|COMPLETED|Overall Study||657
6585181|NCT01949337|7509655|FG001|COMPLETED|Overall Study||654
6585182|NCT01949337|7509654|FG000|NOT COMPLETED|Overall Study||0
6585183|NCT01949337|7509655|FG001|NOT COMPLETED|Overall Study||0
6585184|NCT01949389|7509661|FG000|STARTED|Overall Study||51
6585185|NCT01949389|7509661|FG000|COMPLETED|Overall Study||51
6585186|NCT01949389|7509661|FG000|NOT COMPLETED|Overall Study||0
6585187|NCT01949480|7509667|FG000|STARTED|Overall Study||20
6585188|NCT01949480|7509668|FG001|STARTED|Overall Study||22
6585189|NCT01949480|7509667|FG000|COMPLETED|Overall Study||15
6585190|NCT01949480|7509668|FG001|COMPLETED|Overall Study||14
6585191|NCT01949480|7509667|FG000|NOT COMPLETED|Overall Study||5
6585192|NCT01949480|7509668|FG001|NOT COMPLETED|Overall Study||8
6585193|NCT01949532|7509676|FG000|STARTED|Overall Study||15
6585194|NCT01949532|7509677|FG001|STARTED|Overall Study||11
6585195|NCT01949532|7509676|FG000|COMPLETED|Overall Study||12
6585196|NCT01949532|7509677|FG001|COMPLETED|Overall Study||8
6585197|NCT01949532|7509676|FG000|NOT COMPLETED|Overall Study||3
6585198|NCT01949532|7509677|FG001|NOT COMPLETED|Overall Study||3
6585199|NCT01949545|7509687|FG000|STARTED|Overall Study||11
6585200|NCT01949545|7509688|FG001|STARTED|Overall Study||17
6585201|NCT01949545|7509689|FG002|STARTED|Overall Study||14
6585202|NCT01949545|7509690|FG003|STARTED|Overall Study||4
6585203|NCT01949545|7509687|FG000|COMPLETED|Overall Study||11
6585204|NCT01949545|7509688|FG001|COMPLETED|Overall Study||17
6585205|NCT01949545|7509689|FG002|COMPLETED|Overall Study||14
6585206|NCT01949545|7509690|FG003|COMPLETED|Overall Study||4
6585207|NCT01949545|7509687|FG000|NOT COMPLETED|Overall Study||0
6585208|NCT01949545|7509688|FG001|NOT COMPLETED|Overall Study||0
6585209|NCT01949545|7509689|FG002|NOT COMPLETED|Overall Study||0
6585210|NCT01949545|7509690|FG003|NOT COMPLETED|Overall Study||0
6585211|NCT01949662|7509702|FG000|STARTED|Overall Study||47
6585212|NCT01949662|7509703|FG001|STARTED|Overall Study||43
6585213|NCT01949662|7509702|FG000|COMPLETED|Overall Study||29
6585214|NCT01949662|7509703|FG001|COMPLETED|Overall Study||29
6585215|NCT01949662|7509702|FG000|NOT COMPLETED|Overall Study||18
6585216|NCT01949662|7509703|FG001|NOT COMPLETED|Overall Study||14
6585217|NCT01949779|7509709|FG000|STARTED|Overall Study||81
6585218|NCT01949779|7509709|FG000|COMPLETED|Overall Study||79
6585219|NCT01949779|7509709|FG000|NOT COMPLETED|Overall Study||2
6585220|NCT01949844|7509713|FG000|STARTED|Overall Study||44
6585221|NCT01949844|7509713|FG000|COMPLETED|Overall Study||44
6585222|NCT01949844|7509713|FG000|NOT COMPLETED|Overall Study||0
6585223|NCT01949870|7509717|FG000|STARTED|Overall Study||6
6585224|NCT01949870|7509717|FG000|Received Treatment|Overall Study||4
6585225|NCT01949870|7509717|FG000|COMPLETED|Overall Study||0
6585226|NCT01949870|7509717|FG000|NOT COMPLETED|Overall Study||6
6585227|NCT01950013|7509724|FG000|STARTED|Overall Study||15
6585228|NCT01950013|7509725|FG001|STARTED|Overall Study||15
6585229|NCT01950013|7509726|FG002|STARTED|Overall Study||15
6585230|NCT01950013|7509724|FG000|COMPLETED|Overall Study||15
6585231|NCT01950013|7509725|FG001|COMPLETED|Overall Study||13
6585232|NCT01950013|7509726|FG002|COMPLETED|Overall Study||15
6585233|NCT01950013|7509724|FG000|NOT COMPLETED|Overall Study||0
6585234|NCT01950013|7509725|FG001|NOT COMPLETED|Overall Study||2
6585235|NCT01950013|7509726|FG002|NOT COMPLETED|Overall Study||0
6585236|NCT01950039|7509736|FG000|STARTED|Overall Study||15
6585237|NCT01950039|7509737|FG001|STARTED|Overall Study||13
6585238|NCT01950039|7509736|FG000|Study Drug Initiated|Overall Study||14
6585239|NCT01950039|7509737|FG001|Study Drug Initiated|Overall Study||13
6585240|NCT01950039|7509736|FG000|Completed Clamp|Overall Study||13
6585241|NCT01950039|7509737|FG001|Completed Clamp|Overall Study||12
6585242|NCT01950039|7509736|FG000|Completed MRI|Overall Study||13
6585243|NCT01950039|7509737|FG001|Completed MRI|Overall Study||12
6585244|NCT01950039|7509736|FG000|Completed Endothelial Evaluation|Overall Study||14
6585245|NCT01950039|7509737|FG001|Completed Endothelial Evaluation|Overall Study||12
6585246|NCT01950039|7509736|FG000|COMPLETED|Overall Study||14
6585247|NCT01950039|7509737|FG001|COMPLETED|Overall Study||13
6585248|NCT01950039|7509736|FG000|NOT COMPLETED|Overall Study||1
6585249|NCT01950039|7509737|FG001|NOT COMPLETED|Overall Study||0
6585250|NCT01950078|7509745|FG000|STARTED|Overall Study||1025
6585251|NCT01950078|7509746|FG001|STARTED|Overall Study||508
6585252|NCT01950078|7509745|FG000|COMPLETED|Overall Study||1005
6585253|NCT01950078|7509746|FG001|COMPLETED|Overall Study||496
6585254|NCT01950078|7509745|FG000|NOT COMPLETED|Overall Study||20
6585255|NCT01950078|7509746|FG001|NOT COMPLETED|Overall Study||12
6585256|NCT01950169|7509755|FG000|STARTED|Overall Study||28
6585257|NCT01950169|7509756|FG001|STARTED|Overall Study||26
6585258|NCT01950169|7509757|FG002|STARTED|Overall Study||25
6585259|NCT01950169|7509755|FG000|COMPLETED|Overall Study||25
6585260|NCT01950169|7509756|FG001|COMPLETED|Overall Study||18
6585261|NCT01950169|7509757|FG002|COMPLETED|Overall Study||24
6585262|NCT01950169|7509755|FG000|NOT COMPLETED|Overall Study||3
6585263|NCT01950169|7509756|FG001|NOT COMPLETED|Overall Study||8
6585264|NCT01950169|7509757|FG002|NOT COMPLETED|Overall Study||1
6585265|NCT01950260|7509768|FG000|STARTED|Overall Study||30
6585266|NCT01950260|7509769|FG001|STARTED|Overall Study||31
6585267|NCT01950260|7509768|FG000|COMPLETED|Overall Study||30
6585268|NCT01950260|7509769|FG001|COMPLETED|Overall Study||31
6585269|NCT01950260|7509768|FG000|NOT COMPLETED|Overall Study||0
6585270|NCT01950260|7509769|FG001|NOT COMPLETED|Overall Study||0
6585271|NCT01950273|7509777|FG000|STARTED|Overall Study||49
6585272|NCT01950273|7509778|FG001|STARTED|Overall Study||46
6585273|NCT01950273|7509777|FG000|COMPLETED|Overall Study||45
6585274|NCT01950273|7509778|FG001|COMPLETED|Overall Study||46
6585275|NCT01950273|7509777|FG000|NOT COMPLETED|Overall Study||4
6585276|NCT01950273|7509778|FG001|NOT COMPLETED|Overall Study||0
6585277|NCT01950299|7509787|FG000|STARTED|Overall Study||33
6585278|NCT01950299|7509788|FG001|STARTED|Overall Study||31
6585279|NCT01950299|7509789|FG002|STARTED|Overall Study||35
6585280|NCT01950299|7509787|FG000|COMPLETED|Overall Study||22
6585281|NCT01950299|7509788|FG001|COMPLETED|Overall Study||27
6585282|NCT01950299|7509789|FG002|COMPLETED|Overall Study||28
6585283|NCT01950299|7509787|FG000|NOT COMPLETED|Overall Study||11
6585284|NCT01950299|7509788|FG001|NOT COMPLETED|Overall Study||4
6585285|NCT01950299|7509789|FG002|NOT COMPLETED|Overall Study||7
6585286|NCT01950364|7509799|FG000|STARTED|Overall Study||10
6585287|NCT01950364|7509800|FG001|STARTED|Overall Study||10
6585288|NCT01950364|7509799|FG000|COMPLETED|Overall Study||0
6585289|NCT01950364|7509800|FG001|COMPLETED|Overall Study||0
6585290|NCT01950364|7509799|FG000|NOT COMPLETED|Overall Study||10
6585291|NCT01950364|7509800|FG001|NOT COMPLETED|Overall Study||10
6585292|NCT01950663|7509806|FG000|STARTED|Overall Study||468
6585293|NCT01950663|7509806|FG000|COMPLETED|Overall Study||467
6585294|NCT01950663|7509806|FG000|NOT COMPLETED|Overall Study||1
6585295|NCT01950741|7509810|FG000|STARTED|Overall Study||48
6585296|NCT01950741|7509810|FG000|COMPLETED|Overall Study||45
6585297|NCT01950741|7509810|FG000|NOT COMPLETED|Overall Study||3
6585298|NCT01950780|7509814|FG000|STARTED|Overall Study||12
6585299|NCT01950780|7509814|FG000|COMPLETED|Overall Study||12
6585300|NCT01950780|7509814|FG000|NOT COMPLETED|Overall Study||0
6585301|NCT01950819|7509821|FG000|STARTED|Overall Study||1022
6585302|NCT01950819|7509822|FG001|STARTED|Overall Study||1015
6585303|NCT01950819|7509821|FG000|COMPLETED|Overall Study||893
6585304|NCT01950819|7509822|FG001|COMPLETED|Overall Study||881
6585305|NCT01950819|7509821|FG000|NOT COMPLETED|Overall Study||129
6585306|NCT01950819|7509822|FG001|NOT COMPLETED|Overall Study||134
6585307|NCT01951066|7509828|FG000|STARTED|First Intervention (Baseline to Week 16)||10
6585308|NCT01951066|7509829|FG001|STARTED|First Intervention (Baseline to Week 16)||10
6585309|NCT01951066|7509828|FG000|COMPLETED|First Intervention (Baseline to Week 16)||10
6585310|NCT01951066|7509829|FG001|COMPLETED|First Intervention (Baseline to Week 16)||10
6585311|NCT01951066|7509828|FG000|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
6585312|NCT01951066|7509829|FG001|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
6585313|NCT01951066|7509828|FG000|STARTED|Second Intervention (Week 16 to Week 32)||10
6585314|NCT01951066|7509829|FG001|STARTED|Second Intervention (Week 16 to Week 32)||10
6585315|NCT01951066|7509828|FG000|COMPLETED|Second Intervention (Week 16 to Week 32)||10
6585316|NCT01951066|7509829|FG001|COMPLETED|Second Intervention (Week 16 to Week 32)||10
6585317|NCT01951066|7509828|FG000|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
6585318|NCT01951066|7509829|FG001|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
6585319|NCT01951092|7509834|FG000|STARTED|Overall Study||32
6585320|NCT01951092|7509834|FG000|COMPLETED|Overall Study||20
6585321|NCT01951092|7509834|FG000|NOT COMPLETED|Overall Study||12
6585322|NCT01951105|7509841|FG000|STARTED|Overall Study||11
6585323|NCT01951105|7509842|FG001|STARTED|Overall Study||31
6585324|NCT01951105|7509843|FG002|STARTED|Overall Study||30
6585325|NCT01951105|7509841|FG000|Completed 12 Weeks Treatment|Overall Study||10
6585326|NCT01951105|7509842|FG001|Completed 12 Weeks Treatment|Overall Study||24
6585327|NCT01951105|7509843|FG002|Completed 12 Weeks Treatment|Overall Study||28
6585328|NCT01951105|7509841|FG000|COMPLETED|Overall Study||10
6585329|NCT01951105|7509842|FG001|COMPLETED|Overall Study||21
6585330|NCT01951105|7509843|FG002|COMPLETED|Overall Study||28
6585331|NCT01951105|7509841|FG000|NOT COMPLETED|Overall Study||1
6585332|NCT01951105|7509842|FG001|NOT COMPLETED|Overall Study||10
6585333|NCT01951105|7509843|FG002|NOT COMPLETED|Overall Study||2
6585334|NCT01951118|7509857|FG000|STARTED|Overall Study||121
6585335|NCT01951118|7509857|FG000|COMPLETED|Overall Study||94
6585336|NCT01951118|7509857|FG000|NOT COMPLETED|Overall Study||27
6585337|NCT01951157|7509869|FG000|STARTED|Overall Study||22
6585338|NCT01951157|7509870|FG001|STARTED|Overall Study||22
6585339|NCT01951157|7509871|FG002|STARTED|Overall Study||25
6585340|NCT01951157|7509869|FG000|COMPLETED|Overall Study||0
6585341|NCT01951157|7509870|FG001|COMPLETED|Overall Study||0
6585342|NCT01951157|7509871|FG002|COMPLETED|Overall Study||0
6585343|NCT01951157|7509869|FG000|NOT COMPLETED|Overall Study||22
6585344|NCT01951157|7509870|FG001|NOT COMPLETED|Overall Study||22
6585345|NCT01951157|7509871|FG002|NOT COMPLETED|Overall Study||25
6585346|NCT01951170|7509880|FG000|STARTED|Overall Study||52
6585347|NCT01951170|7509880|FG000|COMPLETED|Overall Study||51
6585348|NCT01951170|7509880|FG000|NOT COMPLETED|Overall Study||1
6585349|NCT01951261|7509886|FG000|STARTED|Overall Study||58
6585350|NCT01951261|7509887|FG001|STARTED|Overall Study||58
6585351|NCT01951261|7509886|FG000|Discontinued|Overall Study|"2-readmission when was at home~1-monitor failure~1-new home hospitalitation 4-missing~1-death"|9
6585352|NCT01951261|7509887|FG001|Discontinued|Overall Study|"2-readmission when was at home~1-new home hospitalitation 3-missing"|6
6585353|NCT01951261|7509886|FG000|COMPLETED|Overall Study||49
6585354|NCT01951261|7509887|FG001|COMPLETED|Overall Study||52
6585355|NCT01951261|7509886|FG000|NOT COMPLETED|Overall Study||9
6585356|NCT01951261|7509887|FG001|NOT COMPLETED|Overall Study||6
6585357|NCT01951326|7509895|FG000|STARTED|Overall Study||166
6585358|NCT01951326|7509896|FG001|STARTED|Overall Study||165
6585359|NCT01951326|7509895|FG000|COMPLETED|Overall Study||87
6585360|NCT01951326|7509896|FG001|COMPLETED|Overall Study||87
6585361|NCT01951326|7509895|FG000|NOT COMPLETED|Overall Study||79
6585362|NCT01951326|7509896|FG001|NOT COMPLETED|Overall Study||78
6585363|NCT01951339|7509905|FG000|STARTED|Overall Study||15
6585364|NCT01951339|7509906|FG001|STARTED|Overall Study||15
6585365|NCT01951339|7509905|FG000|COMPLETED|Overall Study||13
6585366|NCT01951339|7509906|FG001|COMPLETED|Overall Study||14
6585367|NCT01951339|7509905|FG000|NOT COMPLETED|Overall Study||2
6585368|NCT01951339|7509906|FG001|NOT COMPLETED|Overall Study||1
6585369|NCT01951352|7509912|FG000|STARTED|Overall Study||10
6585370|NCT01951352|7509912|FG000|COMPLETED|Overall Study||10
6585371|NCT01951352|7509912|FG000|NOT COMPLETED|Overall Study||0
6585372|NCT01951391|7509918|FG000|STARTED|Overall Study||5
6585373|NCT01951391|7509919|FG001|STARTED|Overall Study||5
6585374|NCT01951391|7509918|FG000|COMPLETED|Overall Study||5
6585375|NCT01951391|7509919|FG001|COMPLETED|Overall Study||5
6585376|NCT01951391|7509918|FG000|NOT COMPLETED|Overall Study||0
6585377|NCT01951391|7509919|FG001|NOT COMPLETED|Overall Study||0
6585378|NCT01951417|7509927|FG000|STARTED|Overall Study||81
6585379|NCT01951417|7509927|FG000|COMPLETED|Overall Study||72
6585380|NCT01951417|7509927|FG000|NOT COMPLETED|Overall Study||9
6585381|NCT01951573|7509935|FG000|STARTED|Period 1, First 9 Hours of Wear||17
6585382|NCT01951573|7509936|FG001|STARTED|Period 1, First 9 Hours of Wear||17
6585383|NCT01951573|7509935|FG000|COMPLETED|Period 1, First 9 Hours of Wear||17
6585384|NCT01951573|7509936|FG001|COMPLETED|Period 1, First 9 Hours of Wear||17
6585385|NCT01951573|7509935|FG000|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
6585386|NCT01951573|7509936|FG001|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
6585387|NCT01951573|7509935|FG000|STARTED|Washout Period||17
6585388|NCT01951573|7509936|FG001|STARTED|Washout Period||17
6585389|NCT01951573|7509935|FG000|COMPLETED|Washout Period||17
6585390|NCT01951573|7509936|FG001|COMPLETED|Washout Period||16
6585391|NCT01951573|7509935|FG000|NOT COMPLETED|Washout Period||0
6585392|NCT01951573|7509936|FG001|NOT COMPLETED|Washout Period||1
6585393|NCT01951573|7509935|FG000|STARTED|Period 2, Second 9 Hours of Wear||17
6659273|NCT02487446|7590065|FG000|NOT COMPLETED|Period 2||8
6585394|NCT01951573|7509936|FG001|STARTED|Period 2, Second 9 Hours of Wear||16
6585395|NCT01951573|7509935|FG000|COMPLETED|Period 2, Second 9 Hours of Wear||17
6585396|NCT01951573|7509936|FG001|COMPLETED|Period 2, Second 9 Hours of Wear||16
6659274|NCT02487446|7590066|FG001|NOT COMPLETED|Period 2||5
6585397|NCT01951573|7509935|FG000|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
6585398|NCT01951573|7509936|FG001|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
6585399|NCT01951586|7509944|FG000|STARTED|Overall Study||78
6585400|NCT01951586|7509945|FG001|STARTED|Overall Study||148
6585401|NCT01951586|7509944|FG000|Received Study Drug|Overall Study||76
6585402|NCT01951586|7509945|FG001|Received Study Drug|Overall Study||145
6585403|NCT01951586|7509944|FG000|COMPLETED|Overall Study||0
6585404|NCT01951586|7509945|FG001|COMPLETED|Overall Study||0
6585405|NCT01951586|7509944|FG000|NOT COMPLETED|Overall Study||78
6585406|NCT01951586|7509945|FG001|NOT COMPLETED|Overall Study||148
6585407|NCT01951625|7509957|FG000|STARTED|Treatment Period||92
6585408|NCT01951625|7509958|FG001|STARTED|Treatment Period||91
6585409|NCT01951625|7509959|FG002|STARTED|Treatment Period||91
6585410|NCT01951625|7509960|FG003|STARTED|Treatment Period||91
6585411|NCT01951625|7509961|FG004|STARTED|Treatment Period||91
6585412|NCT01951625|7509957|FG000|COMPLETED|Treatment Period||73
6585413|NCT01951625|7509958|FG001|COMPLETED|Treatment Period||70
6585414|NCT01951625|7509959|FG002|COMPLETED|Treatment Period||76
6585415|NCT01951625|7509960|FG003|COMPLETED|Treatment Period||69
6585416|NCT01951625|7509961|FG004|COMPLETED|Treatment Period||74
6585417|NCT01951625|7509957|FG000|NOT COMPLETED|Treatment Period||19
6585418|NCT01951625|7509958|FG001|NOT COMPLETED|Treatment Period||21
6585419|NCT01951625|7509959|FG002|NOT COMPLETED|Treatment Period||15
6585420|NCT01951625|7509960|FG003|NOT COMPLETED|Treatment Period||22
6585421|NCT01951625|7509961|FG004|NOT COMPLETED|Treatment Period||17
6585422|NCT01951625|7509957|FG000|STARTED|Follow Up Period||87
6585423|NCT01951625|7509958|FG001|STARTED|Follow Up Period||88
6585424|NCT01951625|7509959|FG002|STARTED|Follow Up Period||88
6585425|NCT01951625|7509960|FG003|STARTED|Follow Up Period||87
6585426|NCT01951625|7509961|FG004|STARTED|Follow Up Period||88
6585427|NCT01951625|7509957|FG000|COMPLETED|Follow Up Period||79
6585428|NCT01951625|7509958|FG001|COMPLETED|Follow Up Period||79
6585429|NCT01951625|7509959|FG002|COMPLETED|Follow Up Period||84
6585430|NCT01951625|7509960|FG003|COMPLETED|Follow Up Period||76
6585431|NCT01951625|7509961|FG004|COMPLETED|Follow Up Period||78
6585432|NCT01951625|7509957|FG000|NOT COMPLETED|Follow Up Period||8
6585433|NCT01951625|7509958|FG001|NOT COMPLETED|Follow Up Period||9
6585434|NCT01951625|7509959|FG002|NOT COMPLETED|Follow Up Period||4
6585435|NCT01951625|7509960|FG003|NOT COMPLETED|Follow Up Period||11
6585436|NCT01951625|7509961|FG004|NOT COMPLETED|Follow Up Period||10
6585437|NCT01951638|7509979|FG000|STARTED|Treatment Period||93
6585438|NCT01951638|7509980|FG001|STARTED|Treatment Period||96
6585439|NCT01951638|7509981|FG002|STARTED|Treatment Period||96
6585440|NCT01951638|7509982|FG003|STARTED|Treatment Period||96
6585441|NCT01951638|7509983|FG004|STARTED|Treatment Period||96
6585442|NCT01951638|7509979|FG000|COMPLETED|Treatment Period||80
6585443|NCT01951638|7509980|FG001|COMPLETED|Treatment Period||82
6585444|NCT01951638|7509981|FG002|COMPLETED|Treatment Period||83
6585445|NCT01951638|7509982|FG003|COMPLETED|Treatment Period||80
6585446|NCT01951638|7509983|FG004|COMPLETED|Treatment Period||86
6585447|NCT01951638|7509979|FG000|NOT COMPLETED|Treatment Period||13
6585448|NCT01951638|7509980|FG001|NOT COMPLETED|Treatment Period||14
6585449|NCT01951638|7509981|FG002|NOT COMPLETED|Treatment Period||13
6585450|NCT01951638|7509982|FG003|NOT COMPLETED|Treatment Period||16
6585451|NCT01951638|7509983|FG004|NOT COMPLETED|Treatment Period||10
6585452|NCT01951638|7509979|FG000|STARTED|Follow-up Period||89
6585453|NCT01951638|7509980|FG001|STARTED|Follow-up Period||95
6585454|NCT01951638|7509981|FG002|STARTED|Follow-up Period||95
6585455|NCT01951638|7509982|FG003|STARTED|Follow-up Period||88
6585456|NCT01951638|7509983|FG004|STARTED|Follow-up Period||94
6585457|NCT01951638|7509979|FG000|COMPLETED|Follow-up Period||87
6585458|NCT01951638|7509980|FG001|COMPLETED|Follow-up Period||86
6585459|NCT01951638|7509981|FG002|COMPLETED|Follow-up Period||90
6585460|NCT01951638|7509982|FG003|COMPLETED|Follow-up Period||80
6585461|NCT01951638|7509983|FG004|COMPLETED|Follow-up Period||89
6585462|NCT01951638|7509979|FG000|NOT COMPLETED|Follow-up Period||2
6585463|NCT01951638|7509980|FG001|NOT COMPLETED|Follow-up Period||9
6585464|NCT01951638|7509981|FG002|NOT COMPLETED|Follow-up Period||5
6585465|NCT01951638|7509982|FG003|NOT COMPLETED|Follow-up Period||8
6585466|NCT01951638|7509983|FG004|NOT COMPLETED|Follow-up Period||5
6624340|NCT02216357|7551745|FG000|COMPLETED|Overall Study||12
6624341|NCT02216357|7551746|FG001|COMPLETED|Overall Study||4
6624342|NCT02216357|7551745|FG000|NOT COMPLETED|Overall Study||2
6624343|NCT02216357|7551746|FG001|NOT COMPLETED|Overall Study||1
6624344|NCT02216422|7551752|FG000|STARTED|Overall Study||36
6624345|NCT02216422|7551752|FG000|COMPLETED|Overall Study||36
6624346|NCT02216422|7551752|FG000|NOT COMPLETED|Overall Study||0
6624347|NCT02216526|7551759|FG000|STARTED|Overall Study||45
6624348|NCT02216526|7551760|FG001|STARTED|Overall Study||44
6624349|NCT02216526|7551761|FG002|STARTED|Overall Study||44
6624350|NCT02216526|7551759|FG000|COMPLETED|Overall Study||40
6624351|NCT02216526|7551760|FG001|COMPLETED|Overall Study||41
6624352|NCT02216526|7551761|FG002|COMPLETED|Overall Study||36
6624353|NCT02216526|7551759|FG000|NOT COMPLETED|Overall Study||5
6624354|NCT02216526|7551760|FG001|NOT COMPLETED|Overall Study||3
6624355|NCT02216526|7551761|FG002|NOT COMPLETED|Overall Study||8
6624356|NCT02216591|7551771|FG000|STARTED|Overall Study||11
6624357|NCT02216591|7551772|FG001|STARTED|Overall Study||10
6624358|NCT02216591|7551771|FG000|COMPLETED|Overall Study||11
6624359|NCT02216591|7551772|FG001|COMPLETED|Overall Study||9
6624360|NCT02216591|7551771|FG000|NOT COMPLETED|Overall Study||0
6624361|NCT02216591|7551772|FG001|NOT COMPLETED|Overall Study||1
6624362|NCT02216695|7551778|FG000|STARTED|Overall Study||64882
6624363|NCT02216695|7551778|FG000|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
6624364|NCT02216695|7551778|FG000|NOT COMPLETED|Overall Study||0
6624365|NCT02216773|7551789|FG000|STARTED|Overall Study||28
6624366|NCT02216773|7551790|FG001|STARTED|Overall Study||29
6659275|NCT02487472|7590073|FG000|STARTED|Overall Study||101
6585467|NCT01951651|7509997|FG000|STARTED|Overall Study||12
6585468|NCT01951651|7509998|FG001|STARTED|Overall Study||12
6585469|NCT01951651|7509997|FG000|COMPLETED|Overall Study||8
6585470|NCT01951651|7509998|FG001|COMPLETED|Overall Study||10
6585471|NCT01951651|7509997|FG000|NOT COMPLETED|Overall Study||4
6585472|NCT01951651|7509998|FG001|NOT COMPLETED|Overall Study||2
6585473|NCT01951703|7510006|FG000|STARTED|First Intervention||64
6585474|NCT01951703|7510007|FG001|STARTED|First Intervention||63
6585475|NCT01951703|7510006|FG000|COMPLETED|First Intervention||61
6585476|NCT01951703|7510007|FG001|COMPLETED|First Intervention||62
6585477|NCT01951703|7510006|FG000|NOT COMPLETED|First Intervention||3
6585478|NCT01951703|7510007|FG001|NOT COMPLETED|First Intervention||1
6585479|NCT01951703|7510006|FG000|STARTED|Second Intervention||61
6585480|NCT01951703|7510007|FG001|STARTED|Second Intervention||62
6585481|NCT01951703|7510006|FG000|COMPLETED|Second Intervention||61
6585482|NCT01951703|7510007|FG001|COMPLETED|Second Intervention||60
6585483|NCT01951703|7510006|FG000|NOT COMPLETED|Second Intervention||0
6585484|NCT01951703|7510007|FG001|NOT COMPLETED|Second Intervention||2
6585485|NCT01951768|7510016|FG000|STARTED|Overall Study||43
6585486|NCT01951768|7510017|FG001|STARTED|Overall Study||45
6585487|NCT01951768|7510016|FG000|COMPLETED|Overall Study|43 patients|43
6585488|NCT01951768|7510017|FG001|COMPLETED|Overall Study|45 patients|45
6585489|NCT01951768|7510016|FG000|NOT COMPLETED|Overall Study||0
6585490|NCT01951768|7510017|FG001|NOT COMPLETED|Overall Study||0
6585491|NCT01951820|7510025|FG000|STARTED|Overall Study||34
6585492|NCT01951820|7510026|FG001|STARTED|Overall Study||30
6585493|NCT01951820|7510025|FG000|COMPLETED|Overall Study||34
6585494|NCT01951820|7510026|FG001|COMPLETED|Overall Study||30
6585495|NCT01951820|7510025|FG000|NOT COMPLETED|Overall Study||0
6585496|NCT01951820|7510026|FG001|NOT COMPLETED|Overall Study||0
6585497|NCT01951950|7510034|FG000|STARTED|Overall Study||26
6585498|NCT01951950|7510035|FG001|STARTED|Overall Study||26
6585499|NCT01951950|7510034|FG000|COMPLETED|Overall Study||20
6585500|NCT01951950|7510035|FG001|COMPLETED|Overall Study||20
6585501|NCT01951950|7510034|FG000|NOT COMPLETED|Overall Study||6
6585502|NCT01951950|7510035|FG001|NOT COMPLETED|Overall Study||6
6585503|NCT01951963|7510043|FG000|STARTED|Overall Study||31
6585504|NCT01951963|7510044|FG001|STARTED|Overall Study||32
6585505|NCT01951963|7510043|FG000|COMPLETED|Overall Study||31
6585506|NCT01951963|7510044|FG001|COMPLETED|Overall Study||32
6585507|NCT01951963|7510043|FG000|NOT COMPLETED|Overall Study||0
6585508|NCT01951963|7510044|FG001|NOT COMPLETED|Overall Study||0
6585509|NCT01952015|7510054|FG000|STARTED|Induction||12
6585510|NCT01952015|7510054|FG000|COMPLETED|Induction||11
6585511|NCT01952015|7510054|FG000|NOT COMPLETED|Induction||1
6585512|NCT01952015|7510054|FG000|STARTED|Maintenance||11
6585513|NCT01952015|7510054|FG000|COMPLETED|Maintenance||9
6585514|NCT01952015|7510054|FG000|NOT COMPLETED|Maintenance||2
6585515|NCT01952015|7510054|FG000|STARTED|Treatment Period 3||9
6585516|NCT01952015|7510054|FG000|COMPLETED|Treatment Period 3||0
6585517|NCT01952015|7510054|FG000|NOT COMPLETED|Treatment Period 3||9
6585518|NCT01952041|7510072|FG000|STARTED|Overall Study||62
6585519|NCT01952041|7510073|FG001|STARTED|Overall Study||64
6585520|NCT01952041|7510072|FG000|COMPLETED|Overall Study||45
6585521|NCT01952041|7510073|FG001|COMPLETED|Overall Study||43
6585522|NCT01952041|7510072|FG000|NOT COMPLETED|Overall Study||17
6585523|NCT01952041|7510073|FG001|NOT COMPLETED|Overall Study||21
6585524|NCT01952054|7510079|FG000|STARTED|Overall Study||6
6585525|NCT01952054|7510079|FG000|COMPLETED|Overall Study||5
6585526|NCT01952054|7510079|FG000|NOT COMPLETED|Overall Study||1
6585527|NCT01952080|7510087|FG000|STARTED|Overall Study||5
6585528|NCT01952080|7510088|FG001|STARTED|Overall Study||8
6585529|NCT01952080|7510089|FG002|STARTED|Overall Study||14
6585530|NCT01952080|7510090|FG003|STARTED|Overall Study||15
6585531|NCT01952080|7510087|FG000|Treated|Overall Study||5
6585532|NCT01952080|7510088|FG001|Treated|Overall Study||8
6585533|NCT01952080|7510089|FG002|Treated|Overall Study||14
6585534|NCT01952080|7510090|FG003|Treated|Overall Study||15
6585535|NCT01952080|7510087|FG000|COMPLETED|Overall Study||5
6585536|NCT01952080|7510088|FG001|COMPLETED|Overall Study||7
6585537|NCT01952080|7510089|FG002|COMPLETED|Overall Study||14
6585538|NCT01952080|7510090|FG003|COMPLETED|Overall Study||14
6585539|NCT01952080|7510087|FG000|NOT COMPLETED|Overall Study||0
6585540|NCT01952080|7510088|FG001|NOT COMPLETED|Overall Study||1
6585541|NCT01952080|7510089|FG002|NOT COMPLETED|Overall Study||0
6585542|NCT01952080|7510090|FG003|NOT COMPLETED|Overall Study||1
6585543|NCT01952145|7510102|FG000|STARTED|Overall Study||278
6585544|NCT01952145|7510103|FG001|STARTED|Overall Study||279
6585545|NCT01952145|7510102|FG000|COMPLETED|Overall Study||250
6585546|NCT01952145|7510103|FG001|COMPLETED|Overall Study||265
6585547|NCT01952145|7510102|FG000|NOT COMPLETED|Overall Study||28
6585548|NCT01952145|7510103|FG001|NOT COMPLETED|Overall Study||14
6585549|NCT01952301|7510109|FG000|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
6585550|NCT01952301|7510109|FG000|COMPLETED|Overall Study||30
6585551|NCT01952301|7510109|FG000|NOT COMPLETED|Overall Study||0
6585552|NCT01952366|7510115|FG000|STARTED|Overall Study||169
6585553|NCT01952366|7510115|FG000|COMPLETED|Overall Study||138
6585554|NCT01952366|7510115|FG000|NOT COMPLETED|Overall Study||31
6585555|NCT01952418|7510124|FG000|STARTED|Overall Study||910
6585556|NCT01952418|7510125|FG001|STARTED|Overall Study||895
6585557|NCT01952418|7510124|FG000|COMPLETED|Overall Study||910
6585558|NCT01952418|7510125|FG001|COMPLETED|Overall Study||895
6585559|NCT01952418|7510124|FG000|NOT COMPLETED|Overall Study||0
6585560|NCT01952418|7510125|FG001|NOT COMPLETED|Overall Study||0
6585561|NCT01952444|7510133|FG000|STARTED|Overall Study||20
6585562|NCT01952444|7510134|FG001|STARTED|Overall Study||20
6585563|NCT01952444|7510133|FG000|COMPLETED|Overall Study||20
6585564|NCT01952444|7510134|FG001|COMPLETED|Overall Study||19
6585565|NCT01952444|7510133|FG000|NOT COMPLETED|Overall Study||0
6585566|NCT01952444|7510134|FG001|NOT COMPLETED|Overall Study||1
6585567|NCT01952470|7510147|FG000|STARTED|Overall Study||16
6585568|NCT01952470|7510148|FG001|STARTED|Overall Study||16
6585569|NCT01952470|7510147|FG000|ITT Analysis|Overall Study||16
6585570|NCT01952470|7510148|FG001|ITT Analysis|Overall Study||16
6585571|NCT01952470|7510147|FG000|Discontinued Intervention|Overall Study||2
6585572|NCT01952470|7510148|FG001|Discontinued Intervention|Overall Study||1
6585573|NCT01952470|7510147|FG000|Death|Overall Study||1
6585574|NCT01952470|7510148|FG001|Death|Overall Study||1
6585575|NCT01952470|7510147|FG000|Missing Baseline LCI 2% Data.|Overall Study||0
6585576|NCT01952470|7510148|FG001|Missing Baseline LCI 2% Data.|Overall Study||2
6585577|NCT01952470|7510147|FG000|Missing 1+3 Month LCI 2% Data.|Overall Study||2
6585578|NCT01952470|7510148|FG001|Missing 1+3 Month LCI 2% Data.|Overall Study||1
6585579|NCT01952470|7510147|FG000|Missing 3 Month LCI 2% Data.|Overall Study||1
6585580|NCT01952470|7510148|FG001|Missing 3 Month LCI 2% Data.|Overall Study||0
6585581|NCT01952470|7510147|FG000|COMPLETED|Overall Study||13
6585582|NCT01952470|7510148|FG001|COMPLETED|Overall Study||13
6585583|NCT01952470|7510147|FG000|NOT COMPLETED|Overall Study||3
6585584|NCT01952470|7510148|FG001|NOT COMPLETED|Overall Study||3
6585669|NCT01952600|7510192|FG000|STARTED|Overall Study||80
6585670|NCT01952600|7510193|FG001|STARTED|Overall Study||90
6585671|NCT01952600|7510194|FG002|STARTED|Overall Study||45
6585672|NCT01952600|7510192|FG000|COMPLETED|Overall Study||65
6585673|NCT01952600|7510193|FG001|COMPLETED|Overall Study||77
6585674|NCT01952600|7510194|FG002|COMPLETED|Overall Study||38
6585675|NCT01952600|7510192|FG000|NOT COMPLETED|Overall Study||15
6585676|NCT01952600|7510193|FG001|NOT COMPLETED|Overall Study||13
6585677|NCT01952600|7510194|FG002|NOT COMPLETED|Overall Study||7
6585678|NCT01952665|7510204|FG000|STARTED|Overall Study||37
6585679|NCT01952665|7510205|FG001|STARTED|Overall Study||26
6585680|NCT01952665|7510204|FG000|COMPLETED|Overall Study||31
6585681|NCT01952665|7510205|FG001|COMPLETED|Overall Study||20
6585682|NCT01952665|7510204|FG000|NOT COMPLETED|Overall Study||6
6585683|NCT01952665|7510205|FG001|NOT COMPLETED|Overall Study||6
6585684|NCT01952678|7510216|FG000|STARTED|Overall Study||102
6585685|NCT01952678|7510217|FG001|STARTED|Overall Study||102
6585686|NCT01952678|7510216|FG000|COMPLETED|Overall Study||102
6585687|NCT01952678|7510217|FG001|COMPLETED|Overall Study||102
6585688|NCT01952678|7510216|FG000|NOT COMPLETED|Overall Study||0
6585689|NCT01952678|7510217|FG001|NOT COMPLETED|Overall Study||0
6585690|NCT01952691|7510233|FG000|STARTED|Overall Study||22
6585691|NCT01952691|7510233|FG000|COMPLETED|Overall Study||20
6585692|NCT01952691|7510233|FG000|NOT COMPLETED|Overall Study||2
6585693|NCT01952834|7510237|FG000|STARTED|Overall Study||21
6585694|NCT01952834|7510237|FG000|COMPLETED|Overall Study||20
6585695|NCT01952834|7510237|FG000|NOT COMPLETED|Overall Study||1
6585696|NCT01953003|7510244|FG000|STARTED|Overall Study||56
6585697|NCT01953003|7510245|FG001|STARTED|Overall Study||56
6585698|NCT01953003|7510244|FG000|COMPLETED|Overall Study||0
6585699|NCT01953003|7510245|FG001|COMPLETED|Overall Study||1
6585700|NCT01953003|7510244|FG000|NOT COMPLETED|Overall Study||56
6585701|NCT01953003|7510245|FG001|NOT COMPLETED|Overall Study||55
6585702|NCT01953081|7510253|FG000|STARTED|Overall Study||7
6585703|NCT01953081|7510254|FG001|STARTED|Overall Study||6
6585704|NCT01953081|7510253|FG000|COMPLETED|Overall Study||5
6585705|NCT01953081|7510254|FG001|COMPLETED|Overall Study||3
6585706|NCT01953081|7510253|FG000|NOT COMPLETED|Overall Study||2
6585707|NCT01953081|7510254|FG001|NOT COMPLETED|Overall Study||3
6585708|NCT01953211|7510260|FG000|STARTED|Overall Study|completed prior to clinical trials submission|64
6585709|NCT01953211|7510260|FG000|COMPLETED|Overall Study|completed prior to clinical trials submission|64
6585710|NCT01953211|7510260|FG000|NOT COMPLETED|Overall Study||0
6585711|NCT01953224|7510268|FG000|STARTED|Overall Study||20
6585712|NCT01953224|7510269|FG001|STARTED|Overall Study||20
6585713|NCT01953224|7510268|FG000|COMPLETED|Overall Study||18
6585714|NCT01953224|7510269|FG001|COMPLETED|Overall Study||17
6585715|NCT01953224|7510268|FG000|NOT COMPLETED|Overall Study||2
6585716|NCT01953224|7510269|FG001|NOT COMPLETED|Overall Study||3
6585717|NCT01953237|7510277|FG000|STARTED|Overall Study||10
6585718|NCT01953237|7510278|FG001|STARTED|Overall Study||21
6585719|NCT01953237|7510277|FG000|COMPLETED|Overall Study||10
6585720|NCT01953237|7510278|FG001|COMPLETED|Overall Study||21
6585721|NCT01953237|7510277|FG000|NOT COMPLETED|Overall Study||0
6585722|NCT01953237|7510278|FG001|NOT COMPLETED|Overall Study||0
6585723|NCT01953328|7510292|FG000|STARTED|Overall Study||49
6585724|NCT01953328|7510293|FG001|STARTED|Overall Study||50
6585725|NCT01953328|7510294|FG002|STARTED|Overall Study||50
6585726|NCT01953328|7510295|FG003|STARTED|Overall Study||50
6585727|NCT01953328|7510296|FG004|STARTED|Overall Study||52
6585728|NCT01953328|7510297|FG005|STARTED|Overall Study||51
6585729|NCT01953328|7510298|FG006|STARTED|Overall Study||51
6585730|NCT01953328|7510299|FG007|STARTED|Overall Study||51
6585731|NCT01953328|7510292|FG000|Received Treatment|Overall Study||49
6585732|NCT01953328|7510293|FG001|Received Treatment|Overall Study||50
6585733|NCT01953328|7510294|FG002|Received Treatment|Overall Study||50
6585734|NCT01953328|7510295|FG003|Received Treatment|Overall Study||50
6585735|NCT01953328|7510296|FG004|Received Treatment|Overall Study||52
6585736|NCT01953328|7510297|FG005|Received Treatment|Overall Study||51
6585737|NCT01953328|7510298|FG006|Received Treatment|Overall Study||51
6585738|NCT01953328|7510299|FG007|Received Treatment|Overall Study||51
6585739|NCT01953328|7510292|FG000|COMPLETED|Overall Study||49
6585740|NCT01953328|7510293|FG001|COMPLETED|Overall Study||50
6585741|NCT01953328|7510294|FG002|COMPLETED|Overall Study||50
6585742|NCT01953328|7510295|FG003|COMPLETED|Overall Study||50
6585743|NCT01953328|7510296|FG004|COMPLETED|Overall Study||50
6585744|NCT01953328|7510297|FG005|COMPLETED|Overall Study||51
6585745|NCT01953328|7510298|FG006|COMPLETED|Overall Study||51
6585746|NCT01953328|7510299|FG007|COMPLETED|Overall Study||51
6585747|NCT01953328|7510292|FG000|NOT COMPLETED|Overall Study||0
6585748|NCT01953328|7510293|FG001|NOT COMPLETED|Overall Study||0
6585749|NCT01953328|7510294|FG002|NOT COMPLETED|Overall Study||0
6585750|NCT01953328|7510295|FG003|NOT COMPLETED|Overall Study||0
6585751|NCT01953328|7510296|FG004|NOT COMPLETED|Overall Study||2
6585752|NCT01953328|7510297|FG005|NOT COMPLETED|Overall Study||0
6585753|NCT01953328|7510298|FG006|NOT COMPLETED|Overall Study||0
6585754|NCT01953328|7510299|FG007|NOT COMPLETED|Overall Study||0
6585755|NCT01953354|7510319|FG000|STARTED|Overall Study||9
6585756|NCT01953354|7510320|FG001|STARTED|Overall Study||7
6585757|NCT01953354|7510319|FG000|COMPLETED|Overall Study||8
6585758|NCT01953354|7510320|FG001|COMPLETED|Overall Study||5
6585759|NCT01953354|7510319|FG000|NOT COMPLETED|Overall Study||1
6585760|NCT01953354|7510320|FG001|NOT COMPLETED|Overall Study||2
6585761|NCT01953432|7510328|FG000|STARTED|Overall Study||22
6585762|NCT01953432|7510329|FG001|STARTED|Overall Study||21
6585763|NCT01953432|7510328|FG000|COMPLETED|Overall Study||8
6585764|NCT01953432|7510329|FG001|COMPLETED|Overall Study||6
6585765|NCT01953432|7510328|FG000|NOT COMPLETED|Overall Study||14
6585766|NCT01953432|7510329|FG001|NOT COMPLETED|Overall Study||15
6585767|NCT01953575|7510338|FG000|STARTED|Overall Study||10
6585768|NCT01953575|7510339|FG001|STARTED|Overall Study||10
6585769|NCT01953575|7510340|FG002|STARTED|Overall Study||10
6585770|NCT01953575|7510338|FG000|COMPLETED|Overall Study||10
6585771|NCT01953575|7510339|FG001|COMPLETED|Overall Study||10
6585772|NCT01953575|7510340|FG002|COMPLETED|Overall Study||10
6585773|NCT01953575|7510338|FG000|NOT COMPLETED|Overall Study||0
6585774|NCT01953575|7510339|FG001|NOT COMPLETED|Overall Study||0
6585775|NCT01953575|7510340|FG002|NOT COMPLETED|Overall Study||0
6585776|NCT01953601|7510351|FG000|STARTED|Part 1 (Base Study)||485
6585777|NCT01953601|7510352|FG001|STARTED|Part 1 (Base Study)||484
6585778|NCT01953601|7510353|FG002|STARTED|Part 1 (Base Study)||485
6585779|NCT01953601|7510351|FG000|Treated|Part 1 (Base Study)||483
6585780|NCT01953601|7510352|FG001|Treated|Part 1 (Base Study)||484
6585781|NCT01953601|7510353|FG002|Treated|Part 1 (Base Study)||484
6585782|NCT01953601|7510351|FG000|COMPLETED|Part 1 (Base Study)||234
6585783|NCT01953601|7510352|FG001|COMPLETED|Part 1 (Base Study)||231
6585784|NCT01953601|7510353|FG002|COMPLETED|Part 1 (Base Study)||239
6585785|NCT01953601|7510351|FG000|NOT COMPLETED|Part 1 (Base Study)||251
6585786|NCT01953601|7510352|FG001|NOT COMPLETED|Part 1 (Base Study)||253
6585787|NCT01953601|7510353|FG002|NOT COMPLETED|Part 1 (Base Study)||246
6585788|NCT01953601|7510351|FG000|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|198
6585789|NCT01953601|7510352|FG001|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|191
6585790|NCT01953601|7510353|FG002|STARTED|Part 2 (Extension Study)|Number started refers only to participants completing Part 1, volunteering to continue to Part 2.|204
6585791|NCT01953601|7510351|FG000|Treated|Part 2 (Extension Study)||197
6585792|NCT01953601|7510352|FG001|Treated|Part 2 (Extension Study)||191
6585793|NCT01953601|7510353|FG002|Treated|Part 2 (Extension Study)||204
6585794|NCT01953601|7510351|FG000|COMPLETED|Part 2 (Extension Study)||0
6585795|NCT01953601|7510352|FG001|COMPLETED|Part 2 (Extension Study)||0
6585796|NCT01953601|7510353|FG002|COMPLETED|Part 2 (Extension Study)||0
6585797|NCT01953601|7510351|FG000|NOT COMPLETED|Part 2 (Extension Study)||198
6585798|NCT01953601|7510352|FG001|NOT COMPLETED|Part 2 (Extension Study)||191
6585799|NCT01953601|7510353|FG002|NOT COMPLETED|Part 2 (Extension Study)||204
6585800|NCT01953692|7510373|FG000|STARTED|Overall Study||28
6585801|NCT01953692|7510374|FG001|STARTED|Overall Study||30
6585802|NCT01953692|7510375|FG002|STARTED|Overall Study||31
6585803|NCT01953692|7510376|FG003|STARTED|Overall Study||21
6585804|NCT01953692|7510377|FG004|STARTED|Overall Study||4
6585805|NCT01953692|7510378|FG005|STARTED|Overall Study||22
6585806|NCT01953692|7510379|FG006|STARTED|Overall Study||42
6585807|NCT01953692|7510380|FG007|STARTED|Overall Study||13
6585808|NCT01953692|7510381|FG008|STARTED|Overall Study||6
6585809|NCT01953692|7510373|FG000|COMPLETED|Overall Study||1
6585810|NCT01953692|7510374|FG001|COMPLETED|Overall Study||5
6585811|NCT01953692|7510375|FG002|COMPLETED|Overall Study||11
6585812|NCT01953692|7510376|FG003|COMPLETED|Overall Study||7
6585813|NCT01953692|7510377|FG004|COMPLETED|Overall Study||1
6585814|NCT01953692|7510378|FG005|COMPLETED|Overall Study||4
6585815|NCT01953692|7510379|FG006|COMPLETED|Overall Study||10
6585816|NCT01953692|7510380|FG007|COMPLETED|Overall Study||3
6585817|NCT01953692|7510381|FG008|COMPLETED|Overall Study||1
6585818|NCT01953692|7510373|FG000|NOT COMPLETED|Overall Study||27
6585819|NCT01953692|7510374|FG001|NOT COMPLETED|Overall Study||25
6585820|NCT01953692|7510375|FG002|NOT COMPLETED|Overall Study||20
6585821|NCT01953692|7510376|FG003|NOT COMPLETED|Overall Study||14
6585822|NCT01953692|7510377|FG004|NOT COMPLETED|Overall Study||3
6585823|NCT01953692|7510378|FG005|NOT COMPLETED|Overall Study||18
6585824|NCT01953692|7510379|FG006|NOT COMPLETED|Overall Study||32
6585825|NCT01953692|7510380|FG007|NOT COMPLETED|Overall Study||10
6585826|NCT01953692|7510381|FG008|NOT COMPLETED|Overall Study||5
6585827|NCT01953783|7510411|FG000|STARTED|Overall Study||7
6585828|NCT01953783|7510411|FG000|COMPLETED|Overall Study||5
6585829|NCT01953783|7510411|FG000|NOT COMPLETED|Overall Study||2
6585830|NCT01953874|7510417|FG000|STARTED|Overall Study||65
6585831|NCT01953874|7510418|FG001|STARTED|Overall Study||61
6585832|NCT01953874|7510417|FG000|COMPLETED|Overall Study||65
6585833|NCT01953874|7510418|FG001|COMPLETED|Overall Study||61
6585834|NCT01953874|7510417|FG000|NOT COMPLETED|Overall Study||0
6585835|NCT01953874|7510418|FG001|NOT COMPLETED|Overall Study||0
6585836|NCT01953913|7510425|FG000|STARTED|Overall Study||542
6585837|NCT01953913|7510425|FG000|Treated|Overall Study||541
6585838|NCT01953913|7510425|FG000|COMPLETED|Overall Study||0
6585839|NCT01953913|7510425|FG000|NOT COMPLETED|Overall Study||542
6585840|NCT01954017|7510432|FG000|STARTED|Overall Study||36
6585841|NCT01954017|7510433|FG001|STARTED|Overall Study||33
6585842|NCT01954017|7510434|FG002|STARTED|Overall Study||34
6585843|NCT01954017|7510432|FG000|COMPLETED|Overall Study||31
6585844|NCT01954017|7510433|FG001|COMPLETED|Overall Study||25
6585845|NCT01954017|7510434|FG002|COMPLETED|Overall Study||21
6585846|NCT01954017|7510432|FG000|NOT COMPLETED|Overall Study||5
6585847|NCT01954017|7510433|FG001|NOT COMPLETED|Overall Study||8
6585848|NCT01954017|7510434|FG002|NOT COMPLETED|Overall Study||13
6585849|NCT01954056|7510470|FG000|STARTED|Birth to 60 Days of Life||6
6585850|NCT01954056|7510471|FG001|STARTED|Birth to 60 Days of Life||6
6585851|NCT01954056|7510470|FG000|COMPLETED|Birth to 60 Days of Life||6
6585852|NCT01954056|7510471|FG001|COMPLETED|Birth to 60 Days of Life||6
6585853|NCT01954056|7510470|FG000|NOT COMPLETED|Birth to 60 Days of Life||0
6585854|NCT01954056|7510471|FG001|NOT COMPLETED|Birth to 60 Days of Life||0
6585855|NCT01954056|7510470|FG000|STARTED|Birth to 22-26 Mos. Corrected GA||6
6585856|NCT01954056|7510471|FG001|STARTED|Birth to 22-26 Mos. Corrected GA||6
6585857|NCT01954056|7510470|FG000|COMPLETED|Birth to 22-26 Mos. Corrected GA||5
6585858|NCT01954056|7510471|FG001|COMPLETED|Birth to 22-26 Mos. Corrected GA||6
6585859|NCT01954056|7510470|FG000|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||1
6585860|NCT01954056|7510471|FG001|NOT COMPLETED|Birth to 22-26 Mos. Corrected GA||0
6585861|NCT01954082|7510479|FG000|STARTED|Overall Study||317
6585862|NCT01954082|7510480|FG001|STARTED|Overall Study||321
6585863|NCT01954082|7510479|FG000|Treated|Overall Study|The 4 participants who were not treated either died (3) or withdrew before treatment start (1).|313
6585864|NCT01954082|7510480|FG001|Treated|Overall Study|The 2 participants who were not treated died before treatment start.|319
6585865|NCT01954082|7510479|FG000|COMPLETED|Overall Study|There were 22 infants that received more doses than intended per protocol.|249
6585866|NCT01954082|7510480|FG001|COMPLETED|Overall Study|There were 27 infants that received more doses than intended per protocol.|264
6585867|NCT01954082|7510479|FG000|NOT COMPLETED|Overall Study||68
6585868|NCT01954082|7510480|FG001|NOT COMPLETED|Overall Study||57
6585869|NCT01954121|7510488|FG000|STARTED|Overall Study||220
6585870|NCT01954121|7510489|FG001|STARTED|Overall Study||216
6585871|NCT01954121|7510488|FG000|COMPLETED|Overall Study||93
6585872|NCT01954121|7510489|FG001|COMPLETED|Overall Study||125
6585873|NCT01954121|7510488|FG000|NOT COMPLETED|Overall Study||127
6659276|NCT02487472|7590073|FG000|COMPLETED|Overall Study||90
6659277|NCT02487472|7590073|FG000|NOT COMPLETED|Overall Study||11
6659278|NCT02487485|7590081|FG000|STARTED|Overall Study||12
6659279|NCT02487485|7590082|FG001|STARTED|Overall Study||11
6659280|NCT02487485|7590081|FG000|COMPLETED|Overall Study||9
6659281|NCT02487485|7590082|FG001|COMPLETED|Overall Study||8
6659282|NCT02487485|7590081|FG000|NOT COMPLETED|Overall Study||3
6659283|NCT02487485|7590082|FG001|NOT COMPLETED|Overall Study||3
6659284|NCT02487498|7590088|FG000|STARTED|Period: Period 1||178
6659285|NCT02487498|7590089|FG001|STARTED|Period: Period 1||177
6659286|NCT02487498|7590088|FG000|COMPLETED|Period: Period 1||172
6659287|NCT02487498|7590089|FG001|COMPLETED|Period: Period 1||166
6659288|NCT02487498|7590088|FG000|NOT COMPLETED|Period: Period 1||6
6659289|NCT02487498|7590089|FG001|NOT COMPLETED|Period: Period 1||11
6659290|NCT02487498|7590088|FG000|STARTED|Period: Washout||172
6659291|NCT02487498|7590089|FG001|STARTED|Period: Washout||166
6659292|NCT02487498|7590088|FG000|COMPLETED|Period: Washout||170
6659293|NCT02487498|7590089|FG001|COMPLETED|Period: Washout||159
6659294|NCT02487498|7590088|FG000|NOT COMPLETED|Period: Washout||2
6659295|NCT02487498|7590089|FG001|NOT COMPLETED|Period: Washout||7
6659296|NCT02487498|7590088|FG000|STARTED|Period: Period 2||170
6659297|NCT02487498|7590089|FG001|STARTED|Period: Period 2||159
6659298|NCT02487498|7590088|FG000|COMPLETED|Period: Period 2||164
6659299|NCT02487498|7590089|FG001|COMPLETED|Period: Period 2||154
6659300|NCT02487498|7590088|FG000|NOT COMPLETED|Period: Period 2||6
6659301|NCT02487498|7590089|FG001|NOT COMPLETED|Period: Period 2||5
6585874|NCT01954121|7510489|FG001|NOT COMPLETED|Overall Study||91
6585875|NCT01954251|7510497|FG000|STARTED|Overall Study||413
6585876|NCT01954251|7510498|FG001|STARTED|Overall Study||415
6585877|NCT01954251|7510497|FG000|COMPLETED|Overall Study||400
6585878|NCT01954251|7510498|FG001|COMPLETED|Overall Study||396
6585879|NCT01954251|7510497|FG000|NOT COMPLETED|Overall Study||13
6585880|NCT01954251|7510498|FG001|NOT COMPLETED|Overall Study||19
6585881|NCT01954264|7510505|FG000|STARTED|Overall Study||2421
6585882|NCT01954264|7510505|FG000|COMPLETED|Overall Study||2421
6585883|NCT01954264|7510505|FG000|NOT COMPLETED|Overall Study||0
6585884|NCT01954342|7510526|FG000|STARTED|Overall Study||36
6585885|NCT01954342|7510527|FG001|STARTED|Overall Study||8
6585886|NCT01954342|7510528|FG002|STARTED|Overall Study||10
6585887|NCT01954342|7510529|FG003|STARTED|Overall Study||18
6585888|NCT01954342|7510526|FG000|COMPLETED|Overall Study||36
6585889|NCT01954342|7510527|FG001|COMPLETED|Overall Study||8
6585890|NCT01954342|7510528|FG002|COMPLETED|Overall Study||10
6585891|NCT01954342|7510529|FG003|COMPLETED|Overall Study||0
6585892|NCT01954342|7510526|FG000|NOT COMPLETED|Overall Study||0
6585893|NCT01954342|7510527|FG001|NOT COMPLETED|Overall Study||0
6585894|NCT01954342|7510528|FG002|NOT COMPLETED|Overall Study||0
6585895|NCT01954342|7510529|FG003|NOT COMPLETED|Overall Study||18
6585896|NCT01954394|7510541|FG000|STARTED|Overall Study|Enrolled|331
6585897|NCT01954394|7510542|FG001|STARTED|Overall Study|Enrolled|655
6585898|NCT01954394|7510541|FG000|Treated|Overall Study|Safety population|330
6585899|NCT01954394|7510542|FG001|Treated|Overall Study|Safety population|655
6585900|NCT01954394|7510541|FG000|COMPLETED|Overall Study||301
6585901|NCT01954394|7510542|FG001|COMPLETED|Overall Study||598
6585902|NCT01954394|7510541|FG000|NOT COMPLETED|Overall Study||30
6585903|NCT01954394|7510542|FG001|NOT COMPLETED|Overall Study||57
6585904|NCT01954628|7510552|FG000|STARTED|Overall Study||200
6585905|NCT01954628|7510553|FG001|STARTED|Overall Study||200
6585906|NCT01954628|7510552|FG000|Full Analysis Set (FAS)|Overall Study||200
6585907|NCT01954628|7510553|FG001|Full Analysis Set (FAS)|Overall Study||198
6585908|NCT01954628|7510552|FG000|Safety Set|Overall Study||200
6585909|NCT01954628|7510553|FG001|Safety Set|Overall Study||200
6585910|NCT01954628|7510552|FG000|Pharmacokinetic Population|Overall Study||181
6585911|NCT01954628|7510553|FG001|Pharmacokinetic Population|Overall Study||0
6585912|NCT01954628|7510552|FG000|US 6 Month Ophthalmology Safety Visit|Overall Study||37
6585913|NCT01954628|7510553|FG001|US 6 Month Ophthalmology Safety Visit|Overall Study||32
6585914|NCT01954628|7510552|FG000|COMPLETED|Overall Study||169
6585915|NCT01954628|7510553|FG001|COMPLETED|Overall Study||173
6585916|NCT01954628|7510552|FG000|NOT COMPLETED|Overall Study||31
6585917|NCT01954628|7510553|FG001|NOT COMPLETED|Overall Study||27
6585918|NCT01954745|7510563|FG000|STARTED|Overall Study||19
6585919|NCT01954745|7510563|FG000|COMPLETED|Overall Study||0
6585920|NCT01954745|7510563|FG000|NOT COMPLETED|Overall Study||19
6585921|NCT01954771|7510570|FG000|STARTED|Overall Study||29
6585922|NCT01954771|7510571|FG001|STARTED|Overall Study||32
6585923|NCT01954771|7510572|FG002|STARTED|Overall Study||28
6585924|NCT01954771|7510570|FG000|COMPLETED|Overall Study||22
6585925|NCT01954771|7510571|FG001|COMPLETED|Overall Study||29
6585926|NCT01954771|7510572|FG002|COMPLETED|Overall Study||25
6585927|NCT01954771|7510570|FG000|NOT COMPLETED|Overall Study||7
6585928|NCT01954771|7510571|FG001|NOT COMPLETED|Overall Study||3
6585929|NCT01954771|7510572|FG002|NOT COMPLETED|Overall Study||3
6585930|NCT01954927|7510585|FG000|STARTED|Overall Study||45
6585931|NCT01954927|7510586|FG001|STARTED|Overall Study||45
6585932|NCT01954927|7510585|FG000|COMPLETED|Overall Study||42
6585933|NCT01954927|7510586|FG001|COMPLETED|Overall Study||44
6585934|NCT01954927|7510585|FG000|NOT COMPLETED|Overall Study||3
6585935|NCT01954927|7510586|FG001|NOT COMPLETED|Overall Study||1
6585936|NCT01955005|7510594|FG000|STARTED|Overall Study||30
6585937|NCT01955005|7510595|FG001|STARTED|Overall Study||30
6585938|NCT01955005|7510594|FG000|COMPLETED|Overall Study||27
6585939|NCT01955005|7510595|FG001|COMPLETED|Overall Study||25
6585940|NCT01955005|7510594|FG000|NOT COMPLETED|Overall Study||3
6585941|NCT01955005|7510595|FG001|NOT COMPLETED|Overall Study||5
6585942|NCT01955044|7510604|FG000|STARTED|Overall Study||10
6585943|NCT01955044|7510605|FG001|STARTED|Overall Study||10
6585944|NCT01955044|7510606|FG002|STARTED|Overall Study||10
6585945|NCT01955044|7510604|FG000|COMPLETED|Overall Study||9
6585946|NCT01955044|7510605|FG001|COMPLETED|Overall Study||9
6585947|NCT01955044|7510606|FG002|COMPLETED|Overall Study||10
6585948|NCT01955044|7510604|FG000|NOT COMPLETED|Overall Study||1
6585949|NCT01955044|7510605|FG001|NOT COMPLETED|Overall Study||1
6585950|NCT01955044|7510606|FG002|NOT COMPLETED|Overall Study||0
6585951|NCT01955083|7510616|FG000|STARTED|Overall Study||15
6659302|NCT02487563|7590099|FG000|STARTED|Overall Study||32
6585952|NCT01955083|7510617|FG001|STARTED|Overall Study||15
6585953|NCT01955083|7510616|FG000|COMPLETED|Overall Study||14
6585954|NCT01955083|7510617|FG001|COMPLETED|Overall Study||14
6585955|NCT01955083|7510616|FG000|NOT COMPLETED|Overall Study||1
6585956|NCT01955083|7510617|FG001|NOT COMPLETED|Overall Study||1
6585957|NCT01955122|7510649|FG000|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 59)"|64
6585958|NCT01955122|7510650|FG001|STARTED|Overall Study|"Excluded (n = 5)~Included in analysis (n = 57)"|62
6585959|NCT01955122|7510649|FG000|No.Patients Enrolled|Overall Study||64
6585960|NCT01955122|7510650|FG001|No.Patients Enrolled|Overall Study||62
6585961|NCT01955122|7510649|FG000|No. Patients Completed Double Procedure|Overall Study||59
6659303|NCT02487563|7590100|FG001|STARTED|Overall Study||33
6585962|NCT01955122|7510650|FG001|No. Patients Completed Double Procedure|Overall Study||57
6585963|NCT01955122|7510649|FG000|COMPLETED|Overall Study||59
6585964|NCT01955122|7510650|FG001|COMPLETED|Overall Study||57
6585965|NCT01955122|7510649|FG000|NOT COMPLETED|Overall Study||5
6585966|NCT01955122|7510650|FG001|NOT COMPLETED|Overall Study||5
6585967|NCT01955161|7510665|FG000|STARTED|Overall Study||310
6585968|NCT01955161|7510666|FG001|STARTED|Overall Study||313
6585969|NCT01955161|7510667|FG002|STARTED|Overall Study||310
6585970|NCT01955161|7510665|FG000|Treated|Overall Study||308
6585971|NCT01955161|7510666|FG001|Treated|Overall Study||313
6585972|NCT01955161|7510667|FG002|Treated|Overall Study||309
6585973|NCT01955161|7510665|FG000|COMPLETED|Overall Study||283
6585974|NCT01955161|7510666|FG001|COMPLETED|Overall Study||288
6585975|NCT01955161|7510667|FG002|COMPLETED|Overall Study||275
6585976|NCT01955161|7510665|FG000|NOT COMPLETED|Overall Study||27
6585977|NCT01955161|7510666|FG001|NOT COMPLETED|Overall Study||25
6585978|NCT01955161|7510667|FG002|NOT COMPLETED|Overall Study||35
6585979|NCT01955369|7510675|FG000|STARTED|Overall Study||200
6585980|NCT01955369|7510675|FG000|COMPLETED|Overall Study||200
6585981|NCT01955369|7510675|FG000|NOT COMPLETED|Overall Study||0
6585982|NCT01955382|7510681|FG000|STARTED|Overall Study||35
6585983|NCT01955382|7510682|FG001|STARTED|Overall Study||35
6585984|NCT01955382|7510681|FG000|COMPLETED|Overall Study||35
6585985|NCT01955382|7510682|FG001|COMPLETED|Overall Study||35
6585986|NCT01955382|7510681|FG000|NOT COMPLETED|Overall Study||0
6585987|NCT01955382|7510682|FG001|NOT COMPLETED|Overall Study||0
6585988|NCT01955434|7510689|FG000|STARTED|Overall Study||25
6585989|NCT01955434|7510689|FG000|COMPLETED|Overall Study||25
6585990|NCT01955434|7510689|FG000|NOT COMPLETED|Overall Study||0
6585991|NCT01955473|7510698|FG000|STARTED|Overall Study||3
6585992|NCT01955473|7510699|FG001|STARTED|Overall Study||6
6585993|NCT01955473|7510700|FG002|STARTED|Overall Study||6
6585994|NCT01955473|7510701|FG003|STARTED|Overall Study||6
6585995|NCT01955473|7510702|FG004|STARTED|Overall Study||30
6585996|NCT01955473|7510698|FG000|COMPLETED|Overall Study||3
6585997|NCT01955473|7510699|FG001|COMPLETED|Overall Study||6
6585998|NCT01955473|7510700|FG002|COMPLETED|Overall Study||6
6585999|NCT01955473|7510701|FG003|COMPLETED|Overall Study||6
6586000|NCT01955473|7510702|FG004|COMPLETED|Overall Study||30
6586001|NCT01955473|7510698|FG000|NOT COMPLETED|Overall Study||0
6586002|NCT01955473|7510699|FG001|NOT COMPLETED|Overall Study||0
6586003|NCT01955473|7510700|FG002|NOT COMPLETED|Overall Study||0
6586004|NCT01955473|7510701|FG003|NOT COMPLETED|Overall Study||0
6586005|NCT01955473|7510702|FG004|NOT COMPLETED|Overall Study||0
6586006|NCT01955564|7510725|FG000|STARTED|Overall Study||18
6586007|NCT01955564|7510726|FG001|STARTED|Overall Study||6
6586008|NCT01955564|7510727|FG002|STARTED|Overall Study||6
6586009|NCT01955564|7510728|FG003|STARTED|Overall Study||6
6586010|NCT01955564|7510729|FG004|STARTED|Overall Study||6
6586011|NCT01955564|7510730|FG005|STARTED|Overall Study||6
6586012|NCT01955564|7510731|FG006|STARTED|Overall Study||6
6586013|NCT01955564|7510725|FG000|COMPLETED|Overall Study||18
6586014|NCT01955564|7510726|FG001|COMPLETED|Overall Study||6
6586015|NCT01955564|7510727|FG002|COMPLETED|Overall Study||6
6586016|NCT01955564|7510728|FG003|COMPLETED|Overall Study||6
6586017|NCT01955564|7510729|FG004|COMPLETED|Overall Study||6
6586018|NCT01955564|7510730|FG005|COMPLETED|Overall Study||6
6586019|NCT01955564|7510731|FG006|COMPLETED|Overall Study||6
6586020|NCT01955564|7510725|FG000|NOT COMPLETED|Overall Study||0
6586021|NCT01955564|7510726|FG001|NOT COMPLETED|Overall Study||0
6586022|NCT01955564|7510727|FG002|NOT COMPLETED|Overall Study||0
6586023|NCT01955564|7510728|FG003|NOT COMPLETED|Overall Study||0
6586024|NCT01955564|7510729|FG004|NOT COMPLETED|Overall Study||0
6586025|NCT01955564|7510730|FG005|NOT COMPLETED|Overall Study||0
6586026|NCT01955564|7510731|FG006|NOT COMPLETED|Overall Study||0
6586027|NCT01955629|7510753|FG000|STARTED|Overall Study||4
6586028|NCT01955629|7510753|FG000|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
6586029|NCT01955629|7510753|FG000|NOT COMPLETED|Overall Study||0
6586030|NCT01955707|7510759|FG000|STARTED|Overall Study||82
6586031|NCT01955707|7510760|FG001|STARTED|Overall Study||79
6586032|NCT01955707|7510759|FG000|Withdrew Prior to Dosing|Overall Study||0
6586033|NCT01955707|7510760|FG001|Withdrew Prior to Dosing|Overall Study||1
6586034|NCT01955707|7510759|FG000|Dosed|Overall Study||82
6586035|NCT01955707|7510760|FG001|Dosed|Overall Study||78
6586036|NCT01955707|7510759|FG000|Received Total Volume of Study Drug|Overall Study||82
6586037|NCT01955707|7510760|FG001|Received Total Volume of Study Drug|Overall Study||77
6586038|NCT01955707|7510759|FG000|COMPLETED|Overall Study||62
6586039|NCT01955707|7510760|FG001|COMPLETED|Overall Study||57
6586040|NCT01955707|7510759|FG000|NOT COMPLETED|Overall Study||20
6586041|NCT01955707|7510760|FG001|NOT COMPLETED|Overall Study||22
6586042|NCT01955720|7510766|FG000|STARTED|Overall Study||13
6586043|NCT01955720|7510767|FG001|STARTED|Overall Study||13
6586044|NCT01955720|7510768|FG002|STARTED|Overall Study||3
6586045|NCT01955720|7510769|FG003|STARTED|Overall Study||3
6586046|NCT01955720|7510770|FG004|STARTED|Overall Study||7
6586047|NCT01955720|7510771|FG005|STARTED|Overall Study||7
6586048|NCT01955720|7510766|FG000|Healthy Subjects Aged 45-64|Overall Study||3
6586049|NCT01955720|7510767|FG001|Healthy Subjects Aged 45-64|Overall Study||3
6586050|NCT01955720|7510768|FG002|Healthy Subjects Aged 45-64|Overall Study||3
6586051|NCT01955720|7510769|FG003|Healthy Subjects Aged 45-64|Overall Study||3
6586052|NCT01955720|7510770|FG004|Healthy Subjects Aged 45-64|Overall Study||0
6586053|NCT01955720|7510771|FG005|Healthy Subjects Aged 45-64|Overall Study||0
6586054|NCT01955720|7510766|FG000|Healthy Subjects Aged 65-80|Overall Study||4
6586055|NCT01955720|7510767|FG001|Healthy Subjects Aged 65-80|Overall Study||4
6586056|NCT01955720|7510768|FG002|Healthy Subjects Aged 65-80|Overall Study||0
6586057|NCT01955720|7510769|FG003|Healthy Subjects Aged 65-80|Overall Study||0
6586058|NCT01955720|7510770|FG004|Healthy Subjects Aged 65-80|Overall Study||4
6586059|NCT01955720|7510771|FG005|Healthy Subjects Aged 65-80|Overall Study||4
6586060|NCT01955720|7510766|FG000|Subjects With Mild Renal Impairment|Overall Study||3
6586061|NCT01955720|7510767|FG001|Subjects With Mild Renal Impairment|Overall Study||3
6586062|NCT01955720|7510768|FG002|Subjects With Mild Renal Impairment|Overall Study||0
6586063|NCT01955720|7510769|FG003|Subjects With Mild Renal Impairment|Overall Study||0
6586064|NCT01955720|7510770|FG004|Subjects With Mild Renal Impairment|Overall Study||3
6586065|NCT01955720|7510771|FG005|Subjects With Mild Renal Impairment|Overall Study||3
6586066|NCT01955720|7510766|FG000|Subjects With Moderate Renal Impairment|Overall Study||3
6586067|NCT01955720|7510767|FG001|Subjects With Moderate Renal Impairment|Overall Study||3
6586068|NCT01955720|7510768|FG002|Subjects With Moderate Renal Impairment|Overall Study||0
6586069|NCT01955720|7510769|FG003|Subjects With Moderate Renal Impairment|Overall Study||0
6586070|NCT01955720|7510770|FG004|Subjects With Moderate Renal Impairment|Overall Study||0
6586071|NCT01955720|7510771|FG005|Subjects With Moderate Renal Impairment|Overall Study||0
6586072|NCT01955720|7510766|FG000|COMPLETED|Overall Study||13
6586073|NCT01955720|7510767|FG001|COMPLETED|Overall Study||13
6586074|NCT01955720|7510768|FG002|COMPLETED|Overall Study||3
6586075|NCT01955720|7510769|FG003|COMPLETED|Overall Study||3
6586076|NCT01955720|7510770|FG004|COMPLETED|Overall Study||7
6586077|NCT01955720|7510771|FG005|COMPLETED|Overall Study||7
6586078|NCT01955720|7510766|FG000|NOT COMPLETED|Overall Study||0
6586079|NCT01955720|7510767|FG001|NOT COMPLETED|Overall Study||0
6586080|NCT01955720|7510768|FG002|NOT COMPLETED|Overall Study||0
6586081|NCT01955720|7510769|FG003|NOT COMPLETED|Overall Study||0
6586082|NCT01955720|7510770|FG004|NOT COMPLETED|Overall Study||0
6586083|NCT01955720|7510771|FG005|NOT COMPLETED|Overall Study||0
6586084|NCT01955733|7510820|FG000|STARTED|Period 1||33
6586085|NCT01955733|7510821|FG001|STARTED|Period 1||29
6586086|NCT01955733|7510822|FG002|STARTED|Period 1||29
6586087|NCT01955733|7510820|FG000|COMPLETED|Period 1||32
6586088|NCT01955733|7510821|FG001|COMPLETED|Period 1||29
6586089|NCT01955733|7510822|FG002|COMPLETED|Period 1||29
6586090|NCT01955733|7510820|FG000|NOT COMPLETED|Period 1||1
6586091|NCT01955733|7510821|FG001|NOT COMPLETED|Period 1||0
6586092|NCT01955733|7510822|FG002|NOT COMPLETED|Period 1||0
6586093|NCT01955733|7510820|FG000|STARTED|Period 2||32
6586094|NCT01955733|7510821|FG001|STARTED|Period 2||29
6586095|NCT01955733|7510822|FG002|STARTED|Period 2||29
6586096|NCT01955733|7510820|FG000|COMPLETED|Period 2||20
6586097|NCT01955733|7510821|FG001|COMPLETED|Period 2||10
6586098|NCT01955733|7510822|FG002|COMPLETED|Period 2||8
6586099|NCT01955733|7510820|FG000|NOT COMPLETED|Period 2||12
6586100|NCT01955733|7510821|FG001|NOT COMPLETED|Period 2||19
6586101|NCT01955733|7510822|FG002|NOT COMPLETED|Period 2||21
6586102|NCT01955837|7510832|FG000|STARTED|Overall Study||271
6586103|NCT01955837|7510833|FG001|STARTED|Overall Study||135
6586104|NCT01955837|7510832|FG000|COMPLETED|Overall Study||271
6586105|NCT01955837|7510833|FG001|COMPLETED|Overall Study||135
6586106|NCT01955837|7510832|FG000|NOT COMPLETED|Overall Study||0
6586107|NCT01955837|7510833|FG001|NOT COMPLETED|Overall Study||0
6586108|NCT01955954|7510839|FG000|STARTED|Overall Study||69
6586109|NCT01955954|7510839|FG000|Received Treatment|Overall Study||66
6586110|NCT01955954|7510839|FG000|Completed Treatment|Overall Study||53
6586111|NCT01955954|7510839|FG000|Completed Post-treatment Assessement|Overall Study||48
6586112|NCT01955954|7510839|FG000|Completed 2-month Assessment|Overall Study|Primary endpoint|46
6586113|NCT01955954|7510839|FG000|Completed 6-month Assessement|Overall Study||42
6586114|NCT01955954|7510839|FG000|COMPLETED|Overall Study|12-months|33
6586115|NCT01955954|7510839|FG000|NOT COMPLETED|Overall Study||36
6586116|NCT01956032|7510843|FG000|STARTED|Overall Study||15
6586117|NCT01956032|7510843|FG000|COMPLETED|Overall Study||15
6586118|NCT01956032|7510843|FG000|NOT COMPLETED|Overall Study||0
6586119|NCT01956071|7510847|FG000|STARTED|Overall Study||44
6586120|NCT01956071|7510847|FG000|COMPLETED|Overall Study||44
6586121|NCT01956071|7510847|FG000|NOT COMPLETED|Overall Study||0
6586122|NCT01956097|7510854|FG000|STARTED|Overall Study||30
6586123|NCT01956097|7510855|FG001|STARTED|Overall Study||30
6586124|NCT01956097|7510856|FG002|STARTED|Overall Study||15
6586125|NCT01956097|7510854|FG000|COMPLETED|Overall Study||24
6586126|NCT01956097|7510855|FG001|COMPLETED|Overall Study||28
6586127|NCT01956097|7510856|FG002|COMPLETED|Overall Study||15
6586128|NCT01956097|7510854|FG000|NOT COMPLETED|Overall Study||6
6586129|NCT01956097|7510855|FG001|NOT COMPLETED|Overall Study||2
6586130|NCT01956097|7510856|FG002|NOT COMPLETED|Overall Study||0
6586131|NCT01956123|7510866|FG000|STARTED|COS Cycle 2||252
6586132|NCT01956123|7510867|FG001|STARTED|COS Cycle 2||261
6586133|NCT01956123|7510868|FG002|STARTED|COS Cycle 2||0
6255888|NCT00931255|7154767|FG001|NOT COMPLETED|Overall Study||3
6255889|NCT00669669|7154773|FG000|STARTED|Overall Study||12
6255890|NCT00669669|7154773|FG000|COMPLETED|Overall Study||11
6255891|NCT00669669|7154773|FG000|NOT COMPLETED|Overall Study||1
6255892|NCT00608023|7154780|FG000|STARTED|Overall Study||92
6255893|NCT00608023|7154781|FG001|STARTED|Overall Study||85
6255894|NCT00608023|7154782|FG002|STARTED|Overall Study||86
6255895|NCT00608023|7154780|FG000|COMPLETED|Overall Study||80
6255896|NCT00608023|7154781|FG001|COMPLETED|Overall Study||63
6255897|NCT00608023|7154782|FG002|COMPLETED|Overall Study||72
6255898|NCT00608023|7154780|FG000|NOT COMPLETED|Overall Study||12
6255899|NCT00608023|7154781|FG001|NOT COMPLETED|Overall Study||22
6255900|NCT00608023|7154782|FG002|NOT COMPLETED|Overall Study||14
6255901|NCT00540995|7154795|FG000|STARTED|Overall Study||23
6255902|NCT00540995|7154796|FG001|STARTED|Overall Study||2
6255903|NCT00540995|7154795|FG000|COMPLETED|Overall Study||23
6255904|NCT00540995|7154796|FG001|COMPLETED|Overall Study||2
6255905|NCT00540995|7154795|FG000|NOT COMPLETED|Overall Study||0
6255906|NCT00540995|7154796|FG001|NOT COMPLETED|Overall Study||0
6255907|NCT00418301|7154801|FG000|STARTED|Overall Study||15
6255908|NCT00418301|7154801|FG000|COMPLETED|Overall Study||12
6255909|NCT00418301|7154801|FG000|NOT COMPLETED|Overall Study||3
6586134|NCT01956123|7510869|FG003|STARTED|COS Cycle 2||0
6586135|NCT01956123|7510866|FG000|COMPLETED|COS Cycle 2||238
6586136|NCT01956123|7510867|FG001|COMPLETED|COS Cycle 2||254
6586137|NCT01956123|7510868|FG002|COMPLETED|COS Cycle 2||0
6586138|NCT01956123|7510869|FG003|COMPLETED|COS Cycle 2||0
6586139|NCT01956123|7510866|FG000|NOT COMPLETED|COS Cycle 2||14
6586140|NCT01956123|7510867|FG001|NOT COMPLETED|COS Cycle 2||7
6586141|NCT01956123|7510868|FG002|NOT COMPLETED|COS Cycle 2||0
6586142|NCT01956123|7510869|FG003|NOT COMPLETED|COS Cycle 2||0
6586143|NCT01956123|7510866|FG000|STARTED|COS Cycle 3||0
6586144|NCT01956123|7510867|FG001|STARTED|COS Cycle 3||0
6586145|NCT01956123|7510868|FG002|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|95
6586146|NCT01956123|7510869|FG003|STARTED|COS Cycle 3|Subjects in COS cycle 2 who failed to achieve an ongoing pregnancy could undergo COS cycle 3|93
6586147|NCT01956123|7510866|FG000|COMPLETED|COS Cycle 3||0
6586148|NCT01956123|7510867|FG001|COMPLETED|COS Cycle 3||0
6586149|NCT01956123|7510868|FG002|COMPLETED|COS Cycle 3||89
6586150|NCT01956123|7510869|FG003|COMPLETED|COS Cycle 3||91
6586151|NCT01956123|7510866|FG000|NOT COMPLETED|COS Cycle 3||0
6586152|NCT01956123|7510867|FG001|NOT COMPLETED|COS Cycle 3||0
6586153|NCT01956123|7510868|FG002|NOT COMPLETED|COS Cycle 3||6
6586154|NCT01956123|7510869|FG003|NOT COMPLETED|COS Cycle 3||2
6586155|NCT01956240|7510882|FG000|STARTED|Overall Study||48
6586156|NCT01956240|7510883|FG001|STARTED|Overall Study||49
6586157|NCT01956240|7510882|FG000|COMPLETED|Overall Study||25
6586158|NCT01956240|7510883|FG001|COMPLETED|Overall Study||25
6586159|NCT01956240|7510882|FG000|NOT COMPLETED|Overall Study||23
6586160|NCT01956240|7510883|FG001|NOT COMPLETED|Overall Study||24
6586161|NCT01956279|7510891|FG000|STARTED|Overall Study||82
6586162|NCT01956279|7510892|FG001|STARTED|Overall Study||88
6586163|NCT01956279|7510891|FG000|COMPLETED|Overall Study||68
6586164|NCT01956279|7510892|FG001|COMPLETED|Overall Study||74
6586165|NCT01956279|7510891|FG000|NOT COMPLETED|Overall Study||14
6586166|NCT01956279|7510892|FG001|NOT COMPLETED|Overall Study||14
6586167|NCT01956435|7510898|FG000|STARTED|Overall Study||3
6586168|NCT01956435|7510899|FG001|STARTED|Overall Study||3
6586169|NCT01956435|7510898|FG000|COMPLETED|Overall Study||3
6586170|NCT01956435|7510899|FG001|COMPLETED|Overall Study||3
6586171|NCT01956435|7510898|FG000|NOT COMPLETED|Overall Study||0
6586172|NCT01956435|7510899|FG001|NOT COMPLETED|Overall Study||0
6586173|NCT01956773|7510908|FG000|STARTED|Overall Study||2520
6586174|NCT01956773|7510909|FG001|STARTED|Overall Study||100
6586175|NCT01956773|7510908|FG000|COMPLETED|Overall Study||1892
6586176|NCT01956773|7510909|FG001|COMPLETED|Overall Study||99
6586177|NCT01956773|7510908|FG000|NOT COMPLETED|Overall Study||628
6586178|NCT01956773|7510909|FG001|NOT COMPLETED|Overall Study||1
6586179|NCT01957085|7510915|FG000|STARTED|Overall Study|Per Institutional Review Board requirements, exact dates are not to be reported|366
6586180|NCT01957085|7510915|FG000|COMPLETED|Overall Study|Per Institutional Review Board, exact dates are not to be reported|366
6586181|NCT01957085|7510915|FG000|NOT COMPLETED|Overall Study||0
6586182|NCT01957111|7510922|FG000|STARTED|Overall Study||16
6586183|NCT01957111|7510923|FG001|STARTED|Overall Study||16
6586184|NCT01957111|7510922|FG000|COMPLETED|Overall Study||15
6586185|NCT01957111|7510923|FG001|COMPLETED|Overall Study||15
6586186|NCT01957111|7510922|FG000|NOT COMPLETED|Overall Study||1
6586187|NCT01957111|7510923|FG001|NOT COMPLETED|Overall Study||1
6586188|NCT01957137|7510929|FG000|STARTED|Randomized Portion||30
6586189|NCT01957137|7510929|FG000|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
6586190|NCT01957137|7510929|FG000|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
6586191|NCT01957137|7510929|FG000|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
6586192|NCT01957137|7510929|FG000|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
6586193|NCT01957137|7510929|FG000|COMPLETED|Randomized Portion||28
6586194|NCT01957137|7510929|FG000|NOT COMPLETED|Randomized Portion||2
6586195|NCT01957137|7510929|FG000|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
6586196|NCT01957137|7510929|FG000|COMPLETED|No Stimulation||28
6586197|NCT01957137|7510929|FG000|NOT COMPLETED|No Stimulation||0
6586198|NCT01957150|7510943|FG000|STARTED|Overall Study||142
6586199|NCT01957150|7510944|FG001|STARTED|Overall Study||141
6586200|NCT01957150|7510943|FG000|COMPLETED|Overall Study||87
6586201|NCT01957150|7510944|FG001|COMPLETED|Overall Study||83
6586202|NCT01957150|7510943|FG000|NOT COMPLETED|Overall Study||55
6586203|NCT01957150|7510944|FG001|NOT COMPLETED|Overall Study||58
6586204|NCT01957163|7510953|FG000|STARTED|Overall Study||206
6586205|NCT01957163|7510954|FG001|STARTED|Overall Study||206
6586206|NCT01957163|7510955|FG002|STARTED|Overall Study||207
6586207|NCT01957163|7510953|FG000|COMPLETED|Overall Study||191
6586208|NCT01957163|7510954|FG001|COMPLETED|Overall Study||195
6586209|NCT01957163|7510955|FG002|COMPLETED|Overall Study||189
6586210|NCT01957163|7510953|FG000|NOT COMPLETED|Overall Study||15
6586211|NCT01957163|7510954|FG001|NOT COMPLETED|Overall Study||11
6586212|NCT01957163|7510955|FG002|NOT COMPLETED|Overall Study||18
6586213|NCT01957202|7510963|FG000|STARTED|Treatment Period 1 (8 Days)||3
6586214|NCT01957202|7510964|FG001|STARTED|Treatment Period 1 (8 Days)||6
6586215|NCT01957202|7510965|FG002|STARTED|Treatment Period 1 (8 Days)||6
6586216|NCT01957202|7510966|FG003|STARTED|Treatment Period 1 (8 Days)||3
6586217|NCT01957202|7510967|FG004|STARTED|Treatment Period 1 (8 Days)||3
6586218|NCT01957202|7510968|FG005|STARTED|Treatment Period 1 (8 Days)||2
6586219|NCT01957202|7510969|FG006|STARTED|Treatment Period 1 (8 Days)||3
6586220|NCT01957202|7510970|FG007|STARTED|Treatment Period 1 (8 Days)||3
6586221|NCT01957202|7510971|FG008|STARTED|Treatment Period 1 (8 Days)||3
6586222|NCT01957202|7510972|FG009|STARTED|Treatment Period 1 (8 Days)||6
6586223|NCT01957202|7510973|FG010|STARTED|Treatment Period 1 (8 Days)||3
6586224|NCT01957202|7510974|FG011|STARTED|Treatment Period 1 (8 Days)||6
6586225|NCT01957202|7510975|FG012|STARTED|Treatment Period 1 (8 Days)||3
6586226|NCT01957202|7510976|FG013|STARTED|Treatment Period 1 (8 Days)||3
6586227|NCT01957202|7510977|FG014|STARTED|Treatment Period 1 (8 Days)||6
6586228|NCT01957202|7510978|FG015|STARTED|Treatment Period 1 (8 Days)||3
6586229|NCT01957202|7510979|FG016|STARTED|Treatment Period 1 (8 Days)||6
6586230|NCT01957202|7510980|FG017|STARTED|Treatment Period 1 (8 Days)||3
6586231|NCT01957202|7510963|FG000|COMPLETED|Treatment Period 1 (8 Days)||3
6586232|NCT01957202|7510964|FG001|COMPLETED|Treatment Period 1 (8 Days)||6
6586233|NCT01957202|7510965|FG002|COMPLETED|Treatment Period 1 (8 Days)||6
6586234|NCT01957202|7510966|FG003|COMPLETED|Treatment Period 1 (8 Days)||3
6586235|NCT01957202|7510967|FG004|COMPLETED|Treatment Period 1 (8 Days)||3
6586236|NCT01957202|7510968|FG005|COMPLETED|Treatment Period 1 (8 Days)||2
6586237|NCT01957202|7510969|FG006|COMPLETED|Treatment Period 1 (8 Days)||3
6586238|NCT01957202|7510970|FG007|COMPLETED|Treatment Period 1 (8 Days)||3
6586239|NCT01957202|7510971|FG008|COMPLETED|Treatment Period 1 (8 Days)||3
6586240|NCT01957202|7510972|FG009|COMPLETED|Treatment Period 1 (8 Days)||6
6586241|NCT01957202|7510973|FG010|COMPLETED|Treatment Period 1 (8 Days)||3
6586242|NCT01957202|7510974|FG011|COMPLETED|Treatment Period 1 (8 Days)||6
6586243|NCT01957202|7510975|FG012|COMPLETED|Treatment Period 1 (8 Days)||3
6586244|NCT01957202|7510976|FG013|COMPLETED|Treatment Period 1 (8 Days)||3
6586245|NCT01957202|7510977|FG014|COMPLETED|Treatment Period 1 (8 Days)||6
6586246|NCT01957202|7510978|FG015|COMPLETED|Treatment Period 1 (8 Days)||3
6586247|NCT01957202|7510979|FG016|COMPLETED|Treatment Period 1 (8 Days)||6
6586248|NCT01957202|7510980|FG017|COMPLETED|Treatment Period 1 (8 Days)||3
6586249|NCT01957202|7510963|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586250|NCT01957202|7510964|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586251|NCT01957202|7510965|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586252|NCT01957202|7510966|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586253|NCT01957202|7510967|FG004|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586254|NCT01957202|7510968|FG005|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586255|NCT01957202|7510969|FG006|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586256|NCT01957202|7510970|FG007|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586257|NCT01957202|7510971|FG008|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586258|NCT01957202|7510972|FG009|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586259|NCT01957202|7510973|FG010|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586260|NCT01957202|7510974|FG011|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586261|NCT01957202|7510975|FG012|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586262|NCT01957202|7510976|FG013|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586263|NCT01957202|7510977|FG014|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586264|NCT01957202|7510978|FG015|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586265|NCT01957202|7510979|FG016|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586266|NCT01957202|7510980|FG017|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6586267|NCT01957202|7510963|FG000|STARTED|Washout Period 1 (14 to 28 Days)||3
6586268|NCT01957202|7510964|FG001|STARTED|Washout Period 1 (14 to 28 Days)||6
6586269|NCT01957202|7510965|FG002|STARTED|Washout Period 1 (14 to 28 Days)||6
6586270|NCT01957202|7510966|FG003|STARTED|Washout Period 1 (14 to 28 Days)||3
6586271|NCT01957202|7510967|FG004|STARTED|Washout Period 1 (14 to 28 Days)||3
6586272|NCT01957202|7510968|FG005|STARTED|Washout Period 1 (14 to 28 Days)||2
6586273|NCT01957202|7510969|FG006|STARTED|Washout Period 1 (14 to 28 Days)||3
6586274|NCT01957202|7510970|FG007|STARTED|Washout Period 1 (14 to 28 Days)||3
6586275|NCT01957202|7510971|FG008|STARTED|Washout Period 1 (14 to 28 Days)||3
6586276|NCT01957202|7510972|FG009|STARTED|Washout Period 1 (14 to 28 Days)||6
6586277|NCT01957202|7510973|FG010|STARTED|Washout Period 1 (14 to 28 Days)||3
6586278|NCT01957202|7510974|FG011|STARTED|Washout Period 1 (14 to 28 Days)||6
6586279|NCT01957202|7510975|FG012|STARTED|Washout Period 1 (14 to 28 Days)||3
6586280|NCT01957202|7510976|FG013|STARTED|Washout Period 1 (14 to 28 Days)||3
6586281|NCT01957202|7510977|FG014|STARTED|Washout Period 1 (14 to 28 Days)||6
6586282|NCT01957202|7510978|FG015|STARTED|Washout Period 1 (14 to 28 Days)||3
6586283|NCT01957202|7510979|FG016|STARTED|Washout Period 1 (14 to 28 Days)||6
6586284|NCT01957202|7510980|FG017|STARTED|Washout Period 1 (14 to 28 Days)||3
6586285|NCT01957202|7510963|FG000|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586286|NCT01957202|7510964|FG001|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6586287|NCT01957202|7510965|FG002|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6586288|NCT01957202|7510966|FG003|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586289|NCT01957202|7510967|FG004|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586290|NCT01957202|7510968|FG005|COMPLETED|Washout Period 1 (14 to 28 Days)||2
6586291|NCT01957202|7510969|FG006|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586292|NCT01957202|7510970|FG007|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586293|NCT01957202|7510971|FG008|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586294|NCT01957202|7510972|FG009|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6586295|NCT01957202|7510973|FG010|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586296|NCT01957202|7510974|FG011|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6586297|NCT01957202|7510975|FG012|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6659304|NCT02487563|7590101|FG002|STARTED|Overall Study||32
6659305|NCT02487563|7590099|FG000|COMPLETED|Overall Study||30
6659306|NCT02487563|7590100|FG001|COMPLETED|Overall Study||30
6659307|NCT02487563|7590101|FG002|COMPLETED|Overall Study||31
6659308|NCT02487563|7590099|FG000|NOT COMPLETED|Overall Study||2
6659309|NCT02487563|7590100|FG001|NOT COMPLETED|Overall Study||3
6659310|NCT02487563|7590101|FG002|NOT COMPLETED|Overall Study||1
6659311|NCT02487771|7590114|FG000|STARTED|Overall Study||91
6659312|NCT02487771|7590115|FG001|STARTED|Overall Study||99
6659313|NCT02487771|7590114|FG000|COMPLETED|Overall Study||81
6659314|NCT02487771|7590115|FG001|COMPLETED|Overall Study||85
6659315|NCT02487771|7590114|FG000|NOT COMPLETED|Overall Study||10
6659316|NCT02487771|7590115|FG001|NOT COMPLETED|Overall Study||14
6659317|NCT02487810|7590123|FG000|STARTED|Overall Study||98
6659318|NCT02487810|7590124|FG001|STARTED|Overall Study||102
6659319|NCT02487810|7590123|FG000|COMPLETED|Overall Study||97
6659320|NCT02487810|7590124|FG001|COMPLETED|Overall Study||102
6659321|NCT02487810|7590123|FG000|NOT COMPLETED|Overall Study||1
6659322|NCT02487810|7590124|FG001|NOT COMPLETED|Overall Study||0
6659323|NCT02487966|7590134|FG000|STARTED|Overall Study||29
6659324|NCT02487966|7590135|FG001|STARTED|Overall Study||28
6659325|NCT02487966|7590136|FG002|STARTED|Overall Study||28
6659326|NCT02487966|7590137|FG003|STARTED|Overall Study||27
6659327|NCT02487966|7590134|FG000|COMPLETED|Overall Study||28
6586298|NCT01957202|7510976|FG013|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586299|NCT01957202|7510977|FG014|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6586300|NCT01957202|7510978|FG015|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586301|NCT01957202|7510979|FG016|COMPLETED|Washout Period 1 (14 to 28 Days)||6
6586302|NCT01957202|7510980|FG017|COMPLETED|Washout Period 1 (14 to 28 Days)||3
6586303|NCT01957202|7510963|FG000|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586304|NCT01957202|7510964|FG001|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586305|NCT01957202|7510965|FG002|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586306|NCT01957202|7510966|FG003|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586307|NCT01957202|7510967|FG004|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586308|NCT01957202|7510968|FG005|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586309|NCT01957202|7510969|FG006|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586310|NCT01957202|7510970|FG007|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586311|NCT01957202|7510971|FG008|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586312|NCT01957202|7510972|FG009|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586313|NCT01957202|7510973|FG010|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586314|NCT01957202|7510974|FG011|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586315|NCT01957202|7510975|FG012|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586316|NCT01957202|7510976|FG013|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586317|NCT01957202|7510977|FG014|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586318|NCT01957202|7510978|FG015|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586319|NCT01957202|7510979|FG016|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586320|NCT01957202|7510980|FG017|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
6586321|NCT01957202|7510963|FG000|STARTED|Treatment Period 2 (8 Days)||3
6586322|NCT01957202|7510964|FG001|STARTED|Treatment Period 2 (8 Days)||6
6586323|NCT01957202|7510965|FG002|STARTED|Treatment Period 2 (8 Days)||6
6586324|NCT01957202|7510966|FG003|STARTED|Treatment Period 2 (8 Days)||3
6586325|NCT01957202|7510967|FG004|STARTED|Treatment Period 2 (8 Days)||3
6586326|NCT01957202|7510968|FG005|STARTED|Treatment Period 2 (8 Days)||2
6586327|NCT01957202|7510969|FG006|STARTED|Treatment Period 2 (8 Days)||3
6586328|NCT01957202|7510970|FG007|STARTED|Treatment Period 2 (8 Days)||3
6586329|NCT01957202|7510971|FG008|STARTED|Treatment Period 2 (8 Days)||3
6586330|NCT01957202|7510972|FG009|STARTED|Treatment Period 2 (8 Days)||6
6586331|NCT01957202|7510973|FG010|STARTED|Treatment Period 2 (8 Days)||3
6586332|NCT01957202|7510974|FG011|STARTED|Treatment Period 2 (8 Days)||6
6586333|NCT01957202|7510975|FG012|STARTED|Treatment Period 2 (8 Days)||3
6586334|NCT01957202|7510976|FG013|STARTED|Treatment Period 2 (8 Days)||3
6586335|NCT01957202|7510977|FG014|STARTED|Treatment Period 2 (8 Days)||6
6586336|NCT01957202|7510978|FG015|STARTED|Treatment Period 2 (8 Days)||3
6586337|NCT01957202|7510979|FG016|STARTED|Treatment Period 2 (8 Days)||6
6586338|NCT01957202|7510980|FG017|STARTED|Treatment Period 2 (8 Days)||3
6586339|NCT01957202|7510963|FG000|COMPLETED|Treatment Period 2 (8 Days)||3
6586340|NCT01957202|7510964|FG001|COMPLETED|Treatment Period 2 (8 Days)||5
6586341|NCT01957202|7510965|FG002|COMPLETED|Treatment Period 2 (8 Days)||6
6586342|NCT01957202|7510966|FG003|COMPLETED|Treatment Period 2 (8 Days)||3
6586343|NCT01957202|7510967|FG004|COMPLETED|Treatment Period 2 (8 Days)||3
6586344|NCT01957202|7510968|FG005|COMPLETED|Treatment Period 2 (8 Days)||2
6586345|NCT01957202|7510969|FG006|COMPLETED|Treatment Period 2 (8 Days)||3
6586346|NCT01957202|7510970|FG007|COMPLETED|Treatment Period 2 (8 Days)||3
6586347|NCT01957202|7510971|FG008|COMPLETED|Treatment Period 2 (8 Days)||3
6586348|NCT01957202|7510972|FG009|COMPLETED|Treatment Period 2 (8 Days)||6
6586349|NCT01957202|7510973|FG010|COMPLETED|Treatment Period 2 (8 Days)||3
6586350|NCT01957202|7510974|FG011|COMPLETED|Treatment Period 2 (8 Days)||6
6586351|NCT01957202|7510975|FG012|COMPLETED|Treatment Period 2 (8 Days)||3
6586352|NCT01957202|7510976|FG013|COMPLETED|Treatment Period 2 (8 Days)||3
6586353|NCT01957202|7510977|FG014|COMPLETED|Treatment Period 2 (8 Days)||6
6586354|NCT01957202|7510978|FG015|COMPLETED|Treatment Period 2 (8 Days)||3
6586355|NCT01957202|7510979|FG016|COMPLETED|Treatment Period 2 (8 Days)||5
6586356|NCT01957202|7510980|FG017|COMPLETED|Treatment Period 2 (8 Days)||3
6586357|NCT01957202|7510963|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586358|NCT01957202|7510964|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||1
6586359|NCT01957202|7510965|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586360|NCT01957202|7510966|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586361|NCT01957202|7510967|FG004|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586362|NCT01957202|7510968|FG005|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586363|NCT01957202|7510969|FG006|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586364|NCT01957202|7510970|FG007|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586365|NCT01957202|7510971|FG008|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586366|NCT01957202|7510972|FG009|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586367|NCT01957202|7510973|FG010|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586368|NCT01957202|7510974|FG011|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586369|NCT01957202|7510975|FG012|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586370|NCT01957202|7510976|FG013|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586371|NCT01957202|7510977|FG014|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586372|NCT01957202|7510978|FG015|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586373|NCT01957202|7510979|FG016|NOT COMPLETED|Treatment Period 2 (8 Days)||1
6586374|NCT01957202|7510980|FG017|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6586375|NCT01957202|7510963|FG000|STARTED|Washout Period 2 (14 to 28 Days)||3
6586376|NCT01957202|7510964|FG001|STARTED|Washout Period 2 (14 to 28 Days)||5
6586377|NCT01957202|7510965|FG002|STARTED|Washout Period 2 (14 to 28 Days)||6
6586378|NCT01957202|7510966|FG003|STARTED|Washout Period 2 (14 to 28 Days)||3
6586379|NCT01957202|7510967|FG004|STARTED|Washout Period 2 (14 to 28 Days)||3
6586380|NCT01957202|7510968|FG005|STARTED|Washout Period 2 (14 to 28 Days)||2
6586381|NCT01957202|7510969|FG006|STARTED|Washout Period 2 (14 to 28 Days)||3
6586382|NCT01957202|7510970|FG007|STARTED|Washout Period 2 (14 to 28 Days)||3
6586383|NCT01957202|7510971|FG008|STARTED|Washout Period 2 (14 to 28 Days)||3
6586384|NCT01957202|7510972|FG009|STARTED|Washout Period 2 (14 to 28 Days)||6
6586385|NCT01957202|7510973|FG010|STARTED|Washout Period 2 (14 to 28 Days)||3
6586386|NCT01957202|7510974|FG011|STARTED|Washout Period 2 (14 to 28 Days)||6
6586387|NCT01957202|7510975|FG012|STARTED|Washout Period 2 (14 to 28 Days)||3
6586388|NCT01957202|7510976|FG013|STARTED|Washout Period 2 (14 to 28 Days)||3
6586389|NCT01957202|7510977|FG014|STARTED|Washout Period 2 (14 to 28 Days)||6
6586390|NCT01957202|7510978|FG015|STARTED|Washout Period 2 (14 to 28 Days)||3
6586391|NCT01957202|7510979|FG016|STARTED|Washout Period 2 (14 to 28 Days)||5
6586392|NCT01957202|7510980|FG017|STARTED|Washout Period 2 (14 to 28 Days)||3
6586393|NCT01957202|7510963|FG000|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586394|NCT01957202|7510964|FG001|COMPLETED|Washout Period 2 (14 to 28 Days)||5
6586395|NCT01957202|7510965|FG002|COMPLETED|Washout Period 2 (14 to 28 Days)||6
6586396|NCT01957202|7510966|FG003|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586397|NCT01957202|7510967|FG004|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586398|NCT01957202|7510968|FG005|COMPLETED|Washout Period 2 (14 to 28 Days)||2
6586399|NCT01957202|7510969|FG006|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586400|NCT01957202|7510970|FG007|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586401|NCT01957202|7510971|FG008|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586402|NCT01957202|7510972|FG009|COMPLETED|Washout Period 2 (14 to 28 Days)||6
6586403|NCT01957202|7510973|FG010|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586404|NCT01957202|7510974|FG011|COMPLETED|Washout Period 2 (14 to 28 Days)||6
6586405|NCT01957202|7510975|FG012|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586406|NCT01957202|7510976|FG013|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586407|NCT01957202|7510977|FG014|COMPLETED|Washout Period 2 (14 to 28 Days)||6
6586408|NCT01957202|7510978|FG015|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586409|NCT01957202|7510979|FG016|COMPLETED|Washout Period 2 (14 to 28 Days)||5
6586410|NCT01957202|7510980|FG017|COMPLETED|Washout Period 2 (14 to 28 Days)||3
6586411|NCT01957202|7510963|FG000|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586412|NCT01957202|7510964|FG001|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586413|NCT01957202|7510965|FG002|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586414|NCT01957202|7510966|FG003|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586415|NCT01957202|7510967|FG004|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586416|NCT01957202|7510968|FG005|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586417|NCT01957202|7510969|FG006|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586418|NCT01957202|7510970|FG007|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586419|NCT01957202|7510971|FG008|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586420|NCT01957202|7510972|FG009|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586421|NCT01957202|7510973|FG010|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586422|NCT01957202|7510974|FG011|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586423|NCT01957202|7510975|FG012|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586424|NCT01957202|7510976|FG013|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586425|NCT01957202|7510977|FG014|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586426|NCT01957202|7510978|FG015|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586427|NCT01957202|7510979|FG016|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586428|NCT01957202|7510980|FG017|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
6586429|NCT01957202|7510963|FG000|STARTED|Treatment Period 3 (8 Days)||3
6586430|NCT01957202|7510964|FG001|STARTED|Treatment Period 3 (8 Days)||5
6586431|NCT01957202|7510965|FG002|STARTED|Treatment Period 3 (8 Days)||6
6586432|NCT01957202|7510966|FG003|STARTED|Treatment Period 3 (8 Days)||3
6586433|NCT01957202|7510967|FG004|STARTED|Treatment Period 3 (8 Days)||3
6586434|NCT01957202|7510968|FG005|STARTED|Treatment Period 3 (8 Days)||2
6586435|NCT01957202|7510969|FG006|STARTED|Treatment Period 3 (8 Days)||3
6586436|NCT01957202|7510970|FG007|STARTED|Treatment Period 3 (8 Days)||3
6586437|NCT01957202|7510971|FG008|STARTED|Treatment Period 3 (8 Days)||3
6586438|NCT01957202|7510972|FG009|STARTED|Treatment Period 3 (8 Days)||6
6586439|NCT01957202|7510973|FG010|STARTED|Treatment Period 3 (8 Days)||3
6586440|NCT01957202|7510974|FG011|STARTED|Treatment Period 3 (8 Days)||6
6586441|NCT01957202|7510975|FG012|STARTED|Treatment Period 3 (8 Days)||3
6586442|NCT01957202|7510976|FG013|STARTED|Treatment Period 3 (8 Days)||3
6586443|NCT01957202|7510977|FG014|STARTED|Treatment Period 3 (8 Days)||6
6586444|NCT01957202|7510978|FG015|STARTED|Treatment Period 3 (8 Days)||3
6586445|NCT01957202|7510979|FG016|STARTED|Treatment Period 3 (8 Days)||5
6586446|NCT01957202|7510980|FG017|STARTED|Treatment Period 3 (8 Days)||3
6586447|NCT01957202|7510963|FG000|COMPLETED|Treatment Period 3 (8 Days)||3
6586448|NCT01957202|7510964|FG001|COMPLETED|Treatment Period 3 (8 Days)||5
6586449|NCT01957202|7510965|FG002|COMPLETED|Treatment Period 3 (8 Days)||6
6586450|NCT01957202|7510966|FG003|COMPLETED|Treatment Period 3 (8 Days)||3
6586451|NCT01957202|7510967|FG004|COMPLETED|Treatment Period 3 (8 Days)||3
6659328|NCT02487966|7590135|FG001|COMPLETED|Overall Study||24
6586452|NCT01957202|7510968|FG005|COMPLETED|Treatment Period 3 (8 Days)||2
6586453|NCT01957202|7510969|FG006|COMPLETED|Treatment Period 3 (8 Days)||3
6586454|NCT01957202|7510970|FG007|COMPLETED|Treatment Period 3 (8 Days)||3
6586455|NCT01957202|7510971|FG008|COMPLETED|Treatment Period 3 (8 Days)||3
6586456|NCT01957202|7510972|FG009|COMPLETED|Treatment Period 3 (8 Days)||6
6586457|NCT01957202|7510973|FG010|COMPLETED|Treatment Period 3 (8 Days)||3
6586458|NCT01957202|7510974|FG011|COMPLETED|Treatment Period 3 (8 Days)||6
6586459|NCT01957202|7510975|FG012|COMPLETED|Treatment Period 3 (8 Days)||3
6586460|NCT01957202|7510976|FG013|COMPLETED|Treatment Period 3 (8 Days)||3
6586461|NCT01957202|7510977|FG014|COMPLETED|Treatment Period 3 (8 Days)||6
6586462|NCT01957202|7510978|FG015|COMPLETED|Treatment Period 3 (8 Days)||3
6586463|NCT01957202|7510979|FG016|COMPLETED|Treatment Period 3 (8 Days)||4
6586464|NCT01957202|7510980|FG017|COMPLETED|Treatment Period 3 (8 Days)||3
6586465|NCT01957202|7510963|FG000|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586466|NCT01957202|7510964|FG001|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586467|NCT01957202|7510965|FG002|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586468|NCT01957202|7510966|FG003|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586469|NCT01957202|7510967|FG004|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586470|NCT01957202|7510968|FG005|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586471|NCT01957202|7510969|FG006|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586472|NCT01957202|7510970|FG007|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586473|NCT01957202|7510971|FG008|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586474|NCT01957202|7510972|FG009|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586475|NCT01957202|7510973|FG010|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586476|NCT01957202|7510974|FG011|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586477|NCT01957202|7510975|FG012|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586478|NCT01957202|7510976|FG013|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586479|NCT01957202|7510977|FG014|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586480|NCT01957202|7510978|FG015|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586481|NCT01957202|7510979|FG016|NOT COMPLETED|Treatment Period 3 (8 Days)||1
6586482|NCT01957202|7510980|FG017|NOT COMPLETED|Treatment Period 3 (8 Days)||0
6586483|NCT01957215|7510992|FG000|STARTED|Overall Study||135
6586484|NCT01957215|7510993|FG001|STARTED|Overall Study||135
6586485|NCT01957215|7510992|FG000|COMPLETED|Overall Study||122
6586486|NCT01957215|7510993|FG001|COMPLETED|Overall Study||123
6586487|NCT01957215|7510992|FG000|NOT COMPLETED|Overall Study||13
6586488|NCT01957215|7510993|FG001|NOT COMPLETED|Overall Study||12
6586489|NCT01957384|7511003|FG000|STARTED|Test Period 1 (14 Days)||4
6586490|NCT01957384|7511004|FG001|STARTED|Test Period 1 (14 Days)||4
6586491|NCT01957384|7511005|FG002|STARTED|Test Period 1 (14 Days)||4
6586492|NCT01957384|7511006|FG003|STARTED|Test Period 1 (14 Days)||4
6586493|NCT01957384|7511007|FG004|STARTED|Test Period 1 (14 Days)||3
6586494|NCT01957384|7511008|FG005|STARTED|Test Period 1 (14 Days)||3
6586495|NCT01957384|7511003|FG000|COMPLETED|Test Period 1 (14 Days)||4
6586496|NCT01957384|7511004|FG001|COMPLETED|Test Period 1 (14 Days)||4
6586497|NCT01957384|7511005|FG002|COMPLETED|Test Period 1 (14 Days)||4
6586498|NCT01957384|7511006|FG003|COMPLETED|Test Period 1 (14 Days)||4
6586499|NCT01957384|7511007|FG004|COMPLETED|Test Period 1 (14 Days)||3
6586500|NCT01957384|7511008|FG005|COMPLETED|Test Period 1 (14 Days)||3
6586501|NCT01957384|7511003|FG000|NOT COMPLETED|Test Period 1 (14 Days)||0
6586502|NCT01957384|7511004|FG001|NOT COMPLETED|Test Period 1 (14 Days)||0
6586503|NCT01957384|7511005|FG002|NOT COMPLETED|Test Period 1 (14 Days)||0
6586504|NCT01957384|7511006|FG003|NOT COMPLETED|Test Period 1 (14 Days)||0
6586505|NCT01957384|7511007|FG004|NOT COMPLETED|Test Period 1 (14 Days)||0
6586506|NCT01957384|7511008|FG005|NOT COMPLETED|Test Period 1 (14 Days)||0
6586507|NCT01957384|7511003|FG000|STARTED|Test Period 2 (14 Days)||4
6586508|NCT01957384|7511004|FG001|STARTED|Test Period 2 (14 Days)||4
6586509|NCT01957384|7511005|FG002|STARTED|Test Period 2 (14 Days)||4
6586510|NCT01957384|7511006|FG003|STARTED|Test Period 2 (14 Days)||4
6586511|NCT01957384|7511007|FG004|STARTED|Test Period 2 (14 Days)||3
6586512|NCT01957384|7511008|FG005|STARTED|Test Period 2 (14 Days)||3
6586513|NCT01957384|7511003|FG000|COMPLETED|Test Period 2 (14 Days)||4
6586514|NCT01957384|7511004|FG001|COMPLETED|Test Period 2 (14 Days)||4
6586515|NCT01957384|7511005|FG002|COMPLETED|Test Period 2 (14 Days)||4
6586516|NCT01957384|7511006|FG003|COMPLETED|Test Period 2 (14 Days)||4
6586517|NCT01957384|7511007|FG004|COMPLETED|Test Period 2 (14 Days)||3
6586518|NCT01957384|7511008|FG005|COMPLETED|Test Period 2 (14 Days)||3
6586519|NCT01957384|7511003|FG000|NOT COMPLETED|Test Period 2 (14 Days)||0
6586520|NCT01957384|7511004|FG001|NOT COMPLETED|Test Period 2 (14 Days)||0
6586521|NCT01957384|7511005|FG002|NOT COMPLETED|Test Period 2 (14 Days)||0
6586522|NCT01957384|7511006|FG003|NOT COMPLETED|Test Period 2 (14 Days)||0
6586523|NCT01957384|7511007|FG004|NOT COMPLETED|Test Period 2 (14 Days)||0
6586524|NCT01957384|7511008|FG005|NOT COMPLETED|Test Period 2 (14 Days)||0
6586525|NCT01957384|7511003|FG000|STARTED|Test Period 3 (14 Days)||4
6586526|NCT01957384|7511004|FG001|STARTED|Test Period 3 (14 Days)||4
6586527|NCT01957384|7511005|FG002|STARTED|Test Period 3 (14 Days)||4
6586528|NCT01957384|7511006|FG003|STARTED|Test Period 3 (14 Days)||4
6586529|NCT01957384|7511007|FG004|STARTED|Test Period 3 (14 Days)||3
6586530|NCT01957384|7511008|FG005|STARTED|Test Period 3 (14 Days)||3
6586531|NCT01957384|7511003|FG000|COMPLETED|Test Period 3 (14 Days)||4
6586532|NCT01957384|7511004|FG001|COMPLETED|Test Period 3 (14 Days)||4
6659329|NCT02487966|7590136|FG002|COMPLETED|Overall Study||26
6586533|NCT01957384|7511005|FG002|COMPLETED|Test Period 3 (14 Days)||4
6586534|NCT01957384|7511006|FG003|COMPLETED|Test Period 3 (14 Days)||4
6586535|NCT01957384|7511007|FG004|COMPLETED|Test Period 3 (14 Days)||3
6586536|NCT01957384|7511008|FG005|COMPLETED|Test Period 3 (14 Days)||3
6586537|NCT01957384|7511003|FG000|NOT COMPLETED|Test Period 3 (14 Days)||0
6586538|NCT01957384|7511004|FG001|NOT COMPLETED|Test Period 3 (14 Days)||0
6586539|NCT01957384|7511005|FG002|NOT COMPLETED|Test Period 3 (14 Days)||0
6586540|NCT01957384|7511006|FG003|NOT COMPLETED|Test Period 3 (14 Days)||0
6586541|NCT01957384|7511007|FG004|NOT COMPLETED|Test Period 3 (14 Days)||0
6586542|NCT01957384|7511008|FG005|NOT COMPLETED|Test Period 3 (14 Days)||0
6586543|NCT01957397|7511016|FG000|STARTED|Baseline Own Product||13
6586544|NCT01957397|7511017|FG001|STARTED|Baseline Own Product||13
6586545|NCT01957397|7511016|FG000|COMPLETED|Baseline Own Product||13
6586546|NCT01957397|7511017|FG001|COMPLETED|Baseline Own Product||13
6586547|NCT01957397|7511016|FG000|NOT COMPLETED|Baseline Own Product||0
6586548|NCT01957397|7511017|FG001|NOT COMPLETED|Baseline Own Product||0
6659330|NCT02487966|7590137|FG003|COMPLETED|Overall Study||25
6659331|NCT02487966|7590134|FG000|NOT COMPLETED|Overall Study||1
6659332|NCT02487966|7590135|FG001|NOT COMPLETED|Overall Study||4
6659333|NCT02487966|7590136|FG002|NOT COMPLETED|Overall Study||2
6659334|NCT02487966|7590137|FG003|NOT COMPLETED|Overall Study||2
6659335|NCT02488005|7590147|FG000|STARTED|Overall Study||15
6659336|NCT02488005|7590147|FG000|COMPLETED|Overall Study||13
6659337|NCT02488005|7590147|FG000|NOT COMPLETED|Overall Study||2
6659338|NCT02488018|7590151|FG000|STARTED|Overall Study||10
6659339|NCT02488018|7590151|FG000|COMPLETED|Overall Study||10
6659340|NCT02488018|7590151|FG000|NOT COMPLETED|Overall Study||0
6659341|NCT02488070|7590155|FG000|STARTED|Overall Study||10
6659342|NCT02488070|7590155|FG000|COMPLETED|Overall Study||10
6659343|NCT02488070|7590155|FG000|NOT COMPLETED|Overall Study||0
6659344|NCT02488109|7590162|FG000|STARTED|Treatment in Hospital||60
6659345|NCT02488109|7590163|FG001|STARTED|Treatment in Hospital||56
6659346|NCT02488109|7590162|FG000|Received Treatment|Treatment in Hospital||60
6659347|NCT02488109|7590163|FG001|Received Treatment|Treatment in Hospital||51
6659348|NCT02488109|7590162|FG000|Included in mITT Analysis|Treatment in Hospital||60
6659349|NCT02488109|7590163|FG001|Included in mITT Analysis|Treatment in Hospital||51
6659350|NCT02488109|7590162|FG000|COMPLETED|Treatment in Hospital||60
6659351|NCT02488109|7590163|FG001|COMPLETED|Treatment in Hospital||51
6659352|NCT02488109|7590162|FG000|NOT COMPLETED|Treatment in Hospital||0
6659353|NCT02488109|7590163|FG001|NOT COMPLETED|Treatment in Hospital||5
6659354|NCT02488109|7590162|FG000|STARTED|12-month Follow-Up||60
6659355|NCT02488109|7590163|FG001|STARTED|12-month Follow-Up||51
6659356|NCT02488109|7590162|FG000|Included in mITT Analysis|12-month Follow-Up||60
6659357|NCT02488109|7590163|FG001|Included in mITT Analysis|12-month Follow-Up||51
6659358|NCT02488109|7590162|FG000|COMPLETED|12-month Follow-Up||56
6659359|NCT02488109|7590163|FG001|COMPLETED|12-month Follow-Up||44
6659360|NCT02488109|7590162|FG000|NOT COMPLETED|12-month Follow-Up||4
6659361|NCT02488109|7590163|FG001|NOT COMPLETED|12-month Follow-Up||7
6659362|NCT02488239|7590171|FG000|STARTED|Overall Study||64
6659363|NCT02488239|7590171|FG000|COMPLETED|Overall Study||54
6659364|NCT02488239|7590171|FG000|NOT COMPLETED|Overall Study||10
6659365|NCT02488317|7590178|FG000|STARTED|Overall Study||117
6659366|NCT02488317|7590179|FG001|STARTED|Overall Study||117
6659367|NCT02488317|7590178|FG000|COMPLETED|Overall Study||63
6659368|NCT02488317|7590179|FG001|COMPLETED|Overall Study||70
6659369|NCT02488317|7590178|FG000|NOT COMPLETED|Overall Study||54
6659370|NCT02488317|7590179|FG001|NOT COMPLETED|Overall Study||47
6659371|NCT02488330|7590189|FG000|STARTED|Overall Study||12
6659372|NCT02488330|7590189|FG000|COMPLETED|Overall Study||0
6659373|NCT02488330|7590189|FG000|NOT COMPLETED|Overall Study||12
6659374|NCT02488681|7590193|FG000|STARTED|Overall Study|Patients with Micra implant attempt|276
6659375|NCT02488681|7590193|FG000|COMPLETED|Overall Study|Patients successfully implanted with Micra|269
6659376|NCT02488681|7590193|FG000|NOT COMPLETED|Overall Study||7
6659377|NCT02488824|7590199|FG000|STARTED|Overall Study||21
6659378|NCT02488824|7590200|FG001|STARTED|Overall Study||20
6659379|NCT02488824|7590199|FG000|COMPLETED|Overall Study||20
6659380|NCT02488824|7590200|FG001|COMPLETED|Overall Study||19
6659381|NCT02488824|7590199|FG000|NOT COMPLETED|Overall Study||1
6659382|NCT02488824|7590200|FG001|NOT COMPLETED|Overall Study||1
6659383|NCT02488915|7590206|FG000|STARTED|Overall Study||228
6659384|NCT02488915|7590206|FG000|COMPLETED|Overall Study||202
6659385|NCT02488915|7590206|FG000|NOT COMPLETED|Overall Study||26
6659386|NCT02488980|7590213|FG000|STARTED|Overall Study||104
6659387|NCT02488980|7590214|FG001|STARTED|Overall Study||101
6659388|NCT02488980|7590215|FG002|STARTED|Overall Study||101
6659389|NCT02488980|7590213|FG000|COMPLETED|Overall Study||102
6659390|NCT02488980|7590214|FG001|COMPLETED|Overall Study||99
6659391|NCT02488980|7590215|FG002|COMPLETED|Overall Study||99
6659392|NCT02488980|7590213|FG000|NOT COMPLETED|Overall Study||2
6659393|NCT02488980|7590214|FG001|NOT COMPLETED|Overall Study||2
6659394|NCT02488980|7590215|FG002|NOT COMPLETED|Overall Study||2
6659395|NCT02489045|7590223|FG000|STARTED|Overall Study||178
6659396|NCT02489045|7590223|FG000|COMPLETED|Overall Study||125
6659397|NCT02489045|7590223|FG000|NOT COMPLETED|Overall Study||53
6659398|NCT02489045|7590223|FG000|STARTED|Follow-up|"Only subjects with portal hypertension in overall study were eligible to progress to follow-up"|21
6659399|NCT02489045|7590223|FG000|COMPLETED|Follow-up||11
6586549|NCT01957397|7511016|FG000|STARTED|Test Period 1||13
6586550|NCT01957397|7511017|FG001|STARTED|Test Period 1||13
6659400|NCT02489045|7590223|FG000|NOT COMPLETED|Follow-up||10
6659401|NCT02489110|7590229|FG000|STARTED|Overall Study||75
6659402|NCT02489110|7590230|FG001|STARTED|Overall Study||75
6659403|NCT02489110|7590229|FG000|COMPLETED|Overall Study||48
6659404|NCT02489110|7590230|FG001|COMPLETED|Overall Study||50
6586551|NCT01957397|7511016|FG000|COMPLETED|Test Period 1||11
6586552|NCT01957397|7511017|FG001|COMPLETED|Test Period 1||12
6586553|NCT01957397|7511016|FG000|NOT COMPLETED|Test Period 1||2
6586554|NCT01957397|7511017|FG001|NOT COMPLETED|Test Period 1||1
6586555|NCT01957397|7511016|FG000|STARTED|Test Period 2||11
6586556|NCT01957397|7511017|FG001|STARTED|Test Period 2||12
6586557|NCT01957397|7511016|FG000|COMPLETED|Test Period 2||11
6586558|NCT01957397|7511017|FG001|COMPLETED|Test Period 2||11
6586559|NCT01957397|7511016|FG000|NOT COMPLETED|Test Period 2||0
6586560|NCT01957397|7511017|FG001|NOT COMPLETED|Test Period 2||1
6586561|NCT01957397|7511016|FG000|STARTED|Test Period 3||11
6586562|NCT01957397|7511017|FG001|STARTED|Test Period 3||11
6586563|NCT01957397|7511016|FG000|COMPLETED|Test Period 3||9
6586564|NCT01957397|7511017|FG001|COMPLETED|Test Period 3||9
6586565|NCT01957397|7511016|FG000|NOT COMPLETED|Test Period 3||2
6586566|NCT01957397|7511017|FG001|NOT COMPLETED|Test Period 3||2
6586567|NCT01957410|7511027|FG000|STARTED|Open Label||13
6586568|NCT01957410|7511027|FG000|COMPLETED|Open Label||13
6586569|NCT01957410|7511027|FG000|NOT COMPLETED|Open Label||0
6586570|NCT01957410|7511027|FG000|STARTED|Optional Open Label||13
6586571|NCT01957410|7511027|FG000|COMPLETED|Optional Open Label||13
6586572|NCT01957410|7511027|FG000|NOT COMPLETED|Optional Open Label||0
6586573|NCT01957462|7511031|FG000|STARTED|Test Period 1||16
6586574|NCT01957462|7511032|FG001|STARTED|Test Period 1||15
6586575|NCT01957462|7511031|FG000|COMPLETED|Test Period 1||14
6586576|NCT01957462|7511032|FG001|COMPLETED|Test Period 1||15
6586577|NCT01957462|7511031|FG000|NOT COMPLETED|Test Period 1||2
6586578|NCT01957462|7511032|FG001|NOT COMPLETED|Test Period 1||0
6586579|NCT01957462|7511031|FG000|STARTED|Test Period 2||14
6586580|NCT01957462|7511032|FG001|STARTED|Test Period 2||15
6586581|NCT01957462|7511031|FG000|COMPLETED|Test Period 2||14
6586582|NCT01957462|7511032|FG001|COMPLETED|Test Period 2||15
6586583|NCT01957462|7511031|FG000|NOT COMPLETED|Test Period 2||0
6586584|NCT01957462|7511032|FG001|NOT COMPLETED|Test Period 2||0
6586585|NCT01957475|7511038|FG000|STARTED|Test Period 1||10
6586586|NCT01957475|7511039|FG001|STARTED|Test Period 1||10
6586587|NCT01957475|7511038|FG000|COMPLETED|Test Period 1||8
6586588|NCT01957475|7511039|FG001|COMPLETED|Test Period 1||9
6586589|NCT01957475|7511038|FG000|NOT COMPLETED|Test Period 1||2
6586590|NCT01957475|7511039|FG001|NOT COMPLETED|Test Period 1||1
6586591|NCT01957475|7511038|FG000|STARTED|Test Period 2||9
6586592|NCT01957475|7511039|FG001|STARTED|Test Period 2||8
6586593|NCT01957475|7511038|FG000|COMPLETED|Test Period 2||8
6586594|NCT01957475|7511039|FG001|COMPLETED|Test Period 2||8
6586595|NCT01957475|7511038|FG000|NOT COMPLETED|Test Period 2||1
6586596|NCT01957475|7511039|FG001|NOT COMPLETED|Test Period 2||0
6586597|NCT01957488|7511045|FG000|STARTED|Test Period 1 (2 Weeks)||30
6586598|NCT01957488|7511046|FG001|STARTED|Test Period 1 (2 Weeks)||31
6586599|NCT01957488|7511047|FG002|STARTED|Test Period 1 (2 Weeks)||30
6586600|NCT01957488|7511048|FG003|STARTED|Test Period 1 (2 Weeks)||32
6586601|NCT01957488|7511049|FG004|STARTED|Test Period 1 (2 Weeks)||30
6586602|NCT01957488|7511050|FG005|STARTED|Test Period 1 (2 Weeks)||30
6586603|NCT01957488|7511045|FG000|COMPLETED|Test Period 1 (2 Weeks)||27
6586604|NCT01957488|7511046|FG001|COMPLETED|Test Period 1 (2 Weeks)||28
6586605|NCT01957488|7511047|FG002|COMPLETED|Test Period 1 (2 Weeks)||26
6586606|NCT01957488|7511048|FG003|COMPLETED|Test Period 1 (2 Weeks)||29
6586607|NCT01957488|7511049|FG004|COMPLETED|Test Period 1 (2 Weeks)||27
6586608|NCT01957488|7511050|FG005|COMPLETED|Test Period 1 (2 Weeks)||24
6586609|NCT01957488|7511045|FG000|NOT COMPLETED|Test Period 1 (2 Weeks)||3
6586610|NCT01957488|7511046|FG001|NOT COMPLETED|Test Period 1 (2 Weeks)||3
6586611|NCT01957488|7511047|FG002|NOT COMPLETED|Test Period 1 (2 Weeks)||4
6586612|NCT01957488|7511048|FG003|NOT COMPLETED|Test Period 1 (2 Weeks)||3
6586613|NCT01957488|7511049|FG004|NOT COMPLETED|Test Period 1 (2 Weeks)||3
6586614|NCT01957488|7511050|FG005|NOT COMPLETED|Test Period 1 (2 Weeks)||6
6586615|NCT01957488|7511045|FG000|STARTED|Test Period 2 (2 Weeks)||27
6586616|NCT01957488|7511046|FG001|STARTED|Test Period 2 (2 Weeks)||28
6586617|NCT01957488|7511047|FG002|STARTED|Test Period 2 (2 Weeks)||26
6586618|NCT01957488|7511048|FG003|STARTED|Test Period 2 (2 Weeks)||29
6586619|NCT01957488|7511049|FG004|STARTED|Test Period 2 (2 Weeks)||27
6586620|NCT01957488|7511050|FG005|STARTED|Test Period 2 (2 Weeks)||24
6586621|NCT01957488|7511045|FG000|COMPLETED|Test Period 2 (2 Weeks)||24
6586622|NCT01957488|7511046|FG001|COMPLETED|Test Period 2 (2 Weeks)||27
6586623|NCT01957488|7511047|FG002|COMPLETED|Test Period 2 (2 Weeks)||25
6586624|NCT01957488|7511048|FG003|COMPLETED|Test Period 2 (2 Weeks)||28
6586625|NCT01957488|7511049|FG004|COMPLETED|Test Period 2 (2 Weeks)||25
6586626|NCT01957488|7511050|FG005|COMPLETED|Test Period 2 (2 Weeks)||23
6586627|NCT01957488|7511045|FG000|NOT COMPLETED|Test Period 2 (2 Weeks)||3
6586628|NCT01957488|7511046|FG001|NOT COMPLETED|Test Period 2 (2 Weeks)||1
6586629|NCT01957488|7511047|FG002|NOT COMPLETED|Test Period 2 (2 Weeks)||1
6586630|NCT01957488|7511048|FG003|NOT COMPLETED|Test Period 2 (2 Weeks)||1
6586631|NCT01957488|7511049|FG004|NOT COMPLETED|Test Period 2 (2 Weeks)||2
6586632|NCT01957488|7511050|FG005|NOT COMPLETED|Test Period 2 (2 Weeks)||1
6586633|NCT01957488|7511045|FG000|STARTED|Test Period 3 (2 Weeks)||24
6586634|NCT01957488|7511046|FG001|STARTED|Test Period 3 (2 Weeks)||27
6586635|NCT01957488|7511047|FG002|STARTED|Test Period 3 (2 Weeks)||25
6586636|NCT01957488|7511048|FG003|STARTED|Test Period 3 (2 Weeks)||28
6586637|NCT01957488|7511049|FG004|STARTED|Test Period 3 (2 Weeks)||25
6586638|NCT01957488|7511050|FG005|STARTED|Test Period 3 (2 Weeks)||23
6586639|NCT01957488|7511045|FG000|COMPLETED|Test Period 3 (2 Weeks)||23
6586640|NCT01957488|7511046|FG001|COMPLETED|Test Period 3 (2 Weeks)||26
6586641|NCT01957488|7511047|FG002|COMPLETED|Test Period 3 (2 Weeks)||25
6586642|NCT01957488|7511048|FG003|COMPLETED|Test Period 3 (2 Weeks)||28
6586643|NCT01957488|7511049|FG004|COMPLETED|Test Period 3 (2 Weeks)||25
6586644|NCT01957488|7511050|FG005|COMPLETED|Test Period 3 (2 Weeks)||23
6586645|NCT01957488|7511045|FG000|NOT COMPLETED|Test Period 3 (2 Weeks)||1
6586646|NCT01957488|7511046|FG001|NOT COMPLETED|Test Period 3 (2 Weeks)||1
6586647|NCT01957488|7511047|FG002|NOT COMPLETED|Test Period 3 (2 Weeks)||0
6586648|NCT01957488|7511048|FG003|NOT COMPLETED|Test Period 3 (2 Weeks)||0
6586649|NCT01957488|7511049|FG004|NOT COMPLETED|Test Period 3 (2 Weeks)||0
6586650|NCT01957488|7511050|FG005|NOT COMPLETED|Test Period 3 (2 Weeks)||0
6586651|NCT01957553|7511058|FG000|STARTED|Test Period 1 (21 +- 1 Days)||61
6586652|NCT01957553|7511059|FG001|STARTED|Test Period 1 (21 +- 1 Days)||66
6586653|NCT01957553|7511058|FG000|COMPLETED|Test Period 1 (21 +- 1 Days)||54
6586654|NCT01957553|7511059|FG001|COMPLETED|Test Period 1 (21 +- 1 Days)||63
6586655|NCT01957553|7511058|FG000|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
6586656|NCT01957553|7511059|FG001|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
6586657|NCT01957553|7511058|FG000|STARTED|Test Period 2 (21 +- 1 Days)||54
6586658|NCT01957553|7511059|FG001|STARTED|Test Period 2 (21 +- 1 Days)||63
6586659|NCT01957553|7511058|FG000|COMPLETED|Test Period 2 (21 +- 1 Days)||51
6586660|NCT01957553|7511059|FG001|COMPLETED|Test Period 2 (21 +- 1 Days)||56
6586661|NCT01957553|7511058|FG000|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
6586662|NCT01957553|7511059|FG001|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
6586663|NCT01957579|7511069|FG000|STARTED|Overall Study||3
6586664|NCT01957579|7511070|FG001|STARTED|Overall Study||7
6586665|NCT01957579|7511071|FG002|STARTED|Overall Study||4
6586666|NCT01957579|7511072|FG003|STARTED|Overall Study||6
6586667|NCT01957579|7511069|FG000|COMPLETED|Overall Study||3
6586668|NCT01957579|7511070|FG001|COMPLETED|Overall Study||6
6586669|NCT01957579|7511071|FG002|COMPLETED|Overall Study||2
6586670|NCT01957579|7511072|FG003|COMPLETED|Overall Study||6
6586671|NCT01957579|7511069|FG000|NOT COMPLETED|Overall Study||0
6586672|NCT01957579|7511070|FG001|NOT COMPLETED|Overall Study||1
6586673|NCT01957579|7511071|FG002|NOT COMPLETED|Overall Study||2
6586674|NCT01957579|7511072|FG003|NOT COMPLETED|Overall Study||0
6586675|NCT01957644|7511104|FG000|STARTED|Overall Study||6
6586676|NCT01957644|7511105|FG001|STARTED|Overall Study||6
6586677|NCT01957644|7511106|FG002|STARTED|Overall Study||1
6586678|NCT01957644|7511107|FG003|STARTED|Overall Study||2
6586679|NCT01957644|7511108|FG004|STARTED|Overall Study||1
6586680|NCT01957644|7511104|FG000|COMPLETED|Overall Study||0
6586681|NCT01957644|7511105|FG001|COMPLETED|Overall Study||0
6586682|NCT01957644|7511106|FG002|COMPLETED|Overall Study||0
6586683|NCT01957644|7511107|FG003|COMPLETED|Overall Study||0
6586684|NCT01957644|7511108|FG004|COMPLETED|Overall Study||0
6586685|NCT01957644|7511104|FG000|NOT COMPLETED|Overall Study||6
6586686|NCT01957644|7511105|FG001|NOT COMPLETED|Overall Study||6
6586687|NCT01957644|7511106|FG002|NOT COMPLETED|Overall Study||1
6586688|NCT01957644|7511107|FG003|NOT COMPLETED|Overall Study||2
6586689|NCT01957644|7511108|FG004|NOT COMPLETED|Overall Study||1
6586690|NCT01957657|7511122|FG000|STARTED|Overall Study||4
6586691|NCT01957657|7511122|FG000|COMPLETED|Overall Study||4
6586692|NCT01957657|7511122|FG000|NOT COMPLETED|Overall Study||0
6586693|NCT01957709|7511126|FG000|STARTED|Overall Study||8
6586694|NCT01957709|7511126|FG000|COMPLETED|Overall Study||7
6586695|NCT01957709|7511126|FG000|NOT COMPLETED|Overall Study||1
6586696|NCT01957761|7511130|FG000|STARTED|Overall Study||189
6586697|NCT01957761|7511130|FG000|COMPLETED|Overall Study||189
6586698|NCT01957761|7511130|FG000|NOT COMPLETED|Overall Study||0
6586699|NCT01957787|7511134|FG000|STARTED|Overall Study|Participant who was withdrawn prior to study treatment was not included in Number of Index Tumors.|131
6586700|NCT01957787|7511134|FG000|Intent-to-Treat (ITT) Population|Overall Study||130
6586701|NCT01957787|7511134|FG000|Modified ITT (mITT) Population|Overall Study||128
6586702|NCT01957787|7511134|FG000|COMPLETED|Overall Study||95
6586703|NCT01957787|7511134|FG000|NOT COMPLETED|Overall Study||36
6586704|NCT01957865|7511141|FG000|STARTED|Overall Study||21
6586705|NCT01957865|7511142|FG001|STARTED|Overall Study||20
6586706|NCT01957865|7511143|FG002|STARTED|Overall Study||22
6586707|NCT01957865|7511141|FG000|COMPLETED|Overall Study||21
6586708|NCT01957865|7511142|FG001|COMPLETED|Overall Study||18
6586709|NCT01957865|7511143|FG002|COMPLETED|Overall Study||19
6586710|NCT01957865|7511141|FG000|NOT COMPLETED|Overall Study||0
6586711|NCT01957865|7511142|FG001|NOT COMPLETED|Overall Study||2
6586712|NCT01957865|7511143|FG002|NOT COMPLETED|Overall Study||3
6586713|NCT01957930|7511155|FG000|STARTED|Overall Study||35
6586714|NCT01957930|7511156|FG001|STARTED|Overall Study||37
6586715|NCT01957930|7511157|FG002|STARTED|Overall Study||19
6586716|NCT01957930|7511155|FG000|COMPLETED|Overall Study||35
6586717|NCT01957930|7511156|FG001|COMPLETED|Overall Study||37
6586718|NCT01957930|7511157|FG002|COMPLETED|Overall Study||19
6586719|NCT01957930|7511155|FG000|NOT COMPLETED|Overall Study||0
6586720|NCT01957930|7511156|FG001|NOT COMPLETED|Overall Study||0
6586721|NCT01957930|7511157|FG002|NOT COMPLETED|Overall Study||0
6586722|NCT01958008|7511168|FG000|STARTED|Overall Study||21
6586723|NCT01958008|7511169|FG001|STARTED|Overall Study||21
6586724|NCT01958008|7511170|FG002|STARTED|Overall Study||21
6586725|NCT01958008|7511171|FG003|STARTED|Overall Study||21
6586726|NCT01958008|7511168|FG000|COMPLETED|Overall Study||20
6586727|NCT01958008|7511169|FG001|COMPLETED|Overall Study||21
6586728|NCT01958008|7511170|FG002|COMPLETED|Overall Study||20
6586729|NCT01958008|7511171|FG003|COMPLETED|Overall Study||21
6586730|NCT01958008|7511168|FG000|NOT COMPLETED|Overall Study||1
6586731|NCT01958008|7511169|FG001|NOT COMPLETED|Overall Study||0
6586732|NCT01958008|7511170|FG002|NOT COMPLETED|Overall Study||1
6586733|NCT01958008|7511171|FG003|NOT COMPLETED|Overall Study||0
6586734|NCT01958060|7511190|FG000|STARTED|Overall Study||10
6586735|NCT01958060|7511191|FG001|STARTED|Overall Study||6
6586736|NCT01958060|7511192|FG002|STARTED|Overall Study||6
6586737|NCT01958060|7511193|FG003|STARTED|Overall Study||5
6586738|NCT01958060|7511194|FG004|STARTED|Overall Study||7
6586739|NCT01958060|7511195|FG005|STARTED|Overall Study||1
6586740|NCT01958060|7511190|FG000|COMPLETED|Overall Study||8
6586741|NCT01958060|7511191|FG001|COMPLETED|Overall Study||6
6586742|NCT01958060|7511192|FG002|COMPLETED|Overall Study||6
6586743|NCT01958060|7511193|FG003|COMPLETED|Overall Study||5
6586744|NCT01958060|7511194|FG004|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
6586745|NCT01958060|7511195|FG005|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
6586746|NCT01958060|7511190|FG000|NOT COMPLETED|Overall Study||2
6586747|NCT01958060|7511191|FG001|NOT COMPLETED|Overall Study||0
6586748|NCT01958060|7511192|FG002|NOT COMPLETED|Overall Study||0
6586749|NCT01958060|7511193|FG003|NOT COMPLETED|Overall Study||0
6586750|NCT01958060|7511194|FG004|NOT COMPLETED|Overall Study||1
6586751|NCT01958060|7511195|FG005|NOT COMPLETED|Overall Study||0
6586752|NCT01958073|7511216|FG000|STARTED|Randomized Period||9
6586753|NCT01958073|7511217|FG001|STARTED|Randomized Period||9
6586754|NCT01958073|7511218|FG002|STARTED|Randomized Period||17
6586755|NCT01958073|7511219|FG003|STARTED|Randomized Period||0
6586756|NCT01958073|7511220|FG004|STARTED|Randomized Period||0
6586757|NCT01958073|7511216|FG000|COMPLETED|Randomized Period||7
6586758|NCT01958073|7511217|FG001|COMPLETED|Randomized Period||8
6586759|NCT01958073|7511218|FG002|COMPLETED|Randomized Period||11
6586760|NCT01958073|7511219|FG003|COMPLETED|Randomized Period||0
6586761|NCT01958073|7511220|FG004|COMPLETED|Randomized Period||0
6586762|NCT01958073|7511216|FG000|NOT COMPLETED|Randomized Period||2
6586763|NCT01958073|7511217|FG001|NOT COMPLETED|Randomized Period||1
6586764|NCT01958073|7511218|FG002|NOT COMPLETED|Randomized Period||6
6586765|NCT01958073|7511219|FG003|NOT COMPLETED|Randomized Period||0
6586766|NCT01958073|7511220|FG004|NOT COMPLETED|Randomized Period||0
6586767|NCT01958073|7511216|FG000|STARTED|Open Label Period||0
6586768|NCT01958073|7511217|FG001|STARTED|Open Label Period||0
6586769|NCT01958073|7511218|FG002|STARTED|Open Label Period||0
6586770|NCT01958073|7511219|FG003|STARTED|Open Label Period||5
6586771|NCT01958073|7511220|FG004|STARTED|Open Label Period||17
6586772|NCT01958073|7511216|FG000|COMPLETED|Open Label Period||0
6586773|NCT01958073|7511217|FG001|COMPLETED|Open Label Period||0
6586774|NCT01958073|7511218|FG002|COMPLETED|Open Label Period||0
6586775|NCT01958073|7511219|FG003|COMPLETED|Open Label Period||5
6586776|NCT01958073|7511220|FG004|COMPLETED|Open Label Period||17
6586777|NCT01958073|7511216|FG000|NOT COMPLETED|Open Label Period||0
6586778|NCT01958073|7511217|FG001|NOT COMPLETED|Open Label Period||0
6586779|NCT01958073|7511218|FG002|NOT COMPLETED|Open Label Period||0
6586780|NCT01958073|7511219|FG003|NOT COMPLETED|Open Label Period||0
6586781|NCT01958073|7511220|FG004|NOT COMPLETED|Open Label Period||0
6586782|NCT01958112|7511236|FG000|STARTED|Overall Study||14
6586783|NCT01958112|7511236|FG000|COMPLETED|Overall Study||14
6586784|NCT01958112|7511236|FG000|NOT COMPLETED|Overall Study||0
6586785|NCT01958125|7511242|FG000|STARTED|Overall Study||50
6586786|NCT01958125|7511243|FG001|STARTED|Overall Study||52
6586787|NCT01958125|7511242|FG000|COMPLETED|Overall Study||48
6586788|NCT01958125|7511243|FG001|COMPLETED|Overall Study||44
6586789|NCT01958125|7511242|FG000|NOT COMPLETED|Overall Study||2
6586790|NCT01958125|7511243|FG001|NOT COMPLETED|Overall Study||8
6586791|NCT01958164|7511251|FG000|STARTED|Overall Study|Randomised and treated|6
6586792|NCT01958164|7511252|FG001|STARTED|Overall Study|Randomised and treated|10
6586793|NCT01958164|7511251|FG000|COMPLETED|Overall Study||4
6586794|NCT01958164|7511252|FG001|COMPLETED|Overall Study||5
6586795|NCT01958164|7511251|FG000|NOT COMPLETED|Overall Study||2
6586796|NCT01958164|7511252|FG001|NOT COMPLETED|Overall Study||5
6624367|NCT02216773|7551789|FG000|Underwent Procedure (PVE/RALPPS)|Overall Study||24
6624368|NCT02216773|7551790|FG001|Underwent Procedure (PVE/RALPPS)|Overall Study||26
6624369|NCT02216773|7551789|FG000|COMPLETED|Overall Study||16
6624370|NCT02216773|7551790|FG001|COMPLETED|Overall Study||24
6624371|NCT02216773|7551789|FG000|NOT COMPLETED|Overall Study||12
6624372|NCT02216773|7551790|FG001|NOT COMPLETED|Overall Study||5
6624373|NCT02216812|7551798|FG000|STARTED|Overall Study||67
6624374|NCT02216812|7551799|FG001|STARTED|Overall Study||67
6624375|NCT02216812|7551798|FG000|COMPLETED|Overall Study||57
6624376|NCT02216812|7551799|FG001|COMPLETED|Overall Study||62
6624377|NCT02216812|7551798|FG000|NOT COMPLETED|Overall Study||10
6624378|NCT02216812|7551799|FG001|NOT COMPLETED|Overall Study||5
6624379|NCT02216851|7551807|FG000|STARTED|Overall Study||98
6624380|NCT02216851|7551808|FG001|STARTED|Overall Study||33
6624381|NCT02216851|7551807|FG000|COMPLETED|Overall Study||96
6624382|NCT02216851|7551808|FG001|COMPLETED|Overall Study||32
6624383|NCT02216851|7551807|FG000|NOT COMPLETED|Overall Study||2
6624384|NCT02216851|7551808|FG001|NOT COMPLETED|Overall Study||1
6624385|NCT02217280|7551814|FG000|STARTED|Overall Study||20
6624386|NCT02217280|7551814|FG000|COMPLETED|Overall Study||16
6624387|NCT02217280|7551814|FG000|NOT COMPLETED|Overall Study||4
6624388|NCT02217332|7551819|FG000|STARTED|Overall Study|Safety Population|20
6586797|NCT01958281|7511261|FG000|STARTED|Overall Study||10
6586798|NCT01958281|7511262|FG001|STARTED|Overall Study||10
6586799|NCT01958281|7511263|FG002|STARTED|Overall Study||18
6586800|NCT01958281|7511261|FG000|COMPLETED|Overall Study||4
6586801|NCT01958281|7511262|FG001|COMPLETED|Overall Study||6
6586802|NCT01958281|7511263|FG002|COMPLETED|Overall Study||18
6586803|NCT01958281|7511261|FG000|NOT COMPLETED|Overall Study||6
6586804|NCT01958281|7511262|FG001|NOT COMPLETED|Overall Study||4
6586805|NCT01958281|7511263|FG002|NOT COMPLETED|Overall Study||0
6586806|NCT01958294|7511272|FG000|STARTED|Overall Study||12
6586807|NCT01958294|7511272|FG000|COMPLETED|Overall Study||10
6586808|NCT01958294|7511272|FG000|NOT COMPLETED|Overall Study||2
6586809|NCT01958320|7511278|FG000|STARTED|Overall Study||104
6586810|NCT01958320|7511279|FG001|STARTED|Overall Study||98
6586811|NCT01958320|7511278|FG000|COMPLETED|Overall Study||104
6586812|NCT01958320|7511279|FG001|COMPLETED|Overall Study||98
6586813|NCT01958320|7511278|FG000|NOT COMPLETED|Overall Study||0
6586814|NCT01958320|7511279|FG001|NOT COMPLETED|Overall Study||0
6586815|NCT01958346|7511289|FG000|STARTED|Overall Study||39
6586816|NCT01958346|7511290|FG001|STARTED|Overall Study||39
6586817|NCT01958346|7511289|FG000|COMPLETED|Overall Study||39
6586818|NCT01958346|7511290|FG001|COMPLETED|Overall Study||39
6586819|NCT01958346|7511289|FG000|NOT COMPLETED|Overall Study||0
6586820|NCT01958346|7511290|FG001|NOT COMPLETED|Overall Study||0
6586821|NCT01958437|7511298|FG000|STARTED|Overall Study||11
6586822|NCT01958437|7511299|FG001|STARTED|Overall Study||11
6586823|NCT01958437|7511300|FG002|STARTED|Overall Study||11
6586824|NCT01958437|7511301|FG003|STARTED|Overall Study||11
6586825|NCT01958437|7511298|FG000|COMPLETED|Overall Study||11
6586826|NCT01958437|7511299|FG001|COMPLETED|Overall Study||11
6586827|NCT01958437|7511300|FG002|COMPLETED|Overall Study||10
6586828|NCT01958437|7511301|FG003|COMPLETED|Overall Study||10
6586829|NCT01958437|7511298|FG000|NOT COMPLETED|Overall Study||0
6586830|NCT01958437|7511299|FG001|NOT COMPLETED|Overall Study||0
6586831|NCT01958437|7511300|FG002|NOT COMPLETED|Overall Study||1
6586832|NCT01958437|7511301|FG003|NOT COMPLETED|Overall Study||1
6586833|NCT01958476|7511320|FG000|STARTED|Overall Study||59
6586834|NCT01958476|7511321|FG001|STARTED|Overall Study||58
6586835|NCT01958476|7511320|FG000|COMPLETED|Overall Study||58
6586836|NCT01958476|7511321|FG001|COMPLETED|Overall Study||58
6586837|NCT01958476|7511320|FG000|NOT COMPLETED|Overall Study||1
6586838|NCT01958476|7511321|FG001|NOT COMPLETED|Overall Study||0
6586839|NCT01958489|7511327|FG000|STARTED|Period 1||24
6586840|NCT01958489|7511328|FG001|STARTED|Period 1||0
6586841|NCT01958489|7511327|FG000|Received at Least 1 Dose of Study Drug|Period 1||24
6586842|NCT01958489|7511328|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
6586843|NCT01958489|7511327|FG000|COMPLETED|Period 1||24
6586844|NCT01958489|7511328|FG001|COMPLETED|Period 1||0
6586845|NCT01958489|7511327|FG000|NOT COMPLETED|Period 1||0
6586846|NCT01958489|7511328|FG001|NOT COMPLETED|Period 1||0
6586847|NCT01958489|7511327|FG000|STARTED|Period 2|Participants who completed Period 1 treatment crossed over to Period 2 treatment|0
6586848|NCT01958489|7511328|FG001|STARTED|Period 2|Participants who started Period 2 treatment crossed over from Period 1 treatment|24
6586849|NCT01958489|7511327|FG000|Received at Least 1 Dose of Study Drug|Period 2||0
6586850|NCT01958489|7511328|FG001|Received at Least 1 Dose of Study Drug|Period 2||24
6586851|NCT01958489|7511327|FG000|COMPLETED|Period 2||0
6586852|NCT01958489|7511328|FG001|COMPLETED|Period 2||23
6586853|NCT01958489|7511327|FG000|NOT COMPLETED|Period 2||0
6586854|NCT01958489|7511328|FG001|NOT COMPLETED|Period 2||1
6586855|NCT01958606|7511341|FG000|STARTED|Overall Study||13
6586856|NCT01958606|7511342|FG001|STARTED|Overall Study||5
6586857|NCT01958606|7511341|FG000|COMPLETED|Overall Study||11
6586858|NCT01958606|7511342|FG001|COMPLETED|Overall Study||5
6586859|NCT01958606|7511341|FG000|NOT COMPLETED|Overall Study||2
6586860|NCT01958606|7511342|FG001|NOT COMPLETED|Overall Study||0
6586861|NCT01958619|7511352|FG000|STARTED|Overall Study||15
6586862|NCT01958619|7511353|FG001|STARTED|Overall Study||14
6586863|NCT01958619|7511354|FG002|STARTED|Overall Study||14
6586864|NCT01958619|7511355|FG003|STARTED|Overall Study||12
6586865|NCT01958619|7511352|FG000|COMPLETED|Overall Study||13
6586866|NCT01958619|7511353|FG001|COMPLETED|Overall Study||14
6586867|NCT01958619|7511354|FG002|COMPLETED|Overall Study||13
6586868|NCT01958619|7511355|FG003|COMPLETED|Overall Study||12
6586869|NCT01958619|7511352|FG000|NOT COMPLETED|Overall Study||2
6586870|NCT01958619|7511353|FG001|NOT COMPLETED|Overall Study||0
6586871|NCT01958619|7511354|FG002|NOT COMPLETED|Overall Study||1
6586872|NCT01958619|7511355|FG003|NOT COMPLETED|Overall Study||0
6586873|NCT01958645|7511368|FG000|STARTED|Overall Study||4
6586874|NCT01958645|7511369|FG001|STARTED|Overall Study||4
6586875|NCT01958645|7511370|FG002|STARTED|Overall Study||4
6586876|NCT01958645|7511368|FG000|COMPLETED|Overall Study||4
6586877|NCT01958645|7511369|FG001|COMPLETED|Overall Study||4
6586878|NCT01958645|7511370|FG002|COMPLETED|Overall Study||4
6586879|NCT01958645|7511368|FG000|NOT COMPLETED|Overall Study||0
6586880|NCT01958645|7511369|FG001|NOT COMPLETED|Overall Study||0
6586881|NCT01958645|7511370|FG002|NOT COMPLETED|Overall Study||0
6586882|NCT01958671|7511383|FG000|STARTED|Overall Study||156
6586883|NCT01958671|7511384|FG001|STARTED|Overall Study||152
6586884|NCT01958671|7511385|FG002|STARTED|Overall Study||153
6586885|NCT01958671|7511383|FG000|COMPLETED|Overall Study||137
6586886|NCT01958671|7511384|FG001|COMPLETED|Overall Study||128
6586887|NCT01958671|7511385|FG002|COMPLETED|Overall Study||121
6586888|NCT01958671|7511383|FG000|NOT COMPLETED|Overall Study||19
6586889|NCT01958671|7511384|FG001|NOT COMPLETED|Overall Study||24
6586890|NCT01958671|7511385|FG002|NOT COMPLETED|Overall Study||32
6586891|NCT01958788|7511397|FG000|STARTED|Overall Study||7
6586892|NCT01958788|7511397|FG000|COMPLETED|Overall Study||7
6586893|NCT01958788|7511397|FG000|NOT COMPLETED|Overall Study||0
6586894|NCT01958827|7511401|FG000|STARTED|Overall Study||28
6586895|NCT01958827|7511401|FG000|COMPLETED|Overall Study||18
6586896|NCT01958827|7511401|FG000|NOT COMPLETED|Overall Study||10
6586897|NCT01958918|7511407|FG000|STARTED|Overall Study||356
6586898|NCT01958918|7511408|FG001|STARTED|Overall Study||356
6586899|NCT01958918|7511407|FG000|Full Analysis Set|Overall Study||353
6586900|NCT01958918|7511408|FG001|Full Analysis Set|Overall Study||354
6586901|NCT01958918|7511407|FG000|COMPLETED|Overall Study||313
6586902|NCT01958918|7511408|FG001|COMPLETED|Overall Study||314
6586903|NCT01958918|7511407|FG000|NOT COMPLETED|Overall Study||43
6586904|NCT01958918|7511408|FG001|NOT COMPLETED|Overall Study||42
6586905|NCT01959035|7511414|FG000|STARTED|Overall Study||88
6586906|NCT01959035|7511414|FG000|COMPLETED|Overall Study||77
6586907|NCT01959035|7511414|FG000|NOT COMPLETED|Overall Study||11
6586908|NCT01959048|7511418|FG000|STARTED|Overall Study||3
6586909|NCT01959048|7511418|FG000|COMPLETED|Overall Study||3
6586910|NCT01959048|7511418|FG000|NOT COMPLETED|Overall Study||0
6586911|NCT01959113|7511422|FG000|STARTED|Overall Study||5
6586912|NCT01959113|7511422|FG000|COMPLETED|Overall Study||5
6586913|NCT01959113|7511422|FG000|NOT COMPLETED|Overall Study||0
6586914|NCT01959165|7511432|FG000|STARTED|Overall Study||13
6586915|NCT01959165|7511433|FG001|STARTED|Overall Study|1 patient discontinued the study without any treatment out of 11 patients.|11
6586916|NCT01959165|7511434|FG002|STARTED|Overall Study||12
6586917|NCT01959165|7511435|FG003|STARTED|Overall Study||9
6586918|NCT01959165|7511432|FG000|COMPLETED|Overall Study||12
6586919|NCT01959165|7511433|FG001|COMPLETED|Overall Study||10
6586920|NCT01959165|7511434|FG002|COMPLETED|Overall Study||12
6586921|NCT01959165|7511435|FG003|COMPLETED|Overall Study||7
6586922|NCT01959165|7511432|FG000|NOT COMPLETED|Overall Study||1
6586923|NCT01959165|7511433|FG001|NOT COMPLETED|Overall Study||1
6586924|NCT01959165|7511434|FG002|NOT COMPLETED|Overall Study||0
6586925|NCT01959165|7511435|FG003|NOT COMPLETED|Overall Study||2
6586926|NCT01959178|7511445|FG000|STARTED|Overall Study||73
6586927|NCT01959178|7511446|FG001|STARTED|Overall Study||73
6586928|NCT01959178|7511445|FG000|COMPLETED|Overall Study||71
6586929|NCT01959178|7511446|FG001|COMPLETED|Overall Study||71
6586930|NCT01959178|7511445|FG000|NOT COMPLETED|Overall Study||2
6586931|NCT01959178|7511446|FG001|NOT COMPLETED|Overall Study||2
6586932|NCT01959230|7511454|FG000|STARTED|Overall Study||40
6586933|NCT01959230|7511455|FG001|STARTED|Overall Study||20
6586934|NCT01959230|7511454|FG000|Received at Least 1 Dose of Study Drug|Overall Study||40
6586935|NCT01959230|7511455|FG001|Received at Least 1 Dose of Study Drug|Overall Study||20
6586936|NCT01959230|7511454|FG000|COMPLETED|Overall Study||36
6586937|NCT01959230|7511455|FG001|COMPLETED|Overall Study||19
6586938|NCT01959230|7511454|FG000|NOT COMPLETED|Overall Study||4
6586939|NCT01959230|7511455|FG001|NOT COMPLETED|Overall Study||1
6586940|NCT01959243|7511463|FG000|STARTED|Overall Study||337
6586941|NCT01959243|7511464|FG001|STARTED|Overall Study||170
6586942|NCT01959243|7511463|FG000|Received at Least 1 Dose of Study Drug|Overall Study||337
6586943|NCT01959243|7511464|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
6586944|NCT01959243|7511463|FG000|COMPLETED|Overall Study||324
6586945|NCT01959243|7511464|FG001|COMPLETED|Overall Study||166
6586946|NCT01959243|7511463|FG000|NOT COMPLETED|Overall Study||13
6586947|NCT01959243|7511464|FG001|NOT COMPLETED|Overall Study||4
6586948|NCT01959334|7511472|FG000|STARTED|First Dose||26
6586949|NCT01959334|7511473|FG001|STARTED|First Dose||49
6586950|NCT01959334|7511472|FG000|COMPLETED|First Dose|Each Dosing Period separated by at least 7 calendar days.|26
6586951|NCT01959334|7511473|FG001|COMPLETED|First Dose|Each Dosing Period is separated by at least 7 calendar days.|49
6586952|NCT01959334|7511472|FG000|NOT COMPLETED|First Dose||0
6586953|NCT01959334|7511473|FG001|NOT COMPLETED|First Dose||0
6586954|NCT01959334|7511472|FG000|STARTED|Second Dose||26
6586955|NCT01959334|7511473|FG001|STARTED|Second Dose||49
6586956|NCT01959334|7511472|FG000|COMPLETED|Second Dose||25
6586957|NCT01959334|7511473|FG001|COMPLETED|Second Dose||49
6586958|NCT01959334|7511472|FG000|NOT COMPLETED|Second Dose||1
6586959|NCT01959334|7511473|FG001|NOT COMPLETED|Second Dose||0
6586960|NCT01959334|7511472|FG000|STARTED|Third Dose||25
6586961|NCT01959334|7511473|FG001|STARTED|Third Dose||49
6586962|NCT01959334|7511472|FG000|COMPLETED|Third Dose||25
6586963|NCT01959334|7511473|FG001|COMPLETED|Third Dose||48
6586964|NCT01959334|7511472|FG000|NOT COMPLETED|Third Dose||0
6586965|NCT01959334|7511473|FG001|NOT COMPLETED|Third Dose||1
6586966|NCT01959347|7511481|FG000|STARTED|Overall Study||238
6586967|NCT01959347|7511482|FG001|STARTED|Overall Study||242
6586968|NCT01959347|7511481|FG000|COMPLETED|Overall Study||229
6586969|NCT01959347|7511482|FG001|COMPLETED|Overall Study||235
6586970|NCT01959347|7511481|FG000|NOT COMPLETED|Overall Study||9
6586971|NCT01959347|7511482|FG001|NOT COMPLETED|Overall Study||7
6586972|NCT01959412|7511488|FG000|STARTED|Overall Study||15
6586973|NCT01959412|7511489|FG001|STARTED|Overall Study||15
6586974|NCT01959412|7511490|FG002|STARTED|Overall Study||15
6586975|NCT01959412|7511491|FG003|STARTED|Overall Study||15
6586976|NCT01959412|7511492|FG004|STARTED|Overall Study||16
6586977|NCT01959412|7511493|FG005|STARTED|Overall Study||15
6586978|NCT01959412|7511488|FG000|COMPLETED|Overall Study||14
6586979|NCT01959412|7511489|FG001|COMPLETED|Overall Study||14
6586980|NCT01959412|7511490|FG002|COMPLETED|Overall Study||15
6586981|NCT01959412|7511491|FG003|COMPLETED|Overall Study||13
6586982|NCT01959412|7511492|FG004|COMPLETED|Overall Study||13
6586983|NCT01959412|7511493|FG005|COMPLETED|Overall Study||15
6586984|NCT01959412|7511488|FG000|NOT COMPLETED|Overall Study||1
6586985|NCT01959412|7511489|FG001|NOT COMPLETED|Overall Study||1
6586986|NCT01959412|7511490|FG002|NOT COMPLETED|Overall Study||0
6586987|NCT01959412|7511491|FG003|NOT COMPLETED|Overall Study||2
6586988|NCT01959412|7511492|FG004|NOT COMPLETED|Overall Study||3
6586989|NCT01959412|7511493|FG005|NOT COMPLETED|Overall Study||0
6586990|NCT01959425|7511509|FG000|STARTED|Overall Study||32
6586991|NCT01959425|7511510|FG001|STARTED|Overall Study||31
6586992|NCT01959425|7511509|FG000|COMPLETED|Overall Study||20
6586993|NCT01959425|7511510|FG001|COMPLETED|Overall Study||23
6586994|NCT01959425|7511509|FG000|NOT COMPLETED|Overall Study||12
6586995|NCT01959425|7511510|FG001|NOT COMPLETED|Overall Study||8
6586996|NCT01959490|7511519|FG000|STARTED|Overall Study||5
6586997|NCT01959490|7511520|FG001|STARTED|Overall Study||6
6586998|NCT01959490|7511521|FG002|STARTED|Overall Study||5
6586999|NCT01959490|7511519|FG000|COMPLETED|Overall Study||5
6587000|NCT01959490|7511520|FG001|COMPLETED|Overall Study||6
6587001|NCT01959490|7511521|FG002|COMPLETED|Overall Study||5
6587002|NCT01959490|7511519|FG000|NOT COMPLETED|Overall Study||0
6587003|NCT01959490|7511520|FG001|NOT COMPLETED|Overall Study||0
6587004|NCT01959490|7511521|FG002|NOT COMPLETED|Overall Study||0
6587005|NCT01959503|7511531|FG000|STARTED|Overall Study||107
6587006|NCT01959503|7511532|FG001|STARTED|Overall Study||51
6587007|NCT01959503|7511531|FG000|COMPLETED|Overall Study||104
6587008|NCT01959503|7511532|FG001|COMPLETED|Overall Study||49
6587009|NCT01959503|7511531|FG000|NOT COMPLETED|Overall Study||3
6587010|NCT01959503|7511532|FG001|NOT COMPLETED|Overall Study||2
6587011|NCT01959516|7511538|FG000|STARTED|Epoch 1||63
6587012|NCT01959516|7511539|FG001|STARTED|Epoch 1||63
6587013|NCT01959516|7511538|FG000|Safety Population|Epoch 1||62
6587014|NCT01959516|7511539|FG001|Safety Population|Epoch 1||62
6587015|NCT01959516|7511538|FG000|ITT Population|Epoch 1||62
6587016|NCT01959516|7511539|FG001|ITT Population|Epoch 1||62
6587017|NCT01959516|7511538|FG000|COMPLETED|Epoch 1||53
6587018|NCT01959516|7511539|FG001|COMPLETED|Epoch 1||58
6587019|NCT01959516|7511538|FG000|NOT COMPLETED|Epoch 1||10
6587020|NCT01959516|7511539|FG001|NOT COMPLETED|Epoch 1||5
6587021|NCT01959516|7511538|FG000|STARTED|Epoch 2||63
6659405|NCT02489110|7590229|FG000|NOT COMPLETED|Overall Study||27
6587022|NCT01959516|7511539|FG001|STARTED|Epoch 2||63
6587023|NCT01959516|7511538|FG000|COMPLETED|Epoch 2||61
6587024|NCT01959516|7511539|FG001|COMPLETED|Epoch 2||62
6587025|NCT01959516|7511538|FG000|NOT COMPLETED|Epoch 2||2
6587026|NCT01959516|7511539|FG001|NOT COMPLETED|Epoch 2||1
6587027|NCT01959529|7511547|FG000|STARTED|Overall Study||3818
6587028|NCT01959529|7511548|FG001|STARTED|Overall Study||3819
6587029|NCT01959529|7511547|FG000|Exposed|Overall Study||3809
6587030|NCT01959529|7511548|FG001|Exposed|Overall Study||3806
6587031|NCT01959529|7511547|FG000|COMPLETED|Overall Study||3742
6587032|NCT01959529|7511548|FG001|COMPLETED|Overall Study||3747
6587033|NCT01959529|7511547|FG000|NOT COMPLETED|Overall Study||76
6587034|NCT01959529|7511548|FG001|NOT COMPLETED|Overall Study||72
6587035|NCT01959542|7511554|FG000|STARTED|Overall Study||15
6587036|NCT01959542|7511554|FG000|Evaluable at Visit 1|Overall Study||12
6587037|NCT01959542|7511554|FG000|Evaluable at Visit 2|Overall Study||12
6587038|NCT01959542|7511554|FG000|COMPLETED|Overall Study||12
6587039|NCT01959542|7511554|FG000|NOT COMPLETED|Overall Study||3
6587040|NCT01959581|7511559|FG000|STARTED|Overall Study||30
6587041|NCT01959581|7511559|FG000|COMPLETED|Overall Study||25
6587042|NCT01959581|7511559|FG000|NOT COMPLETED|Overall Study||5
6587043|NCT01959607|7511565|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
6587044|NCT01959607|7511566|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
6587045|NCT01959607|7511567|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
6587046|NCT01959607|7511568|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
6587047|NCT01959607|7511565|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
6587048|NCT01959607|7511566|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
6587049|NCT01959607|7511567|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
6587050|NCT01959607|7511568|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
6587051|NCT01959607|7511565|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6587052|NCT01959607|7511566|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6587053|NCT01959607|7511567|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6587054|NCT01959607|7511568|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6587055|NCT01959607|7511565|FG000|STARTED|First Intervention (Day 1)||22
6587056|NCT01959607|7511566|FG001|STARTED|First Intervention (Day 1)||22
6587057|NCT01959607|7511567|FG002|STARTED|First Intervention (Day 1)||9
6587058|NCT01959607|7511568|FG003|STARTED|First Intervention (Day 1)||9
6587059|NCT01959607|7511565|FG000|COMPLETED|First Intervention (Day 1)||21
6587060|NCT01959607|7511566|FG001|COMPLETED|First Intervention (Day 1)||21
6587061|NCT01959607|7511567|FG002|COMPLETED|First Intervention (Day 1)||9
6587062|NCT01959607|7511568|FG003|COMPLETED|First Intervention (Day 1)||9
6587063|NCT01959607|7511565|FG000|NOT COMPLETED|First Intervention (Day 1)||1
6587064|NCT01959607|7511566|FG001|NOT COMPLETED|First Intervention (Day 1)||1
6587065|NCT01959607|7511567|FG002|NOT COMPLETED|First Intervention (Day 1)||0
6587066|NCT01959607|7511568|FG003|NOT COMPLETED|First Intervention (Day 1)||0
6587067|NCT01959607|7511565|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
6587068|NCT01959607|7511566|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
6587069|NCT01959607|7511567|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
6587070|NCT01959607|7511568|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
6587071|NCT01959607|7511565|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
6587072|NCT01959607|7511566|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
6587073|NCT01959607|7511567|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
6587074|NCT01959607|7511568|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
6587075|NCT01959607|7511565|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6587076|NCT01959607|7511566|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6587077|NCT01959607|7511567|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6587078|NCT01959607|7511568|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6587079|NCT01959607|7511565|FG000|STARTED|Second Intervention (Day 3)||21
6587080|NCT01959607|7511566|FG001|STARTED|Second Intervention (Day 3)||21
6587081|NCT01959607|7511567|FG002|STARTED|Second Intervention (Day 3)||9
6587082|NCT01959607|7511568|FG003|STARTED|Second Intervention (Day 3)||9
6587083|NCT01959607|7511565|FG000|COMPLETED|Second Intervention (Day 3)||21
6587084|NCT01959607|7511566|FG001|COMPLETED|Second Intervention (Day 3)||21
6587085|NCT01959607|7511567|FG002|COMPLETED|Second Intervention (Day 3)||9
6587086|NCT01959607|7511568|FG003|COMPLETED|Second Intervention (Day 3)||9
6587087|NCT01959607|7511565|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
6587088|NCT01959607|7511566|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
6587089|NCT01959607|7511567|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
6587090|NCT01959607|7511568|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
6587091|NCT01959672|7511577|FG000|STARTED|Overall Study||11
6587092|NCT01959672|7511577|FG000|COMPLETED|Overall Study||10
6587093|NCT01959672|7511577|FG000|NOT COMPLETED|Overall Study||1
6587094|NCT01959685|7511584|FG000|STARTED|Overall Study||9
6587095|NCT01959685|7511584|FG000|COMPLETED|Overall Study||9
6587096|NCT01959685|7511584|FG000|NOT COMPLETED|Overall Study||0
6587097|NCT01959698|7511595|FG000|STARTED|Overall Study||3
6587098|NCT01959698|7511596|FG001|STARTED|Overall Study||3
6587099|NCT01959698|7511597|FG002|STARTED|Overall Study||3
6587100|NCT01959698|7511598|FG003|STARTED|Overall Study||3
6587101|NCT01959698|7511599|FG004|STARTED|Overall Study||3
6587102|NCT01959698|7511600|FG005|STARTED|Overall Study||6
6587103|NCT01959698|7511601|FG006|STARTED|Overall Study||8
6587104|NCT01959698|7511595|FG000|COMPLETED|Overall Study||2
6587105|NCT01959698|7511596|FG001|COMPLETED|Overall Study||3
6587106|NCT01959698|7511597|FG002|COMPLETED|Overall Study||2
6587107|NCT01959698|7511598|FG003|COMPLETED|Overall Study||1
6587108|NCT01959698|7511599|FG004|COMPLETED|Overall Study||3
6587109|NCT01959698|7511600|FG005|COMPLETED|Overall Study||3
6587110|NCT01959698|7511601|FG006|COMPLETED|Overall Study||4
6587111|NCT01959698|7511595|FG000|NOT COMPLETED|Overall Study||1
6587112|NCT01959698|7511596|FG001|NOT COMPLETED|Overall Study||0
6587113|NCT01959698|7511597|FG002|NOT COMPLETED|Overall Study||1
6587114|NCT01959698|7511598|FG003|NOT COMPLETED|Overall Study||2
6587115|NCT01959698|7511599|FG004|NOT COMPLETED|Overall Study||0
6587116|NCT01959698|7511600|FG005|NOT COMPLETED|Overall Study||3
6587117|NCT01959698|7511601|FG006|NOT COMPLETED|Overall Study||4
6587118|NCT01959841|7511621|FG000|STARTED|Overall Study||252
6587119|NCT01959841|7511622|FG001|STARTED|Overall Study||250
6587120|NCT01959841|7511623|FG002|STARTED|Overall Study||249
6587121|NCT01959841|7511621|FG000|Full Analysis Set Included|Overall Study||247
6587122|NCT01959841|7511622|FG001|Full Analysis Set Included|Overall Study||243
6587123|NCT01959841|7511623|FG002|Full Analysis Set Included|Overall Study||245
6587124|NCT01959841|7511621|FG000|Full Analysis Set Excluded|Overall Study||5
6587125|NCT01959841|7511622|FG001|Full Analysis Set Excluded|Overall Study||7
6587126|NCT01959841|7511623|FG002|Full Analysis Set Excluded|Overall Study||4
6587127|NCT01959841|7511621|FG000|Reason FAS Excluding 1|Overall Study||5
6587128|NCT01959841|7511622|FG001|Reason FAS Excluding 1|Overall Study||5
6587129|NCT01959841|7511623|FG002|Reason FAS Excluding 1|Overall Study||4
6587130|NCT01959841|7511621|FG000|Reason FAS Excluding 2|Overall Study||0
6587131|NCT01959841|7511622|FG001|Reason FAS Excluding 2|Overall Study||1
6587132|NCT01959841|7511623|FG002|Reason FAS Excluding 2|Overall Study||0
6587133|NCT01959841|7511621|FG000|Reason FAS Excluding 3|Overall Study||0
6587134|NCT01959841|7511622|FG001|Reason FAS Excluding 3|Overall Study||1
6587135|NCT01959841|7511623|FG002|Reason FAS Excluding 3|Overall Study||0
6587136|NCT01959841|7511621|FG000|COMPLETED|Overall Study||209
6587137|NCT01959841|7511622|FG001|COMPLETED|Overall Study||193
6587138|NCT01959841|7511623|FG002|COMPLETED|Overall Study||206
6587139|NCT01959841|7511621|FG000|NOT COMPLETED|Overall Study||43
6587140|NCT01959841|7511622|FG001|NOT COMPLETED|Overall Study||57
6587141|NCT01959841|7511623|FG002|NOT COMPLETED|Overall Study||43
6587142|NCT01959880|7511635|FG000|STARTED|Overall Study||1132
6587143|NCT01959880|7511636|FG001|STARTED|Overall Study||369
6587144|NCT01959880|7511637|FG002|STARTED|Overall Study||209
6587145|NCT01959880|7511638|FG003|STARTED|Overall Study||181
6587146|NCT01959880|7511635|FG000|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
6587147|NCT01959880|7511636|FG001|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
6587148|NCT01959880|7511637|FG002|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
6587149|NCT01959880|7511638|FG003|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
6587150|NCT01959880|7511635|FG000|NOT COMPLETED|Overall Study||1132
6587151|NCT01959880|7511636|FG001|NOT COMPLETED|Overall Study||369
6587152|NCT01959880|7511637|FG002|NOT COMPLETED|Overall Study||208
6587153|NCT01959880|7511638|FG003|NOT COMPLETED|Overall Study||181
6587154|NCT01959919|7511648|FG000|STARTED|Overall Study||86
6587155|NCT01959919|7511648|FG000|COMPLETED|Overall Study||84
6587156|NCT01959919|7511648|FG000|NOT COMPLETED|Overall Study||2
6587157|NCT01959932|7511655|FG000|STARTED|Overall Study||80
6587158|NCT01959932|7511656|FG001|STARTED|Overall Study||41
6587159|NCT01959932|7511657|FG002|STARTED|Overall Study||39
6587160|NCT01959932|7511655|FG000|COMPLETED|Overall Study||79
6587161|NCT01959932|7511656|FG001|COMPLETED|Overall Study||41
6587162|NCT01959932|7511657|FG002|COMPLETED|Overall Study||39
6587163|NCT01959932|7511655|FG000|NOT COMPLETED|Overall Study||1
6587164|NCT01959932|7511656|FG001|NOT COMPLETED|Overall Study||0
6587165|NCT01959932|7511657|FG002|NOT COMPLETED|Overall Study||0
6587166|NCT01959945|7511670|FG000|STARTED|Overall Study||80
6587167|NCT01959945|7511671|FG001|STARTED|Overall Study||78
6587168|NCT01959945|7511672|FG002|STARTED|Overall Study||28
6587169|NCT01959945|7511673|FG003|STARTED|Overall Study||31
6587170|NCT01959945|7511670|FG000|COMPLETED|Overall Study||76
6587171|NCT01959945|7511671|FG001|COMPLETED|Overall Study||75
6587172|NCT01959945|7511672|FG002|COMPLETED|Overall Study||9
6587173|NCT01959945|7511673|FG003|COMPLETED|Overall Study||15
6587174|NCT01959945|7511670|FG000|NOT COMPLETED|Overall Study||4
6659406|NCT02489110|7590230|FG001|NOT COMPLETED|Overall Study||25
6659407|NCT02489123|7590236|FG000|STARTED|Overall Study||8
6659408|NCT02489123|7590236|FG000|COMPLETED|Overall Study||8
6659409|NCT02489123|7590236|FG000|NOT COMPLETED|Overall Study||0
6659410|NCT02489227|7590243|FG000|STARTED|Overall Study||274
6659411|NCT02489227|7590244|FG001|STARTED|Overall Study||135
6659412|NCT02489227|7590245|FG002|STARTED|Overall Study||136
6659413|NCT02489227|7590243|FG000|COMPLETED|Overall Study||220
6659414|NCT02489227|7590244|FG001|COMPLETED|Overall Study||101
6659415|NCT02489227|7590245|FG002|COMPLETED|Overall Study||117
6659416|NCT02489227|7590243|FG000|NOT COMPLETED|Overall Study||54
6659417|NCT02489227|7590244|FG001|NOT COMPLETED|Overall Study||34
6587175|NCT01959945|7511671|FG001|NOT COMPLETED|Overall Study||3
6587176|NCT01959945|7511672|FG002|NOT COMPLETED|Overall Study||19
6587177|NCT01959945|7511673|FG003|NOT COMPLETED|Overall Study||16
6587178|NCT01960075|7511688|FG000|STARTED|Overall Study||149
6587179|NCT01960075|7511689|FG001|STARTED|Overall Study||149
6587180|NCT01960075|7511690|FG002|STARTED|Overall Study||180
6587181|NCT01960075|7511688|FG000|COMPLETED|Overall Study||141
6587182|NCT01960075|7511689|FG001|COMPLETED|Overall Study||146
6587183|NCT01960075|7511690|FG002|COMPLETED|Overall Study||173
6587184|NCT01960075|7511688|FG000|NOT COMPLETED|Overall Study||8
6587185|NCT01960075|7511689|FG001|NOT COMPLETED|Overall Study||3
6587186|NCT01960075|7511690|FG002|NOT COMPLETED|Overall Study||7
6587187|NCT01960114|7511700|FG000|STARTED|Overall Study||134
6587188|NCT01960114|7511701|FG001|STARTED|Overall Study||269
6587189|NCT01960114|7511700|FG000|COMPLETED|Overall Study||133
6587190|NCT01960114|7511701|FG001|COMPLETED|Overall Study||268
6587191|NCT01960114|7511700|FG000|NOT COMPLETED|Overall Study||1
6587192|NCT01960114|7511701|FG001|NOT COMPLETED|Overall Study||1
6587193|NCT01960140|7511707|FG000|STARTED|Period 1 (Days 1-2)||40
6587194|NCT01960140|7511707|FG000|Received Simvastatin|Period 1 (Days 1-2)||40
6587195|NCT01960140|7511707|FG000|COMPLETED|Period 1 (Days 1-2)||40
6587196|NCT01960140|7511707|FG000|NOT COMPLETED|Period 1 (Days 1-2)||0
6587197|NCT01960140|7511707|FG000|STARTED|Period 2 (Days 3-18)||40
6587198|NCT01960140|7511707|FG000|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
6587199|NCT01960140|7511707|FG000|Received Simvastatin|Period 2 (Days 3-18)||38
6587200|NCT01960140|7511707|FG000|COMPLETED|Period 2 (Days 3-18)||38
6659418|NCT02489227|7590245|FG002|NOT COMPLETED|Overall Study||19
6659419|NCT02489279|7590257|FG000|STARTED|Overall Study||44
6587201|NCT01960140|7511707|FG000|NOT COMPLETED|Period 2 (Days 3-18)||2
6587202|NCT01960257|7511715|FG000|STARTED|Stage 1 (1-3 Weeks)||77
6587203|NCT01960257|7511716|FG001|STARTED|Stage 1 (1-3 Weeks)||0
6587204|NCT01960257|7511717|FG002|STARTED|Stage 1 (1-3 Weeks)||0
6587205|NCT01960257|7511715|FG000|COMPLETED|Stage 1 (1-3 Weeks)||61
6587206|NCT01960257|7511716|FG001|COMPLETED|Stage 1 (1-3 Weeks)||0
6587207|NCT01960257|7511717|FG002|COMPLETED|Stage 1 (1-3 Weeks)||0
6587208|NCT01960257|7511715|FG000|NOT COMPLETED|Stage 1 (1-3 Weeks)||16
6587209|NCT01960257|7511716|FG001|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
6587210|NCT01960257|7511717|FG002|NOT COMPLETED|Stage 1 (1-3 Weeks)||0
6587211|NCT01960257|7511715|FG000|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
6587212|NCT01960257|7511716|FG001|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
6587213|NCT01960257|7511717|FG002|STARTED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
6587214|NCT01960257|7511715|FG000|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
6587215|NCT01960257|7511716|FG001|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||41
6587216|NCT01960257|7511717|FG002|COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||20
6587217|NCT01960257|7511715|FG000|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
6587218|NCT01960257|7511716|FG001|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
6587219|NCT01960257|7511717|FG002|NOT COMPLETED|Stage 2(1-4 Months, Not to Exceed 12wks)||0
6587220|NCT01960296|7511729|FG000|STARTED|Overall Study||23
6587221|NCT01960296|7511730|FG001|STARTED|Overall Study||25
6587222|NCT01960296|7511729|FG000|COMPLETED|Overall Study||21
6587223|NCT01960296|7511730|FG001|COMPLETED|Overall Study||22
6587224|NCT01960296|7511729|FG000|NOT COMPLETED|Overall Study||2
6587225|NCT01960296|7511730|FG001|NOT COMPLETED|Overall Study||3
6587226|NCT01960348|7511738|FG000|STARTED|Overall Study||148
6587227|NCT01960348|7511739|FG001|STARTED|Overall Study||77
6587228|NCT01960348|7511738|FG000|COMPLETED|Overall Study||138
6587229|NCT01960348|7511739|FG001|COMPLETED|Overall Study||55
6587230|NCT01960348|7511738|FG000|NOT COMPLETED|Overall Study||10
6587231|NCT01960348|7511739|FG001|NOT COMPLETED|Overall Study||22
6587232|NCT01960387|7511745|FG000|STARTED|Overall Study||2
6587233|NCT01960387|7511745|FG000|COMPLETED|Overall Study||2
6587234|NCT01960387|7511745|FG000|NOT COMPLETED|Overall Study||0
6587235|NCT01960400|7511751|FG000|STARTED|Overall Study||11
6587236|NCT01960400|7511752|FG001|STARTED|Overall Study||11
6587237|NCT01960400|7511751|FG000|COMPLETED|Overall Study||11
6587238|NCT01960400|7511752|FG001|COMPLETED|Overall Study||11
6587239|NCT01960400|7511751|FG000|NOT COMPLETED|Overall Study||0
6587240|NCT01960400|7511752|FG001|NOT COMPLETED|Overall Study||0
6587241|NCT01960413|7511760|FG000|STARTED|Overall Study||24
6587242|NCT01960413|7511761|FG001|STARTED|Overall Study||22
6587243|NCT01960413|7511760|FG000|COMPLETED|Overall Study||20
6587244|NCT01960413|7511761|FG001|COMPLETED|Overall Study||21
6587245|NCT01960413|7511760|FG000|NOT COMPLETED|Overall Study||4
6587246|NCT01960413|7511761|FG001|NOT COMPLETED|Overall Study||1
6587247|NCT01960465|7511769|FG000|STARTED|Overall Study||138
6587248|NCT01960465|7511770|FG001|STARTED|Overall Study||82
6587249|NCT01960465|7511769|FG000|COMPLETED|Overall Study||118
6587250|NCT01960465|7511770|FG001|COMPLETED|Overall Study||73
6587251|NCT01960465|7511769|FG000|NOT COMPLETED|Overall Study||20
6587252|NCT01960465|7511770|FG001|NOT COMPLETED|Overall Study||9
6587253|NCT01960725|7511778|FG000|STARTED|Overall Study||33
6587254|NCT01960725|7511779|FG001|STARTED|Overall Study||33
6587255|NCT01960725|7511778|FG000|Received First Vaccine|Overall Study||33
6587256|NCT01960725|7511779|FG001|Received First Vaccine|Overall Study||33
6587257|NCT01960725|7511778|FG000|Recieved Second Vaccine|Overall Study||33
6587258|NCT01960725|7511779|FG001|Recieved Second Vaccine|Overall Study||33
6587259|NCT01960725|7511778|FG000|Received Third Vaccine|Overall Study||32
6587260|NCT01960725|7511779|FG001|Received Third Vaccine|Overall Study||32
6587261|NCT01960725|7511778|FG000|COMPLETED|Overall Study||27
6587262|NCT01960725|7511779|FG001|COMPLETED|Overall Study||28
6587263|NCT01960725|7511778|FG000|NOT COMPLETED|Overall Study||6
6587264|NCT01960725|7511779|FG001|NOT COMPLETED|Overall Study||5
6587265|NCT01960790|7511785|FG000|STARTED|Overall Study||473
6587266|NCT01960790|7511785|FG000|COMPLETED|Overall Study||462
6587267|NCT01960790|7511785|FG000|NOT COMPLETED|Overall Study||11
6587268|NCT01960816|7511789|FG000|STARTED|Overall Study||33
6587269|NCT01960816|7511789|FG000|COMPLETED|Overall Study||32
6587270|NCT01960816|7511789|FG000|NOT COMPLETED|Overall Study||1
6587271|NCT01960842|7511793|FG000|STARTED|Overall Study||31
6587272|NCT01960842|7511793|FG000|COMPLETED|Overall Study||28
6587273|NCT01960842|7511793|FG000|NOT COMPLETED|Overall Study||3
6587274|NCT01960855|7511802|FG000|STARTED|Overall Study||56
6587275|NCT01960855|7511803|FG001|STARTED|Overall Study||55
6587276|NCT01960855|7511804|FG002|STARTED|Overall Study||55
6587277|NCT01960855|7511805|FG003|STARTED|Overall Study||55
6587278|NCT01960855|7511806|FG004|STARTED|Overall Study||55
6587279|NCT01960855|7511802|FG000|COMPLETED|Overall Study||45
6587280|NCT01960855|7511803|FG001|COMPLETED|Overall Study||51
6587281|NCT01960855|7511804|FG002|COMPLETED|Overall Study||46
6587282|NCT01960855|7511805|FG003|COMPLETED|Overall Study||51
6587283|NCT01960855|7511806|FG004|COMPLETED|Overall Study||50
6587284|NCT01960855|7511802|FG000|NOT COMPLETED|Overall Study||11
6587285|NCT01960855|7511803|FG001|NOT COMPLETED|Overall Study||4
6587286|NCT01960855|7511804|FG002|NOT COMPLETED|Overall Study||9
6587287|NCT01960855|7511805|FG003|NOT COMPLETED|Overall Study||4
6587288|NCT01960855|7511806|FG004|NOT COMPLETED|Overall Study||5
6587289|NCT01960907|7511820|FG000|STARTED|Overall Study||158
6587290|NCT01960907|7511821|FG001|STARTED|Overall Study||154
6587291|NCT01960907|7511820|FG000|COMPLETED|Overall Study||122
6587292|NCT01960907|7511821|FG001|COMPLETED|Overall Study||109
6587293|NCT01960907|7511820|FG000|NOT COMPLETED|Overall Study||36
6587294|NCT01960907|7511821|FG001|NOT COMPLETED|Overall Study||45
6587295|NCT01960998|7511832|FG000|STARTED|Overall Study||101
6587296|NCT01960998|7511833|FG001|STARTED|Overall Study||96
6587297|NCT01960998|7511832|FG000|COMPLETED|Overall Study||90
6587298|NCT01960998|7511833|FG001|COMPLETED|Overall Study||85
6587299|NCT01960998|7511832|FG000|NOT COMPLETED|Overall Study||11
6587300|NCT01960998|7511833|FG001|NOT COMPLETED|Overall Study||11
6587301|NCT01961089|7511841|FG000|STARTED|Overall Study||40
6587302|NCT01961089|7511841|FG000|COMPLETED|Overall Study||40
6587303|NCT01961089|7511841|FG000|NOT COMPLETED|Overall Study||0
6587304|NCT01961115|7511848|FG000|STARTED|Overall Study||2
6587305|NCT01961115|7511849|FG001|STARTED|Overall Study||0
6587306|NCT01961115|7511850|FG002|STARTED|Overall Study||9
6587307|NCT01961115|7511848|FG000|COMPLETED|Overall Study||0
6587308|NCT01961115|7511849|FG001|COMPLETED|Overall Study||0
6587309|NCT01961115|7511850|FG002|COMPLETED|Overall Study||5
6587310|NCT01961115|7511848|FG000|NOT COMPLETED|Overall Study||2
6587311|NCT01961115|7511849|FG001|NOT COMPLETED|Overall Study||0
6587312|NCT01961115|7511850|FG002|NOT COMPLETED|Overall Study||4
6587313|NCT01961167|7511858|FG000|STARTED|Overall Study||27
6587314|NCT01961167|7511858|FG000|COMPLETED|Overall Study||27
6587315|NCT01961167|7511858|FG000|NOT COMPLETED|Overall Study||0
6587316|NCT01961271|7511862|FG000|STARTED|Overall Study||114
6587317|NCT01961271|7511862|FG000|COMPLETED|Overall Study||64
6587318|NCT01961271|7511862|FG000|NOT COMPLETED|Overall Study||50
6587319|NCT01961297|7511868|FG000|STARTED|Overall Study||30
6587320|NCT01961297|7511869|FG001|STARTED|Overall Study||23
6587321|NCT01961297|7511868|FG000|COMPLETED|Overall Study||28
6587322|NCT01961297|7511869|FG001|COMPLETED|Overall Study||22
6587323|NCT01961297|7511868|FG000|NOT COMPLETED|Overall Study||2
6587324|NCT01961297|7511869|FG001|NOT COMPLETED|Overall Study||1
6587325|NCT01961323|7511875|FG000|STARTED|Overall Study||70
6587326|NCT01961323|7511875|FG000|COMPLETED|Overall Study||21
6587327|NCT01961323|7511875|FG000|NOT COMPLETED|Overall Study||49
6587328|NCT01961349|7511882|FG000|STARTED|Overall Study||54
6587329|NCT01961349|7511883|FG001|STARTED|Overall Study||107
6587330|NCT01961349|7511884|FG002|STARTED|Overall Study||111
6587331|NCT01961349|7511882|FG000|COMPLETED|Overall Study||51
6587332|NCT01961349|7511883|FG001|COMPLETED|Overall Study||101
6587333|NCT01961349|7511884|FG002|COMPLETED|Overall Study||109
6587334|NCT01961349|7511882|FG000|NOT COMPLETED|Overall Study||3
6587335|NCT01961349|7511883|FG001|NOT COMPLETED|Overall Study||6
6587336|NCT01961349|7511884|FG002|NOT COMPLETED|Overall Study||2
6587337|NCT01961362|7511892|FG000|STARTED|Overall Study||19
6587338|NCT01961362|7511892|FG000|COMPLETED|Overall Study||19
6587339|NCT01961362|7511892|FG000|NOT COMPLETED|Overall Study||0
6587340|NCT01961544|7511896|FG000|STARTED|Overall Study||101
6587341|NCT01961544|7511896|FG000|COMPLETED|Overall Study||88
6587342|NCT01961544|7511896|FG000|NOT COMPLETED|Overall Study||13
6587343|NCT01961609|7511902|FG000|STARTED|Initiation||119
6587344|NCT01961609|7511903|FG001|STARTED|Initiation||116
6587345|NCT01961609|7511904|FG002|STARTED|Initiation||0
6587346|NCT01961609|7511905|FG003|STARTED|Initiation||0
6587347|NCT01961609|7511902|FG000|Safety Set|Initiation||118
6587348|NCT01961609|7511903|FG001|Safety Set|Initiation||115
6587349|NCT01961609|7511904|FG002|Safety Set|Initiation||0
6587350|NCT01961609|7511905|FG003|Safety Set|Initiation||0
6587351|NCT01961609|7511902|FG000|Full Analysis Set|Initiation||118
6587352|NCT01961609|7511903|FG001|Full Analysis Set|Initiation||115
6587353|NCT01961609|7511904|FG002|Full Analysis Set|Initiation||0
6587354|NCT01961609|7511905|FG003|Full Analysis Set|Initiation||0
6587355|NCT01961609|7511902|FG000|COMPLETED|Initiation||107
6587356|NCT01961609|7511903|FG001|COMPLETED|Initiation||103
6587357|NCT01961609|7511904|FG002|COMPLETED|Initiation||0
6587358|NCT01961609|7511905|FG003|COMPLETED|Initiation||0
6587359|NCT01961609|7511902|FG000|NOT COMPLETED|Initiation||12
6587360|NCT01961609|7511903|FG001|NOT COMPLETED|Initiation||13
6587361|NCT01961609|7511904|FG002|NOT COMPLETED|Initiation||0
6587362|NCT01961609|7511905|FG003|NOT COMPLETED|Initiation||0
6587363|NCT01961609|7511902|FG000|STARTED|Maintenance 1 (Weeks 17 - 48)||107
6587364|NCT01961609|7511903|FG001|STARTED|Maintenance 1 (Weeks 17 - 48)||66
6587365|NCT01961609|7511904|FG002|STARTED|Maintenance 1 (Weeks 17 - 48)||37
6587366|NCT01961609|7511905|FG003|STARTED|Maintenance 1 (Weeks 17 - 48)||0
6587367|NCT01961609|7511902|FG000|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||107
6587368|NCT01961609|7511903|FG001|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||66
6587369|NCT01961609|7511904|FG002|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||37
6587370|NCT01961609|7511905|FG003|Full Analysis Set|Maintenance 1 (Weeks 17 - 48)||0
6587371|NCT01961609|7511902|FG000|Safety Set|Maintenance 1 (Weeks 17 - 48)||107
6587372|NCT01961609|7511903|FG001|Safety Set|Maintenance 1 (Weeks 17 - 48)||66
6587373|NCT01961609|7511904|FG002|Safety Set|Maintenance 1 (Weeks 17 - 48)||37
6587374|NCT01961609|7511905|FG003|Safety Set|Maintenance 1 (Weeks 17 - 48)||0
6587375|NCT01961609|7511902|FG000|COMPLETED|Maintenance 1 (Weeks 17 - 48)||84
6587376|NCT01961609|7511903|FG001|COMPLETED|Maintenance 1 (Weeks 17 - 48)||55
6587377|NCT01961609|7511904|FG002|COMPLETED|Maintenance 1 (Weeks 17 - 48)||18
6587378|NCT01961609|7511905|FG003|COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
6587379|NCT01961609|7511902|FG000|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||23
6587380|NCT01961609|7511903|FG001|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||11
6587381|NCT01961609|7511904|FG002|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||19
6587382|NCT01961609|7511905|FG003|NOT COMPLETED|Maintenance 1 (Weeks 17 - 48)||0
6587383|NCT01961609|7511902|FG000|STARTED|Maintanence 2 (Weeks 49 - 72)||83
6587384|NCT01961609|7511903|FG001|STARTED|Maintanence 2 (Weeks 49 - 72)||31
6587385|NCT01961609|7511904|FG002|STARTED|Maintanence 2 (Weeks 49 - 72)||16
6587386|NCT01961609|7511905|FG003|STARTED|Maintanence 2 (Weeks 49 - 72)||24
6587387|NCT01961609|7511902|FG000|Safety Set|Maintanence 2 (Weeks 49 - 72)||83
6587388|NCT01961609|7511903|FG001|Safety Set|Maintanence 2 (Weeks 49 - 72)||31
6587389|NCT01961609|7511904|FG002|Safety Set|Maintanence 2 (Weeks 49 - 72)||16
6587390|NCT01961609|7511905|FG003|Safety Set|Maintanence 2 (Weeks 49 - 72)||24
6587391|NCT01961609|7511902|FG000|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||83
6587392|NCT01961609|7511903|FG001|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||31
6587393|NCT01961609|7511904|FG002|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||16
6587394|NCT01961609|7511905|FG003|Full Analysis Set|Maintanence 2 (Weeks 49 - 72)||24
6587395|NCT01961609|7511902|FG000|COMPLETED|Maintanence 2 (Weeks 49 - 72)||71
6587396|NCT01961609|7511903|FG001|COMPLETED|Maintanence 2 (Weeks 49 - 72)||25
6587397|NCT01961609|7511904|FG002|COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
6587398|NCT01961609|7511905|FG003|COMPLETED|Maintanence 2 (Weeks 49 - 72)||17
6587399|NCT01961609|7511902|FG000|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||12
6587400|NCT01961609|7511903|FG001|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||6
6587401|NCT01961609|7511904|FG002|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||4
6587402|NCT01961609|7511905|FG003|NOT COMPLETED|Maintanence 2 (Weeks 49 - 72)||7
6587403|NCT01961687|7511922|FG000|STARTED|Overall Study||121
6587404|NCT01961687|7511922|FG000|COMPLETED|Overall Study||60
6587405|NCT01961687|7511922|FG000|NOT COMPLETED|Overall Study||61
6587406|NCT01961882|7511928|FG000|STARTED|Overall Study||69
6587407|NCT01961882|7511929|FG001|STARTED|Overall Study||65
6587408|NCT01961882|7511928|FG000|COMPLETED|Overall Study||19
6587409|NCT01961882|7511929|FG001|COMPLETED|Overall Study||23
6587410|NCT01961882|7511928|FG000|NOT COMPLETED|Overall Study||50
6587411|NCT01961882|7511929|FG001|NOT COMPLETED|Overall Study||42
6587412|NCT01961921|7511935|FG000|STARTED|Overall Study||27
6587413|NCT01961921|7511935|FG000|COMPLETED|Overall Study||25
6587414|NCT01961921|7511935|FG000|NOT COMPLETED|Overall Study||2
6587415|NCT01962025|7511941|FG000|STARTED|Overall Study||8
6587416|NCT01962025|7511942|FG001|STARTED|Overall Study||6
6587417|NCT01962025|7511941|FG000|COMPLETED|Overall Study||8
6587418|NCT01962025|7511942|FG001|COMPLETED|Overall Study||6
6659420|NCT02489279|7590258|FG001|STARTED|Overall Study||41
6659421|NCT02489279|7590257|FG000|COMPLETED|Overall Study||32
6659422|NCT02489279|7590258|FG001|COMPLETED|Overall Study||31
6659423|NCT02489279|7590257|FG000|NOT COMPLETED|Overall Study||12
6659424|NCT02489279|7590258|FG001|NOT COMPLETED|Overall Study||10
6737515|NCT03266588|7666797|FG001|Treated|Long-term Treatment Period||481
6737516|NCT03266588|7666798|FG002|Treated|Long-term Treatment Period||286
6737517|NCT03266588|7666796|FG000|COMPLETED|Long-term Treatment Period||683
6737518|NCT03266588|7666797|FG001|COMPLETED|Long-term Treatment Period||271
6737519|NCT03266588|7666798|FG002|COMPLETED|Long-term Treatment Period||243
6737520|NCT03266588|7666796|FG000|NOT COMPLETED|Long-term Treatment Period||406
6737521|NCT03266588|7666797|FG001|NOT COMPLETED|Long-term Treatment Period||240
6737522|NCT03266588|7666798|FG002|NOT COMPLETED|Long-term Treatment Period||65
6737523|NCT03267212|7666806|FG000|STARTED|First Intervention|Non-invasive ventilation|6
6737524|NCT03267212|7666807|FG001|STARTED|First Intervention|"First Intervention (1 day), Washout (2 days), and Second Intervention (1 day)"|9
6737525|NCT03267212|7666806|FG000|High SCI|First Intervention||2
6737526|NCT03267212|7666807|FG001|High SCI|First Intervention||5
6737527|NCT03267212|7666806|FG000|Low SCI|First Intervention||4
6737528|NCT03267212|7666807|FG001|Low SCI|First Intervention||4
6737529|NCT03267212|7666806|FG000|COMPLETED|First Intervention||5
6737530|NCT03267212|7666807|FG001|COMPLETED|First Intervention||6
6737531|NCT03267212|7666806|FG000|NOT COMPLETED|First Intervention||1
6737532|NCT03267212|7666807|FG001|NOT COMPLETED|First Intervention||3
6737533|NCT03267212|7666806|FG000|STARTED|Washout (Min 2 Days / Max 7 Days)||5
6737534|NCT03267212|7666807|FG001|STARTED|Washout (Min 2 Days / Max 7 Days)||6
6737535|NCT03267212|7666806|FG000|COMPLETED|Washout (Min 2 Days / Max 7 Days)||4
6737536|NCT03267212|7666807|FG001|COMPLETED|Washout (Min 2 Days / Max 7 Days)||6
6737537|NCT03267212|7666806|FG000|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||1
6737538|NCT03267212|7666807|FG001|NOT COMPLETED|Washout (Min 2 Days / Max 7 Days)||0
6737539|NCT03267212|7666806|FG000|STARTED|Second Intervention||4
6737540|NCT03267212|7666807|FG001|STARTED|Second Intervention||6
6737541|NCT03267212|7666806|FG000|COMPLETED|Second Intervention||4
6737542|NCT03267212|7666807|FG001|COMPLETED|Second Intervention||6
6737543|NCT03267212|7666806|FG000|NOT COMPLETED|Second Intervention||0
6737544|NCT03267212|7666807|FG001|NOT COMPLETED|Second Intervention||0
6737545|NCT03267264|7666817|FG000|STARTED|Overall Study||66
6737546|NCT03267264|7666818|FG001|STARTED|Overall Study||49
6737547|NCT03267264|7666819|FG002|STARTED|Overall Study||68
6737548|NCT03267264|7666820|FG003|STARTED|Overall Study||65
6737549|NCT03267264|7666817|FG000|Sequence A(Nucleus)|Overall Study||34
6737550|NCT03267264|7666818|FG001|Sequence A(Nucleus)|Overall Study||25
6737551|NCT03267264|7666819|FG002|Sequence A(Nucleus)|Overall Study||33
6737552|NCT03267264|7666820|FG003|Sequence A(Nucleus)|Overall Study||33
6737553|NCT03267264|7666817|FG000|Sequence B(Comparator)|Overall Study||32
6737554|NCT03267264|7666818|FG001|Sequence B(Comparator)|Overall Study||24
6587419|NCT01962025|7511941|FG000|NOT COMPLETED|Overall Study||0
6587420|NCT01962025|7511942|FG001|NOT COMPLETED|Overall Study||0
6587421|NCT01962103|7511959|FG000|STARTED|Phase 1||16
6587422|NCT01962103|7511960|FG001|STARTED|Phase 1||8
6587423|NCT01962103|7511961|FG002|STARTED|Phase 1||14
6587424|NCT01962103|7511962|FG003|STARTED|Phase 1||11
6587425|NCT01962103|7511963|FG004|STARTED|Phase 1||8
6587426|NCT01962103|7511964|FG005|STARTED|Phase 1||7
6587427|NCT01962103|7511965|FG006|STARTED|Phase 1||0
6587428|NCT01962103|7511966|FG007|STARTED|Phase 1||0
6587429|NCT01962103|7511967|FG008|STARTED|Phase 1||0
6587430|NCT01962103|7511959|FG000|COMPLETED|Phase 1||0
6587431|NCT01962103|7511960|FG001|COMPLETED|Phase 1||0
6587432|NCT01962103|7511961|FG002|COMPLETED|Phase 1||0
6587433|NCT01962103|7511962|FG003|COMPLETED|Phase 1||0
6587434|NCT01962103|7511963|FG004|COMPLETED|Phase 1||0
6587435|NCT01962103|7511964|FG005|COMPLETED|Phase 1||0
6587436|NCT01962103|7511965|FG006|COMPLETED|Phase 1||0
6587437|NCT01962103|7511966|FG007|COMPLETED|Phase 1||0
6587438|NCT01962103|7511967|FG008|COMPLETED|Phase 1||0
6587439|NCT01962103|7511959|FG000|NOT COMPLETED|Phase 1||16
6587440|NCT01962103|7511960|FG001|NOT COMPLETED|Phase 1||8
6587441|NCT01962103|7511961|FG002|NOT COMPLETED|Phase 1||14
6587442|NCT01962103|7511962|FG003|NOT COMPLETED|Phase 1||11
6587443|NCT01962103|7511963|FG004|NOT COMPLETED|Phase 1||8
6587444|NCT01962103|7511964|FG005|NOT COMPLETED|Phase 1||7
6587445|NCT01962103|7511965|FG006|NOT COMPLETED|Phase 1||0
6587446|NCT01962103|7511966|FG007|NOT COMPLETED|Phase 1||0
6587447|NCT01962103|7511967|FG008|NOT COMPLETED|Phase 1||0
6587448|NCT01962103|7511959|FG000|STARTED|Phase 2||0
6587449|NCT01962103|7511960|FG001|STARTED|Phase 2||0
6587450|NCT01962103|7511961|FG002|STARTED|Phase 2||0
6587451|NCT01962103|7511962|FG003|STARTED|Phase 2||0
6587452|NCT01962103|7511963|FG004|STARTED|Phase 2||0
6587453|NCT01962103|7511964|FG005|STARTED|Phase 2||0
6587454|NCT01962103|7511965|FG006|STARTED|Phase 2||14
6587455|NCT01962103|7511966|FG007|STARTED|Phase 2||14
6587456|NCT01962103|7511967|FG008|STARTED|Phase 2||14
6587457|NCT01962103|7511959|FG000|COMPLETED|Phase 2||0
6587458|NCT01962103|7511960|FG001|COMPLETED|Phase 2||0
6587459|NCT01962103|7511961|FG002|COMPLETED|Phase 2||0
6587460|NCT01962103|7511962|FG003|COMPLETED|Phase 2||0
6587461|NCT01962103|7511963|FG004|COMPLETED|Phase 2||0
6587462|NCT01962103|7511964|FG005|COMPLETED|Phase 2||0
6587463|NCT01962103|7511965|FG006|COMPLETED|Phase 2|completed treatment|0
6587464|NCT01962103|7511966|FG007|COMPLETED|Phase 2|completed treatment|0
6587465|NCT01962103|7511967|FG008|COMPLETED|Phase 2|completed treatment|0
6587466|NCT01962103|7511959|FG000|NOT COMPLETED|Phase 2||0
6587467|NCT01962103|7511960|FG001|NOT COMPLETED|Phase 2||0
6587468|NCT01962103|7511961|FG002|NOT COMPLETED|Phase 2||0
6587469|NCT01962103|7511962|FG003|NOT COMPLETED|Phase 2||0
6587470|NCT01962103|7511963|FG004|NOT COMPLETED|Phase 2||0
6587471|NCT01962103|7511964|FG005|NOT COMPLETED|Phase 2||0
6587472|NCT01962103|7511965|FG006|NOT COMPLETED|Phase 2||14
6587473|NCT01962103|7511966|FG007|NOT COMPLETED|Phase 2||14
6587474|NCT01962103|7511967|FG008|NOT COMPLETED|Phase 2||14
6587475|NCT01962207|7511991|FG000|STARTED|Persistence Phase (5 Years)||76
6587476|NCT01962207|7511992|FG001|STARTED|Persistence Phase (5 Years)||23
6587477|NCT01962207|7511993|FG002|STARTED|Persistence Phase (5 Years)||115
6587478|NCT01962207|7511994|FG003|STARTED|Persistence Phase (5 Years)||29
6587479|NCT01962207|7511991|FG000|COMPLETED|Persistence Phase (5 Years)||47
6587480|NCT01962207|7511992|FG001|COMPLETED|Persistence Phase (5 Years)||10
6587481|NCT01962207|7511993|FG002|COMPLETED|Persistence Phase (5 Years)||71
6587482|NCT01962207|7511994|FG003|COMPLETED|Persistence Phase (5 Years)||17
6587483|NCT01962207|7511991|FG000|NOT COMPLETED|Persistence Phase (5 Years)||29
6587484|NCT01962207|7511992|FG001|NOT COMPLETED|Persistence Phase (5 Years)||13
6587485|NCT01962207|7511993|FG002|NOT COMPLETED|Persistence Phase (5 Years)||44
6587486|NCT01962207|7511994|FG003|NOT COMPLETED|Persistence Phase (5 Years)||12
6587487|NCT01962207|7511991|FG000|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|67
6587488|NCT01962207|7511992|FG001|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|16
6587489|NCT01962207|7511993|FG002|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|77
6587490|NCT01962207|7511994|FG003|STARTED|Booster Phase (6 Months)|Eligible participants from persistence phase who provided consent to get enrolled in booster phase.|21
6587491|NCT01962207|7511991|FG000|COMPLETED|Booster Phase (6 Months)||67
6587492|NCT01962207|7511992|FG001|COMPLETED|Booster Phase (6 Months)||16
6587493|NCT01962207|7511993|FG002|COMPLETED|Booster Phase (6 Months)||77
6587494|NCT01962207|7511994|FG003|COMPLETED|Booster Phase (6 Months)||21
6587495|NCT01962207|7511991|FG000|NOT COMPLETED|Booster Phase (6 Months)||0
6587496|NCT01962207|7511992|FG001|NOT COMPLETED|Booster Phase (6 Months)||0
6587497|NCT01962207|7511993|FG002|NOT COMPLETED|Booster Phase (6 Months)||0
6587498|NCT01962207|7511994|FG003|NOT COMPLETED|Booster Phase (6 Months)||0
6587499|NCT01962298|7512013|FG000|STARTED|Overall Study||15
6659425|NCT02489344|7590264|FG000|STARTED|ACT13739 (Initial Study): 26 Weeks||11
6659426|NCT02489344|7590264|FG000|COMPLETED|ACT13739 (Initial Study): 26 Weeks||9
6659427|NCT02489344|7590264|FG000|NOT COMPLETED|ACT13739 (Initial Study): 26 Weeks||2
6659428|NCT02489344|7590264|FG000|STARTED|LTS14116 (Extension Study): 31 Months||8
6659429|NCT02489344|7590264|FG000|COMPLETED|LTS14116 (Extension Study): 31 Months||5
6659430|NCT02489344|7590264|FG000|NOT COMPLETED|LTS14116 (Extension Study): 31 Months||3
6659431|NCT02489357|7590268|FG000|STARTED|Overall Study||12
6587500|NCT01962298|7512014|FG001|STARTED|Overall Study||15
6587501|NCT01962298|7512015|FG002|STARTED|Overall Study||15
6587502|NCT01962298|7512016|FG003|STARTED|Overall Study||15
6587503|NCT01962298|7512017|FG004|STARTED|Overall Study||15
6587504|NCT01962298|7512013|FG000|Received Intervention|Overall Study|1 subject did not receive the planned intervention and received a different one for clinical reasons|14
6587505|NCT01962298|7512014|FG001|Received Intervention|Overall Study||15
6587506|NCT01962298|7512015|FG002|Received Intervention|Overall Study||15
6587507|NCT01962298|7512016|FG003|Received Intervention|Overall Study||15
6587508|NCT01962298|7512017|FG004|Received Intervention|Overall Study||15
6587509|NCT01962298|7512013|FG000|COMPLETED|Overall Study||12
6587510|NCT01962298|7512014|FG001|COMPLETED|Overall Study||11
6587511|NCT01962298|7512015|FG002|COMPLETED|Overall Study||10
6587512|NCT01962298|7512016|FG003|COMPLETED|Overall Study||13
6587513|NCT01962298|7512017|FG004|COMPLETED|Overall Study||9
6587514|NCT01962298|7512013|FG000|NOT COMPLETED|Overall Study||3
6587515|NCT01962298|7512014|FG001|NOT COMPLETED|Overall Study||4
6587516|NCT01962298|7512015|FG002|NOT COMPLETED|Overall Study||5
6587517|NCT01962298|7512016|FG003|NOT COMPLETED|Overall Study||2
6587518|NCT01962298|7512017|FG004|NOT COMPLETED|Overall Study||6
6587519|NCT01962428|7512031|FG000|STARTED|Overall Study||139
6587520|NCT01962428|7512032|FG001|STARTED|Overall Study||139
6587521|NCT01962428|7512031|FG000|COMPLETED|Overall Study||129
6587522|NCT01962428|7512032|FG001|COMPLETED|Overall Study||133
6587523|NCT01962428|7512031|FG000|NOT COMPLETED|Overall Study||10
6587524|NCT01962428|7512032|FG001|NOT COMPLETED|Overall Study||6
6587525|NCT01962441|7512041|FG000|STARTED|Randomized Period||200
6587526|NCT01962441|7512042|FG001|STARTED|Randomized Period||201
6587527|NCT01962441|7512043|FG002|STARTED|Randomized Period||200
6587528|NCT01962441|7512041|FG000|COMPLETED|Randomized Period||190
6587529|NCT01962441|7512042|FG001|COMPLETED|Randomized Period||190
6587530|NCT01962441|7512043|FG002|COMPLETED|Randomized Period||189
6587531|NCT01962441|7512041|FG000|NOT COMPLETED|Randomized Period||10
6587532|NCT01962441|7512042|FG001|NOT COMPLETED|Randomized Period||11
6587533|NCT01962441|7512043|FG002|NOT COMPLETED|Randomized Period||11
6587534|NCT01962441|7512041|FG000|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
6587535|NCT01962441|7512042|FG001|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
6587536|NCT01962441|7512043|FG002|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
6587537|NCT01962441|7512041|FG000|COMPLETED|Retreatment Substudy||18
6587538|NCT01962441|7512042|FG001|COMPLETED|Retreatment Substudy||10
6587539|NCT01962441|7512043|FG002|COMPLETED|Retreatment Substudy||0
6587540|NCT01962441|7512041|FG000|NOT COMPLETED|Retreatment Substudy||2
6587541|NCT01962441|7512042|FG001|NOT COMPLETED|Retreatment Substudy||0
6587542|NCT01962441|7512043|FG002|NOT COMPLETED|Retreatment Substudy||0
6587543|NCT01962493|7512054|FG000|STARTED|Overall Study||78
6587544|NCT01962493|7512055|FG001|STARTED|Overall Study||82
6587545|NCT01962493|7512054|FG000|COMPLETED|Overall Study||73
6587546|NCT01962493|7512055|FG001|COMPLETED|Overall Study||77
6587547|NCT01962493|7512054|FG000|NOT COMPLETED|Overall Study||5
6587548|NCT01962493|7512055|FG001|NOT COMPLETED|Overall Study||5
6587549|NCT01962558|7512063|FG000|STARTED|Overall Study||16
6587550|NCT01962558|7512064|FG001|STARTED|Overall Study||14
6587551|NCT01962558|7512063|FG000|Acute Study|Overall Study||16
6587552|NCT01962558|7512064|FG001|Acute Study|Overall Study||14
6587553|NCT01962558|7512063|FG000|12-Weeks|Overall Study||16
6587554|NCT01962558|7512064|FG001|12-Weeks|Overall Study||14
6587555|NCT01962558|7512063|FG000|COMPLETED|Overall Study||16
6587556|NCT01962558|7512064|FG001|COMPLETED|Overall Study||14
6587557|NCT01962558|7512063|FG000|NOT COMPLETED|Overall Study||0
6587558|NCT01962558|7512064|FG001|NOT COMPLETED|Overall Study||0
6587559|NCT01962688|7512072|FG000|STARTED|Overall Study||19
6587560|NCT01962688|7512073|FG001|STARTED|Overall Study||18
6587561|NCT01962688|7512072|FG000|COMPLETED|Overall Study||19
6587562|NCT01962688|7512073|FG001|COMPLETED|Overall Study||18
6587563|NCT01962688|7512072|FG000|NOT COMPLETED|Overall Study||0
6587564|NCT01962688|7512073|FG001|NOT COMPLETED|Overall Study||0
6587565|NCT01962714|7512081|FG000|STARTED|Overall Study||91
6587566|NCT01962714|7512082|FG001|STARTED|Overall Study||93
6587567|NCT01962714|7512081|FG000|Immediate Post-treatment Assessment|Overall Study||63
6587568|NCT01962714|7512082|FG001|Immediate Post-treatment Assessment|Overall Study||57
6587569|NCT01962714|7512081|FG000|3-month Follow-up|Overall Study||58
6587570|NCT01962714|7512082|FG001|3-month Follow-up|Overall Study||56
6587571|NCT01962714|7512081|FG000|COMPLETED|Overall Study||61
6587572|NCT01962714|7512082|FG001|COMPLETED|Overall Study||60
6587573|NCT01962714|7512081|FG000|NOT COMPLETED|Overall Study||30
6587574|NCT01962714|7512082|FG001|NOT COMPLETED|Overall Study||33
6587575|NCT01962870|7512090|FG000|STARTED|Overall Study||13
6587576|NCT01962870|7512091|FG001|STARTED|Overall Study||17
6587577|NCT01962870|7512090|FG000|COMPLETED|Overall Study||13
6587578|NCT01962870|7512091|FG001|COMPLETED|Overall Study||17
6587579|NCT01962870|7512090|FG000|NOT COMPLETED|Overall Study||0
6587580|NCT01962870|7512091|FG001|NOT COMPLETED|Overall Study||0
6587581|NCT01962896|7512097|FG000|STARTED|Overall Study||4
6587582|NCT01962896|7512097|FG000|COMPLETED|Overall Study||0
6587583|NCT01962896|7512097|FG000|NOT COMPLETED|Overall Study||4
6587584|NCT01962922|7512104|FG000|STARTED|PK Portion Day 7||27
6587585|NCT01962922|7512105|FG001|STARTED|PK Portion Day 7||23
6587586|NCT01962922|7512104|FG000|COMPLETED|PK Portion Day 7||23
6587587|NCT01962922|7512105|FG001|COMPLETED|PK Portion Day 7||23
6587588|NCT01962922|7512104|FG000|NOT COMPLETED|PK Portion Day 7||4
6587589|NCT01962922|7512105|FG001|NOT COMPLETED|PK Portion Day 7||0
6587590|NCT01962922|7512104|FG000|STARTED|PK Portion Day 14||23
6587591|NCT01962922|7512105|FG001|STARTED|PK Portion Day 14||23
6587592|NCT01962922|7512104|FG000|COMPLETED|PK Portion Day 14||23
6587593|NCT01962922|7512105|FG001|COMPLETED|PK Portion Day 14||23
6587594|NCT01962922|7512104|FG000|NOT COMPLETED|PK Portion Day 14||0
6587595|NCT01962922|7512105|FG001|NOT COMPLETED|PK Portion Day 14||0
6587596|NCT01962922|7512104|FG000|STARTED|PK Portion Day 21||23
6587597|NCT01962922|7512105|FG001|STARTED|PK Portion Day 21||23
6587598|NCT01962922|7512104|FG000|COMPLETED|PK Portion Day 21||23
6587599|NCT01962922|7512105|FG001|COMPLETED|PK Portion Day 21||23
6587600|NCT01962922|7512104|FG000|NOT COMPLETED|PK Portion Day 21||0
6587601|NCT01962922|7512105|FG001|NOT COMPLETED|PK Portion Day 21||0
6587602|NCT01962922|7512104|FG000|STARTED|Extendion Portion (up to Month 6)||23
6587603|NCT01962922|7512105|FG001|STARTED|Extendion Portion (up to Month 6)||23
6587604|NCT01962922|7512104|FG000|COMPLETED|Extendion Portion (up to Month 6)||18
6587605|NCT01962922|7512105|FG001|COMPLETED|Extendion Portion (up to Month 6)||20
6587606|NCT01962922|7512104|FG000|NOT COMPLETED|Extendion Portion (up to Month 6)||5
6587607|NCT01962922|7512105|FG001|NOT COMPLETED|Extendion Portion (up to Month 6)||3
6587608|NCT01962961|7512114|FG000|STARTED|Overall Study||9
6587609|NCT01962961|7512115|FG001|STARTED|Overall Study||8
6587610|NCT01962961|7512116|FG002|STARTED|Overall Study||7
6587611|NCT01962961|7512114|FG000|COMPLETED|Overall Study||9
6587612|NCT01962961|7512115|FG001|COMPLETED|Overall Study||7
6587613|NCT01962961|7512116|FG002|COMPLETED|Overall Study||6
6587614|NCT01962961|7512114|FG000|NOT COMPLETED|Overall Study||0
6587615|NCT01962961|7512115|FG001|NOT COMPLETED|Overall Study||1
6587616|NCT01962961|7512116|FG002|NOT COMPLETED|Overall Study||1
6587617|NCT01962987|7512127|FG000|STARTED|Overall Study||190
6587618|NCT01962987|7512128|FG001|STARTED|Overall Study||191
6587619|NCT01962987|7512129|FG002|STARTED|Overall Study||95
6587620|NCT01962987|7512127|FG000|COMPLETED|Overall Study||160
6587621|NCT01962987|7512128|FG001|COMPLETED|Overall Study||163
6587622|NCT01962987|7512129|FG002|COMPLETED|Overall Study||83
6587623|NCT01962987|7512127|FG000|NOT COMPLETED|Overall Study||30
6587624|NCT01962987|7512128|FG001|NOT COMPLETED|Overall Study||28
6587625|NCT01962987|7512129|FG002|NOT COMPLETED|Overall Study||12
6587626|NCT01963078|7512141|FG000|STARTED|Overall Study||9
6587627|NCT01963078|7512142|FG001|STARTED|Overall Study||10
6587628|NCT01963078|7512143|FG002|STARTED|Overall Study||10
6587629|NCT01963078|7512144|FG003|STARTED|Overall Study||9
6587630|NCT01963078|7512141|FG000|COMPLETED|Overall Study||8
6587631|NCT01963078|7512142|FG001|COMPLETED|Overall Study||9
6587632|NCT01963078|7512143|FG002|COMPLETED|Overall Study||9
6587633|NCT01963078|7512144|FG003|COMPLETED|Overall Study||7
6587634|NCT01963078|7512141|FG000|NOT COMPLETED|Overall Study||1
6587635|NCT01963078|7512142|FG001|NOT COMPLETED|Overall Study||1
6587636|NCT01963078|7512143|FG002|NOT COMPLETED|Overall Study||1
6587637|NCT01963078|7512144|FG003|NOT COMPLETED|Overall Study||2
6587638|NCT01963091|7512156|FG000|STARTED|Overall Study||17
6587639|NCT01963091|7512157|FG001|STARTED|Overall Study||16
6587640|NCT01963091|7512156|FG000|COMPLETED|Overall Study||17
6587641|NCT01963091|7512157|FG001|COMPLETED|Overall Study||16
6587642|NCT01963091|7512156|FG000|NOT COMPLETED|Overall Study||0
6587643|NCT01963091|7512157|FG001|NOT COMPLETED|Overall Study||0
6587644|NCT01963117|7512163|FG000|STARTED|Overall Study||11
6587645|NCT01963117|7512163|FG000|COMPLETED|Overall Study||10
6587646|NCT01963117|7512163|FG000|NOT COMPLETED|Overall Study||1
6587647|NCT01963143|7512170|FG000|STARTED|Overall Study||14
6587648|NCT01963143|7512171|FG001|STARTED|Overall Study||19
6587649|NCT01963143|7512172|FG002|STARTED|Overall Study||15
6587650|NCT01963143|7512170|FG000|COMPLETED|Overall Study||14
6587651|NCT01963143|7512171|FG001|COMPLETED|Overall Study||18
6587652|NCT01963143|7512172|FG002|COMPLETED|Overall Study||14
6587653|NCT01963143|7512170|FG000|NOT COMPLETED|Overall Study||0
6587654|NCT01963143|7512171|FG001|NOT COMPLETED|Overall Study||1
6587655|NCT01963143|7512172|FG002|NOT COMPLETED|Overall Study||1
6587656|NCT01963169|7512181|FG000|STARTED|Overall Study||301
6587657|NCT01963169|7512182|FG001|STARTED|Overall Study||302
6587658|NCT01963169|7512183|FG002|STARTED|Overall Study||263
6587659|NCT01963169|7512181|FG000|COMPLETED|Overall Study||242
6587660|NCT01963169|7512182|FG001|COMPLETED|Overall Study||220
6587661|NCT01963169|7512183|FG002|COMPLETED|Overall Study||237
6587662|NCT01963169|7512181|FG000|NOT COMPLETED|Overall Study||59
6587663|NCT01963169|7512182|FG001|NOT COMPLETED|Overall Study||82
6587664|NCT01963169|7512183|FG002|NOT COMPLETED|Overall Study||26
6587665|NCT01963234|7512194|FG000|STARTED|Overall Study||268
6587666|NCT01963234|7512195|FG001|STARTED|Overall Study||171
6587667|NCT01963234|7512194|FG000|COMPLETED|Overall Study||207
6587668|NCT01963234|7512195|FG001|COMPLETED|Overall Study||171
6587669|NCT01963234|7512194|FG000|NOT COMPLETED|Overall Study||61
6587670|NCT01963234|7512195|FG001|NOT COMPLETED|Overall Study||0
6587671|NCT01963260|7512217|FG000|STARTED|Overall Study||6
6587672|NCT01963260|7512218|FG001|STARTED|Overall Study||6
6587673|NCT01963260|7512219|FG002|STARTED|Overall Study||6
6587674|NCT01963260|7512220|FG003|STARTED|Overall Study||6
6587675|NCT01963260|7512221|FG004|STARTED|Overall Study||6
6587676|NCT01963260|7512222|FG005|STARTED|Overall Study||10
6587677|NCT01963260|7512223|FG006|STARTED|Overall Study||3
6587678|NCT01963260|7512224|FG007|STARTED|Overall Study||2
6587679|NCT01963260|7512225|FG008|STARTED|Overall Study||1
6587680|NCT01963260|7512226|FG009|STARTED|Overall Study||4
6587681|NCT01963260|7512217|FG000|Treated|Overall Study||6
6587682|NCT01963260|7512218|FG001|Treated|Overall Study||6
6587683|NCT01963260|7512219|FG002|Treated|Overall Study||6
6587684|NCT01963260|7512220|FG003|Treated|Overall Study||6
6587685|NCT01963260|7512221|FG004|Treated|Overall Study||6
6587686|NCT01963260|7512222|FG005|Treated|Overall Study||10
6587687|NCT01963260|7512223|FG006|Treated|Overall Study||3
6587688|NCT01963260|7512224|FG007|Treated|Overall Study||2
6587689|NCT01963260|7512225|FG008|Treated|Overall Study||1
6587690|NCT01963260|7512226|FG009|Treated|Overall Study||4
6587691|NCT01963260|7512217|FG000|COMPLETED|Overall Study||4
6587692|NCT01963260|7512218|FG001|COMPLETED|Overall Study||6
6587693|NCT01963260|7512219|FG002|COMPLETED|Overall Study||6
6587694|NCT01963260|7512220|FG003|COMPLETED|Overall Study||5
6587695|NCT01963260|7512221|FG004|COMPLETED|Overall Study||4
6587696|NCT01963260|7512222|FG005|COMPLETED|Overall Study||10
6587697|NCT01963260|7512223|FG006|COMPLETED|Overall Study||3
6587698|NCT01963260|7512224|FG007|COMPLETED|Overall Study||2
6587699|NCT01963260|7512225|FG008|COMPLETED|Overall Study||1
6587700|NCT01963260|7512226|FG009|COMPLETED|Overall Study||4
6587701|NCT01963260|7512217|FG000|NOT COMPLETED|Overall Study||2
6587702|NCT01963260|7512218|FG001|NOT COMPLETED|Overall Study||0
6587703|NCT01963260|7512219|FG002|NOT COMPLETED|Overall Study||0
6587704|NCT01963260|7512220|FG003|NOT COMPLETED|Overall Study||1
6587705|NCT01963260|7512221|FG004|NOT COMPLETED|Overall Study||2
6587706|NCT01963260|7512222|FG005|NOT COMPLETED|Overall Study||0
6587707|NCT01963260|7512223|FG006|NOT COMPLETED|Overall Study||0
6587708|NCT01963260|7512224|FG007|NOT COMPLETED|Overall Study||0
6587709|NCT01963260|7512225|FG008|NOT COMPLETED|Overall Study||0
6587710|NCT01963260|7512226|FG009|NOT COMPLETED|Overall Study||0
6587711|NCT01963403|7512257|FG000|STARTED|Overall Study||13
6587712|NCT01963403|7512258|FG001|STARTED|Overall Study||13
6587713|NCT01963403|7512257|FG000|COMPLETED|Overall Study|Follow-up over three months|11
6587714|NCT01963403|7512258|FG001|COMPLETED|Overall Study|Follow-up over three months|9
6587715|NCT01963403|7512257|FG000|NOT COMPLETED|Overall Study||2
6587716|NCT01963403|7512258|FG001|NOT COMPLETED|Overall Study||4
6587717|NCT01963481|7512266|FG000|STARTED|Overall Study||23
6587718|NCT01963481|7512266|FG000|COMPLETED|Overall Study||23
6587719|NCT01963481|7512266|FG000|NOT COMPLETED|Overall Study||0
6587720|NCT01963611|7512275|FG000|STARTED|Overall Study||51
6587721|NCT01963611|7512276|FG001|STARTED|Overall Study||49
6587722|NCT01963611|7512277|FG002|STARTED|Overall Study||52
6587723|NCT01963611|7512278|FG003|STARTED|Overall Study||52
6587724|NCT01963611|7512279|FG004|STARTED|Overall Study||51
6587725|NCT01963611|7512275|FG000|Safety Analysis Set|Overall Study||51
6587726|NCT01963611|7512276|FG001|Safety Analysis Set|Overall Study||49
6587727|NCT01963611|7512277|FG002|Safety Analysis Set|Overall Study||52
6587728|NCT01963611|7512278|FG003|Safety Analysis Set|Overall Study||52
6587729|NCT01963611|7512279|FG004|Safety Analysis Set|Overall Study||50
6587730|NCT01963611|7512275|FG000|COMPLETED|Overall Study||0
6587731|NCT01963611|7512276|FG001|COMPLETED|Overall Study||0
6587732|NCT01963611|7512277|FG002|COMPLETED|Overall Study||0
6587733|NCT01963611|7512278|FG003|COMPLETED|Overall Study||0
6587734|NCT01963611|7512279|FG004|COMPLETED|Overall Study||0
6587735|NCT01963611|7512275|FG000|NOT COMPLETED|Overall Study||51
6587736|NCT01963611|7512276|FG001|NOT COMPLETED|Overall Study||49
6587737|NCT01963611|7512277|FG002|NOT COMPLETED|Overall Study||52
6587738|NCT01963611|7512278|FG003|NOT COMPLETED|Overall Study||52
6587739|NCT01963611|7512279|FG004|NOT COMPLETED|Overall Study||51
6587740|NCT01963676|7512294|FG000|STARTED|Overall Study||14
6587741|NCT01963676|7512295|FG001|STARTED|Overall Study||13
6587742|NCT01963676|7512294|FG000|COMPLETED|Overall Study||13
6587743|NCT01963676|7512295|FG001|COMPLETED|Overall Study||13
6587744|NCT01963676|7512294|FG000|NOT COMPLETED|Overall Study||1
6587745|NCT01963676|7512295|FG001|NOT COMPLETED|Overall Study||0
6587746|NCT01963767|7512303|FG000|STARTED|Overall Study||58
6587747|NCT01963767|7512304|FG001|STARTED|Overall Study||55
6587748|NCT01963767|7512303|FG000|COMPLETED|Overall Study||52
6587749|NCT01963767|7512304|FG001|COMPLETED|Overall Study||53
6587750|NCT01963767|7512303|FG000|NOT COMPLETED|Overall Study||6
6587751|NCT01963767|7512304|FG001|NOT COMPLETED|Overall Study||2
6587752|NCT01963793|7512310|FG000|STARTED|Overall Study||20
6587753|NCT01963793|7512310|FG000|COMPLETED|Overall Study||20
6587754|NCT01963793|7512310|FG000|NOT COMPLETED|Overall Study||0
6587755|NCT01963845|7512327|FG000|STARTED|Overall Study||25
6587756|NCT01963845|7512328|FG001|STARTED|Overall Study||25
6587757|NCT01963845|7512327|FG000|COMPLETED|Overall Study||25
6587758|NCT01963845|7512328|FG001|COMPLETED|Overall Study||25
6587759|NCT01963845|7512327|FG000|NOT COMPLETED|Overall Study||0
6587760|NCT01963845|7512328|FG001|NOT COMPLETED|Overall Study||0
6587761|NCT01963923|7512336|FG000|STARTED|3 Weeks Post-surgery||20
6587762|NCT01963923|7512337|FG001|STARTED|3 Weeks Post-surgery||20
6587763|NCT01963923|7512336|FG000|COMPLETED|3 Weeks Post-surgery||12
6587764|NCT01963923|7512337|FG001|COMPLETED|3 Weeks Post-surgery||10
6587765|NCT01963923|7512336|FG000|NOT COMPLETED|3 Weeks Post-surgery||8
6587766|NCT01963923|7512337|FG001|NOT COMPLETED|3 Weeks Post-surgery||10
6587767|NCT01963923|7512336|FG000|STARTED|3 Months Post-surgery||12
6587768|NCT01963923|7512337|FG001|STARTED|3 Months Post-surgery||10
6587769|NCT01963923|7512336|FG000|COMPLETED|3 Months Post-surgery||10
6587770|NCT01963923|7512337|FG001|COMPLETED|3 Months Post-surgery||9
6587771|NCT01963923|7512336|FG000|NOT COMPLETED|3 Months Post-surgery||2
6587772|NCT01963923|7512337|FG001|NOT COMPLETED|3 Months Post-surgery||1
6624389|NCT02217332|7551819|FG000|COMPLETED|Overall Study|Subjects who continued to optional open-label treatment|13
6624390|NCT02217332|7551819|FG000|NOT COMPLETED|Overall Study||7
6624391|NCT02217410|7551826|FG000|STARTED|Overall Study||7
6624392|NCT02217410|7551827|FG001|STARTED|Overall Study||34
6624393|NCT02217410|7551828|FG002|STARTED|Overall Study||18
6624394|NCT02217410|7551826|FG000|COMPLETED|Overall Study||6
6624395|NCT02217410|7551827|FG001|COMPLETED|Overall Study||30
6624396|NCT02217410|7551828|FG002|COMPLETED|Overall Study||13
6624397|NCT02217410|7551826|FG000|NOT COMPLETED|Overall Study||1
6624398|NCT02217410|7551827|FG001|NOT COMPLETED|Overall Study||4
6624399|NCT02217410|7551828|FG002|NOT COMPLETED|Overall Study||5
6624400|NCT02217436|7551843|FG000|STARTED|Overall Study||40
6624401|NCT02217436|7551844|FG001|STARTED|Overall Study||40
6624402|NCT02217436|7551843|FG000|COMPLETED|Overall Study||39
6624403|NCT02217436|7551844|FG001|COMPLETED|Overall Study||38
6624404|NCT02217436|7551843|FG000|NOT COMPLETED|Overall Study||1
6624405|NCT02217436|7551844|FG001|NOT COMPLETED|Overall Study||2
6624406|NCT02217475|7551853|FG000|STARTED|Treatment Period 1 (Year 1)||72
6624407|NCT02217475|7551854|FG001|STARTED|Treatment Period 1 (Year 1)||72
6624408|NCT02217475|7551855|FG002|STARTED|Treatment Period 1 (Year 1)||145
6624409|NCT02217475|7551853|FG000|Safety Analysis Set|Treatment Period 1 (Year 1)||72
6624410|NCT02217475|7551854|FG001|Safety Analysis Set|Treatment Period 1 (Year 1)||72
6624411|NCT02217475|7551855|FG002|Safety Analysis Set|Treatment Period 1 (Year 1)||144
6624412|NCT02217475|7551853|FG000|COMPLETED|Treatment Period 1 (Year 1)||62
6624413|NCT02217475|7551854|FG001|COMPLETED|Treatment Period 1 (Year 1)||64
6624414|NCT02217475|7551855|FG002|COMPLETED|Treatment Period 1 (Year 1)||124
6624415|NCT02217475|7551853|FG000|NOT COMPLETED|Treatment Period 1 (Year 1)||10
6624416|NCT02217475|7551854|FG001|NOT COMPLETED|Treatment Period 1 (Year 1)||8
6624417|NCT02217475|7551855|FG002|NOT COMPLETED|Treatment Period 1 (Year 1)||21
6624418|NCT02217475|7551853|FG000|STARTED|Discontinued After Period 1||62
6624419|NCT02217475|7551854|FG001|STARTED|Discontinued After Period 1||64
6624420|NCT02217475|7551855|FG002|STARTED|Discontinued After Period 1||124
6624421|NCT02217475|7551853|FG000|COMPLETED|Discontinued After Period 1||60
6624422|NCT02217475|7551854|FG001|COMPLETED|Discontinued After Period 1||61
6624423|NCT02217475|7551855|FG002|COMPLETED|Discontinued After Period 1||121
6624424|NCT02217475|7551853|FG000|NOT COMPLETED|Discontinued After Period 1||2
6624425|NCT02217475|7551854|FG001|NOT COMPLETED|Discontinued After Period 1||3
6624426|NCT02217475|7551855|FG002|NOT COMPLETED|Discontinued After Period 1||3
6624427|NCT02217475|7551853|FG000|STARTED|Treatment Period 2 (Year 2)||60
6624428|NCT02217475|7551854|FG001|STARTED|Treatment Period 2 (Year 2)||61
6624429|NCT02217475|7551855|FG002|STARTED|Treatment Period 2 (Year 2)||121
6624430|NCT02217475|7551853|FG000|COMPLETED|Treatment Period 2 (Year 2)||58
6624431|NCT02217475|7551854|FG001|COMPLETED|Treatment Period 2 (Year 2)||59
6624432|NCT02217475|7551855|FG002|COMPLETED|Treatment Period 2 (Year 2)||109
6624433|NCT02217475|7551853|FG000|NOT COMPLETED|Treatment Period 2 (Year 2)||2
6624434|NCT02217475|7551854|FG001|NOT COMPLETED|Treatment Period 2 (Year 2)||2
6624435|NCT02217475|7551855|FG002|NOT COMPLETED|Treatment Period 2 (Year 2)||12
6624436|NCT02217501|7551874|FG000|STARTED|Overall Study||77
6624437|NCT02217501|7551875|FG001|STARTED|Overall Study||82
6624438|NCT02217501|7551874|FG000|COMPLETED|Overall Study||74
6624439|NCT02217501|7551875|FG001|COMPLETED|Overall Study||78
6624440|NCT02217501|7551874|FG000|NOT COMPLETED|Overall Study||3
6624441|NCT02217501|7551875|FG001|NOT COMPLETED|Overall Study||4
6659432|NCT02489357|7590268|FG000|COMPLETED|Overall Study||12
6659433|NCT02489357|7590268|FG000|NOT COMPLETED|Overall Study||0
6659434|NCT02489500|7590274|FG000|STARTED|Overall Study||2
6659435|NCT02489500|7590275|FG001|STARTED|Overall Study||1
6659436|NCT02489500|7590274|FG000|COMPLETED|Overall Study||1
6659437|NCT02489500|7590275|FG001|COMPLETED|Overall Study||0
6659438|NCT02489500|7590274|FG000|NOT COMPLETED|Overall Study||1
6659439|NCT02489500|7590275|FG001|NOT COMPLETED|Overall Study||1
6659440|NCT02489630|7590283|FG000|STARTED|Overall Study||53
6659441|NCT02489630|7590284|FG001|STARTED|Overall Study||63
6659442|NCT02489630|7590283|FG000|COMPLETED|Overall Study||51
6659443|NCT02489630|7590284|FG001|COMPLETED|Overall Study||61
6659444|NCT02489630|7590283|FG000|NOT COMPLETED|Overall Study||2
6659445|NCT02489630|7590284|FG001|NOT COMPLETED|Overall Study||2
6659446|NCT02489734|7590292|FG000|STARTED|Overall Study||56
6659447|NCT02489734|7590293|FG001|STARTED|Overall Study||53
6659448|NCT02489734|7590292|FG000|COMPLETED|Overall Study||39
6659449|NCT02489734|7590293|FG001|COMPLETED|Overall Study||53
6659450|NCT02489734|7590292|FG000|NOT COMPLETED|Overall Study||17
6659451|NCT02489734|7590293|FG001|NOT COMPLETED|Overall Study||0
6659452|NCT02489773|7590301|FG000|STARTED|Overall Study||98
6659453|NCT02489773|7590302|FG001|STARTED|Overall Study||52
6659454|NCT02489773|7590301|FG000|COMPLETED|Overall Study||91
6659455|NCT02489773|7590302|FG001|COMPLETED|Overall Study||50
6659456|NCT02489773|7590301|FG000|NOT COMPLETED|Overall Study||7
6659457|NCT02489773|7590302|FG001|NOT COMPLETED|Overall Study||2
6659458|NCT02489799|7590310|FG000|STARTED|Overall Study||45
6659459|NCT02489799|7590311|FG001|STARTED|Overall Study||47
6659460|NCT02489799|7590310|FG000|Presurgical Consent Visit (V2)|Overall Study||40
6659461|NCT02489799|7590311|FG001|Presurgical Consent Visit (V2)|Overall Study||39
6659462|NCT02489799|7590310|FG000|Postsurgical One Week Visit (V3)|Overall Study||40
6587773|NCT01964092|7512352|FG000|STARTED|Overall Study||229
6587774|NCT01964092|7512353|FG001|STARTED|Overall Study||181
6587775|NCT01964092|7512352|FG000|COMPLETED|Overall Study||227
6587776|NCT01964092|7512353|FG001|COMPLETED|Overall Study||181
6587777|NCT01964092|7512352|FG000|NOT COMPLETED|Overall Study||2
6587778|NCT01964092|7512353|FG001|NOT COMPLETED|Overall Study||0
6587779|NCT01964105|7512362|FG000|STARTED|Overall Study||15
6587780|NCT01964105|7512363|FG001|STARTED|Overall Study||75
6587781|NCT01964105|7512364|FG002|STARTED|Overall Study||10
6587782|NCT01964105|7512362|FG000|COMPLETED|Overall Study||13
6587783|NCT01964105|7512363|FG001|COMPLETED|Overall Study||62
6587784|NCT01964105|7512364|FG002|COMPLETED|Overall Study||10
6587785|NCT01964105|7512362|FG000|NOT COMPLETED|Overall Study||2
6587786|NCT01964105|7512363|FG001|NOT COMPLETED|Overall Study||13
6587787|NCT01964105|7512364|FG002|NOT COMPLETED|Overall Study||0
6587788|NCT01964222|7512374|FG000|STARTED|Overall Study||101
6587789|NCT01964222|7512375|FG001|STARTED|Overall Study||100
6587790|NCT01964222|7512374|FG000|COMPLETED|Overall Study||86
6587791|NCT01964222|7512375|FG001|COMPLETED|Overall Study||89
6587792|NCT01964222|7512374|FG000|NOT COMPLETED|Overall Study||15
6587793|NCT01964222|7512375|FG001|NOT COMPLETED|Overall Study||11
6587794|NCT01964300|7512383|FG000|STARTED|Overall Study||7
6587795|NCT01964300|7512384|FG001|STARTED|Overall Study||12
6587796|NCT01964300|7512383|FG000|COMPLETED|Overall Study||1
6587797|NCT01964300|7512384|FG001|COMPLETED|Overall Study||1
6587798|NCT01964300|7512383|FG000|NOT COMPLETED|Overall Study||6
6587799|NCT01964300|7512384|FG001|NOT COMPLETED|Overall Study||11
6587800|NCT01964326|7512390|FG000|STARTED|Overall Study||1311
6587801|NCT01964326|7512390|FG000|COMPLETED|Overall Study||1014
6587802|NCT01964326|7512390|FG000|NOT COMPLETED|Overall Study||297
6587803|NCT01964352|7512398|FG000|STARTED|Overall Study||204
6587804|NCT01964352|7512399|FG001|STARTED|Overall Study||203
6587805|NCT01964352|7512400|FG002|STARTED|Overall Study||202
6587806|NCT01964352|7512401|FG003|STARTED|Overall Study||203
6587807|NCT01964352|7512398|FG000|COMPLETED|Overall Study||178
6587808|NCT01964352|7512399|FG001|COMPLETED|Overall Study||192
6587809|NCT01964352|7512400|FG002|COMPLETED|Overall Study||196
6587810|NCT01964352|7512401|FG003|COMPLETED|Overall Study||195
6587811|NCT01964352|7512398|FG000|NOT COMPLETED|Overall Study||26
6587812|NCT01964352|7512399|FG001|NOT COMPLETED|Overall Study||11
6587813|NCT01964352|7512400|FG002|NOT COMPLETED|Overall Study||6
6587814|NCT01964352|7512401|FG003|NOT COMPLETED|Overall Study||8
6587815|NCT01964378|7512413|FG000|STARTED|Overall Study||66
6587816|NCT01964378|7512414|FG001|STARTED|Overall Study||66
6587817|NCT01964378|7512413|FG000|Participants Treated (Safety Set)|Overall Study||65
6587818|NCT01964378|7512414|FG001|Participants Treated (Safety Set)|Overall Study|"4 Participants died during treatment, hereof 2 with withdrawal... as primary reason for discont."|61
6587819|NCT01964378|7512413|FG000|COMPLETED|Overall Study||41
6587820|NCT01964378|7512414|FG001|COMPLETED|Overall Study||45
6587821|NCT01964378|7512413|FG000|NOT COMPLETED|Overall Study||25
6587822|NCT01964378|7512414|FG001|NOT COMPLETED|Overall Study||21
6587823|NCT01964430|7512422|FG000|STARTED|Overall Study||432
6587824|NCT01964430|7512423|FG001|STARTED|Overall Study||434
6587825|NCT01964430|7512422|FG000|Treated Population|Overall Study||429
6587826|NCT01964430|7512423|FG001|Treated Population|Overall Study||423
6587827|NCT01964430|7512422|FG000|COMPLETED|Overall Study||287
6587828|NCT01964430|7512423|FG001|COMPLETED|Overall Study||310
6587829|NCT01964430|7512422|FG000|NOT COMPLETED|Overall Study||145
6587830|NCT01964430|7512423|FG001|NOT COMPLETED|Overall Study||124
6587831|NCT01964521|7512429|FG000|STARTED|Overall Study||24
6587832|NCT01964521|7512429|FG000|COMPLETED|Overall Study||20
6587833|NCT01964521|7512429|FG000|NOT COMPLETED|Overall Study||4
6587834|NCT01964547|7512436|FG000|STARTED|Overall Study||62
6587835|NCT01964547|7512437|FG001|STARTED|Overall Study||59
6587836|NCT01964547|7512436|FG000|COMPLETED|Overall Study||50
6587837|NCT01964547|7512437|FG001|COMPLETED|Overall Study||48
6587838|NCT01964547|7512436|FG000|NOT COMPLETED|Overall Study||12
6587839|NCT01964547|7512437|FG001|NOT COMPLETED|Overall Study||11
6587840|NCT01964716|7512445|FG000|STARTED|Overall Study||250
6587841|NCT01964716|7512446|FG001|STARTED|Overall Study||250
6587842|NCT01964716|7512445|FG000|Vaccinated Dose 1|Overall Study||250
6587843|NCT01964716|7512446|FG001|Vaccinated Dose 1|Overall Study||250
6587844|NCT01964716|7512445|FG000|Vaccinated Dose 2|Overall Study||249
6587845|NCT01964716|7512446|FG001|Vaccinated Dose 2|Overall Study||248
6587846|NCT01964716|7512445|FG000|Vaccinated Dose 3|Overall Study||247
6587847|NCT01964716|7512446|FG001|Vaccinated Dose 3|Overall Study||244
6587848|NCT01964716|7512445|FG000|COMPLETED|Overall Study||245
6587849|NCT01964716|7512446|FG001|COMPLETED|Overall Study||244
6587850|NCT01964716|7512445|FG000|NOT COMPLETED|Overall Study||5
6587851|NCT01964716|7512446|FG001|NOT COMPLETED|Overall Study||6
6587852|NCT01964755|7512460|FG000|STARTED|Overall Study||6
6587853|NCT01964755|7512460|FG000|Cycle 2|Overall Study||5
6659463|NCT02489799|7590311|FG001|Postsurgical One Week Visit (V3)|Overall Study||39
6587854|NCT01964755|7512460|FG000|Cycle 3|Overall Study||4
6587855|NCT01964755|7512460|FG000|Cycle 4|Overall Study||4
6587856|NCT01964755|7512460|FG000|Cycle 5|Overall Study||4
6587857|NCT01964755|7512460|FG000|COMPLETED|Overall Study||4
6587858|NCT01964755|7512460|FG000|NOT COMPLETED|Overall Study||2
6587859|NCT01964898|7512466|FG000|STARTED|Overall Study||31
6587860|NCT01964898|7512467|FG001|STARTED|Overall Study||33
6587861|NCT01964898|7512466|FG000|12 Week Assessment|Overall Study||25
6587862|NCT01964898|7512467|FG001|12 Week Assessment|Overall Study||30
6659464|NCT02489799|7590310|FG000|COMPLETED|Overall Study||36
6659465|NCT02489799|7590311|FG001|COMPLETED|Overall Study||38
6659466|NCT02489799|7590310|FG000|NOT COMPLETED|Overall Study||9
6659467|NCT02489799|7590311|FG001|NOT COMPLETED|Overall Study||9
6659468|NCT02489968|7590319|FG000|STARTED|Open-label Treatment Period||439
6587863|NCT01964898|7512466|FG000|COMPLETED|Overall Study||24
6587864|NCT01964898|7512467|FG001|COMPLETED|Overall Study||26
6587865|NCT01964898|7512466|FG000|NOT COMPLETED|Overall Study||7
6587866|NCT01964898|7512467|FG001|NOT COMPLETED|Overall Study||7
6587867|NCT01964924|7512473|FG000|STARTED|Trametinib Monotherapy||37
6587868|NCT01964924|7512474|FG001|STARTED|Trametinib Monotherapy||0
6587869|NCT01964924|7512473|FG000|COMPLETED|Trametinib Monotherapy||18
6587870|NCT01964924|7512474|FG001|COMPLETED|Trametinib Monotherapy||0
6587871|NCT01964924|7512473|FG000|NOT COMPLETED|Trametinib Monotherapy||19
6587872|NCT01964924|7512474|FG001|NOT COMPLETED|Trametinib Monotherapy||0
6587873|NCT01964924|7512473|FG000|STARTED|Trametinib + GSK2141||0
6587874|NCT01964924|7512474|FG001|STARTED|Trametinib + GSK2141|Progressed in Part 1 and therefore initiated combination treatment in Part 2|19
6587875|NCT01964924|7512473|FG000|COMPLETED|Trametinib + GSK2141||0
6587876|NCT01964924|7512474|FG001|COMPLETED|Trametinib + GSK2141||19
6587877|NCT01964924|7512473|FG000|NOT COMPLETED|Trametinib + GSK2141||0
6587878|NCT01964924|7512474|FG001|NOT COMPLETED|Trametinib + GSK2141||0
6587879|NCT01964950|7512485|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
6587880|NCT01964950|7512485|FG000|COMPLETED|Overall Study||1076
6587881|NCT01964950|7512485|FG000|NOT COMPLETED|Overall Study||25
6587882|NCT01964963|7512492|FG000|STARTED|Overall Study||19192
6587883|NCT01964963|7512492|FG000|COMPLETED|Overall Study||18249
6587884|NCT01964963|7512492|FG000|NOT COMPLETED|Overall Study||943
6587885|NCT01964976|7512498|FG000|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
6587886|NCT01964976|7512498|FG000|COMPLETED|Overall Study||1065
6587887|NCT01964976|7512498|FG000|NOT COMPLETED|Overall Study||31
6587888|NCT01965002|7512505|FG000|STARTED|Overall Study||5
6587889|NCT01965002|7512505|FG000|COMPLETED|Overall Study||5
6587890|NCT01965002|7512505|FG000|NOT COMPLETED|Overall Study||0
6587891|NCT01965067|7512513|FG000|STARTED|Overall Study||30
6587892|NCT01965067|7512514|FG001|STARTED|Overall Study||30
6587893|NCT01965067|7512513|FG000|COMPLETED|Overall Study||30
6587894|NCT01965067|7512514|FG001|COMPLETED|Overall Study||30
6587895|NCT01965067|7512513|FG000|NOT COMPLETED|Overall Study||0
6587896|NCT01965067|7512514|FG001|NOT COMPLETED|Overall Study||0
6587897|NCT01965158|7512522|FG000|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
6587898|NCT01965158|7512523|FG001|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
6587899|NCT01965158|7512522|FG000|Received Treatment|Overall Study||272
6587900|NCT01965158|7512523|FG001|Received Treatment|Overall Study||273
6587901|NCT01965158|7512522|FG000|COMPLETED|Overall Study||233
6587902|NCT01965158|7512523|FG001|COMPLETED|Overall Study||238
6587903|NCT01965158|7512522|FG000|NOT COMPLETED|Overall Study||41
6587904|NCT01965158|7512523|FG001|NOT COMPLETED|Overall Study||35
6587905|NCT01965262|7512529|FG000|STARTED|First Intervention (7 Days)||15
6587906|NCT01965262|7512530|FG001|STARTED|First Intervention (7 Days)||15
6587907|NCT01965262|7512529|FG000|COMPLETED|First Intervention (7 Days)||15
6587908|NCT01965262|7512530|FG001|COMPLETED|First Intervention (7 Days)||15
6587909|NCT01965262|7512529|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6587910|NCT01965262|7512530|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6587911|NCT01965262|7512529|FG000|STARTED|Second Intervention (7 Days)||15
6587912|NCT01965262|7512530|FG001|STARTED|Second Intervention (7 Days)||15
6587913|NCT01965262|7512529|FG000|COMPLETED|Second Intervention (7 Days)||14
6587914|NCT01965262|7512530|FG001|COMPLETED|Second Intervention (7 Days)||5
6587915|NCT01965262|7512529|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
6587916|NCT01965262|7512530|FG001|NOT COMPLETED|Second Intervention (7 Days)||10
6587917|NCT01965288|7512538|FG000|STARTED|Overall Study||30
6587918|NCT01965288|7512539|FG001|STARTED|Overall Study||30
6587919|NCT01965288|7512538|FG000|COMPLETED|Overall Study||30
6587920|NCT01965288|7512539|FG001|COMPLETED|Overall Study||30
6587921|NCT01965288|7512538|FG000|NOT COMPLETED|Overall Study||0
6587922|NCT01965288|7512539|FG001|NOT COMPLETED|Overall Study||0
6587923|NCT01965327|7512557|FG000|STARTED|Overall Study||12
6587924|NCT01965327|7512557|FG000|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
6587925|NCT01965327|7512557|FG000|NOT COMPLETED|Overall Study||2
6587926|NCT01965366|7512563|FG000|STARTED|Overall Study||13
6587927|NCT01965366|7512564|FG001|STARTED|Overall Study||14
6587928|NCT01965366|7512563|FG000|COMPLETED|Overall Study||3
6587929|NCT01965366|7512564|FG001|COMPLETED|Overall Study||9
6587930|NCT01965366|7512563|FG000|NOT COMPLETED|Overall Study||10
6587931|NCT01965366|7512564|FG001|NOT COMPLETED|Overall Study||5
6587932|NCT01965431|7512570|FG000|STARTED|Overall Study|Started are actually Treated subjects|8
6587933|NCT01965431|7512571|FG001|STARTED|Overall Study||8
6587934|NCT01965431|7512572|FG002|STARTED|Overall Study||8
6587935|NCT01965431|7512573|FG003|STARTED|Overall Study||8
6587936|NCT01965431|7512574|FG004|STARTED|Overall Study||8
6587937|NCT01965431|7512575|FG005|STARTED|Overall Study||8
6587938|NCT01965431|7512570|FG000|COMPLETED|Overall Study||2
6587939|NCT01965431|7512571|FG001|COMPLETED|Overall Study||2
6587940|NCT01965431|7512572|FG002|COMPLETED|Overall Study||2
6587941|NCT01965431|7512573|FG003|COMPLETED|Overall Study||2
6587942|NCT01965431|7512574|FG004|COMPLETED|Overall Study||2
6587943|NCT01965431|7512575|FG005|COMPLETED|Overall Study||2
6587944|NCT01965431|7512570|FG000|NOT COMPLETED|Overall Study||6
6587945|NCT01965431|7512571|FG001|NOT COMPLETED|Overall Study||6
6587946|NCT01965431|7512572|FG002|NOT COMPLETED|Overall Study||6
6587947|NCT01965431|7512573|FG003|NOT COMPLETED|Overall Study||6
6587948|NCT01965431|7512574|FG004|NOT COMPLETED|Overall Study||6
6587949|NCT01965431|7512575|FG005|NOT COMPLETED|Overall Study||6
6587950|NCT01965535|7512587|FG000|STARTED|Overall Study||78
6587951|NCT01965535|7512588|FG001|STARTED|Overall Study||77
6587952|NCT01965535|7512587|FG000|COMPLETED|Overall Study||76
6587953|NCT01965535|7512588|FG001|COMPLETED|Overall Study||76
6587954|NCT01965535|7512587|FG000|NOT COMPLETED|Overall Study||2
6587955|NCT01965535|7512588|FG001|NOT COMPLETED|Overall Study||1
6587956|NCT01965561|7512594|FG000|STARTED|Overall Study||10
6587957|NCT01965561|7512594|FG000|COMPLETED|Overall Study||10
6587958|NCT01965561|7512594|FG000|NOT COMPLETED|Overall Study||0
6587959|NCT01965600|7512601|FG000|STARTED|First Intervention||6
6587960|NCT01965600|7512602|FG001|STARTED|First Intervention||8
6587961|NCT01965600|7512603|FG002|STARTED|First Intervention||5
6587962|NCT01965600|7512604|FG003|STARTED|First Intervention||4
6587963|NCT01965600|7512601|FG000|Received at Least One Dose of Drug|First Intervention||6
6587964|NCT01965600|7512602|FG001|Received at Least One Dose of Drug|First Intervention||8
6587965|NCT01965600|7512603|FG002|Received at Least One Dose of Drug|First Intervention||5
6587966|NCT01965600|7512604|FG003|Received at Least One Dose of Drug|First Intervention||4
6587967|NCT01965600|7512601|FG000|COMPLETED|First Intervention||6
6587968|NCT01965600|7512602|FG001|COMPLETED|First Intervention||8
6587969|NCT01965600|7512603|FG002|COMPLETED|First Intervention||5
6587970|NCT01965600|7512604|FG003|COMPLETED|First Intervention||4
6587971|NCT01965600|7512601|FG000|NOT COMPLETED|First Intervention||0
6587972|NCT01965600|7512602|FG001|NOT COMPLETED|First Intervention||0
6587973|NCT01965600|7512603|FG002|NOT COMPLETED|First Intervention||0
6587974|NCT01965600|7512604|FG003|NOT COMPLETED|First Intervention||0
6587975|NCT01965600|7512601|FG000|STARTED|Washout Period of Approximately 15 Days||6
6587976|NCT01965600|7512602|FG001|STARTED|Washout Period of Approximately 15 Days||8
6587977|NCT01965600|7512603|FG002|STARTED|Washout Period of Approximately 15 Days||5
6587978|NCT01965600|7512604|FG003|STARTED|Washout Period of Approximately 15 Days||4
6587979|NCT01965600|7512601|FG000|COMPLETED|Washout Period of Approximately 15 Days||4
6587980|NCT01965600|7512602|FG001|COMPLETED|Washout Period of Approximately 15 Days||4
6587981|NCT01965600|7512603|FG002|COMPLETED|Washout Period of Approximately 15 Days||3
6587982|NCT01965600|7512604|FG003|COMPLETED|Washout Period of Approximately 15 Days||2
6587983|NCT01965600|7512601|FG000|NOT COMPLETED|Washout Period of Approximately 15 Days||2
6587984|NCT01965600|7512602|FG001|NOT COMPLETED|Washout Period of Approximately 15 Days||4
6587985|NCT01965600|7512603|FG002|NOT COMPLETED|Washout Period of Approximately 15 Days||2
6587986|NCT01965600|7512604|FG003|NOT COMPLETED|Washout Period of Approximately 15 Days||2
6587987|NCT01965600|7512601|FG000|STARTED|Second Intervention||4
6587988|NCT01965600|7512602|FG001|STARTED|Second Intervention||4
6587989|NCT01965600|7512603|FG002|STARTED|Second Intervention||3
6587990|NCT01965600|7512604|FG003|STARTED|Second Intervention||2
6587991|NCT01965600|7512601|FG000|COMPLETED|Second Intervention||4
6587992|NCT01965600|7512602|FG001|COMPLETED|Second Intervention||4
6587993|NCT01965600|7512603|FG002|COMPLETED|Second Intervention||1
6587994|NCT01965600|7512604|FG003|COMPLETED|Second Intervention||0
6587995|NCT01965600|7512601|FG000|NOT COMPLETED|Second Intervention||0
6587996|NCT01965600|7512602|FG001|NOT COMPLETED|Second Intervention||0
6587997|NCT01965600|7512603|FG002|NOT COMPLETED|Second Intervention||2
6587998|NCT01965600|7512604|FG003|NOT COMPLETED|Second Intervention||2
6587999|NCT01965652|7512614|FG000|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
6588000|NCT01965652|7512615|FG001|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
6588001|NCT01965652|7512614|FG000|Received Treatment|Overall Study||622
6588002|NCT01965652|7512615|FG001|Received Treatment|Overall Study||623
6588003|NCT01965652|7512614|FG000|COMPLETED|Overall Study||413
6588004|NCT01965652|7512615|FG001|COMPLETED|Overall Study||413
6588005|NCT01965652|7512614|FG000|NOT COMPLETED|Overall Study||210
6588006|NCT01965652|7512615|FG001|NOT COMPLETED|Overall Study||210
6588007|NCT01965665|7512621|FG000|STARTED|Overall Study||20
6588008|NCT01965665|7512621|FG000|COMPLETED|Overall Study||19
6588009|NCT01965665|7512621|FG000|NOT COMPLETED|Overall Study||1
6588010|NCT01965756|7512627|FG000|STARTED|Overall Study||10
6588011|NCT01965756|7512628|FG001|STARTED|Overall Study||10
6588012|NCT01965756|7512627|FG000|COMPLETED|Overall Study||10
6588013|NCT01965756|7512628|FG001|COMPLETED|Overall Study||10
6588014|NCT01965756|7512627|FG000|NOT COMPLETED|Overall Study||0
6588015|NCT01965756|7512628|FG001|NOT COMPLETED|Overall Study||0
6588016|NCT01965834|7512638|FG000|STARTED|Overall Study||6
6588017|NCT01965834|7512638|FG000|COMPLETED|Overall Study||2
6588018|NCT01965834|7512638|FG000|NOT COMPLETED|Overall Study||4
6588019|NCT01965860|7512645|FG000|STARTED|Overall Study||11
6588020|NCT01965860|7512646|FG001|STARTED|Overall Study||10
6588021|NCT01965860|7512647|FG002|STARTED|Overall Study||11
6588022|NCT01965860|7512645|FG000|COMPLETED|Overall Study||9
6588023|NCT01965860|7512646|FG001|COMPLETED|Overall Study||10
6588024|NCT01965860|7512647|FG002|COMPLETED|Overall Study||10
6588025|NCT01965860|7512645|FG000|NOT COMPLETED|Overall Study||2
6588026|NCT01965860|7512646|FG001|NOT COMPLETED|Overall Study||0
6588027|NCT01965860|7512647|FG002|NOT COMPLETED|Overall Study||1
6588028|NCT01965899|7512655|FG000|STARTED|Overall Study||151
6588029|NCT01965899|7512655|FG000|COMPLETED|Overall Study||145
6588030|NCT01965899|7512655|FG000|NOT COMPLETED|Overall Study||6
6588031|NCT01965938|7512662|FG000|STARTED|Overall Study||21
6588032|NCT01965938|7512663|FG001|STARTED|Overall Study||20
6588033|NCT01965938|7512662|FG000|COMPLETED|Overall Study||20
6588034|NCT01965938|7512663|FG001|COMPLETED|Overall Study||20
6588035|NCT01965938|7512662|FG000|NOT COMPLETED|Overall Study||1
6588036|NCT01965938|7512663|FG001|NOT COMPLETED|Overall Study||0
6588037|NCT01966003|7512673|FG000|STARTED|Overall Study||328
6588038|NCT01966003|7512674|FG001|STARTED|Overall Study||314
6588039|NCT01966003|7512673|FG000|Received Study Drug|Overall Study||324
6588040|NCT01966003|7512674|FG001|Received Study Drug|Overall Study||309
6588041|NCT01966003|7512673|FG000|COMPLETED|Overall Study||58
6588042|NCT01966003|7512674|FG001|COMPLETED|Overall Study||44
6588043|NCT01966003|7512673|FG000|NOT COMPLETED|Overall Study||270
6588044|NCT01966003|7512674|FG001|NOT COMPLETED|Overall Study||270
6588045|NCT01966042|7512680|FG000|STARTED|Overall Study||13
6588046|NCT01966042|7512680|FG000|COMPLETED|Overall Study||11
6588047|NCT01966042|7512680|FG000|NOT COMPLETED|Overall Study||2
6588048|NCT01966068|7512686|FG000|STARTED|Overall Study||294
6588049|NCT01966068|7512686|FG000|Used the MyAsthma Portal at Least Once|Overall Study||237
6588050|NCT01966068|7512686|FG000|Use the MyAsthma Portal More Than Once|Overall Study||156
6659469|NCT02489968|7590320|FG001|STARTED|Open-label Treatment Period|1 subject did not receive treatment and hence excluded. Started represents treated numbers.|440
6659470|NCT02489968|7590321|FG002|STARTED|Open-label Treatment Period||0
6659471|NCT02489968|7590322|FG003|STARTED|Open-label Treatment Period||0
6659472|NCT02489968|7590323|FG004|STARTED|Open-label Treatment Period||0
6659473|NCT02489968|7590324|FG005|STARTED|Open-label Treatment Period||0
6659474|NCT02489968|7590319|FG000|COMPLETED|Open-label Treatment Period||215
6659475|NCT02489968|7590320|FG001|COMPLETED|Open-label Treatment Period||232
6659476|NCT02489968|7590321|FG002|COMPLETED|Open-label Treatment Period||0
6588051|NCT01966068|7512686|FG000|COMPLETED|Overall Study||156
6588052|NCT01966068|7512686|FG000|NOT COMPLETED|Overall Study||138
6588053|NCT01966107|7512693|FG000|STARTED|Overall Study||1812
6588054|NCT01966107|7512694|FG001|STARTED|Overall Study||1818
6588055|NCT01966107|7512693|FG000|Full Analysis Set|Overall Study||1791
6588056|NCT01966107|7512694|FG001|Full Analysis Set|Overall Study||1798
6588057|NCT01966107|7512693|FG000|COMPLETED|Overall Study||1010
6588058|NCT01966107|7512694|FG001|COMPLETED|Overall Study||937
6588059|NCT01966107|7512693|FG000|NOT COMPLETED|Overall Study||802
6588060|NCT01966107|7512694|FG001|NOT COMPLETED|Overall Study||881
6588061|NCT01966120|7512702|FG000|STARTED|Overall Study||55
6588062|NCT01966120|7512703|FG001|STARTED|Overall Study||32
6588063|NCT01966120|7512702|FG000|COMPLETED|Overall Study||54
6588064|NCT01966120|7512703|FG001|COMPLETED|Overall Study||26
6588065|NCT01966120|7512702|FG000|NOT COMPLETED|Overall Study||1
6588066|NCT01966120|7512703|FG001|NOT COMPLETED|Overall Study||6
6588067|NCT01966159|7512711|FG000|STARTED|Overall Study||205
6588068|NCT01966159|7512712|FG001|STARTED|Overall Study||207
6588069|NCT01966159|7512711|FG000|COMPLETED|Overall Study||205
6588070|NCT01966159|7512712|FG001|COMPLETED|Overall Study||207
6588071|NCT01966159|7512711|FG000|NOT COMPLETED|Overall Study||0
6588072|NCT01966159|7512712|FG001|NOT COMPLETED|Overall Study||0
6588073|NCT01966354|7512721|FG000|STARTED|Overall Study||75
6588074|NCT01966354|7512722|FG001|STARTED|Overall Study||73
6588075|NCT01966354|7512723|FG002|STARTED|Overall Study||72
6588076|NCT01966354|7512721|FG000|COMPLETED|Overall Study||75
6588077|NCT01966354|7512722|FG001|COMPLETED|Overall Study||73
6588078|NCT01966354|7512723|FG002|COMPLETED|Overall Study||72
6588079|NCT01966354|7512721|FG000|NOT COMPLETED|Overall Study||0
6588080|NCT01966354|7512722|FG001|NOT COMPLETED|Overall Study||0
6588081|NCT01966354|7512723|FG002|NOT COMPLETED|Overall Study||0
6588082|NCT01966380|7512731|FG000|STARTED|Overall Study||3
6588083|NCT01966380|7512732|FG001|STARTED|Overall Study||3
6588084|NCT01966380|7512731|FG000|COMPLETED|Overall Study||3
6588085|NCT01966380|7512732|FG001|COMPLETED|Overall Study||2
6588086|NCT01966380|7512731|FG000|NOT COMPLETED|Overall Study||0
6588087|NCT01966380|7512732|FG001|NOT COMPLETED|Overall Study||1
6588088|NCT01966419|7512740|FG000|STARTED|Overall Study||115
6588089|NCT01966419|7512741|FG001|STARTED|Overall Study||116
6588090|NCT01966419|7512740|FG000|Intent to Treat Population (ITT)T)115|Overall Study||115
6588091|NCT01966419|7512741|FG001|Intent to Treat Population (ITT)T)115|Overall Study||116
6588092|NCT01966419|7512740|FG000|Safety Analysis Set (SAS)|Overall Study||112
6588093|NCT01966419|7512741|FG001|Safety Analysis Set (SAS)|Overall Study||114
6588094|NCT01966419|7512740|FG000|COMPLETED|Overall Study||74
6588095|NCT01966419|7512741|FG001|COMPLETED|Overall Study||80
6588096|NCT01966419|7512740|FG000|NOT COMPLETED|Overall Study||41
6588097|NCT01966419|7512741|FG001|NOT COMPLETED|Overall Study||36
6588098|NCT01966432|7512750|FG000|STARTED|Overall Study||10
6588099|NCT01966432|7512751|FG001|STARTED|Overall Study||34
6588100|NCT01966432|7512752|FG002|STARTED|Overall Study||54
6588101|NCT01966432|7512750|FG000|COMPLETED|Overall Study||5
6588102|NCT01966432|7512751|FG001|COMPLETED|Overall Study||21
6588103|NCT01966432|7512752|FG002|COMPLETED|Overall Study||28
6588104|NCT01966432|7512750|FG000|NOT COMPLETED|Overall Study||5
6588105|NCT01966432|7512751|FG001|NOT COMPLETED|Overall Study||13
6588106|NCT01966432|7512752|FG002|NOT COMPLETED|Overall Study||26
6588107|NCT01966445|7512768|FG000|STARTED|Part1 (Median Exposure of 6.143 Weeks)||1
6588108|NCT01966445|7512769|FG001|STARTED|Part1 (Median Exposure of 6.143 Weeks)||3
6588109|NCT01966445|7512770|FG002|STARTED|Part1 (Median Exposure of 6.143 Weeks)||2
6588110|NCT01966445|7512771|FG003|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
6588111|NCT01966445|7512772|FG004|STARTED|Part1 (Median Exposure of 6.143 Weeks)||4
6588112|NCT01966445|7512773|FG005|STARTED|Part1 (Median Exposure of 6.143 Weeks)||5
6588113|NCT01966445|7512774|FG006|STARTED|Part1 (Median Exposure of 6.143 Weeks)||0
6588114|NCT01966445|7512768|FG000|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6588115|NCT01966445|7512769|FG001|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6588116|NCT01966445|7512770|FG002|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6588117|NCT01966445|7512771|FG003|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
6588118|NCT01966445|7512772|FG004|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6588119|NCT01966445|7512773|FG005|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||4
6588120|NCT01966445|7512774|FG006|COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
6588121|NCT01966445|7512768|FG000|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
6588122|NCT01966445|7512769|FG001|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||2
6588123|NCT01966445|7512770|FG002|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6588124|NCT01966445|7512771|FG003|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
6588125|NCT01966445|7512772|FG004|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||3
6588126|NCT01966445|7512773|FG005|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||1
6588127|NCT01966445|7512774|FG006|NOT COMPLETED|Part1 (Median Exposure of 6.143 Weeks)||0
6588128|NCT01966445|7512768|FG000|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6588129|NCT01966445|7512769|FG001|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6588130|NCT01966445|7512770|FG002|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6588131|NCT01966445|7512771|FG003|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6588132|NCT01966445|7512772|FG004|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6588133|NCT01966445|7512773|FG005|STARTED|Part2 (Median Exposure of 7.143 Weeks)||0
6588134|NCT01966445|7512774|FG006|STARTED|Part2 (Median Exposure of 7.143 Weeks)||9
6588135|NCT01966445|7512768|FG000|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588136|NCT01966445|7512769|FG001|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588137|NCT01966445|7512770|FG002|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588138|NCT01966445|7512771|FG003|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588139|NCT01966445|7512772|FG004|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588140|NCT01966445|7512773|FG005|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588141|NCT01966445|7512774|FG006|COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||4
6588142|NCT01966445|7512768|FG000|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588143|NCT01966445|7512769|FG001|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588144|NCT01966445|7512770|FG002|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588145|NCT01966445|7512771|FG003|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588146|NCT01966445|7512772|FG004|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588147|NCT01966445|7512773|FG005|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||0
6588148|NCT01966445|7512774|FG006|NOT COMPLETED|Part2 (Median Exposure of 7.143 Weeks)||5
6588149|NCT01966458|7512792|FG000|STARTED|Overall Study||308
6588150|NCT01966458|7512793|FG001|STARTED|Overall Study||157
6588151|NCT01966458|7512792|FG000|COMPLETED|Overall Study||304
6588152|NCT01966458|7512793|FG001|COMPLETED|Overall Study||155
6588153|NCT01966458|7512792|FG000|NOT COMPLETED|Overall Study||4
6588154|NCT01966458|7512793|FG001|NOT COMPLETED|Overall Study||2
6588155|NCT01966718|7512799|FG000|STARTED|Overall Study||8
6588156|NCT01966718|7512799|FG000|COMPLETED|Overall Study||8
6588157|NCT01966718|7512799|FG000|NOT COMPLETED|Overall Study||0
6588158|NCT01966770|7512805|FG000|STARTED|Overall Study||20
6588159|NCT01966770|7512805|FG000|COMPLETED|Overall Study||20
6588160|NCT01966770|7512805|FG000|NOT COMPLETED|Overall Study||0
6588161|NCT01966796|7512843|FG000|STARTED|Overall Study||15
6588162|NCT01966796|7512844|FG001|STARTED|Overall Study||51
6588163|NCT01966796|7512845|FG002|STARTED|Overall Study||195
6588164|NCT01966796|7512846|FG003|STARTED|Overall Study||269
6588165|NCT01966796|7512843|FG000|COMPLETED|Overall Study||15
6588166|NCT01966796|7512844|FG001|COMPLETED|Overall Study||51
6588167|NCT01966796|7512845|FG002|COMPLETED|Overall Study||195
6588168|NCT01966796|7512846|FG003|COMPLETED|Overall Study||269
6588169|NCT01966796|7512843|FG000|NOT COMPLETED|Overall Study||0
6588170|NCT01966796|7512844|FG001|NOT COMPLETED|Overall Study||0
6588171|NCT01966796|7512845|FG002|NOT COMPLETED|Overall Study||0
6588172|NCT01966796|7512846|FG003|NOT COMPLETED|Overall Study||0
6588173|NCT01966809|7512860|FG000|STARTED|Overall Study||1
6588174|NCT01966809|7512860|FG000|COMPLETED|Overall Study||1
6588175|NCT01966809|7512860|FG000|NOT COMPLETED|Overall Study||0
6588176|NCT01966900|7512866|FG000|STARTED|Overall Study||8
6588177|NCT01966900|7512867|FG001|STARTED|Overall Study||6
6588178|NCT01966900|7512866|FG000|COMPLETED|Overall Study||6
6588179|NCT01966900|7512867|FG001|COMPLETED|Overall Study||6
6588180|NCT01966900|7512866|FG000|NOT COMPLETED|Overall Study||2
6588181|NCT01966900|7512867|FG001|NOT COMPLETED|Overall Study||0
6588182|NCT01966926|7512875|FG000|STARTED|Overall Study||15
6588183|NCT01966926|7512876|FG001|STARTED|Overall Study||15
6588184|NCT01966926|7512875|FG000|COMPLETED|Overall Study||15
6588185|NCT01966926|7512876|FG001|COMPLETED|Overall Study||15
6588186|NCT01966926|7512875|FG000|NOT COMPLETED|Overall Study||0
6588187|NCT01966926|7512876|FG001|NOT COMPLETED|Overall Study||0
6588188|NCT01966978|7512884|FG000|STARTED|Overall Study||61
6588189|NCT01966978|7512885|FG001|STARTED|Overall Study||59
6588190|NCT01966978|7512884|FG000|COMPLETED|Overall Study||44
6588191|NCT01966978|7512885|FG001|COMPLETED|Overall Study||46
6588192|NCT01966978|7512884|FG000|NOT COMPLETED|Overall Study||17
6588193|NCT01966978|7512885|FG001|NOT COMPLETED|Overall Study||13
6588194|NCT01967069|7512893|FG000|STARTED|Overall Study||182
6588195|NCT01967069|7512894|FG001|STARTED|Overall Study||95
6588196|NCT01967069|7512893|FG000|COMPLETED|Overall Study||174
6588197|NCT01967069|7512894|FG001|COMPLETED|Overall Study||87
6588198|NCT01967069|7512893|FG000|NOT COMPLETED|Overall Study||8
6588199|NCT01967069|7512894|FG001|NOT COMPLETED|Overall Study||8
6588200|NCT01967121|7512903|FG000|STARTED|Overall Study||25
6588201|NCT01967121|7512904|FG001|STARTED|Overall Study||25
6588202|NCT01967121|7512905|FG002|STARTED|Overall Study||25
6588203|NCT01967121|7512903|FG000|COMPLETED|Overall Study||25
6588204|NCT01967121|7512904|FG001|COMPLETED|Overall Study||25
6588205|NCT01967121|7512905|FG002|COMPLETED|Overall Study||25
6588206|NCT01967121|7512903|FG000|NOT COMPLETED|Overall Study||0
6588207|NCT01967121|7512904|FG001|NOT COMPLETED|Overall Study||0
6588208|NCT01967121|7512905|FG002|NOT COMPLETED|Overall Study||0
6588209|NCT01967134|7512916|FG000|STARTED|Overall Study||8
6588210|NCT01967134|7512917|FG001|STARTED|Overall Study||8
6588211|NCT01967134|7512918|FG002|STARTED|Overall Study||9
6588212|NCT01967134|7512916|FG000|COMPLETED|Overall Study||8
6588213|NCT01967134|7512917|FG001|COMPLETED|Overall Study||7
6588214|NCT01967134|7512918|FG002|COMPLETED|Overall Study||9
6588215|NCT01967134|7512916|FG000|NOT COMPLETED|Overall Study||0
6588216|NCT01967134|7512917|FG001|NOT COMPLETED|Overall Study||1
6588217|NCT01967134|7512918|FG002|NOT COMPLETED|Overall Study||0
6588218|NCT01967147|7512928|FG000|STARTED|Overall Study||112
6588219|NCT01967147|7512929|FG001|STARTED|Overall Study||102
6588220|NCT01967147|7512928|FG000|COMPLETED|Overall Study||99
6588221|NCT01967147|7512929|FG001|COMPLETED|Overall Study||82
6588222|NCT01967147|7512928|FG000|NOT COMPLETED|Overall Study||13
6588223|NCT01967147|7512929|FG001|NOT COMPLETED|Overall Study||20
6588224|NCT01967173|7512944|FG000|STARTED|Overall Study||69
6588225|NCT01967173|7512945|FG001|STARTED|Overall Study||69
6588226|NCT01967173|7512946|FG002|STARTED|Overall Study||71
6588227|NCT01967173|7512947|FG003|STARTED|Overall Study||71
6588228|NCT01967173|7512948|FG004|STARTED|Overall Study||73
6588229|NCT01967173|7512949|FG005|STARTED|Overall Study||72
6588230|NCT01967173|7512950|FG006|STARTED|Overall Study||75
6588231|NCT01967173|7512951|FG007|STARTED|Overall Study||74
6588232|NCT01967173|7512944|FG000|Completed 1st Period|Overall Study||58
6588233|NCT01967173|7512945|FG001|Completed 1st Period|Overall Study||60
6588234|NCT01967173|7512946|FG002|Completed 1st Period|Overall Study||67
6588235|NCT01967173|7512947|FG003|Completed 1st Period|Overall Study||65
6588236|NCT01967173|7512948|FG004|Completed 1st Period|Overall Study||64
6588237|NCT01967173|7512949|FG005|Completed 1st Period|Overall Study||62
6588238|NCT01967173|7512950|FG006|Completed 1st Period|Overall Study||67
6588239|NCT01967173|7512951|FG007|Completed 1st Period|Overall Study||69
6588240|NCT01967173|7512944|FG000|Completed 2nd Period|Overall Study||52
6588241|NCT01967173|7512945|FG001|Completed 2nd Period|Overall Study||58
6588242|NCT01967173|7512946|FG002|Completed 2nd Period|Overall Study||63
6588243|NCT01967173|7512947|FG003|Completed 2nd Period|Overall Study||62
6588244|NCT01967173|7512948|FG004|Completed 2nd Period|Overall Study||63
6588245|NCT01967173|7512949|FG005|Completed 2nd Period|Overall Study||57
6588246|NCT01967173|7512950|FG006|Completed 2nd Period|Overall Study||63
6588247|NCT01967173|7512951|FG007|Completed 2nd Period|Overall Study||61
6588248|NCT01967173|7512944|FG000|Completed 3rd Period|Overall Study||48
6588249|NCT01967173|7512945|FG001|Completed 3rd Period|Overall Study||54
6588250|NCT01967173|7512946|FG002|Completed 3rd Period|Overall Study||60
6588251|NCT01967173|7512947|FG003|Completed 3rd Period|Overall Study||61
6588252|NCT01967173|7512948|FG004|Completed 3rd Period|Overall Study||59
6588253|NCT01967173|7512949|FG005|Completed 3rd Period|Overall Study||56
6588254|NCT01967173|7512950|FG006|Completed 3rd Period|Overall Study||59
6588255|NCT01967173|7512951|FG007|Completed 3rd Period|Overall Study||56
6588256|NCT01967173|7512944|FG000|Completed 4th Period|Overall Study||45
6588257|NCT01967173|7512945|FG001|Completed 4th Period|Overall Study||52
6588258|NCT01967173|7512946|FG002|Completed 4th Period|Overall Study||55
6588259|NCT01967173|7512947|FG003|Completed 4th Period|Overall Study||57
6588260|NCT01967173|7512948|FG004|Completed 4th Period|Overall Study||56
6588261|NCT01967173|7512949|FG005|Completed 4th Period|Overall Study||49
6588262|NCT01967173|7512950|FG006|Completed 4th Period|Overall Study||57
6588263|NCT01967173|7512951|FG007|Completed 4th Period|Overall Study||50
6588264|NCT01967173|7512944|FG000|COMPLETED|Overall Study||45
6588265|NCT01967173|7512945|FG001|COMPLETED|Overall Study||52
6588266|NCT01967173|7512946|FG002|COMPLETED|Overall Study||55
6588267|NCT01967173|7512947|FG003|COMPLETED|Overall Study||57
6588268|NCT01967173|7512948|FG004|COMPLETED|Overall Study||56
6588269|NCT01967173|7512949|FG005|COMPLETED|Overall Study||49
6588270|NCT01967173|7512950|FG006|COMPLETED|Overall Study||57
6588271|NCT01967173|7512951|FG007|COMPLETED|Overall Study||50
6588272|NCT01967173|7512944|FG000|NOT COMPLETED|Overall Study||24
6588273|NCT01967173|7512945|FG001|NOT COMPLETED|Overall Study||17
6588274|NCT01967173|7512946|FG002|NOT COMPLETED|Overall Study||16
6588275|NCT01967173|7512947|FG003|NOT COMPLETED|Overall Study||14
6588276|NCT01967173|7512948|FG004|NOT COMPLETED|Overall Study||17
6588277|NCT01967173|7512949|FG005|NOT COMPLETED|Overall Study||23
6588278|NCT01967173|7512950|FG006|NOT COMPLETED|Overall Study||18
6588279|NCT01967173|7512951|FG007|NOT COMPLETED|Overall Study||24
6588280|NCT01967225|7512967|FG000|STARTED|Overall Study||84
6588281|NCT01967225|7512968|FG001|STARTED|Overall Study||41
6588282|NCT01967225|7512967|FG000|Participants Received Treatment|Overall Study||83
6588283|NCT01967225|7512968|FG001|Participants Received Treatment|Overall Study||41
6588284|NCT01967225|7512967|FG000|COMPLETED|Overall Study||72
6588285|NCT01967225|7512968|FG001|COMPLETED|Overall Study||38
6588286|NCT01967225|7512967|FG000|NOT COMPLETED|Overall Study||12
6588287|NCT01967225|7512968|FG001|NOT COMPLETED|Overall Study||3
6659477|NCT02489968|7590322|FG003|COMPLETED|Open-label Treatment Period||0
6659478|NCT02489968|7590323|FG004|COMPLETED|Open-label Treatment Period||0
6659479|NCT02489968|7590324|FG005|COMPLETED|Open-label Treatment Period||0
6659480|NCT02489968|7590319|FG000|NOT COMPLETED|Open-label Treatment Period||224
6659481|NCT02489968|7590320|FG001|NOT COMPLETED|Open-label Treatment Period||208
6659482|NCT02489968|7590321|FG002|NOT COMPLETED|Open-label Treatment Period||0
6659483|NCT02489968|7590322|FG003|NOT COMPLETED|Open-label Treatment Period||0
6659484|NCT02489968|7590323|FG004|NOT COMPLETED|Open-label Treatment Period||0
6659485|NCT02489968|7590324|FG005|NOT COMPLETED|Open-label Treatment Period||0
6659486|NCT02489968|7590319|FG000|STARTED|Double-blind Treatment Period||0
6659487|NCT02489968|7590320|FG001|STARTED|Double-blind Treatment Period||0
6659488|NCT02489968|7590321|FG002|STARTED|Double-blind Treatment Period||107
6659489|NCT02489968|7590322|FG003|STARTED|Double-blind Treatment Period||108
6659490|NCT02489968|7590323|FG004|STARTED|Double-blind Treatment Period||116
6659491|NCT02489968|7590324|FG005|STARTED|Double-blind Treatment Period||116
6659492|NCT02489968|7590319|FG000|COMPLETED|Double-blind Treatment Period||0
6659493|NCT02489968|7590320|FG001|COMPLETED|Double-blind Treatment Period||0
6659494|NCT02489968|7590321|FG002|COMPLETED|Double-blind Treatment Period||105
6659495|NCT02489968|7590322|FG003|COMPLETED|Double-blind Treatment Period||100
6659496|NCT02489968|7590323|FG004|COMPLETED|Double-blind Treatment Period||110
6659497|NCT02489968|7590324|FG005|COMPLETED|Double-blind Treatment Period||108
6659498|NCT02489968|7590319|FG000|NOT COMPLETED|Double-blind Treatment Period||0
6659499|NCT02489968|7590320|FG001|NOT COMPLETED|Double-blind Treatment Period||0
6659500|NCT02489968|7590321|FG002|NOT COMPLETED|Double-blind Treatment Period||2
6659501|NCT02489968|7590322|FG003|NOT COMPLETED|Double-blind Treatment Period||8
6659502|NCT02489968|7590323|FG004|NOT COMPLETED|Double-blind Treatment Period||6
6659503|NCT02489968|7590324|FG005|NOT COMPLETED|Double-blind Treatment Period||8
6659504|NCT02489981|7590336|FG000|STARTED|Overall Study||340
6659505|NCT02489981|7590336|FG000|COMPLETED|Overall Study||213
6659506|NCT02489981|7590336|FG000|NOT COMPLETED|Overall Study||127
6659507|NCT02490293|7590342|FG000|STARTED|Overall Study||96
6659508|NCT02490293|7590343|FG001|STARTED|Overall Study||102
6659509|NCT02490293|7590342|FG000|COMPLETED|Overall Study||94
6659510|NCT02490293|7590343|FG001|COMPLETED|Overall Study||99
6659511|NCT02490293|7590342|FG000|NOT COMPLETED|Overall Study||2
6659512|NCT02490293|7590343|FG001|NOT COMPLETED|Overall Study||3
6659513|NCT02490371|7590351|FG000|STARTED|Overall Study||12
6659514|NCT02490371|7590352|FG001|STARTED|Overall Study||12
6659515|NCT02490371|7590351|FG000|COMPLETED|Overall Study||11
6659516|NCT02490371|7590352|FG001|COMPLETED|Overall Study||11
6659517|NCT02490371|7590351|FG000|NOT COMPLETED|Overall Study||1
6659518|NCT02490371|7590352|FG001|NOT COMPLETED|Overall Study||1
6659519|NCT02490475|7590362|FG000|STARTED|Period 1: First 6 Cycles||6
6659520|NCT02490475|7590363|FG001|STARTED|Period 1: First 6 Cycles||2
6659521|NCT02490475|7590364|FG002|STARTED|Period 1: First 6 Cycles||6
6659522|NCT02490475|7590365|FG003|STARTED|Period 1: First 6 Cycles||5
6659523|NCT02490475|7590362|FG000|COMPLETED|Period 1: First 6 Cycles||0
6659524|NCT02490475|7590363|FG001|COMPLETED|Period 1: First 6 Cycles||0
6659525|NCT02490475|7590364|FG002|COMPLETED|Period 1: First 6 Cycles||0
6659526|NCT02490475|7590365|FG003|COMPLETED|Period 1: First 6 Cycles||0
6659527|NCT02490475|7590362|FG000|NOT COMPLETED|Period 1: First 6 Cycles||6
6659528|NCT02490475|7590363|FG001|NOT COMPLETED|Period 1: First 6 Cycles||2
6659529|NCT02490475|7590364|FG002|NOT COMPLETED|Period 1: First 6 Cycles||6
6659530|NCT02490475|7590365|FG003|NOT COMPLETED|Period 1: First 6 Cycles||5
6659531|NCT02490475|7590362|FG000|STARTED|Period 2: Extension Phase||1
6659532|NCT02490475|7590363|FG001|STARTED|Period 2: Extension Phase||0
6659533|NCT02490475|7590364|FG002|STARTED|Period 2: Extension Phase||3
6659534|NCT02490475|7590365|FG003|STARTED|Period 2: Extension Phase||1
6659535|NCT02490475|7590362|FG000|COMPLETED|Period 2: Extension Phase||0
6659536|NCT02490475|7590363|FG001|COMPLETED|Period 2: Extension Phase||0
6659537|NCT02490475|7590364|FG002|COMPLETED|Period 2: Extension Phase||0
6659538|NCT02490475|7590365|FG003|COMPLETED|Period 2: Extension Phase||0
6659539|NCT02490475|7590362|FG000|NOT COMPLETED|Period 2: Extension Phase||1
6659540|NCT02490475|7590363|FG001|NOT COMPLETED|Period 2: Extension Phase||0
6659541|NCT02490475|7590364|FG002|NOT COMPLETED|Period 2: Extension Phase||3
6659542|NCT02490475|7590365|FG003|NOT COMPLETED|Period 2: Extension Phase||1
6659543|NCT02490631|7590388|FG000|STARTED|Overall Study||79
6659544|NCT02490631|7590389|FG001|STARTED|Overall Study||78
6659545|NCT02490631|7590388|FG000|COMPLETED|Overall Study||76
6659546|NCT02490631|7590389|FG001|COMPLETED|Overall Study||75
6659547|NCT02490631|7590388|FG000|NOT COMPLETED|Overall Study||3
6659548|NCT02490631|7590389|FG001|NOT COMPLETED|Overall Study||3
6659549|NCT02490670|7590397|FG000|STARTED|Period 1 (19 Days)||14
6659550|NCT02490670|7590398|FG001|STARTED|Period 1 (19 Days)||14
6588288|NCT01967277|7512978|FG000|STARTED|Overall Study||22
6588289|NCT01967277|7512979|FG001|STARTED|Overall Study||22
6588290|NCT01967277|7512978|FG000|COMPLETED|Overall Study||21
6588291|NCT01967277|7512979|FG001|COMPLETED|Overall Study||19
6588292|NCT01967277|7512978|FG000|NOT COMPLETED|Overall Study||1
6588293|NCT01967277|7512979|FG001|NOT COMPLETED|Overall Study||3
6588294|NCT01967342|7512988|FG000|STARTED|Overall Study||98
6588295|NCT01967342|7512989|FG001|STARTED|Overall Study||95
6588296|NCT01967342|7512990|FG002|STARTED|Overall Study||97
6588297|NCT01967342|7512988|FG000|5-week Follow-up|Overall Study||83
6588298|NCT01967342|7512989|FG001|5-week Follow-up|Overall Study||78
6588299|NCT01967342|7512990|FG002|5-week Follow-up|Overall Study||76
6588300|NCT01967342|7512988|FG000|10-week Follow-up|Overall Study||78
6588301|NCT01967342|7512989|FG001|10-week Follow-up|Overall Study||83
6588302|NCT01967342|7512990|FG002|10-week Follow-up|Overall Study||80
6588303|NCT01967342|7512988|FG000|COMPLETED|Overall Study||71
6588304|NCT01967342|7512989|FG001|COMPLETED|Overall Study||70
6588305|NCT01967342|7512990|FG002|COMPLETED|Overall Study||68
6588306|NCT01967342|7512988|FG000|NOT COMPLETED|Overall Study||27
6588307|NCT01967342|7512989|FG001|NOT COMPLETED|Overall Study||25
6588308|NCT01967342|7512990|FG002|NOT COMPLETED|Overall Study||29
6588309|NCT01967433|7513000|FG000|STARTED|Overall Study||61
6588310|NCT01967433|7513001|FG001|STARTED|Overall Study||59
6588311|NCT01967433|7513000|FG000|COMPLETED|Overall Study||61
6588312|NCT01967433|7513001|FG001|COMPLETED|Overall Study||58
6588313|NCT01967433|7513000|FG000|NOT COMPLETED|Overall Study||0
6588314|NCT01967433|7513001|FG001|NOT COMPLETED|Overall Study||1
6588315|NCT01967537|7513013|FG000|STARTED|Overall Study||341
6588316|NCT01967537|7513013|FG000|COMPLETED|Overall Study||281
6588317|NCT01967537|7513013|FG000|NOT COMPLETED|Overall Study||60
6588318|NCT01967550|7513019|FG000|STARTED|Overall Study||153
6588319|NCT01967550|7513020|FG001|STARTED|Overall Study||151
6588320|NCT01967550|7513019|FG000|COMPLETED|Overall Study||148
6588321|NCT01967550|7513020|FG001|COMPLETED|Overall Study||149
6588322|NCT01967550|7513019|FG000|NOT COMPLETED|Overall Study||5
6588323|NCT01967550|7513020|FG001|NOT COMPLETED|Overall Study||2
6588324|NCT01967576|7513026|FG000|STARTED|Overall Study||14
6588325|NCT01967576|7513026|FG000|COMPLETED|Overall Study||7
6588326|NCT01967576|7513026|FG000|NOT COMPLETED|Overall Study||7
6588327|NCT01967628|7513032|FG000|STARTED|Overall Study||48
6588328|NCT01967628|7513033|FG001|STARTED|Overall Study||50
6588329|NCT01967628|7513032|FG000|COMPLETED|Overall Study||21
6588330|NCT01967628|7513033|FG001|COMPLETED|Overall Study||19
6588331|NCT01967628|7513032|FG000|NOT COMPLETED|Overall Study||27
6588332|NCT01967628|7513033|FG001|NOT COMPLETED|Overall Study||31
6588333|NCT01967641|7513039|FG000|STARTED|Randomized||51
6588334|NCT01967641|7513039|FG000|COMPLETED|Randomized|Completed week 12|43
6588335|NCT01967641|7513039|FG000|NOT COMPLETED|Randomized||8
6588336|NCT01967641|7513039|FG000|STARTED|Admission to Inpatient Phase||43
6588337|NCT01967641|7513039|FG000|COMPLETED|Admission to Inpatient Phase|Completed 7 week inpatient phase|31
6588338|NCT01967641|7513039|FG000|NOT COMPLETED|Admission to Inpatient Phase||12
6588339|NCT01967641|7513039|FG000|STARTED|12-week Outpatient Phase||31
6588340|NCT01967641|7513039|FG000|COMPLETED|12-week Outpatient Phase|Completed week 12 of outpatient phase|18
6588341|NCT01967641|7513039|FG000|NOT COMPLETED|12-week Outpatient Phase||13
6588342|NCT01967706|7513046|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
6588343|NCT01967706|7513047|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
6588344|NCT01967706|7513048|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
6588345|NCT01967706|7513049|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
6588346|NCT01967706|7513046|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
6588347|NCT01967706|7513047|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
6588348|NCT01967706|7513048|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
6588349|NCT01967706|7513049|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
6659551|NCT02490670|7590397|FG000|COMPLETED|Period 1 (19 Days)||14
6588350|NCT01967706|7513046|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588351|NCT01967706|7513047|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588352|NCT01967706|7513048|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588353|NCT01967706|7513049|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588354|NCT01967706|7513046|FG000|STARTED|First Intervention (Day 1)||22
6588355|NCT01967706|7513047|FG001|STARTED|First Intervention (Day 1)||22
6588356|NCT01967706|7513048|FG002|STARTED|First Intervention (Day 1)||9
6588357|NCT01967706|7513049|FG003|STARTED|First Intervention (Day 1)||9
6588358|NCT01967706|7513046|FG000|COMPLETED|First Intervention (Day 1)||21
6588359|NCT01967706|7513047|FG001|COMPLETED|First Intervention (Day 1)||22
6588360|NCT01967706|7513048|FG002|COMPLETED|First Intervention (Day 1)||9
6588361|NCT01967706|7513049|FG003|COMPLETED|First Intervention (Day 1)||9
6588362|NCT01967706|7513046|FG000|NOT COMPLETED|First Intervention (Day 1)||1
6588363|NCT01967706|7513047|FG001|NOT COMPLETED|First Intervention (Day 1)||0
6588364|NCT01967706|7513048|FG002|NOT COMPLETED|First Intervention (Day 1)||0
6588365|NCT01967706|7513049|FG003|NOT COMPLETED|First Intervention (Day 1)||0
6588366|NCT01967706|7513046|FG000|STARTED|Washout Period of 1 Day (Day 2)||21
6588367|NCT01967706|7513047|FG001|STARTED|Washout Period of 1 Day (Day 2)||22
6588368|NCT01967706|7513048|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
6588369|NCT01967706|7513049|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
6588370|NCT01967706|7513046|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||21
6588371|NCT01967706|7513047|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||22
6588372|NCT01967706|7513048|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
6588373|NCT01967706|7513049|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
6588374|NCT01967706|7513046|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588375|NCT01967706|7513047|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588376|NCT01967706|7513048|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588377|NCT01967706|7513049|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588378|NCT01967706|7513046|FG000|STARTED|Second Intervention (Day 3)||21
6588379|NCT01967706|7513047|FG001|STARTED|Second Intervention (Day 3)||22
6588380|NCT01967706|7513048|FG002|STARTED|Second Intervention (Day 3)||9
6588381|NCT01967706|7513049|FG003|STARTED|Second Intervention (Day 3)||9
6588382|NCT01967706|7513046|FG000|COMPLETED|Second Intervention (Day 3)||21
6588383|NCT01967706|7513047|FG001|COMPLETED|Second Intervention (Day 3)||22
6588384|NCT01967706|7513048|FG002|COMPLETED|Second Intervention (Day 3)||9
6588385|NCT01967706|7513049|FG003|COMPLETED|Second Intervention (Day 3)||9
6588386|NCT01967706|7513046|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
6588387|NCT01967706|7513047|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
6588388|NCT01967706|7513048|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
6588389|NCT01967706|7513049|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
6588390|NCT01967719|7513060|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
6588391|NCT01967719|7513061|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
6588392|NCT01967719|7513062|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
6588393|NCT01967719|7513063|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
6588394|NCT01967719|7513060|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
6588395|NCT01967719|7513061|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||22
6588396|NCT01967719|7513062|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
6588397|NCT01967719|7513063|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
6588398|NCT01967719|7513060|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588399|NCT01967719|7513061|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588400|NCT01967719|7513062|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588401|NCT01967719|7513063|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588402|NCT01967719|7513060|FG000|STARTED|First Intervention (Day 1)||22
6588403|NCT01967719|7513061|FG001|STARTED|First Intervention (Day 1)||22
6588404|NCT01967719|7513062|FG002|STARTED|First Intervention (Day 1)||9
6588405|NCT01967719|7513063|FG003|STARTED|First Intervention (Day 1)||9
6588406|NCT01967719|7513060|FG000|COMPLETED|First Intervention (Day 1)||22
6588407|NCT01967719|7513061|FG001|COMPLETED|First Intervention (Day 1)||21
6588408|NCT01967719|7513062|FG002|COMPLETED|First Intervention (Day 1)||9
6588409|NCT01967719|7513063|FG003|COMPLETED|First Intervention (Day 1)||8
6588410|NCT01967719|7513060|FG000|NOT COMPLETED|First Intervention (Day 1)||0
6588411|NCT01967719|7513061|FG001|NOT COMPLETED|First Intervention (Day 1)||1
6588412|NCT01967719|7513062|FG002|NOT COMPLETED|First Intervention (Day 1)||0
6588413|NCT01967719|7513063|FG003|NOT COMPLETED|First Intervention (Day 1)||1
6588414|NCT01967719|7513060|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
6588415|NCT01967719|7513061|FG001|STARTED|Washout Period of 1 Day (Day 2)||21
6588416|NCT01967719|7513062|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
6588417|NCT01967719|7513063|FG003|STARTED|Washout Period of 1 Day (Day 2)||8
6659552|NCT02490670|7590398|FG001|COMPLETED|Period 1 (19 Days)||14
6659553|NCT02490670|7590397|FG000|NOT COMPLETED|Period 1 (19 Days)||0
6659554|NCT02490670|7590398|FG001|NOT COMPLETED|Period 1 (19 Days)||0
6659555|NCT02490670|7590397|FG000|STARTED|Washout Period (7 Days)||14
6659556|NCT02490670|7590398|FG001|STARTED|Washout Period (7 Days)||14
6659557|NCT02490670|7590397|FG000|COMPLETED|Washout Period (7 Days)||14
6659558|NCT02490670|7590398|FG001|COMPLETED|Washout Period (7 Days)||14
6659559|NCT02490670|7590397|FG000|NOT COMPLETED|Washout Period (7 Days)||0
6659560|NCT02490670|7590398|FG001|NOT COMPLETED|Washout Period (7 Days)||0
6659561|NCT02490670|7590397|FG000|STARTED|Period 2 (19 Days)||14
6659562|NCT02490670|7590398|FG001|STARTED|Period 2 (19 Days)||14
6659563|NCT02490670|7590397|FG000|COMPLETED|Period 2 (19 Days)||14
6659564|NCT02490670|7590398|FG001|COMPLETED|Period 2 (19 Days)||14
6659565|NCT02490670|7590397|FG000|NOT COMPLETED|Period 2 (19 Days)||0
6659566|NCT02490670|7590398|FG001|NOT COMPLETED|Period 2 (19 Days)||0
6659567|NCT02490878|7590406|FG000|STARTED|Overall Study||10
6659568|NCT02490878|7590407|FG001|STARTED|Overall Study||9
6659569|NCT02490878|7590406|FG000|Eligible Participants|Overall Study||10
6659570|NCT02490878|7590407|FG001|Eligible Participants|Overall Study||8
6659571|NCT02490878|7590406|FG000|COMPLETED|Overall Study||10
6659572|NCT02490878|7590407|FG001|COMPLETED|Overall Study||6
6659573|NCT02490878|7590406|FG000|NOT COMPLETED|Overall Study||0
6659574|NCT02490878|7590407|FG001|NOT COMPLETED|Overall Study||3
6588418|NCT01967719|7513060|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
6588419|NCT01967719|7513061|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||21
6588420|NCT01967719|7513062|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
6588421|NCT01967719|7513063|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||8
6588422|NCT01967719|7513060|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588423|NCT01967719|7513061|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588424|NCT01967719|7513062|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588425|NCT01967719|7513063|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588426|NCT01967719|7513060|FG000|STARTED|Second Intervention (Day 3)||22
6588427|NCT01967719|7513061|FG001|STARTED|Second Intervention (Day 3)||21
6588428|NCT01967719|7513062|FG002|STARTED|Second Intervention (Day 3)||9
6588429|NCT01967719|7513063|FG003|STARTED|Second Intervention (Day 3)||8
6588430|NCT01967719|7513060|FG000|COMPLETED|Second Intervention (Day 3)||22
6659575|NCT02491073|7590415|FG000|STARTED|Overall Study||37
6659576|NCT02491073|7590416|FG001|STARTED|Overall Study||34
6588431|NCT01967719|7513061|FG001|COMPLETED|Second Intervention (Day 3)||20
6588432|NCT01967719|7513062|FG002|COMPLETED|Second Intervention (Day 3)||9
6588433|NCT01967719|7513063|FG003|COMPLETED|Second Intervention (Day 3)||8
6588434|NCT01967719|7513060|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
6588435|NCT01967719|7513061|FG001|NOT COMPLETED|Second Intervention (Day 3)||1
6588436|NCT01967719|7513062|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
6588437|NCT01967719|7513063|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
6588438|NCT01967732|7513075|FG000|STARTED|Washout Period of 1 Day (Day 0)||22
6588439|NCT01967732|7513076|FG001|STARTED|Washout Period of 1 Day (Day 0)||22
6588440|NCT01967732|7513077|FG002|STARTED|Washout Period of 1 Day (Day 0)||9
6588441|NCT01967732|7513078|FG003|STARTED|Washout Period of 1 Day (Day 0)||9
6588442|NCT01967732|7513075|FG000|COMPLETED|Washout Period of 1 Day (Day 0)||22
6588443|NCT01967732|7513076|FG001|COMPLETED|Washout Period of 1 Day (Day 0)||21
6588444|NCT01967732|7513077|FG002|COMPLETED|Washout Period of 1 Day (Day 0)||9
6588445|NCT01967732|7513078|FG003|COMPLETED|Washout Period of 1 Day (Day 0)||9
6588446|NCT01967732|7513075|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588447|NCT01967732|7513076|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
6588448|NCT01967732|7513077|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588449|NCT01967732|7513078|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
6588450|NCT01967732|7513075|FG000|STARTED|First Intervention (Day 1)||22
6588451|NCT01967732|7513076|FG001|STARTED|First Intervention (Day 1)||21
6588452|NCT01967732|7513077|FG002|STARTED|First Intervention (Day 1)||9
6588453|NCT01967732|7513078|FG003|STARTED|First Intervention (Day 1)||9
6588454|NCT01967732|7513075|FG000|COMPLETED|First Intervention (Day 1)||22
6588455|NCT01967732|7513076|FG001|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
6588456|NCT01967732|7513077|FG002|COMPLETED|First Intervention (Day 1)||9
6588457|NCT01967732|7513078|FG003|COMPLETED|First Intervention (Day 1)||9
6588458|NCT01967732|7513075|FG000|NOT COMPLETED|First Intervention (Day 1)||0
6588459|NCT01967732|7513076|FG001|NOT COMPLETED|First Intervention (Day 1)||1
6588460|NCT01967732|7513077|FG002|NOT COMPLETED|First Intervention (Day 1)||0
6588461|NCT01967732|7513078|FG003|NOT COMPLETED|First Intervention (Day 1)||0
6588462|NCT01967732|7513075|FG000|STARTED|Washout Period of 1 Day (Day 2)||22
6588463|NCT01967732|7513076|FG001|STARTED|Washout Period of 1 Day (Day 2)||20
6588464|NCT01967732|7513077|FG002|STARTED|Washout Period of 1 Day (Day 2)||9
6588465|NCT01967732|7513078|FG003|STARTED|Washout Period of 1 Day (Day 2)||9
6588466|NCT01967732|7513075|FG000|COMPLETED|Washout Period of 1 Day (Day 2)||22
6588467|NCT01967732|7513076|FG001|COMPLETED|Washout Period of 1 Day (Day 2)||20
6588468|NCT01967732|7513077|FG002|COMPLETED|Washout Period of 1 Day (Day 2)||9
6588469|NCT01967732|7513078|FG003|COMPLETED|Washout Period of 1 Day (Day 2)||9
6588470|NCT01967732|7513075|FG000|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588471|NCT01967732|7513076|FG001|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588472|NCT01967732|7513077|FG002|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588473|NCT01967732|7513078|FG003|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
6588474|NCT01967732|7513075|FG000|STARTED|Second Intervention (Day 3)||22
6588475|NCT01967732|7513076|FG001|STARTED|Second Intervention (Day 3)||20
6588476|NCT01967732|7513077|FG002|STARTED|Second Intervention (Day 3)||9
6588477|NCT01967732|7513078|FG003|STARTED|Second Intervention (Day 3)||9
6588478|NCT01967732|7513075|FG000|COMPLETED|Second Intervention (Day 3)||22
6588479|NCT01967732|7513076|FG001|COMPLETED|Second Intervention (Day 3)||20
6588480|NCT01967732|7513077|FG002|COMPLETED|Second Intervention (Day 3)||9
6588481|NCT01967732|7513078|FG003|COMPLETED|Second Intervention (Day 3)||9
6659577|NCT02491073|7590415|FG000|COMPLETED|Overall Study||36
6659578|NCT02491073|7590416|FG001|COMPLETED|Overall Study||34
6659579|NCT02491073|7590415|FG000|NOT COMPLETED|Overall Study||1
6659580|NCT02491073|7590416|FG001|NOT COMPLETED|Overall Study||0
6659581|NCT02491359|7590438|FG000|STARTED|Overall Study||20
6659582|NCT02491359|7590438|FG000|COMPLETED|Overall Study||4
6659583|NCT02491359|7590438|FG000|NOT COMPLETED|Overall Study||16
6659584|NCT02491437|7590446|FG000|STARTED|Overall Study||520
6659585|NCT02491437|7590447|FG001|STARTED|Overall Study||514
6659586|NCT02491437|7590446|FG000|Safety Sample|Overall Study||518
6659587|NCT02491437|7590447|FG001|Safety Sample|Overall Study||512
6659588|NCT02491437|7590446|FG000|Full Analysis Sample|Overall Study||494
6659589|NCT02491437|7590447|FG001|Full Analysis Sample|Overall Study||489
6659590|NCT02491437|7590446|FG000|COMPLETED|Overall Study||168
6659591|NCT02491437|7590447|FG001|COMPLETED|Overall Study||157
6659592|NCT02491437|7590446|FG000|NOT COMPLETED|Overall Study||352
6659593|NCT02491437|7590447|FG001|NOT COMPLETED|Overall Study||357
6659594|NCT02491463|7590459|FG000|STARTED|Overall Study||7
6659595|NCT02491463|7590460|FG001|STARTED|Overall Study||31
6659596|NCT02491463|7590461|FG002|STARTED|Overall Study||19
6659597|NCT02491463|7590462|FG003|STARTED|Overall Study||15
6659598|NCT02491463|7590459|FG000|COMPLETED|Overall Study||5
6659599|NCT02491463|7590460|FG001|COMPLETED|Overall Study||21
6659600|NCT02491463|7590461|FG002|COMPLETED|Overall Study||15
6659601|NCT02491463|7590462|FG003|COMPLETED|Overall Study||14
6659602|NCT02491463|7590459|FG000|NOT COMPLETED|Overall Study||2
6659603|NCT02491463|7590460|FG001|NOT COMPLETED|Overall Study||10
6588482|NCT01967732|7513075|FG000|NOT COMPLETED|Second Intervention (Day 3)||0
6588483|NCT01967732|7513076|FG001|NOT COMPLETED|Second Intervention (Day 3)||0
6588484|NCT01967732|7513077|FG002|NOT COMPLETED|Second Intervention (Day 3)||0
6588485|NCT01967732|7513078|FG003|NOT COMPLETED|Second Intervention (Day 3)||0
6588486|NCT01967784|7513086|FG000|STARTED|Overall Study||100
6588487|NCT01967784|7513086|FG000|COMPLETED|Overall Study||100
6588488|NCT01967784|7513086|FG000|NOT COMPLETED|Overall Study||0
6588489|NCT01967836|7513090|FG000|STARTED|Overall Study||20
6588490|NCT01967836|7513090|FG000|COMPLETED|Overall Study||11
6588491|NCT01967836|7513090|FG000|NOT COMPLETED|Overall Study||9
6588492|NCT01967862|7513095|FG000|STARTED|Overall Study||54
6588493|NCT01967862|7513095|FG000|COMPLETED|Overall Study||54
6588494|NCT01967862|7513095|FG000|NOT COMPLETED|Overall Study||0
6588495|NCT01967888|7513101|FG000|STARTED|Overall Study||52
6588496|NCT01967888|7513102|FG001|STARTED|Overall Study||52
6588497|NCT01967888|7513101|FG000|COMPLETED|Overall Study||42
6588498|NCT01967888|7513102|FG001|COMPLETED|Overall Study||45
6588499|NCT01967888|7513101|FG000|NOT COMPLETED|Overall Study||10
6588500|NCT01967888|7513102|FG001|NOT COMPLETED|Overall Study||7
6588501|NCT01967940|7513111|FG000|STARTED|Part 1||12
6588502|NCT01967940|7513112|FG001|STARTED|Part 1||28
6588503|NCT01967940|7513113|FG002|STARTED|Part 1||15
6588504|NCT01967940|7513114|FG003|STARTED|Part 1||0
6588505|NCT01967940|7513111|FG000|COMPLETED|Part 1||12
6588506|NCT01967940|7513112|FG001|COMPLETED|Part 1||28
6588507|NCT01967940|7513113|FG002|COMPLETED|Part 1||15
6588508|NCT01967940|7513114|FG003|COMPLETED|Part 1||0
6588509|NCT01967940|7513111|FG000|NOT COMPLETED|Part 1||0
6588510|NCT01967940|7513112|FG001|NOT COMPLETED|Part 1||0
6588511|NCT01967940|7513113|FG002|NOT COMPLETED|Part 1||0
6588512|NCT01967940|7513114|FG003|NOT COMPLETED|Part 1||0
6588513|NCT01967940|7513111|FG000|STARTED|Part 2|4 participants completed Part 1 and did not enter Part 2; 8 participants moved to the Part 2 group|0
6588514|NCT01967940|7513112|FG001|STARTED|Part 2|12 participants completed Part 1 and did not enter Part 2; 16 participants moved to the Part 2 group|0
6588515|NCT01967940|7513113|FG002|STARTED|Part 2|1 participant completed Part 1 and did not enter Part 2; 14 participants moved to the Part 2 group|0
6588516|NCT01967940|7513114|FG003|STARTED|Part 2|38 participants from the Part 1 groups moved to this Part 2 E/C/F/TAF + ATV group|38
6588517|NCT01967940|7513111|FG000|COMPLETED|Part 2||0
6588518|NCT01967940|7513112|FG001|COMPLETED|Part 2||0
6588519|NCT01967940|7513113|FG002|COMPLETED|Part 2||0
6588520|NCT01967940|7513114|FG003|COMPLETED|Part 2||35
6588521|NCT01967940|7513111|FG000|NOT COMPLETED|Part 2||0
6588522|NCT01967940|7513112|FG001|NOT COMPLETED|Part 2||0
6588523|NCT01967940|7513113|FG002|NOT COMPLETED|Part 2||0
6588524|NCT01967940|7513114|FG003|NOT COMPLETED|Part 2||3
6588525|NCT01968031|7513127|FG000|STARTED|Overall Study||204
6588526|NCT01968031|7513128|FG001|STARTED|Overall Study||202
6588527|NCT01968031|7513129|FG002|STARTED|Overall Study||207
6588528|NCT01968031|7513127|FG000|Completed Week 2|Overall Study||197
6588529|NCT01968031|7513128|FG001|Completed Week 2|Overall Study||190
6588530|NCT01968031|7513129|FG002|Completed Week 2|Overall Study||199
6588531|NCT01968031|7513127|FG000|Completed Week 6|Overall Study||191
6588532|NCT01968031|7513128|FG001|Completed Week 6|Overall Study||183
6588533|NCT01968031|7513129|FG002|Completed Week 6|Overall Study||187
6588534|NCT01968031|7513127|FG000|Completed Week 10|Overall Study||187
6588535|NCT01968031|7513128|FG001|Completed Week 10|Overall Study||181
6588536|NCT01968031|7513129|FG002|Completed Week 10|Overall Study||181
6588537|NCT01968031|7513127|FG000|COMPLETED|Overall Study||186
6588538|NCT01968031|7513128|FG001|COMPLETED|Overall Study||182
6588539|NCT01968031|7513129|FG002|COMPLETED|Overall Study||178
6588540|NCT01968031|7513127|FG000|NOT COMPLETED|Overall Study||18
6588541|NCT01968031|7513128|FG001|NOT COMPLETED|Overall Study||20
6588542|NCT01968031|7513129|FG002|NOT COMPLETED|Overall Study||29
6588543|NCT01968057|7513137|FG000|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
6588544|NCT01968057|7513137|FG000|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
6588545|NCT01968057|7513137|FG000|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
6588546|NCT01968057|7513137|FG000|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
6588547|NCT01968057|7513137|FG000|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
6588548|NCT01968057|7513137|FG000|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
6588549|NCT01968057|7513137|FG000|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
6588550|NCT01968057|7513137|FG000|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
6588551|NCT01968070|7513161|FG000|STARTED|Period 1||4
6588552|NCT01968070|7513162|FG001|STARTED|Period 1||4
6588553|NCT01968070|7513163|FG002|STARTED|Period 1||4
6588554|NCT01968070|7513164|FG003|STARTED|Period 1||4
6588555|NCT01968070|7513165|FG004|STARTED|Period 1||4
6588556|NCT01968070|7513166|FG005|STARTED|Period 1||4
6588557|NCT01968070|7513167|FG006|STARTED|Period 1||10
6588558|NCT01968070|7513168|FG007|STARTED|Period 1||2
6588559|NCT01968070|7513169|FG008|STARTED|Period 1||2
6588560|NCT01968070|7513170|FG009|STARTED|Period 1||9
6588561|NCT01968070|7513171|FG010|STARTED|Period 1||2
6588562|NCT01968070|7513172|FG011|STARTED|Period 1||2
6588563|NCT01968070|7513173|FG012|STARTED|Period 1||9
6588564|NCT01968070|7513174|FG013|STARTED|Period 1||2
6588565|NCT01968070|7513175|FG014|STARTED|Period 1||2
6588566|NCT01968070|7513176|FG015|STARTED|Period 1||9
6588567|NCT01968070|7513177|FG016|STARTED|Period 1||2
6588568|NCT01968070|7513178|FG017|STARTED|Period 1||2
6588569|NCT01968070|7513161|FG000|COMPLETED|Period 1||4
6588570|NCT01968070|7513162|FG001|COMPLETED|Period 1||3
6588571|NCT01968070|7513163|FG002|COMPLETED|Period 1||4
6588572|NCT01968070|7513164|FG003|COMPLETED|Period 1||2
6588573|NCT01968070|7513165|FG004|COMPLETED|Period 1||3
6588574|NCT01968070|7513166|FG005|COMPLETED|Period 1||4
6588575|NCT01968070|7513167|FG006|COMPLETED|Period 1||8
6588576|NCT01968070|7513168|FG007|COMPLETED|Period 1||2
6588577|NCT01968070|7513169|FG008|COMPLETED|Period 1||2
6588578|NCT01968070|7513170|FG009|COMPLETED|Period 1||9
6588579|NCT01968070|7513171|FG010|COMPLETED|Period 1||2
6588580|NCT01968070|7513172|FG011|COMPLETED|Period 1||1
6588581|NCT01968070|7513173|FG012|COMPLETED|Period 1||9
6588582|NCT01968070|7513174|FG013|COMPLETED|Period 1||2
6588583|NCT01968070|7513175|FG014|COMPLETED|Period 1||2
6588584|NCT01968070|7513176|FG015|COMPLETED|Period 1||8
6588585|NCT01968070|7513177|FG016|COMPLETED|Period 1||2
6588586|NCT01968070|7513178|FG017|COMPLETED|Period 1||2
6588587|NCT01968070|7513161|FG000|NOT COMPLETED|Period 1||0
6588588|NCT01968070|7513162|FG001|NOT COMPLETED|Period 1||1
6588589|NCT01968070|7513163|FG002|NOT COMPLETED|Period 1||0
6588590|NCT01968070|7513164|FG003|NOT COMPLETED|Period 1||2
6588591|NCT01968070|7513165|FG004|NOT COMPLETED|Period 1||1
6588592|NCT01968070|7513166|FG005|NOT COMPLETED|Period 1||0
6588593|NCT01968070|7513167|FG006|NOT COMPLETED|Period 1||2
6588594|NCT01968070|7513168|FG007|NOT COMPLETED|Period 1||0
6588595|NCT01968070|7513169|FG008|NOT COMPLETED|Period 1||0
6588596|NCT01968070|7513170|FG009|NOT COMPLETED|Period 1||0
6588597|NCT01968070|7513171|FG010|NOT COMPLETED|Period 1||0
6588598|NCT01968070|7513172|FG011|NOT COMPLETED|Period 1||1
6588599|NCT01968070|7513173|FG012|NOT COMPLETED|Period 1||0
6588600|NCT01968070|7513174|FG013|NOT COMPLETED|Period 1||0
6588601|NCT01968070|7513175|FG014|NOT COMPLETED|Period 1||0
6588602|NCT01968070|7513176|FG015|NOT COMPLETED|Period 1||1
6588603|NCT01968070|7513177|FG016|NOT COMPLETED|Period 1||0
6588604|NCT01968070|7513178|FG017|NOT COMPLETED|Period 1||0
6588605|NCT01968070|7513161|FG000|STARTED|Period 2||4
6588606|NCT01968070|7513162|FG001|STARTED|Period 2|1 participant was added to replace the participant who discontinued the period 1.|4
6588607|NCT01968070|7513163|FG002|STARTED|Period 2||4
6588608|NCT01968070|7513164|FG003|STARTED|Period 2|2 participants were added to replace the 2 participants who discontinued the period 1.|4
6588609|NCT01968070|7513165|FG004|STARTED|Period 2||3
6588610|NCT01968070|7513166|FG005|STARTED|Period 2||4
6588611|NCT01968070|7513167|FG006|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588612|NCT01968070|7513168|FG007|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588613|NCT01968070|7513169|FG008|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588614|NCT01968070|7513170|FG009|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588615|NCT01968070|7513171|FG010|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588616|NCT01968070|7513172|FG011|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588617|NCT01968070|7513173|FG012|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588618|NCT01968070|7513174|FG013|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588619|NCT01968070|7513175|FG014|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588620|NCT01968070|7513176|FG015|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588621|NCT01968070|7513177|FG016|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588622|NCT01968070|7513178|FG017|STARTED|Period 2|Part 2 (Cohorts 3 to 6) was planned only for one period.|0
6588623|NCT01968070|7513161|FG000|COMPLETED|Period 2||4
6588624|NCT01968070|7513162|FG001|COMPLETED|Period 2||4
6588625|NCT01968070|7513163|FG002|COMPLETED|Period 2||4
6588626|NCT01968070|7513164|FG003|COMPLETED|Period 2||4
6588627|NCT01968070|7513165|FG004|COMPLETED|Period 2||2
6588628|NCT01968070|7513166|FG005|COMPLETED|Period 2||4
6588629|NCT01968070|7513167|FG006|COMPLETED|Period 2||0
6588630|NCT01968070|7513168|FG007|COMPLETED|Period 2||0
6588631|NCT01968070|7513169|FG008|COMPLETED|Period 2||0
6588632|NCT01968070|7513170|FG009|COMPLETED|Period 2||0
6588633|NCT01968070|7513171|FG010|COMPLETED|Period 2||0
6588634|NCT01968070|7513172|FG011|COMPLETED|Period 2||0
6588635|NCT01968070|7513173|FG012|COMPLETED|Period 2||0
6588636|NCT01968070|7513174|FG013|COMPLETED|Period 2||0
6588637|NCT01968070|7513175|FG014|COMPLETED|Period 2||0
6588638|NCT01968070|7513176|FG015|COMPLETED|Period 2||0
6588639|NCT01968070|7513177|FG016|COMPLETED|Period 2||0
6588640|NCT01968070|7513178|FG017|COMPLETED|Period 2||0
6588641|NCT01968070|7513161|FG000|NOT COMPLETED|Period 2||0
6588642|NCT01968070|7513162|FG001|NOT COMPLETED|Period 2||0
6588643|NCT01968070|7513163|FG002|NOT COMPLETED|Period 2||0
6588644|NCT01968070|7513164|FG003|NOT COMPLETED|Period 2||0
6588645|NCT01968070|7513165|FG004|NOT COMPLETED|Period 2||1
6588646|NCT01968070|7513166|FG005|NOT COMPLETED|Period 2||0
6588647|NCT01968070|7513167|FG006|NOT COMPLETED|Period 2||0
6588648|NCT01968070|7513168|FG007|NOT COMPLETED|Period 2||0
6588649|NCT01968070|7513169|FG008|NOT COMPLETED|Period 2||0
6588650|NCT01968070|7513170|FG009|NOT COMPLETED|Period 2||0
6588651|NCT01968070|7513171|FG010|NOT COMPLETED|Period 2||0
6588652|NCT01968070|7513172|FG011|NOT COMPLETED|Period 2||0
6588653|NCT01968070|7513173|FG012|NOT COMPLETED|Period 2||0
6588654|NCT01968070|7513174|FG013|NOT COMPLETED|Period 2||0
6588655|NCT01968070|7513175|FG014|NOT COMPLETED|Period 2||0
6588656|NCT01968070|7513176|FG015|NOT COMPLETED|Period 2||0
6588657|NCT01968070|7513177|FG016|NOT COMPLETED|Period 2||0
6588658|NCT01968070|7513178|FG017|NOT COMPLETED|Period 2||0
6588659|NCT01968070|7513161|FG000|STARTED|Period 3||4
6588660|NCT01968070|7513162|FG001|STARTED|Period 3||4
6588661|NCT01968070|7513163|FG002|STARTED|Period 3||4
6588662|NCT01968070|7513164|FG003|STARTED|Period 3||4
6588663|NCT01968070|7513165|FG004|STARTED|Period 3||3
6588664|NCT01968070|7513166|FG005|STARTED|Period 3||4
6588665|NCT01968070|7513167|FG006|STARTED|Period 3||0
6588666|NCT01968070|7513168|FG007|STARTED|Period 3||0
6588667|NCT01968070|7513169|FG008|STARTED|Period 3||0
6588668|NCT01968070|7513170|FG009|STARTED|Period 3||0
6588669|NCT01968070|7513171|FG010|STARTED|Period 3||0
6588670|NCT01968070|7513172|FG011|STARTED|Period 3||0
6588671|NCT01968070|7513173|FG012|STARTED|Period 3||0
6588672|NCT01968070|7513174|FG013|STARTED|Period 3||0
6588673|NCT01968070|7513175|FG014|STARTED|Period 3||0
6588674|NCT01968070|7513176|FG015|STARTED|Period 3||0
6588675|NCT01968070|7513177|FG016|STARTED|Period 3||0
6588676|NCT01968070|7513178|FG017|STARTED|Period 3||0
6588677|NCT01968070|7513161|FG000|COMPLETED|Period 3||4
6588678|NCT01968070|7513162|FG001|COMPLETED|Period 3||4
6588679|NCT01968070|7513163|FG002|COMPLETED|Period 3||4
6588680|NCT01968070|7513164|FG003|COMPLETED|Period 3||4
6588681|NCT01968070|7513165|FG004|COMPLETED|Period 3||3
6588682|NCT01968070|7513166|FG005|COMPLETED|Period 3||4
6588683|NCT01968070|7513167|FG006|COMPLETED|Period 3||0
6588684|NCT01968070|7513168|FG007|COMPLETED|Period 3||0
6588685|NCT01968070|7513169|FG008|COMPLETED|Period 3||0
6588686|NCT01968070|7513170|FG009|COMPLETED|Period 3||0
6588687|NCT01968070|7513171|FG010|COMPLETED|Period 3||0
6588688|NCT01968070|7513172|FG011|COMPLETED|Period 3||0
6588689|NCT01968070|7513173|FG012|COMPLETED|Period 3||0
6588690|NCT01968070|7513174|FG013|COMPLETED|Period 3||0
6588691|NCT01968070|7513175|FG014|COMPLETED|Period 3||0
6588692|NCT01968070|7513176|FG015|COMPLETED|Period 3||0
6588693|NCT01968070|7513177|FG016|COMPLETED|Period 3||0
6588694|NCT01968070|7513178|FG017|COMPLETED|Period 3||0
6588695|NCT01968070|7513161|FG000|NOT COMPLETED|Period 3||0
6588696|NCT01968070|7513162|FG001|NOT COMPLETED|Period 3||0
6588697|NCT01968070|7513163|FG002|NOT COMPLETED|Period 3||0
6588698|NCT01968070|7513164|FG003|NOT COMPLETED|Period 3||0
6588699|NCT01968070|7513165|FG004|NOT COMPLETED|Period 3||0
6588700|NCT01968070|7513166|FG005|NOT COMPLETED|Period 3||0
6588701|NCT01968070|7513167|FG006|NOT COMPLETED|Period 3||0
6588702|NCT01968070|7513168|FG007|NOT COMPLETED|Period 3||0
6588703|NCT01968070|7513169|FG008|NOT COMPLETED|Period 3||0
6588704|NCT01968070|7513170|FG009|NOT COMPLETED|Period 3||0
6588705|NCT01968070|7513171|FG010|NOT COMPLETED|Period 3||0
6588706|NCT01968070|7513172|FG011|NOT COMPLETED|Period 3||0
6588707|NCT01968070|7513173|FG012|NOT COMPLETED|Period 3||0
6588708|NCT01968070|7513174|FG013|NOT COMPLETED|Period 3||0
6588709|NCT01968070|7513175|FG014|NOT COMPLETED|Period 3||0
6588710|NCT01968070|7513176|FG015|NOT COMPLETED|Period 3||0
6588711|NCT01968070|7513177|FG016|NOT COMPLETED|Period 3||0
6588712|NCT01968070|7513178|FG017|NOT COMPLETED|Period 3||0
6588713|NCT01968135|7513218|FG000|STARTED|Overall Study||16
6588714|NCT01968135|7513219|FG001|STARTED|Overall Study||16
6588715|NCT01968135|7513218|FG000|COMPLETED|Overall Study||16
6588716|NCT01968135|7513219|FG001|COMPLETED|Overall Study||16
6588717|NCT01968135|7513218|FG000|NOT COMPLETED|Overall Study||0
6588718|NCT01968135|7513219|FG001|NOT COMPLETED|Overall Study||0
6588719|NCT01968213|7513227|FG000|STARTED|Overall Study||375
6588720|NCT01968213|7513228|FG001|STARTED|Overall Study||189
6588721|NCT01968213|7513227|FG000|COMPLETED|Overall Study||285
6588722|NCT01968213|7513228|FG001|COMPLETED|Overall Study||180
6588723|NCT01968213|7513227|FG000|NOT COMPLETED|Overall Study||90
6588724|NCT01968213|7513228|FG001|NOT COMPLETED|Overall Study||9
6588725|NCT01968317|7513236|FG000|STARTED|Overall Study||76
6588726|NCT01968317|7513237|FG001|STARTED|Overall Study||74
6588727|NCT01968317|7513236|FG000|COMPLETED|Overall Study||76
6588728|NCT01968317|7513237|FG001|COMPLETED|Overall Study||74
6588729|NCT01968317|7513236|FG000|NOT COMPLETED|Overall Study||0
6588730|NCT01968317|7513237|FG001|NOT COMPLETED|Overall Study||0
6588731|NCT01968356|7513251|FG000|STARTED|Overall Study||101
6588732|NCT01968356|7513252|FG001|STARTED|Overall Study||93
6588733|NCT01968356|7513253|FG002|STARTED|Overall Study||96
6588734|NCT01968356|7513254|FG003|STARTED|Overall Study||32
6588735|NCT01968356|7513255|FG004|STARTED|Overall Study||97
6588736|NCT01968356|7513256|FG005|STARTED|Overall Study||99
6588737|NCT01968356|7513257|FG006|STARTED|Overall Study||97
6588738|NCT01968356|7513258|FG007|STARTED|Overall Study||31
6588739|NCT01968356|7513251|FG000|COMPLETED|Overall Study||101
6588740|NCT01968356|7513252|FG001|COMPLETED|Overall Study||93
6588741|NCT01968356|7513253|FG002|COMPLETED|Overall Study||96
6588742|NCT01968356|7513254|FG003|COMPLETED|Overall Study||32
6588743|NCT01968356|7513255|FG004|COMPLETED|Overall Study||97
6588744|NCT01968356|7513256|FG005|COMPLETED|Overall Study||99
6588745|NCT01968356|7513257|FG006|COMPLETED|Overall Study||97
6588746|NCT01968356|7513258|FG007|COMPLETED|Overall Study||31
6588747|NCT01968356|7513251|FG000|NOT COMPLETED|Overall Study||0
6588748|NCT01968356|7513252|FG001|NOT COMPLETED|Overall Study||0
6588749|NCT01968356|7513253|FG002|NOT COMPLETED|Overall Study||0
6588750|NCT01968356|7513254|FG003|NOT COMPLETED|Overall Study||0
6588751|NCT01968356|7513255|FG004|NOT COMPLETED|Overall Study||0
6588752|NCT01968356|7513256|FG005|NOT COMPLETED|Overall Study||0
6588753|NCT01968356|7513257|FG006|NOT COMPLETED|Overall Study||0
6588754|NCT01968356|7513258|FG007|NOT COMPLETED|Overall Study||0
6588755|NCT01968382|7513287|FG000|STARTED|Overall Study||18
6588756|NCT01968382|7513288|FG001|STARTED|Overall Study||19
6588757|NCT01968382|7513289|FG002|STARTED|Overall Study||20
6588758|NCT01968382|7513287|FG000|COMPLETED|Overall Study||18
6588759|NCT01968382|7513288|FG001|COMPLETED|Overall Study||19
6588760|NCT01968382|7513289|FG002|COMPLETED|Overall Study||20
6588761|NCT01968382|7513287|FG000|NOT COMPLETED|Overall Study||0
6588762|NCT01968382|7513288|FG001|NOT COMPLETED|Overall Study||0
6588763|NCT01968382|7513289|FG002|NOT COMPLETED|Overall Study||0
6588764|NCT01968421|7513299|FG000|STARTED|Overall Study|March 1, 2015 was the date for recruiting patients|99
6588765|NCT01968421|7513300|FG001|STARTED|Overall Study|March 1, 2015 was the date for recruiting controls|97
6588766|NCT01968421|7513299|FG000|Starting Trial|Overall Study||99
6588767|NCT01968421|7513300|FG001|Starting Trial|Overall Study||97
6588768|NCT01968421|7513299|FG000|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|99
6588769|NCT01968421|7513300|FG001|COMPLETED|Overall Study|Nov. 23, 2018 is the date for completing the trial|97
6588770|NCT01968421|7513299|FG000|NOT COMPLETED|Overall Study||0
6588771|NCT01968421|7513300|FG001|NOT COMPLETED|Overall Study||0
6588772|NCT01968434|7513308|FG000|STARTED|Overall Study||78
6588773|NCT01968434|7513309|FG001|STARTED|Overall Study||72
6588774|NCT01968434|7513308|FG000|COMPLETED|Overall Study||75
6588775|NCT01968434|7513309|FG001|COMPLETED|Overall Study||66
6588776|NCT01968434|7513308|FG000|NOT COMPLETED|Overall Study||3
6588777|NCT01968434|7513309|FG001|NOT COMPLETED|Overall Study||6
6588778|NCT01968447|7513317|FG000|STARTED|Overall Study||20
6588779|NCT01968447|7513318|FG001|STARTED|Overall Study||20
6588780|NCT01968447|7513317|FG000|COMPLETED|Overall Study||20
6588781|NCT01968447|7513318|FG001|COMPLETED|Overall Study||20
6588782|NCT01968447|7513317|FG000|NOT COMPLETED|Overall Study||0
6588783|NCT01968447|7513318|FG001|NOT COMPLETED|Overall Study||0
6588784|NCT01968551|7513327|FG000|STARTED|Open Label Phase (48 Weeks)||22
6588785|NCT01968551|7513328|FG001|STARTED|Open Label Phase (48 Weeks)||90
6588786|NCT01968551|7513329|FG002|STARTED|Open Label Phase (48 Weeks)||46
6588787|NCT01968551|7513327|FG000|COMPLETED|Open Label Phase (48 Weeks)||20
6588788|NCT01968551|7513328|FG001|COMPLETED|Open Label Phase (48 Weeks)||87
6588789|NCT01968551|7513329|FG002|COMPLETED|Open Label Phase (48 Weeks)||41
6588790|NCT01968551|7513327|FG000|NOT COMPLETED|Open Label Phase (48 Weeks)||2
6588791|NCT01968551|7513328|FG001|NOT COMPLETED|Open Label Phase (48 Weeks)||3
6588792|NCT01968551|7513329|FG002|NOT COMPLETED|Open Label Phase (48 Weeks)||5
6588793|NCT01968551|7513327|FG000|STARTED|Extension Phase||20
6588794|NCT01968551|7513328|FG001|STARTED|Extension Phase||87
6588795|NCT01968551|7513329|FG002|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
6588796|NCT01968551|7513327|FG000|COMPLETED|Extension Phase||19
6588797|NCT01968551|7513328|FG001|COMPLETED|Extension Phase||86
6588798|NCT01968551|7513329|FG002|COMPLETED|Extension Phase||30
6588799|NCT01968551|7513327|FG000|NOT COMPLETED|Extension Phase||1
6588800|NCT01968551|7513328|FG001|NOT COMPLETED|Extension Phase||1
6588801|NCT01968551|7513329|FG002|NOT COMPLETED|Extension Phase||4
6588802|NCT01968694|7513343|FG000|STARTED|Visit 1 (1 Day)||10
6588803|NCT01968694|7513344|FG001|STARTED|Visit 1 (1 Day)||9
6588804|NCT01968694|7513343|FG000|COMPLETED|Visit 1 (1 Day)||10
6588805|NCT01968694|7513344|FG001|COMPLETED|Visit 1 (1 Day)||9
6588806|NCT01968694|7513343|FG000|NOT COMPLETED|Visit 1 (1 Day)||0
6588807|NCT01968694|7513344|FG001|NOT COMPLETED|Visit 1 (1 Day)||0
6588808|NCT01968694|7513343|FG000|STARTED|Washout (1 Month)||10
6588809|NCT01968694|7513344|FG001|STARTED|Washout (1 Month)||9
6588810|NCT01968694|7513343|FG000|COMPLETED|Washout (1 Month)||10
6588811|NCT01968694|7513344|FG001|COMPLETED|Washout (1 Month)||8
6588812|NCT01968694|7513343|FG000|NOT COMPLETED|Washout (1 Month)||0
6588813|NCT01968694|7513344|FG001|NOT COMPLETED|Washout (1 Month)||1
6588814|NCT01968694|7513343|FG000|STARTED|Visit 2 (1 Day)||10
6588815|NCT01968694|7513344|FG001|STARTED|Visit 2 (1 Day)||8
6588816|NCT01968694|7513343|FG000|COMPLETED|Visit 2 (1 Day)||10
6588817|NCT01968694|7513344|FG001|COMPLETED|Visit 2 (1 Day)||8
6588818|NCT01968694|7513343|FG000|NOT COMPLETED|Visit 2 (1 Day)||0
6588819|NCT01968694|7513344|FG001|NOT COMPLETED|Visit 2 (1 Day)||0
6588820|NCT01968707|7513360|FG000|STARTED|Overall Study||247
6588821|NCT01968707|7513361|FG001|STARTED|Overall Study||74
6588822|NCT01968707|7513362|FG002|STARTED|Overall Study||246
6588823|NCT01968707|7513363|FG003|STARTED|Overall Study||245
6588824|NCT01968707|7513364|FG004|STARTED|Overall Study||236
6588825|NCT01968707|7513365|FG005|STARTED|Overall Study||70
6588826|NCT01968707|7513366|FG006|STARTED|Overall Study||238
6588827|NCT01968707|7513367|FG007|STARTED|Overall Study||238
6588828|NCT01968707|7513360|FG000|COMPLETED|Overall Study||198
6588829|NCT01968707|7513361|FG001|COMPLETED|Overall Study||62
6588830|NCT01968707|7513362|FG002|COMPLETED|Overall Study||205
6588831|NCT01968707|7513363|FG003|COMPLETED|Overall Study||201
6588832|NCT01968707|7513364|FG004|COMPLETED|Overall Study||200
6588833|NCT01968707|7513365|FG005|COMPLETED|Overall Study||59
6588834|NCT01968707|7513366|FG006|COMPLETED|Overall Study||204
6588835|NCT01968707|7513367|FG007|COMPLETED|Overall Study||203
6588836|NCT01968707|7513360|FG000|NOT COMPLETED|Overall Study||49
6588837|NCT01968707|7513361|FG001|NOT COMPLETED|Overall Study||12
6588838|NCT01968707|7513362|FG002|NOT COMPLETED|Overall Study||41
6588839|NCT01968707|7513363|FG003|NOT COMPLETED|Overall Study||44
6588840|NCT01968707|7513364|FG004|NOT COMPLETED|Overall Study||36
6588841|NCT01968707|7513365|FG005|NOT COMPLETED|Overall Study||11
6588842|NCT01968707|7513366|FG006|NOT COMPLETED|Overall Study||34
6588843|NCT01968707|7513367|FG007|NOT COMPLETED|Overall Study||35
6588844|NCT01968811|7513400|FG000|STARTED|Overall Study||10
6588845|NCT01968811|7513400|FG000|COMPLETED|Overall Study||5
6588846|NCT01968811|7513400|FG000|NOT COMPLETED|Overall Study||5
6588847|NCT01968954|7513406|FG000|STARTED|Overall Study||354
6588848|NCT01968954|7513407|FG001|STARTED|Overall Study||357
6588849|NCT01968954|7513406|FG000|Treated|Overall Study||353
6588850|NCT01968954|7513407|FG001|Treated|Overall Study||356
6588851|NCT01968954|7513406|FG000|COMPLETED|Overall Study||314
6588852|NCT01968954|7513407|FG001|COMPLETED|Overall Study||314
6588853|NCT01968954|7513406|FG000|NOT COMPLETED|Overall Study||40
6588854|NCT01968954|7513407|FG001|NOT COMPLETED|Overall Study||43
6588855|NCT01968967|7513416|FG000|STARTED|Treatment Period||1071
6588856|NCT01968967|7513417|FG001|STARTED|Treatment Period||1068
6588857|NCT01968967|7513418|FG002|STARTED|Treatment Period||0
6588858|NCT01968967|7513419|FG003|STARTED|Treatment Period||0
6588859|NCT01968967|7513420|FG004|STARTED|Treatment Period||0
6588860|NCT01968967|7513416|FG000|Treated|Treatment Period||1065
6588861|NCT01968967|7513417|FG001|Treated|Treatment Period||1063
6588862|NCT01968967|7513418|FG002|Treated|Treatment Period||0
6588863|NCT01968967|7513419|FG003|Treated|Treatment Period||0
6588864|NCT01968967|7513420|FG004|Treated|Treatment Period||0
6588865|NCT01968967|7513416|FG000|COMPLETED|Treatment Period||925
6588866|NCT01968967|7513417|FG001|COMPLETED|Treatment Period||934
6588867|NCT01968967|7513418|FG002|COMPLETED|Treatment Period||0
6588868|NCT01968967|7513419|FG003|COMPLETED|Treatment Period||0
6588869|NCT01968967|7513420|FG004|COMPLETED|Treatment Period||0
6588870|NCT01968967|7513416|FG000|NOT COMPLETED|Treatment Period||146
6588871|NCT01968967|7513417|FG001|NOT COMPLETED|Treatment Period||134
6588872|NCT01968967|7513418|FG002|NOT COMPLETED|Treatment Period||0
6588873|NCT01968967|7513419|FG003|NOT COMPLETED|Treatment Period||0
6588874|NCT01968967|7513420|FG004|NOT COMPLETED|Treatment Period||0
6588875|NCT01968967|7513416|FG000|STARTED|Extension Period||0
6588876|NCT01968967|7513417|FG001|STARTED|Extension Period||0
6588877|NCT01968967|7513418|FG002|STARTED|Extension Period||47
6588878|NCT01968967|7513419|FG003|STARTED|Extension Period||19
6588879|NCT01968967|7513420|FG004|STARTED|Extension Period||39
6588880|NCT01968967|7513416|FG000|COMPLETED|Extension Period||0
6588881|NCT01968967|7513417|FG001|COMPLETED|Extension Period||0
6588882|NCT01968967|7513418|FG002|COMPLETED|Extension Period||45
6588883|NCT01968967|7513419|FG003|COMPLETED|Extension Period||19
6588884|NCT01968967|7513420|FG004|COMPLETED|Extension Period||34
6588885|NCT01968967|7513416|FG000|NOT COMPLETED|Extension Period||0
6588886|NCT01968967|7513417|FG001|NOT COMPLETED|Extension Period||0
6588887|NCT01968967|7513418|FG002|NOT COMPLETED|Extension Period||2
6588888|NCT01968967|7513419|FG003|NOT COMPLETED|Extension Period||0
6588889|NCT01968967|7513420|FG004|NOT COMPLETED|Extension Period||5
6588890|NCT01968980|7513436|FG000|STARTED|Overall Study||185
6588891|NCT01968980|7513437|FG001|STARTED|Overall Study||185
6588892|NCT01968980|7513436|FG000|COMPLETED|Overall Study||169
6588893|NCT01968980|7513437|FG001|COMPLETED|Overall Study||171
6588894|NCT01968980|7513436|FG000|NOT COMPLETED|Overall Study||16
6588895|NCT01968980|7513437|FG001|NOT COMPLETED|Overall Study||14
6588896|NCT01969058|7513446|FG000|STARTED|Overall Study||50
6588897|NCT01969058|7513447|FG001|STARTED|Overall Study||26
6588898|NCT01969058|7513446|FG000|COMPLETED|Overall Study||47
6588899|NCT01969058|7513447|FG001|COMPLETED|Overall Study||26
6588900|NCT01969058|7513446|FG000|NOT COMPLETED|Overall Study||3
6588901|NCT01969058|7513447|FG001|NOT COMPLETED|Overall Study||0
6588902|NCT01969084|7513455|FG000|STARTED|Overall Study||19
6588903|NCT01969084|7513456|FG001|STARTED|Overall Study||22
6588904|NCT01969084|7513455|FG000|COMPLETED|Overall Study||19
6588905|NCT01969084|7513456|FG001|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
6588906|NCT01969084|7513455|FG000|NOT COMPLETED|Overall Study||0
6588907|NCT01969084|7513456|FG001|NOT COMPLETED|Overall Study||1
6588908|NCT01969162|7513466|FG000|STARTED|Overall Study||35
6588909|NCT01969162|7513466|FG000|COMPLETED|Overall Study||35
6588910|NCT01969162|7513466|FG000|NOT COMPLETED|Overall Study||0
6588911|NCT01969201|7513472|FG000|STARTED|Overall Study||352
6588912|NCT01969201|7513473|FG001|STARTED|Overall Study||358
6588913|NCT01969201|7513472|FG000|COMPLETED|Overall Study||307
6588914|NCT01969201|7513473|FG001|COMPLETED|Overall Study||313
6588915|NCT01969201|7513472|FG000|NOT COMPLETED|Overall Study||45
6588916|NCT01969201|7513473|FG001|NOT COMPLETED|Overall Study||45
6588917|NCT01969214|7513479|FG000|STARTED|Overall Study||101
6588918|NCT01969214|7513479|FG000|COMPLETED|Overall Study||86
6588919|NCT01969214|7513479|FG000|NOT COMPLETED|Overall Study||15
6588920|NCT01969240|7513485|FG000|STARTED|Overall Study||451
6588921|NCT01969240|7513486|FG001|STARTED|Overall Study||447
6588922|NCT01969240|7513485|FG000|COMPLETED|Overall Study||451
6588923|NCT01969240|7513486|FG001|COMPLETED|Overall Study||447
6588924|NCT01969240|7513485|FG000|NOT COMPLETED|Overall Study||0
6588925|NCT01969240|7513486|FG001|NOT COMPLETED|Overall Study||0
6624442|NCT02217527|7551883|FG000|STARTED|Drug Condition 1: First Study Phase||18
6624443|NCT02217527|7551884|FG001|STARTED|Drug Condition 1: First Study Phase||18
6624444|NCT02217527|7551883|FG000|COMPLETED|Drug Condition 1: First Study Phase||17
6624445|NCT02217527|7551884|FG001|COMPLETED|Drug Condition 1: First Study Phase||15
6624446|NCT02217527|7551883|FG000|NOT COMPLETED|Drug Condition 1: First Study Phase||1
6624447|NCT02217527|7551884|FG001|NOT COMPLETED|Drug Condition 1: First Study Phase||3
6624448|NCT02217527|7551883|FG000|STARTED|Drug Condition 2: Second Study Phase||17
6624449|NCT02217527|7551884|FG001|STARTED|Drug Condition 2: Second Study Phase||15
6624450|NCT02217527|7551883|FG000|COMPLETED|Drug Condition 2: Second Study Phase||17
6588926|NCT01969435|7513494|FG000|STARTED|Overall Study||50
6588927|NCT01969435|7513494|FG000|COMPLETED|Overall Study||50
6588928|NCT01969435|7513494|FG000|NOT COMPLETED|Overall Study||0
6588929|NCT01969448|7513501|FG000|STARTED|Overall Study||55
6588930|NCT01969448|7513502|FG001|STARTED|Overall Study||24
6588931|NCT01969448|7513503|FG002|STARTED|Overall Study||0
6588932|NCT01969448|7513501|FG000|COMPLETED|Overall Study||55
6588933|NCT01969448|7513502|FG001|COMPLETED|Overall Study||24
6588934|NCT01969448|7513503|FG002|COMPLETED|Overall Study||0
6588935|NCT01969448|7513501|FG000|NOT COMPLETED|Overall Study||0
6588936|NCT01969448|7513502|FG001|NOT COMPLETED|Overall Study||0
6588937|NCT01969448|7513503|FG002|NOT COMPLETED|Overall Study||0
6588938|NCT01969500|7513513|FG000|STARTED|Overall Study||25
6588939|NCT01969500|7513514|FG001|STARTED|Overall Study||26
6588940|NCT01969500|7513513|FG000|COMPLETED|Overall Study||24
6588941|NCT01969500|7513514|FG001|COMPLETED|Overall Study||24
6588942|NCT01969500|7513513|FG000|NOT COMPLETED|Overall Study||1
6588943|NCT01969500|7513514|FG001|NOT COMPLETED|Overall Study||2
6588944|NCT01969539|7513520|FG000|STARTED|Overall Study||11
6588945|NCT01969539|7513520|FG000|COMPLETED|Overall Study||11
6588946|NCT01969539|7513520|FG000|NOT COMPLETED|Overall Study||0
6588947|NCT01969708|7513526|FG000|STARTED|Overall Study||180
6588948|NCT01969708|7513527|FG001|STARTED|Overall Study||182
6588949|NCT01969708|7513526|FG000|COMPLETED|Overall Study||175
6588950|NCT01969708|7513527|FG001|COMPLETED|Overall Study||173
6588951|NCT01969708|7513526|FG000|NOT COMPLETED|Overall Study||5
6588952|NCT01969708|7513527|FG001|NOT COMPLETED|Overall Study||9
6588953|NCT01969721|7513533|FG000|STARTED|Overall Study||58
6588954|NCT01969721|7513534|FG001|STARTED|Overall Study||69
6588955|NCT01969721|7513535|FG002|STARTED|Overall Study||50
6588956|NCT01969721|7513536|FG003|STARTED|Overall Study||52
6588957|NCT01969721|7513533|FG000|COMPLETED|Overall Study||54
6588958|NCT01969721|7513534|FG001|COMPLETED|Overall Study||57
6588959|NCT01969721|7513535|FG002|COMPLETED|Overall Study||45
6588960|NCT01969721|7513536|FG003|COMPLETED|Overall Study||46
6588961|NCT01969721|7513533|FG000|NOT COMPLETED|Overall Study||4
6588962|NCT01969721|7513534|FG001|NOT COMPLETED|Overall Study||12
6588963|NCT01969721|7513535|FG002|NOT COMPLETED|Overall Study||5
6588964|NCT01969721|7513536|FG003|NOT COMPLETED|Overall Study||6
6588965|NCT01969747|7513550|FG000|STARTED|Overall Study||19
6588966|NCT01969747|7513551|FG001|STARTED|Overall Study||19
6588967|NCT01969747|7513552|FG002|STARTED|Overall Study||19
6588968|NCT01969747|7513553|FG003|STARTED|Overall Study||18
6588969|NCT01969747|7513550|FG000|COMPLETED|Overall Study||19
6588970|NCT01969747|7513551|FG001|COMPLETED|Overall Study||19
6588971|NCT01969747|7513552|FG002|COMPLETED|Overall Study||19
6588972|NCT01969747|7513553|FG003|COMPLETED|Overall Study||18
6588973|NCT01969747|7513550|FG000|NOT COMPLETED|Overall Study||0
6588974|NCT01969747|7513551|FG001|NOT COMPLETED|Overall Study||0
6588975|NCT01969747|7513552|FG002|NOT COMPLETED|Overall Study||0
6588976|NCT01969747|7513553|FG003|NOT COMPLETED|Overall Study||0
6588977|NCT01969799|7513565|FG000|STARTED|Overall Study||71
6588978|NCT01969799|7513566|FG001|STARTED|Overall Study||72
6588979|NCT01969799|7513565|FG000|COMPLETED|Overall Study||54
6588980|NCT01969799|7513566|FG001|COMPLETED|Overall Study||58
6588981|NCT01969799|7513565|FG000|NOT COMPLETED|Overall Study||17
6588982|NCT01969799|7513566|FG001|NOT COMPLETED|Overall Study||14
6588983|NCT01969851|7513575|FG000|STARTED|Overall Study||10
6588984|NCT01969851|7513576|FG001|STARTED|Overall Study||24
6588985|NCT01969851|7513577|FG002|STARTED|Overall Study||21
6588986|NCT01969851|7513575|FG000|COMPLETED|Overall Study||9
6588987|NCT01969851|7513576|FG001|COMPLETED|Overall Study||21
6588988|NCT01969851|7513577|FG002|COMPLETED|Overall Study||14
6588989|NCT01969851|7513575|FG000|NOT COMPLETED|Overall Study||1
6588990|NCT01969851|7513576|FG001|NOT COMPLETED|Overall Study||3
6588991|NCT01969851|7513577|FG002|NOT COMPLETED|Overall Study||7
6588992|NCT01969916|7513585|FG000|STARTED|Overall Study||150
6588993|NCT01969916|7513585|FG000|COMPLETED|Overall Study||105
6588994|NCT01969916|7513585|FG000|NOT COMPLETED|Overall Study||45
6588995|NCT01970007|7513589|FG000|STARTED|Overall Study||243
6588996|NCT01970007|7513589|FG000|COMPLETED|Overall Study||188
6588997|NCT01970007|7513589|FG000|NOT COMPLETED|Overall Study||55
6588998|NCT01970176|7513595|FG000|STARTED|Overall Study||14
6588999|NCT01970176|7513596|FG001|STARTED|Overall Study||6
6589000|NCT01970176|7513595|FG000|COMPLETED|Overall Study||14
6589001|NCT01970176|7513596|FG001|COMPLETED|Overall Study||6
6589002|NCT01970176|7513595|FG000|NOT COMPLETED|Overall Study||0
6589003|NCT01970176|7513596|FG001|NOT COMPLETED|Overall Study||0
6589004|NCT01970241|7513604|FG000|STARTED|Overall Study||46
6589005|NCT01970241|7513605|FG001|STARTED|Overall Study||39
6589006|NCT01970241|7513604|FG000|COMPLETED|Overall Study||29
6589007|NCT01970241|7513605|FG001|COMPLETED|Overall Study||31
6589008|NCT01970241|7513604|FG000|NOT COMPLETED|Overall Study||17
6589009|NCT01970241|7513605|FG001|NOT COMPLETED|Overall Study||8
6589010|NCT01970371|7513616|FG000|STARTED|Overall Study||18
6589011|NCT01970371|7513617|FG001|STARTED|Overall Study||21
6659604|NCT02491463|7590461|FG002|NOT COMPLETED|Overall Study||4
6589012|NCT01970371|7513618|FG002|STARTED|Overall Study||30
6589013|NCT01970371|7513616|FG000|COMPLETED|Overall Study||10
6589014|NCT01970371|7513617|FG001|COMPLETED|Overall Study||8
6589015|NCT01970371|7513618|FG002|COMPLETED|Overall Study||17
6589016|NCT01970371|7513616|FG000|NOT COMPLETED|Overall Study||8
6589017|NCT01970371|7513617|FG001|NOT COMPLETED|Overall Study||13
6659605|NCT02491463|7590462|FG003|NOT COMPLETED|Overall Study||1
6589018|NCT01970371|7513618|FG002|NOT COMPLETED|Overall Study||13
6589019|NCT01970397|7513630|FG000|STARTED|Overall Study||69
6589020|NCT01970397|7513631|FG001|STARTED|Overall Study||69
6589021|NCT01970397|7513630|FG000|COMPLETED|Overall Study||67
6589022|NCT01970397|7513631|FG001|COMPLETED|Overall Study||64
6589023|NCT01970397|7513630|FG000|NOT COMPLETED|Overall Study||2
6589024|NCT01970397|7513631|FG001|NOT COMPLETED|Overall Study||5
6589025|NCT01970475|7513639|FG000|STARTED|Overall Study||264
6589026|NCT01970475|7513640|FG001|STARTED|Overall Study||262
6589027|NCT01970475|7513639|FG000|COMPLETED|Overall Study||243
6589028|NCT01970475|7513640|FG001|COMPLETED|Overall Study||251
6589029|NCT01970475|7513639|FG000|NOT COMPLETED|Overall Study||21
6589030|NCT01970475|7513640|FG001|NOT COMPLETED|Overall Study||11
6589031|NCT01970488|7513648|FG000|STARTED|Part 1: Through Week 16||175
6589032|NCT01970488|7513649|FG001|STARTED|Part 1: Through Week 16||175
6589033|NCT01970488|7513650|FG002|STARTED|Part 1: Through Week 16||0
6589034|NCT01970488|7513651|FG003|STARTED|Part 1: Through Week 16||0
6589035|NCT01970488|7513652|FG004|STARTED|Part 1: Through Week 16||0
6589036|NCT01970488|7513648|FG000|Received Treatment|Part 1: Through Week 16||174
6589037|NCT01970488|7513649|FG001|Received Treatment|Part 1: Through Week 16||173
6589038|NCT01970488|7513650|FG002|Received Treatment|Part 1: Through Week 16||0
6589039|NCT01970488|7513651|FG003|Received Treatment|Part 1: Through Week 16||0
6589040|NCT01970488|7513652|FG004|Received Treatment|Part 1: Through Week 16||0
6589041|NCT01970488|7513648|FG000|COMPLETED|Part 1: Through Week 16||164
6589042|NCT01970488|7513649|FG001|COMPLETED|Part 1: Through Week 16||162
6589043|NCT01970488|7513650|FG002|COMPLETED|Part 1: Through Week 16||0
6589044|NCT01970488|7513651|FG003|COMPLETED|Part 1: Through Week 16||0
6589045|NCT01970488|7513652|FG004|COMPLETED|Part 1: Through Week 16||0
6589046|NCT01970488|7513648|FG000|NOT COMPLETED|Part 1: Through Week 16||11
6589047|NCT01970488|7513649|FG001|NOT COMPLETED|Part 1: Through Week 16||13
6589048|NCT01970488|7513650|FG002|NOT COMPLETED|Part 1: Through Week 16||0
6589049|NCT01970488|7513651|FG003|NOT COMPLETED|Part 1: Through Week 16||0
6589050|NCT01970488|7513652|FG004|NOT COMPLETED|Part 1: Through Week 16||0
6589051|NCT01970488|7513648|FG000|STARTED|Part 2: Post Week 16||0
6589052|NCT01970488|7513649|FG001|STARTED|Part 2: Post Week 16||0
6589053|NCT01970488|7513650|FG002|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
6589054|NCT01970488|7513651|FG003|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
6589055|NCT01970488|7513652|FG004|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
6589056|NCT01970488|7513648|FG000|COMPLETED|Part 2: Post Week 16||0
6589057|NCT01970488|7513649|FG001|COMPLETED|Part 2: Post Week 16||0
6589058|NCT01970488|7513650|FG002|COMPLETED|Part 2: Post Week 16||135
6589059|NCT01970488|7513651|FG003|COMPLETED|Part 2: Post Week 16||71
6589060|NCT01970488|7513652|FG004|COMPLETED|Part 2: Post Week 16||69
6589061|NCT01970488|7513648|FG000|NOT COMPLETED|Part 2: Post Week 16||0
6589062|NCT01970488|7513649|FG001|NOT COMPLETED|Part 2: Post Week 16||0
6589063|NCT01970488|7513650|FG002|NOT COMPLETED|Part 2: Post Week 16||17
6589064|NCT01970488|7513651|FG003|NOT COMPLETED|Part 2: Post Week 16||8
6589065|NCT01970488|7513652|FG004|NOT COMPLETED|Part 2: Post Week 16||8
6589066|NCT01970527|7513669|FG000|STARTED|Pre-treatment/Baseline||9
6589067|NCT01970527|7513670|FG001|STARTED|Pre-treatment/Baseline||14
6589068|NCT01970527|7513669|FG000|COMPLETED|Pre-treatment/Baseline||8
6589069|NCT01970527|7513670|FG001|COMPLETED|Pre-treatment/Baseline||14
6589070|NCT01970527|7513669|FG000|NOT COMPLETED|Pre-treatment/Baseline||1
6589071|NCT01970527|7513670|FG001|NOT COMPLETED|Pre-treatment/Baseline||0
6589072|NCT01970527|7513669|FG000|STARTED|Treatment||8
6589073|NCT01970527|7513670|FG001|STARTED|Treatment||14
6589074|NCT01970527|7513669|FG000|COMPLETED|Treatment||8
6589075|NCT01970527|7513670|FG001|COMPLETED|Treatment||11
6589076|NCT01970527|7513669|FG000|NOT COMPLETED|Treatment||0
6589077|NCT01970527|7513670|FG001|NOT COMPLETED|Treatment||3
6589078|NCT01970527|7513669|FG000|STARTED|Follow-up Clinic Visit||8
6589079|NCT01970527|7513670|FG001|STARTED|Follow-up Clinic Visit||11
6589080|NCT01970527|7513669|FG000|COMPLETED|Follow-up Clinic Visit||7
6589081|NCT01970527|7513670|FG001|COMPLETED|Follow-up Clinic Visit||8
6589082|NCT01970527|7513669|FG000|NOT COMPLETED|Follow-up Clinic Visit||1
6589083|NCT01970527|7513670|FG001|NOT COMPLETED|Follow-up Clinic Visit||3
6589084|NCT01970540|7513682|FG000|STARTED|Overall Study||73
6589085|NCT01970540|7513683|FG001|STARTED|Overall Study||28
6589086|NCT01970540|7513684|FG002|STARTED|Overall Study||19
6589087|NCT01970540|7513682|FG000|COMPLETED|Overall Study||0
6589088|NCT01970540|7513683|FG001|COMPLETED|Overall Study||0
6589089|NCT01970540|7513684|FG002|COMPLETED|Overall Study||0
6589090|NCT01970540|7513682|FG000|NOT COMPLETED|Overall Study||73
6589091|NCT01970540|7513683|FG001|NOT COMPLETED|Overall Study||28
6589092|NCT01970540|7513684|FG002|NOT COMPLETED|Overall Study||19
6589093|NCT01970592|7513703|FG000|STARTED|Overall Study|Completed all training sessions|56
6589094|NCT01970592|7513703|FG000|COMPLETED|Overall Study||50
6589095|NCT01970592|7513703|FG000|NOT COMPLETED|Overall Study||6
6589096|NCT01970787|7513707|FG000|STARTED|Overall Study||22
6589097|NCT01970787|7513707|FG000|COMPLETED|Overall Study||21
6589098|NCT01970787|7513707|FG000|NOT COMPLETED|Overall Study||1
6589099|NCT01970878|7513715|FG000|STARTED|Overall Study||290
6589100|NCT01970878|7513716|FG001|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
6589101|NCT01970878|7513717|FG002|STARTED|Overall Study||213
6589102|NCT01970878|7513718|FG003|STARTED|Overall Study||171
6589103|NCT01970878|7513715|FG000|COMPLETED|Overall Study||253
6589104|NCT01970878|7513716|FG001|COMPLETED|Overall Study||191
6589105|NCT01970878|7513717|FG002|COMPLETED|Overall Study||187
6589106|NCT01970878|7513718|FG003|COMPLETED|Overall Study||147
6589107|NCT01970878|7513715|FG000|NOT COMPLETED|Overall Study||37
6589108|NCT01970878|7513716|FG001|NOT COMPLETED|Overall Study||27
6589109|NCT01970878|7513717|FG002|NOT COMPLETED|Overall Study||26
6589110|NCT01970878|7513718|FG003|NOT COMPLETED|Overall Study||24
6589111|NCT01970943|7513728|FG000|STARTED|Overall Study||11
6589112|NCT01970943|7513729|FG001|STARTED|Overall Study||12
6589113|NCT01970943|7513728|FG000|COMPLETED|Overall Study||8
6589114|NCT01970943|7513729|FG001|COMPLETED|Overall Study||11
6589115|NCT01970943|7513728|FG000|NOT COMPLETED|Overall Study||3
6589116|NCT01970943|7513729|FG001|NOT COMPLETED|Overall Study||1
6589117|NCT01970982|7513738|FG000|STARTED|Overall Study||80
6589118|NCT01970982|7513739|FG001|STARTED|Overall Study||40
6589119|NCT01970982|7513740|FG002|STARTED|Overall Study||40
6589120|NCT01970982|7513738|FG000|COMPLETED|Overall Study||80
6589121|NCT01970982|7513739|FG001|COMPLETED|Overall Study||40
6589122|NCT01970982|7513740|FG002|COMPLETED|Overall Study||38
6589123|NCT01970982|7513738|FG000|NOT COMPLETED|Overall Study||0
6589124|NCT01970982|7513739|FG001|NOT COMPLETED|Overall Study||0
6589125|NCT01970982|7513740|FG002|NOT COMPLETED|Overall Study||2
6589126|NCT01970995|7513752|FG000|STARTED|Confinement Period (Population at Day 5)||78
6589127|NCT01970995|7513753|FG001|STARTED|Confinement Period (Population at Day 5)||42
6589128|NCT01970995|7513754|FG002|STARTED|Confinement Period (Population at Day 5)||40
6589129|NCT01970995|7513752|FG000|COMPLETED|Confinement Period (Population at Day 5)||77
6589130|NCT01970995|7513753|FG001|COMPLETED|Confinement Period (Population at Day 5)||41
6589131|NCT01970995|7513754|FG002|COMPLETED|Confinement Period (Population at Day 5)||39
6589132|NCT01970995|7513752|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||1
6589133|NCT01970995|7513753|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
6589134|NCT01970995|7513754|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||1
6589135|NCT01970995|7513752|FG000|STARTED|End of Study (Population at Day 90)||77
6589136|NCT01970995|7513753|FG001|STARTED|End of Study (Population at Day 90)||41
6589137|NCT01970995|7513754|FG002|STARTED|End of Study (Population at Day 90)||39
6589138|NCT01970995|7513752|FG000|COMPLETED|End of Study (Population at Day 90)||76
6589139|NCT01970995|7513753|FG001|COMPLETED|End of Study (Population at Day 90)||41
6589140|NCT01970995|7513754|FG002|COMPLETED|End of Study (Population at Day 90)||38
6589141|NCT01970995|7513752|FG000|NOT COMPLETED|End of Study (Population at Day 90)||1
6589142|NCT01970995|7513753|FG001|NOT COMPLETED|End of Study (Population at Day 90)||0
6589143|NCT01970995|7513754|FG002|NOT COMPLETED|End of Study (Population at Day 90)||1
6589144|NCT01971086|7513762|FG000|STARTED|Overall Study||300
6589145|NCT01971086|7513762|FG000|COMPLETED|Overall Study||300
6589146|NCT01971086|7513762|FG000|NOT COMPLETED|Overall Study||0
6589147|NCT01971203|7513769|FG000|STARTED|Overall Study||26
6589148|NCT01971203|7513770|FG001|STARTED|Overall Study||29
6589149|NCT01971203|7513769|FG000|COMPLETED|Overall Study||17
6589150|NCT01971203|7513770|FG001|COMPLETED|Overall Study||21
6589151|NCT01971203|7513769|FG000|NOT COMPLETED|Overall Study||9
6589152|NCT01971203|7513770|FG001|NOT COMPLETED|Overall Study||8
6589153|NCT01971255|7513778|FG000|STARTED|Overall Study||32
6589154|NCT01971255|7513779|FG001|STARTED|Overall Study||42
6589155|NCT01971255|7513778|FG000|COMPLETED|Overall Study||31
6589156|NCT01971255|7513779|FG001|COMPLETED|Overall Study||40
6589157|NCT01971255|7513778|FG000|NOT COMPLETED|Overall Study||1
6589158|NCT01971255|7513779|FG001|NOT COMPLETED|Overall Study||2
6589159|NCT01971346|7513785|FG000|STARTED|Overall Study|Four subjects signed the informed consent and terminated the study before beginning.|50
6589160|NCT01971346|7513785|FG000|COMPLETED|Overall Study||42
6589161|NCT01971346|7513785|FG000|NOT COMPLETED|Overall Study||8
6589162|NCT01971385|7513800|FG000|STARTED|Overall Study||17
6589163|NCT01971385|7513801|FG001|STARTED|Overall Study||18
6589164|NCT01971385|7513802|FG002|STARTED|Overall Study||19
6589165|NCT01971385|7513800|FG000|COMPLETED|Overall Study||14
6589166|NCT01971385|7513801|FG001|COMPLETED|Overall Study||13
6589167|NCT01971385|7513802|FG002|COMPLETED|Overall Study||15
6589168|NCT01971385|7513800|FG000|NOT COMPLETED|Overall Study||3
6589169|NCT01971385|7513801|FG001|NOT COMPLETED|Overall Study||5
6589170|NCT01971385|7513802|FG002|NOT COMPLETED|Overall Study||4
6589171|NCT01971463|7513809|FG000|STARTED|Overall Study||81
6589172|NCT01971463|7513809|FG000|COMPLETED|Overall Study||81
6589173|NCT01971463|7513809|FG000|NOT COMPLETED|Overall Study||0
6589174|NCT01971476|7513816|FG000|STARTED|Cohort 1: 2 to <12 Years||3
6589175|NCT01971476|7513817|FG001|STARTED|Cohort 1: 2 to <12 Years||3
6589176|NCT01971476|7513818|FG002|STARTED|Cohort 1: 2 to <12 Years||6
6589177|NCT01971476|7513816|FG000|COMPLETED|Cohort 1: 2 to <12 Years||0
6589178|NCT01971476|7513817|FG001|COMPLETED|Cohort 1: 2 to <12 Years||0
6589179|NCT01971476|7513818|FG002|COMPLETED|Cohort 1: 2 to <12 Years||0
6589180|NCT01971476|7513816|FG000|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
6589181|NCT01971476|7513817|FG001|NOT COMPLETED|Cohort 1: 2 to <12 Years||3
6589182|NCT01971476|7513818|FG002|NOT COMPLETED|Cohort 1: 2 to <12 Years||6
6589183|NCT01971476|7513816|FG000|STARTED|Cohort 2: 12 to <18 Years||6
6589184|NCT01971476|7513817|FG001|STARTED|Cohort 2: 12 to <18 Years||4
6589185|NCT01971476|7513818|FG002|STARTED|Cohort 2: 12 to <18 Years||0
6589186|NCT01971476|7513816|FG000|COMPLETED|Cohort 2: 12 to <18 Years||0
6589187|NCT01971476|7513817|FG001|COMPLETED|Cohort 2: 12 to <18 Years||0
6589188|NCT01971476|7513818|FG002|COMPLETED|Cohort 2: 12 to <18 Years||0
6589189|NCT01971476|7513816|FG000|NOT COMPLETED|Cohort 2: 12 to <18 Years||6
6589190|NCT01971476|7513817|FG001|NOT COMPLETED|Cohort 2: 12 to <18 Years||4
6589191|NCT01971476|7513818|FG002|NOT COMPLETED|Cohort 2: 12 to <18 Years||0
6589192|NCT01971554|7513839|FG000|STARTED|Overall Study||9
6589193|NCT01971554|7513840|FG001|STARTED|Overall Study||18
6589194|NCT01971554|7513841|FG002|STARTED|Overall Study||18
6589195|NCT01971554|7513842|FG003|STARTED|Overall Study||18
6589196|NCT01971554|7513839|FG000|COMPLETED|Overall Study||8
6589197|NCT01971554|7513840|FG001|COMPLETED|Overall Study||18
6589198|NCT01971554|7513841|FG002|COMPLETED|Overall Study||18
6589199|NCT01971554|7513842|FG003|COMPLETED|Overall Study||18
6589200|NCT01971554|7513839|FG000|NOT COMPLETED|Overall Study||1
6589201|NCT01971554|7513840|FG001|NOT COMPLETED|Overall Study||0
6589202|NCT01971554|7513841|FG002|NOT COMPLETED|Overall Study||0
6589203|NCT01971554|7513842|FG003|NOT COMPLETED|Overall Study||0
6589204|NCT01971567|7513854|FG000|STARTED|Overall Study||56
6589205|NCT01971567|7513855|FG001|STARTED|Overall Study||51
6589206|NCT01971567|7513854|FG000|COMPLETED|Overall Study||52
6589207|NCT01971567|7513855|FG001|COMPLETED|Overall Study||49
6589208|NCT01971567|7513854|FG000|NOT COMPLETED|Overall Study||4
6589209|NCT01971567|7513855|FG001|NOT COMPLETED|Overall Study||2
6589210|NCT01971580|7513863|FG000|STARTED|Overall Study||14
6589211|NCT01971580|7513864|FG001|STARTED|Overall Study||14
6589212|NCT01971580|7513863|FG000|COMPLETED|Overall Study||10
6589213|NCT01971580|7513864|FG001|COMPLETED|Overall Study||9
6589214|NCT01971580|7513863|FG000|NOT COMPLETED|Overall Study||4
6589215|NCT01971580|7513864|FG001|NOT COMPLETED|Overall Study||5
6589216|NCT01971593|7513872|FG000|STARTED|Overall Study||14
6589217|NCT01971593|7513873|FG001|STARTED|Overall Study||12
6589218|NCT01971593|7513872|FG000|COMPLETED|Overall Study||9
6589219|NCT01971593|7513873|FG001|COMPLETED|Overall Study||8
6589220|NCT01971593|7513872|FG000|NOT COMPLETED|Overall Study||5
6589221|NCT01971593|7513873|FG001|NOT COMPLETED|Overall Study||4
6589222|NCT01971645|7513880|FG000|STARTED|Overall Study||25
6589223|NCT01971645|7513881|FG001|STARTED|Overall Study||27
6589224|NCT01971645|7513882|FG002|STARTED|Overall Study||25
6589225|NCT01971645|7513880|FG000|COMPLETED|Overall Study||23
6589226|NCT01971645|7513881|FG001|COMPLETED|Overall Study||27
6589227|NCT01971645|7513882|FG002|COMPLETED|Overall Study||23
6589228|NCT01971645|7513880|FG000|NOT COMPLETED|Overall Study||2
6589229|NCT01971645|7513881|FG001|NOT COMPLETED|Overall Study||0
6589230|NCT01971645|7513882|FG002|NOT COMPLETED|Overall Study||2
6589231|NCT01971723|7513892|FG000|STARTED|Overall Study||16
6589232|NCT01971723|7513893|FG001|STARTED|Overall Study||16
6589233|NCT01971723|7513892|FG000|COMPLETED|Overall Study||14
6589234|NCT01971723|7513893|FG001|COMPLETED|Overall Study||13
6589235|NCT01971723|7513892|FG000|NOT COMPLETED|Overall Study||2
6589236|NCT01971723|7513893|FG001|NOT COMPLETED|Overall Study||3
6589237|NCT01972061|7513902|FG000|STARTED|Overall Study||1
6589238|NCT01972061|7513903|FG001|STARTED|Overall Study||23
6589239|NCT01972061|7513904|FG002|STARTED|Overall Study||20
6589240|NCT01972061|7513902|FG000|COMPLETED|Overall Study||1
6589241|NCT01972061|7513903|FG001|COMPLETED|Overall Study||23
6589242|NCT01972061|7513904|FG002|COMPLETED|Overall Study||20
6589243|NCT01972061|7513902|FG000|NOT COMPLETED|Overall Study||0
6589244|NCT01972061|7513903|FG001|NOT COMPLETED|Overall Study||0
6589245|NCT01972061|7513904|FG002|NOT COMPLETED|Overall Study||0
6589246|NCT01972074|7513915|FG000|STARTED|Overall Study||22
6589247|NCT01972074|7513916|FG001|STARTED|Overall Study||21
6589248|NCT01972074|7513917|FG002|STARTED|Overall Study||18
6589249|NCT01972074|7513915|FG000|COMPLETED|Overall Study||16
6589250|NCT01972074|7513916|FG001|COMPLETED|Overall Study||17
6589251|NCT01972074|7513917|FG002|COMPLETED|Overall Study||15
6589252|NCT01972074|7513915|FG000|NOT COMPLETED|Overall Study||6
6589253|NCT01972074|7513916|FG001|NOT COMPLETED|Overall Study||4
6589254|NCT01972074|7513917|FG002|NOT COMPLETED|Overall Study||3
6589255|NCT01972152|7513924|FG000|STARTED|First Treatment Visit||5
6589256|NCT01972152|7513925|FG001|STARTED|First Treatment Visit||5
6589257|NCT01972152|7513926|FG002|STARTED|First Treatment Visit||5
6589258|NCT01972152|7513927|FG003|STARTED|First Treatment Visit||5
6589259|NCT01972152|7513928|FG004|STARTED|First Treatment Visit||5
6659606|NCT02491671|7590474|FG000|STARTED|Overall Study||129
6659607|NCT02491671|7590475|FG001|STARTED|Overall Study||131
6659608|NCT02491671|7590474|FG000|COMPLETED|Overall Study||118
6659609|NCT02491671|7590475|FG001|COMPLETED|Overall Study||118
6659610|NCT02491671|7590474|FG000|NOT COMPLETED|Overall Study||11
6659611|NCT02491671|7590475|FG001|NOT COMPLETED|Overall Study||13
6659612|NCT02491684|7590483|FG000|STARTED|Pre-treatment Phase||61
6659613|NCT02491684|7590484|FG001|STARTED|Pre-treatment Phase||60
6659614|NCT02491684|7590483|FG000|COMPLETED|Pre-treatment Phase||61
6659615|NCT02491684|7590484|FG001|COMPLETED|Pre-treatment Phase||60
6659616|NCT02491684|7590483|FG000|NOT COMPLETED|Pre-treatment Phase||0
6659617|NCT02491684|7590484|FG001|NOT COMPLETED|Pre-treatment Phase||0
6659618|NCT02491684|7590483|FG000|STARTED|Treatment Phase||61
6659619|NCT02491684|7590484|FG001|STARTED|Treatment Phase||60
6659620|NCT02491684|7590483|FG000|COMPLETED|Treatment Phase||58
6659621|NCT02491684|7590484|FG001|COMPLETED|Treatment Phase||57
6659622|NCT02491684|7590483|FG000|NOT COMPLETED|Treatment Phase||3
6659623|NCT02491684|7590484|FG001|NOT COMPLETED|Treatment Phase||3
6659624|NCT02491788|7590492|FG000|STARTED|Overall Study||8
6659625|NCT02491788|7590493|FG001|STARTED|Overall Study||11
6659626|NCT02491788|7590492|FG000|COMPLETED|Overall Study||8
6589260|NCT01972152|7513929|FG005|STARTED|First Treatment Visit||5
6589261|NCT01972152|7513924|FG000|COMPLETED|First Treatment Visit||5
6589262|NCT01972152|7513925|FG001|COMPLETED|First Treatment Visit||4
6589263|NCT01972152|7513926|FG002|COMPLETED|First Treatment Visit||5
6589264|NCT01972152|7513927|FG003|COMPLETED|First Treatment Visit||5
6589265|NCT01972152|7513928|FG004|COMPLETED|First Treatment Visit||5
6589266|NCT01972152|7513929|FG005|COMPLETED|First Treatment Visit||5
6589267|NCT01972152|7513924|FG000|NOT COMPLETED|First Treatment Visit||0
6589268|NCT01972152|7513925|FG001|NOT COMPLETED|First Treatment Visit||1
6589269|NCT01972152|7513926|FG002|NOT COMPLETED|First Treatment Visit||0
6589270|NCT01972152|7513927|FG003|NOT COMPLETED|First Treatment Visit||0
6589271|NCT01972152|7513928|FG004|NOT COMPLETED|First Treatment Visit||0
6589272|NCT01972152|7513929|FG005|NOT COMPLETED|First Treatment Visit||0
6589273|NCT01972152|7513924|FG000|STARTED|Second Treatment Visit||5
6589274|NCT01972152|7513925|FG001|STARTED|Second Treatment Visit||4
6589275|NCT01972152|7513926|FG002|STARTED|Second Treatment Visit||5
6589276|NCT01972152|7513927|FG003|STARTED|Second Treatment Visit||5
6589277|NCT01972152|7513928|FG004|STARTED|Second Treatment Visit||5
6589278|NCT01972152|7513929|FG005|STARTED|Second Treatment Visit||5
6589279|NCT01972152|7513924|FG000|COMPLETED|Second Treatment Visit||5
6589280|NCT01972152|7513925|FG001|COMPLETED|Second Treatment Visit||3
6589281|NCT01972152|7513926|FG002|COMPLETED|Second Treatment Visit||5
6589282|NCT01972152|7513927|FG003|COMPLETED|Second Treatment Visit||5
6589283|NCT01972152|7513928|FG004|COMPLETED|Second Treatment Visit||5
6589284|NCT01972152|7513929|FG005|COMPLETED|Second Treatment Visit||5
6589285|NCT01972152|7513924|FG000|NOT COMPLETED|Second Treatment Visit||0
6589286|NCT01972152|7513925|FG001|NOT COMPLETED|Second Treatment Visit||1
6589287|NCT01972152|7513926|FG002|NOT COMPLETED|Second Treatment Visit||0
6589288|NCT01972152|7513927|FG003|NOT COMPLETED|Second Treatment Visit||0
6589289|NCT01972152|7513928|FG004|NOT COMPLETED|Second Treatment Visit||0
6589290|NCT01972152|7513929|FG005|NOT COMPLETED|Second Treatment Visit||0
6589291|NCT01972152|7513924|FG000|STARTED|Third Treatment Visit||5
6589292|NCT01972152|7513925|FG001|STARTED|Third Treatment Visit||3
6589293|NCT01972152|7513926|FG002|STARTED|Third Treatment Visit||5
6589294|NCT01972152|7513927|FG003|STARTED|Third Treatment Visit||5
6589295|NCT01972152|7513928|FG004|STARTED|Third Treatment Visit||5
6589296|NCT01972152|7513929|FG005|STARTED|Third Treatment Visit||5
6589297|NCT01972152|7513924|FG000|COMPLETED|Third Treatment Visit||5
6589298|NCT01972152|7513925|FG001|COMPLETED|Third Treatment Visit||3
6589299|NCT01972152|7513926|FG002|COMPLETED|Third Treatment Visit||5
6589300|NCT01972152|7513927|FG003|COMPLETED|Third Treatment Visit||5
6589301|NCT01972152|7513928|FG004|COMPLETED|Third Treatment Visit||5
6589302|NCT01972152|7513929|FG005|COMPLETED|Third Treatment Visit||5
6589303|NCT01972152|7513924|FG000|NOT COMPLETED|Third Treatment Visit||0
6589304|NCT01972152|7513925|FG001|NOT COMPLETED|Third Treatment Visit||0
6589305|NCT01972152|7513926|FG002|NOT COMPLETED|Third Treatment Visit||0
6589306|NCT01972152|7513927|FG003|NOT COMPLETED|Third Treatment Visit||0
6589307|NCT01972152|7513928|FG004|NOT COMPLETED|Third Treatment Visit||0
6589308|NCT01972152|7513929|FG005|NOT COMPLETED|Third Treatment Visit||0
6589309|NCT01972204|7513942|FG000|STARTED|Overall Study||62
6589310|NCT01972204|7513943|FG001|STARTED|Overall Study||63
6589311|NCT01972204|7513942|FG000|COMPLETED|Overall Study||58
6589312|NCT01972204|7513943|FG001|COMPLETED|Overall Study||59
6589313|NCT01972204|7513942|FG000|NOT COMPLETED|Overall Study||4
6589314|NCT01972204|7513943|FG001|NOT COMPLETED|Overall Study||4
6589315|NCT01972282|7513949|FG000|STARTED|Overall Study||1020
6589316|NCT01972282|7513949|FG000|COMPLETED|Overall Study||1005
6589317|NCT01972282|7513949|FG000|NOT COMPLETED|Overall Study||15
6589318|NCT01972308|7513955|FG000|STARTED|Overall Study||156
6589319|NCT01972308|7513956|FG001|STARTED|Overall Study||156
6589320|NCT01972308|7513955|FG000|COMPLETED|Overall Study||148
6589321|NCT01972308|7513956|FG001|COMPLETED|Overall Study||148
6589322|NCT01972308|7513955|FG000|NOT COMPLETED|Overall Study||8
6659627|NCT02491788|7590493|FG001|COMPLETED|Overall Study||11
6659628|NCT02491788|7590492|FG000|NOT COMPLETED|Overall Study||0
6659629|NCT02491788|7590493|FG001|NOT COMPLETED|Overall Study||0
6659630|NCT02491892|7590501|FG000|STARTED|Overall Study||41
6659631|NCT02491892|7590502|FG001|STARTED|Overall Study||38
6659632|NCT02491892|7590501|FG000|Treated|Overall Study||41
6659633|NCT02491892|7590502|FG001|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
6659634|NCT02491892|7590501|FG000|COMPLETED|Overall Study||0
6659635|NCT02491892|7590502|FG001|COMPLETED|Overall Study||0
6659636|NCT02491892|7590501|FG000|NOT COMPLETED|Overall Study||41
6659637|NCT02491892|7590502|FG001|NOT COMPLETED|Overall Study||38
6659638|NCT02491944|7590508|FG000|STARTED|Overall Study||10
6659639|NCT02491944|7590508|FG000|COMPLETED|Overall Study||10
6659640|NCT02491944|7590508|FG000|NOT COMPLETED|Overall Study||0
6659641|NCT02492100|7590512|FG000|STARTED|Overall Study||47
6589323|NCT01972308|7513956|FG001|NOT COMPLETED|Overall Study||8
6589324|NCT01972438|7513966|FG000|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
6589325|NCT01972438|7513967|FG001|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
6589326|NCT01972438|7513966|FG000|COMPLETED|Baseline-Month 3 Crossover Period||6
6589327|NCT01972438|7513967|FG001|COMPLETED|Baseline-Month 3 Crossover Period||6
6659642|NCT02492100|7590512|FG000|COMPLETED|Overall Study||46
6659643|NCT02492100|7590512|FG000|NOT COMPLETED|Overall Study||1
6589328|NCT01972438|7513966|FG000|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
6589329|NCT01972438|7513967|FG001|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
6589330|NCT01972438|7513966|FG000|STARTED|Months 3-6 Crossover Period||6
6589331|NCT01972438|7513967|FG001|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
6589332|NCT01972438|7513966|FG000|COMPLETED|Months 3-6 Crossover Period||6
6589333|NCT01972438|7513967|FG001|COMPLETED|Months 3-6 Crossover Period||6
6589334|NCT01972438|7513966|FG000|NOT COMPLETED|Months 3-6 Crossover Period||0
6589335|NCT01972438|7513967|FG001|NOT COMPLETED|Months 3-6 Crossover Period||1
6589336|NCT01972438|7513966|FG000|STARTED|Months 6-12 Study Period||6
6589337|NCT01972438|7513967|FG001|STARTED|Months 6-12 Study Period||6
6589338|NCT01972438|7513966|FG000|COMPLETED|Months 6-12 Study Period||3
6589339|NCT01972438|7513967|FG001|COMPLETED|Months 6-12 Study Period||4
6589340|NCT01972438|7513966|FG000|NOT COMPLETED|Months 6-12 Study Period||3
6589341|NCT01972438|7513967|FG001|NOT COMPLETED|Months 6-12 Study Period||2
6589342|NCT01972438|7513966|FG000|STARTED|Post Month 12 Study Period||3
6589343|NCT01972438|7513967|FG001|STARTED|Post Month 12 Study Period||4
6589344|NCT01972438|7513966|FG000|COMPLETED|Post Month 12 Study Period||0
6589345|NCT01972438|7513967|FG001|COMPLETED|Post Month 12 Study Period||0
6589346|NCT01972438|7513966|FG000|NOT COMPLETED|Post Month 12 Study Period||3
6589347|NCT01972438|7513967|FG001|NOT COMPLETED|Post Month 12 Study Period||4
6589348|NCT01972464|7513977|FG000|STARTED|Treatment Period (Week 1 Through Week 8)||19
6589349|NCT01972464|7513978|FG001|STARTED|Treatment Period (Week 1 Through Week 8)||22
6589350|NCT01972464|7513977|FG000|COMPLETED|Treatment Period (Week 1 Through Week 8)||16
6589351|NCT01972464|7513978|FG001|COMPLETED|Treatment Period (Week 1 Through Week 8)||18
6589352|NCT01972464|7513977|FG000|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||3
6589353|NCT01972464|7513978|FG001|NOT COMPLETED|Treatment Period (Week 1 Through Week 8)||4
6589354|NCT01972464|7513977|FG000|STARTED|3-Month Follow-Up (Week 20)||16
6589355|NCT01972464|7513978|FG001|STARTED|3-Month Follow-Up (Week 20)||18
6589356|NCT01972464|7513977|FG000|COMPLETED|3-Month Follow-Up (Week 20)||15
6589357|NCT01972464|7513978|FG001|COMPLETED|3-Month Follow-Up (Week 20)||17
6589358|NCT01972464|7513977|FG000|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
6589359|NCT01972464|7513978|FG001|NOT COMPLETED|3-Month Follow-Up (Week 20)||1
6589360|NCT01972516|7513987|FG000|STARTED|Overall Study||3
6589361|NCT01972516|7513988|FG001|STARTED|Overall Study||1
6589362|NCT01972516|7513987|FG000|COMPLETED|Overall Study||3
6589363|NCT01972516|7513988|FG001|COMPLETED|Overall Study||1
6589364|NCT01972516|7513987|FG000|NOT COMPLETED|Overall Study||0
6589365|NCT01972516|7513988|FG001|NOT COMPLETED|Overall Study||0
6589366|NCT01972529|7513998|FG000|STARTED|Overall Study||48
6589367|NCT01972529|7513999|FG001|STARTED|Overall Study||90
6589368|NCT01972529|7514000|FG002|STARTED|Overall Study||34
6589369|NCT01972529|7514001|FG003|STARTED|Overall Study||59
6589370|NCT01972529|7513998|FG000|COMPLETED|Overall Study||46
6589371|NCT01972529|7513999|FG001|COMPLETED|Overall Study||85
6589372|NCT01972529|7514000|FG002|COMPLETED|Overall Study||32
6589373|NCT01972529|7514001|FG003|COMPLETED|Overall Study||55
6589374|NCT01972529|7513998|FG000|NOT COMPLETED|Overall Study||2
6589375|NCT01972529|7513999|FG001|NOT COMPLETED|Overall Study||5
6589376|NCT01972529|7514000|FG002|NOT COMPLETED|Overall Study||2
6589377|NCT01972529|7514001|FG003|NOT COMPLETED|Overall Study||4
6589378|NCT01972568|7514015|FG000|STARTED|Overall Study||102
6589379|NCT01972568|7514016|FG001|STARTED|Overall Study||104
6589380|NCT01972568|7514017|FG002|STARTED|Overall Study||100
6589381|NCT01972568|7514015|FG000|COMPLETED|Overall Study||86
6589382|NCT01972568|7514016|FG001|COMPLETED|Overall Study||92
6589383|NCT01972568|7514017|FG002|COMPLETED|Overall Study||84
6589384|NCT01972568|7514015|FG000|NOT COMPLETED|Overall Study||16
6589385|NCT01972568|7514016|FG001|NOT COMPLETED|Overall Study||12
6589386|NCT01972568|7514017|FG002|NOT COMPLETED|Overall Study||16
6589387|NCT01972659|7514027|FG000|STARTED|Overall Study||40
6589388|NCT01972659|7514028|FG001|STARTED|Overall Study||40
6589389|NCT01972659|7514027|FG000|COMPLETED|Overall Study||36
6589390|NCT01972659|7514028|FG001|COMPLETED|Overall Study||37
6589391|NCT01972659|7514027|FG000|NOT COMPLETED|Overall Study||4
6589392|NCT01972659|7514028|FG001|NOT COMPLETED|Overall Study||3
6589393|NCT01972724|7514037|FG000|STARTED|Double-Blind||19
6589394|NCT01972724|7514038|FG001|STARTED|Double-Blind||18
6589395|NCT01972724|7514039|FG002|STARTED|Double-Blind||0
6589396|NCT01972724|7514037|FG000|Intent-to-treat:Received Study Drug|Double-Blind||17
6589397|NCT01972724|7514038|FG001|Intent-to-treat:Received Study Drug|Double-Blind||17
6589398|NCT01972724|7514039|FG002|Intent-to-treat:Received Study Drug|Double-Blind||0
6589399|NCT01972724|7514037|FG000|COMPLETED|Double-Blind||10
6589400|NCT01972724|7514038|FG001|COMPLETED|Double-Blind||9
6589401|NCT01972724|7514039|FG002|COMPLETED|Double-Blind||0
6589402|NCT01972724|7514037|FG000|NOT COMPLETED|Double-Blind||9
6589403|NCT01972724|7514038|FG001|NOT COMPLETED|Double-Blind||9
6589404|NCT01972724|7514039|FG002|NOT COMPLETED|Double-Blind||0
6589405|NCT01972724|7514037|FG000|STARTED|Open-Label||0
6589406|NCT01972724|7514038|FG001|STARTED|Open-Label||0
6589407|NCT01972724|7514039|FG002|STARTED|Open-Label||77
6589408|NCT01972724|7514037|FG000|COMPLETED|Open-Label||0
6589409|NCT01972724|7514038|FG001|COMPLETED|Open-Label||0
6589410|NCT01972724|7514039|FG002|COMPLETED|Open-Label||72
6589411|NCT01972724|7514037|FG000|NOT COMPLETED|Open-Label||0
6589412|NCT01972724|7514038|FG001|NOT COMPLETED|Open-Label||0
6589413|NCT01972724|7514039|FG002|NOT COMPLETED|Open-Label||5
6589414|NCT01972776|7514053|FG000|STARTED|Part 1||6
6589415|NCT01972776|7514054|FG001|STARTED|Part 1||6
6589416|NCT01972776|7514055|FG002|STARTED|Part 1||8
6589417|NCT01972776|7514056|FG003|STARTED|Part 1||7
6589418|NCT01972776|7514057|FG004|STARTED|Part 1||0
6589419|NCT01972776|7514058|FG005|STARTED|Part 1||0
6589420|NCT01972776|7514053|FG000|COMPLETED|Part 1||6
6589421|NCT01972776|7514054|FG001|COMPLETED|Part 1||6
6589422|NCT01972776|7514055|FG002|COMPLETED|Part 1||6
6589423|NCT01972776|7514056|FG003|COMPLETED|Part 1||6
6589424|NCT01972776|7514057|FG004|COMPLETED|Part 1||0
6278962|NCT00140231|7178649|FG000|COMPLETED|Washout 8weeks||7
6589425|NCT01972776|7514058|FG005|COMPLETED|Part 1||0
6589426|NCT01972776|7514053|FG000|NOT COMPLETED|Part 1||0
6589427|NCT01972776|7514054|FG001|NOT COMPLETED|Part 1||0
6589428|NCT01972776|7514055|FG002|NOT COMPLETED|Part 1||2
6659644|NCT02492451|7590520|FG000|STARTED|Overall Study||40
6659645|NCT02492451|7590521|FG001|STARTED|Overall Study||39
6659646|NCT02492451|7590522|FG002|STARTED|Overall Study||39
6659647|NCT02492451|7590520|FG000|COMPLETED|Overall Study||40
6659648|NCT02492451|7590521|FG001|COMPLETED|Overall Study||39
6589429|NCT01972776|7514056|FG003|NOT COMPLETED|Part 1||1
6589430|NCT01972776|7514057|FG004|NOT COMPLETED|Part 1||0
6589431|NCT01972776|7514058|FG005|NOT COMPLETED|Part 1||0
6589432|NCT01972776|7514053|FG000|STARTED|Part 2||0
6589433|NCT01972776|7514054|FG001|STARTED|Part 2||0
6589434|NCT01972776|7514055|FG002|STARTED|Part 2||0
6589435|NCT01972776|7514056|FG003|STARTED|Part 2||0
6589436|NCT01972776|7514057|FG004|STARTED|Part 2||14
6589437|NCT01972776|7514058|FG005|STARTED|Part 2||7
6589438|NCT01972776|7514053|FG000|COMPLETED|Part 2||0
6589439|NCT01972776|7514054|FG001|COMPLETED|Part 2||0
6589440|NCT01972776|7514055|FG002|COMPLETED|Part 2||0
6589441|NCT01972776|7514056|FG003|COMPLETED|Part 2||0
6589442|NCT01972776|7514057|FG004|COMPLETED|Part 2||1
6589443|NCT01972776|7514058|FG005|COMPLETED|Part 2||0
6589444|NCT01972776|7514053|FG000|NOT COMPLETED|Part 2||0
6589445|NCT01972776|7514054|FG001|NOT COMPLETED|Part 2||0
6589446|NCT01972776|7514055|FG002|NOT COMPLETED|Part 2||0
6589447|NCT01972776|7514056|FG003|NOT COMPLETED|Part 2||0
6589448|NCT01972776|7514057|FG004|NOT COMPLETED|Part 2||13
6589449|NCT01972776|7514058|FG005|NOT COMPLETED|Part 2||7
6589450|NCT01972789|7514074|FG000|STARTED|Overall Study||174
6589451|NCT01972789|7514075|FG001|STARTED|Overall Study||175
6589452|NCT01972789|7514074|FG000|COMPLETED|Overall Study||134
6589453|NCT01972789|7514075|FG001|COMPLETED|Overall Study||145
6589454|NCT01972789|7514074|FG000|NOT COMPLETED|Overall Study||40
6589455|NCT01972789|7514075|FG001|NOT COMPLETED|Overall Study||30
6589456|NCT01972841|7514087|FG000|STARTED|Overall Study||447
6589457|NCT01972841|7514088|FG001|STARTED|Overall Study||441
6589458|NCT01972841|7514089|FG002|STARTED|Overall Study||437
6589459|NCT01972841|7514090|FG003|STARTED|Overall Study||434
6589460|NCT01972841|7514091|FG004|STARTED|Overall Study||885
6589461|NCT01972841|7514092|FG005|STARTED|Overall Study||883
6589462|NCT01972841|7514087|FG000|COMPLETED|Overall Study||404
6589463|NCT01972841|7514088|FG001|COMPLETED|Overall Study||397
6589464|NCT01972841|7514089|FG002|COMPLETED|Overall Study||387
6589465|NCT01972841|7514090|FG003|COMPLETED|Overall Study||397
6589466|NCT01972841|7514091|FG004|COMPLETED|Overall Study||802
6589467|NCT01972841|7514092|FG005|COMPLETED|Overall Study||798
6589468|NCT01972841|7514087|FG000|NOT COMPLETED|Overall Study||43
6589469|NCT01972841|7514088|FG001|NOT COMPLETED|Overall Study||44
6589470|NCT01972841|7514089|FG002|NOT COMPLETED|Overall Study||50
6589471|NCT01972841|7514090|FG003|NOT COMPLETED|Overall Study||37
6589472|NCT01972841|7514091|FG004|NOT COMPLETED|Overall Study||83
6589473|NCT01972841|7514092|FG005|NOT COMPLETED|Overall Study||85
6589474|NCT01973036|7514108|FG000|STARTED|Overall Study||108
6589475|NCT01973036|7514109|FG001|STARTED|Overall Study||93
6589476|NCT01973036|7514108|FG000|Received Assigned Intervention|Overall Study||113
6589477|NCT01973036|7514109|FG001|Received Assigned Intervention|Overall Study||88
6589478|NCT01973036|7514108|FG000|COMPLETED|Overall Study||108
6589479|NCT01973036|7514109|FG001|COMPLETED|Overall Study||93
6589480|NCT01973036|7514108|FG000|NOT COMPLETED|Overall Study||0
6589481|NCT01973036|7514109|FG001|NOT COMPLETED|Overall Study||0
6589482|NCT01973205|7514118|FG000|STARTED|Overall Study||453
6589483|NCT01973205|7514119|FG001|STARTED|Overall Study||447
6589484|NCT01973205|7514118|FG000|COMPLETED|Overall Study||423
6589485|NCT01973205|7514119|FG001|COMPLETED|Overall Study||425
6589486|NCT01973205|7514118|FG000|NOT COMPLETED|Overall Study||30
6589487|NCT01973205|7514119|FG001|NOT COMPLETED|Overall Study||22
6589488|NCT01973218|7514127|FG000|STARTED|Overall Study||176
6589489|NCT01973218|7514128|FG001|STARTED|Overall Study||88
6659649|NCT02492451|7590522|FG002|COMPLETED|Overall Study||39
6659650|NCT02492451|7590520|FG000|NOT COMPLETED|Overall Study||0
6589490|NCT01973218|7514127|FG000|COMPLETED|Overall Study||174
6589491|NCT01973218|7514128|FG001|COMPLETED|Overall Study||88
6589492|NCT01973218|7514127|FG000|NOT COMPLETED|Overall Study||2
6589493|NCT01973218|7514128|FG001|NOT COMPLETED|Overall Study||0
6589494|NCT01973231|7514138|FG000|STARTED|Overall Study||202
6589495|NCT01973231|7514139|FG001|STARTED|Overall Study||202
6589496|NCT01973231|7514138|FG000|COMPLETED|Overall Study||191
6589497|NCT01973231|7514139|FG001|COMPLETED|Overall Study||190
6589498|NCT01973231|7514138|FG000|NOT COMPLETED|Overall Study||11
6589499|NCT01973231|7514139|FG001|NOT COMPLETED|Overall Study||12
6589500|NCT01973283|7514145|FG000|STARTED|Overall Study||100
6589501|NCT01973283|7514145|FG000|COMPLETED|Overall Study||96
6589502|NCT01973283|7514145|FG000|NOT COMPLETED|Overall Study||4
6589503|NCT01973335|7514155|FG000|STARTED|Overall Study||9
6589504|NCT01973335|7514156|FG001|STARTED|Overall Study||7
6589505|NCT01973335|7514157|FG002|STARTED|Overall Study||9
6589506|NCT01973335|7514158|FG003|STARTED|Overall Study||9
6589507|NCT01973335|7514155|FG000|COMPLETED|Overall Study||9
6589508|NCT01973335|7514156|FG001|COMPLETED|Overall Study||7
6589509|NCT01973335|7514157|FG002|COMPLETED|Overall Study||9
6589510|NCT01973335|7514158|FG003|COMPLETED|Overall Study||9
6589511|NCT01973335|7514155|FG000|NOT COMPLETED|Overall Study||0
6589512|NCT01973335|7514156|FG001|NOT COMPLETED|Overall Study||0
6589513|NCT01973335|7514157|FG002|NOT COMPLETED|Overall Study||0
6589514|NCT01973335|7514158|FG003|NOT COMPLETED|Overall Study||0
6589515|NCT01973348|7514172|FG000|STARTED|Overall Study||27
6589516|NCT01973348|7514173|FG001|STARTED|Overall Study||18
6589517|NCT01973348|7514174|FG002|STARTED|Overall Study||0
6589518|NCT01973348|7514175|FG003|STARTED|Overall Study||0
6589519|NCT01973348|7514172|FG000|COMPLETED|Overall Study||19
6589520|NCT01973348|7514173|FG001|COMPLETED|Overall Study||15
6589521|NCT01973348|7514174|FG002|COMPLETED|Overall Study||0
6589522|NCT01973348|7514175|FG003|COMPLETED|Overall Study||0
6589523|NCT01973348|7514172|FG000|NOT COMPLETED|Overall Study||8
6589524|NCT01973348|7514173|FG001|NOT COMPLETED|Overall Study||3
6589525|NCT01973348|7514174|FG002|NOT COMPLETED|Overall Study||0
6589526|NCT01973348|7514175|FG003|NOT COMPLETED|Overall Study||0
6589527|NCT01973387|7514187|FG000|STARTED|Overall Study||106
6589528|NCT01973387|7514188|FG001|STARTED|Overall Study||54
6589529|NCT01973387|7514187|FG000|Treated|Overall Study||104
6589530|NCT01973387|7514188|FG001|Treated|Overall Study||52
6589531|NCT01973387|7514187|FG000|COMPLETED|Overall Study||0
6589532|NCT01973387|7514188|FG001|COMPLETED|Overall Study||36
6589533|NCT01973387|7514187|FG000|NOT COMPLETED|Overall Study||106
6589534|NCT01973387|7514188|FG001|NOT COMPLETED|Overall Study||18
6589535|NCT01973413|7514196|FG000|STARTED|Overall Study||12
6589536|NCT01973413|7514197|FG001|STARTED|Overall Study||20
6589537|NCT01973413|7514196|FG000|COMPLETED|Overall Study||11
6589538|NCT01973413|7514197|FG001|COMPLETED|Overall Study||20
6589539|NCT01973413|7514196|FG000|NOT COMPLETED|Overall Study||1
6589540|NCT01973413|7514197|FG001|NOT COMPLETED|Overall Study||0
6589541|NCT01973439|7514204|FG000|STARTED|Overall Study||23
6589542|NCT01973439|7514204|FG000|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
6589543|NCT01973439|7514204|FG000|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
6589544|NCT01973439|7514204|FG000|COMPLETED|Overall Study||18
6589545|NCT01973439|7514204|FG000|NOT COMPLETED|Overall Study||5
6589546|NCT01973491|7514208|FG000|STARTED|Baseline Control Period (8 Weeks)||37
6589547|NCT01973491|7514208|FG000|COMPLETED|Baseline Control Period (8 Weeks)||19
6589548|NCT01973491|7514208|FG000|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
6589549|NCT01973491|7514208|FG000|STARTED|Titration Period(4 Weeks)||19
6589550|NCT01973491|7514208|FG000|COMPLETED|Titration Period(4 Weeks)||19
6589551|NCT01973491|7514208|FG000|NOT COMPLETED|Titration Period(4 Weeks)||0
6589552|NCT01973491|7514208|FG000|STARTED|Treatment Period (16 Weeks)||19
6589553|NCT01973491|7514208|FG000|COMPLETED|Treatment Period (16 Weeks)||18
6589554|NCT01973491|7514208|FG000|NOT COMPLETED|Treatment Period (16 Weeks)||1
6589555|NCT01973569|7514215|FG000|STARTED|Overall Study||228
6589556|NCT01973569|7514216|FG001|STARTED|Overall Study||225
6589557|NCT01973569|7514217|FG002|STARTED|Overall Study||226
6589558|NCT01973569|7514215|FG000|Received Study Drug|Overall Study||222
6589559|NCT01973569|7514216|FG001|Received Study Drug|Overall Study||222
6589560|NCT01973569|7514217|FG002|Received Study Drug|Overall Study||223
6589561|NCT01973569|7514215|FG000|Did Not Receive Study Drug|Overall Study||6
6589562|NCT01973569|7514216|FG001|Did Not Receive Study Drug|Overall Study||3
6589563|NCT01973569|7514217|FG002|Did Not Receive Study Drug|Overall Study||3
6589564|NCT01973569|7514215|FG000|Discontinued Study Treatment|Overall Study||23
6589565|NCT01973569|7514216|FG001|Discontinued Study Treatment|Overall Study||22
6589566|NCT01973569|7514217|FG002|Discontinued Study Treatment|Overall Study||15
6589567|NCT01973569|7514215|FG000|Discontinued Study|Overall Study||23
6589568|NCT01973569|7514216|FG001|Discontinued Study|Overall Study||22
6589569|NCT01973569|7514217|FG002|Discontinued Study|Overall Study||15
6589570|NCT01973569|7514215|FG000|COMPLETED|Overall Study||199
6589571|NCT01973569|7514216|FG001|COMPLETED|Overall Study||200
6589572|NCT01973569|7514217|FG002|COMPLETED|Overall Study||208
6589573|NCT01973569|7514215|FG000|NOT COMPLETED|Overall Study||29
6589574|NCT01973569|7514216|FG001|NOT COMPLETED|Overall Study||25
6589575|NCT01973569|7514217|FG002|NOT COMPLETED|Overall Study||18
6589576|NCT01973595|7514229|FG000|STARTED|Intervention Phase 1||15
6589577|NCT01973595|7514230|FG001|STARTED|Intervention Phase 1||14
6589578|NCT01973595|7514231|FG002|STARTED|Intervention Phase 1||15
6589579|NCT01973595|7514232|FG003|STARTED|Intervention Phase 1||14
6589580|NCT01973595|7514229|FG000|COMPLETED|Intervention Phase 1||15
6589581|NCT01973595|7514230|FG001|COMPLETED|Intervention Phase 1||14
6589582|NCT01973595|7514231|FG002|COMPLETED|Intervention Phase 1||15
6589583|NCT01973595|7514232|FG003|COMPLETED|Intervention Phase 1||14
6589584|NCT01973595|7514229|FG000|NOT COMPLETED|Intervention Phase 1||0
6589585|NCT01973595|7514230|FG001|NOT COMPLETED|Intervention Phase 1||0
6589586|NCT01973595|7514231|FG002|NOT COMPLETED|Intervention Phase 1||0
6589587|NCT01973595|7514232|FG003|NOT COMPLETED|Intervention Phase 1||0
6589588|NCT01973595|7514229|FG000|STARTED|Washout||15
6589589|NCT01973595|7514230|FG001|STARTED|Washout||14
6589590|NCT01973595|7514231|FG002|STARTED|Washout||15
6589591|NCT01973595|7514232|FG003|STARTED|Washout||14
6589592|NCT01973595|7514229|FG000|COMPLETED|Washout||14
6589593|NCT01973595|7514230|FG001|COMPLETED|Washout||14
6589594|NCT01973595|7514231|FG002|COMPLETED|Washout||14
6589595|NCT01973595|7514232|FG003|COMPLETED|Washout||14
6589596|NCT01973595|7514229|FG000|NOT COMPLETED|Washout||1
6589597|NCT01973595|7514230|FG001|NOT COMPLETED|Washout||0
6589598|NCT01973595|7514231|FG002|NOT COMPLETED|Washout||1
6589599|NCT01973595|7514232|FG003|NOT COMPLETED|Washout||0
6589600|NCT01973595|7514229|FG000|STARTED|Intervention Phase 2||14
6589601|NCT01973595|7514230|FG001|STARTED|Intervention Phase 2||14
6589602|NCT01973595|7514231|FG002|STARTED|Intervention Phase 2||14
6589603|NCT01973595|7514232|FG003|STARTED|Intervention Phase 2||14
6589604|NCT01973595|7514229|FG000|COMPLETED|Intervention Phase 2||14
6589605|NCT01973595|7514230|FG001|COMPLETED|Intervention Phase 2||14
6589606|NCT01973595|7514231|FG002|COMPLETED|Intervention Phase 2||14
6589607|NCT01973595|7514232|FG003|COMPLETED|Intervention Phase 2||14
6589608|NCT01973595|7514229|FG000|NOT COMPLETED|Intervention Phase 2||0
6589609|NCT01973595|7514230|FG001|NOT COMPLETED|Intervention Phase 2||0
6589610|NCT01973595|7514231|FG002|NOT COMPLETED|Intervention Phase 2||0
6589611|NCT01973595|7514232|FG003|NOT COMPLETED|Intervention Phase 2||0
6589612|NCT01973608|7514247|FG000|STARTED|Overall Study||2
6589613|NCT01973608|7514248|FG001|STARTED|Overall Study||2
6589614|NCT01973608|7514249|FG002|STARTED|Overall Study||6
6589615|NCT01973608|7514250|FG003|STARTED|Overall Study||2
6589616|NCT01973608|7514247|FG000|COMPLETED|Overall Study||2
6589617|NCT01973608|7514248|FG001|COMPLETED|Overall Study||2
6589618|NCT01973608|7514249|FG002|COMPLETED|Overall Study||6
6589619|NCT01973608|7514250|FG003|COMPLETED|Overall Study||2
6589620|NCT01973608|7514247|FG000|NOT COMPLETED|Overall Study||0
6589621|NCT01973608|7514248|FG001|NOT COMPLETED|Overall Study||0
6589622|NCT01973608|7514249|FG002|NOT COMPLETED|Overall Study||0
6589623|NCT01973608|7514250|FG003|NOT COMPLETED|Overall Study||0
6589624|NCT01973777|7514264|FG000|STARTED|Overall Study|January 2014|51
6589625|NCT01973777|7514264|FG000|One Year Follow-up|Overall Study||44
6659651|NCT02492451|7590521|FG001|NOT COMPLETED|Overall Study||0
6659652|NCT02492451|7590522|FG002|NOT COMPLETED|Overall Study||0
6659653|NCT02492750|7590533|FG000|STARTED|Overall Study||4
6659654|NCT02492750|7590534|FG001|STARTED|Overall Study||4
6659655|NCT02492750|7590535|FG002|STARTED|Overall Study||6
6659656|NCT02492750|7590533|FG000|COMPLETED|Overall Study||4
6659657|NCT02492750|7590534|FG001|COMPLETED|Overall Study||4
6659658|NCT02492750|7590535|FG002|COMPLETED|Overall Study||6
6659659|NCT02492750|7590533|FG000|NOT COMPLETED|Overall Study||0
6659660|NCT02492750|7590534|FG001|NOT COMPLETED|Overall Study||0
6659661|NCT02492750|7590535|FG002|NOT COMPLETED|Overall Study||0
6659662|NCT02492763|7590547|FG000|STARTED|Overall Study||46
6659663|NCT02492763|7590548|FG001|STARTED|Overall Study||44
6659664|NCT02492763|7590549|FG002|STARTED|Overall Study||43
6659665|NCT02492763|7590550|FG003|STARTED|Overall Study||43
6659666|NCT02492763|7590547|FG000|Treated|Overall Study||46
6659667|NCT02492763|7590548|FG001|Treated|Overall Study||44
6659668|NCT02492763|7590549|FG002|Treated|Overall Study||43
6659669|NCT02492763|7590550|FG003|Treated|Overall Study||42
6659670|NCT02492763|7590547|FG000|COMPLETED|Overall Study||30
6659671|NCT02492763|7590548|FG001|COMPLETED|Overall Study||29
6659672|NCT02492763|7590549|FG002|COMPLETED|Overall Study||33
6659673|NCT02492763|7590550|FG003|COMPLETED|Overall Study||30
6659674|NCT02492763|7590547|FG000|NOT COMPLETED|Overall Study||16
6659675|NCT02492763|7590548|FG001|NOT COMPLETED|Overall Study||15
6659676|NCT02492763|7590549|FG002|NOT COMPLETED|Overall Study||10
6659677|NCT02492763|7590550|FG003|NOT COMPLETED|Overall Study||13
6659678|NCT02492802|7590560|FG000|STARTED|Overall Study||64
6659679|NCT02492802|7590560|FG000|COMPLETED|Overall Study||64
6659680|NCT02492802|7590560|FG000|NOT COMPLETED|Overall Study||0
6659681|NCT02492841|7590567|FG000|STARTED|Overall Study||56
6659682|NCT02492841|7590568|FG001|STARTED|Overall Study||53
6659683|NCT02492841|7590569|FG002|STARTED|Overall Study||60
6659684|NCT02492841|7590567|FG000|COMPLETED|Overall Study||22
6659685|NCT02492841|7590568|FG001|COMPLETED|Overall Study||22
6659686|NCT02492841|7590569|FG002|COMPLETED|Overall Study||25
6589626|NCT01973777|7514264|FG000|COMPLETED|Overall Study||44
6589627|NCT01973777|7514264|FG000|NOT COMPLETED|Overall Study||7
6589628|NCT01973972|7514270|FG000|STARTED|Overall Study||127
6589629|NCT01973972|7514271|FG001|STARTED|Overall Study||136
6589630|NCT01973972|7514270|FG000|COMPLETED|Overall Study||109
6589631|NCT01973972|7514271|FG001|COMPLETED|Overall Study||117
6589632|NCT01973972|7514270|FG000|NOT COMPLETED|Overall Study||18
6589633|NCT01973972|7514271|FG001|NOT COMPLETED|Overall Study||19
6589634|NCT01973998|7514279|FG000|STARTED|Overall Study||33
6589635|NCT01973998|7514280|FG001|STARTED|Overall Study||35
6589636|NCT01973998|7514279|FG000|COMPLETED|Overall Study||31
6589637|NCT01973998|7514280|FG001|COMPLETED|Overall Study||33
6589638|NCT01973998|7514279|FG000|NOT COMPLETED|Overall Study||2
6659687|NCT02492841|7590567|FG000|NOT COMPLETED|Overall Study||34
6589639|NCT01973998|7514280|FG001|NOT COMPLETED|Overall Study||2
6589640|NCT01974050|7514286|FG000|STARTED|Overall Study||166
6589641|NCT01974050|7514286|FG000|COMPLETED|Overall Study||141
6589642|NCT01974050|7514286|FG000|NOT COMPLETED|Overall Study||25
6589643|NCT01974089|7514292|FG000|STARTED|Overall Study||53
6589644|NCT01974089|7514293|FG001|STARTED|Overall Study||101
6589645|NCT01974089|7514292|FG000|COMPLETED|Overall Study||53
6589646|NCT01974089|7514293|FG001|COMPLETED|Overall Study||101
6589647|NCT01974089|7514292|FG000|NOT COMPLETED|Overall Study||0
6589648|NCT01974089|7514293|FG001|NOT COMPLETED|Overall Study||0
6589649|NCT01974102|7514303|FG000|STARTED|Overall Study||22
6589650|NCT01974102|7514304|FG001|STARTED|Overall Study||20
6589651|NCT01974102|7514303|FG000|COMPLETED|Overall Study||15
6589652|NCT01974102|7514304|FG001|COMPLETED|Overall Study||19
6589653|NCT01974102|7514303|FG000|NOT COMPLETED|Overall Study||7
6589654|NCT01974102|7514304|FG001|NOT COMPLETED|Overall Study||1
6589655|NCT01974141|7514314|FG000|STARTED|Overall Study||1044
6589656|NCT01974141|7514315|FG001|STARTED|Overall Study||1058
6589657|NCT01974141|7514314|FG000|COMPLETED|Overall Study||948
6589658|NCT01974141|7514315|FG001|COMPLETED|Overall Study||976
6589659|NCT01974141|7514314|FG000|NOT COMPLETED|Overall Study||96
6589660|NCT01974141|7514315|FG001|NOT COMPLETED|Overall Study||82
6589661|NCT01974245|7514323|FG000|STARTED|Overall Study||27
6589662|NCT01974245|7514324|FG001|STARTED|Overall Study||28
6589663|NCT01974245|7514323|FG000|COMPLETED|Overall Study||18
6589664|NCT01974245|7514324|FG001|COMPLETED|Overall Study||20
6589665|NCT01974245|7514323|FG000|NOT COMPLETED|Overall Study||9
6589666|NCT01974245|7514324|FG001|NOT COMPLETED|Overall Study||8
6589667|NCT01974323|7514332|FG000|STARTED|Overall Study||1118
6589668|NCT01974323|7514333|FG001|STARTED|Overall Study||1120
6589669|NCT01974323|7514332|FG000|COMPLETED|Overall Study||1026
6589670|NCT01974323|7514333|FG001|COMPLETED|Overall Study||1027
6589671|NCT01974323|7514332|FG000|NOT COMPLETED|Overall Study||92
6589672|NCT01974323|7514333|FG001|NOT COMPLETED|Overall Study||93
6589673|NCT01974687|7514364|FG000|STARTED|Overall Study||6
6589674|NCT01974687|7514365|FG001|STARTED|Overall Study||6
6589675|NCT01974687|7514366|FG002|STARTED|Overall Study||6
6589676|NCT01974687|7514367|FG003|STARTED|Overall Study||6
6589677|NCT01974687|7514368|FG004|STARTED|Overall Study||2
6589678|NCT01974687|7514369|FG005|STARTED|Overall Study||6
6589679|NCT01974687|7514370|FG006|STARTED|Overall Study||3
6589680|NCT01974687|7514371|FG007|STARTED|Overall Study||3
6589681|NCT01974687|7514372|FG008|STARTED|Overall Study||3
6589682|NCT01974687|7514373|FG009|STARTED|Overall Study||3
6589683|NCT01974687|7514374|FG010|STARTED|Overall Study||3
6589684|NCT01974687|7514375|FG011|STARTED|Overall Study||13
6589685|NCT01974687|7514376|FG012|STARTED|Overall Study||13
6589686|NCT01974687|7514377|FG013|STARTED|Overall Study||10
6589687|NCT01974687|7514378|FG014|STARTED|Overall Study||19
6589688|NCT01974687|7514379|FG015|STARTED|Overall Study||9
6589689|NCT01974687|7514380|FG016|STARTED|Overall Study||9
6589690|NCT01974687|7514381|FG017|STARTED|Overall Study||11
6589691|NCT01974687|7514382|FG018|STARTED|Overall Study||9
6589692|NCT01974687|7514383|FG019|STARTED|Overall Study||3
6589693|NCT01974687|7514384|FG020|STARTED|Overall Study||3
6589694|NCT01974687|7514385|FG021|STARTED|Overall Study||8
6589695|NCT01974687|7514386|FG022|STARTED|Overall Study||8
6589696|NCT01974687|7514387|FG023|STARTED|Overall Study||6
6589697|NCT01974687|7514388|FG024|STARTED|Overall Study||10
6589698|NCT01974687|7514364|FG000|Treated|Overall Study||6
6589699|NCT01974687|7514365|FG001|Treated|Overall Study||6
6589700|NCT01974687|7514366|FG002|Treated|Overall Study||6
6589701|NCT01974687|7514367|FG003|Treated|Overall Study||6
6589702|NCT01974687|7514368|FG004|Treated|Overall Study||2
6589703|NCT01974687|7514369|FG005|Treated|Overall Study||6
6589704|NCT01974687|7514370|FG006|Treated|Overall Study||3
6589705|NCT01974687|7514371|FG007|Treated|Overall Study||3
6589706|NCT01974687|7514372|FG008|Treated|Overall Study||3
6589707|NCT01974687|7514373|FG009|Treated|Overall Study||3
6589708|NCT01974687|7514374|FG010|Treated|Overall Study||3
6659688|NCT02492841|7590568|FG001|NOT COMPLETED|Overall Study||31
6659689|NCT02492841|7590569|FG002|NOT COMPLETED|Overall Study||35
6589709|NCT01974687|7514375|FG011|Treated|Overall Study|2 participants discontinued prior to receiving study drug|11
6589710|NCT01974687|7514376|FG012|Treated|Overall Study|3 participants discontinued prior to receiving study drug|10
6589711|NCT01974687|7514377|FG013|Treated|Overall Study|2 participants discontinued prior to receiving study drug|8
6589712|NCT01974687|7514378|FG014|Treated|Overall Study|1 participant discontinued prior to receiving study drug|18
6589713|NCT01974687|7514379|FG015|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
6589714|NCT01974687|7514380|FG016|Treated|Overall Study|1 participant discontinued prior to receiving study drug|8
6589715|NCT01974687|7514381|FG017|Treated|Overall Study|3 participants discontinued prior to receiving study drug|8
6589716|NCT01974687|7514382|FG018|Treated|Overall Study||9
6589717|NCT01974687|7514383|FG019|Treated|Overall Study||3
6589718|NCT01974687|7514384|FG020|Treated|Overall Study||3
6589719|NCT01974687|7514385|FG021|Treated|Overall Study||8
6589720|NCT01974687|7514386|FG022|Treated|Overall Study||8
6589721|NCT01974687|7514387|FG023|Treated|Overall Study||6
6589722|NCT01974687|7514388|FG024|Treated|Overall Study||10
6589723|NCT01974687|7514364|FG000|COMPLETED|Overall Study||6
6589724|NCT01974687|7514365|FG001|COMPLETED|Overall Study||6
6589725|NCT01974687|7514366|FG002|COMPLETED|Overall Study||6
6589726|NCT01974687|7514367|FG003|COMPLETED|Overall Study||6
6589727|NCT01974687|7514368|FG004|COMPLETED|Overall Study||2
6589728|NCT01974687|7514369|FG005|COMPLETED|Overall Study||6
6589729|NCT01974687|7514370|FG006|COMPLETED|Overall Study||3
6589730|NCT01974687|7514371|FG007|COMPLETED|Overall Study||3
6589731|NCT01974687|7514372|FG008|COMPLETED|Overall Study||3
6589732|NCT01974687|7514373|FG009|COMPLETED|Overall Study||3
6589733|NCT01974687|7514374|FG010|COMPLETED|Overall Study||3
6589734|NCT01974687|7514375|FG011|COMPLETED|Overall Study||11
6589735|NCT01974687|7514376|FG012|COMPLETED|Overall Study||10
6589736|NCT01974687|7514377|FG013|COMPLETED|Overall Study||8
6589737|NCT01974687|7514378|FG014|COMPLETED|Overall Study||18
6589738|NCT01974687|7514379|FG015|COMPLETED|Overall Study||8
6589739|NCT01974687|7514380|FG016|COMPLETED|Overall Study||8
6589740|NCT01974687|7514381|FG017|COMPLETED|Overall Study||8
6589741|NCT01974687|7514382|FG018|COMPLETED|Overall Study||9
6589742|NCT01974687|7514383|FG019|COMPLETED|Overall Study||3
6589743|NCT01974687|7514384|FG020|COMPLETED|Overall Study||3
6589744|NCT01974687|7514385|FG021|COMPLETED|Overall Study||8
6589745|NCT01974687|7514386|FG022|COMPLETED|Overall Study||8
6589746|NCT01974687|7514387|FG023|COMPLETED|Overall Study||6
6589747|NCT01974687|7514388|FG024|COMPLETED|Overall Study||10
6589748|NCT01974687|7514364|FG000|NOT COMPLETED|Overall Study||0
6589749|NCT01974687|7514365|FG001|NOT COMPLETED|Overall Study||0
6589750|NCT01974687|7514366|FG002|NOT COMPLETED|Overall Study||0
6589751|NCT01974687|7514367|FG003|NOT COMPLETED|Overall Study||0
6589752|NCT01974687|7514368|FG004|NOT COMPLETED|Overall Study||0
6589753|NCT01974687|7514369|FG005|NOT COMPLETED|Overall Study||0
6589754|NCT01974687|7514370|FG006|NOT COMPLETED|Overall Study||0
6589755|NCT01974687|7514371|FG007|NOT COMPLETED|Overall Study||0
6589756|NCT01974687|7514372|FG008|NOT COMPLETED|Overall Study||0
6589757|NCT01974687|7514373|FG009|NOT COMPLETED|Overall Study||0
6589758|NCT01974687|7514374|FG010|NOT COMPLETED|Overall Study||0
6589759|NCT01974687|7514375|FG011|NOT COMPLETED|Overall Study||2
6589760|NCT01974687|7514376|FG012|NOT COMPLETED|Overall Study||3
6589761|NCT01974687|7514377|FG013|NOT COMPLETED|Overall Study||2
6589762|NCT01974687|7514378|FG014|NOT COMPLETED|Overall Study||1
6589763|NCT01974687|7514379|FG015|NOT COMPLETED|Overall Study||1
6589764|NCT01974687|7514380|FG016|NOT COMPLETED|Overall Study||1
6589765|NCT01974687|7514381|FG017|NOT COMPLETED|Overall Study||3
6589766|NCT01974687|7514382|FG018|NOT COMPLETED|Overall Study||0
6589767|NCT01974687|7514383|FG019|NOT COMPLETED|Overall Study||0
6589768|NCT01974687|7514384|FG020|NOT COMPLETED|Overall Study||0
6589769|NCT01974687|7514385|FG021|NOT COMPLETED|Overall Study||0
6589770|NCT01974687|7514386|FG022|NOT COMPLETED|Overall Study||0
6589771|NCT01974687|7514387|FG023|NOT COMPLETED|Overall Study||0
6589772|NCT01974687|7514388|FG024|NOT COMPLETED|Overall Study||0
6589773|NCT01974700|7514470|FG000|STARTED|Overall Study||5
6589774|NCT01974700|7514471|FG001|STARTED|Overall Study||3
6589775|NCT01974700|7514470|FG000|COMPLETED|Overall Study||5
6589776|NCT01974700|7514471|FG001|COMPLETED|Overall Study||3
6589777|NCT01974700|7514470|FG000|NOT COMPLETED|Overall Study||0
6589778|NCT01974700|7514471|FG001|NOT COMPLETED|Overall Study||0
6589779|NCT01974752|7514479|FG000|STARTED|Overall Study||97
6589780|NCT01974752|7514480|FG001|STARTED|Overall Study||32
6589781|NCT01974752|7514479|FG000|COMPLETED|Overall Study||60
6589782|NCT01974752|7514480|FG001|COMPLETED|Overall Study||17
6589783|NCT01974752|7514479|FG000|NOT COMPLETED|Overall Study||37
6589784|NCT01974752|7514480|FG001|NOT COMPLETED|Overall Study||15
6589785|NCT01974817|7514486|FG000|STARTED|Overall Study||25
6589786|NCT01974817|7514486|FG000|COMPLETED|Overall Study||17
6589787|NCT01974817|7514486|FG000|NOT COMPLETED|Overall Study||8
6589788|NCT01974895|7514492|FG000|STARTED|Overall Study||158
6589789|NCT01974895|7514493|FG001|STARTED|Overall Study||156
6589790|NCT01974895|7514492|FG000|COMPLETED|Overall Study||143
6589791|NCT01974895|7514493|FG001|COMPLETED|Overall Study||141
6589792|NCT01974895|7514492|FG000|NOT COMPLETED|Overall Study||15
6589793|NCT01974895|7514493|FG001|NOT COMPLETED|Overall Study||15
6589794|NCT01975090|7514499|FG000|STARTED|Overall Study||129
6589795|NCT01975090|7514499|FG000|6-month Follow-up|Overall Study||117
6589796|NCT01975090|7514499|FG000|COMPLETED|Overall Study||117
6589797|NCT01975090|7514499|FG000|NOT COMPLETED|Overall Study||12
6589798|NCT01975220|7514512|FG000|STARTED|Test Period 1||12
6589799|NCT01975220|7514513|FG001|STARTED|Test Period 1||12
6589800|NCT01975220|7514514|FG002|STARTED|Test Period 1||12
6589801|NCT01975220|7514515|FG003|STARTED|Test Period 1||12
6589802|NCT01975220|7514516|FG004|STARTED|Test Period 1||12
6589803|NCT01975220|7514517|FG005|STARTED|Test Period 1||12
6589804|NCT01975220|7514512|FG000|COMPLETED|Test Period 1||12
6589805|NCT01975220|7514513|FG001|COMPLETED|Test Period 1||11
6589806|NCT01975220|7514514|FG002|COMPLETED|Test Period 1||12
6589807|NCT01975220|7514515|FG003|COMPLETED|Test Period 1||12
6589808|NCT01975220|7514516|FG004|COMPLETED|Test Period 1||12
6589809|NCT01975220|7514517|FG005|COMPLETED|Test Period 1||12
6589810|NCT01975220|7514512|FG000|NOT COMPLETED|Test Period 1||0
6589811|NCT01975220|7514513|FG001|NOT COMPLETED|Test Period 1||1
6589812|NCT01975220|7514514|FG002|NOT COMPLETED|Test Period 1||0
6589813|NCT01975220|7514515|FG003|NOT COMPLETED|Test Period 1||0
6589814|NCT01975220|7514516|FG004|NOT COMPLETED|Test Period 1||0
6589815|NCT01975220|7514517|FG005|NOT COMPLETED|Test Period 1||0
6589816|NCT01975220|7514512|FG000|STARTED|Test Period 2||12
6589817|NCT01975220|7514513|FG001|STARTED|Test Period 2||11
6589818|NCT01975220|7514514|FG002|STARTED|Test Period 2||12
6589819|NCT01975220|7514515|FG003|STARTED|Test Period 2||12
6589820|NCT01975220|7514516|FG004|STARTED|Test Period 2||12
6589821|NCT01975220|7514517|FG005|STARTED|Test Period 2||12
6589822|NCT01975220|7514512|FG000|COMPLETED|Test Period 2||12
6589823|NCT01975220|7514513|FG001|COMPLETED|Test Period 2||11
6589824|NCT01975220|7514514|FG002|COMPLETED|Test Period 2||12
6589825|NCT01975220|7514515|FG003|COMPLETED|Test Period 2||12
6589826|NCT01975220|7514516|FG004|COMPLETED|Test Period 2||12
6589827|NCT01975220|7514517|FG005|COMPLETED|Test Period 2||12
6589828|NCT01975220|7514512|FG000|NOT COMPLETED|Test Period 2||0
6589829|NCT01975220|7514513|FG001|NOT COMPLETED|Test Period 2||0
6589830|NCT01975220|7514514|FG002|NOT COMPLETED|Test Period 2||0
6589831|NCT01975220|7514515|FG003|NOT COMPLETED|Test Period 2||0
6589832|NCT01975220|7514516|FG004|NOT COMPLETED|Test Period 2||0
6589833|NCT01975220|7514517|FG005|NOT COMPLETED|Test Period 2||0
6589834|NCT01975246|7514534|FG000|STARTED|Overall Study||149
6589835|NCT01975246|7514535|FG001|STARTED|Overall Study||160
6589836|NCT01975246|7514534|FG000|COMPLETED|Overall Study||145
6589837|NCT01975246|7514535|FG001|COMPLETED|Overall Study||158
6589838|NCT01975246|7514534|FG000|NOT COMPLETED|Overall Study||4
6589839|NCT01975246|7514535|FG001|NOT COMPLETED|Overall Study||2
6589840|NCT01975285|7514543|FG000|STARTED|Overall Study||30
6589841|NCT01975285|7514544|FG001|STARTED|Overall Study||30
6589842|NCT01975285|7514543|FG000|COMPLETED|Overall Study||28
6589843|NCT01975285|7514544|FG001|COMPLETED|Overall Study||28
6589844|NCT01975285|7514543|FG000|NOT COMPLETED|Overall Study||2
6589845|NCT01975285|7514544|FG001|NOT COMPLETED|Overall Study||2
6589846|NCT01975376|7514552|FG000|STARTED|Overall Study||8390
6589847|NCT01975376|7514553|FG001|STARTED|Overall Study||8394
6589848|NCT01975376|7514552|FG000|Treated|Overall Study||8374
6589849|NCT01975376|7514553|FG001|Treated|Overall Study||8386
6589850|NCT01975376|7514552|FG000|COMPLETED|Overall Study||8164
6589851|NCT01975376|7514553|FG001|COMPLETED|Overall Study||8177
6589852|NCT01975376|7514552|FG000|NOT COMPLETED|Overall Study||226
6589853|NCT01975376|7514553|FG001|NOT COMPLETED|Overall Study||217
6589854|NCT01975389|7514561|FG000|STARTED|Overall Study||5283
6589855|NCT01975389|7514562|FG001|STARTED|Overall Study||5281
6589856|NCT01975389|7514561|FG000|Treated|Overall Study||5279
6589857|NCT01975389|7514562|FG001|Treated|Overall Study||5276
6589858|NCT01975389|7514561|FG000|COMPLETED|Overall Study||5031
6589859|NCT01975389|7514562|FG001|COMPLETED|Overall Study||5045
6589860|NCT01975389|7514561|FG000|NOT COMPLETED|Overall Study||252
6589861|NCT01975389|7514562|FG001|NOT COMPLETED|Overall Study||236
6589862|NCT01975428|7514570|FG000|STARTED|Overall Study||85
6589863|NCT01975428|7514571|FG001|STARTED|Overall Study||97
6589864|NCT01975428|7514570|FG000|COMPLETED|Overall Study||65
6589865|NCT01975428|7514571|FG001|COMPLETED|Overall Study||83
6589866|NCT01975428|7514570|FG000|NOT COMPLETED|Overall Study||20
6589867|NCT01975428|7514571|FG001|NOT COMPLETED|Overall Study||14
6589868|NCT01975519|7514579|FG000|STARTED|Overall Study||3
6589869|NCT01975519|7514580|FG001|STARTED|Overall Study||108
6589870|NCT01975519|7514579|FG000|Phase 1b|Overall Study||3
6589871|NCT01975519|7514580|FG001|Phase 1b|Overall Study||23
6589872|NCT01975519|7514579|FG000|Phase 2a Soft Tissue Sarcoma|Overall Study||0
6589873|NCT01975519|7514580|FG001|Phase 2a Soft Tissue Sarcoma|Overall Study||63
6589874|NCT01975519|7514579|FG000|Phase 2a Angiosarcoma Cohort|Overall Study||0
6589875|NCT01975519|7514580|FG001|Phase 2a Angiosarcoma Cohort|Overall Study||22
6589876|NCT01975519|7514579|FG000|COMPLETED|Overall Study||3
6589877|NCT01975519|7514580|FG001|COMPLETED|Overall Study||108
6589878|NCT01975519|7514579|FG000|NOT COMPLETED|Overall Study||0
6589879|NCT01975519|7514580|FG001|NOT COMPLETED|Overall Study||0
6589880|NCT01975675|7514598|FG000|STARTED|Overall Study||83
6589881|NCT01975675|7514599|FG001|STARTED|Overall Study||83
6589882|NCT01975675|7514600|FG002|STARTED|Overall Study||88
6589883|NCT01975675|7514601|FG003|STARTED|Overall Study||87
6589884|NCT01975675|7514598|FG000|COMPLETED|Overall Study||83
6589885|NCT01975675|7514599|FG001|COMPLETED|Overall Study||82
6589886|NCT01975675|7514600|FG002|COMPLETED|Overall Study||88
6589887|NCT01975675|7514601|FG003|COMPLETED|Overall Study||87
6589888|NCT01975675|7514598|FG000|NOT COMPLETED|Overall Study||0
6589889|NCT01975675|7514599|FG001|NOT COMPLETED|Overall Study||1
6589890|NCT01975675|7514600|FG002|NOT COMPLETED|Overall Study||0
6589891|NCT01975675|7514601|FG003|NOT COMPLETED|Overall Study||0
6589892|NCT01975701|7514611|FG000|STARTED|Overall Study||26
6589893|NCT01975701|7514611|FG000|COMPLETED|Overall Study||1
6589894|NCT01975701|7514611|FG000|NOT COMPLETED|Overall Study||25
6589895|NCT01975831|7514624|FG000|STARTED|Overall Study||3
6589896|NCT01975831|7514625|FG001|STARTED|Overall Study||11
6589897|NCT01975831|7514626|FG002|STARTED|Overall Study||4
6589898|NCT01975831|7514627|FG003|STARTED|Overall Study||4
6589899|NCT01975831|7514628|FG004|STARTED|Overall Study||19
6589900|NCT01975831|7514629|FG005|STARTED|Overall Study||16
6589901|NCT01975831|7514630|FG006|STARTED|Overall Study||16
6589902|NCT01975831|7514631|FG007|STARTED|Overall Study||16
6589903|NCT01975831|7514632|FG008|STARTED|Overall Study||15
6589904|NCT01975831|7514624|FG000|COMPLETED|Overall Study||0
6589905|NCT01975831|7514625|FG001|COMPLETED|Overall Study||2
6589906|NCT01975831|7514626|FG002|COMPLETED|Overall Study||0
6589907|NCT01975831|7514627|FG003|COMPLETED|Overall Study||0
6589908|NCT01975831|7514628|FG004|COMPLETED|Overall Study||1
6589909|NCT01975831|7514629|FG005|COMPLETED|Overall Study||2
6589910|NCT01975831|7514630|FG006|COMPLETED|Overall Study||0
6589911|NCT01975831|7514631|FG007|COMPLETED|Overall Study||1
6589912|NCT01975831|7514632|FG008|COMPLETED|Overall Study||3
6589913|NCT01975831|7514624|FG000|NOT COMPLETED|Overall Study||3
6589914|NCT01975831|7514625|FG001|NOT COMPLETED|Overall Study||9
6589915|NCT01975831|7514626|FG002|NOT COMPLETED|Overall Study||4
6589916|NCT01975831|7514627|FG003|NOT COMPLETED|Overall Study||4
6589917|NCT01975831|7514628|FG004|NOT COMPLETED|Overall Study||18
6589918|NCT01975831|7514629|FG005|NOT COMPLETED|Overall Study||14
6589919|NCT01975831|7514630|FG006|NOT COMPLETED|Overall Study||16
6589920|NCT01975831|7514631|FG007|NOT COMPLETED|Overall Study||15
6589921|NCT01975831|7514632|FG008|NOT COMPLETED|Overall Study||12
6589922|NCT01975909|7514654|FG000|STARTED|Overall Study||10
6589923|NCT01975909|7514655|FG001|STARTED|Overall Study||10
6589924|NCT01975909|7514654|FG000|COMPLETED|Overall Study||10
6589925|NCT01975909|7514655|FG001|COMPLETED|Overall Study||10
6589926|NCT01975909|7514654|FG000|NOT COMPLETED|Overall Study||0
6589927|NCT01975909|7514655|FG001|NOT COMPLETED|Overall Study||0
6589928|NCT01975922|7514663|FG000|STARTED|Overall Study||45
6589929|NCT01975922|7514664|FG001|STARTED|Overall Study||52
6589930|NCT01975922|7514663|FG000|COMPLETED|Overall Study||45
6589931|NCT01975922|7514664|FG001|COMPLETED|Overall Study||43
6589932|NCT01975922|7514663|FG000|NOT COMPLETED|Overall Study||0
6589933|NCT01975922|7514664|FG001|NOT COMPLETED|Overall Study||9
6589934|NCT01975935|7514672|FG000|STARTED|Overall Study||21
6589935|NCT01975935|7514673|FG001|STARTED|Overall Study||21
6589936|NCT01975935|7514672|FG000|COMPLETED|Overall Study||18
6589937|NCT01975935|7514673|FG001|COMPLETED|Overall Study||20
6589938|NCT01975935|7514672|FG000|NOT COMPLETED|Overall Study||3
6589939|NCT01975935|7514673|FG001|NOT COMPLETED|Overall Study||1
6589940|NCT01975948|7514683|FG000|STARTED|Overall Study||56
6589941|NCT01975948|7514684|FG001|STARTED|Overall Study||55
6589942|NCT01975948|7514685|FG002|STARTED|Overall Study||72
6589943|NCT01975948|7514686|FG003|STARTED|Overall Study||57
6589944|NCT01975948|7514683|FG000|COMPLETED|Overall Study||39
6589945|NCT01975948|7514684|FG001|COMPLETED|Overall Study||34
6589946|NCT01975948|7514685|FG002|COMPLETED|Overall Study||65
6589947|NCT01975948|7514686|FG003|COMPLETED|Overall Study||51
6589948|NCT01975948|7514683|FG000|NOT COMPLETED|Overall Study||17
6589949|NCT01975948|7514684|FG001|NOT COMPLETED|Overall Study||21
6589950|NCT01975948|7514685|FG002|NOT COMPLETED|Overall Study||7
6589951|NCT01975948|7514686|FG003|NOT COMPLETED|Overall Study||6
6589952|NCT01975974|7514696|FG000|STARTED|Overall Study||100
6589953|NCT01975974|7514696|FG000|COMPLETED|Overall Study||100
6589954|NCT01975974|7514696|FG000|NOT COMPLETED|Overall Study||0
6589955|NCT01976104|7514704|FG000|STARTED|Overall Study||43
6589956|NCT01976104|7514705|FG001|STARTED|Overall Study||70
6589957|NCT01976104|7514706|FG002|STARTED|Overall Study||33
6589958|NCT01976104|7514707|FG003|STARTED|Overall Study||58
6589959|NCT01976104|7514704|FG000|COMPLETED|Overall Study||37
6589960|NCT01976104|7514705|FG001|COMPLETED|Overall Study||68
6589961|NCT01976104|7514706|FG002|COMPLETED|Overall Study||31
6589962|NCT01976104|7514707|FG003|COMPLETED|Overall Study||55
6589963|NCT01976104|7514704|FG000|NOT COMPLETED|Overall Study||6
6589964|NCT01976104|7514705|FG001|NOT COMPLETED|Overall Study||2
6589965|NCT01976104|7514706|FG002|NOT COMPLETED|Overall Study||2
6589966|NCT01976104|7514707|FG003|NOT COMPLETED|Overall Study||3
6589967|NCT01976299|7514720|FG000|STARTED|Overall Study||292
6589968|NCT01976299|7514721|FG001|STARTED|Overall Study||286
6589969|NCT01976299|7514720|FG000|Completed Procedure|Overall Study||283
6589970|NCT01976299|7514721|FG001|Completed Procedure|Overall Study||284
6589971|NCT01976299|7514720|FG000|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
6589972|NCT01976299|7514721|FG001|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
6589973|NCT01976299|7514720|FG000|NOT COMPLETED|Overall Study||23
6589974|NCT01976299|7514721|FG001|NOT COMPLETED|Overall Study||6
6624451|NCT02217527|7551884|FG001|COMPLETED|Drug Condition 2: Second Study Phase||14
6624452|NCT02217527|7551883|FG000|NOT COMPLETED|Drug Condition 2: Second Study Phase||0
6624453|NCT02217527|7551884|FG001|NOT COMPLETED|Drug Condition 2: Second Study Phase||1
6624454|NCT02217566|7551890|FG000|STARTED|Overall Study||46
6589975|NCT01976312|7514729|FG000|STARTED|Overall Study||190
6589976|NCT01976312|7514730|FG001|STARTED|Overall Study||62
6589977|NCT01976312|7514729|FG000|Completed 3 Months|Overall Study||186
6589978|NCT01976312|7514730|FG001|Completed 3 Months|Overall Study||60
6589979|NCT01976312|7514729|FG000|Discontinued Study Prior to 3 Months|Overall Study||4
6589980|NCT01976312|7514730|FG001|Discontinued Study Prior to 3 Months|Overall Study||2
6589981|NCT01976312|7514729|FG000|COMPLETED|Overall Study|Completed study at 12 months|173
6589982|NCT01976312|7514730|FG001|COMPLETED|Overall Study|Completed study at 12 months|53
6589983|NCT01976312|7514729|FG000|NOT COMPLETED|Overall Study||17
6589984|NCT01976312|7514730|FG001|NOT COMPLETED|Overall Study||9
6589985|NCT01976338|7514739|FG000|STARTED|Overall Study||190
6589986|NCT01976338|7514740|FG001|STARTED|Overall Study||93
6589987|NCT01976338|7514739|FG000|Completed 6 Months|Overall Study||185
6589988|NCT01976338|7514740|FG001|Completed 6 Months|Overall Study||91
6589989|NCT01976338|7514739|FG000|Discontinued Study Prior to 6 Months|Overall Study||5
6589990|NCT01976338|7514740|FG001|Discontinued Study Prior to 6 Months|Overall Study||2
6589991|NCT01976338|7514739|FG000|COMPLETED|Overall Study|12 months|177
6589992|NCT01976338|7514740|FG001|COMPLETED|Overall Study|12 months|89
6589993|NCT01976338|7514739|FG000|NOT COMPLETED|Overall Study||13
6589994|NCT01976338|7514740|FG001|NOT COMPLETED|Overall Study||4
6589995|NCT01976364|7514747|FG000|STARTED|Main Study (36 Months)||686
6589996|NCT01976364|7514748|FG001|STARTED|Main Study (36 Months)||0
6589997|NCT01976364|7514749|FG002|STARTED|Main Study (36 Months)||0
6589998|NCT01976364|7514747|FG000|COMPLETED|Main Study (36 Months)||465
6589999|NCT01976364|7514748|FG001|COMPLETED|Main Study (36 Months)||0
6590000|NCT01976364|7514749|FG002|COMPLETED|Main Study (36 Months)||0
6659690|NCT02492854|7590582|FG000|STARTED|Overall Study||5
6659691|NCT02492854|7590583|FG001|STARTED|Overall Study||3
6659692|NCT02492854|7590582|FG000|COMPLETED|Overall Study||5
6659693|NCT02492854|7590583|FG001|COMPLETED|Overall Study||3
6659694|NCT02492854|7590582|FG000|NOT COMPLETED|Overall Study||0
6659695|NCT02492854|7590583|FG001|NOT COMPLETED|Overall Study||0
6659696|NCT02492880|7590589|FG000|STARTED|Overall Study||15
6659697|NCT02492880|7590589|FG000|COMPLETED|Overall Study||13
6659698|NCT02492880|7590589|FG000|NOT COMPLETED|Overall Study||2
6659699|NCT02492958|7590597|FG000|STARTED|Overall Study||34
6659700|NCT02492958|7590598|FG001|STARTED|Overall Study||34
6659701|NCT02492958|7590599|FG002|STARTED|Overall Study||34
6659702|NCT02492958|7590600|FG003|STARTED|Overall Study||34
6659703|NCT02492958|7590597|FG000|COMPLETED|Overall Study||33
6659704|NCT02492958|7590598|FG001|COMPLETED|Overall Study||34
6659705|NCT02492958|7590599|FG002|COMPLETED|Overall Study||32
6659706|NCT02492958|7590600|FG003|COMPLETED|Overall Study||34
6659707|NCT02492958|7590597|FG000|NOT COMPLETED|Overall Study||1
6659708|NCT02492958|7590598|FG001|NOT COMPLETED|Overall Study||0
6659709|NCT02492958|7590599|FG002|NOT COMPLETED|Overall Study||2
6659710|NCT02492958|7590600|FG003|NOT COMPLETED|Overall Study||0
6659711|NCT02492984|7590612|FG000|STARTED|Overall Study||73
6659712|NCT02492984|7590613|FG001|STARTED|Overall Study||14
6659713|NCT02492984|7590612|FG000|COMPLETED|Overall Study||70
6659714|NCT02492984|7590613|FG001|COMPLETED|Overall Study||14
6659715|NCT02492984|7590612|FG000|NOT COMPLETED|Overall Study||3
6659716|NCT02492984|7590613|FG001|NOT COMPLETED|Overall Study||0
6659717|NCT02492997|7590624|FG000|STARTED|Overall Study||21
6659718|NCT02492997|7590625|FG001|STARTED|Overall Study||21
6659719|NCT02492997|7590624|FG000|COMPLETED|Overall Study||19
6659720|NCT02492997|7590625|FG001|COMPLETED|Overall Study||20
6659721|NCT02492997|7590624|FG000|NOT COMPLETED|Overall Study||2
6659722|NCT02492997|7590625|FG001|NOT COMPLETED|Overall Study||1
6659723|NCT02493036|7590634|FG000|STARTED|Overall Study||17
6659724|NCT02493036|7590635|FG001|STARTED|Overall Study||20
6659725|NCT02493036|7590636|FG002|STARTED|Overall Study||17
6659726|NCT02493036|7590634|FG000|COMPLETED|Overall Study||16
6659727|NCT02493036|7590635|FG001|COMPLETED|Overall Study||18
6659728|NCT02493036|7590636|FG002|COMPLETED|Overall Study||15
6659729|NCT02493036|7590634|FG000|NOT COMPLETED|Overall Study||1
6659730|NCT02493036|7590635|FG001|NOT COMPLETED|Overall Study||2
6659731|NCT02493036|7590636|FG002|NOT COMPLETED|Overall Study||2
6659732|NCT02493062|7590644|FG000|STARTED|Overall Study||35
6659733|NCT02493062|7590644|FG000|COMPLETED|Overall Study||23
6659734|NCT02493062|7590644|FG000|NOT COMPLETED|Overall Study||12
6659735|NCT02493088|7590648|FG000|STARTED|Overall Study||11
6659736|NCT02493088|7590648|FG000|COMPLETED|Overall Study||11
6659737|NCT02493088|7590648|FG000|NOT COMPLETED|Overall Study||0
6659738|NCT02493127|7590654|FG000|STARTED|Overall Study||61
6659739|NCT02493127|7590655|FG001|STARTED|Overall Study||61
6659740|NCT02493127|7590654|FG000|COMPLETED|Overall Study||60
6659741|NCT02493127|7590655|FG001|COMPLETED|Overall Study||60
6659742|NCT02493127|7590654|FG000|NOT COMPLETED|Overall Study||1
6659743|NCT02493127|7590655|FG001|NOT COMPLETED|Overall Study||1
6659744|NCT02493257|7590665|FG000|STARTED|Overall Study||11
6659745|NCT02493257|7590666|FG001|STARTED|Overall Study||11
6659746|NCT02493257|7590665|FG000|4 Week Follow up|Overall Study||11
6659747|NCT02493257|7590666|FG001|4 Week Follow up|Overall Study||11
6659748|NCT02493257|7590665|FG000|12 Week Follow up|Overall Study||10
6659749|NCT02493257|7590666|FG001|12 Week Follow up|Overall Study||10
6659750|NCT02493257|7590665|FG000|COMPLETED|Overall Study||10
6659751|NCT02493257|7590666|FG001|COMPLETED|Overall Study||10
6659752|NCT02493257|7590665|FG000|NOT COMPLETED|Overall Study||1
6659753|NCT02493257|7590666|FG001|NOT COMPLETED|Overall Study||1
6590001|NCT01976364|7514747|FG000|NOT COMPLETED|Main Study (36 Months)||221
6590002|NCT01976364|7514748|FG001|NOT COMPLETED|Main Study (36 Months)||0
6590003|NCT01976364|7514749|FG002|NOT COMPLETED|Main Study (36 Months)||0
6590004|NCT01976364|7514747|FG000|STARTED|Sub-study (12 Months)||0
6590005|NCT01976364|7514748|FG001|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|89
6590006|NCT01976364|7514749|FG002|STARTED|Sub-study (12 Months)|Participants from main study who consented to take part in sub-study, continued into sub-study.|90
6590007|NCT01976364|7514747|FG000|COMPLETED|Sub-study (12 Months)||0
6590008|NCT01976364|7514748|FG001|COMPLETED|Sub-study (12 Months)||83
6590009|NCT01976364|7514749|FG002|COMPLETED|Sub-study (12 Months)||85
6590010|NCT01976364|7514747|FG000|NOT COMPLETED|Sub-study (12 Months)||0
6590011|NCT01976364|7514748|FG001|NOT COMPLETED|Sub-study (12 Months)||6
6590012|NCT01976364|7514749|FG002|NOT COMPLETED|Sub-study (12 Months)||5
6590013|NCT01976390|7514760|FG000|STARTED|Overall Study||41
6590014|NCT01976390|7514761|FG001|STARTED|Overall Study||19
6590015|NCT01976390|7514760|FG000|COMPLETED|Overall Study||41
6590016|NCT01976390|7514761|FG001|COMPLETED|Overall Study||19
6590017|NCT01976390|7514760|FG000|NOT COMPLETED|Overall Study||0
6590018|NCT01976390|7514761|FG001|NOT COMPLETED|Overall Study||0
6590019|NCT01976416|7514769|FG000|STARTED|Overall Study||104
6590020|NCT01976416|7514770|FG001|STARTED|Overall Study||104
6590021|NCT01976416|7514769|FG000|COMPLETED|Overall Study||102
6590022|NCT01976416|7514770|FG001|COMPLETED|Overall Study||102
6590023|NCT01976416|7514769|FG000|NOT COMPLETED|Overall Study||2
6590024|NCT01976416|7514770|FG001|NOT COMPLETED|Overall Study||2
6590025|NCT01976442|7514778|FG000|STARTED|Overall Study||69
6590026|NCT01976442|7514779|FG001|STARTED|Overall Study||31
6590027|NCT01976442|7514778|FG000|COMPLETED|Overall Study||69
6590028|NCT01976442|7514779|FG001|COMPLETED|Overall Study||31
6590029|NCT01976442|7514778|FG000|NOT COMPLETED|Overall Study||0
6590030|NCT01976442|7514779|FG001|NOT COMPLETED|Overall Study||0
6590031|NCT01976507|7514785|FG000|STARTED|Overall Study||101
6590032|NCT01976507|7514785|FG000|Received Initial Dose of Dabigatran|Overall Study||100
6590033|NCT01976507|7514785|FG000|COMPLETED|Overall Study||94
6590034|NCT01976507|7514785|FG000|NOT COMPLETED|Overall Study||7
6590035|NCT01976572|7514789|FG000|STARTED|Overall Study||6
6590036|NCT01976572|7514790|FG001|STARTED|Overall Study||6
6590037|NCT01976572|7514791|FG002|STARTED|Overall Study||6
6590038|NCT01976572|7514789|FG000|COMPLETED|Overall Study||6
6590039|NCT01976572|7514790|FG001|COMPLETED|Overall Study||6
6590040|NCT01976572|7514791|FG002|COMPLETED|Overall Study||6
6590041|NCT01976572|7514789|FG000|NOT COMPLETED|Overall Study||0
6590042|NCT01976572|7514790|FG001|NOT COMPLETED|Overall Study||0
6590043|NCT01976572|7514791|FG002|NOT COMPLETED|Overall Study||0
6590044|NCT01976624|7514800|FG000|STARTED|Overall Study||756
6590045|NCT01976624|7514800|FG000|COMPLETED|Overall Study||742
6590046|NCT01976624|7514800|FG000|NOT COMPLETED|Overall Study||14
6590047|NCT01976650|7514804|FG000|STARTED|Overall Study||724
6590048|NCT01976650|7514804|FG000|COMPLETED|Overall Study||718
6590049|NCT01976650|7514804|FG000|NOT COMPLETED|Overall Study||6
6590050|NCT01976663|7514808|FG000|STARTED|Overall Study||126
6590051|NCT01976663|7514808|FG000|Received Touch-up Treatment|Overall Study||63
6590052|NCT01976663|7514808|FG000|Received Asymmetry Correction|Overall Study||45
6590053|NCT01976663|7514808|FG000|Received Repeat Treatment|Overall Study||85
6590054|NCT01976663|7514808|FG000|COMPLETED|Overall Study||84
6590055|NCT01976663|7514808|FG000|NOT COMPLETED|Overall Study||42
6590056|NCT01976728|7514820|FG000|STARTED|Overall Study||10
6590057|NCT01976728|7514821|FG001|STARTED|Overall Study||9
6590058|NCT01976728|7514822|FG002|STARTED|Overall Study||10
6590059|NCT01976728|7514823|FG003|STARTED|Overall Study||10
6590060|NCT01976728|7514820|FG000|Dosed|Overall Study||10
6590061|NCT01976728|7514821|FG001|Dosed|Overall Study||9
6590062|NCT01976728|7514822|FG002|Dosed|Overall Study||10
6590063|NCT01976728|7514823|FG003|Dosed|Overall Study||10
6590064|NCT01976728|7514820|FG000|COMPLETED|Overall Study||9
6590065|NCT01976728|7514821|FG001|COMPLETED|Overall Study||9
6590066|NCT01976728|7514822|FG002|COMPLETED|Overall Study||10
6590067|NCT01976728|7514823|FG003|COMPLETED|Overall Study||10
6590068|NCT01976728|7514820|FG000|NOT COMPLETED|Overall Study||1
6590069|NCT01976728|7514821|FG001|NOT COMPLETED|Overall Study||0
6590070|NCT01976728|7514822|FG002|NOT COMPLETED|Overall Study||0
6590071|NCT01976728|7514823|FG003|NOT COMPLETED|Overall Study||0
6590072|NCT01976741|7514859|FG000|STARTED|Overall Study||4
6659754|NCT02493361|7590672|FG000|STARTED|Overall Study||24
6659755|NCT02493361|7590672|FG000|Week 24 Assessment|Overall Study||21
6659756|NCT02493361|7590672|FG000|COMPLETED|Overall Study||21
6659757|NCT02493361|7590672|FG000|NOT COMPLETED|Overall Study||3
6659758|NCT02493452|7590679|FG000|STARTED|Overall Study||379
6590073|NCT01976741|7514860|FG001|STARTED|Overall Study||4
6590074|NCT01976741|7514861|FG002|STARTED|Overall Study||4
6590075|NCT01976741|7514862|FG003|STARTED|Overall Study||3
6590076|NCT01976741|7514863|FG004|STARTED|Overall Study||4
6590077|NCT01976741|7514864|FG005|STARTED|Overall Study||4
6590078|NCT01976741|7514865|FG006|STARTED|Overall Study||23
6590079|NCT01976741|7514866|FG007|STARTED|Overall Study||74
6590080|NCT01976741|7514867|FG008|STARTED|Overall Study||8
6590081|NCT01976741|7514868|FG009|STARTED|Overall Study||40
6590082|NCT01976741|7514859|FG000|COMPLETED|Overall Study||3
6590083|NCT01976741|7514860|FG001|COMPLETED|Overall Study||4
6590084|NCT01976741|7514861|FG002|COMPLETED|Overall Study||1
6659759|NCT02493452|7590680|FG001|STARTED|Overall Study||377
6590085|NCT01976741|7514862|FG003|COMPLETED|Overall Study||2
6590086|NCT01976741|7514863|FG004|COMPLETED|Overall Study||4
6590087|NCT01976741|7514864|FG005|COMPLETED|Overall Study||4
6590088|NCT01976741|7514865|FG006|COMPLETED|Overall Study||19
6590089|NCT01976741|7514866|FG007|COMPLETED|Overall Study||62
6590090|NCT01976741|7514867|FG008|COMPLETED|Overall Study||7
6590091|NCT01976741|7514868|FG009|COMPLETED|Overall Study||36
6590092|NCT01976741|7514859|FG000|NOT COMPLETED|Overall Study||1
6590093|NCT01976741|7514860|FG001|NOT COMPLETED|Overall Study||0
6590094|NCT01976741|7514861|FG002|NOT COMPLETED|Overall Study||3
6590095|NCT01976741|7514862|FG003|NOT COMPLETED|Overall Study||1
6590096|NCT01976741|7514863|FG004|NOT COMPLETED|Overall Study||0
6590097|NCT01976741|7514864|FG005|NOT COMPLETED|Overall Study||0
6590098|NCT01976741|7514865|FG006|NOT COMPLETED|Overall Study||4
6590099|NCT01976741|7514866|FG007|NOT COMPLETED|Overall Study||12
6590100|NCT01976741|7514867|FG008|NOT COMPLETED|Overall Study||1
6590101|NCT01976741|7514868|FG009|NOT COMPLETED|Overall Study||4
6590102|NCT01976806|7514904|FG000|STARTED|Overall Study||27
6590103|NCT01976806|7514905|FG001|STARTED|Overall Study||28
6590104|NCT01976806|7514904|FG000|COMPLETED|Overall Study||24
6590105|NCT01976806|7514905|FG001|COMPLETED|Overall Study||22
6590106|NCT01976806|7514904|FG000|NOT COMPLETED|Overall Study||3
6590107|NCT01976806|7514905|FG001|NOT COMPLETED|Overall Study||6
6590108|NCT01976819|7514911|FG000|STARTED|Overall Study||16
6590109|NCT01976819|7514911|FG000|COMPLETED|Overall Study||11
6590110|NCT01976819|7514911|FG000|NOT COMPLETED|Overall Study||5
6590111|NCT01976845|7514923|FG000|STARTED|Overall Study||48
6590112|NCT01976845|7514924|FG001|STARTED|Overall Study||48
6590113|NCT01976845|7514925|FG002|STARTED|Overall Study||43
6590114|NCT01976845|7514923|FG000|COMPLETED|Overall Study||40
6590115|NCT01976845|7514924|FG001|COMPLETED|Overall Study||40
6590116|NCT01976845|7514925|FG002|COMPLETED|Overall Study||40
6590117|NCT01976845|7514923|FG000|NOT COMPLETED|Overall Study||8
6590118|NCT01976845|7514924|FG001|NOT COMPLETED|Overall Study||8
6590119|NCT01976845|7514925|FG002|NOT COMPLETED|Overall Study||3
6590120|NCT01976871|7514933|FG000|STARTED|Overall Study||21
6590121|NCT01976871|7514933|FG000|COMPLETED|Overall Study||20
6590122|NCT01976871|7514933|FG000|NOT COMPLETED|Overall Study||1
6590123|NCT01976975|7514939|FG000|STARTED|Overall Study||226
6590124|NCT01976975|7514940|FG001|STARTED|Overall Study||44
6590125|NCT01976975|7514939|FG000|COMPLETED|Overall Study||79
6590126|NCT01976975|7514940|FG001|COMPLETED|Overall Study||32
6590127|NCT01976975|7514939|FG000|NOT COMPLETED|Overall Study||147
6590128|NCT01976975|7514940|FG001|NOT COMPLETED|Overall Study||12
6590129|NCT01976988|7514948|FG000|STARTED|Overall Study||208
6590130|NCT01976988|7514949|FG001|STARTED|Overall Study||202
6590131|NCT01976988|7514948|FG000|COMPLETED|Overall Study||192
6590132|NCT01976988|7514949|FG001|COMPLETED|Overall Study||184
6590133|NCT01976988|7514948|FG000|NOT COMPLETED|Overall Study||16
6590134|NCT01976988|7514949|FG001|NOT COMPLETED|Overall Study||18
6590135|NCT01977040|7514957|FG000|STARTED|Overall Study||68
6590136|NCT01977040|7514957|FG000|COMPLETED|Overall Study||66
6590137|NCT01977040|7514957|FG000|NOT COMPLETED|Overall Study||2
6590138|NCT01977092|7514967|FG000|STARTED|Overall Study||149
6590139|NCT01977092|7514968|FG001|STARTED|Overall Study||181
6590140|NCT01977092|7514967|FG000|COMPLETED|Overall Study||118
6590141|NCT01977092|7514968|FG001|COMPLETED|Overall Study||151
6590142|NCT01977092|7514967|FG000|NOT COMPLETED|Overall Study||31
6590143|NCT01977092|7514968|FG001|NOT COMPLETED|Overall Study||30
6590144|NCT01977222|7514974|FG000|STARTED|Overall Study||12
6590145|NCT01977222|7514974|FG000|COMPLETED|Overall Study||11
6590146|NCT01977222|7514974|FG000|NOT COMPLETED|Overall Study||1
6590147|NCT01977352|7514980|FG000|STARTED|Overall Study||21
6590148|NCT01977352|7514981|FG001|STARTED|Overall Study||21
6590149|NCT01977352|7514980|FG000|COMPLETED|Overall Study||20
6590150|NCT01977352|7514981|FG001|COMPLETED|Overall Study||19
6590151|NCT01977352|7514980|FG000|NOT COMPLETED|Overall Study||1
6590152|NCT01977352|7514981|FG001|NOT COMPLETED|Overall Study||2
6590153|NCT01977456|7514987|FG000|STARTED|Overall Study||27
6590154|NCT01977456|7514987|FG000|COMPLETED|Overall Study||22
6590155|NCT01977456|7514987|FG000|NOT COMPLETED|Overall Study||5
6590156|NCT01977482|7514997|FG000|STARTED|Overall Study||39
6590157|NCT01977482|7514998|FG001|STARTED|Overall Study||39
6590158|NCT01977482|7514999|FG002|STARTED|Overall Study||40
6590159|NCT01977482|7515000|FG003|STARTED|Overall Study||39
6590160|NCT01977482|7515001|FG004|STARTED|Overall Study||40
6590161|NCT01977482|7515002|FG005|STARTED|Overall Study||19
6590162|NCT01977482|7514997|FG000|COMPLETED|Overall Study||36
6590163|NCT01977482|7514998|FG001|COMPLETED|Overall Study||30
6590164|NCT01977482|7514999|FG002|COMPLETED|Overall Study||35
6590165|NCT01977482|7515000|FG003|COMPLETED|Overall Study||35
6590166|NCT01977482|7515001|FG004|COMPLETED|Overall Study||37
6590167|NCT01977482|7515002|FG005|COMPLETED|Overall Study||14
6590168|NCT01977482|7514997|FG000|NOT COMPLETED|Overall Study||3
6590169|NCT01977482|7514998|FG001|NOT COMPLETED|Overall Study||9
6590170|NCT01977482|7514999|FG002|NOT COMPLETED|Overall Study||5
6590171|NCT01977482|7515000|FG003|NOT COMPLETED|Overall Study||4
6590172|NCT01977482|7515001|FG004|NOT COMPLETED|Overall Study||3
6590173|NCT01977482|7515002|FG005|NOT COMPLETED|Overall Study||5
6590174|NCT01977547|7515023|FG000|STARTED|Overall Study||768
6590175|NCT01977547|7515024|FG001|STARTED|Overall Study||770
6590176|NCT01977547|7515023|FG000|COMPLETED|Overall Study||728
6590177|NCT01977547|7515024|FG001|COMPLETED|Overall Study||733
6590178|NCT01977547|7515023|FG000|NOT COMPLETED|Overall Study||40
6590179|NCT01977547|7515024|FG001|NOT COMPLETED|Overall Study||37
6590180|NCT01977573|7515034|FG000|STARTED|Overall Study||136
6590181|NCT01977573|7515035|FG001|STARTED|Overall Study||44
6590182|NCT01977573|7515036|FG002|STARTED|Overall Study||36
6590183|NCT01977573|7515037|FG003|STARTED|Overall Study||36
6590184|NCT01977573|7515034|FG000|COMPLETED|Overall Study||116
6590185|NCT01977573|7515035|FG001|COMPLETED|Overall Study||41
6590186|NCT01977573|7515036|FG002|COMPLETED|Overall Study||32
6590187|NCT01977573|7515037|FG003|COMPLETED|Overall Study||33
6590188|NCT01977573|7515034|FG000|NOT COMPLETED|Overall Study||20
6590189|NCT01977573|7515035|FG001|NOT COMPLETED|Overall Study||3
6590190|NCT01977573|7515036|FG002|NOT COMPLETED|Overall Study||4
6590191|NCT01977573|7515037|FG003|NOT COMPLETED|Overall Study||3
6590192|NCT01977599|7515050|FG000|STARTED|Overall Study||1118
6590193|NCT01977599|7515051|FG001|STARTED|Overall Study||1122
6590194|NCT01977599|7515050|FG000|COMPLETED|Overall Study||1118
6590195|NCT01977599|7515051|FG001|COMPLETED|Overall Study||1122
6590196|NCT01977599|7515050|FG000|NOT COMPLETED|Overall Study||0
6590197|NCT01977599|7515051|FG001|NOT COMPLETED|Overall Study||0
6590198|NCT01977612|7515059|FG000|STARTED|Overall Study||85
6590199|NCT01977612|7515060|FG001|STARTED|Overall Study||80
6590200|NCT01977612|7515059|FG000|COMPLETED|Overall Study||84
6590201|NCT01977612|7515060|FG001|COMPLETED|Overall Study||79
6590202|NCT01977612|7515059|FG000|NOT COMPLETED|Overall Study||1
6590203|NCT01977612|7515060|FG001|NOT COMPLETED|Overall Study||1
6590204|NCT01977625|7515066|FG000|STARTED|First Intervention (4 Weeks)||11
6590205|NCT01977625|7515067|FG001|STARTED|First Intervention (4 Weeks)||7
6590206|NCT01977625|7515066|FG000|COMPLETED|First Intervention (4 Weeks)||8
6590207|NCT01977625|7515067|FG001|COMPLETED|First Intervention (4 Weeks)||7
6590208|NCT01977625|7515066|FG000|NOT COMPLETED|First Intervention (4 Weeks)||3
6590209|NCT01977625|7515067|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6590210|NCT01977625|7515066|FG000|STARTED|Washout (2 Weeks)||8
6590211|NCT01977625|7515067|FG001|STARTED|Washout (2 Weeks)||7
6590212|NCT01977625|7515066|FG000|COMPLETED|Washout (2 Weeks)||8
6590213|NCT01977625|7515067|FG001|COMPLETED|Washout (2 Weeks)||7
6590214|NCT01977625|7515066|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6590215|NCT01977625|7515067|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6590216|NCT01977625|7515066|FG000|STARTED|Second Intervention (4 Weeks)||8
6590217|NCT01977625|7515067|FG001|STARTED|Second Intervention (4 Weeks)||7
6590218|NCT01977625|7515066|FG000|COMPLETED|Second Intervention (4 Weeks)||7
6590219|NCT01977625|7515067|FG001|COMPLETED|Second Intervention (4 Weeks)||7
6590220|NCT01977625|7515066|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
6590221|NCT01977625|7515067|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
6590222|NCT01977651|7515075|FG000|STARTED|4 Month Treatment Period||423
6590223|NCT01977651|7515075|FG000|COMPLETED|4 Month Treatment Period||322
6590224|NCT01977651|7515075|FG000|NOT COMPLETED|4 Month Treatment Period||101
6590225|NCT01977651|7515075|FG000|STARTED|1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the 1 year extension period|287
6590226|NCT01977651|7515075|FG000|COMPLETED|1 Year Extension Period||157
6590227|NCT01977651|7515075|FG000|NOT COMPLETED|1 Year Extension Period||130
6590228|NCT01977651|7515075|FG000|STARTED|Post 1 Year Extension Period|Participants who benefited from enzalutamide treatment continued in the post 1 year extension period|145
6590229|NCT01977651|7515075|FG000|COMPLETED|Post 1 Year Extension Period||1
6590230|NCT01977651|7515075|FG000|NOT COMPLETED|Post 1 Year Extension Period||144
6590231|NCT01977677|7515082|FG000|STARTED|Overall Study||3
6590232|NCT01977677|7515083|FG001|STARTED|Overall Study||6
6590233|NCT01977677|7515084|FG002|STARTED|Overall Study||21
6590234|NCT01977677|7515082|FG000|COMPLETED|Overall Study||3
6590235|NCT01977677|7515083|FG001|COMPLETED|Overall Study||6
6590236|NCT01977677|7515084|FG002|COMPLETED|Overall Study||20
6590237|NCT01977677|7515082|FG000|NOT COMPLETED|Overall Study||0
6590238|NCT01977677|7515083|FG001|NOT COMPLETED|Overall Study||0
6590239|NCT01977677|7515084|FG002|NOT COMPLETED|Overall Study||1
6590240|NCT01977690|7515094|FG000|STARTED|Overall Study||15
6590241|NCT01977690|7515095|FG001|STARTED|Overall Study||15
6590242|NCT01977690|7515094|FG000|COMPLETED|Overall Study||15
6590243|NCT01977690|7515095|FG001|COMPLETED|Overall Study||11
6590244|NCT01977690|7515094|FG000|NOT COMPLETED|Overall Study||0
6590245|NCT01977690|7515095|FG001|NOT COMPLETED|Overall Study||4
6590246|NCT01977781|7515103|FG000|STARTED|Overall Study||24
6590247|NCT01977781|7515104|FG001|STARTED|Overall Study||16
6590248|NCT01977781|7515103|FG000|COMPLETED|Overall Study||18
6590249|NCT01977781|7515104|FG001|COMPLETED|Overall Study||15
6590250|NCT01977781|7515103|FG000|NOT COMPLETED|Overall Study||6
6590251|NCT01977781|7515104|FG001|NOT COMPLETED|Overall Study||1
6590252|NCT01977794|7515112|FG000|STARTED|Overall Study||100
6590253|NCT01977794|7515113|FG001|STARTED|Overall Study||100
6590254|NCT01977794|7515112|FG000|COMPLETED|Overall Study||92
6590255|NCT01977794|7515113|FG001|COMPLETED|Overall Study||94
6590256|NCT01977794|7515112|FG000|NOT COMPLETED|Overall Study||8
6590257|NCT01977794|7515113|FG001|NOT COMPLETED|Overall Study||6
6590258|NCT01977820|7515121|FG000|STARTED|Overall Study||1
6590259|NCT01977820|7515122|FG001|STARTED|Overall Study||1
6590260|NCT01977820|7515121|FG000|COMPLETED|Overall Study||0
6590261|NCT01977820|7515122|FG001|COMPLETED|Overall Study||0
6590262|NCT01977820|7515121|FG000|NOT COMPLETED|Overall Study||1
6590263|NCT01977820|7515122|FG001|NOT COMPLETED|Overall Study||1
6590264|NCT01977846|7515130|FG000|STARTED|Total Study - Retrospective||251
6590265|NCT01977846|7515131|FG001|STARTED|Total Study - Retrospective||0
6590266|NCT01977846|7515130|FG000|COMPLETED|Total Study - Retrospective||251
6590267|NCT01977846|7515131|FG001|COMPLETED|Total Study - Retrospective||0
6590268|NCT01977846|7515130|FG000|NOT COMPLETED|Total Study - Retrospective||0
6590269|NCT01977846|7515131|FG001|NOT COMPLETED|Total Study - Retrospective||0
6590270|NCT01977846|7515130|FG000|STARTED|Total Study - Prospective||0
6590271|NCT01977846|7515131|FG001|STARTED|Total Study - Prospective||259
6590272|NCT01977846|7515130|FG000|COMPLETED|Total Study - Prospective||0
6590273|NCT01977846|7515131|FG001|COMPLETED|Total Study - Prospective||230
6590274|NCT01977846|7515130|FG000|NOT COMPLETED|Total Study - Prospective||0
6590275|NCT01977846|7515131|FG001|NOT COMPLETED|Total Study - Prospective||29
6590276|NCT01977898|7515140|FG000|STARTED|Overall Study||28
6590277|NCT01977898|7515141|FG001|STARTED|Overall Study||35
6590278|NCT01977898|7515140|FG000|COMPLETED|Overall Study||27
6590279|NCT01977898|7515141|FG001|COMPLETED|Overall Study||34
6590280|NCT01977898|7515140|FG000|NOT COMPLETED|Overall Study||1
6590281|NCT01977898|7515141|FG001|NOT COMPLETED|Overall Study||1
6590282|NCT01977937|7515149|FG000|STARTED|Overall Study||27
6590283|NCT01977937|7515150|FG001|STARTED|Overall Study||28
6590284|NCT01977937|7515149|FG000|COMPLETED|Overall Study||24
6590285|NCT01977937|7515150|FG001|COMPLETED|Overall Study||26
6590286|NCT01977937|7515149|FG000|NOT COMPLETED|Overall Study||3
6590287|NCT01977937|7515150|FG001|NOT COMPLETED|Overall Study||2
6590288|NCT01978093|7515158|FG000|STARTED|Overall Study||297
6590289|NCT01978093|7515159|FG001|STARTED|Overall Study||303
6590290|NCT01978093|7515158|FG000|COMPLETED|Overall Study||232
6590291|NCT01978093|7515159|FG001|COMPLETED|Overall Study||230
6590292|NCT01978093|7515158|FG000|NOT COMPLETED|Overall Study||65
6590293|NCT01978093|7515159|FG001|NOT COMPLETED|Overall Study||73
6590294|NCT01978119|7515168|FG000|STARTED|Treatment Period 1 (12 Weeks)||40
6590295|NCT01978119|7515169|FG001|STARTED|Treatment Period 1 (12 Weeks)||42
6590296|NCT01978119|7515168|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||38
6590297|NCT01978119|7515169|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||42
6590298|NCT01978119|7515168|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
6590299|NCT01978119|7515169|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
6590300|NCT01978119|7515168|FG000|STARTED|Washout Period 1 (3 Weeks)||38
6590301|NCT01978119|7515169|FG001|STARTED|Washout Period 1 (3 Weeks)||42
6590302|NCT01978119|7515168|FG000|COMPLETED|Washout Period 1 (3 Weeks)||38
6590303|NCT01978119|7515169|FG001|COMPLETED|Washout Period 1 (3 Weeks)||42
6590304|NCT01978119|7515168|FG000|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
6590305|NCT01978119|7515169|FG001|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
6590306|NCT01978119|7515168|FG000|STARTED|Treatment Period 2 (12 Weeks)||38
6590307|NCT01978119|7515169|FG001|STARTED|Treatment Period 2 (12 Weeks)||42
6590308|NCT01978119|7515168|FG000|COMPLETED|Treatment Period 2 (12 Weeks)||38
6590309|NCT01978119|7515169|FG001|COMPLETED|Treatment Period 2 (12 Weeks)||40
6590310|NCT01978119|7515168|FG000|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
6590311|NCT01978119|7515169|FG001|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
6590312|NCT01978145|7515175|FG000|STARTED|Treatment Period 1||214
6590313|NCT01978145|7515176|FG001|STARTED|Treatment Period 1||212
6590314|NCT01978145|7515175|FG000|COMPLETED|Treatment Period 1||205
6590315|NCT01978145|7515176|FG001|COMPLETED|Treatment Period 1||196
6590316|NCT01978145|7515175|FG000|NOT COMPLETED|Treatment Period 1||9
6590317|NCT01978145|7515176|FG001|NOT COMPLETED|Treatment Period 1||16
6590318|NCT01978145|7515175|FG000|STARTED|Washout Period 1||205
6590319|NCT01978145|7515176|FG001|STARTED|Washout Period 1||196
6659760|NCT02493452|7590681|FG002|STARTED|Overall Study||379
6659761|NCT02493452|7590679|FG000|COMPLETED|Overall Study||329
6659762|NCT02493452|7590680|FG001|COMPLETED|Overall Study||328
6659763|NCT02493452|7590681|FG002|COMPLETED|Overall Study||325
6659764|NCT02493452|7590679|FG000|NOT COMPLETED|Overall Study||50
6659765|NCT02493452|7590680|FG001|NOT COMPLETED|Overall Study||49
6659766|NCT02493452|7590681|FG002|NOT COMPLETED|Overall Study||54
6659767|NCT02493517|7590691|FG000|STARTED|Overall Study||64
6659768|NCT02493517|7590692|FG001|STARTED|Overall Study||64
6659769|NCT02493517|7590691|FG000|COMPLETED|Overall Study||62
6659770|NCT02493517|7590692|FG001|COMPLETED|Overall Study||57
6659771|NCT02493517|7590691|FG000|NOT COMPLETED|Overall Study||2
6659772|NCT02493517|7590692|FG001|NOT COMPLETED|Overall Study||7
6659773|NCT02493608|7590702|FG000|STARTED|Overall Study||48
6659774|NCT02493608|7590703|FG001|STARTED|Overall Study||48
6659775|NCT02493608|7590702|FG000|COMPLETED|Overall Study||48
6659776|NCT02493608|7590703|FG001|COMPLETED|Overall Study||48
6659777|NCT02493608|7590702|FG000|NOT COMPLETED|Overall Study||0
6659778|NCT02493608|7590703|FG001|NOT COMPLETED|Overall Study||0
6659779|NCT02493621|7590711|FG000|STARTED|Overall Study||58
6659780|NCT02493621|7590712|FG001|STARTED|Overall Study||58
6659781|NCT02493621|7590711|FG000|COMPLETED|Overall Study||58
6659782|NCT02493621|7590712|FG001|COMPLETED|Overall Study||58
6278963|NCT00140231|7178650|FG001|COMPLETED|Washout 8weeks||6
6590320|NCT01978145|7515175|FG000|COMPLETED|Washout Period 1||204
6659783|NCT02493621|7590711|FG000|NOT COMPLETED|Overall Study||0
6659784|NCT02493621|7590712|FG001|NOT COMPLETED|Overall Study||0
6659785|NCT02493660|7590720|FG000|STARTED|Overall Study|ITT|93
6659786|NCT02493660|7590721|FG001|STARTED|Overall Study|ITT|91
6659787|NCT02493660|7590720|FG000|COMPLETED|Overall Study||93
6659788|NCT02493660|7590721|FG001|COMPLETED|Overall Study|Investigator requested subject be discontinued prior to any post-procedure efficacy assessments.|90
6590321|NCT01978145|7515176|FG001|COMPLETED|Washout Period 1||193
6590322|NCT01978145|7515175|FG000|NOT COMPLETED|Washout Period 1||1
6590323|NCT01978145|7515176|FG001|NOT COMPLETED|Washout Period 1||3
6590324|NCT01978145|7515175|FG000|STARTED|Treatment Period 2||204
6590325|NCT01978145|7515176|FG001|STARTED|Treatment Period 2||193
6590326|NCT01978145|7515175|FG000|COMPLETED|Treatment Period 2||185
6590327|NCT01978145|7515176|FG001|COMPLETED|Treatment Period 2||179
6590328|NCT01978145|7515175|FG000|NOT COMPLETED|Treatment Period 2||19
6590329|NCT01978145|7515176|FG001|NOT COMPLETED|Treatment Period 2||14
6590330|NCT01978184|7515184|FG000|STARTED|Overall Study||43
6590331|NCT01978184|7515185|FG001|STARTED|Overall Study||61
6590332|NCT01978184|7515184|FG000|COMPLETED|Overall Study||30
6590333|NCT01978184|7515185|FG001|COMPLETED|Overall Study||41
6590334|NCT01978184|7515184|FG000|NOT COMPLETED|Overall Study||13
6590335|NCT01978184|7515185|FG001|NOT COMPLETED|Overall Study||20
6590336|NCT01978236|7515191|FG000|STARTED|Overall Study||6
6590337|NCT01978236|7515191|FG000|COMPLETED|Overall Study||4
6590338|NCT01978236|7515191|FG000|NOT COMPLETED|Overall Study||2
6590339|NCT01978262|7515195|FG000|STARTED|Overall Study||103
6590340|NCT01978262|7515195|FG000|COMPLETED|Overall Study||92
6590341|NCT01978262|7515195|FG000|NOT COMPLETED|Overall Study||11
6590342|NCT01978314|7515205|FG000|STARTED|Overall Study||8
6590343|NCT01978314|7515206|FG001|STARTED|Overall Study||8
6590344|NCT01978314|7515207|FG002|STARTED|Overall Study||8
6590345|NCT01978314|7515208|FG003|STARTED|Overall Study||1
6590346|NCT01978314|7515209|FG004|STARTED|Overall Study||8
6590347|NCT01978314|7515205|FG000|COMPLETED|Overall Study||8
6590348|NCT01978314|7515206|FG001|COMPLETED|Overall Study||8
6590349|NCT01978314|7515207|FG002|COMPLETED|Overall Study||8
6590350|NCT01978314|7515208|FG003|COMPLETED|Overall Study||1
6590351|NCT01978314|7515209|FG004|COMPLETED|Overall Study||8
6590352|NCT01978314|7515205|FG000|NOT COMPLETED|Overall Study||0
6590353|NCT01978314|7515206|FG001|NOT COMPLETED|Overall Study||0
6590354|NCT01978314|7515207|FG002|NOT COMPLETED|Overall Study||0
6590355|NCT01978314|7515208|FG003|NOT COMPLETED|Overall Study||0
6590356|NCT01978314|7515209|FG004|NOT COMPLETED|Overall Study||0
6590357|NCT01978509|7515235|FG000|STARTED|Overall Study||10
6590358|NCT01978509|7515236|FG001|STARTED|Overall Study||13
6590359|NCT01978509|7515237|FG002|STARTED|Overall Study||9
6590360|NCT01978509|7515235|FG000|COMPLETED|Overall Study||8
6590361|NCT01978509|7515236|FG001|COMPLETED|Overall Study||8
6590362|NCT01978509|7515237|FG002|COMPLETED|Overall Study||9
6590363|NCT01978509|7515235|FG000|NOT COMPLETED|Overall Study||2
6590364|NCT01978509|7515236|FG001|NOT COMPLETED|Overall Study||5
6590365|NCT01978509|7515237|FG002|NOT COMPLETED|Overall Study||0
6590366|NCT01978600|7515247|FG000|STARTED|Overall Study||44
6590367|NCT01978600|7515248|FG001|STARTED|Overall Study||42
6590368|NCT01978600|7515247|FG000|COMPLETED|Overall Study||44
6590369|NCT01978600|7515248|FG001|COMPLETED|Overall Study||42
6590370|NCT01978600|7515247|FG000|NOT COMPLETED|Overall Study||0
6590371|NCT01978600|7515248|FG001|NOT COMPLETED|Overall Study||0
6590372|NCT01978743|7515254|FG000|STARTED|Overall Study||10
6590373|NCT01978743|7515254|FG000|COMPLETED|Overall Study||10
6590374|NCT01978743|7515254|FG000|NOT COMPLETED|Overall Study||0
6590375|NCT01978912|7515263|FG000|STARTED|Overall Study||6
6590376|NCT01978912|7515264|FG001|STARTED|Overall Study||6
6590377|NCT01978912|7515265|FG002|STARTED|Overall Study||6
6590378|NCT01978912|7515266|FG003|STARTED|Overall Study||6
6590379|NCT01978912|7515263|FG000|COMPLETED|Overall Study||3
6590380|NCT01978912|7515264|FG001|COMPLETED|Overall Study||3
6590381|NCT01978912|7515265|FG002|COMPLETED|Overall Study||3
6590382|NCT01978912|7515266|FG003|COMPLETED|Overall Study||3
6590383|NCT01978912|7515263|FG000|NOT COMPLETED|Overall Study||3
6590384|NCT01978912|7515264|FG001|NOT COMPLETED|Overall Study||3
6590385|NCT01978912|7515265|FG002|NOT COMPLETED|Overall Study||3
6590386|NCT01978912|7515266|FG003|NOT COMPLETED|Overall Study||3
6590387|NCT01979016|7515278|FG000|STARTED|Overall Study||27
6590388|NCT01979016|7515279|FG001|STARTED|Overall Study||27
6590389|NCT01979016|7515278|FG000|COMPLETED|Overall Study||25
6590390|NCT01979016|7515279|FG001|COMPLETED|Overall Study||26
6590391|NCT01979016|7515278|FG000|NOT COMPLETED|Overall Study||2
6590392|NCT01979016|7515279|FG001|NOT COMPLETED|Overall Study||1
6590393|NCT01979029|7515287|FG000|STARTED|Overall Study||29
6590394|NCT01979029|7515288|FG001|STARTED|Overall Study||28
6590395|NCT01979029|7515287|FG000|COMPLETED|Overall Study||29
6590396|NCT01979029|7515288|FG001|COMPLETED|Overall Study||28
6590397|NCT01979029|7515287|FG000|NOT COMPLETED|Overall Study||0
6590398|NCT01979029|7515288|FG001|NOT COMPLETED|Overall Study||0
6590399|NCT01979133|7515294|FG000|STARTED|Overall Study||10
6590400|NCT01979133|7515294|FG000|COMPLETED|Overall Study||7
6590401|NCT01979133|7515294|FG000|NOT COMPLETED|Overall Study||3
6590402|NCT01979159|7515311|FG000|STARTED|Overall Study||4
6590403|NCT01979159|7515311|FG000|COMPLETED|Overall Study||4
6590404|NCT01979159|7515311|FG000|NOT COMPLETED|Overall Study||0
6590405|NCT01979185|7515319|FG000|STARTED|Period 1||15
6590406|NCT01979185|7515320|FG001|STARTED|Period 1||15
6590407|NCT01979185|7515319|FG000|COMPLETED|Period 1||15
6590408|NCT01979185|7515320|FG001|COMPLETED|Period 1||15
6590409|NCT01979185|7515319|FG000|NOT COMPLETED|Period 1||0
6590410|NCT01979185|7515320|FG001|NOT COMPLETED|Period 1||0
6590411|NCT01979185|7515319|FG000|STARTED|Period 2||15
6590412|NCT01979185|7515320|FG001|STARTED|Period 2||15
6590413|NCT01979185|7515319|FG000|COMPLETED|Period 2||15
6624455|NCT02217566|7551890|FG000|COMPLETED|Overall Study||35
6590414|NCT01979185|7515320|FG001|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
6590415|NCT01979185|7515319|FG000|NOT COMPLETED|Period 2||0
6590416|NCT01979185|7515320|FG001|NOT COMPLETED|Period 2||1
6590417|NCT01979276|7515326|FG000|STARTED|Overall Study||2
6590418|NCT01979276|7515326|FG000|COMPLETED|Overall Study||2
6590419|NCT01979276|7515326|FG000|NOT COMPLETED|Overall Study||0
6590420|NCT01979445|7515332|FG000|STARTED|Overall Study||3
6590421|NCT01979445|7515333|FG001|STARTED|Overall Study||3
6590422|NCT01979445|7515334|FG002|STARTED|Overall Study||6
6590423|NCT01979445|7515335|FG003|STARTED|Overall Study||3
6590424|NCT01979445|7515332|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6590425|NCT01979445|7515333|FG001|Received at Least 1 Dose of Study Drug|Overall Study||3
6590426|NCT01979445|7515334|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6590427|NCT01979445|7515335|FG003|Received at Least 1 Dose of Study Drug|Overall Study||3
6590428|NCT01979445|7515332|FG000|ITT Population|Overall Study||3
6590429|NCT01979445|7515333|FG001|ITT Population|Overall Study||3
6590430|NCT01979445|7515334|FG002|ITT Population|Overall Study||6
6590431|NCT01979445|7515335|FG003|ITT Population|Overall Study||3
6590432|NCT01979445|7515332|FG000|COMPLETED|Overall Study||3
6590433|NCT01979445|7515333|FG001|COMPLETED|Overall Study||3
6590434|NCT01979445|7515334|FG002|COMPLETED|Overall Study||6
6590435|NCT01979445|7515335|FG003|COMPLETED|Overall Study||3
6590436|NCT01979445|7515332|FG000|NOT COMPLETED|Overall Study||0
6590437|NCT01979445|7515333|FG001|NOT COMPLETED|Overall Study||0
6590438|NCT01979445|7515334|FG002|NOT COMPLETED|Overall Study||0
6590439|NCT01979445|7515335|FG003|NOT COMPLETED|Overall Study||0
6590440|NCT01979523|7515355|FG000|STARTED|Overall Study||21
6590441|NCT01979523|7515356|FG001|STARTED|Overall Study||21
6590442|NCT01979523|7515355|FG000|COMPLETED|Overall Study||20
6590443|NCT01979523|7515356|FG001|COMPLETED|Overall Study||21
6590444|NCT01979523|7515355|FG000|NOT COMPLETED|Overall Study||1
6590445|NCT01979523|7515356|FG001|NOT COMPLETED|Overall Study||0
6590446|NCT01979614|7515365|FG000|STARTED|Overall Study||30
6590447|NCT01979614|7515366|FG001|STARTED|Overall Study||28
6590448|NCT01979614|7515365|FG000|Safety Analysis Set|Overall Study||30
6590449|NCT01979614|7515366|FG001|Safety Analysis Set|Overall Study||28
6590450|NCT01979614|7515365|FG000|PK Analysis Set|Overall Study||30
6590451|NCT01979614|7515366|FG001|PK Analysis Set|Overall Study||0
6590452|NCT01979614|7515365|FG000|PD Analysis Set|Overall Study||25
6590453|NCT01979614|7515366|FG001|PD Analysis Set|Overall Study||26
6590454|NCT01979614|7515365|FG000|COMPLETED|Overall Study||29
6590455|NCT01979614|7515366|FG001|COMPLETED|Overall Study||27
6590456|NCT01979614|7515365|FG000|NOT COMPLETED|Overall Study||1
6590457|NCT01979614|7515366|FG001|NOT COMPLETED|Overall Study||1
6590458|NCT01979835|7515372|FG000|STARTED|Primary Outcome SA Measurment||1030
6590459|NCT01979835|7515372|FG000|COMPLETED|Primary Outcome SA Measurment||1012
6590460|NCT01979835|7515372|FG000|NOT COMPLETED|Primary Outcome SA Measurment||18
6590461|NCT01979835|7515372|FG000|STARTED|Follow-up||1012
6590462|NCT01979835|7515372|FG000|COMPLETED|Follow-up||980
6590463|NCT01979835|7515372|FG000|NOT COMPLETED|Follow-up||32
6590464|NCT01979952|7515378|FG000|STARTED|Overall Study||56
6590465|NCT01979952|7515379|FG001|STARTED|Overall Study||57
6590466|NCT01979952|7515378|FG000|COMPLETED|Overall Study||48
6590467|NCT01979952|7515379|FG001|COMPLETED|Overall Study||51
6590468|NCT01979952|7515378|FG000|NOT COMPLETED|Overall Study||8
6590469|NCT01979952|7515379|FG001|NOT COMPLETED|Overall Study||6
6590470|NCT01980056|7515388|FG000|STARTED|Overall Study||4
6590471|NCT01980056|7515389|FG001|STARTED|Overall Study||4
6590472|NCT01980056|7515390|FG002|STARTED|Overall Study||2
6590473|NCT01980056|7515388|FG000|COMPLETED|Overall Study||3
6590474|NCT01980056|7515389|FG001|COMPLETED|Overall Study||3
6590475|NCT01980056|7515390|FG002|COMPLETED|Overall Study||2
6590476|NCT01980056|7515388|FG000|NOT COMPLETED|Overall Study||1
6590477|NCT01980056|7515389|FG001|NOT COMPLETED|Overall Study||1
6590478|NCT01980056|7515390|FG002|NOT COMPLETED|Overall Study||0
6590479|NCT01980095|7515404|FG000|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|78
6590480|NCT01980095|7515405|FG001|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
6590481|NCT01980095|7515404|FG000|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
6590482|NCT01980095|7515405|FG001|Treated|Overall Study||41
6590483|NCT01980095|7515404|FG000|COMPLETED|Overall Study||63
6590484|NCT01980095|7515405|FG001|COMPLETED|Overall Study||30
6590485|NCT01980095|7515404|FG000|NOT COMPLETED|Overall Study||15
6590486|NCT01980095|7515405|FG001|NOT COMPLETED|Overall Study||11
6590487|NCT01980485|7515415|FG000|STARTED|Overall Study||120
6590488|NCT01980485|7515416|FG001|STARTED|Overall Study||105
6590489|NCT01980485|7515415|FG000|COMPLETED|Overall Study||84
6590490|NCT01980485|7515416|FG001|COMPLETED|Overall Study||80
6590491|NCT01980485|7515415|FG000|NOT COMPLETED|Overall Study||36
6590492|NCT01980485|7515416|FG001|NOT COMPLETED|Overall Study||25
6590493|NCT01980524|7515424|FG000|STARTED|Study Day 1||4
6590494|NCT01980524|7515425|FG001|STARTED|Study Day 1||4
6590495|NCT01980524|7515424|FG000|COMPLETED|Study Day 1||4
6590496|NCT01980524|7515425|FG001|COMPLETED|Study Day 1||4
6590497|NCT01980524|7515424|FG000|NOT COMPLETED|Study Day 1||0
6590498|NCT01980524|7515425|FG001|NOT COMPLETED|Study Day 1||0
6590499|NCT01980524|7515424|FG000|STARTED|Washout (at Least 2 Weeks)||4
6590500|NCT01980524|7515425|FG001|STARTED|Washout (at Least 2 Weeks)||4
6590501|NCT01980524|7515424|FG000|COMPLETED|Washout (at Least 2 Weeks)||4
6590502|NCT01980524|7515425|FG001|COMPLETED|Washout (at Least 2 Weeks)||4
6590503|NCT01980524|7515424|FG000|NOT COMPLETED|Washout (at Least 2 Weeks)||0
6590504|NCT01980524|7515425|FG001|NOT COMPLETED|Washout (at Least 2 Weeks)||0
6590505|NCT01980524|7515424|FG000|STARTED|Study Day 2||4
6590506|NCT01980524|7515425|FG001|STARTED|Study Day 2||4
6590507|NCT01980524|7515424|FG000|COMPLETED|Study Day 2||4
6590508|NCT01980524|7515425|FG001|COMPLETED|Study Day 2||4
6590509|NCT01980524|7515424|FG000|NOT COMPLETED|Study Day 2||0
6590510|NCT01980524|7515425|FG001|NOT COMPLETED|Study Day 2||0
6590511|NCT01980589|7515434|FG000|STARTED|Overall Study||3
6590512|NCT01980589|7515435|FG001|STARTED|Overall Study||3
6590513|NCT01980589|7515436|FG002|STARTED|Overall Study||16
6590514|NCT01980589|7515434|FG000|COMPLETED|Overall Study||3
6590515|NCT01980589|7515435|FG001|COMPLETED|Overall Study||3
6590516|NCT01980589|7515436|FG002|COMPLETED|Overall Study||16
6590517|NCT01980589|7515434|FG000|NOT COMPLETED|Overall Study||0
6590518|NCT01980589|7515435|FG001|NOT COMPLETED|Overall Study||0
6590519|NCT01980589|7515436|FG002|NOT COMPLETED|Overall Study||0
6590520|NCT01980628|7515444|FG000|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
6590521|NCT01980628|7515444|FG000|COMPLETED|Overall Study|Participants who remain on treatment at Final Analysis.|0
6590522|NCT01980628|7515444|FG000|NOT COMPLETED|Overall Study||63
6590523|NCT01980654|7515451|FG000|STARTED|Overall Study||60
6590524|NCT01980654|7515452|FG001|STARTED|Overall Study||20
6590525|NCT01980654|7515451|FG000|COMPLETED|Overall Study||60
6590526|NCT01980654|7515452|FG001|COMPLETED|Overall Study||20
6590527|NCT01980654|7515451|FG000|NOT COMPLETED|Overall Study||0
6590528|NCT01980654|7515452|FG001|NOT COMPLETED|Overall Study||0
6590529|NCT01980706|7515461|FG000|STARTED|Overall Study||40
6590530|NCT01980706|7515462|FG001|STARTED|Overall Study||43
6590531|NCT01980706|7515463|FG002|STARTED|Overall Study||37
6590532|NCT01980706|7515461|FG000|COMPLETED|Overall Study||23
6590533|NCT01980706|7515462|FG001|COMPLETED|Overall Study||26
6590534|NCT01980706|7515463|FG002|COMPLETED|Overall Study||24
6590535|NCT01980706|7515461|FG000|NOT COMPLETED|Overall Study||17
6590536|NCT01980706|7515462|FG001|NOT COMPLETED|Overall Study||17
6590537|NCT01980706|7515463|FG002|NOT COMPLETED|Overall Study||13
6590538|NCT01980771|7515473|FG000|STARTED|Overall Study||436
6590539|NCT01980771|7515474|FG001|STARTED|Overall Study||424
6590540|NCT01980771|7515473|FG000|COMPLETED|Overall Study||352
6590541|NCT01980771|7515474|FG001|COMPLETED|Overall Study||305
6590542|NCT01980771|7515473|FG000|NOT COMPLETED|Overall Study||84
6590543|NCT01980771|7515474|FG001|NOT COMPLETED|Overall Study||119
6590544|NCT01980888|7515482|FG000|STARTED|Overall Study||157
6590545|NCT01980888|7515483|FG001|STARTED|Overall Study||154
6590546|NCT01980888|7515482|FG000|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|13
6590547|NCT01980888|7515483|FG001|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|21
6590548|NCT01980888|7515482|FG000|NOT COMPLETED|Overall Study||144
6590549|NCT01980888|7515483|FG001|NOT COMPLETED|Overall Study||133
6590550|NCT01980914|7515489|FG000|STARTED|Overall Study||11
6590551|NCT01980914|7515489|FG000|COMPLETED|Overall Study||11
6590552|NCT01980914|7515489|FG000|NOT COMPLETED|Overall Study||0
6590553|NCT01980992|7515496|FG000|STARTED|52 Weeks Blinded Study Treatment||23
6590554|NCT01980992|7515497|FG001|STARTED|52 Weeks Blinded Study Treatment||23
6590555|NCT01980992|7515496|FG000|COMPLETED|52 Weeks Blinded Study Treatment||21
6590556|NCT01980992|7515497|FG001|COMPLETED|52 Weeks Blinded Study Treatment||19
6590557|NCT01980992|7515496|FG000|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
6590558|NCT01980992|7515497|FG001|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
6590559|NCT01980992|7515496|FG000|STARTED|52 Weeks Open Label Active Wheat OIT||21
6590560|NCT01980992|7515497|FG001|STARTED|52 Weeks Open Label Active Wheat OIT||19
6590561|NCT01980992|7515496|FG000|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
6590562|NCT01980992|7515497|FG001|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
6590563|NCT01980992|7515496|FG000|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
6590564|NCT01980992|7515497|FG001|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
6590565|NCT01981057|7515512|FG000|STARTED|Overall Study||50
6590566|NCT01981057|7515513|FG001|STARTED|Overall Study||50
6590567|NCT01981057|7515512|FG000|COMPLETED|Overall Study||50
6590568|NCT01981057|7515513|FG001|COMPLETED|Overall Study||50
6590569|NCT01981057|7515512|FG000|NOT COMPLETED|Overall Study||0
6590570|NCT01981057|7515513|FG001|NOT COMPLETED|Overall Study||0
6590571|NCT01981109|7515519|FG000|STARTED|Overall Study||225
6590572|NCT01981109|7515519|FG000|COMPLETED|Overall Study||1
6590573|NCT01981109|7515519|FG000|NOT COMPLETED|Overall Study||224
6590574|NCT01981122|7515526|FG000|STARTED|Overall Study||25
6590575|NCT01981122|7515527|FG001|STARTED|Overall Study||27
6590576|NCT01981122|7515526|FG000|COMPLETED|Overall Study||11
6590577|NCT01981122|7515527|FG001|COMPLETED|Overall Study||7
6590578|NCT01981122|7515526|FG000|NOT COMPLETED|Overall Study||14
6590579|NCT01981122|7515527|FG001|NOT COMPLETED|Overall Study||20
6590580|NCT01981187|7515533|FG000|STARTED|Overall Study||12
6590581|NCT01981187|7515533|FG000|COMPLETED|Overall Study||0
6590582|NCT01981187|7515533|FG000|NOT COMPLETED|Overall Study||12
6590583|NCT01981356|7515539|FG000|STARTED|Overall Study||12
6590584|NCT01981356|7515540|FG001|STARTED|Overall Study||6
6590585|NCT01981356|7515539|FG000|COMPLETED|Overall Study||5
6590586|NCT01981356|7515540|FG001|COMPLETED|Overall Study||4
6590587|NCT01981356|7515539|FG000|NOT COMPLETED|Overall Study||7
6590588|NCT01981356|7515540|FG001|NOT COMPLETED|Overall Study||2
6590589|NCT01981473|7515550|FG000|STARTED|Overall Study||202
6590590|NCT01981473|7515551|FG001|STARTED|Overall Study||199
6590591|NCT01981473|7515552|FG002|STARTED|Overall Study||204
6590592|NCT01981473|7515550|FG000|COMPLETED|Overall Study||200
6590593|NCT01981473|7515551|FG001|COMPLETED|Overall Study||199
6590594|NCT01981473|7515552|FG002|COMPLETED|Overall Study||196
6590595|NCT01981473|7515550|FG000|NOT COMPLETED|Overall Study||2
6590596|NCT01981473|7515551|FG001|NOT COMPLETED|Overall Study||0
6590597|NCT01981473|7515552|FG002|NOT COMPLETED|Overall Study||8
6590598|NCT01981564|7515565|FG000|STARTED|Overall Study||107
6590599|NCT01981564|7515566|FG001|STARTED|Overall Study||115
6590600|NCT01981564|7515565|FG000|COMPLETED|Overall Study||98
6590601|NCT01981564|7515566|FG001|COMPLETED|Overall Study||106
6590602|NCT01981564|7515565|FG000|NOT COMPLETED|Overall Study||9
6590603|NCT01981564|7515566|FG001|NOT COMPLETED|Overall Study||9
6590604|NCT01981590|7515573|FG000|STARTED|Overall Study||15
6590605|NCT01981590|7515573|FG000|COMPLETED|Overall Study||15
6590606|NCT01981590|7515573|FG000|NOT COMPLETED|Overall Study||0
6590607|NCT01981616|7515580|FG000|STARTED|Overall Study||64
6590608|NCT01981616|7515581|FG001|STARTED|Overall Study||63
6590609|NCT01981616|7515580|FG000|COMPLETED|Overall Study||63
6590610|NCT01981616|7515581|FG001|COMPLETED|Overall Study||62
6590611|NCT01981616|7515580|FG000|NOT COMPLETED|Overall Study||1
6590612|NCT01981616|7515581|FG001|NOT COMPLETED|Overall Study||1
6590613|NCT01981759|7515589|FG000|STARTED|Overall Study||28
6590614|NCT01981759|7515590|FG001|STARTED|Overall Study||30
6590615|NCT01981759|7515589|FG000|Baseline (Week 1)|Overall Study||28
6590616|NCT01981759|7515590|FG001|Baseline (Week 1)|Overall Study||30
6590617|NCT01981759|7515589|FG000|Randomization (Week 3)|Overall Study||28
6590618|NCT01981759|7515590|FG001|Randomization (Week 3)|Overall Study||30
6590619|NCT01981759|7515589|FG000|Completed Week 12|Overall Study||22
6590620|NCT01981759|7515590|FG001|Completed Week 12|Overall Study||22
6590621|NCT01981759|7515589|FG000|COMPLETED|Overall Study||21
6590622|NCT01981759|7515590|FG001|COMPLETED|Overall Study||19
6590623|NCT01981759|7515589|FG000|NOT COMPLETED|Overall Study||7
6590624|NCT01981759|7515590|FG001|NOT COMPLETED|Overall Study||11
6590625|NCT01981772|7515598|FG000|STARTED|Overall Study||45
6590626|NCT01981772|7515599|FG001|STARTED|Overall Study||43
6590627|NCT01981772|7515598|FG000|COMPLETED|Overall Study||45
6590628|NCT01981772|7515599|FG001|COMPLETED|Overall Study||43
6590629|NCT01981772|7515598|FG000|NOT COMPLETED|Overall Study||0
6590630|NCT01981772|7515599|FG001|NOT COMPLETED|Overall Study||0
6590631|NCT01981863|7515607|FG000|STARTED|Overall Study||20
6590632|NCT01981863|7515608|FG001|STARTED|Overall Study||20
6590633|NCT01981863|7515607|FG000|COMPLETED|Overall Study||20
6590634|NCT01981863|7515608|FG001|COMPLETED|Overall Study||20
6590635|NCT01981863|7515607|FG000|NOT COMPLETED|Overall Study||0
6590636|NCT01981863|7515608|FG001|NOT COMPLETED|Overall Study||0
6590637|NCT01981954|7515614|FG000|STARTED|Titration Period||23
6590638|NCT01981954|7515614|FG000|Treated|Titration Period||23
6590639|NCT01981954|7515614|FG000|COMPLETED|Titration Period||22
6590640|NCT01981954|7515614|FG000|NOT COMPLETED|Titration Period||1
6590641|NCT01981954|7515614|FG000|STARTED|Fixed-Dose Assessment Period||22
6590642|NCT01981954|7515614|FG000|Treated|Fixed-Dose Assessment Period||22
6590643|NCT01981954|7515614|FG000|COMPLETED|Fixed-Dose Assessment Period||21
6590644|NCT01981954|7515614|FG000|NOT COMPLETED|Fixed-Dose Assessment Period||1
6590645|NCT01981967|7515620|FG000|STARTED|Overall Study||6851
6590646|NCT01981967|7515621|FG001|STARTED|Overall Study||3149
6590647|NCT01981967|7515620|FG000|COMPLETED|Overall Study||6851
6590648|NCT01981967|7515621|FG001|COMPLETED|Overall Study||3149
6590649|NCT01981967|7515620|FG000|NOT COMPLETED|Overall Study||0
6590650|NCT01981967|7515621|FG001|NOT COMPLETED|Overall Study||0
6590651|NCT01982123|7515627|FG000|STARTED|Overall Study||12
6590652|NCT01982123|7515627|FG000|COMPLETED|Overall Study||12
6590653|NCT01982123|7515627|FG000|NOT COMPLETED|Overall Study||0
6590654|NCT01982240|7515634|FG000|STARTED|Overall Study||452
6590655|NCT01982240|7515635|FG001|STARTED|Overall Study||453
6590656|NCT01982240|7515636|FG002|STARTED|Overall Study||441
6590657|NCT01982240|7515634|FG000|COMPLETED|Overall Study||385
6590658|NCT01982240|7515635|FG001|COMPLETED|Overall Study||384
6590659|NCT01982240|7515636|FG002|COMPLETED|Overall Study||371
6590660|NCT01982240|7515634|FG000|NOT COMPLETED|Overall Study||67
6590661|NCT01982240|7515635|FG001|NOT COMPLETED|Overall Study||69
6590662|NCT01982240|7515636|FG002|NOT COMPLETED|Overall Study||70
6590663|NCT01982292|7515650|FG000|STARTED|Overall Study|"Started indicates Randomized set"|215
6590664|NCT01982292|7515651|FG001|STARTED|Overall Study||108
6659789|NCT02493660|7590720|FG000|NOT COMPLETED|Overall Study||0
6659790|NCT02493660|7590721|FG001|NOT COMPLETED|Overall Study||1
6659791|NCT02493712|7590730|FG000|STARTED|Overall Study||16
6659792|NCT02493712|7590731|FG001|STARTED|Overall Study||18
6659793|NCT02493712|7590732|FG002|STARTED|Overall Study||17
6590665|NCT01982292|7515650|FG000|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
6590666|NCT01982292|7515651|FG001|Full Analaysis Set (FAS)|Overall Study||108
6590667|NCT01982292|7515650|FG000|Safety Set|Overall Study||212
6590668|NCT01982292|7515651|FG001|Safety Set|Overall Study||108
6590669|NCT01982292|7515650|FG000|COMPLETED|Overall Study||203
6590670|NCT01982292|7515651|FG001|COMPLETED|Overall Study||107
6590671|NCT01982292|7515650|FG000|NOT COMPLETED|Overall Study||12
6590672|NCT01982292|7515651|FG001|NOT COMPLETED|Overall Study||1
6590673|NCT01982331|7515659|FG000|STARTED|Received Vaccination 1||28
6590674|NCT01982331|7515660|FG001|STARTED|Received Vaccination 1||10
6590675|NCT01982331|7515659|FG000|COMPLETED|Received Vaccination 1||28
6590676|NCT01982331|7515660|FG001|COMPLETED|Received Vaccination 1||10
6590677|NCT01982331|7515659|FG000|NOT COMPLETED|Received Vaccination 1||0
6590678|NCT01982331|7515660|FG001|NOT COMPLETED|Received Vaccination 1||0
6590679|NCT01982331|7515659|FG000|STARTED|Received Vaccination 2||28
6590680|NCT01982331|7515660|FG001|STARTED|Received Vaccination 2||10
6590681|NCT01982331|7515659|FG000|COMPLETED|Received Vaccination 2||27
6590682|NCT01982331|7515660|FG001|COMPLETED|Received Vaccination 2||7
6590683|NCT01982331|7515659|FG000|NOT COMPLETED|Received Vaccination 2||1
6590684|NCT01982331|7515660|FG001|NOT COMPLETED|Received Vaccination 2||3
6590685|NCT01982331|7515659|FG000|STARTED|Completed Study (Day 112)||27
6590686|NCT01982331|7515660|FG001|STARTED|Completed Study (Day 112)||7
6590687|NCT01982331|7515659|FG000|COMPLETED|Completed Study (Day 112)||25
6590688|NCT01982331|7515660|FG001|COMPLETED|Completed Study (Day 112)||7
6590689|NCT01982331|7515659|FG000|NOT COMPLETED|Completed Study (Day 112)||2
6590690|NCT01982331|7515660|FG001|NOT COMPLETED|Completed Study (Day 112)||0
6590691|NCT01982435|7515668|FG000|STARTED|Overall Study||15
6590692|NCT01982435|7515669|FG001|STARTED|Overall Study||12
6590693|NCT01982435|7515668|FG000|COMPLETED|Overall Study||14
6590694|NCT01982435|7515669|FG001|COMPLETED|Overall Study||12
6590695|NCT01982435|7515668|FG000|NOT COMPLETED|Overall Study||1
6590696|NCT01982435|7515669|FG001|NOT COMPLETED|Overall Study||0
6590697|NCT01982539|7515675|FG000|STARTED|Overall Study||25
6590698|NCT01982539|7515675|FG000|COMPLETED|Overall Study||25
6590699|NCT01982539|7515675|FG000|NOT COMPLETED|Overall Study||0
6590700|NCT01982643|7515679|FG000|STARTED|Overall Study||49
6590701|NCT01982643|7515679|FG000|COMPLETED|Overall Study||37
6590702|NCT01982643|7515679|FG000|NOT COMPLETED|Overall Study||12
6590703|NCT01982682|7515683|FG000|STARTED|Overall Study||41
6590704|NCT01982682|7515683|FG000|COMPLETED|Overall Study||40
6590705|NCT01982682|7515683|FG000|NOT COMPLETED|Overall Study||1
6590706|NCT01982695|7515690|FG000|STARTED|Overall Study||12
6590707|NCT01982695|7515691|FG001|STARTED|Overall Study||11
6590708|NCT01982695|7515690|FG000|COMPLETED|Overall Study||12
6590709|NCT01982695|7515691|FG001|COMPLETED|Overall Study||10
6590710|NCT01982695|7515690|FG000|NOT COMPLETED|Overall Study||0
6590711|NCT01982695|7515691|FG001|NOT COMPLETED|Overall Study||1
6590712|NCT01982773|7515699|FG000|STARTED|Overall Study||58
6590713|NCT01982773|7515700|FG001|STARTED|Overall Study||60
6590714|NCT01982773|7515699|FG000|COMPLETED|Overall Study||50
6590715|NCT01982773|7515700|FG001|COMPLETED|Overall Study||56
6590716|NCT01982773|7515699|FG000|NOT COMPLETED|Overall Study||8
6590717|NCT01982773|7515700|FG001|NOT COMPLETED|Overall Study||4
6590718|NCT01982786|7515708|FG000|STARTED|Overall Study||29
6590719|NCT01982786|7515709|FG001|STARTED|Overall Study||28
6590720|NCT01982786|7515708|FG000|COMPLETED|Overall Study||29
6590721|NCT01982786|7515709|FG001|COMPLETED|Overall Study||28
6590722|NCT01982786|7515708|FG000|NOT COMPLETED|Overall Study||0
6590723|NCT01982786|7515709|FG001|NOT COMPLETED|Overall Study||0
6590724|NCT01982812|7515717|FG000|STARTED|Overall Study||23
6590725|NCT01982812|7515718|FG001|STARTED|Overall Study||21
6590726|NCT01982812|7515717|FG000|COMPLETED|Overall Study||22
6590727|NCT01982812|7515718|FG001|COMPLETED|Overall Study||11
6590728|NCT01982812|7515717|FG000|NOT COMPLETED|Overall Study||1
6590729|NCT01982812|7515718|FG001|NOT COMPLETED|Overall Study||10
6590730|NCT01982942|7515726|FG000|STARTED|Overall Study||129
6590731|NCT01982942|7515727|FG001|STARTED|Overall Study||126
6590732|NCT01982942|7515726|FG000|COMPLETED|Overall Study||108
6590733|NCT01982942|7515727|FG001|COMPLETED|Overall Study||112
6590734|NCT01982942|7515726|FG000|NOT COMPLETED|Overall Study||21
6590735|NCT01982942|7515727|FG001|NOT COMPLETED|Overall Study||14
6624456|NCT02217566|7551890|FG000|NOT COMPLETED|Overall Study||11
6624457|NCT02217618|7551894|FG000|STARTED|Overall Study||16
6624458|NCT02217618|7551894|FG000|Received Study Drug|Overall Study||16
6624459|NCT02217618|7551894|FG000|COMPLETED|Overall Study||16
6624460|NCT02217618|7551894|FG000|NOT COMPLETED|Overall Study||0
6624461|NCT02217800|7551898|FG000|STARTED|Overall Study||8
6624462|NCT02217800|7551898|FG000|COMPLETED|Overall Study||8
6624463|NCT02217800|7551898|FG000|NOT COMPLETED|Overall Study||0
6624464|NCT02217878|7551912|FG000|STARTED|Overall Study||37
6624465|NCT02217878|7551913|FG001|STARTED|Overall Study||37
6624466|NCT02217878|7551912|FG000|COMPLETED|Overall Study||35
6624467|NCT02217878|7551913|FG001|COMPLETED|Overall Study||35
6624468|NCT02217878|7551912|FG000|NOT COMPLETED|Overall Study||2
6624469|NCT02217878|7551913|FG001|NOT COMPLETED|Overall Study||2
6624470|NCT02217904|7551924|FG000|STARTED|Overall Study||6
6624471|NCT02217904|7551925|FG001|STARTED|Overall Study||6
6624472|NCT02217904|7551926|FG002|STARTED|Overall Study||6
6624473|NCT02217904|7551927|FG003|STARTED|Overall Study||6
6624474|NCT02217904|7551928|FG004|STARTED|Overall Study||6
6624475|NCT02217904|7551929|FG005|STARTED|Overall Study||0
6624476|NCT02217904|7551930|FG006|STARTED|Overall Study||0
6624477|NCT02217904|7551924|FG000|COMPLETED|Overall Study||6
6624478|NCT02217904|7551925|FG001|COMPLETED|Overall Study||6
6624479|NCT02217904|7551926|FG002|COMPLETED|Overall Study||6
6624480|NCT02217904|7551927|FG003|COMPLETED|Overall Study||6
6624481|NCT02217904|7551928|FG004|COMPLETED|Overall Study||6
6624482|NCT02217904|7551929|FG005|COMPLETED|Overall Study||0
6624483|NCT02217904|7551930|FG006|COMPLETED|Overall Study||0
6624484|NCT02217904|7551924|FG000|NOT COMPLETED|Overall Study||0
6624485|NCT02217904|7551925|FG001|NOT COMPLETED|Overall Study||0
6590736|NCT01982955|7515738|FG000|STARTED|Overall Study||6
6590737|NCT01982955|7515739|FG001|STARTED|Overall Study||12
6590738|NCT01982955|7515740|FG002|STARTED|Overall Study||31
6590739|NCT01982955|7515741|FG003|STARTED|Overall Study||24
6590740|NCT01982955|7515742|FG004|STARTED|Overall Study||15
6590741|NCT01982955|7515738|FG000|Treated|Overall Study||6
6590742|NCT01982955|7515739|FG001|Treated|Overall Study||12
6590743|NCT01982955|7515740|FG002|Treated|Overall Study||31
6590744|NCT01982955|7515741|FG003|Treated|Overall Study||23
6590745|NCT01982955|7515742|FG004|Treated|Overall Study||15
6590746|NCT01982955|7515738|FG000|COMPLETED|Overall Study||6
6590747|NCT01982955|7515739|FG001|COMPLETED|Overall Study||12
6590748|NCT01982955|7515740|FG002|COMPLETED|Overall Study||27
6590749|NCT01982955|7515741|FG003|COMPLETED|Overall Study||23
6590750|NCT01982955|7515742|FG004|COMPLETED|Overall Study||15
6590751|NCT01982955|7515738|FG000|NOT COMPLETED|Overall Study||0
6590752|NCT01982955|7515739|FG001|NOT COMPLETED|Overall Study||0
6590753|NCT01982955|7515740|FG002|NOT COMPLETED|Overall Study||4
6590754|NCT01982955|7515741|FG003|NOT COMPLETED|Overall Study||1
6590755|NCT01982955|7515742|FG004|NOT COMPLETED|Overall Study||0
6590756|NCT01982968|7515757|FG000|STARTED|Overall Study||29
6590757|NCT01982968|7515758|FG001|STARTED|Overall Study||29
6590758|NCT01982968|7515757|FG000|COMPLETED|Overall Study||21
6590759|NCT01982968|7515758|FG001|COMPLETED|Overall Study||27
6590760|NCT01982968|7515757|FG000|NOT COMPLETED|Overall Study||8
6590761|NCT01982968|7515758|FG001|NOT COMPLETED|Overall Study||2
6590762|NCT01983020|7515768|FG000|STARTED|Overall Study||12
6590763|NCT01983020|7515769|FG001|STARTED|Overall Study||11
6590764|NCT01983020|7515770|FG002|STARTED|Overall Study||12
6590765|NCT01983020|7515771|FG003|STARTED|Overall Study||11
6590766|NCT01983020|7515768|FG000|COMPLETED|Overall Study||12
6590767|NCT01983020|7515769|FG001|COMPLETED|Overall Study||11
6590768|NCT01983020|7515770|FG002|COMPLETED|Overall Study||12
6590769|NCT01983020|7515771|FG003|COMPLETED|Overall Study||11
6590770|NCT01983020|7515768|FG000|NOT COMPLETED|Overall Study||0
6590771|NCT01983020|7515769|FG001|NOT COMPLETED|Overall Study||0
6590772|NCT01983020|7515770|FG002|NOT COMPLETED|Overall Study||0
6590773|NCT01983020|7515771|FG003|NOT COMPLETED|Overall Study||0
6590774|NCT01983111|7515783|FG000|STARTED|Overall Study||70
6590775|NCT01983111|7515784|FG001|STARTED|Overall Study||66
6590776|NCT01983111|7515783|FG000|COMPLETED|Overall Study||58
6590777|NCT01983111|7515784|FG001|COMPLETED|Overall Study||59
6590778|NCT01983111|7515783|FG000|NOT COMPLETED|Overall Study||12
6590779|NCT01983111|7515784|FG001|NOT COMPLETED|Overall Study||7
6590780|NCT01983228|7515792|FG000|STARTED|Overall Study||249
6590781|NCT01983228|7515793|FG001|STARTED|Overall Study||251
6590782|NCT01983228|7515792|FG000|COMPLETED|Overall Study||211
6590783|NCT01983228|7515793|FG001|COMPLETED|Overall Study||189
6590784|NCT01983228|7515792|FG000|NOT COMPLETED|Overall Study||38
6590785|NCT01983228|7515793|FG001|NOT COMPLETED|Overall Study||62
6590786|NCT01983254|7515803|FG000|STARTED|Overall Study|86 patients, 39 caregivers|125
6590787|NCT01983254|7515804|FG001|STARTED|Overall Study|89 patients, 47 caregivers|136
6590788|NCT01983254|7515803|FG000|Interview 1|Overall Study|86 patients, 39 caregivers|125
6590789|NCT01983254|7515804|FG001|Interview 1|Overall Study|89 patients, 47 caregivers|136
6590790|NCT01983254|7515803|FG000|Interview 2|Overall Study|65 patients, 30 caregivers|95
6590791|NCT01983254|7515804|FG001|Interview 2|Overall Study|71 patients, 39 caregivers|110
6590792|NCT01983254|7515803|FG000|Interview 3|Overall Study|62 patients, 29 caregivers|91
6590793|NCT01983254|7515804|FG001|Interview 3|Overall Study|69 patients, 37 caregivers|106
6590794|NCT01983254|7515803|FG000|COMPLETED|Overall Study|62 patients, 29 caregivers|91
6590795|NCT01983254|7515804|FG001|COMPLETED|Overall Study|69 patients, 37 caregivers|106
6590796|NCT01983254|7515803|FG000|NOT COMPLETED|Overall Study||34
6590797|NCT01983254|7515804|FG001|NOT COMPLETED|Overall Study||30
6590798|NCT01983293|7515812|FG000|STARTED|Overall Study||161
6590799|NCT01983293|7515813|FG001|STARTED|Overall Study||81
6590800|NCT01983293|7515812|FG000|COMPLETED|Overall Study||128
6590801|NCT01983293|7515813|FG001|COMPLETED|Overall Study||62
6590802|NCT01983293|7515812|FG000|NOT COMPLETED|Overall Study||33
6590803|NCT01983293|7515813|FG001|NOT COMPLETED|Overall Study||19
6590804|NCT01983566|7515823|FG000|STARTED|Test Period 1||4
6590805|NCT01983566|7515824|FG001|STARTED|Test Period 1||4
6590806|NCT01983566|7515825|FG002|STARTED|Test Period 1||4
6590807|NCT01983566|7515826|FG003|STARTED|Test Period 1||4
6590808|NCT01983566|7515823|FG000|COMPLETED|Test Period 1||4
6590809|NCT01983566|7515824|FG001|COMPLETED|Test Period 1||4
6590810|NCT01983566|7515825|FG002|COMPLETED|Test Period 1||4
6590811|NCT01983566|7515826|FG003|COMPLETED|Test Period 1||4
6590812|NCT01983566|7515823|FG000|NOT COMPLETED|Test Period 1||0
6590813|NCT01983566|7515824|FG001|NOT COMPLETED|Test Period 1||0
6590814|NCT01983566|7515825|FG002|NOT COMPLETED|Test Period 1||0
6590815|NCT01983566|7515826|FG003|NOT COMPLETED|Test Period 1||0
6590816|NCT01983566|7515823|FG000|STARTED|Wash-Out 1||4
6590817|NCT01983566|7515824|FG001|STARTED|Wash-Out 1||4
6590818|NCT01983566|7515825|FG002|STARTED|Wash-Out 1||4
6590819|NCT01983566|7515826|FG003|STARTED|Wash-Out 1||4
6590820|NCT01983566|7515823|FG000|COMPLETED|Wash-Out 1||4
6590821|NCT01983566|7515824|FG001|COMPLETED|Wash-Out 1||4
6590822|NCT01983566|7515825|FG002|COMPLETED|Wash-Out 1||4
6590823|NCT01983566|7515826|FG003|COMPLETED|Wash-Out 1||4
6590824|NCT01983566|7515823|FG000|NOT COMPLETED|Wash-Out 1||0
6590825|NCT01983566|7515824|FG001|NOT COMPLETED|Wash-Out 1||0
6590826|NCT01983566|7515825|FG002|NOT COMPLETED|Wash-Out 1||0
6590827|NCT01983566|7515826|FG003|NOT COMPLETED|Wash-Out 1||0
6590828|NCT01983566|7515823|FG000|STARTED|Test Period 2||4
6590829|NCT01983566|7515824|FG001|STARTED|Test Period 2||4
6590830|NCT01983566|7515825|FG002|STARTED|Test Period 2||4
6590831|NCT01983566|7515826|FG003|STARTED|Test Period 2||4
6590832|NCT01983566|7515823|FG000|COMPLETED|Test Period 2||4
6590833|NCT01983566|7515824|FG001|COMPLETED|Test Period 2||4
6590834|NCT01983566|7515825|FG002|COMPLETED|Test Period 2||4
6590835|NCT01983566|7515826|FG003|COMPLETED|Test Period 2||4
6590836|NCT01983566|7515823|FG000|NOT COMPLETED|Test Period 2||0
6590837|NCT01983566|7515824|FG001|NOT COMPLETED|Test Period 2||0
6590838|NCT01983566|7515825|FG002|NOT COMPLETED|Test Period 2||0
6590839|NCT01983566|7515826|FG003|NOT COMPLETED|Test Period 2||0
6590840|NCT01983566|7515823|FG000|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
6590841|NCT01983566|7515824|FG001|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
6590842|NCT01983566|7515825|FG002|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
6590843|NCT01983566|7515826|FG003|STARTED|Wash-Out 2||4
6590844|NCT01983566|7515823|FG000|COMPLETED|Wash-Out 2||2
6590845|NCT01983566|7515824|FG001|COMPLETED|Wash-Out 2||3
6590846|NCT01983566|7515825|FG002|COMPLETED|Wash-Out 2||2
6590847|NCT01983566|7515826|FG003|COMPLETED|Wash-Out 2||4
6590848|NCT01983566|7515823|FG000|NOT COMPLETED|Wash-Out 2||0
6590849|NCT01983566|7515824|FG001|NOT COMPLETED|Wash-Out 2||0
6590850|NCT01983566|7515825|FG002|NOT COMPLETED|Wash-Out 2||0
6590851|NCT01983566|7515826|FG003|NOT COMPLETED|Wash-Out 2||0
6590852|NCT01983566|7515823|FG000|STARTED|Test Period 3||2
6590853|NCT01983566|7515824|FG001|STARTED|Test Period 3||3
6590854|NCT01983566|7515825|FG002|STARTED|Test Period 3||2
6590855|NCT01983566|7515826|FG003|STARTED|Test Period 3||4
6590856|NCT01983566|7515823|FG000|COMPLETED|Test Period 3||2
6590857|NCT01983566|7515824|FG001|COMPLETED|Test Period 3||3
6590858|NCT01983566|7515825|FG002|COMPLETED|Test Period 3||2
6590859|NCT01983566|7515826|FG003|COMPLETED|Test Period 3||4
6590860|NCT01983566|7515823|FG000|NOT COMPLETED|Test Period 3||0
6590861|NCT01983566|7515824|FG001|NOT COMPLETED|Test Period 3||0
6590862|NCT01983566|7515825|FG002|NOT COMPLETED|Test Period 3||0
6590863|NCT01983566|7515826|FG003|NOT COMPLETED|Test Period 3||0
6590864|NCT01983566|7515823|FG000|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
6590865|NCT01983566|7515824|FG001|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
6590866|NCT01983566|7515825|FG002|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
6590867|NCT01983566|7515826|FG003|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
6590868|NCT01983566|7515823|FG000|COMPLETED|Wash-Out 3||0
6590869|NCT01983566|7515824|FG001|COMPLETED|Wash-Out 3||0
6590870|NCT01983566|7515825|FG002|COMPLETED|Wash-Out 3||0
6590871|NCT01983566|7515826|FG003|COMPLETED|Wash-Out 3||0
6590872|NCT01983566|7515823|FG000|NOT COMPLETED|Wash-Out 3||0
6590873|NCT01983566|7515824|FG001|NOT COMPLETED|Wash-Out 3||0
6590874|NCT01983566|7515825|FG002|NOT COMPLETED|Wash-Out 3||0
6590875|NCT01983566|7515826|FG003|NOT COMPLETED|Wash-Out 3||0
6590876|NCT01983566|7515823|FG000|STARTED|Test Period 4||0
6590877|NCT01983566|7515824|FG001|STARTED|Test Period 4||0
6590878|NCT01983566|7515825|FG002|STARTED|Test Period 4||0
6590879|NCT01983566|7515826|FG003|STARTED|Test Period 4||0
6590880|NCT01983566|7515823|FG000|COMPLETED|Test Period 4||0
6590881|NCT01983566|7515824|FG001|COMPLETED|Test Period 4||0
6590882|NCT01983566|7515825|FG002|COMPLETED|Test Period 4||0
6590883|NCT01983566|7515826|FG003|COMPLETED|Test Period 4||0
6590884|NCT01983566|7515823|FG000|NOT COMPLETED|Test Period 4||0
6590885|NCT01983566|7515824|FG001|NOT COMPLETED|Test Period 4||0
6590886|NCT01983566|7515825|FG002|NOT COMPLETED|Test Period 4||0
6590887|NCT01983566|7515826|FG003|NOT COMPLETED|Test Period 4||0
6590888|NCT01983683|7515839|FG000|STARTED|Overall Study||298
6590889|NCT01983683|7515840|FG001|STARTED|Overall Study||311
6590890|NCT01983683|7515839|FG000|COMPLETED|Overall Study||260
6590891|NCT01983683|7515840|FG001|COMPLETED|Overall Study||260
6590892|NCT01983683|7515839|FG000|NOT COMPLETED|Overall Study||38
6590893|NCT01983683|7515840|FG001|NOT COMPLETED|Overall Study||51
6590894|NCT01983787|7515846|FG000|STARTED|Overall Study||10
6590895|NCT01983787|7515846|FG000|COMPLETED|Overall Study||10
6590896|NCT01983787|7515846|FG000|NOT COMPLETED|Overall Study||0
6590897|NCT01983826|7515871|FG000|STARTED|Overall Study||13
6590898|NCT01983826|7515872|FG001|STARTED|Overall Study||8
6590899|NCT01983826|7515871|FG000|COMPLETED|Overall Study||13
6590900|NCT01983826|7515872|FG001|COMPLETED|Overall Study||8
6590901|NCT01983826|7515871|FG000|NOT COMPLETED|Overall Study||0
6590902|NCT01983826|7515872|FG001|NOT COMPLETED|Overall Study||0
6590903|NCT01983839|7515882|FG000|STARTED|Overall Study||18
6590904|NCT01983839|7515882|FG000|COMPLETED|Overall Study||18
6659794|NCT02493712|7590730|FG000|COMPLETED|Overall Study||14
6659795|NCT02493712|7590731|FG001|COMPLETED|Overall Study||12
6590905|NCT01983839|7515882|FG000|NOT COMPLETED|Overall Study||0
6590906|NCT01983878|7515886|FG000|STARTED|Overall Study||36
6590907|NCT01983878|7515886|FG000|Received At Least One Dose of Study Drug|Overall Study||36
6590908|NCT01983878|7515886|FG000|COMPLETED|Overall Study||36
6590909|NCT01983878|7515886|FG000|NOT COMPLETED|Overall Study||0
6590910|NCT01983930|7515893|FG000|STARTED|Overall Study||41
6590911|NCT01983930|7515894|FG001|STARTED|Overall Study||38
6590912|NCT01983930|7515893|FG000|COMPLETED|Overall Study||32
6590913|NCT01983930|7515894|FG001|COMPLETED|Overall Study||29
6590914|NCT01983930|7515893|FG000|NOT COMPLETED|Overall Study||9
6590915|NCT01983930|7515894|FG001|NOT COMPLETED|Overall Study||9
6590916|NCT01983969|7515904|FG000|STARTED|Overall Study||37
6590917|NCT01983969|7515905|FG001|STARTED|Overall Study||19
6590918|NCT01983969|7515906|FG002|STARTED|Overall Study||5
6590919|NCT01983969|7515904|FG000|COMPLETED|Overall Study||37
6590920|NCT01983969|7515905|FG001|COMPLETED|Overall Study||18
6590921|NCT01983969|7515906|FG002|COMPLETED|Overall Study||5
6590922|NCT01983969|7515904|FG000|NOT COMPLETED|Overall Study||0
6590923|NCT01983969|7515905|FG001|NOT COMPLETED|Overall Study||1
6590924|NCT01983969|7515906|FG002|NOT COMPLETED|Overall Study||0
6590925|NCT01984164|7515920|FG000|STARTED|Overall Study||87
6590926|NCT01984164|7515921|FG001|STARTED|Overall Study||89
6590927|NCT01984164|7515920|FG000|COMPLETED|Overall Study||77
6590928|NCT01984164|7515921|FG001|COMPLETED|Overall Study||64
6590929|NCT01984164|7515920|FG000|NOT COMPLETED|Overall Study||10
6590930|NCT01984164|7515921|FG001|NOT COMPLETED|Overall Study||25
6590931|NCT01984229|7515929|FG000|STARTED|Period 1||6
6590932|NCT01984229|7515930|FG001|STARTED|Period 1||17
6590933|NCT01984229|7515929|FG000|COMPLETED|Period 1||6
6590934|NCT01984229|7515930|FG001|COMPLETED|Period 1||17
6590935|NCT01984229|7515929|FG000|NOT COMPLETED|Period 1||0
6590936|NCT01984229|7515930|FG001|NOT COMPLETED|Period 1||0
6590937|NCT01984229|7515929|FG000|STARTED|Period 2||6
6590938|NCT01984229|7515930|FG001|STARTED|Period 2||17
6590939|NCT01984229|7515929|FG000|COMPLETED|Period 2||6
6590940|NCT01984229|7515930|FG001|COMPLETED|Period 2||17
6590941|NCT01984229|7515929|FG000|NOT COMPLETED|Period 2||0
6590942|NCT01984229|7515930|FG001|NOT COMPLETED|Period 2||0
6590943|NCT01984229|7515929|FG000|STARTED|Period 3||6
6590944|NCT01984229|7515930|FG001|STARTED|Period 3||17
6590945|NCT01984229|7515929|FG000|COMPLETED|Period 3||6
6590946|NCT01984229|7515930|FG001|COMPLETED|Period 3||17
6590947|NCT01984229|7515929|FG000|NOT COMPLETED|Period 3||0
6590948|NCT01984229|7515930|FG001|NOT COMPLETED|Period 3||0
6590949|NCT01984229|7515929|FG000|STARTED|Safety Follow-up Period||6
6590950|NCT01984229|7515930|FG001|STARTED|Safety Follow-up Period||17
6590951|NCT01984229|7515929|FG000|COMPLETED|Safety Follow-up Period||4
6590952|NCT01984229|7515930|FG001|COMPLETED|Safety Follow-up Period||16
6659796|NCT02493712|7590732|FG002|COMPLETED|Overall Study||11
6659797|NCT02493712|7590730|FG000|NOT COMPLETED|Overall Study||2
6659798|NCT02493712|7590731|FG001|NOT COMPLETED|Overall Study||6
6659799|NCT02493712|7590732|FG002|NOT COMPLETED|Overall Study||6
6659800|NCT02493764|7590742|FG000|STARTED|Overall Study||268
6659801|NCT02493764|7590743|FG001|STARTED|Overall Study||269
6659802|NCT02493764|7590742|FG000|COMPLETED|Overall Study||185
6659803|NCT02493764|7590743|FG001|COMPLETED|Overall Study||187
6659804|NCT02493764|7590742|FG000|NOT COMPLETED|Overall Study||83
6659805|NCT02493764|7590743|FG001|NOT COMPLETED|Overall Study||82
6659806|NCT02493777|7590751|FG000|STARTED|Overall Study||65
6659807|NCT02493777|7590752|FG001|STARTED|Overall Study||54
6659808|NCT02493777|7590751|FG000|COMPLETED|Overall Study||65
6659809|NCT02493777|7590752|FG001|COMPLETED|Overall Study||53
6659810|NCT02493777|7590751|FG000|NOT COMPLETED|Overall Study||0
6659811|NCT02493777|7590752|FG001|NOT COMPLETED|Overall Study||1
6659812|NCT02493855|7590761|FG000|STARTED|Overall Study||21
6659813|NCT02493855|7590762|FG001|STARTED|Overall Study||19
6659814|NCT02493855|7590763|FG002|STARTED|Overall Study||6
6659815|NCT02493855|7590761|FG000|COMPLETED|Overall Study||19
6659816|NCT02493855|7590762|FG001|COMPLETED|Overall Study||18
6659817|NCT02493855|7590763|FG002|COMPLETED|Overall Study||6
6659818|NCT02493855|7590761|FG000|NOT COMPLETED|Overall Study||2
6659819|NCT02493855|7590762|FG001|NOT COMPLETED|Overall Study||1
6659820|NCT02493855|7590763|FG002|NOT COMPLETED|Overall Study||0
6659821|NCT02493868|7590771|FG000|STARTED|Induction Phase: DE Participants||437
6659822|NCT02493868|7590772|FG001|STARTED|Induction Phase: DE Participants||0
6659823|NCT02493868|7590771|FG000|COMPLETED|Induction Phase: DE Participants|Participants who completed and met predefined response criteria continued to OP phase.|273
6659824|NCT02493868|7590772|FG001|COMPLETED|Induction Phase: DE Participants||0
6659825|NCT02493868|7590771|FG000|NOT COMPLETED|Induction Phase: DE Participants||164
6659826|NCT02493868|7590772|FG001|NOT COMPLETED|Induction Phase: DE Participants||0
6659827|NCT02493868|7590771|FG000|STARTED|Optimization Phase: DE+TE Participants|Total participants: direct-entry (273) + esketamine-treated transferred-entry participants (182).|455
6659828|NCT02493868|7590772|FG001|STARTED|Optimization Phase: DE+TE Participants|Placebo treated transferred-entry participant.|86
6659829|NCT02493868|7590771|FG000|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria randomized to MA phase|297
6659830|NCT02493868|7590772|FG001|COMPLETED|Optimization Phase: DE+TE Participants|Participants who completed and met predefined remission/response criteria continued to MA phase.|54
6659831|NCT02493868|7590771|FG000|NOT COMPLETED|Optimization Phase: DE+TE Participants||158
6590953|NCT01984229|7515929|FG000|NOT COMPLETED|Safety Follow-up Period||2
6590954|NCT01984229|7515930|FG001|NOT COMPLETED|Safety Follow-up Period||1
6590955|NCT01984242|7515945|FG000|STARTED|Overall Study||101
6590956|NCT01984242|7515946|FG001|STARTED|Overall Study||103
6590957|NCT01984242|7515947|FG002|STARTED|Overall Study||101
6590958|NCT01984242|7515945|FG000|Treated|Overall Study||101
6590959|NCT01984242|7515946|FG001|Treated|Overall Study||103
6590960|NCT01984242|7515947|FG002|Treated|Overall Study||100
6590961|NCT01984242|7515945|FG000|COMPLETED|Overall Study||0
6590962|NCT01984242|7515946|FG001|COMPLETED|Overall Study||0
6590963|NCT01984242|7515947|FG002|COMPLETED|Overall Study||0
6590964|NCT01984242|7515945|FG000|NOT COMPLETED|Overall Study||101
6590965|NCT01984242|7515946|FG001|NOT COMPLETED|Overall Study||103
6590966|NCT01984242|7515947|FG002|NOT COMPLETED|Overall Study||101
6590967|NCT01984294|7515966|FG000|STARTED|Overall Study||35
6590968|NCT01984294|7515967|FG001|STARTED|Overall Study||32
6590969|NCT01984294|7515968|FG002|STARTED|Overall Study||34
6590970|NCT01984294|7515966|FG000|COMPLETED|Overall Study||31
6590971|NCT01984294|7515967|FG001|COMPLETED|Overall Study||29
6590972|NCT01984294|7515968|FG002|COMPLETED|Overall Study||27
6590973|NCT01984294|7515966|FG000|NOT COMPLETED|Overall Study||4
6590974|NCT01984294|7515967|FG001|NOT COMPLETED|Overall Study||3
6590975|NCT01984294|7515968|FG002|NOT COMPLETED|Overall Study||7
6590976|NCT01984398|7515978|FG000|STARTED|Treatment Period 1||4
6590977|NCT01984398|7515979|FG001|STARTED|Treatment Period 1||4
6590978|NCT01984398|7515980|FG002|STARTED|Treatment Period 1||4
6590979|NCT01984398|7515981|FG003|STARTED|Treatment Period 1||4
6590980|NCT01984398|7515978|FG000|COMPLETED|Treatment Period 1||4
6590981|NCT01984398|7515979|FG001|COMPLETED|Treatment Period 1||4
6590982|NCT01984398|7515980|FG002|COMPLETED|Treatment Period 1||4
6590983|NCT01984398|7515981|FG003|COMPLETED|Treatment Period 1||4
6590984|NCT01984398|7515978|FG000|NOT COMPLETED|Treatment Period 1||0
6590985|NCT01984398|7515979|FG001|NOT COMPLETED|Treatment Period 1||0
6590986|NCT01984398|7515980|FG002|NOT COMPLETED|Treatment Period 1||0
6590987|NCT01984398|7515981|FG003|NOT COMPLETED|Treatment Period 1||0
6590988|NCT01984398|7515978|FG000|STARTED|Washout Period of 5 to 7 Days||4
6590989|NCT01984398|7515979|FG001|STARTED|Washout Period of 5 to 7 Days||4
6590990|NCT01984398|7515980|FG002|STARTED|Washout Period of 5 to 7 Days||4
6590991|NCT01984398|7515981|FG003|STARTED|Washout Period of 5 to 7 Days||4
6590992|NCT01984398|7515978|FG000|COMPLETED|Washout Period of 5 to 7 Days||4
6590993|NCT01984398|7515979|FG001|COMPLETED|Washout Period of 5 to 7 Days||4
6590994|NCT01984398|7515980|FG002|COMPLETED|Washout Period of 5 to 7 Days||4
6590995|NCT01984398|7515981|FG003|COMPLETED|Washout Period of 5 to 7 Days||4
6590996|NCT01984398|7515978|FG000|NOT COMPLETED|Washout Period of 5 to 7 Days||0
6590997|NCT01984398|7515979|FG001|NOT COMPLETED|Washout Period of 5 to 7 Days||0
6590998|NCT01984398|7515980|FG002|NOT COMPLETED|Washout Period of 5 to 7 Days||0
6590999|NCT01984398|7515981|FG003|NOT COMPLETED|Washout Period of 5 to 7 Days||0
6591000|NCT01984398|7515978|FG000|STARTED|Treatment Period 2||4
6591001|NCT01984398|7515979|FG001|STARTED|Treatment Period 2||4
6591002|NCT01984398|7515980|FG002|STARTED|Treatment Period 2||4
6591003|NCT01984398|7515981|FG003|STARTED|Treatment Period 2||4
6591004|NCT01984398|7515978|FG000|COMPLETED|Treatment Period 2||4
6591005|NCT01984398|7515979|FG001|COMPLETED|Treatment Period 2||4
6591006|NCT01984398|7515980|FG002|COMPLETED|Treatment Period 2||4
6591007|NCT01984398|7515981|FG003|COMPLETED|Treatment Period 2||4
6591008|NCT01984398|7515978|FG000|NOT COMPLETED|Treatment Period 2||0
6591009|NCT01984398|7515979|FG001|NOT COMPLETED|Treatment Period 2||0
6591010|NCT01984398|7515980|FG002|NOT COMPLETED|Treatment Period 2||0
6591011|NCT01984398|7515981|FG003|NOT COMPLETED|Treatment Period 2||0
6591012|NCT01984424|7515993|FG000|STARTED|Overall Study||73
6591013|NCT01984424|7515994|FG001|STARTED|Overall Study||145
6591014|NCT01984424|7515993|FG000|COMPLETED|Overall Study||70
6591015|NCT01984424|7515994|FG001|COMPLETED|Overall Study||138
6591016|NCT01984424|7515993|FG000|NOT COMPLETED|Overall Study||3
6591017|NCT01984424|7515994|FG001|NOT COMPLETED|Overall Study||7
6591018|NCT01984515|7516000|FG000|STARTED|Overall Study||59
6591019|NCT01984515|7516000|FG000|Received CBT Session|Overall Study||40
6591020|NCT01984515|7516000|FG000|COMPLETED|Overall Study||40
6591021|NCT01984515|7516000|FG000|NOT COMPLETED|Overall Study||19
6591022|NCT01984684|7516006|FG000|STARTED|Overall Study||423
6591023|NCT01984684|7516007|FG001|STARTED|Overall Study||427
6591024|NCT01984684|7516006|FG000|COMPLETED|Overall Study||366
6591025|NCT01984684|7516007|FG001|COMPLETED|Overall Study||368
6591026|NCT01984684|7516006|FG000|NOT COMPLETED|Overall Study||57
6591027|NCT01984684|7516007|FG001|NOT COMPLETED|Overall Study||59
6591028|NCT01984697|7516018|FG000|STARTED|Overall Study||301
6591029|NCT01984697|7516019|FG001|STARTED|Overall Study||301
6591030|NCT01984697|7516020|FG002|STARTED|Overall Study||301
6591031|NCT01984697|7516021|FG003|STARTED|Overall Study||301
6591032|NCT01984697|7516022|FG004|STARTED|Overall Study||314
6591033|NCT01984697|7516018|FG000|Vaccination 1|Overall Study||301
6591034|NCT01984697|7516019|FG001|Vaccination 1|Overall Study||301
6591035|NCT01984697|7516020|FG002|Vaccination 1|Overall Study||300
6591036|NCT01984697|7516021|FG003|Vaccination 1|Overall Study||300
6591037|NCT01984697|7516022|FG004|Vaccination 1|Overall Study||314
6591038|NCT01984697|7516018|FG000|Vaccination 2|Overall Study||293
6591039|NCT01984697|7516019|FG001|Vaccination 2|Overall Study||296
6591040|NCT01984697|7516020|FG002|Vaccination 2|Overall Study||291
6591041|NCT01984697|7516021|FG003|Vaccination 2|Overall Study||298
6591042|NCT01984697|7516022|FG004|Vaccination 2|Overall Study||313
6591043|NCT01984697|7516018|FG000|Vaccination 3|Overall Study||0
6591044|NCT01984697|7516019|FG001|Vaccination 3|Overall Study||0
6591045|NCT01984697|7516020|FG002|Vaccination 3|Overall Study||0
6591046|NCT01984697|7516021|FG003|Vaccination 3|Overall Study||293
6591047|NCT01984697|7516022|FG004|Vaccination 3|Overall Study||311
6591048|NCT01984697|7516018|FG000|Month 36 Vaccination|Overall Study||270
6591049|NCT01984697|7516019|FG001|Month 36 Vaccination|Overall Study||281
6591050|NCT01984697|7516020|FG002|Month 36 Vaccination|Overall Study||280
6591051|NCT01984697|7516021|FG003|Month 36 Vaccination|Overall Study||9
6591052|NCT01984697|7516022|FG004|Month 36 Vaccination|Overall Study||31
6591053|NCT01984697|7516018|FG000|COMPLETED|Overall Study||258
6591054|NCT01984697|7516019|FG001|COMPLETED|Overall Study||270
6591055|NCT01984697|7516020|FG002|COMPLETED|Overall Study||272
6591056|NCT01984697|7516021|FG003|COMPLETED|Overall Study||280
6591057|NCT01984697|7516022|FG004|COMPLETED|Overall Study||279
6591058|NCT01984697|7516018|FG000|NOT COMPLETED|Overall Study||43
6591059|NCT01984697|7516019|FG001|NOT COMPLETED|Overall Study||31
6591060|NCT01984697|7516020|FG002|NOT COMPLETED|Overall Study||29
6591061|NCT01984697|7516021|FG003|NOT COMPLETED|Overall Study||21
6591062|NCT01984697|7516022|FG004|NOT COMPLETED|Overall Study||35
6591063|NCT01984892|7516034|FG000|STARTED|Overall Study||8
6591064|NCT01984892|7516034|FG000|COMPLETED|Overall Study|1 completed all study visits up until the termination of the study, last study visit not done.|1
6591065|NCT01984892|7516034|FG000|NOT COMPLETED|Overall Study||7
6591066|NCT01985126|7516040|FG000|STARTED|Overall Study||18
6591067|NCT01985126|7516041|FG001|STARTED|Overall Study||106
6591068|NCT01985126|7516040|FG000|COMPLETED|Overall Study||0
6591069|NCT01985126|7516041|FG001|COMPLETED|Overall Study||0
6591070|NCT01985126|7516040|FG000|NOT COMPLETED|Overall Study||18
6591071|NCT01985126|7516041|FG001|NOT COMPLETED|Overall Study||106
6591072|NCT01985321|7516049|FG000|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
6591073|NCT01985321|7516050|FG001|STARTED|Overall Study|This is treatment eligible subjects only|83
6591074|NCT01985321|7516049|FG000|COMPLETED|Overall Study||79
6591075|NCT01985321|7516050|FG001|COMPLETED|Overall Study||78
6591076|NCT01985321|7516049|FG000|NOT COMPLETED|Overall Study||11
6591077|NCT01985321|7516050|FG001|NOT COMPLETED|Overall Study||5
6591078|NCT01985334|7516064|FG000|STARTED|Overall Study||130
6591079|NCT01985334|7516065|FG001|STARTED|Overall Study||387
6591080|NCT01985334|7516066|FG002|STARTED|Overall Study||420
6591081|NCT01985334|7516067|FG003|STARTED|Overall Study||1262
6591082|NCT01985334|7516068|FG004|STARTED|Overall Study||274
6591083|NCT01985334|7516069|FG005|STARTED|Overall Study||822
6591084|NCT01985334|7516070|FG006|STARTED|Overall Study||274
6591085|NCT01985334|7516071|FG007|STARTED|Overall Study||820
6591086|NCT01985334|7516064|FG000|The Intention-to-treat (ITT) Population|Overall Study||122
6591087|NCT01985334|7516065|FG001|The Intention-to-treat (ITT) Population|Overall Study||369
6591088|NCT01985334|7516066|FG002|The Intention-to-treat (ITT) Population|Overall Study||420
6591089|NCT01985334|7516067|FG003|The Intention-to-treat (ITT) Population|Overall Study||1254
6591090|NCT01985334|7516068|FG004|The Intention-to-treat (ITT) Population|Overall Study||269
6591091|NCT01985334|7516069|FG005|The Intention-to-treat (ITT) Population|Overall Study||811
6591092|NCT01985334|7516070|FG006|The Intention-to-treat (ITT) Population|Overall Study||268
6591093|NCT01985334|7516071|FG007|The Intention-to-treat (ITT) Population|Overall Study||811
6591094|NCT01985334|7516064|FG000|COMPLETED|Overall Study||107
6591095|NCT01985334|7516065|FG001|COMPLETED|Overall Study||303
6591096|NCT01985334|7516066|FG002|COMPLETED|Overall Study||367
6591097|NCT01985334|7516067|FG003|COMPLETED|Overall Study||1033
6591098|NCT01985334|7516068|FG004|COMPLETED|Overall Study||234
6591099|NCT01985334|7516069|FG005|COMPLETED|Overall Study||666
6591100|NCT01985334|7516070|FG006|COMPLETED|Overall Study||237
6591101|NCT01985334|7516071|FG007|COMPLETED|Overall Study||699
6591102|NCT01985334|7516064|FG000|NOT COMPLETED|Overall Study||23
6591103|NCT01985334|7516065|FG001|NOT COMPLETED|Overall Study||84
6591104|NCT01985334|7516066|FG002|NOT COMPLETED|Overall Study||53
6591105|NCT01985334|7516067|FG003|NOT COMPLETED|Overall Study||229
6591106|NCT01985334|7516068|FG004|NOT COMPLETED|Overall Study||40
6591107|NCT01985334|7516069|FG005|NOT COMPLETED|Overall Study||156
6591108|NCT01985334|7516070|FG006|NOT COMPLETED|Overall Study||37
6591109|NCT01985334|7516071|FG007|NOT COMPLETED|Overall Study||121
6591110|NCT01985360|7516105|FG000|STARTED|Overall Study||388
6591111|NCT01985360|7516106|FG001|STARTED|Overall Study||389
6591112|NCT01985360|7516105|FG000|COMPLETED|Overall Study||379
6591113|NCT01985360|7516106|FG001|COMPLETED|Overall Study||386
6591114|NCT01985360|7516105|FG000|NOT COMPLETED|Overall Study||9
6591115|NCT01985360|7516106|FG001|NOT COMPLETED|Overall Study||3
6591116|NCT01985425|7516114|FG000|STARTED|Overall Study||49
6591117|NCT01985425|7516115|FG001|STARTED|Overall Study||51
6591118|NCT01985425|7516114|FG000|COMPLETED|Overall Study||49
6591119|NCT01985425|7516115|FG001|COMPLETED|Overall Study||51
6591120|NCT01985425|7516114|FG000|NOT COMPLETED|Overall Study||0
6591121|NCT01985425|7516115|FG001|NOT COMPLETED|Overall Study||0
6591122|NCT01985542|7516123|FG000|STARTED|Overall Study||7
6591123|NCT01985542|7516124|FG001|STARTED|Overall Study||9
6591124|NCT01985542|7516123|FG000|COMPLETED|Overall Study||3
6591125|NCT01985542|7516124|FG001|COMPLETED|Overall Study||3
6591126|NCT01985542|7516123|FG000|NOT COMPLETED|Overall Study||4
6591127|NCT01985542|7516124|FG001|NOT COMPLETED|Overall Study||6
6591128|NCT01985581|7516133|FG000|STARTED|First Intervention||25
6591129|NCT01985581|7516134|FG001|STARTED|First Intervention||25
6591130|NCT01985581|7516133|FG000|COMPLETED|First Intervention||22
6591131|NCT01985581|7516134|FG001|COMPLETED|First Intervention||23
6591132|NCT01985581|7516133|FG000|NOT COMPLETED|First Intervention||3
6591133|NCT01985581|7516134|FG001|NOT COMPLETED|First Intervention||2
6591134|NCT01985581|7516133|FG000|STARTED|Second Intervention||22
6591135|NCT01985581|7516134|FG001|STARTED|Second Intervention||23
6591136|NCT01985581|7516133|FG000|COMPLETED|Second Intervention||20
6591137|NCT01985581|7516134|FG001|COMPLETED|Second Intervention||19
6591138|NCT01985581|7516133|FG000|NOT COMPLETED|Second Intervention||2
6591139|NCT01985581|7516134|FG001|NOT COMPLETED|Second Intervention||4
6591140|NCT01985685|7516153|FG000|STARTED|Overall Study||27
6591141|NCT01985685|7516154|FG001|STARTED|Overall Study||29
6591142|NCT01985685|7516153|FG000|COMPLETED|Overall Study||27
6591143|NCT01985685|7516154|FG001|COMPLETED|Overall Study||29
6591144|NCT01985685|7516153|FG000|NOT COMPLETED|Overall Study||0
6591145|NCT01985685|7516154|FG001|NOT COMPLETED|Overall Study||0
6591146|NCT01985763|7516160|FG000|STARTED|Overall Study||13
6591147|NCT01985763|7516160|FG000|COMPLETED|Overall Study||13
6591148|NCT01985763|7516160|FG000|NOT COMPLETED|Overall Study||0
6591149|NCT01985932|7516165|FG000|STARTED|Overall Study||15
6591150|NCT01985932|7516165|FG000|COMPLETED|Overall Study||15
6591151|NCT01985932|7516165|FG000|NOT COMPLETED|Overall Study||0
6591152|NCT01985958|7516169|FG000|STARTED|Overall Study||4
6591153|NCT01985958|7516169|FG000|COMPLETED|Overall Study||3
6591154|NCT01985958|7516169|FG000|NOT COMPLETED|Overall Study||1
6591155|NCT01985971|7516173|FG000|STARTED|Overall Study||2
6591156|NCT01985971|7516173|FG000|COMPLETED|Overall Study||1
6591157|NCT01985971|7516173|FG000|NOT COMPLETED|Overall Study||1
6591158|NCT01986010|7516194|FG000|STARTED|Overall Study||13
6591159|NCT01986010|7516195|FG001|STARTED|Overall Study||14
6591160|NCT01986010|7516196|FG002|STARTED|Overall Study||14
6591161|NCT01986010|7516197|FG003|STARTED|Overall Study||10
6591162|NCT01986010|7516198|FG004|STARTED|Overall Study||11
6591163|NCT01986010|7516199|FG005|STARTED|Overall Study||19
6591164|NCT01986010|7516200|FG006|STARTED|Overall Study||10
6591165|NCT01986010|7516201|FG007|STARTED|Overall Study||4
6591166|NCT01986010|7516202|FG008|STARTED|Overall Study||12
6591167|NCT01986010|7516203|FG009|STARTED|Overall Study||10
6591168|NCT01986010|7516204|FG010|STARTED|Overall Study||10
6591169|NCT01986010|7516205|FG011|STARTED|Overall Study||11
6591170|NCT01986010|7516206|FG012|STARTED|Overall Study||10
6591171|NCT01986010|7516207|FG013|STARTED|Overall Study||11
6591172|NCT01986010|7516208|FG014|STARTED|Overall Study||16
6591173|NCT01986010|7516209|FG015|STARTED|Overall Study||11
6591174|NCT01986010|7516210|FG016|STARTED|Overall Study||4
6591175|NCT01986010|7516194|FG000|Vaccination 1|Overall Study||13
6591176|NCT01986010|7516195|FG001|Vaccination 1|Overall Study||14
6591177|NCT01986010|7516196|FG002|Vaccination 1|Overall Study||14
6591178|NCT01986010|7516197|FG003|Vaccination 1|Overall Study||10
6591179|NCT01986010|7516198|FG004|Vaccination 1|Overall Study||11
6591180|NCT01986010|7516199|FG005|Vaccination 1|Overall Study||19
6591181|NCT01986010|7516200|FG006|Vaccination 1|Overall Study||10
6591182|NCT01986010|7516201|FG007|Vaccination 1|Overall Study||4
6591183|NCT01986010|7516202|FG008|Vaccination 1|Overall Study||12
6591184|NCT01986010|7516203|FG009|Vaccination 1|Overall Study||10
6591185|NCT01986010|7516204|FG010|Vaccination 1|Overall Study||10
6591186|NCT01986010|7516205|FG011|Vaccination 1|Overall Study||11
6591187|NCT01986010|7516206|FG012|Vaccination 1|Overall Study||10
6591188|NCT01986010|7516207|FG013|Vaccination 1|Overall Study||11
6591189|NCT01986010|7516208|FG014|Vaccination 1|Overall Study||16
6591190|NCT01986010|7516209|FG015|Vaccination 1|Overall Study||11
6591191|NCT01986010|7516210|FG016|Vaccination 1|Overall Study||4
6591192|NCT01986010|7516194|FG000|Vaccination 2|Overall Study||12
6591193|NCT01986010|7516195|FG001|Vaccination 2|Overall Study||13
6591194|NCT01986010|7516196|FG002|Vaccination 2|Overall Study||12
6591195|NCT01986010|7516197|FG003|Vaccination 2|Overall Study||10
6591196|NCT01986010|7516198|FG004|Vaccination 2|Overall Study||9
6591197|NCT01986010|7516199|FG005|Vaccination 2|Overall Study||19
6591198|NCT01986010|7516200|FG006|Vaccination 2|Overall Study||10
6591199|NCT01986010|7516201|FG007|Vaccination 2|Overall Study||4
6591200|NCT01986010|7516202|FG008|Vaccination 2|Overall Study||11
6591201|NCT01986010|7516203|FG009|Vaccination 2|Overall Study||10
6591202|NCT01986010|7516204|FG010|Vaccination 2|Overall Study||10
6591203|NCT01986010|7516205|FG011|Vaccination 2|Overall Study||10
6591204|NCT01986010|7516206|FG012|Vaccination 2|Overall Study||10
6591205|NCT01986010|7516207|FG013|Vaccination 2|Overall Study||9
6591206|NCT01986010|7516208|FG014|Vaccination 2|Overall Study||16
6591207|NCT01986010|7516209|FG015|Vaccination 2|Overall Study||10
6591208|NCT01986010|7516210|FG016|Vaccination 2|Overall Study||4
6591209|NCT01986010|7516194|FG000|Vaccination 3|Overall Study||10
6591210|NCT01986010|7516195|FG001|Vaccination 3|Overall Study||10
6591211|NCT01986010|7516196|FG002|Vaccination 3|Overall Study||9
6591212|NCT01986010|7516197|FG003|Vaccination 3|Overall Study||10
6591213|NCT01986010|7516198|FG004|Vaccination 3|Overall Study||9
6591214|NCT01986010|7516199|FG005|Vaccination 3|Overall Study||15
6591215|NCT01986010|7516200|FG006|Vaccination 3|Overall Study||10
6591216|NCT01986010|7516201|FG007|Vaccination 3|Overall Study||4
6591217|NCT01986010|7516202|FG008|Vaccination 3|Overall Study||10
6591218|NCT01986010|7516203|FG009|Vaccination 3|Overall Study||10
6591219|NCT01986010|7516204|FG010|Vaccination 3|Overall Study||10
6591220|NCT01986010|7516205|FG011|Vaccination 3|Overall Study||8
6591221|NCT01986010|7516206|FG012|Vaccination 3|Overall Study||10
6591222|NCT01986010|7516207|FG013|Vaccination 3|Overall Study||9
6591223|NCT01986010|7516208|FG014|Vaccination 3|Overall Study||13
6591224|NCT01986010|7516209|FG015|Vaccination 3|Overall Study||10
6591225|NCT01986010|7516210|FG016|Vaccination 3|Overall Study||4
6591226|NCT01986010|7516194|FG000|COMPLETED|Overall Study||7
6591227|NCT01986010|7516195|FG001|COMPLETED|Overall Study||6
6591228|NCT01986010|7516196|FG002|COMPLETED|Overall Study||7
6591229|NCT01986010|7516197|FG003|COMPLETED|Overall Study||8
6591230|NCT01986010|7516198|FG004|COMPLETED|Overall Study||6
6591231|NCT01986010|7516199|FG005|COMPLETED|Overall Study||11
6591232|NCT01986010|7516200|FG006|COMPLETED|Overall Study||10
6591233|NCT01986010|7516201|FG007|COMPLETED|Overall Study||4
6591234|NCT01986010|7516202|FG008|COMPLETED|Overall Study||6
6591235|NCT01986010|7516203|FG009|COMPLETED|Overall Study||7
6591236|NCT01986010|7516204|FG010|COMPLETED|Overall Study||3
6591237|NCT01986010|7516205|FG011|COMPLETED|Overall Study||1
6591238|NCT01986010|7516206|FG012|COMPLETED|Overall Study||0
6591239|NCT01986010|7516207|FG013|COMPLETED|Overall Study||0
6659832|NCT02493868|7590772|FG001|NOT COMPLETED|Optimization Phase: DE+TE Participants||32
6659833|NCT02493868|7590771|FG000|STARTED|Maintenance Phase: DE+TE Participants|152 participants randomized from intranasal esketamine arm after OP phase: DE (90) + TE (62)|152
6659834|NCT02493868|7590772|FG001|STARTED|Maintenance Phase: DE+TE Participants|145 participants randomized from intranasal esketamine arm after OP phase+54 continued from OP phase|199
6659835|NCT02493868|7590771|FG000|Stable Remitters|Maintenance Phase: DE+TE Participants||90
6659836|NCT02493868|7590772|FG001|Stable Remitters|Maintenance Phase: DE+TE Participants||86
6659837|NCT02493868|7590771|FG000|Stable Responders|Maintenance Phase: DE+TE Participants||62
6659838|NCT02493868|7590772|FG001|Stable Responders|Maintenance Phase: DE+TE Participants||59
6659839|NCT02493868|7590771|FG000|COMPLETED|Maintenance Phase: DE+TE Participants||139
6659840|NCT02493868|7590772|FG001|COMPLETED|Maintenance Phase: DE+TE Participants||177
6659841|NCT02493868|7590771|FG000|NOT COMPLETED|Maintenance Phase: DE+TE Participants||13
6659842|NCT02493868|7590772|FG001|NOT COMPLETED|Maintenance Phase: DE+TE Participants||22
6659843|NCT02493868|7590771|FG000|STARTED|Follow-up Phase||481
6659844|NCT02493868|7590772|FG001|STARTED|Follow-up Phase||64
6659845|NCT02493868|7590771|FG000|COMPLETED|Follow-up Phase||470
6659846|NCT02493868|7590772|FG001|COMPLETED|Follow-up Phase||62
6659847|NCT02493868|7590771|FG000|NOT COMPLETED|Follow-up Phase||11
6659848|NCT02493868|7590772|FG001|NOT COMPLETED|Follow-up Phase||2
6659849|NCT02493946|7590787|FG000|STARTED|DB Period||126
6659850|NCT02493946|7590788|FG001|STARTED|DB Period||64
6659851|NCT02493946|7590789|FG002|STARTED|DB Period||0
6659852|NCT02493946|7590787|FG000|COMPLETED|DB Period||118
6659853|NCT02493946|7590788|FG001|COMPLETED|DB Period||59
6659854|NCT02493946|7590789|FG002|COMPLETED|DB Period||0
6659855|NCT02493946|7590787|FG000|NOT COMPLETED|DB Period||8
6659856|NCT02493946|7590788|FG001|NOT COMPLETED|DB Period||5
6659857|NCT02493946|7590789|FG002|NOT COMPLETED|DB Period||0
6659858|NCT02493946|7590787|FG000|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
6659859|NCT02493946|7590788|FG001|STARTED|Open Label Period|Only the BTX-A-HAC Solution 50 U - LT Analyses arm is applicable for this period.|0
6659860|NCT02493946|7590789|FG002|STARTED|Open Label Period|The previous period relates to DB period only, this period relates to OL treatment only.|595
6659861|NCT02493946|7590787|FG000|COMPLETED|Open Label Period||0
6591240|NCT01986010|7516208|FG014|COMPLETED|Overall Study||6
6591241|NCT01986010|7516209|FG015|COMPLETED|Overall Study||0
6591242|NCT01986010|7516210|FG016|COMPLETED|Overall Study||0
6591243|NCT01986010|7516194|FG000|NOT COMPLETED|Overall Study||6
6591244|NCT01986010|7516195|FG001|NOT COMPLETED|Overall Study||8
6591245|NCT01986010|7516196|FG002|NOT COMPLETED|Overall Study||7
6591246|NCT01986010|7516197|FG003|NOT COMPLETED|Overall Study||2
6591247|NCT01986010|7516198|FG004|NOT COMPLETED|Overall Study||5
6591248|NCT01986010|7516199|FG005|NOT COMPLETED|Overall Study||8
6591249|NCT01986010|7516200|FG006|NOT COMPLETED|Overall Study||0
6591250|NCT01986010|7516201|FG007|NOT COMPLETED|Overall Study||0
6591251|NCT01986010|7516202|FG008|NOT COMPLETED|Overall Study||6
6591252|NCT01986010|7516203|FG009|NOT COMPLETED|Overall Study||3
6591253|NCT01986010|7516204|FG010|NOT COMPLETED|Overall Study||7
6591254|NCT01986010|7516205|FG011|NOT COMPLETED|Overall Study||10
6591255|NCT01986010|7516206|FG012|NOT COMPLETED|Overall Study||10
6591256|NCT01986010|7516207|FG013|NOT COMPLETED|Overall Study||11
6591257|NCT01986010|7516208|FG014|NOT COMPLETED|Overall Study||10
6591258|NCT01986010|7516209|FG015|NOT COMPLETED|Overall Study||11
6591259|NCT01986010|7516210|FG016|NOT COMPLETED|Overall Study||4
6591260|NCT01986062|7516258|FG000|STARTED|Overall Study||47
6591261|NCT01986062|7516259|FG001|STARTED|Overall Study||50
6591262|NCT01986062|7516258|FG000|COMPLETED|Overall Study||46
6591263|NCT01986062|7516259|FG001|COMPLETED|Overall Study||49
6591264|NCT01986062|7516258|FG000|NOT COMPLETED|Overall Study||1
6591265|NCT01986062|7516259|FG001|NOT COMPLETED|Overall Study||1
6591266|NCT01986140|7516267|FG000|STARTED|Overall Study||157
6591267|NCT01986140|7516268|FG001|STARTED|Overall Study||79
6591268|NCT01986140|7516267|FG000|COMPLETED|Overall Study||122
6591269|NCT01986140|7516268|FG001|COMPLETED|Overall Study||51
6591270|NCT01986140|7516267|FG000|NOT COMPLETED|Overall Study||35
6591271|NCT01986140|7516268|FG001|NOT COMPLETED|Overall Study||28
6591272|NCT01986231|7516274|FG000|STARTED|Overall Study||12
6591273|NCT01986231|7516274|FG000|COMPLETED|Overall Study||11
6591274|NCT01986231|7516274|FG000|NOT COMPLETED|Overall Study||1
6591275|NCT01986348|7516282|FG000|STARTED|Overall Study||8
6591276|NCT01986348|7516283|FG001|STARTED|Overall Study||24
6591277|NCT01986348|7516284|FG002|STARTED|Overall Study||14
6591278|NCT01986348|7516285|FG003|STARTED|Overall Study||30
6591279|NCT01986348|7516282|FG000|COMPLETED|Overall Study||0
6591280|NCT01986348|7516283|FG001|COMPLETED|Overall Study||0
6591281|NCT01986348|7516284|FG002|COMPLETED|Overall Study||0
6591282|NCT01986348|7516285|FG003|COMPLETED|Overall Study||0
6591283|NCT01986348|7516282|FG000|NOT COMPLETED|Overall Study||8
6591284|NCT01986348|7516283|FG001|NOT COMPLETED|Overall Study||24
6591285|NCT01986348|7516284|FG002|NOT COMPLETED|Overall Study||14
6591286|NCT01986348|7516285|FG003|NOT COMPLETED|Overall Study||30
6591287|NCT01986361|7516300|FG000|STARTED|Overall Study||101
6591288|NCT01986361|7516301|FG001|STARTED|Overall Study||21
6591289|NCT01986361|7516300|FG000|COMPLETED|Overall Study||101
6591290|NCT01986361|7516301|FG001|COMPLETED|Overall Study||21
6591291|NCT01986361|7516300|FG000|NOT COMPLETED|Overall Study||0
6591292|NCT01986361|7516301|FG001|NOT COMPLETED|Overall Study||0
6591293|NCT01986647|7516311|FG000|STARTED|Overall Study||152
6591294|NCT01986647|7516312|FG001|STARTED|Overall Study||146
6591295|NCT01986647|7516313|FG002|STARTED|Overall Study||49
6591296|NCT01986647|7516314|FG003|STARTED|Overall Study||77
6591297|NCT01986647|7516311|FG000|COMPLETED|Overall Study||142
6591298|NCT01986647|7516312|FG001|COMPLETED|Overall Study||139
6591299|NCT01986647|7516313|FG002|COMPLETED|Overall Study||37
6591300|NCT01986647|7516314|FG003|COMPLETED|Overall Study||66
6591301|NCT01986647|7516311|FG000|NOT COMPLETED|Overall Study||10
6591302|NCT01986647|7516312|FG001|NOT COMPLETED|Overall Study||7
6591303|NCT01986647|7516313|FG002|NOT COMPLETED|Overall Study||12
6591304|NCT01986647|7516314|FG003|NOT COMPLETED|Overall Study||11
6591305|NCT01986686|7516330|FG000|STARTED|Overall Study||81
6591306|NCT01986686|7516331|FG001|STARTED|Overall Study||26
6591307|NCT01986686|7516330|FG000|COMPLETED|Overall Study||81
6591308|NCT01986686|7516331|FG001|COMPLETED|Overall Study||26
6591309|NCT01986686|7516330|FG000|NOT COMPLETED|Overall Study||0
6591310|NCT01986686|7516331|FG001|NOT COMPLETED|Overall Study||0
6591311|NCT01986790|7516340|FG000|STARTED|Overall Study||91
6591312|NCT01986790|7516341|FG001|STARTED|Overall Study||154
6591313|NCT01986790|7516342|FG002|STARTED|Overall Study||98
6591314|NCT01986790|7516340|FG000|COMPLETED|Overall Study||91
6591315|NCT01986790|7516341|FG001|COMPLETED|Overall Study||154
6591316|NCT01986790|7516342|FG002|COMPLETED|Overall Study||98
6591317|NCT01986790|7516340|FG000|NOT COMPLETED|Overall Study||0
6591318|NCT01986790|7516341|FG001|NOT COMPLETED|Overall Study||0
6591319|NCT01986790|7516342|FG002|NOT COMPLETED|Overall Study||0
6591320|NCT01986829|7516350|FG000|STARTED|Overall Study||9
6591321|NCT01986829|7516350|FG000|COMPLETED|Overall Study||8
6591322|NCT01986829|7516350|FG000|NOT COMPLETED|Overall Study||1
6591323|NCT01986855|7516360|FG000|STARTED|Overall Study||158
6591324|NCT01986855|7516361|FG001|STARTED|Overall Study||156
6591325|NCT01986855|7516362|FG002|STARTED|Overall Study||154
6591326|NCT01986855|7516360|FG000|Treated|Overall Study||158
6591327|NCT01986855|7516361|FG001|Treated|Overall Study||155
6591328|NCT01986855|7516362|FG002|Treated|Overall Study||154
6591329|NCT01986855|7516360|FG000|COMPLETED|Overall Study||145
6591330|NCT01986855|7516361|FG001|COMPLETED|Overall Study||142
6591331|NCT01986855|7516362|FG002|COMPLETED|Overall Study||143
6591332|NCT01986855|7516360|FG000|NOT COMPLETED|Overall Study||13
6591333|NCT01986855|7516361|FG001|NOT COMPLETED|Overall Study||14
6591334|NCT01986855|7516362|FG002|NOT COMPLETED|Overall Study||11
6591335|NCT01986881|7516373|FG000|STARTED|Overall Study||2752
6591336|NCT01986881|7516374|FG001|STARTED|Overall Study||2747
6591337|NCT01986881|7516375|FG002|STARTED|Overall Study||2747
6591338|NCT01986881|7516373|FG000|Treated|Overall Study||2746
6591339|NCT01986881|7516374|FG001|Treated|Overall Study||2747
6591340|NCT01986881|7516375|FG002|Treated|Overall Study||2745
6591341|NCT01986881|7516373|FG000|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||348
6591342|NCT01986881|7516374|FG001|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||370
6591343|NCT01986881|7516375|FG002|Participants Enrolled in the Insulin +/- Metformin Glycemic Sub-Study|Overall Study||347
6591344|NCT01986881|7516373|FG000|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||55
6591345|NCT01986881|7516374|FG001|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||54
6624486|NCT02217904|7551926|FG002|NOT COMPLETED|Overall Study||0
6591346|NCT01986881|7516375|FG002|Participants Enrolled in the Sulfonylurea Monotherapy Glycemic Sub-Study|Overall Study||48
6591347|NCT01986881|7516373|FG000|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||100
6591348|NCT01986881|7516374|FG001|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||113
6591349|NCT01986881|7516375|FG002|Participants Enrolled in the Metformin With Sulfonylurea Glycemic Sub-Study|Overall Study||117
6591350|NCT01986881|7516373|FG000|COMPLETED|Overall Study||2422
6591351|NCT01986881|7516374|FG001|COMPLETED|Overall Study||2401
6591352|NCT01986881|7516375|FG002|COMPLETED|Overall Study||2389
6591353|NCT01986881|7516373|FG000|NOT COMPLETED|Overall Study||330
6591354|NCT01986881|7516374|FG001|NOT COMPLETED|Overall Study||346
6591355|NCT01986881|7516375|FG002|NOT COMPLETED|Overall Study||358
6591356|NCT01986907|7516406|FG000|STARTED|Overall Study||936
6591357|NCT01986907|7516406|FG000|COMPLETED|Overall Study||774
6591358|NCT01986907|7516406|FG000|NOT COMPLETED|Overall Study||162
6591359|NCT01986920|7516413|FG000|STARTED|A- 101 25%||35
6591360|NCT01986920|7516414|FG001|STARTED|A- 101 25%||0
6591361|NCT01986920|7516415|FG002|STARTED|A- 101 25%||0
6591362|NCT01986920|7516416|FG003|STARTED|A- 101 25%||0
6591363|NCT01986920|7516413|FG000|COMPLETED|A- 101 25%||34
6591364|NCT01986920|7516414|FG001|COMPLETED|A- 101 25%||0
6591365|NCT01986920|7516415|FG002|COMPLETED|A- 101 25%||0
6591366|NCT01986920|7516416|FG003|COMPLETED|A- 101 25%||0
6591367|NCT01986920|7516413|FG000|NOT COMPLETED|A- 101 25%||1
6591368|NCT01986920|7516414|FG001|NOT COMPLETED|A- 101 25%||0
6591369|NCT01986920|7516415|FG002|NOT COMPLETED|A- 101 25%||0
6591370|NCT01986920|7516416|FG003|NOT COMPLETED|A- 101 25%||0
6591371|NCT01986920|7516413|FG000|STARTED|A-101 32.5%||0
6591372|NCT01986920|7516414|FG001|STARTED|A-101 32.5%||35
6591373|NCT01986920|7516415|FG002|STARTED|A-101 32.5%||0
6591374|NCT01986920|7516416|FG003|STARTED|A-101 32.5%||0
6591375|NCT01986920|7516413|FG000|COMPLETED|A-101 32.5%||0
6591376|NCT01986920|7516414|FG001|COMPLETED|A-101 32.5%||34
6591377|NCT01986920|7516415|FG002|COMPLETED|A-101 32.5%||0
6591378|NCT01986920|7516416|FG003|COMPLETED|A-101 32.5%||0
6591379|NCT01986920|7516413|FG000|NOT COMPLETED|A-101 32.5%||0
6591380|NCT01986920|7516414|FG001|NOT COMPLETED|A-101 32.5%||1
6591381|NCT01986920|7516415|FG002|NOT COMPLETED|A-101 32.5%||0
6591382|NCT01986920|7516416|FG003|NOT COMPLETED|A-101 32.5%||0
6591383|NCT01986920|7516413|FG000|STARTED|A-101 40%||0
6591384|NCT01986920|7516414|FG001|STARTED|A-101 40%||0
6591385|NCT01986920|7516415|FG002|STARTED|A-101 40%||35
6591386|NCT01986920|7516416|FG003|STARTED|A-101 40%||0
6591387|NCT01986920|7516413|FG000|COMPLETED|A-101 40%||0
6591388|NCT01986920|7516414|FG001|COMPLETED|A-101 40%||0
6591389|NCT01986920|7516415|FG002|COMPLETED|A-101 40%||34
6591390|NCT01986920|7516416|FG003|COMPLETED|A-101 40%||0
6591391|NCT01986920|7516413|FG000|NOT COMPLETED|A-101 40%||0
6591392|NCT01986920|7516414|FG001|NOT COMPLETED|A-101 40%||0
6591393|NCT01986920|7516415|FG002|NOT COMPLETED|A-101 40%||1
6591394|NCT01986920|7516416|FG003|NOT COMPLETED|A-101 40%||0
6591395|NCT01986920|7516413|FG000|STARTED|Placebo||0
6591396|NCT01986920|7516414|FG001|STARTED|Placebo||0
6591397|NCT01986920|7516415|FG002|STARTED|Placebo||0
6591398|NCT01986920|7516416|FG003|STARTED|Placebo||35
6591399|NCT01986920|7516413|FG000|COMPLETED|Placebo||0
6591400|NCT01986920|7516414|FG001|COMPLETED|Placebo||0
6591401|NCT01986920|7516415|FG002|COMPLETED|Placebo||0
6591402|NCT01986920|7516416|FG003|COMPLETED|Placebo||34
6591403|NCT01986920|7516413|FG000|NOT COMPLETED|Placebo||0
6591404|NCT01986920|7516414|FG001|NOT COMPLETED|Placebo||0
6591405|NCT01986920|7516415|FG002|NOT COMPLETED|Placebo||0
6591406|NCT01986920|7516416|FG003|NOT COMPLETED|Placebo||1
6591407|NCT01986946|7516428|FG000|STARTED|Overall Study||5
6591408|NCT01986946|7516429|FG001|STARTED|Overall Study||9
6591409|NCT01986946|7516428|FG000|COMPLETED|Overall Study||5
6591410|NCT01986946|7516429|FG001|COMPLETED|Overall Study||9
6591411|NCT01986946|7516428|FG000|NOT COMPLETED|Overall Study||0
6591412|NCT01986946|7516429|FG001|NOT COMPLETED|Overall Study||0
6591413|NCT01986985|7516435|FG000|STARTED|Overall Study||58
6591414|NCT01986985|7516435|FG000|COMPLETED|Overall Study||51
6591415|NCT01986985|7516435|FG000|NOT COMPLETED|Overall Study||7
6591416|NCT01987089|7516441|FG000|STARTED|Overall Study||31
6591417|NCT01987089|7516442|FG001|STARTED|Overall Study||32
6591418|NCT01987089|7516441|FG000|COMPLETED|Overall Study||30
6591419|NCT01987089|7516442|FG001|COMPLETED|Overall Study||28
6591420|NCT01987089|7516441|FG000|NOT COMPLETED|Overall Study||1
6591421|NCT01987089|7516442|FG001|NOT COMPLETED|Overall Study||4
6591422|NCT01987102|7516450|FG000|STARTED|2 Courses of HDMTX With SOC Rescue||8
6591423|NCT01987102|7516451|FG001|STARTED|2 Courses of HDMTX With SOC Rescue||10
6591424|NCT01987102|7516450|FG000|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
6591425|NCT01987102|7516451|FG001|COMPLETED|2 Courses of HDMTX With SOC Rescue||4
6591426|NCT01987102|7516450|FG000|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||4
6591427|NCT01987102|7516451|FG001|NOT COMPLETED|2 Courses of HDMTX With SOC Rescue||6
6591428|NCT01987102|7516450|FG000|STARTED|2 Courses of HDMTX With MOD Rescue||4
6591429|NCT01987102|7516451|FG001|STARTED|2 Courses of HDMTX With MOD Rescue||4
6591430|NCT01987102|7516450|FG000|COMPLETED|2 Courses of HDMTX With MOD Rescue||4
6591431|NCT01987102|7516451|FG001|COMPLETED|2 Courses of HDMTX With MOD Rescue||3
6591432|NCT01987102|7516450|FG000|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||0
6591433|NCT01987102|7516451|FG001|NOT COMPLETED|2 Courses of HDMTX With MOD Rescue||1
6591434|NCT01987219|7516464|FG000|STARTED|Overall Study||2
6591435|NCT01987219|7516465|FG001|STARTED|Overall Study||2
6591436|NCT01987219|7516466|FG002|STARTED|Overall Study||7
6591437|NCT01987219|7516467|FG003|STARTED|Overall Study||2
6591438|NCT01987219|7516468|FG004|STARTED|Overall Study||1
6591439|NCT01987219|7516469|FG005|STARTED|Overall Study||1
6591440|NCT01987219|7516464|FG000|COMPLETED|Overall Study||2
6591441|NCT01987219|7516465|FG001|COMPLETED|Overall Study||2
6591442|NCT01987219|7516466|FG002|COMPLETED|Overall Study||6
6591443|NCT01987219|7516467|FG003|COMPLETED|Overall Study||2
6591444|NCT01987219|7516468|FG004|COMPLETED|Overall Study||1
6591445|NCT01987219|7516469|FG005|COMPLETED|Overall Study||1
6591446|NCT01987219|7516464|FG000|NOT COMPLETED|Overall Study||0
6591447|NCT01987219|7516465|FG001|NOT COMPLETED|Overall Study||0
6591448|NCT01987219|7516466|FG002|NOT COMPLETED|Overall Study||1
6591449|NCT01987219|7516467|FG003|NOT COMPLETED|Overall Study||0
6591450|NCT01987219|7516468|FG004|NOT COMPLETED|Overall Study||0
6591451|NCT01987219|7516469|FG005|NOT COMPLETED|Overall Study||0
6591452|NCT01987232|7516482|FG000|STARTED|Overall Study||5
6591453|NCT01987232|7516483|FG001|STARTED|Overall Study||3
6591454|NCT01987232|7516484|FG002|STARTED|Overall Study||3
6591455|NCT01987232|7516485|FG003|STARTED|Overall Study||15
6591456|NCT01987232|7516486|FG004|STARTED|Overall Study||6
6591457|NCT01987232|7516482|FG000|COMPLETED|Overall Study||5
6591458|NCT01987232|7516483|FG001|COMPLETED|Overall Study||3
6591459|NCT01987232|7516484|FG002|COMPLETED|Overall Study||3
6591460|NCT01987232|7516485|FG003|COMPLETED|Overall Study||14
6591461|NCT01987232|7516486|FG004|COMPLETED|Overall Study||6
6591462|NCT01987232|7516482|FG000|NOT COMPLETED|Overall Study||0
6591463|NCT01987232|7516483|FG001|NOT COMPLETED|Overall Study||0
6591464|NCT01987232|7516484|FG002|NOT COMPLETED|Overall Study||0
6591465|NCT01987232|7516485|FG003|NOT COMPLETED|Overall Study||1
6591466|NCT01987232|7516486|FG004|NOT COMPLETED|Overall Study||0
6591467|NCT01987349|7516508|FG000|STARTED|Overall Study||6
6591468|NCT01987349|7516509|FG001|STARTED|Overall Study||6
6591469|NCT01987349|7516510|FG002|STARTED|Overall Study||8
6591470|NCT01987349|7516511|FG003|STARTED|Overall Study||6
6591471|NCT01987349|7516512|FG004|STARTED|Overall Study||6
6591472|NCT01987349|7516513|FG005|STARTED|Overall Study||6
6591473|NCT01987349|7516514|FG006|STARTED|Overall Study||10
6591474|NCT01987349|7516515|FG007|STARTED|Overall Study||25
6591475|NCT01987349|7516508|FG000|COMPLETED|Overall Study||6
6591476|NCT01987349|7516509|FG001|COMPLETED|Overall Study||6
6591477|NCT01987349|7516510|FG002|COMPLETED|Overall Study||8
6591478|NCT01987349|7516511|FG003|COMPLETED|Overall Study||6
6591479|NCT01987349|7516512|FG004|COMPLETED|Overall Study||6
6591480|NCT01987349|7516513|FG005|COMPLETED|Overall Study||6
6591481|NCT01987349|7516514|FG006|COMPLETED|Overall Study||10
6591482|NCT01987349|7516515|FG007|COMPLETED|Overall Study||24
6591483|NCT01987349|7516508|FG000|NOT COMPLETED|Overall Study||0
6591484|NCT01987349|7516509|FG001|NOT COMPLETED|Overall Study||0
6591485|NCT01987349|7516510|FG002|NOT COMPLETED|Overall Study||0
6591486|NCT01987349|7516511|FG003|NOT COMPLETED|Overall Study||0
6591487|NCT01987349|7516512|FG004|NOT COMPLETED|Overall Study||0
6591488|NCT01987349|7516513|FG005|NOT COMPLETED|Overall Study||0
6591489|NCT01987349|7516514|FG006|NOT COMPLETED|Overall Study||0
6591490|NCT01987349|7516515|FG007|NOT COMPLETED|Overall Study||1
6591491|NCT01987401|7516540|FG000|STARTED|Overall Study||591
6591492|NCT01987401|7516541|FG001|STARTED|Overall Study||591
6591493|NCT01987401|7516542|FG002|STARTED|Overall Study||60
6591494|NCT01987401|7516540|FG000|COMPLETED|Overall Study||137
6591495|NCT01987401|7516541|FG001|COMPLETED|Overall Study||121
6591496|NCT01987401|7516542|FG002|COMPLETED|Overall Study||16
6591497|NCT01987401|7516540|FG000|NOT COMPLETED|Overall Study||454
6591498|NCT01987401|7516541|FG001|NOT COMPLETED|Overall Study||470
6591499|NCT01987401|7516542|FG002|NOT COMPLETED|Overall Study||44
6591500|NCT01987414|7516552|FG000|STARTED|Overall Study||10
6591501|NCT01987414|7516553|FG001|STARTED|Overall Study||8
6591502|NCT01987414|7516552|FG000|COMPLETED|Overall Study||8
6591503|NCT01987414|7516553|FG001|COMPLETED|Overall Study||6
6591504|NCT01987414|7516552|FG000|NOT COMPLETED|Overall Study||2
6591505|NCT01987414|7516553|FG001|NOT COMPLETED|Overall Study||2
6591506|NCT01987427|7516562|FG000|STARTED|Overall Study||78
6591507|NCT01987427|7516563|FG001|STARTED|Overall Study||78
6591508|NCT01987427|7516564|FG002|STARTED|Overall Study||79
6591509|NCT01987427|7516562|FG000|COMPLETED|Overall Study||64
6591510|NCT01987427|7516563|FG001|COMPLETED|Overall Study||68
6591511|NCT01987427|7516564|FG002|COMPLETED|Overall Study||59
6591512|NCT01987427|7516562|FG000|NOT COMPLETED|Overall Study||14
6591513|NCT01987427|7516563|FG001|NOT COMPLETED|Overall Study||10
6591514|NCT01987427|7516564|FG002|NOT COMPLETED|Overall Study||20
6591515|NCT01987453|7516575|FG000|STARTED|Overall Study||51
6591516|NCT01987453|7516576|FG001|STARTED|Overall Study||41
6591517|NCT01987453|7516577|FG002|STARTED|Overall Study||8
6591518|NCT01987453|7516575|FG000|COMPLETED|Overall Study||50
6591519|NCT01987453|7516576|FG001|COMPLETED|Overall Study||29
6591520|NCT01987453|7516577|FG002|COMPLETED|Overall Study||7
6591521|NCT01987453|7516575|FG000|NOT COMPLETED|Overall Study||1
6591522|NCT01987453|7516576|FG001|NOT COMPLETED|Overall Study||12
6591523|NCT01987453|7516577|FG002|NOT COMPLETED|Overall Study||1
6591524|NCT01987479|7516589|FG000|STARTED|Overall Study||150
6591525|NCT01987479|7516589|FG000|COMPLETED|Overall Study||133
6591526|NCT01987479|7516589|FG000|NOT COMPLETED|Overall Study||17
6591527|NCT01987505|7516595|FG000|STARTED|Overall Study||140
6591528|NCT01987505|7516595|FG000|COMPLETED|Overall Study||106
6591529|NCT01987505|7516595|FG000|NOT COMPLETED|Overall Study||34
6591530|NCT01987557|7516604|FG000|STARTED|Overall Study||16
6591531|NCT01987557|7516605|FG001|STARTED|Overall Study||16
6591532|NCT01987557|7516606|FG002|STARTED|Overall Study||16
6591533|NCT01987557|7516604|FG000|COMPLETED|Overall Study||13
6591534|NCT01987557|7516605|FG001|COMPLETED|Overall Study||13
6591535|NCT01987557|7516606|FG002|COMPLETED|Overall Study||13
6591536|NCT01987557|7516604|FG000|NOT COMPLETED|Overall Study||3
6591537|NCT01987557|7516605|FG001|NOT COMPLETED|Overall Study||3
6591538|NCT01987557|7516606|FG002|NOT COMPLETED|Overall Study||3
6591539|NCT01987583|7516616|FG000|STARTED|Overall Study||40
6591540|NCT01987583|7516617|FG001|STARTED|Overall Study||40
6591541|NCT01987583|7516616|FG000|COMPLETED|Overall Study||37
6591542|NCT01987583|7516617|FG001|COMPLETED|Overall Study||38
6591543|NCT01987583|7516616|FG000|NOT COMPLETED|Overall Study||3
6591544|NCT01987583|7516617|FG001|NOT COMPLETED|Overall Study||2
6591545|NCT01987596|7516625|FG000|STARTED|Overall Study||12
6591546|NCT01987596|7516626|FG001|STARTED|Overall Study||11
6591547|NCT01987596|7516625|FG000|COMPLETED|Overall Study||11
6591548|NCT01987596|7516626|FG001|COMPLETED|Overall Study||10
6591549|NCT01987596|7516625|FG000|NOT COMPLETED|Overall Study||1
6591550|NCT01987596|7516626|FG001|NOT COMPLETED|Overall Study||1
6591551|NCT01987609|7516638|FG000|STARTED|Overall Study|one arm on one patient|7
6591552|NCT01987609|7516638|FG000|Hylenex Injected in Arm|Overall Study||6
6591553|NCT01987609|7516638|FG000|Normal Saline Injected in Arm|Overall Study||6
6591554|NCT01987609|7516638|FG000|COMPLETED|Overall Study||6
6591555|NCT01987609|7516638|FG000|NOT COMPLETED|Overall Study||1
6591556|NCT01987752|7516652|FG000|STARTED|Overall Study||732
6591557|NCT01987752|7516652|FG000|COMPLETED|Overall Study||732
6591558|NCT01987752|7516652|FG000|NOT COMPLETED|Overall Study||0
6591559|NCT01987765|7516656|FG000|STARTED|Overall Study||847
6591560|NCT01987765|7516656|FG000|COMPLETED|Overall Study||745
6591561|NCT01987765|7516656|FG000|NOT COMPLETED|Overall Study||102
6591562|NCT01987817|7516662|FG000|STARTED|Overall Study||29
6591563|NCT01987817|7516663|FG001|STARTED|Overall Study||27
6591564|NCT01987817|7516662|FG000|COMPLETED|Overall Study||23
6591565|NCT01987817|7516663|FG001|COMPLETED|Overall Study||26
6591566|NCT01987817|7516662|FG000|NOT COMPLETED|Overall Study||6
6591567|NCT01987817|7516663|FG001|NOT COMPLETED|Overall Study||1
6591568|NCT01987830|7516670|FG000|STARTED|Overall Study||13
6659862|NCT02493946|7590788|FG001|COMPLETED|Open Label Period||0
6591569|NCT01987830|7516670|FG000|COMPLETED|Overall Study||12
6591570|NCT01987830|7516670|FG000|NOT COMPLETED|Overall Study||1
6591571|NCT01987895|7516676|FG000|STARTED|Overall Study||306
6591572|NCT01987895|7516677|FG001|STARTED|Overall Study||326
6591573|NCT01987895|7516676|FG000|COMPLETED|Overall Study||276
6591574|NCT01987895|7516677|FG001|COMPLETED|Overall Study||296
6591575|NCT01987895|7516676|FG000|NOT COMPLETED|Overall Study||30
6591576|NCT01987895|7516677|FG001|NOT COMPLETED|Overall Study||30
6591577|NCT01987908|7516683|FG000|STARTED|Placebo Lead-in Period||23
6591578|NCT01987908|7516684|FG001|STARTED|Placebo Lead-in Period||0
6591579|NCT01987908|7516685|FG002|STARTED|Placebo Lead-in Period||0
6591580|NCT01987908|7516683|FG000|COMPLETED|Placebo Lead-in Period||14
6591581|NCT01987908|7516684|FG001|COMPLETED|Placebo Lead-in Period||0
6591582|NCT01987908|7516685|FG002|COMPLETED|Placebo Lead-in Period||0
6591583|NCT01987908|7516683|FG000|NOT COMPLETED|Placebo Lead-in Period||9
6591584|NCT01987908|7516684|FG001|NOT COMPLETED|Placebo Lead-in Period||0
6591585|NCT01987908|7516685|FG002|NOT COMPLETED|Placebo Lead-in Period||0
6591586|NCT01987908|7516683|FG000|STARTED|Treatment Period||0
6591587|NCT01987908|7516684|FG001|STARTED|Treatment Period||11
6591588|NCT01987908|7516685|FG002|STARTED|Treatment Period||3
6591589|NCT01987908|7516683|FG000|COMPLETED|Treatment Period||0
6591590|NCT01987908|7516684|FG001|COMPLETED|Treatment Period||10
6591591|NCT01987908|7516685|FG002|COMPLETED|Treatment Period||2
6591592|NCT01987908|7516683|FG000|NOT COMPLETED|Treatment Period||0
6591593|NCT01987908|7516684|FG001|NOT COMPLETED|Treatment Period||1
6591594|NCT01987908|7516685|FG002|NOT COMPLETED|Treatment Period||1
6591595|NCT01987908|7516683|FG000|STARTED|Post-Treatment Observation Period||0
6591596|NCT01987908|7516684|FG001|STARTED|Post-Treatment Observation Period||10
6591597|NCT01987908|7516685|FG002|STARTED|Post-Treatment Observation Period||2
6591598|NCT01987908|7516683|FG000|COMPLETED|Post-Treatment Observation Period||0
6591599|NCT01987908|7516684|FG001|COMPLETED|Post-Treatment Observation Period||7
6591600|NCT01987908|7516685|FG002|COMPLETED|Post-Treatment Observation Period||2
6591601|NCT01987908|7516683|FG000|NOT COMPLETED|Post-Treatment Observation Period||0
6591602|NCT01987908|7516684|FG001|NOT COMPLETED|Post-Treatment Observation Period||3
6591603|NCT01987908|7516685|FG002|NOT COMPLETED|Post-Treatment Observation Period||0
6591604|NCT01987960|7516711|FG000|STARTED|Period 1||417
6591605|NCT01987960|7516712|FG001|STARTED|Period 1||0
6591606|NCT01987960|7516713|FG002|STARTED|Period 1||0
6591607|NCT01987960|7516714|FG003|STARTED|Period 1||0
6591608|NCT01987960|7516711|FG000|COMPLETED|Period 1||231
6591609|NCT01987960|7516712|FG001|COMPLETED|Period 1||0
6591610|NCT01987960|7516713|FG002|COMPLETED|Period 1||0
6591611|NCT01987960|7516714|FG003|COMPLETED|Period 1||0
6591612|NCT01987960|7516711|FG000|NOT COMPLETED|Period 1||186
6591613|NCT01987960|7516712|FG001|NOT COMPLETED|Period 1||0
6591614|NCT01987960|7516713|FG002|NOT COMPLETED|Period 1||0
6591615|NCT01987960|7516714|FG003|NOT COMPLETED|Period 1||0
6591616|NCT01987960|7516711|FG000|STARTED|Period 2||0
6591617|NCT01987960|7516712|FG001|STARTED|Period 2||17
6591618|NCT01987960|7516713|FG002|STARTED|Period 2||23
6591619|NCT01987960|7516714|FG003|STARTED|Period 2||0
6591620|NCT01987960|7516711|FG000|COMPLETED|Period 2||0
6591621|NCT01987960|7516712|FG001|COMPLETED|Period 2||12
6591622|NCT01987960|7516713|FG002|COMPLETED|Period 2||14
6591623|NCT01987960|7516714|FG003|COMPLETED|Period 2||0
6591624|NCT01987960|7516711|FG000|NOT COMPLETED|Period 2||0
6591625|NCT01987960|7516712|FG001|NOT COMPLETED|Period 2||5
6591626|NCT01987960|7516713|FG002|NOT COMPLETED|Period 2||9
6591627|NCT01987960|7516714|FG003|NOT COMPLETED|Period 2||0
6591628|NCT01987960|7516711|FG000|STARTED|Period 3||0
6591629|NCT01987960|7516712|FG001|STARTED|Period 3||0
6591630|NCT01987960|7516713|FG002|STARTED|Period 3||0
6591631|NCT01987960|7516714|FG003|STARTED|Period 3||190
6591632|NCT01987960|7516711|FG000|COMPLETED|Period 3||0
6591633|NCT01987960|7516712|FG001|COMPLETED|Period 3||0
6591634|NCT01987960|7516713|FG002|COMPLETED|Period 3||0
6591635|NCT01987960|7516714|FG003|COMPLETED|Period 3||119
6591636|NCT01987960|7516711|FG000|NOT COMPLETED|Period 3||0
6591637|NCT01987960|7516712|FG001|NOT COMPLETED|Period 3||0
6591638|NCT01987960|7516713|FG002|NOT COMPLETED|Period 3||0
6591639|NCT01987960|7516714|FG003|NOT COMPLETED|Period 3||71
6591640|NCT01987986|7516728|FG000|STARTED|Overall Study||43
6591641|NCT01987986|7516729|FG001|STARTED|Overall Study||43
6591642|NCT01987986|7516730|FG002|STARTED|Overall Study||40
6591643|NCT01987986|7516731|FG003|STARTED|Overall Study||24
6591644|NCT01987986|7516728|FG000|COMPLETED|Overall Study||41
6591645|NCT01987986|7516729|FG001|COMPLETED|Overall Study||43
6591646|NCT01987986|7516730|FG002|COMPLETED|Overall Study||38
6591647|NCT01987986|7516731|FG003|COMPLETED|Overall Study||24
6591648|NCT01987986|7516728|FG000|NOT COMPLETED|Overall Study||2
6591649|NCT01987986|7516729|FG001|NOT COMPLETED|Overall Study||0
6591650|NCT01987986|7516730|FG002|NOT COMPLETED|Overall Study||2
6591651|NCT01987986|7516731|FG003|NOT COMPLETED|Overall Study||0
6591652|NCT01988012|7516741|FG000|STARTED|Overall Study||100
6591653|NCT01988012|7516741|FG000|COMPLETED|Overall Study||85
6591654|NCT01988012|7516741|FG000|NOT COMPLETED|Overall Study||15
6591655|NCT01988090|7516747|FG000|STARTED|Start Treament After Randomization||46
6591656|NCT01988090|7516748|FG001|STARTED|Start Treament After Randomization||47
6591657|NCT01988090|7516747|FG000|COMPLETED|Start Treament After Randomization||44
6591658|NCT01988090|7516748|FG001|COMPLETED|Start Treament After Randomization||43
6591659|NCT01988090|7516747|FG000|NOT COMPLETED|Start Treament After Randomization||2
6591660|NCT01988090|7516748|FG001|NOT COMPLETED|Start Treament After Randomization||4
6591661|NCT01988090|7516747|FG000|STARTED|Complete Study After Start||44
6591662|NCT01988090|7516748|FG001|STARTED|Complete Study After Start||43
6591663|NCT01988090|7516747|FG000|COMPLETED|Complete Study After Start||41
6591664|NCT01988090|7516748|FG001|COMPLETED|Complete Study After Start||42
6591665|NCT01988090|7516747|FG000|NOT COMPLETED|Complete Study After Start||3
6591666|NCT01988090|7516748|FG001|NOT COMPLETED|Complete Study After Start||1
6591667|NCT01988103|7516757|FG000|STARTED|Placebo-Controlled Phase Week 0-16||84
6591668|NCT01988103|7516758|FG001|STARTED|Placebo-Controlled Phase Week 0-16||85
6591669|NCT01988103|7516759|FG002|STARTED|Placebo-Controlled Phase Week 0-16||85
6591670|NCT01988103|7516760|FG003|STARTED|Placebo-Controlled Phase Week 0-16||0
6591671|NCT01988103|7516761|FG004|STARTED|Placebo-Controlled Phase Week 0-16||0
6591672|NCT01988103|7516757|FG000|COMPLETED|Placebo-Controlled Phase Week 0-16||72
6591673|NCT01988103|7516758|FG001|COMPLETED|Placebo-Controlled Phase Week 0-16||69
6591674|NCT01988103|7516759|FG002|COMPLETED|Placebo-Controlled Phase Week 0-16||76
6591675|NCT01988103|7516760|FG003|COMPLETED|Placebo-Controlled Phase Week 0-16||0
6591676|NCT01988103|7516761|FG004|COMPLETED|Placebo-Controlled Phase Week 0-16||0
6591677|NCT01988103|7516757|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||12
6591678|NCT01988103|7516758|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||16
6591679|NCT01988103|7516759|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||9
6591680|NCT01988103|7516760|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
6591681|NCT01988103|7516761|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-16||0
6591682|NCT01988103|7516757|FG000|STARTED|Active Treatment Phase (Weeks 16-68)||0
6591683|NCT01988103|7516758|FG001|STARTED|Active Treatment Phase (Weeks 16-68)||69
6591684|NCT01988103|7516759|FG002|STARTED|Active Treatment Phase (Weeks 16-68)||76
6591685|NCT01988103|7516760|FG003|STARTED|Active Treatment Phase (Weeks 16-68)||36
6591686|NCT01988103|7516761|FG004|STARTED|Active Treatment Phase (Weeks 16-68)||35
6591687|NCT01988103|7516757|FG000|COMPLETED|Active Treatment Phase (Weeks 16-68)||0
6591688|NCT01988103|7516758|FG001|COMPLETED|Active Treatment Phase (Weeks 16-68)||56
6591689|NCT01988103|7516759|FG002|COMPLETED|Active Treatment Phase (Weeks 16-68)||65
6591690|NCT01988103|7516760|FG003|COMPLETED|Active Treatment Phase (Weeks 16-68)||33
6591691|NCT01988103|7516761|FG004|COMPLETED|Active Treatment Phase (Weeks 16-68)||30
6591692|NCT01988103|7516757|FG000|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||0
6591693|NCT01988103|7516758|FG001|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||13
6591694|NCT01988103|7516759|FG002|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||11
6591695|NCT01988103|7516760|FG003|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||3
6591696|NCT01988103|7516761|FG004|NOT COMPLETED|Active Treatment Phase (Weeks 16-68)||5
6591697|NCT01988103|7516757|FG000|STARTED|Observational Follow-up Phase||12
6591698|NCT01988103|7516758|FG001|STARTED|Observational Follow-up Phase||82
6591699|NCT01988103|7516759|FG002|STARTED|Observational Follow-up Phase||83
6591700|NCT01988103|7516760|FG003|STARTED|Observational Follow-up Phase||36
6591701|NCT01988103|7516761|FG004|STARTED|Observational Follow-up Phase||33
6591702|NCT01988103|7516757|FG000|COMPLETED|Observational Follow-up Phase||12
6591703|NCT01988103|7516758|FG001|COMPLETED|Observational Follow-up Phase||79
6591704|NCT01988103|7516759|FG002|COMPLETED|Observational Follow-up Phase||82
6591705|NCT01988103|7516760|FG003|COMPLETED|Observational Follow-up Phase||36
6591706|NCT01988103|7516761|FG004|COMPLETED|Observational Follow-up Phase||33
6591707|NCT01988103|7516757|FG000|NOT COMPLETED|Observational Follow-up Phase||0
6591708|NCT01988103|7516758|FG001|NOT COMPLETED|Observational Follow-up Phase||3
6591709|NCT01988103|7516759|FG002|NOT COMPLETED|Observational Follow-up Phase||1
6591710|NCT01988103|7516760|FG003|NOT COMPLETED|Observational Follow-up Phase||0
6591711|NCT01988103|7516761|FG004|NOT COMPLETED|Observational Follow-up Phase||0
6591712|NCT01988129|7516778|FG000|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
6591713|NCT01988129|7516779|FG001|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
6591714|NCT01988129|7516778|FG000|Attended Education Session|Overall Study||542
6591715|NCT01988129|7516779|FG001|Attended Education Session|Overall Study||18
6591716|NCT01988129|7516778|FG000|Screened for Sleep Disorders|Overall Study||416
6591717|NCT01988129|7516779|FG001|Screened for Sleep Disorders|Overall Study||15
6591718|NCT01988129|7516778|FG000|Completed 1-year Follow-up Survey|Overall Study||100
6591719|NCT01988129|7516779|FG001|Completed 1-year Follow-up Survey|Overall Study||4
6591720|NCT01988129|7516778|FG000|COMPLETED|Overall Study||601
6591721|NCT01988129|7516779|FG001|COMPLETED|Overall Study||588
6591722|NCT01988129|7516778|FG000|NOT COMPLETED|Overall Study||0
6591723|NCT01988129|7516779|FG001|NOT COMPLETED|Overall Study||0
6591724|NCT01988246|7516790|FG000|STARTED|Overall Study||15
6591725|NCT01988246|7516791|FG001|STARTED|Overall Study||15
6591726|NCT01988246|7516790|FG000|COMPLETED|Overall Study||14
6591727|NCT01988246|7516791|FG001|COMPLETED|Overall Study||15
6591728|NCT01988246|7516790|FG000|NOT COMPLETED|Overall Study||1
6591729|NCT01988246|7516791|FG001|NOT COMPLETED|Overall Study||0
6591730|NCT01988376|7516799|FG000|STARTED|Overall Study||129
6591731|NCT01988376|7516800|FG001|STARTED|Overall Study||129
6591732|NCT01988376|7516799|FG000|COMPLETED|Overall Study||129
6591733|NCT01988376|7516800|FG001|COMPLETED|Overall Study||129
6591734|NCT01988376|7516799|FG000|NOT COMPLETED|Overall Study||0
6591735|NCT01988376|7516800|FG001|NOT COMPLETED|Overall Study||0
6591736|NCT01988402|7516808|FG000|STARTED|Overall Study||16
6591737|NCT01988402|7516809|FG001|STARTED|Overall Study||19
6591738|NCT01988402|7516808|FG000|COMPLETED|Overall Study||14
6591739|NCT01988402|7516809|FG001|COMPLETED|Overall Study||17
6591740|NCT01988402|7516808|FG000|NOT COMPLETED|Overall Study||2
6591741|NCT01988402|7516809|FG001|NOT COMPLETED|Overall Study||2
6591742|NCT01988415|7516815|FG000|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
6591743|NCT01988415|7516815|FG000|COMPLETED|Overall Study||26
6591744|NCT01988415|7516815|FG000|NOT COMPLETED|Overall Study||0
6591745|NCT01988662|7516823|FG000|STARTED|Overall Study||104
6591746|NCT01988662|7516824|FG001|STARTED|Overall Study||101
6591747|NCT01988662|7516823|FG000|COMPLETED|Overall Study||100
6591748|NCT01988662|7516824|FG001|COMPLETED|Overall Study||99
6591749|NCT01988662|7516823|FG000|NOT COMPLETED|Overall Study||4
6591750|NCT01988662|7516824|FG001|NOT COMPLETED|Overall Study||2
6591751|NCT01988779|7516833|FG000|STARTED|Overall Study||12
6591752|NCT01988779|7516834|FG001|STARTED|Overall Study||13
6591753|NCT01988779|7516833|FG000|COMPLETED|Overall Study||9
6591754|NCT01988779|7516834|FG001|COMPLETED|Overall Study||11
6591755|NCT01988779|7516833|FG000|NOT COMPLETED|Overall Study||3
6591756|NCT01988779|7516834|FG001|NOT COMPLETED|Overall Study||2
6591757|NCT01988857|7516840|FG000|STARTED|Overall Study||300
6591758|NCT01988857|7516840|FG000|COMPLETED|Overall Study||300
6591759|NCT01988857|7516840|FG000|NOT COMPLETED|Overall Study||0
6591760|NCT01988922|7516847|FG000|STARTED|Overall Study||10
6591761|NCT01988922|7516848|FG001|STARTED|Overall Study||10
6591762|NCT01988922|7516849|FG002|STARTED|Overall Study||10
6591763|NCT01988922|7516847|FG000|COMPLETED|Overall Study||10
6591764|NCT01988922|7516848|FG001|COMPLETED|Overall Study||10
6591765|NCT01988922|7516849|FG002|COMPLETED|Overall Study||10
6591766|NCT01988922|7516847|FG000|NOT COMPLETED|Overall Study||0
6591767|NCT01988922|7516848|FG001|NOT COMPLETED|Overall Study||0
6591768|NCT01988922|7516849|FG002|NOT COMPLETED|Overall Study||0
6591769|NCT01989130|7516862|FG000|STARTED|Overall Study||43
6591770|NCT01989130|7516863|FG001|STARTED|Overall Study||27
6591771|NCT01989130|7516862|FG000|COMPLETED|Overall Study||43
6591772|NCT01989130|7516863|FG001|COMPLETED|Overall Study||27
6591773|NCT01989130|7516862|FG000|NOT COMPLETED|Overall Study||0
6591774|NCT01989130|7516863|FG001|NOT COMPLETED|Overall Study||0
6591775|NCT01989156|7516872|FG000|STARTED|Confinement Period (Population at Day 5)||80
6591776|NCT01989156|7516873|FG001|STARTED|Confinement Period (Population at Day 5)||41
6591777|NCT01989156|7516874|FG002|STARTED|Confinement Period (Population at Day 5)||39
6591778|NCT01989156|7516872|FG000|COMPLETED|Confinement Period (Population at Day 5)||80
6591779|NCT01989156|7516873|FG001|COMPLETED|Confinement Period (Population at Day 5)||40
6591780|NCT01989156|7516874|FG002|COMPLETED|Confinement Period (Population at Day 5)||34
6591781|NCT01989156|7516872|FG000|NOT COMPLETED|Confinement Period (Population at Day 5)||0
6591782|NCT01989156|7516873|FG001|NOT COMPLETED|Confinement Period (Population at Day 5)||1
6591783|NCT01989156|7516874|FG002|NOT COMPLETED|Confinement Period (Population at Day 5)||5
6591784|NCT01989156|7516872|FG000|STARTED|End of Study (Population at Day 90)||80
6591785|NCT01989156|7516873|FG001|STARTED|End of Study (Population at Day 90)||40
6591786|NCT01989156|7516874|FG002|STARTED|End of Study (Population at Day 90)||34
6591787|NCT01989156|7516872|FG000|COMPLETED|End of Study (Population at Day 90)||73
6591788|NCT01989156|7516873|FG001|COMPLETED|End of Study (Population at Day 90)||35
6591789|NCT01989156|7516874|FG002|COMPLETED|End of Study (Population at Day 90)||31
6591790|NCT01989156|7516872|FG000|NOT COMPLETED|End of Study (Population at Day 90)||7
6591791|NCT01989156|7516873|FG001|NOT COMPLETED|End of Study (Population at Day 90)||5
6591792|NCT01989156|7516874|FG002|NOT COMPLETED|End of Study (Population at Day 90)||3
6591793|NCT01989169|7516884|FG000|STARTED|Period 1||15
6591794|NCT01989169|7516885|FG001|STARTED|Period 1||15
6591795|NCT01989169|7516884|FG000|COMPLETED|Period 1||15
6591796|NCT01989169|7516885|FG001|COMPLETED|Period 1||15
6591797|NCT01989169|7516884|FG000|NOT COMPLETED|Period 1||0
6591798|NCT01989169|7516885|FG001|NOT COMPLETED|Period 1||0
6591799|NCT01989169|7516884|FG000|STARTED|Period 2||15
6591800|NCT01989169|7516885|FG001|STARTED|Period 2||15
6591801|NCT01989169|7516884|FG000|COMPLETED|Period 2||15
6591802|NCT01989169|7516885|FG001|COMPLETED|Period 2||14
6591803|NCT01989169|7516884|FG000|NOT COMPLETED|Period 2||0
6591804|NCT01989169|7516885|FG001|NOT COMPLETED|Period 2||1
6591805|NCT01989195|7516891|FG000|STARTED|Overall Study||6
6591806|NCT01989195|7516891|FG000|COMPLETED|Overall Study||6
6591807|NCT01989195|7516891|FG000|NOT COMPLETED|Overall Study||0
6591808|NCT01989208|7516900|FG000|STARTED|200 mg (7 Days)||4
6591809|NCT01989208|7516901|FG001|STARTED|200 mg (7 Days)||12
6591810|NCT01989208|7516900|FG000|COMPLETED|200 mg (7 Days)||4
6591811|NCT01989208|7516901|FG001|COMPLETED|200 mg (7 Days)||11
6591812|NCT01989208|7516900|FG000|NOT COMPLETED|200 mg (7 Days)||0
6591813|NCT01989208|7516901|FG001|NOT COMPLETED|200 mg (7 Days)||1
6591814|NCT01989208|7516900|FG000|STARTED|400 mg (7 Days)||4
6591815|NCT01989208|7516901|FG001|STARTED|400 mg (7 Days)||11
6591816|NCT01989208|7516900|FG000|COMPLETED|400 mg (7 Days)||4
6591817|NCT01989208|7516901|FG001|COMPLETED|400 mg (7 Days)||11
6591818|NCT01989208|7516900|FG000|NOT COMPLETED|400 mg (7 Days)||0
6591819|NCT01989208|7516901|FG001|NOT COMPLETED|400 mg (7 Days)||0
6591820|NCT01989208|7516900|FG000|STARTED|800 mg (7 Days)||4
6591821|NCT01989208|7516901|FG001|STARTED|800 mg (7 Days)||11
6591822|NCT01989208|7516900|FG000|COMPLETED|800 mg (7 Days)||4
6591823|NCT01989208|7516901|FG001|COMPLETED|800 mg (7 Days)||11
6591824|NCT01989208|7516900|FG000|NOT COMPLETED|800 mg (7 Days)||0
6591825|NCT01989208|7516901|FG001|NOT COMPLETED|800 mg (7 Days)||0
6591826|NCT01989221|7516919|FG000|STARTED|Overall Study||14
6591827|NCT01989221|7516919|FG000|COMPLETED|Overall Study||14
6591828|NCT01989221|7516919|FG000|NOT COMPLETED|Overall Study||0
6591829|NCT01989455|7516928|FG000|STARTED|Overall Study||14
6591830|NCT01989455|7516929|FG001|STARTED|Overall Study||14
6591831|NCT01989455|7516930|FG002|STARTED|Overall Study||14
6591832|NCT01989455|7516931|FG003|STARTED|Overall Study||14
6591833|NCT01989455|7516932|FG004|STARTED|Overall Study||8
6591834|NCT01989455|7516928|FG000|COMPLETED|Overall Study||14
6591835|NCT01989455|7516929|FG001|COMPLETED|Overall Study||12
6591836|NCT01989455|7516930|FG002|COMPLETED|Overall Study||13
6591837|NCT01989455|7516931|FG003|COMPLETED|Overall Study||14
6591838|NCT01989455|7516932|FG004|COMPLETED|Overall Study||7
6591839|NCT01989455|7516928|FG000|NOT COMPLETED|Overall Study||0
6591840|NCT01989455|7516929|FG001|NOT COMPLETED|Overall Study||2
6591841|NCT01989455|7516930|FG002|NOT COMPLETED|Overall Study||1
6591842|NCT01989455|7516931|FG003|NOT COMPLETED|Overall Study||0
6591843|NCT01989455|7516932|FG004|NOT COMPLETED|Overall Study||1
6591844|NCT01989468|7516951|FG000|STARTED|Overall Study||138
6591845|NCT01989468|7516952|FG001|STARTED|Overall Study||139
6591846|NCT01989468|7516953|FG002|STARTED|Overall Study||64
6591847|NCT01989468|7516954|FG003|STARTED|Overall Study||65
6591848|NCT01989468|7516955|FG004|STARTED|Overall Study||8
6591849|NCT01989468|7516951|FG000|COMPLETED|Overall Study||91
6591850|NCT01989468|7516952|FG001|COMPLETED|Overall Study||102
6591851|NCT01989468|7516953|FG002|COMPLETED|Overall Study||45
6591852|NCT01989468|7516954|FG003|COMPLETED|Overall Study||49
6591853|NCT01989468|7516955|FG004|COMPLETED|Overall Study||0
6591854|NCT01989468|7516951|FG000|NOT COMPLETED|Overall Study||47
6591855|NCT01989468|7516952|FG001|NOT COMPLETED|Overall Study||37
6591856|NCT01989468|7516953|FG002|NOT COMPLETED|Overall Study||19
6591857|NCT01989468|7516954|FG003|NOT COMPLETED|Overall Study||16
6591858|NCT01989468|7516955|FG004|NOT COMPLETED|Overall Study||8
6591859|NCT01989546|7516968|FG000|STARTED|Overall Study||9
6591860|NCT01989546|7516968|FG000|COMPLETED|Overall Study||0
6591861|NCT01989546|7516968|FG000|NOT COMPLETED|Overall Study||9
6591862|NCT01989572|7516978|FG000|STARTED|Overall Study||109
6591863|NCT01989572|7516979|FG001|STARTED|Overall Study||111
6591864|NCT01989572|7516980|FG002|STARTED|Overall Study||109
6591865|NCT01989572|7516981|FG003|STARTED|Overall Study||107
6591866|NCT01989572|7516982|FG004|STARTED|Overall Study||190
6591867|NCT01989572|7516983|FG005|STARTED|Overall Study||189
6591868|NCT01989572|7516978|FG000|Treated|Overall Study||104
6591869|NCT01989572|7516979|FG001|Treated|Overall Study||110
6591870|NCT01989572|7516980|FG002|Treated|Overall Study||107
6591871|NCT01989572|7516981|FG003|Treated|Overall Study||104
6591872|NCT01989572|7516982|FG004|Treated|Overall Study||186
6591873|NCT01989572|7516983|FG005|Treated|Overall Study||171
6591874|NCT01989572|7516978|FG000|COMPLETED|Overall Study||54
6591875|NCT01989572|7516979|FG001|COMPLETED|Overall Study||53
6591876|NCT01989572|7516980|FG002|COMPLETED|Overall Study||47
6591877|NCT01989572|7516981|FG003|COMPLETED|Overall Study||56
6591878|NCT01989572|7516982|FG004|COMPLETED|Overall Study||92
6591879|NCT01989572|7516983|FG005|COMPLETED|Overall Study||79
6591880|NCT01989572|7516978|FG000|NOT COMPLETED|Overall Study||55
6591881|NCT01989572|7516979|FG001|NOT COMPLETED|Overall Study||58
6591882|NCT01989572|7516980|FG002|NOT COMPLETED|Overall Study||62
6591883|NCT01989572|7516981|FG003|NOT COMPLETED|Overall Study||51
6591884|NCT01989572|7516982|FG004|NOT COMPLETED|Overall Study||98
6591885|NCT01989572|7516983|FG005|NOT COMPLETED|Overall Study||110
6591886|NCT01989689|7517003|FG000|STARTED|Baseline||11
6591887|NCT01989689|7517004|FG001|STARTED|Baseline||13
6591888|NCT01989689|7517003|FG000|COMPLETED|Baseline||11
6591889|NCT01989689|7517004|FG001|COMPLETED|Baseline||13
6659863|NCT02493946|7590789|FG002|COMPLETED|Open Label Period||509
6659864|NCT02493946|7590787|FG000|NOT COMPLETED|Open Label Period||0
6659865|NCT02493946|7590788|FG001|NOT COMPLETED|Open Label Period||0
6659866|NCT02493946|7590789|FG002|NOT COMPLETED|Open Label Period||86
6659867|NCT02494076|7590799|FG000|STARTED|Overall Study||26
6659868|NCT02494076|7590800|FG001|STARTED|Overall Study||26
6659869|NCT02494076|7590799|FG000|COMPLETED|Overall Study||26
6659870|NCT02494076|7590800|FG001|COMPLETED|Overall Study||26
6659871|NCT02494076|7590799|FG000|NOT COMPLETED|Overall Study||0
6659872|NCT02494076|7590800|FG001|NOT COMPLETED|Overall Study||0
6659873|NCT02494102|7590808|FG000|STARTED|Overall Study||42
6659874|NCT02494102|7590809|FG001|STARTED|Overall Study||47
6659875|NCT02494102|7590808|FG000|COMPLETED|Overall Study||42
6659876|NCT02494102|7590809|FG001|COMPLETED|Overall Study||47
6659877|NCT02494102|7590808|FG000|NOT COMPLETED|Overall Study||0
6659878|NCT02494102|7590809|FG001|NOT COMPLETED|Overall Study||0
6659879|NCT02494180|7590817|FG000|STARTED|Overall Study||85
6659880|NCT02494180|7590818|FG001|STARTED|Overall Study||85
6659881|NCT02494180|7590817|FG000|COMPLETED|Overall Study||85
6659882|NCT02494180|7590818|FG001|COMPLETED|Overall Study||85
6659883|NCT02494180|7590817|FG000|NOT COMPLETED|Overall Study||0
6659884|NCT02494180|7590818|FG001|NOT COMPLETED|Overall Study||0
6659885|NCT02494297|7590824|FG000|STARTED|Overall Study||1597
6659886|NCT02494297|7590824|FG000|COMPLETED|Overall Study|As there was no Follow-Up in this study, participation equals completion|1597
6659887|NCT02494297|7590824|FG000|NOT COMPLETED|Overall Study||0
6659888|NCT02494323|7590828|FG000|STARTED|Overall Study||70
6659889|NCT02494323|7590828|FG000|COMPLETED|Overall Study||70
6659890|NCT02494323|7590828|FG000|NOT COMPLETED|Overall Study||0
6659891|NCT02494336|7590834|FG000|STARTED|Overall Study||24
6659892|NCT02494336|7590835|FG001|STARTED|Overall Study||24
6659893|NCT02494336|7590834|FG000|COMPLETED|Overall Study||24
6659894|NCT02494336|7590835|FG001|COMPLETED|Overall Study||24
6659895|NCT02494336|7590834|FG000|NOT COMPLETED|Overall Study||0
6659896|NCT02494336|7590835|FG001|NOT COMPLETED|Overall Study||0
6659897|NCT02494401|7590843|FG000|STARTED|Overall Study||134
6659898|NCT02494401|7590844|FG001|STARTED|Overall Study||133
6659899|NCT02494401|7590843|FG000|Week 16|Overall Study||123
6659900|NCT02494401|7590844|FG001|Week 16|Overall Study||124
6659901|NCT02494401|7590843|FG000|6 Month Follow up|Overall Study||109
6659902|NCT02494401|7590844|FG001|6 Month Follow up|Overall Study||106
6591890|NCT01989689|7517003|FG000|NOT COMPLETED|Baseline||0
6591891|NCT01989689|7517004|FG001|NOT COMPLETED|Baseline||0
6591892|NCT01989689|7517003|FG000|STARTED|Treatment Period 1 ( 3 Months)||11
6659903|NCT02494401|7590843|FG000|COMPLETED|Overall Study||109
6659904|NCT02494401|7590844|FG001|COMPLETED|Overall Study||106
6659905|NCT02494401|7590843|FG000|NOT COMPLETED|Overall Study||25
6591893|NCT01989689|7517004|FG001|STARTED|Treatment Period 1 ( 3 Months)||13
6591894|NCT01989689|7517003|FG000|COMPLETED|Treatment Period 1 ( 3 Months)||11
6591895|NCT01989689|7517004|FG001|COMPLETED|Treatment Period 1 ( 3 Months)||10
6591896|NCT01989689|7517003|FG000|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
6591897|NCT01989689|7517004|FG001|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
6591898|NCT01989689|7517003|FG000|STARTED|Treatment Period ( 3 Months)||11
6591899|NCT01989689|7517004|FG001|STARTED|Treatment Period ( 3 Months)||10
6591900|NCT01989689|7517003|FG000|COMPLETED|Treatment Period ( 3 Months)||11
6591901|NCT01989689|7517004|FG001|COMPLETED|Treatment Period ( 3 Months)||10
6591902|NCT01989689|7517003|FG000|NOT COMPLETED|Treatment Period ( 3 Months)||0
6591903|NCT01989689|7517004|FG001|NOT COMPLETED|Treatment Period ( 3 Months)||0
6591904|NCT01989754|7517014|FG000|STARTED|Overall Study||2905
6591905|NCT01989754|7517015|FG001|STARTED|Overall Study||2907
6591906|NCT01989754|7517014|FG000|Treated|Overall Study||2903
6591907|NCT01989754|7517015|FG001|Treated|Overall Study||2904
6591908|NCT01989754|7517014|FG000|COMPLETED|Overall Study|Participants who died are included in this category.|2866
6591909|NCT01989754|7517015|FG001|COMPLETED|Overall Study|Participants who died are included in this category.|2872
6591910|NCT01989754|7517014|FG000|NOT COMPLETED|Overall Study||39
6591911|NCT01989754|7517015|FG001|NOT COMPLETED|Overall Study||35
6624487|NCT02217904|7551927|FG003|NOT COMPLETED|Overall Study||0
6624488|NCT02217904|7551928|FG004|NOT COMPLETED|Overall Study||0
6624489|NCT02217904|7551929|FG005|NOT COMPLETED|Overall Study||0
6624490|NCT02217904|7551930|FG006|NOT COMPLETED|Overall Study||0
6624491|NCT02217982|7551944|FG000|STARTED|Overall Study||1
6624492|NCT02217982|7551945|FG001|STARTED|Overall Study||4
6624493|NCT02217982|7551944|FG000|COMPLETED|Overall Study|Trial closed before patient finished|0
6624494|NCT02217982|7551945|FG001|COMPLETED|Overall Study||3
6624495|NCT02217982|7551944|FG000|NOT COMPLETED|Overall Study||1
6624496|NCT02217982|7551945|FG001|NOT COMPLETED|Overall Study||1
6624497|NCT02218008|7551954|FG000|STARTED|Stage 1 (S1)||280
6624498|NCT02218008|7551955|FG001|STARTED|Stage 1 (S1)||63
6624499|NCT02218008|7551956|FG002|STARTED|Stage 1 (S1)||63
6624500|NCT02218008|7551957|FG003|STARTED|Stage 1 (S1)||0
6624501|NCT02218008|7551958|FG004|STARTED|Stage 1 (S1)||0
6624502|NCT02218008|7551959|FG005|STARTED|Stage 1 (S1)||0
6624503|NCT02218008|7551954|FG000|COMPLETED|Stage 1 (S1)||258
6624504|NCT02218008|7551955|FG001|COMPLETED|Stage 1 (S1)||56
6624505|NCT02218008|7551956|FG002|COMPLETED|Stage 1 (S1)||48
6624506|NCT02218008|7551957|FG003|COMPLETED|Stage 1 (S1)||0
6624507|NCT02218008|7551958|FG004|COMPLETED|Stage 1 (S1)||0
6624508|NCT02218008|7551959|FG005|COMPLETED|Stage 1 (S1)||0
6624509|NCT02218008|7551954|FG000|NOT COMPLETED|Stage 1 (S1)||22
6624510|NCT02218008|7551955|FG001|NOT COMPLETED|Stage 1 (S1)||7
6624511|NCT02218008|7551956|FG002|NOT COMPLETED|Stage 1 (S1)||15
6624512|NCT02218008|7551957|FG003|NOT COMPLETED|Stage 1 (S1)||0
6624513|NCT02218008|7551958|FG004|NOT COMPLETED|Stage 1 (S1)||0
6624514|NCT02218008|7551959|FG005|NOT COMPLETED|Stage 1 (S1)||0
6624515|NCT02218008|7551954|FG000|STARTED|Stage 2 (S2)||0
6624516|NCT02218008|7551955|FG001|STARTED|Stage 2 (S2)||0
6624517|NCT02218008|7551956|FG002|STARTED|Stage 2 (S2)||0
6624518|NCT02218008|7551957|FG003|STARTED|Stage 2 (S2)||62
6624519|NCT02218008|7551958|FG004|STARTED|Stage 2 (S2)||62
6624520|NCT02218008|7551959|FG005|STARTED|Stage 2 (S2)||63
6624521|NCT02218008|7551954|FG000|COMPLETED|Stage 2 (S2)||0
6624522|NCT02218008|7551955|FG001|COMPLETED|Stage 2 (S2)||0
6624523|NCT02218008|7551956|FG002|COMPLETED|Stage 2 (S2)||0
6624524|NCT02218008|7551957|FG003|COMPLETED|Stage 2 (S2)||58
6624525|NCT02218008|7551958|FG004|COMPLETED|Stage 2 (S2)||58
6624526|NCT02218008|7551959|FG005|COMPLETED|Stage 2 (S2)||57
6624527|NCT02218008|7551954|FG000|NOT COMPLETED|Stage 2 (S2)||0
6624528|NCT02218008|7551955|FG001|NOT COMPLETED|Stage 2 (S2)||0
6624529|NCT02218008|7551956|FG002|NOT COMPLETED|Stage 2 (S2)||0
6624530|NCT02218008|7551957|FG003|NOT COMPLETED|Stage 2 (S2)||4
6624531|NCT02218008|7551958|FG004|NOT COMPLETED|Stage 2 (S2)||4
6624532|NCT02218008|7551959|FG005|NOT COMPLETED|Stage 2 (S2)||6
6624533|NCT02218164|7551973|FG000|STARTED|Overall Study||8
6624534|NCT02218164|7551973|FG000|COMPLETED|Overall Study||8
6624535|NCT02218164|7551973|FG000|NOT COMPLETED|Overall Study||0
6624536|NCT02218190|7551979|FG000|STARTED|Overall Study||13
6624537|NCT02218190|7551980|FG001|STARTED|Overall Study||13
6624538|NCT02218190|7551979|FG000|COMPLETED|Overall Study||13
6624539|NCT02218190|7551980|FG001|COMPLETED|Overall Study||13
6624540|NCT02218190|7551979|FG000|NOT COMPLETED|Overall Study||0
6624541|NCT02218190|7551980|FG001|NOT COMPLETED|Overall Study||0
6624542|NCT02218203|7551986|FG000|STARTED|Overall Study||26
6624543|NCT02218203|7551986|FG000|Placebo Dex v. 0mg/km LBM Lidocaine|Overall Study||24
6624544|NCT02218203|7551986|FG000|Placebo Dex v. 1mg/km LBM Lidocaine|Overall Study||24
6624545|NCT02218203|7551986|FG000|Placebo Dex v. 2mg/km LBM Lidocaine|Overall Study||24
6624546|NCT02218203|7551986|FG000|Placebo Dex v. 4mg/km LBM Lidocaine|Overall Study||24
6624547|NCT02218203|7551986|FG000|Low Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||26
6624548|NCT02218203|7551986|FG000|Low Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||26
6624549|NCT02218203|7551986|FG000|Low Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||26
6624550|NCT02218203|7551986|FG000|Low Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||26
6624551|NCT02218203|7551986|FG000|Medium Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
6624552|NCT02218203|7551986|FG000|Medium Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
6624553|NCT02218203|7551986|FG000|Medium Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
6591912|NCT01989793|7517023|FG000|STARTED|Overall Study||18
6591913|NCT01989793|7517024|FG001|STARTED|Overall Study||19
6591914|NCT01989793|7517023|FG000|COMPLETED|Overall Study||10
6591915|NCT01989793|7517024|FG001|COMPLETED|Overall Study||15
6591916|NCT01989793|7517023|FG000|NOT COMPLETED|Overall Study||8
6591917|NCT01989793|7517024|FG001|NOT COMPLETED|Overall Study||4
6591918|NCT01989910|7517032|FG000|STARTED|Overall Study||53
6591919|NCT01989910|7517033|FG001|STARTED|Overall Study||54
6591920|NCT01989910|7517032|FG000|COMPLETED|Overall Study||51
6591921|NCT01989910|7517033|FG001|COMPLETED|Overall Study||54
6591922|NCT01989910|7517032|FG000|NOT COMPLETED|Overall Study||2
6591923|NCT01989910|7517033|FG001|NOT COMPLETED|Overall Study||0
6591924|NCT01989975|7517039|FG000|STARTED|Overall Study||40
6591925|NCT01989975|7517039|FG000|COMPLETED|Overall Study||40
6591926|NCT01989975|7517039|FG000|NOT COMPLETED|Overall Study||0
6591927|NCT01990261|7517043|FG000|STARTED|Overall Study||33
6591928|NCT01990261|7517043|FG000|Treated|Overall Study||29
6591929|NCT01990261|7517043|FG000|COMPLETED|Overall Study||8
6591930|NCT01990261|7517043|FG000|NOT COMPLETED|Overall Study||25
6591931|NCT01990300|7517047|FG000|STARTED|Overall Study||3281
6591932|NCT01990300|7517047|FG000|COMPLETED|Overall Study||3139
6591933|NCT01990300|7517047|FG000|NOT COMPLETED|Overall Study||142
6591934|NCT01990313|7517051|FG000|STARTED|Overall Study||15
6591935|NCT01990313|7517051|FG000|COMPLETED|Overall Study||14
6591936|NCT01990313|7517051|FG000|NOT COMPLETED|Overall Study||1
6591937|NCT01990339|7517055|FG000|STARTED|Overall Study||14965
6591938|NCT01990339|7517055|FG000|COMPLETED|Overall Study||12653
6591939|NCT01990339|7517055|FG000|NOT COMPLETED|Overall Study||2312
6591940|NCT01990495|7517061|FG000|STARTED|Overall Study||18
6591941|NCT01990495|7517062|FG001|STARTED|Overall Study||19
6591942|NCT01990495|7517061|FG000|COMPLETED|Overall Study||13
6591943|NCT01990495|7517062|FG001|COMPLETED|Overall Study||15
6591944|NCT01990495|7517061|FG000|NOT COMPLETED|Overall Study||5
6591945|NCT01990495|7517062|FG001|NOT COMPLETED|Overall Study||4
6591946|NCT01990534|7517070|FG000|STARTED|Overall Study||60
6591947|NCT01990534|7517070|FG000|COMPLETED|Overall Study||25
6591948|NCT01990534|7517070|FG000|NOT COMPLETED|Overall Study||35
6591949|NCT01990560|7517074|FG000|STARTED|Overall Study||8
6591950|NCT01990560|7517074|FG000|COMPLETED|Overall Study||7
6591951|NCT01990560|7517074|FG000|NOT COMPLETED|Overall Study||1
6591952|NCT01990573|7517081|FG000|STARTED|Overall Study||20
6591953|NCT01990573|7517082|FG001|STARTED|Overall Study||14
6591954|NCT01990573|7517083|FG002|STARTED|Overall Study||17
6591955|NCT01990573|7517081|FG000|COMPLETED|Overall Study||20
6591956|NCT01990573|7517082|FG001|COMPLETED|Overall Study||14
6591957|NCT01990573|7517083|FG002|COMPLETED|Overall Study||16
6591958|NCT01990573|7517081|FG000|NOT COMPLETED|Overall Study||0
6591959|NCT01990573|7517082|FG001|NOT COMPLETED|Overall Study||0
6591960|NCT01990573|7517083|FG002|NOT COMPLETED|Overall Study||1
6591961|NCT01990612|7517093|FG000|STARTED|Overall Study||3044
6591962|NCT01990612|7517094|FG001|STARTED|Overall Study||3062
6591963|NCT01990612|7517093|FG000|COMPLETED|Overall Study||3037
6591964|NCT01990612|7517094|FG001|COMPLETED|Overall Study||3059
6591965|NCT01990612|7517093|FG000|NOT COMPLETED|Overall Study||7
6591966|NCT01990612|7517094|FG001|NOT COMPLETED|Overall Study||3
6591967|NCT01990664|7517102|FG000|STARTED|Overall Study||102
6591968|NCT01990664|7517103|FG001|STARTED|Overall Study||90
6591969|NCT01990664|7517102|FG000|COMPLETED|Overall Study||95
6591970|NCT01990664|7517103|FG001|COMPLETED|Overall Study||79
6591971|NCT01990664|7517102|FG000|NOT COMPLETED|Overall Study||7
6591972|NCT01990664|7517103|FG001|NOT COMPLETED|Overall Study||11
6591973|NCT01990677|7517111|FG000|STARTED|Overall Study||12
6591974|NCT01990677|7517112|FG001|STARTED|Overall Study||6
6591975|NCT01990677|7517111|FG000|COMPLETED|Overall Study||10
6591976|NCT01990677|7517112|FG001|COMPLETED|Overall Study||5
6591977|NCT01990677|7517111|FG000|NOT COMPLETED|Overall Study||2
6591978|NCT01990677|7517112|FG001|NOT COMPLETED|Overall Study||1
6591979|NCT01990703|7517120|FG000|STARTED|Overall Study||147
6591980|NCT01990703|7517121|FG001|STARTED|Overall Study||138
6591981|NCT01990703|7517120|FG000|COMPLETED|Overall Study||108
6591982|NCT01990703|7517121|FG001|COMPLETED|Overall Study||93
6591983|NCT01990703|7517120|FG000|NOT COMPLETED|Overall Study||39
6591984|NCT01990703|7517121|FG001|NOT COMPLETED|Overall Study||45
6591985|NCT01990742|7517129|FG000|STARTED|Overall Study|This is a facility-level intervention, access to individual level records occurred via MDS data only|3259
6591986|NCT01990742|7517130|FG001|STARTED|Overall Study|This is a facility-level control , access to individual participants occurred only via MDS records.|4331
6591987|NCT01990742|7517129|FG000|COMPLETED|Overall Study|Fourteen facilities completed the intervention.|2852
6591988|NCT01990742|7517130|FG001|COMPLETED|Overall Study|Eleven nursing homes completed the control group /usual care allocation.|2978
6591989|NCT01990742|7517129|FG000|NOT COMPLETED|Overall Study||407
6591990|NCT01990742|7517130|FG001|NOT COMPLETED|Overall Study||1353
6591991|NCT01990768|7517139|FG000|STARTED|Intervention Started||345
6591992|NCT01990768|7517140|FG001|STARTED|Intervention Started||345
6591993|NCT01990768|7517141|FG002|STARTED|Intervention Started||373
6591994|NCT01990768|7517139|FG000|COMPLETED|Intervention Started||309
6591995|NCT01990768|7517140|FG001|COMPLETED|Intervention Started||312
6591996|NCT01990768|7517141|FG002|COMPLETED|Intervention Started||346
6591997|NCT01990768|7517139|FG000|NOT COMPLETED|Intervention Started||36
6591998|NCT01990768|7517140|FG001|NOT COMPLETED|Intervention Started||33
6591999|NCT01990768|7517141|FG002|NOT COMPLETED|Intervention Started||27
6592000|NCT01990768|7517139|FG000|STARTED|Prehospital Study Drug Infusion||309
6592001|NCT01990768|7517140|FG001|STARTED|Prehospital Study Drug Infusion||312
6592002|NCT01990768|7517141|FG002|STARTED|Prehospital Study Drug Infusion||346
6592003|NCT01990768|7517139|FG000|COMPLETED|Prehospital Study Drug Infusion||290
6592004|NCT01990768|7517140|FG001|COMPLETED|Prehospital Study Drug Infusion||285
6592005|NCT01990768|7517141|FG002|COMPLETED|Prehospital Study Drug Infusion||327
6592006|NCT01990768|7517139|FG000|NOT COMPLETED|Prehospital Study Drug Infusion||19
6592007|NCT01990768|7517140|FG001|NOT COMPLETED|Prehospital Study Drug Infusion||27
6592008|NCT01990768|7517141|FG002|NOT COMPLETED|Prehospital Study Drug Infusion||19
6592009|NCT01990768|7517139|FG000|STARTED|In-Hospital Study Drug Infusion||309
6592010|NCT01990768|7517140|FG001|STARTED|In-Hospital Study Drug Infusion||312
6592011|NCT01990768|7517141|FG002|STARTED|In-Hospital Study Drug Infusion||346
6592012|NCT01990768|7517139|FG000|COMPLETED|In-Hospital Study Drug Infusion||214
6592013|NCT01990768|7517140|FG001|COMPLETED|In-Hospital Study Drug Infusion||229
6592014|NCT01990768|7517141|FG002|COMPLETED|In-Hospital Study Drug Infusion||266
6592015|NCT01990768|7517139|FG000|NOT COMPLETED|In-Hospital Study Drug Infusion||95
6592016|NCT01990768|7517140|FG001|NOT COMPLETED|In-Hospital Study Drug Infusion||83
6592017|NCT01990768|7517141|FG002|NOT COMPLETED|In-Hospital Study Drug Infusion||80
6592018|NCT01990768|7517139|FG000|STARTED|6-Month Follow-up||309
6592019|NCT01990768|7517140|FG001|STARTED|6-Month Follow-up||312
6592020|NCT01990768|7517141|FG002|STARTED|6-Month Follow-up||346
6592021|NCT01990768|7517139|FG000|COMPLETED|6-Month Follow-up||270
6592022|NCT01990768|7517140|FG001|COMPLETED|6-Month Follow-up||261
6592023|NCT01990768|7517141|FG002|COMPLETED|6-Month Follow-up||288
6592024|NCT01990768|7517139|FG000|NOT COMPLETED|6-Month Follow-up||39
6592025|NCT01990768|7517140|FG001|NOT COMPLETED|6-Month Follow-up||51
6592026|NCT01990768|7517141|FG002|NOT COMPLETED|6-Month Follow-up||58
6592027|NCT01990794|7517150|FG000|STARTED|Overall Study||13
6592028|NCT01990794|7517150|FG000|One Month Into Study|Overall Study||10
6592029|NCT01990794|7517150|FG000|COMPLETED|Overall Study||10
6592030|NCT01990794|7517150|FG000|NOT COMPLETED|Overall Study||3
6592031|NCT01990820|7517239|FG000|STARTED|Overall Study||13
6592032|NCT01990820|7517240|FG001|STARTED|Overall Study||12
6592033|NCT01990820|7517239|FG000|COMPLETED|Overall Study||13
6592034|NCT01990820|7517240|FG001|COMPLETED|Overall Study||12
6592035|NCT01990820|7517239|FG000|NOT COMPLETED|Overall Study||0
6592036|NCT01990820|7517240|FG001|NOT COMPLETED|Overall Study||0
6592037|NCT01990859|7517246|FG000|STARTED|Treatment (4 Doses Over 12 Weeks)||20
6592038|NCT01990859|7517246|FG000|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
6592039|NCT01990859|7517246|FG000|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
6592040|NCT01990859|7517246|FG000|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
6592041|NCT01990859|7517246|FG000|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
6592042|NCT01990859|7517246|FG000|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
6592043|NCT01990859|7517246|FG000|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
6592044|NCT01990859|7517246|FG000|COMPLETED|90 Day Follow Up for All Participants||20
6592045|NCT01990859|7517246|FG000|NOT COMPLETED|90 Day Follow Up for All Participants||0
6592046|NCT01990898|7517251|FG000|STARTED|Overall Study||26
6592047|NCT01990898|7517251|FG000|3 Months|Overall Study||22
6592048|NCT01990898|7517251|FG000|COMPLETED|Overall Study||22
6592049|NCT01990898|7517251|FG000|NOT COMPLETED|Overall Study||4
6592050|NCT01990950|7517255|FG000|STARTED|Overall Study||21
6592051|NCT01990950|7517255|FG000|COMPLETED|Overall Study||10
6592052|NCT01990950|7517255|FG000|NOT COMPLETED|Overall Study||11
6592053|NCT01991197|7517261|FG000|STARTED|Overall Study||9
6592054|NCT01991197|7517262|FG001|STARTED|Overall Study||11
6592055|NCT01991197|7517261|FG000|COMPLETED|Overall Study||6
6592056|NCT01991197|7517262|FG001|COMPLETED|Overall Study||8
6592057|NCT01991197|7517261|FG000|NOT COMPLETED|Overall Study||3
6592058|NCT01991197|7517262|FG001|NOT COMPLETED|Overall Study||3
6592059|NCT01991314|7517275|FG000|STARTED|Overall Study||45
6592060|NCT01991314|7517276|FG001|STARTED|Overall Study||43
6592061|NCT01991314|7517275|FG000|COMPLETED|Overall Study||34
6592062|NCT01991314|7517276|FG001|COMPLETED|Overall Study||32
6592063|NCT01991314|7517275|FG000|NOT COMPLETED|Overall Study||11
6592064|NCT01991314|7517276|FG001|NOT COMPLETED|Overall Study||11
6592065|NCT01991470|7517282|FG000|STARTED|Enlite 1 Period||161
6592066|NCT01991470|7517282|FG000|COMPLETED|Enlite 1 Period||141
6592067|NCT01991470|7517282|FG000|NOT COMPLETED|Enlite 1 Period||20
6592068|NCT01991470|7517282|FG000|STARTED|Enlite 3 Period|Additional 25 subjects who participated only Enlite 3 phase|158
6592069|NCT01991470|7517282|FG000|COMPLETED|Enlite 3 Period||146
6592070|NCT01991470|7517282|FG000|NOT COMPLETED|Enlite 3 Period||12
6592071|NCT01991483|7517298|FG000|STARTED|Dose Level: Placebo||7
6592072|NCT01991483|7517299|FG001|STARTED|Dose Level: Placebo||0
6592073|NCT01991483|7517300|FG002|STARTED|Dose Level: Placebo||0
6592074|NCT01991483|7517301|FG003|STARTED|Dose Level: Placebo||0
6592075|NCT01991483|7517298|FG000|Received at Least One Dose of Study Drug|Dose Level: Placebo||7
6592076|NCT01991483|7517299|FG001|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
6592077|NCT01991483|7517300|FG002|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
6592078|NCT01991483|7517301|FG003|Received at Least One Dose of Study Drug|Dose Level: Placebo||0
6592079|NCT01991483|7517298|FG000|COMPLETED|Dose Level: Placebo||7
6592080|NCT01991483|7517299|FG001|COMPLETED|Dose Level: Placebo||0
6592081|NCT01991483|7517300|FG002|COMPLETED|Dose Level: Placebo||0
6592082|NCT01991483|7517301|FG003|COMPLETED|Dose Level: Placebo||0
6592083|NCT01991483|7517298|FG000|NOT COMPLETED|Dose Level: Placebo||0
6592084|NCT01991483|7517299|FG001|NOT COMPLETED|Dose Level: Placebo||0
6592085|NCT01991483|7517300|FG002|NOT COMPLETED|Dose Level: Placebo||0
6592086|NCT01991483|7517301|FG003|NOT COMPLETED|Dose Level: Placebo||0
6592087|NCT01991483|7517298|FG000|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|0
6592088|NCT01991483|7517299|FG001|STARTED|Dose Level 300 mg|Multiple periods were added for each dose level to represent dose escalation.|6
6592089|NCT01991483|7517300|FG002|STARTED|Dose Level 300 mg||0
6592090|NCT01991483|7517301|FG003|STARTED|Dose Level 300 mg||0
6592091|NCT01991483|7517298|FG000|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
6592092|NCT01991483|7517299|FG001|Received at Least One Dose of Study Drug|Dose Level 300 mg||6
6592093|NCT01991483|7517300|FG002|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
6592094|NCT01991483|7517301|FG003|Received at Least One Dose of Study Drug|Dose Level 300 mg||0
6592095|NCT01991483|7517298|FG000|COMPLETED|Dose Level 300 mg||0
6592096|NCT01991483|7517299|FG001|COMPLETED|Dose Level 300 mg||6
6592097|NCT01991483|7517300|FG002|COMPLETED|Dose Level 300 mg||0
6592098|NCT01991483|7517301|FG003|COMPLETED|Dose Level 300 mg||0
6592099|NCT01991483|7517298|FG000|NOT COMPLETED|Dose Level 300 mg||0
6592100|NCT01991483|7517299|FG001|NOT COMPLETED|Dose Level 300 mg||0
6592101|NCT01991483|7517300|FG002|NOT COMPLETED|Dose Level 300 mg||0
6592102|NCT01991483|7517301|FG003|NOT COMPLETED|Dose Level 300 mg||0
6592103|NCT01991483|7517298|FG000|STARTED|Dose Level 600 mg||0
6592104|NCT01991483|7517299|FG001|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|0
6592105|NCT01991483|7517300|FG002|STARTED|Dose Level 600 mg|Multiple periods were added for each dose level to represent dose escalation.|11
6592106|NCT01991483|7517301|FG003|STARTED|Dose Level 600 mg||0
6592107|NCT01991483|7517298|FG000|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
6592108|NCT01991483|7517299|FG001|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
6592109|NCT01991483|7517300|FG002|Receive at Least One Dose of Study Drug|Dose Level 600 mg||11
6592110|NCT01991483|7517301|FG003|Receive at Least One Dose of Study Drug|Dose Level 600 mg||0
6592111|NCT01991483|7517298|FG000|COMPLETED|Dose Level 600 mg||0
6592112|NCT01991483|7517299|FG001|COMPLETED|Dose Level 600 mg||0
6592113|NCT01991483|7517300|FG002|COMPLETED|Dose Level 600 mg||9
6592114|NCT01991483|7517301|FG003|COMPLETED|Dose Level 600 mg||0
6592115|NCT01991483|7517298|FG000|NOT COMPLETED|Dose Level 600 mg||0
6592116|NCT01991483|7517299|FG001|NOT COMPLETED|Dose Level 600 mg||0
6592117|NCT01991483|7517300|FG002|NOT COMPLETED|Dose Level 600 mg||2
6592118|NCT01991483|7517301|FG003|NOT COMPLETED|Dose Level 600 mg||0
6592119|NCT01991483|7517298|FG000|STARTED|Dose Level 1000 mg||0
6592120|NCT01991483|7517299|FG001|STARTED|Dose Level 1000 mg||0
6592121|NCT01991483|7517300|FG002|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|0
6592122|NCT01991483|7517301|FG003|STARTED|Dose Level 1000 mg|Multiple periods were added for each dose level to represent dose escalation.|4
6592123|NCT01991483|7517298|FG000|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
6592124|NCT01991483|7517299|FG001|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
6592125|NCT01991483|7517300|FG002|Received at Least One Dose of Study Drug|Dose Level 1000 mg||0
6592126|NCT01991483|7517301|FG003|Received at Least One Dose of Study Drug|Dose Level 1000 mg||4
6592127|NCT01991483|7517298|FG000|COMPLETED|Dose Level 1000 mg||0
6592128|NCT01991483|7517299|FG001|COMPLETED|Dose Level 1000 mg||0
6592129|NCT01991483|7517300|FG002|COMPLETED|Dose Level 1000 mg||0
6592130|NCT01991483|7517301|FG003|COMPLETED|Dose Level 1000 mg||3
6592131|NCT01991483|7517298|FG000|NOT COMPLETED|Dose Level 1000 mg||0
6592132|NCT01991483|7517299|FG001|NOT COMPLETED|Dose Level 1000 mg||0
6592133|NCT01991483|7517300|FG002|NOT COMPLETED|Dose Level 1000 mg||0
6592134|NCT01991483|7517301|FG003|NOT COMPLETED|Dose Level 1000 mg||1
6592135|NCT01991522|7517316|FG000|STARTED|Overall Study||16
6592136|NCT01991522|7517317|FG001|STARTED|Overall Study||17
6592137|NCT01991522|7517316|FG000|COMPLETED|Overall Study||16
6592138|NCT01991522|7517317|FG001|COMPLETED|Overall Study||17
6592139|NCT01991522|7517316|FG000|NOT COMPLETED|Overall Study||0
6592140|NCT01991522|7517317|FG001|NOT COMPLETED|Overall Study||0
6592141|NCT01991548|7517323|FG000|STARTED|Overall Study||40
6592142|NCT01991548|7517323|FG000|COMPLETED|Overall Study||39
6592143|NCT01991548|7517323|FG000|NOT COMPLETED|Overall Study||1
6592144|NCT01991743|7517331|FG000|STARTED|Overall Study||60
6592145|NCT01991743|7517332|FG001|STARTED|Overall Study||60
6592146|NCT01991743|7517333|FG002|STARTED|Overall Study||60
6592147|NCT01991743|7517334|FG003|STARTED|Overall Study||60
6592148|NCT01991743|7517331|FG000|COMPLETED|Overall Study||60
6592149|NCT01991743|7517332|FG001|COMPLETED|Overall Study||60
6592150|NCT01991743|7517333|FG002|COMPLETED|Overall Study||59
6592151|NCT01991743|7517334|FG003|COMPLETED|Overall Study||60
6592152|NCT01991743|7517331|FG000|NOT COMPLETED|Overall Study||0
6592153|NCT01991743|7517332|FG001|NOT COMPLETED|Overall Study||0
6592154|NCT01991743|7517333|FG002|NOT COMPLETED|Overall Study||1
6592155|NCT01991743|7517334|FG003|NOT COMPLETED|Overall Study||0
6592156|NCT01991795|7517346|FG000|STARTED|Overall Study||9645
6592157|NCT01991795|7517347|FG001|STARTED|Overall Study||9626
6592158|NCT01991795|7517346|FG000|COMPLETED|Overall Study||9496
6592159|NCT01991795|7517347|FG001|COMPLETED|Overall Study||9503
6592160|NCT01991795|7517346|FG000|NOT COMPLETED|Overall Study||149
6592161|NCT01991795|7517347|FG001|NOT COMPLETED|Overall Study||123
6592162|NCT01991808|7517353|FG000|STARTED|Overall Study||16
6592163|NCT01991808|7517353|FG000|COMPLETED|Overall Study||16
6592164|NCT01991808|7517353|FG000|NOT COMPLETED|Overall Study||0
6592165|NCT01991821|7517359|FG000|STARTED|Overall Study||169
6592166|NCT01991821|7517360|FG001|STARTED|Overall Study||178
6592167|NCT01991821|7517359|FG000|COMPLETED|Overall Study||6
6592168|NCT01991821|7517360|FG001|COMPLETED|Overall Study||11
6592169|NCT01991821|7517359|FG000|NOT COMPLETED|Overall Study||163
6592170|NCT01991821|7517360|FG001|NOT COMPLETED|Overall Study||167
6592171|NCT01991860|7517370|FG000|STARTED|Overall Study||176
6592172|NCT01991860|7517371|FG001|STARTED|Overall Study||166
6592173|NCT01991860|7517370|FG000|COMPLETED|Overall Study||172
6592174|NCT01991860|7517371|FG001|COMPLETED|Overall Study||164
6592175|NCT01991860|7517370|FG000|NOT COMPLETED|Overall Study||4
6592176|NCT01991860|7517371|FG001|NOT COMPLETED|Overall Study||2
6592177|NCT01991977|7517377|FG000|STARTED|Overall Study||91
6592178|NCT01991977|7517377|FG000|Received PET Tracer|Overall Study||84
6592179|NCT01991977|7517377|FG000|Received IMRT Treatment|Overall Study||79
6592180|NCT01991977|7517377|FG000|Evaluable for the Primary Outcome|Overall Study||39
6592181|NCT01991977|7517377|FG000|COMPLETED|Overall Study||79
6592182|NCT01991977|7517377|FG000|NOT COMPLETED|Overall Study||12
6592183|NCT01991990|7517383|FG000|STARTED|Overall Study||6
6592184|NCT01991990|7517384|FG001|STARTED|Overall Study||12
6592185|NCT01991990|7517383|FG000|COMPLETED|Overall Study||6
6592186|NCT01991990|7517384|FG001|COMPLETED|Overall Study||12
6592187|NCT01991990|7517383|FG000|NOT COMPLETED|Overall Study||0
6592188|NCT01991990|7517384|FG001|NOT COMPLETED|Overall Study||0
6592189|NCT01992016|7517396|FG000|STARTED|Overall Study||4
6592190|NCT01992016|7517397|FG001|STARTED|Overall Study||7
6592191|NCT01992016|7517396|FG000|COMPLETED|Overall Study||4
6592192|NCT01992016|7517397|FG001|COMPLETED|Overall Study||7
6592193|NCT01992016|7517396|FG000|NOT COMPLETED|Overall Study||0
6592194|NCT01992016|7517397|FG001|NOT COMPLETED|Overall Study||0
6592195|NCT01992094|7517406|FG000|STARTED|Overall Study||1335
6592196|NCT01992094|7517407|FG001|STARTED|Overall Study||676
6592197|NCT01992094|7517408|FG002|STARTED|Overall Study||669
6592198|NCT01992094|7517406|FG000|COMPLETED|Overall Study||1285
6592199|NCT01992094|7517407|FG001|COMPLETED|Overall Study||652
6592200|NCT01992094|7517408|FG002|COMPLETED|Overall Study||648
6592201|NCT01992094|7517406|FG000|NOT COMPLETED|Overall Study||50
6592202|NCT01992094|7517407|FG001|NOT COMPLETED|Overall Study||24
6592203|NCT01992094|7517408|FG002|NOT COMPLETED|Overall Study||21
6592204|NCT01992107|7517435|FG000|STARTED|Overall Study||1159
6592205|NCT01992107|7517436|FG001|STARTED|Overall Study||593
6592206|NCT01992107|7517437|FG002|STARTED|Overall Study||581
6592207|NCT01992107|7517435|FG000|COMPLETED|Overall Study||1091
6592208|NCT01992107|7517436|FG001|COMPLETED|Overall Study||560
6592209|NCT01992107|7517437|FG002|COMPLETED|Overall Study||545
6592210|NCT01992107|7517435|FG000|NOT COMPLETED|Overall Study||68
6592211|NCT01992107|7517436|FG001|NOT COMPLETED|Overall Study||33
6592212|NCT01992107|7517437|FG002|NOT COMPLETED|Overall Study||36
6592213|NCT01992159|7517466|FG000|STARTED|Overall Study||63
6592214|NCT01992159|7517467|FG001|STARTED|Overall Study||63
6592215|NCT01992159|7517468|FG002|STARTED|Overall Study||63
6592216|NCT01992159|7517469|FG003|STARTED|Overall Study||63
6592217|NCT01992159|7517466|FG000|Received Treatment|Overall Study||63
6592218|NCT01992159|7517467|FG001|Received Treatment|Overall Study||63
6592219|NCT01992159|7517468|FG002|Received Treatment|Overall Study||63
6592220|NCT01992159|7517469|FG003|Received Treatment|Overall Study||63
6592221|NCT01992159|7517466|FG000|Completed First 12 Months of Study|Overall Study||59
6592222|NCT01992159|7517467|FG001|Completed First 12 Months of Study|Overall Study||56
6592223|NCT01992159|7517468|FG002|Completed First 12 Months of Study|Overall Study||63
6592224|NCT01992159|7517469|FG003|Completed First 12 Months of Study|Overall Study||59
6592225|NCT01992159|7517466|FG000|COMPLETED|Overall Study||59
6592226|NCT01992159|7517467|FG001|COMPLETED|Overall Study||55
6592227|NCT01992159|7517468|FG002|COMPLETED|Overall Study||62
6592228|NCT01992159|7517469|FG003|COMPLETED|Overall Study||59
6592229|NCT01992159|7517466|FG000|NOT COMPLETED|Overall Study||4
6592230|NCT01992159|7517467|FG001|NOT COMPLETED|Overall Study||8
6592231|NCT01992159|7517468|FG002|NOT COMPLETED|Overall Study||1
6592232|NCT01992159|7517469|FG003|NOT COMPLETED|Overall Study||4
6592233|NCT01992172|7517481|FG000|STARTED|Overall Study||7
6592234|NCT01992172|7517482|FG001|STARTED|Overall Study||0
6592235|NCT01992172|7517481|FG000|COMPLETED|Overall Study||7
6592236|NCT01992172|7517482|FG001|COMPLETED|Overall Study||0
6592237|NCT01992172|7517481|FG000|NOT COMPLETED|Overall Study||0
6592238|NCT01992172|7517482|FG001|NOT COMPLETED|Overall Study||0
6592239|NCT01992185|7517490|FG000|STARTED|Overall Study||7
6592240|NCT01992185|7517491|FG001|STARTED|Overall Study||8
6592241|NCT01992185|7517490|FG000|COMPLETED|Overall Study||7
6592242|NCT01992185|7517491|FG001|COMPLETED|Overall Study||8
6592243|NCT01992185|7517490|FG000|NOT COMPLETED|Overall Study||0
6592244|NCT01992185|7517491|FG001|NOT COMPLETED|Overall Study||0
6592245|NCT01992354|7517497|FG000|STARTED|Overall Study||4
6592246|NCT01992354|7517497|FG000|COMPLETED|Overall Study||4
6592247|NCT01992354|7517497|FG000|NOT COMPLETED|Overall Study||0
6592248|NCT01992380|7517505|FG000|STARTED|Overall Study||6
6592249|NCT01992380|7517506|FG001|STARTED|Overall Study||8
6592250|NCT01992380|7517507|FG002|STARTED|Overall Study||10
6592251|NCT01992380|7517505|FG000|COMPLETED|Overall Study||6
6592252|NCT01992380|7517506|FG001|COMPLETED|Overall Study||8
6592253|NCT01992380|7517507|FG002|COMPLETED|Overall Study||10
6592254|NCT01992380|7517505|FG000|NOT COMPLETED|Overall Study||0
6592255|NCT01992380|7517506|FG001|NOT COMPLETED|Overall Study||0
6592256|NCT01992380|7517507|FG002|NOT COMPLETED|Overall Study||0
6592257|NCT01992523|7517515|FG000|STARTED|Overall Study||41
6592258|NCT01992523|7517516|FG001|STARTED|Overall Study||41
6592259|NCT01992523|7517515|FG000|COMPLETED|Overall Study||41
6592260|NCT01992523|7517516|FG001|COMPLETED|Overall Study||41
6592261|NCT01992523|7517515|FG000|NOT COMPLETED|Overall Study||0
6592262|NCT01992523|7517516|FG001|NOT COMPLETED|Overall Study||0
6592263|NCT01992536|7517534|FG000|STARTED|Overall Study||26
6592264|NCT01992536|7517535|FG001|STARTED|Overall Study||25
6592265|NCT01992536|7517536|FG002|STARTED|Overall Study||17
6592266|NCT01992536|7517537|FG003|STARTED|Overall Study||24
6592267|NCT01992536|7517538|FG004|STARTED|Overall Study||11
6592268|NCT01992536|7517539|FG005|STARTED|Overall Study||21
6592269|NCT01992536|7517540|FG006|STARTED|Overall Study||7
6592270|NCT01992536|7517541|FG007|STARTED|Overall Study||21
6592271|NCT01992536|7517542|FG008|STARTED|Overall Study||19
6592272|NCT01992536|7517543|FG009|STARTED|Overall Study||19
6592273|NCT01992536|7517534|FG000|COMPLETED|Overall Study||22
6592274|NCT01992536|7517535|FG001|COMPLETED|Overall Study||22
6592275|NCT01992536|7517536|FG002|COMPLETED|Overall Study||16
6592276|NCT01992536|7517537|FG003|COMPLETED|Overall Study||22
6592277|NCT01992536|7517538|FG004|COMPLETED|Overall Study||11
6592278|NCT01992536|7517539|FG005|COMPLETED|Overall Study||20
6592279|NCT01992536|7517540|FG006|COMPLETED|Overall Study||0
6592280|NCT01992536|7517541|FG007|COMPLETED|Overall Study||21
6592281|NCT01992536|7517542|FG008|COMPLETED|Overall Study||18
6592282|NCT01992536|7517543|FG009|COMPLETED|Overall Study||18
6592283|NCT01992536|7517534|FG000|NOT COMPLETED|Overall Study||4
6592284|NCT01992536|7517535|FG001|NOT COMPLETED|Overall Study||3
6592285|NCT01992536|7517536|FG002|NOT COMPLETED|Overall Study||1
6592286|NCT01992536|7517537|FG003|NOT COMPLETED|Overall Study||2
6592287|NCT01992536|7517538|FG004|NOT COMPLETED|Overall Study||0
6592288|NCT01992536|7517539|FG005|NOT COMPLETED|Overall Study||1
6592289|NCT01992536|7517540|FG006|NOT COMPLETED|Overall Study||7
6592290|NCT01992536|7517541|FG007|NOT COMPLETED|Overall Study||0
6592291|NCT01992536|7517542|FG008|NOT COMPLETED|Overall Study||1
6592292|NCT01992536|7517543|FG009|NOT COMPLETED|Overall Study||1
6592293|NCT01992549|7517585|FG000|STARTED|Overall Study||48
6592294|NCT01992549|7517585|FG000|SAF Population|Overall Study||48
6592295|NCT01992549|7517585|FG000|ITT Population|Overall Study||47
6592296|NCT01992549|7517585|FG000|PROPH Population|Overall Study||47
6592297|NCT01992549|7517585|FG000|BLEED Population|Overall Study||29
6592298|NCT01992549|7517585|FG000|SURG Population|Overall Study||3
6592299|NCT01992549|7517585|FG000|COMPLETED|Overall Study||44
6592300|NCT01992549|7517585|FG000|NOT COMPLETED|Overall Study||4
6592301|NCT01992757|7517595|FG000|STARTED|Overall Study||51
6592302|NCT01992757|7517595|FG000|COMPLETED|Overall Study||49
6592303|NCT01992757|7517595|FG000|NOT COMPLETED|Overall Study||2
6592304|NCT01992874|7517600|FG000|STARTED|Part A||21
6592305|NCT01992874|7517601|FG001|STARTED|Part A||17
6592306|NCT01992874|7517602|FG002|STARTED|Part A||0
6592307|NCT01992874|7517600|FG000|COMPLETED|Part A||21
6592308|NCT01992874|7517601|FG001|COMPLETED|Part A||17
6592309|NCT01992874|7517602|FG002|COMPLETED|Part A||0
6592310|NCT01992874|7517600|FG000|NOT COMPLETED|Part A||0
6592311|NCT01992874|7517601|FG001|NOT COMPLETED|Part A||0
6592312|NCT01992874|7517602|FG002|NOT COMPLETED|Part A||0
6592313|NCT01992874|7517600|FG000|STARTED|Part B||0
6592314|NCT01992874|7517601|FG001|STARTED|Part B||0
6592315|NCT01992874|7517602|FG002|STARTED|Part B||38
6592316|NCT01992874|7517600|FG000|COMPLETED|Part B||0
6592317|NCT01992874|7517601|FG001|COMPLETED|Part B||0
6592318|NCT01992874|7517602|FG002|COMPLETED|Part B||38
6592319|NCT01992874|7517600|FG000|NOT COMPLETED|Part B||0
6592320|NCT01992874|7517601|FG001|NOT COMPLETED|Part B||0
6592321|NCT01992874|7517602|FG002|NOT COMPLETED|Part B||0
6592322|NCT01993017|7517615|FG000|STARTED|Overall Study||499
6592323|NCT01993017|7517616|FG001|STARTED|Overall Study||501
6592324|NCT01993017|7517617|FG002|STARTED|Overall Study||500
6592325|NCT01993017|7517615|FG000|COMPLETED|Overall Study||393
6592326|NCT01993017|7517616|FG001|COMPLETED|Overall Study||411
6592327|NCT01993017|7517617|FG002|COMPLETED|Overall Study||421
6592328|NCT01993017|7517615|FG000|NOT COMPLETED|Overall Study||106
6592329|NCT01993017|7517616|FG001|NOT COMPLETED|Overall Study||90
6592330|NCT01993017|7517617|FG002|NOT COMPLETED|Overall Study||79
6592331|NCT01993030|7517628|FG000|STARTED|Overall Study||36
6592332|NCT01993030|7517629|FG001|STARTED|Overall Study||35
6592333|NCT01993030|7517628|FG000|COMPLETED|Overall Study||36
6592334|NCT01993030|7517629|FG001|COMPLETED|Overall Study||31
6592335|NCT01993030|7517628|FG000|NOT COMPLETED|Overall Study||0
6592336|NCT01993030|7517629|FG001|NOT COMPLETED|Overall Study||4
6592337|NCT01993108|7517637|FG000|STARTED|Overall Study||11
6592338|NCT01993108|7517638|FG001|STARTED|Overall Study||12
6592339|NCT01993108|7517637|FG000|COMPLETED|Overall Study||11
6592340|NCT01993108|7517638|FG001|COMPLETED|Overall Study||12
6592341|NCT01993108|7517637|FG000|NOT COMPLETED|Overall Study||0
6592342|NCT01993108|7517638|FG001|NOT COMPLETED|Overall Study||0
6592343|NCT01993186|7517658|FG000|STARTED|Double-Blind Placebo-Controlled Period||25
6592344|NCT01993186|7517659|FG001|STARTED|Double-Blind Placebo-Controlled Period||11
6592345|NCT01993186|7517658|FG000|COMPLETED|Double-Blind Placebo-Controlled Period||23
6592346|NCT01993186|7517659|FG001|COMPLETED|Double-Blind Placebo-Controlled Period||11
6592347|NCT01993186|7517658|FG000|NOT COMPLETED|Double-Blind Placebo-Controlled Period||2
6592348|NCT01993186|7517659|FG001|NOT COMPLETED|Double-Blind Placebo-Controlled Period||0
6592349|NCT01993186|7517658|FG000|STARTED|Open-Label Extension Period||23
6592350|NCT01993186|7517659|FG001|STARTED|Open-Label Extension Period||11
6592351|NCT01993186|7517658|FG000|COMPLETED|Open-Label Extension Period||16
6592352|NCT01993186|7517659|FG001|COMPLETED|Open-Label Extension Period||5
6592353|NCT01993186|7517658|FG000|NOT COMPLETED|Open-Label Extension Period||7
6659906|NCT02494401|7590844|FG001|NOT COMPLETED|Overall Study||27
6659907|NCT02494440|7590850|FG000|STARTED|Overall Study||90
6659908|NCT02494440|7590850|FG000|COMPLETED|Overall Study||90
6659909|NCT02494440|7590850|FG000|NOT COMPLETED|Overall Study||0
6659910|NCT02494518|7590857|FG000|STARTED|Overall Study||11
6659911|NCT02494518|7590858|FG001|STARTED|Overall Study||12
6659912|NCT02494518|7590859|FG002|STARTED|Overall Study||11
6659913|NCT02494518|7590857|FG000|COMPLETED|Overall Study||10
6659914|NCT02494518|7590858|FG001|COMPLETED|Overall Study||10
6659915|NCT02494518|7590859|FG002|COMPLETED|Overall Study||8
6659916|NCT02494518|7590857|FG000|NOT COMPLETED|Overall Study||1
6659917|NCT02494518|7590858|FG001|NOT COMPLETED|Overall Study||2
6659918|NCT02494518|7590859|FG002|NOT COMPLETED|Overall Study||3
6592354|NCT01993186|7517659|FG001|NOT COMPLETED|Open-Label Extension Period||6
6592355|NCT01993238|7517666|FG000|STARTED|Overall Study||11
6592356|NCT01993238|7517666|FG000|COMPLETED|Overall Study||11
6592357|NCT01993238|7517666|FG000|NOT COMPLETED|Overall Study||0
6592358|NCT01993329|7517676|FG000|STARTED|Period 1||3
6592359|NCT01993329|7517677|FG001|STARTED|Period 1||4
6592360|NCT01993329|7517678|FG002|STARTED|Period 1||3
6592361|NCT01993329|7517679|FG003|STARTED|Period 1||3
6592362|NCT01993329|7517680|FG004|STARTED|Period 1||3
6592363|NCT01993329|7517681|FG005|STARTED|Period 1||4
6592364|NCT01993329|7517676|FG000|COMPLETED|Period 1||3
6592365|NCT01993329|7517677|FG001|COMPLETED|Period 1||4
6592366|NCT01993329|7517678|FG002|COMPLETED|Period 1||3
6592367|NCT01993329|7517679|FG003|COMPLETED|Period 1||3
6592368|NCT01993329|7517680|FG004|COMPLETED|Period 1||3
6592369|NCT01993329|7517681|FG005|COMPLETED|Period 1||4
6592370|NCT01993329|7517676|FG000|NOT COMPLETED|Period 1||0
6592371|NCT01993329|7517677|FG001|NOT COMPLETED|Period 1||0
6592372|NCT01993329|7517678|FG002|NOT COMPLETED|Period 1||0
6592373|NCT01993329|7517679|FG003|NOT COMPLETED|Period 1||0
6592374|NCT01993329|7517680|FG004|NOT COMPLETED|Period 1||0
6592375|NCT01993329|7517681|FG005|NOT COMPLETED|Period 1||0
6592376|NCT01993329|7517676|FG000|STARTED|Wash-out||3
6592377|NCT01993329|7517677|FG001|STARTED|Wash-out||4
6592378|NCT01993329|7517678|FG002|STARTED|Wash-out||3
6592379|NCT01993329|7517679|FG003|STARTED|Wash-out||3
6592380|NCT01993329|7517680|FG004|STARTED|Wash-out||3
6592381|NCT01993329|7517681|FG005|STARTED|Wash-out||4
6592382|NCT01993329|7517676|FG000|COMPLETED|Wash-out||3
6592383|NCT01993329|7517677|FG001|COMPLETED|Wash-out||4
6592384|NCT01993329|7517678|FG002|COMPLETED|Wash-out||3
6592385|NCT01993329|7517679|FG003|COMPLETED|Wash-out||3
6592386|NCT01993329|7517680|FG004|COMPLETED|Wash-out||3
6592387|NCT01993329|7517681|FG005|COMPLETED|Wash-out||4
6592388|NCT01993329|7517676|FG000|NOT COMPLETED|Wash-out||0
6592389|NCT01993329|7517677|FG001|NOT COMPLETED|Wash-out||0
6592390|NCT01993329|7517678|FG002|NOT COMPLETED|Wash-out||0
6592391|NCT01993329|7517679|FG003|NOT COMPLETED|Wash-out||0
6592392|NCT01993329|7517680|FG004|NOT COMPLETED|Wash-out||0
6592393|NCT01993329|7517681|FG005|NOT COMPLETED|Wash-out||0
6592394|NCT01993329|7517676|FG000|STARTED|Period 2||3
6592395|NCT01993329|7517677|FG001|STARTED|Period 2||4
6592396|NCT01993329|7517678|FG002|STARTED|Period 2||3
6592397|NCT01993329|7517679|FG003|STARTED|Period 2||3
6592398|NCT01993329|7517680|FG004|STARTED|Period 2||3
6592399|NCT01993329|7517681|FG005|STARTED|Period 2||4
6592400|NCT01993329|7517676|FG000|COMPLETED|Period 2||3
6592401|NCT01993329|7517677|FG001|COMPLETED|Period 2||4
6592402|NCT01993329|7517678|FG002|COMPLETED|Period 2||3
6592403|NCT01993329|7517679|FG003|COMPLETED|Period 2||3
6592404|NCT01993329|7517680|FG004|COMPLETED|Period 2||3
6592405|NCT01993329|7517681|FG005|COMPLETED|Period 2||3
6592406|NCT01993329|7517676|FG000|NOT COMPLETED|Period 2||0
6659919|NCT02494583|7590870|FG000|STARTED|Overall Study||256
6659920|NCT02494583|7590871|FG001|STARTED|Overall Study||257
6659921|NCT02494583|7590872|FG002|STARTED|Overall Study||250
6659922|NCT02494583|7590870|FG000|Treated|Overall Study|1 participant randomized to the pembro combo arm received pembrolizumab monotherapy by mistake.|254
6659923|NCT02494583|7590871|FG001|Treated|Overall Study||250
6659924|NCT02494583|7590872|FG002|Treated|Overall Study||244
6659925|NCT02494583|7590870|FG000|COMPLETED|Overall Study||0
6659926|NCT02494583|7590871|FG001|COMPLETED|Overall Study||0
6659927|NCT02494583|7590872|FG002|COMPLETED|Overall Study||0
6659928|NCT02494583|7590870|FG000|NOT COMPLETED|Overall Study||256
6659929|NCT02494583|7590871|FG001|NOT COMPLETED|Overall Study||257
6659930|NCT02494583|7590872|FG002|NOT COMPLETED|Overall Study||250
6659931|NCT02494596|7590880|FG000|STARTED|Overall Study||5
6659932|NCT02494596|7590881|FG001|STARTED|Overall Study||7
6659933|NCT02494596|7590882|FG002|STARTED|Overall Study||7
6659934|NCT02494596|7590880|FG000|COMPLETED|Overall Study||2
6659935|NCT02494596|7590881|FG001|COMPLETED|Overall Study||2
6659936|NCT02494596|7590882|FG002|COMPLETED|Overall Study||6
6659937|NCT02494596|7590880|FG000|NOT COMPLETED|Overall Study||3
6592407|NCT01993329|7517677|FG001|NOT COMPLETED|Period 2||0
6592408|NCT01993329|7517678|FG002|NOT COMPLETED|Period 2||0
6592409|NCT01993329|7517679|FG003|NOT COMPLETED|Period 2||0
6592410|NCT01993329|7517680|FG004|NOT COMPLETED|Period 2||0
6592411|NCT01993329|7517681|FG005|NOT COMPLETED|Period 2||1
6592412|NCT01993329|7517676|FG000|STARTED|Wash-out||3
6592413|NCT01993329|7517677|FG001|STARTED|Wash-out||4
6592414|NCT01993329|7517678|FG002|STARTED|Wash-out||3
6592415|NCT01993329|7517679|FG003|STARTED|Wash-out||3
6592416|NCT01993329|7517680|FG004|STARTED|Wash-out||3
6592417|NCT01993329|7517681|FG005|STARTED|Wash-out||3
6592418|NCT01993329|7517676|FG000|COMPLETED|Wash-out||3
6592419|NCT01993329|7517677|FG001|COMPLETED|Wash-out||3
6592420|NCT01993329|7517678|FG002|COMPLETED|Wash-out||3
6592421|NCT01993329|7517679|FG003|COMPLETED|Wash-out||3
6592422|NCT01993329|7517680|FG004|COMPLETED|Wash-out||3
6592423|NCT01993329|7517681|FG005|COMPLETED|Wash-out||3
6592424|NCT01993329|7517676|FG000|NOT COMPLETED|Wash-out||0
6592425|NCT01993329|7517677|FG001|NOT COMPLETED|Wash-out||1
6592426|NCT01993329|7517678|FG002|NOT COMPLETED|Wash-out||0
6592427|NCT01993329|7517679|FG003|NOT COMPLETED|Wash-out||0
6592428|NCT01993329|7517680|FG004|NOT COMPLETED|Wash-out||0
6592429|NCT01993329|7517681|FG005|NOT COMPLETED|Wash-out||0
6592430|NCT01993329|7517676|FG000|STARTED|Period 3||3
6592431|NCT01993329|7517677|FG001|STARTED|Period 3||3
6592432|NCT01993329|7517678|FG002|STARTED|Period 3||3
6592433|NCT01993329|7517679|FG003|STARTED|Period 3||3
6592434|NCT01993329|7517680|FG004|STARTED|Period 3||3
6592435|NCT01993329|7517681|FG005|STARTED|Period 3||3
6592436|NCT01993329|7517676|FG000|COMPLETED|Period 3||3
6592437|NCT01993329|7517677|FG001|COMPLETED|Period 3||3
6592438|NCT01993329|7517678|FG002|COMPLETED|Period 3||3
6592439|NCT01993329|7517679|FG003|COMPLETED|Period 3||3
6592440|NCT01993329|7517680|FG004|COMPLETED|Period 3||3
6592441|NCT01993329|7517681|FG005|COMPLETED|Period 3||3
6592442|NCT01993329|7517676|FG000|NOT COMPLETED|Period 3||0
6592443|NCT01993329|7517677|FG001|NOT COMPLETED|Period 3||0
6592444|NCT01993329|7517678|FG002|NOT COMPLETED|Period 3||0
6592445|NCT01993329|7517679|FG003|NOT COMPLETED|Period 3||0
6592446|NCT01993329|7517680|FG004|NOT COMPLETED|Period 3||0
6592447|NCT01993329|7517681|FG005|NOT COMPLETED|Period 3||0
6592448|NCT01993615|7517695|FG000|STARTED|Overall Study||40
6592449|NCT01993615|7517696|FG001|STARTED|Overall Study||40
6592450|NCT01993615|7517695|FG000|COMPLETED|Overall Study||39
6592451|NCT01993615|7517696|FG001|COMPLETED|Overall Study||40
6592452|NCT01993615|7517695|FG000|NOT COMPLETED|Overall Study||1
6592453|NCT01993615|7517696|FG001|NOT COMPLETED|Overall Study||0
6592454|NCT01993667|7517704|FG000|STARTED|Overall Study||64
6592455|NCT01993667|7517705|FG001|STARTED|Overall Study||66
6592456|NCT01993667|7517704|FG000|COMPLETED|Overall Study||43
6592457|NCT01993667|7517705|FG001|COMPLETED|Overall Study||47
6592458|NCT01993667|7517704|FG000|NOT COMPLETED|Overall Study||21
6592459|NCT01993667|7517705|FG001|NOT COMPLETED|Overall Study||19
6592460|NCT01993823|7517713|FG000|STARTED|Overall Study||95
6592461|NCT01993823|7517714|FG001|STARTED|Overall Study||95
6592462|NCT01993823|7517713|FG000|COMPLETED|Overall Study||88
6592463|NCT01993823|7517714|FG001|COMPLETED|Overall Study||79
6592464|NCT01993823|7517713|FG000|NOT COMPLETED|Overall Study||7
6592465|NCT01993823|7517714|FG001|NOT COMPLETED|Overall Study||16
6592466|NCT01993836|7517723|FG000|STARTED|Overall Study|This represents the number of enrolled patients who completed baseline cognitive testing|72
6592467|NCT01993836|7517724|FG001|STARTED|Overall Study||68
6592468|NCT01993836|7517725|FG002|STARTED|Overall Study||51
6592469|NCT01993836|7517723|FG000|COMPLETED|Overall Study||55
6592470|NCT01993836|7517724|FG001|COMPLETED|Overall Study||55
6592471|NCT01993836|7517725|FG002|COMPLETED|Overall Study||46
6592472|NCT01993836|7517723|FG000|NOT COMPLETED|Overall Study||17
6592473|NCT01993836|7517724|FG001|NOT COMPLETED|Overall Study||13
6592474|NCT01993836|7517725|FG002|NOT COMPLETED|Overall Study||5
6592475|NCT01993849|7517735|FG000|STARTED|Overall Study||12
6592476|NCT01993849|7517736|FG001|STARTED|Overall Study||11
6592477|NCT01993849|7517735|FG000|COMPLETED|Overall Study||9
6592478|NCT01993849|7517736|FG001|COMPLETED|Overall Study||9
6592479|NCT01993849|7517735|FG000|NOT COMPLETED|Overall Study||3
6592480|NCT01993849|7517736|FG001|NOT COMPLETED|Overall Study||2
6592481|NCT01993875|7517746|FG000|STARTED|Overall Study||82
6592482|NCT01993875|7517747|FG001|STARTED|Overall Study||82
6592483|NCT01993875|7517746|FG000|COMPLETED|Overall Study||75
6592484|NCT01993875|7517747|FG001|COMPLETED|Overall Study||76
6592485|NCT01993875|7517746|FG000|NOT COMPLETED|Overall Study||7
6592486|NCT01993875|7517747|FG001|NOT COMPLETED|Overall Study||6
6592487|NCT01993888|7517756|FG000|STARTED|Overall Study||50
6592488|NCT01993888|7517757|FG001|STARTED|Overall Study||52
6592489|NCT01993888|7517756|FG000|COMPLETED|Overall Study||48
6592490|NCT01993888|7517757|FG001|COMPLETED|Overall Study||49
6592491|NCT01993888|7517756|FG000|NOT COMPLETED|Overall Study||2
6592492|NCT01993888|7517757|FG001|NOT COMPLETED|Overall Study||3
6592493|NCT01993927|7517763|FG000|STARTED|Overall Study||742
6592494|NCT01993927|7517763|FG000|COMPLETED|Overall Study||713
6592495|NCT01993927|7517763|FG000|NOT COMPLETED|Overall Study||29
6592496|NCT01993940|7517769|FG000|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
6592497|NCT01993940|7517770|FG001|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
6592498|NCT01993940|7517769|FG000|Received Treatment|Overall Study||272
6592499|NCT01993940|7517770|FG001|Received Treatment|Overall Study||276
6592500|NCT01993940|7517769|FG000|COMPLETED|Overall Study||237
6592501|NCT01993940|7517770|FG001|COMPLETED|Overall Study||232
6592502|NCT01993940|7517769|FG000|NOT COMPLETED|Overall Study||40
6592503|NCT01993940|7517770|FG001|NOT COMPLETED|Overall Study||44
6592504|NCT01994109|7517779|FG000|STARTED|Double-blind Phase (Part A)||63
6592505|NCT01994109|7517780|FG001|STARTED|Double-blind Phase (Part A)||64
6592506|NCT01994109|7517781|FG002|STARTED|Double-blind Phase (Part A)||60
6592507|NCT01994109|7517782|FG003|STARTED|Double-blind Phase (Part A)||0
6592508|NCT01994109|7517779|FG000|COMPLETED|Double-blind Phase (Part A)||62
6592509|NCT01994109|7517780|FG001|COMPLETED|Double-blind Phase (Part A)||61
6592510|NCT01994109|7517781|FG002|COMPLETED|Double-blind Phase (Part A)||53
6592511|NCT01994109|7517782|FG003|COMPLETED|Double-blind Phase (Part A)||0
6592512|NCT01994109|7517779|FG000|NOT COMPLETED|Double-blind Phase (Part A)||1
6592513|NCT01994109|7517780|FG001|NOT COMPLETED|Double-blind Phase (Part A)||3
6592514|NCT01994109|7517781|FG002|NOT COMPLETED|Double-blind Phase (Part A)||7
6592515|NCT01994109|7517782|FG003|NOT COMPLETED|Double-blind Phase (Part A)||0
6592516|NCT01994109|7517779|FG000|STARTED|Open-label Phase (Part B)||0
6592517|NCT01994109|7517780|FG001|STARTED|Open-label Phase (Part B)||0
6592518|NCT01994109|7517781|FG002|STARTED|Open-label Phase (Part B)|No placebo group in Part B.|0
6592519|NCT01994109|7517782|FG003|STARTED|Open-label Phase (Part B)|61 from 2500 U group, 57 from 3500 U group, 52 from Placebo group continued to Part B|170
6592520|NCT01994109|7517779|FG000|COMPLETED|Open-label Phase (Part B)||0
6592521|NCT01994109|7517780|FG001|COMPLETED|Open-label Phase (Part B)||0
6592522|NCT01994109|7517781|FG002|COMPLETED|Open-label Phase (Part B)|No placebo group in Part B.|0
6592523|NCT01994109|7517782|FG003|COMPLETED|Open-label Phase (Part B)||128
6592524|NCT01994109|7517779|FG000|NOT COMPLETED|Open-label Phase (Part B)||0
6592525|NCT01994109|7517780|FG001|NOT COMPLETED|Open-label Phase (Part B)||0
6592526|NCT01994109|7517781|FG002|NOT COMPLETED|Open-label Phase (Part B)||0
6592527|NCT01994109|7517782|FG003|NOT COMPLETED|Open-label Phase (Part B)||42
6592528|NCT01994226|7517794|FG000|STARTED|Overall Study||199
6592529|NCT01994226|7517795|FG001|STARTED|Overall Study||200
6592530|NCT01994226|7517794|FG000|COMPLETED|Overall Study||180
6592531|NCT01994226|7517795|FG001|COMPLETED|Overall Study||179
6592532|NCT01994226|7517794|FG000|NOT COMPLETED|Overall Study||19
6592533|NCT01994226|7517795|FG001|NOT COMPLETED|Overall Study||21
6592534|NCT01994291|7517804|FG000|STARTED|Overall Study||99
6592535|NCT01994291|7517805|FG001|STARTED|Overall Study||43
6592536|NCT01994291|7517806|FG002|STARTED|Overall Study||56
6592537|NCT01994291|7517804|FG000|Received Treatment|Overall Study||99
6592538|NCT01994291|7517805|FG001|Received Treatment|Overall Study||43
6592539|NCT01994291|7517806|FG002|Received Treatment|Overall Study||56
6592540|NCT01994291|7517804|FG000|COMPLETED|Overall Study||84
6592541|NCT01994291|7517805|FG001|COMPLETED|Overall Study||36
6592542|NCT01994291|7517806|FG002|COMPLETED|Overall Study||47
6592543|NCT01994291|7517804|FG000|NOT COMPLETED|Overall Study||15
6592544|NCT01994291|7517805|FG001|NOT COMPLETED|Overall Study||7
6592545|NCT01994291|7517806|FG002|NOT COMPLETED|Overall Study||9
6592546|NCT01994395|7517817|FG000|STARTED|Overall Study||26
6592547|NCT01994395|7517818|FG001|STARTED|Overall Study||27
6592548|NCT01994395|7517817|FG000|COMPLETED|Overall Study||25
6592549|NCT01994395|7517818|FG001|COMPLETED|Overall Study||25
6592550|NCT01994395|7517817|FG000|NOT COMPLETED|Overall Study||1
6592551|NCT01994395|7517818|FG001|NOT COMPLETED|Overall Study||2
6592552|NCT01994486|7517824|FG000|STARTED|Overall Study||20
6592553|NCT01994486|7517824|FG000|COMPLETED|Overall Study||20
6592554|NCT01994486|7517824|FG000|NOT COMPLETED|Overall Study||0
6592555|NCT01994538|7517832|FG000|STARTED|Overall Study||136
6592556|NCT01994538|7517833|FG001|STARTED|Overall Study||136
6592557|NCT01994538|7517832|FG000|COMPLETED|Overall Study||136
6592558|NCT01994538|7517833|FG001|COMPLETED|Overall Study||136
6592559|NCT01994538|7517832|FG000|NOT COMPLETED|Overall Study||0
6592560|NCT01994538|7517833|FG001|NOT COMPLETED|Overall Study||0
6592561|NCT01994590|7517839|FG000|STARTED|Overall Study||4
6592562|NCT01994590|7517839|FG000|COMPLETED|Overall Study||2
6592563|NCT01994590|7517839|FG000|NOT COMPLETED|Overall Study||2
6592564|NCT01994629|7517845|FG000|STARTED|Overall Study||100
6592565|NCT01994629|7517846|FG001|STARTED|Overall Study||102
6592566|NCT01994629|7517845|FG000|COMPLETED|Overall Study||99
6592567|NCT01994629|7517846|FG001|COMPLETED|Overall Study||99
6592568|NCT01994629|7517845|FG000|NOT COMPLETED|Overall Study||1
6592569|NCT01994629|7517846|FG001|NOT COMPLETED|Overall Study||3
6592570|NCT01994720|7517854|FG000|STARTED|Overall Study||6589
6592571|NCT01994720|7517855|FG001|STARTED|Overall Study||6610
6592572|NCT01994720|7517854|FG000|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
6592573|NCT01994720|7517855|FG001|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
6592574|NCT01994720|7517854|FG000|NOT COMPLETED|Overall Study||46
6592575|NCT01994720|7517855|FG001|NOT COMPLETED|Overall Study||56
6592576|NCT01994746|7517861|FG000|STARTED|First Visit||39
6592577|NCT01994746|7517862|FG001|STARTED|First Visit||38
6592578|NCT01994746|7517861|FG000|Received At Least 1 Dose|First Visit||39
6592579|NCT01994746|7517862|FG001|Received At Least 1 Dose|First Visit||38
6592580|NCT01994746|7517861|FG000|COMPLETED|First Visit||39
6592581|NCT01994746|7517862|FG001|COMPLETED|First Visit||38
6592582|NCT01994746|7517861|FG000|NOT COMPLETED|First Visit||0
6592583|NCT01994746|7517862|FG001|NOT COMPLETED|First Visit||0
6592584|NCT01994746|7517861|FG000|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
6592585|NCT01994746|7517862|FG001|STARTED|Second Visit||38
6592586|NCT01994746|7517861|FG000|Completed Both Dosing Visits|Second Visit||38
6592587|NCT01994746|7517862|FG001|Completed Both Dosing Visits|Second Visit||38
6592588|NCT01994746|7517861|FG000|COMPLETED|Second Visit||38
6592589|NCT01994746|7517862|FG001|COMPLETED|Second Visit||38
6592590|NCT01994746|7517861|FG000|NOT COMPLETED|Second Visit||0
6592591|NCT01994746|7517862|FG001|NOT COMPLETED|Second Visit||0
6592592|NCT01994785|7517872|FG000|STARTED|Overall Study||109
6592593|NCT01994785|7517873|FG001|STARTED|Overall Study||109
6592594|NCT01994785|7517874|FG002|STARTED|Overall Study||117
6592595|NCT01994785|7517875|FG003|STARTED|Overall Study||117
6592596|NCT01994785|7517872|FG000|COMPLETED|Overall Study||101
6592597|NCT01994785|7517873|FG001|COMPLETED|Overall Study||108
6592598|NCT01994785|7517874|FG002|COMPLETED|Overall Study||117
6592599|NCT01994785|7517875|FG003|COMPLETED|Overall Study||114
6592600|NCT01994785|7517872|FG000|NOT COMPLETED|Overall Study||8
6592601|NCT01994785|7517873|FG001|NOT COMPLETED|Overall Study||1
6592602|NCT01994785|7517874|FG002|NOT COMPLETED|Overall Study||0
6592603|NCT01994785|7517875|FG003|NOT COMPLETED|Overall Study||3
6592604|NCT01994837|7517885|FG000|STARTED|Overall Study||32
6592605|NCT01994837|7517885|FG000|Treated|Overall Study||32
6592606|NCT01994837|7517885|FG000|COMPLETED|Overall Study||0
6592607|NCT01994837|7517885|FG000|NOT COMPLETED|Overall Study||32
6592608|NCT01994850|7517889|FG000|STARTED|Overall Study||32
6592609|NCT01994850|7517889|FG000|COMPLETED|Overall Study||30
6592610|NCT01994850|7517889|FG000|NOT COMPLETED|Overall Study||2
6592611|NCT01994863|7517893|FG000|STARTED|Period 1||11
6592612|NCT01994863|7517894|FG001|STARTED|Period 1||12
6592613|NCT01994863|7517893|FG000|COMPLETED|Period 1||4
6592614|NCT01994863|7517894|FG001|COMPLETED|Period 1||9
6592615|NCT01994863|7517893|FG000|NOT COMPLETED|Period 1||7
6592616|NCT01994863|7517894|FG001|NOT COMPLETED|Period 1||3
6592617|NCT01994863|7517893|FG000|STARTED|Period 2||8
6592618|NCT01994863|7517894|FG001|STARTED|Period 2||9
6592619|NCT01994863|7517893|FG000|COMPLETED|Period 2||7
6592620|NCT01994863|7517894|FG001|COMPLETED|Period 2||5
6592621|NCT01994863|7517893|FG000|NOT COMPLETED|Period 2||1
6592622|NCT01994863|7517894|FG001|NOT COMPLETED|Period 2||4
6592623|NCT01994876|7517900|FG000|STARTED|Baseline - Own Product||9
6592624|NCT01994876|7517901|FG001|STARTED|Baseline - Own Product||9
6592625|NCT01994876|7517900|FG000|COMPLETED|Baseline - Own Product||9
6592626|NCT01994876|7517901|FG001|COMPLETED|Baseline - Own Product||9
6592627|NCT01994876|7517900|FG000|NOT COMPLETED|Baseline - Own Product||0
6592628|NCT01994876|7517901|FG001|NOT COMPLETED|Baseline - Own Product||0
6592629|NCT01994876|7517900|FG000|STARTED|Test Period 1||9
6592630|NCT01994876|7517901|FG001|STARTED|Test Period 1||9
6592631|NCT01994876|7517900|FG000|COMPLETED|Test Period 1||9
6592632|NCT01994876|7517901|FG001|COMPLETED|Test Period 1||7
6592633|NCT01994876|7517900|FG000|NOT COMPLETED|Test Period 1||0
6592634|NCT01994876|7517901|FG001|NOT COMPLETED|Test Period 1||2
6592635|NCT01994876|7517900|FG000|STARTED|Test Period 2||9
6592636|NCT01994876|7517901|FG001|STARTED|Test Period 2||7
6592637|NCT01994876|7517900|FG000|COMPLETED|Test Period 2||8
6592638|NCT01994876|7517901|FG001|COMPLETED|Test Period 2||6
6592639|NCT01994876|7517900|FG000|NOT COMPLETED|Test Period 2||1
6592640|NCT01994876|7517901|FG001|NOT COMPLETED|Test Period 2||1
6592641|NCT01994889|7517912|FG000|STARTED|Overall Study||88
6592642|NCT01994889|7517913|FG001|STARTED|Overall Study||176
6592643|NCT01994889|7517914|FG002|STARTED|Overall Study||177
6592644|NCT01994889|7517912|FG000|COMPLETED|Overall Study||60
6592645|NCT01994889|7517913|FG001|COMPLETED|Overall Study||113
6592646|NCT01994889|7517914|FG002|COMPLETED|Overall Study||85
6592647|NCT01994889|7517912|FG000|NOT COMPLETED|Overall Study||28
6592648|NCT01994889|7517913|FG001|NOT COMPLETED|Overall Study||63
6592649|NCT01994889|7517914|FG002|NOT COMPLETED|Overall Study||92
6592650|NCT01994902|7517921|FG000|STARTED|Test Period 1||63
6659938|NCT02494596|7590881|FG001|NOT COMPLETED|Overall Study||5
6659939|NCT02494596|7590882|FG002|NOT COMPLETED|Overall Study||1
6659940|NCT02494713|7590893|FG000|STARTED|Overall Study||4
6659941|NCT02494713|7590893|FG000|COMPLETED|Overall Study||4
6659942|NCT02494713|7590893|FG000|NOT COMPLETED|Overall Study||0
6659943|NCT02494778|7590897|FG000|STARTED|Overall Study||248
6659944|NCT02494778|7590897|FG000|COMPLETED|Overall Study||27
6659945|NCT02494778|7590897|FG000|NOT COMPLETED|Overall Study||221
6659946|NCT02494817|7590903|FG000|STARTED|Overall Study|representing 81 couples|162
6659947|NCT02494817|7590904|FG001|STARTED|Overall Study|representing 68 couples|136
6592651|NCT01994902|7517922|FG001|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
6592652|NCT01994902|7517921|FG000|COMPLETED|Test Period 1||57
6592653|NCT01994902|7517922|FG001|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
6592654|NCT01994902|7517921|FG000|NOT COMPLETED|Test Period 1||6
6592655|NCT01994902|7517922|FG001|NOT COMPLETED|Test Period 1||3
6592656|NCT01994902|7517921|FG000|STARTED|Test Period 2||57
6592657|NCT01994902|7517922|FG001|STARTED|Test Period 2||61
6592658|NCT01994902|7517921|FG000|COMPLETED|Test Period 2||57
6592659|NCT01994902|7517922|FG001|COMPLETED|Test Period 2||55
6592660|NCT01994902|7517921|FG000|NOT COMPLETED|Test Period 2||0
6592661|NCT01994902|7517922|FG001|NOT COMPLETED|Test Period 2||6
6592662|NCT01994954|7517930|FG000|STARTED|Overall Study||99
6592663|NCT01994954|7517931|FG001|STARTED|Overall Study||97
6592664|NCT01994954|7517930|FG000|COMPLETED|Overall Study||74
6592665|NCT01994954|7517931|FG001|COMPLETED|Overall Study||67
6592666|NCT01994954|7517930|FG000|NOT COMPLETED|Overall Study||25
6592667|NCT01994954|7517931|FG001|NOT COMPLETED|Overall Study||30
6592668|NCT01994993|7517948|FG000|STARTED|Overall Study||63
6592669|NCT01994993|7517949|FG001|STARTED|Overall Study||47
6592670|NCT01994993|7517950|FG002|STARTED|Overall Study||70
6592671|NCT01994993|7517951|FG003|STARTED|Overall Study||55
6592672|NCT01994993|7517952|FG004|STARTED|Overall Study||24
6592673|NCT01994993|7517948|FG000|COMPLETED|Overall Study||28
6592674|NCT01994993|7517949|FG001|COMPLETED|Overall Study||12
6592675|NCT01994993|7517950|FG002|COMPLETED|Overall Study||23
6592676|NCT01994993|7517951|FG003|COMPLETED|Overall Study||9
6592677|NCT01994993|7517952|FG004|COMPLETED|Overall Study||22
6592678|NCT01994993|7517948|FG000|NOT COMPLETED|Overall Study||35
6592679|NCT01994993|7517949|FG001|NOT COMPLETED|Overall Study||35
6592680|NCT01994993|7517950|FG002|NOT COMPLETED|Overall Study||47
6592681|NCT01994993|7517951|FG003|NOT COMPLETED|Overall Study||46
6592682|NCT01994993|7517952|FG004|NOT COMPLETED|Overall Study||2
6592683|NCT01995045|7517966|FG000|STARTED|Overall Study||29
6592684|NCT01995045|7517967|FG001|STARTED|Overall Study||28
6592685|NCT01995045|7517966|FG000|COMPLETED|Overall Study||29
6592686|NCT01995045|7517967|FG001|COMPLETED|Overall Study||28
6592687|NCT01995045|7517966|FG000|NOT COMPLETED|Overall Study||0
6592688|NCT01995045|7517967|FG001|NOT COMPLETED|Overall Study||0
6592689|NCT01995071|7517985|FG000|STARTED|Overall Study||8
6592690|NCT01995071|7517986|FG001|STARTED|Overall Study||8
6592691|NCT01995071|7517987|FG002|STARTED|Overall Study||9
6592692|NCT01995071|7517988|FG003|STARTED|Overall Study||8
6592693|NCT01995071|7517989|FG004|STARTED|Overall Study||8
6592694|NCT01995071|7517990|FG005|STARTED|Overall Study||8
6592695|NCT01995071|7517991|FG006|STARTED|Overall Study||8
6592696|NCT01995071|7517992|FG007|STARTED|Overall Study||8
6592697|NCT01995071|7517993|FG008|STARTED|Overall Study||8
6592698|NCT01995071|7517994|FG009|STARTED|Overall Study||8
6592699|NCT01995071|7517995|FG010|STARTED|Overall Study||8
6592700|NCT01995071|7517996|FG011|STARTED|Overall Study||0
6592701|NCT01995071|7517985|FG000|COMPLETED|Overall Study||7
6592702|NCT01995071|7517986|FG001|COMPLETED|Overall Study||8
6592703|NCT01995071|7517987|FG002|COMPLETED|Overall Study||8
6592704|NCT01995071|7517988|FG003|COMPLETED|Overall Study||8
6592705|NCT01995071|7517989|FG004|COMPLETED|Overall Study||7
6592706|NCT01995071|7517990|FG005|COMPLETED|Overall Study||8
6592707|NCT01995071|7517991|FG006|COMPLETED|Overall Study||7
6592708|NCT01995071|7517992|FG007|COMPLETED|Overall Study||6
6592709|NCT01995071|7517993|FG008|COMPLETED|Overall Study||7
6592710|NCT01995071|7517994|FG009|COMPLETED|Overall Study||8
6592711|NCT01995071|7517995|FG010|COMPLETED|Overall Study||7
6592712|NCT01995071|7517996|FG011|COMPLETED|Overall Study||0
6592713|NCT01995071|7517985|FG000|NOT COMPLETED|Overall Study||1
6592714|NCT01995071|7517986|FG001|NOT COMPLETED|Overall Study||0
6592715|NCT01995071|7517987|FG002|NOT COMPLETED|Overall Study||1
6592716|NCT01995071|7517988|FG003|NOT COMPLETED|Overall Study||0
6592717|NCT01995071|7517989|FG004|NOT COMPLETED|Overall Study||1
6592718|NCT01995071|7517990|FG005|NOT COMPLETED|Overall Study||0
6592719|NCT01995071|7517991|FG006|NOT COMPLETED|Overall Study||1
6592720|NCT01995071|7517992|FG007|NOT COMPLETED|Overall Study||2
6592721|NCT01995071|7517993|FG008|NOT COMPLETED|Overall Study||1
6592722|NCT01995071|7517994|FG009|NOT COMPLETED|Overall Study||0
6592723|NCT01995071|7517995|FG010|NOT COMPLETED|Overall Study||1
6592724|NCT01995071|7517996|FG011|NOT COMPLETED|Overall Study||0
6592725|NCT01995123|7518030|FG000|STARTED|Overall Study||63
6592726|NCT01995123|7518031|FG001|STARTED|Overall Study||61
6592727|NCT01995123|7518030|FG000|COMPLETED|Overall Study||45
6592728|NCT01995123|7518031|FG001|COMPLETED|Overall Study||46
6592729|NCT01995123|7518030|FG000|NOT COMPLETED|Overall Study||18
6592730|NCT01995123|7518031|FG001|NOT COMPLETED|Overall Study||15
6592731|NCT01995136|7518037|FG000|STARTED|Overall Study||32
6592732|NCT01995136|7518037|FG000|COMPLETED|Overall Study||31
6592733|NCT01995136|7518037|FG000|NOT COMPLETED|Overall Study||1
6592734|NCT01995201|7518043|FG000|STARTED|From Baseline Until Week 24||74
6592735|NCT01995201|7518044|FG001|STARTED|From Baseline Until Week 24||327
6592736|NCT01995201|7518045|FG002|STARTED|From Baseline Until Week 24||0
6592737|NCT01995201|7518046|FG003|STARTED|From Baseline Until Week 24||0
6592738|NCT01995201|7518047|FG004|STARTED|From Baseline Until Week 24||0
6592739|NCT01995201|7518048|FG005|STARTED|From Baseline Until Week 24||0
6592740|NCT01995201|7518049|FG006|STARTED|From Baseline Until Week 24||0
6592741|NCT01995201|7518043|FG000|COMPLETED|From Baseline Until Week 24||64
6592742|NCT01995201|7518044|FG001|COMPLETED|From Baseline Until Week 24||281
6592743|NCT01995201|7518045|FG002|COMPLETED|From Baseline Until Week 24||0
6592744|NCT01995201|7518046|FG003|COMPLETED|From Baseline Until Week 24||0
6592745|NCT01995201|7518047|FG004|COMPLETED|From Baseline Until Week 24||0
6592746|NCT01995201|7518048|FG005|COMPLETED|From Baseline Until Week 24||0
6592747|NCT01995201|7518049|FG006|COMPLETED|From Baseline Until Week 24||0
6592748|NCT01995201|7518043|FG000|NOT COMPLETED|From Baseline Until Week 24||10
6592749|NCT01995201|7518044|FG001|NOT COMPLETED|From Baseline Until Week 24||46
6592750|NCT01995201|7518045|FG002|NOT COMPLETED|From Baseline Until Week 24||0
6592751|NCT01995201|7518046|FG003|NOT COMPLETED|From Baseline Until Week 24||0
6592752|NCT01995201|7518047|FG004|NOT COMPLETED|From Baseline Until Week 24||0
6592753|NCT01995201|7518048|FG005|NOT COMPLETED|From Baseline Until Week 24||0
6592754|NCT01995201|7518049|FG006|NOT COMPLETED|From Baseline Until Week 24||0
6592755|NCT01995201|7518043|FG000|STARTED|From Week 24 Until Week 48||0
6592756|NCT01995201|7518044|FG001|STARTED|From Week 24 Until Week 48||0
6592757|NCT01995201|7518045|FG002|STARTED|From Week 24 Until Week 48||89
6592758|NCT01995201|7518046|FG003|STARTED|From Week 24 Until Week 48||90
6592759|NCT01995201|7518047|FG004|STARTED|From Week 24 Until Week 48||95
6592760|NCT01995201|7518048|FG005|STARTED|From Week 24 Until Week 48||67
6592761|NCT01995201|7518049|FG006|STARTED|From Week 24 Until Week 48||2
6592762|NCT01995201|7518043|FG000|COMPLETED|From Week 24 Until Week 48||0
6592763|NCT01995201|7518044|FG001|COMPLETED|From Week 24 Until Week 48||0
6592764|NCT01995201|7518045|FG002|COMPLETED|From Week 24 Until Week 48||84
6592765|NCT01995201|7518046|FG003|COMPLETED|From Week 24 Until Week 48||89
6592766|NCT01995201|7518047|FG004|COMPLETED|From Week 24 Until Week 48||89
6592767|NCT01995201|7518048|FG005|COMPLETED|From Week 24 Until Week 48||59
6592768|NCT01995201|7518049|FG006|COMPLETED|From Week 24 Until Week 48||0
6592769|NCT01995201|7518043|FG000|NOT COMPLETED|From Week 24 Until Week 48||0
6592770|NCT01995201|7518044|FG001|NOT COMPLETED|From Week 24 Until Week 48||0
6592771|NCT01995201|7518045|FG002|NOT COMPLETED|From Week 24 Until Week 48||5
6592772|NCT01995201|7518046|FG003|NOT COMPLETED|From Week 24 Until Week 48||1
6592773|NCT01995201|7518047|FG004|NOT COMPLETED|From Week 24 Until Week 48||6
6592774|NCT01995201|7518048|FG005|NOT COMPLETED|From Week 24 Until Week 48||8
6592775|NCT01995201|7518049|FG006|NOT COMPLETED|From Week 24 Until Week 48||2
6592776|NCT01995266|7518070|FG000|STARTED|Overall Study||159
6592777|NCT01995266|7518070|FG000|COMPLETED|Overall Study||150
6592778|NCT01995266|7518070|FG000|NOT COMPLETED|Overall Study||9
6592779|NCT01995357|7518074|FG000|STARTED|Period 1||4
6592780|NCT01995357|7518075|FG001|STARTED|Period 1||3
6592781|NCT01995357|7518076|FG002|STARTED|Period 1||4
6592782|NCT01995357|7518077|FG003|STARTED|Period 1||3
6592783|NCT01995357|7518078|FG004|STARTED|Period 1||4
6592784|NCT01995357|7518079|FG005|STARTED|Period 1||4
6592785|NCT01995357|7518074|FG000|COMPLETED|Period 1||4
6592786|NCT01995357|7518075|FG001|COMPLETED|Period 1||3
6592787|NCT01995357|7518076|FG002|COMPLETED|Period 1||4
6592788|NCT01995357|7518077|FG003|COMPLETED|Period 1||3
6592789|NCT01995357|7518078|FG004|COMPLETED|Period 1||4
6592790|NCT01995357|7518079|FG005|COMPLETED|Period 1||4
6592791|NCT01995357|7518074|FG000|NOT COMPLETED|Period 1||0
6592792|NCT01995357|7518075|FG001|NOT COMPLETED|Period 1||0
6592793|NCT01995357|7518076|FG002|NOT COMPLETED|Period 1||0
6592794|NCT01995357|7518077|FG003|NOT COMPLETED|Period 1||0
6592795|NCT01995357|7518078|FG004|NOT COMPLETED|Period 1||0
6592796|NCT01995357|7518079|FG005|NOT COMPLETED|Period 1||0
6592797|NCT01995357|7518074|FG000|STARTED|Period 2||4
6592798|NCT01995357|7518075|FG001|STARTED|Period 2||3
6592799|NCT01995357|7518076|FG002|STARTED|Period 2||4
6592800|NCT01995357|7518077|FG003|STARTED|Period 2||3
6592801|NCT01995357|7518078|FG004|STARTED|Period 2||4
6592802|NCT01995357|7518079|FG005|STARTED|Period 2||4
6592803|NCT01995357|7518074|FG000|COMPLETED|Period 2||4
6592804|NCT01995357|7518075|FG001|COMPLETED|Period 2||3
6592805|NCT01995357|7518076|FG002|COMPLETED|Period 2||4
6592806|NCT01995357|7518077|FG003|COMPLETED|Period 2||3
6592807|NCT01995357|7518078|FG004|COMPLETED|Period 2||4
6592808|NCT01995357|7518079|FG005|COMPLETED|Period 2||4
6592809|NCT01995357|7518074|FG000|NOT COMPLETED|Period 2||0
6659948|NCT02494817|7590903|FG000|3 Month Assessment|Overall Study|represents 59 couples and 7 partnered men|125
6659949|NCT02494817|7590904|FG001|3 Month Assessment|Overall Study|represents 44 couples and 4 partnered men|92
6659950|NCT02494817|7590903|FG000|6 Month Assessment|Overall Study|represents 52 couples and 11 partnered men|115
6659951|NCT02494817|7590904|FG001|6 Month Assessment|Overall Study|represents 45 couples and 8 partnered men|98
6659952|NCT02494817|7590903|FG000|COMPLETED|Overall Study|49 couples and 9 partnered men completed all 3 assessments (baseline, 3- and 6-month)|107
6659953|NCT02494817|7590904|FG001|COMPLETED|Overall Study|41 couples and 5 partnered men completed all 3 assessments (baseline, 3- and 6-month)|87
6659954|NCT02494817|7590903|FG000|NOT COMPLETED|Overall Study||55
6659955|NCT02494817|7590904|FG001|NOT COMPLETED|Overall Study||49
6659956|NCT02495025|7590912|FG000|STARTED|Overall Study||77
6659957|NCT02495025|7590913|FG001|STARTED|Overall Study||75
6659958|NCT02495025|7590912|FG000|COMPLETED|Overall Study||51
6659959|NCT02495025|7590913|FG001|COMPLETED|Overall Study||61
6659960|NCT02495025|7590912|FG000|NOT COMPLETED|Overall Study||26
6659961|NCT02495025|7590913|FG001|NOT COMPLETED|Overall Study||14
6659962|NCT02495038|7590922|FG000|STARTED|Overall Study||27
6659963|NCT02495038|7590923|FG001|STARTED|Overall Study||27
6659964|NCT02495038|7590924|FG002|STARTED|Overall Study||27
6659965|NCT02495038|7590922|FG000|COMPLETED|Overall Study||27
6659966|NCT02495038|7590923|FG001|COMPLETED|Overall Study||27
6659967|NCT02495038|7590924|FG002|COMPLETED|Overall Study||27
6659968|NCT02495038|7590922|FG000|NOT COMPLETED|Overall Study||0
6592810|NCT01995357|7518075|FG001|NOT COMPLETED|Period 2||0
6592811|NCT01995357|7518076|FG002|NOT COMPLETED|Period 2||0
6592812|NCT01995357|7518077|FG003|NOT COMPLETED|Period 2||0
6592813|NCT01995357|7518078|FG004|NOT COMPLETED|Period 2||0
6592814|NCT01995357|7518079|FG005|NOT COMPLETED|Period 2||0
6592815|NCT01995357|7518074|FG000|STARTED|Period 3||4
6592816|NCT01995357|7518075|FG001|STARTED|Period 3||3
6592817|NCT01995357|7518076|FG002|STARTED|Period 3||4
6592818|NCT01995357|7518077|FG003|STARTED|Period 3||3
6592819|NCT01995357|7518078|FG004|STARTED|Period 3||4
6592820|NCT01995357|7518079|FG005|STARTED|Period 3||4
6592821|NCT01995357|7518074|FG000|COMPLETED|Period 3||4
6592822|NCT01995357|7518075|FG001|COMPLETED|Period 3||3
6592823|NCT01995357|7518076|FG002|COMPLETED|Period 3||4
6592824|NCT01995357|7518077|FG003|COMPLETED|Period 3||3
6592825|NCT01995357|7518078|FG004|COMPLETED|Period 3||4
6592826|NCT01995357|7518079|FG005|COMPLETED|Period 3||4
6592827|NCT01995357|7518074|FG000|NOT COMPLETED|Period 3||0
6592828|NCT01995357|7518075|FG001|NOT COMPLETED|Period 3||0
6592829|NCT01995357|7518076|FG002|NOT COMPLETED|Period 3||0
6592830|NCT01995357|7518077|FG003|NOT COMPLETED|Period 3||0
6592831|NCT01995357|7518078|FG004|NOT COMPLETED|Period 3||0
6592832|NCT01995357|7518079|FG005|NOT COMPLETED|Period 3||0
6592833|NCT01995357|7518074|FG000|STARTED|Period 4||4
6592834|NCT01995357|7518075|FG001|STARTED|Period 4||3
6592835|NCT01995357|7518076|FG002|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
6592836|NCT01995357|7518077|FG003|STARTED|Period 4||3
6659969|NCT02495038|7590923|FG001|NOT COMPLETED|Overall Study||0
6659970|NCT02495038|7590924|FG002|NOT COMPLETED|Overall Study||0
6659971|NCT02495103|7590934|FG000|STARTED|Overall Study||3
6659972|NCT02495103|7590935|FG001|STARTED|Overall Study||4
6659973|NCT02495103|7590934|FG000|COMPLETED|Overall Study||3
6659974|NCT02495103|7590935|FG001|COMPLETED|Overall Study||4
6659975|NCT02495103|7590934|FG000|NOT COMPLETED|Overall Study||0
6659976|NCT02495103|7590935|FG001|NOT COMPLETED|Overall Study||0
6659977|NCT02495168|7590946|FG000|STARTED|Overall Study||504
6659978|NCT02495168|7590947|FG001|STARTED|Overall Study||516
6659979|NCT02495168|7590948|FG002|STARTED|Overall Study||127
6659980|NCT02495168|7590946|FG000|Safety Population|Overall Study||501
6659981|NCT02495168|7590947|FG001|Safety Population|Overall Study||514
6659982|NCT02495168|7590948|FG002|Safety Population|Overall Study||126
6659983|NCT02495168|7590946|FG000|Modified Intent-to-Treat Population|Overall Study||468
6659984|NCT02495168|7590947|FG001|Modified Intent-to-Treat Population|Overall Study||478
6659985|NCT02495168|7590948|FG002|Modified Intent-to-Treat Population|Overall Study||111
6659986|NCT02495168|7590946|FG000|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
6659987|NCT02495168|7590947|FG001|Day1 Per-protocol Set (D1PPS) Population|Overall Study||437
6659988|NCT02495168|7590948|FG002|Day1 Per-protocol Set (D1PPS) Population|Overall Study||99
6659989|NCT02495168|7590946|FG000|Day 42 (D42PPS) Population|Overall Study||382
6659990|NCT02495168|7590947|FG001|Day 42 (D42PPS) Population|Overall Study||383
6659991|NCT02495168|7590948|FG002|Day 42 (D42PPS) Population|Overall Study||88
6659992|NCT02495168|7590946|FG000|COMPLETED|Overall Study||466
6659993|NCT02495168|7590947|FG001|COMPLETED|Overall Study||462
6659994|NCT02495168|7590948|FG002|COMPLETED|Overall Study||110
6659995|NCT02495168|7590946|FG000|NOT COMPLETED|Overall Study||38
6659996|NCT02495168|7590947|FG001|NOT COMPLETED|Overall Study||54
6659997|NCT02495168|7590948|FG002|NOT COMPLETED|Overall Study||17
6659998|NCT02495233|7590958|FG000|STARTED|Overall Study||3
6659999|NCT02495233|7590959|FG001|STARTED|Overall Study||7
6660000|NCT02495233|7590958|FG000|COMPLETED|Overall Study||3
6660001|NCT02495233|7590959|FG001|COMPLETED|Overall Study||6
6660002|NCT02495233|7590958|FG000|NOT COMPLETED|Overall Study||0
6660003|NCT02495233|7590959|FG001|NOT COMPLETED|Overall Study||1
6660004|NCT02495259|7590968|FG000|STARTED|Overall Study||7
6660005|NCT02495259|7590969|FG001|STARTED|Overall Study||4
6660006|NCT02495259|7590970|FG002|STARTED|Overall Study||8
6660007|NCT02495259|7590968|FG000|COMPLETED|Overall Study||7
6660008|NCT02495259|7590969|FG001|COMPLETED|Overall Study||3
6592837|NCT01995357|7518078|FG004|STARTED|Period 4||4
6592838|NCT01995357|7518079|FG005|STARTED|Period 4||4
6592839|NCT01995357|7518074|FG000|COMPLETED|Period 4||4
6592840|NCT01995357|7518075|FG001|COMPLETED|Period 4||3
6592841|NCT01995357|7518076|FG002|COMPLETED|Period 4||4
6592842|NCT01995357|7518077|FG003|COMPLETED|Period 4||3
6592843|NCT01995357|7518078|FG004|COMPLETED|Period 4||4
6660009|NCT02495259|7590970|FG002|COMPLETED|Overall Study||8
6660010|NCT02495259|7590968|FG000|NOT COMPLETED|Overall Study||0
6660011|NCT02495259|7590969|FG001|NOT COMPLETED|Overall Study||1
6592844|NCT01995357|7518079|FG005|COMPLETED|Period 4||4
6592845|NCT01995357|7518074|FG000|NOT COMPLETED|Period 4||0
6592846|NCT01995357|7518075|FG001|NOT COMPLETED|Period 4||0
6592847|NCT01995357|7518076|FG002|NOT COMPLETED|Period 4||0
6592848|NCT01995357|7518077|FG003|NOT COMPLETED|Period 4||0
6592849|NCT01995357|7518078|FG004|NOT COMPLETED|Period 4||0
6592850|NCT01995357|7518079|FG005|NOT COMPLETED|Period 4||0
6592851|NCT01995357|7518074|FG000|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
6592852|NCT01995357|7518075|FG001|STARTED|Period 5||3
6592853|NCT01995357|7518076|FG002|STARTED|Period 5||4
6592854|NCT01995357|7518077|FG003|STARTED|Period 5||3
6592855|NCT01995357|7518078|FG004|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
6592856|NCT01995357|7518079|FG005|STARTED|Period 5||4
6592857|NCT01995357|7518074|FG000|COMPLETED|Period 5||2
6592858|NCT01995357|7518075|FG001|COMPLETED|Period 5||3
6592859|NCT01995357|7518076|FG002|COMPLETED|Period 5||3
6592860|NCT01995357|7518077|FG003|COMPLETED|Period 5||3
6592861|NCT01995357|7518078|FG004|COMPLETED|Period 5||4
6592862|NCT01995357|7518079|FG005|COMPLETED|Period 5||4
6592863|NCT01995357|7518074|FG000|NOT COMPLETED|Period 5||2
6592864|NCT01995357|7518075|FG001|NOT COMPLETED|Period 5||0
6592865|NCT01995357|7518076|FG002|NOT COMPLETED|Period 5||1
6592866|NCT01995357|7518077|FG003|NOT COMPLETED|Period 5||0
6592867|NCT01995357|7518078|FG004|NOT COMPLETED|Period 5||0
6592868|NCT01995357|7518079|FG005|NOT COMPLETED|Period 5||0
6592869|NCT01995461|7518095|FG000|STARTED|Overall Study||26
6592870|NCT01995461|7518095|FG000|COMPLETED|Overall Study||21
6592871|NCT01995461|7518095|FG000|NOT COMPLETED|Overall Study||5
6592872|NCT01995487|7518101|FG000|STARTED|Overall Study||958
6592873|NCT01995487|7518102|FG001|STARTED|Overall Study||961
6592874|NCT01995487|7518101|FG000|COMPLETED|Overall Study||884
6592875|NCT01995487|7518102|FG001|COMPLETED|Overall Study||878
6592876|NCT01995487|7518101|FG000|NOT COMPLETED|Overall Study||74
6592877|NCT01995487|7518102|FG001|NOT COMPLETED|Overall Study||83
6592878|NCT01995513|7518108|FG000|STARTED|Open Label Treatment Period||509
6592879|NCT01995513|7518109|FG001|STARTED|Open Label Treatment Period||0
6592880|NCT01995513|7518110|FG002|STARTED|Open Label Treatment Period||0
6592881|NCT01995513|7518108|FG000|COMPLETED|Open Label Treatment Period||251
6592882|NCT01995513|7518109|FG001|COMPLETED|Open Label Treatment Period||0
6592883|NCT01995513|7518110|FG002|COMPLETED|Open Label Treatment Period||0
6592884|NCT01995513|7518108|FG000|NOT COMPLETED|Open Label Treatment Period||258
6592885|NCT01995513|7518109|FG001|NOT COMPLETED|Open Label Treatment Period||0
6592886|NCT01995513|7518110|FG002|NOT COMPLETED|Open Label Treatment Period||0
6592887|NCT01995513|7518108|FG000|STARTED|Double Blind Treatment Period||0
6592888|NCT01995513|7518109|FG001|STARTED|Double Blind Treatment Period||126
6592889|NCT01995513|7518110|FG002|STARTED|Double Blind Treatment Period||125
6592890|NCT01995513|7518108|FG000|Treated|Double Blind Treatment Period||0
6592891|NCT01995513|7518109|FG001|Treated|Double Blind Treatment Period||125
6592892|NCT01995513|7518110|FG002|Treated|Double Blind Treatment Period||124
6592893|NCT01995513|7518108|FG000|COMPLETED|Double Blind Treatment Period||0
6592894|NCT01995513|7518109|FG001|COMPLETED|Double Blind Treatment Period||0
6592895|NCT01995513|7518110|FG002|COMPLETED|Double Blind Treatment Period||0
6592896|NCT01995513|7518108|FG000|NOT COMPLETED|Double Blind Treatment Period||0
6592897|NCT01995513|7518109|FG001|NOT COMPLETED|Double Blind Treatment Period||126
6592898|NCT01995513|7518110|FG002|NOT COMPLETED|Double Blind Treatment Period||125
6592899|NCT01995526|7518120|FG000|STARTED|Overall Study||11
6592900|NCT01995526|7518120|FG000|Received One Dose of Study Drug|Overall Study||11
6592901|NCT01995526|7518120|FG000|COMPLETED|Overall Study||10
6592902|NCT01995526|7518120|FG000|NOT COMPLETED|Overall Study||1
6592903|NCT01995539|7518124|FG000|STARTED|Overall Study||181
6592904|NCT01995539|7518124|FG000|COMPLETED|Overall Study||148
6592905|NCT01995539|7518124|FG000|NOT COMPLETED|Overall Study||33
6592906|NCT01995552|7518128|FG000|STARTED|Overall Study|There were 249 patients were included for Baseline cohort and 233 in analysis cohort|250
6592907|NCT01995552|7518128|FG000|COMPLETED|Overall Study|There were 233 patients who were eligible for primary objective analysis|233
6592908|NCT01995552|7518128|FG000|NOT COMPLETED|Overall Study||17
6592909|NCT01995825|7518136|FG000|STARTED|Overall Study||18
6592910|NCT01995825|7518137|FG001|STARTED|Overall Study||17
6592911|NCT01995825|7518136|FG000|COMPLETED|Overall Study||17
6391798|NCT00838110|7303729|FG003|Treated|Overall Study||244
6391799|NCT00838110|7303726|FG000|COMPLETED|Overall Study||105
6391800|NCT00838110|7303727|FG001|COMPLETED|Overall Study||106
6592912|NCT01995825|7518137|FG001|COMPLETED|Overall Study||17
6592913|NCT01995825|7518136|FG000|NOT COMPLETED|Overall Study||1
6592914|NCT01995825|7518137|FG001|NOT COMPLETED|Overall Study||0
6592915|NCT01995838|7518150|FG000|STARTED|Overall Study||56
6592916|NCT01995838|7518151|FG001|STARTED|Overall Study||32
6592917|NCT01995838|7518152|FG002|STARTED|Overall Study||27
6592918|NCT01995838|7518153|FG003|STARTED|Overall Study||38
6592919|NCT01995838|7518154|FG004|STARTED|Overall Study||32
6592920|NCT01995838|7518155|FG005|STARTED|Overall Study||56
6592921|NCT01995838|7518156|FG006|STARTED|Overall Study||50
6592922|NCT01995838|7518150|FG000|COMPLETED|Overall Study||51
6592923|NCT01995838|7518151|FG001|COMPLETED|Overall Study||30
6592924|NCT01995838|7518152|FG002|COMPLETED|Overall Study||27
6592925|NCT01995838|7518153|FG003|COMPLETED|Overall Study||36
6592926|NCT01995838|7518154|FG004|COMPLETED|Overall Study||30
6592927|NCT01995838|7518155|FG005|COMPLETED|Overall Study||54
6592928|NCT01995838|7518156|FG006|COMPLETED|Overall Study||45
6592929|NCT01995838|7518150|FG000|NOT COMPLETED|Overall Study||5
6592930|NCT01995838|7518151|FG001|NOT COMPLETED|Overall Study||2
6592931|NCT01995838|7518152|FG002|NOT COMPLETED|Overall Study||0
6592932|NCT01995838|7518153|FG003|NOT COMPLETED|Overall Study||2
6592933|NCT01995838|7518154|FG004|NOT COMPLETED|Overall Study||2
6592934|NCT01995838|7518155|FG005|NOT COMPLETED|Overall Study||2
6592935|NCT01995838|7518156|FG006|NOT COMPLETED|Overall Study||5
6592936|NCT01996033|7518173|FG000|STARTED|Overall Study||25
6592937|NCT01996033|7518173|FG000|COMPLETED|Overall Study||16
6592938|NCT01996033|7518173|FG000|NOT COMPLETED|Overall Study||9
6592939|NCT01996241|7518179|FG000|STARTED|Overall Study||1164
6592940|NCT01996241|7518180|FG001|STARTED|Overall Study||1111
6592941|NCT01996241|7518179|FG000|COMPLETED|Overall Study||912
6592942|NCT01996241|7518180|FG001|COMPLETED|Overall Study||876
6592943|NCT01996241|7518179|FG000|NOT COMPLETED|Overall Study||252
6592944|NCT01996241|7518180|FG001|NOT COMPLETED|Overall Study||235
6592945|NCT01996254|7518190|FG000|STARTED|Overall Study||5
6592946|NCT01996254|7518191|FG001|STARTED|Overall Study||14
6592947|NCT01996254|7518192|FG002|STARTED|Overall Study||14
6592948|NCT01996254|7518190|FG000|Safety Set|Overall Study||5
6592949|NCT01996254|7518191|FG001|Safety Set|Overall Study||14
6592950|NCT01996254|7518192|FG002|Safety Set|Overall Study||14
6592951|NCT01996254|7518190|FG000|Full Analysis Set|Overall Study||0
6592952|NCT01996254|7518191|FG001|Full Analysis Set|Overall Study||12
6592953|NCT01996254|7518192|FG002|Full Analysis Set|Overall Study||14
6592954|NCT01996254|7518190|FG000|Long Term Analysis Set|Overall Study||0
6592955|NCT01996254|7518191|FG001|Long Term Analysis Set|Overall Study||12
6592956|NCT01996254|7518192|FG002|Long Term Analysis Set|Overall Study||14
6592957|NCT01996254|7518190|FG000|Per Protocol Set|Overall Study||0
6592958|NCT01996254|7518191|FG001|Per Protocol Set|Overall Study||10
6592959|NCT01996254|7518192|FG002|Per Protocol Set|Overall Study||13
6592960|NCT01996254|7518190|FG000|COMPLETED|Overall Study||4
6592961|NCT01996254|7518191|FG001|COMPLETED|Overall Study||9
6592962|NCT01996254|7518192|FG002|COMPLETED|Overall Study||6
6592963|NCT01996254|7518190|FG000|NOT COMPLETED|Overall Study||1
6592964|NCT01996254|7518191|FG001|NOT COMPLETED|Overall Study||5
6592965|NCT01996254|7518192|FG002|NOT COMPLETED|Overall Study||8
6624554|NCT02218203|7551986|FG000|Medium Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
6624555|NCT02218203|7551986|FG000|High Dose Dex v. 0mg/km LBM Lidocaine|Overall Study||24
6624556|NCT02218203|7551986|FG000|High Dose Dex v. 1mg/km LBM Lidocaine|Overall Study||24
6624557|NCT02218203|7551986|FG000|High Dose Dex v. 2mg/km LBM Lidocaine|Overall Study||24
6624558|NCT02218203|7551986|FG000|High Dose Dex v. 4mg/km LBM Lidocaine|Overall Study||24
6624559|NCT02218203|7551986|FG000|COMPLETED|Overall Study|2 subjects did not complete the placebo, medium dose, and high dose dex/lido combination arms.|26
6624560|NCT02218203|7551986|FG000|NOT COMPLETED|Overall Study||0
6624561|NCT02218216|7552010|FG000|STARTED|Overall Study||14
6624562|NCT02218216|7552011|FG001|STARTED|Overall Study||2
6624563|NCT02218216|7552012|FG002|STARTED|Overall Study||3
6624564|NCT02218216|7552010|FG000|COMPLETED|Overall Study||8
6624565|NCT02218216|7552011|FG001|COMPLETED|Overall Study||2
6624566|NCT02218216|7552012|FG002|COMPLETED|Overall Study||3
6624567|NCT02218216|7552010|FG000|NOT COMPLETED|Overall Study||6
6624568|NCT02218216|7552011|FG001|NOT COMPLETED|Overall Study||0
6624569|NCT02218216|7552012|FG002|NOT COMPLETED|Overall Study||0
6624570|NCT02218242|7552020|FG000|STARTED|Overall Study||9
6624571|NCT02218242|7552020|FG000|COMPLETED|Overall Study||9
6624572|NCT02218242|7552020|FG000|NOT COMPLETED|Overall Study||0
6624573|NCT02218268|7552024|FG000|STARTED|First Phase (2 Hours)||30
6624574|NCT02218268|7552025|FG001|STARTED|First Phase (2 Hours)||30
6624575|NCT02218268|7552024|FG000|COMPLETED|First Phase (2 Hours)||30
6624576|NCT02218268|7552025|FG001|COMPLETED|First Phase (2 Hours)||30
6624577|NCT02218268|7552024|FG000|NOT COMPLETED|First Phase (2 Hours)||0
6624578|NCT02218268|7552025|FG001|NOT COMPLETED|First Phase (2 Hours)||0
6624579|NCT02218268|7552024|FG000|STARTED|24 Hour Washout||30
6624580|NCT02218268|7552025|FG001|STARTED|24 Hour Washout||30
6624581|NCT02218268|7552024|FG000|COMPLETED|24 Hour Washout||19
6624582|NCT02218268|7552025|FG001|COMPLETED|24 Hour Washout||21
6624583|NCT02218268|7552024|FG000|NOT COMPLETED|24 Hour Washout||11
6624584|NCT02218268|7552025|FG001|NOT COMPLETED|24 Hour Washout||9
6624585|NCT02218268|7552024|FG000|STARTED|Final Phase (2 Hours)||19
6624586|NCT02218268|7552025|FG001|STARTED|Final Phase (2 Hours)||21
6624587|NCT02218268|7552024|FG000|COMPLETED|Final Phase (2 Hours)||19
6624588|NCT02218268|7552025|FG001|COMPLETED|Final Phase (2 Hours)||21
6624589|NCT02218268|7552024|FG000|NOT COMPLETED|Final Phase (2 Hours)||0
6624590|NCT02218268|7552025|FG001|NOT COMPLETED|Final Phase (2 Hours)||0
6624591|NCT02218307|7552033|FG000|STARTED|Overall Study||34
6624592|NCT02218307|7552034|FG001|STARTED|Overall Study||34
6624593|NCT02218307|7552033|FG000|COMPLETED|Overall Study||25
6624594|NCT02218307|7552034|FG001|COMPLETED|Overall Study||33
6624595|NCT02218307|7552033|FG000|NOT COMPLETED|Overall Study||9
6624596|NCT02218307|7552034|FG001|NOT COMPLETED|Overall Study||1
6624597|NCT02218320|7552042|FG000|STARTED|Overall Study|First participant visit on this arm Dec 2014|10
6624598|NCT02218320|7552043|FG001|STARTED|Overall Study|First participant contact on this arm was December 2014|10
6624599|NCT02218320|7552042|FG000|COMPLETED|Overall Study|Last participant contact on this arm was June 2015|10
6660012|NCT02495259|7590970|FG002|NOT COMPLETED|Overall Study||0
6592966|NCT01996319|7518204|FG000|STARTED|Overall Study||96
6592967|NCT01996319|7518205|FG001|STARTED|Overall Study||98
6592968|NCT01996319|7518204|FG000|COMPLETED|Overall Study||88
6592969|NCT01996319|7518205|FG001|COMPLETED|Overall Study||95
6592970|NCT01996319|7518204|FG000|NOT COMPLETED|Overall Study||8
6592971|NCT01996319|7518205|FG001|NOT COMPLETED|Overall Study||3
6592972|NCT01996332|7518211|FG000|STARTED|Overall Study||1805
6592973|NCT01996332|7518211|FG000|COMPLETED|Overall Study||0
6592974|NCT01996332|7518211|FG000|NOT COMPLETED|Overall Study||1805
6592975|NCT01996592|7518215|FG000|STARTED|Overall Study||575
6592976|NCT01996592|7518215|FG000|COMPLETED|Overall Study||530
6592977|NCT01996592|7518215|FG000|NOT COMPLETED|Overall Study||45
6592978|NCT01996644|7518226|FG000|STARTED|Overall Study||20
6592979|NCT01996644|7518227|FG001|STARTED|Overall Study||16
6592980|NCT01996644|7518226|FG000|COMPLETED|Overall Study||20
6592981|NCT01996644|7518227|FG001|COMPLETED|Overall Study||16
6592982|NCT01996644|7518226|FG000|NOT COMPLETED|Overall Study||0
6592983|NCT01996644|7518227|FG001|NOT COMPLETED|Overall Study||0
6592984|NCT01996657|7518239|FG000|STARTED|Overall Study||250
6592985|NCT01996657|7518240|FG001|STARTED|Overall Study||250
6592986|NCT01996657|7518241|FG002|STARTED|Overall Study||248
6592987|NCT01996657|7518239|FG000|COMPLETED|Overall Study||237
6592988|NCT01996657|7518240|FG001|COMPLETED|Overall Study||239
6592989|NCT01996657|7518241|FG002|COMPLETED|Overall Study||234
6592990|NCT01996657|7518239|FG000|NOT COMPLETED|Overall Study||13
6592991|NCT01996657|7518240|FG001|NOT COMPLETED|Overall Study||11
6592992|NCT01996657|7518241|FG002|NOT COMPLETED|Overall Study||14
6592993|NCT01996709|7518251|FG000|STARTED|Overall Study||66
6592994|NCT01996709|7518252|FG001|STARTED|Overall Study||68
6592995|NCT01996709|7518251|FG000|COMPLETED|Overall Study||61
6592996|NCT01996709|7518252|FG001|COMPLETED|Overall Study||67
6592997|NCT01996709|7518251|FG000|NOT COMPLETED|Overall Study||5
6592998|NCT01996709|7518252|FG001|NOT COMPLETED|Overall Study||1
6592999|NCT01996748|7518264|FG000|STARTED|Overall Study||66
6593000|NCT01996748|7518265|FG001|STARTED|Overall Study||69
6593001|NCT01996748|7518264|FG000|COMPLETED|Overall Study||58
6593002|NCT01996748|7518265|FG001|COMPLETED|Overall Study||63
6593003|NCT01996748|7518264|FG000|NOT COMPLETED|Overall Study||8
6593004|NCT01996748|7518265|FG001|NOT COMPLETED|Overall Study||6
6593005|NCT01996813|7518275|FG000|STARTED|Overall Study||23
6593006|NCT01996813|7518276|FG001|STARTED|Overall Study||24
6593007|NCT01996813|7518275|FG000|COMPLETED|Overall Study||23
6593008|NCT01996813|7518276|FG001|COMPLETED|Overall Study||24
6593009|NCT01996813|7518275|FG000|NOT COMPLETED|Overall Study||0
6593010|NCT01996813|7518276|FG001|NOT COMPLETED|Overall Study||0
6593011|NCT01996826|7518284|FG000|STARTED|Overall Study||39
6593012|NCT01996826|7518285|FG001|STARTED|Overall Study||36
6593013|NCT01996826|7518284|FG000|COMPLETED|Overall Study||32
6593014|NCT01996826|7518285|FG001|COMPLETED|Overall Study||33
6593015|NCT01996826|7518284|FG000|NOT COMPLETED|Overall Study||7
6593016|NCT01996826|7518285|FG001|NOT COMPLETED|Overall Study||3
6593017|NCT01996839|7518294|FG000|STARTED|Overall Study||172
6593018|NCT01996839|7518295|FG001|STARTED|Overall Study||171
6593019|NCT01996839|7518296|FG002|STARTED|Overall Study||171
6593020|NCT01996839|7518294|FG000|COMPLETED|Overall Study||80
6593021|NCT01996839|7518295|FG001|COMPLETED|Overall Study||133
6593022|NCT01996839|7518296|FG002|COMPLETED|Overall Study||139
6593023|NCT01996839|7518294|FG000|NOT COMPLETED|Overall Study||92
6593024|NCT01996839|7518295|FG001|NOT COMPLETED|Overall Study||38
6593025|NCT01996839|7518296|FG002|NOT COMPLETED|Overall Study||32
6593026|NCT01996904|7518306|FG000|STARTED|Overall Study||139
6593027|NCT01996904|7518307|FG001|STARTED|Overall Study||117
6593028|NCT01996904|7518306|FG000|COMPLETED|Overall Study||101
6593029|NCT01996904|7518307|FG001|COMPLETED|Overall Study||90
6593030|NCT01996904|7518306|FG000|NOT COMPLETED|Overall Study||38
6593031|NCT01996904|7518307|FG001|NOT COMPLETED|Overall Study||27
6593032|NCT01996917|7518313|FG000|STARTED|Overall Study||21
6593033|NCT01996917|7518313|FG000|COMPLETED|Overall Study||21
6593034|NCT01996917|7518313|FG000|NOT COMPLETED|Overall Study||0
6593035|NCT01996943|7518320|FG000|STARTED|Overall Study||50
6593036|NCT01996943|7518321|FG001|STARTED|Overall Study||50
6593037|NCT01996943|7518320|FG000|COMPLETED|Overall Study||50
6593038|NCT01996943|7518321|FG001|COMPLETED|Overall Study||50
6593039|NCT01996943|7518320|FG000|NOT COMPLETED|Overall Study||0
6593040|NCT01996943|7518321|FG001|NOT COMPLETED|Overall Study||0
6593041|NCT01997125|7518327|FG000|STARTED|Overall Study||1
6593042|NCT01997125|7518327|FG000|COMPLETED|Overall Study||1
6593043|NCT01997125|7518327|FG000|NOT COMPLETED|Overall Study||0
6593044|NCT01997216|7518331|FG000|STARTED|First 9 Hours||18
6593045|NCT01997216|7518332|FG001|STARTED|First 9 Hours||21
6593046|NCT01997216|7518331|FG000|COMPLETED|First 9 Hours||18
6593047|NCT01997216|7518332|FG001|COMPLETED|First 9 Hours||21
6593048|NCT01997216|7518331|FG000|NOT COMPLETED|First 9 Hours||0
6593049|NCT01997216|7518332|FG001|NOT COMPLETED|First 9 Hours||0
6593050|NCT01997216|7518331|FG000|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
6593051|NCT01997216|7518332|FG001|STARTED|Second 9 Hours||21
6593052|NCT01997216|7518331|FG000|COMPLETED|Second 9 Hours||19
6593053|NCT01997216|7518332|FG001|COMPLETED|Second 9 Hours||21
6593054|NCT01997216|7518331|FG000|NOT COMPLETED|Second 9 Hours||0
6593055|NCT01997216|7518332|FG001|NOT COMPLETED|Second 9 Hours||0
6593056|NCT01997229|7518340|FG000|STARTED|Overall Study||62
6593057|NCT01997229|7518341|FG001|STARTED|Overall Study||63
6593058|NCT01997229|7518340|FG000|COMPLETED|Overall Study||57
6593059|NCT01997229|7518341|FG001|COMPLETED|Overall Study||61
6593060|NCT01997229|7518340|FG000|NOT COMPLETED|Overall Study||5
6593061|NCT01997229|7518341|FG001|NOT COMPLETED|Overall Study||2
6593062|NCT01997281|7518349|FG000|STARTED|Overall Study||7
6593063|NCT01997281|7518350|FG001|STARTED|Overall Study||7
6593064|NCT01997281|7518349|FG000|Withdrawal|Overall Study||1
6593065|NCT01997281|7518350|FG001|Withdrawal|Overall Study||0
6593066|NCT01997281|7518349|FG000|COMPLETED|Overall Study||6
6593067|NCT01997281|7518350|FG001|COMPLETED|Overall Study||7
6593068|NCT01997281|7518349|FG000|NOT COMPLETED|Overall Study||1
6593069|NCT01997281|7518350|FG001|NOT COMPLETED|Overall Study||0
6593070|NCT01997333|7518358|FG000|STARTED|Randomization and Treatment||109
6593071|NCT01997333|7518359|FG001|STARTED|Randomization and Treatment||218
6593072|NCT01997333|7518358|FG000|COMPLETED|Randomization and Treatment||6
6593073|NCT01997333|7518359|FG001|COMPLETED|Randomization and Treatment||15
6593074|NCT01997333|7518358|FG000|NOT COMPLETED|Randomization and Treatment||103
6593075|NCT01997333|7518359|FG001|NOT COMPLETED|Randomization and Treatment||203
6593076|NCT01997333|7518358|FG000|STARTED|Survival Follow up||92
6593077|NCT01997333|7518359|FG001|STARTED|Survival Follow up||213
6593078|NCT01997333|7518358|FG000|COMPLETED|Survival Follow up||76
6593079|NCT01997333|7518359|FG001|COMPLETED|Survival Follow up||199
6593080|NCT01997333|7518358|FG000|NOT COMPLETED|Survival Follow up||16
6593081|NCT01997333|7518359|FG001|NOT COMPLETED|Survival Follow up||14
6593082|NCT01997398|7518367|FG000|STARTED|Overall Study||35
6593083|NCT01997398|7518367|FG000|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
6593084|NCT01997398|7518367|FG000|NOT COMPLETED|Overall Study||1
6593085|NCT01997411|7518381|FG000|STARTED|Overall Study||6
6593086|NCT01997411|7518382|FG001|STARTED|Overall Study||6
6593087|NCT01997411|7518383|FG002|STARTED|Overall Study||6
6593088|NCT01997411|7518384|FG003|STARTED|Overall Study||6
6593089|NCT01997411|7518385|FG004|STARTED|Overall Study||6
6593090|NCT01997411|7518386|FG005|STARTED|Overall Study||6
6593091|NCT01997411|7518387|FG006|STARTED|Overall Study||6
6593092|NCT01997411|7518388|FG007|STARTED|Overall Study||6
6593093|NCT01997411|7518381|FG000|COMPLETED|Overall Study||6
6593094|NCT01997411|7518382|FG001|COMPLETED|Overall Study||6
6593095|NCT01997411|7518383|FG002|COMPLETED|Overall Study||6
6593096|NCT01997411|7518384|FG003|COMPLETED|Overall Study||6
6593097|NCT01997411|7518385|FG004|COMPLETED|Overall Study||6
6593098|NCT01997411|7518386|FG005|COMPLETED|Overall Study||5
6593099|NCT01997411|7518387|FG006|COMPLETED|Overall Study||6
6593100|NCT01997411|7518388|FG007|COMPLETED|Overall Study||6
6593101|NCT01997411|7518381|FG000|NOT COMPLETED|Overall Study||0
6593102|NCT01997411|7518382|FG001|NOT COMPLETED|Overall Study||0
6593103|NCT01997411|7518383|FG002|NOT COMPLETED|Overall Study||0
6593104|NCT01997411|7518384|FG003|NOT COMPLETED|Overall Study||0
6593105|NCT01997411|7518385|FG004|NOT COMPLETED|Overall Study||0
6593106|NCT01997411|7518386|FG005|NOT COMPLETED|Overall Study||1
6593107|NCT01997411|7518387|FG006|NOT COMPLETED|Overall Study||0
6593108|NCT01997411|7518388|FG007|NOT COMPLETED|Overall Study||0
6593109|NCT01997437|7518406|FG000|STARTED|Overall Study||6
6593110|NCT01997437|7518406|FG000|COMPLETED|Overall Study||6
6593111|NCT01997437|7518406|FG000|NOT COMPLETED|Overall Study||0
6593112|NCT01997515|7518412|FG000|STARTED|Overall Study||40
6593113|NCT01997515|7518413|FG001|STARTED|Overall Study||40
6593114|NCT01997515|7518412|FG000|COMPLETED|Overall Study||36
6593115|NCT01997515|7518413|FG001|COMPLETED|Overall Study||35
6593116|NCT01997515|7518412|FG000|NOT COMPLETED|Overall Study||4
6593117|NCT01997515|7518413|FG001|NOT COMPLETED|Overall Study||5
6593118|NCT01997723|7518419|FG000|STARTED|Overall Study||75
6593119|NCT01997723|7518419|FG000|COMPLETED|Overall Study||75
6593120|NCT01997723|7518419|FG000|NOT COMPLETED|Overall Study||0
6593121|NCT01997892|7518423|FG000|STARTED|Overall Study||1027
6593122|NCT01997892|7518423|FG000|Received Darbepoetin Alfa|Overall Study||987
6593123|NCT01997892|7518423|FG000|COMPLETED|Overall Study||959
6593124|NCT01997892|7518423|FG000|NOT COMPLETED|Overall Study||68
6593125|NCT01997905|7518432|FG000|STARTED|Overall Study||13
6593126|NCT01997905|7518432|FG000|Baseline Completed|Overall Study||11
6593127|NCT01997905|7518432|FG000|COMPLETED|Overall Study||10
6593128|NCT01997905|7518432|FG000|NOT COMPLETED|Overall Study||3
6593129|NCT01998243|7518438|FG000|STARTED|Overall Study||42
6593130|NCT01998243|7518439|FG001|STARTED|Overall Study||39
6593131|NCT01998243|7518438|FG000|COMPLETED|Overall Study||34
6660013|NCT02495389|7590978|FG000|STARTED|Overall Study||84
6660014|NCT02495389|7590978|FG000|COMPLETED|Overall Study||44
6593132|NCT01998243|7518439|FG001|COMPLETED|Overall Study||32
6593133|NCT01998243|7518438|FG000|NOT COMPLETED|Overall Study||8
6593134|NCT01998243|7518439|FG001|NOT COMPLETED|Overall Study||7
6593135|NCT01998269|7518447|FG000|STARTED|Overall Study||193
6593136|NCT01998269|7518447|FG000|COMPLETED|Overall Study||193
6593137|NCT01998269|7518447|FG000|NOT COMPLETED|Overall Study||0
6593138|NCT01998360|7518453|FG000|STARTED|Overall Study||50
6593139|NCT01998360|7518454|FG001|STARTED|Overall Study||50
6593140|NCT01998360|7518453|FG000|COMPLETED|Overall Study||50
6593141|NCT01998360|7518454|FG001|COMPLETED|Overall Study||50
6593142|NCT01998360|7518453|FG000|NOT COMPLETED|Overall Study||0
6593143|NCT01998360|7518454|FG001|NOT COMPLETED|Overall Study||0
6593144|NCT01998399|7518462|FG000|STARTED|Overall Study||12
6593145|NCT01998399|7518463|FG001|STARTED|Overall Study||13
6593146|NCT01998399|7518462|FG000|COMPLETED|Overall Study||4
6593147|NCT01998399|7518463|FG001|COMPLETED|Overall Study||4
6593148|NCT01998399|7518462|FG000|NOT COMPLETED|Overall Study||8
6593149|NCT01998399|7518463|FG001|NOT COMPLETED|Overall Study||9
6593150|NCT01998438|7518472|FG000|STARTED|Overall Study||319
6593151|NCT01998438|7518473|FG001|STARTED|Overall Study||318
6593152|NCT01998438|7518474|FG002|STARTED|Overall Study||318
6593153|NCT01998438|7518472|FG000|COMPLETED|Overall Study||319
6593154|NCT01998438|7518473|FG001|COMPLETED|Overall Study||318
6593155|NCT01998438|7518474|FG002|COMPLETED|Overall Study||318
6593156|NCT01998438|7518472|FG000|NOT COMPLETED|Overall Study||0
6593157|NCT01998438|7518473|FG001|NOT COMPLETED|Overall Study||0
6593158|NCT01998438|7518474|FG002|NOT COMPLETED|Overall Study||0
6593159|NCT01998477|7518484|FG000|STARTED|Overall Study||282
6593160|NCT01998477|7518485|FG001|STARTED|Overall Study||148
6593161|NCT01998477|7518484|FG000|COMPLETED|Overall Study||272
6593162|NCT01998477|7518485|FG001|COMPLETED|Overall Study||143
6593163|NCT01998477|7518484|FG000|NOT COMPLETED|Overall Study||10
6593164|NCT01998477|7518485|FG001|NOT COMPLETED|Overall Study||5
6593165|NCT01998581|7518518|FG000|STARTED|Overall Study||169
6593166|NCT01998581|7518519|FG001|STARTED|Overall Study||56
6593167|NCT01998581|7518518|FG000|COMPLETED|Overall Study||123
6593168|NCT01998581|7518519|FG001|COMPLETED|Overall Study||44
6593169|NCT01998581|7518518|FG000|NOT COMPLETED|Overall Study||46
6593170|NCT01998581|7518519|FG001|NOT COMPLETED|Overall Study||12
6593171|NCT01998633|7518528|FG000|STARTED|Overall Study||47
6593172|NCT01998633|7518528|FG000|COMPLETED|Overall Study||46
6593173|NCT01998633|7518528|FG000|NOT COMPLETED|Overall Study||1
6593174|NCT01998737|7518538|FG000|STARTED|Overall Study||911
6593175|NCT01998737|7518539|FG001|STARTED|Overall Study||100
6593176|NCT01998737|7518538|FG000|COMPLETED|Overall Study||888
6593177|NCT01998737|7518539|FG001|COMPLETED|Overall Study||100
6593178|NCT01998737|7518538|FG000|NOT COMPLETED|Overall Study||23
6593179|NCT01998737|7518539|FG001|NOT COMPLETED|Overall Study||0
6593180|NCT01998880|7518547|FG000|STARTED|Overall Study||233
6593181|NCT01998880|7518548|FG001|STARTED|Overall Study||118
6593182|NCT01998880|7518547|FG000|Received Study Drug|Overall Study||230
6593183|NCT01998880|7518548|FG001|Received Study Drug|Overall Study||116
6593184|NCT01998880|7518547|FG000|COMPLETED|Overall Study|Completed=Completed treatment.|205
6593185|NCT01998880|7518548|FG001|COMPLETED|Overall Study||78
6593186|NCT01998880|7518547|FG000|NOT COMPLETED|Overall Study||28
6593187|NCT01998880|7518548|FG001|NOT COMPLETED|Overall Study||40
6593188|NCT01998893|7518554|FG000|STARTED|Overall Study||38
6593189|NCT01998893|7518554|FG000|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
6593190|NCT01998893|7518554|FG000|2nd Treatment Cycle Started|Overall Study||5
6593191|NCT01998893|7518554|FG000|2nd Treatment Cycle Completed Until PD|Overall Study||3
6593192|NCT01998893|7518554|FG000|COMPLETED|Overall Study||21
6593193|NCT01998893|7518554|FG000|NOT COMPLETED|Overall Study||17
6593194|NCT01998906|7518561|FG000|STARTED|Overall Study||115
6593195|NCT01998906|7518562|FG001|STARTED|Overall Study||116
6593196|NCT01998906|7518563|FG002|STARTED|Overall Study||99
6593197|NCT01998906|7518561|FG000|COMPLETED|Overall Study||1
6593198|NCT01998906|7518562|FG001|COMPLETED|Overall Study||2
6593199|NCT01998906|7518563|FG002|COMPLETED|Overall Study||1
6593200|NCT01998906|7518561|FG000|NOT COMPLETED|Overall Study||114
6593201|NCT01998906|7518562|FG001|NOT COMPLETED|Overall Study||114
6593202|NCT01998906|7518563|FG002|NOT COMPLETED|Overall Study||98
6593203|NCT01998919|7518576|FG000|STARTED|Overall Study||79
6593204|NCT01998919|7518577|FG001|STARTED|Overall Study||74
6593205|NCT01998919|7518576|FG000|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
6593206|NCT01998919|7518577|FG001|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
6593207|NCT01998919|7518576|FG000|COMPLETED|Overall Study||37
6593208|NCT01998919|7518577|FG001|COMPLETED|Overall Study||39
6593209|NCT01998919|7518576|FG000|NOT COMPLETED|Overall Study||42
6593210|NCT01998919|7518577|FG001|NOT COMPLETED|Overall Study||35
6593211|NCT01998958|7518590|FG000|STARTED|Period 1 (Panel A and B)||33
6593212|NCT01998958|7518591|FG001|STARTED|Period 1 (Panel A and B)||11
6593213|NCT01998958|7518592|FG002|STARTED|Period 1 (Panel A and B)||11
6593214|NCT01998958|7518593|FG003|STARTED|Period 1 (Panel A and B)||12
6593215|NCT01998958|7518594|FG004|STARTED|Period 1 (Panel A and B)||21
6593216|NCT01998958|7518595|FG005|STARTED|Period 1 (Panel A and B)||11
6593217|NCT01998958|7518596|FG006|STARTED|Period 1 (Panel A and B)||9
6593218|NCT01998958|7518597|FG007|STARTED|Period 1 (Panel A and B)||0
6593219|NCT01998958|7518598|FG008|STARTED|Period 1 (Panel A and B)||0
6593220|NCT01998958|7518599|FG009|STARTED|Period 1 (Panel A and B)||0
6593221|NCT01998958|7518600|FG010|STARTED|Period 1 (Panel A and B)||0
6593222|NCT01998958|7518601|FG011|STARTED|Period 1 (Panel A and B)||0
6593223|NCT01998958|7518602|FG012|STARTED|Period 1 (Panel A and B)||0
6593224|NCT01998958|7518603|FG013|STARTED|Period 1 (Panel A and B)||0
6593225|NCT01998958|7518604|FG014|STARTED|Period 1 (Panel A and B)||0
6593226|NCT01998958|7518605|FG015|STARTED|Period 1 (Panel A and B)||0
6593227|NCT01998958|7518606|FG016|STARTED|Period 1 (Panel A and B)||0
6593228|NCT01998958|7518607|FG017|STARTED|Period 1 (Panel A and B)||0
6660015|NCT02495389|7590978|FG000|NOT COMPLETED|Overall Study||40
6660016|NCT02495454|7590982|FG000|STARTED|Overall Study||34
6593229|NCT01998958|7518608|FG018|STARTED|Period 1 (Panel A and B)||0
6593230|NCT01998958|7518609|FG019|STARTED|Period 1 (Panel A and B)||0
6593231|NCT01998958|7518610|FG020|STARTED|Period 1 (Panel A and B)||0
6593232|NCT01998958|7518611|FG021|STARTED|Period 1 (Panel A and B)||0
6593233|NCT01998958|7518612|FG022|STARTED|Period 1 (Panel A and B)||0
6593234|NCT01998958|7518613|FG023|STARTED|Period 1 (Panel A and B)||0
6593235|NCT01998958|7518614|FG024|STARTED|Period 1 (Panel A and B)||0
6593236|NCT01998958|7518615|FG025|STARTED|Period 1 (Panel A and B)||0
6593237|NCT01998958|7518616|FG026|STARTED|Period 1 (Panel A and B)||0
6593238|NCT01998958|7518617|FG027|STARTED|Period 1 (Panel A and B)||0
6593239|NCT01998958|7518618|FG028|STARTED|Period 1 (Panel A and B)||0
6593240|NCT01998958|7518619|FG029|STARTED|Period 1 (Panel A and B)||0
6593241|NCT01998958|7518620|FG030|STARTED|Period 1 (Panel A and B)||0
6593242|NCT01998958|7518621|FG031|STARTED|Period 1 (Panel A and B)||0
6593243|NCT01998958|7518590|FG000|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||9
6593244|NCT01998958|7518591|FG001|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593245|NCT01998958|7518592|FG002|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593246|NCT01998958|7518593|FG003|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593247|NCT01998958|7518594|FG004|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593248|NCT01998958|7518595|FG005|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593249|NCT01998958|7518596|FG006|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593250|NCT01998958|7518597|FG007|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593251|NCT01998958|7518598|FG008|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593252|NCT01998958|7518599|FG009|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593253|NCT01998958|7518600|FG010|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593254|NCT01998958|7518601|FG011|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593255|NCT01998958|7518602|FG012|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593256|NCT01998958|7518603|FG013|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593257|NCT01998958|7518604|FG014|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593258|NCT01998958|7518605|FG015|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593259|NCT01998958|7518606|FG016|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593260|NCT01998958|7518607|FG017|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593261|NCT01998958|7518608|FG018|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593262|NCT01998958|7518609|FG019|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593263|NCT01998958|7518610|FG020|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593264|NCT01998958|7518611|FG021|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593265|NCT01998958|7518612|FG022|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593266|NCT01998958|7518613|FG023|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593267|NCT01998958|7518614|FG024|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593268|NCT01998958|7518615|FG025|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593269|NCT01998958|7518616|FG026|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593270|NCT01998958|7518617|FG027|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593271|NCT01998958|7518618|FG028|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593272|NCT01998958|7518619|FG029|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593273|NCT01998958|7518620|FG030|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593274|NCT01998958|7518621|FG031|Rerandomized to Esketamine 56 mg|Period 1 (Panel A and B)||0
6593275|NCT01998958|7518590|FG000|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||8
6593276|NCT01998958|7518591|FG001|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593277|NCT01998958|7518592|FG002|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593278|NCT01998958|7518593|FG003|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593279|NCT01998958|7518594|FG004|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593280|NCT01998958|7518595|FG005|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593281|NCT01998958|7518596|FG006|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593282|NCT01998958|7518597|FG007|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593283|NCT01998958|7518598|FG008|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593284|NCT01998958|7518599|FG009|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593285|NCT01998958|7518600|FG010|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593286|NCT01998958|7518601|FG011|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593287|NCT01998958|7518602|FG012|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593288|NCT01998958|7518603|FG013|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593289|NCT01998958|7518604|FG014|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593290|NCT01998958|7518605|FG015|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593291|NCT01998958|7518606|FG016|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593292|NCT01998958|7518607|FG017|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593293|NCT01998958|7518608|FG018|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593294|NCT01998958|7518609|FG019|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593295|NCT01998958|7518610|FG020|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593296|NCT01998958|7518611|FG021|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593297|NCT01998958|7518612|FG022|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593298|NCT01998958|7518613|FG023|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593299|NCT01998958|7518614|FG024|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593300|NCT01998958|7518615|FG025|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593301|NCT01998958|7518616|FG026|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593302|NCT01998958|7518617|FG027|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593303|NCT01998958|7518618|FG028|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593304|NCT01998958|7518619|FG029|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593305|NCT01998958|7518620|FG030|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593306|NCT01998958|7518621|FG031|Rerandomized to Esketamine 28mg|Period 1 (Panel A and B)||0
6593307|NCT01998958|7518590|FG000|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||5
6593308|NCT01998958|7518591|FG001|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593309|NCT01998958|7518592|FG002|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593310|NCT01998958|7518593|FG003|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593311|NCT01998958|7518594|FG004|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593312|NCT01998958|7518595|FG005|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593313|NCT01998958|7518596|FG006|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593314|NCT01998958|7518597|FG007|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593315|NCT01998958|7518598|FG008|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593316|NCT01998958|7518599|FG009|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593317|NCT01998958|7518600|FG010|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593318|NCT01998958|7518601|FG011|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593319|NCT01998958|7518602|FG012|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593320|NCT01998958|7518603|FG013|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593321|NCT01998958|7518604|FG014|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593322|NCT01998958|7518605|FG015|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593323|NCT01998958|7518606|FG016|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593324|NCT01998958|7518607|FG017|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593325|NCT01998958|7518608|FG018|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593326|NCT01998958|7518609|FG019|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593327|NCT01998958|7518610|FG020|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593328|NCT01998958|7518611|FG021|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593329|NCT01998958|7518612|FG022|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593330|NCT01998958|7518613|FG023|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593331|NCT01998958|7518614|FG024|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593332|NCT01998958|7518615|FG025|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593333|NCT01998958|7518616|FG026|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593334|NCT01998958|7518617|FG027|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593335|NCT01998958|7518618|FG028|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593336|NCT01998958|7518619|FG029|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593337|NCT01998958|7518620|FG030|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593338|NCT01998958|7518621|FG031|Rerandomized to Esketamine 84mg|Period 1 (Panel A and B)||0
6593339|NCT01998958|7518590|FG000|COMPLETED|Period 1 (Panel A and B)||32
6593340|NCT01998958|7518591|FG001|COMPLETED|Period 1 (Panel A and B)||8
6593341|NCT01998958|7518592|FG002|COMPLETED|Period 1 (Panel A and B)||11
6593342|NCT01998958|7518593|FG003|COMPLETED|Period 1 (Panel A and B)||12
6593343|NCT01998958|7518594|FG004|COMPLETED|Period 1 (Panel A and B)||21
6593344|NCT01998958|7518595|FG005|COMPLETED|Period 1 (Panel A and B)||11
6593345|NCT01998958|7518596|FG006|COMPLETED|Period 1 (Panel A and B)||9
6593346|NCT01998958|7518597|FG007|COMPLETED|Period 1 (Panel A and B)||0
6593347|NCT01998958|7518598|FG008|COMPLETED|Period 1 (Panel A and B)||0
6593348|NCT01998958|7518599|FG009|COMPLETED|Period 1 (Panel A and B)||0
6593349|NCT01998958|7518600|FG010|COMPLETED|Period 1 (Panel A and B)||0
6593350|NCT01998958|7518601|FG011|COMPLETED|Period 1 (Panel A and B)||0
6593351|NCT01998958|7518602|FG012|COMPLETED|Period 1 (Panel A and B)||0
6593352|NCT01998958|7518603|FG013|COMPLETED|Period 1 (Panel A and B)||0
6593353|NCT01998958|7518604|FG014|COMPLETED|Period 1 (Panel A and B)||0
6593354|NCT01998958|7518605|FG015|COMPLETED|Period 1 (Panel A and B)||0
6593355|NCT01998958|7518606|FG016|COMPLETED|Period 1 (Panel A and B)||0
6593356|NCT01998958|7518607|FG017|COMPLETED|Period 1 (Panel A and B)||0
6593357|NCT01998958|7518608|FG018|COMPLETED|Period 1 (Panel A and B)||0
6593358|NCT01998958|7518609|FG019|COMPLETED|Period 1 (Panel A and B)||0
6593359|NCT01998958|7518610|FG020|COMPLETED|Period 1 (Panel A and B)||0
6593360|NCT01998958|7518611|FG021|COMPLETED|Period 1 (Panel A and B)||0
6593361|NCT01998958|7518612|FG022|COMPLETED|Period 1 (Panel A and B)||0
6593362|NCT01998958|7518613|FG023|COMPLETED|Period 1 (Panel A and B)||0
6660017|NCT02495454|7590982|FG000|COMPLETED|Overall Study|One case excluded for violation of inclusion criteria (transformed lymphoma)|33
6660018|NCT02495454|7590982|FG000|NOT COMPLETED|Overall Study||1
6660019|NCT02495467|7590989|FG000|STARTED|First Intervention (4 Weeks)||114
6660020|NCT02495467|7590990|FG001|STARTED|First Intervention (4 Weeks)||118
6660021|NCT02495467|7590989|FG000|COMPLETED|First Intervention (4 Weeks)||114
6660022|NCT02495467|7590990|FG001|COMPLETED|First Intervention (4 Weeks)|One subject completed visits in treatment Period 1 but never used treatment|118
6660023|NCT02495467|7590989|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6660024|NCT02495467|7590990|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6660025|NCT02495467|7590989|FG000|STARTED|Washout (1 Week)||114
6660026|NCT02495467|7590990|FG001|STARTED|Washout (1 Week)||118
6660027|NCT02495467|7590989|FG000|COMPLETED|Washout (1 Week)||112
6660028|NCT02495467|7590990|FG001|COMPLETED|Washout (1 Week)||116
6660029|NCT02495467|7590989|FG000|NOT COMPLETED|Washout (1 Week)||2
6660030|NCT02495467|7590990|FG001|NOT COMPLETED|Washout (1 Week)||2
6660031|NCT02495467|7590989|FG000|STARTED|Second Intervention (4 Weeks)||112
6660032|NCT02495467|7590990|FG001|STARTED|Second Intervention (4 Weeks)||116
6593363|NCT01998958|7518614|FG024|COMPLETED|Period 1 (Panel A and B)||0
6593364|NCT01998958|7518615|FG025|COMPLETED|Period 1 (Panel A and B)||0
6593365|NCT01998958|7518616|FG026|COMPLETED|Period 1 (Panel A and B)||0
6593366|NCT01998958|7518617|FG027|COMPLETED|Period 1 (Panel A and B)||0
6593367|NCT01998958|7518618|FG028|COMPLETED|Period 1 (Panel A and B)||0
6593368|NCT01998958|7518619|FG029|COMPLETED|Period 1 (Panel A and B)||0
6593369|NCT01998958|7518620|FG030|COMPLETED|Period 1 (Panel A and B)||0
6593370|NCT01998958|7518621|FG031|COMPLETED|Period 1 (Panel A and B)||0
6593371|NCT01998958|7518590|FG000|NOT COMPLETED|Period 1 (Panel A and B)||1
6593372|NCT01998958|7518591|FG001|NOT COMPLETED|Period 1 (Panel A and B)||3
6593373|NCT01998958|7518592|FG002|NOT COMPLETED|Period 1 (Panel A and B)||0
6593374|NCT01998958|7518593|FG003|NOT COMPLETED|Period 1 (Panel A and B)||0
6593375|NCT01998958|7518594|FG004|NOT COMPLETED|Period 1 (Panel A and B)||0
6593376|NCT01998958|7518595|FG005|NOT COMPLETED|Period 1 (Panel A and B)||0
6593377|NCT01998958|7518596|FG006|NOT COMPLETED|Period 1 (Panel A and B)||0
6593378|NCT01998958|7518597|FG007|NOT COMPLETED|Period 1 (Panel A and B)||0
6593379|NCT01998958|7518598|FG008|NOT COMPLETED|Period 1 (Panel A and B)||0
6593380|NCT01998958|7518599|FG009|NOT COMPLETED|Period 1 (Panel A and B)||0
6593381|NCT01998958|7518600|FG010|NOT COMPLETED|Period 1 (Panel A and B)||0
6593382|NCT01998958|7518601|FG011|NOT COMPLETED|Period 1 (Panel A and B)||0
6593383|NCT01998958|7518602|FG012|NOT COMPLETED|Period 1 (Panel A and B)||0
6593384|NCT01998958|7518603|FG013|NOT COMPLETED|Period 1 (Panel A and B)||0
6593385|NCT01998958|7518604|FG014|NOT COMPLETED|Period 1 (Panel A and B)||0
6593386|NCT01998958|7518605|FG015|NOT COMPLETED|Period 1 (Panel A and B)||0
6593387|NCT01998958|7518606|FG016|NOT COMPLETED|Period 1 (Panel A and B)||0
6593388|NCT01998958|7518607|FG017|NOT COMPLETED|Period 1 (Panel A and B)||0
6593389|NCT01998958|7518608|FG018|NOT COMPLETED|Period 1 (Panel A and B)||0
6593390|NCT01998958|7518609|FG019|NOT COMPLETED|Period 1 (Panel A and B)||0
6593391|NCT01998958|7518610|FG020|NOT COMPLETED|Period 1 (Panel A and B)||0
6593392|NCT01998958|7518611|FG021|NOT COMPLETED|Period 1 (Panel A and B)||0
6593393|NCT01998958|7518612|FG022|NOT COMPLETED|Period 1 (Panel A and B)||0
6593394|NCT01998958|7518613|FG023|NOT COMPLETED|Period 1 (Panel A and B)||0
6593395|NCT01998958|7518614|FG024|NOT COMPLETED|Period 1 (Panel A and B)||0
6593396|NCT01998958|7518615|FG025|NOT COMPLETED|Period 1 (Panel A and B)||0
6593397|NCT01998958|7518616|FG026|NOT COMPLETED|Period 1 (Panel A and B)||0
6593398|NCT01998958|7518617|FG027|NOT COMPLETED|Period 1 (Panel A and B)||0
6593399|NCT01998958|7518618|FG028|NOT COMPLETED|Period 1 (Panel A and B)||0
6593400|NCT01998958|7518619|FG029|NOT COMPLETED|Period 1 (Panel A and B)||0
6593401|NCT01998958|7518620|FG030|NOT COMPLETED|Period 1 (Panel A and B)||0
6593402|NCT01998958|7518621|FG031|NOT COMPLETED|Period 1 (Panel A and B)||0
6593403|NCT01998958|7518590|FG000|STARTED|Period 2 (Panel A and B)||0
6593404|NCT01998958|7518591|FG001|STARTED|Period 2 (Panel A and B)||0
6593405|NCT01998958|7518592|FG002|STARTED|Period 2 (Panel A and B)||0
6593406|NCT01998958|7518593|FG003|STARTED|Period 2 (Panel A and B)||0
6593407|NCT01998958|7518594|FG004|STARTED|Period 2 (Panel A and B)||0
6593408|NCT01998958|7518595|FG005|STARTED|Period 2 (Panel A and B)||0
6593409|NCT01998958|7518596|FG006|STARTED|Period 2 (Panel A and B)||0
6593410|NCT01998958|7518597|FG007|STARTED|Period 2 (Panel A and B)||6
6593411|NCT01998958|7518598|FG008|STARTED|Period 2 (Panel A and B)||4
6593412|NCT01998958|7518599|FG009|STARTED|Period 2 (Panel A and B)||8
6593413|NCT01998958|7518600|FG010|STARTED|Period 2 (Panel A and B)||9
6593414|NCT01998958|7518601|FG011|STARTED|Period 2 (Panel A and B)||5
6593415|NCT01998958|7518602|FG012|STARTED|Period 2 (Panel A and B)||8
6593416|NCT01998958|7518603|FG013|STARTED|Period 2 (Panel A and B)||11
6593417|NCT01998958|7518604|FG014|STARTED|Period 2 (Panel A and B)||12
6593418|NCT01998958|7518605|FG015|STARTED|Period 2 (Panel A and B)||5
6593419|NCT01998958|7518606|FG016|STARTED|Period 2 (Panel A and B)||8
6593420|NCT01998958|7518607|FG017|STARTED|Period 2 (Panel A and B)||5
6593421|NCT01998958|7518608|FG018|STARTED|Period 2 (Panel A and B)||3
6593422|NCT01998958|7518609|FG019|STARTED|Period 2 (Panel A and B)||11
6593423|NCT01998958|7518610|FG020|STARTED|Period 2 (Panel A and B)||9
6593424|NCT01998958|7518611|FG021|STARTED|Period 2 (Panel A and B)||0
6593425|NCT01998958|7518612|FG022|STARTED|Period 2 (Panel A and B)||0
6593426|NCT01998958|7518613|FG023|STARTED|Period 2 (Panel A and B)||0
6593427|NCT01998958|7518614|FG024|STARTED|Period 2 (Panel A and B)||0
6593428|NCT01998958|7518615|FG025|STARTED|Period 2 (Panel A and B)||0
6593429|NCT01998958|7518616|FG026|STARTED|Period 2 (Panel A and B)||0
6593430|NCT01998958|7518617|FG027|STARTED|Period 2 (Panel A and B)||0
6593431|NCT01998958|7518618|FG028|STARTED|Period 2 (Panel A and B)||0
6593432|NCT01998958|7518619|FG029|STARTED|Period 2 (Panel A and B)||0
6593433|NCT01998958|7518620|FG030|STARTED|Period 2 (Panel A and B)||0
6593434|NCT01998958|7518621|FG031|STARTED|Period 2 (Panel A and B)||0
6593435|NCT01998958|7518590|FG000|COMPLETED|Period 2 (Panel A and B)||0
6593436|NCT01998958|7518591|FG001|COMPLETED|Period 2 (Panel A and B)||0
6593437|NCT01998958|7518592|FG002|COMPLETED|Period 2 (Panel A and B)||0
6593438|NCT01998958|7518593|FG003|COMPLETED|Period 2 (Panel A and B)||0
6593439|NCT01998958|7518594|FG004|COMPLETED|Period 2 (Panel A and B)||0
6593440|NCT01998958|7518595|FG005|COMPLETED|Period 2 (Panel A and B)||0
6593441|NCT01998958|7518596|FG006|COMPLETED|Period 2 (Panel A and B)||0
6593442|NCT01998958|7518597|FG007|COMPLETED|Period 2 (Panel A and B)||6
6593443|NCT01998958|7518598|FG008|COMPLETED|Period 2 (Panel A and B)||4
6593444|NCT01998958|7518599|FG009|COMPLETED|Period 2 (Panel A and B)||8
6593445|NCT01998958|7518600|FG010|COMPLETED|Period 2 (Panel A and B)||8
6593446|NCT01998958|7518601|FG011|COMPLETED|Period 2 (Panel A and B)||5
6593447|NCT01998958|7518602|FG012|COMPLETED|Period 2 (Panel A and B)||8
6593448|NCT01998958|7518603|FG013|COMPLETED|Period 2 (Panel A and B)||11
6593449|NCT01998958|7518604|FG014|COMPLETED|Period 2 (Panel A and B)||10
6593450|NCT01998958|7518605|FG015|COMPLETED|Period 2 (Panel A and B)||5
6593451|NCT01998958|7518606|FG016|COMPLETED|Period 2 (Panel A and B)||8
6593452|NCT01998958|7518607|FG017|COMPLETED|Period 2 (Panel A and B)||5
6593453|NCT01998958|7518608|FG018|COMPLETED|Period 2 (Panel A and B)||2
6593454|NCT01998958|7518609|FG019|COMPLETED|Period 2 (Panel A and B)||11
6593455|NCT01998958|7518610|FG020|COMPLETED|Period 2 (Panel A and B)||9
6593456|NCT01998958|7518611|FG021|COMPLETED|Period 2 (Panel A and B)||0
6593457|NCT01998958|7518612|FG022|COMPLETED|Period 2 (Panel A and B)||0
6593458|NCT01998958|7518613|FG023|COMPLETED|Period 2 (Panel A and B)||0
6593459|NCT01998958|7518614|FG024|COMPLETED|Period 2 (Panel A and B)||0
6593460|NCT01998958|7518615|FG025|COMPLETED|Period 2 (Panel A and B)||0
6593461|NCT01998958|7518616|FG026|COMPLETED|Period 2 (Panel A and B)||0
6593462|NCT01998958|7518617|FG027|COMPLETED|Period 2 (Panel A and B)||0
6593463|NCT01998958|7518618|FG028|COMPLETED|Period 2 (Panel A and B)||0
6593464|NCT01998958|7518619|FG029|COMPLETED|Period 2 (Panel A and B)||0
6593465|NCT01998958|7518620|FG030|COMPLETED|Period 2 (Panel A and B)||0
6593466|NCT01998958|7518621|FG031|COMPLETED|Period 2 (Panel A and B)||0
6593467|NCT01998958|7518590|FG000|NOT COMPLETED|Period 2 (Panel A and B)||0
6593468|NCT01998958|7518591|FG001|NOT COMPLETED|Period 2 (Panel A and B)||0
6593469|NCT01998958|7518592|FG002|NOT COMPLETED|Period 2 (Panel A and B)||0
6593470|NCT01998958|7518593|FG003|NOT COMPLETED|Period 2 (Panel A and B)||0
6593471|NCT01998958|7518594|FG004|NOT COMPLETED|Period 2 (Panel A and B)||0
6593472|NCT01998958|7518595|FG005|NOT COMPLETED|Period 2 (Panel A and B)||0
6593473|NCT01998958|7518596|FG006|NOT COMPLETED|Period 2 (Panel A and B)||0
6593474|NCT01998958|7518597|FG007|NOT COMPLETED|Period 2 (Panel A and B)||0
6593475|NCT01998958|7518598|FG008|NOT COMPLETED|Period 2 (Panel A and B)||0
6593476|NCT01998958|7518599|FG009|NOT COMPLETED|Period 2 (Panel A and B)||0
6593477|NCT01998958|7518600|FG010|NOT COMPLETED|Period 2 (Panel A and B)||1
6593478|NCT01998958|7518601|FG011|NOT COMPLETED|Period 2 (Panel A and B)||0
6593479|NCT01998958|7518602|FG012|NOT COMPLETED|Period 2 (Panel A and B)||0
6593480|NCT01998958|7518603|FG013|NOT COMPLETED|Period 2 (Panel A and B)||0
6593481|NCT01998958|7518604|FG014|NOT COMPLETED|Period 2 (Panel A and B)||2
6593482|NCT01998958|7518605|FG015|NOT COMPLETED|Period 2 (Panel A and B)||0
6593483|NCT01998958|7518606|FG016|NOT COMPLETED|Period 2 (Panel A and B)||0
6593484|NCT01998958|7518607|FG017|NOT COMPLETED|Period 2 (Panel A and B)||0
6593485|NCT01998958|7518608|FG018|NOT COMPLETED|Period 2 (Panel A and B)||1
6593486|NCT01998958|7518609|FG019|NOT COMPLETED|Period 2 (Panel A and B)||0
6593487|NCT01998958|7518610|FG020|NOT COMPLETED|Period 2 (Panel A and B)||0
6593488|NCT01998958|7518611|FG021|NOT COMPLETED|Period 2 (Panel A and B)||0
6593489|NCT01998958|7518612|FG022|NOT COMPLETED|Period 2 (Panel A and B)||0
6593490|NCT01998958|7518613|FG023|NOT COMPLETED|Period 2 (Panel A and B)||0
6593491|NCT01998958|7518614|FG024|NOT COMPLETED|Period 2 (Panel A and B)||0
6593492|NCT01998958|7518615|FG025|NOT COMPLETED|Period 2 (Panel A and B)||0
6593493|NCT01998958|7518616|FG026|NOT COMPLETED|Period 2 (Panel A and B)||0
6593494|NCT01998958|7518617|FG027|NOT COMPLETED|Period 2 (Panel A and B)||0
6593495|NCT01998958|7518618|FG028|NOT COMPLETED|Period 2 (Panel A and B)||0
6593496|NCT01998958|7518619|FG029|NOT COMPLETED|Period 2 (Panel A and B)||0
6593497|NCT01998958|7518620|FG030|NOT COMPLETED|Period 2 (Panel A and B)||0
6593498|NCT01998958|7518621|FG031|NOT COMPLETED|Period 2 (Panel A and B)||0
6593499|NCT01998958|7518590|FG000|STARTED|Open Label Phase (Optional)||0
6593500|NCT01998958|7518591|FG001|STARTED|Open Label Phase (Optional)||0
6593501|NCT01998958|7518592|FG002|STARTED|Open Label Phase (Optional)||0
6593502|NCT01998958|7518593|FG003|STARTED|Open Label Phase (Optional)||0
6593503|NCT01998958|7518594|FG004|STARTED|Open Label Phase (Optional)||0
6593504|NCT01998958|7518595|FG005|STARTED|Open Label Phase (Optional)||0
6593505|NCT01998958|7518596|FG006|STARTED|Open Label Phase (Optional)||0
6593506|NCT01998958|7518597|FG007|STARTED|Open Label Phase (Optional)||0
6593507|NCT01998958|7518598|FG008|STARTED|Open Label Phase (Optional)||0
6593508|NCT01998958|7518599|FG009|STARTED|Open Label Phase (Optional)||0
6593509|NCT01998958|7518600|FG010|STARTED|Open Label Phase (Optional)||0
6593510|NCT01998958|7518601|FG011|STARTED|Open Label Phase (Optional)||0
6593511|NCT01998958|7518602|FG012|STARTED|Open Label Phase (Optional)||0
6593512|NCT01998958|7518603|FG013|STARTED|Open Label Phase (Optional)||0
6593513|NCT01998958|7518604|FG014|STARTED|Open Label Phase (Optional)||0
6593514|NCT01998958|7518605|FG015|STARTED|Open Label Phase (Optional)||0
6593515|NCT01998958|7518606|FG016|STARTED|Open Label Phase (Optional)||0
6593516|NCT01998958|7518607|FG017|STARTED|Open Label Phase (Optional)||0
6593517|NCT01998958|7518608|FG018|STARTED|Open Label Phase (Optional)||0
6593518|NCT01998958|7518609|FG019|STARTED|Open Label Phase (Optional)||0
6593519|NCT01998958|7518610|FG020|STARTED|Open Label Phase (Optional)||0
6593520|NCT01998958|7518611|FG021|STARTED|Open Label Phase (Optional)||10
6593521|NCT01998958|7518612|FG022|STARTED|Open Label Phase (Optional)||20
6593522|NCT01998958|7518613|FG023|STARTED|Open Label Phase (Optional)||27
6593523|NCT01998958|7518614|FG024|STARTED|Open Label Phase (Optional)||13
6593524|NCT01998958|7518615|FG025|STARTED|Open Label Phase (Optional)||7
6593525|NCT01998958|7518616|FG026|STARTED|Open Label Phase (Optional)||19
6593526|NCT01998958|7518617|FG027|STARTED|Open Label Phase (Optional)||0
6593527|NCT01998958|7518618|FG028|STARTED|Open Label Phase (Optional)||0
6593528|NCT01998958|7518619|FG029|STARTED|Open Label Phase (Optional)||0
6593529|NCT01998958|7518620|FG030|STARTED|Open Label Phase (Optional)||0
6593530|NCT01998958|7518621|FG031|STARTED|Open Label Phase (Optional)||0
6593531|NCT01998958|7518590|FG000|COMPLETED|Open Label Phase (Optional)||0
6593532|NCT01998958|7518591|FG001|COMPLETED|Open Label Phase (Optional)||0
6593533|NCT01998958|7518592|FG002|COMPLETED|Open Label Phase (Optional)||0
6593534|NCT01998958|7518593|FG003|COMPLETED|Open Label Phase (Optional)||0
6593535|NCT01998958|7518594|FG004|COMPLETED|Open Label Phase (Optional)||0
6593536|NCT01998958|7518595|FG005|COMPLETED|Open Label Phase (Optional)||0
6593537|NCT01998958|7518596|FG006|COMPLETED|Open Label Phase (Optional)||0
6593538|NCT01998958|7518597|FG007|COMPLETED|Open Label Phase (Optional)||0
6593539|NCT01998958|7518598|FG008|COMPLETED|Open Label Phase (Optional)||0
6593540|NCT01998958|7518599|FG009|COMPLETED|Open Label Phase (Optional)||0
6593541|NCT01998958|7518600|FG010|COMPLETED|Open Label Phase (Optional)||0
6593542|NCT01998958|7518601|FG011|COMPLETED|Open Label Phase (Optional)||0
6593543|NCT01998958|7518602|FG012|COMPLETED|Open Label Phase (Optional)||0
6593544|NCT01998958|7518603|FG013|COMPLETED|Open Label Phase (Optional)||0
6593545|NCT01998958|7518604|FG014|COMPLETED|Open Label Phase (Optional)||0
6593546|NCT01998958|7518605|FG015|COMPLETED|Open Label Phase (Optional)||0
6593547|NCT01998958|7518606|FG016|COMPLETED|Open Label Phase (Optional)||0
6593548|NCT01998958|7518607|FG017|COMPLETED|Open Label Phase (Optional)||0
6593549|NCT01998958|7518608|FG018|COMPLETED|Open Label Phase (Optional)||0
6593550|NCT01998958|7518609|FG019|COMPLETED|Open Label Phase (Optional)||0
6593551|NCT01998958|7518610|FG020|COMPLETED|Open Label Phase (Optional)||0
6593552|NCT01998958|7518611|FG021|COMPLETED|Open Label Phase (Optional)||7
6593553|NCT01998958|7518612|FG022|COMPLETED|Open Label Phase (Optional)||11
6593554|NCT01998958|7518613|FG023|COMPLETED|Open Label Phase (Optional)||23
6593555|NCT01998958|7518614|FG024|COMPLETED|Open Label Phase (Optional)||13
6593556|NCT01998958|7518615|FG025|COMPLETED|Open Label Phase (Optional)||7
6593557|NCT01998958|7518616|FG026|COMPLETED|Open Label Phase (Optional)||19
6593558|NCT01998958|7518617|FG027|COMPLETED|Open Label Phase (Optional)||0
6593559|NCT01998958|7518618|FG028|COMPLETED|Open Label Phase (Optional)||0
6593560|NCT01998958|7518619|FG029|COMPLETED|Open Label Phase (Optional)||0
6593561|NCT01998958|7518620|FG030|COMPLETED|Open Label Phase (Optional)||0
6593562|NCT01998958|7518621|FG031|COMPLETED|Open Label Phase (Optional)||0
6593563|NCT01998958|7518590|FG000|NOT COMPLETED|Open Label Phase (Optional)||0
6593564|NCT01998958|7518591|FG001|NOT COMPLETED|Open Label Phase (Optional)||0
6593565|NCT01998958|7518592|FG002|NOT COMPLETED|Open Label Phase (Optional)||0
6593566|NCT01998958|7518593|FG003|NOT COMPLETED|Open Label Phase (Optional)||0
6593567|NCT01998958|7518594|FG004|NOT COMPLETED|Open Label Phase (Optional)||0
6593568|NCT01998958|7518595|FG005|NOT COMPLETED|Open Label Phase (Optional)||0
6593569|NCT01998958|7518596|FG006|NOT COMPLETED|Open Label Phase (Optional)||0
6593570|NCT01998958|7518597|FG007|NOT COMPLETED|Open Label Phase (Optional)||0
6593571|NCT01998958|7518598|FG008|NOT COMPLETED|Open Label Phase (Optional)||0
6593572|NCT01998958|7518599|FG009|NOT COMPLETED|Open Label Phase (Optional)||0
6593573|NCT01998958|7518600|FG010|NOT COMPLETED|Open Label Phase (Optional)||0
6593574|NCT01998958|7518601|FG011|NOT COMPLETED|Open Label Phase (Optional)||0
6593575|NCT01998958|7518602|FG012|NOT COMPLETED|Open Label Phase (Optional)||0
6593576|NCT01998958|7518603|FG013|NOT COMPLETED|Open Label Phase (Optional)||0
6593577|NCT01998958|7518604|FG014|NOT COMPLETED|Open Label Phase (Optional)||0
6593578|NCT01998958|7518605|FG015|NOT COMPLETED|Open Label Phase (Optional)||0
6593579|NCT01998958|7518606|FG016|NOT COMPLETED|Open Label Phase (Optional)||0
6593580|NCT01998958|7518607|FG017|NOT COMPLETED|Open Label Phase (Optional)||0
6593581|NCT01998958|7518608|FG018|NOT COMPLETED|Open Label Phase (Optional)||0
6593582|NCT01998958|7518609|FG019|NOT COMPLETED|Open Label Phase (Optional)||0
6593583|NCT01998958|7518610|FG020|NOT COMPLETED|Open Label Phase (Optional)||0
6593584|NCT01998958|7518611|FG021|NOT COMPLETED|Open Label Phase (Optional)||3
6593585|NCT01998958|7518612|FG022|NOT COMPLETED|Open Label Phase (Optional)||9
6593586|NCT01998958|7518613|FG023|NOT COMPLETED|Open Label Phase (Optional)||4
6593587|NCT01998958|7518614|FG024|NOT COMPLETED|Open Label Phase (Optional)||0
6593588|NCT01998958|7518615|FG025|NOT COMPLETED|Open Label Phase (Optional)||0
6593589|NCT01998958|7518616|FG026|NOT COMPLETED|Open Label Phase (Optional)||0
6593590|NCT01998958|7518617|FG027|NOT COMPLETED|Open Label Phase (Optional)||0
6593591|NCT01998958|7518618|FG028|NOT COMPLETED|Open Label Phase (Optional)||0
6593592|NCT01998958|7518619|FG029|NOT COMPLETED|Open Label Phase (Optional)||0
6593593|NCT01998958|7518620|FG030|NOT COMPLETED|Open Label Phase (Optional)||0
6593594|NCT01998958|7518621|FG031|NOT COMPLETED|Open Label Phase (Optional)||0
6593595|NCT01998958|7518590|FG000|STARTED|Follow-up Phase||0
6593596|NCT01998958|7518591|FG001|STARTED|Follow-up Phase||0
6593597|NCT01998958|7518592|FG002|STARTED|Follow-up Phase||0
6593598|NCT01998958|7518593|FG003|STARTED|Follow-up Phase||0
6593599|NCT01998958|7518594|FG004|STARTED|Follow-up Phase||0
6593600|NCT01998958|7518595|FG005|STARTED|Follow-up Phase||0
6593601|NCT01998958|7518596|FG006|STARTED|Follow-up Phase||0
6593602|NCT01998958|7518597|FG007|STARTED|Follow-up Phase||0
6593603|NCT01998958|7518598|FG008|STARTED|Follow-up Phase||0
6593604|NCT01998958|7518599|FG009|STARTED|Follow-up Phase||0
6593605|NCT01998958|7518600|FG010|STARTED|Follow-up Phase||0
6593606|NCT01998958|7518601|FG011|STARTED|Follow-up Phase||0
6593607|NCT01998958|7518602|FG012|STARTED|Follow-up Phase||0
6593608|NCT01998958|7518603|FG013|STARTED|Follow-up Phase||0
6593609|NCT01998958|7518604|FG014|STARTED|Follow-up Phase||0
6593610|NCT01998958|7518605|FG015|STARTED|Follow-up Phase||0
6593611|NCT01998958|7518606|FG016|STARTED|Follow-up Phase||0
6593612|NCT01998958|7518607|FG017|STARTED|Follow-up Phase||0
6593613|NCT01998958|7518608|FG018|STARTED|Follow-up Phase||0
6593614|NCT01998958|7518609|FG019|STARTED|Follow-up Phase||0
6593615|NCT01998958|7518610|FG020|STARTED|Follow-up Phase||0
6593616|NCT01998958|7518611|FG021|STARTED|Follow-up Phase||0
6593617|NCT01998958|7518612|FG022|STARTED|Follow-up Phase||0
6593618|NCT01998958|7518613|FG023|STARTED|Follow-up Phase||0
6593619|NCT01998958|7518614|FG024|STARTED|Follow-up Phase||0
6593620|NCT01998958|7518615|FG025|STARTED|Follow-up Phase||0
6593621|NCT01998958|7518616|FG026|STARTED|Follow-up Phase||0
6593622|NCT01998958|7518617|FG027|STARTED|Follow-up Phase||1
6593623|NCT01998958|7518618|FG028|STARTED|Follow-up Phase||4
6593624|NCT01998958|7518619|FG029|STARTED|Follow-up Phase||12
6593625|NCT01998958|7518620|FG030|STARTED|Follow-up Phase||39
6593626|NCT01998958|7518621|FG031|STARTED|Follow-up Phase||42
6593627|NCT01998958|7518590|FG000|COMPLETED|Follow-up Phase||0
6593628|NCT01998958|7518591|FG001|COMPLETED|Follow-up Phase||0
6593629|NCT01998958|7518592|FG002|COMPLETED|Follow-up Phase||0
6593630|NCT01998958|7518593|FG003|COMPLETED|Follow-up Phase||0
6593631|NCT01998958|7518594|FG004|COMPLETED|Follow-up Phase||0
6593632|NCT01998958|7518595|FG005|COMPLETED|Follow-up Phase||0
6593633|NCT01998958|7518596|FG006|COMPLETED|Follow-up Phase||0
6593634|NCT01998958|7518597|FG007|COMPLETED|Follow-up Phase||0
6593635|NCT01998958|7518598|FG008|COMPLETED|Follow-up Phase||0
6593636|NCT01998958|7518599|FG009|COMPLETED|Follow-up Phase||0
6593637|NCT01998958|7518600|FG010|COMPLETED|Follow-up Phase||0
6593638|NCT01998958|7518601|FG011|COMPLETED|Follow-up Phase||0
6593639|NCT01998958|7518602|FG012|COMPLETED|Follow-up Phase||0
6593640|NCT01998958|7518603|FG013|COMPLETED|Follow-up Phase||0
6593641|NCT01998958|7518604|FG014|COMPLETED|Follow-up Phase||0
6593642|NCT01998958|7518605|FG015|COMPLETED|Follow-up Phase||0
6593643|NCT01998958|7518606|FG016|COMPLETED|Follow-up Phase||0
6593644|NCT01998958|7518607|FG017|COMPLETED|Follow-up Phase||0
6593645|NCT01998958|7518608|FG018|COMPLETED|Follow-up Phase||0
6593646|NCT01998958|7518609|FG019|COMPLETED|Follow-up Phase||0
6593647|NCT01998958|7518610|FG020|COMPLETED|Follow-up Phase||0
6593648|NCT01998958|7518611|FG021|COMPLETED|Follow-up Phase||0
6593649|NCT01998958|7518612|FG022|COMPLETED|Follow-up Phase||0
6593650|NCT01998958|7518613|FG023|COMPLETED|Follow-up Phase||0
6593651|NCT01998958|7518614|FG024|COMPLETED|Follow-up Phase||0
6593652|NCT01998958|7518615|FG025|COMPLETED|Follow-up Phase||0
6593653|NCT01998958|7518616|FG026|COMPLETED|Follow-up Phase||0
6593654|NCT01998958|7518617|FG027|COMPLETED|Follow-up Phase||1
6593655|NCT01998958|7518618|FG028|COMPLETED|Follow-up Phase||4
6593656|NCT01998958|7518619|FG029|COMPLETED|Follow-up Phase||12
6593657|NCT01998958|7518620|FG030|COMPLETED|Follow-up Phase||39
6593658|NCT01998958|7518621|FG031|COMPLETED|Follow-up Phase||42
6593659|NCT01998958|7518590|FG000|NOT COMPLETED|Follow-up Phase||0
6593660|NCT01998958|7518591|FG001|NOT COMPLETED|Follow-up Phase||0
6593661|NCT01998958|7518592|FG002|NOT COMPLETED|Follow-up Phase||0
6593662|NCT01998958|7518593|FG003|NOT COMPLETED|Follow-up Phase||0
6593663|NCT01998958|7518594|FG004|NOT COMPLETED|Follow-up Phase||0
6593664|NCT01998958|7518595|FG005|NOT COMPLETED|Follow-up Phase||0
6593665|NCT01998958|7518596|FG006|NOT COMPLETED|Follow-up Phase||0
6593666|NCT01998958|7518597|FG007|NOT COMPLETED|Follow-up Phase||0
6593667|NCT01998958|7518598|FG008|NOT COMPLETED|Follow-up Phase||0
6593668|NCT01998958|7518599|FG009|NOT COMPLETED|Follow-up Phase||0
6593669|NCT01998958|7518600|FG010|NOT COMPLETED|Follow-up Phase||0
6593670|NCT01998958|7518601|FG011|NOT COMPLETED|Follow-up Phase||0
6593671|NCT01998958|7518602|FG012|NOT COMPLETED|Follow-up Phase||0
6593672|NCT01998958|7518603|FG013|NOT COMPLETED|Follow-up Phase||0
6593673|NCT01998958|7518604|FG014|NOT COMPLETED|Follow-up Phase||0
6593674|NCT01998958|7518605|FG015|NOT COMPLETED|Follow-up Phase||0
6593675|NCT01998958|7518606|FG016|NOT COMPLETED|Follow-up Phase||0
6593676|NCT01998958|7518607|FG017|NOT COMPLETED|Follow-up Phase||0
6593677|NCT01998958|7518608|FG018|NOT COMPLETED|Follow-up Phase||0
6593678|NCT01998958|7518609|FG019|NOT COMPLETED|Follow-up Phase||0
6593679|NCT01998958|7518610|FG020|NOT COMPLETED|Follow-up Phase||0
6593680|NCT01998958|7518611|FG021|NOT COMPLETED|Follow-up Phase||0
6593681|NCT01998958|7518612|FG022|NOT COMPLETED|Follow-up Phase||0
6593682|NCT01998958|7518613|FG023|NOT COMPLETED|Follow-up Phase||0
6593683|NCT01998958|7518614|FG024|NOT COMPLETED|Follow-up Phase||0
6593684|NCT01998958|7518615|FG025|NOT COMPLETED|Follow-up Phase||0
6593685|NCT01998958|7518616|FG026|NOT COMPLETED|Follow-up Phase||0
6593686|NCT01998958|7518617|FG027|NOT COMPLETED|Follow-up Phase||0
6593687|NCT01998958|7518618|FG028|NOT COMPLETED|Follow-up Phase||0
6593688|NCT01998958|7518619|FG029|NOT COMPLETED|Follow-up Phase||0
6593689|NCT01998958|7518620|FG030|NOT COMPLETED|Follow-up Phase||0
6593690|NCT01998958|7518621|FG031|NOT COMPLETED|Follow-up Phase||0
6593691|NCT01998984|7518675|FG000|STARTED|Overall Study||55
6593692|NCT01998984|7518676|FG001|STARTED|Overall Study||59
6593693|NCT01998984|7518677|FG002|STARTED|Overall Study||49
6593694|NCT01998984|7518678|FG003|STARTED|Overall Study||61
6593695|NCT01998984|7518675|FG000|COMPLETED|Overall Study||55
6593696|NCT01998984|7518676|FG001|COMPLETED|Overall Study||58
6593697|NCT01998984|7518677|FG002|COMPLETED|Overall Study||48
6593698|NCT01998984|7518678|FG003|COMPLETED|Overall Study||58
6593699|NCT01998984|7518675|FG000|NOT COMPLETED|Overall Study||0
6593700|NCT01998984|7518676|FG001|NOT COMPLETED|Overall Study||1
6593701|NCT01998984|7518677|FG002|NOT COMPLETED|Overall Study||1
6593702|NCT01998984|7518678|FG003|NOT COMPLETED|Overall Study||3
6593703|NCT01999114|7518693|FG000|STARTED|Overall Study||66
6593704|NCT01999114|7518694|FG001|STARTED|Overall Study||66
6593705|NCT01999114|7518695|FG002|STARTED|Overall Study||66
6593706|NCT01999114|7518696|FG003|STARTED|Overall Study||65
6593707|NCT01999114|7518697|FG004|STARTED|Overall Study||65
6593708|NCT01999114|7518693|FG000|COMPLETED|Overall Study||58
6593709|NCT01999114|7518694|FG001|COMPLETED|Overall Study||59
6593710|NCT01999114|7518695|FG002|COMPLETED|Overall Study||61
6593711|NCT01999114|7518696|FG003|COMPLETED|Overall Study||62
6593712|NCT01999114|7518697|FG004|COMPLETED|Overall Study||61
6593713|NCT01999114|7518693|FG000|NOT COMPLETED|Overall Study||8
6593714|NCT01999114|7518694|FG001|NOT COMPLETED|Overall Study||7
6593715|NCT01999114|7518695|FG002|NOT COMPLETED|Overall Study||5
6593716|NCT01999114|7518696|FG003|NOT COMPLETED|Overall Study||3
6593717|NCT01999114|7518697|FG004|NOT COMPLETED|Overall Study||4
6593718|NCT01999192|7518727|FG000|STARTED|Main Phase I||83
6593719|NCT01999192|7518728|FG001|STARTED|Main Phase I||80
6593720|NCT01999192|7518729|FG002|STARTED|Main Phase I||78
6593721|NCT01999192|7518730|FG003|STARTED|Main Phase I||80
6593722|NCT01999192|7518727|FG000|COMPLETED|Main Phase I||72
6593723|NCT01999192|7518728|FG001|COMPLETED|Main Phase I||70
6593724|NCT01999192|7518729|FG002|COMPLETED|Main Phase I||70
6593725|NCT01999192|7518730|FG003|COMPLETED|Main Phase I||72
6593726|NCT01999192|7518727|FG000|NOT COMPLETED|Main Phase I||11
6593727|NCT01999192|7518728|FG001|NOT COMPLETED|Main Phase I||10
6593728|NCT01999192|7518729|FG002|NOT COMPLETED|Main Phase I||8
6593729|NCT01999192|7518730|FG003|NOT COMPLETED|Main Phase I||8
6593730|NCT01999192|7518727|FG000|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
6593731|NCT01999192|7518728|FG001|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
6593732|NCT01999192|7518729|FG002|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
6593733|NCT01999192|7518730|FG003|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
6593734|NCT01999192|7518727|FG000|COMPLETED|Main Phase II||55
6593735|NCT01999192|7518728|FG001|COMPLETED|Main Phase II||66
6593736|NCT01999192|7518729|FG002|COMPLETED|Main Phase II||76
6593737|NCT01999192|7518730|FG003|COMPLETED|Main Phase II||43
6593738|NCT01999192|7518727|FG000|NOT COMPLETED|Main Phase II||9
6593739|NCT01999192|7518728|FG001|NOT COMPLETED|Main Phase II||9
6593740|NCT01999192|7518729|FG002|NOT COMPLETED|Main Phase II||22
6593741|NCT01999192|7518730|FG003|NOT COMPLETED|Main Phase II||1
6593742|NCT01999192|7518727|FG000|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
6593743|NCT01999192|7518728|FG001|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
6593744|NCT01999192|7518729|FG002|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
6593745|NCT01999192|7518730|FG003|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
6593746|NCT01999192|7518727|FG000|COMPLETED|Extension Phase||41
6593747|NCT01999192|7518728|FG001|COMPLETED|Extension Phase||38
6593748|NCT01999192|7518729|FG002|COMPLETED|Extension Phase||44
6593749|NCT01999192|7518730|FG003|COMPLETED|Extension Phase||0
6593750|NCT01999192|7518727|FG000|NOT COMPLETED|Extension Phase||13
6593751|NCT01999192|7518728|FG001|NOT COMPLETED|Extension Phase||18
6593752|NCT01999192|7518729|FG002|NOT COMPLETED|Extension Phase||24
6593753|NCT01999192|7518730|FG003|NOT COMPLETED|Extension Phase||0
6593754|NCT01999218|7518743|FG000|STARTED|Overall Study||448
6593755|NCT01999218|7518744|FG001|STARTED|Overall Study||441
6593756|NCT01999218|7518745|FG002|STARTED|Overall Study||437
6593757|NCT01999218|7518743|FG000|Treated|Overall Study||448
6593758|NCT01999218|7518744|FG001|Treated|Overall Study||440
6593759|NCT01999218|7518745|FG002|Treated|Overall Study||437
6593760|NCT01999218|7518743|FG000|Site Issue|Overall Study||445
6593761|NCT01999218|7518744|FG001|Site Issue|Overall Study||435
6593762|NCT01999218|7518745|FG002|Site Issue|Overall Study||435
6593763|NCT01999218|7518743|FG000|COMPLETED|Overall Study||339
6593764|NCT01999218|7518744|FG001|COMPLETED|Overall Study||340
6593765|NCT01999218|7518745|FG002|COMPLETED|Overall Study||327
6593766|NCT01999218|7518743|FG000|NOT COMPLETED|Overall Study||109
6593767|NCT01999218|7518744|FG001|NOT COMPLETED|Overall Study||101
6593768|NCT01999218|7518745|FG002|NOT COMPLETED|Overall Study||110
6593769|NCT01999231|7518757|FG000|STARTED|Overall Study||6
6593770|NCT01999231|7518758|FG001|STARTED|Overall Study||6
6593771|NCT01999231|7518759|FG002|STARTED|Overall Study||6
6593772|NCT01999231|7518760|FG003|STARTED|Overall Study||6
6593773|NCT01999231|7518757|FG000|COMPLETED|Overall Study||6
6593774|NCT01999231|7518758|FG001|COMPLETED|Overall Study||6
6593775|NCT01999231|7518759|FG002|COMPLETED|Overall Study||6
6593776|NCT01999231|7518760|FG003|COMPLETED|Overall Study||6
6593777|NCT01999231|7518757|FG000|NOT COMPLETED|Overall Study||0
6593778|NCT01999231|7518758|FG001|NOT COMPLETED|Overall Study||0
6593779|NCT01999231|7518759|FG002|NOT COMPLETED|Overall Study||0
6593780|NCT01999231|7518760|FG003|NOT COMPLETED|Overall Study||0
6593781|NCT01999322|7518774|FG000|STARTED|Overall Study||25
6593782|NCT01999322|7518775|FG001|STARTED|Overall Study||12
6593783|NCT01999322|7518774|FG000|COMPLETED|Overall Study||24
6593784|NCT01999322|7518775|FG001|COMPLETED|Overall Study||12
6593785|NCT01999322|7518774|FG000|NOT COMPLETED|Overall Study||1
6593786|NCT01999322|7518775|FG001|NOT COMPLETED|Overall Study||0
6624600|NCT02218320|7552043|FG001|COMPLETED|Overall Study|Last participant contact on this arm was October 2015|10
6624601|NCT02218320|7552042|FG000|NOT COMPLETED|Overall Study||0
6624602|NCT02218320|7552043|FG001|NOT COMPLETED|Overall Study||0
6624603|NCT02218372|7552051|FG000|STARTED|Overall Study||100
6624604|NCT02218372|7552052|FG001|STARTED|Overall Study||48
6624605|NCT02218372|7552051|FG000|Treated|Overall Study||98
6624606|NCT02218372|7552052|FG001|Treated|Overall Study||44
6624607|NCT02218372|7552051|FG000|COMPLETED|Overall Study||95
6624608|NCT02218372|7552052|FG001|COMPLETED|Overall Study||42
6624609|NCT02218372|7552051|FG000|NOT COMPLETED|Overall Study||5
6624610|NCT02218372|7552052|FG001|NOT COMPLETED|Overall Study||6
6624611|NCT02218424|7552065|FG000|STARTED|Overall Study||30
6624612|NCT02218424|7552066|FG001|STARTED|Overall Study||30
6624613|NCT02218424|7552065|FG000|COMPLETED|Overall Study||30
6624614|NCT02218424|7552066|FG001|COMPLETED|Overall Study||30
6624615|NCT02218424|7552065|FG000|NOT COMPLETED|Overall Study||0
6624616|NCT02218424|7552066|FG001|NOT COMPLETED|Overall Study||0
6624617|NCT02218463|7552074|FG000|STARTED|Overall Study||21
6624618|NCT02218463|7552075|FG001|STARTED|Overall Study||22
6624619|NCT02218463|7552074|FG000|COMPLETED|Overall Study||18
6624620|NCT02218463|7552075|FG001|COMPLETED|Overall Study||19
6624621|NCT02218463|7552074|FG000|NOT COMPLETED|Overall Study||3
6624622|NCT02218463|7552075|FG001|NOT COMPLETED|Overall Study||3
6624623|NCT02218489|7552083|FG000|STARTED|Overall Study||101
6624624|NCT02218489|7552084|FG001|STARTED|Overall Study||104
6624625|NCT02218489|7552083|FG000|COMPLETED|Overall Study||96
6624626|NCT02218489|7552084|FG001|COMPLETED|Overall Study||101
6624627|NCT02218489|7552083|FG000|NOT COMPLETED|Overall Study||5
6624628|NCT02218489|7552084|FG001|NOT COMPLETED|Overall Study||3
6624629|NCT02218541|7552093|FG000|STARTED|Overall Study||11
6624630|NCT02218541|7552094|FG001|STARTED|Overall Study||11
6624631|NCT02218541|7552093|FG000|COMPLETED|Overall Study||5
6624632|NCT02218541|7552094|FG001|COMPLETED|Overall Study||9
6624633|NCT02218541|7552093|FG000|NOT COMPLETED|Overall Study||6
6593787|NCT01999335|7518786|FG000|STARTED|Overall Study||3
6593788|NCT01999335|7518787|FG001|STARTED|Overall Study||1
6593789|NCT01999335|7518788|FG002|STARTED|Overall Study||7
6593790|NCT01999335|7518789|FG003|STARTED|Overall Study||10
6593791|NCT01999335|7518790|FG004|STARTED|Overall Study||12
6593792|NCT01999335|7518786|FG000|Received Study Treatment|Overall Study||3
6593793|NCT01999335|7518787|FG001|Received Study Treatment|Overall Study||1
6593794|NCT01999335|7518788|FG002|Received Study Treatment|Overall Study||7
6593795|NCT01999335|7518789|FG003|Received Study Treatment|Overall Study||10
6593796|NCT01999335|7518790|FG004|Received Study Treatment|Overall Study||10
6593797|NCT01999335|7518786|FG000|COMPLETED|Overall Study||3
6593798|NCT01999335|7518787|FG001|COMPLETED|Overall Study||1
6593799|NCT01999335|7518788|FG002|COMPLETED|Overall Study||7
6593800|NCT01999335|7518789|FG003|COMPLETED|Overall Study||10
6593801|NCT01999335|7518790|FG004|COMPLETED|Overall Study||10
6593802|NCT01999335|7518786|FG000|NOT COMPLETED|Overall Study||0
6593803|NCT01999335|7518787|FG001|NOT COMPLETED|Overall Study||0
6593804|NCT01999335|7518788|FG002|NOT COMPLETED|Overall Study||0
6660033|NCT02495467|7590989|FG000|COMPLETED|Second Intervention (4 Weeks)||112
6660034|NCT02495467|7590990|FG001|COMPLETED|Second Intervention (4 Weeks)||113
6660035|NCT02495467|7590989|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6660036|NCT02495467|7590990|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
6660037|NCT02495623|7590999|FG000|STARTED|Overall Study||25
6660038|NCT02495623|7591000|FG001|STARTED|Overall Study||26
6660039|NCT02495623|7591001|FG002|STARTED|Overall Study||28
6660040|NCT02495623|7590999|FG000|Dosed|Overall Study||22
6660041|NCT02495623|7591000|FG001|Dosed|Overall Study||19
6660042|NCT02495623|7591001|FG002|Dosed|Overall Study||22
6660043|NCT02495623|7590999|FG000|COMPLETED|Overall Study||20
6660044|NCT02495623|7591000|FG001|COMPLETED|Overall Study||17
6660045|NCT02495623|7591001|FG002|COMPLETED|Overall Study||20
6660046|NCT02495623|7590999|FG000|NOT COMPLETED|Overall Study||5
6660047|NCT02495623|7591000|FG001|NOT COMPLETED|Overall Study||9
6660048|NCT02495623|7591001|FG002|NOT COMPLETED|Overall Study||8
6660049|NCT02495779|7591009|FG000|STARTED|Overall Study||54
6660050|NCT02495779|7591009|FG000|COMPLETED|Overall Study||48
6660051|NCT02495779|7591009|FG000|NOT COMPLETED|Overall Study||6
6660052|NCT02495831|7591013|FG000|STARTED|First Intervention||13
6660053|NCT02495831|7591014|FG001|STARTED|First Intervention||10
6660054|NCT02495831|7591013|FG000|COMPLETED|First Intervention||13
6660055|NCT02495831|7591014|FG001|COMPLETED|First Intervention||10
6660056|NCT02495831|7591013|FG000|NOT COMPLETED|First Intervention||0
6660057|NCT02495831|7591014|FG001|NOT COMPLETED|First Intervention||0
6660058|NCT02495831|7591013|FG000|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
6660059|NCT02495831|7591014|FG001|STARTED|Second Intervention||10
6660060|NCT02495831|7591013|FG000|COMPLETED|Second Intervention||12
6660061|NCT02495831|7591014|FG001|COMPLETED|Second Intervention||10
6660062|NCT02495831|7591013|FG000|NOT COMPLETED|Second Intervention||0
6660063|NCT02495831|7591014|FG001|NOT COMPLETED|Second Intervention||0
6660064|NCT02495844|7591022|FG000|STARTED|Overall Study||27
6660065|NCT02495844|7591023|FG001|STARTED|Overall Study||28
6660066|NCT02495844|7591022|FG000|COMPLETED|Overall Study||26
6660067|NCT02495844|7591023|FG001|COMPLETED|Overall Study||24
6660068|NCT02495844|7591022|FG000|NOT COMPLETED|Overall Study||1
6660069|NCT02495844|7591023|FG001|NOT COMPLETED|Overall Study||4
6660070|NCT02495857|7591034|FG000|STARTED|Overall Study||200
6660071|NCT02495857|7591035|FG001|STARTED|Overall Study||200
6660072|NCT02495857|7591036|FG002|STARTED|Overall Study||199
6660073|NCT02495857|7591034|FG000|COMPLETED|Overall Study||178
6660074|NCT02495857|7591035|FG001|COMPLETED|Overall Study||184
6660075|NCT02495857|7591036|FG002|COMPLETED|Overall Study||181
6660076|NCT02495857|7591034|FG000|NOT COMPLETED|Overall Study||22
6660077|NCT02495857|7591035|FG001|NOT COMPLETED|Overall Study||16
6660078|NCT02495857|7591036|FG002|NOT COMPLETED|Overall Study||18
6660079|NCT02495883|7591046|FG000|STARTED|Overall Study||32
6660080|NCT02495883|7591047|FG001|STARTED|Overall Study||24
6660081|NCT02495883|7591046|FG000|COMPLETED|Overall Study||31
6660082|NCT02495883|7591047|FG001|COMPLETED|Overall Study||24
6660083|NCT02495883|7591046|FG000|NOT COMPLETED|Overall Study||1
6660084|NCT02495883|7591047|FG001|NOT COMPLETED|Overall Study||0
6660085|NCT02495948|7591052|FG000|STARTED|Period 1, First 30 Days of Wear||83
6660086|NCT02495948|7591053|FG001|STARTED|Period 1, First 30 Days of Wear||84
6660087|NCT02495948|7591052|FG000|COMPLETED|Period 1, First 30 Days of Wear||83
6660088|NCT02495948|7591053|FG001|COMPLETED|Period 1, First 30 Days of Wear||83
6660089|NCT02495948|7591052|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
6660090|NCT02495948|7591053|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||1
6660091|NCT02495948|7591052|FG000|STARTED|Period 2, Second 30 Days of Wear||83
6660092|NCT02495948|7591053|FG001|STARTED|Period 2, Second 30 Days of Wear||83
6660093|NCT02495948|7591052|FG000|COMPLETED|Period 2, Second 30 Days of Wear||82
6660094|NCT02495948|7591053|FG001|COMPLETED|Period 2, Second 30 Days of Wear||82
6660095|NCT02495948|7591052|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
6660096|NCT02495948|7591053|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
6660097|NCT02496000|7591063|FG000|STARTED|Overall Study||64
6660098|NCT02496000|7591064|FG001|STARTED|Overall Study||61
6660099|NCT02496000|7591065|FG002|STARTED|Overall Study||63
6660100|NCT02496000|7591063|FG000|COMPLETED|Overall Study||62
6660101|NCT02496000|7591064|FG001|COMPLETED|Overall Study||56
6660102|NCT02496000|7591065|FG002|COMPLETED|Overall Study||61
6593805|NCT01999335|7518789|FG003|NOT COMPLETED|Overall Study||0
6593806|NCT01999335|7518790|FG004|NOT COMPLETED|Overall Study||2
6593807|NCT01999348|7518805|FG000|STARTED|Overall Study||1553
6593808|NCT01999348|7518805|FG000|COMPLETED|Overall Study||1433
6593809|NCT01999348|7518805|FG000|NOT COMPLETED|Overall Study||120
6593810|NCT01999400|7518809|FG000|STARTED|First Intervention (1 Day)||6
6593811|NCT01999400|7518810|FG001|STARTED|First Intervention (1 Day)||6
6593812|NCT01999400|7518811|FG002|STARTED|First Intervention (1 Day)||5
6593813|NCT01999400|7518812|FG003|STARTED|First Intervention (1 Day)||5
6593814|NCT01999400|7518813|FG004|STARTED|First Intervention (1 Day)||4
6593815|NCT01999400|7518814|FG005|STARTED|First Intervention (1 Day)||4
6593816|NCT01999400|7518809|FG000|COMPLETED|First Intervention (1 Day)||4
6593817|NCT01999400|7518810|FG001|COMPLETED|First Intervention (1 Day)||4
6593818|NCT01999400|7518811|FG002|COMPLETED|First Intervention (1 Day)||3
6593819|NCT01999400|7518812|FG003|COMPLETED|First Intervention (1 Day)||2
6593820|NCT01999400|7518813|FG004|COMPLETED|First Intervention (1 Day)||4
6593821|NCT01999400|7518814|FG005|COMPLETED|First Intervention (1 Day)||3
6593822|NCT01999400|7518809|FG000|NOT COMPLETED|First Intervention (1 Day)||2
6593823|NCT01999400|7518810|FG001|NOT COMPLETED|First Intervention (1 Day)||2
6593824|NCT01999400|7518811|FG002|NOT COMPLETED|First Intervention (1 Day)||2
6593825|NCT01999400|7518812|FG003|NOT COMPLETED|First Intervention (1 Day)||3
6593826|NCT01999400|7518813|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6593827|NCT01999400|7518814|FG005|NOT COMPLETED|First Intervention (1 Day)||1
6593828|NCT01999400|7518809|FG000|STARTED|Washout (10 Days)||5
6593829|NCT01999400|7518810|FG001|STARTED|Washout (10 Days)||4
6593830|NCT01999400|7518811|FG002|STARTED|Washout (10 Days)||3
6593831|NCT01999400|7518812|FG003|STARTED|Washout (10 Days)||2
6593832|NCT01999400|7518813|FG004|STARTED|Washout (10 Days)||3
6593833|NCT01999400|7518814|FG005|STARTED|Washout (10 Days)||3
6593834|NCT01999400|7518809|FG000|COMPLETED|Washout (10 Days)||5
6593835|NCT01999400|7518810|FG001|COMPLETED|Washout (10 Days)||4
6593836|NCT01999400|7518811|FG002|COMPLETED|Washout (10 Days)||3
6593837|NCT01999400|7518812|FG003|COMPLETED|Washout (10 Days)||2
6593838|NCT01999400|7518813|FG004|COMPLETED|Washout (10 Days)||3
6593839|NCT01999400|7518814|FG005|COMPLETED|Washout (10 Days)||3
6593840|NCT01999400|7518809|FG000|NOT COMPLETED|Washout (10 Days)||0
6593841|NCT01999400|7518810|FG001|NOT COMPLETED|Washout (10 Days)||0
6593842|NCT01999400|7518811|FG002|NOT COMPLETED|Washout (10 Days)||0
6593843|NCT01999400|7518812|FG003|NOT COMPLETED|Washout (10 Days)||0
6593844|NCT01999400|7518813|FG004|NOT COMPLETED|Washout (10 Days)||0
6593845|NCT01999400|7518814|FG005|NOT COMPLETED|Washout (10 Days)||0
6593846|NCT01999400|7518809|FG000|STARTED|Second Intervention (1 Day)||5
6593847|NCT01999400|7518810|FG001|STARTED|Second Intervention (1 Day)||4
6593848|NCT01999400|7518811|FG002|STARTED|Second Intervention (1 Day)||3
6593849|NCT01999400|7518812|FG003|STARTED|Second Intervention (1 Day)||2
6593850|NCT01999400|7518813|FG004|STARTED|Second Intervention (1 Day)||3
6593851|NCT01999400|7518814|FG005|STARTED|Second Intervention (1 Day)||3
6593852|NCT01999400|7518809|FG000|COMPLETED|Second Intervention (1 Day)||5
6593853|NCT01999400|7518810|FG001|COMPLETED|Second Intervention (1 Day)||4
6660103|NCT02496000|7591063|FG000|NOT COMPLETED|Overall Study||2
6660104|NCT02496000|7591064|FG001|NOT COMPLETED|Overall Study||5
6660105|NCT02496000|7591065|FG002|NOT COMPLETED|Overall Study||2
6660106|NCT02496091|7591074|FG000|STARTED|Overall Study||144
6660107|NCT02496091|7591074|FG000|COMPLETED|Overall Study||142
6660108|NCT02496091|7591074|FG000|NOT COMPLETED|Overall Study||2
6660109|NCT02496221|7591079|FG000|STARTED|Treatment Period 1 - 4 Days||10
6593854|NCT01999400|7518811|FG002|COMPLETED|Second Intervention (1 Day)||3
6593855|NCT01999400|7518812|FG003|COMPLETED|Second Intervention (1 Day)||2
6593856|NCT01999400|7518813|FG004|COMPLETED|Second Intervention (1 Day)||3
6593857|NCT01999400|7518814|FG005|COMPLETED|Second Intervention (1 Day)||3
6593858|NCT01999400|7518809|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6593859|NCT01999400|7518810|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6593860|NCT01999400|7518811|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6593861|NCT01999400|7518812|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6593862|NCT01999400|7518813|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6593863|NCT01999400|7518814|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
6593864|NCT01999400|7518809|FG000|STARTED|Washout (10 Days)||2
6593865|NCT01999400|7518810|FG001|STARTED|Washout (10 Days)||0
6593866|NCT01999400|7518811|FG002|STARTED|Washout (10 Days)||1
6593867|NCT01999400|7518812|FG003|STARTED|Washout (10 Days)||1
6593868|NCT01999400|7518813|FG004|STARTED|Washout (10 Days)||1
6593869|NCT01999400|7518814|FG005|STARTED|Washout (10 Days)||1
6593870|NCT01999400|7518809|FG000|COMPLETED|Washout (10 Days)||2
6593871|NCT01999400|7518810|FG001|COMPLETED|Washout (10 Days)||0
6593872|NCT01999400|7518811|FG002|COMPLETED|Washout (10 Days)||1
6593873|NCT01999400|7518812|FG003|COMPLETED|Washout (10 Days)||1
6593874|NCT01999400|7518813|FG004|COMPLETED|Washout (10 Days)||1
6593875|NCT01999400|7518814|FG005|COMPLETED|Washout (10 Days)||1
6593876|NCT01999400|7518809|FG000|NOT COMPLETED|Washout (10 Days)||0
6593877|NCT01999400|7518810|FG001|NOT COMPLETED|Washout (10 Days)||0
6593878|NCT01999400|7518811|FG002|NOT COMPLETED|Washout (10 Days)||0
6278964|NCT00140231|7178649|FG000|NOT COMPLETED|Washout 8weeks||0
6593879|NCT01999400|7518812|FG003|NOT COMPLETED|Washout (10 Days)||0
6593880|NCT01999400|7518813|FG004|NOT COMPLETED|Washout (10 Days)||0
6593881|NCT01999400|7518814|FG005|NOT COMPLETED|Washout (10 Days)||0
6593882|NCT01999400|7518809|FG000|STARTED|Third Intervention (1 Day)||2
6593883|NCT01999400|7518810|FG001|STARTED|Third Intervention (1 Day)||0
6593884|NCT01999400|7518811|FG002|STARTED|Third Intervention (1 Day)||1
6593885|NCT01999400|7518812|FG003|STARTED|Third Intervention (1 Day)||1
6593886|NCT01999400|7518813|FG004|STARTED|Third Intervention (1 Day)||1
6593887|NCT01999400|7518814|FG005|STARTED|Third Intervention (1 Day)||1
6593888|NCT01999400|7518809|FG000|COMPLETED|Third Intervention (1 Day)||2
6593889|NCT01999400|7518810|FG001|COMPLETED|Third Intervention (1 Day)||0
6593890|NCT01999400|7518811|FG002|COMPLETED|Third Intervention (1 Day)||1
6593891|NCT01999400|7518812|FG003|COMPLETED|Third Intervention (1 Day)||1
6593892|NCT01999400|7518813|FG004|COMPLETED|Third Intervention (1 Day)||1
6593893|NCT01999400|7518814|FG005|COMPLETED|Third Intervention (1 Day)||0
6593894|NCT01999400|7518809|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6593895|NCT01999400|7518810|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6593896|NCT01999400|7518811|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6593897|NCT01999400|7518812|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6593898|NCT01999400|7518813|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
6593899|NCT01999400|7518814|FG005|NOT COMPLETED|Third Intervention (1 Day)||1
6593900|NCT01999400|7518809|FG000|STARTED|Washout (10 Days)||1
6593901|NCT01999400|7518810|FG001|STARTED|Washout (10 Days)||0
6593902|NCT01999400|7518811|FG002|STARTED|Washout (10 Days)||1
6593903|NCT01999400|7518812|FG003|STARTED|Washout (10 Days)||0
6593904|NCT01999400|7518813|FG004|STARTED|Washout (10 Days)||0
6593905|NCT01999400|7518814|FG005|STARTED|Washout (10 Days)||0
6593906|NCT01999400|7518809|FG000|COMPLETED|Washout (10 Days)||1
6593907|NCT01999400|7518810|FG001|COMPLETED|Washout (10 Days)||0
6593908|NCT01999400|7518811|FG002|COMPLETED|Washout (10 Days)||1
6593909|NCT01999400|7518812|FG003|COMPLETED|Washout (10 Days)||0
6593910|NCT01999400|7518813|FG004|COMPLETED|Washout (10 Days)||0
6593911|NCT01999400|7518814|FG005|COMPLETED|Washout (10 Days)||0
6593912|NCT01999400|7518809|FG000|NOT COMPLETED|Washout (10 Days)||0
6593913|NCT01999400|7518810|FG001|NOT COMPLETED|Washout (10 Days)||0
6593914|NCT01999400|7518811|FG002|NOT COMPLETED|Washout (10 Days)||0
6593915|NCT01999400|7518812|FG003|NOT COMPLETED|Washout (10 Days)||0
6593916|NCT01999400|7518813|FG004|NOT COMPLETED|Washout (10 Days)||0
6593917|NCT01999400|7518814|FG005|NOT COMPLETED|Washout (10 Days)||0
6593918|NCT01999400|7518809|FG000|STARTED|Fourth Intervention (1 Day)||1
6593919|NCT01999400|7518810|FG001|STARTED|Fourth Intervention (1 Day)||0
6593920|NCT01999400|7518811|FG002|STARTED|Fourth Intervention (1 Day)||1
6593921|NCT01999400|7518812|FG003|STARTED|Fourth Intervention (1 Day)||0
6593922|NCT01999400|7518813|FG004|STARTED|Fourth Intervention (1 Day)||0
6593923|NCT01999400|7518814|FG005|STARTED|Fourth Intervention (1 Day)||0
6593924|NCT01999400|7518809|FG000|COMPLETED|Fourth Intervention (1 Day)||1
6593925|NCT01999400|7518810|FG001|COMPLETED|Fourth Intervention (1 Day)||0
6593926|NCT01999400|7518811|FG002|COMPLETED|Fourth Intervention (1 Day)||1
6593927|NCT01999400|7518812|FG003|COMPLETED|Fourth Intervention (1 Day)||0
6593928|NCT01999400|7518813|FG004|COMPLETED|Fourth Intervention (1 Day)||0
6593929|NCT01999400|7518814|FG005|COMPLETED|Fourth Intervention (1 Day)||0
6593930|NCT01999400|7518809|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
6593931|NCT01999400|7518810|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
6593932|NCT01999400|7518811|FG002|NOT COMPLETED|Fourth Intervention (1 Day)||0
6593933|NCT01999400|7518812|FG003|NOT COMPLETED|Fourth Intervention (1 Day)||0
6593934|NCT01999400|7518813|FG004|NOT COMPLETED|Fourth Intervention (1 Day)||0
6593935|NCT01999400|7518814|FG005|NOT COMPLETED|Fourth Intervention (1 Day)||0
6593936|NCT01999465|7518826|FG000|STARTED|Overall Study||10
6593937|NCT01999465|7518827|FG001|STARTED|Overall Study||10
6593938|NCT01999465|7518826|FG000|COMPLETED|Overall Study||10
6593939|NCT01999465|7518827|FG001|COMPLETED|Overall Study||7
6593940|NCT01999465|7518826|FG000|NOT COMPLETED|Overall Study||0
6593941|NCT01999465|7518827|FG001|NOT COMPLETED|Overall Study||3
6593942|NCT01999517|7518835|FG000|STARTED|Overall Study||68
6593943|NCT01999517|7518836|FG001|STARTED|Overall Study||54
6593944|NCT01999517|7518835|FG000|COMPLETED|Overall Study||68
6593945|NCT01999517|7518836|FG001|COMPLETED|Overall Study||54
6593946|NCT01999517|7518835|FG000|NOT COMPLETED|Overall Study||0
6593947|NCT01999517|7518836|FG001|NOT COMPLETED|Overall Study||0
6593948|NCT01999530|7518842|FG000|STARTED|Overall Study||20
6593949|NCT01999530|7518842|FG000|COMPLETED|Overall Study||7
6593950|NCT01999530|7518842|FG000|NOT COMPLETED|Overall Study||13
6593951|NCT01999777|7518848|FG000|STARTED|Overall Study||31
6593952|NCT01999777|7518849|FG001|STARTED|Overall Study||31
6593953|NCT01999777|7518848|FG000|COMPLETED|Overall Study||31
6593954|NCT01999777|7518849|FG001|COMPLETED|Overall Study||31
6593955|NCT01999777|7518848|FG000|NOT COMPLETED|Overall Study||0
6593956|NCT01999777|7518849|FG001|NOT COMPLETED|Overall Study||0
6593957|NCT01999868|7518858|FG000|STARTED|Lead-in Phase (Week 0 - 12)||45
6593958|NCT01999868|7518859|FG001|STARTED|Lead-in Phase (Week 0 - 12)||46
6593959|NCT01999868|7518860|FG002|STARTED|Lead-in Phase (Week 0 - 12)||17
6593960|NCT01999868|7518858|FG000|COMPLETED|Lead-in Phase (Week 0 - 12)||45
6593961|NCT01999868|7518859|FG001|COMPLETED|Lead-in Phase (Week 0 - 12)||46
6593962|NCT01999868|7518860|FG002|COMPLETED|Lead-in Phase (Week 0 - 12)||12
6593963|NCT01999868|7518858|FG000|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
6593964|NCT01999868|7518859|FG001|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||0
6593965|NCT01999868|7518860|FG002|NOT COMPLETED|Lead-in Phase (Week 0 - 12)||5
6593966|NCT01999868|7518858|FG000|STARTED|Blinded Treatment Phase (Week 12 - 40)||45
6593967|NCT01999868|7518859|FG001|STARTED|Blinded Treatment Phase (Week 12 - 40)||46
6593968|NCT01999868|7518860|FG002|STARTED|Blinded Treatment Phase (Week 12 - 40)|Participants didn't meet eligibility requirements for randomization or withdrew prior to Week 12.|0
6593969|NCT01999868|7518858|FG000|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||27
6593970|NCT01999868|7518859|FG001|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||35
6593971|NCT01999868|7518860|FG002|COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
6593972|NCT01999868|7518858|FG000|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||18
6593973|NCT01999868|7518859|FG001|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||11
6593974|NCT01999868|7518860|FG002|NOT COMPLETED|Blinded Treatment Phase (Week 12 - 40)||0
6593975|NCT01999868|7518858|FG000|STARTED|Blinded Observation Phase (Week 40 - 88)||27
6593976|NCT01999868|7518859|FG001|STARTED|Blinded Observation Phase (Week 40 - 88)||35
6593977|NCT01999868|7518860|FG002|STARTED|Blinded Observation Phase (Week 40 - 88)||0
6593978|NCT01999868|7518858|FG000|COMPLETED|Blinded Observation Phase (Week 40 - 88)||4
6593979|NCT01999868|7518859|FG001|COMPLETED|Blinded Observation Phase (Week 40 - 88)||6
6593980|NCT01999868|7518860|FG002|COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
6593981|NCT01999868|7518858|FG000|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||23
6593982|NCT01999868|7518859|FG001|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||29
6593983|NCT01999868|7518860|FG002|NOT COMPLETED|Blinded Observation Phase (Week 40 - 88)||0
6593984|NCT01999894|7518868|FG000|STARTED|Overall Study||102
6593985|NCT01999894|7518868|FG000|COMPLETED|Overall Study||66
6593986|NCT01999894|7518868|FG000|NOT COMPLETED|Overall Study||36
6593987|NCT01999920|7518875|FG000|STARTED|Overall Study||13
6593988|NCT01999920|7518876|FG001|STARTED|Overall Study||11
6593989|NCT01999920|7518875|FG000|COMPLETED|Overall Study||7
6593990|NCT01999920|7518876|FG001|COMPLETED|Overall Study||9
6593991|NCT01999920|7518875|FG000|NOT COMPLETED|Overall Study||6
6593992|NCT01999920|7518876|FG001|NOT COMPLETED|Overall Study||2
6593993|NCT01999946|7518885|FG000|STARTED|Overall Study||61
6593994|NCT01999946|7518886|FG001|STARTED|Overall Study||58
6593995|NCT01999946|7518887|FG002|STARTED|Overall Study||79
6593996|NCT01999946|7518885|FG000|COMPLETED|Overall Study||59
6593997|NCT01999946|7518886|FG001|COMPLETED|Overall Study||56
6593998|NCT01999946|7518887|FG002|COMPLETED|Overall Study||0
6593999|NCT01999946|7518885|FG000|NOT COMPLETED|Overall Study||2
6594000|NCT01999946|7518886|FG001|NOT COMPLETED|Overall Study||2
6594001|NCT01999946|7518887|FG002|NOT COMPLETED|Overall Study||79
6594002|NCT01999972|7518900|FG000|STARTED|Dose Escalation Part||5
6594003|NCT01999972|7518901|FG001|STARTED|Dose Escalation Part||3
6594004|NCT01999972|7518902|FG002|STARTED|Dose Escalation Part||5
6594005|NCT01999972|7518903|FG003|STARTED|Dose Escalation Part||11
6594006|NCT01999972|7518904|FG004|STARTED|Dose Escalation Part||0
6594007|NCT01999972|7518905|FG005|STARTED|Dose Escalation Part||0
6594008|NCT01999972|7518900|FG000|Treated|Dose Escalation Part||5
6594009|NCT01999972|7518901|FG001|Treated|Dose Escalation Part||3
6594010|NCT01999972|7518902|FG002|Treated|Dose Escalation Part||4
6594011|NCT01999972|7518903|FG003|Treated|Dose Escalation Part||10
6594012|NCT01999972|7518904|FG004|Treated|Dose Escalation Part||0
6594013|NCT01999972|7518905|FG005|Treated|Dose Escalation Part||0
6594014|NCT01999972|7518900|FG000|COMPLETED|Dose Escalation Part||0
6594015|NCT01999972|7518901|FG001|COMPLETED|Dose Escalation Part||0
6594016|NCT01999972|7518902|FG002|COMPLETED|Dose Escalation Part||0
6594017|NCT01999972|7518903|FG003|COMPLETED|Dose Escalation Part||0
6594018|NCT01999972|7518904|FG004|COMPLETED|Dose Escalation Part||0
6594019|NCT01999972|7518905|FG005|COMPLETED|Dose Escalation Part||0
6594020|NCT01999972|7518900|FG000|NOT COMPLETED|Dose Escalation Part||5
6594021|NCT01999972|7518901|FG001|NOT COMPLETED|Dose Escalation Part||3
6594022|NCT01999972|7518902|FG002|NOT COMPLETED|Dose Escalation Part||5
6594023|NCT01999972|7518903|FG003|NOT COMPLETED|Dose Escalation Part||11
6594024|NCT01999972|7518904|FG004|NOT COMPLETED|Dose Escalation Part||0
6594025|NCT01999972|7518905|FG005|NOT COMPLETED|Dose Escalation Part||0
6594026|NCT01999972|7518900|FG000|STARTED|Dose Expansion Part||0
6594027|NCT01999972|7518901|FG001|STARTED|Dose Expansion Part||0
6594028|NCT01999972|7518902|FG002|STARTED|Dose Expansion Part||0
6594029|NCT01999972|7518903|FG003|STARTED|Dose Expansion Part||0
6594030|NCT01999972|7518904|FG004|STARTED|Dose Expansion Part||21
6594031|NCT01999972|7518905|FG005|STARTED|Dose Expansion Part||7
6594032|NCT01999972|7518900|FG000|Treated|Dose Expansion Part||0
6594033|NCT01999972|7518901|FG001|Treated|Dose Expansion Part||0
6594034|NCT01999972|7518902|FG002|Treated|Dose Expansion Part||0
6594035|NCT01999972|7518903|FG003|Treated|Dose Expansion Part||0
6594036|NCT01999972|7518904|FG004|Treated|Dose Expansion Part||21
6594037|NCT01999972|7518905|FG005|Treated|Dose Expansion Part||7
6594038|NCT01999972|7518900|FG000|COMPLETED|Dose Expansion Part||0
6594039|NCT01999972|7518901|FG001|COMPLETED|Dose Expansion Part||0
6594040|NCT01999972|7518902|FG002|COMPLETED|Dose Expansion Part||0
6594041|NCT01999972|7518903|FG003|COMPLETED|Dose Expansion Part||0
6594042|NCT01999972|7518904|FG004|COMPLETED|Dose Expansion Part||0
6594043|NCT01999972|7518905|FG005|COMPLETED|Dose Expansion Part||0
6594044|NCT01999972|7518900|FG000|NOT COMPLETED|Dose Expansion Part||0
6594045|NCT01999972|7518901|FG001|NOT COMPLETED|Dose Expansion Part||0
6594046|NCT01999972|7518902|FG002|NOT COMPLETED|Dose Expansion Part||0
6594047|NCT01999972|7518903|FG003|NOT COMPLETED|Dose Expansion Part||0
6594048|NCT01999972|7518904|FG004|NOT COMPLETED|Dose Expansion Part||21
6594049|NCT01999972|7518905|FG005|NOT COMPLETED|Dose Expansion Part||7
6594050|NCT01999985|7518921|FG000|STARTED|Overall Study||8
6594051|NCT01999985|7518922|FG001|STARTED|Overall Study||3
6594052|NCT01999985|7518923|FG002|STARTED|Overall Study||14
6594053|NCT01999985|7518921|FG000|COMPLETED|Overall Study||8
6594054|NCT01999985|7518922|FG001|COMPLETED|Overall Study||3
6594055|NCT01999985|7518923|FG002|COMPLETED|Overall Study||14
6594056|NCT01999985|7518921|FG000|NOT COMPLETED|Overall Study||0
6594057|NCT01999985|7518922|FG001|NOT COMPLETED|Overall Study||0
6594058|NCT01999985|7518923|FG002|NOT COMPLETED|Overall Study||0
6594059|NCT02000154|7518929|FG000|STARTED|Overall Study||1
6594060|NCT02000154|7518929|FG000|COMPLETED|Overall Study||1
6594061|NCT02000154|7518929|FG000|NOT COMPLETED|Overall Study||0
6594062|NCT02000180|7518935|FG000|STARTED|Overall Study||18
6594063|NCT02000180|7518936|FG001|STARTED|Overall Study||19
6594064|NCT02000180|7518935|FG000|COMPLETED|Overall Study||18
6594065|NCT02000180|7518936|FG001|COMPLETED|Overall Study||19
6594066|NCT02000180|7518935|FG000|NOT COMPLETED|Overall Study||0
6594067|NCT02000180|7518936|FG001|NOT COMPLETED|Overall Study||0
6594068|NCT02000440|7518942|FG000|STARTED|Overall Study||17
6594069|NCT02000440|7518942|FG000|COMPLETED|Overall Study||13
6594070|NCT02000440|7518942|FG000|NOT COMPLETED|Overall Study||4
6594071|NCT02000531|7518948|FG000|STARTED|Overall Study||21
6594072|NCT02000531|7518949|FG001|STARTED|Overall Study||24
6594073|NCT02000531|7518948|FG000|Safety Population|Overall Study||21
6594074|NCT02000531|7518949|FG001|Safety Population|Overall Study||24
6594075|NCT02000531|7518948|FG000|COMPLETED|Overall Study||17
6594076|NCT02000531|7518949|FG001|COMPLETED|Overall Study||16
6594077|NCT02000531|7518948|FG000|NOT COMPLETED|Overall Study||4
6594078|NCT02000531|7518949|FG001|NOT COMPLETED|Overall Study||8
6594079|NCT02000583|7518957|FG000|STARTED|Overall Study||78
6594080|NCT02000583|7518958|FG001|STARTED|Overall Study||39
6594081|NCT02000583|7518957|FG000|COMPLETED|Overall Study||75
6594082|NCT02000583|7518958|FG001|COMPLETED|Overall Study||34
6594083|NCT02000583|7518957|FG000|NOT COMPLETED|Overall Study||3
6594084|NCT02000583|7518958|FG001|NOT COMPLETED|Overall Study||5
6594085|NCT02000752|7518966|FG000|STARTED|Overall Study||60
6594086|NCT02000752|7518967|FG001|STARTED|Overall Study||60
6594087|NCT02000752|7518966|FG000|COMPLETED|Overall Study||29
6594088|NCT02000752|7518967|FG001|COMPLETED|Overall Study||47
6594089|NCT02000752|7518966|FG000|NOT COMPLETED|Overall Study||31
6594090|NCT02000752|7518967|FG001|NOT COMPLETED|Overall Study||13
6594091|NCT02000817|7518977|FG000|STARTED|Overall Study||6
6594092|NCT02000817|7518978|FG001|STARTED|Overall Study||9
6594093|NCT02000817|7518979|FG002|STARTED|Overall Study||8
6594094|NCT02000817|7518980|FG003|STARTED|Overall Study||7
6594095|NCT02000817|7518977|FG000|COMPLETED|Overall Study||4
6594096|NCT02000817|7518978|FG001|COMPLETED|Overall Study||8
6594097|NCT02000817|7518979|FG002|COMPLETED|Overall Study||7
6594098|NCT02000817|7518980|FG003|COMPLETED|Overall Study||7
6594099|NCT02000817|7518977|FG000|NOT COMPLETED|Overall Study||2
6594100|NCT02000817|7518978|FG001|NOT COMPLETED|Overall Study||1
6594101|NCT02000817|7518979|FG002|NOT COMPLETED|Overall Study||1
6594102|NCT02000817|7518980|FG003|NOT COMPLETED|Overall Study||0
6594103|NCT02000908|7518995|FG000|STARTED|Overall Study||30
6594104|NCT02000908|7518996|FG001|STARTED|Overall Study||40
6594105|NCT02000908|7518995|FG000|COMPLETED|Overall Study||28
6594106|NCT02000908|7518996|FG001|COMPLETED|Overall Study||36
6594107|NCT02000908|7518995|FG000|NOT COMPLETED|Overall Study||2
6594108|NCT02000908|7518996|FG001|NOT COMPLETED|Overall Study||4
6594109|NCT02000921|7519005|FG000|STARTED|Overall Study||27
6594110|NCT02000921|7519006|FG001|STARTED|Overall Study||53
6594111|NCT02000921|7519007|FG002|STARTED|Overall Study||56
6594112|NCT02000921|7519005|FG000|COMPLETED|Overall Study||22
6594113|NCT02000921|7519006|FG001|COMPLETED|Overall Study||37
6594114|NCT02000921|7519007|FG002|COMPLETED|Overall Study||46
6594115|NCT02000921|7519005|FG000|NOT COMPLETED|Overall Study||5
6594116|NCT02000921|7519006|FG001|NOT COMPLETED|Overall Study||16
6594117|NCT02000921|7519007|FG002|NOT COMPLETED|Overall Study||10
6594118|NCT02000973|7519019|FG000|STARTED|Overall Study||20
6594119|NCT02000973|7519020|FG001|STARTED|Overall Study||20
6594120|NCT02000973|7519021|FG002|STARTED|Overall Study||20
6594121|NCT02000973|7519022|FG003|STARTED|Overall Study||20
6594122|NCT02000973|7519019|FG000|COMPLETED|Overall Study||20
6594123|NCT02000973|7519020|FG001|COMPLETED|Overall Study||20
6594124|NCT02000973|7519021|FG002|COMPLETED|Overall Study||20
6594125|NCT02000973|7519022|FG003|COMPLETED|Overall Study||20
6594126|NCT02000973|7519019|FG000|NOT COMPLETED|Overall Study||0
6594127|NCT02000973|7519020|FG001|NOT COMPLETED|Overall Study||0
6594128|NCT02000973|7519021|FG002|NOT COMPLETED|Overall Study||0
6594129|NCT02000973|7519022|FG003|NOT COMPLETED|Overall Study||0
6594130|NCT02001051|7519034|FG000|STARTED|Overall Study||2
6594131|NCT02001051|7519035|FG001|STARTED|Overall Study||2
6594132|NCT02001051|7519034|FG000|COMPLETED|Overall Study||2
6594133|NCT02001051|7519035|FG001|COMPLETED|Overall Study||1
6594134|NCT02001051|7519034|FG000|NOT COMPLETED|Overall Study||0
6594135|NCT02001051|7519035|FG001|NOT COMPLETED|Overall Study||1
6594136|NCT02001064|7519043|FG000|STARTED|Overall Study||30
6594137|NCT02001064|7519044|FG001|STARTED|Overall Study||30
6594138|NCT02001064|7519043|FG000|COMPLETED|Overall Study||28
6594139|NCT02001064|7519044|FG001|COMPLETED|Overall Study||29
6594140|NCT02001064|7519043|FG000|NOT COMPLETED|Overall Study||2
6594141|NCT02001064|7519044|FG001|NOT COMPLETED|Overall Study||1
6594142|NCT02001181|7519052|FG000|STARTED|Overall Study||35
6594143|NCT02001181|7519053|FG001|STARTED|Overall Study||34
6594144|NCT02001181|7519052|FG000|COMPLETED|Overall Study||34
6594145|NCT02001181|7519053|FG001|COMPLETED|Overall Study||31
6594146|NCT02001181|7519052|FG000|NOT COMPLETED|Overall Study||1
6594147|NCT02001181|7519053|FG001|NOT COMPLETED|Overall Study||3
6594148|NCT02001194|7519063|FG000|STARTED|Intervention Period (13 Weeks)|17 teams|68
6594149|NCT02001194|7519064|FG001|STARTED|Intervention Period (13 Weeks)|20 teams|80
6594150|NCT02001194|7519065|FG002|STARTED|Intervention Period (13 Weeks)|19 teams|76
6594151|NCT02001194|7519066|FG003|STARTED|Intervention Period (13 Weeks)|20 teams|80
6594152|NCT02001194|7519063|FG000|COMPLETED|Intervention Period (13 Weeks)|16 teams|67
6594153|NCT02001194|7519064|FG001|COMPLETED|Intervention Period (13 Weeks)|20 teams|80
6594154|NCT02001194|7519065|FG002|COMPLETED|Intervention Period (13 Weeks)|19 teams|74
6594155|NCT02001194|7519066|FG003|COMPLETED|Intervention Period (13 Weeks)|20 teams|78
6594156|NCT02001194|7519063|FG000|NOT COMPLETED|Intervention Period (13 Weeks)||1
6594157|NCT02001194|7519064|FG001|NOT COMPLETED|Intervention Period (13 Weeks)||0
6594158|NCT02001194|7519065|FG002|NOT COMPLETED|Intervention Period (13 Weeks)||2
6594159|NCT02001194|7519066|FG003|NOT COMPLETED|Intervention Period (13 Weeks)||2
6594160|NCT02001194|7519063|FG000|STARTED|Follow-Up Period (13 Weeks)||67
6594161|NCT02001194|7519064|FG001|STARTED|Follow-Up Period (13 Weeks)||80
6594162|NCT02001194|7519065|FG002|STARTED|Follow-Up Period (13 Weeks)||74
6660110|NCT02496221|7591080|FG001|STARTED|Treatment Period 1 - 4 Days||10
6660111|NCT02496221|7591079|FG000|COMPLETED|Treatment Period 1 - 4 Days||10
6660112|NCT02496221|7591080|FG001|COMPLETED|Treatment Period 1 - 4 Days||10
6660113|NCT02496221|7591079|FG000|NOT COMPLETED|Treatment Period 1 - 4 Days||0
6660114|NCT02496221|7591080|FG001|NOT COMPLETED|Treatment Period 1 - 4 Days||0
6660115|NCT02496221|7591079|FG000|STARTED|Treatment Period 2 - 4 Days||10
6660116|NCT02496221|7591080|FG001|STARTED|Treatment Period 2 - 4 Days||10
6660117|NCT02496221|7591079|FG000|COMPLETED|Treatment Period 2 - 4 Days||8
6660118|NCT02496221|7591080|FG001|COMPLETED|Treatment Period 2 - 4 Days||9
6660119|NCT02496221|7591079|FG000|NOT COMPLETED|Treatment Period 2 - 4 Days||2
6660120|NCT02496221|7591080|FG001|NOT COMPLETED|Treatment Period 2 - 4 Days||1
6660121|NCT02496533|7591090|FG000|STARTED|Overall Study||105
6660122|NCT02496533|7591091|FG001|STARTED|Overall Study||112
6660123|NCT02496533|7591090|FG000|COMPLETED|Overall Study||102
6660124|NCT02496533|7591091|FG001|COMPLETED|Overall Study||106
6660125|NCT02496533|7591090|FG000|NOT COMPLETED|Overall Study||3
6660126|NCT02496533|7591091|FG001|NOT COMPLETED|Overall Study||6
6660127|NCT02496702|7591099|FG000|STARTED|Overall Study||30
6660128|NCT02496702|7591100|FG001|STARTED|Overall Study||30
6660129|NCT02496702|7591099|FG000|Received Allocated Intervention|Overall Study||21
6660130|NCT02496702|7591100|FG001|Received Allocated Intervention|Overall Study||0
6660131|NCT02496702|7591099|FG000|Did Not Receive Allocated Intervention|Overall Study||9
6660132|NCT02496702|7591100|FG001|Did Not Receive Allocated Intervention|Overall Study||0
6660133|NCT02496702|7591099|FG000|COMPLETED|Overall Study||22
6660134|NCT02496702|7591100|FG001|COMPLETED|Overall Study||22
6660135|NCT02496702|7591099|FG000|NOT COMPLETED|Overall Study||8
6660136|NCT02496702|7591100|FG001|NOT COMPLETED|Overall Study||8
6660137|NCT02496767|7591110|FG000|STARTED|Open-label Lead-in Phase||744
6660138|NCT02496767|7591111|FG001|STARTED|Open-label Lead-in Phase||0
6660139|NCT02496767|7591112|FG002|STARTED|Open-label Lead-in Phase||0
6660140|NCT02496767|7591113|FG003|STARTED|Open-label Lead-in Phase||0
6660141|NCT02496767|7591114|FG004|STARTED|Open-label Lead-in Phase||0
6660142|NCT02496767|7591115|FG005|STARTED|Open-label Lead-in Phase||0
6660143|NCT02496767|7591116|FG006|STARTED|Open-label Lead-in Phase||0
6660144|NCT02496767|7591117|FG007|STARTED|Open-label Lead-in Phase||0
6660145|NCT02496767|7591110|FG000|COMPLETED|Open-label Lead-in Phase||565
6660146|NCT02496767|7591111|FG001|COMPLETED|Open-label Lead-in Phase||0
6660147|NCT02496767|7591112|FG002|COMPLETED|Open-label Lead-in Phase||0
6660148|NCT02496767|7591113|FG003|COMPLETED|Open-label Lead-in Phase||0
6660149|NCT02496767|7591114|FG004|COMPLETED|Open-label Lead-in Phase||0
6660150|NCT02496767|7591115|FG005|COMPLETED|Open-label Lead-in Phase||0
6660151|NCT02496767|7591116|FG006|COMPLETED|Open-label Lead-in Phase||0
6660152|NCT02496767|7591117|FG007|COMPLETED|Open-label Lead-in Phase||0
6660153|NCT02496767|7591110|FG000|NOT COMPLETED|Open-label Lead-in Phase||179
6660154|NCT02496767|7591111|FG001|NOT COMPLETED|Open-label Lead-in Phase||0
6660155|NCT02496767|7591112|FG002|NOT COMPLETED|Open-label Lead-in Phase||0
6660156|NCT02496767|7591113|FG003|NOT COMPLETED|Open-label Lead-in Phase||0
6660157|NCT02496767|7591114|FG004|NOT COMPLETED|Open-label Lead-in Phase||0
6660158|NCT02496767|7591115|FG005|NOT COMPLETED|Open-label Lead-in Phase||0
6660159|NCT02496767|7591116|FG006|NOT COMPLETED|Open-label Lead-in Phase||0
6660160|NCT02496767|7591117|FG007|NOT COMPLETED|Open-label Lead-in Phase||0
6660161|NCT02496767|7591110|FG000|STARTED|Double-blind, Placebo-controlled Phase||0
6660162|NCT02496767|7591111|FG001|STARTED|Double-blind, Placebo-controlled Phase||188
6660163|NCT02496767|7591112|FG002|STARTED|Double-blind, Placebo-controlled Phase||126
6660164|NCT02496767|7591113|FG003|STARTED|Double-blind, Placebo-controlled Phase||126
6660165|NCT02496767|7591114|FG004|STARTED|Double-blind, Placebo-controlled Phase||125
6660166|NCT02496767|7591115|FG005|STARTED|Double-blind, Placebo-controlled Phase||0
6660167|NCT02496767|7591116|FG006|STARTED|Double-blind, Placebo-controlled Phase||0
6594163|NCT02001194|7519066|FG003|STARTED|Follow-Up Period (13 Weeks)||78
6594164|NCT02001194|7519063|FG000|COMPLETED|Follow-Up Period (13 Weeks)||64
6594165|NCT02001194|7519064|FG001|COMPLETED|Follow-Up Period (13 Weeks)||78
6594166|NCT02001194|7519065|FG002|COMPLETED|Follow-Up Period (13 Weeks)||73
6594167|NCT02001194|7519066|FG003|COMPLETED|Follow-Up Period (13 Weeks)||78
6594168|NCT02001194|7519063|FG000|NOT COMPLETED|Follow-Up Period (13 Weeks)||3
6594169|NCT02001194|7519064|FG001|NOT COMPLETED|Follow-Up Period (13 Weeks)||2
6594170|NCT02001194|7519065|FG002|NOT COMPLETED|Follow-Up Period (13 Weeks)||1
6594171|NCT02001194|7519066|FG003|NOT COMPLETED|Follow-Up Period (13 Weeks)||0
6594172|NCT02001558|7519078|FG000|STARTED|Overall Study||32
6594173|NCT02001558|7519079|FG001|STARTED|Overall Study||33
6594174|NCT02001558|7519078|FG000|COMPLETED|Overall Study||24
6594175|NCT02001558|7519079|FG001|COMPLETED|Overall Study||19
6594176|NCT02001558|7519078|FG000|NOT COMPLETED|Overall Study||8
6594177|NCT02001558|7519079|FG001|NOT COMPLETED|Overall Study||14
6594178|NCT02001688|7519088|FG000|STARTED|Overall Study||12
6594179|NCT02001688|7519089|FG001|STARTED|Overall Study||12
6594180|NCT02001688|7519090|FG002|STARTED|Overall Study||12
6594181|NCT02001688|7519088|FG000|COMPLETED|Overall Study||12
6594182|NCT02001688|7519089|FG001|COMPLETED|Overall Study||11
6594183|NCT02001688|7519090|FG002|COMPLETED|Overall Study||11
6594184|NCT02001688|7519088|FG000|NOT COMPLETED|Overall Study||0
6594185|NCT02001688|7519089|FG001|NOT COMPLETED|Overall Study||1
6594186|NCT02001688|7519090|FG002|NOT COMPLETED|Overall Study||1
6594187|NCT02001714|7519101|FG000|STARTED|Overall Study||232
6594188|NCT02001714|7519102|FG001|STARTED|Overall Study||231
6594189|NCT02001714|7519101|FG000|COMPLETED|Overall Study||210
6594190|NCT02001714|7519102|FG001|COMPLETED|Overall Study||219
6594191|NCT02001714|7519101|FG000|NOT COMPLETED|Overall Study||22
6594192|NCT02001714|7519102|FG001|NOT COMPLETED|Overall Study||12
6594193|NCT02001987|7519108|FG000|STARTED|Core Study Period (24 Weeks)||139
6594194|NCT02001987|7519108|FG000|COMPLETED|Core Study Period (24 Weeks)||116
6594195|NCT02001987|7519108|FG000|NOT COMPLETED|Core Study Period (24 Weeks)||23
6594196|NCT02001987|7519108|FG000|STARTED|LTE Period (52 Weeks)||116
6594197|NCT02001987|7519108|FG000|COMPLETED|LTE Period (52 Weeks)||107
6594198|NCT02001987|7519108|FG000|NOT COMPLETED|LTE Period (52 Weeks)||9
6594199|NCT02002091|7519119|FG000|STARTED|Screening||122
6594200|NCT02002091|7519120|FG001|STARTED|Screening||205
6594201|NCT02002091|7519119|FG000|COMPLETED|Screening||109
6594202|NCT02002091|7519120|FG001|COMPLETED|Screening||191
6594203|NCT02002091|7519119|FG000|NOT COMPLETED|Screening||13
6594204|NCT02002091|7519120|FG001|NOT COMPLETED|Screening||14
6594205|NCT02002091|7519119|FG000|STARTED|One Year Follow up||109
6594206|NCT02002091|7519120|FG001|STARTED|One Year Follow up||191
6594207|NCT02002091|7519119|FG000|COMPLETED|One Year Follow up||109
6594208|NCT02002091|7519120|FG001|COMPLETED|One Year Follow up||191
6594209|NCT02002091|7519119|FG000|NOT COMPLETED|One Year Follow up||0
6594210|NCT02002091|7519120|FG001|NOT COMPLETED|One Year Follow up||0
6594211|NCT02002182|7519157|FG000|STARTED|Overall Study||9
6594212|NCT02002182|7519158|FG001|STARTED|Overall Study||6
6594213|NCT02002182|7519157|FG000|COMPLETED|Overall Study||4
6594214|NCT02002182|7519158|FG001|COMPLETED|Overall Study||5
6594215|NCT02002182|7519157|FG000|NOT COMPLETED|Overall Study||5
6594216|NCT02002182|7519158|FG001|NOT COMPLETED|Overall Study||1
6594217|NCT02002208|7519166|FG000|STARTED|Overall Study||69
6594218|NCT02002208|7519167|FG001|STARTED|Overall Study||70
6594219|NCT02002208|7519166|FG000|COMPLETED|Overall Study||32
6594220|NCT02002208|7519167|FG001|COMPLETED|Overall Study||30
6594221|NCT02002208|7519166|FG000|NOT COMPLETED|Overall Study||37
6594222|NCT02002208|7519167|FG001|NOT COMPLETED|Overall Study||40
6594223|NCT02002221|7519175|FG000|STARTED|Overall Study||78
6594224|NCT02002221|7519176|FG001|STARTED|Overall Study||78
6594225|NCT02002221|7519175|FG000|COMPLETED|Overall Study||76
6594226|NCT02002221|7519176|FG001|COMPLETED|Overall Study||75
6594227|NCT02002221|7519175|FG000|NOT COMPLETED|Overall Study||2
6594228|NCT02002221|7519176|FG001|NOT COMPLETED|Overall Study||3
6594229|NCT02002494|7519182|FG000|STARTED|Overall Study||27
6594230|NCT02002494|7519182|FG000|COMPLETED|Overall Study||27
6594231|NCT02002494|7519182|FG000|NOT COMPLETED|Overall Study||0
6594232|NCT02002533|7519199|FG000|STARTED|Overall Study||34
6594233|NCT02002533|7519200|FG001|STARTED|Overall Study||37
6594234|NCT02002533|7519199|FG000|COMPLETED|Overall Study||28
6594235|NCT02002533|7519200|FG001|COMPLETED|Overall Study||19
6594236|NCT02002533|7519199|FG000|NOT COMPLETED|Overall Study||6
6594237|NCT02002533|7519200|FG001|NOT COMPLETED|Overall Study||18
6594238|NCT02002650|7519209|FG000|STARTED|Overall Study||1297
6594239|NCT02002650|7519210|FG001|STARTED|Overall Study||1303
6594240|NCT02002650|7519209|FG000|COMPLETED|Overall Study||1297
6594241|NCT02002650|7519210|FG001|COMPLETED|Overall Study||1303
6594242|NCT02002650|7519209|FG000|NOT COMPLETED|Overall Study||0
6594243|NCT02002650|7519210|FG001|NOT COMPLETED|Overall Study||0
6594244|NCT02002689|7519217|FG000|STARTED|Overall Study||10
6594245|NCT02002689|7519217|FG000|COMPLETED|Overall Study||0
6594246|NCT02002689|7519217|FG000|NOT COMPLETED|Overall Study||10
6594247|NCT02002702|7519224|FG000|STARTED|Overall Study||16
6594248|NCT02002702|7519225|FG001|STARTED|Overall Study||15
6594249|NCT02002702|7519226|FG002|STARTED|Overall Study||15
6594250|NCT02002702|7519224|FG000|COMPLETED|Overall Study||16
6594251|NCT02002702|7519225|FG001|COMPLETED|Overall Study||15
6594252|NCT02002702|7519226|FG002|COMPLETED|Overall Study||15
6594253|NCT02002702|7519224|FG000|NOT COMPLETED|Overall Study||0
6594254|NCT02002702|7519225|FG001|NOT COMPLETED|Overall Study||0
6594255|NCT02002702|7519226|FG002|NOT COMPLETED|Overall Study||0
6594256|NCT02002767|7519236|FG000|STARTED|Overall Study||9
6594257|NCT02002767|7519237|FG001|STARTED|Overall Study||10
6594258|NCT02002767|7519236|FG000|COMPLETED|Overall Study||9
6594259|NCT02002767|7519237|FG001|COMPLETED|Overall Study||10
6594260|NCT02002767|7519236|FG000|NOT COMPLETED|Overall Study||0
6594261|NCT02002767|7519237|FG001|NOT COMPLETED|Overall Study||0
6594262|NCT02002832|7519245|FG000|STARTED|Overall Study||194
6594263|NCT02002832|7519246|FG001|STARTED|Overall Study||194
6594264|NCT02002832|7519245|FG000|COMPLETED|Overall Study||166
6594265|NCT02002832|7519246|FG001|COMPLETED|Overall Study||168
6594266|NCT02002832|7519245|FG000|NOT COMPLETED|Overall Study||28
6594267|NCT02002832|7519246|FG001|NOT COMPLETED|Overall Study||26
6594268|NCT02002871|7519253|FG000|STARTED|Overall Study||21
6594269|NCT02002871|7519253|FG000|COMPLETED|Overall Study||20
6594270|NCT02002871|7519253|FG000|NOT COMPLETED|Overall Study||1
6594271|NCT02002884|7519261|FG000|STARTED|Main Period (MP)||87
6594272|NCT02002884|7519262|FG001|STARTED|Main Period (MP)||88
6594273|NCT02002884|7519263|FG002|STARTED|Main Period (MP)||176
6594274|NCT02002884|7519264|FG003|STARTED|Main Period (MP)||0
6594275|NCT02002884|7519261|FG000|Treated|Main Period (MP)||87
6594276|NCT02002884|7519262|FG001|Treated|Main Period (MP)||87
6594277|NCT02002884|7519263|FG002|Treated|Main Period (MP)||176
6594278|NCT02002884|7519264|FG003|Treated|Main Period (MP)||0
6594279|NCT02002884|7519261|FG000|COMPLETED|Main Period (MP)||81
6594280|NCT02002884|7519262|FG001|COMPLETED|Main Period (MP)||82
6594281|NCT02002884|7519263|FG002|COMPLETED|Main Period (MP)||168
6594282|NCT02002884|7519264|FG003|COMPLETED|Main Period (MP)||0
6594283|NCT02002884|7519261|FG000|NOT COMPLETED|Main Period (MP)||6
6594284|NCT02002884|7519262|FG001|NOT COMPLETED|Main Period (MP)||6
6594285|NCT02002884|7519263|FG002|NOT COMPLETED|Main Period (MP)||8
6594286|NCT02002884|7519264|FG003|NOT COMPLETED|Main Period (MP)||0
6594287|NCT02002884|7519261|FG000|STARTED|Open-Label Extension Period (OLEX)||0
6594288|NCT02002884|7519262|FG001|STARTED|Open-Label Extension Period (OLEX)||0
6594289|NCT02002884|7519263|FG002|STARTED|Open-Label Extension Period (OLEX)||0
6594290|NCT02002884|7519264|FG003|STARTED|Open-Label Extension Period (OLEX)||331
6594291|NCT02002884|7519261|FG000|COMPLETED|Open-Label Extension Period (OLEX)||0
6594292|NCT02002884|7519262|FG001|COMPLETED|Open-Label Extension Period (OLEX)||0
6594293|NCT02002884|7519263|FG002|COMPLETED|Open-Label Extension Period (OLEX)||0
6594294|NCT02002884|7519264|FG003|COMPLETED|Open-Label Extension Period (OLEX)||281
6594295|NCT02002884|7519261|FG000|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
6594296|NCT02002884|7519262|FG001|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
6594297|NCT02002884|7519263|FG002|NOT COMPLETED|Open-Label Extension Period (OLEX)||0
6594298|NCT02002884|7519264|FG003|NOT COMPLETED|Open-Label Extension Period (OLEX)||50
6594299|NCT02002936|7519274|FG000|STARTED|Overall Study||1
6594300|NCT02002936|7519274|FG000|COMPLETED|Overall Study||1
6594301|NCT02002936|7519274|FG000|NOT COMPLETED|Overall Study||0
6594302|NCT02002975|7519278|FG000|STARTED|Overall Study||18223
6594303|NCT02002975|7519278|FG000|COMPLETED|Overall Study||17651
6594304|NCT02002975|7519278|FG000|NOT COMPLETED|Overall Study||572
6594305|NCT02003014|7519282|FG000|STARTED|Overall Study||899
6594306|NCT02003014|7519282|FG000|COMPLETED|Overall Study||880
6594307|NCT02003014|7519282|FG000|NOT COMPLETED|Overall Study||19
6594308|NCT02003053|7519288|FG000|STARTED|Overall Study||4
6594309|NCT02003053|7519289|FG001|STARTED|Overall Study||3
6594310|NCT02003053|7519288|FG000|COMPLETED|Overall Study||4
6594311|NCT02003053|7519289|FG001|COMPLETED|Overall Study||3
6594312|NCT02003053|7519288|FG000|NOT COMPLETED|Overall Study||0
6594313|NCT02003053|7519289|FG001|NOT COMPLETED|Overall Study||0
6594314|NCT02003183|7519297|FG000|STARTED|Overall Study||7
6594315|NCT02003183|7519298|FG001|STARTED|Overall Study||17
6594316|NCT02003183|7519297|FG000|COMPLETED|Overall Study||7
6594317|NCT02003183|7519298|FG001|COMPLETED|Overall Study||15
6594318|NCT02003183|7519297|FG000|NOT COMPLETED|Overall Study||0
6594319|NCT02003183|7519298|FG001|NOT COMPLETED|Overall Study||2
6594320|NCT02003352|7519304|FG000|STARTED|Overall Study||98
6594321|NCT02003352|7519304|FG000|COMPLETED|Overall Study||98
6594322|NCT02003352|7519304|FG000|NOT COMPLETED|Overall Study||0
6594323|NCT02003365|7519311|FG000|STARTED|Overall Study||10
6594324|NCT02003365|7519312|FG001|STARTED|Overall Study||30
6594325|NCT02003365|7519313|FG002|STARTED|Overall Study||10
6594326|NCT02003365|7519311|FG000|COMPLETED|Overall Study||10
6594327|NCT02003365|7519312|FG001|COMPLETED|Overall Study||30
6594328|NCT02003365|7519313|FG002|COMPLETED|Overall Study||9
6594329|NCT02003365|7519311|FG000|NOT COMPLETED|Overall Study||0
6594330|NCT02003365|7519312|FG001|NOT COMPLETED|Overall Study||0
6594331|NCT02003365|7519313|FG002|NOT COMPLETED|Overall Study||1
6594332|NCT02003391|7519323|FG000|STARTED|Overall Study||81
6594333|NCT02003391|7519324|FG001|STARTED|Overall Study||75
6594334|NCT02003391|7519323|FG000|Safety Population|Overall Study||81
6594335|NCT02003391|7519324|FG001|Safety Population|Overall Study||75
6594336|NCT02003391|7519323|FG000|Intent to Treat Population|Overall Study||78
6594337|NCT02003391|7519324|FG001|Intent to Treat Population|Overall Study||73
6594338|NCT02003391|7519323|FG000|COMPLETED|Overall Study||78
6594339|NCT02003391|7519324|FG001|COMPLETED|Overall Study||73
6594340|NCT02003391|7519323|FG000|NOT COMPLETED|Overall Study||3
6594341|NCT02003391|7519324|FG001|NOT COMPLETED|Overall Study||2
6594342|NCT02003404|7519330|FG000|STARTED|Overall Study||17
6594343|NCT02003404|7519330|FG000|COMPLETED|Overall Study||17
6594344|NCT02003404|7519330|FG000|NOT COMPLETED|Overall Study||0
6594345|NCT02003508|7519338|FG000|STARTED|Overall Study||179
6594346|NCT02003508|7519339|FG001|STARTED|Overall Study||166
6594347|NCT02003508|7519338|FG000|COMPLETED|Overall Study||179
6594348|NCT02003508|7519339|FG001|COMPLETED|Overall Study||166
6594349|NCT02003508|7519338|FG000|NOT COMPLETED|Overall Study||0
6594350|NCT02003508|7519339|FG001|NOT COMPLETED|Overall Study||0
6594351|NCT02003534|7519345|FG000|STARTED|Overall Study||376
6594352|NCT02003534|7519345|FG000|COMPLETED|Overall Study||329
6594353|NCT02003534|7519345|FG000|NOT COMPLETED|Overall Study||47
6624634|NCT02218541|7552094|FG001|NOT COMPLETED|Overall Study||2
6624635|NCT02218736|7552103|FG000|STARTED|Overall Study||45
6624636|NCT02218736|7552104|FG001|STARTED|Overall Study||44
6624637|NCT02218736|7552103|FG000|COMPLETED|Overall Study||33
6624638|NCT02218736|7552104|FG001|COMPLETED|Overall Study||35
6624639|NCT02218736|7552103|FG000|NOT COMPLETED|Overall Study||12
6624640|NCT02218736|7552104|FG001|NOT COMPLETED|Overall Study||9
6624641|NCT02219009|7552112|FG000|STARTED|Overall Study||37
6624642|NCT02219009|7552113|FG001|STARTED|Overall Study||30
6624643|NCT02219009|7552112|FG000|COMPLETED|Overall Study||27
6624644|NCT02219009|7552113|FG001|COMPLETED|Overall Study||22
6624645|NCT02219009|7552112|FG000|NOT COMPLETED|Overall Study||10
6624646|NCT02219009|7552113|FG001|NOT COMPLETED|Overall Study||8
6624647|NCT02219048|7552121|FG000|STARTED|Overall Study||26
6624648|NCT02219048|7552122|FG001|STARTED|Overall Study||25
6624649|NCT02219048|7552121|FG000|COMPLETED|Overall Study||5
6624650|NCT02219048|7552122|FG001|COMPLETED|Overall Study||4
6624651|NCT02219048|7552121|FG000|NOT COMPLETED|Overall Study||21
6624652|NCT02219048|7552122|FG001|NOT COMPLETED|Overall Study||21
6624653|NCT02219087|7552130|FG000|STARTED|Overall Study||30
6624654|NCT02219087|7552131|FG001|STARTED|Overall Study||30
6624655|NCT02219087|7552130|FG000|COMPLETED|Overall Study||30
6624656|NCT02219087|7552131|FG001|COMPLETED|Overall Study|Randomization envelope pulled out of sequence for consented patient. Excluded by request of IRB|29
6624657|NCT02219087|7552130|FG000|NOT COMPLETED|Overall Study||0
6624658|NCT02219087|7552131|FG001|NOT COMPLETED|Overall Study||1
6624659|NCT02219256|7552149|FG000|STARTED|Overall Study||12
6624660|NCT02219256|7552150|FG001|STARTED|Overall Study||4
6624661|NCT02219256|7552151|FG002|STARTED|Overall Study||4
6624662|NCT02219256|7552152|FG003|STARTED|Overall Study||4
6624663|NCT02219256|7552153|FG004|STARTED|Overall Study||6
6624664|NCT02219256|7552154|FG005|STARTED|Overall Study||6
6624665|NCT02219256|7552155|FG006|STARTED|Overall Study||6
6624666|NCT02219256|7552156|FG007|STARTED|Overall Study||8
6624667|NCT02219256|7552157|FG008|STARTED|Overall Study||6
6624668|NCT02219256|7552158|FG009|STARTED|Overall Study||6
6624669|NCT02219256|7552159|FG010|STARTED|Overall Study||6
6624670|NCT02219256|7552160|FG011|STARTED|Overall Study||6
6624671|NCT02219256|7552149|FG000|COMPLETED|Overall Study||12
6624672|NCT02219256|7552150|FG001|COMPLETED|Overall Study||4
6624673|NCT02219256|7552151|FG002|COMPLETED|Overall Study||4
6624674|NCT02219256|7552152|FG003|COMPLETED|Overall Study||4
6624675|NCT02219256|7552153|FG004|COMPLETED|Overall Study||6
6624676|NCT02219256|7552154|FG005|COMPLETED|Overall Study||6
6624677|NCT02219256|7552155|FG006|COMPLETED|Overall Study||6
6624678|NCT02219256|7552156|FG007|COMPLETED|Overall Study||8
6624679|NCT02219256|7552157|FG008|COMPLETED|Overall Study||6
6624680|NCT02219256|7552158|FG009|COMPLETED|Overall Study||6
6624681|NCT02219256|7552159|FG010|COMPLETED|Overall Study||6
6624682|NCT02219256|7552160|FG011|COMPLETED|Overall Study||6
6624683|NCT02219256|7552149|FG000|NOT COMPLETED|Overall Study||0
6624684|NCT02219256|7552150|FG001|NOT COMPLETED|Overall Study||0
6624685|NCT02219256|7552151|FG002|NOT COMPLETED|Overall Study||0
6624686|NCT02219256|7552152|FG003|NOT COMPLETED|Overall Study||0
6624687|NCT02219256|7552153|FG004|NOT COMPLETED|Overall Study||0
6624688|NCT02219256|7552154|FG005|NOT COMPLETED|Overall Study||0
6624689|NCT02219256|7552155|FG006|NOT COMPLETED|Overall Study||0
6624690|NCT02219256|7552156|FG007|NOT COMPLETED|Overall Study||0
6624691|NCT02219256|7552157|FG008|NOT COMPLETED|Overall Study||0
6624692|NCT02219256|7552158|FG009|NOT COMPLETED|Overall Study||0
6624693|NCT02219256|7552159|FG010|NOT COMPLETED|Overall Study||0
6624694|NCT02219256|7552160|FG011|NOT COMPLETED|Overall Study||0
6624695|NCT02219282|7552188|FG000|STARTED|Overall Study||33
6624696|NCT02219282|7552189|FG001|STARTED|Overall Study||33
6624697|NCT02219282|7552188|FG000|COMPLETED|Overall Study||32
6624698|NCT02219282|7552189|FG001|COMPLETED|Overall Study||32
6624699|NCT02219282|7552188|FG000|NOT COMPLETED|Overall Study||1
6624700|NCT02219282|7552189|FG001|NOT COMPLETED|Overall Study||1
6624701|NCT02219308|7552201|FG000|STARTED|Overall Study||32
6624702|NCT02219308|7552202|FG001|STARTED|Overall Study||35
6624703|NCT02219308|7552201|FG000|COMPLETED|Overall Study||31
6624704|NCT02219308|7552202|FG001|COMPLETED|Overall Study||33
6624705|NCT02219308|7552201|FG000|NOT COMPLETED|Overall Study||1
6624706|NCT02219308|7552202|FG001|NOT COMPLETED|Overall Study||2
6624707|NCT02219321|7552210|FG000|STARTED|Overall Study||1
6624708|NCT02219321|7552211|FG001|STARTED|Overall Study||2
6624709|NCT02219321|7552210|FG000|COMPLETED|Overall Study||1
6624710|NCT02219321|7552211|FG001|COMPLETED|Overall Study||2
6624711|NCT02219321|7552210|FG000|NOT COMPLETED|Overall Study||0
6624712|NCT02219321|7552211|FG001|NOT COMPLETED|Overall Study||0
6624713|NCT02219334|7552219|FG000|STARTED|Overall Study||32
6624714|NCT02219334|7552220|FG001|STARTED|Overall Study||23
6624715|NCT02219334|7552219|FG000|COMPLETED|Overall Study||24
6624716|NCT02219334|7552220|FG001|COMPLETED|Overall Study||20
6594354|NCT02003573|7519352|FG000|STARTED|Overall Study|Started are treated patients|3
6594355|NCT02003573|7519353|FG001|STARTED|Overall Study|Started are treated patients|4
6594356|NCT02003573|7519354|FG002|STARTED|Overall Study|Started are treated patients|6
6594357|NCT02003573|7519352|FG000|COMPLETED|Overall Study||0
6594358|NCT02003573|7519353|FG001|COMPLETED|Overall Study||0
6594359|NCT02003573|7519354|FG002|COMPLETED|Overall Study||0
6594360|NCT02003573|7519352|FG000|NOT COMPLETED|Overall Study||3
6594361|NCT02003573|7519353|FG001|NOT COMPLETED|Overall Study||4
6594362|NCT02003573|7519354|FG002|NOT COMPLETED|Overall Study||6
6594363|NCT02003625|7519366|FG000|STARTED|Overall Study||15
6594364|NCT02003625|7519367|FG001|STARTED|Overall Study||15
6594365|NCT02003625|7519366|FG000|Received Transplant|Overall Study||14
6594366|NCT02003625|7519367|FG001|Received Transplant|Overall Study||12
6594367|NCT02003625|7519366|FG000|COMPLETED|Overall Study||14
6594368|NCT02003625|7519367|FG001|COMPLETED|Overall Study||12
6594369|NCT02003625|7519366|FG000|NOT COMPLETED|Overall Study||1
6594370|NCT02003625|7519367|FG001|NOT COMPLETED|Overall Study||3
6594371|NCT02003638|7519375|FG000|STARTED|Overall Study||6
6594372|NCT02003638|7519376|FG001|STARTED|Overall Study||3
6594373|NCT02003638|7519375|FG000|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
6594374|NCT02003638|7519376|FG001|COMPLETED|Overall Study||3
6594375|NCT02003638|7519375|FG000|NOT COMPLETED|Overall Study||1
6594376|NCT02003638|7519376|FG001|NOT COMPLETED|Overall Study||0
6594377|NCT02003898|7519382|FG000|STARTED|Overall Study||372
6594378|NCT02003898|7519382|FG000|COMPLETED|Overall Study||305
6594379|NCT02003898|7519382|FG000|NOT COMPLETED|Overall Study||67
6594380|NCT02003911|7519388|FG000|STARTED|Overall Study||80
6594381|NCT02003911|7519389|FG001|STARTED|Overall Study||79
6594382|NCT02003911|7519388|FG000|COMPLETED|Overall Study||78
6594383|NCT02003911|7519389|FG001|COMPLETED|Overall Study||72
6594384|NCT02003911|7519388|FG000|NOT COMPLETED|Overall Study||2
6594385|NCT02003911|7519389|FG001|NOT COMPLETED|Overall Study||7
6594386|NCT02003963|7519397|FG000|STARTED|Overall Study||22
6594387|NCT02003963|7519398|FG001|STARTED|Overall Study||19
6594388|NCT02003963|7519397|FG000|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
6594389|NCT02003963|7519398|FG001|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
6594390|NCT02003963|7519397|FG000|NOT COMPLETED|Overall Study||2
6594391|NCT02003963|7519398|FG001|NOT COMPLETED|Overall Study||1
6594392|NCT02004093|7519408|FG000|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
6594393|NCT02004093|7519409|FG001|STARTED|Overall Study||74
6594394|NCT02004093|7519408|FG000|COMPLETED|Overall Study||1
6594395|NCT02004093|7519409|FG001|COMPLETED|Overall Study||1
6594396|NCT02004093|7519408|FG000|NOT COMPLETED|Overall Study||74
6594397|NCT02004093|7519409|FG001|NOT COMPLETED|Overall Study||73
6594398|NCT02004132|7519418|FG000|STARTED|Overall Study||12
6594399|NCT02004132|7519418|FG000|Received Study Drug|Overall Study||12
6594400|NCT02004132|7519418|FG000|COMPLETED|Overall Study||12
6594401|NCT02004132|7519418|FG000|NOT COMPLETED|Overall Study||0
6594402|NCT02004158|7519422|FG000|STARTED|Overall Study||23
6594403|NCT02004158|7519422|FG000|COMPLETED|Overall Study||20
6594404|NCT02004158|7519422|FG000|NOT COMPLETED|Overall Study||3
6594405|NCT02004236|7519431|FG000|STARTED|Overall Study||75
6594406|NCT02004236|7519432|FG001|STARTED|Overall Study||75
6594407|NCT02004236|7519433|FG002|STARTED|Overall Study||75
6594408|NCT02004236|7519431|FG000|COMPLETED|Overall Study||75
6594409|NCT02004236|7519432|FG001|COMPLETED|Overall Study||75
6594410|NCT02004236|7519433|FG002|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
6594411|NCT02004236|7519431|FG000|NOT COMPLETED|Overall Study||0
6594412|NCT02004236|7519432|FG001|NOT COMPLETED|Overall Study||0
6594413|NCT02004236|7519433|FG002|NOT COMPLETED|Overall Study||16
6594414|NCT02004262|7519448|FG000|STARTED|Overall Study||73
6594415|NCT02004262|7519449|FG001|STARTED|Overall Study||68
6594416|NCT02004262|7519450|FG002|STARTED|Overall Study||72
6594417|NCT02004262|7519451|FG003|STARTED|Overall Study||29
6594418|NCT02004262|7519452|FG004|STARTED|Overall Study||31
6594419|NCT02004262|7519453|FG005|STARTED|Overall Study||30
6594420|NCT02004262|7519448|FG000|Treated|Overall Study||68
6594421|NCT02004262|7519449|FG001|Treated|Overall Study||58
6594422|NCT02004262|7519450|FG002|Treated|Overall Study||43
6594423|NCT02004262|7519451|FG003|Treated|Overall Study||26
6594424|NCT02004262|7519452|FG004|Treated|Overall Study||29
6594425|NCT02004262|7519453|FG005|Treated|Overall Study||11
6594426|NCT02004262|7519448|FG000|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6594427|NCT02004262|7519449|FG001|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6594428|NCT02004262|7519450|FG002|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6594429|NCT02004262|7519451|FG003|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6737555|NCT03267264|7666819|FG002|Sequence B(Comparator)|Overall Study||33
6594430|NCT02004262|7519452|FG004|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6594431|NCT02004262|7519453|FG005|COMPLETED|Overall Study|"Subjects followed until lost to follow-up/consent withdrawn/death, so no subjects completed study."|0
6594432|NCT02004262|7519448|FG000|NOT COMPLETED|Overall Study||73
6594433|NCT02004262|7519449|FG001|NOT COMPLETED|Overall Study||68
6594434|NCT02004262|7519450|FG002|NOT COMPLETED|Overall Study||72
6594435|NCT02004262|7519451|FG003|NOT COMPLETED|Overall Study||29
6594436|NCT02004262|7519452|FG004|NOT COMPLETED|Overall Study||31
6594437|NCT02004262|7519453|FG005|NOT COMPLETED|Overall Study||30
6594438|NCT02004288|7519469|FG000|STARTED|Overall Study||15
6594439|NCT02004288|7519470|FG001|STARTED|Overall Study||16
6594440|NCT02004288|7519469|FG000|COMPLETED|Overall Study||14
6594441|NCT02004288|7519470|FG001|COMPLETED|Overall Study||15
6594442|NCT02004288|7519469|FG000|NOT COMPLETED|Overall Study||1
6594443|NCT02004288|7519470|FG001|NOT COMPLETED|Overall Study||1
6594444|NCT02004353|7519476|FG000|STARTED|Overall Study||1518
6594445|NCT02004353|7519476|FG000|COMPLETED|Overall Study||184
6594446|NCT02004353|7519476|FG000|NOT COMPLETED|Overall Study||1334
6594447|NCT02004366|7519485|FG000|STARTED|In-hospital||128
6594448|NCT02004366|7519486|FG001|STARTED|In-hospital||122
6594449|NCT02004366|7519487|FG002|STARTED|In-hospital||0
6594450|NCT02004366|7519488|FG003|STARTED|In-hospital||0
6594451|NCT02004366|7519489|FG004|STARTED|In-hospital||0
6594452|NCT02004366|7519485|FG000|COMPLETED|In-hospital||128
6594453|NCT02004366|7519486|FG001|COMPLETED|In-hospital||122
6594454|NCT02004366|7519487|FG002|COMPLETED|In-hospital||0
6594455|NCT02004366|7519488|FG003|COMPLETED|In-hospital||0
6594456|NCT02004366|7519489|FG004|COMPLETED|In-hospital||0
6594457|NCT02004366|7519485|FG000|NOT COMPLETED|In-hospital||0
6594458|NCT02004366|7519486|FG001|NOT COMPLETED|In-hospital||0
6594459|NCT02004366|7519487|FG002|NOT COMPLETED|In-hospital||0
6594460|NCT02004366|7519488|FG003|NOT COMPLETED|In-hospital||0
6594461|NCT02004366|7519489|FG004|NOT COMPLETED|In-hospital||0
6594462|NCT02004366|7519485|FG000|STARTED|On Discharge||0
6594463|NCT02004366|7519486|FG001|STARTED|On Discharge||0
6594464|NCT02004366|7519487|FG002|STARTED|On Discharge||92
6594465|NCT02004366|7519488|FG003|STARTED|On Discharge||93
6594466|NCT02004366|7519489|FG004|STARTED|On Discharge||39
6594467|NCT02004366|7519485|FG000|COMPLETED|On Discharge||0
6594468|NCT02004366|7519486|FG001|COMPLETED|On Discharge||0
6594469|NCT02004366|7519487|FG002|COMPLETED|On Discharge||92
6594470|NCT02004366|7519488|FG003|COMPLETED|On Discharge||93
6594471|NCT02004366|7519489|FG004|COMPLETED|On Discharge||39
6594472|NCT02004366|7519485|FG000|NOT COMPLETED|On Discharge||0
6594473|NCT02004366|7519486|FG001|NOT COMPLETED|On Discharge||0
6594474|NCT02004366|7519487|FG002|NOT COMPLETED|On Discharge||0
6594475|NCT02004366|7519488|FG003|NOT COMPLETED|On Discharge||0
6594476|NCT02004366|7519489|FG004|NOT COMPLETED|On Discharge||0
6594477|NCT02004613|7519504|FG000|STARTED|Overall Study||400
6594478|NCT02004613|7519505|FG001|STARTED|Overall Study||398
6594479|NCT02004613|7519504|FG000|COMPLETED|Overall Study||398
6594480|NCT02004613|7519505|FG001|COMPLETED|Overall Study||396
6594481|NCT02004613|7519504|FG000|NOT COMPLETED|Overall Study||2
6594482|NCT02004613|7519505|FG001|NOT COMPLETED|Overall Study||2
6594483|NCT02004847|7519513|FG000|STARTED|Overall Study||24
6594484|NCT02004847|7519514|FG001|STARTED|Overall Study||23
6594485|NCT02004847|7519513|FG000|COMPLETED|Overall Study||23
6594486|NCT02004847|7519514|FG001|COMPLETED|Overall Study||22
6594487|NCT02004847|7519513|FG000|NOT COMPLETED|Overall Study||1
6594488|NCT02004847|7519514|FG001|NOT COMPLETED|Overall Study||1
6594489|NCT02004873|7519529|FG000|STARTED|Overall Study|Micra Implant Attempt|725
6594490|NCT02004873|7519529|FG000|Micra Implant Success|Overall Study||719
6594491|NCT02004873|7519529|FG000|COMPLETED|Overall Study|6-Month Follow-up|301
6594492|NCT02004873|7519529|FG000|NOT COMPLETED|Overall Study||424
6594493|NCT02004886|7519540|FG000|STARTED|Overall Study||19
6594494|NCT02004886|7519541|FG001|STARTED|Overall Study||18
6594495|NCT02004886|7519542|FG002|STARTED|Overall Study||18
6594496|NCT02004886|7519543|FG003|STARTED|Overall Study||19
6594497|NCT02004886|7519540|FG000|COMPLETED|Overall Study||18
6594498|NCT02004886|7519541|FG001|COMPLETED|Overall Study||17
6594499|NCT02004886|7519542|FG002|COMPLETED|Overall Study||18
6594500|NCT02004886|7519543|FG003|COMPLETED|Overall Study||19
6594501|NCT02004886|7519540|FG000|NOT COMPLETED|Overall Study||1
6594502|NCT02004886|7519541|FG001|NOT COMPLETED|Overall Study||1
6594503|NCT02004886|7519542|FG002|NOT COMPLETED|Overall Study||0
6594504|NCT02004886|7519543|FG003|NOT COMPLETED|Overall Study||0
6594505|NCT02004977|7519555|FG000|STARTED|Overall Study||463
6594506|NCT02004977|7519556|FG001|STARTED|Overall Study||441
6594507|NCT02004977|7519555|FG000|COMPLETED|Overall Study||409
6594508|NCT02004977|7519556|FG001|COMPLETED|Overall Study||436
6594509|NCT02004977|7519555|FG000|NOT COMPLETED|Overall Study||54
6594510|NCT02004977|7519556|FG001|NOT COMPLETED|Overall Study||5
6594511|NCT02004990|7519562|FG000|STARTED|Overall Study||12
6594512|NCT02004990|7519562|FG000|COMPLETED|Overall Study||12
6594513|NCT02004990|7519562|FG000|NOT COMPLETED|Overall Study||0
6594514|NCT02005016|7519566|FG000|STARTED|Overall Study||46
6594515|NCT02005016|7519566|FG000|COMPLETED|Overall Study||44
6594516|NCT02005016|7519566|FG000|NOT COMPLETED|Overall Study||2
6594517|NCT02005029|7519572|FG000|STARTED|First Intervention (1 Day)||5
6594518|NCT02005029|7519573|FG001|STARTED|First Intervention (1 Day)||5
6594519|NCT02005029|7519572|FG000|COMPLETED|First Intervention (1 Day)||4
6594520|NCT02005029|7519573|FG001|COMPLETED|First Intervention (1 Day)||5
6594521|NCT02005029|7519572|FG000|NOT COMPLETED|First Intervention (1 Day)||1
6594522|NCT02005029|7519573|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6594523|NCT02005029|7519572|FG000|STARTED|Washout (2 Weeks)||4
6594524|NCT02005029|7519573|FG001|STARTED|Washout (2 Weeks)||5
6594525|NCT02005029|7519572|FG000|COMPLETED|Washout (2 Weeks)||4
6594526|NCT02005029|7519573|FG001|COMPLETED|Washout (2 Weeks)||5
6594527|NCT02005029|7519572|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6594528|NCT02005029|7519573|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6594529|NCT02005029|7519572|FG000|STARTED|Second Intervention (1 Day)||4
6594530|NCT02005029|7519573|FG001|STARTED|Second Intervention (1 Day)||5
6594531|NCT02005029|7519572|FG000|COMPLETED|Second Intervention (1 Day)||4
6594532|NCT02005029|7519573|FG001|COMPLETED|Second Intervention (1 Day)||5
6594533|NCT02005029|7519572|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6594534|NCT02005029|7519573|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6594535|NCT02005211|7519604|FG000|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
6594536|NCT02005211|7519605|FG001|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
6594537|NCT02005211|7519606|FG002|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
6594538|NCT02005211|7519607|FG003|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
6594539|NCT02005211|7519608|FG004|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594540|NCT02005211|7519609|FG005|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594541|NCT02005211|7519610|FG006|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594542|NCT02005211|7519604|FG000|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
6594543|NCT02005211|7519605|FG001|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
6594544|NCT02005211|7519606|FG002|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
6594545|NCT02005211|7519607|FG003|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
6594546|NCT02005211|7519608|FG004|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594547|NCT02005211|7519609|FG005|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594548|NCT02005211|7519610|FG006|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594549|NCT02005211|7519604|FG000|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594550|NCT02005211|7519605|FG001|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594551|NCT02005211|7519606|FG002|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594552|NCT02005211|7519607|FG003|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594553|NCT02005211|7519608|FG004|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594554|NCT02005211|7519609|FG005|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594555|NCT02005211|7519610|FG006|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
6594556|NCT02005211|7519604|FG000|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594557|NCT02005211|7519605|FG001|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594558|NCT02005211|7519606|FG002|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594559|NCT02005211|7519607|FG003|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594560|NCT02005211|7519608|FG004|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
6594561|NCT02005211|7519609|FG005|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
6594562|NCT02005211|7519610|FG006|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
6594563|NCT02005211|7519604|FG000|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594564|NCT02005211|7519605|FG001|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594565|NCT02005211|7519606|FG002|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594566|NCT02005211|7519607|FG003|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594567|NCT02005211|7519608|FG004|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
6594568|NCT02005211|7519609|FG005|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
6594569|NCT02005211|7519610|FG006|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
6594570|NCT02005211|7519604|FG000|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594571|NCT02005211|7519605|FG001|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594572|NCT02005211|7519606|FG002|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594573|NCT02005211|7519607|FG003|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594574|NCT02005211|7519608|FG004|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
6594575|NCT02005211|7519609|FG005|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594576|NCT02005211|7519610|FG006|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
6594577|NCT02005250|7519635|FG000|STARTED|Overall Study||61
6594578|NCT02005250|7519636|FG001|STARTED|Overall Study||32
6594579|NCT02005250|7519635|FG000|COMPLETED|Overall Study||46
6594580|NCT02005250|7519636|FG001|COMPLETED|Overall Study||27
6594581|NCT02005250|7519635|FG000|NOT COMPLETED|Overall Study||15
6594582|NCT02005250|7519636|FG001|NOT COMPLETED|Overall Study||5
6594583|NCT02005276|7519646|FG000|STARTED|Overall Study||65
6594584|NCT02005276|7519647|FG001|STARTED|Overall Study||41
6594585|NCT02005276|7519648|FG002|STARTED|Overall Study||59
6594586|NCT02005276|7519649|FG003|STARTED|Overall Study||44
6594587|NCT02005276|7519646|FG000|Completed Intervention|Overall Study||61
6594588|NCT02005276|7519647|FG001|Completed Intervention|Overall Study||39
6594589|NCT02005276|7519648|FG002|Completed Intervention|Overall Study||56
6594590|NCT02005276|7519649|FG003|Completed Intervention|Overall Study||42
6594591|NCT02005276|7519646|FG000|COMPLETED|Overall Study||60
6594592|NCT02005276|7519647|FG001|COMPLETED|Overall Study||39
6594593|NCT02005276|7519648|FG002|COMPLETED|Overall Study||56
6594594|NCT02005276|7519649|FG003|COMPLETED|Overall Study||41
6594595|NCT02005276|7519646|FG000|NOT COMPLETED|Overall Study||5
6594596|NCT02005276|7519647|FG001|NOT COMPLETED|Overall Study||2
6594597|NCT02005276|7519648|FG002|NOT COMPLETED|Overall Study||3
6594598|NCT02005276|7519649|FG003|NOT COMPLETED|Overall Study||3
6594599|NCT02005354|7519663|FG000|STARTED|Overall Study||35
6594600|NCT02005354|7519664|FG001|STARTED|Overall Study||35
6594601|NCT02005354|7519663|FG000|COMPLETED|Overall Study||35
6594602|NCT02005354|7519664|FG001|COMPLETED|Overall Study||35
6594603|NCT02005354|7519663|FG000|NOT COMPLETED|Overall Study||0
6594604|NCT02005354|7519664|FG001|NOT COMPLETED|Overall Study||0
6594605|NCT02005393|7519670|FG000|STARTED|Overall Study||20
6594606|NCT02005393|7519670|FG000|COMPLETED|Overall Study||20
6594607|NCT02005393|7519670|FG000|NOT COMPLETED|Overall Study||0
6594608|NCT02005484|7519674|FG000|STARTED|Overall Study||6
6594609|NCT02005484|7519674|FG000|COMPLETED|Overall Study||2
6594610|NCT02005484|7519674|FG000|NOT COMPLETED|Overall Study||4
6594611|NCT02005510|7519680|FG000|STARTED|Randomized (Round 1)|Excludes 163 determined to be ineligible post-randomization due to delays in data warehouse update.|8120
6594612|NCT02005510|7519681|FG001|STARTED|Randomized (Round 1)|Excludes 196 determined to be ineligible post-randomization due to delays in data warehouse update.|8111
6594613|NCT02005510|7519680|FG000|COMPLETED|Randomized (Round 1)||8120
6594614|NCT02005510|7519681|FG001|COMPLETED|Randomized (Round 1)||8111
6594615|NCT02005510|7519680|FG000|NOT COMPLETED|Randomized (Round 1)||0
6594616|NCT02005510|7519681|FG001|NOT COMPLETED|Randomized (Round 1)||0
6594617|NCT02005510|7519680|FG000|STARTED|Rerandomized (Round 2)|Excludes 10 determined to be ineligible post-randomization due to delays in data warehouse update.|1631
6594618|NCT02005510|7519681|FG001|STARTED|Rerandomized (Round 2)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|1585
6594619|NCT02005510|7519680|FG000|COMPLETED|Rerandomized (Round 2)||1631
6594620|NCT02005510|7519681|FG001|COMPLETED|Rerandomized (Round 2)||1585
6594621|NCT02005510|7519680|FG000|NOT COMPLETED|Rerandomized (Round 2)||0
6594622|NCT02005510|7519681|FG001|NOT COMPLETED|Rerandomized (Round 2)||0
6594623|NCT02005510|7519680|FG000|STARTED|Rerandomized (Round 3)|Excludes 5 determined to be ineligible post-randomization due to delays in data warehouse update.|209
6594624|NCT02005510|7519681|FG001|STARTED|Rerandomized (Round 3)||195
6594625|NCT02005510|7519680|FG000|COMPLETED|Rerandomized (Round 3)||209
6594626|NCT02005510|7519681|FG001|COMPLETED|Rerandomized (Round 3)||195
6594627|NCT02005510|7519680|FG000|NOT COMPLETED|Rerandomized (Round 3)||0
6594628|NCT02005510|7519681|FG001|NOT COMPLETED|Rerandomized (Round 3)||0
6594629|NCT02005536|7519687|FG000|STARTED|Overall Study||60
6594630|NCT02005536|7519687|FG000|COMPLETED|Overall Study||60
6594631|NCT02005536|7519687|FG000|NOT COMPLETED|Overall Study||0
6594632|NCT02005549|7519691|FG000|STARTED|Overall Study||18
6594633|NCT02005549|7519691|FG000|COMPLETED|Overall Study||18
6594634|NCT02005549|7519691|FG000|NOT COMPLETED|Overall Study||0
6594635|NCT02005562|7519697|FG000|STARTED|Overall Study||127
6594636|NCT02005562|7519698|FG001|STARTED|Overall Study||125
6594637|NCT02005562|7519697|FG000|Transplanted|Overall Study||126
6594638|NCT02005562|7519698|FG001|Transplanted|Overall Study||121
6594639|NCT02005562|7519697|FG000|COMPLETED|Overall Study||115
6594640|NCT02005562|7519698|FG001|COMPLETED|Overall Study||110
6594641|NCT02005562|7519697|FG000|NOT COMPLETED|Overall Study||12
6594642|NCT02005562|7519698|FG001|NOT COMPLETED|Overall Study||15
6594643|NCT02005601|7519706|FG000|STARTED|Overall Study||53
6594644|NCT02005601|7519707|FG001|STARTED|Overall Study||53
6594645|NCT02005601|7519706|FG000|COMPLETED|Overall Study||53
6594646|NCT02005601|7519707|FG001|COMPLETED|Overall Study||53
6594647|NCT02005601|7519706|FG000|NOT COMPLETED|Overall Study||0
6594648|NCT02005601|7519707|FG001|NOT COMPLETED|Overall Study||0
6594649|NCT02005627|7519715|FG000|STARTED|Overall Study||23
6594650|NCT02005627|7519716|FG001|STARTED|Overall Study||23
6594651|NCT02005627|7519715|FG000|COMPLETED|Overall Study||21
6594652|NCT02005627|7519716|FG001|COMPLETED|Overall Study||19
6594653|NCT02005627|7519715|FG000|NOT COMPLETED|Overall Study||2
6594654|NCT02005627|7519716|FG001|NOT COMPLETED|Overall Study||4
6594655|NCT02005666|7519726|FG000|STARTED|Overall Study||338
6594656|NCT02005666|7519727|FG001|STARTED|Overall Study||343
6594657|NCT02005666|7519728|FG002|STARTED|Overall Study||169
6594658|NCT02005666|7519726|FG000|COMPLETED|Overall Study||311
6594659|NCT02005666|7519727|FG001|COMPLETED|Overall Study||299
6594660|NCT02005666|7519728|FG002|COMPLETED|Overall Study||160
6594661|NCT02005666|7519726|FG000|NOT COMPLETED|Overall Study||27
6594662|NCT02005666|7519727|FG001|NOT COMPLETED|Overall Study||44
6594663|NCT02005666|7519728|FG002|NOT COMPLETED|Overall Study||9
6594664|NCT02005692|7519736|FG000|STARTED|Overall Study||70
6594665|NCT02005692|7519736|FG000|COMPLETED|Overall Study||63
6594666|NCT02005692|7519736|FG000|NOT COMPLETED|Overall Study||7
6594667|NCT02005887|7519743|FG000|STARTED|Overall Study||26
6594668|NCT02005887|7519744|FG001|STARTED|Overall Study||25
6594669|NCT02005887|7519743|FG000|COMPLETED|Overall Study||26
6594670|NCT02005887|7519744|FG001|COMPLETED|Overall Study||23
6594671|NCT02005887|7519743|FG000|NOT COMPLETED|Overall Study||0
6594672|NCT02005887|7519744|FG001|NOT COMPLETED|Overall Study||2
6594673|NCT02006056|7519752|FG000|STARTED|Overall Study||26
6594674|NCT02006056|7519753|FG001|STARTED|Overall Study||4
6594675|NCT02006056|7519752|FG000|COMPLETED|Overall Study||26
6660168|NCT02496767|7591117|FG007|STARTED|Double-blind, Placebo-controlled Phase||0
6660169|NCT02496767|7591110|FG000|COMPLETED|Double-blind, Placebo-controlled Phase||0
6660170|NCT02496767|7591111|FG001|COMPLETED|Double-blind, Placebo-controlled Phase||132
6660171|NCT02496767|7591112|FG002|COMPLETED|Double-blind, Placebo-controlled Phase||80
6660172|NCT02496767|7591113|FG003|COMPLETED|Double-blind, Placebo-controlled Phase||65
6660173|NCT02496767|7591114|FG004|COMPLETED|Double-blind, Placebo-controlled Phase||59
6594676|NCT02006056|7519753|FG001|COMPLETED|Overall Study||4
6594677|NCT02006056|7519752|FG000|NOT COMPLETED|Overall Study||0
6594678|NCT02006056|7519753|FG001|NOT COMPLETED|Overall Study||0
6594679|NCT02006108|7519759|FG000|STARTED|Overall Study||21
6594680|NCT02006108|7519759|FG000|MR Imaging|Overall Study||19
6594681|NCT02006108|7519759|FG000|COMPLETED|Overall Study||19
6594682|NCT02006108|7519759|FG000|NOT COMPLETED|Overall Study||2
6660174|NCT02496767|7591115|FG005|COMPLETED|Double-blind, Placebo-controlled Phase||0
6660175|NCT02496767|7591116|FG006|COMPLETED|Double-blind, Placebo-controlled Phase||0
6660176|NCT02496767|7591117|FG007|COMPLETED|Double-blind, Placebo-controlled Phase||0
6660177|NCT02496767|7591110|FG000|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6660178|NCT02496767|7591111|FG001|NOT COMPLETED|Double-blind, Placebo-controlled Phase||56
6660179|NCT02496767|7591112|FG002|NOT COMPLETED|Double-blind, Placebo-controlled Phase||46
6660180|NCT02496767|7591113|FG003|NOT COMPLETED|Double-blind, Placebo-controlled Phase||61
6660181|NCT02496767|7591114|FG004|NOT COMPLETED|Double-blind, Placebo-controlled Phase||66
6660182|NCT02496767|7591115|FG005|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6660183|NCT02496767|7591116|FG006|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6660184|NCT02496767|7591117|FG007|NOT COMPLETED|Double-blind, Placebo-controlled Phase||0
6660185|NCT02496767|7591110|FG000|STARTED|Double-blind, Withdrawal Phase||0
6660186|NCT02496767|7591111|FG001|STARTED|Double-blind, Withdrawal Phase||0
6660187|NCT02496767|7591112|FG002|STARTED|Double-blind, Withdrawal Phase||0
6660188|NCT02496767|7591113|FG003|STARTED|Double-blind, Withdrawal Phase||0
6660189|NCT02496767|7591114|FG004|STARTED|Double-blind, Withdrawal Phase||0
6660190|NCT02496767|7591115|FG005|STARTED|Double-blind, Withdrawal Phase||132
6660191|NCT02496767|7591116|FG006|STARTED|Double-blind, Withdrawal Phase||103
6660192|NCT02496767|7591117|FG007|STARTED|Double-blind, Withdrawal Phase||101
6660193|NCT02496767|7591110|FG000|COMPLETED|Double-blind, Withdrawal Phase||0
6660194|NCT02496767|7591111|FG001|COMPLETED|Double-blind, Withdrawal Phase||0
6660195|NCT02496767|7591112|FG002|COMPLETED|Double-blind, Withdrawal Phase||0
6660196|NCT02496767|7591113|FG003|COMPLETED|Double-blind, Withdrawal Phase||0
6660197|NCT02496767|7591114|FG004|COMPLETED|Double-blind, Withdrawal Phase||0
6660198|NCT02496767|7591115|FG005|COMPLETED|Double-blind, Withdrawal Phase||126
6660199|NCT02496767|7591116|FG006|COMPLETED|Double-blind, Withdrawal Phase||99
6660200|NCT02496767|7591117|FG007|COMPLETED|Double-blind, Withdrawal Phase||96
6660201|NCT02496767|7591110|FG000|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6660202|NCT02496767|7591111|FG001|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6660203|NCT02496767|7591112|FG002|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6660204|NCT02496767|7591113|FG003|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6660205|NCT02496767|7591114|FG004|NOT COMPLETED|Double-blind, Withdrawal Phase||0
6660206|NCT02496767|7591115|FG005|NOT COMPLETED|Double-blind, Withdrawal Phase||6
6660207|NCT02496767|7591116|FG006|NOT COMPLETED|Double-blind, Withdrawal Phase||4
6660208|NCT02496767|7591117|FG007|NOT COMPLETED|Double-blind, Withdrawal Phase||5
6660209|NCT02496884|7591135|FG000|STARTED|Overall Study||17
6660210|NCT02496884|7591136|FG001|STARTED|Overall Study||34
6660211|NCT02496884|7591137|FG002|STARTED|Overall Study||1
6660212|NCT02496884|7591138|FG003|STARTED|Overall Study||4
6660213|NCT02496884|7591135|FG000|Safety Analysis Set|Overall Study||17
6660214|NCT02496884|7591136|FG001|Safety Analysis Set|Overall Study||34
6660215|NCT02496884|7591137|FG002|Safety Analysis Set|Overall Study||1
6660216|NCT02496884|7591138|FG003|Safety Analysis Set|Overall Study||4
6660217|NCT02496884|7591135|FG000|Modified Intent to Treat Set (mITT)|Overall Study||17
6660218|NCT02496884|7591136|FG001|Modified Intent to Treat Set (mITT)|Overall Study||34
6660219|NCT02496884|7591137|FG002|Modified Intent to Treat Set (mITT)|Overall Study||1
6660220|NCT02496884|7591138|FG003|Modified Intent to Treat Set (mITT)|Overall Study||4
6660221|NCT02496884|7591135|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6660222|NCT02496884|7591136|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||33
6660223|NCT02496884|7591137|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6660224|NCT02496884|7591138|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6660225|NCT02496884|7591135|FG000|Completed Treatment Per Protocol|Overall Study||16
6660226|NCT02496884|7591136|FG001|Completed Treatment Per Protocol|Overall Study||27
6660227|NCT02496884|7591137|FG002|Completed Treatment Per Protocol|Overall Study||1
6660228|NCT02496884|7591138|FG003|Completed Treatment Per Protocol|Overall Study||3
6660229|NCT02496884|7591135|FG000|COMPLETED|Overall Study||15
6660230|NCT02496884|7591136|FG001|COMPLETED|Overall Study||31
6660231|NCT02496884|7591137|FG002|COMPLETED|Overall Study||1
6660232|NCT02496884|7591138|FG003|COMPLETED|Overall Study||4
6660233|NCT02496884|7591135|FG000|NOT COMPLETED|Overall Study||2
6660234|NCT02496884|7591136|FG001|NOT COMPLETED|Overall Study||3
6660235|NCT02496884|7591137|FG002|NOT COMPLETED|Overall Study||0
6660236|NCT02496884|7591138|FG003|NOT COMPLETED|Overall Study||0
6660237|NCT02497001|7591152|FG000|STARTED|Overall Study||640
6660238|NCT02497001|7591153|FG001|STARTED|Overall Study||627
6660239|NCT02497001|7591154|FG002|STARTED|Overall Study||316
6660240|NCT02497001|7591155|FG003|STARTED|Overall Study||319
6660241|NCT02497001|7591152|FG000|COMPLETED|Overall Study||566
6660242|NCT02497001|7591153|FG001|COMPLETED|Overall Study||524
6660243|NCT02497001|7591154|FG002|COMPLETED|Overall Study||266
6660244|NCT02497001|7591155|FG003|COMPLETED|Overall Study||278
6660245|NCT02497001|7591152|FG000|NOT COMPLETED|Overall Study||74
6660246|NCT02497001|7591153|FG001|NOT COMPLETED|Overall Study||103
6660247|NCT02497001|7591154|FG002|NOT COMPLETED|Overall Study||50
6660248|NCT02497001|7591155|FG003|NOT COMPLETED|Overall Study||41
6660249|NCT02497040|7591171|FG000|STARTED|Overall Study||30
6660250|NCT02497040|7591172|FG001|STARTED|Overall Study||30
6660251|NCT02497040|7591173|FG002|STARTED|Overall Study||30
6660252|NCT02497040|7591171|FG000|COMPLETED|Overall Study||30
6660253|NCT02497040|7591172|FG001|COMPLETED|Overall Study||30
6660254|NCT02497040|7591173|FG002|COMPLETED|Overall Study||30
6660255|NCT02497040|7591171|FG000|NOT COMPLETED|Overall Study||0
6594683|NCT02006121|7519765|FG000|STARTED|Double Blind Phase||54
6594684|NCT02006121|7519766|FG001|STARTED|Double Blind Phase||53
6594685|NCT02006121|7519765|FG000|COMPLETED|Double Blind Phase|Early switching to open label: 1 for lack of efficacy, 1 could not tolerate 3 mg/hour minimum rate|42
6594686|NCT02006121|7519766|FG001|COMPLETED|Double Blind Phase|16 placebo-treated patients early switched to open label phase due to lack of efficacy|29
6594687|NCT02006121|7519765|FG000|NOT COMPLETED|Double Blind Phase||12
6594688|NCT02006121|7519766|FG001|NOT COMPLETED|Double Blind Phase||24
6594689|NCT02006121|7519765|FG000|STARTED|Open Label Phase|From Apo: 38 completers and 2 early switched; From Placebo: 28 completers and 16 early switched|84
6594690|NCT02006121|7519766|FG001|STARTED|Open Label Phase|No patients received placebo in the open label phase|0
6594691|NCT02006121|7519765|FG000|COMPLETED|Open Label Phase|30 who continued on apomorphine from blinded phase, 29 who switched to apomorphine from placebo|59
6594692|NCT02006121|7519766|FG001|COMPLETED|Open Label Phase||0
6594693|NCT02006121|7519765|FG000|NOT COMPLETED|Open Label Phase||25
6594694|NCT02006121|7519766|FG001|NOT COMPLETED|Open Label Phase||0
6594695|NCT02006160|7519778|FG000|STARTED|Overall Study||45
6594696|NCT02006160|7519779|FG001|STARTED|Overall Study||16
6594697|NCT02006160|7519778|FG000|COMPLETED|Overall Study||41
6594698|NCT02006160|7519779|FG001|COMPLETED|Overall Study||16
6594699|NCT02006160|7519778|FG000|NOT COMPLETED|Overall Study||4
6594700|NCT02006160|7519779|FG001|NOT COMPLETED|Overall Study||0
6594701|NCT02006264|7519787|FG000|STARTED|Overall Study||15
6594702|NCT02006264|7519788|FG001|STARTED|Overall Study||15
6594703|NCT02006264|7519787|FG000|COMPLETED|Overall Study||14
6594704|NCT02006264|7519788|FG001|COMPLETED|Overall Study||15
6594705|NCT02006264|7519787|FG000|NOT COMPLETED|Overall Study||1
6594706|NCT02006264|7519788|FG001|NOT COMPLETED|Overall Study||0
6594707|NCT02006342|7519796|FG000|STARTED|Overall Study||20
6594708|NCT02006342|7519797|FG001|STARTED|Overall Study||20
6594709|NCT02006342|7519796|FG000|COMPLETED|Overall Study||19
6594710|NCT02006342|7519797|FG001|COMPLETED|Overall Study||20
6594711|NCT02006342|7519796|FG000|NOT COMPLETED|Overall Study||1
6594712|NCT02006342|7519797|FG001|NOT COMPLETED|Overall Study||0
6594713|NCT02006420|7519805|FG000|STARTED|Overall Study||24
6594714|NCT02006420|7519806|FG001|STARTED|Overall Study||21
6594715|NCT02006420|7519805|FG000|COMPLETED|Overall Study||24
6594716|NCT02006420|7519806|FG001|COMPLETED|Overall Study||21
6594717|NCT02006420|7519805|FG000|NOT COMPLETED|Overall Study||0
6594718|NCT02006420|7519806|FG001|NOT COMPLETED|Overall Study||0
6594719|NCT02006472|7519823|FG000|STARTED|Period 1 (Through Week 26)||82
6594720|NCT02006472|7519824|FG001|STARTED|Period 1 (Through Week 26)||81
6594721|NCT02006472|7519825|FG002|STARTED|Period 1 (Through Week 26)||82
6594722|NCT02006472|7519826|FG003|STARTED|Period 1 (Through Week 26)||81
6594723|NCT02006472|7519827|FG004|STARTED|Period 1 (Through Week 26)||82
6594724|NCT02006472|7519823|FG000|ITT|Period 1 (Through Week 26)||82
6594725|NCT02006472|7519824|FG001|ITT|Period 1 (Through Week 26)||81
6594726|NCT02006472|7519825|FG002|ITT|Period 1 (Through Week 26)||82
6594727|NCT02006472|7519826|FG003|ITT|Period 1 (Through Week 26)||81
6594728|NCT02006472|7519827|FG004|ITT|Period 1 (Through Week 26)||82
6594729|NCT02006472|7519823|FG000|FAS|Period 1 (Through Week 26)||81
6594730|NCT02006472|7519824|FG001|FAS|Period 1 (Through Week 26)||75
6594731|NCT02006472|7519825|FG002|FAS|Period 1 (Through Week 26)||79
6594732|NCT02006472|7519826|FG003|FAS|Period 1 (Through Week 26)||81
6594733|NCT02006472|7519827|FG004|FAS|Period 1 (Through Week 26)||81
6594734|NCT02006472|7519823|FG000|Safety Set|Period 1 (Through Week 26)||82
6594735|NCT02006472|7519824|FG001|Safety Set|Period 1 (Through Week 26)||81
6594736|NCT02006472|7519825|FG002|Safety Set|Period 1 (Through Week 26)||82
6594737|NCT02006472|7519826|FG003|Safety Set|Period 1 (Through Week 26)||81
6594738|NCT02006472|7519827|FG004|Safety Set|Period 1 (Through Week 26)||82
6594739|NCT02006472|7519823|FG000|COMPLETED|Period 1 (Through Week 26)||70
6594740|NCT02006472|7519824|FG001|COMPLETED|Period 1 (Through Week 26)||59
6594741|NCT02006472|7519825|FG002|COMPLETED|Period 1 (Through Week 26)||65
6594742|NCT02006472|7519826|FG003|COMPLETED|Period 1 (Through Week 26)||67
6594743|NCT02006472|7519827|FG004|COMPLETED|Period 1 (Through Week 26)||62
6594744|NCT02006472|7519823|FG000|NOT COMPLETED|Period 1 (Through Week 26)||12
6594745|NCT02006472|7519824|FG001|NOT COMPLETED|Period 1 (Through Week 26)||22
6594746|NCT02006472|7519825|FG002|NOT COMPLETED|Period 1 (Through Week 26)||17
6594747|NCT02006472|7519826|FG003|NOT COMPLETED|Period 1 (Through Week 26)||14
6594748|NCT02006472|7519827|FG004|NOT COMPLETED|Period 1 (Through Week 26)||20
6594749|NCT02006472|7519823|FG000|STARTED|Period 2 (Through Week 52)||57
6594750|NCT02006472|7519824|FG001|STARTED|Period 2 (Through Week 52)||49
6594751|NCT02006472|7519825|FG002|STARTED|Period 2 (Through Week 52)||54
6594752|NCT02006472|7519826|FG003|STARTED|Period 2 (Through Week 52)||56
6594753|NCT02006472|7519827|FG004|STARTED|Period 2 (Through Week 52)||46
6594754|NCT02006472|7519823|FG000|Started Treatment in Period 2|Period 2 (Through Week 52)||57
6594755|NCT02006472|7519824|FG001|Started Treatment in Period 2|Period 2 (Through Week 52)||49
6594756|NCT02006472|7519825|FG002|Started Treatment in Period 2|Period 2 (Through Week 52)||52
6594757|NCT02006472|7519826|FG003|Started Treatment in Period 2|Period 2 (Through Week 52)||56
6660256|NCT02497040|7591172|FG001|NOT COMPLETED|Overall Study||0
6660257|NCT02497040|7591173|FG002|NOT COMPLETED|Overall Study||0
6594758|NCT02006472|7519827|FG004|Started Treatment in Period 2|Period 2 (Through Week 52)||46
6594759|NCT02006472|7519823|FG000|COMPLETED|Period 2 (Through Week 52)||52
6594760|NCT02006472|7519824|FG001|COMPLETED|Period 2 (Through Week 52)||43
6594761|NCT02006472|7519825|FG002|COMPLETED|Period 2 (Through Week 52)||44
6594762|NCT02006472|7519826|FG003|COMPLETED|Period 2 (Through Week 52)||53
6594763|NCT02006472|7519827|FG004|COMPLETED|Period 2 (Through Week 52)||44
6594764|NCT02006472|7519823|FG000|NOT COMPLETED|Period 2 (Through Week 52)||5
6594765|NCT02006472|7519824|FG001|NOT COMPLETED|Period 2 (Through Week 52)||6
6594766|NCT02006472|7519825|FG002|NOT COMPLETED|Period 2 (Through Week 52)||10
6594767|NCT02006472|7519826|FG003|NOT COMPLETED|Period 2 (Through Week 52)||3
6594768|NCT02006472|7519827|FG004|NOT COMPLETED|Period 2 (Through Week 52)||2
6594769|NCT02006576|7519847|FG000|STARTED|Overall Study||35
6594770|NCT02006576|7519848|FG001|STARTED|Overall Study||51
6594771|NCT02006576|7519849|FG002|STARTED|Overall Study||32
6594772|NCT02006576|7519847|FG000|COMPLETED|Overall Study||17
6594773|NCT02006576|7519848|FG001|COMPLETED|Overall Study||44
6594774|NCT02006576|7519849|FG002|COMPLETED|Overall Study||15
6594775|NCT02006576|7519847|FG000|NOT COMPLETED|Overall Study||18
6594776|NCT02006576|7519848|FG001|NOT COMPLETED|Overall Study||7
6594777|NCT02006576|7519849|FG002|NOT COMPLETED|Overall Study||17
6594778|NCT02006628|7519859|FG000|STARTED|Overall Study||43
6594779|NCT02006628|7519860|FG001|STARTED|Overall Study||45
6594780|NCT02006628|7519859|FG000|Received at Least 1 Dose of Study Drug|Overall Study||43
6594781|NCT02006628|7519860|FG001|Received at Least 1 Dose of Study Drug|Overall Study||45
6594782|NCT02006628|7519859|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||42
6594783|NCT02006628|7519860|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||44
6594784|NCT02006628|7519859|FG000|COMPLETED|Overall Study||40
6594785|NCT02006628|7519860|FG001|COMPLETED|Overall Study||43
6594786|NCT02006628|7519859|FG000|NOT COMPLETED|Overall Study||3
6594787|NCT02006628|7519860|FG001|NOT COMPLETED|Overall Study||2
6594788|NCT02006641|7519869|FG000|STARTED|Overall Study||284
6594789|NCT02006641|7519870|FG001|STARTED|Overall Study||290
6594790|NCT02006641|7519871|FG002|STARTED|Overall Study||284
6594791|NCT02006641|7519869|FG000|Treated|Overall Study||282
6594792|NCT02006641|7519870|FG001|Treated|Overall Study||285
6594793|NCT02006641|7519871|FG002|Treated|Overall Study||281
6594794|NCT02006641|7519869|FG000|COMPLETED|Overall Study||258
6594795|NCT02006641|7519870|FG001|COMPLETED|Overall Study||257
6594796|NCT02006641|7519871|FG002|COMPLETED|Overall Study||248
6594797|NCT02006641|7519869|FG000|NOT COMPLETED|Overall Study||26
6594798|NCT02006641|7519870|FG001|NOT COMPLETED|Overall Study||33
6594799|NCT02006641|7519871|FG002|NOT COMPLETED|Overall Study||36
6594800|NCT02006654|7519881|FG000|STARTED|Overall Study||369
6594801|NCT02006654|7519882|FG001|STARTED|Overall Study||365
6594802|NCT02006654|7519881|FG000|Treated|Overall Study||365
6594803|NCT02006654|7519882|FG001|Treated|Overall Study||363
6594804|NCT02006654|7519881|FG000|COMPLETED|Overall Study||324
6594805|NCT02006654|7519882|FG001|COMPLETED|Overall Study||321
6594806|NCT02006654|7519881|FG000|NOT COMPLETED|Overall Study||45
6594807|NCT02006654|7519882|FG001|NOT COMPLETED|Overall Study||44
6594808|NCT02006667|7519889|FG000|STARTED|Overall Study||13
6594809|NCT02006667|7519889|FG000|COMPLETED|Overall Study||7
6594810|NCT02006667|7519889|FG000|NOT COMPLETED|Overall Study||6
6594811|NCT02006693|7519895|FG000|STARTED|Overall Study||112
6594812|NCT02006693|7519896|FG001|STARTED|Overall Study||87
6594813|NCT02006693|7519895|FG000|COMPLETED|Overall Study||84
6594814|NCT02006693|7519896|FG001|COMPLETED|Overall Study||74
6594815|NCT02006693|7519895|FG000|NOT COMPLETED|Overall Study||28
6594816|NCT02006693|7519896|FG001|NOT COMPLETED|Overall Study||13
6594817|NCT02006706|7519902|FG000|STARTED|Overall Study||15
6660258|NCT02497235|7591186|FG000|STARTED|Overall Study||2
6660259|NCT02497235|7591187|FG001|STARTED|Overall Study||2
6660260|NCT02497235|7591188|FG002|STARTED|Overall Study||2
6660261|NCT02497235|7591189|FG003|STARTED|Overall Study||2
6660262|NCT02497235|7591190|FG004|STARTED|Overall Study||3
6660263|NCT02497235|7591186|FG000|COMPLETED|Overall Study||2
6660264|NCT02497235|7591187|FG001|COMPLETED|Overall Study||2
6660265|NCT02497235|7591188|FG002|COMPLETED|Overall Study||2
6660266|NCT02497235|7591189|FG003|COMPLETED|Overall Study||2
6660267|NCT02497235|7591190|FG004|COMPLETED|Overall Study||3
6660268|NCT02497235|7591186|FG000|NOT COMPLETED|Overall Study||0
6660269|NCT02497235|7591187|FG001|NOT COMPLETED|Overall Study||0
6660270|NCT02497235|7591188|FG002|NOT COMPLETED|Overall Study||0
6660271|NCT02497235|7591189|FG003|NOT COMPLETED|Overall Study||0
6660272|NCT02497235|7591190|FG004|NOT COMPLETED|Overall Study||0
6660273|NCT02497287|7591205|FG000|STARTED|Induction Phase (4 Weeks)|Included DE participants (691) and non-responders from TRD3005 (88).|779
6660274|NCT02497287|7591205|FG000|COMPLETED|Induction Phase (4 Weeks)||580
6660275|NCT02497287|7591205|FG000|NOT COMPLETED|Induction Phase (4 Weeks)||199
6660276|NCT02497287|7591205|FG000|STARTED|Optimization/Maintenance (48 Weeks)|Included who completed IND phase (580) + responders from TRD3005 (23).|603
6660277|NCT02497287|7591205|FG000|COMPLETED|Optimization/Maintenance (48 Weeks)||150
6660278|NCT02497287|7591205|FG000|NOT COMPLETED|Optimization/Maintenance (48 Weeks)||453
6660279|NCT02497287|7591205|FG000|STARTED|Follow-up Phase (4 Week)|Included non-responders (IND phase) or discontinued treatment phase or completed OP/MA phase.|357
6594818|NCT02006706|7519902|FG000|COMPLETED|Overall Study||14
6594819|NCT02006706|7519902|FG000|NOT COMPLETED|Overall Study||1
6594820|NCT02006719|7519908|FG000|STARTED|Overall Study||237
6594821|NCT02006719|7519909|FG001|STARTED|Overall Study||85
6594822|NCT02006719|7519908|FG000|COMPLETED|Overall Study||219
6594823|NCT02006719|7519909|FG001|COMPLETED|Overall Study||80
6594824|NCT02006719|7519908|FG000|NOT COMPLETED|Overall Study||18
6594825|NCT02006719|7519909|FG001|NOT COMPLETED|Overall Study||5
6594826|NCT02006732|7519919|FG000|STARTED|Overall Study||202
6594827|NCT02006732|7519920|FG001|STARTED|Overall Study||203
6594828|NCT02006732|7519921|FG002|STARTED|Overall Study||202
6594829|NCT02006732|7519922|FG003|STARTED|Overall Study||202
6594830|NCT02006732|7519919|FG000|COMPLETED|Overall Study||182
6594831|NCT02006732|7519920|FG001|COMPLETED|Overall Study||191
6594832|NCT02006732|7519921|FG002|COMPLETED|Overall Study||193
6594833|NCT02006732|7519922|FG003|COMPLETED|Overall Study||198
6594834|NCT02006732|7519919|FG000|NOT COMPLETED|Overall Study||20
6594835|NCT02006732|7519920|FG001|NOT COMPLETED|Overall Study||12
6594836|NCT02006732|7519921|FG002|NOT COMPLETED|Overall Study||9
6594837|NCT02006732|7519922|FG003|NOT COMPLETED|Overall Study||4
6594838|NCT02006758|7519932|FG000|STARTED|Overall Study|Total number of enrolled participants|68
6594839|NCT02006758|7519932|FG000|Underwent Renal Denervation|Overall Study|Underwent renal denervation|67
6594840|NCT02006758|7519932|FG000|1-month Follow up|Overall Study|1-month follow up completed|66
6594841|NCT02006758|7519932|FG000|6-month Follow up|Overall Study|6-month follow up completed|60
6594842|NCT02006758|7519932|FG000|12-month Follow up|Overall Study|12-month follow up completed|55
6594843|NCT02006758|7519932|FG000|COMPLETED|Overall Study||55
6594844|NCT02006758|7519932|FG000|NOT COMPLETED|Overall Study||13
6594845|NCT02006836|7519940|FG000|STARTED|Case-control Period: Month 1- Month 6||20
6594846|NCT02006836|7519941|FG001|STARTED|Case-control Period: Month 1- Month 6||20
6594847|NCT02006836|7519942|FG002|STARTED|Case-control Period: Month 1- Month 6||0
6594848|NCT02006836|7519940|FG000|COMPLETED|Case-control Period: Month 1- Month 6||20
6594849|NCT02006836|7519941|FG001|COMPLETED|Case-control Period: Month 1- Month 6||20
6594850|NCT02006836|7519942|FG002|COMPLETED|Case-control Period: Month 1- Month 6||0
6594851|NCT02006836|7519940|FG000|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
6594852|NCT02006836|7519941|FG001|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
6594853|NCT02006836|7519942|FG002|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
6594854|NCT02006836|7519940|FG000|STARTED|Self-control Period: Month 7-month 12||0
6594855|NCT02006836|7519941|FG001|STARTED|Self-control Period: Month 7-month 12||0
6594856|NCT02006836|7519942|FG002|STARTED|Self-control Period: Month 7-month 12||19
6594857|NCT02006836|7519940|FG000|COMPLETED|Self-control Period: Month 7-month 12||0
6594858|NCT02006836|7519941|FG001|COMPLETED|Self-control Period: Month 7-month 12||0
6594859|NCT02006836|7519942|FG002|COMPLETED|Self-control Period: Month 7-month 12||19
6594860|NCT02006836|7519940|FG000|NOT COMPLETED|Self-control Period: Month 7-month 12||0
6594861|NCT02006836|7519941|FG001|NOT COMPLETED|Self-control Period: Month 7-month 12||0
6594862|NCT02006836|7519942|FG002|NOT COMPLETED|Self-control Period: Month 7-month 12||0
6594863|NCT02006888|7519955|FG000|STARTED|Overall Study||158
6594864|NCT02006888|7519956|FG001|STARTED|Overall Study||156
6594865|NCT02006888|7519957|FG002|STARTED|Overall Study||80
6594866|NCT02006888|7519955|FG000|COMPLETED|Overall Study||122
6594867|NCT02006888|7519956|FG001|COMPLETED|Overall Study||122
6594868|NCT02006888|7519957|FG002|COMPLETED|Overall Study||58
6594869|NCT02006888|7519955|FG000|NOT COMPLETED|Overall Study||36
6594870|NCT02006888|7519956|FG001|NOT COMPLETED|Overall Study||34
6594871|NCT02006888|7519957|FG002|NOT COMPLETED|Overall Study||22
6594872|NCT02006979|7519967|FG000|STARTED|Overall Study||14
6594873|NCT02006979|7519968|FG001|STARTED|Overall Study||13
6594874|NCT02006979|7519967|FG000|COMPLETED|Overall Study||13
6594875|NCT02006979|7519968|FG001|COMPLETED|Overall Study||11
6594876|NCT02006979|7519967|FG000|NOT COMPLETED|Overall Study||1
6594877|NCT02006979|7519968|FG001|NOT COMPLETED|Overall Study||2
6594878|NCT02007070|7519974|FG000|STARTED|Overall Study||38
6594879|NCT02007070|7519974|FG000|COMPLETED|Overall Study|Completed 2 years of treatment.|5
6594880|NCT02007070|7519974|FG000|NOT COMPLETED|Overall Study||33
6594881|NCT02007096|7519980|FG000|STARTED|Overall Study||63
6594882|NCT02007096|7519981|FG001|STARTED|Overall Study||64
6594883|NCT02007096|7519980|FG000|COMPLETED|Overall Study||52
6594884|NCT02007096|7519981|FG001|COMPLETED|Overall Study||48
6594885|NCT02007096|7519980|FG000|NOT COMPLETED|Overall Study||11
6594886|NCT02007096|7519981|FG001|NOT COMPLETED|Overall Study||16
6594887|NCT02007109|7519987|FG000|STARTED|Overall Study||193
6594888|NCT02007109|7519987|FG000|PACU Analysis|Overall Study||184
6594889|NCT02007109|7519987|FG000|COMPLETED|Overall Study||82
6594890|NCT02007109|7519987|FG000|NOT COMPLETED|Overall Study||111
6594891|NCT02007200|7519994|FG000|STARTED|Overall Study||55
6594892|NCT02007200|7519994|FG000|COMPLETED|Overall Study||55
6594893|NCT02007200|7519994|FG000|NOT COMPLETED|Overall Study||0
6594894|NCT02007252|7520000|FG000|STARTED|Overall Study||31
6594895|NCT02007252|7520001|FG001|STARTED|Overall Study||33
6594896|NCT02007252|7520000|FG000|Safety Analysis Set|Overall Study||31
6594897|NCT02007252|7520001|FG001|Safety Analysis Set|Overall Study||33
6594898|NCT02007252|7520000|FG000|Pharmacodynamic Analysis Set|Overall Study||31
6594899|NCT02007252|7520001|FG001|Pharmacodynamic Analysis Set|Overall Study||33
6594900|NCT02007252|7520000|FG000|COMPLETED|Overall Study||20
6594901|NCT02007252|7520001|FG001|COMPLETED|Overall Study||22
6594902|NCT02007252|7520000|FG000|NOT COMPLETED|Overall Study||11
6594903|NCT02007252|7520001|FG001|NOT COMPLETED|Overall Study||11
6594904|NCT02007278|7520009|FG000|STARTED|Overall Study||20
6660280|NCT02497287|7591205|FG000|COMPLETED|Follow-up Phase (4 Week)||326
6594905|NCT02007278|7520010|FG001|STARTED|Overall Study||20
6594906|NCT02007278|7520009|FG000|COMPLETED|Overall Study||18
6594907|NCT02007278|7520010|FG001|COMPLETED|Overall Study||17
6594908|NCT02007278|7520009|FG000|NOT COMPLETED|Overall Study||2
6594909|NCT02007278|7520010|FG001|NOT COMPLETED|Overall Study||3
6594910|NCT02007291|7520016|FG000|STARTED|Overall Study||48
6594911|NCT02007291|7520017|FG001|STARTED|Overall Study||23
6594912|NCT02007291|7520016|FG000|COMPLETED|Overall Study||48
6594913|NCT02007291|7520017|FG001|COMPLETED|Overall Study||23
6594914|NCT02007291|7520016|FG000|NOT COMPLETED|Overall Study||0
6594915|NCT02007291|7520017|FG001|NOT COMPLETED|Overall Study||0
6594916|NCT02007369|7520026|FG000|STARTED|Overall Study||42
6594917|NCT02007369|7520027|FG001|STARTED|Overall Study||40
6594918|NCT02007369|7520028|FG002|STARTED|Overall Study||54
6594919|NCT02007369|7520026|FG000|COMPLETED|Overall Study||42
6594920|NCT02007369|7520027|FG001|COMPLETED|Overall Study||40
6594921|NCT02007369|7520028|FG002|COMPLETED|Overall Study||54
6594922|NCT02007369|7520026|FG000|NOT COMPLETED|Overall Study||0
6594923|NCT02007369|7520027|FG001|NOT COMPLETED|Overall Study||0
6594924|NCT02007369|7520028|FG002|NOT COMPLETED|Overall Study||0
6594925|NCT02007434|7520044|FG000|STARTED|Overall Study||17
6594926|NCT02007434|7520045|FG001|STARTED|Overall Study||4
6594927|NCT02007434|7520046|FG002|STARTED|Overall Study||17
6594928|NCT02007434|7520047|FG003|STARTED|Overall Study||4
6594929|NCT02007434|7520048|FG004|STARTED|Overall Study||16
6594930|NCT02007434|7520049|FG005|STARTED|Overall Study||4
6594931|NCT02007434|7520050|FG006|STARTED|Overall Study||18
6594932|NCT02007434|7520051|FG007|STARTED|Overall Study||4
6594933|NCT02007434|7520044|FG000|Received Treatment|Overall Study||17
6594934|NCT02007434|7520045|FG001|Received Treatment|Overall Study||3
6594935|NCT02007434|7520046|FG002|Received Treatment|Overall Study||17
6594936|NCT02007434|7520047|FG003|Received Treatment|Overall Study||4
6594937|NCT02007434|7520048|FG004|Received Treatment|Overall Study||16
6594938|NCT02007434|7520049|FG005|Received Treatment|Overall Study||4
6594939|NCT02007434|7520050|FG006|Received Treatment|Overall Study||18
6594940|NCT02007434|7520051|FG007|Received Treatment|Overall Study||4
6594941|NCT02007434|7520044|FG000|COMPLETED|Overall Study||16
6594942|NCT02007434|7520045|FG001|COMPLETED|Overall Study||3
6594943|NCT02007434|7520046|FG002|COMPLETED|Overall Study||16
6594944|NCT02007434|7520047|FG003|COMPLETED|Overall Study||4
6594945|NCT02007434|7520048|FG004|COMPLETED|Overall Study||16
6594946|NCT02007434|7520049|FG005|COMPLETED|Overall Study||4
6594947|NCT02007434|7520050|FG006|COMPLETED|Overall Study||18
6594948|NCT02007434|7520051|FG007|COMPLETED|Overall Study||4
6594949|NCT02007434|7520044|FG000|NOT COMPLETED|Overall Study||1
6594950|NCT02007434|7520045|FG001|NOT COMPLETED|Overall Study||1
6594951|NCT02007434|7520046|FG002|NOT COMPLETED|Overall Study||1
6594952|NCT02007434|7520047|FG003|NOT COMPLETED|Overall Study||0
6594953|NCT02007434|7520048|FG004|NOT COMPLETED|Overall Study||0
6594954|NCT02007434|7520049|FG005|NOT COMPLETED|Overall Study||0
6594955|NCT02007434|7520050|FG006|NOT COMPLETED|Overall Study||0
6594956|NCT02007434|7520051|FG007|NOT COMPLETED|Overall Study||0
6594957|NCT02007512|7520074|FG000|STARTED|Double Blind Treatment Period||63
6594958|NCT02007512|7520075|FG001|STARTED|Double Blind Treatment Period||64
6594959|NCT02007512|7520076|FG002|STARTED|Double Blind Treatment Period||60
6594960|NCT02007512|7520077|FG003|STARTED|Double Blind Treatment Period||60
6594961|NCT02007512|7520074|FG000|Treated|Double Blind Treatment Period||62
6594962|NCT02007512|7520075|FG001|Treated|Double Blind Treatment Period||63
6594963|NCT02007512|7520076|FG002|Treated|Double Blind Treatment Period||60
6594964|NCT02007512|7520077|FG003|Treated|Double Blind Treatment Period||60
6594965|NCT02007512|7520074|FG000|COMPLETED|Double Blind Treatment Period||0
6594966|NCT02007512|7520075|FG001|COMPLETED|Double Blind Treatment Period||0
6594967|NCT02007512|7520076|FG002|COMPLETED|Double Blind Treatment Period||0
6594968|NCT02007512|7520077|FG003|COMPLETED|Double Blind Treatment Period||0
6594969|NCT02007512|7520074|FG000|NOT COMPLETED|Double Blind Treatment Period||63
6594970|NCT02007512|7520075|FG001|NOT COMPLETED|Double Blind Treatment Period||64
6594971|NCT02007512|7520076|FG002|NOT COMPLETED|Double Blind Treatment Period||60
6594972|NCT02007512|7520077|FG003|NOT COMPLETED|Double Blind Treatment Period||60
6594973|NCT02007512|7520074|FG000|STARTED|Open Label Treatment Period||0
6594974|NCT02007512|7520075|FG001|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 21 entered open label period.|21
6594975|NCT02007512|7520076|FG002|STARTED|Open Label Treatment Period||0
6594976|NCT02007512|7520077|FG003|STARTED|Open Label Treatment Period|Of the participants with disease progression in double blind period, 12 entered open label period.|12
6594977|NCT02007512|7520074|FG000|COMPLETED|Open Label Treatment Period||0
6594978|NCT02007512|7520075|FG001|COMPLETED|Open Label Treatment Period||0
6594979|NCT02007512|7520076|FG002|COMPLETED|Open Label Treatment Period||0
6594980|NCT02007512|7520077|FG003|COMPLETED|Open Label Treatment Period||0
6594981|NCT02007512|7520074|FG000|NOT COMPLETED|Open Label Treatment Period||0
6594982|NCT02007512|7520075|FG001|NOT COMPLETED|Open Label Treatment Period||21
6594983|NCT02007512|7520076|FG002|NOT COMPLETED|Open Label Treatment Period||0
6594984|NCT02007512|7520077|FG003|NOT COMPLETED|Open Label Treatment Period||12
6594985|NCT02007577|7520092|FG000|STARTED|Overall Study||27
6594986|NCT02007577|7520093|FG001|STARTED|Overall Study||14
6594987|NCT02007577|7520092|FG000|COMPLETED|Overall Study||26
6594988|NCT02007577|7520093|FG001|COMPLETED|Overall Study||13
6594989|NCT02007577|7520092|FG000|NOT COMPLETED|Overall Study||1
6594990|NCT02007577|7520093|FG001|NOT COMPLETED|Overall Study||1
6594991|NCT02007720|7520101|FG000|STARTED|Overall Study||436
6594992|NCT02007720|7520102|FG001|STARTED|Overall Study||440
6594993|NCT02007720|7520101|FG000|Full Analysis Set|Overall Study||433
6594994|NCT02007720|7520102|FG001|Full Analysis Set|Overall Study||437
6594995|NCT02007720|7520101|FG000|Safety Set|Overall Study||426
6594996|NCT02007720|7520102|FG001|Safety Set|Overall Study||432
6594997|NCT02007720|7520101|FG000|COMPLETED|Overall Study||354
6594998|NCT02007720|7520102|FG001|COMPLETED|Overall Study||368
6594999|NCT02007720|7520101|FG000|NOT COMPLETED|Overall Study||82
6595000|NCT02007720|7520102|FG001|NOT COMPLETED|Overall Study||72
6595001|NCT02007863|7520109|FG000|STARTED|Overall Study||2
6595002|NCT02007863|7520109|FG000|COMPLETED|Overall Study||2
6595003|NCT02007863|7520109|FG000|NOT COMPLETED|Overall Study||0
6595004|NCT02007954|7520113|FG000|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
6595005|NCT02007954|7520113|FG000|Completed First TACE|Overall Study||24
6595006|NCT02007954|7520113|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
6595007|NCT02007954|7520113|FG000|COMPLETED|Overall Study||17
6595008|NCT02007954|7520113|FG000|NOT COMPLETED|Overall Study||7
6595009|NCT02008149|7520120|FG000|STARTED|Overall Study||7
6595010|NCT02008149|7520121|FG001|STARTED|Overall Study||1
6595011|NCT02008149|7520122|FG002|STARTED|Overall Study||1
6595012|NCT02008149|7520120|FG000|COMPLETED|Overall Study||4
6595013|NCT02008149|7520121|FG001|COMPLETED|Overall Study||0
6595014|NCT02008149|7520122|FG002|COMPLETED|Overall Study||1
6595015|NCT02008149|7520120|FG000|NOT COMPLETED|Overall Study||3
6595016|NCT02008149|7520121|FG001|NOT COMPLETED|Overall Study||1
6595017|NCT02008149|7520122|FG002|NOT COMPLETED|Overall Study||0
6595018|NCT02008227|7520132|FG000|STARTED|Overall Study||612
6595019|NCT02008227|7520133|FG001|STARTED|Overall Study||613
6595020|NCT02008227|7520132|FG000|Treated|Overall Study||579
6595021|NCT02008227|7520133|FG001|Treated|Overall Study||608
6595022|NCT02008227|7520132|FG000|COMPLETED|Overall Study||0
6595023|NCT02008227|7520133|FG001|COMPLETED|Overall Study||0
6595024|NCT02008227|7520132|FG000|NOT COMPLETED|Overall Study||612
6595025|NCT02008227|7520133|FG001|NOT COMPLETED|Overall Study||613
6595026|NCT02008318|7520142|FG000|STARTED|Overall Study||41
6595027|NCT02008318|7520143|FG001|STARTED|Overall Study||2
6595028|NCT02008318|7520142|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
6595029|NCT02008318|7520143|FG001|Received At Least 1 Dose of Study Drug|Overall Study||2
6595030|NCT02008318|7520142|FG000|COMPLETED|Overall Study||29
6595031|NCT02008318|7520143|FG001|COMPLETED|Overall Study||1
6595032|NCT02008318|7520142|FG000|NOT COMPLETED|Overall Study||12
6595033|NCT02008318|7520143|FG001|NOT COMPLETED|Overall Study||1
6595034|NCT02008526|7520155|FG000|STARTED|Overall Study||94
6595035|NCT02008526|7520156|FG001|STARTED|Overall Study||99
6595036|NCT02008526|7520157|FG002|STARTED|Overall Study||93
6595037|NCT02008526|7520155|FG000|COMPLETED|Overall Study||86
6595038|NCT02008526|7520156|FG001|COMPLETED|Overall Study||85
6595039|NCT02008526|7520157|FG002|COMPLETED|Overall Study||84
6595040|NCT02008526|7520155|FG000|NOT COMPLETED|Overall Study||8
6595041|NCT02008526|7520156|FG001|NOT COMPLETED|Overall Study||14
6595042|NCT02008526|7520157|FG002|NOT COMPLETED|Overall Study||9
6595043|NCT02008565|7520169|FG000|STARTED|Overall Study||86
6595044|NCT02008565|7520170|FG001|STARTED|Overall Study||84
6595045|NCT02008565|7520171|FG002|STARTED|Overall Study||88
6595046|NCT02008565|7520172|FG003|STARTED|Overall Study||42
6595047|NCT02008565|7520169|FG000|COMPLETED|Overall Study||85
6595048|NCT02008565|7520170|FG001|COMPLETED|Overall Study||83
6595049|NCT02008565|7520171|FG002|COMPLETED|Overall Study||86
6595050|NCT02008565|7520172|FG003|COMPLETED|Overall Study||42
6595051|NCT02008565|7520169|FG000|NOT COMPLETED|Overall Study||1
6595052|NCT02008565|7520170|FG001|NOT COMPLETED|Overall Study||1
6595053|NCT02008565|7520171|FG002|NOT COMPLETED|Overall Study||2
6595054|NCT02008565|7520172|FG003|NOT COMPLETED|Overall Study||0
6595055|NCT02008617|7520186|FG000|STARTED|Overall Study||8
6595056|NCT02008617|7520187|FG001|STARTED|Overall Study||10
6595057|NCT02008617|7520186|FG000|COMPLETED|Overall Study||8
6595058|NCT02008617|7520187|FG001|COMPLETED|Overall Study||10
6595059|NCT02008617|7520186|FG000|NOT COMPLETED|Overall Study||0
6595060|NCT02008617|7520187|FG001|NOT COMPLETED|Overall Study||0
6595061|NCT02008682|7520195|FG000|STARTED|Overall Study||184
6595062|NCT02008682|7520196|FG001|STARTED|Overall Study||184
6595063|NCT02008682|7520195|FG000|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
6595064|NCT02008682|7520196|FG001|Exposed|Overall Study||184
6595065|NCT02008682|7520195|FG000|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
6595066|NCT02008682|7520196|FG001|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
6595067|NCT02008682|7520195|FG000|NOT COMPLETED|Overall Study||27
6595068|NCT02008682|7520196|FG001|NOT COMPLETED|Overall Study||14
6595069|NCT02008773|7520206|FG000|STARTED|Overall Study||40
6595070|NCT02008773|7520207|FG001|STARTED|Overall Study||34
6595071|NCT02008773|7520208|FG002|STARTED|Overall Study||46
6595072|NCT02008773|7520209|FG003|STARTED|Overall Study||50
6595073|NCT02008773|7520206|FG000|COMPLETED|Overall Study||27
6595074|NCT02008773|7520207|FG001|COMPLETED|Overall Study||25
6595075|NCT02008773|7520208|FG002|COMPLETED|Overall Study||32
6595076|NCT02008773|7520209|FG003|COMPLETED|Overall Study||38
6595077|NCT02008773|7520206|FG000|NOT COMPLETED|Overall Study||13
6595078|NCT02008773|7520207|FG001|NOT COMPLETED|Overall Study||9
6595079|NCT02008773|7520208|FG002|NOT COMPLETED|Overall Study||14
6595080|NCT02008773|7520209|FG003|NOT COMPLETED|Overall Study||12
6595081|NCT02008877|7520217|FG000|STARTED|Overall Study||3
6595082|NCT02008877|7520218|FG001|STARTED|Overall Study||7
6595083|NCT02008877|7520219|FG002|STARTED|Overall Study||10
6595084|NCT02008877|7520217|FG000|COMPLETED|Overall Study||3
6595085|NCT02008877|7520218|FG001|COMPLETED|Overall Study||6
6595086|NCT02008877|7520219|FG002|COMPLETED|Overall Study||10
6595087|NCT02008877|7520217|FG000|NOT COMPLETED|Overall Study||0
6595088|NCT02008877|7520218|FG001|NOT COMPLETED|Overall Study||1
6595089|NCT02008877|7520219|FG002|NOT COMPLETED|Overall Study||0
6595090|NCT02008890|7520231|FG000|STARTED|Period 1||80
6595091|NCT02008890|7520232|FG001|STARTED|Period 1||79
6595092|NCT02008890|7520233|FG002|STARTED|Period 1||78
6595093|NCT02008890|7520234|FG003|STARTED|Period 1||0
6595094|NCT02008890|7520235|FG004|STARTED|Period 1||0
6595095|NCT02008890|7520231|FG000|COMPLETED|Period 1||65
6595096|NCT02008890|7520232|FG001|COMPLETED|Period 1||64
6595097|NCT02008890|7520233|FG002|COMPLETED|Period 1||66
6595098|NCT02008890|7520234|FG003|COMPLETED|Period 1||0
6595099|NCT02008890|7520235|FG004|COMPLETED|Period 1||0
6595100|NCT02008890|7520231|FG000|NOT COMPLETED|Period 1||15
6595101|NCT02008890|7520232|FG001|NOT COMPLETED|Period 1||15
6595102|NCT02008890|7520233|FG002|NOT COMPLETED|Period 1||12
6595103|NCT02008890|7520234|FG003|NOT COMPLETED|Period 1||0
6595104|NCT02008890|7520235|FG004|NOT COMPLETED|Period 1||0
6595105|NCT02008890|7520231|FG000|STARTED|Period 2||65
6595106|NCT02008890|7520232|FG001|STARTED|Period 2||64
6595107|NCT02008890|7520233|FG002|STARTED|Period 2||10
6595108|NCT02008890|7520234|FG003|STARTED|Period 2||27
6595109|NCT02008890|7520235|FG004|STARTED|Period 2||28
6595110|NCT02008890|7520231|FG000|COMPLETED|Period 2||38
6595111|NCT02008890|7520232|FG001|COMPLETED|Period 2||49
6595112|NCT02008890|7520233|FG002|COMPLETED|Period 2||9
6595113|NCT02008890|7520234|FG003|COMPLETED|Period 2||13
6595114|NCT02008890|7520235|FG004|COMPLETED|Period 2||20
6595115|NCT02008890|7520231|FG000|NOT COMPLETED|Period 2||27
6595116|NCT02008890|7520232|FG001|NOT COMPLETED|Period 2||15
6595117|NCT02008890|7520233|FG002|NOT COMPLETED|Period 2||1
6595118|NCT02008890|7520234|FG003|NOT COMPLETED|Period 2||14
6595119|NCT02008890|7520235|FG004|NOT COMPLETED|Period 2||8
6595120|NCT02008890|7520231|FG000|STARTED|Extension Period||31
6595121|NCT02008890|7520232|FG001|STARTED|Extension Period||36
6595122|NCT02008890|7520233|FG002|STARTED|Extension Period||0
6595123|NCT02008890|7520234|FG003|STARTED|Extension Period||10
6595124|NCT02008890|7520235|FG004|STARTED|Extension Period||17
6595125|NCT02008890|7520231|FG000|COMPLETED|Extension Period||26
6595126|NCT02008890|7520232|FG001|COMPLETED|Extension Period||31
6595127|NCT02008890|7520233|FG002|COMPLETED|Extension Period||0
6595128|NCT02008890|7520234|FG003|COMPLETED|Extension Period||6
6595129|NCT02008890|7520235|FG004|COMPLETED|Extension Period||13
6595130|NCT02008890|7520231|FG000|NOT COMPLETED|Extension Period||5
6595131|NCT02008890|7520232|FG001|NOT COMPLETED|Extension Period||5
6595132|NCT02008890|7520233|FG002|NOT COMPLETED|Extension Period||0
6595133|NCT02008890|7520234|FG003|NOT COMPLETED|Extension Period||4
6595134|NCT02008890|7520235|FG004|NOT COMPLETED|Extension Period||4
6595135|NCT02008916|7520253|FG000|STARTED|Primary Assessment (up to Week 16)||74
6595136|NCT02008916|7520254|FG001|STARTED|Primary Assessment (up to Week 16)||76
6595137|NCT02008916|7520255|FG002|STARTED|Primary Assessment (up to Week 16)||76
6595138|NCT02008916|7520253|FG000|FAS|Primary Assessment (up to Week 16)||74
6595139|NCT02008916|7520254|FG001|FAS|Primary Assessment (up to Week 16)||76
6595140|NCT02008916|7520255|FG002|FAS|Primary Assessment (up to Week 16)||76
6595141|NCT02008916|7520253|FG000|Safety Set|Primary Assessment (up to Week 16)||74
6595142|NCT02008916|7520254|FG001|Safety Set|Primary Assessment (up to Week 16)||76
6595143|NCT02008916|7520255|FG002|Safety Set|Primary Assessment (up to Week 16)||75
6595144|NCT02008916|7520253|FG000|COMPLETED|Primary Assessment (up to Week 16)||74
6595145|NCT02008916|7520254|FG001|COMPLETED|Primary Assessment (up to Week 16)||75
6595146|NCT02008916|7520255|FG002|COMPLETED|Primary Assessment (up to Week 16)||73
6595147|NCT02008916|7520253|FG000|NOT COMPLETED|Primary Assessment (up to Week 16)||0
6595148|NCT02008916|7520254|FG001|NOT COMPLETED|Primary Assessment (up to Week 16)||1
6595149|NCT02008916|7520255|FG002|NOT COMPLETED|Primary Assessment (up to Week 16)||3
6595150|NCT02008916|7520253|FG000|STARTED|Week 16 - 156||74
6595151|NCT02008916|7520254|FG001|STARTED|Week 16 - 156||75
6595152|NCT02008916|7520255|FG002|STARTED|Week 16 - 156||73
6595153|NCT02008916|7520253|FG000|COMPLETED|Week 16 - 156||55
6595154|NCT02008916|7520254|FG001|COMPLETED|Week 16 - 156||62
6595155|NCT02008916|7520255|FG002|COMPLETED|Week 16 - 156||63
6595156|NCT02008916|7520253|FG000|NOT COMPLETED|Week 16 - 156||19
6595157|NCT02008916|7520254|FG001|NOT COMPLETED|Week 16 - 156||13
6595158|NCT02008916|7520255|FG002|NOT COMPLETED|Week 16 - 156||10
6595159|NCT02008942|7520264|FG000|STARTED|First Intervention||27
6595160|NCT02008942|7520265|FG001|STARTED|First Intervention||30
6595161|NCT02008942|7520264|FG000|COMPLETED|First Intervention||27
6595162|NCT02008942|7520265|FG001|COMPLETED|First Intervention||30
6595163|NCT02008942|7520264|FG000|NOT COMPLETED|First Intervention||0
6595164|NCT02008942|7520265|FG001|NOT COMPLETED|First Intervention||0
6595165|NCT02008942|7520264|FG000|STARTED|Second Intervention||26
6595166|NCT02008942|7520265|FG001|STARTED|Second Intervention||30
6595167|NCT02008942|7520264|FG000|COMPLETED|Second Intervention||25
6595168|NCT02008942|7520265|FG001|COMPLETED|Second Intervention||30
6595169|NCT02008942|7520264|FG000|NOT COMPLETED|Second Intervention||1
6595170|NCT02008942|7520265|FG001|NOT COMPLETED|Second Intervention||0
6595171|NCT02009046|7520273|FG000|STARTED|Overall Study||1025
6595172|NCT02009046|7520274|FG001|STARTED|Overall Study||884
6595173|NCT02009046|7520273|FG000|SEI Curriculum Only|Overall Study||461
6595174|NCT02009046|7520274|FG001|SEI Curriculum Only|Overall Study||0
6624717|NCT02219334|7552219|FG000|NOT COMPLETED|Overall Study||8
6595175|NCT02009046|7520273|FG000|SEI Curriculum + 3 SchoolWide Components|Overall Study||544
6595176|NCT02009046|7520274|FG001|SEI Curriculum + 3 SchoolWide Components|Overall Study||0
6595177|NCT02009046|7520273|FG000|Ctrl Curriculum Only|Overall Study||0
6595178|NCT02009046|7520274|FG001|Ctrl Curriculum Only|Overall Study||456
6595179|NCT02009046|7520273|FG000|Ctrl Curriculm +1 SchoolWide Component|Overall Study||0
6595180|NCT02009046|7520274|FG001|Ctrl Curriculm +1 SchoolWide Component|Overall Study||428
6595181|NCT02009046|7520273|FG000|COMPLETED|Overall Study||769
6595182|NCT02009046|7520274|FG001|COMPLETED|Overall Study||678
6595183|NCT02009046|7520273|FG000|NOT COMPLETED|Overall Study||256
6595184|NCT02009046|7520274|FG001|NOT COMPLETED|Overall Study||206
6595185|NCT02009163|7520288|FG000|STARTED|Open-label Period (Non-randomized)||418
6595186|NCT02009163|7520289|FG001|STARTED|Open-label Period (Non-randomized)||0
6595187|NCT02009163|7520290|FG002|STARTED|Open-label Period (Non-randomized)||0
6595188|NCT02009163|7520288|FG000|COMPLETED|Open-label Period (Non-randomized)||275
6595189|NCT02009163|7520289|FG001|COMPLETED|Open-label Period (Non-randomized)||0
6595190|NCT02009163|7520290|FG002|COMPLETED|Open-label Period (Non-randomized)||0
6595191|NCT02009163|7520288|FG000|NOT COMPLETED|Open-label Period (Non-randomized)||143
6595192|NCT02009163|7520289|FG001|NOT COMPLETED|Open-label Period (Non-randomized)||0
6595193|NCT02009163|7520290|FG002|NOT COMPLETED|Open-label Period (Non-randomized)||0
6595194|NCT02009163|7520288|FG000|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
6595195|NCT02009163|7520289|FG001|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
6595196|NCT02009163|7520290|FG002|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
6595197|NCT02009163|7520288|FG000|COMPLETED|Randomized-withdrawal Period||0
6595198|NCT02009163|7520289|FG001|COMPLETED|Randomized-withdrawal Period||50
6595199|NCT02009163|7520290|FG002|COMPLETED|Randomized-withdrawal Period||102
6595200|NCT02009163|7520288|FG000|NOT COMPLETED|Randomized-withdrawal Period||0
6595201|NCT02009163|7520289|FG001|NOT COMPLETED|Randomized-withdrawal Period||88
6595202|NCT02009163|7520290|FG002|NOT COMPLETED|Randomized-withdrawal Period||35
6595203|NCT02009332|7520306|FG000|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||3
6595204|NCT02009332|7520307|FG001|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595205|NCT02009332|7520308|FG002|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595206|NCT02009332|7520309|FG003|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595207|NCT02009332|7520310|FG004|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595208|NCT02009332|7520311|FG005|STARTED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595209|NCT02009332|7520306|FG000|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)|Cohort 1 completed 6-week treatment.|3
6595210|NCT02009332|7520307|FG001|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595211|NCT02009332|7520308|FG002|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595212|NCT02009332|7520309|FG003|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595213|NCT02009332|7520310|FG004|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595214|NCT02009332|7520311|FG005|COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595215|NCT02009332|7520306|FG000|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595216|NCT02009332|7520307|FG001|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595217|NCT02009332|7520308|FG002|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595218|NCT02009332|7520309|FG003|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595219|NCT02009332|7520310|FG004|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595220|NCT02009332|7520311|FG005|NOT COMPLETED|Phase 1: Dose Level 1 (Weeks 1-10)||0
6595221|NCT02009332|7520306|FG000|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595222|NCT02009332|7520307|FG001|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||4
6595223|NCT02009332|7520308|FG002|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
6595224|NCT02009332|7520309|FG003|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595225|NCT02009332|7520310|FG004|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595226|NCT02009332|7520311|FG005|STARTED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595227|NCT02009332|7520306|FG000|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595228|NCT02009332|7520307|FG001|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2 completed 6-week treatment.|3
6595229|NCT02009332|7520308|FG002|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)|Cohort 2b stopped due to lack of enrollment.|1
6595230|NCT02009332|7520309|FG003|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595231|NCT02009332|7520310|FG004|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595232|NCT02009332|7520311|FG005|COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595233|NCT02009332|7520306|FG000|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595234|NCT02009332|7520307|FG001|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||1
6595235|NCT02009332|7520308|FG002|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595236|NCT02009332|7520309|FG003|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595237|NCT02009332|7520310|FG004|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595238|NCT02009332|7520311|FG005|NOT COMPLETED|Phase 1: Dose Level 2/2b (Wks 11-29)||0
6595239|NCT02009332|7520306|FG000|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595240|NCT02009332|7520307|FG001|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595241|NCT02009332|7520308|FG002|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595242|NCT02009332|7520309|FG003|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||3
6595243|NCT02009332|7520310|FG004|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595244|NCT02009332|7520311|FG005|STARTED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595245|NCT02009332|7520306|FG000|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595246|NCT02009332|7520307|FG001|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595247|NCT02009332|7520308|FG002|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595248|NCT02009332|7520309|FG003|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)|Cohort 3 completed 6-week treatment.|3
6595249|NCT02009332|7520310|FG004|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595250|NCT02009332|7520311|FG005|COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595251|NCT02009332|7520306|FG000|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595252|NCT02009332|7520307|FG001|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595253|NCT02009332|7520308|FG002|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595254|NCT02009332|7520309|FG003|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595255|NCT02009332|7520310|FG004|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595256|NCT02009332|7520311|FG005|NOT COMPLETED|Phase 1: Dose Level 3 (Weeks 30-47)||0
6595257|NCT02009332|7520306|FG000|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595258|NCT02009332|7520307|FG001|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595259|NCT02009332|7520308|FG002|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595260|NCT02009332|7520309|FG003|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595261|NCT02009332|7520310|FG004|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||4
6595262|NCT02009332|7520311|FG005|STARTED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595263|NCT02009332|7520306|FG000|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595264|NCT02009332|7520307|FG001|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595265|NCT02009332|7520308|FG002|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595266|NCT02009332|7520309|FG003|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595267|NCT02009332|7520310|FG004|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)|Cohort 4 completed 6-week treatment.|3
6595268|NCT02009332|7520311|FG005|COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595269|NCT02009332|7520306|FG000|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595270|NCT02009332|7520307|FG001|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595271|NCT02009332|7520308|FG002|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595272|NCT02009332|7520309|FG003|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595273|NCT02009332|7520310|FG004|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||1
6595274|NCT02009332|7520311|FG005|NOT COMPLETED|Phase 1: Dose Level 4 (Weeks 48-77)||0
6595275|NCT02009332|7520306|FG000|STARTED|Phase 2 (Weeks 206-252)||0
6595276|NCT02009332|7520307|FG001|STARTED|Phase 2 (Weeks 206-252)||0
6595277|NCT02009332|7520308|FG002|STARTED|Phase 2 (Weeks 206-252)||0
6595278|NCT02009332|7520309|FG003|STARTED|Phase 2 (Weeks 206-252)||0
6595279|NCT02009332|7520310|FG004|STARTED|Phase 2 (Weeks 206-252)||0
6595280|NCT02009332|7520311|FG005|STARTED|Phase 2 (Weeks 206-252)||6
6595281|NCT02009332|7520306|FG000|COMPLETED|Phase 2 (Weeks 206-252)||0
6595282|NCT02009332|7520307|FG001|COMPLETED|Phase 2 (Weeks 206-252)||0
6595283|NCT02009332|7520308|FG002|COMPLETED|Phase 2 (Weeks 206-252)||0
6595284|NCT02009332|7520309|FG003|COMPLETED|Phase 2 (Weeks 206-252)||0
6595285|NCT02009332|7520310|FG004|COMPLETED|Phase 2 (Weeks 206-252)||0
6595286|NCT02009332|7520311|FG005|COMPLETED|Phase 2 (Weeks 206-252)|Phase 2 stopped due to lack of efficacy.|5
6595287|NCT02009332|7520306|FG000|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
6595288|NCT02009332|7520307|FG001|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
6595289|NCT02009332|7520308|FG002|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
6595290|NCT02009332|7520309|FG003|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
6595291|NCT02009332|7520310|FG004|NOT COMPLETED|Phase 2 (Weeks 206-252)||0
6595292|NCT02009332|7520311|FG005|NOT COMPLETED|Phase 2 (Weeks 206-252)||1
6595293|NCT02009397|7520325|FG000|STARTED|Overall Study||26
6595294|NCT02009397|7520325|FG000|COMPLETED|Overall Study||6
6595295|NCT02009397|7520325|FG000|NOT COMPLETED|Overall Study||20
6595296|NCT02009501|7520331|FG000|STARTED|Overall Study||9
6595297|NCT02009501|7520332|FG001|STARTED|Overall Study||11
6595298|NCT02009501|7520331|FG000|COMPLETED|Overall Study||9
6595299|NCT02009501|7520332|FG001|COMPLETED|Overall Study||11
6595300|NCT02009501|7520331|FG000|NOT COMPLETED|Overall Study||0
6595301|NCT02009501|7520332|FG001|NOT COMPLETED|Overall Study||0
6595302|NCT02009696|7520338|FG000|STARTED|Overall Study||221
6595303|NCT02009696|7520338|FG000|COMPLETED|Overall Study||219
6595304|NCT02009696|7520338|FG000|NOT COMPLETED|Overall Study||2
6595305|NCT02009722|7520344|FG000|STARTED|Overall Study||41
6595306|NCT02009722|7520345|FG001|STARTED|Overall Study||43
6595307|NCT02009722|7520344|FG000|Received Intervention|Overall Study||41
6595308|NCT02009722|7520345|FG001|Received Intervention|Overall Study||42
6595309|NCT02009722|7520344|FG000|COMPLETED|Overall Study||40
6595310|NCT02009722|7520345|FG001|COMPLETED|Overall Study||40
6595311|NCT02009722|7520344|FG000|NOT COMPLETED|Overall Study||1
6595312|NCT02009722|7520345|FG001|NOT COMPLETED|Overall Study||3
6595313|NCT02009865|7520353|FG000|STARTED|Overall Study||81
6595314|NCT02009865|7520354|FG001|STARTED|Overall Study||81
6595315|NCT02009865|7520353|FG000|COMPLETED|Overall Study||80
6595316|NCT02009865|7520354|FG001|COMPLETED|Overall Study||76
6595317|NCT02009865|7520353|FG000|NOT COMPLETED|Overall Study||1
6660281|NCT02497287|7591205|FG000|NOT COMPLETED|Follow-up Phase (4 Week)||31
6595318|NCT02009865|7520354|FG001|NOT COMPLETED|Overall Study||5
6595319|NCT02009878|7520363|FG000|STARTED|Overall Study||10
6595320|NCT02009878|7520364|FG001|STARTED|Overall Study||11
6595321|NCT02009878|7520365|FG002|STARTED|Overall Study||9
6595322|NCT02009878|7520363|FG000|COMPLETED|Overall Study||10
6595323|NCT02009878|7520364|FG001|COMPLETED|Overall Study||10
6595324|NCT02009878|7520365|FG002|COMPLETED|Overall Study||9
6595325|NCT02009878|7520363|FG000|NOT COMPLETED|Overall Study||0
6595326|NCT02009878|7520364|FG001|NOT COMPLETED|Overall Study||1
6595327|NCT02009878|7520365|FG002|NOT COMPLETED|Overall Study||0
6595328|NCT02009930|7520373|FG000|STARTED|Overall Study|5 withdrawn|112
6595329|NCT02009930|7520373|FG000|COMPLETED|Overall Study||107
6595330|NCT02009930|7520373|FG000|NOT COMPLETED|Overall Study||5
6595331|NCT02010021|7520386|FG000|STARTED|Overall Study||10
6595332|NCT02010021|7520387|FG001|STARTED|Overall Study||7
6595333|NCT02010021|7520386|FG000|COMPLETED|Overall Study||10
6595334|NCT02010021|7520387|FG001|COMPLETED|Overall Study||7
6595335|NCT02010021|7520386|FG000|NOT COMPLETED|Overall Study||0
6595336|NCT02010021|7520387|FG001|NOT COMPLETED|Overall Study||0
6595337|NCT02010151|7520395|FG000|STARTED|Overall Study|January 2013 to December 2017|1498
6595338|NCT02010151|7520396|FG001|STARTED|Overall Study|January 2013 to December 2017|1696
6595339|NCT02010151|7520395|FG000|COMPLETED|Overall Study|Text message (TM) sent: 0|1498
6595340|NCT02010151|7520396|FG001|COMPLETED|Overall Study|TM sent: 598|1696
6595341|NCT02010151|7520395|FG000|NOT COMPLETED|Overall Study||0
6595342|NCT02010151|7520396|FG001|NOT COMPLETED|Overall Study||0
6595343|NCT02010203|7520407|FG000|STARTED|Overall Study||10
6595344|NCT02010203|7520408|FG001|STARTED|Overall Study||26
6595345|NCT02010203|7520409|FG002|STARTED|Overall Study||26
6595346|NCT02010203|7520410|FG003|STARTED|Overall Study||26
6595347|NCT02010203|7520411|FG004|STARTED|Overall Study||16
6595348|NCT02010203|7520407|FG000|COMPLETED|Overall Study||10
6595349|NCT02010203|7520408|FG001|COMPLETED|Overall Study||17
6595350|NCT02010203|7520409|FG002|COMPLETED|Overall Study||16
6595351|NCT02010203|7520410|FG003|COMPLETED|Overall Study||23
6595352|NCT02010203|7520411|FG004|COMPLETED|Overall Study||3
6595353|NCT02010203|7520407|FG000|NOT COMPLETED|Overall Study||0
6595354|NCT02010203|7520408|FG001|NOT COMPLETED|Overall Study||9
6595355|NCT02010203|7520409|FG002|NOT COMPLETED|Overall Study||10
6595356|NCT02010203|7520410|FG003|NOT COMPLETED|Overall Study||3
6595357|NCT02010203|7520411|FG004|NOT COMPLETED|Overall Study||13
6595358|NCT02010216|7520423|FG000|STARTED|Overall Study||23
6595359|NCT02010216|7520423|FG000|COMPLETED|Overall Study||23
6595360|NCT02010216|7520423|FG000|NOT COMPLETED|Overall Study||0
6595361|NCT02010255|7520441|FG000|STARTED|Overall Study||28
6595362|NCT02010255|7520442|FG001|STARTED|Overall Study||28
6595363|NCT02010255|7520443|FG002|STARTED|Overall Study||25
6595364|NCT02010255|7520444|FG003|STARTED|Overall Study||26
6595365|NCT02010255|7520445|FG004|STARTED|Overall Study||52
6595366|NCT02010255|7520446|FG005|STARTED|Overall Study||49
6595367|NCT02010255|7520447|FG006|STARTED|Overall Study||34
6595368|NCT02010255|7520448|FG007|STARTED|Overall Study||33
6595369|NCT02010255|7520449|FG008|STARTED|Overall Study||22
6595370|NCT02010255|7520450|FG009|STARTED|Overall Study||23
6595371|NCT02010255|7520451|FG010|STARTED|Overall Study||3
6595372|NCT02010255|7520452|FG011|STARTED|Overall Study||5
6595373|NCT02010255|7520453|FG012|STARTED|Overall Study||3
6595374|NCT02010255|7520454|FG013|STARTED|Overall Study||3
6595375|NCT02010255|7520441|FG000|COMPLETED|Overall Study||22
6595376|NCT02010255|7520442|FG001|COMPLETED|Overall Study||26
6595377|NCT02010255|7520443|FG002|COMPLETED|Overall Study||18
6595378|NCT02010255|7520444|FG003|COMPLETED|Overall Study||20
6595379|NCT02010255|7520445|FG004|COMPLETED|Overall Study||48
6595380|NCT02010255|7520446|FG005|COMPLETED|Overall Study||49
6595381|NCT02010255|7520447|FG006|COMPLETED|Overall Study||33
6595382|NCT02010255|7520448|FG007|COMPLETED|Overall Study||32
6595383|NCT02010255|7520449|FG008|COMPLETED|Overall Study||21
6595384|NCT02010255|7520450|FG009|COMPLETED|Overall Study||23
6595385|NCT02010255|7520451|FG010|COMPLETED|Overall Study||1
6595386|NCT02010255|7520452|FG011|COMPLETED|Overall Study||4
6595387|NCT02010255|7520453|FG012|COMPLETED|Overall Study||3
6595388|NCT02010255|7520454|FG013|COMPLETED|Overall Study||2
6595389|NCT02010255|7520441|FG000|NOT COMPLETED|Overall Study||6
6595390|NCT02010255|7520442|FG001|NOT COMPLETED|Overall Study||2
6595391|NCT02010255|7520443|FG002|NOT COMPLETED|Overall Study||7
6595392|NCT02010255|7520444|FG003|NOT COMPLETED|Overall Study||6
6595393|NCT02010255|7520445|FG004|NOT COMPLETED|Overall Study||4
6595394|NCT02010255|7520446|FG005|NOT COMPLETED|Overall Study||0
6595395|NCT02010255|7520447|FG006|NOT COMPLETED|Overall Study||1
6595396|NCT02010255|7520448|FG007|NOT COMPLETED|Overall Study||1
6595397|NCT02010255|7520449|FG008|NOT COMPLETED|Overall Study||1
6595398|NCT02010255|7520450|FG009|NOT COMPLETED|Overall Study||0
6595399|NCT02010255|7520451|FG010|NOT COMPLETED|Overall Study||2
6595400|NCT02010255|7520452|FG011|NOT COMPLETED|Overall Study||1
6595401|NCT02010255|7520453|FG012|NOT COMPLETED|Overall Study||0
6595402|NCT02010255|7520454|FG013|NOT COMPLETED|Overall Study||1
6595403|NCT02010359|7520511|FG000|STARTED|Overall Study||15
6595404|NCT02010359|7520512|FG001|STARTED|Overall Study||14
6595405|NCT02010359|7520511|FG000|COMPLETED|Overall Study||13
6595406|NCT02010359|7520512|FG001|COMPLETED|Overall Study||12
6595407|NCT02010359|7520511|FG000|NOT COMPLETED|Overall Study||2
6595408|NCT02010359|7520512|FG001|NOT COMPLETED|Overall Study||2
6624718|NCT02219334|7552220|FG001|NOT COMPLETED|Overall Study||3
6624719|NCT02219438|7552228|FG000|STARTED|Overall Study||13
6624720|NCT02219438|7552229|FG001|STARTED|Overall Study||11
6624721|NCT02219438|7552228|FG000|COMPLETED|Overall Study||13
6624722|NCT02219438|7552229|FG001|COMPLETED|Overall Study||11
6624723|NCT02219438|7552228|FG000|NOT COMPLETED|Overall Study||0
6624724|NCT02219438|7552229|FG001|NOT COMPLETED|Overall Study||0
6624725|NCT02219464|7552239|FG000|STARTED|Overall Study||30
6595409|NCT02010567|7520523|FG000|STARTED|Overall Study||3
6595410|NCT02010567|7520524|FG001|STARTED|Overall Study||6
6595411|NCT02010567|7520525|FG002|STARTED|Overall Study||14
6595412|NCT02010567|7520526|FG003|STARTED|Overall Study||3
6595413|NCT02010567|7520527|FG004|STARTED|Overall Study||6
6595414|NCT02010567|7520523|FG000|COMPLETED|Overall Study||3
6595415|NCT02010567|7520524|FG001|COMPLETED|Overall Study||6
6595416|NCT02010567|7520525|FG002|COMPLETED|Overall Study||13
6595417|NCT02010567|7520526|FG003|COMPLETED|Overall Study||3
6595418|NCT02010567|7520527|FG004|COMPLETED|Overall Study||5
6595419|NCT02010567|7520523|FG000|NOT COMPLETED|Overall Study||0
6595420|NCT02010567|7520524|FG001|NOT COMPLETED|Overall Study||0
6595421|NCT02010567|7520525|FG002|NOT COMPLETED|Overall Study||1
6595422|NCT02010567|7520526|FG003|NOT COMPLETED|Overall Study||0
6595423|NCT02010567|7520527|FG004|NOT COMPLETED|Overall Study||1
6660282|NCT02497391|7591211|FG000|STARTED|Period 1 (14 Days)||16
6660283|NCT02497391|7591212|FG001|STARTED|Period 1 (14 Days)||15
6278965|NCT00140231|7178650|FG001|NOT COMPLETED|Washout 8weeks||0
6660284|NCT02497391|7591213|FG002|STARTED|Period 1 (14 Days)||16
6660285|NCT02497391|7591214|FG003|STARTED|Period 1 (14 Days)||16
6660286|NCT02497391|7591215|FG004|STARTED|Period 1 (14 Days)||16
6660287|NCT02497391|7591216|FG005|STARTED|Period 1 (14 Days)||16
6660288|NCT02497391|7591211|FG000|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6660289|NCT02497391|7591212|FG001|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||15
6660290|NCT02497391|7591213|FG002|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6660291|NCT02497391|7591214|FG003|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6660292|NCT02497391|7591215|FG004|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6660293|NCT02497391|7591216|FG005|Received at Least 1 Dose of Study Drug|Period 1 (14 Days)||16
6660294|NCT02497391|7591211|FG000|COMPLETED|Period 1 (14 Days)||16
6660295|NCT02497391|7591212|FG001|COMPLETED|Period 1 (14 Days)||15
6660296|NCT02497391|7591213|FG002|COMPLETED|Period 1 (14 Days)||16
6660297|NCT02497391|7591214|FG003|COMPLETED|Period 1 (14 Days)||16
6660298|NCT02497391|7591215|FG004|COMPLETED|Period 1 (14 Days)||16
6660299|NCT02497391|7591216|FG005|COMPLETED|Period 1 (14 Days)||16
6660300|NCT02497391|7591211|FG000|NOT COMPLETED|Period 1 (14 Days)||0
6660301|NCT02497391|7591212|FG001|NOT COMPLETED|Period 1 (14 Days)||0
6660302|NCT02497391|7591213|FG002|NOT COMPLETED|Period 1 (14 Days)||0
6660303|NCT02497391|7591214|FG003|NOT COMPLETED|Period 1 (14 Days)||0
6660304|NCT02497391|7591215|FG004|NOT COMPLETED|Period 1 (14 Days)||0
6660305|NCT02497391|7591216|FG005|NOT COMPLETED|Period 1 (14 Days)||0
6660306|NCT02497391|7591211|FG000|STARTED|Period 2 (14 Days)||16
6660307|NCT02497391|7591212|FG001|STARTED|Period 2 (14 Days)||15
6660308|NCT02497391|7591213|FG002|STARTED|Period 2 (14 Days)||16
6660309|NCT02497391|7591214|FG003|STARTED|Period 2 (14 Days)||16
6660310|NCT02497391|7591215|FG004|STARTED|Period 2 (14 Days)||16
6595424|NCT02010632|7520537|FG000|STARTED|First Intervention (7 Days)||16
6595425|NCT02010632|7520538|FG001|STARTED|First Intervention (7 Days)||16
6595426|NCT02010632|7520537|FG000|COMPLETED|First Intervention (7 Days)||16
6595427|NCT02010632|7520538|FG001|COMPLETED|First Intervention (7 Days)||16
6595428|NCT02010632|7520537|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6595429|NCT02010632|7520538|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6595430|NCT02010632|7520537|FG000|STARTED|Wash Out Period (14 Days)||16
6595431|NCT02010632|7520538|FG001|STARTED|Wash Out Period (14 Days)||16
6595432|NCT02010632|7520537|FG000|COMPLETED|Wash Out Period (14 Days)||16
6595433|NCT02010632|7520538|FG001|COMPLETED|Wash Out Period (14 Days)||16
6595434|NCT02010632|7520537|FG000|NOT COMPLETED|Wash Out Period (14 Days)||0
6595435|NCT02010632|7520538|FG001|NOT COMPLETED|Wash Out Period (14 Days)||0
6595436|NCT02010632|7520537|FG000|STARTED|Second Intervention (7 Days)||16
6595437|NCT02010632|7520538|FG001|STARTED|Second Intervention (7 Days)||16
6595438|NCT02010632|7520537|FG000|COMPLETED|Second Intervention (7 Days)||15
6595439|NCT02010632|7520538|FG001|COMPLETED|Second Intervention (7 Days)||16
6595440|NCT02010632|7520537|FG000|NOT COMPLETED|Second Intervention (7 Days)||1
6595441|NCT02010632|7520538|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6595442|NCT02010645|7520544|FG000|STARTED|Overall Study||6
6595443|NCT02010645|7520544|FG000|COMPLETED|Overall Study||6
6595444|NCT02010645|7520544|FG000|NOT COMPLETED|Overall Study||0
6595445|NCT02010684|7520550|FG000|STARTED|Overall Study||39
6595446|NCT02010684|7520551|FG001|STARTED|Overall Study||82
6595447|NCT02010684|7520550|FG000|COMPLETED|Overall Study||27
6595448|NCT02010684|7520551|FG001|COMPLETED|Overall Study||59
6595449|NCT02010684|7520550|FG000|NOT COMPLETED|Overall Study||12
6595450|NCT02010684|7520551|FG001|NOT COMPLETED|Overall Study||23
6595451|NCT02010697|7520560|FG000|STARTED|Overall Study||1044
6595452|NCT02010697|7520561|FG001|STARTED|Overall Study||1038
6595453|NCT02010697|7520562|FG002|STARTED|Overall Study||1043
6595454|NCT02010697|7520560|FG000|COMPLETED|Overall Study||1044
6595455|NCT02010697|7520561|FG001|COMPLETED|Overall Study||1038
6595456|NCT02010697|7520562|FG002|COMPLETED|Overall Study||1043
6595457|NCT02010697|7520560|FG000|NOT COMPLETED|Overall Study||0
6595458|NCT02010697|7520561|FG001|NOT COMPLETED|Overall Study||0
6595459|NCT02010697|7520562|FG002|NOT COMPLETED|Overall Study||0
6595460|NCT02010775|7520575|FG000|STARTED|Overall Study||38
6595461|NCT02010775|7520576|FG001|STARTED|Overall Study||38
6595462|NCT02010775|7520577|FG002|STARTED|Overall Study||37
6595463|NCT02010775|7520578|FG003|STARTED|Overall Study||37
6595464|NCT02010775|7520579|FG004|STARTED|Overall Study||37
6595465|NCT02010775|7520575|FG000|COMPLETED|Overall Study||33
6595466|NCT02010775|7520576|FG001|COMPLETED|Overall Study||35
6595467|NCT02010775|7520577|FG002|COMPLETED|Overall Study||34
6595468|NCT02010775|7520578|FG003|COMPLETED|Overall Study||34
6595469|NCT02010775|7520579|FG004|COMPLETED|Overall Study||31
6595470|NCT02010775|7520575|FG000|NOT COMPLETED|Overall Study||5
6595471|NCT02010775|7520576|FG001|NOT COMPLETED|Overall Study||3
6595472|NCT02010775|7520577|FG002|NOT COMPLETED|Overall Study||3
6595473|NCT02010775|7520578|FG003|NOT COMPLETED|Overall Study||3
6595474|NCT02010775|7520579|FG004|NOT COMPLETED|Overall Study||6
6595475|NCT02010996|7520593|FG000|STARTED|Overall Study||36
6595476|NCT02010996|7520594|FG001|STARTED|Overall Study||36
6595477|NCT02010996|7520593|FG000|COMPLETED|Overall Study||36
6595478|NCT02010996|7520594|FG001|COMPLETED|Overall Study||36
6595479|NCT02010996|7520593|FG000|NOT COMPLETED|Overall Study||0
6595480|NCT02010996|7520594|FG001|NOT COMPLETED|Overall Study||0
6595481|NCT02011113|7520604|FG000|STARTED|Overall Study||36
6595482|NCT02011113|7520604|FG000|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
6595483|NCT02011113|7520604|FG000|NOT COMPLETED|Overall Study||36
6595484|NCT02011386|7520609|FG000|STARTED|Overall Study||53
6595485|NCT02011386|7520609|FG000|COMPLETED|Overall Study||48
6595486|NCT02011386|7520609|FG000|NOT COMPLETED|Overall Study||5
6595487|NCT02011464|7520615|FG000|STARTED|Overall Study||10
6595488|NCT02011464|7520616|FG001|STARTED|Overall Study||10
6595489|NCT02011464|7520615|FG000|COMPLETED|Overall Study||10
6595490|NCT02011464|7520616|FG001|COMPLETED|Overall Study||10
6595491|NCT02011464|7520615|FG000|NOT COMPLETED|Overall Study||0
6595492|NCT02011464|7520616|FG001|NOT COMPLETED|Overall Study||0
6595493|NCT02011490|7520637|FG000|STARTED|Part 1||8
6595494|NCT02011490|7520638|FG001|STARTED|Part 1||8
6595495|NCT02011490|7520639|FG002|STARTED|Part 1||8
6595496|NCT02011490|7520640|FG003|STARTED|Part 1||0
6595497|NCT02011490|7520641|FG004|STARTED|Part 1||0
6595498|NCT02011490|7520642|FG005|STARTED|Part 1||0
6595499|NCT02011490|7520637|FG000|COMPLETED|Part 1||8
6595500|NCT02011490|7520638|FG001|COMPLETED|Part 1||8
6595501|NCT02011490|7520639|FG002|COMPLETED|Part 1||8
6595502|NCT02011490|7520640|FG003|COMPLETED|Part 1||0
6595503|NCT02011490|7520641|FG004|COMPLETED|Part 1||0
6595504|NCT02011490|7520642|FG005|COMPLETED|Part 1||0
6595505|NCT02011490|7520637|FG000|NOT COMPLETED|Part 1||0
6595506|NCT02011490|7520638|FG001|NOT COMPLETED|Part 1||0
6595507|NCT02011490|7520639|FG002|NOT COMPLETED|Part 1||0
6595508|NCT02011490|7520640|FG003|NOT COMPLETED|Part 1||0
6595509|NCT02011490|7520641|FG004|NOT COMPLETED|Part 1||0
6595510|NCT02011490|7520642|FG005|NOT COMPLETED|Part 1||0
6595511|NCT02011490|7520637|FG000|STARTED|Part 2||0
6595512|NCT02011490|7520638|FG001|STARTED|Part 2||0
6660311|NCT02497391|7591216|FG005|STARTED|Period 2 (14 Days)||16
6595513|NCT02011490|7520639|FG002|STARTED|Part 2||0
6624726|NCT02219464|7552240|FG001|STARTED|Overall Study||30
6595514|NCT02011490|7520640|FG003|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
6595515|NCT02011490|7520641|FG004|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
6595516|NCT02011490|7520642|FG005|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
6595517|NCT02011490|7520637|FG000|COMPLETED|Part 2||0
6595518|NCT02011490|7520638|FG001|COMPLETED|Part 2||0
6595519|NCT02011490|7520639|FG002|COMPLETED|Part 2||0
6595520|NCT02011490|7520640|FG003|COMPLETED|Part 2||6
6595521|NCT02011490|7520641|FG004|COMPLETED|Part 2||6
6595522|NCT02011490|7520642|FG005|COMPLETED|Part 2||6
6595523|NCT02011490|7520637|FG000|NOT COMPLETED|Part 2||0
6595524|NCT02011490|7520638|FG001|NOT COMPLETED|Part 2||0
6595525|NCT02011490|7520639|FG002|NOT COMPLETED|Part 2||0
6595526|NCT02011490|7520640|FG003|NOT COMPLETED|Part 2||0
6595527|NCT02011490|7520641|FG004|NOT COMPLETED|Part 2||0
6595528|NCT02011490|7520642|FG005|NOT COMPLETED|Part 2||0
6595529|NCT02011516|7520658|FG000|STARTED|Overall Study||8
6595530|NCT02011516|7520659|FG001|STARTED|Overall Study||8
6595531|NCT02011516|7520658|FG000|COMPLETED|Overall Study||4
6595532|NCT02011516|7520659|FG001|COMPLETED|Overall Study||6
6595533|NCT02011516|7520658|FG000|NOT COMPLETED|Overall Study||4
6595534|NCT02011516|7520659|FG001|NOT COMPLETED|Overall Study||2
6595535|NCT02011893|7520665|FG000|STARTED|Enrollment to Randomization||173
6595536|NCT02011893|7520666|FG001|STARTED|Enrollment to Randomization||0
6595537|NCT02011893|7520667|FG002|STARTED|Enrollment to Randomization||0
6595538|NCT02011893|7520665|FG000|Baseline|Enrollment to Randomization||141
6595539|NCT02011893|7520666|FG001|Baseline|Enrollment to Randomization||0
6595540|NCT02011893|7520667|FG002|Baseline|Enrollment to Randomization||0
6595541|NCT02011893|7520665|FG000|Trial Stimulation Implant|Enrollment to Randomization||121
6595542|NCT02011893|7520666|FG001|Trial Stimulation Implant|Enrollment to Randomization||0
6595543|NCT02011893|7520667|FG002|Trial Stimulation Implant|Enrollment to Randomization||0
6595544|NCT02011893|7520665|FG000|Permanent Stimulation Implant|Enrollment to Randomization||101
6595545|NCT02011893|7520666|FG001|Permanent Stimulation Implant|Enrollment to Randomization||0
6595546|NCT02011893|7520667|FG002|Permanent Stimulation Implant|Enrollment to Randomization||0
6595547|NCT02011893|7520665|FG000|Randomization|Enrollment to Randomization||100
6595548|NCT02011893|7520666|FG001|Randomization|Enrollment to Randomization||0
6595549|NCT02011893|7520667|FG002|Randomization|Enrollment to Randomization||0
6595550|NCT02011893|7520665|FG000|COMPLETED|Enrollment to Randomization||100
6595551|NCT02011893|7520666|FG001|COMPLETED|Enrollment to Randomization||0
6595552|NCT02011893|7520667|FG002|COMPLETED|Enrollment to Randomization||0
6595553|NCT02011893|7520665|FG000|NOT COMPLETED|Enrollment to Randomization||73
6595554|NCT02011893|7520666|FG001|NOT COMPLETED|Enrollment to Randomization||0
6595555|NCT02011893|7520667|FG002|NOT COMPLETED|Enrollment to Randomization||0
6595556|NCT02011893|7520665|FG000|STARTED|Period 1 (Randomization to 12 Weeks)||0
6595557|NCT02011893|7520666|FG001|STARTED|Period 1 (Randomization to 12 Weeks)||45
6595558|NCT02011893|7520667|FG002|STARTED|Period 1 (Randomization to 12 Weeks)||55
6595559|NCT02011893|7520665|FG000|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
6595560|NCT02011893|7520666|FG001|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
6595561|NCT02011893|7520667|FG002|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
6595562|NCT02011893|7520665|FG000|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
6595563|NCT02011893|7520666|FG001|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
6595564|NCT02011893|7520667|FG002|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
6595565|NCT02011893|7520665|FG000|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
6595566|NCT02011893|7520666|FG001|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
6595567|NCT02011893|7520667|FG002|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
6595568|NCT02011893|7520665|FG000|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
6595569|NCT02011893|7520666|FG001|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
6595570|NCT02011893|7520667|FG002|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
6595571|NCT02011893|7520665|FG000|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
6595572|NCT02011893|7520666|FG001|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
6595573|NCT02011893|7520667|FG002|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
6595574|NCT02011893|7520665|FG000|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
6595575|NCT02011893|7520666|FG001|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
6595576|NCT02011893|7520667|FG002|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
6595577|NCT02011893|7520665|FG000|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
6595578|NCT02011893|7520666|FG001|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
6595579|NCT02011893|7520667|FG002|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
6595580|NCT02011893|7520665|FG000|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
6595581|NCT02011893|7520666|FG001|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
6595582|NCT02011893|7520667|FG002|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
6595583|NCT02011893|7520665|FG000|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
6595584|NCT02011893|7520666|FG001|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
6595585|NCT02011893|7520667|FG002|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
6595586|NCT02011945|7520675|FG000|STARTED|Overall Study||2
6595587|NCT02011945|7520676|FG001|STARTED|Overall Study||13
6595588|NCT02011945|7520677|FG002|STARTED|Overall Study||16
6595589|NCT02011945|7520675|FG000|COMPLETED|Overall Study||0
6595590|NCT02011945|7520676|FG001|COMPLETED|Overall Study||3
6595591|NCT02011945|7520677|FG002|COMPLETED|Overall Study||6
6595592|NCT02011945|7520675|FG000|NOT COMPLETED|Overall Study||2
6595593|NCT02011945|7520676|FG001|NOT COMPLETED|Overall Study||10
6595594|NCT02011945|7520677|FG002|NOT COMPLETED|Overall Study||10
6595595|NCT02012192|7520687|FG000|STARTED|Overall Study||90
6595596|NCT02012192|7520688|FG001|STARTED|Overall Study||43
6595597|NCT02012192|7520687|FG000|COMPLETED|Overall Study||63
6595598|NCT02012192|7520688|FG001|COMPLETED|Overall Study||43
6595599|NCT02012192|7520687|FG000|NOT COMPLETED|Overall Study||27
6595600|NCT02012192|7520688|FG001|NOT COMPLETED|Overall Study||0
6595601|NCT02012218|7520699|FG000|STARTED|Overall Study||12
6595602|NCT02012218|7520700|FG001|STARTED|Overall Study||11
6595603|NCT02012218|7520701|FG002|STARTED|Overall Study||13
6595604|NCT02012218|7520702|FG003|STARTED|Overall Study||19
6595605|NCT02012218|7520703|FG004|STARTED|Overall Study||6
6595606|NCT02012218|7520699|FG000|COMPLETED|Overall Study||8
6595607|NCT02012218|7520700|FG001|COMPLETED|Overall Study||10
6595608|NCT02012218|7520701|FG002|COMPLETED|Overall Study||11
6595609|NCT02012218|7520702|FG003|COMPLETED|Overall Study||17
6595610|NCT02012218|7520703|FG004|COMPLETED|Overall Study||5
6595611|NCT02012218|7520699|FG000|NOT COMPLETED|Overall Study||4
6595612|NCT02012218|7520700|FG001|NOT COMPLETED|Overall Study||1
6595613|NCT02012218|7520701|FG002|NOT COMPLETED|Overall Study||2
6595614|NCT02012218|7520702|FG003|NOT COMPLETED|Overall Study||2
6595615|NCT02012218|7520703|FG004|NOT COMPLETED|Overall Study||1
6595616|NCT02012283|7520717|FG000|STARTED|First Intervention||10
6595617|NCT02012283|7520718|FG001|STARTED|First Intervention||10
6595618|NCT02012283|7520717|FG000|COMPLETED|First Intervention||10
6595619|NCT02012283|7520718|FG001|COMPLETED|First Intervention||10
6595620|NCT02012283|7520717|FG000|NOT COMPLETED|First Intervention||0
6595621|NCT02012283|7520718|FG001|NOT COMPLETED|First Intervention||0
6595622|NCT02012283|7520717|FG000|STARTED|Second Intervention||10
6595623|NCT02012283|7520718|FG001|STARTED|Second Intervention||10
6595624|NCT02012283|7520717|FG000|COMPLETED|Second Intervention||10
6595625|NCT02012283|7520718|FG001|COMPLETED|Second Intervention||10
6595626|NCT02012283|7520717|FG000|NOT COMPLETED|Second Intervention||0
6595627|NCT02012283|7520718|FG001|NOT COMPLETED|Second Intervention||0
6595628|NCT02012283|7520717|FG000|STARTED|Third Intervention||10
6595629|NCT02012283|7520718|FG001|STARTED|Third Intervention||10
6595630|NCT02012283|7520717|FG000|COMPLETED|Third Intervention||10
6595631|NCT02012283|7520718|FG001|COMPLETED|Third Intervention||10
6595632|NCT02012283|7520717|FG000|NOT COMPLETED|Third Intervention||0
6595633|NCT02012283|7520718|FG001|NOT COMPLETED|Third Intervention||0
6595634|NCT02012348|7520732|FG000|STARTED|Overall Study||10
6595635|NCT02012348|7520733|FG001|STARTED|Overall Study||10
6595636|NCT02012348|7520734|FG002|STARTED|Overall Study||10
6595637|NCT02012348|7520732|FG000|COMPLETED|Overall Study||10
6595638|NCT02012348|7520733|FG001|COMPLETED|Overall Study||10
6595639|NCT02012348|7520734|FG002|COMPLETED|Overall Study||10
6595640|NCT02012348|7520732|FG000|NOT COMPLETED|Overall Study||0
6595641|NCT02012348|7520733|FG001|NOT COMPLETED|Overall Study||0
6595642|NCT02012348|7520734|FG002|NOT COMPLETED|Overall Study||0
6595643|NCT02012452|7520744|FG000|STARTED|Overall Study||7
6595644|NCT02012452|7520745|FG001|STARTED|Overall Study||2
6595645|NCT02012452|7520744|FG000|COMPLETED|Overall Study||1
6595646|NCT02012452|7520745|FG001|COMPLETED|Overall Study||1
6595647|NCT02012452|7520744|FG000|NOT COMPLETED|Overall Study||6
6595648|NCT02012452|7520745|FG001|NOT COMPLETED|Overall Study||1
6595649|NCT02012491|7520753|FG000|STARTED|Overall Study||151
6595650|NCT02012491|7520754|FG001|STARTED|Overall Study||149
6595651|NCT02012491|7520753|FG000|COMPLETED|Overall Study||149
6595652|NCT02012491|7520754|FG001|COMPLETED|Overall Study||148
6595653|NCT02012491|7520753|FG000|NOT COMPLETED|Overall Study||2
6595654|NCT02012491|7520754|FG001|NOT COMPLETED|Overall Study||1
6595655|NCT02012582|7520764|FG000|STARTED|Overall Study||8
6595656|NCT02012582|7520765|FG001|STARTED|Overall Study||8
6595657|NCT02012582|7520766|FG002|STARTED|Overall Study||8
6595658|NCT02012582|7520767|FG003|STARTED|Overall Study||8
6595659|NCT02012582|7520764|FG000|COMPLETED|Overall Study||8
6595660|NCT02012582|7520765|FG001|COMPLETED|Overall Study||8
6595661|NCT02012582|7520766|FG002|COMPLETED|Overall Study||8
6595662|NCT02012582|7520767|FG003|COMPLETED|Overall Study||7
6595663|NCT02012582|7520764|FG000|NOT COMPLETED|Overall Study||0
6595664|NCT02012582|7520765|FG001|NOT COMPLETED|Overall Study||0
6595665|NCT02012582|7520766|FG002|NOT COMPLETED|Overall Study||0
6595666|NCT02012582|7520767|FG003|NOT COMPLETED|Overall Study||1
6595667|NCT02012621|7520777|FG000|STARTED|Overall Study||807
6595668|NCT02012621|7520777|FG000|Visit 1 Completed|Overall Study||807
6595669|NCT02012621|7520777|FG000|Visit 2 Completed|Overall Study||688
6595670|NCT02012621|7520777|FG000|Visit 3 Completed|Overall Study||444
6595671|NCT02012621|7520777|FG000|COMPLETED|Overall Study||807
6660312|NCT02497391|7591211|FG000|COMPLETED|Period 2 (14 Days)||12
6660313|NCT02497391|7591212|FG001|COMPLETED|Period 2 (14 Days)||14
6660314|NCT02497391|7591213|FG002|COMPLETED|Period 2 (14 Days)||13
6660315|NCT02497391|7591214|FG003|COMPLETED|Period 2 (14 Days)||13
6660316|NCT02497391|7591215|FG004|COMPLETED|Period 2 (14 Days)||14
6660317|NCT02497391|7591216|FG005|COMPLETED|Period 2 (14 Days)||13
6660318|NCT02497391|7591211|FG000|NOT COMPLETED|Period 2 (14 Days)||4
6595672|NCT02012621|7520777|FG000|NOT COMPLETED|Overall Study||0
6660319|NCT02497391|7591212|FG001|NOT COMPLETED|Period 2 (14 Days)||1
6595673|NCT02012686|7520783|FG000|STARTED|Overall Study||50
6595674|NCT02012686|7520784|FG001|STARTED|Overall Study||50
6595675|NCT02012686|7520783|FG000|COMPLETED|Overall Study||50
6595676|NCT02012686|7520784|FG001|COMPLETED|Overall Study||48
6595677|NCT02012686|7520783|FG000|NOT COMPLETED|Overall Study||0
6595678|NCT02012686|7520784|FG001|NOT COMPLETED|Overall Study||2
6595679|NCT02012959|7520790|FG000|STARTED|Treatment Phase A||9
6595680|NCT02012959|7520791|FG001|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
6595681|NCT02012959|7520792|FG002|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
6595682|NCT02012959|7520793|FG003|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
6595683|NCT02012959|7520794|FG004|STARTED|Treatment Phase A|Zero participants noted because participants did not start Phase B yet|0
6595684|NCT02012959|7520790|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase A||9
6595685|NCT02012959|7520791|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
6595686|NCT02012959|7520792|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
6595687|NCT02012959|7520793|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
6595688|NCT02012959|7520794|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase A||0
6595689|NCT02012959|7520790|FG000|COMPLETED|Treatment Phase A||7
6595690|NCT02012959|7520791|FG001|COMPLETED|Treatment Phase A||0
6595691|NCT02012959|7520792|FG002|COMPLETED|Treatment Phase A||0
6595692|NCT02012959|7520793|FG003|COMPLETED|Treatment Phase A||0
6595693|NCT02012959|7520794|FG004|COMPLETED|Treatment Phase A||0
6595694|NCT02012959|7520790|FG000|NOT COMPLETED|Treatment Phase A||2
6595695|NCT02012959|7520791|FG001|NOT COMPLETED|Treatment Phase A||0
6595696|NCT02012959|7520792|FG002|NOT COMPLETED|Treatment Phase A||0
6595697|NCT02012959|7520793|FG003|NOT COMPLETED|Treatment Phase A||0
6595698|NCT02012959|7520794|FG004|NOT COMPLETED|Treatment Phase A||0
6595699|NCT02012959|7520790|FG000|STARTED|Treatment Phase B|Zero participants noted because participants had completed Phase A|0
6595700|NCT02012959|7520791|FG001|STARTED|Treatment Phase B|Participants in this group continued treatment with the study drug|2
6595701|NCT02012959|7520792|FG002|STARTED|Treatment Phase B|Participants in this group did not receive additional study drug after Phase A|3
6595702|NCT02012959|7520793|FG003|STARTED|Treatment Phase B|Participants in this group could continue study drug treatment, per the investigator's discretion|1
6595703|NCT02012959|7520794|FG004|STARTED|Treatment Phase B|Participants in this group could receive the investigator's preferred standard of care|1
6595704|NCT02012959|7520790|FG000|Received At Least 1 Dose of Study Drug|Treatment Phase B||0
6595705|NCT02012959|7520791|FG001|Received At Least 1 Dose of Study Drug|Treatment Phase B||2
6595706|NCT02012959|7520792|FG002|Received At Least 1 Dose of Study Drug|Treatment Phase B||3
6595707|NCT02012959|7520793|FG003|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
6595708|NCT02012959|7520794|FG004|Received At Least 1 Dose of Study Drug|Treatment Phase B||1
6595709|NCT02012959|7520790|FG000|COMPLETED|Treatment Phase B||0
6595710|NCT02012959|7520791|FG001|COMPLETED|Treatment Phase B||2
6595711|NCT02012959|7520792|FG002|COMPLETED|Treatment Phase B||3
6595712|NCT02012959|7520793|FG003|COMPLETED|Treatment Phase B||1
6595713|NCT02012959|7520794|FG004|COMPLETED|Treatment Phase B||1
6595714|NCT02012959|7520790|FG000|NOT COMPLETED|Treatment Phase B||0
6595715|NCT02012959|7520791|FG001|NOT COMPLETED|Treatment Phase B||0
6595716|NCT02012959|7520792|FG002|NOT COMPLETED|Treatment Phase B||0
6660320|NCT02497391|7591213|FG002|NOT COMPLETED|Period 2 (14 Days)||3
6660321|NCT02497391|7591214|FG003|NOT COMPLETED|Period 2 (14 Days)||3
6660322|NCT02497391|7591215|FG004|NOT COMPLETED|Period 2 (14 Days)||2
6660323|NCT02497391|7591216|FG005|NOT COMPLETED|Period 2 (14 Days)||3
6660324|NCT02497391|7591211|FG000|STARTED|Period 3 (14 Days)||12
6660325|NCT02497391|7591212|FG001|STARTED|Period 3 (14 Days)||14
6660326|NCT02497391|7591213|FG002|STARTED|Period 3 (14 Days)||13
6660327|NCT02497391|7591214|FG003|STARTED|Period 3 (14 Days)||13
6660328|NCT02497391|7591215|FG004|STARTED|Period 3 (14 Days)||14
6660329|NCT02497391|7591216|FG005|STARTED|Period 3 (14 Days)||13
6660330|NCT02497391|7591211|FG000|COMPLETED|Period 3 (14 Days)||12
6660331|NCT02497391|7591212|FG001|COMPLETED|Period 3 (14 Days)||13
6660332|NCT02497391|7591213|FG002|COMPLETED|Period 3 (14 Days)||12
6660333|NCT02497391|7591214|FG003|COMPLETED|Period 3 (14 Days)||13
6660334|NCT02497391|7591215|FG004|COMPLETED|Period 3 (14 Days)||13
6660335|NCT02497391|7591216|FG005|COMPLETED|Period 3 (14 Days)||13
6660336|NCT02497391|7591211|FG000|NOT COMPLETED|Period 3 (14 Days)||0
6660337|NCT02497391|7591212|FG001|NOT COMPLETED|Period 3 (14 Days)||1
6660338|NCT02497391|7591213|FG002|NOT COMPLETED|Period 3 (14 Days)||1
6660339|NCT02497391|7591214|FG003|NOT COMPLETED|Period 3 (14 Days)||0
6660340|NCT02497391|7591215|FG004|NOT COMPLETED|Period 3 (14 Days)||1
6660341|NCT02497391|7591216|FG005|NOT COMPLETED|Period 3 (14 Days)||0
6660342|NCT02497404|7591224|FG000|STARTED|Overall Study||40
6660343|NCT02497404|7591224|FG000|COMPLETED|Overall Study||39
6660344|NCT02497404|7591224|FG000|NOT COMPLETED|Overall Study||1
6660345|NCT02497469|7591230|FG000|STARTED|Overall Study||386
6660346|NCT02497469|7591231|FG001|STARTED|Overall Study||385
6660347|NCT02497469|7591230|FG000|Safety Analysis Set|Overall Study||386
6660348|NCT02497469|7591231|FG001|Safety Analysis Set|Overall Study||383
6660349|NCT02497469|7591230|FG000|COMPLETED|Overall Study||217
6660350|NCT02497469|7591231|FG001|COMPLETED|Overall Study||270
6660351|NCT02497469|7591230|FG000|NOT COMPLETED|Overall Study||169
6660352|NCT02497469|7591231|FG001|NOT COMPLETED|Overall Study||115
6660353|NCT02497755|7591239|FG000|STARTED|Overall Study||18
6660354|NCT02497755|7591240|FG001|STARTED|Overall Study||1
6660355|NCT02497755|7591239|FG000|COMPLETED|Overall Study||17
6660356|NCT02497755|7591240|FG001|COMPLETED|Overall Study||1
6660357|NCT02497755|7591239|FG000|NOT COMPLETED|Overall Study||1
6660358|NCT02497755|7591240|FG001|NOT COMPLETED|Overall Study||0
6595717|NCT02012959|7520793|FG003|NOT COMPLETED|Treatment Phase B||0
6595718|NCT02012959|7520794|FG004|NOT COMPLETED|Treatment Phase B||0
6595719|NCT02013037|7520804|FG000|STARTED|Overall Study||36
6595720|NCT02013037|7520804|FG000|COMPLETED|Overall Study||20
6595721|NCT02013037|7520804|FG000|NOT COMPLETED|Overall Study||16
6595722|NCT02013050|7520813|FG000|STARTED|Overall Study||42
6595723|NCT02013050|7520814|FG001|STARTED|Overall Study||41
6595724|NCT02013050|7520815|FG002|STARTED|Overall Study||3
6595725|NCT02013050|7520816|FG003|STARTED|Overall Study||23
6595726|NCT02013050|7520813|FG000|COMPLETED|Overall Study||38
6595727|NCT02013050|7520814|FG001|COMPLETED|Overall Study||36
6595728|NCT02013050|7520815|FG002|COMPLETED|Overall Study||3
6595729|NCT02013050|7520816|FG003|COMPLETED|Overall Study||19
6595730|NCT02013050|7520813|FG000|NOT COMPLETED|Overall Study||4
6595731|NCT02013050|7520814|FG001|NOT COMPLETED|Overall Study||5
6595732|NCT02013050|7520815|FG002|NOT COMPLETED|Overall Study||0
6595733|NCT02013050|7520816|FG003|NOT COMPLETED|Overall Study||4
6595734|NCT02013180|7520828|FG000|STARTED|Overall Study||119
6595735|NCT02013180|7520829|FG001|STARTED|Overall Study||361
6595736|NCT02013180|7520828|FG000|COMPLETED|Overall Study||119
6595737|NCT02013180|7520829|FG001|COMPLETED|Overall Study||361
6595738|NCT02013180|7520828|FG000|NOT COMPLETED|Overall Study||0
6595739|NCT02013180|7520829|FG001|NOT COMPLETED|Overall Study||0
6595740|NCT02013206|7520837|FG000|STARTED|Overall Study||29
6595741|NCT02013206|7520838|FG001|STARTED|Overall Study||23
6595742|NCT02013206|7520837|FG000|Received Study Drug|Overall Study||26
6595743|NCT02013206|7520838|FG001|Received Study Drug|Overall Study||23
6595744|NCT02013206|7520837|FG000|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
6595745|NCT02013206|7520838|FG001|COMPLETED|Overall Study||1
6595746|NCT02013206|7520837|FG000|NOT COMPLETED|Overall Study||27
6660359|NCT02497781|7591249|FG000|STARTED|Overall Study||68
6660360|NCT02497781|7591250|FG001|STARTED|Overall Study||29
6660361|NCT02497781|7591249|FG000|Treated|Overall Study||67
6660362|NCT02497781|7591250|FG001|Treated|Overall Study||28
6660363|NCT02497781|7591249|FG000|COMPLETED|Overall Study||64
6660364|NCT02497781|7591250|FG001|COMPLETED|Overall Study||26
6660365|NCT02497781|7591249|FG000|NOT COMPLETED|Overall Study||4
6660366|NCT02497781|7591250|FG001|NOT COMPLETED|Overall Study||3
6660367|NCT02497937|7591256|FG000|STARTED|Period 1 (Up to 7 Days)||6
6660368|NCT02497937|7591257|FG001|STARTED|Period 1 (Up to 7 Days)||5
6660369|NCT02497937|7591256|FG000|COMPLETED|Period 1 (Up to 7 Days)||6
6660370|NCT02497937|7591257|FG001|COMPLETED|Period 1 (Up to 7 Days)||5
6660371|NCT02497937|7591256|FG000|NOT COMPLETED|Period 1 (Up to 7 Days)||0
6660372|NCT02497937|7591257|FG001|NOT COMPLETED|Period 1 (Up to 7 Days)||0
6660373|NCT02497937|7591256|FG000|STARTED|Washout Period (Up to 14 Days)||6
6660374|NCT02497937|7591257|FG001|STARTED|Washout Period (Up to 14 Days)||5
6660375|NCT02497937|7591256|FG000|COMPLETED|Washout Period (Up to 14 Days)||6
6660376|NCT02497937|7591257|FG001|COMPLETED|Washout Period (Up to 14 Days)||5
6660377|NCT02497937|7591256|FG000|NOT COMPLETED|Washout Period (Up to 14 Days)||0
6660378|NCT02497937|7591257|FG001|NOT COMPLETED|Washout Period (Up to 14 Days)||0
6660379|NCT02497937|7591256|FG000|STARTED|Period 2 (Up to 7 Days)||6
6660380|NCT02497937|7591257|FG001|STARTED|Period 2 (Up to 7 Days)||5
6660381|NCT02497937|7591256|FG000|COMPLETED|Period 2 (Up to 7 Days)||6
6660382|NCT02497937|7591257|FG001|COMPLETED|Period 2 (Up to 7 Days)||5
6660383|NCT02497937|7591256|FG000|NOT COMPLETED|Period 2 (Up to 7 Days)||0
6660384|NCT02497937|7591257|FG001|NOT COMPLETED|Period 2 (Up to 7 Days)||0
6660385|NCT02497976|7591266|FG000|STARTED|Overall Study||28
6660386|NCT02497976|7591267|FG001|STARTED|Overall Study||14
6660387|NCT02497976|7591266|FG000|COMPLETED|Overall Study||26
6660388|NCT02497976|7591267|FG001|COMPLETED|Overall Study||13
6660389|NCT02497976|7591266|FG000|NOT COMPLETED|Overall Study||2
6660390|NCT02497976|7591267|FG001|NOT COMPLETED|Overall Study||1
6737556|NCT03267264|7666820|FG003|Sequence B(Comparator)|Overall Study||32
6737557|NCT03267264|7666817|FG000|COMPLETED|Overall Study||65
6737558|NCT03267264|7666818|FG001|COMPLETED|Overall Study||49
6737559|NCT03267264|7666819|FG002|COMPLETED|Overall Study||66
6737560|NCT03267264|7666820|FG003|COMPLETED|Overall Study||61
6737561|NCT03267264|7666817|FG000|NOT COMPLETED|Overall Study||1
6737562|NCT03267264|7666818|FG001|NOT COMPLETED|Overall Study||0
6737563|NCT03267264|7666819|FG002|NOT COMPLETED|Overall Study||2
6737564|NCT03267264|7666820|FG003|NOT COMPLETED|Overall Study||4
6737565|NCT03267511|7666837|FG000|STARTED|Overall Study||31
6737566|NCT03267511|7666838|FG001|STARTED|Overall Study||31
6737567|NCT03267511|7666839|FG002|STARTED|Overall Study||30
6737568|NCT03267511|7666840|FG003|STARTED|Overall Study||31
6737569|NCT03267511|7666837|FG000|COMPLETED|Overall Study||31
6737570|NCT03267511|7666838|FG001|COMPLETED|Overall Study||31
6737571|NCT03267511|7666839|FG002|COMPLETED|Overall Study||30
6737572|NCT03267511|7666840|FG003|COMPLETED|Overall Study||30
6737573|NCT03267511|7666837|FG000|NOT COMPLETED|Overall Study||0
6737574|NCT03267511|7666838|FG001|NOT COMPLETED|Overall Study||0
6737575|NCT03267511|7666839|FG002|NOT COMPLETED|Overall Study||0
6737576|NCT03267511|7666840|FG003|NOT COMPLETED|Overall Study||1
6737577|NCT03267576|7666854|FG000|STARTED|Period 1: Day 0 to 27||31
6737578|NCT03267576|7666855|FG001|STARTED|Period 1: Day 0 to 27||32
6737579|NCT03267576|7666854|FG000|COMPLETED|Period 1: Day 0 to 27||31
6737580|NCT03267576|7666855|FG001|COMPLETED|Period 1: Day 0 to 27||32
6737581|NCT03267576|7666854|FG000|NOT COMPLETED|Period 1: Day 0 to 27||0
6595747|NCT02013206|7520838|FG001|NOT COMPLETED|Overall Study||22
6595748|NCT02013245|7520848|FG000|STARTED|Overall Study||9
6595749|NCT02013245|7520849|FG001|STARTED|Overall Study||9
6595750|NCT02013245|7520850|FG002|STARTED|Overall Study||9
6595751|NCT02013245|7520851|FG003|STARTED|Overall Study||9
6595752|NCT02013245|7520848|FG000|COMPLETED|Overall Study||9
6595753|NCT02013245|7520849|FG001|COMPLETED|Overall Study||8
6595754|NCT02013245|7520850|FG002|COMPLETED|Overall Study||9
6595755|NCT02013245|7520851|FG003|COMPLETED|Overall Study||9
6595756|NCT02013245|7520848|FG000|NOT COMPLETED|Overall Study||0
6595757|NCT02013245|7520849|FG001|NOT COMPLETED|Overall Study||1
6595758|NCT02013245|7520850|FG002|NOT COMPLETED|Overall Study||0
6595759|NCT02013245|7520851|FG003|NOT COMPLETED|Overall Study||0
6595760|NCT02013375|7520861|FG000|STARTED|Overall Study||2
6595761|NCT02013375|7520861|FG000|COMPLETED|Overall Study||0
6595762|NCT02013375|7520861|FG000|NOT COMPLETED|Overall Study||2
6595763|NCT02013388|7520874|FG000|STARTED|Overall Study||9
6595764|NCT02013388|7520875|FG001|STARTED|Overall Study||6
6595765|NCT02013388|7520876|FG002|STARTED|Overall Study||6
6595766|NCT02013388|7520877|FG003|STARTED|Overall Study||6
6595767|NCT02013388|7520878|FG004|STARTED|Overall Study||6
6595768|NCT02013388|7520879|FG005|STARTED|Overall Study||6
6595769|NCT02013388|7520880|FG006|STARTED|Overall Study||6
6595770|NCT02013388|7520881|FG007|STARTED|Overall Study||4
6595771|NCT02013388|7520874|FG000|COMPLETED|Overall Study||8
6595772|NCT02013388|7520875|FG001|COMPLETED|Overall Study||6
6595773|NCT02013388|7520876|FG002|COMPLETED|Overall Study||6
6595774|NCT02013388|7520877|FG003|COMPLETED|Overall Study||6
6595775|NCT02013388|7520878|FG004|COMPLETED|Overall Study||5
6595776|NCT02013388|7520879|FG005|COMPLETED|Overall Study||6
6595777|NCT02013388|7520880|FG006|COMPLETED|Overall Study||6
6595778|NCT02013388|7520881|FG007|COMPLETED|Overall Study||4
6595779|NCT02013388|7520874|FG000|NOT COMPLETED|Overall Study||1
6595780|NCT02013388|7520875|FG001|NOT COMPLETED|Overall Study||0
6595781|NCT02013388|7520876|FG002|NOT COMPLETED|Overall Study||0
6595782|NCT02013388|7520877|FG003|NOT COMPLETED|Overall Study||0
6595783|NCT02013388|7520878|FG004|NOT COMPLETED|Overall Study||1
6595784|NCT02013388|7520879|FG005|NOT COMPLETED|Overall Study||0
6595785|NCT02013388|7520880|FG006|NOT COMPLETED|Overall Study||0
6595786|NCT02013388|7520881|FG007|NOT COMPLETED|Overall Study||0
6595787|NCT02013531|7520903|FG000|STARTED|Overall Study||37
6595788|NCT02013531|7520903|FG000|COMPLETED|Overall Study||32
6595789|NCT02013531|7520903|FG000|NOT COMPLETED|Overall Study||5
6595790|NCT02013544|7520909|FG000|STARTED|Overall Study||182
6595791|NCT02013544|7520910|FG001|STARTED|Overall Study||376
6595792|NCT02013544|7520909|FG000|Safety Population|Overall Study||180
6595793|NCT02013544|7520910|FG001|Safety Population|Overall Study||374
6595794|NCT02013544|7520909|FG000|ITT Population|Overall Study||157
6595795|NCT02013544|7520910|FG001|ITT Population|Overall Study||325
6595796|NCT02013544|7520909|FG000|COMPLETED|Overall Study||171
6595797|NCT02013544|7520910|FG001|COMPLETED|Overall Study||356
6595798|NCT02013544|7520909|FG000|NOT COMPLETED|Overall Study||11
6595799|NCT02013544|7520910|FG001|NOT COMPLETED|Overall Study||20
6595800|NCT02013609|7520916|FG000|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
6595801|NCT02013609|7520916|FG000|COMPLETED|Overall Study||29
6595802|NCT02013609|7520916|FG000|NOT COMPLETED|Overall Study||18
6595803|NCT02013622|7520920|FG000|STARTED|Overall Study||49
6595804|NCT02013622|7520920|FG000|COMPLETED|Overall Study||25
6595805|NCT02013622|7520920|FG000|NOT COMPLETED|Overall Study||24
6595806|NCT02013674|7520926|FG000|STARTED|Overall Study||15
6595807|NCT02013674|7520927|FG001|STARTED|Overall Study||15
6595808|NCT02013674|7520926|FG000|COMPLETED|Overall Study||14
6595809|NCT02013674|7520927|FG001|COMPLETED|Overall Study||14
6595810|NCT02013674|7520926|FG000|NOT COMPLETED|Overall Study||1
6595811|NCT02013674|7520927|FG001|NOT COMPLETED|Overall Study||1
6595812|NCT02013687|7520937|FG000|STARTED|Overall Study||6
6595813|NCT02013687|7520938|FG001|STARTED|Overall Study||6
6595814|NCT02013687|7520939|FG002|STARTED|Overall Study||16
6595815|NCT02013687|7520940|FG003|STARTED|Overall Study||16
6595816|NCT02013687|7520937|FG000|COMPLETED|Overall Study||6
6595817|NCT02013687|7520938|FG001|COMPLETED|Overall Study||6
6595818|NCT02013687|7520939|FG002|COMPLETED|Overall Study||14
6595819|NCT02013687|7520940|FG003|COMPLETED|Overall Study||14
6595820|NCT02013687|7520937|FG000|NOT COMPLETED|Overall Study||0
6595821|NCT02013687|7520938|FG001|NOT COMPLETED|Overall Study||0
6595822|NCT02013687|7520939|FG002|NOT COMPLETED|Overall Study||2
6595823|NCT02013687|7520940|FG003|NOT COMPLETED|Overall Study||2
6595824|NCT02013765|7520954|FG000|STARTED|Overall Study||5
6595825|NCT02013765|7520954|FG000|COMPLETED|Overall Study||4
6595826|NCT02013765|7520954|FG000|NOT COMPLETED|Overall Study||1
6595827|NCT02013778|7520958|FG000|STARTED|Overall Study||8
6595828|NCT02013778|7520958|FG000|COMPLETED|Overall Study||1
6595829|NCT02013778|7520958|FG000|NOT COMPLETED|Overall Study||7
6595830|NCT02013791|7520971|FG000|STARTED|Period 1||8
6595831|NCT02013791|7520972|FG001|STARTED|Period 1||8
6595832|NCT02013791|7520973|FG002|STARTED|Period 1||4
6595833|NCT02013791|7520974|FG003|STARTED|Period 1||8
6595834|NCT02013791|7520975|FG004|STARTED|Period 1||4
6595835|NCT02013791|7520976|FG005|STARTED|Period 1||8
6595836|NCT02013791|7520977|FG006|STARTED|Period 1||4
6595837|NCT02013791|7520978|FG007|STARTED|Period 1||8
6595838|NCT02013791|7520979|FG008|STARTED|Period 1||3
6595839|NCT02013791|7520971|FG000|COMPLETED|Period 1||8
6595840|NCT02013791|7520972|FG001|COMPLETED|Period 1||6
6595841|NCT02013791|7520973|FG002|COMPLETED|Period 1||4
6595842|NCT02013791|7520974|FG003|COMPLETED|Period 1||7
6595843|NCT02013791|7520975|FG004|COMPLETED|Period 1||4
6595844|NCT02013791|7520976|FG005|COMPLETED|Period 1||8
6595845|NCT02013791|7520977|FG006|COMPLETED|Period 1||3
6595846|NCT02013791|7520978|FG007|COMPLETED|Period 1||7
6595847|NCT02013791|7520979|FG008|COMPLETED|Period 1||3
6595848|NCT02013791|7520971|FG000|NOT COMPLETED|Period 1||0
6595849|NCT02013791|7520972|FG001|NOT COMPLETED|Period 1||2
6595850|NCT02013791|7520973|FG002|NOT COMPLETED|Period 1||0
6595851|NCT02013791|7520974|FG003|NOT COMPLETED|Period 1||1
6595852|NCT02013791|7520975|FG004|NOT COMPLETED|Period 1||0
6595853|NCT02013791|7520976|FG005|NOT COMPLETED|Period 1||0
6595854|NCT02013791|7520977|FG006|NOT COMPLETED|Period 1||1
6595855|NCT02013791|7520978|FG007|NOT COMPLETED|Period 1||1
6595856|NCT02013791|7520979|FG008|NOT COMPLETED|Period 1||0
6595857|NCT02013791|7520971|FG000|STARTED|Period 2||0
6595858|NCT02013791|7520972|FG001|STARTED|Period 2||0
6595859|NCT02013791|7520973|FG002|STARTED|Period 2||2
6595860|NCT02013791|7520974|FG003|STARTED|Period 2||0
6595861|NCT02013791|7520975|FG004|STARTED|Period 2||0
6595862|NCT02013791|7520976|FG005|STARTED|Period 2||0
6595863|NCT02013791|7520977|FG006|STARTED|Period 2||3
6595864|NCT02013791|7520978|FG007|STARTED|Period 2||0
6595865|NCT02013791|7520979|FG008|STARTED|Period 2||0
6595866|NCT02013791|7520971|FG000|COMPLETED|Period 2||0
6595867|NCT02013791|7520972|FG001|COMPLETED|Period 2||0
6595868|NCT02013791|7520973|FG002|COMPLETED|Period 2||2
6595869|NCT02013791|7520974|FG003|COMPLETED|Period 2||0
6595870|NCT02013791|7520975|FG004|COMPLETED|Period 2||0
6595871|NCT02013791|7520976|FG005|COMPLETED|Period 2||0
6595872|NCT02013791|7520977|FG006|COMPLETED|Period 2||3
6595873|NCT02013791|7520978|FG007|COMPLETED|Period 2||0
6595874|NCT02013791|7520979|FG008|COMPLETED|Period 2||0
6595875|NCT02013791|7520971|FG000|NOT COMPLETED|Period 2||0
6595876|NCT02013791|7520972|FG001|NOT COMPLETED|Period 2||0
6595877|NCT02013791|7520973|FG002|NOT COMPLETED|Period 2||0
6595878|NCT02013791|7520974|FG003|NOT COMPLETED|Period 2||0
6595879|NCT02013791|7520975|FG004|NOT COMPLETED|Period 2||0
6595880|NCT02013791|7520976|FG005|NOT COMPLETED|Period 2||0
6595881|NCT02013791|7520977|FG006|NOT COMPLETED|Period 2||0
6595882|NCT02013791|7520978|FG007|NOT COMPLETED|Period 2||0
6595883|NCT02013791|7520979|FG008|NOT COMPLETED|Period 2||0
6595884|NCT02013817|7521000|FG000|STARTED|Overall Study||43
6595885|NCT02013817|7521000|FG000|COMPLETED|Overall Study||16
6595886|NCT02013817|7521000|FG000|NOT COMPLETED|Overall Study||27
6595887|NCT02013830|7521004|FG000|STARTED|Overall Study||45
6595888|NCT02013830|7521004|FG000|COMPLETED|Overall Study||15
6595889|NCT02013830|7521004|FG000|NOT COMPLETED|Overall Study||30
6660391|NCT02498067|7591273|FG000|STARTED|Overall Study||104
6660392|NCT02498067|7591273|FG000|COMPLETED|Overall Study||71
6660393|NCT02498067|7591273|FG000|NOT COMPLETED|Overall Study||33
6660394|NCT02498236|7591287|FG000|STARTED|Overall Study||6
6660395|NCT02498236|7591288|FG001|STARTED|Overall Study||6
6660396|NCT02498236|7591289|FG002|STARTED|Overall Study||6
6660397|NCT02498236|7591290|FG003|STARTED|Overall Study||6
6660398|NCT02498236|7591291|FG004|STARTED|Overall Study||7
6660399|NCT02498236|7591292|FG005|STARTED|Overall Study||6
6660400|NCT02498236|7591293|FG006|STARTED|Overall Study||7
6660401|NCT02498236|7591294|FG007|STARTED|Overall Study||7
6281026|NCT00160693|7180896|FG000|STARTED|Overall Study||402
6595890|NCT02014051|7521008|FG000|STARTED|Overall Study||3
6660402|NCT02498236|7591287|FG000|Randomized|Overall Study||6
6660403|NCT02498236|7591288|FG001|Randomized|Overall Study||6
6660404|NCT02498236|7591289|FG002|Randomized|Overall Study||6
6660405|NCT02498236|7591290|FG003|Randomized|Overall Study||6
6595891|NCT02014051|7521009|FG001|STARTED|Overall Study||6
6595892|NCT02014051|7521008|FG000|COMPLETED|Overall Study||2
6595893|NCT02014051|7521009|FG001|COMPLETED|Overall Study||5
6595894|NCT02014051|7521008|FG000|NOT COMPLETED|Overall Study||1
6595895|NCT02014051|7521009|FG001|NOT COMPLETED|Overall Study||1
6595896|NCT02014116|7521025|FG000|STARTED|Overall Study||3
6595897|NCT02014116|7521026|FG001|STARTED|Overall Study||4
6595898|NCT02014116|7521027|FG002|STARTED|Overall Study||3
6595899|NCT02014116|7521028|FG003|STARTED|Overall Study||7
6595900|NCT02014116|7521029|FG004|STARTED|Overall Study||2
6595901|NCT02014116|7521030|FG005|STARTED|Overall Study||16
6595902|NCT02014116|7521031|FG006|STARTED|Overall Study||1
6595903|NCT02014116|7521032|FG007|STARTED|Overall Study||5
6595904|NCT02014116|7521033|FG008|STARTED|Overall Study||10
6595905|NCT02014116|7521025|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6660406|NCT02498236|7591291|FG004|Randomized|Overall Study||7
6660407|NCT02498236|7591292|FG005|Randomized|Overall Study||6
6660408|NCT02498236|7591293|FG006|Randomized|Overall Study||7
6660409|NCT02498236|7591294|FG007|Randomized|Overall Study||7
6660410|NCT02498236|7591287|FG000|COMPLETED|Overall Study||5
6660411|NCT02498236|7591288|FG001|COMPLETED|Overall Study||6
6595906|NCT02014116|7521026|FG001|Received at Least One Dose of Study Drug|Overall Study||4
6595907|NCT02014116|7521027|FG002|Received at Least One Dose of Study Drug|Overall Study||3
6595908|NCT02014116|7521028|FG003|Received at Least One Dose of Study Drug|Overall Study||7
6595909|NCT02014116|7521029|FG004|Received at Least One Dose of Study Drug|Overall Study||2
6595910|NCT02014116|7521030|FG005|Received at Least One Dose of Study Drug|Overall Study||16
6595911|NCT02014116|7521031|FG006|Received at Least One Dose of Study Drug|Overall Study||1
6595912|NCT02014116|7521032|FG007|Received at Least One Dose of Study Drug|Overall Study||5
6595913|NCT02014116|7521033|FG008|Received at Least One Dose of Study Drug|Overall Study||10
6595914|NCT02014116|7521025|FG000|COMPLETED|Overall Study||0
6595915|NCT02014116|7521026|FG001|COMPLETED|Overall Study||0
6595916|NCT02014116|7521027|FG002|COMPLETED|Overall Study||0
6595917|NCT02014116|7521028|FG003|COMPLETED|Overall Study||0
6595918|NCT02014116|7521029|FG004|COMPLETED|Overall Study||0
6595919|NCT02014116|7521030|FG005|COMPLETED|Overall Study||0
6595920|NCT02014116|7521031|FG006|COMPLETED|Overall Study||0
6595921|NCT02014116|7521032|FG007|COMPLETED|Overall Study||0
6595922|NCT02014116|7521033|FG008|COMPLETED|Overall Study||0
6595923|NCT02014116|7521025|FG000|NOT COMPLETED|Overall Study||3
6595924|NCT02014116|7521026|FG001|NOT COMPLETED|Overall Study||4
6595925|NCT02014116|7521027|FG002|NOT COMPLETED|Overall Study||3
6595926|NCT02014116|7521028|FG003|NOT COMPLETED|Overall Study||7
6595927|NCT02014116|7521029|FG004|NOT COMPLETED|Overall Study||2
6595928|NCT02014116|7521030|FG005|NOT COMPLETED|Overall Study||16
6595929|NCT02014116|7521031|FG006|NOT COMPLETED|Overall Study||1
6595930|NCT02014116|7521032|FG007|NOT COMPLETED|Overall Study||5
6595931|NCT02014116|7521033|FG008|NOT COMPLETED|Overall Study||10
6595932|NCT02014129|7521059|FG000|STARTED|Overall Study||3
6660412|NCT02498236|7591289|FG002|COMPLETED|Overall Study||6
6660413|NCT02498236|7591290|FG003|COMPLETED|Overall Study||6
6660414|NCT02498236|7591291|FG004|COMPLETED|Overall Study||6
6595933|NCT02014129|7521060|FG001|STARTED|Overall Study||3
6595934|NCT02014129|7521061|FG002|STARTED|Overall Study||6
6595935|NCT02014129|7521059|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6595936|NCT02014129|7521060|FG001|Received at Least One Dose of Study Drug|Overall Study||3
6595937|NCT02014129|7521061|FG002|Received at Least One Dose of Study Drug|Overall Study||6
6595938|NCT02014129|7521059|FG000|COMPLETED|Overall Study||3
6595939|NCT02014129|7521060|FG001|COMPLETED|Overall Study||3
6595940|NCT02014129|7521061|FG002|COMPLETED|Overall Study||6
6595941|NCT02014129|7521059|FG000|NOT COMPLETED|Overall Study||0
6595942|NCT02014129|7521060|FG001|NOT COMPLETED|Overall Study||0
6595943|NCT02014129|7521061|FG002|NOT COMPLETED|Overall Study||0
6595944|NCT02014272|7521069|FG000|STARTED|Intervention Period 1||14
6595945|NCT02014272|7521070|FG001|STARTED|Intervention Period 1||14
6595946|NCT02014272|7521069|FG000|COMPLETED|Intervention Period 1||13
6595947|NCT02014272|7521070|FG001|COMPLETED|Intervention Period 1||13
6595948|NCT02014272|7521069|FG000|NOT COMPLETED|Intervention Period 1||1
6595949|NCT02014272|7521070|FG001|NOT COMPLETED|Intervention Period 1||1
6595950|NCT02014272|7521069|FG000|STARTED|Washout Period 1 (7 Days)||13
6595951|NCT02014272|7521070|FG001|STARTED|Washout Period 1 (7 Days)||13
6595952|NCT02014272|7521069|FG000|COMPLETED|Washout Period 1 (7 Days)||13
6595953|NCT02014272|7521070|FG001|COMPLETED|Washout Period 1 (7 Days)||13
6595954|NCT02014272|7521069|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6595955|NCT02014272|7521070|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6595956|NCT02014272|7521069|FG000|STARTED|Intervention Period 2||13
6595957|NCT02014272|7521070|FG001|STARTED|Intervention Period 2||13
6595958|NCT02014272|7521069|FG000|COMPLETED|Intervention Period 2||13
6595959|NCT02014272|7521070|FG001|COMPLETED|Intervention Period 2||13
6595960|NCT02014272|7521069|FG000|NOT COMPLETED|Intervention Period 2||0
6595961|NCT02014272|7521070|FG001|NOT COMPLETED|Intervention Period 2||0
6595962|NCT02014363|7521079|FG000|STARTED|Overall Study||55
6595963|NCT02014363|7521080|FG001|STARTED|Overall Study||54
6595964|NCT02014363|7521081|FG002|STARTED|Overall Study||55
6660415|NCT02498236|7591292|FG005|COMPLETED|Overall Study||6
6660416|NCT02498236|7591293|FG006|COMPLETED|Overall Study||6
6660417|NCT02498236|7591294|FG007|COMPLETED|Overall Study||6
6660418|NCT02498236|7591287|FG000|NOT COMPLETED|Overall Study||1
6660419|NCT02498236|7591288|FG001|NOT COMPLETED|Overall Study||0
6660420|NCT02498236|7591289|FG002|NOT COMPLETED|Overall Study||0
6660421|NCT02498236|7591290|FG003|NOT COMPLETED|Overall Study||0
6660422|NCT02498236|7591291|FG004|NOT COMPLETED|Overall Study||1
6660423|NCT02498236|7591292|FG005|NOT COMPLETED|Overall Study||0
6660424|NCT02498236|7591293|FG006|NOT COMPLETED|Overall Study||1
6660425|NCT02498236|7591294|FG007|NOT COMPLETED|Overall Study||1
6660426|NCT02498418|7591318|FG000|STARTED|Overall Study||247
6660427|NCT02498418|7591319|FG001|STARTED|Overall Study||248
6660428|NCT02498418|7591320|FG002|STARTED|Overall Study||244
6660429|NCT02498418|7591318|FG000|Safety Population|Overall Study||246
6660430|NCT02498418|7591319|FG001|Safety Population|Overall Study||247
6660431|NCT02498418|7591320|FG002|Safety Population|Overall Study||244
6660432|NCT02498418|7591318|FG000|Modified Intent-to-treat Population|Overall Study||183
6660433|NCT02498418|7591319|FG001|Modified Intent-to-treat Population|Overall Study||186
6660434|NCT02498418|7591320|FG002|Modified Intent-to-treat Population|Overall Study||180
6660435|NCT02498418|7591318|FG000|Per-protocol Analysis Set|Overall Study||182
6660436|NCT02498418|7591319|FG001|Per-protocol Analysis Set|Overall Study||181
6660437|NCT02498418|7591320|FG002|Per-protocol Analysis Set|Overall Study||176
6660438|NCT02498418|7591318|FG000|COMPLETED|Overall Study||245
6595965|NCT02014363|7521079|FG000|COMPLETED|Overall Study||38
6595966|NCT02014363|7521080|FG001|COMPLETED|Overall Study||35
6595967|NCT02014363|7521081|FG002|COMPLETED|Overall Study||31
6595968|NCT02014363|7521079|FG000|NOT COMPLETED|Overall Study||17
6595969|NCT02014363|7521080|FG001|NOT COMPLETED|Overall Study||19
6595970|NCT02014363|7521081|FG002|NOT COMPLETED|Overall Study||24
6595971|NCT02014376|7521092|FG000|STARTED|Overall Study||15
6595972|NCT02014376|7521093|FG001|STARTED|Overall Study||16
6595973|NCT02014376|7521094|FG002|STARTED|Overall Study||17
6595974|NCT02014376|7521092|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
6595975|NCT02014376|7521093|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
6595976|NCT02014376|7521094|FG002|Received at Least 1 Dose of Study Drug|Overall Study||17
6595977|NCT02014376|7521092|FG000|COMPLETED|Overall Study||12
6595978|NCT02014376|7521093|FG001|COMPLETED|Overall Study||15
6595979|NCT02014376|7521094|FG002|COMPLETED|Overall Study||17
6595980|NCT02014376|7521092|FG000|NOT COMPLETED|Overall Study||3
6595981|NCT02014376|7521093|FG001|NOT COMPLETED|Overall Study||1
6595982|NCT02014376|7521094|FG002|NOT COMPLETED|Overall Study||0
6595983|NCT02014402|7521106|FG000|STARTED|Overall Study||31
6595984|NCT02014402|7521107|FG001|STARTED|Overall Study||30
6595985|NCT02014402|7521108|FG002|STARTED|Overall Study||35
6595986|NCT02014402|7521109|FG003|STARTED|Overall Study||85
6595987|NCT02014402|7521106|FG000|Human Thrombin|Overall Study||20
6595988|NCT02014402|7521107|FG001|Human Thrombin|Overall Study||20
6595989|NCT02014402|7521108|FG002|Human Thrombin|Overall Study||23
6595990|NCT02014402|7521109|FG003|Human Thrombin|Overall Study||57
6660439|NCT02498418|7591319|FG001|COMPLETED|Overall Study||246
6660440|NCT02498418|7591320|FG002|COMPLETED|Overall Study||238
6595991|NCT02014402|7521106|FG000|Bovine Thrombin|Overall Study||11
6595992|NCT02014402|7521107|FG001|Bovine Thrombin|Overall Study||10
6595993|NCT02014402|7521108|FG002|Bovine Thrombin|Overall Study||12
6595994|NCT02014402|7521109|FG003|Bovine Thrombin|Overall Study||28
6595995|NCT02014402|7521106|FG000|COMPLETED|Overall Study||29
6595996|NCT02014402|7521107|FG001|COMPLETED|Overall Study||27
6595997|NCT02014402|7521108|FG002|COMPLETED|Overall Study||32
6595998|NCT02014402|7521109|FG003|COMPLETED|Overall Study||82
6595999|NCT02014402|7521106|FG000|NOT COMPLETED|Overall Study||2
6596000|NCT02014402|7521107|FG001|NOT COMPLETED|Overall Study||3
6596001|NCT02014402|7521108|FG002|NOT COMPLETED|Overall Study||3
6596002|NCT02014402|7521109|FG003|NOT COMPLETED|Overall Study||3
6596003|NCT02014441|7521126|FG000|STARTED|Overall Study||61
6596004|NCT02014441|7521126|FG000|Received Treatment|Overall Study||60
6596005|NCT02014441|7521126|FG000|COMPLETED|Overall Study||49
6596006|NCT02014441|7521126|FG000|NOT COMPLETED|Overall Study||12
6596007|NCT02014467|7521134|FG000|STARTED|Overall Study||365
6596008|NCT02014467|7521135|FG001|STARTED|Overall Study||119
6596009|NCT02014467|7521134|FG000|COMPLETED|Overall Study||340
6596010|NCT02014467|7521135|FG001|COMPLETED|Overall Study||112
6596011|NCT02014467|7521134|FG000|NOT COMPLETED|Overall Study||25
6596012|NCT02014467|7521135|FG001|NOT COMPLETED|Overall Study||7
6596013|NCT02014480|7521141|FG000|STARTED|Treatment Period 1 (14 Days)||35
6596014|NCT02014480|7521142|FG001|STARTED|Treatment Period 1 (14 Days)||35
6596015|NCT02014480|7521143|FG002|STARTED|Treatment Period 1 (14 Days)||34
6596016|NCT02014480|7521144|FG003|STARTED|Treatment Period 1 (14 Days)||34
6596017|NCT02014480|7521145|FG004|STARTED|Treatment Period 1 (14 Days)||35
6596018|NCT02014480|7521146|FG005|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
6596019|NCT02014480|7521141|FG000|COMPLETED|Treatment Period 1 (14 Days)||35
6596020|NCT02014480|7521142|FG001|COMPLETED|Treatment Period 1 (14 Days)||34
6596021|NCT02014480|7521143|FG002|COMPLETED|Treatment Period 1 (14 Days)||33
6596022|NCT02014480|7521144|FG003|COMPLETED|Treatment Period 1 (14 Days)||32
6596023|NCT02014480|7521145|FG004|COMPLETED|Treatment Period 1 (14 Days)||34
6596024|NCT02014480|7521146|FG005|COMPLETED|Treatment Period 1 (14 Days)||34
6596025|NCT02014480|7521141|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6596026|NCT02014480|7521142|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6596027|NCT02014480|7521143|FG002|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6596028|NCT02014480|7521144|FG003|NOT COMPLETED|Treatment Period 1 (14 Days)||2
6596029|NCT02014480|7521145|FG004|NOT COMPLETED|Treatment Period 1 (14 Days)||1
6596030|NCT02014480|7521146|FG005|NOT COMPLETED|Treatment Period 1 (14 Days)||0
6596031|NCT02014480|7521141|FG000|STARTED|Washout Period 1 (10 to 14 Days)||35
6596032|NCT02014480|7521142|FG001|STARTED|Washout Period 1 (10 to 14 Days)||34
6596033|NCT02014480|7521143|FG002|STARTED|Washout Period 1 (10 to 14 Days)||33
6596034|NCT02014480|7521144|FG003|STARTED|Washout Period 1 (10 to 14 Days)||32
6596035|NCT02014480|7521145|FG004|STARTED|Washout Period 1 (10 to 14 Days)||34
6596036|NCT02014480|7521146|FG005|STARTED|Washout Period 1 (10 to 14 Days)||34
6596037|NCT02014480|7521141|FG000|COMPLETED|Washout Period 1 (10 to 14 Days)||35
6596038|NCT02014480|7521142|FG001|COMPLETED|Washout Period 1 (10 to 14 Days)||34
6596039|NCT02014480|7521143|FG002|COMPLETED|Washout Period 1 (10 to 14 Days)||32
6596040|NCT02014480|7521144|FG003|COMPLETED|Washout Period 1 (10 to 14 Days)||32
6596041|NCT02014480|7521145|FG004|COMPLETED|Washout Period 1 (10 to 14 Days)||34
6596042|NCT02014480|7521146|FG005|COMPLETED|Washout Period 1 (10 to 14 Days)||34
6596043|NCT02014480|7521141|FG000|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6596044|NCT02014480|7521142|FG001|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6596045|NCT02014480|7521143|FG002|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
6660441|NCT02498418|7591318|FG000|NOT COMPLETED|Overall Study||2
6596046|NCT02014480|7521144|FG003|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6596047|NCT02014480|7521145|FG004|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6596048|NCT02014480|7521146|FG005|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
6596049|NCT02014480|7521141|FG000|STARTED|Treatment Period 2 (14 Days)||35
6596050|NCT02014480|7521142|FG001|STARTED|Treatment Period 2 (14 Days)||34
6596051|NCT02014480|7521143|FG002|STARTED|Treatment Period 2 (14 Days)||32
6596052|NCT02014480|7521144|FG003|STARTED|Treatment Period 2 (14 Days)||32
6596053|NCT02014480|7521145|FG004|STARTED|Treatment Period 2 (14 Days)||34
6596054|NCT02014480|7521146|FG005|STARTED|Treatment Period 2 (14 Days)||34
6596055|NCT02014480|7521141|FG000|COMPLETED|Treatment Period 2 (14 Days)||34
6596056|NCT02014480|7521142|FG001|COMPLETED|Treatment Period 2 (14 Days)||33
6596057|NCT02014480|7521143|FG002|COMPLETED|Treatment Period 2 (14 Days)||30
6596058|NCT02014480|7521144|FG003|COMPLETED|Treatment Period 2 (14 Days)||31
6596059|NCT02014480|7521145|FG004|COMPLETED|Treatment Period 2 (14 Days)||34
6596060|NCT02014480|7521146|FG005|COMPLETED|Treatment Period 2 (14 Days)||34
6596061|NCT02014480|7521141|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6596062|NCT02014480|7521142|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6596063|NCT02014480|7521143|FG002|NOT COMPLETED|Treatment Period 2 (14 Days)||2
6596064|NCT02014480|7521144|FG003|NOT COMPLETED|Treatment Period 2 (14 Days)||1
6596065|NCT02014480|7521145|FG004|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6596066|NCT02014480|7521146|FG005|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6596067|NCT02014480|7521141|FG000|STARTED|Washout Period 2 (10 to 14 Days)||34
6596068|NCT02014480|7521142|FG001|STARTED|Washout Period 2 (10 to 14 Days)||33
6596069|NCT02014480|7521143|FG002|STARTED|Washout Period 2 (10 to 14 Days)||30
6596070|NCT02014480|7521144|FG003|STARTED|Washout Period 2 (10 to 14 Days)||31
6596071|NCT02014480|7521145|FG004|STARTED|Washout Period 2 (10 to 14 Days)||34
6596072|NCT02014480|7521146|FG005|STARTED|Washout Period 2 (10 to 14 Days)||34
6596073|NCT02014480|7521141|FG000|COMPLETED|Washout Period 2 (10 to 14 Days)||34
6596074|NCT02014480|7521142|FG001|COMPLETED|Washout Period 2 (10 to 14 Days)||33
6596075|NCT02014480|7521143|FG002|COMPLETED|Washout Period 2 (10 to 14 Days)||30
6596076|NCT02014480|7521144|FG003|COMPLETED|Washout Period 2 (10 to 14 Days)||31
6596077|NCT02014480|7521145|FG004|COMPLETED|Washout Period 2 (10 to 14 Days)||34
6596078|NCT02014480|7521146|FG005|COMPLETED|Washout Period 2 (10 to 14 Days)||34
6596079|NCT02014480|7521141|FG000|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6596080|NCT02014480|7521142|FG001|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6596081|NCT02014480|7521143|FG002|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6596082|NCT02014480|7521144|FG003|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6596083|NCT02014480|7521145|FG004|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6596084|NCT02014480|7521146|FG005|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
6596085|NCT02014480|7521141|FG000|STARTED|Treatment Period 3 (14 Days)||34
6596086|NCT02014480|7521142|FG001|STARTED|Treatment Period 3 (14 Days)||33
6596087|NCT02014480|7521143|FG002|STARTED|Treatment Period 3 (14 Days)||30
6596088|NCT02014480|7521144|FG003|STARTED|Treatment Period 3 (14 Days)||31
6596089|NCT02014480|7521145|FG004|STARTED|Treatment Period 3 (14 Days)||34
6596090|NCT02014480|7521146|FG005|STARTED|Treatment Period 3 (14 Days)||34
6596091|NCT02014480|7521141|FG000|COMPLETED|Treatment Period 3 (14 Days)||34
6596092|NCT02014480|7521142|FG001|COMPLETED|Treatment Period 3 (14 Days)||32
6596093|NCT02014480|7521143|FG002|COMPLETED|Treatment Period 3 (14 Days)||29
6596094|NCT02014480|7521144|FG003|COMPLETED|Treatment Period 3 (14 Days)||31
6596095|NCT02014480|7521145|FG004|COMPLETED|Treatment Period 3 (14 Days)||34
6596096|NCT02014480|7521146|FG005|COMPLETED|Treatment Period 3 (14 Days)||32
6660442|NCT02498418|7591319|FG001|NOT COMPLETED|Overall Study||2
6660443|NCT02498418|7591320|FG002|NOT COMPLETED|Overall Study||6
6660444|NCT02498483|7591330|FG000|STARTED|Overall Study||6
6660445|NCT02498483|7591331|FG001|STARTED|Overall Study||5
6660446|NCT02498483|7591330|FG000|COMPLETED|Overall Study||6
6660447|NCT02498483|7591331|FG001|COMPLETED|Overall Study||5
6660448|NCT02498483|7591330|FG000|NOT COMPLETED|Overall Study||0
6660449|NCT02498483|7591331|FG001|NOT COMPLETED|Overall Study||0
6660450|NCT02498522|7591339|FG000|STARTED|Overall Study||85
6660451|NCT02498522|7591340|FG001|STARTED|Overall Study||85
6660452|NCT02498522|7591339|FG000|COMPLETED|Overall Study||83
6660453|NCT02498522|7591340|FG001|COMPLETED|Overall Study||83
6660454|NCT02498522|7591339|FG000|NOT COMPLETED|Overall Study||2
6660455|NCT02498522|7591340|FG001|NOT COMPLETED|Overall Study||2
6660456|NCT02498652|7591348|FG000|STARTED|Overall Study||20
6660457|NCT02498652|7591349|FG001|STARTED|Overall Study||21
6660458|NCT02498652|7591348|FG000|COMPLETED|Overall Study||20
6660459|NCT02498652|7591349|FG001|COMPLETED|Overall Study|One subject was withdrawn due to noncompliance/protocol violation|20
6660460|NCT02498652|7591348|FG000|NOT COMPLETED|Overall Study||0
6660461|NCT02498652|7591349|FG001|NOT COMPLETED|Overall Study||1
6660462|NCT02498678|7591375|FG000|STARTED|Overall Study||25
6660463|NCT02498678|7591376|FG001|STARTED|Overall Study||25
6660464|NCT02498678|7591375|FG000|COMPLETED|Overall Study||25
6660465|NCT02498678|7591376|FG001|COMPLETED|Overall Study||23
6660466|NCT02498678|7591375|FG000|NOT COMPLETED|Overall Study||0
6660467|NCT02498678|7591376|FG001|NOT COMPLETED|Overall Study||2
6660468|NCT02498769|7591384|FG000|STARTED|Overall Study||63
6660469|NCT02498769|7591385|FG001|STARTED|Overall Study||67
6660470|NCT02498769|7591384|FG000|COMPLETED|Overall Study||63
6660471|NCT02498769|7591385|FG001|COMPLETED|Overall Study||67
6660472|NCT02498769|7591384|FG000|NOT COMPLETED|Overall Study||0
6660473|NCT02498769|7591385|FG001|NOT COMPLETED|Overall Study||0
6596097|NCT02014480|7521141|FG000|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6596098|NCT02014480|7521142|FG001|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6596099|NCT02014480|7521143|FG002|NOT COMPLETED|Treatment Period 3 (14 Days)||1
6596100|NCT02014480|7521144|FG003|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6596101|NCT02014480|7521145|FG004|NOT COMPLETED|Treatment Period 3 (14 Days)||0
6596102|NCT02014480|7521146|FG005|NOT COMPLETED|Treatment Period 3 (14 Days)||2
6596103|NCT02014519|7521154|FG000|STARTED|Overall Study||2000
6596104|NCT02014519|7521154|FG000|COMPLETED|Overall Study||2000
6596105|NCT02014519|7521154|FG000|NOT COMPLETED|Overall Study||0
6596106|NCT02014584|7521168|FG000|STARTED|Double-Blind Period (24 Weeks)||59
6596107|NCT02014584|7521169|FG001|STARTED|Double-Blind Period (24 Weeks)||58
6596108|NCT02014584|7521170|FG002|STARTED|Double-Blind Period (24 Weeks)||0
6596109|NCT02014584|7521171|FG003|STARTED|Double-Blind Period (24 Weeks)||0
6596110|NCT02014584|7521172|FG004|STARTED|Double-Blind Period (24 Weeks)||0
6596111|NCT02014584|7521173|FG005|STARTED|Double-Blind Period (24 Weeks)||0
6596112|NCT02014584|7521168|FG000|COMPLETED|Double-Blind Period (24 Weeks)||57
6596113|NCT02014584|7521169|FG001|COMPLETED|Double-Blind Period (24 Weeks)||52
6596114|NCT02014584|7521170|FG002|COMPLETED|Double-Blind Period (24 Weeks)||0
6596115|NCT02014584|7521171|FG003|COMPLETED|Double-Blind Period (24 Weeks)||0
6596116|NCT02014584|7521172|FG004|COMPLETED|Double-Blind Period (24 Weeks)||0
6596117|NCT02014584|7521173|FG005|COMPLETED|Double-Blind Period (24 Weeks)||0
6596118|NCT02014584|7521168|FG000|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
6596119|NCT02014584|7521169|FG001|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
6596120|NCT02014584|7521170|FG002|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
6596121|NCT02014584|7521171|FG003|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
6596122|NCT02014584|7521172|FG004|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
6596123|NCT02014584|7521173|FG005|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
6596124|NCT02014584|7521168|FG000|STARTED|Open-Label Period (24 Weeks)||0
6596125|NCT02014584|7521169|FG001|STARTED|Open-Label Period (24 Weeks)||0
6596126|NCT02014584|7521170|FG002|STARTED|Open-Label Period (24 Weeks)||49
6596127|NCT02014584|7521171|FG003|STARTED|Open-Label Period (24 Weeks)||48
6596128|NCT02014584|7521172|FG004|STARTED|Open-Label Period (24 Weeks)||0
6596129|NCT02014584|7521173|FG005|STARTED|Open-Label Period (24 Weeks)||0
6596130|NCT02014584|7521168|FG000|COMPLETED|Open-Label Period (24 Weeks)||0
6596131|NCT02014584|7521169|FG001|COMPLETED|Open-Label Period (24 Weeks)||0
6596132|NCT02014584|7521170|FG002|COMPLETED|Open-Label Period (24 Weeks)||44
6596133|NCT02014584|7521171|FG003|COMPLETED|Open-Label Period (24 Weeks)||47
6596134|NCT02014584|7521172|FG004|COMPLETED|Open-Label Period (24 Weeks)||0
6596135|NCT02014584|7521173|FG005|COMPLETED|Open-Label Period (24 Weeks)||0
6596136|NCT02014584|7521168|FG000|NOT COMPLETED|Open-Label Period (24 Weeks)||0
6596137|NCT02014584|7521169|FG001|NOT COMPLETED|Open-Label Period (24 Weeks)||0
6596138|NCT02014584|7521170|FG002|NOT COMPLETED|Open-Label Period (24 Weeks)||5
6596139|NCT02014584|7521171|FG003|NOT COMPLETED|Open-Label Period (24 Weeks)||1
6596140|NCT02014584|7521172|FG004|NOT COMPLETED|Open-Label Period (24 Weeks)||0
6596141|NCT02014584|7521173|FG005|NOT COMPLETED|Open-Label Period (24 Weeks)||0
6596142|NCT02014584|7521168|FG000|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
6596143|NCT02014584|7521169|FG001|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
6596144|NCT02014584|7521170|FG002|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
6596145|NCT02014584|7521171|FG003|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
6596146|NCT02014584|7521172|FG004|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
6596147|NCT02014584|7521173|FG005|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
6596148|NCT02014584|7521168|FG000|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596149|NCT02014584|7521169|FG001|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596150|NCT02014584|7521170|FG002|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596151|NCT02014584|7521171|FG003|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596152|NCT02014584|7521172|FG004|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
6596153|NCT02014584|7521173|FG005|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
6596154|NCT02014584|7521168|FG000|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596155|NCT02014584|7521169|FG001|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596156|NCT02014584|7521170|FG002|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596157|NCT02014584|7521171|FG003|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596158|NCT02014584|7521172|FG004|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
6596159|NCT02014584|7521173|FG005|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
6596160|NCT02014597|7521187|FG000|STARTED|Overall Study||12
6596161|NCT02014597|7521188|FG001|STARTED|Overall Study||11
6596162|NCT02014597|7521187|FG000|COMPLETED|Overall Study||10
6596163|NCT02014597|7521188|FG001|COMPLETED|Overall Study||10
6596164|NCT02014597|7521187|FG000|NOT COMPLETED|Overall Study||2
6596165|NCT02014597|7521188|FG001|NOT COMPLETED|Overall Study||1
6596166|NCT02014740|7521196|FG000|STARTED|Overall Study||55
6596167|NCT02014740|7521197|FG001|STARTED|Overall Study||45
6596168|NCT02014740|7521196|FG000|COMPLETED|Overall Study||49
6596169|NCT02014740|7521197|FG001|COMPLETED|Overall Study||40
6596170|NCT02014740|7521196|FG000|NOT COMPLETED|Overall Study||6
6596171|NCT02014740|7521197|FG001|NOT COMPLETED|Overall Study||5
6596172|NCT02015039|7521205|FG000|STARTED|Overall Study||6
6596173|NCT02015039|7521206|FG001|STARTED|Overall Study||7
6596174|NCT02015039|7521205|FG000|COMPLETED|Overall Study||6
6596175|NCT02015039|7521206|FG001|COMPLETED|Overall Study||6
6596176|NCT02015039|7521205|FG000|NOT COMPLETED|Overall Study||0
6596177|NCT02015039|7521206|FG001|NOT COMPLETED|Overall Study||1
6596178|NCT02015065|7521215|FG000|STARTED|Overall Study||2
6596179|NCT02015065|7521216|FG001|STARTED|Overall Study||5
6596180|NCT02015065|7521217|FG002|STARTED|Overall Study||2
6596181|NCT02015065|7521215|FG000|COMPLETED|Overall Study||1
6596182|NCT02015065|7521216|FG001|COMPLETED|Overall Study||3
6596183|NCT02015065|7521217|FG002|COMPLETED|Overall Study||1
6596184|NCT02015065|7521215|FG000|NOT COMPLETED|Overall Study||1
6596185|NCT02015065|7521216|FG001|NOT COMPLETED|Overall Study||2
6596186|NCT02015065|7521217|FG002|NOT COMPLETED|Overall Study||1
6596187|NCT02015104|7521227|FG000|STARTED|Overall Study||16
6596188|NCT02015104|7521228|FG001|STARTED|Overall Study||16
6596189|NCT02015104|7521227|FG000|COMPLETED|Overall Study||15
6596190|NCT02015104|7521228|FG001|COMPLETED|Overall Study||15
6596191|NCT02015104|7521227|FG000|NOT COMPLETED|Overall Study||1
6596192|NCT02015104|7521228|FG001|NOT COMPLETED|Overall Study||1
6596193|NCT02015195|7521244|FG000|STARTED|Overall Study||16
6596194|NCT02015195|7521245|FG001|STARTED|Overall Study||16
6596195|NCT02015195|7521246|FG002|STARTED|Overall Study||16
6596196|NCT02015195|7521247|FG003|STARTED|Overall Study||1
6596197|NCT02015195|7521248|FG004|STARTED|Overall Study||16
6596198|NCT02015195|7521249|FG005|STARTED|Overall Study||16
6596199|NCT02015195|7521250|FG006|STARTED|Overall Study||16
6596200|NCT02015195|7521244|FG000|COMPLETED|Overall Study||16
6596201|NCT02015195|7521245|FG001|COMPLETED|Overall Study||16
6596202|NCT02015195|7521246|FG002|COMPLETED|Overall Study||16
6596203|NCT02015195|7521247|FG003|COMPLETED|Overall Study||0
6596204|NCT02015195|7521248|FG004|COMPLETED|Overall Study||16
6596205|NCT02015195|7521249|FG005|COMPLETED|Overall Study||16
6596206|NCT02015195|7521250|FG006|COMPLETED|Overall Study||16
6596207|NCT02015195|7521244|FG000|NOT COMPLETED|Overall Study||0
6596208|NCT02015195|7521245|FG001|NOT COMPLETED|Overall Study||0
6596209|NCT02015195|7521246|FG002|NOT COMPLETED|Overall Study||0
6596210|NCT02015195|7521247|FG003|NOT COMPLETED|Overall Study||1
6596211|NCT02015195|7521248|FG004|NOT COMPLETED|Overall Study||0
6596212|NCT02015195|7521249|FG005|NOT COMPLETED|Overall Study||0
6596213|NCT02015195|7521250|FG006|NOT COMPLETED|Overall Study||0
6596214|NCT02015221|7521267|FG000|STARTED|Overall Study||41
6596215|NCT02015221|7521268|FG001|STARTED|Overall Study||40
6596216|NCT02015221|7521267|FG000|COMPLETED|Overall Study||32
6596217|NCT02015221|7521268|FG001|COMPLETED|Overall Study||34
6596218|NCT02015221|7521267|FG000|NOT COMPLETED|Overall Study||9
6596219|NCT02015221|7521268|FG001|NOT COMPLETED|Overall Study||6
6596220|NCT02015234|7521276|FG000|STARTED|Overall Study||79
6596221|NCT02015234|7521277|FG001|STARTED|Overall Study||79
6596222|NCT02015234|7521276|FG000|COMPLETED|Overall Study||43
6596223|NCT02015234|7521277|FG001|COMPLETED|Overall Study||54
6596224|NCT02015234|7521276|FG000|NOT COMPLETED|Overall Study||36
6596225|NCT02015234|7521277|FG001|NOT COMPLETED|Overall Study||25
6596226|NCT02015390|7521287|FG000|STARTED|Overall Study||9
6596227|NCT02015390|7521288|FG001|STARTED|Overall Study||7
6596228|NCT02015390|7521287|FG000|COMPLETED|Overall Study||8
6596229|NCT02015390|7521288|FG001|COMPLETED|Overall Study||3
6596230|NCT02015390|7521287|FG000|NOT COMPLETED|Overall Study||1
6596231|NCT02015390|7521288|FG001|NOT COMPLETED|Overall Study||4
6596232|NCT02015442|7521295|FG000|STARTED|First Intervention (7 Days)||5
6596233|NCT02015442|7521296|FG001|STARTED|First Intervention (7 Days)||4
6596234|NCT02015442|7521295|FG000|COMPLETED|First Intervention (7 Days)||5
6596235|NCT02015442|7521296|FG001|COMPLETED|First Intervention (7 Days)||4
6596236|NCT02015442|7521295|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6596237|NCT02015442|7521296|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6596238|NCT02015442|7521295|FG000|STARTED|Wash-out (4 Weeks)||5
6596239|NCT02015442|7521296|FG001|STARTED|Wash-out (4 Weeks)||4
6596240|NCT02015442|7521295|FG000|COMPLETED|Wash-out (4 Weeks)||5
6596241|NCT02015442|7521296|FG001|COMPLETED|Wash-out (4 Weeks)||4
6596242|NCT02015442|7521295|FG000|NOT COMPLETED|Wash-out (4 Weeks)||0
6596243|NCT02015442|7521296|FG001|NOT COMPLETED|Wash-out (4 Weeks)||0
6596244|NCT02015442|7521295|FG000|STARTED|Second Intervention (7 Days)||5
6596245|NCT02015442|7521296|FG001|STARTED|Second Intervention (7 Days)||4
6660474|NCT02498821|7591393|FG000|STARTED|Overall Study||63
6660475|NCT02498821|7591394|FG001|STARTED|Overall Study||65
6660476|NCT02498821|7591393|FG000|COMPLETED|Overall Study||60
6660477|NCT02498821|7591394|FG001|COMPLETED|Overall Study||60
6660478|NCT02498821|7591393|FG000|NOT COMPLETED|Overall Study||3
6660479|NCT02498821|7591394|FG001|NOT COMPLETED|Overall Study||5
6660480|NCT02498834|7591402|FG000|STARTED|Overall Study||185
6660481|NCT02498834|7591403|FG001|STARTED|Overall Study||174
6660482|NCT02498834|7591402|FG000|COMPLETED|Overall Study||175
6660483|NCT02498834|7591403|FG001|COMPLETED|Overall Study||164
6660484|NCT02498834|7591402|FG000|NOT COMPLETED|Overall Study||10
6660485|NCT02498834|7591403|FG001|NOT COMPLETED|Overall Study||10
6660486|NCT02499029|7591411|FG000|STARTED|Overall Study||18
6660487|NCT02499029|7591412|FG001|STARTED|Overall Study||17
6596246|NCT02015442|7521295|FG000|COMPLETED|Second Intervention (7 Days)||5
6596247|NCT02015442|7521296|FG001|COMPLETED|Second Intervention (7 Days)||4
6596248|NCT02015442|7521295|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6596249|NCT02015442|7521296|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6596250|NCT02015481|7521302|FG000|STARTED|Overall Study||25
6596251|NCT02015481|7521302|FG000|COMPLETED|Overall Study||24
6596252|NCT02015481|7521302|FG000|NOT COMPLETED|Overall Study||1
6660488|NCT02499029|7591411|FG000|COMPLETED|Overall Study||13
6596253|NCT02015520|7521311|FG000|STARTED|Overall Study||40
6596254|NCT02015520|7521312|FG001|STARTED|Overall Study||21
6596255|NCT02015520|7521313|FG002|STARTED|Overall Study||42
6596256|NCT02015520|7521314|FG003|STARTED|Overall Study||40
6596257|NCT02015520|7521311|FG000|COMPLETED|Overall Study||35
6596258|NCT02015520|7521312|FG001|COMPLETED|Overall Study||17
6596259|NCT02015520|7521313|FG002|COMPLETED|Overall Study||35
6596260|NCT02015520|7521314|FG003|COMPLETED|Overall Study||36
6596261|NCT02015520|7521311|FG000|NOT COMPLETED|Overall Study||5
6596262|NCT02015520|7521312|FG001|NOT COMPLETED|Overall Study||4
6596263|NCT02015520|7521313|FG002|NOT COMPLETED|Overall Study||7
6596264|NCT02015520|7521314|FG003|NOT COMPLETED|Overall Study||4
6596265|NCT02015546|7521327|FG000|STARTED|Overall Study||23
6596266|NCT02015546|7521328|FG001|STARTED|Overall Study||21
6596267|NCT02015546|7521329|FG002|STARTED|Overall Study||26
6596268|NCT02015546|7521327|FG000|COMPLETED|Overall Study||20
6596269|NCT02015546|7521328|FG001|COMPLETED|Overall Study||19
6596270|NCT02015546|7521329|FG002|COMPLETED|Overall Study||22
6596271|NCT02015546|7521327|FG000|NOT COMPLETED|Overall Study||3
6596272|NCT02015546|7521328|FG001|NOT COMPLETED|Overall Study||2
6596273|NCT02015546|7521329|FG002|NOT COMPLETED|Overall Study||4
6596274|NCT02015637|7521339|FG000|STARTED|Overall Study||306
6596275|NCT02015637|7521340|FG001|STARTED|Overall Study||154
6596276|NCT02015637|7521339|FG000|COMPLETED|Overall Study||298
6596277|NCT02015637|7521340|FG001|COMPLETED|Overall Study||149
6596278|NCT02015637|7521339|FG000|NOT COMPLETED|Overall Study||8
6596279|NCT02015637|7521340|FG001|NOT COMPLETED|Overall Study||5
6596280|NCT02015676|7521349|FG000|STARTED|Overall Study||15
6596281|NCT02015676|7521350|FG001|STARTED|Overall Study||48
6596282|NCT02015676|7521351|FG002|STARTED|Overall Study||6
6596283|NCT02015676|7521349|FG000|COMPLETED|Overall Study||6
6596284|NCT02015676|7521350|FG001|COMPLETED|Overall Study||14
6596285|NCT02015676|7521351|FG002|COMPLETED|Overall Study||3
6596286|NCT02015676|7521349|FG000|NOT COMPLETED|Overall Study||9
6596287|NCT02015676|7521350|FG001|NOT COMPLETED|Overall Study||34
6596288|NCT02015676|7521351|FG002|NOT COMPLETED|Overall Study||3
6596289|NCT02015754|7521355|FG000|STARTED|Overall Study|17 participants were consented, but 3 participants were screened out prior to treatment|14
6596290|NCT02015754|7521355|FG000|Completed First TACE|Overall Study||14
6596291|NCT02015754|7521355|FG000|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to follow-up|13
6596292|NCT02015754|7521355|FG000|COMPLETED|Overall Study||3
6596293|NCT02015754|7521355|FG000|NOT COMPLETED|Overall Study||11
6660489|NCT02499029|7591412|FG001|COMPLETED|Overall Study||14
6660490|NCT02499029|7591411|FG000|NOT COMPLETED|Overall Study||5
6660491|NCT02499029|7591412|FG001|NOT COMPLETED|Overall Study||3
6660492|NCT02499081|7591418|FG000|STARTED|Overall Study||20
6660493|NCT02499081|7591418|FG000|COMPLETED|Overall Study||1
6660494|NCT02499081|7591418|FG000|NOT COMPLETED|Overall Study||19
6660495|NCT02499120|7591424|FG000|STARTED|Overall Study||65
6660496|NCT02499120|7591425|FG001|STARTED|Overall Study||60
6660497|NCT02499120|7591424|FG000|Received Treatment|Overall Study||64
6660498|NCT02499120|7591425|FG001|Received Treatment|Overall Study||60
6660499|NCT02499120|7591424|FG000|COMPLETED|Overall Study||0
6660500|NCT02499120|7591425|FG001|COMPLETED|Overall Study||0
6660501|NCT02499120|7591424|FG000|NOT COMPLETED|Overall Study||65
6660502|NCT02499120|7591425|FG001|NOT COMPLETED|Overall Study||60
6660503|NCT02499146|7591431|FG000|STARTED|Overall Study||26
6660504|NCT02499146|7591431|FG000|COMPLETED|Overall Study||0
6660505|NCT02499146|7591431|FG000|NOT COMPLETED|Overall Study||26
6660506|NCT02499159|7591437|FG000|STARTED|Randomization||50
6660507|NCT02499159|7591438|FG001|STARTED|Randomization||50
6660508|NCT02499159|7591437|FG000|COMPLETED|Randomization||49
6660509|NCT02499159|7591438|FG001|COMPLETED|Randomization||49
6660510|NCT02499159|7591437|FG000|NOT COMPLETED|Randomization||1
6660511|NCT02499159|7591438|FG001|NOT COMPLETED|Randomization||1
6660512|NCT02499159|7591437|FG000|STARTED|30-Day Follow-Up Phone Call||49
6660513|NCT02499159|7591438|FG001|STARTED|30-Day Follow-Up Phone Call||49
6660514|NCT02499159|7591437|FG000|COMPLETED|30-Day Follow-Up Phone Call||42
6660515|NCT02499159|7591438|FG001|COMPLETED|30-Day Follow-Up Phone Call||47
6660516|NCT02499159|7591437|FG000|NOT COMPLETED|30-Day Follow-Up Phone Call||7
6660517|NCT02499159|7591438|FG001|NOT COMPLETED|30-Day Follow-Up Phone Call||2
6660518|NCT02499172|7591448|FG000|STARTED|Overall Study||900
6660519|NCT02499172|7591449|FG001|STARTED|Overall Study||899
6660520|NCT02499172|7591450|FG002|STARTED|Overall Study||523
6660521|NCT02499172|7591451|FG003|STARTED|Overall Study||436
6660522|NCT02499172|7591448|FG000|COMPLETED|Overall Study||835
6660523|NCT02499172|7591449|FG001|COMPLETED|Overall Study||835
6660524|NCT02499172|7591450|FG002|COMPLETED|Overall Study||0
6660525|NCT02499172|7591451|FG003|COMPLETED|Overall Study||0
6660526|NCT02499172|7591448|FG000|NOT COMPLETED|Overall Study||65
6660527|NCT02499172|7591449|FG001|NOT COMPLETED|Overall Study||64
6660528|NCT02499172|7591450|FG002|NOT COMPLETED|Overall Study||523
6660529|NCT02499172|7591451|FG003|NOT COMPLETED|Overall Study||436
6660530|NCT02499263|7591461|FG000|STARTED|Overall Study||146
6660531|NCT02499263|7591461|FG000|COMPLETED|Overall Study||84
6660532|NCT02499263|7591461|FG000|NOT COMPLETED|Overall Study||62
6660533|NCT02499380|7591465|FG000|STARTED|Overall Study||20
6660534|NCT02499380|7591465|FG000|COMPLETED|Overall Study||17
6660535|NCT02499380|7591465|FG000|NOT COMPLETED|Overall Study||3
6660536|NCT02499406|7591469|FG000|STARTED|Overall Study||17
6660537|NCT02499406|7591469|FG000|COMPLETED|Overall Study||13
6660538|NCT02499406|7591469|FG000|NOT COMPLETED|Overall Study||4
6596294|NCT02015793|7521361|FG000|STARTED|Overall Study||15
6596295|NCT02015793|7521362|FG001|STARTED|Overall Study||15
6596296|NCT02015793|7521361|FG000|Completed Double-Blind Period|Overall Study||14
6596297|NCT02015793|7521362|FG001|Completed Double-Blind Period|Overall Study||14
6596298|NCT02015793|7521361|FG000|Entered Open-label Extension Period|Overall Study||13
6596299|NCT02015793|7521362|FG001|Entered Open-label Extension Period|Overall Study||14
6596300|NCT02015793|7521361|FG000|COMPLETED|Overall Study||11
6596301|NCT02015793|7521362|FG001|COMPLETED|Overall Study||11
6596302|NCT02015793|7521361|FG000|NOT COMPLETED|Overall Study||4
6596303|NCT02015793|7521362|FG001|NOT COMPLETED|Overall Study||4
6596304|NCT02015819|7521378|FG000|STARTED|Overall Study||3
6596305|NCT02015819|7521379|FG001|STARTED|Overall Study||3
6596306|NCT02015819|7521380|FG002|STARTED|Overall Study||3
6596307|NCT02015819|7521381|FG003|STARTED|Overall Study||7
6596308|NCT02015819|7521378|FG000|COMPLETED|Overall Study||3
6596309|NCT02015819|7521379|FG001|COMPLETED|Overall Study||3
6596310|NCT02015819|7521380|FG002|COMPLETED|Overall Study||3
6596311|NCT02015819|7521381|FG003|COMPLETED|Overall Study||6
6596312|NCT02015819|7521378|FG000|NOT COMPLETED|Overall Study||0
6596313|NCT02015819|7521379|FG001|NOT COMPLETED|Overall Study||0
6596314|NCT02015819|7521380|FG002|NOT COMPLETED|Overall Study||0
6596315|NCT02015819|7521381|FG003|NOT COMPLETED|Overall Study||1
6596316|NCT02016105|7521397|FG000|STARTED|TREATMENT PERIOD 1||231
6596317|NCT02016105|7521398|FG001|STARTED|TREATMENT PERIOD 1||234
6596318|NCT02016105|7521399|FG002|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6596319|NCT02016105|7521400|FG003|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6596320|NCT02016105|7521401|FG004|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6596321|NCT02016105|7521402|FG005|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
6596322|NCT02016105|7521397|FG000|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
6596323|NCT02016105|7521398|FG001|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
6596324|NCT02016105|7521399|FG002|COMPLETED|TREATMENT PERIOD 1||0
6596325|NCT02016105|7521400|FG003|COMPLETED|TREATMENT PERIOD 1||0
6596326|NCT02016105|7521401|FG004|COMPLETED|TREATMENT PERIOD 1||0
6596327|NCT02016105|7521402|FG005|COMPLETED|TREATMENT PERIOD 1||0
6596328|NCT02016105|7521397|FG000|NOT COMPLETED|TREATMENT PERIOD 1||30
6596329|NCT02016105|7521398|FG001|NOT COMPLETED|TREATMENT PERIOD 1||33
6596330|NCT02016105|7521399|FG002|NOT COMPLETED|TREATMENT PERIOD 1||0
6596331|NCT02016105|7521400|FG003|NOT COMPLETED|TREATMENT PERIOD 1||0
6596332|NCT02016105|7521401|FG004|NOT COMPLETED|TREATMENT PERIOD 1||0
6596333|NCT02016105|7521402|FG005|NOT COMPLETED|TREATMENT PERIOD 1||0
6596334|NCT02016105|7521397|FG000|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
6596335|NCT02016105|7521398|FG001|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
6596336|NCT02016105|7521399|FG002|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
6596337|NCT02016105|7521400|FG003|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
6596338|NCT02016105|7521401|FG004|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
6596339|NCT02016105|7521402|FG005|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
6596340|NCT02016105|7521397|FG000|COMPLETED|TREATMENT PERIOD 2||0
6596341|NCT02016105|7521398|FG001|COMPLETED|TREATMENT PERIOD 2||0
6596342|NCT02016105|7521399|FG002|COMPLETED|TREATMENT PERIOD 2||57
6596343|NCT02016105|7521400|FG003|COMPLETED|TREATMENT PERIOD 2||116
6596344|NCT02016105|7521401|FG004|COMPLETED|TREATMENT PERIOD 2||59
6596345|NCT02016105|7521402|FG005|COMPLETED|TREATMENT PERIOD 2||112
6596346|NCT02016105|7521397|FG000|NOT COMPLETED|TREATMENT PERIOD 2||0
6596347|NCT02016105|7521398|FG001|NOT COMPLETED|TREATMENT PERIOD 2||0
6596348|NCT02016105|7521399|FG002|NOT COMPLETED|TREATMENT PERIOD 2||6
6596349|NCT02016105|7521400|FG003|NOT COMPLETED|TREATMENT PERIOD 2||11
6596350|NCT02016105|7521401|FG004|NOT COMPLETED|TREATMENT PERIOD 2||4
6596351|NCT02016105|7521402|FG005|NOT COMPLETED|TREATMENT PERIOD 2||14
6596352|NCT02016105|7521397|FG000|STARTED|EXTENSION PERIOD||0
6596353|NCT02016105|7521398|FG001|STARTED|EXTENSION PERIOD||0
6596354|NCT02016105|7521399|FG002|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
6596355|NCT02016105|7521400|FG003|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
6596356|NCT02016105|7521401|FG004|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
6596357|NCT02016105|7521402|FG005|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
6596358|NCT02016105|7521397|FG000|COMPLETED|EXTENSION PERIOD||0
6596359|NCT02016105|7521398|FG001|COMPLETED|EXTENSION PERIOD||0
6596360|NCT02016105|7521399|FG002|COMPLETED|EXTENSION PERIOD||47
6596361|NCT02016105|7521400|FG003|COMPLETED|EXTENSION PERIOD||104
6596362|NCT02016105|7521401|FG004|COMPLETED|EXTENSION PERIOD||50
6596363|NCT02016105|7521402|FG005|COMPLETED|EXTENSION PERIOD||100
6596364|NCT02016105|7521397|FG000|NOT COMPLETED|EXTENSION PERIOD||0
6596365|NCT02016105|7521398|FG001|NOT COMPLETED|EXTENSION PERIOD||0
6596366|NCT02016105|7521399|FG002|NOT COMPLETED|EXTENSION PERIOD||5
6596367|NCT02016105|7521400|FG003|NOT COMPLETED|EXTENSION PERIOD||5
6596368|NCT02016105|7521401|FG004|NOT COMPLETED|EXTENSION PERIOD||6
6596369|NCT02016105|7521402|FG005|NOT COMPLETED|EXTENSION PERIOD||6
6596370|NCT02016170|7521419|FG000|STARTED|Overall Study||27
6596371|NCT02016170|7521420|FG001|STARTED|Overall Study||28
6596372|NCT02016170|7521421|FG002|STARTED|Overall Study||27
6596373|NCT02016170|7521419|FG000|COMPLETED|Overall Study||25
6596374|NCT02016170|7521420|FG001|COMPLETED|Overall Study||27
6596375|NCT02016170|7521421|FG002|COMPLETED|Overall Study||27
6596376|NCT02016170|7521419|FG000|NOT COMPLETED|Overall Study||2
6596377|NCT02016170|7521420|FG001|NOT COMPLETED|Overall Study||1
6596378|NCT02016170|7521421|FG002|NOT COMPLETED|Overall Study||0
6596379|NCT02016183|7521428|FG000|STARTED|Overall Study||3222
6596380|NCT02016183|7521428|FG000|COMPLETED|Overall Study||3157
6596381|NCT02016183|7521428|FG000|NOT COMPLETED|Overall Study||65
6596382|NCT02016235|7521435|FG000|STARTED|Overall Study||10
6596383|NCT02016235|7521436|FG001|STARTED|Overall Study||10
6596384|NCT02016235|7521437|FG002|STARTED|Overall Study||10
6596385|NCT02016235|7521435|FG000|COMPLETED|Overall Study||10
6596386|NCT02016235|7521436|FG001|COMPLETED|Overall Study||10
6596387|NCT02016235|7521437|FG002|COMPLETED|Overall Study||10
6596388|NCT02016235|7521435|FG000|NOT COMPLETED|Overall Study||0
6596389|NCT02016235|7521436|FG001|NOT COMPLETED|Overall Study||0
6596390|NCT02016235|7521437|FG002|NOT COMPLETED|Overall Study||0
6596391|NCT02016300|7521447|FG000|STARTED|Overall Study||12
6596392|NCT02016300|7521448|FG001|STARTED|Overall Study||12
6596393|NCT02016300|7521447|FG000|COMPLETED|Overall Study||12
6596394|NCT02016300|7521448|FG001|COMPLETED|Overall Study||9
6596395|NCT02016300|7521447|FG000|NOT COMPLETED|Overall Study||0
6596396|NCT02016300|7521448|FG001|NOT COMPLETED|Overall Study||3
6596397|NCT02016482|7521456|FG000|STARTED|Period A||108
6596398|NCT02016482|7521457|FG001|STARTED|Period A||109
6596399|NCT02016482|7521456|FG000|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
6596400|NCT02016482|7521457|FG001|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
6596401|NCT02016482|7521456|FG000|NOT COMPLETED|Period A||14
6596402|NCT02016482|7521457|FG001|NOT COMPLETED|Period A||15
6596403|NCT02016482|7521456|FG000|STARTED|Period B||94
6596404|NCT02016482|7521457|FG001|STARTED|Period B||94
6596405|NCT02016482|7521456|FG000|COMPLETED|Period B||81
6596406|NCT02016482|7521457|FG001|COMPLETED|Period B||87
6596407|NCT02016482|7521456|FG000|NOT COMPLETED|Period B||13
6596408|NCT02016482|7521457|FG001|NOT COMPLETED|Period B||7
6596409|NCT02016560|7521471|FG000|STARTED|Exploratory Phase||16
6596410|NCT02016560|7521472|FG001|STARTED|Exploratory Phase||58
6596411|NCT02016560|7521473|FG002|STARTED|Exploratory Phase||98
6596412|NCT02016560|7521474|FG003|STARTED|Exploratory Phase||51
6596413|NCT02016560|7521475|FG004|STARTED|Exploratory Phase||0
6596414|NCT02016560|7521476|FG005|STARTED|Exploratory Phase||0
6596415|NCT02016560|7521471|FG000|COMPLETED|Exploratory Phase||16
6596416|NCT02016560|7521472|FG001|COMPLETED|Exploratory Phase||54
6596417|NCT02016560|7521473|FG002|COMPLETED|Exploratory Phase||62
6596418|NCT02016560|7521474|FG003|COMPLETED|Exploratory Phase||35
6596419|NCT02016560|7521475|FG004|COMPLETED|Exploratory Phase||0
6596420|NCT02016560|7521476|FG005|COMPLETED|Exploratory Phase||0
6596421|NCT02016560|7521471|FG000|NOT COMPLETED|Exploratory Phase||0
6596422|NCT02016560|7521472|FG001|NOT COMPLETED|Exploratory Phase||4
6596423|NCT02016560|7521473|FG002|NOT COMPLETED|Exploratory Phase||36
6596424|NCT02016560|7521474|FG003|NOT COMPLETED|Exploratory Phase||16
6596425|NCT02016560|7521475|FG004|NOT COMPLETED|Exploratory Phase||0
6596426|NCT02016560|7521476|FG005|NOT COMPLETED|Exploratory Phase||0
6596427|NCT02016560|7521471|FG000|STARTED|Confirmatory Phase||0
6596428|NCT02016560|7521472|FG001|STARTED|Confirmatory Phase||0
6596429|NCT02016560|7521473|FG002|STARTED|Confirmatory Phase||0
6596430|NCT02016560|7521474|FG003|STARTED|Confirmatory Phase||0
6596431|NCT02016560|7521475|FG004|STARTED|Confirmatory Phase||98
6596432|NCT02016560|7521476|FG005|STARTED|Confirmatory Phase||62
6596433|NCT02016560|7521471|FG000|COMPLETED|Confirmatory Phase||0
6596434|NCT02016560|7521472|FG001|COMPLETED|Confirmatory Phase||0
6596435|NCT02016560|7521473|FG002|COMPLETED|Confirmatory Phase||0
6596436|NCT02016560|7521474|FG003|COMPLETED|Confirmatory Phase||0
6596437|NCT02016560|7521475|FG004|COMPLETED|Confirmatory Phase||76
6596438|NCT02016560|7521476|FG005|COMPLETED|Confirmatory Phase||35
6596439|NCT02016560|7521471|FG000|NOT COMPLETED|Confirmatory Phase||0
6596440|NCT02016560|7521472|FG001|NOT COMPLETED|Confirmatory Phase||0
6596441|NCT02016560|7521473|FG002|NOT COMPLETED|Confirmatory Phase||0
6596442|NCT02016560|7521474|FG003|NOT COMPLETED|Confirmatory Phase||0
6596443|NCT02016560|7521475|FG004|NOT COMPLETED|Confirmatory Phase||22
6596444|NCT02016560|7521476|FG005|NOT COMPLETED|Confirmatory Phase||27
6596445|NCT02016612|7521502|FG000|STARTED|Overall Study||25
6596446|NCT02016612|7521503|FG001|STARTED|Overall Study||25
6596447|NCT02016612|7521504|FG002|STARTED|Overall Study||26
6596448|NCT02016612|7521505|FG003|STARTED|Overall Study||61
6596449|NCT02016612|7521502|FG000|COMPLETED|Overall Study||25
6596450|NCT02016612|7521503|FG001|COMPLETED|Overall Study||25
6596451|NCT02016612|7521504|FG002|COMPLETED|Overall Study||26
6596452|NCT02016612|7521505|FG003|COMPLETED|Overall Study||61
6596453|NCT02016612|7521502|FG000|NOT COMPLETED|Overall Study||0
6596454|NCT02016612|7521503|FG001|NOT COMPLETED|Overall Study||0
6596455|NCT02016612|7521504|FG002|NOT COMPLETED|Overall Study||0
6596456|NCT02016612|7521505|FG003|NOT COMPLETED|Overall Study||0
6596457|NCT02016625|7521517|FG000|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
6596458|NCT02016625|7521518|FG001|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
6596459|NCT02016625|7521517|FG000|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
6596460|NCT02016625|7521518|FG001|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
6596461|NCT02016625|7521517|FG000|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
6596462|NCT02016625|7521518|FG001|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
6596463|NCT02016625|7521517|FG000|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
6596464|NCT02016625|7521518|FG001|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
6596465|NCT02016625|7521517|FG000|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
6596466|NCT02016625|7521518|FG001|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
6596467|NCT02016625|7521517|FG000|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
6596468|NCT02016625|7521518|FG001|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
6596469|NCT02016690|7521534|FG000|STARTED|Overall Study||312
6596470|NCT02016690|7521534|FG000|Treated|Overall Study||312
6596471|NCT02016690|7521534|FG000|Safety Analysis Set (SAS)|Overall Study||304
6596472|NCT02016690|7521534|FG000|COMPLETED|Overall Study|(Effectiveness analysis set)|288
6596473|NCT02016690|7521534|FG000|NOT COMPLETED|Overall Study||24
6596474|NCT02016716|7521541|FG000|STARTED|Overall Study||53
6596475|NCT02016716|7521542|FG001|STARTED|Overall Study||118
6596476|NCT02016716|7521543|FG002|STARTED|Overall Study||123
6596477|NCT02016716|7521541|FG000|Received Study Treatment|Overall Study||53
6596478|NCT02016716|7521542|FG001|Received Study Treatment|Overall Study||118
6596479|NCT02016716|7521543|FG002|Received Study Treatment|Overall Study||123
6596480|NCT02016716|7521541|FG000|COMPLETED|Overall Study||47
6596481|NCT02016716|7521542|FG001|COMPLETED|Overall Study||110
6596482|NCT02016716|7521543|FG002|COMPLETED|Overall Study||117
6596483|NCT02016716|7521541|FG000|NOT COMPLETED|Overall Study||6
6596484|NCT02016716|7521542|FG001|NOT COMPLETED|Overall Study||8
6596485|NCT02016716|7521543|FG002|NOT COMPLETED|Overall Study||6
6596486|NCT02016755|7521552|FG000|STARTED|Overall Study||10
6596487|NCT02016755|7521552|FG000|Completed Month 18 Clinic Visit|Overall Study||5
6596488|NCT02016755|7521552|FG000|Completed Month 36 LTFU Questionnaire|Overall Study||3
6596489|NCT02016755|7521552|FG000|COMPLETED|Overall Study||3
6596490|NCT02016755|7521552|FG000|NOT COMPLETED|Overall Study||7
6596491|NCT02016885|7521561|FG000|STARTED|Overall Study||38
6596492|NCT02016885|7521562|FG001|STARTED|Overall Study||40
6596493|NCT02016885|7521563|FG002|STARTED|Overall Study||40
6596494|NCT02016885|7521564|FG003|STARTED|Overall Study||40
6596495|NCT02016885|7521565|FG004|STARTED|Overall Study||40
6596496|NCT02016885|7521561|FG000|COMPLETED|Overall Study||34
6596497|NCT02016885|7521562|FG001|COMPLETED|Overall Study||36
6596498|NCT02016885|7521563|FG002|COMPLETED|Overall Study||39
6596499|NCT02016885|7521564|FG003|COMPLETED|Overall Study||30
6596500|NCT02016885|7521565|FG004|COMPLETED|Overall Study||39
6596501|NCT02016885|7521561|FG000|NOT COMPLETED|Overall Study||4
6596502|NCT02016885|7521562|FG001|NOT COMPLETED|Overall Study||4
6596503|NCT02016885|7521563|FG002|NOT COMPLETED|Overall Study||1
6596504|NCT02016885|7521564|FG003|NOT COMPLETED|Overall Study||10
6596505|NCT02016885|7521565|FG004|NOT COMPLETED|Overall Study||1
6596506|NCT02016898|7521579|FG000|STARTED|Overall Study||50
6596507|NCT02016898|7521580|FG001|STARTED|Overall Study||45
6596508|NCT02016898|7521579|FG000|COMPLETED|Overall Study||45
6596509|NCT02016898|7521580|FG001|COMPLETED|Overall Study||40
6596510|NCT02016898|7521579|FG000|NOT COMPLETED|Overall Study||5
6596511|NCT02016898|7521580|FG001|NOT COMPLETED|Overall Study||5
6596512|NCT02016963|7521586|FG000|STARTED|Overall Study||20
6596513|NCT02016963|7521586|FG000|COMPLETED|Overall Study||20
6596514|NCT02016963|7521586|FG000|NOT COMPLETED|Overall Study||0
6596515|NCT02017015|7521591|FG000|STARTED|Overall Study||83
6596516|NCT02017015|7521591|FG000|Safety Population|Overall Study||83
6596517|NCT02017015|7521591|FG000|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
6596518|NCT02017015|7521591|FG000|NOT COMPLETED|Overall Study||69
6596519|NCT02017093|7521598|FG000|STARTED|Overall Study||4
6596520|NCT02017093|7521599|FG001|STARTED|Overall Study||3
6596521|NCT02017093|7521598|FG000|COMPLETED|Overall Study||4
6596522|NCT02017093|7521599|FG001|COMPLETED|Overall Study||3
6596523|NCT02017093|7521598|FG000|NOT COMPLETED|Overall Study||0
6596524|NCT02017093|7521599|FG001|NOT COMPLETED|Overall Study||0
6596525|NCT02017171|7521609|FG000|STARTED|Overall Study||267
6596526|NCT02017171|7521610|FG001|STARTED|Overall Study||263
6596527|NCT02017171|7521609|FG000|COMPLETED|Overall Study||205
6596528|NCT02017171|7521610|FG001|COMPLETED|Overall Study||217
6596529|NCT02017171|7521609|FG000|NOT COMPLETED|Overall Study||62
6596530|NCT02017171|7521610|FG001|NOT COMPLETED|Overall Study||46
6596531|NCT02017210|7521620|FG000|STARTED|Overall Study||17
6596532|NCT02017210|7521621|FG001|STARTED|Overall Study||20
6596533|NCT02017210|7521622|FG002|STARTED|Overall Study||20
6596534|NCT02017210|7521620|FG000|COMPLETED|Overall Study||17
6596535|NCT02017210|7521621|FG001|COMPLETED|Overall Study||20
6596536|NCT02017210|7521622|FG002|COMPLETED|Overall Study||20
6596537|NCT02017210|7521620|FG000|NOT COMPLETED|Overall Study||0
6596538|NCT02017210|7521621|FG001|NOT COMPLETED|Overall Study||0
6596539|NCT02017210|7521622|FG002|NOT COMPLETED|Overall Study||0
6596540|NCT02017223|7521633|FG000|STARTED|Overall Study||12
6596541|NCT02017223|7521633|FG000|COMPLETED|Overall Study||10
6596542|NCT02017223|7521633|FG000|NOT COMPLETED|Overall Study||2
6596543|NCT02017327|7521640|FG000|STARTED|Overall Study||122
6596544|NCT02017327|7521641|FG001|STARTED|Overall Study||125
6596545|NCT02017327|7521642|FG002|STARTED|Overall Study||132
6596546|NCT02017327|7521640|FG000|COMPLETED|Overall Study||106
6596547|NCT02017327|7521641|FG001|COMPLETED|Overall Study||113
6596548|NCT02017327|7521642|FG002|COMPLETED|Overall Study||117
6596549|NCT02017327|7521640|FG000|NOT COMPLETED|Overall Study||16
6596550|NCT02017327|7521641|FG001|NOT COMPLETED|Overall Study||12
6596551|NCT02017327|7521642|FG002|NOT COMPLETED|Overall Study||15
6596552|NCT02017444|7521652|FG000|STARTED|Overall Study||14
6596553|NCT02017444|7521653|FG001|STARTED|Overall Study||17
6596554|NCT02017444|7521652|FG000|COMPLETED|Overall Study||12
6596555|NCT02017444|7521653|FG001|COMPLETED|Overall Study|NB: One participant did not complete primary outcome.|17
6596556|NCT02017444|7521652|FG000|NOT COMPLETED|Overall Study||2
6596557|NCT02017444|7521653|FG001|NOT COMPLETED|Overall Study||0
6596558|NCT02017535|7521663|FG000|STARTED|Overall Study||9
6596559|NCT02017535|7521664|FG001|STARTED|Overall Study||3
6596560|NCT02017535|7521665|FG002|STARTED|Overall Study||2
6596561|NCT02017535|7521666|FG003|STARTED|Overall Study||1
6596562|NCT02017535|7521663|FG000|COMPLETED|Overall Study||8
6596563|NCT02017535|7521664|FG001|COMPLETED|Overall Study||3
6596564|NCT02017535|7521665|FG002|COMPLETED|Overall Study||2
6596565|NCT02017535|7521666|FG003|COMPLETED|Overall Study||1
6596566|NCT02017535|7521663|FG000|NOT COMPLETED|Overall Study||1
6596567|NCT02017535|7521664|FG001|NOT COMPLETED|Overall Study||0
6596568|NCT02017535|7521665|FG002|NOT COMPLETED|Overall Study||0
6596569|NCT02017535|7521666|FG003|NOT COMPLETED|Overall Study||0
6596570|NCT02017574|7521678|FG000|STARTED|Overall Study||12
6596571|NCT02017574|7521679|FG001|STARTED|Overall Study||12
6596572|NCT02017574|7521678|FG000|COMPLETED|Overall Study||12
6596573|NCT02017574|7521679|FG001|COMPLETED|Overall Study||12
6596574|NCT02017574|7521678|FG000|NOT COMPLETED|Overall Study||0
6596575|NCT02017574|7521679|FG001|NOT COMPLETED|Overall Study||0
6596576|NCT02017860|7521685|FG000|STARTED|Overall Study||4
6596577|NCT02017860|7521685|FG000|COMPLETED|Overall Study||2
6596578|NCT02017860|7521685|FG000|NOT COMPLETED|Overall Study||2
6660539|NCT02499497|7591477|FG000|STARTED|Overall Study||36
6660540|NCT02499497|7591478|FG001|STARTED|Overall Study||28
6660541|NCT02499497|7591479|FG002|STARTED|Overall Study||36
6660542|NCT02499497|7591480|FG003|STARTED|Overall Study||14
6660543|NCT02499497|7591477|FG000|COMPLETED|Overall Study||32
6660544|NCT02499497|7591478|FG001|COMPLETED|Overall Study||22
6660545|NCT02499497|7591479|FG002|COMPLETED|Overall Study||35
6660546|NCT02499497|7591480|FG003|COMPLETED|Overall Study||13
6660547|NCT02499497|7591477|FG000|NOT COMPLETED|Overall Study||4
6660548|NCT02499497|7591478|FG001|NOT COMPLETED|Overall Study||6
6660549|NCT02499497|7591479|FG002|NOT COMPLETED|Overall Study||1
6660550|NCT02499497|7591480|FG003|NOT COMPLETED|Overall Study||1
6660551|NCT02499575|7591492|FG000|STARTED|Overall Study||1
6660552|NCT02499575|7591493|FG001|STARTED|Overall Study||1
6660553|NCT02499575|7591492|FG000|COMPLETED|Overall Study||1
6660554|NCT02499575|7591493|FG001|COMPLETED|Overall Study||0
6660555|NCT02499575|7591492|FG000|NOT COMPLETED|Overall Study||0
6660556|NCT02499575|7591493|FG001|NOT COMPLETED|Overall Study||1
6660557|NCT02499692|7591499|FG000|STARTED|Overall Study||103
6660558|NCT02499692|7591499|FG000|COMPLETED|Overall Study||103
6660559|NCT02499692|7591499|FG000|NOT COMPLETED|Overall Study||0
6660560|NCT02499770|7591505|FG000|STARTED|Overall Study||19
6660561|NCT02499770|7591506|FG001|STARTED|Overall Study||77
6660562|NCT02499770|7591505|FG000|COMPLETED|Overall Study||0
6660563|NCT02499770|7591506|FG001|COMPLETED|Overall Study||0
6660564|NCT02499770|7591505|FG000|NOT COMPLETED|Overall Study||19
6660565|NCT02499770|7591506|FG001|NOT COMPLETED|Overall Study||77
6660566|NCT02499783|7591520|FG000|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||102
6660567|NCT02499783|7591521|FG001|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||103
6660568|NCT02499783|7591522|FG002|STARTED|DB Period/Placebo-Controlled: Weeks 0-4||0
6660569|NCT02499783|7591520|FG000|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
6660570|NCT02499783|7591521|FG001|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||98
6660571|NCT02499783|7591522|FG002|COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
6660572|NCT02499783|7591520|FG000|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||4
6660573|NCT02499783|7591521|FG001|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||5
6660574|NCT02499783|7591522|FG002|NOT COMPLETED|DB Period/Placebo-Controlled: Weeks 0-4||0
6660575|NCT02499783|7591520|FG000|STARTED|DB Period: Weeks 0-8||102
6660576|NCT02499783|7591521|FG001|STARTED|DB Period: Weeks 0-8||103
6660577|NCT02499783|7591522|FG002|STARTED|DB Period: Weeks 0-8||0
6660578|NCT02499783|7591520|FG000|COMPLETED|DB Period: Weeks 0-8||92
6660579|NCT02499783|7591521|FG001|COMPLETED|DB Period: Weeks 0-8||96
6596579|NCT02017899|7521695|FG000|STARTED|Overall Study||8
6596580|NCT02017899|7521696|FG001|STARTED|Overall Study||9
6596581|NCT02017899|7521697|FG002|STARTED|Overall Study||8
6596582|NCT02017899|7521698|FG003|STARTED|Overall Study||8
6596583|NCT02017899|7521699|FG004|STARTED|Overall Study||9
6596584|NCT02017899|7521700|FG005|STARTED|Overall Study||8
6596585|NCT02017899|7521695|FG000|COMPLETED|Overall Study||8
6596586|NCT02017899|7521696|FG001|COMPLETED|Overall Study||9
6596587|NCT02017899|7521697|FG002|COMPLETED|Overall Study||8
6596588|NCT02017899|7521698|FG003|COMPLETED|Overall Study||7
6596589|NCT02017899|7521699|FG004|COMPLETED|Overall Study||8
6596590|NCT02017899|7521700|FG005|COMPLETED|Overall Study||8
6596591|NCT02017899|7521695|FG000|NOT COMPLETED|Overall Study||0
6596592|NCT02017899|7521696|FG001|NOT COMPLETED|Overall Study||0
6596593|NCT02017899|7521697|FG002|NOT COMPLETED|Overall Study||0
6596594|NCT02017899|7521698|FG003|NOT COMPLETED|Overall Study||1
6596595|NCT02017899|7521699|FG004|NOT COMPLETED|Overall Study||1
6596596|NCT02017899|7521700|FG005|NOT COMPLETED|Overall Study||0
6596597|NCT02018042|7521714|FG000|STARTED|Overall Study||15
6596598|NCT02018042|7521714|FG000|COMPLETED|Overall Study||14
6596599|NCT02018042|7521714|FG000|NOT COMPLETED|Overall Study||1
6596600|NCT02018107|7521718|FG000|STARTED|Overall Study||27
6596601|NCT02018107|7521718|FG000|COMPLETED|Overall Study||27
6596602|NCT02018107|7521718|FG000|NOT COMPLETED|Overall Study||0
6624727|NCT02219464|7552239|FG000|COMPLETED|Overall Study||27
6624728|NCT02219464|7552240|FG001|COMPLETED|Overall Study||30
6624729|NCT02219464|7552239|FG000|NOT COMPLETED|Overall Study||3
6624730|NCT02219464|7552240|FG001|NOT COMPLETED|Overall Study||0
6624731|NCT02219477|7552249|FG000|STARTED|Overall Study||9
6624732|NCT02219477|7552250|FG001|STARTED|Overall Study||24
6660580|NCT02499783|7591522|FG002|COMPLETED|DB Period: Weeks 0-8||0
6660581|NCT02499783|7591520|FG000|NOT COMPLETED|DB Period: Weeks 0-8||10
6660582|NCT02499783|7591521|FG001|NOT COMPLETED|DB Period: Weeks 0-8||7
6624733|NCT02219477|7552251|FG002|STARTED|Overall Study||3
6624734|NCT02219477|7552249|FG000|COMPLETED|Overall Study||9
6624735|NCT02219477|7552250|FG001|COMPLETED|Overall Study||22
6624736|NCT02219477|7552251|FG002|COMPLETED|Overall Study||2
6624737|NCT02219477|7552249|FG000|NOT COMPLETED|Overall Study||0
6624738|NCT02219477|7552250|FG001|NOT COMPLETED|Overall Study||2
6624739|NCT02219477|7552251|FG002|NOT COMPLETED|Overall Study||1
6624740|NCT02219503|7552260|FG000|STARTED|Overall Study||60
6624741|NCT02219503|7552260|FG000|COMPLETED|Overall Study||60
6624742|NCT02219503|7552260|FG000|NOT COMPLETED|Overall Study||0
6624743|NCT02219516|7552268|FG000|STARTED|Overall Study||8
6624744|NCT02219516|7552269|FG001|STARTED|Overall Study||8
6624745|NCT02219516|7552270|FG002|STARTED|Overall Study||7
6624746|NCT02219516|7552271|FG003|STARTED|Overall Study||8
6624747|NCT02219516|7552268|FG000|COMPLETED|Overall Study||8
6624748|NCT02219516|7552269|FG001|COMPLETED|Overall Study||8
6624749|NCT02219516|7552270|FG002|COMPLETED|Overall Study||7
6624750|NCT02219516|7552271|FG003|COMPLETED|Overall Study||8
6624751|NCT02219516|7552268|FG000|NOT COMPLETED|Overall Study||0
6624752|NCT02219516|7552269|FG001|NOT COMPLETED|Overall Study||0
6624753|NCT02219516|7552270|FG002|NOT COMPLETED|Overall Study||0
6624754|NCT02219516|7552271|FG003|NOT COMPLETED|Overall Study||0
6624755|NCT02219685|7552283|FG000|STARTED|Blinded Treatment Phase||26
6624756|NCT02219685|7552284|FG001|STARTED|Blinded Treatment Phase||14
6624757|NCT02219685|7552283|FG000|COMPLETED|Blinded Treatment Phase||24
6624758|NCT02219685|7552284|FG001|COMPLETED|Blinded Treatment Phase||14
6624759|NCT02219685|7552283|FG000|NOT COMPLETED|Blinded Treatment Phase||2
6624760|NCT02219685|7552284|FG001|NOT COMPLETED|Blinded Treatment Phase||0
6624761|NCT02219685|7552283|FG000|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
6660583|NCT02499783|7591522|FG002|NOT COMPLETED|DB Period: Weeks 0-8||0
6660584|NCT02499783|7591520|FG000|STARTED|Open Label Period: Weeks 8 to 26||0
6624762|NCT02219685|7552284|FG001|STARTED|Open-Label (After Posttreatment Week 4)||14
6624763|NCT02219685|7552283|FG000|COMPLETED|Open-Label (After Posttreatment Week 4)||0
6624764|NCT02219685|7552284|FG001|COMPLETED|Open-Label (After Posttreatment Week 4)||14
6624765|NCT02219685|7552283|FG000|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
6624766|NCT02219685|7552284|FG001|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
6624767|NCT02219815|7552294|FG000|STARTED|Overall Study||44
6624768|NCT02219815|7552295|FG001|STARTED|Overall Study||45
6624769|NCT02219815|7552294|FG000|Post Hospital Discharge Analysis|Overall Study||42
6624770|NCT02219815|7552295|FG001|Post Hospital Discharge Analysis|Overall Study||39
6624771|NCT02219815|7552294|FG000|3 Month Post Surgery|Overall Study||34
6624772|NCT02219815|7552295|FG001|3 Month Post Surgery|Overall Study||31
6624773|NCT02219815|7552294|FG000|COMPLETED|Overall Study||22
6624774|NCT02219815|7552295|FG001|COMPLETED|Overall Study||21
6624775|NCT02219815|7552294|FG000|NOT COMPLETED|Overall Study||22
6624776|NCT02219815|7552295|FG001|NOT COMPLETED|Overall Study||24
6624777|NCT02219932|7552303|FG000|STARTED|Overall Study||319
6596603|NCT02018315|7521722|FG000|STARTED|Overall Study||14
6596604|NCT02018315|7521722|FG000|COMPLETED|Overall Study||14
6596605|NCT02018315|7521722|FG000|NOT COMPLETED|Overall Study||0
6596606|NCT02018445|7521726|FG000|STARTED|Overall Study||36
6596607|NCT02018445|7521726|FG000|COMPLETED|Overall Study||29
6596608|NCT02018445|7521726|FG000|NOT COMPLETED|Overall Study||7
6596609|NCT02018458|7521733|FG000|STARTED|Overall Study||10
6596610|NCT02018458|7521733|FG000|COMPLETED|Overall Study||6
6596611|NCT02018458|7521733|FG000|NOT COMPLETED|Overall Study||4
6596612|NCT02018562|7521739|FG000|STARTED|Overall Study||25
6596613|NCT02018562|7521740|FG001|STARTED|Overall Study||25
6596614|NCT02018562|7521739|FG000|COMPLETED|Overall Study||22
6596615|NCT02018562|7521740|FG001|COMPLETED|Overall Study||25
6596616|NCT02018562|7521739|FG000|NOT COMPLETED|Overall Study||3
6596617|NCT02018562|7521740|FG001|NOT COMPLETED|Overall Study||0
6596618|NCT02018627|7521748|FG000|STARTED|Overall Study||7
6596619|NCT02018627|7521749|FG001|STARTED|Overall Study||6
6596620|NCT02018627|7521748|FG000|COMPLETED|Overall Study||7
6596621|NCT02018627|7521749|FG001|COMPLETED|Overall Study||6
6596622|NCT02018627|7521748|FG000|NOT COMPLETED|Overall Study||0
6596623|NCT02018627|7521749|FG001|NOT COMPLETED|Overall Study||0
6596624|NCT02018653|7521757|FG000|STARTED|Overall Study||1
6596625|NCT02018653|7521758|FG001|STARTED|Overall Study||1
6596626|NCT02018653|7521757|FG000|COMPLETED|Overall Study||1
6596627|NCT02018653|7521758|FG001|COMPLETED|Overall Study||0
6596628|NCT02018653|7521757|FG000|NOT COMPLETED|Overall Study||0
6596629|NCT02018653|7521758|FG001|NOT COMPLETED|Overall Study||1
6596630|NCT02018809|7521768|FG000|STARTED|Overall Study||50
6596631|NCT02018809|7521769|FG001|STARTED|Overall Study||50
6596632|NCT02018809|7521770|FG002|STARTED|Overall Study||50
6596633|NCT02018809|7521771|FG003|STARTED|Overall Study||50
6596634|NCT02018809|7521768|FG000|COMPLETED|Overall Study||50
6596635|NCT02018809|7521769|FG001|COMPLETED|Overall Study||50
6596636|NCT02018809|7521770|FG002|COMPLETED|Overall Study||50
6596637|NCT02018809|7521771|FG003|COMPLETED|Overall Study||50
6596638|NCT02018809|7521768|FG000|NOT COMPLETED|Overall Study||0
6596639|NCT02018809|7521769|FG001|NOT COMPLETED|Overall Study||0
6596640|NCT02018809|7521770|FG002|NOT COMPLETED|Overall Study||0
6596641|NCT02018809|7521771|FG003|NOT COMPLETED|Overall Study||0
6596642|NCT02018822|7521783|FG000|STARTED|Overall Study||50
6596643|NCT02018822|7521784|FG001|STARTED|Overall Study||50
6596644|NCT02018822|7521785|FG002|STARTED|Overall Study||35
6596645|NCT02018822|7521783|FG000|COMPLETED|Overall Study||44
6596646|NCT02018822|7521784|FG001|COMPLETED|Overall Study||42
6596647|NCT02018822|7521785|FG002|COMPLETED|Overall Study||29
6596648|NCT02018822|7521783|FG000|NOT COMPLETED|Overall Study||6
6596649|NCT02018822|7521784|FG001|NOT COMPLETED|Overall Study||8
6596650|NCT02018822|7521785|FG002|NOT COMPLETED|Overall Study||6
6596651|NCT02018887|7521804|FG000|STARTED|Part A: Cohorts 1-2: Period 1||9
6596652|NCT02018887|7521805|FG001|STARTED|Part A: Cohorts 1-2: Period 1||9
6596653|NCT02018887|7521806|FG002|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
6596654|NCT02018887|7521807|FG003|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6596655|NCT02018887|7521808|FG004|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6596656|NCT02018887|7521809|FG005|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6596657|NCT02018887|7521810|FG006|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6596658|NCT02018887|7521811|FG007|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6596659|NCT02018887|7521812|FG008|STARTED|Part A: Cohorts 1-2: Period 1|Placebo was not administered in this period.|0
6596660|NCT02018887|7521813|FG009|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6596661|NCT02018887|7521814|FG010|STARTED|Part A: Cohorts 1-2: Period 1|This dose was not administered in this period.|0
6596662|NCT02018887|7521804|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
6596663|NCT02018887|7521805|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||9
6596664|NCT02018887|7521806|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596665|NCT02018887|7521807|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596666|NCT02018887|7521808|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596667|NCT02018887|7521809|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596668|NCT02018887|7521810|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596669|NCT02018887|7521811|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596670|NCT02018887|7521812|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596671|NCT02018887|7521813|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596672|NCT02018887|7521814|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 1||0
6596673|NCT02018887|7521804|FG000|COMPLETED|Part A: Cohorts 1-2: Period 1||9
6596674|NCT02018887|7521805|FG001|COMPLETED|Part A: Cohorts 1-2: Period 1||9
6596675|NCT02018887|7521806|FG002|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596676|NCT02018887|7521807|FG003|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596677|NCT02018887|7521808|FG004|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596678|NCT02018887|7521809|FG005|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596679|NCT02018887|7521810|FG006|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596680|NCT02018887|7521811|FG007|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596681|NCT02018887|7521812|FG008|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596682|NCT02018887|7521813|FG009|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596683|NCT02018887|7521814|FG010|COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596684|NCT02018887|7521804|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596685|NCT02018887|7521805|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596686|NCT02018887|7521806|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596687|NCT02018887|7521807|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596688|NCT02018887|7521808|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596689|NCT02018887|7521809|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596690|NCT02018887|7521810|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596691|NCT02018887|7521811|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596692|NCT02018887|7521812|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596693|NCT02018887|7521813|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596694|NCT02018887|7521814|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 1||0
6596695|NCT02018887|7521804|FG000|STARTED|Part A: Cohorts 1-2: Period 2||9
6596696|NCT02018887|7521805|FG001|STARTED|Part A: Cohorts 1-2: Period 2||9
6596697|NCT02018887|7521806|FG002|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
6596698|NCT02018887|7521807|FG003|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6596699|NCT02018887|7521808|FG004|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6596700|NCT02018887|7521809|FG005|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6596701|NCT02018887|7521810|FG006|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6596702|NCT02018887|7521811|FG007|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6596703|NCT02018887|7521812|FG008|STARTED|Part A: Cohorts 1-2: Period 2|Placebo was not administered in this period.|0
6596704|NCT02018887|7521813|FG009|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6596705|NCT02018887|7521814|FG010|STARTED|Part A: Cohorts 1-2: Period 2|This dose was not administered in this period.|0
6596706|NCT02018887|7521804|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
6596707|NCT02018887|7521805|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||9
6596708|NCT02018887|7521806|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6624778|NCT02219932|7552304|FG001|STARTED|Overall Study||317
6660585|NCT02499783|7591521|FG001|STARTED|Open Label Period: Weeks 8 to 26||0
6660586|NCT02499783|7591522|FG002|STARTED|Open Label Period: Weeks 8 to 26||188
6660587|NCT02499783|7591520|FG000|COMPLETED|Open Label Period: Weeks 8 to 26||0
6660588|NCT02499783|7591521|FG001|COMPLETED|Open Label Period: Weeks 8 to 26||0
6660589|NCT02499783|7591522|FG002|COMPLETED|Open Label Period: Weeks 8 to 26||159
6660590|NCT02499783|7591520|FG000|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
6660591|NCT02499783|7591521|FG001|NOT COMPLETED|Open Label Period: Weeks 8 to 26||0
6660592|NCT02499783|7591522|FG002|NOT COMPLETED|Open Label Period: Weeks 8 to 26||29
6660593|NCT02499952|7591532|FG000|STARTED|Overall Study||12
6660594|NCT02499952|7591532|FG000|COMPLETED|Overall Study||2
6660595|NCT02499952|7591532|FG000|NOT COMPLETED|Overall Study||10
6660596|NCT02500043|7591538|FG000|STARTED|Overall Study||337
6660597|NCT02500043|7591539|FG001|STARTED|Overall Study||170
6660598|NCT02500043|7591538|FG000|As-Treated (AT) Population|Overall Study||335
6660599|NCT02500043|7591539|FG001|As-Treated (AT) Population|Overall Study||168
6660600|NCT02500043|7591538|FG000|COMPLETED|Overall Study||0
6660601|NCT02500043|7591539|FG001|COMPLETED|Overall Study||0
6660602|NCT02500043|7591538|FG000|NOT COMPLETED|Overall Study||337
6660603|NCT02500043|7591539|FG001|NOT COMPLETED|Overall Study||170
6660604|NCT02500056|7591547|FG000|STARTED|Overall Study||70
6660605|NCT02500056|7591548|FG001|STARTED|Overall Study||73
6660606|NCT02500056|7591547|FG000|COMPLETED|Overall Study||63
6660607|NCT02500056|7591548|FG001|COMPLETED|Overall Study||65
6660608|NCT02500056|7591547|FG000|NOT COMPLETED|Overall Study||7
6660609|NCT02500056|7591548|FG001|NOT COMPLETED|Overall Study||8
6660610|NCT02500368|7591554|FG000|STARTED|First Intervention (1 Week)||20
6660611|NCT02500368|7591555|FG001|STARTED|First Intervention (1 Week)||20
6660612|NCT02500368|7591554|FG000|COMPLETED|First Intervention (1 Week)||20
6660613|NCT02500368|7591555|FG001|COMPLETED|First Intervention (1 Week)||20
6660614|NCT02500368|7591554|FG000|NOT COMPLETED|First Intervention (1 Week)||0
6660615|NCT02500368|7591555|FG001|NOT COMPLETED|First Intervention (1 Week)||0
6660616|NCT02500368|7591554|FG000|STARTED|Second Intervention (1 Week)||20
6660617|NCT02500368|7591555|FG001|STARTED|Second Intervention (1 Week)||20
6660618|NCT02500368|7591554|FG000|COMPLETED|Second Intervention (1 Week)||20
6660619|NCT02500368|7591555|FG001|COMPLETED|Second Intervention (1 Week)||20
6660620|NCT02500368|7591554|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6660621|NCT02500368|7591555|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6660622|NCT02500537|7591563|FG000|STARTED|Overall Study||60
6660623|NCT02500537|7591564|FG001|STARTED|Overall Study||40
6660624|NCT02500537|7591563|FG000|COMPLETED|Overall Study||57
6660625|NCT02500537|7591564|FG001|COMPLETED|Overall Study||39
6660626|NCT02500537|7591563|FG000|NOT COMPLETED|Overall Study||3
6660627|NCT02500537|7591564|FG001|NOT COMPLETED|Overall Study||1
6660628|NCT02500550|7591571|FG000|STARTED|Overall Study||15
6660629|NCT02500550|7591571|FG000|COMPLETED|Overall Study||8
6660630|NCT02500550|7591571|FG000|NOT COMPLETED|Overall Study||7
6660631|NCT02500602|7591577|FG000|STARTED|Treatment Phase||74
6660632|NCT02500602|7591578|FG001|STARTED|Treatment Phase||70
6660633|NCT02500602|7591577|FG000|COMPLETED|Treatment Phase||68
6660634|NCT02500602|7591578|FG001|COMPLETED|Treatment Phase||69
6660635|NCT02500602|7591577|FG000|NOT COMPLETED|Treatment Phase||6
6596709|NCT02018887|7521807|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6596710|NCT02018887|7521808|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6596711|NCT02018887|7521809|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6596712|NCT02018887|7521810|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6596713|NCT02018887|7521811|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6596714|NCT02018887|7521812|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6596715|NCT02018887|7521813|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6596716|NCT02018887|7521814|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 2||0
6596717|NCT02018887|7521804|FG000|COMPLETED|Part A: Cohorts 1-2: Period 2||9
6596718|NCT02018887|7521805|FG001|COMPLETED|Part A: Cohorts 1-2: Period 2||9
6660636|NCT02500602|7591578|FG001|NOT COMPLETED|Treatment Phase||1
6660637|NCT02500602|7591577|FG000|STARTED|Follow Up Phase||68
6660638|NCT02500602|7591578|FG001|STARTED|Follow Up Phase||69
6660639|NCT02500602|7591577|FG000|COMPLETED|Follow Up Phase||53
6660640|NCT02500602|7591578|FG001|COMPLETED|Follow Up Phase||47
6660641|NCT02500602|7591577|FG000|NOT COMPLETED|Follow Up Phase||15
6660642|NCT02500602|7591578|FG001|NOT COMPLETED|Follow Up Phase||22
6660643|NCT02500628|7591588|FG000|STARTED|Overall Study||38
6660644|NCT02500628|7591589|FG001|STARTED|Overall Study||23
6660645|NCT02500628|7591588|FG000|COMPLETED|Overall Study||38
6660646|NCT02500628|7591589|FG001|COMPLETED|Overall Study||23
6660647|NCT02500628|7591588|FG000|NOT COMPLETED|Overall Study||0
6660648|NCT02500628|7591589|FG001|NOT COMPLETED|Overall Study||0
6660649|NCT02500641|7591599|FG000|STARTED|Overall Study||98
6660650|NCT02500641|7591600|FG001|STARTED|Overall Study||98
6660651|NCT02500641|7591599|FG000|COMPLETED|Overall Study||88
6660652|NCT02500641|7591600|FG001|COMPLETED|Overall Study||86
6660653|NCT02500641|7591599|FG000|NOT COMPLETED|Overall Study||10
6660654|NCT02500641|7591600|FG001|NOT COMPLETED|Overall Study||12
6660655|NCT02500706|7591609|FG000|STARTED|Overall Study||342
6660656|NCT02500706|7591610|FG001|STARTED|Overall Study||341
6660657|NCT02500706|7591611|FG002|STARTED|Overall Study||342
6660658|NCT02500706|7591609|FG000|Exposed|Overall Study||342
6660659|NCT02500706|7591610|FG001|Exposed|Overall Study||341
6660660|NCT02500706|7591611|FG002|Exposed|Overall Study||342
6660661|NCT02500706|7591609|FG000|COMPLETED|Overall Study||338
6660662|NCT02500706|7591610|FG001|COMPLETED|Overall Study||334
6660663|NCT02500706|7591611|FG002|COMPLETED|Overall Study||335
6660664|NCT02500706|7591609|FG000|NOT COMPLETED|Overall Study||4
6660665|NCT02500706|7591610|FG001|NOT COMPLETED|Overall Study||7
6660666|NCT02500706|7591611|FG002|NOT COMPLETED|Overall Study||7
6660667|NCT02500719|7591621|FG000|STARTED|Overall Study||14
6660668|NCT02500719|7591622|FG001|STARTED|Overall Study||16
6660669|NCT02500719|7591621|FG000|COMPLETED|Overall Study||11
6660670|NCT02500719|7591622|FG001|COMPLETED|Overall Study||9
6660671|NCT02500719|7591621|FG000|NOT COMPLETED|Overall Study||3
6660672|NCT02500719|7591622|FG001|NOT COMPLETED|Overall Study||7
6660673|NCT02500732|7591630|FG000|STARTED|Overall Study||27
6660674|NCT02500732|7591631|FG001|STARTED|Overall Study||30
6660675|NCT02500732|7591630|FG000|COMPLETED|Overall Study||27
6660676|NCT02500732|7591631|FG001|COMPLETED|Overall Study|Not true event in 1 participant (pseudosyncope)|29
6660677|NCT02500732|7591630|FG000|NOT COMPLETED|Overall Study||0
6660678|NCT02500732|7591631|FG001|NOT COMPLETED|Overall Study||1
6660679|NCT02500758|7591639|FG000|STARTED|First Intervention (2 Minutes)||15
6660680|NCT02500758|7591640|FG001|STARTED|First Intervention (2 Minutes)||15
6660681|NCT02500758|7591639|FG000|COMPLETED|First Intervention (2 Minutes)||15
6660682|NCT02500758|7591640|FG001|COMPLETED|First Intervention (2 Minutes)||14
6660683|NCT02500758|7591639|FG000|NOT COMPLETED|First Intervention (2 Minutes)||0
6660684|NCT02500758|7591640|FG001|NOT COMPLETED|First Intervention (2 Minutes)||1
6660685|NCT02500758|7591639|FG000|STARTED|Washout (1 Week)||15
6660686|NCT02500758|7591640|FG001|STARTED|Washout (1 Week)||14
6660687|NCT02500758|7591639|FG000|COMPLETED|Washout (1 Week)||13
6660688|NCT02500758|7591640|FG001|COMPLETED|Washout (1 Week)||12
6660689|NCT02500758|7591639|FG000|NOT COMPLETED|Washout (1 Week)||2
6660690|NCT02500758|7591640|FG001|NOT COMPLETED|Washout (1 Week)||2
6660691|NCT02500758|7591639|FG000|STARTED|Second Intervention (2 Minutes)||13
6660692|NCT02500758|7591640|FG001|STARTED|Second Intervention (2 Minutes)||12
6660693|NCT02500758|7591639|FG000|COMPLETED|Second Intervention (2 Minutes)||10
6660694|NCT02500758|7591640|FG001|COMPLETED|Second Intervention (2 Minutes)||10
6660695|NCT02500758|7591639|FG000|NOT COMPLETED|Second Intervention (2 Minutes)||3
6660696|NCT02500758|7591640|FG001|NOT COMPLETED|Second Intervention (2 Minutes)||2
6660697|NCT02500836|7591650|FG000|STARTED|Overall Study||259
6660698|NCT02500836|7591651|FG001|STARTED|Overall Study||259
6660699|NCT02500836|7591652|FG002|STARTED|Overall Study||128
6660700|NCT02500836|7591650|FG000|COMPLETED|Overall Study||256
6660701|NCT02500836|7591651|FG001|COMPLETED|Overall Study||254
6660702|NCT02500836|7591652|FG002|COMPLETED|Overall Study||127
6660703|NCT02500836|7591650|FG000|NOT COMPLETED|Overall Study||3
6660704|NCT02500836|7591651|FG001|NOT COMPLETED|Overall Study||5
6660705|NCT02500836|7591652|FG002|NOT COMPLETED|Overall Study||1
6660706|NCT02500979|7591662|FG000|STARTED|Period 1||16
6660707|NCT02500979|7591663|FG001|STARTED|Period 1||17
6660708|NCT02500979|7591662|FG000|COMPLETED|Period 1||12
6660709|NCT02500979|7591663|FG001|COMPLETED|Period 1||16
6660710|NCT02500979|7591662|FG000|NOT COMPLETED|Period 1||4
6660711|NCT02500979|7591663|FG001|NOT COMPLETED|Period 1||1
6660712|NCT02500979|7591662|FG000|STARTED|Period 2||12
6596719|NCT02018887|7521806|FG002|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596720|NCT02018887|7521807|FG003|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596721|NCT02018887|7521808|FG004|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596722|NCT02018887|7521809|FG005|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596723|NCT02018887|7521810|FG006|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596724|NCT02018887|7521811|FG007|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596725|NCT02018887|7521812|FG008|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596726|NCT02018887|7521813|FG009|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596727|NCT02018887|7521814|FG010|COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596728|NCT02018887|7521804|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596729|NCT02018887|7521805|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596730|NCT02018887|7521806|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596731|NCT02018887|7521807|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596732|NCT02018887|7521808|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596733|NCT02018887|7521809|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596734|NCT02018887|7521810|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596735|NCT02018887|7521811|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596736|NCT02018887|7521812|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596737|NCT02018887|7521813|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596738|NCT02018887|7521814|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 2||0
6596739|NCT02018887|7521804|FG000|STARTED|Part A: Cohorts 1-2: Period 3||9
6596740|NCT02018887|7521805|FG001|STARTED|Part A: Cohorts 1-2: Period 3||9
6596741|NCT02018887|7521806|FG002|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
6596742|NCT02018887|7521807|FG003|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6596743|NCT02018887|7521808|FG004|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6596744|NCT02018887|7521809|FG005|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6596745|NCT02018887|7521810|FG006|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6596746|NCT02018887|7521811|FG007|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6596747|NCT02018887|7521812|FG008|STARTED|Part A: Cohorts 1-2: Period 3|Placebo was not administered in this period.|0
6596748|NCT02018887|7521813|FG009|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6596749|NCT02018887|7521814|FG010|STARTED|Part A: Cohorts 1-2: Period 3|This dose was not administered in this period.|0
6596750|NCT02018887|7521804|FG000|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||8
6596751|NCT02018887|7521805|FG001|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||9
6596752|NCT02018887|7521806|FG002|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596753|NCT02018887|7521807|FG003|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596754|NCT02018887|7521808|FG004|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596755|NCT02018887|7521809|FG005|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596756|NCT02018887|7521810|FG006|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596757|NCT02018887|7521811|FG007|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596758|NCT02018887|7521812|FG008|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596759|NCT02018887|7521813|FG009|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596760|NCT02018887|7521814|FG010|Received One Dose of Study Drug|Part A: Cohorts 1-2: Period 3||0
6596761|NCT02018887|7521804|FG000|COMPLETED|Part A: Cohorts 1-2: Period 3||8
6596762|NCT02018887|7521805|FG001|COMPLETED|Part A: Cohorts 1-2: Period 3||9
6596763|NCT02018887|7521806|FG002|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596764|NCT02018887|7521807|FG003|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596765|NCT02018887|7521808|FG004|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596766|NCT02018887|7521809|FG005|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596767|NCT02018887|7521810|FG006|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596768|NCT02018887|7521811|FG007|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596769|NCT02018887|7521812|FG008|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596770|NCT02018887|7521813|FG009|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596771|NCT02018887|7521814|FG010|COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596772|NCT02018887|7521804|FG000|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||1
6596773|NCT02018887|7521805|FG001|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596774|NCT02018887|7521806|FG002|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596775|NCT02018887|7521807|FG003|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596776|NCT02018887|7521808|FG004|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596777|NCT02018887|7521809|FG005|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596778|NCT02018887|7521810|FG006|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596779|NCT02018887|7521811|FG007|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596780|NCT02018887|7521812|FG008|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596781|NCT02018887|7521813|FG009|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596782|NCT02018887|7521814|FG010|NOT COMPLETED|Part A: Cohorts 1-2: Period 3||0
6596783|NCT02018887|7521804|FG000|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
6596784|NCT02018887|7521805|FG001|STARTED|Part B: Cohorts 3-7 Overall|Column for Part A data only.|0
6596785|NCT02018887|7521806|FG002|STARTED|Part B: Cohorts 3-7 Overall||15
6596786|NCT02018887|7521807|FG003|STARTED|Part B: Cohorts 3-7 Overall||9
6596787|NCT02018887|7521808|FG004|STARTED|Part B: Cohorts 3-7 Overall||9
6596788|NCT02018887|7521809|FG005|STARTED|Part B: Cohorts 3-7 Overall||9
6596789|NCT02018887|7521810|FG006|STARTED|Part B: Cohorts 3-7 Overall||9
6596790|NCT02018887|7521811|FG007|STARTED|Part B: Cohorts 3-7 Overall||9
6596791|NCT02018887|7521812|FG008|STARTED|Part B: Cohorts 3-7 Overall|Placebo was not administered in this period.|0
6596792|NCT02018887|7521813|FG009|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
6596793|NCT02018887|7521814|FG010|STARTED|Part B: Cohorts 3-7 Overall|This dose was not administered in this period.|0
6596794|NCT02018887|7521804|FG000|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6596795|NCT02018887|7521805|FG001|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6596796|NCT02018887|7521806|FG002|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||15
6596797|NCT02018887|7521807|FG003|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6596798|NCT02018887|7521808|FG004|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6596799|NCT02018887|7521809|FG005|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6596800|NCT02018887|7521810|FG006|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6596801|NCT02018887|7521811|FG007|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||9
6596802|NCT02018887|7521812|FG008|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6596803|NCT02018887|7521813|FG009|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6596804|NCT02018887|7521814|FG010|Received at Least One Dose of Study Drug|Part B: Cohorts 3-7 Overall||0
6596805|NCT02018887|7521804|FG000|COMPLETED|Part B: Cohorts 3-7 Overall||0
6596806|NCT02018887|7521805|FG001|COMPLETED|Part B: Cohorts 3-7 Overall||0
6596807|NCT02018887|7521806|FG002|COMPLETED|Part B: Cohorts 3-7 Overall||15
6596808|NCT02018887|7521807|FG003|COMPLETED|Part B: Cohorts 3-7 Overall||9
6596809|NCT02018887|7521808|FG004|COMPLETED|Part B: Cohorts 3-7 Overall||8
6596810|NCT02018887|7521809|FG005|COMPLETED|Part B: Cohorts 3-7 Overall||9
6596811|NCT02018887|7521810|FG006|COMPLETED|Part B: Cohorts 3-7 Overall||8
6596812|NCT02018887|7521811|FG007|COMPLETED|Part B: Cohorts 3-7 Overall||5
6596813|NCT02018887|7521812|FG008|COMPLETED|Part B: Cohorts 3-7 Overall||0
6596814|NCT02018887|7521813|FG009|COMPLETED|Part B: Cohorts 3-7 Overall||0
6596815|NCT02018887|7521814|FG010|COMPLETED|Part B: Cohorts 3-7 Overall||0
6596816|NCT02018887|7521804|FG000|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6596817|NCT02018887|7521805|FG001|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6596818|NCT02018887|7521806|FG002|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6596819|NCT02018887|7521807|FG003|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6596820|NCT02018887|7521808|FG004|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
6596821|NCT02018887|7521809|FG005|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6596822|NCT02018887|7521810|FG006|NOT COMPLETED|Part B: Cohorts 3-7 Overall||1
6596823|NCT02018887|7521811|FG007|NOT COMPLETED|Part B: Cohorts 3-7 Overall||4
6596824|NCT02018887|7521812|FG008|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6596825|NCT02018887|7521813|FG009|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6596826|NCT02018887|7521814|FG010|NOT COMPLETED|Part B: Cohorts 3-7 Overall||0
6596827|NCT02018887|7521804|FG000|STARTED|Part C: Cohort 8 Overall||0
6596828|NCT02018887|7521805|FG001|STARTED|Part C: Cohort 8 Overall||0
6596829|NCT02018887|7521806|FG002|STARTED|Part C: Cohort 8 Overall|Placebo was not administered in this period.|0
6596830|NCT02018887|7521807|FG003|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6596831|NCT02018887|7521808|FG004|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6596832|NCT02018887|7521809|FG005|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6596833|NCT02018887|7521810|FG006|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6596834|NCT02018887|7521811|FG007|STARTED|Part C: Cohort 8 Overall|This dose was not administered in this period.|0
6596835|NCT02018887|7521812|FG008|STARTED|Part C: Cohort 8 Overall||10
6596836|NCT02018887|7521813|FG009|STARTED|Part C: Cohort 8 Overall||4
6596837|NCT02018887|7521814|FG010|STARTED|Part C: Cohort 8 Overall||7
6596838|NCT02018887|7521804|FG000|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6596839|NCT02018887|7521805|FG001|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6596840|NCT02018887|7521806|FG002|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6596841|NCT02018887|7521807|FG003|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6596842|NCT02018887|7521808|FG004|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6596843|NCT02018887|7521809|FG005|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6596844|NCT02018887|7521810|FG006|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6596845|NCT02018887|7521811|FG007|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||0
6596846|NCT02018887|7521812|FG008|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||10
6596847|NCT02018887|7521813|FG009|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||4
6596848|NCT02018887|7521814|FG010|Received at Least One Dose of Study Drug|Part C: Cohort 8 Overall||7
6596849|NCT02018887|7521804|FG000|COMPLETED|Part C: Cohort 8 Overall||0
6596850|NCT02018887|7521805|FG001|COMPLETED|Part C: Cohort 8 Overall||0
6596851|NCT02018887|7521806|FG002|COMPLETED|Part C: Cohort 8 Overall||0
6596852|NCT02018887|7521807|FG003|COMPLETED|Part C: Cohort 8 Overall||0
6596853|NCT02018887|7521808|FG004|COMPLETED|Part C: Cohort 8 Overall||0
6596854|NCT02018887|7521809|FG005|COMPLETED|Part C: Cohort 8 Overall||0
6596855|NCT02018887|7521810|FG006|COMPLETED|Part C: Cohort 8 Overall||0
6596856|NCT02018887|7521811|FG007|COMPLETED|Part C: Cohort 8 Overall||0
6596857|NCT02018887|7521812|FG008|COMPLETED|Part C: Cohort 8 Overall||7
6596858|NCT02018887|7521813|FG009|COMPLETED|Part C: Cohort 8 Overall||1
6596859|NCT02018887|7521814|FG010|COMPLETED|Part C: Cohort 8 Overall||6
6596860|NCT02018887|7521804|FG000|NOT COMPLETED|Part C: Cohort 8 Overall||0
6596861|NCT02018887|7521805|FG001|NOT COMPLETED|Part C: Cohort 8 Overall||0
6596862|NCT02018887|7521806|FG002|NOT COMPLETED|Part C: Cohort 8 Overall||0
6596863|NCT02018887|7521807|FG003|NOT COMPLETED|Part C: Cohort 8 Overall||0
6596864|NCT02018887|7521808|FG004|NOT COMPLETED|Part C: Cohort 8 Overall||0
6596865|NCT02018887|7521809|FG005|NOT COMPLETED|Part C: Cohort 8 Overall||0
6596866|NCT02018887|7521810|FG006|NOT COMPLETED|Part C: Cohort 8 Overall||0
6596867|NCT02018887|7521811|FG007|NOT COMPLETED|Part C: Cohort 8 Overall||0
6596868|NCT02018887|7521812|FG008|NOT COMPLETED|Part C: Cohort 8 Overall||3
6596869|NCT02018887|7521813|FG009|NOT COMPLETED|Part C: Cohort 8 Overall||3
6596870|NCT02018887|7521814|FG010|NOT COMPLETED|Part C: Cohort 8 Overall||1
6596871|NCT02019069|7521880|FG000|STARTED|Overall Study||11
6596872|NCT02019069|7521880|FG000|COMPLETED|Overall Study||11
6596873|NCT02019069|7521880|FG000|NOT COMPLETED|Overall Study||0
6596874|NCT02019108|7521886|FG000|STARTED|Overall Study||40
6596875|NCT02019108|7521887|FG001|STARTED|Overall Study||39
6596876|NCT02019108|7521886|FG000|Baseline (Week 0)|Overall Study||40
6596877|NCT02019108|7521887|FG001|Baseline (Week 0)|Overall Study||39
6596878|NCT02019108|7521886|FG000|Follow-up (Week 17)|Overall Study||38
6596879|NCT02019108|7521887|FG001|Follow-up (Week 17)|Overall Study||36
6596880|NCT02019108|7521886|FG000|Retention (Week 21)|Overall Study||35
6596881|NCT02019108|7521887|FG001|Retention (Week 21)|Overall Study||32
6596882|NCT02019108|7521886|FG000|COMPLETED|Overall Study||35
6596883|NCT02019108|7521887|FG001|COMPLETED|Overall Study||32
6596884|NCT02019108|7521886|FG000|NOT COMPLETED|Overall Study||5
6596885|NCT02019108|7521887|FG001|NOT COMPLETED|Overall Study||7
6596886|NCT02019264|7521895|FG000|STARTED|Overall Study||6000
6596887|NCT02019264|7521896|FG001|STARTED|Overall Study||6000
6596888|NCT02019264|7521895|FG000|Safety Analysis Set|Overall Study||5992
6596889|NCT02019264|7521896|FG001|Safety Analysis Set|Overall Study||5995
6596890|NCT02019264|7521895|FG000|COMPLETED|Overall Study||5752
6596891|NCT02019264|7521896|FG001|COMPLETED|Overall Study||5793
6596892|NCT02019264|7521895|FG000|NOT COMPLETED|Overall Study||248
6596893|NCT02019264|7521896|FG001|NOT COMPLETED|Overall Study||207
6596894|NCT02019277|7521902|FG000|STARTED|Overall Study||50
6596895|NCT02019277|7521902|FG000|COMPLETED|Overall Study||38
6596896|NCT02019277|7521902|FG000|NOT COMPLETED|Overall Study||12
6596897|NCT02019420|7521908|FG000|STARTED|Overall Study||366
6596898|NCT02019420|7521909|FG001|STARTED|Overall Study||360
6596899|NCT02019420|7521908|FG000|Treated|Overall Study||361
6596900|NCT02019420|7521909|FG001|Treated|Overall Study||357
6596901|NCT02019420|7521908|FG000|COMPLETED|Overall Study||258
6596902|NCT02019420|7521909|FG001|COMPLETED|Overall Study||254
6596903|NCT02019420|7521908|FG000|NOT COMPLETED|Overall Study||108
6596904|NCT02019420|7521909|FG001|NOT COMPLETED|Overall Study||106
6596905|NCT02019472|7521918|FG000|STARTED|Overall Study||186
6596906|NCT02019472|7521919|FG001|STARTED|Overall Study||186
6596907|NCT02019472|7521920|FG002|STARTED|Overall Study||187
6596908|NCT02019472|7521918|FG000|COMPLETED|Overall Study||149
6596909|NCT02019472|7521919|FG001|COMPLETED|Overall Study||134
6596910|NCT02019472|7521920|FG002|COMPLETED|Overall Study||145
6596911|NCT02019472|7521918|FG000|NOT COMPLETED|Overall Study||37
6596912|NCT02019472|7521919|FG001|NOT COMPLETED|Overall Study||52
6596913|NCT02019472|7521920|FG002|NOT COMPLETED|Overall Study||42
6596914|NCT02019550|7521934|FG000|STARTED|Treatment Period 1 (4 Weeks)||46
6596915|NCT02019550|7521935|FG001|STARTED|Treatment Period 1 (4 Weeks)||51
6596916|NCT02019550|7521934|FG000|COMPLETED|Treatment Period 1 (4 Weeks)||46
6596917|NCT02019550|7521935|FG001|COMPLETED|Treatment Period 1 (4 Weeks)||50
6596918|NCT02019550|7521934|FG000|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
6596919|NCT02019550|7521935|FG001|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
6596920|NCT02019550|7521934|FG000|STARTED|Treatment Period 2 (4 Weeks)||46
6596921|NCT02019550|7521935|FG001|STARTED|Treatment Period 2 (4 Weeks)||50
6596922|NCT02019550|7521934|FG000|COMPLETED|Treatment Period 2 (4 Weeks)||46
6596923|NCT02019550|7521935|FG001|COMPLETED|Treatment Period 2 (4 Weeks)||50
6596924|NCT02019550|7521934|FG000|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6596925|NCT02019550|7521935|FG001|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
6596926|NCT02019563|7521945|FG000|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
6596927|NCT02019563|7521946|FG001|STARTED|Overall Study|72 incisors were treated in the RCT group|30
6596928|NCT02019563|7521945|FG000|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
6596929|NCT02019563|7521946|FG001|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
6596930|NCT02019563|7521945|FG000|NOT COMPLETED|Overall Study||0
6596931|NCT02019563|7521946|FG001|NOT COMPLETED|Overall Study||0
6596932|NCT02019602|7521956|FG000|STARTED|Screening Period||21
6596933|NCT02019602|7521957|FG001|STARTED|Screening Period||16
6596934|NCT02019602|7521956|FG000|COMPLETED|Screening Period||16
6596935|NCT02019602|7521957|FG001|COMPLETED|Screening Period||16
6596936|NCT02019602|7521956|FG000|NOT COMPLETED|Screening Period||5
6596937|NCT02019602|7521957|FG001|NOT COMPLETED|Screening Period||0
6596938|NCT02019602|7521956|FG000|STARTED|Sampling Period||16
6596939|NCT02019602|7521957|FG001|STARTED|Sampling Period||16
6596940|NCT02019602|7521956|FG000|COMPLETED|Sampling Period||16
6596941|NCT02019602|7521957|FG001|COMPLETED|Sampling Period||16
6596942|NCT02019602|7521956|FG000|NOT COMPLETED|Sampling Period||0
6596943|NCT02019602|7521957|FG001|NOT COMPLETED|Sampling Period||0
6596944|NCT02019667|7521964|FG000|STARTED|First Intervention (6 Months)||10
6596945|NCT02019667|7521965|FG001|STARTED|First Intervention (6 Months)||9
6596946|NCT02019667|7521964|FG000|COMPLETED|First Intervention (6 Months)||10
6596947|NCT02019667|7521965|FG001|COMPLETED|First Intervention (6 Months)||8
6596948|NCT02019667|7521964|FG000|NOT COMPLETED|First Intervention (6 Months)||0
6596949|NCT02019667|7521965|FG001|NOT COMPLETED|First Intervention (6 Months)||1
6596950|NCT02019667|7521964|FG000|STARTED|Washout Period (9 Weeks)||10
6596951|NCT02019667|7521965|FG001|STARTED|Washout Period (9 Weeks)||8
6596952|NCT02019667|7521964|FG000|COMPLETED|Washout Period (9 Weeks)||10
6596953|NCT02019667|7521965|FG001|COMPLETED|Washout Period (9 Weeks)||8
6596954|NCT02019667|7521964|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
6596955|NCT02019667|7521965|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
6596956|NCT02019667|7521964|FG000|STARTED|2nd Intervention (6 Months)||10
6596957|NCT02019667|7521965|FG001|STARTED|2nd Intervention (6 Months)||8
6596958|NCT02019667|7521964|FG000|COMPLETED|2nd Intervention (6 Months)||10
6596959|NCT02019667|7521965|FG001|COMPLETED|2nd Intervention (6 Months)||6
6596960|NCT02019667|7521964|FG000|NOT COMPLETED|2nd Intervention (6 Months)||0
6596961|NCT02019667|7521965|FG001|NOT COMPLETED|2nd Intervention (6 Months)||2
6596962|NCT02019667|7521964|FG000|STARTED|Washout Period (9 Weeks)||10
6596963|NCT02019667|7521965|FG001|STARTED|Washout Period (9 Weeks)||6
6596964|NCT02019667|7521964|FG000|COMPLETED|Washout Period (9 Weeks)||10
6596965|NCT02019667|7521965|FG001|COMPLETED|Washout Period (9 Weeks)||6
6596966|NCT02019667|7521964|FG000|NOT COMPLETED|Washout Period (9 Weeks)||0
6596967|NCT02019667|7521965|FG001|NOT COMPLETED|Washout Period (9 Weeks)||0
6596968|NCT02019719|7521978|FG000|STARTED|Overall Study||19
6596969|NCT02019719|7521979|FG001|STARTED|Overall Study||19
6596970|NCT02019719|7521980|FG002|STARTED|Overall Study||20
6596971|NCT02019719|7521981|FG003|STARTED|Overall Study||19
6596972|NCT02019719|7521982|FG004|STARTED|Overall Study||20
6596973|NCT02019719|7521978|FG000|COMPLETED|Overall Study||13
6596974|NCT02019719|7521979|FG001|COMPLETED|Overall Study||18
6596975|NCT02019719|7521980|FG002|COMPLETED|Overall Study||20
6596976|NCT02019719|7521981|FG003|COMPLETED|Overall Study||17
6596977|NCT02019719|7521982|FG004|COMPLETED|Overall Study||18
6596978|NCT02019719|7521978|FG000|NOT COMPLETED|Overall Study||6
6596979|NCT02019719|7521979|FG001|NOT COMPLETED|Overall Study||1
6596980|NCT02019719|7521980|FG002|NOT COMPLETED|Overall Study||0
6596981|NCT02019719|7521981|FG003|NOT COMPLETED|Overall Study||2
6596982|NCT02019719|7521982|FG004|NOT COMPLETED|Overall Study||2
6596983|NCT02019758|7522003|FG000|STARTED|Overall Study|64 received intervention; 1 did not receive intervention|65
6596984|NCT02019758|7522004|FG001|STARTED|Overall Study|63 received intervention; 1 did not receive intervention|64
6596985|NCT02019758|7522003|FG000|Received Intervention|Overall Study||64
6596986|NCT02019758|7522004|FG001|Received Intervention|Overall Study||63
6596987|NCT02019758|7522003|FG000|Did Not Receive Intervention|Overall Study||1
6596988|NCT02019758|7522004|FG001|Did Not Receive Intervention|Overall Study||1
6596989|NCT02019758|7522003|FG000|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
6596990|NCT02019758|7522004|FG001|Lost to Follow-up|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|8
6596991|NCT02019758|7522003|FG000|COMPLETED|Overall Study||56
6596992|NCT02019758|7522004|FG001|COMPLETED|Overall Study|8 were lost to follow-up and did not undergo week 8 endoscopy or other outcome assessments|55
6596993|NCT02019758|7522003|FG000|NOT COMPLETED|Overall Study||9
6596994|NCT02019758|7522004|FG001|NOT COMPLETED|Overall Study||9
6596995|NCT02019888|7522013|FG000|STARTED|Overall Study||148
6596996|NCT02019888|7522014|FG001|STARTED|Overall Study||113
6596997|NCT02019888|7522015|FG002|STARTED|Overall Study||59
6596998|NCT02019888|7522013|FG000|COMPLETED|Overall Study||108
6596999|NCT02019888|7522014|FG001|COMPLETED|Overall Study||83
6597000|NCT02019888|7522015|FG002|COMPLETED|Overall Study||54
6597001|NCT02019888|7522013|FG000|NOT COMPLETED|Overall Study||40
6597002|NCT02019888|7522014|FG001|NOT COMPLETED|Overall Study||30
6597003|NCT02019888|7522015|FG002|NOT COMPLETED|Overall Study||5
6597004|NCT02019927|7522029|FG000|STARTED|Overall Study||46
6597005|NCT02019927|7522030|FG001|STARTED|Overall Study||23
6597006|NCT02019927|7522031|FG002|STARTED|Overall Study||9
6597007|NCT02019927|7522032|FG003|STARTED|Overall Study||5
6597008|NCT02019927|7522033|FG004|STARTED|Overall Study||10
6597009|NCT02019927|7522034|FG005|STARTED|Overall Study||4
6597010|NCT02019927|7522029|FG000|COMPLETED|Overall Study||44
6597011|NCT02019927|7522030|FG001|COMPLETED|Overall Study||19
6597012|NCT02019927|7522031|FG002|COMPLETED|Overall Study||8
6597013|NCT02019927|7522032|FG003|COMPLETED|Overall Study||3
6597014|NCT02019927|7522033|FG004|COMPLETED|Overall Study||7
6597015|NCT02019927|7522034|FG005|COMPLETED|Overall Study||3
6597016|NCT02019927|7522029|FG000|NOT COMPLETED|Overall Study||2
6597017|NCT02019927|7522030|FG001|NOT COMPLETED|Overall Study||4
6597018|NCT02019927|7522031|FG002|NOT COMPLETED|Overall Study||1
6597019|NCT02019927|7522032|FG003|NOT COMPLETED|Overall Study||2
6597020|NCT02019927|7522033|FG004|NOT COMPLETED|Overall Study||3
6597021|NCT02019927|7522034|FG005|NOT COMPLETED|Overall Study||1
6597022|NCT02019940|7522052|FG000|STARTED|Overall Study||18
6597023|NCT02019940|7522052|FG000|COMPLETED|Overall Study||8
6597024|NCT02019940|7522052|FG000|NOT COMPLETED|Overall Study||10
6597025|NCT02019979|7522056|FG000|STARTED|Overall Study||14
6597026|NCT02019979|7522056|FG000|COMPLETED|Overall Study||0
6597027|NCT02019979|7522056|FG000|NOT COMPLETED|Overall Study||14
6597028|NCT02020018|7522062|FG000|STARTED|Overall Study||272
6597029|NCT02020018|7522063|FG001|STARTED|Overall Study||1597
6597030|NCT02020018|7522062|FG000|COMPLETED|Overall Study||272
6597031|NCT02020018|7522063|FG001|COMPLETED|Overall Study||1597
6597032|NCT02020018|7522062|FG000|NOT COMPLETED|Overall Study||0
6597033|NCT02020018|7522063|FG001|NOT COMPLETED|Overall Study||0
6597034|NCT02020031|7522071|FG000|STARTED|Overall Study||11
6597035|NCT02020031|7522072|FG001|STARTED|Overall Study||11
6597036|NCT02020031|7522071|FG000|COMPLETED|Overall Study||10
6597037|NCT02020031|7522072|FG001|COMPLETED|Overall Study||10
6597038|NCT02020031|7522071|FG000|NOT COMPLETED|Overall Study||1
6597039|NCT02020031|7522072|FG001|NOT COMPLETED|Overall Study||1
6597040|NCT02020135|7522080|FG000|STARTED|Overall Study||9
6597041|NCT02020135|7522080|FG000|COMPLETED|Overall Study||0
6597042|NCT02020135|7522080|FG000|NOT COMPLETED|Overall Study||9
6597043|NCT02020252|7522086|FG000|STARTED|Overall Study||120
6597044|NCT02020252|7522086|FG000|COMPLETED|Overall Study||120
6597045|NCT02020252|7522086|FG000|NOT COMPLETED|Overall Study||0
6597046|NCT02020278|7522090|FG000|STARTED|Core Safety Follow-up Component||3
6597047|NCT02020278|7522090|FG000|COMPLETED|Core Safety Follow-up Component||3
6597048|NCT02020278|7522090|FG000|NOT COMPLETED|Core Safety Follow-up Component||0
6597049|NCT02020278|7522090|FG000|STARTED|Optional Tolvaptan Treatment Component||0
6597050|NCT02020278|7522090|FG000|COMPLETED|Optional Tolvaptan Treatment Component||0
6660713|NCT02500979|7591663|FG001|STARTED|Period 2||16
6660714|NCT02500979|7591662|FG000|COMPLETED|Period 2||11
6660715|NCT02500979|7591663|FG001|COMPLETED|Period 2||16
6660716|NCT02500979|7591662|FG000|NOT COMPLETED|Period 2||1
6660717|NCT02500979|7591663|FG001|NOT COMPLETED|Period 2||0
6660718|NCT02501135|7591669|FG000|STARTED|Overall Study||281
6660719|NCT02501135|7591669|FG000|COMPLETED|Overall Study||281
6597051|NCT02020278|7522090|FG000|NOT COMPLETED|Optional Tolvaptan Treatment Component||0
6597052|NCT02020304|7522098|FG000|STARTED|Overall Study||30
6597053|NCT02020304|7522099|FG001|STARTED|Overall Study||28
6597054|NCT02020304|7522098|FG000|COMPLETED|Overall Study||27
6597055|NCT02020304|7522099|FG001|COMPLETED|Overall Study||26
6597056|NCT02020304|7522098|FG000|NOT COMPLETED|Overall Study||3
6597057|NCT02020304|7522099|FG001|NOT COMPLETED|Overall Study||2
6597058|NCT02020369|7522107|FG000|STARTED|Overall Study||14
6597059|NCT02020369|7522108|FG001|STARTED|Overall Study||13
6597060|NCT02020369|7522107|FG000|COMPLETED|Overall Study||11
6597061|NCT02020369|7522108|FG001|COMPLETED|Overall Study||11
6597062|NCT02020369|7522107|FG000|NOT COMPLETED|Overall Study||3
6597063|NCT02020369|7522108|FG001|NOT COMPLETED|Overall Study||2
6597064|NCT02020408|7522117|FG000|STARTED|Overall Study||88
6597065|NCT02020408|7522117|FG000|COMPLETED|Overall Study||85
6597066|NCT02020408|7522117|FG000|NOT COMPLETED|Overall Study||3
6597067|NCT02020512|7522127|FG000|STARTED|Overall Study||87
6597068|NCT02020512|7522127|FG000|COMPLETED|Overall Study||79
6597069|NCT02020512|7522127|FG000|NOT COMPLETED|Overall Study||8
6597070|NCT02020577|7522133|FG000|STARTED|Overall Study||3
6597071|NCT02020577|7522134|FG001|STARTED|Overall Study||55
6597072|NCT02020577|7522133|FG000|COMPLETED|Overall Study||0
6597073|NCT02020577|7522134|FG001|COMPLETED|Overall Study||0
6597074|NCT02020577|7522133|FG000|NOT COMPLETED|Overall Study||3
6597075|NCT02020577|7522134|FG001|NOT COMPLETED|Overall Study||55
6597076|NCT02020590|7522142|FG000|STARTED|Overall Study||22
6597077|NCT02020590|7522142|FG000|COMPLETED|Overall Study||22
6597078|NCT02020590|7522142|FG000|NOT COMPLETED|Overall Study||0
6597079|NCT02020616|7522153|FG000|STARTED|Overall Study||10
6597080|NCT02020616|7522154|FG001|STARTED|Overall Study||8
6597081|NCT02020616|7522155|FG002|STARTED|Overall Study||8
6597082|NCT02020616|7522156|FG003|STARTED|Overall Study||8
6597083|NCT02020616|7522157|FG004|STARTED|Overall Study||8
6597084|NCT02020616|7522158|FG005|STARTED|Overall Study||8
6597085|NCT02020616|7522159|FG006|STARTED|Overall Study||10
6597086|NCT02020616|7522153|FG000|Received at Least One Dose of Study Drug|Overall Study||10
6597087|NCT02020616|7522154|FG001|Received at Least One Dose of Study Drug|Overall Study||8
6597088|NCT02020616|7522155|FG002|Received at Least One Dose of Study Drug|Overall Study||8
6597089|NCT02020616|7522156|FG003|Received at Least One Dose of Study Drug|Overall Study||7
6597090|NCT02020616|7522157|FG004|Received at Least One Dose of Study Drug|Overall Study||8
6597091|NCT02020616|7522158|FG005|Received at Least One Dose of Study Drug|Overall Study||8
6597092|NCT02020616|7522159|FG006|Received at Least One Dose of Study Drug|Overall Study||10
6597093|NCT02020616|7522153|FG000|COMPLETED|Overall Study||10
6597094|NCT02020616|7522154|FG001|COMPLETED|Overall Study||7
6597095|NCT02020616|7522155|FG002|COMPLETED|Overall Study||6
6597096|NCT02020616|7522156|FG003|COMPLETED|Overall Study||6
6597097|NCT02020616|7522157|FG004|COMPLETED|Overall Study||6
6597098|NCT02020616|7522158|FG005|COMPLETED|Overall Study||3
6597099|NCT02020616|7522159|FG006|COMPLETED|Overall Study||6
6597100|NCT02020616|7522153|FG000|NOT COMPLETED|Overall Study||0
6597101|NCT02020616|7522154|FG001|NOT COMPLETED|Overall Study||1
6660720|NCT02501135|7591669|FG000|NOT COMPLETED|Overall Study||0
6660721|NCT02501161|7591681|FG000|STARTED|Overall Study||506
6597102|NCT02020616|7522155|FG002|NOT COMPLETED|Overall Study||2
6597103|NCT02020616|7522156|FG003|NOT COMPLETED|Overall Study||2
6597104|NCT02020616|7522157|FG004|NOT COMPLETED|Overall Study||2
6597105|NCT02020616|7522158|FG005|NOT COMPLETED|Overall Study||5
6597106|NCT02020616|7522159|FG006|NOT COMPLETED|Overall Study||4
6660722|NCT02501161|7591682|FG001|STARTED|Overall Study||506
6660723|NCT02501161|7591681|FG000|Exposed|Overall Study||506
6660724|NCT02501161|7591682|FG001|Exposed|Overall Study||504
6660725|NCT02501161|7591681|FG000|COMPLETED|Overall Study||484
6660726|NCT02501161|7591682|FG001|COMPLETED|Overall Study||481
6660727|NCT02501161|7591681|FG000|NOT COMPLETED|Overall Study||22
6660728|NCT02501161|7591682|FG001|NOT COMPLETED|Overall Study||25
6597107|NCT02020785|7522191|FG000|STARTED|First Intervention (3 Weeks)||15
6597108|NCT02020785|7522192|FG001|STARTED|First Intervention (3 Weeks)||16
6660729|NCT02501265|7591692|FG000|STARTED|Overall Study||63
6660730|NCT02501265|7591693|FG001|STARTED|Overall Study||30
6660731|NCT02501265|7591694|FG002|STARTED|Overall Study||64
6660732|NCT02501265|7591695|FG003|STARTED|Overall Study||31
6660733|NCT02501265|7591692|FG000|COMPLETED|Overall Study||46
6660734|NCT02501265|7591693|FG001|COMPLETED|Overall Study||21
6660735|NCT02501265|7591694|FG002|COMPLETED|Overall Study||46
6660736|NCT02501265|7591695|FG003|COMPLETED|Overall Study||23
6660737|NCT02501265|7591692|FG000|NOT COMPLETED|Overall Study||17
6660738|NCT02501265|7591693|FG001|NOT COMPLETED|Overall Study||9
6597109|NCT02020785|7522191|FG000|COMPLETED|First Intervention (3 Weeks)||15
6597110|NCT02020785|7522192|FG001|COMPLETED|First Intervention (3 Weeks)||16
6597111|NCT02020785|7522191|FG000|NOT COMPLETED|First Intervention (3 Weeks)||0
6597112|NCT02020785|7522192|FG001|NOT COMPLETED|First Intervention (3 Weeks)||0
6597113|NCT02020785|7522191|FG000|STARTED|Second Intervention (3 Weeks)||15
6597114|NCT02020785|7522192|FG001|STARTED|Second Intervention (3 Weeks)||16
6597115|NCT02020785|7522191|FG000|COMPLETED|Second Intervention (3 Weeks)||15
6597116|NCT02020785|7522192|FG001|COMPLETED|Second Intervention (3 Weeks)||16
6597117|NCT02020785|7522191|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||0
6597118|NCT02020785|7522192|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6597119|NCT02020863|7522198|FG000|STARTED|Overall Study||40
6597120|NCT02020863|7522198|FG000|COMPLETED|Overall Study||35
6597121|NCT02020863|7522198|FG000|NOT COMPLETED|Overall Study||5
6597122|NCT02020889|7522204|FG000|STARTED|Overall Study||68
6597123|NCT02020889|7522205|FG001|STARTED|Overall Study||68
6597124|NCT02020889|7522204|FG000|COMPLETED|Overall Study||61
6597125|NCT02020889|7522205|FG001|COMPLETED|Overall Study||65
6597126|NCT02020889|7522204|FG000|NOT COMPLETED|Overall Study||7
6597127|NCT02020889|7522205|FG001|NOT COMPLETED|Overall Study||3
6597128|NCT02020941|7522211|FG000|STARTED|Overall Study||10
6597129|NCT02020941|7522211|FG000|COMPLETED|Overall Study||2
6597130|NCT02020941|7522211|FG000|NOT COMPLETED|Overall Study||8
6597131|NCT02020967|7522217|FG000|STARTED|Overall Study||367
6597132|NCT02020967|7522217|FG000|Examined Participants|Overall Study||329
6597133|NCT02020967|7522217|FG000|COMPLETED|Overall Study||316
6597134|NCT02020967|7522217|FG000|NOT COMPLETED|Overall Study||51
6597135|NCT02021292|7522225|FG000|STARTED|Overall Study||40
6597136|NCT02021292|7522226|FG001|STARTED|Overall Study||40
6597137|NCT02021292|7522225|FG000|COMPLETED|Overall Study||40
6597138|NCT02021292|7522226|FG001|COMPLETED|Overall Study||37
6597139|NCT02021292|7522225|FG000|NOT COMPLETED|Overall Study||0
6597140|NCT02021292|7522226|FG001|NOT COMPLETED|Overall Study||3
6660739|NCT02501265|7591694|FG002|NOT COMPLETED|Overall Study||18
6660740|NCT02501265|7591695|FG003|NOT COMPLETED|Overall Study||8
6660741|NCT02501473|7591712|FG000|STARTED|Overall Study||3
6597141|NCT02021318|7522236|FG000|STARTED|Overall Study||323
6597142|NCT02021318|7522237|FG001|STARTED|Overall Study||293
6597143|NCT02021318|7522236|FG000|COMPLETED|Overall Study||250
6597144|NCT02021318|7522237|FG001|COMPLETED|Overall Study||230
6597145|NCT02021318|7522236|FG000|NOT COMPLETED|Overall Study||73
6597146|NCT02021318|7522237|FG001|NOT COMPLETED|Overall Study||63
6597147|NCT02021331|7522246|FG000|STARTED|Overall Study||2
6597148|NCT02021331|7522247|FG001|STARTED|Overall Study||3
6597149|NCT02021331|7522246|FG000|COMPLETED|Overall Study||2
6597150|NCT02021331|7522247|FG001|COMPLETED|Overall Study||1
6597151|NCT02021331|7522246|FG000|NOT COMPLETED|Overall Study||0
6597152|NCT02021331|7522247|FG001|NOT COMPLETED|Overall Study||2
6597153|NCT02021461|7522253|FG000|STARTED|Overall Study||38
6597154|NCT02021461|7522253|FG000|COMPLETED|Overall Study||38
6597155|NCT02021461|7522253|FG000|NOT COMPLETED|Overall Study||0
6597156|NCT02021565|7522261|FG000|STARTED|Baseline Through Intervention||72
6597157|NCT02021565|7522262|FG001|STARTED|Baseline Through Intervention||54
6597158|NCT02021565|7522261|FG000|Caregivers|Baseline Through Intervention||36
6597159|NCT02021565|7522262|FG001|Caregivers|Baseline Through Intervention||27
6597160|NCT02021565|7522261|FG000|Care Recipients|Baseline Through Intervention||36
6597161|NCT02021565|7522262|FG001|Care Recipients|Baseline Through Intervention||27
6597162|NCT02021565|7522261|FG000|COMPLETED|Baseline Through Intervention||60
6597163|NCT02021565|7522262|FG001|COMPLETED|Baseline Through Intervention||36
6597164|NCT02021565|7522261|FG000|NOT COMPLETED|Baseline Through Intervention||12
6624779|NCT02219932|7552303|FG000|Randomized, Not Treated|Overall Study||0
6660742|NCT02501473|7591713|FG001|STARTED|Overall Study||3
6660743|NCT02501473|7591714|FG002|STARTED|Overall Study||13
6660744|NCT02501473|7591715|FG003|STARTED|Overall Study||14
6660745|NCT02501473|7591716|FG004|STARTED|Overall Study||4
6660746|NCT02501473|7591717|FG005|STARTED|Overall Study||14
6660747|NCT02501473|7591718|FG006|STARTED|Overall Study||1
6660748|NCT02501473|7591719|FG007|STARTED|Overall Study||0
6660749|NCT02501473|7591712|FG000|Treated|Overall Study||3
6660750|NCT02501473|7591713|FG001|Treated|Overall Study||3
6660751|NCT02501473|7591714|FG002|Treated|Overall Study||13
6660752|NCT02501473|7591715|FG003|Treated|Overall Study||13
6660753|NCT02501473|7591716|FG004|Treated|Overall Study||4
6660754|NCT02501473|7591717|FG005|Treated|Overall Study||14
6660755|NCT02501473|7591718|FG006|Treated|Overall Study||1
6660756|NCT02501473|7591719|FG007|Treated|Overall Study||0
6660757|NCT02501473|7591712|FG000|COMPLETED|Overall Study||0
6660758|NCT02501473|7591713|FG001|COMPLETED|Overall Study||0
6660759|NCT02501473|7591714|FG002|COMPLETED|Overall Study||0
6660760|NCT02501473|7591715|FG003|COMPLETED|Overall Study||0
6660761|NCT02501473|7591716|FG004|COMPLETED|Overall Study||0
6660762|NCT02501473|7591717|FG005|COMPLETED|Overall Study||0
6660763|NCT02501473|7591718|FG006|COMPLETED|Overall Study||0
6660764|NCT02501473|7591719|FG007|COMPLETED|Overall Study||0
6660765|NCT02501473|7591712|FG000|NOT COMPLETED|Overall Study||3
6660766|NCT02501473|7591713|FG001|NOT COMPLETED|Overall Study||3
6660767|NCT02501473|7591714|FG002|NOT COMPLETED|Overall Study||13
6660768|NCT02501473|7591715|FG003|NOT COMPLETED|Overall Study||14
6660769|NCT02501473|7591716|FG004|NOT COMPLETED|Overall Study||4
6660770|NCT02501473|7591717|FG005|NOT COMPLETED|Overall Study||14
6660771|NCT02501473|7591718|FG006|NOT COMPLETED|Overall Study||1
6660772|NCT02501473|7591719|FG007|NOT COMPLETED|Overall Study||0
6660773|NCT02501538|7591735|FG000|STARTED|Overall Study||23
6660774|NCT02501538|7591735|FG000|COMPLETED|Overall Study||20
6660775|NCT02501538|7591735|FG000|NOT COMPLETED|Overall Study||3
6660776|NCT02501590|7591744|FG000|STARTED|Overall Study||13
6660777|NCT02501590|7591745|FG001|STARTED|Overall Study||35
6660778|NCT02501590|7591744|FG000|COMPLETED|Overall Study||13
6660779|NCT02501590|7591745|FG001|COMPLETED|Overall Study||35
6660780|NCT02501590|7591744|FG000|NOT COMPLETED|Overall Study||0
6660781|NCT02501590|7591745|FG001|NOT COMPLETED|Overall Study||0
6660782|NCT02501629|7591753|FG000|STARTED|Overall Study||89
6660783|NCT02501629|7591754|FG001|STARTED|Overall Study||88
6660784|NCT02501629|7591753|FG000|COMPLETED|Overall Study||84
6660785|NCT02501629|7591754|FG001|COMPLETED|Overall Study||81
6660786|NCT02501629|7591753|FG000|NOT COMPLETED|Overall Study||5
6660787|NCT02501629|7591754|FG001|NOT COMPLETED|Overall Study||7
6660788|NCT02501642|7591762|FG000|STARTED|Overall Study|Start of study: 10.1.2014|238
6660789|NCT02501642|7591763|FG001|STARTED|Overall Study|Start of study: 10.1.2014|241
6660790|NCT02501642|7591762|FG000|COMPLETED|Overall Study|Study ended 9.30.2018|231
6660791|NCT02501642|7591763|FG001|COMPLETED|Overall Study|Study ended 9.30.2018|230
6660792|NCT02501642|7591762|FG000|NOT COMPLETED|Overall Study||7
6660793|NCT02501642|7591763|FG001|NOT COMPLETED|Overall Study||11
6660794|NCT02501811|7591773|FG000|STARTED|Overall Study||33
6660795|NCT02501811|7591774|FG001|STARTED|Overall Study||29
6660796|NCT02501811|7591775|FG002|STARTED|Overall Study||31
6660797|NCT02501811|7591776|FG003|STARTED|Overall Study||32
6660798|NCT02501811|7591773|FG000|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|29
6660799|NCT02501811|7591774|FG001|COMPLETED|Overall Study||23
6660800|NCT02501811|7591775|FG002|COMPLETED|Overall Study||25
6660801|NCT02501811|7591776|FG003|COMPLETED|Overall Study|includes 1 participant who completed final study visit but died within 30 days after final visit.|25
6660802|NCT02501811|7591773|FG000|NOT COMPLETED|Overall Study||4
6660803|NCT02501811|7591774|FG001|NOT COMPLETED|Overall Study||6
6660804|NCT02501811|7591775|FG002|NOT COMPLETED|Overall Study||6
6660805|NCT02501811|7591776|FG003|NOT COMPLETED|Overall Study||7
6597165|NCT02021565|7522262|FG001|NOT COMPLETED|Baseline Through Intervention||18
6660806|NCT02501902|7591794|FG000|STARTED|Overall Study||3
6660807|NCT02501902|7591795|FG001|STARTED|Overall Study||7
6660808|NCT02501902|7591796|FG002|STARTED|Overall Study||4
6660809|NCT02501902|7591797|FG003|STARTED|Overall Study||11
6660810|NCT02501902|7591798|FG004|STARTED|Overall Study||11
6597166|NCT02021565|7522261|FG000|STARTED|3-month Follow-up||60
6597167|NCT02021565|7522262|FG001|STARTED|3-month Follow-up||36
6597168|NCT02021565|7522261|FG000|Caregivers|3-month Follow-up||30
6597169|NCT02021565|7522262|FG001|Caregivers|3-month Follow-up||18
6597170|NCT02021565|7522261|FG000|Care Recipients|3-month Follow-up||30
6597171|NCT02021565|7522262|FG001|Care Recipients|3-month Follow-up||18
6597172|NCT02021565|7522261|FG000|COMPLETED|3-month Follow-up||50
6597173|NCT02021565|7522262|FG001|COMPLETED|3-month Follow-up||34
6597174|NCT02021565|7522261|FG000|NOT COMPLETED|3-month Follow-up||10
6597175|NCT02021565|7522262|FG001|NOT COMPLETED|3-month Follow-up||2
6597176|NCT02021643|7522276|FG000|STARTED|Overall Study||156
6597177|NCT02021643|7522277|FG001|STARTED|Overall Study||290
6597178|NCT02021643|7522278|FG002|STARTED|Overall Study||11
6597179|NCT02021643|7522279|FG003|STARTED|Overall Study||230
6597180|NCT02021643|7522276|FG000|COMPLETED|Overall Study||147
6597181|NCT02021643|7522277|FG001|COMPLETED|Overall Study||280
6597182|NCT02021643|7522278|FG002|COMPLETED|Overall Study||11
6597183|NCT02021643|7522279|FG003|COMPLETED|Overall Study||218
6597184|NCT02021643|7522276|FG000|NOT COMPLETED|Overall Study||9
6597185|NCT02021643|7522277|FG001|NOT COMPLETED|Overall Study||10
6597186|NCT02021643|7522278|FG002|NOT COMPLETED|Overall Study||0
6597187|NCT02021643|7522279|FG003|NOT COMPLETED|Overall Study||12
6597188|NCT02021656|7522295|FG000|STARTED|Overall Study||384
6597189|NCT02021656|7522295|FG000|COMPLETED|Overall Study||378
6597190|NCT02021656|7522295|FG000|NOT COMPLETED|Overall Study||6
6597191|NCT02021669|7522305|FG000|STARTED|Overall Study||71
6597192|NCT02021669|7522306|FG001|STARTED|Overall Study||73
6597193|NCT02021669|7522305|FG000|COMPLETED|Overall Study||64
6597194|NCT02021669|7522306|FG001|COMPLETED|Overall Study||70
6597195|NCT02021669|7522305|FG000|NOT COMPLETED|Overall Study||7
6597196|NCT02021669|7522306|FG001|NOT COMPLETED|Overall Study||3
6597197|NCT02021812|7522312|FG000|STARTED|Overall Study||31
6597198|NCT02021812|7522312|FG000|COMPLETED|Overall Study||9
6597199|NCT02021812|7522312|FG000|NOT COMPLETED|Overall Study||22
6597200|NCT02021929|7522318|FG000|STARTED|Overall Study||16
6597201|NCT02021929|7522319|FG001|STARTED|Overall Study||12
6597202|NCT02021929|7522318|FG000|COMPLETED|Overall Study||14
6597203|NCT02021929|7522319|FG001|COMPLETED|Overall Study||11
6597204|NCT02021929|7522318|FG000|NOT COMPLETED|Overall Study||2
6597205|NCT02021929|7522319|FG001|NOT COMPLETED|Overall Study||1
6597206|NCT02021942|7522325|FG000|STARTED|Overall Study||16
6597207|NCT02021942|7522325|FG000|COMPLETED|Overall Study||16
6597208|NCT02021942|7522325|FG000|NOT COMPLETED|Overall Study||0
6597209|NCT02021955|7522332|FG000|STARTED|Step 0|Provider attrition=2; Provider addition=3; Patient discharges=14|210
6597210|NCT02021955|7522333|FG001|STARTED|Step 0|Provider attrition=0; Provider addition=0; Patient discharges=0|0
6597211|NCT02021955|7522332|FG000|COMPLETED|Step 0||210
6597212|NCT02021955|7522333|FG001|COMPLETED|Step 0||0
6597213|NCT02021955|7522332|FG000|NOT COMPLETED|Step 0||0
6597214|NCT02021955|7522333|FG001|NOT COMPLETED|Step 0||0
6597215|NCT02021955|7522332|FG000|STARTED|Step 1|Provider attrition=20; Provider addition=2; Patient discharges=14|193
6597216|NCT02021955|7522333|FG001|STARTED|Step 1|Provider attrition=7; Provider addition=0; Patient discharges: 0|18
6597217|NCT02021955|7522332|FG000|COMPLETED|Step 1||193
6597218|NCT02021955|7522333|FG001|COMPLETED|Step 1||18
6597219|NCT02021955|7522332|FG000|NOT COMPLETED|Step 1||0
6597220|NCT02021955|7522333|FG001|NOT COMPLETED|Step 1||0
6660811|NCT02501902|7591799|FG005|STARTED|Overall Study||11
6660812|NCT02501902|7591800|FG006|STARTED|Overall Study||9
6660813|NCT02501902|7591801|FG007|STARTED|Overall Study||20
6660814|NCT02501902|7591794|FG000|COMPLETED|Overall Study||0
6660815|NCT02501902|7591795|FG001|COMPLETED|Overall Study||0
6660816|NCT02501902|7591796|FG002|COMPLETED|Overall Study||0
6660817|NCT02501902|7591797|FG003|COMPLETED|Overall Study||0
6660818|NCT02501902|7591798|FG004|COMPLETED|Overall Study||0
6660819|NCT02501902|7591799|FG005|COMPLETED|Overall Study||0
6660820|NCT02501902|7591800|FG006|COMPLETED|Overall Study||0
6660821|NCT02501902|7591801|FG007|COMPLETED|Overall Study||0
6660822|NCT02501902|7591794|FG000|NOT COMPLETED|Overall Study||3
6660823|NCT02501902|7591795|FG001|NOT COMPLETED|Overall Study||7
6660824|NCT02501902|7591796|FG002|NOT COMPLETED|Overall Study||4
6660825|NCT02501902|7591797|FG003|NOT COMPLETED|Overall Study||11
6660826|NCT02501902|7591798|FG004|NOT COMPLETED|Overall Study||11
6660827|NCT02501902|7591799|FG005|NOT COMPLETED|Overall Study||11
6660828|NCT02501902|7591800|FG006|NOT COMPLETED|Overall Study||9
6597221|NCT02021955|7522332|FG000|STARTED|Step 2|Provider attrition=5; Provider addition=21; Patient discharges=12|165
6597222|NCT02021955|7522333|FG001|STARTED|Step 2|Provider attrition=2; Provider addition=5; Patient discharges=2|21
6597223|NCT02021955|7522332|FG000|COMPLETED|Step 2||165
6597224|NCT02021955|7522333|FG001|COMPLETED|Step 2||21
6597225|NCT02021955|7522332|FG000|NOT COMPLETED|Step 2||0
6660829|NCT02501902|7591801|FG007|NOT COMPLETED|Overall Study||20
6597226|NCT02021955|7522333|FG001|NOT COMPLETED|Step 2||0
6624780|NCT02219932|7552304|FG001|Randomized, Not Treated|Overall Study||1
6660830|NCT02501928|7591827|FG000|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
6597227|NCT02021955|7522332|FG000|STARTED|Step 3|Provider attrition=2; Provider addition=4; Patient discharges=5|175
6660831|NCT02501928|7591828|FG001|STARTED|Overall Study||2
6660832|NCT02501928|7591829|FG002|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
6660833|NCT02501928|7591830|FG003|STARTED|Overall Study|No participant was assigned to this arm, in this LTE study.|0
6660834|NCT02501928|7591831|FG004|STARTED|Overall Study||7
6660835|NCT02501928|7591832|FG005|STARTED|Overall Study||3
6660836|NCT02501928|7591827|FG000|COMPLETED|Overall Study||0
6660837|NCT02501928|7591828|FG001|COMPLETED|Overall Study||2
6660838|NCT02501928|7591829|FG002|COMPLETED|Overall Study||0
6660839|NCT02501928|7591830|FG003|COMPLETED|Overall Study||0
6660840|NCT02501928|7591831|FG004|COMPLETED|Overall Study||6
6660841|NCT02501928|7591832|FG005|COMPLETED|Overall Study||3
6660842|NCT02501928|7591827|FG000|NOT COMPLETED|Overall Study||0
6660843|NCT02501928|7591828|FG001|NOT COMPLETED|Overall Study||0
6660844|NCT02501928|7591829|FG002|NOT COMPLETED|Overall Study||0
6660845|NCT02501928|7591830|FG003|NOT COMPLETED|Overall Study||0
6660846|NCT02501928|7591831|FG004|NOT COMPLETED|Overall Study||1
6660847|NCT02501928|7591832|FG005|NOT COMPLETED|Overall Study||0
6660848|NCT02502019|7591849|FG000|STARTED|Overall Study||27
6660849|NCT02502019|7591849|FG000|COMPLETED|Overall Study||27
6660850|NCT02502019|7591849|FG000|NOT COMPLETED|Overall Study||0
6660851|NCT02502097|7591857|FG000|STARTED|Period 1||4
6660852|NCT02502097|7591858|FG001|STARTED|Period 1||3
6660853|NCT02502097|7591859|FG002|STARTED|Period 1||22
6660854|NCT02502097|7591860|FG003|STARTED|Period 1||22
6660855|NCT02502097|7591857|FG000|COMPLETED|Period 1||4
6660856|NCT02502097|7591858|FG001|COMPLETED|Period 1||3
6660857|NCT02502097|7591859|FG002|COMPLETED|Period 1||21
6660858|NCT02502097|7591860|FG003|COMPLETED|Period 1||22
6660859|NCT02502097|7591857|FG000|NOT COMPLETED|Period 1||0
6660860|NCT02502097|7591858|FG001|NOT COMPLETED|Period 1||0
6660861|NCT02502097|7591859|FG002|NOT COMPLETED|Period 1||1
6660862|NCT02502097|7591860|FG003|NOT COMPLETED|Period 1||0
6660863|NCT02502097|7591857|FG000|STARTED|Wash Out Period||4
6660864|NCT02502097|7591858|FG001|STARTED|Wash Out Period||3
6660865|NCT02502097|7591859|FG002|STARTED|Wash Out Period||21
6660866|NCT02502097|7591860|FG003|STARTED|Wash Out Period||22
6660867|NCT02502097|7591857|FG000|COMPLETED|Wash Out Period||4
6660868|NCT02502097|7591858|FG001|COMPLETED|Wash Out Period||2
6660869|NCT02502097|7591859|FG002|COMPLETED|Wash Out Period||20
6660870|NCT02502097|7591860|FG003|COMPLETED|Wash Out Period||21
6660871|NCT02502097|7591857|FG000|NOT COMPLETED|Wash Out Period||0
6660872|NCT02502097|7591858|FG001|NOT COMPLETED|Wash Out Period||1
6660873|NCT02502097|7591859|FG002|NOT COMPLETED|Wash Out Period||1
6660874|NCT02502097|7591860|FG003|NOT COMPLETED|Wash Out Period||1
6660875|NCT02502097|7591857|FG000|STARTED|Period 2||4
6660876|NCT02502097|7591858|FG001|STARTED|Period 2||2
6660877|NCT02502097|7591859|FG002|STARTED|Period 2||20
6660878|NCT02502097|7591860|FG003|STARTED|Period 2||21
6660879|NCT02502097|7591857|FG000|COMPLETED|Period 2||4
6660880|NCT02502097|7591858|FG001|COMPLETED|Period 2||2
6660881|NCT02502097|7591859|FG002|COMPLETED|Period 2||19
6660882|NCT02502097|7591860|FG003|COMPLETED|Period 2||21
6660883|NCT02502097|7591857|FG000|NOT COMPLETED|Period 2||0
6660884|NCT02502097|7591858|FG001|NOT COMPLETED|Period 2||0
6660885|NCT02502097|7591859|FG002|NOT COMPLETED|Period 2||1
6660886|NCT02502097|7591860|FG003|NOT COMPLETED|Period 2||0
6660887|NCT02502149|7591867|FG000|STARTED|PK1 Assessment Period||24
6660888|NCT02502149|7591868|FG001|STARTED|PK1 Assessment Period||0
6660889|NCT02502149|7591869|FG002|STARTED|PK1 Assessment Period||0
6660890|NCT02502149|7591870|FG003|STARTED|PK1 Assessment Period||0
6660891|NCT02502149|7591871|FG004|STARTED|PK1 Assessment Period||0
6597228|NCT02021955|7522333|FG001|STARTED|Step 3|Provider attrition=0; Provider addition=3; Patient discharges=3|30
6597229|NCT02021955|7522332|FG000|COMPLETED|Step 3||175
6597230|NCT02021955|7522333|FG001|COMPLETED|Step 3||30
6597231|NCT02021955|7522332|FG000|NOT COMPLETED|Step 3||0
6597232|NCT02021955|7522333|FG001|NOT COMPLETED|Step 3||0
6597233|NCT02021955|7522332|FG000|STARTED|Step 4|Provider attrition=0; Provider addition=3; Patient discharges: 13|173
6597234|NCT02021955|7522333|FG001|STARTED|Step 4|Provider attrition=0; Provider addition=1; Patient discharges=0|37
6597235|NCT02021955|7522332|FG000|COMPLETED|Step 4||173
6597236|NCT02021955|7522333|FG001|COMPLETED|Step 4||37
6597237|NCT02021955|7522332|FG000|NOT COMPLETED|Step 4||0
6597238|NCT02021955|7522333|FG001|NOT COMPLETED|Step 4||0
6597239|NCT02021955|7522332|FG000|STARTED|Step 5|Provider attrition=3; Provider addition=0; Patient discharges=11|174
6624781|NCT02219932|7552303|FG000|COMPLETED|Overall Study||254
6660892|NCT02502149|7591867|FG000|COMPLETED|PK1 Assessment Period||24
6660893|NCT02502149|7591868|FG001|COMPLETED|PK1 Assessment Period||0
6660894|NCT02502149|7591869|FG002|COMPLETED|PK1 Assessment Period||0
6660895|NCT02502149|7591870|FG003|COMPLETED|PK1 Assessment Period||0
6660896|NCT02502149|7591871|FG004|COMPLETED|PK1 Assessment Period||0
6660897|NCT02502149|7591867|FG000|NOT COMPLETED|PK1 Assessment Period||0
6660898|NCT02502149|7591868|FG001|NOT COMPLETED|PK1 Assessment Period||0
6660899|NCT02502149|7591869|FG002|NOT COMPLETED|PK1 Assessment Period||0
6660900|NCT02502149|7591870|FG003|NOT COMPLETED|PK1 Assessment Period||0
6660901|NCT02502149|7591871|FG004|NOT COMPLETED|PK1 Assessment Period||0
6660902|NCT02502149|7591867|FG000|STARTED|Intermediate||24
6660903|NCT02502149|7591868|FG001|STARTED|Intermediate||0
6660904|NCT02502149|7591869|FG002|STARTED|Intermediate||0
6660905|NCT02502149|7591870|FG003|STARTED|Intermediate||0
6660906|NCT02502149|7591871|FG004|STARTED|Intermediate||0
6597240|NCT02021955|7522333|FG001|STARTED|Step 5|Provider attrition=0; Provider addition=0; Patient discharges=2|40
6597241|NCT02021955|7522332|FG000|COMPLETED|Step 5||174
6597242|NCT02021955|7522333|FG001|COMPLETED|Step 5||40
6597243|NCT02021955|7522332|FG000|NOT COMPLETED|Step 5||0
6597244|NCT02021955|7522333|FG001|NOT COMPLETED|Step 5||0
6597245|NCT02021955|7522332|FG000|STARTED|Step 6|Provider attrition=0; Provider addition=2; Patient discharges=6|158
6597246|NCT02021955|7522333|FG001|STARTED|Step 6|Provider attrition=0; Provider addition=1; Patient discharges=1|53
6597247|NCT02021955|7522332|FG000|COMPLETED|Step 6||158
6597248|NCT02021955|7522333|FG001|COMPLETED|Step 6||53
6597249|NCT02021955|7522332|FG000|NOT COMPLETED|Step 6||0
6597250|NCT02021955|7522333|FG001|NOT COMPLETED|Step 6||0
6597251|NCT02021955|7522332|FG000|STARTED|Step 7|Provider attrition=0; Provider addition=2; Patient discharges=13|157
6597252|NCT02021955|7522333|FG001|STARTED|Step 7|Provider attrition=0; Provider addition=1; Patient discharges=2|57
6597253|NCT02021955|7522332|FG000|COMPLETED|Step 7||157
6597254|NCT02021955|7522333|FG001|COMPLETED|Step 7||57
6597255|NCT02021955|7522332|FG000|NOT COMPLETED|Step 7||0
6597256|NCT02021955|7522333|FG001|NOT COMPLETED|Step 7||0
6597257|NCT02021955|7522332|FG000|STARTED|Step 8|Provider attrition=1; Provider addition=0; Patient discharges=9|144
6597258|NCT02021955|7522333|FG001|STARTED|Step 8|Provider attrition=0; Provider addition=0; Patient discharges=11|73
6597259|NCT02021955|7522332|FG000|COMPLETED|Step 8||144
6597260|NCT02021955|7522333|FG001|COMPLETED|Step 8||73
6597261|NCT02021955|7522332|FG000|NOT COMPLETED|Step 8||0
6597262|NCT02021955|7522333|FG001|NOT COMPLETED|Step 8||0
6597263|NCT02021955|7522332|FG000|STARTED|Step 9|Provider attrition=2; Provider addition=1; Patient discharges=9|139
6597264|NCT02021955|7522333|FG001|STARTED|Step 9|Provider attrition=1; Provider addition=0; Patient discharges=8|77
6597265|NCT02021955|7522332|FG000|COMPLETED|Step 9||139
6597266|NCT02021955|7522333|FG001|COMPLETED|Step 9||77
6597267|NCT02021955|7522332|FG000|NOT COMPLETED|Step 9||0
6597268|NCT02021955|7522333|FG001|NOT COMPLETED|Step 9||0
6597269|NCT02021955|7522332|FG000|STARTED|Step 10|Provider attrition=0; Provider addition=1; Patient discharges: 8|135
6597270|NCT02021955|7522333|FG001|STARTED|Step 10|Provider attrition=1; Provider addition=0; Patient discharges=5|79
6597271|NCT02021955|7522332|FG000|COMPLETED|Step 10||135
6597272|NCT02021955|7522333|FG001|COMPLETED|Step 10||79
6597273|NCT02021955|7522332|FG000|NOT COMPLETED|Step 10||0
6597274|NCT02021955|7522333|FG001|NOT COMPLETED|Step 10||0
6597275|NCT02021955|7522332|FG000|STARTED|Step 11|Provider attrition=1; Provider addition=0; Patient discharges=11|126
6597276|NCT02021955|7522333|FG001|STARTED|Step 11|Provider attrition=2; Provider addition=2; Patient discharges=7|88
6597277|NCT02021955|7522332|FG000|COMPLETED|Step 11||126
6597278|NCT02021955|7522333|FG001|COMPLETED|Step 11||88
6597279|NCT02021955|7522332|FG000|NOT COMPLETED|Step 11||0
6597280|NCT02021955|7522333|FG001|NOT COMPLETED|Step 11||0
6597281|NCT02021955|7522332|FG000|STARTED|Step 12|Provider attrition=1; Provider addition=0; Patient discharges=3|123
6597282|NCT02021955|7522333|FG001|STARTED|Step 12|Provider attrition=0; Provider addition=2; Patient discharges=1|90
6597283|NCT02021955|7522332|FG000|COMPLETED|Step 12||123
6597284|NCT02021955|7522333|FG001|COMPLETED|Step 12||90
6597285|NCT02021955|7522332|FG000|NOT COMPLETED|Step 12||0
6597286|NCT02021955|7522333|FG001|NOT COMPLETED|Step 12||0
6597287|NCT02021955|7522332|FG000|STARTED|Step 13|Provider attrition=10; Provider addition=0; Patient discharges=4|118
6597288|NCT02021955|7522333|FG001|STARTED|Step 13|Provider attrition=4; Provider addition=0; Patient discharges=5|96
6597289|NCT02021955|7522332|FG000|COMPLETED|Step 13||118
6597290|NCT02021955|7522333|FG001|COMPLETED|Step 13||96
6597291|NCT02021955|7522332|FG000|NOT COMPLETED|Step 13||0
6597292|NCT02021955|7522333|FG001|NOT COMPLETED|Step 13||0
6597293|NCT02021955|7522332|FG000|STARTED|Step 14|Provider attrition=1; Provider addition=9; Patient discharges=7|105
6597294|NCT02021955|7522333|FG001|STARTED|Step 14|Provider attrition=7; Provider addition=11; Patient discharges=3|95
6597295|NCT02021955|7522332|FG000|COMPLETED|Step 14||105
6597296|NCT02021955|7522333|FG001|COMPLETED|Step 14||95
6660907|NCT02502149|7591867|FG000|COMPLETED|Intermediate||23
6660908|NCT02502149|7591868|FG001|COMPLETED|Intermediate||0
6660909|NCT02502149|7591869|FG002|COMPLETED|Intermediate||0
6660910|NCT02502149|7591870|FG003|COMPLETED|Intermediate||0
6660911|NCT02502149|7591871|FG004|COMPLETED|Intermediate||0
6660912|NCT02502149|7591867|FG000|NOT COMPLETED|Intermediate||1
6660913|NCT02502149|7591868|FG001|NOT COMPLETED|Intermediate||0
6660914|NCT02502149|7591869|FG002|NOT COMPLETED|Intermediate||0
6660915|NCT02502149|7591870|FG003|NOT COMPLETED|Intermediate||0
6660916|NCT02502149|7591871|FG004|NOT COMPLETED|Intermediate||0
6660917|NCT02502149|7591867|FG000|STARTED|PK2 Assessment Period||0
6660918|NCT02502149|7591868|FG001|STARTED|PK2 Assessment Period||11
6660919|NCT02502149|7591869|FG002|STARTED|PK2 Assessment Period||12
6660920|NCT02502149|7591870|FG003|STARTED|PK2 Assessment Period||0
6597297|NCT02021955|7522332|FG000|NOT COMPLETED|Step 14||0
6597298|NCT02021955|7522333|FG001|NOT COMPLETED|Step 14||0
6597299|NCT02021955|7522332|FG000|STARTED|Step 15|Provider attrition=0; Provider addition=0; Patient discharges=4|110
6597300|NCT02021955|7522333|FG001|STARTED|Step 15|Provider attrition=0; Provider addition=5; Patient discharges=5|102
6597301|NCT02021955|7522332|FG000|COMPLETED|Step 15||110
6660921|NCT02502149|7591871|FG004|STARTED|PK2 Assessment Period||0
6660922|NCT02502149|7591867|FG000|COMPLETED|PK2 Assessment Period||0
6660923|NCT02502149|7591868|FG001|COMPLETED|PK2 Assessment Period||11
6660924|NCT02502149|7591869|FG002|COMPLETED|PK2 Assessment Period||12
6660925|NCT02502149|7591870|FG003|COMPLETED|PK2 Assessment Period||0
6660926|NCT02502149|7591871|FG004|COMPLETED|PK2 Assessment Period||0
6597302|NCT02021955|7522333|FG001|COMPLETED|Step 15||102
6597303|NCT02021955|7522332|FG000|NOT COMPLETED|Step 15||0
6597304|NCT02021955|7522333|FG001|NOT COMPLETED|Step 15||0
6597305|NCT02021955|7522332|FG000|STARTED|Step 16|Provider attrition=0; Provider addition=0; Patient discharges=2|103
6597306|NCT02021955|7522333|FG001|STARTED|Step 16|Provider attrition=0; Provider addition=3; Patient discharges=3|114
6597307|NCT02021955|7522332|FG000|COMPLETED|Step 16||103
6597308|NCT02021955|7522333|FG001|COMPLETED|Step 16||114
6597309|NCT02021955|7522332|FG000|NOT COMPLETED|Step 16||0
6597310|NCT02021955|7522333|FG001|NOT COMPLETED|Step 16||0
6597311|NCT02021955|7522332|FG000|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=8|99
6597312|NCT02021955|7522333|FG001|STARTED|Step 17|Provider attrition=0; Provider addition=0; Patient discharges=3|121
6597313|NCT02021955|7522332|FG000|COMPLETED|Step 17||99
6597314|NCT02021955|7522333|FG001|COMPLETED|Step 17||121
6597315|NCT02021955|7522332|FG000|NOT COMPLETED|Step 17||0
6597316|NCT02021955|7522333|FG001|NOT COMPLETED|Step 17||0
6597317|NCT02021955|7522332|FG000|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=6|96
6597318|NCT02021955|7522333|FG001|STARTED|Step 18|Provider attrition=0; Provider addition=0; Patient discharges=7|124
6597319|NCT02021955|7522332|FG000|COMPLETED|Step 18||96
6597320|NCT02021955|7522333|FG001|COMPLETED|Step 18||124
6597321|NCT02021955|7522332|FG000|NOT COMPLETED|Step 18||0
6597322|NCT02021955|7522333|FG001|NOT COMPLETED|Step 18||0
6597323|NCT02021955|7522332|FG000|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=5|94
6597324|NCT02021955|7522333|FG001|STARTED|Step 19|Provider attrition=0; Provider addition=0; Patient discharges=9|126
6597325|NCT02021955|7522332|FG000|COMPLETED|Step 19||94
6597326|NCT02021955|7522333|FG001|COMPLETED|Step 19||126
6597327|NCT02021955|7522332|FG000|NOT COMPLETED|Step 19||0
6597328|NCT02021955|7522333|FG001|NOT COMPLETED|Step 19||0
6597329|NCT02021955|7522332|FG000|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|92
6597330|NCT02021955|7522333|FG001|STARTED|Step 20|Provider attrition=0; Provider addition=1; Patient discharges=9|128
6597331|NCT02021955|7522332|FG000|COMPLETED|Step 20||92
6597332|NCT02021955|7522333|FG001|COMPLETED|Step 20||128
6597333|NCT02021955|7522332|FG000|NOT COMPLETED|Step 20||0
6597334|NCT02021955|7522333|FG001|NOT COMPLETED|Step 20||0
6597335|NCT02021955|7522332|FG000|STARTED|Step 21|Provider attrition=0; Provider addition=7; Patient discharges=1|88
6597336|NCT02021955|7522333|FG001|STARTED|Step 21|Provider attrition=0; Provider addition=12; Patient discharges=9|134
6597337|NCT02021955|7522332|FG000|COMPLETED|Step 21||88
6597338|NCT02021955|7522333|FG001|COMPLETED|Step 21||134
6597339|NCT02021955|7522332|FG000|NOT COMPLETED|Step 21||0
6597340|NCT02021955|7522333|FG001|NOT COMPLETED|Step 21||0
6597341|NCT02021955|7522332|FG000|STARTED|Step 22|Provider attrition=0; Provider addition=0; Patient discharges=8|89
6597342|NCT02021955|7522333|FG001|STARTED|Step 22|Provider attrition=0; Provider addition=3; Patient discharges=8|152
6597343|NCT02021955|7522332|FG000|COMPLETED|Step 22||89
6597344|NCT02021955|7522333|FG001|COMPLETED|Step 22||152
6597345|NCT02021955|7522332|FG000|NOT COMPLETED|Step 22||0
6597346|NCT02021955|7522333|FG001|NOT COMPLETED|Step 22||0
6597347|NCT02021955|7522332|FG000|STARTED|Step 23|Provider attrition=0; Provider addition=1; Patient discharges=3|69
6597348|NCT02021955|7522333|FG001|STARTED|Step 23|Provider attrition=0; Provider addition=0; Patient discharges=7|175
6597349|NCT02021955|7522332|FG000|COMPLETED|Step 23||69
6597350|NCT02021955|7522333|FG001|COMPLETED|Step 23||175
6597351|NCT02021955|7522332|FG000|NOT COMPLETED|Step 23||0
6597352|NCT02021955|7522333|FG001|NOT COMPLETED|Step 23||0
6597353|NCT02021955|7522332|FG000|STARTED|Step 24|Provider attrition=0; Provider addition=0; Patient discharges=4|62
6597354|NCT02021955|7522333|FG001|STARTED|Step 24|Provider attrition=1; Provider addition=1; Patient discharges=8|183
6597355|NCT02021955|7522332|FG000|COMPLETED|Step 24||62
6597356|NCT02021955|7522333|FG001|COMPLETED|Step 24||183
6597357|NCT02021955|7522332|FG000|NOT COMPLETED|Step 24||0
6597358|NCT02021955|7522333|FG001|NOT COMPLETED|Step 24||0
6597359|NCT02021955|7522332|FG000|STARTED|Step 25|Provider attrition=0; Provider addition=1; Patient discharges=0|37
6597360|NCT02021955|7522333|FG001|STARTED|Step 25|Provider attrition=1; Provider addition=0; Patient discharges=5|208
6597361|NCT02021955|7522332|FG000|COMPLETED|Step 25||37
6597362|NCT02021955|7522333|FG001|COMPLETED|Step 25||208
6597363|NCT02021955|7522332|FG000|NOT COMPLETED|Step 25||0
6597364|NCT02021955|7522333|FG001|NOT COMPLETED|Step 25||0
6597365|NCT02021955|7522332|FG000|STARTED|Step 26|Provider attrition=0; Provider addition=0; Patient discharges=2|30
6597366|NCT02021955|7522333|FG001|STARTED|Step 26|Provider attrition=0; Provider addition=23; Patient discharges=9|215
6597367|NCT02021955|7522332|FG000|COMPLETED|Step 26||30
6597368|NCT02021955|7522333|FG001|COMPLETED|Step 26||215
6597369|NCT02021955|7522332|FG000|NOT COMPLETED|Step 26||0
6597370|NCT02021955|7522333|FG001|NOT COMPLETED|Step 26||0
6597371|NCT02021955|7522332|FG000|STARTED|Step 27|Provider attrition=1; Provider addition=1; Patient discharges=0|25
6597372|NCT02021955|7522333|FG001|STARTED|Step 27|Provider attrition=1; Provider addition=4; Patient discharges=4|243
6597373|NCT02021955|7522332|FG000|COMPLETED|Step 27||25
6597374|NCT02021955|7522333|FG001|COMPLETED|Step 27||243
6597375|NCT02021955|7522332|FG000|NOT COMPLETED|Step 27||0
6597376|NCT02021955|7522333|FG001|NOT COMPLETED|Step 27||0
6597377|NCT02021955|7522332|FG000|STARTED|Step 28|Provider attrition=0; Provider addition=2; Patient discharges=0|15
6597378|NCT02021955|7522333|FG001|STARTED|Step 28|Provider attrition=3; Provider addition=6; Patient discharges=6|256
6597379|NCT02021955|7522332|FG000|COMPLETED|Step 28||15
6597380|NCT02021955|7522333|FG001|COMPLETED|Step 28||256
6597381|NCT02021955|7522332|FG000|NOT COMPLETED|Step 28||0
6597382|NCT02021955|7522333|FG001|NOT COMPLETED|Step 28||0
6597383|NCT02021955|7522332|FG000|STARTED|Step 29|Provider attrition=0; Provider addition=0; Patient discharges=0|10
6597384|NCT02021955|7522333|FG001|STARTED|Step 29|Provider attrition=1; Provider addition=2; Patient discharges=8|266
6597385|NCT02021955|7522332|FG000|COMPLETED|Step 29||10
6597386|NCT02021955|7522333|FG001|COMPLETED|Step 29||266
6597387|NCT02021955|7522332|FG000|NOT COMPLETED|Step 29||0
6597388|NCT02021955|7522333|FG001|NOT COMPLETED|Step 29||0
6597389|NCT02021955|7522332|FG000|STARTED|Step 30|Provider attrition=0; Provider addition=0; Patient discharges=0|0
6597390|NCT02021955|7522333|FG001|STARTED|Step 30|Provider attrition=0; Provider addition=1; Patient discharges=11|277
6597391|NCT02021955|7522332|FG000|COMPLETED|Step 30||0
6597392|NCT02021955|7522333|FG001|COMPLETED|Step 30||277
6597393|NCT02021955|7522332|FG000|NOT COMPLETED|Step 30||0
6597394|NCT02021955|7522333|FG001|NOT COMPLETED|Step 30||0
6597395|NCT02022007|7522342|FG000|STARTED|Overall Study||13
6597396|NCT02022007|7522343|FG001|STARTED|Overall Study||12
6597397|NCT02022007|7522344|FG002|STARTED|Overall Study||13
6597398|NCT02022007|7522342|FG000|COMPLETED|Overall Study||12
6597399|NCT02022007|7522343|FG001|COMPLETED|Overall Study||11
6597400|NCT02022007|7522344|FG002|COMPLETED|Overall Study||11
6597401|NCT02022007|7522342|FG000|NOT COMPLETED|Overall Study||1
6660927|NCT02502149|7591867|FG000|NOT COMPLETED|PK2 Assessment Period||0
6660928|NCT02502149|7591868|FG001|NOT COMPLETED|PK2 Assessment Period||0
6660929|NCT02502149|7591869|FG002|NOT COMPLETED|PK2 Assessment Period||0
6660930|NCT02502149|7591870|FG003|NOT COMPLETED|PK2 Assessment Period||0
6660931|NCT02502149|7591871|FG004|NOT COMPLETED|PK2 Assessment Period||0
6660932|NCT02502149|7591867|FG000|STARTED|Treatment Period||0
6660933|NCT02502149|7591868|FG001|STARTED|Treatment Period||0
6660934|NCT02502149|7591869|FG002|STARTED|Treatment Period||0
6660935|NCT02502149|7591870|FG003|STARTED|Treatment Period||11
6660936|NCT02502149|7591871|FG004|STARTED|Treatment Period||12
6660937|NCT02502149|7591867|FG000|COMPLETED|Treatment Period||0
6660938|NCT02502149|7591868|FG001|COMPLETED|Treatment Period||0
6660939|NCT02502149|7591869|FG002|COMPLETED|Treatment Period||0
6660940|NCT02502149|7591870|FG003|COMPLETED|Treatment Period||11
6660941|NCT02502149|7591871|FG004|COMPLETED|Treatment Period||12
6660942|NCT02502149|7591867|FG000|NOT COMPLETED|Treatment Period||0
6660943|NCT02502149|7591868|FG001|NOT COMPLETED|Treatment Period||0
6660944|NCT02502149|7591869|FG002|NOT COMPLETED|Treatment Period||0
6660945|NCT02502149|7591870|FG003|NOT COMPLETED|Treatment Period||0
6660946|NCT02502149|7591871|FG004|NOT COMPLETED|Treatment Period||0
6660947|NCT02502461|7591890|FG000|STARTED|Overall Study||46
6660948|NCT02502461|7591891|FG001|STARTED|Overall Study||44
6660949|NCT02502461|7591890|FG000|COMPLETED|Overall Study||46
6660950|NCT02502461|7591891|FG001|COMPLETED|Overall Study||44
6660951|NCT02502461|7591890|FG000|NOT COMPLETED|Overall Study||0
6660952|NCT02502461|7591891|FG001|NOT COMPLETED|Overall Study||0
6660953|NCT02502487|7591900|FG000|STARTED|Overall Study||86
6660954|NCT02502487|7591901|FG001|STARTED|Overall Study||86
6660955|NCT02502487|7591902|FG002|STARTED|Overall Study||86
6660956|NCT02502487|7591900|FG000|COMPLETED|Overall Study||86
6660957|NCT02502487|7591901|FG001|COMPLETED|Overall Study||86
6660958|NCT02502487|7591902|FG002|COMPLETED|Overall Study||86
6660959|NCT02502487|7591900|FG000|NOT COMPLETED|Overall Study||0
6660960|NCT02502487|7591901|FG001|NOT COMPLETED|Overall Study||0
6660961|NCT02502487|7591902|FG002|NOT COMPLETED|Overall Study||0
6660962|NCT02502526|7591913|FG000|STARTED|Overall Study||62
6660963|NCT02502526|7591914|FG001|STARTED|Overall Study||59
6660964|NCT02502526|7591915|FG002|STARTED|Overall Study||61
6660965|NCT02502526|7591913|FG000|Intent-to-Treat (ITT)|Overall Study||57
6660966|NCT02502526|7591914|FG001|Intent-to-Treat (ITT)|Overall Study||57
6660967|NCT02502526|7591915|FG002|Intent-to-Treat (ITT)|Overall Study||59
6660968|NCT02502526|7591913|FG000|COMPLETED|Overall Study||56
6660969|NCT02502526|7591914|FG001|COMPLETED|Overall Study||55
6660970|NCT02502526|7591915|FG002|COMPLETED|Overall Study||55
6660971|NCT02502526|7591913|FG000|NOT COMPLETED|Overall Study||6
6660972|NCT02502526|7591914|FG001|NOT COMPLETED|Overall Study||4
6660973|NCT02502526|7591915|FG002|NOT COMPLETED|Overall Study||6
6660974|NCT02502734|7591924|FG000|STARTED|Double-blind Treatment Period 1||30
6660975|NCT02502734|7591925|FG001|STARTED|Double-blind Treatment Period 1||30
6660976|NCT02502734|7591924|FG000|COMPLETED|Double-blind Treatment Period 1||29
6660977|NCT02502734|7591925|FG001|COMPLETED|Double-blind Treatment Period 1||30
6660978|NCT02502734|7591924|FG000|NOT COMPLETED|Double-blind Treatment Period 1||1
6660979|NCT02502734|7591925|FG001|NOT COMPLETED|Double-blind Treatment Period 1||0
6660980|NCT02502734|7591924|FG000|STARTED|Washout Period||29
6660981|NCT02502734|7591925|FG001|STARTED|Washout Period||30
6660982|NCT02502734|7591924|FG000|COMPLETED|Washout Period||28
6660983|NCT02502734|7591925|FG001|COMPLETED|Washout Period||30
6660984|NCT02502734|7591924|FG000|NOT COMPLETED|Washout Period||1
6597402|NCT02022007|7522343|FG001|NOT COMPLETED|Overall Study||1
6660985|NCT02502734|7591925|FG001|NOT COMPLETED|Washout Period||0
6660986|NCT02502734|7591924|FG000|STARTED|Double-blind Treatment Period 2||28
6660987|NCT02502734|7591925|FG001|STARTED|Double-blind Treatment Period 2||30
6660988|NCT02502734|7591924|FG000|COMPLETED|Double-blind Treatment Period 2||28
6660989|NCT02502734|7591925|FG001|COMPLETED|Double-blind Treatment Period 2||30
6660990|NCT02502734|7591924|FG000|NOT COMPLETED|Double-blind Treatment Period 2||0
6660991|NCT02502734|7591925|FG001|NOT COMPLETED|Double-blind Treatment Period 2||0
6660992|NCT02502864|7591933|FG000|STARTED|Overall Study||9
6660993|NCT02502864|7591933|FG000|COMPLETED|Overall Study||8
6660994|NCT02502864|7591933|FG000|NOT COMPLETED|Overall Study||1
6597403|NCT02022007|7522344|FG002|NOT COMPLETED|Overall Study||2
6597404|NCT02022020|7522352|FG000|STARTED|Overall Study||220
6597405|NCT02022020|7522352|FG000|COMPLETED|Overall Study||220
6597406|NCT02022020|7522352|FG000|NOT COMPLETED|Overall Study||0
6597407|NCT02022033|7522356|FG000|STARTED|Overall Study||25
6597408|NCT02022033|7522356|FG000|COMPLETED|Overall Study||24
6597409|NCT02022033|7522356|FG000|NOT COMPLETED|Overall Study||1
6597410|NCT02022085|7522360|FG000|STARTED|Overall Study||54
6597411|NCT02022085|7522360|FG000|COMPLETED|Overall Study||53
6597412|NCT02022085|7522360|FG000|NOT COMPLETED|Overall Study||1
6597413|NCT02022111|7522366|FG000|STARTED|Overall Study||196
6597414|NCT02022111|7522367|FG001|STARTED|Overall Study||208
6597415|NCT02022111|7522366|FG000|COMPLETED|Overall Study||186
6597416|NCT02022111|7522367|FG001|COMPLETED|Overall Study||193
6597417|NCT02022111|7522366|FG000|NOT COMPLETED|Overall Study||10
6597418|NCT02022111|7522367|FG001|NOT COMPLETED|Overall Study||15
6597419|NCT02022657|7522375|FG000|STARTED|Overall Study||10
6597420|NCT02022657|7522376|FG001|STARTED|Overall Study||8
6597421|NCT02022657|7522377|FG002|STARTED|Overall Study||9
6597422|NCT02022657|7522378|FG003|STARTED|Overall Study||8
6597423|NCT02022657|7522379|FG004|STARTED|Overall Study||8
6597424|NCT02022657|7522380|FG005|STARTED|Overall Study||9
6597425|NCT02022657|7522375|FG000|COMPLETED|Overall Study||8
6597426|NCT02022657|7522376|FG001|COMPLETED|Overall Study||8
6597427|NCT02022657|7522377|FG002|COMPLETED|Overall Study||8
6597428|NCT02022657|7522378|FG003|COMPLETED|Overall Study||8
6597429|NCT02022657|7522379|FG004|COMPLETED|Overall Study||8
6597430|NCT02022657|7522380|FG005|COMPLETED|Overall Study||8
6597431|NCT02022657|7522375|FG000|NOT COMPLETED|Overall Study||2
6597432|NCT02022657|7522376|FG001|NOT COMPLETED|Overall Study||0
6597433|NCT02022657|7522377|FG002|NOT COMPLETED|Overall Study||1
6597434|NCT02022657|7522378|FG003|NOT COMPLETED|Overall Study||0
6597435|NCT02022657|7522379|FG004|NOT COMPLETED|Overall Study||0
6597436|NCT02022657|7522380|FG005|NOT COMPLETED|Overall Study||1
6597437|NCT02022670|7522389|FG000|STARTED|Overall Study||11
6597438|NCT02022670|7522390|FG001|STARTED|Overall Study||10
6597439|NCT02022670|7522391|FG002|STARTED|Overall Study||12
6597440|NCT02022670|7522389|FG000|COMPLETED|Overall Study||10
6597441|NCT02022670|7522390|FG001|COMPLETED|Overall Study||10
6597442|NCT02022670|7522391|FG002|COMPLETED|Overall Study||11
6597443|NCT02022670|7522389|FG000|NOT COMPLETED|Overall Study||1
6597444|NCT02022670|7522390|FG001|NOT COMPLETED|Overall Study||0
6597445|NCT02022670|7522391|FG002|NOT COMPLETED|Overall Study||1
6597446|NCT02022735|7522400|FG000|STARTED|Overall Study||22
6597447|NCT02022735|7522400|FG000|COMPLETED|Overall Study||22
6597448|NCT02022735|7522400|FG000|NOT COMPLETED|Overall Study||0
6597449|NCT02022748|7522412|FG000|STARTED|Overall Study||8
6597450|NCT02022748|7522413|FG001|STARTED|Overall Study||6
6597451|NCT02022748|7522414|FG002|STARTED|Overall Study||13
6597452|NCT02022748|7522412|FG000|Subject Who Started Treatment|Overall Study||8
6597453|NCT02022748|7522413|FG001|Subject Who Started Treatment|Overall Study||6
6597454|NCT02022748|7522414|FG002|Subject Who Started Treatment|Overall Study||13
6597455|NCT02022748|7522412|FG000|Subjects Who Completed Treatment|Overall Study||7
6597456|NCT02022748|7522413|FG001|Subjects Who Completed Treatment|Overall Study||4
6597457|NCT02022748|7522414|FG002|Subjects Who Completed Treatment|Overall Study||13
6597458|NCT02022748|7522412|FG000|COMPLETED|Overall Study||7
6597459|NCT02022748|7522413|FG001|COMPLETED|Overall Study||4
6597460|NCT02022748|7522414|FG002|COMPLETED|Overall Study||13
6597461|NCT02022748|7522412|FG000|NOT COMPLETED|Overall Study||1
6597462|NCT02022748|7522413|FG001|NOT COMPLETED|Overall Study||2
6597463|NCT02022748|7522414|FG002|NOT COMPLETED|Overall Study||0
6597464|NCT02022826|7522422|FG000|STARTED|Overall Study||167
6597465|NCT02022826|7522422|FG000|COMPLETED|Overall Study||139
6597466|NCT02022826|7522422|FG000|NOT COMPLETED|Overall Study||28
6597467|NCT02023099|7522429|FG000|STARTED|Overall Study||215
6597468|NCT02023099|7522430|FG001|STARTED|Overall Study||106
6597469|NCT02023099|7522431|FG002|STARTED|Overall Study||42
6597470|NCT02023099|7522429|FG000|COMPLETED|Overall Study||212
6597471|NCT02023099|7522430|FG001|COMPLETED|Overall Study||106
6597472|NCT02023099|7522431|FG002|COMPLETED|Overall Study||39
6597473|NCT02023099|7522429|FG000|NOT COMPLETED|Overall Study||3
6597474|NCT02023099|7522430|FG001|NOT COMPLETED|Overall Study||0
6597475|NCT02023099|7522431|FG002|NOT COMPLETED|Overall Study||3
6597476|NCT02023112|7522441|FG000|STARTED|Overall Study||85
6597477|NCT02023112|7522442|FG001|STARTED|Overall Study||86
6597478|NCT02023112|7522441|FG000|COMPLETED|Overall Study||83
6597479|NCT02023112|7522442|FG001|COMPLETED|Overall Study||85
6597480|NCT02023112|7522441|FG000|NOT COMPLETED|Overall Study||2
6597481|NCT02023112|7522442|FG001|NOT COMPLETED|Overall Study||1
6597482|NCT02023125|7522452|FG000|STARTED|Period 1||9
6597483|NCT02023125|7522453|FG001|STARTED|Period 1||9
6597484|NCT02023125|7522454|FG002|STARTED|Period 1||24
6597485|NCT02023125|7522452|FG000|COMPLETED|Period 1||9
6597486|NCT02023125|7522453|FG001|COMPLETED|Period 1||9
6597487|NCT02023125|7522454|FG002|COMPLETED|Period 1||24
6597488|NCT02023125|7522452|FG000|NOT COMPLETED|Period 1||0
6597489|NCT02023125|7522453|FG001|NOT COMPLETED|Period 1||0
6597490|NCT02023125|7522454|FG002|NOT COMPLETED|Period 1||0
6597491|NCT02023125|7522452|FG000|STARTED|Washout Period||9
6597492|NCT02023125|7522453|FG001|STARTED|Washout Period||9
6597493|NCT02023125|7522454|FG002|STARTED|Washout Period||24
6597494|NCT02023125|7522452|FG000|COMPLETED|Washout Period||9
6597495|NCT02023125|7522453|FG001|COMPLETED|Washout Period||9
6597496|NCT02023125|7522454|FG002|COMPLETED|Washout Period||24
6597497|NCT02023125|7522452|FG000|NOT COMPLETED|Washout Period||0
6597498|NCT02023125|7522453|FG001|NOT COMPLETED|Washout Period||0
6597499|NCT02023125|7522454|FG002|NOT COMPLETED|Washout Period||0
6597500|NCT02023125|7522452|FG000|STARTED|Period 2||9
6597501|NCT02023125|7522453|FG001|STARTED|Period 2||9
6597502|NCT02023125|7522454|FG002|STARTED|Period 2||24
6597503|NCT02023125|7522452|FG000|COMPLETED|Period 2||9
6597504|NCT02023125|7522453|FG001|COMPLETED|Period 2||9
6597505|NCT02023125|7522454|FG002|COMPLETED|Period 2||24
6597506|NCT02023125|7522452|FG000|NOT COMPLETED|Period 2||0
6597507|NCT02023125|7522453|FG001|NOT COMPLETED|Period 2||0
6597508|NCT02023125|7522454|FG002|NOT COMPLETED|Period 2||0
6597509|NCT02023151|7522466|FG000|STARTED|Overall Study||17
6597510|NCT02023151|7522466|FG000|COMPLETED|Overall Study||13
6597511|NCT02023151|7522466|FG000|NOT COMPLETED|Overall Study||4
6597512|NCT02023242|7522472|FG000|STARTED|Overall Study||75
6660995|NCT02503085|7591937|FG000|STARTED|Period 1||7
6660996|NCT02503085|7591938|FG001|STARTED|Period 1||7
6660997|NCT02503085|7591939|FG002|STARTED|Period 1||7
6660998|NCT02503085|7591940|FG003|STARTED|Period 1||7
6660999|NCT02503085|7591937|FG000|COMPLETED|Period 1||7
6661000|NCT02503085|7591938|FG001|COMPLETED|Period 1||7
6661001|NCT02503085|7591939|FG002|COMPLETED|Period 1||7
6661002|NCT02503085|7591940|FG003|COMPLETED|Period 1||7
6661003|NCT02503085|7591937|FG000|NOT COMPLETED|Period 1||0
6661004|NCT02503085|7591938|FG001|NOT COMPLETED|Period 1||0
6661005|NCT02503085|7591939|FG002|NOT COMPLETED|Period 1||0
6661006|NCT02503085|7591940|FG003|NOT COMPLETED|Period 1||0
6661007|NCT02503085|7591937|FG000|STARTED|Period 1: Washout (3 to 7 Days)||7
6661008|NCT02503085|7591938|FG001|STARTED|Period 1: Washout (3 to 7 Days)||7
6661009|NCT02503085|7591939|FG002|STARTED|Period 1: Washout (3 to 7 Days)||7
6661010|NCT02503085|7591940|FG003|STARTED|Period 1: Washout (3 to 7 Days)||7
6661011|NCT02503085|7591937|FG000|COMPLETED|Period 1: Washout (3 to 7 Days)||7
6661012|NCT02503085|7591938|FG001|COMPLETED|Period 1: Washout (3 to 7 Days)||7
6661013|NCT02503085|7591939|FG002|COMPLETED|Period 1: Washout (3 to 7 Days)||7
6661014|NCT02503085|7591940|FG003|COMPLETED|Period 1: Washout (3 to 7 Days)||7
6661015|NCT02503085|7591937|FG000|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6661016|NCT02503085|7591938|FG001|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6661017|NCT02503085|7591939|FG002|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6661018|NCT02503085|7591940|FG003|NOT COMPLETED|Period 1: Washout (3 to 7 Days)||0
6661019|NCT02503085|7591937|FG000|STARTED|Period 2||7
6661020|NCT02503085|7591938|FG001|STARTED|Period 2||7
6661021|NCT02503085|7591939|FG002|STARTED|Period 2||7
6661022|NCT02503085|7591940|FG003|STARTED|Period 2||7
6661023|NCT02503085|7591937|FG000|COMPLETED|Period 2||7
6661024|NCT02503085|7591938|FG001|COMPLETED|Period 2||7
6661025|NCT02503085|7591939|FG002|COMPLETED|Period 2||7
6661026|NCT02503085|7591940|FG003|COMPLETED|Period 2||7
6661027|NCT02503085|7591937|FG000|NOT COMPLETED|Period 2||0
6661028|NCT02503085|7591938|FG001|NOT COMPLETED|Period 2||0
6661029|NCT02503085|7591939|FG002|NOT COMPLETED|Period 2||0
6661030|NCT02503085|7591940|FG003|NOT COMPLETED|Period 2||0
6661031|NCT02503085|7591937|FG000|STARTED|Period 2: Washout (3 to 7 Days)||7
6661032|NCT02503085|7591938|FG001|STARTED|Period 2: Washout (3 to 7 Days)||7
6661033|NCT02503085|7591939|FG002|STARTED|Period 2: Washout (3 to 7 Days)||7
6661034|NCT02503085|7591940|FG003|STARTED|Period 2: Washout (3 to 7 Days)||7
6661035|NCT02503085|7591937|FG000|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6661036|NCT02503085|7591938|FG001|COMPLETED|Period 2: Washout (3 to 7 Days)||7
6661037|NCT02503085|7591939|FG002|COMPLETED|Period 2: Washout (3 to 7 Days)||6
6661038|NCT02503085|7591940|FG003|COMPLETED|Period 2: Washout (3 to 7 Days)||7
6661039|NCT02503085|7591937|FG000|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
6661040|NCT02503085|7591938|FG001|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6661041|NCT02503085|7591939|FG002|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||1
6661042|NCT02503085|7591940|FG003|NOT COMPLETED|Period 2: Washout (3 to 7 Days)||0
6661043|NCT02503085|7591937|FG000|STARTED|Period 3||6
6661044|NCT02503085|7591938|FG001|STARTED|Period 3||7
6661045|NCT02503085|7591939|FG002|STARTED|Period 3||6
6661046|NCT02503085|7591940|FG003|STARTED|Period 3||7
6661047|NCT02503085|7591937|FG000|COMPLETED|Period 3||6
6661048|NCT02503085|7591938|FG001|COMPLETED|Period 3||7
6661049|NCT02503085|7591939|FG002|COMPLETED|Period 3||6
6661050|NCT02503085|7591940|FG003|COMPLETED|Period 3||7
6661051|NCT02503085|7591937|FG000|NOT COMPLETED|Period 3||0
6661052|NCT02503085|7591938|FG001|NOT COMPLETED|Period 3||0
6661053|NCT02503085|7591939|FG002|NOT COMPLETED|Period 3||0
6661054|NCT02503085|7591940|FG003|NOT COMPLETED|Period 3||0
6661055|NCT02503085|7591937|FG000|STARTED|Period 3: Washout (3 to 7 Days)||6
6661056|NCT02503085|7591938|FG001|STARTED|Period 3: Washout (3 to 7 Days)||7
6661057|NCT02503085|7591939|FG002|STARTED|Period 3: Washout (3 to 7 Days)||6
6661058|NCT02503085|7591940|FG003|STARTED|Period 3: Washout (3 to 7 Days)||7
6661059|NCT02503085|7591937|FG000|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6661060|NCT02503085|7591938|FG001|COMPLETED|Period 3: Washout (3 to 7 Days)||7
6661061|NCT02503085|7591939|FG002|COMPLETED|Period 3: Washout (3 to 7 Days)||6
6597513|NCT02023242|7522473|FG001|STARTED|Overall Study||77
6597514|NCT02023242|7522472|FG000|COMPLETED|Overall Study||72
6597515|NCT02023242|7522473|FG001|COMPLETED|Overall Study||75
6597516|NCT02023242|7522472|FG000|NOT COMPLETED|Overall Study||3
6661062|NCT02503085|7591940|FG003|COMPLETED|Period 3: Washout (3 to 7 Days)||7
6661063|NCT02503085|7591937|FG000|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6597517|NCT02023242|7522473|FG001|NOT COMPLETED|Overall Study||2
6597518|NCT02023268|7522481|FG000|STARTED|Overall Study||52
6597519|NCT02023268|7522482|FG001|STARTED|Overall Study||53
6597520|NCT02023268|7522481|FG000|COMPLETED|Overall Study||52
6661064|NCT02503085|7591938|FG001|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6661065|NCT02503085|7591939|FG002|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6661066|NCT02503085|7591940|FG003|NOT COMPLETED|Period 3: Washout (3 to 7 Days)||0
6661067|NCT02503085|7591937|FG000|STARTED|Period 4||6
6597521|NCT02023268|7522482|FG001|COMPLETED|Overall Study||49
6597522|NCT02023268|7522481|FG000|NOT COMPLETED|Overall Study||0
6597523|NCT02023268|7522482|FG001|NOT COMPLETED|Overall Study||4
6597524|NCT02023411|7522490|FG000|STARTED|Overall Study||10
6597525|NCT02023411|7522491|FG001|STARTED|Overall Study||10
6597526|NCT02023411|7522490|FG000|COMPLETED|Overall Study||10
6597527|NCT02023411|7522491|FG001|COMPLETED|Overall Study||10
6597528|NCT02023411|7522490|FG000|NOT COMPLETED|Overall Study||0
6597529|NCT02023411|7522491|FG001|NOT COMPLETED|Overall Study||0
6597530|NCT02023515|7522500|FG000|STARTED|Overall Study||24
6597531|NCT02023515|7522501|FG001|STARTED|Overall Study||25
6597532|NCT02023515|7522500|FG000|COMPLETED|Overall Study||23
6597533|NCT02023515|7522501|FG001|COMPLETED|Overall Study||22
6597534|NCT02023515|7522500|FG000|NOT COMPLETED|Overall Study||1
6597535|NCT02023515|7522501|FG001|NOT COMPLETED|Overall Study||3
6597536|NCT02023697|7522510|FG000|STARTED|Treatment Period||130
6597537|NCT02023697|7522511|FG001|STARTED|Treatment Period||130
6597538|NCT02023697|7522512|FG002|STARTED|Treatment Period||131
6597539|NCT02023697|7522510|FG000|Received Treatment|Treatment Period||125
6597540|NCT02023697|7522511|FG001|Received Treatment|Treatment Period||124
6597541|NCT02023697|7522512|FG002|Received Treatment|Treatment Period||121
6597542|NCT02023697|7522510|FG000|COMPLETED|Treatment Period||84
6597543|NCT02023697|7522511|FG001|COMPLETED|Treatment Period||67
6597544|NCT02023697|7522512|FG002|COMPLETED|Treatment Period||29
6597545|NCT02023697|7522510|FG000|NOT COMPLETED|Treatment Period||46
6597546|NCT02023697|7522511|FG001|NOT COMPLETED|Treatment Period||63
6597547|NCT02023697|7522512|FG002|NOT COMPLETED|Treatment Period||102
6597548|NCT02023697|7522510|FG000|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
6597549|NCT02023697|7522511|FG001|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|120
6597550|NCT02023697|7522512|FG002|STARTED|Active Follow-up Period|Not all participants in ITT entered active follow-up.|116
6597551|NCT02023697|7522510|FG000|COMPLETED|Active Follow-up Period||28
6597552|NCT02023697|7522511|FG001|COMPLETED|Active Follow-up Period||21
6597553|NCT02023697|7522512|FG002|COMPLETED|Active Follow-up Period||17
6597554|NCT02023697|7522510|FG000|NOT COMPLETED|Active Follow-up Period||92
6597555|NCT02023697|7522511|FG001|NOT COMPLETED|Active Follow-up Period||99
6597556|NCT02023697|7522512|FG002|NOT COMPLETED|Active Follow-up Period||99
6597557|NCT02023697|7522510|FG000|STARTED|Long-term Follow-up Period||28
6597558|NCT02023697|7522511|FG001|STARTED|Long-term Follow-up Period||21
6597559|NCT02023697|7522512|FG002|STARTED|Long-term Follow-up Period||17
6597560|NCT02023697|7522510|FG000|COMPLETED|Long-term Follow-up Period||0
6597561|NCT02023697|7522511|FG001|COMPLETED|Long-term Follow-up Period||0
6597562|NCT02023697|7522512|FG002|COMPLETED|Long-term Follow-up Period||0
6597563|NCT02023697|7522510|FG000|NOT COMPLETED|Long-term Follow-up Period||28
6597564|NCT02023697|7522511|FG001|NOT COMPLETED|Long-term Follow-up Period||21
6597565|NCT02023697|7522512|FG002|NOT COMPLETED|Long-term Follow-up Period||17
6597566|NCT02023801|7522527|FG000|STARTED|Overall Study|Treatment Attempted|24
6597567|NCT02023801|7522527|FG000|Treated|Overall Study|Treatment Completed|24
6597568|NCT02023801|7522527|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
6597569|NCT02023801|7522527|FG000|NOT COMPLETED|Overall Study||0
6597570|NCT02023866|7522531|FG000|STARTED|Overall Study||36
6597571|NCT02023866|7522531|FG000|COMPLETED|Overall Study||30
6597572|NCT02023866|7522531|FG000|NOT COMPLETED|Overall Study||6
6597573|NCT02023879|7522538|FG000|STARTED|Period 1: 24-Week Double-blind Treatment||58
6597574|NCT02023879|7522539|FG001|STARTED|Period 1: 24-Week Double-blind Treatment||116
6597575|NCT02023879|7522540|FG002|STARTED|Period 1: 24-Week Double-blind Treatment||59
6597576|NCT02023879|7522538|FG000|Treated|Period 1: 24-Week Double-blind Treatment||58
6597577|NCT02023879|7522539|FG001|Treated|Period 1: 24-Week Double-blind Treatment||115
6597578|NCT02023879|7522540|FG002|Treated|Period 1: 24-Week Double-blind Treatment||58
6597579|NCT02023879|7522538|FG000|COMPLETED|Period 1: 24-Week Double-blind Treatment||54
6597580|NCT02023879|7522539|FG001|COMPLETED|Period 1: 24-Week Double-blind Treatment||107
6597581|NCT02023879|7522540|FG002|COMPLETED|Period 1: 24-Week Double-blind Treatment||50
6597582|NCT02023879|7522538|FG000|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||4
6597583|NCT02023879|7522539|FG001|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
6597584|NCT02023879|7522540|FG002|NOT COMPLETED|Period 1: 24-Week Double-blind Treatment||9
6597585|NCT02023879|7522538|FG000|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|51
6597586|NCT02023879|7522539|FG001|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|106
6597587|NCT02023879|7522540|FG002|STARTED|Extension Open Label Treatment|The open-label extension period was optional for participants who completed the double-blind period.|48
6597588|NCT02023879|7522538|FG000|COMPLETED|Extension Open Label Treatment||46
6597589|NCT02023879|7522539|FG001|COMPLETED|Extension Open Label Treatment||89
6597590|NCT02023879|7522540|FG002|COMPLETED|Extension Open Label Treatment||43
6597591|NCT02023879|7522538|FG000|NOT COMPLETED|Extension Open Label Treatment||5
6597592|NCT02023879|7522539|FG001|NOT COMPLETED|Extension Open Label Treatment||17
6597593|NCT02023879|7522540|FG002|NOT COMPLETED|Extension Open Label Treatment||5
6597594|NCT02023918|7522555|FG000|STARTED|Overall Study||6
6597595|NCT02023918|7522555|FG000|COMPLETED|Overall Study||6
6597596|NCT02023918|7522555|FG000|NOT COMPLETED|Overall Study||0
6597597|NCT02023944|7522561|FG000|STARTED|Overall Study||25
6597598|NCT02023944|7522562|FG001|STARTED|Overall Study||25
6597599|NCT02023944|7522561|FG000|COMPLETED|Overall Study||25
6597600|NCT02023944|7522562|FG001|COMPLETED|Overall Study||24
6597601|NCT02023944|7522561|FG000|NOT COMPLETED|Overall Study||0
6597602|NCT02023944|7522562|FG001|NOT COMPLETED|Overall Study||1
6597603|NCT02023983|7522571|FG000|STARTED|Overall Study||76
6597604|NCT02023983|7522572|FG001|STARTED|Overall Study||75
6597605|NCT02023983|7522571|FG000|COMPLETED|Overall Study||76
6597606|NCT02023983|7522572|FG001|COMPLETED|Overall Study||75
6597607|NCT02023983|7522571|FG000|NOT COMPLETED|Overall Study||0
6597608|NCT02023983|7522572|FG001|NOT COMPLETED|Overall Study||0
6597609|NCT02024087|7522580|FG000|STARTED|Overall Study||5
6597610|NCT02024087|7522581|FG001|STARTED|Overall Study|Dose change to 0.4 mg/kg and cohort expanded to 16 participants in total at this dose level|16
6597611|NCT02024087|7522580|FG000|COMPLETED|Overall Study||5
6597612|NCT02024087|7522581|FG001|COMPLETED|Overall Study||16
6597613|NCT02024087|7522580|FG000|NOT COMPLETED|Overall Study||0
6597614|NCT02024087|7522581|FG001|NOT COMPLETED|Overall Study||0
6597615|NCT02024165|7522588|FG000|STARTED|Overall Study||71
6597616|NCT02024165|7522588|FG000|COMPLETED|Overall Study||71
6597617|NCT02024165|7522588|FG000|NOT COMPLETED|Overall Study||0
6597618|NCT02024204|7522595|FG000|STARTED|Overall Study||49
6597619|NCT02024204|7522596|FG001|STARTED|Overall Study||11
6661068|NCT02503085|7591938|FG001|STARTED|Period 4||7
6661069|NCT02503085|7591939|FG002|STARTED|Period 4||6
6661070|NCT02503085|7591940|FG003|STARTED|Period 4||7
6661071|NCT02503085|7591937|FG000|COMPLETED|Period 4||6
6661072|NCT02503085|7591938|FG001|COMPLETED|Period 4||7
6661073|NCT02503085|7591939|FG002|COMPLETED|Period 4||6
6661074|NCT02503085|7591940|FG003|COMPLETED|Period 4||7
6661075|NCT02503085|7591937|FG000|NOT COMPLETED|Period 4||0
6661076|NCT02503085|7591938|FG001|NOT COMPLETED|Period 4||0
6661077|NCT02503085|7591939|FG002|NOT COMPLETED|Period 4||0
6661078|NCT02503085|7591940|FG003|NOT COMPLETED|Period 4||0
6661079|NCT02503202|7591952|FG000|STARTED|Base Study: Up to Month 6||266
6661080|NCT02503202|7591953|FG001|STARTED|Base Study: Up to Month 6||265
6661081|NCT02503202|7591954|FG002|STARTED|Base Study: Up to Month 6||267
6661082|NCT02503202|7591955|FG003|STARTED|Base Study: Up to Month 6||266
6661083|NCT02503202|7591956|FG004|STARTED|Base Study: Up to Month 6||133
6661084|NCT02503202|7591952|FG000|Vaccinated|Base Study: Up to Month 6||266
6661085|NCT02503202|7591953|FG001|Vaccinated|Base Study: Up to Month 6||265
6661086|NCT02503202|7591954|FG002|Vaccinated|Base Study: Up to Month 6||266
6661087|NCT02503202|7591955|FG003|Vaccinated|Base Study: Up to Month 6||264
6661088|NCT02503202|7591956|FG004|Vaccinated|Base Study: Up to Month 6||133
6661089|NCT02503202|7591952|FG000|COMPLETED|Base Study: Up to Month 6||248
6661090|NCT02503202|7591953|FG001|COMPLETED|Base Study: Up to Month 6||253
6661091|NCT02503202|7591954|FG002|COMPLETED|Base Study: Up to Month 6||252
6661092|NCT02503202|7591955|FG003|COMPLETED|Base Study: Up to Month 6||255
6661093|NCT02503202|7591956|FG004|COMPLETED|Base Study: Up to Month 6||130
6661094|NCT02503202|7591952|FG000|NOT COMPLETED|Base Study: Up to Month 6||18
6661095|NCT02503202|7591953|FG001|NOT COMPLETED|Base Study: Up to Month 6||12
6661096|NCT02503202|7591954|FG002|NOT COMPLETED|Base Study: Up to Month 6||15
6661097|NCT02503202|7591955|FG003|NOT COMPLETED|Base Study: Up to Month 6||11
6661098|NCT02503202|7591956|FG004|NOT COMPLETED|Base Study: Up to Month 6||3
6661099|NCT02503202|7591952|FG000|STARTED|Extension: Month 6 to 24||119
6661100|NCT02503202|7591953|FG001|STARTED|Extension: Month 6 to 24||130
6661101|NCT02503202|7591954|FG002|STARTED|Extension: Month 6 to 24||112
6661102|NCT02503202|7591955|FG003|STARTED|Extension: Month 6 to 24||137
6661103|NCT02503202|7591956|FG004|STARTED|Extension: Month 6 to 24||68
6661104|NCT02503202|7591952|FG000|COMPLETED|Extension: Month 6 to 24||108
6661105|NCT02503202|7591953|FG001|COMPLETED|Extension: Month 6 to 24||114
6661106|NCT02503202|7591954|FG002|COMPLETED|Extension: Month 6 to 24||103
6661107|NCT02503202|7591955|FG003|COMPLETED|Extension: Month 6 to 24||119
6661108|NCT02503202|7591956|FG004|COMPLETED|Extension: Month 6 to 24||67
6661109|NCT02503202|7591952|FG000|NOT COMPLETED|Extension: Month 6 to 24||11
6661110|NCT02503202|7591953|FG001|NOT COMPLETED|Extension: Month 6 to 24||16
6661111|NCT02503202|7591954|FG002|NOT COMPLETED|Extension: Month 6 to 24||9
6661112|NCT02503202|7591955|FG003|NOT COMPLETED|Extension: Month 6 to 24||18
6661113|NCT02503202|7591956|FG004|NOT COMPLETED|Extension: Month 6 to 24||1
6661114|NCT02503215|7591968|FG000|STARTED|Overall Study||17
6661115|NCT02503215|7591968|FG000|COMPLETED|Overall Study||14
6661116|NCT02503215|7591968|FG000|NOT COMPLETED|Overall Study||3
6661117|NCT02503254|7591974|FG000|STARTED|Overall Study||41
6661118|NCT02503254|7591975|FG001|STARTED|Overall Study||39
6661119|NCT02503254|7591974|FG000|COMPLETED|Overall Study||41
6597620|NCT02024204|7522595|FG000|COMPLETED|Overall Study||49
6597621|NCT02024204|7522596|FG001|COMPLETED|Overall Study||11
6597622|NCT02024204|7522595|FG000|NOT COMPLETED|Overall Study||0
6597623|NCT02024204|7522596|FG001|NOT COMPLETED|Overall Study||0
6597624|NCT02024386|7522605|FG000|STARTED|Overall Study||6
6597625|NCT02024386|7522606|FG001|STARTED|Overall Study||11
6597626|NCT02024386|7522607|FG002|STARTED|Overall Study||5
6597627|NCT02024386|7522605|FG000|COMPLETED|Overall Study||6
6597628|NCT02024386|7522606|FG001|COMPLETED|Overall Study||11
6597629|NCT02024386|7522607|FG002|COMPLETED|Overall Study||5
6597630|NCT02024386|7522605|FG000|NOT COMPLETED|Overall Study||0
6597631|NCT02024386|7522606|FG001|NOT COMPLETED|Overall Study||0
6597632|NCT02024386|7522607|FG002|NOT COMPLETED|Overall Study||0
6597633|NCT02024477|7522618|FG000|STARTED|Overall Study||21
6597634|NCT02024477|7522619|FG001|STARTED|Overall Study||21
6597635|NCT02024477|7522618|FG000|COMPLETED|Overall Study||21
6597636|NCT02024477|7522619|FG001|COMPLETED|Overall Study||21
6597637|NCT02024477|7522618|FG000|NOT COMPLETED|Overall Study||0
6597638|NCT02024477|7522619|FG001|NOT COMPLETED|Overall Study||0
6597639|NCT02024646|7522628|FG000|STARTED|Overall Study||163
6597640|NCT02024646|7522629|FG001|STARTED|Overall Study||160
6597641|NCT02024646|7522630|FG002|STARTED|Overall Study||161
6597642|NCT02024646|7522628|FG000|COMPLETED|Overall Study||131
6597643|NCT02024646|7522629|FG001|COMPLETED|Overall Study||135
6597644|NCT02024646|7522630|FG002|COMPLETED|Overall Study||133
6597645|NCT02024646|7522628|FG000|NOT COMPLETED|Overall Study||32
6597646|NCT02024646|7522629|FG001|NOT COMPLETED|Overall Study||25
6597647|NCT02024646|7522630|FG002|NOT COMPLETED|Overall Study||28
6597648|NCT02024698|7522638|FG000|STARTED|First Intervention (7 Days)||16
6597649|NCT02024698|7522639|FG001|STARTED|First Intervention (7 Days)||27
6597650|NCT02024698|7522638|FG000|COMPLETED|First Intervention (7 Days)||16
6597651|NCT02024698|7522639|FG001|COMPLETED|First Intervention (7 Days)||26
6597652|NCT02024698|7522638|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6597653|NCT02024698|7522639|FG001|NOT COMPLETED|First Intervention (7 Days)||1
6597654|NCT02024698|7522638|FG000|STARTED|Second Intervention (7 Days)||16
6597655|NCT02024698|7522639|FG001|STARTED|Second Intervention (7 Days)||26
6597656|NCT02024698|7522638|FG000|Received Etafilcon A Twice|Second Intervention (7 Days)||1
6597657|NCT02024698|7522639|FG001|Received Etafilcon A Twice|Second Intervention (7 Days)||0
6597658|NCT02024698|7522638|FG000|COMPLETED|Second Intervention (7 Days)||16
6597659|NCT02024698|7522639|FG001|COMPLETED|Second Intervention (7 Days)||26
6597660|NCT02024698|7522638|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6597661|NCT02024698|7522639|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6597662|NCT02024711|7522647|FG000|STARTED|Overall Study||130
6597663|NCT02024711|7522648|FG001|STARTED|Overall Study||132
6597664|NCT02024711|7522647|FG000|COMPLETED|Overall Study||129
6597665|NCT02024711|7522648|FG001|COMPLETED|Overall Study||128
6597666|NCT02024711|7522647|FG000|NOT COMPLETED|Overall Study||1
6661120|NCT02503254|7591975|FG001|COMPLETED|Overall Study||39
6661121|NCT02503254|7591974|FG000|NOT COMPLETED|Overall Study||0
6661122|NCT02503254|7591975|FG001|NOT COMPLETED|Overall Study||0
6661123|NCT02503332|7591985|FG000|STARTED|Overall Study||86
6661124|NCT02503332|7591986|FG001|STARTED|Overall Study||79
6661125|NCT02503332|7591987|FG002|STARTED|Overall Study||41
6661126|NCT02503332|7591988|FG003|STARTED|Overall Study||40
6661127|NCT02503332|7591985|FG000|COMPLETED|Overall Study||52
6661128|NCT02503332|7591986|FG001|COMPLETED|Overall Study||60
6661129|NCT02503332|7591987|FG002|COMPLETED|Overall Study||33
6661130|NCT02503332|7591988|FG003|COMPLETED|Overall Study||36
6661131|NCT02503332|7591985|FG000|NOT COMPLETED|Overall Study||34
6661132|NCT02503332|7591986|FG001|NOT COMPLETED|Overall Study||19
6661133|NCT02503332|7591987|FG002|NOT COMPLETED|Overall Study||8
6661134|NCT02503332|7591988|FG003|NOT COMPLETED|Overall Study||4
6661135|NCT02503410|7592004|FG000|STARTED|Overall Study||4
6661136|NCT02503410|7592005|FG001|STARTED|Overall Study||3
6661137|NCT02503410|7592004|FG000|COMPLETED|Overall Study||4
6661138|NCT02503410|7592005|FG001|COMPLETED|Overall Study||3
6661139|NCT02503410|7592004|FG000|NOT COMPLETED|Overall Study||0
6661140|NCT02503410|7592005|FG001|NOT COMPLETED|Overall Study||0
6661141|NCT02503501|7592018|FG000|STARTED|Overall Study||19
6661142|NCT02503501|7592019|FG001|STARTED|Overall Study||16
6661143|NCT02503501|7592018|FG000|COMPLETED|Overall Study||18
6661144|NCT02503501|7592019|FG001|COMPLETED|Overall Study||13
6661145|NCT02503501|7592018|FG000|NOT COMPLETED|Overall Study||1
6661146|NCT02503501|7592019|FG001|NOT COMPLETED|Overall Study||3
6661147|NCT02503540|7592025|FG000|STARTED|Overall Study||31
6661148|NCT02503540|7592025|FG000|COMPLETED|Overall Study||28
6661149|NCT02503540|7592025|FG000|NOT COMPLETED|Overall Study||3
6597667|NCT02024711|7522648|FG001|NOT COMPLETED|Overall Study||4
6597668|NCT02024724|7522656|FG000|STARTED|Overall Study||30
6597669|NCT02024724|7522657|FG001|STARTED|Overall Study||30
6597670|NCT02024724|7522656|FG000|COMPLETED|Overall Study||29
6597671|NCT02024724|7522657|FG001|COMPLETED|Overall Study||30
6597672|NCT02024724|7522656|FG000|NOT COMPLETED|Overall Study||1
6597673|NCT02024724|7522657|FG001|NOT COMPLETED|Overall Study||0
6597674|NCT02024750|7522665|FG000|STARTED|Overall Study||106
6597675|NCT02024750|7522666|FG001|STARTED|Overall Study||108
6597676|NCT02024750|7522665|FG000|COMPLETED|Overall Study||104
6597677|NCT02024750|7522666|FG001|COMPLETED|Overall Study||107
6597678|NCT02024750|7522665|FG000|NOT COMPLETED|Overall Study||2
6597679|NCT02024750|7522666|FG001|NOT COMPLETED|Overall Study||1
6597680|NCT02024867|7522674|FG000|STARTED|Overall Study||134
6597681|NCT02024867|7522675|FG001|STARTED|Overall Study||131
6597682|NCT02024867|7522674|FG000|COMPLETED|Overall Study||125
6597683|NCT02024867|7522675|FG001|COMPLETED|Overall Study||124
6661150|NCT02503735|7592029|FG000|STARTED|Overall Study||10
6661151|NCT02503735|7592029|FG000|SVR 12 (12week Post Treatment RNA Neg)|Overall Study||8
6661152|NCT02503735|7592029|FG000|COMPLETED|Overall Study||10
6661153|NCT02503735|7592029|FG000|NOT COMPLETED|Overall Study||0
6661154|NCT02503787|7592039|FG000|STARTED|Enrollment||64
6661155|NCT02503787|7592039|FG000|COMPLETED|Enrollment||44
6661156|NCT02503787|7592039|FG000|NOT COMPLETED|Enrollment||20
6597684|NCT02024867|7522674|FG000|NOT COMPLETED|Overall Study||9
6597685|NCT02024867|7522675|FG001|NOT COMPLETED|Overall Study||7
6597686|NCT02024932|7522687|FG000|STARTED|Overall Study||2
6597687|NCT02024932|7522688|FG001|STARTED|Overall Study||4
6597688|NCT02024932|7522689|FG002|STARTED|Overall Study||2
6597689|NCT02024932|7522690|FG003|STARTED|Overall Study||2
6597690|NCT02024932|7522691|FG004|STARTED|Overall Study||18
6597691|NCT02024932|7522692|FG005|STARTED|Overall Study||9
6597692|NCT02024932|7522687|FG000|Safety Analysis Set|Overall Study||2
6597693|NCT02024932|7522688|FG001|Safety Analysis Set|Overall Study||4
6597694|NCT02024932|7522689|FG002|Safety Analysis Set|Overall Study||2
6597695|NCT02024932|7522690|FG003|Safety Analysis Set|Overall Study||2
6597696|NCT02024932|7522691|FG004|Safety Analysis Set|Overall Study||18
6597697|NCT02024932|7522692|FG005|Safety Analysis Set|Overall Study||9
6597698|NCT02024932|7522687|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||2
6597699|NCT02024932|7522688|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6597700|NCT02024932|7522689|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6597701|NCT02024932|7522690|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||2
6597702|NCT02024932|7522691|FG004|Pharmacokinetic (PK) Analysis Set|Overall Study||18
6597703|NCT02024932|7522692|FG005|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6597704|NCT02024932|7522687|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||2
6597705|NCT02024932|7522688|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
6597706|NCT02024932|7522689|FG002|Pharmacodynamic (PD) Analysis Set|Overall Study||2
6597707|NCT02024932|7522690|FG003|Pharmacodynamic (PD) Analysis Set|Overall Study||2
6597708|NCT02024932|7522691|FG004|Pharmacodynamic (PD) Analysis Set|Overall Study||18
6597709|NCT02024932|7522692|FG005|Pharmacodynamic (PD) Analysis Set|Overall Study||9
6597710|NCT02024932|7522687|FG000|COMPLETED|Overall Study||0
6597711|NCT02024932|7522688|FG001|COMPLETED|Overall Study||1
6597712|NCT02024932|7522689|FG002|COMPLETED|Overall Study||2
6597713|NCT02024932|7522690|FG003|COMPLETED|Overall Study||0
6597714|NCT02024932|7522691|FG004|COMPLETED|Overall Study||16
6597715|NCT02024932|7522692|FG005|COMPLETED|Overall Study||9
6597716|NCT02024932|7522687|FG000|NOT COMPLETED|Overall Study||2
6597717|NCT02024932|7522688|FG001|NOT COMPLETED|Overall Study||3
6597718|NCT02024932|7522689|FG002|NOT COMPLETED|Overall Study||0
6597719|NCT02024932|7522690|FG003|NOT COMPLETED|Overall Study||2
6597720|NCT02024932|7522691|FG004|NOT COMPLETED|Overall Study||2
6597721|NCT02024932|7522692|FG005|NOT COMPLETED|Overall Study||0
6597722|NCT02024971|7522712|FG000|STARTED|Overall Study||1103
6597723|NCT02024971|7522712|FG000|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
6597724|NCT02024971|7522712|FG000|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
6597725|NCT02024971|7522712|FG000|NOT COMPLETED|Overall Study||36
6597726|NCT02025075|7522718|FG000|STARTED|Overall Study||16
6597727|NCT02025075|7522719|FG001|STARTED|Overall Study||21
6597728|NCT02025075|7522718|FG000|COMPLETED|Overall Study||16
6597729|NCT02025075|7522719|FG001|COMPLETED|Overall Study||19
6597730|NCT02025075|7522718|FG000|NOT COMPLETED|Overall Study||0
6597731|NCT02025075|7522719|FG001|NOT COMPLETED|Overall Study||2
6597732|NCT02025179|7522734|FG000|STARTED|Overall Study||8
6597733|NCT02025179|7522735|FG001|STARTED|Overall Study||9
6597734|NCT02025179|7522736|FG002|STARTED|Overall Study||8
6597735|NCT02025179|7522734|FG000|COMPLETED|Overall Study||8
6597736|NCT02025179|7522735|FG001|COMPLETED|Overall Study||9
6597737|NCT02025179|7522736|FG002|COMPLETED|Overall Study||7
6597738|NCT02025179|7522734|FG000|NOT COMPLETED|Overall Study||0
6597739|NCT02025179|7522735|FG001|NOT COMPLETED|Overall Study||0
6661157|NCT02503787|7592039|FG000|STARTED|Device Trial (HD Programming Trial)||44
6661158|NCT02503787|7592039|FG000|COMPLETED|Device Trial (HD Programming Trial)||37
6661159|NCT02503787|7592039|FG000|NOT COMPLETED|Device Trial (HD Programming Trial)||7
6661160|NCT02503787|7592039|FG000|STARTED|Successful Trial (≥50% Pain Relief)||37
6661161|NCT02503787|7592039|FG000|COMPLETED|Successful Trial (≥50% Pain Relief)||32
6661162|NCT02503787|7592039|FG000|NOT COMPLETED|Successful Trial (≥50% Pain Relief)||5
6661163|NCT02503787|7592039|FG000|STARTED|Implant to 3 Month Endpoint||32
6661164|NCT02503787|7592039|FG000|COMPLETED|Implant to 3 Month Endpoint||29
6661165|NCT02503787|7592039|FG000|NOT COMPLETED|Implant to 3 Month Endpoint||3
6661166|NCT02503852|7592047|FG000|STARTED|Overall Study||16
6597740|NCT02025179|7522736|FG002|NOT COMPLETED|Overall Study||1
6597741|NCT02025205|7522746|FG000|STARTED|Overall Study||43
6597742|NCT02025205|7522747|FG001|STARTED|Overall Study||50
6597743|NCT02025205|7522746|FG000|COMPLETED|Overall Study||40
6597744|NCT02025205|7522747|FG001|COMPLETED|Overall Study||47
6597745|NCT02025205|7522746|FG000|NOT COMPLETED|Overall Study||3
6597746|NCT02025205|7522747|FG001|NOT COMPLETED|Overall Study||3
6597747|NCT02025426|7522755|FG000|STARTED|Overall Study||9
6597748|NCT02025426|7522756|FG001|STARTED|Overall Study||4
6597749|NCT02025426|7522755|FG000|COMPLETED|Overall Study||9
6597750|NCT02025426|7522756|FG001|COMPLETED|Overall Study||4
6597751|NCT02025426|7522755|FG000|NOT COMPLETED|Overall Study||0
6597752|NCT02025426|7522756|FG001|NOT COMPLETED|Overall Study||0
6597753|NCT02025439|7522764|FG000|STARTED|Overall Study||2
6597754|NCT02025439|7522765|FG001|STARTED|Overall Study||2
6597755|NCT02025439|7522764|FG000|COMPLETED|Overall Study||2
6597756|NCT02025439|7522765|FG001|COMPLETED|Overall Study||2
6597757|NCT02025439|7522764|FG000|NOT COMPLETED|Overall Study||0
6597758|NCT02025439|7522765|FG001|NOT COMPLETED|Overall Study||0
6597759|NCT02025530|7522775|FG000|STARTED|Overall Study||296
6597760|NCT02025530|7522776|FG001|STARTED|Overall Study||734
6597761|NCT02025530|7522775|FG000|COMPLETED|Overall Study||291
6597762|NCT02025530|7522776|FG001|COMPLETED|Overall Study||733
6597763|NCT02025530|7522775|FG000|NOT COMPLETED|Overall Study||5
6597764|NCT02025530|7522776|FG001|NOT COMPLETED|Overall Study||1
6597765|NCT02025621|7522784|FG000|STARTED|Overall Study||442
6597766|NCT02025621|7522785|FG001|STARTED|Overall Study||440
6597767|NCT02025621|7522784|FG000|COMPLETED|Overall Study||428
6597768|NCT02025621|7522785|FG001|COMPLETED|Overall Study||421
6597769|NCT02025621|7522784|FG000|NOT COMPLETED|Overall Study||14
6597770|NCT02025621|7522785|FG001|NOT COMPLETED|Overall Study||19
6597771|NCT02025634|7522793|FG000|STARTED|Overall Study||65
6597772|NCT02025634|7522794|FG001|STARTED|Overall Study||54
6597773|NCT02025634|7522793|FG000|COMPLETED|Overall Study||65
6597774|NCT02025634|7522794|FG001|COMPLETED|Overall Study||54
6597775|NCT02025634|7522793|FG000|NOT COMPLETED|Overall Study||0
6597776|NCT02025634|7522794|FG001|NOT COMPLETED|Overall Study||0
6624782|NCT02219932|7552304|FG001|COMPLETED|Overall Study||266
6624783|NCT02219932|7552303|FG000|NOT COMPLETED|Overall Study||65
6624784|NCT02219932|7552304|FG001|NOT COMPLETED|Overall Study||51
6624785|NCT02219997|7552312|FG000|STARTED|First Filter||33
6624786|NCT02219997|7552313|FG001|STARTED|First Filter||17
6624787|NCT02219997|7552314|FG002|STARTED|First Filter||18
6624788|NCT02219997|7552312|FG000|COMPLETED|First Filter||33
6624789|NCT02219997|7552313|FG001|COMPLETED|First Filter||17
6624790|NCT02219997|7552314|FG002|COMPLETED|First Filter||18
6624791|NCT02219997|7552312|FG000|NOT COMPLETED|First Filter||0
6624792|NCT02219997|7552313|FG001|NOT COMPLETED|First Filter||0
6624793|NCT02219997|7552314|FG002|NOT COMPLETED|First Filter||0
6624794|NCT02219997|7552312|FG000|STARTED|Second Filter||0
6624795|NCT02219997|7552313|FG001|STARTED|Second Filter||17
6624796|NCT02219997|7552314|FG002|STARTED|Second Filter||18
6624797|NCT02219997|7552312|FG000|COMPLETED|Second Filter||0
6624798|NCT02219997|7552313|FG001|COMPLETED|Second Filter||17
6624799|NCT02219997|7552314|FG002|COMPLETED|Second Filter||18
6624800|NCT02219997|7552312|FG000|NOT COMPLETED|Second Filter||0
6624801|NCT02219997|7552313|FG001|NOT COMPLETED|Second Filter||0
6624802|NCT02219997|7552314|FG002|NOT COMPLETED|Second Filter||0
6624803|NCT02220205|7552327|FG000|STARTED|Overall Study||30
6624804|NCT02220205|7552328|FG001|STARTED|Overall Study||30
6624805|NCT02220205|7552327|FG000|COMPLETED|Overall Study||29
6624806|NCT02220205|7552328|FG001|COMPLETED|Overall Study||30
6624807|NCT02220205|7552327|FG000|NOT COMPLETED|Overall Study||1
6624808|NCT02220205|7552328|FG001|NOT COMPLETED|Overall Study||0
6624809|NCT02220712|7552334|FG000|STARTED|Overall Study||17
6624810|NCT02220712|7552334|FG000|COMPLETED|Overall Study||13
6624811|NCT02220712|7552334|FG000|NOT COMPLETED|Overall Study||4
6624812|NCT02220725|7552346|FG000|STARTED|Overall Study||14
6624813|NCT02220725|7552347|FG001|STARTED|Overall Study||27
6624814|NCT02220725|7552348|FG002|STARTED|Overall Study||13
6624815|NCT02220725|7552349|FG003|STARTED|Overall Study||26
6624816|NCT02220725|7552346|FG000|COMPLETED|Overall Study||14
6624817|NCT02220725|7552347|FG001|COMPLETED|Overall Study||27
6624818|NCT02220725|7552348|FG002|COMPLETED|Overall Study||13
6624819|NCT02220725|7552349|FG003|COMPLETED|Overall Study||24
6624820|NCT02220725|7552346|FG000|NOT COMPLETED|Overall Study||0
6624821|NCT02220725|7552347|FG001|NOT COMPLETED|Overall Study||0
6624822|NCT02220725|7552348|FG002|NOT COMPLETED|Overall Study||0
6624823|NCT02220725|7552349|FG003|NOT COMPLETED|Overall Study||2
6624824|NCT02220764|7552364|FG000|STARTED|Overall Study||24
6624825|NCT02220764|7552365|FG001|STARTED|Overall Study||8
6624826|NCT02220764|7552364|FG000|COMPLETED|Overall Study||20
6624827|NCT02220764|7552365|FG001|COMPLETED|Overall Study||7
6624828|NCT02220764|7552364|FG000|NOT COMPLETED|Overall Study||4
6624829|NCT02220764|7552365|FG001|NOT COMPLETED|Overall Study||1
6624830|NCT02220907|7552371|FG000|STARTED|Overall Study||153
6624831|NCT02220907|7552371|FG000|COMPLETED|Overall Study||142
6624832|NCT02220907|7552371|FG000|NOT COMPLETED|Overall Study||11
6624833|NCT02220920|7552377|FG000|STARTED|Overall Study||76
6624834|NCT02220920|7552378|FG001|STARTED|Overall Study||70
6624835|NCT02220920|7552377|FG000|COMPLETED|Overall Study||73
6624836|NCT02220920|7552378|FG001|COMPLETED|Overall Study||67
6624837|NCT02220920|7552377|FG000|NOT COMPLETED|Overall Study||3
6624838|NCT02220920|7552378|FG001|NOT COMPLETED|Overall Study||3
6624839|NCT02220998|7552386|FG000|STARTED|Overall Study||135
6624840|NCT02220998|7552387|FG001|STARTED|Overall Study||134
6624841|NCT02220998|7552386|FG000|COMPLETED|Overall Study||128
6624842|NCT02220998|7552387|FG001|COMPLETED|Overall Study||123
6624843|NCT02220998|7552386|FG000|NOT COMPLETED|Overall Study||7
6624844|NCT02220998|7552387|FG001|NOT COMPLETED|Overall Study||11
6624845|NCT02221219|7552397|FG000|STARTED|Overall Study||36
6624846|NCT02221219|7552398|FG001|STARTED|Overall Study||87
6624847|NCT02221219|7552399|FG002|STARTED|Overall Study||41
6624848|NCT02221219|7552400|FG003|STARTED|Overall Study||92
6624849|NCT02221219|7552397|FG000|COMPLETED|Overall Study||36
6624850|NCT02221219|7552398|FG001|COMPLETED|Overall Study||87
6624851|NCT02221219|7552399|FG002|COMPLETED|Overall Study||41
6597777|NCT02025647|7522800|FG000|STARTED|Overall Study||139
6597778|NCT02025647|7522800|FG000|Session 1 (Narrative Module)|Overall Study||139
6597779|NCT02025647|7522800|FG000|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS~15 technology issues or administered wrong session"|97
6597780|NCT02025647|7522800|FG000|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues~3 administered wrong session"|117
6597781|NCT02025647|7522800|FG000|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS~36 lost to follow up"|76
6597782|NCT02025647|7522800|FG000|COMPLETED|Overall Study||139
6597783|NCT02025647|7522800|FG000|NOT COMPLETED|Overall Study||0
6597784|NCT02025725|7522806|FG000|STARTED|Overall Study||102
6597785|NCT02025725|7522807|FG001|STARTED|Overall Study||103
6597786|NCT02025725|7522806|FG000|COMPLETED|Overall Study||91
6597787|NCT02025725|7522807|FG001|COMPLETED|Overall Study||99
6597788|NCT02025725|7522806|FG000|NOT COMPLETED|Overall Study||11
6597789|NCT02025725|7522807|FG001|NOT COMPLETED|Overall Study||4
6597790|NCT02025751|7522817|FG000|STARTED|Overall Study||26
6597791|NCT02025751|7522818|FG001|STARTED|Overall Study||27
6597792|NCT02025751|7522817|FG000|COMPLETED|Overall Study||25
6597793|NCT02025751|7522818|FG001|COMPLETED|Overall Study||24
6597794|NCT02025751|7522817|FG000|NOT COMPLETED|Overall Study||1
6597795|NCT02025751|7522818|FG001|NOT COMPLETED|Overall Study||3
6597796|NCT02025829|7522826|FG000|STARTED|Overall Study||3
6597797|NCT02025829|7522827|FG001|STARTED|Overall Study||11
6597798|NCT02025829|7522826|FG000|COMPLETED|Overall Study||3
6597799|NCT02025829|7522827|FG001|COMPLETED|Overall Study||11
6597800|NCT02025829|7522826|FG000|NOT COMPLETED|Overall Study||0
6597801|NCT02025829|7522827|FG001|NOT COMPLETED|Overall Study||0
6597802|NCT02025907|7522836|FG000|STARTED|Overall Study|Participant flow is presented for safety population.|108
6597803|NCT02025907|7522837|FG001|STARTED|Overall Study|Participant flow is presented for safety population.|108
6597804|NCT02025907|7522836|FG000|COMPLETED|Overall Study||81
6597805|NCT02025907|7522837|FG001|COMPLETED|Overall Study||96
6597806|NCT02025907|7522836|FG000|NOT COMPLETED|Overall Study||27
6597807|NCT02025907|7522837|FG001|NOT COMPLETED|Overall Study||12
6597808|NCT02025985|7522848|FG000|STARTED|Overall Study||25
6597809|NCT02025985|7522849|FG001|STARTED|Overall Study||23
6597810|NCT02025985|7522850|FG002|STARTED|Overall Study||25
6597811|NCT02025985|7522851|FG003|STARTED|Overall Study||21
6597812|NCT02025985|7522852|FG004|STARTED|Overall Study||20
6597813|NCT02025985|7522848|FG000|Modified Intent-to-treat(mITT)Population|Overall Study||23
6597814|NCT02025985|7522849|FG001|Modified Intent-to-treat(mITT)Population|Overall Study||22
6597815|NCT02025985|7522850|FG002|Modified Intent-to-treat(mITT)Population|Overall Study||25
6597816|NCT02025985|7522851|FG003|Modified Intent-to-treat(mITT)Population|Overall Study||21
6597817|NCT02025985|7522852|FG004|Modified Intent-to-treat(mITT)Population|Overall Study||20
6597818|NCT02025985|7522848|FG000|COMPLETED|Overall Study||0
6597819|NCT02025985|7522849|FG001|COMPLETED|Overall Study||0
6597820|NCT02025985|7522850|FG002|COMPLETED|Overall Study||0
6597821|NCT02025985|7522851|FG003|COMPLETED|Overall Study||0
6597822|NCT02025985|7522852|FG004|COMPLETED|Overall Study||0
6597823|NCT02025985|7522848|FG000|NOT COMPLETED|Overall Study||25
6597824|NCT02025985|7522849|FG001|NOT COMPLETED|Overall Study||23
6597825|NCT02025985|7522850|FG002|NOT COMPLETED|Overall Study||25
6597826|NCT02025985|7522851|FG003|NOT COMPLETED|Overall Study||21
6597827|NCT02025985|7522852|FG004|NOT COMPLETED|Overall Study||20
6597828|NCT02026011|7522868|FG000|STARTED|Allocation 1 (First Set of Medication)||46
6597829|NCT02026011|7522869|FG001|STARTED|Allocation 1 (First Set of Medication)||41
6597830|NCT02026011|7522868|FG000|COMPLETED|Allocation 1 (First Set of Medication)||38
6597831|NCT02026011|7522869|FG001|COMPLETED|Allocation 1 (First Set of Medication)||39
6597832|NCT02026011|7522868|FG000|NOT COMPLETED|Allocation 1 (First Set of Medication)||8
6597833|NCT02026011|7522869|FG001|NOT COMPLETED|Allocation 1 (First Set of Medication)||2
6597834|NCT02026011|7522868|FG000|STARTED|Allocation 2 (Second Set of Medication)||38
6597835|NCT02026011|7522869|FG001|STARTED|Allocation 2 (Second Set of Medication)||37
6597836|NCT02026011|7522868|FG000|COMPLETED|Allocation 2 (Second Set of Medication)||37
6597837|NCT02026011|7522869|FG001|COMPLETED|Allocation 2 (Second Set of Medication)||35
6597838|NCT02026011|7522868|FG000|NOT COMPLETED|Allocation 2 (Second Set of Medication)||1
6597839|NCT02026011|7522869|FG001|NOT COMPLETED|Allocation 2 (Second Set of Medication)||2
6597840|NCT02026063|7522880|FG000|STARTED|Overall Study||22
6597841|NCT02026063|7522881|FG001|STARTED|Overall Study||102
6597842|NCT02026063|7522880|FG000|COMPLETED|Overall Study||13
6597843|NCT02026063|7522881|FG001|COMPLETED|Overall Study||53
6597844|NCT02026063|7522880|FG000|NOT COMPLETED|Overall Study||9
6597845|NCT02026063|7522881|FG001|NOT COMPLETED|Overall Study||49
6597846|NCT02026141|7522890|FG000|STARTED|Overall Study||20
6597847|NCT02026141|7522891|FG001|STARTED|Overall Study||20
6597848|NCT02026141|7522890|FG000|COMPLETED|Overall Study||20
6597849|NCT02026141|7522891|FG001|COMPLETED|Overall Study||19
6597850|NCT02026141|7522890|FG000|NOT COMPLETED|Overall Study||0
6597851|NCT02026141|7522891|FG001|NOT COMPLETED|Overall Study||1
6597852|NCT02026193|7522899|FG000|STARTED|Overall Study||3
6661167|NCT02503852|7592048|FG001|STARTED|Overall Study||22
6661168|NCT02503852|7592049|FG002|STARTED|Overall Study||24
6661169|NCT02503852|7592050|FG003|STARTED|Overall Study||9
6661170|NCT02503852|7592047|FG000|COMPLETED|Overall Study||12
6597853|NCT02026193|7522900|FG001|STARTED|Overall Study||8
6597854|NCT02026193|7522899|FG000|COMPLETED|Overall Study||3
6597855|NCT02026193|7522900|FG001|COMPLETED|Overall Study||8
6661171|NCT02503852|7592048|FG001|COMPLETED|Overall Study||19
6597856|NCT02026193|7522899|FG000|NOT COMPLETED|Overall Study||0
6597857|NCT02026193|7522900|FG001|NOT COMPLETED|Overall Study||0
6597858|NCT02026206|7522908|FG000|STARTED|Overall Study||44
6597859|NCT02026206|7522909|FG001|STARTED|Overall Study||44
6597860|NCT02026206|7522908|FG000|COMPLETED|Overall Study||40
6597861|NCT02026206|7522909|FG001|COMPLETED|Overall Study||36
6597862|NCT02026206|7522908|FG000|NOT COMPLETED|Overall Study||4
6597863|NCT02026206|7522909|FG001|NOT COMPLETED|Overall Study||8
6597864|NCT02026258|7522917|FG000|STARTED|Randomized||20
6597865|NCT02026258|7522918|FG001|STARTED|Randomized||21
6597866|NCT02026258|7522917|FG000|COMPLETED|Randomized||16
6597867|NCT02026258|7522918|FG001|COMPLETED|Randomized||19
6597868|NCT02026258|7522917|FG000|NOT COMPLETED|Randomized||4
6597869|NCT02026258|7522918|FG001|NOT COMPLETED|Randomized||2
6597870|NCT02026258|7522917|FG000|STARTED|Recieved Allocated Intervention||16
6597871|NCT02026258|7522918|FG001|STARTED|Recieved Allocated Intervention||19
6597872|NCT02026258|7522917|FG000|COMPLETED|Recieved Allocated Intervention||15
6597873|NCT02026258|7522918|FG001|COMPLETED|Recieved Allocated Intervention||17
6597874|NCT02026258|7522917|FG000|NOT COMPLETED|Recieved Allocated Intervention||1
6597875|NCT02026258|7522918|FG001|NOT COMPLETED|Recieved Allocated Intervention||2
6597876|NCT02026297|7522927|FG000|STARTED|Overall Study||7
6597877|NCT02026297|7522928|FG001|STARTED|Overall Study||13
6597878|NCT02026297|7522927|FG000|COMPLETED|Overall Study||7
6597879|NCT02026297|7522928|FG001|COMPLETED|Overall Study||13
6597880|NCT02026297|7522927|FG000|NOT COMPLETED|Overall Study||0
6597881|NCT02026297|7522928|FG001|NOT COMPLETED|Overall Study||0
6597882|NCT02026453|7522937|FG000|STARTED|Overall Study||101
6597883|NCT02026453|7522938|FG001|STARTED|Overall Study||103
6597884|NCT02026453|7522939|FG002|STARTED|Overall Study||102
6597885|NCT02026453|7522937|FG000|COMPLETED|Overall Study||95
6597886|NCT02026453|7522938|FG001|COMPLETED|Overall Study||94
6597887|NCT02026453|7522939|FG002|COMPLETED|Overall Study||89
6597888|NCT02026453|7522937|FG000|NOT COMPLETED|Overall Study||6
6597889|NCT02026453|7522938|FG001|NOT COMPLETED|Overall Study||9
6597890|NCT02026453|7522939|FG002|NOT COMPLETED|Overall Study||13
6597891|NCT02026687|7522949|FG000|STARTED|Overall Study||40
6597892|NCT02026687|7522950|FG001|STARTED|Overall Study||40
6597893|NCT02026687|7522949|FG000|COMPLETED|Overall Study||39
6597894|NCT02026687|7522950|FG001|COMPLETED|Overall Study||38
6597895|NCT02026687|7522949|FG000|NOT COMPLETED|Overall Study||1
6597896|NCT02026687|7522950|FG001|NOT COMPLETED|Overall Study||2
6597897|NCT02027025|7522959|FG000|STARTED|Overall Study||48
6597898|NCT02027025|7522960|FG001|STARTED|Overall Study||47
6597899|NCT02027025|7522961|FG002|STARTED|Overall Study||47
6597900|NCT02027025|7522959|FG000|COMPLETED|Overall Study||47
6597901|NCT02027025|7522960|FG001|COMPLETED|Overall Study||42
6597902|NCT02027025|7522961|FG002|COMPLETED|Overall Study||46
6597903|NCT02027025|7522959|FG000|NOT COMPLETED|Overall Study||1
6597904|NCT02027025|7522960|FG001|NOT COMPLETED|Overall Study||5
6597905|NCT02027025|7522961|FG002|NOT COMPLETED|Overall Study||1
6597906|NCT02027311|7522982|FG000|STARTED|Overall Study||33
6597907|NCT02027311|7522983|FG001|STARTED|Overall Study||35
6597908|NCT02027311|7522982|FG000|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
6597909|NCT02027311|7522983|FG001|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
6597910|NCT02027311|7522982|FG000|NOT COMPLETED|Overall Study||3
6597911|NCT02027311|7522983|FG001|NOT COMPLETED|Overall Study||2
6597912|NCT02027376|7522991|FG000|STARTED|Overall Study||5
6597913|NCT02027376|7522992|FG001|STARTED|Overall Study||4
6597914|NCT02027376|7522993|FG002|STARTED|Overall Study||3
6597915|NCT02027376|7522991|FG000|COMPLETED|Overall Study||4
6597916|NCT02027376|7522992|FG001|COMPLETED|Overall Study||4
6597917|NCT02027376|7522993|FG002|COMPLETED|Overall Study||3
6597918|NCT02027376|7522991|FG000|NOT COMPLETED|Overall Study||1
6597919|NCT02027376|7522992|FG001|NOT COMPLETED|Overall Study||0
6597920|NCT02027376|7522993|FG002|NOT COMPLETED|Overall Study||0
6597921|NCT02027402|7523005|FG000|STARTED|Overall Study||98
6597922|NCT02027402|7523006|FG001|STARTED|Overall Study||100
6597923|NCT02027402|7523005|FG000|COMPLETED|Overall Study||94
6597924|NCT02027402|7523006|FG001|COMPLETED|Overall Study||99
6597925|NCT02027402|7523005|FG000|NOT COMPLETED|Overall Study||4
6597926|NCT02027402|7523006|FG001|NOT COMPLETED|Overall Study||1
6597927|NCT02027428|7523016|FG000|STARTED|Induction||427
6597928|NCT02027428|7523017|FG001|STARTED|Induction||0
6597929|NCT02027428|7523018|FG002|STARTED|Induction||0
6597930|NCT02027428|7523016|FG000|Received Study Drug|Induction||420
6597931|NCT02027428|7523017|FG001|Received Study Drug|Induction||0
6597932|NCT02027428|7523018|FG002|Received Study Drug|Induction||0
6597933|NCT02027428|7523016|FG000|COMPLETED|Induction|If radiologically CR, PR or SD after 4 cycles of treatment, participants continue on to Maintenance.|202
6597934|NCT02027428|7523017|FG001|COMPLETED|Induction||0
6597935|NCT02027428|7523018|FG002|COMPLETED|Induction||0
6597936|NCT02027428|7523016|FG000|NOT COMPLETED|Induction||225
6597937|NCT02027428|7523017|FG001|NOT COMPLETED|Induction||0
6597938|NCT02027428|7523018|FG002|NOT COMPLETED|Induction||0
6597939|NCT02027428|7523016|FG000|STARTED|Maintenance||0
6597940|NCT02027428|7523017|FG001|STARTED|Maintenance||136
6597941|NCT02027428|7523018|FG002|STARTED|Maintenance||66
6597942|NCT02027428|7523016|FG000|COMPLETED|Maintenance||0
6597943|NCT02027428|7523017|FG001|COMPLETED|Maintenance||12
6597944|NCT02027428|7523018|FG002|COMPLETED|Maintenance||6
6597945|NCT02027428|7523016|FG000|NOT COMPLETED|Maintenance||0
6597946|NCT02027428|7523017|FG001|NOT COMPLETED|Maintenance||124
6597947|NCT02027428|7523018|FG002|NOT COMPLETED|Maintenance||60
6597948|NCT02027428|7523016|FG000|STARTED|Survival Follow-up||0
6597949|NCT02027428|7523017|FG001|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|117
6597950|NCT02027428|7523018|FG002|STARTED|Survival Follow-up|Participants are not taking study intervention but are on appropriate standard of care.|55
6597951|NCT02027428|7523016|FG000|COMPLETED|Survival Follow-up||0
6597952|NCT02027428|7523017|FG001|COMPLETED|Survival Follow-up||38
6597953|NCT02027428|7523018|FG002|COMPLETED|Survival Follow-up||9
6597954|NCT02027428|7523016|FG000|NOT COMPLETED|Survival Follow-up||0
6597955|NCT02027428|7523017|FG001|NOT COMPLETED|Survival Follow-up||79
6597956|NCT02027428|7523018|FG002|NOT COMPLETED|Survival Follow-up||46
6597957|NCT02027545|7523043|FG000|STARTED|Overall Study||261
6597958|NCT02027545|7523044|FG001|STARTED|Overall Study||175
6597959|NCT02027545|7523043|FG000|COMPLETED|Overall Study||259
6597960|NCT02027545|7523044|FG001|COMPLETED|Overall Study||173
6597961|NCT02027545|7523043|FG000|NOT COMPLETED|Overall Study||2
6597962|NCT02027545|7523044|FG001|NOT COMPLETED|Overall Study||2
6597963|NCT02027558|7523052|FG000|STARTED|Overall Study||62
6597964|NCT02027558|7523053|FG001|STARTED|Overall Study||63
6597965|NCT02027558|7523052|FG000|Post-treatment|Overall Study||49
6597966|NCT02027558|7523053|FG001|Post-treatment|Overall Study||60
6597967|NCT02027558|7523052|FG000|3-month Follow-up|Overall Study||53
6597968|NCT02027558|7523053|FG001|3-month Follow-up|Overall Study||58
6597969|NCT02027558|7523052|FG000|6-month Follow-up|Overall Study||53
6597970|NCT02027558|7523053|FG001|6-month Follow-up|Overall Study||61
6597971|NCT02027558|7523052|FG000|COMPLETED|Overall Study||53
6597972|NCT02027558|7523053|FG001|COMPLETED|Overall Study||61
6597973|NCT02027558|7523052|FG000|NOT COMPLETED|Overall Study||9
6597974|NCT02027558|7523053|FG001|NOT COMPLETED|Overall Study||2
6597975|NCT02027623|7523063|FG000|STARTED|Overall Study||77
6597976|NCT02027623|7523064|FG001|STARTED|Overall Study||77
6597977|NCT02027623|7523063|FG000|COMPLETED|Overall Study||68
6597978|NCT02027623|7523064|FG001|COMPLETED|Overall Study||65
6597979|NCT02027623|7523063|FG000|NOT COMPLETED|Overall Study||9
6597980|NCT02027623|7523064|FG001|NOT COMPLETED|Overall Study||12
6597981|NCT02027701|7523071|FG000|STARTED|Overall Study||82
6597982|NCT02027701|7523071|FG000|COMPLETED|Overall Study||66
6597983|NCT02027701|7523071|FG000|NOT COMPLETED|Overall Study||16
6597984|NCT02027844|7523080|FG000|STARTED|Overall Study||39
6597985|NCT02027844|7523081|FG001|STARTED|Overall Study||39
6597986|NCT02027844|7523082|FG002|STARTED|Overall Study||39
6597987|NCT02027844|7523080|FG000|COMPLETED|Overall Study||34
6597988|NCT02027844|7523081|FG001|COMPLETED|Overall Study||33
6597989|NCT02027844|7523082|FG002|COMPLETED|Overall Study||37
6597990|NCT02027844|7523080|FG000|NOT COMPLETED|Overall Study||5
6597991|NCT02027844|7523081|FG001|NOT COMPLETED|Overall Study||6
6597992|NCT02027844|7523082|FG002|NOT COMPLETED|Overall Study||2
6597993|NCT02027883|7523092|FG000|STARTED|Overall Study||50
6597994|NCT02027883|7523093|FG001|STARTED|Overall Study||50
6597995|NCT02027883|7523092|FG000|COMPLETED|Overall Study||50
6597996|NCT02027883|7523093|FG001|COMPLETED|Overall Study||50
6597997|NCT02027883|7523092|FG000|NOT COMPLETED|Overall Study||0
6597998|NCT02027883|7523093|FG001|NOT COMPLETED|Overall Study||0
6597999|NCT02028065|7523106|FG000|STARTED|Randomization Through Start Treatment|Randomized|76
6598000|NCT02028065|7523107|FG001|STARTED|Randomization Through Start Treatment|Randomized|154
6598001|NCT02028065|7523108|FG002|STARTED|Randomization Through Start Treatment|Randomized|152
6598002|NCT02028065|7523106|FG000|COMPLETED|Randomization Through Start Treatment||75
6598003|NCT02028065|7523107|FG001|COMPLETED|Randomization Through Start Treatment||151
6598004|NCT02028065|7523108|FG002|COMPLETED|Randomization Through Start Treatment||149
6598005|NCT02028065|7523106|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
6598006|NCT02028065|7523107|FG001|NOT COMPLETED|Randomization Through Start Treatment||3
6598007|NCT02028065|7523108|FG002|NOT COMPLETED|Randomization Through Start Treatment||3
6598008|NCT02028065|7523106|FG000|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
6598009|NCT02028065|7523107|FG001|STARTED|Treatment Through Study Completion||151
6598010|NCT02028065|7523108|FG002|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
6598011|NCT02028065|7523106|FG000|Received First Dose|Treatment Through Study Completion||76
6598012|NCT02028065|7523107|FG001|Received First Dose|Treatment Through Study Completion||151
6598013|NCT02028065|7523108|FG002|Received First Dose|Treatment Through Study Completion||148
6661172|NCT02503852|7592049|FG002|COMPLETED|Overall Study||21
6661173|NCT02503852|7592050|FG003|COMPLETED|Overall Study||8
6661174|NCT02503852|7592047|FG000|NOT COMPLETED|Overall Study||4
6661175|NCT02503852|7592048|FG001|NOT COMPLETED|Overall Study||3
6661176|NCT02503852|7592049|FG002|NOT COMPLETED|Overall Study||3
6661177|NCT02503852|7592050|FG003|NOT COMPLETED|Overall Study||1
6661178|NCT02503865|7592063|FG000|STARTED|Overall Study||70
6661179|NCT02503865|7592064|FG001|STARTED|Overall Study||269
6598014|NCT02028065|7523106|FG000|Received Second Dose|Treatment Through Study Completion||69
6598015|NCT02028065|7523107|FG001|Received Second Dose|Treatment Through Study Completion||140
6598016|NCT02028065|7523108|FG002|Received Second Dose|Treatment Through Study Completion||138
6598017|NCT02028065|7523106|FG000|Received Third Dose|Treatment Through Study Completion||64
6598018|NCT02028065|7523107|FG001|Received Third Dose|Treatment Through Study Completion||136
6661180|NCT02503865|7592065|FG002|STARTED|Overall Study||66
6661181|NCT02503865|7592063|FG000|COMPLETED|Overall Study||65
6598019|NCT02028065|7523108|FG002|Received Third Dose|Treatment Through Study Completion||134
6598020|NCT02028065|7523106|FG000|COMPLETED|Treatment Through Study Completion||64
6598021|NCT02028065|7523107|FG001|COMPLETED|Treatment Through Study Completion||136
6598022|NCT02028065|7523108|FG002|COMPLETED|Treatment Through Study Completion||134
6598023|NCT02028065|7523106|FG000|NOT COMPLETED|Treatment Through Study Completion||12
6598024|NCT02028065|7523107|FG001|NOT COMPLETED|Treatment Through Study Completion||15
6598025|NCT02028065|7523108|FG002|NOT COMPLETED|Treatment Through Study Completion||14
6598026|NCT02028169|7523116|FG000|STARTED|Overall Study||120
6598027|NCT02028169|7523116|FG000|COMPLETED|Overall Study||92
6598028|NCT02028169|7523116|FG000|NOT COMPLETED|Overall Study||28
6598029|NCT02028182|7523120|FG000|STARTED|Overall Study||22
6598030|NCT02028182|7523120|FG000|COMPLETED|Overall Study||20
6598031|NCT02028182|7523120|FG000|NOT COMPLETED|Overall Study||2
6598032|NCT02028208|7523128|FG000|STARTED|Overall Study||21
6598033|NCT02028208|7523129|FG001|STARTED|Overall Study||13
6598034|NCT02028208|7523130|FG002|STARTED|Overall Study||22
6598035|NCT02028208|7523128|FG000|COMPLETED|Overall Study||21
6598036|NCT02028208|7523129|FG001|COMPLETED|Overall Study||13
6598037|NCT02028208|7523130|FG002|COMPLETED|Overall Study||21
6598038|NCT02028208|7523128|FG000|NOT COMPLETED|Overall Study||0
6598039|NCT02028208|7523129|FG001|NOT COMPLETED|Overall Study||0
6598040|NCT02028208|7523130|FG002|NOT COMPLETED|Overall Study||1
6598041|NCT02028221|7523140|FG000|STARTED|Overall Study||75
6598042|NCT02028221|7523141|FG001|STARTED|Overall Study||76
6598043|NCT02028221|7523140|FG000|COMPLETED|Overall Study||62
6598044|NCT02028221|7523141|FG001|COMPLETED|Overall Study||56
6598045|NCT02028221|7523140|FG000|NOT COMPLETED|Overall Study||13
6598046|NCT02028221|7523141|FG001|NOT COMPLETED|Overall Study||20
6598047|NCT02028247|7523150|FG000|STARTED|Overall Study||77
6598048|NCT02028247|7523151|FG001|STARTED|Overall Study||71
6598049|NCT02028247|7523152|FG002|STARTED|Overall Study||19
6598050|NCT02028247|7523150|FG000|COMPLETED|Overall Study||67
6598051|NCT02028247|7523151|FG001|COMPLETED|Overall Study||59
6598052|NCT02028247|7523152|FG002|COMPLETED|Overall Study||15
6598053|NCT02028247|7523150|FG000|NOT COMPLETED|Overall Study||10
6598054|NCT02028247|7523151|FG001|NOT COMPLETED|Overall Study||12
6598055|NCT02028247|7523152|FG002|NOT COMPLETED|Overall Study||4
6598056|NCT02028325|7523160|FG000|STARTED|Overall Study||136
6598057|NCT02028325|7523160|FG000|COMPLETED|Overall Study||126
6598058|NCT02028325|7523160|FG000|NOT COMPLETED|Overall Study||10
6661182|NCT02503865|7592064|FG001|COMPLETED|Overall Study||222
6661183|NCT02503865|7592065|FG002|COMPLETED|Overall Study||64
6661184|NCT02503865|7592063|FG000|NOT COMPLETED|Overall Study||5
6661185|NCT02503865|7592064|FG001|NOT COMPLETED|Overall Study||47
6661186|NCT02503865|7592065|FG002|NOT COMPLETED|Overall Study||2
6661187|NCT02503982|7592074|FG000|STARTED|Overall Study||13
6661188|NCT02503982|7592074|FG000|COMPLETED|Overall Study||13
6661189|NCT02503982|7592074|FG000|NOT COMPLETED|Overall Study||0
6661190|NCT02504073|7592078|FG000|STARTED|Overall Study||54
6661191|NCT02504073|7592078|FG000|COMPLETED|Overall Study||54
6661192|NCT02504073|7592078|FG000|NOT COMPLETED|Overall Study||0
6661193|NCT02504216|7592085|FG000|STARTED|Overall Study||3286
6661194|NCT02504216|7592086|FG001|STARTED|Overall Study||3278
6661195|NCT02504216|7592085|FG000|Received Treatment|Overall Study||3256
6661196|NCT02504216|7592086|FG001|Received Treatment|Overall Study||3248
6661197|NCT02504216|7592085|FG000|COMPLETED|Overall Study||3275
6661198|NCT02504216|7592086|FG001|COMPLETED|Overall Study||3263
6661199|NCT02504216|7592085|FG000|NOT COMPLETED|Overall Study||11
6661200|NCT02504216|7592086|FG001|NOT COMPLETED|Overall Study||15
6661201|NCT02504268|7592095|FG000|STARTED|Overall Study||451
6661202|NCT02504268|7592096|FG001|STARTED|Overall Study||301
6661203|NCT02504268|7592097|FG002|STARTED|Overall Study||242
6661204|NCT02504268|7592098|FG003|STARTED|Overall Study||0
6661205|NCT02504268|7592099|FG004|STARTED|Overall Study||0
6661206|NCT02504268|7592100|FG005|STARTED|Overall Study||0
6661207|NCT02504268|7592101|FG006|STARTED|Overall Study||0
6661208|NCT02504268|7592102|FG007|STARTED|Overall Study||0
6661209|NCT02504268|7592103|FG008|STARTED|Overall Study||0
6661210|NCT02504268|7592095|FG000|Induction to Open Label|Overall Study||289
6661211|NCT02504268|7592096|FG001|Induction to Open Label|Overall Study||196
6661212|NCT02504268|7592097|FG002|Induction to Open Label|Overall Study||147
6661213|NCT02504268|7592098|FG003|Induction to Open Label|Overall Study||0
6598059|NCT02028676|7523173|FG000|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
6598060|NCT02028676|7523174|FG001|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
6598061|NCT02028676|7523175|FG002|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
6661214|NCT02504268|7592099|FG004|Induction to Open Label|Overall Study||0
6661215|NCT02504268|7592100|FG005|Induction to Open Label|Overall Study||0
6661216|NCT02504268|7592101|FG006|Induction to Open Label|Overall Study||0
6661217|NCT02504268|7592102|FG007|Induction to Open Label|Overall Study||0
6661218|NCT02504268|7592103|FG008|Induction to Open Label|Overall Study||0
6661219|NCT02504268|7592095|FG000|Early Escaped to Open Label|Overall Study||10
6661220|NCT02504268|7592096|FG001|Early Escaped to Open Label|Overall Study||21
6661221|NCT02504268|7592097|FG002|Early Escaped to Open Label|Overall Study||8
6661222|NCT02504268|7592098|FG003|Early Escaped to Open Label|Overall Study||0
6661223|NCT02504268|7592099|FG004|Early Escaped to Open Label|Overall Study||0
6598062|NCT02028676|7523176|FG003|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
6598063|NCT02028676|7523177|FG004|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
6598064|NCT02028676|7523178|FG005|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
6598065|NCT02028676|7523179|FG006|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
6598066|NCT02028676|7523180|FG007|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
6661224|NCT02504268|7592100|FG005|Early Escaped to Open Label|Overall Study||0
6661225|NCT02504268|7592101|FG006|Early Escaped to Open Label|Overall Study||0
6661226|NCT02504268|7592102|FG007|Early Escaped to Open Label|Overall Study||0
6661227|NCT02504268|7592103|FG008|Early Escaped to Open Label|Overall Study||0
6661228|NCT02504268|7592095|FG000|Induction to De-Escalation|Overall Study||94
6661229|NCT02504268|7592096|FG001|Induction to De-Escalation|Overall Study||37
6661230|NCT02504268|7592097|FG002|Induction to De-Escalation|Overall Study||53
6661231|NCT02504268|7592098|FG003|Induction to De-Escalation|Overall Study||0
6661232|NCT02504268|7592099|FG004|Induction to De-Escalation|Overall Study||0
6661233|NCT02504268|7592100|FG005|Induction to De-Escalation|Overall Study||0
6661234|NCT02504268|7592101|FG006|Induction to De-Escalation|Overall Study||0
6661235|NCT02504268|7592102|FG007|Induction to De-Escalation|Overall Study||0
6661236|NCT02504268|7592103|FG008|Induction to De-Escalation|Overall Study||0
6661237|NCT02504268|7592095|FG000|Randomized in De-Escalation Period|Overall Study||0
6661238|NCT02504268|7592096|FG001|Randomized in De-Escalation Period|Overall Study||0
6661239|NCT02504268|7592097|FG002|Randomized in De-Escalation Period|Overall Study||0
6661240|NCT02504268|7592098|FG003|Randomized in De-Escalation Period|Overall Study||50
6661241|NCT02504268|7592099|FG004|Randomized in De-Escalation Period|Overall Study||50
6661242|NCT02504268|7592100|FG005|Randomized in De-Escalation Period|Overall Study||47
6661243|NCT02504268|7592101|FG006|Randomized in De-Escalation Period|Overall Study||37
6661244|NCT02504268|7592102|FG007|Randomized in De-Escalation Period|Overall Study||0
6661245|NCT02504268|7592103|FG008|Randomized in De-Escalation Period|Overall Study||0
6661246|NCT02504268|7592095|FG000|De-Escalation to Open Label Extension|Overall Study||0
6661247|NCT02504268|7592096|FG001|De-Escalation to Open Label Extension|Overall Study||0
6661248|NCT02504268|7592097|FG002|De-Escalation to Open Label Extension|Overall Study||0
6661249|NCT02504268|7592098|FG003|De-Escalation to Open Label Extension|Overall Study||36
6661250|NCT02504268|7592099|FG004|De-Escalation to Open Label Extension|Overall Study||30
6661251|NCT02504268|7592100|FG005|De-Escalation to Open Label Extension|Overall Study||32
6661252|NCT02504268|7592101|FG006|De-Escalation to Open Label Extension|Overall Study||22
6661253|NCT02504268|7592102|FG007|De-Escalation to Open Label Extension|Overall Study||0
6661254|NCT02504268|7592103|FG008|De-Escalation to Open Label Extension|Overall Study||0
6661255|NCT02504268|7592095|FG000|Early Escaped De-Escalation to Open Label Period|Overall Study||0
6661256|NCT02504268|7592096|FG001|Early Escaped De-Escalation to Open Label Period|Overall Study||0
6661257|NCT02504268|7592097|FG002|Early Escaped De-Escalation to Open Label Period|Overall Study||0
6661258|NCT02504268|7592098|FG003|Early Escaped De-Escalation to Open Label Period|Overall Study||2
6598067|NCT02028676|7523181|FG008|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
6598068|NCT02028676|7523173|FG000|COMPLETED|Initial Enrolment: CDM vs LCM||606
6598069|NCT02028676|7523174|FG001|COMPLETED|Initial Enrolment: CDM vs LCM||600
6598070|NCT02028676|7523175|FG002|COMPLETED|Initial Enrolment: CDM vs LCM||0
6598071|NCT02028676|7523176|FG003|COMPLETED|Initial Enrolment: CDM vs LCM||0
6598072|NCT02028676|7523177|FG004|COMPLETED|Initial Enrolment: CDM vs LCM||0
6598073|NCT02028676|7523178|FG005|COMPLETED|Initial Enrolment: CDM vs LCM||0
6598074|NCT02028676|7523179|FG006|COMPLETED|Initial Enrolment: CDM vs LCM||0
6598075|NCT02028676|7523180|FG007|COMPLETED|Initial Enrolment: CDM vs LCM||0
6598076|NCT02028676|7523181|FG008|COMPLETED|Initial Enrolment: CDM vs LCM||0
6598077|NCT02028676|7523173|FG000|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598078|NCT02028676|7523174|FG001|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598079|NCT02028676|7523175|FG002|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598080|NCT02028676|7523176|FG003|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598081|NCT02028676|7523177|FG004|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598082|NCT02028676|7523178|FG005|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598083|NCT02028676|7523179|FG006|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598084|NCT02028676|7523180|FG007|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598085|NCT02028676|7523181|FG008|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
6598086|NCT02028676|7523173|FG000|STARTED|Initial Enrolment: Induction ART||0
6598087|NCT02028676|7523174|FG001|STARTED|Initial Enrolment: Induction ART||0
6598088|NCT02028676|7523175|FG002|STARTED|Initial Enrolment: Induction ART||397
6598089|NCT02028676|7523176|FG003|STARTED|Initial Enrolment: Induction ART||404
6598090|NCT02028676|7523177|FG004|STARTED|Initial Enrolment: Induction ART||405
6598091|NCT02028676|7523178|FG005|STARTED|Initial Enrolment: Induction ART||0
6598092|NCT02028676|7523179|FG006|STARTED|Initial Enrolment: Induction ART||0
6598093|NCT02028676|7523180|FG007|STARTED|Initial Enrolment: Induction ART||0
6598094|NCT02028676|7523181|FG008|STARTED|Initial Enrolment: Induction ART||0
6598095|NCT02028676|7523173|FG000|COMPLETED|Initial Enrolment: Induction ART||0
6598096|NCT02028676|7523174|FG001|COMPLETED|Initial Enrolment: Induction ART||0
6598097|NCT02028676|7523175|FG002|COMPLETED|Initial Enrolment: Induction ART||397
6598098|NCT02028676|7523176|FG003|COMPLETED|Initial Enrolment: Induction ART||404
6598099|NCT02028676|7523177|FG004|COMPLETED|Initial Enrolment: Induction ART||405
6598100|NCT02028676|7523178|FG005|COMPLETED|Initial Enrolment: Induction ART||0
6598101|NCT02028676|7523179|FG006|COMPLETED|Initial Enrolment: Induction ART||0
6598102|NCT02028676|7523180|FG007|COMPLETED|Initial Enrolment: Induction ART||0
6598103|NCT02028676|7523181|FG008|COMPLETED|Initial Enrolment: Induction ART||0
6598104|NCT02028676|7523173|FG000|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598105|NCT02028676|7523174|FG001|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598106|NCT02028676|7523175|FG002|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598107|NCT02028676|7523176|FG003|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598108|NCT02028676|7523177|FG004|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598109|NCT02028676|7523178|FG005|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598110|NCT02028676|7523179|FG006|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598111|NCT02028676|7523180|FG007|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598112|NCT02028676|7523181|FG008|NOT COMPLETED|Initial Enrolment: Induction ART||0
6598113|NCT02028676|7523173|FG000|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6598114|NCT02028676|7523174|FG001|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6598115|NCT02028676|7523175|FG002|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6598116|NCT02028676|7523176|FG003|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6598117|NCT02028676|7523177|FG004|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6598118|NCT02028676|7523178|FG005|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
6598119|NCT02028676|7523179|FG006|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
6598120|NCT02028676|7523180|FG007|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6598121|NCT02028676|7523181|FG008|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
6598122|NCT02028676|7523173|FG000|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598123|NCT02028676|7523174|FG001|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598124|NCT02028676|7523175|FG002|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598125|NCT02028676|7523176|FG003|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598126|NCT02028676|7523177|FG004|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598127|NCT02028676|7523178|FG005|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
6598128|NCT02028676|7523179|FG006|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
6598129|NCT02028676|7523180|FG007|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598130|NCT02028676|7523181|FG008|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598131|NCT02028676|7523173|FG000|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598132|NCT02028676|7523174|FG001|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598133|NCT02028676|7523175|FG002|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598134|NCT02028676|7523176|FG003|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598135|NCT02028676|7523177|FG004|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598136|NCT02028676|7523178|FG005|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6624852|NCT02221219|7552400|FG003|COMPLETED|Overall Study||92
6624853|NCT02221219|7552397|FG000|NOT COMPLETED|Overall Study||0
6624854|NCT02221219|7552398|FG001|NOT COMPLETED|Overall Study||0
6624855|NCT02221219|7552399|FG002|NOT COMPLETED|Overall Study||0
6624856|NCT02221219|7552400|FG003|NOT COMPLETED|Overall Study||0
6624857|NCT02221284|7552414|FG000|STARTED|Overall Study||964
6598137|NCT02028676|7523179|FG006|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598138|NCT02028676|7523180|FG007|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598139|NCT02028676|7523181|FG008|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
6598140|NCT02028676|7523173|FG000|STARTED|Subsequent Cotrimoxazole Randomization||0
6598141|NCT02028676|7523174|FG001|STARTED|Subsequent Cotrimoxazole Randomization||0
6598142|NCT02028676|7523175|FG002|STARTED|Subsequent Cotrimoxazole Randomization||0
6598143|NCT02028676|7523176|FG003|STARTED|Subsequent Cotrimoxazole Randomization||0
6598144|NCT02028676|7523177|FG004|STARTED|Subsequent Cotrimoxazole Randomization||0
6598145|NCT02028676|7523178|FG005|STARTED|Subsequent Cotrimoxazole Randomization||0
6598146|NCT02028676|7523179|FG006|STARTED|Subsequent Cotrimoxazole Randomization||0
6598147|NCT02028676|7523180|FG007|STARTED|Subsequent Cotrimoxazole Randomization||376
6598148|NCT02028676|7523181|FG008|STARTED|Subsequent Cotrimoxazole Randomization||382
6598149|NCT02028676|7523173|FG000|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598150|NCT02028676|7523174|FG001|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598151|NCT02028676|7523175|FG002|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598152|NCT02028676|7523176|FG003|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598153|NCT02028676|7523177|FG004|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598154|NCT02028676|7523178|FG005|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598155|NCT02028676|7523179|FG006|COMPLETED|Subsequent Cotrimoxazole Randomization||0
6624858|NCT02221284|7552414|FG000|COMPLETED|Overall Study||903
6624859|NCT02221284|7552414|FG000|NOT COMPLETED|Overall Study||61
6624860|NCT02221349|7552426|FG000|STARTED|Overall Study||15
6624861|NCT02221349|7552427|FG001|STARTED|Overall Study||15
6624862|NCT02221349|7552426|FG000|COMPLETED|Overall Study||14
6624863|NCT02221349|7552427|FG001|COMPLETED|Overall Study||15
6624864|NCT02221349|7552426|FG000|NOT COMPLETED|Overall Study||1
6624865|NCT02221349|7552427|FG001|NOT COMPLETED|Overall Study||0
6624866|NCT02221557|7552433|FG000|STARTED|Overall Study||8
6624867|NCT02221557|7552433|FG000|COMPLETED|Overall Study||5
6624868|NCT02221557|7552433|FG000|NOT COMPLETED|Overall Study||3
6624869|NCT02221648|7552439|FG000|STARTED|Overall Study||22
6624870|NCT02221648|7552440|FG001|STARTED|Overall Study||21
6624871|NCT02221648|7552439|FG000|COMPLETED|Overall Study||19
6624872|NCT02221648|7552440|FG001|COMPLETED|Overall Study||18
6624873|NCT02221648|7552439|FG000|NOT COMPLETED|Overall Study||3
6624874|NCT02221648|7552440|FG001|NOT COMPLETED|Overall Study||3
6624875|NCT02221674|7552453|FG000|STARTED|Overall Study||8
6624876|NCT02221674|7552454|FG001|STARTED|Overall Study||6
6624877|NCT02221674|7552455|FG002|STARTED|Overall Study||5
6624878|NCT02221674|7552453|FG000|COMPLETED|Overall Study||7
6624879|NCT02221674|7552454|FG001|COMPLETED|Overall Study||6
6624880|NCT02221674|7552455|FG002|COMPLETED|Overall Study||5
6624881|NCT02221674|7552453|FG000|NOT COMPLETED|Overall Study||1
6624882|NCT02221674|7552454|FG001|NOT COMPLETED|Overall Study||0
6624883|NCT02221674|7552455|FG002|NOT COMPLETED|Overall Study||0
6624884|NCT02221739|7552466|FG000|STARTED|Overall Study||39
6624885|NCT02221739|7552466|FG000|COMPLETED|Overall Study||21
6624886|NCT02221739|7552466|FG000|NOT COMPLETED|Overall Study||18
6624887|NCT02221869|7552473|FG000|STARTED|Overall Study||31
6624888|NCT02221869|7552474|FG001|STARTED|Overall Study||32
6624889|NCT02221869|7552475|FG002|STARTED|Overall Study||43
6624890|NCT02221869|7552473|FG000|COMPLETED|Overall Study||30
6624891|NCT02221869|7552474|FG001|COMPLETED|Overall Study||32
6624892|NCT02221869|7552475|FG002|COMPLETED|Overall Study||33
6624893|NCT02221869|7552473|FG000|NOT COMPLETED|Overall Study||1
6624894|NCT02221869|7552474|FG001|NOT COMPLETED|Overall Study||0
6624895|NCT02221869|7552475|FG002|NOT COMPLETED|Overall Study||10
6624896|NCT02221882|7552487|FG000|STARTED|Overall Study||3
6624897|NCT02221882|7552488|FG001|STARTED|Overall Study||3
6624898|NCT02221882|7552489|FG002|STARTED|Overall Study||11
6624899|NCT02221882|7552490|FG003|STARTED|Overall Study||3
6624900|NCT02221882|7552491|FG004|STARTED|Overall Study||5
6624901|NCT02221882|7552492|FG005|STARTED|Overall Study||4
6598156|NCT02028676|7523180|FG007|COMPLETED|Subsequent Cotrimoxazole Randomization||376
6598157|NCT02028676|7523181|FG008|COMPLETED|Subsequent Cotrimoxazole Randomization||382
6598158|NCT02028676|7523173|FG000|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598159|NCT02028676|7523174|FG001|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598160|NCT02028676|7523175|FG002|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598161|NCT02028676|7523176|FG003|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598162|NCT02028676|7523177|FG004|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598163|NCT02028676|7523178|FG005|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598164|NCT02028676|7523179|FG006|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598165|NCT02028676|7523180|FG007|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598166|NCT02028676|7523181|FG008|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
6598167|NCT02028715|7523207|FG000|STARTED|Overall Study||34
6598168|NCT02028715|7523208|FG001|STARTED|Overall Study||34
6598169|NCT02028715|7523207|FG000|COMPLETED|Overall Study||29
6598170|NCT02028715|7523208|FG001|COMPLETED|Overall Study||30
6598171|NCT02028715|7523207|FG000|NOT COMPLETED|Overall Study||5
6598172|NCT02028715|7523208|FG001|NOT COMPLETED|Overall Study||4
6598173|NCT02028754|7523216|FG000|STARTED|Overall Study||90
6598174|NCT02028754|7523217|FG001|STARTED|Overall Study||90
6598175|NCT02028754|7523216|FG000|COMPLETED|Overall Study||83
6598176|NCT02028754|7523217|FG001|COMPLETED|Overall Study||82
6598177|NCT02028754|7523216|FG000|NOT COMPLETED|Overall Study||7
6598178|NCT02028754|7523217|FG001|NOT COMPLETED|Overall Study||8
6598179|NCT02028767|7523223|FG000|STARTED|Treatment Period 1||16
6598180|NCT02028767|7523224|FG001|STARTED|Treatment Period 1||16
6598181|NCT02028767|7523223|FG000|COMPLETED|Treatment Period 1||16
6598182|NCT02028767|7523224|FG001|COMPLETED|Treatment Period 1||16
6598183|NCT02028767|7523223|FG000|NOT COMPLETED|Treatment Period 1||0
6598184|NCT02028767|7523224|FG001|NOT COMPLETED|Treatment Period 1||0
6598185|NCT02028767|7523223|FG000|STARTED|Treatment Period 2||16
6598186|NCT02028767|7523224|FG001|STARTED|Treatment Period 2||16
6598187|NCT02028767|7523223|FG000|COMPLETED|Treatment Period 2||14
6598188|NCT02028767|7523224|FG001|COMPLETED|Treatment Period 2||16
6598189|NCT02028767|7523223|FG000|NOT COMPLETED|Treatment Period 2||2
6598190|NCT02028767|7523224|FG001|NOT COMPLETED|Treatment Period 2||0
6598191|NCT02028780|7523242|FG000|STARTED|Observation Phase||6
6598192|NCT02028780|7523243|FG001|STARTED|Observation Phase||2
6598193|NCT02028780|7523244|FG002|STARTED|Observation Phase||6
6598194|NCT02028780|7523245|FG003|STARTED|Observation Phase||6
6598195|NCT02028780|7523246|FG004|STARTED|Observation Phase||6
6598196|NCT02028780|7523247|FG005|STARTED|Observation Phase||6
6598197|NCT02028780|7523248|FG006|STARTED|Observation Phase||9
6598198|NCT02028780|7523249|FG007|STARTED|Observation Phase||3
6598199|NCT02028780|7523250|FG008|STARTED|Observation Phase||9
6598200|NCT02028780|7523251|FG009|STARTED|Observation Phase||9
6598201|NCT02028780|7523252|FG010|STARTED|Observation Phase||9
6598202|NCT02028780|7523253|FG011|STARTED|Observation Phase||9
6598203|NCT02028780|7523242|FG000|COMPLETED|Observation Phase||6
6598204|NCT02028780|7523243|FG001|COMPLETED|Observation Phase||2
6598205|NCT02028780|7523244|FG002|COMPLETED|Observation Phase||6
6598206|NCT02028780|7523245|FG003|COMPLETED|Observation Phase||6
6598207|NCT02028780|7523246|FG004|COMPLETED|Observation Phase||6
6598208|NCT02028780|7523247|FG005|COMPLETED|Observation Phase||6
6598209|NCT02028780|7523248|FG006|COMPLETED|Observation Phase||9
6598210|NCT02028780|7523249|FG007|COMPLETED|Observation Phase||3
6598211|NCT02028780|7523250|FG008|COMPLETED|Observation Phase||9
6598212|NCT02028780|7523251|FG009|COMPLETED|Observation Phase||9
6598213|NCT02028780|7523252|FG010|COMPLETED|Observation Phase||9
6598214|NCT02028780|7523253|FG011|COMPLETED|Observation Phase||9
6598215|NCT02028780|7523242|FG000|NOT COMPLETED|Observation Phase||0
6598216|NCT02028780|7523243|FG001|NOT COMPLETED|Observation Phase||0
6598217|NCT02028780|7523244|FG002|NOT COMPLETED|Observation Phase||0
6598218|NCT02028780|7523245|FG003|NOT COMPLETED|Observation Phase||0
6598219|NCT02028780|7523246|FG004|NOT COMPLETED|Observation Phase||0
6598220|NCT02028780|7523247|FG005|NOT COMPLETED|Observation Phase||0
6598221|NCT02028780|7523248|FG006|NOT COMPLETED|Observation Phase||0
6598222|NCT02028780|7523249|FG007|NOT COMPLETED|Observation Phase||0
6598223|NCT02028780|7523250|FG008|NOT COMPLETED|Observation Phase||0
6598224|NCT02028780|7523251|FG009|NOT COMPLETED|Observation Phase||0
6598225|NCT02028780|7523252|FG010|NOT COMPLETED|Observation Phase||0
6598226|NCT02028780|7523253|FG011|NOT COMPLETED|Observation Phase||0
6598227|NCT02028780|7523242|FG000|STARTED|Follow up Phase||6
6598228|NCT02028780|7523243|FG001|STARTED|Follow up Phase||2
6598229|NCT02028780|7523244|FG002|STARTED|Follow up Phase||6
6598230|NCT02028780|7523245|FG003|STARTED|Follow up Phase||6
6598231|NCT02028780|7523246|FG004|STARTED|Follow up Phase||6
6598232|NCT02028780|7523247|FG005|STARTED|Follow up Phase||6
6598233|NCT02028780|7523248|FG006|STARTED|Follow up Phase||9
6598234|NCT02028780|7523249|FG007|STARTED|Follow up Phase||3
6598235|NCT02028780|7523250|FG008|STARTED|Follow up Phase||9
6598236|NCT02028780|7523251|FG009|STARTED|Follow up Phase||9
6598237|NCT02028780|7523252|FG010|STARTED|Follow up Phase||9
6598238|NCT02028780|7523253|FG011|STARTED|Follow up Phase||9
6598239|NCT02028780|7523242|FG000|COMPLETED|Follow up Phase||6
6598240|NCT02028780|7523243|FG001|COMPLETED|Follow up Phase||2
6598241|NCT02028780|7523244|FG002|COMPLETED|Follow up Phase||6
6598242|NCT02028780|7523245|FG003|COMPLETED|Follow up Phase||6
6598243|NCT02028780|7523246|FG004|COMPLETED|Follow up Phase||6
6598244|NCT02028780|7523247|FG005|COMPLETED|Follow up Phase||6
6598245|NCT02028780|7523248|FG006|COMPLETED|Follow up Phase||9
6598246|NCT02028780|7523249|FG007|COMPLETED|Follow up Phase||3
6598247|NCT02028780|7523250|FG008|COMPLETED|Follow up Phase||9
6598248|NCT02028780|7523251|FG009|COMPLETED|Follow up Phase||9
6598249|NCT02028780|7523252|FG010|COMPLETED|Follow up Phase||9
6598250|NCT02028780|7523253|FG011|COMPLETED|Follow up Phase||9
6598251|NCT02028780|7523242|FG000|NOT COMPLETED|Follow up Phase||0
6598252|NCT02028780|7523243|FG001|NOT COMPLETED|Follow up Phase||0
6598253|NCT02028780|7523244|FG002|NOT COMPLETED|Follow up Phase||0
6598254|NCT02028780|7523245|FG003|NOT COMPLETED|Follow up Phase||0
6598255|NCT02028780|7523246|FG004|NOT COMPLETED|Follow up Phase||0
6598256|NCT02028780|7523247|FG005|NOT COMPLETED|Follow up Phase||0
6598257|NCT02028780|7523248|FG006|NOT COMPLETED|Follow up Phase||0
6598258|NCT02028780|7523249|FG007|NOT COMPLETED|Follow up Phase||0
6598259|NCT02028780|7523250|FG008|NOT COMPLETED|Follow up Phase||0
6598260|NCT02028780|7523251|FG009|NOT COMPLETED|Follow up Phase||0
6598261|NCT02028780|7523252|FG010|NOT COMPLETED|Follow up Phase||0
6598262|NCT02028780|7523253|FG011|NOT COMPLETED|Follow up Phase||0
6598263|NCT02028871|7523299|FG000|STARTED|Overall Study||14
6598264|NCT02028871|7523300|FG001|STARTED|Overall Study||12
6661259|NCT02504268|7592099|FG004|Early Escaped De-Escalation to Open Label Period|Overall Study||5
6661260|NCT02504268|7592100|FG005|Early Escaped De-Escalation to Open Label Period|Overall Study||4
6661261|NCT02504268|7592101|FG006|Early Escaped De-Escalation to Open Label Period|Overall Study||3
6661262|NCT02504268|7592102|FG007|Early Escaped De-Escalation to Open Label Period|Overall Study||0
6661263|NCT02504268|7592103|FG008|Early Escaped De-Escalation to Open Label Period|Overall Study||0
6661264|NCT02504268|7592095|FG000|Open Label and Open Label Extension Period|Overall Study||0
6661265|NCT02504268|7592096|FG001|Open Label and Open Label Extension Period|Overall Study||0
6661266|NCT02504268|7592097|FG002|Open Label and Open Label Extension Period|Overall Study||0
6661267|NCT02504268|7592098|FG003|Open Label and Open Label Extension Period|Overall Study||0
6661268|NCT02504268|7592099|FG004|Open Label and Open Label Extension Period|Overall Study||0
6661269|NCT02504268|7592100|FG005|Open Label and Open Label Extension Period|Overall Study||0
6661270|NCT02504268|7592101|FG006|Open Label and Open Label Extension Period|Overall Study||0
6661271|NCT02504268|7592102|FG007|Open Label and Open Label Extension Period|Overall Study||685
6661272|NCT02504268|7592103|FG008|Open Label and Open Label Extension Period|Overall Study||120
6661273|NCT02504268|7592095|FG000|COMPLETED|Overall Study||388
6661274|NCT02504268|7592096|FG001|COMPLETED|Overall Study||233
6661275|NCT02504268|7592097|FG002|COMPLETED|Overall Study||201
6661276|NCT02504268|7592098|FG003|COMPLETED|Overall Study||0
6661277|NCT02504268|7592099|FG004|COMPLETED|Overall Study||0
6661278|NCT02504268|7592100|FG005|COMPLETED|Overall Study||0
6661279|NCT02504268|7592101|FG006|COMPLETED|Overall Study||0
6661280|NCT02504268|7592102|FG007|COMPLETED|Overall Study||0
6661281|NCT02504268|7592103|FG008|COMPLETED|Overall Study||0
6661282|NCT02504268|7592095|FG000|NOT COMPLETED|Overall Study||63
6661283|NCT02504268|7592096|FG001|NOT COMPLETED|Overall Study||68
6661284|NCT02504268|7592097|FG002|NOT COMPLETED|Overall Study||41
6661285|NCT02504268|7592098|FG003|NOT COMPLETED|Overall Study||0
6661286|NCT02504268|7592099|FG004|NOT COMPLETED|Overall Study||0
6661287|NCT02504268|7592100|FG005|NOT COMPLETED|Overall Study||0
6661288|NCT02504268|7592101|FG006|NOT COMPLETED|Overall Study||0
6661289|NCT02504268|7592102|FG007|NOT COMPLETED|Overall Study||0
6661290|NCT02504268|7592103|FG008|NOT COMPLETED|Overall Study||0
6661291|NCT02504294|7592125|FG000|STARTED|Overall Study||212
6661292|NCT02504294|7592126|FG001|STARTED|Overall Study||206
6661293|NCT02504294|7592125|FG000|COMPLETED|Overall Study||156
6661294|NCT02504294|7592126|FG001|COMPLETED|Overall Study||158
6661295|NCT02504294|7592125|FG000|NOT COMPLETED|Overall Study||56
6661296|NCT02504294|7592126|FG001|NOT COMPLETED|Overall Study||48
6661297|NCT02504320|7592136|FG000|STARTED|Treatment Period 1||19
6661298|NCT02504320|7592137|FG001|STARTED|Treatment Period 1||19
6661299|NCT02504320|7592138|FG002|STARTED|Treatment Period 1||20
6661300|NCT02504320|7592139|FG003|STARTED|Treatment Period 1||20
6661301|NCT02504320|7592136|FG000|COMPLETED|Treatment Period 1||19
6661302|NCT02504320|7592137|FG001|COMPLETED|Treatment Period 1||19
6661303|NCT02504320|7592138|FG002|COMPLETED|Treatment Period 1||19
6598265|NCT02028871|7523299|FG000|COMPLETED|Overall Study||10
6598266|NCT02028871|7523300|FG001|COMPLETED|Overall Study||9
6598267|NCT02028871|7523299|FG000|NOT COMPLETED|Overall Study||4
6598268|NCT02028871|7523300|FG001|NOT COMPLETED|Overall Study||3
6598269|NCT02029040|7523311|FG000|STARTED|Overall Study||27
6598270|NCT02029040|7523312|FG001|STARTED|Overall Study||25
6598271|NCT02029040|7523311|FG000|COMPLETED|Overall Study||27
6598272|NCT02029040|7523312|FG001|COMPLETED|Overall Study||25
6598273|NCT02029040|7523311|FG000|NOT COMPLETED|Overall Study||0
6598274|NCT02029040|7523312|FG001|NOT COMPLETED|Overall Study||0
6598275|NCT02029196|7523320|FG000|STARTED|Overall Study||306
6598276|NCT02029196|7523321|FG001|STARTED|Overall Study||102
6598277|NCT02029196|7523320|FG000|COMPLETED|Overall Study||286
6661304|NCT02504320|7592139|FG003|COMPLETED|Treatment Period 1||20
6661305|NCT02504320|7592136|FG000|NOT COMPLETED|Treatment Period 1||0
6661306|NCT02504320|7592137|FG001|NOT COMPLETED|Treatment Period 1||0
6661307|NCT02504320|7592138|FG002|NOT COMPLETED|Treatment Period 1||1
6661308|NCT02504320|7592139|FG003|NOT COMPLETED|Treatment Period 1||0
6661309|NCT02504320|7592136|FG000|STARTED|Treatment Period 2||19
6661310|NCT02504320|7592137|FG001|STARTED|Treatment Period 2||19
6661311|NCT02504320|7592138|FG002|STARTED|Treatment Period 2||19
6661312|NCT02504320|7592139|FG003|STARTED|Treatment Period 2||20
6598278|NCT02029196|7523321|FG001|COMPLETED|Overall Study||101
6598279|NCT02029196|7523320|FG000|NOT COMPLETED|Overall Study||20
6598280|NCT02029196|7523321|FG001|NOT COMPLETED|Overall Study||1
6598281|NCT02029235|7523329|FG000|STARTED|Overall Study||34
6598282|NCT02029235|7523330|FG001|STARTED|Overall Study||31
6598283|NCT02029235|7523329|FG000|COMPLETED|Overall Study||30
6598284|NCT02029235|7523330|FG001|COMPLETED|Overall Study||30
6598285|NCT02029235|7523329|FG000|NOT COMPLETED|Overall Study||4
6598286|NCT02029235|7523330|FG001|NOT COMPLETED|Overall Study||1
6598287|NCT02029274|7523340|FG000|STARTED|Overall Study||5
6598288|NCT02029274|7523341|FG001|STARTED|Overall Study||4
6598289|NCT02029274|7523342|FG002|STARTED|Overall Study||4
6598290|NCT02029274|7523343|FG003|STARTED|Overall Study||4
6598291|NCT02029274|7523340|FG000|Fixed Dose Period 2|Overall Study||5
6598292|NCT02029274|7523341|FG001|Fixed Dose Period 2|Overall Study||4
6598293|NCT02029274|7523342|FG002|Fixed Dose Period 2|Overall Study||4
6598294|NCT02029274|7523343|FG003|Fixed Dose Period 2|Overall Study||4
6598295|NCT02029274|7523340|FG000|COMPLETED|Overall Study||4
6598296|NCT02029274|7523341|FG001|COMPLETED|Overall Study||4
6598297|NCT02029274|7523342|FG002|COMPLETED|Overall Study||2
6598298|NCT02029274|7523343|FG003|COMPLETED|Overall Study||2
6598299|NCT02029274|7523340|FG000|NOT COMPLETED|Overall Study||1
6598300|NCT02029274|7523341|FG001|NOT COMPLETED|Overall Study||0
6598301|NCT02029274|7523342|FG002|NOT COMPLETED|Overall Study||2
6598302|NCT02029274|7523343|FG003|NOT COMPLETED|Overall Study||2
6598303|NCT02029417|7523357|FG000|STARTED|Overall Study||2
6598304|NCT02029417|7523357|FG000|COMPLETED|Overall Study||0
6598305|NCT02029417|7523357|FG000|NOT COMPLETED|Overall Study||2
6598306|NCT02029495|7523364|FG000|STARTED|Overall Study||159
6598307|NCT02029495|7523365|FG001|STARTED|Overall Study||158
6598308|NCT02029495|7523366|FG002|STARTED|Overall Study||161
6661313|NCT02504320|7592136|FG000|COMPLETED|Treatment Period 2||19
6661314|NCT02504320|7592137|FG001|COMPLETED|Treatment Period 2||18
6661315|NCT02504320|7592138|FG002|COMPLETED|Treatment Period 2||19
6661316|NCT02504320|7592139|FG003|COMPLETED|Treatment Period 2||20
6661317|NCT02504320|7592136|FG000|NOT COMPLETED|Treatment Period 2||0
6661318|NCT02504320|7592137|FG001|NOT COMPLETED|Treatment Period 2||1
6661319|NCT02504320|7592138|FG002|NOT COMPLETED|Treatment Period 2||0
6661320|NCT02504320|7592139|FG003|NOT COMPLETED|Treatment Period 2||0
6661321|NCT02504320|7592136|FG000|STARTED|Treatment Period 3||19
6661322|NCT02504320|7592137|FG001|STARTED|Treatment Period 3||18
6661323|NCT02504320|7592138|FG002|STARTED|Treatment Period 3||19
6661324|NCT02504320|7592139|FG003|STARTED|Treatment Period 3||20
6661325|NCT02504320|7592136|FG000|COMPLETED|Treatment Period 3||19
6661326|NCT02504320|7592137|FG001|COMPLETED|Treatment Period 3||18
6661327|NCT02504320|7592138|FG002|COMPLETED|Treatment Period 3||18
6661328|NCT02504320|7592139|FG003|COMPLETED|Treatment Period 3||19
6661329|NCT02504320|7592136|FG000|NOT COMPLETED|Treatment Period 3||0
6661330|NCT02504320|7592137|FG001|NOT COMPLETED|Treatment Period 3||0
6661331|NCT02504320|7592138|FG002|NOT COMPLETED|Treatment Period 3||1
6661332|NCT02504320|7592139|FG003|NOT COMPLETED|Treatment Period 3||1
6661333|NCT02504320|7592136|FG000|STARTED|Treatment Period 4||19
6661334|NCT02504320|7592137|FG001|STARTED|Treatment Period 4||18
6661335|NCT02504320|7592138|FG002|STARTED|Treatment Period 4||18
6661336|NCT02504320|7592139|FG003|STARTED|Treatment Period 4||19
6661337|NCT02504320|7592136|FG000|COMPLETED|Treatment Period 4||19
6661338|NCT02504320|7592137|FG001|COMPLETED|Treatment Period 4||18
6661339|NCT02504320|7592138|FG002|COMPLETED|Treatment Period 4||18
6661340|NCT02504320|7592139|FG003|COMPLETED|Treatment Period 4||19
6661341|NCT02504320|7592136|FG000|NOT COMPLETED|Treatment Period 4||0
6661342|NCT02504320|7592137|FG001|NOT COMPLETED|Treatment Period 4||0
6661343|NCT02504320|7592138|FG002|NOT COMPLETED|Treatment Period 4||0
6661344|NCT02504320|7592139|FG003|NOT COMPLETED|Treatment Period 4||0
6661345|NCT02504424|7592149|FG000|STARTED|Overall Study||50
6661346|NCT02504424|7592149|FG000|COMPLETED|Overall Study||48
6661347|NCT02504424|7592149|FG000|NOT COMPLETED|Overall Study||2
6661348|NCT02504502|7592156|FG000|STARTED|Routine Care vs. Enhanced Report||24
6661349|NCT02504502|7592157|FG001|STARTED|Routine Care vs. Enhanced Report||28
6661350|NCT02504502|7592156|FG000|COMPLETED|Routine Care vs. Enhanced Report||20
6661351|NCT02504502|7592157|FG001|COMPLETED|Routine Care vs. Enhanced Report||21
6661352|NCT02504502|7592156|FG000|NOT COMPLETED|Routine Care vs. Enhanced Report||4
6661353|NCT02504502|7592157|FG001|NOT COMPLETED|Routine Care vs. Enhanced Report||7
6661354|NCT02504502|7592156|FG000|STARTED|Crossover to Enhanced Report||20
6661355|NCT02504502|7592157|FG001|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
6661356|NCT02504502|7592156|FG000|COMPLETED|Crossover to Enhanced Report||15
6661357|NCT02504502|7592157|FG001|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
6661358|NCT02504502|7592156|FG000|NOT COMPLETED|Crossover to Enhanced Report||5
6598309|NCT02029495|7523364|FG000|COMPLETED|Overall Study||158
6598310|NCT02029495|7523365|FG001|COMPLETED|Overall Study||158
6661359|NCT02504502|7592157|FG001|NOT COMPLETED|Crossover to Enhanced Report||0
6661360|NCT02504541|7592163|FG000|STARTED|Overall Study||133
6661361|NCT02504541|7592163|FG000|COMPLETED|Overall Study||113
6661362|NCT02504541|7592163|FG000|NOT COMPLETED|Overall Study||20
6661363|NCT02504554|7592169|FG000|STARTED|Overall Study|1 participant was switched from the oral group to the rectal group due to nausea/vomiting.|12
6661364|NCT02504554|7592170|FG001|STARTED|Overall Study||6
6661365|NCT02504554|7592169|FG000|COMPLETED|Overall Study||12
6598311|NCT02029495|7523366|FG002|COMPLETED|Overall Study||159
6598312|NCT02029495|7523364|FG000|NOT COMPLETED|Overall Study||1
6598313|NCT02029495|7523365|FG001|NOT COMPLETED|Overall Study||0
6598314|NCT02029495|7523366|FG002|NOT COMPLETED|Overall Study||2
6598315|NCT02029521|7523376|FG000|STARTED|Overall Study||24
6598316|NCT02029521|7523377|FG001|STARTED|Overall Study||23
6598317|NCT02029521|7523376|FG000|COMPLETED|Overall Study||22
6598318|NCT02029521|7523377|FG001|COMPLETED|Overall Study||22
6598319|NCT02029521|7523376|FG000|NOT COMPLETED|Overall Study||2
6598320|NCT02029521|7523377|FG001|NOT COMPLETED|Overall Study||1
6598321|NCT02029638|7523389|FG000|STARTED|Overall Study||2
6598322|NCT02029638|7523390|FG001|STARTED|Overall Study||1
6598323|NCT02029638|7523391|FG002|STARTED|Overall Study||1
6598324|NCT02029638|7523389|FG000|COMPLETED|Overall Study||0
6598325|NCT02029638|7523390|FG001|COMPLETED|Overall Study||1
6598326|NCT02029638|7523391|FG002|COMPLETED|Overall Study||0
6598327|NCT02029638|7523389|FG000|NOT COMPLETED|Overall Study||2
6598328|NCT02029638|7523390|FG001|NOT COMPLETED|Overall Study||0
6598329|NCT02029638|7523391|FG002|NOT COMPLETED|Overall Study||1
6598330|NCT02029703|7523401|FG000|STARTED|Overall Study||20
6598331|NCT02029703|7523402|FG001|STARTED|Overall Study||22
6598332|NCT02029703|7523401|FG000|COMPLETED|Overall Study||20
6598333|NCT02029703|7523402|FG001|COMPLETED|Overall Study||22
6598334|NCT02029703|7523401|FG000|NOT COMPLETED|Overall Study||0
6598335|NCT02029703|7523402|FG001|NOT COMPLETED|Overall Study||0
6598336|NCT02029755|7523411|FG000|STARTED|Overall Study||36
6598337|NCT02029755|7523412|FG001|STARTED|Overall Study||36
6598338|NCT02029755|7523413|FG002|STARTED|Overall Study||36
6598339|NCT02029755|7523411|FG000|COMPLETED|Overall Study||36
6598340|NCT02029755|7523412|FG001|COMPLETED|Overall Study||36
6598341|NCT02029755|7523413|FG002|COMPLETED|Overall Study||36
6598342|NCT02029755|7523411|FG000|NOT COMPLETED|Overall Study||0
6598343|NCT02029755|7523412|FG001|NOT COMPLETED|Overall Study||0
6661366|NCT02504554|7592170|FG001|COMPLETED|Overall Study||6
6661367|NCT02504554|7592169|FG000|NOT COMPLETED|Overall Study||0
6661368|NCT02504554|7592170|FG001|NOT COMPLETED|Overall Study||0
6661369|NCT02504619|7592176|FG000|STARTED|Overall Study||1
6661370|NCT02504619|7592176|FG000|COMPLETED|Overall Study||1
6661371|NCT02504619|7592176|FG000|NOT COMPLETED|Overall Study||0
6661372|NCT02504645|7592183|FG000|STARTED|Overall Study||101
6661373|NCT02504645|7592184|FG001|STARTED|Overall Study||101
6661374|NCT02504645|7592183|FG000|COMPLETED|Overall Study||77
6661375|NCT02504645|7592184|FG001|COMPLETED|Overall Study||76
6661376|NCT02504645|7592183|FG000|NOT COMPLETED|Overall Study||24
6661377|NCT02504645|7592184|FG001|NOT COMPLETED|Overall Study||25
6661378|NCT02504671|7592196|FG000|STARTED|Overall Study||37
6661379|NCT02504671|7592197|FG001|STARTED|Overall Study||37
6661380|NCT02504671|7592198|FG002|STARTED|Overall Study||37
6661381|NCT02504671|7592199|FG003|STARTED|Overall Study||37
6661382|NCT02504671|7592200|FG004|STARTED|Overall Study||37
6661383|NCT02504671|7592201|FG005|STARTED|Overall Study||37
6661384|NCT02504671|7592196|FG000|COMPLETED|Overall Study||25
6661385|NCT02504671|7592197|FG001|COMPLETED|Overall Study||23
6661386|NCT02504671|7592198|FG002|COMPLETED|Overall Study||27
6661387|NCT02504671|7592199|FG003|COMPLETED|Overall Study||27
6661388|NCT02504671|7592200|FG004|COMPLETED|Overall Study||25
6661389|NCT02504671|7592201|FG005|COMPLETED|Overall Study||23
6661390|NCT02504671|7592196|FG000|NOT COMPLETED|Overall Study||12
6661391|NCT02504671|7592197|FG001|NOT COMPLETED|Overall Study||14
6661392|NCT02504671|7592198|FG002|NOT COMPLETED|Overall Study||10
6661393|NCT02504671|7592199|FG003|NOT COMPLETED|Overall Study||10
6661394|NCT02504671|7592200|FG004|NOT COMPLETED|Overall Study||12
6661395|NCT02504671|7592201|FG005|NOT COMPLETED|Overall Study||14
6661396|NCT02504723|7592217|FG000|STARTED|Overall Study||60
6661397|NCT02504723|7592218|FG001|STARTED|Overall Study||61
6661398|NCT02504723|7592217|FG000|COMPLETED|Overall Study||60
6661399|NCT02504723|7592218|FG001|COMPLETED|Overall Study||61
6661400|NCT02504723|7592217|FG000|NOT COMPLETED|Overall Study||0
6661401|NCT02504723|7592218|FG001|NOT COMPLETED|Overall Study||0
6661402|NCT02504775|7592224|FG000|STARTED|Period 1||14
6661403|NCT02504775|7592225|FG001|STARTED|Period 1||14
6661404|NCT02504775|7592224|FG000|COMPLETED|Period 1||14
6661405|NCT02504775|7592225|FG001|COMPLETED|Period 1||14
6661406|NCT02504775|7592224|FG000|NOT COMPLETED|Period 1||0
6661407|NCT02504775|7592225|FG001|NOT COMPLETED|Period 1||0
6661408|NCT02504775|7592224|FG000|STARTED|Washout||14
6598344|NCT02029755|7523413|FG002|NOT COMPLETED|Overall Study||0
6598345|NCT02029872|7523423|FG000|STARTED|Overall Study||9
6598346|NCT02029872|7523424|FG001|STARTED|Overall Study||9
6598347|NCT02029872|7523423|FG000|COMPLETED|Overall Study||7
6661409|NCT02504775|7592225|FG001|STARTED|Washout||14
6661410|NCT02504775|7592224|FG000|COMPLETED|Washout||14
6661411|NCT02504775|7592225|FG001|COMPLETED|Washout||14
6661412|NCT02504775|7592224|FG000|NOT COMPLETED|Washout||0
6661413|NCT02504775|7592225|FG001|NOT COMPLETED|Washout||0
6661414|NCT02504775|7592224|FG000|STARTED|Period 2||14
6661415|NCT02504775|7592225|FG001|STARTED|Period 2||14
6661416|NCT02504775|7592224|FG000|COMPLETED|Period 2||14
6661417|NCT02504775|7592225|FG001|COMPLETED|Period 2||14
6661418|NCT02504775|7592224|FG000|NOT COMPLETED|Period 2||0
6661419|NCT02504775|7592225|FG001|NOT COMPLETED|Period 2||0
6661420|NCT02504827|7592233|FG000|STARTED|Overall Study||12
6661421|NCT02504827|7592233|FG000|COMPLETED|Overall Study||11
6661422|NCT02504827|7592233|FG000|NOT COMPLETED|Overall Study||1
6661423|NCT02504892|7592237|FG000|STARTED|Overall Study||3
6598348|NCT02029872|7523424|FG001|COMPLETED|Overall Study||6
6598349|NCT02029872|7523423|FG000|NOT COMPLETED|Overall Study||2
6598350|NCT02029872|7523424|FG001|NOT COMPLETED|Overall Study||3
6598351|NCT02029911|7523430|FG000|STARTED|Overall Study|Treatment Attempted|60
6598352|NCT02029911|7523430|FG000|Treated|Overall Study|Treatment Completed|60
6598353|NCT02029911|7523430|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
6598354|NCT02029911|7523430|FG000|NOT COMPLETED|Overall Study||0
6598355|NCT02029976|7523436|FG000|STARTED|YR-1 Post Intervention vs Baseline||132
6598356|NCT02029976|7523437|FG001|STARTED|YR-1 Post Intervention vs Baseline||132
6598357|NCT02029976|7523436|FG000|COMPLETED|YR-1 Post Intervention vs Baseline||120
6598358|NCT02029976|7523437|FG001|COMPLETED|YR-1 Post Intervention vs Baseline||124
6598359|NCT02029976|7523436|FG000|NOT COMPLETED|YR-1 Post Intervention vs Baseline||12
6598360|NCT02029976|7523437|FG001|NOT COMPLETED|YR-1 Post Intervention vs Baseline||8
6598361|NCT02029976|7523436|FG000|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
6598362|NCT02029976|7523437|FG001|STARTED|YR-2 Follow Up vs Baseline|Attrition at end of year 2 was calculated based on baseline enrollment|132
6598363|NCT02029976|7523436|FG000|COMPLETED|YR-2 Follow Up vs Baseline||122
6598364|NCT02029976|7523437|FG001|COMPLETED|YR-2 Follow Up vs Baseline||124
6598365|NCT02029976|7523436|FG000|NOT COMPLETED|YR-2 Follow Up vs Baseline||10
6598366|NCT02029976|7523437|FG001|NOT COMPLETED|YR-2 Follow Up vs Baseline||8
6598367|NCT02029989|7523445|FG000|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
6598368|NCT02029989|7523446|FG001|STARTED|Overall Study||60
6598369|NCT02029989|7523445|FG000|COMPLETED|Overall Study||45
6598370|NCT02029989|7523446|FG001|COMPLETED|Overall Study||49
6598371|NCT02029989|7523445|FG000|NOT COMPLETED|Overall Study||16
6598372|NCT02029989|7523446|FG001|NOT COMPLETED|Overall Study||11
6598373|NCT02030002|7523452|FG000|STARTED|Enrollment||49
6598374|NCT02030002|7523452|FG000|COMPLETED|Enrollment||44
6598375|NCT02030002|7523452|FG000|NOT COMPLETED|Enrollment||5
6661424|NCT02504892|7592237|FG000|COMPLETED|Overall Study||1
6661425|NCT02504892|7592237|FG000|NOT COMPLETED|Overall Study||2
6661426|NCT02504931|7592243|FG000|STARTED|Overall Study||26
6661427|NCT02504931|7592244|FG001|STARTED|Overall Study||23
6661428|NCT02504931|7592243|FG000|COMPLETED|Overall Study||14
6661429|NCT02504931|7592244|FG001|COMPLETED|Overall Study||13
6661430|NCT02504931|7592243|FG000|NOT COMPLETED|Overall Study||12
6661431|NCT02504931|7592244|FG001|NOT COMPLETED|Overall Study||10
6661432|NCT02505217|7592252|FG000|STARTED|Overall Study||105
6661433|NCT02505217|7592253|FG001|STARTED|Overall Study||95
6661434|NCT02505217|7592252|FG000|COMPLETED|Overall Study||104
6661435|NCT02505217|7592253|FG001|COMPLETED|Overall Study||93
6661436|NCT02505217|7592252|FG000|NOT COMPLETED|Overall Study||1
6661437|NCT02505217|7592253|FG001|NOT COMPLETED|Overall Study||2
6661438|NCT02505269|7592259|FG000|STARTED|Overall Study||34
6661439|NCT02505269|7592259|FG000|COMPLETED|Overall Study||34
6661440|NCT02505269|7592259|FG000|NOT COMPLETED|Overall Study||0
6661441|NCT02505334|7592265|FG000|STARTED|Main Treatment Period||233
6661442|NCT02505334|7592266|FG001|STARTED|Main Treatment Period||233
6661443|NCT02505334|7592265|FG000|COMPLETED|Main Treatment Period||218
6661444|NCT02505334|7592266|FG001|COMPLETED|Main Treatment Period||194
6661445|NCT02505334|7592265|FG000|NOT COMPLETED|Main Treatment Period||15
6661446|NCT02505334|7592266|FG001|NOT COMPLETED|Main Treatment Period||39
6661447|NCT02505334|7592265|FG000|STARTED|Extension Treatment Period|6 subjects withdrew from the trial after the main period and prior to entering the extension period|212
6661448|NCT02505334|7592266|FG001|STARTED|Extension Treatment Period|This treatment arm is not considered for this period as the subjects were treated for 26 weeks|0
6661449|NCT02505334|7592265|FG000|COMPLETED|Extension Treatment Period||194
6661450|NCT02505334|7592266|FG001|COMPLETED|Extension Treatment Period||0
6661451|NCT02505334|7592265|FG000|NOT COMPLETED|Extension Treatment Period||18
6661452|NCT02505334|7592266|FG001|NOT COMPLETED|Extension Treatment Period||0
6598376|NCT02030002|7523452|FG000|STARTED|APC Flash-Free Adhesive Coated Appliance||44
6661453|NCT02505542|7592272|FG000|STARTED|Part A: Open-Label Period||736
6661454|NCT02505542|7592273|FG001|STARTED|Part A: Open-Label Period||0
6661455|NCT02505542|7592274|FG002|STARTED|Part A: Open-Label Period||0
6661456|NCT02505542|7592275|FG003|STARTED|Part A: Open-Label Period||0
6661457|NCT02505542|7592272|FG000|COMPLETED|Part A: Open-Label Period||659
6661458|NCT02505542|7592273|FG001|COMPLETED|Part A: Open-Label Period||0
6598377|NCT02030002|7523452|FG000|COMPLETED|APC Flash-Free Adhesive Coated Appliance||44
6598378|NCT02030002|7523452|FG000|NOT COMPLETED|APC Flash-Free Adhesive Coated Appliance||0
6598379|NCT02030002|7523452|FG000|STARTED|APC II Adhesive Coated Appliance System||44
6598380|NCT02030002|7523452|FG000|COMPLETED|APC II Adhesive Coated Appliance System||44
6598381|NCT02030002|7523452|FG000|NOT COMPLETED|APC II Adhesive Coated Appliance System||0
6598382|NCT02030002|7523452|FG000|STARTED|Follow-up||44
6598383|NCT02030002|7523452|FG000|COMPLETED|Follow-up||42
6598384|NCT02030002|7523452|FG000|NOT COMPLETED|Follow-up||2
6598385|NCT02030041|7523461|FG000|STARTED|Overall Study||11
6598386|NCT02030041|7523462|FG001|STARTED|Overall Study||11
6598387|NCT02030041|7523463|FG002|STARTED|Overall Study||11
6598388|NCT02030041|7523461|FG000|COMPLETED|Overall Study||9
6598389|NCT02030041|7523462|FG001|COMPLETED|Overall Study||9
6598390|NCT02030041|7523463|FG002|COMPLETED|Overall Study||10
6598391|NCT02030041|7523461|FG000|NOT COMPLETED|Overall Study||2
6598392|NCT02030041|7523462|FG001|NOT COMPLETED|Overall Study||2
6598393|NCT02030041|7523463|FG002|NOT COMPLETED|Overall Study||1
6598394|NCT02030080|7523475|FG000|STARTED|Overall Study|25 teams|100
6598395|NCT02030080|7523476|FG001|STARTED|Overall Study|16 teams|64
6598396|NCT02030080|7523477|FG002|STARTED|Overall Study|20 teams|80
6598397|NCT02030080|7523478|FG003|STARTED|Overall Study|11 teams|44
6598398|NCT02030080|7523475|FG000|COMPLETED|Overall Study||100
6598399|NCT02030080|7523476|FG001|COMPLETED|Overall Study||64
6598400|NCT02030080|7523477|FG002|COMPLETED|Overall Study||80
6598401|NCT02030080|7523478|FG003|COMPLETED|Overall Study||42
6598402|NCT02030080|7523475|FG000|NOT COMPLETED|Overall Study||0
6598403|NCT02030080|7523476|FG001|NOT COMPLETED|Overall Study||0
6598404|NCT02030080|7523477|FG002|NOT COMPLETED|Overall Study||0
6598405|NCT02030080|7523478|FG003|NOT COMPLETED|Overall Study||2
6598406|NCT02030119|7523492|FG000|STARTED|Overall Study||70
6598407|NCT02030119|7523493|FG001|STARTED|Overall Study||70
6598408|NCT02030119|7523494|FG002|STARTED|Overall Study||71
6598409|NCT02030119|7523495|FG003|STARTED|Overall Study||70
6598410|NCT02030119|7523492|FG000|COMPLETED|Overall Study||67
6598411|NCT02030119|7523493|FG001|COMPLETED|Overall Study||68
6598412|NCT02030119|7523494|FG002|COMPLETED|Overall Study||65
6598413|NCT02030119|7523495|FG003|COMPLETED|Overall Study||67
6598414|NCT02030119|7523492|FG000|NOT COMPLETED|Overall Study||3
6598415|NCT02030119|7523493|FG001|NOT COMPLETED|Overall Study||2
6598416|NCT02030119|7523494|FG002|NOT COMPLETED|Overall Study||6
6598417|NCT02030119|7523495|FG003|NOT COMPLETED|Overall Study||3
6598418|NCT02030288|7523507|FG000|STARTED|Overall Study||89
6598419|NCT02030288|7523508|FG001|STARTED|Overall Study||89
6598420|NCT02030288|7523507|FG000|COMPLETED|Overall Study||89
6598421|NCT02030288|7523508|FG001|COMPLETED|Overall Study||89
6598422|NCT02030288|7523507|FG000|NOT COMPLETED|Overall Study||0
6598423|NCT02030288|7523508|FG001|NOT COMPLETED|Overall Study||0
6598424|NCT02030405|7523518|FG000|STARTED|Overall Study||4
6598425|NCT02030405|7523518|FG000|COMPLETED|Overall Study||2
6598426|NCT02030405|7523518|FG000|NOT COMPLETED|Overall Study||2
6598427|NCT02030535|7523523|FG000|STARTED|Treatment Period 1 (1 Day)||53
6598428|NCT02030535|7523523|FG000|COMPLETED|Treatment Period 1 (1 Day)||53
6598429|NCT02030535|7523523|FG000|NOT COMPLETED|Treatment Period 1 (1 Day)||0
6598430|NCT02030535|7523523|FG000|STARTED|Washout Period 1 (21 Days)||53
6598431|NCT02030535|7523523|FG000|COMPLETED|Washout Period 1 (21 Days)||52
6598432|NCT02030535|7523523|FG000|NOT COMPLETED|Washout Period 1 (21 Days)||1
6598433|NCT02030535|7523523|FG000|STARTED|Treatment Period 2 (1 Day)||52
6598434|NCT02030535|7523523|FG000|COMPLETED|Treatment Period 2 (1 Day)||52
6598435|NCT02030535|7523523|FG000|NOT COMPLETED|Treatment Period 2 (1 Day)||0
6598436|NCT02030535|7523523|FG000|STARTED|Washout Period 2 (21 Days)||52
6598437|NCT02030535|7523523|FG000|COMPLETED|Washout Period 2 (21 Days)||52
6598438|NCT02030535|7523523|FG000|NOT COMPLETED|Washout Period 2 (21 Days)||0
6598439|NCT02030535|7523523|FG000|STARTED|Treatment Period 3 (1 Day)||52
6598440|NCT02030535|7523523|FG000|COMPLETED|Treatment Period 3 (1 Day)||52
6598441|NCT02030535|7523523|FG000|NOT COMPLETED|Treatment Period 3 (1 Day)||0
6598442|NCT02030574|7523537|FG000|STARTED|Overall Study||2
6598443|NCT02030574|7523537|FG000|COMPLETED|Overall Study||2
6598444|NCT02030574|7523537|FG000|NOT COMPLETED|Overall Study||0
6598445|NCT02030600|7523543|FG000|STARTED|Treatment Period 1||361
6598446|NCT02030600|7523544|FG001|STARTED|Treatment Period 1||360
6598447|NCT02030600|7523543|FG000|Exposed|Treatment Period 1||356
6598448|NCT02030600|7523544|FG001|Exposed|Treatment Period 1||357
6598449|NCT02030600|7523543|FG000|COMPLETED|Treatment Period 1||308
6598450|NCT02030600|7523544|FG001|COMPLETED|Treatment Period 1||315
6598451|NCT02030600|7523543|FG000|NOT COMPLETED|Treatment Period 1||53
6598452|NCT02030600|7523544|FG001|NOT COMPLETED|Treatment Period 1||45
6598453|NCT02030600|7523543|FG000|STARTED|Treatment Period 2||308
6598454|NCT02030600|7523544|FG001|STARTED|Treatment Period 2||315
6598455|NCT02030600|7523543|FG000|COMPLETED|Treatment Period 2||283
6598456|NCT02030600|7523544|FG001|COMPLETED|Treatment Period 2||297
6598457|NCT02030600|7523543|FG000|NOT COMPLETED|Treatment Period 2||25
6598458|NCT02030600|7523544|FG001|NOT COMPLETED|Treatment Period 2||18
6598459|NCT02030821|7523556|FG000|STARTED|Overall Study||48
6598460|NCT02030821|7523557|FG001|STARTED|Overall Study||46
6598461|NCT02030821|7523558|FG002|STARTED|Overall Study||78
6598462|NCT02030821|7523559|FG003|STARTED|Overall Study||74
6598463|NCT02030821|7523556|FG000|COMPLETED|Overall Study||46
6598464|NCT02030821|7523557|FG001|COMPLETED|Overall Study||44
6598465|NCT02030821|7523558|FG002|COMPLETED|Overall Study||73
6598466|NCT02030821|7523559|FG003|COMPLETED|Overall Study||72
6598467|NCT02030821|7523556|FG000|NOT COMPLETED|Overall Study||2
6598468|NCT02030821|7523557|FG001|NOT COMPLETED|Overall Study||2
6598469|NCT02030821|7523558|FG002|NOT COMPLETED|Overall Study||5
6598470|NCT02030821|7523559|FG003|NOT COMPLETED|Overall Study||2
6598471|NCT02030834|7523572|FG000|STARTED|Overall Study||50
6598472|NCT02030834|7523573|FG001|STARTED|Overall Study||3
6598473|NCT02030834|7523574|FG002|STARTED|Overall Study||10
6598474|NCT02030834|7523572|FG000|COMPLETED|Overall Study||39
6598475|NCT02030834|7523573|FG001|COMPLETED|Overall Study||3
6598476|NCT02030834|7523574|FG002|COMPLETED|Overall Study||7
6598477|NCT02030834|7523572|FG000|NOT COMPLETED|Overall Study||11
6598478|NCT02030834|7523573|FG001|NOT COMPLETED|Overall Study||0
6598479|NCT02030834|7523574|FG002|NOT COMPLETED|Overall Study||3
6598480|NCT02030847|7523582|FG000|STARTED|Overall Study||42
6598481|NCT02030847|7523582|FG000|COMPLETED|Overall Study||5
6598482|NCT02030847|7523582|FG000|NOT COMPLETED|Overall Study||37
6598483|NCT02030886|7523589|FG000|STARTED|Overall Study||14
6598484|NCT02030886|7523590|FG001|STARTED|Overall Study||6
6598485|NCT02030886|7523589|FG000|COMPLETED|Overall Study||14
6598486|NCT02030886|7523590|FG001|COMPLETED|Overall Study||6
6598487|NCT02030886|7523589|FG000|NOT COMPLETED|Overall Study||0
6598488|NCT02030886|7523590|FG001|NOT COMPLETED|Overall Study||0
6598489|NCT02031146|7523600|FG000|STARTED|Overall Study||11
6598490|NCT02031146|7523601|FG001|STARTED|Overall Study||3
6598491|NCT02031146|7523602|FG002|STARTED|Overall Study||18
6598492|NCT02031146|7523603|FG003|STARTED|Overall Study||148
6598493|NCT02031146|7523604|FG004|STARTED|Overall Study||42
6661459|NCT02505542|7592274|FG002|COMPLETED|Part A: Open-Label Period||0
6661460|NCT02505542|7592275|FG003|COMPLETED|Part A: Open-Label Period||0
6661461|NCT02505542|7592272|FG000|NOT COMPLETED|Part A: Open-Label Period||77
6661462|NCT02505542|7592273|FG001|NOT COMPLETED|Part A: Open-Label Period||0
6661463|NCT02505542|7592274|FG002|NOT COMPLETED|Part A: Open-Label Period||0
6661464|NCT02505542|7592275|FG003|NOT COMPLETED|Part A: Open-Label Period||0
6661465|NCT02505542|7592272|FG000|STARTED|Completed Part A, Did Not Enter Part B||659
6661466|NCT02505542|7592273|FG001|STARTED|Completed Part A, Did Not Enter Part B||0
6661467|NCT02505542|7592274|FG002|STARTED|Completed Part A, Did Not Enter Part B||0
6661468|NCT02505542|7592275|FG003|STARTED|Completed Part A, Did Not Enter Part B||0
6661469|NCT02505542|7592272|FG000|COMPLETED|Completed Part A, Did Not Enter Part B||313
6661470|NCT02505542|7592273|FG001|COMPLETED|Completed Part A, Did Not Enter Part B||0
6661471|NCT02505542|7592274|FG002|COMPLETED|Completed Part A, Did Not Enter Part B||0
6661472|NCT02505542|7592275|FG003|COMPLETED|Completed Part A, Did Not Enter Part B||0
6661473|NCT02505542|7592272|FG000|NOT COMPLETED|Completed Part A, Did Not Enter Part B||346
6661474|NCT02505542|7592273|FG001|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
6661475|NCT02505542|7592274|FG002|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
6661476|NCT02505542|7592275|FG003|NOT COMPLETED|Completed Part A, Did Not Enter Part B||0
6661477|NCT02505542|7592272|FG000|STARTED|Part B: Double-Blind Period||0
6661478|NCT02505542|7592273|FG001|STARTED|Part B: Double-Blind Period||104
6661479|NCT02505542|7592274|FG002|STARTED|Part B: Double-Blind Period||104
6661480|NCT02505542|7592275|FG003|STARTED|Part B: Double-Blind Period||105
6661481|NCT02505542|7592272|FG000|Started Escape Period|Part B: Double-Blind Period||0
6661482|NCT02505542|7592273|FG001|Started Escape Period|Part B: Double-Blind Period||73
6661483|NCT02505542|7592274|FG002|Started Escape Period|Part B: Double-Blind Period||7
6661484|NCT02505542|7592275|FG003|Started Escape Period|Part B: Double-Blind Period||15
6661485|NCT02505542|7592272|FG000|COMPLETED|Part B: Double-Blind Period||0
6661486|NCT02505542|7592273|FG001|COMPLETED|Part B: Double-Blind Period||92
6661487|NCT02505542|7592274|FG002|COMPLETED|Part B: Double-Blind Period||95
6661488|NCT02505542|7592275|FG003|COMPLETED|Part B: Double-Blind Period||98
6661489|NCT02505542|7592272|FG000|NOT COMPLETED|Part B: Double-Blind Period||0
6661490|NCT02505542|7592273|FG001|NOT COMPLETED|Part B: Double-Blind Period||12
6661491|NCT02505542|7592274|FG002|NOT COMPLETED|Part B: Double-Blind Period||9
6661492|NCT02505542|7592275|FG003|NOT COMPLETED|Part B: Double-Blind Period||7
6661493|NCT02505867|7592303|FG000|STARTED|Overall Study||6
6661494|NCT02505867|7592304|FG001|STARTED|Overall Study||6
6661495|NCT02505867|7592303|FG000|COMPLETED|Overall Study||0
6661496|NCT02505867|7592304|FG001|COMPLETED|Overall Study||0
6661497|NCT02505867|7592303|FG000|NOT COMPLETED|Overall Study||6
6661498|NCT02505867|7592304|FG001|NOT COMPLETED|Overall Study||6
6661499|NCT02505919|7592312|FG000|STARTED|Treatment||117
6661500|NCT02505919|7592313|FG001|STARTED|Treatment||67
6661501|NCT02505919|7592312|FG000|COMPLETED|Treatment||116
6661502|NCT02505919|7592313|FG001|COMPLETED|Treatment||65
6661503|NCT02505919|7592312|FG000|NOT COMPLETED|Treatment||1
6598494|NCT02031146|7523605|FG005|STARTED|Overall Study||4
6598495|NCT02031146|7523606|FG006|STARTED|Overall Study||5
6598496|NCT02031146|7523600|FG000|Considered in Analysis|Overall Study||11
6598497|NCT02031146|7523601|FG001|Considered in Analysis|Overall Study||3
6598498|NCT02031146|7523602|FG002|Considered in Analysis|Overall Study||18
6598499|NCT02031146|7523603|FG003|Considered in Analysis|Overall Study||48
6598500|NCT02031146|7523604|FG004|Considered in Analysis|Overall Study||16
6598501|NCT02031146|7523605|FG005|Considered in Analysis|Overall Study||0
6598502|NCT02031146|7523606|FG006|Considered in Analysis|Overall Study||0
6598503|NCT02031146|7523600|FG000|COMPLETED|Overall Study||11
6598504|NCT02031146|7523601|FG001|COMPLETED|Overall Study||3
6598505|NCT02031146|7523602|FG002|COMPLETED|Overall Study||18
6598506|NCT02031146|7523603|FG003|COMPLETED|Overall Study||48
6598507|NCT02031146|7523604|FG004|COMPLETED|Overall Study||16
6598508|NCT02031146|7523605|FG005|COMPLETED|Overall Study||0
6598509|NCT02031146|7523606|FG006|COMPLETED|Overall Study||0
6598510|NCT02031146|7523600|FG000|NOT COMPLETED|Overall Study||0
6598511|NCT02031146|7523601|FG001|NOT COMPLETED|Overall Study||0
6598512|NCT02031146|7523602|FG002|NOT COMPLETED|Overall Study||0
6598513|NCT02031146|7523603|FG003|NOT COMPLETED|Overall Study||100
6598514|NCT02031146|7523604|FG004|NOT COMPLETED|Overall Study||26
6598515|NCT02031146|7523605|FG005|NOT COMPLETED|Overall Study||4
6598516|NCT02031146|7523606|FG006|NOT COMPLETED|Overall Study||5
6598517|NCT02031237|7523618|FG000|STARTED|Overall Study||14
6598518|NCT02031237|7523619|FG001|STARTED|Overall Study||35
6598519|NCT02031237|7523620|FG002|STARTED|Overall Study||3
6598520|NCT02031237|7523618|FG000|COMPLETED|Overall Study||9
6598521|NCT02031237|7523619|FG001|COMPLETED|Overall Study||21
6598522|NCT02031237|7523620|FG002|COMPLETED|Overall Study||0
6598523|NCT02031237|7523618|FG000|NOT COMPLETED|Overall Study||5
6598524|NCT02031237|7523619|FG001|NOT COMPLETED|Overall Study||14
6598525|NCT02031237|7523620|FG002|NOT COMPLETED|Overall Study||3
6598526|NCT02031276|7523630|FG000|STARTED|Period 1 Double-blind IV||39
6598527|NCT02031276|7523631|FG001|STARTED|Period 1 Double-blind IV||41
6598528|NCT02031276|7523632|FG002|STARTED|Period 1 Double-blind IV||41
6598529|NCT02031276|7523630|FG000|COMPLETED|Period 1 Double-blind IV||33
6598530|NCT02031276|7523631|FG001|COMPLETED|Period 1 Double-blind IV||35
6598531|NCT02031276|7523632|FG002|COMPLETED|Period 1 Double-blind IV||40
6598532|NCT02031276|7523630|FG000|NOT COMPLETED|Period 1 Double-blind IV||6
6598533|NCT02031276|7523631|FG001|NOT COMPLETED|Period 1 Double-blind IV||6
6598534|NCT02031276|7523632|FG002|NOT COMPLETED|Period 1 Double-blind IV||1
6598535|NCT02031276|7523630|FG000|STARTED|Period 2 Open-label Risankizumab IV||33
6598536|NCT02031276|7523631|FG001|STARTED|Period 2 Open-label Risankizumab IV||35
6598537|NCT02031276|7523632|FG002|STARTED|Period 2 Open-label Risankizumab IV|1 participant did not enter Period 2 (declined open-label treatment in Period 2)|39
6598538|NCT02031276|7523630|FG000|COMPLETED|Period 2 Open-label Risankizumab IV||29
6598539|NCT02031276|7523631|FG001|COMPLETED|Period 2 Open-label Risankizumab IV||33
6598540|NCT02031276|7523632|FG002|COMPLETED|Period 2 Open-label Risankizumab IV||38
6598541|NCT02031276|7523630|FG000|NOT COMPLETED|Period 2 Open-label Risankizumab IV||4
6598542|NCT02031276|7523631|FG001|NOT COMPLETED|Period 2 Open-label Risankizumab IV||2
6598543|NCT02031276|7523632|FG002|NOT COMPLETED|Period 2 Open-label Risankizumab IV||1
6598544|NCT02031276|7523630|FG000|STARTED|Period 3 Open-label Risankizumab SC|10 participants did not enter period 3 (not in clinical remission)|19
6598545|NCT02031276|7523631|FG001|STARTED|Period 3 Open-label Risankizumab SC|11 participants did not enter period 3 (not in clinical remission)|22
6598546|NCT02031276|7523632|FG002|STARTED|Period 3 Open-label Risankizumab SC|17 participants did not enter period 3 (not in clinical remission)|21
6598547|NCT02031276|7523630|FG000|COMPLETED|Period 3 Open-label Risankizumab SC||16
6598548|NCT02031276|7523631|FG001|COMPLETED|Period 3 Open-label Risankizumab SC||19
6598549|NCT02031276|7523632|FG002|COMPLETED|Period 3 Open-label Risankizumab SC||19
6598550|NCT02031276|7523630|FG000|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
6598551|NCT02031276|7523631|FG001|NOT COMPLETED|Period 3 Open-label Risankizumab SC||3
6598552|NCT02031276|7523632|FG002|NOT COMPLETED|Period 3 Open-label Risankizumab SC||2
6598553|NCT02031302|7523646|FG000|STARTED|Overall Study||1014
6598554|NCT02031302|7523647|FG001|STARTED|Overall Study||50
6598555|NCT02031302|7523646|FG000|COMPLETED|Overall Study||850
6598556|NCT02031302|7523647|FG001|COMPLETED|Overall Study||50
6661504|NCT02505919|7592313|FG001|NOT COMPLETED|Treatment||2
6661505|NCT02505919|7592312|FG000|STARTED|1 Week Follow-Up||116
6661506|NCT02505919|7592313|FG001|STARTED|1 Week Follow-Up||65
6661507|NCT02505919|7592312|FG000|COMPLETED|1 Week Follow-Up||116
6661508|NCT02505919|7592313|FG001|COMPLETED|1 Week Follow-Up||65
6661509|NCT02505919|7592312|FG000|NOT COMPLETED|1 Week Follow-Up||0
6661510|NCT02505919|7592313|FG001|NOT COMPLETED|1 Week Follow-Up||0
6661511|NCT02505919|7592312|FG000|STARTED|1 Month Follow-Up||116
6661512|NCT02505919|7592313|FG001|STARTED|1 Month Follow-Up||65
6661513|NCT02505919|7592312|FG000|COMPLETED|1 Month Follow-Up||116
6661514|NCT02505919|7592313|FG001|COMPLETED|1 Month Follow-Up||65
6661515|NCT02505919|7592312|FG000|NOT COMPLETED|1 Month Follow-Up||0
6661516|NCT02505919|7592313|FG001|NOT COMPLETED|1 Month Follow-Up||0
6661517|NCT02505919|7592312|FG000|STARTED|3 Months Follow-Up||116
6661518|NCT02505919|7592313|FG001|STARTED|3 Months Follow-Up||65
6661519|NCT02505919|7592312|FG000|COMPLETED|3 Months Follow-Up||116
6661520|NCT02505919|7592313|FG001|COMPLETED|3 Months Follow-Up||65
6661521|NCT02505919|7592312|FG000|NOT COMPLETED|3 Months Follow-Up||0
6661522|NCT02505919|7592313|FG001|NOT COMPLETED|3 Months Follow-Up||0
6661523|NCT02505919|7592312|FG000|STARTED|6 Months Follow-Up||116
6661524|NCT02505919|7592313|FG001|STARTED|6 Months Follow-Up||65
6661525|NCT02505919|7592312|FG000|COMPLETED|6 Months Follow-Up||116
6661526|NCT02505919|7592313|FG001|COMPLETED|6 Months Follow-Up||63
6661527|NCT02505919|7592312|FG000|NOT COMPLETED|6 Months Follow-Up||0
6661528|NCT02505919|7592313|FG001|NOT COMPLETED|6 Months Follow-Up||2
6661529|NCT02505919|7592312|FG000|STARTED|12 Months Follow-Up||116
6661530|NCT02505919|7592313|FG001|STARTED|12 Months Follow-Up||63
6661531|NCT02505919|7592312|FG000|COMPLETED|12 Months Follow-Up||115
6661532|NCT02505919|7592313|FG001|COMPLETED|12 Months Follow-Up||61
6598557|NCT02031302|7523646|FG000|NOT COMPLETED|Overall Study||164
6598558|NCT02031302|7523647|FG001|NOT COMPLETED|Overall Study||0
6598559|NCT02031432|7523654|FG000|STARTED|Overall Study||76
6598560|NCT02031432|7523654|FG000|Completing the Titration Phase|Overall Study||67
6598561|NCT02031432|7523654|FG000|Completing the Treatment|Overall Study||39
6598562|NCT02031432|7523654|FG000|COMPLETED|Overall Study||38
6598563|NCT02031432|7523654|FG000|NOT COMPLETED|Overall Study||38
6598564|NCT02031458|7523661|FG000|STARTED|May 8, 2015 to January 11, 2019||138
6598565|NCT02031458|7523662|FG001|STARTED|May 8, 2015 to January 11, 2019||269
6598566|NCT02031458|7523663|FG002|STARTED|May 8, 2015 to January 11, 2019||252
6598567|NCT02031458|7523661|FG000|COMPLETED|May 8, 2015 to January 11, 2019||0
6598568|NCT02031458|7523662|FG001|COMPLETED|May 8, 2015 to January 11, 2019||0
6598569|NCT02031458|7523663|FG002|COMPLETED|May 8, 2015 to January 11, 2019||0
6598570|NCT02031458|7523661|FG000|NOT COMPLETED|May 8, 2015 to January 11, 2019||138
6598571|NCT02031458|7523662|FG001|NOT COMPLETED|May 8, 2015 to January 11, 2019||269
6598572|NCT02031458|7523663|FG002|NOT COMPLETED|May 8, 2015 to January 11, 2019||252
6598573|NCT02031458|7523661|FG000|STARTED|Baseline to May 8, 2015||139
6598574|NCT02031458|7523662|FG001|STARTED|Baseline to May 8, 2015||267
6598575|NCT02031458|7523663|FG002|STARTED|Baseline to May 8, 2015||253
6598576|NCT02031458|7523661|FG000|COMPLETED|Baseline to May 8, 2015||0
6598577|NCT02031458|7523662|FG001|COMPLETED|Baseline to May 8, 2015||0
6598578|NCT02031458|7523663|FG002|COMPLETED|Baseline to May 8, 2015||0
6598579|NCT02031458|7523661|FG000|NOT COMPLETED|Baseline to May 8, 2015||139
6598580|NCT02031458|7523662|FG001|NOT COMPLETED|Baseline to May 8, 2015||267
6598581|NCT02031458|7523663|FG002|NOT COMPLETED|Baseline to May 8, 2015||253
6598582|NCT02031471|7523673|FG000|STARTED|24 Week Treatment Period||57
6598583|NCT02031471|7523673|FG000|COMPLETED|24 Week Treatment Period||46
6598584|NCT02031471|7523673|FG000|NOT COMPLETED|24 Week Treatment Period||11
6598585|NCT02031471|7523673|FG000|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
6598586|NCT02031471|7523673|FG000|COMPLETED|Long Term Extension (LTE) Period||37
6598587|NCT02031471|7523673|FG000|NOT COMPLETED|Long Term Extension (LTE) Period||2
6598588|NCT02031536|7523679|FG000|STARTED|Overall Study||2
6598589|NCT02031536|7523680|FG001|STARTED|Overall Study||0
6598590|NCT02031536|7523679|FG000|COMPLETED|Overall Study||1
6598591|NCT02031536|7523680|FG001|COMPLETED|Overall Study||0
6598592|NCT02031536|7523679|FG000|NOT COMPLETED|Overall Study||1
6598593|NCT02031536|7523680|FG001|NOT COMPLETED|Overall Study||0
6598594|NCT02031627|7523689|FG000|STARTED|Overall Study||7
6598595|NCT02031627|7523690|FG001|STARTED|Overall Study||7
6598596|NCT02031627|7523691|FG002|STARTED|Overall Study||7
6598597|NCT02031627|7523689|FG000|COMPLETED|Overall Study||7
6598598|NCT02031627|7523690|FG001|COMPLETED|Overall Study||7
6598599|NCT02031627|7523691|FG002|COMPLETED|Overall Study||7
6598600|NCT02031627|7523689|FG000|NOT COMPLETED|Overall Study||0
6598601|NCT02031627|7523690|FG001|NOT COMPLETED|Overall Study||0
6598602|NCT02031627|7523691|FG002|NOT COMPLETED|Overall Study||0
6598603|NCT02031640|7523704|FG000|STARTED|Screening Period|Consented|1113
6598604|NCT02031640|7523705|FG001|STARTED|Screening Period||0
6598605|NCT02031640|7523706|FG002|STARTED|Screening Period||0
6598606|NCT02031640|7523707|FG003|STARTED|Screening Period||0
6598607|NCT02031640|7523708|FG004|STARTED|Screening Period||0
6598608|NCT02031640|7523709|FG005|STARTED|Screening Period||0
6598609|NCT02031640|7523704|FG000|COMPLETED|Screening Period||701
6598610|NCT02031640|7523705|FG001|COMPLETED|Screening Period||0
6598611|NCT02031640|7523706|FG002|COMPLETED|Screening Period||0
6598612|NCT02031640|7523707|FG003|COMPLETED|Screening Period||0
6598613|NCT02031640|7523708|FG004|COMPLETED|Screening Period||0
6598614|NCT02031640|7523709|FG005|COMPLETED|Screening Period||0
6598615|NCT02031640|7523704|FG000|NOT COMPLETED|Screening Period||412
6598616|NCT02031640|7523705|FG001|NOT COMPLETED|Screening Period||0
6598617|NCT02031640|7523706|FG002|NOT COMPLETED|Screening Period||0
6598618|NCT02031640|7523707|FG003|NOT COMPLETED|Screening Period||0
6598619|NCT02031640|7523708|FG004|NOT COMPLETED|Screening Period||0
6598620|NCT02031640|7523709|FG005|NOT COMPLETED|Screening Period||0
6598621|NCT02031640|7523704|FG000|STARTED|Run-In Period||701
6598622|NCT02031640|7523705|FG001|STARTED|Run-In Period||0
6661533|NCT02505919|7592312|FG000|NOT COMPLETED|12 Months Follow-Up||1
6661534|NCT02505919|7592313|FG001|NOT COMPLETED|12 Months Follow-Up||2
6661535|NCT02505919|7592312|FG000|STARTED|24 Months Follow-Up||115
6598623|NCT02031640|7523706|FG002|STARTED|Run-In Period||0
6598624|NCT02031640|7523707|FG003|STARTED|Run-In Period||0
6598625|NCT02031640|7523708|FG004|STARTED|Run-In Period||0
6598626|NCT02031640|7523709|FG005|STARTED|Run-In Period||0
6598627|NCT02031640|7523704|FG000|COMPLETED|Run-In Period||532
6598628|NCT02031640|7523705|FG001|COMPLETED|Run-In Period||0
6598629|NCT02031640|7523706|FG002|COMPLETED|Run-In Period||0
6598630|NCT02031640|7523707|FG003|COMPLETED|Run-In Period||0
6598631|NCT02031640|7523708|FG004|COMPLETED|Run-In Period||0
6598632|NCT02031640|7523709|FG005|COMPLETED|Run-In Period||0
6598633|NCT02031640|7523704|FG000|NOT COMPLETED|Run-In Period||169
6598634|NCT02031640|7523705|FG001|NOT COMPLETED|Run-In Period||0
6598635|NCT02031640|7523706|FG002|NOT COMPLETED|Run-In Period||0
6598636|NCT02031640|7523707|FG003|NOT COMPLETED|Run-In Period||0
6598637|NCT02031640|7523708|FG004|NOT COMPLETED|Run-In Period||0
6598638|NCT02031640|7523709|FG005|NOT COMPLETED|Run-In Period||0
6598639|NCT02031640|7523704|FG000|STARTED|Double-blind Treatment Period||0
6598640|NCT02031640|7523705|FG001|STARTED|Double-blind Treatment Period||106
6598641|NCT02031640|7523706|FG002|STARTED|Double-blind Treatment Period||106
6598642|NCT02031640|7523707|FG003|STARTED|Double-blind Treatment Period||106
6598643|NCT02031640|7523708|FG004|STARTED|Double-blind Treatment Period||107
6598644|NCT02031640|7523709|FG005|STARTED|Double-blind Treatment Period||107
6598645|NCT02031640|7523704|FG000|Full Analysis Set|Double-blind Treatment Period||0
6598646|NCT02031640|7523705|FG001|Full Analysis Set|Double-blind Treatment Period||106
6598647|NCT02031640|7523706|FG002|Full Analysis Set|Double-blind Treatment Period||104
6598648|NCT02031640|7523707|FG003|Full Analysis Set|Double-blind Treatment Period||106
6598649|NCT02031640|7523708|FG004|Full Analysis Set|Double-blind Treatment Period||106
6598650|NCT02031640|7523709|FG005|Full Analysis Set|Double-blind Treatment Period||107
6598651|NCT02031640|7523704|FG000|COMPLETED|Double-blind Treatment Period||0
6598652|NCT02031640|7523705|FG001|COMPLETED|Double-blind Treatment Period||84
6598653|NCT02031640|7523706|FG002|COMPLETED|Double-blind Treatment Period||100
6598654|NCT02031640|7523707|FG003|COMPLETED|Double-blind Treatment Period||99
6598655|NCT02031640|7523708|FG004|COMPLETED|Double-blind Treatment Period||96
6598656|NCT02031640|7523709|FG005|COMPLETED|Double-blind Treatment Period||104
6598657|NCT02031640|7523704|FG000|NOT COMPLETED|Double-blind Treatment Period||0
6598658|NCT02031640|7523705|FG001|NOT COMPLETED|Double-blind Treatment Period||22
6598659|NCT02031640|7523706|FG002|NOT COMPLETED|Double-blind Treatment Period||6
6598660|NCT02031640|7523707|FG003|NOT COMPLETED|Double-blind Treatment Period||7
6598661|NCT02031640|7523708|FG004|NOT COMPLETED|Double-blind Treatment Period||11
6598662|NCT02031640|7523709|FG005|NOT COMPLETED|Double-blind Treatment Period||3
6598663|NCT02031679|7523730|FG000|STARTED|Overall Study||14
6598664|NCT02031679|7523731|FG001|STARTED|Overall Study||14
6598665|NCT02031679|7523730|FG000|COMPLETED|Overall Study||14
6598666|NCT02031679|7523731|FG001|COMPLETED|Overall Study||12
6598667|NCT02031679|7523730|FG000|NOT COMPLETED|Overall Study||0
6598668|NCT02031679|7523731|FG001|NOT COMPLETED|Overall Study||2
6598669|NCT02031770|7523737|FG000|STARTED|Overall Study||10
6598670|NCT02031770|7523738|FG001|STARTED|Overall Study||10
6598671|NCT02031770|7523737|FG000|COMPLETED|Overall Study||9
6598672|NCT02031770|7523738|FG001|COMPLETED|Overall Study||9
6598673|NCT02031770|7523737|FG000|NOT COMPLETED|Overall Study||1
6598674|NCT02031770|7523738|FG001|NOT COMPLETED|Overall Study||1
6598675|NCT02031978|7523744|FG000|STARTED|Overall Study||4367
6598676|NCT02031978|7523744|FG000|COMPLETED|Overall Study||4367
6598677|NCT02031978|7523744|FG000|NOT COMPLETED|Overall Study||0
6598678|NCT02032173|7523748|FG000|STARTED|Overall Study||31
6598679|NCT02032173|7523748|FG000|Included Population - Main Group|Overall Study||31
6598680|NCT02032173|7523748|FG000|Rescue Group|Overall Study|1 participant moved to Rescue Group at M6 and trial discontinued before any data was collected.|1
6598681|NCT02032173|7523748|FG000|COMPLETED|Overall Study||0
6598682|NCT02032173|7523748|FG000|NOT COMPLETED|Overall Study||31
6598683|NCT02032212|7523756|FG000|STARTED|Overall Study||3
6598684|NCT02032212|7523757|FG001|STARTED|Overall Study||3
6598685|NCT02032212|7523758|FG002|STARTED|Overall Study||3
6598686|NCT02032212|7523759|FG003|STARTED|Overall Study||3
6598687|NCT02032212|7523756|FG000|COMPLETED|Overall Study||3
6598688|NCT02032212|7523757|FG001|COMPLETED|Overall Study||3
6598689|NCT02032212|7523758|FG002|COMPLETED|Overall Study||3
6598690|NCT02032212|7523759|FG003|COMPLETED|Overall Study||3
6598691|NCT02032212|7523756|FG000|NOT COMPLETED|Overall Study||0
6598692|NCT02032212|7523757|FG001|NOT COMPLETED|Overall Study||0
6598693|NCT02032212|7523758|FG002|NOT COMPLETED|Overall Study||0
6598694|NCT02032212|7523759|FG003|NOT COMPLETED|Overall Study||0
6598695|NCT02032238|7523771|FG000|STARTED|Overall Study||12
6598696|NCT02032238|7523772|FG001|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
6598697|NCT02032238|7523771|FG000|COMPLETED|Overall Study||10
6598698|NCT02032238|7523772|FG001|COMPLETED|Overall Study||0
6598699|NCT02032238|7523771|FG000|NOT COMPLETED|Overall Study||2
6598700|NCT02032238|7523772|FG001|NOT COMPLETED|Overall Study||0
6598701|NCT02032407|7523778|FG000|STARTED|Overall Study||68
6598702|NCT02032407|7523778|FG000|COMPLETED|Overall Study||63
6598703|NCT02032407|7523778|FG000|NOT COMPLETED|Overall Study||5
6598704|NCT02032420|7523784|FG000|STARTED|Overall Study||18
6598705|NCT02032420|7523785|FG001|STARTED|Overall Study||17
6598706|NCT02032420|7523784|FG000|COMPLETED|Overall Study||18
6598707|NCT02032420|7523785|FG001|COMPLETED|Overall Study||17
6661536|NCT02505919|7592313|FG001|STARTED|24 Months Follow-Up||61
6661537|NCT02505919|7592312|FG000|COMPLETED|24 Months Follow-Up||112
6598708|NCT02032420|7523784|FG000|NOT COMPLETED|Overall Study||0
6598709|NCT02032420|7523785|FG001|NOT COMPLETED|Overall Study||0
6598710|NCT02032433|7523793|FG000|STARTED|Overall Study||283
6598711|NCT02032433|7523794|FG001|STARTED|Overall Study||287
6598712|NCT02032433|7523793|FG000|COMPLETED|Overall Study||205
6598713|NCT02032433|7523794|FG001|COMPLETED|Overall Study||225
6598714|NCT02032433|7523793|FG000|NOT COMPLETED|Overall Study||78
6598715|NCT02032433|7523794|FG001|NOT COMPLETED|Overall Study||62
6598716|NCT02032550|7523802|FG000|STARTED|Overall Study||371
6598717|NCT02032550|7523803|FG001|STARTED|Overall Study||372
6598718|NCT02032550|7523802|FG000|COMPLETED|Overall Study||343
6598719|NCT02032550|7523803|FG001|COMPLETED|Overall Study||350
6661538|NCT02505919|7592313|FG001|COMPLETED|24 Months Follow-Up||60
6661539|NCT02505919|7592312|FG000|NOT COMPLETED|24 Months Follow-Up||3
6598720|NCT02032550|7523802|FG000|NOT COMPLETED|Overall Study||28
6598721|NCT02032550|7523803|FG001|NOT COMPLETED|Overall Study||22
6598722|NCT02032641|7523809|FG000|STARTED|Overall Study|18 Brows enrolled for evaluation|9
6598723|NCT02032641|7523809|FG000|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
6598724|NCT02032641|7523809|FG000|NOT COMPLETED|Overall Study||1
6598725|NCT02032680|7523817|FG000|STARTED|Overall Study||22
6598726|NCT02032680|7523818|FG001|STARTED|Overall Study||8
6598727|NCT02032680|7523817|FG000|COMPLETED|Overall Study||16
6598728|NCT02032680|7523818|FG001|COMPLETED|Overall Study||7
6598729|NCT02032680|7523817|FG000|NOT COMPLETED|Overall Study||6
6598730|NCT02032680|7523818|FG001|NOT COMPLETED|Overall Study||1
6598731|NCT02032706|7523824|FG000|STARTED|Overall Study||36
6598732|NCT02032706|7523824|FG000|COMPLETED|Overall Study||30
6598733|NCT02032706|7523824|FG000|NOT COMPLETED|Overall Study||6
6598734|NCT02032758|7523830|FG000|STARTED|Overall Study||27
6598735|NCT02032758|7523831|FG001|STARTED|Overall Study||11
6598736|NCT02032758|7523830|FG000|COMPLETED|Overall Study||27
6598737|NCT02032758|7523831|FG001|COMPLETED|Overall Study||11
6598738|NCT02032758|7523830|FG000|NOT COMPLETED|Overall Study||0
6598739|NCT02032758|7523831|FG001|NOT COMPLETED|Overall Study||0
6598740|NCT02032810|7523839|FG000|STARTED|Overall Study||6
6598741|NCT02032810|7523840|FG001|STARTED|Overall Study||11
6598742|NCT02032810|7523839|FG000|COMPLETED|Overall Study||6
6598743|NCT02032810|7523840|FG001|COMPLETED|Overall Study||11
6598744|NCT02032810|7523839|FG000|NOT COMPLETED|Overall Study||0
6598745|NCT02032810|7523840|FG001|NOT COMPLETED|Overall Study||0
6598746|NCT02032875|7523852|FG000|STARTED|Treatment Period||53
6598747|NCT02032875|7523853|FG001|STARTED|Treatment Period||60
6598748|NCT02032875|7523852|FG000|COMPLETED|Treatment Period||52
6598749|NCT02032875|7523853|FG001|COMPLETED|Treatment Period||56
6598750|NCT02032875|7523852|FG000|NOT COMPLETED|Treatment Period||1
6598751|NCT02032875|7523853|FG001|NOT COMPLETED|Treatment Period||4
6598752|NCT02032875|7523852|FG000|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
6598753|NCT02032875|7523853|FG001|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
6598754|NCT02032875|7523852|FG000|COMPLETED|Follow-up Period||50
6598755|NCT02032875|7523853|FG001|COMPLETED|Follow-up Period||46
6598756|NCT02032875|7523852|FG000|NOT COMPLETED|Follow-up Period||3
6598757|NCT02032875|7523853|FG001|NOT COMPLETED|Follow-up Period||11
6598758|NCT02032888|7523863|FG000|STARTED|Treatment Period||101
6598759|NCT02032888|7523864|FG001|STARTED|Treatment Period||50
6598760|NCT02032888|7523865|FG002|STARTED|Treatment Period||52
6598761|NCT02032888|7523863|FG000|COMPLETED|Treatment Period||99
6598762|NCT02032888|7523864|FG001|COMPLETED|Treatment Period||48
6598763|NCT02032888|7523865|FG002|COMPLETED|Treatment Period||52
6598764|NCT02032888|7523863|FG000|NOT COMPLETED|Treatment Period||2
6598765|NCT02032888|7523864|FG001|NOT COMPLETED|Treatment Period||2
6598766|NCT02032888|7523865|FG002|NOT COMPLETED|Treatment Period||0
6598767|NCT02032888|7523863|FG000|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
6598768|NCT02032888|7523864|FG001|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
6598769|NCT02032888|7523865|FG002|STARTED|Follow-up Period||52
6598770|NCT02032888|7523863|FG000|COMPLETED|Follow-up Period||97
6598771|NCT02032888|7523864|FG001|COMPLETED|Follow-up Period||47
6598772|NCT02032888|7523865|FG002|COMPLETED|Follow-up Period||52
6598773|NCT02032888|7523863|FG000|NOT COMPLETED|Follow-up Period||3
6598774|NCT02032888|7523864|FG001|NOT COMPLETED|Follow-up Period||2
6598775|NCT02032888|7523865|FG002|NOT COMPLETED|Follow-up Period||0
6598776|NCT02032901|7523884|FG000|STARTED|Treatment Period (12 Weeks)||101
6598777|NCT02032901|7523885|FG001|STARTED|Treatment Period (12 Weeks)||51
6598778|NCT02032901|7523884|FG000|COMPLETED|Treatment Period (12 Weeks)||100
6598779|NCT02032901|7523885|FG001|COMPLETED|Treatment Period (12 Weeks)||51
6598780|NCT02032901|7523884|FG000|NOT COMPLETED|Treatment Period (12 Weeks)||1
6598781|NCT02032901|7523885|FG001|NOT COMPLETED|Treatment Period (12 Weeks)||0
6598782|NCT02032901|7523884|FG000|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
6598783|NCT02032901|7523885|FG001|STARTED|Follow-Up Period (24 Weeks)||51
6598784|NCT02032901|7523884|FG000|COMPLETED|Follow-Up Period (24 Weeks)||101
6598785|NCT02032901|7523885|FG001|COMPLETED|Follow-Up Period (24 Weeks)||50
6598786|NCT02032901|7523884|FG000|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
6598787|NCT02032901|7523885|FG001|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
6598788|NCT02033005|7523896|FG000|STARTED|Overall Study||80
6598789|NCT02033005|7523897|FG001|STARTED|Overall Study||9
6598790|NCT02033005|7523898|FG002|STARTED|Overall Study||35
6598791|NCT02033005|7523896|FG000|COMPLETED|Overall Study||36
6598792|NCT02033005|7523897|FG001|COMPLETED|Overall Study||9
6598793|NCT02033005|7523898|FG002|COMPLETED|Overall Study||25
6598794|NCT02033005|7523896|FG000|NOT COMPLETED|Overall Study||44
6598795|NCT02033005|7523897|FG001|NOT COMPLETED|Overall Study||0
6598796|NCT02033005|7523898|FG002|NOT COMPLETED|Overall Study||10
6598797|NCT02033083|7523909|FG000|STARTED|Overall Study||90
6598798|NCT02033083|7523910|FG001|STARTED|Overall Study||90
6598799|NCT02033083|7523909|FG000|COMPLETED|Overall Study||89
6598800|NCT02033083|7523910|FG001|COMPLETED|Overall Study||89
6598801|NCT02033083|7523909|FG000|NOT COMPLETED|Overall Study||1
6598802|NCT02033083|7523910|FG001|NOT COMPLETED|Overall Study||1
6598803|NCT02033174|7523916|FG000|STARTED|First Intervention||8
6598804|NCT02033174|7523917|FG001|STARTED|First Intervention||8
6598805|NCT02033174|7523916|FG000|COMPLETED|First Intervention||8
6598806|NCT02033174|7523917|FG001|COMPLETED|First Intervention||8
6598807|NCT02033174|7523916|FG000|NOT COMPLETED|First Intervention||0
6598808|NCT02033174|7523917|FG001|NOT COMPLETED|First Intervention||0
6598809|NCT02033174|7523916|FG000|STARTED|Washout (1 Week)||8
6598810|NCT02033174|7523917|FG001|STARTED|Washout (1 Week)||8
6598811|NCT02033174|7523916|FG000|COMPLETED|Washout (1 Week)||8
6598812|NCT02033174|7523917|FG001|COMPLETED|Washout (1 Week)||8
6598813|NCT02033174|7523916|FG000|NOT COMPLETED|Washout (1 Week)||0
6661540|NCT02505919|7592313|FG001|NOT COMPLETED|24 Months Follow-Up||1
6661541|NCT02505919|7592312|FG000|STARTED|36 Months Follow-Up||112
6661542|NCT02505919|7592313|FG001|STARTED|36 Months Follow-Up||60
6661543|NCT02505919|7592312|FG000|COMPLETED|36 Months Follow-Up||97
6661544|NCT02505919|7592313|FG001|COMPLETED|36 Months Follow-Up||55
6661545|NCT02505919|7592312|FG000|NOT COMPLETED|36 Months Follow-Up||15
6661546|NCT02505919|7592313|FG001|NOT COMPLETED|36 Months Follow-Up||5
6661547|NCT02505945|7592321|FG000|STARTED|Overall Study||102
6661548|NCT02505945|7592322|FG001|STARTED|Overall Study||50
6661549|NCT02505945|7592321|FG000|COMPLETED|Overall Study||80
6661550|NCT02505945|7592322|FG001|COMPLETED|Overall Study||46
6661551|NCT02505945|7592321|FG000|NOT COMPLETED|Overall Study||22
6661552|NCT02505945|7592322|FG001|NOT COMPLETED|Overall Study||4
6661553|NCT02506036|7592330|FG000|STARTED|First Intervention (4-6 Weeks)||3
6661554|NCT02506036|7592331|FG001|STARTED|First Intervention (4-6 Weeks)||3
6661555|NCT02506036|7592330|FG000|COMPLETED|First Intervention (4-6 Weeks)||2
6661556|NCT02506036|7592331|FG001|COMPLETED|First Intervention (4-6 Weeks)||1
6661557|NCT02506036|7592330|FG000|NOT COMPLETED|First Intervention (4-6 Weeks)||1
6661558|NCT02506036|7592331|FG001|NOT COMPLETED|First Intervention (4-6 Weeks)||2
6661559|NCT02506036|7592330|FG000|STARTED|Washout (1-2 Weeks)||2
6661560|NCT02506036|7592331|FG001|STARTED|Washout (1-2 Weeks)||1
6661561|NCT02506036|7592330|FG000|COMPLETED|Washout (1-2 Weeks)||2
6661562|NCT02506036|7592331|FG001|COMPLETED|Washout (1-2 Weeks)||1
6661563|NCT02506036|7592330|FG000|NOT COMPLETED|Washout (1-2 Weeks)||0
6661564|NCT02506036|7592331|FG001|NOT COMPLETED|Washout (1-2 Weeks)||0
6661565|NCT02506036|7592330|FG000|STARTED|Second Intervention (4-6 Weeks)||2
6661566|NCT02506036|7592331|FG001|STARTED|Second Intervention (4-6 Weeks)||1
6661567|NCT02506036|7592330|FG000|COMPLETED|Second Intervention (4-6 Weeks)||2
6661568|NCT02506036|7592331|FG001|COMPLETED|Second Intervention (4-6 Weeks)||1
6661569|NCT02506036|7592330|FG000|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
6661570|NCT02506036|7592331|FG001|NOT COMPLETED|Second Intervention (4-6 Weeks)||0
6661571|NCT02506114|7592340|FG000|STARTED|Overall Study||5
6661572|NCT02506114|7592341|FG001|STARTED|Overall Study||4
6661573|NCT02506114|7592342|FG002|STARTED|Overall Study||6
6661574|NCT02506114|7592340|FG000|COMPLETED|Overall Study||5
6661575|NCT02506114|7592341|FG001|COMPLETED|Overall Study||4
6661576|NCT02506114|7592342|FG002|COMPLETED|Overall Study||6
6661577|NCT02506114|7592340|FG000|NOT COMPLETED|Overall Study||0
6661578|NCT02506114|7592341|FG001|NOT COMPLETED|Overall Study||0
6661579|NCT02506114|7592342|FG002|NOT COMPLETED|Overall Study||0
6661580|NCT02506257|7592354|FG000|STARTED|Overall Study||26
6661581|NCT02506257|7592355|FG001|STARTED|Overall Study||28
6661582|NCT02506257|7592356|FG002|STARTED|Overall Study||27
6661583|NCT02506257|7592357|FG003|STARTED|Overall Study||9
6661584|NCT02506257|7592354|FG000|COMPLETED|Overall Study||26
6661585|NCT02506257|7592355|FG001|COMPLETED|Overall Study||26
6661586|NCT02506257|7592356|FG002|COMPLETED|Overall Study||23
6661587|NCT02506257|7592357|FG003|COMPLETED|Overall Study||9
6661588|NCT02506257|7592354|FG000|NOT COMPLETED|Overall Study||0
6661589|NCT02506257|7592355|FG001|NOT COMPLETED|Overall Study||2
6661590|NCT02506257|7592356|FG002|NOT COMPLETED|Overall Study||4
6661591|NCT02506257|7592357|FG003|NOT COMPLETED|Overall Study||0
6661592|NCT02506309|7592369|FG000|STARTED|Overall Study||84
6661593|NCT02506309|7592370|FG001|STARTED|Overall Study||84
6661594|NCT02506309|7592369|FG000|COMPLETED|Overall Study||66
6661595|NCT02506309|7592370|FG001|COMPLETED|Overall Study||64
6661596|NCT02506309|7592369|FG000|NOT COMPLETED|Overall Study||18
6661597|NCT02506309|7592370|FG001|NOT COMPLETED|Overall Study||20
6598814|NCT02033174|7523917|FG001|NOT COMPLETED|Washout (1 Week)||0
6598815|NCT02033174|7523916|FG000|STARTED|Second Intervention||8
6598816|NCT02033174|7523917|FG001|STARTED|Second Intervention||8
6598817|NCT02033174|7523916|FG000|COMPLETED|Second Intervention||8
6661598|NCT02506634|7592384|FG000|STARTED|Overall Study||374
6661599|NCT02506634|7592384|FG000|Participants Who Were Diagnosed as GERD|Overall Study||154
6661600|NCT02506634|7592384|FG000|Participants Who Received PPI Treatment|Overall Study||357
6661601|NCT02506634|7592384|FG000|Participants Who Finished GERDQ|Overall Study||342
6661602|NCT02506634|7592384|FG000|COMPLETED|Overall Study||357
6661603|NCT02506634|7592384|FG000|NOT COMPLETED|Overall Study||17
6737582|NCT03267576|7666855|FG001|NOT COMPLETED|Period 1: Day 0 to 27||0
6737583|NCT03267576|7666854|FG000|STARTED|Washout Period: 16 Days||31
6737584|NCT03267576|7666855|FG001|STARTED|Washout Period: 16 Days||32
6737585|NCT03267576|7666854|FG000|COMPLETED|Washout Period: 16 Days||31
6737586|NCT03267576|7666855|FG001|COMPLETED|Washout Period: 16 Days||32
6737587|NCT03267576|7666854|FG000|NOT COMPLETED|Washout Period: 16 Days||0
6737588|NCT03267576|7666855|FG001|NOT COMPLETED|Washout Period: 16 Days||0
6737589|NCT03267576|7666854|FG000|STARTED|Period 2: Day 44 to 71||31
6737590|NCT03267576|7666855|FG001|STARTED|Period 2: Day 44 to 71||32
6737591|NCT03267576|7666854|FG000|COMPLETED|Period 2: Day 44 to 71||30
6598818|NCT02033174|7523917|FG001|COMPLETED|Second Intervention||8
6598819|NCT02033174|7523916|FG000|NOT COMPLETED|Second Intervention||0
6598820|NCT02033174|7523917|FG001|NOT COMPLETED|Second Intervention||0
6598821|NCT02033200|7523925|FG000|STARTED|Overall Study||40
6598822|NCT02033200|7523926|FG001|STARTED|Overall Study||40
6598823|NCT02033200|7523925|FG000|COMPLETED|Overall Study||40
6598824|NCT02033200|7523926|FG001|COMPLETED|Overall Study||40
6598825|NCT02033200|7523925|FG000|NOT COMPLETED|Overall Study||0
6598826|NCT02033200|7523926|FG001|NOT COMPLETED|Overall Study||0
6598827|NCT02033213|7523934|FG000|STARTED|Overall Study||8
6598828|NCT02033213|7523935|FG001|STARTED|Overall Study||8
6598829|NCT02033213|7523934|FG000|COMPLETED|Overall Study||8
6598830|NCT02033213|7523935|FG001|COMPLETED|Overall Study||8
6598831|NCT02033213|7523934|FG000|NOT COMPLETED|Overall Study||0
6598832|NCT02033213|7523935|FG001|NOT COMPLETED|Overall Study||0
6598833|NCT02033317|7523943|FG000|STARTED|Overall Study||6
6598834|NCT02033317|7523943|FG000|COMPLETED|Overall Study||6
6598835|NCT02033317|7523943|FG000|NOT COMPLETED|Overall Study||0
6624902|NCT02221882|7552487|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6624903|NCT02221882|7552488|FG001|Received at Least One Dose of Study Drug|Overall Study||3
6624904|NCT02221882|7552489|FG002|Received at Least One Dose of Study Drug|Overall Study||11
6624905|NCT02221882|7552490|FG003|Received at Least One Dose of Study Drug|Overall Study||3
6624906|NCT02221882|7552491|FG004|Received at Least One Dose of Study Drug|Overall Study||5
6624907|NCT02221882|7552492|FG005|Received at Least One Dose of Study Drug|Overall Study||4
6624908|NCT02221882|7552487|FG000|COMPLETED|Overall Study||3
6624909|NCT02221882|7552488|FG001|COMPLETED|Overall Study||2
6624910|NCT02221882|7552489|FG002|COMPLETED|Overall Study||7
6624911|NCT02221882|7552490|FG003|COMPLETED|Overall Study||1
6624912|NCT02221882|7552491|FG004|COMPLETED|Overall Study||3
6624913|NCT02221882|7552492|FG005|COMPLETED|Overall Study||2
6624914|NCT02221882|7552487|FG000|NOT COMPLETED|Overall Study||0
6624915|NCT02221882|7552488|FG001|NOT COMPLETED|Overall Study||1
6624916|NCT02221882|7552489|FG002|NOT COMPLETED|Overall Study||4
6624917|NCT02221882|7552490|FG003|NOT COMPLETED|Overall Study||2
6624918|NCT02221882|7552491|FG004|NOT COMPLETED|Overall Study||2
6624919|NCT02221882|7552492|FG005|NOT COMPLETED|Overall Study||2
6624920|NCT02221947|7552513|FG000|STARTED|Overall Study||6
6624921|NCT02221947|7552514|FG001|STARTED|Overall Study||3
6624922|NCT02221947|7552513|FG000|COMPLETED|Overall Study||6
6624923|NCT02221947|7552514|FG001|COMPLETED|Overall Study||3
6624924|NCT02221947|7552513|FG000|NOT COMPLETED|Overall Study||0
6624925|NCT02221947|7552514|FG001|NOT COMPLETED|Overall Study||0
6624926|NCT02222129|7552525|FG000|STARTED|Overall Study||100
6624927|NCT02222129|7552526|FG001|STARTED|Overall Study||106
6624928|NCT02222129|7552525|FG000|COMPLETED|Overall Study||100
6624929|NCT02222129|7552526|FG001|COMPLETED|Overall Study||106
6624930|NCT02222129|7552525|FG000|NOT COMPLETED|Overall Study||0
6624931|NCT02222129|7552526|FG001|NOT COMPLETED|Overall Study||0
6624932|NCT02222181|7552532|FG000|STARTED|Overall Study||163
6624933|NCT02222181|7552532|FG000|COMPLETED|Overall Study||55
6624934|NCT02222181|7552532|FG000|NOT COMPLETED|Overall Study||108
6624935|NCT02222207|7552536|FG000|STARTED|Overall Study||52
6624936|NCT02222207|7552536|FG000|Treated and Valid for Full Analysis Set|Overall Study||51
6624937|NCT02222207|7552536|FG000|COMPLETED|Overall Study||48
6624938|NCT02222207|7552536|FG000|NOT COMPLETED|Overall Study||4
6624939|NCT02222246|7552542|FG000|STARTED|Overall Study||53
6624940|NCT02222246|7552543|FG001|STARTED|Overall Study||53
6624941|NCT02222246|7552542|FG000|COMPLETED|Overall Study||26
6624942|NCT02222246|7552543|FG001|COMPLETED|Overall Study||26
6624943|NCT02222246|7552542|FG000|NOT COMPLETED|Overall Study||27
6624944|NCT02222246|7552543|FG001|NOT COMPLETED|Overall Study||27
6624945|NCT02222337|7552553|FG000|STARTED|Overall Study||140
6624946|NCT02222337|7552554|FG001|STARTED|Overall Study|132 participants were enrolled but 2 withdrew and never provided any data.|132
6624947|NCT02222337|7552553|FG000|COMPLETED|Overall Study||114
6624948|NCT02222337|7552554|FG001|COMPLETED|Overall Study||108
6624949|NCT02222337|7552553|FG000|NOT COMPLETED|Overall Study||26
6624950|NCT02222337|7552554|FG001|NOT COMPLETED|Overall Study||24
6624951|NCT02222493|7552566|FG000|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||324
6624952|NCT02222493|7552567|FG001|STARTED|Period 1: First Dose-Week 30 (Pre-dose)||326
6624953|NCT02222493|7552566|FG000|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||323
6624954|NCT02222493|7552567|FG001|Received Treatment|Period 1: First Dose-Week 30 (Pre-dose)||326
6624955|NCT02222493|7552566|FG000|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||280
6624956|NCT02222493|7552567|FG001|COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||286
6624957|NCT02222493|7552566|FG000|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||44
6624958|NCT02222493|7552567|FG001|NOT COMPLETED|Period 1: First Dose-Week 30 (Pre-dose)||40
6624959|NCT02222493|7552566|FG000|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||423
6624960|NCT02222493|7552567|FG001|STARTED|Period 2: Week30 Dosing-Week54(Pre-dose)||143
6624961|NCT02222493|7552566|FG000|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||380
6624962|NCT02222493|7552567|FG001|COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||126
6624963|NCT02222493|7552566|FG000|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||43
6624964|NCT02222493|7552567|FG001|NOT COMPLETED|Period 2: Week30 Dosing-Week54(Pre-dose)||17
6624965|NCT02222493|7552566|FG000|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||505
6624966|NCT02222493|7552567|FG001|STARTED|Period 3: Week 54 Dosing-Week 78 Visit||0
6624967|NCT02222493|7552566|FG000|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||474
6598836|NCT02033369|7523949|FG000|STARTED|Overall Study||26
6598837|NCT02033369|7523950|FG001|STARTED|Overall Study||26
6598838|NCT02033369|7523949|FG000|COMPLETED|Overall Study||21
6598839|NCT02033369|7523950|FG001|COMPLETED|Overall Study||21
6598840|NCT02033369|7523949|FG000|NOT COMPLETED|Overall Study||5
6598841|NCT02033369|7523950|FG001|NOT COMPLETED|Overall Study||5
6598842|NCT02033382|7523956|FG000|STARTED|Overall Study||83
6598843|NCT02033382|7523957|FG001|STARTED|Overall Study||82
6598844|NCT02033382|7523956|FG000|COMPLETED|Overall Study||32
6598845|NCT02033382|7523957|FG001|COMPLETED|Overall Study||36
6598846|NCT02033382|7523956|FG000|NOT COMPLETED|Overall Study||51
6598847|NCT02033382|7523957|FG001|NOT COMPLETED|Overall Study||46
6598848|NCT02033499|7523970|FG000|STARTED|Overall Study||152
6598849|NCT02033499|7523971|FG001|STARTED|Overall Study||150
6598850|NCT02033499|7523972|FG002|STARTED|Overall Study||148
6598851|NCT02033499|7523970|FG000|COMPLETED|Overall Study||147
6598852|NCT02033499|7523971|FG001|COMPLETED|Overall Study||142
6598853|NCT02033499|7523972|FG002|COMPLETED|Overall Study||139
6598854|NCT02033499|7523970|FG000|NOT COMPLETED|Overall Study||5
6598855|NCT02033499|7523971|FG001|NOT COMPLETED|Overall Study||8
6598856|NCT02033499|7523972|FG002|NOT COMPLETED|Overall Study||9
6598857|NCT02033694|7523981|FG000|STARTED|Overall Study||1271
6598858|NCT02033694|7523981|FG000|COMPLETED|Overall Study||1271
6598859|NCT02033694|7523981|FG000|NOT COMPLETED|Overall Study||0
6598860|NCT02033759|7523988|FG000|STARTED|Overall Study||22
6598861|NCT02033759|7523989|FG001|STARTED|Overall Study||21
6598862|NCT02033759|7523988|FG000|COMPLETED|Overall Study||19
6598863|NCT02033759|7523989|FG001|COMPLETED|Overall Study||19
6598864|NCT02033759|7523988|FG000|NOT COMPLETED|Overall Study||3
6598865|NCT02033759|7523989|FG001|NOT COMPLETED|Overall Study||2
6598866|NCT02033850|7523997|FG000|STARTED|Overall Study||23
6598867|NCT02033850|7523998|FG001|STARTED|Overall Study||23
6598868|NCT02033850|7523997|FG000|COMPLETED|Overall Study||21
6598869|NCT02033850|7523998|FG001|COMPLETED|Overall Study||22
6598870|NCT02033850|7523997|FG000|NOT COMPLETED|Overall Study||2
6598871|NCT02033850|7523998|FG001|NOT COMPLETED|Overall Study||1
6598872|NCT02033876|7524006|FG000|STARTED|Overall Study||12
6598873|NCT02033876|7524007|FG001|STARTED|Overall Study||12
6598874|NCT02033876|7524006|FG000|COMPLETED|Overall Study||12
6598875|NCT02033876|7524007|FG001|COMPLETED|Overall Study||12
6598876|NCT02033876|7524006|FG000|NOT COMPLETED|Overall Study||0
6598877|NCT02033876|7524007|FG001|NOT COMPLETED|Overall Study||0
6598878|NCT02033889|7524016|FG000|STARTED|Overall Study||209
6598879|NCT02033889|7524017|FG001|STARTED|Overall Study||207
6598880|NCT02033889|7524018|FG002|STARTED|Overall Study||205
6598881|NCT02033889|7524016|FG000|COMPLETED|Overall Study||175
6598882|NCT02033889|7524017|FG001|COMPLETED|Overall Study||187
6598883|NCT02033889|7524018|FG002|COMPLETED|Overall Study||180
6598884|NCT02033889|7524016|FG000|NOT COMPLETED|Overall Study||34
6598885|NCT02033889|7524017|FG001|NOT COMPLETED|Overall Study||20
6598886|NCT02033889|7524018|FG002|NOT COMPLETED|Overall Study||25
6598887|NCT02033993|7524028|FG000|STARTED|Overall Study||99
6598888|NCT02033993|7524029|FG001|STARTED|Overall Study||100
6598889|NCT02033993|7524028|FG000|COMPLETED|Overall Study||96
6598890|NCT02033993|7524029|FG001|COMPLETED|Overall Study||91
6598891|NCT02033993|7524028|FG000|NOT COMPLETED|Overall Study||3
6598892|NCT02033993|7524029|FG001|NOT COMPLETED|Overall Study||9
6598893|NCT02034006|7524037|FG000|STARTED|Overall Study||200
6598894|NCT02034006|7524037|FG000|Once Treated Patients|Overall Study||70
6598895|NCT02034006|7524037|FG000|Re-treated Patients|Overall Study||130
6598896|NCT02034006|7524037|FG000|COMPLETED|Overall Study||186
6598897|NCT02034006|7524037|FG000|NOT COMPLETED|Overall Study||14
6598898|NCT02034019|7524046|FG000|STARTED|Overall Study||164
6598899|NCT02034019|7524047|FG001|STARTED|Overall Study||83
6598900|NCT02034019|7524046|FG000|COMPLETED|Overall Study||163
6598901|NCT02034019|7524047|FG001|COMPLETED|Overall Study||81
6598902|NCT02034019|7524046|FG000|NOT COMPLETED|Overall Study||1
6598903|NCT02034019|7524047|FG001|NOT COMPLETED|Overall Study||2
6598904|NCT02034058|7524053|FG000|STARTED|Overall Study|Study stopped early per pre-defined criteria for interim analysis.|152
6598905|NCT02034058|7524053|FG000|COMPLETED|Overall Study||149
6598906|NCT02034058|7524053|FG000|NOT COMPLETED|Overall Study||3
6598907|NCT02034162|7524059|FG000|STARTED|Double-blind||146
6598908|NCT02034162|7524060|FG001|STARTED|Double-blind||149
6598909|NCT02034162|7524061|FG002|STARTED|Double-blind||0
6598910|NCT02034162|7524059|FG000|COMPLETED|Double-blind||137
6598911|NCT02034162|7524060|FG001|COMPLETED|Double-blind||141
6598912|NCT02034162|7524061|FG002|COMPLETED|Double-blind||0
6598913|NCT02034162|7524059|FG000|NOT COMPLETED|Double-blind||9
6598914|NCT02034162|7524060|FG001|NOT COMPLETED|Double-blind||8
6598915|NCT02034162|7524061|FG002|NOT COMPLETED|Double-blind||0
6598916|NCT02034162|7524059|FG000|STARTED|Open-label||0
6598917|NCT02034162|7524060|FG001|STARTED|Open-label||0
6598918|NCT02034162|7524061|FG002|STARTED|Open-label||278
6598919|NCT02034162|7524059|FG000|COMPLETED|Open-label||0
6598920|NCT02034162|7524060|FG001|COMPLETED|Open-label||0
6598921|NCT02034162|7524061|FG002|COMPLETED|Open-label||278
6598922|NCT02034162|7524059|FG000|NOT COMPLETED|Open-label||0
6598923|NCT02034162|7524060|FG001|NOT COMPLETED|Open-label||0
6598924|NCT02034162|7524061|FG002|NOT COMPLETED|Open-label||0
6598925|NCT02034175|7524072|FG000|STARTED|Overall Study||190
6598926|NCT02034175|7524072|FG000|COMPLETED|Overall Study||190
6598927|NCT02034175|7524072|FG000|NOT COMPLETED|Overall Study||0
6598928|NCT02034409|7524078|FG000|STARTED|Sham Run-in Period||140
6598929|NCT02034409|7524079|FG001|STARTED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
6598930|NCT02034409|7524078|FG000|COMPLETED|Sham Run-in Period||136
6598931|NCT02034409|7524079|FG001|COMPLETED|Sham Run-in Period|Number started is zero because there is no PLIUS arm in Sham Run-in Period|0
6598932|NCT02034409|7524078|FG000|NOT COMPLETED|Sham Run-in Period||4
6598933|NCT02034409|7524079|FG001|NOT COMPLETED|Sham Run-in Period||0
6598934|NCT02034409|7524078|FG000|STARTED|Sham-Controlled Treatment Period|Number started in Sham Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|67
6598935|NCT02034409|7524079|FG001|STARTED|Sham-Controlled Treatment Period|Number started in PLIUS Arm of Sham-Controlled Treatment Period Milestone not equal to Sham Run-in Period Milestone because participants in this Milestone are randomly assigned to either Sham or PLIUS treatment arm.|69
6598936|NCT02034409|7524078|FG000|COMPLETED|Sham-Controlled Treatment Period||55
6598937|NCT02034409|7524079|FG001|COMPLETED|Sham-Controlled Treatment Period||54
6598938|NCT02034409|7524078|FG000|NOT COMPLETED|Sham-Controlled Treatment Period||12
6598939|NCT02034409|7524079|FG001|NOT COMPLETED|Sham-Controlled Treatment Period||15
6598940|NCT02034435|7524087|FG000|STARTED|Overall Study||13
6598941|NCT02034435|7524088|FG001|STARTED|Overall Study||15
6598942|NCT02034435|7524089|FG002|STARTED|Overall Study||7
6598943|NCT02034435|7524090|FG003|STARTED|Overall Study||9
6598944|NCT02034435|7524087|FG000|Aim 1|Overall Study||13
6598945|NCT02034435|7524088|FG001|Aim 1|Overall Study||15
6598946|NCT02034435|7524089|FG002|Aim 1|Overall Study||0
6598947|NCT02034435|7524090|FG003|Aim 1|Overall Study||0
6598948|NCT02034435|7524087|FG000|Aim 2|Overall Study||0
6598949|NCT02034435|7524088|FG001|Aim 2|Overall Study||0
6598950|NCT02034435|7524089|FG002|Aim 2|Overall Study||7
6598951|NCT02034435|7524090|FG003|Aim 2|Overall Study||9
6598952|NCT02034435|7524087|FG000|COMPLETED|Overall Study||11
6598953|NCT02034435|7524088|FG001|COMPLETED|Overall Study||13
6598954|NCT02034435|7524089|FG002|COMPLETED|Overall Study||7
6598955|NCT02034435|7524090|FG003|COMPLETED|Overall Study||8
6598956|NCT02034435|7524087|FG000|NOT COMPLETED|Overall Study||2
6598957|NCT02034435|7524088|FG001|NOT COMPLETED|Overall Study||2
6598958|NCT02034435|7524089|FG002|NOT COMPLETED|Overall Study||0
6598959|NCT02034435|7524090|FG003|NOT COMPLETED|Overall Study||1
6598960|NCT02034474|7524102|FG000|STARTED|Overall Study||19
6598961|NCT02034474|7524103|FG001|STARTED|Overall Study||17
6598962|NCT02034474|7524102|FG000|1 Dose|Overall Study||2
6598963|NCT02034474|7524103|FG001|1 Dose|Overall Study||4
6598964|NCT02034474|7524102|FG000|2 Doses|Overall Study||2
6598965|NCT02034474|7524103|FG001|2 Doses|Overall Study||0
6598966|NCT02034474|7524102|FG000|3 Doses|Overall Study||15
6598967|NCT02034474|7524103|FG001|3 Doses|Overall Study||13
6598968|NCT02034474|7524102|FG000|COMPLETED|Overall Study||15
6598969|NCT02034474|7524103|FG001|COMPLETED|Overall Study||13
6598970|NCT02034474|7524102|FG000|NOT COMPLETED|Overall Study||4
6598971|NCT02034474|7524103|FG001|NOT COMPLETED|Overall Study||4
6598972|NCT02034513|7524113|FG000|STARTED|Overall Study||249
6598973|NCT02034513|7524114|FG001|STARTED|Overall Study||252
6598974|NCT02034513|7524113|FG000|Exposed|Overall Study||249
6598975|NCT02034513|7524114|FG001|Exposed|Overall Study||251
6598976|NCT02034513|7524113|FG000|COMPLETED|Overall Study||200
6598977|NCT02034513|7524114|FG001|COMPLETED|Overall Study||195
6598978|NCT02034513|7524113|FG000|NOT COMPLETED|Overall Study||49
6598979|NCT02034513|7524114|FG001|NOT COMPLETED|Overall Study||57
6598980|NCT02034552|7524125|FG000|STARTED|Overall Study||22
6598981|NCT02034552|7524126|FG001|STARTED|Overall Study||24
6598982|NCT02034552|7524127|FG002|STARTED|Overall Study||22
6598983|NCT02034552|7524125|FG000|Received Treatment|Overall Study||19
6598984|NCT02034552|7524126|FG001|Received Treatment|Overall Study||22
6598985|NCT02034552|7524127|FG002|Received Treatment|Overall Study||22
6598986|NCT02034552|7524125|FG000|COMPLETED|Overall Study||8
6598987|NCT02034552|7524126|FG001|COMPLETED|Overall Study||4
6598988|NCT02034552|7524127|FG002|COMPLETED|Overall Study||5
6598989|NCT02034552|7524125|FG000|NOT COMPLETED|Overall Study||14
6598990|NCT02034552|7524126|FG001|NOT COMPLETED|Overall Study||20
6661604|NCT02506660|7592424|FG000|STARTED|Overall Study||64
6661605|NCT02506660|7592425|FG001|STARTED|Overall Study||64
6661606|NCT02506660|7592424|FG000|COMPLETED|Overall Study||62
6661607|NCT02506660|7592425|FG001|COMPLETED|Overall Study||63
6661608|NCT02506660|7592424|FG000|NOT COMPLETED|Overall Study||2
6661609|NCT02506660|7592425|FG001|NOT COMPLETED|Overall Study||1
6661610|NCT02506673|7592433|FG000|STARTED|Overall Study||13
6661611|NCT02506673|7592434|FG001|STARTED|Overall Study||13
6661612|NCT02506673|7592433|FG000|COMPLETED|Overall Study||13
6661613|NCT02506673|7592434|FG001|COMPLETED|Overall Study||13
6661614|NCT02506673|7592433|FG000|NOT COMPLETED|Overall Study||0
6661615|NCT02506673|7592434|FG001|NOT COMPLETED|Overall Study||0
6661616|NCT02506816|7592440|FG000|STARTED|Overall Study||36
6661617|NCT02506816|7592440|FG000|Samples Availability|Overall Study|31 of 36 patients had valid samples for analysis of biomarkers (primary and secondary analysis)|31
6661618|NCT02506816|7592440|FG000|COMPLETED|Overall Study||33
6661619|NCT02506816|7592440|FG000|NOT COMPLETED|Overall Study||3
6661620|NCT02506868|7592446|FG000|STARTED|Main Period of Study (24 Weeks)||98
6661621|NCT02506868|7592447|FG001|STARTED|Main Period of Study (24 Weeks)||98
6661622|NCT02506868|7592446|FG000|mITT Population|Main Period of Study (24 Weeks)||98
6661623|NCT02506868|7592447|FG001|mITT Population|Main Period of Study (24 Weeks)|One patient from Aranesp group was excluded prior to the first administration|97
6598991|NCT02034552|7524127|FG002|NOT COMPLETED|Overall Study||17
6598992|NCT02034565|7524135|FG000|STARTED|Overall Study||7
6598993|NCT02034565|7524136|FG001|STARTED|Overall Study||7
6598994|NCT02034565|7524135|FG000|COMPLETED|Overall Study||6
6598995|NCT02034565|7524136|FG001|COMPLETED|Overall Study||7
6661624|NCT02506868|7592446|FG000|Per Protocol Population|Main Period of Study (24 Weeks)||86
6661625|NCT02506868|7592447|FG001|Per Protocol Population|Main Period of Study (24 Weeks)||90
6661626|NCT02506868|7592446|FG000|COMPLETED|Main Period of Study (24 Weeks)||86
6661627|NCT02506868|7592447|FG001|COMPLETED|Main Period of Study (24 Weeks)||90
6661628|NCT02506868|7592446|FG000|NOT COMPLETED|Main Period of Study (24 Weeks)||12
6661629|NCT02506868|7592447|FG001|NOT COMPLETED|Main Period of Study (24 Weeks)||8
6661630|NCT02506868|7592446|FG000|STARTED|Additional Period of Study (Until 52W)||86
6661631|NCT02506868|7592447|FG001|STARTED|Additional Period of Study (Until 52W)||90
6661632|NCT02506868|7592446|FG000|COMPLETED|Additional Period of Study (Until 52W)||83
6661633|NCT02506868|7592447|FG001|COMPLETED|Additional Period of Study (Until 52W)||85
6661634|NCT02506868|7592446|FG000|NOT COMPLETED|Additional Period of Study (Until 52W)||3
6661635|NCT02506868|7592447|FG001|NOT COMPLETED|Additional Period of Study (Until 52W)||5
6661636|NCT02506881|7592461|FG000|STARTED|First Intervention (Day 1)||13
6661637|NCT02506881|7592462|FG001|STARTED|First Intervention (Day 1)||12
6661638|NCT02506881|7592463|FG002|STARTED|First Intervention (Day 1)||25
6661639|NCT02506881|7592464|FG003|STARTED|First Intervention (Day 1)||24
6661640|NCT02506881|7592461|FG000|COMPLETED|First Intervention (Day 1)||12
6661641|NCT02506881|7592462|FG001|COMPLETED|First Intervention (Day 1)||12
6661642|NCT02506881|7592463|FG002|COMPLETED|First Intervention (Day 1)||12
6661643|NCT02506881|7592464|FG003|COMPLETED|First Intervention (Day 1)||12
6661644|NCT02506881|7592461|FG000|NOT COMPLETED|First Intervention (Day 1)||1
6661645|NCT02506881|7592462|FG001|NOT COMPLETED|First Intervention (Day 1)||0
6661646|NCT02506881|7592463|FG002|NOT COMPLETED|First Intervention (Day 1)||13
6661647|NCT02506881|7592464|FG003|NOT COMPLETED|First Intervention (Day 1)||12
6661648|NCT02506881|7592461|FG000|STARTED|Washout (at Least 25 Days)||12
6661649|NCT02506881|7592462|FG001|STARTED|Washout (at Least 25 Days)||12
6661650|NCT02506881|7592463|FG002|STARTED|Washout (at Least 25 Days)||12
6661651|NCT02506881|7592464|FG003|STARTED|Washout (at Least 25 Days)||12
6661652|NCT02506881|7592461|FG000|COMPLETED|Washout (at Least 25 Days)||12
6661653|NCT02506881|7592462|FG001|COMPLETED|Washout (at Least 25 Days)||12
6661654|NCT02506881|7592463|FG002|COMPLETED|Washout (at Least 25 Days)||12
6661655|NCT02506881|7592464|FG003|COMPLETED|Washout (at Least 25 Days)||12
6661656|NCT02506881|7592461|FG000|NOT COMPLETED|Washout (at Least 25 Days)||0
6661657|NCT02506881|7592462|FG001|NOT COMPLETED|Washout (at Least 25 Days)||0
6661658|NCT02506881|7592463|FG002|NOT COMPLETED|Washout (at Least 25 Days)||0
6661659|NCT02506881|7592464|FG003|NOT COMPLETED|Washout (at Least 25 Days)||0
6661660|NCT02506881|7592461|FG000|STARTED|Second Intervention (Day 1)||12
6661661|NCT02506881|7592462|FG001|STARTED|Second Intervention (Day 1)||12
6661662|NCT02506881|7592463|FG002|STARTED|Second Intervention (Day 1)||12
6661663|NCT02506881|7592464|FG003|STARTED|Second Intervention (Day 1)||12
6661664|NCT02506881|7592461|FG000|COMPLETED|Second Intervention (Day 1)||12
6661665|NCT02506881|7592462|FG001|COMPLETED|Second Intervention (Day 1)||12
6661666|NCT02506881|7592463|FG002|COMPLETED|Second Intervention (Day 1)||12
6661667|NCT02506881|7592464|FG003|COMPLETED|Second Intervention (Day 1)||12
6661668|NCT02506881|7592461|FG000|NOT COMPLETED|Second Intervention (Day 1)||0
6661669|NCT02506881|7592462|FG001|NOT COMPLETED|Second Intervention (Day 1)||0
6661670|NCT02506881|7592463|FG002|NOT COMPLETED|Second Intervention (Day 1)||0
6661671|NCT02506881|7592464|FG003|NOT COMPLETED|Second Intervention (Day 1)||0
6661672|NCT02507011|7592484|FG000|STARTED|First Intervention||1
6661673|NCT02507011|7592485|FG001|STARTED|First Intervention||1
6661674|NCT02507011|7592484|FG000|COMPLETED|First Intervention||1
6661675|NCT02507011|7592485|FG001|COMPLETED|First Intervention||1
6661676|NCT02507011|7592484|FG000|NOT COMPLETED|First Intervention||0
6661677|NCT02507011|7592485|FG001|NOT COMPLETED|First Intervention||0
6661678|NCT02507011|7592484|FG000|STARTED|Second Intervention||1
6661679|NCT02507011|7592485|FG001|STARTED|Second Intervention||1
6661680|NCT02507011|7592484|FG000|COMPLETED|Second Intervention||1
6661681|NCT02507011|7592485|FG001|COMPLETED|Second Intervention||1
6661682|NCT02507011|7592484|FG000|NOT COMPLETED|Second Intervention||0
6661683|NCT02507011|7592485|FG001|NOT COMPLETED|Second Intervention||0
6661684|NCT02507219|7592491|FG000|STARTED|Overall Study||5
6661685|NCT02507219|7592492|FG001|STARTED|Overall Study||4
6661686|NCT02507219|7592493|FG002|STARTED|Overall Study||3
6661687|NCT02507219|7592494|FG003|STARTED|Overall Study||3
6661688|NCT02507219|7592495|FG004|STARTED|Overall Study||4
6661689|NCT02507219|7592496|FG005|STARTED|Overall Study||3
6661690|NCT02507219|7592491|FG000|COMPLETED|Overall Study||4
6661691|NCT02507219|7592492|FG001|COMPLETED|Overall Study||4
6598996|NCT02034565|7524135|FG000|NOT COMPLETED|Overall Study||1
6598997|NCT02034565|7524136|FG001|NOT COMPLETED|Overall Study||0
6598998|NCT02034578|7524144|FG000|STARTED|Overall Study||4
6598999|NCT02034578|7524145|FG001|STARTED|Overall Study||3
6599000|NCT02034578|7524146|FG002|STARTED|Overall Study||4
6599001|NCT02034578|7524147|FG003|STARTED|Overall Study||3
6661692|NCT02507219|7592493|FG002|COMPLETED|Overall Study||3
6661693|NCT02507219|7592494|FG003|COMPLETED|Overall Study||3
6661694|NCT02507219|7592495|FG004|COMPLETED|Overall Study||3
6661695|NCT02507219|7592496|FG005|COMPLETED|Overall Study||3
6599002|NCT02034578|7524148|FG004|STARTED|Overall Study||4
6599003|NCT02034578|7524149|FG005|STARTED|Overall Study||3
6599004|NCT02034578|7524144|FG000|COMPLETED|Overall Study||4
6599005|NCT02034578|7524145|FG001|COMPLETED|Overall Study||3
6599006|NCT02034578|7524146|FG002|COMPLETED|Overall Study||4
6599007|NCT02034578|7524147|FG003|COMPLETED|Overall Study||3
6599008|NCT02034578|7524148|FG004|COMPLETED|Overall Study||4
6599009|NCT02034578|7524149|FG005|COMPLETED|Overall Study||3
6599010|NCT02034578|7524144|FG000|NOT COMPLETED|Overall Study||0
6599011|NCT02034578|7524145|FG001|NOT COMPLETED|Overall Study||0
6599012|NCT02034578|7524146|FG002|NOT COMPLETED|Overall Study||0
6599013|NCT02034578|7524147|FG003|NOT COMPLETED|Overall Study||0
6599014|NCT02034578|7524148|FG004|NOT COMPLETED|Overall Study||0
6599015|NCT02034578|7524149|FG005|NOT COMPLETED|Overall Study||0
6599016|NCT02034591|7524158|FG000|STARTED|Overall Study||4
6599017|NCT02034591|7524159|FG001|STARTED|Overall Study||3
6599018|NCT02034591|7524160|FG002|STARTED|Overall Study||4
6661696|NCT02507219|7592491|FG000|NOT COMPLETED|Overall Study||1
6661697|NCT02507219|7592492|FG001|NOT COMPLETED|Overall Study||0
6661698|NCT02507219|7592493|FG002|NOT COMPLETED|Overall Study||0
6661699|NCT02507219|7592494|FG003|NOT COMPLETED|Overall Study||0
6661700|NCT02507219|7592495|FG004|NOT COMPLETED|Overall Study||1
6661701|NCT02507219|7592496|FG005|NOT COMPLETED|Overall Study||0
6661702|NCT02507297|7592506|FG000|STARTED|Overall Study||16
6661703|NCT02507297|7592507|FG001|STARTED|Overall Study||13
6661704|NCT02507297|7592506|FG000|COMPLETED|Overall Study||15
6661705|NCT02507297|7592507|FG001|COMPLETED|Overall Study||12
6661706|NCT02507297|7592506|FG000|NOT COMPLETED|Overall Study||1
6661707|NCT02507297|7592507|FG001|NOT COMPLETED|Overall Study||1
6661708|NCT02507349|7592515|FG000|STARTED|Overall Study||1232
6661709|NCT02507349|7592516|FG001|STARTED|Overall Study||1211
6661710|NCT02507349|7592515|FG000|COMPLETED|Overall Study||1045
6661711|NCT02507349|7592516|FG001|COMPLETED|Overall Study||1050
6661712|NCT02507349|7592515|FG000|NOT COMPLETED|Overall Study||187
6661713|NCT02507349|7592516|FG001|NOT COMPLETED|Overall Study||161
6661714|NCT02507375|7592524|FG000|STARTED|Overall Study||6
6661715|NCT02507375|7592525|FG001|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
6661716|NCT02507375|7592524|FG000|Cycle 1|Overall Study||6
6661717|NCT02507375|7592525|FG001|Cycle 1|Overall Study||9
6661718|NCT02507375|7592524|FG000|Received Pertuzumab|Overall Study||6
6661719|NCT02507375|7592525|FG001|Received Pertuzumab|Overall Study||6
6661720|NCT02507375|7592524|FG000|Cycle 2|Overall Study||5
6661721|NCT02507375|7592525|FG001|Cycle 2|Overall Study||5
6661722|NCT02507375|7592524|FG000|Cycle 3|Overall Study||4
6661723|NCT02507375|7592525|FG001|Cycle 3|Overall Study||5
6661724|NCT02507375|7592524|FG000|Cycle 4|Overall Study||4
6661725|NCT02507375|7592525|FG001|Cycle 4|Overall Study||2
6661726|NCT02507375|7592524|FG000|Cycle 5|Overall Study||3
6661727|NCT02507375|7592525|FG001|Cycle 5|Overall Study||1
6661728|NCT02507375|7592524|FG000|Cycle 6|Overall Study||3
6661729|NCT02507375|7592525|FG001|Cycle 6|Overall Study||1
6661730|NCT02507375|7592524|FG000|Extension Period|Overall Study||2
6661731|NCT02507375|7592525|FG001|Extension Period|Overall Study||1
6661732|NCT02507375|7592524|FG000|COMPLETED|Overall Study||2
6661733|NCT02507375|7592525|FG001|COMPLETED|Overall Study||1
6661734|NCT02507375|7592524|FG000|NOT COMPLETED|Overall Study||4
6661735|NCT02507375|7592525|FG001|NOT COMPLETED|Overall Study||8
6661736|NCT02507388|7592537|FG000|STARTED|Overall Study||25
6661737|NCT02507388|7592538|FG001|STARTED|Overall Study||25
6661738|NCT02507388|7592537|FG000|COMPLETED|Overall Study||25
6661739|NCT02507388|7592538|FG001|COMPLETED|Overall Study||25
6661740|NCT02507388|7592537|FG000|NOT COMPLETED|Overall Study||0
6661741|NCT02507388|7592538|FG001|NOT COMPLETED|Overall Study||0
6661742|NCT02507752|7592545|FG000|STARTED|Overall Study||72
6661743|NCT02507752|7592545|FG000|COMPLETED|Overall Study||55
6661744|NCT02507752|7592545|FG000|NOT COMPLETED|Overall Study||17
6661745|NCT02508077|7592549|FG000|STARTED|Overall Study||1
6661746|NCT02508077|7592549|FG000|COMPLETED|Overall Study||1
6661747|NCT02508077|7592549|FG000|NOT COMPLETED|Overall Study||0
6661748|NCT02508103|7592555|FG000|STARTED|Overall Study||5
6661749|NCT02508103|7592556|FG001|STARTED|Overall Study||5
6661750|NCT02508103|7592555|FG000|COMPLETED|Overall Study||5
6661751|NCT02508103|7592556|FG001|COMPLETED|Overall Study||5
6661752|NCT02508103|7592555|FG000|NOT COMPLETED|Overall Study||0
6661753|NCT02508103|7592556|FG001|NOT COMPLETED|Overall Study||0
6661754|NCT02508116|7592564|FG000|STARTED|Overall Study||252
6661755|NCT02508116|7592565|FG001|STARTED|Overall Study||257
6661756|NCT02508116|7592564|FG000|Received Intervention as Randomized|Overall Study||249
6599019|NCT02034591|7524161|FG003|STARTED|Overall Study||3
6599020|NCT02034591|7524162|FG004|STARTED|Overall Study||4
6661757|NCT02508116|7592565|FG001|Received Intervention as Randomized|Overall Study||255
6661758|NCT02508116|7592564|FG000|COMPLETED|Overall Study||244
6661759|NCT02508116|7592565|FG001|COMPLETED|Overall Study||250
6661760|NCT02508116|7592564|FG000|NOT COMPLETED|Overall Study||8
6661761|NCT02508116|7592565|FG001|NOT COMPLETED|Overall Study||7
6599021|NCT02034591|7524163|FG005|STARTED|Overall Study||3
6599022|NCT02034591|7524158|FG000|COMPLETED|Overall Study||4
6599023|NCT02034591|7524159|FG001|COMPLETED|Overall Study||3
6661762|NCT02508194|7592573|FG000|STARTED|Overall Study||949
6661763|NCT02508194|7592574|FG001|STARTED|Overall Study||951
6661764|NCT02508194|7592573|FG000|COMPLETED|Overall Study||897
6661765|NCT02508194|7592574|FG001|COMPLETED|Overall Study||907
6661766|NCT02508194|7592573|FG000|NOT COMPLETED|Overall Study||52
6599024|NCT02034591|7524160|FG002|COMPLETED|Overall Study||4
6599025|NCT02034591|7524161|FG003|COMPLETED|Overall Study||3
6599026|NCT02034591|7524162|FG004|COMPLETED|Overall Study||3
6599027|NCT02034591|7524163|FG005|COMPLETED|Overall Study||3
6599028|NCT02034591|7524158|FG000|NOT COMPLETED|Overall Study||0
6599029|NCT02034591|7524159|FG001|NOT COMPLETED|Overall Study||0
6599030|NCT02034591|7524160|FG002|NOT COMPLETED|Overall Study||0
6599031|NCT02034591|7524161|FG003|NOT COMPLETED|Overall Study||0
6599032|NCT02034591|7524162|FG004|NOT COMPLETED|Overall Study||1
6599033|NCT02034591|7524163|FG005|NOT COMPLETED|Overall Study||0
6599034|NCT02034708|7524174|FG000|STARTED|First Contrast Agent Injection (1 Day)||138
6599035|NCT02034708|7524175|FG001|STARTED|First Contrast Agent Injection (1 Day)||130
6599036|NCT02034708|7524174|FG000|COMPLETED|First Contrast Agent Injection (1 Day)||138
6599037|NCT02034708|7524175|FG001|COMPLETED|First Contrast Agent Injection (1 Day)||130
6599038|NCT02034708|7524174|FG000|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
6599039|NCT02034708|7524175|FG001|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
6599040|NCT02034708|7524174|FG000|STARTED|Wash-out (From 2 Days up to 14 Days)||138
6599041|NCT02034708|7524175|FG001|STARTED|Wash-out (From 2 Days up to 14 Days)||130
6599042|NCT02034708|7524174|FG000|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
6599043|NCT02034708|7524175|FG001|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
6599044|NCT02034708|7524174|FG000|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
6599045|NCT02034708|7524175|FG001|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
6599046|NCT02034708|7524174|FG000|STARTED|Second Contrast Agent Injection (1 Day)||129
6599047|NCT02034708|7524175|FG001|STARTED|Second Contrast Agent Injection (1 Day)||120
6599048|NCT02034708|7524174|FG000|COMPLETED|Second Contrast Agent Injection (1 Day)||129
6599049|NCT02034708|7524175|FG001|COMPLETED|Second Contrast Agent Injection (1 Day)||120
6599050|NCT02034708|7524174|FG000|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
6599051|NCT02034708|7524175|FG001|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
6599052|NCT02034799|7524188|FG000|STARTED|Overall Study||129
6599053|NCT02034799|7524189|FG001|STARTED|Overall Study||127
6599054|NCT02034799|7524188|FG000|COMPLETED|Overall Study||127
6599055|NCT02034799|7524189|FG001|COMPLETED|Overall Study||123
6599056|NCT02034799|7524188|FG000|NOT COMPLETED|Overall Study||2
6599057|NCT02034799|7524189|FG001|NOT COMPLETED|Overall Study||4
6599058|NCT02034877|7524197|FG000|STARTED|Overall Study||200
6599059|NCT02034877|7524198|FG001|STARTED|Overall Study||999
6599060|NCT02034877|7524197|FG000|COMPLETED|Overall Study||200
6599061|NCT02034877|7524198|FG001|COMPLETED|Overall Study||993
6599062|NCT02034877|7524197|FG000|NOT COMPLETED|Overall Study||0
6599063|NCT02034877|7524198|FG001|NOT COMPLETED|Overall Study||6
6599064|NCT02034916|7524206|FG000|STARTED|Overall Study||49
6599065|NCT02034916|7524207|FG001|STARTED|Overall Study||35
6599066|NCT02034916|7524206|FG000|Treated|Overall Study||48
6599067|NCT02034916|7524207|FG001|Treated|Overall Study||35
6599068|NCT02034916|7524206|FG000|COMPLETED|Overall Study||0
6661767|NCT02508194|7592574|FG001|NOT COMPLETED|Overall Study||44
6661768|NCT02508207|7592582|FG000|STARTED|Overall Study||7
6661769|NCT02508207|7592583|FG001|STARTED|Overall Study||27
6661770|NCT02508207|7592582|FG000|COMPLETED|Overall Study||7
6661771|NCT02508207|7592583|FG001|COMPLETED|Overall Study||27
6661772|NCT02508207|7592582|FG000|NOT COMPLETED|Overall Study||0
6661773|NCT02508207|7592583|FG001|NOT COMPLETED|Overall Study||0
6661774|NCT02508259|7592591|FG000|STARTED|Overall Study||5
6661775|NCT02508259|7592592|FG001|STARTED|Overall Study||5
6661776|NCT02508259|7592591|FG000|COMPLETED|Overall Study||5
6661777|NCT02508259|7592592|FG001|COMPLETED|Overall Study||5
6661778|NCT02508259|7592591|FG000|NOT COMPLETED|Overall Study||0
6661779|NCT02508259|7592592|FG001|NOT COMPLETED|Overall Study||0
6661780|NCT02508389|7592601|FG000|STARTED|Overall Study||73
6661781|NCT02508389|7592602|FG001|STARTED|Overall Study||76
6661782|NCT02508389|7592603|FG002|STARTED|Overall Study||74
6661783|NCT02508389|7592601|FG000|COMPLETED|Overall Study||45
6661784|NCT02508389|7592602|FG001|COMPLETED|Overall Study||45
6661785|NCT02508389|7592603|FG002|COMPLETED|Overall Study||42
6661786|NCT02508389|7592601|FG000|NOT COMPLETED|Overall Study||28
6661787|NCT02508389|7592602|FG001|NOT COMPLETED|Overall Study||31
6661788|NCT02508389|7592603|FG002|NOT COMPLETED|Overall Study||32
6661789|NCT02508428|7592613|FG000|STARTED|Overall Study||114
6661790|NCT02508428|7592614|FG001|STARTED|Overall Study||111
6661791|NCT02508428|7592613|FG000|COMPLETED|Overall Study||62
6661792|NCT02508428|7592614|FG001|COMPLETED|Overall Study||44
6661793|NCT02508428|7592613|FG000|NOT COMPLETED|Overall Study||52
6661794|NCT02508428|7592614|FG001|NOT COMPLETED|Overall Study||67
6661795|NCT02508480|7592622|FG000|STARTED|Overall Study||95
6661796|NCT02508480|7592623|FG001|STARTED|Overall Study||97
6661797|NCT02508480|7592622|FG000|Post-Treatment Assessment|Overall Study||87
6661798|NCT02508480|7592623|FG001|Post-Treatment Assessment|Overall Study||89
6661799|NCT02508480|7592622|FG000|Three Month Follow-up|Overall Study||84
6661800|NCT02508480|7592623|FG001|Three Month Follow-up|Overall Study||86
6661801|NCT02508480|7592622|FG000|Six-Month Follow-Up|Overall Study||84
6661802|NCT02508480|7592623|FG001|Six-Month Follow-Up|Overall Study||86
6661803|NCT02508480|7592622|FG000|COMPLETED|Overall Study||90
6661804|NCT02508480|7592623|FG001|COMPLETED|Overall Study||93
6661805|NCT02508480|7592622|FG000|NOT COMPLETED|Overall Study||5
6661806|NCT02508480|7592623|FG001|NOT COMPLETED|Overall Study||4
6661807|NCT02508532|7592636|FG000|STARTED|Part 1 - Dose Determining Period||6
6661808|NCT02508532|7592637|FG001|STARTED|Part 1 - Dose Determining Period||6
6599069|NCT02034916|7524207|FG001|COMPLETED|Overall Study||0
6599070|NCT02034916|7524206|FG000|NOT COMPLETED|Overall Study||49
6599071|NCT02034916|7524207|FG001|NOT COMPLETED|Overall Study||35
6599072|NCT02035202|7524217|FG000|STARTED|Overall Study||85
6599073|NCT02035202|7524218|FG001|STARTED|Overall Study||85
6599074|NCT02035202|7524219|FG002|STARTED|Overall Study||85
6599075|NCT02035202|7524217|FG000|COMPLETED|Overall Study||77
6599076|NCT02035202|7524218|FG001|COMPLETED|Overall Study||69
6599077|NCT02035202|7524219|FG002|COMPLETED|Overall Study||83
6599078|NCT02035202|7524217|FG000|NOT COMPLETED|Overall Study||8
6599079|NCT02035202|7524218|FG001|NOT COMPLETED|Overall Study||16
6599080|NCT02035202|7524219|FG002|NOT COMPLETED|Overall Study||2
6599081|NCT02035267|7524231|FG000|STARTED|Overall Study||31
6599082|NCT02035267|7524232|FG001|STARTED|Overall Study||16
6599083|NCT02035267|7524233|FG002|STARTED|Overall Study||30
6599084|NCT02035267|7524234|FG003|STARTED|Overall Study||16
6599085|NCT02035267|7524231|FG000|COMPLETED|Overall Study||31
6599086|NCT02035267|7524232|FG001|COMPLETED|Overall Study||15
6599087|NCT02035267|7524233|FG002|COMPLETED|Overall Study||28
6599088|NCT02035267|7524234|FG003|COMPLETED|Overall Study||15
6599089|NCT02035267|7524231|FG000|NOT COMPLETED|Overall Study||0
6599090|NCT02035267|7524232|FG001|NOT COMPLETED|Overall Study||1
6599091|NCT02035267|7524233|FG002|NOT COMPLETED|Overall Study||2
6599092|NCT02035267|7524234|FG003|NOT COMPLETED|Overall Study||1
6599093|NCT02035332|7524246|FG000|STARTED|Overall Study|Treatment Attempted|21
6599094|NCT02035332|7524246|FG000|Treated|Overall Study|Treatment Completed|20
6599095|NCT02035332|7524246|FG000|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
6599096|NCT02035332|7524246|FG000|NOT COMPLETED|Overall Study||1
6599097|NCT02035345|7524250|FG000|STARTED|Overall Study||15
6599098|NCT02035345|7524250|FG000|COMPLETED|Overall Study||15
6599099|NCT02035345|7524250|FG000|NOT COMPLETED|Overall Study||0
6599100|NCT02035475|7524255|FG000|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
6599101|NCT02035475|7524255|FG000|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
6599102|NCT02035475|7524255|FG000|NOT COMPLETED|Overall Study||6
6599103|NCT02035553|7524263|FG000|STARTED|Overall Study||91
6599104|NCT02035553|7524264|FG001|STARTED|Overall Study||90
6599105|NCT02035553|7524263|FG000|COMPLETED|Overall Study||73
6599106|NCT02035553|7524264|FG001|COMPLETED|Overall Study||67
6599107|NCT02035553|7524263|FG000|NOT COMPLETED|Overall Study||18
6599108|NCT02035553|7524264|FG001|NOT COMPLETED|Overall Study||23
6599109|NCT02035696|7524274|FG000|STARTED|Overall Study||174
6599110|NCT02035696|7524275|FG001|STARTED|Overall Study||166
6599111|NCT02035696|7524276|FG002|STARTED|Overall Study||167
6599112|NCT02035696|7524277|FG003|STARTED|Overall Study||164
6599113|NCT02035696|7524274|FG000|COMPLETED|Overall Study||171
6599114|NCT02035696|7524275|FG001|COMPLETED|Overall Study||163
6599115|NCT02035696|7524276|FG002|COMPLETED|Overall Study||164
6599116|NCT02035696|7524277|FG003|COMPLETED|Overall Study||161
6599117|NCT02035696|7524274|FG000|NOT COMPLETED|Overall Study||3
6599118|NCT02035696|7524275|FG001|NOT COMPLETED|Overall Study||3
6599119|NCT02035696|7524276|FG002|NOT COMPLETED|Overall Study||3
6599120|NCT02035696|7524277|FG003|NOT COMPLETED|Overall Study||3
6599121|NCT02035748|7524291|FG000|STARTED|Overall Study||468
6599122|NCT02035748|7524291|FG000|COMPLETED|Overall Study||448
6599123|NCT02035748|7524291|FG000|NOT COMPLETED|Overall Study||20
6599124|NCT02036294|7524298|FG000|STARTED|Overall Study||120
6599125|NCT02036294|7524299|FG001|STARTED|Overall Study||120
6599126|NCT02036294|7524298|FG000|COMPLETED|Overall Study||111
6599127|NCT02036294|7524299|FG001|COMPLETED|Overall Study||109
6599128|NCT02036294|7524298|FG000|NOT COMPLETED|Overall Study||9
6599129|NCT02036294|7524299|FG001|NOT COMPLETED|Overall Study||11
6661809|NCT02508532|7592638|FG002|STARTED|Part 1 - Dose Determining Period||6
6661810|NCT02508532|7592639|FG003|STARTED|Part 1 - Dose Determining Period||6
6661811|NCT02508532|7592640|FG004|STARTED|Part 1 - Dose Determining Period||6
6661812|NCT02508532|7592641|FG005|STARTED|Part 1 - Dose Determining Period||6
6661813|NCT02508532|7592642|FG006|STARTED|Part 1 - Dose Determining Period||7
6661814|NCT02508532|7592643|FG007|STARTED|Part 1 - Dose Determining Period||3
6661815|NCT02508532|7592644|FG008|STARTED|Part 1 - Dose Determining Period|This group includes patients enrolled in Part 1 and Part 2 at a starting dose of 300 or 400 mg QD. This group was not used to determine the MTD in Part 1|0
6661816|NCT02508532|7592636|FG000|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
6661817|NCT02508532|7592637|FG001|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
6661818|NCT02508532|7592638|FG002|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
6661819|NCT02508532|7592639|FG003|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
6661820|NCT02508532|7592640|FG004|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
6661821|NCT02508532|7592641|FG005|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||6
6661822|NCT02508532|7592642|FG006|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||7
6661823|NCT02508532|7592643|FG007|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
6661824|NCT02508532|7592644|FG008|Patients From Part 1 Included in the Part 2 Analyses|Part 1 - Dose Determining Period||0
6661825|NCT02508532|7592636|FG000|COMPLETED|Part 1 - Dose Determining Period||6
6599130|NCT02036320|7524305|FG000|STARTED|Period 1||95
6599131|NCT02036320|7524306|FG001|STARTED|Period 1||95
6599132|NCT02036320|7524305|FG000|COMPLETED|Period 1||95
6599133|NCT02036320|7524306|FG001|COMPLETED|Period 1||95
6599134|NCT02036320|7524305|FG000|NOT COMPLETED|Period 1||0
6599135|NCT02036320|7524306|FG001|NOT COMPLETED|Period 1||0
6599136|NCT02036320|7524305|FG000|STARTED|Period 2||95
6599137|NCT02036320|7524306|FG001|STARTED|Period 2||95
6599138|NCT02036320|7524305|FG000|COMPLETED|Period 2||95
6661826|NCT02508532|7592637|FG001|COMPLETED|Part 1 - Dose Determining Period||6
6661827|NCT02508532|7592638|FG002|COMPLETED|Part 1 - Dose Determining Period||6
6661828|NCT02508532|7592639|FG003|COMPLETED|Part 1 - Dose Determining Period||6
6661829|NCT02508532|7592640|FG004|COMPLETED|Part 1 - Dose Determining Period||6
6661830|NCT02508532|7592641|FG005|COMPLETED|Part 1 - Dose Determining Period||6
6661831|NCT02508532|7592642|FG006|COMPLETED|Part 1 - Dose Determining Period||6
6661832|NCT02508532|7592643|FG007|COMPLETED|Part 1 - Dose Determining Period||2
6661833|NCT02508532|7592644|FG008|COMPLETED|Part 1 - Dose Determining Period||0
6661834|NCT02508532|7592636|FG000|NOT COMPLETED|Part 1 - Dose Determining Period||0
6661835|NCT02508532|7592637|FG001|NOT COMPLETED|Part 1 - Dose Determining Period||0
6661836|NCT02508532|7592638|FG002|NOT COMPLETED|Part 1 - Dose Determining Period||0
6661837|NCT02508532|7592639|FG003|NOT COMPLETED|Part 1 - Dose Determining Period||0
6661838|NCT02508532|7592640|FG004|NOT COMPLETED|Part 1 - Dose Determining Period||0
6661839|NCT02508532|7592641|FG005|NOT COMPLETED|Part 1 - Dose Determining Period||0
6661840|NCT02508532|7592642|FG006|NOT COMPLETED|Part 1 - Dose Determining Period||1
6661841|NCT02508532|7592643|FG007|NOT COMPLETED|Part 1 - Dose Determining Period||1
6661842|NCT02508532|7592644|FG008|NOT COMPLETED|Part 1 - Dose Determining Period||0
6661843|NCT02508532|7592636|FG000|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
6661844|NCT02508532|7592637|FG001|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
6661845|NCT02508532|7592638|FG002|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
6661846|NCT02508532|7592639|FG003|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
6661847|NCT02508532|7592640|FG004|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
6661848|NCT02508532|7592641|FG005|STARTED|Part 2 - Treatment|"Part 1 Only:~6 Patients from this group are included in the 300 or 400 mg QD group."|0
6661849|NCT02508532|7592642|FG006|STARTED|Part 2 - Treatment|"Part 1 Only:~7 Patients from this group are included in the 300 or 400 mg QD group."|0
6661850|NCT02508532|7592643|FG007|STARTED|Part 2 - Treatment|These patients are not included in Part 2 analyses|0
6661851|NCT02508532|7592644|FG008|STARTED|Part 2 - Treatment|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
6661852|NCT02508532|7592636|FG000|COMPLETED|Part 2 - Treatment||0
6661853|NCT02508532|7592637|FG001|COMPLETED|Part 2 - Treatment||0
6599139|NCT02036320|7524306|FG001|COMPLETED|Period 2||95
6599140|NCT02036320|7524305|FG000|NOT COMPLETED|Period 2||0
6599141|NCT02036320|7524306|FG001|NOT COMPLETED|Period 2||0
6599142|NCT02036424|7524314|FG000|STARTED|Overall Study|23 study eyes, not number of subjects|23
6599143|NCT02036424|7524315|FG001|STARTED|Overall Study|27 study eyes, not number of subjects|27
6599144|NCT02036424|7524314|FG000|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
6599145|NCT02036424|7524315|FG001|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
6599146|NCT02036424|7524314|FG000|NOT COMPLETED|Overall Study||0
6599147|NCT02036424|7524315|FG001|NOT COMPLETED|Overall Study||0
6599148|NCT02036502|7524329|FG000|STARTED|Part 1:Dose Determination/Escalation||6
6599149|NCT02036502|7524330|FG001|STARTED|Part 1:Dose Determination/Escalation||4
6599150|NCT02036502|7524331|FG002|STARTED|Part 1:Dose Determination/Escalation||0
6599151|NCT02036502|7524332|FG003|STARTED|Part 1:Dose Determination/Escalation||0
6599152|NCT02036502|7524333|FG004|STARTED|Part 1:Dose Determination/Escalation||0
6599153|NCT02036502|7524334|FG005|STARTED|Part 1:Dose Determination/Escalation||0
6599154|NCT02036502|7524335|FG006|STARTED|Part 1:Dose Determination/Escalation||0
6661854|NCT02508532|7592638|FG002|COMPLETED|Part 2 - Treatment||0
6661855|NCT02508532|7592639|FG003|COMPLETED|Part 2 - Treatment||0
6661856|NCT02508532|7592640|FG004|COMPLETED|Part 2 - Treatment||0
6661857|NCT02508532|7592641|FG005|COMPLETED|Part 2 - Treatment||0
6661858|NCT02508532|7592642|FG006|COMPLETED|Part 2 - Treatment||0
6661859|NCT02508532|7592643|FG007|COMPLETED|Part 2 - Treatment||0
6661860|NCT02508532|7592644|FG008|COMPLETED|Part 2 - Treatment||0
6661861|NCT02508532|7592636|FG000|NOT COMPLETED|Part 2 - Treatment||0
6661862|NCT02508532|7592637|FG001|NOT COMPLETED|Part 2 - Treatment||0
6661863|NCT02508532|7592638|FG002|NOT COMPLETED|Part 2 - Treatment||0
6661864|NCT02508532|7592639|FG003|NOT COMPLETED|Part 2 - Treatment||0
6661865|NCT02508532|7592640|FG004|NOT COMPLETED|Part 2 - Treatment||0
6661866|NCT02508532|7592641|FG005|NOT COMPLETED|Part 2 - Treatment||0
6661867|NCT02508532|7592642|FG006|NOT COMPLETED|Part 2 - Treatment||0
6661868|NCT02508532|7592643|FG007|NOT COMPLETED|Part 2 - Treatment||0
6661869|NCT02508532|7592644|FG008|NOT COMPLETED|Part 2 - Treatment||217
6661870|NCT02508532|7592636|FG000|STARTED|Part 1 and Part 2 End of Study||6
6661871|NCT02508532|7592637|FG001|STARTED|Part 1 and Part 2 End of Study||6
6661872|NCT02508532|7592638|FG002|STARTED|Part 1 and Part 2 End of Study||6
6661873|NCT02508532|7592639|FG003|STARTED|Part 1 and Part 2 End of Study||6
6661874|NCT02508532|7592640|FG004|STARTED|Part 1 and Part 2 End of Study||6
6661875|NCT02508532|7592641|FG005|STARTED|Part 1 and Part 2 End of Study|These 6 patients are included in the 300 or 400 mg QD dose group|0
6661876|NCT02508532|7592642|FG006|STARTED|Part 1 and Part 2 End of Study|These 7 patients are included in the 300 or 400 mg QD dose group|0
6661877|NCT02508532|7592643|FG007|STARTED|Part 1 and Part 2 End of Study||3
6661878|NCT02508532|7592644|FG008|STARTED|Part 1 and Part 2 End of Study|Includes 13 patients enrolled in Part 1 at a starting dose of 300 mg (n = 6) or 400 mg (n = 7) QD.|217
6661879|NCT02508532|7592636|FG000|COMPLETED|Part 1 and Part 2 End of Study||0
6661880|NCT02508532|7592637|FG001|COMPLETED|Part 1 and Part 2 End of Study||0
6661881|NCT02508532|7592638|FG002|COMPLETED|Part 1 and Part 2 End of Study||0
6661882|NCT02508532|7592639|FG003|COMPLETED|Part 1 and Part 2 End of Study||0
6661883|NCT02508532|7592640|FG004|COMPLETED|Part 1 and Part 2 End of Study||0
6661884|NCT02508532|7592641|FG005|COMPLETED|Part 1 and Part 2 End of Study||0
6661885|NCT02508532|7592642|FG006|COMPLETED|Part 1 and Part 2 End of Study||0
6661886|NCT02508532|7592643|FG007|COMPLETED|Part 1 and Part 2 End of Study||0
6661887|NCT02508532|7592644|FG008|COMPLETED|Part 1 and Part 2 End of Study||0
6661888|NCT02508532|7592636|FG000|NOT COMPLETED|Part 1 and Part 2 End of Study||6
6661889|NCT02508532|7592637|FG001|NOT COMPLETED|Part 1 and Part 2 End of Study||6
6661890|NCT02508532|7592638|FG002|NOT COMPLETED|Part 1 and Part 2 End of Study||6
6661891|NCT02508532|7592639|FG003|NOT COMPLETED|Part 1 and Part 2 End of Study||6
6661892|NCT02508532|7592640|FG004|NOT COMPLETED|Part 1 and Part 2 End of Study||6
6661893|NCT02508532|7592641|FG005|NOT COMPLETED|Part 1 and Part 2 End of Study||0
6661894|NCT02508532|7592642|FG006|NOT COMPLETED|Part 1 and Part 2 End of Study||0
6661895|NCT02508532|7592643|FG007|NOT COMPLETED|Part 1 and Part 2 End of Study||3
6661896|NCT02508532|7592644|FG008|NOT COMPLETED|Part 1 and Part 2 End of Study||217
6661897|NCT02508636|7592673|FG000|STARTED|Overall Study||11
6661898|NCT02508636|7592673|FG000|COMPLETED|Overall Study||11
6661899|NCT02508636|7592673|FG000|NOT COMPLETED|Overall Study||0
6661900|NCT02508649|7592681|FG000|STARTED|Overall Study||283
6661901|NCT02508649|7592682|FG001|STARTED|Overall Study||197
6661902|NCT02508649|7592683|FG002|STARTED|Overall Study||189
6661903|NCT02508649|7592684|FG003|STARTED|Overall Study||199
6661904|NCT02508649|7592681|FG000|Dosed|Overall Study||266
6661905|NCT02508649|7592682|FG001|Dosed|Overall Study||191
6661906|NCT02508649|7592683|FG002|Dosed|Overall Study||177
6661907|NCT02508649|7592684|FG003|Dosed|Overall Study||194
6661908|NCT02508649|7592681|FG000|COMPLETED|Overall Study||265
6661909|NCT02508649|7592682|FG001|COMPLETED|Overall Study||184
6661910|NCT02508649|7592683|FG002|COMPLETED|Overall Study||174
6661911|NCT02508649|7592684|FG003|COMPLETED|Overall Study||189
6661912|NCT02508649|7592681|FG000|NOT COMPLETED|Overall Study||18
6661913|NCT02508649|7592682|FG001|NOT COMPLETED|Overall Study||13
6661914|NCT02508649|7592683|FG002|NOT COMPLETED|Overall Study||15
6661915|NCT02508649|7592684|FG003|NOT COMPLETED|Overall Study||10
6661916|NCT02508701|7592701|FG000|STARTED|Overall Study||9
6661917|NCT02508701|7592702|FG001|STARTED|Overall Study||6
6661918|NCT02508701|7592703|FG002|STARTED|Overall Study||5
6661919|NCT02508701|7592704|FG003|STARTED|Overall Study||4
6661920|NCT02508701|7592701|FG000|COMPLETED|Overall Study||0
6661921|NCT02508701|7592702|FG001|COMPLETED|Overall Study||1
6661922|NCT02508701|7592703|FG002|COMPLETED|Overall Study||0
6661923|NCT02508701|7592704|FG003|COMPLETED|Overall Study||1
6661924|NCT02508701|7592701|FG000|NOT COMPLETED|Overall Study||9
6661925|NCT02508701|7592702|FG001|NOT COMPLETED|Overall Study||5
6661926|NCT02508701|7592703|FG002|NOT COMPLETED|Overall Study||5
6661927|NCT02508701|7592704|FG003|NOT COMPLETED|Overall Study||3
6661928|NCT02508935|7592718|FG000|STARTED|Overall Study||23
6599155|NCT02036502|7524336|FG007|STARTED|Part 1:Dose Determination/Escalation||0
6599156|NCT02036502|7524329|FG000|Treated|Part 1:Dose Determination/Escalation||6
6599157|NCT02036502|7524330|FG001|Treated|Part 1:Dose Determination/Escalation||3
6599158|NCT02036502|7524331|FG002|Treated|Part 1:Dose Determination/Escalation||0
6599159|NCT02036502|7524332|FG003|Treated|Part 1:Dose Determination/Escalation||0
6599160|NCT02036502|7524333|FG004|Treated|Part 1:Dose Determination/Escalation||0
6599161|NCT02036502|7524334|FG005|Treated|Part 1:Dose Determination/Escalation||0
6599162|NCT02036502|7524335|FG006|Treated|Part 1:Dose Determination/Escalation||0
6599163|NCT02036502|7524336|FG007|Treated|Part 1:Dose Determination/Escalation||0
6599164|NCT02036502|7524329|FG000|COMPLETED|Part 1:Dose Determination/Escalation||0
6599165|NCT02036502|7524330|FG001|COMPLETED|Part 1:Dose Determination/Escalation||0
6599166|NCT02036502|7524331|FG002|COMPLETED|Part 1:Dose Determination/Escalation||0
6599167|NCT02036502|7524332|FG003|COMPLETED|Part 1:Dose Determination/Escalation||0
6599168|NCT02036502|7524333|FG004|COMPLETED|Part 1:Dose Determination/Escalation||0
6599169|NCT02036502|7524334|FG005|COMPLETED|Part 1:Dose Determination/Escalation||0
6599170|NCT02036502|7524335|FG006|COMPLETED|Part 1:Dose Determination/Escalation||0
6599171|NCT02036502|7524336|FG007|COMPLETED|Part 1:Dose Determination/Escalation||0
6599172|NCT02036502|7524329|FG000|NOT COMPLETED|Part 1:Dose Determination/Escalation||6
6599173|NCT02036502|7524330|FG001|NOT COMPLETED|Part 1:Dose Determination/Escalation||4
6599174|NCT02036502|7524331|FG002|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
6599175|NCT02036502|7524332|FG003|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
6599176|NCT02036502|7524333|FG004|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
6599177|NCT02036502|7524334|FG005|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
6599178|NCT02036502|7524335|FG006|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
6599179|NCT02036502|7524336|FG007|NOT COMPLETED|Part 1:Dose Determination/Escalation||0
6599180|NCT02036502|7524329|FG000|STARTED|Part 2:Dose Confirmation||0
6599181|NCT02036502|7524330|FG001|STARTED|Part 2:Dose Confirmation||0
6599182|NCT02036502|7524331|FG002|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|6
6599183|NCT02036502|7524332|FG003|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|2
6599184|NCT02036502|7524333|FG004|STARTED|Part 2:Dose Confirmation|Participants added to study for dose confirmation.|1
6599185|NCT02036502|7524334|FG005|STARTED|Part 2:Dose Confirmation||0
6599186|NCT02036502|7524335|FG006|STARTED|Part 2:Dose Confirmation||0
6599187|NCT02036502|7524336|FG007|STARTED|Part 2:Dose Confirmation||0
6599188|NCT02036502|7524329|FG000|Treated|Part 2:Dose Confirmation||0
6599189|NCT02036502|7524330|FG001|Treated|Part 2:Dose Confirmation||0
6599190|NCT02036502|7524331|FG002|Treated|Part 2:Dose Confirmation||6
6599191|NCT02036502|7524332|FG003|Treated|Part 2:Dose Confirmation||1
6599192|NCT02036502|7524333|FG004|Treated|Part 2:Dose Confirmation||1
6599193|NCT02036502|7524334|FG005|Treated|Part 2:Dose Confirmation||0
6599194|NCT02036502|7524335|FG006|Treated|Part 2:Dose Confirmation||0
6599195|NCT02036502|7524336|FG007|Treated|Part 2:Dose Confirmation||0
6599196|NCT02036502|7524329|FG000|COMPLETED|Part 2:Dose Confirmation||0
6599197|NCT02036502|7524330|FG001|COMPLETED|Part 2:Dose Confirmation||0
6599198|NCT02036502|7524331|FG002|COMPLETED|Part 2:Dose Confirmation||0
6599199|NCT02036502|7524332|FG003|COMPLETED|Part 2:Dose Confirmation||0
6599200|NCT02036502|7524333|FG004|COMPLETED|Part 2:Dose Confirmation||0
6599201|NCT02036502|7524334|FG005|COMPLETED|Part 2:Dose Confirmation||0
6599202|NCT02036502|7524335|FG006|COMPLETED|Part 2:Dose Confirmation||0
6599203|NCT02036502|7524336|FG007|COMPLETED|Part 2:Dose Confirmation||0
6599204|NCT02036502|7524329|FG000|NOT COMPLETED|Part 2:Dose Confirmation||0
6599205|NCT02036502|7524330|FG001|NOT COMPLETED|Part 2:Dose Confirmation||0
6599206|NCT02036502|7524331|FG002|NOT COMPLETED|Part 2:Dose Confirmation||6
6599207|NCT02036502|7524332|FG003|NOT COMPLETED|Part 2:Dose Confirmation||2
6599208|NCT02036502|7524333|FG004|NOT COMPLETED|Part 2:Dose Confirmation||1
6599209|NCT02036502|7524334|FG005|NOT COMPLETED|Part 2:Dose Confirmation||0
6599210|NCT02036502|7524335|FG006|NOT COMPLETED|Part 2:Dose Confirmation||0
6599211|NCT02036502|7524336|FG007|NOT COMPLETED|Part 2:Dose Confirmation||0
6599212|NCT02036502|7524329|FG000|STARTED|Part 3:Dose Expansion||0
6599213|NCT02036502|7524330|FG001|STARTED|Part 3:Dose Expansion||0
6599214|NCT02036502|7524331|FG002|STARTED|Part 3:Dose Expansion||0
6599215|NCT02036502|7524332|FG003|STARTED|Part 3:Dose Expansion||0
6599216|NCT02036502|7524333|FG004|STARTED|Part 3:Dose Expansion||0
6599217|NCT02036502|7524334|FG005|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|47
6599218|NCT02036502|7524335|FG006|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|1
6599219|NCT02036502|7524336|FG007|STARTED|Part 3:Dose Expansion|Participants added to study for dose expansion|10
6661929|NCT02508935|7592718|FG000|COMPLETED|Overall Study||0
6661930|NCT02508935|7592718|FG000|NOT COMPLETED|Overall Study||23
6661931|NCT02509026|7592724|FG000|STARTED|Induction Period (24 Weeks)||210
6661932|NCT02509026|7592724|FG000|Treated|Induction Period (24 Weeks)||209
6599220|NCT02036502|7524329|FG000|Treated|Part 3:Dose Expansion||0
6599221|NCT02036502|7524330|FG001|Treated|Part 3:Dose Expansion||0
6599222|NCT02036502|7524331|FG002|Treated|Part 3:Dose Expansion||0
6599223|NCT02036502|7524332|FG003|Treated|Part 3:Dose Expansion||0
6599224|NCT02036502|7524333|FG004|Treated|Part 3:Dose Expansion||0
6599225|NCT02036502|7524334|FG005|Treated|Part 3:Dose Expansion||45
6599226|NCT02036502|7524335|FG006|Treated|Part 3:Dose Expansion||1
6599227|NCT02036502|7524336|FG007|Treated|Part 3:Dose Expansion||10
6661933|NCT02509026|7592724|FG000|COMPLETED|Induction Period (24 Weeks)||188
6599228|NCT02036502|7524329|FG000|COMPLETED|Part 3:Dose Expansion||0
6599229|NCT02036502|7524330|FG001|COMPLETED|Part 3:Dose Expansion||0
6599230|NCT02036502|7524331|FG002|COMPLETED|Part 3:Dose Expansion||0
6599231|NCT02036502|7524332|FG003|COMPLETED|Part 3:Dose Expansion||0
6599232|NCT02036502|7524333|FG004|COMPLETED|Part 3:Dose Expansion||0
6599233|NCT02036502|7524334|FG005|COMPLETED|Part 3:Dose Expansion||0
6599234|NCT02036502|7524335|FG006|COMPLETED|Part 3:Dose Expansion||0
6599235|NCT02036502|7524336|FG007|COMPLETED|Part 3:Dose Expansion||0
6599236|NCT02036502|7524329|FG000|NOT COMPLETED|Part 3:Dose Expansion||0
6599237|NCT02036502|7524330|FG001|NOT COMPLETED|Part 3:Dose Expansion||0
6599238|NCT02036502|7524331|FG002|NOT COMPLETED|Part 3:Dose Expansion||0
6599239|NCT02036502|7524332|FG003|NOT COMPLETED|Part 3:Dose Expansion||0
6599240|NCT02036502|7524333|FG004|NOT COMPLETED|Part 3:Dose Expansion||0
6599241|NCT02036502|7524334|FG005|NOT COMPLETED|Part 3:Dose Expansion||47
6599242|NCT02036502|7524335|FG006|NOT COMPLETED|Part 3:Dose Expansion||1
6599243|NCT02036502|7524336|FG007|NOT COMPLETED|Part 3:Dose Expansion||10
6599244|NCT02036515|7524359|FG000|STARTED|Overall Study||156
6599245|NCT02036515|7524360|FG001|STARTED|Overall Study||155
6599246|NCT02036515|7524361|FG002|STARTED|Overall Study||153
6599247|NCT02036515|7524359|FG000|Treated|Overall Study||156
6599248|NCT02036515|7524360|FG001|Treated|Overall Study||153
6599249|NCT02036515|7524361|FG002|Treated|Overall Study||153
6599250|NCT02036515|7524359|FG000|COMPLETED|Overall Study||151
6599251|NCT02036515|7524360|FG001|COMPLETED|Overall Study||143
6599252|NCT02036515|7524361|FG002|COMPLETED|Overall Study||139
6599253|NCT02036515|7524359|FG000|NOT COMPLETED|Overall Study||5
6599254|NCT02036515|7524360|FG001|NOT COMPLETED|Overall Study||12
6599255|NCT02036515|7524361|FG002|NOT COMPLETED|Overall Study||14
6599256|NCT02036541|7524369|FG000|STARTED|Overall Study||65
6599257|NCT02036541|7524369|FG000|Completed Endpoint Visit|Overall Study||54
6599258|NCT02036541|7524369|FG000|COMPLETED|Overall Study||49
6599259|NCT02036541|7524369|FG000|NOT COMPLETED|Overall Study||16
6599260|NCT02036580|7524376|FG000|STARTED|Overall Study||8
6599261|NCT02036580|7524377|FG001|STARTED|Overall Study||8
6599262|NCT02036580|7524378|FG002|STARTED|Overall Study||4
6599263|NCT02036580|7524376|FG000|COMPLETED|Overall Study||7
6599264|NCT02036580|7524377|FG001|COMPLETED|Overall Study||7
6599265|NCT02036580|7524378|FG002|COMPLETED|Overall Study||4
6599266|NCT02036580|7524376|FG000|NOT COMPLETED|Overall Study||1
6599267|NCT02036580|7524377|FG001|NOT COMPLETED|Overall Study||1
6599268|NCT02036580|7524378|FG002|NOT COMPLETED|Overall Study||0
6599269|NCT02036645|7524398|FG000|STARTED|SAD Cohorts : Study Part 1|Pooled across cohorts 1-5 (2 per cohort)|12
6599270|NCT02036645|7524399|FG001|STARTED|SAD Cohorts : Study Part 1||3
6599271|NCT02036645|7524400|FG002|STARTED|SAD Cohorts : Study Part 1||6
6599272|NCT02036645|7524401|FG003|STARTED|SAD Cohorts : Study Part 1||6
6599273|NCT02036645|7524402|FG004|STARTED|SAD Cohorts : Study Part 1||6
6599274|NCT02036645|7524403|FG005|STARTED|SAD Cohorts : Study Part 1||6
6599275|NCT02036645|7524404|FG006|STARTED|SAD Cohorts : Study Part 1||6
6599276|NCT02036645|7524405|FG007|STARTED|SAD Cohorts : Study Part 1||0
6599277|NCT02036645|7524406|FG008|STARTED|SAD Cohorts : Study Part 1||0
6599278|NCT02036645|7524407|FG009|STARTED|SAD Cohorts : Study Part 1||0
6599279|NCT02036645|7524408|FG010|STARTED|SAD Cohorts : Study Part 1||0
6599280|NCT02036645|7524409|FG011|STARTED|SAD Cohorts : Study Part 1||0
6599281|NCT02036645|7524398|FG000|COMPLETED|SAD Cohorts : Study Part 1||12
6599282|NCT02036645|7524399|FG001|COMPLETED|SAD Cohorts : Study Part 1||3
6599283|NCT02036645|7524400|FG002|COMPLETED|SAD Cohorts : Study Part 1||6
6599284|NCT02036645|7524401|FG003|COMPLETED|SAD Cohorts : Study Part 1||5
6599285|NCT02036645|7524402|FG004|COMPLETED|SAD Cohorts : Study Part 1||6
6599286|NCT02036645|7524403|FG005|COMPLETED|SAD Cohorts : Study Part 1||6
6599287|NCT02036645|7524404|FG006|COMPLETED|SAD Cohorts : Study Part 1||5
6599288|NCT02036645|7524405|FG007|COMPLETED|SAD Cohorts : Study Part 1||0
6599289|NCT02036645|7524406|FG008|COMPLETED|SAD Cohorts : Study Part 1||0
6599290|NCT02036645|7524407|FG009|COMPLETED|SAD Cohorts : Study Part 1||0
6599291|NCT02036645|7524408|FG010|COMPLETED|SAD Cohorts : Study Part 1||0
6599292|NCT02036645|7524409|FG011|COMPLETED|SAD Cohorts : Study Part 1||0
6599293|NCT02036645|7524398|FG000|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599294|NCT02036645|7524399|FG001|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6661934|NCT02509026|7592724|FG000|NOT COMPLETED|Induction Period (24 Weeks)||22
6661935|NCT02509026|7592724|FG000|STARTED|Withdrawal Period (40 Weeks)|Participants who completed Period 1 and achieved ASDAS-CRP<1.3 were eligible to enter into Period 2|119
6599295|NCT02036645|7524400|FG002|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599296|NCT02036645|7524401|FG003|NOT COMPLETED|SAD Cohorts : Study Part 1||1
6599297|NCT02036645|7524402|FG004|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599298|NCT02036645|7524403|FG005|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599299|NCT02036645|7524404|FG006|NOT COMPLETED|SAD Cohorts : Study Part 1||1
6599300|NCT02036645|7524405|FG007|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599301|NCT02036645|7524406|FG008|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599302|NCT02036645|7524407|FG009|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599303|NCT02036645|7524408|FG010|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599304|NCT02036645|7524409|FG011|NOT COMPLETED|SAD Cohorts : Study Part 1||0
6599305|NCT02036645|7524398|FG000|STARTED|MAD Cohorts: Study Part 2|Pooled across Cohorts 7 to 9 (2 per cohort)|0
6599306|NCT02036645|7524399|FG001|STARTED|MAD Cohorts: Study Part 2||0
6599307|NCT02036645|7524400|FG002|STARTED|MAD Cohorts: Study Part 2||0
6599308|NCT02036645|7524401|FG003|STARTED|MAD Cohorts: Study Part 2||0
6599309|NCT02036645|7524402|FG004|STARTED|MAD Cohorts: Study Part 2||0
6599310|NCT02036645|7524403|FG005|STARTED|MAD Cohorts: Study Part 2||0
6599311|NCT02036645|7524404|FG006|STARTED|MAD Cohorts: Study Part 2||0
6599312|NCT02036645|7524405|FG007|STARTED|MAD Cohorts: Study Part 2||8
6599313|NCT02036645|7524406|FG008|STARTED|MAD Cohorts: Study Part 2||6
6599314|NCT02036645|7524407|FG009|STARTED|MAD Cohorts: Study Part 2||6
6599315|NCT02036645|7524408|FG010|STARTED|MAD Cohorts: Study Part 2||6
6599316|NCT02036645|7524409|FG011|STARTED|MAD Cohorts: Study Part 2||6
6599317|NCT02036645|7524398|FG000|COMPLETED|MAD Cohorts: Study Part 2||0
6599318|NCT02036645|7524399|FG001|COMPLETED|MAD Cohorts: Study Part 2||0
6599319|NCT02036645|7524400|FG002|COMPLETED|MAD Cohorts: Study Part 2||0
6599320|NCT02036645|7524401|FG003|COMPLETED|MAD Cohorts: Study Part 2||0
6599321|NCT02036645|7524402|FG004|COMPLETED|MAD Cohorts: Study Part 2||0
6599322|NCT02036645|7524403|FG005|COMPLETED|MAD Cohorts: Study Part 2||0
6599323|NCT02036645|7524404|FG006|COMPLETED|MAD Cohorts: Study Part 2||0
6599324|NCT02036645|7524405|FG007|COMPLETED|MAD Cohorts: Study Part 2||8
6599325|NCT02036645|7524406|FG008|COMPLETED|MAD Cohorts: Study Part 2||6
6599326|NCT02036645|7524407|FG009|COMPLETED|MAD Cohorts: Study Part 2||6
6599327|NCT02036645|7524408|FG010|COMPLETED|MAD Cohorts: Study Part 2||6
6599328|NCT02036645|7524409|FG011|COMPLETED|MAD Cohorts: Study Part 2||6
6599329|NCT02036645|7524398|FG000|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599330|NCT02036645|7524399|FG001|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599331|NCT02036645|7524400|FG002|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599332|NCT02036645|7524401|FG003|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599333|NCT02036645|7524402|FG004|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599334|NCT02036645|7524403|FG005|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599335|NCT02036645|7524404|FG006|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599336|NCT02036645|7524405|FG007|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599337|NCT02036645|7524406|FG008|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599338|NCT02036645|7524407|FG009|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599339|NCT02036645|7524408|FG010|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599340|NCT02036645|7524409|FG011|NOT COMPLETED|MAD Cohorts: Study Part 2||0
6599341|NCT02036775|7524447|FG000|STARTED|Treatment Period 1 (6 Days)||4
6599342|NCT02036775|7524448|FG001|STARTED|Treatment Period 1 (6 Days)||4
6599343|NCT02036775|7524449|FG002|STARTED|Treatment Period 1 (6 Days)||4
6599344|NCT02036775|7524450|FG003|STARTED|Treatment Period 1 (6 Days)||4
6599345|NCT02036775|7524451|FG004|STARTED|Treatment Period 1 (6 Days)||4
6599346|NCT02036775|7524452|FG005|STARTED|Treatment Period 1 (6 Days)||4
6599347|NCT02036775|7524447|FG000|COMPLETED|Treatment Period 1 (6 Days)||4
6599348|NCT02036775|7524448|FG001|COMPLETED|Treatment Period 1 (6 Days)||4
6599349|NCT02036775|7524449|FG002|COMPLETED|Treatment Period 1 (6 Days)||4
6599350|NCT02036775|7524450|FG003|COMPLETED|Treatment Period 1 (6 Days)||4
6599351|NCT02036775|7524451|FG004|COMPLETED|Treatment Period 1 (6 Days)||4
6599352|NCT02036775|7524452|FG005|COMPLETED|Treatment Period 1 (6 Days)||4
6599353|NCT02036775|7524447|FG000|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6599354|NCT02036775|7524448|FG001|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6599355|NCT02036775|7524449|FG002|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6599356|NCT02036775|7524450|FG003|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6599357|NCT02036775|7524451|FG004|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6599358|NCT02036775|7524452|FG005|NOT COMPLETED|Treatment Period 1 (6 Days)||0
6599359|NCT02036775|7524447|FG000|STARTED|Treatment Period 2 (6 Days)||4
6599360|NCT02036775|7524448|FG001|STARTED|Treatment Period 2 (6 Days)||4
6599361|NCT02036775|7524449|FG002|STARTED|Treatment Period 2 (6 Days)||4
6599362|NCT02036775|7524450|FG003|STARTED|Treatment Period 2 (6 Days)||4
6599363|NCT02036775|7524451|FG004|STARTED|Treatment Period 2 (6 Days)||4
6599364|NCT02036775|7524452|FG005|STARTED|Treatment Period 2 (6 Days)||4
6599365|NCT02036775|7524447|FG000|COMPLETED|Treatment Period 2 (6 Days)||4
6599366|NCT02036775|7524448|FG001|COMPLETED|Treatment Period 2 (6 Days)||4
6599367|NCT02036775|7524449|FG002|COMPLETED|Treatment Period 2 (6 Days)||4
6599368|NCT02036775|7524450|FG003|COMPLETED|Treatment Period 2 (6 Days)||4
6599369|NCT02036775|7524451|FG004|COMPLETED|Treatment Period 2 (6 Days)||4
6599370|NCT02036775|7524452|FG005|COMPLETED|Treatment Period 2 (6 Days)||3
6599371|NCT02036775|7524447|FG000|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6599372|NCT02036775|7524448|FG001|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6599373|NCT02036775|7524449|FG002|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6599374|NCT02036775|7524450|FG003|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6599375|NCT02036775|7524451|FG004|NOT COMPLETED|Treatment Period 2 (6 Days)||0
6599376|NCT02036775|7524452|FG005|NOT COMPLETED|Treatment Period 2 (6 Days)||1
6599377|NCT02036775|7524447|FG000|STARTED|Treatment Period 3 (6 Days)||4
6599378|NCT02036775|7524448|FG001|STARTED|Treatment Period 3 (6 Days)||4
6599379|NCT02036775|7524449|FG002|STARTED|Treatment Period 3 (6 Days)||4
6599380|NCT02036775|7524450|FG003|STARTED|Treatment Period 3 (6 Days)||4
6599381|NCT02036775|7524451|FG004|STARTED|Treatment Period 3 (6 Days)||4
6599382|NCT02036775|7524452|FG005|STARTED|Treatment Period 3 (6 Days)||3
6599383|NCT02036775|7524447|FG000|COMPLETED|Treatment Period 3 (6 Days)||4
6599384|NCT02036775|7524448|FG001|COMPLETED|Treatment Period 3 (6 Days)||4
6599385|NCT02036775|7524449|FG002|COMPLETED|Treatment Period 3 (6 Days)||4
6599386|NCT02036775|7524450|FG003|COMPLETED|Treatment Period 3 (6 Days)||4
6599387|NCT02036775|7524451|FG004|COMPLETED|Treatment Period 3 (6 Days)||4
6599388|NCT02036775|7524452|FG005|COMPLETED|Treatment Period 3 (6 Days)||3
6599389|NCT02036775|7524447|FG000|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6599390|NCT02036775|7524448|FG001|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6599391|NCT02036775|7524449|FG002|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6599392|NCT02036775|7524450|FG003|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6599393|NCT02036775|7524451|FG004|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6599394|NCT02036775|7524452|FG005|NOT COMPLETED|Treatment Period 3 (6 Days)||0
6599395|NCT02036840|7524460|FG000|STARTED|Overall Study||513
6599396|NCT02036840|7524460|FG000|COMPLETED|Overall Study||513
6599397|NCT02036840|7524460|FG000|NOT COMPLETED|Overall Study||0
6599398|NCT02036853|7524466|FG000|STARTED|Overall Study||6
6599399|NCT02036853|7524467|FG001|STARTED|Overall Study||14
6599400|NCT02036853|7524466|FG000|COMPLETED|Overall Study||6
6599401|NCT02036853|7524467|FG001|COMPLETED|Overall Study||8
6599402|NCT02036853|7524466|FG000|NOT COMPLETED|Overall Study||0
6661936|NCT02509026|7592724|FG000|COMPLETED|Withdrawal Period (40 Weeks)||112
6661937|NCT02509026|7592724|FG000|NOT COMPLETED|Withdrawal Period (40 Weeks)||7
6661938|NCT02509026|7592724|FG000|STARTED|Retreatment Period (12 Weeks)|Participants who completed Period 2 and achieved ASDAS-ESR>=2.1 were eligible to enter into Period 3|88
6661939|NCT02509026|7592724|FG000|Treated|Retreatment Period (12 Weeks)||87
6661940|NCT02509026|7592724|FG000|COMPLETED|Retreatment Period (12 Weeks)||84
6661941|NCT02509026|7592724|FG000|NOT COMPLETED|Retreatment Period (12 Weeks)||4
6661942|NCT02509065|7592733|FG000|STARTED|Overall Study||1
6661943|NCT02509065|7592734|FG001|STARTED|Overall Study||1
6661944|NCT02509065|7592735|FG002|STARTED|Overall Study||2
6661945|NCT02509065|7592736|FG003|STARTED|Overall Study||1
6661946|NCT02509065|7592737|FG004|STARTED|Overall Study||1
6661947|NCT02509065|7592738|FG005|STARTED|Overall Study||1
6661948|NCT02509065|7592739|FG006|STARTED|Overall Study||1
6661949|NCT02509065|7592740|FG007|STARTED|Overall Study||1
6661950|NCT02509065|7592741|FG008|STARTED|Overall Study||1
6661951|NCT02509065|7592742|FG009|STARTED|Overall Study||1
6661952|NCT02509065|7592743|FG010|STARTED|Overall Study||1
6661953|NCT02509065|7592744|FG011|STARTED|Overall Study||1
6661954|NCT02509065|7592745|FG012|STARTED|Overall Study||1
6661955|NCT02509065|7592746|FG013|STARTED|Overall Study||1
6661956|NCT02509065|7592747|FG014|STARTED|Overall Study||1
6661957|NCT02509065|7592748|FG015|STARTED|Overall Study||1
6661958|NCT02509065|7592749|FG016|STARTED|Overall Study||1
6661959|NCT02509065|7592750|FG017|STARTED|Overall Study||1
6661960|NCT02509065|7592751|FG018|STARTED|Overall Study||1
6661961|NCT02509065|7592752|FG019|STARTED|Overall Study||1
6661962|NCT02509065|7592753|FG020|STARTED|Overall Study||1
6661963|NCT02509065|7592754|FG021|STARTED|Overall Study||1
6661964|NCT02509065|7592755|FG022|STARTED|Overall Study||1
6661965|NCT02509065|7592733|FG000|COMPLETED|Overall Study||1
6661966|NCT02509065|7592734|FG001|COMPLETED|Overall Study||1
6661967|NCT02509065|7592735|FG002|COMPLETED|Overall Study||2
6661968|NCT02509065|7592736|FG003|COMPLETED|Overall Study||1
6661969|NCT02509065|7592737|FG004|COMPLETED|Overall Study||1
6661970|NCT02509065|7592738|FG005|COMPLETED|Overall Study||1
6661971|NCT02509065|7592739|FG006|COMPLETED|Overall Study||1
6661972|NCT02509065|7592740|FG007|COMPLETED|Overall Study||1
6661973|NCT02509065|7592741|FG008|COMPLETED|Overall Study||1
6661974|NCT02509065|7592742|FG009|COMPLETED|Overall Study||1
6661975|NCT02509065|7592743|FG010|COMPLETED|Overall Study||1
6661976|NCT02509065|7592744|FG011|COMPLETED|Overall Study||1
6661977|NCT02509065|7592745|FG012|COMPLETED|Overall Study||1
6661978|NCT02509065|7592746|FG013|COMPLETED|Overall Study||1
6661979|NCT02509065|7592747|FG014|COMPLETED|Overall Study||1
6661980|NCT02509065|7592748|FG015|COMPLETED|Overall Study||1
6661981|NCT02509065|7592749|FG016|COMPLETED|Overall Study||1
6661982|NCT02509065|7592750|FG017|COMPLETED|Overall Study||1
6661983|NCT02509065|7592751|FG018|COMPLETED|Overall Study||1
6661984|NCT02509065|7592752|FG019|COMPLETED|Overall Study||1
6661985|NCT02509065|7592753|FG020|COMPLETED|Overall Study||1
6661986|NCT02509065|7592754|FG021|COMPLETED|Overall Study||1
6661987|NCT02509065|7592755|FG022|COMPLETED|Overall Study||1
6661988|NCT02509065|7592733|FG000|NOT COMPLETED|Overall Study||0
6661989|NCT02509065|7592734|FG001|NOT COMPLETED|Overall Study||0
6661990|NCT02509065|7592735|FG002|NOT COMPLETED|Overall Study||0
6661991|NCT02509065|7592736|FG003|NOT COMPLETED|Overall Study||0
6661992|NCT02509065|7592737|FG004|NOT COMPLETED|Overall Study||0
6661993|NCT02509065|7592738|FG005|NOT COMPLETED|Overall Study||0
6661994|NCT02509065|7592739|FG006|NOT COMPLETED|Overall Study||0
6661995|NCT02509065|7592740|FG007|NOT COMPLETED|Overall Study||0
6661996|NCT02509065|7592741|FG008|NOT COMPLETED|Overall Study||0
6661997|NCT02509065|7592742|FG009|NOT COMPLETED|Overall Study||0
6661998|NCT02509065|7592743|FG010|NOT COMPLETED|Overall Study||0
6661999|NCT02509065|7592744|FG011|NOT COMPLETED|Overall Study||0
6662000|NCT02509065|7592745|FG012|NOT COMPLETED|Overall Study||0
6662001|NCT02509065|7592746|FG013|NOT COMPLETED|Overall Study||0
6662002|NCT02509065|7592747|FG014|NOT COMPLETED|Overall Study||0
6662003|NCT02509065|7592748|FG015|NOT COMPLETED|Overall Study||0
6662004|NCT02509065|7592749|FG016|NOT COMPLETED|Overall Study||0
6662005|NCT02509065|7592750|FG017|NOT COMPLETED|Overall Study||0
6662006|NCT02509065|7592751|FG018|NOT COMPLETED|Overall Study||0
6662007|NCT02509065|7592752|FG019|NOT COMPLETED|Overall Study||0
6662008|NCT02509065|7592753|FG020|NOT COMPLETED|Overall Study||0
6662009|NCT02509065|7592754|FG021|NOT COMPLETED|Overall Study||0
6599403|NCT02036853|7524467|FG001|NOT COMPLETED|Overall Study||6
6662010|NCT02509065|7592755|FG022|NOT COMPLETED|Overall Study||0
6662011|NCT02509078|7592773|FG000|STARTED|Overall Study||502
6662012|NCT02509078|7592774|FG001|STARTED|Overall Study||506
6599404|NCT02037061|7524475|FG000|STARTED|Overall Study||22
6599405|NCT02037061|7524476|FG001|STARTED|Overall Study||24
6599406|NCT02037061|7524475|FG000|COMPLETED|Overall Study||22
6599407|NCT02037061|7524476|FG001|COMPLETED|Overall Study||24
6599408|NCT02037061|7524475|FG000|NOT COMPLETED|Overall Study||0
6599409|NCT02037061|7524476|FG001|NOT COMPLETED|Overall Study||0
6599410|NCT02037165|7524489|FG000|STARTED|Period 1 (2 Days)|randomized subjects|5
6599411|NCT02037165|7524490|FG001|STARTED|Period 1 (2 Days)|randomized subjects|5
6599412|NCT02037165|7524491|FG002|STARTED|Period 1 (2 Days)|randomized subjects|5
6599413|NCT02037165|7524492|FG003|STARTED|Period 1 (2 Days)|randomized subjects|5
6599414|NCT02037165|7524493|FG004|STARTED|Period 1 (2 Days)|randomized subjects|5
6599415|NCT02037165|7524489|FG000|COMPLETED|Period 1 (2 Days)||5
6599416|NCT02037165|7524490|FG001|COMPLETED|Period 1 (2 Days)||5
6599417|NCT02037165|7524491|FG002|COMPLETED|Period 1 (2 Days)||5
6599418|NCT02037165|7524492|FG003|COMPLETED|Period 1 (2 Days)||5
6599419|NCT02037165|7524493|FG004|COMPLETED|Period 1 (2 Days)||5
6599420|NCT02037165|7524489|FG000|NOT COMPLETED|Period 1 (2 Days)||0
6599421|NCT02037165|7524490|FG001|NOT COMPLETED|Period 1 (2 Days)||0
6599422|NCT02037165|7524491|FG002|NOT COMPLETED|Period 1 (2 Days)||0
6599423|NCT02037165|7524492|FG003|NOT COMPLETED|Period 1 (2 Days)||0
6599424|NCT02037165|7524493|FG004|NOT COMPLETED|Period 1 (2 Days)||0
6599425|NCT02037165|7524489|FG000|STARTED|Washout Period 1 (6 Days)||5
6599426|NCT02037165|7524490|FG001|STARTED|Washout Period 1 (6 Days)||5
6599427|NCT02037165|7524491|FG002|STARTED|Washout Period 1 (6 Days)||5
6599428|NCT02037165|7524492|FG003|STARTED|Washout Period 1 (6 Days)||5
6599429|NCT02037165|7524493|FG004|STARTED|Washout Period 1 (6 Days)||5
6599430|NCT02037165|7524489|FG000|COMPLETED|Washout Period 1 (6 Days)||5
6599431|NCT02037165|7524490|FG001|COMPLETED|Washout Period 1 (6 Days)||5
6599432|NCT02037165|7524491|FG002|COMPLETED|Washout Period 1 (6 Days)||5
6599433|NCT02037165|7524492|FG003|COMPLETED|Washout Period 1 (6 Days)||5
6599434|NCT02037165|7524493|FG004|COMPLETED|Washout Period 1 (6 Days)||5
6599435|NCT02037165|7524489|FG000|NOT COMPLETED|Washout Period 1 (6 Days)||0
6599436|NCT02037165|7524490|FG001|NOT COMPLETED|Washout Period 1 (6 Days)||0
6599437|NCT02037165|7524491|FG002|NOT COMPLETED|Washout Period 1 (6 Days)||0
6599438|NCT02037165|7524492|FG003|NOT COMPLETED|Washout Period 1 (6 Days)||0
6599439|NCT02037165|7524493|FG004|NOT COMPLETED|Washout Period 1 (6 Days)||0
6599440|NCT02037165|7524489|FG000|STARTED|Period 2 (2 Days)||5
6599441|NCT02037165|7524490|FG001|STARTED|Period 2 (2 Days)||5
6599442|NCT02037165|7524491|FG002|STARTED|Period 2 (2 Days)||5
6599443|NCT02037165|7524492|FG003|STARTED|Period 2 (2 Days)||5
6599444|NCT02037165|7524493|FG004|STARTED|Period 2 (2 Days)||5
6599445|NCT02037165|7524489|FG000|COMPLETED|Period 2 (2 Days)||5
6599446|NCT02037165|7524490|FG001|COMPLETED|Period 2 (2 Days)||5
6662013|NCT02509078|7592773|FG000|COMPLETED|Overall Study||501
6662014|NCT02509078|7592774|FG001|COMPLETED|Overall Study||505
6662015|NCT02509078|7592773|FG000|NOT COMPLETED|Overall Study||1
6662016|NCT02509078|7592774|FG001|NOT COMPLETED|Overall Study||1
6662017|NCT02509117|7592792|FG000|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662018|NCT02509117|7592793|FG001|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662019|NCT02509117|7592794|FG002|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662020|NCT02509117|7592795|FG003|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662021|NCT02509117|7592796|FG004|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662022|NCT02509117|7592797|FG005|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662023|NCT02509117|7592798|FG006|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662024|NCT02509117|7592799|FG007|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662025|NCT02509117|7592800|FG008|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||4
6662026|NCT02509117|7592801|FG009|STARTED|Period 1-Part A:4 Days; Part B,C:19 Days||10
6662027|NCT02509117|7592792|FG000|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662028|NCT02509117|7592793|FG001|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||1
6662029|NCT02509117|7592794|FG002|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662030|NCT02509117|7592795|FG003|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662031|NCT02509117|7592796|FG004|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662032|NCT02509117|7592797|FG005|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662033|NCT02509117|7592798|FG006|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
6599447|NCT02037165|7524491|FG002|COMPLETED|Period 2 (2 Days)||5
6599448|NCT02037165|7524492|FG003|COMPLETED|Period 2 (2 Days)||5
6599449|NCT02037165|7524493|FG004|COMPLETED|Period 2 (2 Days)||5
6599450|NCT02037165|7524489|FG000|NOT COMPLETED|Period 2 (2 Days)||0
6599451|NCT02037165|7524490|FG001|NOT COMPLETED|Period 2 (2 Days)||0
6599452|NCT02037165|7524491|FG002|NOT COMPLETED|Period 2 (2 Days)||0
6599453|NCT02037165|7524492|FG003|NOT COMPLETED|Period 2 (2 Days)||0
6599454|NCT02037165|7524493|FG004|NOT COMPLETED|Period 2 (2 Days)||0
6599455|NCT02037165|7524489|FG000|STARTED|Washout Period 2 (6 Days)||5
6599456|NCT02037165|7524490|FG001|STARTED|Washout Period 2 (6 Days)||5
6599457|NCT02037165|7524491|FG002|STARTED|Washout Period 2 (6 Days)||5
6599458|NCT02037165|7524492|FG003|STARTED|Washout Period 2 (6 Days)||5
6599459|NCT02037165|7524493|FG004|STARTED|Washout Period 2 (6 Days)||5
6599460|NCT02037165|7524489|FG000|COMPLETED|Washout Period 2 (6 Days)||5
6599461|NCT02037165|7524490|FG001|COMPLETED|Washout Period 2 (6 Days)||5
6599462|NCT02037165|7524491|FG002|COMPLETED|Washout Period 2 (6 Days)||5
6599463|NCT02037165|7524492|FG003|COMPLETED|Washout Period 2 (6 Days)||5
6599464|NCT02037165|7524493|FG004|COMPLETED|Washout Period 2 (6 Days)||5
6599465|NCT02037165|7524489|FG000|NOT COMPLETED|Washout Period 2 (6 Days)||0
6599466|NCT02037165|7524490|FG001|NOT COMPLETED|Washout Period 2 (6 Days)||0
6599467|NCT02037165|7524491|FG002|NOT COMPLETED|Washout Period 2 (6 Days)||0
6599468|NCT02037165|7524492|FG003|NOT COMPLETED|Washout Period 2 (6 Days)||0
6599469|NCT02037165|7524493|FG004|NOT COMPLETED|Washout Period 2 (6 Days)||0
6599470|NCT02037165|7524489|FG000|STARTED|Period 3 (2 Days)||5
6599471|NCT02037165|7524490|FG001|STARTED|Period 3 (2 Days)||5
6599472|NCT02037165|7524491|FG002|STARTED|Period 3 (2 Days)||5
6599473|NCT02037165|7524492|FG003|STARTED|Period 3 (2 Days)||5
6599474|NCT02037165|7524493|FG004|STARTED|Period 3 (2 Days)||5
6599475|NCT02037165|7524489|FG000|COMPLETED|Period 3 (2 Days)||5
6599476|NCT02037165|7524490|FG001|COMPLETED|Period 3 (2 Days)||5
6599477|NCT02037165|7524491|FG002|COMPLETED|Period 3 (2 Days)||5
6599478|NCT02037165|7524492|FG003|COMPLETED|Period 3 (2 Days)||5
6599479|NCT02037165|7524493|FG004|COMPLETED|Period 3 (2 Days)||5
6599480|NCT02037165|7524489|FG000|NOT COMPLETED|Period 3 (2 Days)||0
6599481|NCT02037165|7524490|FG001|NOT COMPLETED|Period 3 (2 Days)||0
6599482|NCT02037165|7524491|FG002|NOT COMPLETED|Period 3 (2 Days)||0
6599483|NCT02037165|7524492|FG003|NOT COMPLETED|Period 3 (2 Days)||0
6599484|NCT02037165|7524493|FG004|NOT COMPLETED|Period 3 (2 Days)||0
6599485|NCT02037165|7524489|FG000|STARTED|Washout Period 3 (6 Days)||5
6599486|NCT02037165|7524490|FG001|STARTED|Washout Period 3 (6 Days)||5
6599487|NCT02037165|7524491|FG002|STARTED|Washout Period 3 (6 Days)||5
6599488|NCT02037165|7524492|FG003|STARTED|Washout Period 3 (6 Days)||5
6599489|NCT02037165|7524493|FG004|STARTED|Washout Period 3 (6 Days)||5
6599490|NCT02037165|7524489|FG000|COMPLETED|Washout Period 3 (6 Days)||5
6599491|NCT02037165|7524490|FG001|COMPLETED|Washout Period 3 (6 Days)||5
6599492|NCT02037165|7524491|FG002|COMPLETED|Washout Period 3 (6 Days)||5
6599493|NCT02037165|7524492|FG003|COMPLETED|Washout Period 3 (6 Days)||5
6599494|NCT02037165|7524493|FG004|COMPLETED|Washout Period 3 (6 Days)||5
6599495|NCT02037165|7524489|FG000|NOT COMPLETED|Washout Period 3 (6 Days)||0
6599496|NCT02037165|7524490|FG001|NOT COMPLETED|Washout Period 3 (6 Days)||0
6599497|NCT02037165|7524491|FG002|NOT COMPLETED|Washout Period 3 (6 Days)||0
6599498|NCT02037165|7524492|FG003|NOT COMPLETED|Washout Period 3 (6 Days)||0
6599499|NCT02037165|7524493|FG004|NOT COMPLETED|Washout Period 3 (6 Days)||0
6599500|NCT02037165|7524489|FG000|STARTED|Period 4 (2 Days)||5
6599501|NCT02037165|7524490|FG001|STARTED|Period 4 (2 Days)||5
6599502|NCT02037165|7524491|FG002|STARTED|Period 4 (2 Days)||5
6599503|NCT02037165|7524492|FG003|STARTED|Period 4 (2 Days)||5
6599504|NCT02037165|7524493|FG004|STARTED|Period 4 (2 Days)||5
6599505|NCT02037165|7524489|FG000|COMPLETED|Period 4 (2 Days)||5
6599506|NCT02037165|7524490|FG001|COMPLETED|Period 4 (2 Days)||5
6599507|NCT02037165|7524491|FG002|COMPLETED|Period 4 (2 Days)||5
6599508|NCT02037165|7524492|FG003|COMPLETED|Period 4 (2 Days)||5
6599509|NCT02037165|7524493|FG004|COMPLETED|Period 4 (2 Days)||5
6599510|NCT02037165|7524489|FG000|NOT COMPLETED|Period 4 (2 Days)||0
6599511|NCT02037165|7524490|FG001|NOT COMPLETED|Period 4 (2 Days)||0
6599512|NCT02037165|7524491|FG002|NOT COMPLETED|Period 4 (2 Days)||0
6599513|NCT02037165|7524492|FG003|NOT COMPLETED|Period 4 (2 Days)||0
6599514|NCT02037165|7524493|FG004|NOT COMPLETED|Period 4 (2 Days)||0
6599515|NCT02037165|7524489|FG000|STARTED|Washout Period 4 (6 Days)||5
6599516|NCT02037165|7524490|FG001|STARTED|Washout Period 4 (6 Days)||5
6599517|NCT02037165|7524491|FG002|STARTED|Washout Period 4 (6 Days)||5
6599518|NCT02037165|7524492|FG003|STARTED|Washout Period 4 (6 Days)||5
6599519|NCT02037165|7524493|FG004|STARTED|Washout Period 4 (6 Days)||5
6599520|NCT02037165|7524489|FG000|COMPLETED|Washout Period 4 (6 Days)||5
6599521|NCT02037165|7524490|FG001|COMPLETED|Washout Period 4 (6 Days)||5
6599522|NCT02037165|7524491|FG002|COMPLETED|Washout Period 4 (6 Days)||5
6599523|NCT02037165|7524492|FG003|COMPLETED|Washout Period 4 (6 Days)||5
6599524|NCT02037165|7524493|FG004|COMPLETED|Washout Period 4 (6 Days)||4
6599525|NCT02037165|7524489|FG000|NOT COMPLETED|Washout Period 4 (6 Days)||0
6599526|NCT02037165|7524490|FG001|NOT COMPLETED|Washout Period 4 (6 Days)||0
6599527|NCT02037165|7524491|FG002|NOT COMPLETED|Washout Period 4 (6 Days)||0
6599528|NCT02037165|7524492|FG003|NOT COMPLETED|Washout Period 4 (6 Days)||0
6599529|NCT02037165|7524493|FG004|NOT COMPLETED|Washout Period 4 (6 Days)||1
6599530|NCT02037165|7524489|FG000|STARTED|Period 5 (2 Days)||5
6599531|NCT02037165|7524490|FG001|STARTED|Period 5 (2 Days)||5
6599532|NCT02037165|7524491|FG002|STARTED|Period 5 (2 Days)||5
6599533|NCT02037165|7524492|FG003|STARTED|Period 5 (2 Days)||5
6599534|NCT02037165|7524493|FG004|STARTED|Period 5 (2 Days)||4
6599535|NCT02037165|7524489|FG000|COMPLETED|Period 5 (2 Days)||5
6599536|NCT02037165|7524490|FG001|COMPLETED|Period 5 (2 Days)||5
6599537|NCT02037165|7524491|FG002|COMPLETED|Period 5 (2 Days)||5
6599538|NCT02037165|7524492|FG003|COMPLETED|Period 5 (2 Days)||5
6599539|NCT02037165|7524493|FG004|COMPLETED|Period 5 (2 Days)||4
6599540|NCT02037165|7524489|FG000|NOT COMPLETED|Period 5 (2 Days)||0
6599541|NCT02037165|7524490|FG001|NOT COMPLETED|Period 5 (2 Days)||0
6599542|NCT02037165|7524491|FG002|NOT COMPLETED|Period 5 (2 Days)||0
6599543|NCT02037165|7524492|FG003|NOT COMPLETED|Period 5 (2 Days)||0
6599544|NCT02037165|7524493|FG004|NOT COMPLETED|Period 5 (2 Days)||0
6599545|NCT02037204|7524509|FG000|STARTED|Overall Study||35
6599546|NCT02037204|7524509|FG000|COMPLETED|Overall Study||35
6599547|NCT02037204|7524509|FG000|NOT COMPLETED|Overall Study||0
6599548|NCT02037230|7524518|FG000|STARTED|Overall Study||1
6599549|NCT02037230|7524519|FG001|STARTED|Overall Study||13
6599550|NCT02037230|7524520|FG002|STARTED|Overall Study||9
6599551|NCT02037230|7524521|FG003|STARTED|Overall Study||11
6599552|NCT02037230|7524518|FG000|Completed 4 Cycles of Treatment|Overall Study||1
6599553|NCT02037230|7524519|FG001|Completed 4 Cycles of Treatment|Overall Study||9
6599554|NCT02037230|7524520|FG002|Completed 4 Cycles of Treatment|Overall Study||7
6599555|NCT02037230|7524521|FG003|Completed 4 Cycles of Treatment|Overall Study||9
6599556|NCT02037230|7524518|FG000|COMPLETED|Overall Study||0
6599557|NCT02037230|7524519|FG001|COMPLETED|Overall Study||7
6599558|NCT02037230|7524520|FG002|COMPLETED|Overall Study||3
6599559|NCT02037230|7524521|FG003|COMPLETED|Overall Study||5
6599560|NCT02037230|7524518|FG000|NOT COMPLETED|Overall Study||1
6599561|NCT02037230|7524519|FG001|NOT COMPLETED|Overall Study||6
6599562|NCT02037230|7524520|FG002|NOT COMPLETED|Overall Study||6
6599563|NCT02037230|7524521|FG003|NOT COMPLETED|Overall Study||6
6599564|NCT02037256|7524534|FG000|STARTED|Overall Study||3
6599565|NCT02037256|7524535|FG001|STARTED|Overall Study||20
6599566|NCT02037256|7524534|FG000|COMPLETED|Overall Study||3
6599567|NCT02037256|7524535|FG001|COMPLETED|Overall Study||17
6599568|NCT02037256|7524534|FG000|NOT COMPLETED|Overall Study||0
6599569|NCT02037256|7524535|FG001|NOT COMPLETED|Overall Study||3
6599570|NCT02037295|7524547|FG000|STARTED|Phase 1: Crossover UF and OF||9
6599571|NCT02037295|7524548|FG001|STARTED|Phase 1: Crossover UF and OF||7
6599572|NCT02037295|7524549|FG002|STARTED|Phase 1: Crossover UF and OF||4
6599573|NCT02037295|7524550|FG003|STARTED|Phase 1: Crossover UF and OF||7
6662034|NCT02509117|7592799|FG007|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662035|NCT02509117|7592800|FG008|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||4
6662036|NCT02509117|7592801|FG009|Treated|Period 1-Part A:4 Days; Part B,C:19 Days||10
6662037|NCT02509117|7592792|FG000|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662038|NCT02509117|7592793|FG001|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
6662039|NCT02509117|7592794|FG002|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662040|NCT02509117|7592795|FG003|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662041|NCT02509117|7592796|FG004|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662042|NCT02509117|7592797|FG005|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662043|NCT02509117|7592798|FG006|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662044|NCT02509117|7592799|FG007|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662045|NCT02509117|7592800|FG008|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||4
6662046|NCT02509117|7592801|FG009|COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||8
6662047|NCT02509117|7592792|FG000|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6662048|NCT02509117|7592793|FG001|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||1
6662049|NCT02509117|7592794|FG002|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6662050|NCT02509117|7592795|FG003|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6662051|NCT02509117|7592796|FG004|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6662052|NCT02509117|7592797|FG005|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6662053|NCT02509117|7592798|FG006|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6662054|NCT02509117|7592799|FG007|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6662055|NCT02509117|7592800|FG008|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||0
6662056|NCT02509117|7592801|FG009|NOT COMPLETED|Period 1-Part A:4 Days; Part B,C:19 Days||2
6662057|NCT02509117|7592792|FG000|STARTED|Washout Period 1 (Part A: 7 Days)||2
6662058|NCT02509117|7592793|FG001|STARTED|Washout Period 1 (Part A: 7 Days)||1
6662059|NCT02509117|7592794|FG002|STARTED|Washout Period 1 (Part A: 7 Days)||2
6662060|NCT02509117|7592795|FG003|STARTED|Washout Period 1 (Part A: 7 Days)||2
6662061|NCT02509117|7592796|FG004|STARTED|Washout Period 1 (Part A: 7 Days)||0
6662062|NCT02509117|7592797|FG005|STARTED|Washout Period 1 (Part A: 7 Days)||0
6662063|NCT02509117|7592798|FG006|STARTED|Washout Period 1 (Part A: 7 Days)||0
6662064|NCT02509117|7592799|FG007|STARTED|Washout Period 1 (Part A: 7 Days)||0
6662065|NCT02509117|7592800|FG008|STARTED|Washout Period 1 (Part A: 7 Days)||0
6662066|NCT02509117|7592801|FG009|STARTED|Washout Period 1 (Part A: 7 Days)||0
6662067|NCT02509117|7592792|FG000|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
6662068|NCT02509117|7592793|FG001|COMPLETED|Washout Period 1 (Part A: 7 Days)||1
6662069|NCT02509117|7592794|FG002|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
6662070|NCT02509117|7592795|FG003|COMPLETED|Washout Period 1 (Part A: 7 Days)||2
6662071|NCT02509117|7592796|FG004|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662072|NCT02509117|7592797|FG005|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662073|NCT02509117|7592798|FG006|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662074|NCT02509117|7592799|FG007|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662075|NCT02509117|7592800|FG008|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662076|NCT02509117|7592801|FG009|COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662077|NCT02509117|7592792|FG000|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662078|NCT02509117|7592793|FG001|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662079|NCT02509117|7592794|FG002|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662080|NCT02509117|7592795|FG003|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662081|NCT02509117|7592796|FG004|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662082|NCT02509117|7592797|FG005|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662083|NCT02509117|7592798|FG006|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6599574|NCT02037295|7524547|FG000|COMPLETED|Phase 1: Crossover UF and OF||9
6599575|NCT02037295|7524548|FG001|COMPLETED|Phase 1: Crossover UF and OF||7
6599576|NCT02037295|7524549|FG002|COMPLETED|Phase 1: Crossover UF and OF||4
6599577|NCT02037295|7524550|FG003|COMPLETED|Phase 1: Crossover UF and OF||7
6662084|NCT02509117|7592799|FG007|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662085|NCT02509117|7592800|FG008|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6599578|NCT02037295|7524547|FG000|NOT COMPLETED|Phase 1: Crossover UF and OF||0
6599579|NCT02037295|7524548|FG001|NOT COMPLETED|Phase 1: Crossover UF and OF||0
6599580|NCT02037295|7524549|FG002|NOT COMPLETED|Phase 1: Crossover UF and OF||0
6599581|NCT02037295|7524550|FG003|NOT COMPLETED|Phase 1: Crossover UF and OF||0
6599582|NCT02037295|7524547|FG000|STARTED|Phase 2: Vancomycin and Placebo||9
6599583|NCT02037295|7524548|FG001|STARTED|Phase 2: Vancomycin and Placebo||7
6599584|NCT02037295|7524549|FG002|STARTED|Phase 2: Vancomycin and Placebo||4
6599585|NCT02037295|7524550|FG003|STARTED|Phase 2: Vancomycin and Placebo||7
6599586|NCT02037295|7524547|FG000|COMPLETED|Phase 2: Vancomycin and Placebo||8
6599587|NCT02037295|7524548|FG001|COMPLETED|Phase 2: Vancomycin and Placebo||7
6599588|NCT02037295|7524549|FG002|COMPLETED|Phase 2: Vancomycin and Placebo||4
6599589|NCT02037295|7524550|FG003|COMPLETED|Phase 2: Vancomycin and Placebo||6
6599590|NCT02037295|7524547|FG000|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
6599591|NCT02037295|7524548|FG001|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
6599592|NCT02037295|7524549|FG002|NOT COMPLETED|Phase 2: Vancomycin and Placebo||0
6599593|NCT02037295|7524550|FG003|NOT COMPLETED|Phase 2: Vancomycin and Placebo||1
6599594|NCT02037347|7524562|FG000|STARTED|Overall Study||1
6599595|NCT02037347|7524562|FG000|COMPLETED|Overall Study||1
6599596|NCT02037347|7524562|FG000|NOT COMPLETED|Overall Study||0
6599597|NCT02037425|7524566|FG000|STARTED|Overall Study||44
6599598|NCT02037425|7524566|FG000|Randomized to Treatment|Overall Study||32
6599599|NCT02037425|7524566|FG000|COMPLETED|Overall Study||18
6599600|NCT02037425|7524566|FG000|NOT COMPLETED|Overall Study||26
6599601|NCT02037438|7524574|FG000|STARTED|Overall Study||920
6599602|NCT02037438|7524575|FG001|STARTED|Overall Study||916
6599603|NCT02037438|7524574|FG000|COMPLETED|Overall Study||574
6599604|NCT02037438|7524575|FG001|COMPLETED|Overall Study||561
6599605|NCT02037438|7524574|FG000|NOT COMPLETED|Overall Study||346
6599606|NCT02037438|7524575|FG001|NOT COMPLETED|Overall Study||355
6599607|NCT02037477|7524585|FG000|STARTED|Treatment Period 1||5
6599608|NCT02037477|7524586|FG001|STARTED|Treatment Period 1||5
6599609|NCT02037477|7524587|FG002|STARTED|Treatment Period 1||5
6599610|NCT02037477|7524588|FG003|STARTED|Treatment Period 1||5
6599611|NCT02037477|7524585|FG000|COMPLETED|Treatment Period 1||5
6599612|NCT02037477|7524586|FG001|COMPLETED|Treatment Period 1||5
6599613|NCT02037477|7524587|FG002|COMPLETED|Treatment Period 1||4
6599614|NCT02037477|7524588|FG003|COMPLETED|Treatment Period 1||5
6599615|NCT02037477|7524585|FG000|NOT COMPLETED|Treatment Period 1||0
6599616|NCT02037477|7524586|FG001|NOT COMPLETED|Treatment Period 1||0
6599617|NCT02037477|7524587|FG002|NOT COMPLETED|Treatment Period 1||1
6599618|NCT02037477|7524588|FG003|NOT COMPLETED|Treatment Period 1||0
6599619|NCT02037477|7524585|FG000|STARTED|Treatment Period 2||5
6599620|NCT02037477|7524586|FG001|STARTED|Treatment Period 2||5
6599621|NCT02037477|7524587|FG002|STARTED|Treatment Period 2||4
6599622|NCT02037477|7524588|FG003|STARTED|Treatment Period 2||5
6599623|NCT02037477|7524585|FG000|COMPLETED|Treatment Period 2||5
6599624|NCT02037477|7524586|FG001|COMPLETED|Treatment Period 2||5
6599625|NCT02037477|7524587|FG002|COMPLETED|Treatment Period 2||4
6599626|NCT02037477|7524588|FG003|COMPLETED|Treatment Period 2||5
6599627|NCT02037477|7524585|FG000|NOT COMPLETED|Treatment Period 2||0
6599628|NCT02037477|7524586|FG001|NOT COMPLETED|Treatment Period 2||0
6599629|NCT02037477|7524587|FG002|NOT COMPLETED|Treatment Period 2||0
6599630|NCT02037477|7524588|FG003|NOT COMPLETED|Treatment Period 2||0
6599631|NCT02037555|7524600|FG000|STARTED|Overall Study||213
6599632|NCT02037555|7524601|FG001|STARTED|Overall Study||212
6599633|NCT02037555|7524600|FG000|Dosed|Overall Study||201
6599634|NCT02037555|7524601|FG001|Dosed|Overall Study||198
6599635|NCT02037555|7524600|FG000|Dosed and Operated On|Overall Study||200
6599636|NCT02037555|7524601|FG001|Dosed and Operated On|Overall Study||196
6599637|NCT02037555|7524600|FG000|COMPLETED|Overall Study||190
6599638|NCT02037555|7524601|FG001|COMPLETED|Overall Study||191
6599639|NCT02037555|7524600|FG000|NOT COMPLETED|Overall Study||23
6599640|NCT02037555|7524601|FG001|NOT COMPLETED|Overall Study||21
6599641|NCT02037568|7524609|FG000|STARTED|Overall Study||83
6599642|NCT02037568|7524610|FG001|STARTED|Overall Study||76
6599643|NCT02037568|7524609|FG000|Month 1.5 (Post Transplantation)|Overall Study||79
6599644|NCT02037568|7524610|FG001|Month 1.5 (Post Transplantation)|Overall Study||76
6599645|NCT02037568|7524609|FG000|Month 3 (Post Transplantation)|Overall Study||66
6599646|NCT02037568|7524610|FG001|Month 3 (Post Transplantation)|Overall Study||62
6599647|NCT02037568|7524609|FG000|Month 6 (Post Transplantation)|Overall Study||63
6599648|NCT02037568|7524610|FG001|Month 6 (Post Transplantation)|Overall Study||52
6599649|NCT02037568|7524609|FG000|COMPLETED|Overall Study||47
6599650|NCT02037568|7524610|FG001|COMPLETED|Overall Study||37
6599651|NCT02037568|7524609|FG000|NOT COMPLETED|Overall Study||36
6599652|NCT02037568|7524610|FG001|NOT COMPLETED|Overall Study||39
6599653|NCT02037607|7524616|FG000|STARTED|Overall Study||100
6599654|NCT02037607|7524616|FG000|COMPLETED|Overall Study||91
6599655|NCT02037607|7524616|FG000|NOT COMPLETED|Overall Study||9
6599656|NCT02037776|7524622|FG000|STARTED|Overall Study||61
6599657|NCT02037776|7524623|FG001|STARTED|Overall Study||64
6599658|NCT02037776|7524622|FG000|COMPLETED|Overall Study||56
6599659|NCT02037776|7524623|FG001|COMPLETED|Overall Study||60
6599660|NCT02037776|7524622|FG000|NOT COMPLETED|Overall Study||5
6599661|NCT02037776|7524623|FG001|NOT COMPLETED|Overall Study||4
6599662|NCT02037893|7524633|FG000|STARTED|Overall Study||32
6599663|NCT02037893|7524634|FG001|STARTED|Overall Study||25
6599664|NCT02037893|7524635|FG002|STARTED|Overall Study||27
6599665|NCT02037893|7524636|FG003|STARTED|Overall Study||28
6599666|NCT02037893|7524633|FG000|COMPLETED|Overall Study||32
6599667|NCT02037893|7524634|FG001|COMPLETED|Overall Study||25
6599668|NCT02037893|7524635|FG002|COMPLETED|Overall Study||26
6599669|NCT02037893|7524636|FG003|COMPLETED|Overall Study||28
6599670|NCT02037893|7524633|FG000|NOT COMPLETED|Overall Study||0
6599671|NCT02037893|7524634|FG001|NOT COMPLETED|Overall Study||0
6599672|NCT02037893|7524635|FG002|NOT COMPLETED|Overall Study||1
6599673|NCT02037893|7524636|FG003|NOT COMPLETED|Overall Study||0
6599674|NCT02037984|7524654|FG000|STARTED|Overall Study||20
6599675|NCT02037984|7524655|FG001|STARTED|Overall Study||20
6599676|NCT02037984|7524656|FG002|STARTED|Overall Study||50
6599677|NCT02037984|7524657|FG003|STARTED|Overall Study||51
6599678|NCT02037984|7524658|FG004|STARTED|Overall Study||50
6599679|NCT02037984|7524659|FG005|STARTED|Overall Study||49
6599680|NCT02037984|7524660|FG006|STARTED|Overall Study||50
6599681|NCT02037984|7524661|FG007|STARTED|Overall Study||51
6599682|NCT02037984|7524654|FG000|COMPLETED|Overall Study||19
6599683|NCT02037984|7524655|FG001|COMPLETED|Overall Study||20
6599684|NCT02037984|7524656|FG002|COMPLETED|Overall Study||38
6599685|NCT02037984|7524657|FG003|COMPLETED|Overall Study||30
6599686|NCT02037984|7524658|FG004|COMPLETED|Overall Study||38
6662086|NCT02509117|7592801|FG009|NOT COMPLETED|Washout Period 1 (Part A: 7 Days)||0
6662087|NCT02509117|7592792|FG000|STARTED|Period 2 -Part A: 4 Days||2
6662088|NCT02509117|7592793|FG001|STARTED|Period 2 -Part A: 4 Days|1 participant was added in intervention period 2|2
6662089|NCT02509117|7592794|FG002|STARTED|Period 2 -Part A: 4 Days||2
6662090|NCT02509117|7592795|FG003|STARTED|Period 2 -Part A: 4 Days||2
6662091|NCT02509117|7592796|FG004|STARTED|Period 2 -Part A: 4 Days||0
6662092|NCT02509117|7592797|FG005|STARTED|Period 2 -Part A: 4 Days||0
6662093|NCT02509117|7592798|FG006|STARTED|Period 2 -Part A: 4 Days||0
6662094|NCT02509117|7592799|FG007|STARTED|Period 2 -Part A: 4 Days||0
6662095|NCT02509117|7592800|FG008|STARTED|Period 2 -Part A: 4 Days||0
6662096|NCT02509117|7592801|FG009|STARTED|Period 2 -Part A: 4 Days||0
6662097|NCT02509117|7592792|FG000|Treated|Period 2 -Part A: 4 Days||2
6662098|NCT02509117|7592793|FG001|Treated|Period 2 -Part A: 4 Days||2
6662099|NCT02509117|7592794|FG002|Treated|Period 2 -Part A: 4 Days||2
6662100|NCT02509117|7592795|FG003|Treated|Period 2 -Part A: 4 Days||2
6662101|NCT02509117|7592796|FG004|Treated|Period 2 -Part A: 4 Days||0
6662102|NCT02509117|7592797|FG005|Treated|Period 2 -Part A: 4 Days||0
6662103|NCT02509117|7592798|FG006|Treated|Period 2 -Part A: 4 Days||0
6662104|NCT02509117|7592799|FG007|Treated|Period 2 -Part A: 4 Days||0
6662105|NCT02509117|7592800|FG008|Treated|Period 2 -Part A: 4 Days||0
6662106|NCT02509117|7592801|FG009|Treated|Period 2 -Part A: 4 Days||0
6662107|NCT02509117|7592792|FG000|COMPLETED|Period 2 -Part A: 4 Days||2
6662108|NCT02509117|7592793|FG001|COMPLETED|Period 2 -Part A: 4 Days||2
6662109|NCT02509117|7592794|FG002|COMPLETED|Period 2 -Part A: 4 Days||2
6662110|NCT02509117|7592795|FG003|COMPLETED|Period 2 -Part A: 4 Days||2
6662111|NCT02509117|7592796|FG004|COMPLETED|Period 2 -Part A: 4 Days||0
6662112|NCT02509117|7592797|FG005|COMPLETED|Period 2 -Part A: 4 Days||0
6662113|NCT02509117|7592798|FG006|COMPLETED|Period 2 -Part A: 4 Days||0
6662114|NCT02509117|7592799|FG007|COMPLETED|Period 2 -Part A: 4 Days||0
6662115|NCT02509117|7592800|FG008|COMPLETED|Period 2 -Part A: 4 Days||0
6662116|NCT02509117|7592801|FG009|COMPLETED|Period 2 -Part A: 4 Days||0
6662117|NCT02509117|7592792|FG000|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662118|NCT02509117|7592793|FG001|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662119|NCT02509117|7592794|FG002|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662120|NCT02509117|7592795|FG003|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662121|NCT02509117|7592796|FG004|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662122|NCT02509117|7592797|FG005|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662123|NCT02509117|7592798|FG006|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662124|NCT02509117|7592799|FG007|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662125|NCT02509117|7592800|FG008|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662126|NCT02509117|7592801|FG009|NOT COMPLETED|Period 2 -Part A: 4 Days||0
6662127|NCT02509117|7592792|FG000|STARTED|Washout Period 2 (Part A: 7 Days)||2
6662128|NCT02509117|7592793|FG001|STARTED|Washout Period 2 (Part A: 7 Days)||2
6662129|NCT02509117|7592794|FG002|STARTED|Washout Period 2 (Part A: 7 Days)||2
6662130|NCT02509117|7592795|FG003|STARTED|Washout Period 2 (Part A: 7 Days)||2
6662131|NCT02509117|7592796|FG004|STARTED|Washout Period 2 (Part A: 7 Days)||0
6599687|NCT02037984|7524659|FG005|COMPLETED|Overall Study||37
6599688|NCT02037984|7524660|FG006|COMPLETED|Overall Study||33
6599689|NCT02037984|7524661|FG007|COMPLETED|Overall Study||39
6599690|NCT02037984|7524654|FG000|NOT COMPLETED|Overall Study||1
6599691|NCT02037984|7524655|FG001|NOT COMPLETED|Overall Study||0
6599692|NCT02037984|7524656|FG002|NOT COMPLETED|Overall Study||12
6599693|NCT02037984|7524657|FG003|NOT COMPLETED|Overall Study||21
6599694|NCT02037984|7524658|FG004|NOT COMPLETED|Overall Study||12
6599695|NCT02037984|7524659|FG005|NOT COMPLETED|Overall Study||12
6599696|NCT02037984|7524660|FG006|NOT COMPLETED|Overall Study||17
6599697|NCT02037984|7524661|FG007|NOT COMPLETED|Overall Study||12
6599698|NCT02038010|7524689|FG000|STARTED|Completed 1st Cycle and Started Cycle 2||11
6599699|NCT02038010|7524690|FG001|STARTED|Completed 1st Cycle and Started Cycle 2||6
6599700|NCT02038010|7524691|FG002|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
6599701|NCT02038010|7524692|FG003|STARTED|Completed 1st Cycle and Started Cycle 2|Due to safety data, dose was de-escalated and no patients enrolled at this dose.|0
6599702|NCT02038010|7524689|FG000|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||11
6599703|NCT02038010|7524690|FG001|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||5
6599704|NCT02038010|7524691|FG002|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
6599705|NCT02038010|7524692|FG003|Completed 1st Cycle|Completed 1st Cycle and Started Cycle 2||0
6599706|NCT02038010|7524689|FG000|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||10
6599707|NCT02038010|7524690|FG001|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||4
6599708|NCT02038010|7524691|FG002|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
6599709|NCT02038010|7524692|FG003|Continued on to Cycle 2|Completed 1st Cycle and Started Cycle 2||0
6599710|NCT02038010|7524689|FG000|COMPLETED|Completed 1st Cycle and Started Cycle 2||10
6599711|NCT02038010|7524690|FG001|COMPLETED|Completed 1st Cycle and Started Cycle 2||4
6599712|NCT02038010|7524691|FG002|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
6599713|NCT02038010|7524692|FG003|COMPLETED|Completed 1st Cycle and Started Cycle 2||0
6599714|NCT02038010|7524689|FG000|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||1
6599715|NCT02038010|7524690|FG001|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||2
6599716|NCT02038010|7524691|FG002|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
6599717|NCT02038010|7524692|FG003|NOT COMPLETED|Completed 1st Cycle and Started Cycle 2||0
6599718|NCT02038010|7524689|FG000|STARTED|Completed 3 Cycles/Reached 1st Response||10
6599719|NCT02038010|7524690|FG001|STARTED|Completed 3 Cycles/Reached 1st Response||4
6599720|NCT02038010|7524691|FG002|STARTED|Completed 3 Cycles/Reached 1st Response||0
6599721|NCT02038010|7524692|FG003|STARTED|Completed 3 Cycles/Reached 1st Response||0
6599722|NCT02038010|7524689|FG000|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||10
6599723|NCT02038010|7524690|FG001|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||4
6599724|NCT02038010|7524691|FG002|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
6599725|NCT02038010|7524692|FG003|Completed 3 Cycles|Completed 3 Cycles/Reached 1st Response||0
6599726|NCT02038010|7524689|FG000|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||9
6599727|NCT02038010|7524690|FG001|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||3
6599728|NCT02038010|7524691|FG002|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
6599729|NCT02038010|7524692|FG003|Continued to Cycle 4|Completed 3 Cycles/Reached 1st Response||0
6599730|NCT02038010|7524689|FG000|COMPLETED|Completed 3 Cycles/Reached 1st Response||9
6599731|NCT02038010|7524690|FG001|COMPLETED|Completed 3 Cycles/Reached 1st Response||3
6599732|NCT02038010|7524691|FG002|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
6599733|NCT02038010|7524692|FG003|COMPLETED|Completed 3 Cycles/Reached 1st Response||0
6599734|NCT02038010|7524689|FG000|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
6599735|NCT02038010|7524690|FG001|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||1
6599736|NCT02038010|7524691|FG002|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
6599737|NCT02038010|7524692|FG003|NOT COMPLETED|Completed 3 Cycles/Reached 1st Response||0
6599738|NCT02038010|7524689|FG000|STARTED|Follow Up||11
6599739|NCT02038010|7524690|FG001|STARTED|Follow Up||6
6599740|NCT02038010|7524691|FG002|STARTED|Follow Up||0
6599741|NCT02038010|7524692|FG003|STARTED|Follow Up||0
6599742|NCT02038010|7524689|FG000|COMPLETED|Follow Up||4
6599743|NCT02038010|7524690|FG001|COMPLETED|Follow Up||3
6599744|NCT02038010|7524691|FG002|COMPLETED|Follow Up||0
6599745|NCT02038010|7524692|FG003|COMPLETED|Follow Up||0
6599746|NCT02038010|7524689|FG000|NOT COMPLETED|Follow Up||7
6599747|NCT02038010|7524690|FG001|NOT COMPLETED|Follow Up||3
6599748|NCT02038010|7524691|FG002|NOT COMPLETED|Follow Up||0
6599749|NCT02038010|7524692|FG003|NOT COMPLETED|Follow Up||0
6599750|NCT02038023|7524700|FG000|STARTED|Overall Study||74
6599751|NCT02038023|7524700|FG000|COMPLETED|Overall Study||73
6599752|NCT02038023|7524700|FG000|NOT COMPLETED|Overall Study||1
6599753|NCT02038036|7524708|FG000|STARTED|Core Study||74
6599754|NCT02038036|7524709|FG001|STARTED|Core Study||75
6599755|NCT02038036|7524708|FG000|Full Analysis Set|Core Study||74
6599756|NCT02038036|7524709|FG001|Full Analysis Set|Core Study||75
6599757|NCT02038036|7524708|FG000|Crossover Set|Core Study||0
6599758|NCT02038036|7524709|FG001|Crossover Set|Core Study||58
6599759|NCT02038036|7524708|FG000|COMPLETED|Core Study||59
6599760|NCT02038036|7524709|FG001|COMPLETED|Core Study||61
6599761|NCT02038036|7524708|FG000|NOT COMPLETED|Core Study||15
6599762|NCT02038036|7524709|FG001|NOT COMPLETED|Core Study||14
6599763|NCT02038036|7524708|FG000|STARTED|Crossover Period||0
6599764|NCT02038036|7524709|FG001|STARTED|Crossover Period|58 participants were eligible to crossover to the ruxolitinib arm|58
6599765|NCT02038036|7524708|FG000|COMPLETED|Crossover Period||0
6599766|NCT02038036|7524709|FG001|COMPLETED|Crossover Period||38
6599767|NCT02038036|7524708|FG000|NOT COMPLETED|Crossover Period||0
6599768|NCT02038036|7524709|FG001|NOT COMPLETED|Crossover Period||20
6599769|NCT02038049|7524720|FG000|STARTED|Overall Study||4
6599770|NCT02038049|7524721|FG001|STARTED|Overall Study||4
6599771|NCT02038049|7524720|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||4
6599772|NCT02038049|7524721|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||4
6599773|NCT02038049|7524720|FG000|COMPLETED|Overall Study||3
6599774|NCT02038049|7524721|FG001|COMPLETED|Overall Study||4
6599775|NCT02038049|7524720|FG000|NOT COMPLETED|Overall Study||1
6599776|NCT02038049|7524721|FG001|NOT COMPLETED|Overall Study||0
6599777|NCT02038075|7524733|FG000|STARTED|Overall Study||76
6599778|NCT02038075|7524734|FG001|STARTED|Overall Study||76
6599779|NCT02038075|7524733|FG000|COMPLETED|Overall Study||73
6599780|NCT02038075|7524734|FG001|COMPLETED|Overall Study||76
6599781|NCT02038075|7524733|FG000|NOT COMPLETED|Overall Study||3
6599782|NCT02038075|7524734|FG001|NOT COMPLETED|Overall Study||0
6599783|NCT02038179|7524740|FG000|STARTED|Phase 1 (4 Weeks)||52
6599784|NCT02038179|7524741|FG001|STARTED|Phase 1 (4 Weeks)||47
6599785|NCT02038179|7524740|FG000|COMPLETED|Phase 1 (4 Weeks)||48
6599786|NCT02038179|7524741|FG001|COMPLETED|Phase 1 (4 Weeks)||42
6599787|NCT02038179|7524740|FG000|NOT COMPLETED|Phase 1 (4 Weeks)||4
6599788|NCT02038179|7524741|FG001|NOT COMPLETED|Phase 1 (4 Weeks)||5
6599789|NCT02038179|7524740|FG000|STARTED|Washout (2-4 Weeks)||48
6599790|NCT02038179|7524741|FG001|STARTED|Washout (2-4 Weeks)||42
6599791|NCT02038179|7524740|FG000|COMPLETED|Washout (2-4 Weeks)||46
6599792|NCT02038179|7524741|FG001|COMPLETED|Washout (2-4 Weeks)||40
6599793|NCT02038179|7524740|FG000|NOT COMPLETED|Washout (2-4 Weeks)||2
6599794|NCT02038179|7524741|FG001|NOT COMPLETED|Washout (2-4 Weeks)||2
6599795|NCT02038179|7524740|FG000|STARTED|Phase 2 (4 Weeks)||46
6599796|NCT02038179|7524741|FG001|STARTED|Phase 2 (4 Weeks)||40
6662132|NCT02509117|7592797|FG005|STARTED|Washout Period 2 (Part A: 7 Days)||0
6662133|NCT02509117|7592798|FG006|STARTED|Washout Period 2 (Part A: 7 Days)||0
6662134|NCT02509117|7592799|FG007|STARTED|Washout Period 2 (Part A: 7 Days)||0
6662135|NCT02509117|7592800|FG008|STARTED|Washout Period 2 (Part A: 7 Days)||0
6662136|NCT02509117|7592801|FG009|STARTED|Washout Period 2 (Part A: 7 Days)||0
6662137|NCT02509117|7592792|FG000|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
6662138|NCT02509117|7592793|FG001|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
6662139|NCT02509117|7592794|FG002|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
6662140|NCT02509117|7592795|FG003|COMPLETED|Washout Period 2 (Part A: 7 Days)||2
6662141|NCT02509117|7592796|FG004|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662142|NCT02509117|7592797|FG005|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662143|NCT02509117|7592798|FG006|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662144|NCT02509117|7592799|FG007|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662145|NCT02509117|7592800|FG008|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662146|NCT02509117|7592801|FG009|COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662147|NCT02509117|7592792|FG000|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662148|NCT02509117|7592793|FG001|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662149|NCT02509117|7592794|FG002|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662150|NCT02509117|7592795|FG003|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662151|NCT02509117|7592796|FG004|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662152|NCT02509117|7592797|FG005|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662153|NCT02509117|7592798|FG006|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662154|NCT02509117|7592799|FG007|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662155|NCT02509117|7592800|FG008|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662156|NCT02509117|7592801|FG009|NOT COMPLETED|Washout Period 2 (Part A: 7 Days)||0
6662157|NCT02509117|7592792|FG000|STARTED|Period 3 -Part A: 4 Days||2
6662158|NCT02509117|7592793|FG001|STARTED|Period 3 -Part A: 4 Days||2
6662159|NCT02509117|7592794|FG002|STARTED|Period 3 -Part A: 4 Days||2
6662160|NCT02509117|7592795|FG003|STARTED|Period 3 -Part A: 4 Days||2
6599797|NCT02038179|7524740|FG000|COMPLETED|Phase 2 (4 Weeks)||44
6599798|NCT02038179|7524741|FG001|COMPLETED|Phase 2 (4 Weeks)||38
6599799|NCT02038179|7524740|FG000|NOT COMPLETED|Phase 2 (4 Weeks)||2
6599800|NCT02038179|7524741|FG001|NOT COMPLETED|Phase 2 (4 Weeks)||2
6599801|NCT02038218|7524749|FG000|STARTED|Overall Study|Drug tolerated - Arm 1: No liver disease - 98.7 mg/m2. No alterations of liver functions.|22
6599802|NCT02038218|7524750|FG001|STARTED|Overall Study|Drug tolerated - Arm 2: liver involvement - 85.5 mg/m2. No alterations of liver functions.|7
6599803|NCT02038218|7524749|FG000|COMPLETED|Overall Study|22 patients are included in a publication in progress|22
6599804|NCT02038218|7524750|FG001|COMPLETED|Overall Study|5 patients are included in a publication in progress|7
6599805|NCT02038218|7524749|FG000|NOT COMPLETED|Overall Study||0
6599806|NCT02038218|7524750|FG001|NOT COMPLETED|Overall Study||0
6599807|NCT02038543|7524760|FG000|STARTED|Overall Study||7
6599808|NCT02038543|7524761|FG001|STARTED|Overall Study||4
6599809|NCT02038543|7524762|FG002|STARTED|Overall Study||8
6599810|NCT02038543|7524763|FG003|STARTED|Overall Study||3
6599811|NCT02038543|7524760|FG000|COMPLETED|Overall Study||7
6599812|NCT02038543|7524761|FG001|COMPLETED|Overall Study||4
6599813|NCT02038543|7524762|FG002|COMPLETED|Overall Study||8
6599814|NCT02038543|7524763|FG003|COMPLETED|Overall Study||1
6599815|NCT02038543|7524760|FG000|NOT COMPLETED|Overall Study||0
6599816|NCT02038543|7524761|FG001|NOT COMPLETED|Overall Study||0
6599817|NCT02038543|7524762|FG002|NOT COMPLETED|Overall Study||0
6599818|NCT02038543|7524763|FG003|NOT COMPLETED|Overall Study||2
6599819|NCT02038569|7524773|FG000|STARTED|Overall Study||107
6599820|NCT02038569|7524773|FG000|COMPLETED|Overall Study||102
6599821|NCT02038569|7524773|FG000|NOT COMPLETED|Overall Study||5
6599822|NCT02038647|7524780|FG000|STARTED|Overall Study||89
6599823|NCT02038647|7524781|FG001|STARTED|Overall Study||89
6599824|NCT02038647|7524780|FG000|COMPLETED|Overall Study||0
6599825|NCT02038647|7524781|FG001|COMPLETED|Overall Study||0
6599826|NCT02038647|7524780|FG000|NOT COMPLETED|Overall Study||89
6599827|NCT02038647|7524781|FG001|NOT COMPLETED|Overall Study||89
6599828|NCT02038764|7524792|FG000|STARTED|Overall Study||7
6599829|NCT02038764|7524793|FG001|STARTED|Overall Study||8
6599830|NCT02038764|7524794|FG002|STARTED|Overall Study||9
6599831|NCT02038764|7524795|FG003|STARTED|Overall Study||5
6599832|NCT02038764|7524796|FG004|STARTED|Overall Study||8
6599833|NCT02038764|7524792|FG000|COMPLETED|Overall Study||6
6599834|NCT02038764|7524793|FG001|COMPLETED|Overall Study||7
6599835|NCT02038764|7524794|FG002|COMPLETED|Overall Study||7
6599836|NCT02038764|7524795|FG003|COMPLETED|Overall Study||5
6599837|NCT02038764|7524796|FG004|COMPLETED|Overall Study||7
6599838|NCT02038764|7524792|FG000|NOT COMPLETED|Overall Study||1
6599839|NCT02038764|7524793|FG001|NOT COMPLETED|Overall Study||1
6599840|NCT02038764|7524794|FG002|NOT COMPLETED|Overall Study||2
6599841|NCT02038764|7524795|FG003|NOT COMPLETED|Overall Study||0
6599842|NCT02038764|7524796|FG004|NOT COMPLETED|Overall Study||1
6599843|NCT02038790|7524812|FG000|STARTED|Day 0 - First Treatment||16
6599844|NCT02038790|7524813|FG001|STARTED|Day 0 - First Treatment||17
6599845|NCT02038790|7524812|FG000|COMPLETED|Day 0 - First Treatment||15
6662161|NCT02509117|7592796|FG004|STARTED|Period 3 -Part A: 4 Days||0
6662162|NCT02509117|7592797|FG005|STARTED|Period 3 -Part A: 4 Days||0
6662163|NCT02509117|7592798|FG006|STARTED|Period 3 -Part A: 4 Days||0
6662164|NCT02509117|7592799|FG007|STARTED|Period 3 -Part A: 4 Days||0
6662165|NCT02509117|7592800|FG008|STARTED|Period 3 -Part A: 4 Days||0
6662166|NCT02509117|7592801|FG009|STARTED|Period 3 -Part A: 4 Days||0
6662167|NCT02509117|7592792|FG000|COMPLETED|Period 3 -Part A: 4 Days||2
6662168|NCT02509117|7592793|FG001|COMPLETED|Period 3 -Part A: 4 Days||2
6662169|NCT02509117|7592794|FG002|COMPLETED|Period 3 -Part A: 4 Days||2
6662170|NCT02509117|7592795|FG003|COMPLETED|Period 3 -Part A: 4 Days||2
6662171|NCT02509117|7592796|FG004|COMPLETED|Period 3 -Part A: 4 Days||0
6662172|NCT02509117|7592797|FG005|COMPLETED|Period 3 -Part A: 4 Days||0
6662173|NCT02509117|7592798|FG006|COMPLETED|Period 3 -Part A: 4 Days||0
6662174|NCT02509117|7592799|FG007|COMPLETED|Period 3 -Part A: 4 Days||0
6662175|NCT02509117|7592800|FG008|COMPLETED|Period 3 -Part A: 4 Days||0
6662176|NCT02509117|7592801|FG009|COMPLETED|Period 3 -Part A: 4 Days||0
6662177|NCT02509117|7592792|FG000|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662178|NCT02509117|7592793|FG001|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662179|NCT02509117|7592794|FG002|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662180|NCT02509117|7592795|FG003|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662181|NCT02509117|7592796|FG004|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662182|NCT02509117|7592797|FG005|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662183|NCT02509117|7592798|FG006|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662184|NCT02509117|7592799|FG007|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662185|NCT02509117|7592800|FG008|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662186|NCT02509117|7592801|FG009|NOT COMPLETED|Period 3 -Part A: 4 Days||0
6662187|NCT02509117|7592792|FG000|STARTED|Washout Period 3 (Part A: 7 Days)||2
6662188|NCT02509117|7592793|FG001|STARTED|Washout Period 3 (Part A: 7 Days)||2
6662189|NCT02509117|7592794|FG002|STARTED|Washout Period 3 (Part A: 7 Days)||2
6662190|NCT02509117|7592795|FG003|STARTED|Washout Period 3 (Part A: 7 Days)||2
6662191|NCT02509117|7592796|FG004|STARTED|Washout Period 3 (Part A: 7 Days)||0
6662192|NCT02509117|7592797|FG005|STARTED|Washout Period 3 (Part A: 7 Days)||0
6662193|NCT02509117|7592798|FG006|STARTED|Washout Period 3 (Part A: 7 Days)||0
6662194|NCT02509117|7592799|FG007|STARTED|Washout Period 3 (Part A: 7 Days)||0
6662195|NCT02509117|7592800|FG008|STARTED|Washout Period 3 (Part A: 7 Days)||0
6662196|NCT02509117|7592801|FG009|STARTED|Washout Period 3 (Part A: 7 Days)||0
6662197|NCT02509117|7592792|FG000|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
6662198|NCT02509117|7592793|FG001|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
6599846|NCT02038790|7524813|FG001|COMPLETED|Day 0 - First Treatment||16
6599847|NCT02038790|7524812|FG000|NOT COMPLETED|Day 0 - First Treatment||1
6599848|NCT02038790|7524813|FG001|NOT COMPLETED|Day 0 - First Treatment||1
6599849|NCT02038790|7524812|FG000|STARTED|Day 1 - Second Treatment||15
6599850|NCT02038790|7524813|FG001|STARTED|Day 1 - Second Treatment||16
6599851|NCT02038790|7524812|FG000|COMPLETED|Day 1 - Second Treatment||15
6599852|NCT02038790|7524813|FG001|COMPLETED|Day 1 - Second Treatment||16
6599853|NCT02038790|7524812|FG000|NOT COMPLETED|Day 1 - Second Treatment||0
6599854|NCT02038790|7524813|FG001|NOT COMPLETED|Day 1 - Second Treatment||0
6599855|NCT02038829|7524820|FG000|STARTED|Treatment Period 1||8
6599856|NCT02038829|7524821|FG001|STARTED|Treatment Period 1||8
6599857|NCT02038829|7524822|FG002|STARTED|Treatment Period 1||8
6599858|NCT02038829|7524823|FG003|STARTED|Treatment Period 1||8
6599859|NCT02038829|7524824|FG004|STARTED|Treatment Period 1||8
6599860|NCT02038829|7524825|FG005|STARTED|Treatment Period 1||8
6599861|NCT02038829|7524826|FG006|STARTED|Treatment Period 1||8
6599862|NCT02038829|7524827|FG007|STARTED|Treatment Period 1||8
6599863|NCT02038829|7524828|FG008|STARTED|Treatment Period 1||8
6599864|NCT02038829|7524829|FG009|STARTED|Treatment Period 1||8
6599865|NCT02038829|7524830|FG010|STARTED|Treatment Period 1||8
6599866|NCT02038829|7524831|FG011|STARTED|Treatment Period 1||8
6599867|NCT02038829|7524820|FG000|COMPLETED|Treatment Period 1||8
6599868|NCT02038829|7524821|FG001|COMPLETED|Treatment Period 1||8
6662199|NCT02509117|7592794|FG002|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
6662200|NCT02509117|7592795|FG003|COMPLETED|Washout Period 3 (Part A: 7 Days)||2
6662201|NCT02509117|7592796|FG004|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662202|NCT02509117|7592797|FG005|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662203|NCT02509117|7592798|FG006|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662204|NCT02509117|7592799|FG007|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662205|NCT02509117|7592800|FG008|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662206|NCT02509117|7592801|FG009|COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662207|NCT02509117|7592792|FG000|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662208|NCT02509117|7592793|FG001|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662209|NCT02509117|7592794|FG002|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662210|NCT02509117|7592795|FG003|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662211|NCT02509117|7592796|FG004|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662212|NCT02509117|7592797|FG005|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662213|NCT02509117|7592798|FG006|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662214|NCT02509117|7592799|FG007|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662215|NCT02509117|7592800|FG008|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662216|NCT02509117|7592801|FG009|NOT COMPLETED|Washout Period 3 (Part A: 7 Days)||0
6662217|NCT02509117|7592792|FG000|STARTED|Period 4 -Part A: 4 Days||2
6662218|NCT02509117|7592793|FG001|STARTED|Period 4 -Part A: 4 Days||2
6662219|NCT02509117|7592794|FG002|STARTED|Period 4 -Part A: 4 Days||2
6662220|NCT02509117|7592795|FG003|STARTED|Period 4 -Part A: 4 Days||2
6662221|NCT02509117|7592796|FG004|STARTED|Period 4 -Part A: 4 Days||0
6662222|NCT02509117|7592797|FG005|STARTED|Period 4 -Part A: 4 Days||0
6662223|NCT02509117|7592798|FG006|STARTED|Period 4 -Part A: 4 Days||0
6662224|NCT02509117|7592799|FG007|STARTED|Period 4 -Part A: 4 Days||0
6662225|NCT02509117|7592800|FG008|STARTED|Period 4 -Part A: 4 Days||0
6662226|NCT02509117|7592801|FG009|STARTED|Period 4 -Part A: 4 Days||0
6662227|NCT02509117|7592792|FG000|COMPLETED|Period 4 -Part A: 4 Days||2
6662228|NCT02509117|7592793|FG001|COMPLETED|Period 4 -Part A: 4 Days||2
6662229|NCT02509117|7592794|FG002|COMPLETED|Period 4 -Part A: 4 Days||2
6662230|NCT02509117|7592795|FG003|COMPLETED|Period 4 -Part A: 4 Days||2
6662231|NCT02509117|7592796|FG004|COMPLETED|Period 4 -Part A: 4 Days||0
6662232|NCT02509117|7592797|FG005|COMPLETED|Period 4 -Part A: 4 Days||0
6662233|NCT02509117|7592798|FG006|COMPLETED|Period 4 -Part A: 4 Days||0
6662234|NCT02509117|7592799|FG007|COMPLETED|Period 4 -Part A: 4 Days||0
6662235|NCT02509117|7592800|FG008|COMPLETED|Period 4 -Part A: 4 Days||0
6662236|NCT02509117|7592801|FG009|COMPLETED|Period 4 -Part A: 4 Days||0
6662237|NCT02509117|7592792|FG000|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662238|NCT02509117|7592793|FG001|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662239|NCT02509117|7592794|FG002|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662240|NCT02509117|7592795|FG003|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662241|NCT02509117|7592796|FG004|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662242|NCT02509117|7592797|FG005|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662243|NCT02509117|7592798|FG006|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662244|NCT02509117|7592799|FG007|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662245|NCT02509117|7592800|FG008|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662246|NCT02509117|7592801|FG009|NOT COMPLETED|Period 4 -Part A: 4 Days||0
6662247|NCT02509156|7592841|FG000|STARTED|Open-Label Lead-In Phase||6
6662248|NCT02509156|7592842|FG001|STARTED|Open-Label Lead-In Phase||0
6662249|NCT02509156|7592841|FG000|COMPLETED|Open-Label Lead-In Phase||6
6662250|NCT02509156|7592842|FG001|COMPLETED|Open-Label Lead-In Phase||0
6662251|NCT02509156|7592841|FG000|NOT COMPLETED|Open-Label Lead-In Phase||0
6662252|NCT02509156|7592842|FG001|NOT COMPLETED|Open-Label Lead-In Phase||0
6662253|NCT02509156|7592841|FG000|STARTED|Randomized Phase|Includes randomized participants only|14
6662254|NCT02509156|7592842|FG001|STARTED|Randomized Phase||17
6662255|NCT02509156|7592841|FG000|COMPLETED|Randomized Phase||12
6599869|NCT02038829|7524822|FG002|COMPLETED|Treatment Period 1||8
6599870|NCT02038829|7524823|FG003|COMPLETED|Treatment Period 1||8
6599871|NCT02038829|7524824|FG004|COMPLETED|Treatment Period 1||8
6599872|NCT02038829|7524825|FG005|COMPLETED|Treatment Period 1||8
6599873|NCT02038829|7524826|FG006|COMPLETED|Treatment Period 1||8
6599874|NCT02038829|7524827|FG007|COMPLETED|Treatment Period 1||8
6599875|NCT02038829|7524828|FG008|COMPLETED|Treatment Period 1||8
6599876|NCT02038829|7524829|FG009|COMPLETED|Treatment Period 1||8
6599877|NCT02038829|7524830|FG010|COMPLETED|Treatment Period 1||8
6599878|NCT02038829|7524831|FG011|COMPLETED|Treatment Period 1||8
6599879|NCT02038829|7524820|FG000|NOT COMPLETED|Treatment Period 1||0
6599880|NCT02038829|7524821|FG001|NOT COMPLETED|Treatment Period 1||0
6599881|NCT02038829|7524822|FG002|NOT COMPLETED|Treatment Period 1||0
6599882|NCT02038829|7524823|FG003|NOT COMPLETED|Treatment Period 1||0
6599883|NCT02038829|7524824|FG004|NOT COMPLETED|Treatment Period 1||0
6599884|NCT02038829|7524825|FG005|NOT COMPLETED|Treatment Period 1||0
6599885|NCT02038829|7524826|FG006|NOT COMPLETED|Treatment Period 1||0
6599886|NCT02038829|7524827|FG007|NOT COMPLETED|Treatment Period 1||0
6599887|NCT02038829|7524828|FG008|NOT COMPLETED|Treatment Period 1||0
6599888|NCT02038829|7524829|FG009|NOT COMPLETED|Treatment Period 1||0
6599889|NCT02038829|7524830|FG010|NOT COMPLETED|Treatment Period 1||0
6599890|NCT02038829|7524831|FG011|NOT COMPLETED|Treatment Period 1||0
6599891|NCT02038829|7524820|FG000|STARTED|Washout Period 1||8
6662256|NCT02509156|7592842|FG001|COMPLETED|Randomized Phase||16
6662257|NCT02509156|7592841|FG000|NOT COMPLETED|Randomized Phase||2
6662258|NCT02509156|7592842|FG001|NOT COMPLETED|Randomized Phase||1
6662259|NCT02509481|7592850|FG000|STARTED|Overall Study||1265
6662260|NCT02509481|7592851|FG001|STARTED|Overall Study||1447
6662261|NCT02509481|7592850|FG000|COMPLETED|Overall Study||1265
6662262|NCT02509481|7592851|FG001|COMPLETED|Overall Study||1447
6662263|NCT02509481|7592850|FG000|NOT COMPLETED|Overall Study||0
6662264|NCT02509481|7592851|FG001|NOT COMPLETED|Overall Study||0
6662265|NCT02509585|7592857|FG000|STARTED|Overall Study||18
6662266|NCT02509585|7592857|FG000|COMPLETED|Overall Study||18
6662267|NCT02509585|7592857|FG000|NOT COMPLETED|Overall Study||0
6662268|NCT02509624|7592866|FG000|STARTED|Overall Study||10
6662269|NCT02509624|7592867|FG001|STARTED|Overall Study||10
6662270|NCT02509624|7592868|FG002|STARTED|Overall Study||10
6662271|NCT02509624|7592869|FG003|STARTED|Overall Study||22
6662272|NCT02509624|7592866|FG000|COMPLETED|Overall Study||10
6662273|NCT02509624|7592867|FG001|COMPLETED|Overall Study||10
6662274|NCT02509624|7592868|FG002|COMPLETED|Overall Study||10
6662275|NCT02509624|7592869|FG003|COMPLETED|Overall Study||22
6662276|NCT02509624|7592866|FG000|NOT COMPLETED|Overall Study||0
6662277|NCT02509624|7592867|FG001|NOT COMPLETED|Overall Study||0
6662278|NCT02509624|7592868|FG002|NOT COMPLETED|Overall Study||0
6662279|NCT02509624|7592869|FG003|NOT COMPLETED|Overall Study||0
6662280|NCT02509767|7592884|FG000|STARTED|Overall Study||201
6662281|NCT02509767|7592885|FG001|STARTED|Overall Study||200
6662282|NCT02509767|7592884|FG000|COMPLETED|Overall Study||157
6662283|NCT02509767|7592885|FG001|COMPLETED|Overall Study||159
6662284|NCT02509767|7592884|FG000|NOT COMPLETED|Overall Study||44
6662285|NCT02509767|7592885|FG001|NOT COMPLETED|Overall Study||41
6662286|NCT02509936|7592896|FG000|STARTED|Overall Study||163
6662287|NCT02509936|7592897|FG001|STARTED|Overall Study||161
6662288|NCT02509936|7592896|FG000|COMPLETED|Overall Study||151
6662289|NCT02509936|7592897|FG001|COMPLETED|Overall Study||145
6662290|NCT02509936|7592896|FG000|NOT COMPLETED|Overall Study||12
6662291|NCT02509936|7592897|FG001|NOT COMPLETED|Overall Study||16
6662292|NCT02510001|7592911|FG000|STARTED|Overall Study||6
6662293|NCT02510001|7592912|FG001|STARTED|Overall Study||5
6662294|NCT02510001|7592913|FG002|STARTED|Overall Study||6
6662295|NCT02510001|7592914|FG003|STARTED|Overall Study||8
6662296|NCT02510001|7592915|FG004|STARTED|Overall Study||8
6662297|NCT02510001|7592916|FG005|STARTED|Overall Study||7
6662298|NCT02510001|7592917|FG006|STARTED|Overall Study||5
6662299|NCT02510001|7592918|FG007|STARTED|Overall Study||37
6662300|NCT02510001|7592911|FG000|COMPLETED|Overall Study||6
6662301|NCT02510001|7592912|FG001|COMPLETED|Overall Study||5
6662302|NCT02510001|7592913|FG002|COMPLETED|Overall Study||6
6662303|NCT02510001|7592914|FG003|COMPLETED|Overall Study||6
6662304|NCT02510001|7592915|FG004|COMPLETED|Overall Study||4
6662305|NCT02510001|7592916|FG005|COMPLETED|Overall Study||5
6662306|NCT02510001|7592917|FG006|COMPLETED|Overall Study||3
6662307|NCT02510001|7592918|FG007|COMPLETED|Overall Study||30
6662308|NCT02510001|7592911|FG000|NOT COMPLETED|Overall Study||0
6662309|NCT02510001|7592912|FG001|NOT COMPLETED|Overall Study||0
6662310|NCT02510001|7592913|FG002|NOT COMPLETED|Overall Study||0
6662311|NCT02510001|7592914|FG003|NOT COMPLETED|Overall Study||2
6662312|NCT02510001|7592915|FG004|NOT COMPLETED|Overall Study||4
6662313|NCT02510001|7592916|FG005|NOT COMPLETED|Overall Study||2
6662314|NCT02510001|7592917|FG006|NOT COMPLETED|Overall Study||2
6662315|NCT02510001|7592918|FG007|NOT COMPLETED|Overall Study||7
6662316|NCT02510014|7592956|FG000|STARTED|Run-In Period (Days -14 to Day -1)||508
6662317|NCT02510014|7592957|FG001|STARTED|Run-In Period (Days -14 to Day -1)||267
6662318|NCT02510014|7592956|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||412
6662319|NCT02510014|7592957|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||257
6662320|NCT02510014|7592956|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||96
6662321|NCT02510014|7592957|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||10
6662322|NCT02510014|7592956|FG000|STARTED|Treatment Period||412
6662323|NCT02510014|7592957|FG001|STARTED|Treatment Period||257
6599892|NCT02038829|7524821|FG001|STARTED|Washout Period 1||8
6599893|NCT02038829|7524822|FG002|STARTED|Washout Period 1||8
6599894|NCT02038829|7524823|FG003|STARTED|Washout Period 1||8
6599895|NCT02038829|7524824|FG004|STARTED|Washout Period 1||8
6599896|NCT02038829|7524825|FG005|STARTED|Washout Period 1||8
6599897|NCT02038829|7524826|FG006|STARTED|Washout Period 1||8
6599898|NCT02038829|7524827|FG007|STARTED|Washout Period 1||8
6599899|NCT02038829|7524828|FG008|STARTED|Washout Period 1||8
6599900|NCT02038829|7524829|FG009|STARTED|Washout Period 1||8
6599901|NCT02038829|7524830|FG010|STARTED|Washout Period 1||8
6599902|NCT02038829|7524831|FG011|STARTED|Washout Period 1||8
6599903|NCT02038829|7524820|FG000|COMPLETED|Washout Period 1||8
6599904|NCT02038829|7524821|FG001|COMPLETED|Washout Period 1||8
6662324|NCT02510014|7592956|FG000|COMPLETED|Treatment Period||206
6662325|NCT02510014|7592957|FG001|COMPLETED|Treatment Period||200
6662326|NCT02510014|7592956|FG000|NOT COMPLETED|Treatment Period||206
6662327|NCT02510014|7592957|FG001|NOT COMPLETED|Treatment Period||57
6662328|NCT02510144|7592965|FG000|STARTED|Overall Study||39
6662329|NCT02510144|7592966|FG001|STARTED|Overall Study||41
6662330|NCT02510144|7592965|FG000|COMPLETED|Overall Study||39
6662331|NCT02510144|7592966|FG001|COMPLETED|Overall Study||41
6662332|NCT02510144|7592965|FG000|NOT COMPLETED|Overall Study||0
6662333|NCT02510144|7592966|FG001|NOT COMPLETED|Overall Study||0
6662334|NCT02510664|7592975|FG000|STARTED|Overall Study||84
6662335|NCT02510664|7592976|FG001|STARTED|Overall Study||84
6662336|NCT02510664|7592977|FG002|STARTED|Overall Study||4
6662337|NCT02510664|7592975|FG000|COMPLETED|Overall Study||64
6662338|NCT02510664|7592976|FG001|COMPLETED|Overall Study||64
6662339|NCT02510664|7592977|FG002|COMPLETED|Overall Study||4
6662340|NCT02510664|7592975|FG000|NOT COMPLETED|Overall Study||20
6662341|NCT02510664|7592976|FG001|NOT COMPLETED|Overall Study||20
6662342|NCT02510664|7592977|FG002|NOT COMPLETED|Overall Study||0
6662343|NCT02510794|7592994|FG000|STARTED|Overall Study||59
6662344|NCT02510794|7592995|FG001|STARTED|Overall Study||62
6662345|NCT02510794|7592996|FG002|STARTED|Overall Study||63
6662346|NCT02510794|7592997|FG003|STARTED|Overall Study||41
6662347|NCT02510794|7592994|FG000|COMPLETED|Overall Study||51
6662348|NCT02510794|7592995|FG001|COMPLETED|Overall Study||56
6662349|NCT02510794|7592996|FG002|COMPLETED|Overall Study||56
6662350|NCT02510794|7592997|FG003|COMPLETED|Overall Study||36
6662351|NCT02510794|7592994|FG000|NOT COMPLETED|Overall Study||8
6662352|NCT02510794|7592995|FG001|NOT COMPLETED|Overall Study||6
6662353|NCT02510794|7592996|FG002|NOT COMPLETED|Overall Study||7
6662354|NCT02510794|7592997|FG003|NOT COMPLETED|Overall Study||5
6662355|NCT02510820|7593009|FG000|STARTED|First Intervention (4 Weeks)||21
6662356|NCT02510820|7593010|FG001|STARTED|First Intervention (4 Weeks)||27
6662357|NCT02510820|7593009|FG000|COMPLETED|First Intervention (4 Weeks)||21
6662358|NCT02510820|7593010|FG001|COMPLETED|First Intervention (4 Weeks)||26
6662359|NCT02510820|7593009|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6662360|NCT02510820|7593010|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
6662361|NCT02510820|7593009|FG000|STARTED|Washout (1 Week)||21
6662362|NCT02510820|7593010|FG001|STARTED|Washout (1 Week)||26
6662363|NCT02510820|7593009|FG000|COMPLETED|Washout (1 Week)||21
6662364|NCT02510820|7593010|FG001|COMPLETED|Washout (1 Week)||26
6662365|NCT02510820|7593009|FG000|NOT COMPLETED|Washout (1 Week)||0
6662366|NCT02510820|7593010|FG001|NOT COMPLETED|Washout (1 Week)||0
6662367|NCT02510820|7593009|FG000|STARTED|Second Intervention (4 Weeks)||21
6662368|NCT02510820|7593010|FG001|STARTED|Second Intervention (4 Weeks)||26
6662369|NCT02510820|7593009|FG000|COMPLETED|Second Intervention (4 Weeks)||20
6662370|NCT02510820|7593010|FG001|COMPLETED|Second Intervention (4 Weeks)||26
6662371|NCT02510820|7593009|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
6662372|NCT02510820|7593010|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
6662373|NCT02511184|7593019|FG000|STARTED|Overall Study||2
6662374|NCT02511184|7593020|FG001|STARTED|Overall Study||7
6662375|NCT02511184|7593019|FG000|COMPLETED|Overall Study||0
6662376|NCT02511184|7593020|FG001|COMPLETED|Overall Study||0
6662377|NCT02511184|7593019|FG000|NOT COMPLETED|Overall Study||2
6662378|NCT02511184|7593020|FG001|NOT COMPLETED|Overall Study||7
6662379|NCT02511236|7593029|FG000|STARTED|Overall Study||165
6662380|NCT02511236|7593030|FG001|STARTED|Overall Study||191
6662381|NCT02511236|7593029|FG000|COMPLETED|Overall Study||125
6662382|NCT02511236|7593030|FG001|COMPLETED|Overall Study||146
6662383|NCT02511236|7593029|FG000|NOT COMPLETED|Overall Study||40
6662384|NCT02511236|7593030|FG001|NOT COMPLETED|Overall Study||45
6662385|NCT02511379|7593036|FG000|STARTED|Overall Study||14
6599905|NCT02038829|7524822|FG002|COMPLETED|Washout Period 1||8
6599906|NCT02038829|7524823|FG003|COMPLETED|Washout Period 1||8
6599907|NCT02038829|7524824|FG004|COMPLETED|Washout Period 1||7
6662386|NCT02511379|7593036|FG000|COMPLETED|Overall Study||14
6662387|NCT02511379|7593036|FG000|NOT COMPLETED|Overall Study||0
6662388|NCT02511431|7593046|FG000|STARTED|Treatment||4
6662389|NCT02511431|7593047|FG001|STARTED|Treatment||4
6662390|NCT02511431|7593048|FG002|STARTED|Treatment||4
6662391|NCT02511431|7593049|FG003|STARTED|Treatment||3
6662392|NCT02511431|7593050|FG004|STARTED|Treatment||3
6662393|NCT02511431|7593051|FG005|STARTED|Treatment||3
6662394|NCT02511431|7593046|FG000|COMPLETED|Treatment||4
6662395|NCT02511431|7593047|FG001|COMPLETED|Treatment||4
6662396|NCT02511431|7593048|FG002|COMPLETED|Treatment||3
6662397|NCT02511431|7593049|FG003|COMPLETED|Treatment||3
6599908|NCT02038829|7524825|FG005|COMPLETED|Washout Period 1||8
6662398|NCT02511431|7593050|FG004|COMPLETED|Treatment||3
6662399|NCT02511431|7593051|FG005|COMPLETED|Treatment||2
6662400|NCT02511431|7593046|FG000|NOT COMPLETED|Treatment||0
6662401|NCT02511431|7593047|FG001|NOT COMPLETED|Treatment||0
6662402|NCT02511431|7593048|FG002|NOT COMPLETED|Treatment||1
6662403|NCT02511431|7593049|FG003|NOT COMPLETED|Treatment||0
6662404|NCT02511431|7593050|FG004|NOT COMPLETED|Treatment||0
6662405|NCT02511431|7593051|FG005|NOT COMPLETED|Treatment||1
6662406|NCT02511431|7593046|FG000|STARTED|Post-treatment Follow-up||4
6662407|NCT02511431|7593047|FG001|STARTED|Post-treatment Follow-up||4
6662408|NCT02511431|7593048|FG002|STARTED|Post-treatment Follow-up||3
6662409|NCT02511431|7593049|FG003|STARTED|Post-treatment Follow-up||3
6662410|NCT02511431|7593050|FG004|STARTED|Post-treatment Follow-up||3
6662411|NCT02511431|7593051|FG005|STARTED|Post-treatment Follow-up||2
6662412|NCT02511431|7593046|FG000|COMPLETED|Post-treatment Follow-up||4
6662413|NCT02511431|7593047|FG001|COMPLETED|Post-treatment Follow-up||4
6662414|NCT02511431|7593048|FG002|COMPLETED|Post-treatment Follow-up||3
6662415|NCT02511431|7593049|FG003|COMPLETED|Post-treatment Follow-up||3
6662416|NCT02511431|7593050|FG004|COMPLETED|Post-treatment Follow-up||3
6662417|NCT02511431|7593051|FG005|COMPLETED|Post-treatment Follow-up||2
6662418|NCT02511431|7593046|FG000|NOT COMPLETED|Post-treatment Follow-up||0
6662419|NCT02511431|7593047|FG001|NOT COMPLETED|Post-treatment Follow-up||0
6662420|NCT02511431|7593048|FG002|NOT COMPLETED|Post-treatment Follow-up||0
6662421|NCT02511431|7593049|FG003|NOT COMPLETED|Post-treatment Follow-up||0
6662422|NCT02511431|7593050|FG004|NOT COMPLETED|Post-treatment Follow-up||0
6662423|NCT02511431|7593051|FG005|NOT COMPLETED|Post-treatment Follow-up||0
6662424|NCT02511535|7593069|FG000|STARTED|Overall Study||49
6662425|NCT02511535|7593070|FG001|STARTED|Overall Study||21
6662426|NCT02511535|7593071|FG002|STARTED|Overall Study||49
6662427|NCT02511535|7593069|FG000|COMPLETED|Overall Study||49
6662428|NCT02511535|7593070|FG001|COMPLETED|Overall Study||21
6662429|NCT02511535|7593071|FG002|COMPLETED|Overall Study||49
6662430|NCT02511535|7593069|FG000|NOT COMPLETED|Overall Study||0
6662431|NCT02511535|7593070|FG001|NOT COMPLETED|Overall Study||0
6662432|NCT02511535|7593071|FG002|NOT COMPLETED|Overall Study||0
6662433|NCT02511561|7593082|FG000|STARTED|Overall Study||25
6662434|NCT02511561|7593083|FG001|STARTED|Overall Study||25
6662435|NCT02511561|7593084|FG002|STARTED|Overall Study||25
6662436|NCT02511561|7593082|FG000|COMPLETED|Overall Study||25
6662437|NCT02511561|7593083|FG001|COMPLETED|Overall Study||25
6662438|NCT02511561|7593084|FG002|COMPLETED|Overall Study||25
6662439|NCT02511561|7593082|FG000|NOT COMPLETED|Overall Study||0
6599909|NCT02038829|7524826|FG006|COMPLETED|Washout Period 1||8
6599910|NCT02038829|7524827|FG007|COMPLETED|Washout Period 1||8
6599911|NCT02038829|7524828|FG008|COMPLETED|Washout Period 1||8
6599912|NCT02038829|7524829|FG009|COMPLETED|Washout Period 1||8
6599913|NCT02038829|7524830|FG010|COMPLETED|Washout Period 1||8
6599914|NCT02038829|7524831|FG011|COMPLETED|Washout Period 1||8
6599915|NCT02038829|7524820|FG000|NOT COMPLETED|Washout Period 1||0
6599916|NCT02038829|7524821|FG001|NOT COMPLETED|Washout Period 1||0
6599917|NCT02038829|7524822|FG002|NOT COMPLETED|Washout Period 1||0
6599918|NCT02038829|7524823|FG003|NOT COMPLETED|Washout Period 1||0
6599919|NCT02038829|7524824|FG004|NOT COMPLETED|Washout Period 1||1
6662440|NCT02511561|7593083|FG001|NOT COMPLETED|Overall Study||0
6662441|NCT02511561|7593084|FG002|NOT COMPLETED|Overall Study||0
6662442|NCT02511587|7593095|FG000|STARTED|Overall Study||58
6662443|NCT02511587|7593096|FG001|STARTED|Overall Study||58
6662444|NCT02511587|7593095|FG000|COMPLETED|Overall Study||58
6662445|NCT02511587|7593096|FG001|COMPLETED|Overall Study||58
6662446|NCT02511587|7593095|FG000|NOT COMPLETED|Overall Study||0
6662447|NCT02511587|7593096|FG001|NOT COMPLETED|Overall Study||0
6662448|NCT02511678|7593102|FG000|STARTED|Overall Study||73
6599920|NCT02038829|7524825|FG005|NOT COMPLETED|Washout Period 1||0
6599921|NCT02038829|7524826|FG006|NOT COMPLETED|Washout Period 1||0
6662449|NCT02511678|7593102|FG000|Intent-to-Treat (ITT) Population|Overall Study|Participants for whom cryoablation via Galil Medical cryoablation system was attempted or performed.|66
6662450|NCT02511678|7593102|FG000|Participants Discontinued Pre-Treatment|Overall Study||7
6662451|NCT02511678|7593102|FG000|Safety Population|Overall Study|Participants for whom received the complete study cryoablation procedure.|65
6662452|NCT02511678|7593102|FG000|COMPLETED|Overall Study||37
6662453|NCT02511678|7593102|FG000|NOT COMPLETED|Overall Study||36
6662454|NCT02511717|7593109|FG000|STARTED|Overall Study||10
6599922|NCT02038829|7524827|FG007|NOT COMPLETED|Washout Period 1||0
6599923|NCT02038829|7524828|FG008|NOT COMPLETED|Washout Period 1||0
6599924|NCT02038829|7524829|FG009|NOT COMPLETED|Washout Period 1||0
6599925|NCT02038829|7524830|FG010|NOT COMPLETED|Washout Period 1||0
6599926|NCT02038829|7524831|FG011|NOT COMPLETED|Washout Period 1||0
6599927|NCT02038829|7524820|FG000|STARTED|Treatment Period 2||8
6599928|NCT02038829|7524821|FG001|STARTED|Treatment Period 2||8
6599929|NCT02038829|7524822|FG002|STARTED|Treatment Period 2||8
6599930|NCT02038829|7524823|FG003|STARTED|Treatment Period 2||8
6599931|NCT02038829|7524824|FG004|STARTED|Treatment Period 2||7
6599932|NCT02038829|7524825|FG005|STARTED|Treatment Period 2||8
6599933|NCT02038829|7524826|FG006|STARTED|Treatment Period 2||8
6599934|NCT02038829|7524827|FG007|STARTED|Treatment Period 2||8
6599935|NCT02038829|7524828|FG008|STARTED|Treatment Period 2||8
6599936|NCT02038829|7524829|FG009|STARTED|Treatment Period 2||8
6599937|NCT02038829|7524830|FG010|STARTED|Treatment Period 2||8
6599938|NCT02038829|7524831|FG011|STARTED|Treatment Period 2||8
6599939|NCT02038829|7524820|FG000|COMPLETED|Treatment Period 2||7
6599940|NCT02038829|7524821|FG001|COMPLETED|Treatment Period 2||8
6599941|NCT02038829|7524822|FG002|COMPLETED|Treatment Period 2||8
6599942|NCT02038829|7524823|FG003|COMPLETED|Treatment Period 2||8
6599943|NCT02038829|7524824|FG004|COMPLETED|Treatment Period 2||7
6599944|NCT02038829|7524825|FG005|COMPLETED|Treatment Period 2||8
6599945|NCT02038829|7524826|FG006|COMPLETED|Treatment Period 2||8
6599946|NCT02038829|7524827|FG007|COMPLETED|Treatment Period 2||8
6599947|NCT02038829|7524828|FG008|COMPLETED|Treatment Period 2||8
6599948|NCT02038829|7524829|FG009|COMPLETED|Treatment Period 2||8
6599949|NCT02038829|7524830|FG010|COMPLETED|Treatment Period 2||7
6599950|NCT02038829|7524831|FG011|COMPLETED|Treatment Period 2||8
6599951|NCT02038829|7524820|FG000|NOT COMPLETED|Treatment Period 2||1
6599952|NCT02038829|7524821|FG001|NOT COMPLETED|Treatment Period 2||0
6599953|NCT02038829|7524822|FG002|NOT COMPLETED|Treatment Period 2||0
6599954|NCT02038829|7524823|FG003|NOT COMPLETED|Treatment Period 2||0
6599955|NCT02038829|7524824|FG004|NOT COMPLETED|Treatment Period 2||0
6599956|NCT02038829|7524825|FG005|NOT COMPLETED|Treatment Period 2||0
6599957|NCT02038829|7524826|FG006|NOT COMPLETED|Treatment Period 2||0
6662455|NCT02511717|7593110|FG001|STARTED|Overall Study||10
6662456|NCT02511717|7593109|FG000|COMPLETED|Overall Study||8
6662457|NCT02511717|7593110|FG001|COMPLETED|Overall Study||10
6662458|NCT02511717|7593109|FG000|NOT COMPLETED|Overall Study||2
6662459|NCT02511717|7593110|FG001|NOT COMPLETED|Overall Study||0
6662460|NCT02511730|7593116|FG000|STARTED|First Reading Session||50
6662461|NCT02511730|7593117|FG001|STARTED|First Reading Session||50
6662462|NCT02511730|7593116|FG000|COMPLETED|First Reading Session||50
6662463|NCT02511730|7593117|FG001|COMPLETED|First Reading Session||50
6662464|NCT02511730|7593116|FG000|NOT COMPLETED|First Reading Session||0
6662465|NCT02511730|7593117|FG001|NOT COMPLETED|First Reading Session||0
6662466|NCT02511730|7593116|FG000|STARTED|4 Week Memory Washout Period||50
6662467|NCT02511730|7593117|FG001|STARTED|4 Week Memory Washout Period||50
6662468|NCT02511730|7593116|FG000|COMPLETED|4 Week Memory Washout Period||50
6662469|NCT02511730|7593117|FG001|COMPLETED|4 Week Memory Washout Period||50
6662470|NCT02511730|7593116|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
6662471|NCT02511730|7593117|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
6662472|NCT02511730|7593116|FG000|STARTED|Session Reading Session||50
6662473|NCT02511730|7593117|FG001|STARTED|Session Reading Session||50
6662474|NCT02511730|7593116|FG000|COMPLETED|Session Reading Session||50
6662475|NCT02511730|7593117|FG001|COMPLETED|Session Reading Session||50
6662476|NCT02511730|7593116|FG000|NOT COMPLETED|Session Reading Session||0
6662477|NCT02511730|7593117|FG001|NOT COMPLETED|Session Reading Session||0
6662478|NCT02511782|7593126|FG000|STARTED|Overall Study||51
6662479|NCT02511782|7593127|FG001|STARTED|Overall Study||2
6662480|NCT02511782|7593128|FG002|STARTED|Overall Study||10
6662481|NCT02511782|7593126|FG000|COMPLETED|Overall Study||50
6662482|NCT02511782|7593127|FG001|COMPLETED|Overall Study||2
6599958|NCT02038829|7524827|FG007|NOT COMPLETED|Treatment Period 2||0
6599959|NCT02038829|7524828|FG008|NOT COMPLETED|Treatment Period 2||0
6599960|NCT02038829|7524829|FG009|NOT COMPLETED|Treatment Period 2||0
6599961|NCT02038829|7524830|FG010|NOT COMPLETED|Treatment Period 2||1
6599962|NCT02038829|7524831|FG011|NOT COMPLETED|Treatment Period 2||0
6599963|NCT02038829|7524820|FG000|STARTED|Washout Period 2||7
6662483|NCT02511782|7593128|FG002|COMPLETED|Overall Study||10
6662484|NCT02511782|7593126|FG000|NOT COMPLETED|Overall Study||1
6662485|NCT02511782|7593127|FG001|NOT COMPLETED|Overall Study||0
6662486|NCT02511782|7593128|FG002|NOT COMPLETED|Overall Study||0
6662487|NCT02512042|7593138|FG000|STARTED|Overall Study||495
6662488|NCT02512042|7593139|FG001|STARTED|Overall Study||478
6599964|NCT02038829|7524821|FG001|STARTED|Washout Period 2||8
6662489|NCT02512042|7593138|FG000|COMPLETED|Overall Study||472
6599965|NCT02038829|7524822|FG002|STARTED|Washout Period 2||8
6599966|NCT02038829|7524823|FG003|STARTED|Washout Period 2||8
6599967|NCT02038829|7524824|FG004|STARTED|Washout Period 2||7
6599968|NCT02038829|7524825|FG005|STARTED|Washout Period 2||8
6599969|NCT02038829|7524826|FG006|STARTED|Washout Period 2||8
6599970|NCT02038829|7524827|FG007|STARTED|Washout Period 2||8
6599971|NCT02038829|7524828|FG008|STARTED|Washout Period 2||8
6599972|NCT02038829|7524829|FG009|STARTED|Washout Period 2||8
6599973|NCT02038829|7524830|FG010|STARTED|Washout Period 2||7
6599974|NCT02038829|7524831|FG011|STARTED|Washout Period 2||8
6599975|NCT02038829|7524820|FG000|COMPLETED|Washout Period 2||7
6599976|NCT02038829|7524821|FG001|COMPLETED|Washout Period 2||8
6599977|NCT02038829|7524822|FG002|COMPLETED|Washout Period 2||8
6599978|NCT02038829|7524823|FG003|COMPLETED|Washout Period 2||8
6599979|NCT02038829|7524824|FG004|COMPLETED|Washout Period 2||7
6599980|NCT02038829|7524825|FG005|COMPLETED|Washout Period 2||7
6599981|NCT02038829|7524826|FG006|COMPLETED|Washout Period 2||8
6599982|NCT02038829|7524827|FG007|COMPLETED|Washout Period 2||8
6599983|NCT02038829|7524828|FG008|COMPLETED|Washout Period 2||7
6599984|NCT02038829|7524829|FG009|COMPLETED|Washout Period 2||8
6599985|NCT02038829|7524830|FG010|COMPLETED|Washout Period 2||7
6599986|NCT02038829|7524831|FG011|COMPLETED|Washout Period 2||8
6599987|NCT02038829|7524820|FG000|NOT COMPLETED|Washout Period 2||0
6599988|NCT02038829|7524821|FG001|NOT COMPLETED|Washout Period 2||0
6599989|NCT02038829|7524822|FG002|NOT COMPLETED|Washout Period 2||0
6599990|NCT02038829|7524823|FG003|NOT COMPLETED|Washout Period 2||0
6599991|NCT02038829|7524824|FG004|NOT COMPLETED|Washout Period 2||0
6599992|NCT02038829|7524825|FG005|NOT COMPLETED|Washout Period 2||1
6599993|NCT02038829|7524826|FG006|NOT COMPLETED|Washout Period 2||0
6599994|NCT02038829|7524827|FG007|NOT COMPLETED|Washout Period 2||0
6599995|NCT02038829|7524828|FG008|NOT COMPLETED|Washout Period 2||1
6599996|NCT02038829|7524829|FG009|NOT COMPLETED|Washout Period 2||0
6599997|NCT02038829|7524830|FG010|NOT COMPLETED|Washout Period 2||0
6599998|NCT02038829|7524831|FG011|NOT COMPLETED|Washout Period 2||0
6599999|NCT02038829|7524820|FG000|STARTED|Treatment Period 3||7
6600000|NCT02038829|7524821|FG001|STARTED|Treatment Period 3||8
6600001|NCT02038829|7524822|FG002|STARTED|Treatment Period 3||8
6600002|NCT02038829|7524823|FG003|STARTED|Treatment Period 3||8
6600003|NCT02038829|7524824|FG004|STARTED|Treatment Period 3||7
6600004|NCT02038829|7524825|FG005|STARTED|Treatment Period 3||7
6600005|NCT02038829|7524826|FG006|STARTED|Treatment Period 3||8
6600006|NCT02038829|7524827|FG007|STARTED|Treatment Period 3||8
6600007|NCT02038829|7524828|FG008|STARTED|Treatment Period 3||7
6600008|NCT02038829|7524829|FG009|STARTED|Treatment Period 3||8
6600009|NCT02038829|7524830|FG010|STARTED|Treatment Period 3||7
6600010|NCT02038829|7524831|FG011|STARTED|Treatment Period 3||8
6600011|NCT02038829|7524820|FG000|COMPLETED|Treatment Period 3||7
6600012|NCT02038829|7524821|FG001|COMPLETED|Treatment Period 3||8
6600013|NCT02038829|7524822|FG002|COMPLETED|Treatment Period 3||8
6600014|NCT02038829|7524823|FG003|COMPLETED|Treatment Period 3||8
6600015|NCT02038829|7524824|FG004|COMPLETED|Treatment Period 3||7
6600016|NCT02038829|7524825|FG005|COMPLETED|Treatment Period 3||7
6600017|NCT02038829|7524826|FG006|COMPLETED|Treatment Period 3||8
6600018|NCT02038829|7524827|FG007|COMPLETED|Treatment Period 3||8
6600019|NCT02038829|7524828|FG008|COMPLETED|Treatment Period 3||7
6600020|NCT02038829|7524829|FG009|COMPLETED|Treatment Period 3||8
6600021|NCT02038829|7524830|FG010|COMPLETED|Treatment Period 3||7
6600022|NCT02038829|7524831|FG011|COMPLETED|Treatment Period 3||8
6600023|NCT02038829|7524820|FG000|NOT COMPLETED|Treatment Period 3||0
6600024|NCT02038829|7524821|FG001|NOT COMPLETED|Treatment Period 3||0
6600025|NCT02038829|7524822|FG002|NOT COMPLETED|Treatment Period 3||0
6600026|NCT02038829|7524823|FG003|NOT COMPLETED|Treatment Period 3||0
6600027|NCT02038829|7524824|FG004|NOT COMPLETED|Treatment Period 3||0
6600028|NCT02038829|7524825|FG005|NOT COMPLETED|Treatment Period 3||0
6600029|NCT02038829|7524826|FG006|NOT COMPLETED|Treatment Period 3||0
6600030|NCT02038829|7524827|FG007|NOT COMPLETED|Treatment Period 3||0
6600031|NCT02038829|7524828|FG008|NOT COMPLETED|Treatment Period 3||0
6600032|NCT02038829|7524829|FG009|NOT COMPLETED|Treatment Period 3||0
6600033|NCT02038829|7524830|FG010|NOT COMPLETED|Treatment Period 3||0
6600034|NCT02038829|7524831|FG011|NOT COMPLETED|Treatment Period 3||0
6600035|NCT02038829|7524820|FG000|STARTED|Washout Period 3||7
6600036|NCT02038829|7524821|FG001|STARTED|Washout Period 3||8
6600037|NCT02038829|7524822|FG002|STARTED|Washout Period 3||8
6600038|NCT02038829|7524823|FG003|STARTED|Washout Period 3||8
6600039|NCT02038829|7524824|FG004|STARTED|Washout Period 3||7
6600040|NCT02038829|7524825|FG005|STARTED|Washout Period 3||7
6600041|NCT02038829|7524826|FG006|STARTED|Washout Period 3||8
6600042|NCT02038829|7524827|FG007|STARTED|Washout Period 3||8
6600043|NCT02038829|7524828|FG008|STARTED|Washout Period 3||7
6600044|NCT02038829|7524829|FG009|STARTED|Washout Period 3||8
6600045|NCT02038829|7524830|FG010|STARTED|Washout Period 3||7
6600046|NCT02038829|7524831|FG011|STARTED|Washout Period 3||8
6600047|NCT02038829|7524820|FG000|COMPLETED|Washout Period 3||7
6600048|NCT02038829|7524821|FG001|COMPLETED|Washout Period 3||8
6600049|NCT02038829|7524822|FG002|COMPLETED|Washout Period 3||8
6600050|NCT02038829|7524823|FG003|COMPLETED|Washout Period 3||8
6600051|NCT02038829|7524824|FG004|COMPLETED|Washout Period 3||7
6600052|NCT02038829|7524825|FG005|COMPLETED|Washout Period 3||7
6600053|NCT02038829|7524826|FG006|COMPLETED|Washout Period 3||8
6600054|NCT02038829|7524827|FG007|COMPLETED|Washout Period 3||8
6600055|NCT02038829|7524828|FG008|COMPLETED|Washout Period 3||7
6600056|NCT02038829|7524829|FG009|COMPLETED|Washout Period 3||8
6600057|NCT02038829|7524830|FG010|COMPLETED|Washout Period 3||7
6600058|NCT02038829|7524831|FG011|COMPLETED|Washout Period 3||8
6600059|NCT02038829|7524820|FG000|NOT COMPLETED|Washout Period 3||0
6600060|NCT02038829|7524821|FG001|NOT COMPLETED|Washout Period 3||0
6600061|NCT02038829|7524822|FG002|NOT COMPLETED|Washout Period 3||0
6600062|NCT02038829|7524823|FG003|NOT COMPLETED|Washout Period 3||0
6600063|NCT02038829|7524824|FG004|NOT COMPLETED|Washout Period 3||0
6600064|NCT02038829|7524825|FG005|NOT COMPLETED|Washout Period 3||0
6600065|NCT02038829|7524826|FG006|NOT COMPLETED|Washout Period 3||0
6600066|NCT02038829|7524827|FG007|NOT COMPLETED|Washout Period 3||0
6600067|NCT02038829|7524828|FG008|NOT COMPLETED|Washout Period 3||0
6600068|NCT02038829|7524829|FG009|NOT COMPLETED|Washout Period 3||0
6600069|NCT02038829|7524830|FG010|NOT COMPLETED|Washout Period 3||0
6600070|NCT02038829|7524831|FG011|NOT COMPLETED|Washout Period 3||0
6600071|NCT02038829|7524820|FG000|STARTED|Treatment Period 4||7
6600072|NCT02038829|7524821|FG001|STARTED|Treatment Period 4||8
6600073|NCT02038829|7524822|FG002|STARTED|Treatment Period 4||8
6600074|NCT02038829|7524823|FG003|STARTED|Treatment Period 4||8
6600075|NCT02038829|7524824|FG004|STARTED|Treatment Period 4||7
6600076|NCT02038829|7524825|FG005|STARTED|Treatment Period 4||7
6600077|NCT02038829|7524826|FG006|STARTED|Treatment Period 4||8
6600078|NCT02038829|7524827|FG007|STARTED|Treatment Period 4||8
6600079|NCT02038829|7524828|FG008|STARTED|Treatment Period 4||7
6600080|NCT02038829|7524829|FG009|STARTED|Treatment Period 4||8
6600081|NCT02038829|7524830|FG010|STARTED|Treatment Period 4||7
6600082|NCT02038829|7524831|FG011|STARTED|Treatment Period 4||8
6600083|NCT02038829|7524820|FG000|COMPLETED|Treatment Period 4||7
6600084|NCT02038829|7524821|FG001|COMPLETED|Treatment Period 4||7
6600085|NCT02038829|7524822|FG002|COMPLETED|Treatment Period 4||8
6600086|NCT02038829|7524823|FG003|COMPLETED|Treatment Period 4||8
6600087|NCT02038829|7524824|FG004|COMPLETED|Treatment Period 4||7
6600088|NCT02038829|7524825|FG005|COMPLETED|Treatment Period 4||7
6600089|NCT02038829|7524826|FG006|COMPLETED|Treatment Period 4||8
6600090|NCT02038829|7524827|FG007|COMPLETED|Treatment Period 4||8
6600091|NCT02038829|7524828|FG008|COMPLETED|Treatment Period 4||7
6600092|NCT02038829|7524829|FG009|COMPLETED|Treatment Period 4||8
6600093|NCT02038829|7524830|FG010|COMPLETED|Treatment Period 4||7
6600094|NCT02038829|7524831|FG011|COMPLETED|Treatment Period 4||8
6600095|NCT02038829|7524820|FG000|NOT COMPLETED|Treatment Period 4||0
6600096|NCT02038829|7524821|FG001|NOT COMPLETED|Treatment Period 4||1
6600097|NCT02038829|7524822|FG002|NOT COMPLETED|Treatment Period 4||0
6600098|NCT02038829|7524823|FG003|NOT COMPLETED|Treatment Period 4||0
6600099|NCT02038829|7524824|FG004|NOT COMPLETED|Treatment Period 4||0
6600100|NCT02038829|7524825|FG005|NOT COMPLETED|Treatment Period 4||0
6600101|NCT02038829|7524826|FG006|NOT COMPLETED|Treatment Period 4||0
6600102|NCT02038829|7524827|FG007|NOT COMPLETED|Treatment Period 4||0
6600103|NCT02038829|7524828|FG008|NOT COMPLETED|Treatment Period 4||0
6600104|NCT02038829|7524829|FG009|NOT COMPLETED|Treatment Period 4||0
6600105|NCT02038829|7524830|FG010|NOT COMPLETED|Treatment Period 4||0
6600106|NCT02038829|7524831|FG011|NOT COMPLETED|Treatment Period 4||0
6600107|NCT02038829|7524820|FG000|STARTED|Washout Period 4||7
6600108|NCT02038829|7524821|FG001|STARTED|Washout Period 4||7
6600109|NCT02038829|7524822|FG002|STARTED|Washout Period 4||8
6600110|NCT02038829|7524823|FG003|STARTED|Washout Period 4||8
6600111|NCT02038829|7524824|FG004|STARTED|Washout Period 4||7
6600112|NCT02038829|7524825|FG005|STARTED|Washout Period 4||7
6600113|NCT02038829|7524826|FG006|STARTED|Washout Period 4||8
6600114|NCT02038829|7524827|FG007|STARTED|Washout Period 4||8
6600115|NCT02038829|7524828|FG008|STARTED|Washout Period 4||7
6600116|NCT02038829|7524829|FG009|STARTED|Washout Period 4||8
6600117|NCT02038829|7524830|FG010|STARTED|Washout Period 4||7
6600118|NCT02038829|7524831|FG011|STARTED|Washout Period 4||8
6600119|NCT02038829|7524820|FG000|COMPLETED|Washout Period 4||7
6600120|NCT02038829|7524821|FG001|COMPLETED|Washout Period 4||7
6600121|NCT02038829|7524822|FG002|COMPLETED|Washout Period 4||8
6600122|NCT02038829|7524823|FG003|COMPLETED|Washout Period 4||8
6600123|NCT02038829|7524824|FG004|COMPLETED|Washout Period 4||7
6600124|NCT02038829|7524825|FG005|COMPLETED|Washout Period 4||7
6600125|NCT02038829|7524826|FG006|COMPLETED|Washout Period 4||7
6600126|NCT02038829|7524827|FG007|COMPLETED|Washout Period 4||8
6600127|NCT02038829|7524828|FG008|COMPLETED|Washout Period 4||7
6600128|NCT02038829|7524829|FG009|COMPLETED|Washout Period 4||8
6600129|NCT02038829|7524830|FG010|COMPLETED|Washout Period 4||7
6600130|NCT02038829|7524831|FG011|COMPLETED|Washout Period 4||8
6600131|NCT02038829|7524820|FG000|NOT COMPLETED|Washout Period 4||0
6600132|NCT02038829|7524821|FG001|NOT COMPLETED|Washout Period 4||0
6600133|NCT02038829|7524822|FG002|NOT COMPLETED|Washout Period 4||0
6600134|NCT02038829|7524823|FG003|NOT COMPLETED|Washout Period 4||0
6600135|NCT02038829|7524824|FG004|NOT COMPLETED|Washout Period 4||0
6600136|NCT02038829|7524825|FG005|NOT COMPLETED|Washout Period 4||0
6600137|NCT02038829|7524826|FG006|NOT COMPLETED|Washout Period 4||1
6600138|NCT02038829|7524827|FG007|NOT COMPLETED|Washout Period 4||0
6600139|NCT02038829|7524828|FG008|NOT COMPLETED|Washout Period 4||0
6600140|NCT02038829|7524829|FG009|NOT COMPLETED|Washout Period 4||0
6600141|NCT02038829|7524830|FG010|NOT COMPLETED|Washout Period 4||0
6600142|NCT02038829|7524831|FG011|NOT COMPLETED|Washout Period 4||0
6600143|NCT02038829|7524820|FG000|STARTED|Treatment Period 5||7
6600144|NCT02038829|7524821|FG001|STARTED|Treatment Period 5||7
6662490|NCT02512042|7593139|FG001|COMPLETED|Overall Study||453
6662491|NCT02512042|7593138|FG000|NOT COMPLETED|Overall Study||23
6662492|NCT02512042|7593139|FG001|NOT COMPLETED|Overall Study||25
6662493|NCT02512068|7593147|FG000|STARTED|Overall Study||55
6662494|NCT02512068|7593148|FG001|STARTED|Overall Study||52
6662495|NCT02512068|7593147|FG000|COMPLETED|Overall Study||43
6662496|NCT02512068|7593148|FG001|COMPLETED|Overall Study||39
6662497|NCT02512068|7593147|FG000|NOT COMPLETED|Overall Study||12
6662498|NCT02512068|7593148|FG001|NOT COMPLETED|Overall Study||13
6662499|NCT02512094|7593154|FG000|STARTED|Overall Study||53
6662500|NCT02512094|7593154|FG000|COMPLETED|Overall Study||53
6662501|NCT02512094|7593154|FG000|NOT COMPLETED|Overall Study||0
6662502|NCT02512224|7593160|FG000|STARTED|Overall Study||2912
6662503|NCT02512224|7593161|FG001|STARTED|Overall Study||2912
6662504|NCT02512224|7593160|FG000|COMPLETED|Overall Study||2912
6662505|NCT02512224|7593161|FG001|COMPLETED|Overall Study||2912
6662506|NCT02512224|7593160|FG000|NOT COMPLETED|Overall Study||0
6662507|NCT02512224|7593161|FG001|NOT COMPLETED|Overall Study||0
6662508|NCT02512276|7593169|FG000|STARTED|Overall Study||2038
6662509|NCT02512276|7593170|FG001|STARTED|Overall Study||2040
6662510|NCT02512276|7593169|FG000|COMPLETED|Overall Study||2030
6662511|NCT02512276|7593170|FG001|COMPLETED|Overall Study||2029
6662512|NCT02512276|7593169|FG000|NOT COMPLETED|Overall Study||8
6662513|NCT02512276|7593170|FG001|NOT COMPLETED|Overall Study||11
6662514|NCT02512302|7593176|FG000|STARTED|Period 1||3
6662515|NCT02512302|7593177|FG001|STARTED|Period 1||3
6662516|NCT02512302|7593178|FG002|STARTED|Period 1||4
6662517|NCT02512302|7593179|FG003|STARTED|Period 1||3
6662518|NCT02512302|7593180|FG004|STARTED|Period 1||3
6662519|NCT02512302|7593181|FG005|STARTED|Period 1||3
6662520|NCT02512302|7593182|FG006|STARTED|Period 1||2
6662521|NCT02512302|7593183|FG007|STARTED|Period 1||3
6662522|NCT02512302|7593184|FG008|STARTED|Period 1||3
6662523|NCT02512302|7593185|FG009|STARTED|Period 1||3
6662524|NCT02512302|7593176|FG000|COMPLETED|Period 1||3
6662525|NCT02512302|7593177|FG001|COMPLETED|Period 1||2
6662526|NCT02512302|7593178|FG002|COMPLETED|Period 1||4
6662527|NCT02512302|7593179|FG003|COMPLETED|Period 1||3
6662528|NCT02512302|7593180|FG004|COMPLETED|Period 1||3
6662529|NCT02512302|7593181|FG005|COMPLETED|Period 1||3
6662530|NCT02512302|7593182|FG006|COMPLETED|Period 1||2
6662531|NCT02512302|7593183|FG007|COMPLETED|Period 1||3
6662532|NCT02512302|7593184|FG008|COMPLETED|Period 1||3
6662533|NCT02512302|7593185|FG009|COMPLETED|Period 1||3
6662534|NCT02512302|7593176|FG000|NOT COMPLETED|Period 1||0
6662535|NCT02512302|7593177|FG001|NOT COMPLETED|Period 1||1
6662536|NCT02512302|7593178|FG002|NOT COMPLETED|Period 1||0
6662537|NCT02512302|7593179|FG003|NOT COMPLETED|Period 1||0
6662538|NCT02512302|7593180|FG004|NOT COMPLETED|Period 1||0
6662539|NCT02512302|7593181|FG005|NOT COMPLETED|Period 1||0
6662540|NCT02512302|7593182|FG006|NOT COMPLETED|Period 1||0
6662541|NCT02512302|7593183|FG007|NOT COMPLETED|Period 1||0
6662542|NCT02512302|7593184|FG008|NOT COMPLETED|Period 1||0
6662543|NCT02512302|7593185|FG009|NOT COMPLETED|Period 1||0
6662544|NCT02512302|7593176|FG000|STARTED|Period 2||3
6662545|NCT02512302|7593177|FG001|STARTED|Period 2||2
6662546|NCT02512302|7593178|FG002|STARTED|Period 2||4
6662547|NCT02512302|7593179|FG003|STARTED|Period 2||3
6662548|NCT02512302|7593180|FG004|STARTED|Period 2||3
6662549|NCT02512302|7593181|FG005|STARTED|Period 2||3
6662550|NCT02512302|7593182|FG006|STARTED|Period 2||2
6662551|NCT02512302|7593183|FG007|STARTED|Period 2||3
6662552|NCT02512302|7593184|FG008|STARTED|Period 2||3
6662553|NCT02512302|7593185|FG009|STARTED|Period 2||3
6662554|NCT02512302|7593176|FG000|COMPLETED|Period 2||3
6662555|NCT02512302|7593177|FG001|COMPLETED|Period 2||2
6662556|NCT02512302|7593178|FG002|COMPLETED|Period 2||4
6662557|NCT02512302|7593179|FG003|COMPLETED|Period 2||3
6662558|NCT02512302|7593180|FG004|COMPLETED|Period 2||3
6662559|NCT02512302|7593181|FG005|COMPLETED|Period 2||3
6662560|NCT02512302|7593182|FG006|COMPLETED|Period 2||2
6662561|NCT02512302|7593183|FG007|COMPLETED|Period 2||3
6662562|NCT02512302|7593184|FG008|COMPLETED|Period 2||3
6662563|NCT02512302|7593185|FG009|COMPLETED|Period 2||2
6662564|NCT02512302|7593176|FG000|NOT COMPLETED|Period 2||0
6662565|NCT02512302|7593177|FG001|NOT COMPLETED|Period 2||0
6600145|NCT02038829|7524822|FG002|STARTED|Treatment Period 5||8
6662566|NCT02512302|7593178|FG002|NOT COMPLETED|Period 2||0
6662567|NCT02512302|7593179|FG003|NOT COMPLETED|Period 2||0
6662568|NCT02512302|7593180|FG004|NOT COMPLETED|Period 2||0
6662569|NCT02512302|7593181|FG005|NOT COMPLETED|Period 2||0
6662570|NCT02512302|7593182|FG006|NOT COMPLETED|Period 2||0
6662571|NCT02512302|7593183|FG007|NOT COMPLETED|Period 2||0
6662572|NCT02512302|7593184|FG008|NOT COMPLETED|Period 2||0
6662573|NCT02512302|7593185|FG009|NOT COMPLETED|Period 2||1
6662574|NCT02512302|7593176|FG000|STARTED|Period 3||3
6662575|NCT02512302|7593177|FG001|STARTED|Period 3||2
6662576|NCT02512302|7593178|FG002|STARTED|Period 3||4
6662577|NCT02512302|7593179|FG003|STARTED|Period 3||3
6662578|NCT02512302|7593180|FG004|STARTED|Period 3||3
6662579|NCT02512302|7593181|FG005|STARTED|Period 3||3
6662580|NCT02512302|7593182|FG006|STARTED|Period 3||2
6662581|NCT02512302|7593183|FG007|STARTED|Period 3||3
6662582|NCT02512302|7593184|FG008|STARTED|Period 3||3
6662583|NCT02512302|7593185|FG009|STARTED|Period 3||2
6662584|NCT02512302|7593176|FG000|COMPLETED|Period 3||3
6662585|NCT02512302|7593177|FG001|COMPLETED|Period 3||2
6600146|NCT02038829|7524823|FG003|STARTED|Treatment Period 5||8
6600147|NCT02038829|7524824|FG004|STARTED|Treatment Period 5||7
6600148|NCT02038829|7524825|FG005|STARTED|Treatment Period 5||7
6600149|NCT02038829|7524826|FG006|STARTED|Treatment Period 5||7
6600150|NCT02038829|7524827|FG007|STARTED|Treatment Period 5||8
6600151|NCT02038829|7524828|FG008|STARTED|Treatment Period 5||7
6600152|NCT02038829|7524829|FG009|STARTED|Treatment Period 5||8
6600153|NCT02038829|7524830|FG010|STARTED|Treatment Period 5||7
6600154|NCT02038829|7524831|FG011|STARTED|Treatment Period 5||8
6600155|NCT02038829|7524820|FG000|COMPLETED|Treatment Period 5||7
6600156|NCT02038829|7524821|FG001|COMPLETED|Treatment Period 5||7
6600157|NCT02038829|7524822|FG002|COMPLETED|Treatment Period 5||8
6600158|NCT02038829|7524823|FG003|COMPLETED|Treatment Period 5||8
6600159|NCT02038829|7524824|FG004|COMPLETED|Treatment Period 5||7
6600160|NCT02038829|7524825|FG005|COMPLETED|Treatment Period 5||7
6600161|NCT02038829|7524826|FG006|COMPLETED|Treatment Period 5||7
6600162|NCT02038829|7524827|FG007|COMPLETED|Treatment Period 5||8
6600163|NCT02038829|7524828|FG008|COMPLETED|Treatment Period 5||7
6600164|NCT02038829|7524829|FG009|COMPLETED|Treatment Period 5||8
6600165|NCT02038829|7524830|FG010|COMPLETED|Treatment Period 5||7
6600166|NCT02038829|7524831|FG011|COMPLETED|Treatment Period 5||8
6600167|NCT02038829|7524820|FG000|NOT COMPLETED|Treatment Period 5||0
6600168|NCT02038829|7524821|FG001|NOT COMPLETED|Treatment Period 5||0
6600169|NCT02038829|7524822|FG002|NOT COMPLETED|Treatment Period 5||0
6600170|NCT02038829|7524823|FG003|NOT COMPLETED|Treatment Period 5||0
6600171|NCT02038829|7524824|FG004|NOT COMPLETED|Treatment Period 5||0
6600172|NCT02038829|7524825|FG005|NOT COMPLETED|Treatment Period 5||0
6600173|NCT02038829|7524826|FG006|NOT COMPLETED|Treatment Period 5||0
6600174|NCT02038829|7524827|FG007|NOT COMPLETED|Treatment Period 5||0
6600175|NCT02038829|7524828|FG008|NOT COMPLETED|Treatment Period 5||0
6600176|NCT02038829|7524829|FG009|NOT COMPLETED|Treatment Period 5||0
6600177|NCT02038829|7524830|FG010|NOT COMPLETED|Treatment Period 5||0
6600178|NCT02038829|7524831|FG011|NOT COMPLETED|Treatment Period 5||0
6600179|NCT02038829|7524820|FG000|STARTED|Washout Period 5||7
6600180|NCT02038829|7524821|FG001|STARTED|Washout Period 5||7
6600181|NCT02038829|7524822|FG002|STARTED|Washout Period 5||8
6600182|NCT02038829|7524823|FG003|STARTED|Washout Period 5||8
6662586|NCT02512302|7593178|FG002|COMPLETED|Period 3||3
6662587|NCT02512302|7593179|FG003|COMPLETED|Period 3||3
6662588|NCT02512302|7593180|FG004|COMPLETED|Period 3||3
6662589|NCT02512302|7593181|FG005|COMPLETED|Period 3||3
6662590|NCT02512302|7593182|FG006|COMPLETED|Period 3||2
6662591|NCT02512302|7593183|FG007|COMPLETED|Period 3||3
6662592|NCT02512302|7593184|FG008|COMPLETED|Period 3||3
6662593|NCT02512302|7593185|FG009|COMPLETED|Period 3||2
6662594|NCT02512302|7593176|FG000|NOT COMPLETED|Period 3||0
6662595|NCT02512302|7593177|FG001|NOT COMPLETED|Period 3||0
6662596|NCT02512302|7593178|FG002|NOT COMPLETED|Period 3||1
6662597|NCT02512302|7593179|FG003|NOT COMPLETED|Period 3||0
6662598|NCT02512302|7593180|FG004|NOT COMPLETED|Period 3||0
6662599|NCT02512302|7593181|FG005|NOT COMPLETED|Period 3||0
6662600|NCT02512302|7593182|FG006|NOT COMPLETED|Period 3||0
6662601|NCT02512302|7593183|FG007|NOT COMPLETED|Period 3||0
6662602|NCT02512302|7593184|FG008|NOT COMPLETED|Period 3||0
6662603|NCT02512302|7593185|FG009|NOT COMPLETED|Period 3||0
6662604|NCT02512302|7593176|FG000|STARTED|Period 4||3
6662605|NCT02512302|7593177|FG001|STARTED|Period 4||2
6662606|NCT02512302|7593178|FG002|STARTED|Period 4||3
6662607|NCT02512302|7593179|FG003|STARTED|Period 4||3
6662608|NCT02512302|7593180|FG004|STARTED|Period 4||3
6662609|NCT02512302|7593181|FG005|STARTED|Period 4||3
6662610|NCT02512302|7593182|FG006|STARTED|Period 4||2
6662611|NCT02512302|7593183|FG007|STARTED|Period 4||3
6662612|NCT02512302|7593184|FG008|STARTED|Period 4||3
6662613|NCT02512302|7593185|FG009|STARTED|Period 4||2
6662614|NCT02512302|7593176|FG000|COMPLETED|Period 4||3
6600183|NCT02038829|7524824|FG004|STARTED|Washout Period 5||7
6662615|NCT02512302|7593177|FG001|COMPLETED|Period 4||2
6662616|NCT02512302|7593178|FG002|COMPLETED|Period 4||3
6662617|NCT02512302|7593179|FG003|COMPLETED|Period 4||3
6662618|NCT02512302|7593180|FG004|COMPLETED|Period 4||3
6662619|NCT02512302|7593181|FG005|COMPLETED|Period 4||3
6662620|NCT02512302|7593182|FG006|COMPLETED|Period 4||1
6662621|NCT02512302|7593183|FG007|COMPLETED|Period 4||3
6662622|NCT02512302|7593184|FG008|COMPLETED|Period 4||3
6600184|NCT02038829|7524825|FG005|STARTED|Washout Period 5||7
6600185|NCT02038829|7524826|FG006|STARTED|Washout Period 5||7
6600186|NCT02038829|7524827|FG007|STARTED|Washout Period 5||8
6662623|NCT02512302|7593185|FG009|COMPLETED|Period 4||2
6662624|NCT02512302|7593176|FG000|NOT COMPLETED|Period 4||0
6662625|NCT02512302|7593177|FG001|NOT COMPLETED|Period 4||0
6662626|NCT02512302|7593178|FG002|NOT COMPLETED|Period 4||0
6662627|NCT02512302|7593179|FG003|NOT COMPLETED|Period 4||0
6662628|NCT02512302|7593180|FG004|NOT COMPLETED|Period 4||0
6662629|NCT02512302|7593181|FG005|NOT COMPLETED|Period 4||0
6600187|NCT02038829|7524828|FG008|STARTED|Washout Period 5||7
6600188|NCT02038829|7524829|FG009|STARTED|Washout Period 5||8
6600189|NCT02038829|7524830|FG010|STARTED|Washout Period 5||7
6662630|NCT02512302|7593182|FG006|NOT COMPLETED|Period 4||1
6662631|NCT02512302|7593183|FG007|NOT COMPLETED|Period 4||0
6662632|NCT02512302|7593184|FG008|NOT COMPLETED|Period 4||0
6662633|NCT02512302|7593185|FG009|NOT COMPLETED|Period 4||0
6600190|NCT02038829|7524831|FG011|STARTED|Washout Period 5||8
6600191|NCT02038829|7524820|FG000|COMPLETED|Washout Period 5||7
6600192|NCT02038829|7524821|FG001|COMPLETED|Washout Period 5||7
6600193|NCT02038829|7524822|FG002|COMPLETED|Washout Period 5||8
6600194|NCT02038829|7524823|FG003|COMPLETED|Washout Period 5||8
6600195|NCT02038829|7524824|FG004|COMPLETED|Washout Period 5||7
6600196|NCT02038829|7524825|FG005|COMPLETED|Washout Period 5||7
6600197|NCT02038829|7524826|FG006|COMPLETED|Washout Period 5||7
6600198|NCT02038829|7524827|FG007|COMPLETED|Washout Period 5||8
6600199|NCT02038829|7524828|FG008|COMPLETED|Washout Period 5||7
6600200|NCT02038829|7524829|FG009|COMPLETED|Washout Period 5||8
6600201|NCT02038829|7524830|FG010|COMPLETED|Washout Period 5||7
6600202|NCT02038829|7524831|FG011|COMPLETED|Washout Period 5||8
6600203|NCT02038829|7524820|FG000|NOT COMPLETED|Washout Period 5||0
6600204|NCT02038829|7524821|FG001|NOT COMPLETED|Washout Period 5||0
6600205|NCT02038829|7524822|FG002|NOT COMPLETED|Washout Period 5||0
6600206|NCT02038829|7524823|FG003|NOT COMPLETED|Washout Period 5||0
6600207|NCT02038829|7524824|FG004|NOT COMPLETED|Washout Period 5||0
6600208|NCT02038829|7524825|FG005|NOT COMPLETED|Washout Period 5||0
6600209|NCT02038829|7524826|FG006|NOT COMPLETED|Washout Period 5||0
6600210|NCT02038829|7524827|FG007|NOT COMPLETED|Washout Period 5||0
6600211|NCT02038829|7524828|FG008|NOT COMPLETED|Washout Period 5||0
6600212|NCT02038829|7524829|FG009|NOT COMPLETED|Washout Period 5||0
6600213|NCT02038829|7524830|FG010|NOT COMPLETED|Washout Period 5||0
6600214|NCT02038829|7524831|FG011|NOT COMPLETED|Washout Period 5||0
6600215|NCT02038829|7524820|FG000|STARTED|Treatment Period 6||7
6600216|NCT02038829|7524821|FG001|STARTED|Treatment Period 6||7
6600217|NCT02038829|7524822|FG002|STARTED|Treatment Period 6||8
6600218|NCT02038829|7524823|FG003|STARTED|Treatment Period 6||8
6600219|NCT02038829|7524824|FG004|STARTED|Treatment Period 6||7
6600220|NCT02038829|7524825|FG005|STARTED|Treatment Period 6||7
6600221|NCT02038829|7524826|FG006|STARTED|Treatment Period 6||7
6600222|NCT02038829|7524827|FG007|STARTED|Treatment Period 6||8
6600223|NCT02038829|7524828|FG008|STARTED|Treatment Period 6||7
6600224|NCT02038829|7524829|FG009|STARTED|Treatment Period 6||8
6600225|NCT02038829|7524830|FG010|STARTED|Treatment Period 6||7
6600226|NCT02038829|7524831|FG011|STARTED|Treatment Period 6||8
6600227|NCT02038829|7524820|FG000|COMPLETED|Treatment Period 6||7
6600228|NCT02038829|7524821|FG001|COMPLETED|Treatment Period 6||7
6600229|NCT02038829|7524822|FG002|COMPLETED|Treatment Period 6||7
6600230|NCT02038829|7524823|FG003|COMPLETED|Treatment Period 6||8
6600231|NCT02038829|7524824|FG004|COMPLETED|Treatment Period 6||7
6600232|NCT02038829|7524825|FG005|COMPLETED|Treatment Period 6||7
6600233|NCT02038829|7524826|FG006|COMPLETED|Treatment Period 6||7
6600234|NCT02038829|7524827|FG007|COMPLETED|Treatment Period 6||8
6600235|NCT02038829|7524828|FG008|COMPLETED|Treatment Period 6||7
6600236|NCT02038829|7524829|FG009|COMPLETED|Treatment Period 6||8
6600237|NCT02038829|7524830|FG010|COMPLETED|Treatment Period 6||7
6600238|NCT02038829|7524831|FG011|COMPLETED|Treatment Period 6||8
6600239|NCT02038829|7524820|FG000|NOT COMPLETED|Treatment Period 6||0
6600240|NCT02038829|7524821|FG001|NOT COMPLETED|Treatment Period 6||0
6600241|NCT02038829|7524822|FG002|NOT COMPLETED|Treatment Period 6||1
6600242|NCT02038829|7524823|FG003|NOT COMPLETED|Treatment Period 6||0
6600243|NCT02038829|7524824|FG004|NOT COMPLETED|Treatment Period 6||0
6600244|NCT02038829|7524825|FG005|NOT COMPLETED|Treatment Period 6||0
6600245|NCT02038829|7524826|FG006|NOT COMPLETED|Treatment Period 6||0
6600246|NCT02038829|7524827|FG007|NOT COMPLETED|Treatment Period 6||0
6600247|NCT02038829|7524828|FG008|NOT COMPLETED|Treatment Period 6||0
6662634|NCT02512302|7593176|FG000|STARTED|Period 5||3
6662635|NCT02512302|7593177|FG001|STARTED|Period 5||2
6662636|NCT02512302|7593178|FG002|STARTED|Period 5||3
6662637|NCT02512302|7593179|FG003|STARTED|Period 5||3
6662638|NCT02512302|7593180|FG004|STARTED|Period 5||3
6662639|NCT02512302|7593181|FG005|STARTED|Period 5||3
6662640|NCT02512302|7593182|FG006|STARTED|Period 5||1
6662641|NCT02512302|7593183|FG007|STARTED|Period 5||3
6662642|NCT02512302|7593184|FG008|STARTED|Period 5||3
6662643|NCT02512302|7593185|FG009|STARTED|Period 5||2
6662644|NCT02512302|7593176|FG000|COMPLETED|Period 5||3
6662645|NCT02512302|7593177|FG001|COMPLETED|Period 5||2
6662646|NCT02512302|7593178|FG002|COMPLETED|Period 5||3
6662647|NCT02512302|7593179|FG003|COMPLETED|Period 5||3
6662648|NCT02512302|7593180|FG004|COMPLETED|Period 5||3
6662649|NCT02512302|7593181|FG005|COMPLETED|Period 5||3
6662650|NCT02512302|7593182|FG006|COMPLETED|Period 5||1
6662651|NCT02512302|7593183|FG007|COMPLETED|Period 5||3
6662652|NCT02512302|7593184|FG008|COMPLETED|Period 5||3
6662653|NCT02512302|7593185|FG009|COMPLETED|Period 5||2
6662654|NCT02512302|7593176|FG000|NOT COMPLETED|Period 5||0
6600248|NCT02038829|7524829|FG009|NOT COMPLETED|Treatment Period 6||0
6600249|NCT02038829|7524830|FG010|NOT COMPLETED|Treatment Period 6||0
6600250|NCT02038829|7524831|FG011|NOT COMPLETED|Treatment Period 6||0
6600251|NCT02038881|7524849|FG000|STARTED|Overall Study||27
6600252|NCT02038881|7524850|FG001|STARTED|Overall Study||29
6600253|NCT02038881|7524851|FG002|STARTED|Overall Study||31
6600254|NCT02038881|7524849|FG000|COMPLETED|Overall Study||24
6600255|NCT02038881|7524850|FG001|COMPLETED|Overall Study||29
6662655|NCT02512302|7593177|FG001|NOT COMPLETED|Period 5||0
6662656|NCT02512302|7593178|FG002|NOT COMPLETED|Period 5||0
6662657|NCT02512302|7593179|FG003|NOT COMPLETED|Period 5||0
6662658|NCT02512302|7593180|FG004|NOT COMPLETED|Period 5||0
6662659|NCT02512302|7593181|FG005|NOT COMPLETED|Period 5||0
6600256|NCT02038881|7524851|FG002|COMPLETED|Overall Study||30
6600257|NCT02038881|7524849|FG000|NOT COMPLETED|Overall Study||3
6600258|NCT02038881|7524850|FG001|NOT COMPLETED|Overall Study||0
6600259|NCT02038881|7524851|FG002|NOT COMPLETED|Overall Study||1
6600260|NCT02038894|7524864|FG000|STARTED|Overall Study||60
6600261|NCT02038894|7524865|FG001|STARTED|Overall Study||58
6600262|NCT02038894|7524866|FG002|STARTED|Overall Study||61
6600263|NCT02038894|7524864|FG000|COMPLETED|Overall Study||60
6600264|NCT02038894|7524865|FG001|COMPLETED|Overall Study||58
6600265|NCT02038894|7524866|FG002|COMPLETED|Overall Study||61
6600266|NCT02038894|7524864|FG000|NOT COMPLETED|Overall Study||0
6600267|NCT02038894|7524865|FG001|NOT COMPLETED|Overall Study||0
6600268|NCT02038894|7524866|FG002|NOT COMPLETED|Overall Study||0
6600269|NCT02038907|7524892|FG000|STARTED|Overall Study||30
6600270|NCT02038907|7524893|FG001|STARTED|Overall Study||30
6600271|NCT02038907|7524894|FG002|STARTED|Overall Study||30
6600272|NCT02038907|7524895|FG003|STARTED|Overall Study||31
6600273|NCT02038907|7524896|FG004|STARTED|Overall Study||30
6600274|NCT02038907|7524897|FG005|STARTED|Overall Study||31
6600275|NCT02038907|7524898|FG006|STARTED|Overall Study||30
6600276|NCT02038907|7524899|FG007|STARTED|Overall Study||32
6600277|NCT02038907|7524900|FG008|STARTED|Overall Study||29
6600278|NCT02038907|7524901|FG009|STARTED|Overall Study||30
6600279|NCT02038907|7524902|FG010|STARTED|Overall Study||29
6600280|NCT02038907|7524903|FG011|STARTED|Overall Study||28
6600281|NCT02038907|7524904|FG012|STARTED|Overall Study||29
6600282|NCT02038907|7524905|FG013|STARTED|Overall Study||31
6600283|NCT02038907|7524892|FG000|COMPLETED|Overall Study||30
6600284|NCT02038907|7524893|FG001|COMPLETED|Overall Study||30
6600285|NCT02038907|7524894|FG002|COMPLETED|Overall Study||30
6600286|NCT02038907|7524895|FG003|COMPLETED|Overall Study||31
6600287|NCT02038907|7524896|FG004|COMPLETED|Overall Study||30
6600288|NCT02038907|7524897|FG005|COMPLETED|Overall Study||31
6600289|NCT02038907|7524898|FG006|COMPLETED|Overall Study||30
6600290|NCT02038907|7524899|FG007|COMPLETED|Overall Study||32
6600291|NCT02038907|7524900|FG008|COMPLETED|Overall Study||29
6600292|NCT02038907|7524901|FG009|COMPLETED|Overall Study||30
6600293|NCT02038907|7524902|FG010|COMPLETED|Overall Study||27
6600294|NCT02038907|7524903|FG011|COMPLETED|Overall Study||28
6600295|NCT02038907|7524904|FG012|COMPLETED|Overall Study||29
6600296|NCT02038907|7524905|FG013|COMPLETED|Overall Study||31
6600297|NCT02038907|7524892|FG000|NOT COMPLETED|Overall Study||0
6600298|NCT02038907|7524893|FG001|NOT COMPLETED|Overall Study||0
6600299|NCT02038907|7524894|FG002|NOT COMPLETED|Overall Study||0
6600300|NCT02038907|7524895|FG003|NOT COMPLETED|Overall Study||0
6600301|NCT02038907|7524896|FG004|NOT COMPLETED|Overall Study||0
6600302|NCT02038907|7524897|FG005|NOT COMPLETED|Overall Study||0
6600303|NCT02038907|7524898|FG006|NOT COMPLETED|Overall Study||0
6600304|NCT02038907|7524899|FG007|NOT COMPLETED|Overall Study||0
6600305|NCT02038907|7524900|FG008|NOT COMPLETED|Overall Study||0
6600306|NCT02038907|7524901|FG009|NOT COMPLETED|Overall Study||0
6600307|NCT02038907|7524902|FG010|NOT COMPLETED|Overall Study||2
6600308|NCT02038907|7524903|FG011|NOT COMPLETED|Overall Study||0
6600309|NCT02038907|7524904|FG012|NOT COMPLETED|Overall Study||0
6600310|NCT02038907|7524905|FG013|NOT COMPLETED|Overall Study||0
6662660|NCT02512302|7593182|FG006|NOT COMPLETED|Period 5||0
6662661|NCT02512302|7593183|FG007|NOT COMPLETED|Period 5||0
6662662|NCT02512302|7593184|FG008|NOT COMPLETED|Period 5||0
6662663|NCT02512302|7593185|FG009|NOT COMPLETED|Period 5||0
6662664|NCT02512393|7593200|FG000|STARTED|Overall Study||21
6662665|NCT02512393|7593201|FG001|STARTED|Overall Study||20
6600311|NCT02038920|7524939|FG000|STARTED|Induction Phase (Week 0 to 14)||79
6600312|NCT02038920|7524940|FG001|STARTED|Induction Phase (Week 0 to 14)||78
6600313|NCT02038920|7524941|FG002|STARTED|Induction Phase (Week 0 to 14)||0
6600314|NCT02038920|7524942|FG003|STARTED|Induction Phase (Week 0 to 14)||0
6600315|NCT02038920|7524943|FG004|STARTED|Induction Phase (Week 0 to 14)||0
6600316|NCT02038920|7524944|FG005|STARTED|Induction Phase (Week 0 to 14)||0
6600317|NCT02038920|7524939|FG000|COMPLETED|Induction Phase (Week 0 to 14)||73
6600318|NCT02038920|7524940|FG001|COMPLETED|Induction Phase (Week 0 to 14)||66
6600319|NCT02038920|7524941|FG002|COMPLETED|Induction Phase (Week 0 to 14)||0
6600320|NCT02038920|7524942|FG003|COMPLETED|Induction Phase (Week 0 to 14)||0
6662666|NCT02512393|7593200|FG000|COMPLETED|Overall Study||20
6662667|NCT02512393|7593201|FG001|COMPLETED|Overall Study||20
6600321|NCT02038920|7524943|FG004|COMPLETED|Induction Phase (Week 0 to 14)||0
6600322|NCT02038920|7524944|FG005|COMPLETED|Induction Phase (Week 0 to 14)||0
6600323|NCT02038920|7524939|FG000|NOT COMPLETED|Induction Phase (Week 0 to 14)||6
6600324|NCT02038920|7524940|FG001|NOT COMPLETED|Induction Phase (Week 0 to 14)||12
6600325|NCT02038920|7524941|FG002|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
6600326|NCT02038920|7524942|FG003|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
6600327|NCT02038920|7524943|FG004|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
6600328|NCT02038920|7524944|FG005|NOT COMPLETED|Induction Phase (Week 0 to 14)||0
6600329|NCT02038920|7524939|FG000|STARTED|Maintenance Phase (Week 14 to 60)||0
6600330|NCT02038920|7524940|FG001|STARTED|Maintenance Phase (Week 14 to 60)||0
6600331|NCT02038920|7524941|FG002|STARTED|Maintenance Phase (Week 14 to 60)||12
6600332|NCT02038920|7524942|FG003|STARTED|Maintenance Phase (Week 14 to 60)||12
6600333|NCT02038920|7524943|FG004|STARTED|Maintenance Phase (Week 14 to 60)||17
6600334|NCT02038920|7524944|FG005|STARTED|Maintenance Phase (Week 14 to 60)||0
6600335|NCT02038920|7524939|FG000|COMPLETED|Maintenance Phase (Week 14 to 60)||0
6600336|NCT02038920|7524940|FG001|COMPLETED|Maintenance Phase (Week 14 to 60)||0
6600337|NCT02038920|7524941|FG002|COMPLETED|Maintenance Phase (Week 14 to 60)||7
6600338|NCT02038920|7524942|FG003|COMPLETED|Maintenance Phase (Week 14 to 60)||4
6600339|NCT02038920|7524943|FG004|COMPLETED|Maintenance Phase (Week 14 to 60)||5
6600340|NCT02038920|7524944|FG005|COMPLETED|Maintenance Phase (Week 14 to 60)||0
6600341|NCT02038920|7524939|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
6600342|NCT02038920|7524940|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
6600343|NCT02038920|7524941|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||5
6600344|NCT02038920|7524942|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||8
6600345|NCT02038920|7524943|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||12
6600346|NCT02038920|7524944|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to 60)||0
6600347|NCT02038920|7524939|FG000|STARTED|Open Label Cohort (Week 10 to 154)||0
6600348|NCT02038920|7524940|FG001|STARTED|Open Label Cohort (Week 10 to 154)||0
6600349|NCT02038920|7524941|FG002|STARTED|Open Label Cohort (Week 10 to 154)||0
6600350|NCT02038920|7524942|FG003|STARTED|Open Label Cohort (Week 10 to 154)||0
6600351|NCT02038920|7524943|FG004|STARTED|Open Label Cohort (Week 10 to 154)||0
6600352|NCT02038920|7524944|FG005|STARTED|Open Label Cohort (Week 10 to 154)||134
6600353|NCT02038920|7524939|FG000|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600354|NCT02038920|7524940|FG001|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600355|NCT02038920|7524941|FG002|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600356|NCT02038920|7524942|FG003|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600357|NCT02038920|7524943|FG004|COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600358|NCT02038920|7524944|FG005|COMPLETED|Open Label Cohort (Week 10 to 154)||57
6600359|NCT02038920|7524939|FG000|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600360|NCT02038920|7524940|FG001|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600361|NCT02038920|7524941|FG002|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600362|NCT02038920|7524942|FG003|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600363|NCT02038920|7524943|FG004|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||0
6600364|NCT02038920|7524944|FG005|NOT COMPLETED|Open Label Cohort (Week 10 to 154)||77
6600365|NCT02038933|7524963|FG000|STARTED|Overall Study||121
6600366|NCT02038933|7524963|FG000|COMPLETED|Overall Study||0
6600367|NCT02038933|7524963|FG000|NOT COMPLETED|Overall Study||121
6600368|NCT02038959|7524970|FG000|STARTED|Overall Study||98
6600369|NCT02038959|7524971|FG001|STARTED|Overall Study||97
6600370|NCT02038959|7524970|FG000|COMPLETED|Overall Study||92
6600371|NCT02038959|7524971|FG001|COMPLETED|Overall Study||89
6600372|NCT02038959|7524970|FG000|NOT COMPLETED|Overall Study||6
6600373|NCT02038959|7524971|FG001|NOT COMPLETED|Overall Study||8
6600374|NCT02039115|7524979|FG000|STARTED|Overall Study||1
6600375|NCT02039115|7524980|FG001|STARTED|Overall Study||0
6600376|NCT02039115|7524979|FG000|COMPLETED|Overall Study||1
6600377|NCT02039115|7524980|FG001|COMPLETED|Overall Study||0
6600378|NCT02039115|7524979|FG000|NOT COMPLETED|Overall Study||0
6600379|NCT02039115|7524980|FG001|NOT COMPLETED|Overall Study||0
6600380|NCT02039219|7524988|FG000|STARTED|Treatment||11
6600381|NCT02039219|7524989|FG001|STARTED|Treatment||8
6600382|NCT02039219|7524988|FG000|COMPLETED|Treatment||7
6600383|NCT02039219|7524989|FG001|COMPLETED|Treatment||6
6600384|NCT02039219|7524988|FG000|NOT COMPLETED|Treatment||4
6600385|NCT02039219|7524989|FG001|NOT COMPLETED|Treatment||2
6662668|NCT02512393|7593200|FG000|NOT COMPLETED|Overall Study||1
6662669|NCT02512393|7593201|FG001|NOT COMPLETED|Overall Study||0
6662670|NCT02512419|7593209|FG000|STARTED|Overall Study||24
6662671|NCT02512419|7593210|FG001|STARTED|Overall Study||24
6662672|NCT02512419|7593209|FG000|COMPLETED|Overall Study|2 participants became ineligible after enrolling therefore were not included in analysis.|22
6662673|NCT02512419|7593210|FG001|COMPLETED|Overall Study||24
6662674|NCT02512419|7593209|FG000|NOT COMPLETED|Overall Study||2
6662675|NCT02512419|7593210|FG001|NOT COMPLETED|Overall Study||0
6662676|NCT02512575|7593226|FG000|STARTED|Overall Study||6
6662677|NCT02512575|7593227|FG001|STARTED|Overall Study||6
6600386|NCT02039219|7524988|FG000|STARTED|Follow up||7
6600387|NCT02039219|7524989|FG001|STARTED|Follow up||6
6600388|NCT02039219|7524988|FG000|COMPLETED|Follow up||7
6600389|NCT02039219|7524989|FG001|COMPLETED|Follow up||5
6600390|NCT02039219|7524988|FG000|NOT COMPLETED|Follow up||0
6662678|NCT02512575|7593228|FG002|STARTED|Overall Study||6
6600391|NCT02039219|7524989|FG001|NOT COMPLETED|Follow up||1
6600392|NCT02039375|7524995|FG000|STARTED|Overall Study||35
6600393|NCT02039375|7524995|FG000|COMPLETED|Overall Study||33
6600394|NCT02039375|7524995|FG000|NOT COMPLETED|Overall Study||2
6600395|NCT02039414|7525001|FG000|STARTED|Overall Study||22
6600396|NCT02039414|7525002|FG001|STARTED|Overall Study||18
6600397|NCT02039414|7525001|FG000|COMPLETED|Overall Study||16
6600398|NCT02039414|7525002|FG001|COMPLETED|Overall Study||16
6600399|NCT02039414|7525001|FG000|NOT COMPLETED|Overall Study||6
6600400|NCT02039414|7525002|FG001|NOT COMPLETED|Overall Study||2
6600401|NCT02039427|7525012|FG000|STARTED|Overall Study||48
6600402|NCT02039427|7525013|FG001|STARTED|Overall Study||48
6600403|NCT02039427|7525014|FG002|STARTED|Overall Study||48
6600404|NCT02039427|7525015|FG003|STARTED|Overall Study||48
6600405|NCT02039427|7525012|FG000|COMPLETED|Overall Study||45
6600406|NCT02039427|7525013|FG001|COMPLETED|Overall Study||47
6600407|NCT02039427|7525014|FG002|COMPLETED|Overall Study||45
6600408|NCT02039427|7525015|FG003|COMPLETED|Overall Study||43
6600409|NCT02039427|7525012|FG000|NOT COMPLETED|Overall Study||3
6600410|NCT02039427|7525013|FG001|NOT COMPLETED|Overall Study||1
6600411|NCT02039427|7525014|FG002|NOT COMPLETED|Overall Study||3
6600412|NCT02039427|7525015|FG003|NOT COMPLETED|Overall Study||5
6600413|NCT02039505|7525032|FG000|STARTED|Induction Phase (Week 0 to Week 14)||82
6600414|NCT02039505|7525033|FG001|STARTED|Induction Phase (Week 0 to Week 14)||164
6600415|NCT02039505|7525034|FG002|STARTED|Induction Phase (Week 0 to Week 14)||46
6600416|NCT02039505|7525035|FG003|STARTED|Induction Phase (Week 0 to Week 14)||0
6600417|NCT02039505|7525036|FG004|STARTED|Induction Phase (Week 0 to Week 14)||0
6600418|NCT02039505|7525037|FG005|STARTED|Induction Phase (Week 0 to Week 14)||0
6600419|NCT02039505|7525038|FG006|STARTED|Induction Phase (Week 0 to Week 14)||0
6600420|NCT02039505|7525032|FG000|COMPLETED|Induction Phase (Week 0 to Week 14)||78
6600421|NCT02039505|7525033|FG001|COMPLETED|Induction Phase (Week 0 to Week 14)||155
6600422|NCT02039505|7525034|FG002|COMPLETED|Induction Phase (Week 0 to Week 14)||36
6600423|NCT02039505|7525035|FG003|COMPLETED|Induction Phase (Week 0 to Week 14)||0
6600424|NCT02039505|7525036|FG004|COMPLETED|Induction Phase (Week 0 to Week 14)||0
6600425|NCT02039505|7525037|FG005|COMPLETED|Induction Phase (Week 0 to Week 14)||0
6600426|NCT02039505|7525038|FG006|COMPLETED|Induction Phase (Week 0 to Week 14)||0
6600427|NCT02039505|7525032|FG000|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||4
6600428|NCT02039505|7525033|FG001|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||9
6600429|NCT02039505|7525034|FG002|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||10
6600430|NCT02039505|7525035|FG003|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
6600431|NCT02039505|7525036|FG004|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
6600432|NCT02039505|7525037|FG005|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
6600433|NCT02039505|7525038|FG006|NOT COMPLETED|Induction Phase (Week 0 to Week 14)||0
6600434|NCT02039505|7525032|FG000|STARTED|Maintenance Phase (Week 14 to Week 60)||0
6600435|NCT02039505|7525033|FG001|STARTED|Maintenance Phase (Week 14 to Week 60)||0
6600436|NCT02039505|7525034|FG002|STARTED|Maintenance Phase (Week 14 to Week 60)||0
6600437|NCT02039505|7525035|FG003|STARTED|Maintenance Phase (Week 14 to Week 60)||42
6600438|NCT02039505|7525036|FG004|STARTED|Maintenance Phase (Week 14 to Week 60)||41
6600439|NCT02039505|7525037|FG005|STARTED|Maintenance Phase (Week 14 to Week 60)||26
6600440|NCT02039505|7525038|FG006|STARTED|Maintenance Phase (Week 14 to Week 60)||0
6600441|NCT02039505|7525032|FG000|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6600442|NCT02039505|7525033|FG001|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6600443|NCT02039505|7525034|FG002|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6600444|NCT02039505|7525035|FG003|COMPLETED|Maintenance Phase (Week 14 to Week 60)||18
6600445|NCT02039505|7525036|FG004|COMPLETED|Maintenance Phase (Week 14 to Week 60)||30
6600446|NCT02039505|7525037|FG005|COMPLETED|Maintenance Phase (Week 14 to Week 60)||12
6600447|NCT02039505|7525038|FG006|COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6600448|NCT02039505|7525032|FG000|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6600449|NCT02039505|7525033|FG001|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6600450|NCT02039505|7525034|FG002|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6600451|NCT02039505|7525035|FG003|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||24
6600452|NCT02039505|7525036|FG004|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||11
6600453|NCT02039505|7525037|FG005|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||14
6600454|NCT02039505|7525038|FG006|NOT COMPLETED|Maintenance Phase (Week 14 to Week 60)||0
6600455|NCT02039505|7525032|FG000|STARTED|Open-Label (Week 10 up to Week 154)||0
6600456|NCT02039505|7525033|FG001|STARTED|Open-Label (Week 10 up to Week 154)||0
6600457|NCT02039505|7525034|FG002|STARTED|Open-Label (Week 10 up to Week 154)||0
6600458|NCT02039505|7525035|FG003|STARTED|Open-Label (Week 10 up to Week 154)||0
6600459|NCT02039505|7525036|FG004|STARTED|Open-Label (Week 10 up to Week 154)||0
6600460|NCT02039505|7525037|FG005|STARTED|Open-Label (Week 10 up to Week 154)||0
6600461|NCT02039505|7525038|FG006|STARTED|Open-Label (Week 10 up to Week 154)||259
6600462|NCT02039505|7525032|FG000|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600463|NCT02039505|7525033|FG001|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600464|NCT02039505|7525034|FG002|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600465|NCT02039505|7525035|FG003|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600466|NCT02039505|7525036|FG004|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600467|NCT02039505|7525037|FG005|COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600468|NCT02039505|7525038|FG006|COMPLETED|Open-Label (Week 10 up to Week 154)||188
6600469|NCT02039505|7525032|FG000|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600470|NCT02039505|7525033|FG001|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600471|NCT02039505|7525034|FG002|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600472|NCT02039505|7525035|FG003|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600473|NCT02039505|7525036|FG004|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600474|NCT02039505|7525037|FG005|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||0
6600475|NCT02039505|7525038|FG006|NOT COMPLETED|Open-Label (Week 10 up to Week 154)||71
6600476|NCT02039674|7525072|FG000|STARTED|Overall Study||13
6600477|NCT02039674|7525073|FG001|STARTED|Overall Study||12
6600478|NCT02039674|7525074|FG002|STARTED|Overall Study||12
6600479|NCT02039674|7525075|FG003|STARTED|Overall Study||13
6600480|NCT02039674|7525076|FG004|STARTED|Overall Study||12
6600481|NCT02039674|7525077|FG005|STARTED|Overall Study||12
6600482|NCT02039674|7525078|FG006|STARTED|Overall Study||3
6600483|NCT02039674|7525079|FG007|STARTED|Overall Study||3
6600484|NCT02039674|7525080|FG008|STARTED|Overall Study||12
6600485|NCT02039674|7525081|FG009|STARTED|Overall Study||12
6600486|NCT02039674|7525082|FG010|STARTED|Overall Study||7
6600487|NCT02039674|7525083|FG011|STARTED|Overall Study||60
6600488|NCT02039674|7525084|FG012|STARTED|Overall Study||63
6600489|NCT02039674|7525085|FG013|STARTED|Overall Study||33
6600490|NCT02039674|7525072|FG000|Treated|Overall Study||13
6600491|NCT02039674|7525073|FG001|Treated|Overall Study||12
6600492|NCT02039674|7525074|FG002|Treated|Overall Study||11
6600493|NCT02039674|7525075|FG003|Treated|Overall Study||13
6600494|NCT02039674|7525076|FG004|Treated|Overall Study||12
6600495|NCT02039674|7525077|FG005|Treated|Overall Study||12
6600496|NCT02039674|7525078|FG006|Treated|Overall Study||3
6600497|NCT02039674|7525079|FG007|Treated|Overall Study||3
6600498|NCT02039674|7525080|FG008|Treated|Overall Study||12
6600499|NCT02039674|7525081|FG009|Treated|Overall Study||12
6600500|NCT02039674|7525082|FG010|Treated|Overall Study||7
6600501|NCT02039674|7525083|FG011|Treated|Overall Study||59
6600502|NCT02039674|7525084|FG012|Treated|Overall Study||62
6600503|NCT02039674|7525085|FG013|Treated|Overall Study||33
6600504|NCT02039674|7525072|FG000|COMPLETED|Overall Study||1
6600505|NCT02039674|7525073|FG001|COMPLETED|Overall Study||0
6600506|NCT02039674|7525074|FG002|COMPLETED|Overall Study||0
6662679|NCT02512575|7593229|FG003|STARTED|Overall Study||6
6662680|NCT02512575|7593230|FG004|STARTED|Overall Study||6
6662681|NCT02512575|7593231|FG005|STARTED|Overall Study||6
6662682|NCT02512575|7593232|FG006|STARTED|Overall Study||6
6662683|NCT02512575|7593233|FG007|STARTED|Overall Study||6
6662684|NCT02512575|7593234|FG008|STARTED|Overall Study||6
6662685|NCT02512575|7593235|FG009|STARTED|Overall Study||18
6662686|NCT02512575|7593226|FG000|COMPLETED|Overall Study||6
6662687|NCT02512575|7593227|FG001|COMPLETED|Overall Study||6
6662688|NCT02512575|7593228|FG002|COMPLETED|Overall Study||6
6662689|NCT02512575|7593229|FG003|COMPLETED|Overall Study||6
6662690|NCT02512575|7593230|FG004|COMPLETED|Overall Study||6
6662691|NCT02512575|7593231|FG005|COMPLETED|Overall Study||6
6662692|NCT02512575|7593232|FG006|COMPLETED|Overall Study||6
6662693|NCT02512575|7593233|FG007|COMPLETED|Overall Study||6
6662694|NCT02512575|7593234|FG008|COMPLETED|Overall Study||6
6662695|NCT02512575|7593235|FG009|COMPLETED|Overall Study||18
6662696|NCT02512575|7593226|FG000|NOT COMPLETED|Overall Study||0
6662697|NCT02512575|7593227|FG001|NOT COMPLETED|Overall Study||0
6662698|NCT02512575|7593228|FG002|NOT COMPLETED|Overall Study||0
6662699|NCT02512575|7593229|FG003|NOT COMPLETED|Overall Study||0
6662700|NCT02512575|7593230|FG004|NOT COMPLETED|Overall Study||0
6662701|NCT02512575|7593231|FG005|NOT COMPLETED|Overall Study||0
6662702|NCT02512575|7593232|FG006|NOT COMPLETED|Overall Study||0
6662703|NCT02512575|7593233|FG007|NOT COMPLETED|Overall Study||0
6662704|NCT02512575|7593234|FG008|NOT COMPLETED|Overall Study||0
6662705|NCT02512575|7593235|FG009|NOT COMPLETED|Overall Study||0
6662706|NCT02512679|7593257|FG000|STARTED|Overall Study||20
6662707|NCT02512679|7593258|FG001|STARTED|Overall Study||0
6662708|NCT02512679|7593257|FG000|COMPLETED|Overall Study||20
6662709|NCT02512679|7593258|FG001|COMPLETED|Overall Study||0
6662710|NCT02512679|7593257|FG000|NOT COMPLETED|Overall Study||0
6662711|NCT02512679|7593258|FG001|NOT COMPLETED|Overall Study||0
6600507|NCT02039674|7525075|FG003|COMPLETED|Overall Study||0
6600508|NCT02039674|7525076|FG004|COMPLETED|Overall Study||0
6600509|NCT02039674|7525077|FG005|COMPLETED|Overall Study||0
6600510|NCT02039674|7525078|FG006|COMPLETED|Overall Study||0
6600511|NCT02039674|7525079|FG007|COMPLETED|Overall Study||0
6600512|NCT02039674|7525080|FG008|COMPLETED|Overall Study||0
6600513|NCT02039674|7525081|FG009|COMPLETED|Overall Study||0
6600514|NCT02039674|7525082|FG010|COMPLETED|Overall Study||0
6600515|NCT02039674|7525083|FG011|COMPLETED|Overall Study||0
6600516|NCT02039674|7525084|FG012|COMPLETED|Overall Study||0
6662712|NCT02512783|7593264|FG000|STARTED|Overall Study||96
6662713|NCT02512783|7593265|FG001|STARTED|Overall Study||75
6662714|NCT02512783|7593264|FG000|COMPLETED|Overall Study||96
6662715|NCT02512783|7593265|FG001|COMPLETED|Overall Study||75
6662716|NCT02512783|7593264|FG000|NOT COMPLETED|Overall Study||0
6662717|NCT02512783|7593265|FG001|NOT COMPLETED|Overall Study||0
6662718|NCT02512809|7593274|FG000|STARTED|Overall Study||25
6662719|NCT02512809|7593274|FG000|COMPLETED|Overall Study||25
6662720|NCT02512809|7593274|FG000|NOT COMPLETED|Overall Study||0
6600517|NCT02039674|7525085|FG013|COMPLETED|Overall Study||0
6600518|NCT02039674|7525072|FG000|NOT COMPLETED|Overall Study||12
6600519|NCT02039674|7525073|FG001|NOT COMPLETED|Overall Study||12
6600520|NCT02039674|7525074|FG002|NOT COMPLETED|Overall Study||12
6600521|NCT02039674|7525075|FG003|NOT COMPLETED|Overall Study||13
6600522|NCT02039674|7525076|FG004|NOT COMPLETED|Overall Study||12
6600523|NCT02039674|7525077|FG005|NOT COMPLETED|Overall Study||12
6600524|NCT02039674|7525078|FG006|NOT COMPLETED|Overall Study||3
6600525|NCT02039674|7525079|FG007|NOT COMPLETED|Overall Study||3
6600526|NCT02039674|7525080|FG008|NOT COMPLETED|Overall Study||12
6600527|NCT02039674|7525081|FG009|NOT COMPLETED|Overall Study||12
6600528|NCT02039674|7525082|FG010|NOT COMPLETED|Overall Study||7
6600529|NCT02039674|7525083|FG011|NOT COMPLETED|Overall Study||60
6600530|NCT02039674|7525084|FG012|NOT COMPLETED|Overall Study||63
6600531|NCT02039674|7525085|FG013|NOT COMPLETED|Overall Study||33
6600532|NCT02039687|7525122|FG000|STARTED|Overall Study||16
6600533|NCT02039687|7525123|FG001|STARTED|Overall Study||16
6600534|NCT02039687|7525124|FG002|STARTED|Overall Study||16
6600535|NCT02039687|7525125|FG003|STARTED|Overall Study||16
6600536|NCT02039687|7525122|FG000|COMPLETED|Overall Study||16
6600537|NCT02039687|7525123|FG001|COMPLETED|Overall Study||15
6600538|NCT02039687|7525124|FG002|COMPLETED|Overall Study||13
6600539|NCT02039687|7525125|FG003|COMPLETED|Overall Study||16
6600540|NCT02039687|7525122|FG000|NOT COMPLETED|Overall Study||0
6600541|NCT02039687|7525123|FG001|NOT COMPLETED|Overall Study||1
6600542|NCT02039687|7525124|FG002|NOT COMPLETED|Overall Study||3
6600543|NCT02039687|7525125|FG003|NOT COMPLETED|Overall Study||0
6600544|NCT02039726|7525137|FG000|STARTED|Overall Study||245
6600545|NCT02039726|7525138|FG001|STARTED|Overall Study||122
6600546|NCT02039726|7525137|FG000|Ongoing (as of Data Cutoff)|Overall Study||45
6600547|NCT02039726|7525138|FG001|Ongoing (as of Data Cutoff)|Overall Study||16
6600548|NCT02039726|7525137|FG000|Did Not Receive Treatment|Overall Study||4
6600549|NCT02039726|7525138|FG001|Did Not Receive Treatment|Overall Study||28
6600550|NCT02039726|7525137|FG000|COMPLETED|Overall Study||200
6600551|NCT02039726|7525138|FG001|COMPLETED|Overall Study||106
6600552|NCT02039726|7525137|FG000|NOT COMPLETED|Overall Study||45
6600553|NCT02039726|7525138|FG001|NOT COMPLETED|Overall Study||16
6600554|NCT02039778|7525144|FG000|STARTED|Overall Study||4
6600555|NCT02039778|7525144|FG000|COMPLETED|Overall Study||0
6600556|NCT02039778|7525144|FG000|NOT COMPLETED|Overall Study||4
6600557|NCT02039817|7525150|FG000|STARTED|Overall Study||8
6600558|NCT02039817|7525151|FG001|STARTED|Overall Study||8
6600559|NCT02039817|7525150|FG000|COMPLETED|Overall Study||8
6600560|NCT02039817|7525151|FG001|COMPLETED|Overall Study||8
6600561|NCT02039817|7525150|FG000|NOT COMPLETED|Overall Study||0
6600562|NCT02039817|7525151|FG001|NOT COMPLETED|Overall Study||0
6600563|NCT02039856|7525158|FG000|STARTED|Overall Study||2720
6600564|NCT02039856|7525159|FG001|STARTED|Overall Study||1180
6600565|NCT02039856|7525158|FG000|Baseline Started - Patients|Overall Study||2183
6600566|NCT02039856|7525159|FG001|Baseline Started - Patients|Overall Study||919
6600567|NCT02039856|7525158|FG000|Baseline Completed - Patients|Overall Study||953
6600568|NCT02039856|7525159|FG001|Baseline Completed - Patients|Overall Study||442
6600569|NCT02039856|7525158|FG000|Baseline Started - Providers/Staff|Overall Study||537
6600570|NCT02039856|7525159|FG001|Baseline Started - Providers/Staff|Overall Study||261
6600571|NCT02039856|7525158|FG000|Baseline Completed -Providers/Staff|Overall Study||194
6600572|NCT02039856|7525159|FG001|Baseline Completed -Providers/Staff|Overall Study||94
6600573|NCT02039856|7525158|FG000|Total Baseline Completed|Overall Study||1147
6600574|NCT02039856|7525159|FG001|Total Baseline Completed|Overall Study||536
6600575|NCT02039856|7525158|FG000|12-month Started-patients|Overall Study||953
6662721|NCT02512861|7593280|FG000|STARTED|Overall Study||44
6662722|NCT02512861|7593281|FG001|STARTED|Overall Study||49
6662723|NCT02512861|7593280|FG000|COMPLETED|Overall Study||38
6662724|NCT02512861|7593281|FG001|COMPLETED|Overall Study||40
6662725|NCT02512861|7593280|FG000|NOT COMPLETED|Overall Study||6
6662726|NCT02512861|7593281|FG001|NOT COMPLETED|Overall Study||9
6662727|NCT02512874|7593287|FG000|STARTED|Overall Study||65
6662728|NCT02512874|7593287|FG000|COMPLETED|Overall Study||63
6662729|NCT02512874|7593287|FG000|NOT COMPLETED|Overall Study||2
6662730|NCT02512900|7593293|FG000|STARTED|Overall Study||11
6662731|NCT02512900|7593294|FG001|STARTED|Overall Study||10
6662732|NCT02512900|7593293|FG000|COMPLETED|Overall Study||11
6662733|NCT02512900|7593294|FG001|COMPLETED|Overall Study||10
6662734|NCT02512900|7593293|FG000|NOT COMPLETED|Overall Study||0
6662735|NCT02512900|7593294|FG001|NOT COMPLETED|Overall Study||0
6662736|NCT02512965|7593303|FG000|STARTED|Overall Study||115
6662737|NCT02512965|7593304|FG001|STARTED|Overall Study||114
6662738|NCT02512965|7593303|FG000|COMPLETED|Overall Study||115
6662739|NCT02512965|7593304|FG001|COMPLETED|Overall Study|4 patients did not receive any dose of the assigned treatment.|110
6600576|NCT02039856|7525159|FG001|12-month Started-patients|Overall Study||442
6600577|NCT02039856|7525158|FG000|12-month Completed- Patients|Overall Study||580
6600578|NCT02039856|7525159|FG001|12-month Completed- Patients|Overall Study||241
6600579|NCT02039856|7525158|FG000|12-month Providers/Staff|Overall Study||0
6600580|NCT02039856|7525159|FG001|12-month Providers/Staff|Overall Study||0
6600581|NCT02039856|7525158|FG000|24-month Started|Overall Study||1518
6662740|NCT02512965|7593303|FG000|NOT COMPLETED|Overall Study||0
6662741|NCT02512965|7593304|FG001|NOT COMPLETED|Overall Study||4
6662742|NCT02513095|7593312|FG000|STARTED|Overall Study||17
6662743|NCT02513095|7593313|FG001|STARTED|Overall Study||17
6600582|NCT02039856|7525159|FG001|24-month Started|Overall Study||746
6600583|NCT02039856|7525158|FG000|24-month Started - Patients|Overall Study||953
6600584|NCT02039856|7525159|FG001|24-month Started - Patients|Overall Study||442
6600585|NCT02039856|7525158|FG000|24-month Completed - Patients|Overall Study||519
6600586|NCT02039856|7525159|FG001|24-month Completed - Patients|Overall Study||222
6600587|NCT02039856|7525158|FG000|24-month Started Providers/Staff|Overall Study||565
6600588|NCT02039856|7525159|FG001|24-month Started Providers/Staff|Overall Study||304
6600589|NCT02039856|7525158|FG000|24-month Completed Providers/Staff|Overall Study||174
6600590|NCT02039856|7525159|FG001|24-month Completed Providers/Staff|Overall Study||105
6600591|NCT02039856|7525158|FG000|Total 24-month Completed|Overall Study||693
6600592|NCT02039856|7525159|FG001|Total 24-month Completed|Overall Study||327
6600593|NCT02039856|7525158|FG000|COMPLETED|Overall Study||693
6600594|NCT02039856|7525159|FG001|COMPLETED|Overall Study||327
6600595|NCT02039856|7525158|FG000|NOT COMPLETED|Overall Study||2027
6600596|NCT02039856|7525159|FG001|NOT COMPLETED|Overall Study||853
6600597|NCT02039908|7525167|FG000|STARTED|Phase 1-Summer||129
6600598|NCT02039908|7525168|FG001|STARTED|Phase 1-Summer||138
6600599|NCT02039908|7525169|FG002|STARTED|Phase 1-Summer||0
6600600|NCT02039908|7525170|FG003|STARTED|Phase 1-Summer||0
6600601|NCT02039908|7525167|FG000|COMPLETED|Phase 1-Summer||116
6662744|NCT02513095|7593312|FG000|Treatment Phase - Up to 120 Minutes|Overall Study||17
6662745|NCT02513095|7593313|FG001|Treatment Phase - Up to 120 Minutes|Overall Study||17
6662746|NCT02513095|7593312|FG000|COMPLETED|Overall Study||17
6662747|NCT02513095|7593313|FG001|COMPLETED|Overall Study||17
6662748|NCT02513095|7593312|FG000|NOT COMPLETED|Overall Study||0
6662749|NCT02513095|7593313|FG001|NOT COMPLETED|Overall Study||0
6662750|NCT02513121|7593321|FG000|STARTED|Overall Study||20
6662751|NCT02513121|7593322|FG001|STARTED|Overall Study||20
6662752|NCT02513121|7593321|FG000|COMPLETED|Overall Study||20
6662753|NCT02513121|7593322|FG001|COMPLETED|Overall Study||20
6662754|NCT02513121|7593321|FG000|NOT COMPLETED|Overall Study||0
6662755|NCT02513121|7593322|FG001|NOT COMPLETED|Overall Study||0
6662756|NCT02513160|7593334|FG000|STARTED|Run-In Period (Days -14 to Day -1)|Enrolled|713
6662757|NCT02513160|7593335|FG001|STARTED|Run-In Period (Days -14 to Day -1)||0
6662758|NCT02513160|7593336|FG002|STARTED|Run-In Period (Days -14 to Day -1)||0
6662759|NCT02513160|7593337|FG003|STARTED|Run-In Period (Days -14 to Day -1)||0
6662760|NCT02513160|7593334|FG000|COMPLETED|Run-In Period (Days -14 to Day -1)||425
6662761|NCT02513160|7593335|FG001|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6662762|NCT02513160|7593336|FG002|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6662763|NCT02513160|7593337|FG003|COMPLETED|Run-In Period (Days -14 to Day -1)||0
6662764|NCT02513160|7593334|FG000|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||288
6662765|NCT02513160|7593335|FG001|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6662766|NCT02513160|7593336|FG002|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6662767|NCT02513160|7593337|FG003|NOT COMPLETED|Run-In Period (Days -14 to Day -1)||0
6662768|NCT02513160|7593334|FG000|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|107
6662769|NCT02513160|7593335|FG001|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|108
6662770|NCT02513160|7593336|FG002|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
6662771|NCT02513160|7593337|FG003|STARTED|Treatment Period (Day 0 to Week 6)|Randomized|105
6662772|NCT02513160|7593334|FG000|COMPLETED|Treatment Period (Day 0 to Week 6)||101
6662773|NCT02513160|7593335|FG001|COMPLETED|Treatment Period (Day 0 to Week 6)||104
6662774|NCT02513160|7593336|FG002|COMPLETED|Treatment Period (Day 0 to Week 6)||104
6662775|NCT02513160|7593337|FG003|COMPLETED|Treatment Period (Day 0 to Week 6)||103
6662776|NCT02513160|7593334|FG000|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||6
6662777|NCT02513160|7593335|FG001|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||4
6662778|NCT02513160|7593336|FG002|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||1
6662779|NCT02513160|7593337|FG003|NOT COMPLETED|Treatment Period (Day 0 to Week 6)||2
6662780|NCT02513212|7593350|FG000|STARTED|Overall Study||12
6662781|NCT02513212|7593351|FG001|STARTED|Overall Study||12
6662782|NCT02513212|7593350|FG000|COMPLETED|Overall Study||11
6662783|NCT02513212|7593351|FG001|COMPLETED|Overall Study||12
6662784|NCT02513212|7593350|FG000|NOT COMPLETED|Overall Study||1
6662785|NCT02513212|7593351|FG001|NOT COMPLETED|Overall Study||0
6662786|NCT02513446|7593359|FG000|STARTED|Period 1||8
6662787|NCT02513446|7593360|FG001|STARTED|Period 1||8
6662788|NCT02513446|7593359|FG000|COMPLETED|Period 1||8
6662789|NCT02513446|7593360|FG001|COMPLETED|Period 1||8
6662790|NCT02513446|7593359|FG000|NOT COMPLETED|Period 1||0
6662791|NCT02513446|7593360|FG001|NOT COMPLETED|Period 1||0
6662792|NCT02513446|7593359|FG000|STARTED|Washout Period of 10 Days||8
6662793|NCT02513446|7593360|FG001|STARTED|Washout Period of 10 Days||8
6662794|NCT02513446|7593359|FG000|COMPLETED|Washout Period of 10 Days||8
6662795|NCT02513446|7593360|FG001|COMPLETED|Washout Period of 10 Days||8
6662796|NCT02513446|7593359|FG000|NOT COMPLETED|Washout Period of 10 Days||0
6662797|NCT02513446|7593360|FG001|NOT COMPLETED|Washout Period of 10 Days||0
6662798|NCT02513446|7593359|FG000|STARTED|Period 2||8
6662799|NCT02513446|7593360|FG001|STARTED|Period 2||8
6662800|NCT02513446|7593359|FG000|COMPLETED|Period 2||8
6662801|NCT02513446|7593360|FG001|COMPLETED|Period 2||8
6662802|NCT02513446|7593359|FG000|NOT COMPLETED|Period 2||0
6662803|NCT02513446|7593360|FG001|NOT COMPLETED|Period 2||0
6662804|NCT02513459|7593367|FG000|STARTED|Overall Study||65
6662805|NCT02513459|7593367|FG000|COMPLETED|Overall Study||44
6662806|NCT02513459|7593367|FG000|NOT COMPLETED|Overall Study||21
6662807|NCT02513472|7593378|FG000|STARTED|Overall Study||66
6662808|NCT02513472|7593379|FG001|STARTED|Overall Study||101
6600602|NCT02039908|7525168|FG001|COMPLETED|Phase 1-Summer||132
6600603|NCT02039908|7525169|FG002|COMPLETED|Phase 1-Summer||0
6600604|NCT02039908|7525170|FG003|COMPLETED|Phase 1-Summer||0
6600605|NCT02039908|7525167|FG000|NOT COMPLETED|Phase 1-Summer||13
6600606|NCT02039908|7525168|FG001|NOT COMPLETED|Phase 1-Summer||6
6600607|NCT02039908|7525169|FG002|NOT COMPLETED|Phase 1-Summer||0
6600608|NCT02039908|7525170|FG003|NOT COMPLETED|Phase 1-Summer||0
6600609|NCT02039908|7525167|FG000|STARTED|Phase 2-School Year||0
6600610|NCT02039908|7525168|FG001|STARTED|Phase 2-School Year||0
6600611|NCT02039908|7525169|FG002|STARTED|Phase 2-School Year||121
6600612|NCT02039908|7525170|FG003|STARTED|Phase 2-School Year||124
6600613|NCT02039908|7525167|FG000|COMPLETED|Phase 2-School Year||0
6600614|NCT02039908|7525168|FG001|COMPLETED|Phase 2-School Year||0
6600615|NCT02039908|7525169|FG002|COMPLETED|Phase 2-School Year||109
6600616|NCT02039908|7525170|FG003|COMPLETED|Phase 2-School Year||116
6600617|NCT02039908|7525167|FG000|NOT COMPLETED|Phase 2-School Year||0
6600618|NCT02039908|7525168|FG001|NOT COMPLETED|Phase 2-School Year||0
6600619|NCT02039908|7525169|FG002|NOT COMPLETED|Phase 2-School Year||12
6600620|NCT02039908|7525170|FG003|NOT COMPLETED|Phase 2-School Year||8
6600621|NCT02039947|7525182|FG000|STARTED|Overall Study||76
6600622|NCT02039947|7525183|FG001|STARTED|Overall Study||16
6600623|NCT02039947|7525184|FG002|STARTED|Overall Study||16
6600624|NCT02039947|7525185|FG003|STARTED|Overall Study||17
6600625|NCT02039947|7525182|FG000|COMPLETED|Overall Study||76
6600626|NCT02039947|7525183|FG001|COMPLETED|Overall Study||16
6600627|NCT02039947|7525184|FG002|COMPLETED|Overall Study||16
6600628|NCT02039947|7525185|FG003|COMPLETED|Overall Study||17
6600629|NCT02039947|7525182|FG000|NOT COMPLETED|Overall Study||0
6600630|NCT02039947|7525183|FG001|NOT COMPLETED|Overall Study||0
6600631|NCT02039947|7525184|FG002|NOT COMPLETED|Overall Study||0
6600632|NCT02039947|7525185|FG003|NOT COMPLETED|Overall Study||0
6600633|NCT02040077|7525202|FG000|STARTED|Overall Study||27
6600634|NCT02040077|7525203|FG001|STARTED|Overall Study||24
6600635|NCT02040077|7525204|FG002|STARTED|Overall Study||25
6600636|NCT02040077|7525202|FG000|COMPLETED|Overall Study||27
6600637|NCT02040077|7525203|FG001|COMPLETED|Overall Study||24
6600638|NCT02040077|7525204|FG002|COMPLETED|Overall Study||25
6600639|NCT02040077|7525202|FG000|NOT COMPLETED|Overall Study||0
6600640|NCT02040077|7525203|FG001|NOT COMPLETED|Overall Study||0
6600641|NCT02040077|7525204|FG002|NOT COMPLETED|Overall Study||0
6600642|NCT02040090|7525215|FG000|STARTED|Overall Study||59
6600643|NCT02040090|7525216|FG001|STARTED|Overall Study||59
6600644|NCT02040090|7525215|FG000|COMPLETED|Overall Study||56
6600645|NCT02040090|7525216|FG001|COMPLETED|Overall Study||57
6600646|NCT02040090|7525215|FG000|NOT COMPLETED|Overall Study||3
6600647|NCT02040090|7525216|FG001|NOT COMPLETED|Overall Study||2
6600648|NCT02040116|7525222|FG000|STARTED|Overall Study||19
6600649|NCT02040116|7525222|FG000|COMPLETED|Overall Study||19
6662809|NCT02513472|7593378|FG000|Phase 1b Safety run-in|Overall Study||3
6662810|NCT02513472|7593379|FG001|Phase 1b Safety run-in|Overall Study||4
6662811|NCT02513472|7593378|FG000|Phase 2|Overall Study||63
6662812|NCT02513472|7593379|FG001|Phase 2|Overall Study||97
6662813|NCT02513472|7593378|FG000|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|1
6662814|NCT02513472|7593379|FG001|COMPLETED|Overall Study|Treatment ongoing at data cutoff.|8
6662815|NCT02513472|7593378|FG000|NOT COMPLETED|Overall Study||65
6662816|NCT02513472|7593379|FG001|NOT COMPLETED|Overall Study||93
6662817|NCT02513498|7593388|FG000|STARTED|Overall Study||50
6662818|NCT02513498|7593388|FG000|COMPLETED|Overall Study||26
6662819|NCT02513498|7593388|FG000|NOT COMPLETED|Overall Study||24
6662820|NCT02513550|7593400|FG000|STARTED|Double Blind Treatment Period||310
6662821|NCT02513550|7593401|FG001|STARTED|Double Blind Treatment Period||306
6662822|NCT02513550|7593402|FG002|STARTED|Double Blind Treatment Period||611
6662823|NCT02513550|7593403|FG003|STARTED|Double Blind Treatment Period||9
6662824|NCT02513550|7593404|FG004|STARTED|Double Blind Treatment Period||5
6662825|NCT02513550|7593405|FG005|STARTED|Double Blind Treatment Period||16
6662826|NCT02513550|7593400|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Period||310
6662827|NCT02513550|7593401|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Period||306
6662828|NCT02513550|7593402|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Period||609
6662829|NCT02513550|7593403|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Period||9
6662830|NCT02513550|7593404|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Period||5
6662831|NCT02513550|7593405|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Period||16
6662832|NCT02513550|7593400|FG000|COMPLETED|Double Blind Treatment Period||274
6662833|NCT02513550|7593401|FG001|COMPLETED|Double Blind Treatment Period||268
6662834|NCT02513550|7593402|FG002|COMPLETED|Double Blind Treatment Period||537
6662835|NCT02513550|7593403|FG003|COMPLETED|Double Blind Treatment Period||9
6662836|NCT02513550|7593404|FG004|COMPLETED|Double Blind Treatment Period||4
6662837|NCT02513550|7593405|FG005|COMPLETED|Double Blind Treatment Period||15
6662838|NCT02513550|7593400|FG000|NOT COMPLETED|Double Blind Treatment Period||36
6600650|NCT02040116|7525222|FG000|NOT COMPLETED|Overall Study||0
6600651|NCT02040259|7525230|FG000|STARTED|Overall Study||2008
6600652|NCT02040259|7525230|FG000|COMPLETED|Overall Study||1645
6600653|NCT02040259|7525230|FG000|NOT COMPLETED|Overall Study||363
6600654|NCT02040298|7525238|FG000|STARTED|First Intervention (3 Months)||25
6600655|NCT02040298|7525239|FG001|STARTED|First Intervention (3 Months)||25
6600656|NCT02040298|7525238|FG000|COMPLETED|First Intervention (3 Months)||25
6600657|NCT02040298|7525239|FG001|COMPLETED|First Intervention (3 Months)||25
6600658|NCT02040298|7525238|FG000|NOT COMPLETED|First Intervention (3 Months)||0
6600659|NCT02040298|7525239|FG001|NOT COMPLETED|First Intervention (3 Months)||0
6600660|NCT02040298|7525238|FG000|STARTED|Second Intervention (2 Months)||25
6600661|NCT02040298|7525239|FG001|STARTED|Second Intervention (2 Months)||25
6600662|NCT02040298|7525238|FG000|COMPLETED|Second Intervention (2 Months)||25
6600663|NCT02040298|7525239|FG001|COMPLETED|Second Intervention (2 Months)||25
6600664|NCT02040298|7525238|FG000|NOT COMPLETED|Second Intervention (2 Months)||0
6600665|NCT02040298|7525239|FG001|NOT COMPLETED|Second Intervention (2 Months)||0
6600666|NCT02040428|7525253|FG000|STARTED|Overall Study||75
6600667|NCT02040428|7525254|FG001|STARTED|Overall Study||81
6600668|NCT02040428|7525253|FG000|Intent to Treat (Randomized Subjects)|Overall Study||76
6600669|NCT02040428|7525254|FG001|Intent to Treat (Randomized Subjects)|Overall Study||80
6600670|NCT02040428|7525253|FG000|COMPLETED|Overall Study||70
6600671|NCT02040428|7525254|FG001|COMPLETED|Overall Study||77
6600672|NCT02040428|7525253|FG000|NOT COMPLETED|Overall Study||5
6600673|NCT02040428|7525254|FG001|NOT COMPLETED|Overall Study||4
6624968|NCT02222493|7552567|FG001|COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
6624969|NCT02222493|7552566|FG000|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||31
6624970|NCT02222493|7552567|FG001|NOT COMPLETED|Period 3: Week 54 Dosing-Week 78 Visit||0
6624971|NCT02222558|7552586|FG000|STARTED|Period 1: Single Dose||25
6624972|NCT02222558|7552587|FG001|STARTED|Period 1: Single Dose||0
6624973|NCT02222558|7552588|FG002|STARTED|Period 1: Single Dose||0
6624974|NCT02222558|7552589|FG003|STARTED|Period 1: Single Dose||0
6624975|NCT02222558|7552590|FG004|STARTED|Period 1: Single Dose||0
6624976|NCT02222558|7552591|FG005|STARTED|Period 1: Single Dose||0
6624977|NCT02222558|7552586|FG000|COMPLETED|Period 1: Single Dose||21
6624978|NCT02222558|7552587|FG001|COMPLETED|Period 1: Single Dose||0
6624979|NCT02222558|7552588|FG002|COMPLETED|Period 1: Single Dose||0
6624980|NCT02222558|7552589|FG003|COMPLETED|Period 1: Single Dose||0
6624981|NCT02222558|7552590|FG004|COMPLETED|Period 1: Single Dose||0
6624982|NCT02222558|7552591|FG005|COMPLETED|Period 1: Single Dose||0
6624983|NCT02222558|7552586|FG000|NOT COMPLETED|Period 1: Single Dose||4
6624984|NCT02222558|7552587|FG001|NOT COMPLETED|Period 1: Single Dose||0
6624985|NCT02222558|7552588|FG002|NOT COMPLETED|Period 1: Single Dose||0
6624986|NCT02222558|7552589|FG003|NOT COMPLETED|Period 1: Single Dose||0
6624987|NCT02222558|7552590|FG004|NOT COMPLETED|Period 1: Single Dose||0
6624988|NCT02222558|7552591|FG005|NOT COMPLETED|Period 1: Single Dose||0
6624989|NCT02222558|7552586|FG000|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6624990|NCT02222558|7552587|FG001|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
6624991|NCT02222558|7552588|FG002|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6624992|NCT02222558|7552589|FG003|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6624993|NCT02222558|7552590|FG004|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6624994|NCT02222558|7552591|FG005|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
6624995|NCT02222558|7552586|FG000|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6624996|NCT02222558|7552587|FG001|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
6624997|NCT02222558|7552588|FG002|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6624998|NCT02222558|7552589|FG003|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6624999|NCT02222558|7552590|FG004|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6625000|NCT02222558|7552591|FG005|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6625001|NCT02222558|7552586|FG000|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6625002|NCT02222558|7552587|FG001|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6625003|NCT02222558|7552588|FG002|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6625004|NCT02222558|7552589|FG003|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6625005|NCT02222558|7552590|FG004|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6625006|NCT02222558|7552591|FG005|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
6625007|NCT02222558|7552586|FG000|STARTED|Period 3||0
6625008|NCT02222558|7552587|FG001|STARTED|Period 3||0
6625009|NCT02222558|7552588|FG002|STARTED|Period 3||4
6625010|NCT02222558|7552589|FG003|STARTED|Period 3||1
6625011|NCT02222558|7552590|FG004|STARTED|Period 3||8
6625012|NCT02222558|7552591|FG005|STARTED|Period 3||8
6625013|NCT02222558|7552586|FG000|COMPLETED|Period 3||0
6625014|NCT02222558|7552587|FG001|COMPLETED|Period 3||0
6625015|NCT02222558|7552588|FG002|COMPLETED|Period 3||4
6625016|NCT02222558|7552589|FG003|COMPLETED|Period 3||1
6625017|NCT02222558|7552590|FG004|COMPLETED|Period 3||8
6625018|NCT02222558|7552591|FG005|COMPLETED|Period 3||7
6625019|NCT02222558|7552586|FG000|NOT COMPLETED|Period 3||0
6625020|NCT02222558|7552587|FG001|NOT COMPLETED|Period 3||0
6625021|NCT02222558|7552588|FG002|NOT COMPLETED|Period 3||0
6625022|NCT02222558|7552589|FG003|NOT COMPLETED|Period 3||0
6625023|NCT02222558|7552590|FG004|NOT COMPLETED|Period 3||0
6625024|NCT02222558|7552591|FG005|NOT COMPLETED|Period 3||1
6625025|NCT02222610|7552608|FG000|STARTED|Baseline to W48||8
6625026|NCT02222610|7552609|FG001|STARTED|Baseline to W48||16
6625027|NCT02222610|7552610|FG002|STARTED|Baseline to W48||16
6625028|NCT02222610|7552608|FG000|COMPLETED|Baseline to W48||8
6625029|NCT02222610|7552609|FG001|COMPLETED|Baseline to W48||14
6625030|NCT02222610|7552610|FG002|COMPLETED|Baseline to W48||15
6625031|NCT02222610|7552608|FG000|NOT COMPLETED|Baseline to W48||0
6625032|NCT02222610|7552609|FG001|NOT COMPLETED|Baseline to W48||2
6625033|NCT02222610|7552610|FG002|NOT COMPLETED|Baseline to W48||1
6625034|NCT02222610|7552608|FG000|STARTED|Baseline to W104||8
6600674|NCT02040532|7525260|FG000|STARTED|Overall Study||32
6600675|NCT02040532|7525260|FG000|Received at Least One Dose of Medication|Overall Study||26
6600676|NCT02040532|7525260|FG000|COMPLETED|Overall Study||20
6600677|NCT02040532|7525260|FG000|NOT COMPLETED|Overall Study||12
6600678|NCT02040623|7525267|FG000|STARTED|Overall Study||11
6600679|NCT02040623|7525268|FG001|STARTED|Overall Study||12
6600680|NCT02040623|7525269|FG002|STARTED|Overall Study||12
6600681|NCT02040623|7525267|FG000|COMPLETED|Overall Study||7
6600682|NCT02040623|7525268|FG001|COMPLETED|Overall Study||6
6600683|NCT02040623|7525269|FG002|COMPLETED|Overall Study||10
6600684|NCT02040623|7525267|FG000|NOT COMPLETED|Overall Study||4
6600685|NCT02040623|7525268|FG001|NOT COMPLETED|Overall Study||6
6600686|NCT02040623|7525269|FG002|NOT COMPLETED|Overall Study||2
6600687|NCT02040766|7525282|FG000|STARTED|Overall Study||127
6600688|NCT02040766|7525283|FG001|STARTED|Overall Study||126
6600689|NCT02040766|7525284|FG002|STARTED|Overall Study||125
6600690|NCT02040766|7525285|FG003|STARTED|Overall Study||125
6600691|NCT02040766|7525286|FG004|STARTED|Overall Study||125
6600692|NCT02040766|7525282|FG000|COMPLETED|Overall Study||109
6600693|NCT02040766|7525283|FG001|COMPLETED|Overall Study||116
6600694|NCT02040766|7525284|FG002|COMPLETED|Overall Study||113
6600695|NCT02040766|7525285|FG003|COMPLETED|Overall Study||112
6600696|NCT02040766|7525286|FG004|COMPLETED|Overall Study||112
6600697|NCT02040766|7525282|FG000|NOT COMPLETED|Overall Study||18
6600698|NCT02040766|7525283|FG001|NOT COMPLETED|Overall Study||10
6600699|NCT02040766|7525284|FG002|NOT COMPLETED|Overall Study||12
6600700|NCT02040766|7525285|FG003|NOT COMPLETED|Overall Study||13
6600701|NCT02040766|7525286|FG004|NOT COMPLETED|Overall Study||13
6600702|NCT02040779|7525302|FG000|STARTED|Overall Study||91
6600703|NCT02040779|7525303|FG001|STARTED|Overall Study||90
6662839|NCT02513550|7593401|FG001|NOT COMPLETED|Double Blind Treatment Period||38
6662840|NCT02513550|7593402|FG002|NOT COMPLETED|Double Blind Treatment Period||74
6662841|NCT02513550|7593403|FG003|NOT COMPLETED|Double Blind Treatment Period||0
6662842|NCT02513550|7593404|FG004|NOT COMPLETED|Double Blind Treatment Period||1
6662843|NCT02513550|7593405|FG005|NOT COMPLETED|Double Blind Treatment Period||1
6662844|NCT02513550|7593400|FG000|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|285
6600704|NCT02040779|7525304|FG002|STARTED|Overall Study||92
6600705|NCT02040779|7525302|FG000|Full Analysis Set (FAS)|Overall Study||90
6600706|NCT02040779|7525303|FG001|Full Analysis Set (FAS)|Overall Study||88
6600707|NCT02040779|7525304|FG002|Full Analysis Set (FAS)|Overall Study||92
6600708|NCT02040779|7525302|FG000|COMPLETED|Overall Study||79
6600709|NCT02040779|7525303|FG001|COMPLETED|Overall Study||83
6600710|NCT02040779|7525304|FG002|COMPLETED|Overall Study||88
6600711|NCT02040779|7525302|FG000|NOT COMPLETED|Overall Study||12
6600712|NCT02040779|7525303|FG001|NOT COMPLETED|Overall Study||7
6600713|NCT02040779|7525304|FG002|NOT COMPLETED|Overall Study||4
6600714|NCT02040805|7525314|FG000|STARTED|Overall Study||160
6600715|NCT02040805|7525315|FG001|STARTED|Overall Study||163
6600716|NCT02040805|7525314|FG000|COMPLETED|Overall Study||118
6600717|NCT02040805|7525315|FG001|COMPLETED|Overall Study||113
6600718|NCT02040805|7525314|FG000|NOT COMPLETED|Overall Study||42
6600719|NCT02040805|7525315|FG001|NOT COMPLETED|Overall Study||50
6600720|NCT02040844|7525324|FG000|STARTED|Overall Study||138
6600721|NCT02040844|7525325|FG001|STARTED|Overall Study||148
6600722|NCT02040844|7525326|FG002|STARTED|Overall Study||144
6600723|NCT02040844|7525324|FG000|COMPLETED|Overall Study||88
6600724|NCT02040844|7525325|FG001|COMPLETED|Overall Study||109
6600725|NCT02040844|7525326|FG002|COMPLETED|Overall Study||97
6600726|NCT02040844|7525324|FG000|NOT COMPLETED|Overall Study||50
6600727|NCT02040844|7525325|FG001|NOT COMPLETED|Overall Study||39
6600728|NCT02040844|7525326|FG002|NOT COMPLETED|Overall Study||47
6600729|NCT02040870|7525334|FG000|STARTED|Overall Study||103
6600730|NCT02040870|7525334|FG000|Entered Post-treatment Follow-up|Overall Study||2
6662845|NCT02513550|7593401|FG001|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|283
6662846|NCT02513550|7593402|FG002|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|559
6662847|NCT02513550|7593403|FG003|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|9
6662848|NCT02513550|7593404|FG004|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|4
6662849|NCT02513550|7593405|FG005|STARTED|Post-Treatment Follow-up Period|Participants who discontinued double blind phase had an option to enter post-treatment phase.|15
6662850|NCT02513550|7593400|FG000|COMPLETED|Post-Treatment Follow-up Period||254
6662851|NCT02513550|7593401|FG001|COMPLETED|Post-Treatment Follow-up Period||244
6662852|NCT02513550|7593402|FG002|COMPLETED|Post-Treatment Follow-up Period||496
6600731|NCT02040870|7525334|FG000|Entered Survival Follow-up|Overall Study||75
6600732|NCT02040870|7525334|FG000|Discontinue From Study|Overall Study||26
6600733|NCT02040870|7525334|FG000|COMPLETED|Overall Study||0
6600734|NCT02040870|7525334|FG000|NOT COMPLETED|Overall Study||103
6600735|NCT02041091|7525340|FG000|STARTED|Treatment||112
6600736|NCT02041091|7525341|FG001|STARTED|Treatment||114
6600737|NCT02041091|7525340|FG000|Received At Least One Dose of Study Drug|Treatment||112
6600738|NCT02041091|7525341|FG001|Received At Least One Dose of Study Drug|Treatment||114
6600739|NCT02041091|7525340|FG000|Participated in Follow Up|Treatment||106
6600740|NCT02041091|7525341|FG001|Participated in Follow Up|Treatment||96
6600741|NCT02041091|7525340|FG000|COMPLETED|Treatment||90
6600742|NCT02041091|7525341|FG001|COMPLETED|Treatment||91
6600743|NCT02041091|7525340|FG000|NOT COMPLETED|Treatment||22
6600744|NCT02041091|7525341|FG001|NOT COMPLETED|Treatment||23
6600745|NCT02041091|7525340|FG000|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|85
6600746|NCT02041091|7525341|FG001|STARTED|Optional Safety Extension Period|Participation was optional for the Safety Extension Period.|82
6600747|NCT02041091|7525340|FG000|COMPLETED|Optional Safety Extension Period||0
6600748|NCT02041091|7525341|FG001|COMPLETED|Optional Safety Extension Period||0
6600749|NCT02041091|7525340|FG000|NOT COMPLETED|Optional Safety Extension Period||85
6600750|NCT02041091|7525341|FG001|NOT COMPLETED|Optional Safety Extension Period||82
6600751|NCT02041104|7525355|FG000|STARTED|Overall Study||28
6600752|NCT02041104|7525356|FG001|STARTED|Overall Study||23
6600753|NCT02041104|7525355|FG000|COMPLETED|Overall Study||27
6600754|NCT02041104|7525356|FG001|COMPLETED|Overall Study||16
6600755|NCT02041104|7525355|FG000|NOT COMPLETED|Overall Study||1
6600756|NCT02041104|7525356|FG001|NOT COMPLETED|Overall Study||7
6600757|NCT02041221|7525370|FG000|STARTED|Part 1||6
6600758|NCT02041221|7525371|FG001|STARTED|Part 1||6
6600759|NCT02041221|7525372|FG002|STARTED|Part 1||6
6600760|NCT02041221|7525373|FG003|STARTED|Part 1||6
6600761|NCT02041221|7525374|FG004|STARTED|Part 1||6
6600762|NCT02041221|7525375|FG005|STARTED|Part 1||10
6600763|NCT02041221|7525370|FG000|COMPLETED|Part 1||6
6600764|NCT02041221|7525371|FG001|COMPLETED|Part 1||6
6600765|NCT02041221|7525372|FG002|COMPLETED|Part 1||6
6600766|NCT02041221|7525373|FG003|COMPLETED|Part 1||6
6600767|NCT02041221|7525374|FG004|COMPLETED|Part 1||6
6600768|NCT02041221|7525375|FG005|COMPLETED|Part 1||10
6600769|NCT02041221|7525370|FG000|NOT COMPLETED|Part 1||0
6600770|NCT02041221|7525371|FG001|NOT COMPLETED|Part 1||0
6600771|NCT02041221|7525372|FG002|NOT COMPLETED|Part 1||0
6600772|NCT02041221|7525373|FG003|NOT COMPLETED|Part 1||0
6600773|NCT02041221|7525374|FG004|NOT COMPLETED|Part 1||0
6600774|NCT02041221|7525375|FG005|NOT COMPLETED|Part 1||0
6600775|NCT02041221|7525370|FG000|STARTED|Part 2||6
6600776|NCT02041221|7525371|FG001|STARTED|Part 2||6
6600777|NCT02041221|7525372|FG002|STARTED|Part 2||6
6600778|NCT02041221|7525373|FG003|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
6600779|NCT02041221|7525374|FG004|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
6600780|NCT02041221|7525375|FG005|STARTED|Part 2||6
6600781|NCT02041221|7525370|FG000|COMPLETED|Part 2||6
6600782|NCT02041221|7525371|FG001|COMPLETED|Part 2||6
6600783|NCT02041221|7525372|FG002|COMPLETED|Part 2||5
6600784|NCT02041221|7525373|FG003|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
6600785|NCT02041221|7525374|FG004|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
6600786|NCT02041221|7525375|FG005|COMPLETED|Part 2||6
6600787|NCT02041221|7525370|FG000|NOT COMPLETED|Part 2||0
6600788|NCT02041221|7525371|FG001|NOT COMPLETED|Part 2||0
6600789|NCT02041221|7525372|FG002|NOT COMPLETED|Part 2||1
6600790|NCT02041221|7525373|FG003|NOT COMPLETED|Part 2||0
6600791|NCT02041221|7525374|FG004|NOT COMPLETED|Part 2||0
6600792|NCT02041221|7525375|FG005|NOT COMPLETED|Part 2||0
6600793|NCT02041286|7525389|FG000|STARTED|Overall Study||136
6600794|NCT02041286|7525389|FG000|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
6600795|NCT02041286|7525389|FG000|NOT COMPLETED|Overall Study||1
6600796|NCT02041299|7525397|FG000|STARTED|Overall Study||152
6600797|NCT02041299|7525398|FG001|STARTED|Overall Study|Two participants double-enrolled under different subject numbers so were each counted twice.|78
6600798|NCT02041299|7525397|FG000|COMPLETED|Overall Study||106
6600799|NCT02041299|7525398|FG001|COMPLETED|Overall Study||58
6600800|NCT02041299|7525397|FG000|NOT COMPLETED|Overall Study||46
6600801|NCT02041299|7525398|FG001|NOT COMPLETED|Overall Study||20
6600802|NCT02041325|7525410|FG000|STARTED|Overall Study||22
6600803|NCT02041325|7525411|FG001|STARTED|Overall Study||16
6600804|NCT02041325|7525410|FG000|COMPLETED|Overall Study||19
6600805|NCT02041325|7525411|FG001|COMPLETED|Overall Study||13
6600806|NCT02041325|7525410|FG000|NOT COMPLETED|Overall Study||3
6662853|NCT02513550|7593403|FG003|COMPLETED|Post-Treatment Follow-up Period||9
6662854|NCT02513550|7593404|FG004|COMPLETED|Post-Treatment Follow-up Period||4
6662855|NCT02513550|7593405|FG005|COMPLETED|Post-Treatment Follow-up Period||15
6662856|NCT02513550|7593400|FG000|NOT COMPLETED|Post-Treatment Follow-up Period||31
6662857|NCT02513550|7593401|FG001|NOT COMPLETED|Post-Treatment Follow-up Period||39
6662858|NCT02513550|7593402|FG002|NOT COMPLETED|Post-Treatment Follow-up Period||63
6662859|NCT02513550|7593403|FG003|NOT COMPLETED|Post-Treatment Follow-up Period||0
6662860|NCT02513550|7593404|FG004|NOT COMPLETED|Post-Treatment Follow-up Period||0
6662861|NCT02513550|7593405|FG005|NOT COMPLETED|Post-Treatment Follow-up Period||0
6662862|NCT02513641|7593427|FG000|STARTED|Overall Study||8
6600807|NCT02041325|7525411|FG001|NOT COMPLETED|Overall Study||3
6600808|NCT02041377|7525421|FG000|STARTED|Overall Study||134
6600809|NCT02041377|7525421|FG000|COMPLETED|Overall Study||134
6600810|NCT02041377|7525421|FG000|NOT COMPLETED|Overall Study||0
6600811|NCT02041429|7525429|FG000|STARTED|Overall Study||3
6600812|NCT02041429|7525430|FG001|STARTED|Overall Study||4
6600813|NCT02041429|7525431|FG002|STARTED|Overall Study||7
6600814|NCT02041429|7525432|FG003|STARTED|Overall Study||6
6600815|NCT02041429|7525429|FG000|Treated|Overall Study||3
6600816|NCT02041429|7525430|FG001|Treated|Overall Study||3
6600817|NCT02041429|7525431|FG002|Treated|Overall Study||7
6600818|NCT02041429|7525432|FG003|Treated|Overall Study||6
6600819|NCT02041429|7525429|FG000|Evaluable for Dose Limiting Toxicity|Overall Study||3
6600820|NCT02041429|7525430|FG001|Evaluable for Dose Limiting Toxicity|Overall Study||3
6600821|NCT02041429|7525431|FG002|Evaluable for Dose Limiting Toxicity|Overall Study||6
6600822|NCT02041429|7525432|FG003|Evaluable for Dose Limiting Toxicity|Overall Study||6
6600823|NCT02041429|7525429|FG000|COMPLETED|Overall Study||0
6600824|NCT02041429|7525430|FG001|COMPLETED|Overall Study||0
6600825|NCT02041429|7525431|FG002|COMPLETED|Overall Study||0
6600826|NCT02041429|7525432|FG003|COMPLETED|Overall Study||0
6600827|NCT02041429|7525429|FG000|NOT COMPLETED|Overall Study||3
6600828|NCT02041429|7525430|FG001|NOT COMPLETED|Overall Study||4
6600829|NCT02041429|7525431|FG002|NOT COMPLETED|Overall Study||7
6600830|NCT02041429|7525432|FG003|NOT COMPLETED|Overall Study||6
6600831|NCT02041494|7525449|FG000|STARTED|Overall Study||82
6600832|NCT02041494|7525450|FG001|STARTED|Overall Study||83
6600833|NCT02041494|7525449|FG000|COMPLETED|Overall Study||63
6600834|NCT02041494|7525450|FG001|COMPLETED|Overall Study||63
6600835|NCT02041494|7525449|FG000|NOT COMPLETED|Overall Study||19
6600836|NCT02041494|7525450|FG001|NOT COMPLETED|Overall Study||20
6600837|NCT02041520|7525459|FG000|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
6600838|NCT02041520|7525460|FG001|STARTED|Overall Study|35 patients randomly assigned to placebo|35
6600839|NCT02041520|7525459|FG000|COMPLETED|Overall Study||29
6600840|NCT02041520|7525460|FG001|COMPLETED|Overall Study||28
6600841|NCT02041520|7525459|FG000|NOT COMPLETED|Overall Study||6
6600842|NCT02041520|7525460|FG001|NOT COMPLETED|Overall Study||7
6600843|NCT02041702|7525470|FG000|STARTED|Overall Study||140
6600844|NCT02041702|7525471|FG001|STARTED|Overall Study||143
6600845|NCT02041702|7525470|FG000|Pre MRI Scan/ Pre Waitng|Overall Study||129
6600846|NCT02041702|7525471|FG001|Pre MRI Scan/ Pre Waitng|Overall Study||140
6600847|NCT02041702|7525470|FG000|Post MRI Scan/ Post Waiting|Overall Study||129
6600848|NCT02041702|7525471|FG001|Post MRI Scan/ Post Waiting|Overall Study||140
6600849|NCT02041702|7525470|FG000|COMPLETED|Overall Study||129
6600850|NCT02041702|7525471|FG001|COMPLETED|Overall Study||134
6600851|NCT02041702|7525470|FG000|NOT COMPLETED|Overall Study||11
6600852|NCT02041702|7525471|FG001|NOT COMPLETED|Overall Study||9
6600853|NCT02041923|7525479|FG000|STARTED|Overall Study||102
6600854|NCT02041923|7525480|FG001|STARTED|Overall Study||96
6600855|NCT02041923|7525479|FG000|COMPLETED|Overall Study||76
6600856|NCT02041923|7525480|FG001|COMPLETED|Overall Study||66
6600857|NCT02041923|7525479|FG000|NOT COMPLETED|Overall Study||26
6600858|NCT02041923|7525480|FG001|NOT COMPLETED|Overall Study||30
6600859|NCT02041962|7525490|FG000|STARTED|Overall Study||123
6600860|NCT02041962|7525491|FG001|STARTED|Overall Study||115
6600861|NCT02041962|7525490|FG000|Participants Completing 6 mo. f/up|Overall Study||69
6600862|NCT02041962|7525491|FG001|Participants Completing 6 mo. f/up|Overall Study||44
6600863|NCT02041962|7525490|FG000|Participants Completing 12 mo. f/up|Overall Study||42
6600864|NCT02041962|7525491|FG001|Participants Completing 12 mo. f/up|Overall Study||31
6600865|NCT02041962|7525490|FG000|COMPLETED|Overall Study||42
6600866|NCT02041962|7525491|FG001|COMPLETED|Overall Study||31
6600867|NCT02041962|7525490|FG000|NOT COMPLETED|Overall Study||81
6600868|NCT02041962|7525491|FG001|NOT COMPLETED|Overall Study||84
6600869|NCT02042014|7525497|FG000|STARTED|Overall Study||8
6600870|NCT02042014|7525497|FG000|COMPLETED|Overall Study||0
6600871|NCT02042014|7525497|FG000|NOT COMPLETED|Overall Study||8
6600872|NCT02042131|7525504|FG000|STARTED|Overall Study||32
6600873|NCT02042131|7525505|FG001|STARTED|Overall Study||32
6600874|NCT02042131|7525506|FG002|STARTED|Overall Study||33
6600875|NCT02042131|7525504|FG000|COMPLETED|Overall Study||32
6600876|NCT02042131|7525505|FG001|COMPLETED|Overall Study||32
6600877|NCT02042131|7525506|FG002|COMPLETED|Overall Study||33
6600878|NCT02042131|7525504|FG000|NOT COMPLETED|Overall Study||0
6600879|NCT02042131|7525505|FG001|NOT COMPLETED|Overall Study||0
6600880|NCT02042131|7525506|FG002|NOT COMPLETED|Overall Study||0
6600881|NCT02042183|7525518|FG000|STARTED|Overall Study||404
6600882|NCT02042183|7525519|FG001|STARTED|Overall Study||202
6600883|NCT02042183|7525518|FG000|Safety Population|Overall Study||400
6600884|NCT02042183|7525519|FG001|Safety Population|Overall Study||195
6600885|NCT02042183|7525518|FG000|Modified Intent-to-treat (mITT)|Overall Study||399
6600886|NCT02042183|7525519|FG001|Modified Intent-to-treat (mITT)|Overall Study||195
6600887|NCT02042183|7525518|FG000|COMPLETED|Overall Study||339
6600888|NCT02042183|7525519|FG001|COMPLETED|Overall Study||166
6600889|NCT02042183|7525518|FG000|NOT COMPLETED|Overall Study||65
6600890|NCT02042183|7525519|FG001|NOT COMPLETED|Overall Study||36
6600891|NCT02042274|7525527|FG000|STARTED|Overall Study||12
6600892|NCT02042274|7525527|FG000|COMPLETED|Overall Study||12
6600893|NCT02042274|7525527|FG000|NOT COMPLETED|Overall Study||0
6600894|NCT02042404|7525531|FG000|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
6600895|NCT02042404|7525532|FG001|STARTED|Overall Study||5
6600896|NCT02042404|7525531|FG000|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
6600897|NCT02042404|7525532|FG001|COMPLETED|Overall Study||5
6600898|NCT02042404|7525531|FG000|NOT COMPLETED|Overall Study||5
6600899|NCT02042404|7525532|FG001|NOT COMPLETED|Overall Study||0
6600900|NCT02042443|7525541|FG000|STARTED|Overall Study||27
6600901|NCT02042443|7525542|FG001|STARTED|Overall Study||26
6600902|NCT02042443|7525541|FG000|Eligible and Analyzable|Overall Study||24
6600903|NCT02042443|7525542|FG001|Eligible and Analyzable|Overall Study||20
6600904|NCT02042443|7525541|FG000|COMPLETED|Overall Study||0
6600905|NCT02042443|7525542|FG001|COMPLETED|Overall Study||0
6600906|NCT02042443|7525541|FG000|NOT COMPLETED|Overall Study||27
6600907|NCT02042443|7525542|FG001|NOT COMPLETED|Overall Study||26
6600908|NCT02042534|7525551|FG000|STARTED|Overall Study||101
6600909|NCT02042534|7525552|FG001|STARTED|Overall Study||94
6600910|NCT02042534|7525551|FG000|COMPLETED|Overall Study||101
6600911|NCT02042534|7525552|FG001|COMPLETED|Overall Study||94
6600912|NCT02042534|7525551|FG000|NOT COMPLETED|Overall Study||0
6600913|NCT02042534|7525552|FG001|NOT COMPLETED|Overall Study||0
6600914|NCT02042872|7525560|FG000|STARTED|Overall Study||8
6600915|NCT02042872|7525561|FG001|STARTED|Overall Study||13
6600916|NCT02042872|7525560|FG000|COMPLETED|Overall Study||8
6600917|NCT02042872|7525561|FG001|COMPLETED|Overall Study||8
6600918|NCT02042872|7525560|FG000|NOT COMPLETED|Overall Study||0
6600919|NCT02042872|7525561|FG001|NOT COMPLETED|Overall Study||5
6600920|NCT02042911|7525567|FG000|STARTED|Overall Study||10
6600921|NCT02042911|7525567|FG000|COMPLETED|Overall Study||9
6600922|NCT02042911|7525567|FG000|NOT COMPLETED|Overall Study||1
6600923|NCT02043015|7525571|FG000|STARTED|Overall Study||115
6600924|NCT02043015|7525571|FG000|COMPLETED|Overall Study||87
6600925|NCT02043015|7525571|FG000|NOT COMPLETED|Overall Study||28
6600926|NCT02043132|7525579|FG000|STARTED|Overall Study||58
6600927|NCT02043132|7525580|FG001|STARTED|Overall Study||58
6600928|NCT02043132|7525579|FG000|COMPLETED|Overall Study||53
6600929|NCT02043132|7525580|FG001|COMPLETED|Overall Study||49
6662863|NCT02513641|7593427|FG000|COMPLETED|Overall Study||8
6662864|NCT02513641|7593427|FG000|NOT COMPLETED|Overall Study||0
6662865|NCT02513719|7593431|FG000|STARTED|At 8 Months Clinical Follow-up||312
6662866|NCT02513719|7593431|FG000|COMPLETED|At 8 Months Clinical Follow-up||312
6662867|NCT02513719|7593431|FG000|NOT COMPLETED|At 8 Months Clinical Follow-up||0
6662868|NCT02513719|7593431|FG000|STARTED|At 1 Year Clinical Follow-up||312
6662869|NCT02513719|7593431|FG000|COMPLETED|At 1 Year Clinical Follow-up||305
6662870|NCT02513719|7593431|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||7
6662871|NCT02513719|7593431|FG000|STARTED|At 2 Years Clinical Follow-up||305
6662872|NCT02513719|7593431|FG000|COMPLETED|At 2 Years Clinical Follow-up||300
6662873|NCT02513719|7593431|FG000|NOT COMPLETED|At 2 Years Clinical Follow-up||5
6662874|NCT02513719|7593431|FG000|STARTED|At 3 Years Clinical Follow-up||300
6662875|NCT02513719|7593431|FG000|COMPLETED|At 3 Years Clinical Follow-up||289
6662876|NCT02513719|7593431|FG000|NOT COMPLETED|At 3 Years Clinical Follow-up||11
6662877|NCT02513719|7593431|FG000|STARTED|At 4 Years Clinical Follow-up||289
6662878|NCT02513719|7593431|FG000|COMPLETED|At 4 Years Clinical Follow-up||273
6662879|NCT02513719|7593431|FG000|NOT COMPLETED|At 4 Years Clinical Follow-up||16
6662880|NCT02513719|7593431|FG000|STARTED|At 5 Years Clinical Follow-up||273
6662881|NCT02513719|7593431|FG000|COMPLETED|At 5 Years Clinical Follow-up||254
6662882|NCT02513719|7593431|FG000|NOT COMPLETED|At 5 Years Clinical Follow-up||19
6662883|NCT02513732|7593435|FG000|STARTED|Overall Study||100
6662884|NCT02513732|7593435|FG000|COMPLETED|Overall Study||78
6662885|NCT02513732|7593435|FG000|NOT COMPLETED|Overall Study||22
6662886|NCT02513745|7593441|FG000|STARTED|Overall Study||42
6662887|NCT02513745|7593442|FG001|STARTED|Overall Study||42
6662888|NCT02513745|7593441|FG000|COMPLETED|Overall Study||39
6662889|NCT02513745|7593442|FG001|COMPLETED|Overall Study||39
6662890|NCT02513745|7593441|FG000|NOT COMPLETED|Overall Study||3
6662891|NCT02513745|7593442|FG001|NOT COMPLETED|Overall Study||3
6662892|NCT02513771|7593450|FG000|STARTED|Overall Study||45
6662893|NCT02513771|7593451|FG001|STARTED|Overall Study||45
6662894|NCT02513771|7593450|FG000|COMPLETED|Overall Study||43
6662895|NCT02513771|7593451|FG001|COMPLETED|Overall Study||44
6662896|NCT02513771|7593450|FG000|NOT COMPLETED|Overall Study||2
6662897|NCT02513771|7593451|FG001|NOT COMPLETED|Overall Study||1
6662898|NCT02513823|7593457|FG000|STARTED|Overall Study||27
6662899|NCT02513823|7593457|FG000|COMPLETED|Overall Study||22
6662900|NCT02513823|7593457|FG000|NOT COMPLETED|Overall Study||5
6662901|NCT02513940|7593461|FG000|STARTED|Overall Study|This was a crossover study, with a total n=14. All 14 subjects completed each phase of the study|2
6662902|NCT02513940|7593462|FG001|STARTED|Overall Study||3
6662903|NCT02513940|7593463|FG002|STARTED|Overall Study||2
6662904|NCT02513940|7593464|FG003|STARTED|Overall Study||2
6662905|NCT02513940|7593465|FG004|STARTED|Overall Study||2
6662906|NCT02513940|7593466|FG005|STARTED|Overall Study||3
6662907|NCT02513940|7593461|FG000|COMPLETED|Overall Study||2
6662908|NCT02513940|7593462|FG001|COMPLETED|Overall Study||3
6662909|NCT02513940|7593463|FG002|COMPLETED|Overall Study||2
6662910|NCT02513940|7593464|FG003|COMPLETED|Overall Study||2
6662911|NCT02513940|7593465|FG004|COMPLETED|Overall Study||2
6662912|NCT02513940|7593466|FG005|COMPLETED|Overall Study||3
6662913|NCT02513940|7593461|FG000|NOT COMPLETED|Overall Study||0
6662914|NCT02513940|7593462|FG001|NOT COMPLETED|Overall Study||0
6662915|NCT02513940|7593463|FG002|NOT COMPLETED|Overall Study||0
6662916|NCT02513940|7593464|FG003|NOT COMPLETED|Overall Study||0
6662917|NCT02513940|7593465|FG004|NOT COMPLETED|Overall Study||0
6662918|NCT02513940|7593466|FG005|NOT COMPLETED|Overall Study||0
6662919|NCT02514044|7593476|FG000|STARTED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
6662920|NCT02514044|7593476|FG000|COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||10
6662921|NCT02514044|7593476|FG000|NOT COMPLETED|Dexedrine+tDCS+Speech Therapy (1 Day)||0
6600930|NCT02043132|7525579|FG000|NOT COMPLETED|Overall Study||5
6600931|NCT02043132|7525580|FG001|NOT COMPLETED|Overall Study||9
6600932|NCT02043145|7525589|FG000|STARTED|Overall Study||55
6600933|NCT02043145|7525590|FG001|STARTED|Overall Study||247
6600934|NCT02043145|7525591|FG002|STARTED|Overall Study||425
6600935|NCT02043145|7525589|FG000|COMPLETED|Overall Study||55
6600936|NCT02043145|7525590|FG001|COMPLETED|Overall Study||247
6600937|NCT02043145|7525591|FG002|COMPLETED|Overall Study||425
6600938|NCT02043145|7525589|FG000|NOT COMPLETED|Overall Study||0
6600939|NCT02043145|7525590|FG001|NOT COMPLETED|Overall Study||0
6600940|NCT02043145|7525591|FG002|NOT COMPLETED|Overall Study||0
6600941|NCT02043197|7525601|FG000|STARTED|Overall Study||300
6600942|NCT02043197|7525601|FG000|COMPLETED|Overall Study||292
6600943|NCT02043197|7525601|FG000|NOT COMPLETED|Overall Study||8
6600944|NCT02043301|7525608|FG000|STARTED|Overall Study||25
6600945|NCT02043301|7525609|FG001|STARTED|Overall Study||25
6600946|NCT02043301|7525610|FG002|STARTED|Overall Study||25
6600947|NCT02043301|7525608|FG000|COMPLETED|Overall Study||25
6600948|NCT02043301|7525609|FG001|COMPLETED|Overall Study||24
6600949|NCT02043301|7525610|FG002|COMPLETED|Overall Study||25
6600950|NCT02043301|7525608|FG000|NOT COMPLETED|Overall Study||0
6600951|NCT02043301|7525609|FG001|NOT COMPLETED|Overall Study||1
6600952|NCT02043301|7525610|FG002|NOT COMPLETED|Overall Study||0
6600953|NCT02043366|7525624|FG000|STARTED|Overall Study||30
6600954|NCT02043366|7525625|FG001|STARTED|Overall Study||30
6600955|NCT02043366|7525626|FG002|STARTED|Overall Study||30
6600956|NCT02043366|7525627|FG003|STARTED|Overall Study||30
6600957|NCT02043366|7525628|FG004|STARTED|Overall Study||30
6600958|NCT02043366|7525629|FG005|STARTED|Overall Study||30
6600959|NCT02043366|7525624|FG000|COMPLETED|Overall Study||28
6600960|NCT02043366|7525625|FG001|COMPLETED|Overall Study||28
6600961|NCT02043366|7525626|FG002|COMPLETED|Overall Study||28
6600962|NCT02043366|7525627|FG003|COMPLETED|Overall Study||28
6600963|NCT02043366|7525628|FG004|COMPLETED|Overall Study||28
6600964|NCT02043366|7525629|FG005|COMPLETED|Overall Study||28
6600965|NCT02043366|7525624|FG000|NOT COMPLETED|Overall Study||2
6600966|NCT02043366|7525625|FG001|NOT COMPLETED|Overall Study||2
6600967|NCT02043366|7525626|FG002|NOT COMPLETED|Overall Study||2
6600968|NCT02043366|7525627|FG003|NOT COMPLETED|Overall Study||2
6600969|NCT02043366|7525628|FG004|NOT COMPLETED|Overall Study||2
6600970|NCT02043366|7525629|FG005|NOT COMPLETED|Overall Study||2
6600971|NCT02043379|7525647|FG000|STARTED|Overall Study||30
6600972|NCT02043379|7525648|FG001|STARTED|Overall Study||20
6600973|NCT02043379|7525647|FG000|COMPLETED|Overall Study||30
6600974|NCT02043379|7525648|FG001|COMPLETED|Overall Study||20
6600975|NCT02043379|7525647|FG000|NOT COMPLETED|Overall Study||0
6600976|NCT02043379|7525648|FG001|NOT COMPLETED|Overall Study||0
6600977|NCT02043509|7525656|FG000|STARTED|Baseline to 1st Follow-up||203
6600978|NCT02043509|7525657|FG001|STARTED|Baseline to 1st Follow-up||204
6600979|NCT02043509|7525656|FG000|COMPLETED|Baseline to 1st Follow-up||138
6600980|NCT02043509|7525657|FG001|COMPLETED|Baseline to 1st Follow-up||157
6600981|NCT02043509|7525656|FG000|NOT COMPLETED|Baseline to 1st Follow-up||65
6600982|NCT02043509|7525657|FG001|NOT COMPLETED|Baseline to 1st Follow-up||47
6600983|NCT02043509|7525656|FG000|STARTED|Baseline to 2nd Follow-up||203
6600984|NCT02043509|7525657|FG001|STARTED|Baseline to 2nd Follow-up||204
6600985|NCT02043509|7525656|FG000|COMPLETED|Baseline to 2nd Follow-up||129
6600986|NCT02043509|7525657|FG001|COMPLETED|Baseline to 2nd Follow-up||132
6600987|NCT02043509|7525656|FG000|NOT COMPLETED|Baseline to 2nd Follow-up||74
6600988|NCT02043509|7525657|FG001|NOT COMPLETED|Baseline to 2nd Follow-up||72
6600989|NCT02043548|7525665|FG000|STARTED|Overall Study||18
6600990|NCT02043548|7525666|FG001|STARTED|Overall Study||18
6600991|NCT02043548|7525665|FG000|COMPLETED|Overall Study||17
6600992|NCT02043548|7525666|FG001|COMPLETED|Overall Study||17
6600993|NCT02043548|7525665|FG000|NOT COMPLETED|Overall Study||1
6600994|NCT02043548|7525666|FG001|NOT COMPLETED|Overall Study||1
6600995|NCT02043574|7525674|FG000|STARTED|Overall Study||25
6600996|NCT02043574|7525675|FG001|STARTED|Overall Study||26
6600997|NCT02043574|7525674|FG000|COMPLETED|Overall Study||19
6600998|NCT02043574|7525675|FG001|COMPLETED|Overall Study||20
6600999|NCT02043574|7525674|FG000|NOT COMPLETED|Overall Study||6
6601000|NCT02043574|7525675|FG001|NOT COMPLETED|Overall Study||6
6601001|NCT02043652|7525682|FG000|STARTED|Overall Study||119
6601002|NCT02043652|7525682|FG000|COMPLETED|Overall Study||93
6601003|NCT02043652|7525682|FG000|NOT COMPLETED|Overall Study||26
6601004|NCT02043704|7525688|FG000|STARTED|Overall Study||50
6601005|NCT02043704|7525689|FG001|STARTED|Overall Study||50
6601006|NCT02043704|7525688|FG000|COMPLETED|Overall Study||47
6601007|NCT02043704|7525689|FG001|COMPLETED|Overall Study||43
6601008|NCT02043704|7525688|FG000|NOT COMPLETED|Overall Study||3
6601009|NCT02043704|7525689|FG001|NOT COMPLETED|Overall Study||7
6601010|NCT02043782|7525695|FG000|STARTED|Period 1||7
6601011|NCT02043782|7525696|FG001|STARTED|Period 1||6
6601012|NCT02043782|7525697|FG002|STARTED|Period 1||7
6601013|NCT02043782|7525698|FG003|STARTED|Period 1||6
6601014|NCT02043782|7525699|FG004|STARTED|Period 1||6
6601015|NCT02043782|7525700|FG005|STARTED|Period 1||6
6601016|NCT02043782|7525695|FG000|COMPLETED|Period 1||7
6601017|NCT02043782|7525696|FG001|COMPLETED|Period 1||6
6601018|NCT02043782|7525697|FG002|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
6601019|NCT02043782|7525698|FG003|COMPLETED|Period 1||6
6601020|NCT02043782|7525699|FG004|COMPLETED|Period 1||6
6601021|NCT02043782|7525700|FG005|COMPLETED|Period 1||6
6601022|NCT02043782|7525695|FG000|NOT COMPLETED|Period 1||0
6601023|NCT02043782|7525696|FG001|NOT COMPLETED|Period 1||0
6601024|NCT02043782|7525697|FG002|NOT COMPLETED|Period 1||1
6601025|NCT02043782|7525698|FG003|NOT COMPLETED|Period 1||0
6601026|NCT02043782|7525699|FG004|NOT COMPLETED|Period 1||0
6601027|NCT02043782|7525700|FG005|NOT COMPLETED|Period 1||0
6601028|NCT02043782|7525695|FG000|STARTED|Period 2||7
6601029|NCT02043782|7525696|FG001|STARTED|Period 2||6
6601030|NCT02043782|7525697|FG002|STARTED|Period 2||6
6601031|NCT02043782|7525698|FG003|STARTED|Period 2||6
6601032|NCT02043782|7525699|FG004|STARTED|Period 2||6
6601033|NCT02043782|7525700|FG005|STARTED|Period 2||6
6601034|NCT02043782|7525695|FG000|COMPLETED|Period 2||7
6601035|NCT02043782|7525696|FG001|COMPLETED|Period 2||6
6601036|NCT02043782|7525697|FG002|COMPLETED|Period 2||6
6601037|NCT02043782|7525698|FG003|COMPLETED|Period 2||6
6601038|NCT02043782|7525699|FG004|COMPLETED|Period 2||6
6601039|NCT02043782|7525700|FG005|COMPLETED|Period 2||6
6601040|NCT02043782|7525695|FG000|NOT COMPLETED|Period 2||0
6601041|NCT02043782|7525696|FG001|NOT COMPLETED|Period 2||0
6601042|NCT02043782|7525697|FG002|NOT COMPLETED|Period 2||0
6601043|NCT02043782|7525698|FG003|NOT COMPLETED|Period 2||0
6601044|NCT02043782|7525699|FG004|NOT COMPLETED|Period 2||0
6601045|NCT02043782|7525700|FG005|NOT COMPLETED|Period 2||0
6601046|NCT02043782|7525695|FG000|STARTED|Period 3||7
6601047|NCT02043782|7525696|FG001|STARTED|Period 3||6
6601048|NCT02043782|7525697|FG002|STARTED|Period 3||6
6601049|NCT02043782|7525698|FG003|STARTED|Period 3||6
6662922|NCT02514044|7593476|FG000|STARTED|Washout (1 Week)||10
6662923|NCT02514044|7593476|FG000|COMPLETED|Washout (1 Week)||10
6662924|NCT02514044|7593476|FG000|NOT COMPLETED|Washout (1 Week)||0
6662925|NCT02514044|7593476|FG000|STARTED|Placebo+tDCS+Speech Therapy (1 Day)||10
6662926|NCT02514044|7593476|FG000|COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||10
6662927|NCT02514044|7593476|FG000|NOT COMPLETED|Placebo+tDCS+Speech Therapy (1 Day)||0
6662928|NCT02514070|7593486|FG000|STARTED|Weeks 0 to Week 6||19
6662929|NCT02514070|7593487|FG001|STARTED|Weeks 0 to Week 6||20
6662930|NCT02514070|7593486|FG000|COMPLETED|Weeks 0 to Week 6||17
6662931|NCT02514070|7593487|FG001|COMPLETED|Weeks 0 to Week 6||16
6662932|NCT02514070|7593486|FG000|NOT COMPLETED|Weeks 0 to Week 6||2
6662933|NCT02514070|7593487|FG001|NOT COMPLETED|Weeks 0 to Week 6||4
6662934|NCT02514070|7593486|FG000|STARTED|Week 6 to Week 14 - Washout Period||17
6662935|NCT02514070|7593487|FG001|STARTED|Week 6 to Week 14 - Washout Period||16
6662936|NCT02514070|7593486|FG000|COMPLETED|Week 6 to Week 14 - Washout Period||17
6662937|NCT02514070|7593487|FG001|COMPLETED|Week 6 to Week 14 - Washout Period||16
6662938|NCT02514070|7593486|FG000|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
6662939|NCT02514070|7593487|FG001|NOT COMPLETED|Week 6 to Week 14 - Washout Period||0
6662940|NCT02514070|7593486|FG000|STARTED|Week 14 to Week 20||17
6662941|NCT02514070|7593487|FG001|STARTED|Week 14 to Week 20||16
6662942|NCT02514070|7593486|FG000|COMPLETED|Week 14 to Week 20||16
6662943|NCT02514070|7593487|FG001|COMPLETED|Week 14 to Week 20||14
6662944|NCT02514070|7593486|FG000|NOT COMPLETED|Week 14 to Week 20||1
6662945|NCT02514070|7593487|FG001|NOT COMPLETED|Week 14 to Week 20||2
6662946|NCT02514122|7593499|FG000|STARTED|Overall Study||32
6662947|NCT02514122|7593500|FG001|STARTED|Overall Study||29
6662948|NCT02514122|7593499|FG000|COMPLETED|Overall Study|one participant dropped out for religious reasons; one for needle phobia|30
6662949|NCT02514122|7593500|FG001|COMPLETED|Overall Study||29
6662950|NCT02514122|7593499|FG000|NOT COMPLETED|Overall Study||2
6662951|NCT02514122|7593500|FG001|NOT COMPLETED|Overall Study||0
6662952|NCT02514174|7593506|FG000|STARTED|Overall Study||25
6662953|NCT02514174|7593506|FG000|COMPLETED|Overall Study||0
6662954|NCT02514174|7593506|FG000|NOT COMPLETED|Overall Study||25
6662955|NCT02514473|7593512|FG000|STARTED|Overall Study||101
6662956|NCT02514473|7593513|FG001|STARTED|Overall Study||103
6662957|NCT02514473|7593512|FG000|COMPLETED|Overall Study||98
6662958|NCT02514473|7593513|FG001|COMPLETED|Overall Study||98
6662959|NCT02514473|7593512|FG000|NOT COMPLETED|Overall Study||3
6662960|NCT02514473|7593513|FG001|NOT COMPLETED|Overall Study||5
6662961|NCT02514551|7593522|FG000|STARTED|Overall Study||123
6662962|NCT02514551|7593523|FG001|STARTED|Overall Study||122
6662963|NCT02514551|7593522|FG000|Received at Least One Dose of Study Drug|Overall Study||123
6662964|NCT02514551|7593523|FG001|Received at Least One Dose of Study Drug|Overall Study||120
6662965|NCT02514551|7593522|FG000|COMPLETED|Overall Study||123
6662966|NCT02514551|7593523|FG001|COMPLETED|Overall Study||119
6662967|NCT02514551|7593522|FG000|NOT COMPLETED|Overall Study||0
6662968|NCT02514551|7593523|FG001|NOT COMPLETED|Overall Study||3
6662969|NCT02514577|7593532|FG000|STARTED|Overall Study||143
6662970|NCT02514577|7593533|FG001|STARTED|Overall Study||74
6662971|NCT02514577|7593532|FG000|Intent-to-Treat (ITT) Population|Overall Study||143
6662972|NCT02514577|7593533|FG001|Intent-to-Treat (ITT) Population|Overall Study||74
6662973|NCT02514577|7593532|FG000|Safety Population|Overall Study||142
6601050|NCT02043782|7525699|FG004|STARTED|Period 3||6
6601051|NCT02043782|7525700|FG005|STARTED|Period 3||6
6281027|NCT00160693|7180896|FG000|COMPLETED|Overall Study||167
6601052|NCT02043782|7525695|FG000|COMPLETED|Period 3||7
6601053|NCT02043782|7525696|FG001|COMPLETED|Period 3||6
6601054|NCT02043782|7525697|FG002|COMPLETED|Period 3||6
6662974|NCT02514577|7593533|FG001|Safety Population|Overall Study||72
6662975|NCT02514577|7593532|FG000|COMPLETED|Overall Study||129
6601055|NCT02043782|7525698|FG003|COMPLETED|Period 3||6
6601056|NCT02043782|7525699|FG004|COMPLETED|Period 3||6
6601057|NCT02043782|7525700|FG005|COMPLETED|Period 3||6
6601058|NCT02043782|7525695|FG000|NOT COMPLETED|Period 3||0
6601059|NCT02043782|7525696|FG001|NOT COMPLETED|Period 3||0
6601060|NCT02043782|7525697|FG002|NOT COMPLETED|Period 3||0
6601061|NCT02043782|7525698|FG003|NOT COMPLETED|Period 3||0
6601062|NCT02043782|7525699|FG004|NOT COMPLETED|Period 3||0
6601063|NCT02043782|7525700|FG005|NOT COMPLETED|Period 3||0
6601064|NCT02043808|7525710|FG000|STARTED|Overall Study||12793
6601065|NCT02043808|7525711|FG001|STARTED|Overall Study||12793
6601066|NCT02043808|7525710|FG000|COMPLETED|Overall Study||12793
6601067|NCT02043808|7525711|FG001|COMPLETED|Overall Study||12793
6601068|NCT02043808|7525710|FG000|NOT COMPLETED|Overall Study||0
6601069|NCT02043808|7525711|FG001|NOT COMPLETED|Overall Study||0
6601070|NCT02043899|7525717|FG000|STARTED|Overall Study||36
6601071|NCT02043899|7525717|FG000|Underwent Routine [123I]mIBG Planar and SPECT/CT Imaging|Overall Study||32
6601072|NCT02043899|7525717|FG000|Underwent [124I]mIBG PET/CT Imaging|Overall Study||9
6601073|NCT02043899|7525717|FG000|COMPLETED|Overall Study||9
6601074|NCT02043899|7525717|FG000|NOT COMPLETED|Overall Study||27
6601075|NCT02043938|7525721|FG000|STARTED|Overall Study||46
6601076|NCT02043938|7525721|FG000|COMPLETED|Overall Study||36
6601077|NCT02043938|7525721|FG000|NOT COMPLETED|Overall Study||10
6601078|NCT02044094|7525728|FG000|STARTED|RBP-6000 Injection 1 (Day 1 to Day 28)||39
6601079|NCT02044094|7525728|FG000|Intent to Treat Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects who receive >=1 dose of RBP-6000 and have >=1 complete sequence of hydromorphone challenges|38
6601080|NCT02044094|7525728|FG000|Completers Population|RBP-6000 Injection 1 (Day 1 to Day 28)|Subjects that reached Day 28 + completed all challenges at Week 4 were considered study completers.|30
6601081|NCT02044094|7525728|FG000|COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||30
6662976|NCT02514577|7593533|FG001|COMPLETED|Overall Study||61
6662977|NCT02514577|7593532|FG000|NOT COMPLETED|Overall Study||14
6662978|NCT02514577|7593533|FG001|NOT COMPLETED|Overall Study||13
6662979|NCT02514746|7593541|FG000|STARTED|Overall Study||437
6662980|NCT02514746|7593542|FG001|STARTED|Overall Study||124
6662981|NCT02514746|7593541|FG000|Valid Serology 3 Years Post Primary Dose|Overall Study||437
6662982|NCT02514746|7593542|FG001|Valid Serology 3 Years Post Primary Dose|Overall Study||123
6662983|NCT02514746|7593541|FG000|Valid Serology 4 Years Post Primary Dose|Overall Study||424
6662984|NCT02514746|7593542|FG001|Valid Serology 4 Years Post Primary Dose|Overall Study||109
6662985|NCT02514746|7593541|FG000|Received CD-JEV Booster Vaccine|Overall Study||424
6662986|NCT02514746|7593542|FG001|Received CD-JEV Booster Vaccine|Overall Study||109
6662987|NCT02514746|7593541|FG000|COMPLETED|Overall Study||415
6662988|NCT02514746|7593542|FG001|COMPLETED|Overall Study||109
6662989|NCT02514746|7593541|FG000|NOT COMPLETED|Overall Study||22
6662990|NCT02514746|7593542|FG001|NOT COMPLETED|Overall Study||15
6662991|NCT02514772|7593552|FG000|STARTED|Overall Study||53
6662992|NCT02514772|7593553|FG001|STARTED|Overall Study||54
6662993|NCT02514772|7593552|FG000|COMPLETED|Overall Study||50
6662994|NCT02514772|7593553|FG001|COMPLETED|Overall Study||52
6662995|NCT02514772|7593552|FG000|NOT COMPLETED|Overall Study||3
6662996|NCT02514772|7593553|FG001|NOT COMPLETED|Overall Study||2
6662997|NCT02514824|7593563|FG000|STARTED|Overall Study||4
6662998|NCT02514824|7593564|FG001|STARTED|Overall Study||5
6662999|NCT02514824|7593565|FG002|STARTED|Overall Study||0
6663000|NCT02514824|7593566|FG003|STARTED|Overall Study||0
6663001|NCT02514824|7593563|FG000|Evaluable for Dose-limiting Toxicity|Overall Study||3
6663002|NCT02514824|7593564|FG001|Evaluable for Dose-limiting Toxicity|Overall Study||5
6663003|NCT02514824|7593565|FG002|Evaluable for Dose-limiting Toxicity|Overall Study||0
6663004|NCT02514824|7593566|FG003|Evaluable for Dose-limiting Toxicity|Overall Study||0
6663005|NCT02514824|7593563|FG000|COMPLETED|Overall Study||3
6663006|NCT02514824|7593564|FG001|COMPLETED|Overall Study||4
6663007|NCT02514824|7593565|FG002|COMPLETED|Overall Study||0
6663008|NCT02514824|7593566|FG003|COMPLETED|Overall Study||0
6663009|NCT02514824|7593563|FG000|NOT COMPLETED|Overall Study||1
6663010|NCT02514824|7593564|FG001|NOT COMPLETED|Overall Study||1
6663011|NCT02514824|7593565|FG002|NOT COMPLETED|Overall Study||0
6663012|NCT02514824|7593566|FG003|NOT COMPLETED|Overall Study||0
6663013|NCT02514889|7593575|FG000|STARTED|Randomization/Allocation to Condition||131
6663014|NCT02514889|7593576|FG001|STARTED|Randomization/Allocation to Condition||130
6663015|NCT02514889|7593575|FG000|COMPLETED|Randomization/Allocation to Condition||111
6663016|NCT02514889|7593576|FG001|COMPLETED|Randomization/Allocation to Condition||106
6663017|NCT02514889|7593575|FG000|NOT COMPLETED|Randomization/Allocation to Condition||20
6663018|NCT02514889|7593576|FG001|NOT COMPLETED|Randomization/Allocation to Condition||24
6663019|NCT02514889|7593575|FG000|STARTED|Intervention Participation||111
6663020|NCT02514889|7593576|FG001|STARTED|Intervention Participation||106
6663021|NCT02514889|7593575|FG000|COMPLETED|Intervention Participation||102
6663022|NCT02514889|7593576|FG001|COMPLETED|Intervention Participation||98
6663023|NCT02514889|7593575|FG000|NOT COMPLETED|Intervention Participation||9
6663024|NCT02514889|7593576|FG001|NOT COMPLETED|Intervention Participation||8
6663025|NCT02514889|7593575|FG000|STARTED|Follow-up Assessment Participation||102
6663026|NCT02514889|7593576|FG001|STARTED|Follow-up Assessment Participation||98
6663027|NCT02514889|7593575|FG000|COMPLETED|Follow-up Assessment Participation||92
6663028|NCT02514889|7593576|FG001|COMPLETED|Follow-up Assessment Participation||86
6601082|NCT02044094|7525728|FG000|NOT COMPLETED|RBP-6000 Injection 1 (Day 1 to Day 28)||9
6601083|NCT02044094|7525728|FG000|STARTED|RBP-6000 Injection 2 (Day 29 to Week 12)||30
6601084|NCT02044094|7525728|FG000|COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||17
6601085|NCT02044094|7525728|FG000|NOT COMPLETED|RBP-6000 Injection 2 (Day 29 to Week 12)||13
6601086|NCT02044159|7525745|FG000|STARTED|Overall Study||27
6601087|NCT02044159|7525746|FG001|STARTED|Overall Study||30
6663029|NCT02514889|7593575|FG000|NOT COMPLETED|Follow-up Assessment Participation||10
6663030|NCT02514889|7593576|FG001|NOT COMPLETED|Follow-up Assessment Participation||12
6663031|NCT02515045|7593584|FG000|STARTED|Overall Study||29
6663032|NCT02515045|7593585|FG001|STARTED|Overall Study||30
6663033|NCT02515045|7593586|FG002|STARTED|Overall Study||59
6663034|NCT02515045|7593584|FG000|COMPLETED|Overall Study||29
6663035|NCT02515045|7593585|FG001|COMPLETED|Overall Study||26
6663036|NCT02515045|7593586|FG002|COMPLETED|Overall Study||55
6663037|NCT02515045|7593584|FG000|NOT COMPLETED|Overall Study||0
6663038|NCT02515045|7593585|FG001|NOT COMPLETED|Overall Study||4
6663039|NCT02515045|7593586|FG002|NOT COMPLETED|Overall Study||4
6663040|NCT02515058|7593596|FG000|STARTED|Overall Study||21
6663041|NCT02515058|7593597|FG001|STARTED|Overall Study||22
6663042|NCT02515058|7593596|FG000|COMPLETED|Overall Study||18
6663043|NCT02515058|7593597|FG001|COMPLETED|Overall Study||20
6663044|NCT02515058|7593596|FG000|NOT COMPLETED|Overall Study||3
6663045|NCT02515058|7593597|FG001|NOT COMPLETED|Overall Study||2
6663046|NCT02515097|7593605|FG000|STARTED|Overall Study||142
6663047|NCT02515097|7593606|FG001|STARTED|Overall Study||71
6663048|NCT02515097|7593605|FG000|Intent-to-Treat (ITT) Population|Overall Study||142
6663049|NCT02515097|7593606|FG001|Intent-to-Treat (ITT) Population|Overall Study||71
6663050|NCT02515097|7593605|FG000|Safety Population|Overall Study||142
6663051|NCT02515097|7593606|FG001|Safety Population|Overall Study||70
6663052|NCT02515097|7593605|FG000|COMPLETED|Overall Study||135
6663053|NCT02515097|7593606|FG001|COMPLETED|Overall Study||65
6663054|NCT02515097|7593605|FG000|NOT COMPLETED|Overall Study||7
6663055|NCT02515097|7593606|FG001|NOT COMPLETED|Overall Study||6
6663056|NCT02515253|7593614|FG000|STARTED|Overall Study||17
6663057|NCT02515253|7593615|FG001|STARTED|Overall Study||16
6663058|NCT02515253|7593614|FG000|COMPLETED|Overall Study||10
6663059|NCT02515253|7593615|FG001|COMPLETED|Overall Study||8
6663060|NCT02515253|7593614|FG000|NOT COMPLETED|Overall Study||7
6663061|NCT02515253|7593615|FG001|NOT COMPLETED|Overall Study||8
6737592|NCT03267576|7666855|FG001|COMPLETED|Period 2: Day 44 to 71||30
6737593|NCT03267576|7666854|FG000|NOT COMPLETED|Period 2: Day 44 to 71||1
6737594|NCT03267576|7666855|FG001|NOT COMPLETED|Period 2: Day 44 to 71||2
6737595|NCT03267940|7666867|FG000|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
6737596|NCT03267940|7666868|FG001|STARTED|Run-in Portion (Max. Exposure: 508 Days)||9
6737597|NCT03267940|7666869|FG002|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
6737598|NCT03267940|7666870|FG003|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
6737599|NCT03267940|7666871|FG004|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
6737600|NCT03267940|7666872|FG005|STARTED|Run-in Portion (Max. Exposure: 508 Days)||0
6737601|NCT03267940|7666867|FG000|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
6737602|NCT03267940|7666868|FG001|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||9
6737603|NCT03267940|7666869|FG002|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
6737604|NCT03267940|7666870|FG003|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
6737605|NCT03267940|7666871|FG004|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
6737606|NCT03267940|7666872|FG005|Received at Least 1 Dose of Study Drug|Run-in Portion (Max. Exposure: 508 Days)||0
6737607|NCT03267940|7666867|FG000|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||1
6737608|NCT03267940|7666868|FG001|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||2
6737609|NCT03267940|7666869|FG002|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6737610|NCT03267940|7666870|FG003|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6737611|NCT03267940|7666871|FG004|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6737612|NCT03267940|7666872|FG005|COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6737613|NCT03267940|7666867|FG000|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||8
6737614|NCT03267940|7666868|FG001|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||7
6737615|NCT03267940|7666869|FG002|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6737616|NCT03267940|7666870|FG003|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6737617|NCT03267940|7666871|FG004|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6737618|NCT03267940|7666872|FG005|NOT COMPLETED|Run-in Portion (Max. Exposure: 508 Days)||0
6737619|NCT03267940|7666867|FG000|STARTED|Expansion (Maximum Exposure: 421 Days)||0
6737620|NCT03267940|7666868|FG001|STARTED|Expansion (Maximum Exposure: 421 Days)||0
6737621|NCT03267940|7666869|FG002|STARTED|Expansion (Maximum Exposure: 421 Days)||24
6737622|NCT03267940|7666870|FG003|STARTED|Expansion (Maximum Exposure: 421 Days)||22
6737623|NCT03267940|7666871|FG004|STARTED|Expansion (Maximum Exposure: 421 Days)||11
6737624|NCT03267940|7666872|FG005|STARTED|Expansion (Maximum Exposure: 421 Days)||10
6601088|NCT02044159|7525745|FG000|COMPLETED|Overall Study||23
6601089|NCT02044159|7525746|FG001|COMPLETED|Overall Study||26
6601090|NCT02044159|7525745|FG000|NOT COMPLETED|Overall Study||4
6601091|NCT02044159|7525746|FG001|NOT COMPLETED|Overall Study||4
6601092|NCT02044367|7525755|FG000|STARTED|Overall Study||9
6601093|NCT02044367|7525756|FG001|STARTED|Overall Study||9
6601094|NCT02044367|7525757|FG002|STARTED|Overall Study||9
6601095|NCT02044367|7525758|FG003|STARTED|Overall Study||9
6601096|NCT02044367|7525759|FG004|STARTED|Overall Study||9
6601097|NCT02044367|7525760|FG005|STARTED|Overall Study||9
6601098|NCT02044367|7525755|FG000|COMPLETED|Overall Study||9
6601099|NCT02044367|7525756|FG001|COMPLETED|Overall Study||9
6601100|NCT02044367|7525757|FG002|COMPLETED|Overall Study||9
6601101|NCT02044367|7525758|FG003|COMPLETED|Overall Study||9
6601102|NCT02044367|7525759|FG004|COMPLETED|Overall Study||9
6601103|NCT02044367|7525760|FG005|COMPLETED|Overall Study||9
6601104|NCT02044367|7525755|FG000|NOT COMPLETED|Overall Study||0
6601105|NCT02044367|7525756|FG001|NOT COMPLETED|Overall Study||0
6601106|NCT02044367|7525757|FG002|NOT COMPLETED|Overall Study||0
6601107|NCT02044367|7525758|FG003|NOT COMPLETED|Overall Study||0
6601108|NCT02044367|7525759|FG004|NOT COMPLETED|Overall Study||0
6601109|NCT02044367|7525760|FG005|NOT COMPLETED|Overall Study||0
6601110|NCT02044380|7525772|FG000|STARTED|Overall Study|Started are the treated patients|14
6601111|NCT02044380|7525772|FG000|COMPLETED|Overall Study||14
6601112|NCT02044380|7525772|FG000|NOT COMPLETED|Overall Study||0
6601113|NCT02044393|7525778|FG000|STARTED|Period 1||10
6601114|NCT02044393|7525779|FG001|STARTED|Period 1||10
6601115|NCT02044393|7525778|FG000|COMPLETED|Period 1||10
6601116|NCT02044393|7525779|FG001|COMPLETED|Period 1||10
6601117|NCT02044393|7525778|FG000|NOT COMPLETED|Period 1||0
6601118|NCT02044393|7525779|FG001|NOT COMPLETED|Period 1||0
6601119|NCT02044393|7525778|FG000|STARTED|Period 2||10
6601120|NCT02044393|7525779|FG001|STARTED|Period 2||10
6601121|NCT02044393|7525778|FG000|COMPLETED|Period 2||10
6601122|NCT02044393|7525779|FG001|COMPLETED|Period 2||10
6601123|NCT02044393|7525778|FG000|NOT COMPLETED|Period 2||0
6601124|NCT02044393|7525779|FG001|NOT COMPLETED|Period 2||0
6601125|NCT02044419|7525792|FG000|STARTED|First Intervention||11
6601126|NCT02044419|7525793|FG001|STARTED|First Intervention||10
6601127|NCT02044419|7525794|FG002|STARTED|First Intervention||11
6601128|NCT02044419|7525792|FG000|COMPLETED|First Intervention||11
6601129|NCT02044419|7525793|FG001|COMPLETED|First Intervention||9
6601130|NCT02044419|7525794|FG002|COMPLETED|First Intervention||10
6601131|NCT02044419|7525792|FG000|NOT COMPLETED|First Intervention||0
6601132|NCT02044419|7525793|FG001|NOT COMPLETED|First Intervention||1
6601133|NCT02044419|7525794|FG002|NOT COMPLETED|First Intervention||1
6601134|NCT02044419|7525792|FG000|STARTED|Second Intervention||11
6601135|NCT02044419|7525793|FG001|STARTED|Second Intervention||9
6601136|NCT02044419|7525794|FG002|STARTED|Second Intervention||10
6601137|NCT02044419|7525792|FG000|COMPLETED|Second Intervention||11
6601138|NCT02044419|7525793|FG001|COMPLETED|Second Intervention||9
6601139|NCT02044419|7525794|FG002|COMPLETED|Second Intervention||10
6601140|NCT02044419|7525792|FG000|NOT COMPLETED|Second Intervention||0
6601141|NCT02044419|7525793|FG001|NOT COMPLETED|Second Intervention||0
6601142|NCT02044419|7525794|FG002|NOT COMPLETED|Second Intervention||0
6601143|NCT02044419|7525792|FG000|STARTED|Third Intervention||11
6601144|NCT02044419|7525793|FG001|STARTED|Third Intervention||9
6601145|NCT02044419|7525794|FG002|STARTED|Third Intervention||10
6601146|NCT02044419|7525792|FG000|COMPLETED|Third Intervention||11
6601147|NCT02044419|7525793|FG001|COMPLETED|Third Intervention||9
6601148|NCT02044419|7525794|FG002|COMPLETED|Third Intervention||10
6601149|NCT02044419|7525792|FG000|NOT COMPLETED|Third Intervention||0
6601150|NCT02044419|7525793|FG001|NOT COMPLETED|Third Intervention||0
6601151|NCT02044419|7525794|FG002|NOT COMPLETED|Third Intervention||0
6601152|NCT02044458|7525804|FG000|STARTED|Overall Study||65
6601153|NCT02044458|7525805|FG001|STARTED|Overall Study||69
6601154|NCT02044458|7525804|FG000|COMPLETED|Overall Study||62
6601155|NCT02044458|7525805|FG001|COMPLETED|Overall Study||61
6601156|NCT02044458|7525804|FG000|NOT COMPLETED|Overall Study||3
6601157|NCT02044458|7525805|FG001|NOT COMPLETED|Overall Study||8
6601158|NCT02044510|7525813|FG000|STARTED|Overall Study||16
6601159|NCT02044510|7525814|FG001|STARTED|Overall Study||16
6601160|NCT02044510|7525813|FG000|COMPLETED|Overall Study||15
6601161|NCT02044510|7525814|FG001|COMPLETED|Overall Study||14
6601162|NCT02044510|7525813|FG000|NOT COMPLETED|Overall Study||1
6601163|NCT02044510|7525814|FG001|NOT COMPLETED|Overall Study||2
6601164|NCT02044796|7525822|FG000|STARTED|Overall Study||9
6601165|NCT02044796|7525823|FG001|STARTED|Overall Study||9
6601166|NCT02044796|7525824|FG002|STARTED|Overall Study||9
6601167|NCT02044796|7525825|FG003|STARTED|Overall Study||6
6601168|NCT02044796|7525826|FG004|STARTED|Overall Study||10
6601169|NCT02044796|7525827|FG005|STARTED|Overall Study||6
6601170|NCT02044796|7525828|FG006|STARTED|Overall Study||6
6601171|NCT02044796|7525829|FG007|STARTED|Overall Study||4
6601172|NCT02044796|7525830|FG008|STARTED|Overall Study||106
6601173|NCT02044796|7525831|FG009|STARTED|Overall Study||34
6601174|NCT02044796|7525822|FG000|COMPLETED|Overall Study||9
6601175|NCT02044796|7525823|FG001|COMPLETED|Overall Study||9
6601176|NCT02044796|7525824|FG002|COMPLETED|Overall Study||9
6601177|NCT02044796|7525825|FG003|COMPLETED|Overall Study||6
6601178|NCT02044796|7525826|FG004|COMPLETED|Overall Study||10
6601179|NCT02044796|7525827|FG005|COMPLETED|Overall Study||6
6601180|NCT02044796|7525828|FG006|COMPLETED|Overall Study||6
6601181|NCT02044796|7525829|FG007|COMPLETED|Overall Study||4
6601182|NCT02044796|7525830|FG008|COMPLETED|Overall Study||106
6601183|NCT02044796|7525831|FG009|COMPLETED|Overall Study||34
6601184|NCT02044796|7525822|FG000|NOT COMPLETED|Overall Study||0
6601185|NCT02044796|7525823|FG001|NOT COMPLETED|Overall Study||0
6601186|NCT02044796|7525824|FG002|NOT COMPLETED|Overall Study||0
6601187|NCT02044796|7525825|FG003|NOT COMPLETED|Overall Study||0
6601188|NCT02044796|7525826|FG004|NOT COMPLETED|Overall Study||0
6601189|NCT02044796|7525827|FG005|NOT COMPLETED|Overall Study||0
6601190|NCT02044796|7525828|FG006|NOT COMPLETED|Overall Study||0
6601191|NCT02044796|7525829|FG007|NOT COMPLETED|Overall Study||0
6601192|NCT02044796|7525830|FG008|NOT COMPLETED|Overall Study||0
6601193|NCT02044796|7525831|FG009|NOT COMPLETED|Overall Study||0
6601194|NCT02044874|7525852|FG000|STARTED|Overall Study||201
6601195|NCT02044874|7525853|FG001|STARTED|Overall Study||202
6601196|NCT02044874|7525854|FG002|STARTED|Overall Study||200
6601197|NCT02044874|7525852|FG000|COMPLETED|Overall Study||171
6601198|NCT02044874|7525853|FG001|COMPLETED|Overall Study||147
6601199|NCT02044874|7525854|FG002|COMPLETED|Overall Study||140
6601200|NCT02044874|7525852|FG000|NOT COMPLETED|Overall Study||30
6601201|NCT02044874|7525853|FG001|NOT COMPLETED|Overall Study||55
6601202|NCT02044874|7525854|FG002|NOT COMPLETED|Overall Study||60
6601203|NCT02044991|7525866|FG000|STARTED|Overall Study||2
6601204|NCT02044991|7525867|FG001|STARTED|Overall Study||0
6601205|NCT02044991|7525866|FG000|COMPLETED|Overall Study||2
6601206|NCT02044991|7525867|FG001|COMPLETED|Overall Study||0
6601207|NCT02044991|7525866|FG000|NOT COMPLETED|Overall Study||0
6601208|NCT02044991|7525867|FG001|NOT COMPLETED|Overall Study||0
6601209|NCT02045095|7525873|FG000|STARTED|Overall Study||3
6601210|NCT02045095|7525874|FG001|STARTED|Overall Study||4
6601211|NCT02045095|7525875|FG002|STARTED|Overall Study||4
6601212|NCT02045095|7525876|FG003|STARTED|Overall Study||4
6663062|NCT02515279|7593621|FG000|STARTED|Overall Study||463
6663063|NCT02515279|7593621|FG000|COMPLETED|Overall Study||359
6663064|NCT02515279|7593621|FG000|NOT COMPLETED|Overall Study||104
6663065|NCT02515305|7593628|FG000|STARTED|Overall Study||385
6663066|NCT02515305|7593629|FG001|STARTED|Overall Study||378
6663067|NCT02515305|7593630|FG002|STARTED|Overall Study||127
6663068|NCT02515305|7593628|FG000|COMPLETED|Overall Study||356
6663069|NCT02515305|7593629|FG001|COMPLETED|Overall Study||343
6663070|NCT02515305|7593630|FG002|COMPLETED|Overall Study||113
6663071|NCT02515305|7593628|FG000|NOT COMPLETED|Overall Study||29
6663072|NCT02515305|7593629|FG001|NOT COMPLETED|Overall Study||35
6663073|NCT02515305|7593630|FG002|NOT COMPLETED|Overall Study||14
6663074|NCT02515331|7593641|FG000|STARTED|Overall Study||17
6663075|NCT02515331|7593642|FG001|STARTED|Overall Study||15
6663076|NCT02515331|7593643|FG002|STARTED|Overall Study||32
6663077|NCT02515331|7593641|FG000|Primary Pharmacodynamic Analysis Set|Overall Study||15
6663078|NCT02515331|7593642|FG001|Primary Pharmacodynamic Analysis Set|Overall Study||14
6663079|NCT02515331|7593643|FG002|Primary Pharmacodynamic Analysis Set|Overall Study||29
6663080|NCT02515331|7593641|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||17
6663081|NCT02515331|7593642|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||15
6663082|NCT02515331|7593643|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6663083|NCT02515331|7593641|FG000|COMPLETED|Overall Study||15
6663084|NCT02515331|7593642|FG001|COMPLETED|Overall Study||15
6663085|NCT02515331|7593643|FG002|COMPLETED|Overall Study||28
6663086|NCT02515331|7593641|FG000|NOT COMPLETED|Overall Study||2
6663087|NCT02515331|7593642|FG001|NOT COMPLETED|Overall Study||0
6663088|NCT02515331|7593643|FG002|NOT COMPLETED|Overall Study||4
6663089|NCT02515630|7593653|FG000|STARTED|Overall Study||41
6663090|NCT02515630|7593653|FG000|COMPLETED|Overall Study||25
6663091|NCT02515630|7593653|FG000|NOT COMPLETED|Overall Study||16
6663092|NCT02515656|7593662|FG000|STARTED|Overall Study||326
6663093|NCT02515656|7593663|FG001|STARTED|Overall Study||332
6663094|NCT02515656|7593662|FG000|Full Analysis Set (FAS)|Overall Study||302
6663095|NCT02515656|7593663|FG001|Full Analysis Set (FAS)|Overall Study||309
6663096|NCT02515656|7593662|FG000|Per Protocol Set (PPS)|Overall Study||277
6663097|NCT02515656|7593663|FG001|Per Protocol Set (PPS)|Overall Study||275
6663098|NCT02515656|7593662|FG000|Safety Population|Overall Study||325
6663099|NCT02515656|7593663|FG001|Safety Population|Overall Study||328
6663100|NCT02515656|7593662|FG000|COMPLETED|Overall Study||270
6663101|NCT02515656|7593663|FG001|COMPLETED|Overall Study||261
6663102|NCT02515656|7593662|FG000|NOT COMPLETED|Overall Study||56
6663103|NCT02515656|7593663|FG001|NOT COMPLETED|Overall Study||71
6663104|NCT02515669|7593673|FG000|STARTED|24 Week Double-Blind Phase||11
6663105|NCT02515669|7593674|FG001|STARTED|24 Week Double-Blind Phase||7
6663106|NCT02515669|7593675|FG002|STARTED|24 Week Double-Blind Phase||6
6601213|NCT02045095|7525877|FG004|STARTED|Overall Study||5
6601214|NCT02045095|7525878|FG005|STARTED|Overall Study||8
6601215|NCT02045095|7525879|FG006|STARTED|Overall Study||1
6601216|NCT02045095|7525873|FG000|COMPLETED|Overall Study||0
6663107|NCT02515669|7593676|FG003|STARTED|24 Week Double-Blind Phase||19
6663108|NCT02515669|7593673|FG000|COMPLETED|24 Week Double-Blind Phase||11
6663109|NCT02515669|7593674|FG001|COMPLETED|24 Week Double-Blind Phase||7
6663110|NCT02515669|7593675|FG002|COMPLETED|24 Week Double-Blind Phase||6
6663111|NCT02515669|7593676|FG003|COMPLETED|24 Week Double-Blind Phase||19
6601217|NCT02045095|7525874|FG001|COMPLETED|Overall Study||0
6601218|NCT02045095|7525875|FG002|COMPLETED|Overall Study||0
6601219|NCT02045095|7525876|FG003|COMPLETED|Overall Study||0
6663112|NCT02515669|7593673|FG000|NOT COMPLETED|24 Week Double-Blind Phase||0
6663113|NCT02515669|7593674|FG001|NOT COMPLETED|24 Week Double-Blind Phase||0
6663114|NCT02515669|7593675|FG002|NOT COMPLETED|24 Week Double-Blind Phase||0
6601220|NCT02045095|7525877|FG004|COMPLETED|Overall Study||0
6601221|NCT02045095|7525878|FG005|COMPLETED|Overall Study||0
6601222|NCT02045095|7525879|FG006|COMPLETED|Overall Study||0
6601223|NCT02045095|7525873|FG000|NOT COMPLETED|Overall Study||3
6601224|NCT02045095|7525874|FG001|NOT COMPLETED|Overall Study||4
6601225|NCT02045095|7525875|FG002|NOT COMPLETED|Overall Study||4
6601226|NCT02045095|7525876|FG003|NOT COMPLETED|Overall Study||4
6601227|NCT02045095|7525877|FG004|NOT COMPLETED|Overall Study||5
6601228|NCT02045095|7525878|FG005|NOT COMPLETED|Overall Study||8
6601229|NCT02045095|7525879|FG006|NOT COMPLETED|Overall Study||1
6601230|NCT02045108|7525899|FG000|STARTED|Overall Study||22
6601231|NCT02045108|7525900|FG001|STARTED|Overall Study||15
6601232|NCT02045108|7525901|FG002|STARTED|Overall Study||20
6601233|NCT02045108|7525902|FG003|STARTED|Overall Study||20
6601234|NCT02045108|7525899|FG000|COMPLETED|Overall Study||21
6601235|NCT02045108|7525900|FG001|COMPLETED|Overall Study||12
6601236|NCT02045108|7525901|FG002|COMPLETED|Overall Study||18
6601237|NCT02045108|7525902|FG003|COMPLETED|Overall Study||19
6601238|NCT02045108|7525899|FG000|NOT COMPLETED|Overall Study||1
6601239|NCT02045108|7525900|FG001|NOT COMPLETED|Overall Study||3
6601240|NCT02045108|7525901|FG002|NOT COMPLETED|Overall Study||2
6601241|NCT02045108|7525902|FG003|NOT COMPLETED|Overall Study||1
6601242|NCT02045212|7525914|FG000|STARTED|Overall Study||13
6601243|NCT02045212|7525915|FG001|STARTED|Overall Study||9
6601244|NCT02045212|7525914|FG000|COMPLETED|Overall Study||11
6601245|NCT02045212|7525915|FG001|COMPLETED|Overall Study||8
6601246|NCT02045212|7525914|FG000|NOT COMPLETED|Overall Study||2
6601247|NCT02045212|7525915|FG001|NOT COMPLETED|Overall Study||1
6601248|NCT02045238|7525927|FG000|STARTED|Overall Study||16
6601249|NCT02045238|7525928|FG001|STARTED|Overall Study||15
6601250|NCT02045238|7525927|FG000|COMPLETED|Overall Study||9
6601251|NCT02045238|7525928|FG001|COMPLETED|Overall Study||14
6601252|NCT02045238|7525927|FG000|NOT COMPLETED|Overall Study||7
6601253|NCT02045238|7525928|FG001|NOT COMPLETED|Overall Study||1
6601254|NCT02045264|7525934|FG000|STARTED|Overall Study||12
6601255|NCT02045264|7525934|FG000|COMPLETED|Overall Study||12
6601256|NCT02045264|7525934|FG000|NOT COMPLETED|Overall Study||0
6601257|NCT02045277|7525942|FG000|STARTED|Overall Study||59
6601258|NCT02045277|7525943|FG001|STARTED|Overall Study||63
6601259|NCT02045277|7525944|FG002|STARTED|Overall Study||59
6601260|NCT02045277|7525945|FG003|STARTED|Overall Study||31
6601261|NCT02045277|7525942|FG000|COMPLETED|Overall Study||55
6601262|NCT02045277|7525943|FG001|COMPLETED|Overall Study||62
6601263|NCT02045277|7525944|FG002|COMPLETED|Overall Study||47
6601264|NCT02045277|7525945|FG003|COMPLETED|Overall Study||29
6601265|NCT02045277|7525942|FG000|NOT COMPLETED|Overall Study||4
6601266|NCT02045277|7525943|FG001|NOT COMPLETED|Overall Study||1
6601267|NCT02045277|7525944|FG002|NOT COMPLETED|Overall Study||12
6601268|NCT02045277|7525945|FG003|NOT COMPLETED|Overall Study||2
6601269|NCT02045433|7525955|FG000|STARTED|Overall Study||16
6601270|NCT02045433|7525955|FG000|COMPLETED|Overall Study|Study was Prematurely ended due to toxicity|15
6601271|NCT02045433|7525955|FG000|NOT COMPLETED|Overall Study||1
6601272|NCT02045511|7525961|FG000|STARTED|Overall Study||8
6601273|NCT02045511|7525962|FG001|STARTED|Overall Study||7
6601274|NCT02045511|7525961|FG000|COMPLETED|Overall Study||8
6601275|NCT02045511|7525962|FG001|COMPLETED|Overall Study||7
6601276|NCT02045511|7525961|FG000|NOT COMPLETED|Overall Study||0
6601277|NCT02045511|7525962|FG001|NOT COMPLETED|Overall Study||0
6601278|NCT02045732|7525970|FG000|STARTED|Overall Study||1
6601279|NCT02045732|7525971|FG001|STARTED|Overall Study||3
6601280|NCT02045732|7525970|FG000|COMPLETED|Overall Study||0
6601281|NCT02045732|7525971|FG001|COMPLETED|Overall Study||2
6601282|NCT02045732|7525970|FG000|NOT COMPLETED|Overall Study||1
6601283|NCT02045732|7525971|FG001|NOT COMPLETED|Overall Study||1
6601284|NCT02045836|7525979|FG000|STARTED|Overall Study||432
6601285|NCT02045836|7525980|FG001|STARTED|Overall Study||433
6601286|NCT02045836|7525979|FG000|COMPLETED|Overall Study||423
6601287|NCT02045836|7525980|FG001|COMPLETED|Overall Study||419
6601288|NCT02045836|7525979|FG000|NOT COMPLETED|Overall Study||9
6601289|NCT02045836|7525980|FG001|NOT COMPLETED|Overall Study||14
6601290|NCT02045862|7525990|FG000|STARTED|Overall Study||306
6601291|NCT02045862|7525991|FG001|STARTED|Overall Study||305
6601292|NCT02045862|7525992|FG002|STARTED|Overall Study||1218
6601293|NCT02045862|7525990|FG000|Treated|Overall Study||306
6601294|NCT02045862|7525991|FG001|Treated|Overall Study||303
6601295|NCT02045862|7525992|FG002|Treated|Overall Study||1210
6601296|NCT02045862|7525990|FG000|COMPLETED|Overall Study||267
6601297|NCT02045862|7525991|FG001|COMPLETED|Overall Study||265
6601298|NCT02045862|7525992|FG002|COMPLETED|Overall Study||1092
6601299|NCT02045862|7525990|FG000|NOT COMPLETED|Overall Study||39
6601300|NCT02045862|7525991|FG001|NOT COMPLETED|Overall Study||40
6601301|NCT02045862|7525992|FG002|NOT COMPLETED|Overall Study||126
6601302|NCT02045875|7526002|FG000|STARTED|Overall Study||27
6601303|NCT02045875|7526003|FG001|STARTED|Overall Study||23
6601304|NCT02045875|7526002|FG000|COMPLETED|Overall Study||20
6601305|NCT02045875|7526003|FG001|COMPLETED|Overall Study||20
6601306|NCT02045875|7526002|FG000|NOT COMPLETED|Overall Study||7
6601307|NCT02045875|7526003|FG001|NOT COMPLETED|Overall Study||3
6601308|NCT02045979|7526012|FG000|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
6601309|NCT02045979|7526013|FG001|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication..|108
6601310|NCT02045979|7526014|FG002|STARTED|Overall Study|1 subject (not included to the 108) was randomized but did never take any study medication.|108
6601311|NCT02045979|7526012|FG000|COMPLETED|Overall Study||106
6601312|NCT02045979|7526013|FG001|COMPLETED|Overall Study||107
6601313|NCT02045979|7526014|FG002|COMPLETED|Overall Study||107
6601314|NCT02045979|7526012|FG000|NOT COMPLETED|Overall Study||2
6601315|NCT02045979|7526013|FG001|NOT COMPLETED|Overall Study||1
6601316|NCT02045979|7526014|FG002|NOT COMPLETED|Overall Study||1
6601317|NCT02046005|7526025|FG000|STARTED|Overall Study||80
6601318|NCT02046005|7526026|FG001|STARTED|Overall Study||78
6601319|NCT02046005|7526027|FG002|STARTED|Overall Study||80
6601320|NCT02046005|7526025|FG000|COMPLETED|Overall Study||72
6601321|NCT02046005|7526026|FG001|COMPLETED|Overall Study||71
6601322|NCT02046005|7526027|FG002|COMPLETED|Overall Study||70
6601323|NCT02046005|7526025|FG000|NOT COMPLETED|Overall Study||8
6601324|NCT02046005|7526026|FG001|NOT COMPLETED|Overall Study||7
6601325|NCT02046005|7526027|FG002|NOT COMPLETED|Overall Study||10
6601326|NCT02046070|7526038|FG000|STARTED|Overall Study||36
6601327|NCT02046070|7526039|FG001|STARTED|Overall Study||34
6601328|NCT02046070|7526040|FG002|STARTED|Overall Study||78
6601329|NCT02046070|7526038|FG000|COMPLETED|Overall Study||4
6601330|NCT02046070|7526039|FG001|COMPLETED|Overall Study||6
6601331|NCT02046070|7526040|FG002|COMPLETED|Overall Study||8
6601332|NCT02046070|7526038|FG000|NOT COMPLETED|Overall Study||32
6601333|NCT02046070|7526039|FG001|NOT COMPLETED|Overall Study||28
6601334|NCT02046070|7526040|FG002|NOT COMPLETED|Overall Study||70
6601335|NCT02046122|7526048|FG000|STARTED|Overall Study||17
6601336|NCT02046122|7526048|FG000|COMPLETED|Overall Study||8
6601337|NCT02046122|7526048|FG000|NOT COMPLETED|Overall Study||9
6601338|NCT02046135|7526054|FG000|STARTED|Overall Study||26
6601339|NCT02046135|7526055|FG001|STARTED|Overall Study||25
6601340|NCT02046135|7526054|FG000|COMPLETED|Overall Study||26
6601341|NCT02046135|7526055|FG001|COMPLETED|Overall Study||25
6601342|NCT02046135|7526054|FG000|NOT COMPLETED|Overall Study||0
6601343|NCT02046135|7526055|FG001|NOT COMPLETED|Overall Study||0
6601344|NCT02046148|7526063|FG000|STARTED|Overall Study||49
6601345|NCT02046148|7526064|FG001|STARTED|Overall Study||26
6601346|NCT02046148|7526063|FG000|COMPLETED|Overall Study||48
6601347|NCT02046148|7526064|FG001|COMPLETED|Overall Study||23
6601348|NCT02046148|7526063|FG000|NOT COMPLETED|Overall Study||1
6601349|NCT02046148|7526064|FG001|NOT COMPLETED|Overall Study||3
6601350|NCT02046174|7526070|FG000|STARTED|Overall Study||42
6601351|NCT02046174|7526071|FG001|STARTED|Overall Study||3
6601352|NCT02046174|7526070|FG000|COMPLETED|Overall Study||41
6601353|NCT02046174|7526071|FG001|COMPLETED|Overall Study||3
6601354|NCT02046174|7526070|FG000|NOT COMPLETED|Overall Study||1
6663115|NCT02515669|7593676|FG003|NOT COMPLETED|24 Week Double-Blind Phase||0
6663116|NCT02515669|7593673|FG000|STARTED|228 Week Open-Label Phase|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
6601355|NCT02046174|7526071|FG001|NOT COMPLETED|Overall Study||0
6601356|NCT02046200|7526156|FG000|STARTED|First Intervention (1 Day)||5
6601357|NCT02046200|7526157|FG001|STARTED|First Intervention (1 Day)||6
6601358|NCT02046200|7526156|FG000|COMPLETED|First Intervention (1 Day)||5
6601359|NCT02046200|7526157|FG001|COMPLETED|First Intervention (1 Day)||6
6601360|NCT02046200|7526156|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6601361|NCT02046200|7526157|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6601362|NCT02046200|7526156|FG000|STARTED|Second Intervention (1 Day)||5
6601363|NCT02046200|7526157|FG001|STARTED|Second Intervention (1 Day)||6
6601364|NCT02046200|7526156|FG000|COMPLETED|Second Intervention (1 Day)||5
6601365|NCT02046200|7526157|FG001|COMPLETED|Second Intervention (1 Day)||6
6601366|NCT02046200|7526156|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6601367|NCT02046200|7526157|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6601368|NCT02046265|7526175|FG000|STARTED|Overall Study||17
6601369|NCT02046265|7526176|FG001|STARTED|Overall Study||17
6601370|NCT02046265|7526177|FG002|STARTED|Overall Study||12
6601371|NCT02046265|7526178|FG003|STARTED|Overall Study||14
6601372|NCT02046265|7526175|FG000|COMPLETED|Overall Study||16
6601373|NCT02046265|7526176|FG001|COMPLETED|Overall Study||15
6601374|NCT02046265|7526177|FG002|COMPLETED|Overall Study||10
6601375|NCT02046265|7526178|FG003|COMPLETED|Overall Study||12
6601376|NCT02046265|7526175|FG000|NOT COMPLETED|Overall Study||1
6601377|NCT02046265|7526176|FG001|NOT COMPLETED|Overall Study||2
6601378|NCT02046265|7526177|FG002|NOT COMPLETED|Overall Study||2
6601379|NCT02046265|7526178|FG003|NOT COMPLETED|Overall Study||2
6601380|NCT02046317|7526190|FG000|STARTED|Overall Study||4
6601381|NCT02046317|7526191|FG001|STARTED|Overall Study||8
6601382|NCT02046317|7526190|FG000|COMPLETED|Overall Study||4
6601383|NCT02046317|7526191|FG001|COMPLETED|Overall Study||8
6601384|NCT02046317|7526190|FG000|NOT COMPLETED|Overall Study||0
6601385|NCT02046317|7526191|FG001|NOT COMPLETED|Overall Study||0
6601386|NCT02046369|7526199|FG000|STARTED|Overall Study||176
6601387|NCT02046369|7526200|FG001|STARTED|Overall Study||174
6601388|NCT02046369|7526199|FG000|COMPLETED|Overall Study||162
6601389|NCT02046369|7526200|FG001|COMPLETED|Overall Study||156
6601390|NCT02046369|7526199|FG000|NOT COMPLETED|Overall Study||14
6601391|NCT02046369|7526200|FG001|NOT COMPLETED|Overall Study||18
6601392|NCT02046382|7526208|FG000|STARTED|Overall Study||65
6601393|NCT02046382|7526209|FG001|STARTED|Overall Study||67
6601394|NCT02046382|7526208|FG000|COMPLETED|Overall Study||57
6601395|NCT02046382|7526209|FG001|COMPLETED|Overall Study||47
6601396|NCT02046382|7526208|FG000|NOT COMPLETED|Overall Study||8
6601397|NCT02046382|7526209|FG001|NOT COMPLETED|Overall Study||20
6601398|NCT02046525|7526217|FG000|STARTED|Overall Study||5
6601399|NCT02046525|7526218|FG001|STARTED|Overall Study||5
6601400|NCT02046525|7526217|FG000|COMPLETED|Overall Study||5
6601401|NCT02046525|7526218|FG001|COMPLETED|Overall Study||5
6601402|NCT02046525|7526217|FG000|NOT COMPLETED|Overall Study||0
6601403|NCT02046525|7526218|FG001|NOT COMPLETED|Overall Study||0
6601404|NCT02046564|7526226|FG000|STARTED|Overall Study||209
6601405|NCT02046564|7526227|FG001|STARTED|Overall Study||203
6601406|NCT02046564|7526226|FG000|COMPLETED|Overall Study||194
6601407|NCT02046564|7526227|FG001|COMPLETED|Overall Study||183
6601408|NCT02046564|7526226|FG000|NOT COMPLETED|Overall Study||15
6601409|NCT02046564|7526227|FG001|NOT COMPLETED|Overall Study||20
6601410|NCT02046603|7526235|FG000|STARTED|Overall Study||22
6601411|NCT02046603|7526236|FG001|STARTED|Overall Study||140
6601412|NCT02046603|7526235|FG000|Received at Least 1 Dose of Tocilizumab|Overall Study||21
6601413|NCT02046603|7526236|FG001|Received at Least 1 Dose of Tocilizumab|Overall Study||140
6601414|NCT02046603|7526235|FG000|COMPLETED|Overall Study||7
6601415|NCT02046603|7526236|FG001|COMPLETED|Overall Study||65
6601416|NCT02046603|7526235|FG000|NOT COMPLETED|Overall Study||15
6601417|NCT02046603|7526236|FG001|NOT COMPLETED|Overall Study||75
6601418|NCT02046616|7526243|FG000|STARTED|24-Week Treatment Period||133
6601419|NCT02046616|7526243|FG000|COMPLETED|24-Week Treatment Period||114
6601420|NCT02046616|7526243|FG000|NOT COMPLETED|24-Week Treatment Period||19
6601421|NCT02046616|7526243|FG000|STARTED|8-Week FU Period||114
6601422|NCT02046616|7526243|FG000|COMPLETED|8-Week FU Period||113
6601423|NCT02046616|7526243|FG000|NOT COMPLETED|8-Week FU Period||1
6601424|NCT02046772|7526249|FG000|STARTED|Overall Study||30
6601425|NCT02046772|7526250|FG001|STARTED|Overall Study||33
6601426|NCT02046772|7526249|FG000|COMPLETED|Overall Study||30
6601427|NCT02046772|7526250|FG001|COMPLETED|Overall Study||33
6663117|NCT02515669|7593674|FG001|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 1 RO cohort for the open-label phase.|9
6663118|NCT02515669|7593675|FG002|STARTED|228 Week Open-Label Phase|2 DB placebo participants switched to the Panel 2 RO cohort for the open-label phase.|8
6601428|NCT02046772|7526249|FG000|NOT COMPLETED|Overall Study||0
6601429|NCT02046772|7526250|FG001|NOT COMPLETED|Overall Study||0
6601430|NCT02046863|7526256|FG000|STARTED|Overall Study||7
6601431|NCT02046863|7526256|FG000|COMPLETED|Overall Study||7
6601432|NCT02046863|7526256|FG000|NOT COMPLETED|Overall Study||0
6601433|NCT02046902|7526263|FG000|STARTED|Overall Study||336
6601434|NCT02046902|7526264|FG001|STARTED|Overall Study||113
6601435|NCT02046902|7526265|FG002|STARTED|Overall Study||137
6601436|NCT02046902|7526263|FG000|COMPLETED|Overall Study||336
6601437|NCT02046902|7526264|FG001|COMPLETED|Overall Study||113
6601438|NCT02046902|7526265|FG002|COMPLETED|Overall Study||137
6601439|NCT02046902|7526263|FG000|NOT COMPLETED|Overall Study||0
6601440|NCT02046902|7526264|FG001|NOT COMPLETED|Overall Study||0
6601441|NCT02046902|7526265|FG002|NOT COMPLETED|Overall Study||0
6601442|NCT02046941|7526273|FG000|STARTED|Overall Study||17
6601443|NCT02046941|7526273|FG000|COMPLETED|Overall Study||10
6601444|NCT02046941|7526273|FG000|NOT COMPLETED|Overall Study||7
6601445|NCT02046980|7526280|FG000|STARTED|Overall Study||72
6601446|NCT02046980|7526281|FG001|STARTED|Overall Study||72
6601447|NCT02046980|7526282|FG002|STARTED|Overall Study||73
6601448|NCT02046980|7526280|FG000|COMPLETED|Overall Study||70
6601449|NCT02046980|7526281|FG001|COMPLETED|Overall Study||67
6601450|NCT02046980|7526282|FG002|COMPLETED|Overall Study||72
6601451|NCT02046980|7526280|FG000|NOT COMPLETED|Overall Study||2
6601452|NCT02046980|7526281|FG001|NOT COMPLETED|Overall Study||5
6601453|NCT02046980|7526282|FG002|NOT COMPLETED|Overall Study||1
6601454|NCT02046993|7526292|FG000|STARTED|Overall Study||105
6601455|NCT02046993|7526293|FG001|STARTED|Overall Study||105
6601456|NCT02046993|7526292|FG000|3rd Month|Overall Study||104
6601457|NCT02046993|7526293|FG001|3rd Month|Overall Study||97
6601458|NCT02046993|7526292|FG000|6th Month|Overall Study||102
6601459|NCT02046993|7526293|FG001|6th Month|Overall Study||94
6601460|NCT02046993|7526292|FG000|COMPLETED|Overall Study||102
6601461|NCT02046993|7526293|FG001|COMPLETED|Overall Study||94
6601462|NCT02046993|7526292|FG000|NOT COMPLETED|Overall Study||3
6601463|NCT02046993|7526293|FG001|NOT COMPLETED|Overall Study||11
6601464|NCT02047032|7526303|FG000|STARTED|Overall Study||250
6663119|NCT02515669|7593676|FG003|STARTED|228 Week Open-Label Phase|7 DB placebo participants switched to the Panel 3/Expansion RO cohort for the open-label phase.|26
6663120|NCT02515669|7593673|FG000|COMPLETED|228 Week Open-Label Phase||0
6663121|NCT02515669|7593674|FG001|COMPLETED|228 Week Open-Label Phase||0
6663122|NCT02515669|7593675|FG002|COMPLETED|228 Week Open-Label Phase||0
6663123|NCT02515669|7593676|FG003|COMPLETED|228 Week Open-Label Phase||0
6663124|NCT02515669|7593673|FG000|NOT COMPLETED|228 Week Open-Label Phase||0
6663125|NCT02515669|7593674|FG001|NOT COMPLETED|228 Week Open-Label Phase||9
6663126|NCT02515669|7593675|FG002|NOT COMPLETED|228 Week Open-Label Phase||8
6663127|NCT02515669|7593676|FG003|NOT COMPLETED|228 Week Open-Label Phase||26
6663128|NCT02515825|7593708|FG000|STARTED|Overall Study||70
6663129|NCT02515825|7593709|FG001|STARTED|Overall Study||31
6663130|NCT02515825|7593708|FG000|COMPLETED|Overall Study||70
6663131|NCT02515825|7593709|FG001|COMPLETED|Overall Study||31
6663132|NCT02515825|7593708|FG000|NOT COMPLETED|Overall Study||0
6663133|NCT02515825|7593709|FG001|NOT COMPLETED|Overall Study||0
6663134|NCT02515890|7593721|FG000|STARTED|Overall Study||7
6663135|NCT02515890|7593722|FG001|STARTED|Overall Study||4
6663136|NCT02515890|7593723|FG002|STARTED|Overall Study||5
6663137|NCT02515890|7593724|FG003|STARTED|Overall Study||8
6663138|NCT02515890|7593725|FG004|STARTED|Overall Study||8
6663139|NCT02515890|7593721|FG000|COMPLETED|Overall Study||7
6663140|NCT02515890|7593722|FG001|COMPLETED|Overall Study||4
6663141|NCT02515890|7593723|FG002|COMPLETED|Overall Study||5
6663142|NCT02515890|7593724|FG003|COMPLETED|Overall Study||8
6663143|NCT02515890|7593725|FG004|COMPLETED|Overall Study||8
6663144|NCT02515890|7593721|FG000|NOT COMPLETED|Overall Study||0
6663145|NCT02515890|7593722|FG001|NOT COMPLETED|Overall Study||0
6663146|NCT02515890|7593723|FG002|NOT COMPLETED|Overall Study||0
6663147|NCT02515890|7593724|FG003|NOT COMPLETED|Overall Study||0
6663148|NCT02515890|7593725|FG004|NOT COMPLETED|Overall Study||0
6663149|NCT02515942|7593739|FG000|STARTED|Overall Study||36
6663150|NCT02515942|7593740|FG001|STARTED|Overall Study||39
6663151|NCT02515942|7593741|FG002|STARTED|Overall Study||39
6663152|NCT02515942|7593739|FG000|Safety Analysis Set|Overall Study||36
6663153|NCT02515942|7593740|FG001|Safety Analysis Set|Overall Study||39
6663154|NCT02515942|7593741|FG002|Safety Analysis Set|Overall Study||39
6663155|NCT02515942|7593739|FG000|Full Analysis Set (FAS)|Overall Study||35
6663156|NCT02515942|7593740|FG001|Full Analysis Set (FAS)|Overall Study||37
6663157|NCT02515942|7593741|FG002|Full Analysis Set (FAS)|Overall Study||38
6663158|NCT02515942|7593739|FG000|Per Protocol Analysis Set (PPS)|Overall Study||30
6663159|NCT02515942|7593740|FG001|Per Protocol Analysis Set (PPS)|Overall Study||35
6663160|NCT02515942|7593741|FG002|Per Protocol Analysis Set (PPS)|Overall Study||34
6663161|NCT02515942|7593739|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||36
6663162|NCT02515942|7593740|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||39
6663163|NCT02515942|7593741|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||0
6663164|NCT02515942|7593739|FG000|Completed Day 85|Overall Study||35
6663165|NCT02515942|7593740|FG001|Completed Day 85|Overall Study||38
6663166|NCT02515942|7593741|FG002|Completed Day 85|Overall Study||37
6663167|NCT02515942|7593739|FG000|Completed Day 169|Overall Study||32
6663168|NCT02515942|7593740|FG001|Completed Day 169|Overall Study||37
6663169|NCT02515942|7593741|FG002|Completed Day 169|Overall Study||37
6663170|NCT02515942|7593739|FG000|Completed Day 253|Overall Study|One subject missed Day 253 visit|29
6663171|NCT02515942|7593740|FG001|Completed Day 253|Overall Study||37
6663172|NCT02515942|7593741|FG002|Completed Day 253|Overall Study||36
6663173|NCT02515942|7593739|FG000|Completed Day 337|Overall Study||30
6663174|NCT02515942|7593740|FG001|Completed Day 337|Overall Study||36
6663175|NCT02515942|7593741|FG002|Completed Day 337|Overall Study||35
6663176|NCT02515942|7593739|FG000|COMPLETED|Overall Study||29
6663177|NCT02515942|7593740|FG001|COMPLETED|Overall Study||36
6663178|NCT02515942|7593741|FG002|COMPLETED|Overall Study||35
6663179|NCT02515942|7593739|FG000|NOT COMPLETED|Overall Study||7
6663180|NCT02515942|7593740|FG001|NOT COMPLETED|Overall Study||3
6663181|NCT02515942|7593741|FG002|NOT COMPLETED|Overall Study||4
6663182|NCT02515994|7593753|FG000|STARTED|Overall Study||109
6663183|NCT02515994|7593754|FG001|STARTED|Overall Study||112
6663184|NCT02515994|7593753|FG000|COMPLETED|Overall Study||99
6663185|NCT02515994|7593754|FG001|COMPLETED|Overall Study||105
6601465|NCT02047032|7526304|FG001|STARTED|Overall Study||250
6601466|NCT02047032|7526303|FG000|COMPLETED|Overall Study||245
6663186|NCT02515994|7593753|FG000|NOT COMPLETED|Overall Study||10
6663187|NCT02515994|7593754|FG001|NOT COMPLETED|Overall Study||7
6663188|NCT02516046|7593760|FG000|STARTED|Overall Study|Total number of subjects scanned|156
6663189|NCT02516046|7593760|FG000|Died While on Study|Overall Study||73
6663190|NCT02516046|7593760|FG000|Valid Autopsy Results and PET Scan|Overall Study|includes 3 front-runners|67
6601467|NCT02047032|7526304|FG001|COMPLETED|Overall Study||235
6601468|NCT02047032|7526303|FG000|NOT COMPLETED|Overall Study||5
6601469|NCT02047032|7526304|FG001|NOT COMPLETED|Overall Study||15
6601470|NCT02047045|7526314|FG000|STARTED|Baseline||280
6601471|NCT02047045|7526315|FG001|STARTED|Baseline||280
6601472|NCT02047045|7526314|FG000|COMPLETED|Baseline||277
6601473|NCT02047045|7526315|FG001|COMPLETED|Baseline||278
6601474|NCT02047045|7526314|FG000|NOT COMPLETED|Baseline||3
6601475|NCT02047045|7526315|FG001|NOT COMPLETED|Baseline||2
6601476|NCT02047045|7526314|FG000|STARTED|Treatment Period (8 Weeks )||277
6601477|NCT02047045|7526315|FG001|STARTED|Treatment Period (8 Weeks )||278
6601478|NCT02047045|7526314|FG000|COMPLETED|Treatment Period (8 Weeks )||266
6601479|NCT02047045|7526315|FG001|COMPLETED|Treatment Period (8 Weeks )||263
6601480|NCT02047045|7526314|FG000|NOT COMPLETED|Treatment Period (8 Weeks )||11
6601481|NCT02047045|7526315|FG001|NOT COMPLETED|Treatment Period (8 Weeks )||15
6601482|NCT02047045|7526314|FG000|STARTED|Follow-up Period (24 Weeks)||266
6601483|NCT02047045|7526315|FG001|STARTED|Follow-up Period (24 Weeks)||263
6601484|NCT02047045|7526314|FG000|COMPLETED|Follow-up Period (24 Weeks)||265
6601485|NCT02047045|7526315|FG001|COMPLETED|Follow-up Period (24 Weeks)||262
6601486|NCT02047045|7526314|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||1
6601487|NCT02047045|7526315|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||1
6601488|NCT02047110|7526325|FG000|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
6601489|NCT02047110|7526326|FG001|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
6601490|NCT02047110|7526327|FG002|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|39
6601491|NCT02047110|7526328|FG003|STARTED|DB Treatment Period up to Week 24|Started are the treated patients|40
6601492|NCT02047110|7526325|FG000|COMPLETED|DB Treatment Period up to Week 24||35
6601493|NCT02047110|7526326|FG001|COMPLETED|DB Treatment Period up to Week 24||38
6601494|NCT02047110|7526327|FG002|COMPLETED|DB Treatment Period up to Week 24||36
6601495|NCT02047110|7526328|FG003|COMPLETED|DB Treatment Period up to Week 24||38
6601496|NCT02047110|7526325|FG000|NOT COMPLETED|DB Treatment Period up to Week 24||5
6601497|NCT02047110|7526326|FG001|NOT COMPLETED|DB Treatment Period up to Week 24||2
6601498|NCT02047110|7526327|FG002|NOT COMPLETED|DB Treatment Period up to Week 24||3
6601499|NCT02047110|7526328|FG003|NOT COMPLETED|DB Treatment Period up to Week 24||2
6601500|NCT02047110|7526325|FG000|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|9
6601501|NCT02047110|7526326|FG001|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|17
6601502|NCT02047110|7526327|FG002|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|13
6601503|NCT02047110|7526328|FG003|STARTED|DB (Week 12 up to Week 24)|Patients who continued treatment in the DB treatment period up to Week 24|12
6601504|NCT02047110|7526325|FG000|COMPLETED|DB (Week 12 up to Week 24)||9
6601505|NCT02047110|7526326|FG001|COMPLETED|DB (Week 12 up to Week 24)||15
6601506|NCT02047110|7526327|FG002|COMPLETED|DB (Week 12 up to Week 24)||12
6601507|NCT02047110|7526328|FG003|COMPLETED|DB (Week 12 up to Week 24)||12
6663191|NCT02516046|7593760|FG000|COMPLETED|Overall Study|Completed = included in autopsy cohort|64
6663192|NCT02516046|7593760|FG000|NOT COMPLETED|Overall Study||92
6663193|NCT02516098|7593776|FG000|STARTED|Period 1||28
6663194|NCT02516098|7593777|FG001|STARTED|Period 1||28
6663195|NCT02516098|7593776|FG000|COMPLETED|Period 1||27
6663196|NCT02516098|7593777|FG001|COMPLETED|Period 1||28
6663197|NCT02516098|7593776|FG000|NOT COMPLETED|Period 1||1
6663198|NCT02516098|7593777|FG001|NOT COMPLETED|Period 1||0
6663199|NCT02516098|7593776|FG000|STARTED|Washout After Period 1||27
6663200|NCT02516098|7593777|FG001|STARTED|Washout After Period 1||28
6663201|NCT02516098|7593776|FG000|COMPLETED|Washout After Period 1||27
6663202|NCT02516098|7593777|FG001|COMPLETED|Washout After Period 1||27
6663203|NCT02516098|7593776|FG000|NOT COMPLETED|Washout After Period 1||0
6663204|NCT02516098|7593777|FG001|NOT COMPLETED|Washout After Period 1||1
6663205|NCT02516098|7593776|FG000|STARTED|Period 2||27
6663206|NCT02516098|7593777|FG001|STARTED|Period 2||27
6663207|NCT02516098|7593776|FG000|COMPLETED|Period 2||27
6663208|NCT02516098|7593777|FG001|COMPLETED|Period 2||26
6663209|NCT02516098|7593776|FG000|NOT COMPLETED|Period 2||0
6663210|NCT02516098|7593777|FG001|NOT COMPLETED|Period 2||1
6663211|NCT02516098|7593776|FG000|STARTED|Washout After Period 2||27
6663212|NCT02516098|7593777|FG001|STARTED|Washout After Period 2||26
6663213|NCT02516098|7593776|FG000|COMPLETED|Washout After Period 2||27
6663214|NCT02516098|7593777|FG001|COMPLETED|Washout After Period 2||26
6663215|NCT02516098|7593776|FG000|NOT COMPLETED|Washout After Period 2||0
6663216|NCT02516098|7593777|FG001|NOT COMPLETED|Washout After Period 2||0
6663217|NCT02516150|7593783|FG000|STARTED|Overall Study||15
6663218|NCT02516150|7593783|FG000|COMPLETED|Overall Study||15
6663219|NCT02516150|7593783|FG000|NOT COMPLETED|Overall Study||0
6663220|NCT02516163|7593789|FG000|STARTED|Overall Study||52
6663221|NCT02516163|7593789|FG000|COMPLETED|Overall Study||24
6663222|NCT02516163|7593789|FG000|NOT COMPLETED|Overall Study||28
6663223|NCT02516202|7593796|FG000|STARTED|Overall Study||102
6663224|NCT02516202|7593797|FG001|STARTED|Overall Study||100
6663225|NCT02516202|7593798|FG002|STARTED|Overall Study||100
6663226|NCT02516202|7593796|FG000|COMPLETED|Overall Study||100
6663227|NCT02516202|7593797|FG001|COMPLETED|Overall Study||99
6601508|NCT02047110|7526325|FG000|NOT COMPLETED|DB (Week 12 up to Week 24)||0
6601509|NCT02047110|7526326|FG001|NOT COMPLETED|DB (Week 12 up to Week 24)||2
6601510|NCT02047110|7526327|FG002|NOT COMPLETED|DB (Week 12 up to Week 24)||1
6601511|NCT02047110|7526328|FG003|NOT COMPLETED|DB (Week 12 up to Week 24)||0
6601512|NCT02047110|7526325|FG000|STARTED|Escape Treatment Period|Assessment in SpondyloArthritis international Society (ASAS) 20 nonresponders|26
6601513|NCT02047110|7526326|FG001|STARTED|Escape Treatment Period|ASAS 20 nonresponders|21
6601514|NCT02047110|7526327|FG002|STARTED|Escape Treatment Period|ASAS 20 nonresponders|23
6663228|NCT02516202|7593798|FG002|COMPLETED|Overall Study||97
6663229|NCT02516202|7593796|FG000|NOT COMPLETED|Overall Study||2
6663230|NCT02516202|7593797|FG001|NOT COMPLETED|Overall Study||1
6663231|NCT02516202|7593798|FG002|NOT COMPLETED|Overall Study||3
6663232|NCT02516306|7593808|FG000|STARTED|Period 1: Day 1 - 7||50
6663233|NCT02516306|7593809|FG001|STARTED|Period 1: Day 1 - 7||25
6663234|NCT02516306|7593808|FG000|COMPLETED|Period 1: Day 1 - 7||50
6663235|NCT02516306|7593809|FG001|COMPLETED|Period 1: Day 1 - 7||25
6663236|NCT02516306|7593808|FG000|NOT COMPLETED|Period 1: Day 1 - 7||0
6663237|NCT02516306|7593809|FG001|NOT COMPLETED|Period 1: Day 1 - 7||0
6663238|NCT02516306|7593808|FG000|STARTED|Period 2: Day 8 - 91||50
6663239|NCT02516306|7593809|FG001|STARTED|Period 2: Day 8 - 91||25
6663240|NCT02516306|7593808|FG000|COMPLETED|Period 2: Day 8 - 91||49
6663241|NCT02516306|7593809|FG001|COMPLETED|Period 2: Day 8 - 91||23
6663242|NCT02516306|7593808|FG000|NOT COMPLETED|Period 2: Day 8 - 91||1
6663243|NCT02516306|7593809|FG001|NOT COMPLETED|Period 2: Day 8 - 91||2
6663244|NCT02516332|7593818|FG000|STARTED|Overall Study||52
6663245|NCT02516332|7593819|FG001|STARTED|Overall Study||53
6663246|NCT02516332|7593820|FG002|STARTED|Overall Study||23
6663247|NCT02516332|7593818|FG000|COMPLETED|Overall Study||50
6663248|NCT02516332|7593819|FG001|COMPLETED|Overall Study||52
6663249|NCT02516332|7593820|FG002|COMPLETED|Overall Study||21
6663250|NCT02516332|7593818|FG000|NOT COMPLETED|Overall Study||2
6663251|NCT02516332|7593819|FG001|NOT COMPLETED|Overall Study||1
6663252|NCT02516332|7593820|FG002|NOT COMPLETED|Overall Study||2
6663253|NCT02516410|7593830|FG000|STARTED|Overall Study||85
6663254|NCT02516410|7593831|FG001|STARTED|Overall Study||83
6663255|NCT02516410|7593830|FG000|COMPLETED|Overall Study||85
6663256|NCT02516410|7593831|FG001|COMPLETED|Overall Study||81
6663257|NCT02516410|7593830|FG000|NOT COMPLETED|Overall Study||0
6663258|NCT02516410|7593831|FG001|NOT COMPLETED|Overall Study||2
6663259|NCT02516579|7593838|FG000|STARTED|Overall Study||1906
6663260|NCT02516579|7593838|FG000|COMPLETED|Overall Study||1906
6663261|NCT02516579|7593838|FG000|NOT COMPLETED|Overall Study||0
6663262|NCT02516592|7593844|FG000|STARTED|Overall Study||251
6663263|NCT02516592|7593845|FG001|STARTED|Overall Study||251
6391801|NCT00838110|7303728|FG002|COMPLETED|Overall Study||226
6391802|NCT00838110|7303729|FG003|COMPLETED|Overall Study||226
6391803|NCT00838110|7303726|FG000|NOT COMPLETED|Overall Study||22
6391804|NCT00838110|7303727|FG001|NOT COMPLETED|Overall Study||22
6391805|NCT00838110|7303728|FG002|NOT COMPLETED|Overall Study||17
6391806|NCT00838110|7303729|FG003|NOT COMPLETED|Overall Study||18
6663264|NCT02516592|7593844|FG000|Full Analysis Set|Overall Study||248
6663265|NCT02516592|7593845|FG001|Full Analysis Set|Overall Study||250
6663266|NCT02516592|7593844|FG000|COMPLETED|Overall Study||235
6663267|NCT02516592|7593845|FG001|COMPLETED|Overall Study||238
6663268|NCT02516592|7593844|FG000|NOT COMPLETED|Overall Study||16
6663269|NCT02516592|7593845|FG001|NOT COMPLETED|Overall Study||13
6663270|NCT02516605|7593856|FG000|STARTED|Overall Study||11
6663271|NCT02516605|7593857|FG001|STARTED|Overall Study||9
6663272|NCT02516605|7593858|FG002|STARTED|Overall Study||12
6663273|NCT02516605|7593859|FG003|STARTED|Overall Study||8
6663274|NCT02516605|7593860|FG004|STARTED|Overall Study||21
6663275|NCT02516605|7593856|FG000|COMPLETED|Overall Study||11
6663276|NCT02516605|7593857|FG001|COMPLETED|Overall Study||9
6663277|NCT02516605|7593858|FG002|COMPLETED|Overall Study||12
6663278|NCT02516605|7593859|FG003|COMPLETED|Overall Study||7
6663279|NCT02516605|7593860|FG004|COMPLETED|Overall Study||20
6663280|NCT02516605|7593856|FG000|NOT COMPLETED|Overall Study||0
6663281|NCT02516605|7593857|FG001|NOT COMPLETED|Overall Study||0
6663282|NCT02516605|7593858|FG002|NOT COMPLETED|Overall Study||0
6663283|NCT02516605|7593859|FG003|NOT COMPLETED|Overall Study||1
6663284|NCT02516605|7593860|FG004|NOT COMPLETED|Overall Study||1
6663285|NCT02516982|7593880|FG000|STARTED|Overall Study||305
6663286|NCT02516982|7593881|FG001|STARTED|Overall Study||292
6663287|NCT02516982|7593882|FG002|STARTED|Overall Study||174
6663288|NCT02516982|7593883|FG003|STARTED|Overall Study||175
6663289|NCT02516982|7593880|FG000|COMPLETED|Overall Study||273
6663290|NCT02516982|7593881|FG001|COMPLETED|Overall Study||257
6663291|NCT02516982|7593882|FG002|COMPLETED|Overall Study||126
6663292|NCT02516982|7593883|FG003|COMPLETED|Overall Study||125
6663293|NCT02516982|7593880|FG000|NOT COMPLETED|Overall Study||32
6663294|NCT02516982|7593881|FG001|NOT COMPLETED|Overall Study||35
6663295|NCT02516982|7593882|FG002|NOT COMPLETED|Overall Study||48
6663296|NCT02516982|7593883|FG003|NOT COMPLETED|Overall Study||50
6663297|NCT02517021|7593895|FG000|STARTED|Overall Study||203
6663298|NCT02517021|7593896|FG001|STARTED|Overall Study||202
6663299|NCT02517021|7593895|FG000|COMPLETED|Overall Study||120
6663300|NCT02517021|7593896|FG001|COMPLETED|Overall Study||117
6663301|NCT02517021|7593895|FG000|NOT COMPLETED|Overall Study||83
6663302|NCT02517021|7593896|FG001|NOT COMPLETED|Overall Study||85
6663303|NCT02517047|7593902|FG000|STARTED|Overall Study||26
6663304|NCT02517047|7593902|FG000|COMPLETED|Overall Study||24
6601515|NCT02047110|7526328|FG003|STARTED|Escape Treatment Period|ASAS 20 nonresponders|26
6601516|NCT02047110|7526325|FG000|COMPLETED|Escape Treatment Period||23
6601517|NCT02047110|7526326|FG001|COMPLETED|Escape Treatment Period||15
6601518|NCT02047110|7526327|FG002|COMPLETED|Escape Treatment Period||20
6601519|NCT02047110|7526328|FG003|COMPLETED|Escape Treatment Period||24
6601520|NCT02047110|7526325|FG000|NOT COMPLETED|Escape Treatment Period||3
6601521|NCT02047110|7526326|FG001|NOT COMPLETED|Escape Treatment Period||6
6601522|NCT02047110|7526327|FG002|NOT COMPLETED|Escape Treatment Period||3
6601523|NCT02047110|7526328|FG003|NOT COMPLETED|Escape Treatment Period||2
6601524|NCT02047110|7526325|FG000|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|4
6601525|NCT02047110|7526326|FG001|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|8
6601526|NCT02047110|7526327|FG002|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|5
6601527|NCT02047110|7526328|FG003|STARTED|OLE Treatment Period|Patients with loss of ASAS 20 response compared with baseline|9
6601528|NCT02047110|7526325|FG000|COMPLETED|OLE Treatment Period||4
6601529|NCT02047110|7526326|FG001|COMPLETED|OLE Treatment Period||8
6601530|NCT02047110|7526327|FG002|COMPLETED|OLE Treatment Period||4
6601531|NCT02047110|7526328|FG003|COMPLETED|OLE Treatment Period||9
6601532|NCT02047110|7526325|FG000|NOT COMPLETED|OLE Treatment Period||0
6601533|NCT02047110|7526326|FG001|NOT COMPLETED|OLE Treatment Period||0
6601534|NCT02047110|7526327|FG002|NOT COMPLETED|OLE Treatment Period||1
6601535|NCT02047110|7526328|FG003|NOT COMPLETED|OLE Treatment Period||0
6601536|NCT02047227|7526347|FG000|STARTED|Overall Study||462
6601537|NCT02047227|7526348|FG001|STARTED|Overall Study||477
6601538|NCT02047227|7526347|FG000|Completed Ovarian Stimulation Phase|Overall Study||424
6601539|NCT02047227|7526348|FG001|Completed Ovarian Stimulation Phase|Overall Study||440
6601540|NCT02047227|7526347|FG000|COMPLETED|Overall Study||318
6601541|NCT02047227|7526348|FG001|COMPLETED|Overall Study||347
6601542|NCT02047227|7526347|FG000|NOT COMPLETED|Overall Study||144
6601543|NCT02047227|7526348|FG001|NOT COMPLETED|Overall Study||130
6601544|NCT02047253|7526354|FG000|STARTED|Overall Study||28
6601545|NCT02047253|7526354|FG000|COMPLETED|Overall Study||20
6601546|NCT02047253|7526354|FG000|NOT COMPLETED|Overall Study||8
6601547|NCT02047305|7526358|FG000|STARTED|Overall Study||96
6601548|NCT02047305|7526358|FG000|COMPLETED|Overall Study||96
6601549|NCT02047305|7526358|FG000|NOT COMPLETED|Overall Study||0
6601550|NCT02047318|7526362|FG000|STARTED|Core Study Period||19
6601551|NCT02047318|7526362|FG000|Received MRX 14 ug/kg/Day|Core Study Period||6
6601552|NCT02047318|7526362|FG000|Received MRX 35 ug/kg/Day|Core Study Period||6
6601553|NCT02047318|7526362|FG000|Received MRX 70 ug/kg/Day|Core Study Period||6
6601554|NCT02047318|7526362|FG000|Received MRX 140 ug/kg/Day|Core Study Period||11
6601555|NCT02047318|7526362|FG000|Received MRX 280 ug/kg/Day|Core Study Period||19
6601556|NCT02047318|7526362|FG000|COMPLETED|Core Study Period||7
6601557|NCT02047318|7526362|FG000|NOT COMPLETED|Core Study Period||12
6601558|NCT02047318|7526362|FG000|STARTED|52-week Follow-up Treatment Period||6
6601559|NCT02047318|7526362|FG000|COMPLETED|52-week Follow-up Treatment Period||6
6601560|NCT02047318|7526362|FG000|NOT COMPLETED|52-week Follow-up Treatment Period||0
6601561|NCT02047318|7526362|FG000|STARTED|Long-term Follow-up Treatment Period||7
6601562|NCT02047318|7526362|FG000|Received MRX 280 ug/kg/Day|Long-term Follow-up Treatment Period||7
6601563|NCT02047318|7526362|FG000|Received 420 ug/kg/Day|Long-term Follow-up Treatment Period||5
6601564|NCT02047318|7526362|FG000|Received 560 ug/kg/Day|Long-term Follow-up Treatment Period||5
6601565|NCT02047318|7526362|FG000|COMPLETED|Long-term Follow-up Treatment Period||6
6601566|NCT02047318|7526362|FG000|NOT COMPLETED|Long-term Follow-up Treatment Period||1
6601567|NCT02047344|7526379|FG000|STARTED|Overall Study|one patient is not evaluable in process. however, evaluable to safety report.|16
6601568|NCT02047344|7526380|FG001|STARTED|Overall Study||15
6601569|NCT02047344|7526379|FG000|COMPLETED|Overall Study||16
6601570|NCT02047344|7526380|FG001|COMPLETED|Overall Study||15
6601571|NCT02047344|7526379|FG000|NOT COMPLETED|Overall Study||0
6601572|NCT02047344|7526380|FG001|NOT COMPLETED|Overall Study||0
6601573|NCT02047500|7526392|FG000|STARTED|Overall Study||19
6601574|NCT02047500|7526392|FG000|COMPLETED|Overall Study||0
6601575|NCT02047500|7526392|FG000|NOT COMPLETED|Overall Study||19
6601576|NCT02047604|7526402|FG000|STARTED|Overall Study||6
6601577|NCT02047604|7526403|FG001|STARTED|Overall Study||7
6601578|NCT02047604|7526404|FG002|STARTED|Overall Study||6
6601579|NCT02047604|7526405|FG003|STARTED|Overall Study||6
6601580|NCT02047604|7526406|FG004|STARTED|Overall Study||6
6601581|NCT02047604|7526407|FG005|STARTED|Overall Study||10
6601582|NCT02047604|7526402|FG000|COMPLETED|Overall Study||6
6663305|NCT02517047|7593902|FG000|NOT COMPLETED|Overall Study||2
6663306|NCT02517268|7593909|FG000|STARTED|Overall Study||40
6663307|NCT02517268|7593910|FG001|STARTED|Overall Study||37
6663308|NCT02517268|7593909|FG000|COMPLETED|Overall Study||39
6601583|NCT02047604|7526403|FG001|COMPLETED|Overall Study||7
6601584|NCT02047604|7526404|FG002|COMPLETED|Overall Study||6
6601585|NCT02047604|7526405|FG003|COMPLETED|Overall Study||6
6601586|NCT02047604|7526406|FG004|COMPLETED|Overall Study||5
6601587|NCT02047604|7526407|FG005|COMPLETED|Overall Study||9
6601588|NCT02047604|7526402|FG000|NOT COMPLETED|Overall Study||0
6601589|NCT02047604|7526403|FG001|NOT COMPLETED|Overall Study||0
6601590|NCT02047604|7526404|FG002|NOT COMPLETED|Overall Study||0
6601591|NCT02047604|7526405|FG003|NOT COMPLETED|Overall Study||0
6601592|NCT02047604|7526406|FG004|NOT COMPLETED|Overall Study||1
6601593|NCT02047604|7526407|FG005|NOT COMPLETED|Overall Study||1
6625035|NCT02222610|7552609|FG001|STARTED|Baseline to W104||16
6625036|NCT02222610|7552610|FG002|STARTED|Baseline to W104||16
6625037|NCT02222610|7552608|FG000|COMPLETED|Baseline to W104||8
6625038|NCT02222610|7552609|FG001|COMPLETED|Baseline to W104||11
6625039|NCT02222610|7552610|FG002|COMPLETED|Baseline to W104||10
6625040|NCT02222610|7552608|FG000|NOT COMPLETED|Baseline to W104||0
6625041|NCT02222610|7552609|FG001|NOT COMPLETED|Baseline to W104||5
6625042|NCT02222610|7552610|FG002|NOT COMPLETED|Baseline to W104||6
6625043|NCT02222688|7552625|FG000|STARTED|Overall Study||4
6625044|NCT02222688|7552626|FG001|STARTED|Overall Study||3
6625045|NCT02222688|7552627|FG002|STARTED|Overall Study||3
6625046|NCT02222688|7552628|FG003|STARTED|Overall Study||5
6625047|NCT02222688|7552629|FG004|STARTED|Overall Study||3
6625048|NCT02222688|7552630|FG005|STARTED|Overall Study||3
6625049|NCT02222688|7552631|FG006|STARTED|Overall Study||6
6625050|NCT02222688|7552625|FG000|COMPLETED|Overall Study||3
6625051|NCT02222688|7552626|FG001|COMPLETED|Overall Study||3
6625052|NCT02222688|7552627|FG002|COMPLETED|Overall Study||3
6625053|NCT02222688|7552628|FG003|COMPLETED|Overall Study||3
6625054|NCT02222688|7552629|FG004|COMPLETED|Overall Study||2
6625055|NCT02222688|7552630|FG005|COMPLETED|Overall Study||3
6625056|NCT02222688|7552631|FG006|COMPLETED|Overall Study||5
6625057|NCT02222688|7552625|FG000|NOT COMPLETED|Overall Study||1
6625058|NCT02222688|7552626|FG001|NOT COMPLETED|Overall Study||0
6625059|NCT02222688|7552627|FG002|NOT COMPLETED|Overall Study||0
6625060|NCT02222688|7552628|FG003|NOT COMPLETED|Overall Study||2
6625061|NCT02222688|7552629|FG004|NOT COMPLETED|Overall Study||1
6625062|NCT02222688|7552630|FG005|NOT COMPLETED|Overall Study||0
6625063|NCT02222688|7552631|FG006|NOT COMPLETED|Overall Study||1
6625064|NCT02222714|7552654|FG000|STARTED|Overall Study||15
6625065|NCT02222714|7552655|FG001|STARTED|Overall Study||24
6625066|NCT02222714|7552656|FG002|STARTED|Overall Study||12
6625067|NCT02222714|7552657|FG003|STARTED|Overall Study||15
6625068|NCT02222714|7552658|FG004|STARTED|Overall Study||44
6625069|NCT02222714|7552654|FG000|COMPLETED|Overall Study||15
6625070|NCT02222714|7552655|FG001|COMPLETED|Overall Study||22
6625071|NCT02222714|7552656|FG002|COMPLETED|Overall Study||8
6625072|NCT02222714|7552657|FG003|COMPLETED|Overall Study||11
6625073|NCT02222714|7552658|FG004|COMPLETED|Overall Study||37
6625074|NCT02222714|7552654|FG000|NOT COMPLETED|Overall Study||0
6625075|NCT02222714|7552655|FG001|NOT COMPLETED|Overall Study||2
6625076|NCT02222714|7552656|FG002|NOT COMPLETED|Overall Study||4
6625077|NCT02222714|7552657|FG003|NOT COMPLETED|Overall Study||4
6625078|NCT02222714|7552658|FG004|NOT COMPLETED|Overall Study||7
6625079|NCT02222818|7552675|FG000|STARTED|Period 1|Start of CAFR evaluation period|33
6625080|NCT02222818|7552676|FG001|STARTED|Period 1|Start of CAFRPlus evaluation period|33
6625081|NCT02222818|7552675|FG000|COMPLETED|Period 1|End of CAFR evaluation period|33
6625082|NCT02222818|7552676|FG001|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
6625083|NCT02222818|7552675|FG000|NOT COMPLETED|Period 1||0
6625084|NCT02222818|7552676|FG001|NOT COMPLETED|Period 1||3
6625085|NCT02222818|7552675|FG000|STARTED|Period 2|Start of CAFRPlus evaluation period|33
6625086|NCT02222818|7552676|FG001|STARTED|Period 2|Start of CAFR evaluation period|30
6625087|NCT02222818|7552675|FG000|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
6625088|NCT02222818|7552676|FG001|COMPLETED|Period 2|End of CAFR evaluation period|30
6625089|NCT02222818|7552675|FG000|NOT COMPLETED|Period 2||0
6625090|NCT02222818|7552676|FG001|NOT COMPLETED|Period 2||0
6625091|NCT02222870|7552683|FG000|STARTED|Overall Study||30
6625092|NCT02222870|7552684|FG001|STARTED|Overall Study||30
6625093|NCT02222870|7552683|FG000|COMPLETED|Overall Study||30
6625094|NCT02222870|7552684|FG001|COMPLETED|Overall Study||30
6625095|NCT02222870|7552683|FG000|NOT COMPLETED|Overall Study||0
6625096|NCT02222870|7552684|FG001|NOT COMPLETED|Overall Study||0
6625097|NCT02222896|7552690|FG000|STARTED|Abdomen||253
6625098|NCT02222896|7552691|FG001|STARTED|Abdomen||48
6625099|NCT02222896|7552692|FG002|STARTED|Abdomen||253
6625100|NCT02222896|7552690|FG000|COMPLETED|Abdomen||219
6625101|NCT02222896|7552691|FG001|COMPLETED|Abdomen||38
6625102|NCT02222896|7552692|FG002|COMPLETED|Abdomen||221
6625103|NCT02222896|7552690|FG000|NOT COMPLETED|Abdomen||34
6625104|NCT02222896|7552691|FG001|NOT COMPLETED|Abdomen||10
6625105|NCT02222896|7552692|FG002|NOT COMPLETED|Abdomen||32
6625106|NCT02222896|7552690|FG000|STARTED|Groin||254
6625107|NCT02222896|7552691|FG001|STARTED|Groin||48
6625108|NCT02222896|7552692|FG002|STARTED|Groin||250
6625109|NCT02222896|7552690|FG000|COMPLETED|Groin||211
6625110|NCT02222896|7552691|FG001|COMPLETED|Groin||39
6625111|NCT02222896|7552692|FG002|COMPLETED|Groin||210
6625112|NCT02222896|7552690|FG000|NOT COMPLETED|Groin||43
6625113|NCT02222896|7552691|FG001|NOT COMPLETED|Groin||9
6625114|NCT02222896|7552692|FG002|NOT COMPLETED|Groin||40
6625115|NCT02222922|7552712|FG000|STARTED|Overall Study||2
6625116|NCT02222922|7552713|FG001|STARTED|Overall Study||2
6625117|NCT02222922|7552714|FG002|STARTED|Overall Study||2
6625118|NCT02222922|7552715|FG003|STARTED|Overall Study||5
6625119|NCT02222922|7552716|FG004|STARTED|Overall Study||96
6625120|NCT02222922|7552717|FG005|STARTED|Overall Study||6
6625121|NCT02222922|7552718|FG006|STARTED|Overall Study||3
6625122|NCT02222922|7552719|FG007|STARTED|Overall Study||10
6601594|NCT02047643|7526421|FG000|STARTED|Overall Study||9
6601595|NCT02047643|7526422|FG001|STARTED|Overall Study||9
6601596|NCT02047643|7526421|FG000|COMPLETED|Overall Study||9
6601597|NCT02047643|7526422|FG001|COMPLETED|Overall Study||9
6601598|NCT02047643|7526421|FG000|NOT COMPLETED|Overall Study||0
6601599|NCT02047643|7526422|FG001|NOT COMPLETED|Overall Study||0
6601600|NCT02047734|7526431|FG000|STARTED|Overall Study||443
6601601|NCT02047734|7526432|FG001|STARTED|Overall Study||443
6601602|NCT02047734|7526433|FG002|STARTED|Overall Study||434
6601603|NCT02047734|7526431|FG000|Received Treatment|Overall Study|One participant received ozanimod 0.5 mg in error|441
6601604|NCT02047734|7526432|FG001|Received Treatment|Overall Study|One participant received ozanimod 1.0 mg in error|439
6601605|NCT02047734|7526433|FG002|Received Treatment|Overall Study||433
6601606|NCT02047734|7526431|FG000|COMPLETED|Overall Study||376
6601607|NCT02047734|7526432|FG001|COMPLETED|Overall Study||374
6601608|NCT02047734|7526433|FG002|COMPLETED|Overall Study||388
6601609|NCT02047734|7526431|FG000|NOT COMPLETED|Overall Study||67
6601610|NCT02047734|7526432|FG001|NOT COMPLETED|Overall Study||69
6601611|NCT02047734|7526433|FG002|NOT COMPLETED|Overall Study||46
6601612|NCT02047903|7526441|FG000|STARTED|Overall Study||161
6601613|NCT02047903|7526441|FG000|Treated|Overall Study||152
6601614|NCT02047903|7526441|FG000|COMPLETED|Overall Study||102
6601615|NCT02047903|7526441|FG000|NOT COMPLETED|Overall Study||59
6601616|NCT02047981|7526447|FG000|STARTED|MORDOR Stage I Year 1-2||97047
6601617|NCT02047981|7526448|FG001|STARTED|MORDOR Stage I Year 1-2||93191
6601618|NCT02047981|7526447|FG000|COMPLETED|MORDOR Stage I Year 1-2||87650
6601619|NCT02047981|7526448|FG001|COMPLETED|MORDOR Stage I Year 1-2||84474
6601620|NCT02047981|7526447|FG000|NOT COMPLETED|MORDOR Stage I Year 1-2||9397
6601621|NCT02047981|7526448|FG001|NOT COMPLETED|MORDOR Stage I Year 1-2||8717
6601622|NCT02047981|7526447|FG000|STARTED|MORDOR Stage II Year 3||37497
6601623|NCT02047981|7526448|FG001|STARTED|MORDOR Stage II Year 3||33294
6601624|NCT02047981|7526447|FG000|COMPLETED|MORDOR Stage II Year 3||34611
6601625|NCT02047981|7526448|FG001|COMPLETED|MORDOR Stage II Year 3||30931
6601626|NCT02047981|7526447|FG000|NOT COMPLETED|MORDOR Stage II Year 3||2886
6601627|NCT02047981|7526448|FG001|NOT COMPLETED|MORDOR Stage II Year 3||2363
6601628|NCT02048072|7526454|FG000|STARTED|Overall Study||33
6601629|NCT02048072|7526454|FG000|COMPLETED|Overall Study||29
6601630|NCT02048072|7526454|FG000|NOT COMPLETED|Overall Study||4
6601631|NCT02048241|7526460|FG000|STARTED|Overall Study||5
6601632|NCT02048241|7526461|FG001|STARTED|Overall Study||6
6601633|NCT02048241|7526460|FG000|COMPLETED|Overall Study||5
6601634|NCT02048241|7526461|FG001|COMPLETED|Overall Study||5
6601635|NCT02048241|7526460|FG000|NOT COMPLETED|Overall Study||0
6601636|NCT02048241|7526461|FG001|NOT COMPLETED|Overall Study||1
6601637|NCT02048670|7526469|FG000|STARTED|Overall Study||6
6601638|NCT02048670|7526470|FG001|STARTED|Overall Study||6
6601639|NCT02048670|7526469|FG000|COMPLETED|Overall Study||6
6601640|NCT02048670|7526470|FG001|COMPLETED|Overall Study||6
6601641|NCT02048670|7526469|FG000|NOT COMPLETED|Overall Study||0
6601642|NCT02048670|7526470|FG001|NOT COMPLETED|Overall Study||0
6601643|NCT02048826|7526478|FG000|STARTED|Overall Study||16
6601644|NCT02048826|7526479|FG001|STARTED|Overall Study||15
6601645|NCT02048826|7526478|FG000|COMPLETED|Overall Study||15
6601646|NCT02048826|7526479|FG001|COMPLETED|Overall Study||15
6601647|NCT02048826|7526478|FG000|NOT COMPLETED|Overall Study||1
6601648|NCT02048826|7526479|FG001|NOT COMPLETED|Overall Study||0
6601649|NCT02048878|7526487|FG000|STARTED|Overall Study||13
6601650|NCT02048878|7526488|FG001|STARTED|Overall Study||15
6601651|NCT02048878|7526487|FG000|COMPLETED|Overall Study||12
6601652|NCT02048878|7526488|FG001|COMPLETED|Overall Study||12
6601653|NCT02048878|7526487|FG000|NOT COMPLETED|Overall Study||1
6601654|NCT02048878|7526488|FG001|NOT COMPLETED|Overall Study||3
6601655|NCT02048891|7526496|FG000|STARTED|Overall Study||2
6601656|NCT02048891|7526497|FG001|STARTED|Overall Study||1
6601657|NCT02048891|7526496|FG000|COMPLETED|Overall Study||2
6601658|NCT02048891|7526497|FG001|COMPLETED|Overall Study||1
6601659|NCT02048891|7526496|FG000|NOT COMPLETED|Overall Study||0
6601660|NCT02048891|7526497|FG001|NOT COMPLETED|Overall Study||0
6601661|NCT02049151|7526505|FG000|STARTED|Overall Study|2 subjects did not receive treatment|15
6601662|NCT02049151|7526506|FG001|STARTED|Overall Study|1 subject did not receive treatment|17
6601663|NCT02049151|7526505|FG000|COMPLETED|Overall Study||15
6601664|NCT02049151|7526506|FG001|COMPLETED|Overall Study||17
6601665|NCT02049151|7526505|FG000|NOT COMPLETED|Overall Study||0
6601666|NCT02049151|7526506|FG001|NOT COMPLETED|Overall Study||0
6601667|NCT02049307|7526514|FG000|STARTED|Overall Study||52
6601668|NCT02049307|7526515|FG001|STARTED|Overall Study||56
6601669|NCT02049307|7526514|FG000|COMPLETED|Overall Study||50
6601670|NCT02049307|7526515|FG001|COMPLETED|Overall Study||55
6601671|NCT02049307|7526514|FG000|NOT COMPLETED|Overall Study||2
6601672|NCT02049307|7526515|FG001|NOT COMPLETED|Overall Study||1
6601673|NCT02049385|7526523|FG000|STARTED|First Intervention||4
6601674|NCT02049385|7526524|FG001|STARTED|First Intervention||2
6601675|NCT02049385|7526523|FG000|COMPLETED|First Intervention||1
6601676|NCT02049385|7526524|FG001|COMPLETED|First Intervention||2
6601677|NCT02049385|7526523|FG000|NOT COMPLETED|First Intervention||3
6601678|NCT02049385|7526524|FG001|NOT COMPLETED|First Intervention||0
6601679|NCT02049385|7526523|FG000|STARTED|Second Intervention||1
6601680|NCT02049385|7526524|FG001|STARTED|Second Intervention||2
6601681|NCT02049385|7526523|FG000|COMPLETED|Second Intervention||1
6601682|NCT02049385|7526524|FG001|COMPLETED|Second Intervention||0
6601683|NCT02049385|7526523|FG000|NOT COMPLETED|Second Intervention||0
6601684|NCT02049385|7526524|FG001|NOT COMPLETED|Second Intervention||2
6601685|NCT02049437|7526532|FG000|STARTED|Period 1||17
6601686|NCT02049437|7526533|FG001|STARTED|Period 1||17
6601687|NCT02049437|7526532|FG000|COMPLETED|Period 1||15
6601688|NCT02049437|7526533|FG001|COMPLETED|Period 1|Dropout due to low trough levels|16
6601689|NCT02049437|7526532|FG000|NOT COMPLETED|Period 1||2
6601690|NCT02049437|7526533|FG001|NOT COMPLETED|Period 1||1
6601691|NCT02049437|7526532|FG000|STARTED|Washout 1||15
6601692|NCT02049437|7526533|FG001|STARTED|Washout 1||16
6601693|NCT02049437|7526532|FG000|COMPLETED|Washout 1||15
6601694|NCT02049437|7526533|FG001|COMPLETED|Washout 1||16
6663309|NCT02517268|7593910|FG001|COMPLETED|Overall Study||37
6663310|NCT02517268|7593909|FG000|NOT COMPLETED|Overall Study||1
6663311|NCT02517268|7593910|FG001|NOT COMPLETED|Overall Study||0
6663312|NCT02517463|7593918|FG000|STARTED|Overall Study||369
6663313|NCT02517463|7593919|FG001|STARTED|Overall Study||331
6663314|NCT02517463|7593918|FG000|COMPLETED|Overall Study||364
6663315|NCT02517463|7593919|FG001|COMPLETED|Overall Study||329
6663316|NCT02517463|7593918|FG000|NOT COMPLETED|Overall Study||5
6663317|NCT02517463|7593919|FG001|NOT COMPLETED|Overall Study||2
6663318|NCT02517515|7593927|FG000|STARTED|Overall Study||325
6663319|NCT02517515|7593928|FG001|STARTED|Overall Study||325
6663320|NCT02517515|7593927|FG000|COMPLETED|Overall Study||323
6663321|NCT02517515|7593928|FG001|COMPLETED|Overall Study||323
6663322|NCT02517515|7593927|FG000|NOT COMPLETED|Overall Study||2
6663323|NCT02517515|7593928|FG001|NOT COMPLETED|Overall Study||2
6663324|NCT02517528|7593935|FG000|STARTED|Overall Study||104
6663325|NCT02517528|7593935|FG000|COMPLETED|Overall Study||103
6663326|NCT02517528|7593935|FG000|NOT COMPLETED|Overall Study||1
6663327|NCT02517541|7593939|FG000|STARTED|Baseline Period (Own Product)||74
6663328|NCT02517541|7593939|FG000|COMPLETED|Baseline Period (Own Product)||73
6663329|NCT02517541|7593939|FG000|NOT COMPLETED|Baseline Period (Own Product)||1
6663330|NCT02517541|7593939|FG000|STARTED|Test Period (SenSura Mio Convex Soft)||73
6663331|NCT02517541|7593939|FG000|COMPLETED|Test Period (SenSura Mio Convex Soft)||61
6663332|NCT02517541|7593939|FG000|NOT COMPLETED|Test Period (SenSura Mio Convex Soft)||12
6663333|NCT02517567|7593945|FG000|STARTED|First Exposure (8 Hours)||6
6663334|NCT02517567|7593946|FG001|STARTED|First Exposure (8 Hours)||8
6663335|NCT02517567|7593947|FG002|STARTED|First Exposure (8 Hours)||7
6663336|NCT02517567|7593948|FG003|STARTED|First Exposure (8 Hours)||8
6663337|NCT02517567|7593945|FG000|COMPLETED|First Exposure (8 Hours)||6
6663338|NCT02517567|7593946|FG001|COMPLETED|First Exposure (8 Hours)||8
6663339|NCT02517567|7593947|FG002|COMPLETED|First Exposure (8 Hours)||7
6663340|NCT02517567|7593948|FG003|COMPLETED|First Exposure (8 Hours)||8
6663341|NCT02517567|7593945|FG000|NOT COMPLETED|First Exposure (8 Hours)||0
6663342|NCT02517567|7593946|FG001|NOT COMPLETED|First Exposure (8 Hours)||0
6663343|NCT02517567|7593947|FG002|NOT COMPLETED|First Exposure (8 Hours)||0
6663344|NCT02517567|7593948|FG003|NOT COMPLETED|First Exposure (8 Hours)||0
6663345|NCT02517567|7593945|FG000|STARTED|Second Exposure (8 Hours)||6
6663346|NCT02517567|7593946|FG001|STARTED|Second Exposure (8 Hours)||8
6663347|NCT02517567|7593947|FG002|STARTED|Second Exposure (8 Hours)||7
6663348|NCT02517567|7593948|FG003|STARTED|Second Exposure (8 Hours)||8
6663349|NCT02517567|7593945|FG000|COMPLETED|Second Exposure (8 Hours)||6
6663350|NCT02517567|7593946|FG001|COMPLETED|Second Exposure (8 Hours)||8
6663351|NCT02517567|7593947|FG002|COMPLETED|Second Exposure (8 Hours)||7
6663352|NCT02517567|7593948|FG003|COMPLETED|Second Exposure (8 Hours)||8
6663353|NCT02517567|7593945|FG000|NOT COMPLETED|Second Exposure (8 Hours)||0
6663354|NCT02517567|7593946|FG001|NOT COMPLETED|Second Exposure (8 Hours)||0
6663355|NCT02517567|7593947|FG002|NOT COMPLETED|Second Exposure (8 Hours)||0
6663356|NCT02517567|7593948|FG003|NOT COMPLETED|Second Exposure (8 Hours)||0
6663357|NCT02517567|7593945|FG000|STARTED|Third Exposure (8 Hours)||6
6663358|NCT02517567|7593946|FG001|STARTED|Third Exposure (8 Hours)||8
6663359|NCT02517567|7593947|FG002|STARTED|Third Exposure (8 Hours)||7
6663360|NCT02517567|7593948|FG003|STARTED|Third Exposure (8 Hours)||8
6663361|NCT02517567|7593945|FG000|COMPLETED|Third Exposure (8 Hours)||6
6663362|NCT02517567|7593946|FG001|COMPLETED|Third Exposure (8 Hours)||8
6663363|NCT02517567|7593947|FG002|COMPLETED|Third Exposure (8 Hours)||7
6663364|NCT02517567|7593948|FG003|COMPLETED|Third Exposure (8 Hours)||8
6663365|NCT02517567|7593945|FG000|NOT COMPLETED|Third Exposure (8 Hours)||0
6663366|NCT02517567|7593946|FG001|NOT COMPLETED|Third Exposure (8 Hours)||0
6663367|NCT02517567|7593947|FG002|NOT COMPLETED|Third Exposure (8 Hours)||0
6663368|NCT02517567|7593948|FG003|NOT COMPLETED|Third Exposure (8 Hours)||0
6663369|NCT02517567|7593945|FG000|STARTED|Fourth Exposure (8 Hours)||6
6663370|NCT02517567|7593946|FG001|STARTED|Fourth Exposure (8 Hours)||8
6663371|NCT02517567|7593947|FG002|STARTED|Fourth Exposure (8 Hours)|One subject discontinued between Period 3 and Period 4 (withdrawal by subject)|6
6663372|NCT02517567|7593948|FG003|STARTED|Fourth Exposure (8 Hours)||8
6663373|NCT02517567|7593945|FG000|COMPLETED|Fourth Exposure (8 Hours)||6
6663374|NCT02517567|7593946|FG001|COMPLETED|Fourth Exposure (8 Hours)||8
6663375|NCT02517567|7593947|FG002|COMPLETED|Fourth Exposure (8 Hours)||6
6663376|NCT02517567|7593948|FG003|COMPLETED|Fourth Exposure (8 Hours)||8
6663377|NCT02517567|7593945|FG000|NOT COMPLETED|Fourth Exposure (8 Hours)||0
6601695|NCT02049437|7526532|FG000|NOT COMPLETED|Washout 1||0
6601696|NCT02049437|7526533|FG001|NOT COMPLETED|Washout 1||0
6601697|NCT02049437|7526532|FG000|STARTED|Period 2||15
6663378|NCT02517567|7593946|FG001|NOT COMPLETED|Fourth Exposure (8 Hours)||0
6601698|NCT02049437|7526533|FG001|STARTED|Period 2||16
6601699|NCT02049437|7526532|FG000|COMPLETED|Period 2||15
6601700|NCT02049437|7526533|FG001|COMPLETED|Period 2||16
6601701|NCT02049437|7526532|FG000|NOT COMPLETED|Period 2||0
6601702|NCT02049437|7526533|FG001|NOT COMPLETED|Period 2||0
6601703|NCT02049437|7526532|FG000|STARTED|Washout 2||15
6601704|NCT02049437|7526533|FG001|STARTED|Washout 2||16
6601705|NCT02049437|7526532|FG000|COMPLETED|Washout 2||15
6601706|NCT02049437|7526533|FG001|COMPLETED|Washout 2||16
6601707|NCT02049437|7526532|FG000|NOT COMPLETED|Washout 2||0
6601708|NCT02049437|7526533|FG001|NOT COMPLETED|Washout 2||0
6601709|NCT02049450|7526539|FG000|STARTED|Overall Study||30
6601710|NCT02049450|7526539|FG000|Discontinued Treatment Prior to Week 30|Overall Study||4
6601711|NCT02049450|7526539|FG000|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
6601712|NCT02049450|7526539|FG000|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
6601713|NCT02049450|7526539|FG000|NOT COMPLETED|Overall Study||4
6601714|NCT02049476|7526550|FG000|STARTED|Overall Study|First patient enrolled on 1/31/2014|20
6601715|NCT02049476|7526550|FG000|COMPLETED|Overall Study|20th patient completed the study|20
6601716|NCT02049476|7526550|FG000|NOT COMPLETED|Overall Study||0
6601717|NCT02049502|7526554|FG000|STARTED|Overall Study||8
6601718|NCT02049502|7526554|FG000|COMPLETED|Overall Study||8
6601719|NCT02049502|7526554|FG000|NOT COMPLETED|Overall Study||0
6601720|NCT02049749|7526560|FG000|STARTED|Overall Study|40 children plus 40 caregivers|80
6601721|NCT02049749|7526561|FG001|STARTED|Overall Study|80 children plus 80 caregivers|160
6601722|NCT02049749|7526560|FG000|COMPLETED|Overall Study||80
6601723|NCT02049749|7526561|FG001|COMPLETED|Overall Study|80 children plus 80 caregivers|160
6601724|NCT02049749|7526560|FG000|NOT COMPLETED|Overall Study||0
6601725|NCT02049749|7526561|FG001|NOT COMPLETED|Overall Study||0
6601726|NCT02049814|7526570|FG000|STARTED|Overall Study||248
6601727|NCT02049814|7526571|FG001|STARTED|Overall Study||246
6601728|NCT02049814|7526570|FG000|Safety Set|Overall Study||248
6601729|NCT02049814|7526571|FG001|Safety Set|Overall Study||245
6601730|NCT02049814|7526570|FG000|COMPLETED|Overall Study||219
6601731|NCT02049814|7526571|FG001|COMPLETED|Overall Study||219
6601732|NCT02049814|7526570|FG000|NOT COMPLETED|Overall Study||29
6601733|NCT02049814|7526571|FG001|NOT COMPLETED|Overall Study||27
6601734|NCT02049866|7526577|FG000|STARTED|Overall Study||33
6601735|NCT02049866|7526577|FG000|COMPLETED|Overall Study||32
6601736|NCT02049866|7526577|FG000|NOT COMPLETED|Overall Study||1
6601737|NCT02049931|7526584|FG000|STARTED|Overall Study||20
6601738|NCT02049931|7526585|FG001|STARTED|Overall Study||20
6601739|NCT02049931|7526586|FG002|STARTED|Overall Study||20
6601740|NCT02049931|7526584|FG000|COMPLETED|Overall Study||17
6601741|NCT02049931|7526585|FG001|COMPLETED|Overall Study||15
6601742|NCT02049931|7526586|FG002|COMPLETED|Overall Study||17
6601743|NCT02049931|7526584|FG000|NOT COMPLETED|Overall Study||3
6601744|NCT02049931|7526585|FG001|NOT COMPLETED|Overall Study||5
6601745|NCT02049931|7526586|FG002|NOT COMPLETED|Overall Study||3
6601746|NCT02049944|7526594|FG000|STARTED|Overall Study||30
6601747|NCT02049944|7526594|FG000|Obese (BMI 30-40kg/m^2)|Overall Study||14
6601748|NCT02049944|7526594|FG000|Extremely Obese (BMI >40kg/m^2)|Overall Study||14
6601749|NCT02049944|7526594|FG000|COMPLETED|Overall Study||28
6601750|NCT02049944|7526594|FG000|NOT COMPLETED|Overall Study||2
6601751|NCT02049957|7526607|FG000|STARTED|Overall Study||6
6601752|NCT02049957|7526608|FG001|STARTED|Overall Study||6
6601753|NCT02049957|7526609|FG002|STARTED|Overall Study||3
6601754|NCT02049957|7526610|FG003|STARTED|Overall Study||3
6663379|NCT02517567|7593947|FG002|NOT COMPLETED|Fourth Exposure (8 Hours)||0
6663380|NCT02517567|7593948|FG003|NOT COMPLETED|Fourth Exposure (8 Hours)||0
6663381|NCT02517580|7593957|FG000|STARTED|Overall Study||60
6663382|NCT02517580|7593957|FG000|COMPLETED|Overall Study||56
6663383|NCT02517580|7593957|FG000|NOT COMPLETED|Overall Study||4
6663384|NCT02517658|7593964|FG000|STARTED|Overall Study||33
6663385|NCT02517658|7593965|FG001|STARTED|Overall Study||33
6663386|NCT02517658|7593966|FG002|STARTED|Overall Study||33
6663387|NCT02517658|7593964|FG000|COMPLETED|Overall Study||33
6663388|NCT02517658|7593965|FG001|COMPLETED|Overall Study||33
6663389|NCT02517658|7593966|FG002|COMPLETED|Overall Study||33
6663390|NCT02517658|7593964|FG000|NOT COMPLETED|Overall Study||0
6663391|NCT02517658|7593965|FG001|NOT COMPLETED|Overall Study||0
6663392|NCT02517658|7593966|FG002|NOT COMPLETED|Overall Study||0
6663393|NCT02517866|7593974|FG000|STARTED|Overall Study||289
6663394|NCT02517866|7593975|FG001|STARTED|Overall Study||90
6663395|NCT02517866|7593976|FG002|STARTED|Overall Study||1
6663396|NCT02517866|7593974|FG000|COMPLETED|Overall Study||269
6663397|NCT02517866|7593975|FG001|COMPLETED|Overall Study||84
6663398|NCT02517866|7593976|FG002|COMPLETED|Overall Study||1
6663399|NCT02517866|7593974|FG000|NOT COMPLETED|Overall Study||20
6663400|NCT02517866|7593975|FG001|NOT COMPLETED|Overall Study||6
6663401|NCT02517866|7593976|FG002|NOT COMPLETED|Overall Study||0
6663402|NCT02517905|7593988|FG000|STARTED|Overall Study||107
6663403|NCT02517905|7593989|FG001|STARTED|Overall Study||59
6663404|NCT02517905|7593988|FG000|COMPLETED|Overall Study||97
6663405|NCT02517905|7593989|FG001|COMPLETED|Overall Study||57
6663406|NCT02517905|7593988|FG000|NOT COMPLETED|Overall Study||10
6663407|NCT02517905|7593989|FG001|NOT COMPLETED|Overall Study||2
6663408|NCT02517996|7593997|FG000|STARTED|Overall Study||8
6663409|NCT02517996|7593998|FG001|STARTED|Overall Study||9
6663410|NCT02517996|7593997|FG000|COMPLETED|Overall Study||8
6663411|NCT02517996|7593998|FG001|COMPLETED|Overall Study||9
6663412|NCT02517996|7593997|FG000|NOT COMPLETED|Overall Study||0
6601755|NCT02049957|7526611|FG004|STARTED|Overall Study||6
6601756|NCT02049957|7526612|FG005|STARTED|Overall Study||43
6663413|NCT02517996|7593998|FG001|NOT COMPLETED|Overall Study||0
6663414|NCT02518048|7594004|FG000|STARTED|Overall Study||35
6663415|NCT02518048|7594004|FG000|COMPLETED|Overall Study||34
6663416|NCT02518048|7594004|FG000|NOT COMPLETED|Overall Study||1
6663417|NCT02518113|7594013|FG000|STARTED|Overall Study||6
6663418|NCT02518113|7594014|FG001|STARTED|Overall Study||12
6663419|NCT02518113|7594015|FG002|STARTED|Overall Study||15
6663420|NCT02518113|7594016|FG003|STARTED|Overall Study||3
6663421|NCT02518113|7594013|FG000|COMPLETED|Overall Study||3
6663422|NCT02518113|7594014|FG001|COMPLETED|Overall Study||7
6663423|NCT02518113|7594015|FG002|COMPLETED|Overall Study||11
6663424|NCT02518113|7594016|FG003|COMPLETED|Overall Study||3
6663425|NCT02518113|7594013|FG000|NOT COMPLETED|Overall Study||3
6663426|NCT02518113|7594014|FG001|NOT COMPLETED|Overall Study||5
6663427|NCT02518113|7594015|FG002|NOT COMPLETED|Overall Study||4
6663428|NCT02518113|7594016|FG003|NOT COMPLETED|Overall Study||0
6663429|NCT02518191|7594031|FG000|STARTED|Overall Study||171
6663430|NCT02518191|7594032|FG001|STARTED|Overall Study||174
6663431|NCT02518191|7594031|FG000|COMPLETED|Overall Study||165
6663432|NCT02518191|7594032|FG001|COMPLETED|Overall Study||165
6663433|NCT02518191|7594031|FG000|NOT COMPLETED|Overall Study||6
6663434|NCT02518191|7594032|FG001|NOT COMPLETED|Overall Study||9
6663435|NCT02518230|7594042|FG000|STARTED|Overall Study||11
6663436|NCT02518230|7594043|FG001|STARTED|Overall Study||11
6663437|NCT02518230|7594042|FG000|COMPLETED|Overall Study||11
6663438|NCT02518230|7594043|FG001|COMPLETED|Overall Study||11
6663439|NCT02518230|7594042|FG000|NOT COMPLETED|Overall Study||0
6663440|NCT02518230|7594043|FG001|NOT COMPLETED|Overall Study||0
6663441|NCT02518464|7594050|FG000|STARTED|Overall Study||40
6663442|NCT02518464|7594050|FG000|COMPLETED|Overall Study||38
6663443|NCT02518464|7594050|FG000|NOT COMPLETED|Overall Study||2
6601757|NCT02049957|7526613|FG006|STARTED|Overall Study||8
6601758|NCT02049957|7526614|FG007|STARTED|Overall Study||35
6601759|NCT02049957|7526615|FG008|STARTED|Overall Study||8
6601760|NCT02049957|7526607|FG000|COMPLETED|Overall Study||0
6601761|NCT02049957|7526608|FG001|COMPLETED|Overall Study||0
6601762|NCT02049957|7526609|FG002|COMPLETED|Overall Study||0
6601763|NCT02049957|7526610|FG003|COMPLETED|Overall Study||0
6601764|NCT02049957|7526611|FG004|COMPLETED|Overall Study||0
6663444|NCT02518490|7594054|FG000|STARTED|Overall Study||18
6663445|NCT02518490|7594055|FG001|STARTED|Overall Study||18
6663446|NCT02518490|7594054|FG000|COMPLETED|Overall Study||17
6663447|NCT02518490|7594055|FG001|COMPLETED|Overall Study||17
6663448|NCT02518490|7594054|FG000|NOT COMPLETED|Overall Study||1
6663449|NCT02518490|7594055|FG001|NOT COMPLETED|Overall Study||1
6663450|NCT02518620|7594064|FG000|STARTED|Overall Study||257
6663451|NCT02518620|7594065|FG001|STARTED|Overall Study||149
6663452|NCT02518620|7594064|FG000|COMPLETED|Overall Study||205
6663453|NCT02518620|7594065|FG001|COMPLETED|Overall Study||123
6663454|NCT02518620|7594064|FG000|NOT COMPLETED|Overall Study||52
6663455|NCT02518620|7594065|FG001|NOT COMPLETED|Overall Study||26
6663456|NCT02518685|7594075|FG000|STARTED|Overall Study||213
6663457|NCT02518685|7594076|FG001|STARTED|Overall Study||89
6663458|NCT02518685|7594075|FG000|Safety Cohort|Overall Study|Randomized to and successfully received TPS (171) + Open-Label TPS-treated Subjects (32)|203
6663459|NCT02518685|7594076|FG001|Safety Cohort|Overall Study||89
6663460|NCT02518685|7594075|FG000|Randomized Cohort|Overall Study||181
6663461|NCT02518685|7594076|FG001|Randomized Cohort|Overall Study||89
6663462|NCT02518685|7594075|FG000|Enrolled|Overall Study|Includes 171 Successful device deployments, 10 unsuccessful delivery attempts and 32 Open-Label|213
6663463|NCT02518685|7594076|FG001|Enrolled|Overall Study||89
6663464|NCT02518685|7594075|FG000|Per Protocol Analysis|Overall Study|Three TPS-treated subjects were inadvertently unblinded, excluding them from efficacy analyses.|168
6663465|NCT02518685|7594076|FG001|Per Protocol Analysis|Overall Study||89
6663466|NCT02518685|7594075|FG000|COMPLETED|Overall Study|Randomized Completers (139) plus Open-Label Completers (25)|164
6663467|NCT02518685|7594076|FG001|COMPLETED|Overall Study||79
6663468|NCT02518685|7594075|FG000|NOT COMPLETED|Overall Study||49
6663469|NCT02518685|7594076|FG001|NOT COMPLETED|Overall Study||10
6663470|NCT02518919|7594086|FG000|STARTED|Overall Study||21
6663471|NCT02518919|7594087|FG001|STARTED|Overall Study||21
6663472|NCT02518919|7594088|FG002|STARTED|Overall Study||21
6663473|NCT02518919|7594086|FG000|COMPLETED|Overall Study||20
6663474|NCT02518919|7594087|FG001|COMPLETED|Overall Study||20
6663475|NCT02518919|7594088|FG002|COMPLETED|Overall Study||19
6663476|NCT02518919|7594086|FG000|NOT COMPLETED|Overall Study||1
6663477|NCT02518919|7594087|FG001|NOT COMPLETED|Overall Study||1
6663478|NCT02518919|7594088|FG002|NOT COMPLETED|Overall Study||2
6663479|NCT02518971|7594098|FG000|STARTED|Overall Study||87
6663480|NCT02518971|7594099|FG001|STARTED|Overall Study||87
6663481|NCT02518971|7594098|FG000|COMPLETED|Overall Study||64
6663482|NCT02518971|7594099|FG001|COMPLETED|Overall Study||67
6663483|NCT02518971|7594098|FG000|NOT COMPLETED|Overall Study||23
6663484|NCT02518971|7594099|FG001|NOT COMPLETED|Overall Study||20
6663485|NCT02518997|7594106|FG000|STARTED|Overall Study||18
6663486|NCT02518997|7594106|FG000|COMPLETED|Overall Study||18
6663487|NCT02518997|7594106|FG000|NOT COMPLETED|Overall Study||0
6601765|NCT02049957|7526612|FG005|COMPLETED|Overall Study||0
6601766|NCT02049957|7526613|FG006|COMPLETED|Overall Study||0
6601767|NCT02049957|7526614|FG007|COMPLETED|Overall Study||0
6601768|NCT02049957|7526615|FG008|COMPLETED|Overall Study||0
6601769|NCT02049957|7526607|FG000|NOT COMPLETED|Overall Study||6
6601770|NCT02049957|7526608|FG001|NOT COMPLETED|Overall Study||6
6601771|NCT02049957|7526609|FG002|NOT COMPLETED|Overall Study||3
6601772|NCT02049957|7526610|FG003|NOT COMPLETED|Overall Study||3
6601773|NCT02049957|7526611|FG004|NOT COMPLETED|Overall Study||6
6601774|NCT02049957|7526612|FG005|NOT COMPLETED|Overall Study||43
6601775|NCT02049957|7526613|FG006|NOT COMPLETED|Overall Study||8
6601776|NCT02049957|7526614|FG007|NOT COMPLETED|Overall Study||35
6601777|NCT02049957|7526615|FG008|NOT COMPLETED|Overall Study||8
6601778|NCT02050048|7526637|FG000|STARTED|Overall Study||14
6601779|NCT02050048|7526638|FG001|STARTED|Overall Study||12
6601780|NCT02050048|7526637|FG000|COMPLETED|Overall Study||9
6601781|NCT02050048|7526638|FG001|COMPLETED|Overall Study||10
6601782|NCT02050048|7526637|FG000|NOT COMPLETED|Overall Study||5
6601783|NCT02050048|7526638|FG001|NOT COMPLETED|Overall Study||2
6601784|NCT02050321|7526644|FG000|STARTED|Overall Study||2
6601785|NCT02050321|7526644|FG000|COMPLETED|Overall Study||0
6601786|NCT02050321|7526644|FG000|NOT COMPLETED|Overall Study||2
6601787|NCT02050334|7526650|FG000|STARTED|Overall Study||9
6601788|NCT02050334|7526651|FG001|STARTED|Overall Study||9
6601789|NCT02050334|7526650|FG000|COMPLETED|Overall Study||9
6601790|NCT02050334|7526651|FG001|COMPLETED|Overall Study||9
6601791|NCT02050334|7526650|FG000|NOT COMPLETED|Overall Study||0
6601792|NCT02050334|7526651|FG001|NOT COMPLETED|Overall Study||0
6601793|NCT02050373|7526660|FG000|STARTED|Overall Study||34
6601794|NCT02050373|7526661|FG001|STARTED|Overall Study||34
6601795|NCT02050373|7526660|FG000|COMPLETED|Overall Study||27
6601796|NCT02050373|7526661|FG001|COMPLETED|Overall Study||24
6601797|NCT02050373|7526660|FG000|NOT COMPLETED|Overall Study||7
6601798|NCT02050373|7526661|FG001|NOT COMPLETED|Overall Study||10
6601799|NCT02050841|7526668|FG000|STARTED|Overall Study||50
6601800|NCT02050841|7526668|FG000|COMPLETED|Overall Study||49
6601801|NCT02050841|7526668|FG000|NOT COMPLETED|Overall Study||1
6601802|NCT02051296|7526680|FG000|STARTED|Overall Study||66
6601803|NCT02051296|7526681|FG001|STARTED|Overall Study||65
6601804|NCT02051296|7526680|FG000|Received Allocated Intervention|Overall Study||59
6601805|NCT02051296|7526681|FG001|Received Allocated Intervention|Overall Study||58
6601806|NCT02051296|7526680|FG000|COMPLETED|Overall Study||58
6601807|NCT02051296|7526681|FG001|COMPLETED|Overall Study||56
6601808|NCT02051296|7526680|FG000|NOT COMPLETED|Overall Study||8
6601809|NCT02051296|7526681|FG001|NOT COMPLETED|Overall Study||9
6601810|NCT02051335|7526691|FG000|STARTED|Period 1||7
6601811|NCT02051335|7526692|FG001|STARTED|Period 1||7
6601812|NCT02051335|7526693|FG002|STARTED|Period 1||7
6601813|NCT02051335|7526694|FG003|STARTED|Period 1||6
6601814|NCT02051335|7526691|FG000|COMPLETED|Period 1||7
6601815|NCT02051335|7526692|FG001|COMPLETED|Period 1||7
6601816|NCT02051335|7526693|FG002|COMPLETED|Period 1||7
6601817|NCT02051335|7526694|FG003|COMPLETED|Period 1||6
6601818|NCT02051335|7526691|FG000|NOT COMPLETED|Period 1||0
6601819|NCT02051335|7526692|FG001|NOT COMPLETED|Period 1||0
6601820|NCT02051335|7526693|FG002|NOT COMPLETED|Period 1||0
6601821|NCT02051335|7526694|FG003|NOT COMPLETED|Period 1||0
6601822|NCT02051335|7526691|FG000|STARTED|Period 2||7
6601823|NCT02051335|7526692|FG001|STARTED|Period 2||7
6601824|NCT02051335|7526693|FG002|STARTED|Period 2||7
6601825|NCT02051335|7526694|FG003|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
6601826|NCT02051335|7526691|FG000|COMPLETED|Period 2||7
6601827|NCT02051335|7526692|FG001|COMPLETED|Period 2||7
6601828|NCT02051335|7526693|FG002|COMPLETED|Period 2||7
6601829|NCT02051335|7526694|FG003|COMPLETED|Period 2||4
6601830|NCT02051335|7526691|FG000|NOT COMPLETED|Period 2||0
6601831|NCT02051335|7526692|FG001|NOT COMPLETED|Period 2||0
6601832|NCT02051335|7526693|FG002|NOT COMPLETED|Period 2||0
6601833|NCT02051335|7526694|FG003|NOT COMPLETED|Period 2||0
6601834|NCT02051335|7526691|FG000|STARTED|Period 3||7
6601835|NCT02051335|7526692|FG001|STARTED|Period 3||7
6601836|NCT02051335|7526693|FG002|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
6601837|NCT02051335|7526694|FG003|STARTED|Period 3||4
6601838|NCT02051335|7526691|FG000|COMPLETED|Period 3||7
6601839|NCT02051335|7526692|FG001|COMPLETED|Period 3||7
6601840|NCT02051335|7526693|FG002|COMPLETED|Period 3||5
6601841|NCT02051335|7526694|FG003|COMPLETED|Period 3||4
6601842|NCT02051335|7526691|FG000|NOT COMPLETED|Period 3||0
6601843|NCT02051335|7526692|FG001|NOT COMPLETED|Period 3||0
6601844|NCT02051335|7526693|FG002|NOT COMPLETED|Period 3||0
6601845|NCT02051335|7526694|FG003|NOT COMPLETED|Period 3||0
6601846|NCT02051335|7526691|FG000|STARTED|Period 4||7
6601847|NCT02051335|7526692|FG001|STARTED|Period 4||7
6601848|NCT02051335|7526693|FG002|STARTED|Period 4||5
6601849|NCT02051335|7526694|FG003|STARTED|Period 4||4
6601850|NCT02051335|7526691|FG000|COMPLETED|Period 4||7
6601851|NCT02051335|7526692|FG001|COMPLETED|Period 4||7
6601852|NCT02051335|7526693|FG002|COMPLETED|Period 4||5
6601853|NCT02051335|7526694|FG003|COMPLETED|Period 4||4
6601854|NCT02051335|7526691|FG000|NOT COMPLETED|Period 4||0
6601855|NCT02051335|7526692|FG001|NOT COMPLETED|Period 4||0
6601856|NCT02051335|7526693|FG002|NOT COMPLETED|Period 4||0
6601857|NCT02051335|7526694|FG003|NOT COMPLETED|Period 4||0
6601858|NCT02051426|7526706|FG000|STARTED|First Intervention||16
6601859|NCT02051426|7526707|FG001|STARTED|First Intervention||19
6601860|NCT02051426|7526706|FG000|COMPLETED|First Intervention||16
6601861|NCT02051426|7526707|FG001|COMPLETED|First Intervention||19
6601862|NCT02051426|7526706|FG000|NOT COMPLETED|First Intervention||0
6601863|NCT02051426|7526707|FG001|NOT COMPLETED|First Intervention||0
6601864|NCT02051426|7526706|FG000|STARTED|Washout Period of 1 Month||16
6601865|NCT02051426|7526707|FG001|STARTED|Washout Period of 1 Month||19
6601866|NCT02051426|7526706|FG000|COMPLETED|Washout Period of 1 Month||16
6601867|NCT02051426|7526707|FG001|COMPLETED|Washout Period of 1 Month||19
6601868|NCT02051426|7526706|FG000|NOT COMPLETED|Washout Period of 1 Month||0
6601869|NCT02051426|7526707|FG001|NOT COMPLETED|Washout Period of 1 Month||0
6601870|NCT02051426|7526706|FG000|STARTED|Second Intervention||16
6601871|NCT02051426|7526707|FG001|STARTED|Second Intervention||19
6601872|NCT02051426|7526706|FG000|COMPLETED|Second Intervention||16
6601873|NCT02051426|7526707|FG001|COMPLETED|Second Intervention||19
6601874|NCT02051426|7526706|FG000|NOT COMPLETED|Second Intervention||0
6601875|NCT02051426|7526707|FG001|NOT COMPLETED|Second Intervention||0
6601876|NCT02051452|7526715|FG000|STARTED|Overall Study||16
6601877|NCT02051452|7526716|FG001|STARTED|Overall Study||16
6601878|NCT02051452|7526715|FG000|COMPLETED|Overall Study||16
6601879|NCT02051452|7526716|FG001|COMPLETED|Overall Study||16
6601880|NCT02051452|7526715|FG000|NOT COMPLETED|Overall Study||0
6601881|NCT02051452|7526716|FG001|NOT COMPLETED|Overall Study||0
6601882|NCT02051595|7526722|FG000|STARTED|Overall Study||25
6601883|NCT02051595|7526722|FG000|COMPLETED|Overall Study||25
6601884|NCT02051595|7526722|FG000|NOT COMPLETED|Overall Study||0
6601885|NCT02051686|7526728|FG000|STARTED|Overall Study||42
6601886|NCT02051686|7526729|FG001|STARTED|Overall Study||46
6601887|NCT02051686|7526728|FG000|COMPLETED|Overall Study||42
6601888|NCT02051686|7526729|FG001|COMPLETED|Overall Study||46
6601889|NCT02051686|7526728|FG000|NOT COMPLETED|Overall Study||0
6601890|NCT02051686|7526729|FG001|NOT COMPLETED|Overall Study||0
6601891|NCT02051764|7526737|FG000|STARTED|Overall Study||16
6601892|NCT02051764|7526738|FG001|STARTED|Overall Study||28
6663488|NCT02519023|7594115|FG000|STARTED|Overall Study||49
6663489|NCT02519023|7594116|FG001|STARTED|Overall Study||38
6663490|NCT02519023|7594115|FG000|COMPLETED|Overall Study||31
6663491|NCT02519023|7594116|FG001|COMPLETED|Overall Study||31
6663492|NCT02519023|7594115|FG000|NOT COMPLETED|Overall Study||18
6663493|NCT02519023|7594116|FG001|NOT COMPLETED|Overall Study||7
6663494|NCT02519036|7594128|FG000|STARTED|Overall Study||12
6663495|NCT02519036|7594129|FG001|STARTED|Overall Study||3
6663496|NCT02519036|7594130|FG002|STARTED|Overall Study||6
6663497|NCT02519036|7594131|FG003|STARTED|Overall Study||6
6663498|NCT02519036|7594132|FG004|STARTED|Overall Study||9
6663499|NCT02519036|7594133|FG005|STARTED|Overall Study||10
6663500|NCT02519036|7594128|FG000|COMPLETED|Overall Study||12
6663501|NCT02519036|7594129|FG001|COMPLETED|Overall Study||3
6663502|NCT02519036|7594130|FG002|COMPLETED|Overall Study||6
6663503|NCT02519036|7594131|FG003|COMPLETED|Overall Study||6
6663504|NCT02519036|7594132|FG004|COMPLETED|Overall Study||9
6663505|NCT02519036|7594133|FG005|COMPLETED|Overall Study||10
6663506|NCT02519036|7594128|FG000|NOT COMPLETED|Overall Study||0
6663507|NCT02519036|7594129|FG001|NOT COMPLETED|Overall Study||0
6663508|NCT02519036|7594130|FG002|NOT COMPLETED|Overall Study||0
6663509|NCT02519036|7594131|FG003|NOT COMPLETED|Overall Study||0
6663510|NCT02519036|7594132|FG004|NOT COMPLETED|Overall Study||0
6663511|NCT02519036|7594133|FG005|NOT COMPLETED|Overall Study||0
6663512|NCT02519231|7594154|FG000|STARTED|Overall Study||14
6663513|NCT02519231|7594155|FG001|STARTED|Overall Study||14
6663514|NCT02519231|7594154|FG000|COMPLETED|Overall Study|One was lost to follow up and never took the treatment. another never turned in bleeding diary.|12
6663515|NCT02519231|7594155|FG001|COMPLETED|Overall Study|Six participants never turned in their bleeding diaries.|8
6663516|NCT02519231|7594154|FG000|NOT COMPLETED|Overall Study||2
6663517|NCT02519231|7594155|FG001|NOT COMPLETED|Overall Study||6
6663518|NCT02519244|7594163|FG000|STARTED|Overall Study||10
6663519|NCT02519244|7594163|FG000|COMPLETED|Overall Study||10
6663520|NCT02519244|7594163|FG000|NOT COMPLETED|Overall Study||0
6663521|NCT02519387|7594167|FG000|STARTED|Overall Study||78
6663522|NCT02519387|7594167|FG000|COMPLETED|Overall Study||56
6663523|NCT02519387|7594167|FG000|NOT COMPLETED|Overall Study||22
6663524|NCT02519491|7594173|FG000|STARTED|Overall Study||219
6663525|NCT02519491|7594174|FG001|STARTED|Overall Study||219
6663526|NCT02519491|7594173|FG000|COMPLETED|Overall Study||219
6663527|NCT02519491|7594174|FG001|COMPLETED|Overall Study||219
6663528|NCT02519491|7594173|FG000|NOT COMPLETED|Overall Study||0
6663529|NCT02519491|7594174|FG001|NOT COMPLETED|Overall Study||0
6663530|NCT02519504|7594182|FG000|STARTED|Overall Study||319
6601893|NCT02051764|7526737|FG000|COMPLETED|Overall Study||16
6601894|NCT02051764|7526738|FG001|COMPLETED|Overall Study||21
6601895|NCT02051764|7526737|FG000|NOT COMPLETED|Overall Study||0
6601896|NCT02051764|7526738|FG001|NOT COMPLETED|Overall Study||7
6601897|NCT02051790|7526744|FG000|STARTED|Overall Study||241
6601898|NCT02051790|7526744|FG000|COMPLETED|Overall Study||241
6601899|NCT02051790|7526744|FG000|NOT COMPLETED|Overall Study||0
6663531|NCT02519504|7594183|FG001|STARTED|Overall Study||247
6663532|NCT02519504|7594182|FG000|Attended Direct Testing|Overall Study||212
6663533|NCT02519504|7594183|FG001|Attended Direct Testing|Overall Study||149
6663534|NCT02519504|7594182|FG000|COMPLETED|Overall Study||206
6663535|NCT02519504|7594183|FG001|COMPLETED|Overall Study||144
6663536|NCT02519504|7594182|FG000|NOT COMPLETED|Overall Study||113
6663537|NCT02519504|7594183|FG001|NOT COMPLETED|Overall Study||103
6663538|NCT02519595|7594192|FG000|STARTED|Overall Study||58
6601900|NCT02051816|7526752|FG000|STARTED|Overall Study||37
6601901|NCT02051816|7526753|FG001|STARTED|Overall Study||40
6601902|NCT02051816|7526754|FG002|STARTED|Overall Study||37
6601903|NCT02051816|7526755|FG003|STARTED|Overall Study||36
6601904|NCT02051816|7526752|FG000|COMPLETED|Overall Study||37
6601905|NCT02051816|7526753|FG001|COMPLETED|Overall Study||40
6601906|NCT02051816|7526754|FG002|COMPLETED|Overall Study||37
6601907|NCT02051816|7526755|FG003|COMPLETED|Overall Study||36
6601908|NCT02051816|7526752|FG000|NOT COMPLETED|Overall Study||0
6601909|NCT02051816|7526753|FG001|NOT COMPLETED|Overall Study||0
6601910|NCT02051816|7526754|FG002|NOT COMPLETED|Overall Study||0
6601911|NCT02051816|7526755|FG003|NOT COMPLETED|Overall Study||0
6601912|NCT02052011|7526771|FG000|STARTED|Overall Study||21
6601913|NCT02052011|7526772|FG001|STARTED|Overall Study||10
6601914|NCT02052011|7526771|FG000|COMPLETED|Overall Study||17
6601915|NCT02052011|7526772|FG001|COMPLETED|Overall Study||8
6601916|NCT02052011|7526771|FG000|NOT COMPLETED|Overall Study||4
6601917|NCT02052011|7526772|FG001|NOT COMPLETED|Overall Study||2
6601918|NCT02052141|7526780|FG000|STARTED|Intervention Period 1||5
6601919|NCT02052141|7526781|FG001|STARTED|Intervention Period 1||7
6601920|NCT02052141|7526780|FG000|COMPLETED|Intervention Period 1||5
6601921|NCT02052141|7526781|FG001|COMPLETED|Intervention Period 1||7
6601922|NCT02052141|7526780|FG000|NOT COMPLETED|Intervention Period 1||0
6601923|NCT02052141|7526781|FG001|NOT COMPLETED|Intervention Period 1||0
6601924|NCT02052141|7526780|FG000|STARTED|Intervention Period 2||5
6601925|NCT02052141|7526781|FG001|STARTED|Intervention Period 2||7
6601926|NCT02052141|7526780|FG000|COMPLETED|Intervention Period 2||5
6601927|NCT02052141|7526781|FG001|COMPLETED|Intervention Period 2||7
6601928|NCT02052141|7526780|FG000|NOT COMPLETED|Intervention Period 2||0
6601929|NCT02052141|7526781|FG001|NOT COMPLETED|Intervention Period 2||0
6601930|NCT02052310|7526789|FG000|STARTED|Overall Study||522
6601931|NCT02052310|7526790|FG001|STARTED|Overall Study||521
6601932|NCT02052310|7526789|FG000|Received at Least 1 Dose of Study Drug|Overall Study||522
6601933|NCT02052310|7526790|FG001|Received at Least 1 Dose of Study Drug|Overall Study||517
6601934|NCT02052310|7526789|FG000|COMPLETED|Overall Study||307
6601935|NCT02052310|7526790|FG001|COMPLETED|Overall Study||309
6601936|NCT02052310|7526789|FG000|NOT COMPLETED|Overall Study||215
6601937|NCT02052310|7526790|FG001|NOT COMPLETED|Overall Study||212
6601938|NCT02052414|7526796|FG000|STARTED|Overall Study||34
6601939|NCT02052414|7526796|FG000|COMPLETED|Overall Study||17
6601940|NCT02052414|7526796|FG000|NOT COMPLETED|Overall Study||17
6601941|NCT02052440|7526803|FG000|STARTED|Overall Study||50
6601942|NCT02052440|7526804|FG001|STARTED|Overall Study||52
6601943|NCT02052440|7526803|FG000|COMPLETED|Overall Study||50
6601944|NCT02052440|7526804|FG001|COMPLETED|Overall Study||51
6601945|NCT02052440|7526803|FG000|NOT COMPLETED|Overall Study||0
6601946|NCT02052440|7526804|FG001|NOT COMPLETED|Overall Study||1
6601947|NCT02052466|7526810|FG000|STARTED|Overall Study||32
6601948|NCT02052466|7526810|FG000|COMPLETED|Overall Study||30
6601949|NCT02052466|7526810|FG000|NOT COMPLETED|Overall Study||2
6601950|NCT02052544|7526814|FG000|STARTED|Overall Study|First Subject In|123
6601951|NCT02052544|7526814|FG000|COMPLETED|Overall Study|Last Subject Out|123
6601952|NCT02052544|7526814|FG000|NOT COMPLETED|Overall Study||0
6601953|NCT02052557|7526821|FG000|STARTED|Overall Study||26
6601954|NCT02052557|7526822|FG001|STARTED|Overall Study||25
6601955|NCT02052557|7526821|FG000|COMPLETED|Overall Study||26
6601956|NCT02052557|7526822|FG001|COMPLETED|Overall Study||25
6601957|NCT02052557|7526821|FG000|NOT COMPLETED|Overall Study||0
6601958|NCT02052557|7526822|FG001|NOT COMPLETED|Overall Study||0
6601959|NCT02052596|7526832|FG000|STARTED|Active Phase||412
6601960|NCT02052596|7526833|FG001|STARTED|Active Phase||418
6601961|NCT02052596|7526832|FG000|COMPLETED|Active Phase||396
6601962|NCT02052596|7526833|FG001|COMPLETED|Active Phase||398
6601963|NCT02052596|7526832|FG000|NOT COMPLETED|Active Phase||16
6601964|NCT02052596|7526833|FG001|NOT COMPLETED|Active Phase||20
6601965|NCT02052596|7526832|FG000|STARTED|Safety Phase||412
6601966|NCT02052596|7526833|FG001|STARTED|Safety Phase||418
6601967|NCT02052596|7526832|FG000|COMPLETED|Safety Phase||385
6601968|NCT02052596|7526833|FG001|COMPLETED|Safety Phase||383
6601969|NCT02052596|7526832|FG000|NOT COMPLETED|Safety Phase||27
6601970|NCT02052596|7526833|FG001|NOT COMPLETED|Safety Phase||35
6601971|NCT02052635|7526841|FG000|STARTED|Overall Study||7
6601972|NCT02052635|7526842|FG001|STARTED|Overall Study||6
6601973|NCT02052635|7526841|FG000|COMPLETED|Overall Study||7
6601974|NCT02052635|7526842|FG001|COMPLETED|Overall Study||6
6601975|NCT02052635|7526841|FG000|NOT COMPLETED|Overall Study||0
6601976|NCT02052635|7526842|FG001|NOT COMPLETED|Overall Study||0
6601977|NCT02052661|7526848|FG000|STARTED|Overall Study||300
6601978|NCT02052661|7526848|FG000|COMPLETED|Overall Study||300
6601979|NCT02052661|7526848|FG000|NOT COMPLETED|Overall Study||0
6601980|NCT02052752|7526855|FG000|STARTED|Overall Study||30
6601981|NCT02052752|7526856|FG001|STARTED|Overall Study||30
6601982|NCT02052752|7526857|FG002|STARTED|Overall Study||30
6601983|NCT02052752|7526855|FG000|COMPLETED|Overall Study||30
6601984|NCT02052752|7526856|FG001|COMPLETED|Overall Study||30
6601985|NCT02052752|7526857|FG002|COMPLETED|Overall Study||30
6601986|NCT02052752|7526855|FG000|NOT COMPLETED|Overall Study||0
6601987|NCT02052752|7526856|FG001|NOT COMPLETED|Overall Study||0
6601988|NCT02052752|7526857|FG002|NOT COMPLETED|Overall Study||0
6601989|NCT02052895|7526869|FG000|STARTED|Overall Study||196
6601990|NCT02052895|7526870|FG001|STARTED|Overall Study||15
6601991|NCT02052895|7526871|FG002|STARTED|Overall Study||15
6601992|NCT02052895|7526869|FG000|COMPLETED|Overall Study||196
6601993|NCT02052895|7526870|FG001|COMPLETED|Overall Study||15
6601994|NCT02052895|7526871|FG002|COMPLETED|Overall Study||15
6601995|NCT02052895|7526869|FG000|NOT COMPLETED|Overall Study||0
6601996|NCT02052895|7526870|FG001|NOT COMPLETED|Overall Study||0
6601997|NCT02052895|7526871|FG002|NOT COMPLETED|Overall Study||0
6601998|NCT02052960|7526880|FG000|STARTED|Overall Study||117
6601999|NCT02052960|7526881|FG001|STARTED|Overall Study||123
6602000|NCT02052960|7526880|FG000|Treated Patients|Overall Study||115
6602001|NCT02052960|7526881|FG001|Treated Patients|Overall Study||122
6602002|NCT02052960|7526880|FG000|COMPLETED|Overall Study||63
6602003|NCT02052960|7526881|FG001|COMPLETED|Overall Study||77
6602004|NCT02052960|7526880|FG000|NOT COMPLETED|Overall Study||54
6602005|NCT02052960|7526881|FG001|NOT COMPLETED|Overall Study||46
6602006|NCT02053077|7526890|FG000|STARTED|Overall Study||150
6602007|NCT02053077|7526890|FG000|COMPLETED|Overall Study||150
6602008|NCT02053077|7526890|FG000|NOT COMPLETED|Overall Study||0
6602009|NCT02053168|7526894|FG000|STARTED|Overall Study||25
6602010|NCT02053168|7526894|FG000|COMPLETED|Overall Study||22
6602011|NCT02053168|7526894|FG000|NOT COMPLETED|Overall Study||3
6602012|NCT02053259|7526902|FG000|STARTED|Overall Study||25
6602013|NCT02053259|7526903|FG001|STARTED|Overall Study||24
6602014|NCT02053259|7526904|FG002|STARTED|Overall Study||24
6602015|NCT02053259|7526905|FG003|STARTED|Overall Study||23
6602016|NCT02053259|7526902|FG000|COMPLETED|Overall Study||25
6602017|NCT02053259|7526903|FG001|COMPLETED|Overall Study||24
6602018|NCT02053259|7526904|FG002|COMPLETED|Overall Study||24
6602019|NCT02053259|7526905|FG003|COMPLETED|Overall Study||23
6602020|NCT02053259|7526902|FG000|NOT COMPLETED|Overall Study||0
6602021|NCT02053259|7526903|FG001|NOT COMPLETED|Overall Study||0
6602022|NCT02053259|7526904|FG002|NOT COMPLETED|Overall Study||0
6602023|NCT02053259|7526905|FG003|NOT COMPLETED|Overall Study||0
6602024|NCT02053376|7526915|FG000|STARTED|Overall Study||43
6602025|NCT02053376|7526915|FG000|COMPLETED|Overall Study||43
6602026|NCT02053376|7526915|FG000|NOT COMPLETED|Overall Study||0
6602027|NCT02053493|7526921|FG000|STARTED|Overall Study||51
6602028|NCT02053493|7526922|FG001|STARTED|Overall Study||59
6602029|NCT02053493|7526921|FG000|COMPLETED|Overall Study||50
6602030|NCT02053493|7526922|FG001|COMPLETED|Overall Study||58
6602031|NCT02053493|7526921|FG000|NOT COMPLETED|Overall Study||1
6602032|NCT02053493|7526922|FG001|NOT COMPLETED|Overall Study||1
6602033|NCT02053610|7526930|FG000|STARTED|Overall Study||330
6602034|NCT02053610|7526931|FG001|STARTED|Overall Study||333
6602035|NCT02053610|7526930|FG000|Received Study Drug|Overall Study||326
6602036|NCT02053610|7526931|FG001|Received Study Drug|Overall Study||331
6602037|NCT02053610|7526930|FG000|COMPLETED|Overall Study|Completed=Completed Treatment|288
6602038|NCT02053610|7526931|FG001|COMPLETED|Overall Study|Completed=Completed Treatment|266
6602039|NCT02053610|7526930|FG000|NOT COMPLETED|Overall Study||42
6602040|NCT02053610|7526931|FG001|NOT COMPLETED|Overall Study||67
6602041|NCT02053753|7526939|FG000|STARTED|Overall Study||72
6602042|NCT02053753|7526940|FG001|STARTED|Overall Study||74
6602043|NCT02053753|7526939|FG000|Received Treatment|Overall Study||71
6602044|NCT02053753|7526940|FG001|Received Treatment|Overall Study||71
6602045|NCT02053753|7526939|FG000|COMPLETED|Overall Study||65
6602046|NCT02053753|7526940|FG001|COMPLETED|Overall Study||66
6602047|NCT02053753|7526939|FG000|NOT COMPLETED|Overall Study||7
6602048|NCT02053753|7526940|FG001|NOT COMPLETED|Overall Study||8
6602049|NCT02054130|7526950|FG000|STARTED|Overall Study||138
6602050|NCT02054130|7526951|FG001|STARTED|Overall Study||138
6602051|NCT02054130|7526952|FG002|STARTED|Overall Study||137
6602052|NCT02054130|7526953|FG003|STARTED|Overall Study||137
6602053|NCT02054130|7526950|FG000|COMPLETED|Overall Study||130
6602054|NCT02054130|7526951|FG001|COMPLETED|Overall Study||127
6602055|NCT02054130|7526952|FG002|COMPLETED|Overall Study||122
6602056|NCT02054130|7526953|FG003|COMPLETED|Overall Study||115
6602057|NCT02054130|7526950|FG000|NOT COMPLETED|Overall Study||8
6602058|NCT02054130|7526951|FG001|NOT COMPLETED|Overall Study||11
6602059|NCT02054130|7526952|FG002|NOT COMPLETED|Overall Study||15
6602060|NCT02054130|7526953|FG003|NOT COMPLETED|Overall Study||22
6602061|NCT02054156|7526968|FG000|STARTED|Overall Study||110
6602062|NCT02054156|7526969|FG001|STARTED|Overall Study||111
6602063|NCT02054156|7526968|FG000|COMPLETED|Overall Study||35
6602064|NCT02054156|7526969|FG001|COMPLETED|Overall Study||30
6602065|NCT02054156|7526968|FG000|NOT COMPLETED|Overall Study||75
6602066|NCT02054156|7526969|FG001|NOT COMPLETED|Overall Study||81
6602067|NCT02054325|7526977|FG000|STARTED|Overall Study||51
6602068|NCT02054325|7526978|FG001|STARTED|Overall Study||55
6602069|NCT02054325|7526977|FG000|COMPLETED|Overall Study||43
6602070|NCT02054325|7526978|FG001|COMPLETED|Overall Study||50
6602071|NCT02054325|7526977|FG000|NOT COMPLETED|Overall Study||8
6602072|NCT02054325|7526978|FG001|NOT COMPLETED|Overall Study||5
6602073|NCT02054338|7526986|FG000|STARTED|Overall Study||503
6602074|NCT02054338|7526987|FG001|STARTED|Overall Study||501
6602075|NCT02054338|7526986|FG000|COMPLETED|Overall Study||0
6602076|NCT02054338|7526987|FG001|COMPLETED|Overall Study||0
6602077|NCT02054338|7526986|FG000|NOT COMPLETED|Overall Study||503
6602078|NCT02054338|7526987|FG001|NOT COMPLETED|Overall Study||501
6602079|NCT02054481|7526997|FG000|STARTED|Overall Study||43
6602080|NCT02054481|7526998|FG001|STARTED|Overall Study||41
6602081|NCT02054481|7526999|FG002|STARTED|Overall Study||42
6602082|NCT02054481|7527000|FG003|STARTED|Overall Study||40
6602083|NCT02054481|7526997|FG000|COMPLETED|Overall Study||39
6602084|NCT02054481|7526998|FG001|COMPLETED|Overall Study||39
6602085|NCT02054481|7526999|FG002|COMPLETED|Overall Study||40
6602086|NCT02054481|7527000|FG003|COMPLETED|Overall Study||39
6602087|NCT02054481|7526997|FG000|NOT COMPLETED|Overall Study||4
6602088|NCT02054481|7526998|FG001|NOT COMPLETED|Overall Study||2
6602089|NCT02054481|7526999|FG002|NOT COMPLETED|Overall Study||2
6602090|NCT02054481|7527000|FG003|NOT COMPLETED|Overall Study||1
6602091|NCT02054520|7527017|FG000|STARTED|Overall Study||11
6602092|NCT02054520|7527018|FG001|STARTED|Overall Study||16
6602093|NCT02054520|7527019|FG002|STARTED|Overall Study||6
6602094|NCT02054520|7527020|FG003|STARTED|Overall Study||6
6602095|NCT02054520|7527021|FG004|STARTED|Overall Study||5
6602096|NCT02054520|7527022|FG005|STARTED|Overall Study||3
6602097|NCT02054520|7527017|FG000|COMPLETED|Overall Study||2
6602098|NCT02054520|7527018|FG001|COMPLETED|Overall Study||11
6602099|NCT02054520|7527019|FG002|COMPLETED|Overall Study||0
6602100|NCT02054520|7527020|FG003|COMPLETED|Overall Study||0
6602101|NCT02054520|7527021|FG004|COMPLETED|Overall Study||0
6602102|NCT02054520|7527022|FG005|COMPLETED|Overall Study||0
6602103|NCT02054520|7527017|FG000|NOT COMPLETED|Overall Study||9
6602104|NCT02054520|7527018|FG001|NOT COMPLETED|Overall Study||5
6602105|NCT02054520|7527019|FG002|NOT COMPLETED|Overall Study||6
6602106|NCT02054520|7527020|FG003|NOT COMPLETED|Overall Study||6
6602107|NCT02054520|7527021|FG004|NOT COMPLETED|Overall Study||5
6602108|NCT02054520|7527022|FG005|NOT COMPLETED|Overall Study||3
6602109|NCT02054572|7527036|FG000|STARTED|Overall Study||6
6602110|NCT02054572|7527036|FG000|COMPLETED|Overall Study||6
6602111|NCT02054572|7527036|FG000|NOT COMPLETED|Overall Study||0
6602112|NCT02054702|7527042|FG000|STARTED|Overall Study||64
6602113|NCT02054702|7527043|FG001|STARTED|Overall Study||33
6602114|NCT02054702|7527042|FG000|COMPLETED|Overall Study||40
6602115|NCT02054702|7527043|FG001|COMPLETED|Overall Study||21
6602116|NCT02054702|7527042|FG000|NOT COMPLETED|Overall Study||24
6602117|NCT02054702|7527043|FG001|NOT COMPLETED|Overall Study||12
6602118|NCT02054715|7527051|FG000|STARTED|Baseline/Follow-up 1||219
6602119|NCT02054715|7527052|FG001|STARTED|Baseline/Follow-up 1||199
6602120|NCT02054715|7527051|FG000|COMPLETED|Baseline/Follow-up 1||211
6602121|NCT02054715|7527052|FG001|COMPLETED|Baseline/Follow-up 1||192
6602122|NCT02054715|7527051|FG000|NOT COMPLETED|Baseline/Follow-up 1||8
6663539|NCT02519595|7594193|FG001|STARTED|Overall Study||57
6663540|NCT02519595|7594194|FG002|STARTED|Overall Study||56
6663541|NCT02519595|7594192|FG000|COMPLETED|Overall Study||50
6663542|NCT02519595|7594193|FG001|COMPLETED|Overall Study||35
6663543|NCT02519595|7594194|FG002|COMPLETED|Overall Study||40
6663544|NCT02519595|7594192|FG000|NOT COMPLETED|Overall Study||8
6663545|NCT02519595|7594193|FG001|NOT COMPLETED|Overall Study||22
6663546|NCT02519595|7594194|FG002|NOT COMPLETED|Overall Study||16
6663547|NCT02519621|7594205|FG000|STARTED|Overall Study||30
6663548|NCT02519621|7594206|FG001|STARTED|Overall Study||30
6663549|NCT02519621|7594207|FG002|STARTED|Overall Study||30
6663550|NCT02519621|7594205|FG000|COMPLETED|Overall Study||30
6663551|NCT02519621|7594206|FG001|COMPLETED|Overall Study||30
6663552|NCT02519621|7594207|FG002|COMPLETED|Overall Study||30
6663553|NCT02519621|7594205|FG000|NOT COMPLETED|Overall Study||0
6663554|NCT02519621|7594206|FG001|NOT COMPLETED|Overall Study||0
6663555|NCT02519621|7594207|FG002|NOT COMPLETED|Overall Study||0
6663556|NCT02519842|7594217|FG000|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|38
6663557|NCT02519842|7594218|FG001|STARTED|Base Study: Cycle 1|Participants who completed Cycle 1 were invited to participate in optional Cycles 2-6.|37
6663558|NCT02519842|7594219|FG002|STARTED|Base Study: Cycle 1||0
6663559|NCT02519842|7594217|FG000|Treated|Base Study: Cycle 1||37
6663560|NCT02519842|7594218|FG001|Treated|Base Study: Cycle 1||34
6663561|NCT02519842|7594219|FG002|Treated|Base Study: Cycle 1||0
6663562|NCT02519842|7594217|FG000|COMPLETED|Base Study: Cycle 1||36
6663563|NCT02519842|7594218|FG001|COMPLETED|Base Study: Cycle 1||34
6663564|NCT02519842|7594219|FG002|COMPLETED|Base Study: Cycle 1||0
6663565|NCT02519842|7594217|FG000|NOT COMPLETED|Base Study: Cycle 1||2
6663566|NCT02519842|7594218|FG001|NOT COMPLETED|Base Study: Cycle 1||3
6663567|NCT02519842|7594219|FG002|NOT COMPLETED|Base Study: Cycle 1||0
6663568|NCT02519842|7594217|FG000|STARTED|Optional Extension: Cycles 2-6|27 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
6663569|NCT02519842|7594218|FG001|STARTED|Optional Extension: Cycles 2-6|28 participants from this arm in Cycle 1 entered optional Cycles 2-6|0
6663570|NCT02519842|7594219|FG002|STARTED|Optional Extension: Cycles 2-6|Enrollment in Cycles 2-6 was optional.|55
6663571|NCT02519842|7594217|FG000|Treated|Optional Extension: Cycles 2-6||0
6663572|NCT02519842|7594218|FG001|Treated|Optional Extension: Cycles 2-6||0
6663573|NCT02519842|7594219|FG002|Treated|Optional Extension: Cycles 2-6||55
6663574|NCT02519842|7594217|FG000|COMPLETED|Optional Extension: Cycles 2-6||0
6663575|NCT02519842|7594218|FG001|COMPLETED|Optional Extension: Cycles 2-6||0
6663576|NCT02519842|7594219|FG002|COMPLETED|Optional Extension: Cycles 2-6||26
6602123|NCT02054715|7527052|FG001|NOT COMPLETED|Baseline/Follow-up 1||7
6602124|NCT02054715|7527051|FG000|STARTED|Follow-up 2||211
6602125|NCT02054715|7527052|FG001|STARTED|Follow-up 2||192
6602126|NCT02054715|7527051|FG000|COMPLETED|Follow-up 2||192
6602127|NCT02054715|7527052|FG001|COMPLETED|Follow-up 2||173
6602128|NCT02054715|7527051|FG000|NOT COMPLETED|Follow-up 2||19
6663577|NCT02519842|7594217|FG000|NOT COMPLETED|Optional Extension: Cycles 2-6||0
6663578|NCT02519842|7594218|FG001|NOT COMPLETED|Optional Extension: Cycles 2-6||0
6663579|NCT02519842|7594219|FG002|NOT COMPLETED|Optional Extension: Cycles 2-6||29
6663580|NCT02519855|7594229|FG000|STARTED|Overall Study|Participants are included as treated|441
6663581|NCT02519855|7594230|FG001|STARTED|Overall Study|Participants are included as treated|441
6663582|NCT02519855|7594229|FG000|Vaccinated on Day 1|Overall Study||440
6663583|NCT02519855|7594230|FG001|Vaccinated on Day 1|Overall Study||441
6663584|NCT02519855|7594229|FG000|Vaccinated at Week 4|Overall Study||432
6663585|NCT02519855|7594230|FG001|Vaccinated at Week 4|Overall Study||424
6663586|NCT02519855|7594229|FG000|COMPLETED|Overall Study||438
6663587|NCT02519855|7594230|FG001|COMPLETED|Overall Study||437
6663588|NCT02519855|7594229|FG000|NOT COMPLETED|Overall Study||3
6663589|NCT02519855|7594230|FG001|NOT COMPLETED|Overall Study||4
6663590|NCT02520089|7594238|FG000|STARTED|Overall Study||12
6663591|NCT02520089|7594239|FG001|STARTED|Overall Study||11
6663592|NCT02520089|7594238|FG000|COMPLETED|Overall Study||9
6663593|NCT02520089|7594239|FG001|COMPLETED|Overall Study||7
6663594|NCT02520089|7594238|FG000|NOT COMPLETED|Overall Study||3
6663595|NCT02520089|7594239|FG001|NOT COMPLETED|Overall Study||4
6663596|NCT02520284|7594248|FG000|STARTED|Blinded Induction Phase: Up to Week 8||54
6663597|NCT02520284|7594249|FG001|STARTED|Blinded Induction Phase: Up to Week 8||56
6663598|NCT02520284|7594250|FG002|STARTED|Blinded Induction Phase: Up to Week 8||55
6663599|NCT02520284|7594248|FG000|COMPLETED|Blinded Induction Phase: Up to Week 8||52
6663600|NCT02520284|7594249|FG001|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|52
6663601|NCT02520284|7594250|FG002|COMPLETED|Blinded Induction Phase: Up to Week 8|1 Participant completed Blinded Induction Phase but did not continue further in study.|53
6663602|NCT02520284|7594248|FG000|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
6663603|NCT02520284|7594249|FG001|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||4
6663604|NCT02520284|7594250|FG002|NOT COMPLETED|Blinded Induction Phase: Up to Week 8||2
6663605|NCT02520284|7594248|FG000|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|20
6663606|NCT02520284|7594249|FG001|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|16
6663607|NCT02520284|7594250|FG002|STARTED|Blinded Maintenance Phase: Up to Week 51|Participants achieving EBS remission and/or MCS response continued in Blinded Maintenance Phase.|18
6663608|NCT02520284|7594248|FG000|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
6663609|NCT02520284|7594249|FG001|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
6663610|NCT02520284|7594250|FG002|COMPLETED|Blinded Maintenance Phase: Up to Week 51||0
6663611|NCT02520284|7594248|FG000|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||20
6663612|NCT02520284|7594249|FG001|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||16
6663613|NCT02520284|7594250|FG002|NOT COMPLETED|Blinded Maintenance Phase: Up to Week 51||18
6663614|NCT02520284|7594248|FG000|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|32
6663615|NCT02520284|7594249|FG001|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|35
6663616|NCT02520284|7594250|FG002|STARTED|Open-Label MaintenancePhase: Upto Week51|Participants achieving neither EBS remission nor MCS response entered Open-Label Maintenance Phase.|34
6663617|NCT02520284|7594248|FG000|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
6663618|NCT02520284|7594249|FG001|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
6663619|NCT02520284|7594250|FG002|COMPLETED|Open-Label MaintenancePhase: Upto Week51||0
6663620|NCT02520284|7594248|FG000|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||32
6663621|NCT02520284|7594249|FG001|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||35
6663622|NCT02520284|7594250|FG002|NOT COMPLETED|Open-Label MaintenancePhase: Upto Week51||34
6663623|NCT02520310|7594264|FG000|STARTED|At 30 Days Clinical Follow-up||30
6663624|NCT02520310|7594264|FG000|COMPLETED|At 30 Days Clinical Follow-up||30
6663625|NCT02520310|7594264|FG000|NOT COMPLETED|At 30 Days Clinical Follow-up||0
6663626|NCT02520310|7594264|FG000|STARTED|At 6 Months Clinical Follow-up||30
6663627|NCT02520310|7594264|FG000|COMPLETED|At 6 Months Clinical Follow-up||29
6663628|NCT02520310|7594264|FG000|NOT COMPLETED|At 6 Months Clinical Follow-up||1
6663629|NCT02520310|7594264|FG000|STARTED|At 1 Year Clinical Follow-up||29
6663630|NCT02520310|7594264|FG000|COMPLETED|At 1 Year Clinical Follow-up||28
6663631|NCT02520310|7594264|FG000|NOT COMPLETED|At 1 Year Clinical Follow-up||1
6663632|NCT02520310|7594264|FG000|STARTED|At 2 Year Clinical Follow-up||28
6663633|NCT02520310|7594264|FG000|COMPLETED|At 2 Year Clinical Follow-up||28
6663634|NCT02520310|7594264|FG000|NOT COMPLETED|At 2 Year Clinical Follow-up||0
6663635|NCT02520310|7594264|FG000|STARTED|AT 3 Year Clinical Follow-up||28
6663636|NCT02520310|7594264|FG000|COMPLETED|AT 3 Year Clinical Follow-up||24
6663637|NCT02520310|7594264|FG000|NOT COMPLETED|AT 3 Year Clinical Follow-up||4
6663638|NCT02520310|7594264|FG000|STARTED|AT 4 Year Clinical Follow-up||24
6663639|NCT02520310|7594264|FG000|COMPLETED|AT 4 Year Clinical Follow-up||22
6663640|NCT02520310|7594264|FG000|NOT COMPLETED|AT 4 Year Clinical Follow-up||2
6663641|NCT02520388|7594272|FG000|STARTED|Overall Study||82
6663642|NCT02520388|7594273|FG001|STARTED|Overall Study||81
6663643|NCT02520388|7594272|FG000|Treated|Overall Study||81
6663644|NCT02520388|7594273|FG001|Treated|Overall Study||80
6663645|NCT02520388|7594272|FG000|COMPLETED|Overall Study||73
6663646|NCT02520388|7594273|FG001|COMPLETED|Overall Study||65
6663647|NCT02520388|7594272|FG000|NOT COMPLETED|Overall Study||9
6663648|NCT02520388|7594273|FG001|NOT COMPLETED|Overall Study||16
6663649|NCT02520414|7594279|FG000|STARTED|Overall Study||10
6663650|NCT02520414|7594279|FG000|COMPLETED|Overall Study||10
6663651|NCT02520414|7594279|FG000|NOT COMPLETED|Overall Study||0
6663652|NCT02520518|7594287|FG000|STARTED|Overall Study||3
6663653|NCT02520518|7594288|FG001|STARTED|Overall Study||1
6663654|NCT02520518|7594289|FG002|STARTED|Overall Study||3
6663655|NCT02520518|7594290|FG003|STARTED|Overall Study||2
6663656|NCT02520518|7594287|FG000|COMPLETED|Overall Study||3
6663657|NCT02520518|7594288|FG001|COMPLETED|Overall Study||1
6663658|NCT02520518|7594289|FG002|COMPLETED|Overall Study||1
6663659|NCT02520518|7594290|FG003|COMPLETED|Overall Study||1
6663660|NCT02520518|7594287|FG000|NOT COMPLETED|Overall Study||0
6663661|NCT02520518|7594288|FG001|NOT COMPLETED|Overall Study||0
6663662|NCT02520518|7594289|FG002|NOT COMPLETED|Overall Study||2
6663663|NCT02520518|7594290|FG003|NOT COMPLETED|Overall Study||1
6663664|NCT02520531|7594304|FG000|STARTED|Overall Study||42
6663665|NCT02520531|7594305|FG001|STARTED|Overall Study||42
6663666|NCT02520531|7594304|FG000|COMPLETED|Overall Study||36
6663667|NCT02520531|7594305|FG001|COMPLETED|Overall Study||36
6663668|NCT02520531|7594304|FG000|NOT COMPLETED|Overall Study||6
6663669|NCT02520531|7594305|FG001|NOT COMPLETED|Overall Study||6
6663670|NCT02521181|7594314|FG000|STARTED|Overall Study||52
6663671|NCT02521181|7594315|FG001|STARTED|Overall Study||90
6663672|NCT02521181|7594316|FG002|STARTED|Overall Study||52
6663673|NCT02521181|7594314|FG000|COMPLETED|Overall Study|All patients included in primary analysis|52
6663674|NCT02521181|7594315|FG001|COMPLETED|Overall Study|All patients included in primary analysis|90
6663675|NCT02521181|7594316|FG002|COMPLETED|Overall Study|All patients included in primary analysis|52
6663676|NCT02521181|7594314|FG000|NOT COMPLETED|Overall Study||0
6663677|NCT02521181|7594315|FG001|NOT COMPLETED|Overall Study||0
6663678|NCT02521181|7594316|FG002|NOT COMPLETED|Overall Study||0
6663679|NCT02521259|7594326|FG000|STARTED|Overall Study||35
6663680|NCT02521259|7594327|FG001|STARTED|Overall Study||33
6663681|NCT02521259|7594326|FG000|COMPLETED|Overall Study||34
6663682|NCT02521259|7594327|FG001|COMPLETED|Overall Study||28
6663683|NCT02521259|7594326|FG000|NOT COMPLETED|Overall Study||1
6663684|NCT02521259|7594327|FG001|NOT COMPLETED|Overall Study||5
6663685|NCT02521376|7594337|FG000|STARTED|Overall Study||8
6663686|NCT02521376|7594338|FG001|STARTED|Overall Study||18
6663687|NCT02521376|7594339|FG002|STARTED|Overall Study||10
6663688|NCT02521376|7594340|FG003|STARTED|Overall Study||20
6663689|NCT02521376|7594337|FG000|COMPLETED|Overall Study||7
6663690|NCT02521376|7594338|FG001|COMPLETED|Overall Study||18
6663691|NCT02521376|7594339|FG002|COMPLETED|Overall Study||10
6663692|NCT02521376|7594340|FG003|COMPLETED|Overall Study||20
6663693|NCT02521376|7594337|FG000|NOT COMPLETED|Overall Study||1
6663694|NCT02521376|7594338|FG001|NOT COMPLETED|Overall Study||0
6663695|NCT02521376|7594339|FG002|NOT COMPLETED|Overall Study||0
6663696|NCT02521376|7594340|FG003|NOT COMPLETED|Overall Study||0
6663697|NCT02521766|7594360|FG000|STARTED|Overall Study||49
6663698|NCT02521766|7594361|FG001|STARTED|Overall Study||65
6663699|NCT02521766|7594360|FG000|Per Protocol|Overall Study||47
6663700|NCT02521766|7594361|FG001|Per Protocol|Overall Study||65
6663701|NCT02521766|7594360|FG000|COMPLETED|Overall Study||44
6663702|NCT02521766|7594361|FG001|COMPLETED|Overall Study||62
6663703|NCT02521766|7594360|FG000|NOT COMPLETED|Overall Study||5
6663704|NCT02521766|7594361|FG001|NOT COMPLETED|Overall Study||3
6663705|NCT02521792|7594378|FG000|STARTED|Overall Study||6
6663706|NCT02521792|7594378|FG000|Received Treatment|Overall Study||4
6663707|NCT02521792|7594378|FG000|COMPLETED|Overall Study||0
6663708|NCT02521792|7594378|FG000|NOT COMPLETED|Overall Study||6
6663709|NCT02521870|7594390|FG000|STARTED|Phase 1: Dose Escalation||6
6663710|NCT02521870|7594391|FG001|STARTED|Phase 1: Dose Escalation||5
6663711|NCT02521870|7594392|FG002|STARTED|Phase 1: Dose Escalation||5
6663712|NCT02521870|7594393|FG003|STARTED|Phase 1: Dose Escalation||6
6663713|NCT02521870|7594394|FG004|STARTED|Phase 1: Dose Escalation||0
6663714|NCT02521870|7594395|FG005|STARTED|Phase 1: Dose Escalation||0
6663715|NCT02521870|7594396|FG006|STARTED|Phase 1: Dose Escalation||0
6663716|NCT02521870|7594397|FG007|STARTED|Phase 1: Dose Escalation||0
6663717|NCT02521870|7594398|FG008|STARTED|Phase 1: Dose Escalation||0
6663718|NCT02521870|7594399|FG009|STARTED|Phase 1: Dose Escalation||0
6663719|NCT02521870|7594400|FG010|STARTED|Phase 1: Dose Escalation||0
6663720|NCT02521870|7594401|FG011|STARTED|Phase 1: Dose Escalation||0
6663721|NCT02521870|7594390|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
6663722|NCT02521870|7594391|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||3
6663723|NCT02521870|7594392|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663724|NCT02521870|7594393|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||1
6663725|NCT02521870|7594394|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663726|NCT02521870|7594395|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663727|NCT02521870|7594396|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663728|NCT02521870|7594397|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663729|NCT02521870|7594398|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663730|NCT02521870|7594399|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663731|NCT02521870|7594400|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663732|NCT02521870|7594401|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 1: Dose Escalation||0
6663733|NCT02521870|7594390|FG000|COMPLETED|Phase 1: Dose Escalation||1
6663734|NCT02521870|7594391|FG001|COMPLETED|Phase 1: Dose Escalation||1
6663735|NCT02521870|7594392|FG002|COMPLETED|Phase 1: Dose Escalation||1
6663736|NCT02521870|7594393|FG003|COMPLETED|Phase 1: Dose Escalation||0
6663737|NCT02521870|7594394|FG004|COMPLETED|Phase 1: Dose Escalation||0
6663738|NCT02521870|7594395|FG005|COMPLETED|Phase 1: Dose Escalation||0
6663739|NCT02521870|7594396|FG006|COMPLETED|Phase 1: Dose Escalation||0
6663740|NCT02521870|7594397|FG007|COMPLETED|Phase 1: Dose Escalation||0
6663741|NCT02521870|7594398|FG008|COMPLETED|Phase 1: Dose Escalation||0
6663742|NCT02521870|7594399|FG009|COMPLETED|Phase 1: Dose Escalation||0
6663743|NCT02521870|7594400|FG010|COMPLETED|Phase 1: Dose Escalation||0
6663744|NCT02521870|7594401|FG011|COMPLETED|Phase 1: Dose Escalation||0
6663745|NCT02521870|7594390|FG000|NOT COMPLETED|Phase 1: Dose Escalation||5
6663746|NCT02521870|7594391|FG001|NOT COMPLETED|Phase 1: Dose Escalation||4
6663747|NCT02521870|7594392|FG002|NOT COMPLETED|Phase 1: Dose Escalation||4
6663748|NCT02521870|7594393|FG003|NOT COMPLETED|Phase 1: Dose Escalation||6
6663749|NCT02521870|7594394|FG004|NOT COMPLETED|Phase 1: Dose Escalation||0
6663750|NCT02521870|7594395|FG005|NOT COMPLETED|Phase 1: Dose Escalation||0
6663751|NCT02521870|7594396|FG006|NOT COMPLETED|Phase 1: Dose Escalation||0
6663752|NCT02521870|7594397|FG007|NOT COMPLETED|Phase 1: Dose Escalation||0
6663753|NCT02521870|7594398|FG008|NOT COMPLETED|Phase 1: Dose Escalation||0
6663754|NCT02521870|7594399|FG009|NOT COMPLETED|Phase 1: Dose Escalation||0
6663755|NCT02521870|7594400|FG010|NOT COMPLETED|Phase 1: Dose Escalation||0
6663756|NCT02521870|7594401|FG011|NOT COMPLETED|Phase 1: Dose Escalation||0
6663757|NCT02521870|7594390|FG000|STARTED|Phase 2: Dose Expansion||0
6663758|NCT02521870|7594391|FG001|STARTED|Phase 2: Dose Expansion||0
6663759|NCT02521870|7594392|FG002|STARTED|Phase 2: Dose Expansion||0
6663760|NCT02521870|7594393|FG003|STARTED|Phase 2: Dose Expansion||0
6663761|NCT02521870|7594394|FG004|STARTED|Phase 2: Dose Expansion||57
6663762|NCT02521870|7594395|FG005|STARTED|Phase 2: Dose Expansion||25
6663763|NCT02521870|7594396|FG006|STARTED|Phase 2: Dose Expansion||23
6663764|NCT02521870|7594397|FG007|STARTED|Phase 2: Dose Expansion||9
6663765|NCT02521870|7594398|FG008|STARTED|Phase 2: Dose Expansion||24
6663766|NCT02521870|7594399|FG009|STARTED|Phase 2: Dose Expansion||28
6663767|NCT02521870|7594400|FG010|STARTED|Phase 2: Dose Expansion||23
6663768|NCT02521870|7594401|FG011|STARTED|Phase 2: Dose Expansion||30
6663769|NCT02521870|7594390|FG000|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
6663770|NCT02521870|7594391|FG001|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
6663771|NCT02521870|7594392|FG002|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
6663772|NCT02521870|7594393|FG003|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||0
6663773|NCT02521870|7594394|FG004|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||25
6663774|NCT02521870|7594395|FG005|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||7
6663775|NCT02521870|7594396|FG006|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||3
6663776|NCT02521870|7594397|FG007|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||2
6663777|NCT02521870|7594398|FG008|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||9
6663778|NCT02521870|7594399|FG009|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||5
6663779|NCT02521870|7594400|FG010|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||1
6663780|NCT02521870|7594401|FG011|Completed SD-101 Treatment (up to 11 Doses)|Phase 2: Dose Expansion||11
6663781|NCT02521870|7594390|FG000|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663782|NCT02521870|7594391|FG001|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663783|NCT02521870|7594392|FG002|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663784|NCT02521870|7594393|FG003|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663785|NCT02521870|7594394|FG004|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||7
6663786|NCT02521870|7594395|FG005|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||1
6663787|NCT02521870|7594396|FG006|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663788|NCT02521870|7594397|FG007|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663789|NCT02521870|7594398|FG008|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663790|NCT02521870|7594399|FG009|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663791|NCT02521870|7594400|FG010|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663792|NCT02521870|7594401|FG011|Completed SD-101 Treatment Cycle 2 (up to 22 Doses)|Phase 2: Dose Expansion||0
6663793|NCT02521870|7594390|FG000|COMPLETED|Phase 2: Dose Expansion||0
6663794|NCT02521870|7594391|FG001|COMPLETED|Phase 2: Dose Expansion||0
6663795|NCT02521870|7594392|FG002|COMPLETED|Phase 2: Dose Expansion||0
6663796|NCT02521870|7594393|FG003|COMPLETED|Phase 2: Dose Expansion||0
6663797|NCT02521870|7594394|FG004|COMPLETED|Phase 2: Dose Expansion||5
6663798|NCT02521870|7594395|FG005|COMPLETED|Phase 2: Dose Expansion||0
6663799|NCT02521870|7594396|FG006|COMPLETED|Phase 2: Dose Expansion||0
6663800|NCT02521870|7594397|FG007|COMPLETED|Phase 2: Dose Expansion||0
6663801|NCT02521870|7594398|FG008|COMPLETED|Phase 2: Dose Expansion|4 participants completed pembrolizumab treatment (up to 35 cycles).|2
6663802|NCT02521870|7594399|FG009|COMPLETED|Phase 2: Dose Expansion||0
6663803|NCT02521870|7594400|FG010|COMPLETED|Phase 2: Dose Expansion||0
6663804|NCT02521870|7594401|FG011|COMPLETED|Phase 2: Dose Expansion||0
6663805|NCT02521870|7594390|FG000|NOT COMPLETED|Phase 2: Dose Expansion||0
6663806|NCT02521870|7594391|FG001|NOT COMPLETED|Phase 2: Dose Expansion||0
6663807|NCT02521870|7594392|FG002|NOT COMPLETED|Phase 2: Dose Expansion||0
6663808|NCT02521870|7594393|FG003|NOT COMPLETED|Phase 2: Dose Expansion||0
6663809|NCT02521870|7594394|FG004|NOT COMPLETED|Phase 2: Dose Expansion||52
6663810|NCT02521870|7594395|FG005|NOT COMPLETED|Phase 2: Dose Expansion||25
6663811|NCT02521870|7594396|FG006|NOT COMPLETED|Phase 2: Dose Expansion||23
6663812|NCT02521870|7594397|FG007|NOT COMPLETED|Phase 2: Dose Expansion||9
6663813|NCT02521870|7594398|FG008|NOT COMPLETED|Phase 2: Dose Expansion||22
6663814|NCT02521870|7594399|FG009|NOT COMPLETED|Phase 2: Dose Expansion||28
6663815|NCT02521870|7594400|FG010|NOT COMPLETED|Phase 2: Dose Expansion||23
6663816|NCT02521870|7594401|FG011|NOT COMPLETED|Phase 2: Dose Expansion||30
6663817|NCT02521948|7594431|FG000|STARTED|Overall Study||50
6663818|NCT02521948|7594431|FG000|COMPLETED|Overall Study||37
6663819|NCT02521948|7594431|FG000|NOT COMPLETED|Overall Study||13
6663820|NCT02521974|7594440|FG000|STARTED|Overall Study||50
6663821|NCT02521974|7594441|FG001|STARTED|Overall Study||114
6663822|NCT02521974|7594440|FG000|COMPLETED|Overall Study||47
6663823|NCT02521974|7594441|FG001|COMPLETED|Overall Study||110
6663824|NCT02521974|7594440|FG000|NOT COMPLETED|Overall Study||3
6663825|NCT02521974|7594441|FG001|NOT COMPLETED|Overall Study||4
6663826|NCT02522104|7594451|FG000|STARTED|Overall Study||13
6663827|NCT02522104|7594452|FG001|STARTED|Overall Study||15
6663828|NCT02522104|7594453|FG002|STARTED|Overall Study||12
6663829|NCT02522104|7594451|FG000|COMPLETED|Overall Study||10
6663830|NCT02522104|7594452|FG001|COMPLETED|Overall Study||12
6663831|NCT02522104|7594453|FG002|COMPLETED|Overall Study||5
6663832|NCT02522104|7594451|FG000|NOT COMPLETED|Overall Study||3
6663833|NCT02522104|7594452|FG001|NOT COMPLETED|Overall Study||3
6663834|NCT02522104|7594453|FG002|NOT COMPLETED|Overall Study||7
6663835|NCT02522286|7594468|FG000|STARTED|Overall Study||78
6663836|NCT02522286|7594469|FG001|STARTED|Overall Study||75
6663837|NCT02522286|7594470|FG002|STARTED|Overall Study||75
6663838|NCT02522286|7594471|FG003|STARTED|Overall Study||78
6663839|NCT02522286|7594468|FG000|COMPLETED|Overall Study||75
6663840|NCT02522286|7594469|FG001|COMPLETED|Overall Study||75
6663841|NCT02522286|7594470|FG002|COMPLETED|Overall Study||75
6663842|NCT02522286|7594471|FG003|COMPLETED|Overall Study||75
6663843|NCT02522286|7594468|FG000|NOT COMPLETED|Overall Study||3
6663844|NCT02522286|7594469|FG001|NOT COMPLETED|Overall Study||0
6663845|NCT02522286|7594470|FG002|NOT COMPLETED|Overall Study||0
6663846|NCT02522286|7594471|FG003|NOT COMPLETED|Overall Study||3
6663847|NCT02522299|7594483|FG000|STARTED|Overall Study||22
6663848|NCT02522299|7594484|FG001|STARTED|Overall Study||22
6663849|NCT02522299|7594483|FG000|COMPLETED|Overall Study||18
6663850|NCT02522299|7594484|FG001|COMPLETED|Overall Study||21
6663851|NCT02522299|7594483|FG000|NOT COMPLETED|Overall Study||4
6663852|NCT02522299|7594484|FG001|NOT COMPLETED|Overall Study||1
6663853|NCT02522325|7594504|FG000|STARTED|Overall Study||15
6663854|NCT02522325|7594505|FG001|STARTED|Overall Study||15
6663855|NCT02522325|7594504|FG000|COMPLETED|Overall Study||15
6663856|NCT02522325|7594505|FG001|COMPLETED|Overall Study||14
6663857|NCT02522325|7594504|FG000|NOT COMPLETED|Overall Study||0
6663858|NCT02522325|7594505|FG001|NOT COMPLETED|Overall Study||1
6663859|NCT02522377|7594513|FG000|STARTED|Overall Study||7
6663860|NCT02522377|7594514|FG001|STARTED|Overall Study||5
6663861|NCT02522377|7594513|FG000|COMPLETED|Overall Study||3
6663862|NCT02522377|7594514|FG001|COMPLETED|Overall Study||5
6663863|NCT02522377|7594513|FG000|NOT COMPLETED|Overall Study||4
6663864|NCT02522377|7594514|FG001|NOT COMPLETED|Overall Study||0
6663865|NCT02522403|7594522|FG000|STARTED|Overall Study||17
6663866|NCT02522403|7594523|FG001|STARTED|Overall Study||19
6663867|NCT02522403|7594522|FG000|COMPLETED|Overall Study||13
6663868|NCT02522403|7594523|FG001|COMPLETED|Overall Study||13
6663869|NCT02522403|7594522|FG000|NOT COMPLETED|Overall Study||4
6663870|NCT02522403|7594523|FG001|NOT COMPLETED|Overall Study||6
6663871|NCT02522442|7594531|FG000|STARTED|Overall Study||26
6663872|NCT02522442|7594532|FG001|STARTED|Overall Study||22
6663873|NCT02522442|7594531|FG000|COMPLETED|Overall Study||26
6663874|NCT02522442|7594532|FG001|COMPLETED|Overall Study||22
6663875|NCT02522442|7594531|FG000|NOT COMPLETED|Overall Study||0
6663876|NCT02522442|7594532|FG001|NOT COMPLETED|Overall Study||0
6663877|NCT02522481|7594538|FG000|STARTED|Overall Study||175
6663878|NCT02522481|7594538|FG000|COMPLETED|Overall Study||172
6663879|NCT02522481|7594538|FG000|NOT COMPLETED|Overall Study||3
6663880|NCT02522494|7594551|FG000|STARTED|Overall Study||51
6663881|NCT02522494|7594552|FG001|STARTED|Overall Study||51
6663882|NCT02522494|7594551|FG000|Post-CVT Visit Interview|Overall Study||37
6663883|NCT02522494|7594552|FG001|Post-CVT Visit Interview|Overall Study||48
6663884|NCT02522494|7594551|FG000|4-Week Follow Up|Overall Study||37
6663885|NCT02522494|7594552|FG001|4-Week Follow Up|Overall Study||46
6663886|NCT02522494|7594551|FG000|COMPLETED|Overall Study||37
6663887|NCT02522494|7594552|FG001|COMPLETED|Overall Study||46
6663888|NCT02522494|7594551|FG000|NOT COMPLETED|Overall Study||14
6663889|NCT02522494|7594552|FG001|NOT COMPLETED|Overall Study||5
6663890|NCT02522624|7594560|FG000|STARTED|Overall Study||165
6663891|NCT02522624|7594561|FG001|STARTED|Overall Study||163
6663892|NCT02522624|7594560|FG000|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
6663893|NCT02522624|7594561|FG001|COMPLETED|Overall Study||163
6663894|NCT02522624|7594560|FG000|NOT COMPLETED|Overall Study||1
6663895|NCT02522624|7594561|FG001|NOT COMPLETED|Overall Study||0
6663896|NCT02522728|7594569|FG000|STARTED|Overall Study||28
6663897|NCT02522728|7594570|FG001|STARTED|Overall Study||30
6663898|NCT02522728|7594569|FG000|COMPLETED|Overall Study||16
6663899|NCT02522728|7594570|FG001|COMPLETED|Overall Study||19
6663900|NCT02522728|7594569|FG000|NOT COMPLETED|Overall Study||12
6663901|NCT02522728|7594570|FG001|NOT COMPLETED|Overall Study||11
6663902|NCT02522767|7594578|FG000|STARTED|Double-blind||114
6663903|NCT02522767|7594579|FG001|STARTED|Double-blind||114
6663904|NCT02522767|7594578|FG000|COMPLETED|Double-blind||103
6663905|NCT02522767|7594579|FG001|COMPLETED|Double-blind||90
6663906|NCT02522767|7594578|FG000|NOT COMPLETED|Double-blind||11
6663907|NCT02522767|7594579|FG001|NOT COMPLETED|Double-blind||24
6663908|NCT02522767|7594578|FG000|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|88
6663909|NCT02522767|7594579|FG001|STARTED|Open-label|Subjects provided their consent to receive additional 8 weeks open-label treatment with mesalamine.|82
6663910|NCT02522767|7594578|FG000|COMPLETED|Open-label||83
6663911|NCT02522767|7594579|FG001|COMPLETED|Open-label||75
6663912|NCT02522767|7594578|FG000|NOT COMPLETED|Open-label||5
6663913|NCT02522767|7594579|FG001|NOT COMPLETED|Open-label||7
6663914|NCT02522780|7594589|FG000|STARTED|Overall Study||138
6663915|NCT02522780|7594590|FG001|STARTED|Overall Study||138
6663916|NCT02522780|7594589|FG000|Treated|Overall Study||137
6663917|NCT02522780|7594590|FG001|Treated|Overall Study||135
6663918|NCT02522780|7594589|FG000|Intention-to-treat (ITT) Population|Overall Study||136
6663919|NCT02522780|7594590|FG001|Intention-to-treat (ITT) Population|Overall Study||136
6663920|NCT02522780|7594589|FG000|COMPLETED|Overall Study||121
6663921|NCT02522780|7594590|FG001|COMPLETED|Overall Study||111
6663922|NCT02522780|7594589|FG000|NOT COMPLETED|Overall Study||17
6663923|NCT02522780|7594590|FG001|NOT COMPLETED|Overall Study||27
6663924|NCT02522845|7594599|FG000|STARTED|Overall Study||100
6663925|NCT02522845|7594600|FG001|STARTED|Overall Study||104
6663926|NCT02522845|7594599|FG000|COMPLETED|Overall Study||63
6663927|NCT02522845|7594600|FG001|COMPLETED|Overall Study||69
6663928|NCT02522845|7594599|FG000|NOT COMPLETED|Overall Study||37
6663929|NCT02522845|7594600|FG001|NOT COMPLETED|Overall Study||35
6663930|NCT02522884|7594606|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|213
6663931|NCT02522884|7594606|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|195
6663932|NCT02522884|7594606|FG000|NOT COMPLETED|Overall Study||18
6663933|NCT02523196|7594610|FG000|STARTED|Overall Study||20
6663934|NCT02523196|7594610|FG000|Received HVPG|Overall Study||20
6663935|NCT02523196|7594610|FG000|Received HQ Shunt|Overall Study||20
6663936|NCT02523196|7594610|FG000|COMPLETED|Overall Study||20
6663937|NCT02523196|7594610|FG000|NOT COMPLETED|Overall Study||0
6663938|NCT02523235|7594621|FG000|STARTED|Overall Study||56
6663939|NCT02523235|7594622|FG001|STARTED|Overall Study||58
6663940|NCT02523235|7594621|FG000|COMPLETED|Overall Study||56
6663941|NCT02523235|7594622|FG001|COMPLETED|Overall Study||58
6663942|NCT02523235|7594621|FG000|NOT COMPLETED|Overall Study||0
6663943|NCT02523235|7594622|FG001|NOT COMPLETED|Overall Study||0
6663944|NCT02523586|7594629|FG000|STARTED|Overall Study||14
6663945|NCT02523586|7594629|FG000|COMPLETED|Overall Study||10
6663946|NCT02523586|7594629|FG000|NOT COMPLETED|Overall Study||4
6663947|NCT02523599|7594642|FG000|STARTED|Overall Study||204
6663948|NCT02523599|7594643|FG001|STARTED|Overall Study||101
6663949|NCT02523599|7594642|FG000|Randomized But Not Treated|Overall Study||1
6663950|NCT02523599|7594643|FG001|Randomized But Not Treated|Overall Study||0
6663951|NCT02523599|7594642|FG000|COMPLETED|Overall Study||196
6663952|NCT02523599|7594643|FG001|COMPLETED|Overall Study||100
6663953|NCT02523599|7594642|FG000|NOT COMPLETED|Overall Study||8
6663954|NCT02523599|7594643|FG001|NOT COMPLETED|Overall Study||1
6663955|NCT02523690|7594651|FG000|STARTED|Overall Study||3
6663956|NCT02523690|7594652|FG001|STARTED|Overall Study||2
6663957|NCT02523690|7594651|FG000|COMPLETED|Overall Study||3
6663958|NCT02523690|7594652|FG001|COMPLETED|Overall Study||2
6663959|NCT02523690|7594651|FG000|NOT COMPLETED|Overall Study||0
6663960|NCT02523690|7594652|FG001|NOT COMPLETED|Overall Study||0
6663961|NCT02523924|7594658|FG000|STARTED|Overall Study||31
6663962|NCT02523924|7594658|FG000|COMPLETED|Overall Study||31
6663963|NCT02523924|7594658|FG000|NOT COMPLETED|Overall Study||0
6663964|NCT02524054|7594664|FG000|STARTED|Overall Study||7
6663965|NCT02524054|7594665|FG001|STARTED|Overall Study||9
6663966|NCT02524054|7594666|FG002|STARTED|Overall Study||8
6663967|NCT02524054|7594664|FG000|COMPLETED|Overall Study||7
6663968|NCT02524054|7594665|FG001|COMPLETED|Overall Study||9
6663969|NCT02524054|7594666|FG002|COMPLETED|Overall Study||8
6663970|NCT02524054|7594664|FG000|NOT COMPLETED|Overall Study||0
6663971|NCT02524054|7594665|FG001|NOT COMPLETED|Overall Study||0
6663972|NCT02524054|7594666|FG002|NOT COMPLETED|Overall Study||0
6663973|NCT02524106|7594678|FG000|STARTED|Overall Study||6
6663974|NCT02524106|7594679|FG001|STARTED|Overall Study||5
6663975|NCT02524106|7594678|FG000|COMPLETED|Overall Study||6
6663976|NCT02524106|7594679|FG001|COMPLETED|Overall Study||5
6663977|NCT02524106|7594678|FG000|NOT COMPLETED|Overall Study||0
6663978|NCT02524106|7594679|FG001|NOT COMPLETED|Overall Study||0
6663979|NCT02524119|7594685|FG000|STARTED|Overall Study||5
6663980|NCT02524119|7594685|FG000|COMPLETED|Overall Study||5
6663981|NCT02524119|7594685|FG000|NOT COMPLETED|Overall Study||0
6663982|NCT02524145|7594692|FG000|STARTED|Overall Study||15
6663983|NCT02524145|7594693|FG001|STARTED|Overall Study||15
6663984|NCT02524145|7594694|FG002|STARTED|Overall Study||10
6663985|NCT02524145|7594692|FG000|COMPLETED|Overall Study||13
6663986|NCT02524145|7594693|FG001|COMPLETED|Overall Study||13
6663987|NCT02524145|7594694|FG002|COMPLETED|Overall Study||7
6663988|NCT02524145|7594692|FG000|NOT COMPLETED|Overall Study||2
6663989|NCT02524145|7594693|FG001|NOT COMPLETED|Overall Study||2
6663990|NCT02524145|7594694|FG002|NOT COMPLETED|Overall Study||3
6663991|NCT02524158|7594704|FG000|STARTED|12-weeks Assessment||76
6663992|NCT02524158|7594705|FG001|STARTED|12-weeks Assessment||76
6663993|NCT02524158|7594704|FG000|COMPLETED|12-weeks Assessment||57
6663994|NCT02524158|7594705|FG001|COMPLETED|12-weeks Assessment||63
6663995|NCT02524158|7594704|FG000|NOT COMPLETED|12-weeks Assessment||19
6663996|NCT02524158|7594705|FG001|NOT COMPLETED|12-weeks Assessment||13
6663997|NCT02524158|7594704|FG000|STARTED|6-month Assessment||76
6663998|NCT02524158|7594705|FG001|STARTED|6-month Assessment||76
6663999|NCT02524158|7594704|FG000|COMPLETED|6-month Assessment||54
6664000|NCT02524158|7594705|FG001|COMPLETED|6-month Assessment||55
6664001|NCT02524158|7594704|FG000|NOT COMPLETED|6-month Assessment||22
6664002|NCT02524158|7594705|FG001|NOT COMPLETED|6-month Assessment||21
6664003|NCT02524418|7594714|FG000|STARTED|Overall Study||88
6664004|NCT02524418|7594714|FG000|COMPLETED|Overall Study||75
6664005|NCT02524418|7594714|FG000|NOT COMPLETED|Overall Study||13
6664006|NCT02524561|7594724|FG000|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
6664007|NCT02524561|7594725|FG001|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
6664008|NCT02524561|7594726|FG002|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
6664009|NCT02524561|7594724|FG000|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
6664010|NCT02524561|7594725|FG001|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
6664011|NCT02524561|7594726|FG002|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
6664012|NCT02524561|7594724|FG000|COMPLETED|Baseline: Pre-randomization Mammogram||168
6664013|NCT02524561|7594725|FG001|COMPLETED|Baseline: Pre-randomization Mammogram||162
6664014|NCT02524561|7594726|FG002|COMPLETED|Baseline: Pre-randomization Mammogram||187
6664015|NCT02524561|7594724|FG000|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
6664016|NCT02524561|7594725|FG001|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
6664017|NCT02524561|7594726|FG002|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
6664018|NCT02524561|7594724|FG000|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
6664019|NCT02524561|7594725|FG001|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
6664020|NCT02524561|7594726|FG002|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
6664021|NCT02524561|7594724|FG000|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
6664022|NCT02524561|7594725|FG001|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
6664023|NCT02524561|7594726|FG002|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
6664024|NCT02524561|7594724|FG000|COMPLETED|Year 1: Post Randomization Mammograms||168
6664025|NCT02524561|7594725|FG001|COMPLETED|Year 1: Post Randomization Mammograms||162
6664026|NCT02524561|7594726|FG002|COMPLETED|Year 1: Post Randomization Mammograms||187
6664027|NCT02524561|7594724|FG000|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
6664028|NCT02524561|7594725|FG001|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
6664029|NCT02524561|7594726|FG002|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
6664030|NCT02524561|7594724|FG000|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
6664031|NCT02524561|7594725|FG001|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
6664032|NCT02524561|7594726|FG002|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
6664033|NCT02524561|7594724|FG000|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
6664034|NCT02524561|7594725|FG001|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
6664035|NCT02524561|7594726|FG002|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
6664036|NCT02524561|7594724|FG000|COMPLETED|Final: Year 3 or 4 Post-randomization||168
6664037|NCT02524561|7594725|FG001|COMPLETED|Final: Year 3 or 4 Post-randomization||162
6664038|NCT02524561|7594726|FG002|COMPLETED|Final: Year 3 or 4 Post-randomization||187
6664039|NCT02524561|7594724|FG000|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
6664040|NCT02524561|7594725|FG001|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
6664041|NCT02524561|7594726|FG002|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
6737625|NCT03267940|7666867|FG000|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
6737626|NCT03267940|7666868|FG001|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||0
6737627|NCT03267940|7666869|FG002|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||24
6737628|NCT03267940|7666870|FG003|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||22
6737629|NCT03267940|7666871|FG004|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||11
6737630|NCT03267940|7666872|FG005|Received at Least 1 Dose of Study Drug|Expansion (Maximum Exposure: 421 Days)||10
6737631|NCT03267940|7666867|FG000|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6737632|NCT03267940|7666868|FG001|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6737633|NCT03267940|7666869|FG002|COMPLETED|Expansion (Maximum Exposure: 421 Days)||3
6737634|NCT03267940|7666870|FG003|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6737635|NCT03267940|7666871|FG004|COMPLETED|Expansion (Maximum Exposure: 421 Days)||1
6737636|NCT03267940|7666872|FG005|COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6737637|NCT03267940|7666867|FG000|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6737638|NCT03267940|7666868|FG001|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||0
6737639|NCT03267940|7666869|FG002|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||21
6737640|NCT03267940|7666870|FG003|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||22
6737641|NCT03267940|7666871|FG004|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
6737642|NCT03267940|7666872|FG005|NOT COMPLETED|Expansion (Maximum Exposure: 421 Days)||10
6737643|NCT03268343|7666890|FG000|STARTED|Overall Study||12
6737644|NCT03268343|7666891|FG001|STARTED|Overall Study||12
6737645|NCT03268343|7666890|FG000|COMPLETED|Overall Study||12
6737646|NCT03268343|7666891|FG001|COMPLETED|Overall Study||12
6737647|NCT03268343|7666890|FG000|NOT COMPLETED|Overall Study||0
6737648|NCT03268343|7666891|FG001|NOT COMPLETED|Overall Study||0
6737649|NCT03268590|7666898|FG000|STARTED|Overall Study||33
6737650|NCT03268590|7666898|FG000|COMPLETED|Overall Study|One participant did not complete MRI due to a previously undiagnosed subdermal metal shard in scalp.|32
6737651|NCT03268590|7666898|FG000|NOT COMPLETED|Overall Study||1
6737652|NCT03268746|7666905|FG000|STARTED|Overall Study||45
6737653|NCT03268746|7666905|FG000|COMPLETED|Overall Study||44
6737654|NCT03268746|7666905|FG000|NOT COMPLETED|Overall Study||1
6737655|NCT03268941|7666920|FG000|STARTED|Part 1 (Days 1 to 9)||12
6737656|NCT03268941|7666921|FG001|STARTED|Part 1 (Days 1 to 9)||14
6737657|NCT03268941|7666922|FG002|STARTED|Part 1 (Days 1 to 9)||12
6737658|NCT03268941|7666923|FG003|STARTED|Part 1 (Days 1 to 9)||13
6737659|NCT03268941|7666924|FG004|STARTED|Part 1 (Days 1 to 9)||0
6737660|NCT03268941|7666925|FG005|STARTED|Part 1 (Days 1 to 9)||0
6737661|NCT03268941|7666926|FG006|STARTED|Part 1 (Days 1 to 9)||0
6737662|NCT03268941|7666920|FG000|COMPLETED|Part 1 (Days 1 to 9)||11
6737663|NCT03268941|7666921|FG001|COMPLETED|Part 1 (Days 1 to 9)||14
6737664|NCT03268941|7666922|FG002|COMPLETED|Part 1 (Days 1 to 9)||12
6737665|NCT03268941|7666923|FG003|COMPLETED|Part 1 (Days 1 to 9)||11
6737666|NCT03268941|7666924|FG004|COMPLETED|Part 1 (Days 1 to 9)||0
6737667|NCT03268941|7666925|FG005|COMPLETED|Part 1 (Days 1 to 9)||0
6737668|NCT03268941|7666926|FG006|COMPLETED|Part 1 (Days 1 to 9)||0
6737669|NCT03268941|7666920|FG000|NOT COMPLETED|Part 1 (Days 1 to 9)||1
6737670|NCT03268941|7666921|FG001|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6737671|NCT03268941|7666922|FG002|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6737672|NCT03268941|7666923|FG003|NOT COMPLETED|Part 1 (Days 1 to 9)||2
6737673|NCT03268941|7666924|FG004|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6737674|NCT03268941|7666925|FG005|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6737675|NCT03268941|7666926|FG006|NOT COMPLETED|Part 1 (Days 1 to 9)||0
6737676|NCT03268941|7666920|FG000|STARTED|Part 2: Days 17 to 25||0
6737677|NCT03268941|7666921|FG001|STARTED|Part 2: Days 17 to 25||0
6737678|NCT03268941|7666922|FG002|STARTED|Part 2: Days 17 to 25||0
6737679|NCT03268941|7666923|FG003|STARTED|Part 2: Days 17 to 25||0
6737680|NCT03268941|7666924|FG004|STARTED|Part 2: Days 17 to 25||6
6737681|NCT03268941|7666925|FG005|STARTED|Part 2: Days 17 to 25||0
6737682|NCT03268941|7666926|FG006|STARTED|Part 2: Days 17 to 25||15
6737683|NCT03268941|7666920|FG000|Treated|Part 2: Days 17 to 25||0
6737684|NCT03268941|7666921|FG001|Treated|Part 2: Days 17 to 25||0
6737685|NCT03268941|7666922|FG002|Treated|Part 2: Days 17 to 25||0
6664042|NCT02524665|7594734|FG000|STARTED|Overall Study||20
6664043|NCT02524665|7594734|FG000|COMPLETED|Overall Study||19
6664044|NCT02524665|7594734|FG000|NOT COMPLETED|Overall Study||1
6664045|NCT02524730|7594739|FG000|STARTED|Overall Study||205
6664046|NCT02524730|7594739|FG000|COMPLETED|Overall Study||159
6664047|NCT02524730|7594739|FG000|NOT COMPLETED|Overall Study||46
6664048|NCT02524769|7594743|FG000|STARTED|Overall Study||27
6664049|NCT02524769|7594743|FG000|COMPLETED|Overall Study||17
6664050|NCT02524769|7594743|FG000|NOT COMPLETED|Overall Study||10
6664051|NCT02524847|7594747|FG000|STARTED|Overall Study||29
6664052|NCT02524847|7594747|FG000|Completed Treatment Up to Week 12|Overall Study||14
6664053|NCT02524847|7594747|FG000|Started Second Line Treatment|Overall Study||5
6664054|NCT02524847|7594747|FG000|COMPLETED|Overall Study||15
6664055|NCT02524847|7594747|FG000|NOT COMPLETED|Overall Study||14
6664056|NCT02524977|7594754|FG000|STARTED|Overall Study||738
6664057|NCT02524977|7594755|FG001|STARTED|Overall Study||846
6664058|NCT02524977|7594754|FG000|COMPLETED|Overall Study||692
6664059|NCT02524977|7594755|FG001|COMPLETED|Overall Study||801
6664060|NCT02524977|7594754|FG000|NOT COMPLETED|Overall Study||46
6664061|NCT02524977|7594755|FG001|NOT COMPLETED|Overall Study||45
6664062|NCT02525055|7594769|FG000|STARTED|Overall Study||6
6664063|NCT02525055|7594770|FG001|STARTED|Overall Study||6
6664064|NCT02525055|7594771|FG002|STARTED|Overall Study||6
6664065|NCT02525055|7594772|FG003|STARTED|Overall Study||6
6664066|NCT02525055|7594773|FG004|STARTED|Overall Study||6
6664067|NCT02525055|7594774|FG005|STARTED|Overall Study||16
6664068|NCT02525055|7594769|FG000|COMPLETED|Overall Study||6
6664069|NCT02525055|7594770|FG001|COMPLETED|Overall Study||6
6664070|NCT02525055|7594771|FG002|COMPLETED|Overall Study||6
6664071|NCT02525055|7594772|FG003|COMPLETED|Overall Study||6
6664072|NCT02525055|7594773|FG004|COMPLETED|Overall Study||6
6664073|NCT02525055|7594774|FG005|COMPLETED|Overall Study||16
6664074|NCT02525055|7594769|FG000|NOT COMPLETED|Overall Study||0
6664075|NCT02525055|7594770|FG001|NOT COMPLETED|Overall Study||0
6664076|NCT02525055|7594771|FG002|NOT COMPLETED|Overall Study||0
6664077|NCT02525055|7594772|FG003|NOT COMPLETED|Overall Study||0
6664078|NCT02525055|7594773|FG004|NOT COMPLETED|Overall Study||0
6664079|NCT02525055|7594774|FG005|NOT COMPLETED|Overall Study||0
6664080|NCT02525094|7594790|FG000|STARTED|Overall Study||57
6664081|NCT02525094|7594791|FG001|STARTED|Overall Study||56
6664082|NCT02525094|7594790|FG000|Treated|Overall Study||56
6664083|NCT02525094|7594791|FG001|Treated|Overall Study||55
6664084|NCT02525094|7594790|FG000|COMPLETED|Overall Study||49
6664085|NCT02525094|7594791|FG001|COMPLETED|Overall Study||48
6664086|NCT02525094|7594790|FG000|NOT COMPLETED|Overall Study||8
6664087|NCT02525094|7594791|FG001|NOT COMPLETED|Overall Study||8
6664088|NCT02525133|7594800|FG000|STARTED|Overall Study||213
6664089|NCT02525133|7594801|FG001|STARTED|Overall Study||106
6664090|NCT02525133|7594800|FG000|Randomized But Not Treated|Overall Study||4
6664091|NCT02525133|7594801|FG001|Randomized But Not Treated|Overall Study||0
6664092|NCT02525133|7594800|FG000|COMPLETED|Overall Study||203
6664093|NCT02525133|7594801|FG001|COMPLETED|Overall Study||103
6664094|NCT02525133|7594800|FG000|NOT COMPLETED|Overall Study||10
6664095|NCT02525133|7594801|FG001|NOT COMPLETED|Overall Study||3
6664096|NCT02525263|7594807|FG000|STARTED|Overall Study|The single patient in this trial was enrolled on 18 July 2016.|1
6664097|NCT02525263|7594807|FG000|COMPLETED|Overall Study|The trial was completed when the patient reached the specified endpoint of starting hemodialysis.|1
6664098|NCT02525263|7594807|FG000|NOT COMPLETED|Overall Study||0
6664099|NCT02525471|7594813|FG000|STARTED|Overall Study||24
6664100|NCT02525471|7594813|FG000|Randomized/Treated|Overall Study||16
6664101|NCT02525471|7594813|FG000|COMPLETED|Overall Study||13
6664102|NCT02525471|7594813|FG000|NOT COMPLETED|Overall Study||11
6664103|NCT02525523|7594820|FG000|STARTED|Overall Study||69
6664104|NCT02525523|7594821|FG001|STARTED|Overall Study||69
6664105|NCT02525523|7594820|FG000|COMPLETED|Overall Study||46
6664106|NCT02525523|7594821|FG001|COMPLETED|Overall Study||44
6664107|NCT02525523|7594820|FG000|NOT COMPLETED|Overall Study||23
6664108|NCT02525523|7594821|FG001|NOT COMPLETED|Overall Study||25
6664109|NCT02525536|7594830|FG000|STARTED|Overall Study||6
6664110|NCT02525536|7594831|FG001|STARTED|Overall Study||6
6664111|NCT02525536|7594832|FG002|STARTED|Overall Study||6
6664112|NCT02525536|7594830|FG000|COMPLETED|Overall Study||6
6664113|NCT02525536|7594831|FG001|COMPLETED|Overall Study||6
6664114|NCT02525536|7594832|FG002|COMPLETED|Overall Study||6
6664115|NCT02525536|7594830|FG000|NOT COMPLETED|Overall Study||0
6664116|NCT02525536|7594831|FG001|NOT COMPLETED|Overall Study||0
6664117|NCT02525536|7594832|FG002|NOT COMPLETED|Overall Study||0
6664118|NCT02525549|7594843|FG000|STARTED|Overall Study||365
6664119|NCT02525549|7594844|FG001|STARTED|Overall Study||360
6664120|NCT02525549|7594845|FG002|STARTED|Overall Study||178
6664121|NCT02525549|7594843|FG000|COMPLETED|Overall Study||330
6664122|NCT02525549|7594844|FG001|COMPLETED|Overall Study||307
6664123|NCT02525549|7594845|FG002|COMPLETED|Overall Study||159
6664124|NCT02525549|7594843|FG000|NOT COMPLETED|Overall Study||35
6664125|NCT02525549|7594844|FG001|NOT COMPLETED|Overall Study||53
6664126|NCT02525549|7594845|FG002|NOT COMPLETED|Overall Study||19
6664127|NCT02525575|7594853|FG000|STARTED|Overall Study||37
6664128|NCT02525575|7594853|FG000|COMPLETED|Overall Study||22
6664129|NCT02525575|7594853|FG000|NOT COMPLETED|Overall Study||15
6664130|NCT02525588|7594859|FG000|STARTED|Overall Study||48
6664131|NCT02525588|7594860|FG001|STARTED|Overall Study||48
6664132|NCT02525588|7594859|FG000|COMPLETED|Overall Study||42
6664133|NCT02525588|7594860|FG001|COMPLETED|Overall Study||45
6664134|NCT02525588|7594859|FG000|NOT COMPLETED|Overall Study||6
6664135|NCT02525588|7594860|FG001|NOT COMPLETED|Overall Study||3
6664136|NCT02525627|7594868|FG000|STARTED|Overall Study||16
6664137|NCT02525627|7594869|FG001|STARTED|Overall Study||18
6664138|NCT02525627|7594868|FG000|COMPLETED|Overall Study||2
6664139|NCT02525627|7594869|FG001|COMPLETED|Overall Study||5
6664140|NCT02525627|7594868|FG000|NOT COMPLETED|Overall Study||14
6664141|NCT02525627|7594869|FG001|NOT COMPLETED|Overall Study||13
6664142|NCT02525653|7594875|FG000|STARTED|Overall Study||40
6664143|NCT02525653|7594875|FG000|COMPLETED|Overall Study||40
6664144|NCT02525653|7594875|FG000|NOT COMPLETED|Overall Study||0
6664145|NCT02525718|7594881|FG000|STARTED|Overall Study||23
6664146|NCT02525718|7594882|FG001|STARTED|Overall Study||24
6664147|NCT02525718|7594881|FG000|COMPLETED|Overall Study||22
6664148|NCT02525718|7594882|FG001|COMPLETED|Overall Study||23
6664149|NCT02525718|7594881|FG000|NOT COMPLETED|Overall Study||1
6664150|NCT02525718|7594882|FG001|NOT COMPLETED|Overall Study||1
6664151|NCT02525744|7594888|FG000|STARTED|Period 1||6
6664152|NCT02525744|7594889|FG001|STARTED|Period 1||6
6664153|NCT02525744|7594890|FG002|STARTED|Period 1||6
6664154|NCT02525744|7594891|FG003|STARTED|Period 1||6
6664155|NCT02525744|7594888|FG000|Received at Least 1 Dose of Study Drug|Period 1||6
6664156|NCT02525744|7594889|FG001|Received at Least 1 Dose of Study Drug|Period 1||6
6664157|NCT02525744|7594890|FG002|Received at Least 1 Dose of Study Drug|Period 1||5
6664158|NCT02525744|7594891|FG003|Received at Least 1 Dose of Study Drug|Period 1||6
6664159|NCT02525744|7594888|FG000|COMPLETED|Period 1||6
6664160|NCT02525744|7594889|FG001|COMPLETED|Period 1||6
6664161|NCT02525744|7594890|FG002|COMPLETED|Period 1||5
6664162|NCT02525744|7594891|FG003|COMPLETED|Period 1||6
6664163|NCT02525744|7594888|FG000|NOT COMPLETED|Period 1||0
6664164|NCT02525744|7594889|FG001|NOT COMPLETED|Period 1||0
6664165|NCT02525744|7594890|FG002|NOT COMPLETED|Period 1||1
6664166|NCT02525744|7594891|FG003|NOT COMPLETED|Period 1||0
6664167|NCT02525744|7594888|FG000|STARTED|Period 2||6
6664168|NCT02525744|7594889|FG001|STARTED|Period 2||6
6664169|NCT02525744|7594890|FG002|STARTED|Period 2||5
6664170|NCT02525744|7594891|FG003|STARTED|Period 2||6
6664171|NCT02525744|7594888|FG000|Received at Least 1 Dose of Study Drug|Period 2||6
6664172|NCT02525744|7594889|FG001|Received at Least 1 Dose of Study Drug|Period 2||6
6664173|NCT02525744|7594890|FG002|Received at Least 1 Dose of Study Drug|Period 2||5
6664174|NCT02525744|7594891|FG003|Received at Least 1 Dose of Study Drug|Period 2||6
6664175|NCT02525744|7594888|FG000|COMPLETED|Period 2||6
6664176|NCT02525744|7594889|FG001|COMPLETED|Period 2||6
6664177|NCT02525744|7594890|FG002|COMPLETED|Period 2||5
6664178|NCT02525744|7594891|FG003|COMPLETED|Period 2||6
6664179|NCT02525744|7594888|FG000|NOT COMPLETED|Period 2||0
6664180|NCT02525744|7594889|FG001|NOT COMPLETED|Period 2||0
6664181|NCT02525744|7594890|FG002|NOT COMPLETED|Period 2||0
6664182|NCT02525744|7594891|FG003|NOT COMPLETED|Period 2||0
6664183|NCT02525744|7594888|FG000|STARTED|Period 3||6
6664184|NCT02525744|7594889|FG001|STARTED|Period 3||6
6664185|NCT02525744|7594890|FG002|STARTED|Period 3||5
6664186|NCT02525744|7594891|FG003|STARTED|Period 3||6
6664187|NCT02525744|7594888|FG000|Received at Least 1 Dose of Study Drug|Period 3||6
6664188|NCT02525744|7594889|FG001|Received at Least 1 Dose of Study Drug|Period 3||6
6664189|NCT02525744|7594890|FG002|Received at Least 1 Dose of Study Drug|Period 3||5
6664190|NCT02525744|7594891|FG003|Received at Least 1 Dose of Study Drug|Period 3||6
6664191|NCT02525744|7594888|FG000|COMPLETED|Period 3||6
6664192|NCT02525744|7594889|FG001|COMPLETED|Period 3||5
6664193|NCT02525744|7594890|FG002|COMPLETED|Period 3||5
6664194|NCT02525744|7594891|FG003|COMPLETED|Period 3||6
6664195|NCT02525744|7594888|FG000|NOT COMPLETED|Period 3||0
6664196|NCT02525744|7594889|FG001|NOT COMPLETED|Period 3||1
6664197|NCT02525744|7594890|FG002|NOT COMPLETED|Period 3||0
6664198|NCT02525744|7594891|FG003|NOT COMPLETED|Period 3||0
6664199|NCT02525744|7594888|FG000|STARTED|Period 4||6
6664200|NCT02525744|7594889|FG001|STARTED|Period 4||5
6664201|NCT02525744|7594890|FG002|STARTED|Period 4||5
6664202|NCT02525744|7594891|FG003|STARTED|Period 4||6
6664203|NCT02525744|7594888|FG000|Received at Least 1 Dose of Study Drug|Period 4||6
6664204|NCT02525744|7594889|FG001|Received at Least 1 Dose of Study Drug|Period 4||5
6664205|NCT02525744|7594890|FG002|Received at Least 1 Dose of Study Drug|Period 4||5
6664206|NCT02525744|7594891|FG003|Received at Least 1 Dose of Study Drug|Period 4||6
6664207|NCT02525744|7594888|FG000|COMPLETED|Period 4||5
6664208|NCT02525744|7594889|FG001|COMPLETED|Period 4||5
6664209|NCT02525744|7594890|FG002|COMPLETED|Period 4||5
6664210|NCT02525744|7594891|FG003|COMPLETED|Period 4||6
6664211|NCT02525744|7594888|FG000|NOT COMPLETED|Period 4||1
6664212|NCT02525744|7594889|FG001|NOT COMPLETED|Period 4||0
6664213|NCT02525744|7594890|FG002|NOT COMPLETED|Period 4||0
6664214|NCT02525744|7594891|FG003|NOT COMPLETED|Period 4||0
6664215|NCT02525744|7594888|FG000|STARTED|Period 5||5
6664216|NCT02525744|7594889|FG001|STARTED|Period 5||5
6664217|NCT02525744|7594890|FG002|STARTED|Period 5||5
6664218|NCT02525744|7594891|FG003|STARTED|Period 5||6
6664219|NCT02525744|7594888|FG000|Received at Least 1 Dose of Study Drug|Period 5||4
6664220|NCT02525744|7594889|FG001|Received at Least 1 Dose of Study Drug|Period 5||5
6664221|NCT02525744|7594890|FG002|Received at Least 1 Dose of Study Drug|Period 5||5
6664222|NCT02525744|7594891|FG003|Received at Least 1 Dose of Study Drug|Period 5||6
6664223|NCT02525744|7594888|FG000|COMPLETED|Period 5||4
6664224|NCT02525744|7594889|FG001|COMPLETED|Period 5||5
6664225|NCT02525744|7594890|FG002|COMPLETED|Period 5||5
6664226|NCT02525744|7594891|FG003|COMPLETED|Period 5||6
6664227|NCT02525744|7594888|FG000|NOT COMPLETED|Period 5||1
6664228|NCT02525744|7594889|FG001|NOT COMPLETED|Period 5||0
6664229|NCT02525744|7594890|FG002|NOT COMPLETED|Period 5||0
6664230|NCT02525744|7594891|FG003|NOT COMPLETED|Period 5||0
6664231|NCT02525861|7594903|FG000|STARTED|Overall Study||18
6664232|NCT02525861|7594904|FG001|STARTED|Overall Study||16
6664233|NCT02525861|7594903|FG000|COMPLETED|Overall Study||17
6664234|NCT02525861|7594904|FG001|COMPLETED|Overall Study||14
6664235|NCT02525861|7594903|FG000|NOT COMPLETED|Overall Study||1
6664236|NCT02525861|7594904|FG001|NOT COMPLETED|Overall Study||2
6664237|NCT02525874|7594912|FG000|STARTED|Overall Study||218
6664238|NCT02525874|7594912|FG000|COMPLETED|Overall Study||158
6664239|NCT02525874|7594912|FG000|NOT COMPLETED|Overall Study||60
6664240|NCT02526160|7594918|FG000|STARTED|Double-Blind (Placebo-Controlled) Period||66
6664241|NCT02526160|7594919|FG001|STARTED|Double-Blind (Placebo-Controlled) Period||68
6664242|NCT02526160|7594918|FG000|COMPLETED|Double-Blind (Placebo-Controlled) Period||66
6664243|NCT02526160|7594919|FG001|COMPLETED|Double-Blind (Placebo-Controlled) Period||67
6664244|NCT02526160|7594918|FG000|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||0
6664245|NCT02526160|7594919|FG001|NOT COMPLETED|Double-Blind (Placebo-Controlled) Period||1
6664246|NCT02526160|7594918|FG000|STARTED|Open-label Treatment Continuation Period||66
6664247|NCT02526160|7594919|FG001|STARTED|Open-label Treatment Continuation Period||67
6664248|NCT02526160|7594918|FG000|COMPLETED|Open-label Treatment Continuation Period||63
6664249|NCT02526160|7594919|FG001|COMPLETED|Open-label Treatment Continuation Period||63
6664250|NCT02526160|7594918|FG000|NOT COMPLETED|Open-label Treatment Continuation Period||3
6664251|NCT02526160|7594919|FG001|NOT COMPLETED|Open-label Treatment Continuation Period||4
6664252|NCT02526160|7594918|FG000|STARTED|Open-Label Treatment Extension Period I||63
6664253|NCT02526160|7594919|FG001|STARTED|Open-Label Treatment Extension Period I||63
6664254|NCT02526160|7594918|FG000|COMPLETED|Open-Label Treatment Extension Period I||60
6664255|NCT02526160|7594919|FG001|COMPLETED|Open-Label Treatment Extension Period I||59
6664256|NCT02526160|7594918|FG000|NOT COMPLETED|Open-Label Treatment Extension Period I||3
6664257|NCT02526160|7594919|FG001|NOT COMPLETED|Open-Label Treatment Extension Period I||4
6664258|NCT02526160|7594918|FG000|STARTED|Open-Label Treatment Extension Period II||52
6664259|NCT02526160|7594919|FG001|STARTED|Open-Label Treatment Extension Period II||49
6664260|NCT02526160|7594918|FG000|COMPLETED|Open-Label Treatment Extension Period II||51
6664261|NCT02526160|7594919|FG001|COMPLETED|Open-Label Treatment Extension Period II||49
6664262|NCT02526160|7594918|FG000|NOT COMPLETED|Open-Label Treatment Extension Period II||1
6664263|NCT02526160|7594919|FG001|NOT COMPLETED|Open-Label Treatment Extension Period II||0
6664264|NCT02526212|7594932|FG000|STARTED|Overall Study||10
6664265|NCT02526212|7594933|FG001|STARTED|Overall Study||8
6664266|NCT02526212|7594932|FG000|COMPLETED|Overall Study||8
6664267|NCT02526212|7594933|FG001|COMPLETED|Overall Study||7
6664268|NCT02526212|7594932|FG000|NOT COMPLETED|Overall Study||2
6664269|NCT02526212|7594933|FG001|NOT COMPLETED|Overall Study||1
6664270|NCT02526277|7594943|FG000|STARTED|Overall Study||8
6664271|NCT02526277|7594944|FG001|STARTED|Overall Study||6
6664272|NCT02526277|7594945|FG002|STARTED|Overall Study||7
6664273|NCT02526277|7594946|FG003|STARTED|Overall Study||7
6664274|NCT02526277|7594943|FG000|COMPLETED|Overall Study||8
6664275|NCT02526277|7594944|FG001|COMPLETED|Overall Study||6
6664276|NCT02526277|7594945|FG002|COMPLETED|Overall Study||7
6664277|NCT02526277|7594946|FG003|COMPLETED|Overall Study||7
6664278|NCT02526277|7594943|FG000|NOT COMPLETED|Overall Study||0
6664279|NCT02526277|7594944|FG001|NOT COMPLETED|Overall Study||0
6664280|NCT02526277|7594945|FG002|NOT COMPLETED|Overall Study||0
6664281|NCT02526277|7594946|FG003|NOT COMPLETED|Overall Study||0
6664282|NCT02526290|7594959|FG000|STARTED|Overall Study||97
6664283|NCT02526290|7594959|FG000|COMPLETED|Overall Study||89
6664284|NCT02526290|7594959|FG000|NOT COMPLETED|Overall Study||8
6664285|NCT02526524|7594969|FG000|STARTED|Overall Study||94
6664286|NCT02526524|7594970|FG001|STARTED|Overall Study||95
6664287|NCT02526524|7594971|FG002|STARTED|Overall Study||96
6664288|NCT02526524|7594972|FG003|STARTED|Overall Study||96
6664289|NCT02526524|7594973|FG004|STARTED|Overall Study||96
6664290|NCT02526524|7594974|FG005|STARTED|Overall Study||94
6664291|NCT02526524|7594969|FG000|COMPLETED|Overall Study||82
6664292|NCT02526524|7594970|FG001|COMPLETED|Overall Study||86
6664293|NCT02526524|7594971|FG002|COMPLETED|Overall Study||70
6664294|NCT02526524|7594972|FG003|COMPLETED|Overall Study||89
6664295|NCT02526524|7594973|FG004|COMPLETED|Overall Study||72
6664296|NCT02526524|7594974|FG005|COMPLETED|Overall Study||73
6664297|NCT02526524|7594969|FG000|NOT COMPLETED|Overall Study||12
6664298|NCT02526524|7594970|FG001|NOT COMPLETED|Overall Study||9
6664299|NCT02526524|7594971|FG002|NOT COMPLETED|Overall Study||26
6664300|NCT02526524|7594972|FG003|NOT COMPLETED|Overall Study||7
6664301|NCT02526524|7594973|FG004|NOT COMPLETED|Overall Study||24
6664302|NCT02526524|7594974|FG005|NOT COMPLETED|Overall Study||21
6664303|NCT02526550|7594988|FG000|STARTED|Overall Study||50
6664304|NCT02526550|7594988|FG000|COMPLETED|Overall Study||49
6664305|NCT02526550|7594988|FG000|NOT COMPLETED|Overall Study||1
6664306|NCT02526654|7594994|FG000|STARTED|Overall Study||79
6664307|NCT02526654|7594995|FG001|STARTED|Overall Study||36
6664308|NCT02526654|7594994|FG000|COMPLETED|Overall Study||79
6664309|NCT02526654|7594995|FG001|COMPLETED|Overall Study||36
6664310|NCT02526654|7594994|FG000|NOT COMPLETED|Overall Study||0
6664311|NCT02526654|7594995|FG001|NOT COMPLETED|Overall Study||0
6664312|NCT02526667|7595004|FG000|STARTED|Abdomen||284
6664313|NCT02526667|7595005|FG001|STARTED|Abdomen||56
6664314|NCT02526667|7595006|FG002|STARTED|Abdomen||281
6664315|NCT02526667|7595004|FG000|COMPLETED|Abdomen||284
6664316|NCT02526667|7595005|FG001|COMPLETED|Abdomen||56
6664317|NCT02526667|7595006|FG002|COMPLETED|Abdomen||281
6664318|NCT02526667|7595004|FG000|NOT COMPLETED|Abdomen||0
6664319|NCT02526667|7595005|FG001|NOT COMPLETED|Abdomen||0
6664320|NCT02526667|7595006|FG002|NOT COMPLETED|Abdomen||0
6664321|NCT02526667|7595004|FG000|STARTED|Groin||290
6664322|NCT02526667|7595005|FG001|STARTED|Groin||56
6664323|NCT02526667|7595006|FG002|STARTED|Groin||294
6664324|NCT02526667|7595004|FG000|COMPLETED|Groin||290
6664325|NCT02526667|7595005|FG001|COMPLETED|Groin||56
6664326|NCT02526667|7595006|FG002|COMPLETED|Groin||294
6664327|NCT02526667|7595004|FG000|NOT COMPLETED|Groin||0
6664328|NCT02526667|7595005|FG001|NOT COMPLETED|Groin||0
6664329|NCT02526667|7595006|FG002|NOT COMPLETED|Groin||0
6664330|NCT02526680|7595020|FG000|STARTED|Overall Study||27
6664331|NCT02526680|7595020|FG000|COMPLETED|Overall Study||27
6664332|NCT02526680|7595020|FG000|NOT COMPLETED|Overall Study||0
6664333|NCT02526693|7595027|FG000|STARTED|Overall Study||53
6664334|NCT02526693|7595028|FG001|STARTED|Overall Study||51
6664335|NCT02526693|7595027|FG000|COMPLETED|Overall Study||50
6664336|NCT02526693|7595028|FG001|COMPLETED|Overall Study||50
6664337|NCT02526693|7595027|FG000|NOT COMPLETED|Overall Study||3
6664338|NCT02526693|7595028|FG001|NOT COMPLETED|Overall Study||1
6664339|NCT02527148|7595040|FG000|STARTED|Overall Study||50
6664340|NCT02527148|7595041|FG001|STARTED|Overall Study||50
6664341|NCT02527148|7595040|FG000|COMPLETED|Overall Study||49
6664342|NCT02527148|7595041|FG001|COMPLETED|Overall Study||50
6664343|NCT02527148|7595040|FG000|NOT COMPLETED|Overall Study||1
6664344|NCT02527148|7595041|FG001|NOT COMPLETED|Overall Study||0
6664345|NCT02527161|7595049|FG000|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|205
6664346|NCT02527161|7595049|FG000|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 5 year outcome interval.|73
6664347|NCT02527161|7595049|FG000|NOT COMPLETED|Overall Study||132
6664348|NCT02527265|7595056|FG000|STARTED|Overall Study||15
6664349|NCT02527265|7595057|FG001|STARTED|Overall Study||15
6664350|NCT02527265|7595056|FG000|COMPLETED|Overall Study||13
6664351|NCT02527265|7595057|FG001|COMPLETED|Overall Study||11
6664352|NCT02527265|7595056|FG000|NOT COMPLETED|Overall Study||2
6664353|NCT02527265|7595057|FG001|NOT COMPLETED|Overall Study||4
6664354|NCT02527343|7595065|FG000|STARTED|RT Period: Weeks 1 to 52||19
6664355|NCT02527343|7595066|FG001|STARTED|RT Period: Weeks 1 to 52||21
6664356|NCT02527343|7595067|FG002|STARTED|RT Period: Weeks 1 to 52||0
6664357|NCT02527343|7595068|FG003|STARTED|RT Period: Weeks 1 to 52||0
6664358|NCT02527343|7595069|FG004|STARTED|RT Period: Weeks 1 to 52||0
6664359|NCT02527343|7595070|FG005|STARTED|RT Period: Weeks 1 to 52||0
6664360|NCT02527343|7595065|FG000|COMPLETED|RT Period: Weeks 1 to 52||13
6664361|NCT02527343|7595066|FG001|COMPLETED|RT Period: Weeks 1 to 52||14
6664362|NCT02527343|7595067|FG002|COMPLETED|RT Period: Weeks 1 to 52||0
6664363|NCT02527343|7595068|FG003|COMPLETED|RT Period: Weeks 1 to 52||0
6664364|NCT02527343|7595069|FG004|COMPLETED|RT Period: Weeks 1 to 52||0
6664365|NCT02527343|7595070|FG005|COMPLETED|RT Period: Weeks 1 to 52||0
6664366|NCT02527343|7595065|FG000|NOT COMPLETED|RT Period: Weeks 1 to 52||6
6664367|NCT02527343|7595066|FG001|NOT COMPLETED|RT Period: Weeks 1 to 52||7
6664368|NCT02527343|7595067|FG002|NOT COMPLETED|RT Period: Weeks 1 to 52||0
6664369|NCT02527343|7595068|FG003|NOT COMPLETED|RT Period: Weeks 1 to 52||0
6664370|NCT02527343|7595069|FG004|NOT COMPLETED|RT Period: Weeks 1 to 52||0
6664371|NCT02527343|7595070|FG005|NOT COMPLETED|RT Period: Weeks 1 to 52||0
6664372|NCT02527343|7595065|FG000|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
6664373|NCT02527343|7595066|FG001|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
6664374|NCT02527343|7595067|FG002|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|7
6664375|NCT02527343|7595068|FG003|STARTED|RT Post Treatment Follow-up: Weeks 54-65|Only those participants who were entered in the 13-week post-treatment follow-up period after the randomized treatment period.|9
6664376|NCT02527343|7595069|FG004|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
6664377|NCT02527343|7595070|FG005|STARTED|RT Post Treatment Follow-up: Weeks 54-65||0
6664378|NCT02527343|7595065|FG000|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
6664379|NCT02527343|7595066|FG001|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
6664380|NCT02527343|7595067|FG002|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||6
6664381|NCT02527343|7595068|FG003|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||7
6664382|NCT02527343|7595069|FG004|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
6664383|NCT02527343|7595070|FG005|COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
6664384|NCT02527343|7595065|FG000|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
6664385|NCT02527343|7595066|FG001|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
6664386|NCT02527343|7595067|FG002|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||1
6664387|NCT02527343|7595068|FG003|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||2
6664388|NCT02527343|7595069|FG004|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
6664389|NCT02527343|7595070|FG005|NOT COMPLETED|RT Post Treatment Follow-up: Weeks 54-65||0
6664390|NCT02527343|7595065|FG000|STARTED|OLE Period-Year 1: Week 53 to 104||0
6664391|NCT02527343|7595066|FG001|STARTED|OLE Period-Year 1: Week 53 to 104||0
6664392|NCT02527343|7595067|FG002|STARTED|OLE Period-Year 1: Week 53 to 104||0
6664393|NCT02527343|7595068|FG003|STARTED|OLE Period-Year 1: Week 53 to 104||0
6664394|NCT02527343|7595069|FG004|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
6664395|NCT02527343|7595070|FG005|STARTED|OLE Period-Year 1: Week 53 to 104|Only those participants who were entered the in the OLE period (first OLE period) after the randomized treatment period.|12
6664396|NCT02527343|7595065|FG000|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
6664397|NCT02527343|7595066|FG001|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
6664398|NCT02527343|7595067|FG002|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
6664399|NCT02527343|7595068|FG003|COMPLETED|OLE Period-Year 1: Week 53 to 104||0
6664400|NCT02527343|7595069|FG004|COMPLETED|OLE Period-Year 1: Week 53 to 104||1
6664401|NCT02527343|7595070|FG005|COMPLETED|OLE Period-Year 1: Week 53 to 104||3
6664402|NCT02527343|7595065|FG000|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
6664403|NCT02527343|7595066|FG001|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
6664404|NCT02527343|7595067|FG002|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
6664405|NCT02527343|7595068|FG003|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||0
6664406|NCT02527343|7595069|FG004|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||11
6664407|NCT02527343|7595070|FG005|NOT COMPLETED|OLE Period-Year 1: Week 53 to 104||9
6664408|NCT02527343|7595065|FG000|STARTED|OLE Period-Year 2: Week 105 to 156||0
6664409|NCT02527343|7595066|FG001|STARTED|OLE Period-Year 2: Week 105 to 156||0
6664410|NCT02527343|7595067|FG002|STARTED|OLE Period-Year 2: Week 105 to 156||0
6664411|NCT02527343|7595068|FG003|STARTED|OLE Period-Year 2: Week 105 to 156||0
6664412|NCT02527343|7595069|FG004|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|1
6664413|NCT02527343|7595070|FG005|STARTED|OLE Period-Year 2: Week 105 to 156|Only those participants who were continuing the dosing for up to an additional 52 weeks in the second OLE period.|2
6664414|NCT02527343|7595065|FG000|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664415|NCT02527343|7595066|FG001|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664416|NCT02527343|7595067|FG002|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664417|NCT02527343|7595068|FG003|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664418|NCT02527343|7595069|FG004|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664419|NCT02527343|7595070|FG005|COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664420|NCT02527343|7595065|FG000|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664421|NCT02527343|7595066|FG001|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664422|NCT02527343|7595067|FG002|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664423|NCT02527343|7595068|FG003|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||0
6664424|NCT02527343|7595069|FG004|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||1
6664425|NCT02527343|7595070|FG005|NOT COMPLETED|OLE Period-Year 2: Week 105 to 156||2
6664426|NCT02527343|7595065|FG000|STARTED|PT Follow-up: Weeks 104 to 169||0
6664427|NCT02527343|7595066|FG001|STARTED|PT Follow-up: Weeks 104 to 169||0
6664428|NCT02527343|7595067|FG002|STARTED|PT Follow-up: Weeks 104 to 169||0
6664429|NCT02527343|7595068|FG003|STARTED|PT Follow-up: Weeks 104 to 169||0
6664430|NCT02527343|7595069|FG004|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
6664431|NCT02527343|7595070|FG005|STARTED|PT Follow-up: Weeks 104 to 169|Participants who were entered in the post-treatment follow-up after the OLE Period.|12
6664432|NCT02527343|7595065|FG000|COMPLETED|PT Follow-up: Weeks 104 to 169||0
6664433|NCT02527343|7595066|FG001|COMPLETED|PT Follow-up: Weeks 104 to 169||0
6664434|NCT02527343|7595067|FG002|COMPLETED|PT Follow-up: Weeks 104 to 169||0
6664435|NCT02527343|7595068|FG003|COMPLETED|PT Follow-up: Weeks 104 to 169||0
6664436|NCT02527343|7595069|FG004|COMPLETED|PT Follow-up: Weeks 104 to 169||11
6664437|NCT02527343|7595070|FG005|COMPLETED|PT Follow-up: Weeks 104 to 169||11
6664438|NCT02527343|7595065|FG000|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
6664439|NCT02527343|7595066|FG001|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
6664440|NCT02527343|7595067|FG002|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
6664441|NCT02527343|7595068|FG003|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||0
6664442|NCT02527343|7595069|FG004|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
6664443|NCT02527343|7595070|FG005|NOT COMPLETED|PT Follow-up: Weeks 104 to 169||1
6664444|NCT02527421|7595087|FG000|STARTED|Overall Study||2
6664445|NCT02527421|7595088|FG001|STARTED|Overall Study||1
6664446|NCT02527421|7595087|FG000|COMPLETED|Overall Study||1
6664447|NCT02527421|7595088|FG001|COMPLETED|Overall Study||1
6664448|NCT02527421|7595087|FG000|NOT COMPLETED|Overall Study||1
6664449|NCT02527421|7595088|FG001|NOT COMPLETED|Overall Study||0
6664450|NCT02527512|7595096|FG000|STARTED|Overall Study||85
6664451|NCT02527512|7595097|FG001|STARTED|Overall Study||82
6664452|NCT02527512|7595096|FG000|COMPLETED|Overall Study||77
6664453|NCT02527512|7595097|FG001|COMPLETED|Overall Study||76
6664454|NCT02527512|7595096|FG000|NOT COMPLETED|Overall Study||8
6664455|NCT02527512|7595097|FG001|NOT COMPLETED|Overall Study||6
6664456|NCT02527694|7595109|FG000|STARTED|Overall Study||20
6664457|NCT02527694|7595110|FG001|STARTED|Overall Study||29
6664458|NCT02527694|7595109|FG000|COMPLETED|Overall Study||10
6664459|NCT02527694|7595110|FG001|COMPLETED|Overall Study||21
6664460|NCT02527694|7595109|FG000|NOT COMPLETED|Overall Study||10
6664461|NCT02527694|7595110|FG001|NOT COMPLETED|Overall Study||8
6664462|NCT02528188|7595121|FG000|STARTED|Overall Study||1008
6664463|NCT02528188|7595122|FG001|STARTED|Overall Study||1005
6664464|NCT02528188|7595123|FG002|STARTED|Overall Study||1008
6664465|NCT02528188|7595121|FG000|Treated|Overall Study||1002
6664466|NCT02528188|7595122|FG001|Treated|Overall Study||998
6664467|NCT02528188|7595123|FG002|Treated|Overall Study||996
6664468|NCT02528188|7595121|FG000|COMPLETED|Overall Study||741
6664469|NCT02528188|7595122|FG001|COMPLETED|Overall Study||729
6664470|NCT02528188|7595123|FG002|COMPLETED|Overall Study||757
6664471|NCT02528188|7595121|FG000|NOT COMPLETED|Overall Study||267
6664472|NCT02528188|7595122|FG001|NOT COMPLETED|Overall Study||276
6664473|NCT02528188|7595123|FG002|NOT COMPLETED|Overall Study||251
6664474|NCT02528214|7595133|FG000|STARTED|Overall Study||107
6664475|NCT02528214|7595134|FG001|STARTED|Overall Study||103
6664476|NCT02528214|7595133|FG000|Treated|Overall Study||107
6664477|NCT02528214|7595134|FG001|Treated|Overall Study||103
6664478|NCT02528214|7595133|FG000|COMPLETED|Overall Study||107
6664479|NCT02528214|7595134|FG001|COMPLETED|Overall Study||100
6664480|NCT02528214|7595133|FG000|NOT COMPLETED|Overall Study||0
6664481|NCT02528214|7595134|FG001|NOT COMPLETED|Overall Study||3
6664482|NCT02528253|7595146|FG000|STARTED|Overall Study||205
6664483|NCT02528253|7595147|FG001|STARTED|Overall Study||204
6664484|NCT02528253|7595148|FG002|STARTED|Overall Study||407
6664485|NCT02528253|7595149|FG003|STARTED|Overall Study||407
6664486|NCT02528253|7595150|FG004|STARTED|Overall Study||602
6664487|NCT02528253|7595146|FG000|Intent to Treat Population|Overall Study||202
6664488|NCT02528253|7595147|FG001|Intent to Treat Population|Overall Study||204
6664489|NCT02528253|7595148|FG002|Intent to Treat Population|Overall Study||407
6664490|NCT02528253|7595149|FG003|Intent to Treat Population|Overall Study||407
6664491|NCT02528253|7595150|FG004|Intent to Treat Population|Overall Study|3 participants randomized to placebo arm received tramadol during the course of study|605
6664492|NCT02528253|7595146|FG000|Treated at Week 16|Overall Study||99
6664493|NCT02528253|7595147|FG001|Treated at Week 16|Overall Study||95
6664494|NCT02528253|7595148|FG002|Treated at Week 16|Overall Study||236
6664495|NCT02528253|7595149|FG003|Treated at Week 16|Overall Study||242
6664496|NCT02528253|7595150|FG004|Treated at Week 16|Overall Study||307
6664497|NCT02528253|7595146|FG000|COMPLETED|Overall Study||130
6664498|NCT02528253|7595147|FG001|COMPLETED|Overall Study||134
6664499|NCT02528253|7595148|FG002|COMPLETED|Overall Study||267
6664500|NCT02528253|7595149|FG003|COMPLETED|Overall Study||271
6664501|NCT02528253|7595150|FG004|COMPLETED|Overall Study||379
6664502|NCT02528253|7595146|FG000|NOT COMPLETED|Overall Study||75
6664503|NCT02528253|7595147|FG001|NOT COMPLETED|Overall Study||70
6664504|NCT02528253|7595148|FG002|NOT COMPLETED|Overall Study||140
6664505|NCT02528253|7595149|FG003|NOT COMPLETED|Overall Study||136
6664506|NCT02528253|7595150|FG004|NOT COMPLETED|Overall Study||223
6664507|NCT02528305|7595181|FG000|STARTED|Overall Study||12
6664508|NCT02528305|7595181|FG000|End of Control Period Assessment|Overall Study||11
6664509|NCT02528305|7595181|FG000|End of Intervention Period Assessment|Overall Study||9
6664510|NCT02528305|7595181|FG000|COMPLETED|Overall Study||9
6664511|NCT02528305|7595181|FG000|NOT COMPLETED|Overall Study||3
6664512|NCT02528318|7595192|FG000|STARTED|Overall Study||8
6664513|NCT02528318|7595193|FG001|STARTED|Overall Study||8
6664514|NCT02528318|7595194|FG002|STARTED|Overall Study||8
6664515|NCT02528318|7595195|FG003|STARTED|Overall Study|Study was terminated prior to initiation of this intervention|0
6664516|NCT02528318|7595196|FG004|STARTED|Overall Study||24
6664517|NCT02528318|7595192|FG000|COMPLETED|Overall Study||8
6664518|NCT02528318|7595193|FG001|COMPLETED|Overall Study||8
6664519|NCT02528318|7595194|FG002|COMPLETED|Overall Study||8
6664520|NCT02528318|7595195|FG003|COMPLETED|Overall Study||0
6664521|NCT02528318|7595196|FG004|COMPLETED|Overall Study||24
6664522|NCT02528318|7595192|FG000|NOT COMPLETED|Overall Study||0
6664523|NCT02528318|7595193|FG001|NOT COMPLETED|Overall Study||0
6664524|NCT02528318|7595194|FG002|NOT COMPLETED|Overall Study||0
6664525|NCT02528318|7595195|FG003|NOT COMPLETED|Overall Study||0
6664526|NCT02528318|7595196|FG004|NOT COMPLETED|Overall Study||0
6664527|NCT02528331|7595208|FG000|STARTED|Overall Study||2
6664528|NCT02528331|7595208|FG000|COMPLETED|Overall Study||0
6664529|NCT02528331|7595208|FG000|NOT COMPLETED|Overall Study||2
6664530|NCT02528357|7595231|FG000|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
6664531|NCT02528357|7595232|FG001|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||1
6664532|NCT02528357|7595233|FG002|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||8
6664533|NCT02528357|7595234|FG003|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
6664534|NCT02528357|7595235|FG004|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||10
6664535|NCT02528357|7595236|FG005|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
6664536|NCT02528357|7595237|FG006|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||7
6664537|NCT02528357|7595238|FG007|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||4
6664538|NCT02528357|7595239|FG008|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664539|NCT02528357|7595240|FG009|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664540|NCT02528357|7595241|FG010|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664541|NCT02528357|7595242|FG011|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664542|NCT02528357|7595243|FG012|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664543|NCT02528357|7595244|FG013|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664544|NCT02528357|7595245|FG014|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664545|NCT02528357|7595246|FG015|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664546|NCT02528357|7595247|FG016|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664547|NCT02528357|7595248|FG017|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664548|NCT02528357|7595249|FG018|STARTED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664549|NCT02528357|7595231|FG000|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
6664550|NCT02528357|7595232|FG001|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664551|NCT02528357|7595233|FG002|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
6664552|NCT02528357|7595234|FG003|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||9
6664553|NCT02528357|7595235|FG004|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||6
6664554|NCT02528357|7595236|FG005|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
6664555|NCT02528357|7595237|FG006|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||5
6664556|NCT02528357|7595238|FG007|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
6664557|NCT02528357|7595239|FG008|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664558|NCT02528357|7595240|FG009|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664559|NCT02528357|7595241|FG010|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664560|NCT02528357|7595242|FG011|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664561|NCT02528357|7595243|FG012|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664562|NCT02528357|7595244|FG013|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664563|NCT02528357|7595245|FG014|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664564|NCT02528357|7595246|FG015|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664565|NCT02528357|7595247|FG016|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664566|NCT02528357|7595248|FG017|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664567|NCT02528357|7595249|FG018|COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664568|NCT02528357|7595231|FG000|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664569|NCT02528357|7595232|FG001|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
6664570|NCT02528357|7595233|FG002|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
6664571|NCT02528357|7595234|FG003|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||1
6664572|NCT02528357|7595235|FG004|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||4
6664573|NCT02528357|7595236|FG005|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
6664574|NCT02528357|7595237|FG006|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
6664575|NCT02528357|7595238|FG007|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||2
6664576|NCT02528357|7595239|FG008|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664577|NCT02528357|7595240|FG009|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664578|NCT02528357|7595241|FG010|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664579|NCT02528357|7595242|FG011|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664580|NCT02528357|7595243|FG012|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664581|NCT02528357|7595244|FG013|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664582|NCT02528357|7595245|FG014|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664583|NCT02528357|7595246|FG015|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664584|NCT02528357|7595247|FG016|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664585|NCT02528357|7595248|FG017|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664586|NCT02528357|7595249|FG018|NOT COMPLETED|Part1:Monotherapy(Up to Maximum 39weeks)||0
6664587|NCT02528357|7595231|FG000|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664588|NCT02528357|7595232|FG001|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664589|NCT02528357|7595233|FG002|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664590|NCT02528357|7595234|FG003|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664591|NCT02528357|7595235|FG004|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664592|NCT02528357|7595236|FG005|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664593|NCT02528357|7595237|FG006|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664594|NCT02528357|7595238|FG007|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664595|NCT02528357|7595239|FG008|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
6664596|NCT02528357|7595240|FG009|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
6664597|NCT02528357|7595241|FG010|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||10
6664598|NCT02528357|7595242|FG011|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
6664599|NCT02528357|7595243|FG012|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||14
6664600|NCT02528357|7595244|FG013|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
6664601|NCT02528357|7595245|FG014|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||12
6664602|NCT02528357|7595246|FG015|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
6664603|NCT02528357|7595247|FG016|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664604|NCT02528357|7595248|FG017|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664605|NCT02528357|7595249|FG018|STARTED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664606|NCT02528357|7595231|FG000|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664607|NCT02528357|7595232|FG001|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664608|NCT02528357|7595233|FG002|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664609|NCT02528357|7595234|FG003|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664610|NCT02528357|7595235|FG004|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664611|NCT02528357|7595236|FG005|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664612|NCT02528357|7595237|FG006|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664613|NCT02528357|7595238|FG007|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664614|NCT02528357|7595239|FG008|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
6664615|NCT02528357|7595240|FG009|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
6664616|NCT02528357|7595241|FG010|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
6664617|NCT02528357|7595242|FG011|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
6664618|NCT02528357|7595243|FG012|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||9
6664619|NCT02528357|7595244|FG013|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
6664620|NCT02528357|7595245|FG014|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
6664621|NCT02528357|7595246|FG015|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||4
6664622|NCT02528357|7595247|FG016|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664623|NCT02528357|7595248|FG017|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664624|NCT02528357|7595249|FG018|COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664625|NCT02528357|7595231|FG000|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664626|NCT02528357|7595232|FG001|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664627|NCT02528357|7595233|FG002|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664628|NCT02528357|7595234|FG003|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664629|NCT02528357|7595235|FG004|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664630|NCT02528357|7595236|FG005|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664631|NCT02528357|7595237|FG006|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664632|NCT02528357|7595238|FG007|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664633|NCT02528357|7595239|FG008|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
6664634|NCT02528357|7595240|FG009|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||1
6664635|NCT02528357|7595241|FG010|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
6664636|NCT02528357|7595242|FG011|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||3
6664637|NCT02528357|7595243|FG012|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||5
6664638|NCT02528357|7595244|FG013|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||6
6664639|NCT02528357|7595245|FG014|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||7
6664640|NCT02528357|7595246|FG015|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664641|NCT02528357|7595247|FG016|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664642|NCT02528357|7595248|FG017|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664643|NCT02528357|7595249|FG018|NOT COMPLETED|Part2A:Comb. Th. (Up to Maximum 105wks)||0
6664644|NCT02528357|7595231|FG000|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664645|NCT02528357|7595232|FG001|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664646|NCT02528357|7595233|FG002|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664647|NCT02528357|7595234|FG003|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664648|NCT02528357|7595235|FG004|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664649|NCT02528357|7595236|FG005|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664650|NCT02528357|7595237|FG006|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664651|NCT02528357|7595238|FG007|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664652|NCT02528357|7595239|FG008|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664653|NCT02528357|7595240|FG009|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664654|NCT02528357|7595241|FG010|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664655|NCT02528357|7595242|FG011|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664656|NCT02528357|7595243|FG012|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664657|NCT02528357|7595244|FG013|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664658|NCT02528357|7595245|FG014|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664659|NCT02528357|7595246|FG015|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664660|NCT02528357|7595247|FG016|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||9
6664661|NCT02528357|7595248|FG017|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||8
6664662|NCT02528357|7595249|FG018|STARTED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||5
6664663|NCT02528357|7595231|FG000|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664664|NCT02528357|7595232|FG001|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664665|NCT02528357|7595233|FG002|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664666|NCT02528357|7595234|FG003|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664667|NCT02528357|7595235|FG004|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664668|NCT02528357|7595236|FG005|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664669|NCT02528357|7595237|FG006|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664670|NCT02528357|7595238|FG007|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664671|NCT02528357|7595239|FG008|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664672|NCT02528357|7595240|FG009|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664673|NCT02528357|7595241|FG010|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664674|NCT02528357|7595242|FG011|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664675|NCT02528357|7595243|FG012|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664676|NCT02528357|7595244|FG013|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664677|NCT02528357|7595245|FG014|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664678|NCT02528357|7595246|FG015|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664679|NCT02528357|7595247|FG016|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||6
6664680|NCT02528357|7595248|FG017|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
6664681|NCT02528357|7595249|FG018|COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||2
6664682|NCT02528357|7595231|FG000|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664683|NCT02528357|7595232|FG001|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664684|NCT02528357|7595233|FG002|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664685|NCT02528357|7595234|FG003|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664686|NCT02528357|7595235|FG004|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664687|NCT02528357|7595236|FG005|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664688|NCT02528357|7595237|FG006|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664689|NCT02528357|7595238|FG007|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664690|NCT02528357|7595239|FG008|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664691|NCT02528357|7595240|FG009|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664692|NCT02528357|7595241|FG010|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664693|NCT02528357|7595242|FG011|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664694|NCT02528357|7595243|FG012|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664695|NCT02528357|7595244|FG013|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664696|NCT02528357|7595245|FG014|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664697|NCT02528357|7595246|FG015|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||0
6664698|NCT02528357|7595247|FG016|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
6664699|NCT02528357|7595248|FG017|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||4
6664700|NCT02528357|7595249|FG018|NOT COMPLETED|Part2B:Expan. Coh.(Up to Maximum 33 Wks)||3
6664701|NCT02528370|7595291|FG000|STARTED|Overall Study||119
6664702|NCT02528370|7595292|FG001|STARTED|Overall Study||78
6664703|NCT02528370|7595291|FG000|COMPLETED|Overall Study||102
6664704|NCT02528370|7595292|FG001|COMPLETED|Overall Study||77
6664705|NCT02528370|7595291|FG000|NOT COMPLETED|Overall Study||17
6664706|NCT02528370|7595292|FG001|NOT COMPLETED|Overall Study||1
6664707|NCT02528409|7595300|FG000|STARTED|Overall Study||40
6664708|NCT02528409|7595301|FG001|STARTED|Overall Study||40
6664709|NCT02528409|7595300|FG000|COMPLETED|Overall Study||18
6664710|NCT02528409|7595301|FG001|COMPLETED|Overall Study||24
6664711|NCT02528409|7595300|FG000|NOT COMPLETED|Overall Study||22
6664712|NCT02528409|7595301|FG001|NOT COMPLETED|Overall Study||16
6664713|NCT02528721|7595309|FG000|STARTED|Overall Study||203
6664714|NCT02528721|7595310|FG001|STARTED|Overall Study||79
6664715|NCT02528721|7595309|FG000|COMPLETED|Overall Study||196
6664716|NCT02528721|7595310|FG001|COMPLETED|Overall Study||76
6664717|NCT02528721|7595309|FG000|NOT COMPLETED|Overall Study||7
6664718|NCT02528721|7595310|FG001|NOT COMPLETED|Overall Study||3
6664719|NCT02528786|7595316|FG000|STARTED|Overall Study||8
6664720|NCT02528786|7595316|FG000|COMPLETED|Overall Study||8
6664721|NCT02528786|7595316|FG000|NOT COMPLETED|Overall Study||0
6664722|NCT02528942|7595320|FG000|STARTED|Overall Study||101
6664723|NCT02528942|7595320|FG000|COMPLETED|Overall Study||67
6664724|NCT02528942|7595320|FG000|NOT COMPLETED|Overall Study||34
6664725|NCT02529072|7595326|FG000|STARTED|Overall Study||3
6664726|NCT02529072|7595327|FG001|STARTED|Overall Study||3
6664727|NCT02529072|7595326|FG000|COMPLETED|Overall Study||3
6664728|NCT02529072|7595327|FG001|COMPLETED|Overall Study||3
6664729|NCT02529072|7595326|FG000|NOT COMPLETED|Overall Study||0
6664730|NCT02529072|7595327|FG001|NOT COMPLETED|Overall Study||0
6664731|NCT02529137|7595333|FG000|STARTED|Overall Study||2000
6664732|NCT02529137|7595333|FG000|COMPLETED|Overall Study||1992
6664733|NCT02529137|7595333|FG000|NOT COMPLETED|Overall Study||8
6664734|NCT02529488|7595338|FG000|STARTED|Overall Study||149
6664735|NCT02529488|7595338|FG000|COMPLETED|Overall Study||145
6664736|NCT02529488|7595338|FG000|NOT COMPLETED|Overall Study||4
6664737|NCT02529553|7595355|FG000|STARTED|Overall Study||1
6664738|NCT02529553|7595356|FG001|STARTED|Overall Study||1
6664739|NCT02529553|7595357|FG002|STARTED|Overall Study||1
6664740|NCT02529553|7595358|FG003|STARTED|Overall Study||3
6664741|NCT02529553|7595359|FG004|STARTED|Overall Study||3
6664742|NCT02529553|7595360|FG005|STARTED|Overall Study||4
6664743|NCT02529553|7595361|FG006|STARTED|Overall Study||3
6664744|NCT02529553|7595362|FG007|STARTED|Overall Study||6
6664745|NCT02529553|7595363|FG008|STARTED|Overall Study||3
6664746|NCT02529553|7595355|FG000|COMPLETED|Overall Study||0
6664747|NCT02529553|7595356|FG001|COMPLETED|Overall Study||0
6664748|NCT02529553|7595357|FG002|COMPLETED|Overall Study||0
6664749|NCT02529553|7595358|FG003|COMPLETED|Overall Study||0
6664750|NCT02529553|7595359|FG004|COMPLETED|Overall Study||0
6664751|NCT02529553|7595360|FG005|COMPLETED|Overall Study||0
6664752|NCT02529553|7595361|FG006|COMPLETED|Overall Study||0
6664753|NCT02529553|7595362|FG007|COMPLETED|Overall Study||0
6664754|NCT02529553|7595363|FG008|COMPLETED|Overall Study||0
6664755|NCT02529553|7595355|FG000|NOT COMPLETED|Overall Study||1
6664756|NCT02529553|7595356|FG001|NOT COMPLETED|Overall Study||1
6664757|NCT02529553|7595357|FG002|NOT COMPLETED|Overall Study||1
6664758|NCT02529553|7595358|FG003|NOT COMPLETED|Overall Study||3
6664759|NCT02529553|7595359|FG004|NOT COMPLETED|Overall Study||3
6664760|NCT02529553|7595360|FG005|NOT COMPLETED|Overall Study||4
6664761|NCT02529553|7595361|FG006|NOT COMPLETED|Overall Study||3
6664762|NCT02529553|7595362|FG007|NOT COMPLETED|Overall Study||6
6664763|NCT02529553|7595363|FG008|NOT COMPLETED|Overall Study||3
6664764|NCT02529995|7595386|FG000|STARTED|Part A||15
6664765|NCT02529995|7595387|FG001|STARTED|Part A||16
6664766|NCT02529995|7595386|FG000|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
6664767|NCT02529995|7595387|FG001|COMPLETED|Part A|'Completed' means 'Completed the Study', i.e. zero patient completed the study in part A.|0
6664768|NCT02529995|7595386|FG000|NOT COMPLETED|Part A||15
6664769|NCT02529995|7595387|FG001|NOT COMPLETED|Part A||16
6664770|NCT02529995|7595386|FG000|STARTED|Part B||15
6664771|NCT02529995|7595387|FG001|STARTED|Part B||16
6278966|NCT00140231|7178649|FG000|STARTED|First Fasting State 3 Days With Placebo||7
6278967|NCT00140231|7178650|FG001|STARTED|First Fasting State 3 Days With Placebo||6
6278968|NCT00140231|7178649|FG000|COMPLETED|First Fasting State 3 Days With Placebo||7
6278969|NCT00140231|7178650|FG001|COMPLETED|First Fasting State 3 Days With Placebo||6
6278970|NCT00140231|7178649|FG000|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
6278971|NCT00140231|7178650|FG001|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
6278972|NCT00140231|7178649|FG000|STARTED|Washout 8 Weeks||7
6278973|NCT00140231|7178650|FG001|STARTED|Washout 8 Weeks||6
6278974|NCT00140231|7178649|FG000|COMPLETED|Washout 8 Weeks||7
6278975|NCT00140231|7178650|FG001|COMPLETED|Washout 8 Weeks||6
6278976|NCT00140231|7178649|FG000|NOT COMPLETED|Washout 8 Weeks||0
6278977|NCT00140231|7178650|FG001|NOT COMPLETED|Washout 8 Weeks||0
6278978|NCT00140231|7178649|FG000|STARTED|Fasting State With Leptin and Crossover||7
6278979|NCT00140231|7178650|FG001|STARTED|Fasting State With Leptin and Crossover||6
6278980|NCT00140231|7178649|FG000|COMPLETED|Fasting State With Leptin and Crossover||7
6278981|NCT00140231|7178650|FG001|COMPLETED|Fasting State With Leptin and Crossover||6
6278982|NCT00140231|7178649|FG000|NOT COMPLETED|Fasting State With Leptin and Crossover||0
6278983|NCT00140231|7178650|FG001|NOT COMPLETED|Fasting State With Leptin and Crossover||0
6278984|NCT00140244|7178656|FG000|STARTED|Intervention 1||3
6278985|NCT00140244|7178657|FG001|STARTED|Intervention 1||4
6278986|NCT00140244|7178656|FG000|COMPLETED|Intervention 1||3
6278987|NCT00140244|7178657|FG001|COMPLETED|Intervention 1||4
6278988|NCT00140244|7178656|FG000|NOT COMPLETED|Intervention 1||0
6278989|NCT00140244|7178657|FG001|NOT COMPLETED|Intervention 1||0
6278990|NCT00140244|7178656|FG000|STARTED|Washout||3
6278991|NCT00140244|7178657|FG001|STARTED|Washout||4
6278992|NCT00140244|7178656|FG000|COMPLETED|Washout||3
6278993|NCT00140244|7178657|FG001|COMPLETED|Washout||4
6278994|NCT00140244|7178656|FG000|NOT COMPLETED|Washout||0
6278995|NCT00140244|7178657|FG001|NOT COMPLETED|Washout||0
6278996|NCT00140244|7178656|FG000|STARTED|Intervention 2||3
6664772|NCT02529995|7595386|FG000|COMPLETED|Part B||9
6664773|NCT02529995|7595387|FG001|COMPLETED|Part B||4
6664774|NCT02529995|7595386|FG000|NOT COMPLETED|Part B||6
6664775|NCT02529995|7595387|FG001|NOT COMPLETED|Part B||12
6664776|NCT02530125|7595393|FG000|STARTED|Completed Treatment||4
6664777|NCT02530125|7595393|FG000|COMPLETED|Completed Treatment||3
6664778|NCT02530125|7595393|FG000|NOT COMPLETED|Completed Treatment||1
6664779|NCT02530125|7595393|FG000|STARTED|Followed for Survival for 2 Years||3
6664780|NCT02530125|7595393|FG000|COMPLETED|Followed for Survival for 2 Years||0
6664781|NCT02530125|7595393|FG000|NOT COMPLETED|Followed for Survival for 2 Years||3
6664782|NCT02530151|7595399|FG000|STARTED|Overall Study||37
6664783|NCT02530151|7595400|FG001|STARTED|Overall Study||33
6664784|NCT02530151|7595399|FG000|COMPLETED|Overall Study||16
6664785|NCT02530151|7595400|FG001|COMPLETED|Overall Study||17
6664786|NCT02530151|7595399|FG000|NOT COMPLETED|Overall Study||21
6664787|NCT02530151|7595400|FG001|NOT COMPLETED|Overall Study||16
6664788|NCT02530242|7595408|FG000|STARTED|Overall Study||16
6664789|NCT02530242|7595409|FG001|STARTED|Overall Study||16
6664790|NCT02530242|7595408|FG000|COMPLETED|Overall Study||16
6664791|NCT02530242|7595409|FG001|COMPLETED|Overall Study||15
6664792|NCT02530242|7595408|FG000|NOT COMPLETED|Overall Study||0
6664793|NCT02530242|7595409|FG001|NOT COMPLETED|Overall Study||1
6664794|NCT02530281|7595417|FG000|STARTED|Overall Study||229
6664795|NCT02530281|7595418|FG001|STARTED|Overall Study||115
6664796|NCT02530281|7595417|FG000|COMPLETED|Overall Study||208
6664797|NCT02530281|7595418|FG001|COMPLETED|Overall Study||112
6664798|NCT02530281|7595417|FG000|NOT COMPLETED|Overall Study||21
6664799|NCT02530281|7595418|FG001|NOT COMPLETED|Overall Study||3
6664800|NCT02530294|7595428|FG000|STARTED|Overall Study||234
6664801|NCT02530294|7595429|FG001|STARTED|Overall Study||119
6664802|NCT02530294|7595428|FG000|COMPLETED|Overall Study||218
6664803|NCT02530294|7595429|FG001|COMPLETED|Overall Study||113
6664804|NCT02530294|7595428|FG000|NOT COMPLETED|Overall Study||16
6664805|NCT02530294|7595429|FG001|NOT COMPLETED|Overall Study||6
6664806|NCT02530385|7595437|FG000|STARTED|Overall Study||12
6664807|NCT02530385|7595438|FG001|STARTED|Overall Study||12
6664808|NCT02530385|7595437|FG000|COMPLETED|Overall Study||12
6664809|NCT02530385|7595438|FG001|COMPLETED|Overall Study||11
6664810|NCT02530385|7595437|FG000|NOT COMPLETED|Overall Study||0
6664811|NCT02530385|7595438|FG001|NOT COMPLETED|Overall Study||1
6664812|NCT02530450|7595446|FG000|STARTED|Overall Study||16
6664813|NCT02530450|7595447|FG001|STARTED|Overall Study||14
6664814|NCT02530450|7595446|FG000|COMPLETED|Overall Study||10
6664815|NCT02530450|7595447|FG001|COMPLETED|Overall Study||9
6664816|NCT02530450|7595446|FG000|NOT COMPLETED|Overall Study||6
6664817|NCT02530450|7595447|FG001|NOT COMPLETED|Overall Study||5
6664818|NCT02530476|7595457|FG000|STARTED|Overall Study||4
6664819|NCT02530476|7595458|FG001|STARTED|Overall Study||3
6664820|NCT02530476|7595459|FG002|STARTED|Overall Study||7
6664821|NCT02530476|7595460|FG003|STARTED|Overall Study||3
6664822|NCT02530476|7595457|FG000|COMPLETED|Overall Study||4
6664823|NCT02530476|7595458|FG001|COMPLETED|Overall Study||3
6664824|NCT02530476|7595459|FG002|COMPLETED|Overall Study||7
6664825|NCT02530476|7595460|FG003|COMPLETED|Overall Study||3
6664826|NCT02530476|7595457|FG000|NOT COMPLETED|Overall Study||0
6664827|NCT02530476|7595458|FG001|NOT COMPLETED|Overall Study||0
6664828|NCT02530476|7595459|FG002|NOT COMPLETED|Overall Study||0
6664829|NCT02530476|7595460|FG003|NOT COMPLETED|Overall Study||0
6664830|NCT02530515|7595473|FG000|STARTED|Overall Study||0
6664831|NCT02530515|7595474|FG001|STARTED|Overall Study||0
6664832|NCT02530515|7595475|FG002|STARTED|Overall Study||8
6664833|NCT02530515|7595473|FG000|COMPLETED|Overall Study||0
6664834|NCT02530515|7595474|FG001|COMPLETED|Overall Study||0
6664835|NCT02530515|7595475|FG002|COMPLETED|Overall Study||8
6664836|NCT02530515|7595473|FG000|NOT COMPLETED|Overall Study||0
6664837|NCT02530515|7595474|FG001|NOT COMPLETED|Overall Study||0
6664838|NCT02530515|7595475|FG002|NOT COMPLETED|Overall Study||0
6664839|NCT02530528|7595483|FG000|STARTED|Overall Study||13
6664840|NCT02530528|7595484|FG001|STARTED|Overall Study||13
6664841|NCT02530528|7595485|FG002|STARTED|Overall Study||14
6664842|NCT02530528|7595486|FG003|STARTED|Overall Study||14
6664843|NCT02530528|7595487|FG004|STARTED|Overall Study||13
6664844|NCT02530528|7595488|FG005|STARTED|Overall Study||13
6664845|NCT02530528|7595489|FG006|STARTED|Overall Study||14
6664846|NCT02530528|7595490|FG007|STARTED|Overall Study||14
6664847|NCT02530528|7595483|FG000|COMPLETED|Overall Study|13 participants received CHG Cloth|12
6664848|NCT02530528|7595484|FG001|COMPLETED|Overall Study||12
6664849|NCT02530528|7595485|FG002|COMPLETED|Overall Study|14 participants received CHG cloth|12
6664850|NCT02530528|7595486|FG003|COMPLETED|Overall Study||12
6664851|NCT02530528|7595487|FG004|COMPLETED|Overall Study|13 participants received CHG cloth|12
6664852|NCT02530528|7595488|FG005|COMPLETED|Overall Study||12
6664853|NCT02530528|7595489|FG006|COMPLETED|Overall Study|14 participants received comparator CHG.|12
6664854|NCT02530528|7595490|FG007|COMPLETED|Overall Study||12
6664855|NCT02530528|7595483|FG000|NOT COMPLETED|Overall Study||1
6664856|NCT02530528|7595484|FG001|NOT COMPLETED|Overall Study||1
6664857|NCT02530528|7595485|FG002|NOT COMPLETED|Overall Study||2
6664858|NCT02530528|7595486|FG003|NOT COMPLETED|Overall Study||2
6664859|NCT02530528|7595487|FG004|NOT COMPLETED|Overall Study||1
6664860|NCT02530528|7595488|FG005|NOT COMPLETED|Overall Study||1
6664861|NCT02530528|7595489|FG006|NOT COMPLETED|Overall Study||2
6664862|NCT02530528|7595490|FG007|NOT COMPLETED|Overall Study||2
6664863|NCT02530541|7595504|FG000|STARTED|Overall Study||21
6664864|NCT02530541|7595505|FG001|STARTED|Overall Study||23
6664865|NCT02530541|7595506|FG002|STARTED|Overall Study||22
6664866|NCT02530541|7595507|FG003|STARTED|Overall Study||21
6664867|NCT02530541|7595508|FG004|STARTED|Overall Study||20
6664868|NCT02530541|7595509|FG005|STARTED|Overall Study||19
6664869|NCT02530541|7595504|FG000|COMPLETED|Overall Study||14
6664870|NCT02530541|7595505|FG001|COMPLETED|Overall Study||15
6664871|NCT02530541|7595506|FG002|COMPLETED|Overall Study||14
6664872|NCT02530541|7595507|FG003|COMPLETED|Overall Study||15
6664873|NCT02530541|7595508|FG004|COMPLETED|Overall Study||15
6664874|NCT02530541|7595509|FG005|COMPLETED|Overall Study||14
6664875|NCT02530541|7595504|FG000|NOT COMPLETED|Overall Study||7
6664876|NCT02530541|7595505|FG001|NOT COMPLETED|Overall Study||8
6664877|NCT02530541|7595506|FG002|NOT COMPLETED|Overall Study||8
6664878|NCT02530541|7595507|FG003|NOT COMPLETED|Overall Study||6
6664879|NCT02530541|7595508|FG004|NOT COMPLETED|Overall Study||5
6664880|NCT02530541|7595509|FG005|NOT COMPLETED|Overall Study||5
6664881|NCT02530554|7595518|FG000|STARTED|Overall Study||12
6664882|NCT02530554|7595519|FG001|STARTED|Overall Study||14
6664883|NCT02530554|7595520|FG002|STARTED|Overall Study||12
6664884|NCT02530554|7595521|FG003|STARTED|Overall Study||14
6664885|NCT02530554|7595518|FG000|COMPLETED|Overall Study||12
6664886|NCT02530554|7595519|FG001|COMPLETED|Overall Study||14
6664887|NCT02530554|7595520|FG002|COMPLETED|Overall Study||12
6664888|NCT02530554|7595521|FG003|COMPLETED|Overall Study||14
6664889|NCT02530554|7595518|FG000|NOT COMPLETED|Overall Study||0
6664890|NCT02530554|7595519|FG001|NOT COMPLETED|Overall Study||0
6664891|NCT02530554|7595520|FG002|NOT COMPLETED|Overall Study||0
6664892|NCT02530554|7595521|FG003|NOT COMPLETED|Overall Study||0
6664893|NCT02530619|7595528|FG000|STARTED|Registered for Study||26
6664894|NCT02530619|7595528|FG000|Registered|Registered for Study||26
6664895|NCT02530619|7595528|FG000|Received 1st Dose of Alisertib|Registered for Study||24
6664896|NCT02530619|7595528|FG000|COMPLETED|Registered for Study||24
6664897|NCT02530619|7595528|FG000|NOT COMPLETED|Registered for Study||2
6664898|NCT02530619|7595528|FG000|STARTED|Completed 1st Cycle of Treatment||24
6664899|NCT02530619|7595528|FG000|COMPLETED|Completed 1st Cycle of Treatment||24
6664900|NCT02530619|7595528|FG000|NOT COMPLETED|Completed 1st Cycle of Treatment||0
6664901|NCT02530619|7595528|FG000|STARTED|Continued Treatment Cycles 2 Through 6||24
6664902|NCT02530619|7595528|FG000|COMPLETED|Continued Treatment Cycles 2 Through 6||14
6664903|NCT02530619|7595528|FG000|NOT COMPLETED|Continued Treatment Cycles 2 Through 6||10
6664904|NCT02530619|7595528|FG000|STARTED|Continued Treatment Cycle 7+||14
6664905|NCT02530619|7595528|FG000|COMPLETED|Continued Treatment Cycle 7+||14
6664906|NCT02530619|7595528|FG000|NOT COMPLETED|Continued Treatment Cycle 7+||0
6664907|NCT02530619|7595528|FG000|STARTED|Follow-up Period (6 Months)|Patients who received at least one dose of study drug go into follow-up.|21
6664908|NCT02530619|7595528|FG000|COMPLETED|Follow-up Period (6 Months)||10
6664909|NCT02530619|7595528|FG000|NOT COMPLETED|Follow-up Period (6 Months)||11
6664910|NCT02530671|7595534|FG000|STARTED|Overall Study||55
6664911|NCT02530671|7595535|FG001|STARTED|Overall Study||55
6664912|NCT02530671|7595534|FG000|COMPLETED|Overall Study||52
6664913|NCT02530671|7595535|FG001|COMPLETED|Overall Study||55
6664914|NCT02530671|7595534|FG000|NOT COMPLETED|Overall Study||3
6664915|NCT02530671|7595535|FG001|NOT COMPLETED|Overall Study||0
6664916|NCT02530905|7595543|FG000|STARTED|Double-Blind Period (12 Weeks)||4
6664917|NCT02530905|7595544|FG001|STARTED|Double-Blind Period (12 Weeks)||8
6664918|NCT02530905|7595545|FG002|STARTED|Double-Blind Period (12 Weeks)||0
6664919|NCT02530905|7595543|FG000|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
6664920|NCT02530905|7595544|FG001|Received 4 mg/kg|Double-Blind Period (12 Weeks)||8
6664921|NCT02530905|7595545|FG002|Received 4 mg/kg|Double-Blind Period (12 Weeks)||0
6664922|NCT02530905|7595543|FG000|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
6664923|NCT02530905|7595544|FG001|Received 10 mg/kg|Double-Blind Period (12 Weeks)||8
6664924|NCT02530905|7595545|FG002|Received 10 mg/kg|Double-Blind Period (12 Weeks)||0
6664925|NCT02530905|7595543|FG000|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
6664926|NCT02530905|7595544|FG001|Received 20 mg/kg|Double-Blind Period (12 Weeks)||8
6664927|NCT02530905|7595545|FG002|Received 20 mg/kg|Double-Blind Period (12 Weeks)||0
6664928|NCT02530905|7595543|FG000|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
6664929|NCT02530905|7595544|FG001|Received 30 mg/kg|Double-Blind Period (12 Weeks)||8
6664930|NCT02530905|7595545|FG002|Received 30 mg/kg|Double-Blind Period (12 Weeks)||0
6664931|NCT02530905|7595543|FG000|COMPLETED|Double-Blind Period (12 Weeks)||4
6664932|NCT02530905|7595544|FG001|COMPLETED|Double-Blind Period (12 Weeks)||8
6664933|NCT02530905|7595545|FG002|COMPLETED|Double-Blind Period (12 Weeks)||0
6664934|NCT02530905|7595543|FG000|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
6664935|NCT02530905|7595544|FG001|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
6664936|NCT02530905|7595545|FG002|NOT COMPLETED|Double-Blind Period (12 Weeks)||0
6664937|NCT02530905|7595543|FG000|STARTED|Open Label Extension Period (132 Weeks)||0
6664938|NCT02530905|7595544|FG001|STARTED|Open Label Extension Period (132 Weeks)||0
6664939|NCT02530905|7595545|FG002|STARTED|Open Label Extension Period (132 Weeks)|All participants from the double-blind period amenable to exon 45 skipping were enrolled to open-label extension period.|12
6664940|NCT02530905|7595543|FG000|COMPLETED|Open Label Extension Period (132 Weeks)||0
6664941|NCT02530905|7595544|FG001|COMPLETED|Open Label Extension Period (132 Weeks)||0
6664942|NCT02530905|7595545|FG002|COMPLETED|Open Label Extension Period (132 Weeks)||11
6664943|NCT02530905|7595543|FG000|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
6664944|NCT02530905|7595544|FG001|NOT COMPLETED|Open Label Extension Period (132 Weeks)||0
6664945|NCT02530905|7595545|FG002|NOT COMPLETED|Open Label Extension Period (132 Weeks)||1
6664946|NCT02530970|7595567|FG000|STARTED|Overall Study||1025
6664947|NCT02530970|7595567|FG000|COMPLETED|Overall Study||891
6664948|NCT02530970|7595567|FG000|NOT COMPLETED|Overall Study||134
6664949|NCT02530996|7595571|FG000|STARTED|First Intervention||6
6664950|NCT02530996|7595572|FG001|STARTED|First Intervention||6
6664951|NCT02530996|7595571|FG000|COMPLETED|First Intervention||6
6664952|NCT02530996|7595572|FG001|COMPLETED|First Intervention||6
6664953|NCT02530996|7595571|FG000|NOT COMPLETED|First Intervention||0
6664954|NCT02530996|7595572|FG001|NOT COMPLETED|First Intervention||0
6664955|NCT02530996|7595571|FG000|STARTED|Washout (5 Days)||6
6664956|NCT02530996|7595572|FG001|STARTED|Washout (5 Days)||6
6664957|NCT02530996|7595571|FG000|COMPLETED|Washout (5 Days)||6
6664958|NCT02530996|7595572|FG001|COMPLETED|Washout (5 Days)||6
6664959|NCT02530996|7595571|FG000|NOT COMPLETED|Washout (5 Days)||0
6664960|NCT02530996|7595572|FG001|NOT COMPLETED|Washout (5 Days)||0
6664961|NCT02530996|7595571|FG000|STARTED|Second Intervention||6
6664962|NCT02530996|7595572|FG001|STARTED|Second Intervention||6
6664963|NCT02530996|7595571|FG000|COMPLETED|Second Intervention||6
6664964|NCT02530996|7595572|FG001|COMPLETED|Second Intervention||6
6664965|NCT02530996|7595571|FG000|NOT COMPLETED|Second Intervention||0
6664966|NCT02530996|7595572|FG001|NOT COMPLETED|Second Intervention||0
6664967|NCT02531022|7595584|FG000|STARTED|Overall Study||55
6664968|NCT02531022|7595585|FG001|STARTED|Overall Study||50
6664969|NCT02531022|7595584|FG000|COMPLETED|Overall Study||55
6664970|NCT02531022|7595585|FG001|COMPLETED|Overall Study||48
6664971|NCT02531022|7595584|FG000|NOT COMPLETED|Overall Study||0
6664972|NCT02531022|7595585|FG001|NOT COMPLETED|Overall Study||2
6664973|NCT02531035|7595593|FG000|STARTED|Overall Study||705
6664974|NCT02531035|7595594|FG001|STARTED|Overall Study||700
6664975|NCT02531035|7595593|FG000|Treated|Overall Study||703
6664976|NCT02531035|7595594|FG001|Treated|Overall Study||699
6664977|NCT02531035|7595593|FG000|COMPLETED|Overall Study||624
6664978|NCT02531035|7595594|FG001|COMPLETED|Overall Study||605
6664979|NCT02531035|7595593|FG000|NOT COMPLETED|Overall Study||81
6664980|NCT02531035|7595594|FG001|NOT COMPLETED|Overall Study||95
6664981|NCT02531113|7595600|FG000|STARTED|Induction Period: Week 0 to 12||69
6664982|NCT02531113|7595600|FG000|COMPLETED|Induction Period: Week 0 to 12||58
6664983|NCT02531113|7595600|FG000|NOT COMPLETED|Induction Period: Week 0 to 12||11
6664984|NCT02531113|7595600|FG000|STARTED|Extension Period: Week 12 up to Week 160|6 participants completed induction; did not advance to extension due to lack efficacy.|52
6664985|NCT02531113|7595600|FG000|COMPLETED|Extension Period: Week 12 up to Week 160||14
6664986|NCT02531113|7595600|FG000|NOT COMPLETED|Extension Period: Week 12 up to Week 160||38
6664987|NCT02531321|7595606|FG000|STARTED|Overall Study||7
6664988|NCT02531321|7595607|FG001|STARTED|Overall Study||10
6664989|NCT02531321|7595606|FG000|COMPLETED|Overall Study||5
6664990|NCT02531321|7595607|FG001|COMPLETED|Overall Study||10
6664991|NCT02531321|7595606|FG000|NOT COMPLETED|Overall Study||2
6664992|NCT02531321|7595607|FG001|NOT COMPLETED|Overall Study||0
6664993|NCT02531373|7595622|FG000|STARTED|Overall Study||20
6664994|NCT02531373|7595623|FG001|STARTED|Overall Study||20
6664995|NCT02531373|7595624|FG002|STARTED|Overall Study||20
6664996|NCT02531373|7595625|FG003|STARTED|Overall Study||20
6664997|NCT02531373|7595626|FG004|STARTED|Overall Study||51
6664998|NCT02531373|7595627|FG005|STARTED|Overall Study||51
6664999|NCT02531373|7595628|FG006|STARTED|Overall Study||52
6665000|NCT02531373|7595629|FG007|STARTED|Overall Study||52
6665001|NCT02531373|7595630|FG008|STARTED|Overall Study||52
6665002|NCT02531373|7595622|FG000|Vaccination 1|Overall Study||20
6665003|NCT02531373|7595623|FG001|Vaccination 1|Overall Study||20
6665004|NCT02531373|7595624|FG002|Vaccination 1|Overall Study||20
6665005|NCT02531373|7595625|FG003|Vaccination 1|Overall Study||20
6665006|NCT02531373|7595626|FG004|Vaccination 1|Overall Study||50
6665007|NCT02531373|7595627|FG005|Vaccination 1|Overall Study||50
6665008|NCT02531373|7595628|FG006|Vaccination 1|Overall Study||52
6665009|NCT02531373|7595629|FG007|Vaccination 1|Overall Study||52
6665010|NCT02531373|7595630|FG008|Vaccination 1|Overall Study||52
6665011|NCT02531373|7595622|FG000|Vaccination 2|Overall Study||0
6665012|NCT02531373|7595623|FG001|Vaccination 2|Overall Study||0
6665013|NCT02531373|7595624|FG002|Vaccination 2|Overall Study||0
6665014|NCT02531373|7595625|FG003|Vaccination 2|Overall Study||0
6665015|NCT02531373|7595626|FG004|Vaccination 2|Overall Study||49
6665016|NCT02531373|7595627|FG005|Vaccination 2|Overall Study||48
6665017|NCT02531373|7595628|FG006|Vaccination 2|Overall Study||50
6665018|NCT02531373|7595629|FG007|Vaccination 2|Overall Study||51
6665019|NCT02531373|7595630|FG008|Vaccination 2|Overall Study||51
6665020|NCT02531373|7595622|FG000|Vaccination 3|Overall Study||0
6665021|NCT02531373|7595623|FG001|Vaccination 3|Overall Study||0
6665022|NCT02531373|7595624|FG002|Vaccination 3|Overall Study||0
6665023|NCT02531373|7595625|FG003|Vaccination 3|Overall Study||0
6665024|NCT02531373|7595626|FG004|Vaccination 3|Overall Study||48
6665025|NCT02531373|7595627|FG005|Vaccination 3|Overall Study||47
6665026|NCT02531373|7595628|FG006|Vaccination 3|Overall Study||49
6665027|NCT02531373|7595629|FG007|Vaccination 3|Overall Study||51
6665028|NCT02531373|7595630|FG008|Vaccination 3|Overall Study||49
6665029|NCT02531373|7595622|FG000|Vaccination 4|Overall Study||0
6665030|NCT02531373|7595623|FG001|Vaccination 4|Overall Study||0
6665031|NCT02531373|7595624|FG002|Vaccination 4|Overall Study||0
6665032|NCT02531373|7595625|FG003|Vaccination 4|Overall Study||0
6665033|NCT02531373|7595626|FG004|Vaccination 4|Overall Study||44
6665034|NCT02531373|7595627|FG005|Vaccination 4|Overall Study||43
6665035|NCT02531373|7595628|FG006|Vaccination 4|Overall Study||43
6665036|NCT02531373|7595629|FG007|Vaccination 4|Overall Study||43
6665037|NCT02531373|7595630|FG008|Vaccination 4|Overall Study||43
6665038|NCT02531373|7595622|FG000|COMPLETED|Overall Study||20
6665039|NCT02531373|7595623|FG001|COMPLETED|Overall Study||20
6665040|NCT02531373|7595624|FG002|COMPLETED|Overall Study||20
6665041|NCT02531373|7595625|FG003|COMPLETED|Overall Study||20
6665042|NCT02531373|7595626|FG004|COMPLETED|Overall Study||43
6665043|NCT02531373|7595627|FG005|COMPLETED|Overall Study||42
6665044|NCT02531373|7595628|FG006|COMPLETED|Overall Study||41
6665045|NCT02531373|7595629|FG007|COMPLETED|Overall Study||43
6665046|NCT02531373|7595630|FG008|COMPLETED|Overall Study||43
6665047|NCT02531373|7595622|FG000|NOT COMPLETED|Overall Study||0
6665048|NCT02531373|7595623|FG001|NOT COMPLETED|Overall Study||0
6665049|NCT02531373|7595624|FG002|NOT COMPLETED|Overall Study||0
6665050|NCT02531373|7595625|FG003|NOT COMPLETED|Overall Study||0
6665051|NCT02531373|7595626|FG004|NOT COMPLETED|Overall Study||8
6665052|NCT02531373|7595627|FG005|NOT COMPLETED|Overall Study||9
6665053|NCT02531373|7595628|FG006|NOT COMPLETED|Overall Study||11
6665054|NCT02531373|7595629|FG007|NOT COMPLETED|Overall Study||9
6665055|NCT02531373|7595630|FG008|NOT COMPLETED|Overall Study||9
6665056|NCT02531438|7595653|FG000|STARTED|Overall Study||386
6665057|NCT02531438|7595654|FG001|STARTED|Overall Study||388
6665058|NCT02531438|7595653|FG000|COMPLETED|Overall Study||356
6665059|NCT02531438|7595654|FG001|COMPLETED|Overall Study||362
6665060|NCT02531438|7595653|FG000|NOT COMPLETED|Overall Study||30
6665061|NCT02531438|7595654|FG001|NOT COMPLETED|Overall Study||26
6665062|NCT02531633|7595665|FG000|STARTED|Part A (52 Weeks)||42
6665063|NCT02531633|7595666|FG001|STARTED|Part A (52 Weeks)||39
6665064|NCT02531633|7595667|FG002|STARTED|Part A (52 Weeks)||26
6665065|NCT02531633|7595668|FG003|STARTED|Part A (52 Weeks)||27
6665066|NCT02531633|7595669|FG004|STARTED|Part A (52 Weeks)||27
6665067|NCT02531633|7595670|FG005|STARTED|Part A (52 Weeks)||0
6665068|NCT02531633|7595671|FG006|STARTED|Part A (52 Weeks)||0
6665069|NCT02531633|7595672|FG007|STARTED|Part A (52 Weeks)||0
6665070|NCT02531633|7595673|FG008|STARTED|Part A (52 Weeks)||0
6665071|NCT02531633|7595674|FG009|STARTED|Part A (52 Weeks)||0
6665072|NCT02531633|7595665|FG000|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
6665073|NCT02531633|7595666|FG001|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6665074|NCT02531633|7595667|FG002|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||1
6665075|NCT02531633|7595668|FG003|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6665076|NCT02531633|7595669|FG004|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6665077|NCT02531633|7595670|FG005|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6665078|NCT02531633|7595671|FG006|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6737686|NCT03268941|7666923|FG003|Treated|Part 2: Days 17 to 25||0
6737687|NCT03268941|7666924|FG004|Treated|Part 2: Days 17 to 25||6
6737688|NCT03268941|7666925|FG005|Treated|Part 2: Days 17 to 25||0
6256022|NCT04498273|7154838|FG000|STARTED|Overall Study||165
6256023|NCT04498273|7154839|FG001|STARTED|Overall Study||164
6256024|NCT04498273|7154840|FG002|STARTED|Overall Study||164
6256025|NCT04498273|7154841|FG003|STARTED|Overall Study||164
6256026|NCT04498273|7154838|FG000|COMPLETED|Overall Study||134
6256027|NCT04498273|7154839|FG001|COMPLETED|Overall Study||140
6256028|NCT04498273|7154840|FG002|COMPLETED|Overall Study||143
6256029|NCT04498273|7154841|FG003|COMPLETED|Overall Study||133
6256030|NCT04498273|7154838|FG000|NOT COMPLETED|Overall Study||31
6256031|NCT04498273|7154839|FG001|NOT COMPLETED|Overall Study||24
6256032|NCT04498273|7154840|FG002|NOT COMPLETED|Overall Study||21
6256033|NCT04498273|7154841|FG003|NOT COMPLETED|Overall Study||31
6278997|NCT00140244|7178657|FG001|STARTED|Intervention 2||4
6737689|NCT03268941|7666926|FG006|Treated|Part 2: Days 17 to 25||13
6737690|NCT03268941|7666920|FG000|COMPLETED|Part 2: Days 17 to 25||0
6737691|NCT03268941|7666921|FG001|COMPLETED|Part 2: Days 17 to 25||0
6737692|NCT03268941|7666922|FG002|COMPLETED|Part 2: Days 17 to 25||0
6737693|NCT03268941|7666923|FG003|COMPLETED|Part 2: Days 17 to 25||0
6737694|NCT03268941|7666924|FG004|COMPLETED|Part 2: Days 17 to 25||6
6737695|NCT03268941|7666925|FG005|COMPLETED|Part 2: Days 17 to 25||0
6737696|NCT03268941|7666926|FG006|COMPLETED|Part 2: Days 17 to 25||13
6737697|NCT03268941|7666920|FG000|NOT COMPLETED|Part 2: Days 17 to 25||0
6737698|NCT03268941|7666921|FG001|NOT COMPLETED|Part 2: Days 17 to 25||0
6737699|NCT03268941|7666922|FG002|NOT COMPLETED|Part 2: Days 17 to 25||0
6737700|NCT03268941|7666923|FG003|NOT COMPLETED|Part 2: Days 17 to 25||0
6737701|NCT03268941|7666924|FG004|NOT COMPLETED|Part 2: Days 17 to 25||0
6737702|NCT03268941|7666925|FG005|NOT COMPLETED|Part 2: Days 17 to 25||0
6737703|NCT03268941|7666926|FG006|NOT COMPLETED|Part 2: Days 17 to 25||2
6737704|NCT03268941|7666920|FG000|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6737705|NCT03268941|7666921|FG001|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6737706|NCT03268941|7666922|FG002|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6737707|NCT03268941|7666923|FG003|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6737708|NCT03268941|7666924|FG004|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6737709|NCT03268941|7666925|FG005|STARTED|Part 2: Period 2: Fasted (Day 25)||6
6737710|NCT03268941|7666926|FG006|STARTED|Part 2: Period 2: Fasted (Day 25)||0
6737711|NCT03268941|7666920|FG000|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737712|NCT03268941|7666921|FG001|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737713|NCT03268941|7666922|FG002|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737714|NCT03268941|7666923|FG003|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737715|NCT03268941|7666924|FG004|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737716|NCT03268941|7666925|FG005|COMPLETED|Part 2: Period 2: Fasted (Day 25)||6
6737717|NCT03268941|7666926|FG006|COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737718|NCT03268941|7666920|FG000|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737719|NCT03268941|7666921|FG001|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737720|NCT03268941|7666922|FG002|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737721|NCT03268941|7666923|FG003|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737722|NCT03268941|7666924|FG004|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737723|NCT03268941|7666925|FG005|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6665079|NCT02531633|7595672|FG007|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6665080|NCT02531633|7595673|FG008|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6665081|NCT02531633|7595674|FG009|Completed Part A and Didn't Enter Part B|Part A (52 Weeks)||0
6665082|NCT02531633|7595665|FG000|COMPLETED|Part A (52 Weeks)||8
6665083|NCT02531633|7595666|FG001|COMPLETED|Part A (52 Weeks)||5
6665084|NCT02531633|7595667|FG002|COMPLETED|Part A (52 Weeks)||4
6665085|NCT02531633|7595668|FG003|COMPLETED|Part A (52 Weeks)||5
6665086|NCT02531633|7595669|FG004|COMPLETED|Part A (52 Weeks)||4
6665087|NCT02531633|7595670|FG005|COMPLETED|Part A (52 Weeks)||0
6665088|NCT02531633|7595671|FG006|COMPLETED|Part A (52 Weeks)||0
6665089|NCT02531633|7595672|FG007|COMPLETED|Part A (52 Weeks)||0
6665090|NCT02531633|7595673|FG008|COMPLETED|Part A (52 Weeks)||0
6665091|NCT02531633|7595674|FG009|COMPLETED|Part A (52 Weeks)||0
6665092|NCT02531633|7595665|FG000|NOT COMPLETED|Part A (52 Weeks)||34
6665093|NCT02531633|7595666|FG001|NOT COMPLETED|Part A (52 Weeks)||34
6665094|NCT02531633|7595667|FG002|NOT COMPLETED|Part A (52 Weeks)||22
6665095|NCT02531633|7595668|FG003|NOT COMPLETED|Part A (52 Weeks)||22
6665096|NCT02531633|7595669|FG004|NOT COMPLETED|Part A (52 Weeks)||23
6665097|NCT02531633|7595670|FG005|NOT COMPLETED|Part A (52 Weeks)||0
6665098|NCT02531633|7595671|FG006|NOT COMPLETED|Part A (52 Weeks)||0
6665099|NCT02531633|7595672|FG007|NOT COMPLETED|Part A (52 Weeks)||0
6665100|NCT02531633|7595673|FG008|NOT COMPLETED|Part A (52 Weeks)||0
6665101|NCT02531633|7595674|FG009|NOT COMPLETED|Part A (52 Weeks)||0
6665102|NCT02531633|7595665|FG000|STARTED|Part B (104 Weeks)||0
6665103|NCT02531633|7595666|FG001|STARTED|Part B (104 Weeks)||0
6665104|NCT02531633|7595667|FG002|STARTED|Part B (104 Weeks)||0
6665105|NCT02531633|7595668|FG003|STARTED|Part B (104 Weeks)||0
6665106|NCT02531633|7595669|FG004|STARTED|Part B (104 Weeks)||0
6665107|NCT02531633|7595670|FG005|STARTED|Part B (104 Weeks)||8
6665108|NCT02531633|7595671|FG006|STARTED|Part B (104 Weeks)||5
6665109|NCT02531633|7595672|FG007|STARTED|Part B (104 Weeks)||4
6665110|NCT02531633|7595673|FG008|STARTED|Part B (104 Weeks)||5
6665111|NCT02531633|7595674|FG009|STARTED|Part B (104 Weeks)||4
6665112|NCT02531633|7595665|FG000|COMPLETED|Part B (104 Weeks)||0
6665113|NCT02531633|7595666|FG001|COMPLETED|Part B (104 Weeks)||0
6665114|NCT02531633|7595667|FG002|COMPLETED|Part B (104 Weeks)||0
6665115|NCT02531633|7595668|FG003|COMPLETED|Part B (104 Weeks)||0
6665116|NCT02531633|7595669|FG004|COMPLETED|Part B (104 Weeks)||0
6665117|NCT02531633|7595670|FG005|COMPLETED|Part B (104 Weeks)||0
6665118|NCT02531633|7595671|FG006|COMPLETED|Part B (104 Weeks)||0
6665119|NCT02531633|7595672|FG007|COMPLETED|Part B (104 Weeks)||0
6665120|NCT02531633|7595673|FG008|COMPLETED|Part B (104 Weeks)||0
6665121|NCT02531633|7595674|FG009|COMPLETED|Part B (104 Weeks)||0
6665122|NCT02531633|7595665|FG000|NOT COMPLETED|Part B (104 Weeks)||0
6665123|NCT02531633|7595666|FG001|NOT COMPLETED|Part B (104 Weeks)||0
6665124|NCT02531633|7595667|FG002|NOT COMPLETED|Part B (104 Weeks)||0
6665125|NCT02531633|7595668|FG003|NOT COMPLETED|Part B (104 Weeks)||0
6665126|NCT02531633|7595669|FG004|NOT COMPLETED|Part B (104 Weeks)||0
6665127|NCT02531633|7595670|FG005|NOT COMPLETED|Part B (104 Weeks)||8
6665128|NCT02531633|7595671|FG006|NOT COMPLETED|Part B (104 Weeks)||5
6665129|NCT02531633|7595672|FG007|NOT COMPLETED|Part B (104 Weeks)||4
6665130|NCT02531633|7595673|FG008|NOT COMPLETED|Part B (104 Weeks)||5
6665131|NCT02531633|7595674|FG009|NOT COMPLETED|Part B (104 Weeks)||4
6665132|NCT02531646|7595717|FG000|STARTED|Overall Study||37
6665133|NCT02531646|7595718|FG001|STARTED|Overall Study||18
6665134|NCT02531646|7595719|FG002|STARTED|Overall Study||11
6665135|NCT02531646|7595717|FG000|COMPLETED|Overall Study||32
6665136|NCT02531646|7595718|FG001|COMPLETED|Overall Study||17
6665137|NCT02531646|7595719|FG002|COMPLETED|Overall Study||11
6665138|NCT02531646|7595717|FG000|NOT COMPLETED|Overall Study||5
6665139|NCT02531646|7595718|FG001|NOT COMPLETED|Overall Study||1
6665140|NCT02531646|7595719|FG002|NOT COMPLETED|Overall Study||0
6665141|NCT02531698|7595729|FG000|STARTED|Overall Study||294
6665142|NCT02531698|7595730|FG001|STARTED|Overall Study||106
6665143|NCT02531698|7595729|FG000|COMPLETED|Overall Study||283
6665144|NCT02531698|7595730|FG001|COMPLETED|Overall Study||104
6665145|NCT02531698|7595729|FG000|NOT COMPLETED|Overall Study||11
6665146|NCT02531698|7595730|FG001|NOT COMPLETED|Overall Study||2
6665147|NCT02531802|7595766|FG000|STARTED|Received Vaccination 1||15
6665148|NCT02531802|7595767|FG001|STARTED|Received Vaccination 1||15
6665149|NCT02531802|7595768|FG002|STARTED|Received Vaccination 1||15
6665150|NCT02531802|7595769|FG003|STARTED|Received Vaccination 1||15
6665151|NCT02531802|7595770|FG004|STARTED|Received Vaccination 1||15
6665152|NCT02531802|7595771|FG005|STARTED|Received Vaccination 1||3
6665153|NCT02531802|7595772|FG006|STARTED|Received Vaccination 1||15
6665154|NCT02531802|7595773|FG007|STARTED|Received Vaccination 1||15
6665155|NCT02531802|7595774|FG008|STARTED|Received Vaccination 1||15
6665156|NCT02531802|7595775|FG009|STARTED|Received Vaccination 1||52
6665157|NCT02531802|7595776|FG010|STARTED|Received Vaccination 1||15
6665158|NCT02531802|7595777|FG011|STARTED|Received Vaccination 1||15
6665159|NCT02531802|7595778|FG012|STARTED|Received Vaccination 1||15
6665160|NCT02531802|7595779|FG013|STARTED|Received Vaccination 1||15
6665161|NCT02531802|7595780|FG014|STARTED|Received Vaccination 1||40
6665162|NCT02531802|7595781|FG015|STARTED|Received Vaccination 1||30
6665163|NCT02531802|7595782|FG016|STARTED|Received Vaccination 1||30
6665164|NCT02531802|7595783|FG017|STARTED|Received Vaccination 1||30
6665165|NCT02531802|7595784|FG018|STARTED|Received Vaccination 1||30
6665166|NCT02531802|7595785|FG019|STARTED|Received Vaccination 1||30
6665167|NCT02531802|7595786|FG020|STARTED|Received Vaccination 1||50
6665168|NCT02531802|7595766|FG000|COMPLETED|Received Vaccination 1||15
6665169|NCT02531802|7595767|FG001|COMPLETED|Received Vaccination 1||15
6665170|NCT02531802|7595768|FG002|COMPLETED|Received Vaccination 1||15
6665171|NCT02531802|7595769|FG003|COMPLETED|Received Vaccination 1||15
6665172|NCT02531802|7595770|FG004|COMPLETED|Received Vaccination 1||15
6665173|NCT02531802|7595771|FG005|COMPLETED|Received Vaccination 1||3
6665174|NCT02531802|7595772|FG006|COMPLETED|Received Vaccination 1||15
6665175|NCT02531802|7595773|FG007|COMPLETED|Received Vaccination 1||15
6665176|NCT02531802|7595774|FG008|COMPLETED|Received Vaccination 1||15
6665177|NCT02531802|7595775|FG009|COMPLETED|Received Vaccination 1||52
6665178|NCT02531802|7595776|FG010|COMPLETED|Received Vaccination 1||15
6665179|NCT02531802|7595777|FG011|COMPLETED|Received Vaccination 1||15
6665180|NCT02531802|7595778|FG012|COMPLETED|Received Vaccination 1||15
6665181|NCT02531802|7595779|FG013|COMPLETED|Received Vaccination 1||15
6665182|NCT02531802|7595780|FG014|COMPLETED|Received Vaccination 1||40
6665183|NCT02531802|7595781|FG015|COMPLETED|Received Vaccination 1||30
6665184|NCT02531802|7595782|FG016|COMPLETED|Received Vaccination 1||30
6665185|NCT02531802|7595783|FG017|COMPLETED|Received Vaccination 1||30
6665186|NCT02531802|7595784|FG018|COMPLETED|Received Vaccination 1||30
6665187|NCT02531802|7595785|FG019|COMPLETED|Received Vaccination 1||30
6665188|NCT02531802|7595786|FG020|COMPLETED|Received Vaccination 1||50
6665189|NCT02531802|7595766|FG000|NOT COMPLETED|Received Vaccination 1||0
6665190|NCT02531802|7595767|FG001|NOT COMPLETED|Received Vaccination 1||0
6665191|NCT02531802|7595768|FG002|NOT COMPLETED|Received Vaccination 1||0
6665192|NCT02531802|7595769|FG003|NOT COMPLETED|Received Vaccination 1||0
6665193|NCT02531802|7595770|FG004|NOT COMPLETED|Received Vaccination 1||0
6665194|NCT02531802|7595771|FG005|NOT COMPLETED|Received Vaccination 1||0
6665195|NCT02531802|7595772|FG006|NOT COMPLETED|Received Vaccination 1||0
6665196|NCT02531802|7595773|FG007|NOT COMPLETED|Received Vaccination 1||0
6665197|NCT02531802|7595774|FG008|NOT COMPLETED|Received Vaccination 1||0
6665198|NCT02531802|7595775|FG009|NOT COMPLETED|Received Vaccination 1||0
6665199|NCT02531802|7595776|FG010|NOT COMPLETED|Received Vaccination 1||0
6665200|NCT02531802|7595777|FG011|NOT COMPLETED|Received Vaccination 1||0
6665201|NCT02531802|7595778|FG012|NOT COMPLETED|Received Vaccination 1||0
6665202|NCT02531802|7595779|FG013|NOT COMPLETED|Received Vaccination 1||0
6665203|NCT02531802|7595780|FG014|NOT COMPLETED|Received Vaccination 1||0
6665204|NCT02531802|7595781|FG015|NOT COMPLETED|Received Vaccination 1||0
6665205|NCT02531802|7595782|FG016|NOT COMPLETED|Received Vaccination 1||0
6665206|NCT02531802|7595783|FG017|NOT COMPLETED|Received Vaccination 1||0
6665207|NCT02531802|7595784|FG018|NOT COMPLETED|Received Vaccination 1||0
6665208|NCT02531802|7595785|FG019|NOT COMPLETED|Received Vaccination 1||0
6665209|NCT02531802|7595786|FG020|NOT COMPLETED|Received Vaccination 1||0
6665210|NCT02531802|7595766|FG000|STARTED|Received Vaccination 2||15
6665211|NCT02531802|7595767|FG001|STARTED|Received Vaccination 2||15
6665212|NCT02531802|7595768|FG002|STARTED|Received Vaccination 2||15
6665213|NCT02531802|7595769|FG003|STARTED|Received Vaccination 2||15
6665214|NCT02531802|7595770|FG004|STARTED|Received Vaccination 2||15
6665215|NCT02531802|7595771|FG005|STARTED|Received Vaccination 2||3
6665216|NCT02531802|7595772|FG006|STARTED|Received Vaccination 2||15
6665217|NCT02531802|7595773|FG007|STARTED|Received Vaccination 2||15
6665218|NCT02531802|7595774|FG008|STARTED|Received Vaccination 2||15
6665219|NCT02531802|7595775|FG009|STARTED|Received Vaccination 2||52
6665220|NCT02531802|7595776|FG010|STARTED|Received Vaccination 2||15
6665221|NCT02531802|7595777|FG011|STARTED|Received Vaccination 2||15
6665222|NCT02531802|7595778|FG012|STARTED|Received Vaccination 2||15
6665223|NCT02531802|7595779|FG013|STARTED|Received Vaccination 2||15
6665224|NCT02531802|7595780|FG014|STARTED|Received Vaccination 2||40
6665225|NCT02531802|7595781|FG015|STARTED|Received Vaccination 2||30
6665226|NCT02531802|7595782|FG016|STARTED|Received Vaccination 2||30
6665227|NCT02531802|7595783|FG017|STARTED|Received Vaccination 2||30
6665228|NCT02531802|7595784|FG018|STARTED|Received Vaccination 2||30
6665229|NCT02531802|7595785|FG019|STARTED|Received Vaccination 2||30
6665230|NCT02531802|7595786|FG020|STARTED|Received Vaccination 2||50
6665231|NCT02531802|7595766|FG000|COMPLETED|Received Vaccination 2||15
6665232|NCT02531802|7595767|FG001|COMPLETED|Received Vaccination 2||15
6665233|NCT02531802|7595768|FG002|COMPLETED|Received Vaccination 2||14
6665234|NCT02531802|7595769|FG003|COMPLETED|Received Vaccination 2||15
6665235|NCT02531802|7595770|FG004|COMPLETED|Received Vaccination 2||15
6665236|NCT02531802|7595771|FG005|COMPLETED|Received Vaccination 2||0
6665237|NCT02531802|7595772|FG006|COMPLETED|Received Vaccination 2||15
6665238|NCT02531802|7595773|FG007|COMPLETED|Received Vaccination 2||15
6665239|NCT02531802|7595774|FG008|COMPLETED|Received Vaccination 2||15
6665240|NCT02531802|7595775|FG009|COMPLETED|Received Vaccination 2||49
6665241|NCT02531802|7595776|FG010|COMPLETED|Received Vaccination 2||13
6665242|NCT02531802|7595777|FG011|COMPLETED|Received Vaccination 2||15
6665243|NCT02531802|7595778|FG012|COMPLETED|Received Vaccination 2||13
6665244|NCT02531802|7595779|FG013|COMPLETED|Received Vaccination 2||13
6665245|NCT02531802|7595780|FG014|COMPLETED|Received Vaccination 2||39
6665246|NCT02531802|7595781|FG015|COMPLETED|Received Vaccination 2||30
6665247|NCT02531802|7595782|FG016|COMPLETED|Received Vaccination 2||30
6665248|NCT02531802|7595783|FG017|COMPLETED|Received Vaccination 2||26
6665249|NCT02531802|7595784|FG018|COMPLETED|Received Vaccination 2||27
6665250|NCT02531802|7595785|FG019|COMPLETED|Received Vaccination 2||29
6665251|NCT02531802|7595786|FG020|COMPLETED|Received Vaccination 2||49
6665252|NCT02531802|7595766|FG000|NOT COMPLETED|Received Vaccination 2||0
6665253|NCT02531802|7595767|FG001|NOT COMPLETED|Received Vaccination 2||0
6665254|NCT02531802|7595768|FG002|NOT COMPLETED|Received Vaccination 2||1
6665255|NCT02531802|7595769|FG003|NOT COMPLETED|Received Vaccination 2||0
6665256|NCT02531802|7595770|FG004|NOT COMPLETED|Received Vaccination 2||0
6665257|NCT02531802|7595771|FG005|NOT COMPLETED|Received Vaccination 2||3
6665258|NCT02531802|7595772|FG006|NOT COMPLETED|Received Vaccination 2||0
6665259|NCT02531802|7595773|FG007|NOT COMPLETED|Received Vaccination 2||0
6665260|NCT02531802|7595774|FG008|NOT COMPLETED|Received Vaccination 2||0
6665261|NCT02531802|7595775|FG009|NOT COMPLETED|Received Vaccination 2||3
6665262|NCT02531802|7595776|FG010|NOT COMPLETED|Received Vaccination 2||2
6665263|NCT02531802|7595777|FG011|NOT COMPLETED|Received Vaccination 2||0
6665264|NCT02531802|7595778|FG012|NOT COMPLETED|Received Vaccination 2||2
6665265|NCT02531802|7595779|FG013|NOT COMPLETED|Received Vaccination 2||2
6665266|NCT02531802|7595780|FG014|NOT COMPLETED|Received Vaccination 2||1
6665267|NCT02531802|7595781|FG015|NOT COMPLETED|Received Vaccination 2||0
6665268|NCT02531802|7595782|FG016|NOT COMPLETED|Received Vaccination 2||0
6665269|NCT02531802|7595783|FG017|NOT COMPLETED|Received Vaccination 2||4
6665270|NCT02531802|7595784|FG018|NOT COMPLETED|Received Vaccination 2||3
6665271|NCT02531802|7595785|FG019|NOT COMPLETED|Received Vaccination 2||1
6665272|NCT02531802|7595786|FG020|NOT COMPLETED|Received Vaccination 2||1
6665273|NCT02531867|7595859|FG000|STARTED|Overall Study||13
6665274|NCT02531867|7595859|FG000|COMPLETED|Overall Study||13
6665275|NCT02531867|7595859|FG000|NOT COMPLETED|Overall Study||0
6665276|NCT02531971|7595865|FG000|STARTED|Overall Study||11
6665277|NCT02531971|7595866|FG001|STARTED|Overall Study||13
6665278|NCT02531971|7595865|FG000|COMPLETED|Overall Study||11
6665279|NCT02531971|7595866|FG001|COMPLETED|Overall Study||13
6665280|NCT02531971|7595865|FG000|NOT COMPLETED|Overall Study||0
6665281|NCT02531971|7595866|FG001|NOT COMPLETED|Overall Study||0
6665282|NCT02532010|7595875|FG000|STARTED|Overall Study||9
6665283|NCT02532010|7595876|FG001|STARTED|Overall Study||4
6665284|NCT02532010|7595875|FG000|COMPLETED|Overall Study||0
6665285|NCT02532010|7595876|FG001|COMPLETED|Overall Study||0
6665286|NCT02532010|7595875|FG000|NOT COMPLETED|Overall Study||9
6665287|NCT02532010|7595876|FG001|NOT COMPLETED|Overall Study||4
6665288|NCT02532036|7595882|FG000|STARTED|Overall Study||2
6665289|NCT02532036|7595883|FG001|STARTED|Overall Study||0
6665290|NCT02532036|7595882|FG000|COMPLETED|Overall Study||2
6665291|NCT02532036|7595883|FG001|COMPLETED|Overall Study||0
6665292|NCT02532036|7595882|FG000|NOT COMPLETED|Overall Study||0
6665293|NCT02532036|7595883|FG001|NOT COMPLETED|Overall Study||0
6665294|NCT02532179|7595887|FG000|STARTED|Overall Study||12
6665295|NCT02532179|7595887|FG000|COMPLETED|Overall Study||9
6665296|NCT02532179|7595887|FG000|NOT COMPLETED|Overall Study||3
6665297|NCT02532283|7595893|FG000|STARTED|Overall Study||64
6665298|NCT02532283|7595894|FG001|STARTED|Overall Study||35
6665299|NCT02532283|7595893|FG000|Full Analysis Set|Overall Study||63
6665300|NCT02532283|7595894|FG001|Full Analysis Set|Overall Study||32
6665301|NCT02532283|7595893|FG000|COMPLETED|Overall Study||55
6665302|NCT02532283|7595894|FG001|COMPLETED|Overall Study||30
6665303|NCT02532283|7595893|FG000|NOT COMPLETED|Overall Study||9
6665304|NCT02532283|7595894|FG001|NOT COMPLETED|Overall Study||5
6665305|NCT02532374|7595902|FG000|STARTED|Overall Study||16
6665306|NCT02532374|7595902|FG000|Nicorette Inhalator (Visit 3)|Overall Study||15
6665307|NCT02532374|7595902|FG000|P3L 50 μg/Puff (Visit 4)|Overall Study||15
6665308|NCT02532374|7595902|FG000|P3L 80 μg/Puff (Visit 5)|Overall Study||14
6665309|NCT02532374|7595902|FG000|P3L150 μg/Puff (Visit 6)|Overall Study||14
6665310|NCT02532374|7595902|FG000|COMPLETED|Overall Study||14
6665311|NCT02532374|7595902|FG000|NOT COMPLETED|Overall Study||2
6665312|NCT02532465|7595916|FG000|STARTED|Overall Study||25
6665313|NCT02532465|7595917|FG001|STARTED|Overall Study||25
6665314|NCT02532465|7595916|FG000|COMPLETED|Overall Study||24
6665315|NCT02532465|7595917|FG001|COMPLETED|Overall Study||24
6665316|NCT02532465|7595916|FG000|NOT COMPLETED|Overall Study||1
6665317|NCT02532465|7595917|FG001|NOT COMPLETED|Overall Study||1
6665318|NCT02532517|7595923|FG000|STARTED|Overall Study||45
6665319|NCT02532517|7595923|FG000|mITT Analysis Set|Overall Study||44
6665320|NCT02532517|7595923|FG000|COMPLETED|Overall Study||28
6665321|NCT02532517|7595923|FG000|NOT COMPLETED|Overall Study||17
6665322|NCT02532543|7595931|FG000|STARTED|Overall Study||3
6665323|NCT02532543|7595932|FG001|STARTED|Overall Study||4
6665324|NCT02532543|7595933|FG002|STARTED|Overall Study||5
6665325|NCT02532543|7595934|FG003|STARTED|Overall Study||4
6665326|NCT02532543|7595931|FG000|COMPLETED|Overall Study||3
6665327|NCT02532543|7595932|FG001|COMPLETED|Overall Study||4
6665328|NCT02532543|7595933|FG002|COMPLETED|Overall Study||4
6665329|NCT02532543|7595934|FG003|COMPLETED|Overall Study||4
6665330|NCT02532543|7595931|FG000|NOT COMPLETED|Overall Study||0
6665331|NCT02532543|7595932|FG001|NOT COMPLETED|Overall Study||0
6665332|NCT02532543|7595933|FG002|NOT COMPLETED|Overall Study||1
6665333|NCT02532543|7595934|FG003|NOT COMPLETED|Overall Study||0
6665334|NCT02532556|7595944|FG000|STARTED|Overall Study||12
6665335|NCT02532556|7595944|FG000|COMPLETED|Overall Study||12
6665336|NCT02532556|7595944|FG000|NOT COMPLETED|Overall Study||0
6665337|NCT02532647|7595957|FG000|STARTED|Overall Study||32
6665338|NCT02532647|7595958|FG001|STARTED|Overall Study||16
6665339|NCT02532647|7595959|FG002|STARTED|Overall Study||31
6665340|NCT02532647|7595957|FG000|Safety Population|Overall Study||31
6665341|NCT02532647|7595958|FG001|Safety Population|Overall Study||16
6665342|NCT02532647|7595959|FG002|Safety Population|Overall Study||30
6665343|NCT02532647|7595957|FG000|COMPLETED|Overall Study||31
6665344|NCT02532647|7595958|FG001|COMPLETED|Overall Study||16
6665345|NCT02532647|7595959|FG002|COMPLETED|Overall Study||30
6665346|NCT02532647|7595957|FG000|NOT COMPLETED|Overall Study||1
6665347|NCT02532647|7595958|FG001|NOT COMPLETED|Overall Study||0
6665348|NCT02532647|7595959|FG002|NOT COMPLETED|Overall Study||1
6665349|NCT02532764|7595977|FG000|STARTED|Single Ascending Dose (SAD) Cohorts||6
6665350|NCT02532764|7595978|FG001|STARTED|Single Ascending Dose (SAD) Cohorts||6
6665351|NCT02532764|7595979|FG002|STARTED|Single Ascending Dose (SAD) Cohorts||9
6665352|NCT02532764|7595980|FG003|STARTED|Single Ascending Dose (SAD) Cohorts||6
6665353|NCT02532764|7595981|FG004|STARTED|Single Ascending Dose (SAD) Cohorts||9
6665354|NCT02532764|7595982|FG005|STARTED|Single Ascending Dose (SAD) Cohorts||0
6665355|NCT02532764|7595983|FG006|STARTED|Single Ascending Dose (SAD) Cohorts||0
6665356|NCT02532764|7595984|FG007|STARTED|Single Ascending Dose (SAD) Cohorts||0
6665357|NCT02532764|7595985|FG008|STARTED|Single Ascending Dose (SAD) Cohorts||0
6665358|NCT02532764|7595986|FG009|STARTED|Single Ascending Dose (SAD) Cohorts||0
6665359|NCT02532764|7595977|FG000|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
6665360|NCT02532764|7595978|FG001|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
6665361|NCT02532764|7595979|FG002|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
6665362|NCT02532764|7595980|FG003|COMPLETED|Single Ascending Dose (SAD) Cohorts||6
6665363|NCT02532764|7595981|FG004|COMPLETED|Single Ascending Dose (SAD) Cohorts||9
6665364|NCT02532764|7595982|FG005|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665365|NCT02532764|7595983|FG006|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665366|NCT02532764|7595984|FG007|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665367|NCT02532764|7595985|FG008|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665368|NCT02532764|7595986|FG009|COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665369|NCT02532764|7595977|FG000|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665370|NCT02532764|7595978|FG001|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665371|NCT02532764|7595979|FG002|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665372|NCT02532764|7595980|FG003|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665373|NCT02532764|7595981|FG004|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665374|NCT02532764|7595982|FG005|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665375|NCT02532764|7595983|FG006|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665376|NCT02532764|7595984|FG007|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665377|NCT02532764|7595985|FG008|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665378|NCT02532764|7595986|FG009|NOT COMPLETED|Single Ascending Dose (SAD) Cohorts||0
6665379|NCT02532764|7595977|FG000|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6665380|NCT02532764|7595978|FG001|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6665381|NCT02532764|7595979|FG002|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6665382|NCT02532764|7595980|FG003|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6665383|NCT02532764|7595981|FG004|STARTED|Multiple Ascending Dose (MAD) Cohorst||0
6665384|NCT02532764|7595982|FG005|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
6665385|NCT02532764|7595983|FG006|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
6665386|NCT02532764|7595984|FG007|STARTED|Multiple Ascending Dose (MAD) Cohorst||7
6665387|NCT02532764|7595985|FG008|STARTED|Multiple Ascending Dose (MAD) Cohorst||6
6665388|NCT02532764|7595986|FG009|STARTED|Multiple Ascending Dose (MAD) Cohorst||9
6665389|NCT02532764|7595977|FG000|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665390|NCT02532764|7595978|FG001|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665391|NCT02532764|7595979|FG002|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665392|NCT02532764|7595980|FG003|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665393|NCT02532764|7595981|FG004|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665394|NCT02532764|7595982|FG005|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
6665395|NCT02532764|7595983|FG006|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
6665396|NCT02532764|7595984|FG007|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||6
6665397|NCT02532764|7595985|FG008|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||5
6665398|NCT02532764|7595986|FG009|COMPLETED|Multiple Ascending Dose (MAD) Cohorst||8
6665399|NCT02532764|7595977|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665400|NCT02532764|7595978|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665401|NCT02532764|7595979|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665402|NCT02532764|7595980|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665403|NCT02532764|7595981|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665404|NCT02532764|7595982|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665405|NCT02532764|7595983|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||0
6665406|NCT02532764|7595984|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
6665407|NCT02532764|7595985|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
6665408|NCT02532764|7595986|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD) Cohorst||1
6665409|NCT02532855|7596015|FG000|STARTED|Overall Study||307
6665410|NCT02532855|7596016|FG001|STARTED|Overall Study||307
6665411|NCT02532855|7596015|FG000|Treated|Overall Study||307
6665412|NCT02532855|7596016|FG001|Treated|Overall Study|One participant had a protocol violation, was randomized but did not take study medication.|306
6665413|NCT02532855|7596015|FG000|COMPLETED|Overall Study||299
6665414|NCT02532855|7596016|FG001|COMPLETED|Overall Study||296
6665415|NCT02532855|7596015|FG000|NOT COMPLETED|Overall Study||8
6665416|NCT02532855|7596016|FG001|NOT COMPLETED|Overall Study||11
6665417|NCT02532933|7596024|FG000|STARTED|Overall Study||22
6665418|NCT02532933|7596025|FG001|STARTED|Overall Study||22
6665419|NCT02532933|7596024|FG000|COMPLETED|Overall Study||16
6665420|NCT02532933|7596025|FG001|COMPLETED|Overall Study||16
6665421|NCT02532933|7596024|FG000|NOT COMPLETED|Overall Study||6
6665422|NCT02532933|7596025|FG001|NOT COMPLETED|Overall Study||6
6665423|NCT02532972|7596031|FG000|STARTED|Overall Study||11
6665424|NCT02532972|7596031|FG000|COMPLETED|Overall Study||10
6665425|NCT02532972|7596031|FG000|NOT COMPLETED|Overall Study||1
6665426|NCT02532998|7596035|FG000|STARTED|Overall Study||23
6665427|NCT02532998|7596035|FG000|COMPLETED|Overall Study||23
6665428|NCT02532998|7596035|FG000|NOT COMPLETED|Overall Study||0
6665429|NCT02533063|7596051|FG000|STARTED|Intervention 1 (8 Weeks)||16
6665430|NCT02533063|7596052|FG001|STARTED|Intervention 1 (8 Weeks)||16
6665431|NCT02533063|7596051|FG000|COMPLETED|Intervention 1 (8 Weeks)||14
6665432|NCT02533063|7596052|FG001|COMPLETED|Intervention 1 (8 Weeks)||11
6665433|NCT02533063|7596051|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||2
6665434|NCT02533063|7596052|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||5
6665435|NCT02533063|7596051|FG000|STARTED|Washout (4 Weeks)||14
6665436|NCT02533063|7596052|FG001|STARTED|Washout (4 Weeks)||11
6665437|NCT02533063|7596051|FG000|COMPLETED|Washout (4 Weeks)||14
6665438|NCT02533063|7596052|FG001|COMPLETED|Washout (4 Weeks)||11
6665439|NCT02533063|7596051|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6665440|NCT02533063|7596052|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6665441|NCT02533063|7596051|FG000|STARTED|Intervention 2 (8 Weeks)||14
6665442|NCT02533063|7596052|FG001|STARTED|Intervention 2 (8 Weeks)||11
6665443|NCT02533063|7596051|FG000|COMPLETED|Intervention 2 (8 Weeks)||14
6665444|NCT02533063|7596052|FG001|COMPLETED|Intervention 2 (8 Weeks)||11
6665445|NCT02533063|7596051|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||0
6665446|NCT02533063|7596052|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||0
6737724|NCT03268941|7666926|FG006|NOT COMPLETED|Part 2: Period 2: Fasted (Day 25)||0
6737725|NCT03269435|7666947|FG000|STARTED|Overall Study||51
6737726|NCT03269435|7666948|FG001|STARTED|Overall Study||48
6737727|NCT03269435|7666947|FG000|COMPLETED|Overall Study||51
6737728|NCT03269435|7666948|FG001|COMPLETED|Overall Study||48
6737729|NCT03269435|7666947|FG000|NOT COMPLETED|Overall Study||0
6737730|NCT03269435|7666948|FG001|NOT COMPLETED|Overall Study||0
6737731|NCT03269552|7666954|FG000|STARTED|Overall Study||4
6737732|NCT03269552|7666954|FG000|COMPLETED|Overall Study||2
6737733|NCT03269552|7666954|FG000|NOT COMPLETED|Overall Study||2
6737734|NCT03270085|7666961|FG000|STARTED|Overall Study||15
6737735|NCT03270085|7666962|FG001|STARTED|Overall Study||15
6737736|NCT03270085|7666961|FG000|COMPLETED|Overall Study||14
6737737|NCT03270085|7666962|FG001|COMPLETED|Overall Study||15
6737738|NCT03270085|7666961|FG000|NOT COMPLETED|Overall Study||1
6737739|NCT03270085|7666962|FG001|NOT COMPLETED|Overall Study||0
6737740|NCT03270332|7666970|FG000|STARTED|Overall Study||5
6737741|NCT03270332|7666971|FG001|STARTED|Overall Study||5
6737742|NCT03270332|7666970|FG000|COMPLETED|Overall Study||5
6737743|NCT03270332|7666971|FG001|COMPLETED|Overall Study||4
6737744|NCT03270332|7666970|FG000|NOT COMPLETED|Overall Study||0
6737745|NCT03270332|7666971|FG001|NOT COMPLETED|Overall Study||1
6737746|NCT03270436|7666981|FG000|STARTED|Baseline||213
6737747|NCT03270436|7666982|FG001|STARTED|Baseline||167
6737748|NCT03270436|7666981|FG000|COMPLETED|Baseline||212
6737749|NCT03270436|7666982|FG001|COMPLETED|Baseline||166
6737750|NCT03270436|7666981|FG000|NOT COMPLETED|Baseline||1
6737751|NCT03270436|7666982|FG001|NOT COMPLETED|Baseline||1
6737752|NCT03270436|7666981|FG000|STARTED|Immediate Post-Intervention||213
6737753|NCT03270436|7666982|FG001|STARTED|Immediate Post-Intervention||167
6737754|NCT03270436|7666981|FG000|COMPLETED|Immediate Post-Intervention||172
6737755|NCT03270436|7666982|FG001|COMPLETED|Immediate Post-Intervention||111
6737756|NCT03270436|7666981|FG000|NOT COMPLETED|Immediate Post-Intervention||41
6737757|NCT03270436|7666982|FG001|NOT COMPLETED|Immediate Post-Intervention||56
6737758|NCT03270436|7666981|FG000|STARTED|6 Months Post-Intervention||213
6737759|NCT03270436|7666982|FG001|STARTED|6 Months Post-Intervention||167
6737760|NCT03270436|7666981|FG000|COMPLETED|6 Months Post-Intervention||173
6737761|NCT03270436|7666982|FG001|COMPLETED|6 Months Post-Intervention||116
6737762|NCT03270436|7666981|FG000|NOT COMPLETED|6 Months Post-Intervention||40
6737763|NCT03270436|7666982|FG001|NOT COMPLETED|6 Months Post-Intervention||51
6737764|NCT03270514|7666990|FG000|STARTED|Overall Study||29
6737765|NCT03270514|7666991|FG001|STARTED|Overall Study||31
6737766|NCT03270514|7666990|FG000|COMPLETED|Overall Study||29
6737767|NCT03270514|7666991|FG001|COMPLETED|Overall Study||31
6737768|NCT03270514|7666990|FG000|NOT COMPLETED|Overall Study||0
6737769|NCT03270514|7666991|FG001|NOT COMPLETED|Overall Study||0
6737770|NCT03270644|7666997|FG000|STARTED|Day 1 Lasmiditan Reference||44
6737771|NCT03270644|7666997|FG000|Received at Least One Dose of Study Drug|Day 1 Lasmiditan Reference||44
6737772|NCT03270644|7666997|FG000|COMPLETED|Day 1 Lasmiditan Reference||43
6737773|NCT03270644|7666997|FG000|NOT COMPLETED|Day 1 Lasmiditan Reference||1
6737774|NCT03270644|7666997|FG000|STARTED|Day 4 - 10 Propranolol Reference||43
6737775|NCT03270644|7666997|FG000|Received at Least One Dose of Study Drug|Day 4 - 10 Propranolol Reference||43
6737776|NCT03270644|7666997|FG000|Day 9 Lasmiditan + Propranolol Test|Day 4 - 10 Propranolol Reference||42
6737777|NCT03270644|7666997|FG000|COMPLETED|Day 4 - 10 Propranolol Reference||42
6737778|NCT03270644|7666997|FG000|NOT COMPLETED|Day 4 - 10 Propranolol Reference||1
6737779|NCT03270657|7667008|FG000|STARTED|Overall Study||5
6737780|NCT03270657|7667008|FG000|COMPLETED|Overall Study||4
6737781|NCT03270657|7667008|FG000|NOT COMPLETED|Overall Study||1
6665447|NCT02533089|7596061|FG000|STARTED|Overall Study||605
6665448|NCT02533089|7596062|FG001|STARTED|Overall Study||548
6665449|NCT02533089|7596061|FG000|COMPLETED|Overall Study|4 HC accrued no eligable patients 11 HC no patients with outcome data 241 cases missing outcome|364
6665450|NCT02533089|7596062|FG001|COMPLETED|Overall Study|6 HC accrued no eligible patients 8 HC no patients with outcome data 114 cases missing outcome|434
6665451|NCT02533089|7596061|FG000|NOT COMPLETED|Overall Study||241
6665452|NCT02533089|7596062|FG001|NOT COMPLETED|Overall Study||114
6665453|NCT02533167|7596068|FG000|STARTED|Overall Study||70
6665454|NCT02533167|7596068|FG000|COMPLETED|Overall Study||55
6665455|NCT02533167|7596068|FG000|NOT COMPLETED|Overall Study||15
6665456|NCT02533180|7596075|FG000|STARTED|Overall Study||39
6665457|NCT02533180|7596076|FG001|STARTED|Overall Study||61
6665458|NCT02533180|7596075|FG000|COMPLETED|Overall Study||0
6665459|NCT02533180|7596076|FG001|COMPLETED|Overall Study||14
6665460|NCT02533180|7596075|FG000|NOT COMPLETED|Overall Study||39
6665461|NCT02533180|7596076|FG001|NOT COMPLETED|Overall Study||47
6665462|NCT02533258|7596081|FG000|STARTED|Overall Study||13
6665463|NCT02533258|7596081|FG000|COMPLETED|Overall Study||5
6665464|NCT02533258|7596081|FG000|NOT COMPLETED|Overall Study||8
6665465|NCT02533375|7596085|FG000|STARTED|Overall Study||10
6665466|NCT02533375|7596085|FG000|COMPLETED|Overall Study||5
6665467|NCT02533375|7596085|FG000|NOT COMPLETED|Overall Study||5
6665468|NCT02533401|7596089|FG000|STARTED|Overall Study||34
6665469|NCT02533401|7596089|FG000|COMPLETED|Overall Study||23
6665470|NCT02533401|7596089|FG000|NOT COMPLETED|Overall Study||11
6665471|NCT02533427|7596093|FG000|STARTED|Overall Study||15
6665472|NCT02533427|7596093|FG000|COMPLETED|Overall Study||15
6665473|NCT02533427|7596093|FG000|NOT COMPLETED|Overall Study||0
6665474|NCT02533453|7596100|FG000|STARTED|Overall Study||110
6665475|NCT02533453|7596100|FG000|COMPLETED|Overall Study||101
6665476|NCT02533453|7596100|FG000|NOT COMPLETED|Overall Study||9
6665477|NCT02533466|7596106|FG000|STARTED|Overall Study||16
6665478|NCT02533466|7596107|FG001|STARTED|Overall Study||14
6665479|NCT02533466|7596106|FG000|COMPLETED|Overall Study||16
6665480|NCT02533466|7596107|FG001|COMPLETED|Overall Study||14
6665481|NCT02533466|7596106|FG000|NOT COMPLETED|Overall Study||0
6665482|NCT02533466|7596107|FG001|NOT COMPLETED|Overall Study||0
6665483|NCT02533505|7596115|FG000|STARTED|Overall Study||26
6665484|NCT02533505|7596116|FG001|STARTED|Overall Study||25
6665485|NCT02533505|7596115|FG000|COMPLETED|Overall Study||23
6665486|NCT02533505|7596116|FG001|COMPLETED|Overall Study||24
6665487|NCT02533505|7596115|FG000|NOT COMPLETED|Overall Study||3
6665488|NCT02533505|7596116|FG001|NOT COMPLETED|Overall Study||1
6665489|NCT02533570|7596125|FG000|STARTED|Overall Study||4
6665490|NCT02533570|7596126|FG001|STARTED|Overall Study||8
6665491|NCT02533570|7596127|FG002|STARTED|Overall Study||8
6665492|NCT02533570|7596125|FG000|COMPLETED|Overall Study||4
6665493|NCT02533570|7596126|FG001|COMPLETED|Overall Study||7
6665494|NCT02533570|7596127|FG002|COMPLETED|Overall Study||7
6665495|NCT02533570|7596125|FG000|NOT COMPLETED|Overall Study||0
6665496|NCT02533570|7596126|FG001|NOT COMPLETED|Overall Study||1
6665497|NCT02533570|7596127|FG002|NOT COMPLETED|Overall Study||1
6665498|NCT02533674|7596143|FG000|STARTED|Dose Level I||5
6665499|NCT02533674|7596144|FG001|STARTED|Dose Level I||0
6665500|NCT02533674|7596145|FG002|STARTED|Dose Level I||0
6665501|NCT02533674|7596146|FG003|STARTED|Dose Level I||0
6665502|NCT02533674|7596147|FG004|STARTED|Dose Level I||0
6665503|NCT02533674|7596148|FG005|STARTED|Dose Level I||0
6665504|NCT02533674|7596149|FG006|STARTED|Dose Level I||0
6665505|NCT02533674|7596150|FG007|STARTED|Dose Level I||0
6665506|NCT02533674|7596143|FG000|COMPLETED|Dose Level I||0
6665507|NCT02533674|7596144|FG001|COMPLETED|Dose Level I||0
6665508|NCT02533674|7596145|FG002|COMPLETED|Dose Level I||0
6665509|NCT02533674|7596146|FG003|COMPLETED|Dose Level I||0
6665510|NCT02533674|7596147|FG004|COMPLETED|Dose Level I||0
6665511|NCT02533674|7596148|FG005|COMPLETED|Dose Level I||0
6665512|NCT02533674|7596149|FG006|COMPLETED|Dose Level I||0
6665513|NCT02533674|7596150|FG007|COMPLETED|Dose Level I||0
6665514|NCT02533674|7596143|FG000|NOT COMPLETED|Dose Level I||5
6665515|NCT02533674|7596144|FG001|NOT COMPLETED|Dose Level I||0
6665516|NCT02533674|7596145|FG002|NOT COMPLETED|Dose Level I||0
6665517|NCT02533674|7596146|FG003|NOT COMPLETED|Dose Level I||0
6665518|NCT02533674|7596147|FG004|NOT COMPLETED|Dose Level I||0
6665519|NCT02533674|7596148|FG005|NOT COMPLETED|Dose Level I||0
6665520|NCT02533674|7596149|FG006|NOT COMPLETED|Dose Level I||0
6665521|NCT02533674|7596150|FG007|NOT COMPLETED|Dose Level I||0
6665522|NCT02533674|7596143|FG000|STARTED|Dose Level II||0
6665523|NCT02533674|7596144|FG001|STARTED|Dose Level II||7
6665524|NCT02533674|7596145|FG002|STARTED|Dose Level II||0
6665525|NCT02533674|7596146|FG003|STARTED|Dose Level II||0
6665526|NCT02533674|7596147|FG004|STARTED|Dose Level II||0
6665527|NCT02533674|7596148|FG005|STARTED|Dose Level II||0
6665528|NCT02533674|7596149|FG006|STARTED|Dose Level II||0
6665529|NCT02533674|7596150|FG007|STARTED|Dose Level II||0
6665530|NCT02533674|7596143|FG000|COMPLETED|Dose Level II||0
6665531|NCT02533674|7596144|FG001|COMPLETED|Dose Level II||0
6665532|NCT02533674|7596145|FG002|COMPLETED|Dose Level II||0
6665533|NCT02533674|7596146|FG003|COMPLETED|Dose Level II||0
6665534|NCT02533674|7596147|FG004|COMPLETED|Dose Level II||0
6665535|NCT02533674|7596148|FG005|COMPLETED|Dose Level II||0
6665536|NCT02533674|7596149|FG006|COMPLETED|Dose Level II||0
6665537|NCT02533674|7596150|FG007|COMPLETED|Dose Level II||0
6665538|NCT02533674|7596143|FG000|NOT COMPLETED|Dose Level II||0
6665539|NCT02533674|7596144|FG001|NOT COMPLETED|Dose Level II||7
6665540|NCT02533674|7596145|FG002|NOT COMPLETED|Dose Level II||0
6665541|NCT02533674|7596146|FG003|NOT COMPLETED|Dose Level II||0
6665542|NCT02533674|7596147|FG004|NOT COMPLETED|Dose Level II||0
6665543|NCT02533674|7596148|FG005|NOT COMPLETED|Dose Level II||0
6665544|NCT02533674|7596149|FG006|NOT COMPLETED|Dose Level II||0
6665545|NCT02533674|7596150|FG007|NOT COMPLETED|Dose Level II||0
6665546|NCT02533674|7596143|FG000|STARTED|Dose Level III||0
6665547|NCT02533674|7596144|FG001|STARTED|Dose Level III||0
6665548|NCT02533674|7596145|FG002|STARTED|Dose Level III||4
6665549|NCT02533674|7596146|FG003|STARTED|Dose Level III||0
6665550|NCT02533674|7596147|FG004|STARTED|Dose Level III||0
6665551|NCT02533674|7596148|FG005|STARTED|Dose Level III||0
6665552|NCT02533674|7596149|FG006|STARTED|Dose Level III||0
6665553|NCT02533674|7596150|FG007|STARTED|Dose Level III||0
6665554|NCT02533674|7596143|FG000|COMPLETED|Dose Level III||0
6665555|NCT02533674|7596144|FG001|COMPLETED|Dose Level III||0
6665556|NCT02533674|7596145|FG002|COMPLETED|Dose Level III||0
6665557|NCT02533674|7596146|FG003|COMPLETED|Dose Level III||0
6665558|NCT02533674|7596147|FG004|COMPLETED|Dose Level III||0
6665559|NCT02533674|7596148|FG005|COMPLETED|Dose Level III||0
6665560|NCT02533674|7596149|FG006|COMPLETED|Dose Level III||0
6665561|NCT02533674|7596150|FG007|COMPLETED|Dose Level III||0
6665562|NCT02533674|7596143|FG000|NOT COMPLETED|Dose Level III||0
6665563|NCT02533674|7596144|FG001|NOT COMPLETED|Dose Level III||0
6665564|NCT02533674|7596145|FG002|NOT COMPLETED|Dose Level III||4
6665565|NCT02533674|7596146|FG003|NOT COMPLETED|Dose Level III||0
6665566|NCT02533674|7596147|FG004|NOT COMPLETED|Dose Level III||0
6665567|NCT02533674|7596148|FG005|NOT COMPLETED|Dose Level III||0
6665568|NCT02533674|7596149|FG006|NOT COMPLETED|Dose Level III||0
6665569|NCT02533674|7596150|FG007|NOT COMPLETED|Dose Level III||0
6665570|NCT02533674|7596143|FG000|STARTED|Dose Level IV||0
6665571|NCT02533674|7596144|FG001|STARTED|Dose Level IV||0
6665572|NCT02533674|7596145|FG002|STARTED|Dose Level IV||0
6665573|NCT02533674|7596146|FG003|STARTED|Dose Level IV||5
6665574|NCT02533674|7596147|FG004|STARTED|Dose Level IV||0
6665575|NCT02533674|7596148|FG005|STARTED|Dose Level IV||0
6665576|NCT02533674|7596149|FG006|STARTED|Dose Level IV||0
6665577|NCT02533674|7596150|FG007|STARTED|Dose Level IV||0
6665578|NCT02533674|7596143|FG000|COMPLETED|Dose Level IV||0
6665579|NCT02533674|7596144|FG001|COMPLETED|Dose Level IV||0
6665580|NCT02533674|7596145|FG002|COMPLETED|Dose Level IV||0
6665581|NCT02533674|7596146|FG003|COMPLETED|Dose Level IV||0
6665582|NCT02533674|7596147|FG004|COMPLETED|Dose Level IV||0
6665583|NCT02533674|7596148|FG005|COMPLETED|Dose Level IV||0
6665584|NCT02533674|7596149|FG006|COMPLETED|Dose Level IV||0
6665585|NCT02533674|7596150|FG007|COMPLETED|Dose Level IV||0
6665586|NCT02533674|7596143|FG000|NOT COMPLETED|Dose Level IV||0
6665587|NCT02533674|7596144|FG001|NOT COMPLETED|Dose Level IV||0
6665588|NCT02533674|7596145|FG002|NOT COMPLETED|Dose Level IV||0
6665589|NCT02533674|7596146|FG003|NOT COMPLETED|Dose Level IV||5
6665590|NCT02533674|7596147|FG004|NOT COMPLETED|Dose Level IV||0
6665591|NCT02533674|7596148|FG005|NOT COMPLETED|Dose Level IV||0
6665592|NCT02533674|7596149|FG006|NOT COMPLETED|Dose Level IV||0
6665593|NCT02533674|7596150|FG007|NOT COMPLETED|Dose Level IV||0
6665594|NCT02533674|7596143|FG000|STARTED|Dose Level V||0
6665595|NCT02533674|7596144|FG001|STARTED|Dose Level V||0
6665596|NCT02533674|7596145|FG002|STARTED|Dose Level V||0
6665597|NCT02533674|7596146|FG003|STARTED|Dose Level V||0
6665598|NCT02533674|7596147|FG004|STARTED|Dose Level V||5
6665599|NCT02533674|7596148|FG005|STARTED|Dose Level V||0
6665600|NCT02533674|7596149|FG006|STARTED|Dose Level V||0
6665601|NCT02533674|7596150|FG007|STARTED|Dose Level V||0
6665602|NCT02533674|7596143|FG000|COMPLETED|Dose Level V||0
6665603|NCT02533674|7596144|FG001|COMPLETED|Dose Level V||0
6665604|NCT02533674|7596145|FG002|COMPLETED|Dose Level V||0
6665605|NCT02533674|7596146|FG003|COMPLETED|Dose Level V||0
6665606|NCT02533674|7596147|FG004|COMPLETED|Dose Level V||0
6665607|NCT02533674|7596148|FG005|COMPLETED|Dose Level V||0
6665608|NCT02533674|7596149|FG006|COMPLETED|Dose Level V||0
6665609|NCT02533674|7596150|FG007|COMPLETED|Dose Level V||0
6665610|NCT02533674|7596143|FG000|NOT COMPLETED|Dose Level V||0
6665611|NCT02533674|7596144|FG001|NOT COMPLETED|Dose Level V||0
6665612|NCT02533674|7596145|FG002|NOT COMPLETED|Dose Level V||0
6665613|NCT02533674|7596146|FG003|NOT COMPLETED|Dose Level V||0
6665614|NCT02533674|7596147|FG004|NOT COMPLETED|Dose Level V||5
6665615|NCT02533674|7596148|FG005|NOT COMPLETED|Dose Level V||0
6665616|NCT02533674|7596149|FG006|NOT COMPLETED|Dose Level V||0
6665617|NCT02533674|7596150|FG007|NOT COMPLETED|Dose Level V||0
6665618|NCT02533674|7596143|FG000|STARTED|Dose Level VI||0
6665619|NCT02533674|7596144|FG001|STARTED|Dose Level VI||0
6665620|NCT02533674|7596145|FG002|STARTED|Dose Level VI||0
6665621|NCT02533674|7596146|FG003|STARTED|Dose Level VI||0
6665622|NCT02533674|7596147|FG004|STARTED|Dose Level VI||0
6665623|NCT02533674|7596148|FG005|STARTED|Dose Level VI||9
6665624|NCT02533674|7596149|FG006|STARTED|Dose Level VI||0
6665625|NCT02533674|7596150|FG007|STARTED|Dose Level VI||0
6665626|NCT02533674|7596143|FG000|COMPLETED|Dose Level VI||0
6665627|NCT02533674|7596144|FG001|COMPLETED|Dose Level VI||0
6665628|NCT02533674|7596145|FG002|COMPLETED|Dose Level VI||0
6665629|NCT02533674|7596146|FG003|COMPLETED|Dose Level VI||0
6665630|NCT02533674|7596147|FG004|COMPLETED|Dose Level VI||0
6665631|NCT02533674|7596148|FG005|COMPLETED|Dose Level VI||0
6665632|NCT02533674|7596149|FG006|COMPLETED|Dose Level VI||0
6665633|NCT02533674|7596150|FG007|COMPLETED|Dose Level VI||0
6665634|NCT02533674|7596143|FG000|NOT COMPLETED|Dose Level VI||0
6665635|NCT02533674|7596144|FG001|NOT COMPLETED|Dose Level VI||0
6665636|NCT02533674|7596145|FG002|NOT COMPLETED|Dose Level VI||0
6665637|NCT02533674|7596146|FG003|NOT COMPLETED|Dose Level VI||0
6665638|NCT02533674|7596147|FG004|NOT COMPLETED|Dose Level VI||0
6665639|NCT02533674|7596148|FG005|NOT COMPLETED|Dose Level VI||9
6665640|NCT02533674|7596149|FG006|NOT COMPLETED|Dose Level VI||0
6665641|NCT02533674|7596150|FG007|NOT COMPLETED|Dose Level VI||0
6665642|NCT02533674|7596143|FG000|STARTED|Dose Level VII||0
6665643|NCT02533674|7596144|FG001|STARTED|Dose Level VII||0
6665644|NCT02533674|7596145|FG002|STARTED|Dose Level VII||0
6665645|NCT02533674|7596146|FG003|STARTED|Dose Level VII||0
6665646|NCT02533674|7596147|FG004|STARTED|Dose Level VII||0
6665647|NCT02533674|7596148|FG005|STARTED|Dose Level VII||0
6665648|NCT02533674|7596149|FG006|STARTED|Dose Level VII||16
6665649|NCT02533674|7596150|FG007|STARTED|Dose Level VII||0
6665650|NCT02533674|7596143|FG000|COMPLETED|Dose Level VII||0
6665651|NCT02533674|7596144|FG001|COMPLETED|Dose Level VII||0
6665652|NCT02533674|7596145|FG002|COMPLETED|Dose Level VII||0
6665653|NCT02533674|7596146|FG003|COMPLETED|Dose Level VII||0
6665654|NCT02533674|7596147|FG004|COMPLETED|Dose Level VII||0
6665655|NCT02533674|7596148|FG005|COMPLETED|Dose Level VII||0
6665656|NCT02533674|7596149|FG006|COMPLETED|Dose Level VII||0
6665657|NCT02533674|7596150|FG007|COMPLETED|Dose Level VII||0
6665658|NCT02533674|7596143|FG000|NOT COMPLETED|Dose Level VII||0
6665659|NCT02533674|7596144|FG001|NOT COMPLETED|Dose Level VII||0
6665660|NCT02533674|7596145|FG002|NOT COMPLETED|Dose Level VII||0
6665661|NCT02533674|7596146|FG003|NOT COMPLETED|Dose Level VII||0
6665662|NCT02533674|7596147|FG004|NOT COMPLETED|Dose Level VII||0
6665663|NCT02533674|7596148|FG005|NOT COMPLETED|Dose Level VII||0
6665664|NCT02533674|7596149|FG006|NOT COMPLETED|Dose Level VII||16
6665665|NCT02533674|7596150|FG007|NOT COMPLETED|Dose Level VII||0
6665666|NCT02533674|7596143|FG000|STARTED|Dose Level VIII||0
6665667|NCT02533674|7596144|FG001|STARTED|Dose Level VIII||0
6665668|NCT02533674|7596145|FG002|STARTED|Dose Level VIII||0
6665669|NCT02533674|7596146|FG003|STARTED|Dose Level VIII||0
6665670|NCT02533674|7596147|FG004|STARTED|Dose Level VIII||0
6665671|NCT02533674|7596148|FG005|STARTED|Dose Level VIII||0
6665672|NCT02533674|7596149|FG006|STARTED|Dose Level VIII||0
6665673|NCT02533674|7596150|FG007|STARTED|Dose Level VIII||6
6665674|NCT02533674|7596143|FG000|COMPLETED|Dose Level VIII||0
6665675|NCT02533674|7596144|FG001|COMPLETED|Dose Level VIII||0
6665676|NCT02533674|7596145|FG002|COMPLETED|Dose Level VIII||0
6665677|NCT02533674|7596146|FG003|COMPLETED|Dose Level VIII||0
6665678|NCT02533674|7596147|FG004|COMPLETED|Dose Level VIII||0
6665679|NCT02533674|7596148|FG005|COMPLETED|Dose Level VIII||0
6665680|NCT02533674|7596149|FG006|COMPLETED|Dose Level VIII||0
6665681|NCT02533674|7596150|FG007|COMPLETED|Dose Level VIII||0
6665682|NCT02533674|7596143|FG000|NOT COMPLETED|Dose Level VIII||0
6665683|NCT02533674|7596144|FG001|NOT COMPLETED|Dose Level VIII||0
6665684|NCT02533674|7596145|FG002|NOT COMPLETED|Dose Level VIII||0
6665685|NCT02533674|7596146|FG003|NOT COMPLETED|Dose Level VIII||0
6665686|NCT02533674|7596147|FG004|NOT COMPLETED|Dose Level VIII||0
6665687|NCT02533674|7596148|FG005|NOT COMPLETED|Dose Level VIII||0
6665688|NCT02533674|7596149|FG006|NOT COMPLETED|Dose Level VIII||0
6665689|NCT02533674|7596150|FG007|NOT COMPLETED|Dose Level VIII||6
6665690|NCT02533726|7596170|FG000|STARTED|Initial Allocation||659
6665691|NCT02533726|7596171|FG001|STARTED|Initial Allocation||653
6665692|NCT02533726|7596170|FG000|COMPLETED|Initial Allocation||659
6256034|NCT05224453|7154853|FG000|STARTED|Overall Study||38
6256035|NCT05224453|7154854|FG001|STARTED|Overall Study||38
6256036|NCT05224453|7154853|FG000|COMPLETED|Overall Study||36
6256037|NCT05224453|7154854|FG001|COMPLETED|Overall Study||35
6256038|NCT05224453|7154853|FG000|NOT COMPLETED|Overall Study||2
6256039|NCT05224453|7154854|FG001|NOT COMPLETED|Overall Study||3
6256040|NCT04537078|7154862|FG000|STARTED|Overall Study||45
6256041|NCT04537078|7154863|FG001|STARTED|Overall Study||45
6256042|NCT04537078|7154862|FG000|COMPLETED|Overall Study||41
6256043|NCT04537078|7154863|FG001|COMPLETED|Overall Study||42
6256044|NCT04537078|7154862|FG000|NOT COMPLETED|Overall Study||4
6256045|NCT04537078|7154863|FG001|NOT COMPLETED|Overall Study||3
6278998|NCT00140244|7178656|FG000|COMPLETED|Intervention 2||3
6278999|NCT00140244|7178657|FG001|COMPLETED|Intervention 2||2
6279000|NCT00140244|7178656|FG000|NOT COMPLETED|Intervention 2||0
6279001|NCT00140244|7178657|FG001|NOT COMPLETED|Intervention 2||2
6279002|NCT00140413|7178667|FG000|STARTED|Overall Study||13
6279003|NCT00140413|7178668|FG001|STARTED|Overall Study||7
6665693|NCT02533726|7596171|FG001|COMPLETED|Initial Allocation||653
6665694|NCT02533726|7596170|FG000|NOT COMPLETED|Initial Allocation||0
6665695|NCT02533726|7596171|FG001|NOT COMPLETED|Initial Allocation||0
6665696|NCT02533726|7596170|FG000|STARTED|Treatment|54 participants allocated to Standard Care actually received Optimal Turning|709
6665697|NCT02533726|7596171|FG001|STARTED|Treatment|4 participants allocated to Optimal Turning actually received Standard Care|603
6665698|NCT02533726|7596170|FG000|Per Protocol Population|Treatment||671
6665699|NCT02533726|7596171|FG001|Per Protocol Population|Treatment||555
6665700|NCT02533726|7596170|FG000|COMPLETED|Treatment||709
6665701|NCT02533726|7596171|FG001|COMPLETED|Treatment||603
6665702|NCT02533726|7596170|FG000|NOT COMPLETED|Treatment||0
6665703|NCT02533726|7596171|FG001|NOT COMPLETED|Treatment||0
6665704|NCT02533921|7596179|FG000|STARTED|Overall Study||104
6665705|NCT02533921|7596180|FG001|STARTED|Overall Study||106
6665706|NCT02533921|7596179|FG000|COMPLETED|Overall Study||88
6665707|NCT02533921|7596180|FG001|COMPLETED|Overall Study||95
6665708|NCT02533921|7596179|FG000|NOT COMPLETED|Overall Study||16
6665709|NCT02533921|7596180|FG001|NOT COMPLETED|Overall Study||11
6665710|NCT02533934|7596188|FG000|STARTED|Overall Study||42
6665711|NCT02533934|7596189|FG001|STARTED|Overall Study||26
6665712|NCT02533934|7596188|FG000|COMPLETED|Overall Study||42
6665713|NCT02533934|7596189|FG001|COMPLETED|Overall Study||26
6665714|NCT02533934|7596188|FG000|NOT COMPLETED|Overall Study||0
6665715|NCT02533934|7596189|FG001|NOT COMPLETED|Overall Study||0
6665716|NCT02533999|7596197|FG000|STARTED|Overall Study||38
6665717|NCT02533999|7596198|FG001|STARTED|Overall Study||37
6665718|NCT02533999|7596197|FG000|COMPLETED|Overall Study||32
6665719|NCT02533999|7596198|FG001|COMPLETED|Overall Study||30
6665720|NCT02533999|7596197|FG000|NOT COMPLETED|Overall Study||6
6665721|NCT02533999|7596198|FG001|NOT COMPLETED|Overall Study||7
6665722|NCT02534129|7596204|FG000|STARTED|Overall Study||13
6665723|NCT02534129|7596205|FG001|STARTED|Overall Study||13
6665724|NCT02534129|7596204|FG000|COMPLETED|Overall Study||13
6665725|NCT02534129|7596205|FG001|COMPLETED|Overall Study||13
6665726|NCT02534129|7596204|FG000|NOT COMPLETED|Overall Study||0
6665727|NCT02534129|7596205|FG001|NOT COMPLETED|Overall Study||0
6665728|NCT02534285|7596213|FG000|STARTED|Overall Study||50
6665729|NCT02534285|7596214|FG001|STARTED|Overall Study||50
6665730|NCT02534285|7596213|FG000|COMPLETED|Overall Study||50
6665731|NCT02534285|7596214|FG001|COMPLETED|Overall Study||50
6665732|NCT02534285|7596213|FG000|NOT COMPLETED|Overall Study||0
6665733|NCT02534285|7596214|FG001|NOT COMPLETED|Overall Study||0
6665734|NCT02534324|7596222|FG000|STARTED|Overall Study||98
6665735|NCT02534324|7596223|FG001|STARTED|Overall Study||48
6665736|NCT02534324|7596222|FG000|COMPLETED|Overall Study||73
6665737|NCT02534324|7596223|FG001|COMPLETED|Overall Study||40
6665738|NCT02534324|7596222|FG000|NOT COMPLETED|Overall Study||25
6665739|NCT02534324|7596223|FG001|NOT COMPLETED|Overall Study||8
6665740|NCT02534350|7596231|FG000|STARTED|Overall Study||41
6665741|NCT02534350|7596232|FG001|STARTED|Overall Study||20
6665742|NCT02534350|7596231|FG000|COMPLETED|Overall Study||37
6665743|NCT02534350|7596232|FG001|COMPLETED|Overall Study||20
6665744|NCT02534350|7596231|FG000|NOT COMPLETED|Overall Study||4
6665745|NCT02534350|7596232|FG001|NOT COMPLETED|Overall Study||0
6256046|NCT04425252|7154878|FG000|STARTED|Overall Study||8
6665746|NCT02534493|7596238|FG000|STARTED|Overall Study||13
6665747|NCT02534493|7596238|FG000|COMPLETED|Overall Study||11
6665748|NCT02534493|7596238|FG000|NOT COMPLETED|Overall Study||2
6665749|NCT02534883|7596246|FG000|STARTED|Overall Study||8
6665750|NCT02534883|7596247|FG001|STARTED|Overall Study||3
6665751|NCT02534883|7596246|FG000|COMPLETED|Overall Study||0
6665752|NCT02534883|7596247|FG001|COMPLETED|Overall Study||0
6665753|NCT02534883|7596246|FG000|NOT COMPLETED|Overall Study||8
6665754|NCT02534883|7596247|FG001|NOT COMPLETED|Overall Study||3
6665755|NCT02534896|7596256|FG000|STARTED|Overall Study||49
6665756|NCT02534896|7596257|FG001|STARTED|Overall Study||52
6665757|NCT02534896|7596258|FG002|STARTED|Overall Study||49
6665758|NCT02534896|7596256|FG000|COMPLETED|Overall Study||45
6665759|NCT02534896|7596257|FG001|COMPLETED|Overall Study||51
6665760|NCT02534896|7596258|FG002|COMPLETED|Overall Study||48
6665761|NCT02534896|7596256|FG000|NOT COMPLETED|Overall Study||4
6665762|NCT02534896|7596257|FG001|NOT COMPLETED|Overall Study||1
6665763|NCT02534896|7596258|FG002|NOT COMPLETED|Overall Study||1
6665764|NCT02534935|7596269|FG000|STARTED|Stage 1: 24 Months||44
6665765|NCT02534935|7596270|FG001|STARTED|Stage 1: 24 Months||220
6665766|NCT02534935|7596271|FG002|STARTED|Stage 1: 24 Months||132
6665767|NCT02534935|7596269|FG000|COMPLETED|Stage 1: 24 Months||44
6665768|NCT02534935|7596270|FG001|COMPLETED|Stage 1: 24 Months||210
6665769|NCT02534935|7596271|FG002|COMPLETED|Stage 1: 24 Months||127
6665770|NCT02534935|7596269|FG000|NOT COMPLETED|Stage 1: 24 Months||0
6665771|NCT02534935|7596270|FG001|NOT COMPLETED|Stage 1: 24 Months||10
6665772|NCT02534935|7596271|FG002|NOT COMPLETED|Stage 1: 24 Months||5
6665773|NCT02534935|7596269|FG000|STARTED|Stage 2: 8 Months|Participants entered into Stage 2.|40
6665774|NCT02534935|7596270|FG001|STARTED|Stage 2: 8 Months|Participants who received all 3 doses and entered Stage 2.|174
6665775|NCT02534935|7596271|FG002|STARTED|Stage 2: 8 Months|Participants of HAV/Saline were not eligible for Stage 2.|0
6665776|NCT02534935|7596269|FG000|COMPLETED|Stage 2: 8 Months||40
6665777|NCT02534935|7596270|FG001|COMPLETED|Stage 2: 8 Months||170
6665778|NCT02534935|7596271|FG002|COMPLETED|Stage 2: 8 Months||0
6665779|NCT02534935|7596269|FG000|NOT COMPLETED|Stage 2: 8 Months||0
6665780|NCT02534935|7596270|FG001|NOT COMPLETED|Stage 2: 8 Months||4
6665781|NCT02534935|7596271|FG002|NOT COMPLETED|Stage 2: 8 Months||0
6665782|NCT02534935|7596269|FG000|STARTED|Stage 2: Booster Phase (6 Months)|Participants were not eligible for Booster vaccination in Stage 2.|0
6665783|NCT02534935|7596270|FG001|STARTED|Stage 2: Booster Phase (6 Months)|Participants who received 3 doses of bivalent rLP2086 in Stage 1 and gave consent for booster vaccination.|148
6665784|NCT02534935|7596271|FG002|STARTED|Stage 2: Booster Phase (6 Months)|Participants of HAV/Saline were not eligible for Stage 2.|0
6665785|NCT02534935|7596269|FG000|COMPLETED|Stage 2: Booster Phase (6 Months)||0
6665786|NCT02534935|7596270|FG001|COMPLETED|Stage 2: Booster Phase (6 Months)||147
6665787|NCT02534935|7596271|FG002|COMPLETED|Stage 2: Booster Phase (6 Months)||0
6665788|NCT02534935|7596269|FG000|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
6665789|NCT02534935|7596270|FG001|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||1
6665790|NCT02534935|7596271|FG002|NOT COMPLETED|Stage 2: Booster Phase (6 Months)||0
6665791|NCT02535000|7596299|FG000|STARTED|Overall Study||30
6665792|NCT02535000|7596300|FG001|STARTED|Overall Study||30
6665793|NCT02535000|7596299|FG000|COMPLETED|Overall Study||29
6665794|NCT02535000|7596300|FG001|COMPLETED|Overall Study||28
6665795|NCT02535000|7596299|FG000|NOT COMPLETED|Overall Study||1
6665796|NCT02535000|7596300|FG001|NOT COMPLETED|Overall Study||2
6665797|NCT02535026|7596306|FG000|STARTED|Overall Study||580
6665798|NCT02535026|7596306|FG000|COMPLETED|Overall Study||580
6665799|NCT02535026|7596306|FG000|NOT COMPLETED|Overall Study||0
6665800|NCT02535364|7596320|FG000|STARTED|Part A Screening Through Leukapheresis||82
6665801|NCT02535364|7596320|FG000|COMPLETED|Part A Screening Through Leukapheresis||57
6665802|NCT02535364|7596320|FG000|NOT COMPLETED|Part A Screening Through Leukapheresis||25
6665803|NCT02535364|7596320|FG000|STARTED|Part B Screening||57
6665804|NCT02535364|7596320|FG000|COMPLETED|Part B Screening||40
6665805|NCT02535364|7596320|FG000|NOT COMPLETED|Part B Screening||17
6665806|NCT02535364|7596320|FG000|STARTED|Study Treatment||40
6665807|NCT02535364|7596320|FG000|COMPLETED|Study Treatment||38
6665808|NCT02535364|7596320|FG000|NOT COMPLETED|Study Treatment||2
6665809|NCT02535364|7596320|FG000|STARTED|12-Month Follow-up Period||38
6665810|NCT02535364|7596320|FG000|COMPLETED|12-Month Follow-up Period||3
6665811|NCT02535364|7596320|FG000|NOT COMPLETED|12-Month Follow-up Period||35
6665812|NCT02535416|7596333|FG000|STARTED|Overall Study||4
6665813|NCT02535416|7596334|FG001|STARTED|Overall Study||2
6665814|NCT02535416|7596335|FG002|STARTED|Overall Study||4
6665815|NCT02535416|7596336|FG003|STARTED|Overall Study||4
6665816|NCT02535416|7596337|FG004|STARTED|Overall Study||4
6665817|NCT02535416|7596338|FG005|STARTED|Overall Study||4
6665818|NCT02535416|7596339|FG006|STARTED|Overall Study||6
6665819|NCT02535416|7596340|FG007|STARTED|Overall Study||6
6665820|NCT02535416|7596341|FG008|STARTED|Overall Study||6
6665821|NCT02535416|7596333|FG000|COMPLETED|Overall Study||3
6665822|NCT02535416|7596334|FG001|COMPLETED|Overall Study||2
6665823|NCT02535416|7596335|FG002|COMPLETED|Overall Study||4
6665824|NCT02535416|7596336|FG003|COMPLETED|Overall Study||4
6665825|NCT02535416|7596337|FG004|COMPLETED|Overall Study||4
6665826|NCT02535416|7596338|FG005|COMPLETED|Overall Study||4
6665827|NCT02535416|7596339|FG006|COMPLETED|Overall Study||6
6665828|NCT02535416|7596340|FG007|COMPLETED|Overall Study||6
6665829|NCT02535416|7596341|FG008|COMPLETED|Overall Study||6
6665830|NCT02535416|7596333|FG000|NOT COMPLETED|Overall Study||1
6665831|NCT02535416|7596334|FG001|NOT COMPLETED|Overall Study||0
6665832|NCT02535416|7596335|FG002|NOT COMPLETED|Overall Study||0
6665833|NCT02535416|7596336|FG003|NOT COMPLETED|Overall Study||0
6665834|NCT02535416|7596337|FG004|NOT COMPLETED|Overall Study||0
6665835|NCT02535416|7596338|FG005|NOT COMPLETED|Overall Study||0
6665836|NCT02535416|7596339|FG006|NOT COMPLETED|Overall Study||0
6665837|NCT02535416|7596340|FG007|NOT COMPLETED|Overall Study||0
6665838|NCT02535416|7596341|FG008|NOT COMPLETED|Overall Study||0
6665839|NCT02535481|7596367|FG000|STARTED|Overall Study||22
6665840|NCT02535481|7596368|FG001|STARTED|Overall Study||22
6665841|NCT02535481|7596367|FG000|COMPLETED|Overall Study||22
6665842|NCT02535481|7596368|FG001|COMPLETED|Overall Study||22
6665843|NCT02535481|7596367|FG000|NOT COMPLETED|Overall Study||0
6665844|NCT02535481|7596368|FG001|NOT COMPLETED|Overall Study||0
6665845|NCT02535572|7596376|FG000|STARTED|Overall Study||21
6665846|NCT02535572|7596377|FG001|STARTED|Overall Study||20
6665847|NCT02535572|7596376|FG000|COMPLETED|Overall Study||17
6665848|NCT02535572|7596377|FG001|COMPLETED|Overall Study||17
6665849|NCT02535572|7596376|FG000|NOT COMPLETED|Overall Study||4
6665850|NCT02535572|7596377|FG001|NOT COMPLETED|Overall Study||3
6665851|NCT02535611|7596386|FG000|STARTED|Overall Study||27
6665852|NCT02535611|7596387|FG001|STARTED|Overall Study||20
6665853|NCT02535611|7596386|FG000|COMPLETED|Overall Study||27
6665854|NCT02535611|7596387|FG001|COMPLETED|Overall Study||20
6665855|NCT02535611|7596386|FG000|NOT COMPLETED|Overall Study||0
6665856|NCT02535611|7596387|FG001|NOT COMPLETED|Overall Study||0
6665857|NCT02535715|7596393|FG000|STARTED|Overall Study||4
6665858|NCT02535715|7596394|FG001|STARTED|Overall Study||4
6665859|NCT02535715|7596395|FG002|STARTED|Overall Study||3
6665860|NCT02535715|7596393|FG000|COMPLETED|Overall Study||4
6665861|NCT02535715|7596394|FG001|COMPLETED|Overall Study||4
6665862|NCT02535715|7596395|FG002|COMPLETED|Overall Study||2
6665863|NCT02535715|7596393|FG000|NOT COMPLETED|Overall Study||0
6665864|NCT02535715|7596394|FG001|NOT COMPLETED|Overall Study||0
6665865|NCT02535715|7596395|FG002|NOT COMPLETED|Overall Study||1
6665866|NCT02535741|7596406|FG000|STARTED|Overall Study||168
6665867|NCT02535741|7596406|FG000|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
6665868|NCT02535741|7596406|FG000|NOT COMPLETED|Overall Study||32
6665869|NCT02535806|7596411|FG000|STARTED|Overall Study||2
6665870|NCT02535806|7596411|FG000|COMPLETED|Overall Study||2
6665871|NCT02535806|7596411|FG000|NOT COMPLETED|Overall Study||0
6665872|NCT02535949|7596418|FG000|STARTED|Overall Study||50
6665873|NCT02535949|7596419|FG001|STARTED|Overall Study||50
6665874|NCT02535949|7596420|FG002|STARTED|Overall Study||50
6665875|NCT02535949|7596418|FG000|COMPLETED|Overall Study||49
6665876|NCT02535949|7596419|FG001|COMPLETED|Overall Study||50
6665877|NCT02535949|7596420|FG002|COMPLETED|Overall Study||50
6665878|NCT02535949|7596418|FG000|NOT COMPLETED|Overall Study||1
6665879|NCT02535949|7596419|FG001|NOT COMPLETED|Overall Study||0
6665880|NCT02535949|7596420|FG002|NOT COMPLETED|Overall Study||0
6665881|NCT02536040|7596431|FG000|STARTED|Overall Study||30
6665882|NCT02536040|7596432|FG001|STARTED|Overall Study||36
6665883|NCT02536040|7596431|FG000|COMPLETED|Overall Study||29
6665884|NCT02536040|7596432|FG001|COMPLETED|Overall Study||35
6665885|NCT02536040|7596431|FG000|NOT COMPLETED|Overall Study||1
6665886|NCT02536040|7596432|FG001|NOT COMPLETED|Overall Study||1
6602129|NCT02054715|7527052|FG001|NOT COMPLETED|Follow-up 2||19
6602130|NCT02054754|7527060|FG000|STARTED|Overall Study||6
6602131|NCT02054754|7527061|FG001|STARTED|Overall Study||6
6602132|NCT02054754|7527062|FG002|STARTED|Overall Study||6
6602133|NCT02054754|7527063|FG003|STARTED|Overall Study||6
6602134|NCT02054754|7527064|FG004|STARTED|Overall Study||6
6602135|NCT02054754|7527065|FG005|STARTED|Overall Study||10
6602136|NCT02054754|7527060|FG000|COMPLETED|Overall Study||6
6602137|NCT02054754|7527061|FG001|COMPLETED|Overall Study||6
6602138|NCT02054754|7527062|FG002|COMPLETED|Overall Study||6
6602139|NCT02054754|7527063|FG003|COMPLETED|Overall Study||6
6602140|NCT02054754|7527064|FG004|COMPLETED|Overall Study||6
6665887|NCT02536105|7596438|FG000|STARTED|Concerta Open Label||80
6665888|NCT02536105|7596438|FG000|Completion of Phase|Concerta Open Label||76
6665889|NCT02536105|7596438|FG000|COMPLETED|Concerta Open Label||72
6665890|NCT02536105|7596438|FG000|NOT COMPLETED|Concerta Open Label||8
6665891|NCT02536105|7596438|FG000|STARTED|Placebo||74
6665892|NCT02536105|7596438|FG000|Completion of Placebo Day|Placebo||74
6665893|NCT02536105|7596438|FG000|COMPLETED|Placebo||72
6665894|NCT02536105|7596438|FG000|NOT COMPLETED|Placebo||2
6665895|NCT02536105|7596438|FG000|STARTED|Methylphenidate HCl ER Tablet 1||72
6665896|NCT02536105|7596438|FG000|Completion of MPH HCl ER Tab 1 Day|Methylphenidate HCl ER Tablet 1||72
6665897|NCT02536105|7596438|FG000|COMPLETED|Methylphenidate HCl ER Tablet 1||72
6665898|NCT02536105|7596438|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 1||0
6665899|NCT02536105|7596438|FG000|STARTED|Methylphenidate HCl ER Tablet 2||73
6665900|NCT02536105|7596438|FG000|Completion of MPH HCl ER Tablet 2 Phase|Methylphenidate HCl ER Tablet 2||73
6665901|NCT02536105|7596438|FG000|COMPLETED|Methylphenidate HCl ER Tablet 2||72
6665902|NCT02536105|7596438|FG000|NOT COMPLETED|Methylphenidate HCl ER Tablet 2||1
6391807|NCT00838162|7303743|FG000|STARTED|Overall Study||9
6391808|NCT00838162|7303744|FG001|STARTED|Overall Study||8
6391809|NCT00838162|7303745|FG002|STARTED|Overall Study||8
6391810|NCT00838162|7303746|FG003|STARTED|Overall Study||8
6391811|NCT00838162|7303743|FG000|COMPLETED|Overall Study||9
6391812|NCT00838162|7303744|FG001|COMPLETED|Overall Study||8
6391813|NCT00838162|7303745|FG002|COMPLETED|Overall Study||8
6391814|NCT00838162|7303746|FG003|COMPLETED|Overall Study||8
6391815|NCT00838162|7303743|FG000|NOT COMPLETED|Overall Study||0
6391816|NCT00838162|7303744|FG001|NOT COMPLETED|Overall Study||0
6391817|NCT00838162|7303745|FG002|NOT COMPLETED|Overall Study||0
6391818|NCT00838162|7303746|FG003|NOT COMPLETED|Overall Study||0
6391819|NCT00838201|7303758|FG000|STARTED|Overall Study||186
6391820|NCT00838201|7303759|FG001|STARTED|Overall Study||198
6391821|NCT00838201|7303758|FG000|COMPLETED|Overall Study||144
6391822|NCT00838201|7303759|FG001|COMPLETED|Overall Study||145
6391823|NCT00838201|7303758|FG000|NOT COMPLETED|Overall Study||42
6391824|NCT00838201|7303759|FG001|NOT COMPLETED|Overall Study||53
6391825|NCT00838331|7303765|FG000|STARTED|Fresh Blood Transfusion||17
6391826|NCT00838331|7303765|FG000|COMPLETED|Fresh Blood Transfusion||17
6391827|NCT00838331|7303765|FG000|NOT COMPLETED|Fresh Blood Transfusion||0
6391828|NCT00838331|7303765|FG000|STARTED|Aged Blood Transfusion||17
6391829|NCT00838331|7303765|FG000|COMPLETED|Aged Blood Transfusion||8
6602141|NCT02054754|7527065|FG005|COMPLETED|Overall Study||10
6602142|NCT02054754|7527060|FG000|NOT COMPLETED|Overall Study||0
6602143|NCT02054754|7527061|FG001|NOT COMPLETED|Overall Study||0
6602144|NCT02054754|7527062|FG002|NOT COMPLETED|Overall Study||0
6665903|NCT02536105|7596438|FG000|STARTED|Methylphenidate HCl ER Suspension||74
6665904|NCT02536105|7596438|FG000|Completion of MPH HCl ER Susp Phase|Methylphenidate HCl ER Suspension||74
6665905|NCT02536105|7596438|FG000|COMPLETED|Methylphenidate HCl ER Suspension||72
6665906|NCT02536105|7596438|FG000|NOT COMPLETED|Methylphenidate HCl ER Suspension||2
6665907|NCT02536196|7596451|FG000|STARTED|Overall Study||262
6665908|NCT02536196|7596452|FG001|STARTED|Overall Study||121
6665909|NCT02536196|7596453|FG002|STARTED|Overall Study||95
6665910|NCT02536196|7596451|FG000|COMPLETED|Overall Study||233
6665911|NCT02536196|7596452|FG001|COMPLETED|Overall Study||107
6665912|NCT02536196|7596453|FG002|COMPLETED|Overall Study||95
6665913|NCT02536196|7596451|FG000|NOT COMPLETED|Overall Study||29
6665914|NCT02536196|7596452|FG001|NOT COMPLETED|Overall Study||14
6665915|NCT02536196|7596453|FG002|NOT COMPLETED|Overall Study||0
6665916|NCT02536248|7596462|FG000|STARTED|First Intervention (6 Weeks)||10
6665917|NCT02536248|7596463|FG001|STARTED|First Intervention (6 Weeks)||10
6665918|NCT02536248|7596462|FG000|COMPLETED|First Intervention (6 Weeks)||10
6665919|NCT02536248|7596463|FG001|COMPLETED|First Intervention (6 Weeks)||10
6665920|NCT02536248|7596462|FG000|NOT COMPLETED|First Intervention (6 Weeks)||0
6665921|NCT02536248|7596463|FG001|NOT COMPLETED|First Intervention (6 Weeks)||0
6665922|NCT02536248|7596462|FG000|STARTED|Wash-out (14 Days)||10
6665923|NCT02536248|7596463|FG001|STARTED|Wash-out (14 Days)||10
6665924|NCT02536248|7596462|FG000|COMPLETED|Wash-out (14 Days)||10
6665925|NCT02536248|7596463|FG001|COMPLETED|Wash-out (14 Days)||10
6665926|NCT02536248|7596462|FG000|NOT COMPLETED|Wash-out (14 Days)||0
6665927|NCT02536248|7596463|FG001|NOT COMPLETED|Wash-out (14 Days)||0
6665928|NCT02536248|7596462|FG000|STARTED|Second Intervention (6 Weeks)||10
6665929|NCT02536248|7596463|FG001|STARTED|Second Intervention (6 Weeks)||10
6665930|NCT02536248|7596462|FG000|COMPLETED|Second Intervention (6 Weeks)||10
6665931|NCT02536248|7596463|FG001|COMPLETED|Second Intervention (6 Weeks)||10
6665932|NCT02536248|7596462|FG000|NOT COMPLETED|Second Intervention (6 Weeks)||0
6665933|NCT02536248|7596463|FG001|NOT COMPLETED|Second Intervention (6 Weeks)||0
6665934|NCT02536313|7596471|FG000|STARTED|Overall Study||24
6665935|NCT02536313|7596472|FG001|STARTED|Overall Study||25
6665936|NCT02536313|7596471|FG000|COMPLETED|Overall Study||24
6665937|NCT02536313|7596472|FG001|COMPLETED|Overall Study||24
6665938|NCT02536313|7596471|FG000|NOT COMPLETED|Overall Study||0
6665939|NCT02536313|7596472|FG001|NOT COMPLETED|Overall Study||1
6665940|NCT02536378|7596482|FG000|STARTED|Overall Study||632
6665941|NCT02536378|7596483|FG001|STARTED|Overall Study||60
6665942|NCT02536378|7596482|FG000|COMPLETED|Overall Study||625
6665943|NCT02536378|7596483|FG001|COMPLETED|Overall Study||53
6665944|NCT02536378|7596482|FG000|NOT COMPLETED|Overall Study||7
6665945|NCT02536378|7596483|FG001|NOT COMPLETED|Overall Study||7
6665946|NCT02536404|7596493|FG000|STARTED|Overall Study||112
6665947|NCT02536404|7596494|FG001|STARTED|Overall Study||6
6665948|NCT02536404|7596493|FG000|COMPLETED|Overall Study||92
6665949|NCT02536404|7596494|FG001|COMPLETED|Overall Study||5
6665950|NCT02536404|7596493|FG000|NOT COMPLETED|Overall Study||20
6665951|NCT02536404|7596494|FG001|NOT COMPLETED|Overall Study||1
6665952|NCT02536508|7596503|FG000|STARTED|Overall Study||194
6665953|NCT02536508|7596504|FG001|STARTED|Overall Study||174
6665954|NCT02536508|7596505|FG002|STARTED|Overall Study||88
6665955|NCT02536508|7596503|FG000|COMPLETED|Overall Study||142
6665956|NCT02536508|7596504|FG001|COMPLETED|Overall Study||130
6665957|NCT02536508|7596505|FG002|COMPLETED|Overall Study||65
6665958|NCT02536508|7596503|FG000|NOT COMPLETED|Overall Study||52
6665959|NCT02536508|7596504|FG001|NOT COMPLETED|Overall Study||44
6665960|NCT02536508|7596505|FG002|NOT COMPLETED|Overall Study||23
6665961|NCT02536664|7596515|FG000|STARTED|Overall Study||312
6665962|NCT02536664|7596516|FG001|STARTED|Overall Study||177
6665963|NCT02536664|7596515|FG000|COMPLETED|Overall Study||205
6665964|NCT02536664|7596516|FG001|COMPLETED|Overall Study||97
6665965|NCT02536664|7596515|FG000|NOT COMPLETED|Overall Study||107
6665966|NCT02536664|7596516|FG001|NOT COMPLETED|Overall Study||80
6665967|NCT02536781|7596524|FG000|STARTED|Overall Study||36
6665968|NCT02536781|7596525|FG001|STARTED|Overall Study||34
6665969|NCT02536781|7596524|FG000|COMPLETED|Overall Study||34
6665970|NCT02536781|7596525|FG001|COMPLETED|Overall Study||34
6665971|NCT02536781|7596524|FG000|NOT COMPLETED|Overall Study||2
6665972|NCT02536781|7596525|FG001|NOT COMPLETED|Overall Study||0
6665973|NCT02536833|7596535|FG000|STARTED|Overall Study||112
6665974|NCT02536833|7596536|FG001|STARTED|Overall Study||117
6665975|NCT02536833|7596537|FG002|STARTED|Overall Study||110
6665976|NCT02536833|7596538|FG003|STARTED|Overall Study||116
6665977|NCT02536833|7596535|FG000|COMPLETED|Overall Study||103
6665978|NCT02536833|7596536|FG001|COMPLETED|Overall Study||107
6665979|NCT02536833|7596537|FG002|COMPLETED|Overall Study||95
6665980|NCT02536833|7596538|FG003|COMPLETED|Overall Study||97
6665981|NCT02536833|7596535|FG000|NOT COMPLETED|Overall Study||9
6665982|NCT02536833|7596536|FG001|NOT COMPLETED|Overall Study||10
6665983|NCT02536833|7596537|FG002|NOT COMPLETED|Overall Study||15
6665984|NCT02536833|7596538|FG003|NOT COMPLETED|Overall Study||19
6665985|NCT02536846|7596549|FG000|STARTED|Overall Study||10
6665986|NCT02536846|7596549|FG000|COMPLETED|Overall Study||9
6665987|NCT02536846|7596549|FG000|NOT COMPLETED|Overall Study||1
6665988|NCT02536963|7596554|FG000|STARTED|Overall Study||318
6665989|NCT02536963|7596554|FG000|COMPLETED|Overall Study||300
6665990|NCT02536963|7596554|FG000|NOT COMPLETED|Overall Study||18
6665991|NCT02536976|7596560|FG000|STARTED|Overall Study|2 weeks single blind placebo run-in|3
6665992|NCT02536976|7596561|FG001|STARTED|Overall Study|2 weeks single blind placebo run-in. 1 participant terminated due to unrelated failing health|2
6665993|NCT02536976|7596560|FG000|Randomization|Overall Study|2 weeks double blind mirabegron|3
6665994|NCT02536976|7596561|FG001|Randomization|Overall Study|2 weeks double blind placebo matching mirabegron|1
6665995|NCT02536976|7596560|FG000|Dose Escalation and Maintenance|Overall Study|10 weeks double blind mirabegron|3
6665996|NCT02536976|7596561|FG001|Dose Escalation and Maintenance|Overall Study|10 weeks double blind placebo matching mirabegron|1
6665997|NCT02536976|7596560|FG000|Washout|Overall Study||3
6665998|NCT02536976|7596561|FG001|Washout|Overall Study||1
6665999|NCT02536976|7596560|FG000|COMPLETED|Overall Study||3
6666000|NCT02536976|7596561|FG001|COMPLETED|Overall Study||1
6666001|NCT02536976|7596560|FG000|NOT COMPLETED|Overall Study||0
6666002|NCT02536976|7596561|FG001|NOT COMPLETED|Overall Study||1
6666003|NCT02537015|7596569|FG000|STARTED|Overall Study||81
6666004|NCT02537015|7596569|FG000|COMPLETED|Overall Study||75
6666005|NCT02537015|7596569|FG000|NOT COMPLETED|Overall Study||6
6666006|NCT02537431|7596573|FG000|STARTED|Open-Label Period (Week 0 to Week 48)|Screened and received at least 1 dose of study drug.|14
6666007|NCT02537431|7596573|FG000|COMPLETED|Open-Label Period (Week 0 to Week 48)|Completed Open-Label Period (Week 0 - Week 48)|13
6666008|NCT02537431|7596573|FG000|NOT COMPLETED|Open-Label Period (Week 0 to Week 48)||1
6666009|NCT02537431|7596573|FG000|STARTED|Treatment Extension Period I||13
6666010|NCT02537431|7596573|FG000|COMPLETED|Treatment Extension Period I||13
6666011|NCT02537431|7596573|FG000|NOT COMPLETED|Treatment Extension Period I||0
6666012|NCT02537431|7596573|FG000|STARTED|Treatment Extension Period II|5 participants completing Treatment Extension Period I did not enter Treatment Extension Period II|8
6666013|NCT02537431|7596573|FG000|COMPLETED|Treatment Extension Period II||8
6666014|NCT02537431|7596573|FG000|NOT COMPLETED|Treatment Extension Period II||0
6666015|NCT02537444|7596579|FG000|STARTED|Overall Study||39
6666016|NCT02537444|7596580|FG001|STARTED|Overall Study||39
6666017|NCT02537444|7596579|FG000|Enrolled|Overall Study||39
6666018|NCT02537444|7596580|FG001|Enrolled|Overall Study||39
6666019|NCT02537444|7596579|FG000|Received Study Medication|Overall Study||38
6666020|NCT02537444|7596580|FG001|Received Study Medication|Overall Study||39
6666021|NCT02537444|7596579|FG000|Discontinued Study|Overall Study||39
6666022|NCT02537444|7596580|FG001|Discontinued Study|Overall Study||39
6666023|NCT02537444|7596579|FG000|COMPLETED|Overall Study||0
6666024|NCT02537444|7596580|FG001|COMPLETED|Overall Study||0
6666025|NCT02537444|7596579|FG000|NOT COMPLETED|Overall Study||39
6666026|NCT02537444|7596580|FG001|NOT COMPLETED|Overall Study||39
6666027|NCT02537522|7596586|FG000|STARTED|Phase I - Contralateral||34
6666028|NCT02537522|7596587|FG001|STARTED|Phase I - Contralateral||37
6666029|NCT02537522|7596588|FG002|STARTED|Phase I - Contralateral||0
6666030|NCT02537522|7596589|FG003|STARTED|Phase I - Contralateral||0
6666031|NCT02537522|7596586|FG000|COMPLETED|Phase I - Contralateral||19
6666032|NCT02537522|7596587|FG001|COMPLETED|Phase I - Contralateral||27
6666033|NCT02537522|7596588|FG002|COMPLETED|Phase I - Contralateral||0
6666034|NCT02537522|7596589|FG003|COMPLETED|Phase I - Contralateral||0
6666035|NCT02537522|7596586|FG000|NOT COMPLETED|Phase I - Contralateral||15
6666036|NCT02537522|7596587|FG001|NOT COMPLETED|Phase I - Contralateral||10
6666037|NCT02537522|7596588|FG002|NOT COMPLETED|Phase I - Contralateral||0
6666038|NCT02537522|7596589|FG003|NOT COMPLETED|Phase I - Contralateral||0
6666039|NCT02537522|7596586|FG000|STARTED|Phase II - Period 1 Bilateral||0
6666040|NCT02537522|7596587|FG001|STARTED|Phase II - Period 1 Bilateral||0
6666041|NCT02537522|7596588|FG002|STARTED|Phase II - Period 1 Bilateral||23
6666042|NCT02537522|7596589|FG003|STARTED|Phase II - Period 1 Bilateral||23
6666043|NCT02537522|7596586|FG000|COMPLETED|Phase II - Period 1 Bilateral||0
6666044|NCT02537522|7596587|FG001|COMPLETED|Phase II - Period 1 Bilateral||0
6666045|NCT02537522|7596588|FG002|COMPLETED|Phase II - Period 1 Bilateral||23
6666046|NCT02537522|7596589|FG003|COMPLETED|Phase II - Period 1 Bilateral||22
6666047|NCT02537522|7596586|FG000|NOT COMPLETED|Phase II - Period 1 Bilateral||0
6666048|NCT02537522|7596587|FG001|NOT COMPLETED|Phase II - Period 1 Bilateral||0
6666049|NCT02537522|7596588|FG002|NOT COMPLETED|Phase II - Period 1 Bilateral||0
6666050|NCT02537522|7596589|FG003|NOT COMPLETED|Phase II - Period 1 Bilateral||1
6666051|NCT02537522|7596586|FG000|STARTED|Phase II - Period 2 Bilateral||0
6666052|NCT02537522|7596587|FG001|STARTED|Phase II - Period 2 Bilateral||0
6666053|NCT02537522|7596588|FG002|STARTED|Phase II - Period 2 Bilateral||23
6666054|NCT02537522|7596589|FG003|STARTED|Phase II - Period 2 Bilateral||22
6666055|NCT02537522|7596586|FG000|COMPLETED|Phase II - Period 2 Bilateral||0
6666056|NCT02537522|7596587|FG001|COMPLETED|Phase II - Period 2 Bilateral||0
6666057|NCT02537522|7596588|FG002|COMPLETED|Phase II - Period 2 Bilateral||23
6666058|NCT02537522|7596589|FG003|COMPLETED|Phase II - Period 2 Bilateral||22
6666059|NCT02537522|7596586|FG000|NOT COMPLETED|Phase II - Period 2 Bilateral||0
6666060|NCT02537522|7596587|FG001|NOT COMPLETED|Phase II - Period 2 Bilateral||0
6666061|NCT02537522|7596588|FG002|NOT COMPLETED|Phase II - Period 2 Bilateral||0
6666062|NCT02537522|7596589|FG003|NOT COMPLETED|Phase II - Period 2 Bilateral||0
6666063|NCT02537574|7596598|FG000|STARTED|Overall Study||126
6666064|NCT02537574|7596599|FG001|STARTED|Overall Study||126
6666065|NCT02537574|7596600|FG002|STARTED|Overall Study||126
6666066|NCT02537574|7596598|FG000|COMPLETED|Overall Study||27
6666067|NCT02537574|7596599|FG001|COMPLETED|Overall Study||23
6666068|NCT02537574|7596600|FG002|COMPLETED|Overall Study||18
6666069|NCT02537574|7596598|FG000|NOT COMPLETED|Overall Study||99
6666070|NCT02537574|7596599|FG001|NOT COMPLETED|Overall Study||103
6666071|NCT02537574|7596600|FG002|NOT COMPLETED|Overall Study||108
6666072|NCT02537717|7596608|FG000|STARTED|Overall Study||17
6666073|NCT02537717|7596608|FG000|COMPLETED|Overall Study||17
6666074|NCT02537717|7596608|FG000|NOT COMPLETED|Overall Study||0
6666075|NCT02537730|7596615|FG000|STARTED|First Intervention (7 Days)||17
6666076|NCT02537730|7596616|FG001|STARTED|First Intervention (7 Days)||16
6666077|NCT02537730|7596615|FG000|COMPLETED|First Intervention (7 Days)||17
6666078|NCT02537730|7596616|FG001|COMPLETED|First Intervention (7 Days)||16
6666079|NCT02537730|7596615|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6666080|NCT02537730|7596616|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6666081|NCT02537730|7596615|FG000|STARTED|Second Intervention (7 Days)||17
6666082|NCT02537730|7596616|FG001|STARTED|Second Intervention (7 Days)||16
6666083|NCT02537730|7596615|FG000|COMPLETED|Second Intervention (7 Days)||17
6666084|NCT02537730|7596616|FG001|COMPLETED|Second Intervention (7 Days)||16
6666085|NCT02537730|7596615|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6666086|NCT02537730|7596616|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6666087|NCT02537873|7596624|FG000|STARTED|Overall Study||17
6666088|NCT02537873|7596625|FG001|STARTED|Overall Study||8
6666089|NCT02537873|7596624|FG000|COMPLETED|Overall Study||9
6666090|NCT02537873|7596625|FG001|COMPLETED|Overall Study||4
6666091|NCT02537873|7596624|FG000|NOT COMPLETED|Overall Study||8
6666092|NCT02537873|7596625|FG001|NOT COMPLETED|Overall Study||4
6666093|NCT02537951|7596632|FG000|STARTED|Overall Study||10
6666094|NCT02537951|7596632|FG000|COMPLETED|Overall Study||10
6666095|NCT02537951|7596632|FG000|NOT COMPLETED|Overall Study||0
6666096|NCT02538016|7596640|FG000|STARTED|Overall Study||4
6666097|NCT02538016|7596640|FG000|COMPLETED|Overall Study||4
6666098|NCT02538016|7596640|FG000|NOT COMPLETED|Overall Study||0
6666099|NCT02538029|7596647|FG000|STARTED|Overall Study||24
6666100|NCT02538029|7596648|FG001|STARTED|Overall Study||10
6666101|NCT02538029|7596649|FG002|STARTED|Overall Study||11
6666102|NCT02538029|7596647|FG000|COMPLETED|Overall Study||23
6666103|NCT02538029|7596648|FG001|COMPLETED|Overall Study||10
6666104|NCT02538029|7596649|FG002|COMPLETED|Overall Study||10
6666105|NCT02538029|7596647|FG000|NOT COMPLETED|Overall Study||1
6666106|NCT02538029|7596648|FG001|NOT COMPLETED|Overall Study||0
6666107|NCT02538029|7596649|FG002|NOT COMPLETED|Overall Study||1
6666108|NCT02538042|7596661|FG000|STARTED|Overall Study||17
6666109|NCT02538042|7596662|FG001|STARTED|Overall Study||17
6666110|NCT02538042|7596661|FG000|Completed All MCE Sessions|Overall Study||15
6666111|NCT02538042|7596662|FG001|Completed All MCE Sessions|Overall Study||15
6666112|NCT02538042|7596661|FG000|Attended Post-Quit Visit|Overall Study||15
6666113|NCT02538042|7596662|FG001|Attended Post-Quit Visit|Overall Study||14
6666114|NCT02538042|7596661|FG000|Completed All Post-Quit Visits|Overall Study||12
6666115|NCT02538042|7596662|FG001|Completed All Post-Quit Visits|Overall Study||12
6666116|NCT02538042|7596661|FG000|COMPLETED|Overall Study||6
6666117|NCT02538042|7596662|FG001|COMPLETED|Overall Study||6
6666118|NCT02538042|7596661|FG000|NOT COMPLETED|Overall Study||11
6666119|NCT02538042|7596662|FG001|NOT COMPLETED|Overall Study||11
6666120|NCT02538094|7596670|FG000|STARTED|Intervention 1 (5 Days Per Participant)||2
6666121|NCT02538094|7596671|FG001|STARTED|Intervention 1 (5 Days Per Participant)||5
6666122|NCT02538094|7596670|FG000|COMPLETED|Intervention 1 (5 Days Per Participant)||2
6666123|NCT02538094|7596671|FG001|COMPLETED|Intervention 1 (5 Days Per Participant)||4
6666124|NCT02538094|7596670|FG000|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||0
6666125|NCT02538094|7596671|FG001|NOT COMPLETED|Intervention 1 (5 Days Per Participant)||1
6666126|NCT02538094|7596670|FG000|STARTED|Washout (4 Weeks)||2
6666127|NCT02538094|7596671|FG001|STARTED|Washout (4 Weeks)||4
6666128|NCT02538094|7596670|FG000|COMPLETED|Washout (4 Weeks)||2
6666129|NCT02538094|7596671|FG001|COMPLETED|Washout (4 Weeks)||3
6666130|NCT02538094|7596670|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6666131|NCT02538094|7596671|FG001|NOT COMPLETED|Washout (4 Weeks)||1
6666132|NCT02538094|7596670|FG000|STARTED|Intervention 2 (5 Days Per Participant)||2
6666133|NCT02538094|7596671|FG001|STARTED|Intervention 2 (5 Days Per Participant)||3
6666134|NCT02538094|7596670|FG000|COMPLETED|Intervention 2 (5 Days Per Participant)||2
6666135|NCT02538094|7596671|FG001|COMPLETED|Intervention 2 (5 Days Per Participant)||3
6666136|NCT02538094|7596670|FG000|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
6666137|NCT02538094|7596671|FG001|NOT COMPLETED|Intervention 2 (5 Days Per Participant)||0
6666138|NCT02538107|7596677|FG000|STARTED|Overall Study||290
6666139|NCT02538107|7596677|FG000|COMPLETED|Overall Study||180
6666140|NCT02538107|7596677|FG000|NOT COMPLETED|Overall Study||110
6666141|NCT02538341|7596693|FG000|STARTED|Overall Study||310
6666142|NCT02538341|7596694|FG001|STARTED|Overall Study||307
6666143|NCT02538341|7596693|FG000|Week 6 (Primary Outcome)|Overall Study||303
6666144|NCT02538341|7596694|FG001|Week 6 (Primary Outcome)|Overall Study||299
6666145|NCT02538341|7596693|FG000|Month 6 (Safety Outcome)|Overall Study||276
6666146|NCT02538341|7596694|FG001|Month 6 (Safety Outcome)|Overall Study||260
6666147|NCT02538341|7596693|FG000|1 Year Visit|Overall Study||254
6666148|NCT02538341|7596694|FG001|1 Year Visit|Overall Study||0
6666149|NCT02538341|7596693|FG000|COMPLETED|Overall Study||254
6666150|NCT02538341|7596694|FG001|COMPLETED|Overall Study||260
6666151|NCT02538341|7596693|FG000|NOT COMPLETED|Overall Study||56
6666152|NCT02538341|7596694|FG001|NOT COMPLETED|Overall Study||47
6666153|NCT02538354|7596702|FG000|STARTED|Overall Study||40
6666154|NCT02538354|7596703|FG001|STARTED|Overall Study||30
6666155|NCT02538354|7596702|FG000|COMPLETED|Overall Study||40
6666156|NCT02538354|7596703|FG001|COMPLETED|Overall Study||30
6666157|NCT02538354|7596702|FG000|NOT COMPLETED|Overall Study||0
6666158|NCT02538354|7596703|FG001|NOT COMPLETED|Overall Study||0
6666159|NCT02538419|7596711|FG000|STARTED|Overall Study||20
6666160|NCT02538419|7596712|FG001|STARTED|Overall Study||20
6666161|NCT02538419|7596711|FG000|COMPLETED|Overall Study||20
6666162|NCT02538419|7596712|FG001|COMPLETED|Overall Study||20
6666163|NCT02538419|7596711|FG000|NOT COMPLETED|Overall Study||0
6666164|NCT02538419|7596712|FG001|NOT COMPLETED|Overall Study||0
6666165|NCT02538471|7596718|FG000|STARTED|Overall Study||3
6666166|NCT02538471|7596718|FG000|COMPLETED|Overall Study||1
6666167|NCT02538471|7596718|FG000|NOT COMPLETED|Overall Study||2
6666168|NCT02538523|7596724|FG000|STARTED|Overall Study||29
6666169|NCT02538523|7596725|FG001|STARTED|Overall Study||29
6666170|NCT02538523|7596724|FG000|COMPLETED|Overall Study||29
6666171|NCT02538523|7596725|FG001|COMPLETED|Overall Study||29
6666172|NCT02538523|7596724|FG000|NOT COMPLETED|Overall Study||0
6666173|NCT02538523|7596725|FG001|NOT COMPLETED|Overall Study||0
6666174|NCT02538614|7596731|FG000|STARTED|Overall Study||2
6666175|NCT02538614|7596731|FG000|COMPLETED|Overall Study||0
6666176|NCT02538614|7596731|FG000|NOT COMPLETED|Overall Study||2
6666177|NCT02538679|7596740|FG000|STARTED|Overall Study||24
6666178|NCT02538679|7596741|FG001|STARTED|Overall Study||54
6666179|NCT02538679|7596742|FG002|STARTED|Overall Study||49
6666180|NCT02538679|7596740|FG000|COMPLETED|Overall Study||21
6666181|NCT02538679|7596741|FG001|COMPLETED|Overall Study||45
6666182|NCT02538679|7596742|FG002|COMPLETED|Overall Study||41
6666183|NCT02538679|7596740|FG000|NOT COMPLETED|Overall Study||3
6666184|NCT02538679|7596741|FG001|NOT COMPLETED|Overall Study||9
6666185|NCT02538679|7596742|FG002|NOT COMPLETED|Overall Study||8
6666186|NCT02538783|7596752|FG000|STARTED|Overall Study||130
6666187|NCT02538783|7596753|FG001|STARTED|Overall Study||129
6666188|NCT02538783|7596752|FG000|COMPLETED|Overall Study||130
6666189|NCT02538783|7596753|FG001|COMPLETED|Overall Study||128
6666190|NCT02538783|7596752|FG000|NOT COMPLETED|Overall Study||0
6666191|NCT02538783|7596753|FG001|NOT COMPLETED|Overall Study||1
6666192|NCT02538900|7596762|FG000|STARTED|Overall Study||116
6666193|NCT02538900|7596763|FG001|STARTED|Overall Study||124
6666194|NCT02538900|7596764|FG002|STARTED|Overall Study||65
6666195|NCT02538900|7596762|FG000|COMPLETED|Overall Study||96
6666196|NCT02538900|7596763|FG001|COMPLETED|Overall Study||106
6666197|NCT02538900|7596764|FG002|COMPLETED|Overall Study||48
6666198|NCT02538900|7596762|FG000|NOT COMPLETED|Overall Study||20
6666199|NCT02538900|7596763|FG001|NOT COMPLETED|Overall Study||18
6666200|NCT02538900|7596764|FG002|NOT COMPLETED|Overall Study||17
6666201|NCT02538965|7596772|FG000|STARTED|Treatment Period||17
6666202|NCT02538965|7596772|FG000|COMPLETED|Treatment Period||0
6666203|NCT02538965|7596772|FG000|NOT COMPLETED|Treatment Period||17
6666204|NCT02538965|7596772|FG000|STARTED|Follow-Up Period||17
6666205|NCT02538965|7596772|FG000|COMPLETED|Follow-Up Period||0
6666206|NCT02538965|7596772|FG000|NOT COMPLETED|Follow-Up Period||17
6666207|NCT02539108|7596778|FG000|STARTED|Overall Study||30
6666208|NCT02539108|7596779|FG001|STARTED|Overall Study||30
6666209|NCT02539108|7596778|FG000|COMPLETED|Overall Study||30
6666210|NCT02539108|7596779|FG001|COMPLETED|Overall Study||30
6666211|NCT02539108|7596778|FG000|NOT COMPLETED|Overall Study||0
6666212|NCT02539108|7596779|FG001|NOT COMPLETED|Overall Study||0
6666213|NCT02539134|7596791|FG000|STARTED|Overall Study||10
6666214|NCT02539134|7596792|FG001|STARTED|Overall Study||6
6666215|NCT02539134|7596793|FG002|STARTED|Overall Study||6
6666216|NCT02539134|7596794|FG003|STARTED|Overall Study||6
6666217|NCT02539134|7596795|FG004|STARTED|Overall Study||6
6666218|NCT02539134|7596796|FG005|STARTED|Overall Study||6
6666219|NCT02539134|7596791|FG000|COMPLETED|Overall Study||9
6666220|NCT02539134|7596792|FG001|COMPLETED|Overall Study||6
6666221|NCT02539134|7596793|FG002|COMPLETED|Overall Study||6
6666222|NCT02539134|7596794|FG003|COMPLETED|Overall Study||6
6666223|NCT02539134|7596795|FG004|COMPLETED|Overall Study||6
6666224|NCT02539134|7596796|FG005|COMPLETED|Overall Study||6
6666225|NCT02539134|7596791|FG000|NOT COMPLETED|Overall Study||1
6666226|NCT02539134|7596792|FG001|NOT COMPLETED|Overall Study||0
6666227|NCT02539134|7596793|FG002|NOT COMPLETED|Overall Study||0
6666228|NCT02539134|7596794|FG003|NOT COMPLETED|Overall Study||0
6666229|NCT02539134|7596795|FG004|NOT COMPLETED|Overall Study||0
6666230|NCT02539134|7596796|FG005|NOT COMPLETED|Overall Study||0
6666231|NCT02539342|7596817|FG000|STARTED|Overall Study||1
6666232|NCT02539342|7596818|FG001|STARTED|Overall Study||0
6666233|NCT02539342|7596817|FG000|COMPLETED|Overall Study||1
6666234|NCT02539342|7596818|FG001|COMPLETED|Overall Study||0
6666235|NCT02539342|7596817|FG000|NOT COMPLETED|Overall Study||0
6666236|NCT02539342|7596818|FG001|NOT COMPLETED|Overall Study||0
6666237|NCT02539368|7596829|FG000|STARTED|Overall Study||1522
6666238|NCT02539368|7596830|FG001|STARTED|Overall Study||494
6666239|NCT02539368|7596831|FG002|STARTED|Overall Study||358
6666240|NCT02539368|7596832|FG003|STARTED|Overall Study||67
6666241|NCT02539368|7596833|FG004|STARTED|Overall Study||102
6666242|NCT02539368|7596829|FG000|COMPLETED|Overall Study||1117
6666243|NCT02539368|7596830|FG001|COMPLETED|Overall Study||393
6666244|NCT02539368|7596831|FG002|COMPLETED|Overall Study||291
6666245|NCT02539368|7596832|FG003|COMPLETED|Overall Study||60
6666246|NCT02539368|7596833|FG004|COMPLETED|Overall Study||88
6666247|NCT02539368|7596829|FG000|NOT COMPLETED|Overall Study||405
6666248|NCT02539368|7596830|FG001|NOT COMPLETED|Overall Study||101
6666249|NCT02539368|7596831|FG002|NOT COMPLETED|Overall Study||67
6666250|NCT02539368|7596832|FG003|NOT COMPLETED|Overall Study||7
6666251|NCT02539368|7596833|FG004|NOT COMPLETED|Overall Study||14
6666252|NCT02539459|7596848|FG000|STARTED|Overall Study||20
6666253|NCT02539459|7596848|FG000|COMPLETED|Overall Study||18
6666254|NCT02539459|7596848|FG000|NOT COMPLETED|Overall Study||2
6666255|NCT02539511|7596854|FG000|STARTED|Overall Study||23
6666256|NCT02539511|7596855|FG001|STARTED|Overall Study||17
6666257|NCT02539511|7596854|FG000|COMPLETED|Overall Study||17
6666258|NCT02539511|7596855|FG001|COMPLETED|Overall Study||17
6666259|NCT02539511|7596854|FG000|NOT COMPLETED|Overall Study||6
6666260|NCT02539511|7596855|FG001|NOT COMPLETED|Overall Study||0
6666261|NCT02539654|7596861|FG000|STARTED|Overall Study||14
6666262|NCT02539654|7596861|FG000|COMPLETED|Overall Study||14
6666263|NCT02539654|7596861|FG000|NOT COMPLETED|Overall Study||0
6666264|NCT02539797|7596866|FG000|STARTED|Overall Study||12
6666265|NCT02539797|7596867|FG001|STARTED|Overall Study||13
6666266|NCT02539797|7596868|FG002|STARTED|Overall Study||13
6666267|NCT02539797|7596866|FG000|COMPLETED|Overall Study||12
6666268|NCT02539797|7596867|FG001|COMPLETED|Overall Study||12
6666269|NCT02539797|7596868|FG002|COMPLETED|Overall Study||13
6666270|NCT02539797|7596866|FG000|NOT COMPLETED|Overall Study||0
6666271|NCT02539797|7596867|FG001|NOT COMPLETED|Overall Study||1
6666272|NCT02539797|7596868|FG002|NOT COMPLETED|Overall Study||0
6666273|NCT02539992|7596879|FG000|STARTED|Overall Study||15
6666274|NCT02539992|7596880|FG001|STARTED|Overall Study||11
6666275|NCT02539992|7596881|FG002|STARTED|Overall Study||18
6666276|NCT02539992|7596879|FG000|COMPLETED|Overall Study||15
6666277|NCT02539992|7596880|FG001|COMPLETED|Overall Study||7
6666278|NCT02539992|7596881|FG002|COMPLETED|Overall Study||14
6666279|NCT02539992|7596879|FG000|NOT COMPLETED|Overall Study||0
6666280|NCT02539992|7596880|FG001|NOT COMPLETED|Overall Study||4
6666281|NCT02539992|7596881|FG002|NOT COMPLETED|Overall Study||4
6666282|NCT02540083|7596891|FG000|STARTED|Overall Study||94
6666283|NCT02540083|7596891|FG000|COMPLETED|Overall Study||78
6666284|NCT02540083|7596891|FG000|NOT COMPLETED|Overall Study||16
6666285|NCT02540161|7596899|FG000|STARTED|Overall Study||20
6666286|NCT02540161|7596900|FG001|STARTED|Overall Study||7
6666287|NCT02540161|7596901|FG002|STARTED|Overall Study||5
6666288|NCT02540161|7596902|FG003|STARTED|Overall Study||7
6666289|NCT02540161|7596899|FG000|COMPLETED|Overall Study||20
6666290|NCT02540161|7596900|FG001|COMPLETED|Overall Study||7
6666291|NCT02540161|7596901|FG002|COMPLETED|Overall Study||5
6666292|NCT02540161|7596902|FG003|COMPLETED|Overall Study||7
6666293|NCT02540161|7596899|FG000|NOT COMPLETED|Overall Study||0
6666294|NCT02540161|7596900|FG001|NOT COMPLETED|Overall Study||0
6666295|NCT02540161|7596901|FG002|NOT COMPLETED|Overall Study||0
6666296|NCT02540161|7596902|FG003|NOT COMPLETED|Overall Study||0
6666297|NCT02540213|7596912|FG000|STARTED|Overall Study||240
6666298|NCT02540213|7596912|FG000|COMPLETED|Overall Study||201
6666299|NCT02540213|7596912|FG000|NOT COMPLETED|Overall Study||39
6666300|NCT02540226|7596918|FG000|STARTED|Overall Study||33
6666301|NCT02540226|7596919|FG001|STARTED|Overall Study||33
6666302|NCT02540226|7596918|FG000|COMPLETED|Overall Study||31
6666303|NCT02540226|7596919|FG001|COMPLETED|Overall Study||32
6666304|NCT02540226|7596918|FG000|NOT COMPLETED|Overall Study||2
6666305|NCT02540226|7596919|FG001|NOT COMPLETED|Overall Study||1
6666306|NCT02540265|7596928|FG000|STARTED|Overall Study||20
6666307|NCT02540265|7596929|FG001|STARTED|Overall Study||20
6666308|NCT02540265|7596930|FG002|STARTED|Overall Study||19
6666309|NCT02540265|7596928|FG000|Treatment Completion|Overall Study||20
6666310|NCT02540265|7596929|FG001|Treatment Completion|Overall Study||19
6666311|NCT02540265|7596930|FG002|Treatment Completion|Overall Study||18
6666312|NCT02540265|7596928|FG000|COMPLETED|Overall Study||20
6666313|NCT02540265|7596929|FG001|COMPLETED|Overall Study||20
6666314|NCT02540265|7596930|FG002|COMPLETED|Overall Study||18
6666315|NCT02540265|7596928|FG000|NOT COMPLETED|Overall Study||0
6666316|NCT02540265|7596929|FG001|NOT COMPLETED|Overall Study||0
6666317|NCT02540265|7596930|FG002|NOT COMPLETED|Overall Study||1
6666318|NCT02540291|7596942|FG000|STARTED|Overall Study||8
6666319|NCT02540291|7596943|FG001|STARTED|Overall Study||8
6666320|NCT02540291|7596944|FG002|STARTED|Overall Study||7
6666321|NCT02540291|7596945|FG003|STARTED|Overall Study||7
6666322|NCT02540291|7596942|FG000|COMPLETED|Overall Study||0
6666323|NCT02540291|7596943|FG001|COMPLETED|Overall Study||0
6666324|NCT02540291|7596944|FG002|COMPLETED|Overall Study||0
6666325|NCT02540291|7596945|FG003|COMPLETED|Overall Study||0
6666326|NCT02540291|7596942|FG000|NOT COMPLETED|Overall Study||8
6666327|NCT02540291|7596943|FG001|NOT COMPLETED|Overall Study||8
6666328|NCT02540291|7596944|FG002|NOT COMPLETED|Overall Study||7
6666329|NCT02540291|7596945|FG003|NOT COMPLETED|Overall Study||7
6666330|NCT02540356|7596959|FG000|STARTED|Overall Study||1
6666331|NCT02540356|7596960|FG001|STARTED|Overall Study||0
6666332|NCT02540356|7596959|FG000|COMPLETED|Overall Study||0
6666333|NCT02540356|7596960|FG001|COMPLETED|Overall Study||0
6666334|NCT02540356|7596959|FG000|NOT COMPLETED|Overall Study||1
6666335|NCT02540356|7596960|FG001|NOT COMPLETED|Overall Study||0
6666336|NCT02540447|7596967|FG000|STARTED|Overall Study||40
6666337|NCT02540447|7596968|FG001|STARTED|Overall Study||40
6666338|NCT02540447|7596967|FG000|COMPLETED|Overall Study||40
6666339|NCT02540447|7596968|FG001|COMPLETED|Overall Study||40
6666340|NCT02540447|7596967|FG000|NOT COMPLETED|Overall Study||0
6666341|NCT02540447|7596968|FG001|NOT COMPLETED|Overall Study||0
6666342|NCT02540538|7596977|FG000|STARTED|Overall Study||12
6666343|NCT02540538|7596978|FG001|STARTED|Overall Study||12
6666344|NCT02540538|7596979|FG002|STARTED|Overall Study||10
6666345|NCT02540538|7596977|FG000|COMPLETED|Overall Study||12
6666346|NCT02540538|7596978|FG001|COMPLETED|Overall Study||11
6666347|NCT02540538|7596979|FG002|COMPLETED|Overall Study||10
6666348|NCT02540538|7596977|FG000|NOT COMPLETED|Overall Study||0
6666349|NCT02540538|7596978|FG001|NOT COMPLETED|Overall Study||1
6666350|NCT02540538|7596979|FG002|NOT COMPLETED|Overall Study||0
6666351|NCT02540629|7596989|FG000|STARTED|Overall Study||6201
6666352|NCT02540629|7596990|FG001|STARTED|Overall Study||6469
6666353|NCT02540629|7596989|FG000|COMPLETED|Overall Study||6201
6666354|NCT02540629|7596990|FG001|COMPLETED|Overall Study||6469
6666355|NCT02540629|7596989|FG000|NOT COMPLETED|Overall Study||0
6666356|NCT02540629|7596990|FG001|NOT COMPLETED|Overall Study||0
6666357|NCT02540668|7596997|FG000|STARTED|Period 1 - Warfarin Single Dose||15
6666358|NCT02540668|7596998|FG001|STARTED|Period 1 - Warfarin Single Dose||0
6666359|NCT02540668|7596997|FG000|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||15
6666360|NCT02540668|7596998|FG001|Received at Least One Dose of Study Drug|Period 1 - Warfarin Single Dose||0
6666361|NCT02540668|7596997|FG000|COMPLETED|Period 1 - Warfarin Single Dose||15
6666362|NCT02540668|7596998|FG001|COMPLETED|Period 1 - Warfarin Single Dose||0
6666363|NCT02540668|7596997|FG000|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
6666364|NCT02540668|7596998|FG001|NOT COMPLETED|Period 1 - Warfarin Single Dose||0
6666365|NCT02540668|7596997|FG000|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was administered alone only in Period 1.|0
6666366|NCT02540668|7596998|FG001|STARTED|Period 2 - LY3314814 and Warfarin|Warfarin was co-administered with LY3314814 only in Period 2.|15
6666367|NCT02540668|7596997|FG000|COMPLETED|Period 2 - LY3314814 and Warfarin||0
6666368|NCT02540668|7596998|FG001|COMPLETED|Period 2 - LY3314814 and Warfarin||14
6666369|NCT02540668|7596997|FG000|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||0
6666370|NCT02540668|7596998|FG001|NOT COMPLETED|Period 2 - LY3314814 and Warfarin||1
6666371|NCT02540772|7597007|FG000|STARTED|Overall Study||10
6666372|NCT02540772|7597008|FG001|STARTED|Overall Study||10
6666373|NCT02540772|7597007|FG000|COMPLETED|Overall Study||10
6666374|NCT02540772|7597008|FG001|COMPLETED|Overall Study||10
6666375|NCT02540772|7597007|FG000|NOT COMPLETED|Overall Study||0
6666376|NCT02540772|7597008|FG001|NOT COMPLETED|Overall Study||0
6666377|NCT02540850|7597017|FG000|STARTED|Overall Study||360
6666378|NCT02540850|7597018|FG001|STARTED|Overall Study||396
6666379|NCT02540850|7597019|FG002|STARTED|Overall Study||444
6666380|NCT02540850|7597017|FG000|COMPLETED|Overall Study||291
6666381|NCT02540850|7597018|FG001|COMPLETED|Overall Study||330
6666382|NCT02540850|7597019|FG002|COMPLETED|Overall Study||410
6666383|NCT02540850|7597017|FG000|NOT COMPLETED|Overall Study||69
6666384|NCT02540850|7597018|FG001|NOT COMPLETED|Overall Study||66
6666385|NCT02540850|7597019|FG002|NOT COMPLETED|Overall Study||34
6666386|NCT02540954|7597029|FG000|STARTED|Overall Study||168
6666387|NCT02540954|7597030|FG001|STARTED|Overall Study||168
6666388|NCT02540954|7597029|FG000|Treated|Overall Study||167
6666389|NCT02540954|7597030|FG001|Treated|Overall Study||168
6666390|NCT02540954|7597029|FG000|Post-baseline BCVA Assessment|Overall Study|FAS|165
6666391|NCT02540954|7597030|FG001|Post-baseline BCVA Assessment|Overall Study|FAS|167
6666392|NCT02540954|7597029|FG000|COMPLETED|Overall Study|Completed treatment|149
6666393|NCT02540954|7597030|FG001|COMPLETED|Overall Study|Completed treatment|154
6666394|NCT02540954|7597029|FG000|NOT COMPLETED|Overall Study||19
6666395|NCT02540954|7597030|FG001|NOT COMPLETED|Overall Study||14
6666396|NCT02540993|7597038|FG000|STARTED|Overall Study||2866
6666397|NCT02540993|7597039|FG001|STARTED|Overall Study||2868
6666398|NCT02540993|7597038|FG000|Included in FAS|Overall Study||2833
6666399|NCT02540993|7597039|FG001|Included in FAS|Overall Study||2841
6666400|NCT02540993|7597038|FG000|Treated|Overall Study||2827
6666401|NCT02540993|7597039|FG001|Treated|Overall Study||2831
6666402|NCT02540993|7597038|FG000|COMPLETED|Overall Study||2824
6666403|NCT02540993|7597039|FG001|COMPLETED|Overall Study||2832
6666404|NCT02540993|7597038|FG000|NOT COMPLETED|Overall Study||42
6666405|NCT02540993|7597039|FG001|NOT COMPLETED|Overall Study||36
6666406|NCT02541409|7597047|FG000|STARTED|Overall Study||25
6666407|NCT02541409|7597048|FG001|STARTED|Overall Study||25
6666408|NCT02541409|7597047|FG000|COMPLETED|Overall Study||22
6666409|NCT02541409|7597048|FG001|COMPLETED|Overall Study||22
6666410|NCT02541409|7597047|FG000|NOT COMPLETED|Overall Study||3
6666411|NCT02541409|7597048|FG001|NOT COMPLETED|Overall Study||3
6666412|NCT02541422|7597054|FG000|STARTED|First Intervention||23
6666413|NCT02541422|7597055|FG001|STARTED|First Intervention||26
6666414|NCT02541422|7597054|FG000|COMPLETED|First Intervention||23
6666415|NCT02541422|7597055|FG001|COMPLETED|First Intervention||26
6666416|NCT02541422|7597054|FG000|NOT COMPLETED|First Intervention||0
6666417|NCT02541422|7597055|FG001|NOT COMPLETED|First Intervention||0
6666418|NCT02541422|7597054|FG000|STARTED|Second Intervention||23
6666419|NCT02541422|7597055|FG001|STARTED|Second Intervention||26
6666420|NCT02541422|7597054|FG000|COMPLETED|Second Intervention||23
6666421|NCT02541422|7597055|FG001|COMPLETED|Second Intervention||26
6666422|NCT02541422|7597054|FG000|NOT COMPLETED|Second Intervention||0
6666423|NCT02541422|7597055|FG001|NOT COMPLETED|Second Intervention||0
6666424|NCT02541565|7597061|FG000|STARTED|Overall Study||30
6666425|NCT02541565|7597061|FG000|COMPLETED|Overall Study||27
6666426|NCT02541565|7597061|FG000|NOT COMPLETED|Overall Study||3
6737782|NCT03270943|7667014|FG000|STARTED|Intervention Refinement||6
6737783|NCT03270943|7667015|FG001|STARTED|Intervention Refinement||9
6737784|NCT03270943|7667014|FG000|COMPLETED|Intervention Refinement||6
6737785|NCT03270943|7667015|FG001|COMPLETED|Intervention Refinement||6
6737786|NCT03270943|7667014|FG000|NOT COMPLETED|Intervention Refinement||0
6737787|NCT03270943|7667015|FG001|NOT COMPLETED|Intervention Refinement||3
6737788|NCT03270943|7667014|FG000|STARTED|Randomized (Willingness to be)||30
6737789|NCT03270943|7667015|FG001|STARTED|Randomized (Willingness to be)||32
6737790|NCT03270943|7667014|FG000|COMPLETED|Randomized (Willingness to be)||30
6737791|NCT03270943|7667015|FG001|COMPLETED|Randomized (Willingness to be)||31
6737792|NCT03270943|7667014|FG000|NOT COMPLETED|Randomized (Willingness to be)||0
6737793|NCT03270943|7667015|FG001|NOT COMPLETED|Randomized (Willingness to be)||1
6737794|NCT03271307|7667026|FG000|STARTED|Overall Study||1951
6737795|NCT03271307|7667027|FG001|STARTED|Overall Study||1837
6737796|NCT03271307|7667028|FG002|STARTED|Overall Study||2097
6737797|NCT03271307|7667029|FG003|STARTED|Overall Study||135
6737798|NCT03271307|7667030|FG004|STARTED|Overall Study||349
6737799|NCT03271307|7667026|FG000|COMPLETED|Overall Study||1951
6737800|NCT03271307|7667027|FG001|COMPLETED|Overall Study||1837
6737801|NCT03271307|7667028|FG002|COMPLETED|Overall Study||2097
6737802|NCT03271307|7667029|FG003|COMPLETED|Overall Study||107
6737803|NCT03271307|7667030|FG004|COMPLETED|Overall Study||258
6737804|NCT03271307|7667026|FG000|NOT COMPLETED|Overall Study||0
6737805|NCT03271307|7667027|FG001|NOT COMPLETED|Overall Study||0
6737806|NCT03271307|7667028|FG002|NOT COMPLETED|Overall Study||0
6737807|NCT03271307|7667029|FG003|NOT COMPLETED|Overall Study||28
6737808|NCT03271307|7667030|FG004|NOT COMPLETED|Overall Study||91
6737809|NCT03271424|7667048|FG000|STARTED|November 2015||20
6737810|NCT03271424|7667049|FG001|STARTED|November 2015||0
6737811|NCT03271424|7667050|FG002|STARTED|November 2015||0
6737812|NCT03271424|7667048|FG000|COMPLETED|November 2015||20
6737813|NCT03271424|7667049|FG001|COMPLETED|November 2015||0
6737814|NCT03271424|7667050|FG002|COMPLETED|November 2015||0
6737815|NCT03271424|7667048|FG000|NOT COMPLETED|November 2015||0
6737816|NCT03271424|7667049|FG001|NOT COMPLETED|November 2015||0
6737817|NCT03271424|7667050|FG002|NOT COMPLETED|November 2015||0
6737818|NCT03271424|7667048|FG000|STARTED|December 2015||0
6737819|NCT03271424|7667049|FG001|STARTED|December 2015||35
6737820|NCT03271424|7667050|FG002|STARTED|December 2015||0
6737821|NCT03271424|7667048|FG000|COMPLETED|December 2015||0
6737822|NCT03271424|7667049|FG001|COMPLETED|December 2015||35
6737823|NCT03271424|7667050|FG002|COMPLETED|December 2015||0
6737824|NCT03271424|7667048|FG000|NOT COMPLETED|December 2015||0
6737825|NCT03271424|7667049|FG001|NOT COMPLETED|December 2015||0
6737826|NCT03271424|7667050|FG002|NOT COMPLETED|December 2015||0
6737827|NCT03271424|7667048|FG000|STARTED|April-May 2016||0
6737828|NCT03271424|7667049|FG001|STARTED|April-May 2016||0
6737829|NCT03271424|7667050|FG002|STARTED|April-May 2016||40
6737830|NCT03271424|7667048|FG000|COMPLETED|April-May 2016||0
6737831|NCT03271424|7667049|FG001|COMPLETED|April-May 2016||0
6737832|NCT03271424|7667050|FG002|COMPLETED|April-May 2016||40
6737833|NCT03271424|7667048|FG000|NOT COMPLETED|April-May 2016||0
6737834|NCT03271424|7667049|FG001|NOT COMPLETED|April-May 2016||0
6737835|NCT03271424|7667050|FG002|NOT COMPLETED|April-May 2016||0
6737836|NCT03271528|7667062|FG000|STARTED|Medication Dispense/Exposure Period 1||13
6737837|NCT03271528|7667063|FG001|STARTED|Medication Dispense/Exposure Period 1||14
6737838|NCT03271528|7667062|FG000|COMPLETED|Medication Dispense/Exposure Period 1||11
6737839|NCT03271528|7667063|FG001|COMPLETED|Medication Dispense/Exposure Period 1||12
6737840|NCT03271528|7667062|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
6737841|NCT03271528|7667063|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 1||2
6737842|NCT03271528|7667062|FG000|STARTED|Alcohol Trial 1, Washout Period 1||11
6737843|NCT03271528|7667063|FG001|STARTED|Alcohol Trial 1, Washout Period 1||12
6737844|NCT03271528|7667062|FG000|COMPLETED|Alcohol Trial 1, Washout Period 1||9
6737845|NCT03271528|7667063|FG001|COMPLETED|Alcohol Trial 1, Washout Period 1||11
6737846|NCT03271528|7667062|FG000|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||2
6737847|NCT03271528|7667063|FG001|NOT COMPLETED|Alcohol Trial 1, Washout Period 1||1
6737848|NCT03271528|7667062|FG000|STARTED|Medication Dispense/Exposure Period 2||9
6737849|NCT03271528|7667063|FG001|STARTED|Medication Dispense/Exposure Period 2||11
6737850|NCT03271528|7667062|FG000|COMPLETED|Medication Dispense/Exposure Period 2||8
6666427|NCT02541604|7597077|FG000|STARTED|Overall Study||11
6666428|NCT02541604|7597078|FG001|STARTED|Overall Study||9
6666429|NCT02541604|7597079|FG002|STARTED|Overall Study||11
6666430|NCT02541604|7597080|FG003|STARTED|Overall Study||3
6666431|NCT02541604|7597081|FG004|STARTED|Overall Study||10
6666432|NCT02541604|7597082|FG005|STARTED|Overall Study||10
6666433|NCT02541604|7597083|FG006|STARTED|Overall Study||10
6666434|NCT02541604|7597084|FG007|STARTED|Overall Study||10
6666435|NCT02541604|7597085|FG008|STARTED|Overall Study||4
6666436|NCT02541604|7597086|FG009|STARTED|Overall Study||4
6666437|NCT02541604|7597087|FG010|STARTED|Overall Study||2
6666438|NCT02541604|7597088|FG011|STARTED|Overall Study||3
6666439|NCT02541604|7597077|FG000|COMPLETED|Overall Study||0
6666440|NCT02541604|7597078|FG001|COMPLETED|Overall Study||0
6666441|NCT02541604|7597079|FG002|COMPLETED|Overall Study||0
6666442|NCT02541604|7597080|FG003|COMPLETED|Overall Study||0
6666443|NCT02541604|7597081|FG004|COMPLETED|Overall Study||0
6666444|NCT02541604|7597082|FG005|COMPLETED|Overall Study||0
6666445|NCT02541604|7597083|FG006|COMPLETED|Overall Study||0
6666446|NCT02541604|7597084|FG007|COMPLETED|Overall Study||0
6666447|NCT02541604|7597085|FG008|COMPLETED|Overall Study||0
6666448|NCT02541604|7597086|FG009|COMPLETED|Overall Study||0
6666449|NCT02541604|7597087|FG010|COMPLETED|Overall Study||0
6666450|NCT02541604|7597088|FG011|COMPLETED|Overall Study||0
6666451|NCT02541604|7597077|FG000|NOT COMPLETED|Overall Study||11
6666452|NCT02541604|7597078|FG001|NOT COMPLETED|Overall Study||9
6666453|NCT02541604|7597079|FG002|NOT COMPLETED|Overall Study||11
6666454|NCT02541604|7597080|FG003|NOT COMPLETED|Overall Study||3
6666455|NCT02541604|7597081|FG004|NOT COMPLETED|Overall Study||10
6666456|NCT02541604|7597082|FG005|NOT COMPLETED|Overall Study||10
6666457|NCT02541604|7597083|FG006|NOT COMPLETED|Overall Study||10
6666458|NCT02541604|7597084|FG007|NOT COMPLETED|Overall Study||10
6666459|NCT02541604|7597085|FG008|NOT COMPLETED|Overall Study||4
6666460|NCT02541604|7597086|FG009|NOT COMPLETED|Overall Study||4
6666461|NCT02541604|7597087|FG010|NOT COMPLETED|Overall Study||2
6666462|NCT02541604|7597088|FG011|NOT COMPLETED|Overall Study||3
6666463|NCT02541669|7597142|FG000|STARTED|Open Label Treatment Period||8
6666464|NCT02541669|7597143|FG001|STARTED|Open Label Treatment Period||8
6666465|NCT02541669|7597144|FG002|STARTED|Open Label Treatment Period||0
6666466|NCT02541669|7597145|FG003|STARTED|Open Label Treatment Period||0
6666467|NCT02541669|7597146|FG004|STARTED|Open Label Treatment Period||0
6666468|NCT02541669|7597142|FG000|COMPLETED|Open Label Treatment Period||8
6666469|NCT02541669|7597143|FG001|COMPLETED|Open Label Treatment Period||8
6666470|NCT02541669|7597144|FG002|COMPLETED|Open Label Treatment Period||0
6666471|NCT02541669|7597145|FG003|COMPLETED|Open Label Treatment Period||0
6666472|NCT02541669|7597146|FG004|COMPLETED|Open Label Treatment Period||0
6666473|NCT02541669|7597142|FG000|NOT COMPLETED|Open Label Treatment Period||0
6666474|NCT02541669|7597143|FG001|NOT COMPLETED|Open Label Treatment Period||0
6666475|NCT02541669|7597144|FG002|NOT COMPLETED|Open Label Treatment Period||0
6666476|NCT02541669|7597145|FG003|NOT COMPLETED|Open Label Treatment Period||0
6666477|NCT02541669|7597146|FG004|NOT COMPLETED|Open Label Treatment Period||0
6666478|NCT02541669|7597142|FG000|STARTED|Double-Blinded Treatment Period||0
6666479|NCT02541669|7597143|FG001|STARTED|Double-Blinded Treatment Period||0
6666480|NCT02541669|7597144|FG002|STARTED|Double-Blinded Treatment Period||16
6666481|NCT02541669|7597145|FG003|STARTED|Double-Blinded Treatment Period||16
6666482|NCT02541669|7597146|FG004|STARTED|Double-Blinded Treatment Period||16
6666483|NCT02541669|7597142|FG000|COMPLETED|Double-Blinded Treatment Period||0
6666484|NCT02541669|7597143|FG001|COMPLETED|Double-Blinded Treatment Period||0
6666485|NCT02541669|7597144|FG002|COMPLETED|Double-Blinded Treatment Period||15
6666486|NCT02541669|7597145|FG003|COMPLETED|Double-Blinded Treatment Period||16
6666487|NCT02541669|7597146|FG004|COMPLETED|Double-Blinded Treatment Period||15
6666488|NCT02541669|7597142|FG000|NOT COMPLETED|Double-Blinded Treatment Period||0
6666489|NCT02541669|7597143|FG001|NOT COMPLETED|Double-Blinded Treatment Period||0
6666490|NCT02541669|7597144|FG002|NOT COMPLETED|Double-Blinded Treatment Period||1
6666491|NCT02541669|7597145|FG003|NOT COMPLETED|Double-Blinded Treatment Period||0
6666492|NCT02541669|7597146|FG004|NOT COMPLETED|Double-Blinded Treatment Period||1
6666493|NCT02541812|7597159|FG000|STARTED|Overall Study||10
6666494|NCT02541812|7597160|FG001|STARTED|Overall Study||10
6666495|NCT02541812|7597159|FG000|COMPLETED|Overall Study||10
6666496|NCT02541812|7597160|FG001|COMPLETED|Overall Study||10
6666497|NCT02541812|7597159|FG000|NOT COMPLETED|Overall Study||0
6666498|NCT02541812|7597160|FG001|NOT COMPLETED|Overall Study||0
6666499|NCT02541864|7597169|FG000|STARTED|Overall Study||164
6666500|NCT02541864|7597170|FG001|STARTED|Overall Study||166
6666501|NCT02541864|7597169|FG000|COMPLETED|Overall Study||164
6666502|NCT02541864|7597170|FG001|COMPLETED|Overall Study||166
6666503|NCT02541864|7597169|FG000|NOT COMPLETED|Overall Study||0
6666504|NCT02541864|7597170|FG001|NOT COMPLETED|Overall Study||0
6666505|NCT02541903|7597176|FG000|STARTED|Overall Study||8
6666506|NCT02541903|7597176|FG000|COMPLETED|Overall Study||7
6666507|NCT02541903|7597176|FG000|NOT COMPLETED|Overall Study||1
6666508|NCT02541942|7597180|FG000|STARTED|Overall Study||19
6666509|NCT02541942|7597180|FG000|COMPLETED|Overall Study||19
6666510|NCT02541942|7597180|FG000|NOT COMPLETED|Overall Study||0
6666511|NCT02542046|7597187|FG000|STARTED|Overall Study||300
6666512|NCT02542046|7597188|FG001|STARTED|Overall Study||300
6666513|NCT02542046|7597189|FG002|STARTED|Overall Study||300
6666514|NCT02542046|7597187|FG000|COMPLETED|Overall Study||300
6666515|NCT02542046|7597188|FG001|COMPLETED|Overall Study||300
6666516|NCT02542046|7597189|FG002|COMPLETED|Overall Study||300
6666517|NCT02542046|7597187|FG000|NOT COMPLETED|Overall Study||0
6666518|NCT02542046|7597188|FG001|NOT COMPLETED|Overall Study||0
6666519|NCT02542046|7597189|FG002|NOT COMPLETED|Overall Study||0
6666520|NCT02542072|7597199|FG000|STARTED|First Intervention (1 Month)||44
6666521|NCT02542072|7597200|FG001|STARTED|First Intervention (1 Month)||46
6666522|NCT02542072|7597199|FG000|COMPLETED|First Intervention (1 Month)||39
6666523|NCT02542072|7597200|FG001|COMPLETED|First Intervention (1 Month)||43
6666524|NCT02542072|7597199|FG000|NOT COMPLETED|First Intervention (1 Month)||5
6666525|NCT02542072|7597200|FG001|NOT COMPLETED|First Intervention (1 Month)||3
6666526|NCT02542072|7597199|FG000|STARTED|Second Intervention (1 Month)||39
6666527|NCT02542072|7597200|FG001|STARTED|Second Intervention (1 Month)||43
6666528|NCT02542072|7597199|FG000|COMPLETED|Second Intervention (1 Month)||37
6666529|NCT02542072|7597200|FG001|COMPLETED|Second Intervention (1 Month)||43
6666530|NCT02542072|7597199|FG000|NOT COMPLETED|Second Intervention (1 Month)||2
6666531|NCT02542072|7597200|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
6666532|NCT02542150|7597228|FG000|STARTED|Overall Study||12
6666533|NCT02542150|7597229|FG001|STARTED|Overall Study||12
6666534|NCT02542150|7597228|FG000|Completed Placebo|Overall Study||12
6666535|NCT02542150|7597229|FG001|Completed Placebo|Overall Study||12
6666536|NCT02542150|7597228|FG000|Started Intervention|Overall Study||12
6666537|NCT02542150|7597229|FG001|Started Intervention|Overall Study||12
6666538|NCT02542150|7597228|FG000|COMPLETED|Overall Study||12
6666539|NCT02542150|7597229|FG001|COMPLETED|Overall Study||12
6666540|NCT02542150|7597228|FG000|NOT COMPLETED|Overall Study||0
6666541|NCT02542150|7597229|FG001|NOT COMPLETED|Overall Study||0
6666542|NCT02542280|7597241|FG000|STARTED|Overall Study||174
6666543|NCT02542280|7597242|FG001|STARTED|Overall Study||175
6666544|NCT02542280|7597241|FG000|COMPLETED|Overall Study||162
6666545|NCT02542280|7597242|FG001|COMPLETED|Overall Study||167
6666546|NCT02542280|7597241|FG000|NOT COMPLETED|Overall Study||12
6666547|NCT02542280|7597242|FG001|NOT COMPLETED|Overall Study||8
6666548|NCT02542410|7597250|FG000|STARTED|Overall Study||5
6666549|NCT02542410|7597251|FG001|STARTED|Overall Study||5
6666550|NCT02542410|7597250|FG000|COMPLETED|Overall Study||3
6666551|NCT02542410|7597251|FG001|COMPLETED|Overall Study||4
6666552|NCT02542410|7597250|FG000|NOT COMPLETED|Overall Study||2
6666553|NCT02542410|7597251|FG001|NOT COMPLETED|Overall Study||1
6666554|NCT02542462|7597261|FG000|STARTED|Overall Study||25
6666555|NCT02542462|7597262|FG001|STARTED|Overall Study||25
6666556|NCT02542462|7597263|FG002|STARTED|Overall Study||25
6666557|NCT02542462|7597264|FG003|STARTED|Overall Study||26
6666558|NCT02542462|7597261|FG000|COMPLETED|Overall Study||25
6666559|NCT02542462|7597262|FG001|COMPLETED|Overall Study||25
6666560|NCT02542462|7597263|FG002|COMPLETED|Overall Study||25
6666561|NCT02542462|7597264|FG003|COMPLETED|Overall Study||25
6666562|NCT02542462|7597261|FG000|NOT COMPLETED|Overall Study||0
6666563|NCT02542462|7597262|FG001|NOT COMPLETED|Overall Study||0
6666564|NCT02542462|7597263|FG002|NOT COMPLETED|Overall Study||0
6666565|NCT02542462|7597264|FG003|NOT COMPLETED|Overall Study||1
6666566|NCT02542605|7597275|FG000|STARTED|Part A: PACAP-38 Dose Selection Phase||12
6666567|NCT02542605|7597276|FG001|STARTED|Part A: PACAP-38 Dose Selection Phase||0
6666568|NCT02542605|7597277|FG002|STARTED|Part A: PACAP-38 Dose Selection Phase||0
6666569|NCT02542605|7597275|FG000|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||12
6666570|NCT02542605|7597276|FG001|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
6666571|NCT02542605|7597277|FG002|Received PACAP-38|Part A: PACAP-38 Dose Selection Phase||0
6666572|NCT02542605|7597275|FG000|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||2
6666573|NCT02542605|7597276|FG001|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
6666574|NCT02542605|7597277|FG002|Proceeded to Part B Randomization Phase|Part A: PACAP-38 Dose Selection Phase||0
6666575|NCT02542605|7597275|FG000|COMPLETED|Part A: PACAP-38 Dose Selection Phase||12
6666576|NCT02542605|7597276|FG001|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6666577|NCT02542605|7597277|FG002|COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6666578|NCT02542605|7597275|FG000|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6666579|NCT02542605|7597276|FG001|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6666580|NCT02542605|7597277|FG002|NOT COMPLETED|Part A: PACAP-38 Dose Selection Phase||0
6256047|NCT04425252|7154879|FG001|STARTED|Overall Study||15
6256048|NCT04425252|7154878|FG000|COMPLETED|Overall Study||4
6256049|NCT04425252|7154879|FG001|COMPLETED|Overall Study||13
6256050|NCT04425252|7154878|FG000|NOT COMPLETED|Overall Study||4
6256051|NCT04425252|7154879|FG001|NOT COMPLETED|Overall Study||2
6256052|NCT04368260|7154888|FG000|STARTED|Overall Study||40
6666581|NCT02542605|7597275|FG000|STARTED|Part B: Challenge Phase||23
6666582|NCT02542605|7597276|FG001|STARTED|Part B: Challenge Phase||0
6666583|NCT02542605|7597277|FG002|STARTED|Part B: Challenge Phase||0
6666584|NCT02542605|7597275|FG000|Received PACAP-38|Part B: Challenge Phase||23
6666585|NCT02542605|7597276|FG001|Received PACAP-38|Part B: Challenge Phase||0
6666586|NCT02542605|7597277|FG002|Received PACAP-38|Part B: Challenge Phase||0
6666587|NCT02542605|7597275|FG000|Proceeded to Randomization Phase|Part B: Challenge Phase||15
6666588|NCT02542605|7597276|FG001|Proceeded to Randomization Phase|Part B: Challenge Phase||0
6666589|NCT02542605|7597277|FG002|Proceeded to Randomization Phase|Part B: Challenge Phase||0
6666590|NCT02542605|7597275|FG000|COMPLETED|Part B: Challenge Phase||22
6666591|NCT02542605|7597276|FG001|COMPLETED|Part B: Challenge Phase||0
6666592|NCT02542605|7597277|FG002|COMPLETED|Part B: Challenge Phase||0
6666593|NCT02542605|7597275|FG000|NOT COMPLETED|Part B: Challenge Phase||1
6666594|NCT02542605|7597276|FG001|NOT COMPLETED|Part B: Challenge Phase||0
6666595|NCT02542605|7597277|FG002|NOT COMPLETED|Part B: Challenge Phase||0
6666596|NCT02542605|7597275|FG000|STARTED|Part B: Randomization Phase||0
6666597|NCT02542605|7597276|FG001|STARTED|Part B: Randomization Phase||9
6666598|NCT02542605|7597277|FG002|STARTED|Part B: Randomization Phase||8
6666599|NCT02542605|7597275|FG000|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
6666600|NCT02542605|7597276|FG001|Not PACAP-38 naïve Participants|Part B: Randomization Phase||2
6666601|NCT02542605|7597277|FG002|Not PACAP-38 naïve Participants|Part B: Randomization Phase||0
6666602|NCT02542605|7597275|FG000|PACAP-38 naïve Participants|Part B: Randomization Phase||0
6666603|NCT02542605|7597276|FG001|PACAP-38 naïve Participants|Part B: Randomization Phase||7
6666604|NCT02542605|7597277|FG002|PACAP-38 naïve Participants|Part B: Randomization Phase||8
6666605|NCT02542605|7597275|FG000|Received Placebo/Erenumab|Part B: Randomization Phase||0
6666606|NCT02542605|7597276|FG001|Received Placebo/Erenumab|Part B: Randomization Phase||9
6666607|NCT02542605|7597277|FG002|Received Placebo/Erenumab|Part B: Randomization Phase||7
6666608|NCT02542605|7597275|FG000|COMPLETED|Part B: Randomization Phase||0
6666609|NCT02542605|7597276|FG001|COMPLETED|Part B: Randomization Phase||9
6666610|NCT02542605|7597277|FG002|COMPLETED|Part B: Randomization Phase||7
6666611|NCT02542605|7597275|FG000|NOT COMPLETED|Part B: Randomization Phase||0
6666612|NCT02542605|7597276|FG001|NOT COMPLETED|Part B: Randomization Phase||0
6666613|NCT02542605|7597277|FG002|NOT COMPLETED|Part B: Randomization Phase||1
6666614|NCT02542631|7597288|FG000|STARTED|Overall Study||139
6666615|NCT02542631|7597289|FG001|STARTED|Overall Study||139
6666616|NCT02542631|7597288|FG000|COMPLETED|Overall Study||108
6666617|NCT02542631|7597289|FG001|COMPLETED|Overall Study||108
6666618|NCT02542631|7597288|FG000|NOT COMPLETED|Overall Study||31
6666619|NCT02542631|7597289|FG001|NOT COMPLETED|Overall Study||31
6666620|NCT02542761|7597295|FG000|STARTED|Acclimation Period 1||5
6666621|NCT02542761|7597296|FG001|STARTED|Acclimation Period 1||5
6666622|NCT02542761|7597295|FG000|COMPLETED|Acclimation Period 1||5
6666623|NCT02542761|7597296|FG001|COMPLETED|Acclimation Period 1||5
6666624|NCT02542761|7597295|FG000|NOT COMPLETED|Acclimation Period 1||0
6666625|NCT02542761|7597296|FG001|NOT COMPLETED|Acclimation Period 1||0
6666626|NCT02542761|7597295|FG000|STARTED|First Intervention||5
6666627|NCT02542761|7597296|FG001|STARTED|First Intervention||5
6666628|NCT02542761|7597295|FG000|COMPLETED|First Intervention||5
6666629|NCT02542761|7597296|FG001|COMPLETED|First Intervention||5
6666630|NCT02542761|7597295|FG000|NOT COMPLETED|First Intervention||0
6666631|NCT02542761|7597296|FG001|NOT COMPLETED|First Intervention||0
6666632|NCT02542761|7597295|FG000|STARTED|Acclimation Period 2||5
6666633|NCT02542761|7597296|FG001|STARTED|Acclimation Period 2||5
6666634|NCT02542761|7597295|FG000|COMPLETED|Acclimation Period 2||5
6666635|NCT02542761|7597296|FG001|COMPLETED|Acclimation Period 2||5
6666636|NCT02542761|7597295|FG000|NOT COMPLETED|Acclimation Period 2||0
6666637|NCT02542761|7597296|FG001|NOT COMPLETED|Acclimation Period 2||0
6666638|NCT02542761|7597295|FG000|STARTED|Second Intervention||5
6666639|NCT02542761|7597296|FG001|STARTED|Second Intervention||5
6666640|NCT02542761|7597295|FG000|COMPLETED|Second Intervention||5
6666641|NCT02542761|7597296|FG001|COMPLETED|Second Intervention||5
6666642|NCT02542761|7597295|FG000|NOT COMPLETED|Second Intervention||0
6666643|NCT02542761|7597296|FG001|NOT COMPLETED|Second Intervention||0
6666644|NCT02542865|7597304|FG000|STARTED|Overall Study||462
6666645|NCT02542865|7597305|FG001|STARTED|Overall Study||462
6666646|NCT02542865|7597304|FG000|Treated|Overall Study||460
6666647|NCT02542865|7597305|FG001|Treated|Overall Study||462
6666648|NCT02542865|7597304|FG000|COMPLETED|Overall Study||445
6666649|NCT02542865|7597305|FG001|COMPLETED|Overall Study||462
6666650|NCT02542865|7597304|FG000|NOT COMPLETED|Overall Study||17
6666651|NCT02542865|7597305|FG001|NOT COMPLETED|Overall Study||0
6666652|NCT02542943|7597314|FG000|STARTED|Overall Study||79
6666653|NCT02542943|7597315|FG001|STARTED|Overall Study||80
6666654|NCT02542943|7597316|FG002|STARTED|Overall Study||81
6666655|NCT02542943|7597314|FG000|COMPLETED|Overall Study||78
6666656|NCT02542943|7597315|FG001|COMPLETED|Overall Study||79
6666657|NCT02542943|7597316|FG002|COMPLETED|Overall Study||81
6666658|NCT02542943|7597314|FG000|NOT COMPLETED|Overall Study||1
6666659|NCT02542943|7597315|FG001|NOT COMPLETED|Overall Study||1
6666660|NCT02542943|7597316|FG002|NOT COMPLETED|Overall Study||0
6666661|NCT02543203|7597327|FG000|STARTED|Overall Study||13
6666662|NCT02543203|7597328|FG001|STARTED|Overall Study||15
6666663|NCT02543203|7597327|FG000|COMPLETED|Overall Study||7
6666664|NCT02543203|7597328|FG001|COMPLETED|Overall Study||10
6666665|NCT02543203|7597327|FG000|NOT COMPLETED|Overall Study||6
6666666|NCT02543203|7597328|FG001|NOT COMPLETED|Overall Study||5
6666667|NCT02543294|7597342|FG000|STARTED|Overall Study||20
6666668|NCT02543294|7597342|FG000|COMPLETED|Overall Study||8
6666669|NCT02543294|7597342|FG000|NOT COMPLETED|Overall Study||12
6666670|NCT02543346|7597347|FG000|STARTED|First Priming Visit||26
6666671|NCT02543346|7597348|FG001|STARTED|First Priming Visit||25
6666672|NCT02543346|7597349|FG002|STARTED|First Priming Visit||24
6666673|NCT02543346|7597350|FG003|STARTED|First Priming Visit||23
6666674|NCT02543346|7597347|FG000|COMPLETED|First Priming Visit||26
6666675|NCT02543346|7597348|FG001|COMPLETED|First Priming Visit||25
6666676|NCT02543346|7597349|FG002|COMPLETED|First Priming Visit||24
6666677|NCT02543346|7597350|FG003|COMPLETED|First Priming Visit||23
6666678|NCT02543346|7597347|FG000|NOT COMPLETED|First Priming Visit||0
6666679|NCT02543346|7597348|FG001|NOT COMPLETED|First Priming Visit||0
6666680|NCT02543346|7597349|FG002|NOT COMPLETED|First Priming Visit||0
6666681|NCT02543346|7597350|FG003|NOT COMPLETED|First Priming Visit||0
6666682|NCT02543346|7597347|FG000|STARTED|First Treatment Visit||26
6666683|NCT02543346|7597348|FG001|STARTED|First Treatment Visit||25
6666684|NCT02543346|7597349|FG002|STARTED|First Treatment Visit||24
6666685|NCT02543346|7597350|FG003|STARTED|First Treatment Visit||23
6666686|NCT02543346|7597347|FG000|COMPLETED|First Treatment Visit||26
6666687|NCT02543346|7597348|FG001|COMPLETED|First Treatment Visit||25
6666688|NCT02543346|7597349|FG002|COMPLETED|First Treatment Visit||24
6666689|NCT02543346|7597350|FG003|COMPLETED|First Treatment Visit||23
6666690|NCT02543346|7597347|FG000|NOT COMPLETED|First Treatment Visit||0
6666691|NCT02543346|7597348|FG001|NOT COMPLETED|First Treatment Visit||0
6666692|NCT02543346|7597349|FG002|NOT COMPLETED|First Treatment Visit||0
6666693|NCT02543346|7597350|FG003|NOT COMPLETED|First Treatment Visit||0
6666694|NCT02543346|7597347|FG000|STARTED|Washout (at Least 14 Days)||26
6666695|NCT02543346|7597348|FG001|STARTED|Washout (at Least 14 Days)||25
6666696|NCT02543346|7597349|FG002|STARTED|Washout (at Least 14 Days)||24
6666697|NCT02543346|7597350|FG003|STARTED|Washout (at Least 14 Days)||23
6666698|NCT02543346|7597347|FG000|COMPLETED|Washout (at Least 14 Days)||26
6666699|NCT02543346|7597348|FG001|COMPLETED|Washout (at Least 14 Days)||25
6666700|NCT02543346|7597349|FG002|COMPLETED|Washout (at Least 14 Days)||24
6666701|NCT02543346|7597350|FG003|COMPLETED|Washout (at Least 14 Days)||23
6666702|NCT02543346|7597347|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
6666703|NCT02543346|7597348|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
6666704|NCT02543346|7597349|FG002|NOT COMPLETED|Washout (at Least 14 Days)||0
6666705|NCT02543346|7597350|FG003|NOT COMPLETED|Washout (at Least 14 Days)||0
6666706|NCT02543346|7597347|FG000|STARTED|Second Priming Visit||26
6666707|NCT02543346|7597348|FG001|STARTED|Second Priming Visit||25
6666708|NCT02543346|7597349|FG002|STARTED|Second Priming Visit||24
6666709|NCT02543346|7597350|FG003|STARTED|Second Priming Visit||23
6666710|NCT02543346|7597347|FG000|COMPLETED|Second Priming Visit||25
6666711|NCT02543346|7597348|FG001|COMPLETED|Second Priming Visit||23
6666712|NCT02543346|7597349|FG002|COMPLETED|Second Priming Visit||22
6666713|NCT02543346|7597350|FG003|COMPLETED|Second Priming Visit||21
6666714|NCT02543346|7597347|FG000|NOT COMPLETED|Second Priming Visit||1
6666715|NCT02543346|7597348|FG001|NOT COMPLETED|Second Priming Visit||2
6666716|NCT02543346|7597349|FG002|NOT COMPLETED|Second Priming Visit||2
6666717|NCT02543346|7597350|FG003|NOT COMPLETED|Second Priming Visit||2
6666718|NCT02543346|7597347|FG000|STARTED|Second Treatment Visit||25
6666719|NCT02543346|7597348|FG001|STARTED|Second Treatment Visit||23
6666720|NCT02543346|7597349|FG002|STARTED|Second Treatment Visit||22
6666721|NCT02543346|7597350|FG003|STARTED|Second Treatment Visit||21
6666722|NCT02543346|7597347|FG000|COMPLETED|Second Treatment Visit||25
6666723|NCT02543346|7597348|FG001|COMPLETED|Second Treatment Visit||23
6666724|NCT02543346|7597349|FG002|COMPLETED|Second Treatment Visit||22
6666725|NCT02543346|7597350|FG003|COMPLETED|Second Treatment Visit||21
6666726|NCT02543346|7597347|FG000|NOT COMPLETED|Second Treatment Visit||0
6666727|NCT02543346|7597348|FG001|NOT COMPLETED|Second Treatment Visit||0
6666728|NCT02543346|7597349|FG002|NOT COMPLETED|Second Treatment Visit||0
6666729|NCT02543346|7597350|FG003|NOT COMPLETED|Second Treatment Visit||0
6666730|NCT02543398|7597362|FG000|STARTED|Overall Study||20
6666731|NCT02543398|7597363|FG001|STARTED|Overall Study||20
6666732|NCT02543398|7597362|FG000|COMPLETED|Overall Study||20
6666733|NCT02543398|7597363|FG001|COMPLETED|Overall Study||20
6666734|NCT02543398|7597362|FG000|NOT COMPLETED|Overall Study||0
6666735|NCT02543398|7597363|FG001|NOT COMPLETED|Overall Study||0
6666736|NCT02543437|7597369|FG000|STARTED|Overall Study||117
6666737|NCT02543437|7597369|FG000|COMPLETED|Overall Study||117
6666738|NCT02543437|7597369|FG000|NOT COMPLETED|Overall Study||0
6666739|NCT02543528|7597373|FG000|STARTED|Adaptation Period||0
6666740|NCT02543528|7597374|FG001|STARTED|Adaptation Period||0
6666741|NCT02543528|7597375|FG002|STARTED|Adaptation Period||0
6666742|NCT02543528|7597376|FG003|STARTED|Adaptation Period||0
6666743|NCT02543528|7597377|FG004|STARTED|Adaptation Period||168
6666744|NCT02543528|7597373|FG000|COMPLETED|Adaptation Period||0
6666745|NCT02543528|7597374|FG001|COMPLETED|Adaptation Period||0
6666746|NCT02543528|7597375|FG002|COMPLETED|Adaptation Period||0
6666747|NCT02543528|7597376|FG003|COMPLETED|Adaptation Period||0
6666748|NCT02543528|7597377|FG004|COMPLETED|Adaptation Period||142
6666749|NCT02543528|7597373|FG000|NOT COMPLETED|Adaptation Period||0
6666750|NCT02543528|7597374|FG001|NOT COMPLETED|Adaptation Period||0
6666751|NCT02543528|7597375|FG002|NOT COMPLETED|Adaptation Period||0
6666752|NCT02543528|7597376|FG003|NOT COMPLETED|Adaptation Period||0
6666753|NCT02543528|7597377|FG004|NOT COMPLETED|Adaptation Period||26
6666754|NCT02543528|7597373|FG000|STARTED|Extended Wear Period||36
6666755|NCT02543528|7597374|FG001|STARTED|Extended Wear Period||35
6666756|NCT02543528|7597375|FG002|STARTED|Extended Wear Period||36
6666757|NCT02543528|7597376|FG003|STARTED|Extended Wear Period||35
6666758|NCT02543528|7597377|FG004|STARTED|Extended Wear Period||0
6666759|NCT02543528|7597373|FG000|COMPLETED|Extended Wear Period||8
6666760|NCT02543528|7597374|FG001|COMPLETED|Extended Wear Period||14
6666761|NCT02543528|7597375|FG002|COMPLETED|Extended Wear Period||13
6666762|NCT02543528|7597376|FG003|COMPLETED|Extended Wear Period||23
6666763|NCT02543528|7597377|FG004|COMPLETED|Extended Wear Period||0
6666764|NCT02543528|7597373|FG000|NOT COMPLETED|Extended Wear Period||28
6666765|NCT02543528|7597374|FG001|NOT COMPLETED|Extended Wear Period||21
6666766|NCT02543528|7597375|FG002|NOT COMPLETED|Extended Wear Period||23
6666767|NCT02543528|7597376|FG003|NOT COMPLETED|Extended Wear Period||12
6666768|NCT02543528|7597377|FG004|NOT COMPLETED|Extended Wear Period||0
6666769|NCT02543554|7597393|FG000|STARTED|Overall Study||1192
6666770|NCT02543554|7597394|FG001|STARTED|Overall Study||513
6666771|NCT02543554|7597393|FG000|COMPLETED|Overall Study||1192
6666772|NCT02543554|7597394|FG001|COMPLETED|Overall Study||513
6666773|NCT02543554|7597393|FG000|NOT COMPLETED|Overall Study||0
6666774|NCT02543554|7597394|FG001|NOT COMPLETED|Overall Study||0
6666775|NCT02543658|7597402|FG000|STARTED|Overall Study||40
6666776|NCT02543658|7597403|FG001|STARTED|Overall Study||40
6666777|NCT02543658|7597402|FG000|COMPLETED|Overall Study||40
6666778|NCT02543658|7597403|FG001|COMPLETED|Overall Study||36
6666779|NCT02543658|7597402|FG000|NOT COMPLETED|Overall Study||0
6666780|NCT02543658|7597403|FG001|NOT COMPLETED|Overall Study||4
6666781|NCT02543723|7597412|FG000|STARTED|Overall Study||65
6666782|NCT02543723|7597413|FG001|STARTED|Overall Study||63
6666783|NCT02543723|7597412|FG000|COMPLETED|Overall Study||65
6666784|NCT02543723|7597413|FG001|COMPLETED|Overall Study||63
6666785|NCT02543723|7597412|FG000|NOT COMPLETED|Overall Study||0
6666786|NCT02543723|7597413|FG001|NOT COMPLETED|Overall Study||0
6666787|NCT02543801|7597425|FG000|STARTED|Overall Study||61
6666788|NCT02543801|7597426|FG001|STARTED|Overall Study||60
6666789|NCT02543801|7597427|FG002|STARTED|Overall Study||59
6666790|NCT02543801|7597428|FG003|STARTED|Overall Study||59
6666791|NCT02543801|7597425|FG000|COMPLETED|Overall Study||60
6666792|NCT02543801|7597426|FG001|COMPLETED|Overall Study||58
6666793|NCT02543801|7597427|FG002|COMPLETED|Overall Study||59
6666794|NCT02543801|7597428|FG003|COMPLETED|Overall Study||59
6666795|NCT02543801|7597425|FG000|NOT COMPLETED|Overall Study||1
6666796|NCT02543801|7597426|FG001|NOT COMPLETED|Overall Study||2
6666797|NCT02543801|7597427|FG002|NOT COMPLETED|Overall Study||0
6666798|NCT02543801|7597428|FG003|NOT COMPLETED|Overall Study||0
6666799|NCT02543840|7597440|FG000|STARTED|Overall Study|This is a quasi-experimental design, not a RCT. 1050 veterans did 1436 interviews at 3 time points.|1050
6666800|NCT02543840|7597441|FG001|STARTED|Overall Study||62
6666801|NCT02543840|7597440|FG000|0 Month Timepoint (t0)|Overall Study||593
6666802|NCT02543840|7597441|FG001|0 Month Timepoint (t0)|Overall Study||40
6666803|NCT02543840|7597440|FG000|6 Month Timepoint (t6)|Overall Study|593 participants started at 0 months; 188 repeated and 66 participants added at 6 months timepoint.|66
6666804|NCT02543840|7597441|FG001|6 Month Timepoint (t6)|Overall Study||0
6666805|NCT02543840|7597440|FG000|12 Month Timepoint (t12)|Overall Study|91 continued from 0 months (t0), 16 from 6 months (t6), 91 from t0 & t6; 391 added at 12 months.|391
6666806|NCT02543840|7597441|FG001|12 Month Timepoint (t12)|Overall Study|22 new providers completed at 12 months; 21 completed at both 0 and 12 months. 19 completed only T0.|22
6666807|NCT02543840|7597440|FG000|COMPLETED|Overall Study||1050
6666808|NCT02543840|7597441|FG001|COMPLETED|Overall Study||62
6666809|NCT02543840|7597440|FG000|NOT COMPLETED|Overall Study||0
6666810|NCT02543840|7597441|FG001|NOT COMPLETED|Overall Study||0
6666811|NCT02543892|7597456|FG000|STARTED|Received Vaccination 1||12
6666812|NCT02543892|7597457|FG001|STARTED|Received Vaccination 1||12
6666813|NCT02543892|7597458|FG002|STARTED|Received Vaccination 1||12
6666814|NCT02543892|7597459|FG003|STARTED|Received Vaccination 1||12
6666815|NCT02543892|7597460|FG004|STARTED|Received Vaccination 1||50
6666816|NCT02543892|7597461|FG005|STARTED|Received Vaccination 1||50
6666817|NCT02543892|7597462|FG006|STARTED|Received Vaccination 1||50
6666818|NCT02543892|7597463|FG007|STARTED|Received Vaccination 1||50
6666819|NCT02543892|7597456|FG000|COMPLETED|Received Vaccination 1||12
6666820|NCT02543892|7597457|FG001|COMPLETED|Received Vaccination 1||12
6666821|NCT02543892|7597458|FG002|COMPLETED|Received Vaccination 1||12
6666822|NCT02543892|7597459|FG003|COMPLETED|Received Vaccination 1||12
6666823|NCT02543892|7597460|FG004|COMPLETED|Received Vaccination 1||50
6666824|NCT02543892|7597461|FG005|COMPLETED|Received Vaccination 1||50
6666825|NCT02543892|7597462|FG006|COMPLETED|Received Vaccination 1||50
6666826|NCT02543892|7597463|FG007|COMPLETED|Received Vaccination 1||50
6666827|NCT02543892|7597456|FG000|NOT COMPLETED|Received Vaccination 1||0
6666828|NCT02543892|7597457|FG001|NOT COMPLETED|Received Vaccination 1||0
6666829|NCT02543892|7597458|FG002|NOT COMPLETED|Received Vaccination 1||0
6666830|NCT02543892|7597459|FG003|NOT COMPLETED|Received Vaccination 1||0
6666831|NCT02543892|7597460|FG004|NOT COMPLETED|Received Vaccination 1||0
6666832|NCT02543892|7597461|FG005|NOT COMPLETED|Received Vaccination 1||0
6666833|NCT02543892|7597462|FG006|NOT COMPLETED|Received Vaccination 1||0
6666834|NCT02543892|7597463|FG007|NOT COMPLETED|Received Vaccination 1||0
6666835|NCT02543892|7597456|FG000|STARTED|Received Vaccination 2||12
6666836|NCT02543892|7597457|FG001|STARTED|Received Vaccination 2||12
6666837|NCT02543892|7597458|FG002|STARTED|Received Vaccination 2||12
6666838|NCT02543892|7597459|FG003|STARTED|Received Vaccination 2||12
6666839|NCT02543892|7597460|FG004|STARTED|Received Vaccination 2||50
6666840|NCT02543892|7597461|FG005|STARTED|Received Vaccination 2||50
6666841|NCT02543892|7597462|FG006|STARTED|Received Vaccination 2||50
6666842|NCT02543892|7597463|FG007|STARTED|Received Vaccination 2||50
6666843|NCT02543892|7597456|FG000|COMPLETED|Received Vaccination 2||11
6666844|NCT02543892|7597457|FG001|COMPLETED|Received Vaccination 2||11
6666845|NCT02543892|7597458|FG002|COMPLETED|Received Vaccination 2||12
6666846|NCT02543892|7597459|FG003|COMPLETED|Received Vaccination 2||12
6666847|NCT02543892|7597460|FG004|COMPLETED|Received Vaccination 2||50
6666848|NCT02543892|7597461|FG005|COMPLETED|Received Vaccination 2||49
6666849|NCT02543892|7597462|FG006|COMPLETED|Received Vaccination 2||50
6666850|NCT02543892|7597463|FG007|COMPLETED|Received Vaccination 2||49
6666851|NCT02543892|7597456|FG000|NOT COMPLETED|Received Vaccination 2||1
6666852|NCT02543892|7597457|FG001|NOT COMPLETED|Received Vaccination 2||1
6666853|NCT02543892|7597458|FG002|NOT COMPLETED|Received Vaccination 2||0
6666854|NCT02543892|7597459|FG003|NOT COMPLETED|Received Vaccination 2||0
6666855|NCT02543892|7597460|FG004|NOT COMPLETED|Received Vaccination 2||0
6666856|NCT02543892|7597461|FG005|NOT COMPLETED|Received Vaccination 2||1
6666857|NCT02543892|7597462|FG006|NOT COMPLETED|Received Vaccination 2||0
6666858|NCT02543892|7597463|FG007|NOT COMPLETED|Received Vaccination 2||1
6666859|NCT02543892|7597456|FG000|STARTED|Had Immunology Data||11
6666860|NCT02543892|7597457|FG001|STARTED|Had Immunology Data||11
6666861|NCT02543892|7597458|FG002|STARTED|Had Immunology Data||12
6666862|NCT02543892|7597459|FG003|STARTED|Had Immunology Data||12
6666863|NCT02543892|7597460|FG004|STARTED|Had Immunology Data||50
6666864|NCT02543892|7597461|FG005|STARTED|Had Immunology Data||49
6666865|NCT02543892|7597462|FG006|STARTED|Had Immunology Data||50
6666866|NCT02543892|7597463|FG007|STARTED|Had Immunology Data||49
6666867|NCT02543892|7597456|FG000|COMPLETED|Had Immunology Data||11
6666868|NCT02543892|7597457|FG001|COMPLETED|Had Immunology Data||11
6666869|NCT02543892|7597458|FG002|COMPLETED|Had Immunology Data||12
6666870|NCT02543892|7597459|FG003|COMPLETED|Had Immunology Data||12
6666871|NCT02543892|7597460|FG004|COMPLETED|Had Immunology Data||50
6666872|NCT02543892|7597461|FG005|COMPLETED|Had Immunology Data||49
6666873|NCT02543892|7597462|FG006|COMPLETED|Had Immunology Data|Subject received both vaccinations and attended last visit, but withdrew consent afterwards.|49
6666874|NCT02543892|7597463|FG007|COMPLETED|Had Immunology Data||49
6666875|NCT02543892|7597456|FG000|NOT COMPLETED|Had Immunology Data||0
6666876|NCT02543892|7597457|FG001|NOT COMPLETED|Had Immunology Data||0
6666877|NCT02543892|7597458|FG002|NOT COMPLETED|Had Immunology Data||0
6666878|NCT02543892|7597459|FG003|NOT COMPLETED|Had Immunology Data||0
6666879|NCT02543892|7597460|FG004|NOT COMPLETED|Had Immunology Data||0
6666880|NCT02543892|7597461|FG005|NOT COMPLETED|Had Immunology Data||0
6666881|NCT02543892|7597462|FG006|NOT COMPLETED|Had Immunology Data||1
6666882|NCT02543892|7597463|FG007|NOT COMPLETED|Had Immunology Data||0
6666883|NCT02543918|7597488|FG000|STARTED|Overall Study||41
6666884|NCT02543918|7597489|FG001|STARTED|Overall Study||43
6666885|NCT02543918|7597488|FG000|Received at Least 1 Dose of Study Drug|Overall Study||41
6666886|NCT02543918|7597489|FG001|Received at Least 1 Dose of Study Drug|Overall Study||42
6666887|NCT02543918|7597488|FG000|COMPLETED|Overall Study||38
6666888|NCT02543918|7597489|FG001|COMPLETED|Overall Study||39
6666889|NCT02543918|7597488|FG000|NOT COMPLETED|Overall Study||3
6666890|NCT02543918|7597489|FG001|NOT COMPLETED|Overall Study||4
6666891|NCT02544074|7597516|FG000|STARTED|Overall Study||1
6666892|NCT02544074|7597517|FG001|STARTED|Overall Study||1
6666893|NCT02544074|7597518|FG002|STARTED|Overall Study||1
6666894|NCT02544074|7597519|FG003|STARTED|Overall Study||1
6666895|NCT02544074|7597520|FG004|STARTED|Overall Study||4
6666896|NCT02544074|7597521|FG005|STARTED|Overall Study||1
6666897|NCT02544074|7597522|FG006|STARTED|Overall Study||2
6666898|NCT02544074|7597523|FG007|STARTED|Overall Study||4
6666899|NCT02544074|7597524|FG008|STARTED|Overall Study||6
6666900|NCT02544074|7597525|FG009|STARTED|Overall Study||2
6666901|NCT02544074|7597526|FG010|STARTED|Overall Study||2
6666902|NCT02544074|7597527|FG011|STARTED|Overall Study||3
6666903|NCT02544074|7597528|FG012|STARTED|Overall Study||4
6666904|NCT02544074|7597529|FG013|STARTED|Overall Study||5
6666905|NCT02544074|7597530|FG014|STARTED|Overall Study||5
6666906|NCT02544074|7597531|FG015|STARTED|Overall Study||8
6666907|NCT02544074|7597532|FG016|STARTED|Overall Study||6
6666908|NCT02544074|7597533|FG017|STARTED|Overall Study||3
6666909|NCT02544074|7597534|FG018|STARTED|Overall Study||4
6666910|NCT02544074|7597535|FG019|STARTED|Overall Study||3
6666911|NCT02544074|7597536|FG020|STARTED|Overall Study||3
6666912|NCT02544074|7597516|FG000|COMPLETED|Overall Study||1
6666913|NCT02544074|7597517|FG001|COMPLETED|Overall Study||0
6666914|NCT02544074|7597518|FG002|COMPLETED|Overall Study||1
6666915|NCT02544074|7597519|FG003|COMPLETED|Overall Study||1
6666916|NCT02544074|7597520|FG004|COMPLETED|Overall Study||4
6666917|NCT02544074|7597521|FG005|COMPLETED|Overall Study||0
6666918|NCT02544074|7597522|FG006|COMPLETED|Overall Study||2
6666919|NCT02544074|7597523|FG007|COMPLETED|Overall Study||4
6666920|NCT02544074|7597524|FG008|COMPLETED|Overall Study||6
6666921|NCT02544074|7597525|FG009|COMPLETED|Overall Study||1
6666922|NCT02544074|7597526|FG010|COMPLETED|Overall Study||2
6666923|NCT02544074|7597527|FG011|COMPLETED|Overall Study||3
6666924|NCT02544074|7597528|FG012|COMPLETED|Overall Study||4
6666925|NCT02544074|7597529|FG013|COMPLETED|Overall Study||5
6666926|NCT02544074|7597530|FG014|COMPLETED|Overall Study||5
6666927|NCT02544074|7597531|FG015|COMPLETED|Overall Study||8
6666928|NCT02544074|7597532|FG016|COMPLETED|Overall Study||6
6666929|NCT02544074|7597533|FG017|COMPLETED|Overall Study||3
6666930|NCT02544074|7597534|FG018|COMPLETED|Overall Study||4
6666931|NCT02544074|7597535|FG019|COMPLETED|Overall Study||3
6666932|NCT02544074|7597536|FG020|COMPLETED|Overall Study||3
6666933|NCT02544074|7597516|FG000|NOT COMPLETED|Overall Study||0
6666934|NCT02544074|7597517|FG001|NOT COMPLETED|Overall Study||1
6666935|NCT02544074|7597518|FG002|NOT COMPLETED|Overall Study||0
6666936|NCT02544074|7597519|FG003|NOT COMPLETED|Overall Study||0
6666937|NCT02544074|7597520|FG004|NOT COMPLETED|Overall Study||0
6666938|NCT02544074|7597521|FG005|NOT COMPLETED|Overall Study||1
6666939|NCT02544074|7597522|FG006|NOT COMPLETED|Overall Study||0
6666940|NCT02544074|7597523|FG007|NOT COMPLETED|Overall Study||0
6666941|NCT02544074|7597524|FG008|NOT COMPLETED|Overall Study||0
6666942|NCT02544074|7597525|FG009|NOT COMPLETED|Overall Study||1
6666943|NCT02544074|7597526|FG010|NOT COMPLETED|Overall Study||0
6666944|NCT02544074|7597527|FG011|NOT COMPLETED|Overall Study||0
6666945|NCT02544074|7597528|FG012|NOT COMPLETED|Overall Study||0
6666946|NCT02544074|7597529|FG013|NOT COMPLETED|Overall Study||0
6666947|NCT02544074|7597530|FG014|NOT COMPLETED|Overall Study||0
6666948|NCT02544074|7597531|FG015|NOT COMPLETED|Overall Study||0
6666949|NCT02544074|7597532|FG016|NOT COMPLETED|Overall Study||0
6666950|NCT02544074|7597533|FG017|NOT COMPLETED|Overall Study||0
6666951|NCT02544074|7597534|FG018|NOT COMPLETED|Overall Study||0
6666952|NCT02544074|7597535|FG019|NOT COMPLETED|Overall Study||0
6666953|NCT02544074|7597536|FG020|NOT COMPLETED|Overall Study||0
6666954|NCT02544113|7597572|FG000|STARTED|Overall Study||55
6666955|NCT02544113|7597573|FG001|STARTED|Overall Study||55
6666956|NCT02544113|7597572|FG000|COMPLETED|Overall Study||52
6666957|NCT02544113|7597573|FG001|COMPLETED|Overall Study||51
6666958|NCT02544113|7597572|FG000|NOT COMPLETED|Overall Study||3
6666959|NCT02544113|7597573|FG001|NOT COMPLETED|Overall Study||4
6666960|NCT02544152|7597581|FG000|STARTED|Overall Study||34
6666961|NCT02544152|7597582|FG001|STARTED|Overall Study||37
6666962|NCT02544152|7597581|FG000|Modified Intent to Treat (mITT)|Overall Study||34
6666963|NCT02544152|7597582|FG001|Modified Intent to Treat (mITT)|Overall Study||37
6666964|NCT02544152|7597581|FG000|Safety Analysis Set (SAS)|Overall Study||34
6666965|NCT02544152|7597582|FG001|Safety Analysis Set (SAS)|Overall Study||37
6666966|NCT02544152|7597581|FG000|COMPLETED|Overall Study||33
6666967|NCT02544152|7597582|FG001|COMPLETED|Overall Study||30
6666968|NCT02544152|7597581|FG000|NOT COMPLETED|Overall Study||1
6666969|NCT02544152|7597582|FG001|NOT COMPLETED|Overall Study||7
6666970|NCT02544217|7597594|FG000|STARTED|Overall Study||7
6666971|NCT02544217|7597595|FG001|STARTED|Overall Study||7
6666972|NCT02544217|7597596|FG002|STARTED|Overall Study||4
6666973|NCT02544217|7597597|FG003|STARTED|Overall Study||4
6666974|NCT02544217|7597598|FG004|STARTED|Overall Study||4
6666975|NCT02544217|7597599|FG005|STARTED|Overall Study||6
6666976|NCT02544217|7597594|FG000|COMPLETED|Overall Study||6
6666977|NCT02544217|7597595|FG001|COMPLETED|Overall Study|Two subjects prematurely withdrew from the study for non-medical reasons and were replaced.|6
6666978|NCT02544217|7597596|FG002|COMPLETED|Overall Study||4
6666979|NCT02544217|7597597|FG003|COMPLETED|Overall Study||4
6666980|NCT02544217|7597598|FG004|COMPLETED|Overall Study||4
6666981|NCT02544217|7597599|FG005|COMPLETED|Overall Study||6
6666982|NCT02544217|7597594|FG000|NOT COMPLETED|Overall Study||1
6666983|NCT02544217|7597595|FG001|NOT COMPLETED|Overall Study||1
6666984|NCT02544217|7597596|FG002|NOT COMPLETED|Overall Study||0
6666985|NCT02544217|7597597|FG003|NOT COMPLETED|Overall Study||0
6666986|NCT02544217|7597598|FG004|NOT COMPLETED|Overall Study||0
6666987|NCT02544217|7597599|FG005|NOT COMPLETED|Overall Study||0
6666988|NCT02544321|7597668|FG000|STARTED|Overall Study||43
6666989|NCT02544321|7597669|FG001|STARTED|Overall Study||43
6666990|NCT02544321|7597668|FG000|Completed First Treatment|Overall Study||43
6666991|NCT02544321|7597669|FG001|Completed First Treatment|Overall Study||41
6666992|NCT02544321|7597668|FG000|Completed Washout|Overall Study||43
6666993|NCT02544321|7597669|FG001|Completed Washout|Overall Study||41
6666994|NCT02544321|7597668|FG000|Started Second Treatment|Overall Study||42
6666995|NCT02544321|7597669|FG001|Started Second Treatment|Overall Study||40
6666996|NCT02544321|7597668|FG000|COMPLETED|Overall Study||41
6666997|NCT02544321|7597669|FG001|COMPLETED|Overall Study||39
6666998|NCT02544321|7597668|FG000|NOT COMPLETED|Overall Study||2
6666999|NCT02544321|7597669|FG001|NOT COMPLETED|Overall Study||4
6667000|NCT02544451|7597687|FG000|STARTED|Treatment Period 1 (96 Weeks)||143
6667001|NCT02544451|7597688|FG001|STARTED|Treatment Period 1 (96 Weeks)||96
6667002|NCT02544451|7597689|FG002|STARTED|Treatment Period 1 (96 Weeks)||6
6667003|NCT02544451|7597690|FG003|STARTED|Treatment Period 1 (96 Weeks)||0
6667004|NCT02544451|7597687|FG000|COMPLETED|Treatment Period 1 (96 Weeks)||129
6667005|NCT02544451|7597688|FG001|COMPLETED|Treatment Period 1 (96 Weeks)||84
6667006|NCT02544451|7597689|FG002|COMPLETED|Treatment Period 1 (96 Weeks)||5
6667007|NCT02544451|7597690|FG003|COMPLETED|Treatment Period 1 (96 Weeks)||0
6667008|NCT02544451|7597687|FG000|NOT COMPLETED|Treatment Period 1 (96 Weeks)||14
6667009|NCT02544451|7597688|FG001|NOT COMPLETED|Treatment Period 1 (96 Weeks)||12
6667010|NCT02544451|7597689|FG002|NOT COMPLETED|Treatment Period 1 (96 Weeks)||1
6667011|NCT02544451|7597690|FG003|NOT COMPLETED|Treatment Period 1 (96 Weeks)||0
6667012|NCT02544451|7597687|FG000|STARTED|Treatment Period 2 (168 Weeks)||0
6667013|NCT02544451|7597688|FG001|STARTED|Treatment Period 2 (168 Weeks)||0
6667014|NCT02544451|7597689|FG002|STARTED|Treatment Period 2 (168 Weeks)||0
6667015|NCT02544451|7597690|FG003|STARTED|Treatment Period 2 (168 Weeks)||10
6667016|NCT02544451|7597687|FG000|COMPLETED|Treatment Period 2 (168 Weeks)||0
6667017|NCT02544451|7597688|FG001|COMPLETED|Treatment Period 2 (168 Weeks)||0
6667018|NCT02544451|7597689|FG002|COMPLETED|Treatment Period 2 (168 Weeks)||0
6667019|NCT02544451|7597690|FG003|COMPLETED|Treatment Period 2 (168 Weeks)||0
6667020|NCT02544451|7597687|FG000|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
6667021|NCT02544451|7597688|FG001|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
6667022|NCT02544451|7597689|FG002|NOT COMPLETED|Treatment Period 2 (168 Weeks)||0
6667023|NCT02544451|7597690|FG003|NOT COMPLETED|Treatment Period 2 (168 Weeks)||10
6667024|NCT02544607|7597708|FG000|STARTED|Overall Study||16
6667025|NCT02544607|7597708|FG000|COMPLETED|Overall Study||16
6667026|NCT02544607|7597708|FG000|NOT COMPLETED|Overall Study||0
6667027|NCT02544633|7597717|FG000|STARTED|Treatment Period||28
6667028|NCT02544633|7597718|FG001|STARTED|Treatment Period||20
6667029|NCT02544633|7597719|FG002|STARTED|Treatment Period||8
6667030|NCT02544633|7597720|FG003|STARTED|Treatment Period||12
6667031|NCT02544633|7597717|FG000|COMPLETED|Treatment Period||0
6667032|NCT02544633|7597718|FG001|COMPLETED|Treatment Period||0
6667033|NCT02544633|7597719|FG002|COMPLETED|Treatment Period||0
6667034|NCT02544633|7597720|FG003|COMPLETED|Treatment Period||0
6667035|NCT02544633|7597717|FG000|NOT COMPLETED|Treatment Period||28
6667036|NCT02544633|7597718|FG001|NOT COMPLETED|Treatment Period||20
6667037|NCT02544633|7597719|FG002|NOT COMPLETED|Treatment Period||8
6667038|NCT02544633|7597720|FG003|NOT COMPLETED|Treatment Period||12
6667039|NCT02544633|7597717|FG000|STARTED|Survival Follow-up Period||28
6667040|NCT02544633|7597718|FG001|STARTED|Survival Follow-up Period||19
6667041|NCT02544633|7597719|FG002|STARTED|Survival Follow-up Period||7
6667042|NCT02544633|7597720|FG003|STARTED|Survival Follow-up Period||12
6667043|NCT02544633|7597717|FG000|COMPLETED|Survival Follow-up Period||0
6667044|NCT02544633|7597718|FG001|COMPLETED|Survival Follow-up Period||0
6667045|NCT02544633|7597719|FG002|COMPLETED|Survival Follow-up Period||0
6667046|NCT02544633|7597720|FG003|COMPLETED|Survival Follow-up Period||0
6667047|NCT02544633|7597717|FG000|NOT COMPLETED|Survival Follow-up Period||28
6667048|NCT02544633|7597718|FG001|NOT COMPLETED|Survival Follow-up Period||19
6667049|NCT02544633|7597719|FG002|NOT COMPLETED|Survival Follow-up Period||7
6667050|NCT02544633|7597720|FG003|NOT COMPLETED|Survival Follow-up Period||12
6667051|NCT02544763|7597745|FG000|STARTED|Overall Study||75
6667052|NCT02544763|7597746|FG001|STARTED|Overall Study||73
6667053|NCT02544763|7597747|FG002|STARTED|Overall Study||76
6667054|NCT02544763|7597745|FG000|COMPLETED|Overall Study||65
6667055|NCT02544763|7597746|FG001|COMPLETED|Overall Study||61
6667056|NCT02544763|7597747|FG002|COMPLETED|Overall Study||75
6667057|NCT02544763|7597745|FG000|NOT COMPLETED|Overall Study||10
6667058|NCT02544763|7597746|FG001|NOT COMPLETED|Overall Study||12
6667059|NCT02544763|7597747|FG002|NOT COMPLETED|Overall Study||1
6667060|NCT02544984|7597757|FG000|STARTED|Overall Study||30
6667061|NCT02544984|7597758|FG001|STARTED|Overall Study||30
6667062|NCT02544984|7597757|FG000|COMPLETED|Overall Study||28
6667063|NCT02544984|7597758|FG001|COMPLETED|Overall Study||28
6667064|NCT02544984|7597757|FG000|NOT COMPLETED|Overall Study||2
6667065|NCT02544984|7597758|FG001|NOT COMPLETED|Overall Study||2
6667066|NCT02545075|7597766|FG000|STARTED|Randomization||122
6667067|NCT02545075|7597767|FG001|STARTED|Randomization||60
6667068|NCT02545075|7597766|FG000|COMPLETED|Randomization||122
6667069|NCT02545075|7597767|FG001|COMPLETED|Randomization||53
6667070|NCT02545075|7597766|FG000|NOT COMPLETED|Randomization||0
6667071|NCT02545075|7597767|FG001|NOT COMPLETED|Randomization||7
6667072|NCT02545075|7597766|FG000|STARTED|Treatment||122
6667073|NCT02545075|7597767|FG001|STARTED|Treatment||53
6667074|NCT02545075|7597766|FG000|COMPLETED|Treatment||0
6667075|NCT02545075|7597767|FG001|COMPLETED|Treatment||0
6667076|NCT02545075|7597766|FG000|NOT COMPLETED|Treatment||122
6667077|NCT02545075|7597767|FG001|NOT COMPLETED|Treatment||53
6667078|NCT02545101|7597773|FG000|STARTED|Overall Study||100
6667079|NCT02545101|7597773|FG000|COMPLETED|Overall Study||100
6667080|NCT02545101|7597773|FG000|NOT COMPLETED|Overall Study||0
6667081|NCT02545270|7597780|FG000|STARTED|Overall Study||6
6667082|NCT02545270|7597781|FG001|STARTED|Overall Study||5
6667083|NCT02545270|7597782|FG002|STARTED|Overall Study||5
6667084|NCT02545270|7597780|FG000|COMPLETED|Overall Study||6
6667085|NCT02545270|7597781|FG001|COMPLETED|Overall Study||4
6667086|NCT02545270|7597782|FG002|COMPLETED|Overall Study||3
6667087|NCT02545270|7597780|FG000|NOT COMPLETED|Overall Study||0
6667088|NCT02545270|7597781|FG001|NOT COMPLETED|Overall Study||1
6667089|NCT02545270|7597782|FG002|NOT COMPLETED|Overall Study||2
6667090|NCT02545322|7597791|FG000|STARTED|Overall Study||18
6667091|NCT02545322|7597791|FG000|COMPLETED|Overall Study||15
6667092|NCT02545322|7597791|FG000|NOT COMPLETED|Overall Study||3
6256053|NCT04368260|7154888|FG000|COMPLETED|Overall Study||40
6256054|NCT04368260|7154888|FG000|NOT COMPLETED|Overall Study||0
6667093|NCT02545504|7597797|FG000|STARTED|Overall Study||218
6667094|NCT02545504|7597798|FG001|STARTED|Overall Study||214
6667095|NCT02545504|7597797|FG000|COMPLETED|Overall Study||0
6667096|NCT02545504|7597798|FG001|COMPLETED|Overall Study||0
6667097|NCT02545504|7597797|FG000|NOT COMPLETED|Overall Study||218
6667098|NCT02545504|7597798|FG001|NOT COMPLETED|Overall Study||214
6667099|NCT02545543|7597810|FG000|STARTED|Overall Study||1709
6667100|NCT02545543|7597811|FG001|STARTED|Overall Study||569
6667101|NCT02545543|7597810|FG000|COMPLETED|Overall Study||1628
6667102|NCT02545543|7597811|FG001|COMPLETED|Overall Study||535
6667103|NCT02545543|7597810|FG000|NOT COMPLETED|Overall Study||81
6667104|NCT02545543|7597811|FG001|NOT COMPLETED|Overall Study||34
6667105|NCT02545608|7597821|FG000|STARTED|Overall Study||9
6667106|NCT02545608|7597822|FG001|STARTED|Overall Study|Split hand study design. Total no. of subjects in Randomised group and No-treatment control is 100.|100
6667107|NCT02545608|7597821|FG000|COMPLETED|Overall Study||9
6667108|NCT02545608|7597822|FG001|COMPLETED|Overall Study||93
6667109|NCT02545608|7597821|FG000|NOT COMPLETED|Overall Study||0
6667110|NCT02545608|7597822|FG001|NOT COMPLETED|Overall Study||7
6667111|NCT02545907|7597831|FG000|STARTED|Overall Study||3
6667112|NCT02545907|7597832|FG001|STARTED|Overall Study||3
6667113|NCT02545907|7597833|FG002|STARTED|Overall Study||4
6667114|NCT02545907|7597831|FG000|COMPLETED|Overall Study||3
6667115|NCT02545907|7597832|FG001|COMPLETED|Overall Study||3
6667116|NCT02545907|7597833|FG002|COMPLETED|Overall Study||4
6667117|NCT02545907|7597831|FG000|NOT COMPLETED|Overall Study||0
6667118|NCT02545907|7597832|FG001|NOT COMPLETED|Overall Study||0
6667119|NCT02545907|7597833|FG002|NOT COMPLETED|Overall Study||0
6667120|NCT02545933|7597845|FG000|STARTED|Overall Study||44
6667121|NCT02545933|7597846|FG001|STARTED|Overall Study||43
6667122|NCT02545933|7597847|FG002|STARTED|Overall Study||43
6667123|NCT02545933|7597845|FG000|COMPLETED|Overall Study||38
6667124|NCT02545933|7597846|FG001|COMPLETED|Overall Study||40
6667125|NCT02545933|7597847|FG002|COMPLETED|Overall Study||39
6667126|NCT02545933|7597845|FG000|NOT COMPLETED|Overall Study||6
6667127|NCT02545933|7597846|FG001|NOT COMPLETED|Overall Study||3
6667128|NCT02545933|7597847|FG002|NOT COMPLETED|Overall Study||4
6667129|NCT02546193|7597857|FG000|STARTED|Overall Study||10
6667130|NCT02546193|7597858|FG001|STARTED|Overall Study||10
6667131|NCT02546193|7597859|FG002|STARTED|Overall Study|Enrolled independently (Prospective study). Not counted in Outpatient Foley Catheter Arm.|2
6667132|NCT02546193|7597860|FG003|STARTED|Overall Study||0
6256055|NCT03940326|7154896|FG000|STARTED|Overall Study||45
6256056|NCT03940326|7154897|FG001|STARTED|Overall Study||58
6256057|NCT03940326|7154896|FG000|COMPLETED|Overall Study||45
6256058|NCT03940326|7154897|FG001|COMPLETED|Overall Study||58
6256059|NCT03940326|7154896|FG000|NOT COMPLETED|Overall Study||0
6256060|NCT03940326|7154897|FG001|NOT COMPLETED|Overall Study||0
6256061|NCT03875313|7154908|FG000|STARTED|Overall Study||3
6256062|NCT03875313|7154909|FG001|STARTED|Overall Study||16
6256063|NCT03875313|7154910|FG002|STARTED|Overall Study||6
6256064|NCT03875313|7154911|FG003|STARTED|Overall Study||4
6256065|NCT03875313|7154912|FG004|STARTED|Overall Study||4
6256066|NCT03875313|7154908|FG000|COMPLETED|Overall Study||0
6256067|NCT03875313|7154909|FG001|COMPLETED|Overall Study||0
6256068|NCT03875313|7154910|FG002|COMPLETED|Overall Study||0
6256069|NCT03875313|7154911|FG003|COMPLETED|Overall Study||0
6256070|NCT03875313|7154912|FG004|COMPLETED|Overall Study||0
6256071|NCT03875313|7154908|FG000|NOT COMPLETED|Overall Study||3
6667133|NCT02546193|7597857|FG000|COMPLETED|Overall Study||4
6667134|NCT02546193|7597858|FG001|COMPLETED|Overall Study||4
6667135|NCT02546193|7597859|FG002|COMPLETED|Overall Study||0
6667136|NCT02546193|7597860|FG003|COMPLETED|Overall Study||0
6667137|NCT02546193|7597857|FG000|NOT COMPLETED|Overall Study||6
6667138|NCT02546193|7597858|FG001|NOT COMPLETED|Overall Study||6
6667139|NCT02546193|7597859|FG002|NOT COMPLETED|Overall Study||2
6667140|NCT02546193|7597860|FG003|NOT COMPLETED|Overall Study||0
6667141|NCT02546323|7597868|FG000|STARTED|Overall Study||272
6667142|NCT02546323|7597869|FG001|STARTED|Overall Study||271
6667143|NCT02546323|7597868|FG000|Received Treatment|Overall Study||272
6667144|NCT02546323|7597869|FG001|Received Treatment|Overall Study||268
6667145|NCT02546323|7597868|FG000|COMPLETED|Overall Study||212
6667146|NCT02546323|7597869|FG001|COMPLETED|Overall Study||205
6667147|NCT02546323|7597868|FG000|NOT COMPLETED|Overall Study||60
6667148|NCT02546323|7597869|FG001|NOT COMPLETED|Overall Study||66
6667149|NCT02546362|7597875|FG000|STARTED|4-week Treatment Period||50
6667150|NCT02546362|7597875|FG000|COMPLETED|4-week Treatment Period||47
6667151|NCT02546362|7597875|FG000|NOT COMPLETED|4-week Treatment Period||3
6667152|NCT02546362|7597875|FG000|STARTED|12-week Treatment Period||47
6667153|NCT02546362|7597875|FG000|COMPLETED|12-week Treatment Period||38
6667154|NCT02546362|7597875|FG000|NOT COMPLETED|12-week Treatment Period||9
6667155|NCT02546375|7597879|FG000|STARTED|Overall Study||87
6667156|NCT02546375|7597879|FG000|COMPLETED|Overall Study||87
6667157|NCT02546375|7597879|FG000|NOT COMPLETED|Overall Study||0
6667158|NCT02546388|7597885|FG000|STARTED|Overall Study||4
6667159|NCT02546388|7597886|FG001|STARTED|Overall Study||13
6667160|NCT02546388|7597885|FG000|COMPLETED|Overall Study||4
6667161|NCT02546388|7597886|FG001|COMPLETED|Overall Study||13
6667162|NCT02546388|7597885|FG000|NOT COMPLETED|Overall Study||0
6667163|NCT02546388|7597886|FG001|NOT COMPLETED|Overall Study||0
6667164|NCT02546544|7597893|FG000|STARTED|Overall Study||16
6667165|NCT02546544|7597893|FG000|Received Allocated Intervention|Overall Study||16
6667166|NCT02546544|7597893|FG000|COMPLETED|Overall Study||0
6667167|NCT02546544|7597893|FG000|NOT COMPLETED|Overall Study||16
6667168|NCT02546570|7597899|FG000|STARTED|Overall Study||9
6667169|NCT02546570|7597900|FG001|STARTED|Overall Study||2
6667170|NCT02546570|7597899|FG000|Crossover Order: Oxytocin, Placebo|Overall Study||6
6667171|NCT02546570|7597900|FG001|Crossover Order: Oxytocin, Placebo|Overall Study||2
6667172|NCT02546570|7597899|FG000|Crossover Order: Placebo, Oxytocin|Overall Study||3
6667173|NCT02546570|7597900|FG001|Crossover Order: Placebo, Oxytocin|Overall Study||0
6667174|NCT02546570|7597899|FG000|COMPLETED|Overall Study||9
6667175|NCT02546570|7597900|FG001|COMPLETED|Overall Study||2
6667176|NCT02546570|7597899|FG000|NOT COMPLETED|Overall Study||0
6667177|NCT02546570|7597900|FG001|NOT COMPLETED|Overall Study||0
6667178|NCT02546609|7597913|FG000|STARTED|Overall Study||24
6667179|NCT02546609|7597914|FG001|STARTED|Overall Study||35
6667180|NCT02546609|7597915|FG002|STARTED|Overall Study||32
6667181|NCT02546609|7597913|FG000|COMPLETED|Overall Study||22
6667182|NCT02546609|7597914|FG001|COMPLETED|Overall Study||24
6667183|NCT02546609|7597915|FG002|COMPLETED|Overall Study||25
6667184|NCT02546609|7597913|FG000|NOT COMPLETED|Overall Study||2
6667185|NCT02546609|7597914|FG001|NOT COMPLETED|Overall Study||11
6667186|NCT02546609|7597915|FG002|NOT COMPLETED|Overall Study||7
6667187|NCT02546765|7597927|FG000|STARTED|Overall Study||31
6667188|NCT02546765|7597928|FG001|STARTED|Overall Study||30
6667189|NCT02546765|7597929|FG002|STARTED|Overall Study||30
6667190|NCT02546765|7597930|FG003|STARTED|Overall Study||30
6667191|NCT02546765|7597927|FG000|COMPLETED|Overall Study||31
6667192|NCT02546765|7597928|FG001|COMPLETED|Overall Study|29 Received study drug; 1 withdrew before surgery and after randomization|29
6667193|NCT02546765|7597929|FG002|COMPLETED|Overall Study||30
6667194|NCT02546765|7597930|FG003|COMPLETED|Overall Study||30
6667195|NCT02546765|7597927|FG000|NOT COMPLETED|Overall Study||0
6667196|NCT02546765|7597928|FG001|NOT COMPLETED|Overall Study||1
6667197|NCT02546765|7597929|FG002|NOT COMPLETED|Overall Study||0
6667198|NCT02546765|7597930|FG003|NOT COMPLETED|Overall Study||0
6667199|NCT02546856|7597953|FG000|STARTED|4 Months Evaluation||164
6667200|NCT02546856|7597954|FG001|STARTED|4 Months Evaluation||156
6667201|NCT02546856|7597953|FG000|COMPLETED|4 Months Evaluation||144
6667202|NCT02546856|7597954|FG001|COMPLETED|4 Months Evaluation||145
6667203|NCT02546856|7597953|FG000|NOT COMPLETED|4 Months Evaluation||20
6667204|NCT02546856|7597954|FG001|NOT COMPLETED|4 Months Evaluation||11
6667205|NCT02546856|7597953|FG000|STARTED|6 Months Evaluation||144
6667206|NCT02546856|7597954|FG001|STARTED|6 Months Evaluation||145
6667207|NCT02546856|7597953|FG000|COMPLETED|6 Months Evaluation||136
6667208|NCT02546856|7597954|FG001|COMPLETED|6 Months Evaluation||138
6667209|NCT02546856|7597953|FG000|NOT COMPLETED|6 Months Evaluation||8
6667210|NCT02546856|7597954|FG001|NOT COMPLETED|6 Months Evaluation||7
6667211|NCT02547012|7597974|FG000|STARTED|Overall Study||24
6667212|NCT02547012|7597975|FG001|STARTED|Overall Study||27
6667213|NCT02547012|7597974|FG000|COMPLETED|Overall Study||24
6667214|NCT02547012|7597975|FG001|COMPLETED|Overall Study||27
6667215|NCT02547012|7597974|FG000|NOT COMPLETED|Overall Study||0
6667216|NCT02547012|7597975|FG001|NOT COMPLETED|Overall Study||0
6256072|NCT03875313|7154909|FG001|NOT COMPLETED|Overall Study||16
6667217|NCT02547038|7597983|FG000|STARTED|Overall Study||176
6667218|NCT02547038|7597984|FG001|STARTED|Overall Study||176
6667219|NCT02547038|7597983|FG000|COMPLETED|Overall Study||173
6667220|NCT02547038|7597984|FG001|COMPLETED|Overall Study||174
6667221|NCT02547038|7597983|FG000|NOT COMPLETED|Overall Study||3
6667222|NCT02547038|7597984|FG001|NOT COMPLETED|Overall Study||2
6667223|NCT02547064|7597992|FG000|STARTED|Overall Study||81
6667224|NCT02547064|7597993|FG001|STARTED|Overall Study||81
6667225|NCT02547064|7597992|FG000|COMPLETED|Overall Study||78
6667226|NCT02547064|7597993|FG001|COMPLETED|Overall Study||79
6667227|NCT02547064|7597992|FG000|NOT COMPLETED|Overall Study||3
6667228|NCT02547064|7597993|FG001|NOT COMPLETED|Overall Study||2
6667229|NCT02547220|7598001|FG000|STARTED|Overall Study||19
6667230|NCT02547220|7598002|FG001|STARTED|Overall Study||20
6667231|NCT02547220|7598001|FG000|COMPLETED|Overall Study||0
6667232|NCT02547220|7598002|FG001|COMPLETED|Overall Study||0
6667233|NCT02547220|7598001|FG000|NOT COMPLETED|Overall Study||19
6667234|NCT02547220|7598002|FG001|NOT COMPLETED|Overall Study||20
6667235|NCT02547233|7598010|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
6667236|NCT02547233|7598011|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
6667237|NCT02547233|7598010|FG000|Treated|3-day Treatment and 8-week Follow-up||205
6667238|NCT02547233|7598011|FG001|Treated|3-day Treatment and 8-week Follow-up||100
6667239|NCT02547233|7598010|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||203
6667240|NCT02547233|7598011|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||92
6667241|NCT02547233|7598010|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
6667242|NCT02547233|7598011|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||10
6667243|NCT02547233|7598010|FG000|STARTED|12-month Follow-up||199
6667244|NCT02547233|7598011|FG001|STARTED|12-month Follow-up||84
6667245|NCT02547233|7598010|FG000|COMPLETED|12-month Follow-up||185
6667246|NCT02547233|7598011|FG001|COMPLETED|12-month Follow-up||67
6667247|NCT02547233|7598010|FG000|NOT COMPLETED|12-month Follow-up||14
6667248|NCT02547233|7598011|FG001|NOT COMPLETED|12-month Follow-up||17
6667249|NCT02547363|7598021|FG000|STARTED|3-day Treatment and 8-week Follow-up||211
6667250|NCT02547363|7598022|FG001|STARTED|3-day Treatment and 8-week Follow-up||105
6667251|NCT02547363|7598021|FG000|Treated|3-day Treatment and 8-week Follow-up||209
6667252|NCT02547363|7598022|FG001|Treated|3-day Treatment and 8-week Follow-up||104
6667253|NCT02547363|7598021|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
6667254|NCT02547363|7598022|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||94
6667255|NCT02547363|7598021|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
6667256|NCT02547363|7598022|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||11
6667257|NCT02547363|7598021|FG000|STARTED|12-month Follow-up||204
6667258|NCT02547363|7598022|FG001|STARTED|12-month Follow-up||86
6667259|NCT02547363|7598021|FG000|COMPLETED|12-month Follow-up||194
6667260|NCT02547363|7598022|FG001|COMPLETED|12-month Follow-up||81
6667261|NCT02547363|7598021|FG000|NOT COMPLETED|12-month Follow-up||10
6667262|NCT02547363|7598022|FG001|NOT COMPLETED|12-month Follow-up||5
6667263|NCT02547428|7598032|FG000|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||42
6667264|NCT02547428|7598033|FG001|STARTED|Period 1- Treatment Sequence 1 (3 Weeks)||43
6667265|NCT02547428|7598032|FG000|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||42
6667266|NCT02547428|7598033|FG001|Received at Least 1 Dose of Study Drug|Period 1- Treatment Sequence 1 (3 Weeks)||43
6667267|NCT02547428|7598032|FG000|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||31
6667268|NCT02547428|7598033|FG001|COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||37
6667269|NCT02547428|7598032|FG000|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||11
6667270|NCT02547428|7598033|FG001|NOT COMPLETED|Period 1- Treatment Sequence 1 (3 Weeks)||6
6667271|NCT02547428|7598032|FG000|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||31
6667272|NCT02547428|7598033|FG001|STARTED|Period 2- Treatment Sequence 2 (3 Weeks)||37
6667273|NCT02547428|7598032|FG000|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
6667274|NCT02547428|7598033|FG001|COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||30
6667275|NCT02547428|7598032|FG000|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||1
6667276|NCT02547428|7598033|FG001|NOT COMPLETED|Period 2- Treatment Sequence 2 (3 Weeks)||7
6667277|NCT02547454|7598046|FG000|STARTED|Overall Study||393
6667278|NCT02547454|7598046|FG000|COMPLETED|Overall Study||221
6667279|NCT02547454|7598046|FG000|NOT COMPLETED|Overall Study||172
6667280|NCT02547623|7598052|FG000|STARTED|Overall Study||126
6667281|NCT02547623|7598053|FG001|STARTED|Overall Study||55
6667282|NCT02547623|7598052|FG000|COMPLETED|Overall Study||122
6667283|NCT02547623|7598053|FG001|COMPLETED|Overall Study||52
6667284|NCT02547623|7598052|FG000|NOT COMPLETED|Overall Study||4
6667285|NCT02547623|7598053|FG001|NOT COMPLETED|Overall Study||3
6667286|NCT02547649|7598062|FG000|STARTED|Overall Study||231
6667287|NCT02547649|7598063|FG001|STARTED|Overall Study||231
6667288|NCT02547649|7598064|FG002|STARTED|Overall Study||228
6667289|NCT02547649|7598062|FG000|Vaccinated|Overall Study||231
6667290|NCT02547649|7598063|FG001|Vaccinated|Overall Study||231
6667291|NCT02547649|7598064|FG002|Vaccinated|Overall Study||227
6667292|NCT02547649|7598062|FG000|COMPLETED|Overall Study||228
6667293|NCT02547649|7598063|FG001|COMPLETED|Overall Study||226
6667294|NCT02547649|7598064|FG002|COMPLETED|Overall Study||224
6667295|NCT02547649|7598062|FG000|NOT COMPLETED|Overall Study||3
6667296|NCT02547649|7598063|FG001|NOT COMPLETED|Overall Study||5
6667297|NCT02547649|7598064|FG002|NOT COMPLETED|Overall Study||4
6667298|NCT02547714|7598072|FG000|STARTED|Overall Study||34
6667299|NCT02547714|7598072|FG000|COMPLETED|Overall Study||34
6667300|NCT02547714|7598072|FG000|NOT COMPLETED|Overall Study||0
6667301|NCT02547766|7598077|FG000|STARTED|Overall Study||10
6667302|NCT02547766|7598077|FG000|COMPLETED|Overall Study||9
6667303|NCT02547766|7598077|FG000|NOT COMPLETED|Overall Study||1
6667304|NCT02547779|7598083|FG000|STARTED|Overall Study||5214
6667305|NCT02547779|7598084|FG001|STARTED|Overall Study||5207
6667306|NCT02547779|7598083|FG000|COMPLETED|Overall Study||5214
6667307|NCT02547779|7598084|FG001|COMPLETED|Overall Study||5207
6667308|NCT02547779|7598083|FG000|NOT COMPLETED|Overall Study||0
6667309|NCT02547779|7598084|FG001|NOT COMPLETED|Overall Study||0
6667310|NCT02547922|7598093|FG000|STARTED|Overall Study||46
6667311|NCT02547922|7598094|FG001|STARTED|Overall Study||52
6667312|NCT02547922|7598095|FG002|STARTED|Overall Study||49
6667313|NCT02547922|7598093|FG000|FAS (Full Analysis Set)|Overall Study||45
6667314|NCT02547922|7598094|FG001|FAS (Full Analysis Set)|Overall Study||51
6667315|NCT02547922|7598095|FG002|FAS (Full Analysis Set)|Overall Study||49
6667316|NCT02547922|7598093|FG000|COMPLETED|Overall Study||18
6667317|NCT02547922|7598094|FG001|COMPLETED|Overall Study||28
6667318|NCT02547922|7598095|FG002|COMPLETED|Overall Study||20
6667319|NCT02547922|7598093|FG000|NOT COMPLETED|Overall Study||28
6667320|NCT02547922|7598094|FG001|NOT COMPLETED|Overall Study||24
6667321|NCT02547922|7598095|FG002|NOT COMPLETED|Overall Study||29
6667322|NCT02547935|7598112|FG000|STARTED|Overall Study||155
6667323|NCT02547935|7598113|FG001|STARTED|Overall Study||145
6667324|NCT02547935|7598114|FG002|STARTED|Overall Study||148
6667325|NCT02547935|7598112|FG000|Received Treatment|Overall Study||152
6667326|NCT02547935|7598113|FG001|Received Treatment|Overall Study||145
6667327|NCT02547935|7598114|FG002|Received Treatment|Overall Study||148
6667328|NCT02547935|7598112|FG000|Full Analysis Set|Overall Study||152
6667329|NCT02547935|7598113|FG001|Full Analysis Set|Overall Study||144
6667330|NCT02547935|7598114|FG002|Full Analysis Set|Overall Study||148
6667331|NCT02547935|7598112|FG000|Safety Analysis Set|Overall Study||152
6667332|NCT02547935|7598113|FG001|Safety Analysis Set|Overall Study||145
6667333|NCT02547935|7598114|FG002|Safety Analysis Set|Overall Study||148
6667334|NCT02547935|7598112|FG000|COMPLETED|Overall Study||150
6667335|NCT02547935|7598113|FG001|COMPLETED|Overall Study||137
6667336|NCT02547935|7598114|FG002|COMPLETED|Overall Study||143
6667337|NCT02547935|7598112|FG000|NOT COMPLETED|Overall Study||5
6667338|NCT02547935|7598113|FG001|NOT COMPLETED|Overall Study||8
6667339|NCT02547935|7598114|FG002|NOT COMPLETED|Overall Study||5
6667340|NCT02547974|7598128|FG000|STARTED|Overall Study||15
6667341|NCT02547974|7598129|FG001|STARTED|Overall Study||31
6667342|NCT02547974|7598130|FG002|STARTED|Overall Study||30
6667343|NCT02547974|7598131|FG003|STARTED|Overall Study||44
6667344|NCT02547974|7598128|FG000|COMPLETED|Overall Study||14
6667345|NCT02547974|7598129|FG001|COMPLETED|Overall Study||31
6667346|NCT02547974|7598130|FG002|COMPLETED|Overall Study||30
6667347|NCT02547974|7598131|FG003|COMPLETED|Overall Study||44
6667348|NCT02547974|7598128|FG000|NOT COMPLETED|Overall Study||1
6667349|NCT02547974|7598129|FG001|NOT COMPLETED|Overall Study||0
6667350|NCT02547974|7598130|FG002|NOT COMPLETED|Overall Study||0
6667351|NCT02547974|7598131|FG003|NOT COMPLETED|Overall Study||0
6667352|NCT02547987|7598144|FG000|STARTED|Overall Study||25
6667353|NCT02547987|7598144|FG000|COMPLETED|Overall Study||22
6667354|NCT02547987|7598144|FG000|NOT COMPLETED|Overall Study||3
6667355|NCT02548078|7598150|FG000|STARTED|Overall Study||300
6667356|NCT02548078|7598151|FG001|STARTED|Overall Study||300
6667357|NCT02548078|7598150|FG000|COMPLETED|Overall Study||295
6667358|NCT02548078|7598151|FG001|COMPLETED|Overall Study||294
6667359|NCT02548078|7598150|FG000|NOT COMPLETED|Overall Study||5
6667360|NCT02548078|7598151|FG001|NOT COMPLETED|Overall Study||6
6667361|NCT02548156|7598164|FG000|STARTED|Period 1||5
6667362|NCT02548156|7598165|FG001|STARTED|Period 1||5
6667363|NCT02548156|7598166|FG002|STARTED|Period 1||4
6667364|NCT02548156|7598167|FG003|STARTED|Period 1||5
6667365|NCT02548156|7598168|FG004|STARTED|Period 1||5
6667366|NCT02548156|7598169|FG005|STARTED|Period 1||5
6667367|NCT02548156|7598164|FG000|COMPLETED|Period 1||5
6667368|NCT02548156|7598165|FG001|COMPLETED|Period 1||5
6667369|NCT02548156|7598166|FG002|COMPLETED|Period 1||4
6667370|NCT02548156|7598167|FG003|COMPLETED|Period 1||5
6667371|NCT02548156|7598168|FG004|COMPLETED|Period 1||5
6667372|NCT02548156|7598169|FG005|COMPLETED|Period 1||5
6667373|NCT02548156|7598164|FG000|NOT COMPLETED|Period 1||0
6667374|NCT02548156|7598165|FG001|NOT COMPLETED|Period 1||0
6667375|NCT02548156|7598166|FG002|NOT COMPLETED|Period 1||0
6667376|NCT02548156|7598167|FG003|NOT COMPLETED|Period 1||0
6667377|NCT02548156|7598168|FG004|NOT COMPLETED|Period 1||0
6667378|NCT02548156|7598169|FG005|NOT COMPLETED|Period 1||0
6667379|NCT02548156|7598164|FG000|STARTED|Washout Period 1||5
6667380|NCT02548156|7598165|FG001|STARTED|Washout Period 1||5
6667381|NCT02548156|7598166|FG002|STARTED|Washout Period 1||4
6667382|NCT02548156|7598167|FG003|STARTED|Washout Period 1||5
6667383|NCT02548156|7598168|FG004|STARTED|Washout Period 1||5
6667384|NCT02548156|7598169|FG005|STARTED|Washout Period 1||5
6667385|NCT02548156|7598164|FG000|COMPLETED|Washout Period 1||5
6667386|NCT02548156|7598165|FG001|COMPLETED|Washout Period 1||5
6667387|NCT02548156|7598166|FG002|COMPLETED|Washout Period 1||4
6667388|NCT02548156|7598167|FG003|COMPLETED|Washout Period 1||5
6667389|NCT02548156|7598168|FG004|COMPLETED|Washout Period 1||4
6667390|NCT02548156|7598169|FG005|COMPLETED|Washout Period 1||5
6667391|NCT02548156|7598164|FG000|NOT COMPLETED|Washout Period 1||0
6667392|NCT02548156|7598165|FG001|NOT COMPLETED|Washout Period 1||0
6667393|NCT02548156|7598166|FG002|NOT COMPLETED|Washout Period 1||0
6667394|NCT02548156|7598167|FG003|NOT COMPLETED|Washout Period 1||0
6667395|NCT02548156|7598168|FG004|NOT COMPLETED|Washout Period 1||1
6667396|NCT02548156|7598169|FG005|NOT COMPLETED|Washout Period 1||0
6667397|NCT02548156|7598164|FG000|STARTED|Period 2||5
6667398|NCT02548156|7598165|FG001|STARTED|Period 2||5
6667399|NCT02548156|7598166|FG002|STARTED|Period 2||4
6667400|NCT02548156|7598167|FG003|STARTED|Period 2||5
6667401|NCT02548156|7598168|FG004|STARTED|Period 2||4
6667402|NCT02548156|7598169|FG005|STARTED|Period 2||5
6667403|NCT02548156|7598164|FG000|COMPLETED|Period 2||5
6667404|NCT02548156|7598165|FG001|COMPLETED|Period 2||5
6667405|NCT02548156|7598166|FG002|COMPLETED|Period 2||4
6667406|NCT02548156|7598167|FG003|COMPLETED|Period 2||5
6667407|NCT02548156|7598168|FG004|COMPLETED|Period 2||4
6667408|NCT02548156|7598169|FG005|COMPLETED|Period 2||5
6667409|NCT02548156|7598164|FG000|NOT COMPLETED|Period 2||0
6667410|NCT02548156|7598165|FG001|NOT COMPLETED|Period 2||0
6667411|NCT02548156|7598166|FG002|NOT COMPLETED|Period 2||0
6667412|NCT02548156|7598167|FG003|NOT COMPLETED|Period 2||0
6667413|NCT02548156|7598168|FG004|NOT COMPLETED|Period 2||0
6667414|NCT02548156|7598169|FG005|NOT COMPLETED|Period 2||0
6667415|NCT02548156|7598164|FG000|STARTED|Washout Period 2||5
6667416|NCT02548156|7598165|FG001|STARTED|Washout Period 2||5
6667417|NCT02548156|7598166|FG002|STARTED|Washout Period 2||4
6667418|NCT02548156|7598167|FG003|STARTED|Washout Period 2||5
6667419|NCT02548156|7598168|FG004|STARTED|Washout Period 2||4
6667420|NCT02548156|7598169|FG005|STARTED|Washout Period 2||5
6667421|NCT02548156|7598164|FG000|COMPLETED|Washout Period 2||5
6667422|NCT02548156|7598165|FG001|COMPLETED|Washout Period 2||5
6667423|NCT02548156|7598166|FG002|COMPLETED|Washout Period 2||4
6667424|NCT02548156|7598167|FG003|COMPLETED|Washout Period 2||5
6667425|NCT02548156|7598168|FG004|COMPLETED|Washout Period 2||4
6667426|NCT02548156|7598169|FG005|COMPLETED|Washout Period 2||5
6667427|NCT02548156|7598164|FG000|NOT COMPLETED|Washout Period 2||0
6667428|NCT02548156|7598165|FG001|NOT COMPLETED|Washout Period 2||0
6667429|NCT02548156|7598166|FG002|NOT COMPLETED|Washout Period 2||0
6667430|NCT02548156|7598167|FG003|NOT COMPLETED|Washout Period 2||0
6667431|NCT02548156|7598168|FG004|NOT COMPLETED|Washout Period 2||0
6667432|NCT02548156|7598169|FG005|NOT COMPLETED|Washout Period 2||0
6667433|NCT02548156|7598164|FG000|STARTED|Period 3||5
6667434|NCT02548156|7598165|FG001|STARTED|Period 3||5
6667435|NCT02548156|7598166|FG002|STARTED|Period 3||4
6667436|NCT02548156|7598167|FG003|STARTED|Period 3||5
6667437|NCT02548156|7598168|FG004|STARTED|Period 3||4
6667438|NCT02548156|7598169|FG005|STARTED|Period 3||5
6667439|NCT02548156|7598164|FG000|COMPLETED|Period 3||5
6667440|NCT02548156|7598165|FG001|COMPLETED|Period 3||5
6667441|NCT02548156|7598166|FG002|COMPLETED|Period 3||4
6667442|NCT02548156|7598167|FG003|COMPLETED|Period 3||5
6667443|NCT02548156|7598168|FG004|COMPLETED|Period 3||4
6667444|NCT02548156|7598169|FG005|COMPLETED|Period 3||5
6667445|NCT02548156|7598164|FG000|NOT COMPLETED|Period 3||0
6667446|NCT02548156|7598165|FG001|NOT COMPLETED|Period 3||0
6667447|NCT02548156|7598166|FG002|NOT COMPLETED|Period 3||0
6667448|NCT02548156|7598167|FG003|NOT COMPLETED|Period 3||0
6667449|NCT02548156|7598168|FG004|NOT COMPLETED|Period 3||0
6667450|NCT02548156|7598169|FG005|NOT COMPLETED|Period 3||0
6667451|NCT02548312|7598185|FG000|STARTED|Overall Study||133
6667452|NCT02548312|7598186|FG001|STARTED|Overall Study||133
6667453|NCT02548312|7598187|FG002|STARTED|Overall Study||134
6667454|NCT02548312|7598188|FG003|STARTED|Overall Study||133
6667455|NCT02548312|7598189|FG004|STARTED|Overall Study||133
6667456|NCT02548312|7598190|FG005|STARTED|Overall Study||133
6667457|NCT02548312|7598191|FG006|STARTED|Overall Study||133
6667458|NCT02548312|7598192|FG007|STARTED|Overall Study||133
6667459|NCT02548312|7598185|FG000|COMPLETED|Overall Study||100
6667460|NCT02548312|7598186|FG001|COMPLETED|Overall Study||90
6667461|NCT02548312|7598187|FG002|COMPLETED|Overall Study||96
6667462|NCT02548312|7598188|FG003|COMPLETED|Overall Study||87
6667463|NCT02548312|7598189|FG004|COMPLETED|Overall Study||99
6667464|NCT02548312|7598190|FG005|COMPLETED|Overall Study||93
6667465|NCT02548312|7598191|FG006|COMPLETED|Overall Study||93
6667466|NCT02548312|7598192|FG007|COMPLETED|Overall Study||91
6667467|NCT02548312|7598185|FG000|NOT COMPLETED|Overall Study||33
6667468|NCT02548312|7598186|FG001|NOT COMPLETED|Overall Study||43
6667469|NCT02548312|7598187|FG002|NOT COMPLETED|Overall Study||38
6667470|NCT02548312|7598188|FG003|NOT COMPLETED|Overall Study||46
6667471|NCT02548312|7598189|FG004|NOT COMPLETED|Overall Study||34
6667472|NCT02548312|7598190|FG005|NOT COMPLETED|Overall Study||40
6667473|NCT02548312|7598191|FG006|NOT COMPLETED|Overall Study||40
6667474|NCT02548312|7598192|FG007|NOT COMPLETED|Overall Study||42
6667475|NCT02548455|7598210|FG000|STARTED|Overall Study|A total of 499 subjects were enrolled at 31 investigational sites.|499
6667476|NCT02548455|7598210|FG000|Completed Pre-Discharge|Overall Study||484
6667477|NCT02548455|7598210|FG000|Completed 6-Month Follow-up|Overall Study||259
6667478|NCT02548455|7598210|FG000|Completed 12-Month Follow-up|Overall Study|Study completed prior to all subjects reaching the 6- and 12-month visits.|61
6667479|NCT02548455|7598210|FG000|COMPLETED|Overall Study|Completed 6-Month Follow-up|259
6667480|NCT02548455|7598210|FG000|NOT COMPLETED|Overall Study||240
6667481|NCT02548585|7598221|FG000|STARTED|Overall Study||45
6667482|NCT02548585|7598222|FG001|STARTED|Overall Study||6
6667483|NCT02548585|7598223|FG002|STARTED|Overall Study||6
6667484|NCT02548585|7598224|FG003|STARTED|Overall Study||7
6667485|NCT02548585|7598225|FG004|STARTED|Overall Study||25
6667486|NCT02548585|7598226|FG005|STARTED|Overall Study||12
6667487|NCT02548585|7598227|FG006|STARTED|Overall Study||12
6667488|NCT02548585|7598221|FG000|Treated|Overall Study||45
6667489|NCT02548585|7598222|FG001|Treated|Overall Study||6
6667490|NCT02548585|7598223|FG002|Treated|Overall Study||6
6667491|NCT02548585|7598224|FG003|Treated|Overall Study||7
6667492|NCT02548585|7598225|FG004|Treated|Overall Study||25
6667493|NCT02548585|7598226|FG005|Treated|Overall Study||11
6667494|NCT02548585|7598227|FG006|Treated|Overall Study||12
6667495|NCT02548585|7598221|FG000|COMPLETED|Overall Study||43
6667496|NCT02548585|7598222|FG001|COMPLETED|Overall Study||6
6667497|NCT02548585|7598223|FG002|COMPLETED|Overall Study||6
6667498|NCT02548585|7598224|FG003|COMPLETED|Overall Study||5
6667499|NCT02548585|7598225|FG004|COMPLETED|Overall Study||22
6667500|NCT02548585|7598226|FG005|COMPLETED|Overall Study||10
6667501|NCT02548585|7598227|FG006|COMPLETED|Overall Study||11
6667502|NCT02548585|7598221|FG000|NOT COMPLETED|Overall Study||2
6667503|NCT02548585|7598222|FG001|NOT COMPLETED|Overall Study||0
6667504|NCT02548585|7598223|FG002|NOT COMPLETED|Overall Study||0
6667505|NCT02548585|7598224|FG003|NOT COMPLETED|Overall Study||2
6667506|NCT02548585|7598225|FG004|NOT COMPLETED|Overall Study||3
6667507|NCT02548585|7598226|FG005|NOT COMPLETED|Overall Study||2
6667508|NCT02548585|7598227|FG006|NOT COMPLETED|Overall Study||1
6667509|NCT02548650|7598270|FG000|STARTED|Triple Therapy||30
6667510|NCT02548650|7598271|FG001|STARTED|Triple Therapy||36
6667511|NCT02548650|7598270|FG000|COMPLETED|Triple Therapy||29
6667512|NCT02548650|7598271|FG001|COMPLETED|Triple Therapy||32
6667513|NCT02548650|7598270|FG000|NOT COMPLETED|Triple Therapy||1
6667514|NCT02548650|7598271|FG001|NOT COMPLETED|Triple Therapy||4
6667515|NCT02548650|7598270|FG000|STARTED|Double Therapy||29
6667516|NCT02548650|7598271|FG001|STARTED|Double Therapy||32
6667517|NCT02548650|7598270|FG000|COMPLETED|Double Therapy||28
6667518|NCT02548650|7598271|FG001|COMPLETED|Double Therapy||30
6667519|NCT02548650|7598270|FG000|NOT COMPLETED|Double Therapy||1
6667520|NCT02548650|7598271|FG001|NOT COMPLETED|Double Therapy||2
6667521|NCT02548728|7598279|FG000|STARTED|Overall Study||6
6667522|NCT02548728|7598280|FG001|STARTED|Overall Study||6
6667523|NCT02548728|7598279|FG000|COMPLETED|Overall Study||6
6667524|NCT02548728|7598280|FG001|COMPLETED|Overall Study||6
6667525|NCT02548728|7598279|FG000|NOT COMPLETED|Overall Study||0
6667526|NCT02548728|7598280|FG001|NOT COMPLETED|Overall Study||0
6667527|NCT02548845|7598286|FG000|STARTED|Overall Study||70
6667528|NCT02548845|7598286|FG000|COMPLETED|Overall Study||70
6667529|NCT02548845|7598286|FG000|NOT COMPLETED|Overall Study||0
6667530|NCT02548910|7598296|FG000|STARTED|Overall Study||31
6667531|NCT02548910|7598297|FG001|STARTED|Overall Study||31
6667532|NCT02548910|7598296|FG000|COMPLETED|Overall Study||31
6667533|NCT02548910|7598297|FG001|COMPLETED|Overall Study||31
6667534|NCT02548910|7598296|FG000|NOT COMPLETED|Overall Study||0
6667535|NCT02548910|7598297|FG001|NOT COMPLETED|Overall Study||0
6667536|NCT02548949|7598304|FG000|STARTED|Overall Study||700
6667537|NCT02548949|7598304|FG000|COMPLETED|Overall Study||700
6667538|NCT02548949|7598304|FG000|NOT COMPLETED|Overall Study||0
6667539|NCT02548962|7598310|FG000|STARTED|Overall Study||8
6667540|NCT02548962|7598311|FG001|STARTED|Overall Study||3
6667541|NCT02548962|7598310|FG000|COMPLETED|Overall Study||7
6667542|NCT02548962|7598311|FG001|COMPLETED|Overall Study||3
6667543|NCT02548962|7598310|FG000|NOT COMPLETED|Overall Study||1
6667544|NCT02548962|7598311|FG001|NOT COMPLETED|Overall Study||0
6667545|NCT02549014|7598321|FG000|STARTED|Overall Study||8
6667546|NCT02549014|7598322|FG001|STARTED|Overall Study||8
6667547|NCT02549014|7598321|FG000|COMPLETED|Overall Study||8
6667548|NCT02549014|7598322|FG001|COMPLETED|Overall Study||8
6667549|NCT02549014|7598321|FG000|NOT COMPLETED|Overall Study||0
6667550|NCT02549014|7598322|FG001|NOT COMPLETED|Overall Study||0
6667551|NCT02549027|7598346|FG000|STARTED|Period 1 - MK-1064 or Placebo||5
6667552|NCT02549027|7598347|FG001|STARTED|Period 1 - MK-1064 or Placebo||5
6667553|NCT02549027|7598348|FG002|STARTED|Period 1 - MK-1064 or Placebo||5
6667554|NCT02549027|7598349|FG003|STARTED|Period 1 - MK-1064 or Placebo||5
6667555|NCT02549027|7598350|FG004|STARTED|Period 1 - MK-1064 or Placebo||0
6667556|NCT02549027|7598351|FG005|STARTED|Period 1 - MK-1064 or Placebo||0
6667557|NCT02549027|7598346|FG000|COMPLETED|Period 1 - MK-1064 or Placebo||5
6667558|NCT02549027|7598347|FG001|COMPLETED|Period 1 - MK-1064 or Placebo||5
6667559|NCT02549027|7598348|FG002|COMPLETED|Period 1 - MK-1064 or Placebo||5
6667560|NCT02549027|7598349|FG003|COMPLETED|Period 1 - MK-1064 or Placebo||5
6667561|NCT02549027|7598350|FG004|COMPLETED|Period 1 - MK-1064 or Placebo||0
6667562|NCT02549027|7598351|FG005|COMPLETED|Period 1 - MK-1064 or Placebo||0
6667563|NCT02549027|7598346|FG000|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6667564|NCT02549027|7598347|FG001|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6667565|NCT02549027|7598348|FG002|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6667566|NCT02549027|7598349|FG003|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6667567|NCT02549027|7598350|FG004|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6667568|NCT02549027|7598351|FG005|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
6667569|NCT02549027|7598346|FG000|STARTED|Washout After Period 1||5
6667570|NCT02549027|7598347|FG001|STARTED|Washout After Period 1||5
6667571|NCT02549027|7598348|FG002|STARTED|Washout After Period 1||5
6667572|NCT02549027|7598349|FG003|STARTED|Washout After Period 1||5
6667573|NCT02549027|7598350|FG004|STARTED|Washout After Period 1||0
6667574|NCT02549027|7598351|FG005|STARTED|Washout After Period 1||0
6667575|NCT02549027|7598346|FG000|COMPLETED|Washout After Period 1||5
6667576|NCT02549027|7598347|FG001|COMPLETED|Washout After Period 1||5
6667577|NCT02549027|7598348|FG002|COMPLETED|Washout After Period 1||5
6667578|NCT02549027|7598349|FG003|COMPLETED|Washout After Period 1||5
6667579|NCT02549027|7598350|FG004|COMPLETED|Washout After Period 1||0
6667580|NCT02549027|7598351|FG005|COMPLETED|Washout After Period 1||0
6667581|NCT02549027|7598346|FG000|NOT COMPLETED|Washout After Period 1||0
6667582|NCT02549027|7598347|FG001|NOT COMPLETED|Washout After Period 1||0
6667583|NCT02549027|7598348|FG002|NOT COMPLETED|Washout After Period 1||0
6667584|NCT02549027|7598349|FG003|NOT COMPLETED|Washout After Period 1||0
6667585|NCT02549027|7598350|FG004|NOT COMPLETED|Washout After Period 1||0
6667586|NCT02549027|7598351|FG005|NOT COMPLETED|Washout After Period 1||0
6667587|NCT02549027|7598346|FG000|STARTED|Period 2 - MK-1064 or Placebo||5
6667588|NCT02549027|7598347|FG001|STARTED|Period 2 - MK-1064 or Placebo||5
6667589|NCT02549027|7598348|FG002|STARTED|Period 2 - MK-1064 or Placebo||5
6667590|NCT02549027|7598349|FG003|STARTED|Period 2 - MK-1064 or Placebo||5
6667591|NCT02549027|7598350|FG004|STARTED|Period 2 - MK-1064 or Placebo||0
6667592|NCT02549027|7598351|FG005|STARTED|Period 2 - MK-1064 or Placebo||0
6667593|NCT02549027|7598346|FG000|COMPLETED|Period 2 - MK-1064 or Placebo||5
6667594|NCT02549027|7598347|FG001|COMPLETED|Period 2 - MK-1064 or Placebo||5
6667595|NCT02549027|7598348|FG002|COMPLETED|Period 2 - MK-1064 or Placebo||5
6667596|NCT02549027|7598349|FG003|COMPLETED|Period 2 - MK-1064 or Placebo||5
6667597|NCT02549027|7598350|FG004|COMPLETED|Period 2 - MK-1064 or Placebo||0
6667598|NCT02549027|7598351|FG005|COMPLETED|Period 2 - MK-1064 or Placebo||0
6667599|NCT02549027|7598346|FG000|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6667600|NCT02549027|7598347|FG001|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6667601|NCT02549027|7598348|FG002|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6667602|NCT02549027|7598349|FG003|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6667603|NCT02549027|7598350|FG004|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6667604|NCT02549027|7598351|FG005|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
6667605|NCT02549027|7598346|FG000|STARTED|Washout After Period 2||5
6667606|NCT02549027|7598347|FG001|STARTED|Washout After Period 2||5
6667607|NCT02549027|7598348|FG002|STARTED|Washout After Period 2||5
6667608|NCT02549027|7598349|FG003|STARTED|Washout After Period 2||5
6667609|NCT02549027|7598350|FG004|STARTED|Washout After Period 2||0
6667610|NCT02549027|7598351|FG005|STARTED|Washout After Period 2||0
6667611|NCT02549027|7598346|FG000|COMPLETED|Washout After Period 2||5
6667612|NCT02549027|7598347|FG001|COMPLETED|Washout After Period 2||5
6667613|NCT02549027|7598348|FG002|COMPLETED|Washout After Period 2||5
6667614|NCT02549027|7598349|FG003|COMPLETED|Washout After Period 2||5
6667615|NCT02549027|7598350|FG004|COMPLETED|Washout After Period 2||0
6667616|NCT02549027|7598351|FG005|COMPLETED|Washout After Period 2||0
6667617|NCT02549027|7598346|FG000|NOT COMPLETED|Washout After Period 2||0
6667618|NCT02549027|7598347|FG001|NOT COMPLETED|Washout After Period 2||0
6667619|NCT02549027|7598348|FG002|NOT COMPLETED|Washout After Period 2||0
6667620|NCT02549027|7598349|FG003|NOT COMPLETED|Washout After Period 2||0
6667621|NCT02549027|7598350|FG004|NOT COMPLETED|Washout After Period 2||0
6667622|NCT02549027|7598351|FG005|NOT COMPLETED|Washout After Period 2||0
6667623|NCT02549027|7598346|FG000|STARTED|Period 3 - MK-1064 or Placebo||5
6667624|NCT02549027|7598347|FG001|STARTED|Period 3 - MK-1064 or Placebo||5
6667625|NCT02549027|7598348|FG002|STARTED|Period 3 - MK-1064 or Placebo||5
6667626|NCT02549027|7598349|FG003|STARTED|Period 3 - MK-1064 or Placebo||5
6667627|NCT02549027|7598350|FG004|STARTED|Period 3 - MK-1064 or Placebo||0
6667628|NCT02549027|7598351|FG005|STARTED|Period 3 - MK-1064 or Placebo||0
6667629|NCT02549027|7598346|FG000|COMPLETED|Period 3 - MK-1064 or Placebo||5
6667630|NCT02549027|7598347|FG001|COMPLETED|Period 3 - MK-1064 or Placebo||5
6667631|NCT02549027|7598348|FG002|COMPLETED|Period 3 - MK-1064 or Placebo||5
6667632|NCT02549027|7598349|FG003|COMPLETED|Period 3 - MK-1064 or Placebo||5
6667633|NCT02549027|7598350|FG004|COMPLETED|Period 3 - MK-1064 or Placebo||0
6667634|NCT02549027|7598351|FG005|COMPLETED|Period 3 - MK-1064 or Placebo||0
6667635|NCT02549027|7598346|FG000|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6667636|NCT02549027|7598347|FG001|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6667637|NCT02549027|7598348|FG002|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6667638|NCT02549027|7598349|FG003|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6667639|NCT02549027|7598350|FG004|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6667640|NCT02549027|7598351|FG005|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
6667641|NCT02549027|7598346|FG000|STARTED|Washout After Period 3||5
6667642|NCT02549027|7598347|FG001|STARTED|Washout After Period 3||5
6667643|NCT02549027|7598348|FG002|STARTED|Washout After Period 3||5
6667644|NCT02549027|7598349|FG003|STARTED|Washout After Period 3||5
6667645|NCT02549027|7598350|FG004|STARTED|Washout After Period 3||0
6667646|NCT02549027|7598351|FG005|STARTED|Washout After Period 3||0
6667647|NCT02549027|7598346|FG000|COMPLETED|Washout After Period 3||5
6667648|NCT02549027|7598347|FG001|COMPLETED|Washout After Period 3||5
6667649|NCT02549027|7598348|FG002|COMPLETED|Washout After Period 3||5
6667650|NCT02549027|7598349|FG003|COMPLETED|Washout After Period 3||5
6667651|NCT02549027|7598350|FG004|COMPLETED|Washout After Period 3||0
6667652|NCT02549027|7598351|FG005|COMPLETED|Washout After Period 3||0
6667653|NCT02549027|7598346|FG000|NOT COMPLETED|Washout After Period 3||0
6667654|NCT02549027|7598347|FG001|NOT COMPLETED|Washout After Period 3||0
6667655|NCT02549027|7598348|FG002|NOT COMPLETED|Washout After Period 3||0
6667656|NCT02549027|7598349|FG003|NOT COMPLETED|Washout After Period 3||0
6667657|NCT02549027|7598350|FG004|NOT COMPLETED|Washout After Period 3||0
6667658|NCT02549027|7598351|FG005|NOT COMPLETED|Washout After Period 3||0
6667659|NCT02549027|7598346|FG000|STARTED|Period 4 - MK-1064 or Placebo||5
6667660|NCT02549027|7598347|FG001|STARTED|Period 4 - MK-1064 or Placebo||5
6667661|NCT02549027|7598348|FG002|STARTED|Period 4 - MK-1064 or Placebo||5
6667662|NCT02549027|7598349|FG003|STARTED|Period 4 - MK-1064 or Placebo||5
6667663|NCT02549027|7598350|FG004|STARTED|Period 4 - MK-1064 or Placebo||0
6667664|NCT02549027|7598351|FG005|STARTED|Period 4 - MK-1064 or Placebo||0
6667665|NCT02549027|7598346|FG000|COMPLETED|Period 4 - MK-1064 or Placebo||5
6667666|NCT02549027|7598347|FG001|COMPLETED|Period 4 - MK-1064 or Placebo||5
6667667|NCT02549027|7598348|FG002|COMPLETED|Period 4 - MK-1064 or Placebo||5
6667668|NCT02549027|7598349|FG003|COMPLETED|Period 4 - MK-1064 or Placebo||5
6667669|NCT02549027|7598350|FG004|COMPLETED|Period 4 - MK-1064 or Placebo||0
6667670|NCT02549027|7598351|FG005|COMPLETED|Period 4 - MK-1064 or Placebo||0
6667671|NCT02549027|7598346|FG000|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6667672|NCT02549027|7598347|FG001|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6667673|NCT02549027|7598348|FG002|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6667674|NCT02549027|7598349|FG003|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6667675|NCT02549027|7598350|FG004|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6667676|NCT02549027|7598351|FG005|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
6667677|NCT02549027|7598346|FG000|STARTED|Washout After Period 4||5
6667678|NCT02549027|7598347|FG001|STARTED|Washout After Period 4||5
6667679|NCT02549027|7598348|FG002|STARTED|Washout After Period 4||5
6667680|NCT02549027|7598349|FG003|STARTED|Washout After Period 4||5
6667681|NCT02549027|7598350|FG004|STARTED|Washout After Period 4||0
6667682|NCT02549027|7598351|FG005|STARTED|Washout After Period 4||0
6667683|NCT02549027|7598346|FG000|COMPLETED|Washout After Period 4||5
6667684|NCT02549027|7598347|FG001|COMPLETED|Washout After Period 4||4
6667685|NCT02549027|7598348|FG002|COMPLETED|Washout After Period 4||4
6667686|NCT02549027|7598349|FG003|COMPLETED|Washout After Period 4||4
6667687|NCT02549027|7598350|FG004|COMPLETED|Washout After Period 4||0
6667688|NCT02549027|7598351|FG005|COMPLETED|Washout After Period 4||0
6667689|NCT02549027|7598346|FG000|NOT COMPLETED|Washout After Period 4||0
6667690|NCT02549027|7598347|FG001|NOT COMPLETED|Washout After Period 4||1
6667691|NCT02549027|7598348|FG002|NOT COMPLETED|Washout After Period 4||1
6667692|NCT02549027|7598349|FG003|NOT COMPLETED|Washout After Period 4||1
6667693|NCT02549027|7598350|FG004|NOT COMPLETED|Washout After Period 4||0
6667694|NCT02549027|7598351|FG005|NOT COMPLETED|Washout After Period 4||0
6667695|NCT02549027|7598346|FG000|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
6667696|NCT02549027|7598347|FG001|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
6667697|NCT02549027|7598348|FG002|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
6667698|NCT02549027|7598349|FG003|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
6667699|NCT02549027|7598350|FG004|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
6667700|NCT02549027|7598351|FG005|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
6667701|NCT02549027|7598346|FG000|COMPLETED|Period 5 - MK-6096 or Placebo||0
6667702|NCT02549027|7598347|FG001|COMPLETED|Period 5 - MK-6096 or Placebo||0
6667703|NCT02549027|7598348|FG002|COMPLETED|Period 5 - MK-6096 or Placebo||0
6667704|NCT02549027|7598349|FG003|COMPLETED|Period 5 - MK-6096 or Placebo||0
6667705|NCT02549027|7598350|FG004|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
6667706|NCT02549027|7598351|FG005|COMPLETED|Period 5 - MK-6096 or Placebo||1
6667707|NCT02549027|7598346|FG000|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6667708|NCT02549027|7598347|FG001|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6667709|NCT02549027|7598348|FG002|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6667710|NCT02549027|7598349|FG003|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6667711|NCT02549027|7598350|FG004|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
6667712|NCT02549027|7598351|FG005|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
6667713|NCT02549040|7598366|FG000|STARTED|Period 1||16
6667714|NCT02549040|7598366|FG000|COMPLETED|Period 1||16
6667715|NCT02549040|7598366|FG000|NOT COMPLETED|Period 1||0
6667716|NCT02549040|7598366|FG000|STARTED|Period 2||16
6667717|NCT02549040|7598366|FG000|COMPLETED|Period 2||16
6667718|NCT02549040|7598366|FG000|NOT COMPLETED|Period 2||0
6667719|NCT02549040|7598366|FG000|STARTED|Period 3||16
6667720|NCT02549040|7598366|FG000|COMPLETED|Period 3||16
6667721|NCT02549040|7598366|FG000|NOT COMPLETED|Period 3||0
6667722|NCT02549040|7598366|FG000|STARTED|Period 4||16
6667723|NCT02549040|7598366|FG000|COMPLETED|Period 4||16
6667724|NCT02549040|7598366|FG000|NOT COMPLETED|Period 4||0
6667725|NCT02549040|7598366|FG000|STARTED|Period 5||16
6667726|NCT02549040|7598366|FG000|COMPLETED|Period 5||16
6667727|NCT02549040|7598366|FG000|NOT COMPLETED|Period 5||0
6667728|NCT02549196|7598382|FG000|STARTED|Overall Study||8
6667729|NCT02549196|7598383|FG001|STARTED|Overall Study||1
6667730|NCT02549196|7598384|FG002|STARTED|Overall Study||6
6667731|NCT02549196|7598385|FG003|STARTED|Overall Study||13
6667732|NCT02549196|7598382|FG000|COMPLETED|Overall Study||7
6667733|NCT02549196|7598383|FG001|COMPLETED|Overall Study||1
6667734|NCT02549196|7598384|FG002|COMPLETED|Overall Study||5
6667735|NCT02549196|7598385|FG003|COMPLETED|Overall Study||12
6667736|NCT02549196|7598382|FG000|NOT COMPLETED|Overall Study||1
6667737|NCT02549196|7598383|FG001|NOT COMPLETED|Overall Study||0
6667738|NCT02549196|7598384|FG002|NOT COMPLETED|Overall Study||1
6667739|NCT02549196|7598385|FG003|NOT COMPLETED|Overall Study||1
6667740|NCT02549287|7598397|FG000|STARTED|Overall Study||193
6667741|NCT02549287|7598398|FG001|STARTED|Overall Study||96
6667742|NCT02549287|7598397|FG000|COMPLETED|Overall Study||113
6667743|NCT02549287|7598398|FG001|COMPLETED|Overall Study||64
6667744|NCT02549287|7598397|FG000|NOT COMPLETED|Overall Study||80
6667745|NCT02549287|7598398|FG001|NOT COMPLETED|Overall Study||32
6667746|NCT02549339|7598406|FG000|STARTED|3-day Treatment and 8-week Follow-up||205
6667747|NCT02549339|7598407|FG001|STARTED|3-day Treatment and 8-week Follow-up||104
6667748|NCT02549339|7598406|FG000|Treated|3-day Treatment and 8-week Follow-up||202
6667749|NCT02549339|7598407|FG001|Treated|3-day Treatment and 8-week Follow-up||104
6667750|NCT02549339|7598406|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||201
6667751|NCT02549339|7598407|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||99
6667752|NCT02549339|7598406|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||4
6667753|NCT02549339|7598407|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||5
6667754|NCT02549339|7598406|FG000|STARTED|12-month Follow-up||201
6667755|NCT02549339|7598407|FG001|STARTED|12-month Follow-up||98
6667756|NCT02549339|7598406|FG000|COMPLETED|12-month Follow-up||192
6667757|NCT02549339|7598407|FG001|COMPLETED|12-month Follow-up||87
6667758|NCT02549339|7598406|FG000|NOT COMPLETED|12-month Follow-up||9
6667759|NCT02549339|7598407|FG001|NOT COMPLETED|12-month Follow-up||11
6667760|NCT02549352|7598417|FG000|STARTED|3-day Treatment and 8-week Follow-up||209
6667761|NCT02549352|7598418|FG001|STARTED|3-day Treatment and 8-week Follow-up||102
6667762|NCT02549352|7598417|FG000|Treated|3-day Treatment and 8-week Follow-up||209
6667763|NCT02549352|7598418|FG001|Treated|3-day Treatment and 8-week Follow-up|1 participant was included in 0.037% in the safety analysis set as they received both IMPs in error|101
6667764|NCT02549352|7598417|FG000|COMPLETED|3-day Treatment and 8-week Follow-up||207
6667765|NCT02549352|7598418|FG001|COMPLETED|3-day Treatment and 8-week Follow-up||96
6667766|NCT02549352|7598417|FG000|NOT COMPLETED|3-day Treatment and 8-week Follow-up||2
6667767|NCT02549352|7598418|FG001|NOT COMPLETED|3-day Treatment and 8-week Follow-up||6
6667768|NCT02549352|7598417|FG000|STARTED|12-month Follow-up||207
6667769|NCT02549352|7598418|FG001|STARTED|12-month Follow-up||93
6667770|NCT02549352|7598417|FG000|COMPLETED|12-month Follow-up||199
6667771|NCT02549352|7598418|FG001|COMPLETED|12-month Follow-up||81
6667772|NCT02549352|7598417|FG000|NOT COMPLETED|12-month Follow-up||8
6667773|NCT02549352|7598418|FG001|NOT COMPLETED|12-month Follow-up||12
6667774|NCT02549365|7598428|FG000|STARTED|Overall Study||164
6667775|NCT02549365|7598429|FG001|STARTED|Overall Study||112
6667776|NCT02549365|7598428|FG000|COMPLETED|Overall Study||164
6667777|NCT02549365|7598429|FG001|COMPLETED|Overall Study||112
6667778|NCT02549365|7598428|FG000|NOT COMPLETED|Overall Study||0
6667779|NCT02549365|7598429|FG001|NOT COMPLETED|Overall Study||0
6667780|NCT02549508|7598437|FG000|STARTED|Overall Study||47
6667781|NCT02549508|7598438|FG001|STARTED|Overall Study||38
6667782|NCT02549508|7598437|FG000|COMPLETED|Overall Study||33
6667783|NCT02549508|7598438|FG001|COMPLETED|Overall Study||21
6667784|NCT02549508|7598437|FG000|NOT COMPLETED|Overall Study||14
6667785|NCT02549508|7598438|FG001|NOT COMPLETED|Overall Study||17
6667786|NCT02549573|7598448|FG000|STARTED|Overall Study||6
6667787|NCT02549573|7598449|FG001|STARTED|Overall Study||7
6667788|NCT02549573|7598448|FG000|COMPLETED|Overall Study||6
6667789|NCT02549573|7598449|FG001|COMPLETED|Overall Study||4
6667790|NCT02549573|7598448|FG000|NOT COMPLETED|Overall Study||0
6667791|NCT02549573|7598449|FG001|NOT COMPLETED|Overall Study||3
6667792|NCT02549859|7598455|FG000|STARTED|Visit 1||11
6667793|NCT02549859|7598455|FG000|COMPLETED|Visit 1||11
6667794|NCT02549859|7598455|FG000|NOT COMPLETED|Visit 1||0
6667795|NCT02549859|7598455|FG000|STARTED|Long-term 60 Hz DBS||11
6667796|NCT02549859|7598455|FG000|COMPLETED|Long-term 60 Hz DBS||10
6667797|NCT02549859|7598455|FG000|NOT COMPLETED|Long-term 60 Hz DBS||1
6667798|NCT02549859|7598455|FG000|STARTED|Visit 2||10
6667799|NCT02549859|7598455|FG000|COMPLETED|Visit 2||10
6667800|NCT02549859|7598455|FG000|NOT COMPLETED|Visit 2||0
6667801|NCT02550106|7598463|FG000|STARTED|Overall Study||136
6667802|NCT02550106|7598463|FG000|COMPLETED|Overall Study||124
6667803|NCT02550106|7598463|FG000|NOT COMPLETED|Overall Study||12
6667804|NCT02550132|7598469|FG000|STARTED|Overall Study||25
6667805|NCT02550132|7598469|FG000|COMPLETED|Overall Study||25
6667806|NCT02550132|7598469|FG000|NOT COMPLETED|Overall Study||0
6737851|NCT03271528|7667063|FG001|COMPLETED|Medication Dispense/Exposure Period 2||11
6737852|NCT03271528|7667062|FG000|NOT COMPLETED|Medication Dispense/Exposure Period 2||1
6737853|NCT03271528|7667063|FG001|NOT COMPLETED|Medication Dispense/Exposure Period 2||0
6737854|NCT03271528|7667062|FG000|STARTED|Alcohol Self-Administration Trial 2||8
6737855|NCT03271528|7667063|FG001|STARTED|Alcohol Self-Administration Trial 2||11
6737856|NCT03271528|7667062|FG000|COMPLETED|Alcohol Self-Administration Trial 2||8
6737857|NCT03271528|7667063|FG001|COMPLETED|Alcohol Self-Administration Trial 2||11
6737858|NCT03271528|7667062|FG000|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
6737859|NCT03271528|7667063|FG001|NOT COMPLETED|Alcohol Self-Administration Trial 2||0
6737860|NCT03272139|7667071|FG000|STARTED|Overall Study||63
6737861|NCT03272139|7667072|FG001|STARTED|Overall Study||63
6737862|NCT03272139|7667071|FG000|COMPLETED|Overall Study||63
6737863|NCT03272139|7667072|FG001|COMPLETED|Overall Study||63
6737864|NCT03272139|7667071|FG000|NOT COMPLETED|Overall Study||0
6737865|NCT03272139|7667072|FG001|NOT COMPLETED|Overall Study||0
6737866|NCT03273153|7667080|FG000|STARTED|Overall Study||224
6737867|NCT03273153|7667081|FG001|STARTED|Overall Study||222
6737868|NCT03273153|7667080|FG000|COMPLETED|Overall Study||0
6737869|NCT03273153|7667081|FG001|COMPLETED|Overall Study||0
6737870|NCT03273153|7667080|FG000|NOT COMPLETED|Overall Study||224
6737871|NCT03273153|7667081|FG001|NOT COMPLETED|Overall Study||222
6737872|NCT03273166|7667087|FG000|STARTED|Overall Study||82
6737873|NCT03273166|7667087|FG000|COMPLETED|Overall Study||51
6737874|NCT03273166|7667087|FG000|NOT COMPLETED|Overall Study||31
6737875|NCT03273257|7667094|FG000|STARTED|Overall Study||7
6737876|NCT03273257|7667095|FG001|STARTED|Overall Study||7
6737877|NCT03273257|7667094|FG000|Started Treatment|Overall Study||7
6737878|NCT03273257|7667095|FG001|Started Treatment|Overall Study|Only 6 patients from the placebo group started treatment because 1 patient died after randomization (= study start), but before initiating treatment|6
6737879|NCT03273257|7667094|FG000|Underwent PEA|Overall Study||6
6737880|NCT03273257|7667095|FG001|Underwent PEA|Overall Study||5
6737881|NCT03273257|7667094|FG000|COMPLETED|Overall Study||3
6737882|NCT03273257|7667095|FG001|COMPLETED|Overall Study||3
6737883|NCT03273257|7667094|FG000|NOT COMPLETED|Overall Study||4
6737884|NCT03273257|7667095|FG001|NOT COMPLETED|Overall Study||4
6737885|NCT03273270|7667103|FG000|STARTED|Overall Study||12
6737886|NCT03273270|7667104|FG001|STARTED|Overall Study||8
6737887|NCT03273270|7667103|FG000|COMPLETED|Overall Study||12
6737888|NCT03273270|7667104|FG001|COMPLETED|Overall Study||8
6737889|NCT03273270|7667103|FG000|NOT COMPLETED|Overall Study||0
6737890|NCT03273270|7667104|FG001|NOT COMPLETED|Overall Study||0
6737891|NCT03273283|7667112|FG000|STARTED|Overall Study||99
6737892|NCT03273283|7667113|FG001|STARTED|Overall Study||101
6737893|NCT03273283|7667112|FG000|COMPLETED|Overall Study||72
6737894|NCT03273283|7667113|FG001|COMPLETED|Overall Study||81
6737895|NCT03273283|7667112|FG000|NOT COMPLETED|Overall Study||27
6737896|NCT03273283|7667113|FG001|NOT COMPLETED|Overall Study||20
6737897|NCT03273387|7667121|FG000|STARTED|Overall Study||13
6737898|NCT03273387|7667122|FG001|STARTED|Overall Study||13
6737899|NCT03273387|7667121|FG000|COMPLETED|Overall Study||10
6737900|NCT03273387|7667122|FG001|COMPLETED|Overall Study||10
6737901|NCT03273387|7667121|FG000|NOT COMPLETED|Overall Study||3
6737902|NCT03273387|7667122|FG001|NOT COMPLETED|Overall Study||3
6737903|NCT03273426|7667130|FG000|STARTED|Overall Study||20
6737904|NCT03273426|7667131|FG001|STARTED|Overall Study||20
6737905|NCT03273426|7667130|FG000|COMPLETED|Overall Study||20
6737906|NCT03273426|7667131|FG001|COMPLETED|Overall Study||20
6737907|NCT03273426|7667130|FG000|NOT COMPLETED|Overall Study||0
6737908|NCT03273426|7667131|FG001|NOT COMPLETED|Overall Study||0
6737909|NCT03273543|7667140|FG000|STARTED|Overall Study||10
6737910|NCT03273543|7667141|FG001|STARTED|Overall Study||10
6737911|NCT03273543|7667140|FG000|COMPLETED|Overall Study||10
6737912|NCT03273543|7667141|FG001|COMPLETED|Overall Study||10
6737913|NCT03273543|7667140|FG000|NOT COMPLETED|Overall Study||0
6737914|NCT03273543|7667141|FG001|NOT COMPLETED|Overall Study||0
6737915|NCT03273673|7667149|FG000|STARTED|Overall Study||18
6737916|NCT03273673|7667150|FG001|STARTED|Overall Study||22
6737917|NCT03273673|7667149|FG000|COMPLETED|Overall Study||14
6737918|NCT03273673|7667150|FG001|COMPLETED|Overall Study||22
6737919|NCT03273673|7667149|FG000|NOT COMPLETED|Overall Study||4
6737920|NCT03273673|7667150|FG001|NOT COMPLETED|Overall Study||0
6737921|NCT03273946|7667156|FG000|STARTED|Overall Study||158
6737922|NCT03273946|7667156|FG000|COMPLETED|Overall Study||149
6737923|NCT03273946|7667156|FG000|NOT COMPLETED|Overall Study||9
6737924|NCT03274076|7667162|FG000|STARTED|24 Weeks Double Blind||10
6737925|NCT03274076|7667163|FG001|STARTED|24 Weeks Double Blind||5
6737926|NCT03274076|7667164|FG002|STARTED|24 Weeks Double Blind||0
6737927|NCT03274076|7667165|FG003|STARTED|24 Weeks Double Blind||0
6737928|NCT03274076|7667162|FG000|COMPLETED|24 Weeks Double Blind||10
6737929|NCT03274076|7667163|FG001|COMPLETED|24 Weeks Double Blind||4
6737930|NCT03274076|7667164|FG002|COMPLETED|24 Weeks Double Blind||0
6737931|NCT03274076|7667165|FG003|COMPLETED|24 Weeks Double Blind||0
6737932|NCT03274076|7667162|FG000|NOT COMPLETED|24 Weeks Double Blind||0
6737933|NCT03274076|7667163|FG001|NOT COMPLETED|24 Weeks Double Blind||1
6667807|NCT02550210|7598473|FG000|STARTED|Overall Study||23
6667808|NCT02550210|7598473|FG000|COMPLETED|Overall Study||19
6667809|NCT02550210|7598473|FG000|NOT COMPLETED|Overall Study||4
6667810|NCT02550743|7598481|FG000|STARTED|Overall Study||3
6667811|NCT02550743|7598482|FG001|STARTED|Overall Study||3
6667812|NCT02550743|7598483|FG002|STARTED|Overall Study||1
6667813|NCT02550743|7598484|FG003|STARTED|Overall Study||0
6667814|NCT02550743|7598481|FG000|COMPLETED|Overall Study||3
6667815|NCT02550743|7598482|FG001|COMPLETED|Overall Study||3
6667816|NCT02550743|7598483|FG002|COMPLETED|Overall Study||1
6667817|NCT02550743|7598484|FG003|COMPLETED|Overall Study||0
6667818|NCT02550743|7598481|FG000|NOT COMPLETED|Overall Study||0
6667819|NCT02550743|7598482|FG001|NOT COMPLETED|Overall Study||0
6667820|NCT02550743|7598483|FG002|NOT COMPLETED|Overall Study||0
6667821|NCT02550743|7598484|FG003|NOT COMPLETED|Overall Study||0
6667822|NCT02550795|7598498|FG000|STARTED|Overall Study||50
6667823|NCT02550795|7598499|FG001|STARTED|Overall Study||50
6667824|NCT02550795|7598500|FG002|STARTED|Overall Study||50
6667825|NCT02550795|7598498|FG000|COMPLETED|Overall Study||50
6667826|NCT02550795|7598499|FG001|COMPLETED|Overall Study||49
6667827|NCT02550795|7598500|FG002|COMPLETED|Overall Study||50
6667828|NCT02550795|7598498|FG000|NOT COMPLETED|Overall Study||0
6667829|NCT02550795|7598499|FG001|NOT COMPLETED|Overall Study||1
6667830|NCT02550795|7598500|FG002|NOT COMPLETED|Overall Study||0
6667831|NCT02550873|7598510|FG000|STARTED|Randomized Double Blind||78
6667832|NCT02550873|7598511|FG001|STARTED|Randomized Double Blind||39
6667833|NCT02550873|7598512|FG002|STARTED|Randomized Double Blind||0
6667834|NCT02550873|7598510|FG000|Received Treatment|Randomized Double Blind||77
6667835|NCT02550873|7598511|FG001|Received Treatment|Randomized Double Blind||39
6667836|NCT02550873|7598512|FG002|Received Treatment|Randomized Double Blind||0
6667837|NCT02550873|7598510|FG000|Continue to Open Label Extension|Randomized Double Blind||74
6667838|NCT02550873|7598511|FG001|Continue to Open Label Extension|Randomized Double Blind||37
6667839|NCT02550873|7598512|FG002|Continue to Open Label Extension|Randomized Double Blind||0
6667840|NCT02550873|7598510|FG000|COMPLETED|Randomized Double Blind||74
6667841|NCT02550873|7598511|FG001|COMPLETED|Randomized Double Blind||37
6667842|NCT02550873|7598512|FG002|COMPLETED|Randomized Double Blind||0
6667843|NCT02550873|7598510|FG000|NOT COMPLETED|Randomized Double Blind||4
6667844|NCT02550873|7598511|FG001|NOT COMPLETED|Randomized Double Blind||2
6667845|NCT02550873|7598512|FG002|NOT COMPLETED|Randomized Double Blind||0
6667846|NCT02550873|7598510|FG000|STARTED|Open Label Extension||0
6667847|NCT02550873|7598511|FG001|STARTED|Open Label Extension||0
6667848|NCT02550873|7598512|FG002|STARTED|Open Label Extension||111
6667849|NCT02550873|7598510|FG000|COMPLETED|Open Label Extension||0
6667850|NCT02550873|7598511|FG001|COMPLETED|Open Label Extension||0
6667851|NCT02550873|7598512|FG002|COMPLETED|Open Label Extension|Open Label extension is ongoing|0
6667852|NCT02550873|7598510|FG000|NOT COMPLETED|Open Label Extension||0
6667853|NCT02550873|7598511|FG001|NOT COMPLETED|Open Label Extension||0
6667854|NCT02550873|7598512|FG002|NOT COMPLETED|Open Label Extension||111
6667855|NCT02550938|7598538|FG000|STARTED|Overall Study||44
6667856|NCT02550938|7598539|FG001|STARTED|Overall Study||85
6667857|NCT02550938|7598540|FG002|STARTED|Overall Study||43
6667858|NCT02550938|7598541|FG003|STARTED|Overall Study||81
6667859|NCT02550938|7598538|FG000|COMPLETED|Overall Study||36
6667860|NCT02550938|7598539|FG001|COMPLETED|Overall Study||78
6667861|NCT02550938|7598540|FG002|COMPLETED|Overall Study||31
6667862|NCT02550938|7598541|FG003|COMPLETED|Overall Study||70
6667863|NCT02550938|7598538|FG000|NOT COMPLETED|Overall Study||8
6667864|NCT02550938|7598539|FG001|NOT COMPLETED|Overall Study||7
6667865|NCT02550938|7598540|FG002|NOT COMPLETED|Overall Study||12
6667866|NCT02550938|7598541|FG003|NOT COMPLETED|Overall Study||11
6667867|NCT02551055|7598558|FG000|STARTED|Overall Study||4
6667868|NCT02551055|7598559|FG001|STARTED|Overall Study||6
6667869|NCT02551055|7598560|FG002|STARTED|Overall Study||3
6667870|NCT02551055|7598561|FG003|STARTED|Overall Study||6
6667871|NCT02551055|7598562|FG004|STARTED|Overall Study||7
6667872|NCT02551055|7598563|FG005|STARTED|Overall Study||2
6667873|NCT02551055|7598564|FG006|STARTED|Overall Study||4
6667874|NCT02551055|7598565|FG007|STARTED|Overall Study||0
6667875|NCT02551055|7598558|FG000|COMPLETED|Overall Study||0
6667876|NCT02551055|7598559|FG001|COMPLETED|Overall Study||0
6667877|NCT02551055|7598560|FG002|COMPLETED|Overall Study||1
6667878|NCT02551055|7598561|FG003|COMPLETED|Overall Study||1
6667879|NCT02551055|7598562|FG004|COMPLETED|Overall Study||0
6667880|NCT02551055|7598563|FG005|COMPLETED|Overall Study||1
6667881|NCT02551055|7598564|FG006|COMPLETED|Overall Study||1
6667882|NCT02551055|7598565|FG007|COMPLETED|Overall Study||0
6667883|NCT02551055|7598558|FG000|NOT COMPLETED|Overall Study||4
6667884|NCT02551055|7598559|FG001|NOT COMPLETED|Overall Study||6
6667885|NCT02551055|7598560|FG002|NOT COMPLETED|Overall Study||2
6667886|NCT02551055|7598561|FG003|NOT COMPLETED|Overall Study||5
6667887|NCT02551055|7598562|FG004|NOT COMPLETED|Overall Study||7
6667888|NCT02551055|7598563|FG005|NOT COMPLETED|Overall Study||1
6667889|NCT02551055|7598564|FG006|NOT COMPLETED|Overall Study||3
6667890|NCT02551055|7598565|FG007|NOT COMPLETED|Overall Study||0
6667891|NCT02551094|7598585|FG000|STARTED|Overall Study||2366
6667892|NCT02551094|7598586|FG001|STARTED|Overall Study||2379
6667893|NCT02551094|7598585|FG000|COMPLETED|Overall Study||2226
6667894|NCT02551094|7598586|FG001|COMPLETED|Overall Study||2232
6667895|NCT02551094|7598585|FG000|NOT COMPLETED|Overall Study||140
6667896|NCT02551094|7598586|FG001|NOT COMPLETED|Overall Study||147
6667897|NCT02551159|7598595|FG000|STARTED|Overall Study||413
6667898|NCT02551159|7598596|FG001|STARTED|Overall Study||204
6667899|NCT02551159|7598597|FG002|STARTED|Overall Study||206
6667900|NCT02551159|7598595|FG000|Full Analysis Set|Overall Study||413
6667901|NCT02551159|7598596|FG001|Full Analysis Set|Overall Study||204
6667902|NCT02551159|7598597|FG002|Full Analysis Set|Overall Study||206
6667903|NCT02551159|7598595|FG000|Safety Analysis Set|Overall Study||408
6667904|NCT02551159|7598596|FG001|Safety Analysis Set|Overall Study||202
6667905|NCT02551159|7598597|FG002|Safety Analysis Set|Overall Study||196
6667906|NCT02551159|7598595|FG000|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||190
6667907|NCT02551159|7598596|FG001|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||99
6667908|NCT02551159|7598597|FG002|PD-L1 TC/IC High Subgroup Analysis Set|Overall Study||94
6667909|NCT02551159|7598595|FG000|COMPLETED|Overall Study||0
6667910|NCT02551159|7598596|FG001|COMPLETED|Overall Study||0
6667911|NCT02551159|7598597|FG002|COMPLETED|Overall Study||0
6667912|NCT02551159|7598595|FG000|NOT COMPLETED|Overall Study||413
6667913|NCT02551159|7598596|FG001|NOT COMPLETED|Overall Study||204
6667914|NCT02551159|7598597|FG002|NOT COMPLETED|Overall Study||206
6667915|NCT02551224|7598605|FG000|STARTED|First Intervention||50
6667916|NCT02551224|7598606|FG001|STARTED|First Intervention||50
6667917|NCT02551224|7598605|FG000|COMPLETED|First Intervention||50
6667918|NCT02551224|7598606|FG001|COMPLETED|First Intervention||50
6667919|NCT02551224|7598605|FG000|NOT COMPLETED|First Intervention||0
6667920|NCT02551224|7598606|FG001|NOT COMPLETED|First Intervention||0
6667921|NCT02551224|7598605|FG000|STARTED|Second Intervention (5 Min After First )||50
6667922|NCT02551224|7598606|FG001|STARTED|Second Intervention (5 Min After First )||50
6667923|NCT02551224|7598605|FG000|COMPLETED|Second Intervention (5 Min After First )||50
6667924|NCT02551224|7598606|FG001|COMPLETED|Second Intervention (5 Min After First )||50
6667925|NCT02551224|7598605|FG000|NOT COMPLETED|Second Intervention (5 Min After First )||0
6667926|NCT02551224|7598606|FG001|NOT COMPLETED|Second Intervention (5 Min After First )||0
6667927|NCT02551432|7598612|FG000|STARTED|Overall Study||26
6667928|NCT02551432|7598612|FG000|COMPLETED|Overall Study||26
6667929|NCT02551432|7598612|FG000|NOT COMPLETED|Overall Study||0
6667930|NCT02551653|7598618|FG000|STARTED|Overall Study||5
6667931|NCT02551653|7598619|FG001|STARTED|Overall Study||5
6667932|NCT02551653|7598618|FG000|COMPLETED|Overall Study||5
6667933|NCT02551653|7598619|FG001|COMPLETED|Overall Study||5
6667934|NCT02551653|7598618|FG000|NOT COMPLETED|Overall Study||0
6667935|NCT02551653|7598619|FG001|NOT COMPLETED|Overall Study||0
6667936|NCT02551666|7598627|FG000|STARTED|Overall Study||16
6667937|NCT02551666|7598628|FG001|STARTED|Overall Study||19
6667938|NCT02551666|7598627|FG000|COMPLETED|Overall Study||15
6667939|NCT02551666|7598628|FG001|COMPLETED|Overall Study||16
6667940|NCT02551666|7598627|FG000|NOT COMPLETED|Overall Study||1
6667941|NCT02551666|7598628|FG001|NOT COMPLETED|Overall Study||3
6667942|NCT02551692|7598637|FG000|STARTED|Overall Study||31
6667943|NCT02551692|7598638|FG001|STARTED|Overall Study||27
6667944|NCT02551692|7598639|FG002|STARTED|Overall Study||30
6667945|NCT02551692|7598637|FG000|COMPLETED|Overall Study||30
6667946|NCT02551692|7598638|FG001|COMPLETED|Overall Study||26
6667947|NCT02551692|7598639|FG002|COMPLETED|Overall Study||25
6667948|NCT02551692|7598637|FG000|NOT COMPLETED|Overall Study||1
6667949|NCT02551692|7598638|FG001|NOT COMPLETED|Overall Study||1
6667950|NCT02551692|7598639|FG002|NOT COMPLETED|Overall Study||5
6667951|NCT02551731|7598647|FG000|STARTED|Overall Study||9
6667952|NCT02551731|7598647|FG000|COMPLETED|Overall Study||7
6667953|NCT02551731|7598647|FG000|NOT COMPLETED|Overall Study||2
6667954|NCT02551744|7598653|FG000|STARTED|Overall Study||50
6667955|NCT02551744|7598654|FG001|STARTED|Overall Study||51
6667956|NCT02551744|7598653|FG000|COMPLETED|Overall Study||50
6667957|NCT02551744|7598654|FG001|COMPLETED|Overall Study||51
6667958|NCT02551744|7598653|FG000|NOT COMPLETED|Overall Study||0
6667959|NCT02551744|7598654|FG001|NOT COMPLETED|Overall Study||0
6667960|NCT02551757|7598662|FG000|STARTED|Overall Study||20
6667961|NCT02551757|7598663|FG001|STARTED|Overall Study||20
6667962|NCT02551757|7598662|FG000|COMPLETED|Overall Study||13
6667963|NCT02551757|7598663|FG001|COMPLETED|Overall Study||17
6667964|NCT02551757|7598662|FG000|NOT COMPLETED|Overall Study||7
6667965|NCT02551757|7598663|FG001|NOT COMPLETED|Overall Study||3
6667966|NCT02551770|7598673|FG000|STARTED|Overall Study||51
6667967|NCT02551770|7598674|FG001|STARTED|Overall Study||51
6667968|NCT02551770|7598673|FG000|COMPLETED|Overall Study||48
6667969|NCT02551770|7598674|FG001|COMPLETED|Overall Study||48
6667970|NCT02551770|7598673|FG000|NOT COMPLETED|Overall Study||3
6667971|NCT02551770|7598674|FG001|NOT COMPLETED|Overall Study||3
6667972|NCT02551809|7598682|FG000|STARTED|Overall Study||14
6667973|NCT02551809|7598683|FG001|STARTED|Overall Study||15
6667974|NCT02551809|7598684|FG002|STARTED|Overall Study||14
6667975|NCT02551809|7598682|FG000|COMPLETED|Overall Study||14
6667976|NCT02551809|7598683|FG001|COMPLETED|Overall Study||14
6667977|NCT02551809|7598684|FG002|COMPLETED|Overall Study||13
6667978|NCT02551809|7598682|FG000|NOT COMPLETED|Overall Study||0
6667979|NCT02551809|7598683|FG001|NOT COMPLETED|Overall Study||1
6667980|NCT02551809|7598684|FG002|NOT COMPLETED|Overall Study||1
6667981|NCT02551822|7598694|FG000|STARTED|Overall Study||11
6667982|NCT02551822|7598695|FG001|STARTED|Overall Study||12
6667983|NCT02551822|7598694|FG000|COMPLETED|Overall Study||9
6667984|NCT02551822|7598695|FG001|COMPLETED|Overall Study||10
6667985|NCT02551822|7598694|FG000|NOT COMPLETED|Overall Study||2
6667986|NCT02551822|7598695|FG001|NOT COMPLETED|Overall Study||2
6667987|NCT02551874|7598703|FG000|STARTED|Overall Study||324
6667988|NCT02551874|7598704|FG001|STARTED|Overall Study||326
6667989|NCT02551874|7598703|FG000|Received Treatment in Short-term Study|Overall Study||324
6667990|NCT02551874|7598704|FG001|Received Treatment in Short-term Study|Overall Study||319
6667991|NCT02551874|7598703|FG000|Entered Long-term Study|Overall Study||306
6667992|NCT02551874|7598704|FG001|Entered Long-term Study|Overall Study||294
6667993|NCT02551874|7598703|FG000|Received Treatment in Long-term Study|Overall Study||295
6667994|NCT02551874|7598704|FG001|Received Treatment in Long-term Study|Overall Study||284
6667995|NCT02551874|7598703|FG000|COMPLETED|Overall Study||296
6667996|NCT02551874|7598704|FG001|COMPLETED|Overall Study||287
6667997|NCT02551874|7598703|FG000|NOT COMPLETED|Overall Study||28
6667998|NCT02551874|7598704|FG001|NOT COMPLETED|Overall Study||39
6667999|NCT02551887|7598713|FG000|STARTED|Overall Study||301
6668000|NCT02551887|7598714|FG001|STARTED|Overall Study||124
6668001|NCT02551887|7598715|FG002|STARTED|Overall Study||222
6668002|NCT02551887|7598713|FG000|COMPLETED|Overall Study||301
6668003|NCT02551887|7598714|FG001|COMPLETED|Overall Study||124
6668004|NCT02551887|7598715|FG002|COMPLETED|Overall Study||222
6668005|NCT02551887|7598713|FG000|NOT COMPLETED|Overall Study||0
6668006|NCT02551887|7598714|FG001|NOT COMPLETED|Overall Study||0
6668007|NCT02551887|7598715|FG002|NOT COMPLETED|Overall Study||0
6668008|NCT02552121|7598731|FG000|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||3
6668009|NCT02552121|7598732|FG001|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668010|NCT02552121|7598733|FG002|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668011|NCT02552121|7598734|FG003|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668012|NCT02552121|7598735|FG004|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668013|NCT02552121|7598736|FG005|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668014|NCT02552121|7598737|FG006|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668015|NCT02552121|7598738|FG007|STARTED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668016|NCT02552121|7598731|FG000|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668017|NCT02552121|7598732|FG001|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668018|NCT02552121|7598733|FG002|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668019|NCT02552121|7598734|FG003|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668020|NCT02552121|7598735|FG004|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668021|NCT02552121|7598736|FG005|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668022|NCT02552121|7598737|FG006|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668023|NCT02552121|7598738|FG007|COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668024|NCT02552121|7598731|FG000|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||3
6668025|NCT02552121|7598732|FG001|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668026|NCT02552121|7598733|FG002|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668027|NCT02552121|7598734|FG003|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668028|NCT02552121|7598735|FG004|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668029|NCT02552121|7598736|FG005|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668030|NCT02552121|7598737|FG006|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668031|NCT02552121|7598738|FG007|NOT COMPLETED|Part 1: Dose Level 1 (Weeks 1-16)||0
6668032|NCT02552121|7598731|FG000|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6668033|NCT02552121|7598732|FG001|STARTED|Part 1: Dose Level 2 (Week 17-48)||6
6668034|NCT02552121|7598733|FG002|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6668035|NCT02552121|7598734|FG003|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6668036|NCT02552121|7598735|FG004|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6668037|NCT02552121|7598736|FG005|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6668038|NCT02552121|7598737|FG006|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6668039|NCT02552121|7598738|FG007|STARTED|Part 1: Dose Level 2 (Week 17-48)||0
6668040|NCT02552121|7598731|FG000|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668041|NCT02552121|7598732|FG001|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668042|NCT02552121|7598733|FG002|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668043|NCT02552121|7598734|FG003|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668044|NCT02552121|7598735|FG004|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668045|NCT02552121|7598736|FG005|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668046|NCT02552121|7598737|FG006|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668047|NCT02552121|7598738|FG007|COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668048|NCT02552121|7598731|FG000|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668049|NCT02552121|7598732|FG001|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||6
6668050|NCT02552121|7598733|FG002|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668051|NCT02552121|7598734|FG003|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668052|NCT02552121|7598735|FG004|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668053|NCT02552121|7598736|FG005|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668054|NCT02552121|7598737|FG006|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668055|NCT02552121|7598738|FG007|NOT COMPLETED|Part 1: Dose Level 2 (Week 17-48)||0
6668056|NCT02552121|7598731|FG000|STARTED|Part 2: Cohort Expansion||0
6668057|NCT02552121|7598732|FG001|STARTED|Part 2: Cohort Expansion||0
6668058|NCT02552121|7598733|FG002|STARTED|Part 2: Cohort Expansion||11
6668059|NCT02552121|7598734|FG003|STARTED|Part 2: Cohort Expansion||3
6668060|NCT02552121|7598735|FG004|STARTED|Part 2: Cohort Expansion||1
6668061|NCT02552121|7598736|FG005|STARTED|Part 2: Cohort Expansion||5
6668062|NCT02552121|7598737|FG006|STARTED|Part 2: Cohort Expansion||1
6668063|NCT02552121|7598738|FG007|STARTED|Part 2: Cohort Expansion||3
6668064|NCT02552121|7598731|FG000|COMPLETED|Part 2: Cohort Expansion||0
6668065|NCT02552121|7598732|FG001|COMPLETED|Part 2: Cohort Expansion||0
6668066|NCT02552121|7598733|FG002|COMPLETED|Part 2: Cohort Expansion||0
6668067|NCT02552121|7598734|FG003|COMPLETED|Part 2: Cohort Expansion||0
6668068|NCT02552121|7598735|FG004|COMPLETED|Part 2: Cohort Expansion||0
6668069|NCT02552121|7598736|FG005|COMPLETED|Part 2: Cohort Expansion||1
6668070|NCT02552121|7598737|FG006|COMPLETED|Part 2: Cohort Expansion||0
6668071|NCT02552121|7598738|FG007|COMPLETED|Part 2: Cohort Expansion||0
6668072|NCT02552121|7598731|FG000|NOT COMPLETED|Part 2: Cohort Expansion||0
6668073|NCT02552121|7598732|FG001|NOT COMPLETED|Part 2: Cohort Expansion||0
6668074|NCT02552121|7598733|FG002|NOT COMPLETED|Part 2: Cohort Expansion||11
6668075|NCT02552121|7598734|FG003|NOT COMPLETED|Part 2: Cohort Expansion||3
6668076|NCT02552121|7598735|FG004|NOT COMPLETED|Part 2: Cohort Expansion||1
6668077|NCT02552121|7598736|FG005|NOT COMPLETED|Part 2: Cohort Expansion||4
6668078|NCT02552121|7598737|FG006|NOT COMPLETED|Part 2: Cohort Expansion||1
6668079|NCT02552121|7598738|FG007|NOT COMPLETED|Part 2: Cohort Expansion||3
6668080|NCT02552147|7598770|FG000|STARTED|First Intervention (7 Days)||4
6668081|NCT02552147|7598771|FG001|STARTED|First Intervention (7 Days)||4
6668082|NCT02552147|7598770|FG000|COMPLETED|First Intervention (7 Days)||3
6668083|NCT02552147|7598771|FG001|COMPLETED|First Intervention (7 Days)||4
6668084|NCT02552147|7598770|FG000|NOT COMPLETED|First Intervention (7 Days)||1
6668085|NCT02552147|7598771|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6668086|NCT02552147|7598770|FG000|STARTED|Washout (7 Days)||3
6668087|NCT02552147|7598771|FG001|STARTED|Washout (7 Days)||4
6668088|NCT02552147|7598770|FG000|COMPLETED|Washout (7 Days)||3
6668089|NCT02552147|7598771|FG001|COMPLETED|Washout (7 Days)||4
6668090|NCT02552147|7598770|FG000|NOT COMPLETED|Washout (7 Days)||0
6668091|NCT02552147|7598771|FG001|NOT COMPLETED|Washout (7 Days)||0
6668092|NCT02552147|7598770|FG000|STARTED|Second Intervention (7 Days)||3
6668093|NCT02552147|7598771|FG001|STARTED|Second Intervention (7 Days)||4
6668094|NCT02552147|7598770|FG000|COMPLETED|Second Intervention (7 Days)||1
6668095|NCT02552147|7598771|FG001|COMPLETED|Second Intervention (7 Days)||4
6668096|NCT02552147|7598770|FG000|NOT COMPLETED|Second Intervention (7 Days)||2
6668097|NCT02552147|7598771|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6668098|NCT02552212|7598779|FG000|STARTED|Double-Blind Period (Week 0 - 52)||158
6668099|NCT02552212|7598780|FG001|STARTED|Double-Blind Period (Week 0 - 52)||159
6668100|NCT02552212|7598781|FG002|STARTED|Double-Blind Period (Week 0 - 52)||0
6668101|NCT02552212|7598779|FG000|Received OL CZP|Double-Blind Period (Week 0 - 52)||96
6668102|NCT02552212|7598780|FG001|Received OL CZP|Double-Blind Period (Week 0 - 52)||20
6668103|NCT02552212|7598781|FG002|Received OL CZP|Double-Blind Period (Week 0 - 52)||0
6668104|NCT02552212|7598779|FG000|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||20
6668105|NCT02552212|7598780|FG001|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||22
6668106|NCT02552212|7598781|FG002|Completed Week 52 Without Starting SFE|Double-Blind Period (Week 0 - 52)||0
6668107|NCT02552212|7598779|FG000|COMPLETED|Double-Blind Period (Week 0 - 52)||143
6668108|NCT02552212|7598780|FG001|COMPLETED|Double-Blind Period (Week 0 - 52)||142
6668109|NCT02552212|7598781|FG002|COMPLETED|Double-Blind Period (Week 0 - 52)||0
6668110|NCT02552212|7598779|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||15
6668111|NCT02552212|7598780|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||17
6668112|NCT02552212|7598781|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - 52)||0
6668113|NCT02552212|7598779|FG000|STARTED|SFE Period (Week 52 - 156)||0
6668114|NCT02552212|7598780|FG001|STARTED|SFE Period (Week 52 - 156)||0
6668115|NCT02552212|7598781|FG002|STARTED|SFE Period (Week 52 - 156)|123 subjects from Placebo arm and 120 subjects from CZP 200 mg Q2W arm|243
6668116|NCT02552212|7598779|FG000|COMPLETED|SFE Period (Week 52 - 156)||0
6668117|NCT02552212|7598780|FG001|COMPLETED|SFE Period (Week 52 - 156)||0
6668118|NCT02552212|7598781|FG002|COMPLETED|SFE Period (Week 52 - 156)||206
6668119|NCT02552212|7598779|FG000|NOT COMPLETED|SFE Period (Week 52 - 156)||0
6668120|NCT02552212|7598780|FG001|NOT COMPLETED|SFE Period (Week 52 - 156)||0
6668121|NCT02552212|7598781|FG002|NOT COMPLETED|SFE Period (Week 52 - 156)||37
6668122|NCT02552225|7598799|FG000|STARTED|Overall Study||3
6668123|NCT02552225|7598800|FG001|STARTED|Overall Study||3
6668124|NCT02552225|7598799|FG000|COMPLETED|Overall Study||2
6668125|NCT02552225|7598800|FG001|COMPLETED|Overall Study||3
6668126|NCT02552225|7598799|FG000|NOT COMPLETED|Overall Study||1
6668127|NCT02552225|7598800|FG001|NOT COMPLETED|Overall Study||0
6668128|NCT02552238|7598806|FG000|STARTED|Overall Study||174
6668129|NCT02552238|7598806|FG000|COMPLETED|Overall Study|Of the 174 subjects enrolled in the study, 2 withdrew consent prior to administration of investigational product and 2 discontinued due to post-dose adverse event. Therefore, 170 subjects completed the study.|170
6668130|NCT02552238|7598806|FG000|NOT COMPLETED|Overall Study||4
6668131|NCT02552303|7598821|FG000|STARTED|Allocation||10
6668132|NCT02552303|7598822|FG001|STARTED|Allocation||10
6668133|NCT02552303|7598823|FG002|STARTED|Allocation||8
6668134|NCT02552303|7598824|FG003|STARTED|Allocation||11
6668135|NCT02552303|7598821|FG000|COMPLETED|Allocation||7
6668136|NCT02552303|7598822|FG001|COMPLETED|Allocation||8
6668137|NCT02552303|7598823|FG002|COMPLETED|Allocation||7
6668138|NCT02552303|7598824|FG003|COMPLETED|Allocation||10
6668139|NCT02552303|7598821|FG000|NOT COMPLETED|Allocation||3
6668140|NCT02552303|7598822|FG001|NOT COMPLETED|Allocation||2
6668141|NCT02552303|7598823|FG002|NOT COMPLETED|Allocation||1
6668142|NCT02552303|7598824|FG003|NOT COMPLETED|Allocation||1
6668143|NCT02552303|7598821|FG000|STARTED|Follow-Up||7
6668144|NCT02552303|7598822|FG001|STARTED|Follow-Up||8
6668145|NCT02552303|7598823|FG002|STARTED|Follow-Up||7
6668146|NCT02552303|7598824|FG003|STARTED|Follow-Up||10
6668147|NCT02552303|7598821|FG000|COMPLETED|Follow-Up||7
6668148|NCT02552303|7598822|FG001|COMPLETED|Follow-Up||6
6668149|NCT02552303|7598823|FG002|COMPLETED|Follow-Up||6
6668150|NCT02552303|7598824|FG003|COMPLETED|Follow-Up||10
6668151|NCT02552303|7598821|FG000|NOT COMPLETED|Follow-Up||0
6668152|NCT02552303|7598822|FG001|NOT COMPLETED|Follow-Up||2
6668153|NCT02552303|7598823|FG002|NOT COMPLETED|Follow-Up||1
6668154|NCT02552303|7598824|FG003|NOT COMPLETED|Follow-Up||0
6668155|NCT02552316|7598834|FG000|STARTED|Overall Study||34
6668156|NCT02552316|7598834|FG000|COMPLETED|Overall Study||32
6668157|NCT02552316|7598834|FG000|NOT COMPLETED|Overall Study||2
6668158|NCT02552355|7598886|FG000|STARTED|Overall Study||14
6668159|NCT02552355|7598887|FG001|STARTED|Overall Study||13
6668160|NCT02552355|7598888|FG002|STARTED|Overall Study||14
6668161|NCT02552355|7598889|FG003|STARTED|Overall Study||15
6668162|NCT02552355|7598886|FG000|COMPLETED|Overall Study||14
6668163|NCT02552355|7598887|FG001|COMPLETED|Overall Study||11
6668164|NCT02552355|7598888|FG002|COMPLETED|Overall Study||12
6668165|NCT02552355|7598889|FG003|COMPLETED|Overall Study||14
6668166|NCT02552355|7598886|FG000|NOT COMPLETED|Overall Study||0
6668167|NCT02552355|7598887|FG001|NOT COMPLETED|Overall Study||2
6668168|NCT02552355|7598888|FG002|NOT COMPLETED|Overall Study||2
6668169|NCT02552355|7598889|FG003|NOT COMPLETED|Overall Study||1
6668170|NCT02552368|7598899|FG000|STARTED|Overall Study||23
6668171|NCT02552368|7598899|FG000|COMPLETED|Overall Study||10
6668172|NCT02552368|7598899|FG000|NOT COMPLETED|Overall Study||13
6668173|NCT02552732|7598904|FG000|STARTED|Overall Study||29
6668174|NCT02552732|7598904|FG000|Used Device|Overall Study||23
6668175|NCT02552732|7598904|FG000|Completed Week 1|Overall Study||21
6668176|NCT02552732|7598904|FG000|Completed Week 2|Overall Study||20
6668177|NCT02552732|7598904|FG000|Completed Week 3|Overall Study||19
6668178|NCT02552732|7598904|FG000|Completed Week 4|Overall Study||19
6668179|NCT02552732|7598904|FG000|Completed Day 1 and Day 31 Spirometry|Overall Study||12
6668180|NCT02552732|7598904|FG000|COMPLETED|Overall Study||19
6668181|NCT02552732|7598904|FG000|NOT COMPLETED|Overall Study||10
6668182|NCT02552810|7598911|FG000|STARTED|Overall Study||15
6668183|NCT02552810|7598912|FG001|STARTED|Overall Study||15
6668184|NCT02552810|7598911|FG000|COMPLETED|Overall Study||15
6668185|NCT02552810|7598912|FG001|COMPLETED|Overall Study||15
6668186|NCT02552810|7598911|FG000|NOT COMPLETED|Overall Study||0
6668187|NCT02552810|7598912|FG001|NOT COMPLETED|Overall Study||0
6668188|NCT02552888|7598920|FG000|STARTED|Overall Study|35 participants were enrolled.|35
6668189|NCT02552888|7598921|FG001|STARTED|Overall Study|35 participants were enrolled.|35
6668190|NCT02552888|7598920|FG000|COMPLETED|Overall Study|34 participants completed the study.|34
6668191|NCT02552888|7598921|FG001|COMPLETED|Overall Study|34 participants completed the study|34
6668192|NCT02552888|7598920|FG000|NOT COMPLETED|Overall Study||1
6668193|NCT02552888|7598921|FG001|NOT COMPLETED|Overall Study||1
6668194|NCT02552966|7598931|FG000|STARTED|Overall Study||20
6668195|NCT02552966|7598931|FG000|COMPLETED|Overall Study||15
6668196|NCT02552966|7598931|FG000|NOT COMPLETED|Overall Study||5
6668197|NCT02553135|7598935|FG000|STARTED|Overall Study||6
6668198|NCT02553135|7598935|FG000|COMPLETED|Overall Study||6
6668199|NCT02553135|7598935|FG000|NOT COMPLETED|Overall Study||0
6668200|NCT02553317|7598941|FG000|STARTED|Overall Treatment Period + Follow-up||72
6668201|NCT02553317|7598942|FG001|STARTED|Overall Treatment Period + Follow-up||73
6668202|NCT02553317|7598941|FG000|Received Study Drug|Overall Treatment Period + Follow-up||71
6668203|NCT02553317|7598942|FG001|Received Study Drug|Overall Treatment Period + Follow-up||73
6668204|NCT02553317|7598941|FG000|COMPLETED|Overall Treatment Period + Follow-up||58
6668205|NCT02553317|7598942|FG001|COMPLETED|Overall Treatment Period + Follow-up||50
6668206|NCT02553317|7598941|FG000|NOT COMPLETED|Overall Treatment Period + Follow-up||14
6668207|NCT02553317|7598942|FG001|NOT COMPLETED|Overall Treatment Period + Follow-up||23
6668208|NCT02553317|7598941|FG000|STARTED|Double-blind (DB) Treatment Period|One patient withdrew consent prior to first dosing and did not start the DB treatment period.|71
6668209|NCT02553317|7598942|FG001|STARTED|Double-blind (DB) Treatment Period||73
6668210|NCT02553317|7598941|FG000|COMPLETED|Double-blind (DB) Treatment Period||68
6668211|NCT02553317|7598942|FG001|COMPLETED|Double-blind (DB) Treatment Period||65
6668212|NCT02553317|7598941|FG000|NOT COMPLETED|Double-blind (DB) Treatment Period||3
6668213|NCT02553317|7598942|FG001|NOT COMPLETED|Double-blind (DB) Treatment Period||8
6668214|NCT02553317|7598941|FG000|STARTED|Open-label (OL) Treatment Period|2 patients on caplacizumab had a recurrence of TTP during the DB period and started OL treatment.|2
6668215|NCT02553317|7598942|FG001|STARTED|Open-label (OL) Treatment Period|26 patients on placebo had a recurrence of TTP during the DB period and started OL treatment.|26
6668216|NCT02553317|7598941|FG000|COMPLETED|Open-label (OL) Treatment Period||2
6668217|NCT02553317|7598942|FG001|COMPLETED|Open-label (OL) Treatment Period||22
6668218|NCT02553317|7598941|FG000|NOT COMPLETED|Open-label (OL) Treatment Period||0
6668219|NCT02553317|7598942|FG001|NOT COMPLETED|Open-label (OL) Treatment Period||4
6668220|NCT02553330|7598952|FG000|STARTED|Overall Study||12
6668221|NCT02553330|7598953|FG001|STARTED|Overall Study||39
6668222|NCT02553330|7598954|FG002|STARTED|Overall Study||39
6668223|NCT02553330|7598952|FG000|COMPLETED|Overall Study||7
6668224|NCT02553330|7598953|FG001|COMPLETED|Overall Study||0
6668225|NCT02553330|7598954|FG002|COMPLETED|Overall Study||2
6668226|NCT02553330|7598952|FG000|NOT COMPLETED|Overall Study||5
6668227|NCT02553330|7598953|FG001|NOT COMPLETED|Overall Study||39
6668228|NCT02553330|7598954|FG002|NOT COMPLETED|Overall Study||37
6668229|NCT02553395|7598965|FG000|STARTED|First Intervention||12
6668230|NCT02553395|7598966|FG001|STARTED|First Intervention||18
6668231|NCT02553395|7598965|FG000|COMPLETED|First Intervention||12
6668232|NCT02553395|7598966|FG001|COMPLETED|First Intervention||18
6668233|NCT02553395|7598965|FG000|NOT COMPLETED|First Intervention||0
6668234|NCT02553395|7598966|FG001|NOT COMPLETED|First Intervention||0
6668235|NCT02553395|7598965|FG000|STARTED|Second Intervention||12
6668236|NCT02553395|7598966|FG001|STARTED|Second Intervention||18
6668237|NCT02553395|7598965|FG000|COMPLETED|Second Intervention||12
6668238|NCT02553395|7598966|FG001|COMPLETED|Second Intervention||18
6668239|NCT02553395|7598965|FG000|NOT COMPLETED|Second Intervention||0
6668240|NCT02553395|7598966|FG001|NOT COMPLETED|Second Intervention||0
6668241|NCT02553421|7598975|FG000|STARTED|Overall Study||185
6668242|NCT02553421|7598976|FG001|STARTED|Overall Study||58
6668243|NCT02553421|7598975|FG000|COMPLETED|Overall Study||156
6668244|NCT02553421|7598976|FG001|COMPLETED|Overall Study||57
6668245|NCT02553421|7598975|FG000|NOT COMPLETED|Overall Study||29
6668246|NCT02553421|7598976|FG001|NOT COMPLETED|Overall Study||1
6668247|NCT02553499|7598997|FG000|STARTED|Overall Study||2
6668248|NCT02553499|7598998|FG001|STARTED|Overall Study||2
6668249|NCT02553499|7598999|FG002|STARTED|Overall Study||2
6668250|NCT02553499|7599000|FG003|STARTED|Overall Study||2
6668251|NCT02553499|7599001|FG004|STARTED|Overall Study||3
6668252|NCT02553499|7599002|FG005|STARTED|Overall Study||3
6668253|NCT02553499|7599003|FG006|STARTED|Overall Study||3
6668254|NCT02553499|7599004|FG007|STARTED|Overall Study||3
6668255|NCT02553499|7599005|FG008|STARTED|Overall Study||3
6668256|NCT02553499|7599006|FG009|STARTED|Overall Study||3
6668257|NCT02553499|7599007|FG010|STARTED|Overall Study||3
6668258|NCT02553499|7599008|FG011|STARTED|Overall Study||3
6668259|NCT02553499|7599009|FG012|STARTED|Overall Study||3
6668260|NCT02553499|7599010|FG013|STARTED|Overall Study||2
6668261|NCT02553499|7598997|FG000|COMPLETED|Overall Study||0
6668262|NCT02553499|7598998|FG001|COMPLETED|Overall Study||0
6668263|NCT02553499|7598999|FG002|COMPLETED|Overall Study||0
6668264|NCT02553499|7599000|FG003|COMPLETED|Overall Study||0
6668265|NCT02553499|7599001|FG004|COMPLETED|Overall Study||0
6668266|NCT02553499|7599002|FG005|COMPLETED|Overall Study||0
6668267|NCT02553499|7599003|FG006|COMPLETED|Overall Study||0
6668268|NCT02553499|7599004|FG007|COMPLETED|Overall Study||0
6668269|NCT02553499|7599005|FG008|COMPLETED|Overall Study||0
6668270|NCT02553499|7599006|FG009|COMPLETED|Overall Study||0
6668271|NCT02553499|7599007|FG010|COMPLETED|Overall Study||0
6668272|NCT02553499|7599008|FG011|COMPLETED|Overall Study||0
6668273|NCT02553499|7599009|FG012|COMPLETED|Overall Study||0
6668274|NCT02553499|7599010|FG013|COMPLETED|Overall Study||0
6668275|NCT02553499|7598997|FG000|NOT COMPLETED|Overall Study||2
6668276|NCT02553499|7598998|FG001|NOT COMPLETED|Overall Study||2
6668277|NCT02553499|7598999|FG002|NOT COMPLETED|Overall Study||2
6668278|NCT02553499|7599000|FG003|NOT COMPLETED|Overall Study||2
6668279|NCT02553499|7599001|FG004|NOT COMPLETED|Overall Study||3
6668280|NCT02553499|7599002|FG005|NOT COMPLETED|Overall Study||3
6668281|NCT02553499|7599003|FG006|NOT COMPLETED|Overall Study||3
6668282|NCT02553499|7599004|FG007|NOT COMPLETED|Overall Study||3
6668283|NCT02553499|7599005|FG008|NOT COMPLETED|Overall Study||3
6668284|NCT02553499|7599006|FG009|NOT COMPLETED|Overall Study||3
6668285|NCT02553499|7599007|FG010|NOT COMPLETED|Overall Study||3
6668286|NCT02553499|7599008|FG011|NOT COMPLETED|Overall Study||3
6668287|NCT02553499|7599009|FG012|NOT COMPLETED|Overall Study||3
6668288|NCT02553499|7599010|FG013|NOT COMPLETED|Overall Study||2
6668289|NCT02553512|7599041|FG000|STARTED|Overall Study||167
6668290|NCT02553512|7599041|FG000|COMPLETED|Overall Study||144
6668291|NCT02553512|7599041|FG000|NOT COMPLETED|Overall Study||23
6668292|NCT02553538|7599047|FG000|STARTED|Overall Study||792
6668293|NCT02553538|7599048|FG001|STARTED|Overall Study||820
6668294|NCT02553538|7599047|FG000|COMPLETED|Overall Study||605
6668295|NCT02553538|7599048|FG001|COMPLETED|Overall Study||764
6668296|NCT02553538|7599047|FG000|NOT COMPLETED|Overall Study||187
6668297|NCT02553538|7599048|FG001|NOT COMPLETED|Overall Study||56
6668298|NCT02553629|7599056|FG000|STARTED|Overall Study||53
6668299|NCT02553629|7599057|FG001|STARTED|Overall Study||56
6668300|NCT02553629|7599056|FG000|COMPLETED|Overall Study||50
6668301|NCT02553629|7599057|FG001|COMPLETED|Overall Study||50
6668302|NCT02553629|7599056|FG000|NOT COMPLETED|Overall Study||3
6668303|NCT02553629|7599057|FG001|NOT COMPLETED|Overall Study||6
6668304|NCT02553746|7599065|FG000|STARTED|Overall Study||80
6668305|NCT02553746|7599066|FG001|STARTED|Overall Study||66
6668306|NCT02553746|7599065|FG000|COMPLETED|Overall Study||77
6668307|NCT02553746|7599066|FG001|COMPLETED|Overall Study||64
6668308|NCT02553746|7599065|FG000|NOT COMPLETED|Overall Study||3
6668309|NCT02553746|7599066|FG001|NOT COMPLETED|Overall Study||2
6668310|NCT02553772|7599074|FG000|STARTED|Overall Study||120
6668311|NCT02553772|7599075|FG001|STARTED|Overall Study||122
6668312|NCT02553772|7599074|FG000|COMPLETED|Overall Study||114
6668313|NCT02553772|7599075|FG001|COMPLETED|Overall Study||116
6668314|NCT02553772|7599074|FG000|NOT COMPLETED|Overall Study||6
6668315|NCT02553772|7599075|FG001|NOT COMPLETED|Overall Study||6
6668316|NCT02553798|7599081|FG000|STARTED|Overall Study||564
6668317|NCT02553798|7599081|FG000|COMPLETED|Overall Study||226
6668318|NCT02553798|7599081|FG000|NOT COMPLETED|Overall Study||338
6668319|NCT02553915|7599089|FG000|STARTED|Overall Study||15
6668320|NCT02553915|7599090|FG001|STARTED|Overall Study||15
6668321|NCT02553915|7599091|FG002|STARTED|Overall Study||15
6668322|NCT02553915|7599092|FG003|STARTED|Overall Study||16
6668323|NCT02553915|7599089|FG000|COMPLETED|Overall Study||11
6668324|NCT02553915|7599090|FG001|COMPLETED|Overall Study||14
6668325|NCT02553915|7599091|FG002|COMPLETED|Overall Study||12
6668326|NCT02553915|7599092|FG003|COMPLETED|Overall Study||13
6668327|NCT02553915|7599089|FG000|NOT COMPLETED|Overall Study||4
6668328|NCT02553915|7599090|FG001|NOT COMPLETED|Overall Study||1
6668329|NCT02553915|7599091|FG002|NOT COMPLETED|Overall Study||3
6668330|NCT02553915|7599092|FG003|NOT COMPLETED|Overall Study||3
6668331|NCT02553928|7599104|FG000|STARTED|Overall Study||30
6668332|NCT02553928|7599105|FG001|STARTED|Overall Study||32
6668333|NCT02553928|7599104|FG000|COMPLETED|Overall Study||28
6668334|NCT02553928|7599105|FG001|COMPLETED|Overall Study||29
6668335|NCT02553928|7599104|FG000|NOT COMPLETED|Overall Study||2
6668336|NCT02553928|7599105|FG001|NOT COMPLETED|Overall Study||3
6668337|NCT02554019|7599115|FG000|STARTED|Overall Study||12
6668338|NCT02554019|7599116|FG001|STARTED|Overall Study||12
6668339|NCT02554019|7599117|FG002|STARTED|Overall Study||12
6668340|NCT02554019|7599115|FG000|COMPLETED|Overall Study||10
6668341|NCT02554019|7599116|FG001|COMPLETED|Overall Study||12
6668342|NCT02554019|7599117|FG002|COMPLETED|Overall Study||10
6668343|NCT02554019|7599115|FG000|NOT COMPLETED|Overall Study||2
6668344|NCT02554019|7599116|FG001|NOT COMPLETED|Overall Study||0
6668345|NCT02554019|7599117|FG002|NOT COMPLETED|Overall Study||2
6668346|NCT02554279|7599127|FG000|STARTED|Overall Study||311
6668347|NCT02554279|7599128|FG001|STARTED|Overall Study||309
6668348|NCT02554279|7599127|FG000|Treated|Overall Study||310
6668349|NCT02554279|7599128|FG001|Treated|Overall Study||309
6668350|NCT02554279|7599127|FG000|Completed Day 6 of Stimulation|Overall Study||308
6668351|NCT02554279|7599128|FG001|Completed Day 6 of Stimulation|Overall Study||309
6668352|NCT02554279|7599127|FG000|Received Trigger|Overall Study||293
6668353|NCT02554279|7599128|FG001|Received Trigger|Overall Study||307
6668354|NCT02554279|7599127|FG000|Completed Oocyte Retrieval|Overall Study||292
6668355|NCT02554279|7599128|FG001|Completed Oocyte Retrieval|Overall Study||306
6668356|NCT02554279|7599127|FG000|Completed Fresh Blastocyst Transfer|Overall Study||201
6668357|NCT02554279|7599128|FG001|Completed Fresh Blastocyst Transfer|Overall Study||191
6668358|NCT02554279|7599127|FG000|COMPLETED|Overall Study||279
6668359|NCT02554279|7599128|FG001|COMPLETED|Overall Study||291
6668360|NCT02554279|7599127|FG000|NOT COMPLETED|Overall Study||32
6668361|NCT02554279|7599128|FG001|NOT COMPLETED|Overall Study||18
6668362|NCT02554435|7599143|FG000|STARTED|Overall Study||20
6668363|NCT02554435|7599144|FG001|STARTED|Overall Study||20
6668364|NCT02554435|7599143|FG000|COMPLETED|Overall Study||14
6668365|NCT02554435|7599144|FG001|COMPLETED|Overall Study||19
6668366|NCT02554435|7599143|FG000|NOT COMPLETED|Overall Study||6
6668367|NCT02554435|7599144|FG001|NOT COMPLETED|Overall Study||1
6668368|NCT02554474|7599153|FG000|STARTED|Overall Study||59
6668369|NCT02554474|7599154|FG001|STARTED|Overall Study||59
6668370|NCT02554474|7599153|FG000|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|56
6668371|NCT02554474|7599154|FG001|COMPLETED|Overall Study|Indicates number of participants who completed assessment at the primary endpoint.|57
6668372|NCT02554474|7599153|FG000|NOT COMPLETED|Overall Study||3
6668373|NCT02554474|7599154|FG001|NOT COMPLETED|Overall Study||2
6668374|NCT02554513|7599160|FG000|STARTED|First Treatment Phase (7 Weeks)||3
6668375|NCT02554513|7599161|FG001|STARTED|First Treatment Phase (7 Weeks)||3
6668376|NCT02554513|7599160|FG000|COMPLETED|First Treatment Phase (7 Weeks)||3
6668377|NCT02554513|7599161|FG001|COMPLETED|First Treatment Phase (7 Weeks)||2
6668378|NCT02554513|7599160|FG000|NOT COMPLETED|First Treatment Phase (7 Weeks)||0
6668379|NCT02554513|7599161|FG001|NOT COMPLETED|First Treatment Phase (7 Weeks)||1
6668380|NCT02554513|7599160|FG000|STARTED|Washout (2 Weeks)||3
6668381|NCT02554513|7599161|FG001|STARTED|Washout (2 Weeks)||2
6668382|NCT02554513|7599160|FG000|COMPLETED|Washout (2 Weeks)||3
6668383|NCT02554513|7599161|FG001|COMPLETED|Washout (2 Weeks)||2
6668384|NCT02554513|7599160|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6668385|NCT02554513|7599161|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6668386|NCT02554513|7599160|FG000|STARTED|Second Treatment Phase (7 Weeks)||3
6668387|NCT02554513|7599161|FG001|STARTED|Second Treatment Phase (7 Weeks)||2
6668388|NCT02554513|7599160|FG000|COMPLETED|Second Treatment Phase (7 Weeks)||3
6668389|NCT02554513|7599161|FG001|COMPLETED|Second Treatment Phase (7 Weeks)||2
6668390|NCT02554513|7599160|FG000|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
6668391|NCT02554513|7599161|FG001|NOT COMPLETED|Second Treatment Phase (7 Weeks)||0
6668392|NCT02554656|7599173|FG000|STARTED|Overall Study||89
6668393|NCT02554656|7599173|FG000|COMPLETED|Overall Study||86
6668394|NCT02554656|7599173|FG000|NOT COMPLETED|Overall Study||3
6668395|NCT02554682|7599187|FG000|STARTED|Overall Study||40
6668396|NCT02554682|7599188|FG001|STARTED|Overall Study||40
6668397|NCT02554682|7599189|FG002|STARTED|Overall Study||40
6668398|NCT02554682|7599190|FG003|STARTED|Overall Study||40
6668399|NCT02554682|7599191|FG004|STARTED|Overall Study||40
6668400|NCT02554682|7599192|FG005|STARTED|Overall Study||40
6668401|NCT02554682|7599193|FG006|STARTED|Overall Study||28
6668402|NCT02554682|7599194|FG007|STARTED|Overall Study||28
6668403|NCT02554682|7599195|FG008|STARTED|Overall Study||26
6668404|NCT02554682|7599196|FG009|STARTED|Overall Study||26
6668405|NCT02554682|7599187|FG000|COMPLETED|Overall Study||25
6668406|NCT02554682|7599188|FG001|COMPLETED|Overall Study||28
6668407|NCT02554682|7599189|FG002|COMPLETED|Overall Study||36
6668408|NCT02554682|7599190|FG003|COMPLETED|Overall Study||37
6668409|NCT02554682|7599191|FG004|COMPLETED|Overall Study||38
6668410|NCT02554682|7599192|FG005|COMPLETED|Overall Study||39
6668411|NCT02554682|7599193|FG006|COMPLETED|Overall Study||22
6668412|NCT02554682|7599194|FG007|COMPLETED|Overall Study||22
6668413|NCT02554682|7599195|FG008|COMPLETED|Overall Study||24
6668414|NCT02554682|7599196|FG009|COMPLETED|Overall Study||24
6668415|NCT02554682|7599187|FG000|NOT COMPLETED|Overall Study||15
6668416|NCT02554682|7599188|FG001|NOT COMPLETED|Overall Study||12
6668417|NCT02554682|7599189|FG002|NOT COMPLETED|Overall Study||4
6668418|NCT02554682|7599190|FG003|NOT COMPLETED|Overall Study||3
6668419|NCT02554682|7599191|FG004|NOT COMPLETED|Overall Study||2
6668420|NCT02554682|7599192|FG005|NOT COMPLETED|Overall Study||1
6668421|NCT02554682|7599193|FG006|NOT COMPLETED|Overall Study||6
6668422|NCT02554682|7599194|FG007|NOT COMPLETED|Overall Study||6
6668423|NCT02554682|7599195|FG008|NOT COMPLETED|Overall Study||2
6668424|NCT02554682|7599196|FG009|NOT COMPLETED|Overall Study||2
6668425|NCT02554721|7599226|FG000|STARTED|Overall Study||20
6668426|NCT02554721|7599227|FG001|STARTED|Overall Study||19
6668427|NCT02554721|7599228|FG002|STARTED|Overall Study||19
6668428|NCT02554721|7599229|FG003|STARTED|Overall Study||17
6668429|NCT02554721|7599230|FG004|STARTED|Overall Study||2
6668430|NCT02554721|7599226|FG000|COMPLETED|Overall Study||19
6668431|NCT02554721|7599227|FG001|COMPLETED|Overall Study||19
6668432|NCT02554721|7599228|FG002|COMPLETED|Overall Study||19
6668433|NCT02554721|7599229|FG003|COMPLETED|Overall Study||17
6668434|NCT02554721|7599230|FG004|COMPLETED|Overall Study||0
6668435|NCT02554721|7599226|FG000|NOT COMPLETED|Overall Study||1
6668436|NCT02554721|7599227|FG001|NOT COMPLETED|Overall Study||0
6668437|NCT02554721|7599228|FG002|NOT COMPLETED|Overall Study||0
6668438|NCT02554721|7599229|FG003|NOT COMPLETED|Overall Study||0
6668439|NCT02554721|7599230|FG004|NOT COMPLETED|Overall Study||2
6668440|NCT02554760|7599239|FG000|STARTED|Overall Study||9
6668441|NCT02554760|7599240|FG001|STARTED|Overall Study||10
6256073|NCT03875313|7154910|FG002|NOT COMPLETED|Overall Study||6
6256074|NCT03875313|7154911|FG003|NOT COMPLETED|Overall Study||4
6256075|NCT03875313|7154912|FG004|NOT COMPLETED|Overall Study||4
6668442|NCT02554760|7599239|FG000|COMPLETED|Overall Study||9
6668443|NCT02554760|7599240|FG001|COMPLETED|Overall Study||10
6668444|NCT02554760|7599239|FG000|NOT COMPLETED|Overall Study||0
6668445|NCT02554760|7599240|FG001|NOT COMPLETED|Overall Study||0
6668446|NCT02554786|7599254|FG000|STARTED|Overall Study||445
6668447|NCT02554786|7599255|FG001|STARTED|Overall Study||439
6668448|NCT02554786|7599256|FG002|STARTED|Overall Study||442
6668449|NCT02554786|7599257|FG003|STARTED|Overall Study||444
6668450|NCT02554786|7599258|FG004|STARTED|Overall Study||446
6668451|NCT02554786|7599254|FG000|COMPLETED|Overall Study||410
6668452|NCT02554786|7599255|FG001|COMPLETED|Overall Study||413
6668453|NCT02554786|7599256|FG002|COMPLETED|Overall Study||412
6668454|NCT02554786|7599257|FG003|COMPLETED|Overall Study||403
6668455|NCT02554786|7599258|FG004|COMPLETED|Overall Study||416
6668456|NCT02554786|7599254|FG000|NOT COMPLETED|Overall Study||35
6668457|NCT02554786|7599255|FG001|NOT COMPLETED|Overall Study||26
6668458|NCT02554786|7599256|FG002|NOT COMPLETED|Overall Study||30
6668459|NCT02554786|7599257|FG003|NOT COMPLETED|Overall Study||41
6668460|NCT02554786|7599258|FG004|NOT COMPLETED|Overall Study||30
6668461|NCT02554799|7599276|FG000|STARTED|Overall Study||9
6668462|NCT02554799|7599277|FG001|STARTED|Overall Study||9
6668463|NCT02554799|7599276|FG000|COMPLETED|Overall Study||9
6668464|NCT02554799|7599277|FG001|COMPLETED|Overall Study||9
6668465|NCT02554799|7599276|FG000|NOT COMPLETED|Overall Study||0
6668466|NCT02554799|7599277|FG001|NOT COMPLETED|Overall Study||0
6668467|NCT02554877|7599287|FG000|STARTED|Overall Study||51
6668468|NCT02554877|7599288|FG001|STARTED|Overall Study||51
6668469|NCT02554877|7599289|FG002|STARTED|Overall Study||52
6668470|NCT02554877|7599290|FG003|STARTED|Overall Study||52
6668471|NCT02554877|7599287|FG000|COMPLETED|Overall Study||39
6668472|NCT02554877|7599288|FG001|COMPLETED|Overall Study||44
6668473|NCT02554877|7599289|FG002|COMPLETED|Overall Study||46
6668474|NCT02554877|7599290|FG003|COMPLETED|Overall Study||45
6668475|NCT02554877|7599287|FG000|NOT COMPLETED|Overall Study||12
6668476|NCT02554877|7599288|FG001|NOT COMPLETED|Overall Study||7
6668477|NCT02554877|7599289|FG002|NOT COMPLETED|Overall Study||6
6668478|NCT02554877|7599290|FG003|NOT COMPLETED|Overall Study||7
6668479|NCT02554890|7599302|FG000|STARTED|Double-blind||444
6668480|NCT02554890|7599303|FG001|STARTED|Double-blind||443
6668481|NCT02554890|7599302|FG000|Treated Patients|Double-blind||436
6668482|NCT02554890|7599303|FG001|Treated Patients|Double-blind||439
6668483|NCT02554890|7599302|FG000|COMPLETED|Double-blind||348
6668484|NCT02554890|7599303|FG001|COMPLETED|Double-blind||352
6668485|NCT02554890|7599302|FG000|NOT COMPLETED|Double-blind||96
6668486|NCT02554890|7599303|FG001|NOT COMPLETED|Double-blind||91
6668487|NCT02554890|7599302|FG000|STARTED|Open-label||0
6668488|NCT02554890|7599303|FG001|STARTED|Open-label||887
6668489|NCT02554890|7599302|FG000|COMPLETED|Open-label||0
6668490|NCT02554890|7599303|FG001|COMPLETED|Open-label||835
6668491|NCT02554890|7599302|FG000|NOT COMPLETED|Open-label||0
6668492|NCT02554890|7599303|FG001|NOT COMPLETED|Open-label||52
6668493|NCT02554903|7599313|FG000|STARTED|Overall Study||28
6668494|NCT02554903|7599314|FG001|STARTED|Overall Study||29
6668495|NCT02554903|7599313|FG000|COMPLETED|Overall Study||24
6668496|NCT02554903|7599314|FG001|COMPLETED|Overall Study||24
6668497|NCT02554903|7599313|FG000|NOT COMPLETED|Overall Study||4
6668498|NCT02554903|7599314|FG001|NOT COMPLETED|Overall Study||5
6668499|NCT02554929|7599323|FG000|STARTED|Overall Study||46
6668500|NCT02554929|7599324|FG001|STARTED|Overall Study||44
6668501|NCT02554929|7599323|FG000|Per Protocol Received Intervention|Overall Study||44
6668502|NCT02554929|7599324|FG001|Per Protocol Received Intervention|Overall Study||36
6668503|NCT02554929|7599323|FG000|Per Protocol Post-Intervention|Overall Study||42
6668504|NCT02554929|7599324|FG001|Per Protocol Post-Intervention|Overall Study||36
6668505|NCT02554929|7599323|FG000|Per Protocol 6 Month Follow-up|Overall Study||40
6668506|NCT02554929|7599324|FG001|Per Protocol 6 Month Follow-up|Overall Study||32
6668507|NCT02554929|7599323|FG000|COMPLETED|Overall Study||40
6668508|NCT02554929|7599324|FG001|COMPLETED|Overall Study||32
6668509|NCT02554929|7599323|FG000|NOT COMPLETED|Overall Study||6
6668510|NCT02554929|7599324|FG001|NOT COMPLETED|Overall Study||12
6668511|NCT02554981|7599330|FG000|STARTED|Overall Study||51
6668512|NCT02554981|7599330|FG000|COMPLETED|Overall Study||46
6668513|NCT02554981|7599330|FG000|NOT COMPLETED|Overall Study||5
6668514|NCT02555098|7599334|FG000|STARTED|First Intervention||12
6668515|NCT02555098|7599335|FG001|STARTED|First Intervention||11
6668516|NCT02555098|7599334|FG000|COMPLETED|First Intervention||12
6668517|NCT02555098|7599335|FG001|COMPLETED|First Intervention||11
6668518|NCT02555098|7599334|FG000|NOT COMPLETED|First Intervention||0
6668519|NCT02555098|7599335|FG001|NOT COMPLETED|First Intervention||0
6668520|NCT02555098|7599334|FG000|STARTED|Second Intervention||12
6668521|NCT02555098|7599335|FG001|STARTED|Second Intervention||11
6668522|NCT02555098|7599334|FG000|COMPLETED|Second Intervention||12
6668523|NCT02555098|7599335|FG001|COMPLETED|Second Intervention||11
6668524|NCT02555098|7599334|FG000|NOT COMPLETED|Second Intervention||0
6668525|NCT02555098|7599335|FG001|NOT COMPLETED|Second Intervention||0
6668526|NCT02555215|7599345|FG000|STARTED|Overall Study||20
6668527|NCT02555215|7599345|FG000|COMPLETED|Overall Study||17
6668528|NCT02555215|7599345|FG000|NOT COMPLETED|Overall Study||3
6668529|NCT02555228|7599351|FG000|STARTED|Overall Study|20th August 2015|27
6668530|NCT02555228|7599352|FG001|STARTED|Overall Study|14th August 2015|27
6668531|NCT02555228|7599351|FG000|COMPLETED|Overall Study|19th November 2015|27
6668532|NCT02555228|7599352|FG001|COMPLETED|Overall Study|29th October 2015|27
6668533|NCT02555228|7599351|FG000|NOT COMPLETED|Overall Study||0
6668534|NCT02555228|7599352|FG001|NOT COMPLETED|Overall Study||0
6668535|NCT02555306|7599362|FG000|STARTED|Overall Study||3
6668536|NCT02555306|7599363|FG001|STARTED|Overall Study||3
6668537|NCT02555306|7599364|FG002|STARTED|Overall Study||3
6668538|NCT02555306|7599365|FG003|STARTED|Overall Study||3
6668539|NCT02555306|7599362|FG000|COMPLETED|Overall Study||3
6668540|NCT02555306|7599363|FG001|COMPLETED|Overall Study||3
6668541|NCT02555306|7599364|FG002|COMPLETED|Overall Study||3
6668542|NCT02555306|7599365|FG003|COMPLETED|Overall Study||3
6668543|NCT02555306|7599362|FG000|NOT COMPLETED|Overall Study||0
6668544|NCT02555306|7599363|FG001|NOT COMPLETED|Overall Study||0
6668545|NCT02555306|7599364|FG002|NOT COMPLETED|Overall Study||0
6668546|NCT02555306|7599365|FG003|NOT COMPLETED|Overall Study||0
6668547|NCT02555371|7599375|FG000|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||306
6668548|NCT02555371|7599376|FG001|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668549|NCT02555371|7599377|FG002|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668550|NCT02555371|7599378|FG003|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668551|NCT02555371|7599379|FG004|STARTED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668552|NCT02555371|7599375|FG000|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||295
6668553|NCT02555371|7599376|FG001|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668554|NCT02555371|7599377|FG002|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668555|NCT02555371|7599378|FG003|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668556|NCT02555371|7599379|FG004|COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668557|NCT02555371|7599375|FG000|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||11
6668558|NCT02555371|7599376|FG001|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668559|NCT02555371|7599377|FG002|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668560|NCT02555371|7599378|FG003|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668561|NCT02555371|7599379|FG004|NOT COMPLETED|PartA(Upto 132W)+PartB(Upto 8W)||0
6668562|NCT02555371|7599375|FG000|STARTED|Part C (DB Period: Up to 52W)||0
6668563|NCT02555371|7599376|FG001|STARTED|Part C (DB Period: Up to 52W)||151
6668564|NCT02555371|7599377|FG002|STARTED|Part C (DB Period: Up to 52W)||144
6668565|NCT02555371|7599378|FG003|STARTED|Part C (DB Period: Up to 52W)||0
6668566|NCT02555371|7599379|FG004|STARTED|Part C (DB Period: Up to 52W)||0
6668567|NCT02555371|7599375|FG000|COMPLETED|Part C (DB Period: Up to 52W)||0
6668568|NCT02555371|7599376|FG001|COMPLETED|Part C (DB Period: Up to 52W)||62
6668569|NCT02555371|7599377|FG002|COMPLETED|Part C (DB Period: Up to 52W)||96
6668570|NCT02555371|7599378|FG003|COMPLETED|Part C (DB Period: Up to 52W)||0
6668571|NCT02555371|7599379|FG004|COMPLETED|Part C (DB Period: Up to 52W)||0
6668572|NCT02555371|7599375|FG000|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
6668573|NCT02555371|7599376|FG001|NOT COMPLETED|Part C (DB Period: Up to 52W)||89
6668574|NCT02555371|7599377|FG002|NOT COMPLETED|Part C (DB Period: Up to 52W)||48
6668575|NCT02555371|7599378|FG003|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
6668576|NCT02555371|7599379|FG004|NOT COMPLETED|Part C (DB Period: Up to 52W)||0
6668577|NCT02555371|7599375|FG000|STARTED|PartD(OL: 52W Post-randomization PartC)||0
6668578|NCT02555371|7599376|FG001|STARTED|PartD(OL: 52W Post-randomization PartC)||0
6668579|NCT02555371|7599377|FG002|STARTED|PartD(OL: 52W Post-randomization PartC)||0
6668580|NCT02555371|7599378|FG003|STARTED|PartD(OL: 52W Post-randomization PartC)||84
6668581|NCT02555371|7599379|FG004|STARTED|PartD(OL: 52W Post-randomization PartC)||45
6668582|NCT02555371|7599375|FG000|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6668583|NCT02555371|7599376|FG001|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6668584|NCT02555371|7599377|FG002|COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6668585|NCT02555371|7599378|FG003|COMPLETED|PartD(OL: 52W Post-randomization PartC)||80
6668586|NCT02555371|7599379|FG004|COMPLETED|PartD(OL: 52W Post-randomization PartC)||42
6668587|NCT02555371|7599375|FG000|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6668588|NCT02555371|7599376|FG001|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6668589|NCT02555371|7599377|FG002|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||0
6668590|NCT02555371|7599378|FG003|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||4
6668591|NCT02555371|7599379|FG004|NOT COMPLETED|PartD(OL: 52W Post-randomization PartC)||3
6668592|NCT02555449|7599388|FG000|STARTED|Overall Study||6
6668593|NCT02555449|7599388|FG000|COMPLETED|Overall Study||6
6668594|NCT02555449|7599388|FG000|NOT COMPLETED|Overall Study||0
6668595|NCT02555618|7599394|FG000|STARTED|Overall Study||200
6668596|NCT02555618|7599395|FG001|STARTED|Overall Study||200
6668597|NCT02555618|7599394|FG000|COMPLETED|Overall Study||199
6668598|NCT02555618|7599395|FG001|COMPLETED|Overall Study||200
6668599|NCT02555618|7599394|FG000|NOT COMPLETED|Overall Study||1
6668600|NCT02555618|7599395|FG001|NOT COMPLETED|Overall Study||0
6668601|NCT02555631|7599401|FG000|STARTED|Overall Study||29
6668602|NCT02555631|7599401|FG000|COMPLETED|Overall Study||25
6668603|NCT02555631|7599401|FG000|NOT COMPLETED|Overall Study||4
6668604|NCT02555683|7599408|FG000|STARTED|Overall Study||301
6668605|NCT02555683|7599409|FG001|STARTED|Overall Study||295
6668606|NCT02555683|7599410|FG002|STARTED|Overall Study||298
6668607|NCT02555683|7599408|FG000|FAS/SAF: High Eosinophil Subpopulation|Overall Study||200
6668608|NCT02555683|7599409|FG001|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
6668609|NCT02555683|7599410|FG002|FAS/SAF: High Eosinophil Subpopulation|Overall Study||201
6668610|NCT02555683|7599408|FG000|FAS/SAF: Overall Population|Overall Study||299
6668611|NCT02555683|7599409|FG001|FAS/SAF: Overall Population|Overall Study||293
6668612|NCT02555683|7599410|FG002|FAS/SAF: Overall Population|Overall Study||298
6668613|NCT02555683|7599408|FG000|COMPLETED|Overall Study||282
6668614|NCT02555683|7599409|FG001|COMPLETED|Overall Study||278
6668615|NCT02555683|7599410|FG002|COMPLETED|Overall Study||269
6668616|NCT02555683|7599408|FG000|NOT COMPLETED|Overall Study||19
6668617|NCT02555683|7599409|FG001|NOT COMPLETED|Overall Study||17
6668618|NCT02555683|7599410|FG002|NOT COMPLETED|Overall Study||29
6668619|NCT02555722|7599420|FG000|STARTED|Lens Dispensed||60
6668620|NCT02555722|7599421|FG001|STARTED|Lens Dispensed||30
6668621|NCT02555722|7599420|FG000|COMPLETED|Lens Dispensed||60
6668622|NCT02555722|7599421|FG001|COMPLETED|Lens Dispensed||30
6668623|NCT02555722|7599420|FG000|NOT COMPLETED|Lens Dispensed||0
6668624|NCT02555722|7599421|FG001|NOT COMPLETED|Lens Dispensed||0
6668625|NCT02555722|7599420|FG000|STARTED|Week 1||60
6668626|NCT02555722|7599421|FG001|STARTED|Week 1||30
6668627|NCT02555722|7599420|FG000|COMPLETED|Week 1||60
6668628|NCT02555722|7599421|FG001|COMPLETED|Week 1||30
6668629|NCT02555722|7599420|FG000|NOT COMPLETED|Week 1||0
6668630|NCT02555722|7599421|FG001|NOT COMPLETED|Week 1||0
6668631|NCT02555722|7599420|FG000|STARTED|Week 2||60
6668632|NCT02555722|7599421|FG001|STARTED|Week 2||30
6668633|NCT02555722|7599420|FG000|COMPLETED|Week 2||59
6668634|NCT02555722|7599421|FG001|COMPLETED|Week 2||29
6668635|NCT02555722|7599420|FG000|NOT COMPLETED|Week 2||1
6668636|NCT02555722|7599421|FG001|NOT COMPLETED|Week 2||1
6668637|NCT02555722|7599420|FG000|STARTED|Month 1||59
6668638|NCT02555722|7599421|FG001|STARTED|Month 1||29
6668639|NCT02555722|7599420|FG000|COMPLETED|Month 1||58
6668640|NCT02555722|7599421|FG001|COMPLETED|Month 1||29
6668641|NCT02555722|7599420|FG000|NOT COMPLETED|Month 1||1
6668642|NCT02555722|7599421|FG001|NOT COMPLETED|Month 1||0
6668643|NCT02555722|7599420|FG000|STARTED|Month 2||58
6668644|NCT02555722|7599421|FG001|STARTED|Month 2||29
6668645|NCT02555722|7599420|FG000|COMPLETED|Month 2||54
6668646|NCT02555722|7599421|FG001|COMPLETED|Month 2||29
6668647|NCT02555722|7599420|FG000|NOT COMPLETED|Month 2||4
6668648|NCT02555722|7599421|FG001|NOT COMPLETED|Month 2||0
6668649|NCT02555722|7599420|FG000|STARTED|Month 3||54
6668650|NCT02555722|7599421|FG001|STARTED|Month 3||29
6668651|NCT02555722|7599420|FG000|COMPLETED|Month 3||54
6668652|NCT02555722|7599421|FG001|COMPLETED|Month 3||29
6668653|NCT02555722|7599420|FG000|NOT COMPLETED|Month 3||0
6668654|NCT02555722|7599421|FG001|NOT COMPLETED|Month 3||0
6668655|NCT02555878|7599452|FG000|STARTED|Overall Study||421
6668656|NCT02555878|7599453|FG001|STARTED|Overall Study||420
6668657|NCT02555878|7599452|FG000|Treated|Overall Study||404
6668658|NCT02555878|7599453|FG001|Treated|Overall Study||405
6668659|NCT02555878|7599452|FG000|COMPLETED|Overall Study||255
6668660|NCT02555878|7599453|FG001|COMPLETED|Overall Study||270
6668661|NCT02555878|7599452|FG000|NOT COMPLETED|Overall Study||166
6668662|NCT02555878|7599453|FG001|NOT COMPLETED|Overall Study||150
6668663|NCT02555930|7599459|FG000|STARTED|Overall Study||148
6668664|NCT02555930|7599459|FG000|COMPLETED|Overall Study||148
6668665|NCT02555930|7599459|FG000|NOT COMPLETED|Overall Study||0
6668666|NCT02556112|7599467|FG000|STARTED|Overall Study||40
6668667|NCT02556112|7599468|FG001|STARTED|Overall Study||40
6668668|NCT02556112|7599469|FG002|STARTED|Overall Study||42
6668669|NCT02556112|7599467|FG000|COMPLETED|Overall Study||30
6668670|NCT02556112|7599468|FG001|COMPLETED|Overall Study||23
6668671|NCT02556112|7599469|FG002|COMPLETED|Overall Study||30
6668672|NCT02556112|7599467|FG000|NOT COMPLETED|Overall Study||10
6668673|NCT02556112|7599468|FG001|NOT COMPLETED|Overall Study||17
6668674|NCT02556112|7599469|FG002|NOT COMPLETED|Overall Study||12
6668675|NCT02556138|7599478|FG000|STARTED|Overall Study||8
6668676|NCT02556138|7599478|FG000|COMPLETED|Overall Study|One patient withdrew from the study due to intolerance of the balloon after 1 month.|7
6668677|NCT02556138|7599478|FG000|NOT COMPLETED|Overall Study||1
6668678|NCT02556177|7599484|FG000|STARTED|Overall Study||325
6668679|NCT02556177|7599485|FG001|STARTED|Overall Study||152
6668680|NCT02556177|7599484|FG000|COMPLETED|Overall Study||42
6668681|NCT02556177|7599485|FG001|COMPLETED|Overall Study||91
6668682|NCT02556177|7599484|FG000|NOT COMPLETED|Overall Study||283
6668683|NCT02556177|7599485|FG001|NOT COMPLETED|Overall Study||61
6668684|NCT02556203|7599493|FG000|STARTED|Overall Study||826
6668685|NCT02556203|7599494|FG001|STARTED|Overall Study||818
6668686|NCT02556203|7599493|FG000|Received Treatment|Overall Study||801
6668687|NCT02556203|7599494|FG001|Received Treatment|Overall Study||807
6668688|NCT02556203|7599493|FG000|COMPLETED|Overall Study||799
6668689|NCT02556203|7599494|FG001|COMPLETED|Overall Study||792
6668690|NCT02556203|7599493|FG000|NOT COMPLETED|Overall Study||27
6668691|NCT02556203|7599494|FG001|NOT COMPLETED|Overall Study||26
6668692|NCT02556255|7599500|FG000|STARTED|Overall Study||50
6668693|NCT02556255|7599500|FG000|COMPLETED|Overall Study||46
6668694|NCT02556255|7599500|FG000|NOT COMPLETED|Overall Study||4
6668695|NCT02556307|7599504|FG000|STARTED|Overall Study||270
6668696|NCT02556307|7599504|FG000|Treated|Overall Study||268
6668697|NCT02556307|7599504|FG000|COMPLETED|Overall Study||217
6668698|NCT02556307|7599504|FG000|NOT COMPLETED|Overall Study||53
6668699|NCT02556333|7599508|FG000|STARTED|Overall Study||1
6668700|NCT02556333|7599508|FG000|COMPLETED|Overall Study||1
6668701|NCT02556333|7599508|FG000|NOT COMPLETED|Overall Study||0
6668702|NCT02556554|7599515|FG000|STARTED|Overall Study||8
6668703|NCT02556554|7599516|FG001|STARTED|Overall Study||14
6668704|NCT02556554|7599517|FG002|STARTED|Overall Study||19
6668705|NCT02556554|7599518|FG003|STARTED|Overall Study||12
6668706|NCT02556554|7599519|FG004|STARTED|Overall Study||14
6668707|NCT02556554|7599515|FG000|COMPLETED|Overall Study||8
6668708|NCT02556554|7599516|FG001|COMPLETED|Overall Study||13
6668709|NCT02556554|7599517|FG002|COMPLETED|Overall Study||15
6668710|NCT02556554|7599518|FG003|COMPLETED|Overall Study||12
6668711|NCT02556554|7599519|FG004|COMPLETED|Overall Study||14
6668712|NCT02556554|7599515|FG000|NOT COMPLETED|Overall Study||0
6668713|NCT02556554|7599516|FG001|NOT COMPLETED|Overall Study||1
6668714|NCT02556554|7599517|FG002|NOT COMPLETED|Overall Study||4
6668715|NCT02556554|7599518|FG003|NOT COMPLETED|Overall Study||0
6668716|NCT02556554|7599519|FG004|NOT COMPLETED|Overall Study||0
6668717|NCT02556632|7599533|FG000|STARTED|Overall Study||64
6668718|NCT02556632|7599534|FG001|STARTED|Overall Study||65
6668719|NCT02556632|7599535|FG002|STARTED|Overall Study||62
6668720|NCT02556632|7599533|FG000|COMPLETED|Overall Study||59
6668721|NCT02556632|7599534|FG001|COMPLETED|Overall Study||59
6668722|NCT02556632|7599535|FG002|COMPLETED|Overall Study||53
6668723|NCT02556632|7599533|FG000|NOT COMPLETED|Overall Study||5
6668724|NCT02556632|7599534|FG001|NOT COMPLETED|Overall Study||6
6668725|NCT02556632|7599535|FG002|NOT COMPLETED|Overall Study||9
6668726|NCT02556775|7599547|FG000|STARTED|Overall Study||7
6668727|NCT02556775|7599548|FG001|STARTED|Overall Study||2
6668728|NCT02556775|7599549|FG002|STARTED|Overall Study||5
6668729|NCT02556775|7599550|FG003|STARTED|Overall Study||2
6668730|NCT02556775|7599547|FG000|COMPLETED|Overall Study||5
6668731|NCT02556775|7599548|FG001|COMPLETED|Overall Study||2
6668732|NCT02556775|7599549|FG002|COMPLETED|Overall Study||4
6668733|NCT02556775|7599550|FG003|COMPLETED|Overall Study||2
6668734|NCT02556775|7599547|FG000|NOT COMPLETED|Overall Study||2
6668735|NCT02556775|7599548|FG001|NOT COMPLETED|Overall Study||0
6668736|NCT02556775|7599549|FG002|NOT COMPLETED|Overall Study||1
6668737|NCT02556775|7599550|FG003|NOT COMPLETED|Overall Study||0
6668738|NCT02556788|7599564|FG000|STARTED|Overall Study||602
6668739|NCT02556788|7599565|FG001|STARTED|Overall Study||610
6668740|NCT02556788|7599564|FG000|COMPLETED|Overall Study||558
6668741|NCT02556788|7599565|FG001|COMPLETED|Overall Study||573
6668742|NCT02556788|7599564|FG000|NOT COMPLETED|Overall Study||44
6668743|NCT02556788|7599565|FG001|NOT COMPLETED|Overall Study||37
6668744|NCT02556801|7599575|FG000|STARTED|Overall Study||42
6668745|NCT02556801|7599576|FG001|STARTED|Overall Study||42
6668746|NCT02556801|7599577|FG002|STARTED|Overall Study||42
6668747|NCT02556801|7599578|FG003|STARTED|Overall Study||42
6668748|NCT02556801|7599575|FG000|COMPLETED|Overall Study||40
6668749|NCT02556801|7599576|FG001|COMPLETED|Overall Study||35
6668750|NCT02556801|7599577|FG002|COMPLETED|Overall Study||38
6668751|NCT02556801|7599578|FG003|COMPLETED|Overall Study||37
6668752|NCT02556801|7599575|FG000|NOT COMPLETED|Overall Study||2
6668753|NCT02556801|7599576|FG001|NOT COMPLETED|Overall Study||7
6668754|NCT02556801|7599577|FG002|NOT COMPLETED|Overall Study||4
6668755|NCT02556801|7599578|FG003|NOT COMPLETED|Overall Study||5
6668756|NCT02556918|7599590|FG000|STARTED|Overall Study||100
6668757|NCT02556918|7599591|FG001|STARTED|Overall Study||101
6668758|NCT02556918|7599590|FG000|COMPLETED|Overall Study||91
6668759|NCT02556918|7599591|FG001|COMPLETED|Overall Study||91
6668760|NCT02556918|7599590|FG000|NOT COMPLETED|Overall Study||9
6668761|NCT02556918|7599591|FG001|NOT COMPLETED|Overall Study||10
6668762|NCT02557035|7599600|FG000|STARTED|Overall Study||225
6668763|NCT02557035|7599601|FG001|STARTED|Overall Study||215
6668764|NCT02557035|7599600|FG000|COMPLETED|Overall Study||218
6668765|NCT02557035|7599601|FG001|COMPLETED|Overall Study||206
6668766|NCT02557035|7599600|FG000|NOT COMPLETED|Overall Study||7
6668767|NCT02557035|7599601|FG001|NOT COMPLETED|Overall Study||9
6668768|NCT02557100|7599610|FG000|STARTED|Single Blind Treatment Period||40
6668769|NCT02557100|7599611|FG001|STARTED|Single Blind Treatment Period||40
6668770|NCT02557100|7599612|FG002|STARTED|Single Blind Treatment Period||0
6668771|NCT02557100|7599610|FG000|COMPLETED|Single Blind Treatment Period||40
6668772|NCT02557100|7599611|FG001|COMPLETED|Single Blind Treatment Period||36
6668773|NCT02557100|7599612|FG002|COMPLETED|Single Blind Treatment Period||0
6668774|NCT02557100|7599610|FG000|NOT COMPLETED|Single Blind Treatment Period||0
6668775|NCT02557100|7599611|FG001|NOT COMPLETED|Single Blind Treatment Period||4
6668776|NCT02557100|7599612|FG002|NOT COMPLETED|Single Blind Treatment Period||0
6668777|NCT02557100|7599610|FG000|STARTED|Transition to Open Label||40
6668778|NCT02557100|7599611|FG001|STARTED|Transition to Open Label||36
6668779|NCT02557100|7599612|FG002|STARTED|Transition to Open Label||0
6668780|NCT02557100|7599610|FG000|COMPLETED|Transition to Open Label||0
6668781|NCT02557100|7599611|FG001|COMPLETED|Transition to Open Label||0
6668782|NCT02557100|7599612|FG002|COMPLETED|Transition to Open Label||0
6668783|NCT02557100|7599610|FG000|NOT COMPLETED|Transition to Open Label||40
6668784|NCT02557100|7599611|FG001|NOT COMPLETED|Transition to Open Label||36
6668785|NCT02557100|7599612|FG002|NOT COMPLETED|Transition to Open Label||0
6668786|NCT02557100|7599610|FG000|STARTED|Cumulative Abatacept Period||0
6668787|NCT02557100|7599611|FG001|STARTED|Cumulative Abatacept Period||0
6668788|NCT02557100|7599612|FG002|STARTED|Cumulative Abatacept Period||76
6668789|NCT02557100|7599610|FG000|COMPLETED|Cumulative Abatacept Period||0
6668790|NCT02557100|7599611|FG001|COMPLETED|Cumulative Abatacept Period||0
6668791|NCT02557100|7599612|FG002|COMPLETED|Cumulative Abatacept Period||72
6668792|NCT02557100|7599610|FG000|NOT COMPLETED|Cumulative Abatacept Period||0
6668793|NCT02557100|7599611|FG001|NOT COMPLETED|Cumulative Abatacept Period||0
6668794|NCT02557100|7599612|FG002|NOT COMPLETED|Cumulative Abatacept Period||4
6668795|NCT02557178|7599622|FG000|STARTED|Overall Study||72
6668796|NCT02557178|7599623|FG001|STARTED|Overall Study||74
6668797|NCT02557178|7599622|FG000|COMPLETED|Overall Study||56
6668798|NCT02557178|7599623|FG001|COMPLETED|Overall Study||63
6668799|NCT02557178|7599622|FG000|NOT COMPLETED|Overall Study||16
6668800|NCT02557178|7599623|FG001|NOT COMPLETED|Overall Study||11
6668801|NCT02557399|7599631|FG000|STARTED|Overall Study||172
6668802|NCT02557399|7599632|FG001|STARTED|Overall Study||177
6668803|NCT02557399|7599631|FG000|COMPLETED|Overall Study||165
6668804|NCT02557399|7599632|FG001|COMPLETED|Overall Study||169
6668805|NCT02557399|7599631|FG000|NOT COMPLETED|Overall Study||7
6668806|NCT02557399|7599632|FG001|NOT COMPLETED|Overall Study||8
6668807|NCT02557516|7599645|FG000|STARTED|Overall Study||3
6668808|NCT02557516|7599646|FG001|STARTED|Overall Study||6
6668809|NCT02557516|7599647|FG002|STARTED|Overall Study||4
6668810|NCT02557516|7599648|FG003|STARTED|Overall Study||9
6668811|NCT02557516|7599645|FG000|COMPLETED|Overall Study||2
6668812|NCT02557516|7599646|FG001|COMPLETED|Overall Study||1
6668813|NCT02557516|7599647|FG002|COMPLETED|Overall Study||0
6668814|NCT02557516|7599648|FG003|COMPLETED|Overall Study||0
6668815|NCT02557516|7599645|FG000|NOT COMPLETED|Overall Study||1
6668816|NCT02557516|7599646|FG001|NOT COMPLETED|Overall Study||5
6668817|NCT02557516|7599647|FG002|NOT COMPLETED|Overall Study||4
6668818|NCT02557516|7599648|FG003|NOT COMPLETED|Overall Study||9
6668819|NCT02557555|7599667|FG000|STARTED|Overall Study||100
6668820|NCT02557555|7599667|FG000|COMPLETED|Overall Study||100
6668821|NCT02557555|7599667|FG000|NOT COMPLETED|Overall Study||0
6668822|NCT02557646|7599672|FG000|STARTED|Overall Study||693
6668823|NCT02557646|7599672|FG000|COMPLETED|Overall Study||417
6668824|NCT02557646|7599672|FG000|NOT COMPLETED|Overall Study||276
6668825|NCT02557698|7599678|FG000|STARTED|Overall Study||30
6668826|NCT02557698|7599679|FG001|STARTED|Overall Study||30
6668827|NCT02557698|7599678|FG000|COMPLETED|Overall Study||30
6668828|NCT02557698|7599679|FG001|COMPLETED|Overall Study||30
6668829|NCT02557698|7599678|FG000|NOT COMPLETED|Overall Study||0
6668830|NCT02557698|7599679|FG001|NOT COMPLETED|Overall Study||0
6668831|NCT02558231|7599687|FG000|STARTED|Overall Study||123
6668832|NCT02558231|7599688|FG001|STARTED|Overall Study||124
6668833|NCT02558231|7599687|FG000|Treated|Overall Study||123
6668834|NCT02558231|7599688|FG001|Treated|Overall Study||123
6668835|NCT02558231|7599687|FG000|COMPLETED|Overall Study||98
6668836|NCT02558231|7599688|FG001|COMPLETED|Overall Study||98
6668837|NCT02558231|7599687|FG000|NOT COMPLETED|Overall Study||25
6668838|NCT02558231|7599688|FG001|NOT COMPLETED|Overall Study||26
6668839|NCT02558296|7599696|FG000|STARTED|Completed the Study Through Week 24||1133
6668840|NCT02558296|7599697|FG001|STARTED|Completed the Study Through Week 24||567
6668841|NCT02558296|7599696|FG000|COMPLETED|Completed the Study Through Week 24||1089
6668842|NCT02558296|7599697|FG001|COMPLETED|Completed the Study Through Week 24||542
6668843|NCT02558296|7599696|FG000|NOT COMPLETED|Completed the Study Through Week 24||44
6668844|NCT02558296|7599697|FG001|NOT COMPLETED|Completed the Study Through Week 24||25
6668845|NCT02558296|7599696|FG000|STARTED|Completed the Study||1133
6668846|NCT02558296|7599697|FG001|STARTED|Completed the Study||567
6668847|NCT02558296|7599696|FG000|COMPLETED|Completed the Study||987
6668848|NCT02558296|7599697|FG001|COMPLETED|Completed the Study||482
6668849|NCT02558296|7599696|FG000|NOT COMPLETED|Completed the Study||146
6668850|NCT02558296|7599697|FG001|NOT COMPLETED|Completed the Study||85
6668851|NCT02558374|7599709|FG000|STARTED|Overall Study||351
6668852|NCT02558374|7599710|FG001|STARTED|Overall Study||357
6668853|NCT02558374|7599709|FG000|COMPLETED|Overall Study||243
6668854|NCT02558374|7599710|FG001|COMPLETED|Overall Study||314
6668855|NCT02558374|7599709|FG000|NOT COMPLETED|Overall Study||108
6668856|NCT02558374|7599710|FG001|NOT COMPLETED|Overall Study||43
6737934|NCT03274076|7667164|FG002|NOT COMPLETED|24 Weeks Double Blind||0
6737935|NCT03274076|7667165|FG003|NOT COMPLETED|24 Weeks Double Blind||0
6737936|NCT03274076|7667162|FG000|STARTED|24 Weeks Open Label||0
6737937|NCT03274076|7667163|FG001|STARTED|24 Weeks Open Label||0
6256076|NCT03694353|7154924|FG000|STARTED|Overall Study||37
6256077|NCT03694353|7154924|FG000|COMPLETED|Overall Study||35
6256078|NCT03694353|7154924|FG000|NOT COMPLETED|Overall Study||2
6256079|NCT03583554|7154928|FG000|STARTED|Period 1||4
6256080|NCT03583554|7154929|FG001|STARTED|Period 1||4
6256081|NCT03583554|7154930|FG002|STARTED|Period 1||4
6256082|NCT03583554|7154928|FG000|COMPLETED|Period 1||4
6737938|NCT03274076|7667164|FG002|STARTED|24 Weeks Open Label||10
6737939|NCT03274076|7667165|FG003|STARTED|24 Weeks Open Label||4
6737940|NCT03274076|7667162|FG000|COMPLETED|24 Weeks Open Label||0
6737941|NCT03274076|7667163|FG001|COMPLETED|24 Weeks Open Label||0
6737942|NCT03274076|7667164|FG002|COMPLETED|24 Weeks Open Label||8
6737943|NCT03274076|7667165|FG003|COMPLETED|24 Weeks Open Label||3
6737944|NCT03274076|7667162|FG000|NOT COMPLETED|24 Weeks Open Label||0
6737945|NCT03274076|7667163|FG001|NOT COMPLETED|24 Weeks Open Label||0
6737946|NCT03274076|7667164|FG002|NOT COMPLETED|24 Weeks Open Label||2
6737947|NCT03274076|7667165|FG003|NOT COMPLETED|24 Weeks Open Label||1
6737948|NCT03274440|7667184|FG000|STARTED|Overall Study||3
6737949|NCT03274440|7667185|FG001|STARTED|Overall Study||2
6737950|NCT03274440|7667186|FG002|STARTED|Overall Study||4
6737951|NCT03274440|7667187|FG003|STARTED|Overall Study||1
6737952|NCT03274440|7667188|FG004|STARTED|Overall Study||1
6737953|NCT03274440|7667189|FG005|STARTED|Overall Study||3
6737954|NCT03274440|7667184|FG000|COMPLETED|Overall Study||2
6737955|NCT03274440|7667185|FG001|COMPLETED|Overall Study||2
6737956|NCT03274440|7667186|FG002|COMPLETED|Overall Study||4
6737957|NCT03274440|7667187|FG003|COMPLETED|Overall Study||0
6256083|NCT03583554|7154929|FG001|COMPLETED|Period 1||4
6256084|NCT03583554|7154930|FG002|COMPLETED|Period 1||4
6737958|NCT03274440|7667188|FG004|COMPLETED|Overall Study||1
6737959|NCT03274440|7667189|FG005|COMPLETED|Overall Study||3
6737960|NCT03274440|7667184|FG000|NOT COMPLETED|Overall Study||1
6737961|NCT03274440|7667185|FG001|NOT COMPLETED|Overall Study||0
6256085|NCT03583554|7154928|FG000|NOT COMPLETED|Period 1||0
6737962|NCT03274440|7667186|FG002|NOT COMPLETED|Overall Study||0
6737963|NCT03274440|7667187|FG003|NOT COMPLETED|Overall Study||1
6737964|NCT03274440|7667188|FG004|NOT COMPLETED|Overall Study||0
6737965|NCT03274440|7667189|FG005|NOT COMPLETED|Overall Study||0
6737966|NCT03274453|7667201|FG000|STARTED|Overall Study||38
6668857|NCT02558400|7599719|FG000|STARTED|Overall Study||238
6668858|NCT02558400|7599720|FG001|STARTED|Overall Study||244
6668859|NCT02558400|7599721|FG002|STARTED|Overall Study||236
6668860|NCT02558400|7599719|FG000|COMPLETED|Overall Study||159
6668861|NCT02558400|7599720|FG001|COMPLETED|Overall Study||148
6668862|NCT02558400|7599721|FG002|COMPLETED|Overall Study||203
6668863|NCT02558400|7599719|FG000|NOT COMPLETED|Overall Study||79
6668864|NCT02558400|7599720|FG001|NOT COMPLETED|Overall Study||96
6668865|NCT02558400|7599721|FG002|NOT COMPLETED|Overall Study||33
6668866|NCT02558790|7599732|FG000|STARTED|Overall Study|20 subjects signed consent to participate in the study. 15 subjects began taking L-TAMS.|20
6668867|NCT02558790|7599732|FG000|Treated|Overall Study||15
6668868|NCT02558790|7599732|FG000|COMPLETED|Overall Study||13
6668869|NCT02558790|7599732|FG000|NOT COMPLETED|Overall Study||7
6668870|NCT02558829|7599740|FG000|STARTED|Overall Study||21
6668871|NCT02558829|7599741|FG001|STARTED|Overall Study||21
6668872|NCT02558829|7599742|FG002|STARTED|Overall Study||24
6668873|NCT02558829|7599743|FG003|STARTED|Overall Study||18
6668874|NCT02558829|7599744|FG004|STARTED|Overall Study||18
6668875|NCT02558829|7599745|FG005|STARTED|Overall Study||26
6668876|NCT02558829|7599746|FG006|STARTED|Overall Study||18
6668877|NCT02558829|7599747|FG007|STARTED|Overall Study||11
6668878|NCT02558829|7599740|FG000|COMPLETED|Overall Study||20
6668879|NCT02558829|7599741|FG001|COMPLETED|Overall Study||18
6668880|NCT02558829|7599742|FG002|COMPLETED|Overall Study||21
6668881|NCT02558829|7599743|FG003|COMPLETED|Overall Study||16
6668882|NCT02558829|7599744|FG004|COMPLETED|Overall Study||16
6668883|NCT02558829|7599745|FG005|COMPLETED|Overall Study||24
6668884|NCT02558829|7599746|FG006|COMPLETED|Overall Study||17
6668885|NCT02558829|7599747|FG007|COMPLETED|Overall Study||8
6668886|NCT02558829|7599740|FG000|NOT COMPLETED|Overall Study||1
6668887|NCT02558829|7599741|FG001|NOT COMPLETED|Overall Study||3
6668888|NCT02558829|7599742|FG002|NOT COMPLETED|Overall Study||3
6668889|NCT02558829|7599743|FG003|NOT COMPLETED|Overall Study||2
6668890|NCT02558829|7599744|FG004|NOT COMPLETED|Overall Study||2
6668891|NCT02558829|7599745|FG005|NOT COMPLETED|Overall Study||2
6668892|NCT02558829|7599746|FG006|NOT COMPLETED|Overall Study||1
6668893|NCT02558829|7599747|FG007|NOT COMPLETED|Overall Study||3
6668894|NCT02558894|7599771|FG000|STARTED|Overall Study||32
6668895|NCT02558894|7599772|FG001|STARTED|Overall Study||33
6668896|NCT02558894|7599771|FG000|Patients Who Received IP|Overall Study||32
6668897|NCT02558894|7599772|FG001|Patients Who Received IP|Overall Study||32
6668898|NCT02558894|7599771|FG000|COMPLETED|Overall Study||0
6668899|NCT02558894|7599772|FG001|COMPLETED|Overall Study||0
6668900|NCT02558894|7599771|FG000|NOT COMPLETED|Overall Study||32
6668901|NCT02558894|7599772|FG001|NOT COMPLETED|Overall Study||33
6668902|NCT02559115|7599778|FG000|STARTED|Overall Study||19
6668903|NCT02559115|7599778|FG000|COMPLETED|Overall Study||16
6668904|NCT02559115|7599778|FG000|NOT COMPLETED|Overall Study||3
6668905|NCT02559206|7599790|FG000|STARTED|Overall Study||66
6668906|NCT02559206|7599791|FG001|STARTED|Overall Study||66
6668907|NCT02559206|7599792|FG002|STARTED|Overall Study||67
6668908|NCT02559206|7599793|FG003|STARTED|Overall Study||67
6668909|NCT02559206|7599794|FG004|STARTED|Overall Study||67
6668910|NCT02559206|7599795|FG005|STARTED|Overall Study||67
6668911|NCT02559206|7599796|FG006|STARTED|Overall Study||66
6668912|NCT02559206|7599797|FG007|STARTED|Overall Study||66
6668913|NCT02559206|7599790|FG000|COMPLETED|Overall Study||58
6668914|NCT02559206|7599791|FG001|COMPLETED|Overall Study||54
6668915|NCT02559206|7599792|FG002|COMPLETED|Overall Study||58
6668916|NCT02559206|7599793|FG003|COMPLETED|Overall Study||53
6668917|NCT02559206|7599794|FG004|COMPLETED|Overall Study||55
6668918|NCT02559206|7599795|FG005|COMPLETED|Overall Study||53
6668919|NCT02559206|7599796|FG006|COMPLETED|Overall Study||60
6668920|NCT02559206|7599797|FG007|COMPLETED|Overall Study||57
6668921|NCT02559206|7599790|FG000|NOT COMPLETED|Overall Study||8
6668922|NCT02559206|7599791|FG001|NOT COMPLETED|Overall Study||12
6668923|NCT02559206|7599792|FG002|NOT COMPLETED|Overall Study||9
6668924|NCT02559206|7599793|FG003|NOT COMPLETED|Overall Study||14
6668925|NCT02559206|7599794|FG004|NOT COMPLETED|Overall Study||12
6668926|NCT02559206|7599795|FG005|NOT COMPLETED|Overall Study||14
6668927|NCT02559206|7599796|FG006|NOT COMPLETED|Overall Study||6
6668928|NCT02559206|7599797|FG007|NOT COMPLETED|Overall Study||9
6668929|NCT02559310|7599817|FG000|STARTED|Overall Study||276
6668930|NCT02559310|7599818|FG001|STARTED|Overall Study||275
6668931|NCT02559310|7599817|FG000|COMPLETED|Overall Study||249
6668932|NCT02559310|7599818|FG001|COMPLETED|Overall Study||256
6668933|NCT02559310|7599817|FG000|NOT COMPLETED|Overall Study||27
6668934|NCT02559310|7599818|FG001|NOT COMPLETED|Overall Study||19
6668935|NCT02559414|7599827|FG000|STARTED|Overall Study||11
6668936|NCT02559414|7599828|FG001|STARTED|Overall Study||22
6668937|NCT02559414|7599829|FG002|STARTED|Overall Study||22
6668938|NCT02559414|7599827|FG000|COMPLETED|Overall Study||10
6668939|NCT02559414|7599828|FG001|COMPLETED|Overall Study||20
6668940|NCT02559414|7599829|FG002|COMPLETED|Overall Study||20
6668941|NCT02559414|7599827|FG000|NOT COMPLETED|Overall Study||1
6668942|NCT02559414|7599828|FG001|NOT COMPLETED|Overall Study||2
6668943|NCT02559414|7599829|FG002|NOT COMPLETED|Overall Study||2
6668944|NCT02559505|7599854|FG000|STARTED|Overall Study||49
6668945|NCT02559505|7599855|FG001|STARTED|Overall Study||84
6668946|NCT02559505|7599854|FG000|COMPLETED|Overall Study||22
6668947|NCT02559505|7599855|FG001|COMPLETED|Overall Study||62
6668948|NCT02559505|7599854|FG000|NOT COMPLETED|Overall Study||27
6668949|NCT02559505|7599855|FG001|NOT COMPLETED|Overall Study||22
6668950|NCT02559570|7599878|FG000|STARTED|Overall Study||41
6668951|NCT02559570|7599879|FG001|STARTED|Overall Study||36
6668952|NCT02559570|7599880|FG002|STARTED|Overall Study||41
6668953|NCT02559570|7599881|FG003|STARTED|Overall Study||39
6668954|NCT02559570|7599882|FG004|STARTED|Overall Study||16
6668955|NCT02559570|7599878|FG000|COMPLETED|Overall Study||39
6668956|NCT02559570|7599879|FG001|COMPLETED|Overall Study||34
6668957|NCT02559570|7599880|FG002|COMPLETED|Overall Study||39
6668958|NCT02559570|7599881|FG003|COMPLETED|Overall Study||36
6668959|NCT02559570|7599882|FG004|COMPLETED|Overall Study||14
6668960|NCT02559570|7599878|FG000|NOT COMPLETED|Overall Study||2
6668961|NCT02559570|7599879|FG001|NOT COMPLETED|Overall Study||2
6668962|NCT02559570|7599880|FG002|NOT COMPLETED|Overall Study||2
6668963|NCT02559570|7599881|FG003|NOT COMPLETED|Overall Study||3
6668964|NCT02559570|7599882|FG004|NOT COMPLETED|Overall Study||2
6668965|NCT02559622|7599897|FG000|STARTED|Overall Study||48
6668966|NCT02559622|7599898|FG001|STARTED|Overall Study||54
6668967|NCT02559622|7599899|FG002|STARTED|Overall Study||26
6668968|NCT02559622|7599900|FG003|STARTED|Overall Study||23
6668969|NCT02559622|7599897|FG000|COMPLETED|Overall Study||47
6668970|NCT02559622|7599898|FG001|COMPLETED|Overall Study||49
6668971|NCT02559622|7599899|FG002|COMPLETED|Overall Study||24
6668972|NCT02559622|7599900|FG003|COMPLETED|Overall Study||20
6668973|NCT02559622|7599897|FG000|NOT COMPLETED|Overall Study||1
6668974|NCT02559622|7599898|FG001|NOT COMPLETED|Overall Study||5
6668975|NCT02559622|7599899|FG002|NOT COMPLETED|Overall Study||2
6668976|NCT02559622|7599900|FG003|NOT COMPLETED|Overall Study||3
6668977|NCT02559687|7599914|FG000|STARTED|Overall Study||121
6668978|NCT02559687|7599914|FG000|COMPLETED|Overall Study||0
6668979|NCT02559687|7599914|FG000|NOT COMPLETED|Overall Study||121
6668980|NCT02559713|7599918|FG000|STARTED|Overall Study||11
6668981|NCT02559713|7599918|FG000|Safety Set|Overall Study||11
6668982|NCT02559713|7599918|FG000|Pharmacokinetic Set|Overall Study||11
6668983|NCT02559713|7599918|FG000|COMPLETED|Overall Study||10
6668984|NCT02559713|7599918|FG000|NOT COMPLETED|Overall Study||1
6668985|NCT02559817|7599927|FG000|STARTED|Treatment Period||19
6668986|NCT02559817|7599928|FG001|STARTED|Treatment Period||29
6668987|NCT02559817|7599929|FG002|STARTED|Treatment Period||21
6668988|NCT02559817|7599930|FG003|STARTED|Treatment Period||24
6668989|NCT02559817|7599931|FG004|STARTED|Treatment Period||8
6668990|NCT02559817|7599927|FG000|COMPLETED|Treatment Period||18
6668991|NCT02559817|7599928|FG001|COMPLETED|Treatment Period||27
6668992|NCT02559817|7599929|FG002|COMPLETED|Treatment Period||19
6668993|NCT02559817|7599930|FG003|COMPLETED|Treatment Period||22
6668994|NCT02559817|7599931|FG004|COMPLETED|Treatment Period||8
6668995|NCT02559817|7599927|FG000|NOT COMPLETED|Treatment Period||1
6668996|NCT02559817|7599928|FG001|NOT COMPLETED|Treatment Period||2
6668997|NCT02559817|7599929|FG002|NOT COMPLETED|Treatment Period||2
6668998|NCT02559817|7599930|FG003|NOT COMPLETED|Treatment Period||2
6668999|NCT02559817|7599931|FG004|NOT COMPLETED|Treatment Period||0
6669000|NCT02559817|7599927|FG000|STARTED|Post-treatment Period||18
6669001|NCT02559817|7599928|FG001|STARTED|Post-treatment Period||27
6669002|NCT02559817|7599929|FG002|STARTED|Post-treatment Period|1 participant who did not complete the first period, entered and completed the Post-treatment Period|20
6669003|NCT02559817|7599930|FG003|STARTED|Post-treatment Period||22
6669004|NCT02559817|7599931|FG004|STARTED|Post-treatment Period||8
6669005|NCT02559817|7599927|FG000|COMPLETED|Post-treatment Period||18
6669006|NCT02559817|7599928|FG001|COMPLETED|Post-treatment Period||27
6669007|NCT02559817|7599929|FG002|COMPLETED|Post-treatment Period||20
6669008|NCT02559817|7599930|FG003|COMPLETED|Post-treatment Period||22
6669009|NCT02559817|7599931|FG004|COMPLETED|Post-treatment Period||8
6669010|NCT02559817|7599927|FG000|NOT COMPLETED|Post-treatment Period||0
6669011|NCT02559817|7599928|FG001|NOT COMPLETED|Post-treatment Period||0
6669012|NCT02559817|7599929|FG002|NOT COMPLETED|Post-treatment Period||0
6669013|NCT02559817|7599930|FG003|NOT COMPLETED|Post-treatment Period||0
6669014|NCT02559817|7599931|FG004|NOT COMPLETED|Post-treatment Period||0
6669015|NCT02559895|7599947|FG000|STARTED|Overall Study||224
6669016|NCT02559895|7599948|FG001|STARTED|Overall Study||225
6669017|NCT02559895|7599949|FG002|STARTED|Overall Study||224
6669018|NCT02559895|7599950|FG003|STARTED|Overall Study||225
6669019|NCT02559895|7599947|FG000|Participants Treated|Overall Study||222
6669020|NCT02559895|7599948|FG001|Participants Treated|Overall Study||221
6669021|NCT02559895|7599949|FG002|Participants Treated|Overall Study||223
6669022|NCT02559895|7599950|FG003|Participants Treated|Overall Study||222
6669023|NCT02559895|7599947|FG000|COMPLETED|Overall Study||169
6669024|NCT02559895|7599948|FG001|COMPLETED|Overall Study||172
6669025|NCT02559895|7599949|FG002|COMPLETED|Overall Study||170
6669026|NCT02559895|7599950|FG003|COMPLETED|Overall Study||165
6669027|NCT02559895|7599947|FG000|NOT COMPLETED|Overall Study||55
6669028|NCT02559895|7599948|FG001|NOT COMPLETED|Overall Study||53
6669029|NCT02559895|7599949|FG002|NOT COMPLETED|Overall Study||54
6669030|NCT02559895|7599950|FG003|NOT COMPLETED|Overall Study||60
6669031|NCT02560012|7599960|FG000|STARTED|Overall Study||3
6669032|NCT02560012|7599960|FG000|COMPLETED|Overall Study||1
6669033|NCT02560012|7599960|FG000|NOT COMPLETED|Overall Study||2
6669034|NCT02560025|7599964|FG000|STARTED|Overall Study||42
6669035|NCT02560025|7599964|FG000|COMPLETED|Overall Study||39
6669036|NCT02560025|7599964|FG000|NOT COMPLETED|Overall Study||3
6669037|NCT02560038|7599968|FG000|STARTED|Overall Study||3
6669038|NCT02560038|7599968|FG000|COMPLETED|Overall Study||1
6669039|NCT02560038|7599968|FG000|NOT COMPLETED|Overall Study||2
6669040|NCT02560051|7599975|FG000|STARTED|Overall Study||6
6669041|NCT02560051|7599976|FG001|STARTED|Overall Study||8
6669042|NCT02560051|7599977|FG002|STARTED|Overall Study||5
6669043|NCT02560051|7599975|FG000|COMPLETED|Overall Study||3
6669044|NCT02560051|7599976|FG001|COMPLETED|Overall Study||4
6669045|NCT02560051|7599977|FG002|COMPLETED|Overall Study||4
6669046|NCT02560051|7599975|FG000|NOT COMPLETED|Overall Study||3
6669047|NCT02560051|7599976|FG001|NOT COMPLETED|Overall Study||4
6669048|NCT02560051|7599977|FG002|NOT COMPLETED|Overall Study||1
6669049|NCT02560324|7599987|FG000|STARTED|Period 1 (2 Weeks)||35
6669050|NCT02560324|7599988|FG001|STARTED|Period 1 (2 Weeks)||34
6669051|NCT02560324|7599987|FG000|COMPLETED|Period 1 (2 Weeks)||23
6669052|NCT02560324|7599988|FG001|COMPLETED|Period 1 (2 Weeks)||25
6669053|NCT02560324|7599987|FG000|NOT COMPLETED|Period 1 (2 Weeks)||12
6669054|NCT02560324|7599988|FG001|NOT COMPLETED|Period 1 (2 Weeks)||9
6669055|NCT02560324|7599987|FG000|STARTED|Washout (2 Weeks)||23
6669056|NCT02560324|7599988|FG001|STARTED|Washout (2 Weeks)||25
6669057|NCT02560324|7599987|FG000|COMPLETED|Washout (2 Weeks)||23
6669058|NCT02560324|7599988|FG001|COMPLETED|Washout (2 Weeks)||23
6669059|NCT02560324|7599987|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6669060|NCT02560324|7599988|FG001|NOT COMPLETED|Washout (2 Weeks)||2
6669061|NCT02560324|7599987|FG000|STARTED|Period 2 (2 Weeks)||23
6669062|NCT02560324|7599988|FG001|STARTED|Period 2 (2 Weeks)||23
6669063|NCT02560324|7599987|FG000|COMPLETED|Period 2 (2 Weeks)||22
6669064|NCT02560324|7599988|FG001|COMPLETED|Period 2 (2 Weeks)||21
6669065|NCT02560324|7599987|FG000|NOT COMPLETED|Period 2 (2 Weeks)||1
6669066|NCT02560324|7599988|FG001|NOT COMPLETED|Period 2 (2 Weeks)||2
6669067|NCT02560389|7600001|FG000|STARTED|Overall Study||34
6669068|NCT02560389|7600002|FG001|STARTED|Overall Study||28
6669069|NCT02560389|7600003|FG002|STARTED|Overall Study||29
6669070|NCT02560389|7600001|FG000|COMPLETED|Overall Study||33
6669071|NCT02560389|7600002|FG001|COMPLETED|Overall Study||25
6669072|NCT02560389|7600003|FG002|COMPLETED|Overall Study||27
6669073|NCT02560389|7600001|FG000|NOT COMPLETED|Overall Study||1
6669074|NCT02560389|7600002|FG001|NOT COMPLETED|Overall Study||3
6669075|NCT02560389|7600003|FG002|NOT COMPLETED|Overall Study||2
6669076|NCT02560493|7600013|FG000|STARTED|Overall Study||23
6669077|NCT02560493|7600014|FG001|STARTED|Overall Study||23
6669078|NCT02560493|7600013|FG000|COMPLETED|Overall Study||22
6669079|NCT02560493|7600014|FG001|COMPLETED|Overall Study||23
6669080|NCT02560493|7600013|FG000|NOT COMPLETED|Overall Study||1
6669081|NCT02560493|7600014|FG001|NOT COMPLETED|Overall Study||0
6669082|NCT02560558|7600022|FG000|STARTED|Overall Study||84
6669083|NCT02560558|7600023|FG001|STARTED|Overall Study||82
6669084|NCT02560558|7600022|FG000|COMPLETED|Overall Study||77
6669085|NCT02560558|7600023|FG001|COMPLETED|Overall Study||76
6669086|NCT02560558|7600022|FG000|NOT COMPLETED|Overall Study||7
6669087|NCT02560558|7600023|FG001|NOT COMPLETED|Overall Study||6
6669088|NCT02560584|7600029|FG000|STARTED|Overall Study||304
6669089|NCT02560584|7600029|FG000|COMPLETED|Overall Study||304
6669090|NCT02560584|7600029|FG000|NOT COMPLETED|Overall Study||0
6669091|NCT02560701|7600037|FG000|STARTED|Overall Study||8060
6669092|NCT02560701|7600038|FG001|STARTED|Overall Study||89242
6669093|NCT02560701|7600037|FG000|Carve Out|Overall Study||8060
6669094|NCT02560701|7600038|FG001|Carve Out|Overall Study||88729
6669095|NCT02560701|7600037|FG000|Restrict to Patients Between 12 and 64|Overall Study||7598
6669096|NCT02560701|7600038|FG001|Restrict to Patients Between 12 and 64|Overall Study||82367
6669097|NCT02560701|7600037|FG000|Bipolar Diagnosis Time Constraints|Overall Study||3533
6669098|NCT02560701|7600038|FG001|Bipolar Diagnosis Time Constraints|Overall Study||39427
6669099|NCT02560701|7600037|FG000|Matched Cohort|Overall Study||3517
6669100|NCT02560701|7600038|FG001|Matched Cohort|Overall Study||37776
6669101|NCT02560701|7600037|FG000|COMPLETED|Overall Study||3517
6669102|NCT02560701|7600038|FG001|COMPLETED|Overall Study||37776
6669103|NCT02560701|7600037|FG000|NOT COMPLETED|Overall Study||4543
6256086|NCT03583554|7154929|FG001|NOT COMPLETED|Period 1||0
6669104|NCT02560701|7600038|FG001|NOT COMPLETED|Overall Study||51466
6669105|NCT02560753|7600048|FG000|STARTED|Overall Study||9
6669106|NCT02560753|7600049|FG001|STARTED|Overall Study||9
6669107|NCT02560753|7600050|FG002|STARTED|Overall Study||10
6669108|NCT02560753|7600051|FG003|STARTED|Overall Study||8
6669109|NCT02560753|7600048|FG000|COMPLETED|Overall Study||8
6669110|NCT02560753|7600049|FG001|COMPLETED|Overall Study||9
6669111|NCT02560753|7600050|FG002|COMPLETED|Overall Study||9
6669112|NCT02560753|7600051|FG003|COMPLETED|Overall Study||8
6669113|NCT02560753|7600048|FG000|NOT COMPLETED|Overall Study||1
6669114|NCT02560753|7600049|FG001|NOT COMPLETED|Overall Study||0
6669115|NCT02560753|7600050|FG002|NOT COMPLETED|Overall Study||1
6669116|NCT02560753|7600051|FG003|NOT COMPLETED|Overall Study||0
6669117|NCT02560779|7600063|FG000|STARTED|Overall Study||14
6669118|NCT02560779|7600064|FG001|STARTED|Overall Study||13
6669119|NCT02560779|7600063|FG000|COMPLETED|Overall Study||14
6669120|NCT02560779|7600064|FG001|COMPLETED|Overall Study||13
6669121|NCT02560779|7600063|FG000|NOT COMPLETED|Overall Study||0
6669122|NCT02560779|7600064|FG001|NOT COMPLETED|Overall Study||0
6669123|NCT02560922|7600072|FG000|STARTED|Overall Study||124
6669124|NCT02560922|7600073|FG001|STARTED|Overall Study||124
6669125|NCT02560922|7600072|FG000|COMPLETED|Overall Study||98
6669126|NCT02560922|7600073|FG001|COMPLETED|Overall Study||112
6669127|NCT02560922|7600072|FG000|NOT COMPLETED|Overall Study||26
6669128|NCT02560922|7600073|FG001|NOT COMPLETED|Overall Study||12
6669129|NCT02561000|7600082|FG000|STARTED|Overall Study||34
6669130|NCT02561000|7600083|FG001|STARTED|Overall Study||35
6669131|NCT02561000|7600084|FG002|STARTED|Overall Study||31
6669132|NCT02561000|7600082|FG000|Safety Population|Overall Study|Includes 1 additional patient who was assigned PZ-128 0.3 mg/kg but received placebo in error (evaluated as placebo for primary safety outcome and adverse events).|35
6669133|NCT02561000|7600083|FG001|Safety Population|Overall Study|Excludes 4 patients who did not receive the study drug as allocated: 1 patient received placebo in error and was evaluated as placebo for primary safety outcome and adverse events; 2 patients withdrew full consent immediately after randomization prior to receiving any study drug; and 1 patient had an adverse event shortly after randomization prior to receiving any study drug.|31
6669134|NCT02561000|7600084|FG002|Safety Population|Overall Study||31
6669135|NCT02561000|7600082|FG000|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||34
6669136|NCT02561000|7600083|FG001|Intent-to-Treat (ITT) Population at 30 Days|Overall Study|Excludes 2 patients who withdrew full consent immediately after randomization.|33
6669137|NCT02561000|7600084|FG002|Intent-to-Treat (ITT) Population at 30 Days|Overall Study||31
6669138|NCT02561000|7600082|FG000|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 1 patient who withdrew consent for follow-up 21 days after study drug dosing.|33
6669139|NCT02561000|7600083|FG001|Intent-to-Treat (ITT) Population at 90 Days|Overall Study|Excludes 4 patients: 2 patients withdrew full consent immediately after randomization; 1 patient followed only for 30 day ITT outcome (did not receive any study drug due to adverse event post randomization); and 1 patient withdrew consent for follow-up 7 days after study drug dosing.|31
6669140|NCT02561000|7600084|FG002|Intent-to-Treat (ITT) Population at 90 Days|Overall Study||31
6669141|NCT02561000|7600082|FG000|COMPLETED|Overall Study||32
6669142|NCT02561000|7600083|FG001|COMPLETED|Overall Study||31
6669143|NCT02561000|7600084|FG002|COMPLETED|Overall Study||31
6669144|NCT02561000|7600082|FG000|NOT COMPLETED|Overall Study||2
6669145|NCT02561000|7600083|FG001|NOT COMPLETED|Overall Study||4
6669146|NCT02561000|7600084|FG002|NOT COMPLETED|Overall Study||0
6669147|NCT02561078|7600094|FG000|STARTED|Overall Study||209
6669148|NCT02561078|7600095|FG001|STARTED|Overall Study||211
6669149|NCT02561078|7600094|FG000|Received at Least 1 Dose of Study Drug|Overall Study||208
6669150|NCT02561078|7600095|FG001|Received at Least 1 Dose of Study Drug|Overall Study||210
6669151|NCT02561078|7600094|FG000|COMPLETED|Overall Study||179
6669152|NCT02561078|7600095|FG001|COMPLETED|Overall Study||186
6669153|NCT02561078|7600094|FG000|NOT COMPLETED|Overall Study||30
6669154|NCT02561078|7600095|FG001|NOT COMPLETED|Overall Study||25
6669155|NCT02561130|7600103|FG000|STARTED|Overall Study||77
6669156|NCT02561130|7600104|FG001|STARTED|Overall Study||77
6669157|NCT02561130|7600103|FG000|COMPLETED|Overall Study||76
6669158|NCT02561130|7600104|FG001|COMPLETED|Overall Study||76
6669159|NCT02561130|7600103|FG000|NOT COMPLETED|Overall Study||1
6669160|NCT02561130|7600104|FG001|NOT COMPLETED|Overall Study||1
6669161|NCT02561156|7600123|FG000|STARTED|Part 1||12
6669162|NCT02561156|7600124|FG001|STARTED|Part 1||6
6669163|NCT02561156|7600125|FG002|STARTED|Part 1||6
6669164|NCT02561156|7600126|FG003|STARTED|Part 1||6
6669165|NCT02561156|7600127|FG004|STARTED|Part 1||6
6669166|NCT02561156|7600128|FG005|STARTED|Part 1||6
6669167|NCT02561156|7600129|FG006|STARTED|Part 1||6
6669168|NCT02561156|7600130|FG007|STARTED|Part 1||0
6669169|NCT02561156|7600131|FG008|STARTED|Part 1||0
6669170|NCT02561156|7600132|FG009|STARTED|Part 1||0
6669171|NCT02561156|7600133|FG010|STARTED|Part 1||0
6669172|NCT02561156|7600134|FG011|STARTED|Part 1||0
6669173|NCT02561156|7600135|FG012|STARTED|Part 1||0
6669174|NCT02561156|7600123|FG000|COMPLETED|Part 1||12
6669175|NCT02561156|7600124|FG001|COMPLETED|Part 1||6
6669176|NCT02561156|7600125|FG002|COMPLETED|Part 1||6
6669177|NCT02561156|7600126|FG003|COMPLETED|Part 1||6
6669178|NCT02561156|7600127|FG004|COMPLETED|Part 1||6
6669179|NCT02561156|7600128|FG005|COMPLETED|Part 1||6
6669180|NCT02561156|7600129|FG006|COMPLETED|Part 1||6
6669181|NCT02561156|7600130|FG007|COMPLETED|Part 1||0
6669182|NCT02561156|7600131|FG008|COMPLETED|Part 1||0
6669183|NCT02561156|7600132|FG009|COMPLETED|Part 1||0
6669184|NCT02561156|7600133|FG010|COMPLETED|Part 1||0
6669185|NCT02561156|7600134|FG011|COMPLETED|Part 1||0
6669186|NCT02561156|7600135|FG012|COMPLETED|Part 1||0
6669187|NCT02561156|7600123|FG000|NOT COMPLETED|Part 1||0
6669188|NCT02561156|7600124|FG001|NOT COMPLETED|Part 1||0
6669189|NCT02561156|7600125|FG002|NOT COMPLETED|Part 1||0
6669190|NCT02561156|7600126|FG003|NOT COMPLETED|Part 1||0
6669191|NCT02561156|7600127|FG004|NOT COMPLETED|Part 1||0
6669192|NCT02561156|7600128|FG005|NOT COMPLETED|Part 1||0
6669193|NCT02561156|7600129|FG006|NOT COMPLETED|Part 1||0
6669194|NCT02561156|7600130|FG007|NOT COMPLETED|Part 1||0
6669195|NCT02561156|7600131|FG008|NOT COMPLETED|Part 1||0
6669196|NCT02561156|7600132|FG009|NOT COMPLETED|Part 1||0
6669197|NCT02561156|7600133|FG010|NOT COMPLETED|Part 1||0
6669198|NCT02561156|7600134|FG011|NOT COMPLETED|Part 1||0
6669199|NCT02561156|7600135|FG012|NOT COMPLETED|Part 1||0
6669200|NCT02561156|7600123|FG000|STARTED|Part 2||0
6669201|NCT02561156|7600124|FG001|STARTED|Part 2||0
6669202|NCT02561156|7600125|FG002|STARTED|Part 2||0
6669203|NCT02561156|7600126|FG003|STARTED|Part 2||0
6669204|NCT02561156|7600127|FG004|STARTED|Part 2||0
6669205|NCT02561156|7600128|FG005|STARTED|Part 2||0
6669206|NCT02561156|7600129|FG006|STARTED|Part 2||0
6669207|NCT02561156|7600130|FG007|STARTED|Part 2||10
6669208|NCT02561156|7600131|FG008|STARTED|Part 2||6
6669209|NCT02561156|7600132|FG009|STARTED|Part 2||6
6669210|NCT02561156|7600133|FG010|STARTED|Part 2||6
6669211|NCT02561156|7600134|FG011|STARTED|Part 2||6
6669212|NCT02561156|7600135|FG012|STARTED|Part 2||6
6669213|NCT02561156|7600123|FG000|COMPLETED|Part 2||0
6669214|NCT02561156|7600124|FG001|COMPLETED|Part 2||0
6669215|NCT02561156|7600125|FG002|COMPLETED|Part 2||0
6669216|NCT02561156|7600126|FG003|COMPLETED|Part 2||0
6669217|NCT02561156|7600127|FG004|COMPLETED|Part 2||0
6669218|NCT02561156|7600128|FG005|COMPLETED|Part 2||0
6669219|NCT02561156|7600129|FG006|COMPLETED|Part 2||0
6669220|NCT02561156|7600130|FG007|COMPLETED|Part 2||10
6669221|NCT02561156|7600131|FG008|COMPLETED|Part 2||6
6669222|NCT02561156|7600132|FG009|COMPLETED|Part 2||6
6669223|NCT02561156|7600133|FG010|COMPLETED|Part 2||6
6669224|NCT02561156|7600134|FG011|COMPLETED|Part 2||5
6669225|NCT02561156|7600135|FG012|COMPLETED|Part 2||6
6669226|NCT02561156|7600123|FG000|NOT COMPLETED|Part 2||0
6669227|NCT02561156|7600124|FG001|NOT COMPLETED|Part 2||0
6669228|NCT02561156|7600125|FG002|NOT COMPLETED|Part 2||0
6669229|NCT02561156|7600126|FG003|NOT COMPLETED|Part 2||0
6669230|NCT02561156|7600127|FG004|NOT COMPLETED|Part 2||0
6669231|NCT02561156|7600128|FG005|NOT COMPLETED|Part 2||0
6669232|NCT02561156|7600129|FG006|NOT COMPLETED|Part 2||0
6669233|NCT02561156|7600130|FG007|NOT COMPLETED|Part 2||0
6669234|NCT02561156|7600131|FG008|NOT COMPLETED|Part 2||0
6669235|NCT02561156|7600132|FG009|NOT COMPLETED|Part 2||0
6669236|NCT02561156|7600133|FG010|NOT COMPLETED|Part 2||0
6669237|NCT02561156|7600134|FG011|NOT COMPLETED|Part 2||1
6669238|NCT02561156|7600135|FG012|NOT COMPLETED|Part 2||0
6669239|NCT02561195|7600185|FG000|STARTED|Vaccination 1 to 3||183
6669240|NCT02561195|7600186|FG001|STARTED|Vaccination 1 to 3||184
6669241|NCT02561195|7600187|FG002|STARTED|Vaccination 1 to 3||61
6669242|NCT02561195|7600188|FG003|STARTED|Vaccination 1 to 3||183
6669243|NCT02561195|7600189|FG004|STARTED|Vaccination 1 to 3||183
6669244|NCT02561195|7600190|FG005|STARTED|Vaccination 1 to 3||61
6669245|NCT02561195|7600191|FG006|STARTED|Vaccination 1 to 3||0
6669246|NCT02561195|7600192|FG007|STARTED|Vaccination 1 to 3||0
6669247|NCT02561195|7600193|FG008|STARTED|Vaccination 1 to 3||0
6669248|NCT02561195|7600194|FG009|STARTED|Vaccination 1 to 3||0
6669249|NCT02561195|7600195|FG010|STARTED|Vaccination 1 to 3||0
6669250|NCT02561195|7600196|FG011|STARTED|Vaccination 1 to 3||0
6669251|NCT02561195|7600197|FG012|STARTED|Vaccination 1 to 3||0
6669252|NCT02561195|7600198|FG013|STARTED|Vaccination 1 to 3||0
6669253|NCT02561195|7600185|FG000|Treated|Vaccination 1 to 3||182
6669254|NCT02561195|7600186|FG001|Treated|Vaccination 1 to 3||184
6669255|NCT02561195|7600187|FG002|Treated|Vaccination 1 to 3||61
6669256|NCT02561195|7600188|FG003|Treated|Vaccination 1 to 3||183
6669257|NCT02561195|7600189|FG004|Treated|Vaccination 1 to 3||183
6669258|NCT02561195|7600190|FG005|Treated|Vaccination 1 to 3||61
6669259|NCT02561195|7600191|FG006|Treated|Vaccination 1 to 3||0
6669260|NCT02561195|7600192|FG007|Treated|Vaccination 1 to 3||0
6669261|NCT02561195|7600193|FG008|Treated|Vaccination 1 to 3||0
6669262|NCT02561195|7600194|FG009|Treated|Vaccination 1 to 3||0
6669263|NCT02561195|7600195|FG010|Treated|Vaccination 1 to 3||0
6669264|NCT02561195|7600196|FG011|Treated|Vaccination 1 to 3||0
6669265|NCT02561195|7600197|FG012|Treated|Vaccination 1 to 3||0
6669266|NCT02561195|7600198|FG013|Treated|Vaccination 1 to 3||0
6669267|NCT02561195|7600185|FG000|COMPLETED|Vaccination 1 to 3||160
6669268|NCT02561195|7600186|FG001|COMPLETED|Vaccination 1 to 3||162
6669269|NCT02561195|7600187|FG002|COMPLETED|Vaccination 1 to 3||55
6669270|NCT02561195|7600188|FG003|COMPLETED|Vaccination 1 to 3||157
6669271|NCT02561195|7600189|FG004|COMPLETED|Vaccination 1 to 3||155
6669272|NCT02561195|7600190|FG005|COMPLETED|Vaccination 1 to 3||51
6669273|NCT02561195|7600191|FG006|COMPLETED|Vaccination 1 to 3||0
6669274|NCT02561195|7600192|FG007|COMPLETED|Vaccination 1 to 3||0
6669275|NCT02561195|7600193|FG008|COMPLETED|Vaccination 1 to 3||0
6669276|NCT02561195|7600194|FG009|COMPLETED|Vaccination 1 to 3||0
6669277|NCT02561195|7600195|FG010|COMPLETED|Vaccination 1 to 3||0
6669278|NCT02561195|7600196|FG011|COMPLETED|Vaccination 1 to 3||0
6669279|NCT02561195|7600197|FG012|COMPLETED|Vaccination 1 to 3||0
6669280|NCT02561195|7600198|FG013|COMPLETED|Vaccination 1 to 3||0
6669281|NCT02561195|7600185|FG000|NOT COMPLETED|Vaccination 1 to 3||23
6669282|NCT02561195|7600186|FG001|NOT COMPLETED|Vaccination 1 to 3||22
6669283|NCT02561195|7600187|FG002|NOT COMPLETED|Vaccination 1 to 3||6
6669284|NCT02561195|7600188|FG003|NOT COMPLETED|Vaccination 1 to 3||26
6669285|NCT02561195|7600189|FG004|NOT COMPLETED|Vaccination 1 to 3||28
6669286|NCT02561195|7600190|FG005|NOT COMPLETED|Vaccination 1 to 3||10
6669287|NCT02561195|7600191|FG006|NOT COMPLETED|Vaccination 1 to 3||0
6669288|NCT02561195|7600192|FG007|NOT COMPLETED|Vaccination 1 to 3||0
6669289|NCT02561195|7600193|FG008|NOT COMPLETED|Vaccination 1 to 3||0
6669290|NCT02561195|7600194|FG009|NOT COMPLETED|Vaccination 1 to 3||0
6669291|NCT02561195|7600195|FG010|NOT COMPLETED|Vaccination 1 to 3||0
6669292|NCT02561195|7600196|FG011|NOT COMPLETED|Vaccination 1 to 3||0
6669293|NCT02561195|7600197|FG012|NOT COMPLETED|Vaccination 1 to 3||0
6669294|NCT02561195|7600198|FG013|NOT COMPLETED|Vaccination 1 to 3||0
6669295|NCT02561195|7600185|FG000|STARTED|Extension Stage (Vaccination 4)||0
6669296|NCT02561195|7600186|FG001|STARTED|Extension Stage (Vaccination 4)||0
6669297|NCT02561195|7600187|FG002|STARTED|Extension Stage (Vaccination 4)||0
6669298|NCT02561195|7600188|FG003|STARTED|Extension Stage (Vaccination 4)||0
6669299|NCT02561195|7600189|FG004|STARTED|Extension Stage (Vaccination 4)||0
6669300|NCT02561195|7600190|FG005|STARTED|Extension Stage (Vaccination 4)||0
6669301|NCT02561195|7600191|FG006|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|16
6669302|NCT02561195|7600192|FG007|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|18
6669303|NCT02561195|7600193|FG008|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|24
6669304|NCT02561195|7600194|FG009|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|22
6669305|NCT02561195|7600195|FG010|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|51
6669306|NCT02561195|7600196|FG011|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|52
6669307|NCT02561195|7600197|FG012|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|58
6669308|NCT02561195|7600198|FG013|STARTED|Extension Stage (Vaccination 4)|Participants who met predefined eligibility criteria enrolled into extension stage.|59
6669309|NCT02561195|7600185|FG000|COMPLETED|Extension Stage (Vaccination 4)||0
6669310|NCT02561195|7600186|FG001|COMPLETED|Extension Stage (Vaccination 4)||0
6669311|NCT02561195|7600187|FG002|COMPLETED|Extension Stage (Vaccination 4)||0
6669312|NCT02561195|7600188|FG003|COMPLETED|Extension Stage (Vaccination 4)||0
6669313|NCT02561195|7600189|FG004|COMPLETED|Extension Stage (Vaccination 4)||0
6669314|NCT02561195|7600190|FG005|COMPLETED|Extension Stage (Vaccination 4)||0
6669315|NCT02561195|7600191|FG006|COMPLETED|Extension Stage (Vaccination 4)||14
6669316|NCT02561195|7600192|FG007|COMPLETED|Extension Stage (Vaccination 4)||17
6669317|NCT02561195|7600193|FG008|COMPLETED|Extension Stage (Vaccination 4)||21
6669318|NCT02561195|7600194|FG009|COMPLETED|Extension Stage (Vaccination 4)||20
6669319|NCT02561195|7600195|FG010|COMPLETED|Extension Stage (Vaccination 4)||43
6669320|NCT02561195|7600196|FG011|COMPLETED|Extension Stage (Vaccination 4)||45
6669321|NCT02561195|7600197|FG012|COMPLETED|Extension Stage (Vaccination 4)||51
6669322|NCT02561195|7600198|FG013|COMPLETED|Extension Stage (Vaccination 4)||54
6669323|NCT02561195|7600185|FG000|NOT COMPLETED|Extension Stage (Vaccination 4)||0
6669324|NCT02561195|7600186|FG001|NOT COMPLETED|Extension Stage (Vaccination 4)||0
6669325|NCT02561195|7600187|FG002|NOT COMPLETED|Extension Stage (Vaccination 4)||0
6669326|NCT02561195|7600188|FG003|NOT COMPLETED|Extension Stage (Vaccination 4)||0
6669327|NCT02561195|7600189|FG004|NOT COMPLETED|Extension Stage (Vaccination 4)||0
6669328|NCT02561195|7600190|FG005|NOT COMPLETED|Extension Stage (Vaccination 4)||0
6669329|NCT02561195|7600191|FG006|NOT COMPLETED|Extension Stage (Vaccination 4)||2
6669330|NCT02561195|7600192|FG007|NOT COMPLETED|Extension Stage (Vaccination 4)||1
6669331|NCT02561195|7600193|FG008|NOT COMPLETED|Extension Stage (Vaccination 4)||3
6669332|NCT02561195|7600194|FG009|NOT COMPLETED|Extension Stage (Vaccination 4)||2
6669333|NCT02561195|7600195|FG010|NOT COMPLETED|Extension Stage (Vaccination 4)||8
6669334|NCT02561195|7600196|FG011|NOT COMPLETED|Extension Stage (Vaccination 4)||7
6669335|NCT02561195|7600197|FG012|NOT COMPLETED|Extension Stage (Vaccination 4)||7
6669336|NCT02561195|7600198|FG013|NOT COMPLETED|Extension Stage (Vaccination 4)||5
6669337|NCT02561221|7600232|FG000|STARTED|Overall Study||452
6669338|NCT02561221|7600233|FG001|STARTED|Overall Study||351
6669339|NCT02561221|7600232|FG000|Month 6|Overall Study||386
6669340|NCT02561221|7600233|FG001|Month 6|Overall Study||340
6669341|NCT02561221|7600232|FG000|Month 12|Overall Study||365
6669342|NCT02561221|7600233|FG001|Month 12|Overall Study||326
6669343|NCT02561221|7600232|FG000|Month 18|Overall Study||357
6256087|NCT03583554|7154930|FG002|NOT COMPLETED|Period 1||0
6256088|NCT03583554|7154928|FG000|STARTED|Period 2||4
6669344|NCT02561221|7600233|FG001|Month 18|Overall Study||316
6669345|NCT02561221|7600232|FG000|COMPLETED|Overall Study||362
6669346|NCT02561221|7600233|FG001|COMPLETED|Overall Study||308
6669347|NCT02561221|7600232|FG000|NOT COMPLETED|Overall Study||90
6669348|NCT02561221|7600233|FG001|NOT COMPLETED|Overall Study||43
6669349|NCT02561247|7600239|FG000|STARTED|Overall Study||23
6669350|NCT02561247|7600239|FG000|COMPLETED|Overall Study||17
6669351|NCT02561247|7600239|FG000|NOT COMPLETED|Overall Study||6
6669352|NCT02561273|7600245|FG000|STARTED|Overall Study||40
6669353|NCT02561273|7600246|FG001|STARTED|Overall Study||4
6669354|NCT02561273|7600245|FG000|COMPLETED|Overall Study||39
6669355|NCT02561273|7600246|FG001|COMPLETED|Overall Study||4
6669356|NCT02561273|7600245|FG000|NOT COMPLETED|Overall Study||1
6669357|NCT02561273|7600246|FG001|NOT COMPLETED|Overall Study||0
6669358|NCT02561338|7600259|FG000|STARTED|Overall Study||53
6669359|NCT02561338|7600260|FG001|STARTED|Overall Study||50
6669360|NCT02561338|7600261|FG002|STARTED|Overall Study||51
6669361|NCT02561338|7600262|FG003|STARTED|Overall Study||51
6669362|NCT02561338|7600263|FG004|STARTED|Overall Study||53
6669363|NCT02561338|7600259|FG000|COMPLETED|Overall Study||45
6669364|NCT02561338|7600260|FG001|COMPLETED|Overall Study||44
6669365|NCT02561338|7600261|FG002|COMPLETED|Overall Study||42
6669366|NCT02561338|7600262|FG003|COMPLETED|Overall Study||46
6669367|NCT02561338|7600263|FG004|COMPLETED|Overall Study||51
6669368|NCT02561338|7600259|FG000|NOT COMPLETED|Overall Study||8
6669369|NCT02561338|7600260|FG001|NOT COMPLETED|Overall Study||6
6669370|NCT02561338|7600261|FG002|NOT COMPLETED|Overall Study||9
6669371|NCT02561338|7600262|FG003|NOT COMPLETED|Overall Study||5
6669372|NCT02561338|7600263|FG004|NOT COMPLETED|Overall Study||2
6669373|NCT02561455|7600281|FG000|STARTED|Overall Study||2
6669374|NCT02561455|7600282|FG001|STARTED|Overall Study||3
6669375|NCT02561455|7600283|FG002|STARTED|Overall Study||3
6669376|NCT02561455|7600284|FG003|STARTED|Overall Study||1
6669377|NCT02561455|7600281|FG000|COMPLETED|Overall Study||0
6669378|NCT02561455|7600282|FG001|COMPLETED|Overall Study||1
6669379|NCT02561455|7600283|FG002|COMPLETED|Overall Study||0
6669380|NCT02561455|7600284|FG003|COMPLETED|Overall Study||0
6669381|NCT02561455|7600281|FG000|NOT COMPLETED|Overall Study||2
6669382|NCT02561455|7600282|FG001|NOT COMPLETED|Overall Study||2
6669383|NCT02561455|7600283|FG002|NOT COMPLETED|Overall Study||3
6669384|NCT02561455|7600284|FG003|NOT COMPLETED|Overall Study||1
6669385|NCT02561481|7600296|FG000|STARTED|Pilot Trial||10
6669386|NCT02561481|7600297|FG001|STARTED|Pilot Trial||0
6669387|NCT02561481|7600296|FG000|COMPLETED|Pilot Trial||10
6669388|NCT02561481|7600297|FG001|COMPLETED|Pilot Trial||0
6669389|NCT02561481|7600296|FG000|NOT COMPLETED|Pilot Trial||0
6669390|NCT02561481|7600297|FG001|NOT COMPLETED|Pilot Trial||0
6669391|NCT02561481|7600296|FG000|STARTED|Main Trial - Double Blind Phase||25
6669392|NCT02561481|7600297|FG001|STARTED|Main Trial - Double Blind Phase||25
6669393|NCT02561481|7600296|FG000|COMPLETED|Main Trial - Double Blind Phase||22
6669394|NCT02561481|7600297|FG001|COMPLETED|Main Trial - Double Blind Phase||23
6669395|NCT02561481|7600296|FG000|NOT COMPLETED|Main Trial - Double Blind Phase||3
6669396|NCT02561481|7600297|FG001|NOT COMPLETED|Main Trial - Double Blind Phase||2
6669397|NCT02561481|7600296|FG000|STARTED|Main Trial - Open Label Phase||45
6669398|NCT02561481|7600297|FG001|STARTED|Main Trial - Open Label Phase||0
6669399|NCT02561481|7600296|FG000|COMPLETED|Main Trial - Open Label Phase||32
6669400|NCT02561481|7600297|FG001|COMPLETED|Main Trial - Open Label Phase||0
6669401|NCT02561481|7600296|FG000|NOT COMPLETED|Main Trial - Open Label Phase||13
6669402|NCT02561481|7600297|FG001|NOT COMPLETED|Main Trial - Open Label Phase||0
6669403|NCT02561572|7600308|FG000|STARTED|Overall Study||64
6669404|NCT02561572|7600309|FG001|STARTED|Overall Study||64
6669405|NCT02561572|7600308|FG000|COMPLETED|Overall Study||62
6669406|NCT02561572|7600309|FG001|COMPLETED|Overall Study||62
6669407|NCT02561572|7600308|FG000|NOT COMPLETED|Overall Study||2
6669408|NCT02561572|7600309|FG001|NOT COMPLETED|Overall Study||2
6669409|NCT02561585|7600317|FG000|STARTED|Overall Study||20
6669410|NCT02561585|7600318|FG001|STARTED|Overall Study||11
6669411|NCT02561585|7600317|FG000|COMPLETED|Overall Study||17
6669412|NCT02561585|7600318|FG001|COMPLETED|Overall Study||6
6669413|NCT02561585|7600317|FG000|NOT COMPLETED|Overall Study||3
6669414|NCT02561585|7600318|FG001|NOT COMPLETED|Overall Study||5
6669415|NCT02561702|7600328|FG000|STARTED|First Intervention||2
6669416|NCT02561702|7600329|FG001|STARTED|First Intervention||2
6669417|NCT02561702|7600328|FG000|COMPLETED|First Intervention||2
6669418|NCT02561702|7600329|FG001|COMPLETED|First Intervention||2
6669419|NCT02561702|7600328|FG000|NOT COMPLETED|First Intervention||0
6669420|NCT02561702|7600329|FG001|NOT COMPLETED|First Intervention||0
6669421|NCT02561702|7600328|FG000|STARTED|Washout||2
6669422|NCT02561702|7600329|FG001|STARTED|Washout||2
6669423|NCT02561702|7600328|FG000|COMPLETED|Washout||2
6669424|NCT02561702|7600329|FG001|COMPLETED|Washout||2
6669425|NCT02561702|7600328|FG000|NOT COMPLETED|Washout||0
6669426|NCT02561702|7600329|FG001|NOT COMPLETED|Washout||0
6669427|NCT02561702|7600328|FG000|STARTED|Second Intervention||2
6669428|NCT02561702|7600329|FG001|STARTED|Second Intervention||2
6669429|NCT02561702|7600328|FG000|COMPLETED|Second Intervention||2
6669430|NCT02561702|7600329|FG001|COMPLETED|Second Intervention||2
6669431|NCT02561702|7600328|FG000|NOT COMPLETED|Second Intervention||0
6669432|NCT02561702|7600329|FG001|NOT COMPLETED|Second Intervention||0
6669433|NCT02561806|7600337|FG000|STARTED|Induction Period||166
6669434|NCT02561806|7600338|FG001|STARTED|Induction Period||136
6669435|NCT02561806|7600337|FG000|Received At Least One Dose of Study Drug|Induction Period||166
6669436|NCT02561806|7600338|FG001|Received At Least One Dose of Study Drug|Induction Period||135
6669437|NCT02561806|7600337|FG000|COMPLETED|Induction Period||164
6669438|NCT02561806|7600338|FG001|COMPLETED|Induction Period||131
6669439|NCT02561806|7600337|FG000|NOT COMPLETED|Induction Period||2
6669440|NCT02561806|7600338|FG001|NOT COMPLETED|Induction Period||5
6669441|NCT02561806|7600337|FG000|STARTED|Maintenance Period||164
6669442|NCT02561806|7600338|FG001|STARTED|Maintenance Period||131
6669443|NCT02561806|7600337|FG000|COMPLETED|Maintenance Period||151
6669444|NCT02561806|7600338|FG001|COMPLETED|Maintenance Period||123
6669445|NCT02561806|7600337|FG000|NOT COMPLETED|Maintenance Period||13
6669446|NCT02561806|7600338|FG001|NOT COMPLETED|Maintenance Period||8
6669447|NCT02561806|7600337|FG000|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|157
6669448|NCT02561806|7600338|FG001|STARTED|Post-Treatment Follow-up|Participants who discontinued previous periods had option to enter post treatment follow-up period.|60
6669449|NCT02561806|7600337|FG000|COMPLETED|Post-Treatment Follow-up||155
6669450|NCT02561806|7600338|FG001|COMPLETED|Post-Treatment Follow-up||59
6669451|NCT02561806|7600337|FG000|NOT COMPLETED|Post-Treatment Follow-up||2
6669452|NCT02561806|7600338|FG001|NOT COMPLETED|Post-Treatment Follow-up||1
6669453|NCT02561832|7600361|FG000|STARTED|Overall Study||8
6669454|NCT02561832|7600362|FG001|STARTED|Overall Study||7
6669455|NCT02561832|7600361|FG000|INFORMED CONSENT OBTAINED|Overall Study||8
6669456|NCT02561832|7600362|FG001|INFORMED CONSENT OBTAINED|Overall Study||7
6669457|NCT02561832|7600361|FG000|COMPLETED|Overall Study||1
6669458|NCT02561832|7600362|FG001|COMPLETED|Overall Study||3
6669459|NCT02561832|7600361|FG000|NOT COMPLETED|Overall Study||7
6669460|NCT02561832|7600362|FG001|NOT COMPLETED|Overall Study||4
6669461|NCT02561897|7600370|FG000|STARTED|Overall Study||2
6669462|NCT02561897|7600371|FG001|STARTED|Overall Study||3
6669463|NCT02561897|7600370|FG000|COMPLETED|Overall Study||2
6669464|NCT02561897|7600371|FG001|COMPLETED|Overall Study||3
6669465|NCT02561897|7600370|FG000|NOT COMPLETED|Overall Study||0
6669466|NCT02561897|7600371|FG001|NOT COMPLETED|Overall Study||0
6669467|NCT02562066|7600381|FG000|STARTED|Overall Study||8
6669468|NCT02562066|7600382|FG001|STARTED|Overall Study||8
6669469|NCT02562066|7600383|FG002|STARTED|Overall Study||4
6669470|NCT02562066|7600381|FG000|COMPLETED|Overall Study||7
6669471|NCT02562066|7600382|FG001|COMPLETED|Overall Study||7
6669472|NCT02562066|7600383|FG002|COMPLETED|Overall Study||0
6669473|NCT02562066|7600381|FG000|NOT COMPLETED|Overall Study||1
6669474|NCT02562066|7600382|FG001|NOT COMPLETED|Overall Study||1
6669475|NCT02562066|7600383|FG002|NOT COMPLETED|Overall Study||4
6669476|NCT02562482|7600391|FG000|STARTED|Overall Study||201
6669477|NCT02562482|7600392|FG001|STARTED|Overall Study||199
6669478|NCT02562482|7600391|FG000|Received 1st Injection|Overall Study||197
6669479|NCT02562482|7600392|FG001|Received 1st Injection|Overall Study||199
6669480|NCT02562482|7600391|FG000|Received 2nd Injection|Overall Study||192
6669481|NCT02562482|7600392|FG001|Received 2nd Injection|Overall Study||192
6669482|NCT02562482|7600391|FG000|COMPLETED|Overall Study||180
6669483|NCT02562482|7600392|FG001|COMPLETED|Overall Study||183
6669484|NCT02562482|7600391|FG000|NOT COMPLETED|Overall Study||21
6669485|NCT02562482|7600392|FG001|NOT COMPLETED|Overall Study||16
6669486|NCT02562521|7600400|FG000|STARTED|Overall Study||18
6669487|NCT02562521|7600401|FG001|STARTED|Overall Study||7
6669488|NCT02562521|7600400|FG000|COMPLETED|Overall Study||18
6669489|NCT02562521|7600401|FG001|COMPLETED|Overall Study||7
6669490|NCT02562521|7600400|FG000|NOT COMPLETED|Overall Study||0
6669491|NCT02562521|7600401|FG001|NOT COMPLETED|Overall Study||0
6669492|NCT02562755|7600409|FG000|STARTED|Overall Study||234
6669493|NCT02562755|7600410|FG001|STARTED|Overall Study||225
6669494|NCT02562755|7600409|FG000|Safety Population|Overall Study||218
6669495|NCT02562755|7600410|FG001|Safety Population|Overall Study||217
6669496|NCT02562755|7600409|FG000|COMPLETED|Overall Study||161
6669497|NCT02562755|7600410|FG001|COMPLETED|Overall Study||153
6669498|NCT02562755|7600409|FG000|NOT COMPLETED|Overall Study||73
6669499|NCT02562755|7600410|FG001|NOT COMPLETED|Overall Study||72
6669500|NCT02562898|7600418|FG000|STARTED|Overall Study||10
6669501|NCT02562898|7600419|FG001|STARTED|Overall Study||8
6669502|NCT02562898|7600418|FG000|COMPLETED|Overall Study||10
6669503|NCT02562898|7600419|FG001|COMPLETED|Overall Study||8
6669504|NCT02562898|7600418|FG000|NOT COMPLETED|Overall Study||0
6669505|NCT02562898|7600419|FG001|NOT COMPLETED|Overall Study||0
6669506|NCT02562924|7600428|FG000|STARTED|Overall Study||13
6669507|NCT02562924|7600429|FG001|STARTED|Overall Study||12
6669508|NCT02562924|7600430|FG002|STARTED|Overall Study||12
6669509|NCT02562924|7600428|FG000|COMPLETED|Overall Study||12
6669510|NCT02562924|7600429|FG001|COMPLETED|Overall Study||1
6669511|NCT02562924|7600430|FG002|COMPLETED|Overall Study||8
6669512|NCT02562924|7600428|FG000|NOT COMPLETED|Overall Study||1
6669513|NCT02562924|7600429|FG001|NOT COMPLETED|Overall Study||11
6669514|NCT02562924|7600430|FG002|NOT COMPLETED|Overall Study||4
6669515|NCT02562989|7600444|FG000|STARTED|Overall Study||3
6669516|NCT02562989|7600445|FG001|STARTED|Overall Study||4
6669517|NCT02562989|7600446|FG002|STARTED|Overall Study||6
6669518|NCT02562989|7600444|FG000|COMPLETED|Overall Study||3
6669519|NCT02562989|7600445|FG001|COMPLETED|Overall Study||4
6669520|NCT02562989|7600446|FG002|COMPLETED|Overall Study||6
6669521|NCT02562989|7600444|FG000|NOT COMPLETED|Overall Study||0
6669522|NCT02562989|7600445|FG001|NOT COMPLETED|Overall Study||0
6669523|NCT02562989|7600446|FG002|NOT COMPLETED|Overall Study||0
6669524|NCT02563028|7600454|FG000|STARTED|Overall Study||20
6669525|NCT02563028|7600454|FG000|COMPLETED|Overall Study||18
6669526|NCT02563028|7600454|FG000|NOT COMPLETED|Overall Study||2
6669527|NCT02563067|7600461|FG000|STARTED|Overall Study||296
6669528|NCT02563067|7600462|FG001|STARTED|Overall Study||294
6669529|NCT02563067|7600463|FG002|STARTED|Overall Study||287
6669530|NCT02563067|7600461|FG000|FAS/SAF: High Eosinophils Subpopulation|Overall Study||198
6669531|NCT02563067|7600462|FG001|FAS/SAF: High Eosinophils Subpopulation|Overall Study||196
6669532|NCT02563067|7600463|FG002|FAS/SAF: High Eosinophils Subpopulation|Overall Study||193
6669533|NCT02563067|7600461|FG000|FAS/SAF: Overall Population|Overall Study||296
6669534|NCT02563067|7600462|FG001|FAS/SAF: Overall Population|Overall Study||293
6669535|NCT02563067|7600463|FG002|FAS/SAF: Overall Population|Overall Study||287
6669536|NCT02563067|7600461|FG000|COMPLETED|Overall Study||277
6669537|NCT02563067|7600462|FG001|COMPLETED|Overall Study||268
6669538|NCT02563067|7600463|FG002|COMPLETED|Overall Study||267
6669539|NCT02563067|7600461|FG000|NOT COMPLETED|Overall Study||19
6669540|NCT02563067|7600462|FG001|NOT COMPLETED|Overall Study||26
6669541|NCT02563067|7600463|FG002|NOT COMPLETED|Overall Study||20
6669542|NCT02563093|7600475|FG000|STARTED|Overall Study||52
6669543|NCT02563093|7600476|FG001|STARTED|Overall Study||52
6669544|NCT02563093|7600477|FG002|STARTED|Overall Study||53
6669545|NCT02563093|7600478|FG003|STARTED|Overall Study||51
6669546|NCT02563093|7600475|FG000|COMPLETED|Overall Study||52
6669547|NCT02563093|7600476|FG001|COMPLETED|Overall Study||52
6669548|NCT02563093|7600477|FG002|COMPLETED|Overall Study||53
6669549|NCT02563093|7600478|FG003|COMPLETED|Overall Study||51
6669550|NCT02563093|7600475|FG000|NOT COMPLETED|Overall Study||0
6669551|NCT02563093|7600476|FG001|NOT COMPLETED|Overall Study||0
6669552|NCT02563093|7600477|FG002|NOT COMPLETED|Overall Study||0
6669553|NCT02563093|7600478|FG003|NOT COMPLETED|Overall Study||0
6669554|NCT02563106|7600491|FG000|STARTED|Overall Study||206
6669555|NCT02563106|7600492|FG001|STARTED|Overall Study||207
6669556|NCT02563106|7600491|FG000|COMPLETED|Overall Study||172
6669557|NCT02563106|7600492|FG001|COMPLETED|Overall Study||178
6669558|NCT02563106|7600491|FG000|NOT COMPLETED|Overall Study||34
6669559|NCT02563106|7600492|FG001|NOT COMPLETED|Overall Study||29
6669560|NCT02563496|7600503|FG000|STARTED|Overall Study|No participants were enrolled since they didn't meet inclusion/exclusion criteria.|0
6669561|NCT02563496|7600504|FG001|STARTED|Overall Study||14
6669562|NCT02563496|7600505|FG002|STARTED|Overall Study||5
6669563|NCT02563496|7600506|FG003|STARTED|Overall Study||22
6669564|NCT02563496|7600507|FG004|STARTED|Overall Study||19
6669565|NCT02563496|7600503|FG000|COMPLETED|Overall Study||0
6669566|NCT02563496|7600504|FG001|COMPLETED|Overall Study||14
6669567|NCT02563496|7600505|FG002|COMPLETED|Overall Study||5
6669568|NCT02563496|7600506|FG003|COMPLETED|Overall Study||22
6669569|NCT02563496|7600507|FG004|COMPLETED|Overall Study||19
6669570|NCT02563496|7600503|FG000|NOT COMPLETED|Overall Study||0
6669571|NCT02563496|7600504|FG001|NOT COMPLETED|Overall Study||0
6669572|NCT02563496|7600505|FG002|NOT COMPLETED|Overall Study||0
6669573|NCT02563496|7600506|FG003|NOT COMPLETED|Overall Study||0
6669574|NCT02563496|7600507|FG004|NOT COMPLETED|Overall Study||0
6669575|NCT02563548|7600521|FG000|STARTED|Dose Escalation (Up to 46 Weeks)||3
6669576|NCT02563548|7600522|FG001|STARTED|Dose Escalation (Up to 46 Weeks)||2
6669577|NCT02563548|7600523|FG002|STARTED|Dose Escalation (Up to 46 Weeks)||7
6669578|NCT02563548|7600524|FG003|STARTED|Dose Escalation (Up to 46 Weeks)||2
6669579|NCT02563548|7600525|FG004|STARTED|Dose Escalation (Up to 46 Weeks)||0
6669580|NCT02563548|7600526|FG005|STARTED|Dose Escalation (Up to 46 Weeks)||0
6669581|NCT02563548|7600521|FG000|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||3
6669582|NCT02563548|7600522|FG001|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
6669583|NCT02563548|7600523|FG002|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||7
6669584|NCT02563548|7600524|FG003|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||2
6669585|NCT02563548|7600525|FG004|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
6669586|NCT02563548|7600526|FG005|Received at Least 1 Dose of Study Drug|Dose Escalation (Up to 46 Weeks)||0
6669587|NCT02563548|7600521|FG000|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6669588|NCT02563548|7600522|FG001|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6669589|NCT02563548|7600523|FG002|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6669590|NCT02563548|7600524|FG003|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6669591|NCT02563548|7600525|FG004|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6669592|NCT02563548|7600526|FG005|COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6669593|NCT02563548|7600521|FG000|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||3
6669594|NCT02563548|7600522|FG001|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
6669595|NCT02563548|7600523|FG002|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||7
6669596|NCT02563548|7600524|FG003|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||2
6669597|NCT02563548|7600525|FG004|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6669598|NCT02563548|7600526|FG005|NOT COMPLETED|Dose Escalation (Up to 46 Weeks)||0
6669599|NCT02563548|7600521|FG000|STARTED|Dose Expansion (Up to 60 Weeks)||0
6669600|NCT02563548|7600522|FG001|STARTED|Dose Expansion (Up to 60 Weeks)||0
6669601|NCT02563548|7600523|FG002|STARTED|Dose Expansion (Up to 60 Weeks)||0
6669602|NCT02563548|7600524|FG003|STARTED|Dose Expansion (Up to 60 Weeks)||0
6669603|NCT02563548|7600525|FG004|STARTED|Dose Expansion (Up to 60 Weeks)||25
6669604|NCT02563548|7600526|FG005|STARTED|Dose Expansion (Up to 60 Weeks)||17
6669605|NCT02563548|7600521|FG000|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
6669606|NCT02563548|7600522|FG001|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
6669607|NCT02563548|7600523|FG002|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
6669608|NCT02563548|7600524|FG003|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||0
6669609|NCT02563548|7600525|FG004|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||24
6669610|NCT02563548|7600526|FG005|Received at Least 1 Dose of Study Drug|Dose Expansion (Up to 60 Weeks)||17
6669611|NCT02563548|7600521|FG000|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669612|NCT02563548|7600522|FG001|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669613|NCT02563548|7600523|FG002|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669614|NCT02563548|7600524|FG003|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669615|NCT02563548|7600525|FG004|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669616|NCT02563548|7600526|FG005|COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669617|NCT02563548|7600521|FG000|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669618|NCT02563548|7600522|FG001|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669619|NCT02563548|7600523|FG002|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669620|NCT02563548|7600524|FG003|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||0
6669621|NCT02563548|7600525|FG004|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||25
6669622|NCT02563548|7600526|FG005|NOT COMPLETED|Dose Expansion (Up to 60 Weeks)||17
6669623|NCT02563561|7600549|FG000|STARTED|Overall Study||19
6669624|NCT02563561|7600550|FG001|STARTED|Overall Study||23
6669625|NCT02563561|7600551|FG002|STARTED|Overall Study||20
6669626|NCT02563561|7600549|FG000|Safety Population|Overall Study||19
6669627|NCT02563561|7600550|FG001|Safety Population|Overall Study||21
6669628|NCT02563561|7600551|FG002|Safety Population|Overall Study||17
6669629|NCT02563561|7600549|FG000|COMPLETED|Overall Study||1
6669630|NCT02563561|7600550|FG001|COMPLETED|Overall Study||2
6669631|NCT02563561|7600551|FG002|COMPLETED|Overall Study||3
6669632|NCT02563561|7600549|FG000|NOT COMPLETED|Overall Study||18
6669633|NCT02563561|7600550|FG001|NOT COMPLETED|Overall Study||21
6669634|NCT02563561|7600551|FG002|NOT COMPLETED|Overall Study||17
6669635|NCT02563808|7600561|FG000|STARTED|Overall Study||96
6669636|NCT02563808|7600562|FG001|STARTED|Overall Study|A total of 5 participants enrolled were not included in final data due to data collection error|88
6669637|NCT02563808|7600561|FG000|COMPLETED|Overall Study||96
6669638|NCT02563808|7600562|FG001|COMPLETED|Overall Study||88
6669639|NCT02563808|7600561|FG000|NOT COMPLETED|Overall Study||0
6669640|NCT02563808|7600562|FG001|NOT COMPLETED|Overall Study||0
6669641|NCT02563834|7600570|FG000|STARTED|Control (Saline) Infusion (*Day 1)||10
6669642|NCT02563834|7600571|FG001|STARTED|Control (Saline) Infusion (*Day 1)||8
6669643|NCT02563834|7600570|FG000|COMPLETED|Control (Saline) Infusion (*Day 1)||10
6669644|NCT02563834|7600571|FG001|COMPLETED|Control (Saline) Infusion (*Day 1)||8
6669645|NCT02563834|7600570|FG000|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
6669646|NCT02563834|7600571|FG001|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
6669647|NCT02563834|7600570|FG000|STARTED|Insulin Infusion (*Day 2)||10
6669648|NCT02563834|7600571|FG001|STARTED|Insulin Infusion (*Day 2)||8
6669649|NCT02563834|7600570|FG000|COMPLETED|Insulin Infusion (*Day 2)||10
6669650|NCT02563834|7600571|FG001|COMPLETED|Insulin Infusion (*Day 2)||8
6669651|NCT02563834|7600570|FG000|NOT COMPLETED|Insulin Infusion (*Day 2)||0
6669652|NCT02563834|7600571|FG001|NOT COMPLETED|Insulin Infusion (*Day 2)||0
6669653|NCT02563860|7600579|FG000|STARTED|Overall Study||20
6669654|NCT02563860|7600579|FG000|COMPLETED|Overall Study||19
6669655|NCT02563860|7600579|FG000|NOT COMPLETED|Overall Study||1
6669656|NCT02563899|7600587|FG000|STARTED|Overall Study||18
6669657|NCT02563899|7600588|FG001|STARTED|Overall Study||5
6669658|NCT02563899|7600589|FG002|STARTED|Overall Study||10
6669659|NCT02563899|7600590|FG003|STARTED|Overall Study||6
6669660|NCT02563899|7600587|FG000|COMPLETED|Overall Study||17
6669661|NCT02563899|7600588|FG001|COMPLETED|Overall Study||5
6669662|NCT02563899|7600589|FG002|COMPLETED|Overall Study||9
6669663|NCT02563899|7600590|FG003|COMPLETED|Overall Study||6
6669664|NCT02563899|7600587|FG000|NOT COMPLETED|Overall Study||1
6669665|NCT02563899|7600588|FG001|NOT COMPLETED|Overall Study||0
6669666|NCT02563899|7600589|FG002|NOT COMPLETED|Overall Study||1
6669667|NCT02563899|7600590|FG003|NOT COMPLETED|Overall Study||0
6669668|NCT02563990|7600603|FG000|STARTED|Overall Study||12
6669669|NCT02563990|7600604|FG001|STARTED|Overall Study||14
6669670|NCT02563990|7600603|FG000|COMPLETED|Overall Study||12
6669671|NCT02563990|7600604|FG001|COMPLETED|Overall Study||14
6669672|NCT02563990|7600603|FG000|NOT COMPLETED|Overall Study||0
6669673|NCT02563990|7600604|FG001|NOT COMPLETED|Overall Study||0
6669674|NCT02564016|7600614|FG000|STARTED|Overall Study||22
6669675|NCT02564016|7600615|FG001|STARTED|Overall Study||14
6669676|NCT02564016|7600614|FG000|COMPLETED|Overall Study||4
6669677|NCT02564016|7600615|FG001|COMPLETED|Overall Study||4
6669678|NCT02564016|7600614|FG000|NOT COMPLETED|Overall Study||18
6669679|NCT02564016|7600615|FG001|NOT COMPLETED|Overall Study||10
6669680|NCT02564029|7600621|FG000|STARTED|Overall Study||7
6669681|NCT02564029|7600621|FG000|COMPLETED|Overall Study||7
6669682|NCT02564029|7600621|FG000|NOT COMPLETED|Overall Study||0
6669683|NCT02564042|7600638|FG000|STARTED|Overall Study||38
6669684|NCT02564042|7600639|FG001|STARTED|Overall Study||38
6669685|NCT02564042|7600640|FG002|STARTED|Overall Study||38
6669686|NCT02564042|7600641|FG003|STARTED|Overall Study||38
6669687|NCT02564042|7600642|FG004|STARTED|Overall Study||37
6669688|NCT02564042|7600643|FG005|STARTED|Overall Study||38
6669689|NCT02564042|7600638|FG000|COMPLETED|Overall Study||27
6669690|NCT02564042|7600639|FG001|COMPLETED|Overall Study||30
6669691|NCT02564042|7600640|FG002|COMPLETED|Overall Study||32
6669692|NCT02564042|7600641|FG003|COMPLETED|Overall Study||35
6669693|NCT02564042|7600642|FG004|COMPLETED|Overall Study||26
6669694|NCT02564042|7600643|FG005|COMPLETED|Overall Study||24
6669695|NCT02564042|7600638|FG000|NOT COMPLETED|Overall Study||11
6669696|NCT02564042|7600639|FG001|NOT COMPLETED|Overall Study||8
6669697|NCT02564042|7600640|FG002|NOT COMPLETED|Overall Study||6
6669698|NCT02564042|7600641|FG003|NOT COMPLETED|Overall Study||3
6669699|NCT02564042|7600642|FG004|NOT COMPLETED|Overall Study||11
6669700|NCT02564042|7600643|FG005|NOT COMPLETED|Overall Study||14
6669701|NCT02564055|7600663|FG000|STARTED|Overall Study||40
6669702|NCT02564055|7600664|FG001|STARTED|Overall Study||41
6669703|NCT02564055|7600665|FG002|STARTED|Overall Study||43
6669704|NCT02564055|7600666|FG003|STARTED|Overall Study||41
6669705|NCT02564055|7600667|FG004|STARTED|Overall Study||42
6669706|NCT02564055|7600668|FG005|STARTED|Overall Study||40
6669707|NCT02564055|7600663|FG000|COMPLETED|Overall Study||34
6669708|NCT02564055|7600664|FG001|COMPLETED|Overall Study||36
6669709|NCT02564055|7600665|FG002|COMPLETED|Overall Study||31
6669710|NCT02564055|7600666|FG003|COMPLETED|Overall Study||35
6669711|NCT02564055|7600667|FG004|COMPLETED|Overall Study||27
6669712|NCT02564055|7600668|FG005|COMPLETED|Overall Study||28
6669713|NCT02564055|7600663|FG000|NOT COMPLETED|Overall Study||6
6669714|NCT02564055|7600664|FG001|NOT COMPLETED|Overall Study||5
6669715|NCT02564055|7600665|FG002|NOT COMPLETED|Overall Study||12
6669716|NCT02564055|7600666|FG003|NOT COMPLETED|Overall Study||6
6669717|NCT02564055|7600667|FG004|NOT COMPLETED|Overall Study||15
6669718|NCT02564055|7600668|FG005|NOT COMPLETED|Overall Study||12
6669719|NCT02564120|7600687|FG000|STARTED|Overall Study||1556
6669720|NCT02564120|7600687|FG000|COMPLETED|Overall Study||1110
6669721|NCT02564120|7600687|FG000|NOT COMPLETED|Overall Study||446
6669722|NCT02564198|7600704|FG000|STARTED|Overall Study||8
6669723|NCT02564198|7600705|FG001|STARTED|Overall Study||15
6669724|NCT02564198|7600706|FG002|STARTED|Overall Study||6
6669725|NCT02564198|7600704|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6669726|NCT02564198|7600705|FG001|Received at Least 1 Dose of Study Drug|Overall Study||15
6669727|NCT02564198|7600706|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6669728|NCT02564198|7600704|FG000|COMPLETED|Overall Study||6
6669729|NCT02564198|7600705|FG001|COMPLETED|Overall Study||10
6669730|NCT02564198|7600706|FG002|COMPLETED|Overall Study||6
6669731|NCT02564198|7600704|FG000|NOT COMPLETED|Overall Study||2
6669732|NCT02564198|7600705|FG001|NOT COMPLETED|Overall Study||5
6669733|NCT02564198|7600706|FG002|NOT COMPLETED|Overall Study||0
6669734|NCT02564211|7600716|FG000|STARTED|Overall Study||77
6669735|NCT02564211|7600716|FG000|COMPLETED|Overall Study||73
6669736|NCT02564211|7600716|FG000|NOT COMPLETED|Overall Study||4
6669737|NCT02564354|7600722|FG000|STARTED|Overall Study||10
6669738|NCT02564354|7600723|FG001|STARTED|Overall Study||8
6669739|NCT02564354|7600722|FG000|COMPLETED|Overall Study||10
6669740|NCT02564354|7600723|FG001|COMPLETED|Overall Study||8
6669741|NCT02564354|7600722|FG000|NOT COMPLETED|Overall Study||0
6669742|NCT02564354|7600723|FG001|NOT COMPLETED|Overall Study||0
6669743|NCT02564432|7600729|FG000|STARTED|Overall Study||10
6737967|NCT03274453|7667202|FG001|STARTED|Overall Study||30
6669744|NCT02564432|7600729|FG000|COMPLETED|Overall Study|1 patient suffered periprosthetic fracture at 8 months; 1 failed to osseointegrate|8
6669745|NCT02564432|7600729|FG000|NOT COMPLETED|Overall Study||2
6669746|NCT02564471|7600739|FG000|STARTED|Overall Study||25
6669747|NCT02564471|7600740|FG001|STARTED|Overall Study||26
6669748|NCT02564471|7600741|FG002|STARTED|Overall Study||27
6669749|NCT02564471|7600742|FG003|STARTED|Overall Study||25
6669750|NCT02564471|7600739|FG000|COMPLETED|Overall Study||22
6669751|NCT02564471|7600740|FG001|COMPLETED|Overall Study||23
6669752|NCT02564471|7600741|FG002|COMPLETED|Overall Study||24
6669753|NCT02564471|7600742|FG003|COMPLETED|Overall Study||25
6669754|NCT02564471|7600739|FG000|NOT COMPLETED|Overall Study||3
6669755|NCT02564471|7600740|FG001|NOT COMPLETED|Overall Study||3
6669756|NCT02564471|7600741|FG002|NOT COMPLETED|Overall Study||3
6669757|NCT02564471|7600742|FG003|NOT COMPLETED|Overall Study||0
6669758|NCT02564497|7600754|FG000|STARTED|Overall Study||74
6669759|NCT02564497|7600755|FG001|STARTED|Overall Study||72
6669760|NCT02564497|7600754|FG000|COMPLETED|Overall Study||74
6669761|NCT02564497|7600755|FG001|COMPLETED|Overall Study||72
6669762|NCT02564497|7600754|FG000|NOT COMPLETED|Overall Study||0
6669763|NCT02564497|7600755|FG001|NOT COMPLETED|Overall Study||0
6669764|NCT02564718|7600763|FG000|STARTED|Overall Study||5
6669765|NCT02564718|7600764|FG001|STARTED|Overall Study||5
6669766|NCT02564718|7600763|FG000|COMPLETED|Overall Study||5
6669767|NCT02564718|7600764|FG001|COMPLETED|Overall Study||4
6669768|NCT02564718|7600763|FG000|NOT COMPLETED|Overall Study||0
6669769|NCT02564718|7600764|FG001|NOT COMPLETED|Overall Study||1
6669770|NCT02564887|7600772|FG000|STARTED|Overall Study||16
6669771|NCT02564887|7600773|FG001|STARTED|Overall Study||10
6669772|NCT02564887|7600772|FG000|COMPLETED|Overall Study||10
6669773|NCT02564887|7600773|FG001|COMPLETED|Overall Study||10
6669774|NCT02564887|7600772|FG000|NOT COMPLETED|Overall Study||6
6669775|NCT02564887|7600773|FG001|NOT COMPLETED|Overall Study||0
6669776|NCT02564926|7600783|FG000|STARTED|Overall Study||60
6669777|NCT02564926|7600784|FG001|STARTED|Overall Study||61
6669778|NCT02564926|7600783|FG000|COMPLETED|Overall Study||52
6669779|NCT02564926|7600784|FG001|COMPLETED|Overall Study||54
6669780|NCT02564926|7600783|FG000|NOT COMPLETED|Overall Study||8
6669781|NCT02564926|7600784|FG001|NOT COMPLETED|Overall Study||7
6669782|NCT02564952|7600790|FG000|STARTED|Overall Study||18
6669783|NCT02564952|7600790|FG000|Received at Least 1 Dose of Study Drug|Overall Study||18
6669784|NCT02564952|7600790|FG000|Completed OLE Titration Period|Overall Study||16
6669785|NCT02564952|7600790|FG000|COMPLETED|Overall Study||7
6669786|NCT02564952|7600790|FG000|NOT COMPLETED|Overall Study||11
6669787|NCT02565108|7600796|FG000|STARTED|Overall Study||16
6669788|NCT02565108|7600797|FG001|STARTED|Overall Study||4
6669789|NCT02565108|7600796|FG000|Safety Set|Overall Study||16
6669790|NCT02565108|7600797|FG001|Safety Set|Overall Study||4
6669791|NCT02565108|7600796|FG000|Pharmacokinetic (PK) Set|Overall Study||10
6669792|NCT02565108|7600797|FG001|Pharmacokinetic (PK) Set|Overall Study||3
6669793|NCT02565108|7600796|FG000|COMPLETED|Overall Study||14
6669794|NCT02565108|7600797|FG001|COMPLETED|Overall Study||4
6669795|NCT02565108|7600796|FG000|NOT COMPLETED|Overall Study||2
6669796|NCT02565108|7600797|FG001|NOT COMPLETED|Overall Study||0
6669797|NCT02565147|7600805|FG000|STARTED|Overall Study||38
6669798|NCT02565147|7600806|FG001|STARTED|Overall Study||40
6669799|NCT02565147|7600805|FG000|Received Study Drug|Overall Study||38
6669800|NCT02565147|7600806|FG001|Received Study Drug|Overall Study||40
6669801|NCT02565147|7600805|FG000|Per-Protocol Population|Overall Study||28
6669802|NCT02565147|7600806|FG001|Per-Protocol Population|Overall Study||36
6669803|NCT02565147|7600805|FG000|COMPLETED|Overall Study||32
6669804|NCT02565147|7600806|FG001|COMPLETED|Overall Study||37
6669805|NCT02565147|7600805|FG000|NOT COMPLETED|Overall Study||6
6669806|NCT02565147|7600806|FG001|NOT COMPLETED|Overall Study||3
6669807|NCT02565186|7600814|FG000|STARTED|Overall Study||1046
6669808|NCT02565186|7600815|FG001|STARTED|Overall Study||1125
6669809|NCT02565186|7600814|FG000|Received at Least One Dose of Study Drug|Overall Study||991
6669810|NCT02565186|7600815|FG001|Received at Least One Dose of Study Drug|Overall Study||1039
6669811|NCT02565186|7600814|FG000|COMPLETED|Overall Study||466
6669812|NCT02565186|7600815|FG001|COMPLETED|Overall Study||504
6669813|NCT02565186|7600814|FG000|NOT COMPLETED|Overall Study||580
6669814|NCT02565186|7600815|FG001|NOT COMPLETED|Overall Study||621
6669815|NCT02565381|7600824|FG000|STARTED|Overall Study||25
6669816|NCT02565381|7600825|FG001|STARTED|Overall Study||25
6669817|NCT02565381|7600826|FG002|STARTED|Overall Study||25
6669818|NCT02565381|7600824|FG000|COMPLETED|Overall Study||24
6669819|NCT02565381|7600825|FG001|COMPLETED|Overall Study||25
6669820|NCT02565381|7600826|FG002|COMPLETED|Overall Study||24
6669821|NCT02565381|7600824|FG000|NOT COMPLETED|Overall Study||1
6669822|NCT02565381|7600825|FG001|NOT COMPLETED|Overall Study||0
6256089|NCT03583554|7154929|FG001|STARTED|Period 2||4
6256090|NCT03583554|7154930|FG002|STARTED|Period 2||4
6669823|NCT02565381|7600826|FG002|NOT COMPLETED|Overall Study||1
6669824|NCT02565485|7600836|FG000|STARTED|Overall Study||139
6669825|NCT02565485|7600837|FG001|STARTED|Overall Study||137
6669826|NCT02565485|7600836|FG000|COMPLETED|Overall Study||139
6669827|NCT02565485|7600837|FG001|COMPLETED|Overall Study||137
6669828|NCT02565485|7600836|FG000|NOT COMPLETED|Overall Study||0
6669829|NCT02565485|7600837|FG001|NOT COMPLETED|Overall Study||0
6669830|NCT02565511|7600847|FG000|STARTED|Overall Study||42
6669831|NCT02565511|7600848|FG001|STARTED|Overall Study||23
6256091|NCT03583554|7154928|FG000|COMPLETED|Period 2||3
6256092|NCT03583554|7154929|FG001|COMPLETED|Period 2||4
6256093|NCT03583554|7154930|FG002|COMPLETED|Period 2||3
6256094|NCT03583554|7154928|FG000|NOT COMPLETED|Period 2||1
6256095|NCT03583554|7154929|FG001|NOT COMPLETED|Period 2||0
6256096|NCT03583554|7154930|FG002|NOT COMPLETED|Period 2||1
6256097|NCT03583554|7154928|FG000|STARTED|Period 3||3
6256098|NCT03583554|7154929|FG001|STARTED|Period 3||4
6256099|NCT03583554|7154930|FG002|STARTED|Period 3||3
6669832|NCT02565511|7600849|FG002|STARTED|Overall Study||251
6669833|NCT02565511|7600850|FG003|STARTED|Overall Study||164
6669834|NCT02565511|7600847|FG000|3 Patients Were Mis-randomized|Overall Study||0
6669835|NCT02565511|7600848|FG001|3 Patients Were Mis-randomized|Overall Study||0
6669836|NCT02565511|7600849|FG002|3 Patients Were Mis-randomized|Overall Study||2
6669837|NCT02565511|7600850|FG003|3 Patients Were Mis-randomized|Overall Study||1
6669838|NCT02565511|7600847|FG000|COMPLETED|Overall Study||0
6669839|NCT02565511|7600848|FG001|COMPLETED|Overall Study||0
6669840|NCT02565511|7600849|FG002|COMPLETED|Overall Study||0
6669841|NCT02565511|7600850|FG003|COMPLETED|Overall Study||0
6669842|NCT02565511|7600847|FG000|NOT COMPLETED|Overall Study||42
6669843|NCT02565511|7600848|FG001|NOT COMPLETED|Overall Study||23
6669844|NCT02565511|7600849|FG002|NOT COMPLETED|Overall Study||251
6669845|NCT02565511|7600850|FG003|NOT COMPLETED|Overall Study||164
6669846|NCT02565576|7600862|FG000|STARTED|Overall Study||22
6669847|NCT02565576|7600863|FG001|STARTED|Overall Study||22
6669848|NCT02565576|7600862|FG000|COMPLETED|Overall Study||17
6669849|NCT02565576|7600863|FG001|COMPLETED|Overall Study||17
6669850|NCT02565576|7600862|FG000|NOT COMPLETED|Overall Study||5
6669851|NCT02565576|7600863|FG001|NOT COMPLETED|Overall Study||5
6669852|NCT02565615|7600874|FG000|STARTED|Overall Study||291
6669853|NCT02565615|7600875|FG001|STARTED|Overall Study||3080
6669854|NCT02565615|7600876|FG002|STARTED|Overall Study||21
6669855|NCT02565615|7600877|FG003|STARTED|Overall Study||101
6669856|NCT02565615|7600878|FG004|STARTED|Overall Study||1622
6669857|NCT02565615|7600874|FG000|Treated|Overall Study||291
6669858|NCT02565615|7600875|FG001|Treated|Overall Study||3080
6669859|NCT02565615|7600876|FG002|Treated|Overall Study||21
6669860|NCT02565615|7600877|FG003|Treated|Overall Study||101
6669861|NCT02565615|7600878|FG004|Treated|Overall Study||1055
6669862|NCT02565615|7600874|FG000|COMPLETED|Overall Study||288
6669863|NCT02565615|7600875|FG001|COMPLETED|Overall Study||3044
6669864|NCT02565615|7600876|FG002|COMPLETED|Overall Study||21
6669865|NCT02565615|7600877|FG003|COMPLETED|Overall Study||98
6669866|NCT02565615|7600878|FG004|COMPLETED|Overall Study||21
6669867|NCT02565615|7600874|FG000|NOT COMPLETED|Overall Study||3
6669868|NCT02565615|7600875|FG001|NOT COMPLETED|Overall Study||36
6669869|NCT02565615|7600876|FG002|NOT COMPLETED|Overall Study||0
6669870|NCT02565615|7600877|FG003|NOT COMPLETED|Overall Study||3
6669871|NCT02565615|7600878|FG004|NOT COMPLETED|Overall Study||1601
6669872|NCT02565628|7600892|FG000|STARTED|Overall Study||10
6669873|NCT02565628|7600893|FG001|STARTED|Overall Study||9
6669874|NCT02565628|7600892|FG000|Received Treatment|Overall Study||10
6669875|NCT02565628|7600893|FG001|Received Treatment|Overall Study||9
6669876|NCT02565628|7600892|FG000|COMPLETED|Overall Study||10
6669877|NCT02565628|7600893|FG001|COMPLETED|Overall Study||9
6669878|NCT02565628|7600892|FG000|NOT COMPLETED|Overall Study||0
6669879|NCT02565628|7600893|FG001|NOT COMPLETED|Overall Study||0
6669880|NCT02565706|7600903|FG000|STARTED|Overall Study||178
6669881|NCT02565706|7600904|FG001|STARTED|Overall Study||172
6669882|NCT02565706|7600905|FG002|STARTED|Overall Study||193
6669883|NCT02565706|7600906|FG003|STARTED|Overall Study||201
6669884|NCT02565706|7600903|FG000|COMPLETED|Overall Study||101
6669885|NCT02565706|7600904|FG001|COMPLETED|Overall Study||90
6669886|NCT02565706|7600905|FG002|COMPLETED|Overall Study||104
6669887|NCT02565706|7600906|FG003|COMPLETED|Overall Study||116
6669888|NCT02565706|7600903|FG000|NOT COMPLETED|Overall Study||77
6669889|NCT02565706|7600904|FG001|NOT COMPLETED|Overall Study||82
6669890|NCT02565706|7600905|FG002|NOT COMPLETED|Overall Study||89
6669891|NCT02565706|7600906|FG003|NOT COMPLETED|Overall Study||85
6669892|NCT02565784|7600921|FG000|STARTED|First Treatment||100
6669893|NCT02565784|7600921|FG000|6 Months Follow-up|First Treatment||99
6669894|NCT02565784|7600921|FG000|12 Months Follow-up|First Treatment||98
6669895|NCT02565784|7600921|FG000|COMPLETED|First Treatment||98
6669896|NCT02565784|7600921|FG000|NOT COMPLETED|First Treatment||2
6669897|NCT02565784|7600921|FG000|STARTED|Second Treatment||98
6669898|NCT02565784|7600921|FG000|6 Months Follow-up|Second Treatment||97
6669899|NCT02565784|7600921|FG000|12 Months Follow-up|Second Treatment||96
6669900|NCT02565784|7600921|FG000|COMPLETED|Second Treatment||96
6669901|NCT02565784|7600921|FG000|NOT COMPLETED|Second Treatment||2
6669902|NCT02565810|7600929|FG000|STARTED|Overall Study||49
6669903|NCT02565810|7600929|FG000|COMPLETED|Overall Study||48
6669904|NCT02565810|7600929|FG000|NOT COMPLETED|Overall Study||1
6669905|NCT02565901|7600941|FG000|STARTED|Overall Study||11
6669906|NCT02565901|7600942|FG001|STARTED|Overall Study||11
6669907|NCT02565901|7600943|FG002|STARTED|Overall Study||6
6256100|NCT03583554|7154928|FG000|COMPLETED|Period 3||3
6256101|NCT03583554|7154929|FG001|COMPLETED|Period 3||4
6669908|NCT02565901|7600941|FG000|COMPLETED|Overall Study||11
6669909|NCT02565901|7600942|FG001|COMPLETED|Overall Study||11
6669910|NCT02565901|7600943|FG002|COMPLETED|Overall Study||6
6669911|NCT02565901|7600941|FG000|NOT COMPLETED|Overall Study||0
6669912|NCT02565901|7600942|FG001|NOT COMPLETED|Overall Study||0
6669913|NCT02565901|7600943|FG002|NOT COMPLETED|Overall Study||0
6669914|NCT02565914|7600952|FG000|STARTED|Overall Study||1044
6669915|NCT02565914|7600952|FG000|Safety Set|Overall Study||1042
6669916|NCT02565914|7600952|FG000|COMPLETED|Overall Study||951
6669917|NCT02565914|7600952|FG000|NOT COMPLETED|Overall Study||93
6669918|NCT02566005|7600966|FG000|STARTED|Overall Study||100
6669919|NCT02566005|7600967|FG001|STARTED|Overall Study||100
6669920|NCT02566005|7600966|FG000|COMPLETED|Overall Study||92
6669921|NCT02566005|7600967|FG001|COMPLETED|Overall Study||94
6669922|NCT02566005|7600966|FG000|NOT COMPLETED|Overall Study||8
6669923|NCT02566005|7600967|FG001|NOT COMPLETED|Overall Study||6
6669924|NCT02566031|7600975|FG000|STARTED|Overall Study||189
6669925|NCT02566031|7600976|FG001|STARTED|Overall Study||190
6669926|NCT02566031|7600975|FG000|COMPLETED|Overall Study||169
6669927|NCT02566031|7600976|FG001|COMPLETED|Overall Study||178
6669928|NCT02566031|7600975|FG000|NOT COMPLETED|Overall Study||20
6669929|NCT02566031|7600976|FG001|NOT COMPLETED|Overall Study||12
6669930|NCT02566044|7600986|FG000|STARTED|Overall Study||6
6669931|NCT02566044|7600987|FG001|STARTED|Overall Study||6
6669932|NCT02566044|7600988|FG002|STARTED|Overall Study||4
6669933|NCT02566044|7600986|FG000|COMPLETED|Overall Study||6
6669934|NCT02566044|7600987|FG001|COMPLETED|Overall Study||6
6669935|NCT02566044|7600988|FG002|COMPLETED|Overall Study||4
6669936|NCT02566044|7600986|FG000|NOT COMPLETED|Overall Study||0
6669937|NCT02566044|7600987|FG001|NOT COMPLETED|Overall Study||0
6669938|NCT02566044|7600988|FG002|NOT COMPLETED|Overall Study||0
6669939|NCT02566083|7601003|FG000|STARTED|Overall Study||214
6669940|NCT02566083|7601004|FG001|STARTED|Overall Study||151
6669941|NCT02566083|7601003|FG000|COMPLETED|Overall Study||198
6669942|NCT02566083|7601004|FG001|COMPLETED|Overall Study||141
6669943|NCT02566083|7601003|FG000|NOT COMPLETED|Overall Study||16
6669944|NCT02566083|7601004|FG001|NOT COMPLETED|Overall Study||10
6669945|NCT02566109|7601010|FG000|STARTED|Overall Study||6
6669946|NCT02566109|7601010|FG000|COMPLETED|Overall Study||5
6669947|NCT02566109|7601010|FG000|NOT COMPLETED|Overall Study||1
6669948|NCT02566135|7601016|FG000|STARTED|Overall Study||29
6669949|NCT02566135|7601017|FG001|STARTED|Overall Study||29
6669950|NCT02566135|7601016|FG000|COMPLETED|Overall Study||29
6669951|NCT02566135|7601017|FG001|COMPLETED|Overall Study||29
6669952|NCT02566135|7601016|FG000|NOT COMPLETED|Overall Study||0
6669953|NCT02566135|7601017|FG001|NOT COMPLETED|Overall Study||0
6669954|NCT02566239|7601025|FG000|STARTED|Overall Study||43
6669955|NCT02566239|7601026|FG001|STARTED|Overall Study||48
6669956|NCT02566239|7601025|FG000|COMPLETED|Overall Study||39
6669957|NCT02566239|7601026|FG001|COMPLETED|Overall Study||44
6256102|NCT03583554|7154930|FG002|COMPLETED|Period 3||3
6256103|NCT03583554|7154928|FG000|NOT COMPLETED|Period 3||0
6256104|NCT03583554|7154929|FG001|NOT COMPLETED|Period 3||0
6256105|NCT03583554|7154930|FG002|NOT COMPLETED|Period 3||0
6669958|NCT02566239|7601025|FG000|NOT COMPLETED|Overall Study||4
6669959|NCT02566239|7601026|FG001|NOT COMPLETED|Overall Study||4
6737968|NCT03274453|7667203|FG002|STARTED|Overall Study||32
6737969|NCT03274453|7667204|FG003|STARTED|Overall Study||29
6737970|NCT03274453|7667201|FG000|COMPLETED|Overall Study||34
6737971|NCT03274453|7667202|FG001|COMPLETED|Overall Study||24
6737972|NCT03274453|7667203|FG002|COMPLETED|Overall Study||28
6737973|NCT03274453|7667204|FG003|COMPLETED|Overall Study||25
6737974|NCT03274453|7667201|FG000|NOT COMPLETED|Overall Study||4
6737975|NCT03274453|7667202|FG001|NOT COMPLETED|Overall Study||6
6737976|NCT03274453|7667203|FG002|NOT COMPLETED|Overall Study||4
6737977|NCT03274453|7667204|FG003|NOT COMPLETED|Overall Study||4
6737978|NCT03274466|7667216|FG000|STARTED|Overall Study||147
6737979|NCT03274466|7667217|FG001|STARTED|Overall Study||147
6737980|NCT03274466|7667216|FG000|COMPLETED|Overall Study||124
6737981|NCT03274466|7667217|FG001|COMPLETED|Overall Study||118
6737982|NCT03274466|7667216|FG000|NOT COMPLETED|Overall Study||23
6737983|NCT03274466|7667217|FG001|NOT COMPLETED|Overall Study||29
6737984|NCT03274518|7667225|FG000|STARTED|First Intervention||8
6737985|NCT03274518|7667226|FG001|STARTED|First Intervention|First intervention: expanded hemodialysis, for 30 days.|8
6737986|NCT03274518|7667225|FG000|COMPLETED|First Intervention||8
6737987|NCT03274518|7667226|FG001|COMPLETED|First Intervention||8
6737988|NCT03274518|7667225|FG000|NOT COMPLETED|First Intervention||0
6737989|NCT03274518|7667226|FG001|NOT COMPLETED|First Intervention||0
6737990|NCT03274518|7667225|FG000|STARTED|Washout Period||8
6737991|NCT03274518|7667226|FG001|STARTED|Washout Period|Patients returned from expanded hemodialysis to conventional hemodialysis for 15 days.|8
6737992|NCT03274518|7667225|FG000|COMPLETED|Washout Period||8
6737993|NCT03274518|7667226|FG001|COMPLETED|Washout Period||8
6737994|NCT03274518|7667225|FG000|NOT COMPLETED|Washout Period||0
6737995|NCT03274518|7667226|FG001|NOT COMPLETED|Washout Period||0
6737996|NCT03274518|7667225|FG000|STARTED|Second Intervention||8
6737997|NCT03274518|7667226|FG001|STARTED|Second Intervention|Second intervention: patients from this group underwent online hemodiafiltration for 30 days.|8
6737998|NCT03274518|7667225|FG000|COMPLETED|Second Intervention||8
6737999|NCT03274518|7667226|FG001|COMPLETED|Second Intervention||8
6738000|NCT03274518|7667225|FG000|NOT COMPLETED|Second Intervention||0
6738001|NCT03274518|7667226|FG001|NOT COMPLETED|Second Intervention||0
6738002|NCT03274804|7667232|FG000|STARTED|Overall Study||20
6738003|NCT03274804|7667232|FG000|COMPLETED|Overall Study||20
6738004|NCT03274804|7667232|FG000|NOT COMPLETED|Overall Study||0
6738005|NCT03274856|7667239|FG000|STARTED|Overall Study||10
6256106|NCT03538717|7154941|FG000|STARTED|Overall Study||157
6738006|NCT03274856|7667240|FG001|STARTED|Overall Study||9
6669960|NCT02566265|7601034|FG000|STARTED|Overall Study||81
6669961|NCT02566265|7601035|FG001|STARTED|Overall Study||41
6669962|NCT02566265|7601034|FG000|Day 7 (+/- 2 Days) (Optional)|Overall Study||19
6669963|NCT02566265|7601035|FG001|Day 7 (+/- 2 Days) (Optional)|Overall Study||12
6669964|NCT02566265|7601034|FG000|Day of Second Vaccine|Overall Study||74
6669965|NCT02566265|7601035|FG001|Day of Second Vaccine|Overall Study||41
6669966|NCT02566265|7601034|FG000|30 Days Following 2nd Vaccine|Overall Study||72
6669967|NCT02566265|7601035|FG001|30 Days Following 2nd Vaccine|Overall Study||35
6669968|NCT02566265|7601034|FG000|End of Study Visit (Optional)|Overall Study||38
6669969|NCT02566265|7601035|FG001|End of Study Visit (Optional)|Overall Study||18
6669970|NCT02566265|7601034|FG000|COMPLETED|Overall Study||72
6669971|NCT02566265|7601035|FG001|COMPLETED|Overall Study||35
6669972|NCT02566265|7601034|FG000|NOT COMPLETED|Overall Study||9
6669973|NCT02566265|7601035|FG001|NOT COMPLETED|Overall Study||6
6669974|NCT02566317|7601043|FG000|STARTED|Overall Study||276
6669975|NCT02566317|7601044|FG001|STARTED|Overall Study||354
6669976|NCT02566317|7601043|FG000|COMPLETED|Overall Study||247
6669977|NCT02566317|7601044|FG001|COMPLETED|Overall Study||292
6669978|NCT02566317|7601043|FG000|NOT COMPLETED|Overall Study||29
6669979|NCT02566317|7601044|FG001|NOT COMPLETED|Overall Study||62
6669980|NCT02566369|7601052|FG000|STARTED|Overall Study||612
6669981|NCT02566369|7601053|FG001|STARTED|Overall Study||596
6669982|NCT02566369|7601052|FG000|COMPLETED|Overall Study||540
6669983|NCT02566369|7601053|FG001|COMPLETED|Overall Study||535
6669984|NCT02566369|7601052|FG000|NOT COMPLETED|Overall Study||72
6669985|NCT02566369|7601053|FG001|NOT COMPLETED|Overall Study||61
6669986|NCT02566525|7601061|FG000|STARTED|Overall Study|FPI - CytoSorb Patient 15 Jan 2016|23
6669987|NCT02566525|7601062|FG001|STARTED|Overall Study|FPI - Control Patient 8 Dec 2015|23
6669988|NCT02566525|7601061|FG000|COMPLETED|Overall Study|LPI - CytoSorb Patient 19 Aug 2016|20
6669989|NCT02566525|7601062|FG001|COMPLETED|Overall Study|LPI - Control 16 Aug 2016|18
6669990|NCT02566525|7601061|FG000|NOT COMPLETED|Overall Study||3
6669991|NCT02566525|7601062|FG001|NOT COMPLETED|Overall Study||5
6669992|NCT02566577|7601072|FG000|STARTED|Overall Study||9
6669993|NCT02566577|7601073|FG001|STARTED|Overall Study||6
6669994|NCT02566577|7601072|FG000|COMPLETED|Overall Study||6
6669995|NCT02566577|7601073|FG001|COMPLETED|Overall Study||4
6669996|NCT02566577|7601072|FG000|NOT COMPLETED|Overall Study||3
6669997|NCT02566577|7601073|FG001|NOT COMPLETED|Overall Study||2
6669998|NCT02566590|7601083|FG000|STARTED|Overall Study||10
6669999|NCT02566590|7601084|FG001|STARTED|Overall Study||10
6670000|NCT02566590|7601083|FG000|COMPLETED|Overall Study||10
6670001|NCT02566590|7601084|FG001|COMPLETED|Overall Study||10
6670002|NCT02566590|7601083|FG000|NOT COMPLETED|Overall Study||0
6670003|NCT02566590|7601084|FG001|NOT COMPLETED|Overall Study||0
6670004|NCT02566759|7601107|FG000|STARTED|All Parts||12
6670005|NCT02566759|7601108|FG001|STARTED|All Parts||6
6670006|NCT02566759|7601109|FG002|STARTED|All Parts||6
6670007|NCT02566759|7601110|FG003|STARTED|All Parts||6
6670008|NCT02566759|7601111|FG004|STARTED|All Parts||6
6670009|NCT02566759|7601112|FG005|STARTED|All Parts||6
6670010|NCT02566759|7601113|FG006|STARTED|All Parts||6
6670011|NCT02566759|7601114|FG007|STARTED|All Parts||8
6670012|NCT02566759|7601115|FG008|STARTED|All Parts||6
6670013|NCT02566759|7601116|FG009|STARTED|All Parts||6
6670014|NCT02566759|7601117|FG010|STARTED|All Parts||6
6670015|NCT02566759|7601118|FG011|STARTED|All Parts||6
6670016|NCT02566759|7601119|FG012|STARTED|All Parts||1
6670017|NCT02566759|7601120|FG013|STARTED|All Parts||5
6670018|NCT02566759|7601121|FG014|STARTED|All Parts||8
6670019|NCT02566759|7601122|FG015|STARTED|All Parts||8
6670020|NCT02566759|7601123|FG016|STARTED|All Parts||8
6670021|NCT02566759|7601107|FG000|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|12
6670022|NCT02566759|7601108|FG001|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|5
6670023|NCT02566759|7601109|FG002|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670024|NCT02566759|7601110|FG003|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670025|NCT02566759|7601111|FG004|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670026|NCT02566759|7601112|FG005|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670027|NCT02566759|7601113|FG006|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670028|NCT02566759|7601114|FG007|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|8
6670029|NCT02566759|7601115|FG008|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670030|NCT02566759|7601116|FG009|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670031|NCT02566759|7601117|FG010|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670032|NCT02566759|7601118|FG011|COMPLETED|All Parts|Participants from Part 1 and 2 did not continue in the washout period of Part 4 (crossover part).|6
6670033|NCT02566759|7601119|FG012|COMPLETED|All Parts||0
6670034|NCT02566759|7601120|FG013|COMPLETED|All Parts||0
6670035|NCT02566759|7601121|FG014|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
6670036|NCT02566759|7601122|FG015|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
6738007|NCT03274856|7667239|FG000|COMPLETED|Overall Study||10
6670037|NCT02566759|7601123|FG016|COMPLETED|All Parts|Only participants of Part 4 continued in next period.|8
6670038|NCT02566759|7601107|FG000|NOT COMPLETED|All Parts||0
6670039|NCT02566759|7601108|FG001|NOT COMPLETED|All Parts||1
6670040|NCT02566759|7601109|FG002|NOT COMPLETED|All Parts||0
6670041|NCT02566759|7601110|FG003|NOT COMPLETED|All Parts||0
6670042|NCT02566759|7601111|FG004|NOT COMPLETED|All Parts||0
6670043|NCT02566759|7601112|FG005|NOT COMPLETED|All Parts||0
6670044|NCT02566759|7601113|FG006|NOT COMPLETED|All Parts||0
6670045|NCT02566759|7601114|FG007|NOT COMPLETED|All Parts||0
6670046|NCT02566759|7601115|FG008|NOT COMPLETED|All Parts||0
6670047|NCT02566759|7601116|FG009|NOT COMPLETED|All Parts||0
6670048|NCT02566759|7601117|FG010|NOT COMPLETED|All Parts||0
6670049|NCT02566759|7601118|FG011|NOT COMPLETED|All Parts||0
6670050|NCT02566759|7601119|FG012|NOT COMPLETED|All Parts||1
6670051|NCT02566759|7601120|FG013|NOT COMPLETED|All Parts||5
6670052|NCT02566759|7601121|FG014|NOT COMPLETED|All Parts||0
6670053|NCT02566759|7601122|FG015|NOT COMPLETED|All Parts||0
6670054|NCT02566759|7601123|FG016|NOT COMPLETED|All Parts||0
6670055|NCT02566759|7601107|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670056|NCT02566759|7601108|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670057|NCT02566759|7601109|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670058|NCT02566759|7601110|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670059|NCT02566759|7601111|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670060|NCT02566759|7601112|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670061|NCT02566759|7601113|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670062|NCT02566759|7601114|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670063|NCT02566759|7601115|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670064|NCT02566759|7601116|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670065|NCT02566759|7601117|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670066|NCT02566759|7601118|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670067|NCT02566759|7601119|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670068|NCT02566759|7601120|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670069|NCT02566759|7601121|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6670070|NCT02566759|7601122|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6670071|NCT02566759|7601123|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6670072|NCT02566759|7601107|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670073|NCT02566759|7601108|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670074|NCT02566759|7601109|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670075|NCT02566759|7601110|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670076|NCT02566759|7601111|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670077|NCT02566759|7601112|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670078|NCT02566759|7601113|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670079|NCT02566759|7601114|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670080|NCT02566759|7601115|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670081|NCT02566759|7601116|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670082|NCT02566759|7601117|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670083|NCT02566759|7601118|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670084|NCT02566759|7601119|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670085|NCT02566759|7601120|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670086|NCT02566759|7601121|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6670087|NCT02566759|7601122|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6670088|NCT02566759|7601123|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6670089|NCT02566759|7601107|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670090|NCT02566759|7601108|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670091|NCT02566759|7601109|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670092|NCT02566759|7601110|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670093|NCT02566759|7601111|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670094|NCT02566759|7601112|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670095|NCT02566759|7601113|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670096|NCT02566759|7601114|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670097|NCT02566759|7601115|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670098|NCT02566759|7601116|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670099|NCT02566759|7601117|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670100|NCT02566759|7601118|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670101|NCT02566759|7601119|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670102|NCT02566759|7601120|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670103|NCT02566759|7601121|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670104|NCT02566759|7601122|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670105|NCT02566759|7601123|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670106|NCT02566759|7601107|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670107|NCT02566759|7601108|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670108|NCT02566759|7601109|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670109|NCT02566759|7601110|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670110|NCT02566759|7601111|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670111|NCT02566759|7601112|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670112|NCT02566759|7601113|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670113|NCT02566759|7601114|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670114|NCT02566759|7601115|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670115|NCT02566759|7601116|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670116|NCT02566759|7601117|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670117|NCT02566759|7601118|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670118|NCT02566759|7601119|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670119|NCT02566759|7601120|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670120|NCT02566759|7601121|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6670121|NCT02566759|7601122|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6670122|NCT02566759|7601123|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6670123|NCT02566759|7601107|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670124|NCT02566759|7601108|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670125|NCT02566759|7601109|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670126|NCT02566759|7601110|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670127|NCT02566759|7601111|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670128|NCT02566759|7601112|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670129|NCT02566759|7601113|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670130|NCT02566759|7601114|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670131|NCT02566759|7601115|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670132|NCT02566759|7601116|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670133|NCT02566759|7601117|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670134|NCT02566759|7601118|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670135|NCT02566759|7601119|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670136|NCT02566759|7601120|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670137|NCT02566759|7601121|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
6670138|NCT02566759|7601122|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
6670139|NCT02566759|7601123|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
6670140|NCT02566759|7601107|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670141|NCT02566759|7601108|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670142|NCT02566759|7601109|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670143|NCT02566759|7601110|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670144|NCT02566759|7601111|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670145|NCT02566759|7601112|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670146|NCT02566759|7601113|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670147|NCT02566759|7601114|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670148|NCT02566759|7601115|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670149|NCT02566759|7601116|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670150|NCT02566759|7601117|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670151|NCT02566759|7601118|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670152|NCT02566759|7601119|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670153|NCT02566759|7601120|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670154|NCT02566759|7601121|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670155|NCT02566759|7601122|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670156|NCT02566759|7601123|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||1
6670157|NCT02566759|7601107|FG000|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670158|NCT02566759|7601108|FG001|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670159|NCT02566759|7601109|FG002|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670160|NCT02566759|7601110|FG003|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670161|NCT02566759|7601111|FG004|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670162|NCT02566759|7601112|FG005|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670163|NCT02566759|7601113|FG006|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670164|NCT02566759|7601114|FG007|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670165|NCT02566759|7601115|FG008|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670166|NCT02566759|7601116|FG009|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670167|NCT02566759|7601117|FG010|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670168|NCT02566759|7601118|FG011|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670169|NCT02566759|7601119|FG012|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670170|NCT02566759|7601120|FG013|STARTED|Washout Crossover Period (Part 4:5 Days)||0
6670171|NCT02566759|7601121|FG014|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6670172|NCT02566759|7601122|FG015|STARTED|Washout Crossover Period (Part 4:5 Days)||8
6670173|NCT02566759|7601123|FG016|STARTED|Washout Crossover Period (Part 4:5 Days)||7
6670174|NCT02566759|7601107|FG000|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670175|NCT02566759|7601108|FG001|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670176|NCT02566759|7601109|FG002|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670177|NCT02566759|7601110|FG003|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670178|NCT02566759|7601111|FG004|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670179|NCT02566759|7601112|FG005|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670180|NCT02566759|7601113|FG006|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670181|NCT02566759|7601114|FG007|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670182|NCT02566759|7601115|FG008|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670183|NCT02566759|7601116|FG009|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670184|NCT02566759|7601117|FG010|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670185|NCT02566759|7601118|FG011|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670186|NCT02566759|7601119|FG012|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670187|NCT02566759|7601120|FG013|COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670188|NCT02566759|7601121|FG014|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6670189|NCT02566759|7601122|FG015|COMPLETED|Washout Crossover Period (Part 4:5 Days)||8
6670190|NCT02566759|7601123|FG016|COMPLETED|Washout Crossover Period (Part 4:5 Days)||7
6670191|NCT02566759|7601107|FG000|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670192|NCT02566759|7601108|FG001|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670193|NCT02566759|7601109|FG002|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670194|NCT02566759|7601110|FG003|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670195|NCT02566759|7601111|FG004|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670196|NCT02566759|7601112|FG005|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670197|NCT02566759|7601113|FG006|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670198|NCT02566759|7601114|FG007|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670199|NCT02566759|7601115|FG008|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670200|NCT02566759|7601116|FG009|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670201|NCT02566759|7601117|FG010|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670202|NCT02566759|7601118|FG011|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670203|NCT02566759|7601119|FG012|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670204|NCT02566759|7601120|FG013|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670205|NCT02566759|7601121|FG014|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670206|NCT02566759|7601122|FG015|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670207|NCT02566759|7601123|FG016|NOT COMPLETED|Washout Crossover Period (Part 4:5 Days)||0
6670208|NCT02566759|7601107|FG000|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670209|NCT02566759|7601108|FG001|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670210|NCT02566759|7601109|FG002|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670211|NCT02566759|7601110|FG003|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670212|NCT02566759|7601111|FG004|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670213|NCT02566759|7601112|FG005|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670214|NCT02566759|7601113|FG006|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670215|NCT02566759|7601114|FG007|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670216|NCT02566759|7601115|FG008|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670217|NCT02566759|7601116|FG009|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670218|NCT02566759|7601117|FG010|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670219|NCT02566759|7601118|FG011|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670220|NCT02566759|7601119|FG012|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670221|NCT02566759|7601120|FG013|STARTED|Crossover Treatment (Part 4: 1 Day)||0
6670222|NCT02566759|7601121|FG014|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6670223|NCT02566759|7601122|FG015|STARTED|Crossover Treatment (Part 4: 1 Day)||8
6391830|NCT00838331|7303765|FG000|NOT COMPLETED|Aged Blood Transfusion||9
6391831|NCT00838435|7303769|FG000|STARTED|Part 1 (4 Weeks)||95
6391832|NCT00838435|7303769|FG000|COMPLETED|Part 1 (4 Weeks)||95
6391833|NCT00838435|7303769|FG000|NOT COMPLETED|Part 1 (4 Weeks)||0
6391834|NCT00838435|7303769|FG000|STARTED|PK Sub-Study 2 (4 Weeks)|1 subject declined participation in the PK Sub-Study.|94
6391835|NCT00838435|7303769|FG000|COMPLETED|PK Sub-Study 2 (4 Weeks)||93
6391836|NCT00838435|7303769|FG000|NOT COMPLETED|PK Sub-Study 2 (4 Weeks)||1
6391837|NCT00838435|7303769|FG000|STARTED|Safety/Efficacy Sub-Study 1 (6 Months)|65 of 95 subjects in Part 1 were determined responders & eligible for the Safety/Efficacy Sub-study.|65
6391838|NCT00838435|7303769|FG000|COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||63
6391839|NCT00838435|7303769|FG000|NOT COMPLETED|Safety/Efficacy Sub-Study 1 (6 Months)||2
6391840|NCT00838435|7303769|FG000|STARTED|Part 2 (7 Years)|65 of 95 subjects in Part 1 were determined responders & eligible for the Part 2 of the study.|65
6391841|NCT00838435|7303769|FG000|COMPLETED|Part 2 (7 Years)||49
6391842|NCT00838435|7303769|FG000|NOT COMPLETED|Part 2 (7 Years)||16
6391843|NCT00838513|7303776|FG000|STARTED|Screening Period||23
6391844|NCT00838513|7303776|FG000|COMPLETED|Screening Period||20
6391845|NCT00838513|7303776|FG000|NOT COMPLETED|Screening Period||3
6391846|NCT00838513|7303776|FG000|STARTED|Observation Period (8 Weeks)||20
6391847|NCT00838513|7303776|FG000|COMPLETED|Observation Period (8 Weeks)||20
6391848|NCT00838513|7303776|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
6391849|NCT00838513|7303776|FG000|STARTED|Treatment Period (26 Weeks)||20
6391850|NCT00838513|7303776|FG000|COMPLETED|Treatment Period (26 Weeks)||20
6391851|NCT00838513|7303776|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
6670224|NCT02566759|7601123|FG016|STARTED|Crossover Treatment (Part 4: 1 Day)||7
6670225|NCT02566759|7601107|FG000|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670226|NCT02566759|7601108|FG001|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670227|NCT02566759|7601109|FG002|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670228|NCT02566759|7601110|FG003|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670229|NCT02566759|7601111|FG004|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670230|NCT02566759|7601112|FG005|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670231|NCT02566759|7601113|FG006|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670232|NCT02566759|7601114|FG007|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670233|NCT02566759|7601115|FG008|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670234|NCT02566759|7601116|FG009|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670235|NCT02566759|7601117|FG010|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670236|NCT02566759|7601118|FG011|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670237|NCT02566759|7601119|FG012|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670238|NCT02566759|7601120|FG013|COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670239|NCT02566759|7601121|FG014|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
6670240|NCT02566759|7601122|FG015|COMPLETED|Crossover Treatment (Part 4: 1 Day)||8
6670241|NCT02566759|7601123|FG016|COMPLETED|Crossover Treatment (Part 4: 1 Day)||7
6670242|NCT02566759|7601107|FG000|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670243|NCT02566759|7601108|FG001|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670244|NCT02566759|7601109|FG002|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670245|NCT02566759|7601110|FG003|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670246|NCT02566759|7601111|FG004|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670247|NCT02566759|7601112|FG005|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670248|NCT02566759|7601113|FG006|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670249|NCT02566759|7601114|FG007|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670250|NCT02566759|7601115|FG008|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670251|NCT02566759|7601116|FG009|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670252|NCT02566759|7601117|FG010|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670253|NCT02566759|7601118|FG011|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670254|NCT02566759|7601119|FG012|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670255|NCT02566759|7601120|FG013|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670256|NCT02566759|7601121|FG014|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670257|NCT02566759|7601122|FG015|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670258|NCT02566759|7601123|FG016|NOT COMPLETED|Crossover Treatment (Part 4: 1 Day)||0
6670259|NCT02566785|7601184|FG000|STARTED|Overall Study||15
6670260|NCT02566785|7601185|FG001|STARTED|Overall Study||18
6670261|NCT02566785|7601184|FG000|COMPLETED|Overall Study||14
6670262|NCT02566785|7601185|FG001|COMPLETED|Overall Study||15
6670263|NCT02566785|7601184|FG000|NOT COMPLETED|Overall Study||1
6670264|NCT02566785|7601185|FG001|NOT COMPLETED|Overall Study||3
6670265|NCT02566889|7601193|FG000|STARTED|Overall Study||45
6670266|NCT02566889|7601194|FG001|STARTED|Overall Study||8
6670267|NCT02566889|7601193|FG000|Cross-over to Dose Escalation Group|Overall Study||1
6670268|NCT02566889|7601194|FG001|Cross-over to Dose Escalation Group|Overall Study||0
6670269|NCT02566889|7601193|FG000|COMPLETED|Overall Study||32
6670270|NCT02566889|7601194|FG001|COMPLETED|Overall Study||3
6670271|NCT02566889|7601193|FG000|NOT COMPLETED|Overall Study||13
6670272|NCT02566889|7601194|FG001|NOT COMPLETED|Overall Study||5
6670273|NCT02566902|7601201|FG000|STARTED|Overall Study||60
6670274|NCT02566902|7601202|FG001|STARTED|Overall Study||58
6670275|NCT02566902|7601201|FG000|COMPLETED|Overall Study||58
6670276|NCT02566902|7601202|FG001|COMPLETED|Overall Study||57
6670277|NCT02566902|7601201|FG000|NOT COMPLETED|Overall Study||2
6670278|NCT02566902|7601202|FG001|NOT COMPLETED|Overall Study||1
6670279|NCT02566993|7601210|FG000|STARTED|Overall Study||307
6670280|NCT02566993|7601211|FG001|STARTED|Overall Study||306
6670281|NCT02566993|7601210|FG000|COMPLETED|Overall Study||0
6670282|NCT02566993|7601211|FG001|COMPLETED|Overall Study||0
6670283|NCT02566993|7601210|FG000|NOT COMPLETED|Overall Study||307
6670284|NCT02566993|7601211|FG001|NOT COMPLETED|Overall Study||306
6670285|NCT02567188|7601219|FG000|STARTED|Overall Study||144
6670286|NCT02567188|7601219|FG000|COMPLETED|Overall Study||109
6670287|NCT02567188|7601219|FG000|NOT COMPLETED|Overall Study||35
6670288|NCT02567227|7601226|FG000|STARTED|9 Weeks||192
6670289|NCT02567227|7601227|FG001|STARTED|9 Weeks||191
6670290|NCT02567227|7601226|FG000|COMPLETED|9 Weeks||158
6670291|NCT02567227|7601227|FG001|COMPLETED|9 Weeks||167
6670292|NCT02567227|7601226|FG000|NOT COMPLETED|9 Weeks||34
6670293|NCT02567227|7601227|FG001|NOT COMPLETED|9 Weeks||24
6670294|NCT02567227|7601226|FG000|STARTED|6 Month||158
6670295|NCT02567227|7601227|FG001|STARTED|6 Month||167
6670296|NCT02567227|7601226|FG000|COMPLETED|6 Month||113
6670297|NCT02567227|7601227|FG001|COMPLETED|6 Month||127
6670298|NCT02567227|7601226|FG000|NOT COMPLETED|6 Month||45
6670299|NCT02567227|7601227|FG001|NOT COMPLETED|6 Month||40
6670300|NCT02567227|7601226|FG000|STARTED|12 Months||113
6670301|NCT02567227|7601227|FG001|STARTED|12 Months||127
6670302|NCT02567227|7601226|FG000|COMPLETED|12 Months||82
6670303|NCT02567227|7601227|FG001|COMPLETED|12 Months||93
6670304|NCT02567227|7601226|FG000|NOT COMPLETED|12 Months||31
6670305|NCT02567227|7601227|FG001|NOT COMPLETED|12 Months||34
6670306|NCT02567266|7601236|FG000|STARTED|Overall Study||68
6670307|NCT02567266|7601237|FG001|STARTED|Overall Study||60
6670308|NCT02567266|7601238|FG002|STARTED|Overall Study||68
6670309|NCT02567266|7601236|FG000|Midpoint (8 Weeks)|Overall Study||54
6670310|NCT02567266|7601237|FG001|Midpoint (8 Weeks)|Overall Study||52
6670311|NCT02567266|7601238|FG002|Midpoint (8 Weeks)|Overall Study||55
6670312|NCT02567266|7601236|FG000|Post (16 Weeks)|Overall Study||49
6670313|NCT02567266|7601237|FG001|Post (16 Weeks)|Overall Study||43
6670314|NCT02567266|7601238|FG002|Post (16 Weeks)|Overall Study||53
6670315|NCT02567266|7601236|FG000|Follow-up (28 Weeks)|Overall Study||45
6670316|NCT02567266|7601237|FG001|Follow-up (28 Weeks)|Overall Study||45
6670317|NCT02567266|7601238|FG002|Follow-up (28 Weeks)|Overall Study||52
6670318|NCT02567266|7601236|FG000|COMPLETED|Overall Study||45
6670319|NCT02567266|7601237|FG001|COMPLETED|Overall Study||45
6670320|NCT02567266|7601238|FG002|COMPLETED|Overall Study||52
6670321|NCT02567266|7601236|FG000|NOT COMPLETED|Overall Study||23
6670322|NCT02567266|7601237|FG001|NOT COMPLETED|Overall Study||15
6670323|NCT02567266|7601238|FG002|NOT COMPLETED|Overall Study||16
6670324|NCT02567552|7601248|FG000|STARTED|Overall Study||12
6670325|NCT02567552|7601249|FG001|STARTED|Overall Study||12
6670326|NCT02567552|7601248|FG000|COMPLETED|Overall Study||12
6670327|NCT02567552|7601249|FG001|COMPLETED|Overall Study|dropout by pain in the puncture site|11
6670328|NCT02567552|7601248|FG000|NOT COMPLETED|Overall Study||0
6670329|NCT02567552|7601249|FG001|NOT COMPLETED|Overall Study||1
6670330|NCT02567656|7601261|FG000|STARTED|Overall Study||4
6670331|NCT02567656|7601262|FG001|STARTED|Overall Study||4
6670332|NCT02567656|7601263|FG002|STARTED|Overall Study||5
6670333|NCT02567656|7601264|FG003|STARTED|Overall Study||6
6670334|NCT02567656|7601265|FG004|STARTED|Overall Study||19
6670335|NCT02567656|7601266|FG005|STARTED|Overall Study||20
6670336|NCT02567656|7601261|FG000|COMPLETED|Overall Study||3
6670337|NCT02567656|7601262|FG001|COMPLETED|Overall Study||3
6670338|NCT02567656|7601263|FG002|COMPLETED|Overall Study||3
6670339|NCT02567656|7601264|FG003|COMPLETED|Overall Study||6
6670340|NCT02567656|7601265|FG004|COMPLETED|Overall Study||19
6670341|NCT02567656|7601266|FG005|COMPLETED|Overall Study||20
6670342|NCT02567656|7601261|FG000|NOT COMPLETED|Overall Study||1
6670343|NCT02567656|7601262|FG001|NOT COMPLETED|Overall Study||1
6670344|NCT02567656|7601263|FG002|NOT COMPLETED|Overall Study||2
6670345|NCT02567656|7601264|FG003|NOT COMPLETED|Overall Study||0
6670346|NCT02567656|7601265|FG004|NOT COMPLETED|Overall Study||0
6670347|NCT02567656|7601266|FG005|NOT COMPLETED|Overall Study||0
6670348|NCT02567708|7601280|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||24
6670349|NCT02567708|7601281|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||26
6670350|NCT02567708|7601280|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||22
6670351|NCT02567708|7601281|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||23
6670352|NCT02567708|7601280|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||2
6670353|NCT02567708|7601281|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||3
6670354|NCT02567708|7601280|FG000|STARTED|Washout Period (Up to 4 Weeks)||22
6670355|NCT02567708|7601281|FG001|STARTED|Washout Period (Up to 4 Weeks)||23
6670356|NCT02567708|7601280|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||22
6670357|NCT02567708|7601281|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||23
6670358|NCT02567708|7601280|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
6670359|NCT02567708|7601281|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
6670360|NCT02567708|7601280|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||22
6670361|NCT02567708|7601281|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||23
6670362|NCT02567708|7601280|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||22
6670363|NCT02567708|7601281|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||20
6670364|NCT02567708|7601280|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
6670365|NCT02567708|7601281|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||3
6670366|NCT02567968|7601288|FG000|STARTED|First Intervention||4
6670367|NCT02567968|7601289|FG001|STARTED|First Intervention||4
6670368|NCT02567968|7601288|FG000|COMPLETED|First Intervention||4
6670369|NCT02567968|7601289|FG001|COMPLETED|First Intervention||4
6670370|NCT02567968|7601288|FG000|NOT COMPLETED|First Intervention||0
6670371|NCT02567968|7601289|FG001|NOT COMPLETED|First Intervention||0
6670372|NCT02567968|7601288|FG000|STARTED|Washout (2 Weeks)||4
6670373|NCT02567968|7601289|FG001|STARTED|Washout (2 Weeks)||4
6670374|NCT02567968|7601288|FG000|COMPLETED|Washout (2 Weeks)||4
6670375|NCT02567968|7601289|FG001|COMPLETED|Washout (2 Weeks)||4
6670376|NCT02567968|7601288|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6670377|NCT02567968|7601289|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6670378|NCT02567968|7601288|FG000|STARTED|Second Intervention||4
6670379|NCT02567968|7601289|FG001|STARTED|Second Intervention||4
6670380|NCT02567968|7601288|FG000|COMPLETED|Second Intervention||4
6670381|NCT02567968|7601289|FG001|COMPLETED|Second Intervention||4
6670382|NCT02567968|7601288|FG000|NOT COMPLETED|Second Intervention||0
6670383|NCT02567968|7601289|FG001|NOT COMPLETED|Second Intervention||0
6670384|NCT02568046|7601297|FG000|STARTED|Overall Study||5
6670385|NCT02568046|7601298|FG001|STARTED|Overall Study||5
6670386|NCT02568046|7601297|FG000|COMPLETED|Overall Study||0
6670387|NCT02568046|7601298|FG001|COMPLETED|Overall Study||2
6670388|NCT02568046|7601297|FG000|NOT COMPLETED|Overall Study||5
6670389|NCT02568046|7601298|FG001|NOT COMPLETED|Overall Study||3
6670390|NCT02568072|7601304|FG000|STARTED|Overall Study||120
6670391|NCT02568072|7601304|FG000|COMPLETED|Overall Study||68
6670392|NCT02568072|7601304|FG000|NOT COMPLETED|Overall Study||52
6670393|NCT02568254|7601309|FG000|STARTED|Period 1||13
6670394|NCT02568254|7601310|FG001|STARTED|Period 1||12
6670395|NCT02568254|7601311|FG002|STARTED|Period 1||13
6670396|NCT02568254|7601312|FG003|STARTED|Period 1||12
6670397|NCT02568254|7601313|FG004|STARTED|Period 1||12
6670398|NCT02568254|7601314|FG005|STARTED|Period 1||12
6670399|NCT02568254|7601309|FG000|COMPLETED|Period 1||13
6670400|NCT02568254|7601310|FG001|COMPLETED|Period 1||12
6670401|NCT02568254|7601311|FG002|COMPLETED|Period 1||13
6670402|NCT02568254|7601312|FG003|COMPLETED|Period 1||12
6670403|NCT02568254|7601313|FG004|COMPLETED|Period 1||12
6670404|NCT02568254|7601314|FG005|COMPLETED|Period 1||12
6670405|NCT02568254|7601309|FG000|NOT COMPLETED|Period 1||0
6670406|NCT02568254|7601310|FG001|NOT COMPLETED|Period 1||0
6670407|NCT02568254|7601311|FG002|NOT COMPLETED|Period 1||0
6670408|NCT02568254|7601312|FG003|NOT COMPLETED|Period 1||0
6670409|NCT02568254|7601313|FG004|NOT COMPLETED|Period 1||0
6670410|NCT02568254|7601314|FG005|NOT COMPLETED|Period 1||0
6670411|NCT02568254|7601309|FG000|STARTED|Period 2||13
6670412|NCT02568254|7601310|FG001|STARTED|Period 2||12
6670413|NCT02568254|7601311|FG002|STARTED|Period 2||13
6670414|NCT02568254|7601312|FG003|STARTED|Period 2||12
6670415|NCT02568254|7601313|FG004|STARTED|Period 2||12
6670416|NCT02568254|7601314|FG005|STARTED|Period 2||12
6670417|NCT02568254|7601309|FG000|COMPLETED|Period 2||13
6670418|NCT02568254|7601310|FG001|COMPLETED|Period 2||12
6670419|NCT02568254|7601311|FG002|COMPLETED|Period 2||12
6670420|NCT02568254|7601312|FG003|COMPLETED|Period 2||12
6670421|NCT02568254|7601313|FG004|COMPLETED|Period 2||12
6670422|NCT02568254|7601314|FG005|COMPLETED|Period 2||12
6670423|NCT02568254|7601309|FG000|NOT COMPLETED|Period 2||0
6670424|NCT02568254|7601310|FG001|NOT COMPLETED|Period 2||0
6670425|NCT02568254|7601311|FG002|NOT COMPLETED|Period 2||1
6670426|NCT02568254|7601312|FG003|NOT COMPLETED|Period 2||0
6670427|NCT02568254|7601313|FG004|NOT COMPLETED|Period 2||0
6670428|NCT02568254|7601314|FG005|NOT COMPLETED|Period 2||0
6670429|NCT02568254|7601309|FG000|STARTED|Period 3||13
6670430|NCT02568254|7601310|FG001|STARTED|Period 3||12
6670431|NCT02568254|7601311|FG002|STARTED|Period 3||12
6670432|NCT02568254|7601312|FG003|STARTED|Period 3||12
6670433|NCT02568254|7601313|FG004|STARTED|Period 3||12
6670434|NCT02568254|7601314|FG005|STARTED|Period 3||12
6670435|NCT02568254|7601309|FG000|COMPLETED|Period 3||13
6670436|NCT02568254|7601310|FG001|COMPLETED|Period 3||12
6670437|NCT02568254|7601311|FG002|COMPLETED|Period 3||12
6670438|NCT02568254|7601312|FG003|COMPLETED|Period 3||12
6670439|NCT02568254|7601313|FG004|COMPLETED|Period 3||11
6670440|NCT02568254|7601314|FG005|COMPLETED|Period 3||12
6670441|NCT02568254|7601309|FG000|NOT COMPLETED|Period 3||0
6670442|NCT02568254|7601310|FG001|NOT COMPLETED|Period 3||0
6670443|NCT02568254|7601311|FG002|NOT COMPLETED|Period 3||0
6670444|NCT02568254|7601312|FG003|NOT COMPLETED|Period 3||0
6670445|NCT02568254|7601313|FG004|NOT COMPLETED|Period 3||1
6670446|NCT02568254|7601314|FG005|NOT COMPLETED|Period 3||0
6670447|NCT02568345|7601322|FG000|STARTED|Overall Study||31
6670448|NCT02568345|7601322|FG000|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
6670449|NCT02568345|7601322|FG000|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
6670450|NCT02568345|7601322|FG000|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
6670451|NCT02568345|7601322|FG000|COMPLETED|Overall Study||31
6670452|NCT02568345|7601322|FG000|NOT COMPLETED|Overall Study||0
6670453|NCT02568384|7601326|FG000|STARTED|Overall Study||45
6670454|NCT02568384|7601326|FG000|COMPLETED|Overall Study||43
6670455|NCT02568384|7601326|FG000|NOT COMPLETED|Overall Study||2
6670456|NCT02568397|7601330|FG000|STARTED|Period 1||60
6670457|NCT02568397|7601331|FG001|STARTED|Period 1||0
6670458|NCT02568397|7601330|FG000|Received at Least 1 Dose of Study Drug|Period 1||60
6670459|NCT02568397|7601331|FG001|Received at Least 1 Dose of Study Drug|Period 1||0
6670460|NCT02568397|7601330|FG000|COMPLETED|Period 1||60
6670461|NCT02568397|7601331|FG001|COMPLETED|Period 1||0
6670462|NCT02568397|7601330|FG000|NOT COMPLETED|Period 1||0
6670463|NCT02568397|7601331|FG001|NOT COMPLETED|Period 1||0
6670464|NCT02568397|7601330|FG000|STARTED|Period 2|A single oral dose of 150 mg dabigatran etexilate was administered on Day 1 of Period 1.|0
6670465|NCT02568397|7601331|FG001|STARTED|Period 2|Daily doses of 50 mg LY3314814 were administered daily on Days 3 to 21 of Period 2.|60
6670466|NCT02568397|7601330|FG000|COMPLETED|Period 2||0
6670467|NCT02568397|7601331|FG001|COMPLETED|Period 2||58
6670468|NCT02568397|7601330|FG000|NOT COMPLETED|Period 2||0
6670469|NCT02568397|7601331|FG001|NOT COMPLETED|Period 2||2
6670470|NCT02568475|7601348|FG000|STARTED|Overall Study||97
6670471|NCT02568475|7601349|FG001|STARTED|Overall Study||95
6670472|NCT02568475|7601348|FG000|Post-test|Overall Study||85
6670473|NCT02568475|7601349|FG001|Post-test|Overall Study||82
6670474|NCT02568475|7601348|FG000|COMPLETED|Overall Study||46
6670475|NCT02568475|7601349|FG001|COMPLETED|Overall Study||52
6670476|NCT02568475|7601348|FG000|NOT COMPLETED|Overall Study||51
6670477|NCT02568475|7601349|FG001|NOT COMPLETED|Overall Study||43
6670478|NCT02568644|7601357|FG000|STARTED|Overall Study||30
6670479|NCT02568644|7601358|FG001|STARTED|Overall Study||30
6670480|NCT02568644|7601357|FG000|COMPLETED|Overall Study||30
6670481|NCT02568644|7601358|FG001|COMPLETED|Overall Study||30
6670482|NCT02568644|7601357|FG000|NOT COMPLETED|Overall Study||0
6670483|NCT02568644|7601358|FG001|NOT COMPLETED|Overall Study||0
6670484|NCT02568683|7601368|FG000|STARTED|Overall Study||6
6670485|NCT02568683|7601369|FG001|STARTED|Overall Study||4
6670486|NCT02568683|7601368|FG000|COMPLETED|Overall Study||0
6670487|NCT02568683|7601369|FG001|COMPLETED|Overall Study||0
6670488|NCT02568683|7601368|FG000|NOT COMPLETED|Overall Study||6
6670489|NCT02568683|7601369|FG001|NOT COMPLETED|Overall Study||4
6670490|NCT02568852|7601377|FG000|STARTED|Overall Study||25
6670491|NCT02568852|7601378|FG001|STARTED|Overall Study||25
6670492|NCT02568852|7601377|FG000|COMPLETED|Overall Study||25
6670493|NCT02568852|7601378|FG001|COMPLETED|Overall Study||25
6670494|NCT02568852|7601377|FG000|NOT COMPLETED|Overall Study||0
6670495|NCT02568852|7601378|FG001|NOT COMPLETED|Overall Study||0
6670496|NCT02569086|7601384|FG000|STARTED|Overall Study||22
6670497|NCT02569086|7601384|FG000|COMPLETED|Overall Study||22
6670498|NCT02569086|7601384|FG000|NOT COMPLETED|Overall Study||0
6670499|NCT02569112|7601388|FG000|STARTED|Overall Study||10
6670500|NCT02569112|7601389|FG001|STARTED|Overall Study||10
6670501|NCT02569112|7601388|FG000|COMPLETED|Overall Study||10
6670502|NCT02569112|7601389|FG001|COMPLETED|Overall Study|Each subject received multipolar RF with varipulse technology to only one side of their body.|10
6670503|NCT02569112|7601388|FG000|NOT COMPLETED|Overall Study||0
6670504|NCT02569112|7601389|FG001|NOT COMPLETED|Overall Study||0
6670505|NCT02569398|7601397|FG000|STARTED|Overall Study||185
6670506|NCT02569398|7601398|FG001|STARTED|Overall Study||189
6670507|NCT02569398|7601399|FG002|STARTED|Overall Study||183
6670508|NCT02569398|7601397|FG000|COMPLETED|Overall Study||0
6670509|NCT02569398|7601398|FG001|COMPLETED|Overall Study||0
6670510|NCT02569398|7601399|FG002|COMPLETED|Overall Study||0
6670511|NCT02569398|7601397|FG000|NOT COMPLETED|Overall Study||185
6670512|NCT02569398|7601398|FG001|NOT COMPLETED|Overall Study||189
6670513|NCT02569398|7601399|FG002|NOT COMPLETED|Overall Study||183
6391852|NCT00838513|7303776|FG000|STARTED|Extension Treatment Period||19
6391853|NCT00838513|7303776|FG000|COMPLETED|Extension Treatment Period||18
6391854|NCT00838513|7303776|FG000|NOT COMPLETED|Extension Treatment Period||1
6391855|NCT00838513|7303776|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
6391856|NCT00838513|7303776|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
6391857|NCT00838513|7303776|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
6391858|NCT00838539|7303792|FG000|STARTED|Overall Study||3
6391859|NCT00838539|7303793|FG001|STARTED|Overall Study||6
6391860|NCT00838539|7303794|FG002|STARTED|Overall Study||5
6391861|NCT00838539|7303795|FG003|STARTED|Overall Study||4
6391862|NCT00838539|7303796|FG004|STARTED|Overall Study||6
6391863|NCT00838539|7303797|FG005|STARTED|Overall Study||4
6391864|NCT00838539|7303798|FG006|STARTED|Overall Study||7
6391865|NCT00838539|7303799|FG007|STARTED|Overall Study||6
6391866|NCT00838539|7303800|FG008|STARTED|Overall Study||5
6391867|NCT00838539|7303801|FG009|STARTED|Overall Study||8
6391868|NCT00838539|7303802|FG010|STARTED|Overall Study||5
6391869|NCT00838539|7303803|FG011|STARTED|Overall Study||4
6391870|NCT00838539|7303792|FG000|Received Treatment|Overall Study||3
6391871|NCT00838539|7303793|FG001|Received Treatment|Overall Study||5
6391872|NCT00838539|7303794|FG002|Received Treatment|Overall Study||5
6391873|NCT00838539|7303795|FG003|Received Treatment|Overall Study||4
6391874|NCT00838539|7303796|FG004|Received Treatment|Overall Study||4
6391875|NCT00838539|7303797|FG005|Received Treatment|Overall Study||4
6391876|NCT00838539|7303798|FG006|Received Treatment|Overall Study||7
6391877|NCT00838539|7303799|FG007|Received Treatment|Overall Study||6
6391878|NCT00838539|7303800|FG008|Received Treatment|Overall Study||5
6391879|NCT00838539|7303801|FG009|Received Treatment|Overall Study||8
6391880|NCT00838539|7303802|FG010|Received Treatment|Overall Study||5
6391881|NCT00838539|7303803|FG011|Received Treatment|Overall Study||4
6391882|NCT00838539|7303792|FG000|COMPLETED|Overall Study||0
6391883|NCT00838539|7303793|FG001|COMPLETED|Overall Study||0
6391884|NCT00838539|7303794|FG002|COMPLETED|Overall Study||0
6391885|NCT00838539|7303795|FG003|COMPLETED|Overall Study||0
6391886|NCT00838539|7303796|FG004|COMPLETED|Overall Study||0
6391887|NCT00838539|7303797|FG005|COMPLETED|Overall Study||0
6391888|NCT00838539|7303798|FG006|COMPLETED|Overall Study||2
6391889|NCT00838539|7303799|FG007|COMPLETED|Overall Study||0
6391890|NCT00838539|7303800|FG008|COMPLETED|Overall Study||0
6391891|NCT00838539|7303801|FG009|COMPLETED|Overall Study||0
6391892|NCT00838539|7303802|FG010|COMPLETED|Overall Study||0
6391893|NCT00838539|7303803|FG011|COMPLETED|Overall Study||0
6391894|NCT00838539|7303792|FG000|NOT COMPLETED|Overall Study||3
6391895|NCT00838539|7303793|FG001|NOT COMPLETED|Overall Study||6
6391896|NCT00838539|7303794|FG002|NOT COMPLETED|Overall Study||5
6391897|NCT00838539|7303795|FG003|NOT COMPLETED|Overall Study||4
6391898|NCT00838539|7303796|FG004|NOT COMPLETED|Overall Study||6
6391899|NCT00838539|7303797|FG005|NOT COMPLETED|Overall Study||4
6670514|NCT02569411|7601409|FG000|STARTED|Overall Study||65
6670515|NCT02569411|7601410|FG001|STARTED|Overall Study||64
6670516|NCT02569411|7601409|FG000|COMPLETED|Overall Study||0
6670517|NCT02569411|7601410|FG001|COMPLETED|Overall Study||0
6670518|NCT02569411|7601409|FG000|NOT COMPLETED|Overall Study||65
6670519|NCT02569411|7601410|FG001|NOT COMPLETED|Overall Study||64
6670520|NCT02569437|7601418|FG000|STARTED|Overall Study||24
6670521|NCT02569437|7601419|FG001|STARTED|Overall Study||25
6670522|NCT02569437|7601418|FG000|COMPLETED|Overall Study||12
6670523|NCT02569437|7601419|FG001|COMPLETED|Overall Study||11
6670524|NCT02569437|7601418|FG000|NOT COMPLETED|Overall Study||12
6670525|NCT02569437|7601419|FG001|NOT COMPLETED|Overall Study||14
6670526|NCT02569541|7601425|FG000|STARTED|Overall Study||30
6670527|NCT02569541|7601425|FG000|COMPLETED|Overall Study||9
6670528|NCT02569541|7601425|FG000|NOT COMPLETED|Overall Study||21
6670529|NCT02569632|7601429|FG000|STARTED|Overall Study||18
6670530|NCT02569632|7601429|FG000|COMPLETED|Overall Study||17
6670531|NCT02569632|7601429|FG000|NOT COMPLETED|Overall Study||1
6670532|NCT02569658|7601435|FG000|STARTED|Overall Study||53
6670533|NCT02569658|7601436|FG001|STARTED|Overall Study||57
6670534|NCT02569658|7601435|FG000|COMPLETED|Overall Study||52
6670535|NCT02569658|7601436|FG001|COMPLETED|Overall Study||56
6670536|NCT02569658|7601435|FG000|NOT COMPLETED|Overall Study||1
6670537|NCT02569658|7601436|FG001|NOT COMPLETED|Overall Study||1
6670538|NCT02569710|7601452|FG000|STARTED|Overall Study||20
6670539|NCT02569710|7601453|FG001|STARTED|Overall Study||25
6670540|NCT02569710|7601454|FG002|STARTED|Overall Study||20
6670541|NCT02569710|7601455|FG003|STARTED|Overall Study||20
6670542|NCT02569710|7601456|FG004|STARTED|Overall Study||8
6670543|NCT02569710|7601457|FG005|STARTED|Overall Study||5
6670544|NCT02569710|7601458|FG006|STARTED|Overall Study||14
6670545|NCT02569710|7601459|FG007|STARTED|Overall Study||30
6670546|NCT02569710|7601460|FG008|STARTED|Overall Study||15
6670547|NCT02569710|7601461|FG009|STARTED|Overall Study||4
6670548|NCT02569710|7601452|FG000|COMPLETED|Overall Study||19
6670549|NCT02569710|7601453|FG001|COMPLETED|Overall Study||25
6670550|NCT02569710|7601454|FG002|COMPLETED|Overall Study||20
6670551|NCT02569710|7601455|FG003|COMPLETED|Overall Study||20
6670552|NCT02569710|7601456|FG004|COMPLETED|Overall Study||7
6670553|NCT02569710|7601457|FG005|COMPLETED|Overall Study||4
6670554|NCT02569710|7601458|FG006|COMPLETED|Overall Study||12
6670555|NCT02569710|7601459|FG007|COMPLETED|Overall Study||30
6670556|NCT02569710|7601460|FG008|COMPLETED|Overall Study||14
6670557|NCT02569710|7601461|FG009|COMPLETED|Overall Study||4
6670558|NCT02569710|7601452|FG000|NOT COMPLETED|Overall Study||1
6670559|NCT02569710|7601453|FG001|NOT COMPLETED|Overall Study||0
6670560|NCT02569710|7601454|FG002|NOT COMPLETED|Overall Study||0
6670561|NCT02569710|7601455|FG003|NOT COMPLETED|Overall Study||0
6670562|NCT02569710|7601456|FG004|NOT COMPLETED|Overall Study||1
6670563|NCT02569710|7601457|FG005|NOT COMPLETED|Overall Study||1
6670564|NCT02569710|7601458|FG006|NOT COMPLETED|Overall Study||2
6670565|NCT02569710|7601459|FG007|NOT COMPLETED|Overall Study||0
6670566|NCT02569710|7601460|FG008|NOT COMPLETED|Overall Study||1
6670567|NCT02569710|7601461|FG009|NOT COMPLETED|Overall Study||0
6670568|NCT02569723|7601494|FG000|STARTED|Overall Study||6
6670569|NCT02569723|7601494|FG000|COMPLETED|Overall Study||6
6670570|NCT02569723|7601494|FG000|NOT COMPLETED|Overall Study||0
6670571|NCT02569801|7601500|FG000|STARTED|Overall Study||36
6670572|NCT02569801|7601501|FG001|STARTED|Overall Study||35
6670573|NCT02569801|7601500|FG000|Received Treatment|Overall Study||35
6670574|NCT02569801|7601501|FG001|Received Treatment|Overall Study||35
6670575|NCT02569801|7601500|FG000|COMPLETED|Overall Study||0
6670576|NCT02569801|7601501|FG001|COMPLETED|Overall Study||0
6670577|NCT02569801|7601500|FG000|NOT COMPLETED|Overall Study||36
6670578|NCT02569801|7601501|FG001|NOT COMPLETED|Overall Study||35
6670579|NCT02569853|7601509|FG000|STARTED|Overall Study||131
6670580|NCT02569853|7601510|FG001|STARTED|Overall Study||137
6670581|NCT02569853|7601509|FG000|COMPLETED|Overall Study||111
6670582|NCT02569853|7601510|FG001|COMPLETED|Overall Study||123
6670583|NCT02569853|7601509|FG000|NOT COMPLETED|Overall Study||20
6670584|NCT02569853|7601510|FG001|NOT COMPLETED|Overall Study||14
6670585|NCT02569892|7601518|FG000|STARTED|Overall Study||10
6670586|NCT02569892|7601519|FG001|STARTED|Overall Study||9
6670587|NCT02569892|7601518|FG000|COMPLETED|Overall Study||10
6670588|NCT02569892|7601519|FG001|COMPLETED|Overall Study||8
6670589|NCT02569892|7601518|FG000|NOT COMPLETED|Overall Study||0
6670590|NCT02569892|7601519|FG001|NOT COMPLETED|Overall Study||1
6670591|NCT02569996|7601525|FG000|STARTED|Overall Study||124
6670592|NCT02569996|7601525|FG000|COMPLETED|Overall Study||69
6670593|NCT02569996|7601525|FG000|NOT COMPLETED|Overall Study||55
6670594|NCT02570022|7601531|FG000|STARTED|Overall Study||26
6670595|NCT02570022|7601532|FG001|STARTED|Overall Study||31
6670596|NCT02570022|7601531|FG000|COMPLETED|Overall Study||26
6670597|NCT02570022|7601532|FG001|COMPLETED|Overall Study||31
6670598|NCT02570022|7601531|FG000|NOT COMPLETED|Overall Study||0
6670599|NCT02570022|7601532|FG001|NOT COMPLETED|Overall Study||0
6670600|NCT02570074|7601540|FG000|STARTED|Period 1 (First Dosing Regimen)||9
6670601|NCT02570074|7601541|FG001|STARTED|Period 1 (First Dosing Regimen)||10
6670602|NCT02570074|7601540|FG000|COMPLETED|Period 1 (First Dosing Regimen)||9
6670603|NCT02570074|7601541|FG001|COMPLETED|Period 1 (First Dosing Regimen)||10
6670604|NCT02570074|7601540|FG000|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
6670605|NCT02570074|7601541|FG001|NOT COMPLETED|Period 1 (First Dosing Regimen)||0
6670606|NCT02570074|7601540|FG000|STARTED|Period 2 (Second Dosing Regimen)||9
6670607|NCT02570074|7601541|FG001|STARTED|Period 2 (Second Dosing Regimen)||10
6670608|NCT02570074|7601540|FG000|COMPLETED|Period 2 (Second Dosing Regimen)||8
6670609|NCT02570074|7601541|FG001|COMPLETED|Period 2 (Second Dosing Regimen)||10
6670610|NCT02570074|7601540|FG000|NOT COMPLETED|Period 2 (Second Dosing Regimen)||1
6670611|NCT02570074|7601541|FG001|NOT COMPLETED|Period 2 (Second Dosing Regimen)||0
6670612|NCT02570126|7601561|FG000|STARTED|Overall Study||615
6670613|NCT02570126|7601562|FG001|STARTED|Overall Study||616
6670614|NCT02570126|7601561|FG000|COMPLETED|Overall Study||609
6670615|NCT02570126|7601562|FG001|COMPLETED|Overall Study||607
6670616|NCT02570126|7601561|FG000|NOT COMPLETED|Overall Study||6
6670617|NCT02570126|7601562|FG001|NOT COMPLETED|Overall Study||9
6670618|NCT02570139|7601570|FG000|STARTED|Overall Study|24 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|24
6670619|NCT02570139|7601571|FG001|STARTED|Overall Study|21 subjects treated with SensiCare Protective Barrier|21
6670620|NCT02570139|7601570|FG000|COMPLETED|Overall Study||24
6670621|NCT02570139|7601571|FG001|COMPLETED|Overall Study||21
6670622|NCT02570139|7601570|FG000|NOT COMPLETED|Overall Study||0
6670623|NCT02570139|7601571|FG001|NOT COMPLETED|Overall Study||0
6670624|NCT02570152|7601577|FG000|STARTED|Overall Study||2004
6670625|NCT02570152|7601577|FG000|COMPLETED|Overall Study||1989
6670626|NCT02570152|7601577|FG000|NOT COMPLETED|Overall Study||15
6670627|NCT02570165|7601588|FG000|STARTED|Overall Study||46
6670628|NCT02570165|7601589|FG001|STARTED|Overall Study||46
6670629|NCT02570165|7601590|FG002|STARTED|Overall Study||46
6670630|NCT02570165|7601591|FG003|STARTED|Overall Study||45
6670631|NCT02570165|7601592|FG004|STARTED|Overall Study||47
6670632|NCT02570165|7601593|FG005|STARTED|Overall Study||46
6670633|NCT02570165|7601594|FG006|STARTED|Overall Study||47
6670634|NCT02570165|7601588|FG000|COMPLETED|Overall Study||44
6670635|NCT02570165|7601589|FG001|COMPLETED|Overall Study||43
6670636|NCT02570165|7601590|FG002|COMPLETED|Overall Study||41
6670637|NCT02570165|7601591|FG003|COMPLETED|Overall Study||40
6670638|NCT02570165|7601592|FG004|COMPLETED|Overall Study||41
6670639|NCT02570165|7601593|FG005|COMPLETED|Overall Study||44
6670640|NCT02570165|7601594|FG006|COMPLETED|Overall Study||47
6670641|NCT02570165|7601588|FG000|NOT COMPLETED|Overall Study||2
6670642|NCT02570165|7601589|FG001|NOT COMPLETED|Overall Study||3
6670643|NCT02570165|7601590|FG002|NOT COMPLETED|Overall Study||5
6670644|NCT02570165|7601591|FG003|NOT COMPLETED|Overall Study||5
6670645|NCT02570165|7601592|FG004|NOT COMPLETED|Overall Study||6
6670646|NCT02570165|7601593|FG005|NOT COMPLETED|Overall Study||2
6670647|NCT02570165|7601594|FG006|NOT COMPLETED|Overall Study||0
6670648|NCT02570295|7601612|FG000|STARTED|Overall Study||375
6670649|NCT02570295|7601613|FG001|STARTED|Overall Study||347
6670650|NCT02570295|7601612|FG000|COMPLETED|Overall Study||364
6670651|NCT02570295|7601613|FG001|COMPLETED|Overall Study||289
6670652|NCT02570295|7601612|FG000|NOT COMPLETED|Overall Study||11
6670653|NCT02570295|7601613|FG001|NOT COMPLETED|Overall Study||58
6670654|NCT02570425|7601621|FG000|STARTED|Visit 1||274
6670655|NCT02570425|7601622|FG001|STARTED|Visit 1||242
6670656|NCT02570425|7601621|FG000|COMPLETED|Visit 1||274
6670657|NCT02570425|7601622|FG001|COMPLETED|Visit 1||242
6670658|NCT02570425|7601621|FG000|NOT COMPLETED|Visit 1||0
6670659|NCT02570425|7601622|FG001|NOT COMPLETED|Visit 1||0
6670660|NCT02570425|7601621|FG000|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
6670661|NCT02570425|7601622|FG001|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
6670662|NCT02570425|7601621|FG000|COMPLETED|Visit 2||251
6670663|NCT02570425|7601622|FG001|COMPLETED|Visit 2||247
6670664|NCT02570425|7601621|FG000|NOT COMPLETED|Visit 2||0
6670665|NCT02570425|7601622|FG001|NOT COMPLETED|Visit 2||0
6670666|NCT02570425|7601621|FG000|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
6670667|NCT02570425|7601622|FG001|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
6670668|NCT02570425|7601621|FG000|COMPLETED|Visit 3||229
6670669|NCT02570425|7601622|FG001|COMPLETED|Visit 3||231
6670670|NCT02570425|7601621|FG000|NOT COMPLETED|Visit 3||0
6670671|NCT02570425|7601622|FG001|NOT COMPLETED|Visit 3||0
6670672|NCT02570711|7601633|FG000|STARTED|Overall Study||1
6670673|NCT02570711|7601634|FG001|STARTED|Overall Study||2
6670674|NCT02570711|7601633|FG000|COMPLETED|Overall Study||0
6670675|NCT02570711|7601634|FG001|COMPLETED|Overall Study||0
6670676|NCT02570711|7601633|FG000|NOT COMPLETED|Overall Study||1
6670677|NCT02570711|7601634|FG001|NOT COMPLETED|Overall Study||2
6670678|NCT02570750|7601642|FG000|STARTED|Overall Study||110
6670679|NCT02570750|7601643|FG001|STARTED|Overall Study||73
6670680|NCT02570750|7601642|FG000|COMPLETED|Overall Study||96
6670681|NCT02570750|7601643|FG001|COMPLETED|Overall Study||68
6670682|NCT02570750|7601642|FG000|NOT COMPLETED|Overall Study||14
6670683|NCT02570750|7601643|FG001|NOT COMPLETED|Overall Study||5
6670684|NCT02571049|7601649|FG000|STARTED|Screening||10
6670685|NCT02571049|7601650|FG001|STARTED|Screening||14
6670686|NCT02571049|7601649|FG000|COMPLETED|Screening||8
6670687|NCT02571049|7601650|FG001|COMPLETED|Screening||12
6670688|NCT02571049|7601649|FG000|NOT COMPLETED|Screening||2
6670689|NCT02571049|7601650|FG001|NOT COMPLETED|Screening||2
6670690|NCT02571049|7601649|FG000|STARTED|Randomization||8
6670691|NCT02571049|7601650|FG001|STARTED|Randomization||12
6670692|NCT02571049|7601649|FG000|COMPLETED|Randomization||8
6670693|NCT02571049|7601650|FG001|COMPLETED|Randomization||10
6670694|NCT02571049|7601649|FG000|NOT COMPLETED|Randomization||0
6670695|NCT02571049|7601650|FG001|NOT COMPLETED|Randomization||2
6670696|NCT02571075|7601658|FG000|STARTED|Overall Study||45
6670697|NCT02571075|7601659|FG001|STARTED|Overall Study||50
6670698|NCT02571075|7601658|FG000|COMPLETED|Overall Study||25
6670699|NCT02571075|7601659|FG001|COMPLETED|Overall Study||26
6670700|NCT02571075|7601658|FG000|NOT COMPLETED|Overall Study||20
6670701|NCT02571075|7601659|FG001|NOT COMPLETED|Overall Study||24
6670702|NCT02571153|7601668|FG000|STARTED|Overall Study||45
6670703|NCT02571153|7601669|FG001|STARTED|Overall Study||45
6670704|NCT02571153|7601670|FG002|STARTED|Overall Study||45
6670705|NCT02571153|7601668|FG000|COMPLETED|Overall Study||39
6670706|NCT02571153|7601669|FG001|COMPLETED|Overall Study||37
6670707|NCT02571153|7601670|FG002|COMPLETED|Overall Study||43
6670708|NCT02571153|7601668|FG000|NOT COMPLETED|Overall Study||6
6670709|NCT02571153|7601669|FG001|NOT COMPLETED|Overall Study||8
6670710|NCT02571153|7601670|FG002|NOT COMPLETED|Overall Study||2
6670711|NCT02571218|7601680|FG000|STARTED|Overall Study||40
6670712|NCT02571218|7601681|FG001|STARTED|Overall Study||41
6670713|NCT02571218|7601680|FG000|COMPLETED|Overall Study||40
6670714|NCT02571218|7601681|FG001|COMPLETED|Overall Study||41
6670715|NCT02571218|7601680|FG000|NOT COMPLETED|Overall Study||0
6670716|NCT02571218|7601681|FG001|NOT COMPLETED|Overall Study||0
6670717|NCT02571244|7601689|FG000|STARTED|Overall Study||44
6670718|NCT02571244|7601690|FG001|STARTED|Overall Study||22
6670719|NCT02571244|7601689|FG000|COMPLETED|Overall Study||41
6670720|NCT02571244|7601690|FG001|COMPLETED|Overall Study||21
6670721|NCT02571244|7601689|FG000|NOT COMPLETED|Overall Study||3
6670722|NCT02571244|7601690|FG001|NOT COMPLETED|Overall Study||1
6670723|NCT02571439|7601701|FG000|STARTED|Overall Study||20
6670724|NCT02571439|7601702|FG001|STARTED|Overall Study||21
6670725|NCT02571439|7601701|FG000|COMPLETED|Overall Study||20
6670726|NCT02571439|7601702|FG001|COMPLETED|Overall Study||21
6670727|NCT02571439|7601701|FG000|NOT COMPLETED|Overall Study||0
6670728|NCT02571439|7601702|FG001|NOT COMPLETED|Overall Study||0
6670729|NCT02571452|7601710|FG000|STARTED|Overall Study Treatment||47
6670730|NCT02571452|7601711|FG001|STARTED|Overall Study Treatment||46
6670731|NCT02571452|7601710|FG000|COMPLETED|Overall Study Treatment||47
6670732|NCT02571452|7601711|FG001|COMPLETED|Overall Study Treatment||45
6670733|NCT02571452|7601710|FG000|NOT COMPLETED|Overall Study Treatment||0
6670734|NCT02571452|7601711|FG001|NOT COMPLETED|Overall Study Treatment||1
6670735|NCT02571452|7601710|FG000|STARTED|Overall Study 6-Month Follow-up||47
6670736|NCT02571452|7601711|FG001|STARTED|Overall Study 6-Month Follow-up|Participants in the PMRT arm were not invited to complete 6-Month Follow-up.|0
6670737|NCT02571452|7601710|FG000|COMPLETED|Overall Study 6-Month Follow-up||42
6670738|NCT02571452|7601711|FG001|COMPLETED|Overall Study 6-Month Follow-up||0
6670739|NCT02571452|7601710|FG000|NOT COMPLETED|Overall Study 6-Month Follow-up||5
6670740|NCT02571452|7601711|FG001|NOT COMPLETED|Overall Study 6-Month Follow-up||0
6670741|NCT02571634|7601717|FG000|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
6670742|NCT02571634|7601717|FG000|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
6670743|NCT02571634|7601717|FG000|NOT COMPLETED|Overall Study||0
6670744|NCT02571777|7601727|FG000|STARTED|Overall Study||619
6670745|NCT02571777|7601728|FG001|STARTED|Overall Study||620
6670746|NCT02571777|7601729|FG002|STARTED|Overall Study||618
6670747|NCT02571777|7601730|FG003|STARTED|Overall Study||617
6670748|NCT02571777|7601731|FG004|STARTED|Overall Study||618
6670749|NCT02571777|7601727|FG000|Full Analysis Set (FAS)|Overall Study||615
6670750|NCT02571777|7601728|FG001|Full Analysis Set (FAS)|Overall Study||616
6670751|NCT02571777|7601729|FG002|Full Analysis Set (FAS)|Overall Study||611
6670752|NCT02571777|7601730|FG003|Full Analysis Set (FAS)|Overall Study||607
6670753|NCT02571777|7601731|FG004|Full Analysis Set (FAS)|Overall Study||612
6670754|NCT02571777|7601727|FG000|Safety Set (SAF)|Overall Study||616
6670755|NCT02571777|7601728|FG001|Safety Set (SAF)|Overall Study||617
6670756|NCT02571777|7601729|FG002|Safety Set (SAF)|Overall Study||613
6670757|NCT02571777|7601730|FG003|Safety Set (SAF)|Overall Study||608
6670758|NCT02571777|7601731|FG004|Safety Set (SAF)|Overall Study||618
6670759|NCT02571777|7601727|FG000|COMPLETED|Overall Study||580
6670760|NCT02571777|7601728|FG001|COMPLETED|Overall Study||582
6670761|NCT02571777|7601729|FG002|COMPLETED|Overall Study||577
6670762|NCT02571777|7601730|FG003|COMPLETED|Overall Study||580
6670763|NCT02571777|7601731|FG004|COMPLETED|Overall Study||582
6670764|NCT02571777|7601727|FG000|NOT COMPLETED|Overall Study||39
6670765|NCT02571777|7601728|FG001|NOT COMPLETED|Overall Study||38
6670766|NCT02571777|7601729|FG002|NOT COMPLETED|Overall Study||41
6670767|NCT02571777|7601730|FG003|NOT COMPLETED|Overall Study||37
6670768|NCT02571777|7601731|FG004|NOT COMPLETED|Overall Study||36
6670769|NCT02571972|7601743|FG000|STARTED|Overall Study|2 patients signed consent but withdrew from the study prior to using dorzolamide-timolol drops.|14
6670770|NCT02571972|7601743|FG000|COMPLETED|Overall Study||10
6670771|NCT02571972|7601743|FG000|NOT COMPLETED|Overall Study||4
6670772|NCT02572076|7601747|FG000|STARTED|Overall Study||10
6670773|NCT02572076|7601747|FG000|COMPLETED|Overall Study||9
6670774|NCT02572076|7601747|FG000|NOT COMPLETED|Overall Study||1
6670775|NCT02572167|7601754|FG000|STARTED|Overall Study||6
6670776|NCT02572167|7601755|FG001|STARTED|Overall Study||56
6670777|NCT02572167|7601756|FG002|STARTED|Overall Study||31
6670778|NCT02572167|7601754|FG000|COMPLETED|Overall Study||0
6670779|NCT02572167|7601755|FG001|COMPLETED|Overall Study||0
6670780|NCT02572167|7601756|FG002|COMPLETED|Overall Study||0
6670781|NCT02572167|7601754|FG000|NOT COMPLETED|Overall Study||6
6670782|NCT02572167|7601755|FG001|NOT COMPLETED|Overall Study||56
6670783|NCT02572167|7601756|FG002|NOT COMPLETED|Overall Study||31
6670784|NCT02572388|7601768|FG000|STARTED|Overall Study||11
6670785|NCT02572388|7601769|FG001|STARTED|Overall Study||4
6670786|NCT02572388|7601770|FG002|STARTED|Overall Study||10
6670787|NCT02572388|7601771|FG003|STARTED|Overall Study||6
6670788|NCT02572388|7601768|FG000|COMPLETED|Overall Study||10
6670789|NCT02572388|7601769|FG001|COMPLETED|Overall Study||3
6670790|NCT02572388|7601770|FG002|COMPLETED|Overall Study||8
6670791|NCT02572388|7601771|FG003|COMPLETED|Overall Study||4
6670792|NCT02572388|7601768|FG000|NOT COMPLETED|Overall Study||1
6670793|NCT02572388|7601769|FG001|NOT COMPLETED|Overall Study||1
6670794|NCT02572388|7601770|FG002|NOT COMPLETED|Overall Study||2
6670795|NCT02572388|7601771|FG003|NOT COMPLETED|Overall Study||2
6670796|NCT02572401|7601785|FG000|STARTED|Overall Study||97
6670797|NCT02572401|7601786|FG001|STARTED|Overall Study||98
6670798|NCT02572401|7601787|FG002|STARTED|Overall Study||98
6670799|NCT02572401|7601788|FG003|STARTED|Overall Study||98
6670800|NCT02572401|7601785|FG000|COMPLETED|Overall Study||92
6670801|NCT02572401|7601786|FG001|COMPLETED|Overall Study||90
6670802|NCT02572401|7601787|FG002|COMPLETED|Overall Study||89
6670803|NCT02572401|7601788|FG003|COMPLETED|Overall Study||88
6670804|NCT02572401|7601785|FG000|NOT COMPLETED|Overall Study||5
6670805|NCT02572401|7601786|FG001|NOT COMPLETED|Overall Study||8
6670806|NCT02572401|7601787|FG002|NOT COMPLETED|Overall Study||9
6670807|NCT02572401|7601788|FG003|NOT COMPLETED|Overall Study||10
6670808|NCT02572427|7601800|FG000|STARTED|Overall Study||37
6670809|NCT02572427|7601801|FG001|STARTED|Overall Study||45
6670810|NCT02572427|7601800|FG000|COMPLETED|Overall Study||31
6670811|NCT02572427|7601801|FG001|COMPLETED|Overall Study||36
6670812|NCT02572427|7601800|FG000|NOT COMPLETED|Overall Study||6
6670813|NCT02572427|7601801|FG001|NOT COMPLETED|Overall Study||9
6670814|NCT02572570|7601807|FG000|STARTED|Overall Study||27
6670815|NCT02572570|7601807|FG000|Filtek Bulk Fill Posterior|Overall Study||27
6670816|NCT02572570|7601807|FG000|Filtek Supreme Ultra|Overall Study||27
6670817|NCT02572570|7601807|FG000|1 Year Follow-Up|Overall Study||20
6670818|NCT02572570|7601807|FG000|2 Year Follow-Up|Overall Study||13
6670819|NCT02572570|7601807|FG000|3 Year Follow-Up|Overall Study||5
6670820|NCT02572570|7601807|FG000|5 Year Follow-Up|Overall Study||0
6670821|NCT02572570|7601807|FG000|COMPLETED|Overall Study||0
6670822|NCT02572570|7601807|FG000|NOT COMPLETED|Overall Study||27
6670823|NCT02572609|7601816|FG000|STARTED|Period 1: Treatment Period 1 + Washout||18
6670824|NCT02572609|7601817|FG001|STARTED|Period 1: Treatment Period 1 + Washout||18
6670825|NCT02572609|7601816|FG000|COMPLETED|Period 1: Treatment Period 1 + Washout||18
6670826|NCT02572609|7601817|FG001|COMPLETED|Period 1: Treatment Period 1 + Washout||18
6670827|NCT02572609|7601816|FG000|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
6670828|NCT02572609|7601817|FG001|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
6670829|NCT02572609|7601816|FG000|STARTED|Period 2: Treatment Period 2||18
6670830|NCT02572609|7601817|FG001|STARTED|Period 2: Treatment Period 2||18
6670831|NCT02572609|7601816|FG000|COMPLETED|Period 2: Treatment Period 2||18
6670832|NCT02572609|7601817|FG001|COMPLETED|Period 2: Treatment Period 2||18
6670833|NCT02572609|7601816|FG000|NOT COMPLETED|Period 2: Treatment Period 2||0
6670834|NCT02572609|7601817|FG001|NOT COMPLETED|Period 2: Treatment Period 2||0
6670835|NCT02572752|7601826|FG000|STARTED|Period 1 Including Washout||23
6670836|NCT02572752|7601827|FG001|STARTED|Period 1 Including Washout||23
6670837|NCT02572752|7601828|FG002|STARTED|Period 1 Including Washout||24
6670838|NCT02572752|7601826|FG000|COMPLETED|Period 1 Including Washout||23
6670839|NCT02572752|7601827|FG001|COMPLETED|Period 1 Including Washout||23
6670840|NCT02572752|7601828|FG002|COMPLETED|Period 1 Including Washout||24
6670841|NCT02572752|7601826|FG000|NOT COMPLETED|Period 1 Including Washout||0
6670842|NCT02572752|7601827|FG001|NOT COMPLETED|Period 1 Including Washout||0
6670843|NCT02572752|7601828|FG002|NOT COMPLETED|Period 1 Including Washout||0
6670844|NCT02572752|7601826|FG000|STARTED|Period 2 Including Washout||23
6670845|NCT02572752|7601827|FG001|STARTED|Period 2 Including Washout||23
6670846|NCT02572752|7601828|FG002|STARTED|Period 2 Including Washout||24
6670847|NCT02572752|7601826|FG000|COMPLETED|Period 2 Including Washout||23
6670848|NCT02572752|7601827|FG001|COMPLETED|Period 2 Including Washout||23
6670849|NCT02572752|7601828|FG002|COMPLETED|Period 2 Including Washout||24
6670850|NCT02572752|7601826|FG000|NOT COMPLETED|Period 2 Including Washout||0
6670851|NCT02572752|7601827|FG001|NOT COMPLETED|Period 2 Including Washout||0
6670852|NCT02572752|7601828|FG002|NOT COMPLETED|Period 2 Including Washout||0
6670853|NCT02572752|7601826|FG000|STARTED|Period 3 Including Washout||23
6670854|NCT02572752|7601827|FG001|STARTED|Period 3 Including Washout||23
6670855|NCT02572752|7601828|FG002|STARTED|Period 3 Including Washout||24
6670856|NCT02572752|7601826|FG000|COMPLETED|Period 3 Including Washout||23
6670857|NCT02572752|7601827|FG001|COMPLETED|Period 3 Including Washout||23
6670858|NCT02572752|7601828|FG002|COMPLETED|Period 3 Including Washout||24
6670859|NCT02572752|7601826|FG000|NOT COMPLETED|Period 3 Including Washout||0
6670860|NCT02572752|7601827|FG001|NOT COMPLETED|Period 3 Including Washout||0
6670861|NCT02572752|7601828|FG002|NOT COMPLETED|Period 3 Including Washout||0
6670862|NCT02572817|7601837|FG000|STARTED|Overall Study||91
6670863|NCT02572817|7601838|FG001|STARTED|Overall Study||47
6670864|NCT02572817|7601837|FG000|COMPLETED|Overall Study||82
6670865|NCT02572817|7601838|FG001|COMPLETED|Overall Study||41
6670866|NCT02572817|7601837|FG000|NOT COMPLETED|Overall Study||9
6670867|NCT02572817|7601838|FG001|NOT COMPLETED|Overall Study||6
6670868|NCT02573012|7601846|FG000|STARTED|Overall Study||131
6670869|NCT02573012|7601847|FG001|STARTED|Overall Study||128
6670870|NCT02573012|7601846|FG000|COMPLETED|Overall Study||116
6670871|NCT02573012|7601847|FG001|COMPLETED|Overall Study||113
6670872|NCT02573012|7601846|FG000|NOT COMPLETED|Overall Study||15
6670873|NCT02573012|7601847|FG001|NOT COMPLETED|Overall Study||15
6670874|NCT02573155|7601855|FG000|STARTED|Treatment Period 1||16
6670875|NCT02573155|7601856|FG001|STARTED|Treatment Period 1||38
6670876|NCT02573155|7601855|FG000|COMPLETED|Treatment Period 1||16
6670877|NCT02573155|7601856|FG001|COMPLETED|Treatment Period 1||38
6670878|NCT02573155|7601855|FG000|NOT COMPLETED|Treatment Period 1||0
6670879|NCT02573155|7601856|FG001|NOT COMPLETED|Treatment Period 1||0
6670880|NCT02573155|7601855|FG000|STARTED|Washout Between Treatment Period 1 and 2||16
6670881|NCT02573155|7601856|FG001|STARTED|Washout Between Treatment Period 1 and 2||38
6670882|NCT02573155|7601855|FG000|COMPLETED|Washout Between Treatment Period 1 and 2||16
6670883|NCT02573155|7601856|FG001|COMPLETED|Washout Between Treatment Period 1 and 2||33
6670884|NCT02573155|7601855|FG000|NOT COMPLETED|Washout Between Treatment Period 1 and 2||0
6670885|NCT02573155|7601856|FG001|NOT COMPLETED|Washout Between Treatment Period 1 and 2||5
6670886|NCT02573155|7601855|FG000|STARTED|Period 2||16
6670887|NCT02573155|7601856|FG001|STARTED|Period 2||33
6670888|NCT02573155|7601855|FG000|COMPLETED|Period 2||16
6670889|NCT02573155|7601856|FG001|COMPLETED|Period 2||33
6670890|NCT02573155|7601855|FG000|NOT COMPLETED|Period 2||0
6670891|NCT02573155|7601856|FG001|NOT COMPLETED|Period 2||0
6670892|NCT02573155|7601855|FG000|STARTED|Washout Between Treatment Period 2 and 3||16
6670893|NCT02573155|7601856|FG001|STARTED|Washout Between Treatment Period 2 and 3||33
6670894|NCT02573155|7601855|FG000|COMPLETED|Washout Between Treatment Period 2 and 3||15
6670895|NCT02573155|7601856|FG001|COMPLETED|Washout Between Treatment Period 2 and 3||31
6670896|NCT02573155|7601855|FG000|NOT COMPLETED|Washout Between Treatment Period 2 and 3||1
6670897|NCT02573155|7601856|FG001|NOT COMPLETED|Washout Between Treatment Period 2 and 3||2
6670898|NCT02573155|7601855|FG000|STARTED|Period 3||15
6670899|NCT02573155|7601856|FG001|STARTED|Period 3||31
6670900|NCT02573155|7601855|FG000|COMPLETED|Period 3||15
6670901|NCT02573155|7601856|FG001|COMPLETED|Period 3||31
6670902|NCT02573155|7601855|FG000|NOT COMPLETED|Period 3||0
6670903|NCT02573155|7601856|FG001|NOT COMPLETED|Period 3||0
6670904|NCT02573155|7601855|FG000|STARTED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
6670905|NCT02573155|7601856|FG001|STARTED|Washout Between Treatment Period 3 and 4||31
6670906|NCT02573155|7601855|FG000|COMPLETED|Washout Between Treatment Period 3 and 4|Part 1 comprised 3 treatment periods only|0
6670907|NCT02573155|7601856|FG001|COMPLETED|Washout Between Treatment Period 3 and 4||29
6670908|NCT02573155|7601855|FG000|NOT COMPLETED|Washout Between Treatment Period 3 and 4||0
6670909|NCT02573155|7601856|FG001|NOT COMPLETED|Washout Between Treatment Period 3 and 4||2
6670910|NCT02573155|7601855|FG000|STARTED|Period 4|Part 1 comprised 3 treatment periods only|0
6670911|NCT02573155|7601856|FG001|STARTED|Period 4||29
6670912|NCT02573155|7601855|FG000|COMPLETED|Period 4|Part 1 comprised 3 treatment periods only|0
6670913|NCT02573155|7601856|FG001|COMPLETED|Period 4||29
6670914|NCT02573155|7601855|FG000|NOT COMPLETED|Period 4||0
6670915|NCT02573155|7601856|FG001|NOT COMPLETED|Period 4||0
6670916|NCT02573155|7601855|FG000|STARTED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
6670917|NCT02573155|7601856|FG001|STARTED|Washout Between Treatment Period 4 and 5||29
6670918|NCT02573155|7601855|FG000|COMPLETED|Washout Between Treatment Period 4 and 5|Part 1 comprised 3 treatment periods only|0
6670919|NCT02573155|7601856|FG001|COMPLETED|Washout Between Treatment Period 4 and 5||28
6670920|NCT02573155|7601855|FG000|NOT COMPLETED|Washout Between Treatment Period 4 and 5||0
6670921|NCT02573155|7601856|FG001|NOT COMPLETED|Washout Between Treatment Period 4 and 5||1
6670922|NCT02573155|7601855|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6670923|NCT02573155|7601856|FG001|STARTED|Period 5||28
6670924|NCT02573155|7601855|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6670925|NCT02573155|7601856|FG001|COMPLETED|Period 5||28
6670926|NCT02573155|7601855|FG000|NOT COMPLETED|Period 5||0
6670927|NCT02573155|7601856|FG001|NOT COMPLETED|Period 5||0
6670928|NCT02573181|7601884|FG000|STARTED|Overall Study||127
6670929|NCT02573181|7601885|FG001|STARTED|Overall Study||126
6670930|NCT02573181|7601884|FG000|Vaccinated|Overall Study||127
6670931|NCT02573181|7601885|FG001|Vaccinated|Overall Study||126
6670932|NCT02573181|7601884|FG000|COMPLETED|Overall Study||127
6670933|NCT02573181|7601885|FG001|COMPLETED|Overall Study||126
6670934|NCT02573181|7601884|FG000|NOT COMPLETED|Overall Study||0
6670935|NCT02573181|7601885|FG001|NOT COMPLETED|Overall Study||0
6670936|NCT02573246|7601896|FG000|STARTED|Overall Study||14
6670937|NCT02573246|7601897|FG001|STARTED|Overall Study||15
6670938|NCT02573246|7601898|FG002|STARTED|Overall Study||18
6670939|NCT02573246|7601899|FG003|STARTED|Overall Study||16
6670940|NCT02573246|7601900|FG004|STARTED|Overall Study||15
6670941|NCT02573246|7601896|FG000|COMPLETED|Overall Study||11
6670942|NCT02573246|7601897|FG001|COMPLETED|Overall Study||14
6670943|NCT02573246|7601898|FG002|COMPLETED|Overall Study||15
6670944|NCT02573246|7601899|FG003|COMPLETED|Overall Study||14
6670945|NCT02573246|7601900|FG004|COMPLETED|Overall Study||11
6670946|NCT02573246|7601896|FG000|NOT COMPLETED|Overall Study||3
6670947|NCT02573246|7601897|FG001|NOT COMPLETED|Overall Study||1
6670948|NCT02573246|7601898|FG002|NOT COMPLETED|Overall Study||3
6670949|NCT02573246|7601899|FG003|NOT COMPLETED|Overall Study||2
6670950|NCT02573246|7601900|FG004|NOT COMPLETED|Overall Study||4
6670951|NCT02573311|7601919|FG000|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|1737
6670952|NCT02573311|7601920|FG001|STARTED|Disposition for Part 1|Started are subjects who entered Part 1 and answered the purchase question|364
6670953|NCT02573311|7601919|FG000|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|1730
6670954|NCT02573311|7601920|FG001|COMPLETED|Disposition for Part 1|Completed are the subjects who actually completed Part 1|361
6670955|NCT02573311|7601919|FG000|NOT COMPLETED|Disposition for Part 1||7
6670956|NCT02573311|7601920|FG001|NOT COMPLETED|Disposition for Part 1||3
6670957|NCT02573311|7601919|FG000|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|964
6670958|NCT02573311|7601920|FG001|STARTED|Disposition for Part 2|Started are subjects who purchased study product and are eligible to enter Part-2 of study.|153
6670959|NCT02573311|7601919|FG000|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|754
6670960|NCT02573311|7601920|FG001|COMPLETED|Disposition for Part 2|Completed are the subjects who completed use phase Part-2 (Week 24 and EOS-P2 interviews).|127
6670961|NCT02573311|7601919|FG000|NOT COMPLETED|Disposition for Part 2||210
6670962|NCT02573311|7601920|FG001|NOT COMPLETED|Disposition for Part 2||26
6670963|NCT02573350|7601928|FG000|STARTED|Overall Study||137
6670964|NCT02573350|7601929|FG001|STARTED|Overall Study||76
6670965|NCT02573350|7601928|FG000|Efficacy Analysis Population|Overall Study||132
6670966|NCT02573350|7601929|FG001|Efficacy Analysis Population|Overall Study||73
6670967|NCT02573350|7601928|FG000|Safety Population|Overall Study||137
6670968|NCT02573350|7601929|FG001|Safety Population|Overall Study||76
6670969|NCT02573350|7601928|FG000|COMPLETED|Overall Study||121
6670970|NCT02573350|7601929|FG001|COMPLETED|Overall Study||67
6670971|NCT02573350|7601928|FG000|NOT COMPLETED|Overall Study||16
6670972|NCT02573350|7601929|FG001|NOT COMPLETED|Overall Study||9
6670973|NCT02573402|7601940|FG000|STARTED|Overall Study||12
6670974|NCT02573402|7601941|FG001|STARTED|Overall Study||7
6670975|NCT02573402|7601940|FG000|COMPLETED|Overall Study||12
6670976|NCT02573402|7601941|FG001|COMPLETED|Overall Study||7
6670977|NCT02573402|7601940|FG000|NOT COMPLETED|Overall Study||0
6670978|NCT02573402|7601941|FG001|NOT COMPLETED|Overall Study||0
6670979|NCT02573467|7601951|FG000|STARTED|Double-blind Treatment Epoch||53
6670980|NCT02573467|7601952|FG001|STARTED|Double-blind Treatment Epoch||52
6670981|NCT02573467|7601953|FG002|STARTED|Double-blind Treatment Epoch||51
6670982|NCT02573467|7601954|FG003|STARTED|Double-blind Treatment Epoch||55
6670983|NCT02573467|7601951|FG000|Full Analysis Set|Double-blind Treatment Epoch||53
6670984|NCT02573467|7601952|FG001|Full Analysis Set|Double-blind Treatment Epoch||52
6670985|NCT02573467|7601953|FG002|Full Analysis Set|Double-blind Treatment Epoch||51
6670986|NCT02573467|7601954|FG003|Full Analysis Set|Double-blind Treatment Epoch||55
6670987|NCT02573467|7601951|FG000|COMPLETED|Double-blind Treatment Epoch||0
6670988|NCT02573467|7601952|FG001|COMPLETED|Double-blind Treatment Epoch||0
6670989|NCT02573467|7601953|FG002|COMPLETED|Double-blind Treatment Epoch||0
6256107|NCT03538717|7154941|FG000|COMPLETED|Overall Study||157
6256108|NCT03538717|7154941|FG000|NOT COMPLETED|Overall Study||0
6256109|NCT03408873|7154947|FG000|STARTED|Visit 1 Assessment (Baseline)||30
6670990|NCT02573467|7601954|FG003|COMPLETED|Double-blind Treatment Epoch||0
6670991|NCT02573467|7601951|FG000|NOT COMPLETED|Double-blind Treatment Epoch||53
6670992|NCT02573467|7601952|FG001|NOT COMPLETED|Double-blind Treatment Epoch||52
6670993|NCT02573467|7601953|FG002|NOT COMPLETED|Double-blind Treatment Epoch||51
6670994|NCT02573467|7601954|FG003|NOT COMPLETED|Double-blind Treatment Epoch||55
6670995|NCT02573467|7601951|FG000|STARTED|Post-treatment Follow up Epoch||41
6670996|NCT02573467|7601952|FG001|STARTED|Post-treatment Follow up Epoch||46
6670997|NCT02573467|7601953|FG002|STARTED|Post-treatment Follow up Epoch||44
6670998|NCT02573467|7601954|FG003|STARTED|Post-treatment Follow up Epoch||47
6670999|NCT02573467|7601951|FG000|COMPLETED|Post-treatment Follow up Epoch||35
6671000|NCT02573467|7601952|FG001|COMPLETED|Post-treatment Follow up Epoch||41
6671001|NCT02573467|7601953|FG002|COMPLETED|Post-treatment Follow up Epoch||34
6671002|NCT02573467|7601954|FG003|COMPLETED|Post-treatment Follow up Epoch||44
6671003|NCT02573467|7601951|FG000|NOT COMPLETED|Post-treatment Follow up Epoch||6
6671004|NCT02573467|7601952|FG001|NOT COMPLETED|Post-treatment Follow up Epoch||5
6671005|NCT02573467|7601953|FG002|NOT COMPLETED|Post-treatment Follow up Epoch||10
6671006|NCT02573467|7601954|FG003|NOT COMPLETED|Post-treatment Follow up Epoch||3
6671007|NCT02573493|7601969|FG000|STARTED|Overall Study||40
6671008|NCT02573493|7601970|FG001|STARTED|Overall Study||40
6671009|NCT02573493|7601971|FG002|STARTED|Overall Study||15
6671010|NCT02573493|7601972|FG003|STARTED|Overall Study||1
6671011|NCT02573493|7601969|FG000|COMPLETED|Overall Study||40
6671012|NCT02573493|7601970|FG001|COMPLETED|Overall Study||40
6671013|NCT02573493|7601971|FG002|COMPLETED|Overall Study||15
6671014|NCT02573493|7601972|FG003|COMPLETED|Overall Study||0
6671015|NCT02573493|7601969|FG000|NOT COMPLETED|Overall Study||0
6671016|NCT02573493|7601970|FG001|NOT COMPLETED|Overall Study||0
6671017|NCT02573493|7601971|FG002|NOT COMPLETED|Overall Study||0
6671018|NCT02573493|7601972|FG003|NOT COMPLETED|Overall Study||1
6671019|NCT02573857|7601998|FG000|STARTED|Overall Study||8
6671020|NCT02573857|7601999|FG001|STARTED|Overall Study||8
6671021|NCT02573857|7601998|FG000|COMPLETED|Overall Study||8
6671022|NCT02573857|7601999|FG001|COMPLETED|Overall Study||8
6671023|NCT02573857|7601998|FG000|NOT COMPLETED|Overall Study||0
6671024|NCT02573857|7601999|FG001|NOT COMPLETED|Overall Study||0
6671025|NCT02573870|7602007|FG000|STARTED|Overall Study||20
6671026|NCT02573870|7602008|FG001|STARTED|Overall Study||42
6671027|NCT02573870|7602007|FG000|COMPLETED|Overall Study||20
6671028|NCT02573870|7602008|FG001|COMPLETED|Overall Study||35
6671029|NCT02573870|7602007|FG000|NOT COMPLETED|Overall Study||0
6671030|NCT02573870|7602008|FG001|NOT COMPLETED|Overall Study||7
6671031|NCT02573883|7602016|FG000|STARTED|Six Month Follow Up||25
6671032|NCT02573883|7602017|FG001|STARTED|Six Month Follow Up||27
6671033|NCT02573883|7602018|FG002|STARTED|Six Month Follow Up||0
6671034|NCT02573883|7602019|FG003|STARTED|Six Month Follow Up||0
6671035|NCT02573883|7602016|FG000|COMPLETED|Six Month Follow Up||24
6671036|NCT02573883|7602017|FG001|COMPLETED|Six Month Follow Up||27
6671037|NCT02573883|7602018|FG002|COMPLETED|Six Month Follow Up||0
6671038|NCT02573883|7602019|FG003|COMPLETED|Six Month Follow Up||0
6671039|NCT02573883|7602016|FG000|NOT COMPLETED|Six Month Follow Up||1
6671040|NCT02573883|7602017|FG001|NOT COMPLETED|Six Month Follow Up||0
6671041|NCT02573883|7602018|FG002|NOT COMPLETED|Six Month Follow Up||0
6671042|NCT02573883|7602019|FG003|NOT COMPLETED|Six Month Follow Up||0
6671043|NCT02573883|7602016|FG000|STARTED|One Year Follow Up||13
6671044|NCT02573883|7602017|FG001|STARTED|One Year Follow Up||17
6671045|NCT02573883|7602018|FG002|STARTED|One Year Follow Up||11
6671046|NCT02573883|7602019|FG003|STARTED|One Year Follow Up||10
6671047|NCT02573883|7602016|FG000|COMPLETED|One Year Follow Up||11
6671048|NCT02573883|7602017|FG001|COMPLETED|One Year Follow Up||16
6671049|NCT02573883|7602018|FG002|COMPLETED|One Year Follow Up||11
6671050|NCT02573883|7602019|FG003|COMPLETED|One Year Follow Up||10
6671051|NCT02573883|7602016|FG000|NOT COMPLETED|One Year Follow Up||2
6671052|NCT02573883|7602017|FG001|NOT COMPLETED|One Year Follow Up||1
6671053|NCT02573883|7602018|FG002|NOT COMPLETED|One Year Follow Up||0
6671054|NCT02573883|7602019|FG003|NOT COMPLETED|One Year Follow Up||0
6671055|NCT02573948|7602034|FG000|STARTED|RDS||603
6671056|NCT02573948|7602034|FG000|COMPLETED|RDS||603
6671057|NCT02573948|7602034|FG000|NOT COMPLETED|RDS||0
6738008|NCT03274856|7667240|FG001|COMPLETED|Overall Study||9
6256110|NCT03408873|7154947|FG000|COMPLETED|Visit 1 Assessment (Baseline)||27
6256111|NCT03408873|7154947|FG000|NOT COMPLETED|Visit 1 Assessment (Baseline)||3
6256112|NCT03408873|7154947|FG000|STARTED|Visit 2 Assessment||27
6256113|NCT03408873|7154947|FG000|COMPLETED|Visit 2 Assessment||26
6256114|NCT03408873|7154947|FG000|NOT COMPLETED|Visit 2 Assessment||1
6256115|NCT03408873|7154947|FG000|STARTED|Visit 3 Assessment||26
6256116|NCT03408873|7154947|FG000|COMPLETED|Visit 3 Assessment||25
6671058|NCT02573948|7602034|FG000|STARTED|Longitudinal Cohort|Not on ART a/o MMT. MSM and FSW were prioritized for enrolling,|250
6671059|NCT02573948|7602034|FG000|COMPLETED|Longitudinal Cohort||194
6671060|NCT02573948|7602034|FG000|NOT COMPLETED|Longitudinal Cohort||56
6671061|NCT02574078|7602054|FG000|STARTED|Pre-Treatment Period||13
6671062|NCT02574078|7602055|FG001|STARTED|Pre-Treatment Period||6
6671063|NCT02574078|7602056|FG002|STARTED|Pre-Treatment Period||9
6671064|NCT02574078|7602057|FG003|STARTED|Pre-Treatment Period||35
6671065|NCT02574078|7602058|FG004|STARTED|Pre-Treatment Period||34
6671066|NCT02574078|7602059|FG005|STARTED|Pre-Treatment Period||35
6671067|NCT02574078|7602060|FG006|STARTED|Pre-Treatment Period||18
6671068|NCT02574078|7602061|FG007|STARTED|Pre-Treatment Period||17
6671069|NCT02574078|7602062|FG008|STARTED|Pre-Treatment Period||26
6671070|NCT02574078|7602063|FG009|STARTED|Pre-Treatment Period||26
6671071|NCT02574078|7602064|FG010|STARTED|Pre-Treatment Period||53
6671072|NCT02574078|7602065|FG011|STARTED|Pre-Treatment Period||56
6671073|NCT02574078|7602066|FG012|STARTED|Pre-Treatment Period||13
6671074|NCT02574078|7602054|FG000|COMPLETED|Pre-Treatment Period||13
6671075|NCT02574078|7602055|FG001|COMPLETED|Pre-Treatment Period||6
6671076|NCT02574078|7602056|FG002|COMPLETED|Pre-Treatment Period||9
6671077|NCT02574078|7602057|FG003|COMPLETED|Pre-Treatment Period||35
6671078|NCT02574078|7602058|FG004|COMPLETED|Pre-Treatment Period||34
6671079|NCT02574078|7602059|FG005|COMPLETED|Pre-Treatment Period||34
6671080|NCT02574078|7602060|FG006|COMPLETED|Pre-Treatment Period||14
6671081|NCT02574078|7602061|FG007|COMPLETED|Pre-Treatment Period||14
6671082|NCT02574078|7602062|FG008|COMPLETED|Pre-Treatment Period||25
6671083|NCT02574078|7602063|FG009|COMPLETED|Pre-Treatment Period||26
6671084|NCT02574078|7602064|FG010|COMPLETED|Pre-Treatment Period||49
6671085|NCT02574078|7602065|FG011|COMPLETED|Pre-Treatment Period||55
6671086|NCT02574078|7602066|FG012|COMPLETED|Pre-Treatment Period||13
6671087|NCT02574078|7602054|FG000|NOT COMPLETED|Pre-Treatment Period||0
6671088|NCT02574078|7602055|FG001|NOT COMPLETED|Pre-Treatment Period||0
6671089|NCT02574078|7602056|FG002|NOT COMPLETED|Pre-Treatment Period||0
6671090|NCT02574078|7602057|FG003|NOT COMPLETED|Pre-Treatment Period||0
6671091|NCT02574078|7602058|FG004|NOT COMPLETED|Pre-Treatment Period||0
6671092|NCT02574078|7602059|FG005|NOT COMPLETED|Pre-Treatment Period||1
6671093|NCT02574078|7602060|FG006|NOT COMPLETED|Pre-Treatment Period||4
6671094|NCT02574078|7602061|FG007|NOT COMPLETED|Pre-Treatment Period||3
6671095|NCT02574078|7602062|FG008|NOT COMPLETED|Pre-Treatment Period||1
6671096|NCT02574078|7602063|FG009|NOT COMPLETED|Pre-Treatment Period||0
6671097|NCT02574078|7602064|FG010|NOT COMPLETED|Pre-Treatment Period||4
6671098|NCT02574078|7602065|FG011|NOT COMPLETED|Pre-Treatment Period||1
6671099|NCT02574078|7602066|FG012|NOT COMPLETED|Pre-Treatment Period||0
6671100|NCT02574078|7602054|FG000|STARTED|Treatment Period||13
6671101|NCT02574078|7602055|FG001|STARTED|Treatment Period||6
6671102|NCT02574078|7602056|FG002|STARTED|Treatment Period||9
6671103|NCT02574078|7602057|FG003|STARTED|Treatment Period||35
6671104|NCT02574078|7602058|FG004|STARTED|Treatment Period||34
6671105|NCT02574078|7602059|FG005|STARTED|Treatment Period||34
6671106|NCT02574078|7602060|FG006|STARTED|Treatment Period||14
6671107|NCT02574078|7602061|FG007|STARTED|Treatment Period||14
6671108|NCT02574078|7602062|FG008|STARTED|Treatment Period||25
6671109|NCT02574078|7602063|FG009|STARTED|Treatment Period||26
6671110|NCT02574078|7602064|FG010|STARTED|Treatment Period||49
6671111|NCT02574078|7602065|FG011|STARTED|Treatment Period||55
6671112|NCT02574078|7602066|FG012|STARTED|Treatment Period||13
6671113|NCT02574078|7602054|FG000|COMPLETED|Treatment Period||3
6671114|NCT02574078|7602055|FG001|COMPLETED|Treatment Period||0
6671115|NCT02574078|7602056|FG002|COMPLETED|Treatment Period||0
6671116|NCT02574078|7602057|FG003|COMPLETED|Treatment Period||7
6671117|NCT02574078|7602058|FG004|COMPLETED|Treatment Period||3
6671118|NCT02574078|7602059|FG005|COMPLETED|Treatment Period||1
6671119|NCT02574078|7602060|FG006|COMPLETED|Treatment Period||2
6671120|NCT02574078|7602061|FG007|COMPLETED|Treatment Period||2
6671121|NCT02574078|7602062|FG008|COMPLETED|Treatment Period||1
6671122|NCT02574078|7602063|FG009|COMPLETED|Treatment Period||9
6671123|NCT02574078|7602064|FG010|COMPLETED|Treatment Period||4
6671124|NCT02574078|7602065|FG011|COMPLETED|Treatment Period||8
6671125|NCT02574078|7602066|FG012|COMPLETED|Treatment Period||0
6671126|NCT02574078|7602054|FG000|NOT COMPLETED|Treatment Period||10
6671127|NCT02574078|7602055|FG001|NOT COMPLETED|Treatment Period||6
6671128|NCT02574078|7602056|FG002|NOT COMPLETED|Treatment Period||9
6671129|NCT02574078|7602057|FG003|NOT COMPLETED|Treatment Period||28
6671130|NCT02574078|7602058|FG004|NOT COMPLETED|Treatment Period||31
6671131|NCT02574078|7602059|FG005|NOT COMPLETED|Treatment Period||33
6671132|NCT02574078|7602060|FG006|NOT COMPLETED|Treatment Period||12
6671133|NCT02574078|7602061|FG007|NOT COMPLETED|Treatment Period||12
6671134|NCT02574078|7602062|FG008|NOT COMPLETED|Treatment Period||24
6671135|NCT02574078|7602063|FG009|NOT COMPLETED|Treatment Period||17
6671136|NCT02574078|7602064|FG010|NOT COMPLETED|Treatment Period||45
6671137|NCT02574078|7602065|FG011|NOT COMPLETED|Treatment Period||47
6671138|NCT02574078|7602066|FG012|NOT COMPLETED|Treatment Period||13
6671139|NCT02574247|7602100|FG000|STARTED|Overall Study||10
6671140|NCT02574247|7602101|FG001|STARTED|Overall Study||8
6671141|NCT02574247|7602102|FG002|STARTED|Overall Study||10
6671142|NCT02574247|7602100|FG000|COMPLETED|Overall Study||5
6671143|NCT02574247|7602101|FG001|COMPLETED|Overall Study||5
6671144|NCT02574247|7602102|FG002|COMPLETED|Overall Study||5
6671145|NCT02574247|7602100|FG000|NOT COMPLETED|Overall Study||5
6671146|NCT02574247|7602101|FG001|NOT COMPLETED|Overall Study||3
6671147|NCT02574247|7602102|FG002|NOT COMPLETED|Overall Study||5
6671148|NCT02574260|7602112|FG000|STARTED|Overall Study||3
6671149|NCT02574260|7602112|FG000|COMPLETED|Overall Study||2
6671150|NCT02574260|7602112|FG000|NOT COMPLETED|Overall Study||1
6671151|NCT02574312|7602118|FG000|STARTED|Pre-Operative||44
6671152|NCT02574312|7602119|FG001|STARTED|Pre-Operative||44
6671153|NCT02574312|7602118|FG000|COMPLETED|Pre-Operative||44
6671154|NCT02574312|7602119|FG001|COMPLETED|Pre-Operative||44
6671155|NCT02574312|7602118|FG000|NOT COMPLETED|Pre-Operative||0
6671156|NCT02574312|7602119|FG001|NOT COMPLETED|Pre-Operative||0
6671157|NCT02574312|7602118|FG000|STARTED|3 Months Follow-up||44
6671158|NCT02574312|7602119|FG001|STARTED|3 Months Follow-up||44
6671159|NCT02574312|7602118|FG000|COMPLETED|3 Months Follow-up|One subject withdrew consent|43
6671160|NCT02574312|7602119|FG001|COMPLETED|3 Months Follow-up||44
6671161|NCT02574312|7602118|FG000|NOT COMPLETED|3 Months Follow-up||1
6671162|NCT02574312|7602119|FG001|NOT COMPLETED|3 Months Follow-up||0
6671163|NCT02574520|7602129|FG000|STARTED|Overall Study||48
6671164|NCT02574520|7602130|FG001|STARTED|Overall Study||46
6671165|NCT02574520|7602131|FG002|STARTED|Overall Study||153
6671166|NCT02574520|7602132|FG003|STARTED|Overall Study||152
6671167|NCT02574520|7602129|FG000|Dosed|Overall Study||46
6671168|NCT02574520|7602130|FG001|Dosed|Overall Study||46
6671169|NCT02574520|7602131|FG002|Dosed|Overall Study||148
6671170|NCT02574520|7602132|FG003|Dosed|Overall Study||148
6671171|NCT02574520|7602129|FG000|COMPLETED|Overall Study||46
6671172|NCT02574520|7602130|FG001|COMPLETED|Overall Study||46
6671173|NCT02574520|7602131|FG002|COMPLETED|Overall Study||148
6671174|NCT02574520|7602132|FG003|COMPLETED|Overall Study||144
6671175|NCT02574520|7602129|FG000|NOT COMPLETED|Overall Study||2
6671176|NCT02574520|7602130|FG001|NOT COMPLETED|Overall Study||0
6671177|NCT02574520|7602131|FG002|NOT COMPLETED|Overall Study||5
6671178|NCT02574520|7602132|FG003|NOT COMPLETED|Overall Study||8
6671179|NCT02574598|7602144|FG000|STARTED|Overall Study||40
6671180|NCT02574598|7602145|FG001|STARTED|Overall Study||38
6671181|NCT02574598|7602144|FG000|COMPLETED|Overall Study||40
6671182|NCT02574598|7602145|FG001|COMPLETED|Overall Study||38
6671183|NCT02574598|7602144|FG000|NOT COMPLETED|Overall Study||0
6671184|NCT02574598|7602145|FG001|NOT COMPLETED|Overall Study||0
6671185|NCT02574637|7602156|FG000|STARTED|Double-blind Period||5
6671186|NCT02574637|7602157|FG001|STARTED|Double-blind Period||5
6671187|NCT02574637|7602158|FG002|STARTED|Double-blind Period||9
6671188|NCT02574637|7602159|FG003|STARTED|Double-blind Period||7
6671189|NCT02574637|7602160|FG004|STARTED|Double-blind Period||3
6671190|NCT02574637|7602161|FG005|STARTED|Double-blind Period||0
6671191|NCT02574637|7602162|FG006|STARTED|Double-blind Period||0
6671192|NCT02574637|7602163|FG007|STARTED|Double-blind Period||0
6671193|NCT02574637|7602164|FG008|STARTED|Double-blind Period||0
6671194|NCT02574637|7602165|FG009|STARTED|Double-blind Period||0
6671195|NCT02574637|7602156|FG000|COMPLETED|Double-blind Period||2
6671196|NCT02574637|7602157|FG001|COMPLETED|Double-blind Period||4
6671197|NCT02574637|7602158|FG002|COMPLETED|Double-blind Period||2
6671198|NCT02574637|7602159|FG003|COMPLETED|Double-blind Period||3
6671199|NCT02574637|7602160|FG004|COMPLETED|Double-blind Period||1
6671200|NCT02574637|7602161|FG005|COMPLETED|Double-blind Period||0
6671201|NCT02574637|7602162|FG006|COMPLETED|Double-blind Period||0
6671202|NCT02574637|7602163|FG007|COMPLETED|Double-blind Period||0
6671203|NCT02574637|7602164|FG008|COMPLETED|Double-blind Period||0
6671204|NCT02574637|7602165|FG009|COMPLETED|Double-blind Period||0
6671205|NCT02574637|7602156|FG000|NOT COMPLETED|Double-blind Period||3
6671206|NCT02574637|7602157|FG001|NOT COMPLETED|Double-blind Period||1
6671207|NCT02574637|7602158|FG002|NOT COMPLETED|Double-blind Period||7
6671208|NCT02574637|7602159|FG003|NOT COMPLETED|Double-blind Period||4
6671209|NCT02574637|7602160|FG004|NOT COMPLETED|Double-blind Period||2
6671210|NCT02574637|7602161|FG005|NOT COMPLETED|Double-blind Period||0
6671211|NCT02574637|7602162|FG006|NOT COMPLETED|Double-blind Period||0
6671212|NCT02574637|7602163|FG007|NOT COMPLETED|Double-blind Period||0
6671213|NCT02574637|7602164|FG008|NOT COMPLETED|Double-blind Period||0
6671214|NCT02574637|7602165|FG009|NOT COMPLETED|Double-blind Period||0
6671215|NCT02574637|7602156|FG000|STARTED|Open-label (OL) Period||0
6671216|NCT02574637|7602157|FG001|STARTED|Open-label (OL) Period||0
6671217|NCT02574637|7602158|FG002|STARTED|Open-label (OL) Period||0
6671218|NCT02574637|7602159|FG003|STARTED|Open-label (OL) Period||0
6671219|NCT02574637|7602160|FG004|STARTED|Open-label (OL) Period||0
6671220|NCT02574637|7602161|FG005|STARTED|Open-label (OL) Period||2
6671221|NCT02574637|7602162|FG006|STARTED|Open-label (OL) Period||3
6671222|NCT02574637|7602163|FG007|STARTED|Open-label (OL) Period||2
6671223|NCT02574637|7602164|FG008|STARTED|Open-label (OL) Period||3
6671224|NCT02574637|7602165|FG009|STARTED|Open-label (OL) Period||1
6671225|NCT02574637|7602156|FG000|COMPLETED|Open-label (OL) Period||0
6671226|NCT02574637|7602157|FG001|COMPLETED|Open-label (OL) Period||0
6671227|NCT02574637|7602158|FG002|COMPLETED|Open-label (OL) Period||0
6671228|NCT02574637|7602159|FG003|COMPLETED|Open-label (OL) Period||0
6671229|NCT02574637|7602160|FG004|COMPLETED|Open-label (OL) Period||0
6671230|NCT02574637|7602161|FG005|COMPLETED|Open-label (OL) Period||0
6671231|NCT02574637|7602162|FG006|COMPLETED|Open-label (OL) Period||1
6671232|NCT02574637|7602163|FG007|COMPLETED|Open-label (OL) Period||1
6671233|NCT02574637|7602164|FG008|COMPLETED|Open-label (OL) Period||1
6671234|NCT02574637|7602165|FG009|COMPLETED|Open-label (OL) Period||0
6671235|NCT02574637|7602156|FG000|NOT COMPLETED|Open-label (OL) Period||0
6671236|NCT02574637|7602157|FG001|NOT COMPLETED|Open-label (OL) Period||0
6671237|NCT02574637|7602158|FG002|NOT COMPLETED|Open-label (OL) Period||0
6671238|NCT02574637|7602159|FG003|NOT COMPLETED|Open-label (OL) Period||0
6671239|NCT02574637|7602160|FG004|NOT COMPLETED|Open-label (OL) Period||0
6671240|NCT02574637|7602161|FG005|NOT COMPLETED|Open-label (OL) Period||2
6256117|NCT03408873|7154947|FG000|NOT COMPLETED|Visit 3 Assessment||1
6256118|NCT03408873|7154947|FG000|STARTED|Visit 4 Assessment||25
6256119|NCT03408873|7154947|FG000|COMPLETED|Visit 4 Assessment||23
6256120|NCT03408873|7154947|FG000|NOT COMPLETED|Visit 4 Assessment||2
6256121|NCT03408873|7154947|FG000|STARTED|Visit 5 Assessment||23
6256122|NCT03408873|7154947|FG000|COMPLETED|Visit 5 Assessment||22
6256123|NCT03408873|7154947|FG000|NOT COMPLETED|Visit 5 Assessment||1
6256124|NCT03408873|7154947|FG000|STARTED|Visit 6 Assessment||22
6256125|NCT03408873|7154947|FG000|COMPLETED|Visit 6 Assessment||21
6256126|NCT03408873|7154947|FG000|NOT COMPLETED|Visit 6 Assessment||1
6256127|NCT03408873|7154947|FG000|STARTED|Visit 7 Assessment||21
6256128|NCT03408873|7154947|FG000|COMPLETED|Visit 7 Assessment||21
6671241|NCT02574637|7602162|FG006|NOT COMPLETED|Open-label (OL) Period||2
6671242|NCT02574637|7602163|FG007|NOT COMPLETED|Open-label (OL) Period||1
6671243|NCT02574637|7602164|FG008|NOT COMPLETED|Open-label (OL) Period||2
6671244|NCT02574637|7602165|FG009|NOT COMPLETED|Open-label (OL) Period||1
6671245|NCT02574832|7602186|FG000|STARTED|Overall Study||2
6671246|NCT02574832|7602186|FG000|COMPLETED|Overall Study||2
6671247|NCT02574832|7602186|FG000|NOT COMPLETED|Overall Study||0
6671248|NCT02574845|7602196|FG000|STARTED|Overall Study||3
6671249|NCT02574845|7602197|FG001|STARTED|Overall Study||3
6671250|NCT02574845|7602198|FG002|STARTED|Overall Study||3
6671251|NCT02574845|7602199|FG003|STARTED|Overall Study||3
6671252|NCT02574845|7602200|FG004|STARTED|Overall Study||3
6671253|NCT02574845|7602201|FG005|STARTED|Overall Study||3
6671254|NCT02574845|7602196|FG000|Received T1|Overall Study||3
6671255|NCT02574845|7602197|FG001|Received T1|Overall Study||2
6671256|NCT02574845|7602198|FG002|Received T1|Overall Study||3
6671257|NCT02574845|7602199|FG003|Received T1|Overall Study||3
6671258|NCT02574845|7602200|FG004|Received T1|Overall Study||2
6671259|NCT02574845|7602201|FG005|Received T1|Overall Study|one subject missed treatment period 2|2
6671260|NCT02574845|7602196|FG000|Received T2|Overall Study||3
6671261|NCT02574845|7602197|FG001|Received T2|Overall Study||3
6671262|NCT02574845|7602198|FG002|Received T2|Overall Study||3
6671263|NCT02574845|7602199|FG003|Received T2|Overall Study||3
6671264|NCT02574845|7602200|FG004|Received T2|Overall Study||2
6671265|NCT02574845|7602201|FG005|Received T2|Overall Study||3
6671266|NCT02574845|7602196|FG000|Received T3|Overall Study|one subject missed treatment period 2|2
6671267|NCT02574845|7602197|FG001|Received T3|Overall Study||2
6671268|NCT02574845|7602198|FG002|Received T3|Overall Study||3
6671269|NCT02574845|7602199|FG003|Received T3|Overall Study||3
6671270|NCT02574845|7602200|FG004|Received T3|Overall Study||2
6671271|NCT02574845|7602201|FG005|Received T3|Overall Study||3
6671272|NCT02574845|7602196|FG000|Received T4|Overall Study||3
6671273|NCT02574845|7602197|FG001|Received T4|Overall Study||2
6671274|NCT02574845|7602198|FG002|Received T4|Overall Study||3
6671275|NCT02574845|7602199|FG003|Received T4|Overall Study||3
6671276|NCT02574845|7602200|FG004|Received T4|Overall Study||2
6671277|NCT02574845|7602201|FG005|Received T4|Overall Study||2
6671278|NCT02574845|7602196|FG000|Received T5|Overall Study||3
6671279|NCT02574845|7602197|FG001|Received T5|Overall Study||2
6671280|NCT02574845|7602198|FG002|Received T5|Overall Study||3
6671281|NCT02574845|7602199|FG003|Received T5|Overall Study||3
6671282|NCT02574845|7602200|FG004|Received T5|Overall Study||3
6671283|NCT02574845|7602201|FG005|Received T5|Overall Study||2
6671284|NCT02574845|7602196|FG000|Received R|Overall Study||3
6671285|NCT02574845|7602197|FG001|Received R|Overall Study||2
6671286|NCT02574845|7602198|FG002|Received R|Overall Study||3
6671287|NCT02574845|7602199|FG003|Received R|Overall Study||3
6671288|NCT02574845|7602200|FG004|Received R|Overall Study||2
6671289|NCT02574845|7602201|FG005|Received R|Overall Study||3
6671290|NCT02574845|7602196|FG000|COMPLETED|Overall Study||3
6671291|NCT02574845|7602197|FG001|COMPLETED|Overall Study||2
6671292|NCT02574845|7602198|FG002|COMPLETED|Overall Study||3
6671293|NCT02574845|7602199|FG003|COMPLETED|Overall Study||3
6671294|NCT02574845|7602200|FG004|COMPLETED|Overall Study||2
6671295|NCT02574845|7602201|FG005|COMPLETED|Overall Study||2
6671296|NCT02574845|7602196|FG000|NOT COMPLETED|Overall Study||0
6671297|NCT02574845|7602197|FG001|NOT COMPLETED|Overall Study||1
6671298|NCT02574845|7602198|FG002|NOT COMPLETED|Overall Study||0
6671299|NCT02574845|7602199|FG003|NOT COMPLETED|Overall Study||0
6671300|NCT02574845|7602200|FG004|NOT COMPLETED|Overall Study||1
6671301|NCT02574845|7602201|FG005|NOT COMPLETED|Overall Study||1
6671302|NCT02574858|7602215|FG000|STARTED|Overall Study||25
6671303|NCT02574858|7602215|FG000|COMPLETED|Overall Study||25
6671304|NCT02574858|7602215|FG000|NOT COMPLETED|Overall Study||0
6671305|NCT02575079|7602221|FG000|STARTED|Overall Study||48
6671306|NCT02575079|7602222|FG001|STARTED|Overall Study||71
6671307|NCT02575079|7602221|FG000|COMPLETED|Overall Study||42
6671308|NCT02575079|7602222|FG001|COMPLETED|Overall Study||71
6671309|NCT02575079|7602221|FG000|NOT COMPLETED|Overall Study||6
6671310|NCT02575079|7602222|FG001|NOT COMPLETED|Overall Study||0
6671311|NCT02575300|7602227|FG000|STARTED|Overall Study||20
6671312|NCT02575300|7602227|FG000|COMPLETED|Overall Study||20
6671313|NCT02575300|7602227|FG000|NOT COMPLETED|Overall Study||0
6671314|NCT02575807|7602236|FG000|STARTED|Overall Study||9
6671315|NCT02575807|7602237|FG001|STARTED|Overall Study||4
6671316|NCT02575807|7602238|FG002|STARTED|Overall Study||16
6671317|NCT02575807|7602239|FG003|STARTED|Overall Study||2
6671318|NCT02575807|7602240|FG004|STARTED|Overall Study||4
6671319|NCT02575807|7602236|FG000|Treated|Overall Study||8
6671320|NCT02575807|7602237|FG001|Treated|Overall Study||4
6671321|NCT02575807|7602238|FG002|Treated|Overall Study||16
6671322|NCT02575807|7602239|FG003|Treated|Overall Study||1
6671323|NCT02575807|7602240|FG004|Treated|Overall Study||3
6671324|NCT02575807|7602236|FG000|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6738009|NCT03274856|7667239|FG000|NOT COMPLETED|Overall Study||0
6671325|NCT02575807|7602237|FG001|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6671326|NCT02575807|7602238|FG002|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6671327|NCT02575807|7602239|FG003|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6671328|NCT02575807|7602240|FG004|COMPLETED|Overall Study|Subjects followed until lost to follow-up/consent withdrawn/study termination/death.|0
6671329|NCT02575807|7602236|FG000|NOT COMPLETED|Overall Study||9
6671330|NCT02575807|7602237|FG001|NOT COMPLETED|Overall Study||4
6671331|NCT02575807|7602238|FG002|NOT COMPLETED|Overall Study||16
6671332|NCT02575807|7602239|FG003|NOT COMPLETED|Overall Study||2
6671333|NCT02575807|7602240|FG004|NOT COMPLETED|Overall Study||4
6671334|NCT02575833|7602256|FG000|STARTED|Overall Study||44
6671335|NCT02575833|7602257|FG001|STARTED|Overall Study||45
6671336|NCT02575833|7602256|FG000|Received Study Drug|Overall Study||44
6671337|NCT02575833|7602257|FG001|Received Study Drug|Overall Study||44
6671338|NCT02575833|7602256|FG000|COMPLETED|Overall Study||43
6671339|NCT02575833|7602257|FG001|COMPLETED|Overall Study||44
6671340|NCT02575833|7602256|FG000|NOT COMPLETED|Overall Study||1
6671341|NCT02575833|7602257|FG001|NOT COMPLETED|Overall Study||1
6671342|NCT02575911|7602263|FG000|STARTED|Overall Study||30
6671343|NCT02575911|7602263|FG000|COMPLETED|Overall Study||29
6671344|NCT02575911|7602263|FG000|NOT COMPLETED|Overall Study||1
6671345|NCT02575950|7602275|FG000|STARTED|Overall Study||3
6671346|NCT02575950|7602276|FG001|STARTED|Overall Study||6
6671347|NCT02575950|7602277|FG002|STARTED|Overall Study||6
6671348|NCT02575950|7602278|FG003|STARTED|Overall Study||25
6671349|NCT02575950|7602275|FG000|COMPLETED|Overall Study||3
6671350|NCT02575950|7602276|FG001|COMPLETED|Overall Study||5
6671351|NCT02575950|7602277|FG002|COMPLETED|Overall Study||6
6671352|NCT02575950|7602278|FG003|COMPLETED|Overall Study||20
6671353|NCT02575950|7602275|FG000|NOT COMPLETED|Overall Study||0
6671354|NCT02575950|7602276|FG001|NOT COMPLETED|Overall Study||1
6671355|NCT02575950|7602277|FG002|NOT COMPLETED|Overall Study||0
6671356|NCT02575950|7602278|FG003|NOT COMPLETED|Overall Study||5
6738010|NCT03274856|7667240|FG001|NOT COMPLETED|Overall Study||0
6738011|NCT03274986|7667250|FG000|STARTED|Overall Study||107
6738012|NCT03274986|7667251|FG001|STARTED|Overall Study||113
6738013|NCT03274986|7667250|FG000|Successful Implantation, as Treated|Overall Study||107
6738014|NCT03274986|7667251|FG001|Successful Implantation, as Treated|Overall Study||113
6738015|NCT03274986|7667250|FG000|COMPLETED|Overall Study||107
6738016|NCT03274986|7667251|FG001|COMPLETED|Overall Study||111
6738017|NCT03274986|7667250|FG000|NOT COMPLETED|Overall Study||0
6738018|NCT03274986|7667251|FG001|NOT COMPLETED|Overall Study||2
6738019|NCT03274999|7667264|FG000|STARTED|First Intervention (Day 0)||5
6738020|NCT03274999|7667265|FG001|STARTED|First Intervention (Day 0)||5
6738021|NCT03274999|7667264|FG000|COMPLETED|First Intervention (Day 0)||5
6738022|NCT03274999|7667265|FG001|COMPLETED|First Intervention (Day 0)||5
6738023|NCT03274999|7667264|FG000|NOT COMPLETED|First Intervention (Day 0)||0
6738024|NCT03274999|7667265|FG001|NOT COMPLETED|First Intervention (Day 0)||0
6738025|NCT03274999|7667264|FG000|STARTED|Second Intervention (Day 14)||5
6738026|NCT03274999|7667265|FG001|STARTED|Second Intervention (Day 14)||5
6738027|NCT03274999|7667264|FG000|COMPLETED|Second Intervention (Day 14)||5
6738028|NCT03274999|7667265|FG001|COMPLETED|Second Intervention (Day 14)||5
6738029|NCT03274999|7667264|FG000|NOT COMPLETED|Second Intervention (Day 14)||0
6738030|NCT03274999|7667265|FG001|NOT COMPLETED|Second Intervention (Day 14)||0
6738031|NCT03275246|7667271|FG000|STARTED|Overall Study||8
6738032|NCT03275246|7667271|FG000|COMPLETED|Overall Study||2
6738033|NCT03275246|7667271|FG000|NOT COMPLETED|Overall Study||6
6738034|NCT03275389|7667285|FG000|STARTED|Overall Study||45
6738035|NCT03275389|7667286|FG001|STARTED|Overall Study||46
6738036|NCT03275389|7667287|FG002|STARTED|Overall Study||47
6738037|NCT03275389|7667288|FG003|STARTED|Overall Study||47
6738038|NCT03275389|7667289|FG004|STARTED|Overall Study||48
6738039|NCT03275389|7667290|FG005|STARTED|Overall Study||47
6738040|NCT03275389|7667291|FG006|STARTED|Overall Study||47
6738041|NCT03275389|7667292|FG007|STARTED|Overall Study||48
6738042|NCT03275389|7667293|FG008|STARTED|Overall Study||46
6738043|NCT03275389|7667294|FG009|STARTED|Overall Study||47
6738044|NCT03275389|7667285|FG000|COMPLETED|Overall Study||34
6738045|NCT03275389|7667286|FG001|COMPLETED|Overall Study||30
6738046|NCT03275389|7667287|FG002|COMPLETED|Overall Study||24
6738047|NCT03275389|7667288|FG003|COMPLETED|Overall Study||25
6738048|NCT03275389|7667289|FG004|COMPLETED|Overall Study||32
6738049|NCT03275389|7667290|FG005|COMPLETED|Overall Study||29
6738050|NCT03275389|7667291|FG006|COMPLETED|Overall Study||22
6738051|NCT03275389|7667292|FG007|COMPLETED|Overall Study||30
6738052|NCT03275389|7667293|FG008|COMPLETED|Overall Study||31
6738053|NCT03275389|7667294|FG009|COMPLETED|Overall Study||29
6738054|NCT03275389|7667285|FG000|NOT COMPLETED|Overall Study||11
6738055|NCT03275389|7667286|FG001|NOT COMPLETED|Overall Study||16
6738056|NCT03275389|7667287|FG002|NOT COMPLETED|Overall Study||23
6738057|NCT03275389|7667288|FG003|NOT COMPLETED|Overall Study||22
6738058|NCT03275389|7667289|FG004|NOT COMPLETED|Overall Study||16
6738059|NCT03275389|7667290|FG005|NOT COMPLETED|Overall Study||18
6738060|NCT03275389|7667291|FG006|NOT COMPLETED|Overall Study||25
6738061|NCT03275389|7667292|FG007|NOT COMPLETED|Overall Study||18
6738062|NCT03275389|7667293|FG008|NOT COMPLETED|Overall Study||15
6738063|NCT03275389|7667294|FG009|NOT COMPLETED|Overall Study||18
6671357|NCT02576041|7602286|FG000|STARTED|Placebo (run-in)||18
6671358|NCT02576041|7602286|FG000|COMPLETED|Placebo (run-in)||18
6671359|NCT02576041|7602286|FG000|NOT COMPLETED|Placebo (run-in)||0
6671360|NCT02576041|7602286|FG000|STARTED|Bilastine (Active Treatement)||18
6671361|NCT02576041|7602286|FG000|COMPLETED|Bilastine (Active Treatement)||18
6671362|NCT02576041|7602286|FG000|NOT COMPLETED|Bilastine (Active Treatement)||0
6671363|NCT02576054|7602290|FG000|STARTED|Overall Study||101
6671364|NCT02576054|7602290|FG000|Vaccination 1|Overall Study||100
6671365|NCT02576054|7602290|FG000|Vaccination 2|Overall Study||100
6671366|NCT02576054|7602290|FG000|Vaccination 3|Overall Study||100
6671367|NCT02576054|7602290|FG000|COMPLETED|Overall Study||100
6671368|NCT02576054|7602290|FG000|NOT COMPLETED|Overall Study||1
6671369|NCT02576067|7602298|FG000|STARTED|Overall Study||60
6671370|NCT02576067|7602299|FG001|STARTED|Overall Study||63
6671371|NCT02576067|7602298|FG000|COMPLETED|Overall Study||26
6671372|NCT02576067|7602299|FG001|COMPLETED|Overall Study||27
6671373|NCT02576067|7602298|FG000|NOT COMPLETED|Overall Study||34
6671374|NCT02576067|7602299|FG001|NOT COMPLETED|Overall Study||36
6671375|NCT02576145|7602307|FG000|STARTED|Overall Study||6
6671376|NCT02576145|7602308|FG001|STARTED|Overall Study||5
6671377|NCT02576145|7602307|FG000|COMPLETED|Overall Study||3
6671378|NCT02576145|7602308|FG001|COMPLETED|Overall Study||4
6671379|NCT02576145|7602307|FG000|NOT COMPLETED|Overall Study||3
6671380|NCT02576145|7602308|FG001|NOT COMPLETED|Overall Study||1
6671381|NCT02576249|7602316|FG000|STARTED|Overall Study||15
6671382|NCT02576249|7602317|FG001|STARTED|Overall Study||14
6671383|NCT02576249|7602316|FG000|COMPLETED|Overall Study||15
6671384|NCT02576249|7602317|FG001|COMPLETED|Overall Study||14
6671385|NCT02576249|7602316|FG000|NOT COMPLETED|Overall Study||0
6671386|NCT02576249|7602317|FG001|NOT COMPLETED|Overall Study||0
6671387|NCT02576509|7602325|FG000|STARTED|Pre-Treatment Period||371
6671388|NCT02576509|7602326|FG001|STARTED|Pre-Treatment Period||372
6671389|NCT02576509|7602325|FG000|COMPLETED|Pre-Treatment Period||367
6671390|NCT02576509|7602326|FG001|COMPLETED|Pre-Treatment Period||363
6671391|NCT02576509|7602325|FG000|NOT COMPLETED|Pre-Treatment Period||4
6671392|NCT02576509|7602326|FG001|NOT COMPLETED|Pre-Treatment Period||9
6671393|NCT02576509|7602325|FG000|STARTED|Treatment Period||367
6671394|NCT02576509|7602326|FG001|STARTED|Treatment Period||363
6671395|NCT02576509|7602325|FG000|COMPLETED|Treatment Period||38
6671396|NCT02576509|7602326|FG001|COMPLETED|Treatment Period||8
6671397|NCT02576509|7602325|FG000|NOT COMPLETED|Treatment Period||329
6671398|NCT02576509|7602326|FG001|NOT COMPLETED|Treatment Period||355
6671399|NCT02576509|7602325|FG000|STARTED|Follow-up Period||367
6671400|NCT02576509|7602326|FG001|STARTED|Follow-up Period||363
6671401|NCT02576509|7602325|FG000|COMPLETED|Follow-up Period||318
6671402|NCT02576509|7602326|FG001|COMPLETED|Follow-up Period||311
6671403|NCT02576509|7602325|FG000|NOT COMPLETED|Follow-up Period||49
6671404|NCT02576509|7602326|FG001|NOT COMPLETED|Follow-up Period||52
6671405|NCT02576535|7602332|FG000|STARTED|Overall Study||18
6671406|NCT02576535|7602332|FG000|COMPLETED|Overall Study||16
6671407|NCT02576535|7602332|FG000|NOT COMPLETED|Overall Study||2
6671408|NCT02576587|7602338|FG000|STARTED|Baseline|Total cases baseline visit|161
6671409|NCT02576587|7602339|FG001|STARTED|Baseline|Total controls baseline visit|156
6671410|NCT02576587|7602338|FG000|COMPLETED|Baseline|Baseline visit completed|161
6671411|NCT02576587|7602339|FG001|COMPLETED|Baseline|Baseline visit completed|155
6671412|NCT02576587|7602338|FG000|NOT COMPLETED|Baseline||0
6671413|NCT02576587|7602339|FG001|NOT COMPLETED|Baseline||1
6671414|NCT02576587|7602338|FG000|STARTED|Follow up Period (Case Only)|Completed baseline.|161
6671415|NCT02576587|7602339|FG001|STARTED|Follow up Period (Case Only)|Controls not eligible for follow-up|155
6671416|NCT02576587|7602338|FG000|Selected for Follow up|Follow up Period (Case Only)||61
6671417|NCT02576587|7602339|FG001|Selected for Follow up|Follow up Period (Case Only)||0
6671418|NCT02576587|7602338|FG000|COMPLETED|Follow up Period (Case Only)||44
6671419|NCT02576587|7602339|FG001|COMPLETED|Follow up Period (Case Only)||0
6671420|NCT02576587|7602338|FG000|NOT COMPLETED|Follow up Period (Case Only)||117
6671421|NCT02576587|7602339|FG001|NOT COMPLETED|Follow up Period (Case Only)||155
6671422|NCT02576639|7602352|FG000|STARTED|Overall Study||24
6671423|NCT02576639|7602353|FG001|STARTED|Overall Study||25
6671424|NCT02576639|7602354|FG002|STARTED|Overall Study||25
6671425|NCT02576639|7602355|FG003|STARTED|Overall Study||26
6671426|NCT02576639|7602356|FG004|STARTED|Overall Study||24
6671427|NCT02576639|7602352|FG000|Pharmacodynamic Analysis Set|Overall Study||24
6671428|NCT02576639|7602353|FG001|Pharmacodynamic Analysis Set|Overall Study||24
6671429|NCT02576639|7602354|FG002|Pharmacodynamic Analysis Set|Overall Study||25
6671430|NCT02576639|7602355|FG003|Pharmacodynamic Analysis Set|Overall Study||25
6671431|NCT02576639|7602356|FG004|Pharmacodynamic Analysis Set|Overall Study||25
6671432|NCT02576639|7602352|FG000|Pharmacokinetic Analysis Set|Overall Study||0
6671433|NCT02576639|7602353|FG001|Pharmacokinetic Analysis Set|Overall Study||25
6671434|NCT02576639|7602354|FG002|Pharmacokinetic Analysis Set|Overall Study||25
6671435|NCT02576639|7602355|FG003|Pharmacokinetic Analysis Set|Overall Study||26
6671436|NCT02576639|7602356|FG004|Pharmacokinetic Analysis Set|Overall Study||24
6671437|NCT02576639|7602352|FG000|Safety Analysis Set|Overall Study||24
6671438|NCT02576639|7602353|FG001|Safety Analysis Set|Overall Study||25
6671439|NCT02576639|7602354|FG002|Safety Analysis Set|Overall Study||25
6671440|NCT02576639|7602355|FG003|Safety Analysis Set|Overall Study||26
6671441|NCT02576639|7602356|FG004|Safety Analysis Set|Overall Study||24
6671442|NCT02576639|7602352|FG000|COMPLETED|Overall Study||22
6671443|NCT02576639|7602353|FG001|COMPLETED|Overall Study||23
6671444|NCT02576639|7602354|FG002|COMPLETED|Overall Study||23
6671445|NCT02576639|7602355|FG003|COMPLETED|Overall Study||25
6671446|NCT02576639|7602356|FG004|COMPLETED|Overall Study||20
6671447|NCT02576639|7602352|FG000|NOT COMPLETED|Overall Study||2
6671448|NCT02576639|7602353|FG001|NOT COMPLETED|Overall Study||2
6671449|NCT02576639|7602354|FG002|NOT COMPLETED|Overall Study||2
6671450|NCT02576639|7602355|FG003|NOT COMPLETED|Overall Study||1
6671451|NCT02576639|7602356|FG004|NOT COMPLETED|Overall Study||4
6671452|NCT02576652|7602372|FG000|STARTED|Overall Study||6
6671453|NCT02576652|7602372|FG000|COMPLETED|Overall Study||4
6671454|NCT02576652|7602372|FG000|NOT COMPLETED|Overall Study||2
6671455|NCT02576678|7602379|FG000|STARTED|Overall Study||13
6671456|NCT02576678|7602380|FG001|STARTED|Overall Study||8
6671457|NCT02576678|7602381|FG002|STARTED|Overall Study||21
6671458|NCT02576678|7602379|FG000|Pharmacokinetic (PK) Population|Overall Study||12
6671459|NCT02576678|7602380|FG001|Pharmacokinetic (PK) Population|Overall Study||8
6671460|NCT02576678|7602381|FG002|Pharmacokinetic (PK) Population|Overall Study||18
6671461|NCT02576678|7602379|FG000|COMPLETED|Overall Study||8
6671462|NCT02576678|7602380|FG001|COMPLETED|Overall Study||7
6671463|NCT02576678|7602381|FG002|COMPLETED|Overall Study||16
6671464|NCT02576678|7602379|FG000|NOT COMPLETED|Overall Study||5
6671465|NCT02576678|7602380|FG001|NOT COMPLETED|Overall Study||1
6671466|NCT02576678|7602381|FG002|NOT COMPLETED|Overall Study||5
6671467|NCT02576899|7602391|FG000|STARTED|Overall Study||16
6671468|NCT02576899|7602392|FG001|STARTED|Overall Study||20
6671469|NCT02576899|7602391|FG000|COMPLETED|Overall Study||5
6671470|NCT02576899|7602392|FG001|COMPLETED|Overall Study||7
6671471|NCT02576899|7602391|FG000|NOT COMPLETED|Overall Study||11
6671472|NCT02576899|7602392|FG001|NOT COMPLETED|Overall Study||13
6671473|NCT02576938|7602402|FG000|STARTED|Overall Study||49
6671474|NCT02576938|7602403|FG001|STARTED|Overall Study||37
6671475|NCT02576938|7602404|FG002|STARTED|Overall Study||38
6671476|NCT02576938|7602402|FG000|Received at Least One Dose of Study Drug|Overall Study||49
6671477|NCT02576938|7602403|FG001|Received at Least One Dose of Study Drug|Overall Study||37
6671478|NCT02576938|7602404|FG002|Received at Least One Dose of Study Drug|Overall Study||38
6671479|NCT02576938|7602402|FG000|COMPLETED|Overall Study||29
6671480|NCT02576938|7602403|FG001|COMPLETED|Overall Study||25
6671481|NCT02576938|7602404|FG002|COMPLETED|Overall Study||26
6671482|NCT02576938|7602402|FG000|NOT COMPLETED|Overall Study||20
6671483|NCT02576938|7602403|FG001|NOT COMPLETED|Overall Study||12
6671484|NCT02576938|7602404|FG002|NOT COMPLETED|Overall Study||12
6671485|NCT02576951|7602418|FG000|STARTED|Overall Study||15
6671486|NCT02576951|7602419|FG001|STARTED|Overall Study||3
6671487|NCT02576951|7602420|FG002|STARTED|Overall Study||80
6671488|NCT02576951|7602421|FG003|STARTED|Overall Study||80
6671489|NCT02576951|7602418|FG000|Received at Least One Dose of Study Drug|Overall Study||15
6671490|NCT02576951|7602419|FG001|Received at Least One Dose of Study Drug|Overall Study||3
6671491|NCT02576951|7602420|FG002|Received at Least One Dose of Study Drug|Overall Study||80
6671492|NCT02576951|7602421|FG003|Received at Least One Dose of Study Drug|Overall Study||80
6671493|NCT02576951|7602418|FG000|COMPLETED|Overall Study||14
6671494|NCT02576951|7602419|FG001|COMPLETED|Overall Study||3
6671495|NCT02576951|7602420|FG002|COMPLETED|Overall Study||78
6671496|NCT02576951|7602421|FG003|COMPLETED|Overall Study||75
6671497|NCT02576951|7602418|FG000|NOT COMPLETED|Overall Study||1
6671498|NCT02576951|7602419|FG001|NOT COMPLETED|Overall Study||0
6671499|NCT02576951|7602420|FG002|NOT COMPLETED|Overall Study||2
6671500|NCT02576951|7602421|FG003|NOT COMPLETED|Overall Study||5
6671501|NCT02576977|7602435|FG000|STARTED|Overall Study||126
6671502|NCT02576977|7602436|FG001|STARTED|Overall Study||125
6671503|NCT02576977|7602435|FG000|Treated|Overall Study||122
6671504|NCT02576977|7602436|FG001|Treated|Overall Study||123
6671505|NCT02576977|7602435|FG000|COMPLETED|Overall Study||0
6671506|NCT02576977|7602436|FG001|COMPLETED|Overall Study||0
6671507|NCT02576977|7602435|FG000|NOT COMPLETED|Overall Study||126
6671508|NCT02576977|7602436|FG001|NOT COMPLETED|Overall Study||125
6671509|NCT02576990|7602444|FG000|STARTED|Overall Study||56
6671510|NCT02576990|7602445|FG001|STARTED|Overall Study||24
6671511|NCT02576990|7602444|FG000|Treated|Overall Study||53
6671512|NCT02576990|7602445|FG001|Treated|Overall Study||23
6671513|NCT02576990|7602444|FG000|COMPLETED|Overall Study||0
6671514|NCT02576990|7602445|FG001|COMPLETED|Overall Study||0
6671515|NCT02576990|7602444|FG000|NOT COMPLETED|Overall Study||56
6671516|NCT02576990|7602445|FG001|NOT COMPLETED|Overall Study||24
6671517|NCT02577003|7602453|FG000|STARTED|Overall Study||73
6671518|NCT02577003|7602454|FG001|STARTED|Overall Study||70
6671519|NCT02577003|7602453|FG000|COMPLETED|Overall Study||71
6671520|NCT02577003|7602454|FG001|COMPLETED|Overall Study||65
6671521|NCT02577003|7602453|FG000|NOT COMPLETED|Overall Study||2
6671522|NCT02577003|7602454|FG001|NOT COMPLETED|Overall Study||5
6671523|NCT02577016|7602462|FG000|STARTED|Overall Study||70
6671524|NCT02577016|7602463|FG001|STARTED|Overall Study||71
6671525|NCT02577016|7602462|FG000|COMPLETED|Overall Study||68
6671526|NCT02577016|7602463|FG001|COMPLETED|Overall Study||69
6671527|NCT02577016|7602462|FG000|NOT COMPLETED|Overall Study||2
6671528|NCT02577016|7602463|FG001|NOT COMPLETED|Overall Study||2
6671529|NCT02577029|7602477|FG000|STARTED|Overall Study||10
6671530|NCT02577029|7602478|FG001|STARTED|Overall Study||2
6671531|NCT02577029|7602479|FG002|STARTED|Overall Study||7
6671532|NCT02577029|7602480|FG003|STARTED|Overall Study||12
6671533|NCT02577029|7602481|FG004|STARTED|Overall Study||11
6671534|NCT02577029|7602482|FG005|STARTED|Overall Study||13
6671535|NCT02577029|7602483|FG006|STARTED|Overall Study||12
6671536|NCT02577029|7602484|FG007|STARTED|Overall Study||12
6671537|NCT02577029|7602477|FG000|COMPLETED|Overall Study||0
6671538|NCT02577029|7602478|FG001|COMPLETED|Overall Study||0
6671539|NCT02577029|7602479|FG002|COMPLETED|Overall Study||0
6671540|NCT02577029|7602480|FG003|COMPLETED|Overall Study||0
6671541|NCT02577029|7602481|FG004|COMPLETED|Overall Study||0
6671542|NCT02577029|7602482|FG005|COMPLETED|Overall Study||0
6671543|NCT02577029|7602483|FG006|COMPLETED|Overall Study||0
6671544|NCT02577029|7602484|FG007|COMPLETED|Overall Study||0
6671545|NCT02577029|7602477|FG000|NOT COMPLETED|Overall Study||10
6671546|NCT02577029|7602478|FG001|NOT COMPLETED|Overall Study||2
6671547|NCT02577029|7602479|FG002|NOT COMPLETED|Overall Study||7
6671548|NCT02577029|7602480|FG003|NOT COMPLETED|Overall Study||12
6671549|NCT02577029|7602481|FG004|NOT COMPLETED|Overall Study||11
6671550|NCT02577029|7602482|FG005|NOT COMPLETED|Overall Study||13
6671551|NCT02577029|7602483|FG006|NOT COMPLETED|Overall Study||12
6671552|NCT02577029|7602484|FG007|NOT COMPLETED|Overall Study||12
6671553|NCT02577042|7602504|FG000|STARTED|Overall Study||20
6671554|NCT02577042|7602505|FG001|STARTED|Overall Study||22
6671555|NCT02577042|7602504|FG000|COMPLETED|Overall Study||15
6671556|NCT02577042|7602505|FG001|COMPLETED|Overall Study||19
6671557|NCT02577042|7602504|FG000|NOT COMPLETED|Overall Study||5
6671558|NCT02577042|7602505|FG001|NOT COMPLETED|Overall Study||3
6671559|NCT02577107|7602514|FG000|STARTED|Overall Study||6
6671560|NCT02577107|7602515|FG001|STARTED|Overall Study||6
6671561|NCT02577107|7602514|FG000|COMPLETED|Overall Study||6
6671562|NCT02577107|7602515|FG001|COMPLETED|Overall Study||5
6671563|NCT02577107|7602514|FG000|NOT COMPLETED|Overall Study||0
6671564|NCT02577107|7602515|FG001|NOT COMPLETED|Overall Study||1
6671565|NCT02577146|7602521|FG000|STARTED|Overall Study||74
6671566|NCT02577146|7602521|FG000|COMPLETED|Overall Study||46
6671567|NCT02577146|7602521|FG000|NOT COMPLETED|Overall Study||28
6671568|NCT02577315|7602527|FG000|STARTED|Treatment Period 1 (4 Days)||12
6671569|NCT02577315|7602528|FG001|STARTED|Treatment Period 1 (4 Days)||13
6671570|NCT02577315|7602527|FG000|COMPLETED|Treatment Period 1 (4 Days)||12
6671571|NCT02577315|7602528|FG001|COMPLETED|Treatment Period 1 (4 Days)||12
6671572|NCT02577315|7602527|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6671573|NCT02577315|7602528|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
6671574|NCT02577315|7602527|FG000|STARTED|Washout Period (5 Days)||12
6671575|NCT02577315|7602528|FG001|STARTED|Washout Period (5 Days)||12
6671576|NCT02577315|7602527|FG000|COMPLETED|Washout Period (5 Days)||12
6671577|NCT02577315|7602528|FG001|COMPLETED|Washout Period (5 Days)||12
6671578|NCT02577315|7602527|FG000|NOT COMPLETED|Washout Period (5 Days)||0
6671579|NCT02577315|7602528|FG001|NOT COMPLETED|Washout Period (5 Days)||0
6671580|NCT02577315|7602527|FG000|STARTED|Treatment Period 2 (4 Days)||12
6671581|NCT02577315|7602528|FG001|STARTED|Treatment Period 2 (4 Days)||12
6671582|NCT02577315|7602527|FG000|COMPLETED|Treatment Period 2 (4 Days)||12
6671583|NCT02577315|7602528|FG001|COMPLETED|Treatment Period 2 (4 Days)||12
6671584|NCT02577315|7602527|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6671585|NCT02577315|7602528|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6671586|NCT02577445|7602536|FG000|STARTED|Overall Study||14
6671587|NCT02577445|7602537|FG001|STARTED|Overall Study||17
6671588|NCT02577445|7602536|FG000|COMPLETED|Overall Study|study terminated prematurely|0
6671589|NCT02577445|7602537|FG001|COMPLETED|Overall Study|study terminated prematurely|0
6671590|NCT02577445|7602536|FG000|NOT COMPLETED|Overall Study||14
6671591|NCT02577445|7602537|FG001|NOT COMPLETED|Overall Study||17
6671592|NCT02577510|7602544|FG000|STARTED|Overall Study||21
6671593|NCT02577510|7602545|FG001|STARTED|Overall Study||21
6671594|NCT02577510|7602544|FG000|COMPLETED|Overall Study||21
6671595|NCT02577510|7602545|FG001|COMPLETED|Overall Study||21
6671596|NCT02577510|7602544|FG000|NOT COMPLETED|Overall Study||0
6671597|NCT02577510|7602545|FG001|NOT COMPLETED|Overall Study||0
6671598|NCT02577601|7602554|FG000|STARTED|UPA Only (1 Month)||36
6671599|NCT02577601|7602554|FG000|COMPLETED|UPA Only (1 Month)||36
6671600|NCT02577601|7602554|FG000|NOT COMPLETED|UPA Only (1 Month)||0
6671601|NCT02577601|7602554|FG000|STARTED|Washout (1 Month)||33
6671602|NCT02577601|7602554|FG000|COMPLETED|Washout (1 Month)||33
6671603|NCT02577601|7602554|FG000|NOT COMPLETED|Washout (1 Month)||0
6671604|NCT02577601|7602554|FG000|STARTED|UPA+COC (1 Month)||33
6671605|NCT02577601|7602554|FG000|COMPLETED|UPA+COC (1 Month)||33
6671606|NCT02577601|7602554|FG000|NOT COMPLETED|UPA+COC (1 Month)||0
6671607|NCT02577640|7602565|FG000|STARTED|Dose Escalation Group 1||4
6671608|NCT02577640|7602566|FG001|STARTED|Dose Escalation Group 1||0
6671609|NCT02577640|7602567|FG002|STARTED|Dose Escalation Group 1||0
6671610|NCT02577640|7602568|FG003|STARTED|Dose Escalation Group 1||0
6671611|NCT02577640|7602565|FG000|COMPLETED|Dose Escalation Group 1||3
6671612|NCT02577640|7602566|FG001|COMPLETED|Dose Escalation Group 1||0
6671613|NCT02577640|7602567|FG002|COMPLETED|Dose Escalation Group 1||0
6671614|NCT02577640|7602568|FG003|COMPLETED|Dose Escalation Group 1||0
6671615|NCT02577640|7602565|FG000|NOT COMPLETED|Dose Escalation Group 1||1
6671616|NCT02577640|7602566|FG001|NOT COMPLETED|Dose Escalation Group 1||0
6671617|NCT02577640|7602567|FG002|NOT COMPLETED|Dose Escalation Group 1||0
6671618|NCT02577640|7602568|FG003|NOT COMPLETED|Dose Escalation Group 1||0
6671619|NCT02577640|7602565|FG000|STARTED|Dose Escalation Group 2||0
6671620|NCT02577640|7602566|FG001|STARTED|Dose Escalation Group 2||3
6671621|NCT02577640|7602567|FG002|STARTED|Dose Escalation Group 2||0
6671622|NCT02577640|7602568|FG003|STARTED|Dose Escalation Group 2||0
6671623|NCT02577640|7602565|FG000|COMPLETED|Dose Escalation Group 2||0
6671624|NCT02577640|7602566|FG001|COMPLETED|Dose Escalation Group 2||3
6671625|NCT02577640|7602567|FG002|COMPLETED|Dose Escalation Group 2||0
6671626|NCT02577640|7602568|FG003|COMPLETED|Dose Escalation Group 2||0
6671627|NCT02577640|7602565|FG000|NOT COMPLETED|Dose Escalation Group 2||0
6671628|NCT02577640|7602566|FG001|NOT COMPLETED|Dose Escalation Group 2||0
6671629|NCT02577640|7602567|FG002|NOT COMPLETED|Dose Escalation Group 2||0
6671630|NCT02577640|7602568|FG003|NOT COMPLETED|Dose Escalation Group 2||0
6671631|NCT02577640|7602565|FG000|STARTED|Dose Escalation Group 3||0
6671632|NCT02577640|7602566|FG001|STARTED|Dose Escalation Group 3||0
6671633|NCT02577640|7602567|FG002|STARTED|Dose Escalation Group 3||3
6671634|NCT02577640|7602568|FG003|STARTED|Dose Escalation Group 3||0
6671635|NCT02577640|7602565|FG000|COMPLETED|Dose Escalation Group 3||0
6671636|NCT02577640|7602566|FG001|COMPLETED|Dose Escalation Group 3||0
6671637|NCT02577640|7602567|FG002|COMPLETED|Dose Escalation Group 3||3
6671638|NCT02577640|7602568|FG003|COMPLETED|Dose Escalation Group 3||0
6671639|NCT02577640|7602565|FG000|NOT COMPLETED|Dose Escalation Group 3||0
6671640|NCT02577640|7602566|FG001|NOT COMPLETED|Dose Escalation Group 3||0
6671641|NCT02577640|7602567|FG002|NOT COMPLETED|Dose Escalation Group 3||0
6671642|NCT02577640|7602568|FG003|NOT COMPLETED|Dose Escalation Group 3||0
6671643|NCT02577640|7602565|FG000|STARTED|Maximally Tolerated Dose||0
6671644|NCT02577640|7602566|FG001|STARTED|Maximally Tolerated Dose||0
6671645|NCT02577640|7602567|FG002|STARTED|Maximally Tolerated Dose||0
6671646|NCT02577640|7602568|FG003|STARTED|Maximally Tolerated Dose||1
6671647|NCT02577640|7602565|FG000|COMPLETED|Maximally Tolerated Dose||0
6671648|NCT02577640|7602566|FG001|COMPLETED|Maximally Tolerated Dose||0
6671649|NCT02577640|7602567|FG002|COMPLETED|Maximally Tolerated Dose||0
6671650|NCT02577640|7602568|FG003|COMPLETED|Maximally Tolerated Dose||1
6671651|NCT02577640|7602565|FG000|NOT COMPLETED|Maximally Tolerated Dose||0
6671652|NCT02577640|7602566|FG001|NOT COMPLETED|Maximally Tolerated Dose||0
6671653|NCT02577640|7602567|FG002|NOT COMPLETED|Maximally Tolerated Dose||0
6671654|NCT02577640|7602568|FG003|NOT COMPLETED|Maximally Tolerated Dose||0
6671655|NCT02577718|7602580|FG000|STARTED|Overall Study||60
6671656|NCT02577718|7602580|FG000|COMPLETED|Overall Study||52
6671657|NCT02577718|7602580|FG000|NOT COMPLETED|Overall Study||8
6671658|NCT02577822|7602588|FG000|STARTED|Overall Study||27
6671659|NCT02577822|7602589|FG001|STARTED|Overall Study||33
6671660|NCT02577822|7602588|FG000|COMPLETED|Overall Study||21
6671661|NCT02577822|7602589|FG001|COMPLETED|Overall Study||20
6671662|NCT02577822|7602588|FG000|NOT COMPLETED|Overall Study||6
6671663|NCT02577822|7602589|FG001|NOT COMPLETED|Overall Study||13
6671664|NCT02577887|7602595|FG000|STARTED|Overall Study||2101
6671665|NCT02577887|7602595|FG000|6 Month Follow-up|Overall Study||1938
6671666|NCT02577887|7602595|FG000|COMPLETED|Overall Study||1803
6671667|NCT02577887|7602595|FG000|NOT COMPLETED|Overall Study||298
6671668|NCT02577900|7602602|FG000|STARTED|Overall Study||11
6671669|NCT02577900|7602603|FG001|STARTED|Overall Study||10
6671670|NCT02577900|7602604|FG002|STARTED|Overall Study||10
6671671|NCT02577900|7602602|FG000|COMPLETED|Overall Study||11
6671672|NCT02577900|7602603|FG001|COMPLETED|Overall Study||10
6671673|NCT02577900|7602604|FG002|COMPLETED|Overall Study||10
6671674|NCT02577900|7602602|FG000|NOT COMPLETED|Overall Study||0
6671675|NCT02577900|7602603|FG001|NOT COMPLETED|Overall Study||0
6671676|NCT02577900|7602604|FG002|NOT COMPLETED|Overall Study||0
6671677|NCT02577978|7602614|FG000|STARTED|Overall Study||32
6671678|NCT02577978|7602615|FG001|STARTED|Overall Study||29
6671679|NCT02577978|7602614|FG000|COMPLETED|Overall Study||25
6671680|NCT02577978|7602615|FG001|COMPLETED|Overall Study||25
6671681|NCT02577978|7602614|FG000|NOT COMPLETED|Overall Study||7
6671682|NCT02577978|7602615|FG001|NOT COMPLETED|Overall Study||4
6671683|NCT02577991|7602624|FG000|STARTED|Overall Study||24
6671684|NCT02577991|7602625|FG001|STARTED|Overall Study||27
6671685|NCT02577991|7602626|FG002|STARTED|Overall Study||29
6671686|NCT02577991|7602624|FG000|COMPLETED|Overall Study||21
6671687|NCT02577991|7602625|FG001|COMPLETED|Overall Study||25
6671688|NCT02577991|7602626|FG002|COMPLETED|Overall Study||29
6671689|NCT02577991|7602624|FG000|NOT COMPLETED|Overall Study||3
6671690|NCT02577991|7602625|FG001|NOT COMPLETED|Overall Study||2
6671691|NCT02577991|7602626|FG002|NOT COMPLETED|Overall Study||0
6671692|NCT02578186|7602634|FG000|STARTED|Period 1 (First of Crossover)||17
6671693|NCT02578186|7602635|FG001|STARTED|Period 1 (First of Crossover)||18
6671694|NCT02578186|7602634|FG000|COMPLETED|Period 1 (First of Crossover)||12
6671695|NCT02578186|7602635|FG001|COMPLETED|Period 1 (First of Crossover)||13
6671696|NCT02578186|7602634|FG000|NOT COMPLETED|Period 1 (First of Crossover)||5
6671697|NCT02578186|7602635|FG001|NOT COMPLETED|Period 1 (First of Crossover)||5
6671698|NCT02578186|7602634|FG000|STARTED|Period 2 (Second of Crossover)||12
6671699|NCT02578186|7602635|FG001|STARTED|Period 2 (Second of Crossover)||13
6671700|NCT02578186|7602634|FG000|COMPLETED|Period 2 (Second of Crossover)||12
6671701|NCT02578186|7602635|FG001|COMPLETED|Period 2 (Second of Crossover)||13
6671702|NCT02578186|7602634|FG000|NOT COMPLETED|Period 2 (Second of Crossover)||0
6671703|NCT02578186|7602635|FG001|NOT COMPLETED|Period 2 (Second of Crossover)||0
6671704|NCT02578199|7602641|FG000|STARTED|Overall Study||31
6671705|NCT02578199|7602641|FG000|COMPLETED|Overall Study||27
6671706|NCT02578199|7602641|FG000|NOT COMPLETED|Overall Study||4
6671707|NCT02578238|7602645|FG000|STARTED|Overall Study||143
6671708|NCT02578238|7602645|FG000|COMPLETED|Overall Study||143
6671709|NCT02578238|7602645|FG000|NOT COMPLETED|Overall Study||0
6671710|NCT02578316|7602649|FG000|STARTED|Study Phase||6
6671711|NCT02578316|7602649|FG000|COMPLETED|Study Phase||6
6671712|NCT02578316|7602649|FG000|NOT COMPLETED|Study Phase||0
6671713|NCT02578316|7602649|FG000|STARTED|Extension Phase||6
6671714|NCT02578316|7602649|FG000|COMPLETED|Extension Phase||0
6671715|NCT02578316|7602649|FG000|NOT COMPLETED|Extension Phase||6
6671716|NCT02578706|7602660|FG000|STARTED|Overall Study||9
6671717|NCT02578706|7602661|FG001|STARTED|Overall Study||10
6671718|NCT02578706|7602662|FG002|STARTED|Overall Study||8
6671719|NCT02578706|7602660|FG000|COMPLETED|Overall Study||8
6671720|NCT02578706|7602661|FG001|COMPLETED|Overall Study||5
6671721|NCT02578706|7602662|FG002|COMPLETED|Overall Study||8
6671722|NCT02578706|7602660|FG000|NOT COMPLETED|Overall Study||1
6671723|NCT02578706|7602661|FG001|NOT COMPLETED|Overall Study||5
6671724|NCT02578706|7602662|FG002|NOT COMPLETED|Overall Study||0
6671725|NCT02578745|7602672|FG000|STARTED|Overall Study||60
6671726|NCT02578745|7602673|FG001|STARTED|Overall Study||60
6671727|NCT02578745|7602672|FG000|COMPLETED|Overall Study||60
6671728|NCT02578745|7602673|FG001|COMPLETED|Overall Study||60
6671729|NCT02578745|7602672|FG000|NOT COMPLETED|Overall Study||0
6671730|NCT02578745|7602673|FG001|NOT COMPLETED|Overall Study||0
6671731|NCT02578862|7602682|FG000|STARTED|Overall Study||37
6671732|NCT02578862|7602683|FG001|STARTED|Overall Study||35
6671733|NCT02578862|7602682|FG000|COMPLETED|Overall Study||37
6671734|NCT02578862|7602683|FG001|COMPLETED|Overall Study||33
6671735|NCT02578862|7602682|FG000|NOT COMPLETED|Overall Study||0
6671736|NCT02578862|7602683|FG001|NOT COMPLETED|Overall Study||2
6671737|NCT02578901|7602691|FG000|STARTED|Overall Study||165
6671738|NCT02578901|7602692|FG001|STARTED|Overall Study||165
6671739|NCT02578901|7602691|FG000|COMPLETED|Overall Study||145
6671740|NCT02578901|7602692|FG001|COMPLETED|Overall Study||144
6671741|NCT02578901|7602691|FG000|NOT COMPLETED|Overall Study||20
6671742|NCT02578901|7602692|FG001|NOT COMPLETED|Overall Study||21
6671743|NCT02578940|7602698|FG000|STARTED|Overall Study||109
6671744|NCT02578940|7602698|FG000|Received 18F-fluciclovine|Overall Study||104
6671745|NCT02578940|7602698|FG000|COMPLETED|Overall Study||103
6671746|NCT02578940|7602698|FG000|NOT COMPLETED|Overall Study||6
6671747|NCT02578992|7602706|FG000|STARTED|Overall Study|November 2014|65
6671748|NCT02578992|7602707|FG001|STARTED|Overall Study|November 2014|65
6671749|NCT02578992|7602706|FG000|COMPLETED|Overall Study|October 2015|62
6671750|NCT02578992|7602707|FG001|COMPLETED|Overall Study|October 2015|62
6671751|NCT02578992|7602706|FG000|NOT COMPLETED|Overall Study||3
6671752|NCT02578992|7602707|FG001|NOT COMPLETED|Overall Study||3
6671753|NCT02579057|7602721|FG000|STARTED|Overall Study||19
6671754|NCT02579057|7602722|FG001|STARTED|Overall Study||21
6671755|NCT02579057|7602721|FG000|COMPLETED|Overall Study||19
6671756|NCT02579057|7602722|FG001|COMPLETED|Overall Study||21
6671757|NCT02579057|7602721|FG000|NOT COMPLETED|Overall Study||0
6671758|NCT02579057|7602722|FG001|NOT COMPLETED|Overall Study||0
6671759|NCT02579135|7602730|FG000|STARTED|Overall Study||107
6671760|NCT02579135|7602731|FG001|STARTED|Overall Study||115
6671761|NCT02579135|7602730|FG000|COMPLETED|Overall Study||105
6671762|NCT02579135|7602731|FG001|COMPLETED|Overall Study||106
6671763|NCT02579135|7602730|FG000|NOT COMPLETED|Overall Study||2
6671764|NCT02579135|7602731|FG001|NOT COMPLETED|Overall Study||9
6671765|NCT02579343|7602739|FG000|STARTED|Overall Study||7
6671766|NCT02579343|7602740|FG001|STARTED|Overall Study||6
6671767|NCT02579343|7602739|FG000|COMPLETED|Overall Study||7
6671768|NCT02579343|7602740|FG001|COMPLETED|Overall Study||6
6671769|NCT02579343|7602739|FG000|NOT COMPLETED|Overall Study||0
6671770|NCT02579343|7602740|FG001|NOT COMPLETED|Overall Study||0
6671771|NCT02579382|7602750|FG000|STARTED|Main Study Phase||28
6671772|NCT02579382|7602751|FG001|STARTED|Main Study Phase||53
6671773|NCT02579382|7602752|FG002|STARTED|Main Study Phase||56
6671774|NCT02579382|7602753|FG003|STARTED|Main Study Phase||55
6671775|NCT02579382|7602750|FG000|COMPLETED|Main Study Phase||28
6671776|NCT02579382|7602751|FG001|COMPLETED|Main Study Phase||53
6671777|NCT02579382|7602752|FG002|COMPLETED|Main Study Phase||54
6671778|NCT02579382|7602753|FG003|COMPLETED|Main Study Phase||52
6671779|NCT02579382|7602750|FG000|NOT COMPLETED|Main Study Phase||0
6671780|NCT02579382|7602751|FG001|NOT COMPLETED|Main Study Phase||0
6671781|NCT02579382|7602752|FG002|NOT COMPLETED|Main Study Phase||2
6671782|NCT02579382|7602753|FG003|NOT COMPLETED|Main Study Phase||3
6671783|NCT02579382|7602750|FG000|STARTED|Optional Treatment Extension Phase(OTEP)|1 participant who completed the Main Study Phase did not enter the OTEP.|27
6671784|NCT02579382|7602751|FG001|STARTED|Optional Treatment Extension Phase(OTEP)|2 participants who completed the Main Study Phase did not enter the OTEP.|51
6671785|NCT02579382|7602752|FG002|STARTED|Optional Treatment Extension Phase(OTEP)||54
6671786|NCT02579382|7602753|FG003|STARTED|Optional Treatment Extension Phase(OTEP)|3 participants who completed the Main Study Phase did not enter the OTEP.|49
6671787|NCT02579382|7602750|FG000|COMPLETED|Optional Treatment Extension Phase(OTEP)||26
6671788|NCT02579382|7602751|FG001|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
6671789|NCT02579382|7602752|FG002|COMPLETED|Optional Treatment Extension Phase(OTEP)||50
6671790|NCT02579382|7602753|FG003|COMPLETED|Optional Treatment Extension Phase(OTEP)||44
6671791|NCT02579382|7602750|FG000|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||1
6671792|NCT02579382|7602751|FG001|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||7
6671793|NCT02579382|7602752|FG002|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||4
6671794|NCT02579382|7602753|FG003|NOT COMPLETED|Optional Treatment Extension Phase(OTEP)||5
6671795|NCT02579421|7602775|FG000|STARTED|Overall Study||23
6671796|NCT02579421|7602776|FG001|STARTED|Overall Study||23
6671797|NCT02579421|7602777|FG002|STARTED|Overall Study||6
6671798|NCT02579421|7602778|FG003|STARTED|Overall Study||6
6671799|NCT02579421|7602775|FG000|COMPLETED|Overall Study||17
6671800|NCT02579421|7602776|FG001|COMPLETED|Overall Study||18
6671801|NCT02579421|7602777|FG002|COMPLETED|Overall Study||5
6671802|NCT02579421|7602778|FG003|COMPLETED|Overall Study||3
6671803|NCT02579421|7602775|FG000|NOT COMPLETED|Overall Study||6
6671804|NCT02579421|7602776|FG001|NOT COMPLETED|Overall Study||5
6671805|NCT02579421|7602777|FG002|NOT COMPLETED|Overall Study||1
6671806|NCT02579421|7602778|FG003|NOT COMPLETED|Overall Study||3
6671807|NCT02579603|7602790|FG000|STARTED|Overall Study|Started are the randomised patients|52
6671808|NCT02579603|7602791|FG001|STARTED|Overall Study|Started are the randomised patients|53
6671809|NCT02579603|7602790|FG000|Number of Patients Treated|Overall Study||51
6671810|NCT02579603|7602791|FG001|Number of Patients Treated|Overall Study||53
6671811|NCT02579603|7602790|FG000|COMPLETED|Overall Study||48
6671812|NCT02579603|7602791|FG001|COMPLETED|Overall Study||51
6671813|NCT02579603|7602790|FG000|NOT COMPLETED|Overall Study||4
6671814|NCT02579603|7602791|FG001|NOT COMPLETED|Overall Study||2
6671815|NCT02579616|7602798|FG000|STARTED|Overall Study||29
6671816|NCT02579616|7602798|FG000|Treated|Overall Study||26
6671817|NCT02579616|7602798|FG000|COMPLETED|Overall Study||26
6671818|NCT02579616|7602798|FG000|NOT COMPLETED|Overall Study||3
6671819|NCT02579629|7602805|FG000|STARTED|Overall Study||22
6671820|NCT02579629|7602806|FG001|STARTED|Overall Study||20
6671821|NCT02579629|7602807|FG002|STARTED|Overall Study||22
6671822|NCT02579629|7602805|FG000|COMPLETED|Overall Study||20
6671823|NCT02579629|7602806|FG001|COMPLETED|Overall Study||19
6671824|NCT02579629|7602807|FG002|COMPLETED|Overall Study||20
6671825|NCT02579629|7602805|FG000|NOT COMPLETED|Overall Study||2
6671826|NCT02579629|7602806|FG001|NOT COMPLETED|Overall Study||1
6671827|NCT02579629|7602807|FG002|NOT COMPLETED|Overall Study||2
6671828|NCT02579759|7602818|FG000|STARTED|Overall Study||109
6671829|NCT02579759|7602819|FG001|STARTED|Overall Study||113
6671830|NCT02579759|7602820|FG002|STARTED|Overall Study||101
6671831|NCT02579759|7602818|FG000|COMPLETED|Overall Study||85
6671832|NCT02579759|7602819|FG001|COMPLETED|Overall Study||49
6671833|NCT02579759|7602820|FG002|COMPLETED|Overall Study||80
6671834|NCT02579759|7602818|FG000|NOT COMPLETED|Overall Study||24
6671835|NCT02579759|7602819|FG001|NOT COMPLETED|Overall Study||64
6671836|NCT02579759|7602820|FG002|NOT COMPLETED|Overall Study||21
6671837|NCT02579772|7602830|FG000|STARTED|Overall Study||8
6671838|NCT02579772|7602831|FG001|STARTED|Overall Study||5
6671839|NCT02579772|7602830|FG000|COMPLETED|Overall Study||6
6671840|NCT02579772|7602831|FG001|COMPLETED|Overall Study||3
6671841|NCT02579772|7602830|FG000|NOT COMPLETED|Overall Study||2
6671842|NCT02579772|7602831|FG001|NOT COMPLETED|Overall Study||2
6671843|NCT02579811|7602837|FG000|STARTED|Overall Study||40
6671844|NCT02579811|7602837|FG000|COMPLETED|Overall Study||40
6671845|NCT02579811|7602837|FG000|NOT COMPLETED|Overall Study||0
6671846|NCT02579863|7602843|FG000|STARTED|Overall Study||156
6671847|NCT02579863|7602844|FG001|STARTED|Overall Study||154
6671848|NCT02579863|7602843|FG000|Treated|Overall Study||154
6671849|NCT02579863|7602844|FG001|Treated|Overall Study||148
6671850|NCT02579863|7602843|FG000|COMPLETED|Overall Study||0
6671851|NCT02579863|7602844|FG001|COMPLETED|Overall Study||0
6671852|NCT02579863|7602843|FG000|NOT COMPLETED|Overall Study||156
6671853|NCT02579863|7602844|FG001|NOT COMPLETED|Overall Study||154
6671854|NCT02579876|7602852|FG000|STARTED|Overall Study||15
6671855|NCT02579876|7602853|FG001|STARTED|Overall Study||5
6671856|NCT02579876|7602852|FG000|COMPLETED|Overall Study||14
6671857|NCT02579876|7602853|FG001|COMPLETED|Overall Study||5
6671858|NCT02579876|7602852|FG000|NOT COMPLETED|Overall Study||1
6671859|NCT02579876|7602853|FG001|NOT COMPLETED|Overall Study||0
6671860|NCT02579915|7602861|FG000|STARTED|Overall Study||19
6671861|NCT02579915|7602862|FG001|STARTED|Overall Study||21
6671862|NCT02579915|7602861|FG000|COMPLETED|Overall Study||9
6671863|NCT02579915|7602862|FG001|COMPLETED|Overall Study||16
6671864|NCT02579915|7602861|FG000|NOT COMPLETED|Overall Study||10
6671865|NCT02579915|7602862|FG001|NOT COMPLETED|Overall Study||5
6671866|NCT02579928|7602870|FG000|STARTED|Overall Study||6
6671867|NCT02579928|7602871|FG001|STARTED|Overall Study||11
6671868|NCT02579928|7602870|FG000|COMPLETED|Overall Study||5
6671869|NCT02579928|7602871|FG001|COMPLETED|Overall Study||11
6671870|NCT02579928|7602870|FG000|NOT COMPLETED|Overall Study||1
6671871|NCT02579928|7602871|FG001|NOT COMPLETED|Overall Study||0
6671872|NCT02580188|7602879|FG000|STARTED|Overall Study||35
6671873|NCT02580188|7602880|FG001|STARTED|Overall Study||35
6671874|NCT02580188|7602879|FG000|COMPLETED|Overall Study||32
6671875|NCT02580188|7602880|FG001|COMPLETED|Overall Study||32
6671876|NCT02580188|7602879|FG000|NOT COMPLETED|Overall Study||3
6671877|NCT02580188|7602880|FG001|NOT COMPLETED|Overall Study||3
6671878|NCT02580201|7602889|FG000|STARTED|Overall Study||50
6671879|NCT02580201|7602890|FG001|STARTED|Overall Study||104
6671880|NCT02580201|7602889|FG000|COMPLETED|Overall Study||50
6671881|NCT02580201|7602890|FG001|COMPLETED|Overall Study||104
6671882|NCT02580201|7602889|FG000|NOT COMPLETED|Overall Study||0
6671883|NCT02580201|7602890|FG001|NOT COMPLETED|Overall Study||0
6671884|NCT02580240|7602899|FG000|STARTED|Overall Study||62
6671885|NCT02580240|7602900|FG001|STARTED|Overall Study||58
6671886|NCT02580240|7602899|FG000|COMPLETED|Overall Study||60
6671887|NCT02580240|7602900|FG001|COMPLETED|Overall Study||58
6671888|NCT02580240|7602899|FG000|NOT COMPLETED|Overall Study||2
6671889|NCT02580240|7602900|FG001|NOT COMPLETED|Overall Study||0
6671890|NCT02580318|7602906|FG000|STARTED|Overall Study||54
6671891|NCT02580318|7602906|FG000|Poor Effort|Overall Study||53
6671892|NCT02580318|7602906|FG000|Hyperventilation (Immediate)|Overall Study||54
6671893|NCT02580318|7602906|FG000|Hyperventilation (5 Minutes)|Overall Study||54
6671894|NCT02580318|7602906|FG000|Hyperventilation (10 Minutes)|Overall Study||54
6671895|NCT02580318|7602906|FG000|Drinking Water (Immediate)|Overall Study||51
6671896|NCT02580318|7602906|FG000|Drinking Water (5 Minutes)|Overall Study||54
6671897|NCT02580318|7602906|FG000|COMPLETED|Overall Study||54
6671898|NCT02580318|7602906|FG000|NOT COMPLETED|Overall Study||0
6671899|NCT02580357|7602913|FG000|STARTED|Overall Study||18
6671900|NCT02580357|7602914|FG001|STARTED|Overall Study||18
6671901|NCT02580357|7602915|FG002|STARTED|Overall Study||18
6671902|NCT02580357|7602913|FG000|COMPLETED|Overall Study||15
6671903|NCT02580357|7602914|FG001|COMPLETED|Overall Study||18
6671904|NCT02580357|7602915|FG002|COMPLETED|Overall Study||18
6671905|NCT02580357|7602913|FG000|NOT COMPLETED|Overall Study||3
6671906|NCT02580357|7602914|FG001|NOT COMPLETED|Overall Study||0
6671907|NCT02580357|7602915|FG002|NOT COMPLETED|Overall Study||0
6671908|NCT02580591|7602927|FG000|STARTED|Overall Study||242
6671909|NCT02580591|7602928|FG001|STARTED|Overall Study||242
6671910|NCT02580591|7602929|FG002|STARTED|Overall Study||248
6671911|NCT02580591|7602930|FG003|STARTED|Overall Study||245
6671912|NCT02580591|7602927|FG000|Treated|Overall Study||241
6671913|NCT02580591|7602928|FG001|Treated|Overall Study||241
6671914|NCT02580591|7602929|FG002|Treated|Overall Study||248
6671915|NCT02580591|7602930|FG003|Treated|Overall Study||245
6671916|NCT02580591|7602927|FG000|COMPLETED|Overall Study||224
6671917|NCT02580591|7602928|FG001|COMPLETED|Overall Study||232
6671918|NCT02580591|7602929|FG002|COMPLETED|Overall Study||235
6671919|NCT02580591|7602930|FG003|COMPLETED|Overall Study||233
6671920|NCT02580591|7602927|FG000|NOT COMPLETED|Overall Study||18
6671921|NCT02580591|7602928|FG001|NOT COMPLETED|Overall Study||10
6671922|NCT02580591|7602929|FG002|NOT COMPLETED|Overall Study||13
6671923|NCT02580591|7602930|FG003|NOT COMPLETED|Overall Study||12
6671924|NCT02580799|7602940|FG000|STARTED|Overall Study||30
6671925|NCT02580799|7602940|FG000|COMPLETED|Overall Study||30
6671926|NCT02580799|7602940|FG000|NOT COMPLETED|Overall Study||0
6671927|NCT02580877|7602946|FG000|STARTED|Overall Study||45
6671928|NCT02580877|7602947|FG001|STARTED|Overall Study||47
6671929|NCT02580877|7602946|FG000|COMPLETED|Overall Study||44
6671930|NCT02580877|7602947|FG001|COMPLETED|Overall Study||43
6671931|NCT02580877|7602946|FG000|NOT COMPLETED|Overall Study||1
6671932|NCT02580877|7602947|FG001|NOT COMPLETED|Overall Study||4
6671933|NCT02581111|7602956|FG000|STARTED|Overall Study||98
6671934|NCT02581111|7602957|FG001|STARTED|Overall Study||101
6671935|NCT02581111|7602956|FG000|COMPLETED|Overall Study||96
6671936|NCT02581111|7602957|FG001|COMPLETED|Overall Study||94
6671937|NCT02581111|7602956|FG000|NOT COMPLETED|Overall Study||2
6671938|NCT02581111|7602957|FG001|NOT COMPLETED|Overall Study||7
6671939|NCT02581163|7602963|FG000|STARTED|Overall Study||311
6671940|NCT02581163|7602963|FG000|COMPLETED|Overall Study||282
6671941|NCT02581163|7602963|FG000|NOT COMPLETED|Overall Study||29
6671942|NCT02581189|7602970|FG000|STARTED|Overall Study||534
6671943|NCT02581189|7602970|FG000|COMPLETED|Overall Study||481
6671944|NCT02581189|7602970|FG000|NOT COMPLETED|Overall Study||53
6671945|NCT02581202|7602977|FG000|STARTED|Overall Study||216
6671946|NCT02581202|7602977|FG000|COMPLETED|Overall Study||202
6671947|NCT02581202|7602977|FG000|NOT COMPLETED|Overall Study||14
6671948|NCT02581345|7602984|FG000|STARTED|Part 1: up to Week 16||286
6671949|NCT02581345|7602985|FG001|STARTED|Part 1: up to Week 16||286
6671950|NCT02581345|7602986|FG002|STARTED|Part 1: up to Week 16||0
6671951|NCT02581345|7602987|FG003|STARTED|Part 1: up to Week 16||0
6671952|NCT02581345|7602984|FG000|COMPLETED|Part 1: up to Week 16||271
6671953|NCT02581345|7602985|FG001|COMPLETED|Part 1: up to Week 16||263
6671954|NCT02581345|7602986|FG002|COMPLETED|Part 1: up to Week 16||0
6671955|NCT02581345|7602987|FG003|COMPLETED|Part 1: up to Week 16||0
6671956|NCT02581345|7602984|FG000|NOT COMPLETED|Part 1: up to Week 16||15
6671957|NCT02581345|7602985|FG001|NOT COMPLETED|Part 1: up to Week 16||23
6671958|NCT02581345|7602986|FG002|NOT COMPLETED|Part 1: up to Week 16||0
6671959|NCT02581345|7602987|FG003|NOT COMPLETED|Part 1: up to Week 16||0
6671960|NCT02581345|7602984|FG000|STARTED|Part 2: Week 17 to Week 47||271
6671961|NCT02581345|7602985|FG001|STARTED|Part 2: Week 17 to Week 47||0
6671962|NCT02581345|7602986|FG002|STARTED|Part 2: Week 17 to Week 47||132
6671963|NCT02581345|7602987|FG003|STARTED|Part 2: Week 17 to Week 47||131
6671964|NCT02581345|7602984|FG000|COMPLETED|Part 2: Week 17 to Week 47||242
6671965|NCT02581345|7602985|FG001|COMPLETED|Part 2: Week 17 to Week 47||0
6671966|NCT02581345|7602986|FG002|COMPLETED|Part 2: Week 17 to Week 47||117
6671967|NCT02581345|7602987|FG003|COMPLETED|Part 2: Week 17 to Week 47||119
6671968|NCT02581345|7602984|FG000|NOT COMPLETED|Part 2: Week 17 to Week 47||29
6671969|NCT02581345|7602985|FG001|NOT COMPLETED|Part 2: Week 17 to Week 47||0
6671970|NCT02581345|7602986|FG002|NOT COMPLETED|Part 2: Week 17 to Week 47||15
6671971|NCT02581345|7602987|FG003|NOT COMPLETED|Part 2: Week 17 to Week 47||12
6671972|NCT02581384|7603005|FG000|STARTED|Overall Study||3
6671973|NCT02581384|7603006|FG001|STARTED|Overall Study||2
6671974|NCT02581384|7603005|FG000|COMPLETED|Overall Study||3
6671975|NCT02581384|7603006|FG001|COMPLETED|Overall Study||2
6671976|NCT02581384|7603005|FG000|NOT COMPLETED|Overall Study||0
6671977|NCT02581384|7603006|FG001|NOT COMPLETED|Overall Study||0
6671978|NCT02581410|7603015|FG000|STARTED|Vaccination Phase||215
6671979|NCT02581410|7603016|FG001|STARTED|Vaccination Phase||215
6671980|NCT02581410|7603015|FG000|COMPLETED|Vaccination Phase||213
6671981|NCT02581410|7603016|FG001|COMPLETED|Vaccination Phase||212
6671982|NCT02581410|7603015|FG000|NOT COMPLETED|Vaccination Phase||2
6671983|NCT02581410|7603016|FG001|NOT COMPLETED|Vaccination Phase||3
6671984|NCT02581410|7603015|FG000|STARTED|End of Study Phase||215
6671985|NCT02581410|7603016|FG001|STARTED|End of Study Phase||215
6671986|NCT02581410|7603015|FG000|COMPLETED|End of Study Phase||210
6671987|NCT02581410|7603016|FG001|COMPLETED|End of Study Phase||204
6671988|NCT02581410|7603015|FG000|NOT COMPLETED|End of Study Phase||5
6671989|NCT02581410|7603016|FG001|NOT COMPLETED|End of Study Phase||11
6671990|NCT02581475|7603025|FG000|STARTED|Overall Study||193
6671991|NCT02581475|7603026|FG001|STARTED|Overall Study||193
6671992|NCT02581475|7603025|FG000|COMPLETED|Overall Study||182
6671993|NCT02581475|7603026|FG001|COMPLETED|Overall Study||178
6671994|NCT02581475|7603025|FG000|NOT COMPLETED|Overall Study||11
6671995|NCT02581475|7603026|FG001|NOT COMPLETED|Overall Study||15
6671996|NCT02581488|7603034|FG000|STARTED|Overall Study||51
6671997|NCT02581488|7603035|FG001|STARTED|Overall Study||51
6671998|NCT02581488|7603034|FG000|COMPLETED|Overall Study||42
6671999|NCT02581488|7603035|FG001|COMPLETED|Overall Study||40
6672000|NCT02581488|7603034|FG000|NOT COMPLETED|Overall Study||9
6672001|NCT02581488|7603035|FG001|NOT COMPLETED|Overall Study||11
6672002|NCT02581839|7603041|FG000|STARTED|Overall Study||9
6672003|NCT02581839|7603041|FG000|COMPLETED|Overall Study||9
6672004|NCT02581839|7603041|FG000|NOT COMPLETED|Overall Study||0
6672005|NCT02581865|7603048|FG000|STARTED|Overall Study||40
6672006|NCT02581865|7603049|FG001|STARTED|Overall Study||42
6672007|NCT02581865|7603050|FG002|STARTED|Overall Study||42
6672008|NCT02581865|7603048|FG000|COMPLETED|Overall Study||36
6672009|NCT02581865|7603049|FG001|COMPLETED|Overall Study||35
6672010|NCT02581865|7603050|FG002|COMPLETED|Overall Study||26
6672011|NCT02581865|7603048|FG000|NOT COMPLETED|Overall Study||4
6672012|NCT02581865|7603049|FG001|NOT COMPLETED|Overall Study||7
6672013|NCT02581865|7603050|FG002|NOT COMPLETED|Overall Study||16
6672014|NCT02581891|7603063|FG000|STARTED|Overall Study||135
6672015|NCT02581891|7603064|FG001|STARTED|Overall Study||136
6672016|NCT02581891|7603063|FG000|Completed Treatment|Overall Study||120
6672017|NCT02581891|7603064|FG001|Completed Treatment|Overall Study||117
6672018|NCT02581891|7603063|FG000|COMPLETED|Overall Study||119
6672019|NCT02581891|7603064|FG001|COMPLETED|Overall Study||117
6672020|NCT02581891|7603063|FG000|NOT COMPLETED|Overall Study||16
6672021|NCT02581891|7603064|FG001|NOT COMPLETED|Overall Study||19
6672022|NCT02581995|7603071|FG000|STARTED|Overall Study||560
6672023|NCT02581995|7603071|FG000|Treated|Overall Study||560
6672024|NCT02581995|7603071|FG000|COMPLETED|Overall Study||529
6672025|NCT02581995|7603071|FG000|NOT COMPLETED|Overall Study||31
6672026|NCT02582151|7603077|FG000|STARTED|Overall Study||14
6672027|NCT02582151|7603078|FG001|STARTED|Overall Study||16
6672028|NCT02582151|7603077|FG000|COMPLETED|Overall Study||12
6672029|NCT02582151|7603078|FG001|COMPLETED|Overall Study||16
6672030|NCT02582151|7603077|FG000|NOT COMPLETED|Overall Study||2
6672031|NCT02582151|7603078|FG001|NOT COMPLETED|Overall Study||0
6672032|NCT02582216|7603084|FG000|STARTED|Overall Study||22
6672033|NCT02582216|7603084|FG000|COMPLETED|Overall Study||22
6672034|NCT02582216|7603084|FG000|NOT COMPLETED|Overall Study||0
6672035|NCT02582242|7603091|FG000|STARTED|Overall Study||220
6672036|NCT02582242|7603092|FG001|STARTED|Overall Study||217
6672037|NCT02582242|7603091|FG000|COMPLETED|Overall Study||200
6672038|NCT02582242|7603092|FG001|COMPLETED|Overall Study||200
6672039|NCT02582242|7603091|FG000|NOT COMPLETED|Overall Study||20
6672040|NCT02582242|7603092|FG001|NOT COMPLETED|Overall Study||17
6672041|NCT02582255|7603100|FG000|STARTED|Overall Study||50
6672042|NCT02582255|7603101|FG001|STARTED|Overall Study||50
6672043|NCT02582255|7603100|FG000|COMPLETED|Overall Study||50
6672044|NCT02582255|7603101|FG001|COMPLETED|Overall Study||47
6672045|NCT02582255|7603100|FG000|NOT COMPLETED|Overall Study||0
6256129|NCT03408873|7154947|FG000|NOT COMPLETED|Visit 7 Assessment||0
6256130|NCT03132467|7154951|FG000|STARTED|Overall Study||8
6256131|NCT03132467|7154951|FG000|COMPLETED|Overall Study||4
6256132|NCT03132467|7154951|FG000|NOT COMPLETED|Overall Study||4
6256133|NCT03096288|7154960|FG000|STARTED|Overall Study||19
6256134|NCT03096288|7154961|FG001|STARTED|Overall Study||18
6256135|NCT03096288|7154962|FG002|STARTED|Overall Study||22
6256136|NCT03096288|7154963|FG003|STARTED|Overall Study||25
6256137|NCT03096288|7154960|FG000|COMPLETED|Overall Study||19
6256138|NCT03096288|7154961|FG001|COMPLETED|Overall Study||17
6256139|NCT03096288|7154962|FG002|COMPLETED|Overall Study||22
6256140|NCT03096288|7154963|FG003|COMPLETED|Overall Study||24
6256141|NCT03096288|7154960|FG000|NOT COMPLETED|Overall Study||0
6256142|NCT03096288|7154961|FG001|NOT COMPLETED|Overall Study||1
6256143|NCT03096288|7154962|FG002|NOT COMPLETED|Overall Study||0
6256144|NCT03096288|7154963|FG003|NOT COMPLETED|Overall Study||1
6256145|NCT02919436|7154975|FG000|STARTED|Overall Study||305
6256146|NCT02919436|7154976|FG001|STARTED|Overall Study||305
6256147|NCT02919436|7154975|FG000|COMPLETED|Overall Study||245
6256148|NCT02919436|7154976|FG001|COMPLETED|Overall Study||252
6256149|NCT02919436|7154975|FG000|NOT COMPLETED|Overall Study||60
6256150|NCT02919436|7154976|FG001|NOT COMPLETED|Overall Study||53
6256151|NCT02877134|7154991|FG000|STARTED|Overall Study||72
6256152|NCT02877134|7154992|FG001|STARTED|Overall Study||73
6256153|NCT02877134|7154993|FG002|STARTED|Overall Study||48
6256154|NCT02877134|7154994|FG003|STARTED|Overall Study||50
6256155|NCT02877134|7154995|FG004|STARTED|Overall Study||49
6256156|NCT02877134|7154996|FG005|STARTED|Overall Study||49
6256157|NCT02877134|7154997|FG006|STARTED|Overall Study||47
6256158|NCT02877134|7154991|FG000|Placebo Non Responders at Week 12|Overall Study||44
6256159|NCT02877134|7154992|FG001|Placebo Non Responders at Week 12|Overall Study||0
6256160|NCT02877134|7154993|FG002|Placebo Non Responders at Week 12|Overall Study||31
6256161|NCT02877134|7154994|FG003|Placebo Non Responders at Week 12|Overall Study||0
6256162|NCT02877134|7154995|FG004|Placebo Non Responders at Week 12|Overall Study||0
6256163|NCT02877134|7154996|FG005|Placebo Non Responders at Week 12|Overall Study||0
6256164|NCT02877134|7154997|FG006|Placebo Non Responders at Week 12|Overall Study||0
6256165|NCT02877134|7154991|FG000|COMPLETED|Overall Study||58
6256166|NCT02877134|7154992|FG001|COMPLETED|Overall Study||48
6256167|NCT02877134|7154993|FG002|COMPLETED|Overall Study||42
6256168|NCT02877134|7154994|FG003|COMPLETED|Overall Study||37
6256169|NCT02877134|7154995|FG004|COMPLETED|Overall Study||43
6256170|NCT02877134|7154996|FG005|COMPLETED|Overall Study||42
6256171|NCT02877134|7154997|FG006|COMPLETED|Overall Study||46
6256172|NCT02877134|7154991|FG000|NOT COMPLETED|Overall Study||14
6256173|NCT02877134|7154992|FG001|NOT COMPLETED|Overall Study||25
6256174|NCT02877134|7154993|FG002|NOT COMPLETED|Overall Study||6
6256175|NCT02877134|7154994|FG003|NOT COMPLETED|Overall Study||13
6256176|NCT02877134|7154995|FG004|NOT COMPLETED|Overall Study||6
6256177|NCT02877134|7154996|FG005|NOT COMPLETED|Overall Study||7
6256178|NCT02877134|7154997|FG006|NOT COMPLETED|Overall Study||1
6256191|NCT02135484|7155032|FG000|STARTED|Overall Study||25
6256192|NCT02135484|7155032|FG000|COMPLETED|Overall Study||25
6256193|NCT02135484|7155032|FG000|NOT COMPLETED|Overall Study||0
6279004|NCT00140413|7178667|FG000|Received at Least One Dose of GH|Overall Study||13
6279005|NCT00140413|7178668|FG001|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
6279006|NCT00140413|7178667|FG000|COMPLETED|Overall Study||10
6672046|NCT02582255|7603101|FG001|NOT COMPLETED|Overall Study||3
6672047|NCT02582515|7603110|FG000|STARTED|Overall Study||9
6672048|NCT02582515|7603111|FG001|STARTED|Overall Study||11
6672049|NCT02582515|7603110|FG000|Received Study Intervention|Overall Study||9
6672050|NCT02582515|7603111|FG001|Received Study Intervention|Overall Study||10
6672051|NCT02582515|7603110|FG000|COMPLETED|Overall Study||9
6672052|NCT02582515|7603111|FG001|COMPLETED|Overall Study||10
6672053|NCT02582515|7603110|FG000|NOT COMPLETED|Overall Study||0
6672054|NCT02582515|7603111|FG001|NOT COMPLETED|Overall Study||1
6672055|NCT02582632|7603117|FG000|STARTED|Overall Study||166
6672056|NCT02582632|7603117|FG000|COMPLETED|Overall Study||165
6672057|NCT02582632|7603117|FG000|NOT COMPLETED|Overall Study||1
6672058|NCT02582658|7603121|FG000|STARTED|Overall Study||171
6672059|NCT02582658|7603121|FG000|COMPLETED|Overall Study||146
6672060|NCT02582658|7603121|FG000|NOT COMPLETED|Overall Study||25
6672061|NCT02582671|7603125|FG000|STARTED|Overall Study||101
6672062|NCT02582671|7603125|FG000|COMPLETED|Overall Study||99
6672063|NCT02582671|7603125|FG000|NOT COMPLETED|Overall Study||2
6672064|NCT02582684|7603130|FG000|STARTED|Overall Study||122
6672065|NCT02582684|7603130|FG000|COMPLETED|Overall Study||105
6672066|NCT02582684|7603130|FG000|NOT COMPLETED|Overall Study||17
6672067|NCT02582814|7603136|FG000|STARTED|Overall Study||76
6672068|NCT02582814|7603137|FG001|STARTED|Overall Study||75
6672069|NCT02582814|7603136|FG000|COMPLETED|Overall Study||67
6672070|NCT02582814|7603137|FG001|COMPLETED|Overall Study||68
6672071|NCT02582814|7603136|FG000|NOT COMPLETED|Overall Study||9
6672072|NCT02582814|7603137|FG001|NOT COMPLETED|Overall Study||7
6672073|NCT02582840|7603146|FG000|STARTED|Overall Study||14
6672074|NCT02582840|7603147|FG001|STARTED|Overall Study||14
6672075|NCT02582840|7603148|FG002|STARTED|Overall Study||14
6672076|NCT02582840|7603146|FG000|COMPLETED|Overall Study||14
6672077|NCT02582840|7603147|FG001|COMPLETED|Overall Study||14
6672078|NCT02582840|7603148|FG002|COMPLETED|Overall Study||14
6672079|NCT02582840|7603146|FG000|NOT COMPLETED|Overall Study||0
6672080|NCT02582840|7603147|FG001|NOT COMPLETED|Overall Study||0
6672081|NCT02582840|7603148|FG002|NOT COMPLETED|Overall Study||0
6672082|NCT02582866|7603158|FG000|STARTED|Overall Study||106
6672083|NCT02582866|7603158|FG000|COMPLETED|Overall Study||84
6672084|NCT02582866|7603158|FG000|NOT COMPLETED|Overall Study||22
6672085|NCT02582970|7603162|FG000|STARTED|Overall Study||40
6672086|NCT02582970|7603162|FG000|COMPLETED|Overall Study||40
6672087|NCT02582970|7603162|FG000|NOT COMPLETED|Overall Study||0
6672088|NCT02582983|7603166|FG000|STARTED|Overall Study||23
6672089|NCT02582983|7603166|FG000|COMPLETED|Overall Study||17
6672090|NCT02582983|7603166|FG000|NOT COMPLETED|Overall Study||6
6672091|NCT02583230|7603170|FG000|STARTED|Overall Study||11
6672092|NCT02583230|7603170|FG000|COMPLETED|Overall Study||11
6672093|NCT02583230|7603170|FG000|NOT COMPLETED|Overall Study||0
6672094|NCT02583256|7603178|FG000|STARTED|Overall Study||403
6672095|NCT02583256|7603179|FG001|STARTED|Overall Study||403
6672096|NCT02583256|7603180|FG002|STARTED|Overall Study||402
6672097|NCT02583256|7603181|FG003|STARTED|Overall Study||393
6672098|NCT02583256|7603178|FG000|Exposed|Overall Study||403
6672099|NCT02583256|7603179|FG001|Exposed|Overall Study||403
6672100|NCT02583256|7603180|FG002|Exposed|Overall Study||402
6672101|NCT02583256|7603181|FG003|Exposed|Overall Study||393
6672102|NCT02583256|7603178|FG000|COMPLETED|Overall Study||400
6672103|NCT02583256|7603179|FG001|COMPLETED|Overall Study||401
6672104|NCT02583256|7603180|FG002|COMPLETED|Overall Study||400
6672105|NCT02583256|7603181|FG003|COMPLETED|Overall Study||390
6672106|NCT02583256|7603178|FG000|NOT COMPLETED|Overall Study||3
6672107|NCT02583256|7603179|FG001|NOT COMPLETED|Overall Study||2
6672108|NCT02583256|7603180|FG002|NOT COMPLETED|Overall Study||2
6672109|NCT02583256|7603181|FG003|NOT COMPLETED|Overall Study||3
6672110|NCT02583360|7603195|FG000|STARTED|Overall Study||60
6672111|NCT02583360|7603196|FG001|STARTED|Overall Study||49
6672112|NCT02583360|7603195|FG000|COMPLETED|Overall Study||60
6672113|NCT02583360|7603196|FG001|COMPLETED|Overall Study||49
6672114|NCT02583360|7603195|FG000|NOT COMPLETED|Overall Study||0
6672115|NCT02583360|7603196|FG001|NOT COMPLETED|Overall Study||0
6672116|NCT02583399|7603202|FG000|STARTED|Overall Study||30
6672117|NCT02583399|7603202|FG000|COMPLETED|Overall Study||24
6672118|NCT02583399|7603202|FG000|NOT COMPLETED|Overall Study||6
6672119|NCT02583425|7603206|FG000|STARTED|Screening||27
6672120|NCT02583425|7603206|FG000|COMPLETED|Screening||15
6672121|NCT02583425|7603206|FG000|NOT COMPLETED|Screening||12
6672122|NCT02583425|7603206|FG000|STARTED|Baseline||15
6672123|NCT02583425|7603206|FG000|COMPLETED|Baseline||10
6672124|NCT02583425|7603206|FG000|NOT COMPLETED|Baseline||5
6672125|NCT02583425|7603206|FG000|STARTED|Treatment Period||10
6672126|NCT02583425|7603206|FG000|COMPLETED|Treatment Period||9
6672127|NCT02583425|7603206|FG000|NOT COMPLETED|Treatment Period||1
6672128|NCT02583477|7603213|FG000|STARTED|Overall Study||3
6672129|NCT02583477|7603214|FG001|STARTED|Overall Study||20
6672130|NCT02583477|7603213|FG000|Received Treatment|Overall Study||3
6672131|NCT02583477|7603214|FG001|Received Treatment|Overall Study||20
6672132|NCT02583477|7603213|FG000|Completed Treatment|Overall Study||0
6672133|NCT02583477|7603214|FG001|Completed Treatment|Overall Study||0
6672134|NCT02583477|7603213|FG000|COMPLETED|Overall Study||0
6672135|NCT02583477|7603214|FG001|COMPLETED|Overall Study||0
6672136|NCT02583477|7603213|FG000|NOT COMPLETED|Overall Study||3
6672137|NCT02583477|7603214|FG001|NOT COMPLETED|Overall Study||20
6672138|NCT02583711|7603224|FG000|STARTED|Overall Study||11
6672139|NCT02583711|7603225|FG001|STARTED|Overall Study||38
6672140|NCT02583711|7603226|FG002|STARTED|Overall Study||10
6672141|NCT02583711|7603224|FG000|COMPLETED|Overall Study||11
6672142|NCT02583711|7603225|FG001|COMPLETED|Overall Study||28
6672143|NCT02583711|7603226|FG002|COMPLETED|Overall Study||10
6672144|NCT02583711|7603224|FG000|NOT COMPLETED|Overall Study||0
6672145|NCT02583711|7603225|FG001|NOT COMPLETED|Overall Study||10
6672146|NCT02583711|7603226|FG002|NOT COMPLETED|Overall Study||0
6738064|NCT03275623|7667318|FG000|STARTED|Overall Study||30
6738065|NCT03275623|7667319|FG001|STARTED|Overall Study||30
6738066|NCT03275623|7667318|FG000|COMPLETED|Overall Study||25
6738067|NCT03275623|7667319|FG001|COMPLETED|Overall Study||28
6738068|NCT03275623|7667318|FG000|NOT COMPLETED|Overall Study||5
6738069|NCT03275623|7667319|FG001|NOT COMPLETED|Overall Study||2
6672147|NCT02584140|7603236|FG000|STARTED|Overall Study||136
6672148|NCT02584140|7603236|FG000|COMPLETED|Overall Study||83
6672149|NCT02584140|7603236|FG000|NOT COMPLETED|Overall Study||53
6672150|NCT02584257|7603240|FG000|STARTED|Period 1||9
6672151|NCT02584257|7603241|FG001|STARTED|Period 1||9
6672152|NCT02584257|7603242|FG002|STARTED|Period 1||9
6672153|NCT02584257|7603243|FG003|STARTED|Period 1||8
6672154|NCT02584257|7603244|FG004|STARTED|Period 1||10
6672155|NCT02584257|7603245|FG005|STARTED|Period 1||10
6672156|NCT02584257|7603246|FG006|STARTED|Period 1||18
6672157|NCT02584257|7603247|FG007|STARTED|Period 1||9
6672158|NCT02584257|7603248|FG008|STARTED|Period 1||9
6672159|NCT02584257|7603240|FG000|COMPLETED|Period 1||9
6672160|NCT02584257|7603241|FG001|COMPLETED|Period 1||9
6672161|NCT02584257|7603242|FG002|COMPLETED|Period 1||9
6672162|NCT02584257|7603243|FG003|COMPLETED|Period 1||8
6672163|NCT02584257|7603244|FG004|COMPLETED|Period 1||10
6672164|NCT02584257|7603245|FG005|COMPLETED|Period 1||10
6672165|NCT02584257|7603246|FG006|COMPLETED|Period 1||17
6672166|NCT02584257|7603247|FG007|COMPLETED|Period 1||9
6672167|NCT02584257|7603248|FG008|COMPLETED|Period 1||9
6672168|NCT02584257|7603240|FG000|NOT COMPLETED|Period 1||0
6672169|NCT02584257|7603241|FG001|NOT COMPLETED|Period 1||0
6672170|NCT02584257|7603242|FG002|NOT COMPLETED|Period 1||0
6672171|NCT02584257|7603243|FG003|NOT COMPLETED|Period 1||0
6672172|NCT02584257|7603244|FG004|NOT COMPLETED|Period 1||0
6672173|NCT02584257|7603245|FG005|NOT COMPLETED|Period 1||0
6672174|NCT02584257|7603246|FG006|NOT COMPLETED|Period 1||1
6672175|NCT02584257|7603247|FG007|NOT COMPLETED|Period 1||0
6672176|NCT02584257|7603248|FG008|NOT COMPLETED|Period 1||0
6672177|NCT02584257|7603240|FG000|STARTED|Period 2||9
6672178|NCT02584257|7603241|FG001|STARTED|Period 2||9
6672179|NCT02584257|7603242|FG002|STARTED|Period 2||9
6672180|NCT02584257|7603243|FG003|STARTED|Period 2||8
6672181|NCT02584257|7603244|FG004|STARTED|Period 2||10
6672182|NCT02584257|7603245|FG005|STARTED|Period 2||10
6672183|NCT02584257|7603246|FG006|STARTED|Period 2||17
6672184|NCT02584257|7603247|FG007|STARTED|Period 2||9
6672185|NCT02584257|7603248|FG008|STARTED|Period 2||9
6672186|NCT02584257|7603240|FG000|COMPLETED|Period 2||8
6672187|NCT02584257|7603241|FG001|COMPLETED|Period 2||8
6672188|NCT02584257|7603242|FG002|COMPLETED|Period 2||9
6672189|NCT02584257|7603243|FG003|COMPLETED|Period 2||8
6672190|NCT02584257|7603244|FG004|COMPLETED|Period 2||10
6672191|NCT02584257|7603245|FG005|COMPLETED|Period 2||10
6672192|NCT02584257|7603246|FG006|COMPLETED|Period 2||17
6672193|NCT02584257|7603247|FG007|COMPLETED|Period 2||9
6672194|NCT02584257|7603248|FG008|COMPLETED|Period 2||9
6672195|NCT02584257|7603240|FG000|NOT COMPLETED|Period 2||1
6672196|NCT02584257|7603241|FG001|NOT COMPLETED|Period 2||1
6672197|NCT02584257|7603242|FG002|NOT COMPLETED|Period 2||0
6672198|NCT02584257|7603243|FG003|NOT COMPLETED|Period 2||0
6672199|NCT02584257|7603244|FG004|NOT COMPLETED|Period 2||0
6672200|NCT02584257|7603245|FG005|NOT COMPLETED|Period 2||0
6672201|NCT02584257|7603246|FG006|NOT COMPLETED|Period 2||0
6672202|NCT02584257|7603247|FG007|NOT COMPLETED|Period 2||0
6672203|NCT02584257|7603248|FG008|NOT COMPLETED|Period 2||0
6672204|NCT02584257|7603240|FG000|STARTED|Period 3||8
6672205|NCT02584257|7603241|FG001|STARTED|Period 3||8
6672206|NCT02584257|7603242|FG002|STARTED|Period 3||9
6672207|NCT02584257|7603243|FG003|STARTED|Period 3||8
6672208|NCT02584257|7603244|FG004|STARTED|Period 3||10
6672209|NCT02584257|7603245|FG005|STARTED|Period 3||10
6672210|NCT02584257|7603246|FG006|STARTED|Period 3||17
6672211|NCT02584257|7603247|FG007|STARTED|Period 3||9
6672212|NCT02584257|7603248|FG008|STARTED|Period 3||9
6672213|NCT02584257|7603240|FG000|COMPLETED|Period 3||8
6672214|NCT02584257|7603241|FG001|COMPLETED|Period 3||8
6672215|NCT02584257|7603242|FG002|COMPLETED|Period 3||9
6672216|NCT02584257|7603243|FG003|COMPLETED|Period 3||8
6672217|NCT02584257|7603244|FG004|COMPLETED|Period 3||10
6672218|NCT02584257|7603245|FG005|COMPLETED|Period 3||10
6672219|NCT02584257|7603246|FG006|COMPLETED|Period 3||17
6672220|NCT02584257|7603247|FG007|COMPLETED|Period 3||9
6672221|NCT02584257|7603248|FG008|COMPLETED|Period 3||9
6672222|NCT02584257|7603240|FG000|NOT COMPLETED|Period 3||0
6672223|NCT02584257|7603241|FG001|NOT COMPLETED|Period 3||0
6672224|NCT02584257|7603242|FG002|NOT COMPLETED|Period 3||0
6672225|NCT02584257|7603243|FG003|NOT COMPLETED|Period 3||0
6672226|NCT02584257|7603244|FG004|NOT COMPLETED|Period 3||0
6672227|NCT02584257|7603245|FG005|NOT COMPLETED|Period 3||0
6672228|NCT02584257|7603246|FG006|NOT COMPLETED|Period 3||0
6672229|NCT02584257|7603247|FG007|NOT COMPLETED|Period 3||0
6672230|NCT02584257|7603248|FG008|NOT COMPLETED|Period 3||0
6672231|NCT02584257|7603240|FG000|STARTED|Period 4||8
6672232|NCT02584257|7603241|FG001|STARTED|Period 4||8
6672233|NCT02584257|7603242|FG002|STARTED|Period 4||9
6672234|NCT02584257|7603243|FG003|STARTED|Period 4||8
6672235|NCT02584257|7603244|FG004|STARTED|Period 4||10
6672236|NCT02584257|7603245|FG005|STARTED|Period 4||10
6672237|NCT02584257|7603246|FG006|STARTED|Period 4||17
6672238|NCT02584257|7603247|FG007|STARTED|Period 4||9
6672239|NCT02584257|7603248|FG008|STARTED|Period 4||9
6672240|NCT02584257|7603240|FG000|COMPLETED|Period 4||8
6672241|NCT02584257|7603241|FG001|COMPLETED|Period 4||8
6672242|NCT02584257|7603242|FG002|COMPLETED|Period 4||9
6672243|NCT02584257|7603243|FG003|COMPLETED|Period 4||8
6672244|NCT02584257|7603244|FG004|COMPLETED|Period 4||10
6672245|NCT02584257|7603245|FG005|COMPLETED|Period 4||10
6672246|NCT02584257|7603246|FG006|COMPLETED|Period 4||17
6672247|NCT02584257|7603247|FG007|COMPLETED|Period 4||9
6672248|NCT02584257|7603248|FG008|COMPLETED|Period 4||9
6672249|NCT02584257|7603240|FG000|NOT COMPLETED|Period 4||0
6672250|NCT02584257|7603241|FG001|NOT COMPLETED|Period 4||0
6672251|NCT02584257|7603242|FG002|NOT COMPLETED|Period 4||0
6672252|NCT02584257|7603243|FG003|NOT COMPLETED|Period 4||0
6672253|NCT02584257|7603244|FG004|NOT COMPLETED|Period 4||0
6672254|NCT02584257|7603245|FG005|NOT COMPLETED|Period 4||0
6672255|NCT02584257|7603246|FG006|NOT COMPLETED|Period 4||0
6672256|NCT02584257|7603247|FG007|NOT COMPLETED|Period 4||0
6672257|NCT02584257|7603248|FG008|NOT COMPLETED|Period 4||0
6672258|NCT02584257|7603240|FG000|STARTED|Period 5||8
6672259|NCT02584257|7603241|FG001|STARTED|Period 5||8
6672260|NCT02584257|7603242|FG002|STARTED|Period 5||9
6672261|NCT02584257|7603243|FG003|STARTED|Period 5||8
6672262|NCT02584257|7603244|FG004|STARTED|Period 5||10
6672263|NCT02584257|7603245|FG005|STARTED|Period 5||10
6672264|NCT02584257|7603246|FG006|STARTED|Period 5||17
6672265|NCT02584257|7603247|FG007|STARTED|Period 5||9
6672266|NCT02584257|7603248|FG008|STARTED|Period 5||9
6672267|NCT02584257|7603240|FG000|COMPLETED|Period 5||8
6672268|NCT02584257|7603241|FG001|COMPLETED|Period 5||8
6672269|NCT02584257|7603242|FG002|COMPLETED|Period 5||9
6672270|NCT02584257|7603243|FG003|COMPLETED|Period 5||8
6672271|NCT02584257|7603244|FG004|COMPLETED|Period 5||10
6672272|NCT02584257|7603245|FG005|COMPLETED|Period 5||10
6672273|NCT02584257|7603246|FG006|COMPLETED|Period 5||17
6672274|NCT02584257|7603247|FG007|COMPLETED|Period 5||9
6672275|NCT02584257|7603248|FG008|COMPLETED|Period 5||9
6672276|NCT02584257|7603240|FG000|NOT COMPLETED|Period 5||0
6672277|NCT02584257|7603241|FG001|NOT COMPLETED|Period 5||0
6672278|NCT02584257|7603242|FG002|NOT COMPLETED|Period 5||0
6672279|NCT02584257|7603243|FG003|NOT COMPLETED|Period 5||0
6672280|NCT02584257|7603244|FG004|NOT COMPLETED|Period 5||0
6672281|NCT02584257|7603245|FG005|NOT COMPLETED|Period 5||0
6672282|NCT02584257|7603246|FG006|NOT COMPLETED|Period 5||0
6672283|NCT02584257|7603247|FG007|NOT COMPLETED|Period 5||0
6672284|NCT02584257|7603248|FG008|NOT COMPLETED|Period 5||0
6672285|NCT02584452|7603262|FG000|STARTED|Overall Study||34
6672286|NCT02584452|7603263|FG001|STARTED|Overall Study||23
6672287|NCT02584452|7603262|FG000|COMPLETED|Overall Study||32
6672288|NCT02584452|7603263|FG001|COMPLETED|Overall Study||21
6672289|NCT02584452|7603262|FG000|NOT COMPLETED|Overall Study||2
6672290|NCT02584452|7603263|FG001|NOT COMPLETED|Overall Study||2
6672291|NCT02584504|7603273|FG000|STARTED|Double-blind Treatment|Randomized|54
6672292|NCT02584504|7603274|FG001|STARTED|Double-blind Treatment|Randomized|53
6672293|NCT02584504|7603275|FG002|STARTED|Double-blind Treatment|Randomized|56
6672294|NCT02584504|7603273|FG000|ITT Population|Double-blind Treatment||54
6672295|NCT02584504|7603274|FG001|ITT Population|Double-blind Treatment||53
6672296|NCT02584504|7603275|FG002|ITT Population|Double-blind Treatment||56
6672297|NCT02584504|7603273|FG000|mITT Population|Double-blind Treatment||54
6672298|NCT02584504|7603274|FG001|mITT Population|Double-blind Treatment||53
6672299|NCT02584504|7603275|FG002|mITT Population|Double-blind Treatment||56
6672300|NCT02584504|7603273|FG000|Safety Population|Double-blind Treatment||54
6672301|NCT02584504|7603274|FG001|Safety Population|Double-blind Treatment||53
6672302|NCT02584504|7603275|FG002|Safety Population|Double-blind Treatment||56
6672303|NCT02584504|7603273|FG000|COMPLETED|Double-blind Treatment||54
6672304|NCT02584504|7603274|FG001|COMPLETED|Double-blind Treatment||51
6672305|NCT02584504|7603275|FG002|COMPLETED|Double-blind Treatment||55
6672306|NCT02584504|7603273|FG000|NOT COMPLETED|Double-blind Treatment||0
6672307|NCT02584504|7603274|FG001|NOT COMPLETED|Double-blind Treatment||2
6672308|NCT02584504|7603275|FG002|NOT COMPLETED|Double-blind Treatment||1
6672309|NCT02584504|7603273|FG000|STARTED|Open-label Treatment||54
6672310|NCT02584504|7603274|FG001|STARTED|Open-label Treatment||51
6672311|NCT02584504|7603275|FG002|STARTED|Open-label Treatment||55
6672312|NCT02584504|7603273|FG000|Treated|Open-label Treatment||54
6672313|NCT02584504|7603274|FG001|Treated|Open-label Treatment||50
6672314|NCT02584504|7603275|FG002|Treated|Open-label Treatment||54
6672315|NCT02584504|7603273|FG000|COMPLETED|Open-label Treatment||52
6672316|NCT02584504|7603274|FG001|COMPLETED|Open-label Treatment||47
6672317|NCT02584504|7603275|FG002|COMPLETED|Open-label Treatment||47
6672318|NCT02584504|7603273|FG000|NOT COMPLETED|Open-label Treatment||2
6672319|NCT02584504|7603274|FG001|NOT COMPLETED|Open-label Treatment||4
6672320|NCT02584504|7603275|FG002|NOT COMPLETED|Open-label Treatment||8
6672321|NCT02584608|7603287|FG000|STARTED|Overall Study||12
6672322|NCT02584608|7603287|FG000|COMPLETED|Overall Study||12
6672323|NCT02584608|7603287|FG000|NOT COMPLETED|Overall Study||0
6672324|NCT02584660|7603293|FG000|STARTED|Overall Study||51
6672325|NCT02584660|7603294|FG001|STARTED|Overall Study||63
6672326|NCT02584660|7603293|FG000|Treated|Overall Study||49
6672327|NCT02584660|7603294|FG001|Treated|Overall Study||63
6672328|NCT02584660|7603293|FG000|COMPLETED|Overall Study||44
6672329|NCT02584660|7603294|FG001|COMPLETED|Overall Study||55
6672330|NCT02584660|7603293|FG000|NOT COMPLETED|Overall Study||7
6672331|NCT02584660|7603294|FG001|NOT COMPLETED|Overall Study||8
6672332|NCT02584673|7603302|FG000|STARTED|Overall Study||15
6672333|NCT02584673|7603303|FG001|STARTED|Overall Study||15
6672334|NCT02584673|7603302|FG000|COMPLETED|Overall Study||15
6672335|NCT02584673|7603303|FG001|COMPLETED|Overall Study||15
6672336|NCT02584673|7603302|FG000|NOT COMPLETED|Overall Study||0
6672337|NCT02584673|7603303|FG001|NOT COMPLETED|Overall Study||0
6672338|NCT02584686|7603311|FG000|STARTED|Overall Study||12
6672339|NCT02584686|7603312|FG001|STARTED|Overall Study||12
6672340|NCT02584686|7603311|FG000|COMPLETED|Overall Study||12
6672341|NCT02584686|7603312|FG001|COMPLETED|Overall Study||12
6672342|NCT02584686|7603311|FG000|NOT COMPLETED|Overall Study||0
6672343|NCT02584686|7603312|FG001|NOT COMPLETED|Overall Study||0
6672344|NCT02584725|7603322|FG000|STARTED|Overall Study||28
6672345|NCT02584725|7603323|FG001|STARTED|Overall Study||28
6672346|NCT02584725|7603324|FG002|STARTED|Overall Study||28
6672347|NCT02584725|7603322|FG000|COMPLETED|Overall Study||28
6672348|NCT02584725|7603323|FG001|COMPLETED|Overall Study||28
6672349|NCT02584725|7603324|FG002|COMPLETED|Overall Study||28
6672350|NCT02584725|7603322|FG000|NOT COMPLETED|Overall Study||0
6672351|NCT02584725|7603323|FG001|NOT COMPLETED|Overall Study||0
6672352|NCT02584725|7603324|FG002|NOT COMPLETED|Overall Study||0
6672353|NCT02584790|7603332|FG000|STARTED|Overall Study||55
6672354|NCT02584790|7603332|FG000|COMPLETED|Overall Study||40
6672355|NCT02584790|7603332|FG000|NOT COMPLETED|Overall Study||15
6672356|NCT02584855|7603336|FG000|STARTED|Open-Label Treatment Period||394
6672357|NCT02584855|7603337|FG001|STARTED|Open-Label Treatment Period|Participants completed Open-Label Treatment Period.|0
6672358|NCT02584855|7603338|FG002|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
6672359|NCT02584855|7603339|FG003|STARTED|Open-Label Treatment Period|Participants were randomized to this arm during double-blind withdrawal period.|0
6672360|NCT02584855|7603340|FG004|STARTED|Open-Label Treatment Period||0
6672361|NCT02584855|7603341|FG005|STARTED|Open-Label Treatment Period||0
6672362|NCT02584855|7603336|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||394
6672363|NCT02584855|7603337|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6672364|NCT02584855|7603338|FG002|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6672365|NCT02584855|7603339|FG003|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6672366|NCT02584855|7603340|FG004|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6672367|NCT02584855|7603341|FG005|Received at Least One Dose of Study Drug|Open-Label Treatment Period||0
6672368|NCT02584855|7603336|FG000|Met Randomization Criteria|Open-Label Treatment Period||158
6672369|NCT02584855|7603337|FG001|Met Randomization Criteria|Open-Label Treatment Period||0
6672370|NCT02584855|7603338|FG002|Met Randomization Criteria|Open-Label Treatment Period||0
6672371|NCT02584855|7603339|FG003|Met Randomization Criteria|Open-Label Treatment Period||0
6672372|NCT02584855|7603340|FG004|Met Randomization Criteria|Open-Label Treatment Period||0
6672373|NCT02584855|7603341|FG005|Met Randomization Criteria|Open-Label Treatment Period||0
6672374|NCT02584855|7603336|FG000|Non-randomized|Open-Label Treatment Period||133
6672375|NCT02584855|7603337|FG001|Non-randomized|Open-Label Treatment Period||0
6672376|NCT02584855|7603338|FG002|Non-randomized|Open-Label Treatment Period||0
6672377|NCT02584855|7603339|FG003|Non-randomized|Open-Label Treatment Period||0
6672378|NCT02584855|7603340|FG004|Non-randomized|Open-Label Treatment Period||0
6672379|NCT02584855|7603341|FG005|Non-randomized|Open-Label Treatment Period||0
6672380|NCT02584855|7603336|FG000|COMPLETED|Open-Label Treatment Period||291
6672381|NCT02584855|7603337|FG001|COMPLETED|Open-Label Treatment Period||0
6672382|NCT02584855|7603338|FG002|COMPLETED|Open-Label Treatment Period||0
6672383|NCT02584855|7603339|FG003|COMPLETED|Open-Label Treatment Period||0
6672384|NCT02584855|7603340|FG004|COMPLETED|Open-Label Treatment Period||0
6672385|NCT02584855|7603341|FG005|COMPLETED|Open-Label Treatment Period||0
6672386|NCT02584855|7603336|FG000|NOT COMPLETED|Open-Label Treatment Period||103
6672387|NCT02584855|7603337|FG001|NOT COMPLETED|Open-Label Treatment Period||0
6672388|NCT02584855|7603338|FG002|NOT COMPLETED|Open-Label Treatment Period||0
6672389|NCT02584855|7603339|FG003|NOT COMPLETED|Open-Label Treatment Period||0
6672390|NCT02584855|7603340|FG004|NOT COMPLETED|Open-Label Treatment Period||0
6672391|NCT02584855|7603341|FG005|NOT COMPLETED|Open-Label Treatment Period||0
6672392|NCT02584855|7603336|FG000|STARTED|Double-Blind Withdrawal Period||0
6672393|NCT02584855|7603337|FG001|STARTED|Double-Blind Withdrawal Period|Participants completed open label but did not meet criteria for double-blind withdrawal period.|133
6672394|NCT02584855|7603338|FG002|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
6672395|NCT02584855|7603339|FG003|STARTED|Double-Blind Withdrawal Period|Participants completed open label and met criteria for double-blind withdrawal period.|79
6672396|NCT02584855|7603340|FG004|STARTED|Double-Blind Withdrawal Period||0
6672397|NCT02584855|7603341|FG005|STARTED|Double-Blind Withdrawal Period||0
6672398|NCT02584855|7603336|FG000|Relapsed|Double-Blind Withdrawal Period||0
6672399|NCT02584855|7603337|FG001|Relapsed|Double-Blind Withdrawal Period||0
6672400|NCT02584855|7603338|FG002|Relapsed|Double-Blind Withdrawal Period||67
6672401|NCT02584855|7603339|FG003|Relapsed|Double-Blind Withdrawal Period||30
6672402|NCT02584855|7603340|FG004|Relapsed|Double-Blind Withdrawal Period||0
6672403|NCT02584855|7603341|FG005|Relapsed|Double-Blind Withdrawal Period||0
6672404|NCT02584855|7603336|FG000|COMPLETED|Double-Blind Withdrawal Period||0
6672405|NCT02584855|7603337|FG001|COMPLETED|Double-Blind Withdrawal Period||118
6672406|NCT02584855|7603338|FG002|COMPLETED|Double-Blind Withdrawal Period||77
6672407|NCT02584855|7603339|FG003|COMPLETED|Double-Blind Withdrawal Period||78
6672408|NCT02584855|7603340|FG004|COMPLETED|Double-Blind Withdrawal Period||0
6672409|NCT02584855|7603341|FG005|COMPLETED|Double-Blind Withdrawal Period||0
6672410|NCT02584855|7603336|FG000|NOT COMPLETED|Double-Blind Withdrawal Period||0
6672411|NCT02584855|7603337|FG001|NOT COMPLETED|Double-Blind Withdrawal Period||15
6672412|NCT02584855|7603338|FG002|NOT COMPLETED|Double-Blind Withdrawal Period||2
6672413|NCT02584855|7603339|FG003|NOT COMPLETED|Double-Blind Withdrawal Period||1
6672414|NCT02584855|7603340|FG004|NOT COMPLETED|Double-Blind Withdrawal Period||0
6672415|NCT02584855|7603341|FG005|NOT COMPLETED|Double-Blind Withdrawal Period||0
6672416|NCT02584855|7603336|FG000|STARTED|Post Treatment Follow-up Period||0
6672417|NCT02584855|7603337|FG001|STARTED|Post Treatment Follow-up Period||0
6672418|NCT02584855|7603338|FG002|STARTED|Post Treatment Follow-up Period||0
6672419|NCT02584855|7603339|FG003|STARTED|Post Treatment Follow-up Period||0
6672420|NCT02584855|7603340|FG004|STARTED|Post Treatment Follow-up Period||355
6672421|NCT02584855|7603341|FG005|STARTED|Post Treatment Follow-up Period||12
6672422|NCT02584855|7603336|FG000|COMPLETED|Post Treatment Follow-up Period||0
6672423|NCT02584855|7603337|FG001|COMPLETED|Post Treatment Follow-up Period||0
6672424|NCT02584855|7603338|FG002|COMPLETED|Post Treatment Follow-up Period||0
6672425|NCT02584855|7603339|FG003|COMPLETED|Post Treatment Follow-up Period||0
6672426|NCT02584855|7603340|FG004|COMPLETED|Post Treatment Follow-up Period||347
6672427|NCT02584855|7603341|FG005|COMPLETED|Post Treatment Follow-up Period||12
6672428|NCT02584855|7603336|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
6672429|NCT02584855|7603337|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
6672430|NCT02584855|7603338|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
6672431|NCT02584855|7603339|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
6672432|NCT02584855|7603340|FG004|NOT COMPLETED|Post Treatment Follow-up Period||8
6672433|NCT02584855|7603341|FG005|NOT COMPLETED|Post Treatment Follow-up Period||0
6672434|NCT02584868|7603356|FG000|STARTED|Overall Study||44
6672435|NCT02584868|7603357|FG001|STARTED|Overall Study||44
6672436|NCT02584868|7603356|FG000|COMPLETED|Overall Study||44
6672437|NCT02584868|7603357|FG001|COMPLETED|Overall Study||44
6672438|NCT02584868|7603356|FG000|NOT COMPLETED|Overall Study||0
6672439|NCT02584868|7603357|FG001|NOT COMPLETED|Overall Study||0
6672440|NCT02584959|7603366|FG000|STARTED|Period 1||31
6672441|NCT02584959|7603367|FG001|STARTED|Period 1||29
6672442|NCT02584959|7603368|FG002|STARTED|Period 1||15
6672443|NCT02584959|7603366|FG000|COMPLETED|Period 1||28
6672444|NCT02584959|7603367|FG001|COMPLETED|Period 1||25
6672445|NCT02584959|7603368|FG002|COMPLETED|Period 1||15
6672446|NCT02584959|7603366|FG000|NOT COMPLETED|Period 1||3
6672447|NCT02584959|7603367|FG001|NOT COMPLETED|Period 1||4
6672448|NCT02584959|7603368|FG002|NOT COMPLETED|Period 1||0
6672449|NCT02584959|7603366|FG000|STARTED|Period 2||28
6672450|NCT02584959|7603367|FG001|STARTED|Period 2||25
6672451|NCT02584959|7603368|FG002|STARTED|Period 2||15
6672452|NCT02584959|7603366|FG000|COMPLETED|Period 2||22
6672453|NCT02584959|7603367|FG001|COMPLETED|Period 2||24
6672454|NCT02584959|7603368|FG002|COMPLETED|Period 2||13
6672455|NCT02584959|7603366|FG000|NOT COMPLETED|Period 2||6
6672456|NCT02584959|7603367|FG001|NOT COMPLETED|Period 2||1
6672457|NCT02584959|7603368|FG002|NOT COMPLETED|Period 2||2
6672458|NCT02584998|7603388|FG000|STARTED|Overall Study||260
6672459|NCT02584998|7603389|FG001|STARTED|Overall Study||261
6672460|NCT02584998|7603390|FG002|STARTED|Overall Study||261
6672461|NCT02584998|7603388|FG000|COMPLETED|Overall Study||260
6672462|NCT02584998|7603389|FG001|COMPLETED|Overall Study||261
6672463|NCT02584998|7603390|FG002|COMPLETED|Overall Study||261
6672464|NCT02584998|7603388|FG000|NOT COMPLETED|Overall Study||0
6672465|NCT02584998|7603389|FG001|NOT COMPLETED|Overall Study||0
6672466|NCT02584998|7603390|FG002|NOT COMPLETED|Overall Study||0
6672467|NCT02585245|7603398|FG000|STARTED|Overall Study||607
6672468|NCT02585245|7603398|FG000|COMPLETED|Overall Study||594
6672469|NCT02585245|7603398|FG000|NOT COMPLETED|Overall Study||13
6672470|NCT02585700|7603405|FG000|STARTED|Overall Study||30
6672471|NCT02585700|7603406|FG001|STARTED|Overall Study||30
6672472|NCT02585700|7603405|FG000|COMPLETED|Overall Study||30
6672473|NCT02585700|7603406|FG001|COMPLETED|Overall Study||30
6672474|NCT02585700|7603405|FG000|NOT COMPLETED|Overall Study||0
6672475|NCT02585700|7603406|FG001|NOT COMPLETED|Overall Study||0
6672476|NCT02585713|7603414|FG000|STARTED|Overall Study||150
6672477|NCT02585713|7603415|FG001|STARTED|Overall Study||150
6672478|NCT02585713|7603414|FG000|COMPLETED|Overall Study||145
6672479|NCT02585713|7603415|FG001|COMPLETED|Overall Study||142
6672480|NCT02585713|7603414|FG000|NOT COMPLETED|Overall Study||5
6672481|NCT02585713|7603415|FG001|NOT COMPLETED|Overall Study||8
6672482|NCT02585778|7603425|FG000|STARTED|Overall Study|Randomized|345
6672483|NCT02585778|7603426|FG001|STARTED|Overall Study|Randomized|172
6672484|NCT02585778|7603425|FG000|Treated (Safety Population)|Overall Study||344
6672485|NCT02585778|7603426|FG001|Treated (Safety Population)|Overall Study||170
6672486|NCT02585778|7603425|FG000|ITT Population|Overall Study||336
6672487|NCT02585778|7603426|FG001|ITT Population|Overall Study||167
6672488|NCT02585778|7603425|FG000|mITT Population|Overall Study||333
6672489|NCT02585778|7603426|FG001|mITT Population|Overall Study||164
6672490|NCT02585778|7603425|FG000|T1DM Participants|Overall Study||51
6672491|NCT02585778|7603426|FG001|T1DM Participants|Overall Study||25
6672492|NCT02585778|7603425|FG000|T2DM Participants|Overall Study||294
6672493|NCT02585778|7603426|FG001|T2DM Participants|Overall Study||147
6672494|NCT02585778|7603425|FG000|COMPLETED|Overall Study||312
6672495|NCT02585778|7603426|FG001|COMPLETED|Overall Study||157
6672496|NCT02585778|7603425|FG000|NOT COMPLETED|Overall Study||33
6672497|NCT02585778|7603426|FG001|NOT COMPLETED|Overall Study||15
6672498|NCT02585830|7603436|FG000|STARTED|Overall Study||25
6672499|NCT02585830|7603436|FG000|COMPLETED|Overall Study||22
6672500|NCT02585830|7603436|FG000|NOT COMPLETED|Overall Study||3
6672501|NCT02585843|7603442|FG000|STARTED|Overall Study||10
6672502|NCT02585843|7603443|FG001|STARTED|Overall Study||10
6672503|NCT02585843|7603442|FG000|COMPLETED|Overall Study||9
6672504|NCT02585843|7603443|FG001|COMPLETED|Overall Study||10
6672505|NCT02585843|7603442|FG000|NOT COMPLETED|Overall Study||1
6672506|NCT02585843|7603443|FG001|NOT COMPLETED|Overall Study||0
6672507|NCT02585895|7603451|FG000|STARTED|Primary Period||20
6672508|NCT02585895|7603452|FG001|STARTED|Primary Period||19
6672509|NCT02585895|7603451|FG000|COMPLETED|Primary Period||20
6672510|NCT02585895|7603452|FG001|COMPLETED|Primary Period||19
6672511|NCT02585895|7603451|FG000|NOT COMPLETED|Primary Period||0
6672512|NCT02585895|7603452|FG001|NOT COMPLETED|Primary Period||0
6672513|NCT02585895|7603451|FG000|STARTED|Post-primary Period||20
6672514|NCT02585895|7603452|FG001|STARTED|Post-primary Period||19
6672515|NCT02585895|7603451|FG000|COMPLETED|Post-primary Period||20
6672516|NCT02585895|7603452|FG001|COMPLETED|Post-primary Period||19
6672517|NCT02585895|7603451|FG000|NOT COMPLETED|Post-primary Period||0
6672518|NCT02585895|7603452|FG001|NOT COMPLETED|Post-primary Period||0
6672519|NCT02585934|7603463|FG000|STARTED|Overall Study||661
6672520|NCT02585934|7603464|FG001|STARTED|Overall Study||654
6672521|NCT02585934|7603463|FG000|Safety Population|Overall Study||656
6672522|NCT02585934|7603464|FG001|Safety Population|Overall Study||651
6672523|NCT02585934|7603463|FG000|Intent to Treat (ITT)|Overall Study||643
6672524|NCT02585934|7603464|FG001|Intent to Treat (ITT)|Overall Study||633
6672525|NCT02585934|7603463|FG000|Per Protocol (PP)|Overall Study||603
6672526|NCT02585934|7603464|FG001|Per Protocol (PP)|Overall Study||582
6672527|NCT02585934|7603463|FG000|COMPLETED|Overall Study||592
6672528|NCT02585934|7603464|FG001|COMPLETED|Overall Study||581
6672529|NCT02585934|7603463|FG000|NOT COMPLETED|Overall Study||69
6672530|NCT02585934|7603464|FG001|NOT COMPLETED|Overall Study||73
6672531|NCT02585960|7603478|FG000|STARTED|PK/Safety Assessment Period||57
6672532|NCT02585960|7603479|FG001|STARTED|PK/Safety Assessment Period||58
6672533|NCT02585960|7603480|FG002|STARTED|PK/Safety Assessment Period||6
6672534|NCT02585960|7603478|FG000|Completed 1st 6 Month Period|PK/Safety Assessment Period||57
6672535|NCT02585960|7603479|FG001|Completed 1st 6 Month Period|PK/Safety Assessment Period||53
6672536|NCT02585960|7603480|FG002|Completed 1st 6 Month Period|PK/Safety Assessment Period||0
6672537|NCT02585960|7603478|FG000|Completed 2nd 6 Month Period|PK/Safety Assessment Period||52
6672538|NCT02585960|7603479|FG001|Completed 2nd 6 Month Period|PK/Safety Assessment Period||48
6672539|NCT02585960|7603480|FG002|Completed 2nd 6 Month Period|PK/Safety Assessment Period||0
6672540|NCT02585960|7603478|FG000|COMPLETED|PK/Safety Assessment Period||52
6672541|NCT02585960|7603479|FG001|COMPLETED|PK/Safety Assessment Period||48
6672542|NCT02585960|7603480|FG002|COMPLETED|PK/Safety Assessment Period||0
6672543|NCT02585960|7603478|FG000|NOT COMPLETED|PK/Safety Assessment Period||5
6672544|NCT02585960|7603479|FG001|NOT COMPLETED|PK/Safety Assessment Period||10
6672545|NCT02585960|7603480|FG002|NOT COMPLETED|PK/Safety Assessment Period||6
6672546|NCT02585960|7603478|FG000|STARTED|Prophylactic Treatment Period||52
6672547|NCT02585960|7603479|FG001|STARTED|Prophylactic Treatment Period||48
6672548|NCT02585960|7603480|FG002|STARTED|Prophylactic Treatment Period||0
6672549|NCT02585960|7603478|FG000|COMPLETED|Prophylactic Treatment Period||52
6672550|NCT02585960|7603479|FG001|COMPLETED|Prophylactic Treatment Period||43
6672551|NCT02585960|7603480|FG002|COMPLETED|Prophylactic Treatment Period||0
6672552|NCT02585960|7603478|FG000|NOT COMPLETED|Prophylactic Treatment Period||0
6672553|NCT02585960|7603479|FG001|NOT COMPLETED|Prophylactic Treatment Period||5
6672554|NCT02585960|7603480|FG002|NOT COMPLETED|Prophylactic Treatment Period||0
6672555|NCT02585999|7603491|FG000|STARTED|Overall Study||28
6672556|NCT02585999|7603491|FG000|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
6672557|NCT02585999|7603491|FG000|NOT COMPLETED|Overall Study||2
6672558|NCT02586012|7603496|FG000|STARTED|Overall Study||5
6672559|NCT02586012|7603497|FG001|STARTED|Overall Study||5
6672560|NCT02586012|7603498|FG002|STARTED|Overall Study||5
6672561|NCT02586012|7603499|FG003|STARTED|Overall Study||5
6672562|NCT02586012|7603500|FG004|STARTED|Overall Study||5
6672563|NCT02586012|7603501|FG005|STARTED|Overall Study||5
6672564|NCT02586012|7603496|FG000|COMPLETED|Overall Study||4
6672565|NCT02586012|7603497|FG001|COMPLETED|Overall Study||2
6672566|NCT02586012|7603498|FG002|COMPLETED|Overall Study||4
6672567|NCT02586012|7603499|FG003|COMPLETED|Overall Study||3
6672568|NCT02586012|7603500|FG004|COMPLETED|Overall Study||4
6672569|NCT02586012|7603501|FG005|COMPLETED|Overall Study||2
6672570|NCT02586012|7603496|FG000|NOT COMPLETED|Overall Study||1
6672571|NCT02586012|7603497|FG001|NOT COMPLETED|Overall Study||3
6672572|NCT02586012|7603498|FG002|NOT COMPLETED|Overall Study||1
6672573|NCT02586012|7603499|FG003|NOT COMPLETED|Overall Study||2
6672574|NCT02586012|7603500|FG004|NOT COMPLETED|Overall Study||1
6672575|NCT02586012|7603501|FG005|NOT COMPLETED|Overall Study||3
6672576|NCT02586064|7603512|FG000|STARTED|Overall Study||61
6672577|NCT02586064|7603513|FG001|STARTED|Overall Study||54
6672578|NCT02586064|7603512|FG000|COMPLETED|Overall Study||43
6672579|NCT02586064|7603513|FG001|COMPLETED|Overall Study||26
6672580|NCT02586064|7603512|FG000|NOT COMPLETED|Overall Study||18
6672581|NCT02586064|7603513|FG001|NOT COMPLETED|Overall Study||28
6672582|NCT02586077|7603522|FG000|STARTED|Overall Study||36
6672583|NCT02586077|7603522|FG000|COMPLETED|Overall Study||28
6672584|NCT02586077|7603522|FG000|NOT COMPLETED|Overall Study||8
6672585|NCT02586155|7603529|FG000|STARTED|Overall Study||1215
6672586|NCT02586155|7603530|FG001|STARTED|Overall Study||1210
6672587|NCT02586155|7603529|FG000|Final Number Randomized|Overall Study||1212
6672588|NCT02586155|7603530|FG001|Final Number Randomized|Overall Study||1206
6672589|NCT02586155|7603529|FG000|COMPLETED|Overall Study||1088
6672590|NCT02586155|7603530|FG001|COMPLETED|Overall Study||1083
6672591|NCT02586155|7603529|FG000|NOT COMPLETED|Overall Study||127
6672592|NCT02586155|7603530|FG001|NOT COMPLETED|Overall Study||127
6672593|NCT02586233|7603543|FG000|STARTED|Overall Study||7
6672594|NCT02586233|7603544|FG001|STARTED|Overall Study||7
6672595|NCT02586233|7603545|FG002|STARTED|Overall Study||13
6672596|NCT02586233|7603546|FG003|STARTED|Overall Study||17
6672597|NCT02586233|7603547|FG004|STARTED|Overall Study||18
6672598|NCT02586233|7603548|FG005|STARTED|Overall Study||18
6672599|NCT02586233|7603549|FG006|STARTED|Overall Study||26
6672600|NCT02586233|7603543|FG000|COMPLETED|Overall Study||7
6672601|NCT02586233|7603544|FG001|COMPLETED|Overall Study||5
6672602|NCT02586233|7603545|FG002|COMPLETED|Overall Study||13
6672603|NCT02586233|7603546|FG003|COMPLETED|Overall Study||17
6672604|NCT02586233|7603547|FG004|COMPLETED|Overall Study||16
6672605|NCT02586233|7603548|FG005|COMPLETED|Overall Study||16
6672606|NCT02586233|7603549|FG006|COMPLETED|Overall Study||24
6672607|NCT02586233|7603543|FG000|NOT COMPLETED|Overall Study||0
6672608|NCT02586233|7603544|FG001|NOT COMPLETED|Overall Study||2
6672609|NCT02586233|7603545|FG002|NOT COMPLETED|Overall Study||0
6672610|NCT02586233|7603546|FG003|NOT COMPLETED|Overall Study||0
6672611|NCT02586233|7603547|FG004|NOT COMPLETED|Overall Study||2
6672612|NCT02586233|7603548|FG005|NOT COMPLETED|Overall Study||2
6672613|NCT02586233|7603549|FG006|NOT COMPLETED|Overall Study||2
6672614|NCT02586415|7603571|FG000|STARTED|Overall Study||92
6672615|NCT02586415|7603572|FG001|STARTED|Overall Study||90
6672616|NCT02586415|7603571|FG000|24 Hour Assessment|Overall Study||91
6672617|NCT02586415|7603572|FG001|24 Hour Assessment|Overall Study||90
6672618|NCT02586415|7603571|FG000|Day 30 Assessment|Overall Study||81
6672619|NCT02586415|7603572|FG001|Day 30 Assessment|Overall Study||70
6672620|NCT02586415|7603571|FG000|Day 90 Assessment|Overall Study||78
6672621|NCT02586415|7603572|FG001|Day 90 Assessment|Overall Study||65
6672622|NCT02586415|7603571|FG000|COMPLETED|Overall Study||78
6672623|NCT02586415|7603572|FG001|COMPLETED|Overall Study||65
6672624|NCT02586415|7603571|FG000|NOT COMPLETED|Overall Study||14
6672625|NCT02586415|7603572|FG001|NOT COMPLETED|Overall Study||25
6672626|NCT02586493|7603579|FG000|STARTED|Overall Study||278
6672627|NCT02586493|7603579|FG000|COMPLETED|Overall Study||266
6672628|NCT02586493|7603579|FG000|NOT COMPLETED|Overall Study||12
6672629|NCT02586506|7603583|FG000|STARTED|Overall Study||259
6672630|NCT02586506|7603583|FG000|COMPLETED|Overall Study||250
6672631|NCT02586506|7603583|FG000|NOT COMPLETED|Overall Study||9
6672632|NCT02586727|7603589|FG000|STARTED|Overall Study||20
6672633|NCT02586727|7603590|FG001|STARTED|Overall Study||20
6672634|NCT02586727|7603589|FG000|COMPLETED|Overall Study||19
6672635|NCT02586727|7603590|FG001|COMPLETED|Overall Study||20
6672636|NCT02586727|7603589|FG000|NOT COMPLETED|Overall Study||1
6672637|NCT02586727|7603590|FG001|NOT COMPLETED|Overall Study||0
6672638|NCT02586805|7603600|FG000|STARTED|Overall Study||41
6672639|NCT02586805|7603601|FG001|STARTED|Overall Study||28
6672640|NCT02586805|7603602|FG002|STARTED|Overall Study||29
6672641|NCT02586805|7603603|FG003|STARTED|Overall Study||27
6672642|NCT02586805|7603600|FG000|COMPLETED|Overall Study||35
6672643|NCT02586805|7603601|FG001|COMPLETED|Overall Study||27
6672644|NCT02586805|7603602|FG002|COMPLETED|Overall Study||26
6672645|NCT02586805|7603603|FG003|COMPLETED|Overall Study||25
6672646|NCT02586805|7603600|FG000|NOT COMPLETED|Overall Study||6
6672647|NCT02586805|7603601|FG001|NOT COMPLETED|Overall Study||1
6672648|NCT02586805|7603602|FG002|NOT COMPLETED|Overall Study||3
6672649|NCT02586805|7603603|FG003|NOT COMPLETED|Overall Study||2
6672650|NCT02586896|7603615|FG000|STARTED|Overall Study||150
6672651|NCT02586896|7603616|FG001|STARTED|Overall Study||150
6672652|NCT02586896|7603615|FG000|3-Month Follow-up|Overall Study||126
6672653|NCT02586896|7603616|FG001|3-Month Follow-up|Overall Study||123
6672654|NCT02586896|7603615|FG000|COMPLETED|Overall Study||131
6672655|NCT02586896|7603616|FG001|COMPLETED|Overall Study||133
6672656|NCT02586896|7603615|FG000|NOT COMPLETED|Overall Study||19
6672657|NCT02586896|7603616|FG001|NOT COMPLETED|Overall Study||17
6672658|NCT02586909|7603622|FG000|STARTED|Overall Study||1099
6672659|NCT02586909|7603622|FG000|COMPLETED|Overall Study||151
6672660|NCT02586909|7603622|FG000|NOT COMPLETED|Overall Study||948
6672661|NCT02586974|7603628|FG000|STARTED|Overall Study||32
6672662|NCT02586974|7603629|FG001|STARTED|Overall Study||32
6672663|NCT02586974|7603628|FG000|COMPLETED|Overall Study||32
6672664|NCT02586974|7603629|FG001|COMPLETED|Overall Study||32
6672665|NCT02586974|7603628|FG000|NOT COMPLETED|Overall Study||0
6672666|NCT02586974|7603629|FG001|NOT COMPLETED|Overall Study||0
6672667|NCT02587065|7603637|FG000|STARTED|Overall Study||193
6672668|NCT02587065|7603637|FG000|COMPLETED|Overall Study||166
6672669|NCT02587065|7603637|FG000|NOT COMPLETED|Overall Study||27
6672670|NCT02587117|7603643|FG000|STARTED|Overall Study||13
6672671|NCT02587117|7603644|FG001|STARTED|Overall Study||15
6672672|NCT02587117|7603643|FG000|COMPLETED|Overall Study||13
6672673|NCT02587117|7603644|FG001|COMPLETED|Overall Study||15
6672674|NCT02587117|7603643|FG000|NOT COMPLETED|Overall Study||0
6672675|NCT02587117|7603644|FG001|NOT COMPLETED|Overall Study||0
6672676|NCT02587143|7603652|FG000|STARTED|Overall Study||66
6672677|NCT02587143|7603653|FG001|STARTED|Overall Study||60
6672678|NCT02587143|7603652|FG000|COMPLETED|Overall Study||65
6672679|NCT02587143|7603653|FG001|COMPLETED|Overall Study||60
6672680|NCT02587143|7603652|FG000|NOT COMPLETED|Overall Study||1
6672681|NCT02587143|7603653|FG001|NOT COMPLETED|Overall Study||0
6672682|NCT02587221|7603661|FG000|STARTED|Overall Study||3394
6672683|NCT02587221|7603662|FG001|STARTED|Overall Study||3396
6672684|NCT02587221|7603661|FG000|Treated|Overall Study||3379
6672685|NCT02587221|7603662|FG001|Treated|Overall Study||3382
6672686|NCT02587221|7603661|FG000|COMPLETED|Overall Study||3263
6672687|NCT02587221|7603662|FG001|COMPLETED|Overall Study||3273
6672688|NCT02587221|7603661|FG000|NOT COMPLETED|Overall Study||131
6672689|NCT02587221|7603662|FG001|NOT COMPLETED|Overall Study||123
6672690|NCT02587234|7603670|FG000|STARTED|Overall Study||11
6672691|NCT02587234|7603671|FG001|STARTED|Overall Study||10
6672692|NCT02587234|7603670|FG000|COMPLETED|Overall Study||10
6672693|NCT02587234|7603671|FG001|COMPLETED|Overall Study||7
6672694|NCT02587234|7603670|FG000|NOT COMPLETED|Overall Study||1
6672695|NCT02587234|7603671|FG001|NOT COMPLETED|Overall Study||3
6672696|NCT02587351|7603679|FG000|STARTED|Overall Study||268
6672697|NCT02587351|7603680|FG001|STARTED|Overall Study||264
6672698|NCT02587351|7603679|FG000|COMPLETED|Overall Study||268
6672699|NCT02587351|7603680|FG001|COMPLETED|Overall Study||264
6672700|NCT02587351|7603679|FG000|NOT COMPLETED|Overall Study||0
6672701|NCT02587351|7603680|FG001|NOT COMPLETED|Overall Study||0
6672702|NCT02587819|7603686|FG000|STARTED|Overall Study||21
6672703|NCT02587819|7603686|FG000|Exposed|Overall Study||21
6672704|NCT02587819|7603686|FG000|COMPLETED|Overall Study||19
6672705|NCT02587819|7603686|FG000|NOT COMPLETED|Overall Study||2
6672706|NCT02587962|7603696|FG000|STARTED|Overall Study||3
6672707|NCT02587962|7603697|FG001|STARTED|Overall Study||3
6672708|NCT02587962|7603698|FG002|STARTED|Overall Study||6
6672709|NCT02587962|7603699|FG003|STARTED|Overall Study||7
6672710|NCT02587962|7603700|FG004|STARTED|Overall Study||15
6672711|NCT02587962|7603696|FG000|COMPLETED|Overall Study||1
6672712|NCT02587962|7603697|FG001|COMPLETED|Overall Study||0
6672713|NCT02587962|7603698|FG002|COMPLETED|Overall Study||0
6672714|NCT02587962|7603699|FG003|COMPLETED|Overall Study||1
6672715|NCT02587962|7603700|FG004|COMPLETED|Overall Study||0
6672716|NCT02587962|7603696|FG000|NOT COMPLETED|Overall Study||2
6672717|NCT02587962|7603697|FG001|NOT COMPLETED|Overall Study||3
6672718|NCT02587962|7603698|FG002|NOT COMPLETED|Overall Study||6
6672719|NCT02587962|7603699|FG003|NOT COMPLETED|Overall Study||6
6672720|NCT02587962|7603700|FG004|NOT COMPLETED|Overall Study||15
6672721|NCT02588092|7603725|FG000|STARTED|Overall Study||4
6672722|NCT02588092|7603726|FG001|STARTED|Overall Study||3
6672723|NCT02588092|7603727|FG002|STARTED|Overall Study||3
6672724|NCT02588092|7603728|FG003|STARTED|Overall Study||3
6672725|NCT02588092|7603729|FG004|STARTED|Overall Study||3
6672726|NCT02588092|7603730|FG005|STARTED|Overall Study||3
6672727|NCT02588092|7603731|FG006|STARTED|Overall Study||3
6672728|NCT02588092|7603732|FG007|STARTED|Overall Study||4
6672729|NCT02588092|7603733|FG008|STARTED|Overall Study||6
6672730|NCT02588092|7603734|FG009|STARTED|Overall Study||3
6672731|NCT02588092|7603725|FG000|COMPLETED|Overall Study||0
6672732|NCT02588092|7603726|FG001|COMPLETED|Overall Study||0
6672733|NCT02588092|7603727|FG002|COMPLETED|Overall Study||0
6672734|NCT02588092|7603728|FG003|COMPLETED|Overall Study||0
6672735|NCT02588092|7603729|FG004|COMPLETED|Overall Study||0
6672736|NCT02588092|7603730|FG005|COMPLETED|Overall Study||0
6672737|NCT02588092|7603731|FG006|COMPLETED|Overall Study||0
6672738|NCT02588092|7603732|FG007|COMPLETED|Overall Study||0
6672739|NCT02588092|7603733|FG008|COMPLETED|Overall Study||0
6672740|NCT02588092|7603734|FG009|COMPLETED|Overall Study||0
6672741|NCT02588092|7603725|FG000|NOT COMPLETED|Overall Study||4
6672742|NCT02588092|7603726|FG001|NOT COMPLETED|Overall Study||3
6672743|NCT02588092|7603727|FG002|NOT COMPLETED|Overall Study||3
6672744|NCT02588092|7603728|FG003|NOT COMPLETED|Overall Study||3
6672745|NCT02588092|7603729|FG004|NOT COMPLETED|Overall Study||3
6672746|NCT02588092|7603730|FG005|NOT COMPLETED|Overall Study||3
6672747|NCT02588092|7603731|FG006|NOT COMPLETED|Overall Study||3
6672748|NCT02588092|7603732|FG007|NOT COMPLETED|Overall Study||4
6672749|NCT02588092|7603733|FG008|NOT COMPLETED|Overall Study||6
6672750|NCT02588092|7603734|FG009|NOT COMPLETED|Overall Study||3
6738070|NCT03275766|7667329|FG000|STARTED|Overall Study||12
6738071|NCT03275766|7667330|FG001|STARTED|Overall Study||12
6738072|NCT03275766|7667331|FG002|STARTED|Overall Study||11
6738073|NCT03275766|7667332|FG003|STARTED|Overall Study||10
6738074|NCT03275766|7667329|FG000|Received Intervention|Overall Study||9
6738075|NCT03275766|7667330|FG001|Received Intervention|Overall Study||11
6738076|NCT03275766|7667331|FG002|Received Intervention|Overall Study||10
6738077|NCT03275766|7667332|FG003|Received Intervention|Overall Study||9
6738078|NCT03275766|7667329|FG000|COMPLETED|Overall Study||7
6738079|NCT03275766|7667330|FG001|COMPLETED|Overall Study||5
6738080|NCT03275766|7667331|FG002|COMPLETED|Overall Study||7
6738081|NCT03275766|7667332|FG003|COMPLETED|Overall Study||4
6738082|NCT03275766|7667329|FG000|NOT COMPLETED|Overall Study||5
6738083|NCT03275766|7667330|FG001|NOT COMPLETED|Overall Study||7
6738084|NCT03275766|7667331|FG002|NOT COMPLETED|Overall Study||4
6738085|NCT03275766|7667332|FG003|NOT COMPLETED|Overall Study||6
6738086|NCT03275870|7667342|FG000|STARTED|Overall Study||17
6738087|NCT03275870|7667342|FG000|COMPLETED|Overall Study||3
6738088|NCT03275870|7667342|FG000|NOT COMPLETED|Overall Study||14
6738089|NCT03276026|7667348|FG000|STARTED|Overall Study||35
6738090|NCT03276026|7667349|FG001|STARTED|Overall Study||33
6738091|NCT03276026|7667348|FG000|COMPLETED|Overall Study||34
6672751|NCT04960228|7603762|FG000|STARTED|Overall Study||1098
6672752|NCT04960228|7603763|FG001|STARTED|Overall Study||999
6672753|NCT04960228|7603762|FG000|COMPLETED|Overall Study||810
6672754|NCT04960228|7603763|FG001|COMPLETED|Overall Study||813
6672755|NCT04960228|7603762|FG000|NOT COMPLETED|Overall Study||288
6672756|NCT04960228|7603763|FG001|NOT COMPLETED|Overall Study||186
6672757|NCT03922477|7603769|FG000|STARTED|Overall Study||13
6672758|NCT03922477|7603769|FG000|COMPLETED|Overall Study||0
6672759|NCT03922477|7603769|FG000|NOT COMPLETED|Overall Study||13
6672775|NCT02871934|7603797|FG000|STARTED|Overall Study||193
6672776|NCT02871934|7603798|FG001|STARTED|Overall Study||215
6672777|NCT02871934|7603797|FG000|COMPLETED|Overall Study||193
6672778|NCT02871934|7603798|FG001|COMPLETED|Overall Study||215
6672779|NCT02871934|7603797|FG000|NOT COMPLETED|Overall Study||0
6672780|NCT02871934|7603798|FG001|NOT COMPLETED|Overall Study||0
6672781|NCT02859558|7603809|FG000|STARTED|Step 1||49
6672782|NCT02859558|7603810|FG001|STARTED|Step 1||79
6672783|NCT02859558|7603811|FG002|STARTED|Step 1||60
6672784|NCT02859558|7603812|FG003|STARTED|Step 1||4
6672785|NCT02859558|7603813|FG004|STARTED|Step 1||3
6672786|NCT02859558|7603809|FG000|Completed Week 48|Step 1||41
6672787|NCT02859558|7603810|FG001|Completed Week 48|Step 1||68
6672788|NCT02859558|7603811|FG002|Completed Week 48|Step 1||50
6672789|NCT02859558|7603812|FG003|Completed Week 48|Step 1||0
6672790|NCT02859558|7603813|FG004|Completed Week 48|Step 1||0
6672791|NCT02859558|7603809|FG000|COMPLETED|Step 1||37
6672792|NCT02859558|7603810|FG001|COMPLETED|Step 1||67
6672793|NCT02859558|7603811|FG002|COMPLETED|Step 1||49
6672794|NCT02859558|7603812|FG003|COMPLETED|Step 1||4
6672795|NCT02859558|7603813|FG004|COMPLETED|Step 1||0
6672796|NCT02859558|7603809|FG000|NOT COMPLETED|Step 1||12
6672797|NCT02859558|7603810|FG001|NOT COMPLETED|Step 1||12
6672798|NCT02859558|7603811|FG002|NOT COMPLETED|Step 1||11
6672799|NCT02859558|7603812|FG003|NOT COMPLETED|Step 1||0
6672800|NCT02859558|7603813|FG004|NOT COMPLETED|Step 1||3
6672801|NCT02859558|7603809|FG000|STARTED|Step 2||25
6672802|NCT02859558|7603810|FG001|STARTED|Step 2||39
6672803|NCT02859558|7603811|FG002|STARTED|Step 2||21
6672804|NCT02859558|7603812|FG003|STARTED|Step 2||0
6672805|NCT02859558|7603813|FG004|STARTED|Step 2||0
6672806|NCT02859558|7603809|FG000|COMPLETED|Step 2||0
6672807|NCT02859558|7603810|FG001|COMPLETED|Step 2||0
6672808|NCT02859558|7603811|FG002|COMPLETED|Step 2||0
6672809|NCT02859558|7603812|FG003|COMPLETED|Step 2||0
6672810|NCT02859558|7603813|FG004|COMPLETED|Step 2||0
6672811|NCT02859558|7603809|FG000|NOT COMPLETED|Step 2||25
6672812|NCT02859558|7603810|FG001|NOT COMPLETED|Step 2||39
6672813|NCT02859558|7603811|FG002|NOT COMPLETED|Step 2||21
6672814|NCT02859558|7603812|FG003|NOT COMPLETED|Step 2||0
6672815|NCT02859558|7603813|FG004|NOT COMPLETED|Step 2||0
6672816|NCT02818920|7603823|FG000|STARTED|Overall Study||30
6672817|NCT02818920|7603823|FG000|Completed Surgery|Overall Study||25
6672818|NCT02818920|7603823|FG000|Received Adjuvant Therapy|Overall Study||17
6672819|NCT02818920|7603823|FG000|COMPLETED|Overall Study||12
6672820|NCT02818920|7603823|FG000|NOT COMPLETED|Overall Study||18
6672821|NCT02481310|7603830|FG000|STARTED|Induction Treatment (6 Cycles)||1
6672822|NCT02481310|7603831|FG001|STARTED|Induction Treatment (6 Cycles)||36
6672823|NCT02481310|7603832|FG002|STARTED|Induction Treatment (6 Cycles)||1
6672824|NCT02481310|7603830|FG000|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
6672825|NCT02481310|7603831|FG001|Reached First Evaluable Response|Induction Treatment (6 Cycles)||34
6672826|NCT02481310|7603832|FG002|Reached First Evaluable Response|Induction Treatment (6 Cycles)||1
6672827|NCT02481310|7603830|FG000|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
6672828|NCT02481310|7603831|FG001|Complete 6 Cycles|Induction Treatment (6 Cycles)||30
6672829|NCT02481310|7603832|FG002|Complete 6 Cycles|Induction Treatment (6 Cycles)||1
6672830|NCT02481310|7603830|FG000|COMPLETED|Induction Treatment (6 Cycles)||1
6672831|NCT02481310|7603831|FG001|COMPLETED|Induction Treatment (6 Cycles)||30
6672832|NCT02481310|7603832|FG002|COMPLETED|Induction Treatment (6 Cycles)||1
6672833|NCT02481310|7603830|FG000|NOT COMPLETED|Induction Treatment (6 Cycles)||0
6672834|NCT02481310|7603831|FG001|NOT COMPLETED|Induction Treatment (6 Cycles)||6
6672835|NCT02481310|7603832|FG002|NOT COMPLETED|Induction Treatment (6 Cycles)||0
6672836|NCT02481310|7603830|FG000|STARTED|Maintenance Treatment||1
6672837|NCT02481310|7603831|FG001|STARTED|Maintenance Treatment|9 patients that competed induction did not start maintenance treatment.|21
6672838|NCT02481310|7603832|FG002|STARTED|Maintenance Treatment||1
6672839|NCT02481310|7603830|FG000|Started Maintenance Treatment|Maintenance Treatment||1
6672840|NCT02481310|7603831|FG001|Started Maintenance Treatment|Maintenance Treatment||21
6672841|NCT02481310|7603832|FG002|Started Maintenance Treatment|Maintenance Treatment||1
6672842|NCT02481310|7603830|FG000|COMPLETED|Maintenance Treatment||1
6672843|NCT02481310|7603831|FG001|COMPLETED|Maintenance Treatment||21
6672844|NCT02481310|7603832|FG002|COMPLETED|Maintenance Treatment||1
6672845|NCT02481310|7603830|FG000|NOT COMPLETED|Maintenance Treatment||0
6672846|NCT02481310|7603831|FG001|NOT COMPLETED|Maintenance Treatment||0
6672847|NCT02481310|7603832|FG002|NOT COMPLETED|Maintenance Treatment||0
6672848|NCT02481310|7603830|FG000|STARTED|Follow up||1
6672849|NCT02481310|7603831|FG001|STARTED|Follow up|2 patients died prior to entering follow up, 1 patient withdrew consent and 1 patient currently on treatment.|32
6672850|NCT02481310|7603832|FG002|STARTED|Follow up||1
6672851|NCT02481310|7603830|FG000|COMPLETED|Follow up||1
6672852|NCT02481310|7603831|FG001|COMPLETED|Follow up||29
6672853|NCT02481310|7603832|FG002|COMPLETED|Follow up||1
6672854|NCT02481310|7603830|FG000|NOT COMPLETED|Follow up||0
6672760|NCT03688074|7603775|FG000|STARTED|Overall Study||59
6672761|NCT03688074|7603776|FG001|STARTED|Overall Study||57
6672762|NCT03688074|7603775|FG000|COMPLETED|Overall Study||58
6672763|NCT03688074|7603776|FG001|COMPLETED|Overall Study||56
6672764|NCT03688074|7603775|FG000|NOT COMPLETED|Overall Study||1
6672765|NCT03688074|7603776|FG001|NOT COMPLETED|Overall Study||1
6672766|NCT03342001|7603782|FG000|STARTED|Overall Study||11
6672767|NCT03342001|7603782|FG000|COMPLETED|Overall Study||9
6672768|NCT03342001|7603782|FG000|NOT COMPLETED|Overall Study||2
6672769|NCT03091192|7603788|FG000|STARTED|Overall Study||33
6672770|NCT03091192|7603789|FG001|STARTED|Overall Study||27
6672771|NCT03091192|7603788|FG000|COMPLETED|Overall Study||0
6672772|NCT03091192|7603789|FG001|COMPLETED|Overall Study||0
6672773|NCT03091192|7603788|FG000|NOT COMPLETED|Overall Study||33
6672774|NCT03091192|7603789|FG001|NOT COMPLETED|Overall Study||27
6672855|NCT02481310|7603831|FG001|NOT COMPLETED|Follow up||3
6672856|NCT02481310|7603832|FG002|NOT COMPLETED|Follow up||0
6672857|NCT02343952|7603836|FG000|STARTED|Study Treatment||93
6672858|NCT02343952|7603836|FG000|COMPLETED|Study Treatment||40
6672859|NCT02343952|7603836|FG000|NOT COMPLETED|Study Treatment||53
6672860|NCT02343952|7603836|FG000|STARTED|Follow up||83
6672861|NCT02343952|7603836|FG000|COMPLETED|Follow up||38
6672862|NCT02343952|7603836|FG000|NOT COMPLETED|Follow up||45
6672863|NCT02326155|7603842|FG000|STARTED|Overall Study||407
6672864|NCT02326155|7603843|FG001|STARTED|Overall Study||63
6672865|NCT02326155|7603842|FG000|COMPLETED|Overall Study||13
6672866|NCT02326155|7603843|FG001|COMPLETED|Overall Study||1
6672867|NCT02326155|7603842|FG000|NOT COMPLETED|Overall Study||394
6672868|NCT02326155|7603843|FG001|NOT COMPLETED|Overall Study||62
6672869|NCT02304367|7603849|FG000|STARTED|Overall Study|14 participants with TIO; 1 participant with ENS; 2 participants with XLH|17
6672870|NCT02304367|7603849|FG000|Completed 48 Weeks of Study Drug|Overall Study||16
6672871|NCT02304367|7603849|FG000|Completed 144 Weeks of Study Drug|Overall Study||12
6672872|NCT02304367|7603849|FG000|COMPLETED|Overall Study||9
6672873|NCT02304367|7603849|FG000|NOT COMPLETED|Overall Study||8
6672874|NCT01810705|7603862|FG000|STARTED|Overall Study||83
6672875|NCT01810705|7603863|FG001|STARTED|Overall Study||40
6672876|NCT01810705|7603862|FG000|COMPLETED|Overall Study||10
6672877|NCT01810705|7603863|FG001|COMPLETED|Overall Study||5
6672878|NCT01810705|7603862|FG000|NOT COMPLETED|Overall Study||73
6672879|NCT01810705|7603863|FG001|NOT COMPLETED|Overall Study||35
6672880|NCT02588261|7603871|FG000|STARTED|Overall Study||267
6672881|NCT02588261|7603872|FG001|STARTED|Overall Study||263
6672882|NCT02588261|7603871|FG000|Treated|Overall Study||265
6672883|NCT02588261|7603872|FG001|Treated|Overall Study||262
6672884|NCT02588261|7603871|FG000|COMPLETED|Overall Study||0
6672885|NCT02588261|7603872|FG001|COMPLETED|Overall Study||0
6672886|NCT02588261|7603871|FG000|NOT COMPLETED|Overall Study||267
6672887|NCT02588261|7603872|FG001|NOT COMPLETED|Overall Study||263
6672888|NCT02588339|7603878|FG000|STARTED|Overall Study||42
6672889|NCT02588339|7603878|FG000|COMPLETED|Overall Study||39
6672890|NCT02588339|7603878|FG000|NOT COMPLETED|Overall Study||3
6672891|NCT02588573|7603884|FG000|STARTED|Overall Study||45
6672892|NCT02588573|7603885|FG001|STARTED|Overall Study||45
6672893|NCT02588573|7603884|FG000|Randomized Eye Etafilcon A|Overall Study||45
6672894|NCT02588573|7603885|FG001|Randomized Eye Etafilcon A|Overall Study||45
6672895|NCT02588573|7603884|FG000|Randomized Eye Somofilcon A|Overall Study||45
6672896|NCT02588573|7603885|FG001|Randomized Eye Somofilcon A|Overall Study||45
6672897|NCT02588573|7603884|FG000|COMPLETED|Overall Study||45
6672898|NCT02588573|7603885|FG001|COMPLETED|Overall Study||45
6672899|NCT02588573|7603884|FG000|NOT COMPLETED|Overall Study||0
6672900|NCT02588573|7603885|FG001|NOT COMPLETED|Overall Study||0
6672901|NCT02588586|7603903|FG000|STARTED|Overall Study||17
6672902|NCT02588586|7603903|FG000|COMPLETED|Overall Study||15
6672903|NCT02588586|7603903|FG000|NOT COMPLETED|Overall Study||2
6672904|NCT02588599|7603907|FG000|STARTED|Overall Study||54
6672905|NCT02588599|7603907|FG000|COMPLETED|Overall Study||54
6672906|NCT02588599|7603907|FG000|NOT COMPLETED|Overall Study||0
6672907|NCT02588612|7603911|FG000|STARTED|Overall Study||10
6672908|NCT02588612|7603911|FG000|Received T-cell Infusion|Overall Study||5
6672909|NCT02588612|7603911|FG000|COMPLETED|Overall Study||5
6672910|NCT02588612|7603911|FG000|NOT COMPLETED|Overall Study||5
6672911|NCT02588664|7603917|FG000|STARTED|Overall Study||3193
6672912|NCT02588664|7603918|FG001|STARTED|Overall Study||2689
6672913|NCT02588664|7603917|FG000|COMPLETED|Overall Study||1832
6672914|NCT02588664|7603918|FG001|COMPLETED|Overall Study||1644
6672915|NCT02588664|7603917|FG000|NOT COMPLETED|Overall Study||1361
6672916|NCT02588664|7603918|FG001|NOT COMPLETED|Overall Study||1045
6672917|NCT02588833|7603926|FG000|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|3
6672918|NCT02588833|7603927|FG001|STARTED|Part 1|One subject was enrolled in both cohorts, this subject was enrolled twice.|20
6672919|NCT02588833|7603926|FG000|COMPLETED|Part 1||2
6672920|NCT02588833|7603927|FG001|COMPLETED|Part 1||20
6672921|NCT02588833|7603926|FG000|NOT COMPLETED|Part 1||1
6672922|NCT02588833|7603927|FG001|NOT COMPLETED|Part 1||0
6672923|NCT02588833|7603926|FG000|STARTED|Part 2A|Part 2A is not applicable since Cohort 1 subjects proceeded immediately to Part 3.|0
6672924|NCT02588833|7603927|FG001|STARTED|Part 2A||20
6672925|NCT02588833|7603926|FG000|COMPLETED|Part 2A||0
6672926|NCT02588833|7603927|FG001|COMPLETED|Part 2A||18
6672927|NCT02588833|7603926|FG000|NOT COMPLETED|Part 2A||0
6672928|NCT02588833|7603927|FG001|NOT COMPLETED|Part 2A||2
6672929|NCT02588833|7603926|FG000|STARTED|Part 2B||0
6672930|NCT02588833|7603927|FG001|STARTED|Part 2B||18
6672931|NCT02588833|7603926|FG000|COMPLETED|Part 2B||0
6672932|NCT02588833|7603927|FG001|COMPLETED|Part 2B||17
6672933|NCT02588833|7603926|FG000|NOT COMPLETED|Part 2B||0
6672934|NCT02588833|7603927|FG001|NOT COMPLETED|Part 2B||1
6672935|NCT02588833|7603926|FG000|STARTED|Part 2C||0
6672936|NCT02588833|7603927|FG001|STARTED|Part 2C|17 subjects completed Part 2B and 3 entered extension study without participating in Part 2C.|14
6672937|NCT02588833|7603926|FG000|COMPLETED|Part 2C||0
6672938|NCT02588833|7603927|FG001|COMPLETED|Part 2C||12
6672939|NCT02588833|7603926|FG000|NOT COMPLETED|Part 2C||0
6672940|NCT02588833|7603927|FG001|NOT COMPLETED|Part 2C||2
6672941|NCT02588833|7603926|FG000|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|3
6672942|NCT02588833|7603927|FG001|STARTED|Part 3 (Safety Follow-up)|Only subjects who did not enter extension study or Part 2C entered Part 3.|4
6672943|NCT02588833|7603926|FG000|COMPLETED|Part 3 (Safety Follow-up)||3
6672944|NCT02588833|7603927|FG001|COMPLETED|Part 3 (Safety Follow-up)||2
6672945|NCT02588833|7603926|FG000|NOT COMPLETED|Part 3 (Safety Follow-up)||0
6672946|NCT02588833|7603927|FG001|NOT COMPLETED|Part 3 (Safety Follow-up)||2
6672947|NCT02588872|7603936|FG000|STARTED|Overall Study||59
6672948|NCT02588872|7603937|FG001|STARTED|Overall Study||52
6672949|NCT02588872|7603936|FG000|COMPLETED|Overall Study||59
6672950|NCT02588872|7603937|FG001|COMPLETED|Overall Study||52
6672951|NCT02588872|7603936|FG000|NOT COMPLETED|Overall Study||0
6672952|NCT02588872|7603937|FG001|NOT COMPLETED|Overall Study||0
6672953|NCT02588976|7603943|FG000|STARTED|Overall Study||30
6672954|NCT02588976|7603943|FG000|COMPLETED|Overall Study||30
6672955|NCT02588976|7603943|FG000|NOT COMPLETED|Overall Study||0
6672956|NCT02589067|7603950|FG000|STARTED|Overall Study||33
6672957|NCT02589067|7603951|FG001|STARTED|Overall Study||34
6672958|NCT02589067|7603950|FG000|COMPLETED|Overall Study||28
6672959|NCT02589067|7603951|FG001|COMPLETED|Overall Study||28
6672960|NCT02589067|7603950|FG000|NOT COMPLETED|Overall Study||5
6672961|NCT02589067|7603951|FG001|NOT COMPLETED|Overall Study||6
6672962|NCT02589171|7603960|FG000|STARTED|Overall Study||35
6672963|NCT02589171|7603961|FG001|STARTED|Overall Study||35
6672964|NCT02589171|7603960|FG000|Day 1 Follow up|Overall Study||35
6672965|NCT02589171|7603961|FG001|Day 1 Follow up|Overall Study||35
6672966|NCT02589171|7603960|FG000|Week 1 Follow up|Overall Study||35
6672967|NCT02589171|7603961|FG001|Week 1 Follow up|Overall Study||34
6672968|NCT02589171|7603960|FG000|Week 6 Follow up|Overall Study||28
6672969|NCT02589171|7603961|FG001|Week 6 Follow up|Overall Study||30
6672970|NCT02589171|7603960|FG000|COMPLETED|Overall Study||28
6672971|NCT02589171|7603961|FG001|COMPLETED|Overall Study||30
6672972|NCT02589171|7603960|FG000|NOT COMPLETED|Overall Study||7
6672973|NCT02589171|7603961|FG001|NOT COMPLETED|Overall Study||5
6672974|NCT02589405|7603967|FG000|STARTED|Overall Study||50
6672975|NCT02589405|7603967|FG000|COMPLETED|Overall Study||46
6672976|NCT02589405|7603967|FG000|NOT COMPLETED|Overall Study||4
6672977|NCT02589626|7603973|FG000|STARTED|Overall Study|Entered are treated patients|32
6672978|NCT02589626|7603974|FG001|STARTED|Overall Study|Entered are treated patients|33
6672979|NCT02589626|7603973|FG000|COMPLETED|Overall Study||29
6672980|NCT02589626|7603974|FG001|COMPLETED|Overall Study||31
6672981|NCT02589626|7603973|FG000|NOT COMPLETED|Overall Study||3
6672982|NCT02589626|7603974|FG001|NOT COMPLETED|Overall Study||2
6672983|NCT02589639|7603983|FG000|STARTED|Overall Study||90
6672984|NCT02589639|7603984|FG001|STARTED|Overall Study||89
6672985|NCT02589639|7603985|FG002|STARTED|Overall Study||90
6672986|NCT02589639|7603983|FG000|Treated|Overall Study||90
6672987|NCT02589639|7603984|FG001|Treated|Overall Study||86
6672988|NCT02589639|7603985|FG002|Treated|Overall Study||90
6672989|NCT02589639|7603983|FG000|COMPLETED|Overall Study||80
6672990|NCT02589639|7603984|FG001|COMPLETED|Overall Study||79
6672991|NCT02589639|7603985|FG002|COMPLETED|Overall Study||86
6672992|NCT02589639|7603983|FG000|NOT COMPLETED|Overall Study||10
6672993|NCT02589639|7603984|FG001|NOT COMPLETED|Overall Study||10
6672994|NCT02589639|7603985|FG002|NOT COMPLETED|Overall Study||4
6672995|NCT02589665|7603997|FG000|STARTED|Induction Period||63
6672996|NCT02589665|7603998|FG001|STARTED|Induction Period||63
6672997|NCT02589665|7603999|FG002|STARTED|Induction Period||62
6672998|NCT02589665|7604000|FG003|STARTED|Induction Period||61
6672999|NCT02589665|7604001|FG004|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
6673000|NCT02589665|7604002|FG005|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
6673001|NCT02589665|7604003|FG006|STARTED|Induction Period|Participants were assigned to this arm during maintenance period.|0
6673002|NCT02589665|7604004|FG007|STARTED|Induction Period||0
6673003|NCT02589665|7604005|FG008|STARTED|Induction Period||0
6673004|NCT02589665|7604006|FG009|STARTED|Induction Period||0
6673005|NCT02589665|7603997|FG000|Received at Least One Dose of Study Drug|Induction Period||63
6673006|NCT02589665|7603998|FG001|Received at Least One Dose of Study Drug|Induction Period||63
6673007|NCT02589665|7603999|FG002|Received at Least One Dose of Study Drug|Induction Period||62
6673008|NCT02589665|7604000|FG003|Received at Least One Dose of Study Drug|Induction Period||60
6673009|NCT02589665|7604001|FG004|Received at Least One Dose of Study Drug|Induction Period||0
6673010|NCT02589665|7604002|FG005|Received at Least One Dose of Study Drug|Induction Period||0
6673011|NCT02589665|7604003|FG006|Received at Least One Dose of Study Drug|Induction Period||0
6673012|NCT02589665|7604004|FG007|Received at Least One Dose of Study Drug|Induction Period||0
6673013|NCT02589665|7604005|FG008|Received at Least One Dose of Study Drug|Induction Period||0
6673014|NCT02589665|7604006|FG009|Received at Least One Dose of Study Drug|Induction Period||0
6673015|NCT02589665|7603997|FG000|COMPLETED|Induction Period||60
6673016|NCT02589665|7603998|FG001|COMPLETED|Induction Period||61
6673017|NCT02589665|7603999|FG002|COMPLETED|Induction Period||60
6673018|NCT02589665|7604000|FG003|COMPLETED|Induction Period||57
6673019|NCT02589665|7604001|FG004|COMPLETED|Induction Period||0
6673020|NCT02589665|7604002|FG005|COMPLETED|Induction Period||0
6673021|NCT02589665|7604003|FG006|COMPLETED|Induction Period||0
6673022|NCT02589665|7604004|FG007|COMPLETED|Induction Period||0
6673023|NCT02589665|7604005|FG008|COMPLETED|Induction Period||0
6256194|NCT02028884|7155038|FG000|STARTED|Double-blind Period||42
6673024|NCT02589665|7604006|FG009|COMPLETED|Induction Period||0
6673025|NCT02589665|7603997|FG000|NOT COMPLETED|Induction Period||3
6673026|NCT02589665|7603998|FG001|NOT COMPLETED|Induction Period||2
6673027|NCT02589665|7603999|FG002|NOT COMPLETED|Induction Period||2
6673028|NCT02589665|7604000|FG003|NOT COMPLETED|Induction Period||4
6673029|NCT02589665|7604001|FG004|NOT COMPLETED|Induction Period||0
6673030|NCT02589665|7604002|FG005|NOT COMPLETED|Induction Period||0
6673031|NCT02589665|7604003|FG006|NOT COMPLETED|Induction Period||0
6673032|NCT02589665|7604004|FG007|NOT COMPLETED|Induction Period||0
6673033|NCT02589665|7604005|FG008|NOT COMPLETED|Induction Period||0
6673034|NCT02589665|7604006|FG009|NOT COMPLETED|Induction Period||0
6673035|NCT02589665|7603997|FG000|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
6673036|NCT02589665|7603998|FG001|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
6673037|NCT02589665|7603999|FG002|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
6673038|NCT02589665|7604000|FG003|STARTED|Maintenance Period|Participants were assigned to this arm only during induction period.|0
6673039|NCT02589665|7604001|FG004|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|13
6673040|NCT02589665|7604002|FG005|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|47
6673041|NCT02589665|7604003|FG006|STARTED|Maintenance Period|Only participants with a response were re-randomized in maintenance period.|46
6673042|NCT02589665|7604004|FG007|STARTED|Maintenance Period||0
6673043|NCT02589665|7604005|FG008|STARTED|Maintenance Period||0
6673044|NCT02589665|7604006|FG009|STARTED|Maintenance Period||0
6673045|NCT02589665|7603997|FG000|COMPLETED|Maintenance Period||0
6673046|NCT02589665|7603998|FG001|COMPLETED|Maintenance Period||0
6673047|NCT02589665|7603999|FG002|COMPLETED|Maintenance Period||0
6673048|NCT02589665|7604000|FG003|COMPLETED|Maintenance Period||0
6673049|NCT02589665|7604001|FG004|COMPLETED|Maintenance Period||0
6673050|NCT02589665|7604002|FG005|COMPLETED|Maintenance Period||0
6673051|NCT02589665|7604003|FG006|COMPLETED|Maintenance Period||0
6673052|NCT02589665|7604004|FG007|COMPLETED|Maintenance Period||0
6673053|NCT02589665|7604005|FG008|COMPLETED|Maintenance Period||0
6673054|NCT02589665|7604006|FG009|COMPLETED|Maintenance Period||0
6673055|NCT02589665|7603997|FG000|NOT COMPLETED|Maintenance Period||0
6673056|NCT02589665|7603998|FG001|NOT COMPLETED|Maintenance Period||0
6673057|NCT02589665|7603999|FG002|NOT COMPLETED|Maintenance Period||0
6673058|NCT02589665|7604000|FG003|NOT COMPLETED|Maintenance Period||0
6673059|NCT02589665|7604001|FG004|NOT COMPLETED|Maintenance Period||13
6673060|NCT02589665|7604002|FG005|NOT COMPLETED|Maintenance Period||47
6673061|NCT02589665|7604003|FG006|NOT COMPLETED|Maintenance Period||46
6673062|NCT02589665|7604004|FG007|NOT COMPLETED|Maintenance Period||0
6673063|NCT02589665|7604005|FG008|NOT COMPLETED|Maintenance Period||0
6673064|NCT02589665|7604006|FG009|NOT COMPLETED|Maintenance Period||0
6673065|NCT02589665|7603997|FG000|STARTED|Induction Extension Period||0
6673066|NCT02589665|7603998|FG001|STARTED|Induction Extension Period||0
6673067|NCT02589665|7603999|FG002|STARTED|Induction Extension Period||0
6673068|NCT02589665|7604000|FG003|STARTED|Induction Extension Period||0
6673069|NCT02589665|7604001|FG004|STARTED|Induction Extension Period||0
6673070|NCT02589665|7604002|FG005|STARTED|Induction Extension Period||0
6673071|NCT02589665|7604003|FG006|STARTED|Induction Extension Period||0
6673072|NCT02589665|7604004|FG007|STARTED|Induction Extension Period||32
6673073|NCT02589665|7604005|FG008|STARTED|Induction Extension Period||96
6673074|NCT02589665|7604006|FG009|STARTED|Induction Extension Period||0
6673075|NCT02589665|7603997|FG000|COMPLETED|Induction Extension Period||0
6673076|NCT02589665|7603998|FG001|COMPLETED|Induction Extension Period||0
6673077|NCT02589665|7603999|FG002|COMPLETED|Induction Extension Period||0
6673078|NCT02589665|7604000|FG003|COMPLETED|Induction Extension Period||0
6673079|NCT02589665|7604001|FG004|COMPLETED|Induction Extension Period||0
6673080|NCT02589665|7604002|FG005|COMPLETED|Induction Extension Period||0
6673081|NCT02589665|7604003|FG006|COMPLETED|Induction Extension Period||0
6673082|NCT02589665|7604004|FG007|COMPLETED|Induction Extension Period||30
6673083|NCT02589665|7604005|FG008|COMPLETED|Induction Extension Period||84
6673084|NCT02589665|7604006|FG009|COMPLETED|Induction Extension Period||0
6673085|NCT02589665|7603997|FG000|NOT COMPLETED|Induction Extension Period||0
6673086|NCT02589665|7603998|FG001|NOT COMPLETED|Induction Extension Period||0
6673087|NCT02589665|7603999|FG002|NOT COMPLETED|Induction Extension Period||0
6673088|NCT02589665|7604000|FG003|NOT COMPLETED|Induction Extension Period||0
6673089|NCT02589665|7604001|FG004|NOT COMPLETED|Induction Extension Period||0
6673090|NCT02589665|7604002|FG005|NOT COMPLETED|Induction Extension Period||0
6673091|NCT02589665|7604003|FG006|NOT COMPLETED|Induction Extension Period||0
6673092|NCT02589665|7604004|FG007|NOT COMPLETED|Induction Extension Period||2
6673093|NCT02589665|7604005|FG008|NOT COMPLETED|Induction Extension Period||12
6673094|NCT02589665|7604006|FG009|NOT COMPLETED|Induction Extension Period||0
6673095|NCT02589665|7603997|FG000|STARTED|Maintenance Extension Period||0
6673096|NCT02589665|7603998|FG001|STARTED|Maintenance Extension Period||0
6673097|NCT02589665|7603999|FG002|STARTED|Maintenance Extension Period||0
6673098|NCT02589665|7604000|FG003|STARTED|Maintenance Extension Period||0
6673099|NCT02589665|7604001|FG004|STARTED|Maintenance Extension Period||0
6673100|NCT02589665|7604002|FG005|STARTED|Maintenance Extension Period||0
6673101|NCT02589665|7604003|FG006|STARTED|Maintenance Extension Period||0
6673102|NCT02589665|7604004|FG007|STARTED|Maintenance Extension Period||0
6673103|NCT02589665|7604005|FG008|STARTED|Maintenance Extension Period||0
6673104|NCT02589665|7604006|FG009|STARTED|Maintenance Extension Period||68
6673105|NCT02589665|7603997|FG000|COMPLETED|Maintenance Extension Period||0
6673106|NCT02589665|7603998|FG001|COMPLETED|Maintenance Extension Period||0
6673107|NCT02589665|7603999|FG002|COMPLETED|Maintenance Extension Period||0
6673108|NCT02589665|7604000|FG003|COMPLETED|Maintenance Extension Period||0
6673109|NCT02589665|7604001|FG004|COMPLETED|Maintenance Extension Period||0
6673110|NCT02589665|7604002|FG005|COMPLETED|Maintenance Extension Period||0
6673111|NCT02589665|7604003|FG006|COMPLETED|Maintenance Extension Period||0
6673112|NCT02589665|7604004|FG007|COMPLETED|Maintenance Extension Period||0
6673113|NCT02589665|7604005|FG008|COMPLETED|Maintenance Extension Period||0
6673114|NCT02589665|7604006|FG009|COMPLETED|Maintenance Extension Period||0
6673115|NCT02589665|7603997|FG000|NOT COMPLETED|Maintenance Extension Period||0
6673116|NCT02589665|7603998|FG001|NOT COMPLETED|Maintenance Extension Period||0
6673117|NCT02589665|7603999|FG002|NOT COMPLETED|Maintenance Extension Period||0
6673118|NCT02589665|7604000|FG003|NOT COMPLETED|Maintenance Extension Period||0
6673119|NCT02589665|7604001|FG004|NOT COMPLETED|Maintenance Extension Period||0
6673120|NCT02589665|7604002|FG005|NOT COMPLETED|Maintenance Extension Period||0
6673121|NCT02589665|7604003|FG006|NOT COMPLETED|Maintenance Extension Period||0
6673122|NCT02589665|7604004|FG007|NOT COMPLETED|Maintenance Extension Period||0
6673123|NCT02589665|7604005|FG008|NOT COMPLETED|Maintenance Extension Period||0
6673124|NCT02589665|7604006|FG009|NOT COMPLETED|Maintenance Extension Period||68
6673125|NCT02589808|7604030|FG000|STARTED|Overall Study||76
6673126|NCT02589808|7604030|FG000|COMPLETED|Overall Study||76
6673127|NCT02589808|7604030|FG000|NOT COMPLETED|Overall Study||0
6673128|NCT02589847|7604036|FG000|STARTED|Overall Study||162
6673129|NCT02589847|7604037|FG001|STARTED|Overall Study||110
6673130|NCT02589847|7604036|FG000|Safety Population|Overall Study||149
6673131|NCT02589847|7604037|FG001|Safety Population|Overall Study||0
6673132|NCT02589847|7604036|FG000|Full Analysis Set (FAS)|Overall Study||149
6673133|NCT02589847|7604037|FG001|Full Analysis Set (FAS)|Overall Study||104
6673134|NCT02589847|7604036|FG000|Evaluable|Overall Study||142
6673135|NCT02589847|7604037|FG001|Evaluable|Overall Study||75
6673136|NCT02589847|7604036|FG000|COMPLETED|Overall Study||107
6673137|NCT02589847|7604037|FG001|COMPLETED|Overall Study||39
6673138|NCT02589847|7604036|FG000|NOT COMPLETED|Overall Study||55
6673139|NCT02589847|7604037|FG001|NOT COMPLETED|Overall Study||71
6673140|NCT02589977|7604047|FG000|STARTED|Overall Study||23
6673141|NCT02589977|7604048|FG001|STARTED|Overall Study||20
6673142|NCT02589977|7604049|FG002|STARTED|Overall Study||12
6673143|NCT02589977|7604047|FG000|COMPLETED|Overall Study||17
6673144|NCT02589977|7604048|FG001|COMPLETED|Overall Study||15
6673145|NCT02589977|7604049|FG002|COMPLETED|Overall Study||8
6673146|NCT02589977|7604047|FG000|NOT COMPLETED|Overall Study||6
6673147|NCT02589977|7604048|FG001|NOT COMPLETED|Overall Study||5
6673148|NCT02589977|7604049|FG002|NOT COMPLETED|Overall Study||4
6673149|NCT02590003|7604059|FG000|STARTED|Overall Study||1
6673150|NCT02590003|7604060|FG001|STARTED|Overall Study||2
6673151|NCT02590003|7604059|FG000|COMPLETED|Overall Study||0
6673152|NCT02590003|7604060|FG001|COMPLETED|Overall Study||0
6673153|NCT02590003|7604059|FG000|NOT COMPLETED|Overall Study||1
6673154|NCT02590003|7604060|FG001|NOT COMPLETED|Overall Study||2
6673155|NCT02590354|7604066|FG000|STARTED|Phase 1||114
6673156|NCT02590354|7604066|FG000|COMPLETED|Phase 1||16
6673157|NCT02590354|7604066|FG000|NOT COMPLETED|Phase 1||98
6673158|NCT02590354|7604066|FG000|STARTED|Phase 2 - Treatment Interruption||16
6673159|NCT02590354|7604066|FG000|COMPLETED|Phase 2 - Treatment Interruption||14
6673160|NCT02590354|7604066|FG000|NOT COMPLETED|Phase 2 - Treatment Interruption||2
6673161|NCT02590406|7604073|FG000|STARTED|Overall Study||25
6673162|NCT02590406|7604074|FG001|STARTED|Overall Study||25
6673163|NCT02590406|7604073|FG000|COMPLETED|Overall Study||24
6673164|NCT02590406|7604074|FG001|COMPLETED|Overall Study||24
6673165|NCT02590406|7604073|FG000|NOT COMPLETED|Overall Study||1
6673166|NCT02590406|7604074|FG001|NOT COMPLETED|Overall Study||1
6673167|NCT02590432|7604082|FG000|STARTED|Open-label Treatment Period||508
6673168|NCT02590432|7604083|FG001|STARTED|Open-label Treatment Period||318
6673169|NCT02590432|7604084|FG002|STARTED|Open-label Treatment Period||0
6673170|NCT02590432|7604085|FG003|STARTED|Open-label Treatment Period||0
6673171|NCT02590432|7604086|FG004|STARTED|Open-label Treatment Period||0
6673172|NCT02590432|7604087|FG005|STARTED|Open-label Treatment Period||0
6673173|NCT02590432|7604088|FG006|STARTED|Open-label Treatment Period||0
6673174|NCT02590432|7604089|FG007|STARTED|Open-label Treatment Period||0
6673175|NCT02590432|7604090|FG008|STARTED|Open-label Treatment Period||0
6673176|NCT02590432|7604082|FG000|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|276
6673177|NCT02590432|7604083|FG001|COMPLETED|Open-label Treatment Period|Participants were not randomized to Double-blind Treatment Period.|166
6673178|NCT02590432|7604084|FG002|COMPLETED|Open-label Treatment Period||0
6673179|NCT02590432|7604085|FG003|COMPLETED|Open-label Treatment Period||0
6673180|NCT02590432|7604086|FG004|COMPLETED|Open-label Treatment Period||0
6673181|NCT02590432|7604087|FG005|COMPLETED|Open-label Treatment Period||0
6673182|NCT02590432|7604088|FG006|COMPLETED|Open-label Treatment Period||0
6673183|NCT02590432|7604089|FG007|COMPLETED|Open-label Treatment Period||0
6673184|NCT02590432|7604090|FG008|COMPLETED|Open-label Treatment Period||0
6673185|NCT02590432|7604082|FG000|NOT COMPLETED|Open-label Treatment Period||232
6673186|NCT02590432|7604083|FG001|NOT COMPLETED|Open-label Treatment Period||152
6673187|NCT02590432|7604084|FG002|NOT COMPLETED|Open-label Treatment Period||0
6673188|NCT02590432|7604085|FG003|NOT COMPLETED|Open-label Treatment Period||0
6673189|NCT02590432|7604086|FG004|NOT COMPLETED|Open-label Treatment Period||0
6673190|NCT02590432|7604087|FG005|NOT COMPLETED|Open-label Treatment Period||0
6673191|NCT02590432|7604088|FG006|NOT COMPLETED|Open-label Treatment Period||0
6673192|NCT02590432|7604089|FG007|NOT COMPLETED|Open-label Treatment Period||0
6673193|NCT02590432|7604090|FG008|NOT COMPLETED|Open-label Treatment Period||0
6673194|NCT02590432|7604082|FG000|STARTED|Double-blind Treatment Period||0
6673195|NCT02590432|7604083|FG001|STARTED|Double-blind Treatment Period||0
6673196|NCT02590432|7604084|FG002|STARTED|Double-blind Treatment Period||18
6673197|NCT02590432|7604085|FG003|STARTED|Double-blind Treatment Period||18
6673198|NCT02590432|7604086|FG004|STARTED|Double-blind Treatment Period||16
6673199|NCT02590432|7604087|FG005|STARTED|Double-blind Treatment Period||32
6673200|NCT02590432|7604088|FG006|STARTED|Double-blind Treatment Period||30
6673201|NCT02590432|7604089|FG007|STARTED|Double-blind Treatment Period||0
6673202|NCT02590432|7604090|FG008|STARTED|Double-blind Treatment Period||0
6673203|NCT02590432|7604082|FG000|COMPLETED|Double-blind Treatment Period||0
6673204|NCT02590432|7604083|FG001|COMPLETED|Double-blind Treatment Period||0
6673205|NCT02590432|7604084|FG002|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|1
6673206|NCT02590432|7604085|FG003|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|3
6673207|NCT02590432|7604086|FG004|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|7
6673208|NCT02590432|7604087|FG005|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|6
6673209|NCT02590432|7604088|FG006|COMPLETED|Double-blind Treatment Period|Participants did not enter Dose-reduced Open Label Treatment Period.|9
6673210|NCT02590432|7604089|FG007|COMPLETED|Double-blind Treatment Period||0
6673211|NCT02590432|7604090|FG008|COMPLETED|Double-blind Treatment Period||0
6673212|NCT02590432|7604082|FG000|NOT COMPLETED|Double-blind Treatment Period||0
6673213|NCT02590432|7604083|FG001|NOT COMPLETED|Double-blind Treatment Period||0
6673214|NCT02590432|7604084|FG002|NOT COMPLETED|Double-blind Treatment Period||17
6673215|NCT02590432|7604085|FG003|NOT COMPLETED|Double-blind Treatment Period||15
6673216|NCT02590432|7604086|FG004|NOT COMPLETED|Double-blind Treatment Period||9
6673217|NCT02590432|7604087|FG005|NOT COMPLETED|Double-blind Treatment Period||26
6673218|NCT02590432|7604088|FG006|NOT COMPLETED|Double-blind Treatment Period||21
6673219|NCT02590432|7604089|FG007|NOT COMPLETED|Double-blind Treatment Period||0
6673220|NCT02590432|7604090|FG008|NOT COMPLETED|Double-blind Treatment Period||0
6673221|NCT02590432|7604082|FG000|STARTED|Dose-reduced Open Label Treatment Period||0
6673222|NCT02590432|7604083|FG001|STARTED|Dose-reduced Open Label Treatment Period||0
6673223|NCT02590432|7604084|FG002|STARTED|Dose-reduced Open Label Treatment Period||0
6673224|NCT02590432|7604085|FG003|STARTED|Dose-reduced Open Label Treatment Period||0
6673225|NCT02590432|7604086|FG004|STARTED|Dose-reduced Open Label Treatment Period||0
6673226|NCT02590432|7604087|FG005|STARTED|Dose-reduced Open Label Treatment Period||0
6673227|NCT02590432|7604088|FG006|STARTED|Dose-reduced Open Label Treatment Period||0
6673228|NCT02590432|7604089|FG007|STARTED|Dose-reduced Open Label Treatment Period||31
6673229|NCT02590432|7604090|FG008|STARTED|Dose-reduced Open Label Treatment Period||26
6673230|NCT02590432|7604082|FG000|COMPLETED|Dose-reduced Open Label Treatment Period||0
6673231|NCT02590432|7604083|FG001|COMPLETED|Dose-reduced Open Label Treatment Period||0
6673232|NCT02590432|7604084|FG002|COMPLETED|Dose-reduced Open Label Treatment Period||0
6673233|NCT02590432|7604085|FG003|COMPLETED|Dose-reduced Open Label Treatment Period||0
6673234|NCT02590432|7604086|FG004|COMPLETED|Dose-reduced Open Label Treatment Period||0
6673235|NCT02590432|7604087|FG005|COMPLETED|Dose-reduced Open Label Treatment Period||0
6673236|NCT02590432|7604088|FG006|COMPLETED|Dose-reduced Open Label Treatment Period||0
6673237|NCT02590432|7604089|FG007|COMPLETED|Dose-reduced Open Label Treatment Period||13
6673238|NCT02590432|7604090|FG008|COMPLETED|Dose-reduced Open Label Treatment Period||8
6673239|NCT02590432|7604082|FG000|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6673240|NCT02590432|7604083|FG001|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6673241|NCT02590432|7604084|FG002|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6673242|NCT02590432|7604085|FG003|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6673243|NCT02590432|7604086|FG004|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6673244|NCT02590432|7604087|FG005|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6673245|NCT02590432|7604088|FG006|NOT COMPLETED|Dose-reduced Open Label Treatment Period||0
6673246|NCT02590432|7604089|FG007|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
6673247|NCT02590432|7604090|FG008|NOT COMPLETED|Dose-reduced Open Label Treatment Period||18
6673248|NCT02590562|7604102|FG000|STARTED|Overall Study||808
6673249|NCT02590562|7604102|FG000|COMPLETED|Overall Study||802
6673250|NCT02590562|7604102|FG000|NOT COMPLETED|Overall Study||6
6673251|NCT02590588|7604112|FG000|STARTED|Overall Study||1
6673252|NCT02590588|7604112|FG000|COMPLETED|Overall Study||0
6673253|NCT02590588|7604112|FG000|NOT COMPLETED|Overall Study||1
6673254|NCT02590939|7604118|FG000|STARTED|Overall Study||52
6673255|NCT02590939|7604119|FG001|STARTED|Overall Study||54
6673256|NCT02590939|7604118|FG000|COMPLETED|Overall Study||47
6673257|NCT02590939|7604119|FG001|COMPLETED|Overall Study||52
6673258|NCT02590939|7604118|FG000|NOT COMPLETED|Overall Study||5
6673259|NCT02590939|7604119|FG001|NOT COMPLETED|Overall Study||2
6673260|NCT02591056|7604125|FG000|STARTED|Overall Study||27
6673261|NCT02591056|7604125|FG000|COMPLETED|Overall Study||27
6673262|NCT02591056|7604125|FG000|NOT COMPLETED|Overall Study||0
6673263|NCT02591238|7604133|FG000|STARTED|Overall Study||16
6673264|NCT02591238|7604134|FG001|STARTED|Overall Study||17
6673265|NCT02591238|7604135|FG002|STARTED|Overall Study||17
6673266|NCT02591238|7604136|FG003|STARTED|Overall Study||18
6673267|NCT02591238|7604133|FG000|COMPLETED|Overall Study||15
6673268|NCT02591238|7604134|FG001|COMPLETED|Overall Study||16
6673269|NCT02591238|7604135|FG002|COMPLETED|Overall Study||17
6673270|NCT02591238|7604136|FG003|COMPLETED|Overall Study||15
6673271|NCT02591238|7604133|FG000|NOT COMPLETED|Overall Study||1
6673272|NCT02591238|7604134|FG001|NOT COMPLETED|Overall Study||1
6673273|NCT02591238|7604135|FG002|NOT COMPLETED|Overall Study||0
6673274|NCT02591238|7604136|FG003|NOT COMPLETED|Overall Study||3
6673275|NCT02591290|7604146|FG000|STARTED|Overall Study||60
6673276|NCT02591290|7604146|FG000|Vaccinated Dose 1|Overall Study||60
6673277|NCT02591290|7604146|FG000|Vaccinated Dose 2|Overall Study||58
6673278|NCT02591290|7604146|FG000|COMPLETED|Overall Study||58
6673279|NCT02591290|7604146|FG000|NOT COMPLETED|Overall Study||2
6673280|NCT02591511|7604152|FG000|STARTED|Overall Study||30
6673281|NCT02591511|7604153|FG001|STARTED|Overall Study||33
6673282|NCT02591511|7604152|FG000|COMPLETED|Overall Study||30
6673283|NCT02591511|7604153|FG001|COMPLETED|Overall Study||33
6673284|NCT02591511|7604152|FG000|NOT COMPLETED|Overall Study||0
6673285|NCT02591511|7604153|FG001|NOT COMPLETED|Overall Study||0
6673286|NCT02591537|7604161|FG000|STARTED|Overall Study||8
6673287|NCT02591537|7604162|FG001|STARTED|Overall Study||8
6673288|NCT02591537|7604161|FG000|COMPLETED|Overall Study||8
6673289|NCT02591537|7604162|FG001|COMPLETED|Overall Study||8
6673290|NCT02591537|7604161|FG000|NOT COMPLETED|Overall Study||0
6673291|NCT02591537|7604162|FG001|NOT COMPLETED|Overall Study||0
6673292|NCT02592018|7604169|FG000|STARTED|Overall Study||15
6673293|NCT02592018|7604169|FG000|COMPLETED|Overall Study||13
6673294|NCT02592018|7604169|FG000|NOT COMPLETED|Overall Study||2
6673295|NCT02592421|7604175|FG000|STARTED|Study 1||20
6673296|NCT02592421|7604176|FG001|STARTED|Study 1||10
6673297|NCT02592421|7604175|FG000|COMPLETED|Study 1||20
6673298|NCT02592421|7604176|FG001|COMPLETED|Study 1||10
6673299|NCT02592421|7604175|FG000|NOT COMPLETED|Study 1||0
6673300|NCT02592421|7604176|FG001|NOT COMPLETED|Study 1||0
6673301|NCT02592421|7604175|FG000|STARTED|Study 2: Glucose Clamp Conditions||20
6673302|NCT02592421|7604176|FG001|STARTED|Study 2: Glucose Clamp Conditions||10
6673303|NCT02592421|7604175|FG000|COMPLETED|Study 2: Glucose Clamp Conditions||20
6673304|NCT02592421|7604176|FG001|COMPLETED|Study 2: Glucose Clamp Conditions||10
6673305|NCT02592421|7604175|FG000|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
6673306|NCT02592421|7604176|FG001|NOT COMPLETED|Study 2: Glucose Clamp Conditions||0
6673307|NCT02592421|7604175|FG000|STARTED|Study 3: Pancreatic Clamp Conditions||20
6673308|NCT02592421|7604176|FG001|STARTED|Study 3: Pancreatic Clamp Conditions||10
6673309|NCT02592421|7604175|FG000|COMPLETED|Study 3: Pancreatic Clamp Conditions||20
6673310|NCT02592421|7604176|FG001|COMPLETED|Study 3: Pancreatic Clamp Conditions||10
6673311|NCT02592421|7604175|FG000|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
6673312|NCT02592421|7604176|FG001|NOT COMPLETED|Study 3: Pancreatic Clamp Conditions||0
6673313|NCT02592434|7604182|FG000|STARTED|Open-Label Phase (18 Weeks)||225
6673314|NCT02592434|7604183|FG001|STARTED|Open-Label Phase (18 Weeks)||0
6673315|NCT02592434|7604184|FG002|STARTED|Open-Label Phase (18 Weeks)||0
6673316|NCT02592434|7604182|FG000|Treated|Open-Label Phase (18 Weeks)||225
6673317|NCT02592434|7604183|FG001|Treated|Open-Label Phase (18 Weeks)||0
6673318|NCT02592434|7604184|FG002|Treated|Open-Label Phase (18 Weeks)||0
6673319|NCT02592434|7604182|FG000|COMPLETED|Open-Label Phase (18 Weeks)||185
6673320|NCT02592434|7604183|FG001|COMPLETED|Open-Label Phase (18 Weeks)||0
6673321|NCT02592434|7604184|FG002|COMPLETED|Open-Label Phase (18 Weeks)||0
6673322|NCT02592434|7604182|FG000|NOT COMPLETED|Open-Label Phase (18 Weeks)||40
6673323|NCT02592434|7604183|FG001|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
6673324|NCT02592434|7604184|FG002|NOT COMPLETED|Open-Label Phase (18 Weeks)||0
6673325|NCT02592434|7604182|FG000|STARTED|Double Blind Phase (26 Weeks)||0
6673326|NCT02592434|7604183|FG001|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase, achieved at least a JIA ACR 30 response in OL phase.|88
6673327|NCT02592434|7604184|FG002|STARTED|Double Blind Phase (26 Weeks)|Only those participants who completed OL phase,achieved at least a JIA ACR 30 response in OL phase.|85
6673328|NCT02592434|7604182|FG000|Treated|Double Blind Phase (26 Weeks)||0
6673329|NCT02592434|7604183|FG001|Treated|Double Blind Phase (26 Weeks)||88
6673330|NCT02592434|7604184|FG002|Treated|Double Blind Phase (26 Weeks)||85
6673331|NCT02592434|7604182|FG000|COMPLETED|Double Blind Phase (26 Weeks)||0
6673332|NCT02592434|7604183|FG001|COMPLETED|Double Blind Phase (26 Weeks)||61
6673333|NCT02592434|7604184|FG002|COMPLETED|Double Blind Phase (26 Weeks)||38
6673334|NCT02592434|7604182|FG000|NOT COMPLETED|Double Blind Phase (26 Weeks)||0
6673335|NCT02592434|7604183|FG001|NOT COMPLETED|Double Blind Phase (26 Weeks)||27
6673336|NCT02592434|7604184|FG002|NOT COMPLETED|Double Blind Phase (26 Weeks)||47
6673337|NCT02592447|7604194|FG000|STARTED|Overall Study||29
6673338|NCT02592447|7604195|FG001|STARTED|Overall Study||15
6673339|NCT02592447|7604194|FG000|COMPLETED|Overall Study||27
6673340|NCT02592447|7604195|FG001|COMPLETED|Overall Study||14
6673341|NCT02592447|7604194|FG000|NOT COMPLETED|Overall Study||2
6673342|NCT02592447|7604195|FG001|NOT COMPLETED|Overall Study||1
6673343|NCT02592486|7604203|FG000|STARTED|Overall Study||81
6673344|NCT02592486|7604204|FG001|STARTED|Overall Study||81
6673345|NCT02592486|7604203|FG000|COMPLETED|Overall Study||81
6673346|NCT02592486|7604204|FG001|COMPLETED|Overall Study||76
6673347|NCT02592486|7604203|FG000|NOT COMPLETED|Overall Study||0
6673348|NCT02592486|7604204|FG001|NOT COMPLETED|Overall Study||5
6673349|NCT02592629|7604213|FG000|STARTED|Overall Study||5
6673350|NCT02592629|7604214|FG001|STARTED|Overall Study||9
6673351|NCT02592629|7604215|FG002|STARTED|Overall Study||5
6673352|NCT02592629|7604213|FG000|COMPLETED|Overall Study||5
6673353|NCT02592629|7604214|FG001|COMPLETED|Overall Study||9
6673354|NCT02592629|7604215|FG002|COMPLETED|Overall Study||5
6673355|NCT02592629|7604213|FG000|NOT COMPLETED|Overall Study||0
6673356|NCT02592629|7604214|FG001|NOT COMPLETED|Overall Study||0
6673357|NCT02592629|7604215|FG002|NOT COMPLETED|Overall Study||0
6673358|NCT02592655|7604225|FG000|STARTED|First Tourniquet, Left Thigh.||19
6673359|NCT02592655|7604225|FG000|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
6673360|NCT02592655|7604225|FG000|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
6673361|NCT02592655|7604225|FG000|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
6673362|NCT02592655|7604225|FG000|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
6673363|NCT02592655|7604225|FG000|COMPLETED|First Tourniquet, Left Thigh.||19
6673364|NCT02592655|7604225|FG000|NOT COMPLETED|First Tourniquet, Left Thigh.||0
6673365|NCT02592655|7604225|FG000|STARTED|Second Tourniquet Right Thigh.||19
6673366|NCT02592655|7604225|FG000|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
6673367|NCT02592655|7604225|FG000|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
6673368|NCT02592655|7604225|FG000|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
6673369|NCT02592655|7604225|FG000|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
6673370|NCT02592655|7604225|FG000|COMPLETED|Second Tourniquet Right Thigh.||19
6673371|NCT02592655|7604225|FG000|NOT COMPLETED|Second Tourniquet Right Thigh.||0
6673372|NCT02592655|7604225|FG000|STARTED|Third Tourniquet, Left Thigh.||19
6673373|NCT02592655|7604225|FG000|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
6673374|NCT02592655|7604225|FG000|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
6673375|NCT02592655|7604225|FG000|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
6673376|NCT02592655|7604225|FG000|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
6673377|NCT02592655|7604225|FG000|COMPLETED|Third Tourniquet, Left Thigh.||19
6673378|NCT02592655|7604225|FG000|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
6673379|NCT02592655|7604225|FG000|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
6673380|NCT02592655|7604225|FG000|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
6673381|NCT02592655|7604225|FG000|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
6673382|NCT02592655|7604225|FG000|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
6673383|NCT02592655|7604225|FG000|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
6673384|NCT02592655|7604225|FG000|COMPLETED|Fourth Tourniquet Right Thigh.||4
6673385|NCT02592655|7604225|FG000|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
6738092|NCT03276026|7667349|FG001|COMPLETED|Overall Study||33
6738093|NCT03276026|7667348|FG000|NOT COMPLETED|Overall Study||1
6738094|NCT03276026|7667349|FG001|NOT COMPLETED|Overall Study||0
6738095|NCT03276078|7667355|FG000|STARTED|Overall Study||20
6738096|NCT03276078|7667355|FG000|COMPLETED|Overall Study||19
6738097|NCT03276078|7667355|FG000|NOT COMPLETED|Overall Study||1
6738098|NCT03276494|7667359|FG000|STARTED|Overall Study||6
6738099|NCT03276494|7667359|FG000|COMPLETED|Overall Study||5
6738100|NCT03276494|7667359|FG000|NOT COMPLETED|Overall Study||1
6738101|NCT03276637|7667363|FG000|STARTED|Overall Study||93
6738102|NCT03276637|7667363|FG000|Completed Pre Survey|Overall Study||93
6738103|NCT03276637|7667363|FG000|Underwent Sequencing|Overall Study||75
6738104|NCT03276637|7667363|FG000|Completed Post Survey|Overall Study||69
6738105|NCT03276637|7667363|FG000|COMPLETED|Overall Study||69
6738106|NCT03276637|7667363|FG000|NOT COMPLETED|Overall Study||24
6738107|NCT03276871|7667370|FG000|STARTED|Overall Study||21
6738108|NCT03276871|7667371|FG001|STARTED|Overall Study||19
6738109|NCT03276871|7667370|FG000|COMPLETED|Overall Study||21
6738110|NCT03276871|7667371|FG001|COMPLETED|Overall Study||19
6738111|NCT03276871|7667370|FG000|NOT COMPLETED|Overall Study||0
6738112|NCT03276871|7667371|FG001|NOT COMPLETED|Overall Study||0
6738113|NCT03276975|7667379|FG000|STARTED|Overall Study||8
6738114|NCT03276975|7667380|FG001|STARTED|Overall Study||7
6738115|NCT03276975|7667379|FG000|Crossover At 2 Months|Overall Study||0
6738116|NCT03276975|7667380|FG001|Crossover At 2 Months|Overall Study||7
6738117|NCT03276975|7667379|FG000|COMPLETED|Overall Study||7
6738118|NCT03276975|7667380|FG001|COMPLETED|Overall Study||7
6738119|NCT03276975|7667379|FG000|NOT COMPLETED|Overall Study||1
6738120|NCT03276975|7667380|FG001|NOT COMPLETED|Overall Study||0
6738121|NCT03277274|7667389|FG000|STARTED|Overall Study||8
6738122|NCT03277274|7667390|FG001|STARTED|Overall Study||10
6738123|NCT03277274|7667391|FG002|STARTED|Overall Study||7
6738124|NCT03277274|7667389|FG000|COMPLETED|Overall Study||8
6738125|NCT03277274|7667390|FG001|COMPLETED|Overall Study||10
6738126|NCT03277274|7667391|FG002|COMPLETED|Overall Study||7
6738127|NCT03277274|7667389|FG000|NOT COMPLETED|Overall Study||0
6738128|NCT03277274|7667390|FG001|NOT COMPLETED|Overall Study||0
6738129|NCT03277274|7667391|FG002|NOT COMPLETED|Overall Study||0
6738130|NCT03277352|7667399|FG000|STARTED|Overall Study||10
6738131|NCT03277352|7667399|FG000|COMPLETED|Overall Study||0
6738132|NCT03277352|7667399|FG000|NOT COMPLETED|Overall Study||10
6738133|NCT03277378|7667406|FG000|STARTED|Overall Study||135
6738134|NCT03277378|7667407|FG001|STARTED|Overall Study||135
6738135|NCT03277378|7667406|FG000|Received Lead Implant|Overall Study||129
6738136|NCT03277378|7667407|FG001|Received Lead Implant|Overall Study||123
6738137|NCT03277378|7667406|FG000|Completed Initial Trial|Overall Study||126
6738138|NCT03277378|7667407|FG001|Completed Initial Trial|Overall Study||122
6738139|NCT03277378|7667406|FG000|Qualified for Permanent Implant|Overall Study||103
6738140|NCT03277378|7667407|FG001|Qualified for Permanent Implant|Overall Study||93
6673386|NCT02592798|7604242|FG000|STARTED|Double-Blind Period 1 (DB1)||17
6673387|NCT02592798|7604243|FG001|STARTED|Double-Blind Period 1 (DB1)||19
6673388|NCT02592798|7604242|FG000|COMPLETED|Double-Blind Period 1 (DB1)||14
6673389|NCT02592798|7604243|FG001|COMPLETED|Double-Blind Period 1 (DB1)||13
6673390|NCT02592798|7604242|FG000|NOT COMPLETED|Double-Blind Period 1 (DB1)||3
6673391|NCT02592798|7604243|FG001|NOT COMPLETED|Double-Blind Period 1 (DB1)||6
6673392|NCT02592798|7604242|FG000|STARTED|Transition From DB1 to DB2||14
6673393|NCT02592798|7604243|FG001|STARTED|Transition From DB1 to DB2||13
6673394|NCT02592798|7604242|FG000|COMPLETED|Transition From DB1 to DB2||11
6673395|NCT02592798|7604243|FG001|COMPLETED|Transition From DB1 to DB2||11
6673396|NCT02592798|7604242|FG000|NOT COMPLETED|Transition From DB1 to DB2||3
6673397|NCT02592798|7604243|FG001|NOT COMPLETED|Transition From DB1 to DB2||2
6673398|NCT02592798|7604242|FG000|STARTED|Double-Blind Period 2 (DB2)||11
6673399|NCT02592798|7604243|FG001|STARTED|Double-Blind Period 2 (DB2)||11
6673400|NCT02592798|7604242|FG000|COMPLETED|Double-Blind Period 2 (DB2)||6
6673401|NCT02592798|7604243|FG001|COMPLETED|Double-Blind Period 2 (DB2)||9
6673402|NCT02592798|7604242|FG000|NOT COMPLETED|Double-Blind Period 2 (DB2)||5
6673403|NCT02592798|7604243|FG001|NOT COMPLETED|Double-Blind Period 2 (DB2)||2
6673404|NCT02592798|7604242|FG000|STARTED|Transition From DB2 to OLE||6
6673405|NCT02592798|7604243|FG001|STARTED|Transition From DB2 to OLE||9
6673406|NCT02592798|7604242|FG000|COMPLETED|Transition From DB2 to OLE||5
6673407|NCT02592798|7604243|FG001|COMPLETED|Transition From DB2 to OLE||9
6673408|NCT02592798|7604242|FG000|NOT COMPLETED|Transition From DB2 to OLE||1
6673409|NCT02592798|7604243|FG001|NOT COMPLETED|Transition From DB2 to OLE||0
6673410|NCT02592798|7604242|FG000|STARTED|Open Label Period (OLE)||10
6673411|NCT02592798|7604243|FG001|STARTED|Open Label Period (OLE)||13
6673412|NCT02592798|7604242|FG000|COMPLETED|Open Label Period (OLE)||6
6673413|NCT02592798|7604243|FG001|COMPLETED|Open Label Period (OLE)||4
6673414|NCT02592798|7604242|FG000|NOT COMPLETED|Open Label Period (OLE)||4
6673415|NCT02592798|7604243|FG001|NOT COMPLETED|Open Label Period (OLE)||9
6673416|NCT02592876|7604258|FG000|STARTED|Overall Study||41
6673417|NCT02592876|7604259|FG001|STARTED|Overall Study||40
6673418|NCT02592876|7604258|FG000|Received Study Drug|Overall Study||40
6673419|NCT02592876|7604259|FG001|Received Study Drug|Overall Study||40
6673420|NCT02592876|7604258|FG000|Completed Treatment|Overall Study||34
6673421|NCT02592876|7604259|FG001|Completed Treatment|Overall Study||32
6673422|NCT02592876|7604258|FG000|COMPLETED|Overall Study||0
6673423|NCT02592876|7604259|FG001|COMPLETED|Overall Study||0
6673424|NCT02592876|7604258|FG000|NOT COMPLETED|Overall Study||41
6673425|NCT02592876|7604259|FG001|NOT COMPLETED|Overall Study||40
6673426|NCT02593006|7604268|FG000|STARTED|Overall Study||257
6673427|NCT02593006|7604269|FG001|STARTED|Overall Study||100
6673428|NCT02593006|7604270|FG002|STARTED|Overall Study||43
6673429|NCT02593006|7604268|FG000|COMPLETED|Overall Study||250
6673430|NCT02593006|7604269|FG001|COMPLETED|Overall Study||93
6673431|NCT02593006|7604270|FG002|COMPLETED|Overall Study||38
6673432|NCT02593006|7604268|FG000|NOT COMPLETED|Overall Study||7
6673433|NCT02593006|7604269|FG001|NOT COMPLETED|Overall Study||7
6673434|NCT02593006|7604270|FG002|NOT COMPLETED|Overall Study||5
6673435|NCT02593032|7604281|FG000|STARTED|Overall Study||17
6673436|NCT02593032|7604282|FG001|STARTED|Overall Study||33
6673437|NCT02593032|7604281|FG000|COMPLETED|Overall Study||17
6673438|NCT02593032|7604282|FG001|COMPLETED|Overall Study||33
6673439|NCT02593032|7604281|FG000|NOT COMPLETED|Overall Study||0
6673440|NCT02593032|7604282|FG001|NOT COMPLETED|Overall Study||0
6673441|NCT02593097|7604290|FG000|STARTED|First Intervention (12 Weeks)||14
6673442|NCT02593097|7604291|FG001|STARTED|First Intervention (12 Weeks)||20
6673443|NCT02593097|7604290|FG000|Received Intervention|First Intervention (12 Weeks)||14
6673444|NCT02593097|7604291|FG001|Received Intervention|First Intervention (12 Weeks)||20
6673445|NCT02593097|7604290|FG000|COMPLETED|First Intervention (12 Weeks)||12
6673446|NCT02593097|7604291|FG001|COMPLETED|First Intervention (12 Weeks)||16
6673447|NCT02593097|7604290|FG000|NOT COMPLETED|First Intervention (12 Weeks)||2
6673448|NCT02593097|7604291|FG001|NOT COMPLETED|First Intervention (12 Weeks)||4
6673449|NCT02593097|7604290|FG000|STARTED|Washout (4 Weeks)||12
6673450|NCT02593097|7604291|FG001|STARTED|Washout (4 Weeks)||16
6673451|NCT02593097|7604290|FG000|COMPLETED|Washout (4 Weeks)||12
6673452|NCT02593097|7604291|FG001|COMPLETED|Washout (4 Weeks)||16
6673453|NCT02593097|7604290|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6673454|NCT02593097|7604291|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6673455|NCT02593097|7604290|FG000|STARTED|Second Intervention (12 Weeks)||12
6673456|NCT02593097|7604291|FG001|STARTED|Second Intervention (12 Weeks)||16
6673457|NCT02593097|7604290|FG000|COMPLETED|Second Intervention (12 Weeks)||9
6673458|NCT02593097|7604291|FG001|COMPLETED|Second Intervention (12 Weeks)||15
6673459|NCT02593097|7604290|FG000|NOT COMPLETED|Second Intervention (12 Weeks)||3
6673460|NCT02593097|7604291|FG001|NOT COMPLETED|Second Intervention (12 Weeks)||1
6673461|NCT02593149|7604299|FG000|STARTED|Run-In||340
6673462|NCT02593149|7604300|FG001|STARTED|Run-In||361
6673463|NCT02593149|7604299|FG000|COMPLETED|Run-In||304
6673464|NCT02593149|7604300|FG001|COMPLETED|Run-In||323
6673465|NCT02593149|7604299|FG000|NOT COMPLETED|Run-In||36
6673466|NCT02593149|7604300|FG001|NOT COMPLETED|Run-In||38
6673467|NCT02593149|7604299|FG000|STARTED|Intervention||942
6673468|NCT02593149|7604300|FG001|STARTED|Intervention||960
6673469|NCT02593149|7604299|FG000|COMPLETED|Intervention||826
6673470|NCT02593149|7604300|FG001|COMPLETED|Intervention||845
6673471|NCT02593149|7604299|FG000|NOT COMPLETED|Intervention||116
6673472|NCT02593149|7604300|FG001|NOT COMPLETED|Intervention||115
6673473|NCT02593305|7604309|FG000|STARTED|Baseline 1||7
6673474|NCT02593305|7604310|FG001|STARTED|Baseline 1||6
6673475|NCT02593305|7604311|FG002|STARTED|Baseline 1||10
6673476|NCT02593305|7604309|FG000|COMPLETED|Baseline 1||7
6673477|NCT02593305|7604310|FG001|COMPLETED|Baseline 1||6
6673478|NCT02593305|7604311|FG002|COMPLETED|Baseline 1||10
6673479|NCT02593305|7604309|FG000|NOT COMPLETED|Baseline 1||0
6673480|NCT02593305|7604310|FG001|NOT COMPLETED|Baseline 1||0
6673481|NCT02593305|7604311|FG002|NOT COMPLETED|Baseline 1||0
6673482|NCT02593305|7604309|FG000|STARTED|Post 1||7
6673483|NCT02593305|7604310|FG001|STARTED|Post 1||6
6673484|NCT02593305|7604311|FG002|STARTED|Post 1||10
6673485|NCT02593305|7604309|FG000|COMPLETED|Post 1||7
6673486|NCT02593305|7604310|FG001|COMPLETED|Post 1||6
6673487|NCT02593305|7604311|FG002|COMPLETED|Post 1||0
6673488|NCT02593305|7604309|FG000|NOT COMPLETED|Post 1||0
6673489|NCT02593305|7604310|FG001|NOT COMPLETED|Post 1||0
6673490|NCT02593305|7604311|FG002|NOT COMPLETED|Post 1||10
6673491|NCT02593305|7604309|FG000|STARTED|Baseline 2||7
6673492|NCT02593305|7604310|FG001|STARTED|Baseline 2||6
6673493|NCT02593305|7604311|FG002|STARTED|Baseline 2||0
6673494|NCT02593305|7604309|FG000|COMPLETED|Baseline 2||7
6673495|NCT02593305|7604310|FG001|COMPLETED|Baseline 2||6
6673496|NCT02593305|7604311|FG002|COMPLETED|Baseline 2||0
6673497|NCT02593305|7604309|FG000|NOT COMPLETED|Baseline 2||0
6673498|NCT02593305|7604310|FG001|NOT COMPLETED|Baseline 2||0
6673499|NCT02593305|7604311|FG002|NOT COMPLETED|Baseline 2||0
6673500|NCT02593305|7604309|FG000|STARTED|Post 2||7
6673501|NCT02593305|7604310|FG001|STARTED|Post 2||6
6673502|NCT02593305|7604311|FG002|STARTED|Post 2||0
6673503|NCT02593305|7604309|FG000|COMPLETED|Post 2||7
6673504|NCT02593305|7604310|FG001|COMPLETED|Post 2||6
6673505|NCT02593305|7604311|FG002|COMPLETED|Post 2||0
6673506|NCT02593305|7604309|FG000|NOT COMPLETED|Post 2||0
6673507|NCT02593305|7604310|FG001|NOT COMPLETED|Post 2||0
6673508|NCT02593305|7604311|FG002|NOT COMPLETED|Post 2||0
6673509|NCT02593318|7604322|FG000|STARTED|Overall Study||16
6673510|NCT02593318|7604323|FG001|STARTED|Overall Study||16
6673511|NCT02593318|7604322|FG000|COMPLETED|Overall Study||15
6673512|NCT02593318|7604323|FG001|COMPLETED|Overall Study||15
6673513|NCT02593318|7604322|FG000|NOT COMPLETED|Overall Study||1
6673514|NCT02593318|7604323|FG001|NOT COMPLETED|Overall Study||1
6673515|NCT02593396|7604337|FG000|STARTED|Overall Study||40
6673516|NCT02593396|7604338|FG001|STARTED|Overall Study||40
6673517|NCT02593396|7604337|FG000|At Least Done One Efficacy Assessment|Overall Study||36
6673518|NCT02593396|7604338|FG001|At Least Done One Efficacy Assessment|Overall Study||36
6673519|NCT02593396|7604337|FG000|COMPLETED|Overall Study||25
6673520|NCT02593396|7604338|FG001|COMPLETED|Overall Study||26
6673521|NCT02593396|7604337|FG000|NOT COMPLETED|Overall Study||15
6673522|NCT02593396|7604338|FG001|NOT COMPLETED|Overall Study||14
6673523|NCT02593539|7604344|FG000|STARTED|Overall Study||5
6673524|NCT02593539|7604344|FG000|COMPLETED|Overall Study||4
6673525|NCT02593539|7604344|FG000|NOT COMPLETED|Overall Study||1
6673526|NCT02593630|7604351|FG000|STARTED|Overall Study||54
6673527|NCT02593630|7604351|FG000|COMPLETED|Overall Study||53
6673528|NCT02593630|7604351|FG000|NOT COMPLETED|Overall Study||1
6673529|NCT02593773|7604356|FG000|STARTED|Overall Study||86
6673530|NCT02593773|7604356|FG000|COMPLETED|Overall Study||51
6673531|NCT02593773|7604356|FG000|NOT COMPLETED|Overall Study||35
6673532|NCT02593825|7604362|FG000|STARTED|Intervention||67
6673533|NCT02593825|7604363|FG001|STARTED|Intervention||67
6673534|NCT02593825|7604362|FG000|COMPLETED|Intervention||57
6673535|NCT02593825|7604363|FG001|COMPLETED|Intervention||55
6673536|NCT02593825|7604362|FG000|NOT COMPLETED|Intervention||10
6673537|NCT02593825|7604363|FG001|NOT COMPLETED|Intervention||12
6673538|NCT02593825|7604362|FG000|STARTED|Follow-up||57
6673539|NCT02593825|7604363|FG001|STARTED|Follow-up||55
6673540|NCT02593825|7604362|FG000|COMPLETED|Follow-up||57
6673541|NCT02593825|7604363|FG001|COMPLETED|Follow-up||55
6673542|NCT02593825|7604362|FG000|NOT COMPLETED|Follow-up||0
6673543|NCT02593825|7604363|FG001|NOT COMPLETED|Follow-up||0
6673544|NCT02593864|7604371|FG000|STARTED|Overall Study||25
6673545|NCT02593864|7604371|FG000|COMPLETED|Overall Study||19
6673546|NCT02593864|7604371|FG000|NOT COMPLETED|Overall Study||6
6673547|NCT02593903|7604377|FG000|STARTED|Overall Study||35
6673548|NCT02593903|7604378|FG001|STARTED|Overall Study||32
6673549|NCT02593903|7604377|FG000|COMPLETED|Overall Study||35
6673550|NCT02593903|7604378|FG001|COMPLETED|Overall Study||31
6673551|NCT02593903|7604377|FG000|NOT COMPLETED|Overall Study||0
6673552|NCT02593903|7604378|FG001|NOT COMPLETED|Overall Study||1
6673553|NCT02594098|7604386|FG000|STARTED|Overall Study||27
6673554|NCT02594098|7604387|FG001|STARTED|Overall Study||14
6673555|NCT02594098|7604386|FG000|COMPLETED|Overall Study||1
6673556|NCT02594098|7604387|FG001|COMPLETED|Overall Study||1
6673557|NCT02594098|7604386|FG000|NOT COMPLETED|Overall Study||26
6673558|NCT02594098|7604387|FG001|NOT COMPLETED|Overall Study||13
6673559|NCT02594111|7604397|FG000|STARTED|Overall Study||366
6673560|NCT02594111|7604398|FG001|STARTED|Overall Study||348
6673561|NCT02594111|7604397|FG000|COMPLETED|Overall Study||366
6673562|NCT02594111|7604398|FG001|COMPLETED|Overall Study||348
6673563|NCT02594111|7604397|FG000|NOT COMPLETED|Overall Study||0
6673564|NCT02594111|7604398|FG001|NOT COMPLETED|Overall Study||0
6673565|NCT02594163|7604406|FG000|STARTED|Treatment Period||12
6673566|NCT02594163|7604407|FG001|STARTED|Treatment Period||13
6673567|NCT02594163|7604406|FG000|COMPLETED|Treatment Period||5
6673568|NCT02594163|7604407|FG001|COMPLETED|Treatment Period||1
6673569|NCT02594163|7604406|FG000|NOT COMPLETED|Treatment Period||7
6673570|NCT02594163|7604407|FG001|NOT COMPLETED|Treatment Period||12
6673571|NCT02594163|7604406|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|12
6673572|NCT02594163|7604407|FG001|STARTED|Follow-up Period|All participants were to be followed after treatment|13
6673573|NCT02594163|7604406|FG000|COMPLETED|Follow-up Period||1
6673574|NCT02594163|7604407|FG001|COMPLETED|Follow-up Period||1
6673575|NCT02594163|7604406|FG000|NOT COMPLETED|Follow-up Period||11
6673576|NCT02594163|7604407|FG001|NOT COMPLETED|Follow-up Period||12
6673577|NCT02594644|7604415|FG000|STARTED|Overall Study||16
6673578|NCT02594644|7604416|FG001|STARTED|Overall Study||16
6673579|NCT02594644|7604415|FG000|COMPLETED|Overall Study||16
6673580|NCT02594644|7604416|FG001|COMPLETED|Overall Study||15
6673581|NCT02594644|7604415|FG000|NOT COMPLETED|Overall Study||0
6673582|NCT02594644|7604416|FG001|NOT COMPLETED|Overall Study||1
6673583|NCT02594826|7604434|FG000|STARTED|Overall Study||347
6673584|NCT02594826|7604435|FG001|STARTED|Overall Study||358
6673585|NCT02594826|7604434|FG000|COMPLETED|Overall Study||290
6673586|NCT02594826|7604435|FG001|COMPLETED|Overall Study||298
6673587|NCT02594826|7604434|FG000|NOT COMPLETED|Overall Study||57
6673588|NCT02594826|7604435|FG001|NOT COMPLETED|Overall Study||60
6673589|NCT02595008|7604443|FG000|STARTED|Overall Study||20
6673590|NCT02595008|7604444|FG001|STARTED|Overall Study||4
6673591|NCT02595008|7604443|FG000|COMPLETED|Overall Study||19
6673592|NCT02595008|7604444|FG001|COMPLETED|Overall Study||4
6673593|NCT02595008|7604443|FG000|NOT COMPLETED|Overall Study||1
6673594|NCT02595008|7604444|FG001|NOT COMPLETED|Overall Study||0
6673595|NCT02595073|7604452|FG000|STARTED|Overall Study||61
6673596|NCT02595073|7604453|FG001|STARTED|Overall Study||63
6673597|NCT02595073|7604452|FG000|COMPLETED|Overall Study||59
6673598|NCT02595073|7604453|FG001|COMPLETED|Overall Study||62
6673599|NCT02595073|7604452|FG000|NOT COMPLETED|Overall Study||2
6673600|NCT02595073|7604453|FG001|NOT COMPLETED|Overall Study||1
6673601|NCT02595398|7604461|FG000|STARTED|Overall Study||96
6673602|NCT02595398|7604462|FG001|STARTED|Overall Study||64
6673603|NCT02595398|7604461|FG000|Intention-to-Treat (ITT) Population|Overall Study||96
6673604|NCT02595398|7604462|FG001|Intention-to-Treat (ITT) Population|Overall Study||64
6673605|NCT02595398|7604461|FG000|Safety Population|Overall Study||96
6673606|NCT02595398|7604462|FG001|Safety Population|Overall Study||64
6673607|NCT02595398|7604461|FG000|COMPLETED|Overall Study||92
6673608|NCT02595398|7604462|FG001|COMPLETED|Overall Study||63
6673609|NCT02595398|7604461|FG000|NOT COMPLETED|Overall Study||4
6673610|NCT02595398|7604462|FG001|NOT COMPLETED|Overall Study||1
6673611|NCT02595437|7604468|FG000|STARTED|Triferic Via IV||22
6673612|NCT02595437|7604468|FG000|COMPLETED|Triferic Via IV||21
6673613|NCT02595437|7604468|FG000|NOT COMPLETED|Triferic Via IV||1
6673614|NCT02595437|7604468|FG000|STARTED|Triferic Via Hemodialysate||21
6673615|NCT02595437|7604468|FG000|COMPLETED|Triferic Via Hemodialysate||21
6673616|NCT02595437|7604468|FG000|NOT COMPLETED|Triferic Via Hemodialysate||0
6673617|NCT02595450|7604480|FG000|STARTED|Overall Study||299
6673618|NCT02595450|7604480|FG000|Treated|Overall Study||291
6673619|NCT02595450|7604480|FG000|COMPLETED|Overall Study||218
6673620|NCT02595450|7604480|FG000|NOT COMPLETED|Overall Study||81
6673621|NCT02595502|7604484|FG000|STARTED|Period 1||143
6673622|NCT02595502|7604485|FG001|STARTED|Period 1||142
6673623|NCT02595502|7604484|FG000|COMPLETED|Period 1||142
6673624|NCT02595502|7604485|FG001|COMPLETED|Period 1||140
6673625|NCT02595502|7604484|FG000|NOT COMPLETED|Period 1||1
6673626|NCT02595502|7604485|FG001|NOT COMPLETED|Period 1||2
6673627|NCT02595502|7604484|FG000|STARTED|Period 2||142
6673628|NCT02595502|7604485|FG001|STARTED|Period 2||140
6673629|NCT02595502|7604484|FG000|COMPLETED|Period 2||141
6673630|NCT02595502|7604485|FG001|COMPLETED|Period 2||138
6673631|NCT02595502|7604484|FG000|NOT COMPLETED|Period 2||1
6673632|NCT02595502|7604485|FG001|NOT COMPLETED|Period 2||2
6673633|NCT02595502|7604484|FG000|STARTED|Period 3||141
6673634|NCT02595502|7604485|FG001|STARTED|Period 3||138
6673635|NCT02595502|7604484|FG000|COMPLETED|Period 3||140
6673636|NCT02595502|7604485|FG001|COMPLETED|Period 3||136
6673637|NCT02595502|7604484|FG000|NOT COMPLETED|Period 3||1
6673638|NCT02595502|7604485|FG001|NOT COMPLETED|Period 3||2
6673639|NCT02595528|7604495|FG000|STARTED|Overall Study||41
6673640|NCT02595528|7604496|FG001|STARTED|Overall Study||40
6673641|NCT02595528|7604497|FG002|STARTED|Overall Study||42
6673642|NCT02595528|7604498|FG003|STARTED|Overall Study||40
6673643|NCT02595528|7604495|FG000|COMPLETED|Overall Study||39
6673644|NCT02595528|7604496|FG001|COMPLETED|Overall Study||37
6673645|NCT02595528|7604497|FG002|COMPLETED|Overall Study||41
6673646|NCT02595528|7604498|FG003|COMPLETED|Overall Study||36
6673647|NCT02595528|7604495|FG000|NOT COMPLETED|Overall Study||2
6673648|NCT02595528|7604496|FG001|NOT COMPLETED|Overall Study||3
6673649|NCT02595528|7604497|FG002|NOT COMPLETED|Overall Study||1
6673650|NCT02595528|7604498|FG003|NOT COMPLETED|Overall Study||4
6673651|NCT02595567|7604508|FG000|STARTED|Overall Study||25
6673652|NCT02595567|7604508|FG000|COMPLETED|Overall Study||25
6673653|NCT02595567|7604508|FG000|NOT COMPLETED|Overall Study||0
6673654|NCT02595684|7604514|FG000|STARTED|Overall Study||9
6673655|NCT02595684|7604515|FG001|STARTED|Overall Study||9
6673656|NCT02595684|7604514|FG000|COMPLETED|Overall Study||9
6673657|NCT02595684|7604515|FG001|COMPLETED|Overall Study||9
6673658|NCT02595684|7604514|FG000|NOT COMPLETED|Overall Study||0
6673659|NCT02595684|7604515|FG001|NOT COMPLETED|Overall Study||0
6673660|NCT02595723|7604524|FG000|STARTED|First Intervention (4 Days)||8
6673661|NCT02595723|7604525|FG001|STARTED|First Intervention (4 Days)||6
6673662|NCT02595723|7604526|FG002|STARTED|First Intervention (4 Days)||7
6673663|NCT02595723|7604524|FG000|COMPLETED|First Intervention (4 Days)||8
6673664|NCT02595723|7604525|FG001|COMPLETED|First Intervention (4 Days)||6
6673665|NCT02595723|7604526|FG002|COMPLETED|First Intervention (4 Days)||7
6673666|NCT02595723|7604524|FG000|NOT COMPLETED|First Intervention (4 Days)||0
6673667|NCT02595723|7604525|FG001|NOT COMPLETED|First Intervention (4 Days)||0
6673668|NCT02595723|7604526|FG002|NOT COMPLETED|First Intervention (4 Days)||0
6673669|NCT02595723|7604524|FG000|STARTED|First Washout (21 Days)||8
6673670|NCT02595723|7604525|FG001|STARTED|First Washout (21 Days)||6
6673671|NCT02595723|7604526|FG002|STARTED|First Washout (21 Days)||7
6673672|NCT02595723|7604524|FG000|COMPLETED|First Washout (21 Days)||6
6673673|NCT02595723|7604525|FG001|COMPLETED|First Washout (21 Days)||6
6673674|NCT02595723|7604526|FG002|COMPLETED|First Washout (21 Days)||7
6673675|NCT02595723|7604524|FG000|NOT COMPLETED|First Washout (21 Days)||2
6673676|NCT02595723|7604525|FG001|NOT COMPLETED|First Washout (21 Days)||0
6673677|NCT02595723|7604526|FG002|NOT COMPLETED|First Washout (21 Days)||0
6673678|NCT02595723|7604524|FG000|STARTED|Second Intervention (4 Days)||6
6673679|NCT02595723|7604525|FG001|STARTED|Second Intervention (4 Days)||6
6673680|NCT02595723|7604526|FG002|STARTED|Second Intervention (4 Days)||7
6673681|NCT02595723|7604524|FG000|COMPLETED|Second Intervention (4 Days)||6
6673682|NCT02595723|7604525|FG001|COMPLETED|Second Intervention (4 Days)||6
6673683|NCT02595723|7604526|FG002|COMPLETED|Second Intervention (4 Days)||7
6673684|NCT02595723|7604524|FG000|NOT COMPLETED|Second Intervention (4 Days)||0
6673685|NCT02595723|7604525|FG001|NOT COMPLETED|Second Intervention (4 Days)||0
6673686|NCT02595723|7604526|FG002|NOT COMPLETED|Second Intervention (4 Days)||0
6673687|NCT02595723|7604524|FG000|STARTED|Second Washout (21 Days)||6
6673688|NCT02595723|7604525|FG001|STARTED|Second Washout (21 Days)||6
6673689|NCT02595723|7604526|FG002|STARTED|Second Washout (21 Days)||7
6673690|NCT02595723|7604524|FG000|COMPLETED|Second Washout (21 Days)||6
6673691|NCT02595723|7604525|FG001|COMPLETED|Second Washout (21 Days)||5
6673692|NCT02595723|7604526|FG002|COMPLETED|Second Washout (21 Days)||7
6673693|NCT02595723|7604524|FG000|NOT COMPLETED|Second Washout (21 Days)||0
6673694|NCT02595723|7604525|FG001|NOT COMPLETED|Second Washout (21 Days)||1
6673695|NCT02595723|7604526|FG002|NOT COMPLETED|Second Washout (21 Days)||0
6673696|NCT02595723|7604524|FG000|STARTED|Third Intervention (4 Days)||6
6673697|NCT02595723|7604525|FG001|STARTED|Third Intervention (4 Days)||5
6673698|NCT02595723|7604526|FG002|STARTED|Third Intervention (4 Days)||7
6673699|NCT02595723|7604524|FG000|COMPLETED|Third Intervention (4 Days)||6
6673700|NCT02595723|7604525|FG001|COMPLETED|Third Intervention (4 Days)||5
6673701|NCT02595723|7604526|FG002|COMPLETED|Third Intervention (4 Days)||7
6673702|NCT02595723|7604524|FG000|NOT COMPLETED|Third Intervention (4 Days)||0
6673703|NCT02595723|7604525|FG001|NOT COMPLETED|Third Intervention (4 Days)||0
6673704|NCT02595723|7604526|FG002|NOT COMPLETED|Third Intervention (4 Days)||0
6673705|NCT02595749|7604536|FG000|STARTED|Overall Study||45
6673706|NCT02595749|7604537|FG001|STARTED|Overall Study||38
6673707|NCT02595749|7604536|FG000|COMPLETED|Overall Study||33
6673708|NCT02595749|7604537|FG001|COMPLETED|Overall Study||31
6673709|NCT02595749|7604536|FG000|NOT COMPLETED|Overall Study||12
6673710|NCT02595749|7604537|FG001|NOT COMPLETED|Overall Study||7
6673711|NCT02595970|7604543|FG000|STARTED|Overall Study||120
6673712|NCT02595970|7604543|FG000|COMPLETED|Overall Study|Out of 100 patients who completed treatment period 2, 20 patients completed the extension period.|100
6673713|NCT02595970|7604543|FG000|NOT COMPLETED|Overall Study||20
6673714|NCT02595983|7604547|FG000|STARTED|Overall Study||12
6673715|NCT02595983|7604547|FG000|COMPLETED|Overall Study||8
6673716|NCT02595983|7604547|FG000|NOT COMPLETED|Overall Study||4
6673717|NCT02596009|7604552|FG000|STARTED|Overall Study||14
6673718|NCT02596009|7604553|FG001|STARTED|Overall Study||16
6673719|NCT02596009|7604554|FG002|STARTED|Overall Study||16
6673720|NCT02596009|7604555|FG003|STARTED|Overall Study||16
6673721|NCT02596009|7604556|FG004|STARTED|Overall Study||18
6673722|NCT02596009|7604557|FG005|STARTED|Overall Study||17
6673723|NCT02596009|7604552|FG000|COMPLETED|Overall Study||14
6673724|NCT02596009|7604553|FG001|COMPLETED|Overall Study||15
6673725|NCT02596009|7604554|FG002|COMPLETED|Overall Study||16
6673726|NCT02596009|7604555|FG003|COMPLETED|Overall Study||16
6673727|NCT02596009|7604556|FG004|COMPLETED|Overall Study||18
6673728|NCT02596009|7604557|FG005|COMPLETED|Overall Study||17
6673729|NCT02596009|7604552|FG000|NOT COMPLETED|Overall Study||0
6673730|NCT02596009|7604553|FG001|NOT COMPLETED|Overall Study||1
6673731|NCT02596009|7604554|FG002|NOT COMPLETED|Overall Study||0
6673732|NCT02596009|7604555|FG003|NOT COMPLETED|Overall Study||0
6673733|NCT02596009|7604556|FG004|NOT COMPLETED|Overall Study||0
6673734|NCT02596009|7604557|FG005|NOT COMPLETED|Overall Study||0
6673735|NCT02596022|7604565|FG000|STARTED|Overall Study||10
6673736|NCT02596022|7604566|FG001|STARTED|Overall Study||8
6673737|NCT02596022|7604565|FG000|COMPLETED|Overall Study||10
6673738|NCT02596022|7604566|FG001|COMPLETED|Overall Study||8
6673739|NCT02596022|7604565|FG000|NOT COMPLETED|Overall Study||0
6673740|NCT02596022|7604566|FG001|NOT COMPLETED|Overall Study||0
6673741|NCT02596035|7604575|FG000|STARTED|Overall Study||97
6673742|NCT02596035|7604576|FG001|STARTED|Overall Study||44
6673743|NCT02596035|7604577|FG002|STARTED|Overall Study||1
6673744|NCT02596035|7604575|FG000|COMPLETED|Overall Study||11
6673745|NCT02596035|7604576|FG001|COMPLETED|Overall Study||0
6673746|NCT02596035|7604577|FG002|COMPLETED|Overall Study||0
6673747|NCT02596035|7604575|FG000|NOT COMPLETED|Overall Study||86
6673748|NCT02596035|7604576|FG001|NOT COMPLETED|Overall Study||44
6673749|NCT02596035|7604577|FG002|NOT COMPLETED|Overall Study||1
6673750|NCT02596230|7604589|FG000|STARTED|Objective 1, One Visit During 14 Days||3714
6673751|NCT02596230|7604590|FG001|STARTED|Objective 1, One Visit During 14 Days||1006
6673752|NCT02596230|7604591|FG002|STARTED|Objective 1, One Visit During 14 Days||0
6673753|NCT02596230|7604592|FG003|STARTED|Objective 1, One Visit During 14 Days||1375
6673754|NCT02596230|7604593|FG004|STARTED|Objective 1, One Visit During 14 Days||0
6673755|NCT02596230|7604589|FG000|COMPLETED|Objective 1, One Visit During 14 Days||3714
6673756|NCT02596230|7604590|FG001|COMPLETED|Objective 1, One Visit During 14 Days||1006
6673757|NCT02596230|7604591|FG002|COMPLETED|Objective 1, One Visit During 14 Days||0
6673758|NCT02596230|7604592|FG003|COMPLETED|Objective 1, One Visit During 14 Days||1375
6673759|NCT02596230|7604593|FG004|COMPLETED|Objective 1, One Visit During 14 Days||0
6673760|NCT02596230|7604589|FG000|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6673761|NCT02596230|7604590|FG001|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6673762|NCT02596230|7604591|FG002|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6673763|NCT02596230|7604592|FG003|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6673764|NCT02596230|7604593|FG004|NOT COMPLETED|Objective 1, One Visit During 14 Days||0
6673765|NCT02596230|7604589|FG000|STARTED|Screening Period for Objective 2||3714
6673766|NCT02596230|7604590|FG001|STARTED|Screening Period for Objective 2||1006
6673767|NCT02596230|7604591|FG002|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|910
6673768|NCT02596230|7604592|FG003|STARTED|Screening Period for Objective 2||1375
6673769|NCT02596230|7604593|FG004|STARTED|Screening Period for Objective 2|Participants entering the study after the completion of objective 1.|792
6673770|NCT02596230|7604589|FG000|COMPLETED|Screening Period for Objective 2||0
6673771|NCT02596230|7604590|FG001|COMPLETED|Screening Period for Objective 2||778
6673772|NCT02596230|7604591|FG002|COMPLETED|Screening Period for Objective 2||910
6673773|NCT02596230|7604592|FG003|COMPLETED|Screening Period for Objective 2||529
6673774|NCT02596230|7604593|FG004|COMPLETED|Screening Period for Objective 2||792
6673775|NCT02596230|7604589|FG000|NOT COMPLETED|Screening Period for Objective 2||3714
6673776|NCT02596230|7604590|FG001|NOT COMPLETED|Screening Period for Objective 2||228
6673777|NCT02596230|7604591|FG002|NOT COMPLETED|Screening Period for Objective 2||0
6673778|NCT02596230|7604592|FG003|NOT COMPLETED|Screening Period for Objective 2||846
6673779|NCT02596230|7604593|FG004|NOT COMPLETED|Screening Period for Objective 2||0
6673780|NCT02596230|7604589|FG000|STARTED|Objective 2, One Year||0
6673781|NCT02596230|7604590|FG001|STARTED|Objective 2, One Year||778
6673782|NCT02596230|7604591|FG002|STARTED|Objective 2, One Year||910
6673783|NCT02596230|7604592|FG003|STARTED|Objective 2, One Year||529
6673784|NCT02596230|7604593|FG004|STARTED|Objective 2, One Year||792
6673785|NCT02596230|7604589|FG000|COMPLETED|Objective 2, One Year||0
6673786|NCT02596230|7604590|FG001|COMPLETED|Objective 2, One Year||710
6673787|NCT02596230|7604591|FG002|COMPLETED|Objective 2, One Year||812
6673788|NCT02596230|7604592|FG003|COMPLETED|Objective 2, One Year||471
6673789|NCT02596230|7604593|FG004|COMPLETED|Objective 2, One Year||714
6673790|NCT02596230|7604589|FG000|NOT COMPLETED|Objective 2, One Year||0
6673791|NCT02596230|7604590|FG001|NOT COMPLETED|Objective 2, One Year||68
6673792|NCT02596230|7604591|FG002|NOT COMPLETED|Objective 2, One Year||98
6673793|NCT02596230|7604592|FG003|NOT COMPLETED|Objective 2, One Year||58
6673794|NCT02596230|7604593|FG004|NOT COMPLETED|Objective 2, One Year||78
6673795|NCT02596321|7604605|FG000|STARTED|Overall Study||56
6673796|NCT02596321|7604606|FG001|STARTED|Overall Study||56
6673797|NCT02596321|7604605|FG000|COMPLETED|Overall Study||53
6673798|NCT02596321|7604606|FG001|COMPLETED|Overall Study||56
6673799|NCT02596321|7604605|FG000|NOT COMPLETED|Overall Study||3
6673800|NCT02596321|7604606|FG001|NOT COMPLETED|Overall Study||0
6673801|NCT02596451|7604615|FG000|STARTED|Overall Study||385
6673802|NCT02596451|7604616|FG001|STARTED|Overall Study||392
6673803|NCT02596451|7604617|FG002|STARTED|Overall Study||387
6673804|NCT02596451|7604615|FG000|COMPLETED|Overall Study||381
6673805|NCT02596451|7604616|FG001|COMPLETED|Overall Study||374
6673806|NCT02596451|7604617|FG002|COMPLETED|Overall Study||373
6673807|NCT02596451|7604615|FG000|NOT COMPLETED|Overall Study||4
6673808|NCT02596451|7604616|FG001|NOT COMPLETED|Overall Study||18
6673809|NCT02596451|7604617|FG002|NOT COMPLETED|Overall Study||14
6673810|NCT02596620|7604626|FG000|STARTED|Overall Study|Started from 1st October 2013|82
6673811|NCT02596620|7604627|FG001|STARTED|Overall Study|Started from 1st October 2013|82
6673812|NCT02596620|7604626|FG000|COMPLETED|Overall Study|Completed on 30th September 2015|81
6673813|NCT02596620|7604627|FG001|COMPLETED|Overall Study|Completed on 30th September 2015|81
6673814|NCT02596620|7604626|FG000|NOT COMPLETED|Overall Study||1
6673815|NCT02596620|7604627|FG001|NOT COMPLETED|Overall Study||1
6673816|NCT02596711|7604636|FG000|STARTED|Overall Study||9
6673817|NCT02596711|7604637|FG001|STARTED|Overall Study||8
6673818|NCT02596711|7604638|FG002|STARTED|Overall Study||8
6673819|NCT02596711|7604636|FG000|Visit 2|Overall Study||9
6673820|NCT02596711|7604637|FG001|Visit 2|Overall Study||7
6673821|NCT02596711|7604638|FG002|Visit 2|Overall Study||6
6673822|NCT02596711|7604636|FG000|Visit 3|Overall Study||7
6673823|NCT02596711|7604637|FG001|Visit 3|Overall Study||8
6673824|NCT02596711|7604638|FG002|Visit 3|Overall Study||6
6673825|NCT02596711|7604636|FG000|3 Month Follow-up|Overall Study||8
6673826|NCT02596711|7604637|FG001|3 Month Follow-up|Overall Study||6
6673827|NCT02596711|7604638|FG002|3 Month Follow-up|Overall Study||6
6673828|NCT02596711|7604636|FG000|6 Month Follow-up|Overall Study||8
6673829|NCT02596711|7604637|FG001|6 Month Follow-up|Overall Study||6
6673830|NCT02596711|7604638|FG002|6 Month Follow-up|Overall Study||5
6673831|NCT02596711|7604636|FG000|COMPLETED|Overall Study||8
6673832|NCT02596711|7604637|FG001|COMPLETED|Overall Study||6
6673833|NCT02596711|7604638|FG002|COMPLETED|Overall Study||5
6673834|NCT02596711|7604636|FG000|NOT COMPLETED|Overall Study||1
6673835|NCT02596711|7604637|FG001|NOT COMPLETED|Overall Study||2
6673836|NCT02596711|7604638|FG002|NOT COMPLETED|Overall Study||3
6673837|NCT02596750|7604648|FG000|STARTED|Baseline||21
6673838|NCT02596750|7604649|FG001|STARTED|Baseline||21
6673839|NCT02596750|7604648|FG000|COMPLETED|Baseline||21
6673840|NCT02596750|7604649|FG001|COMPLETED|Baseline||21
6673841|NCT02596750|7604648|FG000|NOT COMPLETED|Baseline||0
6673842|NCT02596750|7604649|FG001|NOT COMPLETED|Baseline||0
6673843|NCT02596750|7604648|FG000|STARTED|2 Minutes||21
6673844|NCT02596750|7604649|FG001|STARTED|2 Minutes||21
6673845|NCT02596750|7604648|FG000|COMPLETED|2 Minutes||21
6673846|NCT02596750|7604649|FG001|COMPLETED|2 Minutes||21
6673847|NCT02596750|7604648|FG000|NOT COMPLETED|2 Minutes||0
6673848|NCT02596750|7604649|FG001|NOT COMPLETED|2 Minutes||0
6673849|NCT02596750|7604648|FG000|STARTED|5 Minutes||21
6673850|NCT02596750|7604649|FG001|STARTED|5 Minutes||21
6673851|NCT02596750|7604648|FG000|COMPLETED|5 Minutes||21
6673852|NCT02596750|7604649|FG001|COMPLETED|5 Minutes||21
6673853|NCT02596750|7604648|FG000|NOT COMPLETED|5 Minutes||0
6673854|NCT02596750|7604649|FG001|NOT COMPLETED|5 Minutes||0
6673855|NCT02596750|7604648|FG000|STARTED|10 Minutes||21
6673856|NCT02596750|7604649|FG001|STARTED|10 Minutes||21
6673857|NCT02596750|7604648|FG000|COMPLETED|10 Minutes||21
6673858|NCT02596750|7604649|FG001|COMPLETED|10 Minutes||21
6673859|NCT02596750|7604648|FG000|NOT COMPLETED|10 Minutes||0
6673860|NCT02596750|7604649|FG001|NOT COMPLETED|10 Minutes||0
6673861|NCT02596750|7604648|FG000|STARTED|30 Minutes||21
6673862|NCT02596750|7604649|FG001|STARTED|30 Minutes||21
6673863|NCT02596750|7604648|FG000|COMPLETED|30 Minutes||21
6673864|NCT02596750|7604649|FG001|COMPLETED|30 Minutes||21
6673865|NCT02596750|7604648|FG000|NOT COMPLETED|30 Minutes||0
6673866|NCT02596750|7604649|FG001|NOT COMPLETED|30 Minutes||0
6673867|NCT02596854|7604656|FG000|STARTED|Overall Study||117
6673868|NCT02596854|7604656|FG000|COMPLETED|Overall Study||109
6673869|NCT02596854|7604656|FG000|NOT COMPLETED|Overall Study||8
6256195|NCT02028884|7155039|FG001|STARTED|Double-blind Period||41
6256196|NCT02028884|7155038|FG000|COMPLETED|Double-blind Period||24
6256197|NCT02028884|7155039|FG001|COMPLETED|Double-blind Period||18
6256198|NCT02028884|7155038|FG000|NOT COMPLETED|Double-blind Period||18
6256199|NCT02028884|7155039|FG001|NOT COMPLETED|Double-blind Period||23
6256200|NCT02028884|7155038|FG000|STARTED|Open-label Extension Period||24
6256201|NCT02028884|7155039|FG001|STARTED|Open-label Extension Period||18
6256202|NCT02028884|7155038|FG000|COMPLETED|Open-label Extension Period||0
6256203|NCT02028884|7155039|FG001|COMPLETED|Open-label Extension Period||0
6256204|NCT02028884|7155038|FG000|NOT COMPLETED|Open-label Extension Period||24
6256205|NCT02028884|7155039|FG001|NOT COMPLETED|Open-label Extension Period||18
6256206|NCT01983774|7155050|FG000|STARTED|Overall Study||9
6256207|NCT01983774|7155051|FG001|STARTED|Overall Study||8
6256208|NCT01983774|7155050|FG000|COMPLETED|Overall Study||8
6256209|NCT01983774|7155051|FG001|COMPLETED|Overall Study||7
6256210|NCT01983774|7155050|FG000|NOT COMPLETED|Overall Study||1
6256211|NCT01983774|7155051|FG001|NOT COMPLETED|Overall Study||1
6256212|NCT01974206|7155061|FG000|STARTED|Overall Study||74
6256213|NCT01974206|7155062|FG001|STARTED|Overall Study||76
6256214|NCT01974206|7155061|FG000|Received Treatment|Overall Study||74
6256215|NCT01974206|7155062|FG001|Received Treatment|Overall Study||75
6256216|NCT01974206|7155061|FG000|COMPLETED|Overall Study||68
6256217|NCT01974206|7155062|FG001|COMPLETED|Overall Study||75
6256218|NCT01974206|7155061|FG000|NOT COMPLETED|Overall Study||6
6256219|NCT01974206|7155062|FG001|NOT COMPLETED|Overall Study||1
6256220|NCT01970865|7155085|FG000|STARTED|Overall Study||3
6256221|NCT01970865|7155086|FG001|STARTED|Overall Study||3
6256222|NCT01970865|7155087|FG002|STARTED|Overall Study||3
6256223|NCT01970865|7155088|FG003|STARTED|Overall Study||13
6256224|NCT01970865|7155089|FG004|STARTED|Overall Study||17
6256225|NCT01970865|7155090|FG005|STARTED|Overall Study||3
6256226|NCT01970865|7155091|FG006|STARTED|Overall Study||3
6256227|NCT01970865|7155092|FG007|STARTED|Overall Study||3
6256228|NCT01970865|7155093|FG008|STARTED|Overall Study||3
6256229|NCT01970865|7155094|FG009|STARTED|Overall Study||4
6256230|NCT01970865|7155095|FG010|STARTED|Overall Study||30
6256231|NCT01970865|7155096|FG011|STARTED|Overall Study||27
6256232|NCT01970865|7155097|FG012|STARTED|Overall Study||60
6256233|NCT01970865|7155098|FG013|STARTED|Overall Study||66
6256234|NCT01970865|7155099|FG014|STARTED|Overall Study||46
6256235|NCT01970865|7155100|FG015|STARTED|Overall Study||47
6256236|NCT01970865|7155101|FG016|STARTED|Overall Study||3
6673870|NCT02596867|7604660|FG000|STARTED|Overall Study||2
6673871|NCT02596867|7604660|FG000|2 Patients Prospectively Recruited|Overall Study||2
6673872|NCT02596867|7604660|FG000|COMPLETED|Overall Study||2
6673873|NCT02596867|7604660|FG000|NOT COMPLETED|Overall Study||0
6673874|NCT02596893|7604669|FG000|STARTED|Overall Double-Blind Period Weeks 0-52||174
6673875|NCT02596893|7604670|FG001|STARTED|Overall Double-Blind Period Weeks 0-52||176
6673876|NCT02596893|7604671|FG002|STARTED|Overall Double-Blind Period Weeks 0-52||176
6673877|NCT02596893|7604672|FG003|STARTED|Overall Double-Blind Period Weeks 0-52||175
6673878|NCT02596893|7604669|FG000|COMPLETED|Overall Double-Blind Period Weeks 0-52||10
6673879|NCT02596893|7604670|FG001|COMPLETED|Overall Double-Blind Period Weeks 0-52||8
6673880|NCT02596893|7604671|FG002|COMPLETED|Overall Double-Blind Period Weeks 0-52||14
6673881|NCT02596893|7604672|FG003|COMPLETED|Overall Double-Blind Period Weeks 0-52||9
6673882|NCT02596893|7604669|FG000|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||164
6673883|NCT02596893|7604670|FG001|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||168
6673884|NCT02596893|7604671|FG002|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||162
6673885|NCT02596893|7604672|FG003|NOT COMPLETED|Overall Double-Blind Period Weeks 0-52||166
6673886|NCT02596893|7604669|FG000|STARTED|Follow-Up Period Weeks 0 to 52||57
6673887|NCT02596893|7604670|FG001|STARTED|Follow-Up Period Weeks 0 to 52||51
6673888|NCT02596893|7604671|FG002|STARTED|Follow-Up Period Weeks 0 to 52||56
6673889|NCT02596893|7604672|FG003|STARTED|Follow-Up Period Weeks 0 to 52||47
6673890|NCT02596893|7604669|FG000|COMPLETED|Follow-Up Period Weeks 0 to 52||57
6673891|NCT02596893|7604670|FG001|COMPLETED|Follow-Up Period Weeks 0 to 52||51
6673892|NCT02596893|7604671|FG002|COMPLETED|Follow-Up Period Weeks 0 to 52||56
6673893|NCT02596893|7604672|FG003|COMPLETED|Follow-Up Period Weeks 0 to 52||47
6673894|NCT02596893|7604669|FG000|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
6673895|NCT02596893|7604670|FG001|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
6673896|NCT02596893|7604671|FG002|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
6673897|NCT02596893|7604672|FG003|NOT COMPLETED|Follow-Up Period Weeks 0 to 52||0
6673898|NCT02596906|7604684|FG000|STARTED|Overall Study||12
6673899|NCT02596906|7604685|FG001|STARTED|Overall Study||10
6673900|NCT02596906|7604684|FG000|COMPLETED|Overall Study||8
6673901|NCT02596906|7604685|FG001|COMPLETED|Overall Study||7
6673902|NCT02596906|7604684|FG000|NOT COMPLETED|Overall Study||4
6673903|NCT02596906|7604685|FG001|NOT COMPLETED|Overall Study||3
6673904|NCT02596945|7604691|FG000|STARTED|Overall Study||223
6673905|NCT02596945|7604691|FG000|Treated|Overall Study||220
6673906|NCT02596945|7604691|FG000|COMPLETED|Overall Study||167
6673907|NCT02596945|7604691|FG000|NOT COMPLETED|Overall Study||56
6673908|NCT02596958|7604695|FG000|STARTED|Overall Study||996
6673909|NCT02596958|7604695|FG000|COMPLETED|Overall Study||0
6673910|NCT02596958|7604695|FG000|NOT COMPLETED|Overall Study||996
6673911|NCT02596971|7604702|FG000|STARTED|Overall Study||42
6673912|NCT02596971|7604703|FG001|STARTED|Overall Study||7
6673913|NCT02596971|7604704|FG002|STARTED|Overall Study||42
6673914|NCT02596971|7604702|FG000|COMPLETED|Overall Study||32
6673915|NCT02596971|7604703|FG001|COMPLETED|Overall Study||5
6673916|NCT02596971|7604704|FG002|COMPLETED|Overall Study||33
6673917|NCT02596971|7604702|FG000|NOT COMPLETED|Overall Study||10
6673918|NCT02596971|7604703|FG001|NOT COMPLETED|Overall Study||2
6673919|NCT02596971|7604704|FG002|NOT COMPLETED|Overall Study||9
6673920|NCT02597049|7604718|FG000|STARTED|Overall Study||142
6673921|NCT02597049|7604719|FG001|STARTED|Overall Study||142
6673922|NCT02597049|7604720|FG002|STARTED|Overall Study||140
6673923|NCT02597049|7604718|FG000|Received at Least One Dose of Study Drug|Overall Study||142
6673924|NCT02597049|7604719|FG001|Received at Least One Dose of Study Drug|Overall Study||141
6673925|NCT02597049|7604720|FG002|Received at Least One Dose of Study Drug|Overall Study||140
6673926|NCT02597049|7604718|FG000|COMPLETED|Overall Study||135
6673927|NCT02597049|7604719|FG001|COMPLETED|Overall Study||137
6673928|NCT02597049|7604720|FG002|COMPLETED|Overall Study||137
6673929|NCT02597049|7604718|FG000|NOT COMPLETED|Overall Study||7
6673930|NCT02597049|7604719|FG001|NOT COMPLETED|Overall Study||5
6673931|NCT02597049|7604720|FG002|NOT COMPLETED|Overall Study||3
6673932|NCT02597101|7604730|FG000|STARTED|Overall Study||4
6673933|NCT02597101|7604731|FG001|STARTED|Overall Study||5
6673934|NCT02597101|7604730|FG000|COMPLETED|Overall Study||4
6673935|NCT02597101|7604731|FG001|COMPLETED|Overall Study||5
6673936|NCT02597101|7604730|FG000|NOT COMPLETED|Overall Study||0
6673937|NCT02597101|7604731|FG001|NOT COMPLETED|Overall Study||0
6673938|NCT02597127|7604745|FG000|STARTED|Overall Study||60
6673939|NCT02597127|7604746|FG001|STARTED|Overall Study||62
6673940|NCT02597127|7604747|FG002|STARTED|Overall Study||66
6673941|NCT02597127|7604748|FG003|STARTED|Overall Study||65
6673942|NCT02597127|7604749|FG004|STARTED|Overall Study||62
6673943|NCT02597127|7604750|FG005|STARTED|Overall Study||63
6673944|NCT02597127|7604751|FG006|STARTED|Overall Study||61
6673945|NCT02597127|7604752|FG007|STARTED|Overall Study||62
6673946|NCT02597127|7604745|FG000|Treated|Overall Study||60
6673947|NCT02597127|7604746|FG001|Treated|Overall Study||61
6673948|NCT02597127|7604747|FG002|Treated|Overall Study||65
6673949|NCT02597127|7604748|FG003|Treated|Overall Study||65
6673950|NCT02597127|7604749|FG004|Treated|Overall Study||61
6673951|NCT02597127|7604750|FG005|Treated|Overall Study||62
6673952|NCT02597127|7604751|FG006|Treated|Overall Study||61
6673953|NCT02597127|7604752|FG007|Treated|Overall Study||62
6673954|NCT02597127|7604745|FG000|COMPLETED|Overall Study||59
6673955|NCT02597127|7604746|FG001|COMPLETED|Overall Study||59
6673956|NCT02597127|7604747|FG002|COMPLETED|Overall Study||58
6673957|NCT02597127|7604748|FG003|COMPLETED|Overall Study||60
6673958|NCT02597127|7604749|FG004|COMPLETED|Overall Study||57
6673959|NCT02597127|7604750|FG005|COMPLETED|Overall Study||59
6673960|NCT02597127|7604751|FG006|COMPLETED|Overall Study||57
6673961|NCT02597127|7604752|FG007|COMPLETED|Overall Study||60
6673962|NCT02597127|7604745|FG000|NOT COMPLETED|Overall Study||1
6673963|NCT02597127|7604746|FG001|NOT COMPLETED|Overall Study||3
6673964|NCT02597127|7604747|FG002|NOT COMPLETED|Overall Study||8
6673965|NCT02597127|7604748|FG003|NOT COMPLETED|Overall Study||5
6673966|NCT02597127|7604749|FG004|NOT COMPLETED|Overall Study||5
6673967|NCT02597127|7604750|FG005|NOT COMPLETED|Overall Study||4
6673968|NCT02597127|7604751|FG006|NOT COMPLETED|Overall Study||4
6673969|NCT02597127|7604752|FG007|NOT COMPLETED|Overall Study||2
6673970|NCT02597452|7604791|FG000|STARTED|Overall Study||516
6673971|NCT02597452|7604791|FG000|COMPLETED|Overall Study||486
6673972|NCT02597452|7604791|FG000|NOT COMPLETED|Overall Study||30
6673973|NCT02597478|7604797|FG000|STARTED|Overall Study||16
6673974|NCT02597478|7604798|FG001|STARTED|Overall Study||18
6673975|NCT02597478|7604797|FG000|COMPLETED|Overall Study||13
6673976|NCT02597478|7604798|FG001|COMPLETED|Overall Study||17
6673977|NCT02597478|7604797|FG000|NOT COMPLETED|Overall Study||3
6673978|NCT02597478|7604798|FG001|NOT COMPLETED|Overall Study||1
6673979|NCT02597543|7604806|FG000|STARTED|Overall Study||6
6673980|NCT02597543|7604807|FG001|STARTED|Overall Study||8
6673981|NCT02597543|7604806|FG000|COMPLETED|Overall Study||6
6673982|NCT02597543|7604807|FG001|COMPLETED|Overall Study||8
6673983|NCT02597543|7604806|FG000|NOT COMPLETED|Overall Study||0
6673984|NCT02597543|7604807|FG001|NOT COMPLETED|Overall Study||0
6673985|NCT02597582|7604815|FG000|STARTED|Overall Study||21
6673986|NCT02597582|7604816|FG001|STARTED|Overall Study||20
6673987|NCT02597582|7604815|FG000|COMPLETED|Overall Study||21
6673988|NCT02597582|7604816|FG001|COMPLETED|Overall Study||20
6673989|NCT02597582|7604815|FG000|NOT COMPLETED|Overall Study||0
6673990|NCT02597582|7604816|FG001|NOT COMPLETED|Overall Study||0
6673991|NCT02597673|7604828|FG000|STARTED|Overall Study||34
6673992|NCT02597673|7604829|FG001|STARTED|Overall Study||33
6673993|NCT02597673|7604830|FG002|STARTED|Overall Study||33
6673994|NCT02597673|7604831|FG003|STARTED|Overall Study||30
6673995|NCT02597673|7604828|FG000|COMPLETED|Overall Study||31
6673996|NCT02597673|7604829|FG001|COMPLETED|Overall Study||27
6673997|NCT02597673|7604830|FG002|COMPLETED|Overall Study||28
6673998|NCT02597673|7604831|FG003|COMPLETED|Overall Study||25
6673999|NCT02597673|7604828|FG000|NOT COMPLETED|Overall Study||3
6674000|NCT02597673|7604829|FG001|NOT COMPLETED|Overall Study||6
6674001|NCT02597673|7604830|FG002|NOT COMPLETED|Overall Study||5
6674002|NCT02597673|7604831|FG003|NOT COMPLETED|Overall Study||5
6674003|NCT02597712|7604844|FG000|STARTED|Overall Study||13
6674004|NCT02597712|7604845|FG001|STARTED|Overall Study||11
6674005|NCT02597712|7604844|FG000|COMPLETED|Overall Study||10
6674006|NCT02597712|7604845|FG001|COMPLETED|Overall Study||10
6674007|NCT02597712|7604844|FG000|NOT COMPLETED|Overall Study||3
6674008|NCT02597712|7604845|FG001|NOT COMPLETED|Overall Study||1
6674009|NCT02597855|7604853|FG000|STARTED|Overall Study||18
6674010|NCT02597855|7604854|FG001|STARTED|Overall Study||14
6674011|NCT02597855|7604853|FG000|COMPLETED|Overall Study||16
6674012|NCT02597855|7604854|FG001|COMPLETED|Overall Study||13
6674013|NCT02597855|7604853|FG000|NOT COMPLETED|Overall Study||2
6674014|NCT02597855|7604854|FG001|NOT COMPLETED|Overall Study||1
6674015|NCT02597907|7604862|FG000|STARTED|Overall Study||44
6674016|NCT02597907|7604863|FG001|STARTED|Overall Study||44
6674017|NCT02597907|7604862|FG000|COMPLETED|Overall Study||44
6674018|NCT02597907|7604863|FG001|COMPLETED|Overall Study||44
6674019|NCT02597907|7604862|FG000|NOT COMPLETED|Overall Study||0
6674020|NCT02597907|7604863|FG001|NOT COMPLETED|Overall Study||0
6674021|NCT02597920|7604872|FG000|STARTED|Overall Study|Information about study termination is not available for 1 subject.|585
6674022|NCT02597920|7604873|FG001|STARTED|Overall Study||1159
6674023|NCT02597920|7604874|FG002|STARTED|Overall Study||78
6674024|NCT02597920|7604872|FG000|COMPLETED|Overall Study||544
6674025|NCT02597920|7604873|FG001|COMPLETED|Overall Study||1075
6674026|NCT02597920|7604874|FG002|COMPLETED|Overall Study||72
6674027|NCT02597920|7604872|FG000|NOT COMPLETED|Overall Study||41
6674028|NCT02597920|7604873|FG001|NOT COMPLETED|Overall Study||84
6674029|NCT02597920|7604874|FG002|NOT COMPLETED|Overall Study||6
6674030|NCT02597933|7604886|FG000|STARTED|Overall Study|Started are randomised|290
6674031|NCT02597933|7604887|FG001|STARTED|Overall Study|Started are randomised|290
6674032|NCT02597933|7604886|FG000|Treated Patients|Overall Study||288
6674033|NCT02597933|7604887|FG001|Treated Patients|Overall Study||288
6674034|NCT02597933|7604886|FG000|COMPLETED|Overall Study||252
6674035|NCT02597933|7604887|FG001|COMPLETED|Overall Study||239
6674036|NCT02597933|7604886|FG000|NOT COMPLETED|Overall Study||38
6674037|NCT02597933|7604887|FG001|NOT COMPLETED|Overall Study||51
6674038|NCT02597946|7604893|FG000|STARTED|Overall Study||18
6674039|NCT02597946|7604893|FG000|COMPLETED|Overall Study||0
6674040|NCT02597946|7604893|FG000|NOT COMPLETED|Overall Study||18
6674041|NCT02598076|7604899|FG000|STARTED|Overall Study||31
6674042|NCT02598076|7604900|FG001|STARTED|Overall Study||29
6674043|NCT02598076|7604899|FG000|COMPLETED|Overall Study||29
6674044|NCT02598076|7604900|FG001|COMPLETED|Overall Study||26
6674045|NCT02598076|7604899|FG000|NOT COMPLETED|Overall Study||2
6674046|NCT02598076|7604900|FG001|NOT COMPLETED|Overall Study||3
6674047|NCT02598089|7604908|FG000|STARTED|Overall Study||30
6674048|NCT02598089|7604909|FG001|STARTED|Overall Study||30
6674049|NCT02598089|7604908|FG000|COMPLETED|Overall Study||30
6674050|NCT02598089|7604909|FG001|COMPLETED|Overall Study||30
6391900|NCT00838539|7303798|FG006|NOT COMPLETED|Overall Study||5
6391901|NCT00838539|7303799|FG007|NOT COMPLETED|Overall Study||6
6391902|NCT00838539|7303800|FG008|NOT COMPLETED|Overall Study||5
6674051|NCT02598089|7604908|FG000|NOT COMPLETED|Overall Study||0
6674052|NCT02598089|7604909|FG001|NOT COMPLETED|Overall Study||0
6674053|NCT02598128|7604922|FG000|STARTED|Period A: Days -7 to -1||34
6674054|NCT02598128|7604923|FG001|STARTED|Period A: Days -7 to -1||0
6674055|NCT02598128|7604924|FG002|STARTED|Period A: Days -7 to -1||0
6674056|NCT02598128|7604925|FG003|STARTED|Period A: Days -7 to -1||0
6674057|NCT02598128|7604922|FG000|COMPLETED|Period A: Days -7 to -1||33
6674058|NCT02598128|7604923|FG001|COMPLETED|Period A: Days -7 to -1||0
6674059|NCT02598128|7604924|FG002|COMPLETED|Period A: Days -7 to -1||0
6674060|NCT02598128|7604925|FG003|COMPLETED|Period A: Days -7 to -1||0
6674061|NCT02598128|7604922|FG000|NOT COMPLETED|Period A: Days -7 to -1||1
6674062|NCT02598128|7604923|FG001|NOT COMPLETED|Period A: Days -7 to -1||0
6674063|NCT02598128|7604924|FG002|NOT COMPLETED|Period A: Days -7 to -1||0
6674064|NCT02598128|7604925|FG003|NOT COMPLETED|Period A: Days -7 to -1||0
6674065|NCT02598128|7604922|FG000|STARTED|Period B: Days 1 to 11||0
6674066|NCT02598128|7604923|FG001|STARTED|Period B: Days 1 to 11||17
6674067|NCT02598128|7604924|FG002|STARTED|Period B: Days 1 to 11||16
6674068|NCT02598128|7604925|FG003|STARTED|Period B: Days 1 to 11||0
6674069|NCT02598128|7604922|FG000|COMPLETED|Period B: Days 1 to 11||0
6674070|NCT02598128|7604923|FG001|COMPLETED|Period B: Days 1 to 11||17
6674071|NCT02598128|7604924|FG002|COMPLETED|Period B: Days 1 to 11||16
6674072|NCT02598128|7604925|FG003|COMPLETED|Period B: Days 1 to 11||0
6674073|NCT02598128|7604922|FG000|NOT COMPLETED|Period B: Days 1 to 11||0
6674074|NCT02598128|7604923|FG001|NOT COMPLETED|Period B: Days 1 to 11||0
6674075|NCT02598128|7604924|FG002|NOT COMPLETED|Period B: Days 1 to 11||0
6674076|NCT02598128|7604925|FG003|NOT COMPLETED|Period B: Days 1 to 11||0
6674077|NCT02598128|7604922|FG000|STARTED|Period C: Days 12 to 20||0
6674078|NCT02598128|7604923|FG001|STARTED|Period C: Days 12 to 20||0
6674079|NCT02598128|7604924|FG002|STARTED|Period C: Days 12 to 20||0
6674080|NCT02598128|7604925|FG003|STARTED|Period C: Days 12 to 20||33
6674081|NCT02598128|7604922|FG000|COMPLETED|Period C: Days 12 to 20||0
6674082|NCT02598128|7604923|FG001|COMPLETED|Period C: Days 12 to 20||0
6674083|NCT02598128|7604924|FG002|COMPLETED|Period C: Days 12 to 20||0
6674084|NCT02598128|7604925|FG003|COMPLETED|Period C: Days 12 to 20||33
6674085|NCT02598128|7604922|FG000|NOT COMPLETED|Period C: Days 12 to 20||0
6674086|NCT02598128|7604923|FG001|NOT COMPLETED|Period C: Days 12 to 20||0
6674087|NCT02598128|7604924|FG002|NOT COMPLETED|Period C: Days 12 to 20||0
6674088|NCT02598128|7604925|FG003|NOT COMPLETED|Period C: Days 12 to 20||0
6674089|NCT02598193|7604937|FG000|STARTED|Overall Study||89
6674090|NCT02598193|7604937|FG000|COMPLETED|Overall Study||73
6674091|NCT02598193|7604937|FG000|NOT COMPLETED|Overall Study||16
6674092|NCT02598297|7604943|FG000|STARTED|Overall Study|One subject in the ruxolitinib arm was not treated with the study drug|25
6674093|NCT02598297|7604944|FG001|STARTED|Overall Study||24
6674094|NCT02598297|7604943|FG000|Not Treted Wit Study Drug|Overall Study||1
6674095|NCT02598297|7604944|FG001|Not Treted Wit Study Drug|Overall Study||0
6674096|NCT02598297|7604943|FG000|Subjects Followed for Survival|Overall Study||1
6674097|NCT02598297|7604944|FG001|Subjects Followed for Survival|Overall Study||0
6674098|NCT02598297|7604943|FG000|COMPLETED|Overall Study||0
6674099|NCT02598297|7604944|FG001|COMPLETED|Overall Study||0
6674100|NCT02598297|7604943|FG000|NOT COMPLETED|Overall Study||25
6674101|NCT02598297|7604944|FG001|NOT COMPLETED|Overall Study||24
6674102|NCT02598583|7604952|FG000|STARTED|Overall Study||6
6674103|NCT02598583|7604953|FG001|STARTED|Overall Study||7
6674104|NCT02598583|7604952|FG000|COMPLETED|Overall Study||6
6674105|NCT02598583|7604953|FG001|COMPLETED|Overall Study||7
6674106|NCT02598583|7604952|FG000|NOT COMPLETED|Overall Study||0
6674107|NCT02598583|7604953|FG001|NOT COMPLETED|Overall Study||0
6674108|NCT02598934|7604961|FG000|STARTED|Overall Study||154
6674109|NCT02598934|7604962|FG001|STARTED|Overall Study||154
6674110|NCT02598934|7604961|FG000|COMPLETED|Overall Study||135
6674111|NCT02598934|7604962|FG001|COMPLETED|Overall Study||132
6674112|NCT02598934|7604961|FG000|NOT COMPLETED|Overall Study||19
6674113|NCT02598934|7604962|FG001|NOT COMPLETED|Overall Study||22
6674114|NCT02599129|7604970|FG000|STARTED|Overall Study||7
6674115|NCT02599129|7604971|FG001|STARTED|Overall Study||4
6674116|NCT02599129|7604970|FG000|COMPLETED|Overall Study||2
6674117|NCT02599129|7604971|FG001|COMPLETED|Overall Study||1
6674118|NCT02599129|7604970|FG000|NOT COMPLETED|Overall Study||5
6674119|NCT02599129|7604971|FG001|NOT COMPLETED|Overall Study||3
6674120|NCT02599194|7604977|FG000|STARTED|Overall Study||7
6674121|NCT02599194|7604977|FG000|COMPLETED|Overall Study||7
6674122|NCT02599194|7604977|FG000|NOT COMPLETED|Overall Study||0
6674123|NCT02599402|7604983|FG000|STARTED|Overall Study||533
6674124|NCT02599402|7604983|FG000|COMPLETED|Overall Study||0
6674125|NCT02599402|7604983|FG000|NOT COMPLETED|Overall Study||533
6674126|NCT02599441|7605013|FG000|STARTED|Overall Study||9
6674127|NCT02599441|7605013|FG000|COMPLETED|Overall Study||9
6674128|NCT02599441|7605013|FG000|NOT COMPLETED|Overall Study||0
6674129|NCT02599649|7605021|FG000|STARTED|Overall Study||2
6674130|NCT02599649|7605022|FG001|STARTED|Overall Study||0
6674131|NCT02599649|7605023|FG002|STARTED|Overall Study||8
6674132|NCT02599649|7605024|FG003|STARTED|Overall Study||0
6674133|NCT02599649|7605021|FG000|COMPLETED|Overall Study||2
6674134|NCT02599649|7605022|FG001|COMPLETED|Overall Study||0
6674135|NCT02599649|7605023|FG002|COMPLETED|Overall Study||8
6674136|NCT02599649|7605024|FG003|COMPLETED|Overall Study||0
6674137|NCT02599649|7605021|FG000|NOT COMPLETED|Overall Study||0
6674138|NCT02599649|7605022|FG001|NOT COMPLETED|Overall Study||0
6674139|NCT02599649|7605023|FG002|NOT COMPLETED|Overall Study||0
6674140|NCT02599649|7605024|FG003|NOT COMPLETED|Overall Study||0
6674141|NCT02599688|7605034|FG000|STARTED|Overall Study||18
6674142|NCT02599688|7605034|FG000|COMPLETED|Overall Study||14
6674143|NCT02599688|7605034|FG000|NOT COMPLETED|Overall Study||4
6674144|NCT02599766|7605038|FG000|STARTED|Overall Study||22
6674145|NCT02599766|7605038|FG000|COMPLETED|Overall Study||19
6674146|NCT02599766|7605038|FG000|NOT COMPLETED|Overall Study||3
6674147|NCT02599961|7605046|FG000|STARTED|Overall Study||15
6674148|NCT02599961|7605046|FG000|COMPLETED|Overall Study||0
6674149|NCT02599961|7605046|FG000|NOT COMPLETED|Overall Study||15
6674150|NCT02600325|7605050|FG000|STARTED|Overall Study||80
6674151|NCT02600325|7605050|FG000|COMPLETED|Overall Study||80
6674152|NCT02600325|7605050|FG000|NOT COMPLETED|Overall Study||0
6674153|NCT02600351|7605058|FG000|STARTED|Overall Study||17
6674154|NCT02600351|7605059|FG001|STARTED|Overall Study||17
6674155|NCT02600351|7605060|FG002|STARTED|Overall Study||26
6674156|NCT02600351|7605061|FG003|STARTED|Overall Study||27
6674157|NCT02600351|7605058|FG000|COMPLETED|Overall Study||12
6674158|NCT02600351|7605059|FG001|COMPLETED|Overall Study||17
6674159|NCT02600351|7605060|FG002|COMPLETED|Overall Study||20
6674160|NCT02600351|7605061|FG003|COMPLETED|Overall Study||22
6256237|NCT01970865|7155085|FG000|Received Treatment|Overall Study||3
6256238|NCT01970865|7155086|FG001|Received Treatment|Overall Study||3
6256239|NCT01970865|7155087|FG002|Received Treatment|Overall Study||3
6256240|NCT01970865|7155088|FG003|Received Treatment|Overall Study||12
6256241|NCT01970865|7155089|FG004|Received Treatment|Overall Study||17
6256242|NCT01970865|7155090|FG005|Received Treatment|Overall Study||3
6256243|NCT01970865|7155091|FG006|Received Treatment|Overall Study||3
6256244|NCT01970865|7155092|FG007|Received Treatment|Overall Study||3
6256245|NCT01970865|7155093|FG008|Received Treatment|Overall Study||3
6256246|NCT01970865|7155094|FG009|Received Treatment|Overall Study||4
6256247|NCT01970865|7155095|FG010|Received Treatment|Overall Study||30
6674161|NCT02600351|7605058|FG000|NOT COMPLETED|Overall Study||5
6674162|NCT02600351|7605059|FG001|NOT COMPLETED|Overall Study||0
6674163|NCT02600351|7605060|FG002|NOT COMPLETED|Overall Study||6
6674164|NCT02600351|7605061|FG003|NOT COMPLETED|Overall Study||5
6674165|NCT02600403|7605076|FG000|STARTED|Overall Study||44
6674166|NCT02600403|7605077|FG001|STARTED|Overall Study||6
6674167|NCT02600403|7605078|FG002|STARTED|Overall Study||11
6674168|NCT02600403|7605076|FG000|COMPLETED|Overall Study||44
6674169|NCT02600403|7605077|FG001|COMPLETED|Overall Study||6
6674170|NCT02600403|7605078|FG002|COMPLETED|Overall Study||11
6674171|NCT02600403|7605076|FG000|NOT COMPLETED|Overall Study||0
6674172|NCT02600403|7605077|FG001|NOT COMPLETED|Overall Study||0
6674173|NCT02600403|7605078|FG002|NOT COMPLETED|Overall Study||0
6674174|NCT02600559|7605089|FG000|STARTED|Overall Study||501
6674175|NCT02600559|7605089|FG000|COMPLETED|Overall Study||478
6674176|NCT02600559|7605089|FG000|NOT COMPLETED|Overall Study||23
6674177|NCT02600611|7605095|FG000|STARTED|Overall Study||300
6674178|NCT02600611|7605096|FG001|STARTED|Overall Study||300
6674179|NCT02600611|7605095|FG000|COMPLETED|Overall Study||298
6674180|NCT02600611|7605096|FG001|COMPLETED|Overall Study||300
6674181|NCT02600611|7605095|FG000|NOT COMPLETED|Overall Study||2
6674182|NCT02600611|7605096|FG001|NOT COMPLETED|Overall Study||0
6674183|NCT02600637|7605104|FG000|STARTED|Overall Study||19
6674184|NCT02600637|7605105|FG001|STARTED|Overall Study||18
6674185|NCT02600637|7605104|FG000|COMPLETED|Overall Study||14
6674186|NCT02600637|7605105|FG001|COMPLETED|Overall Study||13
6674187|NCT02600637|7605104|FG000|NOT COMPLETED|Overall Study||5
6674188|NCT02600637|7605105|FG001|NOT COMPLETED|Overall Study||5
6674189|NCT02600715|7605113|FG000|STARTED|Overall Study||13
6674190|NCT02600715|7605114|FG001|STARTED|Overall Study||13
6674191|NCT02600715|7605113|FG000|Allocated to Randomization|Overall Study||13
6674192|NCT02600715|7605114|FG001|Allocated to Randomization|Overall Study||13
6674193|NCT02600715|7605113|FG000|Received Treatment and Suppository|Overall Study||13
6674194|NCT02600715|7605114|FG001|Received Treatment and Suppository|Overall Study||13
6674195|NCT02600715|7605113|FG000|Completed 2-week Follow-up Appointment|Overall Study||13
6674196|NCT02600715|7605114|FG001|Completed 2-week Follow-up Appointment|Overall Study||12
6674197|NCT02600715|7605113|FG000|COMPLETED|Overall Study||13
6674198|NCT02600715|7605114|FG001|COMPLETED|Overall Study||13
6674199|NCT02600715|7605113|FG000|NOT COMPLETED|Overall Study||0
6674200|NCT02600715|7605114|FG001|NOT COMPLETED|Overall Study||0
6674201|NCT02600767|7605123|FG000|STARTED|Overall Study||79
6674202|NCT02600767|7605123|FG000|COMPLETED|Overall Study||74
6674203|NCT02600767|7605123|FG000|NOT COMPLETED|Overall Study||5
6674204|NCT02600819|7605127|FG000|STARTED|GEN Phase||55
6674205|NCT02600819|7605128|FG001|STARTED|GEN Phase||0
6674206|NCT02600819|7605127|FG000|COMPLETED|GEN Phase||39
6674207|NCT02600819|7605128|FG001|COMPLETED|GEN Phase||0
6674208|NCT02600819|7605127|FG000|NOT COMPLETED|GEN Phase||16
6674209|NCT02600819|7605128|FG001|NOT COMPLETED|GEN Phase||0
6674210|NCT02600819|7605127|FG000|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|0
6674211|NCT02600819|7605128|FG001|STARTED|BVY OL Extension Phase|Only US participants were eligible to roll over into the Extension Phase per the study protocol.|10
6674212|NCT02600819|7605127|FG000|COMPLETED|BVY OL Extension Phase||0
6674213|NCT02600819|7605128|FG001|COMPLETED|BVY OL Extension Phase||10
6674214|NCT02600819|7605127|FG000|NOT COMPLETED|BVY OL Extension Phase||0
6674215|NCT02600819|7605128|FG001|NOT COMPLETED|BVY OL Extension Phase||0
6674216|NCT02600845|7605134|FG000|STARTED|Overall Study||122
6674217|NCT02600845|7605134|FG000|COMPLETED|Overall Study||104
6674218|NCT02600845|7605134|FG000|NOT COMPLETED|Overall Study||18
6674219|NCT02600871|7605140|FG000|STARTED|Overall Study||52
6674220|NCT02600871|7605141|FG001|STARTED|Overall Study||49
6674221|NCT02600871|7605140|FG000|COMPLETED|Overall Study|51 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
6674222|NCT02600871|7605141|FG001|COMPLETED|Overall Study|45 subjects completed the 7-10 day follow up 39 subjects completed the 30-day follow up|39
6674223|NCT02600871|7605140|FG000|NOT COMPLETED|Overall Study||13
6674224|NCT02600871|7605141|FG001|NOT COMPLETED|Overall Study||10
6674225|NCT02601001|7605151|FG000|STARTED|Dosing Period 1||10
6674226|NCT02601001|7605152|FG001|STARTED|Dosing Period 1||20
6674227|NCT02601001|7605153|FG002|STARTED|Dosing Period 1||20
6674228|NCT02601001|7605154|FG003|STARTED|Dosing Period 1||0
6674229|NCT02601001|7605155|FG004|STARTED|Dosing Period 1||0
6674230|NCT02601001|7605156|FG005|STARTED|Dosing Period 1||0
6674231|NCT02601001|7605157|FG006|STARTED|Dosing Period 1||0
6674232|NCT02601001|7605151|FG000|COMPLETED|Dosing Period 1||10
6674233|NCT02601001|7605152|FG001|COMPLETED|Dosing Period 1||20
6674234|NCT02601001|7605153|FG002|COMPLETED|Dosing Period 1||20
6674235|NCT02601001|7605154|FG003|COMPLETED|Dosing Period 1||0
6674236|NCT02601001|7605155|FG004|COMPLETED|Dosing Period 1||0
6674237|NCT02601001|7605156|FG005|COMPLETED|Dosing Period 1||0
6674238|NCT02601001|7605157|FG006|COMPLETED|Dosing Period 1||0
6674239|NCT02601001|7605151|FG000|NOT COMPLETED|Dosing Period 1||0
6674240|NCT02601001|7605152|FG001|NOT COMPLETED|Dosing Period 1||0
6674241|NCT02601001|7605153|FG002|NOT COMPLETED|Dosing Period 1||0
6674242|NCT02601001|7605154|FG003|NOT COMPLETED|Dosing Period 1||0
6674243|NCT02601001|7605155|FG004|NOT COMPLETED|Dosing Period 1||0
6674244|NCT02601001|7605156|FG005|NOT COMPLETED|Dosing Period 1||0
6674245|NCT02601001|7605157|FG006|NOT COMPLETED|Dosing Period 1||0
6674246|NCT02601001|7605151|FG000|STARTED|Dosing Period 2||10
6674247|NCT02601001|7605152|FG001|STARTED|Dosing Period 2||0
6674248|NCT02601001|7605153|FG002|STARTED|Dosing Period 2||0
6674249|NCT02601001|7605154|FG003|STARTED|Dosing Period 2||7
6674250|NCT02601001|7605155|FG004|STARTED|Dosing Period 2||13
6674251|NCT02601001|7605156|FG005|STARTED|Dosing Period 2||7
6674252|NCT02601001|7605157|FG006|STARTED|Dosing Period 2||13
6674253|NCT02601001|7605151|FG000|COMPLETED|Dosing Period 2||10
6674254|NCT02601001|7605152|FG001|COMPLETED|Dosing Period 2||0
6674255|NCT02601001|7605153|FG002|COMPLETED|Dosing Period 2||0
6674256|NCT02601001|7605154|FG003|COMPLETED|Dosing Period 2||7
6674257|NCT02601001|7605155|FG004|COMPLETED|Dosing Period 2||13
6674258|NCT02601001|7605156|FG005|COMPLETED|Dosing Period 2||7
6674259|NCT02601001|7605157|FG006|COMPLETED|Dosing Period 2||12
6674260|NCT02601001|7605151|FG000|NOT COMPLETED|Dosing Period 2||0
6674261|NCT02601001|7605152|FG001|NOT COMPLETED|Dosing Period 2||0
6674262|NCT02601001|7605153|FG002|NOT COMPLETED|Dosing Period 2||0
6674263|NCT02601001|7605154|FG003|NOT COMPLETED|Dosing Period 2||0
6674264|NCT02601001|7605155|FG004|NOT COMPLETED|Dosing Period 2||0
6674265|NCT02601001|7605156|FG005|NOT COMPLETED|Dosing Period 2||0
6674266|NCT02601001|7605157|FG006|NOT COMPLETED|Dosing Period 2||1
6674267|NCT02601027|7605180|FG000|STARTED|Registration to Surgery||64
6674268|NCT02601027|7605181|FG001|STARTED|Registration to Surgery||56
6674269|NCT02601027|7605180|FG000|COMPLETED|Registration to Surgery||44
6674270|NCT02601027|7605181|FG001|COMPLETED|Registration to Surgery||46
6674271|NCT02601027|7605180|FG000|NOT COMPLETED|Registration to Surgery||20
6674272|NCT02601027|7605181|FG001|NOT COMPLETED|Registration to Surgery||10
6674273|NCT02601027|7605180|FG000|STARTED|Surgery to Assessments||44
6674274|NCT02601027|7605181|FG001|STARTED|Surgery to Assessments||46
6674275|NCT02601027|7605180|FG000|COMPLETED|Surgery to Assessments||44
6674276|NCT02601027|7605181|FG001|COMPLETED|Surgery to Assessments||46
6674277|NCT02601027|7605180|FG000|NOT COMPLETED|Surgery to Assessments||0
6674278|NCT02601027|7605181|FG001|NOT COMPLETED|Surgery to Assessments||0
6674279|NCT02601105|7605187|FG000|STARTED|Placebo Cream; Centella Asiatica Bsln.||15
6674280|NCT02601105|7605187|FG000|COMPLETED|Placebo Cream; Centella Asiatica Bsln.||15
6674281|NCT02601105|7605187|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Bsln.||0
6674282|NCT02601105|7605187|FG000|STARTED|Placebo Cream; Centella Asiatica Week 6||15
6256248|NCT01970865|7155096|FG011|Received Treatment|Overall Study||27
6256249|NCT01970865|7155097|FG012|Received Treatment|Overall Study||60
6256250|NCT01970865|7155098|FG013|Received Treatment|Overall Study||65
6256251|NCT01970865|7155099|FG014|Received Treatment|Overall Study||46
6256252|NCT01970865|7155100|FG015|Received Treatment|Overall Study||47
6674283|NCT02601105|7605187|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 6||15
6674284|NCT02601105|7605187|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 6||0
6674285|NCT02601105|7605187|FG000|STARTED|Placebo Cream; Centella Asiatica Week 12||15
6674286|NCT02601105|7605187|FG000|COMPLETED|Placebo Cream; Centella Asiatica Week 12||13
6674287|NCT02601105|7605187|FG000|NOT COMPLETED|Placebo Cream; Centella Asiatica Week 12||2
6674288|NCT02601170|7605195|FG000|STARTED|Overall Study||11
6674289|NCT02601170|7605196|FG001|STARTED|Overall Study||11
6674290|NCT02601170|7605195|FG000|COMPLETED|Overall Study||11
6674291|NCT02601170|7605196|FG001|COMPLETED|Overall Study||11
6674292|NCT02601170|7605195|FG000|NOT COMPLETED|Overall Study||0
6674293|NCT02601170|7605196|FG001|NOT COMPLETED|Overall Study||0
6674294|NCT02601300|7605202|FG000|STARTED|Induction Phase||41
6674295|NCT02601300|7605202|FG000|COMPLETED|Induction Phase||38
6674296|NCT02601300|7605202|FG000|NOT COMPLETED|Induction Phase||3
6674297|NCT02601300|7605202|FG000|STARTED|Extension Phase|3 completed induction phase; did not enter extension due to withdrawal and lack of efficacy|35
6674298|NCT02601300|7605202|FG000|Treated With IP|Extension Phase||34
6674299|NCT02601300|7605202|FG000|COMPLETED|Extension Phase||18
6674300|NCT02601300|7605202|FG000|NOT COMPLETED|Extension Phase||17
6674301|NCT02601313|7605211|FG000|STARTED|Overall Study||14
6674302|NCT02601313|7605212|FG001|STARTED|Overall Study||74
6674303|NCT02601313|7605213|FG002|STARTED|Overall Study||17
6674304|NCT02601313|7605211|FG000|COMPLETED|Overall Study||8
6674305|NCT02601313|7605212|FG001|COMPLETED|Overall Study||0
6674306|NCT02601313|7605213|FG002|COMPLETED|Overall Study||0
6674307|NCT02601313|7605211|FG000|NOT COMPLETED|Overall Study||6
6674308|NCT02601313|7605212|FG001|NOT COMPLETED|Overall Study||74
6674309|NCT02601313|7605213|FG002|NOT COMPLETED|Overall Study||17
6674310|NCT02601469|7605223|FG000|STARTED|Overall Study||25
6674311|NCT02601469|7605224|FG001|STARTED|Overall Study||1
6674312|NCT02601469|7605223|FG000|COMPLETED|Overall Study||24
6674313|NCT02601469|7605224|FG001|COMPLETED|Overall Study||1
6674314|NCT02601469|7605223|FG000|NOT COMPLETED|Overall Study||1
6674315|NCT02601469|7605224|FG001|NOT COMPLETED|Overall Study||0
6674316|NCT02601560|7605238|FG000|STARTED|Overall Study||8
6674317|NCT02601560|7605239|FG001|STARTED|Overall Study||6
6674318|NCT02601560|7605240|FG002|STARTED|Overall Study||6
6674319|NCT02601560|7605241|FG003|STARTED|Overall Study||6
6674320|NCT02601560|7605242|FG004|STARTED|Overall Study||6
6674321|NCT02601560|7605243|FG005|STARTED|Overall Study||4
6674322|NCT02601560|7605244|FG006|STARTED|Overall Study||6
6674323|NCT02601560|7605245|FG007|STARTED|Overall Study||6
6674324|NCT02601560|7605238|FG000|COMPLETED|Overall Study||8
6674325|NCT02601560|7605239|FG001|COMPLETED|Overall Study||6
6674326|NCT02601560|7605240|FG002|COMPLETED|Overall Study||6
6674327|NCT02601560|7605241|FG003|COMPLETED|Overall Study||6
6674328|NCT02601560|7605242|FG004|COMPLETED|Overall Study||6
6674329|NCT02601560|7605243|FG005|COMPLETED|Overall Study||4
6674330|NCT02601560|7605244|FG006|COMPLETED|Overall Study||5
6674331|NCT02601560|7605245|FG007|COMPLETED|Overall Study||6
6674332|NCT02601560|7605238|FG000|NOT COMPLETED|Overall Study||0
6674333|NCT02601560|7605239|FG001|NOT COMPLETED|Overall Study||0
6674334|NCT02601560|7605240|FG002|NOT COMPLETED|Overall Study||0
6674335|NCT02601560|7605241|FG003|NOT COMPLETED|Overall Study||0
6674336|NCT02601560|7605242|FG004|NOT COMPLETED|Overall Study||0
6674337|NCT02601560|7605243|FG005|NOT COMPLETED|Overall Study||0
6674338|NCT02601560|7605244|FG006|NOT COMPLETED|Overall Study||1
6674339|NCT02601560|7605245|FG007|NOT COMPLETED|Overall Study||0
6674340|NCT02601573|7605275|FG000|STARTED|Overall Study|Number randomized and treated.|23
6674341|NCT02601573|7605276|FG001|STARTED|Overall Study|Number randomized and treated.|24
6674342|NCT02601573|7605277|FG002|STARTED|Overall Study|Number randomized and treated.|17
6674343|NCT02601573|7605278|FG003|STARTED|Overall Study|Number randomized and treated.|18
6674344|NCT02601573|7605279|FG004|STARTED|Overall Study|Number randomized and treated.|18
6674345|NCT02601573|7605275|FG000|COMPLETED|Overall Study||23
6674346|NCT02601573|7605276|FG001|COMPLETED|Overall Study||20
6674347|NCT02601573|7605277|FG002|COMPLETED|Overall Study||16
6674348|NCT02601573|7605278|FG003|COMPLETED|Overall Study||17
6674349|NCT02601573|7605279|FG004|COMPLETED|Overall Study||16
6674350|NCT02601573|7605275|FG000|NOT COMPLETED|Overall Study||0
6674351|NCT02601573|7605276|FG001|NOT COMPLETED|Overall Study||4
6674352|NCT02601573|7605277|FG002|NOT COMPLETED|Overall Study||1
6674353|NCT02601573|7605278|FG003|NOT COMPLETED|Overall Study||1
6674354|NCT02601573|7605279|FG004|NOT COMPLETED|Overall Study||2
6674355|NCT02601625|7605295|FG000|STARTED|Overall Study||6
6674356|NCT02601625|7605296|FG001|STARTED|Overall Study||6
6674357|NCT02601625|7605297|FG002|STARTED|Overall Study||6
6674358|NCT02601625|7605298|FG003|STARTED|Overall Study||12
6674359|NCT02601625|7605295|FG000|COMPLETED|Overall Study||6
6674360|NCT02601625|7605296|FG001|COMPLETED|Overall Study||6
6674361|NCT02601625|7605297|FG002|COMPLETED|Overall Study||5
6674362|NCT02601625|7605298|FG003|COMPLETED|Overall Study||11
6674363|NCT02601625|7605295|FG000|NOT COMPLETED|Overall Study||0
6674364|NCT02601625|7605296|FG001|NOT COMPLETED|Overall Study||0
6674365|NCT02601625|7605297|FG002|NOT COMPLETED|Overall Study||1
6674366|NCT02601625|7605298|FG003|NOT COMPLETED|Overall Study||1
6674367|NCT02601820|7605322|FG000|STARTED|Pre-Treatment (T1)|1601 patients were enrolled and completed Baseline PROs (T1).|1601
6674368|NCT02601820|7605322|FG000|COMPLETED|Pre-Treatment (T1)||1601
6674369|NCT02601820|7605322|FG000|NOT COMPLETED|Pre-Treatment (T1)||0
6738141|NCT03277378|7667406|FG000|Not Qualified for Permanent Implant|Overall Study||19
6674370|NCT02601820|7605322|FG000|STARTED|Early On-Treatment (T2)|Of 1601, 17 were excluded at T2 due to death, withdrawal, other reason. 1584 remained in the study.|1584
6674371|NCT02601820|7605322|FG000|COMPLETED|Early On-Treatment (T2)|Of 1584, 51 were excluded for a missing T2 record. 1533 provided data at T2. Some outcomes missing.|1533
6674372|NCT02601820|7605322|FG000|NOT COMPLETED|Early On-Treatment (T2)||51
6674373|NCT02601820|7605322|FG000|STARTED|Late On-Treatment (T3)|Of 1601, 28 were excluded at T3 due to death, withdrawal, other reason. 1573 remained in the study.|1573
6674374|NCT02601820|7605322|FG000|COMPLETED|Late On-Treatment (T3)|Of 1573, 49 were excluded for a missing T3 record. 1524 provided data at T3. Some outcomes missing.|1524
6674375|NCT02601820|7605322|FG000|NOT COMPLETED|Late On-Treatment (T3)||49
6674376|NCT02601820|7605322|FG000|STARTED|12 Weeks Post-Treatment (T4)|Of 1601, 37 were excluded at T4 due to death, withdrawal, other reason. 1564 remained in the study.|1564
6674377|NCT02601820|7605322|FG000|COMPLETED|12 Weeks Post-Treatment (T4)|Of 1564, 3 were excluded for a missing T4 record. 1561 provided data at T4. Some outcomes missing.|1561
6674378|NCT02601820|7605322|FG000|NOT COMPLETED|12 Weeks Post-Treatment (T4)||3
6674379|NCT02601820|7605322|FG000|STARTED|1-Yr Post-Treatment (T5)|Of 1601, 73 were excluded at T5 due to death, withdrawal, other reason. 1528 remained in the study.|1528
6674380|NCT02601820|7605322|FG000|COMPLETED|1-Yr Post-Treatment (T5)|Of 1528, 88 were excluded for a missing T5 record. 1440 provided data at T5. Some outcomes missing.|1440
6674381|NCT02601820|7605322|FG000|NOT COMPLETED|1-Yr Post-Treatment (T5)||88
6738142|NCT03277378|7667407|FG001|Not Qualified for Permanent Implant|Overall Study||20
6738143|NCT03277378|7667406|FG000|Completed Extended Trial With Tonic Stim|Overall Study||8
6738144|NCT03277378|7667407|FG001|Completed Extended Trial With Tonic Stim|Overall Study||12
6738145|NCT03277378|7667406|FG000|Exit Study|Overall Study||11
6738146|NCT03277378|7667407|FG001|Exit Study|Overall Study||8
6738147|NCT03277378|7667406|FG000|COMPLETED|Overall Study||111
6738148|NCT03277378|7667407|FG001|COMPLETED|Overall Study||101
6738149|NCT03277378|7667406|FG000|NOT COMPLETED|Overall Study||24
6738150|NCT03277378|7667407|FG001|NOT COMPLETED|Overall Study||34
6738151|NCT03277794|7667419|FG000|STARTED|Overall Study||31
6738152|NCT03277794|7667420|FG001|STARTED|Overall Study||34
6738153|NCT03277794|7667419|FG000|COMPLETED|Overall Study||28
6738154|NCT03277794|7667420|FG001|COMPLETED|Overall Study||30
6738155|NCT03277794|7667419|FG000|NOT COMPLETED|Overall Study||3
6738156|NCT03277794|7667420|FG001|NOT COMPLETED|Overall Study||4
6738157|NCT03277846|7667429|FG000|STARTED|Overall Study||50
6738158|NCT03277846|7667430|FG001|STARTED|Overall Study||51
6738159|NCT03277846|7667429|FG000|COMPLETED|Overall Study||38
6738160|NCT03277846|7667430|FG001|COMPLETED|Overall Study||40
6738161|NCT03277846|7667429|FG000|NOT COMPLETED|Overall Study||12
6738162|NCT03277846|7667430|FG001|NOT COMPLETED|Overall Study||11
6738163|NCT03278028|7667438|FG000|STARTED|Overall Study||81
6738164|NCT03278028|7667439|FG001|STARTED|Overall Study||78
6738165|NCT03278028|7667438|FG000|COMPLETED|Overall Study||77
6738166|NCT03278028|7667439|FG001|COMPLETED|Overall Study||76
6738167|NCT03278028|7667438|FG000|NOT COMPLETED|Overall Study||4
6738168|NCT03278028|7667439|FG001|NOT COMPLETED|Overall Study||2
6738169|NCT03278067|7667448|FG000|STARTED|Overall Study||16433
6738170|NCT03278067|7667449|FG001|STARTED|Overall Study||3310
6738171|NCT03278067|7667450|FG002|STARTED|Overall Study||4196
6738172|NCT03278067|7667448|FG000|COMPLETED|Overall Study||16433
6738173|NCT03278067|7667449|FG001|COMPLETED|Overall Study||3310
6738174|NCT03278067|7667450|FG002|COMPLETED|Overall Study||4196
6738175|NCT03278067|7667448|FG000|NOT COMPLETED|Overall Study||0
6738176|NCT03278067|7667449|FG001|NOT COMPLETED|Overall Study||0
6738177|NCT03278067|7667450|FG002|NOT COMPLETED|Overall Study||0
6738178|NCT03278106|7667463|FG000|STARTED|Overall Study||28
6738179|NCT03278106|7667463|FG000|COMPLETED|Overall Study||27
6738180|NCT03278106|7667463|FG000|NOT COMPLETED|Overall Study||1
6738181|NCT03278223|7667469|FG000|STARTED|Overall Study||125
6738182|NCT03278223|7667470|FG001|STARTED|Overall Study||69
6738183|NCT03278223|7667469|FG000|COMPLETED|Overall Study||122
6738184|NCT03278223|7667470|FG001|COMPLETED|Overall Study||65
6738185|NCT03278223|7667469|FG000|NOT COMPLETED|Overall Study||3
6738186|NCT03278223|7667470|FG001|NOT COMPLETED|Overall Study||4
6738187|NCT03278613|7667478|FG000|STARTED|Overall Study||111
6738188|NCT03278613|7667479|FG001|STARTED|Overall Study||55
6738189|NCT03278613|7667478|FG000|COMPLETED|Overall Study||108
6738190|NCT03278613|7667479|FG001|COMPLETED|Overall Study||54
6738191|NCT03278613|7667478|FG000|NOT COMPLETED|Overall Study||3
6738192|NCT03278613|7667479|FG001|NOT COMPLETED|Overall Study||1
6738193|NCT03278886|7667487|FG000|STARTED|Overall Study||8
6738194|NCT03278886|7667488|FG001|STARTED|Overall Study||3
6738195|NCT03278886|7667487|FG000|COMPLETED|Overall Study||8
6738196|NCT03278886|7667488|FG001|COMPLETED|Overall Study||2
6738197|NCT03278886|7667487|FG000|NOT COMPLETED|Overall Study||0
6738198|NCT03278886|7667488|FG001|NOT COMPLETED|Overall Study||1
6738199|NCT03279237|7667494|FG000|STARTED|Overall Study||25
6738200|NCT03279237|7667494|FG000|Chemo-radiation|Overall Study||23
6738201|NCT03279237|7667494|FG000|Surgical Resection|Overall Study||20
6738202|NCT03279237|7667494|FG000|COMPLETED|Overall Study||20
6738203|NCT03279237|7667494|FG000|NOT COMPLETED|Overall Study||5
6738204|NCT03279458|7667498|FG000|STARTED|Overall Study||40
6738205|NCT03279458|7667498|FG000|COMPLETED|Overall Study||40
6738206|NCT03279458|7667498|FG000|NOT COMPLETED|Overall Study||0
6738207|NCT03279731|7667506|FG000|STARTED|Overall Study||19
6738208|NCT03279731|7667507|FG001|STARTED|Overall Study||17
6738209|NCT03279731|7667506|FG000|COMPLETED|Overall Study||13
6738210|NCT03279731|7667507|FG001|COMPLETED|Overall Study||14
6674382|NCT02601833|7605341|FG000|STARTED|Overall Study||56
6674383|NCT02601833|7605342|FG001|STARTED|Overall Study||42
6674384|NCT02601833|7605341|FG000|COMPLETED|Overall Study||40
6674385|NCT02601833|7605342|FG001|COMPLETED|Overall Study||29
6674386|NCT02601833|7605341|FG000|NOT COMPLETED|Overall Study||16
6674387|NCT02601833|7605342|FG001|NOT COMPLETED|Overall Study||13
6674388|NCT02601976|7605351|FG000|STARTED|Overall Study||64
6674389|NCT02601976|7605351|FG000|COMPLETED|Overall Study||64
6674390|NCT02601976|7605351|FG000|NOT COMPLETED|Overall Study||0
6674391|NCT02602080|7605358|FG000|STARTED|Overall Study||21
6674392|NCT02602080|7605359|FG001|STARTED|Overall Study||16
6674393|NCT02602080|7605360|FG002|STARTED|Overall Study||18
6674394|NCT02602080|7605358|FG000|COMPLETED|Overall Study||15
6674395|NCT02602080|7605359|FG001|COMPLETED|Overall Study||15
6674396|NCT02602080|7605360|FG002|COMPLETED|Overall Study||15
6674397|NCT02602080|7605358|FG000|NOT COMPLETED|Overall Study||6
6674398|NCT02602080|7605359|FG001|NOT COMPLETED|Overall Study||1
6674399|NCT02602080|7605360|FG002|NOT COMPLETED|Overall Study||3
6674400|NCT02602223|7605368|FG000|STARTED|Overall Study||9
6674401|NCT02602223|7605368|FG000|COMPLETED|Overall Study||9
6674402|NCT02602223|7605368|FG000|NOT COMPLETED|Overall Study||0
6674403|NCT02602496|7605377|FG000|STARTED|Overall Study||15
6674404|NCT02602496|7605378|FG001|STARTED|Overall Study||20
6674405|NCT02602496|7605379|FG002|STARTED|Overall Study||17
6674406|NCT02602496|7605377|FG000|COMPLETED|Overall Study||14
6674407|NCT02602496|7605378|FG001|COMPLETED|Overall Study||18
6602145|NCT02054754|7527063|FG003|NOT COMPLETED|Overall Study||0
6602146|NCT02054754|7527064|FG004|NOT COMPLETED|Overall Study||0
6602147|NCT02054754|7527065|FG005|NOT COMPLETED|Overall Study||0
6602148|NCT02054897|7527083|FG000|STARTED|Overall Study||129
6602149|NCT02054897|7527084|FG001|STARTED|Overall Study||130
6602150|NCT02054897|7527085|FG002|STARTED|Overall Study||129
6602151|NCT02054897|7527083|FG000|Exposed|Overall Study||128
6602152|NCT02054897|7527084|FG001|Exposed|Overall Study||130
6674408|NCT02602496|7605379|FG002|COMPLETED|Overall Study||17
6674409|NCT02602496|7605377|FG000|NOT COMPLETED|Overall Study||1
6674410|NCT02602496|7605378|FG001|NOT COMPLETED|Overall Study||2
6674411|NCT02602496|7605379|FG002|NOT COMPLETED|Overall Study||0
6674412|NCT02603107|7605389|FG000|STARTED|Randomized Phase||290
6674413|NCT02603107|7605390|FG001|STARTED|Randomized Phase||287
6674414|NCT02603107|7605389|FG000|COMPLETED|Randomized Phase||275
6674415|NCT02603107|7605390|FG001|COMPLETED|Randomized Phase||266
6674416|NCT02603107|7605389|FG000|NOT COMPLETED|Randomized Phase||15
6674417|NCT02603107|7605390|FG001|NOT COMPLETED|Randomized Phase||21
6674418|NCT02603107|7605389|FG000|STARTED|Optional Extension Phase|3 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|272
6674419|NCT02603107|7605390|FG001|STARTED|Optional Extension Phase|21 participants who completed the Randomized Phase did not continue in the Optional Extension Phase.|245
6674420|NCT02603107|7605389|FG000|COMPLETED|Optional Extension Phase||263
6674421|NCT02603107|7605390|FG001|COMPLETED|Optional Extension Phase||232
6674422|NCT02603107|7605389|FG000|NOT COMPLETED|Optional Extension Phase||9
6674423|NCT02603107|7605390|FG001|NOT COMPLETED|Optional Extension Phase||13
6674424|NCT02603120|7605400|FG000|STARTED|Double-Blind Treatment Phase||284
6674425|NCT02603120|7605401|FG001|STARTED|Double-Blind Treatment Phase||283
6674426|NCT02603120|7605400|FG000|COMPLETED|Double-Blind Treatment Phase||265
6674427|NCT02603120|7605401|FG001|COMPLETED|Double-Blind Treatment Phase||267
6674428|NCT02603120|7605400|FG000|NOT COMPLETED|Double-Blind Treatment Phase||19
6674429|NCT02603120|7605401|FG001|NOT COMPLETED|Double-Blind Treatment Phase||16
6674430|NCT02603120|7605400|FG000|STARTED|OL Extension B/F/TAF Treatment Phase||259
6674431|NCT02603120|7605401|FG001|STARTED|OL Extension B/F/TAF Treatment Phase||265
6674432|NCT02603120|7605400|FG000|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
6674433|NCT02603120|7605401|FG001|COMPLETED|OL Extension B/F/TAF Treatment Phase||254
6674434|NCT02603120|7605400|FG000|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||5
6674435|NCT02603120|7605401|FG001|NOT COMPLETED|OL Extension B/F/TAF Treatment Phase||11
6674436|NCT02603172|7605417|FG000|STARTED|Part A (Approximately 16 Weeks)||7
6674437|NCT02603172|7605418|FG001|STARTED|Part A (Approximately 16 Weeks)||1
6674438|NCT02603172|7605419|FG002|STARTED|Part A (Approximately 16 Weeks)||8
6674439|NCT02603172|7605420|FG003|STARTED|Part A (Approximately 16 Weeks)||1
6674440|NCT02603172|7605421|FG004|STARTED|Part A (Approximately 16 Weeks)||0
6674441|NCT02603172|7605422|FG005|STARTED|Part A (Approximately 16 Weeks)||0
6674442|NCT02603172|7605423|FG006|STARTED|Part A (Approximately 16 Weeks)||0
6674443|NCT02603172|7605424|FG007|STARTED|Part A (Approximately 16 Weeks)||0
6674444|NCT02603172|7605417|FG000|COMPLETED|Part A (Approximately 16 Weeks)||7
6674445|NCT02603172|7605418|FG001|COMPLETED|Part A (Approximately 16 Weeks)||1
6674446|NCT02603172|7605419|FG002|COMPLETED|Part A (Approximately 16 Weeks)||7
6674447|NCT02603172|7605420|FG003|COMPLETED|Part A (Approximately 16 Weeks)||1
6674448|NCT02603172|7605421|FG004|COMPLETED|Part A (Approximately 16 Weeks)||0
6674449|NCT02603172|7605422|FG005|COMPLETED|Part A (Approximately 16 Weeks)||0
6674450|NCT02603172|7605423|FG006|COMPLETED|Part A (Approximately 16 Weeks)||0
6674451|NCT02603172|7605424|FG007|COMPLETED|Part A (Approximately 16 Weeks)||0
6674452|NCT02603172|7605417|FG000|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6602153|NCT02054897|7527085|FG002|Exposed|Overall Study||129
6602154|NCT02054897|7527083|FG000|COMPLETED|Overall Study||119
6602155|NCT02054897|7527084|FG001|COMPLETED|Overall Study||123
6602156|NCT02054897|7527085|FG002|COMPLETED|Overall Study||117
6602157|NCT02054897|7527083|FG000|NOT COMPLETED|Overall Study||10
6602158|NCT02054897|7527084|FG001|NOT COMPLETED|Overall Study||7
6674453|NCT02603172|7605418|FG001|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6674454|NCT02603172|7605419|FG002|NOT COMPLETED|Part A (Approximately 16 Weeks)||1
6674455|NCT02603172|7605420|FG003|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6674456|NCT02603172|7605421|FG004|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6674457|NCT02603172|7605422|FG005|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6674458|NCT02603172|7605423|FG006|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6674459|NCT02603172|7605424|FG007|NOT COMPLETED|Part A (Approximately 16 Weeks)||0
6674460|NCT02603172|7605417|FG000|STARTED|Part B (Approximately 7 Weeks)||0
6674461|NCT02603172|7605418|FG001|STARTED|Part B (Approximately 7 Weeks)||1
6674462|NCT02603172|7605419|FG002|STARTED|Part B (Approximately 7 Weeks)||0
6674463|NCT02603172|7605420|FG003|STARTED|Part B (Approximately 7 Weeks)||1
6674464|NCT02603172|7605421|FG004|STARTED|Part B (Approximately 7 Weeks)||6
6674465|NCT02603172|7605422|FG005|STARTED|Part B (Approximately 7 Weeks)||0
6674466|NCT02603172|7605423|FG006|STARTED|Part B (Approximately 7 Weeks)||0
6674467|NCT02603172|7605424|FG007|STARTED|Part B (Approximately 7 Weeks)||0
6674468|NCT02603172|7605417|FG000|COMPLETED|Part B (Approximately 7 Weeks)||0
6674469|NCT02603172|7605418|FG001|COMPLETED|Part B (Approximately 7 Weeks)||1
6674470|NCT02603172|7605419|FG002|COMPLETED|Part B (Approximately 7 Weeks)||0
6674471|NCT02603172|7605420|FG003|COMPLETED|Part B (Approximately 7 Weeks)||1
6674472|NCT02603172|7605421|FG004|COMPLETED|Part B (Approximately 7 Weeks)||6
6674473|NCT02603172|7605422|FG005|COMPLETED|Part B (Approximately 7 Weeks)||0
6674474|NCT02603172|7605423|FG006|COMPLETED|Part B (Approximately 7 Weeks)||0
6674475|NCT02603172|7605424|FG007|COMPLETED|Part B (Approximately 7 Weeks)||0
6674476|NCT02603172|7605417|FG000|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6674477|NCT02603172|7605418|FG001|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6674478|NCT02603172|7605419|FG002|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6674479|NCT02603172|7605420|FG003|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6674480|NCT02603172|7605421|FG004|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6674481|NCT02603172|7605422|FG005|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6674482|NCT02603172|7605423|FG006|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6674483|NCT02603172|7605424|FG007|NOT COMPLETED|Part B (Approximately 7 Weeks)||0
6674484|NCT02603172|7605417|FG000|STARTED|Part C (Approximately 13 Weeks)||0
6674485|NCT02603172|7605418|FG001|STARTED|Part C (Approximately 13 Weeks)||0
6674486|NCT02603172|7605419|FG002|STARTED|Part C (Approximately 13 Weeks)||0
6674487|NCT02603172|7605420|FG003|STARTED|Part C (Approximately 13 Weeks)||0
6674488|NCT02603172|7605421|FG004|STARTED|Part C (Approximately 13 Weeks)||0
6674489|NCT02603172|7605422|FG005|STARTED|Part C (Approximately 13 Weeks)||0
6674490|NCT02603172|7605423|FG006|STARTED|Part C (Approximately 13 Weeks)||0
6674491|NCT02603172|7605424|FG007|STARTED|Part C (Approximately 13 Weeks)||0
6674492|NCT02603172|7605417|FG000|COMPLETED|Part C (Approximately 13 Weeks)||0
6674493|NCT02603172|7605418|FG001|COMPLETED|Part C (Approximately 13 Weeks)||0
6674494|NCT02603172|7605419|FG002|COMPLETED|Part C (Approximately 13 Weeks)||0
6674495|NCT02603172|7605420|FG003|COMPLETED|Part C (Approximately 13 Weeks)||0
6674496|NCT02603172|7605421|FG004|COMPLETED|Part C (Approximately 13 Weeks)||0
6674497|NCT02603172|7605422|FG005|COMPLETED|Part C (Approximately 13 Weeks)||0
6674498|NCT02603172|7605423|FG006|COMPLETED|Part C (Approximately 13 Weeks)||0
6674499|NCT02603172|7605424|FG007|COMPLETED|Part C (Approximately 13 Weeks)||0
6674500|NCT02603172|7605417|FG000|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6674501|NCT02603172|7605418|FG001|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6674502|NCT02603172|7605419|FG002|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6674503|NCT02603172|7605420|FG003|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6674504|NCT02603172|7605421|FG004|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6674505|NCT02603172|7605422|FG005|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6674506|NCT02603172|7605423|FG006|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6674507|NCT02603172|7605424|FG007|NOT COMPLETED|Part C (Approximately 13 Weeks)||0
6674508|NCT02603211|7605440|FG000|STARTED|Overall Study||20
6674509|NCT02603211|7605440|FG000|COMPLETED|Overall Study||20
6674510|NCT02603211|7605440|FG000|NOT COMPLETED|Overall Study||0
6674511|NCT02603393|7605447|FG000|STARTED|Overall Study||527
6674512|NCT02603393|7605448|FG001|STARTED|Overall Study||526
6674513|NCT02603393|7605447|FG000|COMPLETED|Overall Study||456
6674514|NCT02603393|7605448|FG001|COMPLETED|Overall Study||472
6674515|NCT02603393|7605447|FG000|NOT COMPLETED|Overall Study||71
6674516|NCT02603393|7605448|FG001|NOT COMPLETED|Overall Study||54
6674517|NCT02603419|7605460|FG000|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
6674518|NCT02603419|7605461|FG001|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||7
6674519|NCT02603419|7605462|FG002|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
6674520|NCT02603419|7605463|FG003|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
6674521|NCT02603419|7605464|FG004|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||6
6674522|NCT02603419|7605465|FG005|STARTED|Lead-in Phase:Maximum Exposure:123Weeks||0
6674523|NCT02603419|7605460|FG000|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6674524|NCT02603419|7605461|FG001|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6674525|NCT02603419|7605462|FG002|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6674526|NCT02603419|7605463|FG003|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6674527|NCT02603419|7605464|FG004|Treated|Lead-in Phase:Maximum Exposure:123Weeks||6
6674528|NCT02603419|7605465|FG005|Treated|Lead-in Phase:Maximum Exposure:123Weeks||0
6674529|NCT02603419|7605460|FG000|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6674530|NCT02603419|7605461|FG001|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6674531|NCT02603419|7605462|FG002|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6674532|NCT02603419|7605463|FG003|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6674533|NCT02603419|7605464|FG004|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6674534|NCT02603419|7605465|FG005|COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6674535|NCT02603419|7605460|FG000|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
6674536|NCT02603419|7605461|FG001|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||7
6674537|NCT02603419|7605462|FG002|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
6674538|NCT02603419|7605463|FG003|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
6674539|NCT02603419|7605464|FG004|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||6
6674540|NCT02603419|7605465|FG005|NOT COMPLETED|Lead-in Phase:Maximum Exposure:123Weeks||0
6674541|NCT02603419|7605460|FG000|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6674542|NCT02603419|7605461|FG001|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6674543|NCT02603419|7605462|FG002|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6674544|NCT02603419|7605463|FG003|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6674545|NCT02603419|7605464|FG004|STARTED|Expansion Phase:Maximum Exposure:48Weeks||0
6674546|NCT02603419|7605465|FG005|STARTED|Expansion Phase:Maximum Exposure:48Weeks|Participants started expansion phase while other few participants were completing lead-in phase.|3
6674547|NCT02603419|7605460|FG000|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674548|NCT02603419|7605461|FG001|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674549|NCT02603419|7605462|FG002|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674550|NCT02603419|7605463|FG003|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674551|NCT02603419|7605464|FG004|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674552|NCT02603419|7605465|FG005|COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674553|NCT02603419|7605460|FG000|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674554|NCT02603419|7605461|FG001|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674555|NCT02603419|7605462|FG002|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674556|NCT02603419|7605463|FG003|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674557|NCT02603419|7605464|FG004|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||0
6674558|NCT02603419|7605465|FG005|NOT COMPLETED|Expansion Phase:Maximum Exposure:48Weeks||3
6674559|NCT02603666|7605480|FG000|STARTED|Overall Study||130
6674560|NCT02603666|7605480|FG000|COMPLETED|Overall Study||130
6674561|NCT02603666|7605480|FG000|NOT COMPLETED|Overall Study||0
6674562|NCT02603809|7605490|FG000|STARTED|Overall Study||82
6674563|NCT02603809|7605491|FG001|STARTED|Overall Study||82
6674564|NCT02603809|7605492|FG002|STARTED|Overall Study||82
6674565|NCT02603809|7605493|FG003|STARTED|Overall Study||82
6674566|NCT02603809|7605494|FG004|STARTED|Overall Study||81
6674567|NCT02603809|7605495|FG005|STARTED|Overall Study||81
6674568|NCT02603809|7605490|FG000|Per-protocol Set|Overall Study||67
6674569|NCT02603809|7605491|FG001|Per-protocol Set|Overall Study||68
6674570|NCT02603809|7605492|FG002|Per-protocol Set|Overall Study||71
6674571|NCT02603809|7605493|FG003|Per-protocol Set|Overall Study||67
6674572|NCT02603809|7605494|FG004|Per-protocol Set|Overall Study||68
6674573|NCT02603809|7605495|FG005|Per-protocol Set|Overall Study||69
6674574|NCT02603809|7605490|FG000|Modified Per-Protocol Set|Overall Study|One participant had out of analysis window blood pressure measurements.|66
6674575|NCT02603809|7605491|FG001|Modified Per-Protocol Set|Overall Study||68
6674576|NCT02603809|7605492|FG002|Modified Per-Protocol Set|Overall Study||71
6674577|NCT02603809|7605493|FG003|Modified Per-Protocol Set|Overall Study||67
6674578|NCT02603809|7605494|FG004|Modified Per-Protocol Set|Overall Study||68
6674579|NCT02603809|7605495|FG005|Modified Per-Protocol Set|Overall Study||69
6674580|NCT02603809|7605490|FG000|Completed Study|Overall Study||75
6674581|NCT02603809|7605491|FG001|Completed Study|Overall Study||79
6674582|NCT02603809|7605492|FG002|Completed Study|Overall Study||79
6674583|NCT02603809|7605493|FG003|Completed Study|Overall Study||76
6674584|NCT02603809|7605494|FG004|Completed Study|Overall Study||78
6674585|NCT02603809|7605495|FG005|Completed Study|Overall Study||75
6674586|NCT02603809|7605490|FG000|COMPLETED|Overall Study||70
6674587|NCT02603809|7605491|FG001|COMPLETED|Overall Study||74
6674588|NCT02603809|7605492|FG002|COMPLETED|Overall Study||75
6674589|NCT02603809|7605493|FG003|COMPLETED|Overall Study||70
6674590|NCT02603809|7605494|FG004|COMPLETED|Overall Study||70
6256253|NCT01970865|7155101|FG016|Received Treatment|Overall Study||3
6256254|NCT01970865|7155085|FG000|COMPLETED|Overall Study||0
6256255|NCT01970865|7155086|FG001|COMPLETED|Overall Study||0
6256256|NCT01970865|7155087|FG002|COMPLETED|Overall Study||0
6674591|NCT02603809|7605495|FG005|COMPLETED|Overall Study||71
6674592|NCT02603809|7605490|FG000|NOT COMPLETED|Overall Study||12
6674593|NCT02603809|7605491|FG001|NOT COMPLETED|Overall Study||8
6674594|NCT02603809|7605492|FG002|NOT COMPLETED|Overall Study||7
6674595|NCT02603809|7605493|FG003|NOT COMPLETED|Overall Study||12
6674596|NCT02603809|7605494|FG004|NOT COMPLETED|Overall Study||11
6674597|NCT02603809|7605495|FG005|NOT COMPLETED|Overall Study||10
6674598|NCT02603926|7605511|FG000|STARTED|Overall Study||6
6674599|NCT02603926|7605511|FG000|COMPLETED|Overall Study||6
6674600|NCT02603926|7605511|FG000|NOT COMPLETED|Overall Study||0
6674601|NCT02603952|7605520|FG000|STARTED|Overall Study||32
6674602|NCT02603952|7605521|FG001|STARTED|Overall Study||31
6674603|NCT02603952|7605522|FG002|STARTED|Overall Study||31
6674604|NCT02603952|7605523|FG003|STARTED|Overall Study||32
6674605|NCT02603952|7605520|FG000|Treated|Overall Study||32
6674606|NCT02603952|7605521|FG001|Treated|Overall Study||31
6674607|NCT02603952|7605522|FG002|Treated|Overall Study||31
6674608|NCT02603952|7605523|FG003|Treated|Overall Study||31
6674609|NCT02603952|7605520|FG000|COMPLETED|Overall Study||31
6674610|NCT02603952|7605521|FG001|COMPLETED|Overall Study||31
6674611|NCT02603952|7605522|FG002|COMPLETED|Overall Study||31
6674612|NCT02603952|7605523|FG003|COMPLETED|Overall Study||31
6674613|NCT02603952|7605520|FG000|NOT COMPLETED|Overall Study||1
6674614|NCT02603952|7605521|FG001|NOT COMPLETED|Overall Study||0
6674615|NCT02603952|7605522|FG002|NOT COMPLETED|Overall Study||0
6674616|NCT02603952|7605523|FG003|NOT COMPLETED|Overall Study||1
6674617|NCT02604017|7605538|FG000|STARTED|Overall Study||352
6674618|NCT02604017|7605539|FG001|STARTED|Overall Study||351
6674619|NCT02604017|7605538|FG000|COMPLETED|Overall Study||346
6674620|NCT02604017|7605539|FG001|COMPLETED|Overall Study||343
6674621|NCT02604017|7605538|FG000|NOT COMPLETED|Overall Study||6
6674622|NCT02604017|7605539|FG001|NOT COMPLETED|Overall Study||8
6674623|NCT02604160|7605547|FG000|STARTED|Overall Study||2
6674624|NCT02604160|7605548|FG001|STARTED|Overall Study||5
6674625|NCT02604160|7605547|FG000|Received at Least One Dose of Study Drug|Overall Study||2
6674626|NCT02604160|7605548|FG001|Received at Least One Dose of Study Drug|Overall Study||5
6674627|NCT02604160|7605547|FG000|COMPLETED|Overall Study||2
6674628|NCT02604160|7605548|FG001|COMPLETED|Overall Study||3
6674629|NCT02604160|7605547|FG000|NOT COMPLETED|Overall Study||0
6674630|NCT02604160|7605548|FG001|NOT COMPLETED|Overall Study||2
6674631|NCT02604173|7605559|FG000|STARTED|Overall Study||33
6674632|NCT02604173|7605560|FG001|STARTED|Overall Study||35
6674633|NCT02604173|7605561|FG002|STARTED|Overall Study||35
6674634|NCT02604173|7605559|FG000|COMPLETED|Overall Study||33
6674635|NCT02604173|7605560|FG001|COMPLETED|Overall Study||35
6674636|NCT02604173|7605561|FG002|COMPLETED|Overall Study||35
6674637|NCT02604173|7605559|FG000|NOT COMPLETED|Overall Study||0
6674638|NCT02604173|7605560|FG001|NOT COMPLETED|Overall Study||0
6674639|NCT02604173|7605561|FG002|NOT COMPLETED|Overall Study||0
6674640|NCT02604199|7605573|FG000|STARTED|Overall Study||9
6674641|NCT02604199|7605574|FG001|STARTED|Overall Study||11
6674642|NCT02604199|7605575|FG002|STARTED|Overall Study||17
6674643|NCT02604199|7605576|FG003|STARTED|Overall Study||21
6674644|NCT02604199|7605573|FG000|COMPLETED|Overall Study||9
6674645|NCT02604199|7605574|FG001|COMPLETED|Overall Study||8
6674646|NCT02604199|7605575|FG002|COMPLETED|Overall Study||17
6674647|NCT02604199|7605576|FG003|COMPLETED|Overall Study||18
6674648|NCT02604199|7605573|FG000|NOT COMPLETED|Overall Study||0
6674649|NCT02604199|7605574|FG001|NOT COMPLETED|Overall Study||3
6674650|NCT02604199|7605575|FG002|NOT COMPLETED|Overall Study||0
6674651|NCT02604199|7605576|FG003|NOT COMPLETED|Overall Study||3
6674652|NCT02604212|7605593|FG000|STARTED|Overall Study||6
6674653|NCT02604212|7605594|FG001|STARTED|Overall Study||5
6674654|NCT02604212|7605595|FG002|STARTED|Overall Study||10
6674655|NCT02604212|7605596|FG003|STARTED|Overall Study||11
6674656|NCT02604212|7605593|FG000|COMPLETED|Overall Study||4
6674657|NCT02604212|7605594|FG001|COMPLETED|Overall Study||4
6674658|NCT02604212|7605595|FG002|COMPLETED|Overall Study||6
6256257|NCT01970865|7155088|FG003|COMPLETED|Overall Study||0
6256258|NCT01970865|7155089|FG004|COMPLETED|Overall Study||0
6674659|NCT02604212|7605596|FG003|COMPLETED|Overall Study||8
6674660|NCT02604212|7605593|FG000|NOT COMPLETED|Overall Study||2
6674661|NCT02604212|7605594|FG001|NOT COMPLETED|Overall Study||1
6674662|NCT02604212|7605595|FG002|NOT COMPLETED|Overall Study||4
6674663|NCT02604212|7605596|FG003|NOT COMPLETED|Overall Study||3
6674664|NCT02604264|7605613|FG000|STARTED|Run-In||618
6674665|NCT02604264|7605614|FG001|STARTED|Run-In|The 1-mo run-in period data was used to determine pre-study demographics and PBC rate.|611
6674666|NCT02604264|7605613|FG000|COMPLETED|Run-In||618
6674667|NCT02604264|7605614|FG001|COMPLETED|Run-In||611
6674668|NCT02604264|7605613|FG000|NOT COMPLETED|Run-In||0
6674669|NCT02604264|7605614|FG001|NOT COMPLETED|Run-In||0
6674670|NCT02604264|7605613|FG000|STARTED|Intervention||1445
6674671|NCT02604264|7605614|FG001|STARTED|Intervention||1467
6674672|NCT02604264|7605613|FG000|COMPLETED|Intervention||1245
6674673|NCT02604264|7605614|FG001|COMPLETED|Intervention||1225
6674674|NCT02604264|7605613|FG000|NOT COMPLETED|Intervention||200
6674675|NCT02604264|7605614|FG001|NOT COMPLETED|Intervention||242
6674676|NCT02604342|7605622|FG000|STARTED|Overall Study||79
6674677|NCT02604342|7605623|FG001|STARTED|Overall Study||40
6674678|NCT02604342|7605622|FG000|COMPLETED|Overall Study||36
6674679|NCT02604342|7605623|FG001|COMPLETED|Overall Study||17
6674680|NCT02604342|7605622|FG000|NOT COMPLETED|Overall Study||43
6674681|NCT02604342|7605623|FG001|NOT COMPLETED|Overall Study||23
6674682|NCT02604407|7605632|FG000|STARTED|Overall Study||91
6674683|NCT02604407|7605633|FG001|STARTED|Overall Study||92
6674684|NCT02604407|7605634|FG002|STARTED|Overall Study||92
6674685|NCT02604407|7605632|FG000|TREATED|Overall Study||89
6674686|NCT02604407|7605633|FG001|TREATED|Overall Study||92
6674687|NCT02604407|7605634|FG002|TREATED|Overall Study||90
6674688|NCT02604407|7605632|FG000|COMPLETED|Overall Study||80
6674689|NCT02604407|7605633|FG001|COMPLETED|Overall Study||80
6674690|NCT02604407|7605634|FG002|COMPLETED|Overall Study||76
6674691|NCT02604407|7605632|FG000|NOT COMPLETED|Overall Study||11
6674692|NCT02604407|7605633|FG001|NOT COMPLETED|Overall Study||12
6674693|NCT02604407|7605634|FG002|NOT COMPLETED|Overall Study||16
6674694|NCT02604550|7605644|FG000|STARTED|Overall Study||56
6674695|NCT02604550|7605645|FG001|STARTED|Overall Study||59
6674696|NCT02604550|7605644|FG000|COMPLETED|Overall Study||31
6674697|NCT02604550|7605645|FG001|COMPLETED|Overall Study||33
6674698|NCT02604550|7605644|FG000|NOT COMPLETED|Overall Study||25
6674699|NCT02604550|7605645|FG001|NOT COMPLETED|Overall Study||26
6674700|NCT02604589|7605654|FG000|STARTED|Overall Study||3
6674701|NCT02604589|7605655|FG001|STARTED|Overall Study||5
6674702|NCT02604589|7605656|FG002|STARTED|Overall Study||2
6674703|NCT02604589|7605654|FG000|COMPLETED|Overall Study||3
6674704|NCT02604589|7605655|FG001|COMPLETED|Overall Study||5
6674705|NCT02604589|7605656|FG002|COMPLETED|Overall Study||1
6674706|NCT02604589|7605654|FG000|NOT COMPLETED|Overall Study||0
6674707|NCT02604589|7605655|FG001|NOT COMPLETED|Overall Study||0
6674708|NCT02604589|7605656|FG002|NOT COMPLETED|Overall Study||1
6674709|NCT02604810|7605664|FG000|STARTED|IGIV-C 10%, 4-5 Weeks||52
6674710|NCT02604810|7605664|FG000|COMPLETED|IGIV-C 10%, 4-5 Weeks||49
6674711|NCT02604810|7605664|FG000|NOT COMPLETED|IGIV-C 10%, 4-5 Weeks||3
6674712|NCT02604810|7605664|FG000|STARTED|IGSC 20%, 24 Weeks||49
6674713|NCT02604810|7605664|FG000|COMPLETED|IGSC 20%, 24 Weeks||42
6674714|NCT02604810|7605664|FG000|NOT COMPLETED|IGSC 20%, 24 Weeks||7
6674715|NCT02605122|7605672|FG000|STARTED|Overall Study||73
6674716|NCT02605122|7605673|FG001|STARTED|Overall Study||24
6674717|NCT02605122|7605672|FG000|Received Study Drug|Overall Study||70
6674718|NCT02605122|7605673|FG001|Received Study Drug|Overall Study||24
6674719|NCT02605122|7605672|FG000|COMPLETED|Overall Study||68
6674720|NCT02605122|7605673|FG001|COMPLETED|Overall Study||22
6674721|NCT02605122|7605672|FG000|NOT COMPLETED|Overall Study||5
6674722|NCT02605122|7605673|FG001|NOT COMPLETED|Overall Study||2
6674723|NCT02605174|7605683|FG000|STARTED|Overall Study||501
6674724|NCT02605174|7605684|FG001|STARTED|Overall Study||249
6674725|NCT02605174|7605685|FG002|STARTED|Overall Study||502
6674726|NCT02605174|7605686|FG003|STARTED|Overall Study||252
6674727|NCT02605174|7605687|FG004|STARTED|Overall Study||501
6674728|NCT02605174|7605688|FG005|STARTED|Overall Study||249
6674729|NCT02605174|7605689|FG006|STARTED|Overall Study||751
6674730|NCT02605174|7605683|FG000|Received at Least 1 Dose of Study Drug|Overall Study||429
6674731|NCT02605174|7605684|FG001|Received at Least 1 Dose of Study Drug|Overall Study||225
6674732|NCT02605174|7605685|FG002|Received at Least 1 Dose of Study Drug|Overall Study||423
6674733|NCT02605174|7605686|FG003|Received at Least 1 Dose of Study Drug|Overall Study||212
6674734|NCT02605174|7605687|FG004|Received at Least 1 Dose of Study Drug|Overall Study||434
6674735|NCT02605174|7605688|FG005|Received at Least 1 Dose of Study Drug|Overall Study||215
6674736|NCT02605174|7605689|FG006|Received at Least 1 Dose of Study Drug|Overall Study||645
6674737|NCT02605174|7605683|FG000|Received Optional 2nd Dose|Overall Study||206
6674738|NCT02605174|7605684|FG001|Received Optional 2nd Dose|Overall Study||96
6674739|NCT02605174|7605685|FG002|Received Optional 2nd Dose|Overall Study||177
6674740|NCT02605174|7605686|FG003|Received Optional 2nd Dose|Overall Study||83
6674741|NCT02605174|7605687|FG004|Received Optional 2nd Dose|Overall Study||144
6674742|NCT02605174|7605688|FG005|Received Optional 2nd Dose|Overall Study||74
6674743|NCT02605174|7605689|FG006|Received Optional 2nd Dose|Overall Study||361
6674744|NCT02605174|7605683|FG000|COMPLETED|Overall Study||437
6674745|NCT02605174|7605684|FG001|COMPLETED|Overall Study||226
6674746|NCT02605174|7605685|FG002|COMPLETED|Overall Study||426
6674747|NCT02605174|7605686|FG003|COMPLETED|Overall Study||216
6674748|NCT02605174|7605687|FG004|COMPLETED|Overall Study||448
6674749|NCT02605174|7605688|FG005|COMPLETED|Overall Study||217
6674750|NCT02605174|7605689|FG006|COMPLETED|Overall Study||662
6674751|NCT02605174|7605683|FG000|NOT COMPLETED|Overall Study||64
6674752|NCT02605174|7605684|FG001|NOT COMPLETED|Overall Study||23
6674753|NCT02605174|7605685|FG002|NOT COMPLETED|Overall Study||76
6674754|NCT02605174|7605686|FG003|NOT COMPLETED|Overall Study||36
6674755|NCT02605174|7605687|FG004|NOT COMPLETED|Overall Study||53
6674756|NCT02605174|7605688|FG005|NOT COMPLETED|Overall Study||32
6674757|NCT02605174|7605689|FG006|NOT COMPLETED|Overall Study||89
6674758|NCT02605187|7605719|FG000|STARTED|Overall Study||40
6674759|NCT02605187|7605720|FG001|STARTED|Overall Study||21
6674760|NCT02605187|7605721|FG002|STARTED|Overall Study||83
6674761|NCT02605187|7605722|FG003|STARTED|Overall Study||16
6674762|NCT02605187|7605719|FG000|COMPLETED|Overall Study||32
6674763|NCT02605187|7605720|FG001|COMPLETED|Overall Study||19
6674764|NCT02605187|7605721|FG002|COMPLETED|Overall Study||72
6674765|NCT02605187|7605722|FG003|COMPLETED|Overall Study||15
6674766|NCT02605187|7605719|FG000|NOT COMPLETED|Overall Study||8
6674767|NCT02605187|7605720|FG001|NOT COMPLETED|Overall Study||2
6674768|NCT02605187|7605721|FG002|NOT COMPLETED|Overall Study||11
6674769|NCT02605187|7605722|FG003|NOT COMPLETED|Overall Study||1
6674770|NCT02605304|7605734|FG000|STARTED|Overall Study||4
6674771|NCT02605304|7605735|FG001|STARTED|Overall Study||3
6674772|NCT02605304|7605734|FG000|COMPLETED|Overall Study||4
6674773|NCT02605304|7605735|FG001|COMPLETED|Overall Study||3
6674774|NCT02605304|7605734|FG000|NOT COMPLETED|Overall Study||0
6674775|NCT02605304|7605735|FG001|NOT COMPLETED|Overall Study||0
6674776|NCT02605395|7605741|FG000|STARTED|Period 1, Day 1||35
6674777|NCT02605395|7605742|FG001|STARTED|Period 1, Day 1||35
6674778|NCT02605395|7605741|FG000|COMPLETED|Period 1, Day 1||35
6674779|NCT02605395|7605742|FG001|COMPLETED|Period 1, Day 1||35
6674780|NCT02605395|7605741|FG000|NOT COMPLETED|Period 1, Day 1||0
6674781|NCT02605395|7605742|FG001|NOT COMPLETED|Period 1, Day 1||0
6674782|NCT02605395|7605741|FG000|STARTED|Washout Period, Day 2 to Day 7||35
6674783|NCT02605395|7605742|FG001|STARTED|Washout Period, Day 2 to Day 7||35
6674784|NCT02605395|7605741|FG000|COMPLETED|Washout Period, Day 2 to Day 7||35
6674785|NCT02605395|7605742|FG001|COMPLETED|Washout Period, Day 2 to Day 7||35
6674786|NCT02605395|7605741|FG000|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
6674787|NCT02605395|7605742|FG001|NOT COMPLETED|Washout Period, Day 2 to Day 7||0
6674788|NCT02605395|7605741|FG000|STARTED|Period 2, Day 8||35
6674789|NCT02605395|7605742|FG001|STARTED|Period 2, Day 8||35
6674790|NCT02605395|7605741|FG000|COMPLETED|Period 2, Day 8||35
6674791|NCT02605395|7605742|FG001|COMPLETED|Period 2, Day 8||35
6674792|NCT02605395|7605741|FG000|NOT COMPLETED|Period 2, Day 8||0
6674793|NCT02605395|7605742|FG001|NOT COMPLETED|Period 2, Day 8||0
6674794|NCT02605447|7605748|FG000|STARTED|Overall Study||1487
6674795|NCT02605447|7605748|FG000|COMPLETED|Overall Study||1385
6674796|NCT02605447|7605748|FG000|NOT COMPLETED|Overall Study||102
6674797|NCT02605642|7605755|FG000|STARTED|Overall Study||227
6674798|NCT02605642|7605756|FG001|STARTED|Overall Study||107
6674799|NCT02605642|7605755|FG000|Safety Set|Overall Study||221
6674800|NCT02605642|7605756|FG001|Safety Set|Overall Study||107
6674801|NCT02605642|7605755|FG000|COMPLETED|Overall Study||131
6674802|NCT02605642|7605756|FG001|COMPLETED|Overall Study||86
6674803|NCT02605642|7605755|FG000|NOT COMPLETED|Overall Study||96
6674804|NCT02605642|7605756|FG001|NOT COMPLETED|Overall Study||21
6674805|NCT02605837|7605764|FG000|STARTED|Overall Study||105
6674806|NCT02605837|7605765|FG001|STARTED|Overall Study||213
6674807|NCT02605837|7605764|FG000|COMPLETED|Overall Study||94
6674808|NCT02605837|7605765|FG001|COMPLETED|Overall Study||202
6674809|NCT02605837|7605764|FG000|NOT COMPLETED|Overall Study||11
6674810|NCT02605837|7605765|FG001|NOT COMPLETED|Overall Study||11
6674811|NCT02605863|7605774|FG000|STARTED|Overall Study||1
6674812|NCT02605863|7605775|FG001|STARTED|Overall Study||0
6674813|NCT02605863|7605774|FG000|COMPLETED|Overall Study||1
6674814|NCT02605863|7605775|FG001|COMPLETED|Overall Study||0
6674815|NCT02605863|7605774|FG000|NOT COMPLETED|Overall Study||0
6674816|NCT02605863|7605775|FG001|NOT COMPLETED|Overall Study||0
6674817|NCT02605876|7605784|FG000|STARTED|Overall Study||25
6674818|NCT02605876|7605785|FG001|STARTED|Overall Study||25
6674819|NCT02605876|7605786|FG002|STARTED|Overall Study||25
6674820|NCT02605876|7605784|FG000|COMPLETED|Overall Study||25
6674821|NCT02605876|7605785|FG001|COMPLETED|Overall Study||25
6674822|NCT02605876|7605786|FG002|COMPLETED|Overall Study||25
6674823|NCT02605876|7605784|FG000|NOT COMPLETED|Overall Study||0
6674824|NCT02605876|7605785|FG001|NOT COMPLETED|Overall Study||0
6674825|NCT02605876|7605786|FG002|NOT COMPLETED|Overall Study||0
6674826|NCT02605928|7605794|FG000|STARTED|Overall Study||79
6674827|NCT02605928|7605794|FG000|Pivotal Phase, Statistical Phase|Overall Study||51
6674828|NCT02605928|7605794|FG000|COMPLETED|Overall Study||46
6674829|NCT02605928|7605794|FG000|NOT COMPLETED|Overall Study||33
6674830|NCT02605954|7605800|FG000|STARTED|Overall Study||183
6674831|NCT02605954|7605801|FG001|STARTED|Overall Study||92
6674832|NCT02605954|7605800|FG000|COMPLETED|Overall Study||171
6674833|NCT02605954|7605801|FG001|COMPLETED|Overall Study||88
6674834|NCT02605954|7605800|FG000|NOT COMPLETED|Overall Study||12
6674835|NCT02605954|7605801|FG001|NOT COMPLETED|Overall Study||4
6674836|NCT02606253|7605813|FG000|STARTED|Overall Study||20
6674837|NCT02606253|7605814|FG001|STARTED|Overall Study||20
6674838|NCT02606253|7605815|FG002|STARTED|Overall Study||20
6674839|NCT02606253|7605813|FG000|COMPLETED|Overall Study||15
6674840|NCT02606253|7605814|FG001|COMPLETED|Overall Study||18
6674841|NCT02606253|7605815|FG002|COMPLETED|Overall Study||20
6674842|NCT02606253|7605813|FG000|NOT COMPLETED|Overall Study||5
6674843|NCT02606253|7605814|FG001|NOT COMPLETED|Overall Study||2
6674844|NCT02606253|7605815|FG002|NOT COMPLETED|Overall Study||0
6674845|NCT02606500|7605825|FG000|STARTED|Overall Study||35
6674846|NCT02606500|7605826|FG001|STARTED|Overall Study||35
6674847|NCT02606500|7605825|FG000|COMPLETED|Overall Study||35
6674848|NCT02606500|7605826|FG001|COMPLETED|Overall Study||35
6674849|NCT02606500|7605825|FG000|NOT COMPLETED|Overall Study||0
6674850|NCT02606500|7605826|FG001|NOT COMPLETED|Overall Study||0
6674851|NCT02606604|7605834|FG000|STARTED|Overall Study||8
6674852|NCT02606604|7605835|FG001|STARTED|Overall Study||7
6674853|NCT02606604|7605834|FG000|COMPLETED|Overall Study||7
6674854|NCT02606604|7605835|FG001|COMPLETED|Overall Study||7
6674855|NCT02606604|7605834|FG000|NOT COMPLETED|Overall Study||1
6674856|NCT02606604|7605835|FG001|NOT COMPLETED|Overall Study||0
6674857|NCT02606643|7605845|FG000|STARTED|Overall Study||68
6674858|NCT02606643|7605846|FG001|STARTED|Overall Study||76
6674859|NCT02606643|7605845|FG000|COMPLETED|Overall Study||67
6674860|NCT02606643|7605846|FG001|COMPLETED|Overall Study||73
6674861|NCT02606643|7605845|FG000|NOT COMPLETED|Overall Study||1
6674862|NCT02606643|7605846|FG001|NOT COMPLETED|Overall Study||3
6674863|NCT02606708|7605856|FG000|STARTED|Overall Study||314
6674864|NCT02606708|7605856|FG000|COMPLETED|Overall Study||314
6674865|NCT02606708|7605856|FG000|NOT COMPLETED|Overall Study||0
6674866|NCT02606734|7605860|FG000|STARTED|Overall Study||44
6674867|NCT02606734|7605860|FG000|COMPLETED|Overall Study||44
6674868|NCT02606734|7605860|FG000|NOT COMPLETED|Overall Study||0
6674869|NCT02606838|7605864|FG000|STARTED|Overall Study||119
6674870|NCT02606838|7605864|FG000|COMPLETED|Overall Study||119
6674871|NCT02606838|7605864|FG000|NOT COMPLETED|Overall Study||0
6674872|NCT02606877|7605874|FG000|STARTED|Overall Study||20
6674873|NCT02606877|7605875|FG001|STARTED|Overall Study||17
6674874|NCT02606877|7605874|FG000|COMPLETED|Overall Study||16
6674875|NCT02606877|7605875|FG001|COMPLETED|Overall Study||16
6674876|NCT02606877|7605874|FG000|NOT COMPLETED|Overall Study||4
6674877|NCT02606877|7605875|FG001|NOT COMPLETED|Overall Study||1
6674878|NCT02606903|7605885|FG000|STARTED|Overall Study||35
6674879|NCT02606903|7605886|FG001|STARTED|Overall Study||36
6674880|NCT02606903|7605885|FG000|COMPLETED|Overall Study||35
6674881|NCT02606903|7605886|FG001|COMPLETED|Overall Study||36
6674882|NCT02606903|7605885|FG000|NOT COMPLETED|Overall Study||0
6674883|NCT02606903|7605886|FG001|NOT COMPLETED|Overall Study||0
6674884|NCT02607124|7605892|FG000|STARTED|Overall Study|11 participants were enrolled however 1 participant withdrew before starting study treatment.|10
6674885|NCT02607124|7605892|FG000|COMPLETED|Overall Study||10
6674886|NCT02607124|7605892|FG000|NOT COMPLETED|Overall Study||0
6674887|NCT02607228|7605904|FG000|STARTED|Overall Study||5
6674888|NCT02607228|7605905|FG001|STARTED|Overall Study||4
6674889|NCT02607228|7605906|FG002|STARTED|Overall Study||3
6674890|NCT02607228|7605907|FG003|STARTED|Overall Study||6
6674891|NCT02607228|7605908|FG004|STARTED|Overall Study||5
6674892|NCT02607228|7605909|FG005|STARTED|Overall Study||6
6674893|NCT02607228|7605910|FG006|STARTED|Overall Study||2
6674894|NCT02607228|7605904|FG000|COMPLETED|Overall Study||0
6674895|NCT02607228|7605905|FG001|COMPLETED|Overall Study||0
6674896|NCT02607228|7605906|FG002|COMPLETED|Overall Study||0
6674897|NCT02607228|7605907|FG003|COMPLETED|Overall Study||0
6674898|NCT02607228|7605908|FG004|COMPLETED|Overall Study||0
6674899|NCT02607228|7605909|FG005|COMPLETED|Overall Study||0
6674900|NCT02607228|7605910|FG006|COMPLETED|Overall Study||0
6674901|NCT02607228|7605904|FG000|NOT COMPLETED|Overall Study||5
6674902|NCT02607228|7605905|FG001|NOT COMPLETED|Overall Study||4
6674903|NCT02607228|7605906|FG002|NOT COMPLETED|Overall Study||3
6674904|NCT02607228|7605907|FG003|NOT COMPLETED|Overall Study||6
6674905|NCT02607228|7605908|FG004|NOT COMPLETED|Overall Study||5
6674906|NCT02607228|7605909|FG005|NOT COMPLETED|Overall Study||6
6674907|NCT02607228|7605910|FG006|NOT COMPLETED|Overall Study||2
6674908|NCT02607254|7605930|FG000|STARTED|Overall Study||3
6674909|NCT02607254|7605931|FG001|STARTED|Overall Study||3
6674910|NCT02607254|7605932|FG002|STARTED|Overall Study||5
6674911|NCT02607254|7605930|FG000|COMPLETED|Overall Study||3
6674912|NCT02607254|7605931|FG001|COMPLETED|Overall Study||3
6674913|NCT02607254|7605932|FG002|COMPLETED|Overall Study||5
6674914|NCT02607254|7605930|FG000|NOT COMPLETED|Overall Study||0
6674915|NCT02607254|7605931|FG001|NOT COMPLETED|Overall Study||0
6674916|NCT02607254|7605932|FG002|NOT COMPLETED|Overall Study||0
6674917|NCT02607280|7605948|FG000|STARTED|Overall Study||30
6674918|NCT02607280|7605949|FG001|STARTED|Overall Study||5
6674919|NCT02607280|7605948|FG000|Received Study Drug|Overall Study||30
6674920|NCT02607280|7605949|FG001|Received Study Drug|Overall Study||5
6674921|NCT02607280|7605948|FG000|COMPLETED|Overall Study||26
6674922|NCT02607280|7605949|FG001|COMPLETED|Overall Study||4
6674923|NCT02607280|7605948|FG000|NOT COMPLETED|Overall Study||4
6674924|NCT02607280|7605949|FG001|NOT COMPLETED|Overall Study||1
6674925|NCT02607306|7605958|FG000|STARTED|Overall Study||275
6674926|NCT02607306|7605959|FG001|STARTED|Overall Study||271
6674927|NCT02607306|7605960|FG002|STARTED|Overall Study||273
6674928|NCT02607306|7605958|FG000|COMPLETED|Overall Study||254
6674929|NCT02607306|7605959|FG001|COMPLETED|Overall Study||248
6674930|NCT02607306|7605960|FG002|COMPLETED|Overall Study||263
6674931|NCT02607306|7605958|FG000|NOT COMPLETED|Overall Study||21
6674932|NCT02607306|7605959|FG001|NOT COMPLETED|Overall Study||23
6674933|NCT02607306|7605960|FG002|NOT COMPLETED|Overall Study||10
6674934|NCT02607618|7605971|FG000|STARTED|Overall Study||306
6674935|NCT02607618|7605972|FG001|STARTED|Overall Study||307
6674936|NCT02607618|7605971|FG000|COMPLETED|Overall Study||295
6674937|NCT02607618|7605972|FG001|COMPLETED|Overall Study||305
6674938|NCT02607618|7605971|FG000|NOT COMPLETED|Overall Study||11
6674939|NCT02607618|7605972|FG001|NOT COMPLETED|Overall Study||2
6674940|NCT02607735|7605980|FG000|STARTED|Primary Study||264
6674941|NCT02607735|7605981|FG001|STARTED|Primary Study||152
6674942|NCT02607735|7605982|FG002|STARTED|Primary Study||0
6674943|NCT02607735|7605980|FG000|COMPLETED|Primary Study||257
6674944|NCT02607735|7605981|FG001|COMPLETED|Primary Study||152
6674945|NCT02607735|7605982|FG002|COMPLETED|Primary Study||0
6674946|NCT02607735|7605980|FG000|NOT COMPLETED|Primary Study||7
6674947|NCT02607735|7605981|FG001|NOT COMPLETED|Primary Study||0
6674948|NCT02607735|7605982|FG002|NOT COMPLETED|Primary Study||0
6674949|NCT02607735|7605980|FG000|STARTED|Deferred Treatment Substudy||0
6674950|NCT02607735|7605981|FG001|STARTED|Deferred Treatment Substudy||0
6674951|NCT02607735|7605982|FG002|STARTED|Deferred Treatment Substudy||147
6674952|NCT02607735|7605980|FG000|COMPLETED|Deferred Treatment Substudy||0
6674953|NCT02607735|7605981|FG001|COMPLETED|Deferred Treatment Substudy||0
6674954|NCT02607735|7605982|FG002|COMPLETED|Deferred Treatment Substudy||142
6674955|NCT02607735|7605980|FG000|NOT COMPLETED|Deferred Treatment Substudy||0
6674956|NCT02607735|7605981|FG001|NOT COMPLETED|Deferred Treatment Substudy||0
6674957|NCT02607735|7605982|FG002|NOT COMPLETED|Deferred Treatment Substudy||5
6674958|NCT02607800|7605992|FG000|STARTED|Overall Study||502
6674959|NCT02607800|7605993|FG001|STARTED|Overall Study||441
6674960|NCT02607800|7605992|FG000|COMPLETED|Overall Study||492
6674961|NCT02607800|7605993|FG001|COMPLETED|Overall Study||430
6674962|NCT02607800|7605992|FG000|NOT COMPLETED|Overall Study||10
6674963|NCT02607800|7605993|FG001|NOT COMPLETED|Overall Study||11
6674964|NCT02607865|7606004|FG000|STARTED|Overall Study||466
6674965|NCT02607865|7606005|FG001|STARTED|Overall Study||466
6674966|NCT02607865|7606006|FG002|STARTED|Overall Study||465
6674967|NCT02607865|7606007|FG003|STARTED|Overall Study||467
6674968|NCT02607865|7606004|FG000|Full Analysis Set (FAS)|Overall Study||466
6674969|NCT02607865|7606005|FG001|Full Analysis Set (FAS)|Overall Study||465
6674970|NCT02607865|7606006|FG002|Full Analysis Set (FAS)|Overall Study||465
6674971|NCT02607865|7606007|FG003|Full Analysis Set (FAS)|Overall Study||467
6674972|NCT02607865|7606004|FG000|Safety Analysis Set (SAS)|Overall Study||466
6674973|NCT02607865|7606005|FG001|Safety Analysis Set (SAS)|Overall Study||464
6674974|NCT02607865|7606006|FG002|Safety Analysis Set (SAS)|Overall Study||465
6674975|NCT02607865|7606007|FG003|Safety Analysis Set (SAS)|Overall Study||466
6674976|NCT02607865|7606004|FG000|COMPLETED|Overall Study||433
6674977|NCT02607865|7606005|FG001|COMPLETED|Overall Study||436
6674978|NCT02607865|7606006|FG002|COMPLETED|Overall Study||438
6674979|NCT02607865|7606007|FG003|COMPLETED|Overall Study||451
6674980|NCT02607865|7606004|FG000|NOT COMPLETED|Overall Study||33
6674981|NCT02607865|7606005|FG001|NOT COMPLETED|Overall Study||30
6674982|NCT02607865|7606006|FG002|NOT COMPLETED|Overall Study||27
6674983|NCT02607865|7606007|FG003|NOT COMPLETED|Overall Study||16
6674984|NCT02608099|7606019|FG000|STARTED|Overall Study||148
6674985|NCT02608099|7606020|FG001|STARTED|Overall Study||152
6674986|NCT02608099|7606019|FG000|Safety|Overall Study||149
6674987|NCT02608099|7606020|FG001|Safety|Overall Study||151
6674988|NCT02608099|7606019|FG000|COMPLETED|Overall Study||145
6674989|NCT02608099|7606020|FG001|COMPLETED|Overall Study||150
6674990|NCT02608099|7606019|FG000|NOT COMPLETED|Overall Study||3
6674991|NCT02608099|7606020|FG001|NOT COMPLETED|Overall Study||2
6674992|NCT02608177|7606028|FG000|STARTED|Overall Study||2
6674993|NCT02608177|7606029|FG001|STARTED|Overall Study||1
6674994|NCT02608177|7606028|FG000|COMPLETED|Overall Study||2
6674995|NCT02608177|7606029|FG001|COMPLETED|Overall Study||1
6674996|NCT02608177|7606028|FG000|NOT COMPLETED|Overall Study||0
6674997|NCT02608177|7606029|FG001|NOT COMPLETED|Overall Study||0
6674998|NCT02608229|7606039|FG000|STARTED|Overall Study||10
6674999|NCT02608229|7606040|FG001|STARTED|Overall Study||8
6675000|NCT02608229|7606039|FG000|600 mg BVD-523|Overall Study||10
6675001|NCT02608229|7606040|FG001|600 mg BVD-523|Overall Study||2
6675002|NCT02608229|7606039|FG000|450 mg BVD-523|Overall Study||0
6675003|NCT02608229|7606040|FG001|450 mg BVD-523|Overall Study||6
6675004|NCT02608229|7606039|FG000|COMPLETED|Overall Study||10
6675005|NCT02608229|7606040|FG001|COMPLETED|Overall Study||8
6675006|NCT02608229|7606039|FG000|NOT COMPLETED|Overall Study||0
6675007|NCT02608229|7606040|FG001|NOT COMPLETED|Overall Study||0
6675008|NCT02608450|7606050|FG000|STARTED|Overall Study||353
6675009|NCT02608450|7606051|FG001|STARTED|Overall Study||355
6675010|NCT02608450|7606050|FG000|COMPLETED|Overall Study||287
6675011|NCT02608450|7606051|FG001|COMPLETED|Overall Study||290
6675012|NCT02608450|7606050|FG000|NOT COMPLETED|Overall Study||66
6675013|NCT02608450|7606051|FG001|NOT COMPLETED|Overall Study||65
6675014|NCT02608463|7606060|FG000|STARTED|Overall Study||10
6675015|NCT02608463|7606061|FG001|STARTED|Overall Study||5
6675016|NCT02608463|7606062|FG002|STARTED|Overall Study||0
6675017|NCT02608463|7606063|FG003|STARTED|Overall Study|No study participants were enrolled in Part B.|0
6675018|NCT02608463|7606060|FG000|COMPLETED|Overall Study||10
6675019|NCT02608463|7606061|FG001|COMPLETED|Overall Study||5
6675020|NCT02608463|7606062|FG002|COMPLETED|Overall Study||0
6675021|NCT02608463|7606063|FG003|COMPLETED|Overall Study||0
6675022|NCT02608463|7606060|FG000|NOT COMPLETED|Overall Study||0
6675023|NCT02608463|7606061|FG001|NOT COMPLETED|Overall Study||0
6675024|NCT02608463|7606062|FG002|NOT COMPLETED|Overall Study||0
6675025|NCT02608463|7606063|FG003|NOT COMPLETED|Overall Study||0
6675026|NCT02608476|7606073|FG000|STARTED|Overall Study||369
6675027|NCT02608476|7606074|FG001|STARTED|Overall Study||363
6675028|NCT02608476|7606073|FG000|COMPLETED|Overall Study||302
6675029|NCT02608476|7606074|FG001|COMPLETED|Overall Study||282
6256259|NCT01970865|7155090|FG005|COMPLETED|Overall Study||0
6675030|NCT02608476|7606073|FG000|NOT COMPLETED|Overall Study||67
6675031|NCT02608476|7606074|FG001|NOT COMPLETED|Overall Study||81
6675032|NCT02608489|7606082|FG000|STARTED|Overall Study||43
6675033|NCT02608489|7606083|FG001|STARTED|Overall Study||43
6675034|NCT02608489|7606082|FG000|COMPLETED|Overall Study||30
6675035|NCT02608489|7606083|FG001|COMPLETED|Overall Study||33
6675036|NCT02608489|7606082|FG000|NOT COMPLETED|Overall Study||13
6675037|NCT02608489|7606083|FG001|NOT COMPLETED|Overall Study||10
6675038|NCT02608879|7606092|FG000|STARTED|Overall Study||10
6675039|NCT02608879|7606093|FG001|STARTED|Overall Study||6
6675040|NCT02608879|7606094|FG002|STARTED|Overall Study||3
6675041|NCT02608879|7606092|FG000|COMPLETED|Overall Study||9
6675042|NCT02608879|7606093|FG001|COMPLETED|Overall Study||6
6675043|NCT02608879|7606094|FG002|COMPLETED|Overall Study||0
6675044|NCT02608879|7606092|FG000|NOT COMPLETED|Overall Study||1
6675045|NCT02608879|7606093|FG001|NOT COMPLETED|Overall Study||0
6675046|NCT02608879|7606094|FG002|NOT COMPLETED|Overall Study||3
6675047|NCT02608892|7606104|FG000|STARTED|Overall Study||51
6675048|NCT02608892|7606105|FG001|STARTED|Overall Study||49
6675049|NCT02608892|7606104|FG000|COMPLETED|Overall Study||50
6675050|NCT02608892|7606105|FG001|COMPLETED|Overall Study||49
6675051|NCT02608892|7606104|FG000|NOT COMPLETED|Overall Study||1
6675052|NCT02608892|7606105|FG001|NOT COMPLETED|Overall Study||0
6675053|NCT02609100|7606114|FG000|STARTED|Overall Study||2
6675054|NCT02609100|7606115|FG001|STARTED|Overall Study||2
6675055|NCT02609100|7606114|FG000|COMPLETED|Overall Study||2
6675056|NCT02609100|7606115|FG001|COMPLETED|Overall Study||2
6675057|NCT02609100|7606114|FG000|NOT COMPLETED|Overall Study||0
6675058|NCT02609100|7606115|FG001|NOT COMPLETED|Overall Study||0
6675059|NCT02609113|7606125|FG000|STARTED|Overall Study||11
6675060|NCT02609113|7606126|FG001|STARTED|Overall Study||11
6675061|NCT02609113|7606125|FG000|COMPLETED|Overall Study||9
6675062|NCT02609113|7606126|FG001|COMPLETED|Overall Study||9
6675063|NCT02609113|7606125|FG000|NOT COMPLETED|Overall Study||2
6675064|NCT02609113|7606126|FG001|NOT COMPLETED|Overall Study||2
6675065|NCT02609178|7606132|FG000|STARTED|First Crown||0
6675066|NCT02609178|7606133|FG001|STARTED|First Crown||1
6675067|NCT02609178|7606134|FG002|STARTED|First Crown||6
6675068|NCT02609178|7606135|FG003|STARTED|First Crown||3
6675069|NCT02609178|7606136|FG004|STARTED|First Crown||0
6675070|NCT02609178|7606137|FG005|STARTED|First Crown||2
6675071|NCT02609178|7606132|FG000|COMPLETED|First Crown||0
6675072|NCT02609178|7606133|FG001|COMPLETED|First Crown||1
6675073|NCT02609178|7606134|FG002|COMPLETED|First Crown||5
6675074|NCT02609178|7606135|FG003|COMPLETED|First Crown||2
6675075|NCT02609178|7606136|FG004|COMPLETED|First Crown||0
6675076|NCT02609178|7606137|FG005|COMPLETED|First Crown||2
6675077|NCT02609178|7606132|FG000|NOT COMPLETED|First Crown||0
6675078|NCT02609178|7606133|FG001|NOT COMPLETED|First Crown||0
6675079|NCT02609178|7606134|FG002|NOT COMPLETED|First Crown||1
6675080|NCT02609178|7606135|FG003|NOT COMPLETED|First Crown||1
6675081|NCT02609178|7606136|FG004|NOT COMPLETED|First Crown||0
6675082|NCT02609178|7606137|FG005|NOT COMPLETED|First Crown||0
6675083|NCT02609178|7606132|FG000|STARTED|5-minute Washout Time||0
6675084|NCT02609178|7606133|FG001|STARTED|5-minute Washout Time||1
6675085|NCT02609178|7606134|FG002|STARTED|5-minute Washout Time||5
6675086|NCT02609178|7606135|FG003|STARTED|5-minute Washout Time||2
6675087|NCT02609178|7606136|FG004|STARTED|5-minute Washout Time||0
6675088|NCT02609178|7606137|FG005|STARTED|5-minute Washout Time||2
6675089|NCT02609178|7606132|FG000|COMPLETED|5-minute Washout Time||0
6675090|NCT02609178|7606133|FG001|COMPLETED|5-minute Washout Time||1
6675091|NCT02609178|7606134|FG002|COMPLETED|5-minute Washout Time||5
6675092|NCT02609178|7606135|FG003|COMPLETED|5-minute Washout Time||2
6675093|NCT02609178|7606136|FG004|COMPLETED|5-minute Washout Time||0
6675094|NCT02609178|7606137|FG005|COMPLETED|5-minute Washout Time||2
6675095|NCT02609178|7606132|FG000|NOT COMPLETED|5-minute Washout Time||0
6675096|NCT02609178|7606133|FG001|NOT COMPLETED|5-minute Washout Time||0
6675097|NCT02609178|7606134|FG002|NOT COMPLETED|5-minute Washout Time||0
6675098|NCT02609178|7606135|FG003|NOT COMPLETED|5-minute Washout Time||0
6675099|NCT02609178|7606136|FG004|NOT COMPLETED|5-minute Washout Time||0
6675100|NCT02609178|7606137|FG005|NOT COMPLETED|5-minute Washout Time||0
6675101|NCT02609178|7606132|FG000|STARTED|Second Crown||0
6675102|NCT02609178|7606133|FG001|STARTED|Second Crown||1
6675103|NCT02609178|7606134|FG002|STARTED|Second Crown||5
6675104|NCT02609178|7606135|FG003|STARTED|Second Crown||2
6675105|NCT02609178|7606136|FG004|STARTED|Second Crown||0
6675106|NCT02609178|7606137|FG005|STARTED|Second Crown||2
6675107|NCT02609178|7606132|FG000|COMPLETED|Second Crown||0
6675108|NCT02609178|7606133|FG001|COMPLETED|Second Crown||1
6675109|NCT02609178|7606134|FG002|COMPLETED|Second Crown||5
6675110|NCT02609178|7606135|FG003|COMPLETED|Second Crown||2
6675111|NCT02609178|7606136|FG004|COMPLETED|Second Crown||0
6675112|NCT02609178|7606137|FG005|COMPLETED|Second Crown||2
6675113|NCT02609178|7606132|FG000|NOT COMPLETED|Second Crown||0
6675114|NCT02609178|7606133|FG001|NOT COMPLETED|Second Crown||0
6675115|NCT02609178|7606134|FG002|NOT COMPLETED|Second Crown||0
6675116|NCT02609178|7606135|FG003|NOT COMPLETED|Second Crown||0
6675117|NCT02609178|7606136|FG004|NOT COMPLETED|Second Crown||0
6675118|NCT02609178|7606137|FG005|NOT COMPLETED|Second Crown||0
6675119|NCT02609178|7606132|FG000|STARTED|5-minute Washout Time||0
6675120|NCT02609178|7606133|FG001|STARTED|5-minute Washout Time||1
6675121|NCT02609178|7606134|FG002|STARTED|5-minute Washout Time||5
6675122|NCT02609178|7606135|FG003|STARTED|5-minute Washout Time||2
6675123|NCT02609178|7606136|FG004|STARTED|5-minute Washout Time||0
6675124|NCT02609178|7606137|FG005|STARTED|5-minute Washout Time||2
6675125|NCT02609178|7606132|FG000|COMPLETED|5-minute Washout Time||0
6675126|NCT02609178|7606133|FG001|COMPLETED|5-minute Washout Time||1
6675127|NCT02609178|7606134|FG002|COMPLETED|5-minute Washout Time||5
6675128|NCT02609178|7606135|FG003|COMPLETED|5-minute Washout Time||2
6675129|NCT02609178|7606136|FG004|COMPLETED|5-minute Washout Time||0
6675130|NCT02609178|7606137|FG005|COMPLETED|5-minute Washout Time||2
6675131|NCT02609178|7606132|FG000|NOT COMPLETED|5-minute Washout Time||0
6675132|NCT02609178|7606133|FG001|NOT COMPLETED|5-minute Washout Time||0
6675133|NCT02609178|7606134|FG002|NOT COMPLETED|5-minute Washout Time||0
6675134|NCT02609178|7606135|FG003|NOT COMPLETED|5-minute Washout Time||0
6675135|NCT02609178|7606136|FG004|NOT COMPLETED|5-minute Washout Time||0
6675136|NCT02609178|7606137|FG005|NOT COMPLETED|5-minute Washout Time||0
6675137|NCT02609178|7606132|FG000|STARTED|Third Crown||0
6675138|NCT02609178|7606133|FG001|STARTED|Third Crown||1
6675139|NCT02609178|7606134|FG002|STARTED|Third Crown||5
6675140|NCT02609178|7606135|FG003|STARTED|Third Crown||2
6675141|NCT02609178|7606136|FG004|STARTED|Third Crown||0
6675142|NCT02609178|7606137|FG005|STARTED|Third Crown||2
6675143|NCT02609178|7606132|FG000|COMPLETED|Third Crown||0
6675144|NCT02609178|7606133|FG001|COMPLETED|Third Crown||1
6675145|NCT02609178|7606134|FG002|COMPLETED|Third Crown||5
6675146|NCT02609178|7606135|FG003|COMPLETED|Third Crown||2
6675147|NCT02609178|7606136|FG004|COMPLETED|Third Crown||0
6675148|NCT02609178|7606137|FG005|COMPLETED|Third Crown||2
6675149|NCT02609178|7606132|FG000|NOT COMPLETED|Third Crown||0
6675150|NCT02609178|7606133|FG001|NOT COMPLETED|Third Crown||0
6675151|NCT02609178|7606134|FG002|NOT COMPLETED|Third Crown||0
6675152|NCT02609178|7606135|FG003|NOT COMPLETED|Third Crown||0
6675153|NCT02609178|7606136|FG004|NOT COMPLETED|Third Crown||0
6675154|NCT02609178|7606137|FG005|NOT COMPLETED|Third Crown||0
6675155|NCT02609204|7606143|FG000|STARTED|Overall Study||51
6675156|NCT02609204|7606143|FG000|COMPLETED|Overall Study||51
6675157|NCT02609204|7606143|FG000|NOT COMPLETED|Overall Study||0
6675158|NCT02609308|7606150|FG000|STARTED|Overall Study||10
6675159|NCT02609308|7606151|FG001|STARTED|Overall Study||11
6675160|NCT02609308|7606150|FG000|COMPLETED|Overall Study||10
6675161|NCT02609308|7606151|FG001|COMPLETED|Overall Study||11
6675162|NCT02609308|7606150|FG000|NOT COMPLETED|Overall Study||0
6675163|NCT02609308|7606151|FG001|NOT COMPLETED|Overall Study||0
6675164|NCT02609399|7606159|FG000|STARTED|Influenza Season 2015-2016||27
6675165|NCT02609399|7606160|FG001|STARTED|Influenza Season 2015-2016||31
6675166|NCT02609399|7606159|FG000|COMPLETED|Influenza Season 2015-2016||24
6675167|NCT02609399|7606160|FG001|COMPLETED|Influenza Season 2015-2016||29
6675168|NCT02609399|7606159|FG000|NOT COMPLETED|Influenza Season 2015-2016||3
6675169|NCT02609399|7606160|FG001|NOT COMPLETED|Influenza Season 2015-2016||2
6675170|NCT02609399|7606159|FG000|STARTED|Influenza Season 2016-2017||58
6675171|NCT02609399|7606160|FG001|STARTED|Influenza Season 2016-2017||64
6675172|NCT02609399|7606159|FG000|COMPLETED|Influenza Season 2016-2017||49
6675173|NCT02609399|7606160|FG001|COMPLETED|Influenza Season 2016-2017||59
6675174|NCT02609399|7606159|FG000|NOT COMPLETED|Influenza Season 2016-2017||9
6675175|NCT02609399|7606160|FG001|NOT COMPLETED|Influenza Season 2016-2017||5
6675176|NCT02609607|7606170|FG000|STARTED|Overall Study||6
6675177|NCT02609607|7606171|FG001|STARTED|Overall Study||5
6675178|NCT02609607|7606170|FG000|COMPLETED|Overall Study||6
6675179|NCT02609607|7606171|FG001|COMPLETED|Overall Study||4
6675180|NCT02609607|7606170|FG000|NOT COMPLETED|Overall Study||0
6675181|NCT02609607|7606171|FG001|NOT COMPLETED|Overall Study||1
6675182|NCT02609633|7606179|FG000|STARTED|Overall Study||42
6675183|NCT02609633|7606180|FG001|STARTED|Overall Study||56
6675184|NCT02609633|7606179|FG000|Full Analysis Set (FAS)|Overall Study||32
6675185|NCT02609633|7606180|FG001|Full Analysis Set (FAS)|Overall Study||46
6675186|NCT02609633|7606179|FG000|COMPLETED|Overall Study||37
6675187|NCT02609633|7606180|FG001|COMPLETED|Overall Study||54
6675188|NCT02609633|7606179|FG000|NOT COMPLETED|Overall Study||5
6675189|NCT02609633|7606180|FG001|NOT COMPLETED|Overall Study||2
6675190|NCT02609659|7606187|FG000|STARTED|Overall Study||105
6675191|NCT02609659|7606187|FG000|COMPLETED|Overall Study||97
6675192|NCT02609659|7606187|FG000|NOT COMPLETED|Overall Study||8
6675193|NCT02609672|7606193|FG000|STARTED|Overall Study||12
6675194|NCT02609672|7606194|FG001|STARTED|Overall Study||12
6675195|NCT02609672|7606193|FG000|COMPLETED|Overall Study||9
6675196|NCT02609672|7606194|FG001|COMPLETED|Overall Study||11
6675197|NCT02609672|7606193|FG000|NOT COMPLETED|Overall Study||3
6675198|NCT02609672|7606194|FG001|NOT COMPLETED|Overall Study||1
6675199|NCT02609841|7606202|FG000|STARTED|Overall Study||240
6675200|NCT02609841|7606202|FG000|COMPLETED|Overall Study||212
6675201|NCT02609841|7606202|FG000|NOT COMPLETED|Overall Study||28
6675202|NCT02609984|7606210|FG000|STARTED|Overall Study||45
6675203|NCT02609984|7606211|FG001|STARTED|Overall Study||44
6675204|NCT02609984|7606210|FG000|Treated|Overall Study||45
6675205|NCT02609984|7606211|FG001|Treated|Overall Study||43
6675206|NCT02609984|7606210|FG000|COMPLETED|Overall Study||1
6675207|NCT02609984|7606211|FG001|COMPLETED|Overall Study||5
6675208|NCT02609984|7606210|FG000|NOT COMPLETED|Overall Study||44
6675209|NCT02609984|7606211|FG001|NOT COMPLETED|Overall Study||39
6675210|NCT02610140|7606219|FG000|STARTED|Randomization and Treatment Period||166
6675211|NCT02610140|7606220|FG001|STARTED|Randomization and Treatment Period||82
6675212|NCT02610140|7606219|FG000|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|163
6675213|NCT02610140|7606220|FG001|Participants Received Treatment|Randomization and Treatment Period|Safety analysis set|72
6675214|NCT02610140|7606219|FG000|COMPLETED|Randomization and Treatment Period||0
6675215|NCT02610140|7606220|FG001|COMPLETED|Randomization and Treatment Period||0
6675216|NCT02610140|7606219|FG000|NOT COMPLETED|Randomization and Treatment Period||166
6675217|NCT02610140|7606220|FG001|NOT COMPLETED|Randomization and Treatment Period||82
6675218|NCT02610140|7606219|FG000|STARTED|Safety Follow-up||102
6675219|NCT02610140|7606220|FG001|STARTED|Safety Follow-up||45
6675220|NCT02610140|7606219|FG000|COMPLETED|Safety Follow-up||57
6675221|NCT02610140|7606220|FG001|COMPLETED|Safety Follow-up||21
6675222|NCT02610140|7606219|FG000|NOT COMPLETED|Safety Follow-up||45
6675223|NCT02610140|7606220|FG001|NOT COMPLETED|Safety Follow-up||24
6675224|NCT02610140|7606219|FG000|STARTED|Active Follow-up||48
6675225|NCT02610140|7606220|FG001|STARTED|Active Follow-up||26
6675226|NCT02610140|7606219|FG000|COMPLETED|Active Follow-up||0
6675227|NCT02610140|7606220|FG001|COMPLETED|Active Follow-up||0
6675228|NCT02610140|7606219|FG000|NOT COMPLETED|Active Follow-up||48
6675229|NCT02610140|7606220|FG001|NOT COMPLETED|Active Follow-up||26
6675230|NCT02610140|7606219|FG000|STARTED|Long-term Follow-up||123
6675231|NCT02610140|7606220|FG001|STARTED|Long-term Follow-up||66
6675232|NCT02610140|7606219|FG000|COMPLETED|Long-term Follow-up||0
6675233|NCT02610140|7606220|FG001|COMPLETED|Long-term Follow-up||0
6675234|NCT02610140|7606219|FG000|NOT COMPLETED|Long-term Follow-up||123
6675235|NCT02610140|7606220|FG001|NOT COMPLETED|Long-term Follow-up||66
6675236|NCT02610192|7606226|FG000|STARTED|Overall Study|52 subjects had signed consent form, but 50 subjects have been treated. 2 subjects became SF.|50
6675237|NCT02610192|7606226|FG000|COMPLETED|Overall Study||41
6675238|NCT02610192|7606226|FG000|NOT COMPLETED|Overall Study||9
6675239|NCT02610231|7606230|FG000|STARTED|Overall Study||239
6675240|NCT02610231|7606230|FG000|COMPLETED|Overall Study||179
6675241|NCT02610231|7606230|FG000|NOT COMPLETED|Overall Study||60
6675242|NCT02610634|7606239|FG000|STARTED|Overall Study||60
6675243|NCT02610634|7606240|FG001|STARTED|Overall Study||40
6675244|NCT02610634|7606239|FG000|COMPLETED|Overall Study||60
6675245|NCT02610634|7606240|FG001|COMPLETED|Overall Study||40
6675246|NCT02610634|7606239|FG000|NOT COMPLETED|Overall Study||0
6675247|NCT02610634|7606240|FG001|NOT COMPLETED|Overall Study||0
6675248|NCT02610725|7606246|FG000|STARTED|Overall Study||281
6675249|NCT02610725|7606246|FG000|COMPLETED|Overall Study||75
6675250|NCT02610725|7606246|FG000|NOT COMPLETED|Overall Study||206
6675251|NCT02610777|7606252|FG000|STARTED|Overall Study||62
6675252|NCT02610777|7606253|FG001|STARTED|Overall Study||58
6675253|NCT02610777|7606252|FG000|COMPLETED|Overall Study||41
6675254|NCT02610777|7606253|FG001|COMPLETED|Overall Study||36
6675255|NCT02610777|7606252|FG000|NOT COMPLETED|Overall Study||21
6675256|NCT02610777|7606253|FG001|NOT COMPLETED|Overall Study||22
6675257|NCT02610816|7606261|FG000|STARTED|Phase 1||38
6675258|NCT02610816|7606262|FG001|STARTED|Phase 1||25
6675259|NCT02610816|7606263|FG002|STARTED|Phase 1||0
6675260|NCT02610816|7606264|FG003|STARTED|Phase 1||0
6675261|NCT02610816|7606261|FG000|COMPLETED|Phase 1||34
6675262|NCT02610816|7606262|FG001|COMPLETED|Phase 1||17
6675263|NCT02610816|7606263|FG002|COMPLETED|Phase 1||0
6675264|NCT02610816|7606264|FG003|COMPLETED|Phase 1||0
6675265|NCT02610816|7606261|FG000|NOT COMPLETED|Phase 1||4
6675266|NCT02610816|7606262|FG001|NOT COMPLETED|Phase 1||8
6675267|NCT02610816|7606263|FG002|NOT COMPLETED|Phase 1||0
6675268|NCT02610816|7606264|FG003|NOT COMPLETED|Phase 1||0
6675269|NCT02610816|7606261|FG000|STARTED|Phase 2||0
6675270|NCT02610816|7606262|FG001|STARTED|Phase 2||0
6675271|NCT02610816|7606263|FG002|STARTED|Phase 2||19
6675272|NCT02610816|7606264|FG003|STARTED|Phase 2||10
6675273|NCT02610816|7606261|FG000|COMPLETED|Phase 2||0
6675274|NCT02610816|7606262|FG001|COMPLETED|Phase 2||0
6675275|NCT02610816|7606263|FG002|COMPLETED|Phase 2||8
6675276|NCT02610816|7606264|FG003|COMPLETED|Phase 2||4
6675277|NCT02610816|7606261|FG000|NOT COMPLETED|Phase 2||0
6675278|NCT02610816|7606262|FG001|NOT COMPLETED|Phase 2||0
6675279|NCT02610816|7606263|FG002|NOT COMPLETED|Phase 2||11
6675280|NCT02610816|7606264|FG003|NOT COMPLETED|Phase 2||6
6675281|NCT02610842|7606274|FG000|STARTED|Overall Study||27
6675282|NCT02610842|7606274|FG000|COMPLETED|Overall Study||22
6675283|NCT02610842|7606274|FG000|NOT COMPLETED|Overall Study||5
6675284|NCT02610868|7606280|FG000|STARTED|MYOBLOC: Treatment Session 1||187
6675285|NCT02610868|7606280|FG000|COMPLETED|MYOBLOC: Treatment Session 1||180
6675286|NCT02610868|7606280|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 1||7
6675287|NCT02610868|7606280|FG000|STARTED|MYOBLOC: Treatment Session 2||177
6675288|NCT02610868|7606280|FG000|COMPLETED|MYOBLOC: Treatment Session 2||165
6675289|NCT02610868|7606280|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 2||12
6675290|NCT02610868|7606280|FG000|STARTED|MYOBLOC: Treatment Session 3||50
6675291|NCT02610868|7606280|FG000|COMPLETED|MYOBLOC: Treatment Session 3||43
6675292|NCT02610868|7606280|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 3||7
6675293|NCT02610868|7606280|FG000|STARTED|MYOBLOC: Treatment Session 4||24
6675294|NCT02610868|7606280|FG000|COMPLETED|MYOBLOC: Treatment Session 4||22
6675295|NCT02610868|7606280|FG000|NOT COMPLETED|MYOBLOC: Treatment Session 4||2
6675296|NCT02610972|7606302|FG000|STARTED|Overall Study||100
6675297|NCT02610972|7606303|FG001|STARTED|Overall Study||50
6675298|NCT02610972|7606302|FG000|COMPLETED|Overall Study||100
6675299|NCT02610972|7606303|FG001|COMPLETED|Overall Study||50
6675300|NCT02610972|7606302|FG000|NOT COMPLETED|Overall Study||0
6675301|NCT02610972|7606303|FG001|NOT COMPLETED|Overall Study||0
6675302|NCT02611154|7606309|FG000|STARTED|Overall Study||5
6675303|NCT02611154|7606309|FG000|COMPLETED|Overall Study||5
6675304|NCT02611154|7606309|FG000|NOT COMPLETED|Overall Study||0
6675305|NCT02611362|7606330|FG000|STARTED|Overall Study||41
6675306|NCT02611362|7606331|FG001|STARTED|Overall Study||41
6675307|NCT02611362|7606330|FG000|Immediate Posttest (3 Months)|Overall Study||33
6675308|NCT02611362|7606331|FG001|Immediate Posttest (3 Months)|Overall Study||34
6675309|NCT02611362|7606330|FG000|6-month Follow-up|Overall Study||32
6675310|NCT02611362|7606331|FG001|6-month Follow-up|Overall Study||35
6675311|NCT02611362|7606330|FG000|COMPLETED|Overall Study||32
6675312|NCT02611362|7606331|FG001|COMPLETED|Overall Study||35
6675313|NCT02611362|7606330|FG000|NOT COMPLETED|Overall Study||9
6675314|NCT02611362|7606331|FG001|NOT COMPLETED|Overall Study||6
6675315|NCT02611479|7606338|FG000|STARTED|Baseline Enrollment||184
6675316|NCT02611479|7606338|FG000|COMPLETED|Baseline Enrollment||171
6675317|NCT02611479|7606338|FG000|NOT COMPLETED|Baseline Enrollment||13
6675318|NCT02611479|7606338|FG000|STARTED|Post-Surgery Follow-up at 30-90 Days||171
6675319|NCT02611479|7606338|FG000|COMPLETED|Post-Surgery Follow-up at 30-90 Days||169
6675320|NCT02611479|7606338|FG000|NOT COMPLETED|Post-Surgery Follow-up at 30-90 Days||2
6675321|NCT02611479|7606338|FG000|STARTED|Post-Surgery Follow-up at 1-Year||169
6675322|NCT02611479|7606338|FG000|COMPLETED|Post-Surgery Follow-up at 1-Year||151
6675323|NCT02611479|7606338|FG000|NOT COMPLETED|Post-Surgery Follow-up at 1-Year||18
6675324|NCT02611479|7606338|FG000|STARTED|Data Cleaning||151
6675325|NCT02611479|7606338|FG000|COMPLETED|Data Cleaning||149
6675326|NCT02611479|7606338|FG000|NOT COMPLETED|Data Cleaning||2
6675327|NCT02611752|7606344|FG000|STARTED|Overall Study||22
6675328|NCT02611752|7606345|FG001|STARTED|Overall Study||25
6675329|NCT02611752|7606344|FG000|Day 1-3 Hydromorphone Challenge Injs|Overall Study||22
6675330|NCT02611752|7606345|FG001|Day 1-3 Hydromorphone Challenge Injs|Overall Study||25
6675331|NCT02611752|7606344|FG000|Day 4-6 Hydromorphone Challenge Injs|Overall Study||22
6675332|NCT02611752|7606345|FG001|Day 4-6 Hydromorphone Challenge Injs|Overall Study||24
6675333|NCT02611752|7606344|FG000|Day 8-10 Hydromorphone Challenge Injs|Overall Study||22
6675334|NCT02611752|7606345|FG001|Day 8-10 Hydromorphone Challenge Injs|Overall Study||24
6675335|NCT02611752|7606344|FG000|Day11-13 Hydromorphone Challenge Injs|Overall Study||22
6675336|NCT02611752|7606345|FG001|Day11-13 Hydromorphone Challenge Injs|Overall Study||24
6675337|NCT02611752|7606344|FG000|COMPLETED|Overall Study||22
6675338|NCT02611752|7606345|FG001|COMPLETED|Overall Study||24
6675339|NCT02611752|7606344|FG000|NOT COMPLETED|Overall Study||0
6675340|NCT02611752|7606345|FG001|NOT COMPLETED|Overall Study||1
6675341|NCT02611765|7606366|FG000|STARTED|Overall Study||29
6675342|NCT02611765|7606367|FG001|STARTED|Overall Study||35
6675343|NCT02611765|7606366|FG000|COMPLETED|Overall Study||27
6675344|NCT02611765|7606367|FG001|COMPLETED|Overall Study||29
6675345|NCT02611765|7606366|FG000|NOT COMPLETED|Overall Study||2
6675346|NCT02611765|7606367|FG001|NOT COMPLETED|Overall Study||6
6675347|NCT02611778|7606375|FG000|STARTED|Overall Study||238
6675348|NCT02611778|7606376|FG001|STARTED|Overall Study||239
6675349|NCT02611778|7606375|FG000|COMPLETED|Overall Study||226
6675350|NCT02611778|7606376|FG001|COMPLETED|Overall Study||226
6675351|NCT02611778|7606375|FG000|NOT COMPLETED|Overall Study||12
6675352|NCT02611778|7606376|FG001|NOT COMPLETED|Overall Study||13
6675353|NCT02611817|7606386|FG000|STARTED|Open-label Induction Phase||644
6675354|NCT02611817|7606387|FG001|STARTED|Open-label Induction Phase||0
6675355|NCT02611817|7606388|FG002|STARTED|Open-label Induction Phase||0
6675356|NCT02611817|7606386|FG000|COMPLETED|Open-label Induction Phase||594
6675357|NCT02611817|7606387|FG001|COMPLETED|Open-label Induction Phase||0
6675358|NCT02611817|7606388|FG002|COMPLETED|Open-label Induction Phase||0
6675359|NCT02611817|7606386|FG000|NOT COMPLETED|Open-label Induction Phase||50
6675360|NCT02611817|7606387|FG001|NOT COMPLETED|Open-label Induction Phase||0
6675361|NCT02611817|7606388|FG002|NOT COMPLETED|Open-label Induction Phase||0
6675362|NCT02611817|7606386|FG000|STARTED|Double-blind Maintenance Phase||0
6675363|NCT02611817|7606387|FG001|STARTED|Double-blind Maintenance Phase||135
6675364|NCT02611817|7606388|FG002|STARTED|Double-blind Maintenance Phase||275
6675365|NCT02611817|7606386|FG000|COMPLETED|Double-blind Maintenance Phase||0
6675366|NCT02611817|7606387|FG001|COMPLETED|Double-blind Maintenance Phase||73
6675367|NCT02611817|7606388|FG002|COMPLETED|Double-blind Maintenance Phase||168
6675368|NCT02611817|7606386|FG000|NOT COMPLETED|Double-blind Maintenance Phase||0
6675369|NCT02611817|7606387|FG001|NOT COMPLETED|Double-blind Maintenance Phase||62
6675370|NCT02611817|7606388|FG002|NOT COMPLETED|Double-blind Maintenance Phase||107
6675371|NCT02611830|7606399|FG000|STARTED|OL Induction Phase||383
6675372|NCT02611830|7606400|FG001|STARTED|OL Induction Phase||0
6675373|NCT02611830|7606401|FG002|STARTED|OL Induction Phase||0
6675374|NCT02611830|7606402|FG003|STARTED|OL Induction Phase||0
6675375|NCT02611830|7606399|FG000|COMPLETED|OL Induction Phase||353
6675376|NCT02611830|7606400|FG001|COMPLETED|OL Induction Phase||0
6675377|NCT02611830|7606401|FG002|COMPLETED|OL Induction Phase||0
6675378|NCT02611830|7606402|FG003|COMPLETED|OL Induction Phase||0
6675379|NCT02611830|7606399|FG000|NOT COMPLETED|OL Induction Phase||30
6675380|NCT02611830|7606400|FG001|NOT COMPLETED|OL Induction Phase||0
6675381|NCT02611830|7606401|FG002|NOT COMPLETED|OL Induction Phase||0
6675382|NCT02611830|7606402|FG003|NOT COMPLETED|OL Induction Phase||0
6675383|NCT02611830|7606399|FG000|STARTED|Maintenance Phase||0
6675384|NCT02611830|7606400|FG001|STARTED|Maintenance Phase||56
6675385|NCT02611830|7606401|FG002|STARTED|Maintenance Phase||106
6675386|NCT02611830|7606402|FG003|STARTED|Maintenance Phase||54
6675387|NCT02611830|7606399|FG000|COMPLETED|Maintenance Phase||0
6675388|NCT02611830|7606400|FG001|COMPLETED|Maintenance Phase||20
6675389|NCT02611830|7606401|FG002|COMPLETED|Maintenance Phase||75
6675390|NCT02611830|7606402|FG003|COMPLETED|Maintenance Phase||39
6675391|NCT02611830|7606399|FG000|NOT COMPLETED|Maintenance Phase||0
6675392|NCT02611830|7606400|FG001|NOT COMPLETED|Maintenance Phase||36
6675393|NCT02611830|7606401|FG002|NOT COMPLETED|Maintenance Phase||31
6675394|NCT02611830|7606402|FG003|NOT COMPLETED|Maintenance Phase||15
6675395|NCT02611882|7606414|FG000|STARTED|Overall Study||75
6675396|NCT02611882|7606415|FG001|STARTED|Overall Study||150
6675397|NCT02611882|7606416|FG002|STARTED|Overall Study||0
6675398|NCT02611882|7606414|FG000|Completed Surgery Per Protocol|Overall Study||42
6675399|NCT02611882|7606415|FG001|Completed Surgery Per Protocol|Overall Study||0
6675400|NCT02611882|7606416|FG002|Completed Surgery Per Protocol|Overall Study||0
6675401|NCT02611882|7606414|FG000|COMPLETED|Overall Study||42
6675402|NCT02611882|7606415|FG001|COMPLETED|Overall Study||150
6675403|NCT02611882|7606416|FG002|COMPLETED|Overall Study||0
6675404|NCT02611882|7606414|FG000|NOT COMPLETED|Overall Study||33
6675405|NCT02611882|7606415|FG001|NOT COMPLETED|Overall Study||0
6675406|NCT02611882|7606416|FG002|NOT COMPLETED|Overall Study||0
6675407|NCT02612064|7606425|FG000|STARTED|Overall Study||115
6675408|NCT02612064|7606426|FG001|STARTED|Overall Study||115
6675409|NCT02612064|7606425|FG000|COMPLETED|Overall Study||114
6675410|NCT02612064|7606426|FG001|COMPLETED|Overall Study||112
6675411|NCT02612064|7606425|FG000|NOT COMPLETED|Overall Study||1
6675412|NCT02612064|7606426|FG001|NOT COMPLETED|Overall Study||3
6675413|NCT02612077|7606432|FG000|STARTED|Overall Study||765
6675414|NCT02612077|7606432|FG000|Did Not Receive Study Product|Overall Study||5
6675415|NCT02612077|7606432|FG000|Safety Analysis Set|Overall Study||760
6675416|NCT02612077|7606432|FG000|Efficacy Analysis Set|Overall Study||737
6675417|NCT02612077|7606432|FG000|COMPLETED|Overall Study||299
6675418|NCT02612077|7606432|FG000|NOT COMPLETED|Overall Study||466
6675419|NCT02612155|7606441|FG000|STARTED|Overall Study||17
6675420|NCT02612155|7606442|FG001|STARTED|Overall Study||18
6675421|NCT02612155|7606441|FG000|COMPLETED|Overall Study||14
6675422|NCT02612155|7606442|FG001|COMPLETED|Overall Study||15
6675423|NCT02612155|7606441|FG000|NOT COMPLETED|Overall Study||3
6675424|NCT02612155|7606442|FG001|NOT COMPLETED|Overall Study||3
6675425|NCT02612428|7606450|FG000|STARTED|VTL-308||78
6675426|NCT02612428|7606451|FG001|STARTED|VTL-308||73
6675427|NCT02612428|7606450|FG000|COMPLETED|VTL-308||64
6675428|NCT02612428|7606451|FG001|COMPLETED|VTL-308||56
6675429|NCT02612428|7606450|FG000|NOT COMPLETED|VTL-308||14
6675430|NCT02612428|7606451|FG001|NOT COMPLETED|VTL-308||17
6675431|NCT02612428|7606450|FG000|STARTED|VTL-308E||64
6675432|NCT02612428|7606451|FG001|STARTED|VTL-308E||56
6675433|NCT02612428|7606450|FG000|COMPLETED|VTL-308E||53
6675434|NCT02612428|7606451|FG001|COMPLETED|VTL-308E||49
6675435|NCT02612428|7606450|FG000|NOT COMPLETED|VTL-308E||11
6675436|NCT02612428|7606451|FG001|NOT COMPLETED|VTL-308E||7
6738211|NCT03279731|7667506|FG000|NOT COMPLETED|Overall Study||6
6738212|NCT03279731|7667507|FG001|NOT COMPLETED|Overall Study||3
6738213|NCT03280108|7667517|FG000|STARTED|Overall Study||129
6738214|NCT03280108|7667518|FG001|STARTED|Overall Study||114
6738215|NCT03280108|7667517|FG000|COMPLETED|Overall Study||127
6738216|NCT03280108|7667518|FG001|COMPLETED|Overall Study||114
6738217|NCT03280108|7667517|FG000|NOT COMPLETED|Overall Study||2
6738218|NCT03280108|7667518|FG001|NOT COMPLETED|Overall Study||0
6738219|NCT03280121|7667529|FG000|STARTED|Overall Study||14
6738220|NCT03280121|7667529|FG000|COMPLETED|Overall Study||8
6738221|NCT03280121|7667529|FG000|NOT COMPLETED|Overall Study||6
6738222|NCT03280264|7667533|FG000|STARTED|Overall Study||18
6738223|NCT03280264|7667533|FG000|COMPLETED|Overall Study||15
6738224|NCT03280264|7667533|FG000|NOT COMPLETED|Overall Study||3
6738225|NCT03280381|7667540|FG000|STARTED|Overall Study||101
6738226|NCT03280381|7667541|FG001|STARTED|Overall Study||99
6738227|NCT03280381|7667540|FG000|COMPLETED|Overall Study||101
6738228|NCT03280381|7667541|FG001|COMPLETED|Overall Study||97
6738229|NCT03280381|7667540|FG000|NOT COMPLETED|Overall Study||0
6738230|NCT03280381|7667541|FG001|NOT COMPLETED|Overall Study||2
6738231|NCT03280537|7667550|FG000|STARTED|Overall Study||65
6738232|NCT03280537|7667551|FG001|STARTED|Overall Study||62
6738233|NCT03280537|7667550|FG000|COMPLETED|Overall Study||63
6738234|NCT03280537|7667551|FG001|COMPLETED|Overall Study||58
6738235|NCT03280537|7667550|FG000|NOT COMPLETED|Overall Study||2
6738236|NCT03280537|7667551|FG001|NOT COMPLETED|Overall Study||4
6738237|NCT03280550|7667559|FG000|STARTED|Overall Study||66
6738238|NCT03280550|7667560|FG001|STARTED|Overall Study||72
6738239|NCT03280550|7667559|FG000|COMPLETED|Overall Study||64
6738240|NCT03280550|7667560|FG001|COMPLETED|Overall Study||69
6738241|NCT03280550|7667559|FG000|NOT COMPLETED|Overall Study||2
6738242|NCT03280550|7667560|FG001|NOT COMPLETED|Overall Study||3
6675437|NCT02612610|7606461|FG000|STARTED|Overall Study||63
6675438|NCT02612610|7606462|FG001|STARTED|Overall Study||64
6675439|NCT02612610|7606463|FG002|STARTED|Overall Study||63
6675440|NCT02612610|7606464|FG003|STARTED|Overall Study||63
6675441|NCT02612610|7606461|FG000|Treated|Overall Study||63
6675442|NCT02612610|7606462|FG001|Treated|Overall Study||63
6675443|NCT02612610|7606463|FG002|Treated|Overall Study||63
6675444|NCT02612610|7606464|FG003|Treated|Overall Study||63
6675445|NCT02612610|7606461|FG000|COMPLETED|Overall Study||58
6675446|NCT02612610|7606462|FG001|COMPLETED|Overall Study||56
6675447|NCT02612610|7606463|FG002|COMPLETED|Overall Study||58
6675448|NCT02612610|7606464|FG003|COMPLETED|Overall Study||50
6675449|NCT02612610|7606461|FG000|NOT COMPLETED|Overall Study||5
6675450|NCT02612610|7606462|FG001|NOT COMPLETED|Overall Study||8
6675451|NCT02612610|7606463|FG002|NOT COMPLETED|Overall Study||5
6675452|NCT02612610|7606464|FG003|NOT COMPLETED|Overall Study||13
6675453|NCT02612623|7606478|FG000|STARTED|Overall Study||8
6675454|NCT02612623|7606479|FG001|STARTED|Overall Study||6
6675455|NCT02612623|7606480|FG002|STARTED|Overall Study||6
6675456|NCT02612623|7606481|FG003|STARTED|Overall Study||4
6675457|NCT02612623|7606478|FG000|Treated|Overall Study||8
6675458|NCT02612623|7606479|FG001|Treated|Overall Study||5
6675459|NCT02612623|7606480|FG002|Treated|Overall Study||6
6675460|NCT02612623|7606481|FG003|Treated|Overall Study||4
6675461|NCT02612623|7606478|FG000|COMPLETED|Overall Study||7
6675462|NCT02612623|7606479|FG001|COMPLETED|Overall Study||5
6675463|NCT02612623|7606480|FG002|COMPLETED|Overall Study||5
6675464|NCT02612623|7606481|FG003|COMPLETED|Overall Study||4
6675465|NCT02612623|7606478|FG000|NOT COMPLETED|Overall Study||1
6675466|NCT02612623|7606479|FG001|NOT COMPLETED|Overall Study||1
6675467|NCT02612623|7606480|FG002|NOT COMPLETED|Overall Study||1
6675468|NCT02612623|7606481|FG003|NOT COMPLETED|Overall Study||0
6675469|NCT02612688|7606493|FG000|STARTED|Overall Study||33035
6675470|NCT02612688|7606494|FG001|STARTED|Overall Study||70013
6675471|NCT02612688|7606493|FG000|COMPLETED|Overall Study||33035
6675472|NCT02612688|7606494|FG001|COMPLETED|Overall Study||70013
6675473|NCT02612688|7606493|FG000|NOT COMPLETED|Overall Study||0
6675474|NCT02612688|7606494|FG001|NOT COMPLETED|Overall Study||0
6675475|NCT02612727|7606504|FG000|STARTED|Overall Study||87
6675476|NCT02612727|7606505|FG001|STARTED|Overall Study||87
6675477|NCT02612727|7606504|FG000|COMPLETED|Overall Study||82
6675478|NCT02612727|7606505|FG001|COMPLETED|Overall Study||83
6675479|NCT02612727|7606504|FG000|NOT COMPLETED|Overall Study||5
6675480|NCT02612727|7606505|FG001|NOT COMPLETED|Overall Study||4
6675481|NCT02612779|7606513|FG000|STARTED|Overall Study||68
6675482|NCT02612779|7606514|FG001|STARTED|Overall Study||6
6675483|NCT02612779|7606513|FG000|COMPLETED|Overall Study||0
6675484|NCT02612779|7606514|FG001|COMPLETED|Overall Study||0
6675485|NCT02612779|7606513|FG000|NOT COMPLETED|Overall Study||68
6675486|NCT02612779|7606514|FG001|NOT COMPLETED|Overall Study||6
6675487|NCT02612857|7606524|FG000|STARTED|Overall Study||11
6675488|NCT02612857|7606525|FG001|STARTED|Overall Study||9
6675489|NCT02612857|7606526|FG002|STARTED|Overall Study||10
6675490|NCT02612857|7606524|FG000|COMPLETED|Overall Study||8
6675491|NCT02612857|7606525|FG001|COMPLETED|Overall Study||5
6675492|NCT02612857|7606526|FG002|COMPLETED|Overall Study||6
6675493|NCT02612857|7606524|FG000|NOT COMPLETED|Overall Study||3
6675494|NCT02612857|7606525|FG001|NOT COMPLETED|Overall Study||4
6675495|NCT02612857|7606526|FG002|NOT COMPLETED|Overall Study||4
6675496|NCT02612909|7606539|FG000|STARTED|Phase 2||100
6675497|NCT02612909|7606540|FG001|STARTED|Phase 2||100
6675498|NCT02612909|7606541|FG002|STARTED|Phase 2||100
6675499|NCT02612909|7606542|FG003|STARTED|Phase 2||0
6675500|NCT02612909|7606543|FG004|STARTED|Phase 2||0
6675501|NCT02612909|7606539|FG000|Received Injection 1|Phase 2||100
6675502|NCT02612909|7606540|FG001|Received Injection 1|Phase 2||100
6675503|NCT02612909|7606541|FG002|Received Injection 1|Phase 2||100
6675504|NCT02612909|7606542|FG003|Received Injection 1|Phase 2||0
6675505|NCT02612909|7606543|FG004|Received Injection 1|Phase 2||0
6675506|NCT02612909|7606539|FG000|Received Injection 2|Phase 2||98
6675507|NCT02612909|7606540|FG001|Received Injection 2|Phase 2||95
6675508|NCT02612909|7606541|FG002|Received Injection 2|Phase 2||99
6675509|NCT02612909|7606542|FG003|Received Injection 2|Phase 2||0
6675510|NCT02612909|7606543|FG004|Received Injection 2|Phase 2||0
6675511|NCT02612909|7606539|FG000|Completed Day 29 Clinic Visit|Phase 2||98
6675512|NCT02612909|7606540|FG001|Completed Day 29 Clinic Visit|Phase 2||95
6675513|NCT02612909|7606541|FG002|Completed Day 29 Clinic Visit|Phase 2||99
6675514|NCT02612909|7606542|FG003|Completed Day 29 Clinic Visit|Phase 2||0
6675515|NCT02612909|7606543|FG004|Completed Day 29 Clinic Visit|Phase 2||0
6675516|NCT02612909|7606539|FG000|Completed Day 43 Clinic Visit|Phase 2||97
6675517|NCT02612909|7606540|FG001|Completed Day 43 Clinic Visit|Phase 2||94
6675518|NCT02612909|7606541|FG002|Completed Day 43 Clinic Visit|Phase 2||99
6675519|NCT02612909|7606542|FG003|Completed Day 43 Clinic Visit|Phase 2||0
6675520|NCT02612909|7606543|FG004|Completed Day 43 Clinic Visit|Phase 2||0
6675521|NCT02612909|7606539|FG000|COMPLETED|Phase 2||98
6675522|NCT02612909|7606540|FG001|COMPLETED|Phase 2||95
6675523|NCT02612909|7606541|FG002|COMPLETED|Phase 2||99
6675524|NCT02612909|7606542|FG003|COMPLETED|Phase 2||0
6675525|NCT02612909|7606543|FG004|COMPLETED|Phase 2||0
6675526|NCT02612909|7606539|FG000|NOT COMPLETED|Phase 2||2
6675527|NCT02612909|7606540|FG001|NOT COMPLETED|Phase 2||5
6675528|NCT02612909|7606541|FG002|NOT COMPLETED|Phase 2||1
6675529|NCT02612909|7606542|FG003|NOT COMPLETED|Phase 2||0
6675530|NCT02612909|7606543|FG004|NOT COMPLETED|Phase 2||0
6675531|NCT02612909|7606539|FG000|STARTED|Phase 3||0
6675532|NCT02612909|7606540|FG001|STARTED|Phase 3||0
6675533|NCT02612909|7606541|FG002|STARTED|Phase 3||0
6675534|NCT02612909|7606542|FG003|STARTED|Phase 3||105
6675535|NCT02612909|7606543|FG004|STARTED|Phase 3||525
6675536|NCT02612909|7606539|FG000|Received Injection 1|Phase 3||0
6675537|NCT02612909|7606540|FG001|Received Injection 1|Phase 3||0
6675538|NCT02612909|7606541|FG002|Received Injection 1|Phase 3||0
6675539|NCT02612909|7606542|FG003|Received Injection 1|Phase 3||105
6675540|NCT02612909|7606543|FG004|Received Injection 1|Phase 3||525
6675541|NCT02612909|7606539|FG000|Received Injection 2|Phase 3||0
6675542|NCT02612909|7606540|FG001|Received Injection 2|Phase 3||0
6675543|NCT02612909|7606541|FG002|Received Injection 2|Phase 3||0
6675544|NCT02612909|7606542|FG003|Received Injection 2|Phase 3||103
6675545|NCT02612909|7606543|FG004|Received Injection 2|Phase 3||520
6675546|NCT02612909|7606539|FG000|Completed Day 29 Clinic Visit|Phase 3||0
6675547|NCT02612909|7606540|FG001|Completed Day 29 Clinic Visit|Phase 3||0
6675548|NCT02612909|7606541|FG002|Completed Day 29 Clinic Visit|Phase 3||0
6675549|NCT02612909|7606542|FG003|Completed Day 29 Clinic Visit|Phase 3||104
6675550|NCT02612909|7606543|FG004|Completed Day 29 Clinic Visit|Phase 3||525
6675551|NCT02612909|7606539|FG000|Completed Day 43 Clinic Visit|Phase 3||0
6675552|NCT02612909|7606540|FG001|Completed Day 43 Clinic Visit|Phase 3||0
6675553|NCT02612909|7606541|FG002|Completed Day 43 Clinic Visit|Phase 3||0
6675554|NCT02612909|7606542|FG003|Completed Day 43 Clinic Visit|Phase 3||104
6675555|NCT02612909|7606543|FG004|Completed Day 43 Clinic Visit|Phase 3||524
6675556|NCT02612909|7606539|FG000|COMPLETED|Phase 3||0
6675557|NCT02612909|7606540|FG001|COMPLETED|Phase 3||0
6675558|NCT02612909|7606541|FG002|COMPLETED|Phase 3||0
6675559|NCT02612909|7606542|FG003|COMPLETED|Phase 3||104
6675560|NCT02612909|7606543|FG004|COMPLETED|Phase 3||525
6675561|NCT02612909|7606539|FG000|NOT COMPLETED|Phase 3||0
6675562|NCT02612909|7606540|FG001|NOT COMPLETED|Phase 3||0
6675563|NCT02612909|7606541|FG002|NOT COMPLETED|Phase 3||0
6675564|NCT02612909|7606542|FG003|NOT COMPLETED|Phase 3||1
6675565|NCT02612909|7606543|FG004|NOT COMPLETED|Phase 3||0
6675566|NCT02613117|7606559|FG000|STARTED|Overall Study||57
6675567|NCT02613117|7606560|FG001|STARTED|Overall Study||47
6675568|NCT02613117|7606559|FG000|COMPLETED|Overall Study||57
6675569|NCT02613117|7606560|FG001|COMPLETED|Overall Study||47
6675570|NCT02613117|7606559|FG000|NOT COMPLETED|Overall Study||0
6675571|NCT02613117|7606560|FG001|NOT COMPLETED|Overall Study||0
6675572|NCT02613169|7606568|FG000|STARTED|Overall Study||150
6675573|NCT02613169|7606569|FG001|STARTED|Overall Study||150
6675574|NCT02613169|7606568|FG000|COMPLETED|Overall Study||132
6675575|NCT02613169|7606569|FG001|COMPLETED|Overall Study||133
6675576|NCT02613169|7606568|FG000|NOT COMPLETED|Overall Study||18
6675577|NCT02613169|7606569|FG001|NOT COMPLETED|Overall Study||17
6675578|NCT02613182|7606575|FG000|STARTED|Overall Study||34
6675579|NCT02613182|7606575|FG000|Number of Patients Dosed|Overall Study||34
6675580|NCT02613182|7606575|FG000|COMPLETED|Overall Study||0
6675581|NCT02613182|7606575|FG000|NOT COMPLETED|Overall Study||34
6675582|NCT02613208|7606579|FG000|STARTED|Overall Study||111
6675583|NCT02613208|7606579|FG000|COMPLETED|Overall Study||64
6675584|NCT02613208|7606579|FG000|NOT COMPLETED|Overall Study||47
6675585|NCT02613221|7606583|FG000|STARTED|Overall Study||56
6675586|NCT02613221|7606583|FG000|Safety Population: Received Study Drug|Overall Study||55
6675587|NCT02613221|7606583|FG000|COMPLETED|Overall Study||1
6675588|NCT02613221|7606583|FG000|NOT COMPLETED|Overall Study||55
6675589|NCT02613338|7606587|FG000|STARTED|Overall Study||30
6675590|NCT02613338|7606587|FG000|COMPLETED|Overall Study||30
6675591|NCT02613338|7606587|FG000|NOT COMPLETED|Overall Study||0
6675592|NCT02613364|7606594|FG000|STARTED|Overall Study||251
6675593|NCT02613364|7606595|FG001|STARTED|Overall Study||238
6675594|NCT02613364|7606596|FG002|STARTED|Overall Study||251
6675595|NCT02613364|7606594|FG000|COMPLETED|Overall Study||185
6675596|NCT02613364|7606595|FG001|COMPLETED|Overall Study||148
6675597|NCT02613364|7606596|FG002|COMPLETED|Overall Study||175
6675598|NCT02613364|7606594|FG000|NOT COMPLETED|Overall Study||66
6675599|NCT02613364|7606595|FG001|NOT COMPLETED|Overall Study||90
6675600|NCT02613364|7606596|FG002|NOT COMPLETED|Overall Study||76
6675601|NCT02613403|7606608|FG000|STARTED|Overall Study||36
6675602|NCT02613403|7606609|FG001|STARTED|Overall Study||36
6675603|NCT02613403|7606610|FG002|STARTED|Overall Study||9
6675604|NCT02613403|7606611|FG003|STARTED|Overall Study||13
6675605|NCT02613403|7606612|FG004|STARTED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6675606|NCT02613403|7606608|FG000|Treated|Overall Study||35
6675607|NCT02613403|7606609|FG001|Treated|Overall Study||36
6675608|NCT02613403|7606610|FG002|Treated|Overall Study||9
6675609|NCT02613403|7606611|FG003|Treated|Overall Study||13
6675610|NCT02613403|7606612|FG004|Treated|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6675611|NCT02613403|7606608|FG000|COMPLETED|Overall Study||34
6675612|NCT02613403|7606609|FG001|COMPLETED|Overall Study||35
6675613|NCT02613403|7606610|FG002|COMPLETED|Overall Study||9
6675614|NCT02613403|7606611|FG003|COMPLETED|Overall Study||13
6675615|NCT02613403|7606612|FG004|COMPLETED|Overall Study|Study terminated prior to participant recruitment for study Part B.|0
6675616|NCT02613403|7606608|FG000|NOT COMPLETED|Overall Study||2
6675617|NCT02613403|7606609|FG001|NOT COMPLETED|Overall Study||1
6256260|NCT01970865|7155091|FG006|COMPLETED|Overall Study||0
6675618|NCT02613403|7606610|FG002|NOT COMPLETED|Overall Study||0
6675619|NCT02613403|7606611|FG003|NOT COMPLETED|Overall Study||0
6675620|NCT02613403|7606612|FG004|NOT COMPLETED|Overall Study||0
6675621|NCT02613481|7606622|FG000|STARTED|Overall Study||50
6675622|NCT02613481|7606622|FG000|COMPLETED|Overall Study||41
6675623|NCT02613481|7606622|FG000|NOT COMPLETED|Overall Study||9
6675624|NCT02613507|7606628|FG000|STARTED|Overall Study||338
6675625|NCT02613507|7606629|FG001|STARTED|Overall Study||166
6675626|NCT02613507|7606628|FG000|COMPLETED|Overall Study||50
6675627|NCT02613507|7606629|FG001|COMPLETED|Overall Study||2
6675628|NCT02613507|7606628|FG000|NOT COMPLETED|Overall Study||288
6675629|NCT02613507|7606629|FG001|NOT COMPLETED|Overall Study||164
6675630|NCT02613572|7606638|FG000|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||15
6675631|NCT02613572|7606639|FG001|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
6675632|NCT02613572|7606640|FG002|STARTED|Phase I: Tolerability, 600, 800, 1200 mg||0
6675633|NCT02613572|7606638|FG000|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
6675634|NCT02613572|7606639|FG001|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6675635|NCT02613572|7606640|FG002|600 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6675636|NCT02613572|7606638|FG000|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||15
6675637|NCT02613572|7606639|FG001|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6675638|NCT02613572|7606640|FG002|800 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6675639|NCT02613572|7606638|FG000|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||14
6675640|NCT02613572|7606639|FG001|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6675641|NCT02613572|7606640|FG002|1200 mg|Phase I: Tolerability, 600, 800, 1200 mg||0
6675642|NCT02613572|7606638|FG000|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||14
6675643|NCT02613572|7606639|FG001|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
6675644|NCT02613572|7606640|FG002|COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
6675645|NCT02613572|7606638|FG000|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||1
6675646|NCT02613572|7606639|FG001|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
6675647|NCT02613572|7606640|FG002|NOT COMPLETED|Phase I: Tolerability, 600, 800, 1200 mg||0
6675648|NCT02613572|7606638|FG000|STARTED|Phase II: Double-Blind Rand Plac Control||0
6675649|NCT02613572|7606639|FG001|STARTED|Phase II: Double-Blind Rand Plac Control||27
6675650|NCT02613572|7606640|FG002|STARTED|Phase II: Double-Blind Rand Plac Control||26
6675651|NCT02613572|7606638|FG000|COMPLETED|Phase II: Double-Blind Rand Plac Control||0
6675652|NCT02613572|7606639|FG001|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
6675653|NCT02613572|7606640|FG002|COMPLETED|Phase II: Double-Blind Rand Plac Control||26
6675654|NCT02613572|7606638|FG000|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
6675655|NCT02613572|7606639|FG001|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||1
6675656|NCT02613572|7606640|FG002|NOT COMPLETED|Phase II: Double-Blind Rand Plac Control||0
6675657|NCT02613871|7606652|FG000|STARTED|Overall Study||111
6675658|NCT02613871|7606652|FG000|COMPLETED|Overall Study||108
6675659|NCT02613871|7606652|FG000|NOT COMPLETED|Overall Study||3
6675660|NCT02613884|7606656|FG000|STARTED|Overall Study||26
6675661|NCT02613884|7606656|FG000|Safety Endpoint 1|Overall Study||26
6675662|NCT02613884|7606656|FG000|Feasibility Questionnaire|Overall Study||26
6675663|NCT02613884|7606656|FG000|Safety Endpoint 2|Overall Study||26
6675664|NCT02613884|7606656|FG000|Efficacy Endpoint 1|Overall Study||25
6675665|NCT02613884|7606656|FG000|Efficacy Timepoint 2|Overall Study||25
6675666|NCT02613884|7606656|FG000|Efficacy Timepoint 3|Overall Study||24
6675667|NCT02613884|7606656|FG000|COMPLETED|Overall Study||24
6675668|NCT02613884|7606656|FG000|NOT COMPLETED|Overall Study||2
6675669|NCT02613897|7606664|FG000|STARTED|Overall Study||22
6675670|NCT02613897|7606665|FG001|STARTED|Overall Study||22
6675671|NCT02613897|7606666|FG002|STARTED|Overall Study||12
6675672|NCT02613897|7606664|FG000|COMPLETED|Overall Study||22
6675673|NCT02613897|7606665|FG001|COMPLETED|Overall Study||22
6256261|NCT01970865|7155092|FG007|COMPLETED|Overall Study||0
6675674|NCT02613897|7606666|FG002|COMPLETED|Overall Study||12
6675675|NCT02613897|7606664|FG000|NOT COMPLETED|Overall Study||0
6675676|NCT02613897|7606665|FG001|NOT COMPLETED|Overall Study||0
6675677|NCT02613897|7606666|FG002|NOT COMPLETED|Overall Study||0
6675678|NCT02613910|7606675|FG000|STARTED|Overall Study||1
6675679|NCT02613910|7606675|FG000|COMPLETED|Overall Study||0
6675680|NCT02613910|7606675|FG000|NOT COMPLETED|Overall Study||1
6675681|NCT02614079|7606679|FG000|STARTED|Overall Study||6
6675682|NCT02614079|7606679|FG000|COMPLETED|Overall Study|1 participant withdrew from the study prior to completion of DSSEP testing|5
6675683|NCT02614079|7606679|FG000|NOT COMPLETED|Overall Study||1
6675684|NCT02614131|7606690|FG000|STARTED|Overall Study||11
6675685|NCT02614131|7606691|FG001|STARTED|Overall Study||8
6675686|NCT02614131|7606692|FG002|STARTED|Overall Study||8
6675687|NCT02614131|7606693|FG003|STARTED|Overall Study||8
6675688|NCT02614131|7606694|FG004|STARTED|Overall Study||8
6675689|NCT02614131|7606695|FG005|STARTED|Overall Study||2
6675690|NCT02614131|7606696|FG006|STARTED|Overall Study||5
6675691|NCT02614131|7606690|FG000|Received at Least One Dose of Drug|Overall Study||11
6675692|NCT02614131|7606691|FG001|Received at Least One Dose of Drug|Overall Study||8
6675693|NCT02614131|7606692|FG002|Received at Least One Dose of Drug|Overall Study||8
6675694|NCT02614131|7606693|FG003|Received at Least One Dose of Drug|Overall Study||8
6675695|NCT02614131|7606694|FG004|Received at Least One Dose of Drug|Overall Study||8
6675696|NCT02614131|7606695|FG005|Received at Least One Dose of Drug|Overall Study||2
6675697|NCT02614131|7606696|FG006|Received at Least One Dose of Drug|Overall Study||5
6675698|NCT02614131|7606690|FG000|COMPLETED|Overall Study||10
6675699|NCT02614131|7606691|FG001|COMPLETED|Overall Study||8
6675700|NCT02614131|7606692|FG002|COMPLETED|Overall Study||8
6675701|NCT02614131|7606693|FG003|COMPLETED|Overall Study||8
6675702|NCT02614131|7606694|FG004|COMPLETED|Overall Study||8
6675703|NCT02614131|7606695|FG005|COMPLETED|Overall Study||2
6675704|NCT02614131|7606696|FG006|COMPLETED|Overall Study||4
6675705|NCT02614131|7606690|FG000|NOT COMPLETED|Overall Study||1
6675706|NCT02614131|7606691|FG001|NOT COMPLETED|Overall Study||0
6675707|NCT02614131|7606692|FG002|NOT COMPLETED|Overall Study||0
6675708|NCT02614131|7606693|FG003|NOT COMPLETED|Overall Study||0
6675709|NCT02614131|7606694|FG004|NOT COMPLETED|Overall Study||0
6675710|NCT02614131|7606695|FG005|NOT COMPLETED|Overall Study||0
6675711|NCT02614131|7606696|FG006|NOT COMPLETED|Overall Study||1
6675712|NCT02614183|7606721|FG000|STARTED|Double Blind Treatment Phase||434
6675713|NCT02614183|7606722|FG001|STARTED|Double Blind Treatment Phase||214
6675714|NCT02614183|7606723|FG002|STARTED|Double Blind Treatment Phase||214
6675715|NCT02614183|7606721|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||433
6675716|NCT02614183|7606722|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||213
6675717|NCT02614183|7606723|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||212
6675718|NCT02614183|7606721|FG000|Safety Population|Double Blind Treatment Phase||432
6675719|NCT02614183|7606722|FG001|Safety Population|Double Blind Treatment Phase|One pt randomized to placebo received galcanezumab 120mg due to dosing error moved to this group.|206
6675720|NCT02614183|7606723|FG002|Safety Population|Double Blind Treatment Phase|Eight pts discontinued after loading dose of 240mg galcanezumab in 120mg group moved to this group.|220
6675721|NCT02614183|7606721|FG000|COMPLETED|Double Blind Treatment Phase||351
6675722|NCT02614183|7606722|FG001|COMPLETED|Double Blind Treatment Phase||177
6675723|NCT02614183|7606723|FG002|COMPLETED|Double Blind Treatment Phase||175
6675724|NCT02614183|7606721|FG000|NOT COMPLETED|Double Blind Treatment Phase||83
6675725|NCT02614183|7606722|FG001|NOT COMPLETED|Double Blind Treatment Phase||37
6675726|NCT02614183|7606723|FG002|NOT COMPLETED|Double Blind Treatment Phase||39
6675727|NCT02614183|7606721|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|372
6675728|NCT02614183|7606722|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|185
6675729|NCT02614183|7606723|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post-treatment phase.|183
6675730|NCT02614183|7606721|FG000|Safety Population|Post Treatment Follow-up Phase||372
6675731|NCT02614183|7606722|FG001|Safety Population|Post Treatment Follow-up Phase||183
6675732|NCT02614183|7606723|FG002|Safety Population|Post Treatment Follow-up Phase|Two participants who received only 240mg loading dose prior to discontinuation moved to this group.|185
6675733|NCT02614183|7606721|FG000|COMPLETED|Post Treatment Follow-up Phase||354
6675734|NCT02614183|7606722|FG001|COMPLETED|Post Treatment Follow-up Phase||179
6675735|NCT02614183|7606723|FG002|COMPLETED|Post Treatment Follow-up Phase||171
6675736|NCT02614183|7606721|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||18
6675737|NCT02614183|7606722|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||6
6675738|NCT02614183|7606723|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||12
6675739|NCT02614196|7606743|FG000|STARTED|Double Blind Treatment Phase||463
6675740|NCT02614196|7606744|FG001|STARTED|Double Blind Treatment Phase||233
6675741|NCT02614196|7606745|FG002|STARTED|Double Blind Treatment Phase||226
6675742|NCT02614196|7606746|FG003|STARTED|Double Blind Treatment Phase||30
6675743|NCT02614196|7606747|FG004|STARTED|Double Blind Treatment Phase||15
6675744|NCT02614196|7606748|FG005|STARTED|Double Blind Treatment Phase||19
6675745|NCT02614196|7606743|FG000|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||461
6675746|NCT02614196|7606744|FG001|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||231
6675747|NCT02614196|7606745|FG002|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||223
6675748|NCT02614196|7606746|FG003|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||30
6675749|NCT02614196|7606747|FG004|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||14
6256262|NCT01970865|7155093|FG008|COMPLETED|Overall Study||0
6256263|NCT01970865|7155094|FG009|COMPLETED|Overall Study||0
6256264|NCT01970865|7155095|FG010|COMPLETED|Overall Study||0
6256265|NCT01970865|7155096|FG011|COMPLETED|Overall Study||0
6256266|NCT01970865|7155097|FG012|COMPLETED|Overall Study||0
6256267|NCT01970865|7155098|FG013|COMPLETED|Overall Study||0
6675750|NCT02614196|7606748|FG005|Received at Least One Dose of Study Drug|Double Blind Treatment Phase||19
6675751|NCT02614196|7606743|FG000|COMPLETED|Double Blind Treatment Phase||387
6675752|NCT02614196|7606744|FG001|COMPLETED|Double Blind Treatment Phase||203
6675753|NCT02614196|7606745|FG002|COMPLETED|Double Blind Treatment Phase||195
6675754|NCT02614196|7606746|FG003|COMPLETED|Double Blind Treatment Phase||26
6675755|NCT02614196|7606747|FG004|COMPLETED|Double Blind Treatment Phase||14
6675756|NCT02614196|7606748|FG005|COMPLETED|Double Blind Treatment Phase||19
6675757|NCT02614196|7606743|FG000|NOT COMPLETED|Double Blind Treatment Phase||76
6675758|NCT02614196|7606744|FG001|NOT COMPLETED|Double Blind Treatment Phase||30
6675759|NCT02614196|7606745|FG002|NOT COMPLETED|Double Blind Treatment Phase||31
6675760|NCT02614196|7606746|FG003|NOT COMPLETED|Double Blind Treatment Phase||4
6675761|NCT02614196|7606747|FG004|NOT COMPLETED|Double Blind Treatment Phase||1
6675762|NCT02614196|7606748|FG005|NOT COMPLETED|Double Blind Treatment Phase||0
6675763|NCT02614196|7606743|FG000|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|410
6675764|NCT02614196|7606744|FG001|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|213
6675765|NCT02614196|7606745|FG002|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|207
6675766|NCT02614196|7606746|FG003|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|25
6675767|NCT02614196|7606747|FG004|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|15
6675768|NCT02614196|7606748|FG005|STARTED|Post Treatment Follow-up Phase|Participants who discontinued double blind phase had an option to enter post treatment phase|19
6675769|NCT02614196|7606743|FG000|COMPLETED|Post Treatment Follow-up Phase||390
6675770|NCT02614196|7606744|FG001|COMPLETED|Post Treatment Follow-up Phase||208
6675771|NCT02614196|7606745|FG002|COMPLETED|Post Treatment Follow-up Phase||199
6675772|NCT02614196|7606746|FG003|COMPLETED|Post Treatment Follow-up Phase||24
6675773|NCT02614196|7606747|FG004|COMPLETED|Post Treatment Follow-up Phase||13
6675774|NCT02614196|7606748|FG005|COMPLETED|Post Treatment Follow-up Phase||19
6675775|NCT02614196|7606743|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||20
6675776|NCT02614196|7606744|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
6675777|NCT02614196|7606745|FG002|NOT COMPLETED|Post Treatment Follow-up Phase||8
6675778|NCT02614196|7606746|FG003|NOT COMPLETED|Post Treatment Follow-up Phase||1
6675779|NCT02614196|7606747|FG004|NOT COMPLETED|Post Treatment Follow-up Phase||2
6675780|NCT02614196|7606748|FG005|NOT COMPLETED|Post Treatment Follow-up Phase||0
6675781|NCT02614222|7606778|FG000|STARTED|Overall Study||13
6675782|NCT02614222|7606779|FG001|STARTED|Overall Study||14
6675783|NCT02614222|7606778|FG000|COMPLETED|Overall Study||13
6675784|NCT02614222|7606779|FG001|COMPLETED|Overall Study||14
6675785|NCT02614222|7606778|FG000|NOT COMPLETED|Overall Study||0
6675786|NCT02614222|7606779|FG001|NOT COMPLETED|Overall Study||0
6675787|NCT02614261|7606788|FG000|STARTED|Overall Study||558
6675788|NCT02614261|7606789|FG001|STARTED|Overall Study||278
6675789|NCT02614261|7606790|FG002|STARTED|Overall Study||277
6675790|NCT02614261|7606788|FG000|Received at Least One Dose of Study Drug|Overall Study||558
6675791|NCT02614261|7606789|FG001|Received at Least One Dose of Study Drug|Overall Study||278
6675792|NCT02614261|7606790|FG002|Received at Least One Dose of Study Drug|Overall Study||277
6675793|NCT02614261|7606788|FG000|COMPLETED|Overall Study||509
6675794|NCT02614261|7606789|FG001|COMPLETED|Overall Study||263
6675795|NCT02614261|7606790|FG002|COMPLETED|Overall Study||266
6675796|NCT02614261|7606788|FG000|NOT COMPLETED|Overall Study||49
6675797|NCT02614261|7606789|FG001|NOT COMPLETED|Overall Study||15
6675798|NCT02614261|7606790|FG002|NOT COMPLETED|Overall Study||11
6675799|NCT02614274|7606806|FG000|STARTED|Overall Study||9
6675800|NCT02614274|7606806|FG000|COMPLETED|Overall Study||5
6675801|NCT02614274|7606806|FG000|NOT COMPLETED|Overall Study||4
6675802|NCT02614287|7606812|FG000|STARTED|Open Label (OL) Treatment Phase||135
6675803|NCT02614287|7606813|FG001|STARTED|Open Label (OL) Treatment Phase||135
6675804|NCT02614287|7606812|FG000|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
6675805|NCT02614287|7606813|FG001|Received at Least One Dose of Study Drug|Open Label (OL) Treatment Phase||135
6675806|NCT02614287|7606812|FG000|COMPLETED|Open Label (OL) Treatment Phase||97
6675807|NCT02614287|7606813|FG001|COMPLETED|Open Label (OL) Treatment Phase||113
6675808|NCT02614287|7606812|FG000|NOT COMPLETED|Open Label (OL) Treatment Phase||38
6675809|NCT02614287|7606813|FG001|NOT COMPLETED|Open Label (OL) Treatment Phase||22
6675810|NCT02614287|7606812|FG000|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|112
6675811|NCT02614287|7606813|FG001|STARTED|Post Treatment Follow-up Phase|Follow-up period was optional, few participants who completed OL period didn't enter follow-up.|124
6675812|NCT02614287|7606812|FG000|COMPLETED|Post Treatment Follow-up Phase||103
6675813|NCT02614287|7606813|FG001|COMPLETED|Post Treatment Follow-up Phase||119
6675814|NCT02614287|7606812|FG000|NOT COMPLETED|Post Treatment Follow-up Phase||9
6675815|NCT02614287|7606813|FG001|NOT COMPLETED|Post Treatment Follow-up Phase||5
6675816|NCT02614469|7606826|FG000|STARTED|Period 1||9
6675817|NCT02614469|7606827|FG001|STARTED|Period 1||9
6675818|NCT02614469|7606826|FG000|COMPLETED|Period 1||9
6675819|NCT02614469|7606827|FG001|COMPLETED|Period 1||9
6675820|NCT02614469|7606826|FG000|NOT COMPLETED|Period 1||0
6675821|NCT02614469|7606827|FG001|NOT COMPLETED|Period 1||0
6675822|NCT02614469|7606826|FG000|STARTED|Period 2||9
6675823|NCT02614469|7606827|FG001|STARTED|Period 2||9
6675824|NCT02614469|7606826|FG000|COMPLETED|Period 2||9
6675825|NCT02614469|7606827|FG001|COMPLETED|Period 2||9
6675826|NCT02614469|7606826|FG000|NOT COMPLETED|Period 2||0
6675827|NCT02614469|7606827|FG001|NOT COMPLETED|Period 2||0
6675828|NCT02614560|7606835|FG000|STARTED|Overall Study||6
6675829|NCT02614560|7606836|FG001|STARTED|Overall Study||8
6675830|NCT02614560|7606835|FG000|COMPLETED|Overall Study||0
6675831|NCT02614560|7606836|FG001|COMPLETED|Overall Study||6
6675832|NCT02614560|7606835|FG000|NOT COMPLETED|Overall Study||6
6675833|NCT02614560|7606836|FG001|NOT COMPLETED|Overall Study||2
6675834|NCT02614703|7606844|FG000|STARTED|Overall Study||31
6675835|NCT02614703|7606845|FG001|STARTED|Overall Study||29
6675836|NCT02614703|7606844|FG000|COMPLETED|Overall Study||24
6675837|NCT02614703|7606845|FG001|COMPLETED|Overall Study||28
6675838|NCT02614703|7606844|FG000|NOT COMPLETED|Overall Study||7
6675839|NCT02614703|7606845|FG001|NOT COMPLETED|Overall Study||1
6675840|NCT02614729|7606853|FG000|STARTED|Overall Study||18
6675841|NCT02614729|7606854|FG001|STARTED|Overall Study||17
6675842|NCT02614729|7606853|FG000|COMPLETED|Overall Study||17
6675843|NCT02614729|7606854|FG001|COMPLETED|Overall Study||17
6675844|NCT02614729|7606853|FG000|NOT COMPLETED|Overall Study||1
6675845|NCT02614729|7606854|FG001|NOT COMPLETED|Overall Study||0
6675846|NCT02614794|7606864|FG000|STARTED|Overall Study||410
6675847|NCT02614794|7606865|FG001|STARTED|Overall Study||202
6675848|NCT02614794|7606864|FG000|COMPLETED|Overall Study||0
6675849|NCT02614794|7606865|FG001|COMPLETED|Overall Study||0
6675850|NCT02614794|7606864|FG000|NOT COMPLETED|Overall Study||410
6675851|NCT02614794|7606865|FG001|NOT COMPLETED|Overall Study||202
6675852|NCT02614924|7606873|FG000|STARTED|Overall Study||20
6675853|NCT02614924|7606874|FG001|STARTED|Overall Study||20
6675854|NCT02614924|7606873|FG000|COMPLETED|Overall Study||20
6675855|NCT02614924|7606874|FG001|COMPLETED|Overall Study||20
6675856|NCT02614924|7606873|FG000|NOT COMPLETED|Overall Study||0
6675857|NCT02614924|7606874|FG001|NOT COMPLETED|Overall Study||0
6675858|NCT02615145|7606884|FG000|STARTED|Overall Study||145
6675859|NCT02615145|7606885|FG001|STARTED|Overall Study||278
6675860|NCT02615145|7606886|FG002|STARTED|Overall Study||48
6675861|NCT02615145|7606887|FG003|STARTED|Overall Study||1
6675862|NCT02615145|7606884|FG000|2 DAA + Ribavirin (RBV)|Overall Study||0
6675863|NCT02615145|7606885|FG001|2 DAA + Ribavirin (RBV)|Overall Study||0
6675864|NCT02615145|7606886|FG002|2 DAA + Ribavirin (RBV)|Overall Study||45
6675865|NCT02615145|7606887|FG003|2 DAA + Ribavirin (RBV)|Overall Study||0
6675866|NCT02615145|7606884|FG000|3DAA|Overall Study||5
6675867|NCT02615145|7606885|FG001|3DAA|Overall Study||261
6675868|NCT02615145|7606886|FG002|3DAA|Overall Study||0
6675869|NCT02615145|7606887|FG003|3DAA|Overall Study||0
6675870|NCT02615145|7606884|FG000|3DAA + RBV|Overall Study||140
6675871|NCT02615145|7606885|FG001|3DAA + RBV|Overall Study||17
6675872|NCT02615145|7606886|FG002|3DAA + RBV|Overall Study||2
6675873|NCT02615145|7606887|FG003|3DAA + RBV|Overall Study||0
6675874|NCT02615145|7606884|FG000|COMPLETED|Overall Study||118
6675875|NCT02615145|7606885|FG001|COMPLETED|Overall Study||263
6675876|NCT02615145|7606886|FG002|COMPLETED|Overall Study||40
6675877|NCT02615145|7606887|FG003|COMPLETED|Overall Study||0
6675878|NCT02615145|7606884|FG000|NOT COMPLETED|Overall Study||27
6675879|NCT02615145|7606885|FG001|NOT COMPLETED|Overall Study||15
6675880|NCT02615145|7606886|FG002|NOT COMPLETED|Overall Study||8
6675881|NCT02615145|7606887|FG003|NOT COMPLETED|Overall Study||1
6675882|NCT02615158|7606916|FG000|STARTED|Overall Study||94
6675883|NCT02615158|7606917|FG001|STARTED|Overall Study||92
6675884|NCT02615158|7606918|FG002|STARTED|Overall Study||91
6675885|NCT02615158|7606916|FG000|COMPLETED|Overall Study||73
6675886|NCT02615158|7606917|FG001|COMPLETED|Overall Study||76
6675887|NCT02615158|7606918|FG002|COMPLETED|Overall Study||75
6675888|NCT02615158|7606916|FG000|NOT COMPLETED|Overall Study||21
6675889|NCT02615158|7606917|FG001|NOT COMPLETED|Overall Study||16
6675890|NCT02615158|7606918|FG002|NOT COMPLETED|Overall Study||16
6675891|NCT02615171|7606928|FG000|STARTED|Overall Study||32
6675892|NCT02615171|7606929|FG001|STARTED|Overall Study||32
6675893|NCT02615171|7606928|FG000|COMPLETED|Overall Study||30
6675894|NCT02615171|7606929|FG001|COMPLETED|Overall Study||31
6675895|NCT02615171|7606928|FG000|NOT COMPLETED|Overall Study||2
6675896|NCT02615171|7606929|FG001|NOT COMPLETED|Overall Study||1
6675897|NCT02615249|7606935|FG000|STARTED|Overall Study||122
6675898|NCT02615249|7606935|FG000|COMPLETED|Overall Study||121
6675899|NCT02615249|7606935|FG000|NOT COMPLETED|Overall Study||1
6675900|NCT02615470|7606942|FG000|STARTED|Overall Study||58
6675901|NCT02615470|7606943|FG001|STARTED|Overall Study||62
6675902|NCT02615470|7606942|FG000|Completed the Baseline Surveys|Overall Study||46
6675903|NCT02615470|7606943|FG001|Completed the Baseline Surveys|Overall Study||47
6675904|NCT02615470|7606942|FG000|COMPLETED|Overall Study||37
6675905|NCT02615470|7606943|FG001|COMPLETED|Overall Study||30
6675906|NCT02615470|7606942|FG000|NOT COMPLETED|Overall Study||21
6675907|NCT02615470|7606943|FG001|NOT COMPLETED|Overall Study||32
6675908|NCT02615509|7606949|FG000|STARTED|Overall Study||347
6675909|NCT02615509|7606949|FG000|COMPLETED|Overall Study||201
6675910|NCT02615509|7606949|FG000|NOT COMPLETED|Overall Study||146
6675911|NCT02615535|7606955|FG000|STARTED|Overall Study||14
6675912|NCT02615535|7606956|FG001|STARTED|Overall Study||11
6675913|NCT02615535|7606955|FG000|COMPLETED|Overall Study||10
6675914|NCT02615535|7606956|FG001|COMPLETED|Overall Study||10
6675915|NCT02615535|7606955|FG000|NOT COMPLETED|Overall Study||4
6675916|NCT02615535|7606956|FG001|NOT COMPLETED|Overall Study||1
6675917|NCT02615717|7606964|FG000|STARTED|Overall Study||3
6675918|NCT02615717|7606965|FG001|STARTED|Overall Study||3
6675919|NCT02615717|7606964|FG000|COMPLETED|Overall Study||3
6675920|NCT02615717|7606965|FG001|COMPLETED|Overall Study||3
6675921|NCT02615717|7606964|FG000|NOT COMPLETED|Overall Study||0
6675922|NCT02615717|7606965|FG001|NOT COMPLETED|Overall Study||0
6675923|NCT02615743|7606973|FG000|STARTED|Overall Study||21
6675924|NCT02615743|7606974|FG001|STARTED|Overall Study||20
6675925|NCT02615743|7606973|FG000|COMPLETED|Overall Study||15
6675926|NCT02615743|7606974|FG001|COMPLETED|Overall Study||17
6675927|NCT02615743|7606973|FG000|NOT COMPLETED|Overall Study||6
6675928|NCT02615743|7606974|FG001|NOT COMPLETED|Overall Study||3
6675929|NCT02616029|7606982|FG000|STARTED|Overall Study||38
6675930|NCT02616029|7606983|FG001|STARTED|Overall Study||28
6675931|NCT02616029|7606982|FG000|COMPLETED|Overall Study||34
6675932|NCT02616029|7606983|FG001|COMPLETED|Overall Study||26
6675933|NCT02616029|7606982|FG000|NOT COMPLETED|Overall Study||4
6675934|NCT02616029|7606983|FG001|NOT COMPLETED|Overall Study||2
6675935|NCT02616250|7606991|FG000|STARTED|Overall Study||95
6675936|NCT02616250|7606992|FG001|STARTED|Overall Study||95
6675937|NCT02616250|7606991|FG000|COMPLETED|Overall Study||85
6675938|NCT02616250|7606992|FG001|COMPLETED|Overall Study||86
6675939|NCT02616250|7606991|FG000|NOT COMPLETED|Overall Study||10
6675940|NCT02616250|7606992|FG001|NOT COMPLETED|Overall Study||9
6675941|NCT02616380|7606998|FG000|STARTED|Overall Study||100
6675942|NCT02616380|7606998|FG000|COMPLETED|Overall Study||97
6675943|NCT02616380|7606998|FG000|NOT COMPLETED|Overall Study||3
6675944|NCT02616523|7607005|FG000|STARTED|Overall Study|June 2014|20
6675945|NCT02616523|7607006|FG001|STARTED|Overall Study|June 2014|20
6675946|NCT02616523|7607007|FG002|STARTED|Overall Study|June 2014|20
6675947|NCT02616523|7607005|FG000|COMPLETED|Overall Study|April 2015|19
6675948|NCT02616523|7607006|FG001|COMPLETED|Overall Study|April 2015|20
6675949|NCT02616523|7607007|FG002|COMPLETED|Overall Study|April 2015|20
6675950|NCT02616523|7607005|FG000|NOT COMPLETED|Overall Study||1
6675951|NCT02616523|7607006|FG001|NOT COMPLETED|Overall Study||0
6675952|NCT02616523|7607007|FG002|NOT COMPLETED|Overall Study||0
6675953|NCT02616601|7607021|FG000|STARTED|Overall Study||140
6675954|NCT02616601|7607022|FG001|STARTED|Overall Study||140
6675955|NCT02616601|7607023|FG002|STARTED|Overall Study||142
6675956|NCT02616601|7607021|FG000|Safety Population|Overall Study||140
6675957|NCT02616601|7607022|FG001|Safety Population|Overall Study||140
6675958|NCT02616601|7607023|FG002|Safety Population|Overall Study||142
6675959|NCT02616601|7607021|FG000|mITT Population|Overall Study||137
6675960|NCT02616601|7607022|FG001|mITT Population|Overall Study||136
6675961|NCT02616601|7607023|FG002|mITT Population|Overall Study||138
6675962|NCT02616601|7607021|FG000|PP Population|Overall Study||112
6675963|NCT02616601|7607022|FG001|PP Population|Overall Study||121
6675964|NCT02616601|7607023|FG002|PP Population|Overall Study||123
6675965|NCT02616601|7607021|FG000|COMPLETED|Overall Study||131
6675966|NCT02616601|7607022|FG001|COMPLETED|Overall Study||136
6675967|NCT02616601|7607023|FG002|COMPLETED|Overall Study||135
6675968|NCT02616601|7607021|FG000|NOT COMPLETED|Overall Study||9
6675969|NCT02616601|7607022|FG001|NOT COMPLETED|Overall Study||4
6675970|NCT02616601|7607023|FG002|NOT COMPLETED|Overall Study||7
6675971|NCT02616614|7607034|FG000|STARTED|Overall Study||347
6675972|NCT02616614|7607035|FG001|STARTED|Overall Study||345
6675973|NCT02616614|7607036|FG002|STARTED|Overall Study||170
6675974|NCT02616614|7607034|FG000|Safety Population|Overall Study||329
6675975|NCT02616614|7607035|FG001|Safety Population|Overall Study||328
6675976|NCT02616614|7607036|FG002|Safety Population|Overall Study||161
6675977|NCT02616614|7607034|FG000|mITT Population|Overall Study||325
6675978|NCT02616614|7607035|FG001|mITT Population|Overall Study||325
6675979|NCT02616614|7607036|FG002|mITT Population|Overall Study||160
6675980|NCT02616614|7607034|FG000|PP Population|Overall Study||253
6675981|NCT02616614|7607035|FG001|PP Population|Overall Study||255
6675982|NCT02616614|7607036|FG002|PP Population|Overall Study||122
6675983|NCT02616614|7607034|FG000|COMPLETED|Overall Study||282
6675984|NCT02616614|7607035|FG001|COMPLETED|Overall Study||285
6675985|NCT02616614|7607036|FG002|COMPLETED|Overall Study||141
6675986|NCT02616614|7607034|FG000|NOT COMPLETED|Overall Study||65
6675987|NCT02616614|7607035|FG001|NOT COMPLETED|Overall Study||60
6675988|NCT02616614|7607036|FG002|NOT COMPLETED|Overall Study||29
6675989|NCT02616783|7607047|FG000|STARTED|Overall Study||111
6675990|NCT02616783|7607048|FG001|STARTED|Overall Study||56
6675991|NCT02616783|7607047|FG000|COMPLETED|Overall Study||105
6675992|NCT02616783|7607048|FG001|COMPLETED|Overall Study||54
6675993|NCT02616783|7607047|FG000|NOT COMPLETED|Overall Study||6
6675994|NCT02616783|7607048|FG001|NOT COMPLETED|Overall Study||2
6675995|NCT02616900|7607054|FG000|STARTED|Overall Study||74
6675996|NCT02616900|7607054|FG000|Completed 3mo Trial|Overall Study||57
6675997|NCT02616900|7607054|FG000|COMPLETED|Overall Study|Six participants not included in study results because of incomplete data.|51
6675998|NCT02616900|7607054|FG000|NOT COMPLETED|Overall Study||23
6675999|NCT02617628|7607060|FG000|STARTED|Overall Study||74
6676000|NCT02617628|7607061|FG001|STARTED|Overall Study||72
6676001|NCT02617628|7607060|FG000|COMPLETED|Overall Study||12
6676002|NCT02617628|7607061|FG001|COMPLETED|Overall Study||11
6676003|NCT02617628|7607060|FG000|NOT COMPLETED|Overall Study||62
6676004|NCT02617628|7607061|FG001|NOT COMPLETED|Overall Study||61
6676005|NCT02617667|7607073|FG000|STARTED|Overall Study||51
6676006|NCT02617667|7607074|FG001|STARTED|Overall Study||51
6676007|NCT02617667|7607075|FG002|STARTED|Overall Study||52
6676008|NCT02617667|7607076|FG003|STARTED|Overall Study||53
6676009|NCT02617667|7607073|FG000|COMPLETED|Overall Study||50
6676010|NCT02617667|7607074|FG001|COMPLETED|Overall Study||50
6676011|NCT02617667|7607075|FG002|COMPLETED|Overall Study||48
6676012|NCT02617667|7607076|FG003|COMPLETED|Overall Study||52
6676013|NCT02617667|7607073|FG000|NOT COMPLETED|Overall Study||1
6676014|NCT02617667|7607074|FG001|NOT COMPLETED|Overall Study||1
6676015|NCT02617667|7607075|FG002|NOT COMPLETED|Overall Study||4
6676016|NCT02617667|7607076|FG003|NOT COMPLETED|Overall Study||1
6676017|NCT02617784|7607087|FG000|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
6676018|NCT02617784|7607088|FG001|STARTED|Overall Study||12
6676019|NCT02617784|7607087|FG000|First Dose Assessment Period|Overall Study||12
6676020|NCT02617784|7607088|FG001|First Dose Assessment Period|Overall Study||12
6676021|NCT02617784|7607087|FG000|Second Dose Assessment Period|Overall Study||11
6676022|NCT02617784|7607088|FG001|Second Dose Assessment Period|Overall Study||12
6676023|NCT02617784|7607087|FG000|COMPLETED|Overall Study||12
6676024|NCT02617784|7607088|FG001|COMPLETED|Overall Study||12
6676025|NCT02617784|7607087|FG000|NOT COMPLETED|Overall Study||0
6676026|NCT02617784|7607088|FG001|NOT COMPLETED|Overall Study||0
6676027|NCT02617888|7607097|FG000|STARTED|Overall Study||50
6676028|NCT02617888|7607098|FG001|STARTED|Overall Study||51
6676029|NCT02617888|7607099|FG002|STARTED|Overall Study||127
6676030|NCT02617888|7607097|FG000|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
6676031|NCT02617888|7607098|FG001|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
6676032|NCT02617888|7607099|FG002|COMPLETED|Overall Study||127
6676033|NCT02617888|7607097|FG000|NOT COMPLETED|Overall Study||1
6676034|NCT02617888|7607098|FG001|NOT COMPLETED|Overall Study||7
6676035|NCT02617888|7607099|FG002|NOT COMPLETED|Overall Study||0
6676036|NCT02617901|7607106|FG000|STARTED|Overall Study||20
6676037|NCT02617901|7607106|FG000|COMPLETED|Overall Study||20
6676038|NCT02617901|7607106|FG000|NOT COMPLETED|Overall Study||0
6676039|NCT02618031|7607112|FG000|STARTED|Overall Study||46
6676040|NCT02618031|7607113|FG001|STARTED|Overall Study||11
6676041|NCT02618031|7607112|FG000|COMPLETED|Overall Study||45
6676042|NCT02618031|7607113|FG001|COMPLETED|Overall Study||11
6676043|NCT02618031|7607112|FG000|NOT COMPLETED|Overall Study||1
6676044|NCT02618031|7607113|FG001|NOT COMPLETED|Overall Study||0
6676045|NCT02618187|7607127|FG000|STARTED|Overall Study||15
6676046|NCT02618187|7607128|FG001|STARTED|Overall Study||11
6676047|NCT02618187|7607129|FG002|STARTED|Overall Study||15
6676048|NCT02618187|7607130|FG003|STARTED|Overall Study||17
6676049|NCT02618187|7607127|FG000|Completed|Overall Study||13
6676050|NCT02618187|7607128|FG001|Completed|Overall Study||10
6676051|NCT02618187|7607129|FG002|Completed|Overall Study||13
6676052|NCT02618187|7607130|FG003|Completed|Overall Study||13
6676053|NCT02618187|7607127|FG000|COMPLETED|Overall Study||13
6676054|NCT02618187|7607128|FG001|COMPLETED|Overall Study||9
6676055|NCT02618187|7607129|FG002|COMPLETED|Overall Study||11
6676056|NCT02618187|7607130|FG003|COMPLETED|Overall Study||12
6676057|NCT02618187|7607127|FG000|NOT COMPLETED|Overall Study||2
6676058|NCT02618187|7607128|FG001|NOT COMPLETED|Overall Study||2
6676059|NCT02618187|7607129|FG002|NOT COMPLETED|Overall Study||4
6676060|NCT02618187|7607130|FG003|NOT COMPLETED|Overall Study||5
6676061|NCT02618343|7607142|FG000|STARTED|Overall Study||28
6676062|NCT02618343|7607143|FG001|STARTED|Overall Study||23
6676063|NCT02618343|7607142|FG000|COMPLETED|Overall Study||28
6676064|NCT02618343|7607143|FG001|COMPLETED|Overall Study||23
6676065|NCT02618343|7607142|FG000|NOT COMPLETED|Overall Study||0
6676066|NCT02618343|7607143|FG001|NOT COMPLETED|Overall Study||0
6676067|NCT02618382|7607149|FG000|STARTED|Overall Study|Enrolled and consented for study treatment|32
6676068|NCT02618382|7607149|FG000|COMPLETED|Overall Study|Completed Study treatment|29
6676069|NCT02618382|7607149|FG000|NOT COMPLETED|Overall Study||3
6676070|NCT02618512|7607153|FG000|STARTED|Overall Study||3
6676071|NCT02618512|7607153|FG000|COMPLETED|Overall Study||3
6676072|NCT02618512|7607153|FG000|NOT COMPLETED|Overall Study||0
6676073|NCT02618616|7607159|FG000|STARTED|Overall Study||87
6676074|NCT02618616|7607160|FG001|STARTED|Overall Study||42
6676075|NCT02618616|7607159|FG000|COMPLETED|Overall Study||66
6676076|NCT02618616|7607160|FG001|COMPLETED|Overall Study||35
6676077|NCT02618616|7607159|FG000|NOT COMPLETED|Overall Study||21
6676078|NCT02618616|7607160|FG001|NOT COMPLETED|Overall Study||7
6602159|NCT02054897|7527085|FG002|NOT COMPLETED|Overall Study||12
6602160|NCT02055118|7527096|FG000|STARTED|Overall Study||15
6602161|NCT02055118|7527097|FG001|STARTED|Overall Study||34
6602162|NCT02055118|7527098|FG002|STARTED|Overall Study||9
6602163|NCT02055118|7527096|FG000|COMPLETED|Overall Study||15
6602164|NCT02055118|7527097|FG001|COMPLETED|Overall Study||32
6602165|NCT02055118|7527098|FG002|COMPLETED|Overall Study||9
6602166|NCT02055118|7527096|FG000|NOT COMPLETED|Overall Study||0
6602167|NCT02055118|7527097|FG001|NOT COMPLETED|Overall Study||2
6602168|NCT02055118|7527098|FG002|NOT COMPLETED|Overall Study||0
6602169|NCT02055157|7527111|FG000|STARTED|Initial 6 Months||8
6676079|NCT02618642|7607171|FG000|STARTED|Before 10 PILER Irradiation Treatments||15
6676080|NCT02618642|7607172|FG001|STARTED|Before 10 PILER Irradiation Treatments||15
6676081|NCT02618642|7607173|FG002|STARTED|Before 10 PILER Irradiation Treatments||15
6676082|NCT02618642|7607174|FG003|STARTED|Before 10 PILER Irradiation Treatments||15
6602170|NCT02055157|7527112|FG001|STARTED|Initial 6 Months||8
6676083|NCT02618642|7607171|FG000|COMPLETED|Before 10 PILER Irradiation Treatments||15
6676084|NCT02618642|7607172|FG001|COMPLETED|Before 10 PILER Irradiation Treatments||15
6676085|NCT02618642|7607173|FG002|COMPLETED|Before 10 PILER Irradiation Treatments||15
6676086|NCT02618642|7607174|FG003|COMPLETED|Before 10 PILER Irradiation Treatments||15
6676087|NCT02618642|7607171|FG000|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
6676088|NCT02618642|7607172|FG001|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
6676089|NCT02618642|7607173|FG002|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
6676090|NCT02618642|7607174|FG003|NOT COMPLETED|Before 10 PILER Irradiation Treatments||0
6676091|NCT02618642|7607171|FG000|STARTED|After 10 PILER Irradiation Treatments||15
6676092|NCT02618642|7607172|FG001|STARTED|After 10 PILER Irradiation Treatments||15
6676093|NCT02618642|7607173|FG002|STARTED|After 10 PILER Irradiation Treatments||15
6676094|NCT02618642|7607174|FG003|STARTED|After 10 PILER Irradiation Treatments||15
6676095|NCT02618642|7607171|FG000|COMPLETED|After 10 PILER Irradiation Treatments||15
6676096|NCT02618642|7607172|FG001|COMPLETED|After 10 PILER Irradiation Treatments||15
6676097|NCT02618642|7607173|FG002|COMPLETED|After 10 PILER Irradiation Treatments||15
6676098|NCT02618642|7607174|FG003|COMPLETED|After 10 PILER Irradiation Treatments||15
6676099|NCT02618642|7607171|FG000|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
6676100|NCT02618642|7607172|FG001|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
6676101|NCT02618642|7607173|FG002|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
6676102|NCT02618642|7607174|FG003|NOT COMPLETED|After 10 PILER Irradiation Treatments||0
6676103|NCT02618759|7607193|FG000|STARTED|Overall Study||60
6676104|NCT02618759|7607194|FG001|STARTED|Overall Study||59
6602171|NCT02055157|7527113|FG002|STARTED|Initial 6 Months||10
6602172|NCT02055157|7527114|FG003|STARTED|Initial 6 Months||9
6602173|NCT02055157|7527111|FG000|COMPLETED|Initial 6 Months||7
6602174|NCT02055157|7527112|FG001|COMPLETED|Initial 6 Months||7
6602175|NCT02055157|7527113|FG002|COMPLETED|Initial 6 Months||10
6602176|NCT02055157|7527114|FG003|COMPLETED|Initial 6 Months||8
6676105|NCT02618759|7607193|FG000|COMPLETED|Overall Study||58
6676106|NCT02618759|7607194|FG001|COMPLETED|Overall Study||54
6676107|NCT02618759|7607193|FG000|NOT COMPLETED|Overall Study||2
6676108|NCT02618759|7607194|FG001|NOT COMPLETED|Overall Study||5
6676109|NCT02618772|7607202|FG000|STARTED|Overall Study||39
6676110|NCT02618772|7607203|FG001|STARTED|Overall Study||40
6256268|NCT01970865|7155099|FG014|COMPLETED|Overall Study||0
6256269|NCT01970865|7155100|FG015|COMPLETED|Overall Study||0
6256270|NCT01970865|7155101|FG016|COMPLETED|Overall Study||0
6256271|NCT01970865|7155085|FG000|NOT COMPLETED|Overall Study||3
6256272|NCT01970865|7155086|FG001|NOT COMPLETED|Overall Study||3
6256273|NCT01970865|7155087|FG002|NOT COMPLETED|Overall Study||3
6256274|NCT01970865|7155088|FG003|NOT COMPLETED|Overall Study||13
6256275|NCT01970865|7155089|FG004|NOT COMPLETED|Overall Study||17
6256276|NCT01970865|7155090|FG005|NOT COMPLETED|Overall Study||3
6256277|NCT01970865|7155091|FG006|NOT COMPLETED|Overall Study||3
6256278|NCT01970865|7155092|FG007|NOT COMPLETED|Overall Study||3
6602177|NCT02055157|7527111|FG000|NOT COMPLETED|Initial 6 Months||1
6602178|NCT02055157|7527112|FG001|NOT COMPLETED|Initial 6 Months||1
6676111|NCT02618772|7607202|FG000|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
6602179|NCT02055157|7527113|FG002|NOT COMPLETED|Initial 6 Months||0
6676112|NCT02618772|7607203|FG001|Withdrawal by Subject|Overall Study||0
6676113|NCT02618772|7607202|FG000|COMPLETED|Overall Study||38
6676114|NCT02618772|7607203|FG001|COMPLETED|Overall Study||40
6676115|NCT02618772|7607202|FG000|NOT COMPLETED|Overall Study||1
6676116|NCT02618772|7607203|FG001|NOT COMPLETED|Overall Study||0
6676117|NCT02618915|7607211|FG000|STARTED|Overall Study||3
6676118|NCT02618915|7607212|FG001|STARTED|Overall Study||3
6676119|NCT02618915|7607211|FG000|COMPLETED|Overall Study||3
6676120|NCT02618915|7607212|FG001|COMPLETED|Overall Study||3
6676121|NCT02618915|7607211|FG000|NOT COMPLETED|Overall Study||0
6676122|NCT02618915|7607212|FG001|NOT COMPLETED|Overall Study||0
6676123|NCT02618928|7607220|FG000|STARTED|Overall Study||735
6676124|NCT02618928|7607220|FG000|Received Treatment|Overall Study||728
6676125|NCT02618928|7607220|FG000|COMPLETED|Overall Study||677
6676126|NCT02618928|7607220|FG000|NOT COMPLETED|Overall Study||58
6676127|NCT02618967|7607235|FG000|STARTED|Overall Study||6
6676128|NCT02618967|7607236|FG001|STARTED|Overall Study||6
6676129|NCT02618967|7607237|FG002|STARTED|Overall Study||6
6676130|NCT02618967|7607238|FG003|STARTED|Overall Study||6
6676131|NCT02618967|7607239|FG004|STARTED|Overall Study||6
6676132|NCT02618967|7607240|FG005|STARTED|Overall Study||6
6676133|NCT02618967|7607241|FG006|STARTED|Overall Study||6
6676134|NCT02618967|7607242|FG007|STARTED|Overall Study||14
6676135|NCT02618967|7607235|FG000|Received Treatment|Overall Study||6
6676136|NCT02618967|7607236|FG001|Received Treatment|Overall Study||6
6676137|NCT02618967|7607237|FG002|Received Treatment|Overall Study||6
6676138|NCT02618967|7607238|FG003|Received Treatment|Overall Study||6
6676139|NCT02618967|7607239|FG004|Received Treatment|Overall Study||6
6676140|NCT02618967|7607240|FG005|Received Treatment|Overall Study||6
6676141|NCT02618967|7607241|FG006|Received Treatment|Overall Study||6
6676142|NCT02618967|7607242|FG007|Received Treatment|Overall Study||14
6676143|NCT02618967|7607235|FG000|COMPLETED|Overall Study||5
6676144|NCT02618967|7607236|FG001|COMPLETED|Overall Study||6
6676145|NCT02618967|7607237|FG002|COMPLETED|Overall Study||5
6676146|NCT02618967|7607238|FG003|COMPLETED|Overall Study||6
6676147|NCT02618967|7607239|FG004|COMPLETED|Overall Study||4
6676148|NCT02618967|7607240|FG005|COMPLETED|Overall Study||6
6676149|NCT02618967|7607241|FG006|COMPLETED|Overall Study||6
6676150|NCT02618967|7607242|FG007|COMPLETED|Overall Study||14
6676151|NCT02618967|7607235|FG000|NOT COMPLETED|Overall Study||1
6676152|NCT02618967|7607236|FG001|NOT COMPLETED|Overall Study||0
6676153|NCT02618967|7607237|FG002|NOT COMPLETED|Overall Study||1
6676154|NCT02618967|7607238|FG003|NOT COMPLETED|Overall Study||0
6676155|NCT02618967|7607239|FG004|NOT COMPLETED|Overall Study||2
6676156|NCT02618967|7607240|FG005|NOT COMPLETED|Overall Study||0
6676157|NCT02618967|7607241|FG006|NOT COMPLETED|Overall Study||0
6676158|NCT02618967|7607242|FG007|NOT COMPLETED|Overall Study||0
6676159|NCT02619175|7607262|FG000|STARTED|Overall Study||18
6676160|NCT02619175|7607263|FG001|STARTED|Overall Study||16
6676161|NCT02619175|7607262|FG000|COMPLETED|Overall Study||16
6676162|NCT02619175|7607263|FG001|COMPLETED|Overall Study||16
6676163|NCT02619175|7607262|FG000|NOT COMPLETED|Overall Study||2
6676164|NCT02619175|7607263|FG001|NOT COMPLETED|Overall Study||0
6676165|NCT02619396|7607277|FG000|STARTED|Overall Study||20
6676166|NCT02619396|7607278|FG001|STARTED|Overall Study||20
6676167|NCT02619396|7607279|FG002|STARTED|Overall Study||20
6676168|NCT02619396|7607280|FG003|STARTED|Overall Study||20
6676169|NCT02619396|7607277|FG000|COMPLETED|Overall Study||20
6676170|NCT02619396|7607278|FG001|COMPLETED|Overall Study||20
6676171|NCT02619396|7607279|FG002|COMPLETED|Overall Study||20
6676172|NCT02619396|7607280|FG003|COMPLETED|Overall Study||20
6676173|NCT02619396|7607277|FG000|NOT COMPLETED|Overall Study||0
6676174|NCT02619396|7607278|FG001|NOT COMPLETED|Overall Study||0
6676175|NCT02619396|7607279|FG002|NOT COMPLETED|Overall Study||0
6676176|NCT02619396|7607280|FG003|NOT COMPLETED|Overall Study||0
6676177|NCT02619409|7607296|FG000|STARTED|Overall Study||6
6676178|NCT02619409|7607297|FG001|STARTED|Overall Study||6
6676179|NCT02619409|7607298|FG002|STARTED|Overall Study||6
6676180|NCT02619409|7607299|FG003|STARTED|Overall Study||6
6676181|NCT02619409|7607300|FG004|STARTED|Overall Study||6
6676182|NCT02619409|7607296|FG000|COMPLETED|Overall Study||6
6676183|NCT02619409|7607297|FG001|COMPLETED|Overall Study||6
6676184|NCT02619409|7607298|FG002|COMPLETED|Overall Study||6
6676185|NCT02619409|7607299|FG003|COMPLETED|Overall Study||6
6676186|NCT02619409|7607300|FG004|COMPLETED|Overall Study||6
6676187|NCT02619409|7607296|FG000|NOT COMPLETED|Overall Study||0
6676188|NCT02619409|7607297|FG001|NOT COMPLETED|Overall Study||0
6676189|NCT02619409|7607298|FG002|NOT COMPLETED|Overall Study||0
6676190|NCT02619409|7607299|FG003|NOT COMPLETED|Overall Study||0
6676191|NCT02619409|7607300|FG004|NOT COMPLETED|Overall Study||0
6676192|NCT02619591|7607314|FG000|STARTED|Overall Study||139
6676193|NCT02619591|7607315|FG001|STARTED|Overall Study||121
6676194|NCT02619591|7607314|FG000|COMPLETED|Overall Study||0
6676195|NCT02619591|7607315|FG001|COMPLETED|Overall Study||0
6676196|NCT02619591|7607314|FG000|NOT COMPLETED|Overall Study||139
6676197|NCT02619591|7607315|FG001|NOT COMPLETED|Overall Study||121
6676198|NCT02619617|7607321|FG000|STARTED|Period 1 Placebo - 1st AttacK||28
6676199|NCT02619617|7607322|FG001|STARTED|Period 1 Placebo - 1st AttacK||0
6676200|NCT02619617|7607321|FG000|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||20
6676201|NCT02619617|7607322|FG001|Participants Included in PD Analysis|Period 1 Placebo - 1st AttacK||0
6676202|NCT02619617|7607321|FG000|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||28
6676203|NCT02619617|7607322|FG001|Participants in Safety Set for Period 1|Period 1 Placebo - 1st AttacK||0
6676204|NCT02619617|7607321|FG000|COMPLETED|Period 1 Placebo - 1st AttacK||28
6676205|NCT02619617|7607322|FG001|COMPLETED|Period 1 Placebo - 1st AttacK||0
6676206|NCT02619617|7607321|FG000|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
6676207|NCT02619617|7607322|FG001|NOT COMPLETED|Period 1 Placebo - 1st AttacK||0
6676208|NCT02619617|7607321|FG000|STARTED|Period 2 SOM230 - 2nd Attack||0
6676209|NCT02619617|7607322|FG001|STARTED|Period 2 SOM230 - 2nd Attack||28
6676210|NCT02619617|7607321|FG000|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||0
6676211|NCT02619617|7607322|FG001|Participants in Safety Set for Period 2|Period 2 SOM230 - 2nd Attack||28
6676212|NCT02619617|7607321|FG000|COMPLETED|Period 2 SOM230 - 2nd Attack||0
6676213|NCT02619617|7607322|FG001|COMPLETED|Period 2 SOM230 - 2nd Attack||24
6676214|NCT02619617|7607321|FG000|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||0
6676215|NCT02619617|7607322|FG001|NOT COMPLETED|Period 2 SOM230 - 2nd Attack||4
6676216|NCT02619799|7607332|FG000|STARTED|Overall Study||25
6676217|NCT02619799|7607333|FG001|STARTED|Overall Study||25
6676218|NCT02619799|7607332|FG000|COMPLETED|Overall Study||25
6676219|NCT02619799|7607333|FG001|COMPLETED|Overall Study||25
6676220|NCT02619799|7607332|FG000|NOT COMPLETED|Overall Study||0
6676221|NCT02619799|7607333|FG001|NOT COMPLETED|Overall Study||0
6676222|NCT02620020|7607343|FG000|STARTED|Overall Study||141
6676223|NCT02620020|7607344|FG001|STARTED|Overall Study||141
6676224|NCT02620020|7607345|FG002|STARTED|Overall Study||140
6676225|NCT02620020|7607346|FG003|STARTED|Overall Study||141
6676226|NCT02620020|7607343|FG000|Modified Intent to Treat Set (mITT)|Overall Study||140
6676227|NCT02620020|7607344|FG001|Modified Intent to Treat Set (mITT)|Overall Study||139
6676228|NCT02620020|7607345|FG002|Modified Intent to Treat Set (mITT)|Overall Study||139
6676229|NCT02620020|7607346|FG003|Modified Intent to Treat Set (mITT)|Overall Study||140
6676230|NCT02620020|7607343|FG000|COMPLETED|Overall Study||97
6676231|NCT02620020|7607344|FG001|COMPLETED|Overall Study||106
6676232|NCT02620020|7607345|FG002|COMPLETED|Overall Study||115
6676233|NCT02620020|7607346|FG003|COMPLETED|Overall Study||115
6676234|NCT02620020|7607343|FG000|NOT COMPLETED|Overall Study||44
6676235|NCT02620020|7607344|FG001|NOT COMPLETED|Overall Study||35
6676236|NCT02620020|7607345|FG002|NOT COMPLETED|Overall Study||25
6676237|NCT02620020|7607346|FG003|NOT COMPLETED|Overall Study||26
6676238|NCT02620384|7607358|FG000|STARTED|Overall Study||70
6676239|NCT02620384|7607359|FG001|STARTED|Overall Study||73
6676240|NCT02620384|7607358|FG000|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
6676241|NCT02620384|7607359|FG001|COMPLETED|Overall Study|Per protocol design patients must receive both doses of investigational product to be in analysis.|66
6676242|NCT02620384|7607358|FG000|NOT COMPLETED|Overall Study||4
6676243|NCT02620384|7607359|FG001|NOT COMPLETED|Overall Study||7
6676244|NCT02620683|7607365|FG000|STARTED|First Intervention (Visit 1)||12
6676245|NCT02620683|7607366|FG001|STARTED|First Intervention (Visit 1)||11
6676246|NCT02620683|7607365|FG000|COMPLETED|First Intervention (Visit 1)||12
6676247|NCT02620683|7607366|FG001|COMPLETED|First Intervention (Visit 1)||11
6676248|NCT02620683|7607365|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
6676249|NCT02620683|7607366|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
6676250|NCT02620683|7607365|FG000|STARTED|Washout (2 Weeks)||12
6676251|NCT02620683|7607366|FG001|STARTED|Washout (2 Weeks)||11
6676252|NCT02620683|7607365|FG000|COMPLETED|Washout (2 Weeks)||12
6676253|NCT02620683|7607366|FG001|COMPLETED|Washout (2 Weeks)||11
6676254|NCT02620683|7607365|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6676255|NCT02620683|7607366|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6676256|NCT02620683|7607365|FG000|STARTED|Second Intervention (Visit 2)||12
6676257|NCT02620683|7607366|FG001|STARTED|Second Intervention (Visit 2)||11
6676258|NCT02620683|7607365|FG000|COMPLETED|Second Intervention (Visit 2)||12
6676259|NCT02620683|7607366|FG001|COMPLETED|Second Intervention (Visit 2)||11
6676260|NCT02620683|7607365|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
6676261|NCT02620683|7607366|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
6676262|NCT02620774|7607373|FG000|STARTED|Overall Study||10
6676263|NCT02620774|7607374|FG001|STARTED|Overall Study||6
6676264|NCT02620774|7607373|FG000|COMPLETED|Overall Study||10
6676265|NCT02620774|7607374|FG001|COMPLETED|Overall Study||6
6676266|NCT02620774|7607373|FG000|NOT COMPLETED|Overall Study||0
6676267|NCT02620774|7607374|FG001|NOT COMPLETED|Overall Study||0
6676268|NCT02620787|7607382|FG000|STARTED|Overall Study||12
6676269|NCT02620787|7607383|FG001|STARTED|Overall Study||6
6676270|NCT02620787|7607382|FG000|COMPLETED|Overall Study||10
6676271|NCT02620787|7607383|FG001|COMPLETED|Overall Study||6
6676272|NCT02620787|7607382|FG000|NOT COMPLETED|Overall Study||2
6676273|NCT02620787|7607383|FG001|NOT COMPLETED|Overall Study||0
6676274|NCT02620878|7607389|FG000|STARTED|Overall Study||16
6676275|NCT02620878|7607390|FG001|STARTED|Overall Study||16
6676276|NCT02620878|7607389|FG000|COMPLETED|Overall Study||16
6676277|NCT02620878|7607390|FG001|COMPLETED|Overall Study||16
6676278|NCT02620878|7607389|FG000|NOT COMPLETED|Overall Study||0
6676279|NCT02620878|7607390|FG001|NOT COMPLETED|Overall Study||0
6676280|NCT02620904|7607398|FG000|STARTED|Overall Study||4
6676281|NCT02620904|7607399|FG001|STARTED|Overall Study||5
6676282|NCT02620904|7607398|FG000|COMPLETED|Overall Study||4
6676283|NCT02620904|7607399|FG001|COMPLETED|Overall Study||5
6676284|NCT02620904|7607398|FG000|NOT COMPLETED|Overall Study||0
6676285|NCT02620904|7607399|FG001|NOT COMPLETED|Overall Study||0
6676286|NCT02620917|7607405|FG000|STARTED|Overall Study||6623
6676287|NCT02620917|7607405|FG000|COMPLETED|Overall Study||6623
6676288|NCT02620917|7607405|FG000|NOT COMPLETED|Overall Study||0
6676289|NCT02621034|7607414|FG000|STARTED|Overall Study||53
6676290|NCT02621034|7607415|FG001|STARTED|Overall Study||52
6676291|NCT02621034|7607416|FG002|STARTED|Overall Study||55
6676292|NCT02621034|7607414|FG000|COMPLETED|Overall Study||50
6676293|NCT02621034|7607415|FG001|COMPLETED|Overall Study||50
6676294|NCT02621034|7607416|FG002|COMPLETED|Overall Study||50
6676295|NCT02621034|7607414|FG000|NOT COMPLETED|Overall Study||3
6676296|NCT02621034|7607415|FG001|NOT COMPLETED|Overall Study||2
6676297|NCT02621034|7607416|FG002|NOT COMPLETED|Overall Study||5
6676298|NCT02621047|7607429|FG000|STARTED|Overall Study||8
6676299|NCT02621047|7607430|FG001|STARTED|Overall Study||8
6676300|NCT02621047|7607431|FG002|STARTED|Overall Study||12
6676301|NCT02621047|7607429|FG000|COMPLETED|Overall Study||8
6676302|NCT02621047|7607430|FG001|COMPLETED|Overall Study||8
6676303|NCT02621047|7607431|FG002|COMPLETED|Overall Study||11
6676304|NCT02621047|7607429|FG000|NOT COMPLETED|Overall Study||0
6676305|NCT02621047|7607430|FG001|NOT COMPLETED|Overall Study||0
6676306|NCT02621047|7607431|FG002|NOT COMPLETED|Overall Study||1
6676307|NCT02621060|7607442|FG000|STARTED|Overall Study||15
6676308|NCT02621060|7607443|FG001|STARTED|Overall Study||15
6676309|NCT02621060|7607442|FG000|COMPLETED|Overall Study||12
6676310|NCT02621060|7607443|FG001|COMPLETED|Overall Study||14
6676311|NCT02621060|7607442|FG000|NOT COMPLETED|Overall Study||3
6676312|NCT02621060|7607443|FG001|NOT COMPLETED|Overall Study||1
6676313|NCT02621073|7607451|FG000|STARTED|Overall Study||4
6676314|NCT02621073|7607452|FG001|STARTED|Overall Study||3
6676315|NCT02621073|7607451|FG000|COMPLETED|Overall Study||1
6676316|NCT02621073|7607452|FG001|COMPLETED|Overall Study||0
6676317|NCT02621073|7607451|FG000|NOT COMPLETED|Overall Study||3
6676318|NCT02621073|7607452|FG001|NOT COMPLETED|Overall Study||3
6676319|NCT02621463|7607458|FG000|STARTED|Overall Study||29
6676320|NCT02621463|7607458|FG000|COMPLETED|Overall Study||29
6676321|NCT02621463|7607458|FG000|NOT COMPLETED|Overall Study||0
6676322|NCT02621606|7607465|FG000|STARTED|Overall Study||3
6676323|NCT02621606|7607466|FG001|STARTED|Overall Study||7
6676324|NCT02621606|7607467|FG002|STARTED|Overall Study||10
6676325|NCT02621606|7607465|FG000|Treated|Overall Study||3
6676326|NCT02621606|7607466|FG001|Treated|Overall Study||7
6676327|NCT02621606|7607467|FG002|Treated|Overall Study||10
6676328|NCT02621606|7607465|FG000|COMPLETED|Overall Study||3
6676329|NCT02621606|7607466|FG001|COMPLETED|Overall Study||6
6676330|NCT02621606|7607467|FG002|COMPLETED|Overall Study||10
6676331|NCT02621606|7607465|FG000|NOT COMPLETED|Overall Study||0
6676332|NCT02621606|7607466|FG001|NOT COMPLETED|Overall Study||1
6676333|NCT02621606|7607467|FG002|NOT COMPLETED|Overall Study||0
6676334|NCT02621619|7607477|FG000|STARTED|Overall Study||80
6676335|NCT02621619|7607478|FG001|STARTED|Overall Study||79
6676336|NCT02621619|7607477|FG000|COMPLETED|Overall Study||80
6676337|NCT02621619|7607478|FG001|COMPLETED|Overall Study||79
6676338|NCT02621619|7607477|FG000|NOT COMPLETED|Overall Study||0
6676339|NCT02621619|7607478|FG001|NOT COMPLETED|Overall Study||0
6676340|NCT02621892|7607486|FG000|STARTED|Treatment Period||307
6676341|NCT02621892|7607487|FG001|STARTED|Treatment Period||299
6676342|NCT02621892|7607486|FG000|COMPLETED|Treatment Period||261
6676343|NCT02621892|7607487|FG001|COMPLETED|Treatment Period||272
6676344|NCT02621892|7607486|FG000|NOT COMPLETED|Treatment Period||46
6676345|NCT02621892|7607487|FG001|NOT COMPLETED|Treatment Period||27
6676346|NCT02621892|7607486|FG000|STARTED|Randomized Withdrawal Period||261
6676347|NCT02621892|7607487|FG001|STARTED|Randomized Withdrawal Period||272
6676348|NCT02621892|7607486|FG000|COMPLETED|Randomized Withdrawal Period||250
6676349|NCT02621892|7607487|FG001|COMPLETED|Randomized Withdrawal Period||260
6676350|NCT02621892|7607486|FG000|NOT COMPLETED|Randomized Withdrawal Period||11
6676351|NCT02621892|7607487|FG001|NOT COMPLETED|Randomized Withdrawal Period||12
6676352|NCT02621931|7607496|FG000|STARTED|Overall Study||375
6676353|NCT02621931|7607497|FG001|STARTED|Overall Study||376
6676354|NCT02621931|7607498|FG002|STARTED|Overall Study||379
6676355|NCT02621931|7607496|FG000|Safety and ITT Populations|Overall Study||375
6676356|NCT02621931|7607497|FG001|Safety and ITT Populations|Overall Study||376
6676357|NCT02621931|7607498|FG002|Safety and ITT Populations|Overall Study||379
6676358|NCT02621931|7607496|FG000|Full Analysis Set|Overall Study||371
6676359|NCT02621931|7607497|FG001|Full Analysis Set|Overall Study||375
6676360|NCT02621931|7607498|FG002|Full Analysis Set|Overall Study||375
6676361|NCT02621931|7607496|FG000|COMPLETED|Overall Study||342
6676362|NCT02621931|7607497|FG001|COMPLETED|Overall Study||349
6676363|NCT02621931|7607498|FG002|COMPLETED|Overall Study||343
6676364|NCT02621931|7607496|FG000|NOT COMPLETED|Overall Study||33
6676365|NCT02621931|7607497|FG001|NOT COMPLETED|Overall Study||27
6676366|NCT02621931|7607498|FG002|NOT COMPLETED|Overall Study||36
6676367|NCT02621983|7607510|FG000|STARTED|Overall Study||21
6676368|NCT02621983|7607511|FG001|STARTED|Overall Study||17
6676369|NCT02621983|7607510|FG000|COMPLETED|Overall Study||9
6676370|NCT02621983|7607511|FG001|COMPLETED|Overall Study||6
6676371|NCT02621983|7607510|FG000|NOT COMPLETED|Overall Study||12
6676372|NCT02621983|7607511|FG001|NOT COMPLETED|Overall Study||11
6676373|NCT02622074|7607523|FG000|STARTED|Overall Study||10
6676374|NCT02622074|7607524|FG001|STARTED|Overall Study||10
6676375|NCT02622074|7607525|FG002|STARTED|Overall Study||10
6676376|NCT02622074|7607526|FG003|STARTED|Overall Study||10
6676377|NCT02622074|7607527|FG004|STARTED|Overall Study||10
6676378|NCT02622074|7607528|FG005|STARTED|Overall Study||10
6676379|NCT02622074|7607523|FG000|COMPLETED|Overall Study||6
6676380|NCT02622074|7607524|FG001|COMPLETED|Overall Study||9
6676381|NCT02622074|7607525|FG002|COMPLETED|Overall Study||10
6676382|NCT02622074|7607526|FG003|COMPLETED|Overall Study||9
6676383|NCT02622074|7607527|FG004|COMPLETED|Overall Study||9
6676384|NCT02622074|7607528|FG005|COMPLETED|Overall Study||10
6676385|NCT02622074|7607523|FG000|NOT COMPLETED|Overall Study||4
6676386|NCT02622074|7607524|FG001|NOT COMPLETED|Overall Study||1
6676387|NCT02622074|7607525|FG002|NOT COMPLETED|Overall Study||0
6676388|NCT02622074|7607526|FG003|NOT COMPLETED|Overall Study||1
6676389|NCT02622074|7607527|FG004|NOT COMPLETED|Overall Study||1
6676390|NCT02622074|7607528|FG005|NOT COMPLETED|Overall Study||0
6676391|NCT02622113|7607544|FG000|STARTED|Overall Study||67
6676392|NCT02622113|7607545|FG001|STARTED|Overall Study||76
6676393|NCT02622113|7607544|FG000|COMPLETED|Overall Study||62
6676394|NCT02622113|7607545|FG001|COMPLETED|Overall Study||66
6676395|NCT02622113|7607544|FG000|NOT COMPLETED|Overall Study||5
6676396|NCT02622113|7607545|FG001|NOT COMPLETED|Overall Study||10
6676397|NCT02622178|7607554|FG000|STARTED|Overall Study||42
6676398|NCT02622178|7607555|FG001|STARTED|Overall Study||45
6676399|NCT02622178|7607556|FG002|STARTED|Overall Study||49
6676400|NCT02622178|7607554|FG000|COMPLETED|Overall Study||42
6676401|NCT02622178|7607555|FG001|COMPLETED|Overall Study||45
6676402|NCT02622178|7607556|FG002|COMPLETED|Overall Study||49
6676403|NCT02622178|7607554|FG000|NOT COMPLETED|Overall Study||0
6676404|NCT02622178|7607555|FG001|NOT COMPLETED|Overall Study||0
6676405|NCT02622178|7607556|FG002|NOT COMPLETED|Overall Study||0
6676406|NCT02622191|7607567|FG000|STARTED|Overall Study||19
6676407|NCT02622191|7607568|FG001|STARTED|Overall Study||14
6676408|NCT02622191|7607567|FG000|COMPLETED|Overall Study||19
6676409|NCT02622191|7607568|FG001|COMPLETED|Overall Study||14
6676410|NCT02622191|7607567|FG000|NOT COMPLETED|Overall Study||0
6676411|NCT02622191|7607568|FG001|NOT COMPLETED|Overall Study||0
6676412|NCT02622321|7607579|FG000|STARTED|Overall Study||35
6676413|NCT02622321|7607580|FG001|STARTED|Overall Study||18
6676414|NCT02622321|7607581|FG002|STARTED|Overall Study||49
6676415|NCT02622321|7607582|FG003|STARTED|Overall Study||11
6676416|NCT02622321|7607579|FG000|Received at Least One Dose of Treatment|Overall Study|1 participant withdrew prior to study Day 1.|34
6676417|NCT02622321|7607580|FG001|Received at Least One Dose of Treatment|Overall Study||18
6676418|NCT02622321|7607581|FG002|Received at Least One Dose of Treatment|Overall Study||49
6676419|NCT02622321|7607582|FG003|Received at Least One Dose of Treatment|Overall Study||11
6676420|NCT02622321|7607579|FG000|Completed 24 Weeks in the Study|Overall Study||31
6676421|NCT02622321|7607580|FG001|Completed 24 Weeks in the Study|Overall Study|After 24 weeks, all 18 participants in Arm B switched to receive emicizumab prophylaxis.|18
6676422|NCT02622321|7607581|FG002|Completed 24 Weeks in the Study|Overall Study||49
6676423|NCT02622321|7607582|FG003|Completed 24 Weeks in the Study|Overall Study||11
6676424|NCT02622321|7607579|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
6676425|NCT02622321|7607580|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
6676426|NCT02622321|7607581|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
6676427|NCT02622321|7607582|FG003|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
6676428|NCT02622321|7607579|FG000|COMPLETED|Overall Study||32
6676429|NCT02622321|7607580|FG001|COMPLETED|Overall Study||18
6676430|NCT02622321|7607581|FG002|COMPLETED|Overall Study||48
6676431|NCT02622321|7607582|FG003|COMPLETED|Overall Study||11
6676432|NCT02622321|7607579|FG000|NOT COMPLETED|Overall Study||3
6676433|NCT02622321|7607580|FG001|NOT COMPLETED|Overall Study||0
6676434|NCT02622321|7607581|FG002|NOT COMPLETED|Overall Study||1
6676435|NCT02622321|7607582|FG003|NOT COMPLETED|Overall Study||0
6676436|NCT02622568|7607608|FG000|STARTED|Overall Study||14
6676437|NCT02622568|7607609|FG001|STARTED|Overall Study||14
6676438|NCT02622568|7607608|FG000|COMPLETED|Overall Study||9
6676439|NCT02622568|7607609|FG001|COMPLETED|Overall Study||9
6676440|NCT02622568|7607608|FG000|NOT COMPLETED|Overall Study||5
6676441|NCT02622568|7607609|FG001|NOT COMPLETED|Overall Study||5
6738243|NCT03280615|7667568|FG000|STARTED|Overall Study||50
6738244|NCT03280615|7667569|FG001|STARTED|Overall Study||50
6738245|NCT03280615|7667568|FG000|COMPLETED|Overall Study||46
6738246|NCT03280615|7667569|FG001|COMPLETED|Overall Study||45
6738247|NCT03280615|7667568|FG000|NOT COMPLETED|Overall Study||4
6738248|NCT03280615|7667569|FG001|NOT COMPLETED|Overall Study||5
6738249|NCT03281200|7667575|FG000|STARTED|Overall Study||172
6738250|NCT03281200|7667575|FG000|COMPLETED|Overall Study||172
6738251|NCT03281200|7667575|FG000|NOT COMPLETED|Overall Study||0
6738252|NCT03281304|7667581|FG000|STARTED|Overall Study||70
6738253|NCT03281304|7667582|FG001|STARTED|Overall Study||70
6738254|NCT03281304|7667581|FG000|COMPLETED|Overall Study||57
6738255|NCT03281304|7667582|FG001|COMPLETED|Overall Study||58
6738256|NCT03281304|7667581|FG000|NOT COMPLETED|Overall Study||13
6738257|NCT03281304|7667582|FG001|NOT COMPLETED|Overall Study||12
6738258|NCT03281538|7667588|FG000|STARTED|Overall Study||288
6738259|NCT03281538|7667588|FG000|COMPLETED|Overall Study||133
6738260|NCT03281538|7667588|FG000|NOT COMPLETED|Overall Study||155
6738261|NCT03281577|7667596|FG000|STARTED|Overall Study||10
6738262|NCT03281577|7667597|FG001|STARTED|Overall Study||10
6738263|NCT03281577|7667598|FG002|STARTED|Overall Study||9
6738264|NCT03281577|7667599|FG003|STARTED|Overall Study||7
6738265|NCT03281577|7667596|FG000|COMPLETED|Overall Study||9
6738266|NCT03281577|7667597|FG001|COMPLETED|Overall Study||10
6738267|NCT03281577|7667598|FG002|COMPLETED|Overall Study||9
6738268|NCT03281577|7667599|FG003|COMPLETED|Overall Study||6
6738269|NCT03281577|7667596|FG000|NOT COMPLETED|Overall Study||1
6738270|NCT03281577|7667597|FG001|NOT COMPLETED|Overall Study||0
6738271|NCT03281577|7667598|FG002|NOT COMPLETED|Overall Study||0
6738272|NCT03281577|7667599|FG003|NOT COMPLETED|Overall Study||1
6738273|NCT03281668|7667612|FG000|STARTED|Overall Study||29
6738274|NCT03281668|7667612|FG000|COMPLETED|Overall Study||21
6738275|NCT03281668|7667612|FG000|NOT COMPLETED|Overall Study||8
6738276|NCT03281876|7667618|FG000|STARTED|Overall Study||304
6738277|NCT03281876|7667619|FG001|STARTED|Overall Study||302
6738278|NCT03281876|7667618|FG000|COMPLETED|Overall Study||281
6738279|NCT03281876|7667619|FG001|COMPLETED|Overall Study||263
6738280|NCT03281876|7667618|FG000|NOT COMPLETED|Overall Study||23
6738281|NCT03281876|7667619|FG001|NOT COMPLETED|Overall Study||39
6738282|NCT03282071|7667627|FG000|STARTED|Overall Study||75
6738283|NCT03282071|7667628|FG001|STARTED|Overall Study||69
6738284|NCT03282071|7667627|FG000|COMPLETED|Overall Study||65
6738285|NCT03282071|7667628|FG001|COMPLETED|Overall Study||60
6676442|NCT02622724|7607617|FG000|STARTED|Overall Study||144
6676443|NCT02622724|7607618|FG001|STARTED|Overall Study||152
6676444|NCT02622724|7607617|FG000|Subjects Randomised|Overall Study||146
6676445|NCT02622724|7607618|FG001|Subjects Randomised|Overall Study||155
6676446|NCT02622724|7607617|FG000|Short-Term Follow-Up (Day 28)|Overall Study||105
6676447|NCT02622724|7607618|FG001|Short-Term Follow-Up (Day 28)|Overall Study||115
6676448|NCT02622724|7607617|FG000|Long-Term Follow-Up (Day 90)|Overall Study||96
6676449|NCT02622724|7607618|FG001|Long-Term Follow-Up (Day 90)|Overall Study||101
6676450|NCT02622724|7607617|FG000|Long-Term Follow-Up (Day 180)|Overall Study||73
6676451|NCT02622724|7607618|FG001|Long-Term Follow-Up (Day 180)|Overall Study||74
6676452|NCT02622724|7607617|FG000|COMPLETED|Overall Study||51
6676453|NCT02622724|7607618|FG001|COMPLETED|Overall Study||49
6676454|NCT02622724|7607617|FG000|NOT COMPLETED|Overall Study||93
6676455|NCT02622724|7607618|FG001|NOT COMPLETED|Overall Study||103
6676456|NCT02623218|7607635|FG000|STARTED|Overall Study||5
6676457|NCT02623218|7607636|FG001|STARTED|Overall Study||4
6676458|NCT02623218|7607637|FG002|STARTED|Overall Study||4
6676459|NCT02623218|7607638|FG003|STARTED|Overall Study||4
6676460|NCT02623218|7607639|FG004|STARTED|Overall Study||4
6676461|NCT02623218|7607635|FG000|COMPLETED|Overall Study||5
6676462|NCT02623218|7607636|FG001|COMPLETED|Overall Study||3
6676463|NCT02623218|7607637|FG002|COMPLETED|Overall Study||4
6676464|NCT02623218|7607638|FG003|COMPLETED|Overall Study||4
6676465|NCT02623218|7607639|FG004|COMPLETED|Overall Study||4
6676466|NCT02623218|7607635|FG000|NOT COMPLETED|Overall Study||0
6676467|NCT02623218|7607636|FG001|NOT COMPLETED|Overall Study||1
6676468|NCT02623218|7607637|FG002|NOT COMPLETED|Overall Study||0
6676469|NCT02623218|7607638|FG003|NOT COMPLETED|Overall Study||0
6676470|NCT02623218|7607639|FG004|NOT COMPLETED|Overall Study||0
6676471|NCT02623322|7607654|FG000|STARTED|Overall Study||43
6676472|NCT02623322|7607655|FG001|STARTED|Overall Study||41
6676473|NCT02623322|7607656|FG002|STARTED|Overall Study||40
6676474|NCT02623322|7607654|FG000|COMPLETED|Overall Study||41
6676475|NCT02623322|7607655|FG001|COMPLETED|Overall Study||40
6676476|NCT02623322|7607656|FG002|COMPLETED|Overall Study||40
6676477|NCT02623322|7607654|FG000|NOT COMPLETED|Overall Study||2
6676478|NCT02623322|7607655|FG001|NOT COMPLETED|Overall Study||1
6676479|NCT02623322|7607656|FG002|NOT COMPLETED|Overall Study||0
6676480|NCT02623335|7607668|FG000|STARTED|Overall Study||223
6676481|NCT02623335|7607669|FG001|STARTED|Overall Study||223
6676482|NCT02623335|7607668|FG000|T0 Audio Recording (Day of Consultation)|Overall Study||223
6676483|NCT02623335|7607669|FG001|T0 Audio Recording (Day of Consultation)|Overall Study||222
6676484|NCT02623335|7607668|FG000|T1 Survey (24-48 Hours)|Overall Study||216
6676485|NCT02623335|7607669|FG001|T1 Survey (24-48 Hours)|Overall Study||214
6676486|NCT02623335|7607668|FG000|T2 Survey (6-8 Weeks)|Overall Study||199
6676487|NCT02623335|7607669|FG001|T2 Survey (6-8 Weeks)|Overall Study||192
6676488|NCT02623335|7607668|FG000|T3 Survey (12-14 Weeks)|Overall Study||196
6676489|NCT02623335|7607669|FG001|T3 Survey (12-14 Weeks)|Overall Study||187
6676490|NCT02623335|7607668|FG000|COMPLETED|Overall Study||196
6676491|NCT02623335|7607669|FG001|COMPLETED|Overall Study||187
6676492|NCT02623335|7607668|FG000|NOT COMPLETED|Overall Study||27
6676493|NCT02623335|7607669|FG001|NOT COMPLETED|Overall Study||36
6676494|NCT02623348|7607677|FG000|STARTED|Overall Study||30
6676495|NCT02623348|7607678|FG001|STARTED|Overall Study||30
6676496|NCT02623348|7607677|FG000|3-month Assessment|Overall Study||27
6676497|NCT02623348|7607678|FG001|3-month Assessment|Overall Study||26
6676498|NCT02623348|7607677|FG000|COMPLETED|Overall Study||27
6676499|NCT02623348|7607678|FG001|COMPLETED|Overall Study||28
6676500|NCT02623348|7607677|FG000|NOT COMPLETED|Overall Study||3
6676501|NCT02623348|7607678|FG001|NOT COMPLETED|Overall Study||2
6676502|NCT02623361|7607686|FG000|STARTED|Overall Study||40
6676503|NCT02623361|7607687|FG001|STARTED|Overall Study||40
6676504|NCT02623361|7607686|FG000|COMPLETED|Overall Study||40
6676505|NCT02623361|7607687|FG001|COMPLETED|Overall Study||38
6676506|NCT02623361|7607686|FG000|NOT COMPLETED|Overall Study||0
6676507|NCT02623361|7607687|FG001|NOT COMPLETED|Overall Study||2
6676508|NCT02623803|7607695|FG000|STARTED|Overall Study||25
6676509|NCT02623803|7607696|FG001|STARTED|Overall Study||23
6676510|NCT02623803|7607695|FG000|COMPLETED|Overall Study||25
6676511|NCT02623803|7607696|FG001|COMPLETED|Overall Study||23
6676512|NCT02623803|7607695|FG000|NOT COMPLETED|Overall Study||0
6676513|NCT02623803|7607696|FG001|NOT COMPLETED|Overall Study||0
6676514|NCT02623829|7607704|FG000|STARTED|Overall Study||21
6676515|NCT02623829|7607705|FG001|STARTED|Overall Study||21
6676516|NCT02623829|7607704|FG000|COMPLETED|Overall Study||20
6676517|NCT02623829|7607705|FG001|COMPLETED|Overall Study||20
6676518|NCT02623829|7607704|FG000|NOT COMPLETED|Overall Study||1
6676519|NCT02623829|7607705|FG001|NOT COMPLETED|Overall Study||1
6676520|NCT02623855|7607713|FG000|STARTED|Overall Study||56
6676521|NCT02623855|7607714|FG001|STARTED|Overall Study||100
6676522|NCT02623855|7607713|FG000|COMPLETED|Overall Study||46
6676523|NCT02623855|7607714|FG001|COMPLETED|Overall Study||84
6676524|NCT02623855|7607713|FG000|NOT COMPLETED|Overall Study||10
6676525|NCT02623855|7607714|FG001|NOT COMPLETED|Overall Study||16
6676526|NCT02624050|7607722|FG000|STARTED|Overall Study||26
6676527|NCT02624050|7607723|FG001|STARTED|Overall Study||25
6676528|NCT02624050|7607722|FG000|COMPLETED|Overall Study||20
6676529|NCT02624050|7607723|FG001|COMPLETED|Overall Study||25
6676530|NCT02624050|7607722|FG000|NOT COMPLETED|Overall Study||6
6676531|NCT02624050|7607723|FG001|NOT COMPLETED|Overall Study||0
6676532|NCT02624180|7607731|FG000|STARTED|Overall Study||43
6676533|NCT02624180|7607732|FG001|STARTED|Overall Study||38
6676534|NCT02624180|7607731|FG000|COMPLETED|Overall Study||37
6676535|NCT02624180|7607732|FG001|COMPLETED|Overall Study||34
6676536|NCT02624180|7607731|FG000|NOT COMPLETED|Overall Study||6
6676537|NCT02624180|7607732|FG001|NOT COMPLETED|Overall Study||4
6676538|NCT02624284|7607741|FG000|STARTED|Overall Study||49
6676539|NCT02624284|7607742|FG001|STARTED|Overall Study||53
6676540|NCT02624284|7607743|FG002|STARTED|Overall Study||47
6676541|NCT02624284|7607741|FG000|COMPLETED|Overall Study||35
6676542|NCT02624284|7607742|FG001|COMPLETED|Overall Study||35
6676543|NCT02624284|7607743|FG002|COMPLETED|Overall Study||36
6676544|NCT02624284|7607741|FG000|NOT COMPLETED|Overall Study||14
6676545|NCT02624284|7607742|FG001|NOT COMPLETED|Overall Study||18
6676546|NCT02624284|7607743|FG002|NOT COMPLETED|Overall Study||11
6676547|NCT02624375|7607751|FG000|STARTED|Overall Study||10
6676548|NCT02624375|7607751|FG000|COMPLETED|Overall Study||10
6676549|NCT02624375|7607751|FG000|NOT COMPLETED|Overall Study||0
6676550|NCT02624492|7607758|FG000|STARTED|Overall Study||5
6676551|NCT02624492|7607759|FG001|STARTED|Overall Study||8
6676552|NCT02624492|7607760|FG002|STARTED|Overall Study||8
6676553|NCT02624492|7607758|FG000|COMPLETED|Overall Study||3
6676554|NCT02624492|7607759|FG001|COMPLETED|Overall Study||4
6676555|NCT02624492|7607760|FG002|COMPLETED|Overall Study||3
6676556|NCT02624492|7607758|FG000|NOT COMPLETED|Overall Study||2
6676557|NCT02624492|7607759|FG001|NOT COMPLETED|Overall Study||4
6676558|NCT02624492|7607760|FG002|NOT COMPLETED|Overall Study||5
6676559|NCT02624687|7607770|FG000|STARTED|Overall Study||13
6676560|NCT02624687|7607771|FG001|STARTED|Overall Study||14
6676561|NCT02624687|7607770|FG000|COMPLETED|Overall Study||12
6676562|NCT02624687|7607771|FG001|COMPLETED|Overall Study||12
6676563|NCT02624687|7607770|FG000|NOT COMPLETED|Overall Study||1
6676564|NCT02624687|7607771|FG001|NOT COMPLETED|Overall Study||2
6676565|NCT02624700|7607779|FG000|STARTED|Overall Study||9
6676566|NCT02624700|7607780|FG001|STARTED|Overall Study||4
6676567|NCT02624700|7607779|FG000|COMPLETED|Overall Study||9
6676568|NCT02624700|7607780|FG001|COMPLETED|Overall Study||4
6676569|NCT02624700|7607779|FG000|NOT COMPLETED|Overall Study||0
6676570|NCT02624700|7607780|FG001|NOT COMPLETED|Overall Study||0
6676571|NCT02624713|7607790|FG000|STARTED|Overall Study||78
6676572|NCT02624713|7607791|FG001|STARTED|Overall Study||81
6676573|NCT02624713|7607790|FG000|COMPLETED|Overall Study||64
6676574|NCT02624713|7607791|FG001|COMPLETED|Overall Study||81
6676575|NCT02624713|7607790|FG000|NOT COMPLETED|Overall Study||14
6676576|NCT02624713|7607791|FG001|NOT COMPLETED|Overall Study||0
6676577|NCT02624791|7607798|FG000|STARTED|Overall Study||2
6676578|NCT02624791|7607799|FG001|STARTED|Overall Study||1
6676579|NCT02624791|7607800|FG002|STARTED|Overall Study||2
6676580|NCT02624791|7607801|FG003|STARTED|Overall Study||2
6676581|NCT02624791|7607802|FG004|STARTED|Overall Study||2
6676582|NCT02624791|7607803|FG005|STARTED|Overall Study||2
6676583|NCT02624791|7607798|FG000|COMPLETED|Overall Study||0
6676584|NCT02624791|7607799|FG001|COMPLETED|Overall Study||1
6676585|NCT02624791|7607800|FG002|COMPLETED|Overall Study||2
6676586|NCT02624791|7607801|FG003|COMPLETED|Overall Study||2
6676587|NCT02624791|7607802|FG004|COMPLETED|Overall Study||2
6676588|NCT02624791|7607803|FG005|COMPLETED|Overall Study||2
6676589|NCT02624791|7607798|FG000|NOT COMPLETED|Overall Study||2
6676590|NCT02624791|7607799|FG001|NOT COMPLETED|Overall Study||0
6676591|NCT02624791|7607800|FG002|NOT COMPLETED|Overall Study||0
6676592|NCT02624791|7607801|FG003|NOT COMPLETED|Overall Study||0
6676593|NCT02624791|7607802|FG004|NOT COMPLETED|Overall Study||0
6676594|NCT02624791|7607803|FG005|NOT COMPLETED|Overall Study||0
6676595|NCT02624843|7607810|FG000|STARTED|Overall Study||107
6676596|NCT02624843|7607811|FG001|STARTED|Overall Study||108
6676597|NCT02624843|7607812|FG002|STARTED|Overall Study||24
6676598|NCT02624843|7607810|FG000|COMPLETED|Overall Study||70
6676599|NCT02624843|7607811|FG001|COMPLETED|Overall Study||72
6676600|NCT02624843|7607812|FG002|COMPLETED|Overall Study||16
6676601|NCT02624843|7607810|FG000|NOT COMPLETED|Overall Study||37
6676602|NCT02624843|7607811|FG001|NOT COMPLETED|Overall Study||36
6676603|NCT02624843|7607812|FG002|NOT COMPLETED|Overall Study||8
6676604|NCT02624986|7607828|FG000|STARTED|Overall Study||2
6676605|NCT02624986|7607829|FG001|STARTED|Overall Study||3
6676606|NCT02624986|7607830|FG002|STARTED|Overall Study||2
6676607|NCT02624986|7607831|FG003|STARTED|Overall Study||3
6676608|NCT02624986|7607832|FG004|STARTED|Overall Study||4
6676609|NCT02624986|7607833|FG005|STARTED|Overall Study||2
6676610|NCT02624986|7607834|FG006|STARTED|Overall Study||4
6676611|NCT02624986|7607835|FG007|STARTED|Overall Study||5
6676612|NCT02624986|7607828|FG000|Received Any Study Treatment|Overall Study||1
6676613|NCT02624986|7607829|FG001|Received Any Study Treatment|Overall Study||3
6676614|NCT02624986|7607830|FG002|Received Any Study Treatment|Overall Study||2
6676615|NCT02624986|7607831|FG003|Received Any Study Treatment|Overall Study||3
6676616|NCT02624986|7607832|FG004|Received Any Study Treatment|Overall Study||4
6676617|NCT02624986|7607833|FG005|Received Any Study Treatment|Overall Study||2
6676618|NCT02624986|7607834|FG006|Received Any Study Treatment|Overall Study||4
6676619|NCT02624986|7607835|FG007|Received Any Study Treatment|Overall Study||5
6676620|NCT02624986|7607828|FG000|COMPLETED|Overall Study||0
6676621|NCT02624986|7607829|FG001|COMPLETED|Overall Study||0
6676622|NCT02624986|7607830|FG002|COMPLETED|Overall Study||0
6676623|NCT02624986|7607831|FG003|COMPLETED|Overall Study||0
6676624|NCT02624986|7607832|FG004|COMPLETED|Overall Study||0
6676625|NCT02624986|7607833|FG005|COMPLETED|Overall Study||0
6676626|NCT02624986|7607834|FG006|COMPLETED|Overall Study||0
6676627|NCT02624986|7607835|FG007|COMPLETED|Overall Study||0
6676628|NCT02624986|7607828|FG000|NOT COMPLETED|Overall Study||2
6676629|NCT02624986|7607829|FG001|NOT COMPLETED|Overall Study||3
6676630|NCT02624986|7607830|FG002|NOT COMPLETED|Overall Study||2
6676631|NCT02624986|7607831|FG003|NOT COMPLETED|Overall Study||3
6676632|NCT02624986|7607832|FG004|NOT COMPLETED|Overall Study||4
6676633|NCT02624986|7607833|FG005|NOT COMPLETED|Overall Study||2
6676634|NCT02624986|7607834|FG006|NOT COMPLETED|Overall Study||4
6676635|NCT02624986|7607835|FG007|NOT COMPLETED|Overall Study||5
6676636|NCT02625181|7607860|FG000|STARTED|Overall Study||1518
6676637|NCT02625181|7607861|FG001|STARTED|Overall Study||12809
6676638|NCT02625181|7607862|FG002|STARTED|Overall Study||12707
6676639|NCT02625181|7607860|FG000|COMPLETED|Overall Study||1518
6676640|NCT02625181|7607861|FG001|COMPLETED|Overall Study||12809
6676641|NCT02625181|7607862|FG002|COMPLETED|Overall Study||12707
6676642|NCT02625181|7607860|FG000|NOT COMPLETED|Overall Study||0
6676643|NCT02625181|7607861|FG001|NOT COMPLETED|Overall Study||0
6676644|NCT02625181|7607862|FG002|NOT COMPLETED|Overall Study||0
6676645|NCT02625207|7607872|FG000|STARTED|Part 1 (6 Days)||11
6676646|NCT02625207|7607873|FG001|STARTED|Part 1 (6 Days)||12
6676647|NCT02625207|7607874|FG002|STARTED|Part 1 (6 Days)||12
6676648|NCT02625207|7607875|FG003|STARTED|Part 1 (6 Days)||12
6676649|NCT02625207|7607872|FG000|COMPLETED|Part 1 (6 Days)||11
6676650|NCT02625207|7607873|FG001|COMPLETED|Part 1 (6 Days)||12
6676651|NCT02625207|7607874|FG002|COMPLETED|Part 1 (6 Days)||12
6676652|NCT02625207|7607875|FG003|COMPLETED|Part 1 (6 Days)||12
6676653|NCT02625207|7607872|FG000|NOT COMPLETED|Part 1 (6 Days)||0
6676654|NCT02625207|7607873|FG001|NOT COMPLETED|Part 1 (6 Days)||0
6676655|NCT02625207|7607874|FG002|NOT COMPLETED|Part 1 (6 Days)||0
6676656|NCT02625207|7607875|FG003|NOT COMPLETED|Part 1 (6 Days)||0
6676657|NCT02625207|7607872|FG000|STARTED|Part 2 (11 Days)||11
6676658|NCT02625207|7607873|FG001|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
6676659|NCT02625207|7607874|FG002|STARTED|Part 2 (11 Days)||12
6676660|NCT02625207|7607875|FG003|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
6676661|NCT02625207|7607872|FG000|COMPLETED|Part 2 (11 Days)||11
6676662|NCT02625207|7607873|FG001|COMPLETED|Part 2 (11 Days)||0
6676663|NCT02625207|7607874|FG002|COMPLETED|Part 2 (11 Days)||12
6676664|NCT02625207|7607875|FG003|COMPLETED|Part 2 (11 Days)||0
6676665|NCT02625207|7607872|FG000|NOT COMPLETED|Part 2 (11 Days)||0
6676666|NCT02625207|7607873|FG001|NOT COMPLETED|Part 2 (11 Days)||0
6676667|NCT02625207|7607874|FG002|NOT COMPLETED|Part 2 (11 Days)||0
6676668|NCT02625207|7607875|FG003|NOT COMPLETED|Part 2 (11 Days)||0
6676669|NCT02625220|7607891|FG000|STARTED|Overall Study||170
6676670|NCT02625220|7607891|FG000|COMPLETED|Overall Study||163
6676671|NCT02625220|7607891|FG000|NOT COMPLETED|Overall Study||7
6676672|NCT02625233|7607897|FG000|STARTED|Overall Study||49
6676673|NCT02625233|7607898|FG001|STARTED|Overall Study||56
6676674|NCT02625233|7607897|FG000|COMPLETED|Overall Study||47
6676675|NCT02625233|7607898|FG001|COMPLETED|Overall Study||56
6676676|NCT02625233|7607897|FG000|NOT COMPLETED|Overall Study||2
6676677|NCT02625233|7607898|FG001|NOT COMPLETED|Overall Study||0
6676678|NCT02625259|7607909|FG000|STARTED|First Intervention (Day 1)||11
6676679|NCT02625259|7607910|FG001|STARTED|First Intervention (Day 1)||9
6676680|NCT02625259|7607911|FG002|STARTED|First Intervention (Day 1)||8
6676681|NCT02625259|7607912|FG003|STARTED|First Intervention (Day 1)||10
6676682|NCT02625259|7607913|FG004|STARTED|First Intervention (Day 1)||16
6676683|NCT02625259|7607909|FG000|COMPLETED|First Intervention (Day 1)||9
6676684|NCT02625259|7607910|FG001|COMPLETED|First Intervention (Day 1)||8
6676685|NCT02625259|7607911|FG002|COMPLETED|First Intervention (Day 1)||7
6676686|NCT02625259|7607912|FG003|COMPLETED|First Intervention (Day 1)||9
6676687|NCT02625259|7607913|FG004|COMPLETED|First Intervention (Day 1)||16
6676688|NCT02625259|7607909|FG000|NOT COMPLETED|First Intervention (Day 1)||2
6676689|NCT02625259|7607910|FG001|NOT COMPLETED|First Intervention (Day 1)||1
6676690|NCT02625259|7607911|FG002|NOT COMPLETED|First Intervention (Day 1)||1
6676691|NCT02625259|7607912|FG003|NOT COMPLETED|First Intervention (Day 1)||1
6676692|NCT02625259|7607913|FG004|NOT COMPLETED|First Intervention (Day 1)||0
6676693|NCT02625259|7607909|FG000|STARTED|Washout (Day 2 to Day 14)||9
6676694|NCT02625259|7607910|FG001|STARTED|Washout (Day 2 to Day 14)||8
6676695|NCT02625259|7607911|FG002|STARTED|Washout (Day 2 to Day 14)||7
6676696|NCT02625259|7607912|FG003|STARTED|Washout (Day 2 to Day 14)||9
6676697|NCT02625259|7607913|FG004|STARTED|Washout (Day 2 to Day 14)||0
6676698|NCT02625259|7607909|FG000|COMPLETED|Washout (Day 2 to Day 14)||9
6676699|NCT02625259|7607910|FG001|COMPLETED|Washout (Day 2 to Day 14)||8
6676700|NCT02625259|7607911|FG002|COMPLETED|Washout (Day 2 to Day 14)||7
6676701|NCT02625259|7607912|FG003|COMPLETED|Washout (Day 2 to Day 14)||9
6676702|NCT02625259|7607913|FG004|COMPLETED|Washout (Day 2 to Day 14)||0
6676703|NCT02625259|7607909|FG000|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6676704|NCT02625259|7607910|FG001|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6676705|NCT02625259|7607911|FG002|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6676706|NCT02625259|7607912|FG003|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6676707|NCT02625259|7607913|FG004|NOT COMPLETED|Washout (Day 2 to Day 14)||0
6676708|NCT02625259|7607909|FG000|STARTED|Second Intervention (Day 15)||9
6676709|NCT02625259|7607910|FG001|STARTED|Second Intervention (Day 15)||8
6676710|NCT02625259|7607911|FG002|STARTED|Second Intervention (Day 15)||7
6676711|NCT02625259|7607912|FG003|STARTED|Second Intervention (Day 15)||9
6676712|NCT02625259|7607913|FG004|STARTED|Second Intervention (Day 15)||0
6676713|NCT02625259|7607909|FG000|COMPLETED|Second Intervention (Day 15)||9
6676714|NCT02625259|7607910|FG001|COMPLETED|Second Intervention (Day 15)||8
6676715|NCT02625259|7607911|FG002|COMPLETED|Second Intervention (Day 15)||7
6676716|NCT02625259|7607912|FG003|COMPLETED|Second Intervention (Day 15)||9
6676717|NCT02625259|7607913|FG004|COMPLETED|Second Intervention (Day 15)||0
6676718|NCT02625259|7607909|FG000|NOT COMPLETED|Second Intervention (Day 15)||0
6676719|NCT02625259|7607910|FG001|NOT COMPLETED|Second Intervention (Day 15)||0
6676720|NCT02625259|7607911|FG002|NOT COMPLETED|Second Intervention (Day 15)||0
6676721|NCT02625259|7607912|FG003|NOT COMPLETED|Second Intervention (Day 15)||0
6676722|NCT02625259|7607913|FG004|NOT COMPLETED|Second Intervention (Day 15)||0
6676723|NCT02625298|7607930|FG000|STARTED|Overall Study||11
6676724|NCT02625298|7607931|FG001|STARTED|Overall Study||13
6676725|NCT02625298|7607930|FG000|COMPLETED|Overall Study||10
6676726|NCT02625298|7607931|FG001|COMPLETED|Overall Study||13
6676727|NCT02625298|7607930|FG000|NOT COMPLETED|Overall Study||1
6676728|NCT02625298|7607931|FG001|NOT COMPLETED|Overall Study||0
6676729|NCT02625324|7607939|FG000|STARTED|30-Day Follow-up for Primary Endpoint|The 30-day primary endpoint was evaluated when 87 subjects completed 30-day follow-up.|87
6676730|NCT02625324|7607939|FG000|COMPLETED|30-Day Follow-up for Primary Endpoint||86
6676731|NCT02625324|7607939|FG000|NOT COMPLETED|30-Day Follow-up for Primary Endpoint||1
6676732|NCT02625324|7607939|FG000|STARTED|30-Day Follow-up for Secondary Endpoint|The 30-day secondary endpoint was evaluated when 100 subjects completed 30-day follow-up.|100
6676733|NCT02625324|7607939|FG000|COMPLETED|30-Day Follow-up for Secondary Endpoint||99
6676734|NCT02625324|7607939|FG000|NOT COMPLETED|30-Day Follow-up for Secondary Endpoint||1
6676735|NCT02625324|7607939|FG000|STARTED|6-Month Follow-up Subject Accountability|Note that 6-month follow up is not mandatory for OUS subjects|99
6676736|NCT02625324|7607939|FG000|COMPLETED|6-Month Follow-up Subject Accountability||91
6676737|NCT02625324|7607939|FG000|NOT COMPLETED|6-Month Follow-up Subject Accountability||8
6676738|NCT02625324|7607939|FG000|STARTED|12-Month Follow-up Secondary Endpoint||91
6676739|NCT02625324|7607939|FG000|COMPLETED|12-Month Follow-up Secondary Endpoint||87
6676740|NCT02625324|7607939|FG000|NOT COMPLETED|12-Month Follow-up Secondary Endpoint||4
6676741|NCT02625324|7607939|FG000|STARTED|24-Month Follow-up Secondary Endpoint||87
6676742|NCT02625324|7607939|FG000|COMPLETED|24-Month Follow-up Secondary Endpoint||52
6676743|NCT02625324|7607939|FG000|NOT COMPLETED|24-Month Follow-up Secondary Endpoint||35
6676744|NCT02625402|7607951|FG000|STARTED|Overall Study||42
6676745|NCT02625402|7607952|FG001|STARTED|Overall Study||37
6676746|NCT02625402|7607951|FG000|COMPLETED|Overall Study||33
6676747|NCT02625402|7607952|FG001|COMPLETED|Overall Study||25
6676748|NCT02625402|7607951|FG000|NOT COMPLETED|Overall Study||9
6676749|NCT02625402|7607952|FG001|NOT COMPLETED|Overall Study||12
6676750|NCT02625428|7607960|FG000|STARTED|Overall Study||20
6676751|NCT02625428|7607961|FG001|STARTED|Overall Study||20
6676752|NCT02625428|7607960|FG000|COMPLETED|Overall Study||20
6676753|NCT02625428|7607961|FG001|COMPLETED|Overall Study||20
6676754|NCT02625428|7607960|FG000|NOT COMPLETED|Overall Study||0
6676755|NCT02625428|7607961|FG001|NOT COMPLETED|Overall Study||0
6676756|NCT02625545|7607967|FG000|STARTED|Overall Study||45
6676757|NCT02625545|7607967|FG000|3 Month|Overall Study||45
6676758|NCT02625545|7607967|FG000|6 Month|Overall Study||45
6676759|NCT02625545|7607967|FG000|12 Month|Overall Study||45
6676760|NCT02625545|7607967|FG000|COMPLETED|Overall Study||45
6676761|NCT02625545|7607967|FG000|NOT COMPLETED|Overall Study||0
6676762|NCT02625571|7607971|FG000|STARTED|Overall Study||13
6676763|NCT02625571|7607971|FG000|COMPLETED|Overall Study||10
6676764|NCT02625571|7607971|FG000|NOT COMPLETED|Overall Study||3
6676765|NCT02625610|7607977|FG000|STARTED|Overall Study||250
6676766|NCT02625610|7607978|FG001|STARTED|Overall Study||249
6676767|NCT02625610|7607977|FG000|Safety-Maintenance Analysis Set|Overall Study||238
6676768|NCT02625610|7607978|FG001|Safety-Maintenance Analysis Set|Overall Study||243
6676769|NCT02625610|7607977|FG000|COMPLETED|Overall Study||216
6676770|NCT02625610|7607978|FG001|COMPLETED|Overall Study||195
6676771|NCT02625610|7607977|FG000|NOT COMPLETED|Overall Study||34
6676772|NCT02625610|7607978|FG001|NOT COMPLETED|Overall Study||54
6676773|NCT02625623|7607986|FG000|STARTED|Overall Study||186
6676774|NCT02625623|7607987|FG001|STARTED|Overall Study||185
6676775|NCT02625623|7607986|FG000|Treated|Overall Study||177
6676776|NCT02625623|7607987|FG001|Treated|Overall Study||184
6676777|NCT02625623|7607986|FG000|COMPLETED|Overall Study||177
6676778|NCT02625623|7607987|FG001|COMPLETED|Overall Study||184
6676779|NCT02625623|7607986|FG000|NOT COMPLETED|Overall Study||9
6676780|NCT02625623|7607987|FG001|NOT COMPLETED|Overall Study||1
6676781|NCT02625844|7607995|FG000|STARTED|Overall Study||110
6676782|NCT02625844|7607995|FG000|COMPLETED|Overall Study||110
6676783|NCT02625844|7607995|FG000|NOT COMPLETED|Overall Study||0
6676784|NCT02625909|7608001|FG000|STARTED|Overall Study||93
6676785|NCT02625909|7608002|FG001|STARTED|Overall Study||95
6676786|NCT02625909|7608001|FG000|COMPLETED|Overall Study||76
6676787|NCT02625909|7608002|FG001|COMPLETED|Overall Study||86
6676788|NCT02625909|7608001|FG000|NOT COMPLETED|Overall Study||17
6676789|NCT02625909|7608002|FG001|NOT COMPLETED|Overall Study||9
6676790|NCT02625922|7608010|FG000|STARTED|Overall Study||14
6676791|NCT02625922|7608011|FG001|STARTED|Overall Study||12
6676792|NCT02625922|7608010|FG000|Completed Treatment Period 1|Overall Study||12
6676793|NCT02625922|7608011|FG001|Completed Treatment Period 1|Overall Study||10
6676794|NCT02625922|7608010|FG000|Completed Treatment Period 2|Overall Study||11
6676795|NCT02625922|7608011|FG001|Completed Treatment Period 2|Overall Study||8
6676796|NCT02625922|7608010|FG000|COMPLETED|Overall Study||12
6676797|NCT02625922|7608011|FG001|COMPLETED|Overall Study||10
6256279|NCT01970865|7155093|FG008|NOT COMPLETED|Overall Study||3
6676798|NCT02625922|7608010|FG000|NOT COMPLETED|Overall Study||2
6676799|NCT02625922|7608011|FG001|NOT COMPLETED|Overall Study||2
6676800|NCT02625974|7608022|FG000|STARTED|Overall Study||219
6676801|NCT02625974|7608023|FG001|STARTED|Overall Study||111
6676802|NCT02625974|7608022|FG000|Received Treatment|Overall Study||219
6676803|NCT02625974|7608023|FG001|Received Treatment|Overall Study||111
6676804|NCT02625974|7608022|FG000|COMPLETED|Overall Study||203
6676805|NCT02625974|7608023|FG001|COMPLETED|Overall Study||105
6676806|NCT02625974|7608022|FG000|NOT COMPLETED|Overall Study||16
6676807|NCT02625974|7608023|FG001|NOT COMPLETED|Overall Study||6
6676808|NCT02626000|7608065|FG000|STARTED|Overall Study||36
6676809|NCT02626000|7608065|FG000|COMPLETED|Overall Study||6
6676810|NCT02626000|7608065|FG000|NOT COMPLETED|Overall Study||30
6676811|NCT02626026|7608076|FG000|STARTED|Overall Study||8
6676812|NCT02626026|7608077|FG001|STARTED|Overall Study||2
6676813|NCT02626026|7608078|FG002|STARTED|Overall Study||8
6676814|NCT02626026|7608079|FG003|STARTED|Overall Study||2
6676815|NCT02626026|7608080|FG004|STARTED|Overall Study||17
6676816|NCT02626026|7608081|FG005|STARTED|Overall Study||5
6676817|NCT02626026|7608076|FG000|COMPLETED|Overall Study||8
6676818|NCT02626026|7608077|FG001|COMPLETED|Overall Study||2
6676819|NCT02626026|7608078|FG002|COMPLETED|Overall Study||8
6676820|NCT02626026|7608079|FG003|COMPLETED|Overall Study||2
6676821|NCT02626026|7608080|FG004|COMPLETED|Overall Study||16
6676822|NCT02626026|7608081|FG005|COMPLETED|Overall Study||5
6676823|NCT02626026|7608076|FG000|NOT COMPLETED|Overall Study||0
6676824|NCT02626026|7608077|FG001|NOT COMPLETED|Overall Study||0
6676825|NCT02626026|7608078|FG002|NOT COMPLETED|Overall Study||0
6676826|NCT02626026|7608079|FG003|NOT COMPLETED|Overall Study||0
6676827|NCT02626026|7608080|FG004|NOT COMPLETED|Overall Study||1
6676828|NCT02626026|7608081|FG005|NOT COMPLETED|Overall Study||0
6676829|NCT02626156|7608101|FG000|STARTED|Baseline (Visit 1 to Visit 2)||29
6676830|NCT02626156|7608102|FG001|STARTED|Baseline (Visit 1 to Visit 2)||29
6676831|NCT02626156|7608103|FG002|STARTED|Baseline (Visit 1 to Visit 2)||42
6676832|NCT02626156|7608104|FG003|STARTED|Baseline (Visit 1 to Visit 2)||40
6676833|NCT02626156|7608101|FG000|COMPLETED|Baseline (Visit 1 to Visit 2)||23
6676834|NCT02626156|7608102|FG001|COMPLETED|Baseline (Visit 1 to Visit 2)||22
6676835|NCT02626156|7608103|FG002|COMPLETED|Baseline (Visit 1 to Visit 2)||37
6676836|NCT02626156|7608104|FG003|COMPLETED|Baseline (Visit 1 to Visit 2)||35
6676837|NCT02626156|7608101|FG000|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||6
6676838|NCT02626156|7608102|FG001|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||7
6676839|NCT02626156|7608103|FG002|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
6676840|NCT02626156|7608104|FG003|NOT COMPLETED|Baseline (Visit 1 to Visit 2)||5
6676841|NCT02626156|7608101|FG000|STARTED|Study Visit 3||23
6676842|NCT02626156|7608102|FG001|STARTED|Study Visit 3||22
6676843|NCT02626156|7608103|FG002|STARTED|Study Visit 3||37
6676844|NCT02626156|7608104|FG003|STARTED|Study Visit 3||35
6676845|NCT02626156|7608101|FG000|COMPLETED|Study Visit 3||15
6676846|NCT02626156|7608102|FG001|COMPLETED|Study Visit 3||17
6676847|NCT02626156|7608103|FG002|COMPLETED|Study Visit 3||33
6676848|NCT02626156|7608104|FG003|COMPLETED|Study Visit 3||33
6676849|NCT02626156|7608101|FG000|NOT COMPLETED|Study Visit 3||8
6676850|NCT02626156|7608102|FG001|NOT COMPLETED|Study Visit 3||5
6676851|NCT02626156|7608103|FG002|NOT COMPLETED|Study Visit 3||4
6676852|NCT02626156|7608104|FG003|NOT COMPLETED|Study Visit 3||2
6676853|NCT02626156|7608101|FG000|STARTED|Study Visit 4||15
6676854|NCT02626156|7608102|FG001|STARTED|Study Visit 4||17
6676855|NCT02626156|7608103|FG002|STARTED|Study Visit 4||33
6676856|NCT02626156|7608104|FG003|STARTED|Study Visit 4||33
6676857|NCT02626156|7608101|FG000|COMPLETED|Study Visit 4||12
6676858|NCT02626156|7608102|FG001|COMPLETED|Study Visit 4||15
6676859|NCT02626156|7608103|FG002|COMPLETED|Study Visit 4||24
6676860|NCT02626156|7608104|FG003|COMPLETED|Study Visit 4||28
6676861|NCT02626156|7608101|FG000|NOT COMPLETED|Study Visit 4||3
6676862|NCT02626156|7608102|FG001|NOT COMPLETED|Study Visit 4||2
6676863|NCT02626156|7608103|FG002|NOT COMPLETED|Study Visit 4||9
6676864|NCT02626156|7608104|FG003|NOT COMPLETED|Study Visit 4||5
6676865|NCT02626182|7608122|FG000|STARTED|Overall Study||11
6676866|NCT02626182|7608123|FG001|STARTED|Overall Study||3
6676867|NCT02626182|7608122|FG000|COMPLETED|Overall Study||9
6676868|NCT02626182|7608123|FG001|COMPLETED|Overall Study||3
6676869|NCT02626182|7608122|FG000|NOT COMPLETED|Overall Study||2
6676870|NCT02626182|7608123|FG001|NOT COMPLETED|Overall Study||0
6676871|NCT02626611|7608132|FG000|STARTED|Overall Study||20
6676872|NCT02626611|7608133|FG001|STARTED|Overall Study||21
6676873|NCT02626611|7608134|FG002|STARTED|Overall Study||19
6676874|NCT02626611|7608132|FG000|COMPLETED|Overall Study||16
6676875|NCT02626611|7608133|FG001|COMPLETED|Overall Study||20
6676876|NCT02626611|7608134|FG002|COMPLETED|Overall Study||16
6676877|NCT02626611|7608132|FG000|NOT COMPLETED|Overall Study||4
6676878|NCT02626611|7608133|FG001|NOT COMPLETED|Overall Study||1
6676879|NCT02626611|7608134|FG002|NOT COMPLETED|Overall Study||3
6676880|NCT02626780|7608149|FG000|STARTED|Overall Study||7
6676881|NCT02626780|7608149|FG000|Withdrew From Study|Overall Study||3
6676882|NCT02626780|7608149|FG000|COMPLETED|Overall Study||4
6676883|NCT02626780|7608149|FG000|NOT COMPLETED|Overall Study||3
6676884|NCT02626819|7608155|FG000|STARTED|Overall Study||22
6676885|NCT02626819|7608156|FG001|STARTED|Overall Study||23
6676886|NCT02626819|7608155|FG000|COMPLETED|Overall Study||18
6676887|NCT02626819|7608156|FG001|COMPLETED|Overall Study||20
6676888|NCT02626819|7608155|FG000|NOT COMPLETED|Overall Study||4
6676889|NCT02626819|7608156|FG001|NOT COMPLETED|Overall Study||3
6676890|NCT02626910|7608166|FG000|STARTED|Overall Study||23
6676891|NCT02626910|7608167|FG001|STARTED|Overall Study||10
6676892|NCT02626910|7608168|FG002|STARTED|Overall Study||6
6676893|NCT02626910|7608169|FG003|STARTED|Overall Study||10
6676894|NCT02626910|7608166|FG000|COMPLETED|Overall Study||23
6676895|NCT02626910|7608167|FG001|COMPLETED|Overall Study||10
6676896|NCT02626910|7608168|FG002|COMPLETED|Overall Study||6
6676897|NCT02626910|7608169|FG003|COMPLETED|Overall Study||10
6676898|NCT02626910|7608166|FG000|NOT COMPLETED|Overall Study||0
6676899|NCT02626910|7608167|FG001|NOT COMPLETED|Overall Study||0
6676900|NCT02626910|7608168|FG002|NOT COMPLETED|Overall Study||0
6676901|NCT02626910|7608169|FG003|NOT COMPLETED|Overall Study||0
6676902|NCT02627001|7608181|FG000|STARTED|Overall Study||13
6676903|NCT02627001|7608182|FG001|STARTED|Overall Study||14
6676904|NCT02627001|7608181|FG000|COMPLETED|Overall Study||13
6676905|NCT02627001|7608182|FG001|COMPLETED|Overall Study||14
6676906|NCT02627001|7608181|FG000|NOT COMPLETED|Overall Study||0
6676907|NCT02627001|7608182|FG001|NOT COMPLETED|Overall Study||0
6676908|NCT02627118|7608188|FG000|STARTED|Overall Study||10
6676909|NCT02627118|7608188|FG000|COMPLETED|Overall Study||10
6676910|NCT02627118|7608188|FG000|NOT COMPLETED|Overall Study||0
6676911|NCT02627144|7608193|FG000|STARTED|Overall Study||365
6676912|NCT02627144|7608193|FG000|Treated|Overall Study||359
6676913|NCT02627144|7608193|FG000|COMPLETED|Overall Study||0
6676914|NCT02627144|7608193|FG000|NOT COMPLETED|Overall Study||365
6676915|NCT02627495|7608197|FG000|STARTED|Overall Study||9
6676916|NCT02627495|7608197|FG000|COMPLETED|Overall Study||5
6676917|NCT02627495|7608197|FG000|NOT COMPLETED|Overall Study||4
6676918|NCT02627677|7608204|FG000|STARTED|Overall Study||11
6676919|NCT02627677|7608205|FG001|STARTED|Overall Study||21
6676920|NCT02627677|7608206|FG002|STARTED|Overall Study||12
6676921|NCT02627677|7608204|FG000|COMPLETED|Overall Study||0
6676922|NCT02627677|7608205|FG001|COMPLETED|Overall Study||0
6676923|NCT02627677|7608206|FG002|COMPLETED|Overall Study||0
6676924|NCT02627677|7608204|FG000|NOT COMPLETED|Overall Study||11
6676925|NCT02627677|7608205|FG001|NOT COMPLETED|Overall Study||21
6676926|NCT02627677|7608206|FG002|NOT COMPLETED|Overall Study||12
6676927|NCT02627794|7608215|FG000|STARTED|Overall Study||3
6676928|NCT02627794|7608215|FG000|COMPLETED|Overall Study||3
6676929|NCT02627794|7608215|FG000|NOT COMPLETED|Overall Study||0
6676930|NCT02627924|7608222|FG000|STARTED|Overall Study||91
6676931|NCT02627924|7608222|FG000|COMPLETED|Overall Study||79
6676932|NCT02627924|7608222|FG000|NOT COMPLETED|Overall Study||12
6676933|NCT02628028|7608237|FG000|STARTED|Dosing Period||9
6676934|NCT02628028|7608238|FG001|STARTED|Dosing Period||9
6676935|NCT02628028|7608239|FG002|STARTED|Dosing Period||10
6676936|NCT02628028|7608240|FG003|STARTED|Dosing Period||8
6676937|NCT02628028|7608241|FG004|STARTED|Dosing Period||62
6676938|NCT02628028|7608242|FG005|STARTED|Dosing Period||63
6676939|NCT02628028|7608243|FG006|STARTED|Dosing Period||62
6676940|NCT02628028|7608244|FG007|STARTED|Dosing Period||63
6676941|NCT02628028|7608237|FG000|Received at Least 1dose of Study Drug|Dosing Period||9
6676942|NCT02628028|7608238|FG001|Received at Least 1dose of Study Drug|Dosing Period||9
6676943|NCT02628028|7608239|FG002|Received at Least 1dose of Study Drug|Dosing Period||10
6676944|NCT02628028|7608240|FG003|Received at Least 1dose of Study Drug|Dosing Period||8
6676945|NCT02628028|7608241|FG004|Received at Least 1dose of Study Drug|Dosing Period||62
6676946|NCT02628028|7608242|FG005|Received at Least 1dose of Study Drug|Dosing Period||63
6676947|NCT02628028|7608243|FG006|Received at Least 1dose of Study Drug|Dosing Period||62
6676948|NCT02628028|7608244|FG007|Received at Least 1dose of Study Drug|Dosing Period||63
6676949|NCT02628028|7608237|FG000|COMPLETED|Dosing Period||9
6676950|NCT02628028|7608238|FG001|COMPLETED|Dosing Period||9
6676951|NCT02628028|7608239|FG002|COMPLETED|Dosing Period||9
6676952|NCT02628028|7608240|FG003|COMPLETED|Dosing Period||8
6676953|NCT02628028|7608241|FG004|COMPLETED|Dosing Period||46
6676954|NCT02628028|7608242|FG005|COMPLETED|Dosing Period||49
6676955|NCT02628028|7608243|FG006|COMPLETED|Dosing Period||46
6676956|NCT02628028|7608244|FG007|COMPLETED|Dosing Period||48
6676957|NCT02628028|7608237|FG000|NOT COMPLETED|Dosing Period||0
6676958|NCT02628028|7608238|FG001|NOT COMPLETED|Dosing Period||0
6676959|NCT02628028|7608239|FG002|NOT COMPLETED|Dosing Period||1
6676960|NCT02628028|7608240|FG003|NOT COMPLETED|Dosing Period||0
6676961|NCT02628028|7608241|FG004|NOT COMPLETED|Dosing Period||16
6676962|NCT02628028|7608242|FG005|NOT COMPLETED|Dosing Period||14
6676963|NCT02628028|7608243|FG006|NOT COMPLETED|Dosing Period||16
6676964|NCT02628028|7608244|FG007|NOT COMPLETED|Dosing Period||15
6676965|NCT02628028|7608237|FG000|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
6676966|NCT02628028|7608238|FG001|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
6676967|NCT02628028|7608239|FG002|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
6676968|NCT02628028|7608240|FG003|STARTED|Long-term Extension (LTE) Period|LTE period included participants who completed Part B of the study.|0
6676969|NCT02628028|7608241|FG004|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;42 participants completed part B placebo period,re-randomized to LTE period.|0
6676970|NCT02628028|7608242|FG005|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
6676971|NCT02628028|7608243|FG006|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|58
6738286|NCT03282071|7667627|FG000|NOT COMPLETED|Overall Study||10
6676972|NCT02628028|7608244|FG007|STARTED|Long-term Extension (LTE) Period|Part B LTE was optional;14 participants completed part B placebo period,re-randomized to LTE period.|61
6676973|NCT02628028|7608237|FG000|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6676974|NCT02628028|7608238|FG001|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6676975|NCT02628028|7608239|FG002|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6676976|NCT02628028|7608240|FG003|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6676977|NCT02628028|7608241|FG004|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||0
6676978|NCT02628028|7608242|FG005|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
6676979|NCT02628028|7608243|FG006|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
6676980|NCT02628028|7608244|FG007|Placebo Re-randomized in LTE|Long-term Extension (LTE) Period||14
6676981|NCT02628028|7608237|FG000|COMPLETED|Long-term Extension (LTE) Period||0
6676982|NCT02628028|7608238|FG001|COMPLETED|Long-term Extension (LTE) Period||0
6676983|NCT02628028|7608239|FG002|COMPLETED|Long-term Extension (LTE) Period||0
6676984|NCT02628028|7608240|FG003|COMPLETED|Long-term Extension (LTE) Period||0
6676985|NCT02628028|7608241|FG004|COMPLETED|Long-term Extension (LTE) Period||0
6676986|NCT02628028|7608242|FG005|COMPLETED|Long-term Extension (LTE) Period||1
6676987|NCT02628028|7608243|FG006|COMPLETED|Long-term Extension (LTE) Period||0
6676988|NCT02628028|7608244|FG007|COMPLETED|Long-term Extension (LTE) Period||0
6676989|NCT02628028|7608237|FG000|NOT COMPLETED|Long-term Extension (LTE) Period||0
6676990|NCT02628028|7608238|FG001|NOT COMPLETED|Long-term Extension (LTE) Period||0
6676991|NCT02628028|7608239|FG002|NOT COMPLETED|Long-term Extension (LTE) Period||0
6676992|NCT02628028|7608240|FG003|NOT COMPLETED|Long-term Extension (LTE) Period||0
6676993|NCT02628028|7608241|FG004|NOT COMPLETED|Long-term Extension (LTE) Period||0
6676994|NCT02628028|7608242|FG005|NOT COMPLETED|Long-term Extension (LTE) Period||60
6676995|NCT02628028|7608243|FG006|NOT COMPLETED|Long-term Extension (LTE) Period||58
6676996|NCT02628028|7608244|FG007|NOT COMPLETED|Long-term Extension (LTE) Period||61
6676997|NCT02628093|7608268|FG000|STARTED|Overall Study||31
6676998|NCT02628093|7608269|FG001|STARTED|Overall Study||29
6676999|NCT02628093|7608268|FG000|COMPLETED|Overall Study||31
6677000|NCT02628093|7608269|FG001|COMPLETED|Overall Study||29
6677001|NCT02628093|7608268|FG000|NOT COMPLETED|Overall Study||0
6677002|NCT02628093|7608269|FG001|NOT COMPLETED|Overall Study||0
6677003|NCT02628106|7608275|FG000|STARTED|Overall Study||21
6677004|NCT02628106|7608275|FG000|COMPLETED|Overall Study||21
6677005|NCT02628106|7608275|FG000|NOT COMPLETED|Overall Study||0
6677006|NCT02628223|7608281|FG000|STARTED|Overall Study||38
6677007|NCT02628223|7608282|FG001|STARTED|Overall Study||38
6677008|NCT02628223|7608281|FG000|COMPLETED|Overall Study||38
6677009|NCT02628223|7608282|FG001|COMPLETED|Overall Study||36
6677010|NCT02628223|7608281|FG000|NOT COMPLETED|Overall Study||0
6677011|NCT02628223|7608282|FG001|NOT COMPLETED|Overall Study||2
6677012|NCT02628236|7608288|FG000|STARTED|Overall Study||14
6677013|NCT02628236|7608288|FG000|COMPLETED|Overall Study||14
6677014|NCT02628236|7608288|FG000|NOT COMPLETED|Overall Study||0
6677015|NCT02628418|7608294|FG000|STARTED|Overall Study||15
6677016|NCT02628418|7608295|FG001|STARTED|Overall Study||15
6677017|NCT02628418|7608294|FG000|COMPLETED|Overall Study||14
6677018|NCT02628418|7608295|FG001|COMPLETED|Overall Study||13
6677019|NCT02628418|7608294|FG000|NOT COMPLETED|Overall Study||1
6677020|NCT02628418|7608295|FG001|NOT COMPLETED|Overall Study||2
6677021|NCT02628600|7608309|FG000|STARTED|Overall Study||73
6677022|NCT02628600|7608310|FG001|STARTED|Overall Study||90
6677023|NCT02628600|7608309|FG000|Participant Discontinued the Study|Overall Study||24
6677024|NCT02628600|7608310|FG001|Participant Discontinued the Study|Overall Study||32
6677025|NCT02628600|7608309|FG000|COMPLETED|Overall Study||49
6677026|NCT02628600|7608310|FG001|COMPLETED|Overall Study||58
6677027|NCT02628600|7608309|FG000|NOT COMPLETED|Overall Study||24
6677028|NCT02628600|7608310|FG001|NOT COMPLETED|Overall Study||32
6677029|NCT02628743|7608316|FG000|STARTED|Overall Study||131
6677030|NCT02628743|7608316|FG000|COMPLETED|Overall Study||0
6677031|NCT02628743|7608316|FG000|NOT COMPLETED|Overall Study||131
6677032|NCT02628769|7608320|FG000|STARTED|First Intervention||3
6677033|NCT02628769|7608321|FG001|STARTED|First Intervention||3
6677034|NCT02628769|7608320|FG000|COMPLETED|First Intervention||2
6677035|NCT02628769|7608321|FG001|COMPLETED|First Intervention||2
6677036|NCT02628769|7608320|FG000|NOT COMPLETED|First Intervention||1
6677037|NCT02628769|7608321|FG001|NOT COMPLETED|First Intervention||1
6677038|NCT02628769|7608320|FG000|STARTED|Wash Out (28 Days)||2
6677039|NCT02628769|7608321|FG001|STARTED|Wash Out (28 Days)||2
6677040|NCT02628769|7608320|FG000|COMPLETED|Wash Out (28 Days)||2
6677041|NCT02628769|7608321|FG001|COMPLETED|Wash Out (28 Days)||2
6677042|NCT02628769|7608320|FG000|NOT COMPLETED|Wash Out (28 Days)||0
6677043|NCT02628769|7608321|FG001|NOT COMPLETED|Wash Out (28 Days)||0
6677044|NCT02628769|7608320|FG000|STARTED|Second Intervention||2
6677045|NCT02628769|7608321|FG001|STARTED|Second Intervention||2
6677046|NCT02628769|7608320|FG000|COMPLETED|Second Intervention||0
6677047|NCT02628769|7608321|FG001|COMPLETED|Second Intervention||1
6677048|NCT02628769|7608320|FG000|NOT COMPLETED|Second Intervention||2
6677049|NCT02628769|7608321|FG001|NOT COMPLETED|Second Intervention||1
6677050|NCT02628873|7608329|FG000|STARTED|First Test (1 Hour)||14
6677051|NCT02628873|7608330|FG001|STARTED|First Test (1 Hour)||7
6677052|NCT02628873|7608329|FG000|COMPLETED|First Test (1 Hour)||14
6677053|NCT02628873|7608330|FG001|COMPLETED|First Test (1 Hour)||7
6677054|NCT02628873|7608329|FG000|NOT COMPLETED|First Test (1 Hour)||0
6677055|NCT02628873|7608330|FG001|NOT COMPLETED|First Test (1 Hour)||0
6677056|NCT02628873|7608329|FG000|STARTED|Break (1 Hour)||14
6677057|NCT02628873|7608330|FG001|STARTED|Break (1 Hour)||7
6677058|NCT02628873|7608329|FG000|COMPLETED|Break (1 Hour)||14
6677059|NCT02628873|7608330|FG001|COMPLETED|Break (1 Hour)||6
6677060|NCT02628873|7608329|FG000|NOT COMPLETED|Break (1 Hour)||0
6677061|NCT02628873|7608330|FG001|NOT COMPLETED|Break (1 Hour)||1
6677062|NCT02628873|7608329|FG000|STARTED|Second Test (1 Hour)||14
6677063|NCT02628873|7608330|FG001|STARTED|Second Test (1 Hour)||6
6677064|NCT02628873|7608329|FG000|COMPLETED|Second Test (1 Hour)||13
6677065|NCT02628873|7608330|FG001|COMPLETED|Second Test (1 Hour)||6
6677066|NCT02628873|7608329|FG000|NOT COMPLETED|Second Test (1 Hour)||1
6677067|NCT02628873|7608330|FG001|NOT COMPLETED|Second Test (1 Hour)||0
6677068|NCT02628938|7608339|FG000|STARTED|Overall Study||15
6677069|NCT02628938|7608340|FG001|STARTED|Overall Study||15
6677070|NCT02628938|7608341|FG002|STARTED|Overall Study||15
6677071|NCT02628938|7608339|FG000|COMPLETED|Overall Study||10
6677072|NCT02628938|7608340|FG001|COMPLETED|Overall Study||13
6677073|NCT02628938|7608341|FG002|COMPLETED|Overall Study||11
6677074|NCT02628938|7608339|FG000|NOT COMPLETED|Overall Study||5
6677075|NCT02628938|7608340|FG001|NOT COMPLETED|Overall Study||2
6677076|NCT02628938|7608341|FG002|NOT COMPLETED|Overall Study||4
6677077|NCT02628964|7608351|FG000|STARTED|Overall Study||50
6677078|NCT02628964|7608352|FG001|STARTED|Overall Study||50
6677079|NCT02628964|7608351|FG000|COMPLETED|Overall Study||50
6677080|NCT02628964|7608352|FG001|COMPLETED|Overall Study||49
6677081|NCT02628964|7608351|FG000|NOT COMPLETED|Overall Study||0
6677082|NCT02628964|7608352|FG001|NOT COMPLETED|Overall Study||1
6677083|NCT02629094|7608358|FG000|STARTED|Overall Study||5
6677084|NCT02629094|7608358|FG000|COMPLETED|Overall Study||5
6677085|NCT02629094|7608358|FG000|NOT COMPLETED|Overall Study||0
6677086|NCT02629133|7608364|FG000|STARTED|Overall Study||25
6677087|NCT02629133|7608365|FG001|STARTED|Overall Study||25
6677088|NCT02629133|7608364|FG000|COMPLETED|Overall Study||21
6677089|NCT02629133|7608365|FG001|COMPLETED|Overall Study||23
6677090|NCT02629133|7608364|FG000|NOT COMPLETED|Overall Study||4
6677091|NCT02629133|7608365|FG001|NOT COMPLETED|Overall Study||2
6677092|NCT02629354|7608373|FG000|STARTED|Period 1||18
6677093|NCT02629354|7608374|FG001|STARTED|Period 1||18
6677094|NCT02629354|7608373|FG000|COMPLETED|Period 1||18
6677095|NCT02629354|7608374|FG001|COMPLETED|Period 1||18
6677096|NCT02629354|7608373|FG000|NOT COMPLETED|Period 1||0
6677097|NCT02629354|7608374|FG001|NOT COMPLETED|Period 1||0
6677098|NCT02629354|7608373|FG000|STARTED|Washout Period||18
6677099|NCT02629354|7608374|FG001|STARTED|Washout Period||18
6677100|NCT02629354|7608373|FG000|COMPLETED|Washout Period||18
6677101|NCT02629354|7608374|FG001|COMPLETED|Washout Period||18
6677102|NCT02629354|7608373|FG000|NOT COMPLETED|Washout Period||0
6677103|NCT02629354|7608374|FG001|NOT COMPLETED|Washout Period||0
6677104|NCT02629354|7608373|FG000|STARTED|Period 2||18
6677105|NCT02629354|7608374|FG001|STARTED|Period 2||18
6677106|NCT02629354|7608373|FG000|COMPLETED|Period 2||18
6677107|NCT02629354|7608374|FG001|COMPLETED|Period 2||18
6677108|NCT02629354|7608373|FG000|NOT COMPLETED|Period 2||0
6677109|NCT02629354|7608374|FG001|NOT COMPLETED|Period 2||0
6677110|NCT02629354|7608373|FG000|STARTED|Follow-up||18
6677111|NCT02629354|7608374|FG001|STARTED|Follow-up||18
6677112|NCT02629354|7608373|FG000|COMPLETED|Follow-up||18
6677113|NCT02629354|7608374|FG001|COMPLETED|Follow-up||18
6677114|NCT02629354|7608373|FG000|NOT COMPLETED|Follow-up||0
6677115|NCT02629354|7608374|FG001|NOT COMPLETED|Follow-up||0
6677116|NCT02629822|7608380|FG000|STARTED|Base Study||10
6677117|NCT02629822|7608380|FG000|COMPLETED|Base Study||7
6677118|NCT02629822|7608380|FG000|NOT COMPLETED|Base Study||3
6677119|NCT02629822|7608380|FG000|STARTED|Extension Study|Enrollment in Extension Study was voluntary.|6
6677120|NCT02629822|7608380|FG000|COMPLETED|Extension Study||4
6677121|NCT02629822|7608380|FG000|NOT COMPLETED|Extension Study||2
6677122|NCT02629861|7608388|FG000|STARTED|Overall Study||294
6677123|NCT02629861|7608389|FG001|STARTED|Overall Study||291
6677124|NCT02629861|7608390|FG002|STARTED|Overall Study||290
6677125|NCT02629861|7608388|FG000|Intent to Treat (ITT)|Overall Study||294
6677126|NCT02629861|7608389|FG001|Intent to Treat (ITT)|Overall Study||291
6677127|NCT02629861|7608390|FG002|Intent to Treat (ITT)|Overall Study||290
6677128|NCT02629861|7608388|FG000|Safety Population|Overall Study||294
6677129|NCT02629861|7608389|FG001|Safety Population|Overall Study||291
6677130|NCT02629861|7608390|FG002|Safety Population|Overall Study||289
6677131|NCT02629861|7608388|FG000|Full Analysis Set|Overall Study||290
6677132|NCT02629861|7608389|FG001|Full Analysis Set|Overall Study||288
6677133|NCT02629861|7608390|FG002|Full Analysis Set|Overall Study||287
6677134|NCT02629861|7608388|FG000|COMPLETED|Overall Study||265
6677135|NCT02629861|7608389|FG001|COMPLETED|Overall Study||264
6677136|NCT02629861|7608390|FG002|COMPLETED|Overall Study||262
6677137|NCT02629861|7608388|FG000|NOT COMPLETED|Overall Study||29
6677138|NCT02629861|7608389|FG001|NOT COMPLETED|Overall Study||27
6677139|NCT02629861|7608390|FG002|NOT COMPLETED|Overall Study||28
6677140|NCT02629965|7608398|FG000|STARTED|Period 1||92
6677141|NCT02629965|7608399|FG001|STARTED|Period 1||92
6677142|NCT02629965|7608398|FG000|COMPLETED|Period 1||88
6677143|NCT02629965|7608399|FG001|COMPLETED|Period 1||90
6677144|NCT02629965|7608398|FG000|NOT COMPLETED|Period 1||4
6677145|NCT02629965|7608399|FG001|NOT COMPLETED|Period 1||2
6677146|NCT02629965|7608398|FG000|STARTED|Period 2||88
6677147|NCT02629965|7608399|FG001|STARTED|Period 2||90
6677148|NCT02629965|7608398|FG000|COMPLETED|Period 2||87
6677149|NCT02629965|7608399|FG001|COMPLETED|Period 2||90
6677150|NCT02629965|7608398|FG000|NOT COMPLETED|Period 2||1
6677151|NCT02629965|7608399|FG001|NOT COMPLETED|Period 2||0
6677152|NCT02629991|7608407|FG000|STARTED|Overall Study||11
6677153|NCT02629991|7608408|FG001|STARTED|Overall Study||12
6677154|NCT02629991|7608407|FG000|COMPLETED|Overall Study||10
6677155|NCT02629991|7608408|FG001|COMPLETED|Overall Study||11
6677156|NCT02629991|7608407|FG000|NOT COMPLETED|Overall Study||1
6677157|NCT02629991|7608408|FG001|NOT COMPLETED|Overall Study||1
6677158|NCT02630017|7608419|FG000|STARTED|Overall Study||13
6677159|NCT02630017|7608420|FG001|STARTED|Overall Study||12
6677160|NCT02630017|7608421|FG002|STARTED|Overall Study||13
6677161|NCT02630017|7608422|FG003|STARTED|Overall Study||13
6677162|NCT02630017|7608419|FG000|COMPLETED|Overall Study||12
6677163|NCT02630017|7608420|FG001|COMPLETED|Overall Study||11
6677164|NCT02630017|7608421|FG002|COMPLETED|Overall Study||11
6677165|NCT02630017|7608422|FG003|COMPLETED|Overall Study||12
6677166|NCT02630017|7608419|FG000|NOT COMPLETED|Overall Study||1
6677167|NCT02630017|7608420|FG001|NOT COMPLETED|Overall Study||1
6677168|NCT02630017|7608421|FG002|NOT COMPLETED|Overall Study||2
6677169|NCT02630017|7608422|FG003|NOT COMPLETED|Overall Study||1
6677170|NCT02630030|7608432|FG000|STARTED|Overall Study||3
6677171|NCT02630030|7608432|FG000|COMPLETED|Overall Study||3
6677172|NCT02630030|7608432|FG000|NOT COMPLETED|Overall Study||0
6677173|NCT02630186|7608436|FG000|STARTED|Overall Study||3
6677174|NCT02630186|7608436|FG000|COMPLETED|Overall Study||2
6677175|NCT02630186|7608436|FG000|NOT COMPLETED|Overall Study||1
6677176|NCT02630251|7608444|FG000|STARTED|Overall Study||2
6677177|NCT02630251|7608445|FG001|STARTED|Overall Study||1
6677178|NCT02630251|7608446|FG002|STARTED|Overall Study||1
6677179|NCT02630251|7608447|FG003|STARTED|Overall Study||1
6677180|NCT02630251|7608444|FG000|COMPLETED|Overall Study||2
6677181|NCT02630251|7608445|FG001|COMPLETED|Overall Study||1
6677182|NCT02630251|7608446|FG002|COMPLETED|Overall Study||0
6677183|NCT02630251|7608447|FG003|COMPLETED|Overall Study||1
6677184|NCT02630251|7608444|FG000|NOT COMPLETED|Overall Study||0
6677185|NCT02630251|7608445|FG001|NOT COMPLETED|Overall Study||0
6677186|NCT02630251|7608446|FG002|NOT COMPLETED|Overall Study||1
6677187|NCT02630251|7608447|FG003|NOT COMPLETED|Overall Study||0
6677188|NCT02630316|7608459|FG000|STARTED|Overall Study||163
6677189|NCT02630316|7608460|FG001|STARTED|Overall Study||163
6677190|NCT02630316|7608459|FG000|COMPLETED|Overall Study||128
6677191|NCT02630316|7608460|FG001|COMPLETED|Overall Study||130
6677192|NCT02630316|7608459|FG000|NOT COMPLETED|Overall Study||35
6677193|NCT02630316|7608460|FG001|NOT COMPLETED|Overall Study||33
6677298|NCT02630563|7608502|FG000|STARTED|Overall Study||9
6677299|NCT02630563|7608502|FG000|COMPLETED|Overall Study||8
6677300|NCT02630563|7608502|FG000|NOT COMPLETED|Overall Study||1
6677301|NCT02630693|7608509|FG000|STARTED|Overall Study||90
6677302|NCT02630693|7608510|FG001|STARTED|Overall Study||90
6677303|NCT02630693|7608509|FG000|COMPLETED|Overall Study||90
6677304|NCT02630693|7608510|FG001|COMPLETED|Overall Study||89
6677305|NCT02630693|7608509|FG000|NOT COMPLETED|Overall Study||0
6677306|NCT02630693|7608510|FG001|NOT COMPLETED|Overall Study||1
6677307|NCT02630706|7608519|FG000|STARTED|Overall Study||170
6677308|NCT02630706|7608520|FG001|STARTED|Overall Study||169
6677309|NCT02630706|7608521|FG002|STARTED|Overall Study||167
6677310|NCT02630706|7608519|FG000|Treated|Overall Study||170
6677311|NCT02630706|7608520|FG001|Treated|Overall Study||169
6677312|NCT02630706|7608521|FG002|Treated|Overall Study||167
6677313|NCT02630706|7608519|FG000|COMPLETED|Overall Study||163
6677314|NCT02630706|7608520|FG001|COMPLETED|Overall Study||160
6677315|NCT02630706|7608521|FG002|COMPLETED|Overall Study||157
6677316|NCT02630706|7608519|FG000|NOT COMPLETED|Overall Study||7
6677317|NCT02630706|7608520|FG001|NOT COMPLETED|Overall Study||9
6677318|NCT02630706|7608521|FG002|NOT COMPLETED|Overall Study||10
6677319|NCT02630719|7608531|FG000|STARTED|Overall Study||4
6677320|NCT02630719|7608532|FG001|STARTED|Overall Study||6
6677321|NCT02630719|7608531|FG000|COMPLETED|Overall Study||4
6677322|NCT02630719|7608532|FG001|COMPLETED|Overall Study||6
6677323|NCT02630719|7608531|FG000|NOT COMPLETED|Overall Study||0
6677324|NCT02630719|7608532|FG001|NOT COMPLETED|Overall Study||0
6677325|NCT02630953|7608540|FG000|STARTED|6 Month Assessment||97
6677326|NCT02630953|7608541|FG001|STARTED|6 Month Assessment||102
6677327|NCT02630953|7608540|FG000|COMPLETED|6 Month Assessment||83
6677328|NCT02630953|7608541|FG001|COMPLETED|6 Month Assessment||70
6677329|NCT02630953|7608540|FG000|NOT COMPLETED|6 Month Assessment||14
6677330|NCT02630953|7608541|FG001|NOT COMPLETED|6 Month Assessment||32
6677331|NCT02630953|7608540|FG000|STARTED|12 Month Assessment||97
6677332|NCT02630953|7608541|FG001|STARTED|12 Month Assessment||102
6677333|NCT02630953|7608540|FG000|COMPLETED|12 Month Assessment||73
6677334|NCT02630953|7608541|FG001|COMPLETED|12 Month Assessment||64
6677335|NCT02630953|7608540|FG000|NOT COMPLETED|12 Month Assessment||24
6677336|NCT02630953|7608541|FG001|NOT COMPLETED|12 Month Assessment||38
6677337|NCT02630966|7608549|FG000|STARTED|Overall Study||16
6677338|NCT02630966|7608550|FG001|STARTED|Overall Study||18
6677339|NCT02630966|7608549|FG000|COMPLETED|Overall Study||14
6677340|NCT02630966|7608550|FG001|COMPLETED|Overall Study||10
6677341|NCT02630966|7608549|FG000|NOT COMPLETED|Overall Study||2
6677342|NCT02630966|7608550|FG001|NOT COMPLETED|Overall Study||8
6677343|NCT02630992|7608556|FG000|STARTED|Overall Study||112
6677344|NCT02630992|7608556|FG000|COMPLETED|Overall Study||99
6677345|NCT02630992|7608556|FG000|NOT COMPLETED|Overall Study||13
6677346|NCT02631057|7608562|FG000|STARTED|Overall Study||899
6677347|NCT02631057|7608563|FG001|STARTED|Overall Study||3414
6677348|NCT02631057|7608562|FG000|COMPLETED|Overall Study||899
6677349|NCT02631057|7608563|FG001|COMPLETED|Overall Study||3414
6677350|NCT02631057|7608562|FG000|NOT COMPLETED|Overall Study||0
6677351|NCT02631057|7608563|FG001|NOT COMPLETED|Overall Study||0
6677352|NCT02631525|7608571|FG000|STARTED|Overall Study||20
6677353|NCT02631525|7608572|FG001|STARTED|Overall Study||20
6677354|NCT02631525|7608571|FG000|COMPLETED|Overall Study||20
6677355|NCT02631525|7608572|FG001|COMPLETED|Overall Study||20
6677356|NCT02631525|7608571|FG000|NOT COMPLETED|Overall Study||0
6677357|NCT02631525|7608572|FG001|NOT COMPLETED|Overall Study||0
6677358|NCT02631538|7608582|FG000|STARTED|Treatment Period (Up to Week 52)||13
6677359|NCT02631538|7608583|FG001|STARTED|Treatment Period (Up to Week 52)||24
6677360|NCT02631538|7608584|FG002|STARTED|Treatment Period (Up to Week 52)||24
6677361|NCT02631538|7608585|FG003|STARTED|Treatment Period (Up to Week 52)||25
6677362|NCT02631538|7608582|FG000|COMPLETED|Treatment Period (Up to Week 52)||9
6677363|NCT02631538|7608583|FG001|COMPLETED|Treatment Period (Up to Week 52)||17
6677364|NCT02631538|7608584|FG002|COMPLETED|Treatment Period (Up to Week 52)||19
6677365|NCT02631538|7608585|FG003|COMPLETED|Treatment Period (Up to Week 52)||17
6677366|NCT02631538|7608582|FG000|NOT COMPLETED|Treatment Period (Up to Week 52)||4
6677367|NCT02631538|7608583|FG001|NOT COMPLETED|Treatment Period (Up to Week 52)||7
6677368|NCT02631538|7608584|FG002|NOT COMPLETED|Treatment Period (Up to Week 52)||5
6677369|NCT02631538|7608585|FG003|NOT COMPLETED|Treatment Period (Up to Week 52)||8
6677370|NCT02631538|7608582|FG000|STARTED|General Follow-up (GFU) (Up to Week 68)||9
6677371|NCT02631538|7608583|FG001|STARTED|General Follow-up (GFU) (Up to Week 68)||17
6677372|NCT02631538|7608584|FG002|STARTED|General Follow-up (GFU) (Up to Week 68)||19
6677373|NCT02631538|7608585|FG003|STARTED|General Follow-up (GFU) (Up to Week 68)||17
6677374|NCT02631538|7608582|FG000|COMPLETED|General Follow-up (GFU) (Up to Week 68)||8
6677375|NCT02631538|7608583|FG001|COMPLETED|General Follow-up (GFU) (Up to Week 68)||17
6677376|NCT02631538|7608584|FG002|COMPLETED|General Follow-up (GFU) (Up to Week 68)||19
6677377|NCT02631538|7608585|FG003|COMPLETED|General Follow-up (GFU) (Up to Week 68)||16
6677378|NCT02631538|7608582|FG000|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
6677379|NCT02631538|7608583|FG001|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
6677380|NCT02631538|7608584|FG002|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||0
6677381|NCT02631538|7608585|FG003|NOT COMPLETED|General Follow-up (GFU) (Up to Week 68)||1
6677382|NCT02631551|7608599|FG000|STARTED|Overall Study||302
6677383|NCT02631551|7608600|FG001|STARTED|Overall Study||297
6677384|NCT02631551|7608601|FG002|STARTED|Overall Study||294
6677385|NCT02631551|7608602|FG003|STARTED|Overall Study||287
6677386|NCT02631551|7608599|FG000|COMPLETED|Overall Study||289
6677387|NCT02631551|7608600|FG001|COMPLETED|Overall Study||278
6677388|NCT02631551|7608601|FG002|COMPLETED|Overall Study||283
6677389|NCT02631551|7608602|FG003|COMPLETED|Overall Study||276
6677390|NCT02631551|7608599|FG000|NOT COMPLETED|Overall Study||13
6677391|NCT02631551|7608600|FG001|NOT COMPLETED|Overall Study||19
6677392|NCT02631551|7608601|FG002|NOT COMPLETED|Overall Study||11
6677393|NCT02631551|7608602|FG003|NOT COMPLETED|Overall Study||11
6677394|NCT02631590|7608612|FG000|STARTED|Overall Study||24
6677395|NCT02631590|7608612|FG000|COMPLETED|Overall Study||24
6677396|NCT02631590|7608612|FG000|NOT COMPLETED|Overall Study||0
6677397|NCT02631746|7608616|FG000|STARTED|Overall Study||3
6677398|NCT02631746|7608616|FG000|COMPLETED|Overall Study||0
6677399|NCT02631746|7608616|FG000|NOT COMPLETED|Overall Study||3
6677400|NCT02631772|7608622|FG000|STARTED|Overall Study||16
6677401|NCT02631772|7608623|FG001|STARTED|Overall Study||16
6677402|NCT02631772|7608622|FG000|COMPLETED|Overall Study||16
6677403|NCT02631772|7608623|FG001|COMPLETED|Overall Study||16
6677404|NCT02631772|7608622|FG000|NOT COMPLETED|Overall Study||0
6677405|NCT02631772|7608623|FG001|NOT COMPLETED|Overall Study||0
6677406|NCT02631850|7608633|FG000|STARTED|Treatment Period|One participant was withdrawn during treatment because medical records review revealed that the motor deficit was due to an old orthopedic injury and not stroke. This participant had experienced a Transient Ischemic Attack, but no stroke that resulted in lasting neurological motor deficit. 40 participants were thus analyzed for this group in the intent-to-treat analysis even though 41 began treatment.|41
6677407|NCT02631850|7608634|FG001|STARTED|Treatment Period||44
6677408|NCT02631850|7608635|FG002|STARTED|Treatment Period||45
6677409|NCT02631850|7608636|FG003|STARTED|Treatment Period||38
6677410|NCT02631850|7608633|FG000|COMPLETED|Treatment Period||38
6677411|NCT02631850|7608634|FG001|COMPLETED|Treatment Period||38
6677412|NCT02631850|7608635|FG002|COMPLETED|Treatment Period||41
6677413|NCT02631850|7608636|FG003|COMPLETED|Treatment Period||33
6677414|NCT02631850|7608633|FG000|NOT COMPLETED|Treatment Period||3
6256280|NCT01970865|7155094|FG009|NOT COMPLETED|Overall Study||4
6256281|NCT01970865|7155095|FG010|NOT COMPLETED|Overall Study||30
6256282|NCT01970865|7155096|FG011|NOT COMPLETED|Overall Study||27
6256283|NCT01970865|7155097|FG012|NOT COMPLETED|Overall Study||60
6256284|NCT01970865|7155098|FG013|NOT COMPLETED|Overall Study||66
6256285|NCT01970865|7155099|FG014|NOT COMPLETED|Overall Study||46
6256286|NCT01970865|7155100|FG015|NOT COMPLETED|Overall Study||47
6256287|NCT01970865|7155101|FG016|NOT COMPLETED|Overall Study||3
6256298|NCT00589420|7155171|FG000|STARTED|Overall Study||18
6256299|NCT00589420|7155171|FG000|COMPLETED|Overall Study||17
6256300|NCT00589420|7155171|FG000|NOT COMPLETED|Overall Study||1
6279007|NCT00140413|7178668|FG001|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
6279008|NCT00140413|7178667|FG000|NOT COMPLETED|Overall Study||3
6279009|NCT00140413|7178668|FG001|NOT COMPLETED|Overall Study||0
6279010|NCT00140426|7178677|FG000|STARTED|Overall Study||22
6279011|NCT00140426|7178678|FG001|STARTED|Overall Study||19
6279012|NCT00140426|7178677|FG000|COMPLETED|Overall Study||22
6279013|NCT00140426|7178678|FG001|COMPLETED|Overall Study||16
6279014|NCT00140426|7178677|FG000|NOT COMPLETED|Overall Study||0
6279015|NCT00140426|7178678|FG001|NOT COMPLETED|Overall Study||3
6279016|NCT00140556|7178689|FG000|STARTED|Pre Radiation Period: Avastin / Tarceva||28
6279017|NCT00140556|7178689|FG000|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
6279018|NCT00140556|7178689|FG000|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
6279019|NCT00140556|7178689|FG000|STARTED|Chemoradiotherapy Period||28
6279020|NCT00140556|7178689|FG000|COMPLETED|Chemoradiotherapy Period||28
6279021|NCT00140556|7178689|FG000|NOT COMPLETED|Chemoradiotherapy Period||0
6279022|NCT00140621|7178693|FG000|STARTED|Overall Study||6
6279023|NCT00140621|7178693|FG000|COMPLETED|Overall Study||6
6279024|NCT00140621|7178693|FG000|NOT COMPLETED|Overall Study||0
6279025|NCT00140842|7178699|FG000|STARTED|Overall Study||15
6279026|NCT00140842|7178700|FG001|STARTED|Overall Study||15
6279027|NCT00140842|7178699|FG000|COMPLETED|Overall Study||15
6279028|NCT00140842|7178700|FG001|COMPLETED|Overall Study||15
6279029|NCT00140842|7178699|FG000|NOT COMPLETED|Overall Study||0
6279030|NCT00140842|7178700|FG001|NOT COMPLETED|Overall Study||0
6279031|NCT00140855|7178706|FG000|STARTED|Overall Study||6
6279032|NCT00140855|7178706|FG000|COMPLETED|Overall Study||4
6677415|NCT02631850|7608634|FG001|NOT COMPLETED|Treatment Period||6
6677416|NCT02631850|7608635|FG002|NOT COMPLETED|Treatment Period||4
6677417|NCT02631850|7608636|FG003|NOT COMPLETED|Treatment Period||5
6677418|NCT02631850|7608633|FG000|STARTED|6 Month Follow up||38
6677419|NCT02631850|7608634|FG001|STARTED|6 Month Follow up||38
6677420|NCT02631850|7608635|FG002|STARTED|6 Month Follow up||41
6677421|NCT02631850|7608636|FG003|STARTED|6 Month Follow up||33
6677422|NCT02631850|7608633|FG000|COMPLETED|6 Month Follow up||31
6677423|NCT02631850|7608634|FG001|COMPLETED|6 Month Follow up||25
6677424|NCT02631850|7608635|FG002|COMPLETED|6 Month Follow up||35
6677425|NCT02631850|7608636|FG003|COMPLETED|6 Month Follow up||22
6677426|NCT02631850|7608633|FG000|NOT COMPLETED|6 Month Follow up||7
6677427|NCT02631850|7608634|FG001|NOT COMPLETED|6 Month Follow up||13
6677428|NCT02631850|7608635|FG002|NOT COMPLETED|6 Month Follow up||6
6677429|NCT02631850|7608636|FG003|NOT COMPLETED|6 Month Follow up||11
6677430|NCT02631876|7608649|FG000|STARTED|Overall Study||248
6677431|NCT02631876|7608650|FG001|STARTED|Overall Study||118
6677432|NCT02631876|7608649|FG000|Safety Population|Overall Study||243
6677433|NCT02631876|7608650|FG001|Safety Population|Overall Study||109
6677434|NCT02631876|7608649|FG000|COMPLETED|Overall Study||129
6677435|NCT02631876|7608650|FG001|COMPLETED|Overall Study||55
6677436|NCT02631876|7608649|FG000|NOT COMPLETED|Overall Study||119
6677437|NCT02631876|7608650|FG001|NOT COMPLETED|Overall Study||63
6677438|NCT02631954|7608659|FG000|STARTED|Overall Study||12
6677439|NCT02631954|7608660|FG001|STARTED|Overall Study||12
6677440|NCT02631954|7608659|FG000|COMPLETED|Overall Study||12
6677441|NCT02631954|7608660|FG001|COMPLETED|Overall Study||12
6677442|NCT02631954|7608659|FG000|NOT COMPLETED|Overall Study||0
6677443|NCT02631954|7608660|FG001|NOT COMPLETED|Overall Study||0
6677444|NCT02632110|7608671|FG000|STARTED|Overall Study||25
6677445|NCT02632110|7608672|FG001|STARTED|Overall Study||25
6677446|NCT02632110|7608673|FG002|STARTED|Overall Study||27
6677447|NCT02632110|7608674|FG003|STARTED|Overall Study||27
6677448|NCT02632110|7608675|FG004|STARTED|Overall Study||29
6677449|NCT02632110|7608676|FG005|STARTED|Overall Study||29
6677450|NCT02632110|7608677|FG006|STARTED|Overall Study||26
6677451|NCT02632110|7608678|FG007|STARTED|Overall Study||26
6677452|NCT02632110|7608679|FG008|STARTED|Overall Study||30
6677453|NCT02632110|7608680|FG009|STARTED|Overall Study||30
6677454|NCT02632110|7608671|FG000|COMPLETED|Overall Study||24
6677455|NCT02632110|7608672|FG001|COMPLETED|Overall Study||24
6677456|NCT02632110|7608673|FG002|COMPLETED|Overall Study||27
6677457|NCT02632110|7608674|FG003|COMPLETED|Overall Study||27
6677458|NCT02632110|7608675|FG004|COMPLETED|Overall Study||28
6677459|NCT02632110|7608676|FG005|COMPLETED|Overall Study||28
6677460|NCT02632110|7608677|FG006|COMPLETED|Overall Study||23
6677461|NCT02632110|7608678|FG007|COMPLETED|Overall Study||23
6677462|NCT02632110|7608679|FG008|COMPLETED|Overall Study||29
6677463|NCT02632110|7608680|FG009|COMPLETED|Overall Study||29
6677464|NCT02632110|7608671|FG000|NOT COMPLETED|Overall Study||1
6677465|NCT02632110|7608672|FG001|NOT COMPLETED|Overall Study||1
6677466|NCT02632110|7608673|FG002|NOT COMPLETED|Overall Study||0
6677467|NCT02632110|7608674|FG003|NOT COMPLETED|Overall Study||0
6677468|NCT02632110|7608675|FG004|NOT COMPLETED|Overall Study||1
6677469|NCT02632110|7608676|FG005|NOT COMPLETED|Overall Study||1
6677470|NCT02632110|7608677|FG006|NOT COMPLETED|Overall Study||3
6677471|NCT02632110|7608678|FG007|NOT COMPLETED|Overall Study||3
6677472|NCT02632110|7608679|FG008|NOT COMPLETED|Overall Study||1
6677473|NCT02632110|7608680|FG009|NOT COMPLETED|Overall Study||1
6677474|NCT02632526|7608703|FG000|STARTED|Overall Study||36
6677475|NCT02632526|7608704|FG001|STARTED|Overall Study||12
6677476|NCT02632526|7608705|FG002|STARTED|Overall Study||24
6677477|NCT02632526|7608706|FG003|STARTED|Overall Study||12
6677478|NCT02632526|7608707|FG004|STARTED|Overall Study||4
6677479|NCT02632526|7608708|FG005|STARTED|Overall Study||8
6677480|NCT02632526|7608703|FG000|COMPLETED|Overall Study||36
6677481|NCT02632526|7608704|FG001|COMPLETED|Overall Study||12
6677482|NCT02632526|7608705|FG002|COMPLETED|Overall Study||24
6677483|NCT02632526|7608706|FG003|COMPLETED|Overall Study||12
6677484|NCT02632526|7608707|FG004|COMPLETED|Overall Study||4
6677485|NCT02632526|7608708|FG005|COMPLETED|Overall Study||8
6677486|NCT02632526|7608703|FG000|NOT COMPLETED|Overall Study||0
6677487|NCT02632526|7608704|FG001|NOT COMPLETED|Overall Study||0
6677488|NCT02632526|7608705|FG002|NOT COMPLETED|Overall Study||0
6677489|NCT02632526|7608706|FG003|NOT COMPLETED|Overall Study||0
6677490|NCT02632526|7608707|FG004|NOT COMPLETED|Overall Study||0
6677491|NCT02632526|7608708|FG005|NOT COMPLETED|Overall Study||0
6677492|NCT02632552|7608755|FG000|STARTED|Overall Study||80
6677493|NCT02632552|7608756|FG001|STARTED|Overall Study||60
6677494|NCT02632552|7608755|FG000|COMPLETED|Overall Study||57
6677495|NCT02632552|7608756|FG001|COMPLETED|Overall Study||50
6677496|NCT02632552|7608755|FG000|NOT COMPLETED|Overall Study||23
6677497|NCT02632552|7608756|FG001|NOT COMPLETED|Overall Study||10
6677498|NCT02632747|7608765|FG000|STARTED|Treatment Period 1||16
6677499|NCT02632747|7608766|FG001|STARTED|Treatment Period 1||15
6677500|NCT02632747|7608765|FG000|COMPLETED|Treatment Period 1||16
6677501|NCT02632747|7608766|FG001|COMPLETED|Treatment Period 1||15
6677502|NCT02632747|7608765|FG000|NOT COMPLETED|Treatment Period 1||0
6677503|NCT02632747|7608766|FG001|NOT COMPLETED|Treatment Period 1||0
6677504|NCT02632747|7608765|FG000|STARTED|Wash-out Period||16
6677505|NCT02632747|7608766|FG001|STARTED|Wash-out Period||15
6677506|NCT02632747|7608765|FG000|COMPLETED|Wash-out Period||15
6677507|NCT02632747|7608766|FG001|COMPLETED|Wash-out Period||15
6677508|NCT02632747|7608765|FG000|NOT COMPLETED|Wash-out Period||1
6677509|NCT02632747|7608766|FG001|NOT COMPLETED|Wash-out Period||0
6677510|NCT02632747|7608765|FG000|STARTED|Treatment Period 2||15
6677511|NCT02632747|7608766|FG001|STARTED|Treatment Period 2||15
6677512|NCT02632747|7608765|FG000|COMPLETED|Treatment Period 2||15
6677513|NCT02632747|7608766|FG001|COMPLETED|Treatment Period 2||15
6677514|NCT02632747|7608765|FG000|NOT COMPLETED|Treatment Period 2||0
6677515|NCT02632747|7608766|FG001|NOT COMPLETED|Treatment Period 2||0
6677516|NCT02632786|7608774|FG000|STARTED|Overall Study||66
6677517|NCT02632786|7608775|FG001|STARTED|Overall Study||63
6677518|NCT02632786|7608774|FG000|Informed Consent Obtained|Overall Study||66
6677519|NCT02632786|7608775|FG001|Informed Consent Obtained|Overall Study||63
6677520|NCT02632786|7608774|FG000|Randomized and Dosed|Overall Study||66
6677521|NCT02632786|7608775|FG001|Randomized and Dosed|Overall Study||63
6677522|NCT02632786|7608774|FG000|COMPLETED|Overall Study||55
6677523|NCT02632786|7608775|FG001|COMPLETED|Overall Study||56
6677524|NCT02632786|7608774|FG000|NOT COMPLETED|Overall Study||11
6677525|NCT02632786|7608775|FG001|NOT COMPLETED|Overall Study||7
6677526|NCT02632812|7608784|FG000|STARTED|Overall Study||12
6677527|NCT02632812|7608785|FG001|STARTED|Overall Study||12
6677528|NCT02632812|7608784|FG000|COMPLETED|Overall Study||12
6677529|NCT02632812|7608785|FG001|COMPLETED|Overall Study||12
6677530|NCT02632812|7608784|FG000|NOT COMPLETED|Overall Study||0
6677531|NCT02632812|7608785|FG001|NOT COMPLETED|Overall Study||0
6738287|NCT03282071|7667628|FG001|NOT COMPLETED|Overall Study||9
6738288|NCT03282227|7667636|FG000|STARTED|Overall Study||342
6738289|NCT03282227|7667636|FG000|Completed at Least 6 Months|Overall Study||257
6738290|NCT03282227|7667636|FG000|COMPLETED|Overall Study||127
6738291|NCT03282227|7667636|FG000|NOT COMPLETED|Overall Study||215
6738292|NCT03282357|7667640|FG000|STARTED|Overall Study||181
6738293|NCT03282357|7667640|FG000|Safety Evaluation Set|Overall Study||176
6738294|NCT03282357|7667640|FG000|COMPLETED|Overall Study||164
6738295|NCT03282357|7667640|FG000|NOT COMPLETED|Overall Study||17
6738296|NCT03282591|7667647|FG000|STARTED|Overall Study||92
6738297|NCT03282591|7667648|FG001|STARTED|Overall Study||93
6738298|NCT03282591|7667647|FG000|COMPLETED|Overall Study||88
6738299|NCT03282591|7667648|FG001|COMPLETED|Overall Study||89
6738300|NCT03282591|7667647|FG000|NOT COMPLETED|Overall Study||4
6738301|NCT03282591|7667648|FG001|NOT COMPLETED|Overall Study||4
6738302|NCT03282682|7667658|FG000|STARTED|Overall Study||6
6738303|NCT03282682|7667659|FG001|STARTED|Overall Study||8
6738304|NCT03282682|7667660|FG002|STARTED|Overall Study||8
6738305|NCT03282682|7667658|FG000|COMPLETED|Overall Study||6
6738306|NCT03282682|7667659|FG001|COMPLETED|Overall Study||8
6738307|NCT03282682|7667660|FG002|COMPLETED|Overall Study||8
6738308|NCT03282682|7667658|FG000|NOT COMPLETED|Overall Study||0
6738309|NCT03282682|7667659|FG001|NOT COMPLETED|Overall Study||0
6738310|NCT03282682|7667660|FG002|NOT COMPLETED|Overall Study||0
6738311|NCT03283098|7667670|FG000|STARTED|Overall Study||8
6738312|NCT03283098|7667671|FG001|STARTED|Overall Study||25
6738313|NCT03283098|7667670|FG000|COMPLETED|Overall Study||8
6738314|NCT03283098|7667671|FG001|COMPLETED|Overall Study||24
6738315|NCT03283098|7667670|FG000|NOT COMPLETED|Overall Study||0
6738316|NCT03283098|7667671|FG001|NOT COMPLETED|Overall Study||1
6738317|NCT03283319|7667683|FG000|STARTED|Overall Study||62
6738318|NCT03283319|7667684|FG001|STARTED|Overall Study||60
6738319|NCT03283319|7667685|FG002|STARTED|Overall Study||62
6738320|NCT03283319|7667686|FG003|STARTED|Overall Study||61
6738321|NCT03283319|7667687|FG004|STARTED|Overall Study||60
6738322|NCT03283319|7667688|FG005|STARTED|Overall Study||61
6738323|NCT03283319|7667683|FG000|COMPLETED|Overall Study||55
6738324|NCT03283319|7667684|FG001|COMPLETED|Overall Study||54
6738325|NCT03283319|7667685|FG002|COMPLETED|Overall Study||55
6738326|NCT03283319|7667686|FG003|COMPLETED|Overall Study||54
6738327|NCT03283319|7667687|FG004|COMPLETED|Overall Study||56
6738328|NCT03283319|7667688|FG005|COMPLETED|Overall Study||57
6738329|NCT03283319|7667683|FG000|NOT COMPLETED|Overall Study||7
6738330|NCT03283319|7667684|FG001|NOT COMPLETED|Overall Study||6
6738331|NCT03283319|7667685|FG002|NOT COMPLETED|Overall Study||7
6738332|NCT03283319|7667686|FG003|NOT COMPLETED|Overall Study||7
6738333|NCT03283319|7667687|FG004|NOT COMPLETED|Overall Study||4
6738334|NCT03283319|7667688|FG005|NOT COMPLETED|Overall Study||4
6738335|NCT03283436|7667704|FG000|STARTED|Overall Study||50
6738336|NCT03283436|7667705|FG001|STARTED|Overall Study||50
6738337|NCT03283436|7667704|FG000|COMPLETED|Overall Study||44
6677532|NCT02632838|7608793|FG000|STARTED|Overall Study||15
6677533|NCT02632838|7608794|FG001|STARTED|Overall Study||15
6677534|NCT02632838|7608793|FG000|COMPLETED|Overall Study||12
6677535|NCT02632838|7608794|FG001|COMPLETED|Overall Study||13
6677536|NCT02632838|7608793|FG000|NOT COMPLETED|Overall Study||3
6677537|NCT02632838|7608794|FG001|NOT COMPLETED|Overall Study||2
6677538|NCT02633020|7608806|FG000|STARTED|Overall Study||19
6677539|NCT02633020|7608807|FG001|STARTED|Overall Study||9
6677540|NCT02633020|7608806|FG000|COMPLETED|Overall Study||18
6677541|NCT02633020|7608807|FG001|COMPLETED|Overall Study||9
6677542|NCT02633020|7608806|FG000|NOT COMPLETED|Overall Study||1
6677543|NCT02633020|7608807|FG001|NOT COMPLETED|Overall Study||0
6677544|NCT02633046|7608813|FG000|STARTED|Overall Study||63
6677545|NCT02633046|7608813|FG000|Safety Population|Overall Study||63
6677546|NCT02633046|7608813|FG000|COMPLETED|Overall Study||36
6677547|NCT02633046|7608813|FG000|NOT COMPLETED|Overall Study||27
6677548|NCT02633215|7608819|FG000|STARTED|Overall Study||18
6677549|NCT02633215|7608820|FG001|STARTED|Overall Study||18
6677550|NCT02633215|7608819|FG000|COMPLETED|Overall Study||16
6677551|NCT02633215|7608820|FG001|COMPLETED|Overall Study||15
6677552|NCT02633215|7608819|FG000|NOT COMPLETED|Overall Study||2
6677553|NCT02633215|7608820|FG001|NOT COMPLETED|Overall Study||3
6677554|NCT02633306|7608826|FG000|STARTED|Overall Study||9
6677555|NCT02633306|7608826|FG000|COMPLETED|Overall Study||6
6677556|NCT02633306|7608826|FG000|NOT COMPLETED|Overall Study||3
6677557|NCT02633358|7608833|FG000|STARTED|Overall Study||87
6677558|NCT02633358|7608834|FG001|STARTED|Overall Study||54
6677559|NCT02633358|7608833|FG000|COMPLETED|Overall Study||87
6677560|NCT02633358|7608834|FG001|COMPLETED|Overall Study||54
6677561|NCT02633358|7608833|FG000|NOT COMPLETED|Overall Study||0
6677562|NCT02633358|7608834|FG001|NOT COMPLETED|Overall Study||0
6677563|NCT02633371|7608841|FG000|STARTED|Overall Study||10
6677564|NCT02633371|7608841|FG000|COMPLETED|Overall Study||7
6677565|NCT02633371|7608841|FG000|NOT COMPLETED|Overall Study||3
6677566|NCT02633488|7608847|FG000|STARTED|Overall Study||6
6677567|NCT02633488|7608848|FG001|STARTED|Overall Study||5
6677568|NCT02633488|7608847|FG000|COMPLETED|Overall Study||6
6677569|NCT02633488|7608848|FG001|COMPLETED|Overall Study||5
6677570|NCT02633488|7608847|FG000|NOT COMPLETED|Overall Study||0
6677571|NCT02633488|7608848|FG001|NOT COMPLETED|Overall Study||0
6677572|NCT02633501|7608860|FG000|STARTED|Overall Study||14
6677573|NCT02633501|7608861|FG001|STARTED|Overall Study||14
6677574|NCT02633501|7608862|FG002|STARTED|Overall Study||62
6677575|NCT02633501|7608863|FG003|STARTED|Overall Study||63
6677576|NCT02633501|7608864|FG004|STARTED|Overall Study||64
6677577|NCT02633501|7608865|FG005|STARTED|Overall Study||63
6677578|NCT02633501|7608860|FG000|COMPLETED|Overall Study||12
6677579|NCT02633501|7608861|FG001|COMPLETED|Overall Study||11
6677580|NCT02633501|7608862|FG002|COMPLETED|Overall Study||55
6677581|NCT02633501|7608863|FG003|COMPLETED|Overall Study||59
6677582|NCT02633501|7608864|FG004|COMPLETED|Overall Study||53
6677583|NCT02633501|7608865|FG005|COMPLETED|Overall Study||48
6677584|NCT02633501|7608860|FG000|NOT COMPLETED|Overall Study||2
6677585|NCT02633501|7608861|FG001|NOT COMPLETED|Overall Study||3
6677586|NCT02633501|7608862|FG002|NOT COMPLETED|Overall Study||7
6677587|NCT02633501|7608863|FG003|NOT COMPLETED|Overall Study||4
6677588|NCT02633501|7608864|FG004|NOT COMPLETED|Overall Study||11
6677589|NCT02633501|7608865|FG005|NOT COMPLETED|Overall Study||15
6677590|NCT02633527|7608889|FG000|STARTED|Overall Study||24
6677591|NCT02633527|7608890|FG001|STARTED|Overall Study||48
6677592|NCT02633527|7608891|FG002|STARTED|Overall Study||50
6677593|NCT02633527|7608892|FG003|STARTED|Overall Study||49
6677594|NCT02633527|7608893|FG004|STARTED|Overall Study||51
6677595|NCT02633527|7608889|FG000|COMPLETED|Overall Study||21
6677596|NCT02633527|7608890|FG001|COMPLETED|Overall Study||37
6677597|NCT02633527|7608891|FG002|COMPLETED|Overall Study||33
6677598|NCT02633527|7608892|FG003|COMPLETED|Overall Study||35
6677599|NCT02633527|7608893|FG004|COMPLETED|Overall Study||34
6677600|NCT02633527|7608889|FG000|NOT COMPLETED|Overall Study||3
6677601|NCT02633527|7608890|FG001|NOT COMPLETED|Overall Study||11
6677602|NCT02633527|7608891|FG002|NOT COMPLETED|Overall Study||17
6677603|NCT02633527|7608892|FG003|NOT COMPLETED|Overall Study||14
6677604|NCT02633527|7608893|FG004|NOT COMPLETED|Overall Study||17
6677605|NCT02633735|7608907|FG000|STARTED|Pre-implementation Phase||788
6677606|NCT02633735|7608908|FG001|STARTED|Pre-implementation Phase||1011
6677607|NCT02633735|7608907|FG000|COMPLETED|Pre-implementation Phase||788
6677608|NCT02633735|7608908|FG001|COMPLETED|Pre-implementation Phase||1011
6677609|NCT02633735|7608907|FG000|NOT COMPLETED|Pre-implementation Phase||0
6677610|NCT02633735|7608908|FG001|NOT COMPLETED|Pre-implementation Phase||0
6677611|NCT02633735|7608907|FG000|STARTED|Implementation Phase||1991
6677612|NCT02633735|7608908|FG001|STARTED|Implementation Phase||2150
6677613|NCT02633735|7608907|FG000|COMPLETED|Implementation Phase||1991
6677614|NCT02633735|7608908|FG001|COMPLETED|Implementation Phase||2150
6677615|NCT02633735|7608907|FG000|NOT COMPLETED|Implementation Phase||0
6677616|NCT02633735|7608908|FG001|NOT COMPLETED|Implementation Phase||0
6677617|NCT02633787|7608914|FG000|STARTED|Overall Study||110
6677618|NCT02633787|7608914|FG000|COMPLETED|Overall Study||109
6677619|NCT02633787|7608914|FG000|NOT COMPLETED|Overall Study||1
6677620|NCT02633800|7608920|FG000|STARTED|Overall Study||44
6677621|NCT02633800|7608921|FG001|STARTED|Overall Study||43
6677622|NCT02633800|7608920|FG000|COMPLETED|Overall Study||0
6677623|NCT02633800|7608921|FG001|COMPLETED|Overall Study||0
6677624|NCT02633800|7608920|FG000|NOT COMPLETED|Overall Study||44
6677625|NCT02633800|7608921|FG001|NOT COMPLETED|Overall Study||43
6677626|NCT02633956|7608931|FG000|STARTED|Overall Study||20
6677627|NCT02633956|7608932|FG001|STARTED|Overall Study||21
6677628|NCT02633956|7608933|FG002|STARTED|Overall Study||22
6677629|NCT02633956|7608934|FG003|STARTED|Overall Study||21
6677630|NCT02633956|7608931|FG000|COMPLETED|Overall Study||19
6677631|NCT02633956|7608932|FG001|COMPLETED|Overall Study||19
6677632|NCT02633956|7608933|FG002|COMPLETED|Overall Study||20
6677633|NCT02633956|7608934|FG003|COMPLETED|Overall Study||21
6677634|NCT02633956|7608931|FG000|NOT COMPLETED|Overall Study||1
6677635|NCT02633956|7608932|FG001|NOT COMPLETED|Overall Study||2
6677636|NCT02633956|7608933|FG002|NOT COMPLETED|Overall Study||2
6677637|NCT02633956|7608934|FG003|NOT COMPLETED|Overall Study||0
6677638|NCT02634073|7608948|FG000|STARTED|Overall Study||4
6677639|NCT02634073|7608949|FG001|STARTED|Overall Study||4
6677640|NCT02634073|7608950|FG002|STARTED|Overall Study||4
6677641|NCT02634073|7608951|FG003|STARTED|Overall Study||4
6677642|NCT02634073|7608948|FG000|COMPLETED|Overall Study||4
6677643|NCT02634073|7608949|FG001|COMPLETED|Overall Study||4
6677644|NCT02634073|7608950|FG002|COMPLETED|Overall Study||4
6677645|NCT02634073|7608951|FG003|COMPLETED|Overall Study||4
6677646|NCT02634073|7608948|FG000|NOT COMPLETED|Overall Study||0
6677647|NCT02634073|7608949|FG001|NOT COMPLETED|Overall Study||0
6677648|NCT02634073|7608950|FG002|NOT COMPLETED|Overall Study||0
6677649|NCT02634073|7608951|FG003|NOT COMPLETED|Overall Study||0
6677650|NCT02634151|7608963|FG000|STARTED|Overall Study||53
6677651|NCT02634151|7608964|FG001|STARTED|Overall Study||52
6677652|NCT02634151|7608963|FG000|Full Analysis Set|Overall Study||53
6677653|NCT02634151|7608964|FG001|Full Analysis Set|Overall Study||52
6677654|NCT02634151|7608963|FG000|Safety Set|Overall Study||54
6677655|NCT02634151|7608964|FG001|Safety Set|Overall Study||51
6677656|NCT02634151|7608963|FG000|COMPLETED|Overall Study||52
6677657|NCT02634151|7608964|FG001|COMPLETED|Overall Study||50
6677658|NCT02634151|7608963|FG000|NOT COMPLETED|Overall Study||1
6677659|NCT02634151|7608964|FG001|NOT COMPLETED|Overall Study||2
6677660|NCT02634177|7608972|FG000|STARTED|Overall Study||151
6677661|NCT02634177|7608973|FG001|STARTED|Overall Study||153
6677662|NCT02634177|7608972|FG000|COMPLETED|Overall Study||140
6677663|NCT02634177|7608973|FG001|COMPLETED|Overall Study||141
6677664|NCT02634177|7608972|FG000|NOT COMPLETED|Overall Study||11
6677665|NCT02634177|7608973|FG001|NOT COMPLETED|Overall Study||12
6677666|NCT02634320|7608979|FG000|STARTED|Overall Study||51
6677667|NCT02634320|7608979|FG000|COMPLETED|Overall Study||35
6677668|NCT02634320|7608979|FG000|NOT COMPLETED|Overall Study||16
6677669|NCT02634333|7608985|FG000|STARTED|Overall Study|Number of Eyes|200
6677670|NCT02634333|7608986|FG001|STARTED|Overall Study|Number of Eyes|199
6677671|NCT02634333|7608985|FG000|COMPLETED|Overall Study|Number of Eyes|160
6677672|NCT02634333|7608986|FG001|COMPLETED|Overall Study|Number of Eyes|167
6677673|NCT02634333|7608985|FG000|NOT COMPLETED|Overall Study||40
6677674|NCT02634333|7608986|FG001|NOT COMPLETED|Overall Study||32
6677675|NCT02634346|7608996|FG000|STARTED|Overall Study||134
6677676|NCT02634346|7608997|FG001|STARTED|Overall Study||133
6677677|NCT02634346|7608998|FG002|STARTED|Overall Study||134
6677678|NCT02634346|7608996|FG000|COMPLETED|Overall Study||122
6677679|NCT02634346|7608997|FG001|COMPLETED|Overall Study||119
6677680|NCT02634346|7608998|FG002|COMPLETED|Overall Study||111
6677681|NCT02634346|7608996|FG000|NOT COMPLETED|Overall Study||12
6677682|NCT02634346|7608997|FG001|NOT COMPLETED|Overall Study||14
6677683|NCT02634346|7608998|FG002|NOT COMPLETED|Overall Study||23
6677684|NCT02634580|7609010|FG000|STARTED|Double-blind Treatment Period||10
6677685|NCT02634580|7609011|FG001|STARTED|Double-blind Treatment Period||11
6677686|NCT02634580|7609012|FG002|STARTED|Double-blind Treatment Period||19
6677687|NCT02634580|7609013|FG003|STARTED|Double-blind Treatment Period||21
6677688|NCT02634580|7609010|FG000|COMPLETED|Double-blind Treatment Period||9
6677689|NCT02634580|7609011|FG001|COMPLETED|Double-blind Treatment Period||11
6677690|NCT02634580|7609012|FG002|COMPLETED|Double-blind Treatment Period||18
6677691|NCT02634580|7609013|FG003|COMPLETED|Double-blind Treatment Period||20
6677692|NCT02634580|7609010|FG000|NOT COMPLETED|Double-blind Treatment Period||1
6677693|NCT02634580|7609011|FG001|NOT COMPLETED|Double-blind Treatment Period||0
6677694|NCT02634580|7609012|FG002|NOT COMPLETED|Double-blind Treatment Period||1
6677695|NCT02634580|7609013|FG003|NOT COMPLETED|Double-blind Treatment Period||1
6677696|NCT02634580|7609010|FG000|STARTED|Open-label Extension Period||9
6677697|NCT02634580|7609011|FG001|STARTED|Open-label Extension Period||11
6677698|NCT02634580|7609012|FG002|STARTED|Open-label Extension Period||18
6677699|NCT02634580|7609013|FG003|STARTED|Open-label Extension Period|Includes 1 participant who did not complete the double-blind period but had study visits during OLE|21
6677700|NCT02634580|7609010|FG000|Received Open-label Treatment|Open-label Extension Period||9
6677701|NCT02634580|7609011|FG001|Received Open-label Treatment|Open-label Extension Period||11
6677702|NCT02634580|7609012|FG002|Received Open-label Treatment|Open-label Extension Period||18
6677703|NCT02634580|7609013|FG003|Received Open-label Treatment|Open-label Extension Period||20
6677704|NCT02634580|7609010|FG000|COMPLETED|Open-label Extension Period||9
6677705|NCT02634580|7609011|FG001|COMPLETED|Open-label Extension Period||10
6677706|NCT02634580|7609012|FG002|COMPLETED|Open-label Extension Period||18
6677707|NCT02634580|7609013|FG003|COMPLETED|Open-label Extension Period||20
6677708|NCT02634580|7609010|FG000|NOT COMPLETED|Open-label Extension Period||0
6677709|NCT02634580|7609011|FG001|NOT COMPLETED|Open-label Extension Period||1
6677710|NCT02634580|7609012|FG002|NOT COMPLETED|Open-label Extension Period||0
6677711|NCT02634580|7609013|FG003|NOT COMPLETED|Open-label Extension Period||1
6677712|NCT02634684|7609026|FG000|STARTED|Overall Study||19
6677713|NCT02634684|7609027|FG001|STARTED|Overall Study||19
6677714|NCT02634684|7609028|FG002|STARTED|Overall Study||21
6677715|NCT02634684|7609029|FG003|STARTED|Overall Study||23
6677716|NCT02634684|7609026|FG000|COMPLETED|Overall Study||19
6677717|NCT02634684|7609027|FG001|COMPLETED|Overall Study||19
6677718|NCT02634684|7609028|FG002|COMPLETED|Overall Study||21
6677719|NCT02634684|7609029|FG003|COMPLETED|Overall Study||23
6677720|NCT02634684|7609026|FG000|NOT COMPLETED|Overall Study||0
6677721|NCT02634684|7609027|FG001|NOT COMPLETED|Overall Study||0
6677722|NCT02634684|7609028|FG002|NOT COMPLETED|Overall Study||0
6677723|NCT02634684|7609029|FG003|NOT COMPLETED|Overall Study||0
6677724|NCT02634788|7609043|FG000|STARTED|Overall Study||79
6677725|NCT02634788|7609044|FG001|STARTED|Overall Study||81
6677726|NCT02634788|7609045|FG002|STARTED|Overall Study||80
6677727|NCT02634788|7609046|FG003|STARTED|Overall Study||82
6677728|NCT02634788|7609043|FG000|COMPLETED|Overall Study||75
6677729|NCT02634788|7609044|FG001|COMPLETED|Overall Study||71
6677730|NCT02634788|7609045|FG002|COMPLETED|Overall Study||75
6677731|NCT02634788|7609046|FG003|COMPLETED|Overall Study||77
6677732|NCT02634788|7609043|FG000|NOT COMPLETED|Overall Study||4
6677733|NCT02634788|7609044|FG001|NOT COMPLETED|Overall Study||10
6677734|NCT02634788|7609045|FG002|NOT COMPLETED|Overall Study||5
6677735|NCT02634788|7609046|FG003|NOT COMPLETED|Overall Study||5
6677736|NCT02634801|7609059|FG000|STARTED|Treatment Period (Weeks 0 to 24)||54
6677737|NCT02634801|7609060|FG001|STARTED|Treatment Period (Weeks 0 to 24)||54
6677738|NCT02634801|7609061|FG002|STARTED|Treatment Period (Weeks 0 to 24)||54
6677739|NCT02634801|7609059|FG000|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||54
6677740|NCT02634801|7609060|FG001|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
6677741|NCT02634801|7609061|FG002|Received at Least 1 Dose of Study Drug|Treatment Period (Weeks 0 to 24)||52
6677742|NCT02634801|7609059|FG000|COMPLETED|Treatment Period (Weeks 0 to 24)||50
6677743|NCT02634801|7609060|FG001|COMPLETED|Treatment Period (Weeks 0 to 24)||23
6677744|NCT02634801|7609061|FG002|COMPLETED|Treatment Period (Weeks 0 to 24)||49
6677745|NCT02634801|7609059|FG000|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||4
6677746|NCT02634801|7609060|FG001|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||31
6677747|NCT02634801|7609061|FG002|NOT COMPLETED|Treatment Period (Weeks 0 to 24)||5
6677748|NCT02634801|7609059|FG000|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|48
6677749|NCT02634801|7609060|FG001|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|19
6677750|NCT02634801|7609061|FG002|STARTED|Extension Period (Weeks 24 to 36)|Participants had the option to enter the Extension Period or proceed directly to the Followup Period|31
6677751|NCT02634801|7609059|FG000|COMPLETED|Extension Period (Weeks 24 to 36)||45
6677752|NCT02634801|7609060|FG001|COMPLETED|Extension Period (Weeks 24 to 36)||18
6677753|NCT02634801|7609061|FG002|COMPLETED|Extension Period (Weeks 24 to 36)||29
6677754|NCT02634801|7609059|FG000|NOT COMPLETED|Extension Period (Weeks 24 to 36)||3
6677755|NCT02634801|7609060|FG001|NOT COMPLETED|Extension Period (Weeks 24 to 36)||1
6677756|NCT02634801|7609061|FG002|NOT COMPLETED|Extension Period (Weeks 24 to 36)||2
6677757|NCT02634801|7609059|FG000|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|41
6677758|NCT02634801|7609060|FG001|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|26
6677759|NCT02634801|7609061|FG002|STARTED|Follow-up Period|Participants who discontinued previous periods had option to enter post treatment follow-up period.|46
6677760|NCT02634801|7609059|FG000|COMPLETED|Follow-up Period||36
6677761|NCT02634801|7609060|FG001|COMPLETED|Follow-up Period||18
6677762|NCT02634801|7609061|FG002|COMPLETED|Follow-up Period||38
6677763|NCT02634801|7609059|FG000|NOT COMPLETED|Follow-up Period||5
6677764|NCT02634801|7609060|FG001|NOT COMPLETED|Follow-up Period||8
6677765|NCT02634801|7609061|FG002|NOT COMPLETED|Follow-up Period||8
6677766|NCT02634814|7609076|FG000|STARTED|Overall Study||32
6677767|NCT02634814|7609077|FG001|STARTED|Overall Study||29
6677768|NCT02634814|7609078|FG002|STARTED|Overall Study||29
6677769|NCT02634814|7609076|FG000|COMPLETED|Overall Study||30
6677770|NCT02634814|7609077|FG001|COMPLETED|Overall Study||23
6677771|NCT02634814|7609078|FG002|COMPLETED|Overall Study||29
6677772|NCT02634814|7609076|FG000|NOT COMPLETED|Overall Study||2
6677773|NCT02634814|7609077|FG001|NOT COMPLETED|Overall Study||6
6677774|NCT02634814|7609078|FG002|NOT COMPLETED|Overall Study||0
6677775|NCT02634983|7609086|FG000|STARTED|Period One (First Treatment, 8-10 Days)||16
6677776|NCT02634983|7609087|FG001|STARTED|Period One (First Treatment, 8-10 Days)||15
6677777|NCT02634983|7609086|FG000|COMPLETED|Period One (First Treatment, 8-10 Days)||16
6677778|NCT02634983|7609087|FG001|COMPLETED|Period One (First Treatment, 8-10 Days)||15
6677779|NCT02634983|7609086|FG000|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
6677780|NCT02634983|7609087|FG001|NOT COMPLETED|Period One (First Treatment, 8-10 Days)||0
6677781|NCT02634983|7609086|FG000|STARTED|Washout (Approximately 7-14 Days)||16
6677782|NCT02634983|7609087|FG001|STARTED|Washout (Approximately 7-14 Days)||15
6677783|NCT02634983|7609086|FG000|COMPLETED|Washout (Approximately 7-14 Days)||16
6677784|NCT02634983|7609087|FG001|COMPLETED|Washout (Approximately 7-14 Days)||15
6677785|NCT02634983|7609086|FG000|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
6677786|NCT02634983|7609087|FG001|NOT COMPLETED|Washout (Approximately 7-14 Days)||0
6677787|NCT02634983|7609086|FG000|STARTED|Period 2 (Second Treatment, 8-10 Days)||16
6677788|NCT02634983|7609087|FG001|STARTED|Period 2 (Second Treatment, 8-10 Days)||15
6677789|NCT02634983|7609086|FG000|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||14
6677790|NCT02634983|7609087|FG001|COMPLETED|Period 2 (Second Treatment, 8-10 Days)||15
6677791|NCT02634983|7609086|FG000|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||2
6677792|NCT02634983|7609087|FG001|NOT COMPLETED|Period 2 (Second Treatment, 8-10 Days)||0
6677793|NCT02635035|7609095|FG000|STARTED|Overall Study||17
6677794|NCT02635035|7609096|FG001|STARTED|Overall Study||21
6677795|NCT02635035|7609095|FG000|COMPLETED|Overall Study||17
6677796|NCT02635035|7609096|FG001|COMPLETED|Overall Study||21
6677797|NCT02635035|7609095|FG000|NOT COMPLETED|Overall Study||0
6677798|NCT02635035|7609096|FG001|NOT COMPLETED|Overall Study||0
6677799|NCT02635204|7609104|FG000|STARTED|Overall Study||178
6677800|NCT02635204|7609105|FG001|STARTED|Overall Study||89
6677801|NCT02635204|7609104|FG000|COMPLETED|Overall Study||176
6677802|NCT02635204|7609105|FG001|COMPLETED|Overall Study||88
6677803|NCT02635204|7609104|FG000|NOT COMPLETED|Overall Study||2
6677804|NCT02635204|7609105|FG001|NOT COMPLETED|Overall Study||1
6677805|NCT02635347|7609113|FG000|STARTED|Overall Study||51
6677806|NCT02635347|7609114|FG001|STARTED|Overall Study||70
6677807|NCT02635347|7609113|FG000|Screening|Overall Study||51
6677808|NCT02635347|7609114|FG001|Screening|Overall Study||70
6677809|NCT02635347|7609113|FG000|Enrollment|Overall Study||31
6677810|NCT02635347|7609114|FG001|Enrollment|Overall Study||63
6677811|NCT02635347|7609113|FG000|Protocol Completion|Overall Study||22
6677812|NCT02635347|7609114|FG001|Protocol Completion|Overall Study||63
6677813|NCT02635347|7609113|FG000|Follow up|Overall Study||31
6677814|NCT02635347|7609114|FG001|Follow up|Overall Study||63
6677815|NCT02635347|7609113|FG000|Analyses|Overall Study||30
6677816|NCT02635347|7609114|FG001|Analyses|Overall Study||63
6677817|NCT02635347|7609113|FG000|COMPLETED|Overall Study||31
6677818|NCT02635347|7609114|FG001|COMPLETED|Overall Study||63
6677819|NCT02635347|7609113|FG000|NOT COMPLETED|Overall Study||20
6677820|NCT02635347|7609114|FG001|NOT COMPLETED|Overall Study||7
6677821|NCT02635386|7609126|FG000|STARTED|Overall Study||23
6677822|NCT02635386|7609127|FG001|STARTED|Overall Study||23
6677823|NCT02635386|7609128|FG002|STARTED|Overall Study||22
6677824|NCT02635386|7609129|FG003|STARTED|Overall Study||26
6677825|NCT02635386|7609130|FG004|STARTED|Overall Study||25
6677826|NCT02635386|7609126|FG000|COMPLETED|Overall Study||20
6677827|NCT02635386|7609127|FG001|COMPLETED|Overall Study||17
6677828|NCT02635386|7609128|FG002|COMPLETED|Overall Study||20
6677829|NCT02635386|7609129|FG003|COMPLETED|Overall Study||19
6677830|NCT02635386|7609130|FG004|COMPLETED|Overall Study||16
6677831|NCT02635386|7609126|FG000|NOT COMPLETED|Overall Study||3
6677832|NCT02635386|7609127|FG001|NOT COMPLETED|Overall Study||6
6677833|NCT02635386|7609128|FG002|NOT COMPLETED|Overall Study||2
6677834|NCT02635386|7609129|FG003|NOT COMPLETED|Overall Study||7
6677835|NCT02635386|7609130|FG004|NOT COMPLETED|Overall Study||9
6677836|NCT02635425|7609149|FG000|STARTED|Overall Study||15
6677837|NCT02635425|7609150|FG001|STARTED|Overall Study||15
6677838|NCT02635425|7609149|FG000|COMPLETED|Overall Study||15
6677839|NCT02635425|7609150|FG001|COMPLETED|Overall Study||15
6677840|NCT02635425|7609149|FG000|NOT COMPLETED|Overall Study||0
6677841|NCT02635425|7609150|FG001|NOT COMPLETED|Overall Study||0
6677842|NCT02635542|7609158|FG000|STARTED|Overall Study||50
6677843|NCT02635542|7609159|FG001|STARTED|Overall Study||50
6677844|NCT02635542|7609158|FG000|COMPLETED|Overall Study||50
6677845|NCT02635542|7609159|FG001|COMPLETED|Overall Study||50
6677846|NCT02635542|7609158|FG000|NOT COMPLETED|Overall Study||0
6677847|NCT02635542|7609159|FG001|NOT COMPLETED|Overall Study||0
6677848|NCT02635646|7609167|FG000|STARTED|Overall Study||57
6677849|NCT02635646|7609168|FG001|STARTED|Overall Study||65
6677850|NCT02635646|7609167|FG000|COMPLETED|Overall Study||32
6677851|NCT02635646|7609168|FG001|COMPLETED|Overall Study||39
6677852|NCT02635646|7609167|FG000|NOT COMPLETED|Overall Study||25
6677853|NCT02635646|7609168|FG001|NOT COMPLETED|Overall Study||26
6677854|NCT02635724|7609183|FG000|STARTED|Overall Study||41
6677855|NCT02635724|7609184|FG001|STARTED|Overall Study||26
6677856|NCT02635724|7609185|FG002|STARTED|Overall Study||7
6677857|NCT02635724|7609183|FG000|ITT Population|Overall Study||41
6677858|NCT02635724|7609184|FG001|ITT Population|Overall Study||26
6677859|NCT02635724|7609185|FG002|ITT Population|Overall Study||7
6677860|NCT02635724|7609183|FG000|Safety Population|Overall Study||41
6677861|NCT02635724|7609184|FG001|Safety Population|Overall Study||25
6677862|NCT02635724|7609185|FG002|Safety Population|Overall Study||7
6677863|NCT02635724|7609183|FG000|ITTI Population|Overall Study||28
6602180|NCT02055157|7527114|FG003|NOT COMPLETED|Initial 6 Months||1
6602181|NCT02055157|7527111|FG000|STARTED|18-month Extension||7
6602182|NCT02055157|7527112|FG001|STARTED|18-month Extension||7
6602183|NCT02055157|7527113|FG002|STARTED|18-month Extension||10
6602184|NCT02055157|7527114|FG003|STARTED|18-month Extension||8
6602185|NCT02055157|7527111|FG000|COMPLETED|18-month Extension||6
6677864|NCT02635724|7609184|FG001|ITTI Population|Overall Study||19
6677865|NCT02635724|7609185|FG002|ITTI Population|Overall Study||5
6677866|NCT02635724|7609183|FG000|E-R Population|Overall Study||28
6677867|NCT02635724|7609184|FG001|E-R Population|Overall Study||19
6677868|NCT02635724|7609185|FG002|E-R Population|Overall Study||5
6677869|NCT02635724|7609183|FG000|COMPLETED|Overall Study||41
6677870|NCT02635724|7609184|FG001|COMPLETED|Overall Study||25
6677871|NCT02635724|7609185|FG002|COMPLETED|Overall Study||7
6677872|NCT02635724|7609183|FG000|NOT COMPLETED|Overall Study||0
6677873|NCT02635724|7609184|FG001|NOT COMPLETED|Overall Study||1
6677874|NCT02635724|7609185|FG002|NOT COMPLETED|Overall Study||0
6677875|NCT02635737|7609193|FG000|STARTED|Overall Study||29
6677876|NCT02635737|7609193|FG000|COMPLETED|Overall Study||28
6677877|NCT02635737|7609193|FG000|NOT COMPLETED|Overall Study||1
6677878|NCT02635828|7609197|FG000|STARTED|Overall Study||54
6677879|NCT02635828|7609197|FG000|COMPLETED|Overall Study||40
6677880|NCT02635828|7609197|FG000|NOT COMPLETED|Overall Study||14
6677881|NCT02635880|7609201|FG000|STARTED|Overall Study||32
6677882|NCT02635880|7609201|FG000|COMPLETED|Overall Study||32
6677883|NCT02635880|7609201|FG000|NOT COMPLETED|Overall Study||0
6677884|NCT02635984|7609207|FG000|STARTED|Overall Study||53
6677885|NCT02635984|7609208|FG001|STARTED|Overall Study||55
6677886|NCT02635984|7609207|FG000|COMPLETED|Overall Study||50
6677887|NCT02635984|7609208|FG001|COMPLETED|Overall Study||51
6677888|NCT02635984|7609207|FG000|NOT COMPLETED|Overall Study||3
6677889|NCT02635984|7609208|FG001|NOT COMPLETED|Overall Study||4
6677890|NCT02636049|7609214|FG000|STARTED|Overall Study||12
6677891|NCT02636049|7609214|FG000|Triferic 6 mg IV Over 3 Hours|Overall Study||12
6738338|NCT03283436|7667705|FG001|COMPLETED|Overall Study||50
6602186|NCT02055157|7527112|FG001|COMPLETED|18-month Extension||6
6602187|NCT02055157|7527113|FG002|COMPLETED|18-month Extension||10
6602188|NCT02055157|7527114|FG003|COMPLETED|18-month Extension||8
6602189|NCT02055157|7527111|FG000|NOT COMPLETED|18-month Extension||1
6602190|NCT02055157|7527112|FG001|NOT COMPLETED|18-month Extension||1
6602191|NCT02055157|7527113|FG002|NOT COMPLETED|18-month Extension||0
6602192|NCT02055157|7527114|FG003|NOT COMPLETED|18-month Extension||0
6677892|NCT02636049|7609214|FG000|Triferic 35 Micrograms/kg IV Push|Overall Study||12
6677893|NCT02636049|7609214|FG000|COMPLETED|Overall Study||12
6677894|NCT02636049|7609214|FG000|NOT COMPLETED|Overall Study||0
6677895|NCT02636361|7609220|FG000|STARTED|Period 1||5
6677896|NCT02636361|7609221|FG001|STARTED|Period 1||6
6677897|NCT02636361|7609222|FG002|STARTED|Period 1||5
6677898|NCT02636361|7609223|FG003|STARTED|Period 1||5
6677899|NCT02636361|7609224|FG004|STARTED|Period 1||5
6677900|NCT02636361|7609220|FG000|Received at Least One Dose of Study Drug|Period 1||5
6677901|NCT02636361|7609221|FG001|Received at Least One Dose of Study Drug|Period 1||5
6677902|NCT02636361|7609222|FG002|Received at Least One Dose of Study Drug|Period 1||5
6677903|NCT02636361|7609223|FG003|Received at Least One Dose of Study Drug|Period 1||5
6677904|NCT02636361|7609224|FG004|Received at Least One Dose of Study Drug|Period 1||4
6677905|NCT02636361|7609220|FG000|COMPLETED|Period 1||5
6677906|NCT02636361|7609221|FG001|COMPLETED|Period 1||5
6677907|NCT02636361|7609222|FG002|COMPLETED|Period 1||5
6677908|NCT02636361|7609223|FG003|COMPLETED|Period 1||5
6677909|NCT02636361|7609224|FG004|COMPLETED|Period 1||4
6677910|NCT02636361|7609220|FG000|NOT COMPLETED|Period 1||0
6677911|NCT02636361|7609221|FG001|NOT COMPLETED|Period 1||1
6677912|NCT02636361|7609222|FG002|NOT COMPLETED|Period 1||0
6677913|NCT02636361|7609223|FG003|NOT COMPLETED|Period 1||0
6677914|NCT02636361|7609224|FG004|NOT COMPLETED|Period 1||1
6677915|NCT02636361|7609220|FG000|STARTED|Period 2||5
6677916|NCT02636361|7609221|FG001|STARTED|Period 2||5
6677917|NCT02636361|7609222|FG002|STARTED|Period 2||5
6677918|NCT02636361|7609223|FG003|STARTED|Period 2||5
6677919|NCT02636361|7609224|FG004|STARTED|Period 2||4
6677920|NCT02636361|7609220|FG000|COMPLETED|Period 2||5
6677921|NCT02636361|7609221|FG001|COMPLETED|Period 2||5
6677922|NCT02636361|7609222|FG002|COMPLETED|Period 2||5
6677923|NCT02636361|7609223|FG003|COMPLETED|Period 2||5
6677924|NCT02636361|7609224|FG004|COMPLETED|Period 2||4
6677925|NCT02636361|7609220|FG000|NOT COMPLETED|Period 2||0
6677926|NCT02636361|7609221|FG001|NOT COMPLETED|Period 2||0
6677927|NCT02636361|7609222|FG002|NOT COMPLETED|Period 2||0
6677928|NCT02636361|7609223|FG003|NOT COMPLETED|Period 2||0
6677929|NCT02636361|7609224|FG004|NOT COMPLETED|Period 2||0
6677930|NCT02636361|7609220|FG000|STARTED|Period 3||5
6677931|NCT02636361|7609221|FG001|STARTED|Period 3||5
6677932|NCT02636361|7609222|FG002|STARTED|Period 3||5
6677933|NCT02636361|7609223|FG003|STARTED|Period 3||5
6677934|NCT02636361|7609224|FG004|STARTED|Period 3||4
6677935|NCT02636361|7609220|FG000|COMPLETED|Period 3||5
6677936|NCT02636361|7609221|FG001|COMPLETED|Period 3||5
6677937|NCT02636361|7609222|FG002|COMPLETED|Period 3||5
6677938|NCT02636361|7609223|FG003|COMPLETED|Period 3||5
6677939|NCT02636361|7609224|FG004|COMPLETED|Period 3||4
6677940|NCT02636361|7609220|FG000|NOT COMPLETED|Period 3||0
6677941|NCT02636361|7609221|FG001|NOT COMPLETED|Period 3||0
6677942|NCT02636361|7609222|FG002|NOT COMPLETED|Period 3||0
6677943|NCT02636361|7609223|FG003|NOT COMPLETED|Period 3||0
6677944|NCT02636361|7609224|FG004|NOT COMPLETED|Period 3||0
6677945|NCT02636361|7609220|FG000|STARTED|Period 4||5
6677946|NCT02636361|7609221|FG001|STARTED|Period 4||5
6677947|NCT02636361|7609222|FG002|STARTED|Period 4||5
6677948|NCT02636361|7609223|FG003|STARTED|Period 4||5
6677949|NCT02636361|7609224|FG004|STARTED|Period 4||4
6677950|NCT02636361|7609220|FG000|COMPLETED|Period 4||5
6677951|NCT02636361|7609221|FG001|COMPLETED|Period 4||5
6677952|NCT02636361|7609222|FG002|COMPLETED|Period 4||5
6677953|NCT02636361|7609223|FG003|COMPLETED|Period 4||4
6677954|NCT02636361|7609224|FG004|COMPLETED|Period 4||4
6677955|NCT02636361|7609220|FG000|NOT COMPLETED|Period 4||0
6677956|NCT02636361|7609221|FG001|NOT COMPLETED|Period 4||0
6677957|NCT02636361|7609222|FG002|NOT COMPLETED|Period 4||0
6677958|NCT02636361|7609223|FG003|NOT COMPLETED|Period 4||1
6677959|NCT02636361|7609224|FG004|NOT COMPLETED|Period 4||0
6677960|NCT02636361|7609220|FG000|STARTED|Period 5||5
6677961|NCT02636361|7609221|FG001|STARTED|Period 5||5
6677962|NCT02636361|7609222|FG002|STARTED|Period 5||5
6677963|NCT02636361|7609223|FG003|STARTED|Period 5||4
6677964|NCT02636361|7609224|FG004|STARTED|Period 5||4
6677965|NCT02636361|7609220|FG000|COMPLETED|Period 5||5
6677966|NCT02636361|7609221|FG001|COMPLETED|Period 5||5
6677967|NCT02636361|7609222|FG002|COMPLETED|Period 5||5
6677968|NCT02636361|7609223|FG003|COMPLETED|Period 5||4
6677969|NCT02636361|7609224|FG004|COMPLETED|Period 5||4
6677970|NCT02636361|7609220|FG000|NOT COMPLETED|Period 5||0
6677971|NCT02636361|7609221|FG001|NOT COMPLETED|Period 5||0
6677972|NCT02636361|7609222|FG002|NOT COMPLETED|Period 5||0
6677973|NCT02636361|7609223|FG003|NOT COMPLETED|Period 5||0
6677974|NCT02636361|7609224|FG004|NOT COMPLETED|Period 5||0
6677975|NCT02636595|7609238|FG000|STARTED|Overall Study||121
6677976|NCT02636595|7609238|FG000|COMPLETED|Overall Study||119
6677977|NCT02636595|7609238|FG000|NOT COMPLETED|Overall Study||2
6677978|NCT02636608|7609242|FG000|STARTED|Overall Study||244
6677979|NCT02636608|7609242|FG000|Received Treatment|Overall Study||243
6677980|NCT02636608|7609242|FG000|COMPLETED|Overall Study||233
6677981|NCT02636608|7609242|FG000|NOT COMPLETED|Overall Study||11
6677982|NCT02636699|7609251|FG000|STARTED|Overall Study||238
6677983|NCT02636699|7609252|FG001|STARTED|Overall Study||118
6677984|NCT02636699|7609251|FG000|COMPLETED|Overall Study||213
6677985|NCT02636699|7609252|FG001|COMPLETED|Overall Study||107
6677986|NCT02636699|7609251|FG000|NOT COMPLETED|Overall Study||25
6677987|NCT02636699|7609252|FG001|NOT COMPLETED|Overall Study||11
6677988|NCT02636712|7609258|FG000|STARTED|Overall Study||10
6677989|NCT02636712|7609258|FG000|COMPLETED|Overall Study||10
6677990|NCT02636712|7609258|FG000|NOT COMPLETED|Overall Study||0
6677991|NCT02636725|7609263|FG000|STARTED|Baseline||33
6677992|NCT02636725|7609263|FG000|COMPLETED|Baseline||30
6677993|NCT02636725|7609263|FG000|NOT COMPLETED|Baseline||3
6677994|NCT02636725|7609263|FG000|STARTED|Post-Baseline Imaging Assessment||30
6677995|NCT02636725|7609263|FG000|COMPLETED|Post-Baseline Imaging Assessment||30
6677996|NCT02636725|7609263|FG000|NOT COMPLETED|Post-Baseline Imaging Assessment||0
6677997|NCT02636868|7609270|FG000|STARTED|Overall Study||73
6677998|NCT02636868|7609271|FG001|STARTED|Overall Study||76
6677999|NCT02636868|7609272|FG002|STARTED|Overall Study||72
6678000|NCT02636868|7609270|FG000|COMPLETED|Overall Study||73
6678001|NCT02636868|7609271|FG001|COMPLETED|Overall Study||75
6678002|NCT02636868|7609272|FG002|COMPLETED|Overall Study||70
6678003|NCT02636868|7609270|FG000|NOT COMPLETED|Overall Study||0
6678004|NCT02636868|7609271|FG001|NOT COMPLETED|Overall Study||1
6678005|NCT02636868|7609272|FG002|NOT COMPLETED|Overall Study||2
6678006|NCT02636907|7609280|FG000|STARTED|Autoinjector Assessment Period|Assigned to treatment.|77
6678007|NCT02636907|7609280|FG000|COMPLETED|Autoinjector Assessment Period|Completed autoinjector assessment period (Day 50).|73
6678008|NCT02636907|7609280|FG000|NOT COMPLETED|Autoinjector Assessment Period||4
6678009|NCT02636907|7609280|FG000|STARTED|Extension Phase||72
6678010|NCT02636907|7609280|FG000|COMPLETED|Extension Phase||62
6678011|NCT02636907|7609280|FG000|NOT COMPLETED|Extension Phase||10
6678012|NCT02637037|7609286|FG000|STARTED|Overall Study||40
6678013|NCT02637037|7609287|FG001|STARTED|Overall Study||40
6678014|NCT02637037|7609286|FG000|COMPLETED|Overall Study||36
6678015|NCT02637037|7609287|FG001|COMPLETED|Overall Study||39
6678016|NCT02637037|7609286|FG000|NOT COMPLETED|Overall Study||4
6678017|NCT02637037|7609287|FG001|NOT COMPLETED|Overall Study||1
6678018|NCT02637063|7609308|FG000|STARTED|Overall Study||67
6678019|NCT02637063|7609309|FG001|STARTED|Overall Study||68
6678020|NCT02637063|7609310|FG002|STARTED|Overall Study||68
6678021|NCT02637063|7609308|FG000|COMPLETED|Overall Study||62
6678022|NCT02637063|7609309|FG001|COMPLETED|Overall Study||64
6678023|NCT02637063|7609310|FG002|COMPLETED|Overall Study||62
6678024|NCT02637063|7609308|FG000|NOT COMPLETED|Overall Study||5
6678025|NCT02637063|7609309|FG001|NOT COMPLETED|Overall Study||4
6678026|NCT02637063|7609310|FG002|NOT COMPLETED|Overall Study||6
6678027|NCT02637076|7609320|FG000|STARTED|Overall Study||2
6678028|NCT02637076|7609321|FG001|STARTED|Overall Study||15
6678029|NCT02637076|7609320|FG000|COMPLETED|Overall Study||1
6678030|NCT02637076|7609321|FG001|COMPLETED|Overall Study||10
6678031|NCT02637076|7609320|FG000|NOT COMPLETED|Overall Study||1
6678032|NCT02637076|7609321|FG001|NOT COMPLETED|Overall Study||5
6678033|NCT02637141|7609330|FG000|STARTED|Overall Study||22
6678034|NCT02637141|7609331|FG001|STARTED|Overall Study||22
6678035|NCT02637141|7609332|FG002|STARTED|Overall Study||20
6678036|NCT02637141|7609330|FG000|Received Study Drug|Overall Study||22
6678037|NCT02637141|7609331|FG001|Received Study Drug|Overall Study||21
6678038|NCT02637141|7609332|FG002|Received Study Drug|Overall Study||19
6678039|NCT02637141|7609330|FG000|COMPLETED|Overall Study||20
6678040|NCT02637141|7609331|FG001|COMPLETED|Overall Study||20
6678041|NCT02637141|7609332|FG002|COMPLETED|Overall Study||19
6678042|NCT02637141|7609330|FG000|NOT COMPLETED|Overall Study||2
6678043|NCT02637141|7609331|FG001|NOT COMPLETED|Overall Study||2
6678044|NCT02637141|7609332|FG002|NOT COMPLETED|Overall Study||1
6678045|NCT02637232|7609340|FG000|STARTED|Overall Study||301
6678046|NCT02637232|7609340|FG000|COMPLETED|Overall Study||246
6678047|NCT02637232|7609340|FG000|NOT COMPLETED|Overall Study||55
6678048|NCT02637323|7609346|FG000|STARTED|Overall Study||63
6678049|NCT02637323|7609347|FG001|STARTED|Overall Study||18
6678050|NCT02637323|7609346|FG000|COMPLETED|Overall Study||61
6678051|NCT02637323|7609347|FG001|COMPLETED|Overall Study||17
6678052|NCT02637323|7609346|FG000|NOT COMPLETED|Overall Study||2
6678053|NCT02637323|7609347|FG001|NOT COMPLETED|Overall Study||1
6678054|NCT02637427|7609356|FG000|STARTED|Overall Study||27
6678055|NCT02637427|7609357|FG001|STARTED|Overall Study||30
6678056|NCT02637427|7609356|FG000|COMPLETED|Overall Study||27
6678057|NCT02637427|7609357|FG001|COMPLETED|Overall Study||30
6678058|NCT02637427|7609356|FG000|NOT COMPLETED|Overall Study||0
6678059|NCT02637427|7609357|FG001|NOT COMPLETED|Overall Study||0
6678060|NCT02637557|7609367|FG000|STARTED|Overall Study||71
6678061|NCT02637557|7609368|FG001|STARTED|Overall Study||71
6678062|NCT02637557|7609369|FG002|STARTED|Overall Study||71
6678063|NCT02637557|7609370|FG003|STARTED|Overall Study||69
6678064|NCT02637557|7609367|FG000|COMPLETED|Overall Study||63
6678065|NCT02637557|7609368|FG001|COMPLETED|Overall Study||66
6678066|NCT02637557|7609369|FG002|COMPLETED|Overall Study||62
6678067|NCT02637557|7609370|FG003|COMPLETED|Overall Study||62
6678068|NCT02637557|7609367|FG000|NOT COMPLETED|Overall Study||8
6678069|NCT02637557|7609368|FG001|NOT COMPLETED|Overall Study||5
6678070|NCT02637557|7609369|FG002|NOT COMPLETED|Overall Study||9
6678071|NCT02637557|7609370|FG003|NOT COMPLETED|Overall Study||7
6678072|NCT02637804|7609382|FG000|STARTED|First Intervention (1 Week)||27
6678073|NCT02637804|7609383|FG001|STARTED|First Intervention (1 Week)||28
6678074|NCT02637804|7609384|FG002|STARTED|First Intervention (1 Week)||25
6678075|NCT02637804|7609385|FG003|STARTED|First Intervention (1 Week)||26
6678076|NCT02637804|7609382|FG000|COMPLETED|First Intervention (1 Week)||27
6678077|NCT02637804|7609383|FG001|COMPLETED|First Intervention (1 Week)||28
6678078|NCT02637804|7609384|FG002|COMPLETED|First Intervention (1 Week)||25
6678079|NCT02637804|7609385|FG003|COMPLETED|First Intervention (1 Week)||26
6256301|NCT05043142|7155175|FG000|STARTED|Overall Study||3632
6256302|NCT05043142|7155175|FG000|COMPLETED|Overall Study||3443
6256303|NCT05043142|7155175|FG000|NOT COMPLETED|Overall Study||189
6256304|NCT04993339|7155181|FG000|STARTED|Overall Study||14
6256305|NCT04993339|7155182|FG001|STARTED|Overall Study||12
6256306|NCT04993339|7155181|FG000|COMPLETED|Overall Study||11
6256307|NCT04993339|7155182|FG001|COMPLETED|Overall Study||10
6256308|NCT04993339|7155181|FG000|NOT COMPLETED|Overall Study||3
6256309|NCT04993339|7155182|FG001|NOT COMPLETED|Overall Study||2
6256310|NCT04992442|7155188|FG000|STARTED|Treatment Period 1||6
6256311|NCT04992442|7155188|FG000|COMPLETED|Treatment Period 1||6
6678080|NCT02637804|7609382|FG000|NOT COMPLETED|First Intervention (1 Week)||0
6678081|NCT02637804|7609383|FG001|NOT COMPLETED|First Intervention (1 Week)||0
6678082|NCT02637804|7609384|FG002|NOT COMPLETED|First Intervention (1 Week)||0
6678083|NCT02637804|7609385|FG003|NOT COMPLETED|First Intervention (1 Week)||0
6678084|NCT02637804|7609382|FG000|STARTED|Second Intervention (1 Week)||27
6678085|NCT02637804|7609383|FG001|STARTED|Second Intervention (1 Week)||28
6678086|NCT02637804|7609384|FG002|STARTED|Second Intervention (1 Week)||25
6678087|NCT02637804|7609385|FG003|STARTED|Second Intervention (1 Week)||26
6678088|NCT02637804|7609382|FG000|COMPLETED|Second Intervention (1 Week)||27
6678089|NCT02637804|7609383|FG001|COMPLETED|Second Intervention (1 Week)||28
6678090|NCT02637804|7609384|FG002|COMPLETED|Second Intervention (1 Week)||25
6678091|NCT02637804|7609385|FG003|COMPLETED|Second Intervention (1 Week)||26
6678092|NCT02637804|7609382|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6678093|NCT02637804|7609383|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6678094|NCT02637804|7609384|FG002|NOT COMPLETED|Second Intervention (1 Week)||0
6678095|NCT02637804|7609385|FG003|NOT COMPLETED|Second Intervention (1 Week)||0
6678096|NCT02637856|7609402|FG000|STARTED|Main Study (Baseline to Week 100)||608
6678097|NCT02637856|7609403|FG001|STARTED|Main Study (Baseline to Week 100)||0
6678098|NCT02637856|7609402|FG000|COMPLETED|Main Study (Baseline to Week 100)||389
6678099|NCT02637856|7609403|FG001|COMPLETED|Main Study (Baseline to Week 100)||0
6678100|NCT02637856|7609402|FG000|NOT COMPLETED|Main Study (Baseline to Week 100)||219
6678101|NCT02637856|7609403|FG001|NOT COMPLETED|Main Study (Baseline to Week 100)||0
6678102|NCT02637856|7609402|FG000|STARTED|Sub-Study (Week 72 to Week 100)||0
6678103|NCT02637856|7609403|FG001|STARTED|Sub-Study (Week 72 to Week 100)||129
6678104|NCT02637856|7609402|FG000|COMPLETED|Sub-Study (Week 72 to Week 100)||0
6678105|NCT02637856|7609403|FG001|COMPLETED|Sub-Study (Week 72 to Week 100)||125
6678106|NCT02637856|7609402|FG000|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||0
6678107|NCT02637856|7609403|FG001|NOT COMPLETED|Sub-Study (Week 72 to Week 100)||4
6678108|NCT02637895|7609411|FG000|STARTED|Overall Study||21
6678109|NCT02637895|7609412|FG001|STARTED|Overall Study||20
6678110|NCT02637895|7609411|FG000|COMPLETED|Overall Study||15
6678111|NCT02637895|7609412|FG001|COMPLETED|Overall Study||17
6678112|NCT02637895|7609411|FG000|NOT COMPLETED|Overall Study||6
6678113|NCT02637895|7609412|FG001|NOT COMPLETED|Overall Study||3
6678114|NCT02637999|7609422|FG000|STARTED|Overall Study||8
6678115|NCT02637999|7609423|FG001|STARTED|Overall Study||8
6678116|NCT02637999|7609424|FG002|STARTED|Overall Study||8
6678117|NCT02637999|7609422|FG000|COMPLETED|Overall Study||7
6678118|NCT02637999|7609423|FG001|COMPLETED|Overall Study||6
6678119|NCT02637999|7609424|FG002|COMPLETED|Overall Study||6
6678120|NCT02637999|7609422|FG000|NOT COMPLETED|Overall Study||1
6678121|NCT02637999|7609423|FG001|NOT COMPLETED|Overall Study||2
6678122|NCT02637999|7609424|FG002|NOT COMPLETED|Overall Study||2
6678123|NCT02638012|7609432|FG000|STARTED|Overall Study||8
6678124|NCT02638012|7609432|FG000|COMPLETED|Overall Study||7
6678125|NCT02638012|7609432|FG000|NOT COMPLETED|Overall Study||1
6678126|NCT02638051|7609438|FG000|STARTED|Overall Study||130
6678127|NCT02638051|7609439|FG001|STARTED|Overall Study||130
6678128|NCT02638051|7609438|FG000|COMPLETED|Overall Study||130
6678129|NCT02638051|7609439|FG001|COMPLETED|Overall Study||130
6678130|NCT02638051|7609438|FG000|NOT COMPLETED|Overall Study||0
6678131|NCT02638051|7609439|FG001|NOT COMPLETED|Overall Study||0
6678132|NCT02638103|7609449|FG000|STARTED|Overall Study||419
6678133|NCT02638103|7609450|FG001|STARTED|Overall Study||526
6678134|NCT02638103|7609451|FG002|STARTED|Overall Study||420
6678135|NCT02638103|7609452|FG003|STARTED|Overall Study||525
6678136|NCT02638103|7609449|FG000|Safety Analysis Set|Overall Study||418
6678137|NCT02638103|7609450|FG001|Safety Analysis Set|Overall Study||526
6678138|NCT02638103|7609451|FG002|Safety Analysis Set|Overall Study||419
6678139|NCT02638103|7609452|FG003|Safety Analysis Set|Overall Study||525
6678140|NCT02638103|7609449|FG000|Full Analysis Set (FAS)|Overall Study||416
6678141|NCT02638103|7609450|FG001|Full Analysis Set (FAS)|Overall Study||520
6678142|NCT02638103|7609451|FG002|Full Analysis Set (FAS)|Overall Study||419
6678143|NCT02638103|7609452|FG003|Full Analysis Set (FAS)|Overall Study||523
6678144|NCT02638103|7609449|FG000|COMPLETED|Overall Study||313
6678145|NCT02638103|7609450|FG001|COMPLETED|Overall Study||408
6678146|NCT02638103|7609451|FG002|COMPLETED|Overall Study||335
6678147|NCT02638103|7609452|FG003|COMPLETED|Overall Study||383
6678148|NCT02638103|7609449|FG000|NOT COMPLETED|Overall Study||106
6678149|NCT02638103|7609450|FG001|NOT COMPLETED|Overall Study||118
6678150|NCT02638103|7609451|FG002|NOT COMPLETED|Overall Study||85
6678151|NCT02638103|7609452|FG003|NOT COMPLETED|Overall Study||142
6678152|NCT02638168|7609470|FG000|STARTED|Overall Study||3
6678153|NCT02638168|7609471|FG001|STARTED|Overall Study||0
6678154|NCT02638168|7609470|FG000|COMPLETED|Overall Study||3
6678155|NCT02638168|7609471|FG001|COMPLETED|Overall Study||0
6678156|NCT02638168|7609470|FG000|NOT COMPLETED|Overall Study||0
6678157|NCT02638168|7609471|FG001|NOT COMPLETED|Overall Study||0
6678158|NCT02638207|7609478|FG000|STARTED|Overall Study||35
6678159|NCT02638207|7609479|FG001|STARTED|Overall Study||69
6678160|NCT02638207|7609480|FG002|STARTED|Overall Study||38
6678161|NCT02638207|7609478|FG000|COMPLETED|Overall Study||28
6678162|NCT02638207|7609479|FG001|COMPLETED|Overall Study||61
6678163|NCT02638207|7609480|FG002|COMPLETED|Overall Study||34
6678164|NCT02638207|7609478|FG000|NOT COMPLETED|Overall Study||7
6678165|NCT02638207|7609479|FG001|NOT COMPLETED|Overall Study||8
6678166|NCT02638207|7609480|FG002|NOT COMPLETED|Overall Study||4
6678167|NCT02638259|7609492|FG000|STARTED|Treatment Period 1||186
6678168|NCT02638259|7609493|FG001|STARTED|Treatment Period 1||190
6678169|NCT02638259|7609492|FG000|COMPLETED|Treatment Period 1||181
6678170|NCT02638259|7609493|FG001|COMPLETED|Treatment Period 1||172
6678171|NCT02638259|7609492|FG000|NOT COMPLETED|Treatment Period 1||5
6678172|NCT02638259|7609493|FG001|NOT COMPLETED|Treatment Period 1||18
6678173|NCT02638259|7609492|FG000|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (3 not eligible, 2 consent withdrawal, 1 IP delay)|175
6678174|NCT02638259|7609493|FG001|STARTED|Treatment Period 2|6 patients did not proceed to TP2 (4 not eligible, 1 consent withdrawal, 1 adverse event).|166
6678175|NCT02638259|7609492|FG000|COMPLETED|Treatment Period 2||169
6678176|NCT02638259|7609493|FG001|COMPLETED|Treatment Period 2||155
6678177|NCT02638259|7609492|FG000|NOT COMPLETED|Treatment Period 2||6
6678178|NCT02638259|7609493|FG001|NOT COMPLETED|Treatment Period 2||11
6678179|NCT02638337|7609505|FG000|STARTED|Overall Study||316
6678180|NCT02638337|7609506|FG001|STARTED|Overall Study||315
6678181|NCT02638337|7609505|FG000|Received Treatment|Overall Study||313
6678182|NCT02638337|7609506|FG001|Received Treatment|Overall Study||315
6678183|NCT02638337|7609505|FG000|COMPLETED|Overall Study||283
6678184|NCT02638337|7609506|FG001|COMPLETED|Overall Study||279
6678185|NCT02638337|7609505|FG000|NOT COMPLETED|Overall Study||33
6678186|NCT02638337|7609506|FG001|NOT COMPLETED|Overall Study||36
6678187|NCT02638493|7609515|FG000|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
6678188|NCT02638493|7609516|FG001|STARTED|Overall Study||8
6678189|NCT02638493|7609517|FG002|STARTED|Overall Study||8
6678190|NCT02638493|7609515|FG000|COMPLETED|Overall Study||8
6678191|NCT02638493|7609516|FG001|COMPLETED|Overall Study||8
6678192|NCT02638493|7609517|FG002|COMPLETED|Overall Study||8
6678193|NCT02638493|7609515|FG000|NOT COMPLETED|Overall Study||2
6678194|NCT02638493|7609516|FG001|NOT COMPLETED|Overall Study||0
6678195|NCT02638493|7609517|FG002|NOT COMPLETED|Overall Study||0
6678196|NCT02638597|7609527|FG000|STARTED|Overall Study||8
6678197|NCT02638597|7609528|FG001|STARTED|Overall Study||8
6678198|NCT02638597|7609527|FG000|COMPLETED|Overall Study||4
6678199|NCT02638597|7609528|FG001|COMPLETED|Overall Study||3
6678200|NCT02638597|7609527|FG000|NOT COMPLETED|Overall Study||4
6678201|NCT02638597|7609528|FG001|NOT COMPLETED|Overall Study||5
6678202|NCT02638623|7609538|FG000|STARTED|Overall Study||27
6678203|NCT02638623|7609539|FG001|STARTED|Overall Study||25
6678204|NCT02638623|7609538|FG000|COMPLETED|Overall Study||20
6678205|NCT02638623|7609539|FG001|COMPLETED|Overall Study||19
6678206|NCT02638623|7609538|FG000|NOT COMPLETED|Overall Study||7
6678207|NCT02638623|7609539|FG001|NOT COMPLETED|Overall Study||6
6678208|NCT02638948|7609549|FG000|STARTED|Overall Study||75
6678209|NCT02638948|7609550|FG001|STARTED|Overall Study||73
6678210|NCT02638948|7609551|FG002|STARTED|Overall Study||73
6678211|NCT02638948|7609552|FG003|STARTED|Overall Study||26
6678212|NCT02638948|7609549|FG000|COMPLETED|Overall Study||66
6678213|NCT02638948|7609550|FG001|COMPLETED|Overall Study||62
6678214|NCT02638948|7609551|FG002|COMPLETED|Overall Study||66
6678215|NCT02638948|7609552|FG003|COMPLETED|Overall Study||18
6678216|NCT02638948|7609549|FG000|NOT COMPLETED|Overall Study||9
6678217|NCT02638948|7609550|FG001|NOT COMPLETED|Overall Study||11
6678218|NCT02638948|7609551|FG002|NOT COMPLETED|Overall Study||7
6678219|NCT02638948|7609552|FG003|NOT COMPLETED|Overall Study||8
6678220|NCT02638974|7609567|FG000|STARTED|Overall Study||26
6678221|NCT02638974|7609568|FG001|STARTED|Overall Study||25
6678222|NCT02638974|7609567|FG000|COMPLETED|Overall Study||23
6678223|NCT02638974|7609568|FG001|COMPLETED|Overall Study||22
6678224|NCT02638974|7609567|FG000|NOT COMPLETED|Overall Study||3
6678225|NCT02638974|7609568|FG001|NOT COMPLETED|Overall Study||3
6678226|NCT02639052|7609574|FG000|STARTED|Overall Study||35
6678227|NCT02639052|7609574|FG000|Visit 1 (Baseline)|Overall Study||35
6678228|NCT02639052|7609574|FG000|Visit 2 (1-week Follow-up)|Overall Study||35
6678229|NCT02639052|7609574|FG000|Visit 3 (1-month Follow-up)|Overall Study||35
6678230|NCT02639052|7609574|FG000|Visit 4 (3-month Follow-up)|Overall Study||34
6678231|NCT02639052|7609574|FG000|COMPLETED|Overall Study||34
6678232|NCT02639052|7609574|FG000|NOT COMPLETED|Overall Study||1
6678233|NCT02639182|7609582|FG000|STARTED|Overall Study||67
6678234|NCT02639182|7609583|FG001|STARTED|Overall Study||66
6678235|NCT02639182|7609582|FG000|Treated|Overall Study||66
6678236|NCT02639182|7609583|FG001|Treated|Overall Study||65
6678237|NCT02639182|7609582|FG000|COMPLETED|Overall Study||0
6678238|NCT02639182|7609583|FG001|COMPLETED|Overall Study||0
6678239|NCT02639182|7609582|FG000|NOT COMPLETED|Overall Study||67
6678240|NCT02639182|7609583|FG001|NOT COMPLETED|Overall Study||66
6678241|NCT02639247|7609591|FG000|STARTED|Overall Study||182
6678242|NCT02639247|7609592|FG001|STARTED|Overall Study||151
6678243|NCT02639247|7609591|FG000|COMPLETED|Overall Study||177
6678244|NCT02639247|7609592|FG001|COMPLETED|Overall Study||149
6678245|NCT02639247|7609591|FG000|NOT COMPLETED|Overall Study||5
6678246|NCT02639247|7609592|FG001|NOT COMPLETED|Overall Study||2
6678247|NCT02639286|7609600|FG000|STARTED|Overall Study||3
6678248|NCT02639286|7609601|FG001|STARTED|Overall Study||2
6678249|NCT02639286|7609600|FG000|COMPLETED|Overall Study||3
6678250|NCT02639286|7609601|FG001|COMPLETED|Overall Study||2
6678251|NCT02639286|7609600|FG000|NOT COMPLETED|Overall Study||0
6678252|NCT02639286|7609601|FG001|NOT COMPLETED|Overall Study||0
6678253|NCT02639338|7609609|FG000|STARTED|Overall Study||110
6678254|NCT02639338|7609610|FG001|STARTED|Overall Study||110
6678255|NCT02639338|7609609|FG000|COMPLETED|Overall Study||106
6678256|NCT02639338|7609610|FG001|COMPLETED|Overall Study||105
6678257|NCT02639338|7609609|FG000|NOT COMPLETED|Overall Study||4
6678258|NCT02639338|7609610|FG001|NOT COMPLETED|Overall Study||5
6391903|NCT00838539|7303801|FG009|NOT COMPLETED|Overall Study||8
6391904|NCT00838539|7303802|FG010|NOT COMPLETED|Overall Study||5
6391905|NCT00838539|7303803|FG011|NOT COMPLETED|Overall Study||4
6391906|NCT00838565|7303849|FG000|STARTED|Overall Study||9
6391907|NCT00838565|7303850|FG001|STARTED|Overall Study||7
6391908|NCT00838565|7303851|FG002|STARTED|Overall Study||6
6391909|NCT00838565|7303852|FG003|STARTED|Overall Study||6
6391910|NCT00838565|7303853|FG004|STARTED|Overall Study||6
6391911|NCT00838565|7303854|FG005|STARTED|Overall Study||7
6391912|NCT00838565|7303849|FG000|Treated|Overall Study||9
6391913|NCT00838565|7303850|FG001|Treated|Overall Study||6
6391914|NCT00838565|7303851|FG002|Treated|Overall Study||6
6678259|NCT02639351|7609621|FG000|STARTED|Overall Study||16
6678260|NCT02639351|7609622|FG001|STARTED|Overall Study||16
6678261|NCT02639351|7609623|FG002|STARTED|Overall Study||16
6678262|NCT02639351|7609624|FG003|STARTED|Overall Study||16
6678263|NCT02639351|7609625|FG004|STARTED|Overall Study||16
6678264|NCT02639351|7609621|FG000|COMPLETED|Overall Study||16
6678265|NCT02639351|7609622|FG001|COMPLETED|Overall Study||16
6678266|NCT02639351|7609623|FG002|COMPLETED|Overall Study||16
6678267|NCT02639351|7609624|FG003|COMPLETED|Overall Study||16
6678268|NCT02639351|7609625|FG004|COMPLETED|Overall Study||16
6678269|NCT02639351|7609621|FG000|NOT COMPLETED|Overall Study||0
6678270|NCT02639351|7609622|FG001|NOT COMPLETED|Overall Study||0
6678271|NCT02639351|7609623|FG002|NOT COMPLETED|Overall Study||0
6678272|NCT02639351|7609624|FG003|NOT COMPLETED|Overall Study||0
6678273|NCT02639351|7609625|FG004|NOT COMPLETED|Overall Study||0
6678274|NCT02639429|7609641|FG000|STARTED|Overall Study||113
6678275|NCT02639429|7609642|FG001|STARTED|Overall Study||123
6678276|NCT02639429|7609641|FG000|COMPLETED|Overall Study||113
6678277|NCT02639429|7609642|FG001|COMPLETED|Overall Study||123
6678278|NCT02639429|7609641|FG000|NOT COMPLETED|Overall Study||0
6678279|NCT02639429|7609642|FG001|NOT COMPLETED|Overall Study||0
6678280|NCT02639494|7609648|FG000|STARTED|Overall Study||20
6678281|NCT02639494|7609648|FG000|COMPLETED|Overall Study||20
6678282|NCT02639494|7609648|FG000|NOT COMPLETED|Overall Study||0
6678283|NCT02639637|7609655|FG000|STARTED|Overall Study||7
6678284|NCT02639637|7609656|FG001|STARTED|Overall Study||6
6678285|NCT02639637|7609657|FG002|STARTED|Overall Study||2
6678286|NCT02639637|7609658|FG003|STARTED|Overall Study||3
6678287|NCT02639637|7609655|FG000|COMPLETED|Overall Study||7
6678288|NCT02639637|7609656|FG001|COMPLETED|Overall Study||6
6678289|NCT02639637|7609657|FG002|COMPLETED|Overall Study||2
6678290|NCT02639637|7609658|FG003|COMPLETED|Overall Study||3
6678291|NCT02639637|7609655|FG000|NOT COMPLETED|Overall Study||0
6678292|NCT02639637|7609656|FG001|NOT COMPLETED|Overall Study||0
6678293|NCT02639637|7609657|FG002|NOT COMPLETED|Overall Study||0
6678294|NCT02639637|7609658|FG003|NOT COMPLETED|Overall Study||0
6678295|NCT02639884|7609674|FG000|STARTED|Overall Study||51
6678296|NCT02639884|7609674|FG000|COMPLETED|Overall Study||47
6678297|NCT02639884|7609674|FG000|NOT COMPLETED|Overall Study||4
6678298|NCT02640053|7609681|FG000|STARTED|Overall Study||21
6678299|NCT02640053|7609682|FG001|STARTED|Overall Study||21
6678300|NCT02640053|7609681|FG000|COMPLETED|Overall Study||17
6678301|NCT02640053|7609682|FG001|COMPLETED|Overall Study||17
6678302|NCT02640053|7609681|FG000|NOT COMPLETED|Overall Study||4
6678303|NCT02640053|7609682|FG001|NOT COMPLETED|Overall Study||4
6678304|NCT02640157|7609691|FG000|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|233
6678305|NCT02640157|7609692|FG001|STARTED|Overall Study||116
6678306|NCT02640157|7609693|FG002|STARTED|Overall Study|Intent-to-treat population: all participants who received at least 1 dose of study drug|157
6678307|NCT02640157|7609691|FG000|Received Study Drug|Overall Study||233
6678308|NCT02640157|7609692|FG001|Received Study Drug|Overall Study|One participant in Arm B was randomized in error and never dispensed study drug.|115
6678309|NCT02640157|7609693|FG002|Received Study Drug|Overall Study||157
6678310|NCT02640157|7609691|FG000|Completed Study Drug|Overall Study||225
6678311|NCT02640157|7609692|FG001|Completed Study Drug|Overall Study||112
6678312|NCT02640157|7609693|FG002|Completed Study Drug|Overall Study||154
6678313|NCT02640157|7609691|FG000|Discontinued Study Drug|Overall Study||8
6678314|NCT02640157|7609692|FG001|Discontinued Study Drug|Overall Study||3
6678315|NCT02640157|7609693|FG002|Discontinued Study Drug|Overall Study||3
6678316|NCT02640157|7609691|FG000|COMPLETED|Overall Study||220
6678317|NCT02640157|7609692|FG001|COMPLETED|Overall Study||111
6678318|NCT02640157|7609693|FG002|COMPLETED|Overall Study||147
6678319|NCT02640157|7609691|FG000|NOT COMPLETED|Overall Study||13
6678320|NCT02640157|7609692|FG001|NOT COMPLETED|Overall Study||5
6391915|NCT00838565|7303852|FG003|Treated|Overall Study||6
6678321|NCT02640157|7609693|FG002|NOT COMPLETED|Overall Study||10
6678322|NCT02640235|7609704|FG000|STARTED|Overall Study||131
6678323|NCT02640235|7609705|FG001|STARTED|Overall Study||129
6678324|NCT02640235|7609704|FG000|COMPLETED|Overall Study||117
6678325|NCT02640235|7609705|FG001|COMPLETED|Overall Study||115
6678326|NCT02640235|7609704|FG000|NOT COMPLETED|Overall Study||14
6678327|NCT02640235|7609705|FG001|NOT COMPLETED|Overall Study||14
6678328|NCT02640404|7609713|FG000|STARTED|Overall Study||112
6678329|NCT02640404|7609714|FG001|STARTED|Overall Study||112
6678330|NCT02640404|7609713|FG000|COMPLETED|Overall Study||110
6678331|NCT02640404|7609714|FG001|COMPLETED|Overall Study||112
6678332|NCT02640404|7609713|FG000|NOT COMPLETED|Overall Study||2
6678333|NCT02640404|7609714|FG001|NOT COMPLETED|Overall Study||0
6678334|NCT02640482|7609722|FG000|STARTED|Overall Study||202
6678335|NCT02640482|7609723|FG001|STARTED|Overall Study||100
6678336|NCT02640482|7609722|FG000|COMPLETED|Overall Study||199
6678337|NCT02640482|7609723|FG001|COMPLETED|Overall Study||100
6678338|NCT02640482|7609722|FG000|NOT COMPLETED|Overall Study||3
6678339|NCT02640482|7609723|FG001|NOT COMPLETED|Overall Study||0
6678340|NCT02640547|7609729|FG000|STARTED|Overall Study||394
6678341|NCT02640547|7609729|FG000|COMPLETED|Overall Study||383
6678342|NCT02640547|7609729|FG000|NOT COMPLETED|Overall Study||11
6678343|NCT02640612|7609744|FG000|STARTED|Overall Study||225
6678344|NCT02640612|7609745|FG001|STARTED|Overall Study||103
6678345|NCT02640612|7609746|FG002|STARTED|Overall Study||102
6678346|NCT02640612|7609744|FG000|COMPLETED|Overall Study||203
6678347|NCT02640612|7609745|FG001|COMPLETED|Overall Study||89
6678348|NCT02640612|7609746|FG002|COMPLETED|Overall Study||96
6678349|NCT02640612|7609744|FG000|NOT COMPLETED|Overall Study||22
6678350|NCT02640612|7609745|FG001|NOT COMPLETED|Overall Study||14
6678351|NCT02640612|7609746|FG002|NOT COMPLETED|Overall Study||6
6678352|NCT02640716|7609756|FG000|STARTED|Overall Study||30
6678353|NCT02640716|7609757|FG001|STARTED|Overall Study||30
6678354|NCT02640716|7609756|FG000|Training Completion|Overall Study||27
6678355|NCT02640716|7609757|FG001|Training Completion|Overall Study||27
6678356|NCT02640716|7609756|FG000|COMPLETED|Overall Study||23
6678357|NCT02640716|7609757|FG001|COMPLETED|Overall Study||21
6678358|NCT02640716|7609756|FG000|NOT COMPLETED|Overall Study||7
6678359|NCT02640716|7609757|FG001|NOT COMPLETED|Overall Study||9
6678360|NCT02640755|7609765|FG000|STARTED|Single Dose Period (Day 1 - 8)||3
6678361|NCT02640755|7609766|FG001|STARTED|Single Dose Period (Day 1 - 8)||1
6678362|NCT02640755|7609765|FG000|COMPLETED|Single Dose Period (Day 1 - 8)||3
6678363|NCT02640755|7609766|FG001|COMPLETED|Single Dose Period (Day 1 - 8)||1
6678364|NCT02640755|7609765|FG000|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
6678365|NCT02640755|7609766|FG001|NOT COMPLETED|Single Dose Period (Day 1 - 8)||0
6678366|NCT02640755|7609765|FG000|STARTED|Multiple Dose Period (Day 8 - EoS)||3
6678367|NCT02640755|7609766|FG001|STARTED|Multiple Dose Period (Day 8 - EoS)||1
6678368|NCT02640755|7609765|FG000|COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
6678369|NCT02640755|7609766|FG001|COMPLETED|Multiple Dose Period (Day 8 - EoS)||0
6678370|NCT02640755|7609765|FG000|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||2
6678371|NCT02640755|7609766|FG001|NOT COMPLETED|Multiple Dose Period (Day 8 - EoS)||1
6678372|NCT02640807|7609776|FG000|STARTED|Overall Study||9
6678373|NCT02640807|7609777|FG001|STARTED|Overall Study||8
6678374|NCT02640807|7609778|FG002|STARTED|Overall Study||10
6678375|NCT02640807|7609776|FG000|COMPLETED|Overall Study||9
6678376|NCT02640807|7609777|FG001|COMPLETED|Overall Study||8
6678377|NCT02640807|7609778|FG002|COMPLETED|Overall Study||10
6678378|NCT02640807|7609776|FG000|NOT COMPLETED|Overall Study||0
6678379|NCT02640807|7609777|FG001|NOT COMPLETED|Overall Study||0
6678380|NCT02640807|7609778|FG002|NOT COMPLETED|Overall Study||0
6678381|NCT02641067|7609788|FG000|STARTED|Overall Study||8
6678382|NCT02641067|7609789|FG001|STARTED|Overall Study||8
6678383|NCT02641067|7609788|FG000|COMPLETED|Overall Study||8
6678384|NCT02641067|7609789|FG001|COMPLETED|Overall Study||8
6678385|NCT02641067|7609788|FG000|NOT COMPLETED|Overall Study||0
6678386|NCT02641067|7609789|FG001|NOT COMPLETED|Overall Study||0
6678387|NCT02641080|7609797|FG000|STARTED|Overall Study||40
6678388|NCT02641080|7609798|FG001|STARTED|Overall Study||40
6678389|NCT02641080|7609797|FG000|COMPLETED|Overall Study||38
6678390|NCT02641080|7609798|FG001|COMPLETED|Overall Study||33
6678391|NCT02641080|7609797|FG000|NOT COMPLETED|Overall Study||2
6678392|NCT02641080|7609798|FG001|NOT COMPLETED|Overall Study||7
6678393|NCT02641249|7609804|FG000|STARTED|Overall Study||19
6678394|NCT02641249|7609804|FG000|COMPLETED|Overall Study||15
6678395|NCT02641249|7609804|FG000|NOT COMPLETED|Overall Study||4
6678396|NCT02641353|7609809|FG000|STARTED|Overall Study||5
6678397|NCT02641353|7609810|FG001|STARTED|Overall Study||5
6678398|NCT02641353|7609811|FG002|STARTED|Overall Study||6
6678399|NCT02641353|7609812|FG003|STARTED|Overall Study||6
6678400|NCT02641353|7609813|FG004|STARTED|Overall Study||6
6678401|NCT02641353|7609814|FG005|STARTED|Overall Study||6
6678402|NCT02641353|7609809|FG000|COMPLETED|Overall Study||5
6678403|NCT02641353|7609810|FG001|COMPLETED|Overall Study||5
6678404|NCT02641353|7609811|FG002|COMPLETED|Overall Study||6
6678405|NCT02641353|7609812|FG003|COMPLETED|Overall Study||6
6678406|NCT02641353|7609813|FG004|COMPLETED|Overall Study||6
6678407|NCT02641353|7609814|FG005|COMPLETED|Overall Study||6
6678408|NCT02641353|7609809|FG000|NOT COMPLETED|Overall Study||0
6678409|NCT02641353|7609810|FG001|NOT COMPLETED|Overall Study||0
6678410|NCT02641353|7609811|FG002|NOT COMPLETED|Overall Study||0
6678411|NCT02641353|7609812|FG003|NOT COMPLETED|Overall Study||0
6678412|NCT02641353|7609813|FG004|NOT COMPLETED|Overall Study||0
6678413|NCT02641353|7609814|FG005|NOT COMPLETED|Overall Study||0
6678414|NCT02641379|7609836|FG000|STARTED|Overall Study||142
6678415|NCT02641379|7609837|FG001|STARTED|Overall Study||152
6678416|NCT02641379|7609838|FG002|STARTED|Overall Study||78
6678417|NCT02641379|7609839|FG003|STARTED|Overall Study||156
6678418|NCT02641379|7609840|FG004|STARTED|Overall Study||17
6678419|NCT02641379|7609841|FG005|STARTED|Overall Study||36
6678420|NCT02641379|7609842|FG006|STARTED|Overall Study||25
6678421|NCT02641379|7609843|FG007|STARTED|Overall Study||20
6678422|NCT02641379|7609844|FG008|STARTED|Overall Study||42
6678423|NCT02641379|7609845|FG009|STARTED|Overall Study||45
6678424|NCT02641379|7609846|FG010|STARTED|Overall Study||8
6678425|NCT02641379|7609836|FG000|COMPLETED|Overall Study||107
6678426|NCT02641379|7609837|FG001|COMPLETED|Overall Study||101
6678427|NCT02641379|7609838|FG002|COMPLETED|Overall Study||7
6678428|NCT02641379|7609839|FG003|COMPLETED|Overall Study||139
6678429|NCT02641379|7609840|FG004|COMPLETED|Overall Study||0
6678430|NCT02641379|7609841|FG005|COMPLETED|Overall Study||20
6678431|NCT02641379|7609842|FG006|COMPLETED|Overall Study||12
6678432|NCT02641379|7609843|FG007|COMPLETED|Overall Study||1
6678433|NCT02641379|7609844|FG008|COMPLETED|Overall Study||36
6678434|NCT02641379|7609845|FG009|COMPLETED|Overall Study||36
6678435|NCT02641379|7609846|FG010|COMPLETED|Overall Study||0
6678436|NCT02641379|7609836|FG000|NOT COMPLETED|Overall Study||35
6678437|NCT02641379|7609837|FG001|NOT COMPLETED|Overall Study||51
6256312|NCT04992442|7155188|FG000|NOT COMPLETED|Treatment Period 1||0
6256313|NCT04992442|7155188|FG000|STARTED|Washout Period||6
6256314|NCT04992442|7155188|FG000|COMPLETED|Washout Period||6
6256315|NCT04992442|7155188|FG000|NOT COMPLETED|Washout Period||0
6256316|NCT04992442|7155188|FG000|STARTED|Treatment Period 2||6
6256317|NCT04992442|7155188|FG000|COMPLETED|Treatment Period 2||6
6256318|NCT04992442|7155188|FG000|NOT COMPLETED|Treatment Period 2||0
6279033|NCT00140855|7178706|FG000|NOT COMPLETED|Overall Study||2
6279034|NCT00141037|7178712|FG000|STARTED|Overall Study||60
6279035|NCT00141037|7178713|FG001|STARTED|Overall Study||70
6279036|NCT00141037|7178712|FG000|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
6279037|NCT00141037|7178713|FG001|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
6279038|NCT00141037|7178712|FG000|NOT COMPLETED|Overall Study||10
6279039|NCT00141037|7178713|FG001|NOT COMPLETED|Overall Study||18
6279040|NCT00141102|7178721|FG000|STARTED|Overall Study||2238
6279041|NCT00141102|7178722|FG001|STARTED|Overall Study||2246
6678438|NCT02641379|7609838|FG002|NOT COMPLETED|Overall Study||71
6279042|NCT00141102|7178721|FG000|Received Treatment|Overall Study||2223
6279043|NCT00141102|7178722|FG001|Received Treatment|Overall Study||2237
6279044|NCT00141102|7178721|FG000|COMPLETED|Overall Study||1730
6279045|NCT00141102|7178722|FG001|COMPLETED|Overall Study||1621
6279046|NCT00141102|7178721|FG000|NOT COMPLETED|Overall Study||508
6678439|NCT02641379|7609839|FG003|NOT COMPLETED|Overall Study||17
6678440|NCT02641379|7609840|FG004|NOT COMPLETED|Overall Study||17
6678441|NCT02641379|7609841|FG005|NOT COMPLETED|Overall Study||16
6678442|NCT02641379|7609842|FG006|NOT COMPLETED|Overall Study||13
6678443|NCT02641379|7609843|FG007|NOT COMPLETED|Overall Study||19
6678444|NCT02641379|7609844|FG008|NOT COMPLETED|Overall Study||6
6678445|NCT02641379|7609845|FG009|NOT COMPLETED|Overall Study||9
6678446|NCT02641379|7609846|FG010|NOT COMPLETED|Overall Study||8
6678447|NCT02641392|7609878|FG000|STARTED|Overall Study||4
6678448|NCT02641392|7609879|FG001|STARTED|Overall Study||13
6678449|NCT02641392|7609880|FG002|STARTED|Overall Study||293
6678450|NCT02641392|7609878|FG000|COMPLETED|Overall Study||0
6678451|NCT02641392|7609879|FG001|COMPLETED|Overall Study||0
6678452|NCT02641392|7609880|FG002|COMPLETED|Overall Study||0
6678453|NCT02641392|7609878|FG000|NOT COMPLETED|Overall Study||4
6678454|NCT02641392|7609879|FG001|NOT COMPLETED|Overall Study||13
6678455|NCT02641392|7609880|FG002|NOT COMPLETED|Overall Study||293
6678456|NCT02641522|7609888|FG000|STARTED|Overall Study||10
6678457|NCT02641522|7609888|FG000|COMPLETED|Overall Study||10
6678458|NCT02641522|7609888|FG000|NOT COMPLETED|Overall Study||0
6678459|NCT02641561|7609896|FG000|STARTED|Overall Study||48
6678460|NCT02641561|7609897|FG001|STARTED|Overall Study||48
6678461|NCT02641561|7609898|FG002|STARTED|Overall Study||48
6678462|NCT02641561|7609899|FG003|STARTED|Overall Study||48
6678463|NCT02641561|7609896|FG000|COMPLETED|Overall Study||48
6678464|NCT02641561|7609897|FG001|COMPLETED|Overall Study||48
6678465|NCT02641561|7609898|FG002|COMPLETED|Overall Study||48
6678466|NCT02641561|7609899|FG003|COMPLETED|Overall Study||48
6678467|NCT02641561|7609896|FG000|NOT COMPLETED|Overall Study||0
6678468|NCT02641561|7609897|FG001|NOT COMPLETED|Overall Study||0
6678469|NCT02641561|7609898|FG002|NOT COMPLETED|Overall Study||0
6678470|NCT02641561|7609899|FG003|NOT COMPLETED|Overall Study||0
6678471|NCT02641587|7609912|FG000|STARTED|Confinement Period||80
6678472|NCT02641587|7609913|FG001|STARTED|Confinement Period||40
6678473|NCT02641587|7609912|FG000|COMPLETED|Confinement Period||77
6678474|NCT02641587|7609913|FG001|COMPLETED|Confinement Period||39
6678475|NCT02641587|7609912|FG000|NOT COMPLETED|Confinement Period||3
6678476|NCT02641587|7609913|FG001|NOT COMPLETED|Confinement Period||1
6678477|NCT02641587|7609912|FG000|STARTED|Ambulatory Period||77
6678478|NCT02641587|7609913|FG001|STARTED|Ambulatory Period||39
6678479|NCT02641587|7609912|FG000|COMPLETED|Ambulatory Period||76
6678480|NCT02641587|7609913|FG001|COMPLETED|Ambulatory Period||39
6678481|NCT02641587|7609912|FG000|NOT COMPLETED|Ambulatory Period||1
6678482|NCT02641587|7609913|FG001|NOT COMPLETED|Ambulatory Period||0
6738339|NCT03283436|7667704|FG000|NOT COMPLETED|Overall Study||6
6738340|NCT03283436|7667705|FG001|NOT COMPLETED|Overall Study||0
6738341|NCT03283553|7667713|FG000|STARTED|Patient Participant Flow||69
6738342|NCT03283553|7667714|FG001|STARTED|Patient Participant Flow||63
6738343|NCT03283553|7667713|FG000|Patient Baseline Interview|Patient Participant Flow||69
6738344|NCT03283553|7667714|FG001|Patient Baseline Interview|Patient Participant Flow||62
6738345|NCT03283553|7667713|FG000|Patient 3-Month Interview|Patient Participant Flow||67
6738346|NCT03283553|7667714|FG001|Patient 3-Month Interview|Patient Participant Flow||60
6738347|NCT03283553|7667713|FG000|Patient 9-Month Interview|Patient Participant Flow||63
6738348|NCT03283553|7667714|FG001|Patient 9-Month Interview|Patient Participant Flow||57
6738349|NCT03283553|7667713|FG000|Patient 12-Month Interview|Patient Participant Flow||59
6738350|NCT03283553|7667714|FG001|Patient 12-Month Interview|Patient Participant Flow||50
6738351|NCT03283553|7667713|FG000|COMPLETED|Patient Participant Flow||59
6738352|NCT03283553|7667714|FG001|COMPLETED|Patient Participant Flow||50
6738353|NCT03283553|7667713|FG000|NOT COMPLETED|Patient Participant Flow||10
6738354|NCT03283553|7667714|FG001|NOT COMPLETED|Patient Participant Flow||13
6738355|NCT03283553|7667713|FG000|STARTED|Care Partner Participant Flow||69
6738356|NCT03283553|7667714|FG001|STARTED|Care Partner Participant Flow||63
6738357|NCT03283553|7667713|FG000|Care Partner Baseline Interview|Care Partner Participant Flow||69
6738358|NCT03283553|7667714|FG001|Care Partner Baseline Interview|Care Partner Participant Flow||63
6738359|NCT03283553|7667713|FG000|Care Partner 3-Month Interview|Care Partner Participant Flow||69
6738360|NCT03283553|7667714|FG001|Care Partner 3-Month Interview|Care Partner Participant Flow||60
6738361|NCT03283553|7667713|FG000|Care Partner 9-Month Interview|Care Partner Participant Flow||64
6738362|NCT03283553|7667714|FG001|Care Partner 9-Month Interview|Care Partner Participant Flow||55
6738363|NCT03283553|7667713|FG000|Care Partner 12-Month Interview|Care Partner Participant Flow||59
6738364|NCT03283553|7667714|FG001|Care Partner 12-Month Interview|Care Partner Participant Flow||48
6738365|NCT03283553|7667713|FG000|COMPLETED|Care Partner Participant Flow||59
6738366|NCT03283553|7667714|FG001|COMPLETED|Care Partner Participant Flow||48
6738367|NCT03283553|7667713|FG000|NOT COMPLETED|Care Partner Participant Flow||10
6738368|NCT03283553|7667714|FG001|NOT COMPLETED|Care Partner Participant Flow||15
6738369|NCT03283696|7667724|FG000|STARTED|Overall Study||16
6738370|NCT03283696|7667725|FG001|STARTED|Overall Study||8
6738371|NCT03283696|7667724|FG000|Received at Least 1 Dose of Study Drug|Overall Study||16
6738372|NCT03283696|7667725|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
6738373|NCT03283696|7667724|FG000|COMPLETED|Overall Study||9
6738374|NCT03283696|7667725|FG001|COMPLETED|Overall Study||2
6738375|NCT03283696|7667724|FG000|NOT COMPLETED|Overall Study||7
6738376|NCT03283696|7667725|FG001|NOT COMPLETED|Overall Study||6
6738377|NCT03283787|7667734|FG000|STARTED|Overall Study||20
6738378|NCT03283787|7667735|FG001|STARTED|Overall Study||20
6738379|NCT03283787|7667736|FG002|STARTED|Overall Study||20
6738380|NCT03283787|7667734|FG000|COMPLETED|Overall Study||17
6738381|NCT03283787|7667735|FG001|COMPLETED|Overall Study||13
6738382|NCT03283787|7667736|FG002|COMPLETED|Overall Study||13
6738383|NCT03283787|7667734|FG000|NOT COMPLETED|Overall Study||3
6738384|NCT03283787|7667735|FG001|NOT COMPLETED|Overall Study||7
6678483|NCT02641691|7609926|FG000|STARTED|Overall Study||20
6678484|NCT02641691|7609926|FG000|COMPLETED|Overall Study||20
6678485|NCT02641691|7609926|FG000|NOT COMPLETED|Overall Study||0
6678486|NCT02641730|7609939|FG000|STARTED|Placebo Controlled Period (Week 0 - 16)||53
6678487|NCT02641730|7609940|FG001|STARTED|Placebo Controlled Period (Week 0 - 16)||0
6678488|NCT02641730|7609941|FG002|STARTED|Placebo Controlled Period (Week 0 - 16)||0
6678489|NCT02641730|7609942|FG003|STARTED|Placebo Controlled Period (Week 0 - 16)||54
6678490|NCT02641730|7609943|FG004|STARTED|Placebo Controlled Period (Week 0 - 16)||52
6678491|NCT02641730|7609939|FG000|COMPLETED|Placebo Controlled Period (Week 0 - 16)||51
6678492|NCT02641730|7609940|FG001|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6678493|NCT02641730|7609941|FG002|COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6678494|NCT02641730|7609942|FG003|COMPLETED|Placebo Controlled Period (Week 0 - 16)||53
6678495|NCT02641730|7609943|FG004|COMPLETED|Placebo Controlled Period (Week 0 - 16)||50
6678496|NCT02641730|7609939|FG000|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
6678497|NCT02641730|7609940|FG001|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6678498|NCT02641730|7609941|FG002|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||0
6678499|NCT02641730|7609942|FG003|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||1
6678500|NCT02641730|7609943|FG004|NOT COMPLETED|Placebo Controlled Period (Week 0 - 16)||2
6678501|NCT02641730|7609939|FG000|STARTED|After Controlled Period (Week 16 - 52)||0
6678502|NCT02641730|7609940|FG001|STARTED|After Controlled Period (Week 16 - 52)||25
6678503|NCT02641730|7609941|FG002|STARTED|After Controlled Period (Week 16 - 52)||26
6678504|NCT02641730|7609942|FG003|STARTED|After Controlled Period (Week 16 - 52)||53
6678505|NCT02641730|7609943|FG004|STARTED|After Controlled Period (Week 16 - 52)||50
6678506|NCT02641730|7609939|FG000|COMPLETED|After Controlled Period (Week 16 - 52)||0
6678507|NCT02641730|7609940|FG001|COMPLETED|After Controlled Period (Week 16 - 52)||21
6678508|NCT02641730|7609941|FG002|COMPLETED|After Controlled Period (Week 16 - 52)||24
6678509|NCT02641730|7609942|FG003|COMPLETED|After Controlled Period (Week 16 - 52)||45
6678510|NCT02641730|7609943|FG004|COMPLETED|After Controlled Period (Week 16 - 52)||44
6678511|NCT02641730|7609939|FG000|NOT COMPLETED|After Controlled Period (Week 16 - 52)||0
6678512|NCT02641730|7609940|FG001|NOT COMPLETED|After Controlled Period (Week 16 - 52)||4
6678513|NCT02641730|7609941|FG002|NOT COMPLETED|After Controlled Period (Week 16 - 52)||2
6678514|NCT02641730|7609942|FG003|NOT COMPLETED|After Controlled Period (Week 16 - 52)||8
6678515|NCT02641730|7609943|FG004|NOT COMPLETED|After Controlled Period (Week 16 - 52)||6
6678516|NCT02641730|7609939|FG000|STARTED|Observational Period (Week 60 - Week 84)||0
6678517|NCT02641730|7609940|FG001|STARTED|Observational Period (Week 60 - Week 84)||21
6678518|NCT02641730|7609941|FG002|STARTED|Observational Period (Week 60 - Week 84)||24
6678519|NCT02641730|7609942|FG003|STARTED|Observational Period (Week 60 - Week 84)||45
6678520|NCT02641730|7609943|FG004|STARTED|Observational Period (Week 60 - Week 84)||44
6678521|NCT02641730|7609939|FG000|COMPLETED|Observational Period (Week 60 - Week 84)||0
6678522|NCT02641730|7609940|FG001|COMPLETED|Observational Period (Week 60 - Week 84)||21
6678523|NCT02641730|7609941|FG002|COMPLETED|Observational Period (Week 60 - Week 84)||24
6678524|NCT02641730|7609942|FG003|COMPLETED|Observational Period (Week 60 - Week 84)||45
6678525|NCT02641730|7609943|FG004|COMPLETED|Observational Period (Week 60 - Week 84)||43
6678526|NCT02641730|7609939|FG000|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
6678527|NCT02641730|7609940|FG001|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
6678528|NCT02641730|7609941|FG002|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
6678529|NCT02641730|7609942|FG003|NOT COMPLETED|Observational Period (Week 60 - Week 84)||0
6678530|NCT02641730|7609943|FG004|NOT COMPLETED|Observational Period (Week 60 - Week 84)||1
6678531|NCT02641834|7609959|FG000|STARTED|Overall Study||60
6678532|NCT02641834|7609960|FG001|STARTED|Overall Study||58
6678533|NCT02641834|7609959|FG000|COMPLETED|Overall Study||50
6678534|NCT02641834|7609960|FG001|COMPLETED|Overall Study||50
6678535|NCT02641834|7609959|FG000|NOT COMPLETED|Overall Study||10
6678536|NCT02641834|7609960|FG001|NOT COMPLETED|Overall Study||8
6678537|NCT02641912|7609969|FG000|STARTED|Overall Study||53
6678538|NCT02641912|7609970|FG001|STARTED|Overall Study||47
6678539|NCT02641912|7609969|FG000|COMPLETED|Overall Study||53
6678540|NCT02641912|7609970|FG001|COMPLETED|Overall Study||47
6678541|NCT02641912|7609969|FG000|NOT COMPLETED|Overall Study||0
6678542|NCT02641912|7609970|FG001|NOT COMPLETED|Overall Study||0
6678543|NCT02642159|7609982|FG000|STARTED|Overall Study|Randomized|276
6678544|NCT02642159|7609983|FG001|STARTED|Overall Study|Randomized|137
6678545|NCT02642159|7609982|FG000|Treated (Safety Population)|Overall Study||275
6678546|NCT02642159|7609983|FG001|Treated (Safety Population)|Overall Study||137
6678547|NCT02642159|7609982|FG000|ITT Population|Overall Study||273
6678548|NCT02642159|7609983|FG001|ITT Population|Overall Study||136
6678549|NCT02642159|7609982|FG000|ITT: Intent to Prescribe Fenofibrate|Overall Study|Fenofibrate was only 'intended to prescribe' in the Alirocumab arm but not actually administered.|47
6678550|NCT02642159|7609983|FG001|ITT: Intent to Prescribe Fenofibrate|Overall Study||24
6678551|NCT02642159|7609982|FG000|COMPLETED|Overall Study||245
6678552|NCT02642159|7609983|FG001|COMPLETED|Overall Study||129
6678553|NCT02642159|7609982|FG000|NOT COMPLETED|Overall Study||31
6678554|NCT02642159|7609983|FG001|NOT COMPLETED|Overall Study||8
6678555|NCT02642237|7609992|FG000|STARTED|Overall Study||15
6678556|NCT02642237|7609993|FG001|STARTED|Overall Study||15
6678557|NCT02642237|7609992|FG000|COMPLETED|Overall Study||15
6678558|NCT02642237|7609993|FG001|COMPLETED|Overall Study||15
6678559|NCT02642237|7609992|FG000|NOT COMPLETED|Overall Study||0
6678560|NCT02642237|7609993|FG001|NOT COMPLETED|Overall Study||0
6678561|NCT02642393|7610001|FG000|STARTED|Overall Study||149
6678562|NCT02642393|7610002|FG001|STARTED|Overall Study||149
6678563|NCT02642393|7610001|FG000|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 31; In-person off-drug:13; By telephone off-drug: 6"|50
6678564|NCT02642393|7610002|FG001|COMPLETED|Overall Study|"Participants who completed the study:~On-drug: 40; In-person off-drug: 16; By telephone off-drug: 1"|57
6678565|NCT02642393|7610001|FG000|NOT COMPLETED|Overall Study||99
6678566|NCT02642393|7610002|FG001|NOT COMPLETED|Overall Study||92
6678567|NCT02642432|7610008|FG000|STARTED|Overall Study||146
6678568|NCT02642432|7610008|FG000|COMPLETED|Overall Study||138
6678569|NCT02642432|7610008|FG000|NOT COMPLETED|Overall Study||8
6678570|NCT02642536|7610014|FG000|STARTED|Overall Study||21
6678571|NCT02642536|7610015|FG001|STARTED|Overall Study||23
6678572|NCT02642536|7610014|FG000|COMPLETED|Overall Study||19
6678573|NCT02642536|7610015|FG001|COMPLETED|Overall Study||18
6678574|NCT02642536|7610014|FG000|NOT COMPLETED|Overall Study||2
6678575|NCT02642536|7610015|FG001|NOT COMPLETED|Overall Study||5
6678576|NCT02642575|7610021|FG000|STARTED|Overall Study||67
6678577|NCT02642575|7610021|FG000|COMPLETED|Overall Study||67
6678578|NCT02642575|7610021|FG000|NOT COMPLETED|Overall Study||0
6678579|NCT02642614|7610029|FG000|STARTED|Overall Study||30
6678580|NCT02642614|7610030|FG001|STARTED|Overall Study||30
6678581|NCT02642614|7610031|FG002|STARTED|Overall Study||30
6678582|NCT02642614|7610032|FG003|STARTED|Overall Study||30
6678583|NCT02642614|7610029|FG000|COMPLETED|Overall Study||27
6678584|NCT02642614|7610030|FG001|COMPLETED|Overall Study||28
6678585|NCT02642614|7610031|FG002|COMPLETED|Overall Study||28
6678586|NCT02642614|7610032|FG003|COMPLETED|Overall Study||28
6678587|NCT02642614|7610029|FG000|NOT COMPLETED|Overall Study||3
6678588|NCT02642614|7610030|FG001|NOT COMPLETED|Overall Study||2
6678589|NCT02642614|7610031|FG002|NOT COMPLETED|Overall Study||2
6678590|NCT02642614|7610032|FG003|NOT COMPLETED|Overall Study||2
6678591|NCT02642627|7610045|FG000|STARTED|Overall Study||42
6678592|NCT02642627|7610045|FG000|COMPLETED|Overall Study||39
6678593|NCT02642627|7610045|FG000|NOT COMPLETED|Overall Study||3
6678594|NCT02642653|7610052|FG000|STARTED|Overall Study||14
6678595|NCT02642653|7610053|FG001|STARTED|Overall Study||16
6678596|NCT02642653|7610052|FG000|COMPLETED|Overall Study||12
6678597|NCT02642653|7610053|FG001|COMPLETED|Overall Study||16
6678598|NCT02642653|7610052|FG000|NOT COMPLETED|Overall Study||2
6678599|NCT02642653|7610053|FG001|NOT COMPLETED|Overall Study||0
6678600|NCT02642679|7610059|FG000|STARTED|Overall Study||19
6678601|NCT02642679|7610059|FG000|COMPLETED|Overall Study||16
6678602|NCT02642679|7610059|FG000|NOT COMPLETED|Overall Study||3
6678603|NCT02642835|7610063|FG000|STARTED|Overall Study||48
6678604|NCT02642835|7610063|FG000|COMPLETED|Overall Study||48
6678605|NCT02642835|7610063|FG000|NOT COMPLETED|Overall Study||0
6678606|NCT02642952|7610069|FG000|STARTED|Overall Study||21
6678607|NCT02642952|7610070|FG001|STARTED|Overall Study||30
6678608|NCT02642952|7610069|FG000|COMPLETED|Overall Study||19
6678609|NCT02642952|7610070|FG001|COMPLETED|Overall Study||25
6678610|NCT02642952|7610069|FG000|NOT COMPLETED|Overall Study||2
6678611|NCT02642952|7610070|FG001|NOT COMPLETED|Overall Study||5
6678612|NCT02642991|7610076|FG000|STARTED|First Intervention||22
6678613|NCT02642991|7610077|FG001|STARTED|First Intervention||22
6678614|NCT02642991|7610076|FG000|COMPLETED|First Intervention||22
6678615|NCT02642991|7610077|FG001|COMPLETED|First Intervention||22
6678616|NCT02642991|7610076|FG000|NOT COMPLETED|First Intervention||0
6678617|NCT02642991|7610077|FG001|NOT COMPLETED|First Intervention||0
6678618|NCT02642991|7610076|FG000|STARTED|Second Intervention||22
6678619|NCT02642991|7610077|FG001|STARTED|Second Intervention||22
6678620|NCT02642991|7610076|FG000|COMPLETED|Second Intervention||22
6678621|NCT02642991|7610077|FG001|COMPLETED|Second Intervention||22
6678622|NCT02642991|7610076|FG000|NOT COMPLETED|Second Intervention||0
6678623|NCT02642991|7610077|FG001|NOT COMPLETED|Second Intervention||0
6678624|NCT02643004|7610086|FG000|STARTED|First Intervention (One Week)||35
6678625|NCT02643004|7610087|FG001|STARTED|First Intervention (One Week)||35
6678626|NCT02643004|7610086|FG000|COMPLETED|First Intervention (One Week)||35
6678627|NCT02643004|7610087|FG001|COMPLETED|First Intervention (One Week)||35
6678628|NCT02643004|7610086|FG000|NOT COMPLETED|First Intervention (One Week)||0
6678629|NCT02643004|7610087|FG001|NOT COMPLETED|First Intervention (One Week)||0
6678630|NCT02643004|7610086|FG000|STARTED|Second Intervention (One Week)||35
6678631|NCT02643004|7610087|FG001|STARTED|Second Intervention (One Week)||35
6678632|NCT02643004|7610086|FG000|COMPLETED|Second Intervention (One Week)||35
6678633|NCT02643004|7610087|FG001|COMPLETED|Second Intervention (One Week)||35
6678634|NCT02643004|7610086|FG000|NOT COMPLETED|Second Intervention (One Week)||0
6678635|NCT02643004|7610087|FG001|NOT COMPLETED|Second Intervention (One Week)||0
6678636|NCT02643082|7610093|FG000|STARTED|Period 1||10
6678637|NCT02643082|7610094|FG001|STARTED|Period 1||10
6678638|NCT02643082|7610093|FG000|COMPLETED|Period 1||9
6678639|NCT02643082|7610094|FG001|COMPLETED|Period 1||10
6678640|NCT02643082|7610093|FG000|NOT COMPLETED|Period 1||1
6678641|NCT02643082|7610094|FG001|NOT COMPLETED|Period 1||0
6678642|NCT02643082|7610093|FG000|STARTED|Washout||9
6678643|NCT02643082|7610094|FG001|STARTED|Washout||10
6678644|NCT02643082|7610093|FG000|COMPLETED|Washout||9
6678645|NCT02643082|7610094|FG001|COMPLETED|Washout||10
6678646|NCT02643082|7610093|FG000|NOT COMPLETED|Washout||0
6678647|NCT02643082|7610094|FG001|NOT COMPLETED|Washout||0
6678648|NCT02643082|7610093|FG000|STARTED|Period 2||9
6678649|NCT02643082|7610094|FG001|STARTED|Period 2||10
6678650|NCT02643082|7610093|FG000|COMPLETED|Period 2||9
6678651|NCT02643082|7610094|FG001|COMPLETED|Period 2||10
6678652|NCT02643082|7610093|FG000|NOT COMPLETED|Period 2||0
6678653|NCT02643082|7610094|FG001|NOT COMPLETED|Period 2||0
6678654|NCT02643095|7610101|FG000|STARTED|Overall Study||22
6678655|NCT02643095|7610101|FG000|COMPLETED|Overall Study||21
6678656|NCT02643095|7610101|FG000|NOT COMPLETED|Overall Study||1
6678657|NCT02643199|7610105|FG000|STARTED|Overall Study||90
6678658|NCT02643199|7610105|FG000|COMPLETED|Overall Study||90
6678659|NCT02643199|7610105|FG000|NOT COMPLETED|Overall Study||0
6678660|NCT02643225|7610111|FG000|STARTED|Overall Study||40
6678661|NCT02643225|7610112|FG001|STARTED|Overall Study||40
6678662|NCT02643225|7610111|FG000|COMPLETED|Overall Study||40
6678663|NCT02643225|7610112|FG001|COMPLETED|Overall Study||40
6678664|NCT02643225|7610111|FG000|NOT COMPLETED|Overall Study||0
6678665|NCT02643225|7610112|FG001|NOT COMPLETED|Overall Study||0
6678666|NCT02643251|7610121|FG000|STARTED|Overall Study||69
6678667|NCT02643251|7610122|FG001|STARTED|Overall Study||69
6678668|NCT02643251|7610121|FG000|COMPLETED|Overall Study||58
6678669|NCT02643251|7610122|FG001|COMPLETED|Overall Study||67
6678670|NCT02643251|7610121|FG000|NOT COMPLETED|Overall Study||11
6678671|NCT02643251|7610122|FG001|NOT COMPLETED|Overall Study||2
6678672|NCT02643355|7610130|FG000|STARTED|Overall Study||34
6678673|NCT02643355|7610131|FG001|STARTED|Overall Study||35
6678674|NCT02643355|7610130|FG000|COMPLETED|Overall Study||33
6678675|NCT02643355|7610131|FG001|COMPLETED|Overall Study||30
6678676|NCT02643355|7610130|FG000|NOT COMPLETED|Overall Study||1
6678677|NCT02643355|7610131|FG001|NOT COMPLETED|Overall Study||5
6678678|NCT02643394|7610139|FG000|STARTED|Overall Study||55
6678679|NCT02643394|7610140|FG001|STARTED|Overall Study||55
6678680|NCT02643394|7610139|FG000|COMPLETED|Overall Study||51
6678681|NCT02643394|7610140|FG001|COMPLETED|Overall Study||50
6678682|NCT02643394|7610139|FG000|NOT COMPLETED|Overall Study||4
6678683|NCT02643394|7610140|FG001|NOT COMPLETED|Overall Study||5
6678684|NCT02643459|7610148|FG000|STARTED|Overall Study||7901
6678685|NCT02643459|7610149|FG001|STARTED|Overall Study||8900
6678686|NCT02643459|7610148|FG000|COMPLETED|Overall Study||7901
6678687|NCT02643459|7610149|FG001|COMPLETED|Overall Study||8900
6678688|NCT02643459|7610148|FG000|NOT COMPLETED|Overall Study||0
6678689|NCT02643459|7610149|FG001|NOT COMPLETED|Overall Study||0
6678690|NCT02643472|7610158|FG000|STARTED|Overall Study||150
6678691|NCT02643472|7610159|FG001|STARTED|Overall Study||150
6678692|NCT02643472|7610158|FG000|COMPLETED|Overall Study||123
6678693|NCT02643472|7610159|FG001|COMPLETED|Overall Study|One participant completed CESD-10 but not other measures at 12 months; n=115 for other measures.|116
6678694|NCT02643472|7610158|FG000|NOT COMPLETED|Overall Study||27
6678695|NCT02643472|7610159|FG001|NOT COMPLETED|Overall Study||34
6678696|NCT02643615|7610169|FG000|STARTED|Overall Study||9
6678697|NCT02643615|7610170|FG001|STARTED|Overall Study||11
6678698|NCT02643615|7610169|FG000|COMPLETED|Overall Study||9
6678699|NCT02643615|7610170|FG001|COMPLETED|Overall Study||11
6678700|NCT02643615|7610169|FG000|NOT COMPLETED|Overall Study||0
6678701|NCT02643615|7610170|FG001|NOT COMPLETED|Overall Study||0
6678702|NCT02643628|7610179|FG000|STARTED|Overall Study||21
6678703|NCT02643628|7610180|FG001|STARTED|Overall Study||23
6678704|NCT02643628|7610179|FG000|COMPLETED|Overall Study||20
6678705|NCT02643628|7610180|FG001|COMPLETED|Overall Study||17
6678706|NCT02643628|7610179|FG000|NOT COMPLETED|Overall Study||1
6678707|NCT02643628|7610180|FG001|NOT COMPLETED|Overall Study||6
6678708|NCT02643693|7610188|FG000|STARTED|Overall Study||4
6678709|NCT02643693|7610189|FG001|STARTED|Overall Study||4
6678710|NCT02643693|7610190|FG002|STARTED|Overall Study||4
6678711|NCT02643693|7610191|FG003|STARTED|Overall Study||4
6678712|NCT02643693|7610192|FG004|STARTED|Overall Study||4
6678713|NCT02643693|7610193|FG005|STARTED|Overall Study||4
6678714|NCT02643693|7610188|FG000|COMPLETED|Overall Study||2
6678715|NCT02643693|7610189|FG001|COMPLETED|Overall Study||2
6678716|NCT02643693|7610190|FG002|COMPLETED|Overall Study||3
6678717|NCT02643693|7610191|FG003|COMPLETED|Overall Study||4
6678718|NCT02643693|7610192|FG004|COMPLETED|Overall Study||4
6678719|NCT02643693|7610193|FG005|COMPLETED|Overall Study||3
6678720|NCT02643693|7610188|FG000|NOT COMPLETED|Overall Study||2
6678721|NCT02643693|7610189|FG001|NOT COMPLETED|Overall Study||2
6678722|NCT02643693|7610190|FG002|NOT COMPLETED|Overall Study||1
6678723|NCT02643693|7610191|FG003|NOT COMPLETED|Overall Study||0
6678724|NCT02643693|7610192|FG004|NOT COMPLETED|Overall Study||0
6678725|NCT02643693|7610193|FG005|NOT COMPLETED|Overall Study||1
6678726|NCT02643849|7610201|FG000|STARTED|Overall Study||107
6678727|NCT02643849|7610201|FG000|COMPLETED|Overall Study||82
6678728|NCT02643849|7610201|FG000|NOT COMPLETED|Overall Study||25
6678729|NCT02643862|7610207|FG000|STARTED|Overall Study||36
6678730|NCT02643862|7610208|FG001|STARTED|Overall Study||12
6678731|NCT02643862|7610207|FG000|COMPLETED|Overall Study||36
6678732|NCT02643862|7610208|FG001|COMPLETED|Overall Study||12
6678733|NCT02643862|7610207|FG000|NOT COMPLETED|Overall Study||0
6678734|NCT02643862|7610208|FG001|NOT COMPLETED|Overall Study||0
6678735|NCT02643875|7610214|FG000|STARTED|Overall Study||36
6678736|NCT02643875|7610214|FG000|Received 0.75|Overall Study||36
6678737|NCT02643875|7610214|FG000|Received 1.75 D|Overall Study||36
6678738|NCT02643875|7610214|FG000|COMPLETED|Overall Study||28
6678739|NCT02643875|7610214|FG000|NOT COMPLETED|Overall Study||8
6678740|NCT02643979|7610221|FG000|STARTED|Overall Study||11
6678741|NCT02643979|7610222|FG001|STARTED|Overall Study||11
6678742|NCT02643979|7610221|FG000|COMPLETED|Overall Study||11
6678743|NCT02643979|7610222|FG001|COMPLETED|Overall Study||11
6678744|NCT02643979|7610221|FG000|NOT COMPLETED|Overall Study||0
6678745|NCT02643979|7610222|FG001|NOT COMPLETED|Overall Study||0
6678746|NCT02644096|7610230|FG000|STARTED|Overall Study||93
6678747|NCT02644096|7610231|FG001|STARTED|Overall Study||82
6678748|NCT02644096|7610230|FG000|2 Week Interview|Overall Study|Not done in control group|0
6678749|NCT02644096|7610231|FG001|2 Week Interview|Overall Study||68
6678750|NCT02644096|7610230|FG000|10 Week Interview|Overall Study|Not done in control group|0
6678751|NCT02644096|7610231|FG001|10 Week Interview|Overall Study||59
6678752|NCT02644096|7610230|FG000|12 Week SF-36 Questionnaire|Overall Study||68
6678753|NCT02644096|7610231|FG001|12 Week SF-36 Questionnaire|Overall Study||59
6678754|NCT02644096|7610230|FG000|9 Month SF-36 Questionnaire|Overall Study||65
6678755|NCT02644096|7610231|FG001|9 Month SF-36 Questionnaire|Overall Study||57
6678756|NCT02644096|7610230|FG000|COMPLETED|Overall Study||65
6678757|NCT02644096|7610231|FG001|COMPLETED|Overall Study||57
6678758|NCT02644096|7610230|FG000|NOT COMPLETED|Overall Study||28
6678759|NCT02644096|7610231|FG001|NOT COMPLETED|Overall Study||25
6678760|NCT02644109|7610239|FG000|STARTED|Overall Study||24
6678761|NCT02644109|7610240|FG001|STARTED|Overall Study||28
6678762|NCT02644109|7610239|FG000|COMPLETED|Overall Study||24
6678763|NCT02644109|7610240|FG001|COMPLETED|Overall Study||24
6678764|NCT02644109|7610239|FG000|NOT COMPLETED|Overall Study||0
6678765|NCT02644109|7610240|FG001|NOT COMPLETED|Overall Study||4
6678766|NCT02644122|7610246|FG000|STARTED|Overall Study||1
6678767|NCT02644122|7610246|FG000|COMPLETED|Overall Study||0
6678768|NCT02644122|7610246|FG000|NOT COMPLETED|Overall Study||1
6678769|NCT02644278|7610255|FG000|STARTED|Overall Study||3
6678770|NCT02644278|7610256|FG001|STARTED|Overall Study||3
6678771|NCT02644278|7610257|FG002|STARTED|Overall Study||6
6678772|NCT02644278|7610258|FG003|STARTED|Overall Study||3
6678773|NCT02644278|7610255|FG000|COMPLETED|Overall Study||3
6678774|NCT02644278|7610256|FG001|COMPLETED|Overall Study||3
6678775|NCT02644278|7610257|FG002|COMPLETED|Overall Study||6
6678776|NCT02644278|7610258|FG003|COMPLETED|Overall Study||3
6678777|NCT02644278|7610255|FG000|NOT COMPLETED|Overall Study||0
6678778|NCT02644278|7610256|FG001|NOT COMPLETED|Overall Study||0
6678779|NCT02644278|7610257|FG002|NOT COMPLETED|Overall Study||0
6678780|NCT02644278|7610258|FG003|NOT COMPLETED|Overall Study||0
6678781|NCT02644343|7610268|FG000|STARTED|Overall Study||40
6678782|NCT02644343|7610268|FG000|COMPLETED|Overall Study||39
6678783|NCT02644343|7610268|FG000|NOT COMPLETED|Overall Study||1
6678784|NCT02644356|7610272|FG000|STARTED|Overall Study||51
6678785|NCT02644356|7610272|FG000|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
6678786|NCT02644356|7610272|FG000|NOT COMPLETED|Overall Study||2
6678787|NCT02644668|7610279|FG000|STARTED|Overall Study||26
6678788|NCT02644668|7610280|FG001|STARTED|Overall Study||24
6678789|NCT02644668|7610281|FG002|STARTED|Overall Study||20
6678790|NCT02644668|7610279|FG000|COMPLETED|Overall Study||24
6678791|NCT02644668|7610280|FG001|COMPLETED|Overall Study||24
6678792|NCT02644668|7610281|FG002|COMPLETED|Overall Study||17
6678793|NCT02644668|7610279|FG000|NOT COMPLETED|Overall Study||2
6678794|NCT02644668|7610280|FG001|NOT COMPLETED|Overall Study||0
6678795|NCT02644668|7610281|FG002|NOT COMPLETED|Overall Study||3
6678796|NCT02645019|7610296|FG000|STARTED|Overall Study||13
6678797|NCT02645019|7610297|FG001|STARTED|Overall Study||15
6678798|NCT02645019|7610298|FG002|STARTED|Overall Study||15
6678799|NCT02645019|7610299|FG003|STARTED|Overall Study||33
6678800|NCT02645019|7610300|FG004|STARTED|Overall Study||24
6678801|NCT02645019|7610296|FG000|COMPLETED|Overall Study||13
6678802|NCT02645019|7610297|FG001|COMPLETED|Overall Study||15
6678803|NCT02645019|7610298|FG002|COMPLETED|Overall Study||15
6678804|NCT02645019|7610299|FG003|COMPLETED|Overall Study||33
6678805|NCT02645019|7610300|FG004|COMPLETED|Overall Study||24
6678806|NCT02645019|7610296|FG000|NOT COMPLETED|Overall Study||0
6678807|NCT02645019|7610297|FG001|NOT COMPLETED|Overall Study||0
6678808|NCT02645019|7610298|FG002|NOT COMPLETED|Overall Study||0
6678809|NCT02645019|7610299|FG003|NOT COMPLETED|Overall Study||0
6678810|NCT02645019|7610300|FG004|NOT COMPLETED|Overall Study||0
6678811|NCT02645123|7610315|FG000|STARTED|Overall Study||25
6678812|NCT02645123|7610316|FG001|STARTED|Overall Study||25
6678813|NCT02645123|7610317|FG002|STARTED|Overall Study||25
6678814|NCT02645123|7610315|FG000|COMPLETED|Overall Study||25
6678815|NCT02645123|7610316|FG001|COMPLETED|Overall Study||25
6678816|NCT02645123|7610317|FG002|COMPLETED|Overall Study||25
6678817|NCT02645123|7610315|FG000|NOT COMPLETED|Overall Study||0
6678818|NCT02645123|7610316|FG001|NOT COMPLETED|Overall Study||0
6678819|NCT02645123|7610317|FG002|NOT COMPLETED|Overall Study||0
6678820|NCT02645253|7610329|FG000|STARTED|Overall Study||7
6678821|NCT02645253|7610330|FG001|STARTED|Overall Study||7
6678822|NCT02645253|7610331|FG002|STARTED|Overall Study||7
6678823|NCT02645253|7610332|FG003|STARTED|Overall Study||6
6678824|NCT02645253|7610329|FG000|COMPLETED|Overall Study||7
6678825|NCT02645253|7610330|FG001|COMPLETED|Overall Study||7
6678826|NCT02645253|7610331|FG002|COMPLETED|Overall Study||7
6678827|NCT02645253|7610332|FG003|COMPLETED|Overall Study||6
6678828|NCT02645253|7610329|FG000|NOT COMPLETED|Overall Study||0
6678829|NCT02645253|7610330|FG001|NOT COMPLETED|Overall Study||0
6678830|NCT02645253|7610331|FG002|NOT COMPLETED|Overall Study||0
6678831|NCT02645253|7610332|FG003|NOT COMPLETED|Overall Study||0
6678832|NCT02645409|7610349|FG000|STARTED|Overall Study||14
6678833|NCT02645409|7610350|FG001|STARTED|Overall Study|It was decided to not continue with the Radical Nephrectomy arm of the study.|0
6678834|NCT02645409|7610349|FG000|COMPLETED|Overall Study||10
6678835|NCT02645409|7610350|FG001|COMPLETED|Overall Study||0
6678836|NCT02645409|7610349|FG000|NOT COMPLETED|Overall Study||4
6678837|NCT02645409|7610350|FG001|NOT COMPLETED|Overall Study||0
6678838|NCT02645617|7610355|FG000|STARTED|Overall Study||12
6678839|NCT02645617|7610355|FG000|COMPLETED|Overall Study||12
6678840|NCT02645617|7610355|FG000|NOT COMPLETED|Overall Study||0
6678841|NCT02645760|7610361|FG000|STARTED|Overall Study||19
6678842|NCT02645760|7610362|FG001|STARTED|Overall Study||19
6678843|NCT02645760|7610361|FG000|COMPLETED|Overall Study||19
6678844|NCT02645760|7610362|FG001|COMPLETED|Overall Study||19
6678845|NCT02645760|7610361|FG000|NOT COMPLETED|Overall Study||0
6678846|NCT02645760|7610362|FG001|NOT COMPLETED|Overall Study||0
6678847|NCT02646124|7610371|FG000|STARTED|Overall Study||57
6678848|NCT02646124|7610372|FG001|STARTED|Overall Study||57
6678849|NCT02646124|7610371|FG000|COMPLETED|Overall Study||57
6678850|NCT02646124|7610372|FG001|COMPLETED|Overall Study||55
6678851|NCT02646124|7610371|FG000|NOT COMPLETED|Overall Study||0
6678852|NCT02646124|7610372|FG001|NOT COMPLETED|Overall Study||2
6678853|NCT02646332|7610380|FG000|STARTED|Overall Study||124
6678854|NCT02646332|7610381|FG001|STARTED|Overall Study||124
6678855|NCT02646332|7610380|FG000|COMPLETED|Overall Study||124
6678856|NCT02646332|7610381|FG001|COMPLETED|Overall Study||121
6678857|NCT02646332|7610380|FG000|NOT COMPLETED|Overall Study||0
6678858|NCT02646332|7610381|FG001|NOT COMPLETED|Overall Study||3
6678859|NCT02646371|7610389|FG000|STARTED|Overall Study||34
6678860|NCT02646371|7610390|FG001|STARTED|Overall Study||33
6678861|NCT02646371|7610389|FG000|COMPLETED|Overall Study||34
6678862|NCT02646371|7610390|FG001|COMPLETED|Overall Study||33
6678863|NCT02646371|7610389|FG000|NOT COMPLETED|Overall Study||0
6678864|NCT02646371|7610390|FG001|NOT COMPLETED|Overall Study||0
6678865|NCT02646423|7610398|FG000|STARTED|Overall Study||742
6678866|NCT02646423|7610399|FG001|STARTED|Overall Study||743
6678867|NCT02646423|7610398|FG000|COMPLETED|Overall Study||735
6678868|NCT02646423|7610399|FG001|COMPLETED|Overall Study||735
6678869|NCT02646423|7610398|FG000|NOT COMPLETED|Overall Study||7
6678870|NCT02646423|7610399|FG001|NOT COMPLETED|Overall Study||8
6678871|NCT02646449|7610407|FG000|STARTED|Overall Study||4
6678872|NCT02646449|7610408|FG001|STARTED|Overall Study||3
6678873|NCT02646449|7610407|FG000|COMPLETED|Overall Study||4
6678874|NCT02646449|7610408|FG001|COMPLETED|Overall Study||3
6678875|NCT02646449|7610407|FG000|NOT COMPLETED|Overall Study||0
6678876|NCT02646449|7610408|FG001|NOT COMPLETED|Overall Study||0
6678877|NCT02646566|7610417|FG000|STARTED|Overall Study||237
6678878|NCT02646566|7610418|FG001|STARTED|Overall Study||230
6678879|NCT02646566|7610419|FG002|STARTED|Overall Study||235
6678880|NCT02646566|7610417|FG000|COMPLETED|Overall Study||231
6678881|NCT02646566|7610418|FG001|COMPLETED|Overall Study||226
6678882|NCT02646566|7610419|FG002|COMPLETED|Overall Study||230
6678883|NCT02646566|7610417|FG000|NOT COMPLETED|Overall Study||6
6678884|NCT02646566|7610418|FG001|NOT COMPLETED|Overall Study||4
6678885|NCT02646566|7610419|FG002|NOT COMPLETED|Overall Study||5
6678886|NCT02646618|7610429|FG000|STARTED|Overall Study||167
6678887|NCT02646618|7610430|FG001|STARTED|Overall Study||162
6678888|NCT02646618|7610429|FG000|6 Month Follow-up|Overall Study||152
6678889|NCT02646618|7610430|FG001|6 Month Follow-up|Overall Study||150
6678890|NCT02646618|7610429|FG000|COMPLETED|Overall Study||157
6678891|NCT02646618|7610430|FG001|COMPLETED|Overall Study||148
6678892|NCT02646618|7610429|FG000|NOT COMPLETED|Overall Study||10
6678893|NCT02646618|7610430|FG001|NOT COMPLETED|Overall Study||14
6678894|NCT02646761|7610440|FG000|STARTED|Overall Study||18
6678895|NCT02646761|7610441|FG001|STARTED|Overall Study||20
6678896|NCT02646761|7610440|FG000|Subject Withdrew Before Baseline|Overall Study||5
6678897|NCT02646761|7610441|FG001|Subject Withdrew Before Baseline|Overall Study||8
6678898|NCT02646761|7610440|FG000|Baseline Assessment|Overall Study||13
6678899|NCT02646761|7610441|FG001|Baseline Assessment|Overall Study||12
6678900|NCT02646761|7610440|FG000|5-week Assessment|Overall Study||12
6678901|NCT02646761|7610441|FG001|5-week Assessment|Overall Study||10
6678902|NCT02646761|7610440|FG000|COMPLETED|Overall Study||10
6678903|NCT02646761|7610441|FG001|COMPLETED|Overall Study||10
6678904|NCT02646761|7610440|FG000|NOT COMPLETED|Overall Study||8
6678905|NCT02646761|7610441|FG001|NOT COMPLETED|Overall Study||10
6678906|NCT02646826|7610451|FG000|STARTED|Overall Study||21
6678907|NCT02646826|7610452|FG001|STARTED|Overall Study||22
6678908|NCT02646826|7610453|FG002|STARTED|Overall Study||21
6678909|NCT02646826|7610454|FG003|STARTED|Overall Study||22
6678910|NCT02646826|7610451|FG000|COMPLETED|Overall Study||19
6678911|NCT02646826|7610452|FG001|COMPLETED|Overall Study||22
6678912|NCT02646826|7610453|FG002|COMPLETED|Overall Study||20
6678913|NCT02646826|7610454|FG003|COMPLETED|Overall Study||21
6678914|NCT02646826|7610451|FG000|NOT COMPLETED|Overall Study||2
6678915|NCT02646826|7610452|FG001|NOT COMPLETED|Overall Study||0
6678916|NCT02646826|7610453|FG002|NOT COMPLETED|Overall Study||1
6678917|NCT02646826|7610454|FG003|NOT COMPLETED|Overall Study||1
6678918|NCT02646891|7610474|FG000|STARTED|Overall Study||6
6678919|NCT02646891|7610475|FG001|STARTED|Overall Study||12
6678920|NCT02646891|7610476|FG002|STARTED|Overall Study||12
6678921|NCT02646891|7610477|FG003|STARTED|Overall Study||6
6678922|NCT02646891|7610478|FG004|STARTED|Overall Study||12
6678923|NCT02646891|7610479|FG005|STARTED|Overall Study||12
6678924|NCT02646891|7610480|FG006|STARTED|Overall Study||139
6678925|NCT02646891|7610481|FG007|STARTED|Overall Study||140
6678926|NCT02646891|7610482|FG008|STARTED|Overall Study||140
6678927|NCT02646891|7610483|FG009|STARTED|Overall Study||139
6678928|NCT02646891|7610474|FG000|Received at Least 1 Dose|Overall Study||6
6678929|NCT02646891|7610475|FG001|Received at Least 1 Dose|Overall Study||12
6678930|NCT02646891|7610476|FG002|Received at Least 1 Dose|Overall Study||12
6678931|NCT02646891|7610477|FG003|Received at Least 1 Dose|Overall Study||6
6678932|NCT02646891|7610478|FG004|Received at Least 1 Dose|Overall Study||12
6678933|NCT02646891|7610479|FG005|Received at Least 1 Dose|Overall Study||12
6678934|NCT02646891|7610480|FG006|Received at Least 1 Dose|Overall Study||139
6678935|NCT02646891|7610481|FG007|Received at Least 1 Dose|Overall Study|One participant was randomized but determined to be ineligible pre-vaccination.|139
6678936|NCT02646891|7610482|FG008|Received at Least 1 Dose|Overall Study||140
6678937|NCT02646891|7610483|FG009|Received at Least 1 Dose|Overall Study||139
6678938|NCT02646891|7610474|FG000|COMPLETED|Overall Study||4
6678939|NCT02646891|7610475|FG001|COMPLETED|Overall Study||11
6678940|NCT02646891|7610476|FG002|COMPLETED|Overall Study||11
6678941|NCT02646891|7610477|FG003|COMPLETED|Overall Study||6
6678942|NCT02646891|7610478|FG004|COMPLETED|Overall Study||12
6678943|NCT02646891|7610479|FG005|COMPLETED|Overall Study||12
6678944|NCT02646891|7610480|FG006|COMPLETED|Overall Study||130
6678945|NCT02646891|7610481|FG007|COMPLETED|Overall Study||127
6678946|NCT02646891|7610482|FG008|COMPLETED|Overall Study||130
6678947|NCT02646891|7610483|FG009|COMPLETED|Overall Study||134
6678948|NCT02646891|7610474|FG000|NOT COMPLETED|Overall Study||2
6678949|NCT02646891|7610475|FG001|NOT COMPLETED|Overall Study||1
6678950|NCT02646891|7610476|FG002|NOT COMPLETED|Overall Study||1
6678951|NCT02646891|7610477|FG003|NOT COMPLETED|Overall Study||0
6678952|NCT02646891|7610478|FG004|NOT COMPLETED|Overall Study||0
6678953|NCT02646891|7610479|FG005|NOT COMPLETED|Overall Study||0
6678954|NCT02646891|7610480|FG006|NOT COMPLETED|Overall Study||9
6678955|NCT02646891|7610481|FG007|NOT COMPLETED|Overall Study||13
6678956|NCT02646891|7610482|FG008|NOT COMPLETED|Overall Study||10
6678957|NCT02646891|7610483|FG009|NOT COMPLETED|Overall Study||5
6678958|NCT02646917|7610519|FG000|STARTED|Overall Study||21
6678959|NCT02646917|7610520|FG001|STARTED|Overall Study||20
6678960|NCT02646917|7610519|FG000|COMPLETED|Overall Study||21
6678961|NCT02646917|7610520|FG001|COMPLETED|Overall Study||20
6678962|NCT02646917|7610519|FG000|NOT COMPLETED|Overall Study||0
6678963|NCT02646917|7610520|FG001|NOT COMPLETED|Overall Study||0
6678964|NCT02647203|7610533|FG000|STARTED|12 Month Follow-up||173
6678965|NCT02647203|7610534|FG001|STARTED|12 Month Follow-up||172
6678966|NCT02647203|7610533|FG000|COMPLETED|12 Month Follow-up||148
6678967|NCT02647203|7610534|FG001|COMPLETED|12 Month Follow-up||149
6678968|NCT02647203|7610533|FG000|NOT COMPLETED|12 Month Follow-up||25
6678969|NCT02647203|7610534|FG001|NOT COMPLETED|12 Month Follow-up||23
6678970|NCT02647203|7610533|FG000|STARTED|24 Month Follow-up||148
6678971|NCT02647203|7610534|FG001|STARTED|24 Month Follow-up||149
6678972|NCT02647203|7610533|FG000|COMPLETED|24 Month Follow-up||142
6678973|NCT02647203|7610534|FG001|COMPLETED|24 Month Follow-up||138
6678974|NCT02647203|7610533|FG000|NOT COMPLETED|24 Month Follow-up||6
6678975|NCT02647203|7610534|FG001|NOT COMPLETED|24 Month Follow-up||11
6678976|NCT02647281|7610549|FG000|STARTED|Single-Ascending Dose(Part 1-62 Days)||8
6678977|NCT02647281|7610550|FG001|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
6678978|NCT02647281|7610551|FG002|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
6678979|NCT02647281|7610552|FG003|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
6678980|NCT02647281|7610553|FG004|STARTED|Single-Ascending Dose(Part 1-62 Days)||6
6678981|NCT02647281|7610554|FG005|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
6678982|NCT02647281|7610555|FG006|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
6678983|NCT02647281|7610556|FG007|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
6678984|NCT02647281|7610557|FG008|STARTED|Single-Ascending Dose(Part 1-62 Days)||0
6678985|NCT02647281|7610549|FG000|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||8
6678986|NCT02647281|7610550|FG001|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
6678987|NCT02647281|7610551|FG002|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
6678988|NCT02647281|7610552|FG003|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
6678989|NCT02647281|7610553|FG004|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||6
6678990|NCT02647281|7610554|FG005|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678991|NCT02647281|7610555|FG006|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678992|NCT02647281|7610556|FG007|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678993|NCT02647281|7610557|FG008|COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678994|NCT02647281|7610549|FG000|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678995|NCT02647281|7610550|FG001|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678996|NCT02647281|7610551|FG002|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678997|NCT02647281|7610552|FG003|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678998|NCT02647281|7610553|FG004|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6678999|NCT02647281|7610554|FG005|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6679000|NCT02647281|7610555|FG006|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6679001|NCT02647281|7610556|FG007|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6679002|NCT02647281|7610557|FG008|NOT COMPLETED|Single-Ascending Dose(Part 1-62 Days)||0
6679003|NCT02647281|7610549|FG000|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679004|NCT02647281|7610550|FG001|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679005|NCT02647281|7610551|FG002|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679006|NCT02647281|7610552|FG003|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679007|NCT02647281|7610553|FG004|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679008|NCT02647281|7610554|FG005|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
6679009|NCT02647281|7610555|FG006|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
6679010|NCT02647281|7610556|FG007|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
6679011|NCT02647281|7610557|FG008|STARTED|Multiple-Ascending Dose(Part 2-115 Days)||6
6679012|NCT02647281|7610549|FG000|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679013|NCT02647281|7610550|FG001|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679014|NCT02647281|7610551|FG002|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679015|NCT02647281|7610552|FG003|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679016|NCT02647281|7610553|FG004|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679017|NCT02647281|7610554|FG005|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
6679018|NCT02647281|7610555|FG006|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
6679019|NCT02647281|7610556|FG007|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||6
6679020|NCT02647281|7610557|FG008|COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||5
6679021|NCT02647281|7610549|FG000|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679022|NCT02647281|7610550|FG001|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679023|NCT02647281|7610551|FG002|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679024|NCT02647281|7610552|FG003|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679025|NCT02647281|7610553|FG004|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679026|NCT02647281|7610554|FG005|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679027|NCT02647281|7610555|FG006|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679028|NCT02647281|7610556|FG007|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||0
6679029|NCT02647281|7610557|FG008|NOT COMPLETED|Multiple-Ascending Dose(Part 2-115 Days)||1
6679030|NCT02647320|7610591|FG000|STARTED|Overall Study||46
6679031|NCT02647320|7610592|FG001|STARTED|Overall Study||46
6679032|NCT02647320|7610593|FG002|STARTED|Overall Study||69
6679033|NCT02647320|7610594|FG003|STARTED|Overall Study||68
6679034|NCT02647320|7610595|FG004|STARTED|Overall Study||69
6679035|NCT02647320|7610591|FG000|Inadvertently Randomized|Overall Study||0
6679036|NCT02647320|7610592|FG001|Inadvertently Randomized|Overall Study||0
6679037|NCT02647320|7610593|FG002|Inadvertently Randomized|Overall Study||0
6679038|NCT02647320|7610594|FG003|Inadvertently Randomized|Overall Study||1
6679039|NCT02647320|7610595|FG004|Inadvertently Randomized|Overall Study||0
6679040|NCT02647320|7610591|FG000|Safety Set|Overall Study||43
6679041|NCT02647320|7610592|FG001|Safety Set|Overall Study||44
6679042|NCT02647320|7610593|FG002|Safety Set|Overall Study||68
6679043|NCT02647320|7610594|FG003|Safety Set|Overall Study||68
6679044|NCT02647320|7610595|FG004|Safety Set|Overall Study||69
6679045|NCT02647320|7610591|FG000|Modified Intent-to-Treat Set (mITT)|Overall Study||40
6679046|NCT02647320|7610592|FG001|Modified Intent-to-Treat Set (mITT)|Overall Study||38
6679047|NCT02647320|7610593|FG002|Modified Intent-to-Treat Set (mITT)|Overall Study||61
6679048|NCT02647320|7610594|FG003|Modified Intent-to-Treat Set (mITT)|Overall Study||62
6679049|NCT02647320|7610595|FG004|Modified Intent-to-Treat Set (mITT)|Overall Study||62
6679050|NCT02647320|7610591|FG000|COMPLETED|Overall Study||34
6679051|NCT02647320|7610592|FG001|COMPLETED|Overall Study||35
6679052|NCT02647320|7610593|FG002|COMPLETED|Overall Study||54
6679053|NCT02647320|7610594|FG003|COMPLETED|Overall Study||58
6679054|NCT02647320|7610595|FG004|COMPLETED|Overall Study||52
6679055|NCT02647320|7610591|FG000|NOT COMPLETED|Overall Study||12
6679056|NCT02647320|7610592|FG001|NOT COMPLETED|Overall Study||11
6679057|NCT02647320|7610593|FG002|NOT COMPLETED|Overall Study||15
6679058|NCT02647320|7610594|FG003|NOT COMPLETED|Overall Study||10
6679059|NCT02647320|7610595|FG004|NOT COMPLETED|Overall Study||17
6679060|NCT02647346|7610609|FG000|STARTED|Overall Study||132
6679061|NCT02647346|7610609|FG000|COMPLETED|Overall Study||129
6679062|NCT02647346|7610609|FG000|NOT COMPLETED|Overall Study||3
6679063|NCT02647645|7610615|FG000|STARTED|Overall Study||11
6679064|NCT02647645|7610616|FG001|STARTED|Overall Study||10
6679065|NCT02647645|7610615|FG000|COMPLETED|Overall Study||9
6679066|NCT02647645|7610616|FG001|COMPLETED|Overall Study||9
6679067|NCT02647645|7610615|FG000|NOT COMPLETED|Overall Study||2
6679068|NCT02647645|7610616|FG001|NOT COMPLETED|Overall Study||1
6679069|NCT02647658|7610624|FG000|STARTED|Overall Study||1207
6679070|NCT02647658|7610625|FG001|STARTED|Overall Study||1093
6679071|NCT02647658|7610624|FG000|6 Month Assessment|Overall Study||658
6679072|NCT02647658|7610625|FG001|6 Month Assessment|Overall Study||635
6679073|NCT02647658|7610624|FG000|COMPLETED|Overall Study||1192
6679074|NCT02647658|7610625|FG001|COMPLETED|Overall Study||1069
6679075|NCT02647658|7610624|FG000|NOT COMPLETED|Overall Study||15
6679076|NCT02647658|7610625|FG001|NOT COMPLETED|Overall Study||24
6679077|NCT02647788|7610633|FG000|STARTED|Overall Study||70
6679078|NCT02647788|7610634|FG001|STARTED|Overall Study||70
6679079|NCT02647788|7610633|FG000|COMPLETED|Overall Study||54
6679080|NCT02647788|7610634|FG001|COMPLETED|Overall Study||57
6679081|NCT02647788|7610633|FG000|NOT COMPLETED|Overall Study||16
6679082|NCT02647788|7610634|FG001|NOT COMPLETED|Overall Study||13
6679083|NCT02647866|7610645|FG000|STARTED|Overall Study||9
6679084|NCT02647866|7610646|FG001|STARTED|Overall Study||10
6679085|NCT02647866|7610647|FG002|STARTED|Overall Study||9
6679086|NCT02647866|7610648|FG003|STARTED|Overall Study||21
6679087|NCT02647866|7610649|FG004|STARTED|Overall Study||17
6679088|NCT02647866|7610645|FG000|Completed Induction Therapy|Overall Study|Subjects received KHK4083 1.0 mg/kg for 12 weeks|8
6679089|NCT02647866|7610646|FG001|Completed Induction Therapy|Overall Study|Subjects received KHK4083 3.0 mg/kg for 12 weeks|9
6679090|NCT02647866|7610647|FG002|Completed Induction Therapy|Overall Study|Subjects received KHK4083 10.0 mg/kg for 12 weeks|8
6679091|NCT02647866|7610648|FG003|Completed Induction Therapy|Overall Study|Subjects received the maximum tolerated dose of KHK4083 10.0 mg/kg for 12 weeks|19
6679092|NCT02647866|7610649|FG004|Completed Induction Therapy|Overall Study|Subjects received Placebo for 12 weeks|17
6679093|NCT02647866|7610645|FG000|Completed Induction Therapy Follow-Up|Overall Study||5
6679094|NCT02647866|7610646|FG001|Completed Induction Therapy Follow-Up|Overall Study||1
6679095|NCT02647866|7610647|FG002|Completed Induction Therapy Follow-Up|Overall Study||2
6679096|NCT02647866|7610648|FG003|Completed Induction Therapy Follow-Up|Overall Study||0
6679097|NCT02647866|7610649|FG004|Completed Induction Therapy Follow-Up|Overall Study||2
6679098|NCT02647866|7610645|FG000|Completed Long-Term Extension Therapy|Overall Study|10 add'l treatments of KHK4083 (same dose as Induction Therapy) as maintenance therapy.|3
6679099|NCT02647866|7610646|FG001|Completed Long-Term Extension Therapy|Overall Study||0
6679100|NCT02647866|7610647|FG002|Completed Long-Term Extension Therapy|Overall Study||0
6679101|NCT02647866|7610648|FG003|Completed Long-Term Extension Therapy|Overall Study||0
6679102|NCT02647866|7610649|FG004|Completed Long-Term Extension Therapy|Overall Study||0
6679103|NCT02647866|7610645|FG000|Completed LTE Follow-up|Overall Study||2
6679104|NCT02647866|7610646|FG001|Completed LTE Follow-up|Overall Study||0
6679105|NCT02647866|7610647|FG002|Completed LTE Follow-up|Overall Study||0
6679106|NCT02647866|7610648|FG003|Completed LTE Follow-up|Overall Study||0
6679107|NCT02647866|7610649|FG004|Completed LTE Follow-up|Overall Study||0
6679108|NCT02647866|7610645|FG000|Completed Open-Label Extension Therapy|Overall Study||0
6679109|NCT02647866|7610646|FG001|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy.|7
6679110|NCT02647866|7610647|FG002|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|4
6679111|NCT02647866|7610648|FG003|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|17
6679112|NCT02647866|7610649|FG004|Completed Open-Label Extension Therapy|Overall Study|10 add'l treatments of Open-Label KHK4083 (same dose as Induction Therapy) as maintenance therapy|13
6679113|NCT02647866|7610645|FG000|Completed OLE Follow-up|Overall Study||0
6679114|NCT02647866|7610646|FG001|Completed OLE Follow-up|Overall Study||6
6679115|NCT02647866|7610647|FG002|Completed OLE Follow-up|Overall Study||4
6679116|NCT02647866|7610648|FG003|Completed OLE Follow-up|Overall Study||14
6679117|NCT02647866|7610649|FG004|Completed OLE Follow-up|Overall Study||10
6679118|NCT02647866|7610645|FG000|Moved From LTE to OLE Therapy|Overall Study||0
6679119|NCT02647866|7610646|FG001|Moved From LTE to OLE Therapy|Overall Study||5
6679120|NCT02647866|7610647|FG002|Moved From LTE to OLE Therapy|Overall Study||0
6679121|NCT02647866|7610648|FG003|Moved From LTE to OLE Therapy|Overall Study||0
6679122|NCT02647866|7610649|FG004|Moved From LTE to OLE Therapy|Overall Study||2
6679123|NCT02647866|7610645|FG000|Discontinued the Treatment|Overall Study||4
6679124|NCT02647866|7610646|FG001|Discontinued the Treatment|Overall Study||5
6679125|NCT02647866|7610647|FG002|Discontinued the Treatment|Overall Study||5
6679126|NCT02647866|7610648|FG003|Discontinued the Treatment|Overall Study||5
6679127|NCT02647866|7610649|FG004|Discontinued the Treatment|Overall Study||8
6679128|NCT02647866|7610645|FG000|Discontinued the Study|Overall Study||5
6679129|NCT02647866|7610646|FG001|Discontinued the Study|Overall Study||4
6679130|NCT02647866|7610647|FG002|Discontinued the Study|Overall Study||5
6679131|NCT02647866|7610648|FG003|Discontinued the Study|Overall Study||6
6679132|NCT02647866|7610649|FG004|Discontinued the Study|Overall Study||8
6679133|NCT02647866|7610645|FG000|COMPLETED|Overall Study||4
6679134|NCT02647866|7610646|FG001|COMPLETED|Overall Study||6
6679135|NCT02647866|7610647|FG002|COMPLETED|Overall Study||4
6679136|NCT02647866|7610648|FG003|COMPLETED|Overall Study||15
6679137|NCT02647866|7610649|FG004|COMPLETED|Overall Study||9
6679138|NCT02647866|7610645|FG000|NOT COMPLETED|Overall Study||5
6679139|NCT02647866|7610646|FG001|NOT COMPLETED|Overall Study||4
6679140|NCT02647866|7610647|FG002|NOT COMPLETED|Overall Study||5
6679141|NCT02647866|7610648|FG003|NOT COMPLETED|Overall Study||6
6679142|NCT02647866|7610649|FG004|NOT COMPLETED|Overall Study||8
6679143|NCT02647905|7610669|FG000|STARTED|Overall Study||90
6679144|NCT02647905|7610669|FG000|COMPLETED|Overall Study||87
6679145|NCT02647905|7610669|FG000|NOT COMPLETED|Overall Study||3
6679146|NCT02647944|7610675|FG000|STARTED|Overall Study||19
6679147|NCT02647944|7610676|FG001|STARTED|Overall Study||21
6679148|NCT02647944|7610675|FG000|COMPLETED|Overall Study||17
6679149|NCT02647944|7610676|FG001|COMPLETED|Overall Study||18
6679150|NCT02647944|7610675|FG000|NOT COMPLETED|Overall Study||2
6679151|NCT02647944|7610676|FG001|NOT COMPLETED|Overall Study||3
6679152|NCT02648022|7610684|FG000|STARTED|Overall Study||40
6679153|NCT02648022|7610685|FG001|STARTED|Overall Study||39
6679154|NCT02648022|7610684|FG000|COMPLETED|Overall Study||40
6679155|NCT02648022|7610685|FG001|COMPLETED|Overall Study||39
6679156|NCT02648022|7610684|FG000|NOT COMPLETED|Overall Study||0
6679157|NCT02648022|7610685|FG001|NOT COMPLETED|Overall Study||0
6679158|NCT02648178|7610691|FG000|STARTED|Overall Study||19
6679159|NCT02648178|7610691|FG000|COMPLETED|Overall Study||10
6679160|NCT02648178|7610691|FG000|NOT COMPLETED|Overall Study||9
6679161|NCT02648204|7610699|FG000|STARTED|Overall Study||301
6679162|NCT02648204|7610700|FG001|STARTED|Overall Study||300
6679163|NCT02648204|7610701|FG002|STARTED|Overall Study||300
6679164|NCT02648204|7610702|FG003|STARTED|Overall Study||300
6679165|NCT02648204|7610699|FG000|Exposed|Overall Study||301
6679166|NCT02648204|7610700|FG001|Exposed|Overall Study||300
6679167|NCT02648204|7610701|FG002|Exposed|Overall Study||299
6679168|NCT02648204|7610702|FG003|Exposed|Overall Study||299
6256319|NCT04929522|7155204|FG000|STARTED|Overall Study||40
6602193|NCT02055352|7527137|FG000|STARTED|Overall Study||109
6602194|NCT02055352|7527138|FG001|STARTED|Overall Study||113
6602195|NCT02055352|7527137|FG000|Per-Protocol Set (PPS)|Overall Study||108
6602196|NCT02055352|7527138|FG001|Per-Protocol Set (PPS)|Overall Study||111
6679169|NCT02648204|7610699|FG000|COMPLETED|Overall Study||279
6679170|NCT02648204|7610700|FG001|COMPLETED|Overall Study||279
6679171|NCT02648204|7610701|FG002|COMPLETED|Overall Study||287
6679172|NCT02648204|7610702|FG003|COMPLETED|Overall Study||284
6679173|NCT02648204|7610699|FG000|NOT COMPLETED|Overall Study||22
6679174|NCT02648204|7610700|FG001|NOT COMPLETED|Overall Study||21
6679175|NCT02648204|7610701|FG002|NOT COMPLETED|Overall Study||13
6679176|NCT02648204|7610702|FG003|NOT COMPLETED|Overall Study||16
6679177|NCT02648217|7610714|FG000|STARTED|Overall Study||131
6679178|NCT02648217|7610715|FG001|STARTED|Overall Study||132
6679179|NCT02648217|7610714|FG000|Exposed|Overall Study||130
6679180|NCT02648217|7610715|FG001|Exposed|Overall Study||132
6679181|NCT02648217|7610714|FG000|COMPLETED|Overall Study||121
6679182|NCT02648217|7610715|FG001|COMPLETED|Overall Study||127
6679183|NCT02648217|7610714|FG000|NOT COMPLETED|Overall Study||10
6679184|NCT02648217|7610715|FG001|NOT COMPLETED|Overall Study||5
6679185|NCT02648230|7610721|FG000|STARTED|Overall Study||74
6679186|NCT02648230|7610721|FG000|COMPLETED|Overall Study||74
6679187|NCT02648230|7610721|FG000|NOT COMPLETED|Overall Study||0
6679188|NCT02648438|7610728|FG000|STARTED|Overall Study||12
6679189|NCT02648438|7610729|FG001|STARTED|Overall Study||12
6679190|NCT02648438|7610730|FG002|STARTED|Overall Study||6
6679191|NCT02648438|7610728|FG000|COMPLETED|Overall Study||9
6679192|NCT02648438|7610729|FG001|COMPLETED|Overall Study||9
6679193|NCT02648438|7610730|FG002|COMPLETED|Overall Study||6
6679194|NCT02648438|7610728|FG000|NOT COMPLETED|Overall Study||3
6679195|NCT02648438|7610729|FG001|NOT COMPLETED|Overall Study||3
6679196|NCT02648438|7610730|FG002|NOT COMPLETED|Overall Study||0
6679197|NCT02648646|7610746|FG000|STARTED|Overall Study||10
6679198|NCT02648646|7610746|FG000|COMPLETED|Overall Study||8
6679199|NCT02648646|7610746|FG000|NOT COMPLETED|Overall Study||2
6679200|NCT02648880|7610750|FG000|STARTED|Overall Study|Recruitment was significantly limited, only 3 participants were eligible, all enrolled. All three were assigned to the exercise arm, per protocol. No participants were recruited into the control arm and it was eliminated.|3
6679201|NCT02648880|7610750|FG000|COMPLETED|Overall Study||3
6679202|NCT02648880|7610750|FG000|NOT COMPLETED|Overall Study||0
6679203|NCT02648919|7610754|FG000|STARTED|Overall Study||6
6679204|NCT02648919|7610754|FG000|COMPLETED|Overall Study||6
6679205|NCT02648919|7610754|FG000|NOT COMPLETED|Overall Study||0
6679206|NCT02648932|7610761|FG000|STARTED|Overall Study||5
6679207|NCT02648932|7610762|FG001|STARTED|Overall Study||4
6679208|NCT02648932|7610761|FG000|COMPLETED|Overall Study||2
6679209|NCT02648932|7610762|FG001|COMPLETED|Overall Study||3
6679210|NCT02648932|7610761|FG000|NOT COMPLETED|Overall Study||3
6679211|NCT02648932|7610762|FG001|NOT COMPLETED|Overall Study||1
6679212|NCT02648971|7610770|FG000|STARTED|Overall Study||18
6679213|NCT02648971|7610771|FG001|STARTED|Overall Study||18
6679214|NCT02648971|7610770|FG000|COMPLETED|Overall Study||18
6679215|NCT02648971|7610771|FG001|COMPLETED|Overall Study||18
6679216|NCT02648971|7610770|FG000|NOT COMPLETED|Overall Study||0
6679217|NCT02648971|7610771|FG001|NOT COMPLETED|Overall Study||0
6679218|NCT02649192|7610783|FG000|STARTED|Overall Study||5
6679219|NCT02649192|7610784|FG001|STARTED|Overall Study||4
6679220|NCT02649192|7610785|FG002|STARTED|Overall Study||22
6679221|NCT02649192|7610786|FG003|STARTED|Overall Study||22
6679222|NCT02649192|7610787|FG004|STARTED|Overall Study||12
6679223|NCT02649192|7610788|FG005|STARTED|Overall Study||14
6602197|NCT02055352|7527137|FG000|COMPLETED|Overall Study||103
6602198|NCT02055352|7527138|FG001|COMPLETED|Overall Study||96
6602199|NCT02055352|7527137|FG000|NOT COMPLETED|Overall Study||6
6602200|NCT02055352|7527138|FG001|NOT COMPLETED|Overall Study||17
6602201|NCT02055365|7527144|FG000|STARTED|Overall Study||10
6602202|NCT02055365|7527144|FG000|COMPLETED|Overall Study||9
6602203|NCT02055365|7527144|FG000|NOT COMPLETED|Overall Study||1
6679224|NCT02649192|7610783|FG000|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
6679225|NCT02649192|7610784|FG001|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||2
6679226|NCT02649192|7610785|FG002|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||11
6738385|NCT03283787|7667736|FG002|NOT COMPLETED|Overall Study||7
6679227|NCT02649192|7610786|FG003|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||12
6679228|NCT02649192|7610787|FG004|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||7
6679229|NCT02649192|7610788|FG005|Vitamin A Sufficiency (RBP≥22,000 ng/ml)|Overall Study||8
6679230|NCT02649192|7610783|FG000|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||3
6679231|NCT02649192|7610784|FG001|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||2
6679232|NCT02649192|7610785|FG002|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||11
6679233|NCT02649192|7610786|FG003|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||10
6679234|NCT02649192|7610787|FG004|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||5
6679235|NCT02649192|7610788|FG005|Vitamin A Insufficiency (RBP<22,000 ng/m|Overall Study||6
6679236|NCT02649192|7610783|FG000|COMPLETED|Overall Study||5
6679237|NCT02649192|7610784|FG001|COMPLETED|Overall Study||4
6679238|NCT02649192|7610785|FG002|COMPLETED|Overall Study||21
6679239|NCT02649192|7610786|FG003|COMPLETED|Overall Study||20
6679240|NCT02649192|7610787|FG004|COMPLETED|Overall Study||11
6679241|NCT02649192|7610788|FG005|COMPLETED|Overall Study||14
6679242|NCT02649192|7610783|FG000|NOT COMPLETED|Overall Study||0
6679243|NCT02649192|7610784|FG001|NOT COMPLETED|Overall Study||0
6679244|NCT02649192|7610785|FG002|NOT COMPLETED|Overall Study||1
6679245|NCT02649192|7610786|FG003|NOT COMPLETED|Overall Study||2
6679246|NCT02649192|7610787|FG004|NOT COMPLETED|Overall Study||1
6679247|NCT02649192|7610788|FG005|NOT COMPLETED|Overall Study||0
6679248|NCT02649218|7610815|FG000|STARTED|Overall Study||226
6679249|NCT02649218|7610815|FG000|COMPLETED|Overall Study||201
6679250|NCT02649218|7610815|FG000|NOT COMPLETED|Overall Study||25
6679251|NCT02649231|7610824|FG000|STARTED|Overall Study||24
6679252|NCT02649231|7610825|FG001|STARTED|Overall Study||24
6679253|NCT02649231|7610826|FG002|STARTED|Overall Study||23
6679254|NCT02649231|7610827|FG003|STARTED|Overall Study||25
6679255|NCT02649231|7610824|FG000|COMPLETED|Overall Study||20
6679256|NCT02649231|7610825|FG001|COMPLETED|Overall Study||21
6679257|NCT02649231|7610826|FG002|COMPLETED|Overall Study||21
6679258|NCT02649231|7610827|FG003|COMPLETED|Overall Study||23
6679259|NCT02649231|7610824|FG000|NOT COMPLETED|Overall Study||4
6679260|NCT02649231|7610825|FG001|NOT COMPLETED|Overall Study||3
6679261|NCT02649231|7610826|FG002|NOT COMPLETED|Overall Study||2
6679262|NCT02649231|7610827|FG003|NOT COMPLETED|Overall Study||2
6679263|NCT02649322|7610839|FG000|STARTED|Overall Study||58
6679264|NCT02649322|7610840|FG001|STARTED|Overall Study||57
6679265|NCT02649322|7610839|FG000|COMPLETED|Overall Study||58
6679266|NCT02649322|7610840|FG001|COMPLETED|Overall Study||57
6679267|NCT02649322|7610839|FG000|NOT COMPLETED|Overall Study||0
6679268|NCT02649322|7610840|FG001|NOT COMPLETED|Overall Study||0
6679269|NCT02649439|7610848|FG000|STARTED|Overall Study||40
6679270|NCT02649439|7610849|FG001|STARTED|Overall Study||40
6679271|NCT02649439|7610848|FG000|COMPLETED|Overall Study||13
6679272|NCT02649439|7610849|FG001|COMPLETED|Overall Study||12
6679273|NCT02649439|7610848|FG000|NOT COMPLETED|Overall Study||27
6679274|NCT02649439|7610849|FG001|NOT COMPLETED|Overall Study||28
6679275|NCT02649556|7610866|FG000|STARTED|Overall Study||230
6679276|NCT02649556|7610867|FG001|STARTED|Overall Study||424
6679277|NCT02649556|7610868|FG002|STARTED|Overall Study||152
6679278|NCT02649556|7610869|FG003|STARTED|Overall Study||51
6679279|NCT02649556|7610866|FG000|COMPLETED|Overall Study||167
6679280|NCT02649556|7610867|FG001|COMPLETED|Overall Study||312
6679281|NCT02649556|7610868|FG002|COMPLETED|Overall Study||102
6679282|NCT02649556|7610869|FG003|COMPLETED|Overall Study||28
6679283|NCT02649556|7610866|FG000|NOT COMPLETED|Overall Study||63
6679284|NCT02649556|7610867|FG001|NOT COMPLETED|Overall Study||112
6679285|NCT02649556|7610868|FG002|NOT COMPLETED|Overall Study||50
6679286|NCT02649556|7610869|FG003|NOT COMPLETED|Overall Study||23
6679287|NCT02649608|7610879|FG000|STARTED|Overall Study||2
6679288|NCT02649608|7610880|FG001|STARTED|Overall Study||1
6679289|NCT02649608|7610881|FG002|STARTED|Overall Study||3
6679290|NCT02649608|7610882|FG003|STARTED|Overall Study||3
6679291|NCT02649608|7610883|FG004|STARTED|Overall Study||3
6679292|NCT02649608|7610884|FG005|STARTED|Overall Study||2
6679293|NCT02649608|7610885|FG006|STARTED|Overall Study||1
6679294|NCT02649608|7610879|FG000|COMPLETED|Overall Study||2
6679295|NCT02649608|7610880|FG001|COMPLETED|Overall Study||1
6679296|NCT02649608|7610881|FG002|COMPLETED|Overall Study||3
6679297|NCT02649608|7610882|FG003|COMPLETED|Overall Study||3
6679298|NCT02649608|7610883|FG004|COMPLETED|Overall Study||3
6679299|NCT02649608|7610884|FG005|COMPLETED|Overall Study||2
6679300|NCT02649608|7610885|FG006|COMPLETED|Overall Study||1
6679301|NCT02649608|7610879|FG000|NOT COMPLETED|Overall Study||0
6679302|NCT02649608|7610880|FG001|NOT COMPLETED|Overall Study||0
6679303|NCT02649608|7610881|FG002|NOT COMPLETED|Overall Study||0
6679304|NCT02649608|7610882|FG003|NOT COMPLETED|Overall Study||0
6679305|NCT02649608|7610883|FG004|NOT COMPLETED|Overall Study||0
6679306|NCT02649608|7610884|FG005|NOT COMPLETED|Overall Study||0
6679307|NCT02649608|7610885|FG006|NOT COMPLETED|Overall Study||0
6679308|NCT02649634|7610916|FG000|STARTED|Overall Study||69
6679309|NCT02649634|7610917|FG001|STARTED|Overall Study||66
6679310|NCT02649634|7610916|FG000|COMPLETED|Overall Study||66
6679311|NCT02649634|7610917|FG001|COMPLETED|Overall Study||60
6679312|NCT02649634|7610916|FG000|NOT COMPLETED|Overall Study||3
6679313|NCT02649634|7610917|FG001|NOT COMPLETED|Overall Study||6
6679314|NCT02649842|7610923|FG000|STARTED|Overall Study||101
6679315|NCT02649842|7610923|FG000|COMPLETED|Overall Study||101
6679316|NCT02649842|7610923|FG000|NOT COMPLETED|Overall Study||0
6679317|NCT02649894|7610931|FG000|STARTED|Overall Study||81
6679318|NCT02649894|7610932|FG001|STARTED|Overall Study||38
6679319|NCT02649894|7610931|FG000|Device Inserted|Overall Study||77
6679320|NCT02649894|7610932|FG001|Device Inserted|Overall Study||37
6679321|NCT02649894|7610931|FG000|Completed Day 30|Overall Study||56
6679322|NCT02649894|7610932|FG001|Completed Day 30|Overall Study||35
6679323|NCT02649894|7610931|FG000|COMPLETED|Overall Study||37
6679324|NCT02649894|7610932|FG001|COMPLETED|Overall Study||27
6679325|NCT02649894|7610931|FG000|NOT COMPLETED|Overall Study||44
6679326|NCT02649894|7610932|FG001|NOT COMPLETED|Overall Study||11
6679327|NCT02650128|7610938|FG000|STARTED|Overall Study||60
6679328|NCT02650128|7610938|FG000|30 Day Primary and Safety Endpoint|Overall Study||60
6679329|NCT02650128|7610938|FG000|COMPLETED|Overall Study||58
6679330|NCT02650128|7610938|FG000|NOT COMPLETED|Overall Study||2
6679331|NCT02650193|7610946|FG000|STARTED|Overall Study||6
6679332|NCT02650193|7610947|FG001|STARTED|Overall Study||6
6679333|NCT02650193|7610948|FG002|STARTED|Overall Study||13
6679334|NCT02650193|7610946|FG000|COMPLETED|Overall Study||6
6679335|NCT02650193|7610947|FG001|COMPLETED|Overall Study||6
6679336|NCT02650193|7610948|FG002|COMPLETED|Overall Study||13
6679337|NCT02650193|7610946|FG000|NOT COMPLETED|Overall Study||0
6679338|NCT02650193|7610947|FG001|NOT COMPLETED|Overall Study||0
6679339|NCT02650193|7610948|FG002|NOT COMPLETED|Overall Study||0
6679340|NCT02650219|7610959|FG000|STARTED|Overall Study||40
6679341|NCT02650219|7610960|FG001|STARTED|Overall Study||20
6679342|NCT02650219|7610959|FG000|COMPLETED|Overall Study||40
6679343|NCT02650219|7610960|FG001|COMPLETED|Overall Study||20
6679344|NCT02650219|7610959|FG000|NOT COMPLETED|Overall Study||0
6679345|NCT02650219|7610960|FG001|NOT COMPLETED|Overall Study||0
6679346|NCT02650284|7610968|FG000|STARTED|Overall Study||8
6679347|NCT02650284|7610969|FG001|STARTED|Overall Study||9
6679348|NCT02650284|7610968|FG000|COMPLETED|Overall Study||5
6679349|NCT02650284|7610969|FG001|COMPLETED|Overall Study||5
6679350|NCT02650284|7610968|FG000|NOT COMPLETED|Overall Study||3
6679351|NCT02650284|7610969|FG001|NOT COMPLETED|Overall Study||4
6679352|NCT02650440|7610977|FG000|STARTED|Overall Study||10
6679353|NCT02650440|7610978|FG001|STARTED|Overall Study||10
6679354|NCT02650440|7610977|FG000|COMPLETED|Overall Study||10
6679355|NCT02650440|7610978|FG001|COMPLETED|Overall Study||8
6679356|NCT02650440|7610977|FG000|NOT COMPLETED|Overall Study||0
6679357|NCT02650440|7610978|FG001|NOT COMPLETED|Overall Study||2
6679358|NCT02650466|7610984|FG000|STARTED|Overall Study||24
6679359|NCT02650466|7610984|FG000|COMPLETED|Overall Study||17
6679360|NCT02650466|7610984|FG000|NOT COMPLETED|Overall Study||7
6679361|NCT02650856|7610992|FG000|STARTED|Overall Study||19
6679362|NCT02650856|7610993|FG001|STARTED|Overall Study||21
6679363|NCT02650856|7610992|FG000|Baseline|Overall Study||19
6679364|NCT02650856|7610993|FG001|Baseline|Overall Study||21
6679365|NCT02650856|7610992|FG000|24 Hours|Overall Study||19
6679366|NCT02650856|7610993|FG001|24 Hours|Overall Study||21
6679367|NCT02650856|7610992|FG000|48 Hours|Overall Study||19
6679368|NCT02650856|7610993|FG001|48 Hours|Overall Study||21
6679369|NCT02650856|7610992|FG000|72 Hours|Overall Study||19
6679370|NCT02650856|7610993|FG001|72 Hours|Overall Study||21
6679371|NCT02650856|7610992|FG000|COMPLETED|Overall Study||19
6679372|NCT02650856|7610993|FG001|COMPLETED|Overall Study||21
6679373|NCT02650856|7610992|FG000|NOT COMPLETED|Overall Study||0
6679374|NCT02650856|7610993|FG001|NOT COMPLETED|Overall Study||0
6679375|NCT02650895|7611005|FG000|STARTED|Overall Study||10
6679376|NCT02650895|7611006|FG001|STARTED|Overall Study||6
6679377|NCT02650895|7611007|FG002|STARTED|Overall Study||6
6679378|NCT02650895|7611008|FG003|STARTED|Overall Study||6
6679379|NCT02650895|7611009|FG004|STARTED|Overall Study||6
6679380|NCT02650895|7611010|FG005|STARTED|Overall Study||6
6679381|NCT02650895|7611005|FG000|COMPLETED|Overall Study||10
6679382|NCT02650895|7611006|FG001|COMPLETED|Overall Study||5
6679383|NCT02650895|7611007|FG002|COMPLETED|Overall Study||6
6679384|NCT02650895|7611008|FG003|COMPLETED|Overall Study||6
6679385|NCT02650895|7611009|FG004|COMPLETED|Overall Study||6
6679386|NCT02650895|7611010|FG005|COMPLETED|Overall Study||6
6679387|NCT02650895|7611005|FG000|NOT COMPLETED|Overall Study||0
6679388|NCT02650895|7611006|FG001|NOT COMPLETED|Overall Study||1
6679389|NCT02650895|7611007|FG002|NOT COMPLETED|Overall Study||0
6679390|NCT02650895|7611008|FG003|NOT COMPLETED|Overall Study||0
6679391|NCT02650895|7611009|FG004|NOT COMPLETED|Overall Study||0
6679392|NCT02650895|7611010|FG005|NOT COMPLETED|Overall Study||0
6679393|NCT02650921|7611029|FG000|STARTED|Overall Study||92
6679394|NCT02650921|7611029|FG000|COMPLETED|Overall Study||84
6679395|NCT02650921|7611029|FG000|NOT COMPLETED|Overall Study||8
6679396|NCT02650999|7611035|FG000|STARTED|Overall Study||12
6679397|NCT02650999|7611035|FG000|COMPLETED|Overall Study||12
6679398|NCT02650999|7611035|FG000|NOT COMPLETED|Overall Study||0
6679399|NCT02651103|7611039|FG000|STARTED|Overall Study||30
6679400|NCT02651103|7611039|FG000|COMPLETED|Overall Study||30
6679401|NCT02651103|7611039|FG000|NOT COMPLETED|Overall Study||0
6738386|NCT03284229|7667747|FG000|STARTED|Overall Study||28
6738387|NCT03284229|7667747|FG000|COMPLETED|Overall Study||25
6738388|NCT03284229|7667747|FG000|NOT COMPLETED|Overall Study||3
6738389|NCT03284359|7667754|FG000|STARTED|Overall Study||93
6738390|NCT03284359|7667755|FG001|STARTED|Overall Study||89
6738391|NCT03284359|7667754|FG000|COMPLETED|Overall Study||93
6738392|NCT03284359|7667755|FG001|COMPLETED|Overall Study||89
6738393|NCT03284359|7667754|FG000|NOT COMPLETED|Overall Study||0
6738394|NCT03284359|7667755|FG001|NOT COMPLETED|Overall Study||0
6679402|NCT02651116|7611045|FG000|STARTED|Overall Study||68
6679403|NCT02651116|7611046|FG001|STARTED|Overall Study||63
6679404|NCT02651116|7611045|FG000|Treated|Overall Study||68
6679405|NCT02651116|7611046|FG001|Treated|Overall Study||63
6679406|NCT02651116|7611045|FG000|COMPLETED|Overall Study||67
6679407|NCT02651116|7611046|FG001|COMPLETED|Overall Study||62
6679408|NCT02651116|7611045|FG000|NOT COMPLETED|Overall Study||1
6679409|NCT02651116|7611046|FG001|NOT COMPLETED|Overall Study||1
6679410|NCT02651155|7611054|FG000|STARTED|Overall Study||99
6679411|NCT02651155|7611055|FG001|STARTED|Overall Study||105
6679412|NCT02651155|7611054|FG000|COMPLETED|Overall Study||93
6679413|NCT02651155|7611055|FG001|COMPLETED|Overall Study||103
6679414|NCT02651155|7611054|FG000|NOT COMPLETED|Overall Study||6
6679415|NCT02651155|7611055|FG001|NOT COMPLETED|Overall Study||2
6679416|NCT02651194|7611061|FG000|STARTED|Overall Study||104
6679417|NCT02651194|7611061|FG000|COMPLETED|Overall Study||99
6679418|NCT02651194|7611061|FG000|NOT COMPLETED|Overall Study||5
6679419|NCT02651220|7611068|FG000|STARTED|Overall Study||337
6679420|NCT02651220|7611069|FG001|STARTED|Overall Study||335
6679421|NCT02651220|7611070|FG002|STARTED|Overall Study||329
6679422|NCT02651220|7611068|FG000|COMPLETED|Overall Study||314
6679423|NCT02651220|7611069|FG001|COMPLETED|Overall Study||308
6679424|NCT02651220|7611070|FG002|COMPLETED|Overall Study||300
6679425|NCT02651220|7611068|FG000|NOT COMPLETED|Overall Study||23
6679426|NCT02651220|7611069|FG001|NOT COMPLETED|Overall Study||27
6679427|NCT02651220|7611070|FG002|NOT COMPLETED|Overall Study||29
6679428|NCT02651259|7611080|FG000|STARTED|Overall Study||25
6679429|NCT02651259|7611081|FG001|STARTED|Overall Study||25
6679430|NCT02651259|7611080|FG000|COMPLETED|Overall Study||25
6679431|NCT02651259|7611081|FG001|COMPLETED|Overall Study||25
6679432|NCT02651259|7611080|FG000|NOT COMPLETED|Overall Study||0
6679433|NCT02651259|7611081|FG001|NOT COMPLETED|Overall Study||0
6679434|NCT02651272|7611095|FG000|STARTED|Overall Study||4
6679435|NCT02651272|7611095|FG000|COMPLETED|Overall Study||1
6679436|NCT02651272|7611095|FG000|NOT COMPLETED|Overall Study||3
6679437|NCT02651337|7611099|FG000|STARTED|Overall Study||5
6679438|NCT02651337|7611099|FG000|COMPLETED|Overall Study||4
6679439|NCT02651337|7611099|FG000|NOT COMPLETED|Overall Study||1
6679440|NCT02651415|7611103|FG000|STARTED|Overall Study|12 patients were enrolled.|12
6679441|NCT02651415|7611103|FG000|COMPLETED|Overall Study|10 patients were evaluable.|10
6679442|NCT02651415|7611103|FG000|NOT COMPLETED|Overall Study||2
6679443|NCT02651428|7611109|FG000|STARTED|Overall Study||403
6679444|NCT02651428|7611110|FG001|STARTED|Overall Study||403
6679445|NCT02651428|7611109|FG000|COMPLETED|Overall Study||359
6679446|NCT02651428|7611110|FG001|COMPLETED|Overall Study||359
6679447|NCT02651428|7611109|FG000|NOT COMPLETED|Overall Study||44
6679448|NCT02651428|7611110|FG001|NOT COMPLETED|Overall Study||44
6679449|NCT02651467|7611119|FG000|STARTED|Overall Study||74
6679450|NCT02651467|7611120|FG001|STARTED|Overall Study||74
6679451|NCT02651467|7611121|FG002|STARTED|Overall Study||73
6679452|NCT02651467|7611119|FG000|COMPLETED|Overall Study||73
6679453|NCT02651467|7611120|FG001|COMPLETED|Overall Study||74
6679454|NCT02651467|7611121|FG002|COMPLETED|Overall Study||69
6679455|NCT02651467|7611119|FG000|NOT COMPLETED|Overall Study||1
6679456|NCT02651467|7611120|FG001|NOT COMPLETED|Overall Study||0
6679457|NCT02651467|7611121|FG002|NOT COMPLETED|Overall Study||4
6679458|NCT02651545|7611132|FG000|STARTED|Overall Study||30
6679459|NCT02651545|7611133|FG001|STARTED|Overall Study||30
6679460|NCT02651545|7611132|FG000|COMPLETED|Overall Study||7
6679461|NCT02651545|7611133|FG001|COMPLETED|Overall Study||17
6679462|NCT02651545|7611132|FG000|NOT COMPLETED|Overall Study||23
6679463|NCT02651545|7611133|FG001|NOT COMPLETED|Overall Study||13
6679464|NCT02651584|7611141|FG000|STARTED|Overall Study||215
6679465|NCT02651584|7611142|FG001|STARTED|Overall Study||213
6679466|NCT02651584|7611141|FG000|COMPLETED|Overall Study||126
6679467|NCT02651584|7611142|FG001|COMPLETED|Overall Study||121
6679468|NCT02651584|7611141|FG000|NOT COMPLETED|Overall Study||89
6679469|NCT02651584|7611142|FG001|NOT COMPLETED|Overall Study||92
6679470|NCT02651688|7611154|FG000|STARTED|Overall Study||18
6679471|NCT02651688|7611155|FG001|STARTED|Overall Study||17
6679472|NCT02651688|7611156|FG002|STARTED|Overall Study||15
6679473|NCT02651688|7611154|FG000|COMPLETED|Overall Study||16
6679474|NCT02651688|7611155|FG001|COMPLETED|Overall Study||12
6679475|NCT02651688|7611156|FG002|COMPLETED|Overall Study||12
6679476|NCT02651688|7611154|FG000|NOT COMPLETED|Overall Study||2
6679477|NCT02651688|7611155|FG001|NOT COMPLETED|Overall Study||5
6679478|NCT02651688|7611156|FG002|NOT COMPLETED|Overall Study||3
6679479|NCT02651922|7611164|FG000|STARTED|Overall Study||156
6679480|NCT02651922|7611164|FG000|COMPLETED|Overall Study||154
6679481|NCT02651922|7611164|FG000|NOT COMPLETED|Overall Study||2
6679482|NCT02651987|7611170|FG000|STARTED|Overall Study||48
6679483|NCT02651987|7611171|FG001|STARTED|Overall Study||51
6679484|NCT02651987|7611170|FG000|COMPLETED|Overall Study||43
6679485|NCT02651987|7611171|FG001|COMPLETED|Overall Study||46
6679486|NCT02651987|7611170|FG000|NOT COMPLETED|Overall Study||5
6679487|NCT02651987|7611171|FG001|NOT COMPLETED|Overall Study||5
6679488|NCT02652156|7611183|FG000|STARTED|Overall Study||4
6679489|NCT02652156|7611184|FG001|STARTED|Overall Study||6
6679490|NCT02652156|7611185|FG002|STARTED|Overall Study||4
6679491|NCT02652156|7611183|FG000|COMPLETED|Overall Study||3
6679492|NCT02652156|7611184|FG001|COMPLETED|Overall Study||6
6679493|NCT02652156|7611185|FG002|COMPLETED|Overall Study||4
6679494|NCT02652156|7611183|FG000|NOT COMPLETED|Overall Study||1
6679495|NCT02652156|7611184|FG001|NOT COMPLETED|Overall Study||0
6679496|NCT02652156|7611185|FG002|NOT COMPLETED|Overall Study||0
6679497|NCT02652208|7611195|FG000|STARTED|Overall Study||17
6679498|NCT02652208|7611196|FG001|STARTED|Overall Study||17
6679499|NCT02652208|7611195|FG000|COMPLETED|Overall Study||13
6679500|NCT02652208|7611196|FG001|COMPLETED|Overall Study||15
6679501|NCT02652208|7611195|FG000|NOT COMPLETED|Overall Study||4
6679502|NCT02652208|7611196|FG001|NOT COMPLETED|Overall Study||2
6679503|NCT02652221|7611202|FG000|STARTED|Overall Study||55
6679504|NCT02652221|7611202|FG000|COMPLETED|Overall Study||55
6679505|NCT02652221|7611202|FG000|NOT COMPLETED|Overall Study||0
6679506|NCT02652260|7611209|FG000|STARTED|Overall Study||43
6679507|NCT02652260|7611210|FG001|STARTED|Overall Study||43
6679508|NCT02652260|7611209|FG000|COMPLETED|Overall Study||43
6679509|NCT02652260|7611210|FG001|COMPLETED|Overall Study||41
6679510|NCT02652260|7611209|FG000|NOT COMPLETED|Overall Study||0
6679511|NCT02652260|7611210|FG001|NOT COMPLETED|Overall Study||2
6679512|NCT02652390|7611222|FG000|STARTED|Overall Study||37
6679513|NCT02652390|7611223|FG001|STARTED|Overall Study||37
6679514|NCT02652390|7611224|FG002|STARTED|Overall Study||37
6679515|NCT02652390|7611222|FG000|COMPLETED|Overall Study||37
6679516|NCT02652390|7611223|FG001|COMPLETED|Overall Study||37
6679517|NCT02652390|7611224|FG002|COMPLETED|Overall Study||37
6679518|NCT02652390|7611222|FG000|NOT COMPLETED|Overall Study||0
6679519|NCT02652390|7611223|FG001|NOT COMPLETED|Overall Study||0
6679520|NCT02652390|7611224|FG002|NOT COMPLETED|Overall Study||0
6679521|NCT02652416|7611238|FG000|STARTED|Overall Study||18
6679522|NCT02652416|7611239|FG001|STARTED|Overall Study||18
6679523|NCT02652416|7611240|FG002|STARTED|Overall Study||18
6679524|NCT02652416|7611241|FG003|STARTED|Overall Study||18
6679525|NCT02652416|7611238|FG000|Subjects Who Participated in MD Part|Overall Study||6
6679526|NCT02652416|7611239|FG001|Subjects Who Participated in MD Part|Overall Study||0
6679527|NCT02652416|7611240|FG002|Subjects Who Participated in MD Part|Overall Study||0
6679528|NCT02652416|7611241|FG003|Subjects Who Participated in MD Part|Overall Study||18
6679529|NCT02652416|7611238|FG000|COMPLETED|Overall Study||18
6679530|NCT02652416|7611239|FG001|COMPLETED|Overall Study||18
6679531|NCT02652416|7611240|FG002|COMPLETED|Overall Study||18
6679532|NCT02652416|7611241|FG003|COMPLETED|Overall Study||18
6679533|NCT02652416|7611238|FG000|NOT COMPLETED|Overall Study||0
6679534|NCT02652416|7611239|FG001|NOT COMPLETED|Overall Study||0
6679535|NCT02652416|7611240|FG002|NOT COMPLETED|Overall Study||0
6679536|NCT02652416|7611241|FG003|NOT COMPLETED|Overall Study||0
6679537|NCT02652442|7611255|FG000|STARTED|Centrifugation - Distance||6
6679538|NCT02652442|7611255|FG000|COMPLETED|Centrifugation - Distance||5
6679539|NCT02652442|7611255|FG000|NOT COMPLETED|Centrifugation - Distance||1
6679540|NCT02652442|7611255|FG000|STARTED|Centrifugation - Duration||5
6679541|NCT02652442|7611255|FG000|COMPLETED|Centrifugation - Duration||5
6679542|NCT02652442|7611255|FG000|NOT COMPLETED|Centrifugation - Duration||0
6679543|NCT02652442|7611255|FG000|STARTED|Centrifugation - Schedule||5
6679544|NCT02652442|7611255|FG000|COMPLETED|Centrifugation - Schedule||5
6679545|NCT02652442|7611255|FG000|NOT COMPLETED|Centrifugation - Schedule||0
6679546|NCT02652481|7611267|FG000|STARTED|Phase 1||239
6679547|NCT02652481|7611267|FG000|COMPLETED|Phase 1||141
6679548|NCT02652481|7611267|FG000|NOT COMPLETED|Phase 1||98
6679549|NCT02652481|7611267|FG000|STARTED|Phase 2||261
6679550|NCT02652481|7611267|FG000|COMPLETED|Phase 2||243
6679551|NCT02652481|7611267|FG000|NOT COMPLETED|Phase 2||18
6679552|NCT02652624|7611273|FG000|STARTED|Randomized Phase||234
6679553|NCT02652624|7611274|FG001|STARTED|Randomized Phase||236
6679554|NCT02652624|7611273|FG000|COMPLETED|Randomized Phase||231
6679555|NCT02652624|7611274|FG001|COMPLETED|Randomized Phase||231
6679556|NCT02652624|7611273|FG000|NOT COMPLETED|Randomized Phase||3
6679557|NCT02652624|7611274|FG001|NOT COMPLETED|Randomized Phase||5
6679558|NCT02652624|7611273|FG000|STARTED|Extension Phase||231
6679559|NCT02652624|7611274|FG001|STARTED|Extension Phase|3 participants completed the Randomized Phase, but did not enter the Extension Phase.|228
6679560|NCT02652624|7611273|FG000|COMPLETED|Extension Phase||227
6679561|NCT02652624|7611274|FG001|COMPLETED|Extension Phase||224
6679562|NCT02652624|7611273|FG000|NOT COMPLETED|Extension Phase||4
6679563|NCT02652624|7611274|FG001|NOT COMPLETED|Extension Phase||4
6679564|NCT02652767|7611282|FG000|STARTED|Overall Study||39
6679565|NCT02652767|7611282|FG000|Completed Week 48|Overall Study||38
6679566|NCT02652767|7611282|FG000|COMPLETED|Overall Study||35
6679567|NCT02652767|7611282|FG000|NOT COMPLETED|Overall Study||4
6679568|NCT02652780|7611288|FG000|STARTED|Overall Study||37
6679569|NCT02652780|7611288|FG000|COMPLETED|Overall Study||37
6679570|NCT02652780|7611288|FG000|NOT COMPLETED|Overall Study||0
6679571|NCT02653144|7611298|FG000|STARTED|Overall Study||30
6679572|NCT02653144|7611299|FG001|STARTED|Overall Study||28
6679573|NCT02653144|7611300|FG002|STARTED|Overall Study||31
6679574|NCT02653144|7611298|FG000|COMPLETED|Overall Study||30
6679575|NCT02653144|7611299|FG001|COMPLETED|Overall Study||28
6679576|NCT02653144|7611300|FG002|COMPLETED|Overall Study||31
6679577|NCT02653144|7611298|FG000|NOT COMPLETED|Overall Study||0
6679578|NCT02653144|7611299|FG001|NOT COMPLETED|Overall Study||0
6679579|NCT02653144|7611300|FG002|NOT COMPLETED|Overall Study||0
6679580|NCT02653170|7611311|FG000|STARTED|Overall Study||87
6679581|NCT02653170|7611312|FG001|STARTED|Overall Study||88
6679582|NCT02653170|7611313|FG002|STARTED|Overall Study||90
6679583|NCT02653170|7611311|FG000|COMPLETED|Overall Study||70
6679584|NCT02653170|7611312|FG001|COMPLETED|Overall Study||72
6679585|NCT02653170|7611313|FG002|COMPLETED|Overall Study||72
6679586|NCT02653170|7611311|FG000|NOT COMPLETED|Overall Study||17
6679587|NCT02653170|7611312|FG001|NOT COMPLETED|Overall Study||16
6679588|NCT02653170|7611313|FG002|NOT COMPLETED|Overall Study||18
6679589|NCT02653183|7611323|FG000|STARTED|Overall Study||53
6679590|NCT02653183|7611324|FG001|STARTED|Overall Study||50
6679591|NCT02653183|7611323|FG000|COMPLETED|Overall Study||49
6679592|NCT02653183|7611324|FG001|COMPLETED|Overall Study||46
6679593|NCT02653183|7611323|FG000|NOT COMPLETED|Overall Study||4
6679594|NCT02653183|7611324|FG001|NOT COMPLETED|Overall Study||4
6679595|NCT02653300|7611330|FG000|STARTED|Overall Study||10
6679596|NCT02653300|7611330|FG000|COMPLETED|Overall Study||8
6679597|NCT02653300|7611330|FG000|NOT COMPLETED|Overall Study||2
6679598|NCT02653326|7611336|FG000|STARTED|Overall Study||32
6679599|NCT02653326|7611337|FG001|STARTED|Overall Study||34
6679600|NCT02653326|7611336|FG000|COMPLETED|Overall Study||22
6679601|NCT02653326|7611337|FG001|COMPLETED|Overall Study||27
6679602|NCT02653326|7611336|FG000|NOT COMPLETED|Overall Study||10
6679603|NCT02653326|7611337|FG001|NOT COMPLETED|Overall Study||7
6679604|NCT02653391|7611346|FG000|STARTED|Overall Study||18
6679605|NCT02653391|7611347|FG001|STARTED|Overall Study||3
6679606|NCT02653391|7611348|FG002|STARTED|Overall Study||1
6679607|NCT02653391|7611346|FG000|COMPLETED|Overall Study||16
6679608|NCT02653391|7611347|FG001|COMPLETED|Overall Study||1
6679609|NCT02653391|7611348|FG002|COMPLETED|Overall Study||1
6679610|NCT02653391|7611346|FG000|NOT COMPLETED|Overall Study||2
6679611|NCT02653391|7611347|FG001|NOT COMPLETED|Overall Study||2
6679612|NCT02653391|7611348|FG002|NOT COMPLETED|Overall Study||0
6679613|NCT02653417|7611396|FG000|STARTED|Overall Study||38
6679614|NCT02653417|7611397|FG001|STARTED|Overall Study||34
6679615|NCT02653417|7611398|FG002|STARTED|Overall Study||29
6679616|NCT02653417|7611399|FG003|STARTED|Overall Study||38
6679617|NCT02653417|7611396|FG000|COMPLETED|Overall Study||37
6679618|NCT02653417|7611397|FG001|COMPLETED|Overall Study||32
6679619|NCT02653417|7611398|FG002|COMPLETED|Overall Study||26
6679620|NCT02653417|7611399|FG003|COMPLETED|Overall Study||33
6679621|NCT02653417|7611396|FG000|NOT COMPLETED|Overall Study||1
6679622|NCT02653417|7611397|FG001|NOT COMPLETED|Overall Study||2
6679623|NCT02653417|7611398|FG002|NOT COMPLETED|Overall Study||3
6679624|NCT02653417|7611399|FG003|NOT COMPLETED|Overall Study||5
6679625|NCT02653456|7611413|FG000|STARTED|Overall Study||64
6679626|NCT02653456|7611413|FG000|COMPLETED|Overall Study||59
6679627|NCT02653456|7611413|FG000|NOT COMPLETED|Overall Study||5
6679628|NCT02653560|7611418|FG000|STARTED|KMgCit Phase||30
6679629|NCT02653560|7611419|FG001|STARTED|KMgCit Phase||0
6679630|NCT02653560|7611420|FG002|STARTED|KMgCit Phase||0
6679631|NCT02653560|7611421|FG003|STARTED|KMgCit Phase||0
6679632|NCT02653560|7611418|FG000|COMPLETED|KMgCit Phase||30
6679633|NCT02653560|7611419|FG001|COMPLETED|KMgCit Phase||0
6679634|NCT02653560|7611420|FG002|COMPLETED|KMgCit Phase||0
6679635|NCT02653560|7611421|FG003|COMPLETED|KMgCit Phase||0
6679636|NCT02653560|7611418|FG000|NOT COMPLETED|KMgCit Phase||0
6679637|NCT02653560|7611419|FG001|NOT COMPLETED|KMgCit Phase||0
6679638|NCT02653560|7611420|FG002|NOT COMPLETED|KMgCit Phase||0
6679639|NCT02653560|7611421|FG003|NOT COMPLETED|KMgCit Phase||0
6679640|NCT02653560|7611418|FG000|STARTED|K Citrate Phase||0
6679641|NCT02653560|7611419|FG001|STARTED|K Citrate Phase||30
6679642|NCT02653560|7611420|FG002|STARTED|K Citrate Phase||0
6679643|NCT02653560|7611421|FG003|STARTED|K Citrate Phase||0
6679644|NCT02653560|7611418|FG000|COMPLETED|K Citrate Phase||0
6679645|NCT02653560|7611419|FG001|COMPLETED|K Citrate Phase||30
6679646|NCT02653560|7611420|FG002|COMPLETED|K Citrate Phase||0
6679647|NCT02653560|7611421|FG003|COMPLETED|K Citrate Phase||0
6679648|NCT02653560|7611418|FG000|NOT COMPLETED|K Citrate Phase||0
6679649|NCT02653560|7611419|FG001|NOT COMPLETED|K Citrate Phase||0
6679650|NCT02653560|7611420|FG002|NOT COMPLETED|K Citrate Phase||0
6679651|NCT02653560|7611421|FG003|NOT COMPLETED|K Citrate Phase||0
6679652|NCT02653560|7611418|FG000|STARTED|KCl Phase||0
6679653|NCT02653560|7611419|FG001|STARTED|KCl Phase||0
6679654|NCT02653560|7611420|FG002|STARTED|KCl Phase||30
6679655|NCT02653560|7611421|FG003|STARTED|KCl Phase||0
6679656|NCT02653560|7611418|FG000|COMPLETED|KCl Phase||0
6679657|NCT02653560|7611419|FG001|COMPLETED|KCl Phase||0
6679658|NCT02653560|7611420|FG002|COMPLETED|KCl Phase||30
6679659|NCT02653560|7611421|FG003|COMPLETED|KCl Phase||0
6679660|NCT02653560|7611418|FG000|NOT COMPLETED|KCl Phase||0
6679661|NCT02653560|7611419|FG001|NOT COMPLETED|KCl Phase||0
6679662|NCT02653560|7611420|FG002|NOT COMPLETED|KCl Phase||0
6679663|NCT02653560|7611421|FG003|NOT COMPLETED|KCl Phase||0
6679664|NCT02653560|7611418|FG000|STARTED|Placebo Phase||0
6679665|NCT02653560|7611419|FG001|STARTED|Placebo Phase||0
6679666|NCT02653560|7611420|FG002|STARTED|Placebo Phase||0
6679667|NCT02653560|7611421|FG003|STARTED|Placebo Phase||30
6679668|NCT02653560|7611418|FG000|COMPLETED|Placebo Phase||0
6679669|NCT02653560|7611419|FG001|COMPLETED|Placebo Phase||0
6679670|NCT02653560|7611420|FG002|COMPLETED|Placebo Phase||0
6679671|NCT02653560|7611421|FG003|COMPLETED|Placebo Phase||30
6679672|NCT02653560|7611418|FG000|NOT COMPLETED|Placebo Phase||0
6679673|NCT02653560|7611419|FG001|NOT COMPLETED|Placebo Phase||0
6679674|NCT02653560|7611420|FG002|NOT COMPLETED|Placebo Phase||0
6679675|NCT02653560|7611421|FG003|NOT COMPLETED|Placebo Phase||0
6679676|NCT02653625|7611431|FG000|STARTED|Overall Study||24
6679677|NCT02653625|7611431|FG000|COMPLETED|Overall Study||20
6679678|NCT02653625|7611431|FG000|NOT COMPLETED|Overall Study||4
6679679|NCT02653664|7611438|FG000|STARTED|Post-Treatment||110
6679680|NCT02653664|7611439|FG001|STARTED|Post-Treatment||110
6679681|NCT02653664|7611440|FG002|STARTED|Post-Treatment||108
6679682|NCT02653664|7611438|FG000|Primary and Secondary Data|Post-Treatment||93
6679683|NCT02653664|7611439|FG001|Primary and Secondary Data|Post-Treatment||104
6679684|NCT02653664|7611440|FG002|Primary and Secondary Data|Post-Treatment||91
6679685|NCT02653664|7611438|FG000|Primary Outcome Data Only|Post-Treatment||3
6679686|NCT02653664|7611439|FG001|Primary Outcome Data Only|Post-Treatment||0
6679687|NCT02653664|7611440|FG002|Primary Outcome Data Only|Post-Treatment||3
6679688|NCT02653664|7611438|FG000|COMPLETED|Post-Treatment||96
6679689|NCT02653664|7611439|FG001|COMPLETED|Post-Treatment||104
6679690|NCT02653664|7611440|FG002|COMPLETED|Post-Treatment||94
6679691|NCT02653664|7611438|FG000|NOT COMPLETED|Post-Treatment||14
6679692|NCT02653664|7611439|FG001|NOT COMPLETED|Post-Treatment||6
6679693|NCT02653664|7611440|FG002|NOT COMPLETED|Post-Treatment||14
6679694|NCT02653664|7611438|FG000|STARTED|3 Month Follow-Up||110
6679695|NCT02653664|7611439|FG001|STARTED|3 Month Follow-Up||110
6679696|NCT02653664|7611440|FG002|STARTED|3 Month Follow-Up||108
6679697|NCT02653664|7611438|FG000|Primary and Secondary Data|3 Month Follow-Up||83
6679698|NCT02653664|7611439|FG001|Primary and Secondary Data|3 Month Follow-Up||95
6679699|NCT02653664|7611440|FG002|Primary and Secondary Data|3 Month Follow-Up||82
6679700|NCT02653664|7611438|FG000|Primary Outcome Data Only|3 Month Follow-Up||6
6679701|NCT02653664|7611439|FG001|Primary Outcome Data Only|3 Month Follow-Up||0
6679702|NCT02653664|7611440|FG002|Primary Outcome Data Only|3 Month Follow-Up||1
6679703|NCT02653664|7611438|FG000|COMPLETED|3 Month Follow-Up||89
6679704|NCT02653664|7611439|FG001|COMPLETED|3 Month Follow-Up||95
6679705|NCT02653664|7611440|FG002|COMPLETED|3 Month Follow-Up||83
6679706|NCT02653664|7611438|FG000|NOT COMPLETED|3 Month Follow-Up||21
6679707|NCT02653664|7611439|FG001|NOT COMPLETED|3 Month Follow-Up||15
6679708|NCT02653664|7611440|FG002|NOT COMPLETED|3 Month Follow-Up||25
6679709|NCT02653664|7611438|FG000|STARTED|6 Month Follow-Up||110
6679710|NCT02653664|7611439|FG001|STARTED|6 Month Follow-Up||110
6679711|NCT02653664|7611440|FG002|STARTED|6 Month Follow-Up||108
6679712|NCT02653664|7611438|FG000|Primary and Secondary Outcome Data|6 Month Follow-Up||85
6679713|NCT02653664|7611439|FG001|Primary and Secondary Outcome Data|6 Month Follow-Up||87
6679714|NCT02653664|7611440|FG002|Primary and Secondary Outcome Data|6 Month Follow-Up||83
6679715|NCT02653664|7611438|FG000|Primary Outcome Data Only|6 Month Follow-Up||2
6679716|NCT02653664|7611439|FG001|Primary Outcome Data Only|6 Month Follow-Up||2
6679717|NCT02653664|7611440|FG002|Primary Outcome Data Only|6 Month Follow-Up||2
6679718|NCT02653664|7611438|FG000|COMPLETED|6 Month Follow-Up||87
6679719|NCT02653664|7611439|FG001|COMPLETED|6 Month Follow-Up||89
6679720|NCT02653664|7611440|FG002|COMPLETED|6 Month Follow-Up||85
6679721|NCT02653664|7611438|FG000|NOT COMPLETED|6 Month Follow-Up||23
6679722|NCT02653664|7611439|FG001|NOT COMPLETED|6 Month Follow-Up||21
6679723|NCT02653664|7611440|FG002|NOT COMPLETED|6 Month Follow-Up||23
6679724|NCT02653768|7611453|FG000|STARTED|3-Month Follow-Up||230
6679725|NCT02653768|7611454|FG001|STARTED|3-Month Follow-Up||115
6679726|NCT02653768|7611453|FG000|COMPLETED|3-Month Follow-Up||164
6679727|NCT02653768|7611454|FG001|COMPLETED|3-Month Follow-Up||100
6679728|NCT02653768|7611453|FG000|NOT COMPLETED|3-Month Follow-Up||66
6679729|NCT02653768|7611454|FG001|NOT COMPLETED|3-Month Follow-Up||15
6679730|NCT02653768|7611453|FG000|STARTED|6-Month Follow-Up|21 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|209
6679731|NCT02653768|7611454|FG001|STARTED|6-Month Follow-Up|2 participants withdrew/excluded by 3-months, others missed that assessment but remained in study|113
6679732|NCT02653768|7611453|FG000|COMPLETED|6-Month Follow-Up||164
6679733|NCT02653768|7611454|FG001|COMPLETED|6-Month Follow-Up||100
6679734|NCT02653768|7611453|FG000|NOT COMPLETED|6-Month Follow-Up||45
6679735|NCT02653768|7611454|FG001|NOT COMPLETED|6-Month Follow-Up||13
6679736|NCT02653768|7611453|FG000|STARTED|9-Month Follow-Up (Primary)|34 withdrew/excluded before 9 months; others missed prior assessments but remained in study|196
6679737|NCT02653768|7611454|FG001|STARTED|9-Month Follow-Up (Primary)|4 withdrew/excluded before 9 months; others missed prior assessments but remained in study|111
6679738|NCT02653768|7611453|FG000|COMPLETED|9-Month Follow-Up (Primary)|13 withdrew/refused before 9 months; others missed prior assessments but remained in study|163
6679739|NCT02653768|7611454|FG001|COMPLETED|9-Month Follow-Up (Primary)||95
6679740|NCT02653768|7611453|FG000|NOT COMPLETED|9-Month Follow-Up (Primary)||33
6679741|NCT02653768|7611454|FG001|NOT COMPLETED|9-Month Follow-Up (Primary)||16
6679742|NCT02653872|7611460|FG000|STARTED|Overall Study||15
6679743|NCT02653872|7611460|FG000|Treatment Period 1:|Overall Study|Participants received single AZD7986 (25 mg).|15
6679744|NCT02653872|7611460|FG000|Treatment Period 2:|Overall Study|Participants received Verapamil (240 mg; extended release formulation) + AZD7986 (25 mg).|15
6679745|NCT02653872|7611460|FG000|Treatment Period 3:|Overall Study|Participants received: itraconazole 200 mg + AZD7986.|15
6679746|NCT02653872|7611460|FG000|COMPLETED|Overall Study||15
6679747|NCT02653872|7611460|FG000|NOT COMPLETED|Overall Study||0
6679748|NCT02654002|7611483|FG000|STARTED|Overall Study||12
6679749|NCT02654002|7611484|FG001|STARTED|Overall Study||12
6679750|NCT02654002|7611485|FG002|STARTED|Overall Study||12
6679751|NCT02654002|7611486|FG003|STARTED|Overall Study||12
6679752|NCT02654002|7611487|FG004|STARTED|Overall Study||12
6679753|NCT02654002|7611488|FG005|STARTED|Overall Study||12
6679754|NCT02654002|7611489|FG006|STARTED|Overall Study||12
6679755|NCT02654002|7611490|FG007|STARTED|Overall Study||12
6679756|NCT02654002|7611491|FG008|STARTED|Overall Study||24
6679757|NCT02654002|7611483|FG000|COMPLETED|Overall Study||12
6679758|NCT02654002|7611484|FG001|COMPLETED|Overall Study||12
6679759|NCT02654002|7611485|FG002|COMPLETED|Overall Study||12
6679760|NCT02654002|7611486|FG003|COMPLETED|Overall Study||12
6679761|NCT02654002|7611487|FG004|COMPLETED|Overall Study||12
6679762|NCT02654002|7611488|FG005|COMPLETED|Overall Study||11
6679763|NCT02654002|7611489|FG006|COMPLETED|Overall Study||11
6679764|NCT02654002|7611490|FG007|COMPLETED|Overall Study||11
6679765|NCT02654002|7611491|FG008|COMPLETED|Overall Study||24
6679766|NCT02654002|7611483|FG000|NOT COMPLETED|Overall Study||0
6679767|NCT02654002|7611484|FG001|NOT COMPLETED|Overall Study||0
6679768|NCT02654002|7611485|FG002|NOT COMPLETED|Overall Study||0
6679769|NCT02654002|7611486|FG003|NOT COMPLETED|Overall Study||0
6679770|NCT02654002|7611487|FG004|NOT COMPLETED|Overall Study||0
6679771|NCT02654002|7611488|FG005|NOT COMPLETED|Overall Study||1
6679772|NCT02654002|7611489|FG006|NOT COMPLETED|Overall Study||1
6679773|NCT02654002|7611490|FG007|NOT COMPLETED|Overall Study||1
6679774|NCT02654002|7611491|FG008|NOT COMPLETED|Overall Study||0
6679775|NCT02654054|7611529|FG000|STARTED|Treatment Period||102
6679776|NCT02654054|7611530|FG001|STARTED|Treatment Period||104
6679777|NCT02654054|7611531|FG002|STARTED|Treatment Period||207
6679778|NCT02654054|7611529|FG000|Randomized and Treated|Treatment Period||102
6679779|NCT02654054|7611530|FG001|Randomized and Treated|Treatment Period||104
6679780|NCT02654054|7611531|FG002|Randomized and Treated|Treatment Period||206
6679781|NCT02654054|7611529|FG000|COMPLETED|Treatment Period||83
6679782|NCT02654054|7611530|FG001|COMPLETED|Treatment Period||81
6679783|NCT02654054|7611531|FG002|COMPLETED|Treatment Period||164
6679784|NCT02654054|7611529|FG000|NOT COMPLETED|Treatment Period||19
6679785|NCT02654054|7611530|FG001|NOT COMPLETED|Treatment Period||23
6679786|NCT02654054|7611531|FG002|NOT COMPLETED|Treatment Period||43
6679787|NCT02654054|7611529|FG000|STARTED|Post-Treatment Follow-Up Period||25
6679788|NCT02654054|7611530|FG001|STARTED|Post-Treatment Follow-Up Period||32
6679789|NCT02654054|7611531|FG002|STARTED|Post-Treatment Follow-Up Period||59
6679790|NCT02654054|7611529|FG000|COMPLETED|Post-Treatment Follow-Up Period||17
6679791|NCT02654054|7611530|FG001|COMPLETED|Post-Treatment Follow-Up Period||24
6679792|NCT02654054|7611531|FG002|COMPLETED|Post-Treatment Follow-Up Period||29
6679793|NCT02654054|7611529|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||8
6679794|NCT02654054|7611530|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||8
6679795|NCT02654054|7611531|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||30
6679796|NCT02654145|7611540|FG000|STARTED|Overall Study||145
6679797|NCT02654145|7611540|FG000|COMPLETED|Overall Study||138
6679798|NCT02654145|7611540|FG000|NOT COMPLETED|Overall Study||7
6679799|NCT02654483|7611546|FG000|STARTED|Double-blind||7
6679800|NCT02654483|7611547|FG001|STARTED|Double-blind||7
6679801|NCT02654483|7611546|FG000|COMPLETED|Double-blind||7
6679802|NCT02654483|7611547|FG001|COMPLETED|Double-blind||7
6679803|NCT02654483|7611546|FG000|NOT COMPLETED|Double-blind||0
6679804|NCT02654483|7611547|FG001|NOT COMPLETED|Double-blind||0
6679805|NCT02654483|7611546|FG000|STARTED|Open-label|2 participants did not proceed to open-label arm|5
6679806|NCT02654483|7611547|FG001|STARTED|Open-label|4 participants did not continue to open-label arm|3
6679807|NCT02654483|7611546|FG000|COMPLETED|Open-label||5
6679808|NCT02654483|7611547|FG001|COMPLETED|Open-label||3
6679809|NCT02654483|7611546|FG000|NOT COMPLETED|Open-label||0
6679810|NCT02654483|7611547|FG001|NOT COMPLETED|Open-label||0
6679811|NCT02654652|7611561|FG000|STARTED|Overall Study||19
6679812|NCT02654652|7611562|FG001|STARTED|Overall Study||21
6679813|NCT02654652|7611561|FG000|COMPLETED|Overall Study||18
6679814|NCT02654652|7611562|FG001|COMPLETED|Overall Study||18
6679815|NCT02654652|7611561|FG000|NOT COMPLETED|Overall Study||1
6679816|NCT02654652|7611562|FG001|NOT COMPLETED|Overall Study||3
6679817|NCT02654691|7611568|FG000|STARTED|Overall Study||63
6679818|NCT02654691|7611568|FG000|COMPLETED|Overall Study||63
6679819|NCT02654691|7611568|FG000|NOT COMPLETED|Overall Study||0
6679820|NCT02654717|7611574|FG000|STARTED|Overall Study||56
6679821|NCT02654717|7611575|FG001|STARTED|Overall Study||55
6679822|NCT02654717|7611574|FG000|COMPLETED|Overall Study||50
6679823|NCT02654717|7611575|FG001|COMPLETED|Overall Study||50
6679824|NCT02654717|7611574|FG000|NOT COMPLETED|Overall Study||6
6679825|NCT02654717|7611575|FG001|NOT COMPLETED|Overall Study||5
6679826|NCT02654769|7611584|FG000|STARTED|Overall Study||149
6679827|NCT02654769|7611585|FG001|STARTED|Overall Study||149
6679828|NCT02654769|7611586|FG002|STARTED|Overall Study||143
6679829|NCT02654769|7611584|FG000|COMPLETED|Overall Study||145
6679830|NCT02654769|7611585|FG001|COMPLETED|Overall Study||148
6679831|NCT02654769|7611586|FG002|COMPLETED|Overall Study||142
6679832|NCT02654769|7611584|FG000|NOT COMPLETED|Overall Study||4
6679833|NCT02654769|7611585|FG001|NOT COMPLETED|Overall Study||1
6679834|NCT02654769|7611586|FG002|NOT COMPLETED|Overall Study||1
6679835|NCT02654808|7611598|FG000|STARTED|Overall Study||33
6679836|NCT02654808|7611599|FG001|STARTED|Overall Study||33
6679837|NCT02654808|7611600|FG002|STARTED|Overall Study||33
6679838|NCT02654808|7611601|FG003|STARTED|Overall Study||33
6679839|NCT02654808|7611598|FG000|COMPLETED|Overall Study||33
6679840|NCT02654808|7611599|FG001|COMPLETED|Overall Study||33
6679841|NCT02654808|7611600|FG002|COMPLETED|Overall Study||33
6679842|NCT02654808|7611601|FG003|COMPLETED|Overall Study||33
6679843|NCT02654808|7611598|FG000|NOT COMPLETED|Overall Study||0
6679844|NCT02654808|7611599|FG001|NOT COMPLETED|Overall Study||0
6679845|NCT02654808|7611600|FG002|NOT COMPLETED|Overall Study||0
6679846|NCT02654808|7611601|FG003|NOT COMPLETED|Overall Study||0
6679847|NCT02654860|7611619|FG000|STARTED|First Part||3
6679848|NCT02654860|7611620|FG001|STARTED|First Part||3
6679849|NCT02654860|7611621|FG002|STARTED|First Part||3
6679850|NCT02654860|7611622|FG003|STARTED|First Part||0
6679851|NCT02654860|7611619|FG000|COMPLETED|First Part||3
6679852|NCT02654860|7611620|FG001|COMPLETED|First Part||3
6679853|NCT02654860|7611621|FG002|COMPLETED|First Part||3
6679854|NCT02654860|7611622|FG003|COMPLETED|First Part||0
6679855|NCT02654860|7611619|FG000|NOT COMPLETED|First Part||0
6679856|NCT02654860|7611620|FG001|NOT COMPLETED|First Part||0
6679857|NCT02654860|7611621|FG002|NOT COMPLETED|First Part||0
6679858|NCT02654860|7611622|FG003|NOT COMPLETED|First Part||0
6679859|NCT02654860|7611619|FG000|STARTED|Second Part||15
6679860|NCT02654860|7611620|FG001|STARTED|Second Part||15
6679861|NCT02654860|7611621|FG002|STARTED|Second Part||15
6679862|NCT02654860|7611622|FG003|STARTED|Second Part||15
6679863|NCT02654860|7611619|FG000|COMPLETED|Second Part||15
6679864|NCT02654860|7611620|FG001|COMPLETED|Second Part||15
6679865|NCT02654860|7611621|FG002|COMPLETED|Second Part||15
6679866|NCT02654860|7611622|FG003|COMPLETED|Second Part||15
6679867|NCT02654860|7611619|FG000|NOT COMPLETED|Second Part||0
6679868|NCT02654860|7611620|FG001|NOT COMPLETED|Second Part||0
6679869|NCT02654860|7611621|FG002|NOT COMPLETED|Second Part||0
6679870|NCT02654860|7611622|FG003|NOT COMPLETED|Second Part||0
6679871|NCT02654977|7611632|FG000|STARTED|Overall Study||11
6679872|NCT02654977|7611632|FG000|COMPLETED|Overall Study||4
6679873|NCT02654977|7611632|FG000|NOT COMPLETED|Overall Study||7
6679874|NCT02655224|7611638|FG000|STARTED|Overall Study||33
6679875|NCT02655224|7611639|FG001|STARTED|Overall Study||32
6679876|NCT02655224|7611638|FG000|COMPLETED|Overall Study||32
6679877|NCT02655224|7611639|FG001|COMPLETED|Overall Study||31
6679878|NCT02655224|7611638|FG000|NOT COMPLETED|Overall Study||1
6679879|NCT02655224|7611639|FG001|NOT COMPLETED|Overall Study||1
6679880|NCT02655237|7611647|FG000|STARTED|Overall Study||139
6679881|NCT02655237|7611648|FG001|STARTED|Overall Study||142
6679882|NCT02655237|7611647|FG000|COMPLETED|Overall Study||122
6679883|NCT02655237|7611648|FG001|COMPLETED|Overall Study||131
6679884|NCT02655237|7611647|FG000|NOT COMPLETED|Overall Study||17
6679885|NCT02655237|7611648|FG001|NOT COMPLETED|Overall Study||11
6679886|NCT02655354|7611656|FG000|STARTED|Overall Study||265
6679887|NCT02655354|7611657|FG001|STARTED|Overall Study||370
6679888|NCT02655354|7611656|FG000|COMPLETED|Overall Study||188
6679889|NCT02655354|7611657|FG001|COMPLETED|Overall Study||289
6679890|NCT02655354|7611656|FG000|NOT COMPLETED|Overall Study||77
6679891|NCT02655354|7611657|FG001|NOT COMPLETED|Overall Study||81
6679892|NCT02655419|7611665|FG000|STARTED|Overall Study||17
6679893|NCT02655419|7611666|FG001|STARTED|Overall Study||23
6679894|NCT02655419|7611665|FG000|Treated|Overall Study||16
6679895|NCT02655419|7611666|FG001|Treated|Overall Study||18
6679896|NCT02655419|7611665|FG000|COMPLETED|Overall Study||12
6679897|NCT02655419|7611666|FG001|COMPLETED|Overall Study||16
6679898|NCT02655419|7611665|FG000|NOT COMPLETED|Overall Study||5
6679899|NCT02655419|7611666|FG001|NOT COMPLETED|Overall Study||7
6679900|NCT02655510|7611679|FG000|STARTED|Overall Study||6
6679901|NCT02655510|7611680|FG001|STARTED|Overall Study||6
6679902|NCT02655510|7611681|FG002|STARTED|Overall Study||6
6679903|NCT02655510|7611679|FG000|COMPLETED|Overall Study||6
6679904|NCT02655510|7611680|FG001|COMPLETED|Overall Study||6
6679905|NCT02655510|7611681|FG002|COMPLETED|Overall Study||6
6679906|NCT02655510|7611679|FG000|NOT COMPLETED|Overall Study||0
6679907|NCT02655510|7611680|FG001|NOT COMPLETED|Overall Study||0
6679908|NCT02655510|7611681|FG002|NOT COMPLETED|Overall Study||0
6679909|NCT02655653|7611691|FG000|STARTED|Overall Study||56
6679910|NCT02655653|7611692|FG001|STARTED|Overall Study||58
6679911|NCT02655653|7611691|FG000|COMPLETED|Overall Study||56
6679912|NCT02655653|7611692|FG001|COMPLETED|Overall Study||58
6679913|NCT02655653|7611691|FG000|NOT COMPLETED|Overall Study||0
6679914|NCT02655653|7611692|FG001|NOT COMPLETED|Overall Study||0
6679915|NCT02655666|7611704|FG000|STARTED|Overall Study||16
6679916|NCT02655666|7611704|FG000|COMPLETED|Overall Study||4
6679917|NCT02655666|7611704|FG000|NOT COMPLETED|Overall Study||12
6679918|NCT02655679|7611713|FG000|STARTED|Overall Study||21
6679919|NCT02655679|7611714|FG001|STARTED|Overall Study||19
6679920|NCT02655679|7611715|FG002|STARTED|Overall Study||20
6679921|NCT02655679|7611716|FG003|STARTED|Overall Study||24
6679922|NCT02655679|7611717|FG004|STARTED|Overall Study||20
6679923|NCT02655679|7611713|FG000|Received Study Drug (Safety Population)|Overall Study||20
6679924|NCT02655679|7611714|FG001|Received Study Drug (Safety Population)|Overall Study||19
6256320|NCT04929522|7155205|FG001|STARTED|Overall Study||40
6679925|NCT02655679|7611715|FG002|Received Study Drug (Safety Population)|Overall Study||20
6679926|NCT02655679|7611716|FG003|Received Study Drug (Safety Population)|Overall Study||24
6679927|NCT02655679|7611717|FG004|Received Study Drug (Safety Population)|Overall Study||20
6679928|NCT02655679|7611713|FG000|COMPLETED|Overall Study||18
6679929|NCT02655679|7611714|FG001|COMPLETED|Overall Study||16
6679930|NCT02655679|7611715|FG002|COMPLETED|Overall Study||19
6679931|NCT02655679|7611716|FG003|COMPLETED|Overall Study||20
6679932|NCT02655679|7611717|FG004|COMPLETED|Overall Study||19
6679933|NCT02655679|7611713|FG000|NOT COMPLETED|Overall Study||3
6679934|NCT02655679|7611714|FG001|NOT COMPLETED|Overall Study||3
6679935|NCT02655679|7611715|FG002|NOT COMPLETED|Overall Study||1
6679936|NCT02655679|7611716|FG003|NOT COMPLETED|Overall Study||4
6679937|NCT02655679|7611717|FG004|NOT COMPLETED|Overall Study||1
6679938|NCT02655887|7611730|FG000|STARTED|Overall Study|Intent to Treat (ITT) population.|170
6679939|NCT02655887|7611730|FG000|COMPLETED|Overall Study|Completed 12-month follow-up.|156
6256321|NCT04929522|7155206|FG002|STARTED|Overall Study||40
6256322|NCT04929522|7155207|FG003|STARTED|Overall Study||40
6256323|NCT04929522|7155204|FG000|COMPLETED|Overall Study||40
6256324|NCT04929522|7155205|FG001|COMPLETED|Overall Study||40
6256325|NCT04929522|7155206|FG002|COMPLETED|Overall Study||40
6679940|NCT02655887|7611730|FG000|NOT COMPLETED|Overall Study||14
6679941|NCT02656069|7611736|FG000|STARTED|First Intervention||44
6679942|NCT02656069|7611737|FG001|STARTED|First Intervention||36
6679943|NCT02656069|7611736|FG000|COMPLETED|First Intervention||44
6679944|NCT02656069|7611737|FG001|COMPLETED|First Intervention||36
6679945|NCT02656069|7611736|FG000|NOT COMPLETED|First Intervention||0
6679946|NCT02656069|7611737|FG001|NOT COMPLETED|First Intervention||0
6679947|NCT02656069|7611736|FG000|STARTED|Second Intervention||44
6679948|NCT02656069|7611737|FG001|STARTED|Second Intervention||36
6679949|NCT02656069|7611736|FG000|COMPLETED|Second Intervention||43
6679950|NCT02656069|7611737|FG001|COMPLETED|Second Intervention||35
6679951|NCT02656069|7611736|FG000|NOT COMPLETED|Second Intervention||1
6679952|NCT02656069|7611737|FG001|NOT COMPLETED|Second Intervention||1
6679953|NCT02656160|7611743|FG000|STARTED|First Study Night||7
6679954|NCT02656160|7611744|FG001|STARTED|First Study Night||6
6679955|NCT02656160|7611743|FG000|COMPLETED|First Study Night||7
6679956|NCT02656160|7611744|FG001|COMPLETED|First Study Night||6
6679957|NCT02656160|7611743|FG000|NOT COMPLETED|First Study Night||0
6679958|NCT02656160|7611744|FG001|NOT COMPLETED|First Study Night||0
6679959|NCT02656160|7611743|FG000|STARTED|Second Study Night|3 subjects did not return for the second study night|4
6679960|NCT02656160|7611744|FG001|STARTED|Second Study Night||6
6679961|NCT02656160|7611743|FG000|COMPLETED|Second Study Night||4
6679962|NCT02656160|7611744|FG001|COMPLETED|Second Study Night||6
6679963|NCT02656160|7611743|FG000|NOT COMPLETED|Second Study Night||0
6679964|NCT02656160|7611744|FG001|NOT COMPLETED|Second Study Night||0
6679965|NCT02656173|7611752|FG000|STARTED|Overall Study||285
6679966|NCT02656173|7611753|FG001|STARTED|Overall Study||283
6679967|NCT02656173|7611752|FG000|Received Treatment|Overall Study||284
6679968|NCT02656173|7611753|FG001|Received Treatment|Overall Study||282
6679969|NCT02656173|7611752|FG000|COMPLETED|Overall Study||272
6679970|NCT02656173|7611753|FG001|COMPLETED|Overall Study||272
6679971|NCT02656173|7611752|FG000|NOT COMPLETED|Overall Study||13
6679972|NCT02656173|7611753|FG001|NOT COMPLETED|Overall Study||11
6679973|NCT02656329|7611763|FG000|STARTED|Overall Study||164
6679974|NCT02656329|7611764|FG001|STARTED|Overall Study||157
6679975|NCT02656329|7611763|FG000|COMPLETED|Overall Study||0
6679976|NCT02656329|7611764|FG001|COMPLETED|Overall Study||0
6679977|NCT02656329|7611763|FG000|NOT COMPLETED|Overall Study||164
6679978|NCT02656329|7611764|FG001|NOT COMPLETED|Overall Study||157
6679979|NCT02656420|7611775|FG000|STARTED|Overall Study||55
6679980|NCT02656420|7611776|FG001|STARTED|Overall Study||25
6679981|NCT02656420|7611777|FG002|STARTED|Overall Study||35
6679982|NCT02656420|7611778|FG003|STARTED|Overall Study||55
6679983|NCT02656420|7611775|FG000|COMPLETED|Overall Study||55
6679984|NCT02656420|7611776|FG001|COMPLETED|Overall Study||24
6679985|NCT02656420|7611777|FG002|COMPLETED|Overall Study||35
6679986|NCT02656420|7611778|FG003|COMPLETED|Overall Study||55
6679987|NCT02656420|7611775|FG000|NOT COMPLETED|Overall Study||0
6679988|NCT02656420|7611776|FG001|NOT COMPLETED|Overall Study||1
6679989|NCT02656420|7611777|FG002|NOT COMPLETED|Overall Study||0
6679990|NCT02656420|7611778|FG003|NOT COMPLETED|Overall Study||0
6679991|NCT02656485|7611794|FG000|STARTED|Overall Study||9
6679992|NCT02656485|7611795|FG001|STARTED|Overall Study||9
6679993|NCT02656485|7611796|FG002|STARTED|Overall Study||9
6679994|NCT02656485|7611797|FG003|STARTED|Overall Study||9
6679995|NCT02656485|7611794|FG000|COMPLETED|Overall Study||7
6679996|NCT02656485|7611795|FG001|COMPLETED|Overall Study||6
6679997|NCT02656485|7611796|FG002|COMPLETED|Overall Study||7
6679998|NCT02656485|7611797|FG003|COMPLETED|Overall Study||7
6679999|NCT02656485|7611794|FG000|NOT COMPLETED|Overall Study||2
6680000|NCT02656485|7611795|FG001|NOT COMPLETED|Overall Study||3
6680001|NCT02656485|7611796|FG002|NOT COMPLETED|Overall Study||2
6680002|NCT02656485|7611797|FG003|NOT COMPLETED|Overall Study||2
6680003|NCT02656680|7611811|FG000|STARTED|Overall Study||40
6680004|NCT02656680|7611812|FG001|STARTED|Overall Study||40
6680005|NCT02656680|7611811|FG000|COMPLETED|Overall Study||40
6680006|NCT02656680|7611812|FG001|COMPLETED|Overall Study||39
6680007|NCT02656680|7611811|FG000|NOT COMPLETED|Overall Study||0
6680008|NCT02656680|7611812|FG001|NOT COMPLETED|Overall Study||1
6680009|NCT02656693|7611823|FG000|STARTED|Overall Study||326
6680010|NCT02656693|7611824|FG001|STARTED|Overall Study||216
6680011|NCT02656693|7611825|FG002|STARTED|Overall Study||298
6680012|NCT02656693|7611823|FG000|COMPLETED|Overall Study||325
6680013|NCT02656693|7611824|FG001|COMPLETED|Overall Study||214
6680014|NCT02656693|7611825|FG002|COMPLETED|Overall Study||295
6680015|NCT02656693|7611823|FG000|NOT COMPLETED|Overall Study||1
6256326|NCT04929522|7155207|FG003|COMPLETED|Overall Study||40
6680016|NCT02656693|7611824|FG001|NOT COMPLETED|Overall Study||2
6680017|NCT02656693|7611825|FG002|NOT COMPLETED|Overall Study||3
6680018|NCT02656745|7611833|FG000|STARTED|Overall Study||416
6680019|NCT02656745|7611833|FG000|COMPLETED|Overall Study||416
6680020|NCT02656745|7611833|FG000|NOT COMPLETED|Overall Study||0
6680021|NCT02656836|7611840|FG000|STARTED|Overall Study||9
6680022|NCT02656836|7611840|FG000|COMPLETED|Overall Study||6
6680023|NCT02656836|7611840|FG000|NOT COMPLETED|Overall Study||3
6680024|NCT02656875|7611844|FG000|STARTED|Overall Study||768
6680025|NCT02656875|7611844|FG000|COMPLETED|Overall Study||698
6680026|NCT02656875|7611844|FG000|NOT COMPLETED|Overall Study||70
6680027|NCT02657031|7611850|FG000|STARTED|Overall Study||29
6680028|NCT02657031|7611851|FG001|STARTED|Overall Study||25
6680029|NCT02657031|7611850|FG000|COMPLETED|Overall Study||28
6680030|NCT02657031|7611851|FG001|COMPLETED|Overall Study||23
6680031|NCT02657031|7611850|FG000|NOT COMPLETED|Overall Study||1
6680032|NCT02657031|7611851|FG001|NOT COMPLETED|Overall Study||2
6680033|NCT02657226|7611857|FG000|STARTED|Overall Study||15724
6680034|NCT02657226|7611857|FG000|COMPLETED|Overall Study||15724
6680035|NCT02657226|7611857|FG000|NOT COMPLETED|Overall Study||0
6680036|NCT02657252|7611866|FG000|STARTED|Overall Study||57
6680037|NCT02657252|7611867|FG001|STARTED|Overall Study||58
6680038|NCT02657252|7611866|FG000|COMPLETED|Overall Study||47
6680039|NCT02657252|7611867|FG001|COMPLETED|Overall Study||51
6680040|NCT02657252|7611866|FG000|NOT COMPLETED|Overall Study||10
6680041|NCT02657252|7611867|FG001|NOT COMPLETED|Overall Study||7
6680042|NCT02657369|7611873|FG000|STARTED|Overall Study||34
6680043|NCT02657369|7611873|FG000|COMPLETED|Overall Study||0
6680044|NCT02657369|7611873|FG000|NOT COMPLETED|Overall Study||34
6680045|NCT02657408|7611879|FG000|STARTED|Overall Study||28
6680046|NCT02657408|7611880|FG001|STARTED|Overall Study||29
6680047|NCT02657408|7611879|FG000|COMPLETED|Overall Study||25
6680048|NCT02657408|7611880|FG001|COMPLETED|Overall Study||22
6680049|NCT02657408|7611879|FG000|NOT COMPLETED|Overall Study||3
6680050|NCT02657408|7611880|FG001|NOT COMPLETED|Overall Study||7
6680051|NCT02657538|7611886|FG000|STARTED|Overall Study||35
6680052|NCT02657538|7611886|FG000|Received Near Infrared Transillumination|Overall Study||35
6680053|NCT02657538|7611886|FG000|Received Visual Caries Detection + Bite|Overall Study||35
6680054|NCT02657538|7611886|FG000|COMPLETED|Overall Study||31
6680055|NCT02657538|7611886|FG000|NOT COMPLETED|Overall Study||4
6680056|NCT02657564|7611893|FG000|STARTED|Overall Study||1237
6680057|NCT02657564|7611893|FG000|COMPLETED|Overall Study||1163
6680058|NCT02657564|7611893|FG000|NOT COMPLETED|Overall Study||74
6680059|NCT02657629|7611900|FG000|STARTED|Overall Study||14
6680060|NCT02657629|7611901|FG001|STARTED|Overall Study||14
6680061|NCT02657629|7611900|FG000|COMPLETED|Overall Study||12
6680062|NCT02657629|7611901|FG001|COMPLETED|Overall Study||14
6680063|NCT02657629|7611900|FG000|NOT COMPLETED|Overall Study||2
6680064|NCT02657629|7611901|FG001|NOT COMPLETED|Overall Study||0
6680065|NCT02657889|7611911|FG000|STARTED|Overall Study||7
6680066|NCT02657889|7611912|FG001|STARTED|Overall Study||7
6680067|NCT02657889|7611913|FG002|STARTED|Overall Study||53
6680068|NCT02657889|7611914|FG003|STARTED|Overall Study||55
6680069|NCT02657889|7611911|FG000|COMPLETED|Overall Study||0
6680070|NCT02657889|7611912|FG001|COMPLETED|Overall Study||0
6680071|NCT02657889|7611913|FG002|COMPLETED|Overall Study||0
6680072|NCT02657889|7611914|FG003|COMPLETED|Overall Study||0
6680073|NCT02657889|7611911|FG000|NOT COMPLETED|Overall Study||7
6680074|NCT02657889|7611912|FG001|NOT COMPLETED|Overall Study||7
6680075|NCT02657889|7611913|FG002|NOT COMPLETED|Overall Study||53
6680076|NCT02657889|7611914|FG003|NOT COMPLETED|Overall Study||55
6680077|NCT02657915|7611928|FG000|STARTED|Overall Study||24
6680078|NCT02657915|7611929|FG001|STARTED|Overall Study||28
6680079|NCT02657915|7611928|FG000|Intent-to Treat (ITT) Population|Overall Study||24
6680080|NCT02657915|7611929|FG001|Intent-to Treat (ITT) Population|Overall Study||28
6680081|NCT02657915|7611928|FG000|Per-protocol Population|Overall Study||23
6680082|NCT02657915|7611929|FG001|Per-protocol Population|Overall Study||24
6680083|NCT02657915|7611928|FG000|COMPLETED|Overall Study||24
6680084|NCT02657915|7611929|FG001|COMPLETED|Overall Study||28
6680085|NCT02657915|7611928|FG000|NOT COMPLETED|Overall Study||0
6680086|NCT02657915|7611929|FG001|NOT COMPLETED|Overall Study||0
6680087|NCT02657928|7611937|FG000|STARTED|Overall Study||20
6680088|NCT02657928|7611938|FG001|STARTED|Overall Study||20
6680089|NCT02657928|7611937|FG000|COMPLETED|Overall Study||20
6680090|NCT02657928|7611938|FG001|COMPLETED|Overall Study||20
6680091|NCT02657928|7611937|FG000|NOT COMPLETED|Overall Study||0
6680092|NCT02657928|7611938|FG001|NOT COMPLETED|Overall Study||0
6680093|NCT02658019|7611945|FG000|STARTED|Overall Study||29
6680094|NCT02658019|7611945|FG000|COMPLETED|Overall Study||28
6680095|NCT02658019|7611945|FG000|NOT COMPLETED|Overall Study||1
6680096|NCT02658084|7611951|FG000|STARTED|Overall Study||2
6680097|NCT02658084|7611952|FG001|STARTED|Overall Study||0
6680098|NCT02658084|7611951|FG000|COMPLETED|Overall Study||0
6680099|NCT02658084|7611952|FG001|COMPLETED|Overall Study||0
6680100|NCT02658084|7611951|FG000|NOT COMPLETED|Overall Study||2
6680101|NCT02658084|7611952|FG001|NOT COMPLETED|Overall Study||0
6680102|NCT02658149|7611959|FG000|STARTED|Overall Study||50
6256327|NCT04929522|7155204|FG000|NOT COMPLETED|Overall Study||0
6680103|NCT02658149|7611960|FG001|STARTED|Overall Study||50
6680104|NCT02658149|7611959|FG000|COMPLETED|Overall Study||49
6680105|NCT02658149|7611960|FG001|COMPLETED|Overall Study||50
6680106|NCT02658149|7611959|FG000|NOT COMPLETED|Overall Study||1
6680107|NCT02658149|7611960|FG001|NOT COMPLETED|Overall Study||0
6680108|NCT02658175|7611969|FG000|STARTED|Treatment Period: Weeks 1 to 52||51
6680109|NCT02658175|7611970|FG001|STARTED|Treatment Period: Weeks 1 to 52||14
6680110|NCT02658175|7611971|FG002|STARTED|Treatment Period: Weeks 1 to 52||3
6680111|NCT02658175|7611969|FG000|COMPLETED|Treatment Period: Weeks 1 to 52||36
6680112|NCT02658175|7611970|FG001|COMPLETED|Treatment Period: Weeks 1 to 52||7
6680113|NCT02658175|7611971|FG002|COMPLETED|Treatment Period: Weeks 1 to 52||3
6680114|NCT02658175|7611969|FG000|NOT COMPLETED|Treatment Period: Weeks 1 to 52||15
6680115|NCT02658175|7611970|FG001|NOT COMPLETED|Treatment Period: Weeks 1 to 52||7
6680116|NCT02658175|7611971|FG002|NOT COMPLETED|Treatment Period: Weeks 1 to 52||0
6680117|NCT02658175|7611969|FG000|STARTED|1st Extended Treatment: Weeks 53 to 104||36
6680118|NCT02658175|7611970|FG001|STARTED|1st Extended Treatment: Weeks 53 to 104||7
6680119|NCT02658175|7611971|FG002|STARTED|1st Extended Treatment: Weeks 53 to 104||3
6680120|NCT02658175|7611969|FG000|COMPLETED|1st Extended Treatment: Weeks 53 to 104||15
6680121|NCT02658175|7611970|FG001|COMPLETED|1st Extended Treatment: Weeks 53 to 104||5
6680122|NCT02658175|7611971|FG002|COMPLETED|1st Extended Treatment: Weeks 53 to 104||1
6680123|NCT02658175|7611969|FG000|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||21
6680124|NCT02658175|7611970|FG001|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
6680125|NCT02658175|7611971|FG002|NOT COMPLETED|1st Extended Treatment: Weeks 53 to 104||2
6680126|NCT02658175|7611969|FG000|STARTED|2nd Extended Treatment: Weeks 105 to156||1
6680127|NCT02658175|7611970|FG001|STARTED|2nd Extended Treatment: Weeks 105 to156||0
6680128|NCT02658175|7611971|FG002|STARTED|2nd Extended Treatment: Weeks 105 to156||1
6680129|NCT02658175|7611969|FG000|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
6680130|NCT02658175|7611970|FG001|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
6680131|NCT02658175|7611971|FG002|COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
6680132|NCT02658175|7611969|FG000|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
6680133|NCT02658175|7611970|FG001|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||0
6680134|NCT02658175|7611971|FG002|NOT COMPLETED|2nd Extended Treatment: Weeks 105 to156||1
6680135|NCT02658240|7611981|FG000|STARTED|Overall Study||30
6680136|NCT02658240|7611982|FG001|STARTED|Overall Study||30
6680137|NCT02658240|7611981|FG000|COMPLETED|Overall Study||30
6680138|NCT02658240|7611982|FG001|COMPLETED|Overall Study||30
6680139|NCT02658240|7611981|FG000|NOT COMPLETED|Overall Study||0
6680140|NCT02658240|7611982|FG001|NOT COMPLETED|Overall Study||0
6680141|NCT02658448|7611988|FG000|STARTED|Overall Study||19
6680142|NCT02658448|7611988|FG000|COMPLETED|Overall Study|One patient was lost to follow-up after enrollment and prior to visit 1|18
6680143|NCT02658448|7611988|FG000|NOT COMPLETED|Overall Study||1
6680144|NCT02658461|7611995|FG000|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
6680145|NCT02658461|7611996|FG001|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
6680146|NCT02658461|7611997|FG002|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
6680147|NCT02658461|7611995|FG000|COMPLETED|Overall Study||12
6680148|NCT02658461|7611996|FG001|COMPLETED|Overall Study||12
6680149|NCT02658461|7611997|FG002|COMPLETED|Overall Study||12
6680150|NCT02658461|7611995|FG000|NOT COMPLETED|Overall Study||0
6680151|NCT02658461|7611996|FG001|NOT COMPLETED|Overall Study||0
6680152|NCT02658461|7611997|FG002|NOT COMPLETED|Overall Study||0
6680153|NCT02658487|7612007|FG000|STARTED|Overall Study||42
6680154|NCT02658487|7612007|FG000|COMPLETED|Overall Study||26
6680155|NCT02658487|7612007|FG000|NOT COMPLETED|Overall Study||16
6680156|NCT02658630|7612012|FG000|STARTED|Overall Study||46
6680157|NCT02658630|7612012|FG000|COMPLETED|Overall Study||42
6680158|NCT02658630|7612012|FG000|NOT COMPLETED|Overall Study||4
6680159|NCT02658734|7612016|FG000|STARTED|Overall Study||70
6680160|NCT02658734|7612016|FG000|COMPLETED|Overall Study||13
6680161|NCT02658734|7612016|FG000|NOT COMPLETED|Overall Study||57
6680162|NCT02658851|7612020|FG000|STARTED|Overall Study||100
6680163|NCT02658851|7612020|FG000|COMPLETED|Overall Study||100
6680164|NCT02658851|7612020|FG000|NOT COMPLETED|Overall Study||0
6680165|NCT02658994|7612027|FG000|STARTED|Enrollment||287
6680166|NCT02658994|7612028|FG001|STARTED|Enrollment||283
6680167|NCT02658994|7612029|FG002|STARTED|Enrollment||584
6680168|NCT02658994|7612027|FG000|COMPLETED|Enrollment||287
6680169|NCT02658994|7612028|FG001|COMPLETED|Enrollment||283
6680170|NCT02658994|7612029|FG002|COMPLETED|Enrollment||584
6680171|NCT02658994|7612027|FG000|NOT COMPLETED|Enrollment||0
6680172|NCT02658994|7612028|FG001|NOT COMPLETED|Enrollment||0
6680173|NCT02658994|7612029|FG002|NOT COMPLETED|Enrollment||0
6680174|NCT02658994|7612027|FG000|STARTED|3 Month Follow up||287
6680175|NCT02658994|7612028|FG001|STARTED|3 Month Follow up||283
6680176|NCT02658994|7612029|FG002|STARTED|3 Month Follow up||584
6680177|NCT02658994|7612027|FG000|COMPLETED|3 Month Follow up||221
6680178|NCT02658994|7612028|FG001|COMPLETED|3 Month Follow up||223
6680179|NCT02658994|7612029|FG002|COMPLETED|3 Month Follow up||451
6680180|NCT02658994|7612027|FG000|NOT COMPLETED|3 Month Follow up||66
6680181|NCT02658994|7612028|FG001|NOT COMPLETED|3 Month Follow up||60
6680182|NCT02658994|7612029|FG002|NOT COMPLETED|3 Month Follow up||133
6680183|NCT02658994|7612027|FG000|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|287
6680184|NCT02658994|7612028|FG001|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|283
6680185|NCT02658994|7612029|FG002|STARTED|6 Month Follow up|Participants who did not complete 3 month follow up were still eligible for 6 month follow up|584
6680186|NCT02658994|7612027|FG000|COMPLETED|6 Month Follow up||228
6680187|NCT02658994|7612028|FG001|COMPLETED|6 Month Follow up||230
6680188|NCT02658994|7612029|FG002|COMPLETED|6 Month Follow up||471
6680189|NCT02658994|7612027|FG000|NOT COMPLETED|6 Month Follow up||59
6680190|NCT02658994|7612028|FG001|NOT COMPLETED|6 Month Follow up||53
6680191|NCT02658994|7612029|FG002|NOT COMPLETED|6 Month Follow up||113
6680192|NCT02658994|7612027|FG000|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|287
6680193|NCT02658994|7612028|FG001|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|283
6680194|NCT02658994|7612029|FG002|STARTED|12 Month Follow up|Participants who did not complete 6 month follow up were still eligible for 12 month follow up|584
6680195|NCT02658994|7612027|FG000|COMPLETED|12 Month Follow up||228
6680196|NCT02658994|7612028|FG001|COMPLETED|12 Month Follow up||223
6680197|NCT02658994|7612029|FG002|COMPLETED|12 Month Follow up||489
6680198|NCT02658994|7612027|FG000|NOT COMPLETED|12 Month Follow up||59
6680199|NCT02658994|7612028|FG001|NOT COMPLETED|12 Month Follow up||60
6680200|NCT02658994|7612029|FG002|NOT COMPLETED|12 Month Follow up||95
6680201|NCT02658994|7612027|FG000|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|287
6680202|NCT02658994|7612028|FG001|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|283
6680203|NCT02658994|7612029|FG002|STARTED|24 Month Follow up|Participants who did not complete 12 month follow up were still eligible for 24 month follow up|584
6680204|NCT02658994|7612027|FG000|COMPLETED|24 Month Follow up||220
6680205|NCT02658994|7612028|FG001|COMPLETED|24 Month Follow up||210
6680206|NCT02658994|7612029|FG002|COMPLETED|24 Month Follow up||473
6680207|NCT02658994|7612027|FG000|NOT COMPLETED|24 Month Follow up||67
6680208|NCT02658994|7612028|FG001|NOT COMPLETED|24 Month Follow up||73
6680209|NCT02658994|7612029|FG002|NOT COMPLETED|24 Month Follow up||111
6680210|NCT02658994|7612027|FG000|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|287
6680211|NCT02658994|7612028|FG001|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|283
6680212|NCT02658994|7612029|FG002|STARTED|36 Month Follow up|Participants who did not complete 24 month follow up were still eligible for 36 month follow up|584
6680213|NCT02658994|7612027|FG000|COMPLETED|36 Month Follow up||216
6680214|NCT02658994|7612028|FG001|COMPLETED|36 Month Follow up||206
6680215|NCT02658994|7612029|FG002|COMPLETED|36 Month Follow up||467
6680216|NCT02658994|7612027|FG000|NOT COMPLETED|36 Month Follow up||71
6680217|NCT02658994|7612028|FG001|NOT COMPLETED|36 Month Follow up||77
6680218|NCT02658994|7612029|FG002|NOT COMPLETED|36 Month Follow up||117
6680219|NCT02659020|7612045|FG000|STARTED|Overall Study||21
6680220|NCT02659020|7612046|FG001|STARTED|Overall Study||18
6680221|NCT02659020|7612047|FG002|STARTED|Overall Study||15
6680222|NCT02659020|7612048|FG003|STARTED|Overall Study||81
6680223|NCT02659020|7612049|FG004|STARTED|Overall Study||46
6680224|NCT02659020|7612050|FG005|STARTED|Overall Study||86
6680225|NCT02659020|7612051|FG006|STARTED|Overall Study||43
6680226|NCT02659020|7612045|FG000|Received at Least 1 Dose of Study Drug|Overall Study||21
6680227|NCT02659020|7612046|FG001|Received at Least 1 Dose of Study Drug|Overall Study||18
6680228|NCT02659020|7612047|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
6680229|NCT02659020|7612048|FG003|Received at Least 1 Dose of Study Drug|Overall Study||81
6680230|NCT02659020|7612049|FG004|Received at Least 1 Dose of Study Drug|Overall Study||45
6680231|NCT02659020|7612050|FG005|Received at Least 1 Dose of Study Drug|Overall Study||86
6680232|NCT02659020|7612051|FG006|Received at Least 1 Dose of Study Drug|Overall Study||43
6680233|NCT02659020|7612045|FG000|COMPLETED|Overall Study||15
6680234|NCT02659020|7612046|FG001|COMPLETED|Overall Study||11
6680235|NCT02659020|7612047|FG002|COMPLETED|Overall Study||10
6680236|NCT02659020|7612048|FG003|COMPLETED|Overall Study||51
6680237|NCT02659020|7612049|FG004|COMPLETED|Overall Study||26
6680238|NCT02659020|7612050|FG005|COMPLETED|Overall Study||58
6680239|NCT02659020|7612051|FG006|COMPLETED|Overall Study||28
6680240|NCT02659020|7612045|FG000|NOT COMPLETED|Overall Study||6
6680241|NCT02659020|7612046|FG001|NOT COMPLETED|Overall Study||7
6680242|NCT02659020|7612047|FG002|NOT COMPLETED|Overall Study||5
6680243|NCT02659020|7612048|FG003|NOT COMPLETED|Overall Study||30
6680244|NCT02659020|7612049|FG004|NOT COMPLETED|Overall Study||20
6680245|NCT02659020|7612050|FG005|NOT COMPLETED|Overall Study||28
6680246|NCT02659020|7612051|FG006|NOT COMPLETED|Overall Study||15
6680247|NCT02659098|7612074|FG000|STARTED|Overall Study||21
6680248|NCT02659098|7612074|FG000|COMPLETED|Overall Study||14
6680249|NCT02659098|7612074|FG000|NOT COMPLETED|Overall Study||7
6680250|NCT02659150|7612078|FG000|STARTED|Subject Enrollment||16
6680251|NCT02659150|7612078|FG000|COMPLETED|Subject Enrollment||11
6680252|NCT02659150|7612078|FG000|NOT COMPLETED|Subject Enrollment||5
6680253|NCT02659150|7612078|FG000|STARTED|Baseline Imaging||11
6680254|NCT02659150|7612078|FG000|COMPLETED|Baseline Imaging||9
6680255|NCT02659150|7612078|FG000|NOT COMPLETED|Baseline Imaging||2
6680256|NCT02659150|7612078|FG000|STARTED|Study Drug Dosing||9
6680257|NCT02659150|7612078|FG000|COMPLETED|Study Drug Dosing||8
6680258|NCT02659150|7612078|FG000|NOT COMPLETED|Study Drug Dosing||1
6680259|NCT02659150|7612078|FG000|STARTED|Follow-up Imaging||8
6680260|NCT02659150|7612078|FG000|COMPLETED|Follow-up Imaging||8
6680261|NCT02659150|7612078|FG000|NOT COMPLETED|Follow-up Imaging||0
6680262|NCT02659501|7612085|FG000|STARTED|Overall Study||12
6680263|NCT02659501|7612086|FG001|STARTED|Overall Study||12
6680264|NCT02659501|7612085|FG000|COMPLETED|Overall Study||12
6680265|NCT02659501|7612086|FG001|COMPLETED|Overall Study||12
6680266|NCT02659501|7612085|FG000|NOT COMPLETED|Overall Study||0
6680267|NCT02659501|7612086|FG001|NOT COMPLETED|Overall Study||0
6680268|NCT02659540|7612094|FG000|STARTED|Overall Study||10
6680269|NCT02659540|7612095|FG001|STARTED|Overall Study||10
6680270|NCT02659540|7612094|FG000|COMPLETED|Overall Study||4
6680271|NCT02659540|7612095|FG001|COMPLETED|Overall Study||2
6680272|NCT02659540|7612094|FG000|NOT COMPLETED|Overall Study||6
6680273|NCT02659540|7612095|FG001|NOT COMPLETED|Overall Study||8
6680274|NCT02659631|7612111|FG000|STARTED|Overall Study||1
6680275|NCT02659631|7612112|FG001|STARTED|Overall Study||2
6680276|NCT02659631|7612113|FG002|STARTED|Overall Study||3
6680277|NCT02659631|7612114|FG003|STARTED|Overall Study||2
6680278|NCT02659631|7612115|FG004|STARTED|Overall Study||5
6680279|NCT02659631|7612116|FG005|STARTED|Overall Study||5
6680280|NCT02659631|7612117|FG006|STARTED|Overall Study||4
6680281|NCT02659631|7612118|FG007|STARTED|Overall Study||3
6680282|NCT02659631|7612119|FG008|STARTED|Overall Study||2
6680283|NCT02659631|7612120|FG009|STARTED|Overall Study||1
6680284|NCT02659631|7612111|FG000|COMPLETED|Overall Study||0
6680285|NCT02659631|7612112|FG001|COMPLETED|Overall Study||0
6680286|NCT02659631|7612113|FG002|COMPLETED|Overall Study||0
6680287|NCT02659631|7612114|FG003|COMPLETED|Overall Study||0
6680288|NCT02659631|7612115|FG004|COMPLETED|Overall Study||0
6680289|NCT02659631|7612116|FG005|COMPLETED|Overall Study||2
6680290|NCT02659631|7612117|FG006|COMPLETED|Overall Study||3
6680291|NCT02659631|7612118|FG007|COMPLETED|Overall Study||0
6680292|NCT02659631|7612119|FG008|COMPLETED|Overall Study||0
6680293|NCT02659631|7612120|FG009|COMPLETED|Overall Study||1
6680294|NCT02659631|7612111|FG000|NOT COMPLETED|Overall Study||1
6680295|NCT02659631|7612112|FG001|NOT COMPLETED|Overall Study||2
6680296|NCT02659631|7612113|FG002|NOT COMPLETED|Overall Study||3
6680297|NCT02659631|7612114|FG003|NOT COMPLETED|Overall Study||2
6680298|NCT02659631|7612115|FG004|NOT COMPLETED|Overall Study||5
6680299|NCT02659631|7612116|FG005|NOT COMPLETED|Overall Study||3
6680300|NCT02659631|7612117|FG006|NOT COMPLETED|Overall Study||1
6680301|NCT02659631|7612118|FG007|NOT COMPLETED|Overall Study||3
6680302|NCT02659631|7612119|FG008|NOT COMPLETED|Overall Study||2
6680303|NCT02659631|7612120|FG009|NOT COMPLETED|Overall Study||0
6680304|NCT02659709|7612144|FG000|STARTED|Overall Study||50
6680305|NCT02659709|7612144|FG000|COMPLETED|Overall Study||50
6680306|NCT02659709|7612144|FG000|NOT COMPLETED|Overall Study||0
6738395|NCT03284398|7667763|FG000|STARTED|Overall Study||2753
6738396|NCT03284398|7667764|FG001|STARTED|Overall Study||970
6738397|NCT03284398|7667763|FG000|COMPLETED|Overall Study||2753
6738398|NCT03284398|7667764|FG001|COMPLETED|Overall Study||970
6738399|NCT03284398|7667763|FG000|NOT COMPLETED|Overall Study||0
6738400|NCT03284398|7667764|FG001|NOT COMPLETED|Overall Study||0
6738401|NCT03284411|7667776|FG000|STARTED|Overall Study||30
6738402|NCT03284411|7667776|FG000|COMPLETED|Overall Study||30
6738403|NCT03284411|7667776|FG000|NOT COMPLETED|Overall Study||0
6738404|NCT03284424|7667783|FG000|STARTED|Overall Study||105
6738405|NCT03284424|7667784|FG001|STARTED|Overall Study||54
6738406|NCT03284424|7667783|FG000|COMPLETED|Overall Study||0
6738407|NCT03284424|7667784|FG001|COMPLETED|Overall Study||0
6738408|NCT03284424|7667783|FG000|NOT COMPLETED|Overall Study||105
6738409|NCT03284424|7667784|FG001|NOT COMPLETED|Overall Study||54
6738410|NCT03284710|7667793|FG000|STARTED|Overall Study||36
6738411|NCT03284710|7667794|FG001|STARTED|Overall Study||36
6738412|NCT03284710|7667795|FG002|STARTED|Overall Study||36
6738413|NCT03284710|7667796|FG003|STARTED|Overall Study||24
6738414|NCT03284710|7667793|FG000|Month 6.5 Immunogenicity Timepoint|Overall Study||31
6738415|NCT03284710|7667794|FG001|Month 6.5 Immunogenicity Timepoint|Overall Study||31
6738416|NCT03284710|7667795|FG002|Month 6.5 Immunogenicity Timepoint|Overall Study||31
6738417|NCT03284710|7667796|FG003|Month 6.5 Immunogenicity Timepoint|Overall Study||18
6738418|NCT03284710|7667793|FG000|Month 12 Immunogenicity Timepoint|Overall Study||30
6738419|NCT03284710|7667794|FG001|Month 12 Immunogenicity Timepoint|Overall Study||31
6738420|NCT03284710|7667795|FG002|Month 12 Immunogenicity Timepoint|Overall Study||31
6738421|NCT03284710|7667796|FG003|Month 12 Immunogenicity Timepoint|Overall Study||17
6738422|NCT03284710|7667793|FG000|Month 12.5 Immunogenicity Timepoint|Overall Study||0
6738423|NCT03284710|7667794|FG001|Month 12.5 Immunogenicity Timepoint|Overall Study||0
6738424|NCT03284710|7667795|FG002|Month 12.5 Immunogenicity Timepoint|Overall Study||0
6738425|NCT03284710|7667796|FG003|Month 12.5 Immunogenicity Timepoint|Overall Study||0
6738426|NCT03284710|7667793|FG000|Month 18 Immunogenicity Timepoint|Overall Study||0
6738427|NCT03284710|7667794|FG001|Month 18 Immunogenicity Timepoint|Overall Study||0
6738428|NCT03284710|7667795|FG002|Month 18 Immunogenicity Timepoint|Overall Study||0
6738429|NCT03284710|7667796|FG003|Month 18 Immunogenicity Timepoint|Overall Study||0
6738430|NCT03284710|7667793|FG000|COMPLETED|Overall Study||30
6738431|NCT03284710|7667794|FG001|COMPLETED|Overall Study||31
6738432|NCT03284710|7667795|FG002|COMPLETED|Overall Study||32
6738433|NCT03284710|7667796|FG003|COMPLETED|Overall Study||16
6738434|NCT03284710|7667793|FG000|NOT COMPLETED|Overall Study||6
6738435|NCT03284710|7667794|FG001|NOT COMPLETED|Overall Study||5
6738436|NCT03284710|7667795|FG002|NOT COMPLETED|Overall Study||4
6738437|NCT03284710|7667796|FG003|NOT COMPLETED|Overall Study||8
6738438|NCT03285061|7667813|FG000|STARTED|Overall Study||37
6738439|NCT03285061|7667814|FG001|STARTED|Overall Study||38
6738440|NCT03285061|7667813|FG000|COMPLETED|Overall Study||36
6738441|NCT03285061|7667814|FG001|COMPLETED|Overall Study||36
6738442|NCT03285061|7667813|FG000|NOT COMPLETED|Overall Study||1
6738443|NCT03285061|7667814|FG001|NOT COMPLETED|Overall Study||2
6738444|NCT03285113|7667820|FG000|STARTED|Overall Study||10
6738445|NCT03285113|7667820|FG000|COMPLETED|Overall Study||8
6738446|NCT03285113|7667820|FG000|NOT COMPLETED|Overall Study||2
6680307|NCT02659787|7612148|FG000|STARTED|First Intervention (1 Day)||19
6680308|NCT02659787|7612149|FG001|STARTED|First Intervention (1 Day)||19
6680309|NCT02659787|7612148|FG000|COMPLETED|First Intervention (1 Day)||19
6680310|NCT02659787|7612149|FG001|COMPLETED|First Intervention (1 Day)||19
6680311|NCT02659787|7612148|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6680312|NCT02659787|7612149|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6680313|NCT02659787|7612148|FG000|STARTED|Washout (3 Days)||19
6680314|NCT02659787|7612149|FG001|STARTED|Washout (3 Days)||19
6680315|NCT02659787|7612148|FG000|COMPLETED|Washout (3 Days)||19
6680316|NCT02659787|7612149|FG001|COMPLETED|Washout (3 Days)||19
6680317|NCT02659787|7612148|FG000|NOT COMPLETED|Washout (3 Days)||0
6680318|NCT02659787|7612149|FG001|NOT COMPLETED|Washout (3 Days)||0
6680319|NCT02659787|7612148|FG000|STARTED|Second Intervention (1 Day)||19
6680320|NCT02659787|7612149|FG001|STARTED|Second Intervention (1 Day)||19
6680321|NCT02659787|7612148|FG000|COMPLETED|Second Intervention (1 Day)||19
6680322|NCT02659787|7612149|FG001|COMPLETED|Second Intervention (1 Day)||19
6680323|NCT02659787|7612148|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6680324|NCT02659787|7612149|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6680325|NCT02659943|7612162|FG000|STARTED|Overall Study||3
6680326|NCT02659943|7612163|FG001|STARTED|Overall Study||2
6680327|NCT02659943|7612164|FG002|STARTED|Overall Study||1
6680328|NCT02659943|7612165|FG003|STARTED|Overall Study||4
6680329|NCT02659943|7612166|FG004|STARTED|Overall Study||2
6680330|NCT02659943|7612167|FG005|STARTED|Overall Study||9
6680331|NCT02659943|7612168|FG006|STARTED|Overall Study||6
6680332|NCT02659943|7612162|FG000|COMPLETED|Overall Study||2
6680333|NCT02659943|7612163|FG001|COMPLETED|Overall Study||0
6680334|NCT02659943|7612164|FG002|COMPLETED|Overall Study||0
6680335|NCT02659943|7612165|FG003|COMPLETED|Overall Study||1
6680336|NCT02659943|7612166|FG004|COMPLETED|Overall Study||0
6680337|NCT02659943|7612167|FG005|COMPLETED|Overall Study||4
6680338|NCT02659943|7612168|FG006|COMPLETED|Overall Study||0
6680339|NCT02659943|7612162|FG000|NOT COMPLETED|Overall Study||1
6680340|NCT02659943|7612163|FG001|NOT COMPLETED|Overall Study||2
6680341|NCT02659943|7612164|FG002|NOT COMPLETED|Overall Study||1
6680342|NCT02659943|7612165|FG003|NOT COMPLETED|Overall Study||3
6680343|NCT02659943|7612166|FG004|NOT COMPLETED|Overall Study||2
6680344|NCT02659943|7612167|FG005|NOT COMPLETED|Overall Study||5
6680345|NCT02659943|7612168|FG006|NOT COMPLETED|Overall Study||6
6680346|NCT02660112|7612189|FG000|STARTED|Overall Study||10
6680347|NCT02660112|7612189|FG000|COMPLETED|Overall Study||10
6680348|NCT02660112|7612189|FG000|NOT COMPLETED|Overall Study||0
6680349|NCT02660138|7612196|FG000|STARTED|Overall Study||76
6680350|NCT02660138|7612197|FG001|STARTED|Overall Study||76
6680351|NCT02660138|7612198|FG002|STARTED|Overall Study||75
6680352|NCT02660138|7612196|FG000|Subjects Treated in DBPC Cycle|Overall Study||76
6680353|NCT02660138|7612197|FG001|Subjects Treated in DBPC Cycle|Overall Study||75
6680354|NCT02660138|7612198|FG002|Subjects Treated in DBPC Cycle|Overall Study||75
6680355|NCT02660138|7612196|FG000|Subjects Entered in the Dysport Cycles|Overall Study||49
6680356|NCT02660138|7612197|FG001|Subjects Entered in the Dysport Cycles|Overall Study||75
6680357|NCT02660138|7612198|FG002|Subjects Entered in the Dysport Cycles|Overall Study||75
6680358|NCT02660138|7612196|FG000|COMPLETED|Overall Study||6
6680359|NCT02660138|7612197|FG001|COMPLETED|Overall Study||2
6680360|NCT02660138|7612198|FG002|COMPLETED|Overall Study||3
6680361|NCT02660138|7612196|FG000|NOT COMPLETED|Overall Study||70
6680362|NCT02660138|7612197|FG001|NOT COMPLETED|Overall Study||74
6680363|NCT02660138|7612198|FG002|NOT COMPLETED|Overall Study||72
6680364|NCT02660229|7612211|FG000|STARTED|Overall Study|Randomization|34
6680365|NCT02660229|7612212|FG001|STARTED|Overall Study|Randomization|32
6680366|NCT02660229|7612211|FG000|Safety Analysis Set|Overall Study||34
6680367|NCT02660229|7612212|FG001|Safety Analysis Set|Overall Study||32
6680368|NCT02660229|7612211|FG000|FAS Set|Overall Study|Oxycodone group: 1 patient was missed any efficacy assessment.|33
6680369|NCT02660229|7612212|FG001|FAS Set|Overall Study||32
6680370|NCT02660229|7612211|FG000|Per Protocol Set|Overall Study|Adverse events N=1, Prohibited medication N=4|28
6680371|NCT02660229|7612212|FG001|Per Protocol Set|Overall Study|Withdrawal of ICF N=1, IC/EC deviation N=1, Prohibited medication N=1|29
6680372|NCT02660229|7612211|FG000|COMPLETED|Overall Study||32
6680373|NCT02660229|7612212|FG001|COMPLETED|Overall Study||31
6680374|NCT02660229|7612211|FG000|NOT COMPLETED|Overall Study||2
6680375|NCT02660229|7612212|FG001|NOT COMPLETED|Overall Study||1
6680376|NCT02660242|7612218|FG000|STARTED|Control||16
6680377|NCT02660242|7612218|FG000|COMPLETED|Control||16
6680378|NCT02660242|7612218|FG000|NOT COMPLETED|Control||0
6680379|NCT02660242|7612218|FG000|STARTED|Basal Insulin Reduction||16
6680380|NCT02660242|7612218|FG000|COMPLETED|Basal Insulin Reduction||16
6680381|NCT02660242|7612218|FG000|NOT COMPLETED|Basal Insulin Reduction||0
6680382|NCT02660242|7612218|FG000|STARTED|Glucose Tabs|16 participants were randomized but only 15 completed all 4 periods.|16
6680383|NCT02660242|7612218|FG000|COMPLETED|Glucose Tabs||15
6680384|NCT02660242|7612218|FG000|NOT COMPLETED|Glucose Tabs||1
6680385|NCT02660242|7612218|FG000|STARTED|Glucagon Injection|16 participants were randomized but only 15 completed all 4 periods.|16
6680386|NCT02660242|7612218|FG000|COMPLETED|Glucagon Injection||15
6680387|NCT02660242|7612218|FG000|NOT COMPLETED|Glucagon Injection||1
6680388|NCT02660359|7612234|FG000|STARTED|Overall Study||86
6680389|NCT02660359|7612235|FG001|STARTED|Overall Study||86
6680390|NCT02660359|7612236|FG002|STARTED|Overall Study||85
6680391|NCT02660359|7612234|FG000|Subjects Entered in the Dysport Cycles|Overall Study||56
6680392|NCT02660359|7612235|FG001|Subjects Entered in the Dysport Cycles|Overall Study||86
6680393|NCT02660359|7612236|FG002|Subjects Entered in the Dysport Cycles|Overall Study||85
6680394|NCT02660359|7612234|FG000|COMPLETED|Overall Study||0
6680395|NCT02660359|7612235|FG001|COMPLETED|Overall Study||0
6680396|NCT02660359|7612236|FG002|COMPLETED|Overall Study||1
6680397|NCT02660359|7612234|FG000|NOT COMPLETED|Overall Study||86
6680398|NCT02660359|7612235|FG001|NOT COMPLETED|Overall Study||86
6680399|NCT02660359|7612236|FG002|NOT COMPLETED|Overall Study||84
6680400|NCT02660489|7612246|FG000|STARTED|Overall Study||22
6680401|NCT02660489|7612247|FG001|STARTED|Overall Study||22
6680402|NCT02660489|7612246|FG000|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|16
6680403|NCT02660489|7612247|FG001|COMPLETED|Overall Study|Completed with confirmed rhinovirus infection|14
6680404|NCT02660489|7612246|FG000|NOT COMPLETED|Overall Study||6
6680405|NCT02660489|7612247|FG001|NOT COMPLETED|Overall Study||8
6680406|NCT02660580|7612255|FG000|STARTED|Core Treatment Period (Week 1 to 16)||222
6680407|NCT02660580|7612256|FG001|STARTED|Core Treatment Period (Week 1 to 16)||221
6680408|NCT02660580|7612257|FG002|STARTED|Core Treatment Period (Week 1 to 16)||0
6680409|NCT02660580|7612258|FG003|STARTED|Core Treatment Period (Week 1 to 16)||0
6680410|NCT02660580|7612259|FG004|STARTED|Core Treatment Period (Week 1 to 16)||0
6680411|NCT02660580|7612255|FG000|Treated|Core Treatment Period (Week 1 to 16)||221
6680412|NCT02660580|7612256|FG001|Treated|Core Treatment Period (Week 1 to 16)||220
6680413|NCT02660580|7612257|FG002|Treated|Core Treatment Period (Week 1 to 16)||0
6680414|NCT02660580|7612258|FG003|Treated|Core Treatment Period (Week 1 to 16)||0
6680415|NCT02660580|7612259|FG004|Treated|Core Treatment Period (Week 1 to 16)||0
6680416|NCT02660580|7612255|FG000|COMPLETED|Core Treatment Period (Week 1 to 16)||213
6680417|NCT02660580|7612256|FG001|COMPLETED|Core Treatment Period (Week 1 to 16)||202
6680418|NCT02660580|7612257|FG002|COMPLETED|Core Treatment Period (Week 1 to 16)||0
6680419|NCT02660580|7612258|FG003|COMPLETED|Core Treatment Period (Week 1 to 16)||0
6680420|NCT02660580|7612259|FG004|COMPLETED|Core Treatment Period (Week 1 to 16)||0
6680421|NCT02660580|7612255|FG000|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||9
6680422|NCT02660580|7612256|FG001|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||19
6680423|NCT02660580|7612257|FG002|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
6680424|NCT02660580|7612258|FG003|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
6680425|NCT02660580|7612259|FG004|NOT COMPLETED|Core Treatment Period (Week 1 to 16)||0
6680426|NCT02660580|7612255|FG000|STARTED|Extended Treatment Period(Week 16 to 52)||0
6680427|NCT02660580|7612256|FG001|STARTED|Extended Treatment Period(Week 16 to 52)||0
6680428|NCT02660580|7612257|FG002|STARTED|Extended Treatment Period(Week 16 to 52)||213
6680429|NCT02660580|7612258|FG003|STARTED|Extended Treatment Period(Week 16 to 52)||101
6680430|NCT02660580|7612259|FG004|STARTED|Extended Treatment Period(Week 16 to 52)||101
6680431|NCT02660580|7612255|FG000|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
6680432|NCT02660580|7612256|FG001|COMPLETED|Extended Treatment Period(Week 16 to 52)||0
6680433|NCT02660580|7612257|FG002|COMPLETED|Extended Treatment Period(Week 16 to 52)||195
6680434|NCT02660580|7612258|FG003|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
6680435|NCT02660580|7612259|FG004|COMPLETED|Extended Treatment Period(Week 16 to 52)||90
6680436|NCT02660580|7612255|FG000|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
6680437|NCT02660580|7612256|FG001|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||0
6680438|NCT02660580|7612257|FG002|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||18
6680439|NCT02660580|7612258|FG003|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
6680440|NCT02660580|7612259|FG004|NOT COMPLETED|Extended Treatment Period(Week 16 to 52)||11
6680441|NCT02660788|7612280|FG000|STARTED|Overall Study||2749
6680442|NCT02660788|7612281|FG001|STARTED|Overall Study||2749
6680443|NCT02660788|7612280|FG000|COMPLETED|Overall Study||2749
6680444|NCT02660788|7612281|FG001|COMPLETED|Overall Study||2749
6680445|NCT02660788|7612280|FG000|NOT COMPLETED|Overall Study||0
6680446|NCT02660788|7612281|FG001|NOT COMPLETED|Overall Study||0
6680447|NCT02660801|7612287|FG000|STARTED|Overall Study||11
6680448|NCT02660801|7612288|FG001|STARTED|Overall Study||15
6680449|NCT02660801|7612287|FG000|COMPLETED|Overall Study||11
6680450|NCT02660801|7612288|FG001|COMPLETED|Overall Study||15
6680451|NCT02660801|7612287|FG000|NOT COMPLETED|Overall Study||0
6680452|NCT02660801|7612288|FG001|NOT COMPLETED|Overall Study||0
6680453|NCT02660853|7612294|FG000|STARTED|Overall Study||25
6680454|NCT02660853|7612294|FG000|COMPLETED|Overall Study||25
6680455|NCT02660853|7612294|FG000|NOT COMPLETED|Overall Study||0
6680456|NCT02660918|7612300|FG000|STARTED|Overall Study||42
6680457|NCT02660918|7612301|FG001|STARTED|Overall Study||42
6680458|NCT02660918|7612300|FG000|COMPLETED|Overall Study|Age ineligible|41
6680459|NCT02660918|7612301|FG001|COMPLETED|Overall Study|Age ineligible|41
6680460|NCT02660918|7612300|FG000|NOT COMPLETED|Overall Study||1
6680461|NCT02660918|7612301|FG001|NOT COMPLETED|Overall Study||1
6680462|NCT02660944|7612310|FG000|STARTED|Overall Study||42
6680463|NCT02660944|7612311|FG001|STARTED|Overall Study||22
6680464|NCT02660944|7612310|FG000|COMPLETED|Overall Study||25
6680465|NCT02660944|7612311|FG001|COMPLETED|Overall Study||12
6680466|NCT02660944|7612310|FG000|NOT COMPLETED|Overall Study||17
6680467|NCT02660944|7612311|FG001|NOT COMPLETED|Overall Study||10
6680468|NCT02660983|7612319|FG000|STARTED|Double-blind (DB) Phase (24 Weeks)||154
6680469|NCT02660983|7612320|FG001|STARTED|Double-blind (DB) Phase (24 Weeks)||148
6680470|NCT02660983|7612319|FG000|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||153
6680471|NCT02660983|7612320|FG001|Treated/Safety Set|Double-blind (DB) Phase (24 Weeks)||147
6680472|NCT02660983|7612319|FG000|COMPLETED|Double-blind (DB) Phase (24 Weeks)||130
6680473|NCT02660983|7612320|FG001|COMPLETED|Double-blind (DB) Phase (24 Weeks)||122
6680474|NCT02660983|7612319|FG000|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||24
6680475|NCT02660983|7612320|FG001|NOT COMPLETED|Double-blind (DB) Phase (24 Weeks)||26
6680476|NCT02660983|7612319|FG000|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|86
6680477|NCT02660983|7612320|FG001|STARTED|Open Label Extension Phase (24 Weeks)|Eligible participants who consented to continue from DB phase to OLE phase.|75
6680478|NCT02660983|7612319|FG000|Safety Set|Open Label Extension Phase (24 Weeks)||86
6680479|NCT02660983|7612320|FG001|Safety Set|Open Label Extension Phase (24 Weeks)||75
6680480|NCT02660983|7612319|FG000|COMPLETED|Open Label Extension Phase (24 Weeks)||83
6680481|NCT02660983|7612320|FG001|COMPLETED|Open Label Extension Phase (24 Weeks)||66
6680482|NCT02660983|7612319|FG000|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||3
6680483|NCT02660983|7612320|FG001|NOT COMPLETED|Open Label Extension Phase (24 Weeks)||9
6680484|NCT02661061|7612329|FG000|STARTED|Overall Study||5
6680485|NCT02661061|7612330|FG001|STARTED|Overall Study||4
6680486|NCT02661061|7612329|FG000|COMPLETED|Overall Study||3
6680487|NCT02661061|7612330|FG001|COMPLETED|Overall Study||2
6680488|NCT02661061|7612329|FG000|NOT COMPLETED|Overall Study||2
6680489|NCT02661061|7612330|FG001|NOT COMPLETED|Overall Study||2
6680490|NCT02661126|7612338|FG000|STARTED|Overall Study||8
6680491|NCT02661126|7612339|FG001|STARTED|Overall Study||8
6680492|NCT02661126|7612338|FG000|COMPLETED|Overall Study||8
6680493|NCT02661126|7612339|FG001|COMPLETED|Overall Study||8
6680494|NCT02661126|7612338|FG000|NOT COMPLETED|Overall Study||0
6680495|NCT02661126|7612339|FG001|NOT COMPLETED|Overall Study||0
6680496|NCT02661178|7612360|FG000|STARTED|Part 1||1
6680497|NCT02661178|7612361|FG001|STARTED|Part 1||5
6680498|NCT02661178|7612362|FG002|STARTED|Part 1||6
6680499|NCT02661178|7612363|FG003|STARTED|Part 1||6
6680500|NCT02661178|7612364|FG004|STARTED|Part 1||5
6680501|NCT02661178|7612365|FG005|STARTED|Part 1||6
6680502|NCT02661178|7612366|FG006|STARTED|Part 1||6
6680503|NCT02661178|7612367|FG007|STARTED|Part 1||6
6680504|NCT02661178|7612368|FG008|STARTED|Part 1||6
6680505|NCT02661178|7612369|FG009|STARTED|Part 1||12
6680506|NCT02661178|7612370|FG010|STARTED|Part 1||4
6680507|NCT02661178|7612371|FG011|STARTED|Part 1||0
6680508|NCT02661178|7612372|FG012|STARTED|Part 1||0
6680509|NCT02661178|7612373|FG013|STARTED|Part 1||0
6680510|NCT02661178|7612374|FG014|STARTED|Part 1||0
6680511|NCT02661178|7612360|FG000|COMPLETED|Part 1||0
6680512|NCT02661178|7612361|FG001|COMPLETED|Part 1||5
6680513|NCT02661178|7612362|FG002|COMPLETED|Part 1||6
6680514|NCT02661178|7612363|FG003|COMPLETED|Part 1||6
6680515|NCT02661178|7612364|FG004|COMPLETED|Part 1||5
6680516|NCT02661178|7612365|FG005|COMPLETED|Part 1||6
6680517|NCT02661178|7612366|FG006|COMPLETED|Part 1||6
6680518|NCT02661178|7612367|FG007|COMPLETED|Part 1||6
6680519|NCT02661178|7612368|FG008|COMPLETED|Part 1||6
6680520|NCT02661178|7612369|FG009|COMPLETED|Part 1||12
6680521|NCT02661178|7612370|FG010|COMPLETED|Part 1||4
6680522|NCT02661178|7612371|FG011|COMPLETED|Part 1||0
6680523|NCT02661178|7612372|FG012|COMPLETED|Part 1||0
6680524|NCT02661178|7612373|FG013|COMPLETED|Part 1||0
6680525|NCT02661178|7612374|FG014|COMPLETED|Part 1||0
6680526|NCT02661178|7612360|FG000|NOT COMPLETED|Part 1||1
6680527|NCT02661178|7612361|FG001|NOT COMPLETED|Part 1||0
6680528|NCT02661178|7612362|FG002|NOT COMPLETED|Part 1||0
6680529|NCT02661178|7612363|FG003|NOT COMPLETED|Part 1||0
6680530|NCT02661178|7612364|FG004|NOT COMPLETED|Part 1||0
6680531|NCT02661178|7612365|FG005|NOT COMPLETED|Part 1||0
6680532|NCT02661178|7612366|FG006|NOT COMPLETED|Part 1||0
6680533|NCT02661178|7612367|FG007|NOT COMPLETED|Part 1||0
6680534|NCT02661178|7612368|FG008|NOT COMPLETED|Part 1||0
6680535|NCT02661178|7612369|FG009|NOT COMPLETED|Part 1||0
6680536|NCT02661178|7612370|FG010|NOT COMPLETED|Part 1||0
6680537|NCT02661178|7612371|FG011|NOT COMPLETED|Part 1||0
6680538|NCT02661178|7612372|FG012|NOT COMPLETED|Part 1||0
6680539|NCT02661178|7612373|FG013|NOT COMPLETED|Part 1||0
6680540|NCT02661178|7612374|FG014|NOT COMPLETED|Part 1||0
6680541|NCT02661178|7612360|FG000|STARTED|Part 2||0
6680542|NCT02661178|7612361|FG001|STARTED|Part 2||0
6680543|NCT02661178|7612362|FG002|STARTED|Part 2||0
6680544|NCT02661178|7612363|FG003|STARTED|Part 2||0
6680545|NCT02661178|7612364|FG004|STARTED|Part 2||0
6680546|NCT02661178|7612365|FG005|STARTED|Part 2||0
6680547|NCT02661178|7612366|FG006|STARTED|Part 2||0
6680548|NCT02661178|7612367|FG007|STARTED|Part 2||0
6680549|NCT02661178|7612368|FG008|STARTED|Part 2||0
6680550|NCT02661178|7612369|FG009|STARTED|Part 2||0
6680551|NCT02661178|7612370|FG010|STARTED|Part 2||0
6680552|NCT02661178|7612371|FG011|STARTED|Part 2||6
6680553|NCT02661178|7612372|FG012|STARTED|Part 2||6
6680554|NCT02661178|7612373|FG013|STARTED|Part 2||2
6680555|NCT02661178|7612374|FG014|STARTED|Part 2||2
6680556|NCT02661178|7612360|FG000|COMPLETED|Part 2||0
6680557|NCT02661178|7612361|FG001|COMPLETED|Part 2||0
6680558|NCT02661178|7612362|FG002|COMPLETED|Part 2||0
6680559|NCT02661178|7612363|FG003|COMPLETED|Part 2||0
6680560|NCT02661178|7612364|FG004|COMPLETED|Part 2||0
6680561|NCT02661178|7612365|FG005|COMPLETED|Part 2||0
6680562|NCT02661178|7612366|FG006|COMPLETED|Part 2||0
6680563|NCT02661178|7612367|FG007|COMPLETED|Part 2||0
6680564|NCT02661178|7612368|FG008|COMPLETED|Part 2||0
6680565|NCT02661178|7612369|FG009|COMPLETED|Part 2||0
6680566|NCT02661178|7612370|FG010|COMPLETED|Part 2||0
6680567|NCT02661178|7612371|FG011|COMPLETED|Part 2||6
6680568|NCT02661178|7612372|FG012|COMPLETED|Part 2||6
6680569|NCT02661178|7612373|FG013|COMPLETED|Part 2||2
6680570|NCT02661178|7612374|FG014|COMPLETED|Part 2||2
6680571|NCT02661178|7612360|FG000|NOT COMPLETED|Part 2||0
6680572|NCT02661178|7612361|FG001|NOT COMPLETED|Part 2||0
6680573|NCT02661178|7612362|FG002|NOT COMPLETED|Part 2||0
6680574|NCT02661178|7612363|FG003|NOT COMPLETED|Part 2||0
6680575|NCT02661178|7612364|FG004|NOT COMPLETED|Part 2||0
6680576|NCT02661178|7612365|FG005|NOT COMPLETED|Part 2||0
6680577|NCT02661178|7612366|FG006|NOT COMPLETED|Part 2||0
6680578|NCT02661178|7612367|FG007|NOT COMPLETED|Part 2||0
6680579|NCT02661178|7612368|FG008|NOT COMPLETED|Part 2||0
6680580|NCT02661178|7612369|FG009|NOT COMPLETED|Part 2||0
6680581|NCT02661178|7612370|FG010|NOT COMPLETED|Part 2||0
6680582|NCT02661178|7612371|FG011|NOT COMPLETED|Part 2||0
6680583|NCT02661178|7612372|FG012|NOT COMPLETED|Part 2||0
6680584|NCT02661178|7612373|FG013|NOT COMPLETED|Part 2||0
6680585|NCT02661178|7612374|FG014|NOT COMPLETED|Part 2||0
6738447|NCT03285295|7667829|FG000|STARTED|Alinity s HBsAg||17095
6738448|NCT03285295|7667830|FG001|STARTED|Alinity s HBsAg||438
6738449|NCT03285295|7667831|FG002|STARTED|Alinity s HBsAg||403
6738450|NCT03285295|7667832|FG003|STARTED|Alinity s HBsAg||0
6738451|NCT03285295|7667833|FG004|STARTED|Alinity s HBsAg||51
6738452|NCT03285295|7667829|FG000|COMPLETED|Alinity s HBsAg||16993
6738453|NCT03285295|7667830|FG001|COMPLETED|Alinity s HBsAg||432
6738454|NCT03285295|7667831|FG002|COMPLETED|Alinity s HBsAg||403
6738455|NCT03285295|7667832|FG003|COMPLETED|Alinity s HBsAg||0
6738456|NCT03285295|7667833|FG004|COMPLETED|Alinity s HBsAg||51
6738457|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s HBsAg||102
6738458|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s HBsAg||6
6738459|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s HBsAg||0
6738460|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s HBsAg||0
6738461|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s HBsAg||0
6738462|NCT03285295|7667829|FG000|STARTED|Alinity s HBsAg Confirmatory||8
6738463|NCT03285295|7667830|FG001|STARTED|Alinity s HBsAg Confirmatory||432
6738464|NCT03285295|7667831|FG002|STARTED|Alinity s HBsAg Confirmatory||3
6738465|NCT03285295|7667832|FG003|STARTED|Alinity s HBsAg Confirmatory||0
6738466|NCT03285295|7667833|FG004|STARTED|Alinity s HBsAg Confirmatory||0
6738467|NCT03285295|7667829|FG000|COMPLETED|Alinity s HBsAg Confirmatory||8
6738468|NCT03285295|7667830|FG001|COMPLETED|Alinity s HBsAg Confirmatory||432
6738469|NCT03285295|7667831|FG002|COMPLETED|Alinity s HBsAg Confirmatory||3
6738470|NCT03285295|7667832|FG003|COMPLETED|Alinity s HBsAg Confirmatory||0
6738471|NCT03285295|7667833|FG004|COMPLETED|Alinity s HBsAg Confirmatory||0
6738472|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6738473|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6738474|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6738475|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6738476|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s HBsAg Confirmatory||0
6738477|NCT03285295|7667829|FG000|STARTED|Alinity s HBsAg Follow-Up||0
6738478|NCT03285295|7667830|FG001|STARTED|Alinity s HBsAg Follow-Up||0
6738479|NCT03285295|7667831|FG002|STARTED|Alinity s HBsAg Follow-Up||0
6738480|NCT03285295|7667832|FG003|STARTED|Alinity s HBsAg Follow-Up||0
6738481|NCT03285295|7667833|FG004|STARTED|Alinity s HBsAg Follow-Up||0
6738482|NCT03285295|7667829|FG000|COMPLETED|Alinity s HBsAg Follow-Up||0
6738483|NCT03285295|7667830|FG001|COMPLETED|Alinity s HBsAg Follow-Up||0
6738484|NCT03285295|7667831|FG002|COMPLETED|Alinity s HBsAg Follow-Up||0
6738485|NCT03285295|7667832|FG003|COMPLETED|Alinity s HBsAg Follow-Up||0
6738486|NCT03285295|7667833|FG004|COMPLETED|Alinity s HBsAg Follow-Up||0
6738487|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6738488|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6738489|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6738490|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6738491|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s HBsAg Follow-Up||0
6738492|NCT03285295|7667829|FG000|STARTED|Alinity s HTLV I/II||15968
6738493|NCT03285295|7667830|FG001|STARTED|Alinity s HTLV I/II||706
6738494|NCT03285295|7667831|FG002|STARTED|Alinity s HTLV I/II||502
6738495|NCT03285295|7667832|FG003|STARTED|Alinity s HTLV I/II||509
6738496|NCT03285295|7667833|FG004|STARTED|Alinity s HTLV I/II||0
6738497|NCT03285295|7667829|FG000|COMPLETED|Alinity s HTLV I/II||15877
6738498|NCT03285295|7667830|FG001|COMPLETED|Alinity s HTLV I/II||706
6738499|NCT03285295|7667831|FG002|COMPLETED|Alinity s HTLV I/II||502
6738500|NCT03285295|7667832|FG003|COMPLETED|Alinity s HTLV I/II||509
6738501|NCT03285295|7667833|FG004|COMPLETED|Alinity s HTLV I/II||0
6738502|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s HTLV I/II||91
6738503|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s HTLV I/II||0
6738504|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s HTLV I/II||0
6738505|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s HTLV I/II||0
6738506|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s HTLV I/II||0
6738507|NCT03285295|7667829|FG000|STARTED|Alinity s HTLV I/II Follow-Up||12
6738508|NCT03285295|7667830|FG001|STARTED|Alinity s HTLV I/II Follow-Up||0
6738509|NCT03285295|7667831|FG002|STARTED|Alinity s HTLV I/II Follow-Up||0
6738510|NCT03285295|7667832|FG003|STARTED|Alinity s HTLV I/II Follow-Up||0
6738511|NCT03285295|7667833|FG004|STARTED|Alinity s HTLV I/II Follow-Up||0
6738512|NCT03285295|7667829|FG000|COMPLETED|Alinity s HTLV I/II Follow-Up||8
6738513|NCT03285295|7667830|FG001|COMPLETED|Alinity s HTLV I/II Follow-Up||0
6738514|NCT03285295|7667831|FG002|COMPLETED|Alinity s HTLV I/II Follow-Up||0
6738515|NCT03285295|7667832|FG003|COMPLETED|Alinity s HTLV I/II Follow-Up||0
6738516|NCT03285295|7667833|FG004|COMPLETED|Alinity s HTLV I/II Follow-Up||0
6680586|NCT02661217|7612426|FG000|STARTED|Overall Study||500
6680587|NCT02661217|7612427|FG001|STARTED|Overall Study||502
6680588|NCT02661217|7612426|FG000|Started 10 Weeks Treatment Epoch|Overall Study||497
6680589|NCT02661217|7612427|FG001|Started 10 Weeks Treatment Epoch|Overall Study||501
6680590|NCT02661217|7612426|FG000|Completed 10 Weeks Treatment Epoch|Overall Study||460
6680591|NCT02661217|7612427|FG001|Completed 10 Weeks Treatment Epoch|Overall Study||455
6680592|NCT02661217|7612426|FG000|COMPLETED|Overall Study||425
6680593|NCT02661217|7612427|FG001|COMPLETED|Overall Study||419
6680594|NCT02661217|7612426|FG000|NOT COMPLETED|Overall Study||75
6680595|NCT02661217|7612427|FG001|NOT COMPLETED|Overall Study||83
6680596|NCT02661256|7612434|FG000|STARTED|Overall Study|Each participant went through arms in same order: on nCPAP then off nCPAP. 1 participant at a time.|7
6680597|NCT02661256|7612434|FG000|COMPLETED|Overall Study||7
6680598|NCT02661256|7612434|FG000|NOT COMPLETED|Overall Study||0
6680599|NCT02661490|7612445|FG000|STARTED|Overall Study||76
6680600|NCT02661490|7612446|FG001|STARTED|Overall Study||74
6680601|NCT02661490|7612447|FG002|STARTED|Overall Study||72
6680602|NCT02661490|7612448|FG003|STARTED|Overall Study||72
6680603|NCT02661490|7612449|FG004|STARTED|Overall Study||26
6680604|NCT02661490|7612445|FG000|COMPLETED|Overall Study||73
6680605|NCT02661490|7612446|FG001|COMPLETED|Overall Study||72
6680606|NCT02661490|7612447|FG002|COMPLETED|Overall Study||70
6680607|NCT02661490|7612448|FG003|COMPLETED|Overall Study||71
6680608|NCT02661490|7612449|FG004|COMPLETED|Overall Study||23
6680609|NCT02661490|7612445|FG000|NOT COMPLETED|Overall Study||3
6680610|NCT02661490|7612446|FG001|NOT COMPLETED|Overall Study||2
6680611|NCT02661490|7612447|FG002|NOT COMPLETED|Overall Study||2
6680612|NCT02661490|7612448|FG003|NOT COMPLETED|Overall Study||1
6680613|NCT02661490|7612449|FG004|NOT COMPLETED|Overall Study||3
6680614|NCT02661594|7612465|FG000|STARTED|Overall Study||10
6680615|NCT02661594|7612466|FG001|STARTED|Overall Study||11
6680616|NCT02661594|7612467|FG002|STARTED|Overall Study||10
6680617|NCT02661594|7612468|FG003|STARTED|Overall Study||9
6680618|NCT02661594|7612465|FG000|COMPLETED|Overall Study||9
6680619|NCT02661594|7612466|FG001|COMPLETED|Overall Study||11
6680620|NCT02661594|7612467|FG002|COMPLETED|Overall Study||9
6680621|NCT02661594|7612468|FG003|COMPLETED|Overall Study||9
6680622|NCT02661594|7612465|FG000|NOT COMPLETED|Overall Study||1
6680623|NCT02661594|7612466|FG001|NOT COMPLETED|Overall Study||0
6680624|NCT02661594|7612467|FG002|NOT COMPLETED|Overall Study||1
6680625|NCT02661594|7612468|FG003|NOT COMPLETED|Overall Study||0
6680626|NCT02661737|7612478|FG000|STARTED|Overall Study||503
6680627|NCT02661737|7612478|FG000|COMPLETED|Overall Study||469
6680628|NCT02661737|7612478|FG000|NOT COMPLETED|Overall Study||34
6680629|NCT02661815|7612486|FG000|STARTED|Overall Study||6
6680630|NCT02661815|7612487|FG001|STARTED|Overall Study||0
6680631|NCT02661815|7612488|FG002|STARTED|Overall Study||0
6680632|NCT02661815|7612489|FG003|STARTED|Overall Study||0
6680633|NCT02661815|7612486|FG000|COMPLETED|Overall Study||5
6680634|NCT02661815|7612487|FG001|COMPLETED|Overall Study||0
6680635|NCT02661815|7612488|FG002|COMPLETED|Overall Study||0
6680636|NCT02661815|7612489|FG003|COMPLETED|Overall Study||0
6680637|NCT02661815|7612486|FG000|NOT COMPLETED|Overall Study||1
6680638|NCT02661815|7612487|FG001|NOT COMPLETED|Overall Study||0
6680639|NCT02661815|7612488|FG002|NOT COMPLETED|Overall Study||0
6680640|NCT02661815|7612489|FG003|NOT COMPLETED|Overall Study||0
6680641|NCT02661828|7612505|FG000|STARTED|Overall Study||1
6680642|NCT02661828|7612506|FG001|STARTED|Overall Study||0
6256328|NCT04929522|7155205|FG001|NOT COMPLETED|Overall Study||0
6256329|NCT04929522|7155206|FG002|NOT COMPLETED|Overall Study||0
6256330|NCT04929522|7155207|FG003|NOT COMPLETED|Overall Study||0
6279047|NCT00141102|7178722|FG001|NOT COMPLETED|Overall Study||625
6279048|NCT00141115|7178729|FG000|STARTED|Overall Study||3
6279049|NCT00141115|7178729|FG000|COMPLETED|Overall Study||2
6279050|NCT00141115|7178729|FG000|NOT COMPLETED|Overall Study||1
6279051|NCT00141219|7178736|FG000|STARTED|Overall Study||162
6279052|NCT00141219|7178737|FG001|STARTED|Overall Study||78
6279053|NCT00141219|7178736|FG000|COMPLETED|Overall Study||138
6279054|NCT00141219|7178737|FG001|COMPLETED|Overall Study||62
6279055|NCT00141219|7178736|FG000|NOT COMPLETED|Overall Study||24
6279056|NCT00141219|7178737|FG001|NOT COMPLETED|Overall Study||16
6279057|NCT00141271|7178746|FG000|STARTED|Overall Study||171
6279058|NCT00141271|7178747|FG001|STARTED|Overall Study||165
6279059|NCT00141271|7178748|FG002|STARTED|Overall Study||168
6279060|NCT00141271|7178746|FG000|COMPLETED|Overall Study||91
6279061|NCT00141271|7178747|FG001|COMPLETED|Overall Study||102
6279062|NCT00141271|7178748|FG002|COMPLETED|Overall Study||111
6279063|NCT00141271|7178746|FG000|NOT COMPLETED|Overall Study||80
6279064|NCT00141271|7178747|FG001|NOT COMPLETED|Overall Study||63
6279065|NCT00141271|7178748|FG002|NOT COMPLETED|Overall Study||57
6279066|NCT00141297|7178758|FG000|STARTED|Overall Study||3
6279067|NCT00141297|7178759|FG001|STARTED|Overall Study||3
6279068|NCT00141297|7178760|FG002|STARTED|Overall Study||7
6602204|NCT02055404|7527155|FG000|STARTED|Overall Study||3
6602205|NCT02055404|7527155|FG000|COMPLETED|Overall Study||3
6602206|NCT02055404|7527155|FG000|NOT COMPLETED|Overall Study||0
6602207|NCT02055430|7527170|FG000|STARTED|Overall Study||45
6602208|NCT02055430|7527171|FG001|STARTED|Overall Study||45
6602209|NCT02055430|7527170|FG000|COMPLETED|Overall Study||45
6602210|NCT02055430|7527171|FG001|COMPLETED|Overall Study||45
6602211|NCT02055430|7527170|FG000|NOT COMPLETED|Overall Study||0
6602212|NCT02055430|7527171|FG001|NOT COMPLETED|Overall Study||0
6602213|NCT02055638|7527179|FG000|STARTED|Overall Study||49
6602214|NCT02055638|7527180|FG001|STARTED|Overall Study||48
6602215|NCT02055638|7527179|FG000|COMPLETED|Overall Study||39
6602216|NCT02055638|7527180|FG001|COMPLETED|Overall Study||40
6602217|NCT02055638|7527179|FG000|NOT COMPLETED|Overall Study||10
6602218|NCT02055638|7527180|FG001|NOT COMPLETED|Overall Study||8
6602219|NCT02055781|7527189|FG000|STARTED|Overall Study||104
6602220|NCT02055781|7527190|FG001|STARTED|Overall Study||107
6602221|NCT02055781|7527191|FG002|STARTED|Overall Study||100
6602222|NCT02055781|7527189|FG000|COMPLETED|Overall Study||62
6602223|NCT02055781|7527190|FG001|COMPLETED|Overall Study||79
6602224|NCT02055781|7527191|FG002|COMPLETED|Overall Study||63
6602225|NCT02055781|7527189|FG000|NOT COMPLETED|Overall Study||42
6602226|NCT02055781|7527190|FG001|NOT COMPLETED|Overall Study||28
6602227|NCT02055781|7527191|FG002|NOT COMPLETED|Overall Study||37
6602228|NCT02055820|7527209|FG000|STARTED|Phase I: Dose-Finding||7
6602229|NCT02055820|7527210|FG001|STARTED|Phase I: Dose-Finding||3
6602230|NCT02055820|7527211|FG002|STARTED|Phase I: Dose-Finding||8
6680643|NCT02661828|7612505|FG000|COMPLETED|Overall Study||1
6680644|NCT02661828|7612506|FG001|COMPLETED|Overall Study||0
6602231|NCT02055820|7527212|FG003|STARTED|Phase I: Dose-Finding||6
6602232|NCT02055820|7527213|FG004|STARTED|Phase I: Dose-Finding||0
6602233|NCT02055820|7527214|FG005|STARTED|Phase I: Dose-Finding||7
6602234|NCT02055820|7527215|FG006|STARTED|Phase I: Dose-Finding||7
6279069|NCT00141297|7178761|FG003|STARTED|Overall Study||3
6279070|NCT00141297|7178762|FG004|STARTED|Overall Study||22
6279071|NCT00141297|7178763|FG005|STARTED|Overall Study||3
6602235|NCT02055820|7527216|FG007|STARTED|Phase I: Dose-Finding||6
6602236|NCT02055820|7527217|FG008|STARTED|Phase I: Dose-Finding||6
6602237|NCT02055820|7527218|FG009|STARTED|Phase I: Dose-Finding||6
6602238|NCT02055820|7527209|FG000|COMPLETED|Phase I: Dose-Finding||6
6602239|NCT02055820|7527210|FG001|COMPLETED|Phase I: Dose-Finding||3
6279072|NCT00141297|7178764|FG006|STARTED|Overall Study||3
6680645|NCT02661828|7612505|FG000|NOT COMPLETED|Overall Study||0
6680646|NCT02661828|7612506|FG001|NOT COMPLETED|Overall Study||0
6680647|NCT02662023|7612513|FG000|STARTED|Overall Study||12
6680648|NCT02662023|7612514|FG001|STARTED|Overall Study||12
6680649|NCT02662023|7612513|FG000|COMPLETED|Overall Study||12
6680650|NCT02662023|7612514|FG001|COMPLETED|Overall Study||12
6680651|NCT02662023|7612513|FG000|NOT COMPLETED|Overall Study||0
6680652|NCT02662023|7612514|FG001|NOT COMPLETED|Overall Study||0
6680653|NCT02662036|7612522|FG000|STARTED|Overall Study||35
6680654|NCT02662036|7612523|FG001|STARTED|Overall Study||35
6256331|NCT04927858|7155217|FG000|STARTED|Overall Study||460558
6256332|NCT04927858|7155217|FG000|Treated With Empagliflozin|Overall Study||16985
6256333|NCT04927858|7155217|FG000|COMPLETED|Overall Study||460558
6256334|NCT04927858|7155217|FG000|NOT COMPLETED|Overall Study||0
6279073|NCT00141297|7178765|FG007|STARTED|Overall Study||4
6279074|NCT00141297|7178766|FG008|STARTED|Overall Study||20
6279075|NCT00141297|7178767|FG009|STARTED|Overall Study||6
6279076|NCT00141297|7178758|FG000|COMPLETED|Overall Study||0
6279077|NCT00141297|7178759|FG001|COMPLETED|Overall Study||0
6279078|NCT00141297|7178760|FG002|COMPLETED|Overall Study||0
6279079|NCT00141297|7178761|FG003|COMPLETED|Overall Study||0
6279080|NCT00141297|7178762|FG004|COMPLETED|Overall Study||0
6279081|NCT00141297|7178763|FG005|COMPLETED|Overall Study||0
6279082|NCT00141297|7178764|FG006|COMPLETED|Overall Study||0
6279083|NCT00141297|7178765|FG007|COMPLETED|Overall Study||0
6279084|NCT00141297|7178766|FG008|COMPLETED|Overall Study||0
6279085|NCT00141297|7178767|FG009|COMPLETED|Overall Study||0
6279086|NCT00141297|7178758|FG000|NOT COMPLETED|Overall Study||3
6279087|NCT00141297|7178759|FG001|NOT COMPLETED|Overall Study||3
6279088|NCT00141297|7178760|FG002|NOT COMPLETED|Overall Study||7
6279089|NCT00141297|7178761|FG003|NOT COMPLETED|Overall Study||3
6279090|NCT00141297|7178762|FG004|NOT COMPLETED|Overall Study||22
6279091|NCT00141297|7178763|FG005|NOT COMPLETED|Overall Study||3
6279092|NCT00141297|7178764|FG006|NOT COMPLETED|Overall Study||3
6279093|NCT00141297|7178765|FG007|NOT COMPLETED|Overall Study||4
6279094|NCT00141297|7178766|FG008|NOT COMPLETED|Overall Study||20
6279095|NCT00141297|7178767|FG009|NOT COMPLETED|Overall Study||6
6279096|NCT00141453|7178802|FG000|STARTED|Overall Study||288
6279097|NCT00141453|7178803|FG001|STARTED|Overall Study||289
6279098|NCT00141453|7178802|FG000|COMPLETED|Overall Study||282
6279099|NCT00141453|7178803|FG001|COMPLETED|Overall Study||284
6279100|NCT00141453|7178802|FG000|NOT COMPLETED|Overall Study||6
6279101|NCT00141453|7178803|FG001|NOT COMPLETED|Overall Study||5
6279102|NCT00141518|7178812|FG000|STARTED|Overall Study||37
6279103|NCT00141518|7178813|FG001|STARTED|Overall Study||22
6279104|NCT00141518|7178814|FG002|STARTED|Overall Study||18
6279105|NCT00141518|7178812|FG000|Safety Sample|Overall Study||36
6279106|NCT00141518|7178813|FG001|Safety Sample|Overall Study||22
6279107|NCT00141518|7178814|FG002|Safety Sample|Overall Study||18
6279108|NCT00141518|7178812|FG000|Full Analysis Sample|Overall Study||27
6279109|NCT00141518|7178813|FG001|Full Analysis Sample|Overall Study||22
6279110|NCT00141518|7178814|FG002|Full Analysis Sample|Overall Study||18
6279111|NCT00141518|7178812|FG000|COMPLETED|Overall Study||21
6279112|NCT00141518|7178813|FG001|COMPLETED|Overall Study||16
6279113|NCT00141518|7178814|FG002|COMPLETED|Overall Study||12
6279114|NCT00141518|7178812|FG000|NOT COMPLETED|Overall Study||16
6279115|NCT00141518|7178813|FG001|NOT COMPLETED|Overall Study||6
6279116|NCT00141518|7178814|FG002|NOT COMPLETED|Overall Study||6
6279117|NCT00141726|7178824|FG000|STARTED|Overall Study||34
6279118|NCT00141726|7178824|FG000|COMPLETED|Overall Study||31
6279119|NCT00141726|7178824|FG000|NOT COMPLETED|Overall Study||3
6279120|NCT00141739|7178828|FG000|STARTED|Overall Study|Number of evaluable patients|100
6279121|NCT00141739|7178828|FG000|COMPLETED|Overall Study||100
6279122|NCT00141739|7178828|FG000|NOT COMPLETED|Overall Study||0
6279123|NCT00141765|7178834|FG000|STARTED|Overall Study||25
6279124|NCT00141765|7178834|FG000|COMPLETED|Overall Study||25
6279125|NCT00141765|7178834|FG000|NOT COMPLETED|Overall Study||0
6279126|NCT00141778|7178841|FG000|STARTED|Randomization Prior to Study Med||152
6279127|NCT00141778|7178842|FG001|STARTED|Randomization Prior to Study Med||153
6279128|NCT00141778|7178843|FG002|STARTED|Randomization Prior to Study Med||153
6279129|NCT00141778|7178841|FG000|COMPLETED|Randomization Prior to Study Med||147
6279130|NCT00141778|7178842|FG001|COMPLETED|Randomization Prior to Study Med||151
6279131|NCT00141778|7178843|FG002|COMPLETED|Randomization Prior to Study Med||147
6279132|NCT00141778|7178841|FG000|NOT COMPLETED|Randomization Prior to Study Med||5
6279133|NCT00141778|7178842|FG001|NOT COMPLETED|Randomization Prior to Study Med||2
6281028|NCT00160693|7180896|FG000|NOT COMPLETED|Overall Study||235
6680655|NCT02662036|7612522|FG000|COMPLETED|Overall Study||22
6680656|NCT02662036|7612523|FG001|COMPLETED|Overall Study||22
6680657|NCT02662036|7612522|FG000|NOT COMPLETED|Overall Study||13
6680658|NCT02662036|7612523|FG001|NOT COMPLETED|Overall Study||13
6680659|NCT02662244|7612529|FG000|STARTED|Overall Study||33
6680660|NCT02662244|7612529|FG000|COMPLETED|Overall Study||31
6680661|NCT02662244|7612529|FG000|NOT COMPLETED|Overall Study||2
6680662|NCT02662387|7612537|FG000|STARTED|Overall Study||27
6680663|NCT02662387|7612538|FG001|STARTED|Overall Study||28
6680664|NCT02662387|7612537|FG000|COMPLETED|Overall Study||27
6680665|NCT02662387|7612538|FG001|COMPLETED|Overall Study||28
6680666|NCT02662387|7612537|FG000|NOT COMPLETED|Overall Study||0
6680667|NCT02662387|7612538|FG001|NOT COMPLETED|Overall Study||0
6680668|NCT02662556|7612546|FG000|STARTED|Overall Study||140
6680669|NCT02662556|7612546|FG000|COMPLETED|Overall Study||132
6680670|NCT02662556|7612546|FG000|NOT COMPLETED|Overall Study||8
6680671|NCT02662569|7612555|FG000|STARTED|Overall Study||166
6680672|NCT02662569|7612556|FG001|STARTED|Overall Study||161
6680673|NCT02662569|7612557|FG002|STARTED|Overall Study||327
6680674|NCT02662569|7612558|FG003|STARTED|Overall Study||332
6680675|NCT02662569|7612555|FG000|Received Study Drug|Overall Study||164
6680676|NCT02662569|7612556|FG001|Received Study Drug|Overall Study||160
6680677|NCT02662569|7612557|FG002|Received Study Drug|Overall Study||325
6680678|NCT02662569|7612558|FG003|Received Study Drug|Overall Study||332
6680679|NCT02662569|7612555|FG000|COMPLETED|Overall Study||159
6680680|NCT02662569|7612556|FG001|COMPLETED|Overall Study||160
6680681|NCT02662569|7612557|FG002|COMPLETED|Overall Study||321
6680682|NCT02662569|7612558|FG003|COMPLETED|Overall Study||328
6680683|NCT02662569|7612555|FG000|NOT COMPLETED|Overall Study||7
6680684|NCT02662569|7612556|FG001|NOT COMPLETED|Overall Study||1
6680685|NCT02662569|7612557|FG002|NOT COMPLETED|Overall Study||6
6680686|NCT02662569|7612558|FG003|NOT COMPLETED|Overall Study||4
6680687|NCT02662582|7612570|FG000|STARTED|Treatment Period 1 (14 Days)||23
6680688|NCT02662582|7612571|FG001|STARTED|Treatment Period 1 (14 Days)||23
6680689|NCT02662582|7612570|FG000|COMPLETED|Treatment Period 1 (14 Days)||18
6680690|NCT02662582|7612571|FG001|COMPLETED|Treatment Period 1 (14 Days)||19
6680691|NCT02662582|7612570|FG000|NOT COMPLETED|Treatment Period 1 (14 Days)||5
6680692|NCT02662582|7612571|FG001|NOT COMPLETED|Treatment Period 1 (14 Days)||4
6680693|NCT02662582|7612570|FG000|STARTED|Washout Period (14 Days)||18
6680694|NCT02662582|7612571|FG001|STARTED|Washout Period (14 Days)||19
6680695|NCT02662582|7612570|FG000|COMPLETED|Washout Period (14 Days)||18
6680696|NCT02662582|7612571|FG001|COMPLETED|Washout Period (14 Days)||19
6680697|NCT02662582|7612570|FG000|NOT COMPLETED|Washout Period (14 Days)||0
6680698|NCT02662582|7612571|FG001|NOT COMPLETED|Washout Period (14 Days)||0
6680699|NCT02662582|7612570|FG000|STARTED|Treatment Period 2 (14 Days)||18
6680700|NCT02662582|7612571|FG001|STARTED|Treatment Period 2 (14 Days)||19
6680701|NCT02662582|7612570|FG000|COMPLETED|Treatment Period 2 (14 Days)||18
6680702|NCT02662582|7612571|FG001|COMPLETED|Treatment Period 2 (14 Days)||19
6680703|NCT02662582|7612570|FG000|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6680704|NCT02662582|7612571|FG001|NOT COMPLETED|Treatment Period 2 (14 Days)||0
6680705|NCT02662608|7612578|FG000|STARTED|Overall Study||1
6680706|NCT02662608|7612578|FG000|COMPLETED|Overall Study||1
6680707|NCT02662608|7612578|FG000|NOT COMPLETED|Overall Study||0
6680708|NCT02662764|7612582|FG000|STARTED|Overall Study||320
6680709|NCT02662764|7612582|FG000|COMPLETED|Overall Study|First 24-hours of study treatment|290
6680710|NCT02662764|7612582|FG000|NOT COMPLETED|Overall Study||30
6680711|NCT02663128|7612593|FG000|STARTED|Period 1||3
6680712|NCT02663128|7612594|FG001|STARTED|Period 1||3
6680713|NCT02663128|7612595|FG002|STARTED|Period 1||3
6680714|NCT02663128|7612596|FG003|STARTED|Period 1||3
6680715|NCT02663128|7612597|FG004|STARTED|Period 1||3
6680716|NCT02663128|7612598|FG005|STARTED|Period 1||3
6680717|NCT02663128|7612593|FG000|Received at Least One Dose of Study Drug|Period 1||3
6680718|NCT02663128|7612594|FG001|Received at Least One Dose of Study Drug|Period 1||3
6680719|NCT02663128|7612595|FG002|Received at Least One Dose of Study Drug|Period 1||3
6680720|NCT02663128|7612596|FG003|Received at Least One Dose of Study Drug|Period 1||3
6680721|NCT02663128|7612597|FG004|Received at Least One Dose of Study Drug|Period 1||3
6680722|NCT02663128|7612598|FG005|Received at Least One Dose of Study Drug|Period 1||3
6680723|NCT02663128|7612593|FG000|COMPLETED|Period 1||3
6680724|NCT02663128|7612594|FG001|COMPLETED|Period 1||3
6680725|NCT02663128|7612595|FG002|COMPLETED|Period 1||3
6680726|NCT02663128|7612596|FG003|COMPLETED|Period 1||3
6680727|NCT02663128|7612597|FG004|COMPLETED|Period 1||3
6680728|NCT02663128|7612598|FG005|COMPLETED|Period 1||3
6680729|NCT02663128|7612593|FG000|NOT COMPLETED|Period 1||0
6680730|NCT02663128|7612594|FG001|NOT COMPLETED|Period 1||0
6680731|NCT02663128|7612595|FG002|NOT COMPLETED|Period 1||0
6680732|NCT02663128|7612596|FG003|NOT COMPLETED|Period 1||0
6680733|NCT02663128|7612597|FG004|NOT COMPLETED|Period 1||0
6680734|NCT02663128|7612598|FG005|NOT COMPLETED|Period 1||0
6680735|NCT02663128|7612593|FG000|STARTED|Period 2||3
6680736|NCT02663128|7612594|FG001|STARTED|Period 2||3
6680737|NCT02663128|7612595|FG002|STARTED|Period 2||3
6680738|NCT02663128|7612596|FG003|STARTED|Period 2||3
6680739|NCT02663128|7612597|FG004|STARTED|Period 2||3
6680740|NCT02663128|7612598|FG005|STARTED|Period 2||3
6680741|NCT02663128|7612593|FG000|COMPLETED|Period 2||3
6680742|NCT02663128|7612594|FG001|COMPLETED|Period 2||3
6680743|NCT02663128|7612595|FG002|COMPLETED|Period 2||3
6680744|NCT02663128|7612596|FG003|COMPLETED|Period 2||3
6680745|NCT02663128|7612597|FG004|COMPLETED|Period 2||2
6680746|NCT02663128|7612598|FG005|COMPLETED|Period 2||3
6680747|NCT02663128|7612593|FG000|NOT COMPLETED|Period 2||0
6680748|NCT02663128|7612594|FG001|NOT COMPLETED|Period 2||0
6680749|NCT02663128|7612595|FG002|NOT COMPLETED|Period 2||0
6680750|NCT02663128|7612596|FG003|NOT COMPLETED|Period 2||0
6680751|NCT02663128|7612597|FG004|NOT COMPLETED|Period 2||1
6680752|NCT02663128|7612598|FG005|NOT COMPLETED|Period 2||0
6680753|NCT02663128|7612593|FG000|STARTED|Period 3||3
6680754|NCT02663128|7612594|FG001|STARTED|Period 3||3
6680755|NCT02663128|7612595|FG002|STARTED|Period 3||3
6680756|NCT02663128|7612596|FG003|STARTED|Period 3||3
6680757|NCT02663128|7612597|FG004|STARTED|Period 3||2
6680758|NCT02663128|7612598|FG005|STARTED|Period 3||3
6680759|NCT02663128|7612593|FG000|COMPLETED|Period 3||3
6680760|NCT02663128|7612594|FG001|COMPLETED|Period 3||3
6680761|NCT02663128|7612595|FG002|COMPLETED|Period 3||3
6680762|NCT02663128|7612596|FG003|COMPLETED|Period 3||3
6680763|NCT02663128|7612597|FG004|COMPLETED|Period 3||2
6680764|NCT02663128|7612598|FG005|COMPLETED|Period 3||3
6680765|NCT02663128|7612593|FG000|NOT COMPLETED|Period 3||0
6680766|NCT02663128|7612594|FG001|NOT COMPLETED|Period 3||0
6680767|NCT02663128|7612595|FG002|NOT COMPLETED|Period 3||0
6680768|NCT02663128|7612596|FG003|NOT COMPLETED|Period 3||0
6680769|NCT02663128|7612597|FG004|NOT COMPLETED|Period 3||0
6680770|NCT02663128|7612598|FG005|NOT COMPLETED|Period 3||0
6680771|NCT02663232|7612607|FG000|STARTED|Overall Study||264
6680772|NCT02663232|7612607|FG000|COMPLETED|Overall Study||264
6680773|NCT02663232|7612607|FG000|NOT COMPLETED|Overall Study||0
6680774|NCT02663453|7612613|FG000|STARTED|Overall Study||22
6680775|NCT02663453|7612614|FG001|STARTED|Overall Study||22
6680776|NCT02663453|7612613|FG000|COMPLETED|Overall Study||17
6680777|NCT02663453|7612614|FG001|COMPLETED|Overall Study||18
6680778|NCT02663453|7612613|FG000|NOT COMPLETED|Overall Study||5
6680779|NCT02663453|7612614|FG001|NOT COMPLETED|Overall Study||4
6680780|NCT02663674|7612622|FG000|STARTED|Overall Study||33
6680781|NCT02663674|7612623|FG001|STARTED|Overall Study||39
6680782|NCT02663674|7612622|FG000|COMPLETED|Overall Study||26
6680783|NCT02663674|7612623|FG001|COMPLETED|Overall Study||29
6680784|NCT02663674|7612622|FG000|NOT COMPLETED|Overall Study||7
6680785|NCT02663674|7612623|FG001|NOT COMPLETED|Overall Study||10
6680786|NCT02663687|7612634|FG000|STARTED|Overall Study||12
6680787|NCT02663687|7612635|FG001|STARTED|Overall Study||9
6680788|NCT02663687|7612636|FG002|STARTED|Overall Study||9
6680789|NCT02663687|7612637|FG003|STARTED|Overall Study||9
6680790|NCT02663687|7612638|FG004|STARTED|Overall Study||9
6680791|NCT02663687|7612634|FG000|Treatment Period 1 (IV)|Overall Study||12
6680792|NCT02663687|7612635|FG001|Treatment Period 1 (IV)|Overall Study||9
6680793|NCT02663687|7612636|FG002|Treatment Period 1 (IV)|Overall Study||9
6680794|NCT02663687|7612637|FG003|Treatment Period 1 (IV)|Overall Study||9
6680795|NCT02663687|7612638|FG004|Treatment Period 1 (IV)|Overall Study||9
6680796|NCT02663687|7612634|FG000|Treatment Period 2 (SC)|Overall Study||10
6680797|NCT02663687|7612635|FG001|Treatment Period 2 (SC)|Overall Study||9
6680798|NCT02663687|7612636|FG002|Treatment Period 2 (SC)|Overall Study||8
6680799|NCT02663687|7612637|FG003|Treatment Period 2 (SC)|Overall Study||9
6680800|NCT02663687|7612638|FG004|Treatment Period 2 (SC)|Overall Study||9
6680801|NCT02663687|7612634|FG000|COMPLETED|Overall Study||10
6256335|NCT04919161|7155224|FG000|STARTED|Overall Study||16
6256336|NCT04919161|7155225|FG001|STARTED|Overall Study||16
6256337|NCT04919161|7155224|FG000|COMPLETED|Overall Study||15
6256338|NCT04919161|7155225|FG001|COMPLETED|Overall Study||14
6256339|NCT04919161|7155224|FG000|NOT COMPLETED|Overall Study||1
6256340|NCT04919161|7155225|FG001|NOT COMPLETED|Overall Study||2
6256341|NCT04912700|7155256|FG000|STARTED|Overall Study||10880
6256342|NCT04912700|7155257|FG001|STARTED|Overall Study||825
6256343|NCT04912700|7155258|FG002|STARTED|Overall Study||129
6256344|NCT04912700|7155256|FG000|COMPLETED|Overall Study||10880
6256345|NCT04912700|7155257|FG001|COMPLETED|Overall Study||825
6256346|NCT04912700|7155258|FG002|COMPLETED|Overall Study||129
6256347|NCT04912700|7155256|FG000|NOT COMPLETED|Overall Study||0
6256348|NCT04912700|7155257|FG001|NOT COMPLETED|Overall Study||0
6256349|NCT04912700|7155258|FG002|NOT COMPLETED|Overall Study||0
6256350|NCT04912297|7155268|FG000|STARTED|Overall Study||99
6256351|NCT04912297|7155269|FG001|STARTED|Overall Study||87
6256352|NCT04912297|7155268|FG000|COMPLETED|Overall Study||68
6256353|NCT04912297|7155269|FG001|COMPLETED|Overall Study||54
6256354|NCT04912297|7155268|FG000|NOT COMPLETED|Overall Study||31
6256355|NCT04912297|7155269|FG001|NOT COMPLETED|Overall Study||33
6256356|NCT04904640|7155275|FG000|STARTED|Overall Study||150
6256357|NCT04904640|7155275|FG000|COMPLETED|Overall Study||150
6256358|NCT04904640|7155275|FG000|NOT COMPLETED|Overall Study||0
6279134|NCT00141778|7178843|FG002|NOT COMPLETED|Randomization Prior to Study Med||6
6279135|NCT00141778|7178841|FG000|STARTED|Started Study Medication||147
6279136|NCT00141778|7178842|FG001|STARTED|Started Study Medication||151
6279137|NCT00141778|7178843|FG002|STARTED|Started Study Medication||147
6680802|NCT02663687|7612635|FG001|COMPLETED|Overall Study||9
6680803|NCT02663687|7612636|FG002|COMPLETED|Overall Study||8
6680804|NCT02663687|7612637|FG003|COMPLETED|Overall Study||9
6680805|NCT02663687|7612638|FG004|COMPLETED|Overall Study||9
6680806|NCT02663687|7612634|FG000|NOT COMPLETED|Overall Study||2
6680807|NCT02663687|7612635|FG001|NOT COMPLETED|Overall Study||0
6680808|NCT02663687|7612636|FG002|NOT COMPLETED|Overall Study||1
6680809|NCT02663687|7612637|FG003|NOT COMPLETED|Overall Study||0
6680810|NCT02663687|7612638|FG004|NOT COMPLETED|Overall Study||0
6680811|NCT02663817|7612663|FG000|STARTED|Overall Study||52
6680812|NCT02663817|7612663|FG000|COMPLETED|Overall Study||50
6680813|NCT02663817|7612663|FG000|NOT COMPLETED|Overall Study||2
6680814|NCT02663882|7612671|FG000|STARTED|Overall Study||39
6680815|NCT02663882|7612672|FG001|STARTED|Overall Study||36
6680816|NCT02663882|7612671|FG000|COMPLETED|Overall Study||35
6680817|NCT02663882|7612672|FG001|COMPLETED|Overall Study||34
6680818|NCT02663882|7612671|FG000|NOT COMPLETED|Overall Study||4
6680819|NCT02663882|7612672|FG001|NOT COMPLETED|Overall Study||2
6680820|NCT02663895|7612678|FG000|STARTED|Overall Study||12
6680821|NCT02663895|7612678|FG000|COMPLETED|Overall Study||5
6680822|NCT02663895|7612678|FG000|NOT COMPLETED|Overall Study||7
6680823|NCT02664220|7612685|FG000|STARTED|Overall Study||50
6680824|NCT02664220|7612686|FG001|STARTED|Overall Study||50
6680825|NCT02664220|7612685|FG000|COMPLETED|Overall Study||50
6680826|NCT02664220|7612686|FG001|COMPLETED|Overall Study||50
6680827|NCT02664220|7612685|FG000|NOT COMPLETED|Overall Study||0
6680828|NCT02664220|7612686|FG001|NOT COMPLETED|Overall Study||0
6680829|NCT02664272|7612692|FG000|STARTED|Overall Study||40
6680830|NCT02664272|7612692|FG000|COMPLETED|Overall Study||38
6680831|NCT02664272|7612692|FG000|NOT COMPLETED|Overall Study||2
6680832|NCT02664311|7612698|FG000|STARTED|Overall Study||6
6680833|NCT02664311|7612699|FG001|STARTED|Overall Study||3
6680834|NCT02664311|7612698|FG000|COMPLETED|Overall Study||6
6680835|NCT02664311|7612699|FG001|COMPLETED|Overall Study||3
6680836|NCT02664311|7612698|FG000|NOT COMPLETED|Overall Study||0
6680837|NCT02664311|7612699|FG001|NOT COMPLETED|Overall Study||0
6680838|NCT02664363|7612705|FG000|STARTED|Overall Study||3
6680839|NCT02664363|7612705|FG000|COMPLETED|Overall Study||3
6680840|NCT02664363|7612705|FG000|NOT COMPLETED|Overall Study||0
6680841|NCT02664415|7612711|FG000|STARTED|Overall Study||14
6680842|NCT02664415|7612712|FG001|STARTED|Overall Study||5
6680843|NCT02664415|7612711|FG000|COMPLETED|Overall Study||13
6680844|NCT02664415|7612712|FG001|COMPLETED|Overall Study||5
6680845|NCT02664415|7612711|FG000|NOT COMPLETED|Overall Study||1
6680846|NCT02664415|7612712|FG001|NOT COMPLETED|Overall Study||0
6680847|NCT02664532|7612720|FG000|STARTED|Overall Study||75
6680848|NCT02664532|7612721|FG001|STARTED|Overall Study||75
6680849|NCT02664532|7612720|FG000|COMPLETED|Overall Study||75
6680850|NCT02664532|7612721|FG001|COMPLETED|Overall Study||75
6680851|NCT02664532|7612720|FG000|NOT COMPLETED|Overall Study||0
6680852|NCT02664532|7612721|FG001|NOT COMPLETED|Overall Study||0
6680853|NCT02664610|7612729|FG000|STARTED|Overall Study||46
6680854|NCT02664610|7612730|FG001|STARTED|Overall Study||48
6680855|NCT02664610|7612729|FG000|COMPLETED|Overall Study||32
6680856|NCT02664610|7612730|FG001|COMPLETED|Overall Study||41
6680857|NCT02664610|7612729|FG000|NOT COMPLETED|Overall Study||14
6680858|NCT02664610|7612730|FG001|NOT COMPLETED|Overall Study||7
6680859|NCT02664909|7612738|FG000|STARTED|Overall Study||17
6680860|NCT02664909|7612739|FG001|STARTED|Overall Study||19
6680861|NCT02664909|7612738|FG000|COMPLETED|Overall Study||15
6680862|NCT02664909|7612739|FG001|COMPLETED|Overall Study||16
6680863|NCT02664909|7612738|FG000|NOT COMPLETED|Overall Study||2
6680864|NCT02664909|7612739|FG001|NOT COMPLETED|Overall Study||3
6680865|NCT02664922|7612749|FG000|STARTED|Overall Study||11
6680866|NCT02664922|7612750|FG001|STARTED|Overall Study||12
6680867|NCT02664922|7612751|FG002|STARTED|Overall Study||7
6680868|NCT02664922|7612752|FG003|STARTED|Overall Study||5
6680869|NCT02664922|7612749|FG000|COMPLETED|Overall Study||10
6680870|NCT02664922|7612750|FG001|COMPLETED|Overall Study||12
6680871|NCT02664922|7612751|FG002|COMPLETED|Overall Study||7
6680872|NCT02664922|7612752|FG003|COMPLETED|Overall Study||5
6680873|NCT02664922|7612749|FG000|NOT COMPLETED|Overall Study||1
6680874|NCT02664922|7612750|FG001|NOT COMPLETED|Overall Study||0
6680875|NCT02664922|7612751|FG002|NOT COMPLETED|Overall Study||0
6680876|NCT02664922|7612752|FG003|NOT COMPLETED|Overall Study||0
6680877|NCT02664961|7612762|FG000|STARTED|Overall Study||3
6680878|NCT02664961|7612762|FG000|COMPLETED|Overall Study||3
6680879|NCT02664961|7612762|FG000|NOT COMPLETED|Overall Study||0
6680880|NCT02664987|7612766|FG000|STARTED|Overall Study||462
6680881|NCT02664987|7612766|FG000|COMPLETED|Overall Study||462
6680882|NCT02664987|7612766|FG000|NOT COMPLETED|Overall Study||0
6680883|NCT02665052|7612774|FG000|STARTED|Overall Study||11
6680884|NCT02665052|7612775|FG001|STARTED|Overall Study||9
6680885|NCT02665052|7612776|FG002|STARTED|Overall Study||9
6680886|NCT02665052|7612777|FG003|STARTED|Overall Study||19
6680887|NCT02665052|7612774|FG000|COMPLETED|Overall Study||8
6680888|NCT02665052|7612775|FG001|COMPLETED|Overall Study||7
6680889|NCT02665052|7612776|FG002|COMPLETED|Overall Study||9
6680890|NCT02665052|7612777|FG003|COMPLETED|Overall Study||14
6680891|NCT02665052|7612774|FG000|NOT COMPLETED|Overall Study||3
6680892|NCT02665052|7612775|FG001|NOT COMPLETED|Overall Study||2
6680893|NCT02665052|7612776|FG002|NOT COMPLETED|Overall Study||0
6680894|NCT02665052|7612777|FG003|NOT COMPLETED|Overall Study||5
6680895|NCT02665260|7612792|FG000|STARTED|Overall Study||24
6680896|NCT02665260|7612793|FG001|STARTED|Overall Study||23
6680897|NCT02665260|7612794|FG002|STARTED|Overall Study||25
6680898|NCT02665260|7612795|FG003|STARTED|Overall Study||22
6680899|NCT02665260|7612792|FG000|COMPLETED|Overall Study||22
6680900|NCT02665260|7612793|FG001|COMPLETED|Overall Study||22
6680901|NCT02665260|7612794|FG002|COMPLETED|Overall Study||21
6680902|NCT02665260|7612795|FG003|COMPLETED|Overall Study||21
6680903|NCT02665260|7612792|FG000|NOT COMPLETED|Overall Study||2
6680904|NCT02665260|7612793|FG001|NOT COMPLETED|Overall Study||1
6680905|NCT02665260|7612794|FG002|NOT COMPLETED|Overall Study||4
6680906|NCT02665260|7612795|FG003|NOT COMPLETED|Overall Study||1
6680907|NCT02665273|7612811|FG000|STARTED|Overall Study||13
6680908|NCT02665273|7612812|FG001|STARTED|Overall Study||15
6680909|NCT02665273|7612811|FG000|COMPLETED|Overall Study||13
6680910|NCT02665273|7612812|FG001|COMPLETED|Overall Study||15
6680911|NCT02665273|7612811|FG000|NOT COMPLETED|Overall Study||0
6680912|NCT02665273|7612812|FG001|NOT COMPLETED|Overall Study||0
6680913|NCT02665286|7612821|FG000|STARTED|Overall Study||79
6680914|NCT02665286|7612822|FG001|STARTED|Overall Study||80
6680915|NCT02665286|7612823|FG002|STARTED|Overall Study||81
6680916|NCT02665286|7612821|FG000|COMPLETED|Overall Study||76
6680917|NCT02665286|7612822|FG001|COMPLETED|Overall Study||78
6680918|NCT02665286|7612823|FG002|COMPLETED|Overall Study||80
6680919|NCT02665286|7612821|FG000|NOT COMPLETED|Overall Study||3
6680920|NCT02665286|7612822|FG001|NOT COMPLETED|Overall Study||2
6680921|NCT02665286|7612823|FG002|NOT COMPLETED|Overall Study||1
6680922|NCT02665364|7612833|FG000|STARTED|Overall Study||91
6680923|NCT02665364|7612834|FG001|STARTED|Overall Study||93
6680924|NCT02665364|7612833|FG000|COMPLETED|Overall Study||85
6680925|NCT02665364|7612834|FG001|COMPLETED|Overall Study||84
6680926|NCT02665364|7612833|FG000|NOT COMPLETED|Overall Study||6
6680927|NCT02665364|7612834|FG001|NOT COMPLETED|Overall Study||9
6680928|NCT02665455|7612840|FG000|STARTED|Overall Study||83
6680929|NCT02665455|7612840|FG000|COMPLETED|Overall Study||74
6680930|NCT02665455|7612840|FG000|NOT COMPLETED|Overall Study||9
6680931|NCT02665468|7612846|FG000|STARTED|Overall Study||595
6680932|NCT02665468|7612847|FG001|STARTED|Overall Study||601
6680933|NCT02665468|7612846|FG000|COMPLETED|Overall Study||595
6680934|NCT02665468|7612847|FG001|COMPLETED|Overall Study||601
6680935|NCT02665468|7612846|FG000|NOT COMPLETED|Overall Study||0
6680936|NCT02665468|7612847|FG001|NOT COMPLETED|Overall Study||0
6680937|NCT02665689|7612855|FG000|STARTED|Overall Study||2
6680938|NCT02665689|7612856|FG001|STARTED|Overall Study||2
6680939|NCT02665689|7612855|FG000|COMPLETED|Overall Study||0
6680940|NCT02665689|7612856|FG001|COMPLETED|Overall Study||0
6680941|NCT02665689|7612855|FG000|NOT COMPLETED|Overall Study||2
6680942|NCT02665689|7612856|FG001|NOT COMPLETED|Overall Study||2
6680943|NCT02665728|7612862|FG000|STARTED|Overall Study||33
6680944|NCT02665728|7612862|FG000|COMPLETED|Overall Study||33
6680945|NCT02665728|7612862|FG000|NOT COMPLETED|Overall Study||0
6680946|NCT02665741|7612869|FG000|STARTED|Overall Study||42
6680947|NCT02665741|7612870|FG001|STARTED|Overall Study||42
6680948|NCT02665741|7612871|FG002|STARTED|Overall Study||42
6680949|NCT02665741|7612869|FG000|COMPLETED|Overall Study||42
6680950|NCT02665741|7612870|FG001|COMPLETED|Overall Study||42
6680951|NCT02665741|7612871|FG002|COMPLETED|Overall Study||42
6680952|NCT02665741|7612869|FG000|NOT COMPLETED|Overall Study||0
6680953|NCT02665741|7612870|FG001|NOT COMPLETED|Overall Study||0
6680954|NCT02665741|7612871|FG002|NOT COMPLETED|Overall Study||0
6680955|NCT02665975|7612881|FG000|STARTED|Overall Study||46
6680956|NCT02665975|7612882|FG001|STARTED|Overall Study||46
6680957|NCT02665975|7612881|FG000|COMPLETED|Overall Study||37
6680958|NCT02665975|7612882|FG001|COMPLETED|Overall Study||37
6680959|NCT02665975|7612881|FG000|NOT COMPLETED|Overall Study||9
6680960|NCT02665975|7612882|FG001|NOT COMPLETED|Overall Study||9
6680961|NCT02666222|7612888|FG000|STARTED|Overall Study||51
6680962|NCT02666222|7612888|FG000|COMPLETED|Overall Study||49
6680963|NCT02666222|7612888|FG000|NOT COMPLETED|Overall Study||2
6680964|NCT02666352|7612895|FG000|STARTED|Overall Study||8
6680965|NCT02666352|7612896|FG001|STARTED|Overall Study||8
6680966|NCT02666352|7612897|FG002|STARTED|Overall Study||8
6680967|NCT02666352|7612895|FG000|COMPLETED|Overall Study||8
6680968|NCT02666352|7612896|FG001|COMPLETED|Overall Study||8
6680969|NCT02666352|7612897|FG002|COMPLETED|Overall Study||8
6680970|NCT02666352|7612895|FG000|NOT COMPLETED|Overall Study||0
6680971|NCT02666352|7612896|FG001|NOT COMPLETED|Overall Study||0
6680972|NCT02666352|7612897|FG002|NOT COMPLETED|Overall Study||0
6680973|NCT02666508|7612907|FG000|STARTED|Overall Study||31
6680974|NCT02666508|7612908|FG001|STARTED|Overall Study||30
6680975|NCT02666508|7612907|FG000|COMPLETED|Overall Study||31
6680976|NCT02666508|7612908|FG001|COMPLETED|Overall Study||30
6680977|NCT02666508|7612907|FG000|NOT COMPLETED|Overall Study||0
6256359|NCT04901897|7155286|FG000|STARTED|Overall Study||398
6680978|NCT02666508|7612908|FG001|NOT COMPLETED|Overall Study||0
6680979|NCT02666560|7612918|FG000|STARTED|Condition 1 (1 Day)||8
6680980|NCT02666560|7612919|FG001|STARTED|Condition 1 (1 Day)||11
6680981|NCT02666560|7612918|FG000|COMPLETED|Condition 1 (1 Day)||8
6680982|NCT02666560|7612919|FG001|COMPLETED|Condition 1 (1 Day)||11
6680983|NCT02666560|7612918|FG000|NOT COMPLETED|Condition 1 (1 Day)||0
6680984|NCT02666560|7612919|FG001|NOT COMPLETED|Condition 1 (1 Day)||0
6680985|NCT02666560|7612918|FG000|STARTED|Condition 2 (1 Day)||8
6680986|NCT02666560|7612919|FG001|STARTED|Condition 2 (1 Day)||11
6680987|NCT02666560|7612918|FG000|COMPLETED|Condition 2 (1 Day)||8
6680988|NCT02666560|7612919|FG001|COMPLETED|Condition 2 (1 Day)||11
6680989|NCT02666560|7612918|FG000|NOT COMPLETED|Condition 2 (1 Day)||0
6680990|NCT02666560|7612919|FG001|NOT COMPLETED|Condition 2 (1 Day)||0
6680991|NCT02666664|7612928|FG000|STARTED|Overall Study||742
6680992|NCT02666664|7612929|FG001|STARTED|Overall Study||1488
6680993|NCT02666664|7612928|FG000|COMPLETED|Overall Study||706
6680994|NCT02666664|7612929|FG001|COMPLETED|Overall Study||1404
6680995|NCT02666664|7612928|FG000|NOT COMPLETED|Overall Study||36
6680996|NCT02666664|7612929|FG001|NOT COMPLETED|Overall Study||84
6680997|NCT02666742|7612937|FG000|STARTED|Overall Study||123
6680998|NCT02666742|7612938|FG001|STARTED|Overall Study||123
6680999|NCT02666742|7612937|FG000|COMPLETED|Overall Study||123
6681000|NCT02666742|7612938|FG001|COMPLETED|Overall Study||123
6681001|NCT02666742|7612937|FG000|NOT COMPLETED|Overall Study||0
6681002|NCT02666742|7612938|FG001|NOT COMPLETED|Overall Study||0
6681003|NCT02666846|7612949|FG000|STARTED|Overall Study||20
6681004|NCT02666846|7612950|FG001|STARTED|Overall Study||20
6681005|NCT02666846|7612951|FG002|STARTED|Overall Study||20
6681006|NCT02666846|7612949|FG000|COMPLETED|Overall Study||20
6681007|NCT02666846|7612950|FG001|COMPLETED|Overall Study||20
6681008|NCT02666846|7612951|FG002|COMPLETED|Overall Study||20
6681009|NCT02666846|7612949|FG000|NOT COMPLETED|Overall Study||0
6681010|NCT02666846|7612950|FG001|NOT COMPLETED|Overall Study||0
6681011|NCT02666846|7612951|FG002|NOT COMPLETED|Overall Study||0
6681012|NCT02666950|7612981|FG000|STARTED|Overall Study||3
6681013|NCT02666950|7612981|FG000|COMPLETED|Overall Study||3
6681014|NCT02666950|7612981|FG000|NOT COMPLETED|Overall Study||0
6681015|NCT02667236|7612987|FG000|STARTED|Overall Study||223
6681016|NCT02667236|7612988|FG001|STARTED|Overall Study||227
6681017|NCT02667236|7612987|FG000|COMPLETED|Overall Study||220
6681018|NCT02667236|7612988|FG001|COMPLETED|Overall Study||226
6681019|NCT02667236|7612987|FG000|NOT COMPLETED|Overall Study||3
6681020|NCT02667236|7612988|FG001|NOT COMPLETED|Overall Study||1
6681021|NCT02667275|7612996|FG000|STARTED|Overall Study||244
6681022|NCT02667275|7612997|FG001|STARTED|Overall Study||243
6681023|NCT02667275|7612996|FG000|COMPLETED|Overall Study||233
6681024|NCT02667275|7612997|FG001|COMPLETED|Overall Study||228
6681025|NCT02667275|7612996|FG000|NOT COMPLETED|Overall Study||11
6681026|NCT02667275|7612997|FG001|NOT COMPLETED|Overall Study||15
6681027|NCT02667288|7613003|FG000|STARTED|Overall Study||147
6681028|NCT02667288|7613003|FG000|COMPLETED|Overall Study||134
6681029|NCT02667288|7613003|FG000|NOT COMPLETED|Overall Study||13
6681030|NCT02667301|7613007|FG000|STARTED|Overall Study||16
6681031|NCT02667301|7613007|FG000|COMPLETED|Overall Study||14
6681032|NCT02667301|7613007|FG000|NOT COMPLETED|Overall Study||2
6681033|NCT02667392|7613013|FG000|STARTED|Overall Study||11
6681034|NCT02667392|7613013|FG000|COMPLETED|Overall Study||11
6681035|NCT02667392|7613013|FG000|NOT COMPLETED|Overall Study||0
6681036|NCT02667457|7613019|FG000|STARTED|Overall Study||27
6681037|NCT02667457|7613020|FG001|STARTED|Overall Study||12
6681038|NCT02667457|7613019|FG000|Dosed Participants|Overall Study||26
6681039|NCT02667457|7613020|FG001|Dosed Participants|Overall Study||10
6681040|NCT02667457|7613019|FG000|Full Analysis Set Population (FAS)|Overall Study||25
6681041|NCT02667457|7613020|FG001|Full Analysis Set Population (FAS)|Overall Study||10
6681042|NCT02667457|7613019|FG000|COMPLETED|Overall Study||26
6681043|NCT02667457|7613020|FG001|COMPLETED|Overall Study||10
6681044|NCT02667457|7613019|FG000|NOT COMPLETED|Overall Study||1
6681045|NCT02667457|7613020|FG001|NOT COMPLETED|Overall Study||2
6681046|NCT02667626|7613029|FG000|STARTED|Overall Study||86
6681047|NCT02667626|7613030|FG001|STARTED|Overall Study||96
6681048|NCT02667626|7613029|FG000|COMPLETED|Overall Study||86
6681049|NCT02667626|7613030|FG001|COMPLETED|Overall Study||95
6681050|NCT02667626|7613029|FG000|NOT COMPLETED|Overall Study||0
6681051|NCT02667626|7613030|FG001|NOT COMPLETED|Overall Study||1
6681052|NCT02667704|7613039|FG000|STARTED|Treatment Period 1||13
6681053|NCT02667704|7613039|FG000|COMPLETED|Treatment Period 1||13
6681054|NCT02667704|7613039|FG000|NOT COMPLETED|Treatment Period 1||0
6681055|NCT02667704|7613039|FG000|STARTED|Treatment Period 2||13
6681056|NCT02667704|7613039|FG000|COMPLETED|Treatment Period 2||13
6681057|NCT02667704|7613039|FG000|NOT COMPLETED|Treatment Period 2||0
6681058|NCT02667821|7613046|FG000|STARTED|Overall Study||20
6681059|NCT02667821|7613046|FG000|COMPLETED|Overall Study||20
6681060|NCT02667821|7613046|FG000|NOT COMPLETED|Overall Study||0
6681061|NCT02667912|7613053|FG000|STARTED|Overall Study||28
6681062|NCT02667912|7613054|FG001|STARTED|Overall Study||27
6681063|NCT02667912|7613053|FG000|Six Months|Overall Study||27
6681064|NCT02667912|7613054|FG001|Six Months|Overall Study||24
6681065|NCT02667912|7613053|FG000|COMPLETED|Overall Study||23
6681066|NCT02667912|7613054|FG001|COMPLETED|Overall Study||24
6681067|NCT02667912|7613053|FG000|NOT COMPLETED|Overall Study||5
6681068|NCT02667912|7613054|FG001|NOT COMPLETED|Overall Study||3
6681069|NCT02667951|7613062|FG000|STARTED|Overall Study||66
6681070|NCT02667951|7613063|FG001|STARTED|Overall Study||63
6681071|NCT02667951|7613062|FG000|COMPLETED|Overall Study||45
6681072|NCT02667951|7613063|FG001|COMPLETED|Overall Study||40
6681073|NCT02667951|7613062|FG000|NOT COMPLETED|Overall Study||21
6681074|NCT02667951|7613063|FG001|NOT COMPLETED|Overall Study||23
6681075|NCT02668003|7613071|FG000|STARTED|Overall Study||501
6681076|NCT02668003|7613072|FG001|STARTED|Overall Study||501
6681077|NCT02668003|7613071|FG000|COMPLETED|Overall Study||500
6681078|NCT02668003|7613072|FG001|COMPLETED|Overall Study||496
6681079|NCT02668003|7613071|FG000|NOT COMPLETED|Overall Study||1
6681080|NCT02668003|7613072|FG001|NOT COMPLETED|Overall Study||5
6681081|NCT02668185|7613078|FG000|STARTED|Baseline Period (2 Weeks)||20
6681082|NCT02668185|7613079|FG001|STARTED|Baseline Period (2 Weeks)||17
6681083|NCT02668185|7613078|FG000|COMPLETED|Baseline Period (2 Weeks)||20
6681084|NCT02668185|7613079|FG001|COMPLETED|Baseline Period (2 Weeks)||17
6681085|NCT02668185|7613078|FG000|NOT COMPLETED|Baseline Period (2 Weeks)||0
6681086|NCT02668185|7613079|FG001|NOT COMPLETED|Baseline Period (2 Weeks)||0
6681087|NCT02668185|7613078|FG000|STARTED|First Intervention (4 Weeks)||20
6681088|NCT02668185|7613079|FG001|STARTED|First Intervention (4 Weeks)||17
6681089|NCT02668185|7613078|FG000|COMPLETED|First Intervention (4 Weeks)||18
6681090|NCT02668185|7613079|FG001|COMPLETED|First Intervention (4 Weeks)||17
6681091|NCT02668185|7613078|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
6681092|NCT02668185|7613079|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6681093|NCT02668185|7613078|FG000|STARTED|Washout Period (2 Weeks)||18
6681094|NCT02668185|7613079|FG001|STARTED|Washout Period (2 Weeks)||17
6681095|NCT02668185|7613078|FG000|COMPLETED|Washout Period (2 Weeks)||17
6681096|NCT02668185|7613079|FG001|COMPLETED|Washout Period (2 Weeks)||15
6681097|NCT02668185|7613078|FG000|NOT COMPLETED|Washout Period (2 Weeks)||1
6681098|NCT02668185|7613079|FG001|NOT COMPLETED|Washout Period (2 Weeks)||2
6681099|NCT02668185|7613078|FG000|STARTED|Second Intervention (4 Weeks)||17
6681100|NCT02668185|7613079|FG001|STARTED|Second Intervention (4 Weeks)||15
6681101|NCT02668185|7613078|FG000|COMPLETED|Second Intervention (4 Weeks)||16
6681102|NCT02668185|7613079|FG001|COMPLETED|Second Intervention (4 Weeks)||12
6681103|NCT02668185|7613078|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
6681104|NCT02668185|7613079|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||3
6681105|NCT02668185|7613078|FG000|STARTED|Moitoring Period (2 Weeks)||16
6681106|NCT02668185|7613079|FG001|STARTED|Moitoring Period (2 Weeks)||12
6681107|NCT02668185|7613078|FG000|COMPLETED|Moitoring Period (2 Weeks)||16
6681108|NCT02668185|7613079|FG001|COMPLETED|Moitoring Period (2 Weeks)||12
6681109|NCT02668185|7613078|FG000|NOT COMPLETED|Moitoring Period (2 Weeks)||0
6681110|NCT02668185|7613079|FG001|NOT COMPLETED|Moitoring Period (2 Weeks)||0
6681111|NCT02668198|7613085|FG000|STARTED|Overall Study||230
6681112|NCT02668198|7613085|FG000|COMPLETED|Overall Study||230
6681113|NCT02668198|7613085|FG000|NOT COMPLETED|Overall Study||0
6681114|NCT02668302|7613092|FG000|STARTED|Overall Study||20
6681115|NCT02668302|7613093|FG001|STARTED|Overall Study||20
6681116|NCT02668302|7613092|FG000|COMPLETED|Overall Study||19
6681117|NCT02668302|7613093|FG001|COMPLETED|Overall Study||20
6681118|NCT02668302|7613092|FG000|NOT COMPLETED|Overall Study||1
6681119|NCT02668302|7613093|FG001|NOT COMPLETED|Overall Study||0
6681120|NCT02668393|7613101|FG000|STARTED|Overall Study||7
6681121|NCT02668393|7613102|FG001|STARTED|Overall Study||7
6681122|NCT02668393|7613101|FG000|COMPLETED|Overall Study||0
6681123|NCT02668393|7613102|FG001|COMPLETED|Overall Study||1
6681124|NCT02668393|7613101|FG000|NOT COMPLETED|Overall Study||7
6681125|NCT02668393|7613102|FG001|NOT COMPLETED|Overall Study||6
6681126|NCT02668432|7613111|FG000|STARTED|Overall Study||5
6256360|NCT04901897|7155287|FG001|STARTED|Overall Study||202
6256361|NCT04901897|7155288|FG002|STARTED|Overall Study||205
6256362|NCT04901897|7155286|FG000|COMPLETED|Overall Study||393
6256363|NCT04901897|7155287|FG001|COMPLETED|Overall Study||200
6256364|NCT04901897|7155288|FG002|COMPLETED|Overall Study||203
6256365|NCT04901897|7155286|FG000|NOT COMPLETED|Overall Study||5
6256366|NCT04901897|7155287|FG001|NOT COMPLETED|Overall Study||2
6256367|NCT04901897|7155288|FG002|NOT COMPLETED|Overall Study||2
6279138|NCT00141778|7178841|FG000|COMPLETED|Started Study Medication||145
6279139|NCT00141778|7178842|FG001|COMPLETED|Started Study Medication||144
6279140|NCT00141778|7178843|FG002|COMPLETED|Started Study Medication||143
6279141|NCT00141778|7178841|FG000|NOT COMPLETED|Started Study Medication||2
6279142|NCT00141778|7178842|FG001|NOT COMPLETED|Started Study Medication||7
6279143|NCT00141778|7178843|FG002|NOT COMPLETED|Started Study Medication||4
6279144|NCT00141817|7178855|FG000|STARTED|Overall Study||7
6279145|NCT00141817|7178856|FG001|STARTED|Overall Study||10
6279146|NCT00141817|7178857|FG002|STARTED|Overall Study||11
6279147|NCT00141817|7178858|FG003|STARTED|Overall Study||13
6279148|NCT00141817|7178855|FG000|COMPLETED|Overall Study||6
6279149|NCT00141817|7178856|FG001|COMPLETED|Overall Study||10
6279150|NCT00141817|7178857|FG002|COMPLETED|Overall Study||10
6279151|NCT00141817|7178858|FG003|COMPLETED|Overall Study||13
6279152|NCT00141817|7178855|FG000|NOT COMPLETED|Overall Study||1
6279153|NCT00141817|7178856|FG001|NOT COMPLETED|Overall Study||0
6279154|NCT00141817|7178857|FG002|NOT COMPLETED|Overall Study||1
6279155|NCT00141817|7178858|FG003|NOT COMPLETED|Overall Study||0
6279156|NCT00141921|7178868|FG000|STARTED|Overall Study||182
6279157|NCT00141921|7178868|FG000|Received Treatment|Overall Study||181
6279158|NCT00141921|7178868|FG000|COMPLETED|Overall Study||41
6279159|NCT00141921|7178868|FG000|NOT COMPLETED|Overall Study||141
6279160|NCT00142116|7178872|FG000|STARTED|Overall Study||25
6279161|NCT00142116|7178872|FG000|COMPLETED|Overall Study||25
6279162|NCT00142116|7178872|FG000|NOT COMPLETED|Overall Study||0
6279163|NCT00142168|7178877|FG000|STARTED|Overall Study||16
6279164|NCT00142168|7178877|FG000|COMPLETED|Overall Study||16
6279165|NCT00142168|7178877|FG000|NOT COMPLETED|Overall Study||0
6279166|NCT00142298|7178891|FG000|STARTED|Overall Study||667
6279167|NCT00142298|7178892|FG001|STARTED|Overall Study||632
6279168|NCT00142298|7178893|FG002|STARTED|Overall Study||123
6279169|NCT00142298|7178894|FG003|STARTED|Overall Study||206
6279170|NCT00142298|7178895|FG004|STARTED|Overall Study||56
6279171|NCT00142298|7178896|FG005|STARTED|Overall Study||26
6279172|NCT00142298|7178897|FG006|STARTED|Overall Study||23
6279173|NCT00142298|7178898|FG007|STARTED|Overall Study||66
6279174|NCT00142298|7178899|FG008|STARTED|Overall Study||57
6279175|NCT00142298|7178900|FG009|STARTED|Overall Study||13
6279176|NCT00142298|7178891|FG000|Safety Population|Overall Study||655
6279177|NCT00142298|7178892|FG001|Safety Population|Overall Study||626
6279178|NCT00142298|7178893|FG002|Safety Population|Overall Study||122
6279179|NCT00142298|7178894|FG003|Safety Population|Overall Study||206
6279180|NCT00142298|7178895|FG004|Safety Population|Overall Study||50
6279181|NCT00142298|7178896|FG005|Safety Population|Overall Study||26
6279182|NCT00142298|7178897|FG006|Safety Population|Overall Study||23
6279183|NCT00142298|7178898|FG007|Safety Population|Overall Study||66
6279184|NCT00142298|7178899|FG008|Safety Population|Overall Study||57
6279185|NCT00142298|7178900|FG009|Safety Population|Overall Study||13
6279186|NCT00142298|7178891|FG000|Per Protocol Population|Overall Study||635
6279187|NCT00142298|7178892|FG001|Per Protocol Population|Overall Study||606
6279188|NCT00142298|7178893|FG002|Per Protocol Population|Overall Study||120
6279189|NCT00142298|7178894|FG003|Per Protocol Population|Overall Study||202
6279190|NCT00142298|7178895|FG004|Per Protocol Population|Overall Study||50
6279191|NCT00142298|7178896|FG005|Per Protocol Population|Overall Study||25
6279192|NCT00142298|7178897|FG006|Per Protocol Population|Overall Study||19
6279193|NCT00142298|7178898|FG007|Per Protocol Population|Overall Study||64
6279194|NCT00142298|7178899|FG008|Per Protocol Population|Overall Study||56
6279195|NCT00142298|7178900|FG009|Per Protocol Population|Overall Study||13
6681127|NCT02668432|7613112|FG001|STARTED|Overall Study||4
6681128|NCT02668432|7613111|FG000|COMPLETED|Overall Study||5
6681129|NCT02668432|7613112|FG001|COMPLETED|Overall Study||4
6681130|NCT02668432|7613111|FG000|NOT COMPLETED|Overall Study||0
6681131|NCT02668432|7613112|FG001|NOT COMPLETED|Overall Study||0
6681132|NCT02668640|7613118|FG000|STARTED|Overall Study||55
6681133|NCT02668640|7613118|FG000|COMPLETED|Overall Study||41
6681134|NCT02668640|7613118|FG000|NOT COMPLETED|Overall Study||14
6681135|NCT02668692|7613124|FG000|STARTED|Overall Study||101
6681136|NCT02668692|7613125|FG001|STARTED|Overall Study||105
6681137|NCT02668692|7613124|FG000|COMPLETED|Overall Study||100
6681138|NCT02668692|7613125|FG001|COMPLETED|Overall Study||105
6681139|NCT02668692|7613124|FG000|NOT COMPLETED|Overall Study||1
6681140|NCT02668692|7613125|FG001|NOT COMPLETED|Overall Study||0
6681141|NCT02668952|7613133|FG000|STARTED|Overall Study||16
6681142|NCT02668952|7613134|FG001|STARTED|Overall Study||14
6681143|NCT02668952|7613133|FG000|COMPLETED|Overall Study||16
6681144|NCT02668952|7613134|FG001|COMPLETED|Overall Study||14
6681145|NCT02668952|7613133|FG000|NOT COMPLETED|Overall Study||0
6681146|NCT02668952|7613134|FG001|NOT COMPLETED|Overall Study||0
6681147|NCT02669017|7613149|FG000|STARTED|Overall Study||4
6681148|NCT02669017|7613150|FG001|STARTED|Overall Study||4
6681149|NCT02669017|7613151|FG002|STARTED|Overall Study||4
6681150|NCT02669017|7613152|FG003|STARTED|Overall Study||5
6681151|NCT02669017|7613153|FG004|STARTED|Overall Study||16
6681152|NCT02669017|7613154|FG005|STARTED|Overall Study||26
6681153|NCT02669017|7613155|FG006|STARTED|Overall Study||19
6681154|NCT02669017|7613156|FG007|STARTED|Overall Study||69
6681155|NCT02669017|7613157|FG008|STARTED|Overall Study||36
6681156|NCT02669017|7613149|FG000|COMPLETED|Overall Study||3
6681157|NCT02669017|7613150|FG001|COMPLETED|Overall Study||2
6681158|NCT02669017|7613151|FG002|COMPLETED|Overall Study||2
6681159|NCT02669017|7613152|FG003|COMPLETED|Overall Study||1
6681160|NCT02669017|7613153|FG004|COMPLETED|Overall Study||4
6681161|NCT02669017|7613154|FG005|COMPLETED|Overall Study||7
6681162|NCT02669017|7613155|FG006|COMPLETED|Overall Study||8
6681163|NCT02669017|7613156|FG007|COMPLETED|Overall Study||7
6681164|NCT02669017|7613157|FG008|COMPLETED|Overall Study||11
6681165|NCT02669017|7613149|FG000|NOT COMPLETED|Overall Study||1
6681166|NCT02669017|7613150|FG001|NOT COMPLETED|Overall Study||2
6681167|NCT02669017|7613151|FG002|NOT COMPLETED|Overall Study||2
6681168|NCT02669017|7613152|FG003|NOT COMPLETED|Overall Study||4
6681169|NCT02669017|7613153|FG004|NOT COMPLETED|Overall Study||12
6681170|NCT02669017|7613154|FG005|NOT COMPLETED|Overall Study||19
6681171|NCT02669017|7613155|FG006|NOT COMPLETED|Overall Study||11
6681172|NCT02669017|7613156|FG007|NOT COMPLETED|Overall Study||62
6681173|NCT02669017|7613157|FG008|NOT COMPLETED|Overall Study||25
6681174|NCT02669043|7613185|FG000|STARTED|Overall Study||8
6681175|NCT02669043|7613185|FG000|COMPLETED|Overall Study||4
6681176|NCT02669043|7613185|FG000|NOT COMPLETED|Overall Study||4
6681177|NCT02669082|7613189|FG000|STARTED|Overall Study||26
6681178|NCT02669082|7613189|FG000|COMPLETED|Overall Study||25
6681179|NCT02669082|7613189|FG000|NOT COMPLETED|Overall Study||1
6681180|NCT02669095|7613195|FG000|STARTED|Overall Study||75
6681181|NCT02669095|7613196|FG001|STARTED|Overall Study||75
6681182|NCT02669095|7613195|FG000|COMPLETED|Overall Study||74
6681183|NCT02669095|7613196|FG001|COMPLETED|Overall Study||72
6681184|NCT02669095|7613195|FG000|NOT COMPLETED|Overall Study||1
6681185|NCT02669095|7613196|FG001|NOT COMPLETED|Overall Study||3
6681186|NCT02669121|7613204|FG000|STARTED|Overall Study||2377
6681187|NCT02669121|7613205|FG001|STARTED|Overall Study||2371
6681188|NCT02669121|7613204|FG000|Treated (Safety Analysis Set)|Overall Study||2357
6681189|NCT02669121|7613205|FG001|Treated (Safety Analysis Set)|Overall Study||2355
6681190|NCT02669121|7613204|FG000|COMPLETED|Overall Study||2087
6681191|NCT02669121|7613205|FG001|COMPLETED|Overall Study||2089
6681192|NCT02669121|7613204|FG000|NOT COMPLETED|Overall Study||290
6681193|NCT02669121|7613205|FG001|NOT COMPLETED|Overall Study||282
6681194|NCT02669264|7613218|FG000|STARTED|Overall Study||5
6681195|NCT02669264|7613219|FG001|STARTED|Overall Study||7
6681196|NCT02669264|7613220|FG002|STARTED|Overall Study||3
6681197|NCT02669264|7613221|FG003|STARTED|Overall Study||4
6681198|NCT02669264|7613222|FG004|STARTED|Overall Study||5
6681199|NCT02669264|7613223|FG005|STARTED|Overall Study||6
6681200|NCT02669264|7613224|FG006|STARTED|Overall Study||5
6681201|NCT02669264|7613218|FG000|COMPLETED|Overall Study||0
6681202|NCT02669264|7613219|FG001|COMPLETED|Overall Study||1
6681203|NCT02669264|7613220|FG002|COMPLETED|Overall Study||0
6681204|NCT02669264|7613221|FG003|COMPLETED|Overall Study||1
6681205|NCT02669264|7613222|FG004|COMPLETED|Overall Study||0
6681206|NCT02669264|7613223|FG005|COMPLETED|Overall Study||0
6681207|NCT02669264|7613224|FG006|COMPLETED|Overall Study||0
6681208|NCT02669264|7613218|FG000|NOT COMPLETED|Overall Study||5
6681209|NCT02669264|7613219|FG001|NOT COMPLETED|Overall Study||6
6681210|NCT02669264|7613220|FG002|NOT COMPLETED|Overall Study||3
6681211|NCT02669264|7613221|FG003|NOT COMPLETED|Overall Study||3
6681212|NCT02669264|7613222|FG004|NOT COMPLETED|Overall Study||5
6681213|NCT02669264|7613223|FG005|NOT COMPLETED|Overall Study||6
6681214|NCT02669264|7613224|FG006|NOT COMPLETED|Overall Study||5
6681215|NCT02669329|7613242|FG000|STARTED|Overall Study||30
6681216|NCT02669329|7613242|FG000|COMPLETED|Overall Study||30
6681217|NCT02669329|7613242|FG000|NOT COMPLETED|Overall Study||0
6681218|NCT02669407|7613246|FG000|STARTED|Overall Study||14
6681219|NCT02669407|7613246|FG000|COMPLETED|Overall Study||11
6681220|NCT02669407|7613246|FG000|NOT COMPLETED|Overall Study||3
6738517|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||4
6738518|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
6681221|NCT02669433|7613253|FG000|STARTED|Overall Study||91
6681222|NCT02669433|7613254|FG001|STARTED|Overall Study||89
6681223|NCT02669433|7613255|FG002|STARTED|Overall Study||89
6681224|NCT02669433|7613253|FG000|Safety Population|Overall Study||91
6681225|NCT02669433|7613254|FG001|Safety Population|Overall Study||89
6681226|NCT02669433|7613255|FG002|Safety Population|Overall Study||88
6681227|NCT02669433|7613253|FG000|Intent to Treat (ITT) Population|Overall Study||89
6681228|NCT02669433|7613254|FG001|Intent to Treat (ITT) Population|Overall Study||89
6681229|NCT02669433|7613255|FG002|Intent to Treat (ITT) Population|Overall Study||87
6681230|NCT02669433|7613253|FG000|Per-Protocol Population|Overall Study||78
6681231|NCT02669433|7613254|FG001|Per-Protocol Population|Overall Study||79
6681232|NCT02669433|7613255|FG002|Per-Protocol Population|Overall Study||82
6681233|NCT02669433|7613253|FG000|Completers Population|Overall Study||73
6681234|NCT02669433|7613254|FG001|Completers Population|Overall Study||72
6681235|NCT02669433|7613255|FG002|Completers Population|Overall Study||69
6681236|NCT02669433|7613253|FG000|UPDRS Primary Population|Overall Study||87
6681237|NCT02669433|7613254|FG001|UPDRS Primary Population|Overall Study||87
6681238|NCT02669433|7613255|FG002|UPDRS Primary Population|Overall Study||84
6681239|NCT02669433|7613253|FG000|COMPLETED|Overall Study||76
6681240|NCT02669433|7613254|FG001|COMPLETED|Overall Study||75
6681241|NCT02669433|7613255|FG002|COMPLETED|Overall Study||74
6681242|NCT02669433|7613253|FG000|NOT COMPLETED|Overall Study||15
6681243|NCT02669433|7613254|FG001|NOT COMPLETED|Overall Study||14
6681244|NCT02669433|7613255|FG002|NOT COMPLETED|Overall Study||15
6681245|NCT02669615|7613263|FG000|STARTED|Overall Study||24
6681246|NCT02669615|7613263|FG000|COMPLETED|Overall Study||24
6681247|NCT02669615|7613263|FG000|NOT COMPLETED|Overall Study||0
6681248|NCT02669667|7613274|FG000|STARTED|Overall Study||12
6681249|NCT02669667|7613275|FG001|STARTED|Overall Study||4
6681250|NCT02669667|7613276|FG002|STARTED|Overall Study||4
6681251|NCT02669667|7613277|FG003|STARTED|Overall Study||6
6681252|NCT02669667|7613278|FG004|STARTED|Overall Study||6
6681253|NCT02669667|7613279|FG005|STARTED|Overall Study||6
6681254|NCT02669667|7613280|FG006|STARTED|Overall Study||6
6681255|NCT02669667|7613274|FG000|COMPLETED|Overall Study||12
6681256|NCT02669667|7613275|FG001|COMPLETED|Overall Study||4
6681257|NCT02669667|7613276|FG002|COMPLETED|Overall Study||4
6681258|NCT02669667|7613277|FG003|COMPLETED|Overall Study||6
6681259|NCT02669667|7613278|FG004|COMPLETED|Overall Study||6
6681260|NCT02669667|7613279|FG005|COMPLETED|Overall Study||5
6681261|NCT02669667|7613280|FG006|COMPLETED|Overall Study||6
6681262|NCT02669667|7613274|FG000|NOT COMPLETED|Overall Study||0
6681263|NCT02669667|7613275|FG001|NOT COMPLETED|Overall Study||0
6681264|NCT02669667|7613276|FG002|NOT COMPLETED|Overall Study||0
6681265|NCT02669667|7613277|FG003|NOT COMPLETED|Overall Study||0
6681266|NCT02669667|7613278|FG004|NOT COMPLETED|Overall Study||0
6681267|NCT02669667|7613279|FG005|NOT COMPLETED|Overall Study||1
6681268|NCT02669667|7613280|FG006|NOT COMPLETED|Overall Study||0
6681269|NCT02669758|7613302|FG000|STARTED|Overall Study||277
6681270|NCT02669758|7613302|FG000|COMPLETED|Overall Study||183
6681271|NCT02669758|7613302|FG000|NOT COMPLETED|Overall Study||94
6681272|NCT02669784|7613308|FG000|STARTED|Overall Study||18
6681273|NCT02669784|7613309|FG001|STARTED|Overall Study||16
6681274|NCT02669784|7613308|FG000|COMPLETED|Overall Study||18
6681275|NCT02669784|7613309|FG001|COMPLETED|Overall Study||16
6681276|NCT02669784|7613308|FG000|NOT COMPLETED|Overall Study||0
6681277|NCT02669784|7613309|FG001|NOT COMPLETED|Overall Study||0
6681278|NCT02669849|7613318|FG000|STARTED|Overall Study||29
6681279|NCT02669849|7613319|FG001|STARTED|Overall Study||6
6681280|NCT02669849|7613320|FG002|STARTED|Overall Study||32
6681281|NCT02669849|7613318|FG000|COMPLETED|Overall Study||11
6681282|NCT02669849|7613319|FG001|COMPLETED|Overall Study||4
6681283|NCT02669849|7613320|FG002|COMPLETED|Overall Study||8
6681284|NCT02669849|7613318|FG000|NOT COMPLETED|Overall Study||18
6681285|NCT02669849|7613319|FG001|NOT COMPLETED|Overall Study||2
6681286|NCT02669849|7613320|FG002|NOT COMPLETED|Overall Study||24
6681287|NCT02669862|7613331|FG000|STARTED|Overall Study||33
6681288|NCT02669862|7613332|FG001|STARTED|Overall Study||34
6681289|NCT02669862|7613333|FG002|STARTED|Overall Study||31
6681290|NCT02669862|7613331|FG000|COMPLETED|Overall Study||31
6681291|NCT02669862|7613332|FG001|COMPLETED|Overall Study||29
6681292|NCT02669862|7613333|FG002|COMPLETED|Overall Study||26
6681293|NCT02669862|7613331|FG000|NOT COMPLETED|Overall Study||2
6681294|NCT02669862|7613332|FG001|NOT COMPLETED|Overall Study||5
6681295|NCT02669862|7613333|FG002|NOT COMPLETED|Overall Study||5
6681296|NCT02669914|7613347|FG000|STARTED|Overall Study||4
6681297|NCT02669914|7613348|FG001|STARTED|Overall Study||0
6681298|NCT02669914|7613349|FG002|STARTED|Overall Study||0
6681299|NCT02669914|7613347|FG000|COMPLETED|Overall Study||4
6681300|NCT02669914|7613348|FG001|COMPLETED|Overall Study||0
6681301|NCT02669914|7613349|FG002|COMPLETED|Overall Study||0
6681302|NCT02669914|7613347|FG000|NOT COMPLETED|Overall Study||0
6681303|NCT02669914|7613348|FG001|NOT COMPLETED|Overall Study||0
6681304|NCT02669914|7613349|FG002|NOT COMPLETED|Overall Study||0
6681305|NCT02669940|7613359|FG000|STARTED|Overall Study||63
6681306|NCT02669940|7613360|FG001|STARTED|Overall Study||95
6681307|NCT02669940|7613359|FG000|COMPLETED|Overall Study||62
6681308|NCT02669940|7613360|FG001|COMPLETED|Overall Study||92
6681309|NCT02669940|7613359|FG000|NOT COMPLETED|Overall Study||1
6681310|NCT02669940|7613360|FG001|NOT COMPLETED|Overall Study||3
6681311|NCT02670083|7613375|FG000|STARTED|Overall Study||409
6681312|NCT02670083|7613376|FG001|STARTED|Overall Study||404
6681313|NCT02670083|7613375|FG000|COMPLETED|Overall Study||88
6681314|NCT02670083|7613376|FG001|COMPLETED|Overall Study||85
6681315|NCT02670083|7613375|FG000|NOT COMPLETED|Overall Study||321
6681316|NCT02670083|7613376|FG001|NOT COMPLETED|Overall Study||319
6681317|NCT02670122|7613383|FG000|STARTED|Overall Study||131
6681318|NCT02670122|7613383|FG000|COMPLETED|Overall Study|18 patients recieved liver transplantation|127
6681319|NCT02670122|7613383|FG000|NOT COMPLETED|Overall Study||4
6681320|NCT02670330|7613396|FG000|STARTED|Overall Study||75
6681321|NCT02670330|7613397|FG001|STARTED|Overall Study||77
6681322|NCT02670330|7613396|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||75
6681323|NCT02670330|7613397|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||77
6681324|NCT02670330|7613396|FG000|COMPLETED|Overall Study||0
6681325|NCT02670330|7613397|FG001|COMPLETED|Overall Study||0
6681326|NCT02670330|7613396|FG000|NOT COMPLETED|Overall Study||75
6681327|NCT02670330|7613397|FG001|NOT COMPLETED|Overall Study||77
6681328|NCT02670343|7613403|FG000|STARTED|Overall Study||8
6681329|NCT02670343|7613403|FG000|COMPLETED|Overall Study||8
6681330|NCT02670343|7613403|FG000|NOT COMPLETED|Overall Study||0
6681331|NCT02670382|7613407|FG000|STARTED|Placebo lead-in Phase||12
6681332|NCT02670382|7613408|FG001|STARTED|Placebo lead-in Phase||12
6681333|NCT02670382|7613407|FG000|COMPLETED|Placebo lead-in Phase|Two enrolled subjects randomized to receive EPA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 10 subjects continued to the EPA and then DHA supplementation phases. No data were collected from these two subjects.|10
6681334|NCT02670382|7613408|FG001|COMPLETED|Placebo lead-in Phase|One enrolled subjects randomized to receive EDHA as the first intervention decided to stop participation during the placebo lead-in phase. Therefore, only 11 subjects continued to the DHA and then EPA supplementation phases. No data were collected from this subject.|11
6681335|NCT02670382|7613407|FG000|NOT COMPLETED|Placebo lead-in Phase||2
6681336|NCT02670382|7613408|FG001|NOT COMPLETED|Placebo lead-in Phase||1
6681337|NCT02670382|7613407|FG000|STARTED|First Active Intervention|Only 10 of the 12 enrolled subjects randomized to receive EPA as the first supplementation completed the lead-in placebo phase and then entered the EPA supplementation phase.|10
6681338|NCT02670382|7613408|FG001|STARTED|First Active Intervention|Only 11 of the 12 enrolled subjects randomized to receive DHA as the first supplementation completed the lead-in placebo phase and then entered the EDHA supplementation phase.|11
6681339|NCT02670382|7613407|FG000|COMPLETED|First Active Intervention||10
6681340|NCT02670382|7613408|FG001|COMPLETED|First Active Intervention||11
6681341|NCT02670382|7613407|FG000|NOT COMPLETED|First Active Intervention||0
6681342|NCT02670382|7613408|FG001|NOT COMPLETED|First Active Intervention||0
6681343|NCT02670382|7613407|FG000|STARTED|Second Active Intervention||10
6681344|NCT02670382|7613408|FG001|STARTED|Second Active Intervention||11
6681345|NCT02670382|7613407|FG000|COMPLETED|Second Active Intervention||10
6681346|NCT02670382|7613408|FG001|COMPLETED|Second Active Intervention||11
6681347|NCT02670382|7613407|FG000|NOT COMPLETED|Second Active Intervention||0
6681348|NCT02670382|7613408|FG001|NOT COMPLETED|Second Active Intervention||0
6681349|NCT02670473|7613416|FG000|STARTED|Overall Study||35
6681350|NCT02670473|7613416|FG000|COMPLETED|Overall Study||34
6681351|NCT02670473|7613416|FG000|NOT COMPLETED|Overall Study||1
6681352|NCT02670538|7613432|FG000|STARTED|Overall Study||167
6681353|NCT02670538|7613433|FG001|STARTED|Overall Study||168
6681354|NCT02670538|7613434|FG002|STARTED|Overall Study||158
6681355|NCT02670538|7613432|FG000|Safety Population : Received Study Drug|Overall Study||165
6681356|NCT02670538|7613433|FG001|Safety Population : Received Study Drug|Overall Study||167
6681357|NCT02670538|7613434|FG002|Safety Population : Received Study Drug|Overall Study||158
6681358|NCT02670538|7613432|FG000|Intent-to-Treat Population|Overall Study||163
6681359|NCT02670538|7613433|FG001|Intent-to-Treat Population|Overall Study||162
6681360|NCT02670538|7613434|FG002|Intent-to-Treat Population|Overall Study||153
6681361|NCT02670538|7613432|FG000|COMPLETED|Overall Study||135
6681362|NCT02670538|7613433|FG001|COMPLETED|Overall Study||136
6681363|NCT02670538|7613434|FG002|COMPLETED|Overall Study||128
6681364|NCT02670538|7613432|FG000|NOT COMPLETED|Overall Study||32
6681365|NCT02670538|7613433|FG001|NOT COMPLETED|Overall Study||32
6681366|NCT02670538|7613434|FG002|NOT COMPLETED|Overall Study||30
6681367|NCT02670551|7613445|FG000|STARTED|Overall Study||163
6681368|NCT02670551|7613446|FG001|STARTED|Overall Study||160
6681369|NCT02670551|7613447|FG002|STARTED|Overall Study||165
6681370|NCT02670551|7613445|FG000|Received Treatment (Safety Population)|Overall Study||158
6681371|NCT02670551|7613446|FG001|Received Treatment (Safety Population)|Overall Study||157
6681372|NCT02670551|7613447|FG002|Received Treatment (Safety Population)|Overall Study||165
6681373|NCT02670551|7613445|FG000|COMPLETED|Overall Study||135
6681374|NCT02670551|7613446|FG001|COMPLETED|Overall Study||134
6681375|NCT02670551|7613447|FG002|COMPLETED|Overall Study||134
6681376|NCT02670551|7613445|FG000|NOT COMPLETED|Overall Study||28
6681377|NCT02670551|7613446|FG001|NOT COMPLETED|Overall Study||26
6681378|NCT02670551|7613447|FG002|NOT COMPLETED|Overall Study||31
6681379|NCT02670629|7613457|FG000|STARTED|Overall Study||29
6681380|NCT02670629|7613458|FG001|STARTED|Overall Study||29
6681381|NCT02670629|7613457|FG000|COMPLETED|Overall Study||29
6681382|NCT02670629|7613458|FG001|COMPLETED|Overall Study||29
6681383|NCT02670629|7613457|FG000|NOT COMPLETED|Overall Study||0
6681384|NCT02670629|7613458|FG001|NOT COMPLETED|Overall Study||0
6681385|NCT02670811|7613466|FG000|STARTED|Overall Study||18
6681386|NCT02670811|7613467|FG001|STARTED|Overall Study||18
6681387|NCT02670811|7613466|FG000|COMPLETED|Overall Study||17
6681388|NCT02670811|7613467|FG001|COMPLETED|Overall Study||18
6681389|NCT02670811|7613466|FG000|NOT COMPLETED|Overall Study||1
6681390|NCT02670811|7613467|FG001|NOT COMPLETED|Overall Study||0
6681391|NCT02670915|7613476|FG000|STARTED|Overall Study||260
6681392|NCT02670915|7613477|FG001|STARTED|Overall Study||259
6681393|NCT02670915|7613478|FG002|STARTED|Overall Study||258
6681394|NCT02670915|7613476|FG000|COMPLETED|Overall Study||256
6681395|NCT02670915|7613477|FG001|COMPLETED|Overall Study||251
6681396|NCT02670915|7613478|FG002|COMPLETED|Overall Study||253
6681397|NCT02670915|7613476|FG000|NOT COMPLETED|Overall Study||4
6681398|NCT02670915|7613477|FG001|NOT COMPLETED|Overall Study||8
6681399|NCT02670915|7613478|FG002|NOT COMPLETED|Overall Study||5
6681400|NCT02670928|7613488|FG000|STARTED|Overall Study||100
6681401|NCT02670928|7613489|FG001|STARTED|Overall Study||30
6681402|NCT02670928|7613488|FG000|COMPLETED|Overall Study||90
6681403|NCT02670928|7613489|FG001|COMPLETED|Overall Study||29
6681404|NCT02670928|7613488|FG000|NOT COMPLETED|Overall Study||10
6681405|NCT02670928|7613489|FG001|NOT COMPLETED|Overall Study||1
6681406|NCT02671032|7613495|FG000|STARTED|Overall Study||12
6681407|NCT02671032|7613495|FG000|COMPLETED|Overall Study||12
6681408|NCT02671032|7613495|FG000|NOT COMPLETED|Overall Study||0
6681409|NCT02671266|7613501|FG000|STARTED|Overall Study||20
6681410|NCT02671266|7613502|FG001|STARTED|Overall Study||21
6681411|NCT02671266|7613501|FG000|BDD Participants|Overall Study||9
6681412|NCT02671266|7613502|FG001|BDD Participants|Overall Study||9
6681413|NCT02671266|7613501|FG000|OCD Participants|Overall Study||2
6681414|NCT02671266|7613502|FG001|OCD Participants|Overall Study||3
6681415|NCT02671266|7613501|FG000|Healthy Participants|Overall Study||8
6681416|NCT02671266|7613502|FG001|Healthy Participants|Overall Study||8
6681417|NCT02671266|7613501|FG000|COMPLETED|Overall Study||19
6681418|NCT02671266|7613502|FG001|COMPLETED|Overall Study||20
6681419|NCT02671266|7613501|FG000|NOT COMPLETED|Overall Study||1
6681420|NCT02671266|7613502|FG001|NOT COMPLETED|Overall Study||1
6681421|NCT02671422|7613508|FG000|STARTED|Overall Study||260
6681422|NCT02671422|7613508|FG000|Not Treated With Vargatef®|Overall Study||3
6681423|NCT02671422|7613508|FG000|COMPLETED|Overall Study||0
6681424|NCT02671422|7613508|FG000|NOT COMPLETED|Overall Study||260
6681425|NCT02671500|7613512|FG000|STARTED|Overall Study||375
6681426|NCT02671500|7613512|FG000|COMPLETED|Overall Study||361
6681427|NCT02671500|7613512|FG000|NOT COMPLETED|Overall Study||14
6681428|NCT02671760|7613520|FG000|STARTED|Overall Study||13
6681429|NCT02671760|7613521|FG001|STARTED|Overall Study||13
6681430|NCT02671760|7613522|FG002|STARTED|Overall Study||13
6681431|NCT02671760|7613520|FG000|COMPLETED|Overall Study||13
6681432|NCT02671760|7613521|FG001|COMPLETED|Overall Study|1 Subject could not be contacted for f/u phone call. Data included in safety and efficacy analyses.|12
6681433|NCT02671760|7613522|FG002|COMPLETED|Overall Study||13
6681434|NCT02671760|7613520|FG000|NOT COMPLETED|Overall Study||0
6681435|NCT02671760|7613521|FG001|NOT COMPLETED|Overall Study||1
6681436|NCT02671760|7613522|FG002|NOT COMPLETED|Overall Study||0
6681437|NCT02672111|7613532|FG000|STARTED|Overall Study||190
6681438|NCT02672111|7613533|FG001|STARTED|Overall Study||37
6681439|NCT02672111|7613532|FG000|Completed Treatment|Overall Study||138
6681440|NCT02672111|7613533|FG001|Completed Treatment|Overall Study||29
6681441|NCT02672111|7613532|FG000|COMPLETED|Overall Study||132
6681442|NCT02672111|7613533|FG001|COMPLETED|Overall Study||25
6681443|NCT02672111|7613532|FG000|NOT COMPLETED|Overall Study||58
6681444|NCT02672111|7613533|FG001|NOT COMPLETED|Overall Study||12
6681445|NCT02672176|7613542|FG000|STARTED|Overall Study||161
6681446|NCT02672176|7613543|FG001|STARTED|Overall Study||158
6681447|NCT02672176|7613542|FG000|COMPLETED|Overall Study||155
6681448|NCT02672176|7613543|FG001|COMPLETED|Overall Study||132
6681449|NCT02672176|7613542|FG000|NOT COMPLETED|Overall Study||6
6681450|NCT02672176|7613543|FG001|NOT COMPLETED|Overall Study||26
6681451|NCT02672423|7613555|FG000|STARTED|Period 1||7
6681452|NCT02672423|7613556|FG001|STARTED|Period 1||7
6681453|NCT02672423|7613557|FG002|STARTED|Period 1||14
6681454|NCT02672423|7613558|FG003|STARTED|Period 1||15
6681455|NCT02672423|7613559|FG004|STARTED|Period 1||15
6681456|NCT02672423|7613560|FG005|STARTED|Period 1||15
6681457|NCT02672423|7613561|FG006|STARTED|Period 1||15
6681458|NCT02672423|7613562|FG007|STARTED|Period 1||15
6681459|NCT02672423|7613563|FG008|STARTED|Period 1||12
6681460|NCT02672423|7613564|FG009|STARTED|Period 1||12
6681461|NCT02672423|7613555|FG000|Received at Least One Dose of Study Drug|Period 1||7
6681462|NCT02672423|7613556|FG001|Received at Least One Dose of Study Drug|Period 1||7
6681463|NCT02672423|7613557|FG002|Received at Least One Dose of Study Drug|Period 1||14
6681464|NCT02672423|7613558|FG003|Received at Least One Dose of Study Drug|Period 1||15
6681465|NCT02672423|7613559|FG004|Received at Least One Dose of Study Drug|Period 1||15
6681466|NCT02672423|7613560|FG005|Received at Least One Dose of Study Drug|Period 1||15
6681467|NCT02672423|7613561|FG006|Received at Least One Dose of Study Drug|Period 1||15
6681468|NCT02672423|7613562|FG007|Received at Least One Dose of Study Drug|Period 1||15
6681469|NCT02672423|7613563|FG008|Received at Least One Dose of Study Drug|Period 1||12
6681470|NCT02672423|7613564|FG009|Received at Least One Dose of Study Drug|Period 1||12
6681471|NCT02672423|7613555|FG000|COMPLETED|Period 1||7
6681472|NCT02672423|7613556|FG001|COMPLETED|Period 1||7
6681473|NCT02672423|7613557|FG002|COMPLETED|Period 1||14
6681474|NCT02672423|7613558|FG003|COMPLETED|Period 1||15
6681475|NCT02672423|7613559|FG004|COMPLETED|Period 1||14
6681476|NCT02672423|7613560|FG005|COMPLETED|Period 1||15
6681477|NCT02672423|7613561|FG006|COMPLETED|Period 1||15
6681478|NCT02672423|7613562|FG007|COMPLETED|Period 1||15
6681479|NCT02672423|7613563|FG008|COMPLETED|Period 1||12
6681480|NCT02672423|7613564|FG009|COMPLETED|Period 1||12
6681481|NCT02672423|7613555|FG000|NOT COMPLETED|Period 1||0
6681482|NCT02672423|7613556|FG001|NOT COMPLETED|Period 1||0
6681483|NCT02672423|7613557|FG002|NOT COMPLETED|Period 1||0
6681484|NCT02672423|7613558|FG003|NOT COMPLETED|Period 1||0
6681485|NCT02672423|7613559|FG004|NOT COMPLETED|Period 1||1
6681486|NCT02672423|7613560|FG005|NOT COMPLETED|Period 1||0
6681487|NCT02672423|7613561|FG006|NOT COMPLETED|Period 1||0
6681488|NCT02672423|7613562|FG007|NOT COMPLETED|Period 1||0
6681489|NCT02672423|7613563|FG008|NOT COMPLETED|Period 1||0
6681490|NCT02672423|7613564|FG009|NOT COMPLETED|Period 1||0
6681491|NCT02672423|7613555|FG000|STARTED|Washout 1||7
6681492|NCT02672423|7613556|FG001|STARTED|Washout 1||7
6681493|NCT02672423|7613557|FG002|STARTED|Washout 1||14
6681494|NCT02672423|7613558|FG003|STARTED|Washout 1||15
6681495|NCT02672423|7613559|FG004|STARTED|Washout 1||14
6681496|NCT02672423|7613560|FG005|STARTED|Washout 1||15
6681497|NCT02672423|7613561|FG006|STARTED|Washout 1||15
6681498|NCT02672423|7613562|FG007|STARTED|Washout 1||15
6681499|NCT02672423|7613563|FG008|STARTED|Washout 1||12
6681500|NCT02672423|7613564|FG009|STARTED|Washout 1||12
6681501|NCT02672423|7613555|FG000|COMPLETED|Washout 1||7
6681502|NCT02672423|7613556|FG001|COMPLETED|Washout 1||7
6681503|NCT02672423|7613557|FG002|COMPLETED|Washout 1||14
6681504|NCT02672423|7613558|FG003|COMPLETED|Washout 1||15
6681505|NCT02672423|7613559|FG004|COMPLETED|Washout 1||14
6681506|NCT02672423|7613560|FG005|COMPLETED|Washout 1||15
6681507|NCT02672423|7613561|FG006|COMPLETED|Washout 1||15
6681508|NCT02672423|7613562|FG007|COMPLETED|Washout 1||15
6681509|NCT02672423|7613563|FG008|COMPLETED|Washout 1||12
6681510|NCT02672423|7613564|FG009|COMPLETED|Washout 1||12
6681511|NCT02672423|7613555|FG000|NOT COMPLETED|Washout 1||0
6681512|NCT02672423|7613556|FG001|NOT COMPLETED|Washout 1||0
6681513|NCT02672423|7613557|FG002|NOT COMPLETED|Washout 1||0
6681514|NCT02672423|7613558|FG003|NOT COMPLETED|Washout 1||0
6681515|NCT02672423|7613559|FG004|NOT COMPLETED|Washout 1||0
6681516|NCT02672423|7613560|FG005|NOT COMPLETED|Washout 1||0
6681517|NCT02672423|7613561|FG006|NOT COMPLETED|Washout 1||0
6681518|NCT02672423|7613562|FG007|NOT COMPLETED|Washout 1||0
6681519|NCT02672423|7613563|FG008|NOT COMPLETED|Washout 1||0
6681520|NCT02672423|7613564|FG009|NOT COMPLETED|Washout 1||0
6681521|NCT02672423|7613555|FG000|STARTED|Period 2||7
6681522|NCT02672423|7613556|FG001|STARTED|Period 2||7
6681523|NCT02672423|7613557|FG002|STARTED|Period 2||14
6681524|NCT02672423|7613558|FG003|STARTED|Period 2||15
6681525|NCT02672423|7613559|FG004|STARTED|Period 2||14
6681526|NCT02672423|7613560|FG005|STARTED|Period 2||15
6681527|NCT02672423|7613561|FG006|STARTED|Period 2||15
6681528|NCT02672423|7613562|FG007|STARTED|Period 2||15
6681529|NCT02672423|7613563|FG008|STARTED|Period 2||12
6681530|NCT02672423|7613564|FG009|STARTED|Period 2||12
6681531|NCT02672423|7613555|FG000|COMPLETED|Period 2||7
6681532|NCT02672423|7613556|FG001|COMPLETED|Period 2||7
6681533|NCT02672423|7613557|FG002|COMPLETED|Period 2||13
6681534|NCT02672423|7613558|FG003|COMPLETED|Period 2||15
6681535|NCT02672423|7613559|FG004|COMPLETED|Period 2||14
6681536|NCT02672423|7613560|FG005|COMPLETED|Period 2||15
6681537|NCT02672423|7613561|FG006|COMPLETED|Period 2||15
6681538|NCT02672423|7613562|FG007|COMPLETED|Period 2||15
6681539|NCT02672423|7613563|FG008|COMPLETED|Period 2||12
6681540|NCT02672423|7613564|FG009|COMPLETED|Period 2||12
6681541|NCT02672423|7613555|FG000|NOT COMPLETED|Period 2||0
6681542|NCT02672423|7613556|FG001|NOT COMPLETED|Period 2||0
6681543|NCT02672423|7613557|FG002|NOT COMPLETED|Period 2||1
6681544|NCT02672423|7613558|FG003|NOT COMPLETED|Period 2||0
6681545|NCT02672423|7613559|FG004|NOT COMPLETED|Period 2||0
6681546|NCT02672423|7613560|FG005|NOT COMPLETED|Period 2||0
6681547|NCT02672423|7613561|FG006|NOT COMPLETED|Period 2||0
6681548|NCT02672423|7613562|FG007|NOT COMPLETED|Period 2||0
6681549|NCT02672423|7613563|FG008|NOT COMPLETED|Period 2||0
6681550|NCT02672423|7613564|FG009|NOT COMPLETED|Period 2||0
6681551|NCT02672423|7613555|FG000|STARTED|Washout 2||7
6681552|NCT02672423|7613556|FG001|STARTED|Washout 2||7
6681553|NCT02672423|7613557|FG002|STARTED|Washout 2||13
6681554|NCT02672423|7613558|FG003|STARTED|Washout 2||15
6681555|NCT02672423|7613559|FG004|STARTED|Washout 2||14
6681556|NCT02672423|7613560|FG005|STARTED|Washout 2||15
6681557|NCT02672423|7613561|FG006|STARTED|Washout 2||15
6681558|NCT02672423|7613562|FG007|STARTED|Washout 2||15
6681559|NCT02672423|7613563|FG008|STARTED|Washout 2||12
6681560|NCT02672423|7613564|FG009|STARTED|Washout 2||12
6681561|NCT02672423|7613555|FG000|COMPLETED|Washout 2||7
6681562|NCT02672423|7613556|FG001|COMPLETED|Washout 2||7
6681563|NCT02672423|7613557|FG002|COMPLETED|Washout 2||13
6681564|NCT02672423|7613558|FG003|COMPLETED|Washout 2||15
6681565|NCT02672423|7613559|FG004|COMPLETED|Washout 2||14
6681566|NCT02672423|7613560|FG005|COMPLETED|Washout 2||15
6681567|NCT02672423|7613561|FG006|COMPLETED|Washout 2||15
6681568|NCT02672423|7613562|FG007|COMPLETED|Washout 2||15
6681569|NCT02672423|7613563|FG008|COMPLETED|Washout 2||12
6681570|NCT02672423|7613564|FG009|COMPLETED|Washout 2||12
6681571|NCT02672423|7613555|FG000|NOT COMPLETED|Washout 2||0
6681572|NCT02672423|7613556|FG001|NOT COMPLETED|Washout 2||0
6681573|NCT02672423|7613557|FG002|NOT COMPLETED|Washout 2||0
6681574|NCT02672423|7613558|FG003|NOT COMPLETED|Washout 2||0
6681575|NCT02672423|7613559|FG004|NOT COMPLETED|Washout 2||0
6681576|NCT02672423|7613560|FG005|NOT COMPLETED|Washout 2||0
6681577|NCT02672423|7613561|FG006|NOT COMPLETED|Washout 2||0
6681578|NCT02672423|7613562|FG007|NOT COMPLETED|Washout 2||0
6681579|NCT02672423|7613563|FG008|NOT COMPLETED|Washout 2||0
6681580|NCT02672423|7613564|FG009|NOT COMPLETED|Washout 2||0
6681581|NCT02672423|7613555|FG000|STARTED|Period 3|Part A was a 2-period study design.|0
6681582|NCT02672423|7613556|FG001|STARTED|Period 3|Part A was a 2-period study design.|0
6681583|NCT02672423|7613557|FG002|STARTED|Period 3||13
6681584|NCT02672423|7613558|FG003|STARTED|Period 3||15
6681585|NCT02672423|7613559|FG004|STARTED|Period 3||14
6681586|NCT02672423|7613560|FG005|STARTED|Period 3||15
6681587|NCT02672423|7613561|FG006|STARTED|Period 3||15
6681588|NCT02672423|7613562|FG007|STARTED|Period 3||15
6681589|NCT02672423|7613563|FG008|STARTED|Period 3|Part C was a 2-period study design.|0
6681590|NCT02672423|7613564|FG009|STARTED|Period 3|Part C was a 2-period study design.|0
6681591|NCT02672423|7613555|FG000|COMPLETED|Period 3||0
6681592|NCT02672423|7613556|FG001|COMPLETED|Period 3||0
6681593|NCT02672423|7613557|FG002|COMPLETED|Period 3||13
6681594|NCT02672423|7613558|FG003|COMPLETED|Period 3||15
6681595|NCT02672423|7613559|FG004|COMPLETED|Period 3||14
6681596|NCT02672423|7613560|FG005|COMPLETED|Period 3||14
6681597|NCT02672423|7613561|FG006|COMPLETED|Period 3||15
6681598|NCT02672423|7613562|FG007|COMPLETED|Period 3||14
6681599|NCT02672423|7613563|FG008|COMPLETED|Period 3||0
6681600|NCT02672423|7613564|FG009|COMPLETED|Period 3||0
6681601|NCT02672423|7613555|FG000|NOT COMPLETED|Period 3||0
6681602|NCT02672423|7613556|FG001|NOT COMPLETED|Period 3||0
6681603|NCT02672423|7613557|FG002|NOT COMPLETED|Period 3||0
6681604|NCT02672423|7613558|FG003|NOT COMPLETED|Period 3||0
6681605|NCT02672423|7613559|FG004|NOT COMPLETED|Period 3||0
6681606|NCT02672423|7613560|FG005|NOT COMPLETED|Period 3||1
6681607|NCT02672423|7613561|FG006|NOT COMPLETED|Period 3||0
6681608|NCT02672423|7613562|FG007|NOT COMPLETED|Period 3||1
6681609|NCT02672423|7613563|FG008|NOT COMPLETED|Period 3||0
6681610|NCT02672423|7613564|FG009|NOT COMPLETED|Period 3||0
6681611|NCT02672514|7613587|FG000|STARTED|Overall Study||53
6681612|NCT02672514|7613588|FG001|STARTED|Overall Study||51
6256368|NCT04891874|7155298|FG000|STARTED|Overall Study|Participants in this period were recruited from August 1, 2015 to December 31, 2016.|38
6256369|NCT04891874|7155299|FG001|STARTED|Overall Study||38
6256370|NCT04891874|7155298|FG000|COMPLETED|Overall Study||38
6256371|NCT04891874|7155299|FG001|COMPLETED|Overall Study||38
6256372|NCT04891874|7155298|FG000|NOT COMPLETED|Overall Study||0
6256373|NCT04891874|7155299|FG001|NOT COMPLETED|Overall Study||0
6256374|NCT04883541|7155307|FG000|STARTED|Overall Study||46
6256375|NCT04883541|7155308|FG001|STARTED|Overall Study||69
6256376|NCT04883541|7155307|FG000|COMPLETED|Overall Study||30
6256377|NCT04883541|7155308|FG001|COMPLETED|Overall Study||60
6256378|NCT04883541|7155307|FG000|NOT COMPLETED|Overall Study||16
6256379|NCT04883541|7155308|FG001|NOT COMPLETED|Overall Study||9
6256380|NCT04881968|7155314|FG000|STARTED|Overall Study||1261
6256381|NCT04881968|7155314|FG000|COMPLETED|Overall Study||1261
6256382|NCT04881968|7155314|FG000|NOT COMPLETED|Overall Study||0
6256383|NCT04486560|7155318|FG000|STARTED|Overall Study||51
6256384|NCT04486560|7155318|FG000|COMPLETED|Overall Study||50
6256385|NCT04486560|7155318|FG000|NOT COMPLETED|Overall Study||1
6256386|NCT04357782|7155324|FG000|STARTED|Overall Study||10
6256387|NCT04357782|7155325|FG001|STARTED|Overall Study||10
6256388|NCT04357782|7155324|FG000|COMPLETED|Overall Study||9
6256389|NCT04357782|7155325|FG001|COMPLETED|Overall Study||8
6256390|NCT04357782|7155324|FG000|NOT COMPLETED|Overall Study||1
6256391|NCT04357782|7155325|FG001|NOT COMPLETED|Overall Study||2
6256392|NCT04090658|7155333|FG000|STARTED|Overall Study||20
6256393|NCT04090658|7155334|FG001|STARTED|Overall Study||20
6256394|NCT04090658|7155333|FG000|COMPLETED|Overall Study||20
6256395|NCT04090658|7155334|FG001|COMPLETED|Overall Study||20
6256396|NCT04090658|7155333|FG000|NOT COMPLETED|Overall Study||0
6256397|NCT04090658|7155334|FG001|NOT COMPLETED|Overall Study||0
6256398|NCT03811028|7155342|FG000|STARTED|Overall Study||3
6256399|NCT03811028|7155343|FG001|STARTED|Overall Study||3
6256400|NCT03811028|7155342|FG000|COMPLETED|Overall Study||3
6256401|NCT03811028|7155343|FG001|COMPLETED|Overall Study||3
6256402|NCT03811028|7155342|FG000|NOT COMPLETED|Overall Study||0
6256403|NCT03811028|7155343|FG001|NOT COMPLETED|Overall Study||0
6256404|NCT03760068|7155352|FG000|STARTED|Overall Study||238
6256405|NCT03760068|7155353|FG001|STARTED|Overall Study||240
6256406|NCT03760068|7155352|FG000|COMPLETED|Overall Study||224
6256407|NCT03760068|7155353|FG001|COMPLETED|Overall Study||217
6256408|NCT03760068|7155352|FG000|NOT COMPLETED|Overall Study||14
6256409|NCT03760068|7155353|FG001|NOT COMPLETED|Overall Study||23
6256410|NCT03742986|7155362|FG000|STARTED|Overall Study||4
6256411|NCT03742986|7155363|FG001|STARTED|Overall Study||4
6256412|NCT03742986|7155362|FG000|COMPLETED|Overall Study||4
6256413|NCT03742986|7155363|FG001|COMPLETED|Overall Study||4
6256414|NCT03742986|7155362|FG000|NOT COMPLETED|Overall Study||0
6256415|NCT03742986|7155363|FG001|NOT COMPLETED|Overall Study||0
6256416|NCT03628781|7155371|FG000|STARTED|Overall Study||85
6256417|NCT03628781|7155372|FG001|STARTED|Overall Study||84
6256418|NCT03628781|7155371|FG000|6-month Timepoint|Overall Study||63
6256419|NCT03628781|7155372|FG001|6-month Timepoint|Overall Study||79
6681613|NCT02672514|7613587|FG000|COMPLETED|Overall Study||53
6681614|NCT02672514|7613588|FG001|COMPLETED|Overall Study||51
6681615|NCT02672514|7613587|FG000|NOT COMPLETED|Overall Study||0
6681616|NCT02672514|7613588|FG001|NOT COMPLETED|Overall Study||0
6681617|NCT02672553|7613596|FG000|STARTED|Overall Study||51
6681618|NCT02672553|7613597|FG001|STARTED|Overall Study||49
6681619|NCT02672553|7613596|FG000|Intent To Treated (ITT) Randomized Arm|Overall Study|Two (2) subjects randomized to Edwards INTUITY were intraoperative screen failures|49
6681620|NCT02672553|7613597|FG001|Intent To Treated (ITT) Randomized Arm|Overall Study|One (1) subject randomized to Control arm/group withdrew prior to study procedure|48
6681621|NCT02672553|7613596|FG000|As Treated (AT) Randomized Arm/Group|Overall Study||46
6256420|NCT03628781|7155371|FG000|12-month Timepoint|Overall Study||53
6256421|NCT03628781|7155372|FG001|12-month Timepoint|Overall Study||75
6256422|NCT03628781|7155371|FG000|COMPLETED|Overall Study||53
6256423|NCT03628781|7155372|FG001|COMPLETED|Overall Study||75
6256424|NCT03628781|7155371|FG000|NOT COMPLETED|Overall Study||32
6256425|NCT03628781|7155372|FG001|NOT COMPLETED|Overall Study||9
6256426|NCT03560206|7155380|FG000|STARTED|Overall Study||158
6256427|NCT03560206|7155381|FG001|STARTED|Overall Study||158
6256428|NCT03560206|7155380|FG000|COMPLETED|Overall Study||108
6256429|NCT03560206|7155381|FG001|COMPLETED|Overall Study||140
6256430|NCT03560206|7155380|FG000|NOT COMPLETED|Overall Study||50
6256431|NCT03560206|7155381|FG001|NOT COMPLETED|Overall Study||18
6256438|NCT03340766|7155399|FG000|STARTED|Overall Study||12
6256439|NCT03340766|7155400|FG001|STARTED|Overall Study||10
6256440|NCT03340766|7155401|FG002|STARTED|Overall Study||9
6256441|NCT03340766|7155399|FG000|Received Blinatumomab|Overall Study||12
6256442|NCT03340766|7155400|FG001|Received Blinatumomab|Overall Study||10
6256443|NCT03340766|7155401|FG002|Received Blinatumomab|Overall Study||9
6256444|NCT03340766|7155399|FG000|Received Pembrolizumab|Overall Study||10
6256445|NCT03340766|7155400|FG001|Received Pembrolizumab|Overall Study||7
6256446|NCT03340766|7155401|FG002|Received Pembrolizumab|Overall Study||7
6256447|NCT03340766|7155399|FG000|COMPLETED|Overall Study||1
6256448|NCT03340766|7155400|FG001|COMPLETED|Overall Study||0
6256449|NCT03340766|7155401|FG002|COMPLETED|Overall Study||0
6256450|NCT03340766|7155399|FG000|NOT COMPLETED|Overall Study||11
6256451|NCT03340766|7155400|FG001|NOT COMPLETED|Overall Study||10
6256452|NCT03340766|7155401|FG002|NOT COMPLETED|Overall Study||9
6279196|NCT00142298|7178891|FG000|COMPLETED|Overall Study|Completed week 104/week 208.|507
6279197|NCT00142298|7178892|FG001|COMPLETED|Overall Study||456
6279198|NCT00142298|7178893|FG002|COMPLETED|Overall Study||90
6279199|NCT00142298|7178894|FG003|COMPLETED|Overall Study||121
6279200|NCT00142298|7178895|FG004|COMPLETED|Overall Study||46
6279201|NCT00142298|7178896|FG005|COMPLETED|Overall Study||10
6279202|NCT00142298|7178897|FG006|COMPLETED|Overall Study||15
6279203|NCT00142298|7178898|FG007|COMPLETED|Overall Study||58
6279204|NCT00142298|7178899|FG008|COMPLETED|Overall Study||52
6279205|NCT00142298|7178900|FG009|COMPLETED|Overall Study||13
6279206|NCT00142298|7178891|FG000|NOT COMPLETED|Overall Study||160
6279207|NCT00142298|7178892|FG001|NOT COMPLETED|Overall Study||176
6279208|NCT00142298|7178893|FG002|NOT COMPLETED|Overall Study||33
6279209|NCT00142298|7178894|FG003|NOT COMPLETED|Overall Study||85
6279210|NCT00142298|7178895|FG004|NOT COMPLETED|Overall Study||10
6279211|NCT00142298|7178896|FG005|NOT COMPLETED|Overall Study||16
6279212|NCT00142298|7178897|FG006|NOT COMPLETED|Overall Study||8
6279213|NCT00142298|7178898|FG007|NOT COMPLETED|Overall Study||8
6279214|NCT00142298|7178899|FG008|NOT COMPLETED|Overall Study||5
6279215|NCT00142298|7178900|FG009|NOT COMPLETED|Overall Study||0
6279216|NCT00142415|7178928|FG000|STARTED|Overall Study||3
6279217|NCT00142415|7178929|FG001|STARTED|Overall Study||3
6279218|NCT00142415|7178930|FG002|STARTED|Overall Study||6
6279219|NCT00142415|7178931|FG003|STARTED|Overall Study||3
6279220|NCT00142415|7178932|FG004|STARTED|Overall Study||3
6279221|NCT00142415|7178933|FG005|STARTED|Overall Study||8
6279222|NCT00142415|7178928|FG000|COMPLETED|Overall Study||3
6279223|NCT00142415|7178929|FG001|COMPLETED|Overall Study||3
6279224|NCT00142415|7178930|FG002|COMPLETED|Overall Study||6
6279225|NCT00142415|7178931|FG003|COMPLETED|Overall Study||3
6279226|NCT00142415|7178932|FG004|COMPLETED|Overall Study||2
6279227|NCT00142415|7178933|FG005|COMPLETED|Overall Study||6
6279228|NCT00142415|7178928|FG000|NOT COMPLETED|Overall Study||0
6279229|NCT00142415|7178929|FG001|NOT COMPLETED|Overall Study||0
6279230|NCT00142415|7178930|FG002|NOT COMPLETED|Overall Study||0
6279231|NCT00142415|7178931|FG003|NOT COMPLETED|Overall Study||0
6279232|NCT00142415|7178932|FG004|NOT COMPLETED|Overall Study||1
6279233|NCT00142415|7178933|FG005|NOT COMPLETED|Overall Study||2
6279234|NCT00142454|7178949|FG000|STARTED|Overall Study||9
6279235|NCT00142454|7178949|FG000|COMPLETED|Overall Study||9
6279236|NCT00142454|7178949|FG000|NOT COMPLETED|Overall Study||0
6279237|NCT00142506|7178955|FG000|STARTED|Overall Study||184
6279238|NCT00142506|7178956|FG001|STARTED|Overall Study||106
6279239|NCT00142506|7178955|FG000|COMPLETED|Overall Study||112
6279240|NCT00142506|7178956|FG001|COMPLETED|Overall Study||77
6279241|NCT00142506|7178955|FG000|NOT COMPLETED|Overall Study||72
6279242|NCT00142506|7178956|FG001|NOT COMPLETED|Overall Study||29
6279243|NCT00142597|7178964|FG000|STARTED|Overall Study|N=10 underwent PET imaging|23
6279244|NCT00142597|7178965|FG001|STARTED|Overall Study|N=10 underwent PET imaging|23
6279245|NCT00142597|7178964|FG000|COMPLETED|Overall Study|N=10 completed PET imaging|20
6279246|NCT00142597|7178965|FG001|COMPLETED|Overall Study|N=10 completed PET imaging|22
6279247|NCT00142597|7178964|FG000|NOT COMPLETED|Overall Study||3
6681622|NCT02672553|7613597|FG001|As Treated (AT) Randomized Arm/Group|Overall Study||51
6681623|NCT02672553|7613596|FG000|As Intended (AI) Randomized Arm/Group|Overall Study||46
6681624|NCT02672553|7613597|FG001|As Intended (AI) Randomized Arm/Group|Overall Study||48
6681625|NCT02672553|7613596|FG000|COMPLETED|Overall Study||39
6681626|NCT02672553|7613597|FG001|COMPLETED|Overall Study||41
6681627|NCT02672553|7613596|FG000|NOT COMPLETED|Overall Study||12
6681628|NCT02672553|7613597|FG001|NOT COMPLETED|Overall Study||8
6681629|NCT02672852|7613606|FG000|STARTED|Part A1||100
6681630|NCT02672852|7613607|FG001|STARTED|Part A1||407
6681631|NCT02672852|7613608|FG002|STARTED|Part A1||0
6681632|NCT02672852|7613609|FG003|STARTED|Part A1||0
6681633|NCT02672852|7613610|FG004|STARTED|Part A1||0
6681634|NCT02672852|7613611|FG005|STARTED|Part A1||0
6681635|NCT02672852|7613612|FG006|STARTED|Part A1||0
6681636|NCT02672852|7613606|FG000|COMPLETED|Part A1||97
6681637|NCT02672852|7613607|FG001|COMPLETED|Part A1||403
6681638|NCT02672852|7613608|FG002|COMPLETED|Part A1||0
6681639|NCT02672852|7613609|FG003|COMPLETED|Part A1||0
6681640|NCT02672852|7613610|FG004|COMPLETED|Part A1||0
6681641|NCT02672852|7613611|FG005|COMPLETED|Part A1||0
6681642|NCT02672852|7613612|FG006|COMPLETED|Part A1||0
6681643|NCT02672852|7613606|FG000|NOT COMPLETED|Part A1||3
6681644|NCT02672852|7613607|FG001|NOT COMPLETED|Part A1||4
6681645|NCT02672852|7613608|FG002|NOT COMPLETED|Part A1||0
6681646|NCT02672852|7613609|FG003|NOT COMPLETED|Part A1||0
6681647|NCT02672852|7613610|FG004|NOT COMPLETED|Part A1||0
6681648|NCT02672852|7613611|FG005|NOT COMPLETED|Part A1||0
6681649|NCT02672852|7613612|FG006|NOT COMPLETED|Part A1||0
6681650|NCT02672852|7613606|FG000|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
6681651|NCT02672852|7613607|FG001|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|0
6681652|NCT02672852|7613608|FG002|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|93
6681653|NCT02672852|7613609|FG003|STARTED|Part A2|Participants that completed Part A1 continued on to Part A2.|403
6681654|NCT02672852|7613610|FG004|STARTED|Part A2||0
6681655|NCT02672852|7613611|FG005|STARTED|Part A2||0
6681656|NCT02672852|7613612|FG006|STARTED|Part A2||0
6681657|NCT02672852|7613606|FG000|COMPLETED|Part A2||0
6681658|NCT02672852|7613607|FG001|COMPLETED|Part A2||0
6681659|NCT02672852|7613608|FG002|COMPLETED|Part A2||83
6681660|NCT02672852|7613609|FG003|COMPLETED|Part A2||399
6681661|NCT02672852|7613610|FG004|COMPLETED|Part A2||0
6681662|NCT02672852|7613611|FG005|COMPLETED|Part A2||0
6681663|NCT02672852|7613612|FG006|COMPLETED|Part A2||0
6681664|NCT02672852|7613606|FG000|NOT COMPLETED|Part A2||0
6681665|NCT02672852|7613607|FG001|NOT COMPLETED|Part A2||0
6681666|NCT02672852|7613608|FG002|NOT COMPLETED|Part A2||10
6681667|NCT02672852|7613609|FG003|NOT COMPLETED|Part A2||4
6681668|NCT02672852|7613610|FG004|NOT COMPLETED|Part A2||0
6681669|NCT02672852|7613611|FG005|NOT COMPLETED|Part A2||0
6681670|NCT02672852|7613612|FG006|NOT COMPLETED|Part A2||0
6681671|NCT02672852|7613606|FG000|STARTED|Part B||0
6681672|NCT02672852|7613607|FG001|STARTED|Part B||0
6681673|NCT02672852|7613608|FG002|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
6681674|NCT02672852|7613609|FG003|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|0
6681675|NCT02672852|7613610|FG004|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|225
6681676|NCT02672852|7613611|FG005|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|111
6681677|NCT02672852|7613612|FG006|STARTED|Part B|Participants that completed Part A2 continued on to Part B.|63
6681678|NCT02672852|7613606|FG000|COMPLETED|Part B||0
6681679|NCT02672852|7613607|FG001|COMPLETED|Part B||0
6681680|NCT02672852|7613608|FG002|COMPLETED|Part B||0
6681681|NCT02672852|7613609|FG003|COMPLETED|Part B||0
6681682|NCT02672852|7613610|FG004|COMPLETED|Part B||209
6681683|NCT02672852|7613611|FG005|COMPLETED|Part B||100
6681684|NCT02672852|7613612|FG006|COMPLETED|Part B||51
6681685|NCT02672852|7613606|FG000|NOT COMPLETED|Part B||0
6681686|NCT02672852|7613607|FG001|NOT COMPLETED|Part B||0
6681687|NCT02672852|7613608|FG002|NOT COMPLETED|Part B||0
6681688|NCT02672852|7613609|FG003|NOT COMPLETED|Part B||0
6681689|NCT02672852|7613610|FG004|NOT COMPLETED|Part B||16
6681690|NCT02672852|7613611|FG005|NOT COMPLETED|Part B||11
6681691|NCT02672852|7613612|FG006|NOT COMPLETED|Part B||12
6681692|NCT02673138|7613623|FG000|STARTED|Overall Study||10
6681693|NCT02673138|7613623|FG000|Started Day 1|Overall Study||10
6681694|NCT02673138|7613623|FG000|Ended Day 1|Overall Study||10
6681695|NCT02673138|7613623|FG000|Started Day 2|Overall Study||10
6681696|NCT02673138|7613623|FG000|Ended Day 2|Overall Study||10
6681697|NCT02673138|7613623|FG000|COMPLETED|Overall Study||10
6681698|NCT02673138|7613623|FG000|NOT COMPLETED|Overall Study||0
6681699|NCT02673203|7613631|FG000|STARTED|Overall Study||16
6681700|NCT02673203|7613632|FG001|STARTED|Overall Study||15
6681701|NCT02673203|7613631|FG000|COMPLETED|Overall Study||16
6681702|NCT02673203|7613632|FG001|COMPLETED|Overall Study||15
6681703|NCT02673203|7613631|FG000|NOT COMPLETED|Overall Study||0
6681704|NCT02673203|7613632|FG001|NOT COMPLETED|Overall Study||0
6681705|NCT02673372|7613640|FG000|STARTED|Overall Study||30
6681706|NCT02673372|7613641|FG001|STARTED|Overall Study||30
6681707|NCT02673372|7613640|FG000|COMPLETED|Overall Study||30
6681708|NCT02673372|7613641|FG001|COMPLETED|Overall Study||30
6681709|NCT02673372|7613640|FG000|NOT COMPLETED|Overall Study||0
6681710|NCT02673372|7613641|FG001|NOT COMPLETED|Overall Study||0
6681711|NCT02673489|7613649|FG000|STARTED|Treatment Period||54
6681712|NCT02673489|7613650|FG001|STARTED|Treatment Period||24
6681713|NCT02673489|7613649|FG000|COMPLETED|Treatment Period||49
6681714|NCT02673489|7613650|FG001|COMPLETED|Treatment Period||21
6681715|NCT02673489|7613649|FG000|NOT COMPLETED|Treatment Period||5
6681716|NCT02673489|7613650|FG001|NOT COMPLETED|Treatment Period||3
6681717|NCT02673489|7613649|FG000|STARTED|Follow Up Period||50
6681718|NCT02673489|7613650|FG001|STARTED|Follow Up Period||23
6681719|NCT02673489|7613649|FG000|COMPLETED|Follow Up Period||50
6681720|NCT02673489|7613650|FG001|COMPLETED|Follow Up Period||21
6681721|NCT02673489|7613649|FG000|NOT COMPLETED|Follow Up Period||0
6681722|NCT02673489|7613650|FG001|NOT COMPLETED|Follow Up Period||2
6681723|NCT02673515|7613659|FG000|STARTED|Overall Study||30
6681724|NCT02673515|7613660|FG001|STARTED|Overall Study||30
6681725|NCT02673515|7613659|FG000|COMPLETED|Overall Study||28
6681726|NCT02673515|7613660|FG001|COMPLETED|Overall Study||29
6681727|NCT02673515|7613659|FG000|NOT COMPLETED|Overall Study||2
6681728|NCT02673515|7613660|FG001|NOT COMPLETED|Overall Study||1
6681729|NCT02673541|7613668|FG000|STARTED|Overall Study||3
6681730|NCT02673541|7613669|FG001|STARTED|Overall Study||2
6681731|NCT02673541|7613668|FG000|COMPLETED|Overall Study||3
6681732|NCT02673541|7613669|FG001|COMPLETED|Overall Study||2
6681733|NCT02673541|7613668|FG000|NOT COMPLETED|Overall Study||0
6681734|NCT02673541|7613669|FG001|NOT COMPLETED|Overall Study||0
6681735|NCT02673619|7613679|FG000|STARTED|Overall Study||20
6681736|NCT02673619|7613680|FG001|STARTED|Overall Study||5
6681737|NCT02673619|7613681|FG002|STARTED|Overall Study||26
6681738|NCT02673619|7613682|FG003|STARTED|Overall Study||7
6681739|NCT02673619|7613679|FG000|COMPLETED|Overall Study||18
6681740|NCT02673619|7613680|FG001|COMPLETED|Overall Study||4
6681741|NCT02673619|7613681|FG002|COMPLETED|Overall Study||23
6681742|NCT02673619|7613682|FG003|COMPLETED|Overall Study||7
6681743|NCT02673619|7613679|FG000|NOT COMPLETED|Overall Study||2
6681744|NCT02673619|7613680|FG001|NOT COMPLETED|Overall Study||1
6681745|NCT02673619|7613681|FG002|NOT COMPLETED|Overall Study||3
6681746|NCT02673619|7613682|FG003|NOT COMPLETED|Overall Study||0
6681747|NCT02673918|7613695|FG000|STARTED|Overall Study||35
6681748|NCT02673918|7613696|FG001|STARTED|Overall Study||24
6681749|NCT02673918|7613695|FG000|COMPLETED|Overall Study||29
6681750|NCT02673918|7613696|FG001|COMPLETED|Overall Study||20
6681751|NCT02673918|7613695|FG000|NOT COMPLETED|Overall Study||6
6681752|NCT02673918|7613696|FG001|NOT COMPLETED|Overall Study||4
6681753|NCT02673944|7613704|FG000|STARTED|Overall Study||10
6681754|NCT02673944|7613704|FG000|COMPLETED|Overall Study||10
6681755|NCT02673944|7613704|FG000|NOT COMPLETED|Overall Study||0
6681756|NCT02674334|7613711|FG000|STARTED|Overall Study||47
6681757|NCT02674334|7613712|FG001|STARTED|Overall Study||43
6681758|NCT02674334|7613711|FG000|COMPLETED|Overall Study||40
6681759|NCT02674334|7613712|FG001|COMPLETED|Overall Study||40
6681760|NCT02674334|7613711|FG000|NOT COMPLETED|Overall Study||7
6681761|NCT02674334|7613712|FG001|NOT COMPLETED|Overall Study||3
6681762|NCT02674386|7613721|FG000|STARTED|Overall Study||20
6681763|NCT02674386|7613722|FG001|STARTED|Overall Study||117
6681764|NCT02674386|7613723|FG002|STARTED|Overall Study||17
6681765|NCT02674386|7613721|FG000|Safety Analysis Set|Overall Study||20
6681766|NCT02674386|7613722|FG001|Safety Analysis Set|Overall Study||113
6681767|NCT02674386|7613723|FG002|Safety Analysis Set|Overall Study||17
6681768|NCT02674386|7613721|FG000|COMPLETED|Overall Study||20
6681769|NCT02674386|7613722|FG001|COMPLETED|Overall Study||107
6681770|NCT02674386|7613723|FG002|COMPLETED|Overall Study||16
6681771|NCT02674386|7613721|FG000|NOT COMPLETED|Overall Study||0
6681772|NCT02674386|7613722|FG001|NOT COMPLETED|Overall Study||10
6681773|NCT02674386|7613723|FG002|NOT COMPLETED|Overall Study||1
6681774|NCT02674399|7613738|FG000|STARTED|Overall Study||19
6681775|NCT02674399|7613739|FG001|STARTED|Overall Study||9
6681776|NCT02674399|7613738|FG000|COMPLETED|Overall Study||17
6681777|NCT02674399|7613739|FG001|COMPLETED|Overall Study||9
6681778|NCT02674399|7613738|FG000|NOT COMPLETED|Overall Study||2
6681779|NCT02674399|7613739|FG001|NOT COMPLETED|Overall Study||0
6681780|NCT02674412|7613745|FG000|STARTED|Overall Study||5
6681781|NCT02674412|7613746|FG001|STARTED|Overall Study||5
6681782|NCT02674412|7613745|FG000|COMPLETED|Overall Study||5
6681783|NCT02674412|7613746|FG001|COMPLETED|Overall Study||5
6681784|NCT02674412|7613745|FG000|NOT COMPLETED|Overall Study||0
6681785|NCT02674412|7613746|FG001|NOT COMPLETED|Overall Study||0
6681786|NCT02674477|7613755|FG000|STARTED|Overall Study||48
6681787|NCT02674477|7613756|FG001|STARTED|Overall Study||47
6681788|NCT02674477|7613755|FG000|COMPLETED|Overall Study||40
6681789|NCT02674477|7613756|FG001|COMPLETED|Overall Study||45
6681790|NCT02674477|7613755|FG000|NOT COMPLETED|Overall Study||8
6681791|NCT02674477|7613756|FG001|NOT COMPLETED|Overall Study||2
6681792|NCT02674568|7613762|FG000|STARTED|Overall Study|Enrolled and dosed.|339
6681793|NCT02674568|7613762|FG000|Delta-like Protein 3 (DLL3) High|Overall Study||238
6681794|NCT02674568|7613762|FG000|DLL3 Positive|Overall Study||287
6681795|NCT02674568|7613762|FG000|COMPLETED|Overall Study||0
6681796|NCT02674568|7613762|FG000|NOT COMPLETED|Overall Study||339
6681797|NCT02674633|7613773|FG000|STARTED|Overall Study||180
6681798|NCT02674633|7613774|FG001|STARTED|Overall Study||168
6681799|NCT02674633|7613773|FG000|COMPLETED|Overall Study||175
6681800|NCT02674633|7613774|FG001|COMPLETED|Overall Study||164
6681801|NCT02674633|7613773|FG000|NOT COMPLETED|Overall Study||5
6681802|NCT02674633|7613774|FG001|NOT COMPLETED|Overall Study||4
6681803|NCT02674659|7613782|FG000|STARTED|Overall Study||43
6681804|NCT02674659|7613783|FG001|STARTED|Overall Study||44
6681805|NCT02674659|7613782|FG000|COMPLETED|Overall Study||39
6681806|NCT02674659|7613783|FG001|COMPLETED|Overall Study||40
6681807|NCT02674659|7613782|FG000|NOT COMPLETED|Overall Study||4
6681808|NCT02674659|7613783|FG001|NOT COMPLETED|Overall Study||4
6681809|NCT02674685|7613789|FG000|STARTED|Overall Study||237
6681810|NCT02674685|7613789|FG000|COMPLETED|Overall Study||233
6681811|NCT02674685|7613789|FG000|NOT COMPLETED|Overall Study||4
6681812|NCT02674854|7613796|FG000|STARTED|Overall Study||245
6681813|NCT02674854|7613797|FG001|STARTED|Overall Study||255
6681814|NCT02674854|7613798|FG002|STARTED|Overall Study||250
6681815|NCT02674854|7613796|FG000|COMPLETED|Overall Study||221
6681816|NCT02674854|7613797|FG001|COMPLETED|Overall Study||228
6681817|NCT02674854|7613798|FG002|COMPLETED|Overall Study||236
6681818|NCT02674854|7613796|FG000|NOT COMPLETED|Overall Study||24
6681819|NCT02674854|7613797|FG001|NOT COMPLETED|Overall Study||27
6681820|NCT02674854|7613798|FG002|NOT COMPLETED|Overall Study||14
6681821|NCT02675075|7613808|FG000|STARTED|Overall Study||15
6681822|NCT02675075|7613809|FG001|STARTED|Overall Study||19
6681823|NCT02675075|7613808|FG000|COMPLETED|Overall Study||12
6681824|NCT02675075|7613809|FG001|COMPLETED|Overall Study||19
6681825|NCT02675075|7613808|FG000|NOT COMPLETED|Overall Study||3
6681826|NCT02675075|7613809|FG001|NOT COMPLETED|Overall Study||0
6681827|NCT02675517|7613817|FG000|STARTED|Overall Study||1737
6681828|NCT02675517|7613817|FG000|COMPLETED|Overall Study||1578
6681829|NCT02675517|7613817|FG000|NOT COMPLETED|Overall Study||159
6681830|NCT02675543|7613823|FG000|STARTED|Overall Study||15
6681831|NCT02675543|7613824|FG001|STARTED|Overall Study||20
6681832|NCT02675543|7613823|FG000|COMPLETED|Overall Study||15
6681833|NCT02675543|7613824|FG001|COMPLETED|Overall Study||20
6681834|NCT02675543|7613823|FG000|NOT COMPLETED|Overall Study||0
6681835|NCT02675543|7613824|FG001|NOT COMPLETED|Overall Study||0
6681836|NCT02675634|7613830|FG000|STARTED|Test Period 1||10
6681837|NCT02675634|7613831|FG001|STARTED|Test Period 1||8
6681838|NCT02675634|7613832|FG002|STARTED|Test Period 1||9
6681839|NCT02675634|7613833|FG003|STARTED|Test Period 1||9
6681840|NCT02675634|7613834|FG004|STARTED|Test Period 1||10
6681841|NCT02675634|7613835|FG005|STARTED|Test Period 1||9
6681842|NCT02675634|7613830|FG000|COMPLETED|Test Period 1||10
6681843|NCT02675634|7613831|FG001|COMPLETED|Test Period 1||7
6681844|NCT02675634|7613832|FG002|COMPLETED|Test Period 1||8
6681845|NCT02675634|7613833|FG003|COMPLETED|Test Period 1||8
6681846|NCT02675634|7613834|FG004|COMPLETED|Test Period 1||10
6681847|NCT02675634|7613835|FG005|COMPLETED|Test Period 1||9
6681848|NCT02675634|7613830|FG000|NOT COMPLETED|Test Period 1||0
6681849|NCT02675634|7613831|FG001|NOT COMPLETED|Test Period 1||1
6681850|NCT02675634|7613832|FG002|NOT COMPLETED|Test Period 1||1
6681851|NCT02675634|7613833|FG003|NOT COMPLETED|Test Period 1||1
6681852|NCT02675634|7613834|FG004|NOT COMPLETED|Test Period 1||0
6681853|NCT02675634|7613835|FG005|NOT COMPLETED|Test Period 1||0
6681854|NCT02675634|7613830|FG000|STARTED|Test Period 2||10
6681855|NCT02675634|7613831|FG001|STARTED|Test Period 2||7
6681856|NCT02675634|7613832|FG002|STARTED|Test Period 2||8
6681857|NCT02675634|7613833|FG003|STARTED|Test Period 2||8
6681858|NCT02675634|7613834|FG004|STARTED|Test Period 2||10
6681859|NCT02675634|7613835|FG005|STARTED|Test Period 2||9
6681860|NCT02675634|7613830|FG000|COMPLETED|Test Period 2||9
6681861|NCT02675634|7613831|FG001|COMPLETED|Test Period 2||7
6681862|NCT02675634|7613832|FG002|COMPLETED|Test Period 2||8
6681863|NCT02675634|7613833|FG003|COMPLETED|Test Period 2||8
6681864|NCT02675634|7613834|FG004|COMPLETED|Test Period 2||10
6681865|NCT02675634|7613835|FG005|COMPLETED|Test Period 2||8
6681866|NCT02675634|7613830|FG000|NOT COMPLETED|Test Period 2||1
6681867|NCT02675634|7613831|FG001|NOT COMPLETED|Test Period 2||0
6681868|NCT02675634|7613832|FG002|NOT COMPLETED|Test Period 2||0
6681869|NCT02675634|7613833|FG003|NOT COMPLETED|Test Period 2||0
6681870|NCT02675634|7613834|FG004|NOT COMPLETED|Test Period 2||0
6681871|NCT02675634|7613835|FG005|NOT COMPLETED|Test Period 2||1
6681872|NCT02675634|7613830|FG000|STARTED|Test Period 3||9
6681873|NCT02675634|7613831|FG001|STARTED|Test Period 3||7
6681874|NCT02675634|7613832|FG002|STARTED|Test Period 3||8
6681875|NCT02675634|7613833|FG003|STARTED|Test Period 3||8
6681876|NCT02675634|7613834|FG004|STARTED|Test Period 3||10
6681877|NCT02675634|7613835|FG005|STARTED|Test Period 3||8
6681878|NCT02675634|7613830|FG000|COMPLETED|Test Period 3||9
6681879|NCT02675634|7613831|FG001|COMPLETED|Test Period 3||7
6681880|NCT02675634|7613832|FG002|COMPLETED|Test Period 3||8
6681881|NCT02675634|7613833|FG003|COMPLETED|Test Period 3||8
6681882|NCT02675634|7613834|FG004|COMPLETED|Test Period 3||10
6681883|NCT02675634|7613835|FG005|COMPLETED|Test Period 3||8
6681884|NCT02675634|7613830|FG000|NOT COMPLETED|Test Period 3||0
6681885|NCT02675634|7613831|FG001|NOT COMPLETED|Test Period 3||0
6681886|NCT02675634|7613832|FG002|NOT COMPLETED|Test Period 3||0
6681887|NCT02675634|7613833|FG003|NOT COMPLETED|Test Period 3||0
6681888|NCT02675634|7613834|FG004|NOT COMPLETED|Test Period 3||0
6681889|NCT02675634|7613835|FG005|NOT COMPLETED|Test Period 3||0
6681890|NCT02675764|7613845|FG000|STARTED|Overall Study||6
6681891|NCT02675764|7613846|FG001|STARTED|Overall Study||6
6681892|NCT02675764|7613845|FG000|COMPLETED|Overall Study||6
6681893|NCT02675764|7613846|FG001|COMPLETED|Overall Study||6
6681894|NCT02675764|7613845|FG000|NOT COMPLETED|Overall Study||0
6681895|NCT02675764|7613846|FG001|NOT COMPLETED|Overall Study||0
6681896|NCT02675907|7613854|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||100
6681897|NCT02675907|7613855|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||101
6681898|NCT02675907|7613854|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||95
6681899|NCT02675907|7613855|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||96
6681900|NCT02675907|7613854|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
6681901|NCT02675907|7613855|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||5
6681902|NCT02675907|7613854|FG000|STARTED|Study Overall||100
6681903|NCT02675907|7613855|FG001|STARTED|Study Overall||101
6681904|NCT02675907|7613854|FG000|COMPLETED|Study Overall||97
6681905|NCT02675907|7613855|FG001|COMPLETED|Study Overall||97
6681906|NCT02675907|7613854|FG000|NOT COMPLETED|Study Overall||3
6681907|NCT02675907|7613855|FG001|NOT COMPLETED|Study Overall||4
6681908|NCT02675998|7613865|FG000|STARTED|8-Week Treatment Period||74
6681909|NCT02675998|7613866|FG001|STARTED|8-Week Treatment Period||73
6681910|NCT02675998|7613867|FG002|STARTED|8-Week Treatment Period||72
6681911|NCT02675998|7613868|FG003|STARTED|8-Week Treatment Period||0
6681912|NCT02675998|7613865|FG000|COMPLETED|8-Week Treatment Period||57
6681913|NCT02675998|7613866|FG001|COMPLETED|8-Week Treatment Period||54
6681914|NCT02675998|7613867|FG002|COMPLETED|8-Week Treatment Period||53
6681915|NCT02675998|7613868|FG003|COMPLETED|8-Week Treatment Period||0
6681916|NCT02675998|7613865|FG000|NOT COMPLETED|8-Week Treatment Period||17
6681917|NCT02675998|7613866|FG001|NOT COMPLETED|8-Week Treatment Period||19
6681918|NCT02675998|7613867|FG002|NOT COMPLETED|8-Week Treatment Period||19
6681919|NCT02675998|7613868|FG003|NOT COMPLETED|8-Week Treatment Period||0
6681920|NCT02675998|7613865|FG000|STARTED|4-Week Randomized Withdrawal Period||25
6681921|NCT02675998|7613866|FG001|STARTED|4-Week Randomized Withdrawal Period||23
6681922|NCT02675998|7613867|FG002|STARTED|4-Week Randomized Withdrawal Period||34
6681923|NCT02675998|7613868|FG003|STARTED|4-Week Randomized Withdrawal Period||82
6681924|NCT02675998|7613865|FG000|COMPLETED|4-Week Randomized Withdrawal Period||24
6681925|NCT02675998|7613866|FG001|COMPLETED|4-Week Randomized Withdrawal Period||22
6681926|NCT02675998|7613867|FG002|COMPLETED|4-Week Randomized Withdrawal Period||32
6681927|NCT02675998|7613868|FG003|COMPLETED|4-Week Randomized Withdrawal Period||74
6681928|NCT02675998|7613865|FG000|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
6681929|NCT02675998|7613866|FG001|NOT COMPLETED|4-Week Randomized Withdrawal Period||1
6681930|NCT02675998|7613867|FG002|NOT COMPLETED|4-Week Randomized Withdrawal Period||2
6681931|NCT02675998|7613868|FG003|NOT COMPLETED|4-Week Randomized Withdrawal Period||8
6681932|NCT02676375|7613881|FG000|STARTED|Overall Study||14
6681933|NCT02676375|7613882|FG001|STARTED|Overall Study||14
6681934|NCT02676375|7613883|FG002|STARTED|Overall Study||14
6681935|NCT02676375|7613881|FG000|COMPLETED|Overall Study||13
6681936|NCT02676375|7613882|FG001|COMPLETED|Overall Study||10
6681937|NCT02676375|7613883|FG002|COMPLETED|Overall Study||11
6681938|NCT02676375|7613881|FG000|NOT COMPLETED|Overall Study||1
6681939|NCT02676375|7613882|FG001|NOT COMPLETED|Overall Study||4
6681940|NCT02676375|7613883|FG002|NOT COMPLETED|Overall Study||3
6681941|NCT02676466|7613899|FG000|STARTED|Overall Study||109
6681942|NCT02676466|7613900|FG001|STARTED|Overall Study||71
6681943|NCT02676466|7613901|FG002|STARTED|Overall Study||26
6681944|NCT02676466|7613902|FG003|STARTED|Overall Study||17
6681945|NCT02676466|7613903|FG004|STARTED|Overall Study||26
6681946|NCT02676466|7613904|FG005|STARTED|Overall Study||13
6681947|NCT02676466|7613905|FG006|STARTED|Overall Study||13
6681948|NCT02676466|7613906|FG007|STARTED|Overall Study||14
6681949|NCT02676466|7613899|FG000|COMPLETED|Overall Study||105
6681950|NCT02676466|7613900|FG001|COMPLETED|Overall Study||66
6681951|NCT02676466|7613901|FG002|COMPLETED|Overall Study||24
6681952|NCT02676466|7613902|FG003|COMPLETED|Overall Study||17
6681953|NCT02676466|7613903|FG004|COMPLETED|Overall Study||23
6681954|NCT02676466|7613904|FG005|COMPLETED|Overall Study||12
6681955|NCT02676466|7613905|FG006|COMPLETED|Overall Study||12
6681956|NCT02676466|7613906|FG007|COMPLETED|Overall Study||13
6681957|NCT02676466|7613899|FG000|NOT COMPLETED|Overall Study||4
6681958|NCT02676466|7613900|FG001|NOT COMPLETED|Overall Study||5
6681959|NCT02676466|7613901|FG002|NOT COMPLETED|Overall Study||2
6681960|NCT02676466|7613902|FG003|NOT COMPLETED|Overall Study||0
6681961|NCT02676466|7613903|FG004|NOT COMPLETED|Overall Study||3
6681962|NCT02676466|7613904|FG005|NOT COMPLETED|Overall Study||1
6681963|NCT02676466|7613905|FG006|NOT COMPLETED|Overall Study||1
6681964|NCT02676466|7613906|FG007|NOT COMPLETED|Overall Study||1
6681965|NCT02676778|7613931|FG000|STARTED|Overall Study||17
6681966|NCT02676778|7613932|FG001|STARTED|Overall Study||19
6681967|NCT02676778|7613933|FG002|STARTED|Overall Study||1
6681968|NCT02676778|7613931|FG000|COMPLETED|Overall Study||0
6681969|NCT02676778|7613932|FG001|COMPLETED|Overall Study||7
6681970|NCT02676778|7613933|FG002|COMPLETED|Overall Study||0
6681971|NCT02676778|7613931|FG000|NOT COMPLETED|Overall Study||17
6681972|NCT02676778|7613932|FG001|NOT COMPLETED|Overall Study||12
6681973|NCT02676778|7613933|FG002|NOT COMPLETED|Overall Study||1
6681974|NCT02676843|7613942|FG000|STARTED|Overall Study||7
6681975|NCT02676843|7613942|FG000|COMPLETED|Overall Study||7
6681976|NCT02676843|7613942|FG000|NOT COMPLETED|Overall Study||0
6681977|NCT02676882|7613949|FG000|STARTED|Overall Study||13
6681978|NCT02676882|7613950|FG001|STARTED|Overall Study||7
6681979|NCT02676882|7613949|FG000|Evaluable|Overall Study||11
6681980|NCT02676882|7613950|FG001|Evaluable|Overall Study||6
6681981|NCT02676882|7613949|FG000|COMPLETED|Overall Study||10
6681982|NCT02676882|7613950|FG001|COMPLETED|Overall Study||5
6681983|NCT02676882|7613949|FG000|NOT COMPLETED|Overall Study||3
6681984|NCT02676882|7613950|FG001|NOT COMPLETED|Overall Study||2
6681985|NCT02676895|7613959|FG000|STARTED|Overall Study||22
6681986|NCT02676895|7613960|FG001|STARTED|Overall Study||26
6681987|NCT02676895|7613961|FG002|STARTED|Overall Study||24
6681988|NCT02676895|7613959|FG000|COMPLETED|Overall Study||20
6681989|NCT02676895|7613960|FG001|COMPLETED|Overall Study||23
6681990|NCT02676895|7613961|FG002|COMPLETED|Overall Study||21
6681991|NCT02676895|7613959|FG000|NOT COMPLETED|Overall Study||2
6681992|NCT02676895|7613960|FG001|NOT COMPLETED|Overall Study||3
6681993|NCT02676895|7613961|FG002|NOT COMPLETED|Overall Study||3
6681994|NCT02677116|7613979|FG000|STARTED|Overall Study||10
6681995|NCT02677116|7613980|FG001|STARTED|Overall Study||11
6681996|NCT02677116|7613981|FG002|STARTED|Overall Study||9
6681997|NCT02677116|7613982|FG003|STARTED|Overall Study||10
6681998|NCT02677116|7613983|FG004|STARTED|Overall Study||1
6681999|NCT02677116|7613984|FG005|STARTED|Overall Study||13
6682000|NCT02677116|7613985|FG006|STARTED|Overall Study||6
6682001|NCT02677116|7613986|FG007|STARTED|Overall Study||4
6682002|NCT02677116|7613987|FG008|STARTED|Overall Study||4
6682003|NCT02677116|7613979|FG000|Cycle 1 Olaratumab Alone|Overall Study||10
6682004|NCT02677116|7613980|FG001|Cycle 1 Olaratumab Alone|Overall Study||11
6682005|NCT02677116|7613981|FG002|Cycle 1 Olaratumab Alone|Overall Study||9
6682006|NCT02677116|7613982|FG003|Cycle 1 Olaratumab Alone|Overall Study||10
6682007|NCT02677116|7613983|FG004|Cycle 1 Olaratumab Alone|Overall Study||1
6682008|NCT02677116|7613984|FG005|Cycle 1 Olaratumab Alone|Overall Study||13
6682009|NCT02677116|7613985|FG006|Cycle 1 Olaratumab Alone|Overall Study||6
6682010|NCT02677116|7613986|FG007|Cycle 1 Olaratumab Alone|Overall Study||4
6682011|NCT02677116|7613987|FG008|Cycle 1 Olaratumab Alone|Overall Study||4
6682012|NCT02677116|7613979|FG000|Progressive Disease|Overall Study||7
6682013|NCT02677116|7613980|FG001|Progressive Disease|Overall Study||7
6682014|NCT02677116|7613981|FG002|Progressive Disease|Overall Study||6
6682015|NCT02677116|7613982|FG003|Progressive Disease|Overall Study||7
6682016|NCT02677116|7613983|FG004|Progressive Disease|Overall Study||0
6682017|NCT02677116|7613984|FG005|Progressive Disease|Overall Study||9
6682018|NCT02677116|7613985|FG006|Progressive Disease|Overall Study||2
6682019|NCT02677116|7613986|FG007|Progressive Disease|Overall Study||2
6682020|NCT02677116|7613987|FG008|Progressive Disease|Overall Study||2
6682021|NCT02677116|7613979|FG000|COMPLETED|Overall Study||7
6682022|NCT02677116|7613980|FG001|COMPLETED|Overall Study||7
6682023|NCT02677116|7613981|FG002|COMPLETED|Overall Study||6
6682024|NCT02677116|7613982|FG003|COMPLETED|Overall Study||7
6682025|NCT02677116|7613983|FG004|COMPLETED|Overall Study||0
6682026|NCT02677116|7613984|FG005|COMPLETED|Overall Study||9
6682027|NCT02677116|7613985|FG006|COMPLETED|Overall Study||2
6682028|NCT02677116|7613986|FG007|COMPLETED|Overall Study||2
6682029|NCT02677116|7613987|FG008|COMPLETED|Overall Study||2
6682030|NCT02677116|7613979|FG000|NOT COMPLETED|Overall Study||3
6682031|NCT02677116|7613980|FG001|NOT COMPLETED|Overall Study||4
6682032|NCT02677116|7613981|FG002|NOT COMPLETED|Overall Study||3
6682033|NCT02677116|7613982|FG003|NOT COMPLETED|Overall Study||3
6682034|NCT02677116|7613983|FG004|NOT COMPLETED|Overall Study||1
6682035|NCT02677116|7613984|FG005|NOT COMPLETED|Overall Study||4
6682036|NCT02677116|7613985|FG006|NOT COMPLETED|Overall Study||4
6682037|NCT02677116|7613986|FG007|NOT COMPLETED|Overall Study||2
6682038|NCT02677116|7613987|FG008|NOT COMPLETED|Overall Study||2
6682039|NCT02677220|7614030|FG000|STARTED|Overall Study||1
6682040|NCT02677220|7614030|FG000|COMPLETED|Overall Study||0
6682041|NCT02677220|7614030|FG000|NOT COMPLETED|Overall Study||1
6682042|NCT02677324|7614035|FG000|STARTED|Overall Study||33
6682043|NCT02677324|7614035|FG000|COMPLETED|Overall Study||21
6682044|NCT02677324|7614035|FG000|NOT COMPLETED|Overall Study||12
6682045|NCT02677428|7614043|FG000|STARTED|Overall Study||63
6682046|NCT02677428|7614044|FG001|STARTED|Overall Study||55
6682047|NCT02677428|7614043|FG000|COMPLETED|Overall Study||63
6682048|NCT02677428|7614044|FG001|COMPLETED|Overall Study||55
6682049|NCT02677428|7614043|FG000|NOT COMPLETED|Overall Study||0
6682050|NCT02677428|7614044|FG001|NOT COMPLETED|Overall Study||0
6682051|NCT02677493|7614053|FG000|STARTED|Overall Study||1197
6682052|NCT02677493|7614054|FG001|STARTED|Overall Study||298
6682053|NCT02677493|7614055|FG002|STARTED|Overall Study||299
6682054|NCT02677493|7614053|FG000|COMPLETED|Overall Study||1186
6682055|NCT02677493|7614054|FG001|COMPLETED|Overall Study||296
6682056|NCT02677493|7614055|FG002|COMPLETED|Overall Study||296
6682057|NCT02677493|7614053|FG000|NOT COMPLETED|Overall Study||11
6682058|NCT02677493|7614054|FG001|NOT COMPLETED|Overall Study||2
6682059|NCT02677493|7614055|FG002|NOT COMPLETED|Overall Study||3
6682060|NCT02677623|7614070|FG000|STARTED|Overall Study||33
6682061|NCT02677623|7614071|FG001|STARTED|Overall Study||32
6682062|NCT02677623|7614072|FG002|STARTED|Overall Study||32
6682063|NCT02677623|7614073|FG003|STARTED|Overall Study||33
6682064|NCT02677623|7614070|FG000|COMPLETED|Overall Study||33
6682065|NCT02677623|7614071|FG001|COMPLETED|Overall Study||32
6682066|NCT02677623|7614072|FG002|COMPLETED|Overall Study||32
6682067|NCT02677623|7614073|FG003|COMPLETED|Overall Study||33
6682068|NCT02677623|7614070|FG000|NOT COMPLETED|Overall Study||0
6682069|NCT02677623|7614071|FG001|NOT COMPLETED|Overall Study||0
6682070|NCT02677623|7614072|FG002|NOT COMPLETED|Overall Study||0
6682071|NCT02677623|7614073|FG003|NOT COMPLETED|Overall Study||0
6682072|NCT02677701|7614085|FG000|STARTED|Overall Study||62
6682073|NCT02677701|7614086|FG001|STARTED|Overall Study||57
6682074|NCT02677701|7614085|FG000|Treated|Overall Study||61
6682075|NCT02677701|7614086|FG001|Treated|Overall Study||54
6682076|NCT02677701|7614085|FG000|COMPLETED|Overall Study||56
6682077|NCT02677701|7614086|FG001|COMPLETED|Overall Study||52
6682078|NCT02677701|7614085|FG000|NOT COMPLETED|Overall Study||6
6682079|NCT02677701|7614086|FG001|NOT COMPLETED|Overall Study||5
6682080|NCT02677714|7614094|FG000|STARTED|Overall Study||12
6682081|NCT02677714|7614095|FG001|STARTED|Overall Study||2
6682082|NCT02677714|7614094|FG000|COMPLETED|Overall Study||10
6682083|NCT02677714|7614095|FG001|COMPLETED|Overall Study||2
6682084|NCT02677714|7614094|FG000|NOT COMPLETED|Overall Study||2
6682085|NCT02677714|7614095|FG001|NOT COMPLETED|Overall Study||0
6682086|NCT02677740|7614103|FG000|STARTED|Overall Study||7
6682087|NCT02677740|7614104|FG001|STARTED|Overall Study||1
6682088|NCT02677740|7614103|FG000|COMPLETED|Overall Study||7
6682089|NCT02677740|7614104|FG001|COMPLETED|Overall Study||1
6682090|NCT02677740|7614103|FG000|NOT COMPLETED|Overall Study||0
6682091|NCT02677740|7614104|FG001|NOT COMPLETED|Overall Study||0
6682092|NCT02677753|7614112|FG000|STARTED|Overall Study||37
6682093|NCT02677753|7614113|FG001|STARTED|Overall Study||38
6682094|NCT02677753|7614112|FG000|COMPLETED|Overall Study||36
6682095|NCT02677753|7614113|FG001|COMPLETED|Overall Study||38
6682096|NCT02677753|7614112|FG000|NOT COMPLETED|Overall Study||1
6682097|NCT02677753|7614113|FG001|NOT COMPLETED|Overall Study||0
6682098|NCT02677766|7614121|FG000|STARTED|Overall Study||20
6682099|NCT02677766|7614122|FG001|STARTED|Overall Study||20
6682100|NCT02677766|7614121|FG000|COMPLETED|Overall Study||15
6682101|NCT02677766|7614122|FG001|COMPLETED|Overall Study||17
6682102|NCT02677766|7614121|FG000|NOT COMPLETED|Overall Study||5
6682103|NCT02677766|7614122|FG001|NOT COMPLETED|Overall Study||3
6682104|NCT02677779|7614130|FG000|STARTED|Overall Study||10
6682105|NCT02677779|7614131|FG001|STARTED|Overall Study||10
6682106|NCT02677779|7614130|FG000|COMPLETED|Overall Study||10
6682107|NCT02677779|7614131|FG001|COMPLETED|Overall Study||10
6682108|NCT02677779|7614130|FG000|NOT COMPLETED|Overall Study||0
6682109|NCT02677779|7614131|FG001|NOT COMPLETED|Overall Study||0
6682110|NCT02677844|7614139|FG000|STARTED|Period 1||5
6682111|NCT02677844|7614140|FG001|STARTED|Period 1||5
6682112|NCT02677844|7614141|FG002|STARTED|Period 1||5
6682113|NCT02677844|7614142|FG003|STARTED|Period 1||5
6682114|NCT02677844|7614143|FG004|STARTED|Period 1||0
6682115|NCT02677844|7614144|FG005|STARTED|Period 1||0
6682116|NCT02677844|7614145|FG006|STARTED|Period 1||0
6682117|NCT02677844|7614139|FG000|COMPLETED|Period 1||5
6682118|NCT02677844|7614140|FG001|COMPLETED|Period 1||5
6682119|NCT02677844|7614141|FG002|COMPLETED|Period 1||5
6682120|NCT02677844|7614142|FG003|COMPLETED|Period 1||5
6682121|NCT02677844|7614143|FG004|COMPLETED|Period 1||0
6682122|NCT02677844|7614144|FG005|COMPLETED|Period 1||0
6682123|NCT02677844|7614145|FG006|COMPLETED|Period 1||0
6682124|NCT02677844|7614139|FG000|NOT COMPLETED|Period 1||0
6682125|NCT02677844|7614140|FG001|NOT COMPLETED|Period 1||0
6682126|NCT02677844|7614141|FG002|NOT COMPLETED|Period 1||0
6682127|NCT02677844|7614142|FG003|NOT COMPLETED|Period 1||0
6682128|NCT02677844|7614143|FG004|NOT COMPLETED|Period 1||0
6682129|NCT02677844|7614144|FG005|NOT COMPLETED|Period 1||0
6682130|NCT02677844|7614145|FG006|NOT COMPLETED|Period 1||0
6682131|NCT02677844|7614139|FG000|STARTED|Period 2||5
6682132|NCT02677844|7614140|FG001|STARTED|Period 2||5
6682133|NCT02677844|7614141|FG002|STARTED|Period 2||5
6682134|NCT02677844|7614142|FG003|STARTED|Period 2||5
6682135|NCT02677844|7614143|FG004|STARTED|Period 2||0
6682136|NCT02677844|7614144|FG005|STARTED|Period 2||0
6682137|NCT02677844|7614145|FG006|STARTED|Period 2||0
6682138|NCT02677844|7614139|FG000|COMPLETED|Period 2||5
6682139|NCT02677844|7614140|FG001|COMPLETED|Period 2||5
6682140|NCT02677844|7614141|FG002|COMPLETED|Period 2||5
6682141|NCT02677844|7614142|FG003|COMPLETED|Period 2||5
6682142|NCT02677844|7614143|FG004|COMPLETED|Period 2||0
6682143|NCT02677844|7614144|FG005|COMPLETED|Period 2||0
6682144|NCT02677844|7614145|FG006|COMPLETED|Period 2||0
6682145|NCT02677844|7614139|FG000|NOT COMPLETED|Period 2||0
6682146|NCT02677844|7614140|FG001|NOT COMPLETED|Period 2||0
6682147|NCT02677844|7614141|FG002|NOT COMPLETED|Period 2||0
6682148|NCT02677844|7614142|FG003|NOT COMPLETED|Period 2||0
6682149|NCT02677844|7614143|FG004|NOT COMPLETED|Period 2||0
6682150|NCT02677844|7614144|FG005|NOT COMPLETED|Period 2||0
6682151|NCT02677844|7614145|FG006|NOT COMPLETED|Period 2||0
6682152|NCT02677844|7614139|FG000|STARTED|Period 3||5
6682153|NCT02677844|7614140|FG001|STARTED|Period 3||5
6682154|NCT02677844|7614141|FG002|STARTED|Period 3||5
6682155|NCT02677844|7614142|FG003|STARTED|Period 3||5
6682156|NCT02677844|7614143|FG004|STARTED|Period 3||0
6682157|NCT02677844|7614144|FG005|STARTED|Period 3||0
6682158|NCT02677844|7614145|FG006|STARTED|Period 3||0
6682159|NCT02677844|7614139|FG000|COMPLETED|Period 3||5
6682160|NCT02677844|7614140|FG001|COMPLETED|Period 3||5
6682161|NCT02677844|7614141|FG002|COMPLETED|Period 3||5
6682162|NCT02677844|7614142|FG003|COMPLETED|Period 3||4
6682163|NCT02677844|7614143|FG004|COMPLETED|Period 3||0
6682164|NCT02677844|7614144|FG005|COMPLETED|Period 3||0
6682165|NCT02677844|7614145|FG006|COMPLETED|Period 3||0
6682166|NCT02677844|7614139|FG000|NOT COMPLETED|Period 3||0
6682167|NCT02677844|7614140|FG001|NOT COMPLETED|Period 3||0
6682168|NCT02677844|7614141|FG002|NOT COMPLETED|Period 3||0
6682169|NCT02677844|7614142|FG003|NOT COMPLETED|Period 3||1
6682170|NCT02677844|7614143|FG004|NOT COMPLETED|Period 3||0
6682171|NCT02677844|7614144|FG005|NOT COMPLETED|Period 3||0
6682172|NCT02677844|7614145|FG006|NOT COMPLETED|Period 3||0
6682173|NCT02677844|7614139|FG000|STARTED|Period 4||5
6682174|NCT02677844|7614140|FG001|STARTED|Period 4||5
6682175|NCT02677844|7614141|FG002|STARTED|Period 4||5
6682176|NCT02677844|7614142|FG003|STARTED|Period 4||4
6682177|NCT02677844|7614143|FG004|STARTED|Period 4||0
6682178|NCT02677844|7614144|FG005|STARTED|Period 4||0
6682179|NCT02677844|7614145|FG006|STARTED|Period 4||0
6682180|NCT02677844|7614139|FG000|COMPLETED|Period 4||5
6682181|NCT02677844|7614140|FG001|COMPLETED|Period 4||5
6682182|NCT02677844|7614141|FG002|COMPLETED|Period 4||5
6682183|NCT02677844|7614142|FG003|COMPLETED|Period 4||4
6682184|NCT02677844|7614143|FG004|COMPLETED|Period 4||0
6682185|NCT02677844|7614144|FG005|COMPLETED|Period 4||0
6682186|NCT02677844|7614145|FG006|COMPLETED|Period 4||0
6256453|NCT03043599|7155415|FG000|STARTED|Overall Study||21
6256454|NCT03043599|7155415|FG000|COMPLETED|Overall Study||21
6682187|NCT02677844|7614139|FG000|NOT COMPLETED|Period 4||0
6682188|NCT02677844|7614140|FG001|NOT COMPLETED|Period 4||0
6682189|NCT02677844|7614141|FG002|NOT COMPLETED|Period 4||0
6682190|NCT02677844|7614142|FG003|NOT COMPLETED|Period 4||0
6682191|NCT02677844|7614143|FG004|NOT COMPLETED|Period 4||0
6682192|NCT02677844|7614144|FG005|NOT COMPLETED|Period 4||0
6682193|NCT02677844|7614145|FG006|NOT COMPLETED|Period 4||0
6682194|NCT02677844|7614139|FG000|STARTED|Period 4 (DDI)||0
6682195|NCT02677844|7614140|FG001|STARTED|Period 4 (DDI)||0
6682196|NCT02677844|7614141|FG002|STARTED|Period 4 (DDI)||0
6682197|NCT02677844|7614142|FG003|STARTED|Period 4 (DDI)||0
6682198|NCT02677844|7614143|FG004|STARTED|Period 4 (DDI)||7
6682199|NCT02677844|7614144|FG005|STARTED|Period 4 (DDI)||4
6682200|NCT02677844|7614145|FG006|STARTED|Period 4 (DDI)||4
6682201|NCT02677844|7614139|FG000|COMPLETED|Period 4 (DDI)||0
6682202|NCT02677844|7614140|FG001|COMPLETED|Period 4 (DDI)||0
6682203|NCT02677844|7614141|FG002|COMPLETED|Period 4 (DDI)||0
6682204|NCT02677844|7614142|FG003|COMPLETED|Period 4 (DDI)||0
6682205|NCT02677844|7614143|FG004|COMPLETED|Period 4 (DDI)||7
6682206|NCT02677844|7614144|FG005|COMPLETED|Period 4 (DDI)||4
6682207|NCT02677844|7614145|FG006|COMPLETED|Period 4 (DDI)||4
6682208|NCT02677844|7614139|FG000|NOT COMPLETED|Period 4 (DDI)||0
6682209|NCT02677844|7614140|FG001|NOT COMPLETED|Period 4 (DDI)||0
6682210|NCT02677844|7614141|FG002|NOT COMPLETED|Period 4 (DDI)||0
6682211|NCT02677844|7614142|FG003|NOT COMPLETED|Period 4 (DDI)||0
6682212|NCT02677844|7614143|FG004|NOT COMPLETED|Period 4 (DDI)||0
6682213|NCT02677844|7614144|FG005|NOT COMPLETED|Period 4 (DDI)||0
6682214|NCT02677844|7614145|FG006|NOT COMPLETED|Period 4 (DDI)||0
6682215|NCT02677844|7614139|FG000|STARTED|Period 5||0
6682216|NCT02677844|7614140|FG001|STARTED|Period 5||0
6682217|NCT02677844|7614141|FG002|STARTED|Period 5||0
6682218|NCT02677844|7614142|FG003|STARTED|Period 5||0
6682219|NCT02677844|7614143|FG004|STARTED|Period 5||7
6682220|NCT02677844|7614144|FG005|STARTED|Period 5||4
6682221|NCT02677844|7614145|FG006|STARTED|Period 5||4
6682222|NCT02677844|7614139|FG000|COMPLETED|Period 5||0
6682223|NCT02677844|7614140|FG001|COMPLETED|Period 5||0
6682224|NCT02677844|7614141|FG002|COMPLETED|Period 5||0
6682225|NCT02677844|7614142|FG003|COMPLETED|Period 5||0
6682226|NCT02677844|7614143|FG004|COMPLETED|Period 5||7
6682227|NCT02677844|7614144|FG005|COMPLETED|Period 5||4
6682228|NCT02677844|7614145|FG006|COMPLETED|Period 5||4
6682229|NCT02677844|7614139|FG000|NOT COMPLETED|Period 5||0
6682230|NCT02677844|7614140|FG001|NOT COMPLETED|Period 5||0
6682231|NCT02677844|7614141|FG002|NOT COMPLETED|Period 5||0
6682232|NCT02677844|7614142|FG003|NOT COMPLETED|Period 5||0
6682233|NCT02677844|7614143|FG004|NOT COMPLETED|Period 5||0
6682234|NCT02677844|7614144|FG005|NOT COMPLETED|Period 5||0
6682235|NCT02677844|7614145|FG006|NOT COMPLETED|Period 5||0
6682236|NCT02677844|7614139|FG000|STARTED|Period 6||0
6682237|NCT02677844|7614140|FG001|STARTED|Period 6||0
6682238|NCT02677844|7614141|FG002|STARTED|Period 6||0
6682239|NCT02677844|7614142|FG003|STARTED|Period 6||0
6682240|NCT02677844|7614143|FG004|STARTED|Period 6||7
6682241|NCT02677844|7614144|FG005|STARTED|Period 6||4
6682242|NCT02677844|7614145|FG006|STARTED|Period 6||4
6682243|NCT02677844|7614139|FG000|COMPLETED|Period 6||0
6682244|NCT02677844|7614140|FG001|COMPLETED|Period 6||0
6682245|NCT02677844|7614141|FG002|COMPLETED|Period 6||0
6682246|NCT02677844|7614142|FG003|COMPLETED|Period 6||0
6682247|NCT02677844|7614143|FG004|COMPLETED|Period 6||7
6682248|NCT02677844|7614144|FG005|COMPLETED|Period 6||4
6682249|NCT02677844|7614145|FG006|COMPLETED|Period 6||4
6682250|NCT02677844|7614139|FG000|NOT COMPLETED|Period 6||0
6682251|NCT02677844|7614140|FG001|NOT COMPLETED|Period 6||0
6682252|NCT02677844|7614141|FG002|NOT COMPLETED|Period 6||0
6682253|NCT02677844|7614142|FG003|NOT COMPLETED|Period 6||0
6682254|NCT02677844|7614143|FG004|NOT COMPLETED|Period 6||0
6682255|NCT02677844|7614144|FG005|NOT COMPLETED|Period 6||0
6682256|NCT02677844|7614145|FG006|NOT COMPLETED|Period 6||0
6682257|NCT02677844|7614139|FG000|STARTED|Period 7||0
6682258|NCT02677844|7614140|FG001|STARTED|Period 7||0
6682259|NCT02677844|7614141|FG002|STARTED|Period 7||0
6682260|NCT02677844|7614142|FG003|STARTED|Period 7||0
6682261|NCT02677844|7614143|FG004|STARTED|Period 7||7
6682262|NCT02677844|7614144|FG005|STARTED|Period 7||4
6682263|NCT02677844|7614145|FG006|STARTED|Period 7||4
6682264|NCT02677844|7614139|FG000|COMPLETED|Period 7||0
6682265|NCT02677844|7614140|FG001|COMPLETED|Period 7||0
6682266|NCT02677844|7614141|FG002|COMPLETED|Period 7||0
6682267|NCT02677844|7614142|FG003|COMPLETED|Period 7||0
6682268|NCT02677844|7614143|FG004|COMPLETED|Period 7||7
6682269|NCT02677844|7614144|FG005|COMPLETED|Period 7||4
6682270|NCT02677844|7614145|FG006|COMPLETED|Period 7||4
6682271|NCT02677844|7614139|FG000|NOT COMPLETED|Period 7||0
6682272|NCT02677844|7614140|FG001|NOT COMPLETED|Period 7||0
6682273|NCT02677844|7614141|FG002|NOT COMPLETED|Period 7||0
6682274|NCT02677844|7614142|FG003|NOT COMPLETED|Period 7||0
6682275|NCT02677844|7614143|FG004|NOT COMPLETED|Period 7||0
6682276|NCT02677844|7614144|FG005|NOT COMPLETED|Period 7||0
6682277|NCT02677844|7614145|FG006|NOT COMPLETED|Period 7||0
6682278|NCT02678000|7614169|FG000|STARTED|PART 1||7
6682279|NCT02678000|7614170|FG001|STARTED|PART 1||4
6682280|NCT02678000|7614171|FG002|STARTED|PART 1||0
6682281|NCT02678000|7614172|FG003|STARTED|PART 1||0
6682282|NCT02678000|7614173|FG004|STARTED|PART 1||0
6682283|NCT02678000|7614169|FG000|COMPLETED|PART 1||7
6682284|NCT02678000|7614170|FG001|COMPLETED|PART 1||4
6682285|NCT02678000|7614171|FG002|COMPLETED|PART 1||0
6682286|NCT02678000|7614172|FG003|COMPLETED|PART 1||0
6682287|NCT02678000|7614173|FG004|COMPLETED|PART 1||0
6682288|NCT02678000|7614169|FG000|NOT COMPLETED|PART 1||0
6682289|NCT02678000|7614170|FG001|NOT COMPLETED|PART 1||0
6682290|NCT02678000|7614171|FG002|NOT COMPLETED|PART 1||0
6682291|NCT02678000|7614172|FG003|NOT COMPLETED|PART 1||0
6682292|NCT02678000|7614173|FG004|NOT COMPLETED|PART 1||0
6682293|NCT02678000|7614169|FG000|STARTED|PART 2||0
6682294|NCT02678000|7614170|FG001|STARTED|PART 2||0
6682295|NCT02678000|7614171|FG002|STARTED|PART 2||28
6682296|NCT02678000|7614172|FG003|STARTED|PART 2||27
6682297|NCT02678000|7614173|FG004|STARTED|PART 2||18
6682298|NCT02678000|7614169|FG000|COMPLETED|PART 2||0
6682299|NCT02678000|7614170|FG001|COMPLETED|PART 2||0
6682300|NCT02678000|7614171|FG002|COMPLETED|PART 2||25
6682301|NCT02678000|7614172|FG003|COMPLETED|PART 2||26
6682302|NCT02678000|7614173|FG004|COMPLETED|PART 2||18
6682303|NCT02678000|7614169|FG000|NOT COMPLETED|PART 2||0
6682304|NCT02678000|7614170|FG001|NOT COMPLETED|PART 2||0
6682305|NCT02678000|7614171|FG002|NOT COMPLETED|PART 2||3
6682306|NCT02678000|7614172|FG003|NOT COMPLETED|PART 2||1
6682307|NCT02678000|7614173|FG004|NOT COMPLETED|PART 2||0
6682308|NCT02678039|7614200|FG000|STARTED|Overall Study||53
6682309|NCT02678039|7614201|FG001|STARTED|Overall Study||47
6682310|NCT02678039|7614200|FG000|COMPLETED|Overall Study||53
6682311|NCT02678039|7614201|FG001|COMPLETED|Overall Study||47
6682312|NCT02678039|7614200|FG000|NOT COMPLETED|Overall Study||0
6682313|NCT02678039|7614201|FG001|NOT COMPLETED|Overall Study||0
6682314|NCT02678247|7614209|FG000|STARTED|First Intervention (7 Weeks)||15
6682315|NCT02678247|7614210|FG001|STARTED|First Intervention (7 Weeks)||15
6682316|NCT02678247|7614209|FG000|COMPLETED|First Intervention (7 Weeks)||13
6682317|NCT02678247|7614210|FG001|COMPLETED|First Intervention (7 Weeks)||11
6682318|NCT02678247|7614209|FG000|NOT COMPLETED|First Intervention (7 Weeks)||2
6682319|NCT02678247|7614210|FG001|NOT COMPLETED|First Intervention (7 Weeks)||4
6682320|NCT02678247|7614209|FG000|STARTED|Second Intervention (7 Weeks)|One subject crossed over despite not completing all data collection time points for the preceding socket.|14
6682321|NCT02678247|7614210|FG001|STARTED|Second Intervention (7 Weeks)||11
6682322|NCT02678247|7614209|FG000|COMPLETED|Second Intervention (7 Weeks)||10
6682323|NCT02678247|7614210|FG001|COMPLETED|Second Intervention (7 Weeks)||9
6682324|NCT02678247|7614209|FG000|NOT COMPLETED|Second Intervention (7 Weeks)||4
6682325|NCT02678247|7614210|FG001|NOT COMPLETED|Second Intervention (7 Weeks)||2
6682326|NCT02678286|7614223|FG000|STARTED|Treatment Phase (48 Hours Post-Dose 1)||110
6682327|NCT02678286|7614224|FG001|STARTED|Treatment Phase (48 Hours Post-Dose 1)||109
6682328|NCT02678286|7614223|FG000|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||108
6682329|NCT02678286|7614224|FG001|COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||107
6682330|NCT02678286|7614223|FG000|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
6682331|NCT02678286|7614224|FG001|NOT COMPLETED|Treatment Phase (48 Hours Post-Dose 1)||2
6682332|NCT02678286|7614223|FG000|STARTED|Study Overall (28 Day Follow-Up)||110
6682333|NCT02678286|7614224|FG001|STARTED|Study Overall (28 Day Follow-Up)||109
6682334|NCT02678286|7614223|FG000|COMPLETED|Study Overall (28 Day Follow-Up)||104
6682335|NCT02678286|7614224|FG001|COMPLETED|Study Overall (28 Day Follow-Up)||105
6682336|NCT02678286|7614223|FG000|NOT COMPLETED|Study Overall (28 Day Follow-Up)||6
6682337|NCT02678286|7614224|FG001|NOT COMPLETED|Study Overall (28 Day Follow-Up)||4
6682338|NCT02678390|7614232|FG000|STARTED|Control (5 Days)||10
6682339|NCT02678390|7614233|FG001|STARTED|Control (5 Days)||10
6682340|NCT02678390|7614232|FG000|COMPLETED|Control (5 Days)||10
6682341|NCT02678390|7614233|FG001|COMPLETED|Control (5 Days)||10
6682342|NCT02678390|7614232|FG000|NOT COMPLETED|Control (5 Days)||0
6682343|NCT02678390|7614233|FG001|NOT COMPLETED|Control (5 Days)||0
6682344|NCT02678390|7614232|FG000|STARTED|MCT (5 Days)||10
6682345|NCT02678390|7614233|FG001|STARTED|MCT (5 Days)||10
6682346|NCT02678390|7614232|FG000|COMPLETED|MCT (5 Days)||10
6682347|NCT02678390|7614233|FG001|COMPLETED|MCT (5 Days)||10
6682348|NCT02678390|7614232|FG000|NOT COMPLETED|MCT (5 Days)||0
6682349|NCT02678390|7614233|FG001|NOT COMPLETED|MCT (5 Days)||0
6682350|NCT02678390|7614232|FG000|STARTED|AE (1 Day)||10
6682351|NCT02678390|7614233|FG001|STARTED|AE (1 Day)||10
6682352|NCT02678390|7614232|FG000|COMPLETED|AE (1 Day)||10
6682353|NCT02678390|7614233|FG001|COMPLETED|AE (1 Day)||9
6682354|NCT02678390|7614232|FG000|NOT COMPLETED|AE (1 Day)||0
6682355|NCT02678390|7614233|FG001|NOT COMPLETED|AE (1 Day)||1
6682356|NCT02678390|7614232|FG000|STARTED|MCT + AE (5 Days)||10
6682357|NCT02678390|7614233|FG001|STARTED|MCT + AE (5 Days)||9
6682358|NCT02678390|7614232|FG000|COMPLETED|MCT + AE (5 Days)||10
6682359|NCT02678390|7614233|FG001|COMPLETED|MCT + AE (5 Days)||9
6682360|NCT02678390|7614232|FG000|NOT COMPLETED|MCT + AE (5 Days)||0
6682361|NCT02678390|7614233|FG001|NOT COMPLETED|MCT + AE (5 Days)||0
6682362|NCT02678416|7614241|FG000|STARTED|Part 1||12
6682363|NCT02678416|7614241|FG000|Safety Population|Part 1||12
6682364|NCT02678416|7614241|FG000|Modified Intent to Treat (mITT)|Part 1||12
6682365|NCT02678416|7614241|FG000|Per Protocol Population|Part 1||8
6682366|NCT02678416|7614241|FG000|COMPLETED|Part 1||11
6682367|NCT02678416|7614241|FG000|NOT COMPLETED|Part 1||1
6682368|NCT02678416|7614241|FG000|STARTED|Part 2|Part 2 enrolled all new participants|67
6682369|NCT02678416|7614241|FG000|Treated (Safety Population)|Part 2||66
6682370|NCT02678416|7614241|FG000|Modified Intent to Treat Population|Part 2||66
6682371|NCT02678416|7614241|FG000|Pharmacokinetic Population|Part 2||65
6682372|NCT02678416|7614241|FG000|Per Protocol Population|Part 2||64
6682373|NCT02678416|7614241|FG000|COMPLETED|Part 2||64
6682374|NCT02678416|7614241|FG000|NOT COMPLETED|Part 2||3
6682375|NCT02678442|7614261|FG000|STARTED|First Intervention||25
6682376|NCT02678442|7614262|FG001|STARTED|First Intervention||25
6682377|NCT02678442|7614261|FG000|COMPLETED|First Intervention||25
6682378|NCT02678442|7614262|FG001|COMPLETED|First Intervention||25
6682379|NCT02678442|7614261|FG000|NOT COMPLETED|First Intervention||0
6682380|NCT02678442|7614262|FG001|NOT COMPLETED|First Intervention||0
6682381|NCT02678442|7614261|FG000|STARTED|Second Intervention||25
6682382|NCT02678442|7614262|FG001|STARTED|Second Intervention||25
6682383|NCT02678442|7614261|FG000|COMPLETED|Second Intervention||23
6682384|NCT02678442|7614262|FG001|COMPLETED|Second Intervention||23
6682385|NCT02678442|7614261|FG000|NOT COMPLETED|Second Intervention||2
6682386|NCT02678442|7614262|FG001|NOT COMPLETED|Second Intervention||2
6682387|NCT02678676|7614270|FG000|STARTED|Overall Study||1820
6682388|NCT02678676|7614271|FG001|STARTED|Overall Study||1779
6256455|NCT03043599|7155415|FG000|NOT COMPLETED|Overall Study||0
6256456|NCT02968381|7155421|FG000|STARTED|Overall Study||61
6256457|NCT02968381|7155422|FG001|STARTED|Overall Study||60
6256458|NCT02968381|7155421|FG000|COMPLETED|Overall Study||56
6256459|NCT02968381|7155422|FG001|COMPLETED|Overall Study||50
6256460|NCT02968381|7155421|FG000|NOT COMPLETED|Overall Study||5
6256461|NCT02968381|7155422|FG001|NOT COMPLETED|Overall Study||10
6256462|NCT02720185|7155428|FG000|STARTED|Overall Study||5
6256463|NCT02720185|7155428|FG000|COMPLETED|Overall Study||5
6256464|NCT02720185|7155428|FG000|NOT COMPLETED|Overall Study||0
6256465|NCT02706847|7155435|FG000|STARTED|Day 1 to Week 12||85
6256466|NCT02706847|7155436|FG001|STARTED|Day 1 to Week 12||84
6256467|NCT02706847|7155437|FG002|STARTED|Day 1 to Week 12||165
6256468|NCT02706847|7155438|FG003|STARTED|Day 1 to Week 12||165
6256469|NCT02706847|7155435|FG000|Received Study Treatment|Day 1 to Week 12||85
6256470|NCT02706847|7155436|FG001|Received Study Treatment|Day 1 to Week 12||84
6256471|NCT02706847|7155437|FG002|Received Study Treatment|Day 1 to Week 12||164
6256472|NCT02706847|7155438|FG003|Received Study Treatment|Day 1 to Week 12||165
6256473|NCT02706847|7155435|FG000|COMPLETED|Day 1 to Week 12||75
6256474|NCT02706847|7155436|FG001|COMPLETED|Day 1 to Week 12||76
6256475|NCT02706847|7155437|FG002|COMPLETED|Day 1 to Week 12||157
6256476|NCT02706847|7155438|FG003|COMPLETED|Day 1 to Week 12||149
6256477|NCT02706847|7155435|FG000|NOT COMPLETED|Day 1 to Week 12||10
6256478|NCT02706847|7155436|FG001|NOT COMPLETED|Day 1 to Week 12||8
6256479|NCT02706847|7155437|FG002|NOT COMPLETED|Day 1 to Week 12||8
6256480|NCT02706847|7155438|FG003|NOT COMPLETED|Day 1 to Week 12||16
6256481|NCT02706847|7155435|FG000|STARTED|Week 12 to Week 24||75
6256482|NCT02706847|7155436|FG001|STARTED|Week 12 to Week 24||76
6256483|NCT02706847|7155437|FG002|STARTED|Week 12 to Week 24||157
6256484|NCT02706847|7155438|FG003|STARTED|Week 12 to Week 24||149
6256485|NCT02706847|7155435|FG000|Received Study Treatment|Week 12 to Week 24||72
6256486|NCT02706847|7155436|FG001|Received Study Treatment|Week 12 to Week 24||75
6256487|NCT02706847|7155437|FG002|Received Study Treatment|Week 12 to Week 24||156
6256488|NCT02706847|7155438|FG003|Received Study Treatment|Week 12 to Week 24||148
6256489|NCT02706847|7155435|FG000|COMPLETED|Week 12 to Week 24||72
6256490|NCT02706847|7155436|FG001|COMPLETED|Week 12 to Week 24||74
6256491|NCT02706847|7155437|FG002|COMPLETED|Week 12 to Week 24||153
6256492|NCT02706847|7155438|FG003|COMPLETED|Week 12 to Week 24||135
6256493|NCT02706847|7155435|FG000|NOT COMPLETED|Week 12 to Week 24||3
6256494|NCT02706847|7155436|FG001|NOT COMPLETED|Week 12 to Week 24||2
6256495|NCT02706847|7155437|FG002|NOT COMPLETED|Week 12 to Week 24||4
6256496|NCT02706847|7155438|FG003|NOT COMPLETED|Week 12 to Week 24||14
6256497|NCT02701777|7155452|FG000|STARTED|Overall Study||17
6256498|NCT02701777|7155453|FG001|STARTED|Overall Study||16
6256499|NCT02701777|7155454|FG002|STARTED|Overall Study||16
6256500|NCT02701777|7155455|FG003|STARTED|Overall Study||13
6256501|NCT02701777|7155452|FG000|COMPLETED|Overall Study||13
6256502|NCT02701777|7155453|FG001|COMPLETED|Overall Study||13
6256503|NCT02701777|7155454|FG002|COMPLETED|Overall Study||12
6256504|NCT02701777|7155455|FG003|COMPLETED|Overall Study||11
6256505|NCT02701777|7155452|FG000|NOT COMPLETED|Overall Study||4
6256506|NCT02701777|7155453|FG001|NOT COMPLETED|Overall Study||3
6256507|NCT02701777|7155454|FG002|NOT COMPLETED|Overall Study||4
6256508|NCT02701777|7155455|FG003|NOT COMPLETED|Overall Study||2
6256509|NCT02677896|7155471|FG000|STARTED|Overall Study||574
6256510|NCT02677896|7155472|FG001|STARTED|Overall Study||576
6256511|NCT02677896|7155471|FG000|Treated|Overall Study||572
6256512|NCT02677896|7155472|FG001|Treated|Overall Study||574
6256513|NCT02677896|7155471|FG000|COMPLETED|Overall Study||437
6256514|NCT02677896|7155472|FG001|COMPLETED|Overall Study||332
6256515|NCT02677896|7155471|FG000|NOT COMPLETED|Overall Study||137
6256516|NCT02677896|7155472|FG001|NOT COMPLETED|Overall Study||244
6256517|NCT02657434|7155480|FG000|STARTED|Overall Study||286
6256518|NCT02657434|7155481|FG001|STARTED|Overall Study||292
6256519|NCT02657434|7155480|FG000|COMPLETED|Overall Study||0
6256520|NCT02657434|7155481|FG001|COMPLETED|Overall Study||0
6256521|NCT02657434|7155480|FG000|NOT COMPLETED|Overall Study||286
6682389|NCT02678676|7614270|FG000|COMPLETED|Overall Study||932
6682390|NCT02678676|7614271|FG001|COMPLETED|Overall Study||907
6682391|NCT02678676|7614270|FG000|NOT COMPLETED|Overall Study||888
6682392|NCT02678676|7614271|FG001|NOT COMPLETED|Overall Study||872
6682393|NCT02678923|7614279|FG000|STARTED|Overall Study||59
6682394|NCT02678923|7614280|FG001|STARTED|Overall Study||67
6682395|NCT02678923|7614279|FG000|Received at Least 1 Dose of Study Drug|Overall Study||58
6682396|NCT02678923|7614280|FG001|Received at Least 1 Dose of Study Drug|Overall Study||64
6682397|NCT02678923|7614279|FG000|mITT Population|Overall Study||52
6682398|NCT02678923|7614280|FG001|mITT Population|Overall Study||61
6682399|NCT02678923|7614279|FG000|COMPLETED|Overall Study||53
6682400|NCT02678923|7614280|FG001|COMPLETED|Overall Study||62
6682401|NCT02678923|7614279|FG000|NOT COMPLETED|Overall Study||6
6682402|NCT02678923|7614280|FG001|NOT COMPLETED|Overall Study||5
6682403|NCT02679079|7614289|FG000|STARTED|Overall Study||33
6682404|NCT02679079|7614290|FG001|STARTED|Overall Study||32
6682405|NCT02679079|7614291|FG002|STARTED|Overall Study||33
6682406|NCT02679079|7614289|FG000|ITT Analysis Set|Overall Study||31
6682407|NCT02679079|7614290|FG001|ITT Analysis Set|Overall Study||32
6682408|NCT02679079|7614291|FG002|ITT Analysis Set|Overall Study||32
6682409|NCT02679079|7614289|FG000|COMPLETED|Overall Study||29
6682410|NCT02679079|7614290|FG001|COMPLETED|Overall Study||30
6682411|NCT02679079|7614291|FG002|COMPLETED|Overall Study||31
6682412|NCT02679079|7614289|FG000|NOT COMPLETED|Overall Study||4
6682413|NCT02679079|7614290|FG001|NOT COMPLETED|Overall Study||2
6682414|NCT02679079|7614291|FG002|NOT COMPLETED|Overall Study||2
6682415|NCT02679222|7614299|FG000|STARTED|Overall Study||10
6682416|NCT02679222|7614299|FG000|COMPLETED|Overall Study||9
6682417|NCT02679222|7614299|FG000|NOT COMPLETED|Overall Study||1
6682418|NCT02679235|7614311|FG000|STARTED|Overall Study||15
6682419|NCT02679235|7614311|FG000|COMPLETED|Overall Study||11
6682420|NCT02679235|7614311|FG000|NOT COMPLETED|Overall Study||4
6682421|NCT02679274|7614317|FG000|STARTED|Overall Study||2
6682422|NCT02679274|7614318|FG001|STARTED|Overall Study||1
6682423|NCT02679274|7614317|FG000|COMPLETED|Overall Study||1
6682424|NCT02679274|7614318|FG001|COMPLETED|Overall Study||1
6682425|NCT02679274|7614317|FG000|NOT COMPLETED|Overall Study||1
6682426|NCT02679274|7614318|FG001|NOT COMPLETED|Overall Study||0
6682427|NCT02679287|7614326|FG000|STARTED|Period 1: Randomization-Study Session 1||47
6682428|NCT02679287|7614327|FG001|STARTED|Period 1: Randomization-Study Session 1||46
6682429|NCT02679287|7614326|FG000|COMPLETED|Period 1: Randomization-Study Session 1||43
6682430|NCT02679287|7614327|FG001|COMPLETED|Period 1: Randomization-Study Session 1||40
6682431|NCT02679287|7614326|FG000|NOT COMPLETED|Period 1: Randomization-Study Session 1||4
6682432|NCT02679287|7614327|FG001|NOT COMPLETED|Period 1: Randomization-Study Session 1||6
6682433|NCT02679287|7614326|FG000|STARTED|Period 2||43
6682434|NCT02679287|7614327|FG001|STARTED|Period 2||40
6682435|NCT02679287|7614326|FG000|COMPLETED|Period 2||40
6682436|NCT02679287|7614327|FG001|COMPLETED|Period 2||40
6682437|NCT02679287|7614326|FG000|NOT COMPLETED|Period 2||3
6682438|NCT02679287|7614327|FG001|NOT COMPLETED|Period 2||0
6682439|NCT02679287|7614326|FG000|STARTED|Period 3||40
6682440|NCT02679287|7614327|FG001|STARTED|Period 3||40
6682441|NCT02679287|7614326|FG000|COMPLETED|Period 3||40
6682442|NCT02679287|7614327|FG001|COMPLETED|Period 3||39
6682443|NCT02679287|7614326|FG000|NOT COMPLETED|Period 3||0
6682444|NCT02679287|7614327|FG001|NOT COMPLETED|Period 3||1
6682445|NCT02679287|7614326|FG000|STARTED|Phase 4||40
6682446|NCT02679287|7614327|FG001|STARTED|Phase 4||39
6682447|NCT02679287|7614326|FG000|COMPLETED|Phase 4||40
6682448|NCT02679287|7614327|FG001|COMPLETED|Phase 4||39
6682449|NCT02679287|7614326|FG000|NOT COMPLETED|Phase 4||0
6682450|NCT02679287|7614327|FG001|NOT COMPLETED|Phase 4||0
6682451|NCT02679469|7614339|FG000|STARTED|Overall Study||7
6682452|NCT02679469|7614339|FG000|COMPLETED|Overall Study||7
6682453|NCT02679469|7614339|FG000|NOT COMPLETED|Overall Study||0
6682454|NCT02679573|7614345|FG000|STARTED|Overall Study||431
6682455|NCT02679573|7614346|FG001|STARTED|Overall Study||428
6682456|NCT02679573|7614345|FG000|COMPLETED|Overall Study||394
6682457|NCT02679573|7614346|FG001|COMPLETED|Overall Study||389
6682458|NCT02679573|7614345|FG000|NOT COMPLETED|Overall Study||37
6682459|NCT02679573|7614346|FG001|NOT COMPLETED|Overall Study||39
6682460|NCT02679690|7614352|FG000|STARTED|Overall Study||10
6682461|NCT02679690|7614352|FG000|COMPLETED|Overall Study||9
6682462|NCT02679690|7614352|FG000|NOT COMPLETED|Overall Study||1
6682463|NCT02679729|7614367|FG000|STARTED|Overall Study||6
6682464|NCT02679729|7614368|FG001|STARTED|Overall Study||7
6682465|NCT02679729|7614369|FG002|STARTED|Overall Study||6
6682466|NCT02679729|7614370|FG003|STARTED|Overall Study||6
6682467|NCT02679729|7614371|FG004|STARTED|Overall Study||6
6682468|NCT02679729|7614372|FG005|STARTED|Overall Study||6
6682469|NCT02679729|7614373|FG006|STARTED|Overall Study||6
6682470|NCT02679729|7614374|FG007|STARTED|Overall Study||14
6682471|NCT02679729|7614375|FG008|STARTED|Overall Study||6
6682472|NCT02679729|7614367|FG000|COMPLETED|Overall Study||6
6682473|NCT02679729|7614368|FG001|COMPLETED|Overall Study||5
6682474|NCT02679729|7614369|FG002|COMPLETED|Overall Study||6
6682475|NCT02679729|7614370|FG003|COMPLETED|Overall Study||6
6682476|NCT02679729|7614371|FG004|COMPLETED|Overall Study||5
6682477|NCT02679729|7614372|FG005|COMPLETED|Overall Study||6
6682478|NCT02679729|7614373|FG006|COMPLETED|Overall Study||5
6682479|NCT02679729|7614374|FG007|COMPLETED|Overall Study||14
6682480|NCT02679729|7614375|FG008|COMPLETED|Overall Study||6
6682481|NCT02679729|7614367|FG000|NOT COMPLETED|Overall Study||0
6682482|NCT02679729|7614368|FG001|NOT COMPLETED|Overall Study||2
6682483|NCT02679729|7614369|FG002|NOT COMPLETED|Overall Study||0
6682484|NCT02679729|7614370|FG003|NOT COMPLETED|Overall Study||0
6682485|NCT02679729|7614371|FG004|NOT COMPLETED|Overall Study||1
6682486|NCT02679729|7614372|FG005|NOT COMPLETED|Overall Study||0
6682487|NCT02679729|7614373|FG006|NOT COMPLETED|Overall Study||1
6682488|NCT02679729|7614374|FG007|NOT COMPLETED|Overall Study||0
6682489|NCT02679729|7614375|FG008|NOT COMPLETED|Overall Study||0
6682490|NCT02679755|7614409|FG000|STARTED|Overall Study||100
6682491|NCT02679755|7614410|FG001|STARTED|Overall Study||152
6682492|NCT02679755|7614409|FG000|COMPLETED|Overall Study||66
6682493|NCT02679755|7614410|FG001|COMPLETED|Overall Study||47
6682494|NCT02679755|7614409|FG000|NOT COMPLETED|Overall Study||34
6682495|NCT02679755|7614410|FG001|NOT COMPLETED|Overall Study||105
6682496|NCT02679807|7614421|FG000|STARTED|Overall Study||165
6682497|NCT02679807|7614422|FG001|STARTED|Overall Study||169
6682498|NCT02679807|7614421|FG000|COMPLETED|Overall Study||143
6682499|NCT02679807|7614422|FG001|COMPLETED|Overall Study||153
6682500|NCT02679807|7614421|FG000|NOT COMPLETED|Overall Study||22
6682501|NCT02679807|7614422|FG001|NOT COMPLETED|Overall Study||16
6682502|NCT02679911|7614428|FG000|STARTED|Overall Study|Intra-individual study|20
6682503|NCT02679911|7614428|FG000|COMPLETED|Overall Study||20
6682504|NCT02679911|7614428|FG000|NOT COMPLETED|Overall Study||0
6682505|NCT02679976|7614433|FG000|STARTED|Overall Study||30
6682506|NCT02679976|7614433|FG000|Hyperopes|Overall Study||16
6682507|NCT02679976|7614433|FG000|Myopes|Overall Study||14
6682508|NCT02679976|7614433|FG000|COMPLETED|Overall Study||30
6682509|NCT02679976|7614433|FG000|NOT COMPLETED|Overall Study||0
6682510|NCT02680002|7614444|FG000|STARTED|Overall Study||71
6682511|NCT02680002|7614445|FG001|STARTED|Overall Study||70
6682512|NCT02680002|7614446|FG002|STARTED|Overall Study||70
6682513|NCT02680002|7614447|FG003|STARTED|Overall Study||71
6682514|NCT02680002|7614448|FG004|STARTED|Overall Study||70
6682515|NCT02680002|7614449|FG005|STARTED|Overall Study||70
6682516|NCT02680002|7614444|FG000|Day 0 (Dose 1)|Overall Study||70
6682517|NCT02680002|7614445|FG001|Day 0 (Dose 1)|Overall Study||70
6682518|NCT02680002|7614446|FG002|Day 0 (Dose 1)|Overall Study||70
6682519|NCT02680002|7614447|FG003|Day 0 (Dose 1)|Overall Study||71
6682520|NCT02680002|7614448|FG004|Day 0 (Dose 1)|Overall Study||70
6682521|NCT02680002|7614449|FG005|Day 0 (Dose 1)|Overall Study||68
6682522|NCT02680002|7614444|FG000|Day 21 (Dose 2)|Overall Study||63
6682523|NCT02680002|7614445|FG001|Day 21 (Dose 2)|Overall Study||68
6682524|NCT02680002|7614446|FG002|Day 21 (Dose 2)|Overall Study||65
6682525|NCT02680002|7614447|FG003|Day 21 (Dose 2)|Overall Study||69
6682526|NCT02680002|7614448|FG004|Day 21 (Dose 2)|Overall Study||65
6682527|NCT02680002|7614449|FG005|Day 21 (Dose 2)|Overall Study||63
6682528|NCT02680002|7614444|FG000|Day 201|Overall Study||58
6682529|NCT02680002|7614445|FG001|Day 201|Overall Study||66
6682530|NCT02680002|7614446|FG002|Day 201|Overall Study||60
6682531|NCT02680002|7614447|FG003|Day 201|Overall Study||67
6682532|NCT02680002|7614448|FG004|Day 201|Overall Study||59
6682533|NCT02680002|7614449|FG005|Day 201|Overall Study||61
6682534|NCT02680002|7614444|FG000|COMPLETED|Overall Study||58
6682535|NCT02680002|7614445|FG001|COMPLETED|Overall Study||66
6682536|NCT02680002|7614446|FG002|COMPLETED|Overall Study||60
6682537|NCT02680002|7614447|FG003|COMPLETED|Overall Study||67
6682538|NCT02680002|7614448|FG004|COMPLETED|Overall Study||59
6682539|NCT02680002|7614449|FG005|COMPLETED|Overall Study||61
6682540|NCT02680002|7614444|FG000|NOT COMPLETED|Overall Study||13
6682541|NCT02680002|7614445|FG001|NOT COMPLETED|Overall Study||4
6682542|NCT02680002|7614446|FG002|NOT COMPLETED|Overall Study||10
6682543|NCT02680002|7614447|FG003|NOT COMPLETED|Overall Study||4
6682544|NCT02680002|7614448|FG004|NOT COMPLETED|Overall Study||11
6682545|NCT02680002|7614449|FG005|NOT COMPLETED|Overall Study||9
6738519|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
6738520|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
6738521|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s HTLV I/II Follow-Up||0
6738522|NCT03285295|7667829|FG000|STARTED|Alinity s Anti-HCV||17095
6738523|NCT03285295|7667830|FG001|STARTED|Alinity s Anti-HCV||402
6738524|NCT03285295|7667831|FG002|STARTED|Alinity s Anti-HCV||407
6738525|NCT03285295|7667832|FG003|STARTED|Alinity s Anti-HCV||0
6738526|NCT03285295|7667833|FG004|STARTED|Alinity s Anti-HCV||0
6738527|NCT03285295|7667829|FG000|COMPLETED|Alinity s Anti-HCV||16999
6738528|NCT03285295|7667830|FG001|COMPLETED|Alinity s Anti-HCV||402
6738529|NCT03285295|7667831|FG002|COMPLETED|Alinity s Anti-HCV||407
6738530|NCT03285295|7667832|FG003|COMPLETED|Alinity s Anti-HCV||0
6738531|NCT03285295|7667833|FG004|COMPLETED|Alinity s Anti-HCV||0
6738532|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s Anti-HCV||96
6738533|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s Anti-HCV||0
6738534|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s Anti-HCV||0
6738535|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s Anti-HCV||0
6738536|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s Anti-HCV||0
6738537|NCT03285295|7667829|FG000|STARTED|Alinity s Anti-HCV Follow-Up||20
6738538|NCT03285295|7667830|FG001|STARTED|Alinity s Anti-HCV Follow-Up||0
6738539|NCT03285295|7667831|FG002|STARTED|Alinity s Anti-HCV Follow-Up||0
6738540|NCT03285295|7667832|FG003|STARTED|Alinity s Anti-HCV Follow-Up||0
6738541|NCT03285295|7667833|FG004|STARTED|Alinity s Anti-HCV Follow-Up||0
6738542|NCT03285295|7667829|FG000|COMPLETED|Alinity s Anti-HCV Follow-Up||2
6738543|NCT03285295|7667830|FG001|COMPLETED|Alinity s Anti-HCV Follow-Up||0
6738544|NCT03285295|7667831|FG002|COMPLETED|Alinity s Anti-HCV Follow-Up||0
6738545|NCT03285295|7667832|FG003|COMPLETED|Alinity s Anti-HCV Follow-Up||0
6738546|NCT03285295|7667833|FG004|COMPLETED|Alinity s Anti-HCV Follow-Up||0
6738547|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||18
6738548|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
6738549|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
6738550|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
6682546|NCT02680041|7614466|FG000|STARTED|Overall Study||221
6682547|NCT02680041|7614466|FG000|Received 18F-fluciclovine|Overall Study||213
6682548|NCT02680041|7614466|FG000|COMPLETED|Overall Study||211
6682549|NCT02680041|7614466|FG000|NOT COMPLETED|Overall Study||10
6682550|NCT02680054|7614471|FG000|STARTED|Overall Study||38
6682551|NCT02680054|7614471|FG000|COMPLETED|Overall Study||27
6682552|NCT02680054|7614471|FG000|NOT COMPLETED|Overall Study||11
6682553|NCT02680145|7614480|FG000|STARTED|Overall Study||58
6682554|NCT02680145|7614480|FG000|COMPLETED|Overall Study||47
6682555|NCT02680145|7614480|FG000|NOT COMPLETED|Overall Study||11
6682556|NCT02680158|7614484|FG000|STARTED|Overall Study||8
6682557|NCT02680158|7614485|FG001|STARTED|Overall Study||8
6682558|NCT02680158|7614486|FG002|STARTED|Overall Study||8
6682559|NCT02680158|7614487|FG003|STARTED|Overall Study||8
6682560|NCT02680158|7614488|FG004|STARTED|Overall Study||8
6682561|NCT02680158|7614489|FG005|STARTED|Overall Study||8
6682562|NCT02680158|7614484|FG000|COMPLETED|Overall Study||8
6682563|NCT02680158|7614485|FG001|COMPLETED|Overall Study||8
6682564|NCT02680158|7614486|FG002|COMPLETED|Overall Study||8
6682565|NCT02680158|7614487|FG003|COMPLETED|Overall Study||8
6682566|NCT02680158|7614488|FG004|COMPLETED|Overall Study||8
6682567|NCT02680158|7614489|FG005|COMPLETED|Overall Study||8
6682568|NCT02680158|7614484|FG000|NOT COMPLETED|Overall Study||0
6256522|NCT02657434|7155481|FG001|NOT COMPLETED|Overall Study||292
6256523|NCT02564900|7155503|FG000|STARTED|Dose Escalation||3
6256524|NCT02564900|7155504|FG001|STARTED|Dose Escalation||3
6256525|NCT02564900|7155505|FG002|STARTED|Dose Escalation||3
6256526|NCT02564900|7155506|FG003|STARTED|Dose Escalation||6
6256527|NCT02564900|7155507|FG004|STARTED|Dose Escalation||6
6256528|NCT02564900|7155508|FG005|STARTED|Dose Escalation||6
6256529|NCT02564900|7155509|FG006|STARTED|Dose Escalation||0
6256530|NCT02564900|7155510|FG007|STARTED|Dose Escalation||0
6256531|NCT02564900|7155511|FG008|STARTED|Dose Escalation||0
6256532|NCT02564900|7155512|FG009|STARTED|Dose Escalation||0
6256533|NCT02564900|7155513|FG010|STARTED|Dose Escalation||0
6256534|NCT02564900|7155514|FG011|STARTED|Dose Escalation||0
6256535|NCT02564900|7155515|FG012|STARTED|Dose Escalation||0
6256536|NCT02564900|7155516|FG013|STARTED|Dose Escalation||0
6256537|NCT02564900|7155517|FG014|STARTED|Dose Escalation||0
6256538|NCT02564900|7155503|FG000|COMPLETED|Dose Escalation||0
6256539|NCT02564900|7155504|FG001|COMPLETED|Dose Escalation||0
6256540|NCT02564900|7155505|FG002|COMPLETED|Dose Escalation||0
6256541|NCT02564900|7155506|FG003|COMPLETED|Dose Escalation||0
6256542|NCT02564900|7155507|FG004|COMPLETED|Dose Escalation||0
6256543|NCT02564900|7155508|FG005|COMPLETED|Dose Escalation||0
6256544|NCT02564900|7155509|FG006|COMPLETED|Dose Escalation||0
6256545|NCT02564900|7155510|FG007|COMPLETED|Dose Escalation||0
6256546|NCT02564900|7155511|FG008|COMPLETED|Dose Escalation||0
6256547|NCT02564900|7155512|FG009|COMPLETED|Dose Escalation||0
6256548|NCT02564900|7155513|FG010|COMPLETED|Dose Escalation||0
6256549|NCT02564900|7155514|FG011|COMPLETED|Dose Escalation||0
6256550|NCT02564900|7155515|FG012|COMPLETED|Dose Escalation||0
6256551|NCT02564900|7155516|FG013|COMPLETED|Dose Escalation||0
6256552|NCT02564900|7155517|FG014|COMPLETED|Dose Escalation||0
6256553|NCT02564900|7155503|FG000|NOT COMPLETED|Dose Escalation||3
6256554|NCT02564900|7155504|FG001|NOT COMPLETED|Dose Escalation||3
6256555|NCT02564900|7155505|FG002|NOT COMPLETED|Dose Escalation||3
6256556|NCT02564900|7155506|FG003|NOT COMPLETED|Dose Escalation||6
6256557|NCT02564900|7155507|FG004|NOT COMPLETED|Dose Escalation||6
6256558|NCT02564900|7155508|FG005|NOT COMPLETED|Dose Escalation||6
6256559|NCT02564900|7155509|FG006|NOT COMPLETED|Dose Escalation||0
6256560|NCT02564900|7155510|FG007|NOT COMPLETED|Dose Escalation||0
6256561|NCT02564900|7155511|FG008|NOT COMPLETED|Dose Escalation||0
6256562|NCT02564900|7155512|FG009|NOT COMPLETED|Dose Escalation||0
6256563|NCT02564900|7155513|FG010|NOT COMPLETED|Dose Escalation||0
6256564|NCT02564900|7155514|FG011|NOT COMPLETED|Dose Escalation||0
6256565|NCT02564900|7155515|FG012|NOT COMPLETED|Dose Escalation||0
6256566|NCT02564900|7155516|FG013|NOT COMPLETED|Dose Escalation||0
6256567|NCT02564900|7155517|FG014|NOT COMPLETED|Dose Escalation||0
6256568|NCT02564900|7155503|FG000|STARTED|Dose Expansion||0
6256569|NCT02564900|7155504|FG001|STARTED|Dose Expansion||0
6256570|NCT02564900|7155505|FG002|STARTED|Dose Expansion||0
6256571|NCT02564900|7155506|FG003|STARTED|Dose Expansion||0
6256572|NCT02564900|7155507|FG004|STARTED|Dose Expansion||0
6256573|NCT02564900|7155508|FG005|STARTED|Dose Expansion||0
6256574|NCT02564900|7155509|FG006|STARTED|Dose Expansion||49
6256575|NCT02564900|7155510|FG007|STARTED|Dose Expansion||62
6256576|NCT02564900|7155511|FG008|STARTED|Dose Expansion||20
6256577|NCT02564900|7155512|FG009|STARTED|Dose Expansion||33
6256578|NCT02564900|7155513|FG010|STARTED|Dose Expansion||17
6256579|NCT02564900|7155514|FG011|STARTED|Dose Expansion||24
6256580|NCT02564900|7155515|FG012|STARTED|Dose Expansion||18
6256581|NCT02564900|7155516|FG013|STARTED|Dose Expansion||20
6682569|NCT02680158|7614485|FG001|NOT COMPLETED|Overall Study||0
6682570|NCT02680158|7614486|FG002|NOT COMPLETED|Overall Study||0
6682571|NCT02680158|7614487|FG003|NOT COMPLETED|Overall Study||0
6682572|NCT02680158|7614488|FG004|NOT COMPLETED|Overall Study||0
6682573|NCT02680158|7614489|FG005|NOT COMPLETED|Overall Study||0
6682574|NCT02680301|7614499|FG000|STARTED|Overall Study||22
6682575|NCT02680301|7614500|FG001|STARTED|Overall Study||18
6256582|NCT02564900|7155517|FG014|STARTED|Dose Expansion||22
6256583|NCT02564900|7155503|FG000|Enrolled, But Not Dosed|Dose Expansion||0
6256584|NCT02564900|7155504|FG001|Enrolled, But Not Dosed|Dose Expansion||0
6682576|NCT02680301|7614499|FG000|COMPLETED|Overall Study||22
6682577|NCT02680301|7614500|FG001|COMPLETED|Overall Study||17
6682578|NCT02680301|7614499|FG000|NOT COMPLETED|Overall Study||0
6682579|NCT02680301|7614500|FG001|NOT COMPLETED|Overall Study||1
6682580|NCT02680314|7614509|FG000|STARTED|Overall Study||120
6682581|NCT02680314|7614510|FG001|STARTED|Overall Study||123
6682582|NCT02680314|7614509|FG000|COMPLETED|Overall Study||120
6682583|NCT02680314|7614510|FG001|COMPLETED|Overall Study||123
6682584|NCT02680314|7614509|FG000|NOT COMPLETED|Overall Study||0
6682585|NCT02680314|7614510|FG001|NOT COMPLETED|Overall Study||0
6682586|NCT02680457|7614516|FG000|STARTED|Initial Intervention||6
6682587|NCT02680457|7614517|FG001|STARTED|Initial Intervention||6
6682588|NCT02680457|7614516|FG000|COMPLETED|Initial Intervention||6
6682589|NCT02680457|7614517|FG001|COMPLETED|Initial Intervention||6
6682590|NCT02680457|7614516|FG000|NOT COMPLETED|Initial Intervention||0
6682591|NCT02680457|7614517|FG001|NOT COMPLETED|Initial Intervention||0
6682592|NCT02680457|7614516|FG000|STARTED|Washout Period||6
6682593|NCT02680457|7614517|FG001|STARTED|Washout Period||6
6682594|NCT02680457|7614516|FG000|COMPLETED|Washout Period||6
6682595|NCT02680457|7614517|FG001|COMPLETED|Washout Period||6
6682596|NCT02680457|7614516|FG000|NOT COMPLETED|Washout Period||0
6682597|NCT02680457|7614517|FG001|NOT COMPLETED|Washout Period||0
6682598|NCT02680457|7614516|FG000|STARTED|Cross-over Intervention||6
6682599|NCT02680457|7614517|FG001|STARTED|Cross-over Intervention||6
6682600|NCT02680457|7614516|FG000|COMPLETED|Cross-over Intervention||6
6682601|NCT02680457|7614517|FG001|COMPLETED|Cross-over Intervention||6
6682602|NCT02680457|7614516|FG000|NOT COMPLETED|Cross-over Intervention||0
6682603|NCT02680457|7614517|FG001|NOT COMPLETED|Cross-over Intervention||0
6682604|NCT02680639|7614523|FG000|STARTED|Screening Period||10
6682605|NCT02680639|7614524|FG001|STARTED|Screening Period||0
6682606|NCT02680639|7614525|FG002|STARTED|Screening Period||0
6682607|NCT02680639|7614523|FG000|COMPLETED|Screening Period||3
6682608|NCT02680639|7614524|FG001|COMPLETED|Screening Period||0
6682609|NCT02680639|7614525|FG002|COMPLETED|Screening Period||0
6682610|NCT02680639|7614523|FG000|NOT COMPLETED|Screening Period||7
6682611|NCT02680639|7614524|FG001|NOT COMPLETED|Screening Period||0
6682612|NCT02680639|7614525|FG002|NOT COMPLETED|Screening Period||0
6682613|NCT02680639|7614523|FG000|STARTED|High Frequency Oscillation (HFO) Therapy||0
6682614|NCT02680639|7614524|FG001|STARTED|High Frequency Oscillation (HFO) Therapy||2
6682615|NCT02680639|7614525|FG002|STARTED|High Frequency Oscillation (HFO) Therapy||1
6682616|NCT02680639|7614523|FG000|COMPLETED|High Frequency Oscillation (HFO) Therapy||0
6682617|NCT02680639|7614524|FG001|COMPLETED|High Frequency Oscillation (HFO) Therapy||2
6682618|NCT02680639|7614525|FG002|COMPLETED|High Frequency Oscillation (HFO) Therapy||1
6682619|NCT02680639|7614523|FG000|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
6682620|NCT02680639|7614524|FG001|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
6682621|NCT02680639|7614525|FG002|NOT COMPLETED|High Frequency Oscillation (HFO) Therapy||0
6682622|NCT02680665|7614535|FG000|STARTED|Overall Study||120
6682623|NCT02680665|7614535|FG000|COMPLETED|Overall Study||115
6682624|NCT02680665|7614535|FG000|NOT COMPLETED|Overall Study||5
6682625|NCT02680756|7614541|FG000|STARTED|Overall Study||125
6682626|NCT02680756|7614542|FG001|STARTED|Overall Study||125
6682627|NCT02680756|7614541|FG000|Received Treatment|Overall Study||127
6682628|NCT02680756|7614542|FG001|Received Treatment|Overall Study||120
6682629|NCT02680756|7614541|FG000|COMPLETED|Overall Study||93
6682630|NCT02680756|7614542|FG001|COMPLETED|Overall Study||106
6682631|NCT02680756|7614541|FG000|NOT COMPLETED|Overall Study||32
6682632|NCT02680756|7614542|FG001|NOT COMPLETED|Overall Study||19
6682633|NCT02680834|7614550|FG000|STARTED|Overall Study||26
6682634|NCT02680834|7614551|FG001|STARTED|Overall Study||30
6682635|NCT02680834|7614550|FG000|COMPLETED|Overall Study||15
6682636|NCT02680834|7614551|FG001|COMPLETED|Overall Study||27
6682637|NCT02680834|7614550|FG000|NOT COMPLETED|Overall Study||11
6682638|NCT02680834|7614551|FG001|NOT COMPLETED|Overall Study||3
6682639|NCT02680847|7614560|FG000|STARTED|Overall Study||16
6682640|NCT02680847|7614561|FG001|STARTED|Overall Study||9
6682641|NCT02680847|7614562|FG002|STARTED|Overall Study||7
6682642|NCT02680847|7614560|FG000|COMPLETED|Overall Study||11
6682643|NCT02680847|7614561|FG001|COMPLETED|Overall Study||6
6682644|NCT02680847|7614562|FG002|COMPLETED|Overall Study||4
6682645|NCT02680847|7614560|FG000|NOT COMPLETED|Overall Study||5
6682646|NCT02680847|7614561|FG001|NOT COMPLETED|Overall Study||3
6682647|NCT02680847|7614562|FG002|NOT COMPLETED|Overall Study||3
6682648|NCT02681094|7614573|FG000|STARTED|1 -Modified Enrolled Participants Set||293
6682649|NCT02681094|7614574|FG001|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|294
6682650|NCT02681094|7614575|FG002|STARTED|1 -Modified Enrolled Participants Set|A participant was randomized but did not receive treatment|296
6682651|NCT02681094|7614573|FG000|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||273
6682652|NCT02681094|7614574|FG001|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||276
6682653|NCT02681094|7614575|FG002|Participants Completed Treatment Period|1 -Modified Enrolled Participants Set||283
6682654|NCT02681094|7614573|FG000|COMPLETED|1 -Modified Enrolled Participants Set||256
6682655|NCT02681094|7614574|FG001|COMPLETED|1 -Modified Enrolled Participants Set||255
6682656|NCT02681094|7614575|FG002|COMPLETED|1 -Modified Enrolled Participants Set||243
6682657|NCT02681094|7614573|FG000|NOT COMPLETED|1 -Modified Enrolled Participants Set||37
6682658|NCT02681094|7614574|FG001|NOT COMPLETED|1 -Modified Enrolled Participants Set||39
6682659|NCT02681094|7614575|FG002|NOT COMPLETED|1 -Modified Enrolled Participants Set||53
6682660|NCT02681094|7614573|FG000|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|301
6682661|NCT02681094|7614574|FG001|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
6682662|NCT02681094|7614575|FG002|STARTED|2 - Enrolled Participants Set|Population was used for the sensitivity analysis to assess the robustness of the treatment effect.|302
6682663|NCT02681094|7614573|FG000|Participants Completed Treatment Period|2 - Enrolled Participants Set||281
6682664|NCT02681094|7614574|FG001|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|284
6682665|NCT02681094|7614575|FG002|Participants Completed Treatment Period|2 - Enrolled Participants Set|A participant was randomized but did not receive treatment due to screen failure.|289
6682666|NCT02681094|7614573|FG000|COMPLETED|2 - Enrolled Participants Set||261
6682667|NCT02681094|7614574|FG001|COMPLETED|2 - Enrolled Participants Set||261
6682668|NCT02681094|7614575|FG002|COMPLETED|2 - Enrolled Participants Set||248
6682669|NCT02681094|7614573|FG000|NOT COMPLETED|2 - Enrolled Participants Set||40
6682670|NCT02681094|7614574|FG001|NOT COMPLETED|2 - Enrolled Participants Set||41
6682671|NCT02681094|7614575|FG002|NOT COMPLETED|2 - Enrolled Participants Set||54
6682672|NCT02681172|7614584|FG000|STARTED|Overall Study||218
6682673|NCT02681172|7614584|FG000|Safety Analysis Set|Overall Study||205
6682674|NCT02681172|7614584|FG000|Full Analysis Set|Overall Study||205
6682675|NCT02681172|7614584|FG000|Per Protocol Set|Overall Study||205
6682676|NCT02681172|7614584|FG000|COMPLETED|Overall Study||205
6682677|NCT02681172|7614584|FG000|NOT COMPLETED|Overall Study||13
6682678|NCT02681458|7614590|FG000|STARTED|Overall Study||718
6682679|NCT02681458|7614591|FG001|STARTED|Overall Study||718
6682680|NCT02681458|7614590|FG000|COMPLETED|Overall Study||73
6682681|NCT02681458|7614591|FG001|COMPLETED|Overall Study||62
6682682|NCT02681458|7614590|FG000|NOT COMPLETED|Overall Study||645
6682683|NCT02681458|7614591|FG001|NOT COMPLETED|Overall Study||656
6682684|NCT02681510|7614597|FG000|STARTED|Overall Study||36
6682685|NCT02681510|7614597|FG000|COMPLETED|Overall Study||26
6682686|NCT02681510|7614597|FG000|NOT COMPLETED|Overall Study||10
6682687|NCT02681523|7614601|FG000|STARTED|Overall Study||8
6682688|NCT02681523|7614601|FG000|COMPLETED|Overall Study||6
6682689|NCT02681523|7614601|FG000|NOT COMPLETED|Overall Study||2
6682690|NCT02681614|7614605|FG000|STARTED|Overall Study||5
6682691|NCT02681614|7614605|FG000|COMPLETED|Overall Study||5
6682692|NCT02681614|7614605|FG000|NOT COMPLETED|Overall Study||0
6682693|NCT02681757|7614612|FG000|STARTED|Overall Study||47
6682694|NCT02681757|7614613|FG001|STARTED|Overall Study||49
6682695|NCT02681757|7614612|FG000|COMPLETED|Overall Study||47
6682696|NCT02681757|7614613|FG001|COMPLETED|Overall Study||49
6682697|NCT02681757|7614612|FG000|NOT COMPLETED|Overall Study||0
6682698|NCT02681757|7614613|FG001|NOT COMPLETED|Overall Study||0
6682699|NCT02681809|7614622|FG000|STARTED|Overall Study||20
6682700|NCT02681809|7614623|FG001|STARTED|Overall Study||19
6682701|NCT02681809|7614624|FG002|STARTED|Overall Study||9
6682702|NCT02681809|7614622|FG000|COMPLETED|Overall Study||15
6682703|NCT02681809|7614623|FG001|COMPLETED|Overall Study||15
6682704|NCT02681809|7614624|FG002|COMPLETED|Overall Study||8
6682705|NCT02681809|7614622|FG000|NOT COMPLETED|Overall Study||5
6682706|NCT02681809|7614623|FG001|NOT COMPLETED|Overall Study||4
6682707|NCT02681809|7614624|FG002|NOT COMPLETED|Overall Study||1
6682708|NCT02682030|7614634|FG000|STARTED|Overall Study||1
6682709|NCT02682030|7614635|FG001|STARTED|Overall Study||4
6682710|NCT02682030|7614634|FG000|COMPLETED|Overall Study||0
6682711|NCT02682030|7614635|FG001|COMPLETED|Overall Study||2
6682712|NCT02682030|7614634|FG000|NOT COMPLETED|Overall Study||1
6682713|NCT02682030|7614635|FG001|NOT COMPLETED|Overall Study||2
6682714|NCT02682056|7614642|FG000|STARTED|Overall Study||15
6682715|NCT02682056|7614642|FG000|COMPLETED|Overall Study||15
6682716|NCT02682056|7614642|FG000|NOT COMPLETED|Overall Study||0
6682717|NCT02682069|7614650|FG000|STARTED|Overall Study||30
6682718|NCT02682069|7614650|FG000|COMPLETED|Overall Study||30
6682719|NCT02682069|7614650|FG000|NOT COMPLETED|Overall Study||0
6682720|NCT02682264|7614656|FG000|STARTED|Overall Study||317
6682721|NCT02682264|7614657|FG001|STARTED|Overall Study||290
6682722|NCT02682264|7614656|FG000|COMPLETED|Overall Study||179
6682723|NCT02682264|7614657|FG001|COMPLETED|Overall Study||168
6682724|NCT02682264|7614656|FG000|NOT COMPLETED|Overall Study||138
6682725|NCT02682264|7614657|FG001|NOT COMPLETED|Overall Study||122
6682726|NCT02682381|7614666|FG000|STARTED|Overall Study||24
6682727|NCT02682381|7614667|FG001|STARTED|Overall Study||26
6682728|NCT02682381|7614668|FG002|STARTED|Overall Study||9
6682729|NCT02682381|7614666|FG000|COMPLETED|Overall Study||24
6682730|NCT02682381|7614667|FG001|COMPLETED|Overall Study||26
6682731|NCT02682381|7614668|FG002|COMPLETED|Overall Study||9
6682732|NCT02682381|7614666|FG000|NOT COMPLETED|Overall Study||0
6682733|NCT02682381|7614667|FG001|NOT COMPLETED|Overall Study||0
6682734|NCT02682381|7614668|FG002|NOT COMPLETED|Overall Study||0
6682735|NCT02682420|7614676|FG000|STARTED|Overall Study||100
6682736|NCT02682420|7614676|FG000|COMPLETED|Overall Study|Note: 63 participants completed the 6-month visit. The study was discontinued prematurely due to company acquisition and therefore, many participants did not complete their 12-month visit.|63
6682737|NCT02682420|7614676|FG000|NOT COMPLETED|Overall Study||37
6682738|NCT02682498|7614689|FG000|STARTED|Overall Study||18
6682739|NCT02682498|7614690|FG001|STARTED|Overall Study||20
6682740|NCT02682498|7614689|FG000|COMPLETED|Overall Study||18
6682741|NCT02682498|7614690|FG001|COMPLETED|Overall Study||20
6682742|NCT02682498|7614689|FG000|NOT COMPLETED|Overall Study||0
6682743|NCT02682498|7614690|FG001|NOT COMPLETED|Overall Study||0
6682744|NCT02682563|7614699|FG000|STARTED|Overall Study||24
6682745|NCT02682563|7614700|FG001|STARTED|Overall Study||20
6682746|NCT02682563|7614699|FG000|COMPLETED|Overall Study||24
6682747|NCT02682563|7614700|FG001|COMPLETED|Overall Study||20
6682748|NCT02682563|7614699|FG000|NOT COMPLETED|Overall Study||0
6682749|NCT02682563|7614700|FG001|NOT COMPLETED|Overall Study||0
6682750|NCT02682602|7614708|FG000|STARTED|Pre-operative Diseased & Normal Hips||11
6682751|NCT02682602|7614709|FG001|STARTED|Pre-operative Diseased & Normal Hips||10
6256585|NCT02564900|7155505|FG002|Enrolled, But Not Dosed|Dose Expansion||0
6256586|NCT02564900|7155506|FG003|Enrolled, But Not Dosed|Dose Expansion||0
6256587|NCT02564900|7155507|FG004|Enrolled, But Not Dosed|Dose Expansion||0
6256588|NCT02564900|7155508|FG005|Enrolled, But Not Dosed|Dose Expansion||0
6256589|NCT02564900|7155509|FG006|Enrolled, But Not Dosed|Dose Expansion||1
6256590|NCT02564900|7155510|FG007|Enrolled, But Not Dosed|Dose Expansion||1
6256591|NCT02564900|7155511|FG008|Enrolled, But Not Dosed|Dose Expansion||0
6682752|NCT02682602|7614708|FG000|COMPLETED|Pre-operative Diseased & Normal Hips||10
6682753|NCT02682602|7614709|FG001|COMPLETED|Pre-operative Diseased & Normal Hips||10
6682754|NCT02682602|7614708|FG000|NOT COMPLETED|Pre-operative Diseased & Normal Hips||1
6256592|NCT02564900|7155512|FG009|Enrolled, But Not Dosed|Dose Expansion||0
6256593|NCT02564900|7155513|FG010|Enrolled, But Not Dosed|Dose Expansion||0
6256594|NCT02564900|7155514|FG011|Enrolled, But Not Dosed|Dose Expansion||0
6256595|NCT02564900|7155515|FG012|Enrolled, But Not Dosed|Dose Expansion||0
6256596|NCT02564900|7155516|FG013|Enrolled, But Not Dosed|Dose Expansion||0
6256597|NCT02564900|7155517|FG014|Enrolled, But Not Dosed|Dose Expansion||1
6256598|NCT02564900|7155503|FG000|COMPLETED|Dose Expansion||0
6256599|NCT02564900|7155504|FG001|COMPLETED|Dose Expansion||0
6256600|NCT02564900|7155505|FG002|COMPLETED|Dose Expansion||0
6256601|NCT02564900|7155506|FG003|COMPLETED|Dose Expansion||0
6256602|NCT02564900|7155507|FG004|COMPLETED|Dose Expansion||0
6256603|NCT02564900|7155508|FG005|COMPLETED|Dose Expansion||0
6256604|NCT02564900|7155509|FG006|COMPLETED|Dose Expansion||0
6256605|NCT02564900|7155510|FG007|COMPLETED|Dose Expansion||0
6256606|NCT02564900|7155511|FG008|COMPLETED|Dose Expansion||0
6256607|NCT02564900|7155512|FG009|COMPLETED|Dose Expansion||0
6256608|NCT02564900|7155513|FG010|COMPLETED|Dose Expansion||0
6256609|NCT02564900|7155514|FG011|COMPLETED|Dose Expansion||0
6256610|NCT02564900|7155515|FG012|COMPLETED|Dose Expansion||0
6256611|NCT02564900|7155516|FG013|COMPLETED|Dose Expansion||0
6256612|NCT02564900|7155517|FG014|COMPLETED|Dose Expansion||0
6256613|NCT02564900|7155503|FG000|NOT COMPLETED|Dose Expansion||0
6256614|NCT02564900|7155504|FG001|NOT COMPLETED|Dose Expansion||0
6256615|NCT02564900|7155505|FG002|NOT COMPLETED|Dose Expansion||0
6256616|NCT02564900|7155506|FG003|NOT COMPLETED|Dose Expansion||0
6256617|NCT02564900|7155507|FG004|NOT COMPLETED|Dose Expansion||0
6256618|NCT02564900|7155508|FG005|NOT COMPLETED|Dose Expansion||0
6256619|NCT02564900|7155509|FG006|NOT COMPLETED|Dose Expansion||49
6256620|NCT02564900|7155510|FG007|NOT COMPLETED|Dose Expansion||62
6256621|NCT02564900|7155511|FG008|NOT COMPLETED|Dose Expansion||20
6256622|NCT02564900|7155512|FG009|NOT COMPLETED|Dose Expansion||33
6256623|NCT02564900|7155513|FG010|NOT COMPLETED|Dose Expansion||17
6256624|NCT02564900|7155514|FG011|NOT COMPLETED|Dose Expansion||24
6256625|NCT02564900|7155515|FG012|NOT COMPLETED|Dose Expansion||18
6256626|NCT02564900|7155516|FG013|NOT COMPLETED|Dose Expansion||20
6256627|NCT02564900|7155517|FG014|NOT COMPLETED|Dose Expansion||22
6256628|NCT02561299|7155560|FG000|STARTED|Overall Study||32
6256629|NCT02561299|7155561|FG001|STARTED|Overall Study||34
6256630|NCT02561299|7155560|FG000|COMPLETED|Overall Study||27
6256631|NCT02561299|7155561|FG001|COMPLETED|Overall Study||28
6256632|NCT02561299|7155560|FG000|NOT COMPLETED|Overall Study||5
6256633|NCT02561299|7155561|FG001|NOT COMPLETED|Overall Study||6
6256634|NCT02548143|7155569|FG000|STARTED|Overall Study||6
6256635|NCT02548143|7155570|FG001|STARTED|Overall Study||6
6256636|NCT02548143|7155569|FG000|COMPLETED|Overall Study||5
6256637|NCT02548143|7155570|FG001|COMPLETED|Overall Study||5
6256638|NCT02548143|7155569|FG000|NOT COMPLETED|Overall Study||1
6256639|NCT02548143|7155570|FG001|NOT COMPLETED|Overall Study||1
6256640|NCT02448680|7155578|FG000|STARTED|Overall Study||12
6256641|NCT02448680|7155579|FG001|STARTED|Overall Study||13
6256642|NCT02448680|7155578|FG000|COMPLETED|Overall Study||11
6256643|NCT02448680|7155579|FG001|COMPLETED|Overall Study||10
6256644|NCT02448680|7155578|FG000|NOT COMPLETED|Overall Study||1
6256645|NCT02448680|7155579|FG001|NOT COMPLETED|Overall Study||3
6256646|NCT02393859|7155589|FG000|STARTED|Overall Study||54
6256647|NCT02393859|7155590|FG001|STARTED|Overall Study||54
6256648|NCT02393859|7155589|FG000|COMPLETED|Overall Study||0
6256649|NCT02393859|7155590|FG001|COMPLETED|Overall Study||0
6256650|NCT02393859|7155589|FG000|NOT COMPLETED|Overall Study||54
6682755|NCT02682602|7614709|FG001|NOT COMPLETED|Pre-operative Diseased & Normal Hips||0
6682756|NCT02682602|7614708|FG000|STARTED|Post-operative Fluoroscopy for Implanted||10
6256651|NCT02393859|7155590|FG001|NOT COMPLETED|Overall Study||54
6256652|NCT02352103|7155599|FG000|STARTED|Overall Study||60
6256653|NCT02352103|7155600|FG001|STARTED|Overall Study||60
6256654|NCT02352103|7155599|FG000|COMPLETED|Overall Study||60
6256655|NCT02352103|7155600|FG001|COMPLETED|Overall Study||59
6256656|NCT02352103|7155599|FG000|NOT COMPLETED|Overall Study||0
6256657|NCT02352103|7155600|FG001|NOT COMPLETED|Overall Study||1
6256658|NCT02273362|7155609|FG000|STARTED|Overall Study||5
6682757|NCT02682602|7614709|FG001|STARTED|Post-operative Fluoroscopy for Implanted||0
6682758|NCT02682602|7614708|FG000|COMPLETED|Post-operative Fluoroscopy for Implanted||7
6682759|NCT02682602|7614709|FG001|COMPLETED|Post-operative Fluoroscopy for Implanted|Nonimplanted subjects were not analyzed again for the second period, because this would be redundant|0
6682760|NCT02682602|7614708|FG000|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||3
6682761|NCT02682602|7614709|FG001|NOT COMPLETED|Post-operative Fluoroscopy for Implanted||0
6682762|NCT02682784|7614723|FG000|STARTED|Overall Study||40
6682763|NCT02682784|7614724|FG001|STARTED|Overall Study||37
6682764|NCT02682784|7614725|FG002|STARTED|Overall Study||29
6682765|NCT02682784|7614726|FG003|STARTED|Overall Study||32
6682766|NCT02682784|7614723|FG000|COMPLETED|Overall Study||39
6682767|NCT02682784|7614724|FG001|COMPLETED|Overall Study||35
6682768|NCT02682784|7614725|FG002|COMPLETED|Overall Study||27
6682769|NCT02682784|7614726|FG003|COMPLETED|Overall Study||29
6682770|NCT02682784|7614723|FG000|NOT COMPLETED|Overall Study||1
6682771|NCT02682784|7614724|FG001|NOT COMPLETED|Overall Study||2
6682772|NCT02682784|7614725|FG002|NOT COMPLETED|Overall Study||2
6682773|NCT02682784|7614726|FG003|NOT COMPLETED|Overall Study||3
6682774|NCT02682823|7614741|FG000|STARTED|Overall Study||17
6682775|NCT02682823|7614742|FG001|STARTED|Overall Study||19
6682776|NCT02682823|7614743|FG002|STARTED|Overall Study||19
6682777|NCT02682823|7614744|FG003|STARTED|Overall Study||17
6682778|NCT02682823|7614745|FG004|STARTED|Overall Study||19
6682779|NCT02682823|7614741|FG000|Safety Population|Overall Study|All CGs who administered at least one dose of study drug.|17
6682780|NCT02682823|7614742|FG001|Safety Population|Overall Study|All HCPs who administered at least one dose of study drug.|19
6682781|NCT02682823|7614743|FG002|Safety Population|Overall Study|All participants who received at least one dose of study drug.|18
6682782|NCT02682823|7614744|FG003|Safety Population|Overall Study|All participants who received at least one dose of study drug.|17
6682783|NCT02682823|7614745|FG004|Safety Population|Overall Study|All participants who received at least one dose of study drug.|19
6682784|NCT02682823|7614741|FG000|COMPLETED|Overall Study||17
6682785|NCT02682823|7614742|FG001|COMPLETED|Overall Study||18
6682786|NCT02682823|7614743|FG002|COMPLETED|Overall Study||18
6682787|NCT02682823|7614744|FG003|COMPLETED|Overall Study||16
6682788|NCT02682823|7614745|FG004|COMPLETED|Overall Study||18
6682789|NCT02682823|7614741|FG000|NOT COMPLETED|Overall Study||0
6682790|NCT02682823|7614742|FG001|NOT COMPLETED|Overall Study||1
6682791|NCT02682823|7614743|FG002|NOT COMPLETED|Overall Study||1
6682792|NCT02682823|7614744|FG003|NOT COMPLETED|Overall Study||1
6682793|NCT02682823|7614745|FG004|NOT COMPLETED|Overall Study||1
6682794|NCT02683083|7614757|FG000|STARTED|Overall Study||9
6682795|NCT02683083|7614757|FG000|COMPLETED|Overall Study||9
6682796|NCT02683083|7614757|FG000|NOT COMPLETED|Overall Study||0
6682797|NCT02683109|7614763|FG000|STARTED|Overall Study||110
6682798|NCT02683109|7614764|FG001|STARTED|Overall Study||111
6682799|NCT02683109|7614763|FG000|COMPLETED|Overall Study||109
6682800|NCT02683109|7614764|FG001|COMPLETED|Overall Study||111
6682801|NCT02683109|7614763|FG000|NOT COMPLETED|Overall Study||1
6682802|NCT02683109|7614764|FG001|NOT COMPLETED|Overall Study||0
6682803|NCT02683161|7614771|FG000|STARTED|Overall Study||5
6682804|NCT02683161|7614771|FG000|COMPLETED|Overall Study||5
6682805|NCT02683161|7614771|FG000|NOT COMPLETED|Overall Study||0
6682806|NCT02683174|7614775|FG000|STARTED|Overall Study||86
6682807|NCT02683174|7614775|FG000|COMPLETED|Overall Study||86
6682808|NCT02683174|7614775|FG000|NOT COMPLETED|Overall Study||0
6682809|NCT02683187|7614780|FG000|STARTED|Overall Study||40
6682810|NCT02683187|7614780|FG000|COMPLETED|Overall Study||32
6682811|NCT02683187|7614780|FG000|NOT COMPLETED|Overall Study||8
6682812|NCT02683421|7614792|FG000|STARTED|Overall Study||5
6682813|NCT02683421|7614793|FG001|STARTED|Overall Study||4
6682814|NCT02683421|7614794|FG002|STARTED|Overall Study||4
6682815|NCT02683421|7614795|FG003|STARTED|Overall Study||5
6682816|NCT02683421|7614792|FG000|COMPLETED|Overall Study||5
6682817|NCT02683421|7614793|FG001|COMPLETED|Overall Study||4
6682818|NCT02683421|7614794|FG002|COMPLETED|Overall Study||4
6682819|NCT02683421|7614795|FG003|COMPLETED|Overall Study||5
6682820|NCT02683421|7614792|FG000|NOT COMPLETED|Overall Study||0
6682821|NCT02683421|7614793|FG001|NOT COMPLETED|Overall Study||0
6682822|NCT02683421|7614794|FG002|NOT COMPLETED|Overall Study||0
6682823|NCT02683421|7614795|FG003|NOT COMPLETED|Overall Study||0
6682824|NCT02683525|7614805|FG000|STARTED|Overall Study||37
6682825|NCT02683525|7614805|FG000|COMPLETED|Overall Study||29
6682826|NCT02683525|7614805|FG000|NOT COMPLETED|Overall Study||8
6682827|NCT02683577|7614812|FG000|STARTED|Overall Study||8
6682828|NCT02683577|7614813|FG001|STARTED|Overall Study||8
6682829|NCT02683577|7614814|FG002|STARTED|Overall Study||8
6682830|NCT02683577|7614812|FG000|COMPLETED|Overall Study||8
6682831|NCT02683577|7614813|FG001|COMPLETED|Overall Study||8
6682832|NCT02683577|7614814|FG002|COMPLETED|Overall Study||8
6682833|NCT02683577|7614812|FG000|NOT COMPLETED|Overall Study||0
6682834|NCT02683577|7614813|FG001|NOT COMPLETED|Overall Study||0
6682835|NCT02683577|7614814|FG002|NOT COMPLETED|Overall Study||0
6682836|NCT02683668|7614824|FG000|STARTED|Period 1||44
6682837|NCT02683668|7614825|FG001|STARTED|Period 1||0
6682838|NCT02683668|7614826|FG002|STARTED|Period 1||0
6682839|NCT02683668|7614824|FG000|COMPLETED|Period 1||44
6682840|NCT02683668|7614825|FG001|COMPLETED|Period 1||0
6682841|NCT02683668|7614826|FG002|COMPLETED|Period 1||0
6682842|NCT02683668|7614824|FG000|NOT COMPLETED|Period 1||0
6682843|NCT02683668|7614825|FG001|NOT COMPLETED|Period 1||0
6682844|NCT02683668|7614826|FG002|NOT COMPLETED|Period 1||0
6682845|NCT02683668|7614824|FG000|STARTED|Period 2||0
6682846|NCT02683668|7614825|FG001|STARTED|Period 2||44
6682847|NCT02683668|7614826|FG002|STARTED|Period 2||0
6682848|NCT02683668|7614824|FG000|COMPLETED|Period 2||0
6682849|NCT02683668|7614825|FG001|COMPLETED|Period 2||43
6682850|NCT02683668|7614826|FG002|COMPLETED|Period 2||0
6682851|NCT02683668|7614824|FG000|NOT COMPLETED|Period 2||0
6682852|NCT02683668|7614825|FG001|NOT COMPLETED|Period 2||1
6682853|NCT02683668|7614826|FG002|NOT COMPLETED|Period 2||0
6682854|NCT02683668|7614824|FG000|STARTED|Period 3||0
6682855|NCT02683668|7614825|FG001|STARTED|Period 3||0
6682856|NCT02683668|7614826|FG002|STARTED|Period 3||43
6682857|NCT02683668|7614824|FG000|COMPLETED|Period 3||0
6682858|NCT02683668|7614825|FG001|COMPLETED|Period 3||0
6682859|NCT02683668|7614826|FG002|COMPLETED|Period 3||43
6682860|NCT02683668|7614824|FG000|NOT COMPLETED|Period 3||0
6682861|NCT02683668|7614825|FG001|NOT COMPLETED|Period 3||0
6682862|NCT02683668|7614826|FG002|NOT COMPLETED|Period 3||0
6682863|NCT02683707|7614834|FG000|STARTED|Overall Study||105
6682864|NCT02683707|7614835|FG001|STARTED|Overall Study||107
6682865|NCT02683707|7614834|FG000|COMPLETED|Overall Study||105
6682866|NCT02683707|7614835|FG001|COMPLETED|Overall Study||107
6682867|NCT02683707|7614834|FG000|NOT COMPLETED|Overall Study||0
6682868|NCT02683707|7614835|FG001|NOT COMPLETED|Overall Study||0
6682869|NCT02683746|7614843|FG000|STARTED|Overall Study||154
6682870|NCT02683746|7614844|FG001|STARTED|Overall Study||154
6682871|NCT02683746|7614843|FG000|COMPLETED|Overall Study||138
6682872|NCT02683746|7614844|FG001|COMPLETED|Overall Study||140
6682873|NCT02683746|7614843|FG000|NOT COMPLETED|Overall Study||16
6682874|NCT02683746|7614844|FG001|NOT COMPLETED|Overall Study||14
6682875|NCT02683772|7614850|FG000|STARTED|Overall Study||15
6682876|NCT02683772|7614851|FG001|STARTED|Overall Study||23
6682877|NCT02683772|7614850|FG000|COMPLETED|Overall Study||15
6682878|NCT02683772|7614851|FG001|COMPLETED|Overall Study||23
6682879|NCT02683772|7614850|FG000|NOT COMPLETED|Overall Study||0
6682880|NCT02683772|7614851|FG001|NOT COMPLETED|Overall Study||0
6682881|NCT02683785|7614863|FG000|STARTED|Overall Study||22
6682882|NCT02683785|7614864|FG001|STARTED|Overall Study||22
6682883|NCT02683785|7614863|FG000|COMPLETED|Overall Study||21
6682884|NCT02683785|7614864|FG001|COMPLETED|Overall Study||18
6682885|NCT02683785|7614863|FG000|NOT COMPLETED|Overall Study||1
6682886|NCT02683785|7614864|FG001|NOT COMPLETED|Overall Study||4
6682887|NCT02683876|7614874|FG000|STARTED|Overall Study||17
6682888|NCT02683876|7614875|FG001|STARTED|Overall Study||22
6682889|NCT02683876|7614874|FG000|COMPLETED|Overall Study||15
6682890|NCT02683876|7614875|FG001|COMPLETED|Overall Study||22
6682891|NCT02683876|7614874|FG000|NOT COMPLETED|Overall Study||2
6682892|NCT02683876|7614875|FG001|NOT COMPLETED|Overall Study||0
6682893|NCT02683928|7614885|FG000|STARTED|Overall Study||48
6682894|NCT02683928|7614886|FG001|STARTED|Overall Study||16
6682895|NCT02683928|7614885|FG000|COMPLETED|Overall Study||26
6682896|NCT02683928|7614886|FG001|COMPLETED|Overall Study||8
6682897|NCT02683928|7614885|FG000|NOT COMPLETED|Overall Study||22
6682898|NCT02683928|7614886|FG001|NOT COMPLETED|Overall Study||8
6682899|NCT02683941|7614894|FG000|STARTED|Double-blind Phase||51
6682900|NCT02683941|7614895|FG001|STARTED|Double-blind Phase||26
6682901|NCT02683941|7614894|FG000|COMPLETED|Double-blind Phase||41
6682902|NCT02683941|7614895|FG001|COMPLETED|Double-blind Phase||21
6682903|NCT02683941|7614894|FG000|NOT COMPLETED|Double-blind Phase||10
6682904|NCT02683941|7614895|FG001|NOT COMPLETED|Double-blind Phase||5
6682905|NCT02683941|7614894|FG000|STARTED|Open-label Treatment Phase||21
6682906|NCT02683941|7614895|FG001|STARTED|Open-label Treatment Phase||19
6682907|NCT02683941|7614894|FG000|COMPLETED|Open-label Treatment Phase||1
6682908|NCT02683941|7614895|FG001|COMPLETED|Open-label Treatment Phase||6
6682909|NCT02683941|7614894|FG000|NOT COMPLETED|Open-label Treatment Phase||20
6682910|NCT02683941|7614895|FG001|NOT COMPLETED|Open-label Treatment Phase||13
6682911|NCT02683941|7614894|FG000|STARTED|Open-label Follow-up Phase||18
6682912|NCT02683941|7614895|FG001|STARTED|Open-label Follow-up Phase||8
6682913|NCT02683941|7614894|FG000|COMPLETED|Open-label Follow-up Phase||0
6682914|NCT02683941|7614895|FG001|COMPLETED|Open-label Follow-up Phase||0
6682915|NCT02683941|7614894|FG000|NOT COMPLETED|Open-label Follow-up Phase||18
6682916|NCT02683941|7614895|FG001|NOT COMPLETED|Open-label Follow-up Phase||8
6682917|NCT02683954|7614907|FG000|STARTED|Overall Study||30
6682918|NCT02683954|7614908|FG001|STARTED|Overall Study||30
6682919|NCT02683954|7614907|FG000|COMPLETED|Overall Study||30
6682920|NCT02683954|7614908|FG001|COMPLETED|Overall Study||30
6682921|NCT02683954|7614907|FG000|NOT COMPLETED|Overall Study||0
6682922|NCT02683954|7614908|FG001|NOT COMPLETED|Overall Study||0
6682923|NCT02684097|7614916|FG000|STARTED|Overall Study||15
6682924|NCT02684097|7614917|FG001|STARTED|Overall Study||7
6682925|NCT02684097|7614916|FG000|COMPLETED|Overall Study||2
6682926|NCT02684097|7614917|FG001|COMPLETED|Overall Study||1
6682927|NCT02684097|7614916|FG000|NOT COMPLETED|Overall Study||13
6682928|NCT02684097|7614917|FG001|NOT COMPLETED|Overall Study||6
6682929|NCT02684136|7614923|FG000|STARTED|First Intervention (9 Nights)||5
6682930|NCT02684136|7614924|FG001|STARTED|First Intervention (9 Nights)||5
6682931|NCT02684136|7614923|FG000|COMPLETED|First Intervention (9 Nights)||5
6682932|NCT02684136|7614924|FG001|COMPLETED|First Intervention (9 Nights)||5
6682933|NCT02684136|7614923|FG000|NOT COMPLETED|First Intervention (9 Nights)||0
6682934|NCT02684136|7614924|FG001|NOT COMPLETED|First Intervention (9 Nights)||0
6682935|NCT02684136|7614923|FG000|STARTED|Washout (7 Days)||5
6682936|NCT02684136|7614924|FG001|STARTED|Washout (7 Days)||5
6682937|NCT02684136|7614923|FG000|COMPLETED|Washout (7 Days)||5
6682938|NCT02684136|7614924|FG001|COMPLETED|Washout (7 Days)||5
6682939|NCT02684136|7614923|FG000|NOT COMPLETED|Washout (7 Days)||0
6682940|NCT02684136|7614924|FG001|NOT COMPLETED|Washout (7 Days)||0
6682941|NCT02684136|7614923|FG000|STARTED|Second Intervention (9 Nights)||5
6682942|NCT02684136|7614924|FG001|STARTED|Second Intervention (9 Nights)||5
6682943|NCT02684136|7614923|FG000|COMPLETED|Second Intervention (9 Nights)||5
6682944|NCT02684136|7614924|FG001|COMPLETED|Second Intervention (9 Nights)||5
6682945|NCT02684136|7614923|FG000|NOT COMPLETED|Second Intervention (9 Nights)||0
6682946|NCT02684136|7614924|FG001|NOT COMPLETED|Second Intervention (9 Nights)||0
6682947|NCT02684188|7614932|FG000|STARTED|Overall Study||77
6682948|NCT02684188|7614933|FG001|STARTED|Overall Study||50
6682949|NCT02684188|7614932|FG000|COMPLETED|Overall Study||75
6682950|NCT02684188|7614933|FG001|COMPLETED|Overall Study||47
6682951|NCT02684188|7614932|FG000|NOT COMPLETED|Overall Study||2
6682952|NCT02684188|7614933|FG001|NOT COMPLETED|Overall Study||3
6682953|NCT02684279|7614942|FG000|STARTED|Overall Study||528
6682954|NCT02684279|7614942|FG000|COMPLETED|Overall Study||249
6682955|NCT02684279|7614942|FG000|NOT COMPLETED|Overall Study||279
6682956|NCT02684344|7614948|FG000|STARTED|Overall Study||1
6682957|NCT02684344|7614949|FG001|STARTED|Overall Study||4
6682958|NCT02684344|7614948|FG000|COMPLETED|Overall Study||1
6682959|NCT02684344|7614949|FG001|COMPLETED|Overall Study||3
6682960|NCT02684344|7614948|FG000|NOT COMPLETED|Overall Study||0
6682961|NCT02684344|7614949|FG001|NOT COMPLETED|Overall Study||1
6682962|NCT02684357|7614958|FG000|STARTED|Part A||98
6682963|NCT02684357|7614959|FG001|STARTED|Part A||99
6682964|NCT02684357|7614960|FG002|STARTED|Part A||294
6682965|NCT02684357|7614961|FG003|STARTED|Part A||0
6682966|NCT02684357|7614962|FG004|STARTED|Part A||0
6682967|NCT02684357|7614963|FG005|STARTED|Part A||0
6682968|NCT02684357|7614958|FG000|COMPLETED|Part A||94
6682969|NCT02684357|7614959|FG001|COMPLETED|Part A||96
6682970|NCT02684357|7614960|FG002|COMPLETED|Part A||292
6682971|NCT02684357|7614961|FG003|COMPLETED|Part A||0
6682972|NCT02684357|7614962|FG004|COMPLETED|Part A||0
6682973|NCT02684357|7614963|FG005|COMPLETED|Part A||0
6682974|NCT02684357|7614958|FG000|NOT COMPLETED|Part A||4
6682975|NCT02684357|7614959|FG001|NOT COMPLETED|Part A||3
6682976|NCT02684357|7614960|FG002|NOT COMPLETED|Part A||2
6682977|NCT02684357|7614961|FG003|NOT COMPLETED|Part A||0
6682978|NCT02684357|7614962|FG004|NOT COMPLETED|Part A||0
6682979|NCT02684357|7614963|FG005|NOT COMPLETED|Part A||0
6682980|NCT02684357|7614958|FG000|STARTED|Part B||0
6682981|NCT02684357|7614959|FG001|STARTED|Part B||0
6682982|NCT02684357|7614960|FG002|STARTED|Part B||0
6682983|NCT02684357|7614961|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab in Part B|94
6682984|NCT02684357|7614962|FG004|STARTED|Part B|2 participants who received ustekinumab in Part A did not receive a dose of study drug in Part B.|94
6682985|NCT02684357|7614963|FG005|STARTED|Part B|1 participant who received risankizumab in Part A did not receive a dose of study drug in Part B|291
6682986|NCT02684357|7614958|FG000|COMPLETED|Part B||0
6682987|NCT02684357|7614959|FG001|COMPLETED|Part B||0
6682988|NCT02684357|7614960|FG002|COMPLETED|Part B||0
6682989|NCT02684357|7614961|FG003|COMPLETED|Part B||91
6682990|NCT02684357|7614962|FG004|COMPLETED|Part B||90
6682991|NCT02684357|7614963|FG005|COMPLETED|Part B||278
6682992|NCT02684357|7614958|FG000|NOT COMPLETED|Part B||0
6682993|NCT02684357|7614959|FG001|NOT COMPLETED|Part B||0
6682994|NCT02684357|7614960|FG002|NOT COMPLETED|Part B||0
6682995|NCT02684357|7614961|FG003|NOT COMPLETED|Part B||3
6682996|NCT02684357|7614962|FG004|NOT COMPLETED|Part B||4
6682997|NCT02684357|7614963|FG005|NOT COMPLETED|Part B||13
6682998|NCT02684370|7614979|FG000|STARTED|Part A||102
6682999|NCT02684370|7614980|FG001|STARTED|Part A||100
6683000|NCT02684370|7614981|FG002|STARTED|Part A||304
6683001|NCT02684370|7614982|FG003|STARTED|Part A||0
6683002|NCT02684370|7614983|FG004|STARTED|Part A||0
6683003|NCT02684370|7614984|FG005|STARTED|Part A||0
6683004|NCT02684370|7614979|FG000|COMPLETED|Part A||98
6683005|NCT02684370|7614980|FG001|COMPLETED|Part A||99
6683006|NCT02684370|7614981|FG002|COMPLETED|Part A||299
6683007|NCT02684370|7614982|FG003|COMPLETED|Part A||0
6683008|NCT02684370|7614983|FG004|COMPLETED|Part A||0
6683009|NCT02684370|7614984|FG005|COMPLETED|Part A||0
6683010|NCT02684370|7614979|FG000|NOT COMPLETED|Part A||4
6683011|NCT02684370|7614980|FG001|NOT COMPLETED|Part A||1
6683012|NCT02684370|7614981|FG002|NOT COMPLETED|Part A||5
6683013|NCT02684370|7614982|FG003|NOT COMPLETED|Part A||0
6683014|NCT02684370|7614983|FG004|NOT COMPLETED|Part A||0
6683015|NCT02684370|7614984|FG005|NOT COMPLETED|Part A||0
6256659|NCT02273362|7155610|FG001|STARTED|Overall Study||6
6683016|NCT02684370|7614979|FG000|STARTED|Part B||0
6683017|NCT02684370|7614980|FG001|STARTED|Part B||0
6683018|NCT02684370|7614981|FG002|STARTED|Part B||0
6683019|NCT02684370|7614982|FG003|STARTED|Part B|1 participant who received placebo in Part A did not receive a dose of study drug in Part B|97
6683020|NCT02684370|7614983|FG004|STARTED|Part B|Participants who received ustekinumab in Part A received ustekinumab in Part B|99
6683021|NCT02684370|7614984|FG005|STARTED|Part B|2 participants who received risankizumab in Part A did not receive a dose of study drug in Part B|297
6683022|NCT02684370|7614979|FG000|COMPLETED|Part B||0
6683023|NCT02684370|7614980|FG001|COMPLETED|Part B||0
6683024|NCT02684370|7614981|FG002|COMPLETED|Part B||0
6683025|NCT02684370|7614982|FG003|COMPLETED|Part B||95
6683026|NCT02684370|7614983|FG004|COMPLETED|Part B||94
6683027|NCT02684370|7614984|FG005|COMPLETED|Part B||289
6683028|NCT02684370|7614979|FG000|NOT COMPLETED|Part B||0
6683029|NCT02684370|7614980|FG001|NOT COMPLETED|Part B||0
6683030|NCT02684370|7614981|FG002|NOT COMPLETED|Part B||0
6683031|NCT02684370|7614982|FG003|NOT COMPLETED|Part B||2
6683032|NCT02684370|7614983|FG004|NOT COMPLETED|Part B||5
6683033|NCT02684370|7614984|FG005|NOT COMPLETED|Part B||8
6683034|NCT02684396|7615004|FG000|STARTED|Overall Study||6
6683035|NCT02684396|7615005|FG001|STARTED|Overall Study||6
6683036|NCT02684396|7615006|FG002|STARTED|Overall Study||6
6683037|NCT02684396|7615007|FG003|STARTED|Overall Study||6
6683038|NCT02684396|7615008|FG004|STARTED|Overall Study||5
6683039|NCT02684396|7615009|FG005|STARTED|Overall Study||10
6683040|NCT02684396|7615004|FG000|COMPLETED|Overall Study||6
6683041|NCT02684396|7615005|FG001|COMPLETED|Overall Study||6
6683042|NCT02684396|7615006|FG002|COMPLETED|Overall Study||6
6683043|NCT02684396|7615007|FG003|COMPLETED|Overall Study||6
6683044|NCT02684396|7615008|FG004|COMPLETED|Overall Study||5
6683045|NCT02684396|7615009|FG005|COMPLETED|Overall Study||10
6683046|NCT02684396|7615004|FG000|NOT COMPLETED|Overall Study||0
6683047|NCT02684396|7615005|FG001|NOT COMPLETED|Overall Study||0
6683048|NCT02684396|7615006|FG002|NOT COMPLETED|Overall Study||0
6683049|NCT02684396|7615007|FG003|NOT COMPLETED|Overall Study||0
6683050|NCT02684396|7615008|FG004|NOT COMPLETED|Overall Study||0
6683051|NCT02684396|7615009|FG005|NOT COMPLETED|Overall Study||0
6683052|NCT02684435|7615023|FG000|STARTED|Overall Study||63
6683053|NCT02684435|7615023|FG000|COMPLETED|Overall Study||63
6683054|NCT02684435|7615023|FG000|NOT COMPLETED|Overall Study||0
6683055|NCT02684591|7615029|FG000|STARTED|Overall Study||25
6683056|NCT02684591|7615030|FG001|STARTED|Overall Study||25
6683057|NCT02684591|7615029|FG000|COMPLETED|Overall Study||24
6683058|NCT02684591|7615030|FG001|COMPLETED|Overall Study||22
6683059|NCT02684591|7615029|FG000|NOT COMPLETED|Overall Study||1
6683060|NCT02684591|7615030|FG001|NOT COMPLETED|Overall Study||3
6683061|NCT02684604|7615038|FG000|STARTED|Overall Study||44
6683062|NCT02684604|7615039|FG001|STARTED|Overall Study||44
6683063|NCT02684604|7615038|FG000|COMPLETED|Overall Study||44
6683064|NCT02684604|7615039|FG001|COMPLETED|Overall Study||44
6683065|NCT02684604|7615038|FG000|NOT COMPLETED|Overall Study||0
6683066|NCT02684604|7615039|FG001|NOT COMPLETED|Overall Study||0
6683067|NCT02684617|7615048|FG000|STARTED|Overall Study||18
6683068|NCT02684617|7615049|FG001|STARTED|Overall Study||17
6683069|NCT02684617|7615050|FG002|STARTED|Overall Study||40
6683070|NCT02684617|7615048|FG000|Treated|Overall Study||17
6683071|NCT02684617|7615049|FG001|Treated|Overall Study||17
6683072|NCT02684617|7615050|FG002|Treated|Overall Study||38
6683073|NCT02684617|7615048|FG000|COMPLETED|Overall Study||0
6683074|NCT02684617|7615049|FG001|COMPLETED|Overall Study||0
6683075|NCT02684617|7615050|FG002|COMPLETED|Overall Study||0
6683076|NCT02684617|7615048|FG000|NOT COMPLETED|Overall Study||18
6683077|NCT02684617|7615049|FG001|NOT COMPLETED|Overall Study||17
6683078|NCT02684617|7615050|FG002|NOT COMPLETED|Overall Study||40
6683079|NCT02684630|7615060|FG000|STARTED|Overall Study||65
6683080|NCT02684630|7615061|FG001|STARTED|Overall Study||63
6683081|NCT02684630|7615060|FG000|COMPLETED|Overall Study||60
6683082|NCT02684630|7615061|FG001|COMPLETED|Overall Study||60
6683083|NCT02684630|7615060|FG000|NOT COMPLETED|Overall Study||5
6683084|NCT02684630|7615061|FG001|NOT COMPLETED|Overall Study||3
6683085|NCT02684942|7615069|FG000|STARTED|Overall Study||7
6683086|NCT02684942|7615070|FG001|STARTED|Overall Study||7
6683087|NCT02684942|7615071|FG002|STARTED|Overall Study||7
6683088|NCT02684942|7615072|FG003|STARTED|Overall Study||7
6683089|NCT02684942|7615073|FG004|STARTED|Overall Study||6
6683090|NCT02684942|7615074|FG005|STARTED|Overall Study||6
6683091|NCT02684942|7615069|FG000|COMPLETED|Overall Study||7
6683092|NCT02684942|7615070|FG001|COMPLETED|Overall Study||7
6683093|NCT02684942|7615071|FG002|COMPLETED|Overall Study||7
6683094|NCT02684942|7615072|FG003|COMPLETED|Overall Study||7
6683095|NCT02684942|7615073|FG004|COMPLETED|Overall Study||6
6683096|NCT02684942|7615074|FG005|COMPLETED|Overall Study||6
6683097|NCT02684942|7615069|FG000|NOT COMPLETED|Overall Study||0
6683098|NCT02684942|7615070|FG001|NOT COMPLETED|Overall Study||0
6683099|NCT02684942|7615071|FG002|NOT COMPLETED|Overall Study||0
6683100|NCT02684942|7615072|FG003|NOT COMPLETED|Overall Study||0
6683101|NCT02684942|7615073|FG004|NOT COMPLETED|Overall Study||0
6683102|NCT02684942|7615074|FG005|NOT COMPLETED|Overall Study||0
6683103|NCT02684981|7615088|FG000|STARTED|Overall Study||4100
6683104|NCT02684981|7615089|FG001|STARTED|Overall Study||3179
6683105|NCT02684981|7615090|FG002|STARTED|Overall Study||2186
6683106|NCT02684981|7615088|FG000|COMPLETED|Overall Study||3860
6683107|NCT02684981|7615089|FG001|COMPLETED|Overall Study||2969
6683108|NCT02684981|7615090|FG002|COMPLETED|Overall Study||2059
6683109|NCT02684981|7615088|FG000|NOT COMPLETED|Overall Study||240
6683110|NCT02684981|7615089|FG001|NOT COMPLETED|Overall Study||210
6683111|NCT02684981|7615090|FG002|NOT COMPLETED|Overall Study||127
6683112|NCT02685007|7615104|FG000|STARTED|Overall Study||131
6683113|NCT02685007|7615104|FG000|COMPLETED|Overall Study||131
6683114|NCT02685007|7615104|FG000|NOT COMPLETED|Overall Study||0
6683115|NCT02685033|7615110|FG000|STARTED|Overall Study||70
6683116|NCT02685033|7615111|FG001|STARTED|Overall Study||10
6683117|NCT02685033|7615110|FG000|COMPLETED|Overall Study||67
6683118|NCT02685033|7615111|FG001|COMPLETED|Overall Study||8
6683119|NCT02685033|7615110|FG000|NOT COMPLETED|Overall Study||3
6683120|NCT02685033|7615111|FG001|NOT COMPLETED|Overall Study||2
6683121|NCT02685072|7615119|FG000|STARTED|Treatment Period||33
6683122|NCT02685072|7615120|FG001|STARTED|Treatment Period||31
6683123|NCT02685072|7615119|FG000|Completed Week 2 Visit|Treatment Period||23
6683124|NCT02685072|7615120|FG001|Completed Week 2 Visit|Treatment Period||26
6683125|NCT02685072|7615119|FG000|Completed Week 3 Visit|Treatment Period||20
6683126|NCT02685072|7615120|FG001|Completed Week 3 Visit|Treatment Period||23
6683127|NCT02685072|7615119|FG000|Completed Week 4 Visit|Treatment Period||19
6683128|NCT02685072|7615120|FG001|Completed Week 4 Visit|Treatment Period||23
6683129|NCT02685072|7615119|FG000|Completed Week 5 Visit|Treatment Period||19
6683130|NCT02685072|7615120|FG001|Completed Week 5 Visit|Treatment Period||22
6683131|NCT02685072|7615119|FG000|Completed Week 6 Visit|Treatment Period||18
6683132|NCT02685072|7615120|FG001|Completed Week 6 Visit|Treatment Period||19
6683133|NCT02685072|7615119|FG000|Completed Week 7 Visit|Treatment Period||17
6683134|NCT02685072|7615120|FG001|Completed Week 7 Visit|Treatment Period||18
6683135|NCT02685072|7615119|FG000|Completed Week 8 Visit|Treatment Period||20
6683136|NCT02685072|7615120|FG001|Completed Week 8 Visit|Treatment Period|Week 8 data were collected at the 1-month follow-up for 1 participant|22
6683137|NCT02685072|7615119|FG000|COMPLETED|Treatment Period||20
6683138|NCT02685072|7615120|FG001|COMPLETED|Treatment Period||22
6683139|NCT02685072|7615119|FG000|NOT COMPLETED|Treatment Period||13
6683140|NCT02685072|7615120|FG001|NOT COMPLETED|Treatment Period||9
6683141|NCT02685072|7615119|FG000|STARTED|1-Month Follow-Up||20
6683142|NCT02685072|7615120|FG001|STARTED|1-Month Follow-Up||22
6683143|NCT02685072|7615119|FG000|COMPLETED|1-Month Follow-Up||19
6683144|NCT02685072|7615120|FG001|COMPLETED|1-Month Follow-Up||22
6683145|NCT02685072|7615119|FG000|NOT COMPLETED|1-Month Follow-Up||1
6683146|NCT02685072|7615120|FG001|NOT COMPLETED|1-Month Follow-Up||0
6683147|NCT02685072|7615119|FG000|STARTED|3-Month Follow-Up||19
6683148|NCT02685072|7615120|FG001|STARTED|3-Month Follow-Up||22
6683149|NCT02685072|7615119|FG000|COMPLETED|3-Month Follow-Up||19
6683150|NCT02685072|7615120|FG001|COMPLETED|3-Month Follow-Up||22
6683151|NCT02685072|7615119|FG000|NOT COMPLETED|3-Month Follow-Up||0
6683152|NCT02685072|7615120|FG001|NOT COMPLETED|3-Month Follow-Up||0
6683153|NCT02685267|7615129|FG000|STARTED|Overall Study||5
6683154|NCT02685267|7615130|FG001|STARTED|Overall Study||4
6683155|NCT02685267|7615129|FG000|COMPLETED|Overall Study||5
6683156|NCT02685267|7615130|FG001|COMPLETED|Overall Study||4
6683157|NCT02685267|7615129|FG000|NOT COMPLETED|Overall Study||0
6683158|NCT02685267|7615130|FG001|NOT COMPLETED|Overall Study||0
6683159|NCT02685293|7615136|FG000|STARTED|Treatment Period 1||1
6683160|NCT02685293|7615137|FG001|STARTED|Treatment Period 1||3
6683161|NCT02685293|7615136|FG000|COMPLETED|Treatment Period 1||1
6683162|NCT02685293|7615137|FG001|COMPLETED|Treatment Period 1||3
6683163|NCT02685293|7615136|FG000|NOT COMPLETED|Treatment Period 1||0
6683164|NCT02685293|7615137|FG001|NOT COMPLETED|Treatment Period 1||0
6683165|NCT02685293|7615136|FG000|STARTED|Washout Period||1
6683166|NCT02685293|7615137|FG001|STARTED|Washout Period||3
6683167|NCT02685293|7615136|FG000|COMPLETED|Washout Period||1
6683168|NCT02685293|7615137|FG001|COMPLETED|Washout Period||3
6683169|NCT02685293|7615136|FG000|NOT COMPLETED|Washout Period||0
6683170|NCT02685293|7615137|FG001|NOT COMPLETED|Washout Period||0
6683171|NCT02685293|7615136|FG000|STARTED|Treatment Period 2||1
6683172|NCT02685293|7615137|FG001|STARTED|Treatment Period 2||3
6683173|NCT02685293|7615136|FG000|COMPLETED|Treatment Period 2||1
6683174|NCT02685293|7615137|FG001|COMPLETED|Treatment Period 2||3
6683175|NCT02685293|7615136|FG000|NOT COMPLETED|Treatment Period 2||0
6683176|NCT02685293|7615137|FG001|NOT COMPLETED|Treatment Period 2||0
6683177|NCT02685436|7615143|FG000|STARTED|Overall Study|the overall studied group|52
6683178|NCT02685436|7615143|FG000|COMPLETED|Overall Study|GERD positive patients by either combined MII-pH or esophageal biopsy|38
6683179|NCT02685436|7615143|FG000|NOT COMPLETED|Overall Study||14
6683180|NCT02685488|7615149|FG000|STARTED|Overall Study||12
6683181|NCT02685488|7615150|FG001|STARTED|Overall Study||14
6683182|NCT02685488|7615149|FG000|COMPLETED|Overall Study||12
6683183|NCT02685488|7615150|FG001|COMPLETED|Overall Study||13
6683184|NCT02685488|7615149|FG000|NOT COMPLETED|Overall Study||0
6683185|NCT02685488|7615150|FG001|NOT COMPLETED|Overall Study||1
6683186|NCT02685566|7615156|FG000|STARTED|First Reading Session||50
6683187|NCT02685566|7615157|FG001|STARTED|First Reading Session||50
6683188|NCT02685566|7615156|FG000|COMPLETED|First Reading Session||50
6683189|NCT02685566|7615157|FG001|COMPLETED|First Reading Session||50
6683190|NCT02685566|7615156|FG000|NOT COMPLETED|First Reading Session||0
6683191|NCT02685566|7615157|FG001|NOT COMPLETED|First Reading Session||0
6683192|NCT02685566|7615156|FG000|STARTED|4 Week Memory Washout Period||50
6683193|NCT02685566|7615157|FG001|STARTED|4 Week Memory Washout Period||50
6683194|NCT02685566|7615156|FG000|COMPLETED|4 Week Memory Washout Period||50
6683195|NCT02685566|7615157|FG001|COMPLETED|4 Week Memory Washout Period||50
6683196|NCT02685566|7615156|FG000|NOT COMPLETED|4 Week Memory Washout Period||0
6683197|NCT02685566|7615157|FG001|NOT COMPLETED|4 Week Memory Washout Period||0
6683198|NCT02685566|7615156|FG000|STARTED|Second Reading Session||50
6683199|NCT02685566|7615157|FG001|STARTED|Second Reading Session||50
6683200|NCT02685566|7615156|FG000|COMPLETED|Second Reading Session||50
6683201|NCT02685566|7615157|FG001|COMPLETED|Second Reading Session||50
6683202|NCT02685566|7615156|FG000|NOT COMPLETED|Second Reading Session||0
6683203|NCT02685566|7615157|FG001|NOT COMPLETED|Second Reading Session||0
6683204|NCT02685826|7615168|FG000|STARTED|Overall Study||25
6683205|NCT02685826|7615169|FG001|STARTED|Overall Study||10
6683206|NCT02685826|7615170|FG002|STARTED|Overall Study||21
6683207|NCT02685826|7615168|FG000|COMPLETED|Overall Study||0
6683208|NCT02685826|7615169|FG001|COMPLETED|Overall Study||0
6683209|NCT02685826|7615170|FG002|COMPLETED|Overall Study||0
6683210|NCT02685826|7615168|FG000|NOT COMPLETED|Overall Study||25
6683211|NCT02685826|7615169|FG001|NOT COMPLETED|Overall Study||10
6683212|NCT02685826|7615170|FG002|NOT COMPLETED|Overall Study||21
6683213|NCT02685956|7615180|FG000|STARTED|Overall Study||317
6683214|NCT02685956|7615181|FG001|STARTED|Overall Study||1978
6683215|NCT02685956|7615180|FG000|COMPLETED|Overall Study||317
6683216|NCT02685956|7615181|FG001|COMPLETED|Overall Study||1978
6683217|NCT02685956|7615180|FG000|NOT COMPLETED|Overall Study||0
6683218|NCT02685956|7615181|FG001|NOT COMPLETED|Overall Study||0
6683219|NCT02685995|7615191|FG000|STARTED|Overall Study||50
6683220|NCT02685995|7615192|FG001|STARTED|Overall Study||50
6683221|NCT02685995|7615191|FG000|COMPLETED|Overall Study||49
6683222|NCT02685995|7615192|FG001|COMPLETED|Overall Study||49
6683223|NCT02685995|7615191|FG000|NOT COMPLETED|Overall Study||1
6683224|NCT02685995|7615192|FG001|NOT COMPLETED|Overall Study||1
6683225|NCT02686034|7615200|FG000|STARTED|Run-In Period 1||142
6683226|NCT02686034|7615201|FG001|STARTED|Run-In Period 1||143
6683227|NCT02686034|7615200|FG000|COMPLETED|Run-In Period 1||122
6683228|NCT02686034|7615201|FG001|COMPLETED|Run-In Period 1||126
6683229|NCT02686034|7615200|FG000|NOT COMPLETED|Run-In Period 1||20
6683230|NCT02686034|7615201|FG001|NOT COMPLETED|Run-In Period 1||17
6683231|NCT02686034|7615200|FG000|STARTED|Randomized Controlled Period 2||122
6683232|NCT02686034|7615201|FG001|STARTED|Randomized Controlled Period 2||126
6683233|NCT02686034|7615200|FG000|COMPLETED|Randomized Controlled Period 2||117
6683234|NCT02686034|7615201|FG001|COMPLETED|Randomized Controlled Period 2||122
6683235|NCT02686034|7615200|FG000|NOT COMPLETED|Randomized Controlled Period 2||5
6683236|NCT02686034|7615201|FG001|NOT COMPLETED|Randomized Controlled Period 2||4
6683237|NCT02686034|7615200|FG000|STARTED|Open Label Period 3||117
6683238|NCT02686034|7615201|FG001|STARTED|Open Label Period 3||122
6683239|NCT02686034|7615200|FG000|COMPLETED|Open Label Period 3||117
6683240|NCT02686034|7615201|FG001|COMPLETED|Open Label Period 3||121
6683241|NCT02686034|7615200|FG000|NOT COMPLETED|Open Label Period 3||0
6683242|NCT02686034|7615201|FG001|NOT COMPLETED|Open Label Period 3||1
6683243|NCT02686138|7615209|FG000|STARTED|Overall Study||293
6683244|NCT02686138|7615210|FG001|STARTED|Overall Study||300
6683245|NCT02686138|7615209|FG000|COMPLETED|Overall Study||219
6683246|NCT02686138|7615210|FG001|COMPLETED|Overall Study||235
6683247|NCT02686138|7615209|FG000|NOT COMPLETED|Overall Study||74
6683248|NCT02686138|7615210|FG001|NOT COMPLETED|Overall Study||65
6683249|NCT02686164|7615216|FG000|STARTED|Overall Study||30
6683250|NCT02686164|7615216|FG000|COMPLETED|Overall Study||27
6683251|NCT02686164|7615216|FG000|NOT COMPLETED|Overall Study||3
6683252|NCT02686437|7615225|FG000|STARTED|Overall Study||16
6683253|NCT02686437|7615226|FG001|STARTED|Overall Study||20
6683254|NCT02686437|7615225|FG000|COMPLETED|Overall Study||13
6683255|NCT02686437|7615226|FG001|COMPLETED|Overall Study||12
6683256|NCT02686437|7615225|FG000|NOT COMPLETED|Overall Study||3
6683257|NCT02686437|7615226|FG001|NOT COMPLETED|Overall Study||8
6683258|NCT02687035|7615232|FG000|STARTED|Overall Study||1822
6683259|NCT02687035|7615232|FG000|COMPLETED|Overall Study||1638
6683260|NCT02687035|7615232|FG000|NOT COMPLETED|Overall Study||184
6683261|NCT02687126|7615236|FG000|STARTED|Data Collection||106
6683262|NCT02687126|7615236|FG000|COMPLETED|Data Collection||106
6683263|NCT02687126|7615236|FG000|NOT COMPLETED|Data Collection||0
6683264|NCT02687126|7615236|FG000|STARTED|Data Analysis||106
6683265|NCT02687126|7615236|FG000|COMPLETED|Data Analysis||106
6683266|NCT02687126|7615236|FG000|NOT COMPLETED|Data Analysis||0
6683267|NCT02687139|7615243|FG000|STARTED|Overall Study||34
6683268|NCT02687139|7615243|FG000|COMPLETED|Overall Study||34
6683269|NCT02687139|7615243|FG000|NOT COMPLETED|Overall Study||0
6683270|NCT02687191|7615253|FG000|STARTED|Overall Study||3
6683271|NCT02687191|7615254|FG001|STARTED|Overall Study||3
6683272|NCT02687191|7615255|FG002|STARTED|Overall Study||3
6683273|NCT02687191|7615256|FG003|STARTED|Overall Study||6
6683274|NCT02687191|7615257|FG004|STARTED|Overall Study||3
6683275|NCT02687191|7615258|FG005|STARTED|Overall Study||3
6683276|NCT02687191|7615253|FG000|COMPLETED|Overall Study||3
6683277|NCT02687191|7615254|FG001|COMPLETED|Overall Study||2
6683278|NCT02687191|7615255|FG002|COMPLETED|Overall Study||2
6683279|NCT02687191|7615256|FG003|COMPLETED|Overall Study||5
6683280|NCT02687191|7615257|FG004|COMPLETED|Overall Study||2
6683281|NCT02687191|7615258|FG005|COMPLETED|Overall Study||2
6683282|NCT02687191|7615253|FG000|NOT COMPLETED|Overall Study||0
6256660|NCT02273362|7155611|FG002|STARTED|Overall Study||14
6256661|NCT02273362|7155609|FG000|COMPLETED|Overall Study||5
6256662|NCT02273362|7155610|FG001|COMPLETED|Overall Study||6
6256663|NCT02273362|7155611|FG002|COMPLETED|Overall Study||14
6256664|NCT02273362|7155609|FG000|NOT COMPLETED|Overall Study||0
6256665|NCT02273362|7155610|FG001|NOT COMPLETED|Overall Study||0
6256666|NCT02273362|7155611|FG002|NOT COMPLETED|Overall Study||0
6256667|NCT02178358|7155622|FG000|STARTED|Overall Study||20
6256668|NCT02178358|7155623|FG001|STARTED|Overall Study||74
6256669|NCT02178358|7155624|FG002|STARTED|Overall Study||38
6256670|NCT02178358|7155622|FG000|Received at Least 1 Dose of Study Drug|Overall Study||20
6256671|NCT02178358|7155623|FG001|Received at Least 1 Dose of Study Drug|Overall Study||74
6256672|NCT02178358|7155624|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
6256673|NCT02178358|7155622|FG000|COMPLETED|Overall Study||19
6256674|NCT02178358|7155623|FG001|COMPLETED|Overall Study||72
6256675|NCT02178358|7155624|FG002|COMPLETED|Overall Study||36
6256676|NCT02178358|7155622|FG000|NOT COMPLETED|Overall Study||1
6256677|NCT02178358|7155623|FG001|NOT COMPLETED|Overall Study||2
6256678|NCT02178358|7155624|FG002|NOT COMPLETED|Overall Study||2
6256679|NCT02073279|7155635|FG000|STARTED|Double-blind Period||32
6256680|NCT02073279|7155636|FG001|STARTED|Double-blind Period||63
6256681|NCT02073279|7155635|FG000|COMPLETED|Double-blind Period||17
6256682|NCT02073279|7155636|FG001|COMPLETED|Double-blind Period||16
6256683|NCT02073279|7155635|FG000|NOT COMPLETED|Double-blind Period||15
6256684|NCT02073279|7155636|FG001|NOT COMPLETED|Double-blind Period||47
6256685|NCT02073279|7155635|FG000|STARTED|Open-label Extension Period||17
6256686|NCT02073279|7155636|FG001|STARTED|Open-label Extension Period||16
6256687|NCT02073279|7155635|FG000|COMPLETED|Open-label Extension Period||0
6256688|NCT02073279|7155636|FG001|COMPLETED|Open-label Extension Period||0
6256689|NCT02073279|7155635|FG000|NOT COMPLETED|Open-label Extension Period||17
6256690|NCT02073279|7155636|FG001|NOT COMPLETED|Open-label Extension Period||16
6256691|NCT01544127|7155648|FG000|STARTED|Overall Study||33
6256692|NCT01544127|7155649|FG001|STARTED|Overall Study||33
6256693|NCT01544127|7155650|FG002|STARTED|Overall Study||66
6683283|NCT02687191|7615254|FG001|NOT COMPLETED|Overall Study||1
6683284|NCT02687191|7615255|FG002|NOT COMPLETED|Overall Study||1
6683285|NCT02687191|7615256|FG003|NOT COMPLETED|Overall Study||1
6683286|NCT02687191|7615257|FG004|NOT COMPLETED|Overall Study||1
6256694|NCT01544127|7155648|FG000|COMPLETED|Overall Study||22
6256695|NCT01544127|7155649|FG001|COMPLETED|Overall Study||27
6683287|NCT02687191|7615258|FG005|NOT COMPLETED|Overall Study||1
6683288|NCT02687217|7615274|FG000|STARTED|Overall Study||30
6683289|NCT02687217|7615275|FG001|STARTED|Overall Study||30
6683290|NCT02687217|7615274|FG000|COMPLETED|Overall Study||30
6683291|NCT02687217|7615275|FG001|COMPLETED|Overall Study||30
6683292|NCT02687217|7615274|FG000|NOT COMPLETED|Overall Study||0
6683293|NCT02687217|7615275|FG001|NOT COMPLETED|Overall Study||0
6683294|NCT02687412|7615283|FG000|STARTED|Overall Study||50
6683295|NCT02687412|7615284|FG001|STARTED|Overall Study||57
6683296|NCT02687412|7615283|FG000|COMPLETED|Overall Study||50
6683297|NCT02687412|7615284|FG001|COMPLETED|Overall Study||57
6683298|NCT02687412|7615283|FG000|NOT COMPLETED|Overall Study||0
6683299|NCT02687412|7615284|FG001|NOT COMPLETED|Overall Study||0
6683300|NCT02687451|7615296|FG000|STARTED|Overall Study||6
6683301|NCT02687451|7615297|FG001|STARTED|Overall Study||5
6683302|NCT02687451|7615298|FG002|STARTED|Overall Study||5
6683303|NCT02687451|7615299|FG003|STARTED|Overall Study||5
6683304|NCT02687451|7615300|FG004|STARTED|Overall Study||4
6683305|NCT02687451|7615301|FG005|STARTED|Overall Study||3
6683306|NCT02687451|7615296|FG000|COMPLETED|Overall Study||5
6683307|NCT02687451|7615297|FG001|COMPLETED|Overall Study||5
6683308|NCT02687451|7615298|FG002|COMPLETED|Overall Study||5
6683309|NCT02687451|7615299|FG003|COMPLETED|Overall Study||5
6683310|NCT02687451|7615300|FG004|COMPLETED|Overall Study||4
6683311|NCT02687451|7615301|FG005|COMPLETED|Overall Study||2
6683312|NCT02687451|7615296|FG000|NOT COMPLETED|Overall Study||1
6683313|NCT02687451|7615297|FG001|NOT COMPLETED|Overall Study||0
6683314|NCT02687451|7615298|FG002|NOT COMPLETED|Overall Study||0
6683315|NCT02687451|7615299|FG003|NOT COMPLETED|Overall Study||0
6683316|NCT02687451|7615300|FG004|NOT COMPLETED|Overall Study||0
6256696|NCT01544127|7155650|FG002|COMPLETED|Overall Study||52
6256697|NCT01544127|7155648|FG000|NOT COMPLETED|Overall Study||11
6256698|NCT01544127|7155649|FG001|NOT COMPLETED|Overall Study||6
6256699|NCT01544127|7155650|FG002|NOT COMPLETED|Overall Study||14
6256700|NCT00806390|7155661|FG000|STARTED|Overall Study||7
6256701|NCT00806390|7155662|FG001|STARTED|Overall Study||8
6256702|NCT00806390|7155661|FG000|COMPLETED|Overall Study||7
6256703|NCT00806390|7155662|FG001|COMPLETED|Overall Study||8
6256704|NCT00806390|7155661|FG000|NOT COMPLETED|Overall Study||0
6256705|NCT00806390|7155662|FG001|NOT COMPLETED|Overall Study||0
6256706|NCT00566618|7155668|FG000|STARTED|Overall Study||1
6256707|NCT00566618|7155669|FG001|STARTED|Overall Study||6
6256708|NCT00566618|7155670|FG002|STARTED|Overall Study||18
6256709|NCT00566618|7155668|FG000|COMPLETED|Overall Study||0
6256710|NCT00566618|7155669|FG001|COMPLETED|Overall Study||0
6256711|NCT00566618|7155670|FG002|COMPLETED|Overall Study||0
6256712|NCT00566618|7155668|FG000|NOT COMPLETED|Overall Study||1
6256713|NCT00566618|7155669|FG001|NOT COMPLETED|Overall Study||6
6256714|NCT00566618|7155670|FG002|NOT COMPLETED|Overall Study||18
6256715|NCT00442559|7155677|FG000|STARTED|Overall Study||100
6256716|NCT00442559|7155678|FG001|STARTED|Overall Study||91
6256717|NCT00442559|7155677|FG000|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
6256718|NCT00442559|7155678|FG001|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
6256719|NCT00442559|7155677|FG000|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
6256720|NCT00442559|7155678|FG001|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
6256721|NCT00442559|7155677|FG000|NOT COMPLETED|Overall Study||34
6256722|NCT00442559|7155678|FG001|NOT COMPLETED|Overall Study||35
6256723|NCT00117338|7155692|FG000|STARTED|Overall Study||145
6256724|NCT00117338|7155693|FG001|STARTED|Overall Study||131
6256725|NCT00117338|7155692|FG000|COMPLETED|Overall Study||140
6256726|NCT00117338|7155693|FG001|COMPLETED|Overall Study||127
6256727|NCT00117338|7155692|FG000|NOT COMPLETED|Overall Study||5
6256728|NCT00117338|7155693|FG001|NOT COMPLETED|Overall Study||4
6279248|NCT00142597|7178965|FG001|NOT COMPLETED|Overall Study||1
6279249|NCT00142792|7178974|FG000|STARTED|Overall Study||39
6279250|NCT00142792|7178975|FG001|STARTED|Overall Study||41
6279251|NCT00142792|7178976|FG002|STARTED|Overall Study||42
6279252|NCT00142792|7178974|FG000|Completed Intervention|Overall Study||35
6279253|NCT00142792|7178975|FG001|Completed Intervention|Overall Study||37
6279254|NCT00142792|7178976|FG002|Completed Intervention|Overall Study||37
6279255|NCT00142792|7178974|FG000|COMPLETED|Overall Study||27
6279256|NCT00142792|7178975|FG001|COMPLETED|Overall Study||26
6279257|NCT00142792|7178976|FG002|COMPLETED|Overall Study||30
6279258|NCT00142792|7178974|FG000|NOT COMPLETED|Overall Study||12
6279259|NCT00142792|7178975|FG001|NOT COMPLETED|Overall Study||15
6279260|NCT00142792|7178976|FG002|NOT COMPLETED|Overall Study||12
6279261|NCT00142818|7178988|FG000|STARTED|Overall Study||45
6279262|NCT00142818|7178989|FG001|STARTED|Overall Study||40
6279263|NCT00142818|7178990|FG002|STARTED|Overall Study||37
6279264|NCT00142818|7178991|FG003|STARTED|Overall Study||42
6279265|NCT00142818|7178988|FG000|COMPLETED|Overall Study||28
6279266|NCT00142818|7178989|FG001|COMPLETED|Overall Study||19
6279267|NCT00142818|7178990|FG002|COMPLETED|Overall Study||24
6279268|NCT00142818|7178991|FG003|COMPLETED|Overall Study||20
6279269|NCT00142818|7178988|FG000|NOT COMPLETED|Overall Study||17
6279270|NCT00142818|7178989|FG001|NOT COMPLETED|Overall Study||21
6279271|NCT00142818|7178990|FG002|NOT COMPLETED|Overall Study||13
6279272|NCT00142818|7178991|FG003|NOT COMPLETED|Overall Study||22
6279273|NCT00142909|7179007|FG000|STARTED|Randomization||42
6279274|NCT00142909|7179008|FG001|STARTED|Randomization||44
6279275|NCT00142909|7179007|FG000|COMPLETED|Randomization||35
6279276|NCT00142909|7179008|FG001|COMPLETED|Randomization||34
6279277|NCT00142909|7179007|FG000|NOT COMPLETED|Randomization||7
6683317|NCT02687451|7615301|FG005|NOT COMPLETED|Overall Study||1
6683318|NCT02687529|7615319|FG000|STARTED|Overall Study||34
6683319|NCT02687529|7615320|FG001|STARTED|Overall Study||32
6683320|NCT02687529|7615319|FG000|COMPLETED|Overall Study||34
6683321|NCT02687529|7615320|FG001|COMPLETED|Overall Study||32
6683322|NCT02687529|7615319|FG000|NOT COMPLETED|Overall Study||0
6683323|NCT02687529|7615320|FG001|NOT COMPLETED|Overall Study||0
6683324|NCT02687542|7615331|FG000|STARTED|Overall Study||23
6683325|NCT02687542|7615332|FG001|STARTED|Overall Study||13
6683326|NCT02687542|7615333|FG002|STARTED|Overall Study||15
6683327|NCT02687542|7615334|FG003|STARTED|Overall Study||13
6683328|NCT02687542|7615335|FG004|STARTED|Overall Study||44
6683329|NCT02687542|7615331|FG000|COMPLETED|Overall Study||15
6683330|NCT02687542|7615332|FG001|COMPLETED|Overall Study||1
6683331|NCT02687542|7615333|FG002|COMPLETED|Overall Study||1
6683332|NCT02687542|7615334|FG003|COMPLETED|Overall Study||3
6683333|NCT02687542|7615335|FG004|COMPLETED|Overall Study||24
6683334|NCT02687542|7615331|FG000|NOT COMPLETED|Overall Study||8
6683335|NCT02687542|7615332|FG001|NOT COMPLETED|Overall Study||12
6683336|NCT02687542|7615333|FG002|NOT COMPLETED|Overall Study||14
6683337|NCT02687542|7615334|FG003|NOT COMPLETED|Overall Study||10
6683338|NCT02687542|7615335|FG004|NOT COMPLETED|Overall Study||20
6683339|NCT02687711|7615347|FG000|STARTED|Overall Study||544
6683340|NCT02687711|7615347|FG000|COMPLETED|Overall Study||332
6683341|NCT02687711|7615347|FG000|NOT COMPLETED|Overall Study||212
6683342|NCT02687815|7615353|FG000|STARTED|Overall Study||96
6683343|NCT02687815|7615354|FG001|STARTED|Overall Study||96
6683344|NCT02687815|7615353|FG000|COMPLETED|Overall Study||92
6683345|NCT02687815|7615354|FG001|COMPLETED|Overall Study||88
6683346|NCT02687815|7615353|FG000|NOT COMPLETED|Overall Study||4
6683347|NCT02687815|7615354|FG001|NOT COMPLETED|Overall Study||8
6683348|NCT02687919|7615362|FG000|STARTED|Overall Study||16
6683349|NCT02687919|7615363|FG001|STARTED|Overall Study||15
6256729|NCT04851314|7155701|FG000|STARTED|Overall Study||55
6256730|NCT04851314|7155702|FG001|STARTED|Overall Study||55
6256731|NCT04851314|7155701|FG000|COMPLETED|Overall Study||52
6256732|NCT04851314|7155702|FG001|COMPLETED|Overall Study||51
6256733|NCT04851314|7155701|FG000|NOT COMPLETED|Overall Study||3
6256734|NCT04851314|7155702|FG001|NOT COMPLETED|Overall Study||4
6256735|NCT04845633|7155712|FG000|STARTED|Overall Study||12
6256736|NCT04845633|7155713|FG001|STARTED|Overall Study||12
6256737|NCT04845633|7155714|FG002|STARTED|Overall Study||12
6256738|NCT04845633|7155715|FG003|STARTED|Overall Study||12
6256739|NCT04845633|7155712|FG000|COMPLETED|Overall Study||12
6256740|NCT04845633|7155713|FG001|COMPLETED|Overall Study||12
6256741|NCT04845633|7155714|FG002|COMPLETED|Overall Study||12
6256742|NCT04845633|7155715|FG003|COMPLETED|Overall Study||12
6256743|NCT04845633|7155712|FG000|NOT COMPLETED|Overall Study||0
6256744|NCT04845633|7155713|FG001|NOT COMPLETED|Overall Study||0
6256745|NCT04845633|7155714|FG002|NOT COMPLETED|Overall Study||0
6256746|NCT04845633|7155715|FG003|NOT COMPLETED|Overall Study||0
6256747|NCT04821245|7155727|FG000|STARTED|Overall Study||36
6256748|NCT04821245|7155727|FG000|COMPLETED|Overall Study||27
6256749|NCT04821245|7155727|FG000|NOT COMPLETED|Overall Study||9
6256750|NCT04814459|7155735|FG000|STARTED|Overall Study||72
6256751|NCT04814459|7155736|FG001|STARTED|Overall Study||72
6256752|NCT04814459|7155735|FG000|COMPLETED|Overall Study||72
6256753|NCT04814459|7155736|FG001|COMPLETED|Overall Study||72
6256754|NCT04814459|7155735|FG000|NOT COMPLETED|Overall Study||0
6256755|NCT04814459|7155736|FG001|NOT COMPLETED|Overall Study||0
6256756|NCT04799782|7155742|FG000|STARTED|First Intervention||8
6256757|NCT04799782|7155743|FG001|STARTED|First Intervention||7
6256758|NCT04799782|7155742|FG000|COMPLETED|First Intervention||8
6256759|NCT04799782|7155743|FG001|COMPLETED|First Intervention||7
6256760|NCT04799782|7155742|FG000|NOT COMPLETED|First Intervention||0
6256761|NCT04799782|7155743|FG001|NOT COMPLETED|First Intervention||0
6256762|NCT04799782|7155742|FG000|STARTED|Washout||8
6256763|NCT04799782|7155743|FG001|STARTED|Washout||7
6256764|NCT04799782|7155742|FG000|COMPLETED|Washout||6
6256765|NCT04799782|7155743|FG001|COMPLETED|Washout||4
6256766|NCT04799782|7155742|FG000|NOT COMPLETED|Washout||2
6256767|NCT04799782|7155743|FG001|NOT COMPLETED|Washout||3
6256768|NCT04799782|7155742|FG000|STARTED|Second Intervention||6
6256769|NCT04799782|7155743|FG001|STARTED|Second Intervention||4
6256770|NCT04799782|7155742|FG000|COMPLETED|Second Intervention||6
6256771|NCT04799782|7155743|FG001|COMPLETED|Second Intervention||4
6256772|NCT04799782|7155742|FG000|NOT COMPLETED|Second Intervention||0
6256773|NCT04799782|7155743|FG001|NOT COMPLETED|Second Intervention||0
6256774|NCT04780919|7155751|FG000|STARTED|Overall Study||9
6256775|NCT04780919|7155752|FG001|STARTED|Overall Study||9
6256776|NCT04780919|7155751|FG000|COMPLETED|Overall Study||9
6256777|NCT04780919|7155752|FG001|COMPLETED|Overall Study||9
6256778|NCT04780919|7155751|FG000|NOT COMPLETED|Overall Study||0
6256779|NCT04780919|7155752|FG001|NOT COMPLETED|Overall Study||0
6256792|NCT04773028|7155771|FG000|STARTED|Overall Study||24
6256793|NCT04773028|7155772|FG001|STARTED|Overall Study||24
6256794|NCT04773028|7155771|FG000|COMPLETED|Overall Study||24
6683350|NCT02687919|7615362|FG000|COMPLETED|Overall Study||8
6683351|NCT02687919|7615363|FG001|COMPLETED|Overall Study||9
6683352|NCT02687919|7615362|FG000|NOT COMPLETED|Overall Study||8
6683353|NCT02687919|7615363|FG001|NOT COMPLETED|Overall Study||6
6683354|NCT02688153|7615371|FG000|STARTED|Overall Study||62
6683355|NCT02688153|7615372|FG001|STARTED|Overall Study||58
6256795|NCT04773028|7155772|FG001|COMPLETED|Overall Study||24
6256796|NCT04773028|7155771|FG000|NOT COMPLETED|Overall Study||0
6683356|NCT02688153|7615371|FG000|Final Randomized Arm/Group|Overall Study||59
6683357|NCT02688153|7615372|FG001|Final Randomized Arm/Group|Overall Study||61
6683358|NCT02688153|7615371|FG000|COMPLETED|Overall Study||47
6683359|NCT02688153|7615372|FG001|COMPLETED|Overall Study||51
6683360|NCT02688153|7615371|FG000|NOT COMPLETED|Overall Study||15
6683361|NCT02688153|7615372|FG001|NOT COMPLETED|Overall Study||7
6683362|NCT02688192|7615381|FG000|STARTED|Overall Study||25
6683363|NCT02688192|7615382|FG001|STARTED|Overall Study||24
6683364|NCT02688192|7615381|FG000|COMPLETED|Overall Study||13
6683365|NCT02688192|7615382|FG001|COMPLETED|Overall Study||19
6683366|NCT02688192|7615381|FG000|NOT COMPLETED|Overall Study||12
6683367|NCT02688192|7615382|FG001|NOT COMPLETED|Overall Study||5
6683368|NCT02688218|7615391|FG000|STARTED|First Exercise Intervention (2 Hours)||24
6683369|NCT02688218|7615392|FG001|STARTED|First Exercise Intervention (2 Hours)||6
6683370|NCT02688218|7615391|FG000|COMPLETED|First Exercise Intervention (2 Hours)||24
6683371|NCT02688218|7615392|FG001|COMPLETED|First Exercise Intervention (2 Hours)||6
6683372|NCT02688218|7615391|FG000|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
6683373|NCT02688218|7615392|FG001|NOT COMPLETED|First Exercise Intervention (2 Hours)||0
6683374|NCT02688218|7615391|FG000|STARTED|Washout (30 Minutes)||24
6683375|NCT02688218|7615392|FG001|STARTED|Washout (30 Minutes)||6
6683376|NCT02688218|7615391|FG000|COMPLETED|Washout (30 Minutes)||24
6683377|NCT02688218|7615392|FG001|COMPLETED|Washout (30 Minutes)||6
6683378|NCT02688218|7615391|FG000|NOT COMPLETED|Washout (30 Minutes)||0
6683379|NCT02688218|7615392|FG001|NOT COMPLETED|Washout (30 Minutes)||0
6683380|NCT02688218|7615391|FG000|STARTED|Second Exercise Intervention (2 Hours)||24
6683381|NCT02688218|7615392|FG001|STARTED|Second Exercise Intervention (2 Hours)||6
6256780|NCT04779606|7155762|FG000|STARTED|First Phase: Tolerability and Safety||16
6256781|NCT04779606|7155763|FG001|STARTED|First Phase: Tolerability and Safety||4
6256782|NCT04779606|7155762|FG000|COMPLETED|First Phase: Tolerability and Safety||16
6256783|NCT04779606|7155763|FG001|COMPLETED|First Phase: Tolerability and Safety||4
6256784|NCT04779606|7155762|FG000|NOT COMPLETED|First Phase: Tolerability and Safety||0
6256785|NCT04779606|7155763|FG001|NOT COMPLETED|First Phase: Tolerability and Safety||0
6256786|NCT04779606|7155762|FG000|STARTED|Second Phase: Efficacy||68
6256787|NCT04779606|7155763|FG001|STARTED|Second Phase: Efficacy||17
6256788|NCT04779606|7155762|FG000|COMPLETED|Second Phase: Efficacy||68
6256789|NCT04779606|7155763|FG001|COMPLETED|Second Phase: Efficacy||17
6256790|NCT04779606|7155762|FG000|NOT COMPLETED|Second Phase: Efficacy||0
6256791|NCT04779606|7155763|FG001|NOT COMPLETED|Second Phase: Efficacy||0
6256797|NCT04773028|7155772|FG001|NOT COMPLETED|Overall Study||0
6279278|NCT00142909|7179008|FG001|NOT COMPLETED|Randomization||10
6279279|NCT00142909|7179007|FG000|STARTED|Medications Begin||35
6279280|NCT00142909|7179008|FG001|STARTED|Medications Begin||34
6279281|NCT00142909|7179007|FG000|COMPLETED|Medications Begin||26
6279282|NCT00142909|7179008|FG001|COMPLETED|Medications Begin||31
6279283|NCT00142909|7179007|FG000|NOT COMPLETED|Medications Begin||9
6279284|NCT00142909|7179008|FG001|NOT COMPLETED|Medications Begin||3
6279285|NCT00142935|7179017|FG000|STARTED|Overall Study||29
6279286|NCT00142935|7179018|FG001|STARTED|Overall Study||28
6279287|NCT00142935|7179019|FG002|STARTED|Overall Study||30
6279288|NCT00142935|7179017|FG000|COMPLETED|Overall Study||26
6279289|NCT00142935|7179018|FG001|COMPLETED|Overall Study||20
6279290|NCT00142935|7179019|FG002|COMPLETED|Overall Study||23
6279291|NCT00142935|7179017|FG000|NOT COMPLETED|Overall Study||3
6279292|NCT00142935|7179018|FG001|NOT COMPLETED|Overall Study||8
6279293|NCT00142935|7179019|FG002|NOT COMPLETED|Overall Study||7
6279294|NCT00143247|7179031|FG000|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
6279295|NCT00143247|7179031|FG000|COMPLETED|Overall Study||17
6279296|NCT00143247|7179031|FG000|NOT COMPLETED|Overall Study||156
6279297|NCT00143312|7179035|FG000|STARTED|Overall Study||45
6279298|NCT00143312|7179035|FG000|COMPLETED|Overall Study||29
6279299|NCT00143312|7179035|FG000|NOT COMPLETED|Overall Study||16
6279300|NCT00143390|7179041|FG000|STARTED|Overall Study||149
6279301|NCT00143390|7179042|FG001|STARTED|Overall Study||149
6279302|NCT00143390|7179041|FG000|COMPLETED|Overall Study||0
6279303|NCT00143390|7179042|FG001|COMPLETED|Overall Study||0
6279304|NCT00143390|7179041|FG000|NOT COMPLETED|Overall Study||149
6279305|NCT00143390|7179042|FG001|NOT COMPLETED|Overall Study||149
6279306|NCT00143403|7179050|FG000|STARTED|Overall Study||160
6279307|NCT00143403|7179051|FG001|STARTED|Overall Study||161
6279308|NCT00143403|7179050|FG000|Treated|Overall Study||153
6279309|NCT00143403|7179051|FG001|Treated|Overall Study||153
6279310|NCT00143403|7179050|FG000|COMPLETED|Overall Study|Received maximum number of cycles.|125
6279311|NCT00143403|7179051|FG001|COMPLETED|Overall Study|Received maximum number of cycles.|115
6279312|NCT00143403|7179050|FG000|NOT COMPLETED|Overall Study||35
6279313|NCT00143403|7179051|FG001|NOT COMPLETED|Overall Study||46
6279314|NCT00143455|7179061|FG000|STARTED|Cohort 1||39
6279315|NCT00143455|7179062|FG001|STARTED|Cohort 1||39
6279316|NCT00143455|7179063|FG002|STARTED|Cohort 1||0
6279317|NCT00143455|7179064|FG003|STARTED|Cohort 1||0
6279318|NCT00143455|7179061|FG000|Received Treatment|Cohort 1||39
6279319|NCT00143455|7179062|FG001|Received Treatment|Cohort 1||38
6279320|NCT00143455|7179063|FG002|Received Treatment|Cohort 1||0
6279321|NCT00143455|7179064|FG003|Received Treatment|Cohort 1||0
6279322|NCT00143455|7179061|FG000|COMPLETED|Cohort 1||25
6279323|NCT00143455|7179062|FG001|COMPLETED|Cohort 1||22
6683382|NCT02688218|7615391|FG000|COMPLETED|Second Exercise Intervention (2 Hours)||24
6683383|NCT02688218|7615392|FG001|COMPLETED|Second Exercise Intervention (2 Hours)||6
6683384|NCT02688218|7615391|FG000|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
6683385|NCT02688218|7615392|FG001|NOT COMPLETED|Second Exercise Intervention (2 Hours)||0
6683386|NCT02688387|7615402|FG000|STARTED|Part 1, Period 1 (up to 6 Days)||3
6683387|NCT02688387|7615403|FG001|STARTED|Part 1, Period 1 (up to 6 Days)||3
6683388|NCT02688387|7615404|FG002|STARTED|Part 1, Period 1 (up to 6 Days)||4
6683389|NCT02688387|7615405|FG003|STARTED|Part 1, Period 1 (up to 6 Days)||3
6683390|NCT02688387|7615406|FG004|STARTED|Part 1, Period 1 (up to 6 Days)||3
6683391|NCT02688387|7615407|FG005|STARTED|Part 1, Period 1 (up to 6 Days)||2
6683392|NCT02688387|7615408|FG006|STARTED|Part 1, Period 1 (up to 6 Days)||2
6683393|NCT02688387|7615409|FG007|STARTED|Part 1, Period 1 (up to 6 Days)||2
6683394|NCT02688387|7615410|FG008|STARTED|Part 1, Period 1 (up to 6 Days)||2
6683395|NCT02688387|7615411|FG009|STARTED|Part 1, Period 1 (up to 6 Days)||2
6683396|NCT02688387|7615412|FG010|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683397|NCT02688387|7615413|FG011|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683398|NCT02688387|7615414|FG012|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683399|NCT02688387|7615415|FG013|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683400|NCT02688387|7615416|FG014|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683401|NCT02688387|7615417|FG015|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683402|NCT02688387|7615418|FG016|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683403|NCT02688387|7615419|FG017|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683404|NCT02688387|7615420|FG018|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683405|NCT02688387|7615421|FG019|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683406|NCT02688387|7615422|FG020|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683407|NCT02688387|7615423|FG021|STARTED|Part 1, Period 1 (up to 6 Days)||0
6683408|NCT02688387|7615402|FG000|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
6683409|NCT02688387|7615403|FG001|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
6683410|NCT02688387|7615404|FG002|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
6683411|NCT02688387|7615405|FG003|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6683412|NCT02688387|7615406|FG004|COMPLETED|Part 1, Period 1 (up to 6 Days)||3
6683413|NCT02688387|7615407|FG005|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6683414|NCT02688387|7615408|FG006|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6683415|NCT02688387|7615409|FG007|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6683416|NCT02688387|7615410|FG008|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6683417|NCT02688387|7615411|FG009|COMPLETED|Part 1, Period 1 (up to 6 Days)||2
6683418|NCT02688387|7615412|FG010|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683419|NCT02688387|7615413|FG011|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683420|NCT02688387|7615414|FG012|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683421|NCT02688387|7615415|FG013|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683422|NCT02688387|7615416|FG014|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683423|NCT02688387|7615417|FG015|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683424|NCT02688387|7615418|FG016|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683425|NCT02688387|7615419|FG017|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683426|NCT02688387|7615420|FG018|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683427|NCT02688387|7615421|FG019|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683428|NCT02688387|7615422|FG020|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683429|NCT02688387|7615423|FG021|COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683430|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683431|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683432|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
6683433|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||1
6683434|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683435|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683436|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683437|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683438|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683439|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683440|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683441|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683442|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683443|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683444|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683445|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683446|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683447|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683448|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683449|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683450|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683451|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Period 1 (up to 6 Days)||0
6683452|NCT02688387|7615402|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||3
6683453|NCT02688387|7615403|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||3
6683454|NCT02688387|7615404|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||3
6683455|NCT02688387|7615405|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||2
6683456|NCT02688387|7615406|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||3
6683457|NCT02688387|7615407|FG005|STARTED|Part 1, Washout Period 1 (7 Days)||2
6683458|NCT02688387|7615408|FG006|STARTED|Part 1, Washout Period 1 (7 Days)||2
6683459|NCT02688387|7615409|FG007|STARTED|Part 1, Washout Period 1 (7 Days)||2
6683460|NCT02688387|7615410|FG008|STARTED|Part 1, Washout Period 1 (7 Days)||2
6683461|NCT02688387|7615411|FG009|STARTED|Part 1, Washout Period 1 (7 Days)||2
6683462|NCT02688387|7615412|FG010|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683463|NCT02688387|7615413|FG011|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683464|NCT02688387|7615414|FG012|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683465|NCT02688387|7615415|FG013|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683466|NCT02688387|7615416|FG014|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683467|NCT02688387|7615417|FG015|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683468|NCT02688387|7615418|FG016|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683469|NCT02688387|7615419|FG017|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683470|NCT02688387|7615420|FG018|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683471|NCT02688387|7615421|FG019|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683472|NCT02688387|7615422|FG020|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683473|NCT02688387|7615423|FG021|STARTED|Part 1, Washout Period 1 (7 Days)||0
6683474|NCT02688387|7615402|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
6683475|NCT02688387|7615403|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6683476|NCT02688387|7615404|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
6683477|NCT02688387|7615405|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6683478|NCT02688387|7615406|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||3
6683479|NCT02688387|7615407|FG005|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6683480|NCT02688387|7615408|FG006|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6683481|NCT02688387|7615409|FG007|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6683482|NCT02688387|7615410|FG008|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6683483|NCT02688387|7615411|FG009|COMPLETED|Part 1, Washout Period 1 (7 Days)||2
6683484|NCT02688387|7615412|FG010|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683485|NCT02688387|7615413|FG011|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683486|NCT02688387|7615414|FG012|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683487|NCT02688387|7615415|FG013|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683488|NCT02688387|7615416|FG014|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683489|NCT02688387|7615417|FG015|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683490|NCT02688387|7615418|FG016|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683491|NCT02688387|7615419|FG017|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683492|NCT02688387|7615420|FG018|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683493|NCT02688387|7615421|FG019|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683494|NCT02688387|7615422|FG020|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683495|NCT02688387|7615423|FG021|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683496|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683497|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||1
6683498|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683499|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683500|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683501|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683502|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683503|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683504|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683505|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683506|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683507|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683508|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683509|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683510|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683511|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683512|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683513|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683514|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683515|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683516|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683517|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6683518|NCT02688387|7615402|FG000|STARTED|Part 1, Period 2 (up to 6 Days)||3
6683519|NCT02688387|7615403|FG001|STARTED|Part 1, Period 2 (up to 6 Days)||2
6683520|NCT02688387|7615404|FG002|STARTED|Part 1, Period 2 (up to 6 Days)||3
6683521|NCT02688387|7615405|FG003|STARTED|Part 1, Period 2 (up to 6 Days)||2
6683522|NCT02688387|7615406|FG004|STARTED|Part 1, Period 2 (up to 6 Days)||3
6683523|NCT02688387|7615407|FG005|STARTED|Part 1, Period 2 (up to 6 Days)||2
6683524|NCT02688387|7615408|FG006|STARTED|Part 1, Period 2 (up to 6 Days)||2
6683525|NCT02688387|7615409|FG007|STARTED|Part 1, Period 2 (up to 6 Days)||2
6683526|NCT02688387|7615410|FG008|STARTED|Part 1, Period 2 (up to 6 Days)||2
6683527|NCT02688387|7615411|FG009|STARTED|Part 1, Period 2 (up to 6 Days)||2
6683528|NCT02688387|7615412|FG010|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683529|NCT02688387|7615413|FG011|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683530|NCT02688387|7615414|FG012|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683531|NCT02688387|7615415|FG013|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683532|NCT02688387|7615416|FG014|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683533|NCT02688387|7615417|FG015|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683534|NCT02688387|7615418|FG016|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683535|NCT02688387|7615419|FG017|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683536|NCT02688387|7615420|FG018|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683537|NCT02688387|7615421|FG019|STARTED|Part 1, Period 2 (up to 6 Days)||0
6256798|NCT04755595|7155778|FG000|STARTED|Overall Study||20
6683538|NCT02688387|7615422|FG020|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683539|NCT02688387|7615423|FG021|STARTED|Part 1, Period 2 (up to 6 Days)||0
6683540|NCT02688387|7615402|FG000|COMPLETED|Part 1, Period 2 (up to 6 Days)||3
6683541|NCT02688387|7615403|FG001|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683542|NCT02688387|7615404|FG002|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683543|NCT02688387|7615405|FG003|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683544|NCT02688387|7615406|FG004|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683545|NCT02688387|7615407|FG005|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683546|NCT02688387|7615408|FG006|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683547|NCT02688387|7615409|FG007|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683548|NCT02688387|7615410|FG008|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683549|NCT02688387|7615411|FG009|COMPLETED|Part 1, Period 2 (up to 6 Days)||2
6683550|NCT02688387|7615412|FG010|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683551|NCT02688387|7615413|FG011|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683552|NCT02688387|7615414|FG012|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683553|NCT02688387|7615415|FG013|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683554|NCT02688387|7615416|FG014|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683555|NCT02688387|7615417|FG015|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683556|NCT02688387|7615418|FG016|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683557|NCT02688387|7615419|FG017|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683558|NCT02688387|7615420|FG018|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683559|NCT02688387|7615421|FG019|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683560|NCT02688387|7615422|FG020|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683561|NCT02688387|7615423|FG021|COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683562|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683563|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683564|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
6683565|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683566|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||1
6683567|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683568|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683569|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683570|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683571|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683572|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683573|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683574|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683575|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683576|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683577|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683578|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683579|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683580|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683581|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683582|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683583|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Period 2 (up to 6 Days)||0
6683584|NCT02688387|7615402|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||3
6683585|NCT02688387|7615403|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683586|NCT02688387|7615404|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683587|NCT02688387|7615405|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683588|NCT02688387|7615406|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683589|NCT02688387|7615407|FG005|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683590|NCT02688387|7615408|FG006|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683591|NCT02688387|7615409|FG007|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683592|NCT02688387|7615410|FG008|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683593|NCT02688387|7615411|FG009|STARTED|Part 1, Washout Period 2 (7 Days)||2
6683594|NCT02688387|7615412|FG010|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683595|NCT02688387|7615413|FG011|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683596|NCT02688387|7615414|FG012|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683597|NCT02688387|7615415|FG013|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683598|NCT02688387|7615416|FG014|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683599|NCT02688387|7615417|FG015|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683600|NCT02688387|7615418|FG016|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683601|NCT02688387|7615419|FG017|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683602|NCT02688387|7615420|FG018|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683603|NCT02688387|7615421|FG019|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683604|NCT02688387|7615422|FG020|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683605|NCT02688387|7615423|FG021|STARTED|Part 1, Washout Period 2 (7 Days)||0
6683606|NCT02688387|7615402|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||3
6683607|NCT02688387|7615403|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683608|NCT02688387|7615404|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683609|NCT02688387|7615405|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683610|NCT02688387|7615406|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683611|NCT02688387|7615407|FG005|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683612|NCT02688387|7615408|FG006|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683613|NCT02688387|7615409|FG007|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683614|NCT02688387|7615410|FG008|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683615|NCT02688387|7615411|FG009|COMPLETED|Part 1, Washout Period 2 (7 Days)||2
6683616|NCT02688387|7615412|FG010|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683617|NCT02688387|7615413|FG011|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683618|NCT02688387|7615414|FG012|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683619|NCT02688387|7615415|FG013|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683620|NCT02688387|7615416|FG014|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683621|NCT02688387|7615417|FG015|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683622|NCT02688387|7615418|FG016|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683623|NCT02688387|7615419|FG017|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683624|NCT02688387|7615420|FG018|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683625|NCT02688387|7615421|FG019|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683626|NCT02688387|7615422|FG020|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683627|NCT02688387|7615423|FG021|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683628|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683629|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683630|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683631|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683632|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683633|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683634|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683635|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683636|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683637|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683638|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683639|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683640|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6256799|NCT04755595|7155778|FG000|COMPLETED|Overall Study||19
6256800|NCT04755595|7155778|FG000|NOT COMPLETED|Overall Study||1
6279324|NCT00143455|7179063|FG002|COMPLETED|Cohort 1||0
6279325|NCT00143455|7179064|FG003|COMPLETED|Cohort 1||0
6279326|NCT00143455|7179061|FG000|NOT COMPLETED|Cohort 1||14
6279327|NCT00143455|7179062|FG001|NOT COMPLETED|Cohort 1||17
6279328|NCT00143455|7179063|FG002|NOT COMPLETED|Cohort 1||0
6279329|NCT00143455|7179064|FG003|NOT COMPLETED|Cohort 1||0
6279330|NCT00143455|7179061|FG000|STARTED|Cohort 2||0
6279331|NCT00143455|7179062|FG001|STARTED|Cohort 2||0
6279332|NCT00143455|7179063|FG002|STARTED|Cohort 2||203
6279333|NCT00143455|7179064|FG003|STARTED|Cohort 2||204
6279334|NCT00143455|7179061|FG000|Received Treatment|Cohort 2||0
6279335|NCT00143455|7179062|FG001|Received Treatment|Cohort 2||0
6279336|NCT00143455|7179063|FG002|Received Treatment|Cohort 2||202
6279337|NCT00143455|7179064|FG003|Received Treatment|Cohort 2||203
6279338|NCT00143455|7179061|FG000|COMPLETED|Cohort 2||0
6279339|NCT00143455|7179062|FG001|COMPLETED|Cohort 2||0
6279340|NCT00143455|7179063|FG002|COMPLETED|Cohort 2||97
6279341|NCT00143455|7179064|FG003|COMPLETED|Cohort 2||111
6279342|NCT00143455|7179061|FG000|NOT COMPLETED|Cohort 2||0
6279343|NCT00143455|7179062|FG001|NOT COMPLETED|Cohort 2||0
6279344|NCT00143455|7179063|FG002|NOT COMPLETED|Cohort 2||106
6279345|NCT00143455|7179064|FG003|NOT COMPLETED|Cohort 2||93
6683641|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683642|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683643|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683644|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6279346|NCT00143507|7179078|FG000|STARTED|Overall Study||5479
6279347|NCT00143507|7179079|FG001|STARTED|Overall Study||5438
6279348|NCT00143507|7179078|FG000|COMPLETED|Overall Study||4792
6279349|NCT00143507|7179079|FG001|COMPLETED|Overall Study||4786
6279350|NCT00143507|7179078|FG000|NOT COMPLETED|Overall Study||687
6279351|NCT00143507|7179079|FG001|NOT COMPLETED|Overall Study||652
6279352|NCT00143598|7179087|FG000|STARTED|Overall Study||410
6279353|NCT00143598|7179088|FG001|STARTED|Overall Study||396
6279354|NCT00143598|7179087|FG000|COMPLETED|Overall Study||318
6279355|NCT00143598|7179088|FG001|COMPLETED|Overall Study||302
6279356|NCT00143598|7179087|FG000|NOT COMPLETED|Overall Study||92
6279357|NCT00143598|7179088|FG001|NOT COMPLETED|Overall Study||94
6279358|NCT00143819|7179096|FG000|STARTED|Overall Study||5
6279359|NCT00143819|7179097|FG001|STARTED|Overall Study||8
6279360|NCT00143819|7179096|FG000|COMPLETED|Overall Study||3
6279361|NCT00143819|7179097|FG001|COMPLETED|Overall Study||5
6279362|NCT00143819|7179096|FG000|NOT COMPLETED|Overall Study||2
6279363|NCT00143819|7179097|FG001|NOT COMPLETED|Overall Study||3
6279364|NCT00143845|7179107|FG000|STARTED|Overall Study||54
6279365|NCT00143845|7179107|FG000|COMPLETED|Overall Study||54
6279366|NCT00143845|7179107|FG000|NOT COMPLETED|Overall Study||0
6279367|NCT00144027|7179113|FG000|STARTED|Overall Study|participants who consented|39
6279368|NCT00144027|7179114|FG001|STARTED|Overall Study|participants who consented|36
6279369|NCT00144027|7179113|FG000|Completed Baseline Assessment|Overall Study||39
6279370|NCT00144027|7179114|FG001|Completed Baseline Assessment|Overall Study||29
6279371|NCT00144027|7179113|FG000|Completed 6 Month Assessment|Overall Study||37
6279372|NCT00144027|7179114|FG001|Completed 6 Month Assessment|Overall Study||24
6279373|NCT00144027|7179113|FG000|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
6279374|NCT00144027|7179114|FG001|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
6279375|NCT00144027|7179113|FG000|NOT COMPLETED|Overall Study||3
6279376|NCT00144027|7179114|FG001|NOT COMPLETED|Overall Study||11
6683645|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683646|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683647|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683648|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683649|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6683650|NCT02688387|7615402|FG000|STARTED|Part 1, Period 3 (up to 6 Days)||3
6683651|NCT02688387|7615403|FG001|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683652|NCT02688387|7615404|FG002|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683653|NCT02688387|7615405|FG003|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683654|NCT02688387|7615406|FG004|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683655|NCT02688387|7615407|FG005|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683656|NCT02688387|7615408|FG006|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683657|NCT02688387|7615409|FG007|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683658|NCT02688387|7615410|FG008|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683659|NCT02688387|7615411|FG009|STARTED|Part 1, Period 3 (up to 6 Days)||2
6683660|NCT02688387|7615412|FG010|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683661|NCT02688387|7615413|FG011|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683662|NCT02688387|7615414|FG012|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683663|NCT02688387|7615415|FG013|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683664|NCT02688387|7615416|FG014|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683665|NCT02688387|7615417|FG015|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683666|NCT02688387|7615418|FG016|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683667|NCT02688387|7615419|FG017|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683668|NCT02688387|7615420|FG018|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683669|NCT02688387|7615421|FG019|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683670|NCT02688387|7615422|FG020|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683671|NCT02688387|7615423|FG021|STARTED|Part 1, Period 3 (up to 6 Days)||0
6683672|NCT02688387|7615402|FG000|COMPLETED|Part 1, Period 3 (up to 6 Days)||3
6683673|NCT02688387|7615403|FG001|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683674|NCT02688387|7615404|FG002|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683675|NCT02688387|7615405|FG003|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683676|NCT02688387|7615406|FG004|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683677|NCT02688387|7615407|FG005|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683678|NCT02688387|7615408|FG006|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683679|NCT02688387|7615409|FG007|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683680|NCT02688387|7615410|FG008|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683681|NCT02688387|7615411|FG009|COMPLETED|Part 1, Period 3 (up to 6 Days)||2
6683682|NCT02688387|7615412|FG010|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683683|NCT02688387|7615413|FG011|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683684|NCT02688387|7615414|FG012|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683685|NCT02688387|7615415|FG013|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683686|NCT02688387|7615416|FG014|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683687|NCT02688387|7615417|FG015|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683688|NCT02688387|7615418|FG016|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683689|NCT02688387|7615419|FG017|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683690|NCT02688387|7615420|FG018|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683691|NCT02688387|7615421|FG019|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683692|NCT02688387|7615422|FG020|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683693|NCT02688387|7615423|FG021|COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683694|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683695|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683696|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683697|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683698|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683699|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683700|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683701|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683702|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683703|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683704|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683705|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683706|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683707|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683708|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683709|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683710|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683711|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683712|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683713|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683714|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683715|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Period 3 (up to 6 Days)||0
6683716|NCT02688387|7615402|FG000|STARTED|Part 1, Washout Period 3 (7 Days)||3
6683717|NCT02688387|7615403|FG001|STARTED|Part 1, Washout Period 3 (7 Days)||2
6683718|NCT02688387|7615404|FG002|STARTED|Part 1, Washout Period 3 (7 Days)||2
6683719|NCT02688387|7615405|FG003|STARTED|Part 1, Washout Period 3 (7 Days)||2
6683720|NCT02688387|7615406|FG004|STARTED|Part 1, Washout Period 3 (7 Days)||2
6683721|NCT02688387|7615407|FG005|STARTED|Part 1, Washout Period 3 (7 Days)||2
6683722|NCT02688387|7615408|FG006|STARTED|Part 1, Washout Period 3 (7 Days)||2
6256801|NCT04749745|7155783|FG000|STARTED|Overall Study||5
6683723|NCT02688387|7615409|FG007|STARTED|Part 1, Washout Period 3 (7 Days)||2
6683724|NCT02688387|7615410|FG008|STARTED|Part 1, Washout Period 3 (7 Days)||2
6683725|NCT02688387|7615411|FG009|STARTED|Part 1, Washout Period 3 (7 Days)||2
6683726|NCT02688387|7615412|FG010|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683727|NCT02688387|7615413|FG011|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683728|NCT02688387|7615414|FG012|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683729|NCT02688387|7615415|FG013|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683730|NCT02688387|7615416|FG014|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683731|NCT02688387|7615417|FG015|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683732|NCT02688387|7615418|FG016|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683733|NCT02688387|7615419|FG017|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683734|NCT02688387|7615420|FG018|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683735|NCT02688387|7615421|FG019|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683736|NCT02688387|7615422|FG020|STARTED|Part 1, Washout Period 3 (7 Days)||0
6256802|NCT04749745|7155784|FG001|STARTED|Overall Study||6
6256803|NCT04749745|7155783|FG000|First Intervention|Overall Study||4
6256804|NCT04749745|7155784|FG001|First Intervention|Overall Study||6
6256805|NCT04749745|7155783|FG000|Washout|Overall Study||4
6256806|NCT04749745|7155784|FG001|Washout|Overall Study||6
6256807|NCT04749745|7155783|FG000|Second Intervention|Overall Study||4
6256808|NCT04749745|7155784|FG001|Second Intervention|Overall Study||6
6256809|NCT04749745|7155783|FG000|COMPLETED|Overall Study||4
6256810|NCT04749745|7155784|FG001|COMPLETED|Overall Study||6
6256811|NCT04749745|7155783|FG000|NOT COMPLETED|Overall Study||1
6256812|NCT04749745|7155784|FG001|NOT COMPLETED|Overall Study||0
6279377|NCT00144170|7179122|FG000|STARTED|Overall Study||438
6279378|NCT00144170|7179123|FG001|STARTED|Overall Study||428
6279379|NCT00144170|7179122|FG000|COMPLETED|Overall Study||86
6279380|NCT00144170|7179123|FG001|COMPLETED|Overall Study||32
6279381|NCT00144170|7179122|FG000|NOT COMPLETED|Overall Study||352
6279382|NCT00144170|7179123|FG001|NOT COMPLETED|Overall Study||396
6279383|NCT00144300|7179131|FG000|STARTED|Overall Study||121
6279384|NCT00144300|7179132|FG001|STARTED|Overall Study||125
6279385|NCT00144300|7179131|FG000|COMPLETED|Overall Study||92
6279386|NCT00144300|7179132|FG001|COMPLETED|Overall Study||97
6279387|NCT00144300|7179131|FG000|NOT COMPLETED|Overall Study||29
6279388|NCT00144300|7179132|FG001|NOT COMPLETED|Overall Study||28
6279389|NCT00144339|7179140|FG000|STARTED|Overall Study||3006
6279390|NCT00144339|7179141|FG001|STARTED|Overall Study||2986
6279391|NCT00144339|7179140|FG000|COMPLETED|Overall Study||1648
6279392|NCT00144339|7179141|FG001|COMPLETED|Overall Study||1887
6279393|NCT00144339|7179140|FG000|NOT COMPLETED|Overall Study||1358
6279394|NCT00144339|7179141|FG001|NOT COMPLETED|Overall Study||1099
6279395|NCT00144391|7179149|FG000|STARTED|Overall Study||11
6279396|NCT00144391|7179150|FG001|STARTED|Overall Study||9
6279397|NCT00144391|7179149|FG000|COMPLETED|Overall Study||11
6279398|NCT00144391|7179150|FG001|COMPLETED|Overall Study||9
6279399|NCT00144391|7179149|FG000|NOT COMPLETED|Overall Study||0
6279400|NCT00144391|7179150|FG001|NOT COMPLETED|Overall Study||0
6279401|NCT00144781|7179160|FG000|STARTED|Overall Study||8
6279402|NCT00144781|7179161|FG001|STARTED|Overall Study||9
6279403|NCT00144781|7179162|FG002|STARTED|Overall Study||8
6279404|NCT00144781|7179163|FG003|STARTED|Overall Study||9
6279405|NCT00144781|7179160|FG000|COMPLETED|Overall Study||8
6279406|NCT00144781|7179161|FG001|COMPLETED|Overall Study||7
6279407|NCT00144781|7179162|FG002|COMPLETED|Overall Study||8
6279408|NCT00144781|7179163|FG003|COMPLETED|Overall Study||9
6279409|NCT00144781|7179160|FG000|NOT COMPLETED|Overall Study||0
6279410|NCT00144781|7179161|FG001|NOT COMPLETED|Overall Study||2
6279411|NCT00144781|7179162|FG002|NOT COMPLETED|Overall Study||0
6279412|NCT00144781|7179163|FG003|NOT COMPLETED|Overall Study||0
6279413|NCT00144963|7179173|FG000|STARTED|Overall Study||36
6279414|NCT00144963|7179173|FG000|COMPLETED|Overall Study||36
6279415|NCT00144963|7179173|FG000|NOT COMPLETED|Overall Study||0
6279416|NCT00145041|7179177|FG000|STARTED|Overall Study||7
6279417|NCT00145041|7179177|FG000|COMPLETED|Overall Study||7
6279418|NCT00145041|7179177|FG000|NOT COMPLETED|Overall Study||0
6279419|NCT00145119|7179181|FG000|STARTED|Overall Study||312
6279420|NCT00145119|7179181|FG000|COMPLETED|Overall Study||267
6279421|NCT00145119|7179181|FG000|NOT COMPLETED|Overall Study||45
6279422|NCT00145145|7179185|FG000|STARTED|Overall Study||1
6279423|NCT00145145|7179185|FG000|COMPLETED|Overall Study||1
6279424|NCT00145145|7179185|FG000|NOT COMPLETED|Overall Study||0
6279425|NCT00145249|7179192|FG000|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
6279426|NCT00145249|7179193|FG001|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
6279427|NCT00145249|7179194|FG002|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
6279428|NCT00145249|7179192|FG000|COMPLETED|Overall Study||36
6279429|NCT00145249|7179193|FG001|COMPLETED|Overall Study||33
6279430|NCT00145249|7179194|FG002|COMPLETED|Overall Study||31
6279431|NCT00145249|7179192|FG000|NOT COMPLETED|Overall Study||11
6279432|NCT00145249|7179193|FG001|NOT COMPLETED|Overall Study||15
6279433|NCT00145249|7179194|FG002|NOT COMPLETED|Overall Study||17
6279434|NCT00145327|7179205|FG000|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
6279435|NCT00145327|7179206|FG001|STARTED|Overall Study||617
6279436|NCT00145327|7179207|FG002|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
6279437|NCT00145327|7179205|FG000|COMPLETED|Overall Study||474
6279438|NCT00145327|7179206|FG001|COMPLETED|Overall Study||493
6683737|NCT02688387|7615423|FG021|STARTED|Part 1, Washout Period 3 (7 Days)||0
6683738|NCT02688387|7615402|FG000|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683739|NCT02688387|7615403|FG001|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683740|NCT02688387|7615404|FG002|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683741|NCT02688387|7615405|FG003|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683742|NCT02688387|7615406|FG004|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683743|NCT02688387|7615407|FG005|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683744|NCT02688387|7615408|FG006|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683745|NCT02688387|7615409|FG007|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683746|NCT02688387|7615410|FG008|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683747|NCT02688387|7615411|FG009|COMPLETED|Part 1, Washout Period 3 (7 Days)||2
6683748|NCT02688387|7615412|FG010|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683749|NCT02688387|7615413|FG011|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683750|NCT02688387|7615414|FG012|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683751|NCT02688387|7615415|FG013|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683752|NCT02688387|7615416|FG014|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683753|NCT02688387|7615417|FG015|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683754|NCT02688387|7615418|FG016|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683755|NCT02688387|7615419|FG017|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683756|NCT02688387|7615420|FG018|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683757|NCT02688387|7615421|FG019|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683758|NCT02688387|7615422|FG020|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683759|NCT02688387|7615423|FG021|COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683760|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||1
6683761|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683762|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683763|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683764|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683765|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683766|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683767|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683768|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683769|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683770|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683771|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683772|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683773|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683774|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683775|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683776|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683777|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683778|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683779|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683780|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683781|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Washout Period 3 (7 Days)||0
6683782|NCT02688387|7615402|FG000|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683783|NCT02688387|7615403|FG001|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683784|NCT02688387|7615404|FG002|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683785|NCT02688387|7615405|FG003|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683786|NCT02688387|7615406|FG004|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683787|NCT02688387|7615407|FG005|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683788|NCT02688387|7615408|FG006|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683789|NCT02688387|7615409|FG007|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683790|NCT02688387|7615410|FG008|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683791|NCT02688387|7615411|FG009|STARTED|Part 1, Period 4 (up to 6 Days)||2
6683792|NCT02688387|7615412|FG010|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683793|NCT02688387|7615413|FG011|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683794|NCT02688387|7615414|FG012|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683795|NCT02688387|7615415|FG013|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683796|NCT02688387|7615416|FG014|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683797|NCT02688387|7615417|FG015|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683798|NCT02688387|7615418|FG016|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683799|NCT02688387|7615419|FG017|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683800|NCT02688387|7615420|FG018|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683801|NCT02688387|7615421|FG019|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683802|NCT02688387|7615422|FG020|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683803|NCT02688387|7615423|FG021|STARTED|Part 1, Period 4 (up to 6 Days)||0
6683804|NCT02688387|7615402|FG000|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683805|NCT02688387|7615403|FG001|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683806|NCT02688387|7615404|FG002|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683807|NCT02688387|7615405|FG003|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683808|NCT02688387|7615406|FG004|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683809|NCT02688387|7615407|FG005|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683810|NCT02688387|7615408|FG006|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683811|NCT02688387|7615409|FG007|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683812|NCT02688387|7615410|FG008|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683813|NCT02688387|7615411|FG009|COMPLETED|Part 1, Period 4 (up to 6 Days)||2
6683814|NCT02688387|7615412|FG010|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683815|NCT02688387|7615413|FG011|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683816|NCT02688387|7615414|FG012|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683817|NCT02688387|7615415|FG013|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683818|NCT02688387|7615416|FG014|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683819|NCT02688387|7615417|FG015|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683820|NCT02688387|7615418|FG016|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683821|NCT02688387|7615419|FG017|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683822|NCT02688387|7615420|FG018|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683823|NCT02688387|7615421|FG019|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683824|NCT02688387|7615422|FG020|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683825|NCT02688387|7615423|FG021|COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683826|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683827|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683828|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683829|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683830|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683831|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683832|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6256813|NCT04748341|7155792|FG000|STARTED|Overall Study||31
6256814|NCT04748341|7155793|FG001|STARTED|Overall Study||31
6256815|NCT04748341|7155792|FG000|COMPLETED|Overall Study||30
6256816|NCT04748341|7155793|FG001|COMPLETED|Overall Study||30
6256817|NCT04748341|7155792|FG000|NOT COMPLETED|Overall Study||1
6256818|NCT04748341|7155793|FG001|NOT COMPLETED|Overall Study||1
6279439|NCT00145327|7179207|FG002|COMPLETED|Overall Study||975
6279440|NCT00145327|7179205|FG000|NOT COMPLETED|Overall Study||142
6683833|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683834|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683835|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683836|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683837|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683838|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683839|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683840|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683841|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683842|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683843|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683844|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683845|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683846|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683847|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Period 4 (up to 6 Days)||0
6683848|NCT02688387|7615402|FG000|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683849|NCT02688387|7615403|FG001|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683850|NCT02688387|7615404|FG002|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683851|NCT02688387|7615405|FG003|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683852|NCT02688387|7615406|FG004|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683853|NCT02688387|7615407|FG005|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683854|NCT02688387|7615408|FG006|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683855|NCT02688387|7615409|FG007|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683856|NCT02688387|7615410|FG008|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683857|NCT02688387|7615411|FG009|STARTED|Part 1, Washout Period 4 (7 Days)||2
6683858|NCT02688387|7615412|FG010|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683859|NCT02688387|7615413|FG011|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683860|NCT02688387|7615414|FG012|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683861|NCT02688387|7615415|FG013|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683862|NCT02688387|7615416|FG014|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683863|NCT02688387|7615417|FG015|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683864|NCT02688387|7615418|FG016|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683865|NCT02688387|7615419|FG017|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683866|NCT02688387|7615420|FG018|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683867|NCT02688387|7615421|FG019|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683868|NCT02688387|7615422|FG020|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683869|NCT02688387|7615423|FG021|STARTED|Part 1, Washout Period 4 (7 Days)||0
6683870|NCT02688387|7615402|FG000|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683871|NCT02688387|7615403|FG001|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683872|NCT02688387|7615404|FG002|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683873|NCT02688387|7615405|FG003|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683874|NCT02688387|7615406|FG004|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683875|NCT02688387|7615407|FG005|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683876|NCT02688387|7615408|FG006|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683877|NCT02688387|7615409|FG007|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683878|NCT02688387|7615410|FG008|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683879|NCT02688387|7615411|FG009|COMPLETED|Part 1, Washout Period 4 (7 Days)||2
6683880|NCT02688387|7615412|FG010|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683881|NCT02688387|7615413|FG011|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683882|NCT02688387|7615414|FG012|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683883|NCT02688387|7615415|FG013|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6279441|NCT00145327|7179206|FG001|NOT COMPLETED|Overall Study||124
6683884|NCT02688387|7615416|FG014|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683885|NCT02688387|7615417|FG015|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683886|NCT02688387|7615418|FG016|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683887|NCT02688387|7615419|FG017|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683888|NCT02688387|7615420|FG018|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683889|NCT02688387|7615421|FG019|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683890|NCT02688387|7615422|FG020|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683891|NCT02688387|7615423|FG021|COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683892|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683893|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683894|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683895|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683896|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683897|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683898|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683899|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683900|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683901|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683902|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683903|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683904|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683905|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683906|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683907|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683908|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683909|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683910|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683911|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683912|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683913|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Washout Period 4 (7 Days)||0
6683914|NCT02688387|7615402|FG000|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683915|NCT02688387|7615403|FG001|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683916|NCT02688387|7615404|FG002|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683917|NCT02688387|7615405|FG003|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683918|NCT02688387|7615406|FG004|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683919|NCT02688387|7615407|FG005|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683920|NCT02688387|7615408|FG006|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683921|NCT02688387|7615409|FG007|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683922|NCT02688387|7615410|FG008|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683923|NCT02688387|7615411|FG009|STARTED|Part 1, Period 5 (up to 6 Days)||2
6683924|NCT02688387|7615412|FG010|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683925|NCT02688387|7615413|FG011|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683926|NCT02688387|7615414|FG012|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683927|NCT02688387|7615415|FG013|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683928|NCT02688387|7615416|FG014|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683929|NCT02688387|7615417|FG015|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683930|NCT02688387|7615418|FG016|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683931|NCT02688387|7615419|FG017|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683932|NCT02688387|7615420|FG018|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683933|NCT02688387|7615421|FG019|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683934|NCT02688387|7615422|FG020|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683935|NCT02688387|7615423|FG021|STARTED|Part 1, Period 5 (up to 6 Days)||0
6683936|NCT02688387|7615402|FG000|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683937|NCT02688387|7615403|FG001|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683938|NCT02688387|7615404|FG002|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683939|NCT02688387|7615405|FG003|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683940|NCT02688387|7615406|FG004|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683941|NCT02688387|7615407|FG005|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683942|NCT02688387|7615408|FG006|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683943|NCT02688387|7615409|FG007|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683944|NCT02688387|7615410|FG008|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683945|NCT02688387|7615411|FG009|COMPLETED|Part 1, Period 5 (up to 6 Days)||2
6683946|NCT02688387|7615412|FG010|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683947|NCT02688387|7615413|FG011|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683948|NCT02688387|7615414|FG012|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683949|NCT02688387|7615415|FG013|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683950|NCT02688387|7615416|FG014|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683951|NCT02688387|7615417|FG015|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683952|NCT02688387|7615418|FG016|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683953|NCT02688387|7615419|FG017|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683954|NCT02688387|7615420|FG018|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683955|NCT02688387|7615421|FG019|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683956|NCT02688387|7615422|FG020|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683957|NCT02688387|7615423|FG021|COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683958|NCT02688387|7615402|FG000|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683959|NCT02688387|7615403|FG001|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683960|NCT02688387|7615404|FG002|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683961|NCT02688387|7615405|FG003|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683962|NCT02688387|7615406|FG004|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683963|NCT02688387|7615407|FG005|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683964|NCT02688387|7615408|FG006|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683965|NCT02688387|7615409|FG007|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683966|NCT02688387|7615410|FG008|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683967|NCT02688387|7615411|FG009|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683968|NCT02688387|7615412|FG010|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683969|NCT02688387|7615413|FG011|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683970|NCT02688387|7615414|FG012|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683971|NCT02688387|7615415|FG013|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683972|NCT02688387|7615416|FG014|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683973|NCT02688387|7615417|FG015|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683974|NCT02688387|7615418|FG016|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683975|NCT02688387|7615419|FG017|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683976|NCT02688387|7615420|FG018|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683977|NCT02688387|7615421|FG019|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683978|NCT02688387|7615422|FG020|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683979|NCT02688387|7615423|FG021|NOT COMPLETED|Part 1, Period 5 (up to 6 Days)||0
6683980|NCT02688387|7615402|FG000|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683981|NCT02688387|7615403|FG001|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683982|NCT02688387|7615404|FG002|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683983|NCT02688387|7615405|FG003|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683984|NCT02688387|7615406|FG004|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683985|NCT02688387|7615407|FG005|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683986|NCT02688387|7615408|FG006|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683987|NCT02688387|7615409|FG007|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683988|NCT02688387|7615410|FG008|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683989|NCT02688387|7615411|FG009|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683990|NCT02688387|7615412|FG010|STARTED|Part 2, Period 1 (up to 6 Days)||6
6683991|NCT02688387|7615413|FG011|STARTED|Part 2, Period 1 (up to 6 Days)||5
6683992|NCT02688387|7615414|FG012|STARTED|Part 2, Period 1 (up to 6 Days)||5
6683993|NCT02688387|7615415|FG013|STARTED|Part 2, Period 1 (up to 6 Days)||5
6683994|NCT02688387|7615416|FG014|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683995|NCT02688387|7615417|FG015|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683996|NCT02688387|7615418|FG016|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683997|NCT02688387|7615419|FG017|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683998|NCT02688387|7615420|FG018|STARTED|Part 2, Period 1 (up to 6 Days)||0
6683999|NCT02688387|7615421|FG019|STARTED|Part 2, Period 1 (up to 6 Days)||0
6684000|NCT02688387|7615422|FG020|STARTED|Part 2, Period 1 (up to 6 Days)||0
6684001|NCT02688387|7615423|FG021|STARTED|Part 2, Period 1 (up to 6 Days)||0
6684002|NCT02688387|7615402|FG000|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684003|NCT02688387|7615403|FG001|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684004|NCT02688387|7615404|FG002|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684005|NCT02688387|7615405|FG003|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684006|NCT02688387|7615406|FG004|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684007|NCT02688387|7615407|FG005|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684008|NCT02688387|7615408|FG006|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684009|NCT02688387|7615409|FG007|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684010|NCT02688387|7615410|FG008|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684011|NCT02688387|7615411|FG009|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684012|NCT02688387|7615412|FG010|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
6684013|NCT02688387|7615413|FG011|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
6684014|NCT02688387|7615414|FG012|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
6684015|NCT02688387|7615415|FG013|COMPLETED|Part 2, Period 1 (up to 6 Days)||5
6684016|NCT02688387|7615416|FG014|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684017|NCT02688387|7615417|FG015|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684018|NCT02688387|7615418|FG016|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684019|NCT02688387|7615419|FG017|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684020|NCT02688387|7615420|FG018|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684021|NCT02688387|7615421|FG019|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684022|NCT02688387|7615422|FG020|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684023|NCT02688387|7615423|FG021|COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684024|NCT02688387|7615402|FG000|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684025|NCT02688387|7615403|FG001|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684026|NCT02688387|7615404|FG002|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684027|NCT02688387|7615405|FG003|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684028|NCT02688387|7615406|FG004|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684029|NCT02688387|7615407|FG005|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684030|NCT02688387|7615408|FG006|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684031|NCT02688387|7615409|FG007|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684032|NCT02688387|7615410|FG008|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684033|NCT02688387|7615411|FG009|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684034|NCT02688387|7615412|FG010|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||1
6684035|NCT02688387|7615413|FG011|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684036|NCT02688387|7615414|FG012|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684037|NCT02688387|7615415|FG013|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684038|NCT02688387|7615416|FG014|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684039|NCT02688387|7615417|FG015|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684040|NCT02688387|7615418|FG016|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684041|NCT02688387|7615419|FG017|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684042|NCT02688387|7615420|FG018|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684043|NCT02688387|7615421|FG019|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684044|NCT02688387|7615422|FG020|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684045|NCT02688387|7615423|FG021|NOT COMPLETED|Part 2, Period 1 (up to 6 Days)||0
6684046|NCT02688387|7615402|FG000|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684047|NCT02688387|7615403|FG001|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684048|NCT02688387|7615404|FG002|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684049|NCT02688387|7615405|FG003|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684050|NCT02688387|7615406|FG004|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684051|NCT02688387|7615407|FG005|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684052|NCT02688387|7615408|FG006|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684053|NCT02688387|7615409|FG007|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684054|NCT02688387|7615410|FG008|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684055|NCT02688387|7615411|FG009|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684056|NCT02688387|7615412|FG010|STARTED|Part 2, Washout Period 1 (10 Days)||5
6684057|NCT02688387|7615413|FG011|STARTED|Part 2, Washout Period 1 (10 Days)||5
6684058|NCT02688387|7615414|FG012|STARTED|Part 2, Washout Period 1 (10 Days)||5
6684059|NCT02688387|7615415|FG013|STARTED|Part 2, Washout Period 1 (10 Days)||5
6684060|NCT02688387|7615416|FG014|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684061|NCT02688387|7615417|FG015|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684062|NCT02688387|7615418|FG016|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684063|NCT02688387|7615419|FG017|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684064|NCT02688387|7615420|FG018|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684065|NCT02688387|7615421|FG019|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684066|NCT02688387|7615422|FG020|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684067|NCT02688387|7615423|FG021|STARTED|Part 2, Washout Period 1 (10 Days)||0
6684068|NCT02688387|7615402|FG000|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684069|NCT02688387|7615403|FG001|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684070|NCT02688387|7615404|FG002|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684071|NCT02688387|7615405|FG003|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684072|NCT02688387|7615406|FG004|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684073|NCT02688387|7615407|FG005|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684074|NCT02688387|7615408|FG006|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684075|NCT02688387|7615409|FG007|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684076|NCT02688387|7615410|FG008|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684077|NCT02688387|7615411|FG009|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684078|NCT02688387|7615412|FG010|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
6684079|NCT02688387|7615413|FG011|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
6684080|NCT02688387|7615414|FG012|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
6684081|NCT02688387|7615415|FG013|COMPLETED|Part 2, Washout Period 1 (10 Days)||5
6684082|NCT02688387|7615416|FG014|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684083|NCT02688387|7615417|FG015|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684084|NCT02688387|7615418|FG016|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684085|NCT02688387|7615419|FG017|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684086|NCT02688387|7615420|FG018|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684087|NCT02688387|7615421|FG019|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684088|NCT02688387|7615422|FG020|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684089|NCT02688387|7615423|FG021|COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684090|NCT02688387|7615402|FG000|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684091|NCT02688387|7615403|FG001|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684092|NCT02688387|7615404|FG002|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684093|NCT02688387|7615405|FG003|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684094|NCT02688387|7615406|FG004|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684095|NCT02688387|7615407|FG005|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684096|NCT02688387|7615408|FG006|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684097|NCT02688387|7615409|FG007|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684098|NCT02688387|7615410|FG008|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684099|NCT02688387|7615411|FG009|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684100|NCT02688387|7615412|FG010|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684101|NCT02688387|7615413|FG011|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684102|NCT02688387|7615414|FG012|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684103|NCT02688387|7615415|FG013|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684104|NCT02688387|7615416|FG014|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684105|NCT02688387|7615417|FG015|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684106|NCT02688387|7615418|FG016|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684107|NCT02688387|7615419|FG017|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684108|NCT02688387|7615420|FG018|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684109|NCT02688387|7615421|FG019|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684110|NCT02688387|7615422|FG020|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684111|NCT02688387|7615423|FG021|NOT COMPLETED|Part 2, Washout Period 1 (10 Days)||0
6684112|NCT02688387|7615402|FG000|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684113|NCT02688387|7615403|FG001|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684114|NCT02688387|7615404|FG002|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684115|NCT02688387|7615405|FG003|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684116|NCT02688387|7615406|FG004|STARTED|Part 2, Period 2 (up to 6 Days)||0
6256819|NCT04737278|7155801|FG000|STARTED|Overall Study||28
6256820|NCT04737278|7155802|FG001|STARTED|Overall Study||28
6256821|NCT04737278|7155801|FG000|COMPLETED|Overall Study||24
6256822|NCT04737278|7155802|FG001|COMPLETED|Overall Study||25
6256823|NCT04737278|7155801|FG000|NOT COMPLETED|Overall Study||4
6256824|NCT04737278|7155802|FG001|NOT COMPLETED|Overall Study||3
6256831|NCT04600375|7155825|FG000|STARTED|Overall Study||12
6256832|NCT04600375|7155826|FG001|STARTED|Overall Study||10
6256833|NCT04600375|7155825|FG000|COMPLETED|Overall Study||12
6256834|NCT04600375|7155826|FG001|COMPLETED|Overall Study||10
6256835|NCT04600375|7155825|FG000|NOT COMPLETED|Overall Study||0
6256836|NCT04600375|7155826|FG001|NOT COMPLETED|Overall Study||0
6256837|NCT04524598|7155836|FG000|STARTED|Phase I - Feasibility||35
6256838|NCT04524598|7155837|FG001|STARTED|Phase I - Feasibility||25
6256839|NCT04524598|7155838|FG002|STARTED|Phase I - Feasibility||0
6256840|NCT04524598|7155839|FG003|STARTED|Phase I - Feasibility||0
6256841|NCT04524598|7155840|FG004|STARTED|Phase I - Feasibility||0
6256842|NCT04524598|7155836|FG000|COMPLETED|Phase I - Feasibility||31
6256843|NCT04524598|7155837|FG001|COMPLETED|Phase I - Feasibility||20
6256844|NCT04524598|7155838|FG002|COMPLETED|Phase I - Feasibility||0
6256845|NCT04524598|7155839|FG003|COMPLETED|Phase I - Feasibility||0
6256846|NCT04524598|7155840|FG004|COMPLETED|Phase I - Feasibility||0
6256847|NCT04524598|7155836|FG000|NOT COMPLETED|Phase I - Feasibility||4
6256848|NCT04524598|7155837|FG001|NOT COMPLETED|Phase I - Feasibility||5
6256849|NCT04524598|7155838|FG002|NOT COMPLETED|Phase I - Feasibility||0
6256850|NCT04524598|7155839|FG003|NOT COMPLETED|Phase I - Feasibility||0
6256851|NCT04524598|7155840|FG004|NOT COMPLETED|Phase I - Feasibility||0
6256852|NCT04524598|7155836|FG000|STARTED|Phase II - Outcomes||0
6256853|NCT04524598|7155837|FG001|STARTED|Phase II - Outcomes||0
6256854|NCT04524598|7155838|FG002|STARTED|Phase II - Outcomes||80
6256855|NCT04524598|7155839|FG003|STARTED|Phase II - Outcomes||80
6256856|NCT04524598|7155840|FG004|STARTED|Phase II - Outcomes||0
6256857|NCT04524598|7155836|FG000|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
6256858|NCT04524598|7155837|FG001|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
6256859|NCT04524598|7155838|FG002|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||63
6256860|NCT04524598|7155839|FG003|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||58
6256861|NCT04524598|7155840|FG004|Met PHQ-8 Threshold (Baseline >/= 10)|Phase II - Outcomes||0
6256862|NCT04524598|7155836|FG000|COMPLETED|Phase II - Outcomes||0
6256863|NCT04524598|7155837|FG001|COMPLETED|Phase II - Outcomes||0
6256864|NCT04524598|7155838|FG002|COMPLETED|Phase II - Outcomes||54
6256865|NCT04524598|7155839|FG003|COMPLETED|Phase II - Outcomes||67
6256866|NCT04524598|7155840|FG004|COMPLETED|Phase II - Outcomes||0
6256867|NCT04524598|7155836|FG000|NOT COMPLETED|Phase II - Outcomes||0
6256868|NCT04524598|7155837|FG001|NOT COMPLETED|Phase II - Outcomes||0
6256869|NCT04524598|7155838|FG002|NOT COMPLETED|Phase II - Outcomes||26
6256870|NCT04524598|7155839|FG003|NOT COMPLETED|Phase II - Outcomes||13
6684117|NCT02688387|7615407|FG005|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684118|NCT02688387|7615408|FG006|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684119|NCT02688387|7615409|FG007|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684120|NCT02688387|7615410|FG008|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684121|NCT02688387|7615411|FG009|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684122|NCT02688387|7615412|FG010|STARTED|Part 2, Period 2 (up to 6 Days)||5
6684123|NCT02688387|7615413|FG011|STARTED|Part 2, Period 2 (up to 6 Days)||5
6684124|NCT02688387|7615414|FG012|STARTED|Part 2, Period 2 (up to 6 Days)||5
6684125|NCT02688387|7615415|FG013|STARTED|Part 2, Period 2 (up to 6 Days)||5
6684126|NCT02688387|7615416|FG014|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684127|NCT02688387|7615417|FG015|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684128|NCT02688387|7615418|FG016|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684129|NCT02688387|7615419|FG017|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684130|NCT02688387|7615420|FG018|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684131|NCT02688387|7615421|FG019|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684132|NCT02688387|7615422|FG020|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684133|NCT02688387|7615423|FG021|STARTED|Part 2, Period 2 (up to 6 Days)||0
6684134|NCT02688387|7615402|FG000|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684135|NCT02688387|7615403|FG001|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684136|NCT02688387|7615404|FG002|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684137|NCT02688387|7615405|FG003|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684138|NCT02688387|7615406|FG004|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684139|NCT02688387|7615407|FG005|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684140|NCT02688387|7615408|FG006|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684141|NCT02688387|7615409|FG007|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684142|NCT02688387|7615410|FG008|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684143|NCT02688387|7615411|FG009|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684144|NCT02688387|7615412|FG010|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
6684145|NCT02688387|7615413|FG011|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
6684146|NCT02688387|7615414|FG012|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
6684147|NCT02688387|7615415|FG013|COMPLETED|Part 2, Period 2 (up to 6 Days)||5
6684148|NCT02688387|7615416|FG014|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684149|NCT02688387|7615417|FG015|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684150|NCT02688387|7615418|FG016|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684151|NCT02688387|7615419|FG017|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684152|NCT02688387|7615420|FG018|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684153|NCT02688387|7615421|FG019|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684154|NCT02688387|7615422|FG020|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684155|NCT02688387|7615423|FG021|COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684156|NCT02688387|7615402|FG000|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684157|NCT02688387|7615403|FG001|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684158|NCT02688387|7615404|FG002|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684159|NCT02688387|7615405|FG003|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684160|NCT02688387|7615406|FG004|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684161|NCT02688387|7615407|FG005|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684162|NCT02688387|7615408|FG006|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684163|NCT02688387|7615409|FG007|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684164|NCT02688387|7615410|FG008|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684165|NCT02688387|7615411|FG009|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684166|NCT02688387|7615412|FG010|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684167|NCT02688387|7615413|FG011|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684168|NCT02688387|7615414|FG012|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684169|NCT02688387|7615415|FG013|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684170|NCT02688387|7615416|FG014|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684171|NCT02688387|7615417|FG015|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684172|NCT02688387|7615418|FG016|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684173|NCT02688387|7615419|FG017|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684174|NCT02688387|7615420|FG018|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684175|NCT02688387|7615421|FG019|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684176|NCT02688387|7615422|FG020|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684177|NCT02688387|7615423|FG021|NOT COMPLETED|Part 2, Period 2 (up to 6 Days)||0
6684178|NCT02688387|7615402|FG000|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684179|NCT02688387|7615403|FG001|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684180|NCT02688387|7615404|FG002|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684181|NCT02688387|7615405|FG003|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684182|NCT02688387|7615406|FG004|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684183|NCT02688387|7615407|FG005|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684184|NCT02688387|7615408|FG006|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684185|NCT02688387|7615409|FG007|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684186|NCT02688387|7615410|FG008|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684187|NCT02688387|7615411|FG009|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684188|NCT02688387|7615412|FG010|STARTED|Part 2, Washout Period 2 (10 Days)||5
6684189|NCT02688387|7615413|FG011|STARTED|Part 2, Washout Period 2 (10 Days)||5
6684190|NCT02688387|7615414|FG012|STARTED|Part 2, Washout Period 2 (10 Days)||5
6684191|NCT02688387|7615415|FG013|STARTED|Part 2, Washout Period 2 (10 Days)||5
6684192|NCT02688387|7615416|FG014|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684193|NCT02688387|7615417|FG015|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684194|NCT02688387|7615418|FG016|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684195|NCT02688387|7615419|FG017|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684196|NCT02688387|7615420|FG018|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684197|NCT02688387|7615421|FG019|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684198|NCT02688387|7615422|FG020|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684199|NCT02688387|7615423|FG021|STARTED|Part 2, Washout Period 2 (10 Days)||0
6684200|NCT02688387|7615402|FG000|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684201|NCT02688387|7615403|FG001|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684202|NCT02688387|7615404|FG002|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684203|NCT02688387|7615405|FG003|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684204|NCT02688387|7615406|FG004|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684205|NCT02688387|7615407|FG005|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684206|NCT02688387|7615408|FG006|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684207|NCT02688387|7615409|FG007|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684208|NCT02688387|7615410|FG008|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684209|NCT02688387|7615411|FG009|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684210|NCT02688387|7615412|FG010|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
6684211|NCT02688387|7615413|FG011|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
6684212|NCT02688387|7615414|FG012|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
6684213|NCT02688387|7615415|FG013|COMPLETED|Part 2, Washout Period 2 (10 Days)||5
6684214|NCT02688387|7615416|FG014|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684215|NCT02688387|7615417|FG015|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684216|NCT02688387|7615418|FG016|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684217|NCT02688387|7615419|FG017|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684218|NCT02688387|7615420|FG018|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684219|NCT02688387|7615421|FG019|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6256825|NCT04736069|7155810|FG000|STARTED|Overall Study||30
6256826|NCT04736069|7155811|FG001|STARTED|Overall Study||30
6256827|NCT04736069|7155810|FG000|COMPLETED|Overall Study||30
6256828|NCT04736069|7155811|FG001|COMPLETED|Overall Study||22
6256829|NCT04736069|7155810|FG000|NOT COMPLETED|Overall Study||0
6256830|NCT04736069|7155811|FG001|NOT COMPLETED|Overall Study||8
6256871|NCT04524598|7155840|FG004|NOT COMPLETED|Phase II - Outcomes||0
6256872|NCT04524598|7155836|FG000|STARTED|Phase II - Control Extension||0
6256873|NCT04524598|7155837|FG001|STARTED|Phase II - Control Extension||0
6256874|NCT04524598|7155838|FG002|STARTED|Phase II - Control Extension||0
6256875|NCT04524598|7155839|FG003|STARTED|Phase II - Control Extension||0
6256876|NCT04524598|7155840|FG004|STARTED|Phase II - Control Extension||66
6256877|NCT04524598|7155836|FG000|COMPLETED|Phase II - Control Extension||0
6256878|NCT04524598|7155837|FG001|COMPLETED|Phase II - Control Extension||0
6256879|NCT04524598|7155838|FG002|COMPLETED|Phase II - Control Extension||0
6256880|NCT04524598|7155839|FG003|COMPLETED|Phase II - Control Extension||0
6256881|NCT04524598|7155840|FG004|COMPLETED|Phase II - Control Extension||54
6256882|NCT04524598|7155836|FG000|NOT COMPLETED|Phase II - Control Extension||0
6256883|NCT04524598|7155837|FG001|NOT COMPLETED|Phase II - Control Extension||0
6256884|NCT04524598|7155838|FG002|NOT COMPLETED|Phase II - Control Extension||0
6256885|NCT04524598|7155839|FG003|NOT COMPLETED|Phase II - Control Extension||0
6256886|NCT04524598|7155840|FG004|NOT COMPLETED|Phase II - Control Extension||12
6279442|NCT00145327|7179207|FG002|NOT COMPLETED|Overall Study||248
6279443|NCT00145418|7179215|FG000|STARTED|Overall Study||15
6279444|NCT00145418|7179215|FG000|COMPLETED|Overall Study||15
6279445|NCT00145418|7179215|FG000|NOT COMPLETED|Overall Study||0
6279446|NCT00145574|7179222|FG000|STARTED|Double Blind||65
6279447|NCT00145574|7179223|FG001|STARTED|Double Blind||65
6279448|NCT00145574|7179224|FG002|STARTED|Double Blind||64
6279449|NCT00145574|7179222|FG000|COMPLETED|Double Blind||64
6279450|NCT00145574|7179223|FG001|COMPLETED|Double Blind||60
6279451|NCT00145574|7179224|FG002|COMPLETED|Double Blind||62
6279452|NCT00145574|7179222|FG000|NOT COMPLETED|Double Blind||1
6279453|NCT00145574|7179223|FG001|NOT COMPLETED|Double Blind||5
6279454|NCT00145574|7179224|FG002|NOT COMPLETED|Double Blind||2
6279455|NCT00145574|7179222|FG000|STARTED|Open Label Long-term Extension||0
6279456|NCT00145574|7179223|FG001|STARTED|Open Label Long-term Extension||0
6279457|NCT00145574|7179224|FG002|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
6279458|NCT00145574|7179222|FG000|COMPLETED|Open Label Long-term Extension||0
6279459|NCT00145574|7179223|FG001|COMPLETED|Open Label Long-term Extension||0
6279460|NCT00145574|7179224|FG002|COMPLETED|Open Label Long-term Extension||173
6279461|NCT00145574|7179222|FG000|NOT COMPLETED|Open Label Long-term Extension||0
6279462|NCT00145574|7179223|FG001|NOT COMPLETED|Open Label Long-term Extension||0
6279463|NCT00145574|7179224|FG002|NOT COMPLETED|Open Label Long-term Extension||11
6281029|NCT00160706|7180900|FG000|STARTED|Overall Study||310
6281030|NCT00160706|7180900|FG000|COMPLETED|Overall Study||24
6281031|NCT00160706|7180900|FG000|NOT COMPLETED|Overall Study||286
6281032|NCT00161213|7180904|FG000|STARTED|Overall Study||44
6281033|NCT00161213|7180904|FG000|COMPLETED|Overall Study||42
6281034|NCT00161213|7180904|FG000|NOT COMPLETED|Overall Study||2
6281035|NCT00161382|7180910|FG000|STARTED|Overall Study|Number of students allocated to intervention group|598
6281036|NCT00161382|7180911|FG001|STARTED|Overall Study|Number of students allocated to comparison group|847
6281037|NCT00161382|7180910|FG000|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
6684220|NCT02688387|7615422|FG020|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684221|NCT02688387|7615423|FG021|COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684222|NCT02688387|7615402|FG000|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684223|NCT02688387|7615403|FG001|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684224|NCT02688387|7615404|FG002|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684225|NCT02688387|7615405|FG003|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684226|NCT02688387|7615406|FG004|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684227|NCT02688387|7615407|FG005|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684228|NCT02688387|7615408|FG006|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684229|NCT02688387|7615409|FG007|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684230|NCT02688387|7615410|FG008|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684231|NCT02688387|7615411|FG009|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684232|NCT02688387|7615412|FG010|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684233|NCT02688387|7615413|FG011|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684234|NCT02688387|7615414|FG012|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684235|NCT02688387|7615415|FG013|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684236|NCT02688387|7615416|FG014|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684237|NCT02688387|7615417|FG015|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684238|NCT02688387|7615418|FG016|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684239|NCT02688387|7615419|FG017|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684240|NCT02688387|7615420|FG018|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684241|NCT02688387|7615421|FG019|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684242|NCT02688387|7615422|FG020|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684243|NCT02688387|7615423|FG021|NOT COMPLETED|Part 2, Washout Period 2 (10 Days)||0
6684244|NCT02688387|7615402|FG000|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684245|NCT02688387|7615403|FG001|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684246|NCT02688387|7615404|FG002|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684247|NCT02688387|7615405|FG003|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684248|NCT02688387|7615406|FG004|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684249|NCT02688387|7615407|FG005|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684250|NCT02688387|7615408|FG006|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684251|NCT02688387|7615409|FG007|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684252|NCT02688387|7615410|FG008|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684253|NCT02688387|7615411|FG009|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684254|NCT02688387|7615412|FG010|STARTED|Part 2, Period 3 (up to 6 Days)||5
6684255|NCT02688387|7615413|FG011|STARTED|Part 2, Period 3 (up to 6 Days)||5
6684256|NCT02688387|7615414|FG012|STARTED|Part 2, Period 3 (up to 6 Days)||5
6684257|NCT02688387|7615415|FG013|STARTED|Part 2, Period 3 (up to 6 Days)||5
6684258|NCT02688387|7615416|FG014|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684259|NCT02688387|7615417|FG015|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684260|NCT02688387|7615418|FG016|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684261|NCT02688387|7615419|FG017|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684262|NCT02688387|7615420|FG018|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684263|NCT02688387|7615421|FG019|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684264|NCT02688387|7615422|FG020|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684265|NCT02688387|7615423|FG021|STARTED|Part 2, Period 3 (up to 6 Days)||0
6684266|NCT02688387|7615402|FG000|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684267|NCT02688387|7615403|FG001|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684268|NCT02688387|7615404|FG002|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684269|NCT02688387|7615405|FG003|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684270|NCT02688387|7615406|FG004|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684271|NCT02688387|7615407|FG005|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684272|NCT02688387|7615408|FG006|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684273|NCT02688387|7615409|FG007|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684274|NCT02688387|7615410|FG008|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684275|NCT02688387|7615411|FG009|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684276|NCT02688387|7615412|FG010|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
6684277|NCT02688387|7615413|FG011|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
6684278|NCT02688387|7615414|FG012|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
6684279|NCT02688387|7615415|FG013|COMPLETED|Part 2, Period 3 (up to 6 Days)||5
6256887|NCT04334460|7155856|FG000|STARTED|Full Enrollment||81
6256888|NCT04334460|7155857|FG001|STARTED|Full Enrollment||39
6256889|NCT04334460|7155856|FG000|COMPLETED|Full Enrollment||81
6256890|NCT04334460|7155857|FG001|COMPLETED|Full Enrollment||39
6256891|NCT04334460|7155856|FG000|NOT COMPLETED|Full Enrollment||0
6256892|NCT04334460|7155857|FG001|NOT COMPLETED|Full Enrollment||0
6256893|NCT04334460|7155856|FG000|STARTED|Full Analysis Set (FAS)||81
6256894|NCT04334460|7155857|FG001|STARTED|Full Analysis Set (FAS)||39
6256895|NCT04334460|7155856|FG000|COMPLETED|Full Analysis Set (FAS)||77
6256896|NCT04334460|7155857|FG001|COMPLETED|Full Analysis Set (FAS)||38
6256897|NCT04334460|7155856|FG000|NOT COMPLETED|Full Analysis Set (FAS)||4
6256898|NCT04334460|7155857|FG001|NOT COMPLETED|Full Analysis Set (FAS)||1
6256899|NCT04334460|7155856|FG000|STARTED|Safety Analysis Population||81
6256900|NCT04334460|7155857|FG001|STARTED|Safety Analysis Population||39
6256901|NCT04334460|7155856|FG000|COMPLETED|Safety Analysis Population||77
6256902|NCT04334460|7155857|FG001|COMPLETED|Safety Analysis Population||38
6256903|NCT04334460|7155856|FG000|NOT COMPLETED|Safety Analysis Population||4
6256904|NCT04334460|7155857|FG001|NOT COMPLETED|Safety Analysis Population||1
6256905|NCT04247828|7155864|FG000|STARTED|Overall Study||30
6256906|NCT04247828|7155864|FG000|Started - Controls|Overall Study||19
6684280|NCT02688387|7615416|FG014|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684281|NCT02688387|7615417|FG015|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684282|NCT02688387|7615418|FG016|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684283|NCT02688387|7615419|FG017|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684284|NCT02688387|7615420|FG018|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684285|NCT02688387|7615421|FG019|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684286|NCT02688387|7615422|FG020|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684287|NCT02688387|7615423|FG021|COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684288|NCT02688387|7615402|FG000|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684289|NCT02688387|7615403|FG001|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684290|NCT02688387|7615404|FG002|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684291|NCT02688387|7615405|FG003|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684292|NCT02688387|7615406|FG004|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684293|NCT02688387|7615407|FG005|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684294|NCT02688387|7615408|FG006|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684295|NCT02688387|7615409|FG007|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684296|NCT02688387|7615410|FG008|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684297|NCT02688387|7615411|FG009|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684298|NCT02688387|7615412|FG010|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684299|NCT02688387|7615413|FG011|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684300|NCT02688387|7615414|FG012|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684301|NCT02688387|7615415|FG013|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684302|NCT02688387|7615416|FG014|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684303|NCT02688387|7615417|FG015|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684304|NCT02688387|7615418|FG016|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684305|NCT02688387|7615419|FG017|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684306|NCT02688387|7615420|FG018|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684307|NCT02688387|7615421|FG019|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684308|NCT02688387|7615422|FG020|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684309|NCT02688387|7615423|FG021|NOT COMPLETED|Part 2, Period 3 (up to 6 Days)||0
6684310|NCT02688387|7615402|FG000|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684311|NCT02688387|7615403|FG001|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684312|NCT02688387|7615404|FG002|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684313|NCT02688387|7615405|FG003|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684314|NCT02688387|7615406|FG004|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684315|NCT02688387|7615407|FG005|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684316|NCT02688387|7615408|FG006|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684317|NCT02688387|7615409|FG007|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684318|NCT02688387|7615410|FG008|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684319|NCT02688387|7615411|FG009|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684320|NCT02688387|7615412|FG010|STARTED|Part 2, Washout Period 3 (10 Days)||5
6684321|NCT02688387|7615413|FG011|STARTED|Part 2, Washout Period 3 (10 Days)||5
6684322|NCT02688387|7615414|FG012|STARTED|Part 2, Washout Period 3 (10 Days)||5
6684323|NCT02688387|7615415|FG013|STARTED|Part 2, Washout Period 3 (10 Days)||5
6684324|NCT02688387|7615416|FG014|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684325|NCT02688387|7615417|FG015|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684326|NCT02688387|7615418|FG016|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684327|NCT02688387|7615419|FG017|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684328|NCT02688387|7615420|FG018|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684329|NCT02688387|7615421|FG019|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684330|NCT02688387|7615422|FG020|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684331|NCT02688387|7615423|FG021|STARTED|Part 2, Washout Period 3 (10 Days)||0
6684332|NCT02688387|7615402|FG000|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684333|NCT02688387|7615403|FG001|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684334|NCT02688387|7615404|FG002|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684335|NCT02688387|7615405|FG003|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684336|NCT02688387|7615406|FG004|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684337|NCT02688387|7615407|FG005|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684338|NCT02688387|7615408|FG006|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684339|NCT02688387|7615409|FG007|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684340|NCT02688387|7615410|FG008|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684341|NCT02688387|7615411|FG009|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684342|NCT02688387|7615412|FG010|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
6684343|NCT02688387|7615413|FG011|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
6684344|NCT02688387|7615414|FG012|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
6684345|NCT02688387|7615415|FG013|COMPLETED|Part 2, Washout Period 3 (10 Days)||5
6684346|NCT02688387|7615416|FG014|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684347|NCT02688387|7615417|FG015|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684348|NCT02688387|7615418|FG016|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684349|NCT02688387|7615419|FG017|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684350|NCT02688387|7615420|FG018|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684351|NCT02688387|7615421|FG019|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684352|NCT02688387|7615422|FG020|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684353|NCT02688387|7615423|FG021|COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6256907|NCT04247828|7155864|FG000|Started - Participants With SPI|Overall Study||11
6684354|NCT02688387|7615402|FG000|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684355|NCT02688387|7615403|FG001|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684356|NCT02688387|7615404|FG002|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684357|NCT02688387|7615405|FG003|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684358|NCT02688387|7615406|FG004|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684359|NCT02688387|7615407|FG005|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684360|NCT02688387|7615408|FG006|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684361|NCT02688387|7615409|FG007|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684362|NCT02688387|7615410|FG008|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684363|NCT02688387|7615411|FG009|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684364|NCT02688387|7615412|FG010|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684365|NCT02688387|7615413|FG011|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684366|NCT02688387|7615414|FG012|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684367|NCT02688387|7615415|FG013|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684368|NCT02688387|7615416|FG014|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684369|NCT02688387|7615417|FG015|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684370|NCT02688387|7615418|FG016|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684371|NCT02688387|7615419|FG017|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684372|NCT02688387|7615420|FG018|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684373|NCT02688387|7615421|FG019|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684374|NCT02688387|7615422|FG020|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684375|NCT02688387|7615423|FG021|NOT COMPLETED|Part 2, Washout Period 3 (10 Days)||0
6684376|NCT02688387|7615402|FG000|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684377|NCT02688387|7615403|FG001|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684378|NCT02688387|7615404|FG002|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684379|NCT02688387|7615405|FG003|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684380|NCT02688387|7615406|FG004|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684381|NCT02688387|7615407|FG005|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684382|NCT02688387|7615408|FG006|STARTED|Part 2, Period 4 (up to 6 Days)||0
6256908|NCT04247828|7155864|FG000|COMPLETED|Overall Study|16 controls and 5 participants with SPI completed the study|21
6256909|NCT04247828|7155864|FG000|NOT COMPLETED|Overall Study||9
6279464|NCT00145587|7179239|FG000|STARTED|Overall Study||5
6279465|NCT00145587|7179240|FG001|STARTED|Overall Study||1
6279466|NCT00145587|7179239|FG000|COMPLETED|Overall Study||5
6279467|NCT00145587|7179240|FG001|COMPLETED|Overall Study||1
6279468|NCT00145587|7179239|FG000|NOT COMPLETED|Overall Study||0
6279469|NCT00145587|7179240|FG001|NOT COMPLETED|Overall Study||0
6279470|NCT00145600|7179250|FG000|STARTED|Overall Study||91
6279471|NCT00145600|7179251|FG001|STARTED|Overall Study||46
6279472|NCT00145600|7179252|FG002|STARTED|Overall Study||13
6279473|NCT00145600|7179253|FG003|STARTED|Overall Study||146
6279474|NCT00145600|7179250|FG000|COMPLETED|Overall Study||83
6279475|NCT00145600|7179251|FG001|COMPLETED|Overall Study||36
6279476|NCT00145600|7179252|FG002|COMPLETED|Overall Study||8
6279477|NCT00145600|7179253|FG003|COMPLETED|Overall Study||130
6279478|NCT00145600|7179250|FG000|NOT COMPLETED|Overall Study||8
6279479|NCT00145600|7179251|FG001|NOT COMPLETED|Overall Study||10
6279480|NCT00145600|7179252|FG002|NOT COMPLETED|Overall Study||5
6279481|NCT00145600|7179253|FG003|NOT COMPLETED|Overall Study||16
6279482|NCT00145626|7179279|FG000|STARTED|Overall Study||19
6279483|NCT00145626|7179279|FG000|COMPLETED|Overall Study||14
6279484|NCT00145626|7179279|FG000|NOT COMPLETED|Overall Study||5
6279485|NCT00145795|7179301|FG000|STARTED|Overall Study||10
6279486|NCT00145795|7179302|FG001|STARTED|Overall Study||10
6279487|NCT00145795|7179301|FG000|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
6279488|NCT00145795|7179302|FG001|COMPLETED|Overall Study||10
6279489|NCT00145795|7179301|FG000|NOT COMPLETED|Overall Study||1
6279490|NCT00145795|7179302|FG001|NOT COMPLETED|Overall Study||0
6279491|NCT00145977|7179310|FG000|STARTED|Overall Study||19
6279492|NCT00145977|7179311|FG001|STARTED|Overall Study||17
6279493|NCT00145977|7179310|FG000|COMPLETED|Overall Study||17
6279494|NCT00145977|7179311|FG001|COMPLETED|Overall Study||13
6279495|NCT00145977|7179310|FG000|NOT COMPLETED|Overall Study||2
6279496|NCT00145977|7179311|FG001|NOT COMPLETED|Overall Study||4
6279497|NCT00146172|7179325|FG000|STARTED|Overall Study||3
6279498|NCT00146172|7179326|FG001|STARTED|Overall Study||4
6279499|NCT00146172|7179327|FG002|STARTED|Overall Study||4
6279500|NCT00146172|7179328|FG003|STARTED|Overall Study||6
6279501|NCT00146172|7179329|FG004|STARTED|Overall Study||3
6279502|NCT00146172|7179330|FG005|STARTED|Overall Study||7
6279503|NCT00146172|7179331|FG006|STARTED|Overall Study||6
6279504|NCT00146172|7179332|FG007|STARTED|Overall Study||40
6279505|NCT00146172|7179325|FG000|Received Drug|Overall Study||3
6684383|NCT02688387|7615409|FG007|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684384|NCT02688387|7615410|FG008|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684385|NCT02688387|7615411|FG009|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684386|NCT02688387|7615412|FG010|STARTED|Part 2, Period 4 (up to 6 Days)||5
6684387|NCT02688387|7615413|FG011|STARTED|Part 2, Period 4 (up to 6 Days)||5
6684388|NCT02688387|7615414|FG012|STARTED|Part 2, Period 4 (up to 6 Days)||5
6279506|NCT00146172|7179326|FG001|Received Drug|Overall Study||4
6279507|NCT00146172|7179327|FG002|Received Drug|Overall Study||4
6279508|NCT00146172|7179328|FG003|Received Drug|Overall Study||6
6279509|NCT00146172|7179329|FG004|Received Drug|Overall Study||3
6279510|NCT00146172|7179330|FG005|Received Drug|Overall Study||7
6684389|NCT02688387|7615415|FG013|STARTED|Part 2, Period 4 (up to 6 Days)||5
6684390|NCT02688387|7615416|FG014|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684391|NCT02688387|7615417|FG015|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684392|NCT02688387|7615418|FG016|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684393|NCT02688387|7615419|FG017|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684394|NCT02688387|7615420|FG018|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684395|NCT02688387|7615421|FG019|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684396|NCT02688387|7615422|FG020|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684397|NCT02688387|7615423|FG021|STARTED|Part 2, Period 4 (up to 6 Days)||0
6684398|NCT02688387|7615402|FG000|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684399|NCT02688387|7615403|FG001|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684400|NCT02688387|7615404|FG002|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684401|NCT02688387|7615405|FG003|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684402|NCT02688387|7615406|FG004|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684403|NCT02688387|7615407|FG005|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684404|NCT02688387|7615408|FG006|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684405|NCT02688387|7615409|FG007|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684406|NCT02688387|7615410|FG008|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684407|NCT02688387|7615411|FG009|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684408|NCT02688387|7615412|FG010|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
6684409|NCT02688387|7615413|FG011|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
6684410|NCT02688387|7615414|FG012|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
6684411|NCT02688387|7615415|FG013|COMPLETED|Part 2, Period 4 (up to 6 Days)||5
6684412|NCT02688387|7615416|FG014|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684413|NCT02688387|7615417|FG015|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684414|NCT02688387|7615418|FG016|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684415|NCT02688387|7615419|FG017|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684416|NCT02688387|7615420|FG018|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684417|NCT02688387|7615421|FG019|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684418|NCT02688387|7615422|FG020|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684419|NCT02688387|7615423|FG021|COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684420|NCT02688387|7615402|FG000|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684421|NCT02688387|7615403|FG001|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684422|NCT02688387|7615404|FG002|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684423|NCT02688387|7615405|FG003|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684424|NCT02688387|7615406|FG004|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684425|NCT02688387|7615407|FG005|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684426|NCT02688387|7615408|FG006|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684427|NCT02688387|7615409|FG007|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684428|NCT02688387|7615410|FG008|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684429|NCT02688387|7615411|FG009|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684430|NCT02688387|7615412|FG010|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684431|NCT02688387|7615413|FG011|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684432|NCT02688387|7615414|FG012|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684433|NCT02688387|7615415|FG013|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684434|NCT02688387|7615416|FG014|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684435|NCT02688387|7615417|FG015|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684436|NCT02688387|7615418|FG016|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684437|NCT02688387|7615419|FG017|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684438|NCT02688387|7615420|FG018|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684439|NCT02688387|7615421|FG019|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684440|NCT02688387|7615422|FG020|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684441|NCT02688387|7615423|FG021|NOT COMPLETED|Part 2, Period 4 (up to 6 Days)||0
6684442|NCT02688387|7615402|FG000|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684443|NCT02688387|7615403|FG001|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684444|NCT02688387|7615404|FG002|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684445|NCT02688387|7615405|FG003|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6256910|NCT04084769|7155872|FG000|STARTED|Overall Study||191
6256911|NCT04084769|7155873|FG001|STARTED|Overall Study||190
6256912|NCT04084769|7155874|FG002|STARTED|Overall Study||95
6256913|NCT04084769|7155875|FG003|STARTED|Overall Study||94
6256914|NCT04084769|7155872|FG000|Safety Analysis Set (SAfAS)|Overall Study||186
6256915|NCT04084769|7155873|FG001|Safety Analysis Set (SAfAS)|Overall Study||184
6256916|NCT04084769|7155874|FG002|Safety Analysis Set (SAfAS)|Overall Study||93
6256917|NCT04084769|7155875|FG003|Safety Analysis Set (SAfAS)|Overall Study||92
6256918|NCT04084769|7155872|FG000|Full Analysis Set|Overall Study||191
6256919|NCT04084769|7155873|FG001|Full Analysis Set|Overall Study||190
6256920|NCT04084769|7155874|FG002|Full Analysis Set|Overall Study||95
6256921|NCT04084769|7155875|FG003|Full Analysis Set|Overall Study||94
6256922|NCT04084769|7155872|FG000|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||46
6256923|NCT04084769|7155873|FG001|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||45
6256924|NCT04084769|7155874|FG002|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
6256925|NCT04084769|7155875|FG003|Per-Protocol Analysis Set 1 (PPAS1)|Overall Study||0
6256926|NCT04084769|7155872|FG000|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||174
6256927|NCT04084769|7155873|FG001|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||176
6684446|NCT02688387|7615406|FG004|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6256928|NCT04084769|7155874|FG002|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||90
6256929|NCT04084769|7155875|FG003|Per-Protocol Analysis Set 2 (PPAS2)|Overall Study||89
6256930|NCT04084769|7155872|FG000|COMPLETED|Overall Study||187
6684447|NCT02688387|7615407|FG005|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684448|NCT02688387|7615408|FG006|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684449|NCT02688387|7615409|FG007|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684450|NCT02688387|7615410|FG008|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684451|NCT02688387|7615411|FG009|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684452|NCT02688387|7615412|FG010|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684453|NCT02688387|7615413|FG011|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684454|NCT02688387|7615414|FG012|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684455|NCT02688387|7615415|FG013|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684456|NCT02688387|7615416|FG014|STARTED|Part 3A, Period 1 (up to 6 Days)||9
6684457|NCT02688387|7615417|FG015|STARTED|Part 3A, Period 1 (up to 6 Days)||8
6684458|NCT02688387|7615418|FG016|STARTED|Part 3A, Period 1 (up to 6 Days)||8
6684459|NCT02688387|7615419|FG017|STARTED|Part 3A, Period 1 (up to 6 Days)||8
6684460|NCT02688387|7615420|FG018|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684461|NCT02688387|7615421|FG019|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684462|NCT02688387|7615422|FG020|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684463|NCT02688387|7615423|FG021|STARTED|Part 3A, Period 1 (up to 6 Days)||0
6684464|NCT02688387|7615402|FG000|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684465|NCT02688387|7615403|FG001|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684466|NCT02688387|7615404|FG002|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684467|NCT02688387|7615405|FG003|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684468|NCT02688387|7615406|FG004|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684469|NCT02688387|7615407|FG005|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684470|NCT02688387|7615408|FG006|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684471|NCT02688387|7615409|FG007|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684472|NCT02688387|7615410|FG008|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684473|NCT02688387|7615411|FG009|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684474|NCT02688387|7615412|FG010|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684475|NCT02688387|7615413|FG011|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684476|NCT02688387|7615414|FG012|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684477|NCT02688387|7615415|FG013|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684478|NCT02688387|7615416|FG014|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
6684479|NCT02688387|7615417|FG015|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
6684480|NCT02688387|7615418|FG016|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
6684481|NCT02688387|7615419|FG017|COMPLETED|Part 3A, Period 1 (up to 6 Days)||8
6684482|NCT02688387|7615420|FG018|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684483|NCT02688387|7615421|FG019|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684484|NCT02688387|7615422|FG020|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684485|NCT02688387|7615423|FG021|COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684486|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684487|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684488|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684489|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684490|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684491|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684492|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684493|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684494|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684495|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684496|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684497|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684498|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684499|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684500|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||1
6684501|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684502|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684503|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684504|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684505|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684506|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684507|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3A, Period 1 (up to 6 Days)||0
6684508|NCT02688387|7615402|FG000|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684509|NCT02688387|7615403|FG001|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684510|NCT02688387|7615404|FG002|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684511|NCT02688387|7615405|FG003|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684512|NCT02688387|7615406|FG004|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684513|NCT02688387|7615407|FG005|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684514|NCT02688387|7615408|FG006|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684515|NCT02688387|7615409|FG007|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684516|NCT02688387|7615410|FG008|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684517|NCT02688387|7615411|FG009|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684518|NCT02688387|7615412|FG010|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684519|NCT02688387|7615413|FG011|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684520|NCT02688387|7615414|FG012|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684521|NCT02688387|7615415|FG013|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684522|NCT02688387|7615416|FG014|STARTED|Part 3A, Washout Period 1 (10 Days)||8
6684523|NCT02688387|7615417|FG015|STARTED|Part 3A, Washout Period 1 (10 Days)||8
6684524|NCT02688387|7615418|FG016|STARTED|Part 3A, Washout Period 1 (10 Days)||8
6684525|NCT02688387|7615419|FG017|STARTED|Part 3A, Washout Period 1 (10 Days)||8
6684526|NCT02688387|7615420|FG018|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684527|NCT02688387|7615421|FG019|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684528|NCT02688387|7615422|FG020|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684529|NCT02688387|7615423|FG021|STARTED|Part 3A, Washout Period 1 (10 Days)||0
6684530|NCT02688387|7615402|FG000|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684531|NCT02688387|7615403|FG001|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684532|NCT02688387|7615404|FG002|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684533|NCT02688387|7615405|FG003|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684534|NCT02688387|7615406|FG004|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684535|NCT02688387|7615407|FG005|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684536|NCT02688387|7615408|FG006|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684537|NCT02688387|7615409|FG007|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684538|NCT02688387|7615410|FG008|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684539|NCT02688387|7615411|FG009|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684540|NCT02688387|7615412|FG010|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684541|NCT02688387|7615413|FG011|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684542|NCT02688387|7615414|FG012|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684543|NCT02688387|7615415|FG013|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684544|NCT02688387|7615416|FG014|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
6684545|NCT02688387|7615417|FG015|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
6684546|NCT02688387|7615418|FG016|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
6684547|NCT02688387|7615419|FG017|COMPLETED|Part 3A, Washout Period 1 (10 Days)||8
6684548|NCT02688387|7615420|FG018|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684549|NCT02688387|7615421|FG019|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684550|NCT02688387|7615422|FG020|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684551|NCT02688387|7615423|FG021|COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684552|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684553|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684554|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684555|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684556|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684557|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684558|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684559|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684560|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684561|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684562|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684563|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684564|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684565|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684566|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684567|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684568|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684569|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684570|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684571|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684572|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684573|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3A, Washout Period 1 (10 Days)||0
6684574|NCT02688387|7615402|FG000|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684575|NCT02688387|7615403|FG001|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684576|NCT02688387|7615404|FG002|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684577|NCT02688387|7615405|FG003|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684578|NCT02688387|7615406|FG004|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684579|NCT02688387|7615407|FG005|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684580|NCT02688387|7615408|FG006|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684581|NCT02688387|7615409|FG007|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684582|NCT02688387|7615410|FG008|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684583|NCT02688387|7615411|FG009|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684584|NCT02688387|7615412|FG010|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684585|NCT02688387|7615413|FG011|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684586|NCT02688387|7615414|FG012|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684587|NCT02688387|7615415|FG013|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684588|NCT02688387|7615416|FG014|STARTED|Part 3A, Period 2 (up to 6 Days)||8
6684589|NCT02688387|7615417|FG015|STARTED|Part 3A, Period 2 (up to 6 Days)||8
6684590|NCT02688387|7615418|FG016|STARTED|Part 3A, Period 2 (up to 6 Days)||8
6684591|NCT02688387|7615419|FG017|STARTED|Part 3A, Period 2 (up to 6 Days)||8
6684592|NCT02688387|7615420|FG018|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684593|NCT02688387|7615421|FG019|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684594|NCT02688387|7615422|FG020|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684595|NCT02688387|7615423|FG021|STARTED|Part 3A, Period 2 (up to 6 Days)||0
6684596|NCT02688387|7615402|FG000|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684597|NCT02688387|7615403|FG001|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6256931|NCT04084769|7155873|FG001|COMPLETED|Overall Study||186
6684598|NCT02688387|7615404|FG002|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684599|NCT02688387|7615405|FG003|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684600|NCT02688387|7615406|FG004|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684601|NCT02688387|7615407|FG005|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684602|NCT02688387|7615408|FG006|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684603|NCT02688387|7615409|FG007|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684604|NCT02688387|7615410|FG008|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684605|NCT02688387|7615411|FG009|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684606|NCT02688387|7615412|FG010|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684607|NCT02688387|7615413|FG011|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684608|NCT02688387|7615414|FG012|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684609|NCT02688387|7615415|FG013|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684610|NCT02688387|7615416|FG014|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
6684611|NCT02688387|7615417|FG015|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
6684612|NCT02688387|7615418|FG016|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
6684613|NCT02688387|7615419|FG017|COMPLETED|Part 3A, Period 2 (up to 6 Days)||8
6684614|NCT02688387|7615420|FG018|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684615|NCT02688387|7615421|FG019|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684616|NCT02688387|7615422|FG020|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684617|NCT02688387|7615423|FG021|COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684618|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684619|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684620|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684621|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684622|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684623|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684624|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684625|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684626|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684627|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684628|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684629|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684630|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684631|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684632|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684633|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684634|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684635|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684636|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684637|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684638|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684639|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3A, Period 2 (up to 6 Days)||0
6684640|NCT02688387|7615402|FG000|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684641|NCT02688387|7615403|FG001|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684642|NCT02688387|7615404|FG002|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684643|NCT02688387|7615405|FG003|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684644|NCT02688387|7615406|FG004|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684645|NCT02688387|7615407|FG005|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684646|NCT02688387|7615408|FG006|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684647|NCT02688387|7615409|FG007|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684648|NCT02688387|7615410|FG008|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684649|NCT02688387|7615411|FG009|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684650|NCT02688387|7615412|FG010|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684651|NCT02688387|7615413|FG011|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684652|NCT02688387|7615414|FG012|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684653|NCT02688387|7615415|FG013|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684654|NCT02688387|7615416|FG014|STARTED|Part 3A, Washout Period 2 (10 Days)||8
6684655|NCT02688387|7615417|FG015|STARTED|Part 3A, Washout Period 2 (10 Days)||8
6684656|NCT02688387|7615418|FG016|STARTED|Part 3A, Washout Period 2 (10 Days)||8
6684657|NCT02688387|7615419|FG017|STARTED|Part 3A, Washout Period 2 (10 Days)||8
6684658|NCT02688387|7615420|FG018|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684659|NCT02688387|7615421|FG019|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684660|NCT02688387|7615422|FG020|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684661|NCT02688387|7615423|FG021|STARTED|Part 3A, Washout Period 2 (10 Days)||0
6684662|NCT02688387|7615402|FG000|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684663|NCT02688387|7615403|FG001|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684664|NCT02688387|7615404|FG002|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684665|NCT02688387|7615405|FG003|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6256932|NCT04084769|7155874|FG002|COMPLETED|Overall Study||95
6256933|NCT04084769|7155875|FG003|COMPLETED|Overall Study||92
6256934|NCT04084769|7155872|FG000|NOT COMPLETED|Overall Study||4
6256935|NCT04084769|7155873|FG001|NOT COMPLETED|Overall Study||4
6256936|NCT04084769|7155874|FG002|NOT COMPLETED|Overall Study||0
6256937|NCT04084769|7155875|FG003|NOT COMPLETED|Overall Study||2
6256938|NCT04024228|7155892|FG000|STARTED|Overall Study||774
6256939|NCT04024228|7155893|FG001|STARTED|Overall Study||765
6684666|NCT02688387|7615406|FG004|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684667|NCT02688387|7615407|FG005|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684668|NCT02688387|7615408|FG006|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684669|NCT02688387|7615409|FG007|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684670|NCT02688387|7615410|FG008|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684671|NCT02688387|7615411|FG009|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684672|NCT02688387|7615412|FG010|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684673|NCT02688387|7615413|FG011|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684674|NCT02688387|7615414|FG012|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684675|NCT02688387|7615415|FG013|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684676|NCT02688387|7615416|FG014|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
6684677|NCT02688387|7615417|FG015|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
6684678|NCT02688387|7615418|FG016|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
6684679|NCT02688387|7615419|FG017|COMPLETED|Part 3A, Washout Period 2 (10 Days)||8
6684680|NCT02688387|7615420|FG018|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684681|NCT02688387|7615421|FG019|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684682|NCT02688387|7615422|FG020|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684683|NCT02688387|7615423|FG021|COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684684|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684685|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684686|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684687|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684688|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684689|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684690|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684691|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684692|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684693|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684694|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684695|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684696|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684697|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684698|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684699|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684700|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684701|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684702|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684703|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684704|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684705|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3A, Washout Period 2 (10 Days)||0
6684706|NCT02688387|7615402|FG000|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684707|NCT02688387|7615403|FG001|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684708|NCT02688387|7615404|FG002|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684709|NCT02688387|7615405|FG003|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684710|NCT02688387|7615406|FG004|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684711|NCT02688387|7615407|FG005|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684712|NCT02688387|7615408|FG006|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684713|NCT02688387|7615409|FG007|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684714|NCT02688387|7615410|FG008|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684715|NCT02688387|7615411|FG009|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684716|NCT02688387|7615412|FG010|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684717|NCT02688387|7615413|FG011|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684718|NCT02688387|7615414|FG012|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684719|NCT02688387|7615415|FG013|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684720|NCT02688387|7615416|FG014|STARTED|Part 3A, Period 3 (up to 6 Days)||8
6684721|NCT02688387|7615417|FG015|STARTED|Part 3A, Period 3 (up to 6 Days)||8
6684722|NCT02688387|7615418|FG016|STARTED|Part 3A, Period 3 (up to 6 Days)||8
6684723|NCT02688387|7615419|FG017|STARTED|Part 3A, Period 3 (up to 6 Days)||8
6684724|NCT02688387|7615420|FG018|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684725|NCT02688387|7615421|FG019|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684726|NCT02688387|7615422|FG020|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684727|NCT02688387|7615423|FG021|STARTED|Part 3A, Period 3 (up to 6 Days)||0
6684728|NCT02688387|7615402|FG000|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684729|NCT02688387|7615403|FG001|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684730|NCT02688387|7615404|FG002|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684731|NCT02688387|7615405|FG003|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684732|NCT02688387|7615406|FG004|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684733|NCT02688387|7615407|FG005|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684734|NCT02688387|7615408|FG006|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684735|NCT02688387|7615409|FG007|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684736|NCT02688387|7615410|FG008|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684737|NCT02688387|7615411|FG009|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6256940|NCT04024228|7155892|FG000|Vaccinated|Overall Study||772
6256941|NCT04024228|7155893|FG001|Vaccinated|Overall Study||761
6256942|NCT04024228|7155892|FG000|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 392 participants (>=65 years).|769
6256943|NCT04024228|7155893|FG001|Full Analysis Set (FAS)|Overall Study|377 participants (60-64 years) and 381 participants (>=65 years).|758
6684738|NCT02688387|7615412|FG010|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684739|NCT02688387|7615413|FG011|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684740|NCT02688387|7615414|FG012|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684741|NCT02688387|7615415|FG013|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684742|NCT02688387|7615416|FG014|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
6684743|NCT02688387|7615417|FG015|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
6684744|NCT02688387|7615418|FG016|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
6684745|NCT02688387|7615419|FG017|COMPLETED|Part 3A, Period 3 (up to 6 Days)||8
6684746|NCT02688387|7615420|FG018|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684747|NCT02688387|7615421|FG019|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684748|NCT02688387|7615422|FG020|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684749|NCT02688387|7615423|FG021|COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684750|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684751|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684752|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684753|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684754|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684755|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684756|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684757|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684758|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684759|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684760|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684761|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684762|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684763|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684764|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684765|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684766|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684767|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684768|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684769|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684770|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684771|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3A, Period 3 (up to 6 Days)||0
6684772|NCT02688387|7615402|FG000|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684773|NCT02688387|7615403|FG001|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684774|NCT02688387|7615404|FG002|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684775|NCT02688387|7615405|FG003|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684776|NCT02688387|7615406|FG004|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684777|NCT02688387|7615407|FG005|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684778|NCT02688387|7615408|FG006|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684779|NCT02688387|7615409|FG007|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6256944|NCT04024228|7155892|FG000|COMPLETED|Overall Study||770
6256945|NCT04024228|7155893|FG001|COMPLETED|Overall Study||759
6256946|NCT04024228|7155892|FG000|NOT COMPLETED|Overall Study||4
6256947|NCT04024228|7155893|FG001|NOT COMPLETED|Overall Study||6
6256948|NCT03996148|7155904|FG000|STARTED|Overall Study||7
6256949|NCT03996148|7155905|FG001|STARTED|Overall Study||7
6256950|NCT03996148|7155906|FG002|STARTED|Overall Study||7
6256951|NCT03996148|7155904|FG000|COMPLETED|Overall Study||7
6256952|NCT03996148|7155905|FG001|COMPLETED|Overall Study||6
6256953|NCT03996148|7155906|FG002|COMPLETED|Overall Study||7
6256954|NCT03996148|7155904|FG000|NOT COMPLETED|Overall Study||0
6256955|NCT03996148|7155905|FG001|NOT COMPLETED|Overall Study||1
6256956|NCT03996148|7155906|FG002|NOT COMPLETED|Overall Study||0
6256957|NCT03980938|7155916|FG000|STARTED|Treatment Period 1||7
6256958|NCT03980938|7155917|FG001|STARTED|Treatment Period 1||8
6256959|NCT03980938|7155916|FG000|COMPLETED|Treatment Period 1||6
6256960|NCT03980938|7155917|FG001|COMPLETED|Treatment Period 1||7
6256961|NCT03980938|7155916|FG000|NOT COMPLETED|Treatment Period 1||1
6256962|NCT03980938|7155917|FG001|NOT COMPLETED|Treatment Period 1||1
6256963|NCT03980938|7155916|FG000|STARTED|Treatment Period 2||3
6256964|NCT03980938|7155917|FG001|STARTED|Treatment Period 2||2
6256965|NCT03980938|7155916|FG000|COMPLETED|Treatment Period 2|One participant completed the study remotely. On-site visits were no longer permitted due to COVID-19 pandemic. Visits were conducted remotely for Weeks 8 and 10 of Treatment Period 2, and the follow-up visit.|1
6256966|NCT03980938|7155917|FG001|COMPLETED|Treatment Period 2||0
6256967|NCT03980938|7155916|FG000|NOT COMPLETED|Treatment Period 2||2
6684780|NCT02688387|7615410|FG008|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684781|NCT02688387|7615411|FG009|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684782|NCT02688387|7615412|FG010|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684783|NCT02688387|7615413|FG011|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684784|NCT02688387|7615414|FG012|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684785|NCT02688387|7615415|FG013|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684786|NCT02688387|7615416|FG014|STARTED|Part 3A, Washout Period 3 (10 Days)||8
6684787|NCT02688387|7615417|FG015|STARTED|Part 3A, Washout Period 3 (10 Days)||8
6256968|NCT03980938|7155917|FG001|NOT COMPLETED|Treatment Period 2||2
6256969|NCT03863353|7155925|FG000|STARTED|Overall Study||282
6256970|NCT03863353|7155926|FG001|STARTED|Overall Study||221
6256971|NCT03863353|7155925|FG000|COMPLETED|Overall Study||258
6684788|NCT02688387|7615418|FG016|STARTED|Part 3A, Washout Period 3 (10 Days)||8
6684789|NCT02688387|7615419|FG017|STARTED|Part 3A, Washout Period 3 (10 Days)||8
6684790|NCT02688387|7615420|FG018|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684791|NCT02688387|7615421|FG019|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684792|NCT02688387|7615422|FG020|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684793|NCT02688387|7615423|FG021|STARTED|Part 3A, Washout Period 3 (10 Days)||0
6684794|NCT02688387|7615402|FG000|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684795|NCT02688387|7615403|FG001|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684796|NCT02688387|7615404|FG002|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684797|NCT02688387|7615405|FG003|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684798|NCT02688387|7615406|FG004|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684799|NCT02688387|7615407|FG005|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684800|NCT02688387|7615408|FG006|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684801|NCT02688387|7615409|FG007|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6256972|NCT03863353|7155926|FG001|COMPLETED|Overall Study||201
6256973|NCT03863353|7155925|FG000|NOT COMPLETED|Overall Study||24
6256974|NCT03863353|7155926|FG001|NOT COMPLETED|Overall Study||20
6279511|NCT00146172|7179331|FG006|Received Drug|Overall Study||6
6279512|NCT00146172|7179332|FG007|Received Drug|Overall Study||39
6279513|NCT00146172|7179325|FG000|COMPLETED|Overall Study||0
6279514|NCT00146172|7179326|FG001|COMPLETED|Overall Study||0
6279515|NCT00146172|7179327|FG002|COMPLETED|Overall Study||0
6279516|NCT00146172|7179328|FG003|COMPLETED|Overall Study||0
6279517|NCT00146172|7179329|FG004|COMPLETED|Overall Study||0
6279518|NCT00146172|7179330|FG005|COMPLETED|Overall Study||0
6279519|NCT00146172|7179331|FG006|COMPLETED|Overall Study||0
6279520|NCT00146172|7179332|FG007|COMPLETED|Overall Study||0
6279521|NCT00146172|7179325|FG000|NOT COMPLETED|Overall Study||3
6279522|NCT00146172|7179326|FG001|NOT COMPLETED|Overall Study||4
6279523|NCT00146172|7179327|FG002|NOT COMPLETED|Overall Study||4
6279524|NCT00146172|7179328|FG003|NOT COMPLETED|Overall Study||6
6279525|NCT00146172|7179329|FG004|NOT COMPLETED|Overall Study||3
6279526|NCT00146172|7179330|FG005|NOT COMPLETED|Overall Study||7
6279527|NCT00146172|7179331|FG006|NOT COMPLETED|Overall Study||6
6279528|NCT00146172|7179332|FG007|NOT COMPLETED|Overall Study||40
6279529|NCT00146328|7179361|FG000|STARTED|Overall Study||291
6279530|NCT00146328|7179362|FG001|STARTED|Overall Study||255
6279531|NCT00146328|7179363|FG002|STARTED|Overall Study||449
6279532|NCT00146328|7179361|FG000|COMPLETED|Overall Study||150
6279533|NCT00146328|7179362|FG001|COMPLETED|Overall Study||101
6279534|NCT00146328|7179363|FG002|COMPLETED|Overall Study||158
6279535|NCT00146328|7179361|FG000|NOT COMPLETED|Overall Study||141
6279536|NCT00146328|7179362|FG001|NOT COMPLETED|Overall Study||154
6279537|NCT00146328|7179363|FG002|NOT COMPLETED|Overall Study||291
6279538|NCT00146640|7179373|FG000|STARTED|Overall Study||144
6279539|NCT00146640|7179374|FG001|STARTED|Overall Study||144
6279540|NCT00146640|7179373|FG000|COMPLETED|Overall Study||121
6279541|NCT00146640|7179374|FG001|COMPLETED|Overall Study||130
6279542|NCT00146640|7179373|FG000|NOT COMPLETED|Overall Study||23
6279543|NCT00146640|7179374|FG001|NOT COMPLETED|Overall Study||14
6279544|NCT00146757|7179380|FG000|STARTED|Overall Study||16
6279545|NCT00146757|7179381|FG001|STARTED|Overall Study||4
6279546|NCT00146757|7179380|FG000|COMPLETED|Overall Study||14
6279547|NCT00146757|7179381|FG001|COMPLETED|Overall Study||4
6279548|NCT00146757|7179380|FG000|NOT COMPLETED|Overall Study||2
6279549|NCT00146757|7179381|FG001|NOT COMPLETED|Overall Study||0
6279550|NCT00146770|7179389|FG000|STARTED|Overall Study||23
6279551|NCT00146770|7179390|FG001|STARTED|Overall Study||22
6279552|NCT00146770|7179389|FG000|COMPLETED|Overall Study||18
6279553|NCT00146770|7179390|FG001|COMPLETED|Overall Study||22
6279554|NCT00146770|7179389|FG000|NOT COMPLETED|Overall Study||5
6279555|NCT00146770|7179390|FG001|NOT COMPLETED|Overall Study||0
6279556|NCT00146848|7179399|FG000|STARTED|Pre-randomization|Registered|1742
6279557|NCT00146848|7179400|FG001|STARTED|Pre-randomization||0
6279558|NCT00146848|7179401|FG002|STARTED|Pre-randomization||0
6279559|NCT00146848|7179399|FG000|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
6279560|NCT00146848|7179400|FG001|COMPLETED|Pre-randomization||0
6279561|NCT00146848|7179401|FG002|COMPLETED|Pre-randomization||0
6279562|NCT00146848|7179399|FG000|NOT COMPLETED|Pre-randomization||309
6279563|NCT00146848|7179400|FG001|NOT COMPLETED|Pre-randomization||0
6279564|NCT00146848|7179401|FG002|NOT COMPLETED|Pre-randomization||0
6279565|NCT00146848|7179399|FG000|STARTED|Post-randomization||475
6279566|NCT00146848|7179400|FG001|STARTED|Post-randomization||488
6279567|NCT00146848|7179401|FG002|STARTED|Post-randomization||470
6279568|NCT00146848|7179399|FG000|COMPLETED|Post-randomization||437
6279569|NCT00146848|7179400|FG001|COMPLETED|Post-randomization||441
6279570|NCT00146848|7179401|FG002|COMPLETED|Post-randomization||431
6279571|NCT00146848|7179399|FG000|NOT COMPLETED|Post-randomization||38
6279572|NCT00146848|7179400|FG001|NOT COMPLETED|Post-randomization||47
6279573|NCT00146848|7179401|FG002|NOT COMPLETED|Post-randomization||39
6279574|NCT00147017|7179412|FG000|STARTED|Overall Study||6
6279575|NCT00147017|7179413|FG001|STARTED|Overall Study||7
6279576|NCT00147017|7179414|FG002|STARTED|Overall Study||4
6279577|NCT00147017|7179412|FG000|COMPLETED|Overall Study||6
6279578|NCT00147017|7179413|FG001|COMPLETED|Overall Study||7
6279579|NCT00147017|7179414|FG002|COMPLETED|Overall Study||4
6279580|NCT00147017|7179412|FG000|NOT COMPLETED|Overall Study||0
6279581|NCT00147017|7179413|FG001|NOT COMPLETED|Overall Study||0
6684802|NCT02688387|7615410|FG008|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684803|NCT02688387|7615411|FG009|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684804|NCT02688387|7615412|FG010|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684805|NCT02688387|7615413|FG011|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684806|NCT02688387|7615414|FG012|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684807|NCT02688387|7615415|FG013|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684808|NCT02688387|7615416|FG014|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
6684809|NCT02688387|7615417|FG015|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
6684810|NCT02688387|7615418|FG016|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
6684811|NCT02688387|7615419|FG017|COMPLETED|Part 3A, Washout Period 3 (10 Days)||8
6684812|NCT02688387|7615420|FG018|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684813|NCT02688387|7615421|FG019|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684814|NCT02688387|7615422|FG020|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684815|NCT02688387|7615423|FG021|COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684816|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684817|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684818|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684819|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684820|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684821|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684822|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684823|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684824|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6256975|NCT03622593|7155935|FG000|STARTED|Overall Study||317
6256976|NCT03622593|7155936|FG001|STARTED|Overall Study||319
6256977|NCT03622593|7155937|FG002|STARTED|Overall Study||315
6256978|NCT03622593|7155935|FG000|Received at Least One Dose of Study Drug|Overall Study||317
6256979|NCT03622593|7155936|FG001|Received at Least One Dose of Study Drug|Overall Study||319
6256980|NCT03622593|7155937|FG002|Received at Least One Dose of Study Drug|Overall Study||314
6256981|NCT03622593|7155935|FG000|Completed up to Week 56|Overall Study||298
6256982|NCT03622593|7155936|FG001|Completed up to Week 56|Overall Study||312
6256983|NCT03622593|7155937|FG002|Completed up to Week 56|Overall Study||299
6256984|NCT03622593|7155935|FG000|COMPLETED|Overall Study||0
6256985|NCT03622593|7155936|FG001|COMPLETED|Overall Study||0
6256986|NCT03622593|7155937|FG002|COMPLETED|Overall Study||0
6256987|NCT03622593|7155935|FG000|NOT COMPLETED|Overall Study||317
6256988|NCT03622593|7155936|FG001|NOT COMPLETED|Overall Study||319
6256989|NCT03622593|7155937|FG002|NOT COMPLETED|Overall Study||315
6256990|NCT03622580|7155949|FG000|STARTED|Overall Study||315
6256991|NCT03622580|7155950|FG001|STARTED|Overall Study||313
6256992|NCT03622580|7155951|FG002|STARTED|Overall Study||312
6256993|NCT03622580|7155949|FG000|Received at Least One Dose of Study Drug|Overall Study||313
6256994|NCT03622580|7155950|FG001|Received at Least One Dose of Study Drug|Overall Study||313
6256995|NCT03622580|7155951|FG002|Received at Least One Dose of Study Drug|Overall Study||311
6256996|NCT03622580|7155949|FG000|Completed up to Week 56|Overall Study||291
6256997|NCT03622580|7155950|FG001|Completed up to Week 56|Overall Study||289
6256998|NCT03622580|7155951|FG002|Completed up to Week 56|Overall Study||292
6256999|NCT03622580|7155949|FG000|COMPLETED|Overall Study||0
6257000|NCT03622580|7155950|FG001|COMPLETED|Overall Study||0
6257001|NCT03622580|7155951|FG002|COMPLETED|Overall Study||0
6257002|NCT03622580|7155949|FG000|NOT COMPLETED|Overall Study||315
6684825|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684826|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684827|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6257003|NCT03622580|7155950|FG001|NOT COMPLETED|Overall Study||313
6257004|NCT03622580|7155951|FG002|NOT COMPLETED|Overall Study||312
6257005|NCT03572634|7155962|FG000|STARTED|Overall Study||1
6257006|NCT03572634|7155963|FG001|STARTED|Overall Study||2
6257007|NCT03572634|7155962|FG000|COMPLETED|Overall Study||1
6257008|NCT03572634|7155963|FG001|COMPLETED|Overall Study||2
6257009|NCT03572634|7155962|FG000|NOT COMPLETED|Overall Study||0
6257010|NCT03572634|7155963|FG001|NOT COMPLETED|Overall Study||0
6257011|NCT03562156|7155972|FG000|STARTED|Overall Study||217
6257012|NCT03562156|7155973|FG001|STARTED|Overall Study||109
6257013|NCT03562156|7155972|FG000|COMPLETED|Overall Study||182
6257014|NCT03562156|7155973|FG001|COMPLETED|Overall Study||91
6257015|NCT03562156|7155972|FG000|NOT COMPLETED|Overall Study||35
6257016|NCT03562156|7155973|FG001|NOT COMPLETED|Overall Study||18
6257017|NCT03476135|7155981|FG000|STARTED|Overall Study||42
6257018|NCT03476135|7155982|FG001|STARTED|Overall Study||49
6257019|NCT03476135|7155981|FG000|COMPLETED|Overall Study||42
6257020|NCT03476135|7155982|FG001|COMPLETED|Overall Study||49
6257021|NCT03476135|7155981|FG000|NOT COMPLETED|Overall Study||0
6257022|NCT03476135|7155982|FG001|NOT COMPLETED|Overall Study||0
6257023|NCT03333928|7155991|FG000|STARTED|Initial Dosing Period (Period 1)||16
6257024|NCT03333928|7155992|FG001|STARTED|Initial Dosing Period (Period 1)||25
6257025|NCT03333928|7155993|FG002|STARTED|Initial Dosing Period (Period 1)||18
6257026|NCT03333928|7155991|FG000|COMPLETED|Initial Dosing Period (Period 1)||15
6257027|NCT03333928|7155992|FG001|COMPLETED|Initial Dosing Period (Period 1)||21
6257028|NCT03333928|7155993|FG002|COMPLETED|Initial Dosing Period (Period 1)||14
6257029|NCT03333928|7155991|FG000|NOT COMPLETED|Initial Dosing Period (Period 1)||1
6257030|NCT03333928|7155992|FG001|NOT COMPLETED|Initial Dosing Period (Period 1)||4
6684828|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684829|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684830|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684831|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684832|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684833|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684834|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684835|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684836|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684837|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3A, Washout Period 3 (10 Days)||0
6684838|NCT02688387|7615402|FG000|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684839|NCT02688387|7615403|FG001|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684840|NCT02688387|7615404|FG002|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684841|NCT02688387|7615405|FG003|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684842|NCT02688387|7615406|FG004|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684843|NCT02688387|7615407|FG005|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684844|NCT02688387|7615408|FG006|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684845|NCT02688387|7615409|FG007|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684846|NCT02688387|7615410|FG008|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684847|NCT02688387|7615411|FG009|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684848|NCT02688387|7615412|FG010|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684849|NCT02688387|7615413|FG011|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684850|NCT02688387|7615414|FG012|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684851|NCT02688387|7615415|FG013|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684852|NCT02688387|7615416|FG014|STARTED|Part 3A, Period 4 (up to 6 Days)||8
6684853|NCT02688387|7615417|FG015|STARTED|Part 3A, Period 4 (up to 6 Days)||8
6684854|NCT02688387|7615418|FG016|STARTED|Part 3A, Period 4 (up to 6 Days)||8
6684855|NCT02688387|7615419|FG017|STARTED|Part 3A, Period 4 (up to 6 Days)||8
6684856|NCT02688387|7615420|FG018|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684857|NCT02688387|7615421|FG019|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684858|NCT02688387|7615422|FG020|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684859|NCT02688387|7615423|FG021|STARTED|Part 3A, Period 4 (up to 6 Days)||0
6684860|NCT02688387|7615402|FG000|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684861|NCT02688387|7615403|FG001|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684862|NCT02688387|7615404|FG002|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684863|NCT02688387|7615405|FG003|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684864|NCT02688387|7615406|FG004|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684865|NCT02688387|7615407|FG005|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684866|NCT02688387|7615408|FG006|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684867|NCT02688387|7615409|FG007|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684868|NCT02688387|7615410|FG008|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684869|NCT02688387|7615411|FG009|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684870|NCT02688387|7615412|FG010|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684871|NCT02688387|7615413|FG011|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684872|NCT02688387|7615414|FG012|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684873|NCT02688387|7615415|FG013|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684874|NCT02688387|7615416|FG014|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
6684875|NCT02688387|7615417|FG015|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
6684876|NCT02688387|7615418|FG016|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
6684877|NCT02688387|7615419|FG017|COMPLETED|Part 3A, Period 4 (up to 6 Days)||8
6684878|NCT02688387|7615420|FG018|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684879|NCT02688387|7615421|FG019|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684880|NCT02688387|7615422|FG020|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684881|NCT02688387|7615423|FG021|COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684882|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684883|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684884|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684885|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684886|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684887|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684888|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684889|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684890|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684891|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684892|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684893|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684894|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684895|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684896|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684897|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684898|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684899|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684900|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684901|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684902|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684903|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3A, Period 4 (up to 6 Days)||0
6684904|NCT02688387|7615402|FG000|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684905|NCT02688387|7615403|FG001|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684906|NCT02688387|7615404|FG002|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684907|NCT02688387|7615405|FG003|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684908|NCT02688387|7615406|FG004|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684909|NCT02688387|7615407|FG005|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684910|NCT02688387|7615408|FG006|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684911|NCT02688387|7615409|FG007|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684912|NCT02688387|7615410|FG008|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684913|NCT02688387|7615411|FG009|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684914|NCT02688387|7615412|FG010|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684915|NCT02688387|7615413|FG011|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684916|NCT02688387|7615414|FG012|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684917|NCT02688387|7615415|FG013|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684918|NCT02688387|7615416|FG014|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684919|NCT02688387|7615417|FG015|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684920|NCT02688387|7615418|FG016|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684921|NCT02688387|7615419|FG017|STARTED|Part 3B, Period 1 (up to 6 Days)||0
6684922|NCT02688387|7615420|FG018|STARTED|Part 3B, Period 1 (up to 6 Days)||8
6684923|NCT02688387|7615421|FG019|STARTED|Part 3B, Period 1 (up to 6 Days)||8
6684924|NCT02688387|7615422|FG020|STARTED|Part 3B, Period 1 (up to 6 Days)||8
6684925|NCT02688387|7615423|FG021|STARTED|Part 3B, Period 1 (up to 6 Days)||8
6684926|NCT02688387|7615402|FG000|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684927|NCT02688387|7615403|FG001|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684928|NCT02688387|7615404|FG002|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684929|NCT02688387|7615405|FG003|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684930|NCT02688387|7615406|FG004|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684931|NCT02688387|7615407|FG005|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684932|NCT02688387|7615408|FG006|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684933|NCT02688387|7615409|FG007|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684934|NCT02688387|7615410|FG008|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684935|NCT02688387|7615411|FG009|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684936|NCT02688387|7615412|FG010|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684937|NCT02688387|7615413|FG011|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684938|NCT02688387|7615414|FG012|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684939|NCT02688387|7615415|FG013|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684940|NCT02688387|7615416|FG014|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684941|NCT02688387|7615417|FG015|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684942|NCT02688387|7615418|FG016|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684943|NCT02688387|7615419|FG017|COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684944|NCT02688387|7615420|FG018|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
6684945|NCT02688387|7615421|FG019|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
6684946|NCT02688387|7615422|FG020|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
6684947|NCT02688387|7615423|FG021|COMPLETED|Part 3B, Period 1 (up to 6 Days)||8
6684948|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684949|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684950|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684951|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684952|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684953|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684954|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684955|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684956|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684957|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684958|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684959|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684960|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684961|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684962|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684963|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684964|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684965|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684966|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684967|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684968|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684969|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3B, Period 1 (up to 6 Days)||0
6684970|NCT02688387|7615402|FG000|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684971|NCT02688387|7615403|FG001|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684972|NCT02688387|7615404|FG002|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684973|NCT02688387|7615405|FG003|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684974|NCT02688387|7615406|FG004|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684975|NCT02688387|7615407|FG005|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684976|NCT02688387|7615408|FG006|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684977|NCT02688387|7615409|FG007|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684978|NCT02688387|7615410|FG008|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684979|NCT02688387|7615411|FG009|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684980|NCT02688387|7615412|FG010|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684981|NCT02688387|7615413|FG011|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684982|NCT02688387|7615414|FG012|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684983|NCT02688387|7615415|FG013|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684984|NCT02688387|7615416|FG014|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684985|NCT02688387|7615417|FG015|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684986|NCT02688387|7615418|FG016|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684987|NCT02688387|7615419|FG017|STARTED|Part 3B, Washout Period 1 (10 Days)||0
6684988|NCT02688387|7615420|FG018|STARTED|Part 3B, Washout Period 1 (10 Days)||8
6684989|NCT02688387|7615421|FG019|STARTED|Part 3B, Washout Period 1 (10 Days)||8
6684990|NCT02688387|7615422|FG020|STARTED|Part 3B, Washout Period 1 (10 Days)||8
6684991|NCT02688387|7615423|FG021|STARTED|Part 3B, Washout Period 1 (10 Days)||8
6684992|NCT02688387|7615402|FG000|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6684993|NCT02688387|7615403|FG001|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6684994|NCT02688387|7615404|FG002|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6684995|NCT02688387|7615405|FG003|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6684996|NCT02688387|7615406|FG004|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6684997|NCT02688387|7615407|FG005|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6684998|NCT02688387|7615408|FG006|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6684999|NCT02688387|7615409|FG007|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685000|NCT02688387|7615410|FG008|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685001|NCT02688387|7615411|FG009|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685002|NCT02688387|7615412|FG010|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685003|NCT02688387|7615413|FG011|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685004|NCT02688387|7615414|FG012|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685005|NCT02688387|7615415|FG013|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685006|NCT02688387|7615416|FG014|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685007|NCT02688387|7615417|FG015|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685008|NCT02688387|7615418|FG016|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685009|NCT02688387|7615419|FG017|COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685010|NCT02688387|7615420|FG018|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
6685011|NCT02688387|7615421|FG019|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
6685012|NCT02688387|7615422|FG020|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
6685013|NCT02688387|7615423|FG021|COMPLETED|Part 3B, Washout Period 1 (10 Days)||8
6685014|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685015|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685016|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685017|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685018|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685019|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685020|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685021|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685022|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685023|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685024|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685025|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685026|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685027|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685028|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685029|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685030|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685031|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685032|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685033|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685034|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685035|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3B, Washout Period 1 (10 Days)||0
6685036|NCT02688387|7615402|FG000|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685037|NCT02688387|7615403|FG001|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685038|NCT02688387|7615404|FG002|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685039|NCT02688387|7615405|FG003|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685040|NCT02688387|7615406|FG004|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685041|NCT02688387|7615407|FG005|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685042|NCT02688387|7615408|FG006|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685043|NCT02688387|7615409|FG007|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685044|NCT02688387|7615410|FG008|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685045|NCT02688387|7615411|FG009|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685046|NCT02688387|7615412|FG010|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685047|NCT02688387|7615413|FG011|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685048|NCT02688387|7615414|FG012|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685049|NCT02688387|7615415|FG013|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685050|NCT02688387|7615416|FG014|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685051|NCT02688387|7615417|FG015|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685052|NCT02688387|7615418|FG016|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685053|NCT02688387|7615419|FG017|STARTED|Part 3B, Period 2 (up to 6 Days)||0
6685054|NCT02688387|7615420|FG018|STARTED|Part 3B, Period 2 (up to 6 Days)||8
6685055|NCT02688387|7615421|FG019|STARTED|Part 3B, Period 2 (up to 6 Days)||8
6685056|NCT02688387|7615422|FG020|STARTED|Part 3B, Period 2 (up to 6 Days)||8
6685057|NCT02688387|7615423|FG021|STARTED|Part 3B, Period 2 (up to 6 Days)||8
6685058|NCT02688387|7615402|FG000|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685059|NCT02688387|7615403|FG001|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685060|NCT02688387|7615404|FG002|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685061|NCT02688387|7615405|FG003|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685062|NCT02688387|7615406|FG004|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685063|NCT02688387|7615407|FG005|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685064|NCT02688387|7615408|FG006|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685065|NCT02688387|7615409|FG007|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685066|NCT02688387|7615410|FG008|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685067|NCT02688387|7615411|FG009|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685068|NCT02688387|7615412|FG010|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685069|NCT02688387|7615413|FG011|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685070|NCT02688387|7615414|FG012|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685071|NCT02688387|7615415|FG013|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685072|NCT02688387|7615416|FG014|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685073|NCT02688387|7615417|FG015|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685074|NCT02688387|7615418|FG016|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685075|NCT02688387|7615419|FG017|COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685076|NCT02688387|7615420|FG018|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
6685077|NCT02688387|7615421|FG019|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
6685078|NCT02688387|7615422|FG020|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
6685079|NCT02688387|7615423|FG021|COMPLETED|Part 3B, Period 2 (up to 6 Days)||8
6685080|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685081|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685082|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685083|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685084|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685085|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685086|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685087|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685088|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685089|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685090|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685091|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685092|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685093|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685094|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685095|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685096|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685097|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685098|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685099|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685100|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685101|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3B, Period 2 (up to 6 Days)||0
6685102|NCT02688387|7615402|FG000|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685103|NCT02688387|7615403|FG001|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685104|NCT02688387|7615404|FG002|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685105|NCT02688387|7615405|FG003|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685106|NCT02688387|7615406|FG004|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685107|NCT02688387|7615407|FG005|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685108|NCT02688387|7615408|FG006|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685109|NCT02688387|7615409|FG007|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6279582|NCT00147017|7179414|FG002|NOT COMPLETED|Overall Study||0
6685110|NCT02688387|7615410|FG008|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685111|NCT02688387|7615411|FG009|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685112|NCT02688387|7615412|FG010|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685113|NCT02688387|7615413|FG011|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685114|NCT02688387|7615414|FG012|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685115|NCT02688387|7615415|FG013|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685116|NCT02688387|7615416|FG014|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685117|NCT02688387|7615417|FG015|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685118|NCT02688387|7615418|FG016|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685119|NCT02688387|7615419|FG017|STARTED|Part 3B, Washout Period 2 (10 Days)||0
6685120|NCT02688387|7615420|FG018|STARTED|Part 3B, Washout Period 2 (10 Days)||8
6685121|NCT02688387|7615421|FG019|STARTED|Part 3B, Washout Period 2 (10 Days)||8
6685122|NCT02688387|7615422|FG020|STARTED|Part 3B, Washout Period 2 (10 Days)||8
6685123|NCT02688387|7615423|FG021|STARTED|Part 3B, Washout Period 2 (10 Days)||8
6685124|NCT02688387|7615402|FG000|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685125|NCT02688387|7615403|FG001|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685126|NCT02688387|7615404|FG002|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685127|NCT02688387|7615405|FG003|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685128|NCT02688387|7615406|FG004|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685129|NCT02688387|7615407|FG005|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685130|NCT02688387|7615408|FG006|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685131|NCT02688387|7615409|FG007|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685132|NCT02688387|7615410|FG008|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685133|NCT02688387|7615411|FG009|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685134|NCT02688387|7615412|FG010|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685135|NCT02688387|7615413|FG011|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685136|NCT02688387|7615414|FG012|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685137|NCT02688387|7615415|FG013|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685138|NCT02688387|7615416|FG014|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685139|NCT02688387|7615417|FG015|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685140|NCT02688387|7615418|FG016|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685141|NCT02688387|7615419|FG017|COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685142|NCT02688387|7615420|FG018|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
6685143|NCT02688387|7615421|FG019|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
6685144|NCT02688387|7615422|FG020|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
6685145|NCT02688387|7615423|FG021|COMPLETED|Part 3B, Washout Period 2 (10 Days)||8
6685146|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685147|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685148|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685149|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685150|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685151|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685152|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685153|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685154|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685155|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685156|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685157|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685158|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685159|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685160|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685161|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685162|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685163|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685164|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685165|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685166|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685167|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3B, Washout Period 2 (10 Days)||0
6685168|NCT02688387|7615402|FG000|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685169|NCT02688387|7615403|FG001|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685170|NCT02688387|7615404|FG002|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685171|NCT02688387|7615405|FG003|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685172|NCT02688387|7615406|FG004|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685173|NCT02688387|7615407|FG005|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685174|NCT02688387|7615408|FG006|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685175|NCT02688387|7615409|FG007|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685176|NCT02688387|7615410|FG008|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685177|NCT02688387|7615411|FG009|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685178|NCT02688387|7615412|FG010|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685179|NCT02688387|7615413|FG011|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685180|NCT02688387|7615414|FG012|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685181|NCT02688387|7615415|FG013|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685182|NCT02688387|7615416|FG014|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685183|NCT02688387|7615417|FG015|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685184|NCT02688387|7615418|FG016|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685185|NCT02688387|7615419|FG017|STARTED|Part 3B, Period 3 (up to 6 Days)||0
6685186|NCT02688387|7615420|FG018|STARTED|Part 3B, Period 3 (up to 6 Days)||8
6685187|NCT02688387|7615421|FG019|STARTED|Part 3B, Period 3 (up to 6 Days)||8
6685188|NCT02688387|7615422|FG020|STARTED|Part 3B, Period 3 (up to 6 Days)||8
6685189|NCT02688387|7615423|FG021|STARTED|Part 3B, Period 3 (up to 6 Days)||8
6685190|NCT02688387|7615402|FG000|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685191|NCT02688387|7615403|FG001|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685192|NCT02688387|7615404|FG002|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685193|NCT02688387|7615405|FG003|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685194|NCT02688387|7615406|FG004|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685195|NCT02688387|7615407|FG005|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685196|NCT02688387|7615408|FG006|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6257031|NCT03333928|7155993|FG002|NOT COMPLETED|Initial Dosing Period (Period 1)||4
6257032|NCT03333928|7155991|FG000|STARTED|Dose-controlled Extension (Period 2)||22
6257033|NCT03333928|7155992|FG001|STARTED|Dose-controlled Extension (Period 2)||29
6257034|NCT03333928|7155993|FG002|STARTED|Dose-controlled Extension (Period 2)||0
6257035|NCT03333928|7155991|FG000|COMPLETED|Dose-controlled Extension (Period 2)||19
6257036|NCT03333928|7155992|FG001|COMPLETED|Dose-controlled Extension (Period 2)||28
6257037|NCT03333928|7155993|FG002|COMPLETED|Dose-controlled Extension (Period 2)||0
6257038|NCT03333928|7155991|FG000|NOT COMPLETED|Dose-controlled Extension (Period 2)||3
6257039|NCT03333928|7155992|FG001|NOT COMPLETED|Dose-controlled Extension (Period 2)||1
6257040|NCT03333928|7155993|FG002|NOT COMPLETED|Dose-controlled Extension (Period 2)||0
6257041|NCT03333928|7155991|FG000|STARTED|Randomized Withdrawal (Period 3)||10
6257042|NCT03333928|7155992|FG001|STARTED|Randomized Withdrawal (Period 3)||14
6257043|NCT03333928|7155993|FG002|STARTED|Randomized Withdrawal (Period 3)||26
6257044|NCT03333928|7155991|FG000|COMPLETED|Randomized Withdrawal (Period 3)||8
6257045|NCT03333928|7155992|FG001|COMPLETED|Randomized Withdrawal (Period 3)||14
6257046|NCT03333928|7155993|FG002|COMPLETED|Randomized Withdrawal (Period 3)||25
6257047|NCT03333928|7155991|FG000|NOT COMPLETED|Randomized Withdrawal (Period 3)||2
6257048|NCT03333928|7155992|FG001|NOT COMPLETED|Randomized Withdrawal (Period 3)||0
6257049|NCT03333928|7155993|FG002|NOT COMPLETED|Randomized Withdrawal (Period 3)||1
6279583|NCT00147030|7179424|FG000|STARTED|Overall Study||163
6279584|NCT00147030|7179425|FG001|STARTED|Overall Study||162
6279585|NCT00147030|7179424|FG000|COMPLETED|Overall Study||163
6279586|NCT00147030|7179425|FG001|COMPLETED|Overall Study||162
6279587|NCT00147030|7179424|FG000|NOT COMPLETED|Overall Study||0
6279588|NCT00147030|7179425|FG001|NOT COMPLETED|Overall Study||0
6279589|NCT00147043|7179433|FG000|STARTED|Overall Study||5
6279590|NCT00147043|7179433|FG000|COMPLETED|Overall Study||5
6279591|NCT00147043|7179433|FG000|NOT COMPLETED|Overall Study||0
6279592|NCT00147069|7179442|FG000|STARTED|Overall Study||15
6279593|NCT00147069|7179443|FG001|STARTED|Overall Study||15
6279594|NCT00147069|7179444|FG002|STARTED|Overall Study||15
6279595|NCT00147069|7179445|FG003|STARTED|Overall Study||15
6279596|NCT00147069|7179442|FG000|COMPLETED|Overall Study||15
6279597|NCT00147069|7179443|FG001|COMPLETED|Overall Study||15
6279598|NCT00147069|7179444|FG002|COMPLETED|Overall Study||15
6279599|NCT00147069|7179445|FG003|COMPLETED|Overall Study||15
6279600|NCT00147069|7179442|FG000|NOT COMPLETED|Overall Study||0
6279601|NCT00147069|7179443|FG001|NOT COMPLETED|Overall Study||0
6279602|NCT00147069|7179444|FG002|NOT COMPLETED|Overall Study||0
6279603|NCT00147069|7179445|FG003|NOT COMPLETED|Overall Study||0
6279604|NCT00147082|7179458|FG000|STARTED|Overall Study||37
6279605|NCT00147082|7179459|FG001|STARTED|Overall Study||33
6279606|NCT00147082|7179460|FG002|STARTED|Overall Study||30
6279607|NCT00147082|7179458|FG000|COMPLETED|Overall Study||37
6279608|NCT00147082|7179459|FG001|COMPLETED|Overall Study||33
6279609|NCT00147082|7179460|FG002|COMPLETED|Overall Study||30
6279610|NCT00147082|7179458|FG000|NOT COMPLETED|Overall Study||0
6279611|NCT00147082|7179459|FG001|NOT COMPLETED|Overall Study||0
6279612|NCT00147082|7179460|FG002|NOT COMPLETED|Overall Study||0
6279613|NCT00147199|7179470|FG000|STARTED|Overall Study||115
6279614|NCT00147199|7179471|FG001|STARTED|Overall Study||120
6279615|NCT00147199|7179470|FG000|COMPLETED|Overall Study||102
6279616|NCT00147199|7179471|FG001|COMPLETED|Overall Study||110
6279617|NCT00147199|7179470|FG000|NOT COMPLETED|Overall Study||13
6279618|NCT00147199|7179471|FG001|NOT COMPLETED|Overall Study||10
6279619|NCT00147212|7179477|FG000|STARTED|Overall Study||50
6279620|NCT00147212|7179477|FG000|COMPLETED|Overall Study||50
6279621|NCT00147212|7179477|FG000|NOT COMPLETED|Overall Study||0
6279622|NCT00147225|7179487|FG000|STARTED|Overall Study||7
6279623|NCT00147225|7179488|FG001|STARTED|Overall Study||6
6279624|NCT00147225|7179489|FG002|STARTED|Overall Study||8
6279625|NCT00147225|7179490|FG003|STARTED|Overall Study||11
6279626|NCT00147225|7179491|FG004|STARTED|Overall Study||11
6279627|NCT00147225|7179492|FG005|STARTED|Overall Study||12
6279628|NCT00147225|7179487|FG000|COMPLETED|Overall Study||6
6279629|NCT00147225|7179488|FG001|COMPLETED|Overall Study||6
6279630|NCT00147225|7179489|FG002|COMPLETED|Overall Study||6
6279631|NCT00147225|7179490|FG003|COMPLETED|Overall Study||10
6279632|NCT00147225|7179491|FG004|COMPLETED|Overall Study||10
6279633|NCT00147225|7179492|FG005|COMPLETED|Overall Study||10
6279634|NCT00147225|7179487|FG000|NOT COMPLETED|Overall Study||1
6279635|NCT00147225|7179488|FG001|NOT COMPLETED|Overall Study||0
6279636|NCT00147225|7179489|FG002|NOT COMPLETED|Overall Study||2
6279637|NCT00147225|7179490|FG003|NOT COMPLETED|Overall Study||1
6279638|NCT00147225|7179491|FG004|NOT COMPLETED|Overall Study||1
6685197|NCT02688387|7615409|FG007|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685198|NCT02688387|7615410|FG008|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685199|NCT02688387|7615411|FG009|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685200|NCT02688387|7615412|FG010|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685201|NCT02688387|7615413|FG011|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685202|NCT02688387|7615414|FG012|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685203|NCT02688387|7615415|FG013|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685204|NCT02688387|7615416|FG014|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685205|NCT02688387|7615417|FG015|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685206|NCT02688387|7615418|FG016|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685207|NCT02688387|7615419|FG017|COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685208|NCT02688387|7615420|FG018|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
6685209|NCT02688387|7615421|FG019|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
6685210|NCT02688387|7615422|FG020|COMPLETED|Part 3B, Period 3 (up to 6 Days)||7
6685211|NCT02688387|7615423|FG021|COMPLETED|Part 3B, Period 3 (up to 6 Days)||8
6685212|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685213|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685214|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685215|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685216|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685217|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685218|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685219|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685220|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685221|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685222|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685223|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685224|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685225|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685226|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685227|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685228|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685229|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685230|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685231|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685232|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||1
6685233|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3B, Period 3 (up to 6 Days)||0
6685234|NCT02688387|7615402|FG000|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685235|NCT02688387|7615403|FG001|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685236|NCT02688387|7615404|FG002|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685237|NCT02688387|7615405|FG003|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685238|NCT02688387|7615406|FG004|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685239|NCT02688387|7615407|FG005|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685240|NCT02688387|7615408|FG006|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685241|NCT02688387|7615409|FG007|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685242|NCT02688387|7615410|FG008|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685243|NCT02688387|7615411|FG009|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685244|NCT02688387|7615412|FG010|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685245|NCT02688387|7615413|FG011|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685246|NCT02688387|7615414|FG012|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685247|NCT02688387|7615415|FG013|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685248|NCT02688387|7615416|FG014|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685249|NCT02688387|7615417|FG015|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685250|NCT02688387|7615418|FG016|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685251|NCT02688387|7615419|FG017|STARTED|Part 3B, Washout Period 3 (10 Days)||0
6685252|NCT02688387|7615420|FG018|STARTED|Part 3B, Washout Period 3 (10 Days)||8
6685253|NCT02688387|7615421|FG019|STARTED|Part 3B, Washout Period 3 (10 Days)||8
6685254|NCT02688387|7615422|FG020|STARTED|Part 3B, Washout Period 3 (10 Days)||7
6685255|NCT02688387|7615423|FG021|STARTED|Part 3B, Washout Period 3 (10 Days)||8
6685256|NCT02688387|7615402|FG000|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685257|NCT02688387|7615403|FG001|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685258|NCT02688387|7615404|FG002|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685259|NCT02688387|7615405|FG003|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685260|NCT02688387|7615406|FG004|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685261|NCT02688387|7615407|FG005|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685262|NCT02688387|7615408|FG006|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685263|NCT02688387|7615409|FG007|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685264|NCT02688387|7615410|FG008|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685265|NCT02688387|7615411|FG009|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685266|NCT02688387|7615412|FG010|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685267|NCT02688387|7615413|FG011|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685268|NCT02688387|7615414|FG012|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685269|NCT02688387|7615415|FG013|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685270|NCT02688387|7615416|FG014|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685271|NCT02688387|7615417|FG015|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685272|NCT02688387|7615418|FG016|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685273|NCT02688387|7615419|FG017|COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685274|NCT02688387|7615420|FG018|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
6685275|NCT02688387|7615421|FG019|COMPLETED|Part 3B, Washout Period 3 (10 Days)||7
6685276|NCT02688387|7615422|FG020|COMPLETED|Part 3B, Washout Period 3 (10 Days)||6
6685277|NCT02688387|7615423|FG021|COMPLETED|Part 3B, Washout Period 3 (10 Days)||8
6685278|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685279|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685280|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685281|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685282|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685283|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685284|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685285|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685286|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685287|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685288|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685289|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685290|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685291|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685292|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685293|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685294|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685295|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685296|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
6685297|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
6685298|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||1
6685299|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3B, Washout Period 3 (10 Days)||0
6685300|NCT02688387|7615402|FG000|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685301|NCT02688387|7615403|FG001|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685302|NCT02688387|7615404|FG002|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685303|NCT02688387|7615405|FG003|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685304|NCT02688387|7615406|FG004|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685305|NCT02688387|7615407|FG005|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685306|NCT02688387|7615408|FG006|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685307|NCT02688387|7615409|FG007|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685308|NCT02688387|7615410|FG008|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685309|NCT02688387|7615411|FG009|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685310|NCT02688387|7615412|FG010|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685311|NCT02688387|7615413|FG011|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685312|NCT02688387|7615414|FG012|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685313|NCT02688387|7615415|FG013|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685314|NCT02688387|7615416|FG014|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685315|NCT02688387|7615417|FG015|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685316|NCT02688387|7615418|FG016|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685317|NCT02688387|7615419|FG017|STARTED|Part 3B, Period 4 (up to 6 Days)||0
6685318|NCT02688387|7615420|FG018|STARTED|Part 3B, Period 4 (up to 6 Days)||7
6685319|NCT02688387|7615421|FG019|STARTED|Part 3B, Period 4 (up to 6 Days)||7
6685320|NCT02688387|7615422|FG020|STARTED|Part 3B, Period 4 (up to 6 Days)||6
6685321|NCT02688387|7615423|FG021|STARTED|Part 3B, Period 4 (up to 6 Days)||8
6685322|NCT02688387|7615402|FG000|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685323|NCT02688387|7615403|FG001|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685324|NCT02688387|7615404|FG002|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685325|NCT02688387|7615405|FG003|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685326|NCT02688387|7615406|FG004|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685327|NCT02688387|7615407|FG005|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685328|NCT02688387|7615408|FG006|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685329|NCT02688387|7615409|FG007|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685330|NCT02688387|7615410|FG008|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685331|NCT02688387|7615411|FG009|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685332|NCT02688387|7615412|FG010|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685333|NCT02688387|7615413|FG011|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685334|NCT02688387|7615414|FG012|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685335|NCT02688387|7615415|FG013|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685336|NCT02688387|7615416|FG014|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685337|NCT02688387|7615417|FG015|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685338|NCT02688387|7615418|FG016|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685339|NCT02688387|7615419|FG017|COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685340|NCT02688387|7615420|FG018|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
6685341|NCT02688387|7615421|FG019|COMPLETED|Part 3B, Period 4 (up to 6 Days)||7
6685342|NCT02688387|7615422|FG020|COMPLETED|Part 3B, Period 4 (up to 6 Days)||6
6685343|NCT02688387|7615423|FG021|COMPLETED|Part 3B, Period 4 (up to 6 Days)||8
6685344|NCT02688387|7615402|FG000|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685345|NCT02688387|7615403|FG001|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685346|NCT02688387|7615404|FG002|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685347|NCT02688387|7615405|FG003|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685348|NCT02688387|7615406|FG004|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685349|NCT02688387|7615407|FG005|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685350|NCT02688387|7615408|FG006|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685351|NCT02688387|7615409|FG007|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685352|NCT02688387|7615410|FG008|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685353|NCT02688387|7615411|FG009|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685354|NCT02688387|7615412|FG010|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685355|NCT02688387|7615413|FG011|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685356|NCT02688387|7615414|FG012|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685357|NCT02688387|7615415|FG013|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685358|NCT02688387|7615416|FG014|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685359|NCT02688387|7615417|FG015|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685360|NCT02688387|7615418|FG016|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685361|NCT02688387|7615419|FG017|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685362|NCT02688387|7615420|FG018|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685363|NCT02688387|7615421|FG019|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685364|NCT02688387|7615422|FG020|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685365|NCT02688387|7615423|FG021|NOT COMPLETED|Part 3B, Period 4 (up to 6 Days)||0
6685366|NCT02688556|7615471|FG000|STARTED|Overall Study||372
6685367|NCT02688556|7615472|FG001|STARTED|Overall Study||373
6685368|NCT02688556|7615471|FG000|COMPLETED|Overall Study||347
6685369|NCT02688556|7615472|FG001|COMPLETED|Overall Study||361
6685370|NCT02688556|7615471|FG000|NOT COMPLETED|Overall Study||25
6685371|NCT02688556|7615472|FG001|NOT COMPLETED|Overall Study||12
6685372|NCT02688621|7615480|FG000|STARTED|Overall Study||212
6685373|NCT02688621|7615481|FG001|STARTED|Overall Study||206
6685374|NCT02688621|7615480|FG000|COMPLETED|Overall Study||172
6685375|NCT02688621|7615481|FG001|COMPLETED|Overall Study||188
6685376|NCT02688621|7615480|FG000|NOT COMPLETED|Overall Study||40
6685377|NCT02688621|7615481|FG001|NOT COMPLETED|Overall Study||18
6685378|NCT02688764|7615492|FG000|STARTED|Overall Study||66
6685379|NCT02688764|7615493|FG001|STARTED|Overall Study||19
6685380|NCT02688764|7615492|FG000|Treated in Stage 1|Overall Study||66
6685381|NCT02688764|7615493|FG001|Treated in Stage 1|Overall Study||19
6685382|NCT02688764|7615492|FG000|Treated in Stage 2|Overall Study||43
6685383|NCT02688764|7615493|FG001|Treated in Stage 2|Overall Study||8
6685384|NCT02688764|7615492|FG000|COMPLETED|Overall Study||26
6685385|NCT02688764|7615493|FG001|COMPLETED|Overall Study||2
6685386|NCT02688764|7615492|FG000|NOT COMPLETED|Overall Study||40
6685387|NCT02688764|7615493|FG001|NOT COMPLETED|Overall Study||17
6685388|NCT02688829|7615502|FG000|STARTED|Overall Study||21
6685389|NCT02688829|7615502|FG000|COMPLETED|Overall Study||19
6685390|NCT02688829|7615502|FG000|NOT COMPLETED|Overall Study||2
6685391|NCT02688842|7615506|FG000|STARTED|Overall Study||38
6685392|NCT02688842|7615506|FG000|COMPLETED|Overall Study||38
6685393|NCT02688842|7615506|FG000|NOT COMPLETED|Overall Study||0
6685394|NCT02688868|7615510|FG000|STARTED|Overall Study||38
6685395|NCT02688868|7615510|FG000|COMPLETED|Overall Study||34
6685396|NCT02688868|7615510|FG000|NOT COMPLETED|Overall Study||4
6738551|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s Anti-HCV Follow-Up||0
6738552|NCT03285295|7667829|FG000|STARTED|Alinity s HIV Ag/Ab Combo||17095
6738553|NCT03285295|7667830|FG001|STARTED|Alinity s HIV Ag/Ab Combo||1336
6738554|NCT03285295|7667831|FG002|STARTED|Alinity s HIV Ag/Ab Combo||605
6738555|NCT03285295|7667832|FG003|STARTED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
6738556|NCT03285295|7667833|FG004|STARTED|Alinity s HIV Ag/Ab Combo||0
6738557|NCT03285295|7667829|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo||16996
6738558|NCT03285295|7667830|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo||1336
6738559|NCT03285295|7667831|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo||605
6738560|NCT03285295|7667832|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo|Individuals at Increased Risk of HIV Infection from HIV-2 Endemic Areas|535
6738561|NCT03285295|7667833|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo||0
6738562|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||99
6738563|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
6738564|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
6738565|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
6738566|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo||0
6738567|NCT03285295|7667829|FG000|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||15
6738568|NCT03285295|7667830|FG001|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738569|NCT03285295|7667831|FG002|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738570|NCT03285295|7667832|FG003|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738571|NCT03285295|7667833|FG004|STARTED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738572|NCT03285295|7667829|FG000|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||4
6738573|NCT03285295|7667830|FG001|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738574|NCT03285295|7667831|FG002|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738575|NCT03285295|7667832|FG003|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738576|NCT03285295|7667833|FG004|COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738577|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||11
6738578|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738579|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738580|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738581|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s HIV Ag/Ab Combo Follow-Up||0
6738582|NCT03285295|7667829|FG000|STARTED|Alinity s Anti-HBc||15968
6685397|NCT02689063|7615518|FG000|STARTED|Overall Study||75
6685398|NCT02689063|7615519|FG001|STARTED|Overall Study||75
6685399|NCT02689063|7615520|FG002|STARTED|Overall Study||76
6685400|NCT02689063|7615521|FG003|STARTED|Overall Study||50
6685401|NCT02689063|7615518|FG000|COMPLETED|Overall Study||75
6685402|NCT02689063|7615519|FG001|COMPLETED|Overall Study||73
6685403|NCT02689063|7615520|FG002|COMPLETED|Overall Study||73
6685404|NCT02689063|7615521|FG003|COMPLETED|Overall Study||50
6685405|NCT02689063|7615518|FG000|NOT COMPLETED|Overall Study||0
6685406|NCT02689063|7615519|FG001|NOT COMPLETED|Overall Study||2
6685407|NCT02689063|7615520|FG002|NOT COMPLETED|Overall Study||3
6685408|NCT02689063|7615521|FG003|NOT COMPLETED|Overall Study||0
6685409|NCT02689076|7615534|FG000|STARTED|Overall Study||268
6685410|NCT02689076|7615535|FG001|STARTED|Overall Study||337
6685411|NCT02689076|7615536|FG002|STARTED|Overall Study||191
6685412|NCT02689076|7615534|FG000|COMPLETED|Overall Study||87
6685413|NCT02689076|7615535|FG001|COMPLETED|Overall Study||115
6685414|NCT02689076|7615536|FG002|COMPLETED|Overall Study||191
6685415|NCT02689076|7615534|FG000|NOT COMPLETED|Overall Study||181
6685416|NCT02689076|7615535|FG001|NOT COMPLETED|Overall Study||222
6685417|NCT02689076|7615536|FG002|NOT COMPLETED|Overall Study||0
6685418|NCT02689154|7615544|FG000|STARTED|Overall Study||18
6685419|NCT02689154|7615544|FG000|COMPLETED|Overall Study||18
6685420|NCT02689154|7615544|FG000|NOT COMPLETED|Overall Study||0
6685421|NCT02689206|7615553|FG000|STARTED|Overall Study||20
6685422|NCT02689206|7615554|FG001|STARTED|Overall Study||20
6685423|NCT02689206|7615555|FG002|STARTED|Overall Study||20
6685424|NCT02689206|7615556|FG003|STARTED|Overall Study||21
6685425|NCT02689206|7615557|FG004|STARTED|Overall Study||22
6685426|NCT02689206|7615553|FG000|COMPLETED|Overall Study||17
6685427|NCT02689206|7615554|FG001|COMPLETED|Overall Study||19
6685428|NCT02689206|7615555|FG002|COMPLETED|Overall Study||16
6685429|NCT02689206|7615556|FG003|COMPLETED|Overall Study||17
6685430|NCT02689206|7615557|FG004|COMPLETED|Overall Study||14
6685431|NCT02689206|7615553|FG000|NOT COMPLETED|Overall Study||3
6685432|NCT02689206|7615554|FG001|NOT COMPLETED|Overall Study||1
6685433|NCT02689206|7615555|FG002|NOT COMPLETED|Overall Study||4
6685434|NCT02689206|7615556|FG003|NOT COMPLETED|Overall Study||4
6685435|NCT02689206|7615557|FG004|NOT COMPLETED|Overall Study||8
6685436|NCT02689219|7615575|FG000|STARTED|Overall Study||11
6685437|NCT02689219|7615576|FG001|STARTED|Overall Study||7
6685438|NCT02689219|7615575|FG000|COMPLETED|Overall Study||0
6685439|NCT02689219|7615576|FG001|COMPLETED|Overall Study||0
6685440|NCT02689219|7615575|FG000|NOT COMPLETED|Overall Study||11
6685441|NCT02689219|7615576|FG001|NOT COMPLETED|Overall Study||7
6685442|NCT02689492|7615582|FG000|STARTED|Overall Study||401
6685443|NCT02689492|7615582|FG000|COMPLETED|Overall Study||315
6685444|NCT02689492|7615582|FG000|NOT COMPLETED|Overall Study||86
6685445|NCT02689804|7615591|FG000|STARTED|Overall Study||18
6685446|NCT02689804|7615592|FG001|STARTED|Overall Study||16
6685447|NCT02689804|7615591|FG000|COMPLETED|Overall Study||16
6685448|NCT02689804|7615592|FG001|COMPLETED|Overall Study||16
6685449|NCT02689804|7615591|FG000|NOT COMPLETED|Overall Study||2
6685450|NCT02689804|7615592|FG001|NOT COMPLETED|Overall Study||0
6685451|NCT02689973|7615605|FG000|STARTED|Overall Study||311
6685452|NCT02689973|7615606|FG001|STARTED|Overall Study||270
6685453|NCT02689973|7615607|FG002|STARTED|Overall Study||351
6685454|NCT02689973|7615608|FG003|STARTED|Overall Study||285
6685455|NCT02689973|7615605|FG000|COMPLETED|Overall Study||257
6685456|NCT02689973|7615606|FG001|COMPLETED|Overall Study||221
6685457|NCT02689973|7615607|FG002|COMPLETED|Overall Study||279
6685458|NCT02689973|7615608|FG003|COMPLETED|Overall Study||232
6685459|NCT02689973|7615605|FG000|NOT COMPLETED|Overall Study||54
6685460|NCT02689973|7615606|FG001|NOT COMPLETED|Overall Study||49
6685461|NCT02689973|7615607|FG002|NOT COMPLETED|Overall Study||72
6685462|NCT02689973|7615608|FG003|NOT COMPLETED|Overall Study||53
6685463|NCT02690168|7615619|FG000|STARTED|Overall Study||6
6685464|NCT02690168|7615619|FG000|COMPLETED|Overall Study||6
6685465|NCT02690168|7615619|FG000|NOT COMPLETED|Overall Study||0
6685466|NCT02690181|7615630|FG000|STARTED|Overall Study||14
6685467|NCT02690181|7615631|FG001|STARTED|Overall Study||14
6685468|NCT02690181|7615632|FG002|STARTED|Overall Study||15
6685469|NCT02690181|7615633|FG003|STARTED|Overall Study||10
6685470|NCT02690181|7615634|FG004|STARTED|Overall Study||6
6685471|NCT02690181|7615635|FG005|STARTED|Overall Study||21
6685472|NCT02690181|7615630|FG000|COMPLETED|Overall Study||14
6685473|NCT02690181|7615631|FG001|COMPLETED|Overall Study||14
6685474|NCT02690181|7615632|FG002|COMPLETED|Overall Study||15
6685475|NCT02690181|7615633|FG003|COMPLETED|Overall Study||10
6685476|NCT02690181|7615634|FG004|COMPLETED|Overall Study||6
6685477|NCT02690181|7615635|FG005|COMPLETED|Overall Study||21
6685478|NCT02690181|7615630|FG000|NOT COMPLETED|Overall Study||0
6685479|NCT02690181|7615631|FG001|NOT COMPLETED|Overall Study||0
6685480|NCT02690181|7615632|FG002|NOT COMPLETED|Overall Study||0
6685481|NCT02690181|7615633|FG003|NOT COMPLETED|Overall Study||0
6685482|NCT02690181|7615634|FG004|NOT COMPLETED|Overall Study||0
6685483|NCT02690181|7615635|FG005|NOT COMPLETED|Overall Study||0
6685484|NCT02690194|7615652|FG000|STARTED|Overall Study||17
6685485|NCT02690194|7615653|FG001|STARTED|Overall Study||18
6685486|NCT02690194|7615654|FG002|STARTED|Overall Study||19
6685487|NCT02690194|7615652|FG000|COMPLETED|Overall Study||16
6685488|NCT02690194|7615653|FG001|COMPLETED|Overall Study||14
6685489|NCT02690194|7615654|FG002|COMPLETED|Overall Study||19
6685490|NCT02690194|7615652|FG000|NOT COMPLETED|Overall Study||1
6685491|NCT02690194|7615653|FG001|NOT COMPLETED|Overall Study||4
6685492|NCT02690194|7615654|FG002|NOT COMPLETED|Overall Study||0
6685493|NCT02690207|7615662|FG000|STARTED|Overall Study||8687
6685494|NCT02690207|7615662|FG000|COMPLETED|Overall Study||8434
6685495|NCT02690207|7615662|FG000|NOT COMPLETED|Overall Study||253
6685496|NCT02690558|7615666|FG000|STARTED|Overall Study||39
6685497|NCT02690558|7615666|FG000|COMPLETED|Overall Study||39
6685498|NCT02690558|7615666|FG000|NOT COMPLETED|Overall Study||0
6685499|NCT02690649|7615672|FG000|STARTED|Overall Study||80
6685500|NCT02690649|7615673|FG001|STARTED|Overall Study||80
6685501|NCT02690649|7615672|FG000|COMPLETED|Overall Study||79
6685502|NCT02690649|7615673|FG001|COMPLETED|Overall Study||76
6685503|NCT02690649|7615672|FG000|NOT COMPLETED|Overall Study||1
6685504|NCT02690649|7615673|FG001|NOT COMPLETED|Overall Study||4
6685505|NCT02690701|7615683|FG000|STARTED|Treatment Period 1||46
6685506|NCT02690701|7615684|FG001|STARTED|Treatment Period 1||45
6685507|NCT02690701|7615683|FG000|COMPLETED|Treatment Period 1||44
6685508|NCT02690701|7615684|FG001|COMPLETED|Treatment Period 1||42
6685509|NCT02690701|7615683|FG000|NOT COMPLETED|Treatment Period 1||2
6685510|NCT02690701|7615684|FG001|NOT COMPLETED|Treatment Period 1||3
6685511|NCT02690701|7615683|FG000|STARTED|Treatment Period 2|Completed Treatment Period 1 and continued to Treatment Period 2|44
6685512|NCT02690701|7615684|FG001|STARTED|Treatment Period 2||42
6685513|NCT02690701|7615683|FG000|COMPLETED|Treatment Period 2|Completed Treatment Period 2|41
6685514|NCT02690701|7615684|FG001|COMPLETED|Treatment Period 2||37
6685515|NCT02690701|7615683|FG000|NOT COMPLETED|Treatment Period 2||3
6685516|NCT02690701|7615684|FG001|NOT COMPLETED|Treatment Period 2||5
6685517|NCT02690714|7615691|FG000|STARTED|Segment 1: Single-dose Day -4 to Day 0||9
6685518|NCT02690714|7615691|FG000|COMPLETED|Segment 1: Single-dose Day -4 to Day 0|Six participants skipped Segment 1 as they had PK data from Phase 1 study 2002C005G.|9
6685519|NCT02690714|7615691|FG000|NOT COMPLETED|Segment 1: Single-dose Day -4 to Day 0||0
6685520|NCT02690714|7615691|FG000|STARTED|Segment 2: Multi-dose Day 0 to Week 12||15
6685521|NCT02690714|7615691|FG000|COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||15
6685522|NCT02690714|7615691|FG000|NOT COMPLETED|Segment 2: Multi-dose Day 0 to Week 12||0
6685523|NCT02690714|7615691|FG000|STARTED|Segment 3: Extended Treatment Wks 12-48||15
6685524|NCT02690714|7615691|FG000|COMPLETED|Segment 3: Extended Treatment Wks 12-48||15
6685525|NCT02690714|7615691|FG000|NOT COMPLETED|Segment 3: Extended Treatment Wks 12-48||0
6685526|NCT02690714|7615691|FG000|STARTED|Post-Wk 48: Safety Week 48 to EoS Visit|3 subjects from Norway did not go past 48 weeks|12
6685527|NCT02690714|7615691|FG000|COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||10
6685528|NCT02690714|7615691|FG000|NOT COMPLETED|Post-Wk 48: Safety Week 48 to EoS Visit||2
6685529|NCT02690727|7615699|FG000|STARTED|Overall Study||9
6685530|NCT02690727|7615700|FG001|STARTED|Overall Study||9
6685531|NCT02690727|7615699|FG000|COMPLETED|Overall Study||7
6685532|NCT02690727|7615700|FG001|COMPLETED|Overall Study||7
6685533|NCT02690727|7615699|FG000|NOT COMPLETED|Overall Study||2
6685534|NCT02690727|7615700|FG001|NOT COMPLETED|Overall Study||2
6685535|NCT02690935|7615710|FG000|STARTED|Overall Study|Count of participants|51
6685536|NCT02690935|7615711|FG001|STARTED|Overall Study|Count of participants|51
6685537|NCT02690935|7615710|FG000|COMPLETED|Overall Study|Count of participants|51
6685538|NCT02690935|7615711|FG001|COMPLETED|Overall Study|Count of participants|51
6685539|NCT02690935|7615710|FG000|NOT COMPLETED|Overall Study||0
6685540|NCT02690935|7615711|FG001|NOT COMPLETED|Overall Study||0
6685541|NCT02690948|7615719|FG000|STARTED|Overall Study||9
6685542|NCT02690948|7615720|FG001|STARTED|Overall Study||7
6685543|NCT02690948|7615719|FG000|COMPLETED|Overall Study||9
6685544|NCT02690948|7615720|FG001|COMPLETED|Overall Study||7
6685545|NCT02690948|7615719|FG000|NOT COMPLETED|Overall Study||0
6685546|NCT02690948|7615720|FG001|NOT COMPLETED|Overall Study||0
6685547|NCT02690974|7615726|FG000|STARTED|Overall Study||302
6685548|NCT02690974|7615726|FG000|COMPLETED|Overall Study||262
6685549|NCT02690974|7615726|FG000|NOT COMPLETED|Overall Study||40
6685550|NCT02691143|7615732|FG000|STARTED|Overall Study||27
6685551|NCT02691143|7615733|FG001|STARTED|Overall Study||23
6685552|NCT02691143|7615732|FG000|COMPLETED|Overall Study||27
6685553|NCT02691143|7615733|FG001|COMPLETED|Overall Study||23
6685554|NCT02691143|7615732|FG000|NOT COMPLETED|Overall Study||0
6685555|NCT02691143|7615733|FG001|NOT COMPLETED|Overall Study||0
6685556|NCT02691247|7615742|FG000|STARTED|Overall Study||40
6685557|NCT02691247|7615743|FG001|STARTED|Overall Study||24
6685558|NCT02691247|7615744|FG002|STARTED|Overall Study||46
6685559|NCT02691247|7615742|FG000|COMPLETED|Overall Study||37
6685560|NCT02691247|7615743|FG001|COMPLETED|Overall Study||22
6685561|NCT02691247|7615744|FG002|COMPLETED|Overall Study||43
6685562|NCT02691247|7615742|FG000|NOT COMPLETED|Overall Study||3
6685563|NCT02691247|7615743|FG001|NOT COMPLETED|Overall Study||2
6685564|NCT02691247|7615744|FG002|NOT COMPLETED|Overall Study||3
6685565|NCT02691260|7615756|FG000|STARTED|Overall Study||26
6685566|NCT02691260|7615757|FG001|STARTED|Overall Study||26
6685567|NCT02691260|7615758|FG002|STARTED|Overall Study||27
6685568|NCT02691260|7615759|FG003|STARTED|Overall Study||26
6685569|NCT02691260|7615756|FG000|COMPLETED|Overall Study||24
6685570|NCT02691260|7615757|FG001|COMPLETED|Overall Study||24
6685571|NCT02691260|7615758|FG002|COMPLETED|Overall Study||25
6685572|NCT02691260|7615759|FG003|COMPLETED|Overall Study||23
6685573|NCT02691260|7615756|FG000|NOT COMPLETED|Overall Study||2
6685574|NCT02691260|7615757|FG001|NOT COMPLETED|Overall Study||2
6685575|NCT02691260|7615758|FG002|NOT COMPLETED|Overall Study||2
6685576|NCT02691260|7615759|FG003|NOT COMPLETED|Overall Study||3
6685577|NCT02691416|7615771|FG000|STARTED|Overall Study||30
6685578|NCT02691416|7615772|FG001|STARTED|Overall Study||30
6685579|NCT02691416|7615771|FG000|COMPLETED|Overall Study||30
6685580|NCT02691416|7615772|FG001|COMPLETED|Overall Study||30
6685581|NCT02691416|7615771|FG000|NOT COMPLETED|Overall Study||0
6685582|NCT02691416|7615772|FG001|NOT COMPLETED|Overall Study||0
6685583|NCT02691455|7615784|FG000|STARTED|Overall Study||23
6685584|NCT02691455|7615785|FG001|STARTED|Overall Study||22
6685585|NCT02691455|7615784|FG000|Randomized|Overall Study||23
6685586|NCT02691455|7615785|FG001|Randomized|Overall Study||22
6685587|NCT02691455|7615784|FG000|Received Assigned Intervention|Overall Study||22
6685588|NCT02691455|7615785|FG001|Received Assigned Intervention|Overall Study||20
6685589|NCT02691455|7615784|FG000|Week 1 Follow up|Overall Study||22
6685590|NCT02691455|7615785|FG001|Week 1 Follow up|Overall Study||19
6685591|NCT02691455|7615784|FG000|Month 1 Follow up|Overall Study||22
6685592|NCT02691455|7615785|FG001|Month 1 Follow up|Overall Study||18
6685593|NCT02691455|7615784|FG000|Month 3 Follow up|Overall Study||21
6685594|NCT02691455|7615785|FG001|Month 3 Follow up|Overall Study||18
6685595|NCT02691455|7615784|FG000|Month 6 Follow up|Overall Study||19
6685596|NCT02691455|7615785|FG001|Month 6 Follow up|Overall Study||19
6257050|NCT03298984|7156013|FG000|STARTED|Overall Study||3
6257051|NCT03298984|7156014|FG001|STARTED|Overall Study||3
6257052|NCT03298984|7156015|FG002|STARTED|Overall Study||3
6257053|NCT03298984|7156016|FG003|STARTED|Overall Study||23
6257054|NCT03298984|7156013|FG000|COMPLETED|Overall Study||2
6257055|NCT03298984|7156014|FG001|COMPLETED|Overall Study||2
6257056|NCT03298984|7156015|FG002|COMPLETED|Overall Study||1
6257057|NCT03298984|7156016|FG003|COMPLETED|Overall Study||8
6257058|NCT03298984|7156013|FG000|NOT COMPLETED|Overall Study||1
6257059|NCT03298984|7156014|FG001|NOT COMPLETED|Overall Study||1
6257060|NCT03298984|7156015|FG002|NOT COMPLETED|Overall Study||2
6257061|NCT03298984|7156016|FG003|NOT COMPLETED|Overall Study||15
6257062|NCT03175198|7156027|FG000|STARTED|Overall Study||5565
6257063|NCT03175198|7156027|FG000|Safety Set 1|Overall Study||5436
6257064|NCT03175198|7156027|FG000|COMPLETED|Overall Study||3238
6257065|NCT03175198|7156027|FG000|NOT COMPLETED|Overall Study||2327
6257066|NCT03158727|7156033|FG000|STARTED|Overall Study||42
6257067|NCT03158727|7156034|FG001|STARTED|Overall Study||42
6257068|NCT03158727|7156033|FG000|Enrolled, Not Treated|Overall Study||1
6257069|NCT03158727|7156034|FG001|Enrolled, Not Treated|Overall Study||0
6257070|NCT03158727|7156033|FG000|COMPLETED|Overall Study||25
6257071|NCT03158727|7156034|FG001|COMPLETED|Overall Study||23
6257072|NCT03158727|7156033|FG000|NOT COMPLETED|Overall Study||17
6257073|NCT03158727|7156034|FG001|NOT COMPLETED|Overall Study||19
6257074|NCT03075826|7156040|FG000|STARTED|Overall Study||22
6257075|NCT03075826|7156040|FG000|COMPLETED|Overall Study||16
6257076|NCT03075826|7156040|FG000|NOT COMPLETED|Overall Study||6
6257077|NCT02993731|7156046|FG000|STARTED|Overall Study||565
6257078|NCT02993731|7156047|FG001|STARTED|Overall Study||569
6257079|NCT02993731|7156046|FG000|COMPLETED|Overall Study||464
6257080|NCT02993731|7156047|FG001|COMPLETED|Overall Study||464
6257081|NCT02993731|7156046|FG000|NOT COMPLETED|Overall Study||101
6257082|NCT02993731|7156047|FG001|NOT COMPLETED|Overall Study||105
6257083|NCT02831764|7156065|FG000|STARTED|Overall Study||360
6257084|NCT02831764|7156066|FG001|STARTED|Overall Study||359
6257085|NCT02831764|7156065|FG000|COMPLETED|Overall Study||0
6257086|NCT02831764|7156066|FG001|COMPLETED|Overall Study||0
6257087|NCT02831764|7156065|FG000|NOT COMPLETED|Overall Study||360
6257088|NCT02831764|7156066|FG001|NOT COMPLETED|Overall Study||359
6257089|NCT02826161|7156074|FG000|STARTED|Overall Study||1
6257090|NCT02826161|7156075|FG001|STARTED|Overall Study||3
6257091|NCT02826161|7156074|FG000|Discontinued Due to Treatment Related AE|Overall Study||1
6257092|NCT02826161|7156075|FG001|Discontinued Due to Treatment Related AE|Overall Study||0
6257093|NCT02826161|7156074|FG000|Discontinued Due to Death|Overall Study||0
6257094|NCT02826161|7156075|FG001|Discontinued Due to Death|Overall Study||1
6257095|NCT02826161|7156074|FG000|Discontinued Due to Patient Withdrawal|Overall Study||0
6257096|NCT02826161|7156075|FG001|Discontinued Due to Patient Withdrawal|Overall Study||1
6257097|NCT02826161|7156074|FG000|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
6257098|NCT02826161|7156075|FG001|Discontinued Due to Withdrawal of ICF From Further FU|Overall Study||1
6257099|NCT02826161|7156074|FG000|COMPLETED|Overall Study||1
6257100|NCT02826161|7156075|FG001|COMPLETED|Overall Study||3
6257101|NCT02826161|7156074|FG000|NOT COMPLETED|Overall Study||0
6257102|NCT02826161|7156075|FG001|NOT COMPLETED|Overall Study||0
6257103|NCT02586025|7156082|FG000|STARTED|Neoadjuvant Treatment||219
6257104|NCT02586025|7156083|FG001|STARTED|Neoadjuvant Treatment||110
6257105|NCT02586025|7156082|FG000|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||218
6257106|NCT02586025|7156083|FG001|Received at Least One Dose of Study Drug|Neoadjuvant Treatment||110
6257107|NCT02586025|7156082|FG000|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||214
6257108|NCT02586025|7156083|FG001|Completed Neoadjuvant Treatment|Neoadjuvant Treatment||108
6257109|NCT02586025|7156082|FG000|Underwent Surgery|Neoadjuvant Treatment||210
6257110|NCT02586025|7156083|FG001|Underwent Surgery|Neoadjuvant Treatment||105
6257111|NCT02586025|7156082|FG000|COMPLETED|Neoadjuvant Treatment||208
6685597|NCT02691455|7615784|FG000|Month 12 Follow up|Overall Study||16
6685598|NCT02691455|7615785|FG001|Month 12 Follow up|Overall Study||16
6685599|NCT02691455|7615784|FG000|Year 2 Follow up|Overall Study||6
6685600|NCT02691455|7615785|FG001|Year 2 Follow up|Overall Study||9
6685601|NCT02691455|7615784|FG000|Year 3 Follow up|Overall Study||7
6685602|NCT02691455|7615785|FG001|Year 3 Follow up|Overall Study||5
6685603|NCT02691455|7615784|FG000|COMPLETED|Overall Study||7
6685604|NCT02691455|7615785|FG001|COMPLETED|Overall Study||5
6685605|NCT02691455|7615784|FG000|NOT COMPLETED|Overall Study||16
6685606|NCT02691455|7615785|FG001|NOT COMPLETED|Overall Study||17
6685607|NCT02691468|7615793|FG000|STARTED|Overall Study||54
6685608|NCT02691468|7615794|FG001|STARTED|Overall Study||54
6685609|NCT02691468|7615793|FG000|COMPLETED|Overall Study||48
6685610|NCT02691468|7615794|FG001|COMPLETED|Overall Study||52
6685611|NCT02691468|7615793|FG000|NOT COMPLETED|Overall Study||6
6685612|NCT02691468|7615794|FG001|NOT COMPLETED|Overall Study||2
6685613|NCT02691494|7615803|FG000|STARTED|Treatment Period||94
6685614|NCT02691494|7615804|FG001|STARTED|Treatment Period||95
6685615|NCT02691494|7615805|FG002|STARTED|Treatment Period||189
6685616|NCT02691494|7615803|FG000|COMPLETED|Treatment Period|completed treatment period|72
6685617|NCT02691494|7615804|FG001|COMPLETED|Treatment Period|completed treatment period|69
6685618|NCT02691494|7615805|FG002|COMPLETED|Treatment Period|completed treatment period|148
6685619|NCT02691494|7615803|FG000|NOT COMPLETED|Treatment Period||22
6685620|NCT02691494|7615804|FG001|NOT COMPLETED|Treatment Period||26
6685621|NCT02691494|7615805|FG002|NOT COMPLETED|Treatment Period||41
6685622|NCT02691494|7615803|FG000|STARTED|Post-Treatment Follow-Up Period||14
6685623|NCT02691494|7615804|FG001|STARTED|Post-Treatment Follow-Up Period||25
6685624|NCT02691494|7615805|FG002|STARTED|Post-Treatment Follow-Up Period||59
6685625|NCT02691494|7615803|FG000|COMPLETED|Post-Treatment Follow-Up Period||9
6685626|NCT02691494|7615804|FG001|COMPLETED|Post-Treatment Follow-Up Period||18
6685627|NCT02691494|7615805|FG002|COMPLETED|Post-Treatment Follow-Up Period||42
6685628|NCT02691494|7615803|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||5
6685629|NCT02691494|7615804|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||7
6685630|NCT02691494|7615805|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||17
6685631|NCT02691507|7615815|FG000|STARTED|Overall Study||40
6685632|NCT02691507|7615816|FG001|STARTED|Overall Study||13
6685633|NCT02691507|7615815|FG000|COMPLETED|Overall Study||40
6685634|NCT02691507|7615816|FG001|COMPLETED|Overall Study||12
6685635|NCT02691507|7615815|FG000|NOT COMPLETED|Overall Study||0
6685636|NCT02691507|7615816|FG001|NOT COMPLETED|Overall Study||1
6685637|NCT02691572|7615824|FG000|STARTED|Overall Study||40
6685638|NCT02691572|7615825|FG001|STARTED|Overall Study||40
6685639|NCT02691572|7615824|FG000|COMPLETED|Overall Study||39
6257112|NCT02586025|7156083|FG001|COMPLETED|Neoadjuvant Treatment||103
6257113|NCT02586025|7156082|FG000|NOT COMPLETED|Neoadjuvant Treatment||11
6257114|NCT02586025|7156083|FG001|NOT COMPLETED|Neoadjuvant Treatment||7
6257115|NCT02586025|7156082|FG000|STARTED|Adjuvant Treatment||208
6257116|NCT02586025|7156083|FG001|STARTED|Adjuvant Treatment||103
6257117|NCT02586025|7156082|FG000|Started Adjuvant FEC Treatment|Adjuvant Treatment||208
6257118|NCT02586025|7156083|FG001|Started Adjuvant FEC Treatment|Adjuvant Treatment||103
6257119|NCT02586025|7156082|FG000|Started Adjuvant HER2 Treatment|Adjuvant Treatment||204
6257120|NCT02586025|7156083|FG001|Started Adjuvant HER2 Treatment|Adjuvant Treatment||99
6257121|NCT02586025|7156082|FG000|COMPLETED|Adjuvant Treatment||69
6257122|NCT02586025|7156083|FG001|COMPLETED|Adjuvant Treatment||34
6257123|NCT02586025|7156082|FG000|NOT COMPLETED|Adjuvant Treatment||139
6257124|NCT02586025|7156083|FG001|NOT COMPLETED|Adjuvant Treatment||69
6257125|NCT02586025|7156082|FG000|STARTED|Treatment-Free Follow-Up||59
6257126|NCT02586025|7156083|FG001|STARTED|Treatment-Free Follow-Up||38
6257127|NCT02586025|7156082|FG000|COMPLETED|Treatment-Free Follow-Up||3
6257128|NCT02586025|7156083|FG001|COMPLETED|Treatment-Free Follow-Up||3
6257129|NCT02586025|7156082|FG000|NOT COMPLETED|Treatment-Free Follow-Up||56
6257130|NCT02586025|7156083|FG001|NOT COMPLETED|Treatment-Free Follow-Up||35
6257131|NCT02520011|7156092|FG000|STARTED|Overall Study||11
6257132|NCT02520011|7156093|FG001|STARTED|Overall Study||79
6257133|NCT02520011|7156094|FG002|STARTED|Overall Study||14
6257134|NCT02520011|7156092|FG000|Stage 1|Overall Study||0
6257135|NCT02520011|7156093|FG001|Stage 1|Overall Study||32
6257136|NCT02520011|7156094|FG002|Stage 1|Overall Study||10
6257137|NCT02520011|7156092|FG000|Stage 2|Overall Study||11
6257138|NCT02520011|7156093|FG001|Stage 2|Overall Study||47
6257139|NCT02520011|7156094|FG002|Stage 2|Overall Study||4
6257140|NCT02520011|7156092|FG000|COMPLETED|Overall Study||6
6257141|NCT02520011|7156093|FG001|COMPLETED|Overall Study||33
6257142|NCT02520011|7156094|FG002|COMPLETED|Overall Study||5
6257143|NCT02520011|7156092|FG000|NOT COMPLETED|Overall Study||5
6685640|NCT02691572|7615825|FG001|COMPLETED|Overall Study||39
6685641|NCT02691572|7615824|FG000|NOT COMPLETED|Overall Study||1
6685642|NCT02691572|7615825|FG001|NOT COMPLETED|Overall Study||1
6685643|NCT02691702|7615842|FG000|STARTED|Overall Study||10
6685644|NCT02691702|7615843|FG001|STARTED|Overall Study||11
6685645|NCT02691702|7615844|FG002|STARTED|Overall Study||8
6685646|NCT02691702|7615845|FG003|STARTED|Overall Study||8
6685647|NCT02691702|7615846|FG004|STARTED|Overall Study||8
6685648|NCT02691702|7615847|FG005|STARTED|Overall Study||8
6685649|NCT02691702|7615848|FG006|STARTED|Overall Study||8
6685650|NCT02691702|7615849|FG007|STARTED|Overall Study||12
6685651|NCT02691702|7615850|FG008|STARTED|Overall Study||8
6685652|NCT02691702|7615851|FG009|STARTED|Overall Study||8
6685653|NCT02691702|7615852|FG010|STARTED|Overall Study||8
6685654|NCT02691702|7615842|FG000|COMPLETED|Overall Study||8
6685655|NCT02691702|7615843|FG001|COMPLETED|Overall Study||10
6685656|NCT02691702|7615844|FG002|COMPLETED|Overall Study||7
6685657|NCT02691702|7615845|FG003|COMPLETED|Overall Study||8
6685658|NCT02691702|7615846|FG004|COMPLETED|Overall Study||8
6685659|NCT02691702|7615847|FG005|COMPLETED|Overall Study||5
6685660|NCT02691702|7615848|FG006|COMPLETED|Overall Study||5
6685661|NCT02691702|7615849|FG007|COMPLETED|Overall Study||12
6685662|NCT02691702|7615850|FG008|COMPLETED|Overall Study||6
6685663|NCT02691702|7615851|FG009|COMPLETED|Overall Study||6
6685664|NCT02691702|7615852|FG010|COMPLETED|Overall Study||6
6685665|NCT02691702|7615842|FG000|NOT COMPLETED|Overall Study||2
6685666|NCT02691702|7615843|FG001|NOT COMPLETED|Overall Study||1
6685667|NCT02691702|7615844|FG002|NOT COMPLETED|Overall Study||1
6685668|NCT02691702|7615845|FG003|NOT COMPLETED|Overall Study||0
6685669|NCT02691702|7615846|FG004|NOT COMPLETED|Overall Study||0
6685670|NCT02691702|7615847|FG005|NOT COMPLETED|Overall Study||3
6685671|NCT02691702|7615848|FG006|NOT COMPLETED|Overall Study||3
6685672|NCT02691702|7615849|FG007|NOT COMPLETED|Overall Study||0
6685673|NCT02691702|7615850|FG008|NOT COMPLETED|Overall Study||2
6685674|NCT02691702|7615851|FG009|NOT COMPLETED|Overall Study||2
6685675|NCT02691702|7615852|FG010|NOT COMPLETED|Overall Study||2
6685676|NCT02691741|7615886|FG000|STARTED|Overall Study||94
6685677|NCT02691741|7615887|FG001|STARTED|Overall Study||94
6685678|NCT02691741|7615886|FG000|All-Implanted Analysis Set|Overall Study||93
6685679|NCT02691741|7615887|FG001|All-Implanted Analysis Set|Overall Study||89
6685680|NCT02691741|7615886|FG000|Best-Case Analysis Set|Overall Study||86
6685681|NCT02691741|7615887|FG001|Best-Case Analysis Set|Overall Study||85
6685682|NCT02691741|7615886|FG000|Safety Analysis Set|Overall Study||93
6685683|NCT02691741|7615887|FG001|Safety Analysis Set|Overall Study||89
6685684|NCT02691741|7615886|FG000|COMPLETED|Overall Study||93
6685685|NCT02691741|7615887|FG001|COMPLETED|Overall Study||87
6685686|NCT02691741|7615886|FG000|NOT COMPLETED|Overall Study||1
6685687|NCT02691741|7615887|FG001|NOT COMPLETED|Overall Study||7
6685688|NCT02691936|7615900|FG000|STARTED|Overall Study||35
6685689|NCT02691936|7615901|FG001|STARTED|Overall Study||34
6685690|NCT02691936|7615900|FG000|COMPLETED|Overall Study||33
6685691|NCT02691936|7615901|FG001|COMPLETED|Overall Study||29
6685692|NCT02691936|7615900|FG000|NOT COMPLETED|Overall Study||2
6685693|NCT02691936|7615901|FG001|NOT COMPLETED|Overall Study||5
6685694|NCT02691962|7615907|FG000|STARTED|Overall Study||75
6685695|NCT02691962|7615907|FG000|COMPLETED|Overall Study||59
6685696|NCT02691962|7615907|FG000|NOT COMPLETED|Overall Study||16
6685697|NCT02692040|7615929|FG000|STARTED|Overall Study||10
6685698|NCT02692040|7615930|FG001|STARTED|Overall Study||4
6685699|NCT02692040|7615931|FG002|STARTED|Overall Study||5
6685700|NCT02692040|7615932|FG003|STARTED|Overall Study||5
6685701|NCT02692040|7615933|FG004|STARTED|Overall Study||4
6685702|NCT02692040|7615934|FG005|STARTED|Overall Study||5
6685703|NCT02692040|7615935|FG006|STARTED|Overall Study||5
6685704|NCT02692040|7615936|FG007|STARTED|Overall Study||5
6685705|NCT02692040|7615937|FG008|STARTED|Overall Study||5
6685706|NCT02692040|7615938|FG009|STARTED|Overall Study||4
6685707|NCT02692040|7615939|FG010|STARTED|Overall Study||5
6685708|NCT02692040|7615940|FG011|STARTED|Overall Study||5
6685709|NCT02692040|7615941|FG012|STARTED|Overall Study||6
6685710|NCT02692040|7615942|FG013|STARTED|Overall Study||6
6685711|NCT02692040|7615943|FG014|STARTED|Overall Study||6
6685712|NCT02692040|7615944|FG015|STARTED|Overall Study||6
6685713|NCT02692040|7615945|FG016|STARTED|Overall Study||4
6685714|NCT02692040|7615929|FG000|COMPLETED|Overall Study||10
6685715|NCT02692040|7615930|FG001|COMPLETED|Overall Study||4
6685716|NCT02692040|7615931|FG002|COMPLETED|Overall Study||5
6685717|NCT02692040|7615932|FG003|COMPLETED|Overall Study||5
6685718|NCT02692040|7615933|FG004|COMPLETED|Overall Study||4
6602240|NCT02055820|7527211|FG002|COMPLETED|Phase I: Dose-Finding||7
6602241|NCT02055820|7527212|FG003|COMPLETED|Phase I: Dose-Finding||3
6602242|NCT02055820|7527213|FG004|COMPLETED|Phase I: Dose-Finding||0
6602243|NCT02055820|7527214|FG005|COMPLETED|Phase I: Dose-Finding||5
6602244|NCT02055820|7527215|FG006|COMPLETED|Phase I: Dose-Finding||5
6602245|NCT02055820|7527216|FG007|COMPLETED|Phase I: Dose-Finding||6
6602246|NCT02055820|7527217|FG008|COMPLETED|Phase I: Dose-Finding||6
6602247|NCT02055820|7527218|FG009|COMPLETED|Phase I: Dose-Finding||6
6602248|NCT02055820|7527209|FG000|NOT COMPLETED|Phase I: Dose-Finding||1
6602249|NCT02055820|7527210|FG001|NOT COMPLETED|Phase I: Dose-Finding||0
6602250|NCT02055820|7527211|FG002|NOT COMPLETED|Phase I: Dose-Finding||1
6602251|NCT02055820|7527212|FG003|NOT COMPLETED|Phase I: Dose-Finding||3
6602252|NCT02055820|7527213|FG004|NOT COMPLETED|Phase I: Dose-Finding||0
6602253|NCT02055820|7527214|FG005|NOT COMPLETED|Phase I: Dose-Finding||2
6602254|NCT02055820|7527215|FG006|NOT COMPLETED|Phase I: Dose-Finding||2
6685719|NCT02692040|7615934|FG005|COMPLETED|Overall Study||5
6685720|NCT02692040|7615935|FG006|COMPLETED|Overall Study||5
6685721|NCT02692040|7615936|FG007|COMPLETED|Overall Study||5
6685722|NCT02692040|7615937|FG008|COMPLETED|Overall Study||5
6685723|NCT02692040|7615938|FG009|COMPLETED|Overall Study||4
6685724|NCT02692040|7615939|FG010|COMPLETED|Overall Study||5
6685725|NCT02692040|7615940|FG011|COMPLETED|Overall Study||5
6685726|NCT02692040|7615941|FG012|COMPLETED|Overall Study||5
6685727|NCT02692040|7615942|FG013|COMPLETED|Overall Study||3
6685728|NCT02692040|7615943|FG014|COMPLETED|Overall Study||5
6685729|NCT02692040|7615944|FG015|COMPLETED|Overall Study||5
6685730|NCT02692040|7615945|FG016|COMPLETED|Overall Study||4
6602255|NCT02055820|7527216|FG007|NOT COMPLETED|Phase I: Dose-Finding||0
6602256|NCT02055820|7527217|FG008|NOT COMPLETED|Phase I: Dose-Finding||0
6602257|NCT02055820|7527218|FG009|NOT COMPLETED|Phase I: Dose-Finding||0
6685731|NCT02692040|7615929|FG000|NOT COMPLETED|Overall Study||0
6685732|NCT02692040|7615930|FG001|NOT COMPLETED|Overall Study||0
6685733|NCT02692040|7615931|FG002|NOT COMPLETED|Overall Study||0
6685734|NCT02692040|7615932|FG003|NOT COMPLETED|Overall Study||0
6685735|NCT02692040|7615933|FG004|NOT COMPLETED|Overall Study||0
6685736|NCT02692040|7615934|FG005|NOT COMPLETED|Overall Study||0
6685737|NCT02692040|7615935|FG006|NOT COMPLETED|Overall Study||0
6685738|NCT02692040|7615936|FG007|NOT COMPLETED|Overall Study||0
6685739|NCT02692040|7615937|FG008|NOT COMPLETED|Overall Study||0
6685740|NCT02692040|7615938|FG009|NOT COMPLETED|Overall Study||0
6685741|NCT02692040|7615939|FG010|NOT COMPLETED|Overall Study||0
6685742|NCT02692040|7615940|FG011|NOT COMPLETED|Overall Study||0
6685743|NCT02692040|7615941|FG012|NOT COMPLETED|Overall Study||1
6685744|NCT02692040|7615942|FG013|NOT COMPLETED|Overall Study||3
6685745|NCT02692040|7615943|FG014|NOT COMPLETED|Overall Study||1
6685746|NCT02692040|7615944|FG015|NOT COMPLETED|Overall Study||1
6685747|NCT02692040|7615945|FG016|NOT COMPLETED|Overall Study||0
6685748|NCT02692209|7616022|FG000|STARTED|Overall Study||298
6685749|NCT02692209|7616022|FG000|COMPLETED|Overall Study||298
6685750|NCT02692209|7616022|FG000|NOT COMPLETED|Overall Study||0
6685751|NCT02692235|7616030|FG000|STARTED|Overall Study||14
6685752|NCT02692235|7616031|FG001|STARTED|Overall Study||14
6685753|NCT02692235|7616030|FG000|COMPLETED|Overall Study||11
6685754|NCT02692235|7616031|FG001|COMPLETED|Overall Study||11
6685755|NCT02692235|7616030|FG000|NOT COMPLETED|Overall Study||3
6685756|NCT02692235|7616031|FG001|NOT COMPLETED|Overall Study||3
6685757|NCT02692391|7616039|FG000|STARTED|Overall Study||24
6685758|NCT02692391|7616040|FG001|STARTED|Overall Study||18
6685759|NCT02692391|7616039|FG000|COMPLETED|Overall Study||24
6685760|NCT02692391|7616040|FG001|COMPLETED|Overall Study||18
6685761|NCT02692391|7616039|FG000|NOT COMPLETED|Overall Study||0
6685762|NCT02692391|7616040|FG001|NOT COMPLETED|Overall Study||0
6685763|NCT02692417|7616048|FG000|STARTED|Overall Study||9
6685764|NCT02692417|7616049|FG001|STARTED|Overall Study||7
6685765|NCT02692417|7616048|FG000|COMPLETED|Overall Study||3
6685766|NCT02692417|7616049|FG001|COMPLETED|Overall Study||6
6685767|NCT02692417|7616048|FG000|NOT COMPLETED|Overall Study||6
6685768|NCT02692417|7616049|FG001|NOT COMPLETED|Overall Study||1
6685769|NCT02692482|7616057|FG000|STARTED|Overall Study||177
6685770|NCT02692482|7616058|FG001|STARTED|Overall Study||182
6685771|NCT02692482|7616057|FG000|COMPLETED|Overall Study||174
6685772|NCT02692482|7616058|FG001|COMPLETED|Overall Study||178
6685773|NCT02692482|7616057|FG000|NOT COMPLETED|Overall Study||3
6685774|NCT02692482|7616058|FG001|NOT COMPLETED|Overall Study||4
6685775|NCT02692495|7616067|FG000|STARTED|Overall Study||12
6685776|NCT02692495|7616068|FG001|STARTED|Overall Study||4
6685777|NCT02692495|7616067|FG000|COMPLETED|Overall Study||12
6685778|NCT02692495|7616068|FG001|COMPLETED|Overall Study||4
6685779|NCT02692495|7616067|FG000|NOT COMPLETED|Overall Study||0
6685780|NCT02692495|7616068|FG001|NOT COMPLETED|Overall Study||0
6685781|NCT02692560|7616080|FG000|STARTED|Overall Study||29
6685782|NCT02692560|7616081|FG001|STARTED|Overall Study||31
6685783|NCT02692560|7616080|FG000|COMPLETED|Overall Study||29
6685784|NCT02692560|7616081|FG001|COMPLETED|Overall Study||25
6685785|NCT02692560|7616080|FG000|NOT COMPLETED|Overall Study||0
6685786|NCT02692560|7616081|FG001|NOT COMPLETED|Overall Study||6
6685787|NCT02692586|7616087|FG000|STARTED|Overall Study||106
6685788|NCT02692586|7616087|FG000|COMPLETED|Overall Study||103
6685789|NCT02692586|7616087|FG000|NOT COMPLETED|Overall Study||3
6685790|NCT02692703|7616091|FG000|STARTED|Overall Study||100
6685791|NCT02692703|7616091|FG000|COMPLETED|Overall Study||98
6685792|NCT02692703|7616091|FG000|NOT COMPLETED|Overall Study||2
6685793|NCT02692716|7616097|FG000|STARTED|Overall Study||1591
6685794|NCT02692716|7616098|FG001|STARTED|Overall Study||1592
6685795|NCT02692716|7616097|FG000|Full Analysis Set (FAS)|Overall Study||1591
6685796|NCT02692716|7616098|FG001|Full Analysis Set (FAS)|Overall Study||1592
6685797|NCT02692716|7616097|FG000|Exposed|Overall Study||1591
6685798|NCT02692716|7616098|FG001|Exposed|Overall Study||1591
6685799|NCT02692716|7616097|FG000|COMPLETED|Overall Study||1586
6685800|NCT02692716|7616098|FG001|COMPLETED|Overall Study||1586
6685801|NCT02692716|7616097|FG000|NOT COMPLETED|Overall Study||5
6685802|NCT02692716|7616098|FG001|NOT COMPLETED|Overall Study||6
6685803|NCT02692755|7616104|FG000|STARTED|Overall Study||35
6685804|NCT02692755|7616104|FG000|COMPLETED|Overall Study||35
6685805|NCT02692755|7616104|FG000|NOT COMPLETED|Overall Study||0
6685806|NCT02692859|7616111|FG000|STARTED|Overall Study||996
6685807|NCT02692859|7616112|FG001|STARTED|Overall Study||996
6685808|NCT02692859|7616111|FG000|COMPLETED|Overall Study||912
6685809|NCT02692859|7616112|FG001|COMPLETED|Overall Study||901
6685810|NCT02692859|7616111|FG000|NOT COMPLETED|Overall Study||84
6685811|NCT02692859|7616112|FG001|NOT COMPLETED|Overall Study||95
6685812|NCT02693106|7616118|FG000|STARTED|Overall Study||13
6685813|NCT02693106|7616118|FG000|COMPLETED|Overall Study||10
6685814|NCT02693106|7616118|FG000|NOT COMPLETED|Overall Study||3
6685815|NCT02693119|7616130|FG000|STARTED|Double-Blind Period||8
6685816|NCT02693119|7616131|FG001|STARTED|Double-Blind Period||4
6685817|NCT02693119|7616130|FG000|COMPLETED|Double-Blind Period||8
6685818|NCT02693119|7616131|FG001|COMPLETED|Double-Blind Period||4
6685819|NCT02693119|7616130|FG000|NOT COMPLETED|Double-Blind Period||0
6685820|NCT02693119|7616131|FG001|NOT COMPLETED|Double-Blind Period||0
6685821|NCT02693119|7616130|FG000|STARTED|Open-Label Period||8
6685822|NCT02693119|7616131|FG001|STARTED|Open-Label Period||4
6685823|NCT02693119|7616130|FG000|COMPLETED|Open-Label Period||8
6685824|NCT02693119|7616131|FG001|COMPLETED|Open-Label Period||3
6685825|NCT02693119|7616130|FG000|NOT COMPLETED|Open-Label Period||0
6685826|NCT02693119|7616131|FG001|NOT COMPLETED|Open-Label Period||1
6685827|NCT02693132|7616170|FG000|STARTED|Overall Study||17
6685828|NCT02693132|7616171|FG001|STARTED|Overall Study||17
6685829|NCT02693132|7616172|FG002|STARTED|Overall Study||18
6685830|NCT02693132|7616170|FG000|COMPLETED|Overall Study||16
6685831|NCT02693132|7616171|FG001|COMPLETED|Overall Study||16
6685832|NCT02693132|7616172|FG002|COMPLETED|Overall Study||17
6685833|NCT02693132|7616170|FG000|NOT COMPLETED|Overall Study||1
6685834|NCT02693132|7616171|FG001|NOT COMPLETED|Overall Study||1
6685835|NCT02693132|7616172|FG002|NOT COMPLETED|Overall Study||1
6685836|NCT02693262|7616180|FG000|STARTED|Overall Study||4
6685837|NCT02693262|7616181|FG001|STARTED|Overall Study||5
6685838|NCT02693262|7616180|FG000|COMPLETED|Overall Study||4
6685839|NCT02693262|7616181|FG001|COMPLETED|Overall Study||5
6685840|NCT02693262|7616180|FG000|NOT COMPLETED|Overall Study||0
6685841|NCT02693262|7616181|FG001|NOT COMPLETED|Overall Study||0
6685842|NCT02693418|7616192|FG000|STARTED|Overall Study||22
6685843|NCT02693418|7616193|FG001|STARTED|Overall Study||21
6685844|NCT02693418|7616194|FG002|STARTED|Overall Study||21
6685845|NCT02693418|7616195|FG003|STARTED|Overall Study||20
6685846|NCT02693418|7616196|FG004|STARTED|Overall Study||21
6685847|NCT02693418|7616192|FG000|COMPLETED|Overall Study||21
6685848|NCT02693418|7616193|FG001|COMPLETED|Overall Study||19
6685849|NCT02693418|7616194|FG002|COMPLETED|Overall Study||19
6685850|NCT02693418|7616195|FG003|COMPLETED|Overall Study||20
6685851|NCT02693418|7616196|FG004|COMPLETED|Overall Study||21
6685852|NCT02693418|7616192|FG000|NOT COMPLETED|Overall Study||1
6685853|NCT02693418|7616193|FG001|NOT COMPLETED|Overall Study||2
6685854|NCT02693418|7616194|FG002|NOT COMPLETED|Overall Study||2
6685855|NCT02693418|7616195|FG003|NOT COMPLETED|Overall Study||0
6685856|NCT02693418|7616196|FG004|NOT COMPLETED|Overall Study||0
6685857|NCT02693704|7616212|FG000|STARTED|Overall Study||10
6685858|NCT02693704|7616213|FG001|STARTED|Overall Study||10
6685859|NCT02693704|7616214|FG002|STARTED|Overall Study||10
6685860|NCT02693704|7616215|FG003|STARTED|Overall Study||10
6685861|NCT02693704|7616212|FG000|COMPLETED|Overall Study||10
6685862|NCT02693704|7616213|FG001|COMPLETED|Overall Study||10
6685863|NCT02693704|7616214|FG002|COMPLETED|Overall Study||10
6685864|NCT02693704|7616215|FG003|COMPLETED|Overall Study||10
6685865|NCT02693704|7616212|FG000|NOT COMPLETED|Overall Study||0
6685866|NCT02693704|7616213|FG001|NOT COMPLETED|Overall Study||0
6685867|NCT02693704|7616214|FG002|NOT COMPLETED|Overall Study||0
6685868|NCT02693704|7616215|FG003|NOT COMPLETED|Overall Study||0
6685869|NCT02693834|7616225|FG000|STARTED|Baseline Measurement|10 were randomized to PLS AFO first week group (2 dropped out at baseline)|12
6685870|NCT02693834|7616226|FG001|STARTED|Baseline Measurement|11 participants were assigned to DA AFO first group|11
6685871|NCT02693834|7616225|FG000|COMPLETED|Baseline Measurement|10 particiapnts completed wearing PLS AFO during the first week and 10 during the second week|10
6685872|NCT02693834|7616226|FG001|COMPLETED|Baseline Measurement|10 particiapnts completed wearing DA AFO during the first week and 10 the second week (1 was lost)|11
6685873|NCT02693834|7616225|FG000|NOT COMPLETED|Baseline Measurement||2
6685874|NCT02693834|7616226|FG001|NOT COMPLETED|Baseline Measurement||0
6685875|NCT02693834|7616225|FG000|STARTED|Week 1 Practice|During the first week of practice, 10 participants were assigned to PLS AFO group|10
6685876|NCT02693834|7616226|FG001|STARTED|Week 1 Practice|During the first week of practice, 11 participants were assigned to DAAFO group|11
6685877|NCT02693834|7616225|FG000|COMPLETED|Week 1 Practice||10
6685878|NCT02693834|7616226|FG001|COMPLETED|Week 1 Practice||11
6685879|NCT02693834|7616225|FG000|NOT COMPLETED|Week 1 Practice||0
6685880|NCT02693834|7616226|FG001|NOT COMPLETED|Week 1 Practice||0
6685881|NCT02693834|7616225|FG000|STARTED|Week 2 Practice||10
6685882|NCT02693834|7616226|FG001|STARTED|Week 2 Practice||11
6685883|NCT02693834|7616225|FG000|COMPLETED|Week 2 Practice||10
6685884|NCT02693834|7616226|FG001|COMPLETED|Week 2 Practice||10
6685885|NCT02693834|7616225|FG000|NOT COMPLETED|Week 2 Practice||0
6685886|NCT02693834|7616226|FG001|NOT COMPLETED|Week 2 Practice||1
6685887|NCT02694029|7616234|FG000|STARTED|Overall Study||5
6685888|NCT02694029|7616235|FG001|STARTED|Overall Study||5
6685889|NCT02694029|7616234|FG000|First Intervention|Overall Study||5
6685890|NCT02694029|7616235|FG001|First Intervention|Overall Study||5
6685891|NCT02694029|7616234|FG000|Second Intervention|Overall Study||5
6685892|NCT02694029|7616235|FG001|Second Intervention|Overall Study||5
6685893|NCT02694029|7616234|FG000|COMPLETED|Overall Study||5
6685894|NCT02694029|7616235|FG001|COMPLETED|Overall Study||5
6685895|NCT02694029|7616234|FG000|NOT COMPLETED|Overall Study||0
6685896|NCT02694029|7616235|FG001|NOT COMPLETED|Overall Study||0
6685897|NCT02694198|7616245|FG000|STARTED|Overall Study||135
6685898|NCT02694198|7616245|FG000|COMPLETED|Overall Study||135
6685899|NCT02694198|7616245|FG000|NOT COMPLETED|Overall Study||0
6685900|NCT02694315|7616249|FG000|STARTED|Overall Study||200
6685901|NCT02694315|7616249|FG000|COMPLETED|Overall Study||200
6685902|NCT02694315|7616249|FG000|NOT COMPLETED|Overall Study||0
6685903|NCT02694328|7616255|FG000|STARTED|Overall Study||276
6685904|NCT02694328|7616256|FG001|STARTED|Overall Study||274
6685905|NCT02694328|7616255|FG000|COMPLETED|Overall Study||176
6685906|NCT02694328|7616256|FG001|COMPLETED|Overall Study||176
6685907|NCT02694328|7616255|FG000|NOT COMPLETED|Overall Study||100
6685908|NCT02694328|7616256|FG001|NOT COMPLETED|Overall Study||98
6685909|NCT02694445|7616262|FG000|STARTED|Overall Study||3098
6685910|NCT02694445|7616262|FG000|COMPLETED|Overall Study||3046
6685911|NCT02694445|7616262|FG000|NOT COMPLETED|Overall Study||52
6685912|NCT02694523|7616268|FG000|STARTED|Part A||304
6685913|NCT02694523|7616269|FG001|STARTED|Part A||301
6685914|NCT02694523|7616270|FG002|STARTED|Part A||0
6685915|NCT02694523|7616271|FG003|STARTED|Part A||0
6685916|NCT02694523|7616272|FG004|STARTED|Part A||0
6685917|NCT02694523|7616273|FG005|STARTED|Part A||0
6685918|NCT02694523|7616274|FG006|STARTED|Part A||0
6685919|NCT02694523|7616268|FG000|COMPLETED|Part A||291
6685920|NCT02694523|7616269|FG001|COMPLETED|Part A||294
6685921|NCT02694523|7616270|FG002|COMPLETED|Part A||0
6685922|NCT02694523|7616271|FG003|COMPLETED|Part A||0
6685923|NCT02694523|7616272|FG004|COMPLETED|Part A||0
6685924|NCT02694523|7616273|FG005|COMPLETED|Part A||0
6685925|NCT02694523|7616274|FG006|COMPLETED|Part A||0
6685926|NCT02694523|7616268|FG000|NOT COMPLETED|Part A||13
6685927|NCT02694523|7616269|FG001|NOT COMPLETED|Part A||7
6685928|NCT02694523|7616270|FG002|NOT COMPLETED|Part A||0
6685929|NCT02694523|7616271|FG003|NOT COMPLETED|Part A||0
6685930|NCT02694523|7616272|FG004|NOT COMPLETED|Part A||0
6685931|NCT02694523|7616273|FG005|NOT COMPLETED|Part A||0
6685932|NCT02694523|7616274|FG006|NOT COMPLETED|Part A||0
6685933|NCT02694523|7616268|FG000|STARTED|Part B||0
6685934|NCT02694523|7616269|FG001|STARTED|Part B||0
6685935|NCT02694523|7616270|FG002|STARTED|Part B|Participants who received risankizumab in Part A continued to received risankizumab in Part B|294
6685936|NCT02694523|7616271|FG003|STARTED|Part B|Adalimumab responders in Part A continued to received adalimumab in Part B|144
6685937|NCT02694523|7616272|FG004|STARTED|Part B|Adalimumab nonresponders in Part A switched to risankizumab in Part B|38
6685938|NCT02694523|7616273|FG005|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to adalimumab in Part B|56
6685939|NCT02694523|7616274|FG006|STARTED|Part B|Adalimumab inadequate responders in Part A, rerandomized to risankizumab in Part B|53
6685940|NCT02694523|7616268|FG000|COMPLETED|Part B||0
6685941|NCT02694523|7616269|FG001|COMPLETED|Part B||0
6685942|NCT02694523|7616270|FG002|COMPLETED|Part B||274
6685943|NCT02694523|7616271|FG003|COMPLETED|Part B||140
6685944|NCT02694523|7616272|FG004|COMPLETED|Part B||34
6685945|NCT02694523|7616273|FG005|COMPLETED|Part B||51
6685946|NCT02694523|7616274|FG006|COMPLETED|Part B||51
6685947|NCT02694523|7616268|FG000|NOT COMPLETED|Part B||0
6685948|NCT02694523|7616269|FG001|NOT COMPLETED|Part B||0
6685949|NCT02694523|7616270|FG002|NOT COMPLETED|Part B||20
6685950|NCT02694523|7616271|FG003|NOT COMPLETED|Part B||4
6685951|NCT02694523|7616272|FG004|NOT COMPLETED|Part B||4
6685952|NCT02694523|7616273|FG005|NOT COMPLETED|Part B||5
6685953|NCT02694523|7616274|FG006|NOT COMPLETED|Part B||2
6685954|NCT02694536|7616286|FG000|STARTED|Overall Study||80
6685955|NCT02694536|7616286|FG000|COMPLETED|Overall Study||0
6685956|NCT02694536|7616286|FG000|NOT COMPLETED|Overall Study||80
6685957|NCT02694549|7616290|FG000|STARTED|Overall Study||12
6685958|NCT02694549|7616290|FG000|COMPLETED|Overall Study||10
6685959|NCT02694549|7616290|FG000|NOT COMPLETED|Overall Study||2
6685960|NCT02694562|7616294|FG000|STARTED|Overall Study||20
6685961|NCT02694562|7616294|FG000|COMPLETED|Overall Study||2
6685962|NCT02694562|7616294|FG000|NOT COMPLETED|Overall Study||18
6685963|NCT02694601|7616298|FG000|STARTED|Overall Study||10
6685964|NCT02694601|7616298|FG000|COMPLETED|Overall Study||10
6685965|NCT02694601|7616298|FG000|NOT COMPLETED|Overall Study||0
6685966|NCT02694718|7616302|FG000|STARTED|Overall Study||60
6685967|NCT02694718|7616302|FG000|COMPLETED|Overall Study||58
6685968|NCT02694718|7616302|FG000|NOT COMPLETED|Overall Study||2
6685969|NCT02694744|7616308|FG000|STARTED|Overall Study||57
6685970|NCT02694744|7616309|FG001|STARTED|Overall Study||57
6685971|NCT02694744|7616308|FG000|Safety Population|Overall Study||57
6685972|NCT02694744|7616309|FG001|Safety Population|Overall Study||56
6685973|NCT02694744|7616308|FG000|ITT|Overall Study||57
6685974|NCT02694744|7616309|FG001|ITT|Overall Study||55
6685975|NCT02694744|7616308|FG000|COMPLETED|Overall Study||51
6685976|NCT02694744|7616309|FG001|COMPLETED|Overall Study||52
6685977|NCT02694744|7616308|FG000|NOT COMPLETED|Overall Study||6
6685978|NCT02694744|7616309|FG001|NOT COMPLETED|Overall Study||5
6685979|NCT02694835|7616319|FG000|STARTED|Overall Study||41
6685980|NCT02694835|7616320|FG001|STARTED|Overall Study||39
6685981|NCT02694835|7616319|FG000|COMPLETED|Overall Study||41
6685982|NCT02694835|7616320|FG001|COMPLETED|Overall Study||39
6685983|NCT02694835|7616319|FG000|NOT COMPLETED|Overall Study||0
6685984|NCT02694835|7616320|FG001|NOT COMPLETED|Overall Study||0
6685985|NCT02694978|7616328|FG000|STARTED|Overall Study||1006
6685986|NCT02694978|7616329|FG001|STARTED|Overall Study||1008
6685987|NCT02694978|7616328|FG000|Received at Least 1 Dose of Study Drug|Overall Study||997
6685988|NCT02694978|7616329|FG001|Received at Least 1 Dose of Study Drug|Overall Study||1000
6685989|NCT02694978|7616328|FG000|COMPLETED|Overall Study||935
6685990|NCT02694978|7616329|FG001|COMPLETED|Overall Study||948
6685991|NCT02694978|7616328|FG000|NOT COMPLETED|Overall Study||71
6685992|NCT02694978|7616329|FG001|NOT COMPLETED|Overall Study||60
6685993|NCT02695290|7616335|FG000|STARTED|Overall Study||1
6685994|NCT02695290|7616335|FG000|COMPLETED|Overall Study||1
6685995|NCT02695290|7616335|FG000|NOT COMPLETED|Overall Study||0
6685996|NCT02695329|7616341|FG000|STARTED|Overall Study||50
6685997|NCT02695329|7616342|FG001|STARTED|Overall Study||50
6685998|NCT02695329|7616341|FG000|COMPLETED|Overall Study||45
6685999|NCT02695329|7616342|FG001|COMPLETED|Overall Study||45
6686000|NCT02695329|7616341|FG000|NOT COMPLETED|Overall Study||5
6686001|NCT02695329|7616342|FG001|NOT COMPLETED|Overall Study||5
6686002|NCT02695420|7616352|FG000|STARTED|Overall Study||21
6686003|NCT02695420|7616353|FG001|STARTED|Overall Study||21
6686004|NCT02695420|7616354|FG002|STARTED|Overall Study||19
6686005|NCT02695420|7616355|FG003|STARTED|Overall Study||20
6686006|NCT02695420|7616352|FG000|COMPLETED|Overall Study||21
6686007|NCT02695420|7616353|FG001|COMPLETED|Overall Study||20
6686008|NCT02695420|7616354|FG002|COMPLETED|Overall Study||19
6257144|NCT02520011|7156093|FG001|NOT COMPLETED|Overall Study||46
6686009|NCT02695420|7616355|FG003|COMPLETED|Overall Study||20
6686010|NCT02695420|7616352|FG000|NOT COMPLETED|Overall Study||0
6686011|NCT02695420|7616353|FG001|NOT COMPLETED|Overall Study||1
6686012|NCT02695420|7616354|FG002|NOT COMPLETED|Overall Study||0
6686013|NCT02695420|7616355|FG003|NOT COMPLETED|Overall Study||0
6686014|NCT02695446|7616368|FG000|STARTED|Overall Study||12
6686015|NCT02695446|7616368|FG000|COMPLETED|Overall Study||12
6686016|NCT02695446|7616368|FG000|NOT COMPLETED|Overall Study||0
6686017|NCT02695524|7616374|FG000|STARTED|Overall Study||30
6686018|NCT02695524|7616375|FG001|STARTED|Overall Study||30
6686019|NCT02695524|7616374|FG000|COMPLETED|Overall Study||27
6686020|NCT02695524|7616375|FG001|COMPLETED|Overall Study||27
6686021|NCT02695524|7616374|FG000|NOT COMPLETED|Overall Study||3
6686022|NCT02695524|7616375|FG001|NOT COMPLETED|Overall Study||3
6686023|NCT02695537|7616381|FG000|STARTED|Overall Study||89
6686024|NCT02695537|7616381|FG000|COMPLETED|Overall Study||51
6686025|NCT02695537|7616381|FG000|NOT COMPLETED|Overall Study||38
6686026|NCT02695628|7616385|FG000|STARTED|Overall Study||5
6686027|NCT02695628|7616385|FG000|COMPLETED|Overall Study||4
6686028|NCT02695628|7616385|FG000|NOT COMPLETED|Overall Study||1
6686029|NCT02695719|7616391|FG000|STARTED|Overall Study||74
6686030|NCT02695719|7616392|FG001|STARTED|Overall Study||82
6686031|NCT02695719|7616391|FG000|COMPLETED|Overall Study||71
6686032|NCT02695719|7616392|FG001|COMPLETED|Overall Study||72
6686033|NCT02695719|7616391|FG000|NOT COMPLETED|Overall Study||3
6686034|NCT02695719|7616392|FG001|NOT COMPLETED|Overall Study||10
6686053|NCT02696070|7616414|FG000|STARTED|Overall Study||8
6686054|NCT02696070|7616415|FG001|STARTED|Overall Study||14
6686055|NCT02696070|7616414|FG000|COMPLETED|Overall Study||7
6686056|NCT02696070|7616415|FG001|COMPLETED|Overall Study||12
6686057|NCT02696070|7616414|FG000|NOT COMPLETED|Overall Study||1
6686058|NCT02696070|7616415|FG001|NOT COMPLETED|Overall Study||2
6686059|NCT02696083|7616421|FG000|STARTED|Overall Study||19
6686060|NCT02696083|7616421|FG000|COMPLETED|Overall Study||13
6686061|NCT02696083|7616421|FG000|NOT COMPLETED|Overall Study||6
6686062|NCT02696200|7616432|FG000|STARTED|Overall Study||32
6686063|NCT02696200|7616433|FG001|STARTED|Overall Study||30
6686064|NCT02696200|7616432|FG000|COMPLETED|Overall Study||32
6686065|NCT02696200|7616433|FG001|COMPLETED|Overall Study||30
6686066|NCT02696200|7616432|FG000|NOT COMPLETED|Overall Study||0
6686067|NCT02696200|7616433|FG001|NOT COMPLETED|Overall Study||0
6686068|NCT02696291|7616441|FG000|STARTED|Overall Study||5
6686069|NCT02696291|7616442|FG001|STARTED|Overall Study||2
6686070|NCT02696291|7616441|FG000|COMPLETED|Overall Study||5
6686071|NCT02696291|7616442|FG001|COMPLETED|Overall Study||2
6686072|NCT02696291|7616441|FG000|NOT COMPLETED|Overall Study||0
6686073|NCT02696291|7616442|FG001|NOT COMPLETED|Overall Study||0
6686074|NCT02696317|7616448|FG000|STARTED|Habitual, 10 Days of Wear||42
6686075|NCT02696317|7616449|FG001|STARTED|Habitual, 10 Days of Wear||40
6686076|NCT02696317|7616448|FG000|COMPLETED|Habitual, 10 Days of Wear||40
6686077|NCT02696317|7616449|FG001|COMPLETED|Habitual, 10 Days of Wear||36
6686078|NCT02696317|7616448|FG000|NOT COMPLETED|Habitual, 10 Days of Wear||2
6686079|NCT02696317|7616449|FG001|NOT COMPLETED|Habitual, 10 Days of Wear||4
6686080|NCT02696317|7616448|FG000|STARTED|Period 1, 10 Days of Wear||40
6686081|NCT02696317|7616449|FG001|STARTED|Period 1, 10 Days of Wear||36
6257145|NCT02520011|7156094|FG002|NOT COMPLETED|Overall Study||9
6686082|NCT02696317|7616448|FG000|COMPLETED|Period 1, 10 Days of Wear||40
6686083|NCT02696317|7616449|FG001|COMPLETED|Period 1, 10 Days of Wear||36
6686084|NCT02696317|7616448|FG000|NOT COMPLETED|Period 1, 10 Days of Wear||0
6686085|NCT02696317|7616449|FG001|NOT COMPLETED|Period 1, 10 Days of Wear||0
6686086|NCT02696317|7616448|FG000|STARTED|Period 2, 10 Days of Wear||40
6686087|NCT02696317|7616449|FG001|STARTED|Period 2, 10 Days of Wear||36
6686088|NCT02696317|7616448|FG000|COMPLETED|Period 2, 10 Days of Wear||39
6686089|NCT02696317|7616449|FG001|COMPLETED|Period 2, 10 Days of Wear||36
6686090|NCT02696317|7616448|FG000|NOT COMPLETED|Period 2, 10 Days of Wear||1
6686091|NCT02696317|7616449|FG001|NOT COMPLETED|Period 2, 10 Days of Wear||0
6686092|NCT02696434|7616459|FG000|STARTED|Overall Study||50
6686093|NCT02696434|7616460|FG001|STARTED|Overall Study||51
6686094|NCT02696434|7616459|FG000|COMPLETED|Overall Study||28
6686095|NCT02696434|7616460|FG001|COMPLETED|Overall Study||33
6686096|NCT02696434|7616459|FG000|NOT COMPLETED|Overall Study||22
6686097|NCT02696434|7616460|FG001|NOT COMPLETED|Overall Study||18
6686098|NCT02696785|7616470|FG000|STARTED|Blinded Treatment Period||87
6686099|NCT02696785|7616471|FG001|STARTED|Blinded Treatment Period||90
6686100|NCT02696785|7616472|FG002|STARTED|Blinded Treatment Period||83
6686101|NCT02696785|7616473|FG003|STARTED|Blinded Treatment Period||81
6686102|NCT02696785|7616470|FG000|Received at Least One Dose of Study Drug|Blinded Treatment Period||86
6686103|NCT02696785|7616471|FG001|Received at Least One Dose of Study Drug|Blinded Treatment Period||90
6686104|NCT02696785|7616472|FG002|Received at Least One Dose of Study Drug|Blinded Treatment Period||83
6686105|NCT02696785|7616473|FG003|Received at Least One Dose of Study Drug|Blinded Treatment Period||81
6686106|NCT02696785|7616470|FG000|COMPLETED|Blinded Treatment Period||86
6686107|NCT02696785|7616471|FG001|COMPLETED|Blinded Treatment Period||88
6686108|NCT02696785|7616472|FG002|COMPLETED|Blinded Treatment Period||79
6686109|NCT02696785|7616473|FG003|COMPLETED|Blinded Treatment Period||78
6686110|NCT02696785|7616470|FG000|NOT COMPLETED|Blinded Treatment Period||1
6686111|NCT02696785|7616471|FG001|NOT COMPLETED|Blinded Treatment Period||2
6686112|NCT02696785|7616472|FG002|NOT COMPLETED|Blinded Treatment Period||4
6686113|NCT02696785|7616473|FG003|NOT COMPLETED|Blinded Treatment Period||3
6686114|NCT02696785|7616470|FG000|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
6686115|NCT02696785|7616471|FG001|STARTED|Washout Period||88
6686116|NCT02696785|7616472|FG002|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
6686117|NCT02696785|7616473|FG003|STARTED|Washout Period|Washout period occurred only for Adalimumab group.|0
6686118|NCT02696785|7616470|FG000|COMPLETED|Washout Period||0
6686119|NCT02696785|7616471|FG001|COMPLETED|Washout Period||86
6686120|NCT02696785|7616472|FG002|COMPLETED|Washout Period||0
6686121|NCT02696785|7616473|FG003|COMPLETED|Washout Period||0
6686122|NCT02696785|7616470|FG000|NOT COMPLETED|Washout Period||0
6686123|NCT02696785|7616471|FG001|NOT COMPLETED|Washout Period||2
6686124|NCT02696785|7616472|FG002|NOT COMPLETED|Washout Period||0
6686125|NCT02696785|7616473|FG003|NOT COMPLETED|Washout Period||0
6686126|NCT02696785|7616470|FG000|STARTED|Extended Treatment Period||86
6686127|NCT02696785|7616471|FG001|STARTED|Extended Treatment Period||86
6686128|NCT02696785|7616472|FG002|STARTED|Extended Treatment Period||79
6686129|NCT02696785|7616473|FG003|STARTED|Extended Treatment Period||78
6686130|NCT02696785|7616470|FG000|COMPLETED|Extended Treatment Period||83
6686131|NCT02696785|7616471|FG001|COMPLETED|Extended Treatment Period||80
6686132|NCT02696785|7616472|FG002|COMPLETED|Extended Treatment Period||74
6686133|NCT02696785|7616473|FG003|COMPLETED|Extended Treatment Period||72
6686134|NCT02696785|7616470|FG000|NOT COMPLETED|Extended Treatment Period||3
6686135|NCT02696785|7616471|FG001|NOT COMPLETED|Extended Treatment Period||6
6686136|NCT02696785|7616472|FG002|NOT COMPLETED|Extended Treatment Period||5
6686137|NCT02696785|7616473|FG003|NOT COMPLETED|Extended Treatment Period||6
6686138|NCT02696785|7616470|FG000|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|1
6686139|NCT02696785|7616471|FG001|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|0
6686140|NCT02696785|7616472|FG002|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|24
6686141|NCT02696785|7616473|FG003|STARTED|Follow-up Period|Participants who completed study were eligible to enroll RHBY & who didn't enroll entered Follow-Up.|16
6686142|NCT02696785|7616470|FG000|COMPLETED|Follow-up Period||0
6686143|NCT02696785|7616471|FG001|COMPLETED|Follow-up Period||0
6686144|NCT02696785|7616472|FG002|COMPLETED|Follow-up Period||11
6686145|NCT02696785|7616473|FG003|COMPLETED|Follow-up Period||8
6686146|NCT02696785|7616470|FG000|NOT COMPLETED|Follow-up Period||1
6686147|NCT02696785|7616471|FG001|NOT COMPLETED|Follow-up Period||0
6686148|NCT02696785|7616472|FG002|NOT COMPLETED|Follow-up Period||13
6686149|NCT02696785|7616473|FG003|NOT COMPLETED|Follow-up Period||8
6686150|NCT02696798|7616504|FG000|STARTED|Blinded Treatment Dosing Period||104
6686151|NCT02696798|7616505|FG001|STARTED|Blinded Treatment Dosing Period||114
6686152|NCT02696798|7616506|FG002|STARTED|Blinded Treatment Dosing Period||98
6686153|NCT02696798|7616504|FG000|COMPLETED|Blinded Treatment Dosing Period||93
6686154|NCT02696798|7616505|FG001|COMPLETED|Blinded Treatment Dosing Period||99
6686155|NCT02696798|7616506|FG002|COMPLETED|Blinded Treatment Dosing Period||90
6686156|NCT02696798|7616504|FG000|NOT COMPLETED|Blinded Treatment Dosing Period||11
6686157|NCT02696798|7616505|FG001|NOT COMPLETED|Blinded Treatment Dosing Period||15
6686158|NCT02696798|7616506|FG002|NOT COMPLETED|Blinded Treatment Dosing Period||8
6686159|NCT02696798|7616504|FG000|STARTED|Extended Treatment Period||93
6686160|NCT02696798|7616505|FG001|STARTED|Extended Treatment Period|1 participant completed blinded treatment period and entered post-treatment followup period directly|98
6686161|NCT02696798|7616506|FG002|STARTED|Extended Treatment Period||90
6686162|NCT02696798|7616504|FG000|COMPLETED|Extended Treatment Period||81
6686163|NCT02696798|7616505|FG001|COMPLETED|Extended Treatment Period||89
6686164|NCT02696798|7616506|FG002|COMPLETED|Extended Treatment Period||80
6686165|NCT02696798|7616504|FG000|NOT COMPLETED|Extended Treatment Period||12
6686166|NCT02696798|7616505|FG001|NOT COMPLETED|Extended Treatment Period||9
6686167|NCT02696798|7616506|FG002|NOT COMPLETED|Extended Treatment Period||10
6686168|NCT02696798|7616504|FG000|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|5
6686169|NCT02696798|7616505|FG001|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|34
6686170|NCT02696798|7616506|FG002|STARTED|Post-treatment Follow-up Period|Participants who terminate RHBW early or who didn't enroll into RHBY entered Follow-Up Period.|22
6686171|NCT02696798|7616504|FG000|COMPLETED|Post-treatment Follow-up Period||0
6686172|NCT02696798|7616505|FG001|COMPLETED|Post-treatment Follow-up Period||8
6686173|NCT02696798|7616506|FG002|COMPLETED|Post-treatment Follow-up Period||3
6686174|NCT02696798|7616504|FG000|NOT COMPLETED|Post-treatment Follow-up Period||5
6686175|NCT02696798|7616505|FG001|NOT COMPLETED|Post-treatment Follow-up Period||26
6686176|NCT02696798|7616506|FG002|NOT COMPLETED|Post-treatment Follow-up Period||19
6686177|NCT02696850|7616530|FG000|STARTED|Overall Study||40
6686178|NCT02696850|7616531|FG001|STARTED|Overall Study||40
6686179|NCT02696850|7616530|FG000|COMPLETED|Overall Study||29
6686180|NCT02696850|7616531|FG001|COMPLETED|Overall Study||32
6686181|NCT02696850|7616530|FG000|NOT COMPLETED|Overall Study||11
6686182|NCT02696850|7616531|FG001|NOT COMPLETED|Overall Study||8
6686183|NCT02696902|7616540|FG000|STARTED|Overall Study||85
6686184|NCT02696902|7616541|FG001|STARTED|Overall Study||16
6686185|NCT02696902|7616542|FG002|STARTED|Overall Study||87
6686186|NCT02696902|7616540|FG000|Treated|Overall Study||83
6686187|NCT02696902|7616541|FG001|Treated|Overall Study||16
6686188|NCT02696902|7616542|FG002|Treated|Overall Study||85
6686189|NCT02696902|7616540|FG000|Intent-to-treat (ITT) Population|Overall Study||85
6686190|NCT02696902|7616541|FG001|Intent-to-treat (ITT) Population|Overall Study||16
6686191|NCT02696902|7616542|FG002|Intent-to-treat (ITT) Population|Overall Study||87
6686192|NCT02696902|7616540|FG000|As-treated Population|Overall Study||83
6686193|NCT02696902|7616541|FG001|As-treated Population|Overall Study||16
6686194|NCT02696902|7616542|FG002|As-treated Population|Overall Study||85
6686195|NCT02696902|7616540|FG000|Modified Intent-to-treat (mITT) Population|Overall Study||83
6686196|NCT02696902|7616541|FG001|Modified Intent-to-treat (mITT) Population|Overall Study||16
6686197|NCT02696902|7616542|FG002|Modified Intent-to-treat (mITT) Population|Overall Study||85
6686198|NCT02696902|7616540|FG000|COMPLETED|Overall Study||63
6686199|NCT02696902|7616541|FG001|COMPLETED|Overall Study||12
6686200|NCT02696902|7616542|FG002|COMPLETED|Overall Study||59
6686201|NCT02696902|7616540|FG000|NOT COMPLETED|Overall Study||22
6686202|NCT02696902|7616541|FG001|NOT COMPLETED|Overall Study||4
6686203|NCT02696902|7616542|FG002|NOT COMPLETED|Overall Study||28
6686204|NCT02696967|7616556|FG000|STARTED|Overall Study||4
6686205|NCT02696967|7616557|FG001|STARTED|Overall Study||6
6686206|NCT02696967|7616558|FG002|STARTED|Overall Study||6
6686207|NCT02696967|7616559|FG003|STARTED|Overall Study||10
6686208|NCT02696967|7616556|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6686209|NCT02696967|7616557|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||6
6686210|NCT02696967|7616558|FG002|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6686211|NCT02696967|7616559|FG003|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6686212|NCT02696967|7616556|FG000|COMPLETED|Overall Study||4
6686213|NCT02696967|7616557|FG001|COMPLETED|Overall Study||6
6686214|NCT02696967|7616558|FG002|COMPLETED|Overall Study||6
6686215|NCT02696967|7616559|FG003|COMPLETED|Overall Study||10
6686216|NCT02696967|7616556|FG000|NOT COMPLETED|Overall Study||0
6686217|NCT02696967|7616557|FG001|NOT COMPLETED|Overall Study||0
6686218|NCT02696967|7616558|FG002|NOT COMPLETED|Overall Study||0
6686219|NCT02696967|7616559|FG003|NOT COMPLETED|Overall Study||0
6686220|NCT02697071|7616571|FG000|STARTED|Overall Study||18
6686221|NCT02697071|7616572|FG001|STARTED|Overall Study||16
6686222|NCT02697071|7616571|FG000|COMPLETED|Overall Study||18
6686223|NCT02697071|7616572|FG001|COMPLETED|Overall Study||16
6686224|NCT02697071|7616571|FG000|NOT COMPLETED|Overall Study||0
6257146|NCT02315534|7156109|FG000|STARTED|Overall Study||4
6257147|NCT02315534|7156110|FG001|STARTED|Overall Study||30
6257148|NCT02315534|7156109|FG000|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
6257149|NCT02315534|7156110|FG001|Assessment of Dose-limiting Toxicity (DLT)|Overall Study||0
6257150|NCT02315534|7156109|FG000|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||2
6257151|NCT02315534|7156110|FG001|Off Treatment Due to Radiologic Disease Progression (PD)|Overall Study||20
6257152|NCT02315534|7156109|FG000|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||1
6257153|NCT02315534|7156110|FG001|Off Treatment Due to Clinically Unacceptable Toxicities|Overall Study||7
6257154|NCT02315534|7156109|FG000|Off Treatment Due to Patient Request|Overall Study||1
6257155|NCT02315534|7156110|FG001|Off Treatment Due to Patient Request|Overall Study||2
6257156|NCT02315534|7156109|FG000|Off Treatment Due to Clinical PD|Overall Study||0
6257157|NCT02315534|7156110|FG001|Off Treatment Due to Clinical PD|Overall Study||1
6257158|NCT02315534|7156109|FG000|COMPLETED|Overall Study||4
6257159|NCT02315534|7156110|FG001|COMPLETED|Overall Study||30
6257160|NCT02315534|7156109|FG000|NOT COMPLETED|Overall Study||0
6257161|NCT02315534|7156110|FG001|NOT COMPLETED|Overall Study||0
6257162|NCT02279719|7156131|FG000|STARTED|Overall Study||5
6257163|NCT02279719|7156132|FG001|STARTED|Overall Study||10
6257164|NCT02279719|7156133|FG002|STARTED|Overall Study||4
6257165|NCT02279719|7156134|FG003|STARTED|Overall Study||9
6257166|NCT02279719|7156135|FG004|STARTED|Overall Study||28
6257167|NCT02279719|7156136|FG005|STARTED|Overall Study||10
6257168|NCT02279719|7156137|FG006|STARTED|Overall Study||31
6257169|NCT02279719|7156131|FG000|COMPLETED|Overall Study||5
6257170|NCT02279719|7156132|FG001|COMPLETED|Overall Study||10
6257171|NCT02279719|7156133|FG002|COMPLETED|Overall Study||4
6257172|NCT02279719|7156134|FG003|COMPLETED|Overall Study||9
6257173|NCT02279719|7156135|FG004|COMPLETED|Overall Study||25
6257174|NCT02279719|7156136|FG005|COMPLETED|Overall Study||10
6257175|NCT02279719|7156137|FG006|COMPLETED|Overall Study||28
6257176|NCT02279719|7156131|FG000|NOT COMPLETED|Overall Study||0
6257177|NCT02279719|7156132|FG001|NOT COMPLETED|Overall Study||0
6686225|NCT02697071|7616572|FG001|NOT COMPLETED|Overall Study||0
6686226|NCT02697188|7616578|FG000|STARTED|TE Period 1 - 400 mg QD||12
6686227|NCT02697188|7616578|FG000|COMPLETED|TE Period 1 - 400 mg QD||12
6686228|NCT02697188|7616578|FG000|NOT COMPLETED|TE Period 1 - 400 mg QD||0
6686229|NCT02697188|7616578|FG000|STARTED|TU Period 2 - 200 mg QD||12
6686230|NCT02697188|7616578|FG000|COMPLETED|TU Period 2 - 200 mg QD||12
6686231|NCT02697188|7616578|FG000|NOT COMPLETED|TU Period 2 - 200 mg QD||0
6686232|NCT02697188|7616578|FG000|STARTED|TU Period 3 - 200 mg BID||12
6686233|NCT02697188|7616578|FG000|COMPLETED|TU Period 3 - 200 mg BID||12
6686234|NCT02697188|7616578|FG000|NOT COMPLETED|TU Period 3 - 200 mg BID||0
6686235|NCT02697188|7616578|FG000|STARTED|TU Period 4 - 400 BID||12
6686236|NCT02697188|7616578|FG000|COMPLETED|TU Period 4 - 400 BID||12
6686237|NCT02697188|7616578|FG000|NOT COMPLETED|TU Period 4 - 400 BID||0
6686238|NCT02697188|7616578|FG000|STARTED|TE Period 5 - 800 mg BID||12
6686239|NCT02697188|7616578|FG000|COMPLETED|TE Period 5 - 800 mg BID||12
6686240|NCT02697188|7616578|FG000|NOT COMPLETED|TE Period 5 - 800 mg BID||0
6686241|NCT02697214|7616590|FG000|STARTED|Overall Study||26
6686242|NCT02697214|7616591|FG001|STARTED|Overall Study||25
6686243|NCT02697214|7616592|FG002|STARTED|Overall Study||25
6686244|NCT02697214|7616593|FG003|STARTED|Overall Study||24
6686245|NCT02697214|7616594|FG004|STARTED|Overall Study||50
6686246|NCT02697214|7616595|FG005|STARTED|Overall Study||50
6686247|NCT02697214|7616590|FG000|Heart Rate at 2mph|Overall Study||26
6686248|NCT02697214|7616591|FG001|Heart Rate at 2mph|Overall Study||25
6686249|NCT02697214|7616592|FG002|Heart Rate at 2mph|Overall Study||25
6686250|NCT02697214|7616593|FG003|Heart Rate at 2mph|Overall Study||24
6686251|NCT02697214|7616594|FG004|Heart Rate at 2mph|Overall Study||50
6686252|NCT02697214|7616595|FG005|Heart Rate at 2mph|Overall Study||50
6686253|NCT02697214|7616590|FG000|Heart Rate at 3mph|Overall Study||26
6686254|NCT02697214|7616591|FG001|Heart Rate at 3mph|Overall Study||25
6686255|NCT02697214|7616592|FG002|Heart Rate at 3mph|Overall Study||25
6686256|NCT02697214|7616593|FG003|Heart Rate at 3mph|Overall Study||24
6686257|NCT02697214|7616594|FG004|Heart Rate at 3mph|Overall Study||50
6686258|NCT02697214|7616595|FG005|Heart Rate at 3mph|Overall Study||50
6686259|NCT02697214|7616590|FG000|Heart Rate at 4mph|Overall Study||26
6686260|NCT02697214|7616591|FG001|Heart Rate at 4mph|Overall Study||25
6686261|NCT02697214|7616592|FG002|Heart Rate at 4mph|Overall Study||25
6686262|NCT02697214|7616593|FG003|Heart Rate at 4mph|Overall Study||24
6686263|NCT02697214|7616594|FG004|Heart Rate at 4mph|Overall Study||50
6686264|NCT02697214|7616595|FG005|Heart Rate at 4mph|Overall Study||50
6686265|NCT02697214|7616590|FG000|Heart Rate at 6mph|Overall Study||26
6686266|NCT02697214|7616591|FG001|Heart Rate at 6mph|Overall Study||25
6686267|NCT02697214|7616592|FG002|Heart Rate at 6mph|Overall Study||25
6686268|NCT02697214|7616593|FG003|Heart Rate at 6mph|Overall Study||24
6686269|NCT02697214|7616594|FG004|Heart Rate at 6mph|Overall Study||50
6686270|NCT02697214|7616595|FG005|Heart Rate at 6mph|Overall Study||50
6686271|NCT02697214|7616590|FG000|COMPLETED|Overall Study||26
6686272|NCT02697214|7616591|FG001|COMPLETED|Overall Study||25
6686273|NCT02697214|7616592|FG002|COMPLETED|Overall Study||25
6686274|NCT02697214|7616593|FG003|COMPLETED|Overall Study||24
6686275|NCT02697214|7616594|FG004|COMPLETED|Overall Study||50
6686276|NCT02697214|7616595|FG005|COMPLETED|Overall Study||50
6686277|NCT02697214|7616590|FG000|NOT COMPLETED|Overall Study||0
6686278|NCT02697214|7616591|FG001|NOT COMPLETED|Overall Study||0
6686279|NCT02697214|7616592|FG002|NOT COMPLETED|Overall Study||0
6686280|NCT02697214|7616593|FG003|NOT COMPLETED|Overall Study||0
6686281|NCT02697214|7616594|FG004|NOT COMPLETED|Overall Study||0
6686282|NCT02697214|7616595|FG005|NOT COMPLETED|Overall Study||0
6686283|NCT02697240|7616605|FG000|STARTED|Overall Study||4
6686284|NCT02697240|7616605|FG000|COMPLETED|Overall Study||4
6686285|NCT02697240|7616605|FG000|NOT COMPLETED|Overall Study||0
6686286|NCT02697292|7616611|FG000|STARTED|Overall Study||9
6686287|NCT02697292|7616612|FG001|STARTED|Overall Study||8
6686288|NCT02697292|7616611|FG000|COMPLETED|Overall Study||9
6686289|NCT02697292|7616612|FG001|COMPLETED|Overall Study||8
6686290|NCT02697292|7616611|FG000|NOT COMPLETED|Overall Study||0
6686291|NCT02697292|7616612|FG001|NOT COMPLETED|Overall Study||0
6686292|NCT02697435|7616621|FG000|STARTED|Overall Study||25
6686293|NCT02697435|7616622|FG001|STARTED|Overall Study||30
6686294|NCT02697435|7616621|FG000|COMPLETED|Overall Study||24
6686295|NCT02697435|7616622|FG001|COMPLETED|Overall Study||26
6686296|NCT02697435|7616621|FG000|NOT COMPLETED|Overall Study||1
6686297|NCT02697435|7616622|FG001|NOT COMPLETED|Overall Study||4
6686298|NCT02697591|7616639|FG000|STARTED|Overall Study||4
6686299|NCT02697591|7616640|FG001|STARTED|Overall Study||4
6686300|NCT02697591|7616641|FG002|STARTED|Overall Study||4
6686301|NCT02697591|7616642|FG003|STARTED|Overall Study||3
6686302|NCT02697591|7616643|FG004|STARTED|Overall Study||15
6686303|NCT02697591|7616644|FG005|STARTED|Overall Study||18
6686304|NCT02697591|7616645|FG006|STARTED|Overall Study||16
6686305|NCT02697591|7616646|FG007|STARTED|Overall Study||4
6686306|NCT02697591|7616647|FG008|STARTED|Overall Study||10
6686307|NCT02697591|7616648|FG009|STARTED|Overall Study||22
6686308|NCT02697591|7616639|FG000|COMPLETED|Overall Study||0
6686309|NCT02697591|7616640|FG001|COMPLETED|Overall Study||0
6686310|NCT02697591|7616641|FG002|COMPLETED|Overall Study||1
6686311|NCT02697591|7616642|FG003|COMPLETED|Overall Study||0
6686312|NCT02697591|7616643|FG004|COMPLETED|Overall Study||2
6686313|NCT02697591|7616644|FG005|COMPLETED|Overall Study||2
6686314|NCT02697591|7616645|FG006|COMPLETED|Overall Study||0
6686315|NCT02697591|7616646|FG007|COMPLETED|Overall Study||1
6686316|NCT02697591|7616647|FG008|COMPLETED|Overall Study||1
6686317|NCT02697591|7616648|FG009|COMPLETED|Overall Study||2
6686318|NCT02697591|7616639|FG000|NOT COMPLETED|Overall Study||4
6686319|NCT02697591|7616640|FG001|NOT COMPLETED|Overall Study||4
6686320|NCT02697591|7616641|FG002|NOT COMPLETED|Overall Study||3
6686321|NCT02697591|7616642|FG003|NOT COMPLETED|Overall Study||3
6686322|NCT02697591|7616643|FG004|NOT COMPLETED|Overall Study||13
6686323|NCT02697591|7616644|FG005|NOT COMPLETED|Overall Study||16
6686324|NCT02697591|7616645|FG006|NOT COMPLETED|Overall Study||16
6686325|NCT02697591|7616646|FG007|NOT COMPLETED|Overall Study||3
6686326|NCT02697591|7616647|FG008|NOT COMPLETED|Overall Study||9
6686327|NCT02697591|7616648|FG009|NOT COMPLETED|Overall Study||20
6686328|NCT02697617|7616671|FG000|STARTED|Overall Study||9
6686329|NCT02697617|7616672|FG001|STARTED|Overall Study||9
6686330|NCT02697617|7616671|FG000|COMPLETED|Overall Study|15 completed both arms|8
6686331|NCT02697617|7616672|FG001|COMPLETED|Overall Study||7
6686332|NCT02697617|7616671|FG000|NOT COMPLETED|Overall Study||1
6686333|NCT02697617|7616672|FG001|NOT COMPLETED|Overall Study||2
6686334|NCT02697734|7616684|FG000|STARTED|Core Phase - up to Week 48||48
6686335|NCT02697734|7616685|FG001|STARTED|Core Phase - up to Week 48||25
6686336|NCT02697734|7616684|FG000|COMPLETED|Core Phase - up to Week 48||42
6686337|NCT02697734|7616685|FG001|COMPLETED|Core Phase - up to Week 48||23
6686338|NCT02697734|7616684|FG000|NOT COMPLETED|Core Phase - up to Week 48||6
6686339|NCT02697734|7616685|FG001|NOT COMPLETED|Core Phase - up to Week 48||2
6686340|NCT02697734|7616684|FG000|STARTED|Optional Extension Phase||38
6686341|NCT02697734|7616685|FG001|STARTED|Optional Extension Phase||22
6686342|NCT02697734|7616684|FG000|COMPLETED|Optional Extension Phase||33
6686343|NCT02697734|7616685|FG001|COMPLETED|Optional Extension Phase||20
6686344|NCT02697734|7616684|FG000|NOT COMPLETED|Optional Extension Phase||5
6686345|NCT02697734|7616685|FG001|NOT COMPLETED|Optional Extension Phase||2
6686346|NCT02697773|7616702|FG000|STARTED|Overall Study||233
6686347|NCT02697773|7616703|FG001|STARTED|Overall Study||232
6686348|NCT02697773|7616704|FG002|STARTED|Overall Study||233
6686349|NCT02697773|7616702|FG000|Treated|Overall Study||232
6686350|NCT02697773|7616703|FG001|Treated|Overall Study||231
6686351|NCT02697773|7616704|FG002|Treated|Overall Study||233
6686352|NCT02697773|7616702|FG000|COMPLETED|Overall Study||195
6686353|NCT02697773|7616703|FG001|COMPLETED|Overall Study||194
6686354|NCT02697773|7616704|FG002|COMPLETED|Overall Study||193
6686355|NCT02697773|7616702|FG000|NOT COMPLETED|Overall Study||38
6686356|NCT02697773|7616703|FG001|NOT COMPLETED|Overall Study||38
6686357|NCT02697773|7616704|FG002|NOT COMPLETED|Overall Study||40
6686358|NCT02697890|7616714|FG000|STARTED|Overall Study||14
6686359|NCT02697890|7616715|FG001|STARTED|Overall Study||14
6686360|NCT02697890|7616714|FG000|COMPLETED|Overall Study||14
6686361|NCT02697890|7616715|FG001|COMPLETED|Overall Study||14
6686362|NCT02697890|7616714|FG000|NOT COMPLETED|Overall Study||0
6686363|NCT02697890|7616715|FG001|NOT COMPLETED|Overall Study||0
6686364|NCT02697916|7616723|FG000|STARTED|Overall Study||7540
6686365|NCT02697916|7616724|FG001|STARTED|Overall Study||7536
6257178|NCT02279719|7156133|FG002|NOT COMPLETED|Overall Study||0
6257179|NCT02279719|7156134|FG003|NOT COMPLETED|Overall Study||0
6257180|NCT02279719|7156135|FG004|NOT COMPLETED|Overall Study||3
6257181|NCT02279719|7156136|FG005|NOT COMPLETED|Overall Study||0
6257182|NCT02279719|7156137|FG006|NOT COMPLETED|Overall Study||3
6257183|NCT02178956|7156172|FG000|STARTED|Overall Study||357
6257184|NCT02178956|7156173|FG001|STARTED|Overall Study||357
6257185|NCT02178956|7156172|FG000|COMPLETED|Overall Study||286
6257186|NCT02178956|7156173|FG001|COMPLETED|Overall Study||279
6257187|NCT02178956|7156172|FG000|NOT COMPLETED|Overall Study||71
6257188|NCT02178956|7156173|FG001|NOT COMPLETED|Overall Study||78
6257189|NCT02167945|7156183|FG000|STARTED|Overall Study||615
6257190|NCT02167945|7156183|FG000|COMPLETED|Overall Study||366
6257191|NCT02167945|7156183|FG000|NOT COMPLETED|Overall Study||249
6257192|NCT02097420|7156195|FG000|STARTED|Overall Study||20
6257193|NCT02097420|7156195|FG000|COMPLETED|Overall Study||6
6257194|NCT02097420|7156195|FG000|NOT COMPLETED|Overall Study||14
6257195|NCT02024607|7156206|FG000|STARTED|Overall Study||115
6257196|NCT02024607|7156207|FG001|STARTED|Overall Study||41
6257197|NCT02024607|7156208|FG002|STARTED|Overall Study||87
6257198|NCT02024607|7156209|FG003|STARTED|Overall Study||156
6257199|NCT02024607|7156210|FG004|STARTED|Overall Study||40
6257200|NCT02024607|7156211|FG005|STARTED|Overall Study||54
6257201|NCT02024607|7156212|FG006|STARTED|Overall Study||2
6257202|NCT02024607|7156206|FG000|COMPLETED|Overall Study||115
6257203|NCT02024607|7156207|FG001|COMPLETED|Overall Study||41
6257204|NCT02024607|7156208|FG002|COMPLETED|Overall Study||87
6257205|NCT02024607|7156209|FG003|COMPLETED|Overall Study||156
6257206|NCT02024607|7156210|FG004|COMPLETED|Overall Study||40
6257207|NCT02024607|7156211|FG005|COMPLETED|Overall Study||54
6257208|NCT02024607|7156212|FG006|COMPLETED|Overall Study||2
6257209|NCT02024607|7156206|FG000|NOT COMPLETED|Overall Study||0
6257210|NCT02024607|7156207|FG001|NOT COMPLETED|Overall Study||0
6686366|NCT02697916|7616723|FG000|COMPLETED|Overall Study||6962
6686367|NCT02697916|7616724|FG001|COMPLETED|Overall Study||6828
6686368|NCT02697916|7616723|FG000|NOT COMPLETED|Overall Study||578
6686369|NCT02697916|7616724|FG001|NOT COMPLETED|Overall Study||708
6686370|NCT02698033|7616730|FG000|STARTED|Overall Study||7
6686371|NCT02698033|7616730|FG000|COMPLETED|Overall Study||6
6686372|NCT02698033|7616730|FG000|NOT COMPLETED|Overall Study||1
6738583|NCT03285295|7667830|FG001|STARTED|Alinity s Anti-HBc||405
6738584|NCT03285295|7667831|FG002|STARTED|Alinity s Anti-HBc||403
6686373|NCT02698176|7616737|FG000|STARTED|Overall Study||9
6686374|NCT02698176|7616738|FG001|STARTED|Overall Study||3
6686375|NCT02698176|7616739|FG002|STARTED|Overall Study||1
6686376|NCT02698176|7616740|FG003|STARTED|Overall Study|No participants were enrolled in Part B.|0
6686377|NCT02698176|7616737|FG000|COMPLETED|Overall Study||0
6686378|NCT02698176|7616738|FG001|COMPLETED|Overall Study||0
6686379|NCT02698176|7616739|FG002|COMPLETED|Overall Study||0
6686380|NCT02698176|7616740|FG003|COMPLETED|Overall Study||0
6686381|NCT02698176|7616737|FG000|NOT COMPLETED|Overall Study||9
6686382|NCT02698176|7616738|FG001|NOT COMPLETED|Overall Study||3
6686383|NCT02698176|7616739|FG002|NOT COMPLETED|Overall Study||1
6686384|NCT02698176|7616740|FG003|NOT COMPLETED|Overall Study||0
6686385|NCT02698189|7616753|FG000|STARTED|Overall Study||3
6686386|NCT02698189|7616754|FG001|STARTED|Overall Study||6
6686387|NCT02698189|7616753|FG000|COMPLETED|Overall Study||0
6686388|NCT02698189|7616754|FG001|COMPLETED|Overall Study||0
6686389|NCT02698189|7616753|FG000|NOT COMPLETED|Overall Study||3
6686390|NCT02698189|7616754|FG001|NOT COMPLETED|Overall Study||6
6686391|NCT02698215|7616764|FG000|STARTED|Overall Study||83
6686392|NCT02698215|7616765|FG001|STARTED|Overall Study||82
6686393|NCT02698215|7616764|FG000|COMPLETED|Overall Study||55
6686394|NCT02698215|7616765|FG001|COMPLETED|Overall Study||64
6686395|NCT02698215|7616764|FG000|NOT COMPLETED|Overall Study||28
6686396|NCT02698215|7616765|FG001|NOT COMPLETED|Overall Study||18
6686397|NCT02698241|7616771|FG000|STARTED|Overall Study|Number of subjects enrolled the study|79
6686398|NCT02698241|7616771|FG000|Baseline & Programming|Overall Study|Number of subjects that passed screening and completed baseline and programming visit|66
6686399|NCT02698241|7616771|FG000|COMPLETED|Overall Study|Number of subjects completed the study (no early exit or death)|45
6686400|NCT02698241|7616771|FG000|NOT COMPLETED|Overall Study||34
6686401|NCT02698371|7616775|FG000|STARTED|All Participants Flow||38
6686402|NCT02698371|7616775|FG000|COMPLETED|All Participants Flow||35
6686403|NCT02698371|7616775|FG000|NOT COMPLETED|All Participants Flow||3
6686404|NCT02698371|7616775|FG000|STARTED|FBDC-SE (G1; Control) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE (G1control Arm/Group).|35
6686405|NCT02698371|7616775|FG000|COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||32
6686406|NCT02698371|7616775|FG000|NOT COMPLETED|FBDC-SE (G1; Control) Arm/Group Flow||3
6686407|NCT02698371|7616775|FG000|STARTED|FBDC-SE-EE (G2; Control ) Arm/Group Flow|Each participant received one NCCLs restoration with FBDC-SE-EE (G2 control Arm/group)|35
6686408|NCT02698371|7616775|FG000|COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||32
6686409|NCT02698371|7616775|FG000|NOT COMPLETED|FBDC-SE-EE (G2; Control ) Arm/Group Flow||3
6686410|NCT02698371|7616775|FG000|STARTED|FBU-ER (G3) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-ER (G3 Arm/group)|35
6686411|NCT02698371|7616775|FG000|COMPLETED|FBU-ER (G3) Arm/Group Flow||32
6686412|NCT02698371|7616775|FG000|NOT COMPLETED|FBU-ER (G3) Arm/Group Flow||3
6686413|NCT02698371|7616775|FG000|STARTED|FBU-SE (G4) Arm/Group Flow|Each participant received one NCCLs restoration with FBU-SE (G4 Arm/group)|35
6686414|NCT02698371|7616775|FG000|COMPLETED|FBU-SE (G4) Arm/Group Flow||32
6686415|NCT02698371|7616775|FG000|NOT COMPLETED|FBU-SE (G4) Arm/Group Flow||3
6686416|NCT02698371|7616775|FG000|STARTED|ADU-ER (G5) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-ER (G5 Arm/group)|35
6686417|NCT02698371|7616775|FG000|COMPLETED|ADU-ER (G5) Arm/Group Flow||32
6686418|NCT02698371|7616775|FG000|NOT COMPLETED|ADU-ER (G5) Arm/Group Flow||3
6686419|NCT02698371|7616775|FG000|STARTED|ADU-SE (G6) Arm/Group Flow|Each participant received one NCCLs restoration with ADU-SE (G6 Arm/group)|35
6686420|NCT02698371|7616775|FG000|COMPLETED|ADU-SE (G6) Arm/Group Flow||33
6686421|NCT02698371|7616775|FG000|NOT COMPLETED|ADU-SE (G6) Arm/Group Flow||2
6686422|NCT02698410|7616791|FG000|STARTED|Overall Study||40
6686423|NCT02698410|7616791|FG000|COMPLETED|Overall Study||36
6686424|NCT02698410|7616791|FG000|NOT COMPLETED|Overall Study||4
6686425|NCT02698423|7616797|FG000|STARTED|Overall Study||336
6686426|NCT02698423|7616798|FG001|STARTED|Overall Study||331
6686427|NCT02698423|7616797|FG000|COMPLETED|Overall Study||317
6686428|NCT02698423|7616798|FG001|COMPLETED|Overall Study||307
6686429|NCT02698423|7616797|FG000|NOT COMPLETED|Overall Study||19
6686430|NCT02698423|7616798|FG001|NOT COMPLETED|Overall Study||24
6686431|NCT02698436|7616808|FG000|STARTED|Overall Study||59
6686432|NCT02698436|7616809|FG001|STARTED|Overall Study||58
6686433|NCT02698436|7616808|FG000|COMPLETED|Overall Study||52
6686434|NCT02698436|7616809|FG001|COMPLETED|Overall Study||51
6686435|NCT02698436|7616808|FG000|NOT COMPLETED|Overall Study||7
6686436|NCT02698436|7616809|FG001|NOT COMPLETED|Overall Study||7
6686437|NCT02698475|7616815|FG000|STARTED|Main Study Period||44
6686438|NCT02698475|7616815|FG000|COMPLETED|Main Study Period||41
6686439|NCT02698475|7616815|FG000|NOT COMPLETED|Main Study Period||3
6686440|NCT02698475|7616815|FG000|STARTED|Long-Term Extension Period|13 participants did not enter the long-term extension period.|28
6686441|NCT02698475|7616815|FG000|COMPLETED|Long-Term Extension Period||0
6686442|NCT02698475|7616815|FG000|NOT COMPLETED|Long-Term Extension Period||28
6686443|NCT02698566|7616822|FG000|STARTED|Overall Study||35
6686444|NCT02698566|7616823|FG001|STARTED|Overall Study||3
6686445|NCT02698566|7616822|FG000|COMPLETED|Overall Study||35
6686446|NCT02698566|7616823|FG001|COMPLETED|Overall Study||3
6686447|NCT02698566|7616822|FG000|NOT COMPLETED|Overall Study||0
6686448|NCT02698566|7616823|FG001|NOT COMPLETED|Overall Study||0
6686449|NCT02698735|7616827|FG000|STARTED|Overall Study||5
6686450|NCT02698735|7616827|FG000|COMPLETED|Overall Study|There are only 18 out of 20 samples because one patient declined intradermal injection intervention.|5
6686451|NCT02698735|7616827|FG000|NOT COMPLETED|Overall Study||0
6686452|NCT02698787|7616839|FG000|STARTED|First Intervention (3 Months)||6
6686453|NCT02698787|7616840|FG001|STARTED|First Intervention (3 Months)||5
6686454|NCT02698787|7616839|FG000|COMPLETED|First Intervention (3 Months)||6
6686455|NCT02698787|7616840|FG001|COMPLETED|First Intervention (3 Months)||5
6686456|NCT02698787|7616839|FG000|NOT COMPLETED|First Intervention (3 Months)||0
6686457|NCT02698787|7616840|FG001|NOT COMPLETED|First Intervention (3 Months)||0
6686458|NCT02698787|7616839|FG000|STARTED|Second Intervention (3 Months)||6
6686459|NCT02698787|7616840|FG001|STARTED|Second Intervention (3 Months)||5
6686460|NCT02698787|7616839|FG000|COMPLETED|Second Intervention (3 Months)||6
6686461|NCT02698787|7616840|FG001|COMPLETED|Second Intervention (3 Months)||4
6686462|NCT02698787|7616839|FG000|NOT COMPLETED|Second Intervention (3 Months)||0
6686463|NCT02698787|7616840|FG001|NOT COMPLETED|Second Intervention (3 Months)||1
6686464|NCT02698800|7616847|FG000|STARTED|Overall Study||7
6686465|NCT02698800|7616848|FG001|STARTED|Overall Study||8
6686466|NCT02698800|7616847|FG000|COMPLETED|Overall Study||6
6686467|NCT02698800|7616848|FG001|COMPLETED|Overall Study||8
6686468|NCT02698800|7616847|FG000|NOT COMPLETED|Overall Study||1
6686469|NCT02698800|7616848|FG001|NOT COMPLETED|Overall Study||0
6686470|NCT02699099|7616857|FG000|STARTED|Overall Study||231
6686471|NCT02699099|7616858|FG001|STARTED|Overall Study||236
6686472|NCT02699099|7616859|FG002|STARTED|Overall Study||232
6686473|NCT02699099|7616857|FG000|COMPLETED|Overall Study||223
6686474|NCT02699099|7616858|FG001|COMPLETED|Overall Study||233
6686475|NCT02699099|7616859|FG002|COMPLETED|Overall Study||226
6686476|NCT02699099|7616857|FG000|NOT COMPLETED|Overall Study||8
6686477|NCT02699099|7616858|FG001|NOT COMPLETED|Overall Study||3
6686478|NCT02699099|7616859|FG002|NOT COMPLETED|Overall Study||6
6686479|NCT02699125|7616869|FG000|STARTED|Placebo||21
6686480|NCT02699125|7616870|FG001|STARTED|Placebo||20
6686481|NCT02699125|7616869|FG000|COMPLETED|Placebo||18
6686482|NCT02699125|7616870|FG001|COMPLETED|Placebo||16
6686483|NCT02699125|7616869|FG000|NOT COMPLETED|Placebo||3
6686484|NCT02699125|7616870|FG001|NOT COMPLETED|Placebo||4
6686485|NCT02699125|7616869|FG000|STARTED|First Intervention (6 Weeks).||18
6686486|NCT02699125|7616870|FG001|STARTED|First Intervention (6 Weeks).||16
6686487|NCT02699125|7616869|FG000|COMPLETED|First Intervention (6 Weeks).||18
6686488|NCT02699125|7616870|FG001|COMPLETED|First Intervention (6 Weeks).||16
6686489|NCT02699125|7616869|FG000|NOT COMPLETED|First Intervention (6 Weeks).||0
6686490|NCT02699125|7616870|FG001|NOT COMPLETED|First Intervention (6 Weeks).||0
6686491|NCT02699125|7616869|FG000|STARTED|Second Intervention (6 Weeks).||18
6686492|NCT02699125|7616870|FG001|STARTED|Second Intervention (6 Weeks).||16
6686493|NCT02699125|7616869|FG000|COMPLETED|Second Intervention (6 Weeks).||11
6686494|NCT02699125|7616870|FG001|COMPLETED|Second Intervention (6 Weeks).||14
6686495|NCT02699125|7616869|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||7
6686496|NCT02699125|7616870|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
6686497|NCT02699450|7616883|FG000|STARTED|Overall Study||90
6686498|NCT02699450|7616884|FG001|STARTED|Overall Study||55
6686499|NCT02699450|7616885|FG002|STARTED|Overall Study||82
6686500|NCT02699450|7616883|FG000|Received at Least One Dose of Study Drug|Overall Study||89
6686501|NCT02699450|7616884|FG001|Received at Least One Dose of Study Drug|Overall Study||55
6686502|NCT02699450|7616885|FG002|Received at Least One Dose of Study Drug|Overall Study||80
6686503|NCT02699450|7616883|FG000|Completed up to Week 24|Overall Study||81
6686504|NCT02699450|7616884|FG001|Completed up to Week 24|Overall Study||53
6686505|NCT02699450|7616885|FG002|Completed up to Week 24|Overall Study||73
6686506|NCT02699450|7616883|FG000|COMPLETED|Overall Study||75
6686507|NCT02699450|7616884|FG001|COMPLETED|Overall Study||50
6686508|NCT02699450|7616885|FG002|COMPLETED|Overall Study||67
6686509|NCT02699450|7616883|FG000|NOT COMPLETED|Overall Study||15
6686510|NCT02699450|7616884|FG001|NOT COMPLETED|Overall Study||5
6686511|NCT02699450|7616885|FG002|NOT COMPLETED|Overall Study||15
6686512|NCT02699463|7616896|FG000|STARTED|Overall Study||115
6686513|NCT02699463|7616897|FG001|STARTED|Overall Study||118
6686514|NCT02699463|7616896|FG000|COMPLETED|Overall Study||100
6686515|NCT02699463|7616897|FG001|COMPLETED|Overall Study||109
6686516|NCT02699463|7616896|FG000|NOT COMPLETED|Overall Study||15
6686517|NCT02699463|7616897|FG001|NOT COMPLETED|Overall Study||9
6686518|NCT02699593|7616903|FG000|STARTED|Period 1||72
6686519|NCT02699593|7616904|FG001|STARTED|Period 1||69
6686520|NCT02699593|7616903|FG000|COMPLETED|Period 1||67
6686521|NCT02699593|7616904|FG001|COMPLETED|Period 1||62
6686522|NCT02699593|7616903|FG000|NOT COMPLETED|Period 1||5
6686523|NCT02699593|7616904|FG001|NOT COMPLETED|Period 1||7
6686524|NCT02699593|7616903|FG000|STARTED|Period 2||67
6686525|NCT02699593|7616904|FG001|STARTED|Period 2||62
6686526|NCT02699593|7616903|FG000|COMPLETED|Period 2||65
6686527|NCT02699593|7616904|FG001|COMPLETED|Period 2||60
6686528|NCT02699593|7616903|FG000|NOT COMPLETED|Period 2||2
6686529|NCT02699593|7616904|FG001|NOT COMPLETED|Period 2||2
6686530|NCT02699632|7616910|FG000|STARTED|Overall Study||360
6686531|NCT02699632|7616910|FG000|COMPLETED|Overall Study||358
6686532|NCT02699632|7616910|FG000|NOT COMPLETED|Overall Study||2
6686533|NCT02699684|7616917|FG000|STARTED|Period 1, First 30 Days of Wear||37
6686534|NCT02699684|7616918|FG001|STARTED|Period 1, First 30 Days of Wear||38
6686535|NCT02699684|7616917|FG000|COMPLETED|Period 1, First 30 Days of Wear||37
6686536|NCT02699684|7616918|FG001|COMPLETED|Period 1, First 30 Days of Wear||38
6686537|NCT02699684|7616917|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||0
6686538|NCT02699684|7616918|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||0
6686539|NCT02699684|7616917|FG000|STARTED|Period 2, Second 30 Days of Wear||37
6686540|NCT02699684|7616918|FG001|STARTED|Period 2, Second 30 Days of Wear||38
6686541|NCT02699684|7616917|FG000|COMPLETED|Period 2, Second 30 Days of Wear||36
6686542|NCT02699684|7616918|FG001|COMPLETED|Period 2, Second 30 Days of Wear||38
6686543|NCT02699684|7616917|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
6686544|NCT02699684|7616918|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
6686545|NCT02699749|7616939|FG000|STARTED|Overall Study||3
6686546|NCT02699749|7616940|FG001|STARTED|Overall Study||3
6686547|NCT02699749|7616941|FG002|STARTED|Overall Study||16
6686548|NCT02699749|7616942|FG003|STARTED|Overall Study||3
6686549|NCT02699749|7616943|FG004|STARTED|Overall Study||3
6686550|NCT02699749|7616944|FG005|STARTED|Overall Study||9
6686551|NCT02699749|7616945|FG006|STARTED|Overall Study||6
6686552|NCT02699749|7616946|FG007|STARTED|Overall Study||6
6686553|NCT02699749|7616947|FG008|STARTED|Overall Study||6
6686554|NCT02699749|7616948|FG009|STARTED|Overall Study||6
6686555|NCT02699749|7616949|FG010|STARTED|Overall Study||6
6686556|NCT02699749|7616950|FG011|STARTED|Overall Study||4
6686557|NCT02699749|7616951|FG012|STARTED|Overall Study||3
6686558|NCT02699749|7616952|FG013|STARTED|Overall Study||6
6686559|NCT02699749|7616939|FG000|COMPLETED|Overall Study||0
6686560|NCT02699749|7616940|FG001|COMPLETED|Overall Study||0
6686561|NCT02699749|7616941|FG002|COMPLETED|Overall Study||0
6686562|NCT02699749|7616942|FG003|COMPLETED|Overall Study||0
6686563|NCT02699749|7616943|FG004|COMPLETED|Overall Study||0
6686564|NCT02699749|7616944|FG005|COMPLETED|Overall Study||0
6686565|NCT02699749|7616945|FG006|COMPLETED|Overall Study||0
6686566|NCT02699749|7616946|FG007|COMPLETED|Overall Study||0
6686567|NCT02699749|7616947|FG008|COMPLETED|Overall Study||0
6686568|NCT02699749|7616948|FG009|COMPLETED|Overall Study||0
6686569|NCT02699749|7616949|FG010|COMPLETED|Overall Study||0
6686570|NCT02699749|7616950|FG011|COMPLETED|Overall Study||0
6686571|NCT02699749|7616951|FG012|COMPLETED|Overall Study||0
6686572|NCT02699749|7616952|FG013|COMPLETED|Overall Study||0
6686573|NCT02699749|7616939|FG000|NOT COMPLETED|Overall Study||3
6686574|NCT02699749|7616940|FG001|NOT COMPLETED|Overall Study||3
6686575|NCT02699749|7616941|FG002|NOT COMPLETED|Overall Study||16
6686576|NCT02699749|7616942|FG003|NOT COMPLETED|Overall Study||3
6686577|NCT02699749|7616943|FG004|NOT COMPLETED|Overall Study||3
6686578|NCT02699749|7616944|FG005|NOT COMPLETED|Overall Study||9
6686579|NCT02699749|7616945|FG006|NOT COMPLETED|Overall Study||6
6686580|NCT02699749|7616946|FG007|NOT COMPLETED|Overall Study||6
6686581|NCT02699749|7616947|FG008|NOT COMPLETED|Overall Study||6
6686582|NCT02699749|7616948|FG009|NOT COMPLETED|Overall Study||6
6686583|NCT02699749|7616949|FG010|NOT COMPLETED|Overall Study||6
6686584|NCT02699749|7616950|FG011|NOT COMPLETED|Overall Study||4
6686585|NCT02699749|7616951|FG012|NOT COMPLETED|Overall Study||3
6686586|NCT02699749|7616952|FG013|NOT COMPLETED|Overall Study||6
6686587|NCT02699866|7616982|FG000|STARTED|Overall Study|First study centre initiation.|46
6686588|NCT02699866|7616982|FG000|Included|Overall Study||41
6686589|NCT02699866|7616982|FG000|COMPLETED|Overall Study|Last study centre close-out.|38
6686590|NCT02699866|7616982|FG000|NOT COMPLETED|Overall Study||8
6686591|NCT02699892|7616986|FG000|STARTED|Overall Study||130
6686592|NCT02699892|7616986|FG000|COMPLETED|Overall Study||94
6686593|NCT02699892|7616986|FG000|NOT COMPLETED|Overall Study||36
6686594|NCT02699970|7616990|FG000|STARTED|Overall Study||399
6686595|NCT02699970|7616990|FG000|Intra-system|Overall Study||399
6686596|NCT02699970|7616990|FG000|Inter-system|Overall Study||399
6686597|NCT02699970|7616990|FG000|COMPLETED|Overall Study||399
6686598|NCT02699970|7616990|FG000|NOT COMPLETED|Overall Study||0
6686599|NCT02699983|7616997|FG000|STARTED|Overall Study||18
6686600|NCT02699983|7616998|FG001|STARTED|Overall Study||17
6686601|NCT02699983|7616997|FG000|COMPLETED|Overall Study||17
6686602|NCT02699983|7616998|FG001|COMPLETED|Overall Study||17
6686603|NCT02699983|7616997|FG000|NOT COMPLETED|Overall Study||1
6686604|NCT02699983|7616998|FG001|NOT COMPLETED|Overall Study||0
6686605|NCT02699996|7617010|FG000|STARTED|Overall Study||20
6686606|NCT02699996|7617011|FG001|STARTED|Overall Study||11
6686607|NCT02699996|7617010|FG000|COMPLETED|Overall Study||15
6686608|NCT02699996|7617011|FG001|COMPLETED|Overall Study||9
6686609|NCT02699996|7617010|FG000|NOT COMPLETED|Overall Study||5
6686610|NCT02699996|7617011|FG001|NOT COMPLETED|Overall Study||2
6686611|NCT02700165|7617018|FG000|STARTED|Overall Study||14
6686612|NCT02700165|7617018|FG000|COMPLETED|Overall Study||14
6686613|NCT02700165|7617018|FG000|NOT COMPLETED|Overall Study||0
6686614|NCT02700334|7617025|FG000|STARTED|Overall Study||12
6686615|NCT02700334|7617026|FG001|STARTED|Overall Study||12
6686616|NCT02700334|7617025|FG000|COMPLETED|Overall Study||12
6686617|NCT02700334|7617026|FG001|COMPLETED|Overall Study||12
6686618|NCT02700334|7617025|FG000|NOT COMPLETED|Overall Study||0
6686619|NCT02700334|7617026|FG001|NOT COMPLETED|Overall Study||0
6686620|NCT02700412|7617032|FG000|STARTED|Overall Study||80
6686621|NCT02700412|7617032|FG000|COMPLETED|Overall Study||47
6686622|NCT02700412|7617032|FG000|NOT COMPLETED|Overall Study||33
6686623|NCT02700425|7617038|FG000|STARTED|Overall Study||21
6686624|NCT02700425|7617039|FG001|STARTED|Overall Study||20
6686625|NCT02700425|7617038|FG000|COMPLETED|Overall Study||21
6686626|NCT02700425|7617039|FG001|COMPLETED|Overall Study|1 patient withdrew after randomization|19
6686627|NCT02700425|7617038|FG000|NOT COMPLETED|Overall Study||0
6686628|NCT02700425|7617039|FG001|NOT COMPLETED|Overall Study||1
6686629|NCT02700815|7617049|FG000|STARTED|Overall Study||75
6686630|NCT02700815|7617050|FG001|STARTED|Overall Study||223
6686631|NCT02700815|7617051|FG002|STARTED|Overall Study||223
6686632|NCT02700815|7617052|FG003|STARTED|Overall Study||225
6686633|NCT02700815|7617049|FG000|COMPLETED|Overall Study||74
6686634|NCT02700815|7617050|FG001|COMPLETED|Overall Study||216
6686635|NCT02700815|7617051|FG002|COMPLETED|Overall Study||219
6686636|NCT02700815|7617052|FG003|COMPLETED|Overall Study||218
6686637|NCT02700815|7617049|FG000|NOT COMPLETED|Overall Study||1
6686638|NCT02700815|7617050|FG001|NOT COMPLETED|Overall Study||7
6686639|NCT02700815|7617051|FG002|NOT COMPLETED|Overall Study||4
6686640|NCT02700815|7617052|FG003|NOT COMPLETED|Overall Study||7
6686641|NCT02700919|7617065|FG000|STARTED|Overall Study||94
6686642|NCT02700919|7617066|FG001|STARTED|Overall Study||97
6686643|NCT02700919|7617067|FG002|STARTED|Overall Study||91
6686644|NCT02700919|7617065|FG000|COMPLETED|Overall Study||82
6686645|NCT02700919|7617066|FG001|COMPLETED|Overall Study||85
6686646|NCT02700919|7617067|FG002|COMPLETED|Overall Study||87
6686647|NCT02700919|7617065|FG000|NOT COMPLETED|Overall Study||12
6686648|NCT02700919|7617066|FG001|NOT COMPLETED|Overall Study||12
6257211|NCT02024607|7156208|FG002|NOT COMPLETED|Overall Study||0
6257212|NCT02024607|7156209|FG003|NOT COMPLETED|Overall Study||0
6257213|NCT02024607|7156210|FG004|NOT COMPLETED|Overall Study||0
6257214|NCT02024607|7156211|FG005|NOT COMPLETED|Overall Study||0
6257215|NCT02024607|7156212|FG006|NOT COMPLETED|Overall Study||0
6257216|NCT01925131|7156252|FG000|STARTED|Overall Study||5
6257217|NCT01925131|7156253|FG001|STARTED|Overall Study||4
6257218|NCT01925131|7156254|FG002|STARTED|Overall Study||10
6257219|NCT01925131|7156255|FG003|STARTED|Overall Study||5
6257220|NCT01925131|7156256|FG004|STARTED|Overall Study||11
6257221|NCT01925131|7156257|FG005|STARTED|Overall Study||13
6257222|NCT01925131|7156252|FG000|COMPLETED|Overall Study||0
6257223|NCT01925131|7156253|FG001|COMPLETED|Overall Study||2
6257224|NCT01925131|7156254|FG002|COMPLETED|Overall Study||1
6257225|NCT01925131|7156255|FG003|COMPLETED|Overall Study||0
6257226|NCT01925131|7156256|FG004|COMPLETED|Overall Study||0
6257227|NCT01925131|7156257|FG005|COMPLETED|Overall Study||3
6257228|NCT01925131|7156252|FG000|NOT COMPLETED|Overall Study||5
6257229|NCT01925131|7156253|FG001|NOT COMPLETED|Overall Study||2
6257230|NCT01925131|7156254|FG002|NOT COMPLETED|Overall Study||9
6257231|NCT01925131|7156255|FG003|NOT COMPLETED|Overall Study||5
6257232|NCT01925131|7156256|FG004|NOT COMPLETED|Overall Study||11
6257233|NCT01925131|7156257|FG005|NOT COMPLETED|Overall Study||10
6257234|NCT01776307|7156276|FG000|STARTED|Overall Study||49
6257235|NCT01776307|7156277|FG001|STARTED|Overall Study||75
6257236|NCT01776307|7156278|FG002|STARTED|Overall Study||76
6257237|NCT01776307|7156276|FG000|COMPLETED|Overall Study||49
6257238|NCT01776307|7156277|FG001|COMPLETED|Overall Study||75
6257239|NCT01776307|7156278|FG002|COMPLETED|Overall Study||75
6257240|NCT01776307|7156276|FG000|NOT COMPLETED|Overall Study||0
6257241|NCT01776307|7156277|FG001|NOT COMPLETED|Overall Study||0
6257242|NCT01776307|7156278|FG002|NOT COMPLETED|Overall Study||1
6257243|NCT01623167|7156310|FG000|STARTED|Overall Study||30
6257244|NCT01623167|7156311|FG001|STARTED|Overall Study||31
6257245|NCT01623167|7156312|FG002|STARTED|Overall Study||31
6257246|NCT01623167|7156310|FG000|COMPLETED|Overall Study||13
6257247|NCT01623167|7156311|FG001|COMPLETED|Overall Study||17
6257248|NCT01623167|7156312|FG002|COMPLETED|Overall Study||18
6257249|NCT01623167|7156310|FG000|NOT COMPLETED|Overall Study||17
6257250|NCT01623167|7156311|FG001|NOT COMPLETED|Overall Study||14
6257251|NCT01623167|7156312|FG002|NOT COMPLETED|Overall Study||13
6257252|NCT01535274|7156322|FG000|STARTED|Overall Study||28
6257253|NCT01535274|7156323|FG001|STARTED|Overall Study|"29 participants were initially randomized to receive desflurane treatment. One participant initially randomized to the desflurane arm was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below."|29
6257254|NCT01535274|7156322|FG000|Received Propofol|Overall Study||28
6257255|NCT01535274|7156323|FG001|Received Propofol|Overall Study|"Of the 29 participants initially randomized to receive desflurane treatment, one was misallocated to the propofol arm and received propofol treatment, as shown in the reason not completed section below. That participant is included in the baseline characteristics, outcome measures, and adverse events with the propofol arm."|1
6257256|NCT01535274|7156322|FG000|Received Desflurane|Overall Study||0
6257257|NCT01535274|7156323|FG001|Received Desflurane|Overall Study||28
6257258|NCT01535274|7156322|FG000|COMPLETED|Overall Study||28
6686649|NCT02700919|7617067|FG002|NOT COMPLETED|Overall Study||4
6686650|NCT02700984|7617077|FG000|STARTED|Overall Study||215
6686651|NCT02700984|7617078|FG001|STARTED|Overall Study||67
6686652|NCT02700984|7617077|FG000|COMPLETED|Overall Study||200
6686653|NCT02700984|7617078|FG001|COMPLETED|Overall Study||53
6686654|NCT02700984|7617077|FG000|NOT COMPLETED|Overall Study||15
6257259|NCT01535274|7156323|FG001|COMPLETED|Overall Study||27
6257260|NCT01535274|7156322|FG000|NOT COMPLETED|Overall Study||0
6257261|NCT01535274|7156323|FG001|NOT COMPLETED|Overall Study||2
6257262|NCT00544830|7156331|FG000|STARTED|Overall Study||29
6257263|NCT00544830|7156331|FG000|COMPLETED|Overall Study||29
6257264|NCT00544830|7156331|FG000|NOT COMPLETED|Overall Study||0
6257265|NCT00539981|7156337|FG000|STARTED|Overall Study||2344
6257266|NCT00539981|7156338|FG001|STARTED|Overall Study||2304
6257267|NCT00539981|7156337|FG000|COMPLETED|Overall Study||2049
6257268|NCT00539981|7156338|FG001|COMPLETED|Overall Study||2022
6257269|NCT00539981|7156337|FG000|NOT COMPLETED|Overall Study||295
6257270|NCT00539981|7156338|FG001|NOT COMPLETED|Overall Study||282
6279639|NCT00147225|7179492|FG005|NOT COMPLETED|Overall Study||2
6279640|NCT00147251|7179508|FG000|STARTED|Recruitment and Enrollment||271
6686655|NCT02700984|7617078|FG001|NOT COMPLETED|Overall Study||14
6686656|NCT02700997|7617094|FG000|STARTED|Overall Study||17
6686657|NCT02700997|7617094|FG000|COMPLETED|Overall Study||15
6686658|NCT02700997|7617094|FG000|NOT COMPLETED|Overall Study||2
6686659|NCT02701049|7617101|FG000|STARTED|Overall Study|Patients who completed a follow-up survey|209
6686660|NCT02701049|7617102|FG001|STARTED|Overall Study|Patients who completed a follow-up survey|342
6686661|NCT02701049|7617103|FG002|STARTED|Overall Study|Patients who completed a follow-up survey|198
6686662|NCT02701049|7617101|FG000|COMPLETED|Overall Study|Total patients included in analysis|209
6686663|NCT02701049|7617102|FG001|COMPLETED|Overall Study|Total patients included in analysis|342
6686664|NCT02701049|7617103|FG002|COMPLETED|Overall Study|Total patients included in analysis|198
6686665|NCT02701049|7617101|FG000|NOT COMPLETED|Overall Study||0
6686666|NCT02701049|7617102|FG001|NOT COMPLETED|Overall Study||0
6686667|NCT02701049|7617103|FG002|NOT COMPLETED|Overall Study||0
6686668|NCT02701062|7617117|FG000|STARTED|Baseline||376
6686669|NCT02701062|7617118|FG001|STARTED|Baseline||186
6686670|NCT02701062|7617117|FG000|COMPLETED|Baseline||376
6686671|NCT02701062|7617118|FG001|COMPLETED|Baseline||186
6686672|NCT02701062|7617117|FG000|NOT COMPLETED|Baseline||0
6686673|NCT02701062|7617118|FG001|NOT COMPLETED|Baseline||0
6686674|NCT02701062|7617117|FG000|STARTED|Index Procedure||376
6686675|NCT02701062|7617118|FG001|STARTED|Index Procedure||186
6686676|NCT02701062|7617117|FG000|COMPLETED|Index Procedure||376
6686677|NCT02701062|7617118|FG001|COMPLETED|Index Procedure||186
6257271|NCT04732819|7156349|FG000|STARTED|Overall Study||12582
6257272|NCT04732819|7156350|FG001|STARTED|Overall Study||11186
6257273|NCT04732819|7156349|FG000|COMPLETED|Overall Study||12582
6257274|NCT04732819|7156350|FG001|COMPLETED|Overall Study||11186
6257275|NCT04732819|7156349|FG000|NOT COMPLETED|Overall Study||0
6257276|NCT04732819|7156350|FG001|NOT COMPLETED|Overall Study||0
6257277|NCT04732338|7156358|FG000|STARTED|Overall Study||13
6257278|NCT04732338|7156359|FG001|STARTED|Overall Study||13
6257279|NCT04732338|7156358|FG000|COMPLETED|Overall Study||10
6257280|NCT04732338|7156359|FG001|COMPLETED|Overall Study||10
6257281|NCT04732338|7156358|FG000|NOT COMPLETED|Overall Study||3
6257282|NCT04732338|7156359|FG001|NOT COMPLETED|Overall Study||3
6602258|NCT02055820|7527209|FG000|STARTED|Phase II: Expansion||0
6602259|NCT02055820|7527210|FG001|STARTED|Phase II: Expansion||0
6602260|NCT02055820|7527211|FG002|STARTED|Phase II: Expansion||0
6602261|NCT02055820|7527212|FG003|STARTED|Phase II: Expansion||0
6602262|NCT02055820|7527213|FG004|STARTED|Phase II: Expansion||208
6602263|NCT02055820|7527214|FG005|STARTED|Phase II: Expansion||0
6602264|NCT02055820|7527215|FG006|STARTED|Phase II: Expansion||0
6602265|NCT02055820|7527216|FG007|STARTED|Phase II: Expansion||0
6602266|NCT02055820|7527217|FG008|STARTED|Phase II: Expansion||0
6602267|NCT02055820|7527218|FG009|STARTED|Phase II: Expansion||0
6602268|NCT02055820|7527209|FG000|COMPLETED|Phase II: Expansion||0
6602269|NCT02055820|7527210|FG001|COMPLETED|Phase II: Expansion||0
6602270|NCT02055820|7527211|FG002|COMPLETED|Phase II: Expansion||0
6602271|NCT02055820|7527212|FG003|COMPLETED|Phase II: Expansion||0
6602272|NCT02055820|7527213|FG004|COMPLETED|Phase II: Expansion||159
6602273|NCT02055820|7527214|FG005|COMPLETED|Phase II: Expansion||0
6602274|NCT02055820|7527215|FG006|COMPLETED|Phase II: Expansion||0
6602275|NCT02055820|7527216|FG007|COMPLETED|Phase II: Expansion||0
6602276|NCT02055820|7527217|FG008|COMPLETED|Phase II: Expansion||0
6602277|NCT02055820|7527218|FG009|COMPLETED|Phase II: Expansion||0
6602278|NCT02055820|7527209|FG000|NOT COMPLETED|Phase II: Expansion||0
6602279|NCT02055820|7527210|FG001|NOT COMPLETED|Phase II: Expansion||0
6602280|NCT02055820|7527211|FG002|NOT COMPLETED|Phase II: Expansion||0
6602281|NCT02055820|7527212|FG003|NOT COMPLETED|Phase II: Expansion||0
6602282|NCT02055820|7527213|FG004|NOT COMPLETED|Phase II: Expansion||49
6602283|NCT02055820|7527214|FG005|NOT COMPLETED|Phase II: Expansion||0
6602284|NCT02055820|7527215|FG006|NOT COMPLETED|Phase II: Expansion||0
6602285|NCT02055820|7527216|FG007|NOT COMPLETED|Phase II: Expansion||0
6602286|NCT02055820|7527217|FG008|NOT COMPLETED|Phase II: Expansion||0
6602287|NCT02055820|7527218|FG009|NOT COMPLETED|Phase II: Expansion||0
6602288|NCT02055898|7527262|FG000|STARTED|First Intervention (5 Days)||7
6602289|NCT02055898|7527263|FG001|STARTED|First Intervention (5 Days)||6
6602290|NCT02055898|7527262|FG000|COMPLETED|First Intervention (5 Days)||5
6602291|NCT02055898|7527263|FG001|COMPLETED|First Intervention (5 Days)||5
6602292|NCT02055898|7527262|FG000|NOT COMPLETED|First Intervention (5 Days)||2
6602293|NCT02055898|7527263|FG001|NOT COMPLETED|First Intervention (5 Days)||1
6602294|NCT02055898|7527262|FG000|STARTED|Washout (at Least 14 Days)||5
6602295|NCT02055898|7527263|FG001|STARTED|Washout (at Least 14 Days)||5
6602296|NCT02055898|7527262|FG000|COMPLETED|Washout (at Least 14 Days)||5
6602297|NCT02055898|7527263|FG001|COMPLETED|Washout (at Least 14 Days)||5
6602298|NCT02055898|7527262|FG000|NOT COMPLETED|Washout (at Least 14 Days)||0
6602299|NCT02055898|7527263|FG001|NOT COMPLETED|Washout (at Least 14 Days)||0
6602300|NCT02055898|7527262|FG000|STARTED|Second Intervention (5 Days)||5
6602301|NCT02055898|7527263|FG001|STARTED|Second Intervention (5 Days)||5
6602302|NCT02055898|7527262|FG000|COMPLETED|Second Intervention (5 Days)||5
6602303|NCT02055898|7527263|FG001|COMPLETED|Second Intervention (5 Days)||5
6602304|NCT02055898|7527262|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
6602305|NCT02055898|7527263|FG001|NOT COMPLETED|Second Intervention (5 Days)||0
6602306|NCT02055976|7527278|FG000|STARTED|Overall Study||25
6602307|NCT02055976|7527279|FG001|STARTED|Overall Study||24
6686678|NCT02701062|7617117|FG000|NOT COMPLETED|Index Procedure||0
6686679|NCT02701062|7617118|FG001|NOT COMPLETED|Index Procedure||0
6686680|NCT02701062|7617117|FG000|STARTED|Discharge||376
6686681|NCT02701062|7617118|FG001|STARTED|Discharge||186
6686682|NCT02701062|7617117|FG000|COMPLETED|Discharge||376
6686683|NCT02701062|7617118|FG001|COMPLETED|Discharge||186
6686684|NCT02701062|7617117|FG000|NOT COMPLETED|Discharge||0
6686685|NCT02701062|7617118|FG001|NOT COMPLETED|Discharge||0
6686686|NCT02701062|7617117|FG000|STARTED|30 Day Follow-up||376
6686687|NCT02701062|7617118|FG001|STARTED|30 Day Follow-up||186
6686688|NCT02701062|7617117|FG000|COMPLETED|30 Day Follow-up||366
6686689|NCT02701062|7617118|FG001|COMPLETED|30 Day Follow-up||183
6686690|NCT02701062|7617117|FG000|NOT COMPLETED|30 Day Follow-up||10
6686691|NCT02701062|7617118|FG001|NOT COMPLETED|30 Day Follow-up||3
6686692|NCT02701062|7617117|FG000|STARTED|90 Day Follow-up||366
6686693|NCT02701062|7617118|FG001|STARTED|90 Day Follow-up||183
6686694|NCT02701062|7617117|FG000|COMPLETED|90 Day Follow-up||308
6686695|NCT02701062|7617118|FG001|COMPLETED|90 Day Follow-up||72
6686696|NCT02701062|7617117|FG000|NOT COMPLETED|90 Day Follow-up||58
6686697|NCT02701062|7617118|FG001|NOT COMPLETED|90 Day Follow-up||111
6686698|NCT02701062|7617117|FG000|STARTED|365 Day Follow-up||308
6686699|NCT02701062|7617118|FG001|STARTED|365 Day Follow-up||72
6686700|NCT02701062|7617117|FG000|COMPLETED|365 Day Follow-up||294
6686701|NCT02701062|7617118|FG001|COMPLETED|365 Day Follow-up||69
6686702|NCT02701062|7617117|FG000|NOT COMPLETED|365 Day Follow-up||14
6686703|NCT02701062|7617118|FG001|NOT COMPLETED|365 Day Follow-up||3
6686704|NCT02701101|7617132|FG000|STARTED|Overall Study||189
6686705|NCT02701101|7617132|FG000|COMPLETED|Overall Study||189
6686706|NCT02701101|7617132|FG000|NOT COMPLETED|Overall Study||0
6686707|NCT02701257|7617142|FG000|STARTED|Overall Study||6
6686708|NCT02701257|7617143|FG001|STARTED|Overall Study||6
6686709|NCT02701257|7617144|FG002|STARTED|Overall Study||0
6686710|NCT02701257|7617145|FG003|STARTED|Overall Study||4
6686711|NCT02701257|7617146|FG004|STARTED|Overall Study||4
6686712|NCT02701257|7617142|FG000|COMPLETED|Overall Study||6
6686713|NCT02701257|7617143|FG001|COMPLETED|Overall Study||3
6686714|NCT02701257|7617144|FG002|COMPLETED|Overall Study||0
6686715|NCT02701257|7617145|FG003|COMPLETED|Overall Study||3
6686716|NCT02701257|7617146|FG004|COMPLETED|Overall Study||1
6686717|NCT02701257|7617142|FG000|NOT COMPLETED|Overall Study||0
6686718|NCT02701257|7617143|FG001|NOT COMPLETED|Overall Study||3
6686719|NCT02701257|7617144|FG002|NOT COMPLETED|Overall Study||0
6686720|NCT02701257|7617145|FG003|NOT COMPLETED|Overall Study||1
6686721|NCT02701257|7617146|FG004|NOT COMPLETED|Overall Study||3
6686722|NCT02701270|7617162|FG000|STARTED|First Intervention at Visit 1||2
6686723|NCT02701270|7617163|FG001|STARTED|First Intervention at Visit 1||3
6686724|NCT02701270|7617164|FG002|STARTED|First Intervention at Visit 1||3
6686725|NCT02701270|7617165|FG003|STARTED|First Intervention at Visit 1||3
6686726|NCT02701270|7617162|FG000|COMPLETED|First Intervention at Visit 1||2
6686727|NCT02701270|7617163|FG001|COMPLETED|First Intervention at Visit 1||3
6686728|NCT02701270|7617164|FG002|COMPLETED|First Intervention at Visit 1||3
6686729|NCT02701270|7617165|FG003|COMPLETED|First Intervention at Visit 1||3
6686730|NCT02701270|7617162|FG000|NOT COMPLETED|First Intervention at Visit 1||0
6686731|NCT02701270|7617163|FG001|NOT COMPLETED|First Intervention at Visit 1||0
6686732|NCT02701270|7617164|FG002|NOT COMPLETED|First Intervention at Visit 1||0
6686733|NCT02701270|7617165|FG003|NOT COMPLETED|First Intervention at Visit 1||0
6686734|NCT02701270|7617162|FG000|STARTED|Second Intervention at Visit 2||2
6686735|NCT02701270|7617163|FG001|STARTED|Second Intervention at Visit 2||3
6686736|NCT02701270|7617164|FG002|STARTED|Second Intervention at Visit 2||3
6686737|NCT02701270|7617165|FG003|STARTED|Second Intervention at Visit 2||3
6686738|NCT02701270|7617162|FG000|COMPLETED|Second Intervention at Visit 2||2
6686739|NCT02701270|7617163|FG001|COMPLETED|Second Intervention at Visit 2||3
6686740|NCT02701270|7617164|FG002|COMPLETED|Second Intervention at Visit 2||3
6686741|NCT02701270|7617165|FG003|COMPLETED|Second Intervention at Visit 2||3
6686742|NCT02701270|7617162|FG000|NOT COMPLETED|Second Intervention at Visit 2||0
6686743|NCT02701270|7617163|FG001|NOT COMPLETED|Second Intervention at Visit 2||0
6686744|NCT02701270|7617164|FG002|NOT COMPLETED|Second Intervention at Visit 2||0
6686745|NCT02701270|7617165|FG003|NOT COMPLETED|Second Intervention at Visit 2||0
6686746|NCT02701270|7617162|FG000|STARTED|Third Intervention at Visit 3||2
6686747|NCT02701270|7617163|FG001|STARTED|Third Intervention at Visit 3||3
6686748|NCT02701270|7617164|FG002|STARTED|Third Intervention at Visit 3||3
6686749|NCT02701270|7617165|FG003|STARTED|Third Intervention at Visit 3||3
6686750|NCT02701270|7617162|FG000|COMPLETED|Third Intervention at Visit 3||2
6686751|NCT02701270|7617163|FG001|COMPLETED|Third Intervention at Visit 3||3
6686752|NCT02701270|7617164|FG002|COMPLETED|Third Intervention at Visit 3||3
6686753|NCT02701270|7617165|FG003|COMPLETED|Third Intervention at Visit 3||3
6686754|NCT02701270|7617162|FG000|NOT COMPLETED|Third Intervention at Visit 3||0
6686755|NCT02701270|7617163|FG001|NOT COMPLETED|Third Intervention at Visit 3||0
6686756|NCT02701270|7617164|FG002|NOT COMPLETED|Third Intervention at Visit 3||0
6686757|NCT02701270|7617165|FG003|NOT COMPLETED|Third Intervention at Visit 3||0
6686758|NCT02701270|7617162|FG000|STARTED|Fourth Intervention at Visit 4||2
6686759|NCT02701270|7617163|FG001|STARTED|Fourth Intervention at Visit 4||3
6686760|NCT02701270|7617164|FG002|STARTED|Fourth Intervention at Visit 4||3
6686761|NCT02701270|7617165|FG003|STARTED|Fourth Intervention at Visit 4||3
6686762|NCT02701270|7617162|FG000|COMPLETED|Fourth Intervention at Visit 4||2
6686763|NCT02701270|7617163|FG001|COMPLETED|Fourth Intervention at Visit 4||3
6686764|NCT02701270|7617164|FG002|COMPLETED|Fourth Intervention at Visit 4||3
6686765|NCT02701270|7617165|FG003|COMPLETED|Fourth Intervention at Visit 4||3
6686766|NCT02701270|7617162|FG000|NOT COMPLETED|Fourth Intervention at Visit 4||0
6686767|NCT02701270|7617163|FG001|NOT COMPLETED|Fourth Intervention at Visit 4||0
6686768|NCT02701270|7617164|FG002|NOT COMPLETED|Fourth Intervention at Visit 4||0
6686769|NCT02701270|7617165|FG003|NOT COMPLETED|Fourth Intervention at Visit 4||0
6686770|NCT02701296|7617178|FG000|STARTED|Overall Study||42
6686771|NCT02701296|7617179|FG001|STARTED|Overall Study||38
6686772|NCT02701296|7617178|FG000|COMPLETED|Overall Study||42
6686773|NCT02701296|7617179|FG001|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
6686774|NCT02701296|7617178|FG000|NOT COMPLETED|Overall Study||0
6686775|NCT02701296|7617179|FG001|NOT COMPLETED|Overall Study||2
6686776|NCT02701361|7617188|FG000|STARTED|Overall Study||31
6686777|NCT02701361|7617189|FG001|STARTED|Overall Study||31
6686778|NCT02701361|7617190|FG002|STARTED|Overall Study||18
6686779|NCT02701361|7617188|FG000|COMPLETED|Overall Study||22
6686780|NCT02701361|7617189|FG001|COMPLETED|Overall Study||28
6686781|NCT02701361|7617190|FG002|COMPLETED|Overall Study||16
6686782|NCT02701361|7617188|FG000|NOT COMPLETED|Overall Study||9
6686783|NCT02701361|7617189|FG001|NOT COMPLETED|Overall Study||3
6686784|NCT02701361|7617190|FG002|NOT COMPLETED|Overall Study||2
6686785|NCT02701387|7617200|FG000|STARTED|Overall Study||7
6686786|NCT02701387|7617200|FG000|COMPLETED|Overall Study||7
6686787|NCT02701387|7617200|FG000|NOT COMPLETED|Overall Study||0
6686788|NCT02701400|7617207|FG000|STARTED|Overall Study||9
6686789|NCT02701400|7617208|FG001|STARTED|Overall Study||9
6686790|NCT02701400|7617207|FG000|COMPLETED|Overall Study||9
6686791|NCT02701400|7617208|FG001|COMPLETED|Overall Study||9
6686792|NCT02701400|7617207|FG000|NOT COMPLETED|Overall Study||0
6686793|NCT02701400|7617208|FG001|NOT COMPLETED|Overall Study||0
6686794|NCT02701413|7617217|FG000|STARTED|Overall Study||33
6686795|NCT02701413|7617218|FG001|STARTED|Overall Study||33
6686796|NCT02701413|7617217|FG000|COMPLETED|Overall Study||26
6686797|NCT02701413|7617218|FG001|COMPLETED|Overall Study||22
6686798|NCT02701413|7617217|FG000|NOT COMPLETED|Overall Study||7
6686799|NCT02701413|7617218|FG001|NOT COMPLETED|Overall Study||11
6686800|NCT02701582|7617226|FG000|STARTED|Overall Study||35
6686801|NCT02701582|7617227|FG001|STARTED|Overall Study||33
6686802|NCT02701582|7617226|FG000|COMPLETED|Overall Study||33
6686803|NCT02701582|7617227|FG001|COMPLETED|Overall Study||33
6686804|NCT02701582|7617226|FG000|NOT COMPLETED|Overall Study||2
6686805|NCT02701582|7617227|FG001|NOT COMPLETED|Overall Study||0
6686806|NCT02701634|7617237|FG000|STARTED|Overall Study||33
6686807|NCT02701634|7617238|FG001|STARTED|Overall Study||33
6686808|NCT02701634|7617237|FG000|COMPLETED|Overall Study||1
6686809|NCT02701634|7617238|FG001|COMPLETED|Overall Study||2
6686810|NCT02701634|7617237|FG000|NOT COMPLETED|Overall Study||32
6686811|NCT02701634|7617238|FG001|NOT COMPLETED|Overall Study||31
6686812|NCT02701647|7617248|FG000|STARTED|Overall Study||17
6686813|NCT02701647|7617249|FG001|STARTED|Overall Study||17
6686814|NCT02701647|7617250|FG002|STARTED|Overall Study||17
6686815|NCT02701647|7617248|FG000|COMPLETED|Overall Study||17
6686816|NCT02701647|7617249|FG001|COMPLETED|Overall Study||17
6686817|NCT02701647|7617250|FG002|COMPLETED|Overall Study|One participant from sham-TT withdraw due a back injury unrelated to study.|16
6686818|NCT02701647|7617248|FG000|NOT COMPLETED|Overall Study||0
6686819|NCT02701647|7617249|FG001|NOT COMPLETED|Overall Study||0
6686820|NCT02701647|7617250|FG002|NOT COMPLETED|Overall Study||1
6686821|NCT02701764|7617266|FG000|STARTED|Overall Study||21
6686822|NCT02701764|7617267|FG001|STARTED|Overall Study||22
6686823|NCT02701764|7617266|FG000|COMPLETED|Overall Study||21
6686824|NCT02701764|7617267|FG001|COMPLETED|Overall Study||21
6686825|NCT02701764|7617266|FG000|NOT COMPLETED|Overall Study||0
6686826|NCT02701764|7617267|FG001|NOT COMPLETED|Overall Study||1
6686827|NCT02701868|7617276|FG000|STARTED|Overall Study||21
6686828|NCT02701868|7617277|FG001|STARTED|Overall Study||75
6686829|NCT02701868|7617278|FG002|STARTED|Overall Study||75
6686830|NCT02701868|7617276|FG000|COMPLETED|Overall Study||21
6686831|NCT02701868|7617277|FG001|COMPLETED|Overall Study||75
6686832|NCT02701868|7617278|FG002|COMPLETED|Overall Study||75
6686833|NCT02701868|7617276|FG000|NOT COMPLETED|Overall Study||0
6686834|NCT02701868|7617277|FG001|NOT COMPLETED|Overall Study||0
6686835|NCT02701868|7617278|FG002|NOT COMPLETED|Overall Study||0
6686836|NCT02701985|7617289|FG000|STARTED|Overall Study||37
6686837|NCT02701985|7617290|FG001|STARTED|Overall Study||38
6686838|NCT02701985|7617289|FG000|COMPLETED|Overall Study||34
6686839|NCT02701985|7617290|FG001|COMPLETED|Overall Study||32
6686840|NCT02701985|7617289|FG000|NOT COMPLETED|Overall Study||3
6686841|NCT02701985|7617290|FG001|NOT COMPLETED|Overall Study||6
6686842|NCT02702011|7617301|FG000|STARTED|Overall Study|Started are the treated patients.|11
6686843|NCT02702011|7617302|FG001|STARTED|Overall Study|Started are the treated patients.|13
6686844|NCT02702011|7617303|FG002|STARTED|Overall Study|Started are the treated patients.|12
6686845|NCT02702011|7617304|FG003|STARTED|Overall Study|Started are the treated patients.|12
6686846|NCT02702011|7617301|FG000|COMPLETED|Overall Study||11
6686847|NCT02702011|7617302|FG001|COMPLETED|Overall Study||12
6686848|NCT02702011|7617303|FG002|COMPLETED|Overall Study||12
6686849|NCT02702011|7617304|FG003|COMPLETED|Overall Study||12
6686850|NCT02702011|7617301|FG000|NOT COMPLETED|Overall Study||0
6686851|NCT02702011|7617302|FG001|NOT COMPLETED|Overall Study||1
6686852|NCT02702011|7617303|FG002|NOT COMPLETED|Overall Study||0
6686853|NCT02702011|7617304|FG003|NOT COMPLETED|Overall Study||0
6686854|NCT02702193|7617316|FG000|STARTED|Baseline Assessment/Randomization||86
6686855|NCT02702193|7617317|FG001|STARTED|Baseline Assessment/Randomization||87
6686856|NCT02702193|7617316|FG000|COMPLETED|Baseline Assessment/Randomization||85
6686857|NCT02702193|7617317|FG001|COMPLETED|Baseline Assessment/Randomization||87
6686858|NCT02702193|7617316|FG000|NOT COMPLETED|Baseline Assessment/Randomization||1
6686859|NCT02702193|7617317|FG001|NOT COMPLETED|Baseline Assessment/Randomization||0
6686860|NCT02702193|7617316|FG000|STARTED|4 Month Follow up||86
6686861|NCT02702193|7617317|FG001|STARTED|4 Month Follow up||87
6686862|NCT02702193|7617316|FG000|COMPLETED|4 Month Follow up||68
6686863|NCT02702193|7617317|FG001|COMPLETED|4 Month Follow up||69
6686864|NCT02702193|7617316|FG000|NOT COMPLETED|4 Month Follow up||18
6686865|NCT02702193|7617317|FG001|NOT COMPLETED|4 Month Follow up||18
6686866|NCT02702193|7617316|FG000|STARTED|8 Month Follow up||86
6686867|NCT02702193|7617317|FG001|STARTED|8 Month Follow up||87
6686868|NCT02702193|7617316|FG000|COMPLETED|8 Month Follow up||71
6686869|NCT02702193|7617317|FG001|COMPLETED|8 Month Follow up||69
6686870|NCT02702193|7617316|FG000|NOT COMPLETED|8 Month Follow up||15
6686871|NCT02702193|7617317|FG001|NOT COMPLETED|8 Month Follow up||18
6686872|NCT02702193|7617316|FG000|STARTED|12 Month Follow up||86
6686873|NCT02702193|7617317|FG001|STARTED|12 Month Follow up||87
6686874|NCT02702193|7617316|FG000|COMPLETED|12 Month Follow up||69
6686875|NCT02702193|7617317|FG001|COMPLETED|12 Month Follow up||69
6686876|NCT02702193|7617316|FG000|NOT COMPLETED|12 Month Follow up||17
6686877|NCT02702193|7617317|FG001|NOT COMPLETED|12 Month Follow up||18
6686878|NCT02702388|7617325|FG000|STARTED|Overall Study||75
6686879|NCT02702388|7617326|FG001|STARTED|Overall Study||77
6686880|NCT02702388|7617325|FG000|COMPLETED|Overall Study||35
6686881|NCT02702388|7617326|FG001|COMPLETED|Overall Study||26
6686882|NCT02702388|7617325|FG000|NOT COMPLETED|Overall Study||40
6686883|NCT02702388|7617326|FG001|NOT COMPLETED|Overall Study||51
6686884|NCT02702401|7617343|FG000|STARTED|Overall Study||278
6686885|NCT02702401|7617344|FG001|STARTED|Overall Study||135
6686886|NCT02702401|7617343|FG000|Treated|Overall Study||278
6686887|NCT02702401|7617344|FG001|Treated|Overall Study||135
6686888|NCT02702401|7617343|FG000|COMPLETED|Overall Study||0
6686889|NCT02702401|7617344|FG001|COMPLETED|Overall Study||0
6686890|NCT02702401|7617343|FG000|NOT COMPLETED|Overall Study||278
6686891|NCT02702401|7617344|FG001|NOT COMPLETED|Overall Study||135
6686892|NCT02702518|7617352|FG000|STARTED|Overall Study||29
6686893|NCT02702518|7617353|FG001|STARTED|Overall Study||29
6686894|NCT02702518|7617352|FG000|COMPLETED|Overall Study||26
6686895|NCT02702518|7617353|FG001|COMPLETED|Overall Study||25
6686896|NCT02702518|7617352|FG000|NOT COMPLETED|Overall Study||3
6686897|NCT02702518|7617353|FG001|NOT COMPLETED|Overall Study||4
6686898|NCT02702609|7617361|FG000|STARTED|Overall Study||24
6686899|NCT02702609|7617362|FG001|STARTED|Overall Study||21
6686900|NCT02702609|7617361|FG000|Implant Placement|Overall Study||23
6686901|NCT02702609|7617362|FG001|Implant Placement|Overall Study||21
6686902|NCT02702609|7617361|FG000|Crown Delivery|Overall Study||16
6686903|NCT02702609|7617362|FG001|Crown Delivery|Overall Study||18
6686904|NCT02702609|7617361|FG000|COMPLETED|Overall Study||15
6686905|NCT02702609|7617362|FG001|COMPLETED|Overall Study||17
6686906|NCT02702609|7617361|FG000|NOT COMPLETED|Overall Study||9
6686907|NCT02702609|7617362|FG001|NOT COMPLETED|Overall Study||4
6686908|NCT02702921|7617370|FG000|STARTED|Overall Study||98
6686909|NCT02702921|7617371|FG001|STARTED|Overall Study||103
6686910|NCT02702921|7617370|FG000|COMPLETED|Overall Study||84
6686911|NCT02702921|7617371|FG001|COMPLETED|Overall Study||95
6686912|NCT02702921|7617370|FG000|NOT COMPLETED|Overall Study||14
6686913|NCT02702921|7617371|FG001|NOT COMPLETED|Overall Study||8
6686914|NCT02702999|7617379|FG000|STARTED|Overall Study||102
6686915|NCT02702999|7617380|FG001|STARTED|Overall Study||104
6686916|NCT02702999|7617379|FG000|COMPLETED|Overall Study||102
6686917|NCT02702999|7617380|FG001|COMPLETED|Overall Study||104
6686918|NCT02702999|7617379|FG000|NOT COMPLETED|Overall Study||0
6686919|NCT02702999|7617380|FG001|NOT COMPLETED|Overall Study||0
6686920|NCT02703259|7617388|FG000|STARTED|24 Hours Postoperative Assessment||70
6686921|NCT02703259|7617389|FG001|STARTED|24 Hours Postoperative Assessment||67
6686922|NCT02703259|7617388|FG000|COMPLETED|24 Hours Postoperative Assessment||68
6686923|NCT02703259|7617389|FG001|COMPLETED|24 Hours Postoperative Assessment||61
6686924|NCT02703259|7617388|FG000|NOT COMPLETED|24 Hours Postoperative Assessment||2
6686925|NCT02703259|7617389|FG001|NOT COMPLETED|24 Hours Postoperative Assessment||6
6686926|NCT02703259|7617388|FG000|STARTED|2 Weeks Postoperative Assessment||68
6686927|NCT02703259|7617389|FG001|STARTED|2 Weeks Postoperative Assessment||61
6686928|NCT02703259|7617388|FG000|COMPLETED|2 Weeks Postoperative Assessment||58
6686929|NCT02703259|7617389|FG001|COMPLETED|2 Weeks Postoperative Assessment||51
6686930|NCT02703259|7617388|FG000|NOT COMPLETED|2 Weeks Postoperative Assessment||10
6686931|NCT02703259|7617389|FG001|NOT COMPLETED|2 Weeks Postoperative Assessment||10
6686932|NCT02703311|7617395|FG000|STARTED|Overall Study||11
6686933|NCT02703311|7617395|FG000|Implanted|Overall Study||11
6686934|NCT02703311|7617395|FG000|30 Day Follow-Up Completed|Overall Study||9
6686935|NCT02703311|7617395|FG000|COMPLETED|Overall Study||3
6686936|NCT02703311|7617395|FG000|NOT COMPLETED|Overall Study||8
6686937|NCT02703324|7617399|FG000|STARTED|Period One||5
6686938|NCT02703324|7617400|FG001|STARTED|Period One||5
6686939|NCT02703324|7617401|FG002|STARTED|Period One||5
6686940|NCT02703324|7617402|FG003|STARTED|Period One||5
6686941|NCT02703324|7617403|FG004|STARTED|Period One||5
6686942|NCT02703324|7617404|FG005|STARTED|Period One||5
6686943|NCT02703324|7617399|FG000|Received Study Drug|Period One||5
6686944|NCT02703324|7617400|FG001|Received Study Drug|Period One||5
6686945|NCT02703324|7617401|FG002|Received Study Drug|Period One||5
6686946|NCT02703324|7617402|FG003|Received Study Drug|Period One||5
6686947|NCT02703324|7617403|FG004|Received Study Drug|Period One||5
6686948|NCT02703324|7617404|FG005|Received Study Drug|Period One||5
6686949|NCT02703324|7617399|FG000|COMPLETED|Period One||5
6686950|NCT02703324|7617400|FG001|COMPLETED|Period One||5
6686951|NCT02703324|7617401|FG002|COMPLETED|Period One||5
6686952|NCT02703324|7617402|FG003|COMPLETED|Period One||5
6686953|NCT02703324|7617403|FG004|COMPLETED|Period One||5
6686954|NCT02703324|7617404|FG005|COMPLETED|Period One||5
6686955|NCT02703324|7617399|FG000|NOT COMPLETED|Period One||0
6686956|NCT02703324|7617400|FG001|NOT COMPLETED|Period One||0
6686957|NCT02703324|7617401|FG002|NOT COMPLETED|Period One||0
6686958|NCT02703324|7617402|FG003|NOT COMPLETED|Period One||0
6686959|NCT02703324|7617403|FG004|NOT COMPLETED|Period One||0
6686960|NCT02703324|7617404|FG005|NOT COMPLETED|Period One||0
6686961|NCT02703324|7617399|FG000|STARTED|Period Two||5
6686962|NCT02703324|7617400|FG001|STARTED|Period Two||5
6686963|NCT02703324|7617401|FG002|STARTED|Period Two||5
6686964|NCT02703324|7617402|FG003|STARTED|Period Two||5
6686965|NCT02703324|7617403|FG004|STARTED|Period Two||5
6686966|NCT02703324|7617404|FG005|STARTED|Period Two||5
6686967|NCT02703324|7617399|FG000|Received Study Drug|Period Two||5
6686968|NCT02703324|7617400|FG001|Received Study Drug|Period Two||5
6686969|NCT02703324|7617401|FG002|Received Study Drug|Period Two||5
6686970|NCT02703324|7617402|FG003|Received Study Drug|Period Two||5
6686971|NCT02703324|7617403|FG004|Received Study Drug|Period Two||5
6686972|NCT02703324|7617404|FG005|Received Study Drug|Period Two||5
6686973|NCT02703324|7617399|FG000|COMPLETED|Period Two||5
6686974|NCT02703324|7617400|FG001|COMPLETED|Period Two||5
6686975|NCT02703324|7617401|FG002|COMPLETED|Period Two||4
6686976|NCT02703324|7617402|FG003|COMPLETED|Period Two||5
6686977|NCT02703324|7617403|FG004|COMPLETED|Period Two||5
6686978|NCT02703324|7617404|FG005|COMPLETED|Period Two||5
6686979|NCT02703324|7617399|FG000|NOT COMPLETED|Period Two||0
6686980|NCT02703324|7617400|FG001|NOT COMPLETED|Period Two||0
6686981|NCT02703324|7617401|FG002|NOT COMPLETED|Period Two||1
6686982|NCT02703324|7617402|FG003|NOT COMPLETED|Period Two||0
6686983|NCT02703324|7617403|FG004|NOT COMPLETED|Period Two||0
6686984|NCT02703324|7617404|FG005|NOT COMPLETED|Period Two||0
6686985|NCT02703324|7617399|FG000|STARTED|Period Three||5
6686986|NCT02703324|7617400|FG001|STARTED|Period Three||5
6686987|NCT02703324|7617401|FG002|STARTED|Period Three||4
6686988|NCT02703324|7617402|FG003|STARTED|Period Three||5
6686989|NCT02703324|7617403|FG004|STARTED|Period Three||5
6686990|NCT02703324|7617404|FG005|STARTED|Period Three||5
6686991|NCT02703324|7617399|FG000|Received Study Drug|Period Three||5
6686992|NCT02703324|7617400|FG001|Received Study Drug|Period Three||5
6686993|NCT02703324|7617401|FG002|Received Study Drug|Period Three||4
6686994|NCT02703324|7617402|FG003|Received Study Drug|Period Three||5
6686995|NCT02703324|7617403|FG004|Received Study Drug|Period Three||5
6686996|NCT02703324|7617404|FG005|Received Study Drug|Period Three||5
6686997|NCT02703324|7617399|FG000|COMPLETED|Period Three||5
6686998|NCT02703324|7617400|FG001|COMPLETED|Period Three|One participant discontinued after Period 3. Did not enter Period 4.|5
6686999|NCT02703324|7617401|FG002|COMPLETED|Period Three||4
6687000|NCT02703324|7617402|FG003|COMPLETED|Period Three||5
6687001|NCT02703324|7617403|FG004|COMPLETED|Period Three||5
6687002|NCT02703324|7617404|FG005|COMPLETED|Period Three||5
6687003|NCT02703324|7617399|FG000|NOT COMPLETED|Period Three||0
6687004|NCT02703324|7617400|FG001|NOT COMPLETED|Period Three||0
6687005|NCT02703324|7617401|FG002|NOT COMPLETED|Period Three||0
6687006|NCT02703324|7617402|FG003|NOT COMPLETED|Period Three||0
6687007|NCT02703324|7617403|FG004|NOT COMPLETED|Period Three||0
6687008|NCT02703324|7617404|FG005|NOT COMPLETED|Period Three||0
6687009|NCT02703324|7617399|FG000|STARTED|Period Four||5
6687010|NCT02703324|7617400|FG001|STARTED|Period Four|One participant discontinued after Period 3. Did not enter Period 4.|4
6687011|NCT02703324|7617401|FG002|STARTED|Period Four||4
6687012|NCT02703324|7617402|FG003|STARTED|Period Four||5
6687013|NCT02703324|7617403|FG004|STARTED|Period Four||5
6687014|NCT02703324|7617404|FG005|STARTED|Period Four||5
6687015|NCT02703324|7617399|FG000|Received Study Drug|Period Four||5
6687016|NCT02703324|7617400|FG001|Received Study Drug|Period Four||4
6687017|NCT02703324|7617401|FG002|Received Study Drug|Period Four||4
6687018|NCT02703324|7617402|FG003|Received Study Drug|Period Four||5
6687019|NCT02703324|7617403|FG004|Received Study Drug|Period Four||5
6687020|NCT02703324|7617404|FG005|Received Study Drug|Period Four||5
6687021|NCT02703324|7617399|FG000|COMPLETED|Period Four||5
6687022|NCT02703324|7617400|FG001|COMPLETED|Period Four||4
6687023|NCT02703324|7617401|FG002|COMPLETED|Period Four||4
6687024|NCT02703324|7617402|FG003|COMPLETED|Period Four||5
6687025|NCT02703324|7617403|FG004|COMPLETED|Period Four||5
6687026|NCT02703324|7617404|FG005|COMPLETED|Period Four||5
6687027|NCT02703324|7617399|FG000|NOT COMPLETED|Period Four||0
6687028|NCT02703324|7617400|FG001|NOT COMPLETED|Period Four||0
6687029|NCT02703324|7617401|FG002|NOT COMPLETED|Period Four||0
6687030|NCT02703324|7617402|FG003|NOT COMPLETED|Period Four||0
6687031|NCT02703324|7617403|FG004|NOT COMPLETED|Period Four||0
6687032|NCT02703324|7617404|FG005|NOT COMPLETED|Period Four||0
6687033|NCT02703337|7617413|FG000|STARTED|Period One (Part A)||5
6687034|NCT02703337|7617414|FG001|STARTED|Period One (Part A)||5
6687035|NCT02703337|7617415|FG002|STARTED|Period One (Part A)||5
6687036|NCT02703337|7617416|FG003|STARTED|Period One (Part A)||5
6687037|NCT02703337|7617417|FG004|STARTED|Period One (Part A)||5
6687038|NCT02703337|7617418|FG005|STARTED|Period One (Part A)||5
6687039|NCT02703337|7617419|FG006|STARTED|Period One (Part A)||0
6687040|NCT02703337|7617420|FG007|STARTED|Period One (Part A)||0
6687041|NCT02703337|7617413|FG000|Received Study Drug|Period One (Part A)||5
6687042|NCT02703337|7617414|FG001|Received Study Drug|Period One (Part A)||5
6687043|NCT02703337|7617415|FG002|Received Study Drug|Period One (Part A)||5
6687044|NCT02703337|7617416|FG003|Received Study Drug|Period One (Part A)||5
6687045|NCT02703337|7617417|FG004|Received Study Drug|Period One (Part A)||5
6687046|NCT02703337|7617418|FG005|Received Study Drug|Period One (Part A)||5
6257283|NCT04728802|7156367|FG000|STARTED|Overall Study||317
6687047|NCT02703337|7617419|FG006|Received Study Drug|Period One (Part A)||0
6687048|NCT02703337|7617420|FG007|Received Study Drug|Period One (Part A)||0
6687049|NCT02703337|7617413|FG000|COMPLETED|Period One (Part A)||5
6687050|NCT02703337|7617414|FG001|COMPLETED|Period One (Part A)||5
6687051|NCT02703337|7617415|FG002|COMPLETED|Period One (Part A)||5
6687052|NCT02703337|7617416|FG003|COMPLETED|Period One (Part A)||5
6687053|NCT02703337|7617417|FG004|COMPLETED|Period One (Part A)||4
6687054|NCT02703337|7617418|FG005|COMPLETED|Period One (Part A)||5
6687055|NCT02703337|7617419|FG006|COMPLETED|Period One (Part A)||0
6687056|NCT02703337|7617420|FG007|COMPLETED|Period One (Part A)||0
6687057|NCT02703337|7617413|FG000|NOT COMPLETED|Period One (Part A)||0
6687058|NCT02703337|7617414|FG001|NOT COMPLETED|Period One (Part A)||0
6687059|NCT02703337|7617415|FG002|NOT COMPLETED|Period One (Part A)||0
6687060|NCT02703337|7617416|FG003|NOT COMPLETED|Period One (Part A)||0
6687061|NCT02703337|7617417|FG004|NOT COMPLETED|Period One (Part A)||1
6687062|NCT02703337|7617418|FG005|NOT COMPLETED|Period One (Part A)||0
6687063|NCT02703337|7617419|FG006|NOT COMPLETED|Period One (Part A)||0
6687064|NCT02703337|7617420|FG007|NOT COMPLETED|Period One (Part A)||0
6687065|NCT02703337|7617413|FG000|STARTED|Period Two (Part A)||5
6687066|NCT02703337|7617414|FG001|STARTED|Period Two (Part A)||5
6687067|NCT02703337|7617415|FG002|STARTED|Period Two (Part A)||5
6687068|NCT02703337|7617416|FG003|STARTED|Period Two (Part A)||5
6687069|NCT02703337|7617417|FG004|STARTED|Period Two (Part A)||4
6687070|NCT02703337|7617418|FG005|STARTED|Period Two (Part A)||5
6687071|NCT02703337|7617419|FG006|STARTED|Period Two (Part A)||0
6687072|NCT02703337|7617420|FG007|STARTED|Period Two (Part A)||0
6687073|NCT02703337|7617413|FG000|Received Study Drug|Period Two (Part A)||5
6687074|NCT02703337|7617414|FG001|Received Study Drug|Period Two (Part A)||5
6687075|NCT02703337|7617415|FG002|Received Study Drug|Period Two (Part A)||5
6687076|NCT02703337|7617416|FG003|Received Study Drug|Period Two (Part A)||5
6687077|NCT02703337|7617417|FG004|Received Study Drug|Period Two (Part A)||4
6687078|NCT02703337|7617418|FG005|Received Study Drug|Period Two (Part A)||5
6687079|NCT02703337|7617419|FG006|Received Study Drug|Period Two (Part A)||0
6687080|NCT02703337|7617420|FG007|Received Study Drug|Period Two (Part A)||0
6687081|NCT02703337|7617413|FG000|COMPLETED|Period Two (Part A)||5
6687082|NCT02703337|7617414|FG001|COMPLETED|Period Two (Part A)||5
6687083|NCT02703337|7617415|FG002|COMPLETED|Period Two (Part A)||5
6687084|NCT02703337|7617416|FG003|COMPLETED|Period Two (Part A)||5
6687085|NCT02703337|7617417|FG004|COMPLETED|Period Two (Part A)||4
6687086|NCT02703337|7617418|FG005|COMPLETED|Period Two (Part A)||5
6687087|NCT02703337|7617419|FG006|COMPLETED|Period Two (Part A)||0
6687088|NCT02703337|7617420|FG007|COMPLETED|Period Two (Part A)||0
6687089|NCT02703337|7617413|FG000|NOT COMPLETED|Period Two (Part A)||0
6687090|NCT02703337|7617414|FG001|NOT COMPLETED|Period Two (Part A)||0
6687091|NCT02703337|7617415|FG002|NOT COMPLETED|Period Two (Part A)||0
6687092|NCT02703337|7617416|FG003|NOT COMPLETED|Period Two (Part A)||0
6687093|NCT02703337|7617417|FG004|NOT COMPLETED|Period Two (Part A)||0
6687094|NCT02703337|7617418|FG005|NOT COMPLETED|Period Two (Part A)||0
6687095|NCT02703337|7617419|FG006|NOT COMPLETED|Period Two (Part A)||0
6687096|NCT02703337|7617420|FG007|NOT COMPLETED|Period Two (Part A)||0
6687097|NCT02703337|7617413|FG000|STARTED|Period Three (Part A)||5
6687098|NCT02703337|7617414|FG001|STARTED|Period Three (Part A)||5
6687099|NCT02703337|7617415|FG002|STARTED|Period Three (Part A)||5
6687100|NCT02703337|7617416|FG003|STARTED|Period Three (Part A)||5
6257284|NCT04728802|7156368|FG001|STARTED|Overall Study||328
6257285|NCT04728802|7156367|FG000|COMPLETED|Overall Study||288
6257286|NCT04728802|7156368|FG001|COMPLETED|Overall Study||292
6257287|NCT04728802|7156367|FG000|NOT COMPLETED|Overall Study||29
6257288|NCT04728802|7156368|FG001|NOT COMPLETED|Overall Study||36
6257289|NCT04728594|7156377|FG000|STARTED|Overall Study|The number of participants who were sent a follow up email (delayed, three days after the other two arms) was used to see how many started.|3178
6257290|NCT04728594|7156378|FG001|STARTED|Overall Study||3198
6257291|NCT04728594|7156379|FG002|STARTED|Overall Study||3190
6257292|NCT04728594|7156377|FG000|COMPLETED|Overall Study||3178
6257293|NCT04728594|7156378|FG001|COMPLETED|Overall Study||3198
6257294|NCT04728594|7156379|FG002|COMPLETED|Overall Study||3190
6257295|NCT04728594|7156377|FG000|NOT COMPLETED|Overall Study||0
6257296|NCT04728594|7156378|FG001|NOT COMPLETED|Overall Study||0
6257297|NCT04728594|7156379|FG002|NOT COMPLETED|Overall Study||0
6279641|NCT00147251|7179509|FG001|STARTED|Recruitment and Enrollment||277
6279642|NCT00147251|7179508|FG000|COMPLETED|Recruitment and Enrollment||247
6279643|NCT00147251|7179509|FG001|COMPLETED|Recruitment and Enrollment||252
6279644|NCT00147251|7179508|FG000|NOT COMPLETED|Recruitment and Enrollment||24
6279645|NCT00147251|7179509|FG001|NOT COMPLETED|Recruitment and Enrollment||25
6279646|NCT00147251|7179508|FG000|STARTED|Follow up||247
6279647|NCT00147251|7179509|FG001|STARTED|Follow up||252
6279648|NCT00147251|7179508|FG000|COMPLETED|Follow up||247
6279649|NCT00147251|7179509|FG001|COMPLETED|Follow up||252
6279650|NCT00147251|7179508|FG000|NOT COMPLETED|Follow up||0
6279651|NCT00147251|7179509|FG001|NOT COMPLETED|Follow up||0
6279652|NCT00147316|7179517|FG000|STARTED|Overall Study||103
6279653|NCT00147316|7179517|FG000|COMPLETED|Overall Study||103
6279654|NCT00147316|7179517|FG000|NOT COMPLETED|Overall Study||0
6279655|NCT00147446|7179523|FG000|STARTED|Overall Study||60
6279656|NCT00147446|7179524|FG001|STARTED|Overall Study||61
6279657|NCT00147446|7179523|FG000|COMPLETED|Overall Study||60
6279658|NCT00147446|7179524|FG001|COMPLETED|Overall Study||61
6279659|NCT00147446|7179523|FG000|NOT COMPLETED|Overall Study||0
6279660|NCT00147446|7179524|FG001|NOT COMPLETED|Overall Study||0
6279661|NCT00147498|7179536|FG000|STARTED|Overall Study||61
6279662|NCT00147498|7179537|FG001|STARTED|Overall Study||69
6687101|NCT02703337|7617417|FG004|STARTED|Period Three (Part A)||4
6687102|NCT02703337|7617418|FG005|STARTED|Period Three (Part A)||5
6687103|NCT02703337|7617419|FG006|STARTED|Period Three (Part A)||0
6279663|NCT00147498|7179538|FG002|STARTED|Overall Study||69
6279664|NCT00147498|7179539|FG003|STARTED|Overall Study||65
6279665|NCT00147498|7179536|FG000|COMPLETED|Overall Study||58
6279666|NCT00147498|7179537|FG001|COMPLETED|Overall Study||60
6279667|NCT00147498|7179538|FG002|COMPLETED|Overall Study||52
6687104|NCT02703337|7617420|FG007|STARTED|Period Three (Part A)||0
6687105|NCT02703337|7617413|FG000|Received Study Drug|Period Three (Part A)||5
6279668|NCT00147498|7179539|FG003|COMPLETED|Overall Study||48
6279669|NCT00147498|7179536|FG000|NOT COMPLETED|Overall Study||3
6687106|NCT02703337|7617414|FG001|Received Study Drug|Period Three (Part A)||5
6687107|NCT02703337|7617415|FG002|Received Study Drug|Period Three (Part A)||5
6687108|NCT02703337|7617416|FG003|Received Study Drug|Period Three (Part A)||5
6687109|NCT02703337|7617417|FG004|Received Study Drug|Period Three (Part A)||4
6687110|NCT02703337|7617418|FG005|Received Study Drug|Period Three (Part A)||5
6687111|NCT02703337|7617419|FG006|Received Study Drug|Period Three (Part A)||0
6687112|NCT02703337|7617420|FG007|Received Study Drug|Period Three (Part A)||0
6687113|NCT02703337|7617413|FG000|COMPLETED|Period Three (Part A)||5
6687114|NCT02703337|7617414|FG001|COMPLETED|Period Three (Part A)||5
6687115|NCT02703337|7617415|FG002|COMPLETED|Period Three (Part A)||5
6687116|NCT02703337|7617416|FG003|COMPLETED|Period Three (Part A)||5
6687117|NCT02703337|7617417|FG004|COMPLETED|Period Three (Part A)||4
6687118|NCT02703337|7617418|FG005|COMPLETED|Period Three (Part A)||5
6687119|NCT02703337|7617419|FG006|COMPLETED|Period Three (Part A)||0
6687120|NCT02703337|7617420|FG007|COMPLETED|Period Three (Part A)||0
6687121|NCT02703337|7617413|FG000|NOT COMPLETED|Period Three (Part A)||0
6687122|NCT02703337|7617414|FG001|NOT COMPLETED|Period Three (Part A)||0
6687123|NCT02703337|7617415|FG002|NOT COMPLETED|Period Three (Part A)||0
6687124|NCT02703337|7617416|FG003|NOT COMPLETED|Period Three (Part A)||0
6687125|NCT02703337|7617417|FG004|NOT COMPLETED|Period Three (Part A)||0
6687126|NCT02703337|7617418|FG005|NOT COMPLETED|Period Three (Part A)||0
6687127|NCT02703337|7617419|FG006|NOT COMPLETED|Period Three (Part A)||0
6687128|NCT02703337|7617420|FG007|NOT COMPLETED|Period Three (Part A)||0
6687129|NCT02703337|7617413|FG000|STARTED|Period Four (Part A)||5
6687130|NCT02703337|7617414|FG001|STARTED|Period Four (Part A)||5
6687131|NCT02703337|7617415|FG002|STARTED|Period Four (Part A)||5
6687132|NCT02703337|7617416|FG003|STARTED|Period Four (Part A)||5
6687133|NCT02703337|7617417|FG004|STARTED|Period Four (Part A)||4
6687134|NCT02703337|7617418|FG005|STARTED|Period Four (Part A)||5
6687135|NCT02703337|7617419|FG006|STARTED|Period Four (Part A)||0
6687136|NCT02703337|7617420|FG007|STARTED|Period Four (Part A)||0
6687137|NCT02703337|7617413|FG000|Received Study Drug|Period Four (Part A)||5
6687138|NCT02703337|7617414|FG001|Received Study Drug|Period Four (Part A)||5
6687139|NCT02703337|7617415|FG002|Received Study Drug|Period Four (Part A)||5
6687140|NCT02703337|7617416|FG003|Received Study Drug|Period Four (Part A)||5
6687141|NCT02703337|7617417|FG004|Received Study Drug|Period Four (Part A)||4
6687142|NCT02703337|7617418|FG005|Received Study Drug|Period Four (Part A)||5
6687143|NCT02703337|7617419|FG006|Received Study Drug|Period Four (Part A)||0
6687144|NCT02703337|7617420|FG007|Received Study Drug|Period Four (Part A)||0
6687145|NCT02703337|7617413|FG000|COMPLETED|Period Four (Part A)||5
6687146|NCT02703337|7617414|FG001|COMPLETED|Period Four (Part A)||5
6687147|NCT02703337|7617415|FG002|COMPLETED|Period Four (Part A)||5
6687148|NCT02703337|7617416|FG003|COMPLETED|Period Four (Part A)||5
6687149|NCT02703337|7617417|FG004|COMPLETED|Period Four (Part A)||4
6687150|NCT02703337|7617418|FG005|COMPLETED|Period Four (Part A)||5
6687151|NCT02703337|7617419|FG006|COMPLETED|Period Four (Part A)||0
6687152|NCT02703337|7617420|FG007|COMPLETED|Period Four (Part A)||0
6687153|NCT02703337|7617413|FG000|NOT COMPLETED|Period Four (Part A)||0
6687154|NCT02703337|7617414|FG001|NOT COMPLETED|Period Four (Part A)||0
6687155|NCT02703337|7617415|FG002|NOT COMPLETED|Period Four (Part A)||0
6687156|NCT02703337|7617416|FG003|NOT COMPLETED|Period Four (Part A)||0
6687157|NCT02703337|7617417|FG004|NOT COMPLETED|Period Four (Part A)||0
6687158|NCT02703337|7617418|FG005|NOT COMPLETED|Period Four (Part A)||0
6687159|NCT02703337|7617419|FG006|NOT COMPLETED|Period Four (Part A)||0
6687160|NCT02703337|7617420|FG007|NOT COMPLETED|Period Four (Part A)||0
6687161|NCT02703337|7617413|FG000|STARTED|Period Five (Part A)||5
6687162|NCT02703337|7617414|FG001|STARTED|Period Five (Part A)||5
6687163|NCT02703337|7617415|FG002|STARTED|Period Five (Part A)||5
6687164|NCT02703337|7617416|FG003|STARTED|Period Five (Part A)||5
6687165|NCT02703337|7617417|FG004|STARTED|Period Five (Part A)||4
6687166|NCT02703337|7617418|FG005|STARTED|Period Five (Part A)||5
6687167|NCT02703337|7617419|FG006|STARTED|Period Five (Part A)||0
6687168|NCT02703337|7617420|FG007|STARTED|Period Five (Part A)||0
6687169|NCT02703337|7617413|FG000|Received Study Drug|Period Five (Part A)||5
6687170|NCT02703337|7617414|FG001|Received Study Drug|Period Five (Part A)||5
6687171|NCT02703337|7617415|FG002|Received Study Drug|Period Five (Part A)||5
6687172|NCT02703337|7617416|FG003|Received Study Drug|Period Five (Part A)||5
6687173|NCT02703337|7617417|FG004|Received Study Drug|Period Five (Part A)||4
6687174|NCT02703337|7617418|FG005|Received Study Drug|Period Five (Part A)||5
6687175|NCT02703337|7617419|FG006|Received Study Drug|Period Five (Part A)||0
6687176|NCT02703337|7617420|FG007|Received Study Drug|Period Five (Part A)||0
6687177|NCT02703337|7617413|FG000|COMPLETED|Period Five (Part A)||5
6687178|NCT02703337|7617414|FG001|COMPLETED|Period Five (Part A)||5
6687179|NCT02703337|7617415|FG002|COMPLETED|Period Five (Part A)||5
6687180|NCT02703337|7617416|FG003|COMPLETED|Period Five (Part A)||5
6687181|NCT02703337|7617417|FG004|COMPLETED|Period Five (Part A)||4
6687182|NCT02703337|7617418|FG005|COMPLETED|Period Five (Part A)||5
6687183|NCT02703337|7617419|FG006|COMPLETED|Period Five (Part A)||0
6687184|NCT02703337|7617420|FG007|COMPLETED|Period Five (Part A)||0
6687185|NCT02703337|7617413|FG000|NOT COMPLETED|Period Five (Part A)||0
6687186|NCT02703337|7617414|FG001|NOT COMPLETED|Period Five (Part A)||0
6687187|NCT02703337|7617415|FG002|NOT COMPLETED|Period Five (Part A)||0
6687188|NCT02703337|7617416|FG003|NOT COMPLETED|Period Five (Part A)||0
6687189|NCT02703337|7617417|FG004|NOT COMPLETED|Period Five (Part A)||0
6687190|NCT02703337|7617418|FG005|NOT COMPLETED|Period Five (Part A)||0
6687191|NCT02703337|7617419|FG006|NOT COMPLETED|Period Five (Part A)||0
6687192|NCT02703337|7617420|FG007|NOT COMPLETED|Period Five (Part A)||0
6687193|NCT02703337|7617413|FG000|STARTED|Period Six (Part A)||5
6687194|NCT02703337|7617414|FG001|STARTED|Period Six (Part A)||5
6687195|NCT02703337|7617415|FG002|STARTED|Period Six (Part A)||5
6687196|NCT02703337|7617416|FG003|STARTED|Period Six (Part A)||5
6687197|NCT02703337|7617417|FG004|STARTED|Period Six (Part A)||4
6687198|NCT02703337|7617418|FG005|STARTED|Period Six (Part A)||5
6687199|NCT02703337|7617419|FG006|STARTED|Period Six (Part A)||0
6687200|NCT02703337|7617420|FG007|STARTED|Period Six (Part A)||0
6687201|NCT02703337|7617413|FG000|Received Study Drug|Period Six (Part A)||5
6687202|NCT02703337|7617414|FG001|Received Study Drug|Period Six (Part A)||5
6687203|NCT02703337|7617415|FG002|Received Study Drug|Period Six (Part A)||5
6687204|NCT02703337|7617416|FG003|Received Study Drug|Period Six (Part A)||5
6257298|NCT04725500|7156389|FG000|STARTED|Screening||42
6257299|NCT04725500|7156389|FG000|COMPLETED|Screening||15
6257300|NCT04725500|7156389|FG000|NOT COMPLETED|Screening||27
6257301|NCT04725500|7156389|FG000|STARTED|Overnight Polysomnography (PSG)||15
6257302|NCT04725500|7156389|FG000|COMPLETED|Overnight Polysomnography (PSG)||15
6257303|NCT04725500|7156389|FG000|NOT COMPLETED|Overnight Polysomnography (PSG)||0
6257304|NCT04725500|7156389|FG000|STARTED|2 Week Take Home||15
6257305|NCT04725500|7156389|FG000|COMPLETED|2 Week Take Home||10
6257306|NCT04725500|7156389|FG000|NOT COMPLETED|2 Week Take Home||5
6257313|NCT04716426|7156404|FG000|STARTED|Overall Study||50
6257314|NCT04716426|7156405|FG001|STARTED|Overall Study||50
6257315|NCT04716426|7156404|FG000|COMPLETED|Overall Study||48
6257316|NCT04716426|7156405|FG001|COMPLETED|Overall Study||49
6257317|NCT04716426|7156404|FG000|NOT COMPLETED|Overall Study||2
6257318|NCT04716426|7156405|FG001|NOT COMPLETED|Overall Study||1
6257319|NCT04709068|7156411|FG000|STARTED|Overall Study||8
6257320|NCT04709068|7156411|FG000|COMPLETED|Overall Study||8
6257321|NCT04709068|7156411|FG000|NOT COMPLETED|Overall Study||0
6257322|NCT04704713|7156417|FG000|STARTED|Overall Study||15
6257323|NCT04704713|7156418|FG001|STARTED|Overall Study||16
6257324|NCT04704713|7156417|FG000|COMPLETED|Overall Study||11
6257325|NCT04704713|7156418|FG001|COMPLETED|Overall Study||12
6257326|NCT04704713|7156417|FG000|NOT COMPLETED|Overall Study||4
6257327|NCT04704713|7156418|FG001|NOT COMPLETED|Overall Study||4
6257334|NCT04698993|7156437|FG000|STARTED|Overall Study||275
6257335|NCT04698993|7156438|FG001|STARTED|Overall Study||113
6257336|NCT04698993|7156437|FG000|COMPLETED|Overall Study||272
6257337|NCT04698993|7156438|FG001|COMPLETED|Overall Study||106
6257338|NCT04698993|7156437|FG000|NOT COMPLETED|Overall Study||3
6257339|NCT04698993|7156438|FG001|NOT COMPLETED|Overall Study||7
6257343|NCT04693078|7156448|FG000|STARTED|Overall Study||100
6257344|NCT04693078|7156448|FG000|COMPLETED|Overall Study||100
6257345|NCT04693078|7156448|FG000|NOT COMPLETED|Overall Study||0
6257346|NCT04688346|7156454|FG000|STARTED|Overall Study||6
6257347|NCT04688346|7156455|FG001|STARTED|Overall Study||7
6257348|NCT04688346|7156454|FG000|First Intervention|Overall Study||6
6257349|NCT04688346|7156455|FG001|First Intervention|Overall Study||7
6257350|NCT04688346|7156454|FG000|Second Intervention|Overall Study||6
6257351|NCT04688346|7156455|FG001|Second Intervention|Overall Study||7
6257352|NCT04688346|7156454|FG000|COMPLETED|Overall Study||6
6257353|NCT04688346|7156455|FG001|COMPLETED|Overall Study||7
6257354|NCT04688346|7156454|FG000|NOT COMPLETED|Overall Study||0
6257355|NCT04688346|7156455|FG001|NOT COMPLETED|Overall Study||0
6257359|NCT04674644|7156465|FG000|STARTED|Overall Study||850
6257360|NCT04674644|7156465|FG000|COMPLETED|Overall Study||813
6257361|NCT04674644|7156465|FG000|NOT COMPLETED|Overall Study||37
6257362|NCT04673214|7156472|FG000|STARTED|Overall Study||67
6257363|NCT04673214|7156473|FG001|STARTED|Overall Study||47
6257364|NCT04673214|7156472|FG000|Lost to Follow up|Overall Study|These patients were discontinued, given in the first days of their follow-up by video call, they presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; Following the protocol's follow-up criteria, patients were informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patients is searched, registering their death.|2
6257365|NCT04673214|7156473|FG001|Lost to Follow up|Overall Study|This patient was stopped being followed up in the first days of his follow-up by video call. He presented major symptoms such as dyspnea of movement, dyspnea at rest, and chest pain; With the follow-up criteria of the protocol, the patient was informed of their clinical care at the hospital level immediately, and the protocol was no longer followed. Subsequently, when capturing information in the data analysis, the clinical status of the patient is searched, registering death.|1
6257366|NCT04673214|7156472|FG000|COMPLETED|Overall Study||65
6257367|NCT04673214|7156473|FG001|COMPLETED|Overall Study||46
6257368|NCT04673214|7156472|FG000|NOT COMPLETED|Overall Study||2
6257369|NCT04673214|7156473|FG001|NOT COMPLETED|Overall Study||1
6257370|NCT04668989|7156483|FG000|STARTED|First Intervention||36
6257371|NCT04668989|7156484|FG001|STARTED|First Intervention||30
6257372|NCT04668989|7156483|FG000|COMPLETED|First Intervention||36
6257373|NCT04668989|7156484|FG001|COMPLETED|First Intervention||29
6257374|NCT04668989|7156483|FG000|NOT COMPLETED|First Intervention||0
6257375|NCT04668989|7156484|FG001|NOT COMPLETED|First Intervention||1
6257376|NCT04668989|7156483|FG000|STARTED|Second Intervention||36
6257377|NCT04668989|7156484|FG001|STARTED|Second Intervention||29
6257378|NCT04668989|7156483|FG000|COMPLETED|Second Intervention||36
6257379|NCT04668989|7156484|FG001|COMPLETED|Second Intervention||28
6687205|NCT02703337|7617417|FG004|Received Study Drug|Period Six (Part A)||4
6687206|NCT02703337|7617418|FG005|Received Study Drug|Period Six (Part A)||5
6687207|NCT02703337|7617419|FG006|Received Study Drug|Period Six (Part A)||0
6687208|NCT02703337|7617420|FG007|Received Study Drug|Period Six (Part A)||0
6687209|NCT02703337|7617413|FG000|COMPLETED|Period Six (Part A)||5
6687210|NCT02703337|7617414|FG001|COMPLETED|Period Six (Part A)||5
6687211|NCT02703337|7617415|FG002|COMPLETED|Period Six (Part A)||5
6687212|NCT02703337|7617416|FG003|COMPLETED|Period Six (Part A)||5
6687213|NCT02703337|7617417|FG004|COMPLETED|Period Six (Part A)||4
6687214|NCT02703337|7617418|FG005|COMPLETED|Period Six (Part A)||5
6687215|NCT02703337|7617419|FG006|COMPLETED|Period Six (Part A)||0
6687216|NCT02703337|7617420|FG007|COMPLETED|Period Six (Part A)||0
6687217|NCT02703337|7617413|FG000|NOT COMPLETED|Period Six (Part A)||0
6687218|NCT02703337|7617414|FG001|NOT COMPLETED|Period Six (Part A)||0
6687219|NCT02703337|7617415|FG002|NOT COMPLETED|Period Six (Part A)||0
6687220|NCT02703337|7617416|FG003|NOT COMPLETED|Period Six (Part A)||0
6687221|NCT02703337|7617417|FG004|NOT COMPLETED|Period Six (Part A)||0
6687222|NCT02703337|7617418|FG005|NOT COMPLETED|Period Six (Part A)||0
6687223|NCT02703337|7617419|FG006|NOT COMPLETED|Period Six (Part A)||0
6687224|NCT02703337|7617420|FG007|NOT COMPLETED|Period Six (Part A)||0
6687225|NCT02703337|7617413|FG000|STARTED|Part B||0
6687226|NCT02703337|7617414|FG001|STARTED|Part B||0
6687227|NCT02703337|7617415|FG002|STARTED|Part B||0
6687228|NCT02703337|7617416|FG003|STARTED|Part B||0
6687229|NCT02703337|7617417|FG004|STARTED|Part B||0
6687230|NCT02703337|7617418|FG005|STARTED|Part B||0
6687231|NCT02703337|7617419|FG006|STARTED|Part B||15
6687232|NCT02703337|7617420|FG007|STARTED|Part B||14
6687233|NCT02703337|7617413|FG000|Received Study Drug|Part B||0
6687234|NCT02703337|7617414|FG001|Received Study Drug|Part B||0
6687235|NCT02703337|7617415|FG002|Received Study Drug|Part B||0
6687236|NCT02703337|7617416|FG003|Received Study Drug|Part B||0
6687237|NCT02703337|7617417|FG004|Received Study Drug|Part B||0
6687238|NCT02703337|7617418|FG005|Received Study Drug|Part B||0
6687239|NCT02703337|7617419|FG006|Received Study Drug|Part B||15
6687240|NCT02703337|7617420|FG007|Received Study Drug|Part B||14
6687241|NCT02703337|7617413|FG000|COMPLETED|Part B||0
6687242|NCT02703337|7617414|FG001|COMPLETED|Part B||0
6687243|NCT02703337|7617415|FG002|COMPLETED|Part B||0
6687244|NCT02703337|7617416|FG003|COMPLETED|Part B||0
6687245|NCT02703337|7617417|FG004|COMPLETED|Part B||0
6687246|NCT02703337|7617418|FG005|COMPLETED|Part B||0
6687247|NCT02703337|7617419|FG006|COMPLETED|Part B||15
6687248|NCT02703337|7617420|FG007|COMPLETED|Part B||14
6687249|NCT02703337|7617413|FG000|NOT COMPLETED|Part B||0
6687250|NCT02703337|7617414|FG001|NOT COMPLETED|Part B||0
6687251|NCT02703337|7617415|FG002|NOT COMPLETED|Part B||0
6687252|NCT02703337|7617416|FG003|NOT COMPLETED|Part B||0
6687253|NCT02703337|7617417|FG004|NOT COMPLETED|Part B||0
6687254|NCT02703337|7617418|FG005|NOT COMPLETED|Part B||0
6687255|NCT02703337|7617419|FG006|NOT COMPLETED|Part B||0
6687256|NCT02703337|7617420|FG007|NOT COMPLETED|Part B||0
6687257|NCT02703350|7617438|FG000|STARTED|Period One (Part A)||5
6687258|NCT02703350|7617439|FG001|STARTED|Period One (Part A)||5
6687259|NCT02703350|7617440|FG002|STARTED|Period One (Part A)||5
6687260|NCT02703350|7617441|FG003|STARTED|Period One (Part A)||5
6687261|NCT02703350|7617442|FG004|STARTED|Period One (Part A)||5
6687262|NCT02703350|7617443|FG005|STARTED|Period One (Part A)||5
6687263|NCT02703350|7617444|FG006|STARTED|Period One (Part A)||0
6687264|NCT02703350|7617445|FG007|STARTED|Period One (Part A)||0
6687265|NCT02703350|7617438|FG000|Received Study Drug|Period One (Part A)||5
6687266|NCT02703350|7617439|FG001|Received Study Drug|Period One (Part A)||5
6687267|NCT02703350|7617440|FG002|Received Study Drug|Period One (Part A)||5
6687268|NCT02703350|7617441|FG003|Received Study Drug|Period One (Part A)||5
6687269|NCT02703350|7617442|FG004|Received Study Drug|Period One (Part A)||5
6687270|NCT02703350|7617443|FG005|Received Study Drug|Period One (Part A)||5
6687271|NCT02703350|7617444|FG006|Received Study Drug|Period One (Part A)||0
6687272|NCT02703350|7617445|FG007|Received Study Drug|Period One (Part A)||0
6687273|NCT02703350|7617438|FG000|COMPLETED|Period One (Part A)||5
6687274|NCT02703350|7617439|FG001|COMPLETED|Period One (Part A)||5
6687275|NCT02703350|7617440|FG002|COMPLETED|Period One (Part A)||5
6687276|NCT02703350|7617441|FG003|COMPLETED|Period One (Part A)||5
6687277|NCT02703350|7617442|FG004|COMPLETED|Period One (Part A)||5
6687278|NCT02703350|7617443|FG005|COMPLETED|Period One (Part A)||5
6687279|NCT02703350|7617444|FG006|COMPLETED|Period One (Part A)||0
6687280|NCT02703350|7617445|FG007|COMPLETED|Period One (Part A)||0
6687281|NCT02703350|7617438|FG000|NOT COMPLETED|Period One (Part A)||0
6687282|NCT02703350|7617439|FG001|NOT COMPLETED|Period One (Part A)||0
6687283|NCT02703350|7617440|FG002|NOT COMPLETED|Period One (Part A)||0
6687284|NCT02703350|7617441|FG003|NOT COMPLETED|Period One (Part A)||0
6687285|NCT02703350|7617442|FG004|NOT COMPLETED|Period One (Part A)||0
6687286|NCT02703350|7617443|FG005|NOT COMPLETED|Period One (Part A)||0
6687287|NCT02703350|7617444|FG006|NOT COMPLETED|Period One (Part A)||0
6687288|NCT02703350|7617445|FG007|NOT COMPLETED|Period One (Part A)||0
6687289|NCT02703350|7617438|FG000|STARTED|Period Two (Part A)||5
6687290|NCT02703350|7617439|FG001|STARTED|Period Two (Part A)||5
6687291|NCT02703350|7617440|FG002|STARTED|Period Two (Part A)||5
6687292|NCT02703350|7617441|FG003|STARTED|Period Two (Part A)||5
6687293|NCT02703350|7617442|FG004|STARTED|Period Two (Part A)||5
6687294|NCT02703350|7617443|FG005|STARTED|Period Two (Part A)||5
6687295|NCT02703350|7617444|FG006|STARTED|Period Two (Part A)||0
6687296|NCT02703350|7617445|FG007|STARTED|Period Two (Part A)||0
6687297|NCT02703350|7617438|FG000|Received Study Drug|Period Two (Part A)||5
6687298|NCT02703350|7617439|FG001|Received Study Drug|Period Two (Part A)||5
6687299|NCT02703350|7617440|FG002|Received Study Drug|Period Two (Part A)||5
6687300|NCT02703350|7617441|FG003|Received Study Drug|Period Two (Part A)||5
6687301|NCT02703350|7617442|FG004|Received Study Drug|Period Two (Part A)||5
6687302|NCT02703350|7617443|FG005|Received Study Drug|Period Two (Part A)||5
6687303|NCT02703350|7617444|FG006|Received Study Drug|Period Two (Part A)||0
6687304|NCT02703350|7617445|FG007|Received Study Drug|Period Two (Part A)||0
6687305|NCT02703350|7617438|FG000|COMPLETED|Period Two (Part A)||5
6687306|NCT02703350|7617439|FG001|COMPLETED|Period Two (Part A)||5
6687307|NCT02703350|7617440|FG002|COMPLETED|Period Two (Part A)||5
6687308|NCT02703350|7617441|FG003|COMPLETED|Period Two (Part A)||5
6687309|NCT02703350|7617442|FG004|COMPLETED|Period Two (Part A)||5
6687310|NCT02703350|7617443|FG005|COMPLETED|Period Two (Part A)||5
6687311|NCT02703350|7617444|FG006|COMPLETED|Period Two (Part A)||0
6687312|NCT02703350|7617445|FG007|COMPLETED|Period Two (Part A)||0
6687313|NCT02703350|7617438|FG000|NOT COMPLETED|Period Two (Part A)||0
6687314|NCT02703350|7617439|FG001|NOT COMPLETED|Period Two (Part A)||0
6687315|NCT02703350|7617440|FG002|NOT COMPLETED|Period Two (Part A)||0
6687316|NCT02703350|7617441|FG003|NOT COMPLETED|Period Two (Part A)||0
6687317|NCT02703350|7617442|FG004|NOT COMPLETED|Period Two (Part A)||0
6687318|NCT02703350|7617443|FG005|NOT COMPLETED|Period Two (Part A)||0
6687319|NCT02703350|7617444|FG006|NOT COMPLETED|Period Two (Part A)||0
6687320|NCT02703350|7617445|FG007|NOT COMPLETED|Period Two (Part A)||0
6687321|NCT02703350|7617438|FG000|STARTED|Period Three (Part A)||5
6687322|NCT02703350|7617439|FG001|STARTED|Period Three (Part A)||5
6687323|NCT02703350|7617440|FG002|STARTED|Period Three (Part A)||5
6687324|NCT02703350|7617441|FG003|STARTED|Period Three (Part A)||5
6687325|NCT02703350|7617442|FG004|STARTED|Period Three (Part A)||5
6687326|NCT02703350|7617443|FG005|STARTED|Period Three (Part A)||5
6687327|NCT02703350|7617444|FG006|STARTED|Period Three (Part A)||0
6687328|NCT02703350|7617445|FG007|STARTED|Period Three (Part A)||0
6687329|NCT02703350|7617438|FG000|Received Study Drug|Period Three (Part A)||5
6687330|NCT02703350|7617439|FG001|Received Study Drug|Period Three (Part A)||5
6687331|NCT02703350|7617440|FG002|Received Study Drug|Period Three (Part A)||5
6687332|NCT02703350|7617441|FG003|Received Study Drug|Period Three (Part A)||5
6687333|NCT02703350|7617442|FG004|Received Study Drug|Period Three (Part A)||5
6687334|NCT02703350|7617443|FG005|Received Study Drug|Period Three (Part A)||5
6687335|NCT02703350|7617444|FG006|Received Study Drug|Period Three (Part A)||0
6687336|NCT02703350|7617445|FG007|Received Study Drug|Period Three (Part A)||0
6687337|NCT02703350|7617438|FG000|COMPLETED|Period Three (Part A)||5
6687338|NCT02703350|7617439|FG001|COMPLETED|Period Three (Part A)||5
6687339|NCT02703350|7617440|FG002|COMPLETED|Period Three (Part A)||5
6687340|NCT02703350|7617441|FG003|COMPLETED|Period Three (Part A)||5
6687341|NCT02703350|7617442|FG004|COMPLETED|Period Three (Part A)||5
6687342|NCT02703350|7617443|FG005|COMPLETED|Period Three (Part A)||5
6687343|NCT02703350|7617444|FG006|COMPLETED|Period Three (Part A)||0
6687344|NCT02703350|7617445|FG007|COMPLETED|Period Three (Part A)||0
6687345|NCT02703350|7617438|FG000|NOT COMPLETED|Period Three (Part A)||0
6687346|NCT02703350|7617439|FG001|NOT COMPLETED|Period Three (Part A)||0
6687347|NCT02703350|7617440|FG002|NOT COMPLETED|Period Three (Part A)||0
6687348|NCT02703350|7617441|FG003|NOT COMPLETED|Period Three (Part A)||0
6687349|NCT02703350|7617442|FG004|NOT COMPLETED|Period Three (Part A)||0
6687350|NCT02703350|7617443|FG005|NOT COMPLETED|Period Three (Part A)||0
6687351|NCT02703350|7617444|FG006|NOT COMPLETED|Period Three (Part A)||0
6687352|NCT02703350|7617445|FG007|NOT COMPLETED|Period Three (Part A)||0
6687353|NCT02703350|7617438|FG000|STARTED|Period Four (Part A)||5
6687354|NCT02703350|7617439|FG001|STARTED|Period Four (Part A)||5
6687355|NCT02703350|7617440|FG002|STARTED|Period Four (Part A)||5
6687356|NCT02703350|7617441|FG003|STARTED|Period Four (Part A)||5
6687357|NCT02703350|7617442|FG004|STARTED|Period Four (Part A)||5
6687358|NCT02703350|7617443|FG005|STARTED|Period Four (Part A)||5
6687359|NCT02703350|7617444|FG006|STARTED|Period Four (Part A)||0
6687360|NCT02703350|7617445|FG007|STARTED|Period Four (Part A)||0
6687361|NCT02703350|7617438|FG000|Received Study Drug|Period Four (Part A)||5
6687362|NCT02703350|7617439|FG001|Received Study Drug|Period Four (Part A)||5
6687363|NCT02703350|7617440|FG002|Received Study Drug|Period Four (Part A)||5
6687364|NCT02703350|7617441|FG003|Received Study Drug|Period Four (Part A)||5
6687365|NCT02703350|7617442|FG004|Received Study Drug|Period Four (Part A)||5
6687366|NCT02703350|7617443|FG005|Received Study Drug|Period Four (Part A)||5
6687367|NCT02703350|7617444|FG006|Received Study Drug|Period Four (Part A)||0
6687368|NCT02703350|7617445|FG007|Received Study Drug|Period Four (Part A)||0
6687369|NCT02703350|7617438|FG000|COMPLETED|Period Four (Part A)||5
6687370|NCT02703350|7617439|FG001|COMPLETED|Period Four (Part A)||5
6687371|NCT02703350|7617440|FG002|COMPLETED|Period Four (Part A)||5
6687372|NCT02703350|7617441|FG003|COMPLETED|Period Four (Part A)||5
6687373|NCT02703350|7617442|FG004|COMPLETED|Period Four (Part A)||5
6687374|NCT02703350|7617443|FG005|COMPLETED|Period Four (Part A)||5
6687375|NCT02703350|7617444|FG006|COMPLETED|Period Four (Part A)||0
6687376|NCT02703350|7617445|FG007|COMPLETED|Period Four (Part A)||0
6687377|NCT02703350|7617438|FG000|NOT COMPLETED|Period Four (Part A)||0
6687378|NCT02703350|7617439|FG001|NOT COMPLETED|Period Four (Part A)||0
6687379|NCT02703350|7617440|FG002|NOT COMPLETED|Period Four (Part A)||0
6687380|NCT02703350|7617441|FG003|NOT COMPLETED|Period Four (Part A)||0
6687381|NCT02703350|7617442|FG004|NOT COMPLETED|Period Four (Part A)||0
6687382|NCT02703350|7617443|FG005|NOT COMPLETED|Period Four (Part A)||0
6687383|NCT02703350|7617444|FG006|NOT COMPLETED|Period Four (Part A)||0
6687384|NCT02703350|7617445|FG007|NOT COMPLETED|Period Four (Part A)||0
6687385|NCT02703350|7617438|FG000|STARTED|Period Five (Part A)||5
6687386|NCT02703350|7617439|FG001|STARTED|Period Five (Part A)||5
6687387|NCT02703350|7617440|FG002|STARTED|Period Five (Part A)||5
6687388|NCT02703350|7617441|FG003|STARTED|Period Five (Part A)||5
6687389|NCT02703350|7617442|FG004|STARTED|Period Five (Part A)||5
6687390|NCT02703350|7617443|FG005|STARTED|Period Five (Part A)||5
6687391|NCT02703350|7617444|FG006|STARTED|Period Five (Part A)||0
6687392|NCT02703350|7617445|FG007|STARTED|Period Five (Part A)||0
6687393|NCT02703350|7617438|FG000|Received Study Drug|Period Five (Part A)||5
6257307|NCT04724538|7156395|FG000|STARTED|Overall Study||11
6257308|NCT04724538|7156396|FG001|STARTED|Overall Study||14
6257309|NCT04724538|7156395|FG000|COMPLETED|Overall Study||11
6257310|NCT04724538|7156396|FG001|COMPLETED|Overall Study||14
6257311|NCT04724538|7156395|FG000|NOT COMPLETED|Overall Study||0
6257312|NCT04724538|7156396|FG001|NOT COMPLETED|Overall Study||0
6257328|NCT04701814|7156426|FG000|STARTED|Overall Study||20
6257329|NCT04701814|7156427|FG001|STARTED|Overall Study||18
6257330|NCT04701814|7156426|FG000|COMPLETED|Overall Study||15
6257331|NCT04701814|7156427|FG001|COMPLETED|Overall Study||15
6257332|NCT04701814|7156426|FG000|NOT COMPLETED|Overall Study||5
6257333|NCT04701814|7156427|FG001|NOT COMPLETED|Overall Study||3
6257340|NCT04697888|7156444|FG000|STARTED|Overall Study||2
6257341|NCT04697888|7156444|FG000|COMPLETED|Overall Study||2
6257342|NCT04697888|7156444|FG000|NOT COMPLETED|Overall Study||0
6257356|NCT04684992|7156461|FG000|STARTED|Overall Study||36
6257357|NCT04684992|7156461|FG000|COMPLETED|Overall Study||34
6257358|NCT04684992|7156461|FG000|NOT COMPLETED|Overall Study||2
6257380|NCT04668989|7156483|FG000|NOT COMPLETED|Second Intervention||0
6257381|NCT04668989|7156484|FG001|NOT COMPLETED|Second Intervention||1
6279670|NCT00147498|7179537|FG001|NOT COMPLETED|Overall Study||9
6279671|NCT00147498|7179538|FG002|NOT COMPLETED|Overall Study||17
6279672|NCT00147498|7179539|FG003|NOT COMPLETED|Overall Study||17
6279673|NCT00147537|7179553|FG000|STARTED|Phase 1b||3
6279674|NCT00147537|7179554|FG001|STARTED|Phase 1b||2
6279675|NCT00147537|7179555|FG002|STARTED|Phase 1b||4
6279676|NCT00147537|7179556|FG003|STARTED|Phase 1b||3
6279677|NCT00147537|7179557|FG004|STARTED|Phase 1b||3
6279678|NCT00147537|7179558|FG005|STARTED|Phase 1b||3
6279679|NCT00147537|7179559|FG006|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
6279680|NCT00147537|7179560|FG007|STARTED|Phase 1b||7
6279681|NCT00147537|7179561|FG008|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
6279682|NCT00147537|7179562|FG009|STARTED|Phase 1b||0
6279683|NCT00147537|7179563|FG010|STARTED|Phase 1b||0
6279684|NCT00147537|7179553|FG000|COMPLETED|Phase 1b||1
6279685|NCT00147537|7179554|FG001|COMPLETED|Phase 1b||0
6279686|NCT00147537|7179555|FG002|COMPLETED|Phase 1b||0
6279687|NCT00147537|7179556|FG003|COMPLETED|Phase 1b||1
6279688|NCT00147537|7179557|FG004|COMPLETED|Phase 1b||0
6279689|NCT00147537|7179558|FG005|COMPLETED|Phase 1b||0
6279690|NCT00147537|7179559|FG006|COMPLETED|Phase 1b||0
6279691|NCT00147537|7179560|FG007|COMPLETED|Phase 1b||0
6279692|NCT00147537|7179561|FG008|COMPLETED|Phase 1b||1
6279693|NCT00147537|7179562|FG009|COMPLETED|Phase 1b||0
6279694|NCT00147537|7179563|FG010|COMPLETED|Phase 1b||0
6279695|NCT00147537|7179553|FG000|NOT COMPLETED|Phase 1b||2
6279696|NCT00147537|7179554|FG001|NOT COMPLETED|Phase 1b||2
6279697|NCT00147537|7179555|FG002|NOT COMPLETED|Phase 1b||4
6279698|NCT00147537|7179556|FG003|NOT COMPLETED|Phase 1b||2
6279699|NCT00147537|7179557|FG004|NOT COMPLETED|Phase 1b||3
6279700|NCT00147537|7179558|FG005|NOT COMPLETED|Phase 1b||3
6279701|NCT00147537|7179559|FG006|NOT COMPLETED|Phase 1b||18
6279702|NCT00147537|7179560|FG007|NOT COMPLETED|Phase 1b||7
6279703|NCT00147537|7179561|FG008|NOT COMPLETED|Phase 1b||17
6279704|NCT00147537|7179562|FG009|NOT COMPLETED|Phase 1b||0
6279705|NCT00147537|7179563|FG010|NOT COMPLETED|Phase 1b||0
6279706|NCT00147537|7179553|FG000|STARTED|Phase 2||0
6279707|NCT00147537|7179554|FG001|STARTED|Phase 2||0
6279708|NCT00147537|7179555|FG002|STARTED|Phase 2||0
6279709|NCT00147537|7179556|FG003|STARTED|Phase 2||0
6279710|NCT00147537|7179557|FG004|STARTED|Phase 2||0
6279711|NCT00147537|7179558|FG005|STARTED|Phase 2||0
6279712|NCT00147537|7179559|FG006|STARTED|Phase 2||0
6279713|NCT00147537|7179560|FG007|STARTED|Phase 2||0
6279714|NCT00147537|7179561|FG008|STARTED|Phase 2||0
6279715|NCT00147537|7179562|FG009|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
6279716|NCT00147537|7179563|FG010|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
6279717|NCT00147537|7179553|FG000|COMPLETED|Phase 2||0
6279718|NCT00147537|7179554|FG001|COMPLETED|Phase 2||0
6279719|NCT00147537|7179555|FG002|COMPLETED|Phase 2||0
6279720|NCT00147537|7179556|FG003|COMPLETED|Phase 2||0
6279721|NCT00147537|7179557|FG004|COMPLETED|Phase 2||0
6279722|NCT00147537|7179558|FG005|COMPLETED|Phase 2||0
6279723|NCT00147537|7179559|FG006|COMPLETED|Phase 2||0
6279724|NCT00147537|7179560|FG007|COMPLETED|Phase 2||0
6279725|NCT00147537|7179561|FG008|COMPLETED|Phase 2||0
6279726|NCT00147537|7179562|FG009|COMPLETED|Phase 2||5
6279727|NCT00147537|7179563|FG010|COMPLETED|Phase 2||3
6279728|NCT00147537|7179553|FG000|NOT COMPLETED|Phase 2||0
6279729|NCT00147537|7179554|FG001|NOT COMPLETED|Phase 2||0
6279730|NCT00147537|7179555|FG002|NOT COMPLETED|Phase 2||0
6687394|NCT02703350|7617439|FG001|Received Study Drug|Period Five (Part A)||5
6687395|NCT02703350|7617440|FG002|Received Study Drug|Period Five (Part A)||5
6687396|NCT02703350|7617441|FG003|Received Study Drug|Period Five (Part A)||5
6687397|NCT02703350|7617442|FG004|Received Study Drug|Period Five (Part A)||5
6687398|NCT02703350|7617443|FG005|Received Study Drug|Period Five (Part A)||5
6687399|NCT02703350|7617444|FG006|Received Study Drug|Period Five (Part A)||0
6687400|NCT02703350|7617445|FG007|Received Study Drug|Period Five (Part A)||0
6687401|NCT02703350|7617438|FG000|COMPLETED|Period Five (Part A)||5
6687402|NCT02703350|7617439|FG001|COMPLETED|Period Five (Part A)||5
6687403|NCT02703350|7617440|FG002|COMPLETED|Period Five (Part A)||5
6687404|NCT02703350|7617441|FG003|COMPLETED|Period Five (Part A)||5
6687405|NCT02703350|7617442|FG004|COMPLETED|Period Five (Part A)||5
6687406|NCT02703350|7617443|FG005|COMPLETED|Period Five (Part A)||5
6687407|NCT02703350|7617444|FG006|COMPLETED|Period Five (Part A)||0
6687408|NCT02703350|7617445|FG007|COMPLETED|Period Five (Part A)||0
6687409|NCT02703350|7617438|FG000|NOT COMPLETED|Period Five (Part A)||0
6687410|NCT02703350|7617439|FG001|NOT COMPLETED|Period Five (Part A)||0
6687411|NCT02703350|7617440|FG002|NOT COMPLETED|Period Five (Part A)||0
6687412|NCT02703350|7617441|FG003|NOT COMPLETED|Period Five (Part A)||0
6687413|NCT02703350|7617442|FG004|NOT COMPLETED|Period Five (Part A)||0
6687414|NCT02703350|7617443|FG005|NOT COMPLETED|Period Five (Part A)||0
6687415|NCT02703350|7617444|FG006|NOT COMPLETED|Period Five (Part A)||0
6687416|NCT02703350|7617445|FG007|NOT COMPLETED|Period Five (Part A)||0
6687417|NCT02703350|7617438|FG000|STARTED|Period Six (Part A)||5
6687418|NCT02703350|7617439|FG001|STARTED|Period Six (Part A)||5
6687419|NCT02703350|7617440|FG002|STARTED|Period Six (Part A)||5
6687420|NCT02703350|7617441|FG003|STARTED|Period Six (Part A)||5
6687421|NCT02703350|7617442|FG004|STARTED|Period Six (Part A)||5
6687422|NCT02703350|7617443|FG005|STARTED|Period Six (Part A)||5
6687423|NCT02703350|7617444|FG006|STARTED|Period Six (Part A)||0
6687424|NCT02703350|7617445|FG007|STARTED|Period Six (Part A)||0
6687425|NCT02703350|7617438|FG000|Received Study Drug|Period Six (Part A)||5
6687426|NCT02703350|7617439|FG001|Received Study Drug|Period Six (Part A)||5
6687427|NCT02703350|7617440|FG002|Received Study Drug|Period Six (Part A)||5
6687428|NCT02703350|7617441|FG003|Received Study Drug|Period Six (Part A)||5
6687429|NCT02703350|7617442|FG004|Received Study Drug|Period Six (Part A)||5
6687430|NCT02703350|7617443|FG005|Received Study Drug|Period Six (Part A)||5
6687431|NCT02703350|7617444|FG006|Received Study Drug|Period Six (Part A)||0
6687432|NCT02703350|7617445|FG007|Received Study Drug|Period Six (Part A)||0
6687433|NCT02703350|7617438|FG000|COMPLETED|Period Six (Part A)||5
6687434|NCT02703350|7617439|FG001|COMPLETED|Period Six (Part A)||5
6687435|NCT02703350|7617440|FG002|COMPLETED|Period Six (Part A)||5
6687436|NCT02703350|7617441|FG003|COMPLETED|Period Six (Part A)||5
6687437|NCT02703350|7617442|FG004|COMPLETED|Period Six (Part A)||5
6687438|NCT02703350|7617443|FG005|COMPLETED|Period Six (Part A)||5
6687439|NCT02703350|7617444|FG006|COMPLETED|Period Six (Part A)||0
6687440|NCT02703350|7617445|FG007|COMPLETED|Period Six (Part A)||0
6687441|NCT02703350|7617438|FG000|NOT COMPLETED|Period Six (Part A)||0
6687442|NCT02703350|7617439|FG001|NOT COMPLETED|Period Six (Part A)||0
6687443|NCT02703350|7617440|FG002|NOT COMPLETED|Period Six (Part A)||0
6687444|NCT02703350|7617441|FG003|NOT COMPLETED|Period Six (Part A)||0
6687445|NCT02703350|7617442|FG004|NOT COMPLETED|Period Six (Part A)||0
6687446|NCT02703350|7617443|FG005|NOT COMPLETED|Period Six (Part A)||0
6687447|NCT02703350|7617444|FG006|NOT COMPLETED|Period Six (Part A)||0
6687448|NCT02703350|7617445|FG007|NOT COMPLETED|Period Six (Part A)||0
6687449|NCT02703350|7617438|FG000|STARTED|Part B||0
6687450|NCT02703350|7617439|FG001|STARTED|Part B||0
6687451|NCT02703350|7617440|FG002|STARTED|Part B||0
6687452|NCT02703350|7617441|FG003|STARTED|Part B||0
6687453|NCT02703350|7617442|FG004|STARTED|Part B||0
6687454|NCT02703350|7617443|FG005|STARTED|Part B||0
6687455|NCT02703350|7617444|FG006|STARTED|Part B||15
6687456|NCT02703350|7617445|FG007|STARTED|Part B||15
6687457|NCT02703350|7617438|FG000|Received Study Drug|Part B||0
6687458|NCT02703350|7617439|FG001|Received Study Drug|Part B||0
6687459|NCT02703350|7617440|FG002|Received Study Drug|Part B||0
6687460|NCT02703350|7617441|FG003|Received Study Drug|Part B||0
6687461|NCT02703350|7617442|FG004|Received Study Drug|Part B||0
6257382|NCT04668352|7156492|FG000|STARTED|Overall Study||511
6257383|NCT04668352|7156493|FG001|STARTED|Overall Study||513
6257384|NCT04668352|7156492|FG000|COMPLETED|Overall Study||510
6257385|NCT04668352|7156493|FG001|COMPLETED|Overall Study||511
6257386|NCT04668352|7156492|FG000|NOT COMPLETED|Overall Study||1
6257387|NCT04668352|7156493|FG001|NOT COMPLETED|Overall Study||2
6279731|NCT00147537|7179556|FG003|NOT COMPLETED|Phase 2||0
6279732|NCT00147537|7179557|FG004|NOT COMPLETED|Phase 2||0
6279733|NCT00147537|7179558|FG005|NOT COMPLETED|Phase 2||0
6279734|NCT00147537|7179559|FG006|NOT COMPLETED|Phase 2||0
6687462|NCT02703350|7617443|FG005|Received Study Drug|Part B||0
6687463|NCT02703350|7617444|FG006|Received Study Drug|Part B||15
6687464|NCT02703350|7617445|FG007|Received Study Drug|Part B||15
6687465|NCT02703350|7617438|FG000|COMPLETED|Part B||0
6687466|NCT02703350|7617439|FG001|COMPLETED|Part B||0
6687467|NCT02703350|7617440|FG002|COMPLETED|Part B||0
6687468|NCT02703350|7617441|FG003|COMPLETED|Part B||0
6279735|NCT00147537|7179560|FG007|NOT COMPLETED|Phase 2||0
6279736|NCT00147537|7179561|FG008|NOT COMPLETED|Phase 2||0
6279737|NCT00147537|7179562|FG009|NOT COMPLETED|Phase 2||161
6279738|NCT00147537|7179563|FG010|NOT COMPLETED|Phase 2||52
6687469|NCT02703350|7617442|FG004|COMPLETED|Part B||0
6687470|NCT02703350|7617443|FG005|COMPLETED|Part B||0
6687471|NCT02703350|7617444|FG006|COMPLETED|Part B||15
6687472|NCT02703350|7617445|FG007|COMPLETED|Part B||15
6687473|NCT02703350|7617438|FG000|NOT COMPLETED|Part B||0
6687474|NCT02703350|7617439|FG001|NOT COMPLETED|Part B||0
6687475|NCT02703350|7617440|FG002|NOT COMPLETED|Part B||0
6687476|NCT02703350|7617441|FG003|NOT COMPLETED|Part B||0
6687477|NCT02703350|7617442|FG004|NOT COMPLETED|Part B||0
6687478|NCT02703350|7617443|FG005|NOT COMPLETED|Part B||0
6687479|NCT02703350|7617444|FG006|NOT COMPLETED|Part B||0
6687480|NCT02703350|7617445|FG007|NOT COMPLETED|Part B||0
6687481|NCT02703454|7617465|FG000|STARTED|Overall Study||24
6687482|NCT02703454|7617466|FG001|STARTED|Overall Study||27
6687483|NCT02703454|7617465|FG000|Treated|Overall Study||23
6687484|NCT02703454|7617466|FG001|Treated|Overall Study||24
6687485|NCT02703454|7617465|FG000|COMPLETED|Overall Study||13
6687486|NCT02703454|7617466|FG001|COMPLETED|Overall Study||11
6687487|NCT02703454|7617465|FG000|NOT COMPLETED|Overall Study||11
6687488|NCT02703454|7617466|FG001|NOT COMPLETED|Overall Study||16
6687489|NCT02703467|7617475|FG000|STARTED|Overall Study||20
6687490|NCT02703467|7617476|FG001|STARTED|Overall Study||5
6687491|NCT02703467|7617477|FG002|STARTED|Overall Study||45
6687492|NCT02703467|7617475|FG000|COMPLETED|Overall Study||20
6687493|NCT02703467|7617476|FG001|COMPLETED|Overall Study||5
6687494|NCT02703467|7617477|FG002|COMPLETED|Overall Study||45
6687495|NCT02703467|7617475|FG000|NOT COMPLETED|Overall Study||0
6687496|NCT02703467|7617476|FG001|NOT COMPLETED|Overall Study||0
6687497|NCT02703467|7617477|FG002|NOT COMPLETED|Overall Study||0
6687498|NCT02703532|7617493|FG000|STARTED|Overall Study||21
6687499|NCT02703532|7617494|FG001|STARTED|Overall Study||11
6687500|NCT02703532|7617495|FG002|STARTED|Overall Study||21
6687501|NCT02703532|7617496|FG003|STARTED|Overall Study||11
6687502|NCT02703532|7617493|FG000|COMPLETED|Overall Study||19
6687503|NCT02703532|7617494|FG001|COMPLETED|Overall Study||10
6687504|NCT02703532|7617495|FG002|COMPLETED|Overall Study||19
6687505|NCT02703532|7617496|FG003|COMPLETED|Overall Study||10
6687506|NCT02703532|7617493|FG000|NOT COMPLETED|Overall Study||2
6687507|NCT02703532|7617494|FG001|NOT COMPLETED|Overall Study||1
6687508|NCT02703532|7617495|FG002|NOT COMPLETED|Overall Study||2
6687509|NCT02703532|7617496|FG003|NOT COMPLETED|Overall Study||1
6687510|NCT02703636|7617506|FG000|STARTED|Overall Study||118
6687511|NCT02703636|7617506|FG000|COMPLETED|Overall Study||102
6687512|NCT02703636|7617506|FG000|NOT COMPLETED|Overall Study||16
6687513|NCT02703779|7617512|FG000|STARTED|Overall Study||51
6687514|NCT02703779|7617513|FG001|STARTED|Overall Study||50
6687515|NCT02703779|7617512|FG000|COMPLETED|Overall Study||51
6687516|NCT02703779|7617513|FG001|COMPLETED|Overall Study||50
6687517|NCT02703779|7617512|FG000|NOT COMPLETED|Overall Study||0
6687518|NCT02703779|7617513|FG001|NOT COMPLETED|Overall Study||0
6687519|NCT02703909|7617523|FG000|STARTED|Overall Study||36
6687520|NCT02703909|7617524|FG001|STARTED|Overall Study||37
6687521|NCT02703909|7617525|FG002|STARTED|Overall Study||36
6687522|NCT02703909|7617526|FG003|STARTED|Overall Study||35
6687523|NCT02703909|7617523|FG000|COMPLETED|Overall Study||36
6687524|NCT02703909|7617524|FG001|COMPLETED|Overall Study||37
6687525|NCT02703909|7617525|FG002|COMPLETED|Overall Study||36
6687526|NCT02703909|7617526|FG003|COMPLETED|Overall Study||35
6687527|NCT02703909|7617523|FG000|NOT COMPLETED|Overall Study||0
6687528|NCT02703909|7617524|FG001|NOT COMPLETED|Overall Study||0
6687529|NCT02703909|7617525|FG002|NOT COMPLETED|Overall Study||0
6687530|NCT02703909|7617526|FG003|NOT COMPLETED|Overall Study||0
6687531|NCT02703948|7617538|FG000|STARTED|Overall Study||60
6687532|NCT02703948|7617538|FG000|COMPLETED|Overall Study||57
6687533|NCT02703948|7617538|FG000|NOT COMPLETED|Overall Study||3
6687534|NCT02703987|7617544|FG000|STARTED|Visit 3 Intervention (1 Day)||14
6687535|NCT02703987|7617545|FG001|STARTED|Visit 3 Intervention (1 Day)||14
6687536|NCT02703987|7617544|FG000|COMPLETED|Visit 3 Intervention (1 Day)||13
6687537|NCT02703987|7617545|FG001|COMPLETED|Visit 3 Intervention (1 Day)||11
6687538|NCT02703987|7617544|FG000|NOT COMPLETED|Visit 3 Intervention (1 Day)||1
6687539|NCT02703987|7617545|FG001|NOT COMPLETED|Visit 3 Intervention (1 Day)||3
6687540|NCT02703987|7617544|FG000|STARTED|Washout (Minimum 5 Days)||13
6687541|NCT02703987|7617545|FG001|STARTED|Washout (Minimum 5 Days)||11
6687542|NCT02703987|7617544|FG000|COMPLETED|Washout (Minimum 5 Days)||13
6687543|NCT02703987|7617545|FG001|COMPLETED|Washout (Minimum 5 Days)||11
6687544|NCT02703987|7617544|FG000|NOT COMPLETED|Washout (Minimum 5 Days)||0
6687545|NCT02703987|7617545|FG001|NOT COMPLETED|Washout (Minimum 5 Days)||0
6687546|NCT02703987|7617544|FG000|STARTED|Visit 4 Intervention (1 Day)||13
6687547|NCT02703987|7617545|FG001|STARTED|Visit 4 Intervention (1 Day)||11
6687548|NCT02703987|7617544|FG000|COMPLETED|Visit 4 Intervention (1 Day)||12
6687549|NCT02703987|7617545|FG001|COMPLETED|Visit 4 Intervention (1 Day)||10
6687550|NCT02703987|7617544|FG000|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
6687551|NCT02703987|7617545|FG001|NOT COMPLETED|Visit 4 Intervention (1 Day)||1
6687552|NCT02704091|7617553|FG000|STARTED|Overall Study||430
6687553|NCT02704091|7617554|FG001|STARTED|Overall Study||423
6687554|NCT02704091|7617553|FG000|COMPLETED|Overall Study||402
6687555|NCT02704091|7617554|FG001|COMPLETED|Overall Study||400
6687556|NCT02704091|7617553|FG000|NOT COMPLETED|Overall Study||28
6687557|NCT02704091|7617554|FG001|NOT COMPLETED|Overall Study||23
6687558|NCT02704104|7617560|FG000|STARTED|Overall Study||46
6687559|NCT02704104|7617560|FG000|COMPLETED|Overall Study||46
6687560|NCT02704104|7617560|FG000|NOT COMPLETED|Overall Study||0
6687561|NCT02704143|7617568|FG000|STARTED|Overall Study||63
6687562|NCT02704143|7617568|FG000|COMPLETED|Overall Study||53
6687563|NCT02704143|7617568|FG000|NOT COMPLETED|Overall Study||10
6687564|NCT02704156|7617574|FG000|STARTED|Overall Study||85
6687565|NCT02704156|7617575|FG001|STARTED|Overall Study||85
6687566|NCT02704156|7617574|FG000|COMPLETED|Overall Study||85
6687567|NCT02704156|7617575|FG001|COMPLETED|Overall Study||85
6687568|NCT02704156|7617574|FG000|NOT COMPLETED|Overall Study||0
6687569|NCT02704156|7617575|FG001|NOT COMPLETED|Overall Study||0
6687570|NCT02704689|7617581|FG000|STARTED|Overall Study||9
6687571|NCT02704689|7617581|FG000|COMPLETED|Overall Study||6
6687572|NCT02704689|7617581|FG000|NOT COMPLETED|Overall Study||3
6687573|NCT02704702|7617591|FG000|STARTED|Overall Study||6
6687574|NCT02704702|7617592|FG001|STARTED|Overall Study||6
6687575|NCT02704702|7617593|FG002|STARTED|Overall Study||6
6687576|NCT02704702|7617594|FG003|STARTED|Overall Study||6
6687577|NCT02704702|7617595|FG004|STARTED|Overall Study||6
6687578|NCT02704702|7617596|FG005|STARTED|Overall Study||6
6687579|NCT02704702|7617591|FG000|COMPLETED|Overall Study||5
6687580|NCT02704702|7617592|FG001|COMPLETED|Overall Study||6
6687581|NCT02704702|7617593|FG002|COMPLETED|Overall Study||6
6687582|NCT02704702|7617594|FG003|COMPLETED|Overall Study||5
6687583|NCT02704702|7617595|FG004|COMPLETED|Overall Study||4
6687584|NCT02704702|7617596|FG005|COMPLETED|Overall Study||4
6687585|NCT02704702|7617591|FG000|NOT COMPLETED|Overall Study||1
6687586|NCT02704702|7617592|FG001|NOT COMPLETED|Overall Study||0
6687587|NCT02704702|7617593|FG002|NOT COMPLETED|Overall Study||0
6687588|NCT02704702|7617594|FG003|NOT COMPLETED|Overall Study||1
6687589|NCT02704702|7617595|FG004|NOT COMPLETED|Overall Study||2
6687590|NCT02704702|7617596|FG005|NOT COMPLETED|Overall Study||2
6687591|NCT02705105|7617622|FG000|STARTED|Treatment||4
6687592|NCT02705105|7617623|FG001|STARTED|Treatment||110
6687593|NCT02705105|7617622|FG000|Subjects Who Were Replaced|Treatment||1
6687594|NCT02705105|7617623|FG001|Subjects Who Were Replaced|Treatment||0
6687595|NCT02705105|7617622|FG000|D/C From Treatment Phase|Treatment||4
6687596|NCT02705105|7617623|FG001|D/C From Treatment Phase|Treatment||107
6687597|NCT02705105|7617622|FG000|D/C From Follow-Up|Treatment||4
6687598|NCT02705105|7617623|FG001|D/C From Follow-Up|Treatment||110
6687599|NCT02705105|7617622|FG000|COMPLETED|Treatment||0
6687600|NCT02705105|7617623|FG001|COMPLETED|Treatment||1
6687601|NCT02705105|7617622|FG000|NOT COMPLETED|Treatment||4
6687602|NCT02705105|7617623|FG001|NOT COMPLETED|Treatment||109
6687603|NCT02705105|7617622|FG000|STARTED|Follow-Up||4
6687604|NCT02705105|7617623|FG001|STARTED|Follow-Up||110
6687605|NCT02705105|7617622|FG000|COMPLETED|Follow-Up||0
6687606|NCT02705105|7617623|FG001|COMPLETED|Follow-Up||0
6687607|NCT02705105|7617622|FG000|NOT COMPLETED|Follow-Up||4
6687608|NCT02705105|7617623|FG001|NOT COMPLETED|Follow-Up||110
6687609|NCT02705352|7617643|FG000|STARTED|Overall Study||1
6687610|NCT02705352|7617644|FG001|STARTED|Overall Study||0
6687611|NCT02705352|7617643|FG000|COMPLETED|Overall Study||1
6687612|NCT02705352|7617644|FG001|COMPLETED|Overall Study||0
6687613|NCT02705352|7617643|FG000|NOT COMPLETED|Overall Study||0
6687614|NCT02705352|7617644|FG001|NOT COMPLETED|Overall Study||0
6687615|NCT02705365|7617652|FG000|STARTED|Overall Study||400
6687616|NCT02705365|7617653|FG001|STARTED|Overall Study||800
6687617|NCT02705365|7617652|FG000|COMPLETED|Overall Study||400
6687618|NCT02705365|7617653|FG001|COMPLETED|Overall Study||800
6687619|NCT02705365|7617652|FG000|NOT COMPLETED|Overall Study||0
6687620|NCT02705365|7617653|FG001|NOT COMPLETED|Overall Study||0
6687621|NCT02705586|7617659|FG000|STARTED|Overall Study||13
6687622|NCT02705586|7617659|FG000|COMPLETED|Overall Study||5
6687623|NCT02705586|7617659|FG000|NOT COMPLETED|Overall Study||8
6687624|NCT02705625|7617666|FG000|STARTED|Overall Study||82
6687625|NCT02705625|7617667|FG001|STARTED|Overall Study||82
6687626|NCT02705625|7617668|FG002|STARTED|Overall Study||80
6687627|NCT02705625|7617666|FG000|COMPLETED|Overall Study||74
6687628|NCT02705625|7617667|FG001|COMPLETED|Overall Study||72
6687629|NCT02705625|7617668|FG002|COMPLETED|Overall Study||69
6687630|NCT02705625|7617666|FG000|NOT COMPLETED|Overall Study||8
6687631|NCT02705625|7617667|FG001|NOT COMPLETED|Overall Study||10
6687632|NCT02705625|7617668|FG002|NOT COMPLETED|Overall Study||11
6687633|NCT02705716|7617678|FG000|STARTED|Overall Study||72
6687634|NCT02705716|7617679|FG001|STARTED|Overall Study||70
6687635|NCT02705716|7617678|FG000|COMPLETED|Overall Study||68
6687636|NCT02705716|7617679|FG001|COMPLETED|Overall Study||68
6687637|NCT02705716|7617678|FG000|NOT COMPLETED|Overall Study||4
6687638|NCT02705716|7617679|FG001|NOT COMPLETED|Overall Study||2
6687639|NCT02705807|7617685|FG000|STARTED|Overall Study||10
6687640|NCT02705807|7617685|FG000|COMPLETED|Overall Study||10
6687641|NCT02705807|7617685|FG000|NOT COMPLETED|Overall Study||0
6687642|NCT02706041|7617691|FG000|STARTED|Overall Study||18
6687643|NCT02706041|7617692|FG001|STARTED|Overall Study||21
6687644|NCT02706041|7617691|FG000|Received Allocated Intervention|Overall Study||18
6687645|NCT02706041|7617692|FG001|Received Allocated Intervention|Overall Study||18
6687646|NCT02706041|7617691|FG000|COMPLETED|Overall Study||18
6687647|NCT02706041|7617692|FG001|COMPLETED|Overall Study||18
6687648|NCT02706041|7617691|FG000|NOT COMPLETED|Overall Study||0
6687649|NCT02706041|7617692|FG001|NOT COMPLETED|Overall Study||3
6687650|NCT02706249|7617700|FG000|STARTED|Overall Study||25
6687651|NCT02706249|7617701|FG001|STARTED|Overall Study||25
6687652|NCT02706249|7617700|FG000|COMPLETED|Overall Study||23
6687653|NCT02706249|7617701|FG001|COMPLETED|Overall Study||24
6687654|NCT02706249|7617700|FG000|NOT COMPLETED|Overall Study||2
6687655|NCT02706249|7617701|FG001|NOT COMPLETED|Overall Study||1
6687656|NCT02706327|7617712|FG000|STARTED|Overall Study||22
6687657|NCT02706327|7617713|FG001|STARTED|Overall Study||22
6687658|NCT02706327|7617714|FG002|STARTED|Overall Study||23
6687659|NCT02706327|7617712|FG000|COMPLETED|Overall Study||21
6687660|NCT02706327|7617713|FG001|COMPLETED|Overall Study||21
6687661|NCT02706327|7617714|FG002|COMPLETED|Overall Study||21
6687662|NCT02706327|7617712|FG000|NOT COMPLETED|Overall Study||1
6687663|NCT02706327|7617713|FG001|NOT COMPLETED|Overall Study||1
6687664|NCT02706327|7617714|FG002|NOT COMPLETED|Overall Study||2
6687665|NCT02706483|7617722|FG000|STARTED|Overall Study||2272
6687666|NCT02706483|7617722|FG000|COMPLETED|Overall Study||1842
6687667|NCT02706483|7617722|FG000|NOT COMPLETED|Overall Study||430
6687668|NCT02706717|7617728|FG000|STARTED|Overall Study||47
6687669|NCT02706717|7617729|FG001|STARTED|Overall Study|3 placebo participants never initiated study treatment.|46
6687670|NCT02706717|7617728|FG000|COMPLETED|Overall Study||46
6687671|NCT02706717|7617729|FG001|COMPLETED|Overall Study||35
6687672|NCT02706717|7617728|FG000|NOT COMPLETED|Overall Study||1
6687673|NCT02706717|7617729|FG001|NOT COMPLETED|Overall Study||11
6687674|NCT02706834|7617746|FG000|STARTED|Overall Study||3
6687675|NCT02706834|7617747|FG001|STARTED|Overall Study||3
6687676|NCT02706834|7617748|FG002|STARTED|Overall Study||3
6687677|NCT02706834|7617749|FG003|STARTED|Overall Study||3
6687678|NCT02706834|7617750|FG004|STARTED|Overall Study||3
6687679|NCT02706834|7617751|FG005|STARTED|Overall Study||3
6687680|NCT02706834|7617752|FG006|STARTED|Overall Study||3
6687681|NCT02706834|7617753|FG007|STARTED|Overall Study||3
6687682|NCT02706834|7617754|FG008|STARTED|Overall Study||4
6687683|NCT02706834|7617755|FG009|STARTED|Overall Study||4
6687684|NCT02706834|7617756|FG010|STARTED|Overall Study||4
6687685|NCT02706834|7617746|FG000|COMPLETED|Overall Study|Completed = completed study drug|1
6687686|NCT02706834|7617747|FG001|COMPLETED|Overall Study||2
6687687|NCT02706834|7617748|FG002|COMPLETED|Overall Study||2
6687688|NCT02706834|7617749|FG003|COMPLETED|Overall Study||3
6687689|NCT02706834|7617750|FG004|COMPLETED|Overall Study||2
6687690|NCT02706834|7617751|FG005|COMPLETED|Overall Study||3
6687691|NCT02706834|7617752|FG006|COMPLETED|Overall Study||3
6687692|NCT02706834|7617753|FG007|COMPLETED|Overall Study||3
6687693|NCT02706834|7617754|FG008|COMPLETED|Overall Study||4
6687694|NCT02706834|7617755|FG009|COMPLETED|Overall Study||3
6687695|NCT02706834|7617756|FG010|COMPLETED|Overall Study||3
6687696|NCT02706834|7617746|FG000|NOT COMPLETED|Overall Study||2
6687697|NCT02706834|7617747|FG001|NOT COMPLETED|Overall Study||1
6687698|NCT02706834|7617748|FG002|NOT COMPLETED|Overall Study||1
6687699|NCT02706834|7617749|FG003|NOT COMPLETED|Overall Study||0
6687700|NCT02706834|7617750|FG004|NOT COMPLETED|Overall Study||1
6687701|NCT02706834|7617751|FG005|NOT COMPLETED|Overall Study||0
6687702|NCT02706834|7617752|FG006|NOT COMPLETED|Overall Study||0
6687703|NCT02706834|7617753|FG007|NOT COMPLETED|Overall Study||0
6687704|NCT02706834|7617754|FG008|NOT COMPLETED|Overall Study||0
6687705|NCT02706834|7617755|FG009|NOT COMPLETED|Overall Study||1
6687706|NCT02706834|7617756|FG010|NOT COMPLETED|Overall Study||1
6687707|NCT02706873|7617805|FG000|STARTED|Overall Study||315
6687708|NCT02706873|7617806|FG001|STARTED|Overall Study||55
6687709|NCT02706873|7617807|FG002|STARTED|Overall Study||317
6687710|NCT02706873|7617808|FG003|STARTED|Overall Study||315
6687711|NCT02706873|7617805|FG000|Received Study Drug|Overall Study||314
6687712|NCT02706873|7617806|FG001|Received Study Drug|Overall Study||55
6687713|NCT02706873|7617807|FG002|Received Study Drug|Overall Study||317
6687714|NCT02706873|7617808|FG003|Received Study Drug|Overall Study||314
6687715|NCT02706873|7617805|FG000|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
6687716|NCT02706873|7617806|FG001|Global Analysis Population|Overall Study||0
6687717|NCT02706873|7617807|FG002|Global Analysis Population|Overall Study|Includes 27 participants in the Japan sub-study|317
6687718|NCT02706873|7617808|FG003|Global Analysis Population|Overall Study|Includes 28 participants in the Japan sub-study|314
6687719|NCT02706873|7617805|FG000|Japan Sub-study|Overall Study||28
6687720|NCT02706873|7617806|FG001|Japan Sub-study|Overall Study||55
6687721|NCT02706873|7617807|FG002|Japan Sub-study|Overall Study||27
6687722|NCT02706873|7617808|FG003|Japan Sub-study|Overall Study||28
6687723|NCT02706873|7617805|FG000|COMPLETED|Overall Study||268
6687724|NCT02706873|7617806|FG001|COMPLETED|Overall Study||51
6687725|NCT02706873|7617807|FG002|COMPLETED|Overall Study||290
6687726|NCT02706873|7617808|FG003|COMPLETED|Overall Study||282
6687727|NCT02706873|7617805|FG000|NOT COMPLETED|Overall Study||47
6687728|NCT02706873|7617806|FG001|NOT COMPLETED|Overall Study||4
6687729|NCT02706873|7617807|FG002|NOT COMPLETED|Overall Study||27
6687730|NCT02706873|7617808|FG003|NOT COMPLETED|Overall Study||33
6687731|NCT02706886|7617829|FG000|STARTED|Part A: SAD Period||8
6687732|NCT02706886|7617830|FG001|STARTED|Part A: SAD Period||6
6687733|NCT02706886|7617831|FG002|STARTED|Part A: SAD Period||6
6687734|NCT02706886|7617832|FG003|STARTED|Part A: SAD Period||6
6687735|NCT02706886|7617833|FG004|STARTED|Part A: SAD Period||6
6687736|NCT02706886|7617834|FG005|STARTED|Part A: SAD Period||0
6687737|NCT02706886|7617835|FG006|STARTED|Part A: SAD Period||0
6687738|NCT02706886|7617836|FG007|STARTED|Part A: SAD Period||0
6687739|NCT02706886|7617837|FG008|STARTED|Part A: SAD Period||0
6687740|NCT02706886|7617829|FG000|COMPLETED|Part A: SAD Period||8
6687741|NCT02706886|7617830|FG001|COMPLETED|Part A: SAD Period||6
6687742|NCT02706886|7617831|FG002|COMPLETED|Part A: SAD Period||6
6687743|NCT02706886|7617832|FG003|COMPLETED|Part A: SAD Period||4
6687744|NCT02706886|7617833|FG004|COMPLETED|Part A: SAD Period||6
6687745|NCT02706886|7617834|FG005|COMPLETED|Part A: SAD Period||0
6687746|NCT02706886|7617835|FG006|COMPLETED|Part A: SAD Period||0
6687747|NCT02706886|7617836|FG007|COMPLETED|Part A: SAD Period||0
6687748|NCT02706886|7617837|FG008|COMPLETED|Part A: SAD Period||0
6687749|NCT02706886|7617829|FG000|NOT COMPLETED|Part A: SAD Period||0
6687750|NCT02706886|7617830|FG001|NOT COMPLETED|Part A: SAD Period||0
6687751|NCT02706886|7617831|FG002|NOT COMPLETED|Part A: SAD Period||0
6687752|NCT02706886|7617832|FG003|NOT COMPLETED|Part A: SAD Period||2
6687753|NCT02706886|7617833|FG004|NOT COMPLETED|Part A: SAD Period||0
6687754|NCT02706886|7617834|FG005|NOT COMPLETED|Part A: SAD Period||0
6687755|NCT02706886|7617835|FG006|NOT COMPLETED|Part A: SAD Period||0
6687756|NCT02706886|7617836|FG007|NOT COMPLETED|Part A: SAD Period||0
6687757|NCT02706886|7617837|FG008|NOT COMPLETED|Part A: SAD Period||0
6687758|NCT02706886|7617829|FG000|STARTED|Part B: MAD Study Days 1-85||0
6687759|NCT02706886|7617830|FG001|STARTED|Part B: MAD Study Days 1-85||0
6687760|NCT02706886|7617831|FG002|STARTED|Part B: MAD Study Days 1-85||0
6687761|NCT02706886|7617832|FG003|STARTED|Part B: MAD Study Days 1-85||0
6687762|NCT02706886|7617833|FG004|STARTED|Part B: MAD Study Days 1-85||0
6687763|NCT02706886|7617834|FG005|STARTED|Part B: MAD Study Days 1-85||3
6687764|NCT02706886|7617835|FG006|STARTED|Part B: MAD Study Days 1-85||7
6687765|NCT02706886|7617836|FG007|STARTED|Part B: MAD Study Days 1-85||7
6687766|NCT02706886|7617837|FG008|STARTED|Part B: MAD Study Days 1-85||3
6687767|NCT02706886|7617829|FG000|COMPLETED|Part B: MAD Study Days 1-85||0
6687768|NCT02706886|7617830|FG001|COMPLETED|Part B: MAD Study Days 1-85||0
6687769|NCT02706886|7617831|FG002|COMPLETED|Part B: MAD Study Days 1-85||0
6687770|NCT02706886|7617832|FG003|COMPLETED|Part B: MAD Study Days 1-85||0
6687771|NCT02706886|7617833|FG004|COMPLETED|Part B: MAD Study Days 1-85||0
6687772|NCT02706886|7617834|FG005|COMPLETED|Part B: MAD Study Days 1-85||3
6687773|NCT02706886|7617835|FG006|COMPLETED|Part B: MAD Study Days 1-85||7
6687774|NCT02706886|7617836|FG007|COMPLETED|Part B: MAD Study Days 1-85||7
6687775|NCT02706886|7617837|FG008|COMPLETED|Part B: MAD Study Days 1-85||3
6687776|NCT02706886|7617829|FG000|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687777|NCT02706886|7617830|FG001|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687778|NCT02706886|7617831|FG002|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687779|NCT02706886|7617832|FG003|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687780|NCT02706886|7617833|FG004|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687781|NCT02706886|7617834|FG005|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687782|NCT02706886|7617835|FG006|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687783|NCT02706886|7617836|FG007|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687784|NCT02706886|7617837|FG008|NOT COMPLETED|Part B: MAD Study Days 1-85||0
6687785|NCT02706886|7617829|FG000|STARTED|Part B: MAD Study Day 85-End of Study||0
6687786|NCT02706886|7617830|FG001|STARTED|Part B: MAD Study Day 85-End of Study||0
6687787|NCT02706886|7617831|FG002|STARTED|Part B: MAD Study Day 85-End of Study||0
6687788|NCT02706886|7617832|FG003|STARTED|Part B: MAD Study Day 85-End of Study||0
6687789|NCT02706886|7617833|FG004|STARTED|Part B: MAD Study Day 85-End of Study||0
6687790|NCT02706886|7617834|FG005|STARTED|Part B: MAD Study Day 85-End of Study||0
6687791|NCT02706886|7617835|FG006|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
6687792|NCT02706886|7617836|FG007|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|8
6687793|NCT02706886|7617837|FG008|STARTED|Part B: MAD Study Day 85-End of Study|One participant from the Part B: MAD: Placebo arm crossed over to this lumasiran arm.|4
6687794|NCT02706886|7617829|FG000|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687795|NCT02706886|7617830|FG001|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687796|NCT02706886|7617831|FG002|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687797|NCT02706886|7617832|FG003|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687798|NCT02706886|7617833|FG004|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687799|NCT02706886|7617834|FG005|COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687800|NCT02706886|7617835|FG006|COMPLETED|Part B: MAD Study Day 85-End of Study||8
6687801|NCT02706886|7617836|FG007|COMPLETED|Part B: MAD Study Day 85-End of Study||8
6687802|NCT02706886|7617837|FG008|COMPLETED|Part B: MAD Study Day 85-End of Study||4
6687803|NCT02706886|7617829|FG000|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687804|NCT02706886|7617830|FG001|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687805|NCT02706886|7617831|FG002|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687806|NCT02706886|7617832|FG003|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687807|NCT02706886|7617833|FG004|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687808|NCT02706886|7617834|FG005|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687809|NCT02706886|7617835|FG006|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687810|NCT02706886|7617836|FG007|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687811|NCT02706886|7617837|FG008|NOT COMPLETED|Part B: MAD Study Day 85-End of Study||0
6687812|NCT02706899|7617882|FG000|STARTED|Overall Study||13
6687813|NCT02706899|7617883|FG001|STARTED|Overall Study||6
6687814|NCT02706899|7617882|FG000|COMPLETED|Overall Study||0
6687815|NCT02706899|7617883|FG001|COMPLETED|Overall Study||0
6687816|NCT02706899|7617882|FG000|NOT COMPLETED|Overall Study||13
6687817|NCT02706899|7617883|FG001|NOT COMPLETED|Overall Study||6
6687818|NCT02706925|7617898|FG000|STARTED|Overall Study||16
6687819|NCT02706925|7617899|FG001|STARTED|Overall Study||6
6687820|NCT02706925|7617900|FG002|STARTED|Overall Study||6
6687821|NCT02706925|7617901|FG003|STARTED|Overall Study||6
6687822|NCT02706925|7617902|FG004|STARTED|Overall Study||6
6687823|NCT02706925|7617903|FG005|STARTED|Overall Study||5
6687824|NCT02706925|7617904|FG006|STARTED|Overall Study||6
6687825|NCT02706925|7617905|FG007|STARTED|Overall Study||6
6687826|NCT02706925|7617906|FG008|STARTED|Overall Study||6
6687827|NCT02706925|7617898|FG000|COMPLETED|Overall Study||16
6687828|NCT02706925|7617899|FG001|COMPLETED|Overall Study||6
6687829|NCT02706925|7617900|FG002|COMPLETED|Overall Study||6
6687830|NCT02706925|7617901|FG003|COMPLETED|Overall Study||6
6687831|NCT02706925|7617902|FG004|COMPLETED|Overall Study||6
6687832|NCT02706925|7617903|FG005|COMPLETED|Overall Study||5
6687833|NCT02706925|7617904|FG006|COMPLETED|Overall Study||6
6687834|NCT02706925|7617905|FG007|COMPLETED|Overall Study||6
6687835|NCT02706925|7617906|FG008|COMPLETED|Overall Study||6
6687836|NCT02706925|7617898|FG000|NOT COMPLETED|Overall Study||0
6687837|NCT02706925|7617899|FG001|NOT COMPLETED|Overall Study||0
6687838|NCT02706925|7617900|FG002|NOT COMPLETED|Overall Study||0
6687839|NCT02706925|7617901|FG003|NOT COMPLETED|Overall Study||0
6687840|NCT02706925|7617902|FG004|NOT COMPLETED|Overall Study||0
6687841|NCT02706925|7617903|FG005|NOT COMPLETED|Overall Study||0
6687842|NCT02706925|7617904|FG006|NOT COMPLETED|Overall Study||0
6687843|NCT02706925|7617905|FG007|NOT COMPLETED|Overall Study||0
6687844|NCT02706925|7617906|FG008|NOT COMPLETED|Overall Study||0
6687845|NCT02706938|7617936|FG000|STARTED|First Period, 6 Weeks||32
6687846|NCT02706938|7617937|FG001|STARTED|First Period, 6 Weeks||33
6687847|NCT02706938|7617936|FG000|COMPLETED|First Period, 6 Weeks||21
6687848|NCT02706938|7617937|FG001|COMPLETED|First Period, 6 Weeks||31
6687849|NCT02706938|7617936|FG000|NOT COMPLETED|First Period, 6 Weeks||11
6687850|NCT02706938|7617937|FG001|NOT COMPLETED|First Period, 6 Weeks||2
6687851|NCT02706938|7617936|FG000|STARTED|Second Period, 6 Weeks||21
6687852|NCT02706938|7617937|FG001|STARTED|Second Period, 6 Weeks||31
6687853|NCT02706938|7617936|FG000|COMPLETED|Second Period, 6 Weeks|Only data from 20 patients were finally analyzed because of missing data.|21
6687854|NCT02706938|7617937|FG001|COMPLETED|Second Period, 6 Weeks|Only data from 19 patients were finally analyzed because of missing data.|21
6687855|NCT02706938|7617936|FG000|NOT COMPLETED|Second Period, 6 Weeks||0
6687856|NCT02706938|7617937|FG001|NOT COMPLETED|Second Period, 6 Weeks||10
6687857|NCT02706951|7617947|FG000|STARTED|Overall Study||216
6687858|NCT02706951|7617948|FG001|STARTED|Overall Study||217
6687859|NCT02706951|7617949|FG002|STARTED|Overall Study||215
6687860|NCT02706951|7617947|FG000|COMPLETED|Overall Study||202
6687861|NCT02706951|7617948|FG001|COMPLETED|Overall Study||201
6687862|NCT02706951|7617949|FG002|COMPLETED|Overall Study||205
6687863|NCT02706951|7617947|FG000|NOT COMPLETED|Overall Study||14
6687864|NCT02706951|7617948|FG001|NOT COMPLETED|Overall Study||16
6687865|NCT02706951|7617949|FG002|NOT COMPLETED|Overall Study||10
6687866|NCT02707146|7617959|FG000|STARTED|Overall Study||359
6687867|NCT02707146|7617960|FG001|STARTED|Overall Study||391
6687868|NCT02707146|7617959|FG000|COMPLETED|Overall Study||359
6687869|NCT02707146|7617960|FG001|COMPLETED|Overall Study||388
6687870|NCT02707146|7617959|FG000|NOT COMPLETED|Overall Study||0
6687871|NCT02707146|7617960|FG001|NOT COMPLETED|Overall Study||3
6687872|NCT02707172|7617966|FG000|STARTED|1st Set of Experiment||28
6687873|NCT02707172|7617966|FG000|COMPLETED|1st Set of Experiment||28
6687874|NCT02707172|7617966|FG000|NOT COMPLETED|1st Set of Experiment||0
6687875|NCT02707172|7617966|FG000|STARTED|Wash Out||28
6687876|NCT02707172|7617966|FG000|COMPLETED|Wash Out||28
6687877|NCT02707172|7617966|FG000|NOT COMPLETED|Wash Out||0
6687878|NCT02707172|7617966|FG000|STARTED|2nd Set of Experiment||28
6687879|NCT02707172|7617966|FG000|COMPLETED|2nd Set of Experiment||28
6687880|NCT02707172|7617966|FG000|NOT COMPLETED|2nd Set of Experiment||0
6687881|NCT02707432|7617973|FG000|STARTED|Overall Study||72
6687882|NCT02707432|7617974|FG001|STARTED|Overall Study||71
6687883|NCT02707432|7617973|FG000|COMPLETED|Overall Study||57
6687884|NCT02707432|7617974|FG001|COMPLETED|Overall Study||51
6687885|NCT02707432|7617973|FG000|NOT COMPLETED|Overall Study||15
6687886|NCT02707432|7617974|FG001|NOT COMPLETED|Overall Study||20
6687887|NCT02707523|7617983|FG000|STARTED|Overall Study||16
6687888|NCT02707523|7617984|FG001|STARTED|Overall Study||16
6687889|NCT02707523|7617985|FG002|STARTED|Overall Study||16
6687890|NCT02707523|7617983|FG000|COMPLETED|Overall Study||16
6687891|NCT02707523|7617984|FG001|COMPLETED|Overall Study||16
6687892|NCT02707523|7617985|FG002|COMPLETED|Overall Study||16
6687893|NCT02707523|7617983|FG000|NOT COMPLETED|Overall Study||0
6687894|NCT02707523|7617984|FG001|NOT COMPLETED|Overall Study||0
6687895|NCT02707523|7617985|FG002|NOT COMPLETED|Overall Study||0
6738585|NCT03285295|7667832|FG003|STARTED|Alinity s Anti-HBc||0
6738586|NCT03285295|7667833|FG004|STARTED|Alinity s Anti-HBc||0
6738587|NCT03285295|7667829|FG000|COMPLETED|Alinity s Anti-HBc||15877
6738588|NCT03285295|7667830|FG001|COMPLETED|Alinity s Anti-HBc||404
6738589|NCT03285295|7667831|FG002|COMPLETED|Alinity s Anti-HBc||403
6738590|NCT03285295|7667832|FG003|COMPLETED|Alinity s Anti-HBc||0
6738591|NCT03285295|7667833|FG004|COMPLETED|Alinity s Anti-HBc||0
6738592|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s Anti-HBc||91
6738593|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s Anti-HBc||1
6738594|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s Anti-HBc||0
6738595|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s Anti-HBc||0
6738596|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s Anti-HBc||0
6738597|NCT03285295|7667829|FG000|STARTED|Alinity s Anti-HBc Follow-Up||16
6738598|NCT03285295|7667830|FG001|STARTED|Alinity s Anti-HBc Follow-Up||0
6687896|NCT02707601|7617995|FG000|STARTED|Overall Study||76
6687897|NCT02707601|7617996|FG001|STARTED|Overall Study||74
6687898|NCT02707601|7617995|FG000|COMPLETED|Overall Study||72
6687899|NCT02707601|7617996|FG001|COMPLETED|Overall Study||70
6687900|NCT02707601|7617995|FG000|NOT COMPLETED|Overall Study||4
6687901|NCT02707601|7617996|FG001|NOT COMPLETED|Overall Study||4
6687902|NCT02707640|7618008|FG000|STARTED|Overall Study||61
6687903|NCT02707640|7618009|FG001|STARTED|Overall Study||62
6687904|NCT02707640|7618008|FG000|COMPLETED|Overall Study||52
6687905|NCT02707640|7618009|FG001|COMPLETED|Overall Study||55
6687906|NCT02707640|7618008|FG000|NOT COMPLETED|Overall Study||9
6687907|NCT02707640|7618009|FG001|NOT COMPLETED|Overall Study||7
6687908|NCT02707757|7618017|FG000|STARTED|Overall Study||88
6687909|NCT02707757|7618018|FG001|STARTED|Overall Study||96
6687910|NCT02707757|7618017|FG000|COMPLETED|Overall Study||76
6687911|NCT02707757|7618018|FG001|COMPLETED|Overall Study||84
6687912|NCT02707757|7618017|FG000|NOT COMPLETED|Overall Study||12
6687913|NCT02707757|7618018|FG001|NOT COMPLETED|Overall Study||12
6687914|NCT02707770|7618026|FG000|STARTED|Overall Study||10
6687915|NCT02707770|7618027|FG001|STARTED|Overall Study||10
6687916|NCT02707770|7618026|FG000|COMPLETED|Overall Study|One patient withdrew from the study following consent, initial assessment and randomisation|9
6687917|NCT02707770|7618027|FG001|COMPLETED|Overall Study||10
6687918|NCT02707770|7618026|FG000|NOT COMPLETED|Overall Study||1
6687919|NCT02707770|7618027|FG001|NOT COMPLETED|Overall Study||0
6687920|NCT02707861|7618037|FG000|STARTED|Overall Study||41
6687921|NCT02707861|7618038|FG001|STARTED|Overall Study||38
6687922|NCT02707861|7618037|FG000|COMPLETED|Overall Study||0
6687923|NCT02707861|7618038|FG001|COMPLETED|Overall Study||0
6687924|NCT02707861|7618037|FG000|NOT COMPLETED|Overall Study||41
6687925|NCT02707861|7618038|FG001|NOT COMPLETED|Overall Study||38
6687926|NCT02707952|7618048|FG000|STARTED|Overall Study||129
6687927|NCT02707952|7618049|FG001|STARTED|Overall Study||53
6687928|NCT02707952|7618050|FG002|STARTED|Overall Study||103
6687929|NCT02707952|7618051|FG003|STARTED|Overall Study||10
6687930|NCT02707952|7618048|FG000|Participants Who Received Study Drug|Overall Study||129
6687931|NCT02707952|7618049|FG001|Participants Who Received Study Drug|Overall Study||52
6687932|NCT02707952|7618050|FG002|Participants Who Received Study Drug|Overall Study||103
6687933|NCT02707952|7618051|FG003|Participants Who Received Study Drug|Overall Study||10
6687934|NCT02707952|7618048|FG000|COMPLETED|Overall Study||127
6687935|NCT02707952|7618049|FG001|COMPLETED|Overall Study||52
6687936|NCT02707952|7618050|FG002|COMPLETED|Overall Study||101
6687937|NCT02707952|7618051|FG003|COMPLETED|Overall Study||10
6687938|NCT02707952|7618048|FG000|NOT COMPLETED|Overall Study||2
6687939|NCT02707952|7618049|FG001|NOT COMPLETED|Overall Study||1
6687940|NCT02707952|7618050|FG002|NOT COMPLETED|Overall Study||2
6687941|NCT02707952|7618051|FG003|NOT COMPLETED|Overall Study||0
6687942|NCT02707965|7618072|FG000|STARTED|Overall Study||3
6687943|NCT02707965|7618073|FG001|STARTED|Overall Study||2
6687944|NCT02707965|7618074|FG002|STARTED|Overall Study||4
6687945|NCT02707965|7618075|FG003|STARTED|Overall Study||0
6687946|NCT02707965|7618076|FG004|STARTED|Overall Study||2
6687947|NCT02707965|7618077|FG005|STARTED|Overall Study||1
6687948|NCT02707965|7618078|FG006|STARTED|Overall Study||0
6687949|NCT02707965|7618079|FG007|STARTED|Overall Study||3
6687950|NCT02707965|7618080|FG008|STARTED|Overall Study||1
6687951|NCT02707965|7618081|FG009|STARTED|Overall Study||0
6687952|NCT02707965|7618082|FG010|STARTED|Overall Study||1
6687953|NCT02707965|7618083|FG011|STARTED|Overall Study||0
6687954|NCT02707965|7618084|FG012|STARTED|Overall Study||0
6687955|NCT02707965|7618085|FG013|STARTED|Overall Study||2
6687956|NCT02707965|7618086|FG014|STARTED|Overall Study||2
6687957|NCT02707965|7618087|FG015|STARTED|Overall Study||0
6687958|NCT02707965|7618072|FG000|COMPLETED|Overall Study||2
6687959|NCT02707965|7618073|FG001|COMPLETED|Overall Study||1
6687960|NCT02707965|7618074|FG002|COMPLETED|Overall Study||3
6687961|NCT02707965|7618075|FG003|COMPLETED|Overall Study||0
6687962|NCT02707965|7618076|FG004|COMPLETED|Overall Study||2
6687963|NCT02707965|7618077|FG005|COMPLETED|Overall Study||1
6687964|NCT02707965|7618078|FG006|COMPLETED|Overall Study||0
6687965|NCT02707965|7618079|FG007|COMPLETED|Overall Study||0
6687966|NCT02707965|7618080|FG008|COMPLETED|Overall Study||1
6687967|NCT02707965|7618081|FG009|COMPLETED|Overall Study||0
6687968|NCT02707965|7618082|FG010|COMPLETED|Overall Study||1
6687969|NCT02707965|7618083|FG011|COMPLETED|Overall Study||0
6687970|NCT02707965|7618084|FG012|COMPLETED|Overall Study||0
6687971|NCT02707965|7618085|FG013|COMPLETED|Overall Study||2
6687972|NCT02707965|7618086|FG014|COMPLETED|Overall Study||0
6687973|NCT02707965|7618087|FG015|COMPLETED|Overall Study||0
6687974|NCT02707965|7618072|FG000|NOT COMPLETED|Overall Study||1
6687975|NCT02707965|7618073|FG001|NOT COMPLETED|Overall Study||1
6687976|NCT02707965|7618074|FG002|NOT COMPLETED|Overall Study||1
6687977|NCT02707965|7618075|FG003|NOT COMPLETED|Overall Study||0
6687978|NCT02707965|7618076|FG004|NOT COMPLETED|Overall Study||0
6687979|NCT02707965|7618077|FG005|NOT COMPLETED|Overall Study||0
6687980|NCT02707965|7618078|FG006|NOT COMPLETED|Overall Study||0
6687981|NCT02707965|7618079|FG007|NOT COMPLETED|Overall Study||3
6687982|NCT02707965|7618080|FG008|NOT COMPLETED|Overall Study||0
6687983|NCT02707965|7618081|FG009|NOT COMPLETED|Overall Study||0
6687984|NCT02707965|7618082|FG010|NOT COMPLETED|Overall Study||0
6687985|NCT02707965|7618083|FG011|NOT COMPLETED|Overall Study||0
6687986|NCT02707965|7618084|FG012|NOT COMPLETED|Overall Study||0
6687987|NCT02707965|7618085|FG013|NOT COMPLETED|Overall Study||0
6687988|NCT02707965|7618086|FG014|NOT COMPLETED|Overall Study||2
6687989|NCT02707965|7618087|FG015|NOT COMPLETED|Overall Study||0
6687990|NCT02707991|7618122|FG000|STARTED|Overall Study||33
6687991|NCT02707991|7618123|FG001|STARTED|Overall Study||35
6687992|NCT02707991|7618122|FG000|Day 60 Data Collectio|Overall Study||32
6687993|NCT02707991|7618123|FG001|Day 60 Data Collectio|Overall Study||34
6687994|NCT02707991|7618122|FG000|Month 6 Data Collection|Overall Study||32
6687995|NCT02707991|7618123|FG001|Month 6 Data Collection|Overall Study||34
6687996|NCT02707991|7618122|FG000|COMPLETED|Overall Study||32
6687997|NCT02707991|7618123|FG001|COMPLETED|Overall Study||34
6687998|NCT02707991|7618122|FG000|NOT COMPLETED|Overall Study||1
6687999|NCT02707991|7618123|FG001|NOT COMPLETED|Overall Study||1
6688000|NCT02708095|7618132|FG000|STARTED|Overall Study||105
6688001|NCT02708095|7618133|FG001|STARTED|Overall Study||105
6688002|NCT02708095|7618134|FG002|STARTED|Overall Study||104
6688003|NCT02708095|7618132|FG000|Received at Least 1 Dose of Study Drug|Overall Study||105
6688004|NCT02708095|7618133|FG001|Received at Least 1 Dose of Study Drug|Overall Study||105
6688005|NCT02708095|7618134|FG002|Received at Least 1 Dose of Study Drug|Overall Study||104
6688006|NCT02708095|7618132|FG000|COMPLETED|Overall Study||83
6688007|NCT02708095|7618133|FG001|COMPLETED|Overall Study||86
6688008|NCT02708095|7618134|FG002|COMPLETED|Overall Study||86
6688009|NCT02708095|7618132|FG000|NOT COMPLETED|Overall Study||22
6688010|NCT02708095|7618133|FG001|NOT COMPLETED|Overall Study||19
6688011|NCT02708095|7618134|FG002|NOT COMPLETED|Overall Study||18
6688012|NCT02708121|7618146|FG000|STARTED|Overall Study||35
6688013|NCT02708121|7618147|FG001|STARTED|Overall Study||31
6688014|NCT02708121|7618146|FG000|Provided Acceptability Data|Overall Study||20
6688015|NCT02708121|7618147|FG001|Provided Acceptability Data|Overall Study|This condition did not participate in acceptability survey|0
6688016|NCT02708121|7618146|FG000|Treatment Program Use Data Available|Overall Study||34
6688017|NCT02708121|7618147|FG001|Treatment Program Use Data Available|Overall Study||24
6688018|NCT02708121|7618146|FG000|6 Month In-Person Follow Up Data|Overall Study||22
6688019|NCT02708121|7618147|FG001|6 Month In-Person Follow Up Data|Overall Study||19
6688020|NCT02708121|7618146|FG000|6 Month Weight Data Via EHR|Overall Study||14
6688021|NCT02708121|7618147|FG001|6 Month Weight Data Via EHR|Overall Study||13
6688022|NCT02708121|7618146|FG000|COMPLETED|Overall Study||34
6688023|NCT02708121|7618147|FG001|COMPLETED|Overall Study||26
6688024|NCT02708121|7618146|FG000|NOT COMPLETED|Overall Study||1
6688025|NCT02708121|7618147|FG001|NOT COMPLETED|Overall Study||5
6688026|NCT02708186|7618155|FG000|STARTED|Overall Study||16
6688027|NCT02708186|7618156|FG001|STARTED|Overall Study||18
6688028|NCT02708186|7618155|FG000|COMPLETED|Overall Study||14
6688029|NCT02708186|7618156|FG001|COMPLETED|Overall Study||16
6688030|NCT02708186|7618155|FG000|NOT COMPLETED|Overall Study||2
6688031|NCT02708186|7618156|FG001|NOT COMPLETED|Overall Study||2
6688032|NCT02708212|7618164|FG000|STARTED|Overall Study||60
6688033|NCT02708212|7618165|FG001|STARTED|Overall Study||60
6688034|NCT02708212|7618164|FG000|COMPLETED|Overall Study||60
6688035|NCT02708212|7618165|FG001|COMPLETED|Overall Study||60
6688036|NCT02708212|7618164|FG000|NOT COMPLETED|Overall Study||0
6688037|NCT02708212|7618165|FG001|NOT COMPLETED|Overall Study||0
6688038|NCT02708238|7618178|FG000|STARTED|Overall Study||60
6688039|NCT02708238|7618179|FG001|STARTED|Overall Study||60
6688040|NCT02708238|7618180|FG002|STARTED|Overall Study||60
6688041|NCT02708238|7618178|FG000|COMPLETED|Overall Study||60
6688042|NCT02708238|7618179|FG001|COMPLETED|Overall Study||59
6688043|NCT02708238|7618180|FG002|COMPLETED|Overall Study||57
6688044|NCT02708238|7618178|FG000|NOT COMPLETED|Overall Study||0
6688045|NCT02708238|7618179|FG001|NOT COMPLETED|Overall Study||1
6688046|NCT02708238|7618180|FG002|NOT COMPLETED|Overall Study||3
6688047|NCT02708277|7618190|FG000|STARTED|Overall Study||50
6688048|NCT02708277|7618191|FG001|STARTED|Overall Study||43
6688049|NCT02708277|7618190|FG000|COMPLETED|Overall Study||43
6688050|NCT02708277|7618191|FG001|COMPLETED|Overall Study||39
6688051|NCT02708277|7618190|FG000|NOT COMPLETED|Overall Study||7
6688052|NCT02708277|7618191|FG001|NOT COMPLETED|Overall Study||4
6688053|NCT02708290|7618199|FG000|STARTED|Overall Study||1009
6688054|NCT02708290|7618200|FG001|STARTED|Overall Study||1009
6688055|NCT02708290|7618199|FG000|COMPLETED|Overall Study||1009
6688056|NCT02708290|7618200|FG001|COMPLETED|Overall Study||1009
6688057|NCT02708290|7618199|FG000|NOT COMPLETED|Overall Study||0
6688058|NCT02708290|7618200|FG001|NOT COMPLETED|Overall Study||0
6688059|NCT02708355|7618209|FG000|STARTED|Overall Study||21
6688060|NCT02708355|7618210|FG001|STARTED|Overall Study||22
6688061|NCT02708355|7618211|FG002|STARTED|Overall Study||12
6688062|NCT02708355|7618209|FG000|COMPLETED|Overall Study||20
6688063|NCT02708355|7618210|FG001|COMPLETED|Overall Study||22
6688064|NCT02708355|7618211|FG002|COMPLETED|Overall Study||12
6688065|NCT02708355|7618209|FG000|NOT COMPLETED|Overall Study||1
6688066|NCT02708355|7618210|FG001|NOT COMPLETED|Overall Study||0
6688067|NCT02708355|7618211|FG002|NOT COMPLETED|Overall Study||0
6688068|NCT02708433|7618219|FG000|STARTED|First Intervention (Visit 1)||12
6688069|NCT02708433|7618220|FG001|STARTED|First Intervention (Visit 1)||11
6688070|NCT02708433|7618219|FG000|COMPLETED|First Intervention (Visit 1)||12
6688071|NCT02708433|7618220|FG001|COMPLETED|First Intervention (Visit 1)||11
6688072|NCT02708433|7618219|FG000|NOT COMPLETED|First Intervention (Visit 1)||0
6688073|NCT02708433|7618220|FG001|NOT COMPLETED|First Intervention (Visit 1)||0
6688074|NCT02708433|7618219|FG000|STARTED|Washout (at Least 1 Week)||12
6688075|NCT02708433|7618220|FG001|STARTED|Washout (at Least 1 Week)||11
6688076|NCT02708433|7618219|FG000|COMPLETED|Washout (at Least 1 Week)||12
6688077|NCT02708433|7618220|FG001|COMPLETED|Washout (at Least 1 Week)||11
6688078|NCT02708433|7618219|FG000|NOT COMPLETED|Washout (at Least 1 Week)||0
6688079|NCT02708433|7618220|FG001|NOT COMPLETED|Washout (at Least 1 Week)||0
6688080|NCT02708433|7618219|FG000|STARTED|Second Intervention (Visit 2)||12
6688081|NCT02708433|7618220|FG001|STARTED|Second Intervention (Visit 2)||11
6688082|NCT02708433|7618219|FG000|COMPLETED|Second Intervention (Visit 2)||12
6688083|NCT02708433|7618220|FG001|COMPLETED|Second Intervention (Visit 2)||11
6688084|NCT02708433|7618219|FG000|NOT COMPLETED|Second Intervention (Visit 2)||0
6688085|NCT02708433|7618220|FG001|NOT COMPLETED|Second Intervention (Visit 2)||0
6688086|NCT02708485|7618228|FG000|STARTED|Overall Study||3
6688087|NCT02708485|7618229|FG001|STARTED|Overall Study||12
6688088|NCT02708485|7618228|FG000|COMPLETED|Overall Study||0
6688089|NCT02708485|7618229|FG001|COMPLETED|Overall Study||10
6688090|NCT02708485|7618228|FG000|NOT COMPLETED|Overall Study||3
6688091|NCT02708485|7618229|FG001|NOT COMPLETED|Overall Study||2
6688092|NCT02708498|7618243|FG000|STARTED|Overall Study||42
6688093|NCT02708498|7618244|FG001|STARTED|Overall Study||40
6688094|NCT02708498|7618245|FG002|STARTED|Overall Study||152
6688095|NCT02708498|7618246|FG003|STARTED|Overall Study||156
6688096|NCT02708498|7618247|FG004|STARTED|Overall Study||363
6688097|NCT02708498|7618248|FG005|STARTED|Overall Study||330
6688098|NCT02708498|7618249|FG006|STARTED|Overall Study||20
6688099|NCT02708498|7618250|FG007|STARTED|Overall Study||48
6688100|NCT02708498|7618243|FG000|COMPLETED|Overall Study||22
6688101|NCT02708498|7618244|FG001|COMPLETED|Overall Study||21
6688102|NCT02708498|7618245|FG002|COMPLETED|Overall Study||90
6688103|NCT02708498|7618246|FG003|COMPLETED|Overall Study||105
6688104|NCT02708498|7618247|FG004|COMPLETED|Overall Study||167
6688105|NCT02708498|7618248|FG005|COMPLETED|Overall Study||198
6688106|NCT02708498|7618249|FG006|COMPLETED|Overall Study||20
6688107|NCT02708498|7618250|FG007|COMPLETED|Overall Study||48
6688108|NCT02708498|7618243|FG000|NOT COMPLETED|Overall Study||20
6688109|NCT02708498|7618244|FG001|NOT COMPLETED|Overall Study||19
6688110|NCT02708498|7618245|FG002|NOT COMPLETED|Overall Study||62
6688111|NCT02708498|7618246|FG003|NOT COMPLETED|Overall Study||51
6688112|NCT02708498|7618247|FG004|NOT COMPLETED|Overall Study||196
6688113|NCT02708498|7618248|FG005|NOT COMPLETED|Overall Study||132
6688114|NCT02708498|7618249|FG006|NOT COMPLETED|Overall Study||0
6688115|NCT02708498|7618250|FG007|NOT COMPLETED|Overall Study||0
6688116|NCT02708524|7618270|FG000|STARTED|Overall Study||139
6688117|NCT02708524|7618271|FG001|STARTED|Overall Study||136
6688118|NCT02708524|7618272|FG002|STARTED|Overall Study||137
6688119|NCT02708524|7618273|FG003|STARTED|Overall Study||136
6688120|NCT02708524|7618270|FG000|COMPLETED|Overall Study||135
6688121|NCT02708524|7618271|FG001|COMPLETED|Overall Study||130
6688122|NCT02708524|7618272|FG002|COMPLETED|Overall Study||134
6688123|NCT02708524|7618273|FG003|COMPLETED|Overall Study||136
6688124|NCT02708524|7618270|FG000|NOT COMPLETED|Overall Study||4
6688125|NCT02708524|7618271|FG001|NOT COMPLETED|Overall Study||6
6688126|NCT02708524|7618272|FG002|NOT COMPLETED|Overall Study||3
6688127|NCT02708524|7618273|FG003|NOT COMPLETED|Overall Study||0
6688128|NCT02708641|7618283|FG000|STARTED|Overall Study||12
6688129|NCT02708641|7618283|FG000|COMPLETED|Overall Study||12
6688130|NCT02708641|7618283|FG000|NOT COMPLETED|Overall Study||0
6688131|NCT02708745|7618291|FG000|STARTED|Overall Study||91
6688132|NCT02708745|7618292|FG001|STARTED|Overall Study||69
6688133|NCT02708745|7618293|FG002|STARTED|Overall Study||204
6688134|NCT02708745|7618294|FG003|STARTED|Overall Study||198
6688135|NCT02708745|7618291|FG000|COMPLETED|Overall Study||91
6688136|NCT02708745|7618292|FG001|COMPLETED|Overall Study||65
6688137|NCT02708745|7618293|FG002|COMPLETED|Overall Study||121
6688138|NCT02708745|7618294|FG003|COMPLETED|Overall Study||116
6688139|NCT02708745|7618291|FG000|NOT COMPLETED|Overall Study||0
6688140|NCT02708745|7618292|FG001|NOT COMPLETED|Overall Study||4
6688141|NCT02708745|7618293|FG002|NOT COMPLETED|Overall Study||83
6688142|NCT02708745|7618294|FG003|NOT COMPLETED|Overall Study||82
6688143|NCT02708862|7618306|FG000|STARTED|Overall Study||26
6688144|NCT02708862|7618306|FG000|COMPLETED|Overall Study||26
6688145|NCT02708862|7618306|FG000|NOT COMPLETED|Overall Study||0
6688146|NCT02708966|7618315|FG000|STARTED|Overall Study||15
6257388|NCT04653766|7156504|FG000|STARTED|Overall Study||6
6257389|NCT04653766|7156505|FG001|STARTED|Overall Study||6
6257390|NCT04653766|7156506|FG002|STARTED|Overall Study||6
6257391|NCT04653766|7156507|FG003|STARTED|Overall Study||6
6257392|NCT04653766|7156508|FG004|STARTED|Overall Study||8
6257393|NCT04653766|7156504|FG000|COMPLETED|Overall Study||6
6257394|NCT04653766|7156505|FG001|COMPLETED|Overall Study||6
6688147|NCT02708966|7618316|FG001|STARTED|Overall Study||15
6688148|NCT02708966|7618315|FG000|COMPLETED|Overall Study||13
6688149|NCT02708966|7618316|FG001|COMPLETED|Overall Study||13
6688150|NCT02708966|7618315|FG000|NOT COMPLETED|Overall Study||2
6257395|NCT04653766|7156506|FG002|COMPLETED|Overall Study||6
6257396|NCT04653766|7156507|FG003|COMPLETED|Overall Study||6
6688151|NCT02708966|7618316|FG001|NOT COMPLETED|Overall Study||2
6688152|NCT02709005|7618324|FG000|STARTED|Overall Study||73
6688153|NCT02709005|7618325|FG001|STARTED|Overall Study||36
6688154|NCT02709005|7618324|FG000|COMPLETED|Overall Study||69
6688155|NCT02709005|7618325|FG001|COMPLETED|Overall Study||35
6688156|NCT02709005|7618324|FG000|NOT COMPLETED|Overall Study||4
6688157|NCT02709005|7618325|FG001|NOT COMPLETED|Overall Study||1
6688158|NCT02709018|7618333|FG000|STARTED|Overall Study||75
6688159|NCT02709018|7618334|FG001|STARTED|Overall Study||74
6688160|NCT02709018|7618333|FG000|COMPLETED|Overall Study||59
6688161|NCT02709018|7618334|FG001|COMPLETED|Overall Study||58
6688162|NCT02709018|7618333|FG000|NOT COMPLETED|Overall Study||16
6688163|NCT02709018|7618334|FG001|NOT COMPLETED|Overall Study||16
6688164|NCT02709096|7618344|FG000|STARTED|Overall Study||22
6688165|NCT02709096|7618345|FG001|STARTED|Overall Study||11
6688166|NCT02709096|7618344|FG000|COMPLETED|Overall Study||21
6688167|NCT02709096|7618345|FG001|COMPLETED|Overall Study||10
6688168|NCT02709096|7618344|FG000|NOT COMPLETED|Overall Study||1
6257397|NCT04653766|7156508|FG004|COMPLETED|Overall Study||8
6257398|NCT04653766|7156504|FG000|NOT COMPLETED|Overall Study||0
6602308|NCT02055976|7527280|FG002|STARTED|Overall Study||24
6602309|NCT02055976|7527281|FG003|STARTED|Overall Study||26
6257399|NCT04653766|7156505|FG001|NOT COMPLETED|Overall Study||0
6257400|NCT04653766|7156506|FG002|NOT COMPLETED|Overall Study||0
6257401|NCT04653766|7156507|FG003|NOT COMPLETED|Overall Study||0
6257402|NCT04653766|7156508|FG004|NOT COMPLETED|Overall Study||0
6279739|NCT00147745|7179611|FG000|STARTED|Overall Study||16
6279740|NCT00147745|7179612|FG001|STARTED|Overall Study||14
6279741|NCT00147745|7179613|FG002|STARTED|Overall Study||6
6279742|NCT00147745|7179611|FG000|COMPLETED|Overall Study||15
6279743|NCT00147745|7179612|FG001|COMPLETED|Overall Study||14
6279744|NCT00147745|7179613|FG002|COMPLETED|Overall Study||6
6279745|NCT00147745|7179611|FG000|NOT COMPLETED|Overall Study||1
6279746|NCT00147745|7179612|FG001|NOT COMPLETED|Overall Study||0
6279747|NCT00147745|7179613|FG002|NOT COMPLETED|Overall Study||0
6279748|NCT00147823|7179623|FG000|STARTED|Overall Study||32
6279749|NCT00147823|7179624|FG001|STARTED|Overall Study||31
6279750|NCT00147823|7179623|FG000|Week 6 Visit|Overall Study||26
6279751|NCT00147823|7179624|FG001|Week 6 Visit|Overall Study||28
6279752|NCT00147823|7179623|FG000|Month 3 Visit|Overall Study||25
6279753|NCT00147823|7179624|FG001|Month 3 Visit|Overall Study||24
6279754|NCT00147823|7179623|FG000|Month 6 Visit|Overall Study||25
6279755|NCT00147823|7179624|FG001|Month 6 Visit|Overall Study||21
6279756|NCT00147823|7179623|FG000|Month 12 Visit|Overall Study||21
6279757|NCT00147823|7179624|FG001|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
6279758|NCT00147823|7179623|FG000|Month 12 CT Scan|Overall Study||20
6279759|NCT00147823|7179624|FG001|Month 12 CT Scan|Overall Study||25
6279760|NCT00147823|7179623|FG000|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
6279761|NCT00147823|7179624|FG001|Month 18 Visit|Overall Study||20
6279762|NCT00147823|7179623|FG000|Month 24 Visit|Overall Study||21
6279763|NCT00147823|7179624|FG001|Month 24 Visit|Overall Study||18
6279764|NCT00147823|7179623|FG000|COMPLETED|Overall Study||19
6279765|NCT00147823|7179624|FG001|COMPLETED|Overall Study||16
6279766|NCT00147823|7179623|FG000|NOT COMPLETED|Overall Study||13
6279767|NCT00147823|7179624|FG001|NOT COMPLETED|Overall Study||15
6279768|NCT00147966|7179630|FG000|STARTED|Overall Study||24
6279769|NCT00147966|7179630|FG000|COMPLETED|Overall Study||24
6279770|NCT00147966|7179630|FG000|NOT COMPLETED|Overall Study||0
6279771|NCT00148109|7179636|FG000|STARTED|Overall Study||15
6279772|NCT00148109|7179637|FG001|STARTED|Overall Study||21
6279773|NCT00148109|7179636|FG000|COMPLETED|Overall Study||3
6279774|NCT00148109|7179637|FG001|COMPLETED|Overall Study||1
6279775|NCT00148109|7179636|FG000|NOT COMPLETED|Overall Study||12
6279776|NCT00148109|7179637|FG001|NOT COMPLETED|Overall Study||20
6279777|NCT00148122|7179643|FG000|STARTED|Overall Study||40
6279778|NCT00148122|7179643|FG000|COMPLETED|Overall Study||38
6279779|NCT00148122|7179643|FG000|NOT COMPLETED|Overall Study||2
6279780|NCT00148317|7179647|FG000|STARTED|Consolidation (VEL + DEX)||38
6279781|NCT00148317|7179647|FG000|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
6279782|NCT00148317|7179647|FG000|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
6279783|NCT00148317|7179647|FG000|no DOXIL Added|Consolidation (VEL + DEX)||10
6279784|NCT00148317|7179647|FG000|COMPLETED|Consolidation (VEL + DEX)||38
6279785|NCT00148317|7179647|FG000|NOT COMPLETED|Consolidation (VEL + DEX)||0
6279786|NCT00148317|7179647|FG000|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
6279787|NCT00148317|7179647|FG000|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
6279788|NCT00148317|7179647|FG000|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
6279789|NCT00148343|7179656|FG000|STARTED|Overall Study||54
6279790|NCT00148343|7179657|FG001|STARTED|Overall Study||56
6279791|NCT00148343|7179656|FG000|COMPLETED|Overall Study||39
6279792|NCT00148343|7179657|FG001|COMPLETED|Overall Study||45
6279793|NCT00148343|7179656|FG000|NOT COMPLETED|Overall Study||15
6279794|NCT00148343|7179657|FG001|NOT COMPLETED|Overall Study||11
6279795|NCT00148668|7179665|FG000|STARTED|Overall Study||41
6279796|NCT00148668|7179666|FG001|STARTED|Overall Study||40
6279797|NCT00148668|7179665|FG000|COMPLETED|Overall Study||41
6279798|NCT00148668|7179666|FG001|COMPLETED|Overall Study||40
6279799|NCT00148668|7179665|FG000|NOT COMPLETED|Overall Study||0
6279800|NCT00148668|7179666|FG001|NOT COMPLETED|Overall Study||0
6279801|NCT00148759|7179674|FG000|STARTED|Overall Study||11
6279802|NCT00148759|7179675|FG001|STARTED|Overall Study||12
6279803|NCT00148759|7179674|FG000|24-hr PK Sampling|Overall Study||9
6279804|NCT00148759|7179675|FG001|24-hr PK Sampling|Overall Study||11
6279805|NCT00148759|7179674|FG000|COMPLETED|Overall Study||9
6279806|NCT00148759|7179675|FG001|COMPLETED|Overall Study||11
6279807|NCT00148759|7179674|FG000|NOT COMPLETED|Overall Study||2
6688169|NCT02709096|7618345|FG001|NOT COMPLETED|Overall Study||1
6688170|NCT02709109|7618355|FG000|STARTED|Treatment Period 1 (28 Days)||49
6688171|NCT02709109|7618356|FG001|STARTED|Treatment Period 1 (28 Days)||47
6688172|NCT02709109|7618357|FG002|STARTED|Treatment Period 1 (28 Days)||22
6688173|NCT02709109|7618358|FG003|STARTED|Treatment Period 1 (28 Days)||24
6688174|NCT02709109|7618355|FG000|COMPLETED|Treatment Period 1 (28 Days)||45
6688175|NCT02709109|7618356|FG001|COMPLETED|Treatment Period 1 (28 Days)||42
6688176|NCT02709109|7618357|FG002|COMPLETED|Treatment Period 1 (28 Days)||21
6688177|NCT02709109|7618358|FG003|COMPLETED|Treatment Period 1 (28 Days)||24
6688178|NCT02709109|7618355|FG000|NOT COMPLETED|Treatment Period 1 (28 Days)||4
6688179|NCT02709109|7618356|FG001|NOT COMPLETED|Treatment Period 1 (28 Days)||5
6688180|NCT02709109|7618357|FG002|NOT COMPLETED|Treatment Period 1 (28 Days)||1
6688181|NCT02709109|7618358|FG003|NOT COMPLETED|Treatment Period 1 (28 Days)||0
6688182|NCT02709109|7618355|FG000|STARTED|Washout Period (28 Days)||45
6688183|NCT02709109|7618356|FG001|STARTED|Washout Period (28 Days)||42
6688184|NCT02709109|7618357|FG002|STARTED|Washout Period (28 Days)||21
6688185|NCT02709109|7618358|FG003|STARTED|Washout Period (28 Days)||24
6688186|NCT02709109|7618355|FG000|COMPLETED|Washout Period (28 Days)||43
6688187|NCT02709109|7618356|FG001|COMPLETED|Washout Period (28 Days)||40
6688188|NCT02709109|7618357|FG002|COMPLETED|Washout Period (28 Days)||18
6688189|NCT02709109|7618358|FG003|COMPLETED|Washout Period (28 Days)||24
6688190|NCT02709109|7618355|FG000|NOT COMPLETED|Washout Period (28 Days)||2
6688191|NCT02709109|7618356|FG001|NOT COMPLETED|Washout Period (28 Days)||2
6688192|NCT02709109|7618357|FG002|NOT COMPLETED|Washout Period (28 Days)||3
6688193|NCT02709109|7618358|FG003|NOT COMPLETED|Washout Period (28 Days)||0
6688194|NCT02709109|7618355|FG000|STARTED|Treatment Period 2 (28 Days)||43
6688195|NCT02709109|7618356|FG001|STARTED|Treatment Period 2 (28 Days)||40
6688196|NCT02709109|7618357|FG002|STARTED|Treatment Period 2 (28 Days)||18
6688197|NCT02709109|7618358|FG003|STARTED|Treatment Period 2 (28 Days)||24
6688198|NCT02709109|7618355|FG000|COMPLETED|Treatment Period 2 (28 Days)||41
6688199|NCT02709109|7618356|FG001|COMPLETED|Treatment Period 2 (28 Days)||36
6688200|NCT02709109|7618357|FG002|COMPLETED|Treatment Period 2 (28 Days)||15
6688201|NCT02709109|7618358|FG003|COMPLETED|Treatment Period 2 (28 Days)||24
6688202|NCT02709109|7618355|FG000|NOT COMPLETED|Treatment Period 2 (28 Days)||2
6688203|NCT02709109|7618356|FG001|NOT COMPLETED|Treatment Period 2 (28 Days)||4
6688204|NCT02709109|7618357|FG002|NOT COMPLETED|Treatment Period 2 (28 Days)||3
6688205|NCT02709109|7618358|FG003|NOT COMPLETED|Treatment Period 2 (28 Days)||0
6688206|NCT02709330|7618369|FG000|STARTED|Overall Study||50
6688207|NCT02709330|7618370|FG001|STARTED|Overall Study||10
6688208|NCT02709330|7618369|FG000|COMPLETED|Overall Study||37
6688209|NCT02709330|7618370|FG001|COMPLETED|Overall Study||10
6688210|NCT02709330|7618369|FG000|NOT COMPLETED|Overall Study||13
6688211|NCT02709330|7618370|FG001|NOT COMPLETED|Overall Study||0
6688212|NCT02709369|7618376|FG000|STARTED|Overall Study||300
6688213|NCT02709369|7618376|FG000|COMPLETED|Overall Study||273
6688214|NCT02709369|7618376|FG000|NOT COMPLETED|Overall Study||27
6688215|NCT02709486|7618383|FG000|STARTED|Overall Study||282
6688216|NCT02709486|7618384|FG001|STARTED|Overall Study||283
6688217|NCT02709486|7618385|FG002|STARTED|Overall Study||284
6688218|NCT02709486|7618383|FG000|COMPLETED|Overall Study||238
6688219|NCT02709486|7618384|FG001|COMPLETED|Overall Study||249
6257403|NCT04646291|7156532|FG000|STARTED|Overall Study||272
6257404|NCT04646291|7156533|FG001|STARTED|Overall Study||70
6257405|NCT04646291|7156534|FG002|STARTED|Overall Study||8
6257406|NCT04646291|7156532|FG000|COMPLETED|Overall Study||272
6257407|NCT04646291|7156533|FG001|COMPLETED|Overall Study||70
6602310|NCT02055976|7527282|FG004|STARTED|Overall Study||22
6602311|NCT02055976|7527283|FG005|STARTED|Overall Study||25
6602312|NCT02055976|7527284|FG006|STARTED|Overall Study||25
6257408|NCT04646291|7156534|FG002|COMPLETED|Overall Study||8
6257409|NCT04646291|7156532|FG000|NOT COMPLETED|Overall Study||0
6257410|NCT04646291|7156533|FG001|NOT COMPLETED|Overall Study||0
6257411|NCT04646291|7156534|FG002|NOT COMPLETED|Overall Study||0
6257412|NCT04646109|7156550|FG000|STARTED|Overall Study||30
6257413|NCT04646109|7156551|FG001|STARTED|Overall Study||36
6257414|NCT04646109|7156550|FG000|COMPLETED|Overall Study||30
6257415|NCT04646109|7156551|FG001|COMPLETED|Overall Study||30
6257416|NCT04646109|7156550|FG000|NOT COMPLETED|Overall Study||0
6257417|NCT04646109|7156551|FG001|NOT COMPLETED|Overall Study||6
6257418|NCT04637997|7156560|FG000|STARTED|Overall Study||9
6257419|NCT04637997|7156561|FG001|STARTED|Overall Study||9
6257420|NCT04637997|7156560|FG000|COMPLETED|Overall Study||9
6257421|NCT04637997|7156561|FG001|COMPLETED|Overall Study||9
6257422|NCT04637997|7156560|FG000|NOT COMPLETED|Overall Study||0
6257423|NCT04637997|7156561|FG001|NOT COMPLETED|Overall Study||0
6257442|NCT04628221|7156598|FG000|STARTED|Overall Study||40
6257443|NCT04628221|7156598|FG000|COMPLETED|Overall Study||40
6257444|NCT04628221|7156598|FG000|NOT COMPLETED|Overall Study||0
6602313|NCT02055976|7527285|FG007|STARTED|Overall Study||24
6602314|NCT02055976|7527286|FG008|STARTED|Overall Study||23
6602315|NCT02055976|7527278|FG000|COMPLETED|Overall Study||25
6602316|NCT02055976|7527279|FG001|COMPLETED|Overall Study||24
6602317|NCT02055976|7527280|FG002|COMPLETED|Overall Study||23
6602318|NCT02055976|7527281|FG003|COMPLETED|Overall Study||25
6602319|NCT02055976|7527282|FG004|COMPLETED|Overall Study||22
6602320|NCT02055976|7527283|FG005|COMPLETED|Overall Study||24
6602321|NCT02055976|7527284|FG006|COMPLETED|Overall Study||23
6602322|NCT02055976|7527285|FG007|COMPLETED|Overall Study||24
6602323|NCT02055976|7527286|FG008|COMPLETED|Overall Study||23
6688220|NCT02709486|7618385|FG002|COMPLETED|Overall Study||239
6688221|NCT02709486|7618383|FG000|NOT COMPLETED|Overall Study||44
6688222|NCT02709486|7618384|FG001|NOT COMPLETED|Overall Study||34
6688223|NCT02709486|7618385|FG002|NOT COMPLETED|Overall Study||45
6688224|NCT02709538|7618396|FG000|STARTED|Overall Study||400
6688225|NCT02709538|7618397|FG001|STARTED|Overall Study||100
6688226|NCT02709538|7618398|FG002|STARTED|Overall Study||101
6688227|NCT02709538|7618396|FG000|COMPLETED|Overall Study||287
6688228|NCT02709538|7618397|FG001|COMPLETED|Overall Study||72
6688229|NCT02709538|7618398|FG002|COMPLETED|Overall Study||81
6688230|NCT02709538|7618396|FG000|NOT COMPLETED|Overall Study||113
6688231|NCT02709538|7618397|FG001|NOT COMPLETED|Overall Study||28
6688232|NCT02709538|7618398|FG002|NOT COMPLETED|Overall Study||20
6688233|NCT02709577|7618408|FG000|STARTED|Overall Study||12
6688234|NCT02709577|7618409|FG001|STARTED|Overall Study||13
6688235|NCT02709577|7618410|FG002|STARTED|Overall Study||6
6688236|NCT02709577|7618411|FG003|STARTED|Overall Study||5
6688237|NCT02709577|7618408|FG000|COMPLETED|Overall Study||10
6688238|NCT02709577|7618409|FG001|COMPLETED|Overall Study||8
6688239|NCT02709577|7618410|FG002|COMPLETED|Overall Study||4
6688240|NCT02709577|7618411|FG003|COMPLETED|Overall Study||5
6688241|NCT02709577|7618408|FG000|NOT COMPLETED|Overall Study||2
6688242|NCT02709577|7618409|FG001|NOT COMPLETED|Overall Study||5
6688243|NCT02709577|7618410|FG002|NOT COMPLETED|Overall Study||2
6688244|NCT02709577|7618411|FG003|NOT COMPLETED|Overall Study||0
6688245|NCT02709694|7618422|FG000|STARTED|Overall Study||33
6688246|NCT02709694|7618422|FG000|Any Back Pain|Overall Study||19
6688247|NCT02709694|7618422|FG000|No Back Pain|Overall Study||14
6688248|NCT02709694|7618422|FG000|MRI Showing Presence of Sacroiliitis|Overall Study||4
6688249|NCT02709694|7618422|FG000|MRI Not Showing Sacroiliitis|Overall Study||29
6688250|NCT02709694|7618422|FG000|Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||6
6688251|NCT02709694|7618422|FG000|Not Classified as Having Inflammatory Back Pain by the ASAS Criteria|Overall Study||25
6688252|NCT02709694|7618422|FG000|Having Bone Marrow Edema Seen in MRI|Overall Study||33
6688253|NCT02709694|7618422|FG000|Having Erosion (a Structural Lesion) Seen in MRI|Overall Study||33
6688254|NCT02709694|7618422|FG000|Having Fat Metaplasia Seen in MRI|Overall Study||33
6688255|NCT02709694|7618422|FG000|Having Backfill (Type of Structural Lesion) Seen in MRI|Overall Study||33
6688256|NCT02709694|7618422|FG000|Having Ankylosis Seen in MRI|Overall Study||33
6688257|NCT02709694|7618422|FG000|COMPLETED|Overall Study||33
6688258|NCT02709694|7618422|FG000|NOT COMPLETED|Overall Study||0
6688259|NCT02709746|7618441|FG000|STARTED|Phase A (Single-blind Treatment Period)||784
6688260|NCT02709746|7618442|FG001|STARTED|Phase A (Single-blind Treatment Period)||0
6688261|NCT02709746|7618443|FG002|STARTED|Phase A (Single-blind Treatment Period)||0
6688262|NCT02709746|7618444|FG003|STARTED|Phase A (Single-blind Treatment Period)||0
6688263|NCT02709746|7618445|FG004|STARTED|Phase A (Single-blind Treatment Period)||0
6688264|NCT02709746|7618441|FG000|COMPLETED|Phase A (Single-blind Treatment Period)||616
6688265|NCT02709746|7618442|FG001|COMPLETED|Phase A (Single-blind Treatment Period)||0
6688266|NCT02709746|7618443|FG002|COMPLETED|Phase A (Single-blind Treatment Period)||0
6688267|NCT02709746|7618444|FG003|COMPLETED|Phase A (Single-blind Treatment Period)||0
6688268|NCT02709746|7618445|FG004|COMPLETED|Phase A (Single-blind Treatment Period)||0
6688269|NCT02709746|7618441|FG000|NOT COMPLETED|Phase A (Single-blind Treatment Period)||168
6688270|NCT02709746|7618442|FG001|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
6688271|NCT02709746|7618443|FG002|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
6688272|NCT02709746|7618444|FG003|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
6688273|NCT02709746|7618445|FG004|NOT COMPLETED|Phase A (Single-blind Treatment Period)||0
6688274|NCT02709746|7618441|FG000|STARTED|Phase B (Double-blind Treatment Period)||0
6688275|NCT02709746|7618442|FG001|STARTED|Phase B (Double-blind Treatment Period)||147
6688276|NCT02709746|7618443|FG002|STARTED|Phase B (Double-blind Treatment Period)||162
6688277|NCT02709746|7618444|FG003|STARTED|Phase B (Double-blind Treatment Period)||153
6688278|NCT02709746|7618445|FG004|STARTED|Phase B (Double-blind Treatment Period)||154
6688279|NCT02709746|7618441|FG000|COMPLETED|Phase B (Double-blind Treatment Period)||0
6688280|NCT02709746|7618442|FG001|COMPLETED|Phase B (Double-blind Treatment Period)||126
6688281|NCT02709746|7618443|FG002|COMPLETED|Phase B (Double-blind Treatment Period)||140
6688282|NCT02709746|7618444|FG003|COMPLETED|Phase B (Double-blind Treatment Period)||138
6688283|NCT02709746|7618445|FG004|COMPLETED|Phase B (Double-blind Treatment Period)||138
6688284|NCT02709746|7618441|FG000|NOT COMPLETED|Phase B (Double-blind Treatment Period)||0
6688285|NCT02709746|7618442|FG001|NOT COMPLETED|Phase B (Double-blind Treatment Period)||21
6688286|NCT02709746|7618443|FG002|NOT COMPLETED|Phase B (Double-blind Treatment Period)||22
6688287|NCT02709746|7618444|FG003|NOT COMPLETED|Phase B (Double-blind Treatment Period)||15
6688288|NCT02709746|7618445|FG004|NOT COMPLETED|Phase B (Double-blind Treatment Period)||16
6688289|NCT02709785|7618460|FG000|STARTED|Overall Study||24
6688290|NCT02709785|7618461|FG001|STARTED|Overall Study||28
6688291|NCT02709785|7618462|FG002|STARTED|Overall Study||28
6688292|NCT02709785|7618460|FG000|3 Weeks|Overall Study||23
6688293|NCT02709785|7618461|FG001|3 Weeks|Overall Study||27
6688294|NCT02709785|7618462|FG002|3 Weeks|Overall Study||27
6688295|NCT02709785|7618460|FG000|6 Weeks|Overall Study||23
6688296|NCT02709785|7618461|FG001|6 Weeks|Overall Study||26
6688297|NCT02709785|7618462|FG002|6 Weeks|Overall Study||27
6688298|NCT02709785|7618460|FG000|COMPLETED|Overall Study||23
6688299|NCT02709785|7618461|FG001|COMPLETED|Overall Study||26
6688300|NCT02709785|7618462|FG002|COMPLETED|Overall Study||27
6688301|NCT02709785|7618460|FG000|NOT COMPLETED|Overall Study||1
6688302|NCT02709785|7618461|FG001|NOT COMPLETED|Overall Study||2
6688303|NCT02709785|7618462|FG002|NOT COMPLETED|Overall Study||1
6688304|NCT02709889|7618478|FG000|STARTED|Overall Study||43
6688305|NCT02709889|7618479|FG001|STARTED|Overall Study||57
6688306|NCT02709889|7618480|FG002|STARTED|Overall Study||12
6688307|NCT02709889|7618481|FG003|STARTED|Overall Study||88
6688308|NCT02709889|7618478|FG000|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||3
6688309|NCT02709889|7618479|FG001|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
6257424|NCT04634903|7156574|FG000|STARTED|Overall Study||818
6257425|NCT04634903|7156575|FG001|STARTED|Overall Study||821
6257426|NCT04634903|7156576|FG002|STARTED|Overall Study||813
6257427|NCT04634903|7156574|FG000|COMPLETED|Overall Study||669
6257428|NCT04634903|7156575|FG001|COMPLETED|Overall Study||732
6257429|NCT04634903|7156576|FG002|COMPLETED|Overall Study||653
6257430|NCT04634903|7156574|FG000|NOT COMPLETED|Overall Study||149
6257431|NCT04634903|7156575|FG001|NOT COMPLETED|Overall Study||89
6257432|NCT04634903|7156576|FG002|NOT COMPLETED|Overall Study||160
6257445|NCT04625426|7156605|FG000|STARTED|Overall Study||23
6257446|NCT04625426|7156606|FG001|STARTED|Overall Study||37
6257447|NCT04625426|7156607|FG002|STARTED|Overall Study||24
6257448|NCT04625426|7156605|FG000|COMPLETED|Overall Study||9
6257449|NCT04625426|7156606|FG001|COMPLETED|Overall Study||12
6257450|NCT04625426|7156607|FG002|COMPLETED|Overall Study||12
6257451|NCT04625426|7156605|FG000|NOT COMPLETED|Overall Study||14
6257452|NCT04625426|7156606|FG001|NOT COMPLETED|Overall Study||25
6257453|NCT04625426|7156607|FG002|NOT COMPLETED|Overall Study||12
6257454|NCT04617509|7156615|FG000|STARTED|Period 1: Part 1 Formulation A||14
6257455|NCT04617509|7156616|FG001|STARTED|Period 1: Part 1 Formulation A||0
6257456|NCT04617509|7156617|FG002|STARTED|Period 1: Part 1 Formulation A|Subjects were expected to participate in both Part I and Part II, seven visits in total. Subject 112 was prematurely withdrawn from the study due to self-reported Covid-19-like symptoms via phone after Visit 5, i.e. after receiving both GS-248 formulations but prior to the food interaction part. This means subject 112 was withdrawn after Part I Formulation B but before Part II which cannot be visualized in the Period section. The correct number of subjects started Part II is thus 13.|0
6257457|NCT04617509|7156615|FG000|COMPLETED|Period 1: Part 1 Formulation A||14
6257458|NCT04617509|7156616|FG001|COMPLETED|Period 1: Part 1 Formulation A||0
6257459|NCT04617509|7156617|FG002|COMPLETED|Period 1: Part 1 Formulation A||0
6257460|NCT04617509|7156615|FG000|NOT COMPLETED|Period 1: Part 1 Formulation A||0
6257461|NCT04617509|7156616|FG001|NOT COMPLETED|Period 1: Part 1 Formulation A||0
6257462|NCT04617509|7156617|FG002|NOT COMPLETED|Period 1: Part 1 Formulation A||0
6257463|NCT04617509|7156615|FG000|STARTED|Period 2: Part 1 Formulation B||0
6257464|NCT04617509|7156616|FG001|STARTED|Period 2: Part 1 Formulation B||14
6257465|NCT04617509|7156617|FG002|STARTED|Period 2: Part 1 Formulation B||0
6257466|NCT04617509|7156615|FG000|COMPLETED|Period 2: Part 1 Formulation B||0
6257467|NCT04617509|7156616|FG001|COMPLETED|Period 2: Part 1 Formulation B||14
6257468|NCT04617509|7156617|FG002|COMPLETED|Period 2: Part 1 Formulation B||0
6257469|NCT04617509|7156615|FG000|NOT COMPLETED|Period 2: Part 1 Formulation B||0
6257470|NCT04617509|7156616|FG001|NOT COMPLETED|Period 2: Part 1 Formulation B||0
6257471|NCT04617509|7156617|FG002|NOT COMPLETED|Period 2: Part 1 Formulation B||0
6257472|NCT04617509|7156615|FG000|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
6257473|NCT04617509|7156616|FG001|STARTED|Period 3: Part 2 Formulation A Fed Cond.||0
6257474|NCT04617509|7156617|FG002|STARTED|Period 3: Part 2 Formulation A Fed Cond.||14
6257475|NCT04617509|7156615|FG000|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
6257476|NCT04617509|7156616|FG001|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
6257477|NCT04617509|7156617|FG002|COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||13
6257478|NCT04617509|7156615|FG000|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
6257479|NCT04617509|7156616|FG001|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||0
6257480|NCT04617509|7156617|FG002|NOT COMPLETED|Period 3: Part 2 Formulation A Fed Cond.||1
6279808|NCT00148759|7179675|FG001|NOT COMPLETED|Overall Study||1
6688310|NCT02709889|7618480|FG002|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||2
6279809|NCT00148798|7179683|FG000|STARTED|Overall Study|Intent To Treat (ITT) Population|557
6279810|NCT00148798|7179684|FG001|STARTED|Overall Study|ITT Population|568
6279811|NCT00148798|7179683|FG000|COMPLETED|Overall Study||557
6279812|NCT00148798|7179684|FG001|COMPLETED|Overall Study||568
6279813|NCT00148798|7179683|FG000|NOT COMPLETED|Overall Study||0
6279814|NCT00148798|7179684|FG001|NOT COMPLETED|Overall Study||0
6279815|NCT00148941|7179696|FG000|STARTED|Overall Study||1053
6279816|NCT00148941|7179697|FG001|STARTED|Overall Study||1051
6279817|NCT00148941|7179698|FG002|STARTED|Overall Study||1052
6279818|NCT00148941|7179699|FG003|STARTED|Overall Study||1053
6279819|NCT00148941|7179696|FG000|COMPLETED|Overall Study||1035
6279820|NCT00148941|7179697|FG001|COMPLETED|Overall Study||1027
6279821|NCT00148941|7179698|FG002|COMPLETED|Overall Study||1032
6279822|NCT00148941|7179699|FG003|COMPLETED|Overall Study||1029
6279823|NCT00148941|7179696|FG000|NOT COMPLETED|Overall Study||18
6279824|NCT00148941|7179697|FG001|NOT COMPLETED|Overall Study||24
6279825|NCT00148941|7179698|FG002|NOT COMPLETED|Overall Study||20
6279826|NCT00148941|7179699|FG003|NOT COMPLETED|Overall Study||24
6279827|NCT00148954|7179711|FG000|STARTED|Overall Study||985
6279828|NCT00148954|7179712|FG001|STARTED|Overall Study||977
6279829|NCT00148954|7179711|FG000|COMPLETED|Overall Study||678
6279830|NCT00148954|7179712|FG001|COMPLETED|Overall Study||677
6279831|NCT00148954|7179711|FG000|NOT COMPLETED|Overall Study||307
6688311|NCT02709889|7618481|FG003|Large Cell Neuroendocrine Carcinoma(NEC)|Overall Study||4
6688312|NCT02709889|7618478|FG000|Neuroendocrine Prostate Cancer|Overall Study||4
6688313|NCT02709889|7618479|FG001|Neuroendocrine Prostate Cancer|Overall Study||7
6688314|NCT02709889|7618480|FG002|Neuroendocrine Prostate Cancer|Overall Study||3
6688315|NCT02709889|7618481|FG003|Neuroendocrine Prostate Cancer|Overall Study||7
6688316|NCT02709889|7618478|FG000|Gastroenteropancreatic NEC|Overall Study||6
6688317|NCT02709889|7618479|FG001|Gastroenteropancreatic NEC|Overall Study||5
6688318|NCT02709889|7618480|FG002|Gastroenteropancreatic NEC|Overall Study||2
6688319|NCT02709889|7618481|FG003|Gastroenteropancreatic NEC|Overall Study||23
6688320|NCT02709889|7618478|FG000|Other NEC|Overall Study||11
6688321|NCT02709889|7618479|FG001|Other NEC|Overall Study||12
6688322|NCT02709889|7618480|FG002|Other NEC|Overall Study||1
6688323|NCT02709889|7618481|FG003|Other NEC|Overall Study||7
6688324|NCT02709889|7618478|FG000|Malignant Melanoma|Overall Study||3
6688325|NCT02709889|7618479|FG001|Malignant Melanoma|Overall Study||6
6688326|NCT02709889|7618480|FG002|Malignant Melanoma|Overall Study||0
6688327|NCT02709889|7618481|FG003|Malignant Melanoma|Overall Study||11
6688328|NCT02709889|7618478|FG000|Medullary Thyroid Cancer|Overall Study||3
6688329|NCT02709889|7618479|FG001|Medullary Thyroid Cancer|Overall Study||3
6688330|NCT02709889|7618480|FG002|Medullary Thyroid Cancer|Overall Study||0
6688331|NCT02709889|7618481|FG003|Medullary Thyroid Cancer|Overall Study||7
6688332|NCT02709889|7618478|FG000|Glioblastoma|Overall Study||4
6688333|NCT02709889|7618479|FG001|Glioblastoma|Overall Study||4
6688334|NCT02709889|7618480|FG002|Glioblastoma|Overall Study||1
6688335|NCT02709889|7618481|FG003|Glioblastoma|Overall Study||14
6688336|NCT02709889|7618478|FG000|Other Solid Tumors|Overall Study||9
6688337|NCT02709889|7618479|FG001|Other Solid Tumors|Overall Study||16
6688338|NCT02709889|7618480|FG002|Other Solid Tumors|Overall Study||3
6688339|NCT02709889|7618481|FG003|Other Solid Tumors|Overall Study||15
6688340|NCT02709889|7618478|FG000|COMPLETED|Overall Study||0
6688341|NCT02709889|7618479|FG001|COMPLETED|Overall Study||0
6688342|NCT02709889|7618480|FG002|COMPLETED|Overall Study||0
6688343|NCT02709889|7618481|FG003|COMPLETED|Overall Study||0
6688344|NCT02709889|7618478|FG000|NOT COMPLETED|Overall Study||43
6688345|NCT02709889|7618479|FG001|NOT COMPLETED|Overall Study||57
6688346|NCT02709889|7618480|FG002|NOT COMPLETED|Overall Study||12
6688347|NCT02709889|7618481|FG003|NOT COMPLETED|Overall Study||88
6688348|NCT02710045|7618529|FG000|STARTED|Overall Study||106
6688349|NCT02710045|7618530|FG001|STARTED|Overall Study||115
6688350|NCT02710045|7618531|FG002|STARTED|Overall Study||81
6688351|NCT02710045|7618529|FG000|COMPLETED|Overall Study||95
6688352|NCT02710045|7618530|FG001|COMPLETED|Overall Study||98
6688353|NCT02710045|7618531|FG002|COMPLETED|Overall Study||68
6688354|NCT02710045|7618529|FG000|NOT COMPLETED|Overall Study||11
6688355|NCT02710045|7618530|FG001|NOT COMPLETED|Overall Study||17
6688356|NCT02710045|7618531|FG002|NOT COMPLETED|Overall Study||13
6688357|NCT02710071|7618541|FG000|STARTED|Placebo (2 Weeks).||21
6688358|NCT02710071|7618542|FG001|STARTED|Placebo (2 Weeks).||20
6688359|NCT02710071|7618541|FG000|COMPLETED|Placebo (2 Weeks).||21
6688360|NCT02710071|7618542|FG001|COMPLETED|Placebo (2 Weeks).||20
6688361|NCT02710071|7618541|FG000|NOT COMPLETED|Placebo (2 Weeks).||0
6688362|NCT02710071|7618542|FG001|NOT COMPLETED|Placebo (2 Weeks).||0
6688363|NCT02710071|7618541|FG000|STARTED|First Intervention (6 Weeks).||21
6688364|NCT02710071|7618542|FG001|STARTED|First Intervention (6 Weeks).||20
6688365|NCT02710071|7618541|FG000|COMPLETED|First Intervention (6 Weeks).||18
6688366|NCT02710071|7618542|FG001|COMPLETED|First Intervention (6 Weeks).||16
6688367|NCT02710071|7618541|FG000|NOT COMPLETED|First Intervention (6 Weeks).||3
6257433|NCT04633642|7156586|FG000|STARTED|Overall Study|27 participants|27
6257434|NCT04633642|7156587|FG001|STARTED|Overall Study|24 participants|24
6257435|NCT04633642|7156586|FG000|COMPLETED|Overall Study|26 participants|26
6257436|NCT04633642|7156587|FG001|COMPLETED|Overall Study|22 participants|22
6257437|NCT04633642|7156586|FG000|NOT COMPLETED|Overall Study||1
6257438|NCT04633642|7156587|FG001|NOT COMPLETED|Overall Study||2
6257439|NCT04633174|7156593|FG000|STARTED|Overall Study||1
6257440|NCT04633174|7156593|FG000|COMPLETED|Overall Study||1
6257441|NCT04633174|7156593|FG000|NOT COMPLETED|Overall Study||0
6257481|NCT04616430|7156630|FG000|STARTED|Overall Study||30
6257482|NCT04616430|7156631|FG001|STARTED|Overall Study||30
6257483|NCT04616430|7156632|FG002|STARTED|Overall Study||30
6257484|NCT04616430|7156630|FG000|COMPLETED|Overall Study||23
6257485|NCT04616430|7156631|FG001|COMPLETED|Overall Study||2
6257486|NCT04616430|7156632|FG002|COMPLETED|Overall Study||0
6257487|NCT04616430|7156630|FG000|NOT COMPLETED|Overall Study||7
6257488|NCT04616430|7156631|FG001|NOT COMPLETED|Overall Study||28
6257489|NCT04616430|7156632|FG002|NOT COMPLETED|Overall Study||30
6257490|NCT04615507|7156642|FG000|STARTED|Period 1||34
6257491|NCT04615507|7156643|FG001|STARTED|Period 1||34
6688368|NCT02710071|7618542|FG001|NOT COMPLETED|First Intervention (6 Weeks).||4
6688369|NCT02710071|7618541|FG000|STARTED|Second Intervention (6 Weeks).||18
6688370|NCT02710071|7618542|FG001|STARTED|Second Intervention (6 Weeks).||16
6688371|NCT02710071|7618541|FG000|COMPLETED|Second Intervention (6 Weeks).||17
6688372|NCT02710071|7618542|FG001|COMPLETED|Second Intervention (6 Weeks).||14
6688373|NCT02710071|7618541|FG000|NOT COMPLETED|Second Intervention (6 Weeks).||1
6257492|NCT04615507|7156642|FG000|COMPLETED|Period 1||32
6257493|NCT04615507|7156643|FG001|COMPLETED|Period 1||33
6688374|NCT02710071|7618542|FG001|NOT COMPLETED|Second Intervention (6 Weeks).||2
6688375|NCT02710136|7618551|FG000|STARTED|Study Enrollment||10
6688376|NCT02710136|7618552|FG001|STARTED|Study Enrollment||25
6688377|NCT02710136|7618551|FG000|COMPLETED|Study Enrollment||10
6688378|NCT02710136|7618552|FG001|COMPLETED|Study Enrollment||25
6688379|NCT02710136|7618551|FG000|NOT COMPLETED|Study Enrollment||0
6688380|NCT02710136|7618552|FG001|NOT COMPLETED|Study Enrollment||0
6688381|NCT02710136|7618551|FG000|STARTED|Phase 1a[Refer to Arm/Group Description]||10
6688382|NCT02710136|7618552|FG001|STARTED|Phase 1a[Refer to Arm/Group Description]||0
6688383|NCT02710136|7618551|FG000|COMPLETED|Phase 1a[Refer to Arm/Group Description]||9
6688384|NCT02710136|7618552|FG001|COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
6688385|NCT02710136|7618551|FG000|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||1
6688386|NCT02710136|7618552|FG001|NOT COMPLETED|Phase 1a[Refer to Arm/Group Description]||0
6688387|NCT02710136|7618551|FG000|STARTED|Phase 1b[Refer to Arm/Group Description]||4
6688388|NCT02710136|7618552|FG001|STARTED|Phase 1b[Refer to Arm/Group Description]||0
6688389|NCT02710136|7618551|FG000|COMPLETED|Phase 1b[Refer to Arm/Group Description]||4
6688390|NCT02710136|7618552|FG001|COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
6688391|NCT02710136|7618551|FG000|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
6688392|NCT02710136|7618552|FG001|NOT COMPLETED|Phase 1b[Refer to Arm/Group Description]||0
6688393|NCT02710136|7618551|FG000|STARTED|Phase 2 [Refer to Arm/Group Description]||0
6688394|NCT02710136|7618552|FG001|STARTED|Phase 2 [Refer to Arm/Group Description]||25
6688395|NCT02710136|7618551|FG000|COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
6688396|NCT02710136|7618552|FG001|COMPLETED|Phase 2 [Refer to Arm/Group Description]||25
6688397|NCT02710136|7618551|FG000|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
6688398|NCT02710136|7618552|FG001|NOT COMPLETED|Phase 2 [Refer to Arm/Group Description]||0
6688399|NCT02710214|7618561|FG000|STARTED|Overall Study||12
6688400|NCT02710214|7618562|FG001|STARTED|Overall Study||12
6688401|NCT02710214|7618561|FG000|COMPLETED|Overall Study||11
6688402|NCT02710214|7618562|FG001|COMPLETED|Overall Study||10
6688403|NCT02710214|7618561|FG000|NOT COMPLETED|Overall Study||1
6688404|NCT02710214|7618562|FG001|NOT COMPLETED|Overall Study||2
6688405|NCT02710240|7618568|FG000|STARTED|Overall Study||336
6688406|NCT02710240|7618568|FG000|COMPLETED|Overall Study||336
6688407|NCT02710240|7618568|FG000|NOT COMPLETED|Overall Study||0
6688408|NCT02710292|7618572|FG000|STARTED|Period 1, First 10 Days of Wear||47
6688409|NCT02710292|7618573|FG001|STARTED|Period 1, First 10 Days of Wear||52
6688410|NCT02710292|7618572|FG000|COMPLETED|Period 1, First 10 Days of Wear||46
6688411|NCT02710292|7618573|FG001|COMPLETED|Period 1, First 10 Days of Wear||49
6688412|NCT02710292|7618572|FG000|NOT COMPLETED|Period 1, First 10 Days of Wear||1
6688413|NCT02710292|7618573|FG001|NOT COMPLETED|Period 1, First 10 Days of Wear||3
6688414|NCT02710292|7618572|FG000|STARTED|Period 2, Second 10 Days of Wear||46
6688415|NCT02710292|7618573|FG001|STARTED|Period 2, Second 10 Days of Wear||49
6688416|NCT02710292|7618572|FG000|COMPLETED|Period 2, Second 10 Days of Wear||46
6688417|NCT02710292|7618573|FG001|COMPLETED|Period 2, Second 10 Days of Wear||49
6688418|NCT02710292|7618572|FG000|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
6688419|NCT02710292|7618573|FG001|NOT COMPLETED|Period 2, Second 10 Days of Wear||0
6688420|NCT02710422|7618582|FG000|STARTED|Overall Study||12
6688421|NCT02710422|7618583|FG001|STARTED|Overall Study||12
6688422|NCT02710422|7618582|FG000|3 Month Visit|Overall Study||9
6688423|NCT02710422|7618583|FG001|3 Month Visit|Overall Study||11
6688424|NCT02710422|7618582|FG000|6 Month Visit|Overall Study||7
6688425|NCT02710422|7618583|FG001|6 Month Visit|Overall Study||8
6688426|NCT02710422|7618582|FG000|9 Month Visit|Overall Study||5
6688427|NCT02710422|7618583|FG001|9 Month Visit|Overall Study||5
6688428|NCT02710422|7618582|FG000|12 Month Visit|Overall Study||3
6688429|NCT02710422|7618583|FG001|12 Month Visit|Overall Study||3
6688430|NCT02710422|7618582|FG000|COMPLETED|Overall Study||3
6688431|NCT02710422|7618583|FG001|COMPLETED|Overall Study||3
6688432|NCT02710422|7618582|FG000|NOT COMPLETED|Overall Study||9
6688433|NCT02710422|7618583|FG001|NOT COMPLETED|Overall Study||9
6688434|NCT02710526|7618594|FG000|STARTED|Treatment Phase||28
6688435|NCT02710526|7618595|FG001|STARTED|Treatment Phase||20
6688436|NCT02710526|7618596|FG002|STARTED|Treatment Phase||18
6688437|NCT02710526|7618594|FG000|COMPLETED|Treatment Phase||22
6688438|NCT02710526|7618595|FG001|COMPLETED|Treatment Phase||16
6688439|NCT02710526|7618596|FG002|COMPLETED|Treatment Phase||12
6688440|NCT02710526|7618594|FG000|NOT COMPLETED|Treatment Phase||6
6688441|NCT02710526|7618595|FG001|NOT COMPLETED|Treatment Phase||4
6688442|NCT02710526|7618596|FG002|NOT COMPLETED|Treatment Phase||6
6688443|NCT02710526|7618594|FG000|STARTED|Safety Extension||15
6688444|NCT02710526|7618595|FG001|STARTED|Safety Extension||12
6688445|NCT02710526|7618596|FG002|STARTED|Safety Extension||0
6688446|NCT02710526|7618594|FG000|COMPLETED|Safety Extension||14
6688447|NCT02710526|7618595|FG001|COMPLETED|Safety Extension||12
6688448|NCT02710526|7618596|FG002|COMPLETED|Safety Extension||0
6688449|NCT02710526|7618594|FG000|NOT COMPLETED|Safety Extension||1
6688450|NCT02710526|7618595|FG001|NOT COMPLETED|Safety Extension||0
6688451|NCT02710526|7618596|FG002|NOT COMPLETED|Safety Extension||0
6688452|NCT02710591|7618618|FG000|STARTED|Overall Study||5
6688453|NCT02710591|7618619|FG001|STARTED|Overall Study||5
6688454|NCT02710591|7618620|FG002|STARTED|Overall Study||5
6688455|NCT02710591|7618621|FG003|STARTED|Overall Study||5
6688456|NCT02710591|7618618|FG000|COMPLETED|Overall Study||5
6688457|NCT02710591|7618619|FG001|COMPLETED|Overall Study||5
6688458|NCT02710591|7618620|FG002|COMPLETED|Overall Study||5
6688459|NCT02710591|7618621|FG003|COMPLETED|Overall Study||5
6688460|NCT02710591|7618618|FG000|NOT COMPLETED|Overall Study||0
6688461|NCT02710591|7618619|FG001|NOT COMPLETED|Overall Study||0
6688462|NCT02710591|7618620|FG002|NOT COMPLETED|Overall Study||0
6688463|NCT02710591|7618621|FG003|NOT COMPLETED|Overall Study||0
6688464|NCT02710630|7618636|FG000|STARTED|Period 1||7
6688465|NCT02710630|7618637|FG001|STARTED|Period 1||7
6688466|NCT02710630|7618638|FG002|STARTED|Period 1||7
6688467|NCT02710630|7618639|FG003|STARTED|Period 1||7
6688468|NCT02710630|7618640|FG004|STARTED|Period 1||7
6688469|NCT02710630|7618636|FG000|COMPLETED|Period 1||7
6688470|NCT02710630|7618637|FG001|COMPLETED|Period 1||7
6688471|NCT02710630|7618638|FG002|COMPLETED|Period 1||7
6688472|NCT02710630|7618639|FG003|COMPLETED|Period 1||7
6688473|NCT02710630|7618640|FG004|COMPLETED|Period 1||7
6688474|NCT02710630|7618636|FG000|NOT COMPLETED|Period 1||0
6688475|NCT02710630|7618637|FG001|NOT COMPLETED|Period 1||0
6688476|NCT02710630|7618638|FG002|NOT COMPLETED|Period 1||0
6688477|NCT02710630|7618639|FG003|NOT COMPLETED|Period 1||0
6688478|NCT02710630|7618640|FG004|NOT COMPLETED|Period 1||0
6688479|NCT02710630|7618636|FG000|STARTED|Period 2||7
6688480|NCT02710630|7618637|FG001|STARTED|Period 2||7
6688481|NCT02710630|7618638|FG002|STARTED|Period 2||7
6688482|NCT02710630|7618639|FG003|STARTED|Period 2||7
6688483|NCT02710630|7618640|FG004|STARTED|Period 2||7
6688484|NCT02710630|7618636|FG000|Not Treated|Period 2||1
6688485|NCT02710630|7618637|FG001|Not Treated|Period 2||0
6688486|NCT02710630|7618638|FG002|Not Treated|Period 2||0
6688487|NCT02710630|7618639|FG003|Not Treated|Period 2||0
6688488|NCT02710630|7618640|FG004|Not Treated|Period 2||0
6688489|NCT02710630|7618636|FG000|COMPLETED|Period 2||7
6688490|NCT02710630|7618637|FG001|COMPLETED|Period 2||7
6688491|NCT02710630|7618638|FG002|COMPLETED|Period 2||7
6688492|NCT02710630|7618639|FG003|COMPLETED|Period 2||7
6688493|NCT02710630|7618640|FG004|COMPLETED|Period 2||7
6688494|NCT02710630|7618636|FG000|NOT COMPLETED|Period 2||0
6688495|NCT02710630|7618637|FG001|NOT COMPLETED|Period 2||0
6688496|NCT02710630|7618638|FG002|NOT COMPLETED|Period 2||0
6688497|NCT02710630|7618639|FG003|NOT COMPLETED|Period 2||0
6688498|NCT02710630|7618640|FG004|NOT COMPLETED|Period 2||0
6688499|NCT02710630|7618636|FG000|STARTED|Period 3||7
6688500|NCT02710630|7618637|FG001|STARTED|Period 3||7
6688501|NCT02710630|7618638|FG002|STARTED|Period 3||7
6688502|NCT02710630|7618639|FG003|STARTED|Period 3||7
6688503|NCT02710630|7618640|FG004|STARTED|Period 3||7
6688504|NCT02710630|7618636|FG000|COMPLETED|Period 3||7
6688505|NCT02710630|7618637|FG001|COMPLETED|Period 3||7
6688506|NCT02710630|7618638|FG002|COMPLETED|Period 3||7
6688507|NCT02710630|7618639|FG003|COMPLETED|Period 3||7
6688508|NCT02710630|7618640|FG004|COMPLETED|Period 3||7
6688509|NCT02710630|7618636|FG000|NOT COMPLETED|Period 3||0
6688510|NCT02710630|7618637|FG001|NOT COMPLETED|Period 3||0
6688511|NCT02710630|7618638|FG002|NOT COMPLETED|Period 3||0
6688512|NCT02710630|7618639|FG003|NOT COMPLETED|Period 3||0
6688513|NCT02710630|7618640|FG004|NOT COMPLETED|Period 3||0
6688514|NCT02710630|7618636|FG000|STARTED|Period 4||7
6688515|NCT02710630|7618637|FG001|STARTED|Period 4||7
6688516|NCT02710630|7618638|FG002|STARTED|Period 4||7
6688517|NCT02710630|7618639|FG003|STARTED|Period 4||7
6688518|NCT02710630|7618640|FG004|STARTED|Period 4||7
6688519|NCT02710630|7618636|FG000|COMPLETED|Period 4||7
6688520|NCT02710630|7618637|FG001|COMPLETED|Period 4||7
6688521|NCT02710630|7618638|FG002|COMPLETED|Period 4||7
6688522|NCT02710630|7618639|FG003|COMPLETED|Period 4||7
6688523|NCT02710630|7618640|FG004|COMPLETED|Period 4||7
6688524|NCT02710630|7618636|FG000|NOT COMPLETED|Period 4||0
6688525|NCT02710630|7618637|FG001|NOT COMPLETED|Period 4||0
6688526|NCT02710630|7618638|FG002|NOT COMPLETED|Period 4||0
6688527|NCT02710630|7618639|FG003|NOT COMPLETED|Period 4||0
6688528|NCT02710630|7618640|FG004|NOT COMPLETED|Period 4||0
6688529|NCT02710630|7618636|FG000|STARTED|Period 5||7
6688530|NCT02710630|7618637|FG001|STARTED|Period 5||7
6688531|NCT02710630|7618638|FG002|STARTED|Period 5||7
6688532|NCT02710630|7618639|FG003|STARTED|Period 5||7
6688533|NCT02710630|7618640|FG004|STARTED|Period 5||7
6688534|NCT02710630|7618636|FG000|COMPLETED|Period 5||7
6688535|NCT02710630|7618637|FG001|COMPLETED|Period 5||7
6688536|NCT02710630|7618638|FG002|COMPLETED|Period 5||7
6688537|NCT02710630|7618639|FG003|COMPLETED|Period 5||7
6688538|NCT02710630|7618640|FG004|COMPLETED|Period 5||7
6688539|NCT02710630|7618636|FG000|NOT COMPLETED|Period 5||0
6688540|NCT02710630|7618637|FG001|NOT COMPLETED|Period 5||0
6688541|NCT02710630|7618638|FG002|NOT COMPLETED|Period 5||0
6688542|NCT02710630|7618639|FG003|NOT COMPLETED|Period 5||0
6688543|NCT02710630|7618640|FG004|NOT COMPLETED|Period 5||0
6688544|NCT02710630|7618636|FG000|STARTED|Period 6||7
6688545|NCT02710630|7618637|FG001|STARTED|Period 6||7
6688546|NCT02710630|7618638|FG002|STARTED|Period 6||7
6688547|NCT02710630|7618639|FG003|STARTED|Period 6||7
6688548|NCT02710630|7618640|FG004|STARTED|Period 6||7
6688549|NCT02710630|7618636|FG000|COMPLETED|Period 6||7
6688550|NCT02710630|7618637|FG001|COMPLETED|Period 6||7
6688551|NCT02710630|7618638|FG002|COMPLETED|Period 6||7
6688552|NCT02710630|7618639|FG003|COMPLETED|Period 6||7
6688553|NCT02710630|7618640|FG004|COMPLETED|Period 6||7
6688554|NCT02710630|7618636|FG000|NOT COMPLETED|Period 6||0
6688555|NCT02710630|7618637|FG001|NOT COMPLETED|Period 6||0
6688556|NCT02710630|7618638|FG002|NOT COMPLETED|Period 6||0
6688557|NCT02710630|7618639|FG003|NOT COMPLETED|Period 6||0
6688558|NCT02710630|7618640|FG004|NOT COMPLETED|Period 6||0
6688559|NCT02710669|7618657|FG000|STARTED|Overall Study||85
6688560|NCT02710669|7618658|FG001|STARTED|Overall Study||86
6688561|NCT02710669|7618659|FG002|STARTED|Overall Study||21
6688562|NCT02710669|7618657|FG000|COMPLETED|Overall Study||71
6688563|NCT02710669|7618658|FG001|COMPLETED|Overall Study||75
6688564|NCT02710669|7618659|FG002|COMPLETED|Overall Study||19
6688565|NCT02710669|7618657|FG000|NOT COMPLETED|Overall Study||14
6688566|NCT02710669|7618658|FG001|NOT COMPLETED|Overall Study||11
6688567|NCT02710669|7618659|FG002|NOT COMPLETED|Overall Study||2
6688568|NCT02710890|7618669|FG000|STARTED|Overall Study||48
6688569|NCT02710890|7618670|FG001|STARTED|Overall Study||55
6688570|NCT02710890|7618669|FG000|COMPLETED|Overall Study||48
6688571|NCT02710890|7618670|FG001|COMPLETED|Overall Study||55
6688572|NCT02710890|7618669|FG000|NOT COMPLETED|Overall Study||0
6688573|NCT02710890|7618670|FG001|NOT COMPLETED|Overall Study||0
6688574|NCT02710981|7618676|FG000|STARTED|6th Ovulation Induction Cycle (5 Days)||42
6688575|NCT02710981|7618677|FG001|STARTED|6th Ovulation Induction Cycle (5 Days)||0
6688576|NCT02710981|7618676|FG000|COMPLETED|6th Ovulation Induction Cycle (5 Days)||41
6688577|NCT02710981|7618677|FG001|COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
6688578|NCT02710981|7618676|FG000|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||1
6688579|NCT02710981|7618677|FG001|NOT COMPLETED|6th Ovulation Induction Cycle (5 Days)||0
6688580|NCT02710981|7618676|FG000|STARTED|7th Ovulation Induction Cycle (5 Days)||0
6688581|NCT02710981|7618677|FG001|STARTED|7th Ovulation Induction Cycle (5 Days)||41
6688582|NCT02710981|7618676|FG000|COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
6688583|NCT02710981|7618677|FG001|COMPLETED|7th Ovulation Induction Cycle (5 Days)||36
6688584|NCT02710981|7618676|FG000|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||0
6688585|NCT02710981|7618677|FG001|NOT COMPLETED|7th Ovulation Induction Cycle (5 Days)||5
6688586|NCT02711306|7618687|FG000|STARTED|Overall Study||18
6688587|NCT02711306|7618688|FG001|STARTED|Overall Study||18
6688588|NCT02711306|7618687|FG000|COMPLETED|Overall Study||16
6688589|NCT02711306|7618688|FG001|COMPLETED|Overall Study||16
6688590|NCT02711306|7618687|FG000|NOT COMPLETED|Overall Study||2
6688591|NCT02711306|7618688|FG001|NOT COMPLETED|Overall Study||2
6688592|NCT02711345|7618704|FG000|STARTED|Overall Study||2
6688593|NCT02711345|7618705|FG001|STARTED|Overall Study||3
6688594|NCT02711345|7618706|FG002|STARTED|Overall Study||6
6688595|NCT02711345|7618707|FG003|STARTED|Overall Study||4
6688596|NCT02711345|7618708|FG004|STARTED|Overall Study||8
6688597|NCT02711345|7618709|FG005|STARTED|Overall Study||6
6688598|NCT02711345|7618710|FG006|STARTED|Overall Study||12
6688599|NCT02711345|7618711|FG007|STARTED|Overall Study||6
6688600|NCT02711345|7618712|FG008|STARTED|Overall Study||6
6688601|NCT02711345|7618713|FG009|STARTED|Overall Study||12
6688602|NCT02711345|7618704|FG000|COMPLETED|Overall Study||0
6688603|NCT02711345|7618705|FG001|COMPLETED|Overall Study||0
6688604|NCT02711345|7618706|FG002|COMPLETED|Overall Study||0
6688605|NCT02711345|7618707|FG003|COMPLETED|Overall Study||0
6688606|NCT02711345|7618708|FG004|COMPLETED|Overall Study||0
6688607|NCT02711345|7618709|FG005|COMPLETED|Overall Study||0
6688608|NCT02711345|7618710|FG006|COMPLETED|Overall Study||0
6688609|NCT02711345|7618711|FG007|COMPLETED|Overall Study||0
6688610|NCT02711345|7618712|FG008|COMPLETED|Overall Study||0
6688611|NCT02711345|7618713|FG009|COMPLETED|Overall Study||0
6688612|NCT02711345|7618704|FG000|NOT COMPLETED|Overall Study||2
6688613|NCT02711345|7618705|FG001|NOT COMPLETED|Overall Study||3
6688614|NCT02711345|7618706|FG002|NOT COMPLETED|Overall Study||6
6688615|NCT02711345|7618707|FG003|NOT COMPLETED|Overall Study||4
6688616|NCT02711345|7618708|FG004|NOT COMPLETED|Overall Study||8
6688617|NCT02711345|7618709|FG005|NOT COMPLETED|Overall Study||6
6688618|NCT02711345|7618710|FG006|NOT COMPLETED|Overall Study||12
6688619|NCT02711345|7618711|FG007|NOT COMPLETED|Overall Study||6
6688620|NCT02711345|7618712|FG008|NOT COMPLETED|Overall Study||6
6688621|NCT02711345|7618713|FG009|NOT COMPLETED|Overall Study||12
6688622|NCT02711553|7618744|FG000|STARTED|Overall Study||106
6688623|NCT02711553|7618745|FG001|STARTED|Overall Study||52
6688624|NCT02711553|7618746|FG002|STARTED|Overall Study||102
6688625|NCT02711553|7618747|FG003|STARTED|Overall Study||49
6688626|NCT02711553|7618744|FG000|Received at Least 1 Dose of Study Drug|Overall Study||104
6688627|NCT02711553|7618745|FG001|Received at Least 1 Dose of Study Drug|Overall Study||52
6688628|NCT02711553|7618746|FG002|Received at Least 1 Dose of Study Drug|Overall Study||102
6688629|NCT02711553|7618747|FG003|Received at Least 1 Dose of Study Drug|Overall Study||48
6688630|NCT02711553|7618744|FG000|COMPLETED|Overall Study||100
6688631|NCT02711553|7618745|FG001|COMPLETED|Overall Study||47
6688632|NCT02711553|7618746|FG002|COMPLETED|Overall Study||92
6688633|NCT02711553|7618747|FG003|COMPLETED|Overall Study||45
6688634|NCT02711553|7618744|FG000|NOT COMPLETED|Overall Study||6
6688635|NCT02711553|7618745|FG001|NOT COMPLETED|Overall Study||5
6688636|NCT02711553|7618746|FG002|NOT COMPLETED|Overall Study||10
6688637|NCT02711553|7618747|FG003|NOT COMPLETED|Overall Study||4
6688638|NCT02711800|7618759|FG000|STARTED|Overall Study||9
6688639|NCT02711800|7618759|FG000|COMPLETED|Overall Study||7
6688640|NCT02711800|7618759|FG000|NOT COMPLETED|Overall Study||2
6688641|NCT02711839|7618765|FG000|STARTED|Overall Study||20
6688642|NCT02711839|7618766|FG001|STARTED|Overall Study||34
6688643|NCT02711839|7618765|FG000|COMPLETED|Overall Study||16
6688644|NCT02711839|7618766|FG001|COMPLETED|Overall Study||24
6688645|NCT02711839|7618765|FG000|NOT COMPLETED|Overall Study||4
6688646|NCT02711839|7618766|FG001|NOT COMPLETED|Overall Study||10
6688647|NCT02711956|7618787|FG000|STARTED|Overall Study||2
6688648|NCT02711956|7618788|FG001|STARTED|Overall Study||2
6688649|NCT02711956|7618789|FG002|STARTED|Overall Study||3
6688650|NCT02711956|7618790|FG003|STARTED|Overall Study||5
6688651|NCT02711956|7618791|FG004|STARTED|Overall Study||4
6688652|NCT02711956|7618792|FG005|STARTED|Overall Study||3
6688653|NCT02711956|7618793|FG006|STARTED|Overall Study||4
6688654|NCT02711956|7618794|FG007|STARTED|Overall Study||4
6688655|NCT02711956|7618795|FG008|STARTED|Overall Study||4
6688656|NCT02711956|7618796|FG009|STARTED|Overall Study||3
6688657|NCT02711956|7618797|FG010|STARTED|Overall Study||1
6688658|NCT02711956|7618798|FG011|STARTED|Overall Study||9
6688659|NCT02711956|7618799|FG012|STARTED|Overall Study||17
6688660|NCT02711956|7618800|FG013|STARTED|Overall Study||6
6688661|NCT02711956|7618801|FG014|STARTED|Overall Study||8
6688662|NCT02711956|7618787|FG000|COMPLETED|Overall Study||0
6688663|NCT02711956|7618788|FG001|COMPLETED|Overall Study||0
6688664|NCT02711956|7618789|FG002|COMPLETED|Overall Study||1
6688665|NCT02711956|7618790|FG003|COMPLETED|Overall Study||2
6688666|NCT02711956|7618791|FG004|COMPLETED|Overall Study||0
6688667|NCT02711956|7618792|FG005|COMPLETED|Overall Study||1
6688668|NCT02711956|7618793|FG006|COMPLETED|Overall Study||0
6688669|NCT02711956|7618794|FG007|COMPLETED|Overall Study||2
6688670|NCT02711956|7618795|FG008|COMPLETED|Overall Study||0
6688671|NCT02711956|7618796|FG009|COMPLETED|Overall Study||0
6688672|NCT02711956|7618797|FG010|COMPLETED|Overall Study||0
6688673|NCT02711956|7618798|FG011|COMPLETED|Overall Study||0
6688674|NCT02711956|7618799|FG012|COMPLETED|Overall Study||1
6688675|NCT02711956|7618800|FG013|COMPLETED|Overall Study||1
6688676|NCT02711956|7618801|FG014|COMPLETED|Overall Study||0
6688677|NCT02711956|7618787|FG000|NOT COMPLETED|Overall Study||2
6688678|NCT02711956|7618788|FG001|NOT COMPLETED|Overall Study||2
6688679|NCT02711956|7618789|FG002|NOT COMPLETED|Overall Study||2
6688680|NCT02711956|7618790|FG003|NOT COMPLETED|Overall Study||3
6688681|NCT02711956|7618791|FG004|NOT COMPLETED|Overall Study||4
6688682|NCT02711956|7618792|FG005|NOT COMPLETED|Overall Study||2
6688683|NCT02711956|7618793|FG006|NOT COMPLETED|Overall Study||4
6688684|NCT02711956|7618794|FG007|NOT COMPLETED|Overall Study||2
6688685|NCT02711956|7618795|FG008|NOT COMPLETED|Overall Study||4
6688686|NCT02711956|7618796|FG009|NOT COMPLETED|Overall Study||3
6688687|NCT02711956|7618797|FG010|NOT COMPLETED|Overall Study||1
6688688|NCT02711956|7618798|FG011|NOT COMPLETED|Overall Study||9
6688689|NCT02711956|7618799|FG012|NOT COMPLETED|Overall Study||16
6688690|NCT02711956|7618800|FG013|NOT COMPLETED|Overall Study||5
6688691|NCT02711956|7618801|FG014|NOT COMPLETED|Overall Study||8
6688692|NCT02711995|7618842|FG000|STARTED|First Intervention (30 Days)||8
6688693|NCT02711995|7618842|FG000|COMPLETED|First Intervention (30 Days)||8
6688694|NCT02711995|7618842|FG000|NOT COMPLETED|First Intervention (30 Days)||0
6688695|NCT02711995|7618842|FG000|STARTED|Washout (90 Days)||8
6688696|NCT02711995|7618842|FG000|COMPLETED|Washout (90 Days)||7
6688697|NCT02711995|7618842|FG000|NOT COMPLETED|Washout (90 Days)||1
6688698|NCT02711995|7618842|FG000|STARTED|Second Intervention (30 Days)||7
6688699|NCT02711995|7618842|FG000|COMPLETED|Second Intervention (30 Days)||7
6688700|NCT02711995|7618842|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
6688701|NCT02712008|7618851|FG000|STARTED|Baseline (Day 1) up to Week 12||50
6688702|NCT02712008|7618852|FG001|STARTED|Baseline (Day 1) up to Week 12||100
6688703|NCT02712008|7618853|FG002|STARTED|Baseline (Day 1) up to Week 12||152
6688704|NCT02712008|7618854|FG003|STARTED|Baseline (Day 1) up to Week 12||0
6688705|NCT02712008|7618855|FG004|STARTED|Baseline (Day 1) up to Week 12||0
6688706|NCT02712008|7618856|FG005|STARTED|Baseline (Day 1) up to Week 12||0
6688707|NCT02712008|7618857|FG006|STARTED|Baseline (Day 1) up to Week 12||0
6688708|NCT02712008|7618858|FG007|STARTED|Baseline (Day 1) up to Week 12||0
6688709|NCT02712008|7618851|FG000|COMPLETED|Baseline (Day 1) up to Week 12||46
6688710|NCT02712008|7618852|FG001|COMPLETED|Baseline (Day 1) up to Week 12||97
6688711|NCT02712008|7618853|FG002|COMPLETED|Baseline (Day 1) up to Week 12||148
6688712|NCT02712008|7618854|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
6688713|NCT02712008|7618855|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
6688714|NCT02712008|7618856|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
6688715|NCT02712008|7618857|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
6688716|NCT02712008|7618858|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
6688717|NCT02712008|7618851|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
6688718|NCT02712008|7618852|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||3
6688719|NCT02712008|7618853|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||4
6688720|NCT02712008|7618854|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688721|NCT02712008|7618855|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688722|NCT02712008|7618856|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688723|NCT02712008|7618857|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688724|NCT02712008|7618858|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688725|NCT02712008|7618851|FG000|STARTED|From Week 12 up to Week 36|Out of 46 participants that completed Week 12, 45 re-randomized for treatment from Week 12 to 36|45
6688726|NCT02712008|7618852|FG001|STARTED|From Week 12 up to Week 36|Out of 97 participants that completed Week 12, 96 re-randomized to REGN910-3 (6:2mg) Q8 and Q12|0
6688727|NCT02712008|7618853|FG002|STARTED|From Week 12 up to Week 36|Out of 148 that completed Week 12,143 re-randomized to Aflibercept 2mg Q8, Q12, REGN910-3 (6:2mg) Q8|0
6688728|NCT02712008|7618854|FG003|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 44 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q8|44
6688729|NCT02712008|7618855|FG004|STARTED|From Week 12 up to Week 36|Out of 96 that were re-randomized, 52 re-randomized from REGN910-3(6:2 mg)Q4 to REGN910-3(6:2 mg)Q12|52
6688730|NCT02712008|7618856|FG005|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 46 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q8|46
6688731|NCT02712008|7618857|FG006|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 48 re-randomized from Aflibercept 2mg Q4 to Aflibercept 2mg Q12|48
6688732|NCT02712008|7618858|FG007|STARTED|From Week 12 up to Week 36|Out of 143 that were re-randomized, 49 re-randomized from Aflibercept 2mg Q4 to REGN910-3 (6:2mg) Q8|49
6688733|NCT02712008|7618851|FG000|COMPLETED|From Week 12 up to Week 36||44
6688734|NCT02712008|7618852|FG001|COMPLETED|From Week 12 up to Week 36||0
6688735|NCT02712008|7618853|FG002|COMPLETED|From Week 12 up to Week 36||0
6688736|NCT02712008|7618854|FG003|COMPLETED|From Week 12 up to Week 36||42
6688737|NCT02712008|7618855|FG004|COMPLETED|From Week 12 up to Week 36||50
6688738|NCT02712008|7618856|FG005|COMPLETED|From Week 12 up to Week 36||46
6688739|NCT02712008|7618857|FG006|COMPLETED|From Week 12 up to Week 36||43
6688740|NCT02712008|7618858|FG007|COMPLETED|From Week 12 up to Week 36||45
6688741|NCT02712008|7618851|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
6688742|NCT02712008|7618852|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
6688743|NCT02712008|7618853|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
6688744|NCT02712008|7618854|FG003|NOT COMPLETED|From Week 12 up to Week 36||2
6688745|NCT02712008|7618855|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
6688746|NCT02712008|7618856|FG005|NOT COMPLETED|From Week 12 up to Week 36||0
6688747|NCT02712008|7618857|FG006|NOT COMPLETED|From Week 12 up to Week 36||5
6688748|NCT02712008|7618858|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
6688749|NCT02712047|7618872|FG000|STARTED|Treatment Period 1 (35 Days)||14
6688750|NCT02712047|7618873|FG001|STARTED|Treatment Period 1 (35 Days)||13
6688751|NCT02712047|7618872|FG000|COMPLETED|Treatment Period 1 (35 Days)||14
6688752|NCT02712047|7618873|FG001|COMPLETED|Treatment Period 1 (35 Days)||13
6688753|NCT02712047|7618872|FG000|NOT COMPLETED|Treatment Period 1 (35 Days)||0
6688754|NCT02712047|7618873|FG001|NOT COMPLETED|Treatment Period 1 (35 Days)||0
6688755|NCT02712047|7618872|FG000|STARTED|Washout Period (21 Days)||14
6688756|NCT02712047|7618873|FG001|STARTED|Washout Period (21 Days)||13
6688757|NCT02712047|7618872|FG000|COMPLETED|Washout Period (21 Days)||14
6688758|NCT02712047|7618873|FG001|COMPLETED|Washout Period (21 Days)||13
6688759|NCT02712047|7618872|FG000|NOT COMPLETED|Washout Period (21 Days)||0
6688760|NCT02712047|7618873|FG001|NOT COMPLETED|Washout Period (21 Days)||0
6688761|NCT02712047|7618872|FG000|STARTED|Treatment Period 2 (35 Days)||14
6688762|NCT02712047|7618873|FG001|STARTED|Treatment Period 2 (35 Days)||13
6688763|NCT02712047|7618872|FG000|COMPLETED|Treatment Period 2 (35 Days)||14
6688764|NCT02712047|7618873|FG001|COMPLETED|Treatment Period 2 (35 Days)||13
6688765|NCT02712047|7618872|FG000|NOT COMPLETED|Treatment Period 2 (35 Days)||0
6688766|NCT02712047|7618873|FG001|NOT COMPLETED|Treatment Period 2 (35 Days)||0
6688767|NCT02712099|7618881|FG000|STARTED|Overall Study||30
6688768|NCT02712099|7618882|FG001|STARTED|Overall Study||20
6688769|NCT02712099|7618881|FG000|COMPLETED|Overall Study||30
6688770|NCT02712099|7618882|FG001|COMPLETED|Overall Study||20
6688771|NCT02712099|7618881|FG000|NOT COMPLETED|Overall Study||0
6688772|NCT02712099|7618882|FG001|NOT COMPLETED|Overall Study||0
6688773|NCT02712320|7618888|FG000|STARTED|Overall Study||30
6688774|NCT02712320|7618888|FG000|COMPLETED|Overall Study||25
6688775|NCT02712320|7618888|FG000|NOT COMPLETED|Overall Study||5
6688776|NCT02712333|7618894|FG000|STARTED|First Period||34
6688777|NCT02712333|7618895|FG001|STARTED|First Period||26
6688778|NCT02712333|7618894|FG000|COMPLETED|First Period||31
6688779|NCT02712333|7618895|FG001|COMPLETED|First Period||24
6688780|NCT02712333|7618894|FG000|NOT COMPLETED|First Period||3
6688781|NCT02712333|7618895|FG001|NOT COMPLETED|First Period||2
6688782|NCT02712333|7618894|FG000|STARTED|Second Period||31
6688783|NCT02712333|7618895|FG001|STARTED|Second Period||24
6688784|NCT02712333|7618894|FG000|COMPLETED|Second Period||31
6688785|NCT02712333|7618895|FG001|COMPLETED|Second Period||24
6688786|NCT02712333|7618894|FG000|NOT COMPLETED|Second Period||0
6688787|NCT02712333|7618895|FG001|NOT COMPLETED|Second Period||0
6688788|NCT02712359|7618910|FG000|STARTED|Epoch 001: Persistence at Year 8||300
6688789|NCT02712359|7618911|FG001|STARTED|Epoch 001: Persistence at Year 8||300
6688790|NCT02712359|7618912|FG002|STARTED|Epoch 001: Persistence at Year 8||0
6688791|NCT02712359|7618913|FG003|STARTED|Epoch 001: Persistence at Year 8||0
6688792|NCT02712359|7618910|FG000|COMPLETED|Epoch 001: Persistence at Year 8||300
6688793|NCT02712359|7618911|FG001|COMPLETED|Epoch 001: Persistence at Year 8||300
6688794|NCT02712359|7618912|FG002|COMPLETED|Epoch 001: Persistence at Year 8||0
6688795|NCT02712359|7618913|FG003|COMPLETED|Epoch 001: Persistence at Year 8||0
6688796|NCT02712359|7618910|FG000|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
6688797|NCT02712359|7618911|FG001|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
6688798|NCT02712359|7618912|FG002|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
6688799|NCT02712359|7618913|FG003|NOT COMPLETED|Epoch 001: Persistence at Year 8||0
6688800|NCT02712359|7618910|FG000|STARTED|Epoch 002: Persistence at Year 10||0
6688801|NCT02712359|7618911|FG001|STARTED|Epoch 002: Persistence at Year 10||0
6688802|NCT02712359|7618912|FG002|STARTED|Epoch 002: Persistence at Year 10||299
6688803|NCT02712359|7618913|FG003|STARTED|Epoch 002: Persistence at Year 10||300
6688804|NCT02712359|7618910|FG000|COMPLETED|Epoch 002: Persistence at Year 10||0
6688805|NCT02712359|7618911|FG001|COMPLETED|Epoch 002: Persistence at Year 10||0
6688806|NCT02712359|7618912|FG002|COMPLETED|Epoch 002: Persistence at Year 10||299
6688807|NCT02712359|7618913|FG003|COMPLETED|Epoch 002: Persistence at Year 10||300
6688808|NCT02712359|7618910|FG000|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
6688809|NCT02712359|7618911|FG001|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
6688810|NCT02712359|7618912|FG002|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
6688811|NCT02712359|7618913|FG003|NOT COMPLETED|Epoch 002: Persistence at Year 10||0
6688812|NCT02712398|7618923|FG000|STARTED|Overall Study||120
6688813|NCT02712398|7618923|FG000|COMPLETED|Overall Study||83
6688814|NCT02712398|7618923|FG000|NOT COMPLETED|Overall Study||37
6688815|NCT02712424|7618929|FG000|STARTED|Overall Study||315
6688816|NCT02712424|7618930|FG001|STARTED|Overall Study||310
6688817|NCT02712424|7618929|FG000|COMPLETED|Overall Study||281
6688818|NCT02712424|7618930|FG001|COMPLETED|Overall Study||278
6688819|NCT02712424|7618929|FG000|NOT COMPLETED|Overall Study||34
6688820|NCT02712424|7618930|FG001|NOT COMPLETED|Overall Study||32
6688821|NCT02712554|7618938|FG000|STARTED|Part A: Dose Selection Phase||12
6688822|NCT02712554|7618939|FG001|STARTED|Part A: Dose Selection Phase||0
6688823|NCT02712554|7618938|FG000|COMPLETED|Part A: Dose Selection Phase||12
6688824|NCT02712554|7618939|FG001|COMPLETED|Part A: Dose Selection Phase|Subjects who participated in Dose Selection Phase were not eligible to participate in Part B.|0
6688825|NCT02712554|7618938|FG000|NOT COMPLETED|Part A: Dose Selection Phase||0
6688826|NCT02712554|7618939|FG001|NOT COMPLETED|Part A: Dose Selection Phase||0
6688827|NCT02712554|7618938|FG000|STARTED|Part B: Qualification Phase||0
6688828|NCT02712554|7618939|FG001|STARTED|Part B: Qualification Phase||61
6688829|NCT02712554|7618938|FG000|COMPLETED|Part B: Qualification Phase||0
6688830|NCT02712554|7618939|FG001|COMPLETED|Part B: Qualification Phase||40
6688831|NCT02712554|7618938|FG000|NOT COMPLETED|Part B: Qualification Phase||0
6688832|NCT02712554|7618939|FG001|NOT COMPLETED|Part B: Qualification Phase||21
6688833|NCT02712554|7618938|FG000|STARTED|Part B: Treatment Phase||0
6688834|NCT02712554|7618939|FG001|STARTED|Part B: Treatment Phase||40
6688835|NCT02712554|7618938|FG000|COMPLETED|Part B: Treatment Phase||0
6688836|NCT02712554|7618939|FG001|COMPLETED|Part B: Treatment Phase||37
6688837|NCT02712554|7618938|FG000|NOT COMPLETED|Part B: Treatment Phase||0
6688838|NCT02712554|7618939|FG001|NOT COMPLETED|Part B: Treatment Phase||3
6688839|NCT02712788|7618964|FG000|STARTED|Overall Study||2
6688840|NCT02712788|7618965|FG001|STARTED|Overall Study||2
6688841|NCT02712788|7618964|FG000|COMPLETED|Overall Study||0
6688842|NCT02712788|7618965|FG001|COMPLETED|Overall Study||2
6688843|NCT02712788|7618964|FG000|NOT COMPLETED|Overall Study||2
6688844|NCT02712788|7618965|FG001|NOT COMPLETED|Overall Study||0
6688845|NCT02712983|7618980|FG000|STARTED|Treatment Phase||14
6688846|NCT02712983|7618981|FG001|STARTED|Treatment Phase||13
6688847|NCT02712983|7618982|FG002|STARTED|Treatment Phase||7
6688848|NCT02712983|7618983|FG003|STARTED|Treatment Phase||15
6688849|NCT02712983|7618984|FG004|STARTED|Treatment Phase||14
6688850|NCT02712983|7618985|FG005|STARTED|Treatment Phase||7
6688851|NCT02712983|7618986|FG006|STARTED|Treatment Phase||15
6688852|NCT02712983|7618987|FG007|STARTED|Treatment Phase||15
6688853|NCT02712983|7618988|FG008|STARTED|Treatment Phase||7
6688854|NCT02712983|7618980|FG000|Pharmacokinetic Analysis Set|Treatment Phase||14
6688855|NCT02712983|7618981|FG001|Pharmacokinetic Analysis Set|Treatment Phase||13
6688856|NCT02712983|7618982|FG002|Pharmacokinetic Analysis Set|Treatment Phase||0
6688857|NCT02712983|7618983|FG003|Pharmacokinetic Analysis Set|Treatment Phase||15
6688858|NCT02712983|7618984|FG004|Pharmacokinetic Analysis Set|Treatment Phase||14
6688859|NCT02712983|7618985|FG005|Pharmacokinetic Analysis Set|Treatment Phase||0
6688860|NCT02712983|7618986|FG006|Pharmacokinetic Analysis Set|Treatment Phase||15
6688861|NCT02712983|7618987|FG007|Pharmacokinetic Analysis Set|Treatment Phase||14
6688862|NCT02712983|7618988|FG008|Pharmacokinetic Analysis Set|Treatment Phase||0
6688863|NCT02712983|7618980|FG000|COMPLETED|Treatment Phase||9
6688864|NCT02712983|7618981|FG001|COMPLETED|Treatment Phase||12
6688865|NCT02712983|7618982|FG002|COMPLETED|Treatment Phase||6
6688866|NCT02712983|7618983|FG003|COMPLETED|Treatment Phase||7
6688867|NCT02712983|7618984|FG004|COMPLETED|Treatment Phase||10
6688868|NCT02712983|7618985|FG005|COMPLETED|Treatment Phase||7
6688869|NCT02712983|7618986|FG006|COMPLETED|Treatment Phase||6
6688870|NCT02712983|7618987|FG007|COMPLETED|Treatment Phase||6
6688871|NCT02712983|7618988|FG008|COMPLETED|Treatment Phase||5
6688872|NCT02712983|7618980|FG000|NOT COMPLETED|Treatment Phase||5
6688873|NCT02712983|7618981|FG001|NOT COMPLETED|Treatment Phase||1
6688874|NCT02712983|7618982|FG002|NOT COMPLETED|Treatment Phase||1
6688875|NCT02712983|7618983|FG003|NOT COMPLETED|Treatment Phase||8
6688876|NCT02712983|7618984|FG004|NOT COMPLETED|Treatment Phase||4
6688877|NCT02712983|7618985|FG005|NOT COMPLETED|Treatment Phase||0
6688878|NCT02712983|7618986|FG006|NOT COMPLETED|Treatment Phase||9
6688879|NCT02712983|7618987|FG007|NOT COMPLETED|Treatment Phase||9
6688880|NCT02712983|7618988|FG008|NOT COMPLETED|Treatment Phase||2
6688881|NCT02712983|7618980|FG000|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
6688882|NCT02712983|7618981|FG001|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
6688883|NCT02712983|7618982|FG002|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
6688884|NCT02712983|7618983|FG003|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
6688885|NCT02712983|7618984|FG004|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
6688886|NCT02712983|7618985|FG005|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|1
6688887|NCT02712983|7618986|FG006|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|2
6688888|NCT02712983|7618987|FG007|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|3
6688889|NCT02712983|7618988|FG008|STARTED|Post-Treatment Efficacy Follow-Up Phase|All patients who entered Post-Treatment Efficacy Fup Phase|0
6688890|NCT02712983|7618980|FG000|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688891|NCT02712983|7618981|FG001|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688892|NCT02712983|7618982|FG002|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688893|NCT02712983|7618983|FG003|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688894|NCT02712983|7618984|FG004|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688895|NCT02712983|7618985|FG005|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688896|NCT02712983|7618986|FG006|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688897|NCT02712983|7618987|FG007|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688898|NCT02712983|7618988|FG008|COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688899|NCT02712983|7618980|FG000|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688900|NCT02712983|7618981|FG001|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
6688901|NCT02712983|7618982|FG002|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688902|NCT02712983|7618983|FG003|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
6688903|NCT02712983|7618984|FG004|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
6688904|NCT02712983|7618985|FG005|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||1
6688905|NCT02712983|7618986|FG006|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||2
6688906|NCT02712983|7618987|FG007|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||3
6688907|NCT02712983|7618988|FG008|NOT COMPLETED|Post-Treatment Efficacy Follow-Up Phase||0
6688908|NCT02712996|7619010|FG000|STARTED|First Intervention (Study Days 1-42)||8
6688909|NCT02712996|7619011|FG001|STARTED|First Intervention (Study Days 1-42)||9
6688910|NCT02712996|7619010|FG000|COMPLETED|First Intervention (Study Days 1-42)||8
6688911|NCT02712996|7619011|FG001|COMPLETED|First Intervention (Study Days 1-42)||9
6688912|NCT02712996|7619010|FG000|NOT COMPLETED|First Intervention (Study Days 1-42)||0
6688913|NCT02712996|7619011|FG001|NOT COMPLETED|First Intervention (Study Days 1-42)||0
6688914|NCT02712996|7619010|FG000|STARTED|Second Intervention (Study Days 43-84)||8
6688915|NCT02712996|7619011|FG001|STARTED|Second Intervention (Study Days 43-84)||9
6688916|NCT02712996|7619010|FG000|COMPLETED|Second Intervention (Study Days 43-84)||8
6688917|NCT02712996|7619011|FG001|COMPLETED|Second Intervention (Study Days 43-84)||8
6688918|NCT02712996|7619010|FG000|NOT COMPLETED|Second Intervention (Study Days 43-84)||0
6688919|NCT02712996|7619011|FG001|NOT COMPLETED|Second Intervention (Study Days 43-84)||1
6688920|NCT02713178|7619022|FG000|STARTED|Overall Study||76
6688921|NCT02713178|7619023|FG001|STARTED|Overall Study||77
6688922|NCT02713178|7619024|FG002|STARTED|Overall Study||79
6688923|NCT02713178|7619022|FG000|COMPLETED|Overall Study||75
6688924|NCT02713178|7619023|FG001|COMPLETED|Overall Study||73
6688925|NCT02713178|7619024|FG002|COMPLETED|Overall Study||74
6688926|NCT02713178|7619022|FG000|NOT COMPLETED|Overall Study||1
6688927|NCT02713178|7619023|FG001|NOT COMPLETED|Overall Study||4
6688928|NCT02713178|7619024|FG002|NOT COMPLETED|Overall Study||5
6688929|NCT02713204|7619035|FG000|STARTED|Baseline (Day 1) up to Week 12||60
6688930|NCT02713204|7619036|FG001|STARTED|Baseline (Day 1) up to Week 12||122
6688931|NCT02713204|7619037|FG002|STARTED|Baseline (Day 1) up to Week 12||183
6688932|NCT02713204|7619038|FG003|STARTED|Baseline (Day 1) up to Week 12||0
6688933|NCT02713204|7619039|FG004|STARTED|Baseline (Day 1) up to Week 12||0
6688934|NCT02713204|7619040|FG005|STARTED|Baseline (Day 1) up to Week 12||0
6688935|NCT02713204|7619041|FG006|STARTED|Baseline (Day 1) up to Week 12||0
6688936|NCT02713204|7619042|FG007|STARTED|Baseline (Day 1) up to Week 12||0
6257494|NCT04615507|7156642|FG000|NOT COMPLETED|Period 1||2
6257495|NCT04615507|7156643|FG001|NOT COMPLETED|Period 1||1
6257496|NCT04615507|7156642|FG000|STARTED|Period 2||32
6257497|NCT04615507|7156643|FG001|STARTED|Period 2||33
6257498|NCT04615507|7156642|FG000|COMPLETED|Period 2||30
6257499|NCT04615507|7156643|FG001|COMPLETED|Period 2||31
6257500|NCT04615507|7156642|FG000|NOT COMPLETED|Period 2||2
6257501|NCT04615507|7156643|FG001|NOT COMPLETED|Period 2||2
6257502|NCT04615507|7156642|FG000|STARTED|Period 3||30
6257503|NCT04615507|7156643|FG001|STARTED|Period 3||31
6257504|NCT04615507|7156642|FG000|COMPLETED|Period 3||30
6257505|NCT04615507|7156643|FG001|COMPLETED|Period 3||30
6688937|NCT02713204|7619035|FG000|COMPLETED|Baseline (Day 1) up to Week 12||59
6688938|NCT02713204|7619036|FG001|COMPLETED|Baseline (Day 1) up to Week 12||121
6688939|NCT02713204|7619037|FG002|COMPLETED|Baseline (Day 1) up to Week 12||181
6688940|NCT02713204|7619038|FG003|COMPLETED|Baseline (Day 1) up to Week 12||0
6688941|NCT02713204|7619039|FG004|COMPLETED|Baseline (Day 1) up to Week 12||0
6688942|NCT02713204|7619040|FG005|COMPLETED|Baseline (Day 1) up to Week 12||0
6688943|NCT02713204|7619041|FG006|COMPLETED|Baseline (Day 1) up to Week 12||0
6688944|NCT02713204|7619042|FG007|COMPLETED|Baseline (Day 1) up to Week 12||0
6688945|NCT02713204|7619035|FG000|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
6688946|NCT02713204|7619036|FG001|NOT COMPLETED|Baseline (Day 1) up to Week 12||1
6688947|NCT02713204|7619037|FG002|NOT COMPLETED|Baseline (Day 1) up to Week 12||2
6688948|NCT02713204|7619038|FG003|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688949|NCT02713204|7619039|FG004|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688950|NCT02713204|7619040|FG005|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688951|NCT02713204|7619041|FG006|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688952|NCT02713204|7619042|FG007|NOT COMPLETED|Baseline (Day 1) up to Week 12||0
6688953|NCT02713204|7619035|FG000|STARTED|From Week 12 up to Week 36||58
6688954|NCT02713204|7619036|FG001|STARTED|From Week 12 up to Week 36||0
6688955|NCT02713204|7619037|FG002|STARTED|From Week 12 up to Week 36||0
6688956|NCT02713204|7619038|FG003|STARTED|From Week 12 up to Week 36||57
6688957|NCT02713204|7619039|FG004|STARTED|From Week 12 up to Week 36||62
6688958|NCT02713204|7619040|FG005|STARTED|From Week 12 up to Week 36||60
6257506|NCT04615507|7156642|FG000|NOT COMPLETED|Period 3||0
6257507|NCT04615507|7156643|FG001|NOT COMPLETED|Period 3||1
6279832|NCT00148954|7179712|FG001|NOT COMPLETED|Overall Study||300
6279833|NCT00149214|7179720|FG000|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
6279834|NCT00149214|7179721|FG001|STARTED|Overall Study||122
6279835|NCT00149214|7179720|FG000|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
6279836|NCT00149214|7179721|FG001|COMPLETED|Overall Study||105
6279837|NCT00149214|7179720|FG000|NOT COMPLETED|Overall Study||26
6279838|NCT00149214|7179721|FG001|NOT COMPLETED|Overall Study||17
6279839|NCT00149227|7179729|FG000|STARTED|Overall Study||1517
6279840|NCT00149227|7179730|FG001|STARTED|Overall Study||1514
6279841|NCT00149227|7179729|FG000|COMPLETED|Overall Study||1517
6279842|NCT00149227|7179730|FG001|COMPLETED|Overall Study||1514
6279843|NCT00149227|7179729|FG000|NOT COMPLETED|Overall Study||0
6279844|NCT00149227|7179730|FG001|NOT COMPLETED|Overall Study||0
6279845|NCT00149396|7179736|FG000|STARTED|Overall Study||32
6279846|NCT00149396|7179736|FG000|Completed NV1020 Therapy|Overall Study||29
6279847|NCT00149396|7179736|FG000|Completed NV1020 and Chemotherapy|Overall Study||9
6279848|NCT00149396|7179736|FG000|COMPLETED|Overall Study||9
6279849|NCT00149396|7179736|FG000|NOT COMPLETED|Overall Study||23
6279850|NCT00149630|7179749|FG000|STARTED|Overall Study||34
6279851|NCT00149630|7179750|FG001|STARTED|Overall Study||40
6279852|NCT00149630|7179749|FG000|COMPLETED|Overall Study||26
6279853|NCT00149630|7179750|FG001|COMPLETED|Overall Study||35
6279854|NCT00149630|7179749|FG000|NOT COMPLETED|Overall Study||8
6279855|NCT00149630|7179750|FG001|NOT COMPLETED|Overall Study||5
6279856|NCT00149643|7179762|FG000|STARTED|Overall Study||34
6279857|NCT00149643|7179763|FG001|STARTED|Overall Study||36
6279858|NCT00149643|7179762|FG000|COMPLETED|Overall Study||0
6279859|NCT00149643|7179763|FG001|COMPLETED|Overall Study||0
6279860|NCT00149643|7179762|FG000|NOT COMPLETED|Overall Study||34
6279861|NCT00149643|7179763|FG001|NOT COMPLETED|Overall Study||36
6279862|NCT00149669|7179771|FG000|STARTED|Overall Study||32
6279863|NCT00149669|7179772|FG001|STARTED|Overall Study||35
6279864|NCT00149669|7179771|FG000|COMPLETED|Overall Study||29
6279865|NCT00149669|7179772|FG001|COMPLETED|Overall Study||30
6279866|NCT00149669|7179771|FG000|NOT COMPLETED|Overall Study||3
6279867|NCT00149669|7179772|FG001|NOT COMPLETED|Overall Study||5
6279868|NCT00149734|7179780|FG000|STARTED|Overall Study||4
6279869|NCT00149734|7179781|FG001|STARTED|Overall Study||4
6279870|NCT00149734|7179780|FG000|Started Intervention 2|Overall Study||4
6279871|NCT00149734|7179781|FG001|Started Intervention 2|Overall Study||4
6279872|NCT00149734|7179780|FG000|COMPLETED|Overall Study||4
6279873|NCT00149734|7179781|FG001|COMPLETED|Overall Study||4
6279874|NCT00149734|7179780|FG000|NOT COMPLETED|Overall Study||0
6279875|NCT00149734|7179781|FG001|NOT COMPLETED|Overall Study||0
6279876|NCT00149747|7179789|FG000|STARTED|Overall Study||36
6279877|NCT00149747|7179790|FG001|STARTED|Overall Study||30
6279878|NCT00149747|7179789|FG000|COMPLETED|Overall Study||32
6279879|NCT00149747|7179790|FG001|COMPLETED|Overall Study||27
6279880|NCT00149747|7179789|FG000|NOT COMPLETED|Overall Study||4
6279881|NCT00149747|7179790|FG001|NOT COMPLETED|Overall Study||3
6279882|NCT00149799|7179798|FG000|STARTED|Open Label Escitalopram (Phase I)||100
6279883|NCT00149799|7179799|FG001|STARTED|Open Label Escitalopram (Phase I)||0
6279884|NCT00149799|7179800|FG002|STARTED|Open Label Escitalopram (Phase I)||0
6279885|NCT00149799|7179798|FG000|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
6279886|NCT00149799|7179799|FG001|COMPLETED|Open Label Escitalopram (Phase I)||0
6279887|NCT00149799|7179800|FG002|COMPLETED|Open Label Escitalopram (Phase I)||0
6279888|NCT00149799|7179798|FG000|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
6688959|NCT02713204|7619041|FG006|STARTED|From Week 12 up to Week 36||62
6688960|NCT02713204|7619042|FG007|STARTED|From Week 12 up to Week 36||58
6688961|NCT02713204|7619035|FG000|COMPLETED|From Week 12 up to Week 36||57
6688962|NCT02713204|7619036|FG001|COMPLETED|From Week 12 up to Week 36||0
6688963|NCT02713204|7619037|FG002|COMPLETED|From Week 12 up to Week 36||0
6688964|NCT02713204|7619038|FG003|COMPLETED|From Week 12 up to Week 36||53
6688965|NCT02713204|7619039|FG004|COMPLETED|From Week 12 up to Week 36||60
6688966|NCT02713204|7619040|FG005|COMPLETED|From Week 12 up to Week 36||59
6688967|NCT02713204|7619041|FG006|COMPLETED|From Week 12 up to Week 36||60
6688968|NCT02713204|7619042|FG007|COMPLETED|From Week 12 up to Week 36||54
6688969|NCT02713204|7619035|FG000|NOT COMPLETED|From Week 12 up to Week 36||1
6688970|NCT02713204|7619036|FG001|NOT COMPLETED|From Week 12 up to Week 36||0
6688971|NCT02713204|7619037|FG002|NOT COMPLETED|From Week 12 up to Week 36||0
6688972|NCT02713204|7619038|FG003|NOT COMPLETED|From Week 12 up to Week 36||4
6688973|NCT02713204|7619039|FG004|NOT COMPLETED|From Week 12 up to Week 36||2
6688974|NCT02713204|7619040|FG005|NOT COMPLETED|From Week 12 up to Week 36||1
6688975|NCT02713204|7619041|FG006|NOT COMPLETED|From Week 12 up to Week 36||2
6688976|NCT02713204|7619042|FG007|NOT COMPLETED|From Week 12 up to Week 36||4
6688977|NCT02713230|7619062|FG000|STARTED|Overall Study||69
6688978|NCT02713230|7619063|FG001|STARTED|Overall Study||15
6688979|NCT02713230|7619064|FG002|STARTED|Overall Study||71
6688980|NCT02713230|7619062|FG000|COMPLETED|Overall Study||68
6688981|NCT02713230|7619063|FG001|COMPLETED|Overall Study||15
6688982|NCT02713230|7619064|FG002|COMPLETED|Overall Study||71
6688983|NCT02713230|7619062|FG000|NOT COMPLETED|Overall Study||1
6688984|NCT02713230|7619063|FG001|NOT COMPLETED|Overall Study||0
6688985|NCT02713230|7619064|FG002|NOT COMPLETED|Overall Study||0
6688986|NCT02713243|7619073|FG000|STARTED|Overall Study||10
6688987|NCT02713243|7619074|FG001|STARTED|Overall Study||10
6688988|NCT02713243|7619073|FG000|PD Analysis Set|Overall Study||9
6688989|NCT02713243|7619074|FG001|PD Analysis Set|Overall Study||10
6688990|NCT02713243|7619073|FG000|PK Analysis Set|Overall Study||8
6688991|NCT02713243|7619074|FG001|PK Analysis Set|Overall Study||9
6688992|NCT02713243|7619073|FG000|COMPLETED|Overall Study||9
6688993|NCT02713243|7619074|FG001|COMPLETED|Overall Study||8
6688994|NCT02713243|7619073|FG000|NOT COMPLETED|Overall Study||1
6688995|NCT02713243|7619074|FG001|NOT COMPLETED|Overall Study||2
6688996|NCT02713256|7619080|FG000|STARTED|Overall Study||15
6688997|NCT02713256|7619080|FG000|COMPLETED|Overall Study||15
6688998|NCT02713256|7619080|FG000|NOT COMPLETED|Overall Study||0
6688999|NCT02713425|7619084|FG000|STARTED|Overall Study||20
6689000|NCT02713425|7619084|FG000|COMPLETED|Overall Study||20
6689001|NCT02713425|7619084|FG000|NOT COMPLETED|Overall Study||0
6689002|NCT02713490|7619090|FG000|STARTED|Overall Study||71
6689003|NCT02713490|7619091|FG001|STARTED|Overall Study||69
6689004|NCT02713490|7619090|FG000|COMPLETED|Overall Study||68
6689005|NCT02713490|7619091|FG001|COMPLETED|Overall Study||67
6689006|NCT02713490|7619090|FG000|NOT COMPLETED|Overall Study||3
6689007|NCT02713490|7619091|FG001|NOT COMPLETED|Overall Study||2
6689008|NCT02713529|7619104|FG000|STARTED|Overall Study||8
6689009|NCT02713529|7619105|FG001|STARTED|Overall Study||7
6689010|NCT02713529|7619106|FG002|STARTED|Overall Study||42
6689011|NCT02713529|7619107|FG003|STARTED|Overall Study||31
6689012|NCT02713529|7619108|FG004|STARTED|Overall Study||4
6689013|NCT02713529|7619109|FG005|STARTED|Overall Study||19
6689014|NCT02713529|7619110|FG006|STARTED|Overall Study||6
6689015|NCT02713529|7619104|FG000|COMPLETED|Overall Study||1
6689016|NCT02713529|7619105|FG001|COMPLETED|Overall Study||3
6689017|NCT02713529|7619106|FG002|COMPLETED|Overall Study||11
6689018|NCT02713529|7619107|FG003|COMPLETED|Overall Study||2
6689019|NCT02713529|7619108|FG004|COMPLETED|Overall Study||1
6689020|NCT02713529|7619109|FG005|COMPLETED|Overall Study||5
6689021|NCT02713529|7619110|FG006|COMPLETED|Overall Study||2
6689022|NCT02713529|7619104|FG000|NOT COMPLETED|Overall Study||7
6689023|NCT02713529|7619105|FG001|NOT COMPLETED|Overall Study||4
6689024|NCT02713529|7619106|FG002|NOT COMPLETED|Overall Study||31
6689025|NCT02713529|7619107|FG003|NOT COMPLETED|Overall Study||29
6689026|NCT02713529|7619108|FG004|NOT COMPLETED|Overall Study||3
6689027|NCT02713529|7619109|FG005|NOT COMPLETED|Overall Study||14
6689028|NCT02713529|7619110|FG006|NOT COMPLETED|Overall Study||4
6689029|NCT02713542|7619132|FG000|STARTED|Overall Study||60
6689030|NCT02713542|7619133|FG001|STARTED|Overall Study||30
6689031|NCT02713542|7619132|FG000|COMPLETED|Overall Study||42
6689032|NCT02713542|7619133|FG001|COMPLETED|Overall Study||24
6689033|NCT02713542|7619132|FG000|NOT COMPLETED|Overall Study||18
6689034|NCT02713542|7619133|FG001|NOT COMPLETED|Overall Study||6
6689035|NCT02713594|7619141|FG000|STARTED|Overall Study||952
6689036|NCT02713594|7619142|FG001|STARTED|Overall Study||948
6689037|NCT02713594|7619141|FG000|COMPLETED|Overall Study||562
6689038|NCT02713594|7619142|FG001|COMPLETED|Overall Study||552
6689039|NCT02713594|7619141|FG000|NOT COMPLETED|Overall Study||390
6689040|NCT02713594|7619142|FG001|NOT COMPLETED|Overall Study||396
6689041|NCT02713659|7619152|FG000|STARTED|Baseline||60
6689042|NCT02713659|7619153|FG001|STARTED|Baseline||60
6689043|NCT02713659|7619152|FG000|COMPLETED|Baseline||60
6689044|NCT02713659|7619153|FG001|COMPLETED|Baseline||60
6689045|NCT02713659|7619152|FG000|NOT COMPLETED|Baseline||0
6689046|NCT02713659|7619153|FG001|NOT COMPLETED|Baseline||0
6689047|NCT02713659|7619152|FG000|STARTED|6 Month Study Visit||60
6689048|NCT02713659|7619153|FG001|STARTED|6 Month Study Visit||60
6689049|NCT02713659|7619152|FG000|COMPLETED|6 Month Study Visit||53
6689050|NCT02713659|7619153|FG001|COMPLETED|6 Month Study Visit||47
6689051|NCT02713659|7619152|FG000|NOT COMPLETED|6 Month Study Visit||7
6257508|NCT04610489|7156649|FG000|STARTED|Overall Study||117
6257509|NCT04610489|7156649|FG000|COMPLETED|Overall Study||117
6257510|NCT04610489|7156649|FG000|NOT COMPLETED|Overall Study||0
6279889|NCT00149799|7179799|FG001|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
6279890|NCT00149799|7179800|FG002|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
6279891|NCT00149799|7179798|FG000|STARTED|Discontinuation (Phase II)||0
6279892|NCT00149799|7179799|FG001|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|28
6279893|NCT00149799|7179800|FG002|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I and were willing to continue were randomized in Phase II|30
6279894|NCT00149799|7179798|FG000|COMPLETED|Discontinuation (Phase II)||0
6279895|NCT00149799|7179799|FG001|COMPLETED|Discontinuation (Phase II)||25
6279896|NCT00149799|7179800|FG002|COMPLETED|Discontinuation (Phase II)||21
6279897|NCT00149799|7179798|FG000|NOT COMPLETED|Discontinuation (Phase II)||0
6279898|NCT00149799|7179799|FG001|NOT COMPLETED|Discontinuation (Phase II)||3
6602324|NCT02055976|7527278|FG000|NOT COMPLETED|Overall Study||0
6602325|NCT02055976|7527279|FG001|NOT COMPLETED|Overall Study||0
6602326|NCT02055976|7527280|FG002|NOT COMPLETED|Overall Study||1
6602327|NCT02055976|7527281|FG003|NOT COMPLETED|Overall Study||1
6602328|NCT02055976|7527282|FG004|NOT COMPLETED|Overall Study||0
6602329|NCT02055976|7527283|FG005|NOT COMPLETED|Overall Study||1
6602330|NCT02055976|7527284|FG006|NOT COMPLETED|Overall Study||2
6602331|NCT02055976|7527285|FG007|NOT COMPLETED|Overall Study||0
6602332|NCT02055976|7527286|FG008|NOT COMPLETED|Overall Study||0
6602333|NCT02056171|7527315|FG000|STARTED|Overall Study||3
6602334|NCT02056171|7527316|FG001|STARTED|Overall Study||3
6602335|NCT02056171|7527315|FG000|COMPLETED|Overall Study||3
6602336|NCT02056171|7527316|FG001|COMPLETED|Overall Study||3
6602337|NCT02056171|7527315|FG000|NOT COMPLETED|Overall Study||0
6602338|NCT02056171|7527316|FG001|NOT COMPLETED|Overall Study||0
6602339|NCT02056288|7527324|FG000|STARTED|In-Hospital Data||40
6602340|NCT02056288|7527325|FG001|STARTED|In-Hospital Data||38
6602341|NCT02056288|7527324|FG000|COMPLETED|In-Hospital Data||35
6602342|NCT02056288|7527325|FG001|COMPLETED|In-Hospital Data||38
6602343|NCT02056288|7527324|FG000|NOT COMPLETED|In-Hospital Data||5
6602344|NCT02056288|7527325|FG001|NOT COMPLETED|In-Hospital Data||0
6602345|NCT02056288|7527324|FG000|STARTED|48-Hour Post-Discharge Data||35
6602346|NCT02056288|7527325|FG001|STARTED|48-Hour Post-Discharge Data||38
6602347|NCT02056288|7527324|FG000|COMPLETED|48-Hour Post-Discharge Data||21
6602348|NCT02056288|7527325|FG001|COMPLETED|48-Hour Post-Discharge Data||18
6602349|NCT02056288|7527324|FG000|NOT COMPLETED|48-Hour Post-Discharge Data||14
6602350|NCT02056288|7527325|FG001|NOT COMPLETED|48-Hour Post-Discharge Data||20
6602351|NCT02056301|7527333|FG000|STARTED|Overall Study||33
6602352|NCT02056301|7527334|FG001|STARTED|Overall Study||29
6602353|NCT02056301|7527333|FG000|COMPLETED|Overall Study||31
6602354|NCT02056301|7527334|FG001|COMPLETED|Overall Study||23
6602355|NCT02056301|7527333|FG000|NOT COMPLETED|Overall Study||2
6602356|NCT02056301|7527334|FG001|NOT COMPLETED|Overall Study||6
6602357|NCT02056340|7527342|FG000|STARTED|Overall Study||59
6602358|NCT02056340|7527343|FG001|STARTED|Overall Study||57
6602359|NCT02056340|7527342|FG000|COMPLETED|Overall Study||52
6602360|NCT02056340|7527343|FG001|COMPLETED|Overall Study||46
6602361|NCT02056340|7527342|FG000|NOT COMPLETED|Overall Study||7
6602362|NCT02056340|7527343|FG001|NOT COMPLETED|Overall Study||11
6602363|NCT02056392|7527355|FG000|STARTED|Overall Study||10
6602364|NCT02056392|7527356|FG001|STARTED|Overall Study||9
6602365|NCT02056392|7527357|FG002|STARTED|Overall Study||9
6602366|NCT02056392|7527358|FG003|STARTED|Overall Study||9
6602367|NCT02056392|7527359|FG004|STARTED|Overall Study||8
6602368|NCT02056392|7527360|FG005|STARTED|Overall Study||9
6602369|NCT02056392|7527355|FG000|COMPLETED|Overall Study||8
6602370|NCT02056392|7527356|FG001|COMPLETED|Overall Study||8
6602371|NCT02056392|7527357|FG002|COMPLETED|Overall Study||6
6602372|NCT02056392|7527358|FG003|COMPLETED|Overall Study||9
6602373|NCT02056392|7527359|FG004|COMPLETED|Overall Study||7
6602374|NCT02056392|7527360|FG005|COMPLETED|Overall Study||9
6602375|NCT02056392|7527355|FG000|NOT COMPLETED|Overall Study||2
6602376|NCT02056392|7527356|FG001|NOT COMPLETED|Overall Study||1
6602377|NCT02056392|7527357|FG002|NOT COMPLETED|Overall Study||3
6602378|NCT02056392|7527358|FG003|NOT COMPLETED|Overall Study||0
6602379|NCT02056392|7527359|FG004|NOT COMPLETED|Overall Study||1
6602380|NCT02056392|7527360|FG005|NOT COMPLETED|Overall Study||0
6602381|NCT02056431|7527370|FG000|STARTED|Overall Study||604
6602382|NCT02056431|7527371|FG001|STARTED|Overall Study||666
6602383|NCT02056431|7527370|FG000|COMPLETED|Overall Study||560
6602384|NCT02056431|7527371|FG001|COMPLETED|Overall Study||619
6602385|NCT02056431|7527370|FG000|NOT COMPLETED|Overall Study||44
6602386|NCT02056431|7527371|FG001|NOT COMPLETED|Overall Study||47
6602387|NCT02056626|7527383|FG000|STARTED|Overall Study||13
6602388|NCT02056626|7527384|FG001|STARTED|Overall Study||13
6602389|NCT02056626|7527385|FG002|STARTED|Overall Study||4
6602390|NCT02056626|7527386|FG003|STARTED|Overall Study||14
6602391|NCT02056626|7527383|FG000|COMPLETED|Overall Study||10
6602392|NCT02056626|7527384|FG001|COMPLETED|Overall Study||12
6602393|NCT02056626|7527385|FG002|COMPLETED|Overall Study||4
6602394|NCT02056626|7527386|FG003|COMPLETED|Overall Study||14
6602395|NCT02056626|7527383|FG000|NOT COMPLETED|Overall Study||3
6602396|NCT02056626|7527384|FG001|NOT COMPLETED|Overall Study||1
6257511|NCT04608500|7156656|FG000|STARTED|Overall Study||514
6257512|NCT04608500|7156657|FG001|STARTED|Overall Study||257
6257513|NCT04608500|7156656|FG000|COMPLETED|Overall Study||479
6257514|NCT04608500|7156657|FG001|COMPLETED|Overall Study||239
6257515|NCT04608500|7156656|FG000|NOT COMPLETED|Overall Study||35
6257516|NCT04608500|7156657|FG001|NOT COMPLETED|Overall Study||18
6257517|NCT04607291|7156663|FG000|STARTED|Overall Study||183
6257518|NCT04607291|7156663|FG000|COMPLETED|Overall Study||183
6257519|NCT04607291|7156663|FG000|NOT COMPLETED|Overall Study||0
6257520|NCT04599959|7156667|FG000|STARTED|Overall Study||151
6257521|NCT04599959|7156667|FG000|COMPLETED|Overall Study||151
6257522|NCT04599959|7156667|FG000|NOT COMPLETED|Overall Study||0
6257523|NCT04596085|7156675|FG000|STARTED|Overall Study||59
6257524|NCT04596085|7156676|FG001|STARTED|Overall Study||59
6257525|NCT04596085|7156675|FG000|COMPLETED|Overall Study||59
6257526|NCT04596085|7156676|FG001|COMPLETED|Overall Study||59
6257527|NCT04596085|7156675|FG000|NOT COMPLETED|Overall Study||0
6257528|NCT04596085|7156676|FG001|NOT COMPLETED|Overall Study||0
6257529|NCT04590027|7156686|FG000|STARTED|Overall Study||47
6257530|NCT04590027|7156687|FG001|STARTED|Overall Study||39
6257531|NCT04590027|7156686|FG000|COMPLETED|Overall Study||30
6257532|NCT04590027|7156687|FG001|COMPLETED|Overall Study||22
6257533|NCT04590027|7156686|FG000|NOT COMPLETED|Overall Study||17
6257534|NCT04590027|7156687|FG001|NOT COMPLETED|Overall Study||17
6257535|NCT04578457|7156697|FG000|STARTED|Hearing Aid Without NR Enabled (0)||19
6257536|NCT04578457|7156697|FG000|COMPLETED|Hearing Aid Without NR Enabled (0)||17
6257537|NCT04578457|7156697|FG000|NOT COMPLETED|Hearing Aid Without NR Enabled (0)||2
6257538|NCT04578457|7156697|FG000|STARTED|Hearing Aid With NR (1)||19
6257539|NCT04578457|7156697|FG000|COMPLETED|Hearing Aid With NR (1)||17
6257540|NCT04578457|7156697|FG000|NOT COMPLETED|Hearing Aid With NR (1)||2
6257541|NCT04578457|7156697|FG000|STARTED|Hearing Aid With NR (2)||19
6257542|NCT04578457|7156697|FG000|COMPLETED|Hearing Aid With NR (2)||17
6257543|NCT04578457|7156697|FG000|NOT COMPLETED|Hearing Aid With NR (2)||2
6257544|NCT04578457|7156697|FG000|STARTED|Hearing Aid With NR (4)||19
6257545|NCT04578457|7156697|FG000|COMPLETED|Hearing Aid With NR (4)||17
6257546|NCT04578457|7156697|FG000|NOT COMPLETED|Hearing Aid With NR (4)||2
6257547|NCT04578496|7156705|FG000|STARTED|Overall Study||16
6257548|NCT04578496|7156705|FG000|COMPLETED|Overall Study||12
6257549|NCT04578496|7156705|FG000|NOT COMPLETED|Overall Study||4
6257562|NCT04563767|7156730|FG000|STARTED|Overall Study||4
6257563|NCT04563767|7156730|FG000|COMPLETED|Overall Study||4
6257564|NCT04563767|7156730|FG000|NOT COMPLETED|Overall Study||0
6257571|NCT04555525|7156747|FG000|STARTED|Overall Study||75
6257572|NCT04555525|7156748|FG001|STARTED|Overall Study||25
6257573|NCT04555525|7156747|FG000|COMPLETED|Overall Study||72
6257574|NCT04555525|7156748|FG001|COMPLETED|Overall Study||25
6257575|NCT04555525|7156747|FG000|NOT COMPLETED|Overall Study||3
6257576|NCT04555525|7156748|FG001|NOT COMPLETED|Overall Study||0
6257583|NCT04548622|7156766|FG000|STARTED|Overall Study||15
6257584|NCT04548622|7156766|FG000|COMPLETED|Overall Study||15
6257585|NCT04548622|7156766|FG000|NOT COMPLETED|Overall Study||0
6257640|NCT04534764|7156837|FG000|STARTED|Period 1||18
6257641|NCT04534764|7156838|FG001|STARTED|Period 1||17
6257642|NCT04534764|7156837|FG000|COMPLETED|Period 1||18
6257643|NCT04534764|7156838|FG001|COMPLETED|Period 1||17
6257644|NCT04534764|7156837|FG000|NOT COMPLETED|Period 1||0
6257645|NCT04534764|7156838|FG001|NOT COMPLETED|Period 1||0
6257646|NCT04534764|7156837|FG000|STARTED|Period 2||18
6257647|NCT04534764|7156838|FG001|STARTED|Period 2||17
6257648|NCT04534764|7156837|FG000|COMPLETED|Period 2||18
6257649|NCT04534764|7156838|FG001|COMPLETED|Period 2||17
6257650|NCT04534764|7156837|FG000|NOT COMPLETED|Period 2||0
6257651|NCT04534764|7156838|FG001|NOT COMPLETED|Period 2||0
6257652|NCT04534491|7156844|FG000|STARTED|Overall Study||855
6257653|NCT04534491|7156844|FG000|Treated|Overall Study||727
6257654|NCT04534491|7156844|FG000|COMPLETED|Overall Study||703
6257655|NCT04534491|7156844|FG000|NOT COMPLETED|Overall Study||152
6257656|NCT04534465|7156848|FG000|STARTED|Overall Study||10
6257657|NCT04534465|7156849|FG001|STARTED|Overall Study||10
6257658|NCT04534465|7156850|FG002|STARTED|Overall Study||10
6257659|NCT04534465|7156851|FG003|STARTED|Overall Study||10
6257660|NCT04534465|7156852|FG004|STARTED|Overall Study||10
6257661|NCT04534465|7156848|FG000|COMPLETED|Overall Study||10
6257662|NCT04534465|7156849|FG001|COMPLETED|Overall Study||10
6257663|NCT04534465|7156850|FG002|COMPLETED|Overall Study||10
6257664|NCT04534465|7156851|FG003|COMPLETED|Overall Study||10
6257665|NCT04534465|7156852|FG004|COMPLETED|Overall Study||10
6257666|NCT04534465|7156848|FG000|NOT COMPLETED|Overall Study||0
6257667|NCT04534465|7156849|FG001|NOT COMPLETED|Overall Study||0
6257668|NCT04534465|7156850|FG002|NOT COMPLETED|Overall Study||0
6257669|NCT04534465|7156851|FG003|NOT COMPLETED|Overall Study||0
6257670|NCT04534465|7156852|FG004|NOT COMPLETED|Overall Study||0
6257696|NCT04615832|7156894|FG000|STARTED|Overall Study||44
6257697|NCT04615832|7156894|FG000|COMPLETED|Overall Study||44
6257698|NCT04615832|7156894|FG000|NOT COMPLETED|Overall Study||0
6257766|NCT03230838|7156981|FG000|COMPLETED|Overall Study||97
6257767|NCT03230838|7156982|FG001|COMPLETED|Overall Study||33
6257768|NCT03230838|7156981|FG000|NOT COMPLETED|Overall Study||4
6257769|NCT03230838|7156982|FG001|NOT COMPLETED|Overall Study||0
6257770|NCT03183778|7156988|FG000|STARTED|Overall Study||3
6257771|NCT03183778|7156988|FG000|COMPLETED|Overall Study||2
6257772|NCT03183778|7156988|FG000|NOT COMPLETED|Overall Study||1
6257773|NCT03113955|7156992|FG000|STARTED|Overall Study||109
6257550|NCT04577183|7156709|FG000|STARTED|Overall Study||13
6257551|NCT04577183|7156709|FG000|COMPLETED|Overall Study||7
6257552|NCT04577183|7156709|FG000|NOT COMPLETED|Overall Study||6
6257565|NCT04560374|7156736|FG000|STARTED|Overall Study||50
6257566|NCT04560374|7156737|FG001|STARTED|Overall Study||50
6257567|NCT04560374|7156736|FG000|COMPLETED|Overall Study||50
6257568|NCT04560374|7156737|FG001|COMPLETED|Overall Study||50
6257569|NCT04560374|7156736|FG000|NOT COMPLETED|Overall Study||0
6257570|NCT04560374|7156737|FG001|NOT COMPLETED|Overall Study||0
6257577|NCT04553497|7156756|FG000|STARTED|Overall Study||17
6257578|NCT04553497|7156757|FG001|STARTED|Overall Study||18
6257579|NCT04553497|7156756|FG000|COMPLETED|Overall Study||15
6257580|NCT04553497|7156757|FG001|COMPLETED|Overall Study||17
6257581|NCT04553497|7156756|FG000|NOT COMPLETED|Overall Study||2
6257582|NCT04553497|7156757|FG001|NOT COMPLETED|Overall Study||1
6257586|NCT04547036|7156770|FG000|STARTED|Overall Study||129
6257587|NCT04547036|7156770|FG000|COMPLETED|Overall Study||129
6257588|NCT04547036|7156770|FG000|NOT COMPLETED|Overall Study||0
6257671|NCT04533204|7156866|FG000|STARTED|Overall Study||29
6257672|NCT04533204|7156867|FG001|STARTED|Overall Study||30
6257673|NCT04533204|7156866|FG000|COMPLETED|Overall Study||28
6257674|NCT04533204|7156867|FG001|COMPLETED|Overall Study||29
6257675|NCT04533204|7156866|FG000|NOT COMPLETED|Overall Study||1
6257676|NCT04533204|7156867|FG001|NOT COMPLETED|Overall Study||1
6257699|NCT04093258|7156898|FG000|STARTED|Period 1||21
6257700|NCT04093258|7156899|FG001|STARTED|Period 1||20
6257701|NCT04093258|7156898|FG000|COMPLETED|Period 1||21
6257702|NCT04093258|7156899|FG001|COMPLETED|Period 1||20
6257703|NCT04093258|7156898|FG000|NOT COMPLETED|Period 1||0
6257704|NCT04093258|7156899|FG001|NOT COMPLETED|Period 1||0
6257705|NCT04093258|7156898|FG000|STARTED|Period 2||21
6257706|NCT04093258|7156899|FG001|STARTED|Period 2||20
6257707|NCT04093258|7156898|FG000|COMPLETED|Period 2||20
6257708|NCT04093258|7156899|FG001|COMPLETED|Period 2||20
6257709|NCT04093258|7156898|FG000|NOT COMPLETED|Period 2||1
6257710|NCT04093258|7156899|FG001|NOT COMPLETED|Period 2||0
6257711|NCT04011826|7156905|FG000|STARTED|Overall Study||45
6257712|NCT04011826|7156905|FG000|COMPLETED|Overall Study||45
6257713|NCT04011826|7156905|FG000|NOT COMPLETED|Overall Study||0
6257714|NCT03993379|7156913|FG000|STARTED|Overall Study||0
6257715|NCT03993379|7156914|FG001|STARTED|Overall Study||3
6257716|NCT03993379|7156915|FG002|STARTED|Overall Study||0
6257717|NCT03993379|7156916|FG003|STARTED|Overall Study||0
6257718|NCT03993379|7156913|FG000|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
6257719|NCT03993379|7156914|FG001|COMPLETED|Overall Study|Subjects did not complete due to early termination of the study due to business reasons.|0
6257720|NCT03993379|7156915|FG002|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
6257721|NCT03993379|7156916|FG003|COMPLETED|Overall Study|No subjects enrolled in this arm/group.|0
6257722|NCT03993379|7156913|FG000|NOT COMPLETED|Overall Study||0
6257723|NCT03993379|7156914|FG001|NOT COMPLETED|Overall Study||3
6257724|NCT03993379|7156915|FG002|NOT COMPLETED|Overall Study||0
6257725|NCT03993379|7156916|FG003|NOT COMPLETED|Overall Study||0
6257726|NCT03956615|7156926|FG000|STARTED|Overall Study||10
6257727|NCT03956615|7156926|FG000|COMPLETED|Overall Study||3
6257728|NCT03956615|7156926|FG000|NOT COMPLETED|Overall Study||7
6257729|NCT03803059|7156930|FG000|STARTED|Overall Study||35
6257730|NCT03803059|7156930|FG000|COMPLETED|Overall Study||32
6257731|NCT03803059|7156930|FG000|NOT COMPLETED|Overall Study||3
6257732|NCT03723590|7156935|FG000|STARTED|Overall Study||5
6257733|NCT03723590|7156935|FG000|COMPLETED|Overall Study||2
6257734|NCT03723590|7156935|FG000|NOT COMPLETED|Overall Study||3
6257735|NCT03720392|7156941|FG000|STARTED|Overall Study||3
6257736|NCT03720392|7156942|FG001|STARTED|Overall Study||3
6257737|NCT03720392|7156941|FG000|COMPLETED|Overall Study||3
6257738|NCT03720392|7156942|FG001|COMPLETED|Overall Study||3
6257739|NCT03720392|7156941|FG000|NOT COMPLETED|Overall Study||0
6257740|NCT03720392|7156942|FG001|NOT COMPLETED|Overall Study||0
6257741|NCT03515226|7156950|FG000|STARTED|Overall Study||10
6257742|NCT03515226|7156951|FG001|STARTED|Overall Study||15
6257743|NCT03515226|7156950|FG000|COMPLETED|Overall Study||8
6257744|NCT03515226|7156951|FG001|COMPLETED|Overall Study||11
6257745|NCT03515226|7156950|FG000|NOT COMPLETED|Overall Study||2
6257746|NCT03515226|7156951|FG001|NOT COMPLETED|Overall Study||4
6257747|NCT03430895|7156958|FG000|STARTED|Overall Study||15
6257748|NCT03430895|7156958|FG000|COMPLETED|Overall Study||13
6257749|NCT03430895|7156958|FG000|NOT COMPLETED|Overall Study||2
6257750|NCT03321617|7156966|FG000|STARTED|Overall Study||3
6257751|NCT03321617|7156967|FG001|STARTED|Overall Study||3
6257752|NCT03321617|7156968|FG002|STARTED|Overall Study||2
6257753|NCT03321617|7156969|FG003|STARTED|Overall Study||3
6257754|NCT03321617|7156966|FG000|COMPLETED|Overall Study||2
6257755|NCT03321617|7156967|FG001|COMPLETED|Overall Study||3
6257756|NCT03321617|7156968|FG002|COMPLETED|Overall Study||2
6689052|NCT02713659|7619153|FG001|NOT COMPLETED|6 Month Study Visit||13
6257757|NCT03321617|7156969|FG003|COMPLETED|Overall Study||2
6257758|NCT03321617|7156966|FG000|NOT COMPLETED|Overall Study||1
6257759|NCT03321617|7156967|FG001|NOT COMPLETED|Overall Study||0
6257760|NCT03321617|7156968|FG002|NOT COMPLETED|Overall Study||0
6257761|NCT03321617|7156969|FG003|NOT COMPLETED|Overall Study||1
6257762|NCT03230838|7156981|FG000|STARTED|Overall Study||101
6257763|NCT03230838|7156982|FG001|STARTED|Overall Study||33
6257764|NCT03230838|7156981|FG000|Treated|Overall Study||100
6257765|NCT03230838|7156982|FG001|Treated|Overall Study||33
6257553|NCT04574999|7156715|FG000|STARTED|Overall Study||114
6257554|NCT04574999|7156716|FG001|STARTED|Overall Study||53
6257555|NCT04574999|7156715|FG000|COMPLETED|Overall Study||105
6257556|NCT04574999|7156716|FG001|COMPLETED|Overall Study||48
6257557|NCT04574999|7156715|FG000|NOT COMPLETED|Overall Study||9
6257558|NCT04574999|7156716|FG001|NOT COMPLETED|Overall Study||5
6257589|NCT04544566|7156780|FG000|STARTED|Overall Study||2
6257590|NCT04544566|7156781|FG001|STARTED|Overall Study||2
6257591|NCT04544566|7156782|FG002|STARTED|Overall Study||2
6257592|NCT04544566|7156783|FG003|STARTED|Overall Study||2
6257593|NCT04544566|7156784|FG004|STARTED|Overall Study||2
6257594|NCT04544566|7156785|FG005|STARTED|Overall Study||2
6257595|NCT04544566|7156780|FG000|COMPLETED|Overall Study||2
6257596|NCT04544566|7156781|FG001|COMPLETED|Overall Study||2
6257597|NCT04544566|7156782|FG002|COMPLETED|Overall Study||2
6257598|NCT04544566|7156783|FG003|COMPLETED|Overall Study||2
6257599|NCT04544566|7156784|FG004|COMPLETED|Overall Study||2
6257600|NCT04544566|7156785|FG005|COMPLETED|Overall Study||2
6257601|NCT04544566|7156780|FG000|NOT COMPLETED|Overall Study||0
6257602|NCT04544566|7156781|FG001|NOT COMPLETED|Overall Study||0
6257603|NCT04544566|7156782|FG002|NOT COMPLETED|Overall Study||0
6257604|NCT04544566|7156783|FG003|NOT COMPLETED|Overall Study||0
6257605|NCT04544566|7156784|FG004|NOT COMPLETED|Overall Study||0
6257606|NCT04544566|7156785|FG005|NOT COMPLETED|Overall Study||0
6257677|NCT04532164|7156873|FG000|STARTED|Overall Study||137
6257678|NCT04532164|7156873|FG000|Treated|Overall Study||132
6257679|NCT04532164|7156873|FG000|COMPLETED|Overall Study||113
6257680|NCT04532164|7156873|FG000|NOT COMPLETED|Overall Study||24
6257681|NCT04531813|7156878|FG000|STARTED|Overall Study||32
6257682|NCT04531813|7156878|FG000|Treated|Overall Study||31
6257683|NCT04531813|7156878|FG000|COMPLETED|Overall Study||30
6257684|NCT04531813|7156878|FG000|NOT COMPLETED|Overall Study||2
6257685|NCT04531527|7156882|FG000|STARTED|Overall Study||32
6257686|NCT04531527|7156882|FG000|Treated|Overall Study||29
6257687|NCT04531527|7156882|FG000|COMPLETED|Overall Study||29
6257688|NCT04531527|7156882|FG000|NOT COMPLETED|Overall Study||3
6257689|NCT04531540|7156886|FG000|STARTED|Overall Study||225
6257690|NCT04531540|7156886|FG000|Treated|Overall Study||222
6257691|NCT04531540|7156886|FG000|COMPLETED|Overall Study||216
6257692|NCT04531540|7156886|FG000|NOT COMPLETED|Overall Study||9
6257693|NCT04530591|7156890|FG000|STARTED|Overall Study||97
6257694|NCT04530591|7156890|FG000|COMPLETED|Overall Study||97
6257695|NCT04530591|7156890|FG000|NOT COMPLETED|Overall Study||0
6257774|NCT03113955|7156992|FG000|COMPLETED|Overall Study||92
6257775|NCT03113955|7156992|FG000|NOT COMPLETED|Overall Study||17
6257776|NCT03029234|7156996|FG000|STARTED|Overall Study||126
6257777|NCT03029234|7156996|FG000|Received Carfilzomib|Overall Study||123
6257778|NCT03029234|7156996|FG000|COMPLETED|Overall Study||59
6257779|NCT03029234|7156996|FG000|NOT COMPLETED|Overall Study||67
6257780|NCT02995694|7157003|FG000|STARTED|Overall Study||215
6257781|NCT02995694|7157004|FG001|STARTED|Overall Study||211
6257782|NCT02995694|7157005|FG002|STARTED|Overall Study||109
6257783|NCT02995694|7157003|FG000|COMPLETED|Overall Study||181
6257784|NCT02995694|7157004|FG001|COMPLETED|Overall Study||183
6257785|NCT02995694|7157005|FG002|COMPLETED|Overall Study||94
6257786|NCT02995694|7157003|FG000|NOT COMPLETED|Overall Study||34
6257787|NCT02995694|7157004|FG001|NOT COMPLETED|Overall Study||28
6257788|NCT02995694|7157005|FG002|NOT COMPLETED|Overall Study||15
6257789|NCT02926833|7157020|FG000|STARTED|Overall Study||3
6257790|NCT02926833|7157021|FG001|STARTED|Overall Study||4
6257791|NCT02926833|7157022|FG002|STARTED|Overall Study||7
6257792|NCT02926833|7157023|FG003|STARTED|Overall Study||23
6257793|NCT02926833|7157020|FG000|COMPLETED|Overall Study||0
6257794|NCT02926833|7157021|FG001|COMPLETED|Overall Study||0
6257795|NCT02926833|7157022|FG002|COMPLETED|Overall Study||0
6257796|NCT02926833|7157023|FG003|COMPLETED|Overall Study||0
6257797|NCT02926833|7157020|FG000|NOT COMPLETED|Overall Study||3
6257798|NCT02926833|7157021|FG001|NOT COMPLETED|Overall Study||4
6257799|NCT02926833|7157022|FG002|NOT COMPLETED|Overall Study||7
6257800|NCT02926833|7157023|FG003|NOT COMPLETED|Overall Study||23
6257801|NCT02700698|7157036|FG000|STARTED|Overall Study||17
6257802|NCT02700698|7157037|FG001|STARTED|Overall Study||18
6257803|NCT02700698|7157036|FG000|COMPLETED|Overall Study||16
6257804|NCT02700698|7157037|FG001|COMPLETED|Overall Study||18
6257805|NCT02700698|7157036|FG000|NOT COMPLETED|Overall Study||1
6257806|NCT02700698|7157037|FG001|NOT COMPLETED|Overall Study||0
6279899|NCT00149799|7179800|FG002|NOT COMPLETED|Discontinuation (Phase II)||9
6279900|NCT00149825|7179810|FG000|STARTED|Overall Study||15
6279901|NCT00149825|7179811|FG001|STARTED|Overall Study||15
6279902|NCT00149825|7179810|FG000|COMPLETED|Overall Study||10
6279903|NCT00149825|7179811|FG001|COMPLETED|Overall Study||12
6279904|NCT00149825|7179810|FG000|NOT COMPLETED|Overall Study||5
6279905|NCT00149825|7179811|FG001|NOT COMPLETED|Overall Study||3
6279906|NCT00149838|7179819|FG000|STARTED|Phase I||92
6279907|NCT00149838|7179820|FG001|STARTED|Phase I||98
6279908|NCT00149838|7179821|FG002|STARTED|Phase I||0
6279909|NCT00149838|7179822|FG003|STARTED|Phase I||0
6279910|NCT00149838|7179819|FG000|COMPLETED|Phase I||72
6279911|NCT00149838|7179820|FG001|COMPLETED|Phase I||82
6279912|NCT00149838|7179821|FG002|COMPLETED|Phase I||0
6279913|NCT00149838|7179822|FG003|COMPLETED|Phase I||0
6279914|NCT00149838|7179819|FG000|NOT COMPLETED|Phase I||20
6279915|NCT00149838|7179820|FG001|NOT COMPLETED|Phase I||16
6279916|NCT00149838|7179821|FG002|NOT COMPLETED|Phase I||0
6279917|NCT00149838|7179822|FG003|NOT COMPLETED|Phase I||0
6257559|NCT04572997|7156722|FG000|STARTED|Overall Study||21
6257560|NCT04572997|7156722|FG000|COMPLETED|Overall Study||20
6257561|NCT04572997|7156722|FG000|NOT COMPLETED|Overall Study||1
6257607|NCT04542694|7156801|FG000|STARTED|Overall Study||100
6257608|NCT04542694|7156802|FG001|STARTED|Overall Study||100
6257609|NCT04542694|7156801|FG000|COMPLETED|Overall Study||96
6257610|NCT04542694|7156802|FG001|COMPLETED|Overall Study||100
6257611|NCT04542694|7156801|FG000|NOT COMPLETED|Overall Study||4
6257612|NCT04542694|7156802|FG001|NOT COMPLETED|Overall Study||0
6257807|NCT02699086|7157043|FG000|STARTED|Overall Study||0
6257808|NCT02699086|7157044|FG001|STARTED|Overall Study||6
6257809|NCT02699086|7157043|FG000|COMPLETED|Overall Study||0
6257810|NCT02699086|7157044|FG001|COMPLETED|Overall Study||6
6257811|NCT02699086|7157043|FG000|NOT COMPLETED|Overall Study||0
6257812|NCT02699086|7157044|FG001|NOT COMPLETED|Overall Study||0
6257813|NCT02698865|7157054|FG000|STARTED|Overall Study||140
6257814|NCT02698865|7157055|FG001|STARTED|Overall Study||80
6257815|NCT02698865|7157054|FG000|Treated|Overall Study||140
6257816|NCT02698865|7157055|FG001|Treated|Overall Study||80
6257817|NCT02698865|7157054|FG000|COMPLETED|Overall Study||105
6257818|NCT02698865|7157055|FG001|COMPLETED|Overall Study||47
6257819|NCT02698865|7157054|FG000|NOT COMPLETED|Overall Study||35
6257820|NCT02698865|7157055|FG001|NOT COMPLETED|Overall Study||33
6257821|NCT02660086|7157063|FG000|STARTED|Overall Study- 12-month||299
6257822|NCT02660086|7157064|FG001|STARTED|Overall Study- 12-month||303
6257823|NCT02660086|7157063|FG000|COMPLETED|Overall Study- 12-month||273
6257824|NCT02660086|7157064|FG001|COMPLETED|Overall Study- 12-month||274
6257825|NCT02660086|7157063|FG000|NOT COMPLETED|Overall Study- 12-month||26
6257826|NCT02660086|7157064|FG001|NOT COMPLETED|Overall Study- 12-month||29
6257827|NCT02660086|7157063|FG000|STARTED|Overall Study: 24-month Follow-up||281
6257828|NCT02660086|7157064|FG001|STARTED|Overall Study: 24-month Follow-up||278
6257829|NCT02660086|7157063|FG000|COMPLETED|Overall Study: 24-month Follow-up||255
6257830|NCT02660086|7157064|FG001|COMPLETED|Overall Study: 24-month Follow-up||254
6257831|NCT02660086|7157063|FG000|NOT COMPLETED|Overall Study: 24-month Follow-up||26
6257832|NCT02660086|7157064|FG001|NOT COMPLETED|Overall Study: 24-month Follow-up||24
6257833|NCT02335749|7157070|FG000|STARTED|Overall Study||40
6257834|NCT02335749|7157070|FG000|COMPLETED|Overall Study||40
6257835|NCT02335749|7157070|FG000|NOT COMPLETED|Overall Study||0
6257836|NCT02129647|7157074|FG000|STARTED|Overall Study||13
6257837|NCT02129647|7157074|FG000|COMPLETED|Overall Study||10
6257838|NCT02129647|7157074|FG000|NOT COMPLETED|Overall Study||3
6257839|NCT02071901|7157078|FG000|STARTED|Overall Study||31
6257840|NCT02071901|7157078|FG000|COMPLETED|Overall Study||31
6257841|NCT02071901|7157078|FG000|NOT COMPLETED|Overall Study||0
6257842|NCT01959139|7157086|FG000|STARTED|Phase I: Cohort 1||5
6257843|NCT01959139|7157087|FG001|STARTED|Phase I: Cohort 1||0
6257844|NCT01959139|7157088|FG002|STARTED|Phase I: Cohort 1||0
6257845|NCT01959139|7157089|FG003|STARTED|Phase I: Cohort 1||0
6257846|NCT01959139|7157086|FG000|COMPLETED|Phase I: Cohort 1||5
6257847|NCT01959139|7157087|FG001|COMPLETED|Phase I: Cohort 1||0
6257848|NCT01959139|7157088|FG002|COMPLETED|Phase I: Cohort 1||0
6257849|NCT01959139|7157089|FG003|COMPLETED|Phase I: Cohort 1||0
6257850|NCT01959139|7157086|FG000|NOT COMPLETED|Phase I: Cohort 1||0
6257851|NCT01959139|7157087|FG001|NOT COMPLETED|Phase I: Cohort 1||0
6257852|NCT01959139|7157088|FG002|NOT COMPLETED|Phase I: Cohort 1||0
6257853|NCT01959139|7157089|FG003|NOT COMPLETED|Phase I: Cohort 1||0
6257854|NCT01959139|7157086|FG000|STARTED|Phase I: Cohort 2||0
6257855|NCT01959139|7157087|FG001|STARTED|Phase I: Cohort 2||6
6257856|NCT01959139|7157088|FG002|STARTED|Phase I: Cohort 2||0
6257857|NCT01959139|7157089|FG003|STARTED|Phase I: Cohort 2||0
6257858|NCT01959139|7157086|FG000|COMPLETED|Phase I: Cohort 2||0
6257859|NCT01959139|7157087|FG001|COMPLETED|Phase I: Cohort 2||6
6257860|NCT01959139|7157088|FG002|COMPLETED|Phase I: Cohort 2||0
6257861|NCT01959139|7157089|FG003|COMPLETED|Phase I: Cohort 2||0
6689053|NCT02713659|7619152|FG000|STARTED|12 Month Study Visit||57
6689054|NCT02713659|7619153|FG001|STARTED|12 Month Study Visit||55
6689055|NCT02713659|7619152|FG000|COMPLETED|12 Month Study Visit||54
6689056|NCT02713659|7619153|FG001|COMPLETED|12 Month Study Visit||52
6689057|NCT02713659|7619152|FG000|NOT COMPLETED|12 Month Study Visit||3
6689058|NCT02713659|7619153|FG001|NOT COMPLETED|12 Month Study Visit||3
6689059|NCT02713659|7619152|FG000|STARTED|18 Month Study Visit||58
6689060|NCT02713659|7619153|FG001|STARTED|18 Month Study Visit||53
6689061|NCT02713659|7619152|FG000|COMPLETED|18 Month Study Visit||50
6689062|NCT02713659|7619153|FG001|COMPLETED|18 Month Study Visit||50
6689063|NCT02713659|7619152|FG000|NOT COMPLETED|18 Month Study Visit||8
6689064|NCT02713659|7619153|FG001|NOT COMPLETED|18 Month Study Visit||3
6689065|NCT02713659|7619152|FG000|STARTED|24 Month Study Visit||57
6689066|NCT02713659|7619153|FG001|STARTED|24 Month Study Visit||52
6689067|NCT02713659|7619152|FG000|COMPLETED|24 Month Study Visit||49
6257862|NCT01959139|7157086|FG000|NOT COMPLETED|Phase I: Cohort 2||0
6257863|NCT01959139|7157087|FG001|NOT COMPLETED|Phase I: Cohort 2||0
6257864|NCT01959139|7157088|FG002|NOT COMPLETED|Phase I: Cohort 2||0
6257865|NCT01959139|7157089|FG003|NOT COMPLETED|Phase I: Cohort 2||0
6257866|NCT01959139|7157086|FG000|STARTED|Phase II||0
6257867|NCT01959139|7157087|FG001|STARTED|Phase II||0
6257868|NCT01959139|7157088|FG002|STARTED|Phase II||56
6257869|NCT01959139|7157089|FG003|STARTED|Phase II||55
6257870|NCT01959139|7157086|FG000|Assessed for AEs|Phase II||0
6257871|NCT01959139|7157087|FG001|Assessed for AEs|Phase II||0
6257872|NCT01959139|7157088|FG002|Assessed for AEs|Phase II||54
6689068|NCT02713659|7619153|FG001|COMPLETED|24 Month Study Visit||44
6689069|NCT02713659|7619152|FG000|NOT COMPLETED|24 Month Study Visit||8
6689070|NCT02713659|7619153|FG001|NOT COMPLETED|24 Month Study Visit||8
6689071|NCT02713698|7619162|FG000|STARTED|Overall Study||20
6689072|NCT02713698|7619163|FG001|STARTED|Overall Study||20
6689073|NCT02713698|7619164|FG002|STARTED|Overall Study||20
6689074|NCT02713698|7619162|FG000|COMPLETED|Overall Study||20
6689075|NCT02713698|7619163|FG001|COMPLETED|Overall Study||20
6689076|NCT02713698|7619164|FG002|COMPLETED|Overall Study||20
6689077|NCT02713698|7619162|FG000|NOT COMPLETED|Overall Study||0
6689078|NCT02713698|7619163|FG001|NOT COMPLETED|Overall Study||0
6689079|NCT02713698|7619164|FG002|NOT COMPLETED|Overall Study||0
6689080|NCT02713711|7619172|FG000|STARTED|Overall Study||9
6689081|NCT02713711|7619173|FG001|STARTED|Overall Study||6
6689082|NCT02713711|7619174|FG002|STARTED|Overall Study||6
6689083|NCT02713711|7619175|FG003|STARTED|Overall Study||10
6689084|NCT02713711|7619172|FG000|COMPLETED|Overall Study||9
6689085|NCT02713711|7619173|FG001|COMPLETED|Overall Study||6
6689086|NCT02713711|7619174|FG002|COMPLETED|Overall Study||6
6689087|NCT02713711|7619175|FG003|COMPLETED|Overall Study||10
6689088|NCT02713711|7619172|FG000|NOT COMPLETED|Overall Study||0
6689089|NCT02713711|7619173|FG001|NOT COMPLETED|Overall Study||0
6689090|NCT02713711|7619174|FG002|NOT COMPLETED|Overall Study||0
6689091|NCT02713711|7619175|FG003|NOT COMPLETED|Overall Study||0
6689092|NCT02713789|7619191|FG000|STARTED|Overall Study||8
6689093|NCT02713789|7619192|FG001|STARTED|Overall Study||10
6689094|NCT02713789|7619193|FG002|STARTED|Overall Study||8
6689095|NCT02713789|7619191|FG000|COMPLETED|Overall Study||8
6689096|NCT02713789|7619192|FG001|COMPLETED|Overall Study||9
6689097|NCT02713789|7619193|FG002|COMPLETED|Overall Study||7
6689098|NCT02713789|7619191|FG000|NOT COMPLETED|Overall Study||0
6689099|NCT02713789|7619192|FG001|NOT COMPLETED|Overall Study||1
6689100|NCT02713789|7619193|FG002|NOT COMPLETED|Overall Study||1
6689101|NCT02713828|7619203|FG000|STARTED|Overall Study||13
6257613|NCT04542226|7156808|FG000|STARTED|Overall Study||81
6257614|NCT04542226|7156808|FG000|COMPLETED|Overall Study||81
6257615|NCT04542226|7156808|FG000|NOT COMPLETED|Overall Study||0
6257616|NCT04540627|7156815|FG000|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the double-blind period.|6
6257617|NCT04540627|7156816|FG001|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
6257618|NCT04540627|7156817|FG002|STARTED|Open-label Treatment: PK Sentinel|Participants were not enrolled in this arm in the open-label period.|0
6257619|NCT04540627|7156815|FG000|COMPLETED|Open-label Treatment: PK Sentinel||6
6257620|NCT04540627|7156816|FG001|COMPLETED|Open-label Treatment: PK Sentinel||0
6257621|NCT04540627|7156817|FG002|COMPLETED|Open-label Treatment: PK Sentinel||0
6257622|NCT04540627|7156815|FG000|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
6257623|NCT04540627|7156816|FG001|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
6257624|NCT04540627|7156817|FG002|NOT COMPLETED|Open-label Treatment: PK Sentinel||0
6257625|NCT04540627|7156815|FG000|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the double-blind period.|0
6257626|NCT04540627|7156816|FG001|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
6257627|NCT04540627|7156817|FG002|STARTED|Double-blind Treatment: Viral Challenge|Participants were not enrolled in this arm in the open-label period.|25
6257628|NCT04540627|7156815|FG000|COMPLETED|Double-blind Treatment: Viral Challenge||0
6257629|NCT04540627|7156816|FG001|COMPLETED|Double-blind Treatment: Viral Challenge||25
6257630|NCT04540627|7156817|FG002|COMPLETED|Double-blind Treatment: Viral Challenge||25
6257631|NCT04540627|7156815|FG000|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
6257632|NCT04540627|7156816|FG001|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
6257633|NCT04540627|7156817|FG002|NOT COMPLETED|Double-blind Treatment: Viral Challenge||0
6257873|NCT01959139|7157089|FG003|Assessed for AEs|Phase II||51
6257874|NCT01959139|7157086|FG000|COMPLETED|Phase II||0
6257875|NCT01959139|7157087|FG001|COMPLETED|Phase II||0
6257876|NCT01959139|7157088|FG002|COMPLETED|Phase II||0
6257877|NCT01959139|7157089|FG003|COMPLETED|Phase II||0
6257878|NCT01959139|7157086|FG000|NOT COMPLETED|Phase II||0
6257879|NCT01959139|7157087|FG001|NOT COMPLETED|Phase II||0
6257880|NCT01959139|7157088|FG002|NOT COMPLETED|Phase II||56
6257881|NCT01959139|7157089|FG003|NOT COMPLETED|Phase II||55
6257882|NCT01597778|7157106|FG000|STARTED|Overall Study||186
6257883|NCT01597778|7157107|FG001|STARTED|Overall Study||182
6257884|NCT01597778|7157106|FG000|COMPLETED|Overall Study||172
6257885|NCT01597778|7157107|FG001|COMPLETED|Overall Study||153
6257886|NCT01597778|7157106|FG000|NOT COMPLETED|Overall Study||14
6257887|NCT01597778|7157107|FG001|NOT COMPLETED|Overall Study||29
6257888|NCT01522976|7157116|FG000|STARTED|Overall Study||97
6257889|NCT01522976|7157117|FG001|STARTED|Overall Study||92
6257890|NCT01522976|7157118|FG002|STARTED|Overall Study||93
6257891|NCT01522976|7157116|FG000|COMPLETED|Overall Study||0
6257892|NCT01522976|7157117|FG001|COMPLETED|Overall Study||0
6257893|NCT01522976|7157118|FG002|COMPLETED|Overall Study||0
6257894|NCT01522976|7157116|FG000|NOT COMPLETED|Overall Study||97
6257895|NCT01522976|7157117|FG001|NOT COMPLETED|Overall Study||92
6257896|NCT01522976|7157118|FG002|NOT COMPLETED|Overall Study||93
6689102|NCT02713828|7619204|FG001|STARTED|Overall Study||0
6689103|NCT02713828|7619203|FG000|COMPLETED|Overall Study||8
6689104|NCT02713828|7619204|FG001|COMPLETED|Overall Study||0
6689105|NCT02713828|7619203|FG000|NOT COMPLETED|Overall Study||5
6689106|NCT02713828|7619204|FG001|NOT COMPLETED|Overall Study||0
6689107|NCT02714153|7619209|FG000|STARTED|Overall Study||23
6689108|NCT02714153|7619209|FG000|COMPLETED|Overall Study||22
6689109|NCT02714153|7619209|FG000|NOT COMPLETED|Overall Study||1
6689110|NCT02714283|7619215|FG000|STARTED|Overall Study||83589
6689111|NCT02714283|7619216|FG001|STARTED|Overall Study||6500
6689112|NCT02714283|7619215|FG000|COMPLETED|Overall Study||83589
6689113|NCT02714283|7619216|FG001|COMPLETED|Overall Study||6500
6689114|NCT02714283|7619215|FG000|NOT COMPLETED|Overall Study||0
6689115|NCT02714283|7619216|FG001|NOT COMPLETED|Overall Study||0
6689116|NCT02714400|7619226|FG000|STARTED|First Intervention (1 Day)||12
6689117|NCT02714400|7619227|FG001|STARTED|First Intervention (1 Day)||8
6689118|NCT02714400|7619226|FG000|COMPLETED|First Intervention (1 Day)||12
6689119|NCT02714400|7619227|FG001|COMPLETED|First Intervention (1 Day)||8
6689120|NCT02714400|7619226|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6689121|NCT02714400|7619227|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6689122|NCT02714400|7619226|FG000|STARTED|Washout (>4 Days)||12
6689123|NCT02714400|7619227|FG001|STARTED|Washout (>4 Days)||8
6689124|NCT02714400|7619226|FG000|COMPLETED|Washout (>4 Days)||12
6689125|NCT02714400|7619227|FG001|COMPLETED|Washout (>4 Days)||8
6689126|NCT02714400|7619226|FG000|NOT COMPLETED|Washout (>4 Days)||0
6689127|NCT02714400|7619227|FG001|NOT COMPLETED|Washout (>4 Days)||0
6689128|NCT02714400|7619226|FG000|STARTED|Second Intervention (1 Day)||12
6689129|NCT02714400|7619227|FG001|STARTED|Second Intervention (1 Day)||8
6689130|NCT02714400|7619226|FG000|COMPLETED|Second Intervention (1 Day)||12
6689131|NCT02714400|7619227|FG001|COMPLETED|Second Intervention (1 Day)||8
6689132|NCT02714400|7619226|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6689133|NCT02714400|7619227|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6689134|NCT02714426|7619235|FG000|STARTED|Overall Study||21
6689135|NCT02714426|7619236|FG001|STARTED|Overall Study||21
6689136|NCT02714426|7619235|FG000|COMPLETED|Overall Study||19
6689137|NCT02714426|7619236|FG001|COMPLETED|Overall Study||19
6689138|NCT02714426|7619235|FG000|NOT COMPLETED|Overall Study||2
6689139|NCT02714426|7619236|FG001|NOT COMPLETED|Overall Study||2
6689140|NCT02714504|7619244|FG000|STARTED|Overall Study||61
6689141|NCT02714504|7619245|FG001|STARTED|Overall Study||178
6689142|NCT02714504|7619244|FG000|COMPLETED|Overall Study||61
6689143|NCT02714504|7619245|FG001|COMPLETED|Overall Study||178
6689144|NCT02714504|7619244|FG000|NOT COMPLETED|Overall Study||0
6689145|NCT02714504|7619245|FG001|NOT COMPLETED|Overall Study||0
6689146|NCT02714569|7619262|FG000|STARTED|Part A First Intervention||3
6689147|NCT02714569|7619263|FG001|STARTED|Part A First Intervention||3
6689148|NCT02714569|7619264|FG002|STARTED|Part A First Intervention||3
6689149|NCT02714569|7619265|FG003|STARTED|Part A First Intervention||3
6689150|NCT02714569|7619266|FG004|STARTED|Part A First Intervention||3
6689151|NCT02714569|7619267|FG005|STARTED|Part A First Intervention||3
6689152|NCT02714569|7619268|FG006|STARTED|Part A First Intervention||0
6689153|NCT02714569|7619269|FG007|STARTED|Part A First Intervention||0
6689154|NCT02714569|7619270|FG008|STARTED|Part A First Intervention||0
6689155|NCT02714569|7619271|FG009|STARTED|Part A First Intervention||0
6689156|NCT02714569|7619272|FG010|STARTED|Part A First Intervention||0
6689157|NCT02714569|7619262|FG000|Received at Least One Dose of Study Drug|Part A First Intervention||3
6689158|NCT02714569|7619263|FG001|Received at Least One Dose of Study Drug|Part A First Intervention||3
6689159|NCT02714569|7619264|FG002|Received at Least One Dose of Study Drug|Part A First Intervention||3
6689160|NCT02714569|7619265|FG003|Received at Least One Dose of Study Drug|Part A First Intervention||3
6689161|NCT02714569|7619266|FG004|Received at Least One Dose of Study Drug|Part A First Intervention||3
6689162|NCT02714569|7619267|FG005|Received at Least One Dose of Study Drug|Part A First Intervention||3
6689163|NCT02714569|7619268|FG006|Received at Least One Dose of Study Drug|Part A First Intervention||0
6689164|NCT02714569|7619269|FG007|Received at Least One Dose of Study Drug|Part A First Intervention||0
6689165|NCT02714569|7619270|FG008|Received at Least One Dose of Study Drug|Part A First Intervention||0
6689166|NCT02714569|7619271|FG009|Received at Least One Dose of Study Drug|Part A First Intervention||0
6689167|NCT02714569|7619272|FG010|Received at Least One Dose of Study Drug|Part A First Intervention||0
6689168|NCT02714569|7619262|FG000|COMPLETED|Part A First Intervention||3
6689169|NCT02714569|7619263|FG001|COMPLETED|Part A First Intervention||3
6689170|NCT02714569|7619264|FG002|COMPLETED|Part A First Intervention||3
6689171|NCT02714569|7619265|FG003|COMPLETED|Part A First Intervention||3
6689172|NCT02714569|7619266|FG004|COMPLETED|Part A First Intervention||3
6689173|NCT02714569|7619267|FG005|COMPLETED|Part A First Intervention||3
6689174|NCT02714569|7619268|FG006|COMPLETED|Part A First Intervention||0
6689175|NCT02714569|7619269|FG007|COMPLETED|Part A First Intervention||0
6689176|NCT02714569|7619270|FG008|COMPLETED|Part A First Intervention||0
6689177|NCT02714569|7619271|FG009|COMPLETED|Part A First Intervention||0
6689178|NCT02714569|7619272|FG010|COMPLETED|Part A First Intervention||0
6689179|NCT02714569|7619262|FG000|NOT COMPLETED|Part A First Intervention||0
6689180|NCT02714569|7619263|FG001|NOT COMPLETED|Part A First Intervention||0
6689181|NCT02714569|7619264|FG002|NOT COMPLETED|Part A First Intervention||0
6689182|NCT02714569|7619265|FG003|NOT COMPLETED|Part A First Intervention||0
6689183|NCT02714569|7619266|FG004|NOT COMPLETED|Part A First Intervention||0
6689184|NCT02714569|7619267|FG005|NOT COMPLETED|Part A First Intervention||0
6689185|NCT02714569|7619268|FG006|NOT COMPLETED|Part A First Intervention||0
6689186|NCT02714569|7619269|FG007|NOT COMPLETED|Part A First Intervention||0
6689187|NCT02714569|7619270|FG008|NOT COMPLETED|Part A First Intervention||0
6689188|NCT02714569|7619271|FG009|NOT COMPLETED|Part A First Intervention||0
6689189|NCT02714569|7619272|FG010|NOT COMPLETED|Part A First Intervention||0
6689190|NCT02714569|7619262|FG000|STARTED|Part A Second Intervention||3
6689191|NCT02714569|7619263|FG001|STARTED|Part A Second Intervention||3
6689192|NCT02714569|7619264|FG002|STARTED|Part A Second Intervention||3
6689193|NCT02714569|7619265|FG003|STARTED|Part A Second Intervention||3
6689194|NCT02714569|7619266|FG004|STARTED|Part A Second Intervention||3
6689195|NCT02714569|7619267|FG005|STARTED|Part A Second Intervention||3
6689196|NCT02714569|7619268|FG006|STARTED|Part A Second Intervention||0
6689197|NCT02714569|7619269|FG007|STARTED|Part A Second Intervention||0
6689198|NCT02714569|7619270|FG008|STARTED|Part A Second Intervention||0
6689199|NCT02714569|7619271|FG009|STARTED|Part A Second Intervention||0
6689200|NCT02714569|7619272|FG010|STARTED|Part A Second Intervention||0
6689201|NCT02714569|7619262|FG000|Received at Least One Dose of Study Drug|Part A Second Intervention||3
6689202|NCT02714569|7619263|FG001|Received at Least One Dose of Study Drug|Part A Second Intervention||2
6689203|NCT02714569|7619264|FG002|Received at Least One Dose of Study Drug|Part A Second Intervention||3
6689204|NCT02714569|7619265|FG003|Received at Least One Dose of Study Drug|Part A Second Intervention||3
6689205|NCT02714569|7619266|FG004|Received at Least One Dose of Study Drug|Part A Second Intervention||3
6689206|NCT02714569|7619267|FG005|Received at Least One Dose of Study Drug|Part A Second Intervention||3
6689207|NCT02714569|7619268|FG006|Received at Least One Dose of Study Drug|Part A Second Intervention||0
6689208|NCT02714569|7619269|FG007|Received at Least One Dose of Study Drug|Part A Second Intervention||0
6689209|NCT02714569|7619270|FG008|Received at Least One Dose of Study Drug|Part A Second Intervention||0
6689210|NCT02714569|7619271|FG009|Received at Least One Dose of Study Drug|Part A Second Intervention||0
6689211|NCT02714569|7619272|FG010|Received at Least One Dose of Study Drug|Part A Second Intervention||0
6689212|NCT02714569|7619262|FG000|COMPLETED|Part A Second Intervention||3
6689213|NCT02714569|7619263|FG001|COMPLETED|Part A Second Intervention||2
6689214|NCT02714569|7619264|FG002|COMPLETED|Part A Second Intervention||3
6689215|NCT02714569|7619265|FG003|COMPLETED|Part A Second Intervention||3
6689216|NCT02714569|7619266|FG004|COMPLETED|Part A Second Intervention||3
6689217|NCT02714569|7619267|FG005|COMPLETED|Part A Second Intervention||3
6689218|NCT02714569|7619268|FG006|COMPLETED|Part A Second Intervention||0
6689219|NCT02714569|7619269|FG007|COMPLETED|Part A Second Intervention||0
6689220|NCT02714569|7619270|FG008|COMPLETED|Part A Second Intervention||0
6689221|NCT02714569|7619271|FG009|COMPLETED|Part A Second Intervention||0
6689222|NCT02714569|7619272|FG010|COMPLETED|Part A Second Intervention||0
6689223|NCT02714569|7619262|FG000|NOT COMPLETED|Part A Second Intervention||0
6689224|NCT02714569|7619263|FG001|NOT COMPLETED|Part A Second Intervention||1
6689225|NCT02714569|7619264|FG002|NOT COMPLETED|Part A Second Intervention||0
6689226|NCT02714569|7619265|FG003|NOT COMPLETED|Part A Second Intervention||0
6689227|NCT02714569|7619266|FG004|NOT COMPLETED|Part A Second Intervention||0
6689228|NCT02714569|7619267|FG005|NOT COMPLETED|Part A Second Intervention||0
6689229|NCT02714569|7619268|FG006|NOT COMPLETED|Part A Second Intervention||0
6689230|NCT02714569|7619269|FG007|NOT COMPLETED|Part A Second Intervention||0
6689231|NCT02714569|7619270|FG008|NOT COMPLETED|Part A Second Intervention||0
6689232|NCT02714569|7619271|FG009|NOT COMPLETED|Part A Second Intervention||0
6689233|NCT02714569|7619272|FG010|NOT COMPLETED|Part A Second Intervention||0
6689234|NCT02714569|7619262|FG000|STARTED|Part A Third Intervention||3
6689235|NCT02714569|7619263|FG001|STARTED|Part A Third Intervention||2
6689236|NCT02714569|7619264|FG002|STARTED|Part A Third Intervention||3
6689237|NCT02714569|7619265|FG003|STARTED|Part A Third Intervention||3
6689238|NCT02714569|7619266|FG004|STARTED|Part A Third Intervention||3
6689239|NCT02714569|7619267|FG005|STARTED|Part A Third Intervention||3
6689240|NCT02714569|7619268|FG006|STARTED|Part A Third Intervention||0
6689241|NCT02714569|7619269|FG007|STARTED|Part A Third Intervention||0
6689242|NCT02714569|7619270|FG008|STARTED|Part A Third Intervention||0
6689243|NCT02714569|7619271|FG009|STARTED|Part A Third Intervention||0
6689244|NCT02714569|7619272|FG010|STARTED|Part A Third Intervention||0
6689245|NCT02714569|7619262|FG000|Received at Least One Dose of Study Drug|Part A Third Intervention||3
6689246|NCT02714569|7619263|FG001|Received at Least One Dose of Study Drug|Part A Third Intervention||2
6689247|NCT02714569|7619264|FG002|Received at Least One Dose of Study Drug|Part A Third Intervention||2
6689248|NCT02714569|7619265|FG003|Received at Least One Dose of Study Drug|Part A Third Intervention||2
6689249|NCT02714569|7619266|FG004|Received at Least One Dose of Study Drug|Part A Third Intervention||3
6689250|NCT02714569|7619267|FG005|Received at Least One Dose of Study Drug|Part A Third Intervention||3
6689251|NCT02714569|7619268|FG006|Received at Least One Dose of Study Drug|Part A Third Intervention||0
6689252|NCT02714569|7619269|FG007|Received at Least One Dose of Study Drug|Part A Third Intervention||0
6689253|NCT02714569|7619270|FG008|Received at Least One Dose of Study Drug|Part A Third Intervention||0
6689254|NCT02714569|7619271|FG009|Received at Least One Dose of Study Drug|Part A Third Intervention||0
6689255|NCT02714569|7619272|FG010|Received at Least One Dose of Study Drug|Part A Third Intervention||0
6689256|NCT02714569|7619262|FG000|COMPLETED|Part A Third Intervention||3
6689257|NCT02714569|7619263|FG001|COMPLETED|Part A Third Intervention||2
6689258|NCT02714569|7619264|FG002|COMPLETED|Part A Third Intervention||2
6689259|NCT02714569|7619265|FG003|COMPLETED|Part A Third Intervention||2
6689260|NCT02714569|7619266|FG004|COMPLETED|Part A Third Intervention||3
6689261|NCT02714569|7619267|FG005|COMPLETED|Part A Third Intervention||3
6689262|NCT02714569|7619268|FG006|COMPLETED|Part A Third Intervention||0
6689263|NCT02714569|7619269|FG007|COMPLETED|Part A Third Intervention||0
6689264|NCT02714569|7619270|FG008|COMPLETED|Part A Third Intervention||0
6689265|NCT02714569|7619271|FG009|COMPLETED|Part A Third Intervention||0
6257634|NCT04540510|7156830|FG000|STARTED|Overall Study||5
6257635|NCT04540510|7156831|FG001|STARTED|Overall Study||6
6257636|NCT04540510|7156830|FG000|COMPLETED|Overall Study||5
6257637|NCT04540510|7156831|FG001|COMPLETED|Overall Study||6
6257638|NCT04540510|7156830|FG000|NOT COMPLETED|Overall Study||0
6257639|NCT04540510|7156831|FG001|NOT COMPLETED|Overall Study||0
6257897|NCT01286272|7157131|FG000|STARTED|Overall Study||67
6257898|NCT01286272|7157132|FG001|STARTED|Overall Study||65
6257899|NCT01286272|7157131|FG000|COMPLETED|Overall Study||66
6257900|NCT01286272|7157132|FG001|COMPLETED|Overall Study||62
6257901|NCT01286272|7157131|FG000|NOT COMPLETED|Overall Study||1
6257902|NCT01286272|7157132|FG001|NOT COMPLETED|Overall Study||3
6257903|NCT01145495|7157138|FG000|STARTED|Overall Study||63
6257904|NCT01145495|7157138|FG000|COMPLETED|Overall Study||51
6257905|NCT01145495|7157138|FG000|NOT COMPLETED|Overall Study||12
6257906|NCT01134601|7157142|FG000|STARTED|Overall Study||1
6257907|NCT01134601|7157142|FG000|COMPLETED|Overall Study||1
6257908|NCT01134601|7157142|FG000|NOT COMPLETED|Overall Study||0
6257909|NCT01118026|7157146|FG000|STARTED|Overall Study||101
6257910|NCT01118026|7157146|FG000|COMPLETED|Overall Study||101
6257911|NCT01118026|7157146|FG000|NOT COMPLETED|Overall Study||0
6257912|NCT00879086|7157153|FG000|STARTED|Overall Study||52
6257913|NCT00879086|7157154|FG001|STARTED|Overall Study||52
6257914|NCT00879086|7157153|FG000|Safety Analysis Set (SAS)|Overall Study||51
6257915|NCT00879086|7157154|FG001|Safety Analysis Set (SAS)|Overall Study||50
6257916|NCT00879086|7157153|FG000|COMPLETED|Overall Study||0
6257917|NCT00879086|7157154|FG001|COMPLETED|Overall Study||0
6257918|NCT00879086|7157153|FG000|NOT COMPLETED|Overall Study||52
6257919|NCT00879086|7157154|FG001|NOT COMPLETED|Overall Study||52
6257920|NCT00864227|7157160|FG000|STARTED|Overall Study||54
6257921|NCT00864227|7157160|FG000|COMPLETED|Overall Study||50
6257922|NCT00864227|7157160|FG000|NOT COMPLETED|Overall Study||4
6257923|NCT00731731|7157167|FG000|STARTED|Overall Study||12
6257924|NCT00731731|7157168|FG001|STARTED|Overall Study||3
6257925|NCT00731731|7157169|FG002|STARTED|Overall Study||110
6257926|NCT00731731|7157167|FG000|COMPLETED|Overall Study||12
6257927|NCT00731731|7157168|FG001|COMPLETED|Overall Study||3
6257928|NCT00731731|7157169|FG002|COMPLETED|Overall Study||107
6257929|NCT00731731|7157167|FG000|NOT COMPLETED|Overall Study||0
6257930|NCT00731731|7157168|FG001|NOT COMPLETED|Overall Study||0
6257931|NCT00731731|7157169|FG002|NOT COMPLETED|Overall Study||3
6257932|NCT00685360|7157185|FG000|STARTED|Overall Study||161
6257933|NCT00685360|7157186|FG001|STARTED|Overall Study||160
6257934|NCT00685360|7157187|FG002|STARTED|Overall Study||160
6257935|NCT00685360|7157185|FG000|Modified Intent-to-Treat (MITT)|Overall Study||141
6257936|NCT00685360|7157186|FG001|Modified Intent-to-Treat (MITT)|Overall Study||136
6257937|NCT00685360|7157187|FG002|Modified Intent-to-Treat (MITT)|Overall Study||125
6257938|NCT00685360|7157185|FG000|MITT (Solid Culture)|Overall Study||119
6257939|NCT00685360|7157186|FG001|MITT (Solid Culture)|Overall Study||115
6257940|NCT00685360|7157187|FG002|MITT (Solid Culture)|Overall Study||113
6257941|NCT00685360|7157185|FG000|COMPLETED|Overall Study||143
6257942|NCT00685360|7157186|FG001|COMPLETED|Overall Study||146
6257943|NCT00685360|7157187|FG002|COMPLETED|Overall Study||145
6257944|NCT00685360|7157185|FG000|NOT COMPLETED|Overall Study||18
6257945|NCT00685360|7157186|FG001|NOT COMPLETED|Overall Study||14
6257946|NCT00685360|7157187|FG002|NOT COMPLETED|Overall Study||15
6257947|NCT00299728|7157197|FG000|STARTED|Overall Study||11
6257948|NCT00299728|7157198|FG001|STARTED|Overall Study||11
6257949|NCT00299728|7157197|FG000|COMPLETED|Overall Study||11
6257950|NCT00299728|7157198|FG001|COMPLETED|Overall Study||8
6257951|NCT00299728|7157197|FG000|NOT COMPLETED|Overall Study||0
6257952|NCT00299728|7157198|FG001|NOT COMPLETED|Overall Study||3
6257953|NCT00095784|7157204|FG000|STARTED|Overall Study||21
6257954|NCT00095784|7157204|FG000|COMPLETED|Overall Study||21
6257955|NCT00095784|7157204|FG000|NOT COMPLETED|Overall Study||0
6257956|NCT00070499|7157213|FG000|STARTED|Overall Study||75
6257957|NCT00070499|7157214|FG001|STARTED|Overall Study||78
6257958|NCT00070499|7157215|FG002|STARTED|Overall Study||126
6257959|NCT00070499|7157216|FG003|STARTED|Overall Study||127
6257960|NCT00070499|7157213|FG000|Eligible|Overall Study||73
6257961|NCT00070499|7157214|FG001|Eligible|Overall Study||73
6257962|NCT00070499|7157215|FG002|Eligible|Overall Study||123
6257963|NCT00070499|7157216|FG003|Eligible|Overall Study||125
6257964|NCT00070499|7157213|FG000|Eligible and Treated|Overall Study||72
6257965|NCT00070499|7157214|FG001|Eligible and Treated|Overall Study||73
6257966|NCT00070499|7157215|FG002|Eligible and Treated|Overall Study||123
6257967|NCT00070499|7157216|FG003|Eligible and Treated|Overall Study||123
6257968|NCT00070499|7157213|FG000|COMPLETED|Overall Study||37
6257969|NCT00070499|7157214|FG001|COMPLETED|Overall Study||52
6257970|NCT00070499|7157215|FG002|COMPLETED|Overall Study||6
6257971|NCT00070499|7157216|FG003|COMPLETED|Overall Study||17
6257972|NCT00070499|7157213|FG000|NOT COMPLETED|Overall Study||38
6257973|NCT00070499|7157214|FG001|NOT COMPLETED|Overall Study||26
6257974|NCT00070499|7157215|FG002|NOT COMPLETED|Overall Study||120
6257975|NCT00070499|7157216|FG003|NOT COMPLETED|Overall Study||110
6279918|NCT00149838|7179819|FG000|STARTED|Phase II||0
6279919|NCT00149838|7179820|FG001|STARTED|Phase II||0
6689266|NCT02714569|7619272|FG010|COMPLETED|Part A Third Intervention||0
6689267|NCT02714569|7619262|FG000|NOT COMPLETED|Part A Third Intervention||0
6689268|NCT02714569|7619263|FG001|NOT COMPLETED|Part A Third Intervention||0
6689269|NCT02714569|7619264|FG002|NOT COMPLETED|Part A Third Intervention||1
6689270|NCT02714569|7619265|FG003|NOT COMPLETED|Part A Third Intervention||1
6689271|NCT02714569|7619266|FG004|NOT COMPLETED|Part A Third Intervention||0
6689272|NCT02714569|7619267|FG005|NOT COMPLETED|Part A Third Intervention||0
6689273|NCT02714569|7619268|FG006|NOT COMPLETED|Part A Third Intervention||0
6689274|NCT02714569|7619269|FG007|NOT COMPLETED|Part A Third Intervention||0
6689275|NCT02714569|7619270|FG008|NOT COMPLETED|Part A Third Intervention||0
6689276|NCT02714569|7619271|FG009|NOT COMPLETED|Part A Third Intervention||0
6689277|NCT02714569|7619272|FG010|NOT COMPLETED|Part A Third Intervention||0
6689278|NCT02714569|7619262|FG000|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|4
6689279|NCT02714569|7619263|FG001|STARTED|Part A Fourth Intervention||2
6689280|NCT02714569|7619264|FG002|STARTED|Part A Fourth Intervention|An additional participant replaced a discontinued participant.|3
6689281|NCT02714569|7619265|FG003|STARTED|Part A Fourth Intervention||2
6689282|NCT02714569|7619266|FG004|STARTED|Part A Fourth Intervention||3
6689283|NCT02714569|7619267|FG005|STARTED|Part A Fourth Intervention||3
6689284|NCT02714569|7619268|FG006|STARTED|Part A Fourth Intervention||0
6689285|NCT02714569|7619269|FG007|STARTED|Part A Fourth Intervention||0
6689286|NCT02714569|7619270|FG008|STARTED|Part A Fourth Intervention||0
6689287|NCT02714569|7619271|FG009|STARTED|Part A Fourth Intervention||0
6689288|NCT02714569|7619272|FG010|STARTED|Part A Fourth Intervention||0
6689289|NCT02714569|7619262|FG000|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
6689290|NCT02714569|7619263|FG001|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
6689291|NCT02714569|7619264|FG002|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
6689292|NCT02714569|7619265|FG003|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
6689293|NCT02714569|7619266|FG004|Received at Least One Dose of Study Drug|Part A Fourth Intervention||3
6689294|NCT02714569|7619267|FG005|Received at Least One Dose of Study Drug|Part A Fourth Intervention||2
6689295|NCT02714569|7619268|FG006|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
6689296|NCT02714569|7619269|FG007|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
6689297|NCT02714569|7619270|FG008|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
6689298|NCT02714569|7619271|FG009|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
6689299|NCT02714569|7619272|FG010|Received at Least One Dose of Study Drug|Part A Fourth Intervention||0
6689300|NCT02714569|7619262|FG000|COMPLETED|Part A Fourth Intervention||3
6689301|NCT02714569|7619263|FG001|COMPLETED|Part A Fourth Intervention||2
6689302|NCT02714569|7619264|FG002|COMPLETED|Part A Fourth Intervention||3
6689303|NCT02714569|7619265|FG003|COMPLETED|Part A Fourth Intervention||2
6689304|NCT02714569|7619266|FG004|COMPLETED|Part A Fourth Intervention||3
6689305|NCT02714569|7619267|FG005|COMPLETED|Part A Fourth Intervention||2
6689306|NCT02714569|7619268|FG006|COMPLETED|Part A Fourth Intervention||0
6689307|NCT02714569|7619269|FG007|COMPLETED|Part A Fourth Intervention||0
6689308|NCT02714569|7619270|FG008|COMPLETED|Part A Fourth Intervention||0
6689309|NCT02714569|7619271|FG009|COMPLETED|Part A Fourth Intervention||0
6689310|NCT02714569|7619272|FG010|COMPLETED|Part A Fourth Intervention||0
6689311|NCT02714569|7619262|FG000|NOT COMPLETED|Part A Fourth Intervention||1
6689312|NCT02714569|7619263|FG001|NOT COMPLETED|Part A Fourth Intervention||0
6689313|NCT02714569|7619264|FG002|NOT COMPLETED|Part A Fourth Intervention||0
6689314|NCT02714569|7619265|FG003|NOT COMPLETED|Part A Fourth Intervention||0
6689315|NCT02714569|7619266|FG004|NOT COMPLETED|Part A Fourth Intervention||0
6689316|NCT02714569|7619267|FG005|NOT COMPLETED|Part A Fourth Intervention||1
6689317|NCT02714569|7619268|FG006|NOT COMPLETED|Part A Fourth Intervention||0
6689318|NCT02714569|7619269|FG007|NOT COMPLETED|Part A Fourth Intervention||0
6689319|NCT02714569|7619270|FG008|NOT COMPLETED|Part A Fourth Intervention||0
6689320|NCT02714569|7619271|FG009|NOT COMPLETED|Part A Fourth Intervention||0
6689321|NCT02714569|7619272|FG010|NOT COMPLETED|Part A Fourth Intervention||0
6689322|NCT02714569|7619262|FG000|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
6689323|NCT02714569|7619263|FG001|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
6689324|NCT02714569|7619264|FG002|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
6689325|NCT02714569|7619265|FG003|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
6689326|NCT02714569|7619266|FG004|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
6689327|NCT02714569|7619267|FG005|STARTED|Part B (Overall)|Part A participants completed period 4 and were not in part B.|0
6689328|NCT02714569|7619268|FG006|STARTED|Part B (Overall)|Part B participants randomized to receive 5 mg of LY3202328 + atorvastatin/simvastatin.|8
6689329|NCT02714569|7619269|FG007|STARTED|Part B (Overall)|Part B participants randomized to receive 20 mg of LY3202328 + atorvastatin/simvastatin.|8
6689330|NCT02714569|7619270|FG008|STARTED|Part B (Overall)|Part B participants randomized to receive 100 mg of LY3202328 + atorvastatin/simvastatin.|8
6689331|NCT02714569|7619271|FG009|STARTED|Part B (Overall)|Part B participants randomized to receive 300 mg of LY3202328 + atorvastatin/simvastatin.|8
6689332|NCT02714569|7619272|FG010|STARTED|Part B (Overall)|Part B participants randomized to receive placebo instead of LY3202328 + atorvastatin/simvastatin.|8
6689333|NCT02714569|7619262|FG000|COMPLETED|Part B (Overall)||0
6689334|NCT02714569|7619263|FG001|COMPLETED|Part B (Overall)||0
6689335|NCT02714569|7619264|FG002|COMPLETED|Part B (Overall)||0
6689336|NCT02714569|7619265|FG003|COMPLETED|Part B (Overall)||0
6689337|NCT02714569|7619266|FG004|COMPLETED|Part B (Overall)||0
6689338|NCT02714569|7619267|FG005|COMPLETED|Part B (Overall)||0
6689339|NCT02714569|7619268|FG006|COMPLETED|Part B (Overall)||7
6689340|NCT02714569|7619269|FG007|COMPLETED|Part B (Overall)||7
6689341|NCT02714569|7619270|FG008|COMPLETED|Part B (Overall)||8
6689342|NCT02714569|7619271|FG009|COMPLETED|Part B (Overall)||6
6689343|NCT02714569|7619272|FG010|COMPLETED|Part B (Overall)||8
6689344|NCT02714569|7619262|FG000|NOT COMPLETED|Part B (Overall)||0
6689345|NCT02714569|7619263|FG001|NOT COMPLETED|Part B (Overall)||0
6689346|NCT02714569|7619264|FG002|NOT COMPLETED|Part B (Overall)||0
6689347|NCT02714569|7619265|FG003|NOT COMPLETED|Part B (Overall)||0
6689348|NCT02714569|7619266|FG004|NOT COMPLETED|Part B (Overall)||0
6689349|NCT02714569|7619267|FG005|NOT COMPLETED|Part B (Overall)||0
6689350|NCT02714569|7619268|FG006|NOT COMPLETED|Part B (Overall)||1
6689351|NCT02714569|7619269|FG007|NOT COMPLETED|Part B (Overall)||1
6689352|NCT02714569|7619270|FG008|NOT COMPLETED|Part B (Overall)||0
6689353|NCT02714569|7619271|FG009|NOT COMPLETED|Part B (Overall)||2
6689354|NCT02714569|7619272|FG010|NOT COMPLETED|Part B (Overall)||0
6689355|NCT02714595|7619334|FG000|STARTED|Overall Study||101
6689356|NCT02714595|7619335|FG001|STARTED|Overall Study||51
6689357|NCT02714595|7619334|FG000|Received Treatment|Overall Study||101
6689358|NCT02714595|7619335|FG001|Received Treatment|Overall Study||49
6689359|NCT02714595|7619334|FG000|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||80
6689360|NCT02714595|7619335|FG001|Carbapenem-resistant Microbiological Intent-to-treat|Overall Study||38
6689361|NCT02714595|7619334|FG000|COMPLETED|Overall Study||69
6689362|NCT02714595|7619335|FG001|COMPLETED|Overall Study||38
6689363|NCT02714595|7619334|FG000|NOT COMPLETED|Overall Study||32
6689364|NCT02714595|7619335|FG001|NOT COMPLETED|Overall Study||13
6689365|NCT02714868|7619361|FG000|STARTED|Overall Study||47
6689366|NCT02714868|7619362|FG001|STARTED|Overall Study||35
6689367|NCT02714868|7619361|FG000|COMPLETED|Overall Study||42
6689368|NCT02714868|7619362|FG001|COMPLETED|Overall Study||35
6689369|NCT02714868|7619361|FG000|NOT COMPLETED|Overall Study||5
6689370|NCT02714868|7619362|FG001|NOT COMPLETED|Overall Study||0
6689371|NCT02715076|7619375|FG000|STARTED|Overall Study||48
6257976|NCT04450823|7157234|FG000|STARTED|Overall Study||61
6257977|NCT04450823|7157234|FG000|COMPLETED|Overall Study||58
6257978|NCT04450823|7157234|FG000|NOT COMPLETED|Overall Study||3
6257979|NCT04446247|7157238|FG000|STARTED|Overall Study||14
6257980|NCT04446247|7157238|FG000|COMPLETED|Overall Study||14
6257981|NCT04446247|7157238|FG000|NOT COMPLETED|Overall Study||0
6257982|NCT04347564|7157244|FG000|STARTED|Overall Study||45
6257983|NCT04347564|7157244|FG000|COMPLETED|Overall Study||45
6257984|NCT04347564|7157244|FG000|NOT COMPLETED|Overall Study||0
6257988|NCT04274556|7157260|FG000|STARTED|Overall Study||86
6257989|NCT04274556|7157260|FG000|COMPLETED|Overall Study||86
6257990|NCT04274556|7157260|FG000|NOT COMPLETED|Overall Study||0
6257991|NCT04270292|7157264|FG000|STARTED|Overall Study||164
6257992|NCT04270292|7157264|FG000|COMPLETED|Overall Study||164
6257993|NCT04270292|7157264|FG000|NOT COMPLETED|Overall Study||0
6257994|NCT04182217|7157268|FG000|STARTED|Overall Study||91
6257995|NCT04182217|7157268|FG000|COMPLETED|Overall Study||91
6257996|NCT04182217|7157268|FG000|NOT COMPLETED|Overall Study||0
6258000|NCT04083404|7157277|FG000|STARTED|Overall Study||202
6258001|NCT04083404|7157277|FG000|COMPLETED|Overall Study||202
6258002|NCT04083404|7157277|FG000|NOT COMPLETED|Overall Study||0
6258031|NCT03977818|7157314|FG000|STARTED|Overall Study||2165
6258032|NCT03977818|7157314|FG000|COMPLETED|Overall Study||2165
6258033|NCT03977818|7157314|FG000|NOT COMPLETED|Overall Study||0
6258034|NCT03976531|7157318|FG000|STARTED|Overall Study||42
6258035|NCT03976531|7157318|FG000|COMPLETED|Overall Study||42
6258036|NCT03976531|7157318|FG000|NOT COMPLETED|Overall Study||0
6279920|NCT00149838|7179821|FG002|STARTED|Phase II||144
6279921|NCT00149838|7179822|FG003|STARTED|Phase II||0
6279922|NCT00149838|7179819|FG000|COMPLETED|Phase II||0
6279923|NCT00149838|7179820|FG001|COMPLETED|Phase II||0
6279924|NCT00149838|7179821|FG002|COMPLETED|Phase II||144
6279925|NCT00149838|7179822|FG003|COMPLETED|Phase II||0
6279926|NCT00149838|7179819|FG000|NOT COMPLETED|Phase II||0
6279927|NCT00149838|7179820|FG001|NOT COMPLETED|Phase II||0
6279928|NCT00149838|7179821|FG002|NOT COMPLETED|Phase II||0
6279929|NCT00149838|7179822|FG003|NOT COMPLETED|Phase II||0
6279930|NCT00149838|7179819|FG000|STARTED|Phase III||0
6279931|NCT00149838|7179820|FG001|STARTED|Phase III||0
6689372|NCT02715076|7619376|FG001|STARTED|Overall Study||50
6689373|NCT02715076|7619377|FG002|STARTED|Overall Study||49
6689374|NCT02715076|7619378|FG003|STARTED|Overall Study||50
6689375|NCT02715076|7619379|FG004|STARTED|Overall Study||47
6689376|NCT02715076|7619380|FG005|STARTED|Overall Study||48
6689377|NCT02715076|7619375|FG000|COMPLETED|Overall Study||48
6689378|NCT02715076|7619376|FG001|COMPLETED|Overall Study||50
6689379|NCT02715076|7619377|FG002|COMPLETED|Overall Study||49
6689380|NCT02715076|7619378|FG003|COMPLETED|Overall Study||50
6689381|NCT02715076|7619379|FG004|COMPLETED|Overall Study||47
6689382|NCT02715076|7619380|FG005|COMPLETED|Overall Study||48
6689383|NCT02715076|7619375|FG000|NOT COMPLETED|Overall Study||0
6279932|NCT00149838|7179821|FG002|STARTED|Phase III||0
6689384|NCT02715076|7619376|FG001|NOT COMPLETED|Overall Study||0
6689385|NCT02715076|7619377|FG002|NOT COMPLETED|Overall Study||0
6689386|NCT02715076|7619378|FG003|NOT COMPLETED|Overall Study||0
6689387|NCT02715076|7619379|FG004|NOT COMPLETED|Overall Study||0
6689388|NCT02715076|7619380|FG005|NOT COMPLETED|Overall Study||0
6689389|NCT02715258|7619396|FG000|STARTED|Overall Study||140
6689390|NCT02715258|7619397|FG001|STARTED|Overall Study||70
6689391|NCT02715258|7619396|FG000|Intent to Treat/Safety Analysis|Overall Study||138
6689392|NCT02715258|7619397|FG001|Intent to Treat/Safety Analysis|Overall Study||69
6689393|NCT02715258|7619396|FG000|COMPLETED|Overall Study||124
6689394|NCT02715258|7619397|FG001|COMPLETED|Overall Study||64
6689395|NCT02715258|7619396|FG000|NOT COMPLETED|Overall Study||16
6689396|NCT02715258|7619397|FG001|NOT COMPLETED|Overall Study||6
6689397|NCT02715700|7619403|FG000|STARTED|Overall Study||14
6689398|NCT02715700|7619403|FG000|COMPLETED|Overall Study||14
6689399|NCT02715700|7619403|FG000|NOT COMPLETED|Overall Study||0
6689400|NCT02715726|7619413|FG000|STARTED|Overall Study|Randomized|208
6689401|NCT02715726|7619414|FG001|STARTED|Overall Study|Randomized|407
6689402|NCT02715726|7619413|FG000|Treated|Overall Study||207
6689403|NCT02715726|7619414|FG001|Treated|Overall Study||405
6689404|NCT02715726|7619413|FG000|Safety Population|Overall Study||206
6689405|NCT02715726|7619414|FG001|Safety Population|Overall Study||406
6689406|NCT02715726|7619413|FG000|COMPLETED|Overall Study||190
6689407|NCT02715726|7619414|FG001|COMPLETED|Overall Study||380
6689408|NCT02715726|7619413|FG000|NOT COMPLETED|Overall Study||18
6689409|NCT02715726|7619414|FG001|NOT COMPLETED|Overall Study||27
6689410|NCT02715804|7619422|FG000|STARTED|Overall Study||327
6689411|NCT02715804|7619423|FG001|STARTED|Overall Study||165
6689412|NCT02715804|7619422|FG000|Received at Least 1 Dose of Study Drug|Overall Study||323
6689413|NCT02715804|7619423|FG001|Received at Least 1 Dose of Study Drug|Overall Study||158
6689414|NCT02715804|7619422|FG000|Safety Population|Overall Study|3 participants randomized to AG but received PAG|325
6689415|NCT02715804|7619423|FG001|Safety Population|Overall Study|1 participant randomized to PAG but received AG|156
6689416|NCT02715804|7619422|FG000|COMPLETED|Overall Study||98
6689417|NCT02715804|7619423|FG001|COMPLETED|Overall Study||52
6689418|NCT02715804|7619422|FG000|NOT COMPLETED|Overall Study||229
6689419|NCT02715804|7619423|FG001|NOT COMPLETED|Overall Study||113
6689420|NCT02716194|7619432|FG000|STARTED|Period 1 - ADVATE||11
6689421|NCT02716194|7619433|FG001|STARTED|Period 1 - ADVATE||16
6689422|NCT02716194|7619434|FG002|STARTED|Period 1 - ADVATE||13
6689423|NCT02716194|7619432|FG000|COMPLETED|Period 1 - ADVATE||10
6689424|NCT02716194|7619433|FG001|COMPLETED|Period 1 - ADVATE||15
6689425|NCT02716194|7619434|FG002|COMPLETED|Period 1 - ADVATE||13
6689426|NCT02716194|7619432|FG000|NOT COMPLETED|Period 1 - ADVATE||1
6689427|NCT02716194|7619433|FG001|NOT COMPLETED|Period 1 - ADVATE||1
6689428|NCT02716194|7619434|FG002|NOT COMPLETED|Period 1 - ADVATE||0
6689429|NCT02716194|7619432|FG000|STARTED|Period 2 - BAX 826||10
6689430|NCT02716194|7619433|FG001|STARTED|Period 2 - BAX 826||15
6689431|NCT02716194|7619434|FG002|STARTED|Period 2 - BAX 826||13
6689432|NCT02716194|7619432|FG000|COMPLETED|Period 2 - BAX 826||10
6689433|NCT02716194|7619433|FG001|COMPLETED|Period 2 - BAX 826||15
6689434|NCT02716194|7619434|FG002|COMPLETED|Period 2 - BAX 826||13
6689435|NCT02716194|7619432|FG000|NOT COMPLETED|Period 2 - BAX 826||0
6689436|NCT02716194|7619433|FG001|NOT COMPLETED|Period 2 - BAX 826||0
6689437|NCT02716194|7619434|FG002|NOT COMPLETED|Period 2 - BAX 826||0
6689438|NCT02716298|7619455|FG000|STARTED|First Intervention (1 Month)||25
6689439|NCT02716298|7619456|FG001|STARTED|First Intervention (1 Month)||24
6689440|NCT02716298|7619455|FG000|COMPLETED|First Intervention (1 Month)||24
6689441|NCT02716298|7619456|FG001|COMPLETED|First Intervention (1 Month)||23
6689442|NCT02716298|7619455|FG000|NOT COMPLETED|First Intervention (1 Month)||1
6689443|NCT02716298|7619456|FG001|NOT COMPLETED|First Intervention (1 Month)||1
6689444|NCT02716298|7619455|FG000|STARTED|Second Intervention (1 Month)||24
6689445|NCT02716298|7619456|FG001|STARTED|Second Intervention (1 Month)||23
6689446|NCT02716298|7619455|FG000|COMPLETED|Second Intervention (1 Month)||24
6689447|NCT02716298|7619456|FG001|COMPLETED|Second Intervention (1 Month)||23
6689448|NCT02716298|7619455|FG000|NOT COMPLETED|Second Intervention (1 Month)||0
6689449|NCT02716298|7619456|FG001|NOT COMPLETED|Second Intervention (1 Month)||0
6689450|NCT02716324|7619469|FG000|STARTED|Overall Study||149
6689451|NCT02716324|7619470|FG001|STARTED|Overall Study||154
6689452|NCT02716324|7619469|FG000|COMPLETED|Overall Study||130
6689453|NCT02716324|7619470|FG001|COMPLETED|Overall Study||143
6689454|NCT02716324|7619469|FG000|NOT COMPLETED|Overall Study||19
6689455|NCT02716324|7619470|FG001|NOT COMPLETED|Overall Study||11
6738599|NCT03285295|7667831|FG002|STARTED|Alinity s Anti-HBc Follow-Up||0
6738600|NCT03285295|7667832|FG003|STARTED|Alinity s Anti-HBc Follow-Up||0
6738601|NCT03285295|7667833|FG004|STARTED|Alinity s Anti-HBc Follow-Up||0
6738602|NCT03285295|7667829|FG000|COMPLETED|Alinity s Anti-HBc Follow-Up||2
6738603|NCT03285295|7667830|FG001|COMPLETED|Alinity s Anti-HBc Follow-Up||0
6738604|NCT03285295|7667831|FG002|COMPLETED|Alinity s Anti-HBc Follow-Up||0
6738605|NCT03285295|7667832|FG003|COMPLETED|Alinity s Anti-HBc Follow-Up||0
6738606|NCT03285295|7667833|FG004|COMPLETED|Alinity s Anti-HBc Follow-Up||0
6738607|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||14
6738608|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
6738609|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
6738610|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
6738611|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s Anti-HBc Follow-Up||0
6738612|NCT03285295|7667829|FG000|STARTED|Alinity s Chagas||16023
6738613|NCT03285295|7667830|FG001|STARTED|Alinity s Chagas||320
6738614|NCT03285295|7667831|FG002|STARTED|Alinity s Chagas||0
6689456|NCT02716506|7619476|FG000|STARTED|Overall Study||3515
6689457|NCT02716506|7619476|FG000|6 Months|Overall Study|Patients that completed the questionnaires six months after the operation.|2528
6689458|NCT02716506|7619476|FG000|2 Years|Overall Study|Patients that completed the questionnaires two years after the operation.|2351
6689459|NCT02716506|7619476|FG000|COMPLETED|Overall Study||2351
6689460|NCT02716506|7619476|FG000|NOT COMPLETED|Overall Study||1164
6689461|NCT02716584|7619482|FG000|STARTED|Overall Study||35
6689462|NCT02716584|7619483|FG001|STARTED|Overall Study||18
6689463|NCT02716584|7619482|FG000|COMPLETED|Overall Study||27
6689464|NCT02716584|7619483|FG001|COMPLETED|Overall Study||13
6689465|NCT02716584|7619482|FG000|NOT COMPLETED|Overall Study||8
6689466|NCT02716584|7619483|FG001|NOT COMPLETED|Overall Study||5
6689467|NCT02716714|7619491|FG000|STARTED|Overall Study||67
6689468|NCT02716714|7619492|FG001|STARTED|Overall Study||10
6689469|NCT02716714|7619491|FG000|COMPLETED|Overall Study||55
6689470|NCT02716714|7619492|FG001|COMPLETED|Overall Study||8
6689471|NCT02716714|7619491|FG000|NOT COMPLETED|Overall Study||12
6689472|NCT02716714|7619492|FG001|NOT COMPLETED|Overall Study||2
6689473|NCT02716727|7619504|FG000|STARTED|Overall Study||7
6689474|NCT02716727|7619505|FG001|STARTED|Overall Study||9
6689475|NCT02716727|7619504|FG000|COMPLETED|Overall Study||7
6689476|NCT02716727|7619505|FG001|COMPLETED|Overall Study||9
6689477|NCT02716727|7619504|FG000|NOT COMPLETED|Overall Study||0
6689478|NCT02716727|7619505|FG001|NOT COMPLETED|Overall Study||0
6689479|NCT02716779|7619514|FG000|STARTED|Monotherapy||14
6689480|NCT02716779|7619515|FG001|STARTED|Monotherapy||26
6689481|NCT02716779|7619516|FG002|STARTED|Monotherapy||27
6689482|NCT02716779|7619514|FG000|COMPLETED|Monotherapy||14
6689483|NCT02716779|7619515|FG001|COMPLETED|Monotherapy||25
6689484|NCT02716779|7619516|FG002|COMPLETED|Monotherapy||26
6689485|NCT02716779|7619514|FG000|NOT COMPLETED|Monotherapy||0
6689486|NCT02716779|7619515|FG001|NOT COMPLETED|Monotherapy||1
6689487|NCT02716779|7619516|FG002|NOT COMPLETED|Monotherapy||1
6689488|NCT02716779|7619514|FG000|STARTED|Combination Therapy||14
6689489|NCT02716779|7619515|FG001|STARTED|Combination Therapy||25
6689490|NCT02716779|7619516|FG002|STARTED|Combination Therapy||26
6689491|NCT02716779|7619514|FG000|COMPLETED|Combination Therapy||14
6689492|NCT02716779|7619515|FG001|COMPLETED|Combination Therapy||23
6689493|NCT02716779|7619516|FG002|COMPLETED|Combination Therapy||25
6689494|NCT02716779|7619514|FG000|NOT COMPLETED|Combination Therapy||0
6689495|NCT02716779|7619515|FG001|NOT COMPLETED|Combination Therapy||2
6689496|NCT02716779|7619516|FG002|NOT COMPLETED|Combination Therapy||1
6689497|NCT02716805|7619530|FG000|STARTED|Overall Study||6
6689498|NCT02716805|7619531|FG001|STARTED|Overall Study||0
6689499|NCT02716805|7619532|FG002|STARTED|Overall Study||0
6689500|NCT02716805|7619533|FG003|STARTED|Overall Study||0
6689501|NCT02716805|7619530|FG000|COMPLETED|Overall Study||4
6689502|NCT02716805|7619531|FG001|COMPLETED|Overall Study||0
6689503|NCT02716805|7619532|FG002|COMPLETED|Overall Study||0
6689504|NCT02716805|7619533|FG003|COMPLETED|Overall Study||0
6689505|NCT02716805|7619530|FG000|NOT COMPLETED|Overall Study||2
6689506|NCT02716805|7619531|FG001|NOT COMPLETED|Overall Study||0
6689507|NCT02716805|7619532|FG002|NOT COMPLETED|Overall Study||0
6689508|NCT02716805|7619533|FG003|NOT COMPLETED|Overall Study||0
6689509|NCT02716818|7619539|FG000|STARTED|Overall Study||61
6689510|NCT02716818|7619540|FG001|STARTED|Overall Study||61
6689511|NCT02716818|7619539|FG000|COMPLETED|Overall Study||58
6689512|NCT02716818|7619540|FG001|COMPLETED|Overall Study||59
6689513|NCT02716818|7619539|FG000|NOT COMPLETED|Overall Study||3
6689514|NCT02716818|7619540|FG001|NOT COMPLETED|Overall Study||2
6689515|NCT02716896|7619570|FG000|STARTED|Overall Study||1
6689516|NCT02716896|7619571|FG001|STARTED|Overall Study||1
6689517|NCT02716896|7619570|FG000|COMPLETED|Overall Study||1
6689518|NCT02716896|7619571|FG001|COMPLETED|Overall Study||0
6689519|NCT02716896|7619570|FG000|NOT COMPLETED|Overall Study||0
6689520|NCT02716896|7619571|FG001|NOT COMPLETED|Overall Study||1
6689521|NCT02716987|7619583|FG000|STARTED|Overall Study||4
6689522|NCT02716987|7619584|FG001|STARTED|Overall Study||2
6689523|NCT02716987|7619585|FG002|STARTED|Overall Study||5
6689524|NCT02716987|7619586|FG003|STARTED|Overall Study||2
6689525|NCT02716987|7619587|FG004|STARTED|Overall Study||6
6689526|NCT02716987|7619588|FG005|STARTED|Overall Study||1
6689527|NCT02716987|7619583|FG000|COMPLETED|Overall Study||4
6689528|NCT02716987|7619584|FG001|COMPLETED|Overall Study||2
6689529|NCT02716987|7619585|FG002|COMPLETED|Overall Study||4
6689530|NCT02716987|7619586|FG003|COMPLETED|Overall Study||2
6689531|NCT02716987|7619587|FG004|COMPLETED|Overall Study||5
6689532|NCT02716987|7619588|FG005|COMPLETED|Overall Study||0
6689533|NCT02716987|7619583|FG000|NOT COMPLETED|Overall Study||0
6689534|NCT02716987|7619584|FG001|NOT COMPLETED|Overall Study||0
6689535|NCT02716987|7619585|FG002|NOT COMPLETED|Overall Study||1
6689536|NCT02716987|7619586|FG003|NOT COMPLETED|Overall Study||0
6689537|NCT02716987|7619587|FG004|NOT COMPLETED|Overall Study||1
6689538|NCT02716987|7619588|FG005|NOT COMPLETED|Overall Study||1
6689539|NCT02717195|7619617|FG000|STARTED|Prospective Confirmation (PC) Period||711
6689540|NCT02717195|7619618|FG001|STARTED|Prospective Confirmation (PC) Period||387
6689541|NCT02717195|7619619|FG002|STARTED|Prospective Confirmation (PC) Period||0
6689542|NCT02717195|7619620|FG003|STARTED|Prospective Confirmation (PC) Period||0
6689543|NCT02717195|7619621|FG004|STARTED|Prospective Confirmation (PC) Period||0
6689544|NCT02717195|7619617|FG000|COMPLETED|Prospective Confirmation (PC) Period||421
6689545|NCT02717195|7619618|FG001|COMPLETED|Prospective Confirmation (PC) Period||276
6689546|NCT02717195|7619619|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
6689547|NCT02717195|7619620|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
6689548|NCT02717195|7619621|FG004|COMPLETED|Prospective Confirmation (PC) Period||0
6689549|NCT02717195|7619617|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||290
6689550|NCT02717195|7619618|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||111
6689551|NCT02717195|7619619|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6689552|NCT02717195|7619620|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6689553|NCT02717195|7619621|FG004|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6689554|NCT02717195|7619617|FG000|STARTED|Double-blind Treatment (DBT) Period||0
6689555|NCT02717195|7619618|FG001|STARTED|Double-blind Treatment (DBT) Period||0
6689556|NCT02717195|7619619|FG002|STARTED|Double-blind Treatment (DBT) Period||235
6689557|NCT02717195|7619620|FG003|STARTED|Double-blind Treatment (DBT) Period||232
6689558|NCT02717195|7619621|FG004|STARTED|Double-blind Treatment (DBT) Period||230
6689559|NCT02717195|7619617|FG000|COMPLETED|Double-blind Treatment (DBT) Period||0
6689560|NCT02717195|7619618|FG001|COMPLETED|Double-blind Treatment (DBT) Period||0
6689561|NCT02717195|7619619|FG002|COMPLETED|Double-blind Treatment (DBT) Period||198
6689562|NCT02717195|7619620|FG003|COMPLETED|Double-blind Treatment (DBT) Period||188
6689563|NCT02717195|7619621|FG004|COMPLETED|Double-blind Treatment (DBT) Period||200
6689564|NCT02717195|7619617|FG000|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
6689565|NCT02717195|7619618|FG001|NOT COMPLETED|Double-blind Treatment (DBT) Period||0
6689566|NCT02717195|7619619|FG002|NOT COMPLETED|Double-blind Treatment (DBT) Period||37
6689567|NCT02717195|7619620|FG003|NOT COMPLETED|Double-blind Treatment (DBT) Period||44
6689568|NCT02717195|7619621|FG004|NOT COMPLETED|Double-blind Treatment (DBT) Period||30
6689569|NCT02717273|7619636|FG000|STARTED|Overall Study||52
6689570|NCT02717273|7619637|FG001|STARTED|Overall Study||50
6689571|NCT02717273|7619636|FG000|COMPLETED|Overall Study||49
6689572|NCT02717273|7619637|FG001|COMPLETED|Overall Study||48
6689573|NCT02717273|7619636|FG000|NOT COMPLETED|Overall Study||3
6689574|NCT02717273|7619637|FG001|NOT COMPLETED|Overall Study||2
6689575|NCT02717494|7619646|FG000|STARTED|First Intervention (Step 1)||115
6689576|NCT02717494|7619647|FG001|STARTED|First Intervention (Step 1)||115
6689577|NCT02717494|7619648|FG002|STARTED|First Intervention (Step 1)||116
6689578|NCT02717494|7619646|FG000|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
6689579|NCT02717494|7619647|FG001|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||0
6689580|NCT02717494|7619648|FG002|Were Randomized to Step 2A (PPV-23)|First Intervention (Step 1)||53
6689581|NCT02717494|7619646|FG000|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
6689582|NCT02717494|7619647|FG001|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||0
6689583|NCT02717494|7619648|FG002|Were Randomized to Step 2B (PCV-10)|First Intervention (Step 1)||53
6689584|NCT02717494|7619646|FG000|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
6689585|NCT02717494|7619647|FG001|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||0
6689586|NCT02717494|7619648|FG002|Were Enrolled in Step 3 (PCV-10)|First Intervention (Step 1)||4
6689587|NCT02717494|7619646|FG000|COMPLETED|First Intervention (Step 1)||109
6689588|NCT02717494|7619647|FG001|COMPLETED|First Intervention (Step 1)||108
6689589|NCT02717494|7619648|FG002|COMPLETED|First Intervention (Step 1)||111
6689590|NCT02717494|7619646|FG000|NOT COMPLETED|First Intervention (Step 1)||6
6689591|NCT02717494|7619647|FG001|NOT COMPLETED|First Intervention (Step 1)||7
6689592|NCT02717494|7619648|FG002|NOT COMPLETED|First Intervention (Step 1)||5
6689593|NCT02717494|7619646|FG000|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
6689594|NCT02717494|7619647|FG001|STARTED|Second Intervention (Step 2 or Step 3)|Only Step 1 placebo recipients were enrolled in Step 2.|0
6689595|NCT02717494|7619648|FG002|STARTED|Second Intervention (Step 2 or Step 3)|One participant who completed Step 1 did not enroll in Step 2.|110
6689596|NCT02717494|7619646|FG000|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
6689597|NCT02717494|7619647|FG001|Completed Step 2A|Second Intervention (Step 2 or Step 3)||0
6689598|NCT02717494|7619648|FG002|Completed Step 2A|Second Intervention (Step 2 or Step 3)||52
6689599|NCT02717494|7619646|FG000|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
6689600|NCT02717494|7619647|FG001|Completed Step 2B|Second Intervention (Step 2 or Step 3)||0
6689601|NCT02717494|7619648|FG002|Completed Step 2B|Second Intervention (Step 2 or Step 3)||50
6689602|NCT02717494|7619646|FG000|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
6689603|NCT02717494|7619647|FG001|Completed Step 3|Second Intervention (Step 2 or Step 3)||0
6689604|NCT02717494|7619648|FG002|Completed Step 3|Second Intervention (Step 2 or Step 3)||4
6689605|NCT02717494|7619646|FG000|COMPLETED|Second Intervention (Step 2 or Step 3)||0
6689606|NCT02717494|7619647|FG001|COMPLETED|Second Intervention (Step 2 or Step 3)||0
6689607|NCT02717494|7619648|FG002|COMPLETED|Second Intervention (Step 2 or Step 3)||106
6689608|NCT02717494|7619646|FG000|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
6689609|NCT02717494|7619647|FG001|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||0
6689610|NCT02717494|7619648|FG002|NOT COMPLETED|Second Intervention (Step 2 or Step 3)||4
6689611|NCT02717546|7619674|FG000|STARTED|Overall Study||32
6689612|NCT02717546|7619674|FG000|COMPLETED|Overall Study||20
6689613|NCT02717546|7619674|FG000|NOT COMPLETED|Overall Study||12
6689614|NCT02717754|7619684|FG000|STARTED|Overall Study||10
6689615|NCT02717754|7619685|FG001|STARTED|Overall Study||19
6689616|NCT02717754|7619686|FG002|STARTED|Overall Study||20
6689617|NCT02717754|7619687|FG003|STARTED|Overall Study||10
6689618|NCT02717754|7619688|FG004|STARTED|Overall Study||20
6689619|NCT02717754|7619689|FG005|STARTED|Overall Study||20
6689620|NCT02717754|7619684|FG000|COMPLETED|Overall Study||10
6689621|NCT02717754|7619685|FG001|COMPLETED|Overall Study||19
6689622|NCT02717754|7619686|FG002|COMPLETED|Overall Study||20
6689623|NCT02717754|7619687|FG003|COMPLETED|Overall Study||0
6689624|NCT02717754|7619688|FG004|COMPLETED|Overall Study||0
6689625|NCT02717754|7619689|FG005|COMPLETED|Overall Study||0
6689626|NCT02717754|7619684|FG000|NOT COMPLETED|Overall Study||0
6689627|NCT02717754|7619685|FG001|NOT COMPLETED|Overall Study||0
6689628|NCT02717754|7619686|FG002|NOT COMPLETED|Overall Study||0
6689629|NCT02717754|7619687|FG003|NOT COMPLETED|Overall Study||10
6689630|NCT02717754|7619688|FG004|NOT COMPLETED|Overall Study||20
6689631|NCT02717754|7619689|FG005|NOT COMPLETED|Overall Study||20
6689632|NCT02718040|7619699|FG000|STARTED|Overall Study||30
6689633|NCT02718040|7619699|FG000|COMPLETED|Overall Study||30
6689634|NCT02718040|7619699|FG000|NOT COMPLETED|Overall Study||0
6689635|NCT02718118|7619705|FG000|STARTED|Overall Study||30
6689636|NCT02718118|7619706|FG001|STARTED|Overall Study||30
6689637|NCT02718118|7619705|FG000|COMPLETED|Overall Study||28
6689638|NCT02718118|7619706|FG001|COMPLETED|Overall Study||29
6689639|NCT02718118|7619705|FG000|NOT COMPLETED|Overall Study||2
6689640|NCT02718118|7619706|FG001|NOT COMPLETED|Overall Study||1
6689641|NCT02718131|7619714|FG000|STARTED|Overall Study||5
6689642|NCT02718131|7619715|FG001|STARTED|Overall Study||0
6689643|NCT02718131|7619714|FG000|Completed 12 Months|Overall Study||2
6689644|NCT02718131|7619715|FG001|Completed 12 Months|Overall Study||0
6689645|NCT02718131|7619714|FG000|COMPLETED|Overall Study||2
6689646|NCT02718131|7619715|FG001|COMPLETED|Overall Study||0
6689647|NCT02718131|7619714|FG000|NOT COMPLETED|Overall Study||3
6689648|NCT02718131|7619715|FG001|NOT COMPLETED|Overall Study||0
6689649|NCT02718157|7619723|FG000|STARTED|Overall Study||771
6689650|NCT02718157|7619723|FG000|COMPLETED|Overall Study||609
6689651|NCT02718157|7619723|FG000|NOT COMPLETED|Overall Study||162
6689652|NCT02718248|7619727|FG000|STARTED|Overall Study||7
6689653|NCT02718248|7619727|FG000|COMPLETED|Overall Study||7
6689654|NCT02718248|7619727|FG000|NOT COMPLETED|Overall Study||0
6689655|NCT02718326|7619734|FG000|STARTED|Overall Study||133
6689656|NCT02718326|7619735|FG001|STARTED|Overall Study||135
6689657|NCT02718326|7619736|FG002|STARTED|Overall Study||134
6689658|NCT02718326|7619734|FG000|Completed Week 52|Overall Study||109
6689659|NCT02718326|7619735|FG001|Completed Week 52|Overall Study||122
6689660|NCT02718326|7619736|FG002|Completed Week 52|Overall Study||124
6689661|NCT02718326|7619734|FG000|COMPLETED|Overall Study||97
6689662|NCT02718326|7619735|FG001|COMPLETED|Overall Study||111
6689663|NCT02718326|7619736|FG002|COMPLETED|Overall Study||112
6689664|NCT02718326|7619734|FG000|NOT COMPLETED|Overall Study||36
6689665|NCT02718326|7619735|FG001|NOT COMPLETED|Overall Study||24
6689666|NCT02718326|7619736|FG002|NOT COMPLETED|Overall Study||22
6689667|NCT02718417|7619749|FG000|STARTED|Chemotherapy Phase (CP)||332
6689668|NCT02718417|7619750|FG001|STARTED|Chemotherapy Phase (CP)||331
6689669|NCT02718417|7619751|FG002|STARTED|Chemotherapy Phase (CP)||335
6689670|NCT02718417|7619749|FG000|Safety Population|Chemotherapy Phase (CP)||328
6689671|NCT02718417|7619750|FG001|Safety Population|Chemotherapy Phase (CP)||329
6689672|NCT02718417|7619751|FG002|Safety Population|Chemotherapy Phase (CP)||334
6689673|NCT02718417|7619749|FG000|COMPLETED|Chemotherapy Phase (CP)||280
6689674|NCT02718417|7619750|FG001|COMPLETED|Chemotherapy Phase (CP)||294
6689675|NCT02718417|7619751|FG002|COMPLETED|Chemotherapy Phase (CP)||289
6689676|NCT02718417|7619749|FG000|NOT COMPLETED|Chemotherapy Phase (CP)||52
6689677|NCT02718417|7619750|FG001|NOT COMPLETED|Chemotherapy Phase (CP)||37
6689678|NCT02718417|7619751|FG002|NOT COMPLETED|Chemotherapy Phase (CP)||46
6689679|NCT02718417|7619749|FG000|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|267
6689680|NCT02718417|7619750|FG001|STARTED|Maintenance Phase (MP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|288
6689681|NCT02718417|7619751|FG002|STARTED|Maintenance Phase (MP)|After completing CP, participants moved to observation phase. MP was not applicable for this arm.|0
6689682|NCT02718417|7619749|FG000|COMPLETED|Maintenance Phase (MP)||1
6689683|NCT02718417|7619750|FG001|COMPLETED|Maintenance Phase (MP)||1
6689684|NCT02718417|7619751|FG002|COMPLETED|Maintenance Phase (MP)||0
6689685|NCT02718417|7619749|FG000|NOT COMPLETED|Maintenance Phase (MP)||266
6689686|NCT02718417|7619750|FG001|NOT COMPLETED|Maintenance Phase (MP)||287
6689687|NCT02718417|7619751|FG002|NOT COMPLETED|Maintenance Phase (MP)||0
6689688|NCT02718417|7619749|FG000|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
6689689|NCT02718417|7619750|FG001|STARTED|Observation Phase (OP)|After completing MP, participants moved to follow-up phase. OP was not applicable.|0
6689690|NCT02718417|7619751|FG002|STARTED|Observation Phase (OP)|Included participants without evidence of disease progression at the end of Chemotherapy phase.|284
6689691|NCT02718417|7619749|FG000|COMPLETED|Observation Phase (OP)||0
6689692|NCT02718417|7619750|FG001|COMPLETED|Observation Phase (OP)||0
6689693|NCT02718417|7619751|FG002|COMPLETED|Observation Phase (OP)||2
6689694|NCT02718417|7619749|FG000|NOT COMPLETED|Observation Phase (OP)||0
6689695|NCT02718417|7619750|FG001|NOT COMPLETED|Observation Phase (OP)||0
6689696|NCT02718417|7619751|FG002|NOT COMPLETED|Observation Phase (OP)||282
6689697|NCT02718417|7619749|FG000|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|238
6689698|NCT02718417|7619750|FG001|STARTED|Follow-up Phase|Participants not completing MP could also start this phase.|263
6689699|NCT02718417|7619751|FG002|STARTED|Follow-up Phase|Participants not completing OP could also start this phase.|39
6689700|NCT02718417|7619749|FG000|COMPLETED|Follow-up Phase||103
6689701|NCT02718417|7619750|FG001|COMPLETED|Follow-up Phase||91
6689702|NCT02718417|7619751|FG002|COMPLETED|Follow-up Phase||20
6689703|NCT02718417|7619749|FG000|NOT COMPLETED|Follow-up Phase||135
6689704|NCT02718417|7619750|FG001|NOT COMPLETED|Follow-up Phase||172
6689705|NCT02718417|7619751|FG002|NOT COMPLETED|Follow-up Phase||19
6689706|NCT02718417|7619749|FG000|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|139
6689707|NCT02718417|7619750|FG001|STARTED|Long-term Follow-up Phase|Participants not completing follow-up phase could also start this phase.|112
6689708|NCT02718417|7619751|FG002|STARTED|Long-term Follow-up Phase|Participants not completing follow-up could also start this phase.|135
6689709|NCT02718417|7619749|FG000|COMPLETED|Long-term Follow-up Phase||0
6689710|NCT02718417|7619750|FG001|COMPLETED|Long-term Follow-up Phase||0
6689711|NCT02718417|7619751|FG002|COMPLETED|Long-term Follow-up Phase||0
6689712|NCT02718417|7619749|FG000|NOT COMPLETED|Long-term Follow-up Phase||139
6689713|NCT02718417|7619750|FG001|NOT COMPLETED|Long-term Follow-up Phase||112
6689714|NCT02718417|7619751|FG002|NOT COMPLETED|Long-term Follow-up Phase||135
6689715|NCT02718625|7619768|FG000|STARTED|Overall Study||1
6689716|NCT02718625|7619769|FG001|STARTED|Overall Study||2
6689717|NCT02718625|7619768|FG000|COMPLETED|Overall Study||1
6689718|NCT02718625|7619769|FG001|COMPLETED|Overall Study||0
6689719|NCT02718625|7619768|FG000|NOT COMPLETED|Overall Study||0
6689720|NCT02718625|7619769|FG001|NOT COMPLETED|Overall Study||2
6689721|NCT02718898|7619777|FG000|STARTED|Blinded Treatment Period||74
6689722|NCT02718898|7619778|FG001|STARTED|Blinded Treatment Period||75
6689723|NCT02718898|7619779|FG002|STARTED|Blinded Treatment Period||0
6257985|NCT04330157|7157251|FG000|STARTED|Overall Study||50
6257986|NCT04330157|7157251|FG000|COMPLETED|Overall Study||43
6257987|NCT04330157|7157251|FG000|NOT COMPLETED|Overall Study||7
6257997|NCT04160988|7157272|FG000|STARTED|Overall Study||703
6257998|NCT04160988|7157272|FG000|COMPLETED|Overall Study||675
6257999|NCT04160988|7157272|FG000|NOT COMPLETED|Overall Study||28
6689724|NCT02718898|7619780|FG003|STARTED|Blinded Treatment Period||0
6689725|NCT02718898|7619781|FG004|STARTED|Blinded Treatment Period||0
6689726|NCT02718898|7619782|FG005|STARTED|Blinded Treatment Period||0
6689727|NCT02718898|7619783|FG006|STARTED|Blinded Treatment Period||0
6689728|NCT02718898|7619777|FG000|COMPLETED|Blinded Treatment Period||65
6689729|NCT02718898|7619778|FG001|COMPLETED|Blinded Treatment Period||74
6689730|NCT02718898|7619779|FG002|COMPLETED|Blinded Treatment Period||0
6689731|NCT02718898|7619780|FG003|COMPLETED|Blinded Treatment Period||0
6689732|NCT02718898|7619781|FG004|COMPLETED|Blinded Treatment Period||0
6689733|NCT02718898|7619782|FG005|COMPLETED|Blinded Treatment Period||0
6689734|NCT02718898|7619783|FG006|COMPLETED|Blinded Treatment Period||0
6689735|NCT02718898|7619777|FG000|NOT COMPLETED|Blinded Treatment Period||9
6689736|NCT02718898|7619778|FG001|NOT COMPLETED|Blinded Treatment Period||1
6689737|NCT02718898|7619779|FG002|NOT COMPLETED|Blinded Treatment Period||0
6689738|NCT02718898|7619780|FG003|NOT COMPLETED|Blinded Treatment Period||0
6689739|NCT02718898|7619781|FG004|NOT COMPLETED|Blinded Treatment Period||0
6689740|NCT02718898|7619782|FG005|NOT COMPLETED|Blinded Treatment Period||0
6689741|NCT02718898|7619783|FG006|NOT COMPLETED|Blinded Treatment Period||0
6689742|NCT02718898|7619777|FG000|STARTED|Open Label Treatment Period (OLTP)||0
6689743|NCT02718898|7619778|FG001|STARTED|Open Label Treatment Period (OLTP)||0
6258003|NCT04079114|7157281|FG000|STARTED|Overall Study||166
6258004|NCT04079114|7157281|FG000|COMPLETED|Overall Study|Study prematurely terminated.|0
6258005|NCT04079114|7157281|FG000|NOT COMPLETED|Overall Study||166
6258006|NCT04075279|7157285|FG000|STARTED|Overall Study||19
6258007|NCT04075279|7157285|FG000|COMPLETED|Overall Study||19
6258008|NCT04075279|7157285|FG000|NOT COMPLETED|Overall Study||0
6258009|NCT04066686|7157291|FG000|STARTED|Overall Study||14
6258010|NCT04066686|7157292|FG001|STARTED|Overall Study||13
6258011|NCT04066686|7157291|FG000|COMPLETED|Overall Study||12
6258012|NCT04066686|7157292|FG001|COMPLETED|Overall Study||13
6258013|NCT04066686|7157291|FG000|NOT COMPLETED|Overall Study||2
6258014|NCT04066686|7157292|FG001|NOT COMPLETED|Overall Study||0
6258037|NCT03964649|7157332|FG000|STARTED|Overall Study||349
6258038|NCT03964649|7157333|FG001|STARTED|Overall Study||304
6258039|NCT03964649|7157334|FG002|STARTED|Overall Study||2728
6258040|NCT03964649|7157335|FG003|STARTED|Overall Study||192
6258041|NCT03964649|7157336|FG004|STARTED|Overall Study||1948
6258042|NCT03964649|7157337|FG005|STARTED|Overall Study||349
6258043|NCT03964649|7157338|FG006|STARTED|Overall Study||376
6258044|NCT03964649|7157339|FG007|STARTED|Overall Study||325
6258045|NCT03964649|7157340|FG008|STARTED|Overall Study||204
6258046|NCT03964649|7157341|FG009|STARTED|Overall Study||533
6258047|NCT03964649|7157332|FG000|COMPLETED|Overall Study||349
6258048|NCT03964649|7157333|FG001|COMPLETED|Overall Study||304
6258049|NCT03964649|7157334|FG002|COMPLETED|Overall Study||2728
6258050|NCT03964649|7157335|FG003|COMPLETED|Overall Study||192
6258051|NCT03964649|7157336|FG004|COMPLETED|Overall Study||1948
6258052|NCT03964649|7157337|FG005|COMPLETED|Overall Study||349
6258053|NCT03964649|7157338|FG006|COMPLETED|Overall Study||376
6258054|NCT03964649|7157339|FG007|COMPLETED|Overall Study||325
6258055|NCT03964649|7157340|FG008|COMPLETED|Overall Study||204
6258056|NCT03964649|7157341|FG009|COMPLETED|Overall Study||533
6258057|NCT03964649|7157332|FG000|NOT COMPLETED|Overall Study||0
6258058|NCT03964649|7157333|FG001|NOT COMPLETED|Overall Study||0
6258059|NCT03964649|7157334|FG002|NOT COMPLETED|Overall Study||0
6258060|NCT03964649|7157335|FG003|NOT COMPLETED|Overall Study||0
6258061|NCT03964649|7157336|FG004|NOT COMPLETED|Overall Study||0
6689744|NCT02718898|7619779|FG002|STARTED|Open Label Treatment Period (OLTP)||65
6689745|NCT02718898|7619780|FG003|STARTED|Open Label Treatment Period (OLTP)||74
6689746|NCT02718898|7619781|FG004|STARTED|Open Label Treatment Period (OLTP)||0
6689747|NCT02718898|7619782|FG005|STARTED|Open Label Treatment Period (OLTP)||0
6689748|NCT02718898|7619783|FG006|STARTED|Open Label Treatment Period (OLTP)||0
6689749|NCT02718898|7619777|FG000|COMPLETED|Open Label Treatment Period (OLTP)||0
6689750|NCT02718898|7619778|FG001|COMPLETED|Open Label Treatment Period (OLTP)||0
6689751|NCT02718898|7619779|FG002|COMPLETED|Open Label Treatment Period (OLTP)||62
6689752|NCT02718898|7619780|FG003|COMPLETED|Open Label Treatment Period (OLTP)||64
6689753|NCT02718898|7619781|FG004|COMPLETED|Open Label Treatment Period (OLTP)||0
6689754|NCT02718898|7619782|FG005|COMPLETED|Open Label Treatment Period (OLTP)||0
6689755|NCT02718898|7619783|FG006|COMPLETED|Open Label Treatment Period (OLTP)||0
6258015|NCT04058626|7157298|FG000|STARTED|Overall Study||305
6258016|NCT04058626|7157298|FG000|COMPLETED|Overall Study||305
6258017|NCT04058626|7157298|FG000|NOT COMPLETED|Overall Study||0
6258018|NCT04057235|7157302|FG000|STARTED|Overall Study||129
6258019|NCT04057235|7157302|FG000|Had Radiographic Data|Overall Study||58
6258020|NCT04057235|7157302|FG000|Had ODI Data|Overall Study||43
6258021|NCT04057235|7157302|FG000|Had VAS Back Data|Overall Study||45
6258022|NCT04057235|7157302|FG000|Had VAS Leg Data|Overall Study||45
6258023|NCT04057235|7157302|FG000|COMPLETED|Overall Study|All 129 participants had data for at least one of the primary/secondary outcomes or adverse events|129
6258024|NCT04057235|7157302|FG000|NOT COMPLETED|Overall Study||0
6258025|NCT04041037|7157306|FG000|STARTED|Overall Study||2
6258026|NCT04041037|7157306|FG000|COMPLETED|Overall Study||2
6258027|NCT04041037|7157306|FG000|NOT COMPLETED|Overall Study||0
6258062|NCT03964649|7157337|FG005|NOT COMPLETED|Overall Study||0
6258063|NCT03964649|7157338|FG006|NOT COMPLETED|Overall Study||0
6258064|NCT03964649|7157339|FG007|NOT COMPLETED|Overall Study||0
6258065|NCT03964649|7157340|FG008|NOT COMPLETED|Overall Study||0
6258066|NCT03964649|7157341|FG009|NOT COMPLETED|Overall Study||0
6279933|NCT00149838|7179822|FG003|STARTED|Phase III||61
6279934|NCT00149838|7179819|FG000|COMPLETED|Phase III||0
6279935|NCT00149838|7179820|FG001|COMPLETED|Phase III||0
6279936|NCT00149838|7179821|FG002|COMPLETED|Phase III||0
6279937|NCT00149838|7179822|FG003|COMPLETED|Phase III||37
6279938|NCT00149838|7179819|FG000|NOT COMPLETED|Phase III||0
6279939|NCT00149838|7179820|FG001|NOT COMPLETED|Phase III||0
6279940|NCT00149838|7179821|FG002|NOT COMPLETED|Phase III||0
6279941|NCT00149838|7179822|FG003|NOT COMPLETED|Phase III||24
6279942|NCT00149890|7179834|FG000|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
6279943|NCT00149890|7179835|FG001|STARTED|Overall Study||38
6279944|NCT00149890|7179834|FG000|COMPLETED|Overall Study||26
6689756|NCT02718898|7619777|FG000|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6689757|NCT02718898|7619778|FG001|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6689758|NCT02718898|7619779|FG002|NOT COMPLETED|Open Label Treatment Period (OLTP)||3
6689759|NCT02718898|7619780|FG003|NOT COMPLETED|Open Label Treatment Period (OLTP)||10
6689760|NCT02718898|7619781|FG004|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6689761|NCT02718898|7619782|FG005|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6689762|NCT02718898|7619783|FG006|NOT COMPLETED|Open Label Treatment Period (OLTP)||0
6689763|NCT02718898|7619777|FG000|STARTED|Post Treatment Follow-up Period||0
6689764|NCT02718898|7619778|FG001|STARTED|Post Treatment Follow-up Period||0
6689765|NCT02718898|7619779|FG002|STARTED|Post Treatment Follow-up Period||0
6689766|NCT02718898|7619780|FG003|STARTED|Post Treatment Follow-up Period||0
6689767|NCT02718898|7619781|FG004|STARTED|Post Treatment Follow-up Period|One participant who discontinued from placebo blinded treatment had entered post-treatment follow-up|1
6689768|NCT02718898|7619782|FG005|STARTED|Post Treatment Follow-up Period||78
6689769|NCT02718898|7619783|FG006|STARTED|Post Treatment Follow-up Period||49
6689770|NCT02718898|7619777|FG000|COMPLETED|Post Treatment Follow-up Period||0
6689771|NCT02718898|7619778|FG001|COMPLETED|Post Treatment Follow-up Period||0
6689772|NCT02718898|7619779|FG002|COMPLETED|Post Treatment Follow-up Period||0
6689773|NCT02718898|7619780|FG003|COMPLETED|Post Treatment Follow-up Period||0
6689774|NCT02718898|7619781|FG004|COMPLETED|Post Treatment Follow-up Period||0
6689775|NCT02718898|7619782|FG005|COMPLETED|Post Treatment Follow-up Period||67
6689776|NCT02718898|7619783|FG006|COMPLETED|Post Treatment Follow-up Period||44
6689777|NCT02718898|7619777|FG000|NOT COMPLETED|Post Treatment Follow-up Period||0
6689778|NCT02718898|7619778|FG001|NOT COMPLETED|Post Treatment Follow-up Period||0
6689779|NCT02718898|7619779|FG002|NOT COMPLETED|Post Treatment Follow-up Period||0
6689780|NCT02718898|7619780|FG003|NOT COMPLETED|Post Treatment Follow-up Period||0
6689781|NCT02718898|7619781|FG004|NOT COMPLETED|Post Treatment Follow-up Period||1
6689782|NCT02718898|7619782|FG005|NOT COMPLETED|Post Treatment Follow-up Period||11
6689783|NCT02718898|7619783|FG006|NOT COMPLETED|Post Treatment Follow-up Period||5
6689784|NCT02718963|7619798|FG000|STARTED|Overall Study||10
6689785|NCT02718963|7619799|FG001|STARTED|Overall Study||10
6689786|NCT02718963|7619798|FG000|COMPLETED|Overall Study||9
6689787|NCT02718963|7619799|FG001|COMPLETED|Overall Study||9
6689788|NCT02718963|7619798|FG000|NOT COMPLETED|Overall Study||1
6689789|NCT02718963|7619799|FG001|NOT COMPLETED|Overall Study||1
6689790|NCT02719028|7619809|FG000|STARTED|Overall Study||30
6689791|NCT02719028|7619810|FG001|STARTED|Overall Study||30
6689792|NCT02719028|7619811|FG002|STARTED|Overall Study||30
6689793|NCT02719028|7619812|FG003|STARTED|Overall Study||30
6689794|NCT02719028|7619809|FG000|COMPLETED|Overall Study||28
6689795|NCT02719028|7619810|FG001|COMPLETED|Overall Study||28
6689796|NCT02719028|7619811|FG002|COMPLETED|Overall Study||24
6689797|NCT02719028|7619812|FG003|COMPLETED|Overall Study||20
6689798|NCT02719028|7619809|FG000|NOT COMPLETED|Overall Study||2
6689799|NCT02719028|7619810|FG001|NOT COMPLETED|Overall Study||2
6689800|NCT02719028|7619811|FG002|NOT COMPLETED|Overall Study||6
6689801|NCT02719028|7619812|FG003|NOT COMPLETED|Overall Study||10
6689802|NCT02719158|7619825|FG000|STARTED|Overall Study||38
6689803|NCT02719158|7619826|FG001|STARTED|Overall Study||38
6689804|NCT02719158|7619827|FG002|STARTED|Overall Study||19
6689805|NCT02719158|7619825|FG000|COMPLETED|Overall Study||38
6689806|NCT02719158|7619826|FG001|COMPLETED|Overall Study||38
6689807|NCT02719158|7619827|FG002|COMPLETED|Overall Study||18
6689808|NCT02719158|7619825|FG000|NOT COMPLETED|Overall Study||0
6689809|NCT02719158|7619826|FG001|NOT COMPLETED|Overall Study||0
6689810|NCT02719158|7619827|FG002|NOT COMPLETED|Overall Study||1
6689811|NCT02719171|7619840|FG000|STARTED|Overall Study||42
6689812|NCT02719171|7619841|FG001|STARTED|Overall Study||42
6689813|NCT02719171|7619842|FG002|STARTED|Overall Study||42
6258028|NCT04034043|7157310|FG000|STARTED|Overall Study||68
6258029|NCT04034043|7157310|FG000|COMPLETED|Overall Study||68
6258030|NCT04034043|7157310|FG000|NOT COMPLETED|Overall Study||0
6689814|NCT02719171|7619843|FG003|STARTED|Overall Study||39
6689815|NCT02719171|7619844|FG004|STARTED|Overall Study||20
6689816|NCT02719171|7619840|FG000|COMPLETED|Overall Study||41
6689817|NCT02719171|7619841|FG001|COMPLETED|Overall Study||38
6689818|NCT02719171|7619842|FG002|COMPLETED|Overall Study||39
6689819|NCT02719171|7619843|FG003|COMPLETED|Overall Study||37
6689820|NCT02719171|7619844|FG004|COMPLETED|Overall Study||18
6689821|NCT02719171|7619840|FG000|NOT COMPLETED|Overall Study||1
6689822|NCT02719171|7619841|FG001|NOT COMPLETED|Overall Study||4
6689823|NCT02719171|7619842|FG002|NOT COMPLETED|Overall Study||3
6689824|NCT02719171|7619843|FG003|NOT COMPLETED|Overall Study||2
6689825|NCT02719171|7619844|FG004|NOT COMPLETED|Overall Study||2
6689826|NCT02719353|7619859|FG000|STARTED|First Intervention||7
6689827|NCT02719353|7619860|FG001|STARTED|First Intervention||7
6689828|NCT02719353|7619859|FG000|COMPLETED|First Intervention||7
6689829|NCT02719353|7619860|FG001|COMPLETED|First Intervention||6
6689830|NCT02719353|7619859|FG000|NOT COMPLETED|First Intervention||0
6689831|NCT02719353|7619860|FG001|NOT COMPLETED|First Intervention||1
6258067|NCT03941015|7157365|FG000|STARTED|Overall Study||38
6258068|NCT03941015|7157366|FG001|STARTED|Overall Study||207
6258069|NCT03941015|7157365|FG000|COMPLETED|Overall Study||38
6258070|NCT03941015|7157366|FG001|COMPLETED|Overall Study||204
6258071|NCT03941015|7157365|FG000|NOT COMPLETED|Overall Study||0
6258072|NCT03941015|7157366|FG001|NOT COMPLETED|Overall Study||3
6279945|NCT00149890|7179835|FG001|COMPLETED|Overall Study||20
6689832|NCT02719353|7619859|FG000|STARTED|Second Intervention||7
6689833|NCT02719353|7619860|FG001|STARTED|Second Intervention||6
6689834|NCT02719353|7619859|FG000|COMPLETED|Second Intervention||7
6689835|NCT02719353|7619860|FG001|COMPLETED|Second Intervention||6
6689836|NCT02719353|7619859|FG000|NOT COMPLETED|Second Intervention||0
6689837|NCT02719353|7619860|FG001|NOT COMPLETED|Second Intervention||0
6689838|NCT02719366|7619867|FG000|STARTED|First Intervention||6
6689839|NCT02719366|7619868|FG001|STARTED|First Intervention||6
6689840|NCT02719366|7619867|FG000|COMPLETED|First Intervention||6
6689841|NCT02719366|7619868|FG001|COMPLETED|First Intervention||6
6689842|NCT02719366|7619867|FG000|NOT COMPLETED|First Intervention||0
6689843|NCT02719366|7619868|FG001|NOT COMPLETED|First Intervention||0
6689844|NCT02719366|7619867|FG000|STARTED|Second Intervention||6
6689845|NCT02719366|7619868|FG001|STARTED|Second Intervention||6
6689846|NCT02719366|7619867|FG000|COMPLETED|Second Intervention||6
6689847|NCT02719366|7619868|FG001|COMPLETED|Second Intervention||6
6689848|NCT02719366|7619867|FG000|NOT COMPLETED|Second Intervention||0
6689849|NCT02719366|7619868|FG001|NOT COMPLETED|Second Intervention||0
6689850|NCT02719535|7619875|FG000|STARTED|Overall Study||59
6689851|NCT02719535|7619875|FG000|COMPLETED|Overall Study||37
6689852|NCT02719535|7619875|FG000|NOT COMPLETED|Overall Study||22
6689853|NCT02719639|7619879|FG000|STARTED|Overall Study||7443
6689854|NCT02719639|7619879|FG000|COMPLETED|Overall Study||7443
6689855|NCT02719639|7619879|FG000|NOT COMPLETED|Overall Study||0
6689856|NCT02719743|7619888|FG000|STARTED|Overall Study||38
6689857|NCT02719743|7619889|FG001|STARTED|Overall Study||37
6689858|NCT02719743|7619890|FG002|STARTED|Overall Study||38
6689859|NCT02719743|7619891|FG003|STARTED|Overall Study||37
6689860|NCT02719743|7619892|FG004|STARTED|Overall Study||35
6689861|NCT02719743|7619888|FG000|COMPLETED|Overall Study||37
6689862|NCT02719743|7619889|FG001|COMPLETED|Overall Study||34
6689863|NCT02719743|7619890|FG002|COMPLETED|Overall Study||38
6689864|NCT02719743|7619891|FG003|COMPLETED|Overall Study||36
6689865|NCT02719743|7619892|FG004|COMPLETED|Overall Study||33
6689866|NCT02719743|7619888|FG000|NOT COMPLETED|Overall Study||1
6689867|NCT02719743|7619889|FG001|NOT COMPLETED|Overall Study||3
6689868|NCT02719743|7619890|FG002|NOT COMPLETED|Overall Study||0
6689869|NCT02719743|7619891|FG003|NOT COMPLETED|Overall Study||1
6689870|NCT02719743|7619892|FG004|NOT COMPLETED|Overall Study||2
6689871|NCT02719938|7619906|FG000|STARTED|Overall Study||30
6689872|NCT02719938|7619907|FG001|STARTED|Overall Study||32
6689873|NCT02719938|7619906|FG000|COMPLETED|Overall Study||26
6689874|NCT02719938|7619907|FG001|COMPLETED|Overall Study||31
6689875|NCT02719938|7619906|FG000|NOT COMPLETED|Overall Study||4
6689876|NCT02719938|7619907|FG001|NOT COMPLETED|Overall Study||1
6689877|NCT02720042|7619913|FG000|STARTED|Overall Study||84
6689878|NCT02720042|7619913|FG000|COMPLETED|Overall Study||69
6689879|NCT02720042|7619913|FG000|NOT COMPLETED|Overall Study||15
6689880|NCT02720081|7619919|FG000|STARTED|Overall Study||72
6689881|NCT02720081|7619920|FG001|STARTED|Overall Study||70
6689882|NCT02720081|7619919|FG000|Treated|Overall Study||70
6689883|NCT02720081|7619920|FG001|Treated|Overall Study||69
6689884|NCT02720081|7619919|FG000|COMPLETED|Overall Study||68
6689885|NCT02720081|7619920|FG001|COMPLETED|Overall Study||66
6689886|NCT02720081|7619919|FG000|NOT COMPLETED|Overall Study||4
6689887|NCT02720081|7619920|FG001|NOT COMPLETED|Overall Study||4
6689888|NCT02720107|7619926|FG000|STARTED|Overall Study||130
6689889|NCT02720107|7619926|FG000|COMPLETED|Overall Study||130
6689890|NCT02720107|7619926|FG000|NOT COMPLETED|Overall Study||0
6689891|NCT02720198|7619932|FG000|STARTED|Overall Study||29
6689892|NCT02720198|7619933|FG001|STARTED|Overall Study||31
6689893|NCT02720198|7619932|FG000|COMPLETED|Overall Study||29
6689894|NCT02720198|7619933|FG001|COMPLETED|Overall Study||30
6689895|NCT02720198|7619932|FG000|NOT COMPLETED|Overall Study||0
6689896|NCT02720198|7619933|FG001|NOT COMPLETED|Overall Study||1
6689897|NCT02720224|7619939|FG000|STARTED|Overall Study||6
6689898|NCT02720224|7619939|FG000|COMPLETED|Overall Study||6
6689899|NCT02720224|7619939|FG000|NOT COMPLETED|Overall Study||0
6689900|NCT02720484|7619943|FG000|STARTED|Treatment on Study||10
6689901|NCT02720484|7619943|FG000|Reached 1st Response/2 Cycles|Treatment on Study||7
6689902|NCT02720484|7619943|FG000|Treated Cycle 3|Treatment on Study||4
6689903|NCT02720484|7619943|FG000|COMPLETED|Treatment on Study||4
6689904|NCT02720484|7619943|FG000|NOT COMPLETED|Treatment on Study||6
6689905|NCT02720484|7619943|FG000|STARTED|Follow Up for 2 Years|All patients that receive at least one treatment on study go into follow up.|7
6689906|NCT02720484|7619943|FG000|COMPLETED|Follow Up for 2 Years||1
6689907|NCT02720484|7619943|FG000|NOT COMPLETED|Follow Up for 2 Years||6
6689908|NCT02720523|7619951|FG000|STARTED|Period 1: Placebo-controlled Period||49
6689909|NCT02720523|7619952|FG001|STARTED|Period 1: Placebo-controlled Period||49
6689910|NCT02720523|7619953|FG002|STARTED|Period 1: Placebo-controlled Period||49
6689911|NCT02720523|7619954|FG003|STARTED|Period 1: Placebo-controlled Period||50
6689912|NCT02720523|7619955|FG004|STARTED|Period 1: Placebo-controlled Period||0
6689913|NCT02720523|7619956|FG005|STARTED|Period 1: Placebo-controlled Period||0
6689914|NCT02720523|7619957|FG006|STARTED|Period 1: Placebo-controlled Period||0
6689915|NCT02720523|7619951|FG000|COMPLETED|Period 1: Placebo-controlled Period||47
6689916|NCT02720523|7619952|FG001|COMPLETED|Period 1: Placebo-controlled Period||49
6689917|NCT02720523|7619953|FG002|COMPLETED|Period 1: Placebo-controlled Period||47
6689918|NCT02720523|7619954|FG003|COMPLETED|Period 1: Placebo-controlled Period||44
6689919|NCT02720523|7619955|FG004|COMPLETED|Period 1: Placebo-controlled Period||0
6689920|NCT02720523|7619956|FG005|COMPLETED|Period 1: Placebo-controlled Period||0
6689921|NCT02720523|7619957|FG006|COMPLETED|Period 1: Placebo-controlled Period||0
6689922|NCT02720523|7619951|FG000|NOT COMPLETED|Period 1: Placebo-controlled Period||2
6689923|NCT02720523|7619952|FG001|NOT COMPLETED|Period 1: Placebo-controlled Period||0
6689924|NCT02720523|7619953|FG002|NOT COMPLETED|Period 1: Placebo-controlled Period||2
6689925|NCT02720523|7619954|FG003|NOT COMPLETED|Period 1: Placebo-controlled Period||6
6689926|NCT02720523|7619955|FG004|NOT COMPLETED|Period 1: Placebo-controlled Period||0
6689927|NCT02720523|7619956|FG005|NOT COMPLETED|Period 1: Placebo-controlled Period||0
6689928|NCT02720523|7619957|FG006|NOT COMPLETED|Period 1: Placebo-controlled Period||0
6689929|NCT02720523|7619951|FG000|STARTED|Period 2: Long-term Extension Period||0
6689930|NCT02720523|7619952|FG001|STARTED|Period 2: Long-term Extension Period||0
6689931|NCT02720523|7619953|FG002|STARTED|Period 2: Long-term Extension Period||0
6689932|NCT02720523|7619954|FG003|STARTED|Period 2: Long-term Extension Period||0
6689933|NCT02720523|7619955|FG004|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 7.5 mg|65
6689934|NCT02720523|7619956|FG005|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 15 mg|62
6689935|NCT02720523|7619957|FG006|STARTED|Period 2: Long-term Extension Period|Includes participants originally randomized to placebo and upadacitinib 30 mg|60
6689936|NCT02720523|7619951|FG000|COMPLETED|Period 2: Long-term Extension Period||0
6689937|NCT02720523|7619952|FG001|COMPLETED|Period 2: Long-term Extension Period||0
6689938|NCT02720523|7619953|FG002|COMPLETED|Period 2: Long-term Extension Period||0
6689939|NCT02720523|7619954|FG003|COMPLETED|Period 2: Long-term Extension Period||0
6689940|NCT02720523|7619955|FG004|COMPLETED|Period 2: Long-term Extension Period||0
6689941|NCT02720523|7619956|FG005|COMPLETED|Period 2: Long-term Extension Period||0
6689942|NCT02720523|7619957|FG006|COMPLETED|Period 2: Long-term Extension Period||0
6689943|NCT02720523|7619951|FG000|NOT COMPLETED|Period 2: Long-term Extension Period||0
6689944|NCT02720523|7619952|FG001|NOT COMPLETED|Period 2: Long-term Extension Period||0
6689945|NCT02720523|7619953|FG002|NOT COMPLETED|Period 2: Long-term Extension Period||0
6689946|NCT02720523|7619954|FG003|NOT COMPLETED|Period 2: Long-term Extension Period||0
6689947|NCT02720523|7619955|FG004|NOT COMPLETED|Period 2: Long-term Extension Period||65
6689948|NCT02720523|7619956|FG005|NOT COMPLETED|Period 2: Long-term Extension Period||62
6689949|NCT02720523|7619957|FG006|NOT COMPLETED|Period 2: Long-term Extension Period||60
6689950|NCT02720536|7619970|FG000|STARTED|Overall Study||53
6689951|NCT02720536|7619970|FG000|COMPLETED|Overall Study||34
6689952|NCT02720536|7619970|FG000|NOT COMPLETED|Overall Study||19
6689953|NCT02720627|7619980|FG000|STARTED|Overall Study||27
6689954|NCT02720627|7619980|FG000|COMPLETED|Overall Study||27
6689955|NCT02720627|7619980|FG000|NOT COMPLETED|Overall Study||0
6689956|NCT02720757|7619984|FG000|STARTED|Overall Study||132
6689957|NCT02720757|7619984|FG000|COMPLETED|Overall Study||114
6689958|NCT02720757|7619984|FG000|NOT COMPLETED|Overall Study||18
6689959|NCT02720952|7619988|FG000|STARTED|Overall Study||24
6689960|NCT02720952|7619988|FG000|COMPLETED|Overall Study||24
6689961|NCT02720952|7619988|FG000|NOT COMPLETED|Overall Study||0
6689962|NCT02721017|7619998|FG000|STARTED|Hospital Stay|Intraoperative Application of Cryoanalgesia started on Date of Surgery (DOS).|10
6689963|NCT02721017|7619999|FG001|STARTED|Hospital Stay|Thoracic Epidural placed on Date of Surgery (DOS).|10
6689964|NCT02721017|7619998|FG000|COMPLETED|Hospital Stay|Completed during the course of surgery.|10
6689965|NCT02721017|7619999|FG001|COMPLETED|Hospital Stay|Removal occurs prior to Hospital Discharge.|10
6689966|NCT02721017|7619998|FG000|NOT COMPLETED|Hospital Stay||0
6689967|NCT02721017|7619999|FG001|NOT COMPLETED|Hospital Stay||0
6689968|NCT02721017|7619998|FG000|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
6689969|NCT02721017|7619999|FG001|STARTED|Participant Follow Up|Assessment of recovery at 2 weeks, 1 month, 3 month and 12 month intervals.|10
6689970|NCT02721017|7619998|FG000|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
6689971|NCT02721017|7619999|FG001|COMPLETED|Participant Follow Up|12 months after Date of Surgery.|10
6689972|NCT02721017|7619998|FG000|NOT COMPLETED|Participant Follow Up||0
6689973|NCT02721017|7619999|FG001|NOT COMPLETED|Participant Follow Up||0
6689974|NCT02721147|7620010|FG000|STARTED|Overall Study||40
6689975|NCT02721147|7620011|FG001|STARTED|Overall Study||18
6689976|NCT02721147|7620012|FG002|STARTED|Overall Study||31
6689977|NCT02721147|7620010|FG000|COMPLETED|Overall Study||38
6689978|NCT02721147|7620011|FG001|COMPLETED|Overall Study||18
6689979|NCT02721147|7620012|FG002|COMPLETED|Overall Study||31
6689980|NCT02721147|7620010|FG000|NOT COMPLETED|Overall Study||2
6689981|NCT02721147|7620011|FG001|NOT COMPLETED|Overall Study||0
6689982|NCT02721147|7620012|FG002|NOT COMPLETED|Overall Study||0
6689983|NCT02721251|7620023|FG000|STARTED|Overall Study||14
6689984|NCT02721251|7620024|FG001|STARTED|Overall Study||16
6689985|NCT02721251|7620025|FG002|STARTED|Overall Study||17
6689986|NCT02721251|7620023|FG000|COMPLETED|Overall Study||4
6689987|NCT02721251|7620024|FG001|COMPLETED|Overall Study||7
6689988|NCT02721251|7620025|FG002|COMPLETED|Overall Study||6
6689989|NCT02721251|7620023|FG000|NOT COMPLETED|Overall Study||10
6689990|NCT02721251|7620024|FG001|NOT COMPLETED|Overall Study||9
6689991|NCT02721251|7620025|FG002|NOT COMPLETED|Overall Study||11
6689992|NCT02721355|7620036|FG000|STARTED|Overall Study||42
6689993|NCT02721355|7620037|FG001|STARTED|Overall Study||42
6689994|NCT02721355|7620036|FG000|COMPLETED|Overall Study||36
6689995|NCT02721355|7620037|FG001|COMPLETED|Overall Study||41
6689996|NCT02721355|7620036|FG000|NOT COMPLETED|Overall Study||6
6689997|NCT02721355|7620037|FG001|NOT COMPLETED|Overall Study||1
6689998|NCT02721641|7620043|FG000|STARTED|Overall Study||69
6689999|NCT02721641|7620043|FG000|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
6690000|NCT02721641|7620043|FG000|NOT COMPLETED|Overall Study||0
6690001|NCT02721875|7620049|FG000|STARTED|Overall Study||1
6690002|NCT02721875|7620050|FG001|STARTED|Overall Study||0
6690003|NCT02721875|7620049|FG000|COMPLETED|Overall Study||0
6690004|NCT02721875|7620050|FG001|COMPLETED|Overall Study||0
6690005|NCT02721875|7620049|FG000|NOT COMPLETED|Overall Study||1
6690006|NCT02721875|7620050|FG001|NOT COMPLETED|Overall Study||0
6690007|NCT02721966|7620059|FG000|STARTED|Overall Study||167
6690008|NCT02721966|7620060|FG001|STARTED|Overall Study||165
6690009|NCT02721966|7620061|FG002|STARTED|Overall Study||81
6690010|NCT02721966|7620062|FG003|STARTED|Overall Study||80
6690011|NCT02721966|7620063|FG004|STARTED|Overall Study||5
6690012|NCT02721966|7620059|FG000|Completed Period 1 & Went to Period 2|Overall Study||162
6690013|NCT02721966|7620060|FG001|Completed Period 1 & Went to Period 2|Overall Study||153
6690014|NCT02721966|7620061|FG002|Completed Period 1 & Went to Period 2|Overall Study||81
6690015|NCT02721966|7620062|FG003|Completed Period 1 & Went to Period 2|Overall Study||80
6690016|NCT02721966|7620063|FG004|Completed Period 1 & Went to Period 2|Overall Study||0
6690017|NCT02721966|7620059|FG000|COMPLETED|Overall Study||138
6690018|NCT02721966|7620060|FG001|COMPLETED|Overall Study||142
6690019|NCT02721966|7620061|FG002|COMPLETED|Overall Study||72
6690020|NCT02721966|7620062|FG003|COMPLETED|Overall Study||73
6690021|NCT02721966|7620063|FG004|COMPLETED|Overall Study||0
6690022|NCT02721966|7620059|FG000|NOT COMPLETED|Overall Study||29
6690023|NCT02721966|7620060|FG001|NOT COMPLETED|Overall Study||23
6690024|NCT02721966|7620061|FG002|NOT COMPLETED|Overall Study||9
6690025|NCT02721966|7620062|FG003|NOT COMPLETED|Overall Study||7
6690026|NCT02721966|7620063|FG004|NOT COMPLETED|Overall Study||5
6690027|NCT02722044|7620071|FG000|STARTED|Overall Study||33
6690028|NCT02722044|7620071|FG000|COMPLETED|Overall Study||28
6690029|NCT02722044|7620071|FG000|NOT COMPLETED|Overall Study||5
6690030|NCT02722148|7620076|FG000|STARTED|Overall Study||24
6690031|NCT02722148|7620076|FG000|COMPLETED|Overall Study||19
6690032|NCT02722148|7620076|FG000|NOT COMPLETED|Overall Study||5
6690033|NCT02722239|7620082|FG000|STARTED|Overall Study||20
6690034|NCT02722239|7620083|FG001|STARTED|Overall Study||20
6690035|NCT02722239|7620082|FG000|First Intervention (1 Day)|Overall Study||20
6690036|NCT02722239|7620083|FG001|First Intervention (1 Day)|Overall Study||20
6690037|NCT02722239|7620082|FG000|Washout (7 Days)|Overall Study||20
6690038|NCT02722239|7620083|FG001|Washout (7 Days)|Overall Study||20
6690039|NCT02722239|7620082|FG000|Second Intervention (1 Day)|Overall Study||20
6690040|NCT02722239|7620083|FG001|Second Intervention (1 Day)|Overall Study||20
6690041|NCT02722239|7620082|FG000|COMPLETED|Overall Study||20
6690042|NCT02722239|7620083|FG001|COMPLETED|Overall Study||20
6690043|NCT02722239|7620082|FG000|NOT COMPLETED|Overall Study||0
6690044|NCT02722239|7620083|FG001|NOT COMPLETED|Overall Study||0
6690045|NCT02722278|7620092|FG000|STARTED|Overall Study||166
6690046|NCT02722278|7620093|FG001|STARTED|Overall Study||56
6690047|NCT02722278|7620092|FG000|COMPLETED|Overall Study||154
6690048|NCT02722278|7620093|FG001|COMPLETED|Overall Study||49
6690049|NCT02722278|7620092|FG000|NOT COMPLETED|Overall Study||12
6690050|NCT02722278|7620093|FG001|NOT COMPLETED|Overall Study||7
6690051|NCT02722304|7620106|FG000|STARTED|Overall Study||1
6690052|NCT02722304|7620107|FG001|STARTED|Overall Study||0
6690053|NCT02722304|7620108|FG002|STARTED|Overall Study||2
6690054|NCT02722304|7620109|FG003|STARTED|Overall Study||2
6690055|NCT02722304|7620110|FG004|STARTED|Overall Study||2
6690056|NCT02722304|7620106|FG000|Treated|Overall Study||1
6690057|NCT02722304|7620107|FG001|Treated|Overall Study||0
6690058|NCT02722304|7620108|FG002|Treated|Overall Study||1
6690059|NCT02722304|7620109|FG003|Treated|Overall Study||1
6690060|NCT02722304|7620110|FG004|Treated|Overall Study||2
6690061|NCT02722304|7620106|FG000|COMPLETED|Overall Study||0
6690062|NCT02722304|7620107|FG001|COMPLETED|Overall Study||0
6690063|NCT02722304|7620108|FG002|COMPLETED|Overall Study||0
6690064|NCT02722304|7620109|FG003|COMPLETED|Overall Study||0
6690065|NCT02722304|7620110|FG004|COMPLETED|Overall Study||0
6690066|NCT02722304|7620106|FG000|NOT COMPLETED|Overall Study||1
6690067|NCT02722304|7620107|FG001|NOT COMPLETED|Overall Study||0
6690068|NCT02722304|7620108|FG002|NOT COMPLETED|Overall Study||2
6690069|NCT02722304|7620109|FG003|NOT COMPLETED|Overall Study||2
6690070|NCT02722304|7620110|FG004|NOT COMPLETED|Overall Study||2
6690071|NCT02722330|7620124|FG000|STARTED|Overall Study||23
6690072|NCT02722330|7620124|FG000|COMPLETED|Overall Study||23
6690073|NCT02722330|7620124|FG000|NOT COMPLETED|Overall Study||0
6690074|NCT02722408|7620128|FG000|STARTED|Overall Study||8
6690075|NCT02722408|7620128|FG000|COMPLETED|Overall Study||8
6690076|NCT02722408|7620128|FG000|NOT COMPLETED|Overall Study||0
6690077|NCT02722499|7620137|FG000|STARTED|Overall Study||20
6690078|NCT02722499|7620138|FG001|STARTED|Overall Study||20
6690079|NCT02722499|7620139|FG002|STARTED|Overall Study||20
6690080|NCT02722499|7620137|FG000|COMPLETED|Overall Study||18
6690081|NCT02722499|7620138|FG001|COMPLETED|Overall Study||20
6690082|NCT02722499|7620139|FG002|COMPLETED|Overall Study||19
6690083|NCT02722499|7620137|FG000|NOT COMPLETED|Overall Study||2
6690084|NCT02722499|7620138|FG001|NOT COMPLETED|Overall Study||0
6690085|NCT02722499|7620139|FG002|NOT COMPLETED|Overall Study||1
6690086|NCT02722564|7620147|FG000|STARTED|Overall Study||55
6690087|NCT02722564|7620147|FG000|COMPLETED|Overall Study||55
6690088|NCT02722564|7620147|FG000|NOT COMPLETED|Overall Study||0
6690089|NCT02722577|7620151|FG000|STARTED|Overall Study||20
6690090|NCT02722577|7620151|FG000|COMPLETED|Overall Study||20
6690091|NCT02722577|7620151|FG000|NOT COMPLETED|Overall Study||0
6690092|NCT02722837|7620155|FG000|STARTED|Overall Study||119
6690093|NCT02722837|7620155|FG000|COMPLETED|Overall Study||119
6690094|NCT02722837|7620155|FG000|NOT COMPLETED|Overall Study||0
6690095|NCT02722863|7620159|FG000|STARTED|Overall Study||908
6690096|NCT02722863|7620159|FG000|COMPLETED|Overall Study||908
6690097|NCT02722863|7620159|FG000|NOT COMPLETED|Overall Study||0
6690098|NCT02722928|7620166|FG000|STARTED|Overall Study||49
6690099|NCT02722928|7620167|FG001|STARTED|Overall Study||51
6690100|NCT02722928|7620166|FG000|COMPLETED|Overall Study||39
6690101|NCT02722928|7620167|FG001|COMPLETED|Overall Study||31
6690102|NCT02722928|7620166|FG000|NOT COMPLETED|Overall Study||10
6690103|NCT02722928|7620167|FG001|NOT COMPLETED|Overall Study||20
6690104|NCT02722967|7620180|FG000|STARTED|Overall Study||22
6690105|NCT02722967|7620181|FG001|STARTED|Overall Study||12
6690106|NCT02722967|7620182|FG002|STARTED|Overall Study||15
6690107|NCT02722967|7620180|FG000|COMPLETED|Overall Study||17
6690108|NCT02722967|7620181|FG001|COMPLETED|Overall Study||10
6690109|NCT02722967|7620182|FG002|COMPLETED|Overall Study||11
6690110|NCT02722967|7620180|FG000|NOT COMPLETED|Overall Study||5
6690111|NCT02722967|7620181|FG001|NOT COMPLETED|Overall Study||2
6690112|NCT02722967|7620182|FG002|NOT COMPLETED|Overall Study||4
6690113|NCT02723006|7620193|FG000|STARTED|Overall Study||1
6690114|NCT02723006|7620194|FG001|STARTED|Overall Study||9
6690115|NCT02723006|7620195|FG002|STARTED|Overall Study||12
6690116|NCT02723006|7620193|FG000|COMPLETED|Overall Study||0
6690117|NCT02723006|7620194|FG001|COMPLETED|Overall Study||2
6690118|NCT02723006|7620195|FG002|COMPLETED|Overall Study||5
6690119|NCT02723006|7620193|FG000|NOT COMPLETED|Overall Study||1
6690120|NCT02723006|7620194|FG001|NOT COMPLETED|Overall Study||7
6690121|NCT02723006|7620195|FG002|NOT COMPLETED|Overall Study||7
6690122|NCT02723084|7620205|FG000|STARTED|Overall Study||90
6690123|NCT02723084|7620206|FG001|STARTED|Overall Study||46
6690124|NCT02723084|7620205|FG000|COMPLETED|Overall Study||86
6690125|NCT02723084|7620206|FG001|COMPLETED|Overall Study||45
6690126|NCT02723084|7620205|FG000|NOT COMPLETED|Overall Study||4
6690127|NCT02723084|7620206|FG001|NOT COMPLETED|Overall Study||1
6690128|NCT02723175|7620214|FG000|STARTED|Overall Study||8
6690129|NCT02723175|7620215|FG001|STARTED|Overall Study||7
6690130|NCT02723175|7620214|FG000|COMPLETED|Overall Study||4
6690131|NCT02723175|7620215|FG001|COMPLETED|Overall Study||4
6690132|NCT02723175|7620214|FG000|NOT COMPLETED|Overall Study||4
6690133|NCT02723175|7620215|FG001|NOT COMPLETED|Overall Study||3
6690134|NCT02723188|7620224|FG000|STARTED|Overall Study||15
6690135|NCT02723188|7620225|FG001|STARTED|Overall Study||15
6690136|NCT02723188|7620226|FG002|STARTED|Overall Study||15
6690137|NCT02723188|7620224|FG000|COMPLETED|Overall Study||14
6690138|NCT02723188|7620225|FG001|COMPLETED|Overall Study||15
6690139|NCT02723188|7620226|FG002|COMPLETED|Overall Study||15
6690140|NCT02723188|7620224|FG000|NOT COMPLETED|Overall Study||1
6690141|NCT02723188|7620225|FG001|NOT COMPLETED|Overall Study||0
6690142|NCT02723188|7620226|FG002|NOT COMPLETED|Overall Study||0
6690143|NCT02723201|7620237|FG000|STARTED|First Intervention Period||11
6690144|NCT02723201|7620238|FG001|STARTED|First Intervention Period||7
6690145|NCT02723201|7620239|FG002|STARTED|First Intervention Period||7
6690146|NCT02723201|7620237|FG000|COMPLETED|First Intervention Period||11
6690147|NCT02723201|7620238|FG001|COMPLETED|First Intervention Period||7
6690148|NCT02723201|7620239|FG002|COMPLETED|First Intervention Period||7
6690149|NCT02723201|7620237|FG000|NOT COMPLETED|First Intervention Period||0
6690150|NCT02723201|7620238|FG001|NOT COMPLETED|First Intervention Period||0
6690151|NCT02723201|7620239|FG002|NOT COMPLETED|First Intervention Period||0
6690152|NCT02723201|7620237|FG000|STARTED|Washout Period 1||11
6690153|NCT02723201|7620238|FG001|STARTED|Washout Period 1||7
6690154|NCT02723201|7620239|FG002|STARTED|Washout Period 1||7
6690155|NCT02723201|7620237|FG000|COMPLETED|Washout Period 1||11
6690156|NCT02723201|7620238|FG001|COMPLETED|Washout Period 1||7
6690157|NCT02723201|7620239|FG002|COMPLETED|Washout Period 1||7
6690158|NCT02723201|7620237|FG000|NOT COMPLETED|Washout Period 1||0
6690159|NCT02723201|7620238|FG001|NOT COMPLETED|Washout Period 1||0
6690160|NCT02723201|7620239|FG002|NOT COMPLETED|Washout Period 1||0
6690161|NCT02723201|7620237|FG000|STARTED|Second Intervention Period||11
6690162|NCT02723201|7620238|FG001|STARTED|Second Intervention Period||7
6690163|NCT02723201|7620239|FG002|STARTED|Second Intervention Period||7
6690164|NCT02723201|7620237|FG000|COMPLETED|Second Intervention Period||9
6690165|NCT02723201|7620238|FG001|COMPLETED|Second Intervention Period||7
6690166|NCT02723201|7620239|FG002|COMPLETED|Second Intervention Period||7
6690167|NCT02723201|7620237|FG000|NOT COMPLETED|Second Intervention Period||2
6690168|NCT02723201|7620238|FG001|NOT COMPLETED|Second Intervention Period||0
6690169|NCT02723201|7620239|FG002|NOT COMPLETED|Second Intervention Period||0
6690170|NCT02723201|7620237|FG000|STARTED|Washout Period 2||9
6258073|NCT03889028|7157375|FG000|STARTED|Overall Study||144
6258074|NCT03889028|7157376|FG001|STARTED|Overall Study||422
6258075|NCT03889028|7157377|FG002|STARTED|Overall Study||312
6258076|NCT03889028|7157375|FG000|COMPLETED|Overall Study||144
6258077|NCT03889028|7157376|FG001|COMPLETED|Overall Study||422
6258078|NCT03889028|7157377|FG002|COMPLETED|Overall Study||312
6258079|NCT03889028|7157375|FG000|NOT COMPLETED|Overall Study||0
6258080|NCT03889028|7157376|FG001|NOT COMPLETED|Overall Study||0
6258081|NCT03889028|7157377|FG002|NOT COMPLETED|Overall Study||0
6258082|NCT03842683|7157384|FG000|STARTED|Overall Study||472
6258083|NCT03842683|7157384|FG000|COMPLETED|Overall Study||472
6690171|NCT02723201|7620238|FG001|STARTED|Washout Period 2||0
6690172|NCT02723201|7620239|FG002|STARTED|Washout Period 2||0
6690173|NCT02723201|7620237|FG000|COMPLETED|Washout Period 2||9
6690174|NCT02723201|7620238|FG001|COMPLETED|Washout Period 2||0
6690175|NCT02723201|7620239|FG002|COMPLETED|Washout Period 2||0
6690176|NCT02723201|7620237|FG000|NOT COMPLETED|Washout Period 2||0
6690177|NCT02723201|7620238|FG001|NOT COMPLETED|Washout Period 2||0
6690178|NCT02723201|7620239|FG002|NOT COMPLETED|Washout Period 2||0
6690179|NCT02723201|7620237|FG000|STARTED|Third Intervention Period||9
6690180|NCT02723201|7620238|FG001|STARTED|Third Intervention Period||0
6258084|NCT03842683|7157384|FG000|NOT COMPLETED|Overall Study||0
6258085|NCT03839511|7157389|FG000|STARTED|Overall Study||4
6258086|NCT03839511|7157389|FG000|COMPLETED|Overall Study||4
6258087|NCT03839511|7157389|FG000|NOT COMPLETED|Overall Study||0
6279946|NCT00149890|7179834|FG000|NOT COMPLETED|Overall Study||13
6279947|NCT00149890|7179835|FG001|NOT COMPLETED|Overall Study||18
6279948|NCT00149994|7179843|FG000|STARTED|Overall Study|"Started indicates Safety population."|85
6279949|NCT00149994|7179844|FG001|STARTED|Overall Study||86
6690181|NCT02723201|7620239|FG002|STARTED|Third Intervention Period||0
6690182|NCT02723201|7620237|FG000|COMPLETED|Third Intervention Period||9
6690183|NCT02723201|7620238|FG001|COMPLETED|Third Intervention Period||0
6690184|NCT02723201|7620239|FG002|COMPLETED|Third Intervention Period||0
6690185|NCT02723201|7620237|FG000|NOT COMPLETED|Third Intervention Period||0
6690186|NCT02723201|7620238|FG001|NOT COMPLETED|Third Intervention Period||0
6690187|NCT02723201|7620239|FG002|NOT COMPLETED|Third Intervention Period||0
6690188|NCT02723201|7620237|FG000|STARTED|Washout Period 3||9
6690189|NCT02723201|7620238|FG001|STARTED|Washout Period 3||0
6690190|NCT02723201|7620239|FG002|STARTED|Washout Period 3||0
6690191|NCT02723201|7620237|FG000|COMPLETED|Washout Period 3||9
6690192|NCT02723201|7620238|FG001|COMPLETED|Washout Period 3||0
6690193|NCT02723201|7620239|FG002|COMPLETED|Washout Period 3||0
6690194|NCT02723201|7620237|FG000|NOT COMPLETED|Washout Period 3||0
6690195|NCT02723201|7620238|FG001|NOT COMPLETED|Washout Period 3||0
6690196|NCT02723201|7620239|FG002|NOT COMPLETED|Washout Period 3||0
6690197|NCT02723201|7620237|FG000|STARTED|Fourth Intervention Period||9
6690198|NCT02723201|7620238|FG001|STARTED|Fourth Intervention Period||0
6690199|NCT02723201|7620239|FG002|STARTED|Fourth Intervention Period||0
6690200|NCT02723201|7620237|FG000|COMPLETED|Fourth Intervention Period||9
6690201|NCT02723201|7620238|FG001|COMPLETED|Fourth Intervention Period||0
6690202|NCT02723201|7620239|FG002|COMPLETED|Fourth Intervention Period||0
6690203|NCT02723201|7620237|FG000|NOT COMPLETED|Fourth Intervention Period||0
6690204|NCT02723201|7620238|FG001|NOT COMPLETED|Fourth Intervention Period||0
6690205|NCT02723201|7620239|FG002|NOT COMPLETED|Fourth Intervention Period||0
6690206|NCT02723344|7620255|FG000|STARTED|Overall Study||15
6690207|NCT02723344|7620256|FG001|STARTED|Overall Study||16
6690208|NCT02723344|7620255|FG000|COMPLETED|Overall Study||15
6690209|NCT02723344|7620256|FG001|COMPLETED|Overall Study||12
6690210|NCT02723344|7620255|FG000|NOT COMPLETED|Overall Study||0
6690211|NCT02723344|7620256|FG001|NOT COMPLETED|Overall Study||4
6690212|NCT02723591|7620264|FG000|STARTED|Overall Study||300
6690213|NCT02723591|7620265|FG001|STARTED|Overall Study||299
6690214|NCT02723591|7620264|FG000|COMPLETED|Overall Study||204
6690215|NCT02723591|7620265|FG001|COMPLETED|Overall Study||198
6690216|NCT02723591|7620264|FG000|NOT COMPLETED|Overall Study||96
6690217|NCT02723591|7620265|FG001|NOT COMPLETED|Overall Study||101
6690218|NCT02723630|7620277|FG000|STARTED|Intervention Period 1||10
6690219|NCT02723630|7620278|FG001|STARTED|Intervention Period 1||10
6690220|NCT02723630|7620279|FG002|STARTED|Intervention Period 1||10
6690221|NCT02723630|7620280|FG003|STARTED|Intervention Period 1||10
6690222|NCT02723630|7620281|FG004|STARTED|Intervention Period 1||10
6690223|NCT02723630|7620282|FG005|STARTED|Intervention Period 1||10
6690224|NCT02723630|7620277|FG000|COMPLETED|Intervention Period 1||9
6690225|NCT02723630|7620278|FG001|COMPLETED|Intervention Period 1||10
6690226|NCT02723630|7620279|FG002|COMPLETED|Intervention Period 1||10
6690227|NCT02723630|7620280|FG003|COMPLETED|Intervention Period 1||10
6690228|NCT02723630|7620281|FG004|COMPLETED|Intervention Period 1||10
6690229|NCT02723630|7620282|FG005|COMPLETED|Intervention Period 1||10
6690230|NCT02723630|7620277|FG000|NOT COMPLETED|Intervention Period 1||1
6690231|NCT02723630|7620278|FG001|NOT COMPLETED|Intervention Period 1||0
6690232|NCT02723630|7620279|FG002|NOT COMPLETED|Intervention Period 1||0
6690233|NCT02723630|7620280|FG003|NOT COMPLETED|Intervention Period 1||0
6690234|NCT02723630|7620281|FG004|NOT COMPLETED|Intervention Period 1||0
6690235|NCT02723630|7620282|FG005|NOT COMPLETED|Intervention Period 1||0
6690236|NCT02723630|7620277|FG000|STARTED|Intervention Period 2||9
6690237|NCT02723630|7620278|FG001|STARTED|Intervention Period 2||10
6690238|NCT02723630|7620279|FG002|STARTED|Intervention Period 2||10
6690239|NCT02723630|7620280|FG003|STARTED|Intervention Period 2||10
6690240|NCT02723630|7620281|FG004|STARTED|Intervention Period 2||10
6690241|NCT02723630|7620282|FG005|STARTED|Intervention Period 2||10
6690242|NCT02723630|7620277|FG000|COMPLETED|Intervention Period 2||9
6690243|NCT02723630|7620278|FG001|COMPLETED|Intervention Period 2||10
6690244|NCT02723630|7620279|FG002|COMPLETED|Intervention Period 2||10
6690245|NCT02723630|7620280|FG003|COMPLETED|Intervention Period 2||10
6690246|NCT02723630|7620281|FG004|COMPLETED|Intervention Period 2||10
6690247|NCT02723630|7620282|FG005|COMPLETED|Intervention Period 2||10
6690248|NCT02723630|7620277|FG000|NOT COMPLETED|Intervention Period 2||0
6690249|NCT02723630|7620278|FG001|NOT COMPLETED|Intervention Period 2||0
6690250|NCT02723630|7620279|FG002|NOT COMPLETED|Intervention Period 2||0
6281040|NCT00161382|7180911|FG001|NOT COMPLETED|Overall Study||289
6690251|NCT02723630|7620280|FG003|NOT COMPLETED|Intervention Period 2||0
6690252|NCT02723630|7620281|FG004|NOT COMPLETED|Intervention Period 2||0
6690253|NCT02723630|7620282|FG005|NOT COMPLETED|Intervention Period 2||0
6690254|NCT02723630|7620277|FG000|STARTED|Intervention Period 3||9
6690255|NCT02723630|7620278|FG001|STARTED|Intervention Period 3||10
6690256|NCT02723630|7620279|FG002|STARTED|Intervention Period 3||10
6690257|NCT02723630|7620280|FG003|STARTED|Intervention Period 3||10
6690258|NCT02723630|7620281|FG004|STARTED|Intervention Period 3||10
6690259|NCT02723630|7620282|FG005|STARTED|Intervention Period 3||10
6690260|NCT02723630|7620277|FG000|COMPLETED|Intervention Period 3||9
6690261|NCT02723630|7620278|FG001|COMPLETED|Intervention Period 3||9
6690262|NCT02723630|7620279|FG002|COMPLETED|Intervention Period 3||10
6690263|NCT02723630|7620280|FG003|COMPLETED|Intervention Period 3||10
6690264|NCT02723630|7620281|FG004|COMPLETED|Intervention Period 3||10
6690265|NCT02723630|7620282|FG005|COMPLETED|Intervention Period 3||10
6690266|NCT02723630|7620277|FG000|NOT COMPLETED|Intervention Period 3||0
6690267|NCT02723630|7620278|FG001|NOT COMPLETED|Intervention Period 3||1
6690268|NCT02723630|7620279|FG002|NOT COMPLETED|Intervention Period 3||0
6690269|NCT02723630|7620280|FG003|NOT COMPLETED|Intervention Period 3||0
6690270|NCT02723630|7620281|FG004|NOT COMPLETED|Intervention Period 3||0
6690271|NCT02723630|7620282|FG005|NOT COMPLETED|Intervention Period 3||0
6690272|NCT02723786|7620295|FG000|STARTED|Overall Study||7
6690273|NCT02723786|7620295|FG000|COMPLETED|Overall Study||6
6690274|NCT02723786|7620295|FG000|NOT COMPLETED|Overall Study||1
6690275|NCT02723916|7620301|FG000|STARTED|Overall Study||144
6690276|NCT02723916|7620302|FG001|STARTED|Overall Study||143
6690277|NCT02723916|7620301|FG000|COMPLETED|Overall Study||135
6690278|NCT02723916|7620302|FG001|COMPLETED|Overall Study||137
6690279|NCT02723916|7620301|FG000|NOT COMPLETED|Overall Study||9
6690280|NCT02723916|7620302|FG001|NOT COMPLETED|Overall Study||6
6690281|NCT02723929|7620310|FG000|STARTED|Overall Study||30
6690282|NCT02723929|7620311|FG001|STARTED|Overall Study||34
6690283|NCT02723929|7620310|FG000|COMPLETED|Overall Study||24
6690284|NCT02723929|7620311|FG001|COMPLETED|Overall Study||24
6690285|NCT02723929|7620310|FG000|NOT COMPLETED|Overall Study||6
6690286|NCT02723929|7620311|FG001|NOT COMPLETED|Overall Study||10
6690287|NCT02724020|7620322|FG000|STARTED|Overall Study||32
6690288|NCT02724020|7620323|FG001|STARTED|Overall Study||32
6690289|NCT02724020|7620324|FG002|STARTED|Overall Study||32
6690290|NCT02724020|7620322|FG000|Treated (Safety Analysis Set)|Overall Study||32
6690291|NCT02724020|7620323|FG001|Treated (Safety Analysis Set)|Overall Study||32
6690292|NCT02724020|7620324|FG002|Treated (Safety Analysis Set)|Overall Study||31
6690293|NCT02724020|7620322|FG000|COMPLETED|Overall Study||0
6690294|NCT02724020|7620323|FG001|COMPLETED|Overall Study||0
6690295|NCT02724020|7620324|FG002|COMPLETED|Overall Study||0
6690296|NCT02724020|7620322|FG000|NOT COMPLETED|Overall Study||32
6690297|NCT02724020|7620323|FG001|NOT COMPLETED|Overall Study||32
6690298|NCT02724020|7620324|FG002|NOT COMPLETED|Overall Study||32
6690299|NCT02724033|7620335|FG000|STARTED|Overall Study||11
6690300|NCT02724033|7620336|FG001|STARTED|Overall Study||14
6690301|NCT02724033|7620337|FG002|STARTED|Overall Study||12
6690302|NCT02724033|7620335|FG000|COMPLETED|Overall Study||11
6690303|NCT02724033|7620336|FG001|COMPLETED|Overall Study||14
6690304|NCT02724033|7620337|FG002|COMPLETED|Overall Study||12
6690305|NCT02724033|7620335|FG000|NOT COMPLETED|Overall Study||0
6690306|NCT02724033|7620336|FG001|NOT COMPLETED|Overall Study||0
6690307|NCT02724033|7620337|FG002|NOT COMPLETED|Overall Study||0
6690308|NCT02724111|7620347|FG000|STARTED|Overall Study||45
6690309|NCT02724111|7620348|FG001|STARTED|Overall Study||45
6690310|NCT02724111|7620347|FG000|COMPLETED|Overall Study||43
6690311|NCT02724111|7620348|FG001|COMPLETED|Overall Study||40
6690312|NCT02724111|7620347|FG000|NOT COMPLETED|Overall Study||2
6690313|NCT02724111|7620348|FG001|NOT COMPLETED|Overall Study||5
6690314|NCT02724423|7620354|FG000|STARTED|Overall Study||57
6690315|NCT02724423|7620354|FG000|COMPLETED|Overall Study||54
6690316|NCT02724423|7620354|FG000|NOT COMPLETED|Overall Study||3
6690317|NCT02724449|7620359|FG000|STARTED|Overall Study||16
6690318|NCT02724449|7620359|FG000|COMPLETED|Overall Study||16
6690319|NCT02724449|7620359|FG000|NOT COMPLETED|Overall Study||0
6690320|NCT02724462|7620365|FG000|STARTED|3 Month Follow-up Survey||1254
6690321|NCT02724462|7620366|FG001|STARTED|3 Month Follow-up Survey||1249
6690322|NCT02724462|7620365|FG000|COMPLETED|3 Month Follow-up Survey||1043
6690323|NCT02724462|7620366|FG001|COMPLETED|3 Month Follow-up Survey||1050
6690324|NCT02724462|7620365|FG000|NOT COMPLETED|3 Month Follow-up Survey||211
6690325|NCT02724462|7620366|FG001|NOT COMPLETED|3 Month Follow-up Survey||199
6690326|NCT02724462|7620365|FG000|STARTED|6 Month Follow-up Survey||1254
6690327|NCT02724462|7620366|FG001|STARTED|6 Month Follow-up Survey||1249
6690328|NCT02724462|7620365|FG000|COMPLETED|6 Month Follow-up Survey||1058
6690329|NCT02724462|7620366|FG001|COMPLETED|6 Month Follow-up Survey||1078
6690330|NCT02724462|7620365|FG000|NOT COMPLETED|6 Month Follow-up Survey||196
6690331|NCT02724462|7620366|FG001|NOT COMPLETED|6 Month Follow-up Survey||171
6690332|NCT02724462|7620365|FG000|STARTED|12 Month Follow-up Survey||1254
6690333|NCT02724462|7620366|FG001|STARTED|12 Month Follow-up Survey||1249
6690334|NCT02724462|7620365|FG000|COMPLETED|12 Month Follow-up Survey||1040
6690335|NCT02724462|7620366|FG001|COMPLETED|12 Month Follow-up Survey||1067
6690336|NCT02724462|7620365|FG000|NOT COMPLETED|12 Month Follow-up Survey||214
6690337|NCT02724462|7620366|FG001|NOT COMPLETED|12 Month Follow-up Survey||182
6690338|NCT02724592|7620374|FG000|STARTED|Overall Study||35
6690339|NCT02724592|7620375|FG001|STARTED|Overall Study||35
6690340|NCT02724592|7620374|FG000|COMPLETED|Overall Study||31
6690341|NCT02724592|7620375|FG001|COMPLETED|Overall Study||34
6690342|NCT02724592|7620374|FG000|NOT COMPLETED|Overall Study||4
6690343|NCT02724592|7620375|FG001|NOT COMPLETED|Overall Study||1
6690344|NCT02724644|7620383|FG000|STARTED|Overall Study||189
6690345|NCT02724644|7620384|FG001|STARTED|Overall Study||186
6690346|NCT02724644|7620383|FG000|COMPLETED|Overall Study||168
6690347|NCT02724644|7620384|FG001|COMPLETED|Overall Study||182
6690348|NCT02724644|7620383|FG000|NOT COMPLETED|Overall Study||21
6690349|NCT02724644|7620384|FG001|NOT COMPLETED|Overall Study||4
6690350|NCT02724787|7620390|FG000|STARTED|Overall Study||24
6690351|NCT02724787|7620390|FG000|COMPLETED|Overall Study|22 completed treatment. 20 participants returned for post-treatment assessment.|22
6690352|NCT02724787|7620390|FG000|NOT COMPLETED|Overall Study||2
6690353|NCT02724800|7620396|FG000|STARTED|Overall Study||32
6690354|NCT02724800|7620397|FG001|STARTED|Overall Study||31
6690355|NCT02724800|7620396|FG000|COMPLETED|Overall Study||15
6690356|NCT02724800|7620397|FG001|COMPLETED|Overall Study||22
6690357|NCT02724800|7620396|FG000|NOT COMPLETED|Overall Study||17
6690358|NCT02724800|7620397|FG001|NOT COMPLETED|Overall Study||9
6690359|NCT02724839|7620406|FG000|STARTED|Overall Study||13
6690360|NCT02724839|7620407|FG001|STARTED|Overall Study||12
6690361|NCT02724839|7620408|FG002|STARTED|Overall Study||11
6690362|NCT02724839|7620406|FG000|COMPLETED|Overall Study||12
6690363|NCT02724839|7620407|FG001|COMPLETED|Overall Study||8
6690364|NCT02724839|7620408|FG002|COMPLETED|Overall Study||6
6690365|NCT02724839|7620406|FG000|NOT COMPLETED|Overall Study||1
6690366|NCT02724839|7620407|FG001|NOT COMPLETED|Overall Study||4
6690367|NCT02724839|7620408|FG002|NOT COMPLETED|Overall Study||5
6690368|NCT02724956|7620425|FG000|STARTED|Overall Study||27
6690369|NCT02724956|7620426|FG001|STARTED|Overall Study||26
6690370|NCT02724956|7620425|FG000|COMPLETED|Overall Study||26
6690371|NCT02724956|7620426|FG001|COMPLETED|Overall Study||24
6690372|NCT02724956|7620425|FG000|NOT COMPLETED|Overall Study||1
6690373|NCT02724956|7620426|FG001|NOT COMPLETED|Overall Study||2
6690374|NCT02725008|7620434|FG000|STARTED|Overall Study||46
6690375|NCT02725008|7620435|FG001|STARTED|Overall Study||51
6690376|NCT02725008|7620434|FG000|COMPLETED|Overall Study||37
6690377|NCT02725008|7620435|FG001|COMPLETED|Overall Study||39
6690378|NCT02725008|7620434|FG000|NOT COMPLETED|Overall Study||9
6690379|NCT02725008|7620435|FG001|NOT COMPLETED|Overall Study||12
6690380|NCT02725268|7620445|FG000|STARTED|Overall Study||90
6690381|NCT02725268|7620446|FG001|STARTED|Overall Study||90
6690382|NCT02725268|7620447|FG002|STARTED|Overall Study||41
6690383|NCT02725268|7620448|FG003|STARTED|Overall Study||20
6690384|NCT02725268|7620445|FG000|Started|Overall Study||90
6690385|NCT02725268|7620446|FG001|Started|Overall Study||90
6690386|NCT02725268|7620447|FG002|Started|Overall Study||41
6690387|NCT02725268|7620448|FG003|Started|Overall Study||20
6690388|NCT02725268|7620445|FG000|Completed|Overall Study||18
6690389|NCT02725268|7620446|FG001|Completed|Overall Study||20
6690390|NCT02725268|7620447|FG002|Completed|Overall Study||3
6690391|NCT02725268|7620448|FG003|Completed|Overall Study||2
6690392|NCT02725268|7620445|FG000|COMPLETED|Overall Study||18
6690393|NCT02725268|7620446|FG001|COMPLETED|Overall Study||20
6690394|NCT02725268|7620447|FG002|COMPLETED|Overall Study||3
6690395|NCT02725268|7620448|FG003|COMPLETED|Overall Study||2
6690396|NCT02725268|7620445|FG000|NOT COMPLETED|Overall Study||72
6690397|NCT02725268|7620446|FG001|NOT COMPLETED|Overall Study||70
6690398|NCT02725268|7620447|FG002|NOT COMPLETED|Overall Study||38
6690399|NCT02725268|7620448|FG003|NOT COMPLETED|Overall Study||18
6690400|NCT02725411|7620461|FG000|STARTED|Treatment Period (56 Weeks)||92
6690401|NCT02725411|7620462|FG001|STARTED|Treatment Period (56 Weeks)||93
6690402|NCT02725411|7620463|FG002|STARTED|Treatment Period (56 Weeks)||92
6690403|NCT02725411|7620461|FG000|Treated|Treatment Period (56 Weeks)||92
6690404|NCT02725411|7620462|FG001|Treated|Treatment Period (56 Weeks)||93
6690405|NCT02725411|7620463|FG002|Treated|Treatment Period (56 Weeks)||92
6690406|NCT02725411|7620461|FG000|COMPLETED|Treatment Period (56 Weeks)||62
6690407|NCT02725411|7620462|FG001|COMPLETED|Treatment Period (56 Weeks)||43
6690408|NCT02725411|7620463|FG002|COMPLETED|Treatment Period (56 Weeks)||43
6690409|NCT02725411|7620461|FG000|NOT COMPLETED|Treatment Period (56 Weeks)||30
6690410|NCT02725411|7620462|FG001|NOT COMPLETED|Treatment Period (56 Weeks)||50
6690411|NCT02725411|7620463|FG002|NOT COMPLETED|Treatment Period (56 Weeks)||49
6690412|NCT02725411|7620461|FG000|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
6690413|NCT02725411|7620462|FG001|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|93
6690414|NCT02725411|7620463|FG002|STARTED|Follow-up Period (24 Weeks)|All participants on either completion or discontinuation of treatment, entered follow up period.|92
6690415|NCT02725411|7620461|FG000|COMPLETED|Follow-up Period (24 Weeks)||88
6690416|NCT02725411|7620462|FG001|COMPLETED|Follow-up Period (24 Weeks)||82
6690417|NCT02725411|7620463|FG002|COMPLETED|Follow-up Period (24 Weeks)||87
6690418|NCT02725411|7620461|FG000|NOT COMPLETED|Follow-up Period (24 Weeks)||4
6690419|NCT02725411|7620462|FG001|NOT COMPLETED|Follow-up Period (24 Weeks)||11
6690420|NCT02725411|7620463|FG002|NOT COMPLETED|Follow-up Period (24 Weeks)||5
6690421|NCT02725476|7620473|FG000|STARTED|Overall Study||15
6690422|NCT02725476|7620474|FG001|STARTED|Overall Study||5
6690423|NCT02725476|7620473|FG000|COMPLETED|Overall Study||12
6690424|NCT02725476|7620474|FG001|COMPLETED|Overall Study||4
6690425|NCT02725476|7620473|FG000|NOT COMPLETED|Overall Study||3
6690426|NCT02725476|7620474|FG001|NOT COMPLETED|Overall Study||1
6690427|NCT02725515|7620482|FG000|STARTED|Overall Study||53
6690428|NCT02725515|7620483|FG001|STARTED|Overall Study||52
6690429|NCT02725515|7620482|FG000|COMPLETED|Overall Study||28
6690430|NCT02725515|7620483|FG001|COMPLETED|Overall Study||17
6690431|NCT02725515|7620482|FG000|NOT COMPLETED|Overall Study||25
6690432|NCT02725515|7620483|FG001|NOT COMPLETED|Overall Study||35
6690433|NCT02725645|7620489|FG000|STARTED|Overall Study||14
6690434|NCT02725645|7620489|FG000|COMPLETED|Overall Study||14
6690435|NCT02725645|7620489|FG000|NOT COMPLETED|Overall Study||0
6690436|NCT02725710|7620495|FG000|STARTED|Overall Study||48
6690437|NCT02725710|7620496|FG001|STARTED|Overall Study||47
6690438|NCT02725710|7620495|FG000|COMPLETED|Overall Study||47
6690439|NCT02725710|7620496|FG001|COMPLETED|Overall Study||47
6690440|NCT02725710|7620495|FG000|NOT COMPLETED|Overall Study||1
6690441|NCT02725710|7620496|FG001|NOT COMPLETED|Overall Study||0
6690442|NCT02725788|7620504|FG000|STARTED|Overall Study||123
6690443|NCT02725788|7620505|FG001|STARTED|Overall Study||124
6690444|NCT02725788|7620504|FG000|COMPLETED|Overall Study||122
6690445|NCT02725788|7620505|FG001|COMPLETED|Overall Study||122
6690446|NCT02725788|7620504|FG000|NOT COMPLETED|Overall Study||1
6690447|NCT02725788|7620505|FG001|NOT COMPLETED|Overall Study||2
6690448|NCT02725801|7620513|FG000|STARTED|Overall Study||8
6690449|NCT02725801|7620514|FG001|STARTED|Overall Study||12
6690450|NCT02725801|7620513|FG000|COMPLETED|Overall Study||8
6690451|NCT02725801|7620514|FG001|COMPLETED|Overall Study||12
6690452|NCT02725801|7620513|FG000|NOT COMPLETED|Overall Study||0
6690453|NCT02725801|7620514|FG001|NOT COMPLETED|Overall Study||0
6690454|NCT02725866|7620520|FG000|STARTED|Overall Study||216
6690455|NCT02725866|7620520|FG000|COMPLETED|Overall Study||202
6690456|NCT02725866|7620520|FG000|NOT COMPLETED|Overall Study||14
6690457|NCT02726022|7620524|FG000|STARTED|Overall Study||114
6690458|NCT02726022|7620524|FG000|COMPLETED|Overall Study||78
6690459|NCT02726022|7620524|FG000|NOT COMPLETED|Overall Study||36
6690460|NCT02726074|7620528|FG000|STARTED|Overall Study||106
6690461|NCT02726074|7620528|FG000|Treated|Overall Study||102
6690462|NCT02726074|7620528|FG000|COMPLETED|Overall Study||80
6690463|NCT02726074|7620528|FG000|NOT COMPLETED|Overall Study||26
6738615|NCT03285295|7667832|FG003|STARTED|Alinity s Chagas||615
6738616|NCT03285295|7667833|FG004|STARTED|Alinity s Chagas||0
6738617|NCT03285295|7667829|FG000|COMPLETED|Alinity s Chagas||15804
6738618|NCT03285295|7667830|FG001|COMPLETED|Alinity s Chagas||320
6738619|NCT03285295|7667831|FG002|COMPLETED|Alinity s Chagas||0
6738620|NCT03285295|7667832|FG003|COMPLETED|Alinity s Chagas||615
6738621|NCT03285295|7667833|FG004|COMPLETED|Alinity s Chagas||0
6738622|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s Chagas||219
6738623|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s Chagas||0
6738624|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s Chagas||0
6738625|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s Chagas||0
6738626|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s Chagas||0
6738627|NCT03285295|7667829|FG000|STARTED|Alinity s Chagas Follow-Up||14
6738628|NCT03285295|7667830|FG001|STARTED|Alinity s Chagas Follow-Up||0
6738629|NCT03285295|7667831|FG002|STARTED|Alinity s Chagas Follow-Up||0
6738630|NCT03285295|7667832|FG003|STARTED|Alinity s Chagas Follow-Up||0
6738631|NCT03285295|7667833|FG004|STARTED|Alinity s Chagas Follow-Up||0
6738632|NCT03285295|7667829|FG000|COMPLETED|Alinity s Chagas Follow-Up||1
6738633|NCT03285295|7667830|FG001|COMPLETED|Alinity s Chagas Follow-Up||0
6258088|NCT03835546|7157396|FG000|STARTED|Overall Study||15
6258089|NCT03835546|7157397|FG001|STARTED|Overall Study||15
6258090|NCT03835546|7157398|FG002|STARTED|Overall Study||15
6258091|NCT03835546|7157396|FG000|COMPLETED|Overall Study||12
6258092|NCT03835546|7157397|FG001|COMPLETED|Overall Study||15
6258093|NCT03835546|7157398|FG002|COMPLETED|Overall Study||15
6258094|NCT03835546|7157396|FG000|NOT COMPLETED|Overall Study||3
6258095|NCT03835546|7157397|FG001|NOT COMPLETED|Overall Study||0
6258096|NCT03835546|7157398|FG002|NOT COMPLETED|Overall Study||0
6279950|NCT00149994|7179843|FG000|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
6279951|NCT00149994|7179844|FG001|COMPLETED|Overall Study||85
6279952|NCT00149994|7179843|FG000|NOT COMPLETED|Overall Study||1
6279953|NCT00149994|7179844|FG001|NOT COMPLETED|Overall Study||1
6279954|NCT00150345|7179852|FG000|STARTED|Overall Study||81
6279955|NCT00150345|7179853|FG001|STARTED|Overall Study||66
6279956|NCT00150345|7179852|FG000|COMPLETED|Overall Study||47
6279957|NCT00150345|7179853|FG001|COMPLETED|Overall Study||34
6279958|NCT00150345|7179852|FG000|NOT COMPLETED|Overall Study||34
6279959|NCT00150345|7179853|FG001|NOT COMPLETED|Overall Study||32
6279960|NCT00150462|7179871|FG000|STARTED|Overall Study||3
6279961|NCT00150462|7179872|FG001|STARTED|Overall Study||3
6279962|NCT00150462|7179873|FG002|STARTED|Overall Study||4
6279963|NCT00150462|7179874|FG003|STARTED|Overall Study||3
6279964|NCT00150462|7179875|FG004|STARTED|Overall Study||3
6279965|NCT00150462|7179876|FG005|STARTED|Overall Study||4
6279966|NCT00150462|7179877|FG006|STARTED|Overall Study||3
6279967|NCT00150462|7179878|FG007|STARTED|Overall Study||8
6279968|NCT00150462|7179879|FG008|STARTED|Overall Study||6
6279969|NCT00150462|7179880|FG009|STARTED|Overall Study||7
6279970|NCT00150462|7179881|FG010|STARTED|Overall Study||4
6279971|NCT00150462|7179871|FG000|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6279972|NCT00150462|7179872|FG001|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6279973|NCT00150462|7179873|FG002|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6738634|NCT03285295|7667831|FG002|COMPLETED|Alinity s Chagas Follow-Up||0
6738635|NCT03285295|7667832|FG003|COMPLETED|Alinity s Chagas Follow-Up||0
6738636|NCT03285295|7667833|FG004|COMPLETED|Alinity s Chagas Follow-Up||0
6738637|NCT03285295|7667829|FG000|NOT COMPLETED|Alinity s Chagas Follow-Up||13
6738638|NCT03285295|7667830|FG001|NOT COMPLETED|Alinity s Chagas Follow-Up||0
6738639|NCT03285295|7667831|FG002|NOT COMPLETED|Alinity s Chagas Follow-Up||0
6738640|NCT03285295|7667832|FG003|NOT COMPLETED|Alinity s Chagas Follow-Up||0
6690464|NCT02726113|7620534|FG000|STARTED|Total Enrollment||28
6690465|NCT02726113|7620535|FG001|STARTED|Total Enrollment||22
6690466|NCT02726113|7620534|FG000|COMPLETED|Total Enrollment||24
6690467|NCT02726113|7620535|FG001|COMPLETED|Total Enrollment||19
6690468|NCT02726113|7620534|FG000|NOT COMPLETED|Total Enrollment||4
6690469|NCT02726113|7620535|FG001|NOT COMPLETED|Total Enrollment||3
6690470|NCT02726113|7620534|FG000|STARTED|Genomic Analysis||19
6690471|NCT02726113|7620535|FG001|STARTED|Genomic Analysis||14
6690472|NCT02726113|7620534|FG000|COMPLETED|Genomic Analysis||15
6690473|NCT02726113|7620535|FG001|COMPLETED|Genomic Analysis||12
6690474|NCT02726113|7620534|FG000|NOT COMPLETED|Genomic Analysis||4
6690475|NCT02726113|7620535|FG001|NOT COMPLETED|Genomic Analysis||2
6690476|NCT02726178|7620544|FG000|STARTED|Overall Study||28
6690477|NCT02726178|7620545|FG001|STARTED|Overall Study||28
6690478|NCT02726178|7620544|FG000|COMPLETED|Overall Study||28
6690479|NCT02726178|7620545|FG001|COMPLETED|Overall Study||28
6690480|NCT02726178|7620544|FG000|NOT COMPLETED|Overall Study||0
6690481|NCT02726178|7620545|FG001|NOT COMPLETED|Overall Study||0
6690482|NCT02726451|7620555|FG000|STARTED|Overall Study||10
6690483|NCT02726451|7620556|FG001|STARTED|Overall Study||10
6690484|NCT02726451|7620555|FG000|COMPLETED|Overall Study||10
6690485|NCT02726451|7620556|FG001|COMPLETED|Overall Study||10
6690486|NCT02726451|7620555|FG000|NOT COMPLETED|Overall Study||0
6690487|NCT02726451|7620556|FG001|NOT COMPLETED|Overall Study||0
6690488|NCT02726542|7620564|FG000|STARTED|Overall Study||13
6690489|NCT02726542|7620565|FG001|STARTED|Overall Study||11
6690490|NCT02726542|7620564|FG000|COMPLETED|Overall Study||10
6690491|NCT02726542|7620565|FG001|COMPLETED|Overall Study||10
6690492|NCT02726542|7620564|FG000|NOT COMPLETED|Overall Study||3
6690493|NCT02726542|7620565|FG001|NOT COMPLETED|Overall Study||1
6690494|NCT02726620|7620573|FG000|STARTED|Historic Cohort - Three Years||17463
6690495|NCT02726620|7620574|FG001|STARTED|Historic Cohort - Three Years||0
6690496|NCT02726620|7620573|FG000|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||15624
6690497|NCT02726620|7620574|FG001|MAP < 65 mmHg: Primary Analysis|Historic Cohort - Three Years||0
6690498|NCT02726620|7620573|FG000|COMPLETED|Historic Cohort - Three Years||17463
6690499|NCT02726620|7620574|FG001|COMPLETED|Historic Cohort - Three Years||0
6690500|NCT02726620|7620573|FG000|NOT COMPLETED|Historic Cohort - Three Years||0
6690501|NCT02726620|7620574|FG001|NOT COMPLETED|Historic Cohort - Three Years||0
6690502|NCT02726620|7620573|FG000|STARTED|Month 1: Attending Randomization||0
6690503|NCT02726620|7620574|FG001|STARTED|Month 1: Attending Randomization||485
6690504|NCT02726620|7620573|FG000|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||0
6690505|NCT02726620|7620574|FG001|MAP < 65 mmHg: Primary Analysis|Month 1: Attending Randomization||432
6690506|NCT02726620|7620573|FG000|Correct IOH Notifications|Month 1: Attending Randomization||0
6690507|NCT02726620|7620574|FG001|Correct IOH Notifications|Month 1: Attending Randomization||313
6690508|NCT02726620|7620573|FG000|COMPLETED|Month 1: Attending Randomization||0
6690509|NCT02726620|7620574|FG001|COMPLETED|Month 1: Attending Randomization||485
6258097|NCT04461795|7157406|FG000|STARTED|Overall Study||40
6258098|NCT04461795|7157406|FG000|COMPLETED|Overall Study||35
6258099|NCT04461795|7157406|FG000|NOT COMPLETED|Overall Study||5
6258100|NCT04405999|7157413|FG000|STARTED|Overall Study||25
6258101|NCT04405999|7157414|FG001|STARTED|Overall Study||25
6258102|NCT04405999|7157413|FG000|COMPLETED|Overall Study||25
6258103|NCT04405999|7157414|FG001|COMPLETED|Overall Study||25
6258104|NCT04405999|7157413|FG000|NOT COMPLETED|Overall Study||0
6258105|NCT04405999|7157414|FG001|NOT COMPLETED|Overall Study||0
6258106|NCT04383587|7157420|FG000|STARTED|Overall Study||300
6258107|NCT04383587|7157420|FG000|COMPLETED|Overall Study||292
6258108|NCT04383587|7157420|FG000|NOT COMPLETED|Overall Study||8
6258109|NCT04035473|7157427|FG000|STARTED|Screening/Baseline||20
6258110|NCT04035473|7157428|FG001|STARTED|Screening/Baseline||22
6258111|NCT04035473|7157427|FG000|COMPLETED|Screening/Baseline||20
6258112|NCT04035473|7157428|FG001|COMPLETED|Screening/Baseline||20
6258113|NCT04035473|7157427|FG000|NOT COMPLETED|Screening/Baseline||0
6690510|NCT02726620|7620573|FG000|NOT COMPLETED|Month 1: Attending Randomization||0
6690511|NCT02726620|7620574|FG001|NOT COMPLETED|Month 1: Attending Randomization||0
6690512|NCT02726620|7620573|FG000|STARTED|Months 2-3: In-room Providers Randomized||0
6690513|NCT02726620|7620574|FG001|STARTED|Months 2-3: In-room Providers Randomized||1253
6690514|NCT02726620|7620573|FG000|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||0
6690515|NCT02726620|7620574|FG001|MAP < 65 mmHg: Primary Analysis|Months 2-3: In-room Providers Randomized||1103
6690516|NCT02726620|7620573|FG000|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||0
6690517|NCT02726620|7620574|FG001|Correct IOH Notifications|Months 2-3: In-room Providers Randomized||825
6690518|NCT02726620|7620573|FG000|COMPLETED|Months 2-3: In-room Providers Randomized||0
6690519|NCT02726620|7620574|FG001|COMPLETED|Months 2-3: In-room Providers Randomized||1253
6690520|NCT02726620|7620573|FG000|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
6738641|NCT03285295|7667833|FG004|NOT COMPLETED|Alinity s Chagas Follow-Up||0
6258114|NCT04035473|7157428|FG001|NOT COMPLETED|Screening/Baseline||2
6258115|NCT04035473|7157427|FG000|STARTED|Treatment Period 1||20
6258116|NCT04035473|7157428|FG001|STARTED|Treatment Period 1||20
6258117|NCT04035473|7157427|FG000|COMPLETED|Treatment Period 1||20
6258118|NCT04035473|7157428|FG001|COMPLETED|Treatment Period 1||20
6258119|NCT04035473|7157427|FG000|NOT COMPLETED|Treatment Period 1||0
6258120|NCT04035473|7157428|FG001|NOT COMPLETED|Treatment Period 1||0
6279974|NCT00150462|7179874|FG003|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6690521|NCT02726620|7620574|FG001|NOT COMPLETED|Months 2-3: In-room Providers Randomized||0
6690522|NCT02726620|7620573|FG000|STARTED|Through End of Study: All Interventions||0
6690523|NCT02726620|7620574|FG001|STARTED|Through End of Study: All Interventions||3234
6690524|NCT02726620|7620573|FG000|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||0
6690525|NCT02726620|7620574|FG001|MAP < 65 mmHg: Primary Analysis|Through End of Study: All Interventions||2793
6690526|NCT02726620|7620573|FG000|Correct IOH Notifications|Through End of Study: All Interventions||0
6690527|NCT02726620|7620574|FG001|Correct IOH Notifications|Through End of Study: All Interventions||2072
6690528|NCT02726620|7620573|FG000|COMPLETED|Through End of Study: All Interventions||0
6690529|NCT02726620|7620574|FG001|COMPLETED|Through End of Study: All Interventions||3234
6690530|NCT02726620|7620573|FG000|NOT COMPLETED|Through End of Study: All Interventions||0
6690531|NCT02726620|7620574|FG001|NOT COMPLETED|Through End of Study: All Interventions||0
6690532|NCT02726789|7620580|FG000|STARTED|Overall Study||5
6690533|NCT02726789|7620580|FG000|COMPLETED|Overall Study||5
6690534|NCT02726789|7620580|FG000|NOT COMPLETED|Overall Study||0
6690535|NCT02726945|7620588|FG000|STARTED|Overall Study||13
6690536|NCT02726945|7620589|FG001|STARTED|Overall Study||13
6690537|NCT02726945|7620590|FG002|STARTED|Overall Study||13
6690538|NCT02726945|7620588|FG000|COMPLETED|Overall Study||13
6690539|NCT02726945|7620589|FG001|COMPLETED|Overall Study||12
6690540|NCT02726945|7620590|FG002|COMPLETED|Overall Study||12
6690541|NCT02726945|7620588|FG000|NOT COMPLETED|Overall Study||0
6690542|NCT02726945|7620589|FG001|NOT COMPLETED|Overall Study||1
6690543|NCT02726945|7620590|FG002|NOT COMPLETED|Overall Study||1
6690544|NCT02726971|7620600|FG000|STARTED|Overall Study||70
6690545|NCT02726971|7620601|FG001|STARTED|Overall Study||71
6690546|NCT02726971|7620600|FG000|COMPLETED|Overall Study||59
6690547|NCT02726971|7620601|FG001|COMPLETED|Overall Study||62
6690548|NCT02726971|7620600|FG000|NOT COMPLETED|Overall Study||11
6690549|NCT02726971|7620601|FG001|NOT COMPLETED|Overall Study||9
6690550|NCT02727192|7620609|FG000|STARTED|Overall Study||54
6690551|NCT02727192|7620610|FG001|STARTED|Overall Study||54
6690552|NCT02727192|7620611|FG002|STARTED|Overall Study||1
6690553|NCT02727192|7620609|FG000|COMPLETED|Overall Study||53
6690554|NCT02727192|7620610|FG001|COMPLETED|Overall Study||54
6690555|NCT02727192|7620611|FG002|COMPLETED|Overall Study||1
6690556|NCT02727192|7620609|FG000|NOT COMPLETED|Overall Study||1
6690557|NCT02727192|7620610|FG001|NOT COMPLETED|Overall Study||0
6690558|NCT02727192|7620611|FG002|NOT COMPLETED|Overall Study||0
6690559|NCT02727322|7620620|FG000|STARTED|Overall Study||77
6690560|NCT02727322|7620621|FG001|STARTED|Overall Study||77
6690561|NCT02727322|7620620|FG000|COMPLETED|Overall Study||75
6690562|NCT02727322|7620621|FG001|COMPLETED|Overall Study||76
6690563|NCT02727322|7620620|FG000|NOT COMPLETED|Overall Study||2
6690564|NCT02727322|7620621|FG001|NOT COMPLETED|Overall Study||1
6690565|NCT02727660|7620634|FG000|STARTED|Overall Study||619
6690566|NCT02727660|7620635|FG001|STARTED|Overall Study||617
6690567|NCT02727660|7620636|FG002|STARTED|Overall Study||607
6690568|NCT02727660|7620634|FG000|COMPLETED|Overall Study||503
6690569|NCT02727660|7620635|FG001|COMPLETED|Overall Study||501
6690570|NCT02727660|7620636|FG002|COMPLETED|Overall Study||442
6690571|NCT02727660|7620634|FG000|NOT COMPLETED|Overall Study||116
6690572|NCT02727660|7620635|FG001|NOT COMPLETED|Overall Study||116
6690573|NCT02727660|7620636|FG002|NOT COMPLETED|Overall Study||165
6690574|NCT02727699|7620646|FG000|STARTED|Overall Study||91
6690575|NCT02727699|7620647|FG001|STARTED|Overall Study||94
6690576|NCT02727699|7620646|FG000|COMPLETED|Overall Study||82
6690577|NCT02727699|7620647|FG001|COMPLETED|Overall Study||89
6690578|NCT02727699|7620646|FG000|NOT COMPLETED|Overall Study||9
6690579|NCT02727699|7620647|FG001|NOT COMPLETED|Overall Study||5
6690580|NCT02727751|7620653|FG000|STARTED|Overall Study||312
6690581|NCT02727751|7620653|FG000|COMPLETED|Overall Study||262
6690582|NCT02727751|7620653|FG000|NOT COMPLETED|Overall Study||50
6690583|NCT02727777|7620660|FG000|STARTED|Overall Study||4
6690584|NCT02727777|7620661|FG001|STARTED|Overall Study||0
6690585|NCT02727777|7620662|FG002|STARTED|Overall Study||0
6690586|NCT02727777|7620660|FG000|COMPLETED|Overall Study||0
6258121|NCT04035473|7157427|FG000|STARTED|Treatment Period 2|2 subjects withdrew before starting treatment period 2 due to diease progression and withdrawal from study treatment and procedure.|18
6258122|NCT04035473|7157428|FG001|STARTED|Treatment Period 2|1 subject withdrew before starting treatment period 2 due to SAE and investigator's decision.|19
6258123|NCT04035473|7157427|FG000|COMPLETED|Treatment Period 2||18
6258124|NCT04035473|7157428|FG001|COMPLETED|Treatment Period 2||19
6258125|NCT04035473|7157427|FG000|NOT COMPLETED|Treatment Period 2||0
6258126|NCT04035473|7157428|FG001|NOT COMPLETED|Treatment Period 2||0
6258127|NCT04035473|7157427|FG000|STARTED|Follow-up Period||18
6258128|NCT04035473|7157428|FG001|STARTED|Follow-up Period||19
6258129|NCT04035473|7157427|FG000|COMPLETED|Follow-up Period||16
6258130|NCT04035473|7157428|FG001|COMPLETED|Follow-up Period||19
6258131|NCT04035473|7157427|FG000|NOT COMPLETED|Follow-up Period||2
6258132|NCT04035473|7157428|FG001|NOT COMPLETED|Follow-up Period||0
6258133|NCT03905694|7157434|FG000|STARTED|Primary Analysis Period||18
6690587|NCT02727777|7620661|FG001|COMPLETED|Overall Study||0
6690588|NCT02727777|7620662|FG002|COMPLETED|Overall Study||0
6690589|NCT02727777|7620660|FG000|NOT COMPLETED|Overall Study||4
6690590|NCT02727777|7620661|FG001|NOT COMPLETED|Overall Study||0
6690591|NCT02727777|7620662|FG002|NOT COMPLETED|Overall Study||0
6690592|NCT02727816|7620670|FG000|STARTED|Overall Study||35
6690593|NCT02727816|7620670|FG000|COMPLETED|Overall Study||35
6690594|NCT02727816|7620670|FG000|NOT COMPLETED|Overall Study||0
6690595|NCT02727842|7620690|FG000|STARTED|Overall Study||30
6690596|NCT02727842|7620690|FG000|COMPLETED|Overall Study||30
6690597|NCT02727842|7620690|FG000|NOT COMPLETED|Overall Study||0
6690598|NCT02727894|7620696|FG000|STARTED|Overall Study|March 2013|73
6690599|NCT02727894|7620697|FG001|STARTED|Overall Study|March 2013|192
6690600|NCT02727894|7620696|FG000|COMPLETED|Overall Study|September 2015|73
6690601|NCT02727894|7620697|FG001|COMPLETED|Overall Study|September 2015|192
6690602|NCT02727894|7620696|FG000|NOT COMPLETED|Overall Study||0
6690603|NCT02727894|7620697|FG001|NOT COMPLETED|Overall Study||0
6690604|NCT02728089|7620706|FG000|STARTED|Overall Study||115
6690605|NCT02728089|7620706|FG000|Treated|Overall Study||114
6690606|NCT02728089|7620706|FG000|COMPLETED|Overall Study||112
6690607|NCT02728089|7620706|FG000|NOT COMPLETED|Overall Study||3
6690608|NCT02728102|7620713|FG000|STARTED|Overall Study||68
6690609|NCT02728102|7620714|FG001|STARTED|Overall Study||37
6690610|NCT02728102|7620715|FG002|STARTED|Overall Study||35
6690611|NCT02728102|7620713|FG000|COMPLETED|Overall Study||67
6690612|NCT02728102|7620714|FG001|COMPLETED|Overall Study||35
6690613|NCT02728102|7620715|FG002|COMPLETED|Overall Study||33
6690614|NCT02728102|7620713|FG000|NOT COMPLETED|Overall Study||1
6690615|NCT02728102|7620714|FG001|NOT COMPLETED|Overall Study||2
6690616|NCT02728102|7620715|FG002|NOT COMPLETED|Overall Study||2
6690617|NCT02728206|7620722|FG000|STARTED|Overall Study||9
6690618|NCT02728206|7620722|FG000|COMPLETED|Overall Study||8
6690619|NCT02728206|7620722|FG000|NOT COMPLETED|Overall Study||1
6690620|NCT02728830|7620726|FG000|STARTED|Overall Study||39
6690621|NCT02728830|7620726|FG000|COMPLETED|Overall Study||15
6690622|NCT02728830|7620726|FG000|NOT COMPLETED|Overall Study||24
6690623|NCT02728895|7620732|FG000|STARTED|Overall Study||3
6690624|NCT02728895|7620733|FG001|STARTED|Overall Study||21
6690625|NCT02728895|7620732|FG000|COMPLETED|Overall Study||2
6690626|NCT02728895|7620733|FG001|COMPLETED|Overall Study||16
6690627|NCT02728895|7620732|FG000|NOT COMPLETED|Overall Study||1
6690628|NCT02728895|7620733|FG001|NOT COMPLETED|Overall Study||5
6690629|NCT02729025|7620741|FG000|STARTED|Overall Study||64
6690630|NCT02729025|7620742|FG001|STARTED|Overall Study||65
6690631|NCT02729025|7620741|FG000|COMPLETED|Overall Study||64
6690632|NCT02729025|7620742|FG001|COMPLETED|Overall Study||64
6690633|NCT02729025|7620741|FG000|NOT COMPLETED|Overall Study||0
6690634|NCT02729025|7620742|FG001|NOT COMPLETED|Overall Study||1
6690635|NCT02729038|7620752|FG000|STARTED|Part 1 (Up to 44 Days)||8
6690636|NCT02729038|7620753|FG001|STARTED|Part 1 (Up to 44 Days)||8
6690637|NCT02729038|7620754|FG002|STARTED|Part 1 (Up to 44 Days)||8
6690638|NCT02729038|7620755|FG003|STARTED|Part 1 (Up to 44 Days)||0
6690639|NCT02729038|7620752|FG000|COMPLETED|Part 1 (Up to 44 Days)||8
6690640|NCT02729038|7620753|FG001|COMPLETED|Part 1 (Up to 44 Days)||8
6690641|NCT02729038|7620754|FG002|COMPLETED|Part 1 (Up to 44 Days)||8
6690642|NCT02729038|7620755|FG003|COMPLETED|Part 1 (Up to 44 Days)||0
6690643|NCT02729038|7620752|FG000|NOT COMPLETED|Part 1 (Up to 44 Days)||0
6690644|NCT02729038|7620753|FG001|NOT COMPLETED|Part 1 (Up to 44 Days)||0
6690645|NCT02729038|7620754|FG002|NOT COMPLETED|Part 1 (Up to 44 Days)||0
6690646|NCT02729038|7620755|FG003|NOT COMPLETED|Part 1 (Up to 44 Days)||0
6690647|NCT02729038|7620752|FG000|STARTED|Part 2 (Up to 50 Days)||0
6690648|NCT02729038|7620753|FG001|STARTED|Part 2 (Up to 50 Days)||0
6690649|NCT02729038|7620754|FG002|STARTED|Part 2 (Up to 50 Days)||0
6690650|NCT02729038|7620755|FG003|STARTED|Part 2 (Up to 50 Days)||8
6690651|NCT02729038|7620752|FG000|COMPLETED|Part 2 (Up to 50 Days)||0
6690652|NCT02729038|7620753|FG001|COMPLETED|Part 2 (Up to 50 Days)||0
6690653|NCT02729038|7620754|FG002|COMPLETED|Part 2 (Up to 50 Days)||0
6690654|NCT02729038|7620755|FG003|COMPLETED|Part 2 (Up to 50 Days)||8
6690655|NCT02729038|7620752|FG000|NOT COMPLETED|Part 2 (Up to 50 Days)||0
6690656|NCT02729038|7620753|FG001|NOT COMPLETED|Part 2 (Up to 50 Days)||0
6690657|NCT02729038|7620754|FG002|NOT COMPLETED|Part 2 (Up to 50 Days)||0
6690658|NCT02729038|7620755|FG003|NOT COMPLETED|Part 2 (Up to 50 Days)||0
6690659|NCT02729051|7620774|FG000|STARTED|Overall Study||527
6690660|NCT02729051|7620775|FG001|STARTED|Overall Study||528
6690661|NCT02729051|7620774|FG000|COMPLETED|Overall Study||497
6690662|NCT02729051|7620775|FG001|COMPLETED|Overall Study||496
6690663|NCT02729051|7620774|FG000|NOT COMPLETED|Overall Study||30
6690664|NCT02729051|7620775|FG001|NOT COMPLETED|Overall Study||32
6690665|NCT02729194|7620781|FG000|STARTED|Overall Study||16
6690666|NCT02729194|7620781|FG000|COMPLETED|Overall Study||13
6690667|NCT02729194|7620781|FG000|NOT COMPLETED|Overall Study||3
6690668|NCT02729545|7620787|FG000|STARTED|Overall Study||30
6690669|NCT02729545|7620788|FG001|STARTED|Overall Study||30
6690670|NCT02729545|7620787|FG000|COMPLETED|Overall Study||27
6690671|NCT02729545|7620788|FG001|COMPLETED|Overall Study||25
6690672|NCT02729545|7620787|FG000|NOT COMPLETED|Overall Study||3
6690673|NCT02729545|7620788|FG001|NOT COMPLETED|Overall Study||5
6690674|NCT02729740|7620794|FG000|STARTED|Overall Study||995
6690675|NCT02729740|7620794|FG000|COMPLETED|Overall Study||864
6690676|NCT02729740|7620794|FG000|NOT COMPLETED|Overall Study||131
6690677|NCT02729831|7620802|FG000|STARTED|Baseline (Post Decision Aid, Pre-visit)||320
6690678|NCT02729831|7620803|FG001|STARTED|Baseline (Post Decision Aid, Pre-visit)||315
6690679|NCT02729831|7620804|FG002|STARTED|Baseline (Post Decision Aid, Pre-visit)||293
6690680|NCT02729831|7620805|FG003|STARTED|Baseline (Post Decision Aid, Pre-visit)||292
6690681|NCT02729831|7620802|FG000|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||282
6690682|NCT02729831|7620803|FG001|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||292
6690683|NCT02729831|7620804|FG002|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
6690684|NCT02729831|7620805|FG003|COMPLETED|Baseline (Post Decision Aid, Pre-visit)||275
6690685|NCT02729831|7620802|FG000|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||38
6690686|NCT02729831|7620803|FG001|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||23
6690687|NCT02729831|7620804|FG002|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||18
6690688|NCT02729831|7620805|FG003|NOT COMPLETED|Baseline (Post Decision Aid, Pre-visit)||17
6690689|NCT02729831|7620802|FG000|STARTED|1 Week Post-visit||282
6690690|NCT02729831|7620803|FG001|STARTED|1 Week Post-visit||292
6690691|NCT02729831|7620804|FG002|STARTED|1 Week Post-visit||275
6690692|NCT02729831|7620805|FG003|STARTED|1 Week Post-visit||275
6690693|NCT02729831|7620802|FG000|COMPLETED|1 Week Post-visit||239
6690694|NCT02729831|7620803|FG001|COMPLETED|1 Week Post-visit||252
6690695|NCT02729831|7620804|FG002|COMPLETED|1 Week Post-visit||237
6690696|NCT02729831|7620805|FG003|COMPLETED|1 Week Post-visit||239
6690697|NCT02729831|7620802|FG000|NOT COMPLETED|1 Week Post-visit||43
6690698|NCT02729831|7620803|FG001|NOT COMPLETED|1 Week Post-visit||40
6690699|NCT02729831|7620804|FG002|NOT COMPLETED|1 Week Post-visit||38
6690700|NCT02729831|7620805|FG003|NOT COMPLETED|1 Week Post-visit||36
6690701|NCT02729831|7620802|FG000|STARTED|6 Month Follow-up||282
6690702|NCT02729831|7620803|FG001|STARTED|6 Month Follow-up||292
6690703|NCT02729831|7620804|FG002|STARTED|6 Month Follow-up||275
6690704|NCT02729831|7620805|FG003|STARTED|6 Month Follow-up||275
6690705|NCT02729831|7620802|FG000|COMPLETED|6 Month Follow-up||227
6690706|NCT02729831|7620803|FG001|COMPLETED|6 Month Follow-up||238
6690707|NCT02729831|7620804|FG002|COMPLETED|6 Month Follow-up||227
6690708|NCT02729831|7620805|FG003|COMPLETED|6 Month Follow-up||232
6690709|NCT02729831|7620802|FG000|NOT COMPLETED|6 Month Follow-up||55
6690710|NCT02729831|7620803|FG001|NOT COMPLETED|6 Month Follow-up||54
6690711|NCT02729831|7620804|FG002|NOT COMPLETED|6 Month Follow-up||48
6690712|NCT02729831|7620805|FG003|NOT COMPLETED|6 Month Follow-up||43
6690713|NCT02729896|7620818|FG000|STARTED|Overall Study||3
6690714|NCT02729896|7620819|FG001|STARTED|Overall Study||10
6690715|NCT02729896|7620820|FG002|STARTED|Overall Study||23
6690716|NCT02729896|7620818|FG000|COMPLETED|Overall Study||1
6690717|NCT02729896|7620819|FG001|COMPLETED|Overall Study||1
6690718|NCT02729896|7620820|FG002|COMPLETED|Overall Study||1
6690719|NCT02729896|7620818|FG000|NOT COMPLETED|Overall Study||2
6690720|NCT02729896|7620819|FG001|NOT COMPLETED|Overall Study||9
6690721|NCT02729896|7620820|FG002|NOT COMPLETED|Overall Study||22
6690722|NCT02729909|7620831|FG000|STARTED|Overall Study||105
6690723|NCT02729909|7620832|FG001|STARTED|Overall Study||106
6690724|NCT02729909|7620831|FG000|COMPLETED|Overall Study||104
6690725|NCT02729909|7620832|FG001|COMPLETED|Overall Study||101
6690726|NCT02729909|7620831|FG000|NOT COMPLETED|Overall Study||1
6690727|NCT02729909|7620832|FG001|NOT COMPLETED|Overall Study||5
6690728|NCT02730169|7620842|FG000|STARTED|Overall Study||67
6690729|NCT02730169|7620843|FG001|STARTED|Overall Study||66
6690730|NCT02730169|7620844|FG002|STARTED|Overall Study||67
6690731|NCT02730169|7620845|FG003|STARTED|Overall Study||71
6690732|NCT02730169|7620842|FG000|COMPLETED|Overall Study||53
6690733|NCT02730169|7620843|FG001|COMPLETED|Overall Study||45
6690734|NCT02730169|7620844|FG002|COMPLETED|Overall Study||50
6690735|NCT02730169|7620845|FG003|COMPLETED|Overall Study||55
6690736|NCT02730169|7620842|FG000|NOT COMPLETED|Overall Study||14
6690737|NCT02730169|7620843|FG001|NOT COMPLETED|Overall Study||21
6690738|NCT02730169|7620844|FG002|NOT COMPLETED|Overall Study||17
6690739|NCT02730169|7620845|FG003|NOT COMPLETED|Overall Study||16
6690740|NCT02730195|7620855|FG000|STARTED|Overall Study||9
6690741|NCT02730195|7620855|FG000|COMPLETED|Overall Study||8
6690742|NCT02730195|7620855|FG000|NOT COMPLETED|Overall Study||1
6690743|NCT02730208|7620861|FG000|STARTED|Overall Study||20
6690744|NCT02730208|7620862|FG001|STARTED|Overall Study||21
6690745|NCT02730208|7620861|FG000|COMPLETED|Overall Study||20
6690746|NCT02730208|7620862|FG001|COMPLETED|Overall Study||20
6690747|NCT02730208|7620861|FG000|NOT COMPLETED|Overall Study||0
6690748|NCT02730208|7620862|FG001|NOT COMPLETED|Overall Study||1
6690749|NCT02730234|7620868|FG000|STARTED|Overall Study||60
6690750|NCT02730234|7620868|FG000|COMPLETED|Overall Study|8 Deaths|52
6690751|NCT02730234|7620868|FG000|NOT COMPLETED|Overall Study||8
6690752|NCT02730247|7620872|FG000|STARTED|Overall Study||7
6690753|NCT02730247|7620872|FG000|COMPLETED|Overall Study||7
6690754|NCT02730247|7620872|FG000|NOT COMPLETED|Overall Study||0
6690755|NCT02730260|7620878|FG000|STARTED|Overall Study||258
6690756|NCT02730260|7620879|FG001|STARTED|Overall Study||260
6690757|NCT02730260|7620878|FG000|COMPLETED|Overall Study||176
6690758|NCT02730260|7620879|FG001|COMPLETED|Overall Study||185
6690759|NCT02730260|7620878|FG000|NOT COMPLETED|Overall Study||82
6690760|NCT02730260|7620879|FG001|NOT COMPLETED|Overall Study||75
6690761|NCT02730351|7620885|FG000|STARTED|Treatment Period 1 (2 Weeks)||37
6690762|NCT02730351|7620886|FG001|STARTED|Treatment Period 1 (2 Weeks)||37
6690763|NCT02730351|7620885|FG000|COMPLETED|Treatment Period 1 (2 Weeks)||36
6690764|NCT02730351|7620886|FG001|COMPLETED|Treatment Period 1 (2 Weeks)||37
6690765|NCT02730351|7620885|FG000|NOT COMPLETED|Treatment Period 1 (2 Weeks)||1
6690766|NCT02730351|7620886|FG001|NOT COMPLETED|Treatment Period 1 (2 Weeks)||0
6690767|NCT02730351|7620885|FG000|STARTED|Wash-out Period (2 Weeks)||36
6690768|NCT02730351|7620886|FG001|STARTED|Wash-out Period (2 Weeks)||37
6690769|NCT02730351|7620885|FG000|COMPLETED|Wash-out Period (2 Weeks)||35
6690770|NCT02730351|7620886|FG001|COMPLETED|Wash-out Period (2 Weeks)||36
6690771|NCT02730351|7620885|FG000|NOT COMPLETED|Wash-out Period (2 Weeks)||1
6690772|NCT02730351|7620886|FG001|NOT COMPLETED|Wash-out Period (2 Weeks)||1
6690773|NCT02730351|7620885|FG000|STARTED|Treatment Period 2 (2 Weeks)||35
6690774|NCT02730351|7620886|FG001|STARTED|Treatment Period 2 (2 Weeks)||36
6690775|NCT02730351|7620885|FG000|COMPLETED|Treatment Period 2 (2 Weeks)||33
6690776|NCT02730351|7620886|FG001|COMPLETED|Treatment Period 2 (2 Weeks)||36
6690777|NCT02730351|7620885|FG000|NOT COMPLETED|Treatment Period 2 (2 Weeks)||2
6690778|NCT02730351|7620886|FG001|NOT COMPLETED|Treatment Period 2 (2 Weeks)||0
6690779|NCT02730377|7620894|FG000|STARTED|Overall Study||996
6690780|NCT02730377|7620895|FG001|STARTED|Overall Study||995
6258134|NCT03905694|7157434|FG000|COMPLETED|Primary Analysis Period||18
6258135|NCT03905694|7157434|FG000|NOT COMPLETED|Primary Analysis Period||0
6258136|NCT03905694|7157434|FG000|STARTED|Long-term Extension Period||18
6258137|NCT03905694|7157434|FG000|COMPLETED|Long-term Extension Period||0
6258138|NCT03905694|7157434|FG000|NOT COMPLETED|Long-term Extension Period||18
6258139|NCT03891264|7157438|FG000|STARTED|Overall Study||7
6258140|NCT03891264|7157438|FG000|Received Intervention|Overall Study||3
6258141|NCT03891264|7157438|FG000|COMPLETED|Overall Study||2
6258142|NCT03891264|7157438|FG000|NOT COMPLETED|Overall Study||5
6258143|NCT03796676|7157445|FG000|STARTED|Overall Study||96
6258144|NCT03796676|7157446|FG001|STARTED|Overall Study||95
6258145|NCT03796676|7157447|FG002|STARTED|Overall Study||94
6258146|NCT03796676|7157445|FG000|COMPLETED|Overall Study||90
6258147|NCT03796676|7157446|FG001|COMPLETED|Overall Study||92
6258148|NCT03796676|7157447|FG002|COMPLETED|Overall Study||91
6258149|NCT03796676|7157445|FG000|NOT COMPLETED|Overall Study||6
6258150|NCT03796676|7157446|FG001|NOT COMPLETED|Overall Study||3
6258151|NCT03796676|7157447|FG002|NOT COMPLETED|Overall Study||3
6279975|NCT00150462|7179875|FG004|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6279976|NCT00150462|7179876|FG005|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6279977|NCT00150462|7179877|FG006|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6279978|NCT00150462|7179878|FG007|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6279979|NCT00150462|7179879|FG008|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
6279980|NCT00150462|7179880|FG009|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
6279981|NCT00150462|7179881|FG010|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
6279982|NCT00150462|7179871|FG000|NOT COMPLETED|Overall Study||3
6279983|NCT00150462|7179872|FG001|NOT COMPLETED|Overall Study||3
6279984|NCT00150462|7179873|FG002|NOT COMPLETED|Overall Study||4
6279985|NCT00150462|7179874|FG003|NOT COMPLETED|Overall Study||3
6279986|NCT00150462|7179875|FG004|NOT COMPLETED|Overall Study||3
6279987|NCT00150462|7179876|FG005|NOT COMPLETED|Overall Study||4
6279988|NCT00150462|7179877|FG006|NOT COMPLETED|Overall Study||3
6279989|NCT00150462|7179878|FG007|NOT COMPLETED|Overall Study||8
6279990|NCT00150462|7179879|FG008|NOT COMPLETED|Overall Study||6
6279991|NCT00150462|7179880|FG009|NOT COMPLETED|Overall Study||6
6279992|NCT00150462|7179881|FG010|NOT COMPLETED|Overall Study||3
6279993|NCT00150592|7179910|FG000|STARTED|Overall Study||121
6279994|NCT00150592|7179911|FG001|STARTED|Overall Study||57
6279995|NCT00150592|7179910|FG000|COMPLETED|Overall Study||114
6279996|NCT00150592|7179911|FG001|COMPLETED|Overall Study||54
6279997|NCT00150592|7179910|FG000|NOT COMPLETED|Overall Study||7
6279998|NCT00150592|7179911|FG001|NOT COMPLETED|Overall Study||3
6279999|NCT00150618|7179922|FG000|STARTED|Overall Study||62
6280000|NCT00150618|7179923|FG001|STARTED|Overall Study||65
6280001|NCT00150618|7179924|FG002|STARTED|Overall Study||65
6280002|NCT00150618|7179925|FG003|STARTED|Overall Study||66
6280003|NCT00150618|7179926|FG004|STARTED|Overall Study||66
6280004|NCT00150618|7179922|FG000|COMPLETED|Overall Study||45
6280005|NCT00150618|7179923|FG001|COMPLETED|Overall Study||47
6280006|NCT00150618|7179924|FG002|COMPLETED|Overall Study||38
6280007|NCT00150618|7179925|FG003|COMPLETED|Overall Study||40
6280008|NCT00150618|7179926|FG004|COMPLETED|Overall Study||41
6280009|NCT00150618|7179922|FG000|NOT COMPLETED|Overall Study||17
6280010|NCT00150618|7179923|FG001|NOT COMPLETED|Overall Study||18
6280011|NCT00150618|7179924|FG002|NOT COMPLETED|Overall Study||27
6280012|NCT00150618|7179925|FG003|NOT COMPLETED|Overall Study||26
6280013|NCT00150618|7179926|FG004|NOT COMPLETED|Overall Study||25
6280014|NCT00150800|7179938|FG000|STARTED|Overall Study||667
6280015|NCT00150800|7179938|FG000|COMPLETED|Overall Study||171
6280016|NCT00150800|7179938|FG000|NOT COMPLETED|Overall Study||496
6280017|NCT00150813|7179943|FG000|STARTED|Overall Study||66
6280018|NCT00150813|7179943|FG000|COMPLETED|Overall Study||48
6280019|NCT00150813|7179943|FG000|NOT COMPLETED|Overall Study||18
6280020|NCT00150969|7179949|FG000|STARTED|24 Month Main Study||217
6280021|NCT00150969|7179950|FG001|STARTED|24 Month Main Study||223
6280022|NCT00150969|7179949|FG000|COMPLETED|24 Month Main Study||198
6280023|NCT00150969|7179950|FG001|COMPLETED|24 Month Main Study||202
6280024|NCT00150969|7179949|FG000|NOT COMPLETED|24 Month Main Study||19
6280025|NCT00150969|7179950|FG001|NOT COMPLETED|24 Month Main Study||21
6280026|NCT00150969|7179949|FG000|STARTED|24-48 Month Extension||121
6280027|NCT00150969|7179950|FG001|STARTED|24-48 Month Extension||140
6280028|NCT00150969|7179949|FG000|COMPLETED|24-48 Month Extension||33
6280029|NCT00150969|7179950|FG001|COMPLETED|24-48 Month Extension||40
6280030|NCT00150969|7179949|FG000|NOT COMPLETED|24-48 Month Extension||88
6280031|NCT00150969|7179950|FG001|NOT COMPLETED|24-48 Month Extension||100
6280032|NCT00151281|7179957|FG000|STARTED|Overall Study||25
6690781|NCT02730377|7620894|FG000|Treated|Overall Study||980
6690782|NCT02730377|7620895|FG001|Treated|Overall Study||984
6690783|NCT02730377|7620894|FG000|Full Analysis Set (FAS)|Overall Study||996
6690784|NCT02730377|7620895|FG001|Full Analysis Set (FAS)|Overall Study||995
6690785|NCT02730377|7620894|FG000|Safety Analysis Set (SAS)|Overall Study||980
6690786|NCT02730377|7620895|FG001|Safety Analysis Set (SAS)|Overall Study||984
6690787|NCT02730377|7620894|FG000|COMPLETED|Overall Study||446
6690788|NCT02730377|7620895|FG001|COMPLETED|Overall Study||362
6690789|NCT02730377|7620894|FG000|NOT COMPLETED|Overall Study||550
6391916|NCT00838565|7303853|FG004|Treated|Overall Study||6
6391917|NCT00838565|7303854|FG005|Treated|Overall Study||7
6391918|NCT00838565|7303849|FG000|COMPLETED|Overall Study||9
6391919|NCT00838565|7303850|FG001|COMPLETED|Overall Study||4
6391920|NCT00838565|7303851|FG002|COMPLETED|Overall Study||5
6391921|NCT00838565|7303852|FG003|COMPLETED|Overall Study||6
6391922|NCT00838565|7303853|FG004|COMPLETED|Overall Study||6
6391923|NCT00838565|7303854|FG005|COMPLETED|Overall Study||5
6391924|NCT00838565|7303849|FG000|NOT COMPLETED|Overall Study||0
6391925|NCT00838565|7303850|FG001|NOT COMPLETED|Overall Study||3
6391926|NCT00838565|7303851|FG002|NOT COMPLETED|Overall Study||1
6391927|NCT00838565|7303852|FG003|NOT COMPLETED|Overall Study||0
6690790|NCT02730377|7620895|FG001|NOT COMPLETED|Overall Study||633
6690791|NCT02730403|7620901|FG000|STARTED|Overall Study||211
6690792|NCT02730403|7620901|FG000|COMPLETED|Overall Study||157
6690793|NCT02730403|7620901|FG000|NOT COMPLETED|Overall Study||54
6690794|NCT02730455|7620909|FG000|STARTED|Overall Study||94
6690795|NCT02730455|7620910|FG001|STARTED|Overall Study||91
6690796|NCT02730455|7620911|FG002|STARTED|Overall Study||92
6690797|NCT02730455|7620909|FG000|Safety Population|Overall Study||91
6690798|NCT02730455|7620910|FG001|Safety Population|Overall Study||90
6690799|NCT02730455|7620911|FG002|Safety Population|Overall Study||89
6690800|NCT02730455|7620909|FG000|Participants Dosed|Overall Study||91
6690801|NCT02730455|7620910|FG001|Participants Dosed|Overall Study||88
6690802|NCT02730455|7620911|FG002|Participants Dosed|Overall Study||91
6690803|NCT02730455|7620909|FG000|Who Received Total Volume of Study Drug|Overall Study||90
6690804|NCT02730455|7620910|FG001|Who Received Total Volume of Study Drug|Overall Study||88
6690805|NCT02730455|7620911|FG002|Who Received Total Volume of Study Drug|Overall Study||89
6690806|NCT02730455|7620909|FG000|COMPLETED|Overall Study||81
6690807|NCT02730455|7620910|FG001|COMPLETED|Overall Study||77
6690808|NCT02730455|7620911|FG002|COMPLETED|Overall Study||81
6690809|NCT02730455|7620909|FG000|NOT COMPLETED|Overall Study||13
6690810|NCT02730455|7620910|FG001|NOT COMPLETED|Overall Study||14
6690811|NCT02730455|7620911|FG002|NOT COMPLETED|Overall Study||11
6690812|NCT02730598|7620921|FG000|STARTED|Overall Study||14
6690813|NCT02730598|7620922|FG001|STARTED|Overall Study||14
6690814|NCT02730598|7620921|FG000|COMPLETED|Overall Study||10
6690815|NCT02730598|7620922|FG001|COMPLETED|Overall Study||10
6690816|NCT02730598|7620921|FG000|NOT COMPLETED|Overall Study||4
6690817|NCT02730598|7620922|FG001|NOT COMPLETED|Overall Study||4
6690818|NCT02730663|7620928|FG000|STARTED|Overall Study||36
6391928|NCT00838565|7303853|FG004|NOT COMPLETED|Overall Study||0
6690819|NCT02730663|7620928|FG000|COMPLETED|Overall Study||35
6690820|NCT02730663|7620928|FG000|NOT COMPLETED|Overall Study||1
6690821|NCT02730728|7620935|FG000|STARTED|Overall Study||53
6690822|NCT02730728|7620936|FG001|STARTED|Overall Study||53
6690823|NCT02730728|7620937|FG002|STARTED|Overall Study||53
6690824|NCT02730728|7620935|FG000|COMPLETED|Overall Study||53
6690825|NCT02730728|7620936|FG001|COMPLETED|Overall Study||51
6690826|NCT02730728|7620937|FG002|COMPLETED|Overall Study||52
6690827|NCT02730728|7620935|FG000|NOT COMPLETED|Overall Study||0
6690828|NCT02730728|7620936|FG001|NOT COMPLETED|Overall Study||2
6690829|NCT02730728|7620937|FG002|NOT COMPLETED|Overall Study||1
6690830|NCT02730819|7620945|FG000|STARTED|Overall Study||19
6690831|NCT02730819|7620945|FG000|Follow-up Week 2|Overall Study||15
6690832|NCT02730819|7620945|FG000|Follow-up Week 4|Overall Study||16
6690833|NCT02730819|7620945|FG000|Follow-up Week 8|Overall Study||14
6690834|NCT02730819|7620945|FG000|Follow-up Week 12|Overall Study||11
6690835|NCT02730819|7620945|FG000|Follow-up Week 16|Overall Study||11
6690836|NCT02730819|7620945|FG000|Follow-up Week 20|Overall Study||10
6690837|NCT02730819|7620945|FG000|COMPLETED|Overall Study||10
6690838|NCT02730819|7620945|FG000|NOT COMPLETED|Overall Study||9
6690839|NCT02730871|7620951|FG000|STARTED|Overall Study||67
6690840|NCT02730871|7620952|FG001|STARTED|Overall Study||67
6690841|NCT02730871|7620951|FG000|Full Analysis Set (FAS)|Overall Study||67
6690842|NCT02730871|7620952|FG001|Full Analysis Set (FAS)|Overall Study||67
6690843|NCT02730871|7620951|FG000|Safety Analysis Set|Overall Study||67
6690844|NCT02730871|7620952|FG001|Safety Analysis Set|Overall Study||67
6690845|NCT02730871|7620951|FG000|COMPLETED|Overall Study||61
6690846|NCT02730871|7620952|FG001|COMPLETED|Overall Study||67
6690847|NCT02730871|7620951|FG000|NOT COMPLETED|Overall Study||6
6690848|NCT02730871|7620952|FG001|NOT COMPLETED|Overall Study||0
6690849|NCT02730884|7620958|FG000|STARTED|Overall Study||3
6690850|NCT02730884|7620958|FG000|COMPLETED|Overall Study||3
6690851|NCT02730884|7620958|FG000|NOT COMPLETED|Overall Study||0
6690852|NCT02730962|7620964|FG000|STARTED|Overall Study||7
6690853|NCT02730962|7620965|FG001|STARTED|Overall Study||5
6690854|NCT02730962|7620964|FG000|COMPLETED|Overall Study||7
6690855|NCT02730962|7620965|FG001|COMPLETED|Overall Study||5
6690856|NCT02730962|7620964|FG000|NOT COMPLETED|Overall Study||0
6690857|NCT02730962|7620965|FG001|NOT COMPLETED|Overall Study||0
6690858|NCT02730988|7620973|FG000|STARTED|Overall Study||47
6690859|NCT02730988|7620974|FG001|STARTED|Overall Study||49
6690860|NCT02730988|7620973|FG000|COMPLETED|Overall Study||43
6690861|NCT02730988|7620974|FG001|COMPLETED|Overall Study||39
6690862|NCT02730988|7620973|FG000|NOT COMPLETED|Overall Study||4
6690863|NCT02730988|7620974|FG001|NOT COMPLETED|Overall Study||10
6690864|NCT02731131|7620982|FG000|STARTED|Overall Study||6
6690865|NCT02731131|7620983|FG001|STARTED|Overall Study||6
6690866|NCT02731131|7620982|FG000|COMPLETED|Overall Study||6
6690867|NCT02731131|7620983|FG001|COMPLETED|Overall Study||4
6690868|NCT02731131|7620982|FG000|NOT COMPLETED|Overall Study||0
6690869|NCT02731131|7620983|FG001|NOT COMPLETED|Overall Study||2
6690870|NCT02731157|7620989|FG000|STARTED|First Standard RCE||4
6690871|NCT02731157|7620989|FG000|COMPLETED|First Standard RCE||4
6690872|NCT02731157|7620989|FG000|NOT COMPLETED|First Standard RCE||0
6690873|NCT02731157|7620989|FG000|STARTED|First Rejuvenated RCE||4
6690874|NCT02731157|7620989|FG000|COMPLETED|First Rejuvenated RCE||3
6690875|NCT02731157|7620989|FG000|NOT COMPLETED|First Rejuvenated RCE||1
6690876|NCT02731157|7620989|FG000|STARTED|Second Rejuvenated RCE||3
6690877|NCT02731157|7620989|FG000|COMPLETED|Second Rejuvenated RCE||3
6690878|NCT02731157|7620989|FG000|NOT COMPLETED|Second Rejuvenated RCE||0
6690879|NCT02731157|7620989|FG000|STARTED|Third Rejuvenated RCE||3
6690880|NCT02731157|7620989|FG000|COMPLETED|Third Rejuvenated RCE||3
6258152|NCT03681184|7157460|FG000|STARTED|6-Month Double-Blind Period||13
6258153|NCT03681184|7157461|FG001|STARTED|6-Month Double-Blind Period||26
6258154|NCT03681184|7157460|FG000|COMPLETED|6-Month Double-Blind Period||13
6258155|NCT03681184|7157461|FG001|COMPLETED|6-Month Double-Blind Period||25
6258156|NCT03681184|7157460|FG000|NOT COMPLETED|6-Month Double-Blind Period||0
6258157|NCT03681184|7157461|FG001|NOT COMPLETED|6-Month Double-Blind Period||1
6258158|NCT03681184|7157460|FG000|STARTED|3-Month Blinded Extension Period||13
6258159|NCT03681184|7157461|FG001|STARTED|3-Month Blinded Extension Period|1 participant discontinued study drug and entered safety follow up after the DB period.|24
6258160|NCT03681184|7157460|FG000|COMPLETED|3-Month Blinded Extension Period||1
6258161|NCT03681184|7157461|FG001|COMPLETED|3-Month Blinded Extension Period||1
6258162|NCT03681184|7157460|FG000|NOT COMPLETED|3-Month Blinded Extension Period||12
6258163|NCT03681184|7157461|FG001|NOT COMPLETED|3-Month Blinded Extension Period||23
6258164|NCT03681184|7157460|FG000|STARTED|Open-Label Extension Period||1
6258165|NCT03681184|7157461|FG001|STARTED|Open-Label Extension Period||1
6690881|NCT02731157|7620989|FG000|NOT COMPLETED|Third Rejuvenated RCE||0
6690882|NCT02731157|7620989|FG000|STARTED|Second Standard RCE||3
6690883|NCT02731157|7620989|FG000|COMPLETED|Second Standard RCE||3
6690884|NCT02731157|7620989|FG000|NOT COMPLETED|Second Standard RCE||0
6690885|NCT02731157|7620989|FG000|STARTED|Third Standard RCE||3
6690886|NCT02731157|7620989|FG000|COMPLETED|Third Standard RCE||3
6690887|NCT02731157|7620989|FG000|NOT COMPLETED|Third Standard RCE||0
6690888|NCT02731300|7620997|FG000|STARTED|Overall Study||15
6690889|NCT02731300|7620998|FG001|STARTED|Overall Study||7
6690890|NCT02731300|7620997|FG000|COMPLETED|Overall Study||15
6690891|NCT02731300|7620998|FG001|COMPLETED|Overall Study||7
6690892|NCT02731300|7620997|FG000|NOT COMPLETED|Overall Study||0
6690893|NCT02731300|7620998|FG001|NOT COMPLETED|Overall Study||0
6690894|NCT02731313|7621004|FG000|STARTED|Overall Study||367
6690895|NCT02731313|7621004|FG000|COMPLETED|Overall Study||367
6690896|NCT02731313|7621004|FG000|NOT COMPLETED|Overall Study||0
6690897|NCT02731469|7621019|FG000|STARTED|Overall Study||3
6690898|NCT02731469|7621020|FG001|STARTED|Overall Study||3
6690899|NCT02731469|7621021|FG002|STARTED|Overall Study||3
6690900|NCT02731469|7621022|FG003|STARTED|Overall Study||3
6690901|NCT02731469|7621023|FG004|STARTED|Overall Study||3
6690902|NCT02731469|7621024|FG005|STARTED|Overall Study||3
6690903|NCT02731469|7621025|FG006|STARTED|Overall Study||3
6690904|NCT02731469|7621026|FG007|STARTED|Overall Study||6
6690905|NCT02731469|7621027|FG008|STARTED|Overall Study||6
6690906|NCT02731469|7621028|FG009|STARTED|Overall Study||6
6690907|NCT02731469|7621029|FG010|STARTED|Overall Study||6
6690908|NCT02731469|7621019|FG000|COMPLETED|Overall Study||3
6690909|NCT02731469|7621020|FG001|COMPLETED|Overall Study||3
6690910|NCT02731469|7621021|FG002|COMPLETED|Overall Study||3
6690911|NCT02731469|7621022|FG003|COMPLETED|Overall Study||3
6690912|NCT02731469|7621023|FG004|COMPLETED|Overall Study||3
6690913|NCT02731469|7621024|FG005|COMPLETED|Overall Study||3
6690914|NCT02731469|7621025|FG006|COMPLETED|Overall Study||3
6690915|NCT02731469|7621026|FG007|COMPLETED|Overall Study||6
6690916|NCT02731469|7621027|FG008|COMPLETED|Overall Study||6
6690917|NCT02731469|7621028|FG009|COMPLETED|Overall Study||6
6690918|NCT02731469|7621029|FG010|COMPLETED|Overall Study||6
6690919|NCT02731469|7621019|FG000|NOT COMPLETED|Overall Study||0
6690920|NCT02731469|7621020|FG001|NOT COMPLETED|Overall Study||0
6690921|NCT02731469|7621021|FG002|NOT COMPLETED|Overall Study||0
6690922|NCT02731469|7621022|FG003|NOT COMPLETED|Overall Study||0
6690923|NCT02731469|7621023|FG004|NOT COMPLETED|Overall Study||0
6690924|NCT02731469|7621024|FG005|NOT COMPLETED|Overall Study||0
6690925|NCT02731469|7621025|FG006|NOT COMPLETED|Overall Study||0
6690926|NCT02731469|7621026|FG007|NOT COMPLETED|Overall Study||0
6690927|NCT02731469|7621027|FG008|NOT COMPLETED|Overall Study||0
6690928|NCT02731469|7621028|FG009|NOT COMPLETED|Overall Study||0
6690929|NCT02731469|7621029|FG010|NOT COMPLETED|Overall Study||0
6690930|NCT02731638|7621055|FG000|STARTED|Overall Study||35
6690931|NCT02731638|7621056|FG001|STARTED|Overall Study||35
6690932|NCT02731638|7621055|FG000|COMPLETED|Overall Study||29
6690933|NCT02731638|7621056|FG001|COMPLETED|Overall Study||26
6690934|NCT02731638|7621055|FG000|NOT COMPLETED|Overall Study||6
6690935|NCT02731638|7621056|FG001|NOT COMPLETED|Overall Study||9
6690936|NCT02731690|7621062|FG000|STARTED|Overall Study||42
6690937|NCT02731690|7621062|FG000|COMPLETED|Overall Study||12
6690938|NCT02731690|7621062|FG000|NOT COMPLETED|Overall Study||30
6690939|NCT02731729|7621068|FG000|STARTED|Overall Study||10
6690940|NCT02731729|7621069|FG001|STARTED|Overall Study||10
6690941|NCT02731729|7621068|FG000|COMPLETED|Overall Study||1
6690942|NCT02731729|7621069|FG001|COMPLETED|Overall Study||2
6690943|NCT02731729|7621068|FG000|NOT COMPLETED|Overall Study||9
6690944|NCT02731729|7621069|FG001|NOT COMPLETED|Overall Study||8
6690945|NCT02731742|7621079|FG000|STARTED|Overall Study||3
6690946|NCT02731742|7621080|FG001|STARTED|Overall Study||3
6690947|NCT02731742|7621081|FG002|STARTED|Overall Study||6
6690948|NCT02731742|7621082|FG003|STARTED|Overall Study||2
6690949|NCT02731742|7621079|FG000|COMPLETED|Overall Study||0
6690950|NCT02731742|7621080|FG001|COMPLETED|Overall Study||0
6690951|NCT02731742|7621081|FG002|COMPLETED|Overall Study||0
6690952|NCT02731742|7621082|FG003|COMPLETED|Overall Study||0
6690953|NCT02731742|7621079|FG000|NOT COMPLETED|Overall Study||3
6690954|NCT02731742|7621080|FG001|NOT COMPLETED|Overall Study||3
6690955|NCT02731742|7621081|FG002|NOT COMPLETED|Overall Study||6
6690956|NCT02731742|7621082|FG003|NOT COMPLETED|Overall Study||2
6690957|NCT02731755|7621092|FG000|STARTED|First Intervention||8
6690958|NCT02731755|7621093|FG001|STARTED|First Intervention||10
6690959|NCT02731755|7621092|FG000|COMPLETED|First Intervention||8
6690960|NCT02731755|7621093|FG001|COMPLETED|First Intervention||8
6690961|NCT02731755|7621092|FG000|NOT COMPLETED|First Intervention||0
6690962|NCT02731755|7621093|FG001|NOT COMPLETED|First Intervention||2
6690963|NCT02731755|7621092|FG000|STARTED|Second Intervention||8
6690964|NCT02731755|7621093|FG001|STARTED|Second Intervention||8
6690965|NCT02731755|7621092|FG000|COMPLETED|Second Intervention||8
6690966|NCT02731755|7621093|FG001|COMPLETED|Second Intervention||8
6690967|NCT02731755|7621092|FG000|NOT COMPLETED|Second Intervention||0
6690968|NCT02731755|7621093|FG001|NOT COMPLETED|Second Intervention||0
6690969|NCT02731820|7621101|FG000|STARTED|Overall Study||20
6690970|NCT02731820|7621102|FG001|STARTED|Overall Study||20
6690971|NCT02731820|7621101|FG000|COMPLETED|Overall Study||17
6690972|NCT02731820|7621102|FG001|COMPLETED|Overall Study||18
6690973|NCT02731820|7621101|FG000|NOT COMPLETED|Overall Study||3
6690974|NCT02731820|7621102|FG001|NOT COMPLETED|Overall Study||2
6690975|NCT02731833|7621110|FG000|STARTED|Overall Study||111
6690976|NCT02731833|7621111|FG001|STARTED|Overall Study||111
6690977|NCT02731833|7621110|FG000|COMPLETED|Overall Study||111
6690978|NCT02731833|7621111|FG001|COMPLETED|Overall Study||111
6690979|NCT02731833|7621110|FG000|NOT COMPLETED|Overall Study||0
6690980|NCT02731833|7621111|FG001|NOT COMPLETED|Overall Study||0
6690981|NCT02732015|7621119|FG000|STARTED|Overall Study||9
6690982|NCT02732015|7621120|FG001|STARTED|Overall Study||27
6690983|NCT02732015|7621119|FG000|COMPLETED|Overall Study||9
6690984|NCT02732015|7621120|FG001|COMPLETED|Overall Study||26
6690985|NCT02732015|7621119|FG000|NOT COMPLETED|Overall Study||0
6690986|NCT02732015|7621120|FG001|NOT COMPLETED|Overall Study||1
6690987|NCT02732119|7621131|FG000|STARTED|Phase I||8
6690988|NCT02732119|7621132|FG001|STARTED|Phase I||10
6690989|NCT02732119|7621133|FG002|STARTED|Phase I||7
6690990|NCT02732119|7621134|FG003|STARTED|Phase I||0
6690991|NCT02732119|7621135|FG004|STARTED|Phase I||0
6690992|NCT02732119|7621131|FG000|COMPLETED|Phase I||0
6690993|NCT02732119|7621132|FG001|COMPLETED|Phase I||0
6690994|NCT02732119|7621133|FG002|COMPLETED|Phase I||0
6690995|NCT02732119|7621134|FG003|COMPLETED|Phase I||0
6690996|NCT02732119|7621135|FG004|COMPLETED|Phase I||0
6690997|NCT02732119|7621131|FG000|NOT COMPLETED|Phase I||8
6690998|NCT02732119|7621132|FG001|NOT COMPLETED|Phase I||10
6690999|NCT02732119|7621133|FG002|NOT COMPLETED|Phase I||7
6691000|NCT02732119|7621134|FG003|NOT COMPLETED|Phase I||0
6691001|NCT02732119|7621135|FG004|NOT COMPLETED|Phase I||0
6691002|NCT02732119|7621131|FG000|STARTED|Phase II||0
6691003|NCT02732119|7621132|FG001|STARTED|Phase II||0
6691004|NCT02732119|7621133|FG002|STARTED|Phase II||0
6691005|NCT02732119|7621134|FG003|STARTED|Phase II||46
6691006|NCT02732119|7621135|FG004|STARTED|Phase II||33
6691007|NCT02732119|7621131|FG000|Protocol Analysis Set|Phase II||0
6691008|NCT02732119|7621132|FG001|Protocol Analysis Set|Phase II||0
6691009|NCT02732119|7621133|FG002|Protocol Analysis Set|Phase II||0
6691010|NCT02732119|7621134|FG003|Protocol Analysis Set|Phase II||46
6691011|NCT02732119|7621135|FG004|Protocol Analysis Set|Phase II||32
6691012|NCT02732119|7621131|FG000|COMPLETED|Phase II||0
6691013|NCT02732119|7621132|FG001|COMPLETED|Phase II||0
6691014|NCT02732119|7621133|FG002|COMPLETED|Phase II||0
6691015|NCT02732119|7621134|FG003|COMPLETED|Phase II||0
6691016|NCT02732119|7621135|FG004|COMPLETED|Phase II||0
6691017|NCT02732119|7621131|FG000|NOT COMPLETED|Phase II||0
6691018|NCT02732119|7621132|FG001|NOT COMPLETED|Phase II||0
6691019|NCT02732119|7621133|FG002|NOT COMPLETED|Phase II||0
6691020|NCT02732119|7621134|FG003|NOT COMPLETED|Phase II||46
6691021|NCT02732119|7621135|FG004|NOT COMPLETED|Phase II||33
6691022|NCT02732145|7621151|FG000|STARTED|Overall Study||82
6691023|NCT02732145|7621152|FG001|STARTED|Overall Study||82
6691024|NCT02732145|7621153|FG002|STARTED|Overall Study||82
6691025|NCT02732145|7621154|FG003|STARTED|Overall Study||82
6691026|NCT02732145|7621151|FG000|COMPLETED|Overall Study||82
6691027|NCT02732145|7621152|FG001|COMPLETED|Overall Study||82
6691028|NCT02732145|7621153|FG002|COMPLETED|Overall Study||82
6691029|NCT02732145|7621154|FG003|COMPLETED|Overall Study||82
6691030|NCT02732145|7621151|FG000|NOT COMPLETED|Overall Study||0
6691031|NCT02732145|7621152|FG001|NOT COMPLETED|Overall Study||0
6691032|NCT02732145|7621153|FG002|NOT COMPLETED|Overall Study||0
6691033|NCT02732145|7621154|FG003|NOT COMPLETED|Overall Study||0
6691034|NCT02732210|7621186|FG000|STARTED|Overall Study||303
6691035|NCT02732210|7621187|FG001|STARTED|Overall Study||632
6691036|NCT02732210|7621186|FG000|COMPLETED|Overall Study||218
6691037|NCT02732210|7621187|FG001|COMPLETED|Overall Study||338
6691038|NCT02732210|7621186|FG000|NOT COMPLETED|Overall Study||85
6691039|NCT02732210|7621187|FG001|NOT COMPLETED|Overall Study||294
6691040|NCT02732366|7621195|FG000|STARTED|Overall Study||23
6691041|NCT02732366|7621196|FG001|STARTED|Overall Study||23
6691042|NCT02732366|7621195|FG000|Withdrawal by Participant|Overall Study||5
6691043|NCT02732366|7621196|FG001|Withdrawal by Participant|Overall Study||2
6691044|NCT02732366|7621195|FG000|COMPLETED|Overall Study||18
6691045|NCT02732366|7621196|FG001|COMPLETED|Overall Study||21
6691046|NCT02732366|7621195|FG000|NOT COMPLETED|Overall Study||5
6691047|NCT02732366|7621196|FG001|NOT COMPLETED|Overall Study||2
6691048|NCT02732561|7621207|FG000|STARTED|Overall Study||5
6691049|NCT02732561|7621208|FG001|STARTED|Overall Study||5
6691050|NCT02732561|7621207|FG000|COMPLETED|Overall Study||3
6691051|NCT02732561|7621208|FG001|COMPLETED|Overall Study||4
6691052|NCT02732561|7621207|FG000|NOT COMPLETED|Overall Study||2
6691053|NCT02732561|7621208|FG001|NOT COMPLETED|Overall Study||1
6691054|NCT02732587|7621214|FG000|STARTED|Overall Study||5
6691055|NCT02732587|7621214|FG000|COMPLETED|Overall Study||5
6691056|NCT02732587|7621214|FG000|NOT COMPLETED|Overall Study||0
6691057|NCT02732600|7621220|FG000|STARTED|Overall Study||3525
6691058|NCT02732600|7621221|FG001|STARTED|Overall Study||2091
6691059|NCT02732600|7621220|FG000|Sub-set of Sites Newly Delivering PS Services|Overall Study||899
6691060|NCT02732600|7621221|FG001|Sub-set of Sites Newly Delivering PS Services|Overall Study||1484
6691061|NCT02732600|7621220|FG000|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||118
6691062|NCT02732600|7621221|FG001|Veteran Baseline Veteran (Sub-set of 23 Sites)|Overall Study||145
6691063|NCT02732600|7621220|FG000|Veteran 6-months (Sub-set 23 Sites)|Overall Study||70
6691064|NCT02732600|7621221|FG001|Veteran 6-months (Sub-set 23 Sites)|Overall Study||84
6691065|NCT02732600|7621220|FG000|Veteran 1-year (Sub-set 23 Sites)|Overall Study||54
6691066|NCT02732600|7621221|FG001|Veteran 1-year (Sub-set 23 Sites)|Overall Study||71
6691067|NCT02732600|7621220|FG000|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||12
6691068|NCT02732600|7621221|FG001|Peer Specialist Responses at 6-months (All 25 Sites)|Overall Study||14
6691069|NCT02732600|7621220|FG000|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||5
6691070|NCT02732600|7621221|FG001|Peer Specialist Responses at 1-year (All 25 Sites)|Overall Study||12
6691071|NCT02732600|7621220|FG000|Supervisor Responses 6-months (All 25 Sites)|Overall Study||10
6691072|NCT02732600|7621221|FG001|Supervisor Responses 6-months (All 25 Sites)|Overall Study||21
6691073|NCT02732600|7621220|FG000|Supervisor 1-year (All 25 Sites)|Overall Study||6
6691074|NCT02732600|7621221|FG001|Supervisor 1-year (All 25 Sites)|Overall Study||10
6691075|NCT02732600|7621220|FG000|COMPLETED|Overall Study||100
6691076|NCT02732600|7621221|FG001|COMPLETED|Overall Study||113
6691077|NCT02732600|7621220|FG000|NOT COMPLETED|Overall Study||3425
6691078|NCT02732600|7621221|FG001|NOT COMPLETED|Overall Study||1978
6691079|NCT02732639|7621228|FG000|STARTED|Overall Study||31
6691080|NCT02732639|7621228|FG000|COMPLETED|Overall Study||30
6691081|NCT02732639|7621228|FG000|NOT COMPLETED|Overall Study||1
6691082|NCT02732847|7621234|FG000|STARTED|Overall Study||75
6691083|NCT02732847|7621235|FG001|STARTED|Overall Study||74
6691084|NCT02732847|7621234|FG000|COMPLETED|Overall Study||33
6691085|NCT02732847|7621235|FG001|COMPLETED|Overall Study||32
6691086|NCT02732847|7621234|FG000|NOT COMPLETED|Overall Study||42
6691087|NCT02732847|7621235|FG001|NOT COMPLETED|Overall Study||42
6691088|NCT02732899|7621243|FG000|STARTED|Overall Study||10
6691089|NCT02732899|7621244|FG001|STARTED|Overall Study||10
6691090|NCT02732899|7621243|FG000|COMPLETED|Overall Study||10
6691091|NCT02732899|7621244|FG001|COMPLETED|Overall Study||10
6691092|NCT02732899|7621243|FG000|NOT COMPLETED|Overall Study||0
6691093|NCT02732899|7621244|FG001|NOT COMPLETED|Overall Study||0
6691094|NCT02732912|7621252|FG000|STARTED|Overall Study||97
6691095|NCT02732912|7621253|FG001|STARTED|Overall Study||109
6691096|NCT02732912|7621252|FG000|COMPLETED|Overall Study||87
6691097|NCT02732912|7621253|FG001|COMPLETED|Overall Study||91
6691098|NCT02732912|7621252|FG000|NOT COMPLETED|Overall Study||10
6691099|NCT02732912|7621253|FG001|NOT COMPLETED|Overall Study||18
6691100|NCT02732938|7621261|FG000|STARTED|Overall Study||4
6691101|NCT02732938|7621262|FG001|STARTED|Overall Study||18
6691102|NCT02732938|7621263|FG002|STARTED|Overall Study||0
6691103|NCT02732938|7621261|FG000|Received Treatment|Overall Study||4
6691104|NCT02732938|7621262|FG001|Received Treatment|Overall Study||17
6691105|NCT02732938|7621263|FG002|Received Treatment|Overall Study||0
6691106|NCT02732938|7621261|FG000|COMPLETED|Overall Study||0
6691107|NCT02732938|7621262|FG001|COMPLETED|Overall Study||0
6691108|NCT02732938|7621263|FG002|COMPLETED|Overall Study||0
6691109|NCT02732938|7621261|FG000|NOT COMPLETED|Overall Study||4
6691110|NCT02732938|7621262|FG001|NOT COMPLETED|Overall Study||18
6691111|NCT02732938|7621263|FG002|NOT COMPLETED|Overall Study||0
6691112|NCT02732951|7621273|FG000|STARTED|Overall Study||53
6691113|NCT02732951|7621274|FG001|STARTED|Overall Study||52
6691114|NCT02732951|7621273|FG000|COMPLETED|Overall Study||48
6691115|NCT02732951|7621274|FG001|COMPLETED|Overall Study||46
6691116|NCT02732951|7621273|FG000|NOT COMPLETED|Overall Study||5
6691117|NCT02732951|7621274|FG001|NOT COMPLETED|Overall Study||6
6691118|NCT02733367|7621280|FG000|STARTED|Overall Study||18
6691119|NCT02733367|7621280|FG000|COMPLETED|Overall Study||12
6691120|NCT02733367|7621280|FG000|NOT COMPLETED|Overall Study||6
6691121|NCT02733588|7621285|FG000|STARTED|Overall Study||7
6691122|NCT02733588|7621285|FG000|COMPLETED|Overall Study||7
6691123|NCT02733588|7621285|FG000|NOT COMPLETED|Overall Study||0
6691124|NCT02733627|7621293|FG000|STARTED|Overall Study||9
6691125|NCT02733627|7621294|FG001|STARTED|Overall Study||9
6691126|NCT02733627|7621295|FG002|STARTED|Overall Study||9
6691127|NCT02733627|7621296|FG003|STARTED|Overall Study||9
6691128|NCT02733627|7621293|FG000|COMPLETED|Overall Study||9
6691129|NCT02733627|7621294|FG001|COMPLETED|Overall Study||8
6691130|NCT02733627|7621295|FG002|COMPLETED|Overall Study||7
6691131|NCT02733627|7621296|FG003|COMPLETED|Overall Study||9
6691132|NCT02733627|7621293|FG000|NOT COMPLETED|Overall Study||0
6691133|NCT02733627|7621294|FG001|NOT COMPLETED|Overall Study||1
6691134|NCT02733627|7621295|FG002|NOT COMPLETED|Overall Study||2
6691135|NCT02733627|7621296|FG003|NOT COMPLETED|Overall Study||0
6691136|NCT02733653|7621306|FG000|STARTED|Overall Study||50
6691137|NCT02733653|7621306|FG000|COMPLETED|Overall Study||49
6691138|NCT02733653|7621306|FG000|NOT COMPLETED|Overall Study||1
6691139|NCT02733757|7621314|FG000|STARTED|Overall Study||20
6691140|NCT02733757|7621315|FG001|STARTED|Overall Study||20
6691141|NCT02733757|7621316|FG002|STARTED|Overall Study||20
6691142|NCT02733757|7621317|FG003|STARTED|Overall Study||20
6691143|NCT02733757|7621314|FG000|COMPLETED|Overall Study||20
6691144|NCT02733757|7621315|FG001|COMPLETED|Overall Study||20
6691145|NCT02733757|7621316|FG002|COMPLETED|Overall Study||20
6691146|NCT02733757|7621317|FG003|COMPLETED|Overall Study||20
6691147|NCT02733757|7621314|FG000|NOT COMPLETED|Overall Study||0
6691148|NCT02733757|7621315|FG001|NOT COMPLETED|Overall Study||0
6691149|NCT02733757|7621316|FG002|NOT COMPLETED|Overall Study||0
6691150|NCT02733757|7621317|FG003|NOT COMPLETED|Overall Study||0
6691151|NCT02733991|7621329|FG000|STARTED|Overall Study||76
6691152|NCT02733991|7621330|FG001|STARTED|Overall Study||77
6691153|NCT02733991|7621329|FG000|COMPLETED|Overall Study||75
6691154|NCT02733991|7621330|FG001|COMPLETED|Overall Study||72
6691155|NCT02733991|7621329|FG000|NOT COMPLETED|Overall Study||1
6691156|NCT02733991|7621330|FG001|NOT COMPLETED|Overall Study||5
6691157|NCT02734056|7621338|FG000|STARTED|Overall Study||50
6691158|NCT02734056|7621339|FG001|STARTED|Overall Study||50
6691159|NCT02734056|7621338|FG000|COMPLETED|Overall Study||50
6691160|NCT02734056|7621339|FG001|COMPLETED|Overall Study||49
6691161|NCT02734056|7621338|FG000|NOT COMPLETED|Overall Study||0
6691162|NCT02734056|7621339|FG001|NOT COMPLETED|Overall Study||1
6691163|NCT02734147|7621347|FG000|STARTED|Overall Study||12
6691164|NCT02734147|7621348|FG001|STARTED|Overall Study||12
6691165|NCT02734147|7621347|FG000|COMPLETED|Overall Study||9
6691166|NCT02734147|7621348|FG001|COMPLETED|Overall Study||11
6691167|NCT02734147|7621347|FG000|NOT COMPLETED|Overall Study||3
6691168|NCT02734147|7621348|FG001|NOT COMPLETED|Overall Study||1
6691169|NCT02734212|7621356|FG000|STARTED|Overall Study||29
6691170|NCT02734212|7621357|FG001|STARTED|Overall Study||28
6691171|NCT02734212|7621356|FG000|COMPLETED|Overall Study||24
6691172|NCT02734212|7621357|FG001|COMPLETED|Overall Study||18
6691173|NCT02734212|7621356|FG000|NOT COMPLETED|Overall Study||5
6691174|NCT02734212|7621357|FG001|NOT COMPLETED|Overall Study||10
6691175|NCT02734238|7621366|FG000|STARTED|Overall Study||26
6691176|NCT02734238|7621367|FG001|STARTED|Overall Study||24
6691177|NCT02734238|7621366|FG000|COMPLETED|Overall Study||26
6691178|NCT02734238|7621367|FG001|COMPLETED|Overall Study||24
6691179|NCT02734238|7621366|FG000|NOT COMPLETED|Overall Study||0
6691180|NCT02734238|7621367|FG001|NOT COMPLETED|Overall Study||0
6691181|NCT02734355|7621375|FG000|STARTED|Overall Study||34
6691182|NCT02734355|7621376|FG001|STARTED|Overall Study||30
6691183|NCT02734355|7621375|FG000|COMPLETED|Overall Study||34
6691184|NCT02734355|7621376|FG001|COMPLETED|Overall Study||30
6691185|NCT02734355|7621375|FG000|NOT COMPLETED|Overall Study||0
6691186|NCT02734355|7621376|FG001|NOT COMPLETED|Overall Study||0
6691187|NCT02734498|7621385|FG000|STARTED|Overall Study||2
6691188|NCT02734498|7621386|FG001|STARTED|Overall Study||0
6691189|NCT02734498|7621387|FG002|STARTED|Overall Study||0
6691190|NCT02734498|7621385|FG000|COMPLETED|Overall Study||2
6691191|NCT02734498|7621386|FG001|COMPLETED|Overall Study||0
6691192|NCT02734498|7621387|FG002|COMPLETED|Overall Study||0
6691193|NCT02734498|7621385|FG000|NOT COMPLETED|Overall Study||0
6691194|NCT02734498|7621386|FG001|NOT COMPLETED|Overall Study||0
6691195|NCT02734498|7621387|FG002|NOT COMPLETED|Overall Study||0
6691196|NCT02734576|7621395|FG000|STARTED|Overall Study||10
6691197|NCT02734576|7621395|FG000|COMPLETED|Overall Study||10
6691198|NCT02734576|7621395|FG000|NOT COMPLETED|Overall Study||0
6691199|NCT02734693|7621402|FG000|STARTED|Overall Study||56
6691200|NCT02734693|7621403|FG001|STARTED|Overall Study||56
6691201|NCT02734693|7621404|FG002|STARTED|Overall Study||20
6691202|NCT02734693|7621402|FG000|COMPLETED|Overall Study||50
6691203|NCT02734693|7621403|FG001|COMPLETED|Overall Study||53
6691204|NCT02734693|7621404|FG002|COMPLETED|Overall Study||17
6691205|NCT02734693|7621402|FG000|NOT COMPLETED|Overall Study||6
6691206|NCT02734693|7621403|FG001|NOT COMPLETED|Overall Study||3
6691207|NCT02734693|7621404|FG002|NOT COMPLETED|Overall Study||3
6691208|NCT02734810|7621414|FG000|STARTED|Overall Study||15
6691209|NCT02734810|7621415|FG001|STARTED|Overall Study||0
6691210|NCT02734810|7621414|FG000|COMPLETED|Overall Study||13
6691211|NCT02734810|7621415|FG001|COMPLETED|Overall Study||0
6691212|NCT02734810|7621414|FG000|NOT COMPLETED|Overall Study||2
6691213|NCT02734810|7621415|FG001|NOT COMPLETED|Overall Study||0
6691214|NCT02734849|7621424|FG000|STARTED|Overall Study|One patient was randomized but never received study treatment and excluded from all analysis sets.|16
6691215|NCT02734849|7621425|FG001|STARTED|Overall Study||14
6691216|NCT02734849|7621426|FG002|STARTED|Overall Study||10
6691217|NCT02734849|7621424|FG000|COMPLETED|Overall Study||12
6691218|NCT02734849|7621425|FG001|COMPLETED|Overall Study||14
6691219|NCT02734849|7621426|FG002|COMPLETED|Overall Study||9
6691220|NCT02734849|7621424|FG000|NOT COMPLETED|Overall Study||4
6691221|NCT02734849|7621425|FG001|NOT COMPLETED|Overall Study||0
6691222|NCT02734849|7621426|FG002|NOT COMPLETED|Overall Study||1
6691223|NCT02734862|7621437|FG000|STARTED|Part A||35
6691224|NCT02734862|7621438|FG001|STARTED|Part A||36
6691225|NCT02734862|7621439|FG002|STARTED|Part A||36
6691226|NCT02734862|7621437|FG000|COMPLETED|Part A||23
6691227|NCT02734862|7621438|FG001|COMPLETED|Part A||28
6691228|NCT02734862|7621439|FG002|COMPLETED|Part A||22
6691229|NCT02734862|7621437|FG000|NOT COMPLETED|Part A||12
6691230|NCT02734862|7621438|FG001|NOT COMPLETED|Part A||8
6691231|NCT02734862|7621439|FG002|NOT COMPLETED|Part A||14
6691232|NCT02734862|7621437|FG000|STARTED|Part B||46
6691233|NCT02734862|7621438|FG001|STARTED|Part B||21
6691234|NCT02734862|7621439|FG002|STARTED|Part B||33
6691235|NCT02734862|7621437|FG000|COMPLETED|Part B||33
6691236|NCT02734862|7621438|FG001|COMPLETED|Part B||14
6691237|NCT02734862|7621439|FG002|COMPLETED|Part B||28
6691238|NCT02734862|7621437|FG000|NOT COMPLETED|Part B||13
6691239|NCT02734862|7621438|FG001|NOT COMPLETED|Part B||7
6691240|NCT02734862|7621439|FG002|NOT COMPLETED|Part B||5
6691241|NCT02734953|7621448|FG000|STARTED|Overall Study||10
6691242|NCT02734953|7621448|FG000|COMPLETED|Overall Study||10
6691243|NCT02734953|7621448|FG000|NOT COMPLETED|Overall Study||0
6691244|NCT02734979|7621452|FG000|STARTED|Overall Study||1
6691245|NCT02734979|7621452|FG000|COMPLETED|Overall Study||1
6691246|NCT02734979|7621452|FG000|NOT COMPLETED|Overall Study||0
6691247|NCT02735096|7621464|FG000|STARTED|Overall Study||4
6691248|NCT02735096|7621464|FG000|COMPLETED|Overall Study||3
6691249|NCT02735096|7621464|FG000|NOT COMPLETED|Overall Study||1
6691250|NCT02735174|7621468|FG000|STARTED|Overall Study||21
6691251|NCT02735174|7621468|FG000|COMPLETED|Overall Study||21
6691252|NCT02735174|7621468|FG000|NOT COMPLETED|Overall Study||0
6691253|NCT02735187|7621474|FG000|STARTED|Overall Study||25
6691254|NCT02735187|7621475|FG001|STARTED|Overall Study||26
6691255|NCT02735187|7621474|FG000|COMPLETED|Overall Study||21
6691256|NCT02735187|7621475|FG001|COMPLETED|Overall Study||25
6691257|NCT02735187|7621474|FG000|NOT COMPLETED|Overall Study||4
6691258|NCT02735187|7621475|FG001|NOT COMPLETED|Overall Study||1
6691259|NCT02735200|7621489|FG000|STARTED|Overall Study||200
6691260|NCT02735200|7621490|FG001|STARTED|Overall Study||350
6691261|NCT02735200|7621489|FG000|COMPLETED|Overall Study||192
6691262|NCT02735200|7621490|FG001|COMPLETED|Overall Study||345
6691263|NCT02735200|7621489|FG000|NOT COMPLETED|Overall Study||8
6691264|NCT02735200|7621490|FG001|NOT COMPLETED|Overall Study||5
6691265|NCT02735382|7621500|FG000|STARTED|Overall Study||7481
6691266|NCT02735382|7621501|FG001|STARTED|Overall Study||7155
6691267|NCT02735382|7621502|FG002|STARTED|Overall Study||184
6691268|NCT02735382|7621503|FG003|STARTED|Overall Study||110
6691269|NCT02735382|7621500|FG000|COMPLETED|Overall Study||7481
6691270|NCT02735382|7621501|FG001|COMPLETED|Overall Study||7155
6691271|NCT02735382|7621502|FG002|COMPLETED|Overall Study||184
6691272|NCT02735382|7621503|FG003|COMPLETED|Overall Study||110
6691273|NCT02735382|7621500|FG000|NOT COMPLETED|Overall Study||0
6691274|NCT02735382|7621501|FG001|NOT COMPLETED|Overall Study||0
6691275|NCT02735382|7621502|FG002|NOT COMPLETED|Overall Study||0
6691276|NCT02735382|7621503|FG003|NOT COMPLETED|Overall Study||0
6691277|NCT02735421|7621513|FG000|STARTED|Overall Study||67
6691278|NCT02735421|7621513|FG000|COMPLETED|Overall Study||54
6691279|NCT02735421|7621513|FG000|NOT COMPLETED|Overall Study||13
6738642|NCT03285308|7667864|FG000|STARTED|Overall Study||167
6738643|NCT03285308|7667865|FG001|STARTED|Overall Study||169
6738644|NCT03285308|7667864|FG000|Safety Population|Overall Study||163
6738645|NCT03285308|7667865|FG001|Safety Population|Overall Study||163
6738646|NCT03285308|7667864|FG000|COMPLETED|Overall Study||147
6738647|NCT03285308|7667865|FG001|COMPLETED|Overall Study||146
6738648|NCT03285308|7667864|FG000|NOT COMPLETED|Overall Study||20
6738649|NCT03285308|7667865|FG001|NOT COMPLETED|Overall Study||23
6738650|NCT03285373|7667872|FG000|STARTED|Overall Study||314
6738651|NCT03285373|7667873|FG001|STARTED|Overall Study||253
6738652|NCT03285373|7667874|FG002|STARTED|Overall Study||266
6738653|NCT03285373|7667875|FG003|STARTED|Overall Study||130
6738654|NCT03285373|7667872|FG000|COMPLETED|Overall Study||314
6738655|NCT03285373|7667873|FG001|COMPLETED|Overall Study||253
6738656|NCT03285373|7667874|FG002|COMPLETED|Overall Study||266
6738657|NCT03285373|7667875|FG003|COMPLETED|Overall Study||130
6738658|NCT03285373|7667872|FG000|NOT COMPLETED|Overall Study||0
6738659|NCT03285373|7667873|FG001|NOT COMPLETED|Overall Study||0
6738660|NCT03285373|7667874|FG002|NOT COMPLETED|Overall Study||0
6738661|NCT03285373|7667875|FG003|NOT COMPLETED|Overall Study||0
6738662|NCT03285477|7667886|FG000|STARTED|Treatment and Response Assessment Period||176
6738663|NCT03285477|7667887|FG001|STARTED|Treatment and Response Assessment Period||175
6738664|NCT03285477|7667886|FG000|COMPLETED|Treatment and Response Assessment Period||174
6738665|NCT03285477|7667887|FG001|COMPLETED|Treatment and Response Assessment Period||175
6738666|NCT03285477|7667886|FG000|NOT COMPLETED|Treatment and Response Assessment Period||2
6738667|NCT03285477|7667887|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
6738668|NCT03285477|7667886|FG000|STARTED|Recurrence Follow-up Period||8
6738669|NCT03285477|7667887|FG001|STARTED|Recurrence Follow-up Period||77
6738670|NCT03285477|7667886|FG000|COMPLETED|Recurrence Follow-up Period||2
6738671|NCT03285477|7667887|FG001|COMPLETED|Recurrence Follow-up Period||22
6738672|NCT03285477|7667886|FG000|NOT COMPLETED|Recurrence Follow-up Period||6
6738673|NCT03285477|7667887|FG001|NOT COMPLETED|Recurrence Follow-up Period||55
6738674|NCT03285490|7667896|FG000|STARTED|Treatment and Response Assessment Period||173
6738675|NCT03285490|7667897|FG001|STARTED|Treatment and Response Assessment Period||178
6738676|NCT03285490|7667896|FG000|COMPLETED|Treatment and Response Assessment Period||173
6738677|NCT03285490|7667897|FG001|COMPLETED|Treatment and Response Assessment Period||178
6738678|NCT03285490|7667896|FG000|NOT COMPLETED|Treatment and Response Assessment Period||0
6738679|NCT03285490|7667897|FG001|NOT COMPLETED|Treatment and Response Assessment Period||0
6738680|NCT03285490|7667896|FG000|STARTED|Recurrence Follow-up Period||22
6738681|NCT03285490|7667897|FG001|STARTED|Recurrence Follow-up Period||97
6738682|NCT03285490|7667896|FG000|COMPLETED|Recurrence Follow-up Period||4
6738683|NCT03285490|7667897|FG001|COMPLETED|Recurrence Follow-up Period||36
6738684|NCT03285490|7667896|FG000|NOT COMPLETED|Recurrence Follow-up Period||18
6738685|NCT03285490|7667897|FG001|NOT COMPLETED|Recurrence Follow-up Period||61
6738686|NCT03285529|7667906|FG000|STARTED|Overall Study||30
6738687|NCT03285529|7667907|FG001|STARTED|Overall Study||30
6738688|NCT03285529|7667906|FG000|COMPLETED|Overall Study||30
6738689|NCT03285529|7667907|FG001|COMPLETED|Overall Study||30
6738690|NCT03285529|7667906|FG000|NOT COMPLETED|Overall Study||0
6738691|NCT03285529|7667907|FG001|NOT COMPLETED|Overall Study||0
6738692|NCT03285542|7667915|FG000|STARTED|Overall Study||30
6738693|NCT03285542|7667916|FG001|STARTED|Overall Study||30
6738694|NCT03285542|7667915|FG000|COMPLETED|Overall Study||30
6738695|NCT03285542|7667916|FG001|COMPLETED|Overall Study||30
6738696|NCT03285542|7667915|FG000|NOT COMPLETED|Overall Study||0
6738697|NCT03285542|7667916|FG001|NOT COMPLETED|Overall Study||0
6738698|NCT03285555|7667924|FG000|STARTED|Overall Study||30
6738699|NCT03285555|7667925|FG001|STARTED|Overall Study||30
6738700|NCT03285555|7667924|FG000|COMPLETED|Overall Study||30
6738701|NCT03285555|7667925|FG001|COMPLETED|Overall Study||30
6738702|NCT03285555|7667924|FG000|NOT COMPLETED|Overall Study||0
6738703|NCT03285555|7667925|FG001|NOT COMPLETED|Overall Study||0
6738704|NCT03285594|7667934|FG000|STARTED|Overall Study||144
6738705|NCT03285594|7667935|FG001|STARTED|Overall Study||141
6738706|NCT03285594|7667936|FG002|STARTED|Overall Study||286
6738707|NCT03285594|7667934|FG000|Treated|Overall Study||144
6738708|NCT03285594|7667935|FG001|Treated|Overall Study||141
6738709|NCT03285594|7667936|FG002|Treated|Overall Study||285
6738710|NCT03285594|7667934|FG000|COMPLETED|Overall Study||129
6691280|NCT02735551|7621523|FG000|STARTED|Overall Study||3
6691281|NCT02735551|7621524|FG001|STARTED|Overall Study||0
6691282|NCT02735551|7621525|FG002|STARTED|Overall Study||0
6691283|NCT02735551|7621523|FG000|COMPLETED|Overall Study||3
6691284|NCT02735551|7621524|FG001|COMPLETED|Overall Study||0
6691285|NCT02735551|7621525|FG002|COMPLETED|Overall Study||0
6691286|NCT02735551|7621523|FG000|NOT COMPLETED|Overall Study||0
6691287|NCT02735551|7621524|FG001|NOT COMPLETED|Overall Study||0
6691288|NCT02735551|7621525|FG002|NOT COMPLETED|Overall Study||0
6691289|NCT02735577|7621533|FG000|STARTED|Disulfiram Treatment||7
6691290|NCT02735577|7621533|FG000|COMPLETED|Disulfiram Treatment||6
6691291|NCT02735577|7621533|FG000|NOT COMPLETED|Disulfiram Treatment||1
6691292|NCT02735577|7621533|FG000|STARTED|Optional 28 Days of Disulfiram Treatment||6
6691293|NCT02735577|7621533|FG000|COMPLETED|Optional 28 Days of Disulfiram Treatment||4
6691294|NCT02735577|7621533|FG000|NOT COMPLETED|Optional 28 Days of Disulfiram Treatment||2
6691295|NCT02735642|7621539|FG000|STARTED|Overall Study||1046
6691296|NCT02735642|7621540|FG001|STARTED|Overall Study||152
6691297|NCT02735642|7621539|FG000|COMPLETED|Overall Study||1046
6691298|NCT02735642|7621540|FG001|COMPLETED|Overall Study||152
6691299|NCT02735642|7621539|FG000|NOT COMPLETED|Overall Study||0
6691300|NCT02735642|7621540|FG001|NOT COMPLETED|Overall Study||0
6691301|NCT02735915|7621550|FG000|STARTED|Overall Study||70
6691302|NCT02735915|7621550|FG000|Vaccinated|Overall Study||62
6691303|NCT02735915|7621550|FG000|COMPLETED|Overall Study||59
6691304|NCT02735915|7621550|FG000|NOT COMPLETED|Overall Study||11
6691305|NCT02735980|7621559|FG000|STARTED|Overall Study||58
6691306|NCT02735980|7621560|FG001|STARTED|Overall Study||60
6691307|NCT02735980|7621561|FG002|STARTED|Overall Study||15
6691308|NCT02735980|7621559|FG000|Received at Least 1 Dose of Study Drug|Overall Study||56
6691309|NCT02735980|7621560|FG001|Received at Least 1 Dose of Study Drug|Overall Study||60
6691310|NCT02735980|7621561|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
6691311|NCT02735980|7621559|FG000|COMPLETED|Overall Study||48
6691312|NCT02735980|7621560|FG001|COMPLETED|Overall Study||49
6691313|NCT02735980|7621561|FG002|COMPLETED|Overall Study||14
6691314|NCT02735980|7621559|FG000|NOT COMPLETED|Overall Study||10
6691315|NCT02735980|7621560|FG001|NOT COMPLETED|Overall Study||11
6691316|NCT02735980|7621561|FG002|NOT COMPLETED|Overall Study||1
6691317|NCT02736175|7621576|FG000|STARTED|Overall Study||216
6691318|NCT02736175|7621577|FG001|STARTED|Overall Study||222
6691319|NCT02736175|7621576|FG000|COMPLETED|Overall Study||214
6691320|NCT02736175|7621577|FG001|COMPLETED|Overall Study||221
6691321|NCT02736175|7621576|FG000|NOT COMPLETED|Overall Study||2
6691322|NCT02736175|7621577|FG001|NOT COMPLETED|Overall Study||1
6691323|NCT02736188|7621583|FG000|STARTED|Overall Study||142
6691324|NCT02736188|7621583|FG000|COMPLETED|Overall Study||0
6691325|NCT02736188|7621583|FG000|NOT COMPLETED|Overall Study||142
6691326|NCT02736409|7621593|FG000|STARTED|Overall Study||23
6691327|NCT02736409|7621594|FG001|STARTED|Overall Study||25
6691328|NCT02736409|7621595|FG002|STARTED|Overall Study||106
6691329|NCT02736409|7621596|FG003|STARTED|Overall Study||65
6691330|NCT02736409|7621593|FG000|COMPLETED|Overall Study||19
6691331|NCT02736409|7621594|FG001|COMPLETED|Overall Study||22
6691332|NCT02736409|7621595|FG002|COMPLETED|Overall Study||80
6691333|NCT02736409|7621596|FG003|COMPLETED|Overall Study||53
6691334|NCT02736409|7621593|FG000|NOT COMPLETED|Overall Study||4
6391929|NCT00838565|7303854|FG005|NOT COMPLETED|Overall Study||2
6391930|NCT00838578|7303873|FG000|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
6391931|NCT00838578|7303873|FG000|COMPLETED|Overall Study||63
6391932|NCT00838578|7303873|FG000|NOT COMPLETED|Overall Study||2
6391933|NCT00838682|7303883|FG000|STARTED|Overall Study||54
6691335|NCT02736409|7621594|FG001|NOT COMPLETED|Overall Study||3
6691336|NCT02736409|7621595|FG002|NOT COMPLETED|Overall Study||26
6691337|NCT02736409|7621596|FG003|NOT COMPLETED|Overall Study||12
6691338|NCT02736474|7621609|FG000|STARTED|Overall Study||11
6691339|NCT02736474|7621610|FG001|STARTED|Overall Study||11
6691340|NCT02736474|7621609|FG000|COMPLETED|Overall Study||11
6691341|NCT02736474|7621610|FG001|COMPLETED|Overall Study||10
6691342|NCT02736474|7621609|FG000|NOT COMPLETED|Overall Study||0
6691343|NCT02736474|7621610|FG001|NOT COMPLETED|Overall Study||1
6691344|NCT02736578|7621618|FG000|STARTED|Overall Study||6
6691345|NCT02736578|7621619|FG001|STARTED|Overall Study||2
6691346|NCT02736578|7621618|FG000|COMPLETED|Overall Study||5
6691347|NCT02736578|7621619|FG001|COMPLETED|Overall Study||2
6691348|NCT02736578|7621618|FG000|NOT COMPLETED|Overall Study||1
6691349|NCT02736578|7621619|FG001|NOT COMPLETED|Overall Study||0
6691350|NCT02736721|7621629|FG000|STARTED|Overall Study||41
6691351|NCT02736721|7621629|FG000|COMPLETED|Overall Study||25
6691352|NCT02736721|7621629|FG000|NOT COMPLETED|Overall Study||16
6691353|NCT02736825|7621635|FG000|STARTED|Overall Study||127
6691354|NCT02736825|7621636|FG001|STARTED|Overall Study||135
6691355|NCT02736825|7621635|FG000|COMPLETED|Overall Study||117
6691356|NCT02736825|7621636|FG001|COMPLETED|Overall Study||123
6691357|NCT02736825|7621635|FG000|NOT COMPLETED|Overall Study||10
6691358|NCT02736825|7621636|FG001|NOT COMPLETED|Overall Study||12
6691359|NCT02736890|7621645|FG000|STARTED|First 12 Weeks||5
6691360|NCT02736890|7621646|FG001|STARTED|First 12 Weeks||3
6691361|NCT02736890|7621645|FG000|COMPLETED|First 12 Weeks||5
6691362|NCT02736890|7621646|FG001|COMPLETED|First 12 Weeks||3
6691363|NCT02736890|7621645|FG000|NOT COMPLETED|First 12 Weeks||0
6691364|NCT02736890|7621646|FG001|NOT COMPLETED|First 12 Weeks||0
6691365|NCT02736890|7621645|FG000|STARTED|Crossover Next 12 Weeks||5
6691366|NCT02736890|7621646|FG001|STARTED|Crossover Next 12 Weeks||3
6691367|NCT02736890|7621645|FG000|COMPLETED|Crossover Next 12 Weeks||3
6691368|NCT02736890|7621646|FG001|COMPLETED|Crossover Next 12 Weeks||1
6691369|NCT02736890|7621645|FG000|NOT COMPLETED|Crossover Next 12 Weeks||2
6691370|NCT02736890|7621646|FG001|NOT COMPLETED|Crossover Next 12 Weeks||2
6691371|NCT02736955|7621655|FG000|STARTED|Overall Study||36
6691372|NCT02736955|7621656|FG001|STARTED|Overall Study||117
6691373|NCT02736955|7621657|FG002|STARTED|Overall Study||8
6691374|NCT02736955|7621655|FG000|COMPLETED|Overall Study||29
6691375|NCT02736955|7621656|FG001|COMPLETED|Overall Study||103
6691376|NCT02736955|7621657|FG002|COMPLETED|Overall Study||6
6691377|NCT02736955|7621655|FG000|NOT COMPLETED|Overall Study||7
6691378|NCT02736955|7621656|FG001|NOT COMPLETED|Overall Study||14
6691379|NCT02736955|7621657|FG002|NOT COMPLETED|Overall Study||2
6691380|NCT02737072|7621669|FG000|STARTED|Overall Study||3
6691381|NCT02737072|7621670|FG001|STARTED|Overall Study||3
6691382|NCT02737072|7621671|FG002|STARTED|Overall Study||3
6691383|NCT02737072|7621669|FG000|Received at Least One Dose of Drug|Overall Study||3
6691384|NCT02737072|7621670|FG001|Received at Least One Dose of Drug|Overall Study||3
6691385|NCT02737072|7621671|FG002|Received at Least One Dose of Drug|Overall Study||3
6691386|NCT02737072|7621669|FG000|COMPLETED|Overall Study||3
6691387|NCT02737072|7621670|FG001|COMPLETED|Overall Study||3
6691388|NCT02737072|7621671|FG002|COMPLETED|Overall Study||3
6691389|NCT02737072|7621669|FG000|NOT COMPLETED|Overall Study||0
6691390|NCT02737072|7621670|FG001|NOT COMPLETED|Overall Study||0
6691391|NCT02737072|7621671|FG002|NOT COMPLETED|Overall Study||0
6691392|NCT02737163|7621683|FG000|STARTED|Overall Study|114 encounter assessments were completed on 95 participants over 15 months|95
6691393|NCT02737163|7621683|FG000|COMPLETED|Overall Study||95
6691394|NCT02737163|7621683|FG000|NOT COMPLETED|Overall Study||0
6691395|NCT02737332|7621689|FG000|STARTED|Overall Study||29
6691396|NCT02737332|7621690|FG001|STARTED|Overall Study||24
6691397|NCT02737332|7621689|FG000|COMPLETED|Overall Study||28
6691398|NCT02737332|7621690|FG001|COMPLETED|Overall Study||23
6691399|NCT02737332|7621689|FG000|NOT COMPLETED|Overall Study||1
6691400|NCT02737332|7621690|FG001|NOT COMPLETED|Overall Study||1
6691401|NCT02737358|7621700|FG000|STARTED|Overall Study||55
6691402|NCT02737358|7621701|FG001|STARTED|Overall Study||59
6691403|NCT02737358|7621700|FG000|COMPLETED|Overall Study||46
6691404|NCT02737358|7621701|FG001|COMPLETED|Overall Study||44
6691405|NCT02737358|7621700|FG000|NOT COMPLETED|Overall Study||9
6258166|NCT03681184|7157460|FG000|COMPLETED|Open-Label Extension Period||0
6258167|NCT03681184|7157461|FG001|COMPLETED|Open-Label Extension Period||0
6258168|NCT03681184|7157460|FG000|NOT COMPLETED|Open-Label Extension Period||1
6258169|NCT03681184|7157461|FG001|NOT COMPLETED|Open-Label Extension Period||1
6258170|NCT03366220|7157469|FG000|STARTED|Overall Study||4
6258171|NCT03366220|7157470|FG001|STARTED|Overall Study||4
6258172|NCT03366220|7157469|FG000|COMPLETED|Overall Study||4
6258173|NCT03366220|7157470|FG001|COMPLETED|Overall Study||4
6258174|NCT03366220|7157469|FG000|NOT COMPLETED|Overall Study||0
6258175|NCT03366220|7157470|FG001|NOT COMPLETED|Overall Study||0
6258176|NCT03215810|7157476|FG000|STARTED|Overall Study||20
6258177|NCT03215810|7157476|FG000|COMPLETED|Overall Study||16
6258178|NCT03215810|7157476|FG000|NOT COMPLETED|Overall Study||4
6258179|NCT02989857|7157482|FG000|STARTED|Randomization Phase||126
6258180|NCT02989857|7157483|FG001|STARTED|Randomization Phase||61
6258181|NCT02989857|7157484|FG002|STARTED|Randomization Phase||0
6258182|NCT02989857|7157482|FG000|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
6258183|NCT02989857|7157483|FG001|COMPLETED|Randomization Phase|Completed implies the participants who completed the study treatment.|0
6258184|NCT02989857|7157484|FG002|COMPLETED|Randomization Phase||0
6258185|NCT02989857|7157482|FG000|NOT COMPLETED|Randomization Phase||126
6258186|NCT02989857|7157483|FG001|NOT COMPLETED|Randomization Phase||61
6258187|NCT02989857|7157484|FG002|NOT COMPLETED|Randomization Phase||0
6258188|NCT02989857|7157482|FG000|STARTED|Cross Over Phase||0
6258189|NCT02989857|7157483|FG001|STARTED|Cross Over Phase||0
6258190|NCT02989857|7157484|FG002|STARTED|Cross Over Phase|Participants who had experienced disease progression and received placebo were allowed to cross over to receive AG-120.|43
6258191|NCT02989857|7157482|FG000|COMPLETED|Cross Over Phase||0
6258192|NCT02989857|7157483|FG001|COMPLETED|Cross Over Phase||0
6258193|NCT02989857|7157484|FG002|COMPLETED|Cross Over Phase|Completed implies the participants who completed the study treatment.|0
6258194|NCT02989857|7157482|FG000|NOT COMPLETED|Cross Over Phase||0
6258195|NCT02989857|7157483|FG001|NOT COMPLETED|Cross Over Phase||0
6258196|NCT02989857|7157484|FG002|NOT COMPLETED|Cross Over Phase||43
6258197|NCT02983799|7157496|FG000|STARTED|Overall Study||75
6258198|NCT02983799|7157497|FG001|STARTED|Overall Study||26
6258199|NCT02983799|7157498|FG002|STARTED|Overall Study||68
6258200|NCT02983799|7157499|FG003|STARTED|Overall Study||90
6258201|NCT02983799|7157500|FG004|STARTED|Overall Study||13
6258202|NCT02983799|7157496|FG000|COMPLETED|Overall Study||25
6258203|NCT02983799|7157497|FG001|COMPLETED|Overall Study||8
6258204|NCT02983799|7157498|FG002|COMPLETED|Overall Study||18
6258205|NCT02983799|7157499|FG003|COMPLETED|Overall Study||14
6258206|NCT02983799|7157500|FG004|COMPLETED|Overall Study||3
6258207|NCT02983799|7157496|FG000|NOT COMPLETED|Overall Study||50
6258208|NCT02983799|7157497|FG001|NOT COMPLETED|Overall Study||18
6258209|NCT02983799|7157498|FG002|NOT COMPLETED|Overall Study||50
6258210|NCT02983799|7157499|FG003|NOT COMPLETED|Overall Study||76
6691406|NCT02737358|7621701|FG001|NOT COMPLETED|Overall Study||15
6691407|NCT02737397|7621707|FG000|STARTED|Overall Study||13
6691408|NCT02737397|7621707|FG000|JMI-001|Overall Study||13
6691409|NCT02737397|7621707|FG000|SJP-304|Overall Study||12
6691410|NCT02737397|7621707|FG000|SJP-223|Overall Study||13
6691411|NCT02737397|7621707|FG000|Placebo|Overall Study||13
6691412|NCT02737397|7621707|FG000|COMPLETED|Overall Study||13
6691413|NCT02737397|7621707|FG000|NOT COMPLETED|Overall Study||0
6691414|NCT02737501|7621719|FG000|STARTED|Randomized Phase||137
6691415|NCT02737501|7621720|FG001|STARTED|Randomized Phase||138
6691416|NCT02737501|7621721|FG002|STARTED|Randomized Phase||0
6691417|NCT02737501|7621719|FG000|Safety Analysis Set|Randomized Phase||136
6691418|NCT02737501|7621720|FG001|Safety Analysis Set|Randomized Phase||137
6691419|NCT02737501|7621721|FG002|Safety Analysis Set|Randomized Phase||0
6691420|NCT02737501|7621719|FG000|COMPLETED|Randomized Phase||20
6691421|NCT02737501|7621720|FG001|COMPLETED|Randomized Phase||84
6691422|NCT02737501|7621721|FG002|COMPLETED|Randomized Phase||0
6691423|NCT02737501|7621719|FG000|NOT COMPLETED|Randomized Phase||117
6691424|NCT02737501|7621720|FG001|NOT COMPLETED|Randomized Phase||54
6691425|NCT02737501|7621721|FG002|NOT COMPLETED|Randomized Phase||0
6691426|NCT02737501|7621719|FG000|STARTED|Crossover Phase||0
6691427|NCT02737501|7621720|FG001|STARTED|Crossover Phase||0
6691428|NCT02737501|7621721|FG002|STARTED|Crossover Phase||65
6691429|NCT02737501|7621719|FG000|COMPLETED|Crossover Phase||0
6691430|NCT02737501|7621720|FG001|COMPLETED|Crossover Phase||0
6691431|NCT02737501|7621721|FG002|COMPLETED|Crossover Phase||10
6691432|NCT02737501|7621719|FG000|NOT COMPLETED|Crossover Phase||0
6691433|NCT02737501|7621720|FG001|NOT COMPLETED|Crossover Phase||0
6691434|NCT02737501|7621721|FG002|NOT COMPLETED|Crossover Phase||55
6691435|NCT02737592|7621729|FG000|STARTED|Overall Study||34
6691436|NCT02737592|7621729|FG000|COMPLETED|Overall Study||33
6691437|NCT02737592|7621729|FG000|NOT COMPLETED|Overall Study||1
6691438|NCT02737618|7621733|FG000|STARTED|Overall Study||43
6691439|NCT02737618|7621733|FG000|COMPLETED|Overall Study||34
6691440|NCT02737618|7621733|FG000|NOT COMPLETED|Overall Study||9
6691441|NCT02737631|7621737|FG000|STARTED|Overall Study||222
6691442|NCT02737631|7621737|FG000|COMPLETED|Overall Study||222
6691443|NCT02737631|7621737|FG000|NOT COMPLETED|Overall Study||0
6691444|NCT02737722|7621745|FG000|STARTED|Overall Study||8
6691445|NCT02737722|7621746|FG001|STARTED|Overall Study||8
6691446|NCT02737722|7621747|FG002|STARTED|Overall Study||8
6691447|NCT02737722|7621748|FG003|STARTED|Overall Study||6
6691448|NCT02737722|7621745|FG000|COMPLETED|Overall Study||8
6691449|NCT02737722|7621746|FG001|COMPLETED|Overall Study||8
6691450|NCT02737722|7621747|FG002|COMPLETED|Overall Study||7
6691451|NCT02737722|7621748|FG003|COMPLETED|Overall Study||6
6691452|NCT02737722|7621745|FG000|NOT COMPLETED|Overall Study||0
6691453|NCT02737722|7621746|FG001|NOT COMPLETED|Overall Study||0
6691454|NCT02737722|7621747|FG002|NOT COMPLETED|Overall Study||1
6691455|NCT02737722|7621748|FG003|NOT COMPLETED|Overall Study||0
6691456|NCT02737826|7621758|FG000|STARTED|Phase I - Buprenorphine Initiation||27
6691457|NCT02737826|7621759|FG001|STARTED|Phase I - Buprenorphine Initiation||0
6691458|NCT02737826|7621760|FG002|STARTED|Phase I - Buprenorphine Initiation||0
6691459|NCT02737826|7621758|FG000|COMPLETED|Phase I - Buprenorphine Initiation||27
6691460|NCT02737826|7621759|FG001|COMPLETED|Phase I - Buprenorphine Initiation||0
6691461|NCT02737826|7621760|FG002|COMPLETED|Phase I - Buprenorphine Initiation||0
6691462|NCT02737826|7621758|FG000|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
6691463|NCT02737826|7621759|FG001|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
6691464|NCT02737826|7621760|FG002|NOT COMPLETED|Phase I - Buprenorphine Initiation||0
6691465|NCT02737826|7621758|FG000|STARTED|Phase II - Randomization + Taper||0
6691466|NCT02737826|7621759|FG001|STARTED|Phase II - Randomization + Taper||13
6691467|NCT02737826|7621760|FG002|STARTED|Phase II - Randomization + Taper||14
6691468|NCT02737826|7621758|FG000|COMPLETED|Phase II - Randomization + Taper||0
6691469|NCT02737826|7621759|FG001|COMPLETED|Phase II - Randomization + Taper||1
6691470|NCT02737826|7621760|FG002|COMPLETED|Phase II - Randomization + Taper||0
6691471|NCT02737826|7621758|FG000|NOT COMPLETED|Phase II - Randomization + Taper||0
6691472|NCT02737826|7621759|FG001|NOT COMPLETED|Phase II - Randomization + Taper||12
6691473|NCT02737826|7621760|FG002|NOT COMPLETED|Phase II - Randomization + Taper||14
6691474|NCT02737852|7621769|FG000|STARTED|Overall Study||32
6691475|NCT02737852|7621769|FG000|COMPLETED|Overall Study||30
6691476|NCT02737852|7621769|FG000|NOT COMPLETED|Overall Study||2
6691477|NCT02737891|7621775|FG000|STARTED|Overall Study||30
6691478|NCT02737891|7621776|FG001|STARTED|Overall Study||30
6691479|NCT02737891|7621775|FG000|COMPLETED|Overall Study||30
6691480|NCT02737891|7621776|FG001|COMPLETED|Overall Study||28
6691481|NCT02737891|7621775|FG000|NOT COMPLETED|Overall Study||0
6691482|NCT02737891|7621776|FG001|NOT COMPLETED|Overall Study||2
6691483|NCT02737917|7621784|FG000|STARTED|Overall Study||103
6691484|NCT02737917|7621785|FG001|STARTED|Overall Study||103
6691485|NCT02737917|7621784|FG000|COMPLETED|Overall Study||100
6691486|NCT02737917|7621785|FG001|COMPLETED|Overall Study||100
6691487|NCT02737917|7621784|FG000|NOT COMPLETED|Overall Study||3
6691488|NCT02737917|7621785|FG001|NOT COMPLETED|Overall Study||3
6691489|NCT02737930|7621793|FG000|STARTED|Overall Study||5
6691490|NCT02737930|7621794|FG001|STARTED|Overall Study||7
6691491|NCT02737930|7621793|FG000|COMPLETED|Overall Study||5
6691492|NCT02737930|7621794|FG001|COMPLETED|Overall Study||6
6691493|NCT02737930|7621793|FG000|NOT COMPLETED|Overall Study||0
6691494|NCT02737930|7621794|FG001|NOT COMPLETED|Overall Study||1
6691495|NCT02738008|7621803|FG000|STARTED|Overall Study||1
6691496|NCT02738008|7621804|FG001|STARTED|Overall Study||6
6691497|NCT02738008|7621805|FG002|STARTED|Overall Study||5
6691498|NCT02738008|7621803|FG000|COMPLETED|Overall Study||0
6691499|NCT02738008|7621804|FG001|COMPLETED|Overall Study||0
6691500|NCT02738008|7621805|FG002|COMPLETED|Overall Study||0
6691501|NCT02738008|7621803|FG000|NOT COMPLETED|Overall Study||1
6691502|NCT02738008|7621804|FG001|NOT COMPLETED|Overall Study||6
6691503|NCT02738008|7621805|FG002|NOT COMPLETED|Overall Study||5
6691504|NCT02738086|7621815|FG000|STARTED|Overall Study||16
6691505|NCT02738086|7621816|FG001|STARTED|Overall Study||15
6691506|NCT02738086|7621815|FG000|COMPLETED|Overall Study||14
6691507|NCT02738086|7621816|FG001|COMPLETED|Overall Study||13
6691508|NCT02738086|7621815|FG000|NOT COMPLETED|Overall Study||2
6691509|NCT02738086|7621816|FG001|NOT COMPLETED|Overall Study||2
6691510|NCT02738138|7621827|FG000|STARTED|Overall Study||137
6691511|NCT02738138|7621828|FG001|STARTED|Overall Study||16
6691512|NCT02738138|7621827|FG000|COMPLETED|Overall Study||134
6691513|NCT02738138|7621828|FG001|COMPLETED|Overall Study||15
6691514|NCT02738138|7621827|FG000|NOT COMPLETED|Overall Study||3
6691515|NCT02738138|7621828|FG001|NOT COMPLETED|Overall Study||1
6691516|NCT02738151|7621835|FG000|STARTED|Overall Study||466
6691517|NCT02738151|7621836|FG001|STARTED|Overall Study||463
6691518|NCT02738151|7621835|FG000|Treated|Overall Study||462
6691519|NCT02738151|7621836|FG001|Treated|Overall Study||462
6691520|NCT02738151|7621835|FG000|COMPLETED|Overall Study||443
6691521|NCT02738151|7621836|FG001|COMPLETED|Overall Study||432
6691522|NCT02738151|7621835|FG000|NOT COMPLETED|Overall Study||23
6691523|NCT02738151|7621836|FG001|NOT COMPLETED|Overall Study||31
6691524|NCT02738203|7621844|FG000|STARTED|Overall Study||110
6691525|NCT02738203|7621845|FG001|STARTED|Overall Study||110
6691526|NCT02738203|7621844|FG000|COMPLETED|Overall Study||108
6691527|NCT02738203|7621845|FG001|COMPLETED|Overall Study||107
6691528|NCT02738203|7621844|FG000|NOT COMPLETED|Overall Study||2
6691529|NCT02738203|7621845|FG001|NOT COMPLETED|Overall Study||3
6691530|NCT02738333|7621854|FG000|STARTED|Overall Study||106
6691531|NCT02738333|7621855|FG001|STARTED|Overall Study||108
6691532|NCT02738333|7621856|FG002|STARTED|Overall Study||25
6691533|NCT02738333|7621854|FG000|COMPLETED|Overall Study||104
6691534|NCT02738333|7621855|FG001|COMPLETED|Overall Study||108
6691535|NCT02738333|7621856|FG002|COMPLETED|Overall Study||25
6691536|NCT02738333|7621854|FG000|NOT COMPLETED|Overall Study||2
6691537|NCT02738333|7621855|FG001|NOT COMPLETED|Overall Study||0
6691538|NCT02738333|7621856|FG002|NOT COMPLETED|Overall Study||0
6691539|NCT02738450|7621868|FG000|STARTED|Overall Study||6
6691540|NCT02738450|7621869|FG001|STARTED|Overall Study||6
6691541|NCT02738450|7621870|FG002|STARTED|Overall Study||4
6691542|NCT02738450|7621868|FG000|COMPLETED|Overall Study||6
6691543|NCT02738450|7621869|FG001|COMPLETED|Overall Study||4
6691544|NCT02738450|7621870|FG002|COMPLETED|Overall Study||4
6691545|NCT02738450|7621868|FG000|NOT COMPLETED|Overall Study||0
6691546|NCT02738450|7621869|FG001|NOT COMPLETED|Overall Study||2
6691547|NCT02738450|7621870|FG002|NOT COMPLETED|Overall Study||0
6691548|NCT02738580|7621881|FG000|STARTED|Overall Study|56 patients were assigned to this arms.|56
6691549|NCT02738580|7621882|FG001|STARTED|Overall Study||56
6691550|NCT02738580|7621881|FG000|COMPLETED|Overall Study|"3 cycles cancelled due to por response to stimullation.~1 cycle cancelled due to SAE."|52
6691551|NCT02738580|7621882|FG001|COMPLETED|Overall Study|"2 cycles cancelled due to por response to stimullation~1 patient withdrawal~1 excluded"|52
6691552|NCT02738580|7621881|FG000|NOT COMPLETED|Overall Study||4
6691553|NCT02738580|7621882|FG001|NOT COMPLETED|Overall Study||4
6691554|NCT02738775|7621894|FG000|STARTED|Overall Study||8
6691555|NCT02738775|7621895|FG001|STARTED|Overall Study||8
6691556|NCT02738775|7621896|FG002|STARTED|Overall Study||8
6691557|NCT02738775|7621897|FG003|STARTED|Overall Study||9
6691558|NCT02738775|7621898|FG004|STARTED|Overall Study||8
6691559|NCT02738775|7621899|FG005|STARTED|Overall Study||8
6691560|NCT02738775|7621894|FG000|Initially Treated With Placebo|Overall Study||0
6691561|NCT02738775|7621895|FG001|Initially Treated With Placebo|Overall Study||0
6691562|NCT02738775|7621896|FG002|Initially Treated With Placebo|Overall Study||0
6691563|NCT02738775|7621897|FG003|Initially Treated With Placebo|Overall Study||1
6691564|NCT02738775|7621898|FG004|Initially Treated With Placebo|Overall Study||0
6691565|NCT02738775|7621899|FG005|Initially Treated With Placebo|Overall Study||0
6691566|NCT02738775|7621894|FG000|COMPLETED|Overall Study||8
6691567|NCT02738775|7621895|FG001|COMPLETED|Overall Study||6
6691568|NCT02738775|7621896|FG002|COMPLETED|Overall Study||8
6691569|NCT02738775|7621897|FG003|COMPLETED|Overall Study||8
6691570|NCT02738775|7621898|FG004|COMPLETED|Overall Study||8
6691571|NCT02738775|7621899|FG005|COMPLETED|Overall Study||7
6691572|NCT02738775|7621894|FG000|NOT COMPLETED|Overall Study||0
6691573|NCT02738775|7621895|FG001|NOT COMPLETED|Overall Study||2
6691574|NCT02738775|7621896|FG002|NOT COMPLETED|Overall Study||0
6691575|NCT02738775|7621897|FG003|NOT COMPLETED|Overall Study||1
6691576|NCT02738775|7621898|FG004|NOT COMPLETED|Overall Study||0
6691577|NCT02738775|7621899|FG005|NOT COMPLETED|Overall Study||1
6691578|NCT02738801|7621919|FG000|STARTED|Overall Study||6
6691579|NCT02738801|7621920|FG001|STARTED|Overall Study||17
6691580|NCT02738801|7621919|FG000|COMPLETED|Overall Study||5
6691581|NCT02738801|7621920|FG001|COMPLETED|Overall Study||15
6691582|NCT02738801|7621919|FG000|NOT COMPLETED|Overall Study||1
6691583|NCT02738801|7621920|FG001|NOT COMPLETED|Overall Study||2
6691584|NCT02738840|7621927|FG000|STARTED|Overall Study||56
6691585|NCT02738840|7621927|FG000|COMPLETED|Overall Study||48
6691586|NCT02738840|7621927|FG000|NOT COMPLETED|Overall Study||8
6691587|NCT02738879|7621933|FG000|STARTED|Overall Study||374
6691588|NCT02738879|7621934|FG001|STARTED|Overall Study||372
6691589|NCT02738879|7621933|FG000|Treated|Overall Study||373
6691590|NCT02738879|7621934|FG001|Treated|Overall Study||370
6691591|NCT02738879|7621933|FG000|COMPLETED|Overall Study||361
6691592|NCT02738879|7621934|FG001|COMPLETED|Overall Study||347
6691593|NCT02738879|7621933|FG000|NOT COMPLETED|Overall Study||13
6691594|NCT02738879|7621934|FG001|NOT COMPLETED|Overall Study||25
6691595|NCT02739100|7621940|FG000|STARTED|Overall Study||13
6691596|NCT02739100|7621940|FG000|Triferic 2 Micromolar Via Hemodialysate|Overall Study||13
6691597|NCT02739100|7621940|FG000|Triferic 6.6 mg IV Predialyzer|Overall Study||13
6691598|NCT02739100|7621940|FG000|Triferic 6.6. mg IV Post-dialyzer|Overall Study||13
6691599|NCT02739100|7621940|FG000|COMPLETED|Overall Study||13
6691600|NCT02739100|7621940|FG000|NOT COMPLETED|Overall Study||0
6691601|NCT02739269|7621950|FG000|STARTED|Overall Study||100
6258211|NCT02983799|7157500|FG004|NOT COMPLETED|Overall Study||10
6258212|NCT02971683|7157518|FG000|STARTED|Overall Study||75
6258213|NCT02971683|7157519|FG001|STARTED|Overall Study||73
6258214|NCT02971683|7157518|FG000|COMPLETED|Overall Study||69
6258215|NCT02971683|7157519|FG001|COMPLETED|Overall Study||65
6258216|NCT02971683|7157518|FG000|NOT COMPLETED|Overall Study||6
6258217|NCT02971683|7157519|FG001|NOT COMPLETED|Overall Study||8
6258218|NCT02682992|7157525|FG000|STARTED|Overall Study||47
6258219|NCT02682992|7157525|FG000|COMPLETED|Overall Study||47
6258220|NCT02682992|7157525|FG000|NOT COMPLETED|Overall Study||0
6258221|NCT02631577|7157531|FG000|STARTED|Overall Study||4
6258222|NCT02631577|7157532|FG001|STARTED|Overall Study||34
6258223|NCT02631577|7157531|FG000|COMPLETED|Overall Study||3
6258224|NCT02631577|7157532|FG001|COMPLETED|Overall Study||24
6258225|NCT02631577|7157531|FG000|NOT COMPLETED|Overall Study||1
6258226|NCT02631577|7157532|FG001|NOT COMPLETED|Overall Study||10
6258227|NCT02573779|7157540|FG000|STARTED|Overall Study||74
6258228|NCT02573779|7157541|FG001|STARTED|Overall Study||43
6258229|NCT02573779|7157540|FG000|COMPLETED|Overall Study||74
6258230|NCT02573779|7157541|FG001|COMPLETED|Overall Study||43
6258231|NCT02573779|7157540|FG000|NOT COMPLETED|Overall Study||0
6258232|NCT02573779|7157541|FG001|NOT COMPLETED|Overall Study||0
6280033|NCT00151281|7179957|FG000|COMPLETED|Overall Study||22
6280034|NCT00151281|7179957|FG000|NOT COMPLETED|Overall Study||3
6280035|NCT00151320|7179964|FG000|STARTED|Overall Study||76
6280036|NCT00151320|7179964|FG000|COMPLETED|Overall Study||76
6280037|NCT00151320|7179964|FG000|NOT COMPLETED|Overall Study||0
6280038|NCT00151372|7179971|FG000|STARTED|Overall Study||67
6280039|NCT00151372|7179972|FG001|STARTED|Overall Study||74
6280040|NCT00151372|7179971|FG000|COMPLETED|Overall Study||38
6280041|NCT00151372|7179972|FG001|COMPLETED|Overall Study||45
6280042|NCT00151372|7179971|FG000|NOT COMPLETED|Overall Study||29
6280043|NCT00151372|7179972|FG001|NOT COMPLETED|Overall Study||29
6280044|NCT00151411|7179980|FG000|STARTED|Overall Study||55
6280045|NCT00151411|7179981|FG001|STARTED|Overall Study||59
6280046|NCT00151411|7179980|FG000|COMPLETED|Overall Study||22
6280047|NCT00151411|7179981|FG001|COMPLETED|Overall Study||16
6280048|NCT00151411|7179980|FG000|NOT COMPLETED|Overall Study||33
6280049|NCT00151411|7179981|FG001|NOT COMPLETED|Overall Study||43
6280050|NCT00151476|7179990|FG000|STARTED|FAP Identified Subjects||13
6280051|NCT00151476|7179991|FG001|STARTED|FAP Identified Subjects||55
6280052|NCT00151476|7179990|FG000|COMPLETED|FAP Identified Subjects||13
6280053|NCT00151476|7179991|FG001|COMPLETED|FAP Identified Subjects||54
6280054|NCT00151476|7179990|FG000|NOT COMPLETED|FAP Identified Subjects||0
6280055|NCT00151476|7179991|FG001|NOT COMPLETED|FAP Identified Subjects||1
6280056|NCT00151476|7179990|FG000|STARTED|FAP Analyzed Subjects||13
6280057|NCT00151476|7179991|FG001|STARTED|FAP Analyzed Subjects||54
6280058|NCT00151476|7179990|FG000|COMPLETED|FAP Analyzed Subjects||13
6280059|NCT00151476|7179991|FG001|COMPLETED|FAP Analyzed Subjects||51
6280060|NCT00151476|7179990|FG000|NOT COMPLETED|FAP Analyzed Subjects||0
6280061|NCT00151476|7179991|FG001|NOT COMPLETED|FAP Analyzed Subjects||3
6280062|NCT00151775|7180003|FG000|STARTED|Period 2 - Double-Blind Dose Response||95
6280063|NCT00151775|7180004|FG001|STARTED|Period 2 - Double-Blind Dose Response||95
6280064|NCT00151775|7180005|FG002|STARTED|Period 2 - Double-Blind Dose Response||0
6280065|NCT00151775|7180006|FG003|STARTED|Period 2 - Double-Blind Dose Response||0
6280066|NCT00151775|7180007|FG004|STARTED|Period 2 - Double-Blind Dose Response||0
6280067|NCT00151775|7180008|FG005|STARTED|Period 2 - Double-Blind Dose Response||56
6280068|NCT00151775|7180009|FG006|STARTED|Period 2 - Double-Blind Dose Response||56
6280069|NCT00151775|7180010|FG007|STARTED|Period 2 - Double-Blind Dose Response||0
6280070|NCT00151775|7180011|FG008|STARTED|Period 2 - Double-Blind Dose Response||0
6280071|NCT00151775|7180012|FG009|STARTED|Period 2 - Double-Blind Dose Response||0
6280072|NCT00151775|7180013|FG010|STARTED|Period 2 - Double-Blind Dose Response||60
6280073|NCT00151775|7180014|FG011|STARTED|Period 2 - Double-Blind Dose Response||0
6280074|NCT00151775|7180003|FG000|COMPLETED|Period 2 - Double-Blind Dose Response||93
6280075|NCT00151775|7180004|FG001|COMPLETED|Period 2 - Double-Blind Dose Response||89
6280076|NCT00151775|7180005|FG002|COMPLETED|Period 2 - Double-Blind Dose Response||0
6280077|NCT00151775|7180006|FG003|COMPLETED|Period 2 - Double-Blind Dose Response||0
6691602|NCT02739269|7621951|FG001|STARTED|Overall Study||100
6280078|NCT00151775|7180007|FG004|COMPLETED|Period 2 - Double-Blind Dose Response||0
6281041|NCT00161473|7180919|FG000|STARTED|Overall Study||12
6691603|NCT02739269|7621950|FG000|COMPLETED|Overall Study||93
6691604|NCT02739269|7621951|FG001|COMPLETED|Overall Study||96
6691605|NCT02739269|7621950|FG000|NOT COMPLETED|Overall Study||7
6691606|NCT02739269|7621951|FG001|NOT COMPLETED|Overall Study||4
6691607|NCT02739321|7621959|FG000|STARTED|Overall Study||23
6691608|NCT02739321|7621960|FG001|STARTED|Overall Study||22
6691609|NCT02739321|7621959|FG000|COMPLETED|Overall Study||20
6691610|NCT02739321|7621960|FG001|COMPLETED|Overall Study||18
6691611|NCT02739321|7621959|FG000|NOT COMPLETED|Overall Study||3
6691612|NCT02739321|7621960|FG001|NOT COMPLETED|Overall Study||4
6691613|NCT02739360|7621975|FG000|STARTED|Overall Study||3
6691614|NCT02739360|7621975|FG000|COMPLETED|Overall Study||0
6691615|NCT02739360|7621975|FG000|NOT COMPLETED|Overall Study||3
6691616|NCT02739594|7621981|FG000|STARTED|Overall Study||46
6691617|NCT02739594|7621982|FG001|STARTED|Overall Study||43
6691618|NCT02739594|7621981|FG000|Completed at Week 44|Overall Study||11
6691619|NCT02739594|7621982|FG001|Completed at Week 44|Overall Study||5
6691620|NCT02739594|7621981|FG000|Completed at Week 96|Overall Study||10
6691621|NCT02739594|7621982|FG001|Completed at Week 96|Overall Study||10
6691622|NCT02739594|7621981|FG000|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
6691623|NCT02739594|7621982|FG001|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
6691624|NCT02739594|7621981|FG000|NOT COMPLETED|Overall Study||25
6691625|NCT02739594|7621982|FG001|NOT COMPLETED|Overall Study||28
6691626|NCT02739698|7621991|FG000|STARTED|Overall Study||22
6691627|NCT02739698|7621992|FG001|STARTED|Overall Study||21
6691628|NCT02739698|7621991|FG000|COMPLETED|Overall Study||16
6691629|NCT02739698|7621992|FG001|COMPLETED|Overall Study||16
6691630|NCT02739698|7621991|FG000|NOT COMPLETED|Overall Study||6
6691631|NCT02739698|7621992|FG001|NOT COMPLETED|Overall Study||5
6691632|NCT02739789|7622000|FG000|STARTED|First fMRI Scan||9
6691633|NCT02739789|7622001|FG001|STARTED|First fMRI Scan||10
6691634|NCT02739789|7622000|FG000|COMPLETED|First fMRI Scan||9
6691635|NCT02739789|7622001|FG001|COMPLETED|First fMRI Scan||10
6691636|NCT02739789|7622000|FG000|NOT COMPLETED|First fMRI Scan||0
6691637|NCT02739789|7622001|FG001|NOT COMPLETED|First fMRI Scan||0
6691638|NCT02739789|7622000|FG000|STARTED|~1 Week Waiting Period||9
6691639|NCT02739789|7622001|FG001|STARTED|~1 Week Waiting Period||10
6691640|NCT02739789|7622000|FG000|COMPLETED|~1 Week Waiting Period||9
6691641|NCT02739789|7622001|FG001|COMPLETED|~1 Week Waiting Period||7
6691642|NCT02739789|7622000|FG000|NOT COMPLETED|~1 Week Waiting Period||0
6691643|NCT02739789|7622001|FG001|NOT COMPLETED|~1 Week Waiting Period||3
6691644|NCT02739789|7622000|FG000|STARTED|Second fMRI Scan||9
6691645|NCT02739789|7622001|FG001|STARTED|Second fMRI Scan||7
6691646|NCT02739789|7622000|FG000|COMPLETED|Second fMRI Scan||9
6691647|NCT02739789|7622001|FG001|COMPLETED|Second fMRI Scan||7
6691648|NCT02739789|7622000|FG000|NOT COMPLETED|Second fMRI Scan||0
6691649|NCT02739789|7622001|FG001|NOT COMPLETED|Second fMRI Scan||0
6691650|NCT02739828|7622007|FG000|STARTED|Overall Study||24
6691651|NCT02739828|7622007|FG000|COMPLETED|Overall Study||19
6691652|NCT02739828|7622007|FG000|NOT COMPLETED|Overall Study||5
6691653|NCT02739984|7622013|FG000|STARTED|Overall Study||143
6691654|NCT02739984|7622014|FG001|STARTED|Overall Study||281
6691655|NCT02739984|7622013|FG000|Received Study Drug|Overall Study||141
6691656|NCT02739984|7622014|FG001|Received Study Drug|Overall Study||280
6691657|NCT02739984|7622013|FG000|COMPLETED|Overall Study||138
6691658|NCT02739984|7622014|FG001|COMPLETED|Overall Study||279
6691659|NCT02739984|7622013|FG000|NOT COMPLETED|Overall Study||5
6691660|NCT02739984|7622014|FG001|NOT COMPLETED|Overall Study||2
6691661|NCT02739997|7622020|FG000|STARTED|Overall Study||100
6691662|NCT02739997|7622020|FG000|COMPLETED|Overall Study||98
6691663|NCT02739997|7622020|FG000|NOT COMPLETED|Overall Study||2
6691664|NCT02740049|7622024|FG000|STARTED|Overall Study||9
6691665|NCT02740049|7622024|FG000|COMPLETED|Overall Study||8
6691666|NCT02740049|7622024|FG000|NOT COMPLETED|Overall Study||1
6691667|NCT02740114|7622030|FG000|STARTED|Overall Study||54
6691668|NCT02740114|7622031|FG001|STARTED|Overall Study||48
6691669|NCT02740114|7622030|FG000|COMPLETED|Overall Study||54
6691670|NCT02740114|7622031|FG001|COMPLETED|Overall Study||48
6691671|NCT02740114|7622030|FG000|NOT COMPLETED|Overall Study||0
6691672|NCT02740114|7622031|FG001|NOT COMPLETED|Overall Study||0
6691673|NCT02740153|7622039|FG000|STARTED|Overall Study||101
6691674|NCT02740153|7622040|FG001|STARTED|Overall Study||86
6691675|NCT02740153|7622039|FG000|COMPLETED|Overall Study||101
6691676|NCT02740153|7622040|FG001|COMPLETED|Overall Study||86
6691677|NCT02740153|7622039|FG000|NOT COMPLETED|Overall Study||0
6691678|NCT02740153|7622040|FG001|NOT COMPLETED|Overall Study||0
6691679|NCT02740413|7622048|FG000|STARTED|Overall Study||86
6691680|NCT02740413|7622048|FG000|COMPLETED|Overall Study||86
6691681|NCT02740413|7622048|FG000|NOT COMPLETED|Overall Study||0
6691682|NCT02740478|7622056|FG000|STARTED|Overall Study|Volunteers recruited until quantity 20 completed the study|21
6691683|NCT02740478|7622056|FG000|COMPLETED|Overall Study|One volunteer was very high BMI and uncomfortable lying still during the recordings: test stopped.|20
6691684|NCT02740478|7622056|FG000|NOT COMPLETED|Overall Study||1
6691685|NCT02740504|7622060|FG000|STARTED|Overall Study||20
6691686|NCT02740504|7622060|FG000|COMPLETED|Overall Study||20
6691687|NCT02740504|7622060|FG000|NOT COMPLETED|Overall Study||0
6691688|NCT02740517|7622067|FG000|STARTED|Overall Study||19
6691689|NCT02740517|7622068|FG001|STARTED|Overall Study||11
6691690|NCT02740517|7622069|FG002|STARTED|Overall Study||18
6691691|NCT02740517|7622067|FG000|COMPLETED|Overall Study||19
6691692|NCT02740517|7622068|FG001|COMPLETED|Overall Study||11
6691693|NCT02740517|7622069|FG002|COMPLETED|Overall Study||18
6691694|NCT02740517|7622067|FG000|NOT COMPLETED|Overall Study||0
6691695|NCT02740517|7622068|FG001|NOT COMPLETED|Overall Study||0
6691696|NCT02740517|7622069|FG002|NOT COMPLETED|Overall Study||0
6691697|NCT02740543|7622079|FG000|STARTED|Overall Study||9
6691698|NCT02740543|7622080|FG001|STARTED|Overall Study||9
6691699|NCT02740543|7622079|FG000|COMPLETED|Overall Study||9
6691700|NCT02740543|7622080|FG001|COMPLETED|Overall Study||9
6691701|NCT02740543|7622079|FG000|NOT COMPLETED|Overall Study||0
6691702|NCT02740543|7622080|FG001|NOT COMPLETED|Overall Study||0
6691703|NCT02740582|7622088|FG000|STARTED|First Intervention||29
6691704|NCT02740582|7622089|FG001|STARTED|First Intervention||33
6691705|NCT02740582|7622088|FG000|COMPLETED|First Intervention||24
6691706|NCT02740582|7622089|FG001|COMPLETED|First Intervention||31
6691707|NCT02740582|7622088|FG000|NOT COMPLETED|First Intervention||5
6691708|NCT02740582|7622089|FG001|NOT COMPLETED|First Intervention||2
6691709|NCT02740582|7622088|FG000|STARTED|Washout||24
6691710|NCT02740582|7622089|FG001|STARTED|Washout||31
6691711|NCT02740582|7622088|FG000|COMPLETED|Washout||24
6691712|NCT02740582|7622089|FG001|COMPLETED|Washout||31
6691713|NCT02740582|7622088|FG000|NOT COMPLETED|Washout||0
6258233|NCT02408315|7157549|FG000|STARTED|Overall Study||148
6258234|NCT02408315|7157550|FG001|STARTED|Overall Study||152
6258235|NCT02408315|7157549|FG000|COMPLETED|Overall Study||148
6258236|NCT02408315|7157550|FG001|COMPLETED|Overall Study||152
6258237|NCT02408315|7157549|FG000|NOT COMPLETED|Overall Study||0
6258238|NCT02408315|7157550|FG001|NOT COMPLETED|Overall Study||0
6258239|NCT02300233|7157559|FG000|STARTED|Overall Study||38
6258240|NCT02300233|7157560|FG001|STARTED|Overall Study||25
6258241|NCT02300233|7157561|FG002|STARTED|Overall Study||50
6258242|NCT02300233|7157559|FG000|COMPLETED|Overall Study||34
6258243|NCT02300233|7157560|FG001|COMPLETED|Overall Study||24
6258244|NCT02300233|7157561|FG002|COMPLETED|Overall Study||27
6258245|NCT02300233|7157559|FG000|NOT COMPLETED|Overall Study||4
6258246|NCT02300233|7157560|FG001|NOT COMPLETED|Overall Study||1
6258247|NCT02300233|7157561|FG002|NOT COMPLETED|Overall Study||23
6258248|NCT02211209|7157572|FG000|STARTED|Overall Study||34
6258249|NCT02211209|7157573|FG001|STARTED|Overall Study||33
6258250|NCT02211209|7157572|FG000|Dosed|Overall Study||33
6258251|NCT02211209|7157573|FG001|Dosed|Overall Study||33
6258252|NCT02211209|7157572|FG000|COMPLETED|Overall Study||32
6258253|NCT02211209|7157573|FG001|COMPLETED|Overall Study||19
6258254|NCT02211209|7157572|FG000|NOT COMPLETED|Overall Study||2
6258255|NCT02211209|7157573|FG001|NOT COMPLETED|Overall Study||14
6258256|NCT02125461|7157581|FG000|STARTED|Overall Study||476
6258257|NCT02125461|7157582|FG001|STARTED|Overall Study||237
6258258|NCT02125461|7157581|FG000|Full Analysis Set (FAS)|Overall Study||476
6258259|NCT02125461|7157582|FG001|Full Analysis Set (FAS)|Overall Study||237
6258260|NCT02125461|7157581|FG000|Received Treatment|Overall Study||473
6258261|NCT02125461|7157582|FG001|Received Treatment|Overall Study||236
6258262|NCT02125461|7157581|FG000|Safety Analysis Set|Overall Study||475
6258263|NCT02125461|7157582|FG001|Safety Analysis Set|Overall Study||234
6258264|NCT02125461|7157581|FG000|Completed 12 Months of Treatment|Overall Study||232
6258265|NCT02125461|7157582|FG001|Completed 12 Months of Treatment|Overall Study||82
6258266|NCT02125461|7157581|FG000|COMPLETED|Overall Study||178
6258267|NCT02125461|7157582|FG001|COMPLETED|Overall Study||68
6258268|NCT02125461|7157581|FG000|NOT COMPLETED|Overall Study||298
6258269|NCT02125461|7157582|FG001|NOT COMPLETED|Overall Study||169
6258270|NCT02000115|7157591|FG000|STARTED|Overall Study||381
6258271|NCT02000115|7157592|FG001|STARTED|Overall Study||369
6258272|NCT02000115|7157593|FG002|STARTED|Overall Study||100
6258273|NCT02000115|7157594|FG003|STARTED|Overall Study||53
6258274|NCT02000115|7157591|FG000|COMPLETED|Overall Study|6 subjects missed the One-year follow-up visit|302
6258275|NCT02000115|7157592|FG001|COMPLETED|Overall Study|8 subjects missed the One-year follow-up visit|301
6258276|NCT02000115|7157593|FG002|COMPLETED|Overall Study|1 subject missed the 30 day follow-up visit|99
6258277|NCT02000115|7157594|FG003|COMPLETED|Overall Study||0
6258278|NCT02000115|7157591|FG000|NOT COMPLETED|Overall Study||79
6691714|NCT02740582|7622089|FG001|NOT COMPLETED|Washout||0
6691715|NCT02740582|7622088|FG000|STARTED|Second Intervention||24
6691716|NCT02740582|7622089|FG001|STARTED|Second Intervention||31
6691717|NCT02740582|7622088|FG000|COMPLETED|Second Intervention||23
6691718|NCT02740582|7622089|FG001|COMPLETED|Second Intervention||28
6691719|NCT02740582|7622088|FG000|NOT COMPLETED|Second Intervention||1
6691720|NCT02740582|7622089|FG001|NOT COMPLETED|Second Intervention||3
6691721|NCT02740660|7622097|FG000|STARTED|Overall Study||6
6258279|NCT02000115|7157592|FG001|NOT COMPLETED|Overall Study||68
6258280|NCT02000115|7157593|FG002|NOT COMPLETED|Overall Study||1
6258281|NCT02000115|7157594|FG003|NOT COMPLETED|Overall Study||53
6258282|NCT01888653|7157605|FG000|STARTED|Overall Study||24
6258283|NCT01888653|7157606|FG001|STARTED|Overall Study||26
6258284|NCT01888653|7157605|FG000|COMPLETED|Overall Study||24
6258285|NCT01888653|7157606|FG001|COMPLETED|Overall Study||26
6258286|NCT01888653|7157605|FG000|NOT COMPLETED|Overall Study||0
6258287|NCT01888653|7157606|FG001|NOT COMPLETED|Overall Study||0
6258288|NCT01813227|7157612|FG000|STARTED|Overall Study||7
6691722|NCT02740660|7622098|FG001|STARTED|Overall Study||6
6691723|NCT02740660|7622097|FG000|COMPLETED|Overall Study||6
6691724|NCT02740660|7622098|FG001|COMPLETED|Overall Study||6
6691725|NCT02740660|7622097|FG000|NOT COMPLETED|Overall Study||0
6691726|NCT02740660|7622098|FG001|NOT COMPLETED|Overall Study||0
6691727|NCT02740920|7622104|FG000|STARTED|Overall Study||9
6691728|NCT02740920|7622104|FG000|COMPLETED|Overall Study||9
6691729|NCT02740920|7622104|FG000|NOT COMPLETED|Overall Study||0
6691730|NCT02741076|7622112|FG000|STARTED|Overall Study||13
6691731|NCT02741076|7622113|FG001|STARTED|Overall Study||12
6691732|NCT02741076|7622114|FG002|STARTED|Overall Study||3
6691733|NCT02741076|7622115|FG003|STARTED|Overall Study||4
6691734|NCT02741076|7622112|FG000|COMPLETED|Overall Study||10
6691735|NCT02741076|7622113|FG001|COMPLETED|Overall Study||7
6691736|NCT02741076|7622114|FG002|COMPLETED|Overall Study||1
6691737|NCT02741076|7622115|FG003|COMPLETED|Overall Study||2
6691738|NCT02741076|7622112|FG000|NOT COMPLETED|Overall Study||3
6691739|NCT02741076|7622113|FG001|NOT COMPLETED|Overall Study||5
6691740|NCT02741076|7622114|FG002|NOT COMPLETED|Overall Study||2
6691741|NCT02741076|7622115|FG003|NOT COMPLETED|Overall Study||2
6691742|NCT02741284|7622128|FG000|STARTED|Overall Study||57
6691743|NCT02741284|7622129|FG001|STARTED|Overall Study||57
6691744|NCT02741284|7622128|FG000|COMPLETED|Overall Study||51
6691745|NCT02741284|7622129|FG001|COMPLETED|Overall Study||48
6691746|NCT02741284|7622128|FG000|NOT COMPLETED|Overall Study||6
6691747|NCT02741284|7622129|FG001|NOT COMPLETED|Overall Study||9
6691748|NCT02741297|7622137|FG000|STARTED|Overall Study||73
6691749|NCT02741297|7622137|FG000|COMPLETED|Overall Study||59
6691750|NCT02741297|7622137|FG000|NOT COMPLETED|Overall Study||14
6691751|NCT02741310|7622143|FG000|STARTED|Overall Study||12
6691752|NCT02741310|7622144|FG001|STARTED|Overall Study||22
6691753|NCT02741310|7622143|FG000|COMPLETED|Overall Study||10
6691754|NCT02741310|7622144|FG001|COMPLETED|Overall Study||20
6691755|NCT02741310|7622143|FG000|NOT COMPLETED|Overall Study||2
6691756|NCT02741310|7622144|FG001|NOT COMPLETED|Overall Study||2
6691757|NCT02741518|7622160|FG000|STARTED|Overall Study||11
6691758|NCT02741518|7622161|FG001|STARTED|Overall Study||11
6691759|NCT02741518|7622160|FG000|COMPLETED|Overall Study||10
6691760|NCT02741518|7622161|FG001|COMPLETED|Overall Study||10
6691761|NCT02741518|7622160|FG000|NOT COMPLETED|Overall Study||1
6691762|NCT02741518|7622161|FG001|NOT COMPLETED|Overall Study||1
6691763|NCT02741596|7622169|FG000|STARTED|Overall Study||109
6691764|NCT02741596|7622170|FG001|STARTED|Overall Study||103
6691765|NCT02741596|7622169|FG000|COMPLETED|Overall Study||31
6691766|NCT02741596|7622170|FG001|COMPLETED|Overall Study||25
6691767|NCT02741596|7622169|FG000|NOT COMPLETED|Overall Study||78
6691768|NCT02741596|7622170|FG001|NOT COMPLETED|Overall Study||78
6691769|NCT02741635|7622176|FG000|STARTED|Overall Study||15
6691770|NCT02741635|7622176|FG000|COMPLETED|Overall Study||14
6691771|NCT02741635|7622176|FG000|NOT COMPLETED|Overall Study||1
6691772|NCT02741687|7622183|FG000|STARTED|Overall Study||36
6691773|NCT02741687|7622184|FG001|STARTED|Overall Study||44
6691774|NCT02741687|7622183|FG000|COMPLETED|Overall Study||36
6691775|NCT02741687|7622184|FG001|COMPLETED|Overall Study||44
6691776|NCT02741687|7622183|FG000|NOT COMPLETED|Overall Study||0
6691777|NCT02741687|7622184|FG001|NOT COMPLETED|Overall Study||0
6691778|NCT02741713|7622192|FG000|STARTED|Overall Study||20
6691779|NCT02741713|7622193|FG001|STARTED|Overall Study||20
6691780|NCT02741713|7622192|FG000|COMPLETED|Overall Study||18
6691781|NCT02741713|7622193|FG001|COMPLETED|Overall Study||19
6691782|NCT02741713|7622192|FG000|NOT COMPLETED|Overall Study||2
6691783|NCT02741713|7622193|FG001|NOT COMPLETED|Overall Study||1
6691784|NCT02742077|7622200|FG000|STARTED|Overall Study||20
6691785|NCT02742077|7622200|FG000|COMPLETED|Overall Study||20
6691786|NCT02742077|7622200|FG000|NOT COMPLETED|Overall Study||0
6691787|NCT02742103|7622206|FG000|STARTED|Overall Study||55
6691788|NCT02742103|7622207|FG001|STARTED|Overall Study||28
6691789|NCT02742103|7622206|FG000|COMPLETED|Overall Study||46
6691790|NCT02742103|7622207|FG001|COMPLETED|Overall Study||23
6691791|NCT02742103|7622206|FG000|NOT COMPLETED|Overall Study||9
6691792|NCT02742103|7622207|FG001|NOT COMPLETED|Overall Study||5
6691793|NCT02742129|7622215|FG000|STARTED|Phase 1||53
6691794|NCT02742129|7622216|FG001|STARTED|Phase 1||52
6691795|NCT02742129|7622215|FG000|COMPLETED|Phase 1||51
6691796|NCT02742129|7622216|FG001|COMPLETED|Phase 1||50
6691797|NCT02742129|7622215|FG000|NOT COMPLETED|Phase 1||2
6691798|NCT02742129|7622216|FG001|NOT COMPLETED|Phase 1||2
6691799|NCT02742129|7622215|FG000|STARTED|Phase 2||51
6691800|NCT02742129|7622216|FG001|STARTED|Phase 2||50
6691801|NCT02742129|7622215|FG000|COMPLETED|Phase 2||50
6691802|NCT02742129|7622216|FG001|COMPLETED|Phase 2||48
6691803|NCT02742129|7622215|FG000|NOT COMPLETED|Phase 2||1
6691804|NCT02742129|7622216|FG001|NOT COMPLETED|Phase 2||2
6691805|NCT02742441|7622227|FG000|STARTED|Overall Study||205
6691806|NCT02742441|7622228|FG001|STARTED|Overall Study||204
6691807|NCT02742441|7622227|FG000|COMPLETED|Overall Study||199
6691808|NCT02742441|7622228|FG001|COMPLETED|Overall Study||196
6691809|NCT02742441|7622227|FG000|NOT COMPLETED|Overall Study||6
6691810|NCT02742441|7622228|FG001|NOT COMPLETED|Overall Study||8
6691811|NCT02742519|7622236|FG000|STARTED|Part 1 Treatment Period 1 (8 Weeks)||8
6691812|NCT02742519|7622237|FG001|STARTED|Part 1 Treatment Period 1 (8 Weeks)||6
6691813|NCT02742519|7622238|FG002|STARTED|Part 1 Treatment Period 1 (8 Weeks)||0
6691814|NCT02742519|7622236|FG000|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||8
6691815|NCT02742519|7622237|FG001|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||6
6691816|NCT02742519|7622238|FG002|COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
6691817|NCT02742519|7622236|FG000|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
6691818|NCT02742519|7622237|FG001|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
6691819|NCT02742519|7622238|FG002|NOT COMPLETED|Part 1 Treatment Period 1 (8 Weeks)||0
6691820|NCT02742519|7622236|FG000|STARTED|Part 1 Treatment Period 2 (8 Weeks)||8
6691821|NCT02742519|7622237|FG001|STARTED|Part 1 Treatment Period 2 (8 Weeks)||6
6691822|NCT02742519|7622238|FG002|STARTED|Part 1 Treatment Period 2 (8 Weeks)||0
6691823|NCT02742519|7622236|FG000|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||7
6691824|NCT02742519|7622237|FG001|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||5
6691825|NCT02742519|7622238|FG002|COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
6691826|NCT02742519|7622236|FG000|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
6691827|NCT02742519|7622237|FG001|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||1
6691828|NCT02742519|7622238|FG002|NOT COMPLETED|Part 1 Treatment Period 2 (8 Weeks)||0
6691829|NCT02742519|7622236|FG000|STARTED|Part 2 Open Label Period (32 Weeks)||0
6691830|NCT02742519|7622237|FG001|STARTED|Part 2 Open Label Period (32 Weeks)||0
6691831|NCT02742519|7622238|FG002|STARTED|Part 2 Open Label Period (32 Weeks)|Of 12 participants who completed DB period, only 10 entered OL period & 2 opted for commercial drug.|10
6691832|NCT02742519|7622236|FG000|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6691833|NCT02742519|7622237|FG001|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6691834|NCT02742519|7622238|FG002|COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6691835|NCT02742519|7622236|FG000|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6691836|NCT02742519|7622237|FG001|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||0
6691837|NCT02742519|7622238|FG002|NOT COMPLETED|Part 2 Open Label Period (32 Weeks)||10
6691838|NCT02742532|7622248|FG000|STARTED|Overall Study||31
6691839|NCT02742532|7622249|FG001|STARTED|Overall Study||32
6691840|NCT02742532|7622248|FG000|COMPLETED|Overall Study||28
6691841|NCT02742532|7622249|FG001|COMPLETED|Overall Study||31
6691842|NCT02742532|7622248|FG000|NOT COMPLETED|Overall Study||3
6258289|NCT01813227|7157612|FG000|COMPLETED|Overall Study||7
6258290|NCT01813227|7157612|FG000|NOT COMPLETED|Overall Study||0
6258291|NCT01695317|7157618|FG000|STARTED|Period 1 in the Cross-over Design||36
6258292|NCT01695317|7157619|FG001|STARTED|Period 1 in the Cross-over Design||36
6258293|NCT01695317|7157618|FG000|COMPLETED|Period 1 in the Cross-over Design||34
6258294|NCT01695317|7157619|FG001|COMPLETED|Period 1 in the Cross-over Design||35
6258295|NCT01695317|7157618|FG000|NOT COMPLETED|Period 1 in the Cross-over Design||2
6258296|NCT01695317|7157619|FG001|NOT COMPLETED|Period 1 in the Cross-over Design||1
6258297|NCT01695317|7157618|FG000|STARTED|Cross-over to Period 2||34
6258298|NCT01695317|7157619|FG001|STARTED|Cross-over to Period 2||35
6258299|NCT01695317|7157618|FG000|COMPLETED|Cross-over to Period 2||30
6258300|NCT01695317|7157619|FG001|COMPLETED|Cross-over to Period 2||1
6258301|NCT01695317|7157618|FG000|NOT COMPLETED|Cross-over to Period 2||4
6258302|NCT01695317|7157619|FG001|NOT COMPLETED|Cross-over to Period 2||34
6258303|NCT01683825|7157628|FG000|STARTED|Overall Study||10
6258304|NCT01683825|7157629|FG001|STARTED|Overall Study||6
6258305|NCT01683825|7157630|FG002|STARTED|Overall Study||7
6258306|NCT01683825|7157628|FG000|COMPLETED|Overall Study||10
6258307|NCT01683825|7157629|FG001|COMPLETED|Overall Study||6
6258308|NCT01683825|7157630|FG002|COMPLETED|Overall Study||7
6258309|NCT01683825|7157628|FG000|NOT COMPLETED|Overall Study||0
6258310|NCT01683825|7157629|FG001|NOT COMPLETED|Overall Study||0
6258311|NCT01683825|7157630|FG002|NOT COMPLETED|Overall Study||0
6258312|NCT01515748|7157641|FG000|STARTED|Overall Study||264
6258313|NCT01515748|7157642|FG001|STARTED|Overall Study||266
6258314|NCT01515748|7157641|FG000|Treated|Overall Study||195
6258315|NCT01515748|7157642|FG001|Treated|Overall Study||241
6258316|NCT01515748|7157641|FG000|COMPLETED|Overall Study||144
6258317|NCT01515748|7157642|FG001|COMPLETED|Overall Study||131
6258318|NCT01515748|7157641|FG000|NOT COMPLETED|Overall Study||120
6258319|NCT01515748|7157642|FG001|NOT COMPLETED|Overall Study||135
6258320|NCT01196936|7157651|FG000|STARTED|Overall Study||34
6258321|NCT01196936|7157652|FG001|STARTED|Overall Study||38
6258322|NCT01196936|7157651|FG000|Year One Post Treatment|Overall Study||27
6258323|NCT01196936|7157652|FG001|Year One Post Treatment|Overall Study||28
6258324|NCT01196936|7157651|FG000|COMPLETED|Overall Study||23
6258325|NCT01196936|7157652|FG001|COMPLETED|Overall Study||21
6258326|NCT01196936|7157651|FG000|NOT COMPLETED|Overall Study||11
6258327|NCT01196936|7157652|FG001|NOT COMPLETED|Overall Study||17
6258328|NCT01127451|7157660|FG000|STARTED|Overall Study||43
6258329|NCT01127451|7157661|FG001|STARTED|Overall Study||32
6258330|NCT01127451|7157660|FG000|Safety Analysis Set|Overall Study||43
6258331|NCT01127451|7157661|FG001|Safety Analysis Set|Overall Study||32
6258332|NCT01127451|7157660|FG000|Modified Intent-to-Treat (MITT)|Overall Study||42
6258333|NCT01127451|7157661|FG001|Modified Intent-to-Treat (MITT)|Overall Study||32
6258334|NCT01127451|7157660|FG000|COMPLETED|Overall Study||0
6258335|NCT01127451|7157661|FG001|COMPLETED|Overall Study||0
6258336|NCT01127451|7157660|FG000|NOT COMPLETED|Overall Study||43
6258337|NCT01127451|7157661|FG001|NOT COMPLETED|Overall Study||32
6258338|NCT01004874|7157667|FG000|STARTED|Overall Study||80
6258339|NCT01004874|7157667|FG000|COMPLETED|Overall Study||80
6258340|NCT01004874|7157667|FG000|NOT COMPLETED|Overall Study||0
6280079|NCT00151775|7180008|FG005|COMPLETED|Period 2 - Double-Blind Dose Response||54
6280080|NCT00151775|7180009|FG006|COMPLETED|Period 2 - Double-Blind Dose Response||53
6280081|NCT00151775|7180010|FG007|COMPLETED|Period 2 - Double-Blind Dose Response||0
6280082|NCT00151775|7180011|FG008|COMPLETED|Period 2 - Double-Blind Dose Response||0
6280083|NCT00151775|7180012|FG009|COMPLETED|Period 2 - Double-Blind Dose Response||0
6280084|NCT00151775|7180013|FG010|COMPLETED|Period 2 - Double-Blind Dose Response||59
6280085|NCT00151775|7180014|FG011|COMPLETED|Period 2 - Double-Blind Dose Response||0
6691843|NCT02742532|7622249|FG001|NOT COMPLETED|Overall Study||1
6691844|NCT02742649|7622258|FG000|STARTED|Pre-Randomization Washout Period||55
6691845|NCT02742649|7622259|FG001|STARTED|Pre-Randomization Washout Period||0
6691846|NCT02742649|7622260|FG002|STARTED|Pre-Randomization Washout Period||0
6691847|NCT02742649|7622261|FG003|STARTED|Pre-Randomization Washout Period||0
6691848|NCT02742649|7622262|FG004|STARTED|Pre-Randomization Washout Period||0
6691849|NCT02742649|7622258|FG000|COMPLETED|Pre-Randomization Washout Period||50
6691850|NCT02742649|7622259|FG001|COMPLETED|Pre-Randomization Washout Period||0
6691851|NCT02742649|7622260|FG002|COMPLETED|Pre-Randomization Washout Period||0
6691852|NCT02742649|7622261|FG003|COMPLETED|Pre-Randomization Washout Period||0
6691853|NCT02742649|7622262|FG004|COMPLETED|Pre-Randomization Washout Period||0
6691854|NCT02742649|7622258|FG000|NOT COMPLETED|Pre-Randomization Washout Period||5
6691855|NCT02742649|7622259|FG001|NOT COMPLETED|Pre-Randomization Washout Period||0
6691856|NCT02742649|7622260|FG002|NOT COMPLETED|Pre-Randomization Washout Period||0
6691857|NCT02742649|7622261|FG003|NOT COMPLETED|Pre-Randomization Washout Period||0
6691858|NCT02742649|7622262|FG004|NOT COMPLETED|Pre-Randomization Washout Period||0
6691859|NCT02742649|7622258|FG000|STARTED|Double-Blind Treatment Period||0
6691860|NCT02742649|7622259|FG001|STARTED|Double-Blind Treatment Period||17
6691861|NCT02742649|7622260|FG002|STARTED|Double-Blind Treatment Period||17
6691862|NCT02742649|7622261|FG003|STARTED|Double-Blind Treatment Period||16
6691863|NCT02742649|7622262|FG004|STARTED|Double-Blind Treatment Period||0
6691864|NCT02742649|7622258|FG000|COMPLETED|Double-Blind Treatment Period||0
6691865|NCT02742649|7622259|FG001|COMPLETED|Double-Blind Treatment Period||16
6691866|NCT02742649|7622260|FG002|COMPLETED|Double-Blind Treatment Period||17
6691867|NCT02742649|7622261|FG003|COMPLETED|Double-Blind Treatment Period||16
6691868|NCT02742649|7622262|FG004|COMPLETED|Double-Blind Treatment Period||0
6691869|NCT02742649|7622258|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6691870|NCT02742649|7622259|FG001|NOT COMPLETED|Double-Blind Treatment Period||1
6691871|NCT02742649|7622260|FG002|NOT COMPLETED|Double-Blind Treatment Period||0
6691872|NCT02742649|7622261|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
6691873|NCT02742649|7622262|FG004|NOT COMPLETED|Double-Blind Treatment Period||0
6691874|NCT02742649|7622258|FG000|STARTED|Open-Label Period||0
6691875|NCT02742649|7622259|FG001|STARTED|Open-Label Period||0
6691876|NCT02742649|7622260|FG002|STARTED|Open-Label Period||0
6691877|NCT02742649|7622261|FG003|STARTED|Open-Label Period||0
6691878|NCT02742649|7622262|FG004|STARTED|Open-Label Period||49
6691879|NCT02742649|7622258|FG000|COMPLETED|Open-Label Period||0
6691880|NCT02742649|7622259|FG001|COMPLETED|Open-Label Period||0
6691881|NCT02742649|7622260|FG002|COMPLETED|Open-Label Period||0
6691882|NCT02742649|7622261|FG003|COMPLETED|Open-Label Period||0
6691883|NCT02742649|7622262|FG004|COMPLETED|Open-Label Period||48
6691884|NCT02742649|7622258|FG000|NOT COMPLETED|Open-Label Period||0
6691885|NCT02742649|7622259|FG001|NOT COMPLETED|Open-Label Period||0
6691886|NCT02742649|7622260|FG002|NOT COMPLETED|Open-Label Period||0
6691887|NCT02742649|7622261|FG003|NOT COMPLETED|Open-Label Period||0
6691888|NCT02742649|7622262|FG004|NOT COMPLETED|Open-Label Period||1
6691889|NCT02742766|7622292|FG000|STARTED|Part 1 (Up to 8 Days)||20
6691890|NCT02742766|7622293|FG001|STARTED|Part 1 (Up to 8 Days)||6
6691891|NCT02742766|7622294|FG002|STARTED|Part 1 (Up to 8 Days)||6
6691892|NCT02742766|7622295|FG003|STARTED|Part 1 (Up to 8 Days)||6
6691893|NCT02742766|7622296|FG004|STARTED|Part 1 (Up to 8 Days)||6
6691894|NCT02742766|7622297|FG005|STARTED|Part 1 (Up to 8 Days)||6
6691895|NCT02742766|7622298|FG006|STARTED|Part 1 (Up to 8 Days)||6
6691896|NCT02742766|7622299|FG007|STARTED|Part 1 (Up to 8 Days)||6
6691897|NCT02742766|7622300|FG008|STARTED|Part 1 (Up to 8 Days)||6
6691898|NCT02742766|7622301|FG009|STARTED|Part 1 (Up to 8 Days)||0
6691899|NCT02742766|7622302|FG010|STARTED|Part 1 (Up to 8 Days)||6
6691900|NCT02742766|7622303|FG011|STARTED|Part 1 (Up to 8 Days)||6
6691901|NCT02742766|7622304|FG012|STARTED|Part 1 (Up to 8 Days)||0
6691902|NCT02742766|7622305|FG013|STARTED|Part 1 (Up to 8 Days)||0
6691903|NCT02742766|7622306|FG014|STARTED|Part 1 (Up to 8 Days)||0
6691904|NCT02742766|7622307|FG015|STARTED|Part 1 (Up to 8 Days)||0
6691905|NCT02742766|7622308|FG016|STARTED|Part 1 (Up to 8 Days)||0
6691906|NCT02742766|7622309|FG017|STARTED|Part 1 (Up to 8 Days)||0
6691907|NCT02742766|7622310|FG018|STARTED|Part 1 (Up to 8 Days)||0
6691908|NCT02742766|7622292|FG000|COMPLETED|Part 1 (Up to 8 Days)||20
6691909|NCT02742766|7622293|FG001|COMPLETED|Part 1 (Up to 8 Days)||6
6691910|NCT02742766|7622294|FG002|COMPLETED|Part 1 (Up to 8 Days)||6
6691911|NCT02742766|7622295|FG003|COMPLETED|Part 1 (Up to 8 Days)||6
6691912|NCT02742766|7622296|FG004|COMPLETED|Part 1 (Up to 8 Days)||6
6691913|NCT02742766|7622297|FG005|COMPLETED|Part 1 (Up to 8 Days)||6
6691914|NCT02742766|7622298|FG006|COMPLETED|Part 1 (Up to 8 Days)||6
6691915|NCT02742766|7622299|FG007|COMPLETED|Part 1 (Up to 8 Days)||6
6691916|NCT02742766|7622300|FG008|COMPLETED|Part 1 (Up to 8 Days)||6
6691917|NCT02742766|7622301|FG009|COMPLETED|Part 1 (Up to 8 Days)||0
6691918|NCT02742766|7622302|FG010|COMPLETED|Part 1 (Up to 8 Days)||6
6691919|NCT02742766|7622303|FG011|COMPLETED|Part 1 (Up to 8 Days)||6
6691920|NCT02742766|7622304|FG012|COMPLETED|Part 1 (Up to 8 Days)||0
6691921|NCT02742766|7622305|FG013|COMPLETED|Part 1 (Up to 8 Days)||0
6691922|NCT02742766|7622306|FG014|COMPLETED|Part 1 (Up to 8 Days)||0
6691923|NCT02742766|7622307|FG015|COMPLETED|Part 1 (Up to 8 Days)||0
6691924|NCT02742766|7622308|FG016|COMPLETED|Part 1 (Up to 8 Days)||0
6691925|NCT02742766|7622309|FG017|COMPLETED|Part 1 (Up to 8 Days)||0
6691926|NCT02742766|7622310|FG018|COMPLETED|Part 1 (Up to 8 Days)||0
6691927|NCT02742766|7622292|FG000|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691928|NCT02742766|7622293|FG001|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691929|NCT02742766|7622294|FG002|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691930|NCT02742766|7622295|FG003|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691931|NCT02742766|7622296|FG004|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691932|NCT02742766|7622297|FG005|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691933|NCT02742766|7622298|FG006|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691934|NCT02742766|7622299|FG007|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691935|NCT02742766|7622300|FG008|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691936|NCT02742766|7622301|FG009|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691937|NCT02742766|7622302|FG010|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691938|NCT02742766|7622303|FG011|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691939|NCT02742766|7622304|FG012|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691940|NCT02742766|7622305|FG013|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691941|NCT02742766|7622306|FG014|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691942|NCT02742766|7622307|FG015|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691943|NCT02742766|7622308|FG016|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691944|NCT02742766|7622309|FG017|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691945|NCT02742766|7622310|FG018|NOT COMPLETED|Part 1 (Up to 8 Days)||0
6691946|NCT02742766|7622292|FG000|STARTED|Part 2 (Up to 22 Days)||0
6691947|NCT02742766|7622293|FG001|STARTED|Part 2 (Up to 22 Days)||0
6691948|NCT02742766|7622294|FG002|STARTED|Part 2 (Up to 22 Days)||0
6691949|NCT02742766|7622295|FG003|STARTED|Part 2 (Up to 22 Days)||0
6691950|NCT02742766|7622296|FG004|STARTED|Part 2 (Up to 22 Days)||0
6691951|NCT02742766|7622297|FG005|STARTED|Part 2 (Up to 22 Days)||0
6691952|NCT02742766|7622298|FG006|STARTED|Part 2 (Up to 22 Days)||0
6691953|NCT02742766|7622299|FG007|STARTED|Part 2 (Up to 22 Days)||0
6691954|NCT02742766|7622300|FG008|STARTED|Part 2 (Up to 22 Days)||0
6691955|NCT02742766|7622301|FG009|STARTED|Part 2 (Up to 22 Days)||0
6691956|NCT02742766|7622302|FG010|STARTED|Part 2 (Up to 22 Days)||0
6691957|NCT02742766|7622303|FG011|STARTED|Part 2 (Up to 22 Days)||0
6691958|NCT02742766|7622304|FG012|STARTED|Part 2 (Up to 22 Days)||6
6691959|NCT02742766|7622305|FG013|STARTED|Part 2 (Up to 22 Days)||6
6691960|NCT02742766|7622306|FG014|STARTED|Part 2 (Up to 22 Days)||6
6691961|NCT02742766|7622307|FG015|STARTED|Part 2 (Up to 22 Days)||6
6691962|NCT02742766|7622308|FG016|STARTED|Part 2 (Up to 22 Days)||0
6691963|NCT02742766|7622309|FG017|STARTED|Part 2 (Up to 22 Days)||0
6691964|NCT02742766|7622310|FG018|STARTED|Part 2 (Up to 22 Days)||0
6691965|NCT02742766|7622292|FG000|COMPLETED|Part 2 (Up to 22 Days)||0
6691966|NCT02742766|7622293|FG001|COMPLETED|Part 2 (Up to 22 Days)||0
6691967|NCT02742766|7622294|FG002|COMPLETED|Part 2 (Up to 22 Days)||0
6691968|NCT02742766|7622295|FG003|COMPLETED|Part 2 (Up to 22 Days)||0
6691969|NCT02742766|7622296|FG004|COMPLETED|Part 2 (Up to 22 Days)||0
6691970|NCT02742766|7622297|FG005|COMPLETED|Part 2 (Up to 22 Days)||0
6691971|NCT02742766|7622298|FG006|COMPLETED|Part 2 (Up to 22 Days)||0
6691972|NCT02742766|7622299|FG007|COMPLETED|Part 2 (Up to 22 Days)||0
6691973|NCT02742766|7622300|FG008|COMPLETED|Part 2 (Up to 22 Days)||0
6691974|NCT02742766|7622301|FG009|COMPLETED|Part 2 (Up to 22 Days)||0
6691975|NCT02742766|7622302|FG010|COMPLETED|Part 2 (Up to 22 Days)||0
6691976|NCT02742766|7622303|FG011|COMPLETED|Part 2 (Up to 22 Days)||0
6691977|NCT02742766|7622304|FG012|COMPLETED|Part 2 (Up to 22 Days)||4
6691978|NCT02742766|7622305|FG013|COMPLETED|Part 2 (Up to 22 Days)||0
6691979|NCT02742766|7622306|FG014|COMPLETED|Part 2 (Up to 22 Days)||6
6691980|NCT02742766|7622307|FG015|COMPLETED|Part 2 (Up to 22 Days)|Day 4 study medication interrupted due to an AE and eventually withdrew from study on Day 5.|5
6691981|NCT02742766|7622308|FG016|COMPLETED|Part 2 (Up to 22 Days)||0
6691982|NCT02742766|7622309|FG017|COMPLETED|Part 2 (Up to 22 Days)||0
6691983|NCT02742766|7622310|FG018|COMPLETED|Part 2 (Up to 22 Days)||0
6691984|NCT02742766|7622292|FG000|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691985|NCT02742766|7622293|FG001|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691986|NCT02742766|7622294|FG002|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691987|NCT02742766|7622295|FG003|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691988|NCT02742766|7622296|FG004|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691989|NCT02742766|7622297|FG005|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691990|NCT02742766|7622298|FG006|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691991|NCT02742766|7622299|FG007|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691992|NCT02742766|7622300|FG008|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691993|NCT02742766|7622301|FG009|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691994|NCT02742766|7622302|FG010|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691995|NCT02742766|7622303|FG011|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691996|NCT02742766|7622304|FG012|NOT COMPLETED|Part 2 (Up to 22 Days)||2
6691997|NCT02742766|7622305|FG013|NOT COMPLETED|Part 2 (Up to 22 Days)||6
6691998|NCT02742766|7622306|FG014|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6691999|NCT02742766|7622307|FG015|NOT COMPLETED|Part 2 (Up to 22 Days)||1
6692000|NCT02742766|7622308|FG016|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6692001|NCT02742766|7622309|FG017|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6692002|NCT02742766|7622310|FG018|NOT COMPLETED|Part 2 (Up to 22 Days)||0
6692003|NCT02742766|7622292|FG000|STARTED|Part 3 (Up to 36 Days)||0
6692004|NCT02742766|7622293|FG001|STARTED|Part 3 (Up to 36 Days)||0
6692005|NCT02742766|7622294|FG002|STARTED|Part 3 (Up to 36 Days)||0
6692006|NCT02742766|7622295|FG003|STARTED|Part 3 (Up to 36 Days)||0
6692007|NCT02742766|7622296|FG004|STARTED|Part 3 (Up to 36 Days)||0
6692008|NCT02742766|7622297|FG005|STARTED|Part 3 (Up to 36 Days)||0
6692009|NCT02742766|7622298|FG006|STARTED|Part 3 (Up to 36 Days)||0
6692010|NCT02742766|7622299|FG007|STARTED|Part 3 (Up to 36 Days)||0
6692011|NCT02742766|7622300|FG008|STARTED|Part 3 (Up to 36 Days)||0
6692012|NCT02742766|7622301|FG009|STARTED|Part 3 (Up to 36 Days)||0
6692013|NCT02742766|7622302|FG010|STARTED|Part 3 (Up to 36 Days)||0
6692014|NCT02742766|7622303|FG011|STARTED|Part 3 (Up to 36 Days)||0
6692015|NCT02742766|7622304|FG012|STARTED|Part 3 (Up to 36 Days)||0
6692016|NCT02742766|7622305|FG013|STARTED|Part 3 (Up to 36 Days)||0
6692017|NCT02742766|7622306|FG014|STARTED|Part 3 (Up to 36 Days)||0
6692018|NCT02742766|7622307|FG015|STARTED|Part 3 (Up to 36 Days)||0
6692019|NCT02742766|7622308|FG016|STARTED|Part 3 (Up to 36 Days)||0
6692020|NCT02742766|7622309|FG017|STARTED|Part 3 (Up to 36 Days)||0
6692021|NCT02742766|7622310|FG018|STARTED|Part 3 (Up to 36 Days)||0
6692022|NCT02742766|7622292|FG000|COMPLETED|Part 3 (Up to 36 Days)||0
6692023|NCT02742766|7622293|FG001|COMPLETED|Part 3 (Up to 36 Days)||0
6692024|NCT02742766|7622294|FG002|COMPLETED|Part 3 (Up to 36 Days)||0
6692025|NCT02742766|7622295|FG003|COMPLETED|Part 3 (Up to 36 Days)||0
6692026|NCT02742766|7622296|FG004|COMPLETED|Part 3 (Up to 36 Days)||0
6692027|NCT02742766|7622297|FG005|COMPLETED|Part 3 (Up to 36 Days)||0
6258341|NCT04762771|7157673|FG000|STARTED|Overall Study||1
6258342|NCT04762771|7157674|FG001|STARTED|Overall Study||1
6258343|NCT04762771|7157673|FG000|COMPLETED|Overall Study||1
6258344|NCT04762771|7157674|FG001|COMPLETED|Overall Study||1
6258345|NCT04762771|7157673|FG000|NOT COMPLETED|Overall Study||0
6258346|NCT04762771|7157674|FG001|NOT COMPLETED|Overall Study||0
6258347|NCT04748120|7157682|FG000|STARTED|Overall Study||1
6258348|NCT04748120|7157683|FG001|STARTED|Overall Study||1
6258349|NCT04748120|7157682|FG000|COMPLETED|Overall Study||1
6258350|NCT04748120|7157683|FG001|COMPLETED|Overall Study||1
6258351|NCT04748120|7157682|FG000|NOT COMPLETED|Overall Study||0
6692028|NCT02742766|7622298|FG006|COMPLETED|Part 3 (Up to 36 Days)||0
6692029|NCT02742766|7622299|FG007|COMPLETED|Part 3 (Up to 36 Days)||0
6692030|NCT02742766|7622300|FG008|COMPLETED|Part 3 (Up to 36 Days)||0
6692031|NCT02742766|7622301|FG009|COMPLETED|Part 3 (Up to 36 Days)||0
6692032|NCT02742766|7622302|FG010|COMPLETED|Part 3 (Up to 36 Days)||0
6692033|NCT02742766|7622303|FG011|COMPLETED|Part 3 (Up to 36 Days)||0
6692034|NCT02742766|7622304|FG012|COMPLETED|Part 3 (Up to 36 Days)||0
6692035|NCT02742766|7622305|FG013|COMPLETED|Part 3 (Up to 36 Days)||0
6692036|NCT02742766|7622306|FG014|COMPLETED|Part 3 (Up to 36 Days)||0
6692037|NCT02742766|7622307|FG015|COMPLETED|Part 3 (Up to 36 Days)||0
6692038|NCT02742766|7622308|FG016|COMPLETED|Part 3 (Up to 36 Days)||0
6692039|NCT02742766|7622309|FG017|COMPLETED|Part 3 (Up to 36 Days)||0
6692040|NCT02742766|7622310|FG018|COMPLETED|Part 3 (Up to 36 Days)||0
6692041|NCT02742766|7622292|FG000|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692042|NCT02742766|7622293|FG001|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692043|NCT02742766|7622294|FG002|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692044|NCT02742766|7622295|FG003|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692045|NCT02742766|7622296|FG004|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692046|NCT02742766|7622297|FG005|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692047|NCT02742766|7622298|FG006|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692048|NCT02742766|7622299|FG007|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692049|NCT02742766|7622300|FG008|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692050|NCT02742766|7622301|FG009|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692051|NCT02742766|7622302|FG010|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692052|NCT02742766|7622303|FG011|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692053|NCT02742766|7622304|FG012|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692054|NCT02742766|7622305|FG013|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692055|NCT02742766|7622306|FG014|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692056|NCT02742766|7622307|FG015|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692057|NCT02742766|7622308|FG016|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692058|NCT02742766|7622309|FG017|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692059|NCT02742766|7622310|FG018|NOT COMPLETED|Part 3 (Up to 36 Days)||0
6692060|NCT02742818|7622372|FG000|STARTED|Overall Study||25
6692061|NCT02742818|7622373|FG001|STARTED|Overall Study||25
6692062|NCT02742818|7622372|FG000|COMPLETED|Overall Study||25
6692063|NCT02742818|7622373|FG001|COMPLETED|Overall Study||23
6692064|NCT02742818|7622372|FG000|NOT COMPLETED|Overall Study||0
6692065|NCT02742818|7622373|FG001|NOT COMPLETED|Overall Study||2
6692066|NCT02742987|7622383|FG000|STARTED|Overall Study||21
6692067|NCT02742987|7622384|FG001|STARTED|Overall Study||21
6692068|NCT02742987|7622383|FG000|COMPLETED|Overall Study||21
6692069|NCT02742987|7622384|FG001|COMPLETED|Overall Study||21
6692070|NCT02742987|7622383|FG000|NOT COMPLETED|Overall Study||0
6692071|NCT02742987|7622384|FG001|NOT COMPLETED|Overall Study||0
6692072|NCT02743078|7622390|FG000|STARTED|Overall Study||3
6692073|NCT02743078|7622390|FG000|Eligible Populaton|Overall Study||3
6692074|NCT02743078|7622390|FG000|Eligible With Six-month Follow-up Data|Overall Study||3
6692075|NCT02743078|7622390|FG000|COMPLETED|Overall Study||3
6692076|NCT02743078|7622390|FG000|NOT COMPLETED|Overall Study||0
6692077|NCT02743117|7622396|FG000|STARTED|Overall Study||60
6692078|NCT02743117|7622397|FG001|STARTED|Overall Study||241
6692079|NCT02743117|7622396|FG000|Treated|Overall Study||59
6692080|NCT02743117|7622397|FG001|Treated|Overall Study||241
6692081|NCT02743117|7622396|FG000|COMPLETED|Overall Study||59
6692082|NCT02743117|7622397|FG001|COMPLETED|Overall Study||240
6692083|NCT02743117|7622396|FG000|NOT COMPLETED|Overall Study||1
6692084|NCT02743117|7622397|FG001|NOT COMPLETED|Overall Study||1
6692085|NCT02743221|7622405|FG000|STARTED|Overall Study||77
6692086|NCT02743221|7622406|FG001|STARTED|Overall Study||77
6692087|NCT02743221|7622405|FG000|COMPLETED|Overall Study||21
6692088|NCT02743221|7622406|FG001|COMPLETED|Overall Study||17
6692089|NCT02743221|7622405|FG000|NOT COMPLETED|Overall Study||56
6692090|NCT02743221|7622406|FG001|NOT COMPLETED|Overall Study||60
6692091|NCT02743312|7622414|FG000|STARTED|Overall Study||3
6692092|NCT02743312|7622415|FG001|STARTED|Overall Study||2
6692093|NCT02743312|7622414|FG000|COMPLETED|Overall Study||3
6692094|NCT02743312|7622415|FG001|COMPLETED|Overall Study||2
6692095|NCT02743312|7622414|FG000|NOT COMPLETED|Overall Study||0
6692096|NCT02743312|7622415|FG001|NOT COMPLETED|Overall Study||0
6692097|NCT02743377|7622432|FG000|STARTED|Overall Study||9
6692098|NCT02743377|7622433|FG001|STARTED|Overall Study||6
6692099|NCT02743377|7622432|FG000|Brain PET With 11C Rolipram|Overall Study||8
6692100|NCT02743377|7622433|FG001|Brain PET With 11C Rolipram|Overall Study||3
6692101|NCT02743377|7622432|FG000|Whole Body PET Baseline With 11C Rolipra|Overall Study||5
6692102|NCT02743377|7622433|FG001|Whole Body PET Baseline With 11C Rolipra|Overall Study||4
6692103|NCT02743377|7622432|FG000|Whole Body PET Baseline & Blocked|Overall Study||0
6692104|NCT02743377|7622433|FG001|Whole Body PET Baseline & Blocked|Overall Study||2
6692105|NCT02743377|7622432|FG000|COMPLETED|Overall Study||7
6692106|NCT02743377|7622433|FG001|COMPLETED|Overall Study||6
6692107|NCT02743377|7622432|FG000|NOT COMPLETED|Overall Study||2
6692108|NCT02743377|7622433|FG001|NOT COMPLETED|Overall Study||0
6692109|NCT02743442|7622440|FG000|STARTED|Overall Study||8
6692110|NCT02743442|7622440|FG000|COMPLETED|Overall Study||8
6692111|NCT02743442|7622440|FG000|NOT COMPLETED|Overall Study||0
6692112|NCT02743520|7622444|FG000|STARTED|Overall Study||86
6692113|NCT02743520|7622444|FG000|COMPLETED|Overall Study||85
6692114|NCT02743520|7622444|FG000|NOT COMPLETED|Overall Study||1
6692115|NCT02743702|7622450|FG000|STARTED|Overall Study||11
6692116|NCT02743702|7622451|FG001|STARTED|Overall Study||10
6692117|NCT02743702|7622450|FG000|COMPLETED|Overall Study||11
6692118|NCT02743702|7622451|FG001|COMPLETED|Overall Study||10
6692119|NCT02743702|7622450|FG000|NOT COMPLETED|Overall Study||0
6692120|NCT02743702|7622451|FG001|NOT COMPLETED|Overall Study||0
6692121|NCT02743780|7622462|FG000|STARTED|Part 1 (3 Days)||6
6692122|NCT02743780|7622463|FG001|STARTED|Part 1 (3 Days)||6
6692123|NCT02743780|7622464|FG002|STARTED|Part 1 (3 Days)||6
6692124|NCT02743780|7622465|FG003|STARTED|Part 1 (3 Days)||6
6692125|NCT02743780|7622466|FG004|STARTED|Part 1 (3 Days)||8
6258352|NCT04748120|7157683|FG001|NOT COMPLETED|Overall Study||0
6258353|NCT04559698|7157693|FG000|STARTED|Overall Study||61
6258354|NCT04559698|7157694|FG001|STARTED|Overall Study||60
6258355|NCT04559698|7157693|FG000|Four-month Pre-intervention|Overall Study|Participants in this arm started training immediately after randomization, and therefore, did not have a four-month waiting period prior to receiving the training.|0
6258356|NCT04559698|7157694|FG001|Four-month Pre-intervention|Overall Study||60
6258357|NCT04559698|7157693|FG000|Immediate Pre-intervention|Overall Study||61
6258358|NCT04559698|7157694|FG001|Immediate Pre-intervention|Overall Study||55
6258359|NCT04559698|7157693|FG000|Immediate Post-intervention|Overall Study||52
6258360|NCT04559698|7157694|FG001|Immediate Post-intervention|Overall Study||44
6258361|NCT04559698|7157693|FG000|Four-month Post-intervention|Overall Study||47
6258362|NCT04559698|7157694|FG001|Four-month Post-intervention|Overall Study|Participants in this arm started training four months after randomization (waitlist) and therefore, were not assessed at the four-month follow-up time point due to completion of the study.|0
6258363|NCT04559698|7157693|FG000|COMPLETED|Overall Study||47
6258364|NCT04559698|7157694|FG001|COMPLETED|Overall Study||44
6258365|NCT04559698|7157693|FG000|NOT COMPLETED|Overall Study||14
6258366|NCT04559698|7157694|FG001|NOT COMPLETED|Overall Study||16
6280086|NCT00151775|7180003|FG000|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
6280087|NCT00151775|7180004|FG001|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
6280088|NCT00151775|7180005|FG002|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6280089|NCT00151775|7180006|FG003|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6280090|NCT00151775|7180007|FG004|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6280091|NCT00151775|7180008|FG005|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
6280092|NCT00151775|7180009|FG006|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
6280093|NCT00151775|7180010|FG007|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6280094|NCT00151775|7180011|FG008|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6280095|NCT00151775|7180012|FG009|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6280096|NCT00151775|7180013|FG010|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
6280097|NCT00151775|7180014|FG011|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
6280098|NCT00151775|7180003|FG000|STARTED|Period 3: Double-blind, Withdrawal||48
6280099|NCT00151775|7180004|FG001|STARTED|Period 3: Double-blind, Withdrawal||45
6280100|NCT00151775|7180005|FG002|STARTED|Period 3: Double-blind, Withdrawal||45
6280101|NCT00151775|7180006|FG003|STARTED|Period 3: Double-blind, Withdrawal||44
6280102|NCT00151775|7180007|FG004|STARTED|Period 3: Double-blind, Withdrawal||0
6280103|NCT00151775|7180008|FG005|STARTED|Period 3: Double-blind, Withdrawal||26
6280104|NCT00151775|7180009|FG006|STARTED|Period 3: Double-blind, Withdrawal||27
6280105|NCT00151775|7180010|FG007|STARTED|Period 3: Double-blind, Withdrawal||28
6280106|NCT00151775|7180011|FG008|STARTED|Period 3: Double-blind, Withdrawal||26
6280107|NCT00151775|7180012|FG009|STARTED|Period 3: Double-blind, Withdrawal||0
6280108|NCT00151775|7180013|FG010|STARTED|Period 3: Double-blind, Withdrawal||29
6280109|NCT00151775|7180014|FG011|STARTED|Period 3: Double-blind, Withdrawal||29
6280110|NCT00151775|7180003|FG000|COMPLETED|Period 3: Double-blind, Withdrawal||48
6280111|NCT00151775|7180004|FG001|COMPLETED|Period 3: Double-blind, Withdrawal||45
6280112|NCT00151775|7180005|FG002|COMPLETED|Period 3: Double-blind, Withdrawal||42
6280113|NCT00151775|7180006|FG003|COMPLETED|Period 3: Double-blind, Withdrawal||44
6280114|NCT00151775|7180007|FG004|COMPLETED|Period 3: Double-blind, Withdrawal||0
6280115|NCT00151775|7180008|FG005|COMPLETED|Period 3: Double-blind, Withdrawal||25
6280116|NCT00151775|7180009|FG006|COMPLETED|Period 3: Double-blind, Withdrawal||26
6280117|NCT00151775|7180010|FG007|COMPLETED|Period 3: Double-blind, Withdrawal||27
6280118|NCT00151775|7180011|FG008|COMPLETED|Period 3: Double-blind, Withdrawal||26
6280119|NCT00151775|7180012|FG009|COMPLETED|Period 3: Double-blind, Withdrawal||0
6280120|NCT00151775|7180013|FG010|COMPLETED|Period 3: Double-blind, Withdrawal||29
6280121|NCT00151775|7180014|FG011|COMPLETED|Period 3: Double-blind, Withdrawal||28
6280122|NCT00151775|7180003|FG000|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6280123|NCT00151775|7180004|FG001|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6280124|NCT00151775|7180005|FG002|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
6280125|NCT00151775|7180006|FG003|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6280126|NCT00151775|7180007|FG004|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6280127|NCT00151775|7180008|FG005|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
6280128|NCT00151775|7180009|FG006|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
6280129|NCT00151775|7180010|FG007|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
6280130|NCT00151775|7180011|FG008|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6280131|NCT00151775|7180012|FG009|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6692126|NCT02743780|7622462|FG000|COMPLETED|Part 1 (3 Days)||6
6692127|NCT02743780|7622463|FG001|COMPLETED|Part 1 (3 Days)||6
6692128|NCT02743780|7622464|FG002|COMPLETED|Part 1 (3 Days)||6
6692129|NCT02743780|7622465|FG003|COMPLETED|Part 1 (3 Days)||6
6692130|NCT02743780|7622466|FG004|COMPLETED|Part 1 (3 Days)||8
6692131|NCT02743780|7622462|FG000|NOT COMPLETED|Part 1 (3 Days)||0
6692132|NCT02743780|7622463|FG001|NOT COMPLETED|Part 1 (3 Days)||0
6692133|NCT02743780|7622464|FG002|NOT COMPLETED|Part 1 (3 Days)||0
6692134|NCT02743780|7622465|FG003|NOT COMPLETED|Part 1 (3 Days)||0
6692135|NCT02743780|7622466|FG004|NOT COMPLETED|Part 1 (3 Days)||0
6692136|NCT02743780|7622462|FG000|STARTED|Part 2 (8 Days)||0
6692137|NCT02743780|7622463|FG001|STARTED|Part 2 (8 Days)||6
6692138|NCT02743780|7622464|FG002|STARTED|Part 2 (8 Days)||6
6692139|NCT02743780|7622465|FG003|STARTED|Part 2 (8 Days)||0
6692140|NCT02743780|7622466|FG004|STARTED|Part 2 (8 Days)||4
6692141|NCT02743780|7622462|FG000|COMPLETED|Part 2 (8 Days)||0
6692142|NCT02743780|7622463|FG001|COMPLETED|Part 2 (8 Days)||6
6692143|NCT02743780|7622464|FG002|COMPLETED|Part 2 (8 Days)||6
6692144|NCT02743780|7622465|FG003|COMPLETED|Part 2 (8 Days)||0
6692145|NCT02743780|7622466|FG004|COMPLETED|Part 2 (8 Days)||4
6692146|NCT02743780|7622462|FG000|NOT COMPLETED|Part 2 (8 Days)||0
6692147|NCT02743780|7622463|FG001|NOT COMPLETED|Part 2 (8 Days)||0
6692148|NCT02743780|7622464|FG002|NOT COMPLETED|Part 2 (8 Days)||0
6692149|NCT02743780|7622465|FG003|NOT COMPLETED|Part 2 (8 Days)||0
6692150|NCT02743780|7622466|FG004|NOT COMPLETED|Part 2 (8 Days)||0
6692151|NCT02743780|7622462|FG000|STARTED|Part 3 (7 Days)||0
6692152|NCT02743780|7622463|FG001|STARTED|Part 3 (7 Days)||0
6692153|NCT02743780|7622464|FG002|STARTED|Part 3 (7 Days)||25
6692154|NCT02743780|7622465|FG003|STARTED|Part 3 (7 Days)||0
6692155|NCT02743780|7622466|FG004|STARTED|Part 3 (7 Days)||25
6692156|NCT02743780|7622462|FG000|COMPLETED|Part 3 (7 Days)||0
6692157|NCT02743780|7622463|FG001|COMPLETED|Part 3 (7 Days)||0
6692158|NCT02743780|7622464|FG002|COMPLETED|Part 3 (7 Days)||24
6692159|NCT02743780|7622465|FG003|COMPLETED|Part 3 (7 Days)||0
6692160|NCT02743780|7622466|FG004|COMPLETED|Part 3 (7 Days)||25
6692161|NCT02743780|7622462|FG000|NOT COMPLETED|Part 3 (7 Days)||0
6692162|NCT02743780|7622463|FG001|NOT COMPLETED|Part 3 (7 Days)||0
6692163|NCT02743780|7622464|FG002|NOT COMPLETED|Part 3 (7 Days)||1
6692164|NCT02743780|7622465|FG003|NOT COMPLETED|Part 3 (7 Days)||0
6692165|NCT02743780|7622466|FG004|NOT COMPLETED|Part 3 (7 Days)||0
6692166|NCT02743793|7622488|FG000|STARTED|Overall Study||5
6692167|NCT02743793|7622489|FG001|STARTED|Overall Study||36
6692168|NCT02743793|7622488|FG000|COMPLETED|Overall Study||0
6692169|NCT02743793|7622489|FG001|COMPLETED|Overall Study||0
6692170|NCT02743793|7622488|FG000|NOT COMPLETED|Overall Study||5
6692171|NCT02743793|7622489|FG001|NOT COMPLETED|Overall Study||36
6692172|NCT02743936|7622496|FG000|STARTED|Overall Study||32
6692173|NCT02743936|7622497|FG001|STARTED|Overall Study||32
6692174|NCT02743936|7622496|FG000|COMPLETED|Overall Study||32
6692175|NCT02743936|7622497|FG001|COMPLETED|Overall Study||32
6692176|NCT02743936|7622496|FG000|NOT COMPLETED|Overall Study||0
6692177|NCT02743936|7622497|FG001|NOT COMPLETED|Overall Study||0
6692178|NCT02743949|7622506|FG000|STARTED|Overall Study||86
6692179|NCT02743949|7622507|FG001|STARTED|Overall Study||85
6692180|NCT02743949|7622508|FG002|STARTED|Overall Study||85
6692181|NCT02743949|7622506|FG000|COMPLETED|Overall Study||82
6692182|NCT02743949|7622507|FG001|COMPLETED|Overall Study||84
6692183|NCT02743949|7622508|FG002|COMPLETED|Overall Study||82
6692184|NCT02743949|7622506|FG000|NOT COMPLETED|Overall Study||4
6692185|NCT02743949|7622507|FG001|NOT COMPLETED|Overall Study||1
6692186|NCT02743949|7622508|FG002|NOT COMPLETED|Overall Study||3
6258367|NCT04492475|7157702|FG000|STARTED|Overall Study||487
6258368|NCT04492475|7157703|FG001|STARTED|Overall Study||482
6258369|NCT04492475|7157702|FG000|ITT and Modified ITT Population|Overall Study||487
6258370|NCT04492475|7157703|FG001|ITT and Modified ITT Population|Overall Study||482
6258371|NCT04492475|7157702|FG000|As Treated Population|Overall Study||477
6258372|NCT04492475|7157703|FG001|As Treated Population|Overall Study||468
6258373|NCT04492475|7157702|FG000|COMPLETED|Overall Study||473
6258374|NCT04492475|7157703|FG001|COMPLETED|Overall Study||474
6258375|NCT04492475|7157702|FG000|NOT COMPLETED|Overall Study||14
6258376|NCT04492475|7157703|FG001|NOT COMPLETED|Overall Study||8
6258377|NCT04401579|7157718|FG000|STARTED|Overall Study||515
6258378|NCT04401579|7157719|FG001|STARTED|Overall Study||518
6258379|NCT04401579|7157718|FG000|Treated|Overall Study||507
6258380|NCT04401579|7157719|FG001|Treated|Overall Study||509
6258381|NCT04401579|7157718|FG000|COMPLETED|Overall Study||431
6258382|NCT04401579|7157719|FG001|COMPLETED|Overall Study||408
6692187|NCT02743962|7622518|FG000|STARTED|Overall Study||5
6692188|NCT02743962|7622519|FG001|STARTED|Overall Study||5
6692189|NCT02743962|7622518|FG000|COMPLETED|Overall Study||4
6692190|NCT02743962|7622519|FG001|COMPLETED|Overall Study||5
6692191|NCT02743962|7622518|FG000|NOT COMPLETED|Overall Study||1
6692192|NCT02743962|7622519|FG001|NOT COMPLETED|Overall Study||0
6692193|NCT02744066|7622530|FG000|STARTED|Overall Study||25
6692194|NCT02744066|7622531|FG001|STARTED|Overall Study||30
6692195|NCT02744066|7622530|FG000|COMPLETED|Overall Study||25
6692196|NCT02744066|7622531|FG001|COMPLETED|Overall Study||25
6692197|NCT02744066|7622530|FG000|NOT COMPLETED|Overall Study||0
6258383|NCT04401579|7157718|FG000|NOT COMPLETED|Overall Study||84
6258384|NCT04401579|7157719|FG001|NOT COMPLETED|Overall Study||110
6258385|NCT04321460|7157727|FG000|STARTED|Overall Study||260
6258386|NCT04321460|7157728|FG001|STARTED|Overall Study||260
6258387|NCT04321460|7157727|FG000|Intention to Treat (ITT) Population|Overall Study||260
6692198|NCT02744066|7622531|FG001|NOT COMPLETED|Overall Study||5
6692199|NCT02744391|7622539|FG000|STARTED|Overall Study||47
6692200|NCT02744391|7622539|FG000|COMPLETED|Overall Study||33
6692201|NCT02744391|7622539|FG000|NOT COMPLETED|Overall Study||14
6692202|NCT02744534|7622543|FG000|STARTED|Overall Study||21
6692203|NCT02744534|7622543|FG000|COMPLETED|Overall Study||21
6692204|NCT02744534|7622543|FG000|NOT COMPLETED|Overall Study||0
6692205|NCT02744755|7622551|FG000|STARTED|Study Period 1||177
6692206|NCT02744755|7622552|FG001|STARTED|Study Period 1||176
6692207|NCT02744755|7622551|FG000|COMPLETED|Study Period 1||163
6692208|NCT02744755|7622552|FG001|COMPLETED|Study Period 1||168
6692209|NCT02744755|7622551|FG000|NOT COMPLETED|Study Period 1||14
6692210|NCT02744755|7622552|FG001|NOT COMPLETED|Study Period 1||8
6692211|NCT02744755|7622551|FG000|STARTED|Study Period 2||159
6692212|NCT02744755|7622552|FG001|STARTED|Study Period 2||166
6692213|NCT02744755|7622551|FG000|COMPLETED|Study Period 2||145
6692214|NCT02744755|7622552|FG001|COMPLETED|Study Period 2||158
6692215|NCT02744755|7622551|FG000|NOT COMPLETED|Study Period 2||14
6692216|NCT02744755|7622552|FG001|NOT COMPLETED|Study Period 2||8
6692217|NCT02744846|7622562|FG000|STARTED|5 Year Outcome Assessment||681739
6692218|NCT02744846|7622562|FG000|Excluded Ineligible Patients|5 Year Outcome Assessment|Includes lost to follow-up and patients that had not reached age 4 years by end of study period|319189
6692219|NCT02744846|7622562|FG000|COMPLETED|5 Year Outcome Assessment|Number of patients that meet eligibility criteria|362550
6692220|NCT02744846|7622562|FG000|NOT COMPLETED|5 Year Outcome Assessment||319189
6692221|NCT02744846|7622562|FG000|STARTED|10 Year Outcome Assessment||362550
6692222|NCT02744846|7622562|FG000|Exclude Ineligible Patients|10 Year Outcome Assessment|Loss to follow-up, patients not yet 9 years, or systems that only had data from 2009 to 2016 or less|305820
6692223|NCT02744846|7622562|FG000|COMPLETED|10 Year Outcome Assessment||56730
6692224|NCT02744846|7622562|FG000|NOT COMPLETED|10 Year Outcome Assessment||305820
6692225|NCT02744898|7622570|FG000|STARTED|Overall Study||23
6692226|NCT02744898|7622570|FG000|COMPLETED|Overall Study||19
6692227|NCT02744898|7622570|FG000|NOT COMPLETED|Overall Study||4
6738711|NCT03285594|7667935|FG001|COMPLETED|Overall Study||130
6738712|NCT03285594|7667936|FG002|COMPLETED|Overall Study||249
6738713|NCT03285594|7667934|FG000|NOT COMPLETED|Overall Study||15
6738714|NCT03285594|7667935|FG001|NOT COMPLETED|Overall Study||11
6738715|NCT03285594|7667936|FG002|NOT COMPLETED|Overall Study||37
6738716|NCT03285646|7667947|FG000|STARTED|Overall Study||32
6738717|NCT03285646|7667948|FG001|STARTED|Overall Study||31
6738718|NCT03285646|7667947|FG000|COMPLETED|Overall Study||19
6738719|NCT03285646|7667948|FG001|COMPLETED|Overall Study||27
6738720|NCT03285646|7667947|FG000|NOT COMPLETED|Overall Study||13
6738721|NCT03285646|7667948|FG001|NOT COMPLETED|Overall Study||4
6738722|NCT03285711|7667957|FG000|STARTED|Blinded Phase (Up to Week 16)||4
6738723|NCT03285711|7667958|FG001|STARTED|Blinded Phase (Up to Week 16)||5
6738724|NCT03285711|7667959|FG002|STARTED|Blinded Phase (Up to Week 16)||0
6738725|NCT03285711|7667960|FG003|STARTED|Blinded Phase (Up to Week 16)||0
6738726|NCT03285711|7667957|FG000|COMPLETED|Blinded Phase (Up to Week 16)||1
6738727|NCT03285711|7667958|FG001|COMPLETED|Blinded Phase (Up to Week 16)||4
6738728|NCT03285711|7667959|FG002|COMPLETED|Blinded Phase (Up to Week 16)||0
6738729|NCT03285711|7667960|FG003|COMPLETED|Blinded Phase (Up to Week 16)||0
6738730|NCT03285711|7667957|FG000|NOT COMPLETED|Blinded Phase (Up to Week 16)||3
6738731|NCT03285711|7667958|FG001|NOT COMPLETED|Blinded Phase (Up to Week 16)||1
6738732|NCT03285711|7667959|FG002|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
6738733|NCT03285711|7667960|FG003|NOT COMPLETED|Blinded Phase (Up to Week 16)||0
6738734|NCT03285711|7667957|FG000|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to filgotinib.|0
6738735|NCT03285711|7667958|FG001|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment to lanraplenib.|3
6738736|NCT03285711|7667959|FG002|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from lanraplenib.|1
6738737|NCT03285711|7667960|FG003|STARTED|Blinded Phase (Week 16 to 32)|1 participant switched treatment from filgotinib.|1
6738738|NCT03285711|7667957|FG000|COMPLETED|Blinded Phase (Week 16 to 32)||0
6738739|NCT03285711|7667958|FG001|COMPLETED|Blinded Phase (Week 16 to 32)||3
6738740|NCT03285711|7667959|FG002|COMPLETED|Blinded Phase (Week 16 to 32)||0
6738741|NCT03285711|7667960|FG003|COMPLETED|Blinded Phase (Week 16 to 32)||1
6738742|NCT03285711|7667957|FG000|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
6738743|NCT03285711|7667958|FG001|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
6738744|NCT03285711|7667959|FG002|NOT COMPLETED|Blinded Phase (Week 16 to 32)||1
6738745|NCT03285711|7667960|FG003|NOT COMPLETED|Blinded Phase (Week 16 to 32)||0
6738746|NCT03285711|7667957|FG000|STARTED|Extended Blinded Phase (Week 32 to 52)||0
6738747|NCT03285711|7667958|FG001|STARTED|Extended Blinded Phase (Week 32 to 52)||3
6738748|NCT03285711|7667959|FG002|STARTED|Extended Blinded Phase (Week 32 to 52)||0
6738749|NCT03285711|7667960|FG003|STARTED|Extended Blinded Phase (Week 32 to 52)||1
6738750|NCT03285711|7667957|FG000|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6738751|NCT03285711|7667958|FG001|COMPLETED|Extended Blinded Phase (Week 32 to 52)||2
6738752|NCT03285711|7667959|FG002|COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6738753|NCT03285711|7667960|FG003|COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
6738754|NCT03285711|7667957|FG000|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6738755|NCT03285711|7667958|FG001|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||1
6738756|NCT03285711|7667959|FG002|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6738757|NCT03285711|7667960|FG003|NOT COMPLETED|Extended Blinded Phase (Week 32 to 52)||0
6738758|NCT03285724|7667970|FG000|STARTED|Overall Study||1
6738759|NCT03285724|7667970|FG000|COMPLETED|Overall Study||1
6738760|NCT03285724|7667970|FG000|NOT COMPLETED|Overall Study||0
6738761|NCT03285958|7667976|FG000|STARTED|Overall Study||33
6738762|NCT03285958|7667977|FG001|STARTED|Overall Study||24
6692228|NCT02745080|7622576|FG000|STARTED|Overall Study||426
6692229|NCT02745080|7622577|FG001|STARTED|Overall Study||427
6692230|NCT02745080|7622576|FG000|COMPLETED|Overall Study||371
6692231|NCT02745080|7622577|FG001|COMPLETED|Overall Study||338
6692232|NCT02745080|7622576|FG000|NOT COMPLETED|Overall Study||55
6692233|NCT02745080|7622577|FG001|NOT COMPLETED|Overall Study||89
6692234|NCT02745119|7622588|FG000|STARTED|Overall Study||145
6692235|NCT02745119|7622589|FG001|STARTED|Overall Study||274
6692236|NCT02745119|7622590|FG002|STARTED|Overall Study||146
6692237|NCT02745119|7622591|FG003|STARTED|Overall Study||277
6692238|NCT02745119|7622588|FG000|COMPLETED|Overall Study||0
6692239|NCT02745119|7622589|FG001|COMPLETED|Overall Study||0
6692240|NCT02745119|7622590|FG002|COMPLETED|Overall Study||0
6692241|NCT02745119|7622591|FG003|COMPLETED|Overall Study||0
6692242|NCT02745119|7622588|FG000|NOT COMPLETED|Overall Study||145
6692243|NCT02745119|7622589|FG001|NOT COMPLETED|Overall Study||274
6692244|NCT02745119|7622590|FG002|NOT COMPLETED|Overall Study||146
6692245|NCT02745119|7622591|FG003|NOT COMPLETED|Overall Study||277
6692246|NCT02745145|7622606|FG000|STARTED|Overall Study||10
6692247|NCT02745145|7622607|FG001|STARTED|Overall Study||5
6692248|NCT02745145|7622608|FG002|STARTED|Overall Study||9
6692249|NCT02745145|7622606|FG000|COMPLETED|Overall Study||0
6692250|NCT02745145|7622607|FG001|COMPLETED|Overall Study||0
6692251|NCT02745145|7622608|FG002|COMPLETED|Overall Study||0
6692252|NCT02745145|7622606|FG000|NOT COMPLETED|Overall Study||10
6692253|NCT02745145|7622607|FG001|NOT COMPLETED|Overall Study||5
6692254|NCT02745145|7622608|FG002|NOT COMPLETED|Overall Study||9
6692255|NCT02745353|7622618|FG000|STARTED|First Intervention (2 Weeks)||4
6692256|NCT02745353|7622619|FG001|STARTED|First Intervention (2 Weeks)||3
6692257|NCT02745353|7622618|FG000|COMPLETED|First Intervention (2 Weeks)||1
6692258|NCT02745353|7622619|FG001|COMPLETED|First Intervention (2 Weeks)||1
6692259|NCT02745353|7622618|FG000|NOT COMPLETED|First Intervention (2 Weeks)||3
6692260|NCT02745353|7622619|FG001|NOT COMPLETED|First Intervention (2 Weeks)||2
6692261|NCT02745353|7622618|FG000|STARTED|Washout (3 Days)||1
6692262|NCT02745353|7622619|FG001|STARTED|Washout (3 Days)||1
6692263|NCT02745353|7622618|FG000|COMPLETED|Washout (3 Days)||1
6692264|NCT02745353|7622619|FG001|COMPLETED|Washout (3 Days)||1
6692265|NCT02745353|7622618|FG000|NOT COMPLETED|Washout (3 Days)||0
6692266|NCT02745353|7622619|FG001|NOT COMPLETED|Washout (3 Days)||0
6692267|NCT02745353|7622618|FG000|STARTED|Second Intervention (2 Weeks)||1
6692268|NCT02745353|7622619|FG001|STARTED|Second Intervention (2 Weeks)||1
6692269|NCT02745353|7622618|FG000|COMPLETED|Second Intervention (2 Weeks)||1
6692270|NCT02745353|7622619|FG001|COMPLETED|Second Intervention (2 Weeks)||0
6692271|NCT02745353|7622618|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6692272|NCT02745353|7622619|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||1
6692273|NCT02745392|7622629|FG000|STARTED|Overall Study||91
6692274|NCT02745392|7622630|FG001|STARTED|Overall Study||90
6692275|NCT02745392|7622631|FG002|STARTED|Overall Study||92
6692276|NCT02745392|7622632|FG003|STARTED|Overall Study||92
6692277|NCT02745392|7622629|FG000|COMPLETED|Overall Study||91
6692278|NCT02745392|7622630|FG001|COMPLETED|Overall Study||89
6692279|NCT02745392|7622631|FG002|COMPLETED|Overall Study||92
6692280|NCT02745392|7622632|FG003|COMPLETED|Overall Study||92
6692281|NCT02745392|7622629|FG000|NOT COMPLETED|Overall Study||0
6692282|NCT02745392|7622630|FG001|NOT COMPLETED|Overall Study||1
6692283|NCT02745392|7622631|FG002|NOT COMPLETED|Overall Study||0
6692284|NCT02745392|7622632|FG003|NOT COMPLETED|Overall Study||0
6692285|NCT02745626|7622645|FG000|STARTED|Overall Study||24
6692286|NCT02745626|7622646|FG001|STARTED|Overall Study||22
6692287|NCT02745626|7622647|FG002|STARTED|Overall Study||22
6692288|NCT02745626|7622645|FG000|COMPLETED|Overall Study||21
6692289|NCT02745626|7622646|FG001|COMPLETED|Overall Study||16
6692290|NCT02745626|7622647|FG002|COMPLETED|Overall Study||19
6692291|NCT02745626|7622645|FG000|NOT COMPLETED|Overall Study||3
6692292|NCT02745626|7622646|FG001|NOT COMPLETED|Overall Study||6
6692293|NCT02745626|7622647|FG002|NOT COMPLETED|Overall Study||3
6692294|NCT02746107|7622655|FG000|STARTED|Overall Study||968
6692295|NCT02746107|7622655|FG000|2 Diagrams DA|Overall Study||482
6692296|NCT02746107|7622655|FG000|1 Diagram DA|Overall Study||486
6692297|NCT02746107|7622655|FG000|1year Risk Estimate|Overall Study||483
6692298|NCT02746107|7622655|FG000|5year Risk Estimate|Overall Study||485
6692299|NCT02746107|7622655|FG000|Target=Patient|Overall Study||486
6692300|NCT02746107|7622655|FG000|Target=Physician|Overall Study||482
6692301|NCT02746107|7622655|FG000|CHA2DS2-VASC Score = 1|Overall Study||195
6692302|NCT02746107|7622655|FG000|CHA2DS2-VASC Score = 2|Overall Study||189
6692303|NCT02746107|7622655|FG000|CHA2DS2-VASC Score = 3|Overall Study||195
6692304|NCT02746107|7622655|FG000|CHA2DS2-VASC Score = 4|Overall Study||197
6692305|NCT02746107|7622655|FG000|CHA2DS2-VASC Score = 5|Overall Study||192
6692306|NCT02746107|7622655|FG000|COMPLETED|Overall Study||968
6692307|NCT02746107|7622655|FG000|NOT COMPLETED|Overall Study||0
6692308|NCT02746406|7622670|FG000|STARTED|Overall Study||5
6692309|NCT02746406|7622670|FG000|COMPLETED|Overall Study||5
6692310|NCT02746406|7622670|FG000|NOT COMPLETED|Overall Study||0
6692311|NCT02746575|7622674|FG000|STARTED|Overall Study||70
6692312|NCT02746575|7622674|FG000|COMPLETED|Overall Study||20
6692313|NCT02746575|7622674|FG000|NOT COMPLETED|Overall Study||50
6692314|NCT02746627|7622681|FG000|STARTED|Overall Study||60
6692315|NCT02746627|7622682|FG001|STARTED|Overall Study||30
6692316|NCT02746627|7622683|FG002|STARTED|Overall Study||30
6692317|NCT02746627|7622681|FG000|COMPLETED|Overall Study||59
6692318|NCT02746627|7622682|FG001|COMPLETED|Overall Study||29
6692319|NCT02746627|7622683|FG002|COMPLETED|Overall Study||29
6692320|NCT02746627|7622681|FG000|NOT COMPLETED|Overall Study||1
6692321|NCT02746627|7622682|FG001|NOT COMPLETED|Overall Study||1
6692322|NCT02746627|7622683|FG002|NOT COMPLETED|Overall Study||1
6692323|NCT02746679|7622693|FG000|STARTED|Overall Study||80
6692324|NCT02746679|7622694|FG001|STARTED|Overall Study||81
6692325|NCT02746679|7622693|FG000|COMPLETED|Overall Study||76
6692326|NCT02746679|7622694|FG001|COMPLETED|Overall Study||75
6692327|NCT02746679|7622693|FG000|NOT COMPLETED|Overall Study||4
6692328|NCT02746679|7622694|FG001|NOT COMPLETED|Overall Study||6
6692329|NCT02746705|7622702|FG000|STARTED|Overall Study||17
6692330|NCT02746705|7622703|FG001|STARTED|Overall Study||14
6692331|NCT02746705|7622702|FG000|COMPLETED|Overall Study||15
6692332|NCT02746705|7622703|FG001|COMPLETED|Overall Study||12
6692333|NCT02746705|7622702|FG000|NOT COMPLETED|Overall Study||2
6692334|NCT02746705|7622703|FG001|NOT COMPLETED|Overall Study||2
6692335|NCT02746874|7622711|FG000|STARTED|Overall Study||35
6692336|NCT02746874|7622712|FG001|STARTED|Overall Study||35
6692337|NCT02746874|7622711|FG000|COMPLETED|Overall Study||35
6692338|NCT02746874|7622712|FG001|COMPLETED|Overall Study||32
6692339|NCT02746874|7622711|FG000|NOT COMPLETED|Overall Study||0
6692340|NCT02746874|7622712|FG001|NOT COMPLETED|Overall Study||3
6692341|NCT02746991|7622720|FG000|STARTED|Overall Study||52
6692342|NCT02746991|7622721|FG001|STARTED|Overall Study||101
6692343|NCT02746991|7622720|FG000|COMPLETED|Overall Study||24
6692344|NCT02746991|7622721|FG001|COMPLETED|Overall Study||67
6692345|NCT02746991|7622720|FG000|NOT COMPLETED|Overall Study||28
6692346|NCT02746991|7622721|FG001|NOT COMPLETED|Overall Study||34
6692347|NCT02747004|7622732|FG000|STARTED|Overall Study||78
6692348|NCT02747004|7622733|FG001|STARTED|Overall Study||79
6692349|NCT02747004|7622734|FG002|STARTED|Overall Study||77
6692350|NCT02747004|7622732|FG000|Received at Least One Dose of Study Drug|Overall Study||78
6692351|NCT02747004|7622733|FG001|Received at Least One Dose of Study Drug|Overall Study||79
6692352|NCT02747004|7622734|FG002|Received at Least One Dose of Study Drug|Overall Study||77
6692353|NCT02747004|7622732|FG000|COMPLETED|Overall Study||21
6692354|NCT02747004|7622733|FG001|COMPLETED|Overall Study||30
6692355|NCT02747004|7622734|FG002|COMPLETED|Overall Study||30
6692356|NCT02747004|7622732|FG000|NOT COMPLETED|Overall Study||57
6692357|NCT02747004|7622733|FG001|NOT COMPLETED|Overall Study||49
6692358|NCT02747004|7622734|FG002|NOT COMPLETED|Overall Study||47
6692359|NCT02747043|7622744|FG000|STARTED|Overall Study||128
6692360|NCT02747043|7622745|FG001|STARTED|Overall Study||128
6692361|NCT02747043|7622744|FG000|Treated|Overall Study||128
6692362|NCT02747043|7622745|FG001|Treated|Overall Study||126
6692363|NCT02747043|7622744|FG000|COMPLETED|Overall Study||118
6692364|NCT02747043|7622745|FG001|COMPLETED|Overall Study||123
6692365|NCT02747043|7622744|FG000|NOT COMPLETED|Overall Study||10
6692366|NCT02747043|7622745|FG001|NOT COMPLETED|Overall Study||5
6692367|NCT02747108|7622753|FG000|STARTED|Overall Study||253
6692368|NCT02747108|7622754|FG001|STARTED|Overall Study||62
6692369|NCT02747108|7622753|FG000|COMPLETED|Overall Study||248
6692370|NCT02747108|7622754|FG001|COMPLETED|Overall Study||60
6692371|NCT02747108|7622753|FG000|NOT COMPLETED|Overall Study||5
6692372|NCT02747108|7622754|FG001|NOT COMPLETED|Overall Study||2
6692373|NCT02747186|7622767|FG000|STARTED|First Intervention||12
6692374|NCT02747186|7622768|FG001|STARTED|First Intervention||12
6692375|NCT02747186|7622767|FG000|COMPLETED|First Intervention||12
6692376|NCT02747186|7622768|FG001|COMPLETED|First Intervention||12
6692377|NCT02747186|7622767|FG000|NOT COMPLETED|First Intervention||0
6692378|NCT02747186|7622768|FG001|NOT COMPLETED|First Intervention||0
6692379|NCT02747186|7622767|FG000|STARTED|Washout (1 Week)||12
6692380|NCT02747186|7622768|FG001|STARTED|Washout (1 Week)||12
6692381|NCT02747186|7622767|FG000|COMPLETED|Washout (1 Week)||12
6692382|NCT02747186|7622768|FG001|COMPLETED|Washout (1 Week)||12
6692383|NCT02747186|7622767|FG000|NOT COMPLETED|Washout (1 Week)||0
6692384|NCT02747186|7622768|FG001|NOT COMPLETED|Washout (1 Week)||0
6692385|NCT02747186|7622767|FG000|STARTED|Second Intervention||12
6692386|NCT02747186|7622768|FG001|STARTED|Second Intervention||12
6692387|NCT02747186|7622767|FG000|COMPLETED|Second Intervention||12
6692388|NCT02747186|7622768|FG001|COMPLETED|Second Intervention||12
6692389|NCT02747186|7622767|FG000|NOT COMPLETED|Second Intervention||0
6692390|NCT02747186|7622768|FG001|NOT COMPLETED|Second Intervention||0
6692391|NCT02747238|7622776|FG000|STARTED|Overall Study||12
6692392|NCT02747238|7622777|FG001|STARTED|Overall Study||20
6692393|NCT02747238|7622776|FG000|COMPLETED|Overall Study||9
6692394|NCT02747238|7622777|FG001|COMPLETED|Overall Study||14
6692395|NCT02747238|7622776|FG000|NOT COMPLETED|Overall Study||3
6692396|NCT02747238|7622777|FG001|NOT COMPLETED|Overall Study||6
6692397|NCT02747420|7622785|FG000|STARTED|Overall Study||18
6692398|NCT02747420|7622786|FG001|STARTED|Overall Study||22
6692399|NCT02747420|7622785|FG000|COMPLETED|Overall Study||11
6692400|NCT02747420|7622786|FG001|COMPLETED|Overall Study||18
6692401|NCT02747420|7622785|FG000|NOT COMPLETED|Overall Study||7
6692402|NCT02747420|7622786|FG001|NOT COMPLETED|Overall Study||4
6692403|NCT02747433|7622794|FG000|STARTED|Overall Study||5
6692404|NCT02747433|7622795|FG001|STARTED|Overall Study||5
6692405|NCT02747433|7622794|FG000|COMPLETED|Overall Study||5
6692406|NCT02747433|7622795|FG001|COMPLETED|Overall Study||5
6692407|NCT02747433|7622794|FG000|NOT COMPLETED|Overall Study||0
6692408|NCT02747433|7622795|FG001|NOT COMPLETED|Overall Study||0
6692409|NCT02747615|7622806|FG000|STARTED|Overall Study||30
6692410|NCT02747615|7622807|FG001|STARTED|Overall Study||30
6692411|NCT02747615|7622806|FG000|COMPLETED|Overall Study||30
6692412|NCT02747615|7622807|FG001|COMPLETED|Overall Study||30
6692413|NCT02747615|7622806|FG000|NOT COMPLETED|Overall Study||0
6692414|NCT02747615|7622807|FG001|NOT COMPLETED|Overall Study||0
6692415|NCT02747628|7622816|FG000|STARTED|Overall Study||20
6692416|NCT02747628|7622817|FG001|STARTED|Overall Study||20
6692417|NCT02747628|7622818|FG002|STARTED|Overall Study||20
6692418|NCT02747628|7622816|FG000|COMPLETED|Overall Study||20
6692419|NCT02747628|7622817|FG001|COMPLETED|Overall Study||20
6692420|NCT02747628|7622818|FG002|COMPLETED|Overall Study||20
6692421|NCT02747628|7622816|FG000|NOT COMPLETED|Overall Study||0
6692422|NCT02747628|7622817|FG001|NOT COMPLETED|Overall Study||0
6692423|NCT02747628|7622818|FG002|NOT COMPLETED|Overall Study||0
6692424|NCT02747875|7622828|FG000|STARTED|Overall Study||12
6692425|NCT02747875|7622829|FG001|STARTED|Overall Study||14
6692426|NCT02747875|7622828|FG000|COMPLETED|Overall Study||11
6692427|NCT02747875|7622829|FG001|COMPLETED|Overall Study||13
6692428|NCT02747875|7622828|FG000|NOT COMPLETED|Overall Study||1
6692429|NCT02747875|7622829|FG001|NOT COMPLETED|Overall Study||1
6692430|NCT02747927|7622837|FG000|STARTED|Overall Study||6698
6692431|NCT02747927|7622838|FG001|STARTED|Overall Study||13401
6692432|NCT02747927|7622837|FG000|Treated: Safety Set|Overall Study||6687
6692433|NCT02747927|7622838|FG001|Treated: Safety Set|Overall Study||13380
6258388|NCT04321460|7157728|FG001|Intention to Treat (ITT) Population|Overall Study||260
6258389|NCT04321460|7157727|FG000|Per-protocol (PP) Population|Overall Study||252
6258390|NCT04321460|7157728|FG001|Per-protocol (PP) Population|Overall Study||248
6258391|NCT04321460|7157727|FG000|COMPLETED|Overall Study||259
6258392|NCT04321460|7157728|FG001|COMPLETED|Overall Study||259
6258393|NCT04321460|7157727|FG000|NOT COMPLETED|Overall Study||1
6258394|NCT04321460|7157728|FG001|NOT COMPLETED|Overall Study||1
6258395|NCT04280705|7157736|FG000|STARTED|Overall Study||521
6258396|NCT04280705|7157737|FG001|STARTED|Overall Study||541
6258397|NCT04280705|7157736|FG000|Received Treatment|Overall Study||517
6258398|NCT04280705|7157737|FG001|Received Treatment|Overall Study||531
6258399|NCT04280705|7157736|FG000|COMPLETED|Overall Study||508
6258400|NCT04280705|7157737|FG001|COMPLETED|Overall Study||517
6258401|NCT04280705|7157736|FG000|NOT COMPLETED|Overall Study||13
6258402|NCT04280705|7157737|FG001|NOT COMPLETED|Overall Study||24
6258403|NCT04208750|7157745|FG000|STARTED|Overall Study||58
6258404|NCT04208750|7157746|FG001|STARTED|Overall Study||61
6258405|NCT04208750|7157745|FG000|Visit 2|Overall Study||58
6258406|NCT04208750|7157746|FG001|Visit 2|Overall Study||61
6258407|NCT04208750|7157745|FG000|Visit 3|Overall Study||58
6258408|NCT04208750|7157746|FG001|Visit 3|Overall Study||53
6258409|NCT04208750|7157745|FG000|Visit 4|Overall Study||43
6258410|NCT04208750|7157746|FG001|Visit 4|Overall Study||47
6258411|NCT04208750|7157745|FG000|COMPLETED|Overall Study||42
6258412|NCT04208750|7157746|FG001|COMPLETED|Overall Study||46
6258413|NCT04208750|7157745|FG000|NOT COMPLETED|Overall Study||16
6258414|NCT04208750|7157746|FG001|NOT COMPLETED|Overall Study||15
6258415|NCT04126733|7157752|FG000|STARTED|Treatment Period||70
6258416|NCT04126733|7157752|FG000|COMPLETED|Treatment Period||0
6258417|NCT04126733|7157752|FG000|NOT COMPLETED|Treatment Period||70
6258418|NCT04126733|7157752|FG000|STARTED|Active Follow-up Period|Participants had the option to decline participation in active follow-up.|34
6258419|NCT04126733|7157752|FG000|COMPLETED|Active Follow-up Period||14
6258420|NCT04126733|7157752|FG000|NOT COMPLETED|Active Follow-up Period||20
6258421|NCT04126733|7157752|FG000|STARTED|Long-term Follow-up Period|All participants who accepted long-term follow-up.|6
6258422|NCT04126733|7157752|FG000|COMPLETED|Long-term Follow-up Period||0
6258423|NCT04126733|7157752|FG000|NOT COMPLETED|Long-term Follow-up Period||6
6280132|NCT00151775|7180013|FG010|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
6280133|NCT00151775|7180014|FG011|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
6280134|NCT00151775|7180003|FG000|STARTED|Period 4: Open Label||0
6280135|NCT00151775|7180004|FG001|STARTED|Period 4: Open Label||0
6280136|NCT00151775|7180005|FG002|STARTED|Period 4: Open Label||0
6280137|NCT00151775|7180006|FG003|STARTED|Period 4: Open Label||0
6280138|NCT00151775|7180007|FG004|STARTED|Period 4: Open Label||179
6280139|NCT00151775|7180008|FG005|STARTED|Period 4: Open Label||0
6280140|NCT00151775|7180009|FG006|STARTED|Period 4: Open Label||0
6280141|NCT00151775|7180010|FG007|STARTED|Period 4: Open Label||0
6280142|NCT00151775|7180011|FG008|STARTED|Period 4: Open Label||0
6280143|NCT00151775|7180012|FG009|STARTED|Period 4: Open Label||104
6280144|NCT00151775|7180013|FG010|STARTED|Period 4: Open Label||57
6692434|NCT02747927|7622837|FG000|COMPLETED|Overall Study||6477
6692435|NCT02747927|7622838|FG001|COMPLETED|Overall Study||12943
6692436|NCT02747927|7622837|FG000|NOT COMPLETED|Overall Study||221
6692437|NCT02747927|7622838|FG001|NOT COMPLETED|Overall Study||458
6692438|NCT02748070|7622846|FG000|STARTED|Overall Study||41
6692439|NCT02748070|7622847|FG001|STARTED|Overall Study||40
6280145|NCT00151775|7180014|FG011|STARTED|Period 4: Open Label||0
6280146|NCT00151775|7180003|FG000|COMPLETED|Period 4: Open Label||0
6280147|NCT00151775|7180004|FG001|COMPLETED|Period 4: Open Label||0
6280148|NCT00151775|7180005|FG002|COMPLETED|Period 4: Open Label||0
6280149|NCT00151775|7180006|FG003|COMPLETED|Period 4: Open Label||0
6280150|NCT00151775|7180007|FG004|COMPLETED|Period 4: Open Label||149
6280151|NCT00151775|7180008|FG005|COMPLETED|Period 4: Open Label||0
6280152|NCT00151775|7180009|FG006|COMPLETED|Period 4: Open Label||0
6280153|NCT00151775|7180010|FG007|COMPLETED|Period 4: Open Label||0
6692440|NCT02748070|7622846|FG000|Randomized and Treated|Overall Study||40
6692441|NCT02748070|7622847|FG001|Randomized and Treated|Overall Study||40
6692442|NCT02748070|7622846|FG000|COMPLETED|Overall Study||33
6692443|NCT02748070|7622847|FG001|COMPLETED|Overall Study||39
6692444|NCT02748070|7622846|FG000|NOT COMPLETED|Overall Study||8
6692445|NCT02748070|7622847|FG001|NOT COMPLETED|Overall Study||1
6692446|NCT02748096|7622855|FG000|STARTED|Overall Study||23
6692447|NCT02748096|7622856|FG001|STARTED|Overall Study||22
6692448|NCT02748096|7622855|FG000|COMPLETED|Overall Study||23
6692449|NCT02748096|7622856|FG001|COMPLETED|Overall Study||22
6692450|NCT02748096|7622855|FG000|NOT COMPLETED|Overall Study||0
6692451|NCT02748096|7622856|FG001|NOT COMPLETED|Overall Study||0
6692452|NCT02748213|7622864|FG000|STARTED|Overall Study||113
6692453|NCT02748213|7622865|FG001|STARTED|Overall Study||112
6692454|NCT02748213|7622864|FG000|Treated|Overall Study||112
6692455|NCT02748213|7622865|FG001|Treated|Overall Study||110
6692456|NCT02748213|7622864|FG000|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
6692457|NCT02748213|7622865|FG001|COMPLETED|Overall Study||0
6692458|NCT02748213|7622864|FG000|NOT COMPLETED|Overall Study||113
6692459|NCT02748213|7622865|FG001|NOT COMPLETED|Overall Study||112
6692460|NCT02748317|7622871|FG000|STARTED|Overall Study||96
6692461|NCT02748317|7622871|FG000|COMPLETED|Overall Study||73
6692462|NCT02748317|7622871|FG000|NOT COMPLETED|Overall Study||23
6692463|NCT02748356|7622875|FG000|STARTED|Overall Study||7
6692464|NCT02748356|7622875|FG000|COMPLETED|Overall Study||6
6692465|NCT02748356|7622875|FG000|NOT COMPLETED|Overall Study||1
6692466|NCT02748512|7622881|FG000|STARTED|Overall Study||14
6692467|NCT02748512|7622882|FG001|STARTED|Overall Study||12
6692468|NCT02748512|7622881|FG000|COMPLETED|Overall Study||13
6692469|NCT02748512|7622882|FG001|COMPLETED|Overall Study||11
6692470|NCT02748512|7622881|FG000|NOT COMPLETED|Overall Study||1
6692471|NCT02748512|7622882|FG001|NOT COMPLETED|Overall Study||1
6692472|NCT02748525|7622888|FG000|STARTED|Overall Study||50
6692473|NCT02748525|7622888|FG000|Completed Study Intervention|Overall Study||50
6692474|NCT02748525|7622888|FG000|COMPLETED|Overall Study|Completed 6 months follow up|39
6692475|NCT02748525|7622888|FG000|NOT COMPLETED|Overall Study||11
6692476|NCT02748694|7622907|FG000|STARTED|Overall Study||10
6692477|NCT02748694|7622908|FG001|STARTED|Overall Study||6
6692478|NCT02748694|7622909|FG002|STARTED|Overall Study||6
6692479|NCT02748694|7622910|FG003|STARTED|Overall Study||6
6692480|NCT02748694|7622911|FG004|STARTED|Overall Study||6
6692481|NCT02748694|7622912|FG005|STARTED|Overall Study||6
6692482|NCT02748694|7622913|FG006|STARTED|Overall Study||8
6692483|NCT02748694|7622914|FG007|STARTED|Overall Study||6
6692484|NCT02748694|7622915|FG008|STARTED|Overall Study||6
6692485|NCT02748694|7622916|FG009|STARTED|Overall Study||6
6692486|NCT02748694|7622917|FG010|STARTED|Overall Study||6
6692487|NCT02748694|7622918|FG011|STARTED|Overall Study||9
6692488|NCT02748694|7622919|FG012|STARTED|Overall Study||9
6692489|NCT02748694|7622920|FG013|STARTED|Overall Study||8
6692490|NCT02748694|7622921|FG014|STARTED|Overall Study||16
6692491|NCT02748694|7622907|FG000|COMPLETED|Overall Study||10
6258424|NCT03713281|7157756|FG000|STARTED|Overall Study||28
6258425|NCT03713281|7157756|FG000|COMPLETED|Overall Study||25
6258426|NCT03713281|7157756|FG000|NOT COMPLETED|Overall Study||3
6258427|NCT03608254|7157760|FG000|STARTED|Overall Study||11
6258428|NCT03608254|7157760|FG000|COMPLETED|Overall Study||8
6258429|NCT03608254|7157760|FG000|NOT COMPLETED|Overall Study||3
6258430|NCT03512275|7157766|FG000|STARTED|Overall Study||24
6258431|NCT03512275|7157767|FG001|STARTED|Overall Study||18
6258432|NCT03512275|7157766|FG000|COMPLETED|Overall Study||22
6258433|NCT03512275|7157767|FG001|COMPLETED|Overall Study||11
6258434|NCT03512275|7157766|FG000|NOT COMPLETED|Overall Study||2
6258435|NCT03512275|7157767|FG001|NOT COMPLETED|Overall Study||7
6258436|NCT03414983|7157775|FG000|STARTED|Pre-Treatment||127
6258437|NCT03414983|7157776|FG001|STARTED|Pre-Treatment||68
6258438|NCT03414983|7157775|FG000|COMPLETED|Pre-Treatment||123
6258439|NCT03414983|7157776|FG001|COMPLETED|Pre-Treatment||62
6258440|NCT03414983|7157775|FG000|NOT COMPLETED|Pre-Treatment||4
6258441|NCT03414983|7157776|FG001|NOT COMPLETED|Pre-Treatment||6
6258442|NCT03414983|7157775|FG000|STARTED|Treatment||123
6258443|NCT03414983|7157776|FG001|STARTED|Treatment||62
6258444|NCT03414983|7157775|FG000|COMPLETED|Treatment||4
6258445|NCT03414983|7157776|FG001|COMPLETED|Treatment||2
6258446|NCT03414983|7157775|FG000|NOT COMPLETED|Treatment||119
6692492|NCT02748694|7622908|FG001|COMPLETED|Overall Study||6
6692493|NCT02748694|7622909|FG002|COMPLETED|Overall Study||6
6692494|NCT02748694|7622910|FG003|COMPLETED|Overall Study||6
6692495|NCT02748694|7622911|FG004|COMPLETED|Overall Study||6
6692496|NCT02748694|7622912|FG005|COMPLETED|Overall Study||6
6692497|NCT02748694|7622913|FG006|COMPLETED|Overall Study||8
6692498|NCT02748694|7622914|FG007|COMPLETED|Overall Study||6
6692499|NCT02748694|7622915|FG008|COMPLETED|Overall Study||6
6258447|NCT03414983|7157776|FG001|NOT COMPLETED|Treatment||60
6258448|NCT03383692|7157784|FG000|STARTED|Overall Study||17
6258449|NCT03383692|7157785|FG001|STARTED|Overall Study||23
6692500|NCT02748694|7622916|FG009|COMPLETED|Overall Study||6
6692501|NCT02748694|7622917|FG010|COMPLETED|Overall Study||6
6692502|NCT02748694|7622918|FG011|COMPLETED|Overall Study||9
6692503|NCT02748694|7622919|FG012|COMPLETED|Overall Study||9
6692504|NCT02748694|7622920|FG013|COMPLETED|Overall Study||8
6258450|NCT03383692|7157784|FG000|COMPLETED|Overall Study||11
6692505|NCT02748694|7622921|FG014|COMPLETED|Overall Study||14
6692506|NCT02748694|7622907|FG000|NOT COMPLETED|Overall Study||0
6692507|NCT02748694|7622908|FG001|NOT COMPLETED|Overall Study||0
6692508|NCT02748694|7622909|FG002|NOT COMPLETED|Overall Study||0
6692509|NCT02748694|7622910|FG003|NOT COMPLETED|Overall Study||0
6692510|NCT02748694|7622911|FG004|NOT COMPLETED|Overall Study||0
6692511|NCT02748694|7622912|FG005|NOT COMPLETED|Overall Study||0
6692512|NCT02748694|7622913|FG006|NOT COMPLETED|Overall Study||0
6692513|NCT02748694|7622914|FG007|NOT COMPLETED|Overall Study||0
6692514|NCT02748694|7622915|FG008|NOT COMPLETED|Overall Study||0
6692515|NCT02748694|7622916|FG009|NOT COMPLETED|Overall Study||0
6692516|NCT02748694|7622917|FG010|NOT COMPLETED|Overall Study||0
6692517|NCT02748694|7622918|FG011|NOT COMPLETED|Overall Study||0
6692518|NCT02748694|7622919|FG012|NOT COMPLETED|Overall Study||0
6692519|NCT02748694|7622920|FG013|NOT COMPLETED|Overall Study||0
6692520|NCT02748694|7622921|FG014|NOT COMPLETED|Overall Study||2
6692521|NCT02748785|7622981|FG000|STARTED|Visit 1- Visit 2||69
6258451|NCT03383692|7157785|FG001|COMPLETED|Overall Study||19
6258452|NCT03383692|7157784|FG000|NOT COMPLETED|Overall Study||6
6258453|NCT03383692|7157785|FG001|NOT COMPLETED|Overall Study||4
6258454|NCT03371251|7157799|FG000|STARTED|Overall Study||7
6258455|NCT03371251|7157800|FG001|STARTED|Overall Study||5
6258456|NCT03371251|7157801|FG002|STARTED|Overall Study||9
6258457|NCT03371251|7157802|FG003|STARTED|Overall Study||9
6258458|NCT03371251|7157803|FG004|STARTED|Overall Study||37
6258459|NCT03371251|7157804|FG005|STARTED|Overall Study||76
6258460|NCT03371251|7157799|FG000|COMPLETED|Overall Study||5
6258461|NCT03371251|7157800|FG001|COMPLETED|Overall Study||5
6258462|NCT03371251|7157801|FG002|COMPLETED|Overall Study||8
6258463|NCT03371251|7157802|FG003|COMPLETED|Overall Study||9
6258464|NCT03371251|7157803|FG004|COMPLETED|Overall Study||30
6258465|NCT03371251|7157804|FG005|COMPLETED|Overall Study||71
6258466|NCT03371251|7157799|FG000|NOT COMPLETED|Overall Study||2
6258467|NCT03371251|7157800|FG001|NOT COMPLETED|Overall Study||0
6258468|NCT03371251|7157801|FG002|NOT COMPLETED|Overall Study||1
6258469|NCT03371251|7157802|FG003|NOT COMPLETED|Overall Study||0
6258470|NCT03371251|7157803|FG004|NOT COMPLETED|Overall Study||7
6258471|NCT03371251|7157804|FG005|NOT COMPLETED|Overall Study||5
6258472|NCT03349268|7157824|FG000|STARTED|Overall Study||9117
6258473|NCT03349268|7157825|FG001|STARTED|Overall Study||10296
6258474|NCT03349268|7157826|FG002|STARTED|Overall Study||6319
6258475|NCT03349268|7157824|FG000|COMPLETED|Overall Study||9117
6258476|NCT03349268|7157825|FG001|COMPLETED|Overall Study||10296
6258477|NCT03349268|7157826|FG002|COMPLETED|Overall Study||6319
6258478|NCT03349268|7157824|FG000|NOT COMPLETED|Overall Study||0
6258479|NCT03349268|7157825|FG001|NOT COMPLETED|Overall Study||0
6258480|NCT03349268|7157826|FG002|NOT COMPLETED|Overall Study||0
6258481|NCT03307785|7157844|FG000|STARTED|Part A: Up to 28.5 Months||16
6258482|NCT03307785|7157845|FG001|STARTED|Part A: Up to 28.5 Months||6
6258483|NCT03307785|7157846|FG002|STARTED|Part A: Up to 28.5 Months||0
6258484|NCT03307785|7157847|FG003|STARTED|Part A: Up to 28.5 Months||0
6258485|NCT03307785|7157848|FG004|STARTED|Part A: Up to 28.5 Months||0
6258486|NCT03307785|7157849|FG005|STARTED|Part A: Up to 28.5 Months||0
6258487|NCT03307785|7157850|FG006|STARTED|Part A: Up to 28.5 Months||0
6258488|NCT03307785|7157851|FG007|STARTED|Part A: Up to 28.5 Months||0
6258489|NCT03307785|7157852|FG008|STARTED|Part A: Up to 28.5 Months||0
6258490|NCT03307785|7157853|FG009|STARTED|Part A: Up to 28.5 Months||0
6258491|NCT03307785|7157854|FG010|STARTED|Part A: Up to 28.5 Months||0
6258492|NCT03307785|7157844|FG000|COMPLETED|Part A: Up to 28.5 Months||0
6258493|NCT03307785|7157845|FG001|COMPLETED|Part A: Up to 28.5 Months||0
6258494|NCT03307785|7157846|FG002|COMPLETED|Part A: Up to 28.5 Months||0
6258495|NCT03307785|7157847|FG003|COMPLETED|Part A: Up to 28.5 Months||0
6258496|NCT03307785|7157848|FG004|COMPLETED|Part A: Up to 28.5 Months||0
6258497|NCT03307785|7157849|FG005|COMPLETED|Part A: Up to 28.5 Months||0
6258498|NCT03307785|7157850|FG006|COMPLETED|Part A: Up to 28.5 Months||0
6258499|NCT03307785|7157851|FG007|COMPLETED|Part A: Up to 28.5 Months||0
6258500|NCT03307785|7157852|FG008|COMPLETED|Part A: Up to 28.5 Months||0
6258501|NCT03307785|7157853|FG009|COMPLETED|Part A: Up to 28.5 Months||0
6258502|NCT03307785|7157854|FG010|COMPLETED|Part A: Up to 28.5 Months||0
6258503|NCT03307785|7157844|FG000|NOT COMPLETED|Part A: Up to 28.5 Months||16
6258504|NCT03307785|7157845|FG001|NOT COMPLETED|Part A: Up to 28.5 Months||6
6258505|NCT03307785|7157846|FG002|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258506|NCT03307785|7157847|FG003|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258507|NCT03307785|7157848|FG004|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258508|NCT03307785|7157849|FG005|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258509|NCT03307785|7157850|FG006|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258510|NCT03307785|7157851|FG007|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258511|NCT03307785|7157852|FG008|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258512|NCT03307785|7157853|FG009|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258513|NCT03307785|7157854|FG010|NOT COMPLETED|Part A: Up to 28.5 Months||0
6258514|NCT03307785|7157844|FG000|STARTED|Part B: Up to 28.5 Months||0
6258515|NCT03307785|7157845|FG001|STARTED|Part B: Up to 28.5 Months||0
6258516|NCT03307785|7157846|FG002|STARTED|Part B: Up to 28.5 Months||14
6258517|NCT03307785|7157847|FG003|STARTED|Part B: Up to 28.5 Months||0
6258518|NCT03307785|7157848|FG004|STARTED|Part B: Up to 28.5 Months||0
6258519|NCT03307785|7157849|FG005|STARTED|Part B: Up to 28.5 Months||0
6258520|NCT03307785|7157850|FG006|STARTED|Part B: Up to 28.5 Months||0
6258521|NCT03307785|7157851|FG007|STARTED|Part B: Up to 28.5 Months||0
6692522|NCT02748785|7622982|FG001|STARTED|Visit 1- Visit 2||68
6692523|NCT02748785|7622983|FG002|STARTED|Visit 1- Visit 2||71
6692524|NCT02748785|7622984|FG003|STARTED|Visit 1- Visit 2||69
6692525|NCT02748785|7622981|FG000|COMPLETED|Visit 1- Visit 2||59
6692526|NCT02748785|7622982|FG001|COMPLETED|Visit 1- Visit 2||49
6692527|NCT02748785|7622983|FG002|COMPLETED|Visit 1- Visit 2||57
6692528|NCT02748785|7622984|FG003|COMPLETED|Visit 1- Visit 2||63
6692529|NCT02748785|7622981|FG000|NOT COMPLETED|Visit 1- Visit 2||10
6692530|NCT02748785|7622982|FG001|NOT COMPLETED|Visit 1- Visit 2||19
6692531|NCT02748785|7622983|FG002|NOT COMPLETED|Visit 1- Visit 2||14
6692532|NCT02748785|7622984|FG003|NOT COMPLETED|Visit 1- Visit 2||6
6692533|NCT02748785|7622981|FG000|STARTED|Visit 2-Visit 3||59
6692534|NCT02748785|7622982|FG001|STARTED|Visit 2-Visit 3||49
6692535|NCT02748785|7622983|FG002|STARTED|Visit 2-Visit 3||57
6692536|NCT02748785|7622984|FG003|STARTED|Visit 2-Visit 3||63
6692537|NCT02748785|7622981|FG000|COMPLETED|Visit 2-Visit 3||54
6692538|NCT02748785|7622982|FG001|COMPLETED|Visit 2-Visit 3||44
6692539|NCT02748785|7622983|FG002|COMPLETED|Visit 2-Visit 3||49
6692540|NCT02748785|7622984|FG003|COMPLETED|Visit 2-Visit 3||52
6692541|NCT02748785|7622981|FG000|NOT COMPLETED|Visit 2-Visit 3||5
6692542|NCT02748785|7622982|FG001|NOT COMPLETED|Visit 2-Visit 3||5
6692543|NCT02748785|7622983|FG002|NOT COMPLETED|Visit 2-Visit 3||8
6692544|NCT02748785|7622984|FG003|NOT COMPLETED|Visit 2-Visit 3||11
6692545|NCT02748785|7622981|FG000|STARTED|Visit 3- Visit 4||54
6692546|NCT02748785|7622982|FG001|STARTED|Visit 3- Visit 4||44
6692547|NCT02748785|7622983|FG002|STARTED|Visit 3- Visit 4||49
6692548|NCT02748785|7622984|FG003|STARTED|Visit 3- Visit 4||52
6692549|NCT02748785|7622981|FG000|COMPLETED|Visit 3- Visit 4||53
6692550|NCT02748785|7622982|FG001|COMPLETED|Visit 3- Visit 4||43
6692551|NCT02748785|7622983|FG002|COMPLETED|Visit 3- Visit 4||47
6692552|NCT02748785|7622984|FG003|COMPLETED|Visit 3- Visit 4||50
6692553|NCT02748785|7622981|FG000|NOT COMPLETED|Visit 3- Visit 4||1
6692554|NCT02748785|7622982|FG001|NOT COMPLETED|Visit 3- Visit 4||1
6692555|NCT02748785|7622983|FG002|NOT COMPLETED|Visit 3- Visit 4||2
6692556|NCT02748785|7622984|FG003|NOT COMPLETED|Visit 3- Visit 4||2
6692557|NCT02748863|7622997|FG000|STARTED|Treatment Period 1||72
6692558|NCT02748863|7622998|FG001|STARTED|Treatment Period 1||71
6692559|NCT02748863|7622999|FG002|STARTED|Treatment Period 1||71
6692560|NCT02748863|7623000|FG003|STARTED|Treatment Period 1|Not applicable for this period|0
6692561|NCT02748863|7623001|FG004|STARTED|Treatment Period 1|Not applicable for this period|0
6692562|NCT02748863|7622997|FG000|COMPLETED|Treatment Period 1||72
6692563|NCT02748863|7622998|FG001|COMPLETED|Treatment Period 1||69
6692564|NCT02748863|7622999|FG002|COMPLETED|Treatment Period 1||69
6692565|NCT02748863|7623000|FG003|COMPLETED|Treatment Period 1||0
6692566|NCT02748863|7623001|FG004|COMPLETED|Treatment Period 1||0
6692567|NCT02748863|7622997|FG000|NOT COMPLETED|Treatment Period 1||0
6692568|NCT02748863|7622998|FG001|NOT COMPLETED|Treatment Period 1||2
6692569|NCT02748863|7622999|FG002|NOT COMPLETED|Treatment Period 1||2
6692570|NCT02748863|7623000|FG003|NOT COMPLETED|Treatment Period 1||0
6692571|NCT02748863|7623001|FG004|NOT COMPLETED|Treatment Period 1||0
6692572|NCT02748863|7622997|FG000|STARTED|Treatment Period 2||72
6692573|NCT02748863|7622998|FG001|STARTED|Treatment Period 2||69
6692574|NCT02748863|7622999|FG002|STARTED|Treatment Period 2||0
6692575|NCT02748863|7623000|FG003|STARTED|Treatment Period 2||34
6692576|NCT02748863|7623001|FG004|STARTED|Treatment Period 2||34
6692577|NCT02748863|7622997|FG000|COMPLETED|Treatment Period 2||67
6692578|NCT02748863|7622998|FG001|COMPLETED|Treatment Period 2||66
6692579|NCT02748863|7622999|FG002|COMPLETED|Treatment Period 2||0
6692580|NCT02748863|7623000|FG003|COMPLETED|Treatment Period 2||32
6692581|NCT02748863|7623001|FG004|COMPLETED|Treatment Period 2||33
6692582|NCT02748863|7622997|FG000|NOT COMPLETED|Treatment Period 2||5
6692583|NCT02748863|7622998|FG001|NOT COMPLETED|Treatment Period 2||3
6692584|NCT02748863|7622999|FG002|NOT COMPLETED|Treatment Period 2||0
6692585|NCT02748863|7623000|FG003|NOT COMPLETED|Treatment Period 2||2
6692586|NCT02748863|7623001|FG004|NOT COMPLETED|Treatment Period 2||1
6692587|NCT02748889|7623018|FG000|STARTED|Overall Study||0
6692588|NCT02748889|7623019|FG001|STARTED|Overall Study||1
6692589|NCT02748889|7623018|FG000|COMPLETED|Overall Study||0
6692590|NCT02748889|7623019|FG001|COMPLETED|Overall Study||1
6692591|NCT02748889|7623018|FG000|NOT COMPLETED|Overall Study||0
6692592|NCT02748889|7623019|FG001|NOT COMPLETED|Overall Study||0
6692593|NCT02748928|7623023|FG000|STARTED|Overall Study||62
6692594|NCT02748928|7623023|FG000|COMPLETED|Overall Study||62
6692595|NCT02748928|7623023|FG000|NOT COMPLETED|Overall Study||0
6692596|NCT02749201|7623028|FG000|STARTED|Overall Study||10
6692597|NCT02749201|7623028|FG000|COMPLETED|Overall Study||10
6692598|NCT02749201|7623028|FG000|NOT COMPLETED|Overall Study||0
6692599|NCT02749370|7623032|FG000|STARTED|Overall Study||80
6692600|NCT02749370|7623032|FG000|COMPLETED|Overall Study||66
6692601|NCT02749370|7623032|FG000|NOT COMPLETED|Overall Study||14
6692602|NCT02749721|7623036|FG000|STARTED|Screening||31
6692603|NCT02749721|7623036|FG000|COMPLETED|Screening||25
6692604|NCT02749721|7623036|FG000|NOT COMPLETED|Screening||6
6692605|NCT02749721|7623036|FG000|STARTED|8-week Open-Label Treatment Phase||25
6692606|NCT02749721|7623036|FG000|COMPLETED|8-week Open-Label Treatment Phase||22
6692607|NCT02749721|7623036|FG000|NOT COMPLETED|8-week Open-Label Treatment Phase||3
6692608|NCT02749799|7623042|FG000|STARTED|Overall Study||45
6692609|NCT02749799|7623042|FG000|COMPLETED|Overall Study||37
6692610|NCT02749799|7623042|FG000|NOT COMPLETED|Overall Study||8
6692611|NCT02749903|7623046|FG000|STARTED|Overall Study||46
6692612|NCT02749903|7623046|FG000|COMPLETED|Overall Study||46
6692613|NCT02749903|7623046|FG000|NOT COMPLETED|Overall Study||0
6692614|NCT02750267|7623052|FG000|STARTED|Overall Study||6
6692615|NCT02750267|7623053|FG001|STARTED|Overall Study||6
6692616|NCT02750267|7623052|FG000|COMPLETED|Overall Study||6
6692617|NCT02750267|7623053|FG001|COMPLETED|Overall Study||6
6692618|NCT02750267|7623052|FG000|NOT COMPLETED|Overall Study||0
6692619|NCT02750267|7623053|FG001|NOT COMPLETED|Overall Study||0
6692620|NCT02750306|7623063|FG000|STARTED|Overall Study||142
6692621|NCT02750306|7623064|FG001|STARTED|Overall Study||143
6692622|NCT02750306|7623063|FG000|COMPLETED|Overall Study||136
6692623|NCT02750306|7623064|FG001|COMPLETED|Overall Study||141
6692624|NCT02750306|7623063|FG000|NOT COMPLETED|Overall Study||6
6692625|NCT02750306|7623064|FG001|NOT COMPLETED|Overall Study||2
6692626|NCT02750332|7623070|FG000|STARTED|Treatment Period 1||10
6692627|NCT02750332|7623071|FG001|STARTED|Treatment Period 1||10
6692628|NCT02750332|7623070|FG000|COMPLETED|Treatment Period 1||10
6692629|NCT02750332|7623071|FG001|COMPLETED|Treatment Period 1||9
6692630|NCT02750332|7623070|FG000|NOT COMPLETED|Treatment Period 1||0
6692631|NCT02750332|7623071|FG001|NOT COMPLETED|Treatment Period 1||1
6692632|NCT02750332|7623070|FG000|STARTED|Treatment Period 2||10
6692633|NCT02750332|7623071|FG001|STARTED|Treatment Period 2||9
6692634|NCT02750332|7623070|FG000|COMPLETED|Treatment Period 2||10
6692635|NCT02750332|7623071|FG001|COMPLETED|Treatment Period 2||9
6692636|NCT02750332|7623070|FG000|NOT COMPLETED|Treatment Period 2||0
6692637|NCT02750332|7623071|FG001|NOT COMPLETED|Treatment Period 2||0
6692638|NCT02750345|7623077|FG000|STARTED|Intervention 1||4
6692639|NCT02750345|7623078|FG001|STARTED|Intervention 1||4
6692640|NCT02750345|7623079|FG002|STARTED|Intervention 1||4
6692641|NCT02750345|7623080|FG003|STARTED|Intervention 1||4
6692642|NCT02750345|7623081|FG004|STARTED|Intervention 1||4
6692643|NCT02750345|7623082|FG005|STARTED|Intervention 1||4
6692644|NCT02750345|7623077|FG000|COMPLETED|Intervention 1||4
6692645|NCT02750345|7623078|FG001|COMPLETED|Intervention 1||4
6692646|NCT02750345|7623079|FG002|COMPLETED|Intervention 1||4
6692647|NCT02750345|7623080|FG003|COMPLETED|Intervention 1||4
6692648|NCT02750345|7623081|FG004|COMPLETED|Intervention 1||3
6692649|NCT02750345|7623082|FG005|COMPLETED|Intervention 1||4
6692650|NCT02750345|7623077|FG000|NOT COMPLETED|Intervention 1||0
6692651|NCT02750345|7623078|FG001|NOT COMPLETED|Intervention 1||0
6692652|NCT02750345|7623079|FG002|NOT COMPLETED|Intervention 1||0
6692653|NCT02750345|7623080|FG003|NOT COMPLETED|Intervention 1||0
6692654|NCT02750345|7623081|FG004|NOT COMPLETED|Intervention 1||1
6692655|NCT02750345|7623082|FG005|NOT COMPLETED|Intervention 1||0
6692656|NCT02750345|7623077|FG000|STARTED|Intervention 2||4
6692657|NCT02750345|7623078|FG001|STARTED|Intervention 2||4
6692658|NCT02750345|7623079|FG002|STARTED|Intervention 2||4
6692659|NCT02750345|7623080|FG003|STARTED|Intervention 2||4
6692660|NCT02750345|7623081|FG004|STARTED|Intervention 2||3
6692661|NCT02750345|7623082|FG005|STARTED|Intervention 2||4
6692662|NCT02750345|7623077|FG000|COMPLETED|Intervention 2||4
6692663|NCT02750345|7623078|FG001|COMPLETED|Intervention 2||4
6692664|NCT02750345|7623079|FG002|COMPLETED|Intervention 2||4
6692665|NCT02750345|7623080|FG003|COMPLETED|Intervention 2||4
6692666|NCT02750345|7623081|FG004|COMPLETED|Intervention 2||3
6692667|NCT02750345|7623082|FG005|COMPLETED|Intervention 2||4
6692668|NCT02750345|7623077|FG000|NOT COMPLETED|Intervention 2||0
6692669|NCT02750345|7623078|FG001|NOT COMPLETED|Intervention 2||0
6692670|NCT02750345|7623079|FG002|NOT COMPLETED|Intervention 2||0
6692671|NCT02750345|7623080|FG003|NOT COMPLETED|Intervention 2||0
6692672|NCT02750345|7623081|FG004|NOT COMPLETED|Intervention 2||0
6692673|NCT02750345|7623082|FG005|NOT COMPLETED|Intervention 2||0
6692674|NCT02750345|7623077|FG000|STARTED|Intervention 3||4
6692675|NCT02750345|7623078|FG001|STARTED|Intervention 3||4
6692676|NCT02750345|7623079|FG002|STARTED|Intervention 3||4
6692677|NCT02750345|7623080|FG003|STARTED|Intervention 3||4
6692678|NCT02750345|7623081|FG004|STARTED|Intervention 3||3
6692679|NCT02750345|7623082|FG005|STARTED|Intervention 3||4
6692680|NCT02750345|7623077|FG000|COMPLETED|Intervention 3||4
6692681|NCT02750345|7623078|FG001|COMPLETED|Intervention 3||4
6692682|NCT02750345|7623079|FG002|COMPLETED|Intervention 3||4
6692683|NCT02750345|7623080|FG003|COMPLETED|Intervention 3||4
6692684|NCT02750345|7623081|FG004|COMPLETED|Intervention 3||3
6692685|NCT02750345|7623082|FG005|COMPLETED|Intervention 3||4
6692686|NCT02750345|7623077|FG000|NOT COMPLETED|Intervention 3||0
6692687|NCT02750345|7623078|FG001|NOT COMPLETED|Intervention 3||0
6692688|NCT02750345|7623079|FG002|NOT COMPLETED|Intervention 3||0
6692689|NCT02750345|7623080|FG003|NOT COMPLETED|Intervention 3||0
6692690|NCT02750345|7623081|FG004|NOT COMPLETED|Intervention 3||0
6692691|NCT02750345|7623082|FG005|NOT COMPLETED|Intervention 3||0
6692692|NCT02750410|7623094|FG000|STARTED|Double-Blind Treatment Period||39
6692693|NCT02750410|7623095|FG001|STARTED|Double-Blind Treatment Period||120
6692694|NCT02750410|7623094|FG000|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||39
6692695|NCT02750410|7623095|FG001|Received at Least One Dose of Study Drug|Double-Blind Treatment Period||120
6692696|NCT02750410|7623094|FG000|COMPLETED|Double-Blind Treatment Period||37
6692697|NCT02750410|7623095|FG001|COMPLETED|Double-Blind Treatment Period||117
6692698|NCT02750410|7623094|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
6692699|NCT02750410|7623095|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
6692700|NCT02750410|7623094|FG000|STARTED|Open-Label Extension Period||37
6692701|NCT02750410|7623095|FG001|STARTED|Open-Label Extension Period||117
6692702|NCT02750410|7623094|FG000|COMPLETED|Open-Label Extension Period||31
6692703|NCT02750410|7623095|FG001|COMPLETED|Open-Label Extension Period||111
6692704|NCT02750410|7623094|FG000|NOT COMPLETED|Open-Label Extension Period||6
6692705|NCT02750410|7623095|FG001|NOT COMPLETED|Open-Label Extension Period||6
6692706|NCT02750501|7623105|FG000|STARTED|Overall Study||44
6692707|NCT02750501|7623105|FG000|Enrolled|Overall Study||44
6692708|NCT02750501|7623105|FG000|Treated|Overall Study||39
6692709|NCT02750501|7623105|FG000|COMPLETED|Overall Study||36
6692710|NCT02750501|7623105|FG000|NOT COMPLETED|Overall Study||8
6692711|NCT02750514|7623118|FG000|STARTED|Track 1||40
6692712|NCT02750514|7623119|FG001|STARTED|Track 1||4
6692713|NCT02750514|7623120|FG002|STARTED|Track 1||0
6692714|NCT02750514|7623121|FG003|STARTED|Track 1||3
6692715|NCT02750514|7623122|FG004|STARTED|Track 1||0
6692716|NCT02750514|7623118|FG000|COMPLETED|Track 1|3 participants were re-randomized to track 3 (2 part.) or track 5 (1 part.)|13
6692717|NCT02750514|7623119|FG001|COMPLETED|Track 1||2
6692718|NCT02750514|7623120|FG002|COMPLETED|Track 1||0
6692719|NCT02750514|7623121|FG003|COMPLETED|Track 1||1
6692720|NCT02750514|7623122|FG004|COMPLETED|Track 1||0
6692721|NCT02750514|7623118|FG000|NOT COMPLETED|Track 1||27
6692722|NCT02750514|7623119|FG001|NOT COMPLETED|Track 1||2
6692723|NCT02750514|7623120|FG002|NOT COMPLETED|Track 1||0
6692724|NCT02750514|7623121|FG003|NOT COMPLETED|Track 1||2
6692725|NCT02750514|7623122|FG004|NOT COMPLETED|Track 1||0
6692726|NCT02750514|7623118|FG000|STARTED|Track 2||9
6692727|NCT02750514|7623119|FG001|STARTED|Track 2||8
6692728|NCT02750514|7623120|FG002|STARTED|Track 2||2
6692729|NCT02750514|7623121|FG003|STARTED|Track 2||12
6692730|NCT02750514|7623122|FG004|STARTED|Track 2||0
6692731|NCT02750514|7623118|FG000|COMPLETED|Track 2|2 participants were re-randomized to track 3 (1 part.) or track 5 (1 part.)|3
6692732|NCT02750514|7623119|FG001|COMPLETED|Track 2||0
6692733|NCT02750514|7623120|FG002|COMPLETED|Track 2||0
6692734|NCT02750514|7623121|FG003|COMPLETED|Track 2|1 participant was re-randomized to track 5|5
6692735|NCT02750514|7623122|FG004|COMPLETED|Track 2||0
6692736|NCT02750514|7623118|FG000|NOT COMPLETED|Track 2||6
6692737|NCT02750514|7623119|FG001|NOT COMPLETED|Track 2||8
6692738|NCT02750514|7623120|FG002|NOT COMPLETED|Track 2||2
6692739|NCT02750514|7623121|FG003|NOT COMPLETED|Track 2||7
6692740|NCT02750514|7623122|FG004|NOT COMPLETED|Track 2||0
6692741|NCT02750514|7623118|FG000|STARTED|Track 3||0
6692742|NCT02750514|7623119|FG001|STARTED|Track 3|2 participants had prior treatment in track 1 (1 part.) or track 2 (1 part.)|41
6692743|NCT02750514|7623120|FG002|STARTED|Track 3|1 participant had prior treatment in track 3|16
6692744|NCT02750514|7623121|FG003|STARTED|Track 3|5 participants had prior treatment in track 1 (1 part.) or track 3 (4 part.)|18
6692745|NCT02750514|7623122|FG004|STARTED|Track 3||0
6258522|NCT03307785|7157852|FG008|STARTED|Part B: Up to 28.5 Months||0
6258523|NCT03307785|7157853|FG009|STARTED|Part B: Up to 28.5 Months||0
6258524|NCT03307785|7157854|FG010|STARTED|Part B: Up to 28.5 Months||0
6258525|NCT03307785|7157844|FG000|COMPLETED|Part B: Up to 28.5 Months||0
6258526|NCT03307785|7157845|FG001|COMPLETED|Part B: Up to 28.5 Months||0
6258527|NCT03307785|7157846|FG002|COMPLETED|Part B: Up to 28.5 Months||0
6258528|NCT03307785|7157847|FG003|COMPLETED|Part B: Up to 28.5 Months||0
6258529|NCT03307785|7157848|FG004|COMPLETED|Part B: Up to 28.5 Months||0
6602397|NCT02056626|7527385|FG002|NOT COMPLETED|Overall Study||0
6602398|NCT02056626|7527386|FG003|NOT COMPLETED|Overall Study||0
6602399|NCT02056639|7527398|FG000|STARTED|Overall Study||23
6602400|NCT02056639|7527399|FG001|STARTED|Overall Study||23
6602401|NCT02056639|7527398|FG000|COMPLETED|Overall Study||23
6602402|NCT02056639|7527399|FG001|COMPLETED|Overall Study||23
6602403|NCT02056639|7527398|FG000|NOT COMPLETED|Overall Study||0
6602404|NCT02056639|7527399|FG001|NOT COMPLETED|Overall Study||0
6602405|NCT02056652|7527409|FG000|STARTED|Overall Study||61
6602406|NCT02056652|7527410|FG001|STARTED|Overall Study||61
6602407|NCT02056652|7527409|FG000|COMPLETED|Overall Study||60
6602408|NCT02056652|7527410|FG001|COMPLETED|Overall Study||58
6602409|NCT02056652|7527409|FG000|NOT COMPLETED|Overall Study||1
6602410|NCT02056652|7527410|FG001|NOT COMPLETED|Overall Study||3
6602411|NCT02056834|7527416|FG000|STARTED|Overall Study||36
6602412|NCT02056834|7527416|FG000|6 Weeks|Overall Study||34
6602413|NCT02056834|7527416|FG000|6 Months|Overall Study||31
6602414|NCT02056834|7527416|FG000|COMPLETED|Overall Study||29
6602415|NCT02056834|7527416|FG000|NOT COMPLETED|Overall Study||7
6602416|NCT02057042|7527423|FG000|STARTED|Overall Study||163
6602417|NCT02057042|7527424|FG001|STARTED|Overall Study||167
6602418|NCT02057042|7527423|FG000|COMPLETED|Overall Study||118
6602419|NCT02057042|7527424|FG001|COMPLETED|Overall Study||101
6602420|NCT02057042|7527423|FG000|NOT COMPLETED|Overall Study||45
6602421|NCT02057042|7527424|FG001|NOT COMPLETED|Overall Study||66
6602422|NCT02057068|7527432|FG000|STARTED|Overall Study||60
6602423|NCT02057068|7527433|FG001|STARTED|Overall Study||36
6602424|NCT02057068|7527432|FG000|COMPLETED|Overall Study||52
6602425|NCT02057068|7527433|FG001|COMPLETED|Overall Study||28
6602426|NCT02057068|7527432|FG000|NOT COMPLETED|Overall Study||8
6602427|NCT02057068|7527433|FG001|NOT COMPLETED|Overall Study||8
6602428|NCT02057081|7527443|FG000|STARTED|Overall Study||136
6602429|NCT02057081|7527444|FG001|STARTED|Overall Study||112
6602430|NCT02057081|7527443|FG000|Completed Baseline|Overall Study||88
6602431|NCT02057081|7527444|FG001|Completed Baseline|Overall Study||80
6602432|NCT02057081|7527443|FG000|Post-Treatment Assessment|Overall Study||58
6602433|NCT02057081|7527444|FG001|Post-Treatment Assessment|Overall Study||52
6602434|NCT02057081|7527443|FG000|COMPLETED|Overall Study||46
6602435|NCT02057081|7527444|FG001|COMPLETED|Overall Study||44
6692746|NCT02750514|7623118|FG000|COMPLETED|Track 3||0
6692747|NCT02750514|7623119|FG001|COMPLETED|Track 3|6 participants were re-randomized to track 3 (5 part.) or to track 5 (1 part.)|5
6692748|NCT02750514|7623120|FG002|COMPLETED|Track 3||1
6692749|NCT02750514|7623121|FG003|COMPLETED|Track 3|1 participant was re-randomized to track 5|2
6692750|NCT02750514|7623122|FG004|COMPLETED|Track 3||0
6692751|NCT02750514|7623118|FG000|NOT COMPLETED|Track 3||0
6692752|NCT02750514|7623119|FG001|NOT COMPLETED|Track 3||36
6692753|NCT02750514|7623120|FG002|NOT COMPLETED|Track 3||15
6692754|NCT02750514|7623121|FG003|NOT COMPLETED|Track 3||16
6692755|NCT02750514|7623122|FG004|NOT COMPLETED|Track 3||0
6692756|NCT02750514|7623118|FG000|STARTED|Track 4||0
6692757|NCT02750514|7623119|FG001|STARTED|Track 4||53
6692758|NCT02750514|7623120|FG002|STARTED|Track 4||0
6692759|NCT02750514|7623121|FG003|STARTED|Track 4||60
6692760|NCT02750514|7623122|FG004|STARTED|Track 4||0
6692761|NCT02750514|7623118|FG000|COMPLETED|Track 4||0
6692762|NCT02750514|7623119|FG001|COMPLETED|Track 4|1 participant was re-randomized to track 5|2
6692763|NCT02750514|7623120|FG002|COMPLETED|Track 4||0
6692764|NCT02750514|7623121|FG003|COMPLETED|Track 4||18
6692765|NCT02750514|7623122|FG004|COMPLETED|Track 4||0
6692766|NCT02750514|7623118|FG000|NOT COMPLETED|Track 4||0
6692767|NCT02750514|7623119|FG001|NOT COMPLETED|Track 4||51
6692768|NCT02750514|7623120|FG002|NOT COMPLETED|Track 4||0
6692769|NCT02750514|7623121|FG003|NOT COMPLETED|Track 4||42
6692770|NCT02750514|7623122|FG004|NOT COMPLETED|Track 4||0
6692771|NCT02750514|7623118|FG000|STARTED|Track 5||0
6692772|NCT02750514|7623119|FG001|STARTED|Track 5||0
6692773|NCT02750514|7623120|FG002|STARTED|Track 5||0
6692774|NCT02750514|7623121|FG003|STARTED|Track 5||0
6692775|NCT02750514|7623122|FG004|STARTED|Track 5|6 participants had prior treatment in track 1 (1 part.), 2 (2 part.), 3 (2 part.) or 4 (1 part.)|43
6692776|NCT02750514|7623118|FG000|COMPLETED|Track 5||0
6692777|NCT02750514|7623119|FG001|COMPLETED|Track 5||0
6692778|NCT02750514|7623120|FG002|COMPLETED|Track 5||0
6692779|NCT02750514|7623121|FG003|COMPLETED|Track 5||0
6692780|NCT02750514|7623122|FG004|COMPLETED|Track 5||0
6692781|NCT02750514|7623118|FG000|NOT COMPLETED|Track 5||0
6692782|NCT02750514|7623119|FG001|NOT COMPLETED|Track 5||0
6692783|NCT02750514|7623120|FG002|NOT COMPLETED|Track 5||0
6692784|NCT02750514|7623121|FG003|NOT COMPLETED|Track 5||0
6692785|NCT02750514|7623122|FG004|NOT COMPLETED|Track 5||43
6692786|NCT02750592|7623142|FG000|STARTED|Overall Study||30
6692787|NCT02750592|7623142|FG000|COMPLETED|Overall Study||25
6692788|NCT02750592|7623142|FG000|NOT COMPLETED|Overall Study||5
6692789|NCT02750618|7623146|FG000|STARTED|Overall Study||13
6692790|NCT02750618|7623146|FG000|Completed Week 40|Overall Study||13
6692791|NCT02750618|7623146|FG000|Completed Week 64|Overall Study||13
6692792|NCT02750618|7623146|FG000|COMPLETED|Overall Study||12
6692793|NCT02750618|7623146|FG000|NOT COMPLETED|Overall Study||1
6692794|NCT02750709|7623150|FG000|STARTED|Treatment Period 1||4
6692795|NCT02750709|7623151|FG001|STARTED|Treatment Period 1||4
6692796|NCT02750709|7623152|FG002|STARTED|Treatment Period 1||4
6692797|NCT02750709|7623153|FG003|STARTED|Treatment Period 1||4
6692798|NCT02750709|7623154|FG004|STARTED|Treatment Period 1||4
6692799|NCT02750709|7623155|FG005|STARTED|Treatment Period 1||4
6692800|NCT02750709|7623150|FG000|COMPLETED|Treatment Period 1||4
6692801|NCT02750709|7623151|FG001|COMPLETED|Treatment Period 1||4
6692802|NCT02750709|7623152|FG002|COMPLETED|Treatment Period 1||4
6692803|NCT02750709|7623153|FG003|COMPLETED|Treatment Period 1||4
6692804|NCT02750709|7623154|FG004|COMPLETED|Treatment Period 1||4
6692805|NCT02750709|7623155|FG005|COMPLETED|Treatment Period 1||3
6692806|NCT02750709|7623150|FG000|NOT COMPLETED|Treatment Period 1||0
6692807|NCT02750709|7623151|FG001|NOT COMPLETED|Treatment Period 1||0
6692808|NCT02750709|7623152|FG002|NOT COMPLETED|Treatment Period 1||0
6692809|NCT02750709|7623153|FG003|NOT COMPLETED|Treatment Period 1||0
6692810|NCT02750709|7623154|FG004|NOT COMPLETED|Treatment Period 1||0
6692811|NCT02750709|7623155|FG005|NOT COMPLETED|Treatment Period 1||1
6692812|NCT02750709|7623150|FG000|STARTED|Treatment Period 2||4
6692813|NCT02750709|7623151|FG001|STARTED|Treatment Period 2||4
6692814|NCT02750709|7623152|FG002|STARTED|Treatment Period 2||4
6692815|NCT02750709|7623153|FG003|STARTED|Treatment Period 2||4
6692816|NCT02750709|7623154|FG004|STARTED|Treatment Period 2||4
6692817|NCT02750709|7623155|FG005|STARTED|Treatment Period 2||3
6692818|NCT02750709|7623150|FG000|COMPLETED|Treatment Period 2||4
6692819|NCT02750709|7623151|FG001|COMPLETED|Treatment Period 2||4
6692820|NCT02750709|7623152|FG002|COMPLETED|Treatment Period 2||4
6692821|NCT02750709|7623153|FG003|COMPLETED|Treatment Period 2||4
6692822|NCT02750709|7623154|FG004|COMPLETED|Treatment Period 2||4
6692823|NCT02750709|7623155|FG005|COMPLETED|Treatment Period 2||3
6692824|NCT02750709|7623150|FG000|NOT COMPLETED|Treatment Period 2||0
6692825|NCT02750709|7623151|FG001|NOT COMPLETED|Treatment Period 2||0
6692826|NCT02750709|7623152|FG002|NOT COMPLETED|Treatment Period 2||0
6692827|NCT02750709|7623153|FG003|NOT COMPLETED|Treatment Period 2||0
6692828|NCT02750709|7623154|FG004|NOT COMPLETED|Treatment Period 2||0
6692829|NCT02750709|7623155|FG005|NOT COMPLETED|Treatment Period 2||0
6692830|NCT02750709|7623150|FG000|STARTED|Treatment Period 3||4
6692831|NCT02750709|7623151|FG001|STARTED|Treatment Period 3||4
6692832|NCT02750709|7623152|FG002|STARTED|Treatment Period 3||4
6692833|NCT02750709|7623153|FG003|STARTED|Treatment Period 3||4
6692834|NCT02750709|7623154|FG004|STARTED|Treatment Period 3||4
6692835|NCT02750709|7623155|FG005|STARTED|Treatment Period 3||3
6692836|NCT02750709|7623150|FG000|COMPLETED|Treatment Period 3||4
6692837|NCT02750709|7623151|FG001|COMPLETED|Treatment Period 3||4
6692838|NCT02750709|7623152|FG002|COMPLETED|Treatment Period 3||4
6692839|NCT02750709|7623153|FG003|COMPLETED|Treatment Period 3||4
6692840|NCT02750709|7623154|FG004|COMPLETED|Treatment Period 3||4
6692841|NCT02750709|7623155|FG005|COMPLETED|Treatment Period 3||3
6692842|NCT02750709|7623150|FG000|NOT COMPLETED|Treatment Period 3||0
6692843|NCT02750709|7623151|FG001|NOT COMPLETED|Treatment Period 3||0
6692844|NCT02750709|7623152|FG002|NOT COMPLETED|Treatment Period 3||0
6692845|NCT02750709|7623153|FG003|NOT COMPLETED|Treatment Period 3||0
6692846|NCT02750709|7623154|FG004|NOT COMPLETED|Treatment Period 3||0
6692847|NCT02750709|7623155|FG005|NOT COMPLETED|Treatment Period 3||0
6692848|NCT02750761|7623169|FG000|STARTED|Overall Study||5
6692849|NCT02750761|7623170|FG001|STARTED|Overall Study||5
6692850|NCT02750761|7623171|FG002|STARTED|Overall Study||5
6692851|NCT02750761|7623172|FG003|STARTED|Overall Study||5
6692852|NCT02750761|7623173|FG004|STARTED|Overall Study||6
6692853|NCT02750761|7623174|FG005|STARTED|Overall Study||6
6692854|NCT02750761|7623169|FG000|COMPLETED|Overall Study||5
6692855|NCT02750761|7623170|FG001|COMPLETED|Overall Study||5
6692856|NCT02750761|7623171|FG002|COMPLETED|Overall Study||4
6692857|NCT02750761|7623172|FG003|COMPLETED|Overall Study||5
6692858|NCT02750761|7623173|FG004|COMPLETED|Overall Study||6
6692859|NCT02750761|7623174|FG005|COMPLETED|Overall Study||6
6692860|NCT02750761|7623169|FG000|NOT COMPLETED|Overall Study||0
6692861|NCT02750761|7623170|FG001|NOT COMPLETED|Overall Study||0
6692862|NCT02750761|7623171|FG002|NOT COMPLETED|Overall Study||1
6692863|NCT02750761|7623172|FG003|NOT COMPLETED|Overall Study||0
6692864|NCT02750761|7623173|FG004|NOT COMPLETED|Overall Study||0
6692865|NCT02750761|7623174|FG005|NOT COMPLETED|Overall Study||0
6692866|NCT02750800|7623198|FG000|STARTED|Overall Study||412
6692867|NCT02750800|7623198|FG000|COMPLETED|Overall Study||314
6692868|NCT02750800|7623198|FG000|NOT COMPLETED|Overall Study||98
6692869|NCT02750813|7623216|FG000|STARTED|Period 1, First 14 Days of Wear||125
6692870|NCT02750813|7623217|FG001|STARTED|Period 1, First 14 Days of Wear||121
6692871|NCT02750813|7623216|FG000|COMPLETED|Period 1, First 14 Days of Wear||124
6692872|NCT02750813|7623217|FG001|COMPLETED|Period 1, First 14 Days of Wear||120
6692873|NCT02750813|7623216|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||1
6692874|NCT02750813|7623217|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
6692875|NCT02750813|7623216|FG000|STARTED|Period 2, Second 14 Days of Wear||124
6692876|NCT02750813|7623217|FG001|STARTED|Period 2, Second 14 Days of Wear||120
6692877|NCT02750813|7623216|FG000|COMPLETED|Period 2, Second 14 Days of Wear||124
6692878|NCT02750813|7623217|FG001|COMPLETED|Period 2, Second 14 Days of Wear||120
6692879|NCT02750813|7623216|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6692880|NCT02750813|7623217|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6692881|NCT02750930|7623224|FG000|STARTED|Overall Study||8
6692882|NCT02750930|7623224|FG000|COMPLETED|Overall Study||0
6692883|NCT02750930|7623224|FG000|NOT COMPLETED|Overall Study||8
6692884|NCT02750943|7623230|FG000|STARTED|Overall Study||125
6692885|NCT02750943|7623231|FG001|STARTED|Overall Study||128
6692886|NCT02750943|7623230|FG000|COMPLETED|Overall Study||119
6692887|NCT02750943|7623231|FG001|COMPLETED|Overall Study||119
6692888|NCT02750943|7623230|FG000|NOT COMPLETED|Overall Study||6
6692889|NCT02750943|7623231|FG001|NOT COMPLETED|Overall Study||9
6692890|NCT02751320|7623237|FG000|STARTED|Overall Study||45
6692891|NCT02751320|7623237|FG000|Received Test Product 1|Overall Study||29
6692892|NCT02751320|7623237|FG000|Received Test Prodcut 2|Overall Study||28
6692893|NCT02751320|7623237|FG000|Received Test Prodcut 3|Overall Study||28
6692894|NCT02751320|7623237|FG000|Received Reference Product 1|Overall Study||29
6692895|NCT02751320|7623237|FG000|Received Reference Product 2|Overall Study||28
6692896|NCT02751320|7623237|FG000|Received Reference Product 3|Overall Study||28
6692897|NCT02751320|7623237|FG000|COMPLETED|Overall Study||42
6692898|NCT02751320|7623237|FG000|NOT COMPLETED|Overall Study||3
6692899|NCT02751359|7623262|FG000|STARTED|Overall Study||18
6692900|NCT02751359|7623262|FG000|COMPLETED|Overall Study||17
6692901|NCT02751359|7623262|FG000|NOT COMPLETED|Overall Study||1
6692902|NCT02751385|7623272|FG000|STARTED|Period 1||2
6692903|NCT02751385|7623273|FG001|STARTED|Period 1||0
6692904|NCT02751385|7623272|FG000|COMPLETED|Period 1||2
6692905|NCT02751385|7623273|FG001|COMPLETED|Period 1||0
6692906|NCT02751385|7623272|FG000|NOT COMPLETED|Period 1||0
6692907|NCT02751385|7623273|FG001|NOT COMPLETED|Period 1||0
6692908|NCT02751385|7623272|FG000|STARTED|Period 2||0
6692909|NCT02751385|7623273|FG001|STARTED|Period 2||2
6692910|NCT02751385|7623272|FG000|COMPLETED|Period 2||0
6692911|NCT02751385|7623273|FG001|COMPLETED|Period 2||2
6692912|NCT02751385|7623272|FG000|NOT COMPLETED|Period 2||0
6692913|NCT02751385|7623273|FG001|NOT COMPLETED|Period 2||0
6692914|NCT02751424|7623290|FG000|STARTED|Part 1||6
6692915|NCT02751424|7623291|FG001|STARTED|Part 1||6
6692916|NCT02751424|7623292|FG002|STARTED|Part 1||6
6692917|NCT02751424|7623293|FG003|STARTED|Part 1||6
6692918|NCT02751424|7623294|FG004|STARTED|Part 1||6
6692919|NCT02751424|7623295|FG005|STARTED|Part 1||6
6692920|NCT02751424|7623296|FG006|STARTED|Part 1||12
6692921|NCT02751424|7623297|FG007|STARTED|Part 1||0
6692922|NCT02751424|7623298|FG008|STARTED|Part 1||0
6692923|NCT02751424|7623290|FG000|COMPLETED|Part 1||6
6692924|NCT02751424|7623291|FG001|COMPLETED|Part 1||6
6692925|NCT02751424|7623292|FG002|COMPLETED|Part 1||6
6692926|NCT02751424|7623293|FG003|COMPLETED|Part 1||6
6692927|NCT02751424|7623294|FG004|COMPLETED|Part 1||6
6692928|NCT02751424|7623295|FG005|COMPLETED|Part 1||6
6692929|NCT02751424|7623296|FG006|COMPLETED|Part 1||12
6692930|NCT02751424|7623297|FG007|COMPLETED|Part 1||0
6692931|NCT02751424|7623298|FG008|COMPLETED|Part 1||0
6692932|NCT02751424|7623290|FG000|NOT COMPLETED|Part 1||0
6692933|NCT02751424|7623291|FG001|NOT COMPLETED|Part 1||0
6692934|NCT02751424|7623292|FG002|NOT COMPLETED|Part 1||0
6692935|NCT02751424|7623293|FG003|NOT COMPLETED|Part 1||0
6692936|NCT02751424|7623294|FG004|NOT COMPLETED|Part 1||0
6692937|NCT02751424|7623295|FG005|NOT COMPLETED|Part 1||0
6692938|NCT02751424|7623296|FG006|NOT COMPLETED|Part 1||0
6692939|NCT02751424|7623297|FG007|NOT COMPLETED|Part 1||0
6692940|NCT02751424|7623298|FG008|NOT COMPLETED|Part 1||0
6692941|NCT02751424|7623290|FG000|STARTED|Part 2||0
6692942|NCT02751424|7623291|FG001|STARTED|Part 2||0
6692943|NCT02751424|7623292|FG002|STARTED|Part 2||0
6692944|NCT02751424|7623293|FG003|STARTED|Part 2||0
6692945|NCT02751424|7623294|FG004|STARTED|Part 2||0
6692946|NCT02751424|7623295|FG005|STARTED|Part 2||0
6692947|NCT02751424|7623296|FG006|STARTED|Part 2||0
6692948|NCT02751424|7623297|FG007|STARTED|Part 2||11
6692949|NCT02751424|7623298|FG008|STARTED|Part 2||3
6692950|NCT02751424|7623290|FG000|COMPLETED|Part 2||0
6692951|NCT02751424|7623291|FG001|COMPLETED|Part 2||0
6692952|NCT02751424|7623292|FG002|COMPLETED|Part 2||0
6692953|NCT02751424|7623293|FG003|COMPLETED|Part 2||0
6692954|NCT02751424|7623294|FG004|COMPLETED|Part 2||0
6692955|NCT02751424|7623295|FG005|COMPLETED|Part 2||0
6692956|NCT02751424|7623296|FG006|COMPLETED|Part 2||0
6692957|NCT02751424|7623297|FG007|COMPLETED|Part 2||6
6692958|NCT02751424|7623298|FG008|COMPLETED|Part 2||3
6692959|NCT02751424|7623290|FG000|NOT COMPLETED|Part 2||0
6692960|NCT02751424|7623291|FG001|NOT COMPLETED|Part 2||0
6692961|NCT02751424|7623292|FG002|NOT COMPLETED|Part 2||0
6692962|NCT02751424|7623293|FG003|NOT COMPLETED|Part 2||0
6692963|NCT02751424|7623294|FG004|NOT COMPLETED|Part 2||0
6692964|NCT02751424|7623295|FG005|NOT COMPLETED|Part 2||0
6692965|NCT02751424|7623296|FG006|NOT COMPLETED|Part 2||0
6692966|NCT02751424|7623297|FG007|NOT COMPLETED|Part 2||5
6692967|NCT02751424|7623298|FG008|NOT COMPLETED|Part 2||0
6692968|NCT02751450|7623323|FG000|STARTED|Overall Study||117
6692969|NCT02751450|7623324|FG001|STARTED|Overall Study||116
6692970|NCT02751450|7623323|FG000|COMPLETED|Overall Study||116
6692971|NCT02751450|7623324|FG001|COMPLETED|Overall Study||116
6692972|NCT02751450|7623323|FG000|NOT COMPLETED|Overall Study||1
6692973|NCT02751450|7623324|FG001|NOT COMPLETED|Overall Study||0
6692974|NCT02751580|7623332|FG000|STARTED|Overall Study||37
6692975|NCT02751580|7623332|FG000|COMPLETED|Overall Study||31
6692976|NCT02751580|7623332|FG000|NOT COMPLETED|Overall Study||6
6692977|NCT02751827|7623339|FG000|STARTED|Overall Study||41
6692978|NCT02751827|7623340|FG001|STARTED|Overall Study||171
6692979|NCT02751827|7623341|FG002|STARTED|Overall Study||100
6692980|NCT02751827|7623339|FG000|COMPLETED|Overall Study||41
6692981|NCT02751827|7623340|FG001|COMPLETED|Overall Study||171
6692982|NCT02751827|7623341|FG002|COMPLETED|Overall Study||99
6692983|NCT02751827|7623339|FG000|NOT COMPLETED|Overall Study||0
6692984|NCT02751827|7623340|FG001|NOT COMPLETED|Overall Study||0
6692985|NCT02751827|7623341|FG002|NOT COMPLETED|Overall Study||1
6692986|NCT02751879|7623351|FG000|STARTED|Overall Study||157
6692987|NCT02751879|7623352|FG001|STARTED|Overall Study||71
6692988|NCT02751879|7623351|FG000|On Treatment at Study Completion|Overall Study||81
6692989|NCT02751879|7623352|FG001|On Treatment at Study Completion|Overall Study||41
6692990|NCT02751879|7623351|FG000|COMPLETED|Overall Study||157
6692991|NCT02751879|7623352|FG001|COMPLETED|Overall Study||71
6692992|NCT02751879|7623351|FG000|NOT COMPLETED|Overall Study||0
6692993|NCT02751879|7623352|FG001|NOT COMPLETED|Overall Study||0
6692994|NCT02751931|7623363|FG000|STARTED|Overall Study||56
6692995|NCT02751931|7623364|FG001|STARTED|Overall Study||35
6692996|NCT02751931|7623363|FG000|Treated|Overall Study||55
6692997|NCT02751931|7623364|FG001|Treated|Overall Study||31
6692998|NCT02751931|7623363|FG000|COMPLETED|Overall Study||43
6692999|NCT02751931|7623364|FG001|COMPLETED|Overall Study||27
6693000|NCT02751931|7623363|FG000|NOT COMPLETED|Overall Study||13
6693001|NCT02751931|7623364|FG001|NOT COMPLETED|Overall Study||8
6693002|NCT02751983|7623378|FG000|STARTED|Baseline and Randomization||35
6693003|NCT02751983|7623379|FG001|STARTED|Baseline and Randomization||35
6693004|NCT02751983|7623378|FG000|COMPLETED|Baseline and Randomization||35
6693005|NCT02751983|7623379|FG001|COMPLETED|Baseline and Randomization||35
6693006|NCT02751983|7623378|FG000|NOT COMPLETED|Baseline and Randomization||0
6693007|NCT02751983|7623379|FG001|NOT COMPLETED|Baseline and Randomization||0
6693008|NCT02751983|7623378|FG000|STARTED|Treatment||35
6693009|NCT02751983|7623379|FG001|STARTED|Treatment||35
6693010|NCT02751983|7623378|FG000|COMPLETED|Treatment||31
6693011|NCT02751983|7623379|FG001|COMPLETED|Treatment||35
6693012|NCT02751983|7623378|FG000|NOT COMPLETED|Treatment||4
6693013|NCT02751983|7623379|FG001|NOT COMPLETED|Treatment||0
6693014|NCT02751983|7623378|FG000|STARTED|Post-Treatment Assessment||35
6693015|NCT02751983|7623379|FG001|STARTED|Post-Treatment Assessment||0
6693016|NCT02751983|7623378|FG000|COMPLETED|Post-Treatment Assessment||30
6693017|NCT02751983|7623379|FG001|COMPLETED|Post-Treatment Assessment||0
6693018|NCT02751983|7623378|FG000|NOT COMPLETED|Post-Treatment Assessment||5
6693019|NCT02751983|7623379|FG001|NOT COMPLETED|Post-Treatment Assessment||0
6693020|NCT02751983|7623378|FG000|STARTED|One-Month Follow-Up Assessments||35
6693021|NCT02751983|7623379|FG001|STARTED|One-Month Follow-Up Assessments||35
6693022|NCT02751983|7623378|FG000|COMPLETED|One-Month Follow-Up Assessments||21
6693023|NCT02751983|7623379|FG001|COMPLETED|One-Month Follow-Up Assessments||23
6693024|NCT02751983|7623378|FG000|NOT COMPLETED|One-Month Follow-Up Assessments||14
6693025|NCT02751983|7623379|FG001|NOT COMPLETED|One-Month Follow-Up Assessments||12
6693026|NCT02751983|7623378|FG000|STARTED|Three-Month Follow-Up Assessments||35
6693027|NCT02751983|7623379|FG001|STARTED|Three-Month Follow-Up Assessments||35
6693028|NCT02751983|7623378|FG000|COMPLETED|Three-Month Follow-Up Assessments||23
6693029|NCT02751983|7623379|FG001|COMPLETED|Three-Month Follow-Up Assessments||19
6693030|NCT02751983|7623378|FG000|NOT COMPLETED|Three-Month Follow-Up Assessments||12
6693031|NCT02751983|7623379|FG001|NOT COMPLETED|Three-Month Follow-Up Assessments||16
6693032|NCT02752048|7623388|FG000|STARTED|Overall Study||11
6693033|NCT02752048|7623389|FG001|STARTED|Overall Study||12
6693034|NCT02752048|7623390|FG002|STARTED|Overall Study||13
6693035|NCT02752048|7623388|FG000|COMPLETED|Overall Study||11
6693036|NCT02752048|7623389|FG001|COMPLETED|Overall Study||12
6693037|NCT02752048|7623390|FG002|COMPLETED|Overall Study||10
6693038|NCT02752048|7623388|FG000|NOT COMPLETED|Overall Study||0
6693039|NCT02752048|7623389|FG001|NOT COMPLETED|Overall Study||0
6693040|NCT02752048|7623390|FG002|NOT COMPLETED|Overall Study||3
6693041|NCT02752074|7623400|FG000|STARTED|Overall Study||354
6693042|NCT02752074|7623401|FG001|STARTED|Overall Study||352
6693043|NCT02752074|7623400|FG000|Treated|Overall Study||353
6693044|NCT02752074|7623401|FG001|Treated|Overall Study||352
6693045|NCT02752074|7623400|FG000|COMPLETED|Overall Study||198
6693046|NCT02752074|7623401|FG001|COMPLETED|Overall Study||209
6693047|NCT02752074|7623400|FG000|NOT COMPLETED|Overall Study||156
6693048|NCT02752074|7623401|FG001|NOT COMPLETED|Overall Study||143
6693049|NCT02752087|7623407|FG000|STARTED|Study Period 1||12
6693050|NCT02752087|7623408|FG001|STARTED|Study Period 1||12
6693051|NCT02752087|7623407|FG000|Received Study Drug|Study Period 1||12
6693052|NCT02752087|7623408|FG001|Received Study Drug|Study Period 1||12
6693053|NCT02752087|7623407|FG000|COMPLETED|Study Period 1||12
6693054|NCT02752087|7623408|FG001|COMPLETED|Study Period 1||12
6693055|NCT02752087|7623407|FG000|NOT COMPLETED|Study Period 1||0
6693056|NCT02752087|7623408|FG001|NOT COMPLETED|Study Period 1||0
6693057|NCT02752087|7623407|FG000|STARTED|Washout||12
6693058|NCT02752087|7623408|FG001|STARTED|Washout||12
6693059|NCT02752087|7623407|FG000|COMPLETED|Washout||11
6693060|NCT02752087|7623408|FG001|COMPLETED|Washout||12
6693061|NCT02752087|7623407|FG000|NOT COMPLETED|Washout||1
6693062|NCT02752087|7623408|FG001|NOT COMPLETED|Washout||0
6693063|NCT02752087|7623407|FG000|STARTED|Study Period 2||11
6693064|NCT02752087|7623408|FG001|STARTED|Study Period 2||12
6693065|NCT02752087|7623407|FG000|Received Study Drug|Study Period 2||11
6693066|NCT02752087|7623408|FG001|Received Study Drug|Study Period 2||12
6693067|NCT02752087|7623407|FG000|COMPLETED|Study Period 2||11
6693068|NCT02752087|7623408|FG001|COMPLETED|Study Period 2||12
6693069|NCT02752087|7623407|FG000|NOT COMPLETED|Study Period 2||0
6693070|NCT02752087|7623408|FG001|NOT COMPLETED|Study Period 2||0
6693071|NCT02752087|7623407|FG000|STARTED|Washout||11
6693072|NCT02752087|7623408|FG001|STARTED|Washout||12
6693073|NCT02752087|7623407|FG000|COMPLETED|Washout||11
6693074|NCT02752087|7623408|FG001|COMPLETED|Washout||12
6693075|NCT02752087|7623407|FG000|NOT COMPLETED|Washout||0
6693076|NCT02752087|7623408|FG001|NOT COMPLETED|Washout||0
6693077|NCT02752087|7623407|FG000|STARTED|Study Period 3||11
6693078|NCT02752087|7623408|FG001|STARTED|Study Period 3||12
6693079|NCT02752087|7623407|FG000|Received Study Drug|Study Period 3||11
6693080|NCT02752087|7623408|FG001|Received Study Drug|Study Period 3||12
6693081|NCT02752087|7623407|FG000|COMPLETED|Study Period 3||11
6693082|NCT02752087|7623408|FG001|COMPLETED|Study Period 3||12
6693083|NCT02752087|7623407|FG000|NOT COMPLETED|Study Period 3||0
6693084|NCT02752087|7623408|FG001|NOT COMPLETED|Study Period 3||0
6693085|NCT02752087|7623407|FG000|STARTED|Washout||11
6693086|NCT02752087|7623408|FG001|STARTED|Washout||12
6693087|NCT02752087|7623407|FG000|COMPLETED|Washout||11
6693088|NCT02752087|7623408|FG001|COMPLETED|Washout||12
6693089|NCT02752087|7623407|FG000|NOT COMPLETED|Washout||0
6693090|NCT02752087|7623408|FG001|NOT COMPLETED|Washout||0
6693091|NCT02752087|7623407|FG000|STARTED|Study Period 4||11
6693092|NCT02752087|7623408|FG001|STARTED|Study Period 4||12
6693093|NCT02752087|7623407|FG000|Received Study Drug|Study Period 4||11
6693094|NCT02752087|7623408|FG001|Received Study Drug|Study Period 4||12
6693095|NCT02752087|7623407|FG000|COMPLETED|Study Period 4||11
6693096|NCT02752087|7623408|FG001|COMPLETED|Study Period 4||12
6693097|NCT02752087|7623407|FG000|NOT COMPLETED|Study Period 4||0
6693098|NCT02752087|7623408|FG001|NOT COMPLETED|Study Period 4||0
6693099|NCT02752087|7623407|FG000|STARTED|Follow-up||11
6693100|NCT02752087|7623408|FG001|STARTED|Follow-up||12
6693101|NCT02752087|7623407|FG000|COMPLETED|Follow-up||11
6693102|NCT02752087|7623408|FG001|COMPLETED|Follow-up||12
6693103|NCT02752087|7623407|FG000|NOT COMPLETED|Follow-up||0
6693104|NCT02752087|7623408|FG001|NOT COMPLETED|Follow-up||0
6693105|NCT02752256|7623416|FG000|STARTED|Overall Study||35
6693106|NCT02752256|7623417|FG001|STARTED|Overall Study||41
6693107|NCT02752256|7623416|FG000|COMPLETED|Overall Study||35
6693108|NCT02752256|7623417|FG001|COMPLETED|Overall Study||41
6693109|NCT02752256|7623416|FG000|NOT COMPLETED|Overall Study||0
6693110|NCT02752256|7623417|FG001|NOT COMPLETED|Overall Study||0
6693111|NCT02752490|7623425|FG000|STARTED|Overall Study||409
6693112|NCT02752490|7623426|FG001|STARTED|Overall Study||435
6693113|NCT02752490|7623425|FG000|COMPLETED|Overall Study||409
6693114|NCT02752490|7623426|FG001|COMPLETED|Overall Study||435
6693115|NCT02752490|7623425|FG000|NOT COMPLETED|Overall Study||0
6693116|NCT02752490|7623426|FG001|NOT COMPLETED|Overall Study||0
6693117|NCT02752633|7623432|FG000|STARTED|Overall Study||9
6693118|NCT02752633|7623432|FG000|COMPLETED|Overall Study||8
6693119|NCT02752633|7623432|FG000|NOT COMPLETED|Overall Study||1
6693120|NCT02752776|7623439|FG000|STARTED|Overall Study||663
6693121|NCT02752776|7623440|FG001|STARTED|Overall Study||673
6693122|NCT02752776|7623441|FG002|STARTED|Overall Study||324
6693123|NCT02752776|7623439|FG000|COMPLETED|Overall Study||611
6693124|NCT02752776|7623440|FG001|COMPLETED|Overall Study||597
6693125|NCT02752776|7623441|FG002|COMPLETED|Overall Study||276
6693126|NCT02752776|7623439|FG000|NOT COMPLETED|Overall Study||52
6693127|NCT02752776|7623440|FG001|NOT COMPLETED|Overall Study||76
6693128|NCT02752776|7623441|FG002|NOT COMPLETED|Overall Study||48
6693129|NCT02752802|7623453|FG000|STARTED|Overall Study||48
6693130|NCT02752802|7623454|FG001|STARTED|Overall Study||48
6693131|NCT02752802|7623453|FG000|COMPLETED|Overall Study||47
6693132|NCT02752802|7623454|FG001|COMPLETED|Overall Study||48
6693133|NCT02752802|7623453|FG000|NOT COMPLETED|Overall Study||1
6693134|NCT02752802|7623454|FG001|NOT COMPLETED|Overall Study||0
6693135|NCT02752880|7623464|FG000|STARTED|Overall Study||23
6693136|NCT02752880|7623465|FG001|STARTED|Overall Study||23
6693137|NCT02752880|7623464|FG000|COMPLETED|Overall Study||21
6693138|NCT02752880|7623465|FG001|COMPLETED|Overall Study||20
6693139|NCT02752880|7623464|FG000|NOT COMPLETED|Overall Study||2
6693140|NCT02752880|7623465|FG001|NOT COMPLETED|Overall Study||3
6693141|NCT02752958|7623472|FG000|STARTED|Overall Study||75
6693142|NCT02752958|7623472|FG000|COMPLETED|Overall Study||66
6693143|NCT02752958|7623472|FG000|NOT COMPLETED|Overall Study||9
6693144|NCT02753075|7623481|FG000|STARTED|Overall Study||79
6693145|NCT02753075|7623482|FG001|STARTED|Overall Study||80
6693146|NCT02753075|7623483|FG002|STARTED|Overall Study||81
6693147|NCT02753075|7623481|FG000|COMPLETED|Overall Study||71
6693148|NCT02753075|7623482|FG001|COMPLETED|Overall Study||77
6693149|NCT02753075|7623483|FG002|COMPLETED|Overall Study||78
6693150|NCT02753075|7623481|FG000|NOT COMPLETED|Overall Study||8
6693151|NCT02753075|7623482|FG001|NOT COMPLETED|Overall Study||3
6693152|NCT02753075|7623483|FG002|NOT COMPLETED|Overall Study||3
6693153|NCT02753400|7623494|FG000|STARTED|Overall Study||12
6693154|NCT02753400|7623495|FG001|STARTED|Overall Study||12
6693155|NCT02753400|7623494|FG000|COMPLETED|Overall Study||7
6693156|NCT02753400|7623495|FG001|COMPLETED|Overall Study||11
6693157|NCT02753400|7623494|FG000|NOT COMPLETED|Overall Study||5
6693158|NCT02753400|7623495|FG001|NOT COMPLETED|Overall Study||1
6693159|NCT02753413|7623503|FG000|STARTED|Overall Study||49
6693160|NCT02753413|7623504|FG001|STARTED|Overall Study||51
6693161|NCT02753413|7623503|FG000|COMPLETED|Overall Study||49
6693162|NCT02753413|7623504|FG001|COMPLETED|Overall Study||51
6693163|NCT02753413|7623503|FG000|NOT COMPLETED|Overall Study||0
6693164|NCT02753413|7623504|FG001|NOT COMPLETED|Overall Study||0
6693165|NCT02753595|7623512|FG000|STARTED|Overall Study||5
6693166|NCT02753595|7623513|FG001|STARTED|Overall Study||9
6693167|NCT02753595|7623512|FG000|COMPLETED|Overall Study||3
6693168|NCT02753595|7623513|FG001|COMPLETED|Overall Study||7
6693169|NCT02753595|7623512|FG000|NOT COMPLETED|Overall Study||2
6693170|NCT02753595|7623513|FG001|NOT COMPLETED|Overall Study||2
6693171|NCT02753699|7623521|FG000|STARTED|Overall Study||164
6693172|NCT02753699|7623522|FG001|STARTED|Overall Study||397
6693173|NCT02753699|7623523|FG002|STARTED|Overall Study||162
6693174|NCT02753699|7623521|FG000|COMPLETED|Overall Study||150
6693175|NCT02753699|7623522|FG001|COMPLETED|Overall Study||354
6693176|NCT02753699|7623523|FG002|COMPLETED|Overall Study||139
6693177|NCT02753699|7623521|FG000|NOT COMPLETED|Overall Study||14
6693178|NCT02753699|7623522|FG001|NOT COMPLETED|Overall Study||43
6693179|NCT02753699|7623523|FG002|NOT COMPLETED|Overall Study||23
6693180|NCT02753816|7623536|FG000|STARTED|Overall Study||7
6693181|NCT02753816|7623537|FG001|STARTED|Overall Study||11
6693182|NCT02753816|7623538|FG002|STARTED|Overall Study||7
6693183|NCT02753816|7623536|FG000|Tranexamic Acid|Overall Study||7
6693184|NCT02753816|7623537|FG001|Tranexamic Acid|Overall Study||0
6693185|NCT02753816|7623538|FG002|Tranexamic Acid|Overall Study||7
6693186|NCT02753816|7623536|FG000|Placebo|Overall Study||0
6693187|NCT02753816|7623537|FG001|Placebo|Overall Study||11
6693188|NCT02753816|7623538|FG002|Placebo|Overall Study||7
6693189|NCT02753816|7623536|FG000|COMPLETED|Overall Study||7
6693190|NCT02753816|7623537|FG001|COMPLETED|Overall Study||10
6693191|NCT02753816|7623538|FG002|COMPLETED|Overall Study||7
6693192|NCT02753816|7623536|FG000|NOT COMPLETED|Overall Study||0
6693193|NCT02753816|7623537|FG001|NOT COMPLETED|Overall Study||1
6693194|NCT02753816|7623538|FG002|NOT COMPLETED|Overall Study||0
6693195|NCT02753842|7623550|FG000|STARTED|First Follow-Up (Set of Condoms)||85
6693196|NCT02753842|7623551|FG001|STARTED|First Follow-Up (Set of Condoms)||84
6693197|NCT02753842|7623552|FG002|STARTED|First Follow-Up (Set of Condoms)||85
6693198|NCT02753842|7623553|FG003|STARTED|First Follow-Up (Set of Condoms)||83
6693199|NCT02753842|7623554|FG004|STARTED|First Follow-Up (Set of Condoms)||83
6693200|NCT02753842|7623555|FG005|STARTED|First Follow-Up (Set of Condoms)||84
6693201|NCT02753842|7623550|FG000|COMPLETED|First Follow-Up (Set of Condoms)||75
6693202|NCT02753842|7623551|FG001|COMPLETED|First Follow-Up (Set of Condoms)||76
6693203|NCT02753842|7623552|FG002|COMPLETED|First Follow-Up (Set of Condoms)||76
6693204|NCT02753842|7623553|FG003|COMPLETED|First Follow-Up (Set of Condoms)||81
6693205|NCT02753842|7623554|FG004|COMPLETED|First Follow-Up (Set of Condoms)||76
6693206|NCT02753842|7623555|FG005|COMPLETED|First Follow-Up (Set of Condoms)||79
6693207|NCT02753842|7623550|FG000|NOT COMPLETED|First Follow-Up (Set of Condoms)||10
6693208|NCT02753842|7623551|FG001|NOT COMPLETED|First Follow-Up (Set of Condoms)||8
6693209|NCT02753842|7623552|FG002|NOT COMPLETED|First Follow-Up (Set of Condoms)||9
6693210|NCT02753842|7623553|FG003|NOT COMPLETED|First Follow-Up (Set of Condoms)||2
6693211|NCT02753842|7623554|FG004|NOT COMPLETED|First Follow-Up (Set of Condoms)||7
6693212|NCT02753842|7623555|FG005|NOT COMPLETED|First Follow-Up (Set of Condoms)||5
6693213|NCT02753842|7623550|FG000|STARTED|Second Follow-Up (Set of Condoms)||75
6693214|NCT02753842|7623551|FG001|STARTED|Second Follow-Up (Set of Condoms)||76
6693215|NCT02753842|7623552|FG002|STARTED|Second Follow-Up (Set of Condoms)||76
6693216|NCT02753842|7623553|FG003|STARTED|Second Follow-Up (Set of Condoms)||81
6693217|NCT02753842|7623554|FG004|STARTED|Second Follow-Up (Set of Condoms)||76
6693218|NCT02753842|7623555|FG005|STARTED|Second Follow-Up (Set of Condoms)||79
6693219|NCT02753842|7623550|FG000|COMPLETED|Second Follow-Up (Set of Condoms)||71
6693220|NCT02753842|7623551|FG001|COMPLETED|Second Follow-Up (Set of Condoms)||71
6693221|NCT02753842|7623552|FG002|COMPLETED|Second Follow-Up (Set of Condoms)||71
6693222|NCT02753842|7623553|FG003|COMPLETED|Second Follow-Up (Set of Condoms)||76
6693223|NCT02753842|7623554|FG004|COMPLETED|Second Follow-Up (Set of Condoms)||75
6693224|NCT02753842|7623555|FG005|COMPLETED|Second Follow-Up (Set of Condoms)||72
6693225|NCT02753842|7623550|FG000|NOT COMPLETED|Second Follow-Up (Set of Condoms)||4
6693226|NCT02753842|7623551|FG001|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
6693227|NCT02753842|7623552|FG002|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
6693228|NCT02753842|7623553|FG003|NOT COMPLETED|Second Follow-Up (Set of Condoms)||5
6693229|NCT02753842|7623554|FG004|NOT COMPLETED|Second Follow-Up (Set of Condoms)||1
6693230|NCT02753842|7623555|FG005|NOT COMPLETED|Second Follow-Up (Set of Condoms)||7
6693231|NCT02753842|7623550|FG000|STARTED|Third Follow-Up (Set of Condoms)||71
6258530|NCT03307785|7157849|FG005|COMPLETED|Part B: Up to 28.5 Months||0
6258531|NCT03307785|7157850|FG006|COMPLETED|Part B: Up to 28.5 Months||0
6258532|NCT03307785|7157851|FG007|COMPLETED|Part B: Up to 28.5 Months||0
6258533|NCT03307785|7157852|FG008|COMPLETED|Part B: Up to 28.5 Months||0
6258534|NCT03307785|7157853|FG009|COMPLETED|Part B: Up to 28.5 Months||0
6258535|NCT03307785|7157854|FG010|COMPLETED|Part B: Up to 28.5 Months||0
6258536|NCT03307785|7157844|FG000|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258537|NCT03307785|7157845|FG001|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258538|NCT03307785|7157846|FG002|NOT COMPLETED|Part B: Up to 28.5 Months||14
6258539|NCT03307785|7157847|FG003|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258540|NCT03307785|7157848|FG004|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258541|NCT03307785|7157849|FG005|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258542|NCT03307785|7157850|FG006|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258543|NCT03307785|7157851|FG007|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258544|NCT03307785|7157852|FG008|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258545|NCT03307785|7157853|FG009|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258546|NCT03307785|7157854|FG010|NOT COMPLETED|Part B: Up to 28.5 Months||0
6258547|NCT03307785|7157844|FG000|STARTED|Part C: Up to 22.5 Months||0
6258548|NCT03307785|7157845|FG001|STARTED|Part C: Up to 22.5 Months||0
6258549|NCT03307785|7157846|FG002|STARTED|Part C: Up to 22.5 Months||0
6258550|NCT03307785|7157847|FG003|STARTED|Part C: Up to 22.5 Months||6
6258551|NCT03307785|7157848|FG004|STARTED|Part C: Up to 22.5 Months||7
6258552|NCT03307785|7157849|FG005|STARTED|Part C: Up to 22.5 Months||0
6258553|NCT03307785|7157850|FG006|STARTED|Part C: Up to 22.5 Months||0
6258554|NCT03307785|7157851|FG007|STARTED|Part C: Up to 22.5 Months||0
6258555|NCT03307785|7157852|FG008|STARTED|Part C: Up to 22.5 Months||0
6258556|NCT03307785|7157853|FG009|STARTED|Part C: Up to 22.5 Months||0
6258557|NCT03307785|7157854|FG010|STARTED|Part C: Up to 22.5 Months||0
6258558|NCT03307785|7157844|FG000|COMPLETED|Part C: Up to 22.5 Months||0
6258559|NCT03307785|7157845|FG001|COMPLETED|Part C: Up to 22.5 Months||0
6258560|NCT03307785|7157846|FG002|COMPLETED|Part C: Up to 22.5 Months||0
6258561|NCT03307785|7157847|FG003|COMPLETED|Part C: Up to 22.5 Months||0
6258562|NCT03307785|7157848|FG004|COMPLETED|Part C: Up to 22.5 Months||0
6258563|NCT03307785|7157849|FG005|COMPLETED|Part C: Up to 22.5 Months||0
6258564|NCT03307785|7157850|FG006|COMPLETED|Part C: Up to 22.5 Months||0
6258565|NCT03307785|7157851|FG007|COMPLETED|Part C: Up to 22.5 Months||0
6258566|NCT03307785|7157852|FG008|COMPLETED|Part C: Up to 22.5 Months||0
6258567|NCT03307785|7157853|FG009|COMPLETED|Part C: Up to 22.5 Months||0
6693232|NCT02753842|7623551|FG001|STARTED|Third Follow-Up (Set of Condoms)||71
6258568|NCT03307785|7157854|FG010|COMPLETED|Part C: Up to 22.5 Months||0
6693233|NCT02753842|7623552|FG002|STARTED|Third Follow-Up (Set of Condoms)||71
6693234|NCT02753842|7623553|FG003|STARTED|Third Follow-Up (Set of Condoms)||76
6693235|NCT02753842|7623554|FG004|STARTED|Third Follow-Up (Set of Condoms)||75
6693236|NCT02753842|7623555|FG005|STARTED|Third Follow-Up (Set of Condoms)||72
6693237|NCT02753842|7623550|FG000|COMPLETED|Third Follow-Up (Set of Condoms)||65
6693238|NCT02753842|7623551|FG001|COMPLETED|Third Follow-Up (Set of Condoms)||66
6693239|NCT02753842|7623552|FG002|COMPLETED|Third Follow-Up (Set of Condoms)||68
6693240|NCT02753842|7623553|FG003|COMPLETED|Third Follow-Up (Set of Condoms)||70
6693241|NCT02753842|7623554|FG004|COMPLETED|Third Follow-Up (Set of Condoms)||71
6693242|NCT02753842|7623555|FG005|COMPLETED|Third Follow-Up (Set of Condoms)||69
6693243|NCT02753842|7623550|FG000|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
6693244|NCT02753842|7623551|FG001|NOT COMPLETED|Third Follow-Up (Set of Condoms)||5
6693245|NCT02753842|7623552|FG002|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
6693246|NCT02753842|7623553|FG003|NOT COMPLETED|Third Follow-Up (Set of Condoms)||6
6693247|NCT02753842|7623554|FG004|NOT COMPLETED|Third Follow-Up (Set of Condoms)||4
6693248|NCT02753842|7623555|FG005|NOT COMPLETED|Third Follow-Up (Set of Condoms)||3
6693249|NCT02753881|7623572|FG000|STARTED|Overall Study||10
6693250|NCT02753881|7623573|FG001|STARTED|Overall Study||10
6693251|NCT02753881|7623574|FG002|STARTED|Overall Study||10
6693252|NCT02753881|7623572|FG000|COMPLETED|Overall Study||10
6693253|NCT02753881|7623573|FG001|COMPLETED|Overall Study||10
6693254|NCT02753881|7623574|FG002|COMPLETED|Overall Study||10
6693255|NCT02753881|7623572|FG000|NOT COMPLETED|Overall Study||0
6693256|NCT02753881|7623573|FG001|NOT COMPLETED|Overall Study||0
6693257|NCT02753881|7623574|FG002|NOT COMPLETED|Overall Study||0
6693258|NCT02753920|7623584|FG000|STARTED|Overall Study||87
6693259|NCT02753920|7623585|FG001|STARTED|Overall Study||86
6693260|NCT02753920|7623584|FG000|COMPLETED|Overall Study||87
6693261|NCT02753920|7623585|FG001|COMPLETED|Overall Study||86
6693262|NCT02753920|7623584|FG000|NOT COMPLETED|Overall Study||0
6693263|NCT02753920|7623585|FG001|NOT COMPLETED|Overall Study||0
6693264|NCT02753946|7623597|FG000|STARTED|Overall Study||233
6693265|NCT02753946|7623598|FG001|STARTED|Overall Study||231
6693266|NCT02753946|7623597|FG000|COMPLETED|Overall Study||219
6693267|NCT02753946|7623598|FG001|COMPLETED|Overall Study||222
6693268|NCT02753946|7623597|FG000|NOT COMPLETED|Overall Study||14
6693269|NCT02753946|7623598|FG001|NOT COMPLETED|Overall Study||9
6693270|NCT02754310|7623606|FG000|STARTED|Overall Study||42
6693271|NCT02754310|7623607|FG001|STARTED|Overall Study||43
6693272|NCT02754310|7623606|FG000|COMPLETED|Overall Study||42
6693273|NCT02754310|7623607|FG001|COMPLETED|Overall Study||43
6693274|NCT02754310|7623606|FG000|NOT COMPLETED|Overall Study||0
6693275|NCT02754310|7623607|FG001|NOT COMPLETED|Overall Study||0
6693276|NCT02754427|7623615|FG000|STARTED|Overall Study||21
6693277|NCT02754427|7623616|FG001|STARTED|Overall Study||20
6693278|NCT02754427|7623615|FG000|COMPLETED|Overall Study||21
6693279|NCT02754427|7623616|FG001|COMPLETED|Overall Study||19
6693280|NCT02754427|7623615|FG000|NOT COMPLETED|Overall Study||0
6693281|NCT02754427|7623616|FG001|NOT COMPLETED|Overall Study||1
6693282|NCT02754440|7623626|FG000|STARTED|Overall Study||99
6693283|NCT02754440|7623627|FG001|STARTED|Overall Study||101
6693284|NCT02754440|7623628|FG002|STARTED|Overall Study||100
6693285|NCT02754440|7623629|FG003|STARTED|Overall Study||35
6693286|NCT02754440|7623626|FG000|COMPLETED|Overall Study||93
6693287|NCT02754440|7623627|FG001|COMPLETED|Overall Study||93
6693288|NCT02754440|7623628|FG002|COMPLETED|Overall Study||93
6693289|NCT02754440|7623629|FG003|COMPLETED|Overall Study||0
6693290|NCT02754440|7623626|FG000|NOT COMPLETED|Overall Study||6
6693291|NCT02754440|7623627|FG001|NOT COMPLETED|Overall Study||8
6693292|NCT02754440|7623628|FG002|NOT COMPLETED|Overall Study||7
6693293|NCT02754440|7623629|FG003|NOT COMPLETED|Overall Study||35
6693294|NCT02754492|7623642|FG000|STARTED|Overall Study||97
6693295|NCT02754492|7623643|FG001|STARTED|Overall Study||95
6693296|NCT02754492|7623644|FG002|STARTED|Overall Study||95
6693297|NCT02754492|7623645|FG003|STARTED|Overall Study||23
6693298|NCT02754492|7623642|FG000|COMPLETED|Overall Study||93
6693299|NCT02754492|7623643|FG001|COMPLETED|Overall Study||93
6693300|NCT02754492|7623644|FG002|COMPLETED|Overall Study||93
6693301|NCT02754492|7623645|FG003|COMPLETED|Overall Study||0
6693302|NCT02754492|7623642|FG000|NOT COMPLETED|Overall Study||4
6693303|NCT02754492|7623643|FG001|NOT COMPLETED|Overall Study||2
6693304|NCT02754492|7623644|FG002|NOT COMPLETED|Overall Study||2
6693305|NCT02754492|7623645|FG003|NOT COMPLETED|Overall Study||23
6693306|NCT02754518|7623654|FG000|STARTED|Overall Study||40
6693307|NCT02754518|7623654|FG000|COMPLETED|Overall Study||40
6693308|NCT02754518|7623654|FG000|NOT COMPLETED|Overall Study||0
6693309|NCT02754570|7623658|FG000|STARTED|Overall Study||27
6693310|NCT02754570|7623658|FG000|Visits 1 and 2 (PGA Only)|Overall Study||27
6693311|NCT02754570|7623658|FG000|Visit 3 (PGA + Pilocarpine)|Overall Study||27
6693312|NCT02754570|7623658|FG000|COMPLETED|Overall Study||27
6693313|NCT02754570|7623658|FG000|NOT COMPLETED|Overall Study||0
6693314|NCT02754661|7623666|FG000|STARTED|Overall Study||160
6693315|NCT02754661|7623667|FG001|STARTED|Overall Study||160
6693316|NCT02754661|7623666|FG000|COMPLETED|Overall Study||145
6693317|NCT02754661|7623667|FG001|COMPLETED|Overall Study||141
6693318|NCT02754661|7623666|FG000|NOT COMPLETED|Overall Study||15
6693319|NCT02754661|7623667|FG001|NOT COMPLETED|Overall Study||19
6693320|NCT02754674|7623677|FG000|STARTED|Overall Study||34
6693321|NCT02754674|7623678|FG001|STARTED|Overall Study||33
6693322|NCT02754674|7623677|FG000|COMPLETED|Overall Study||28
6693323|NCT02754674|7623678|FG001|COMPLETED|Overall Study||26
6693324|NCT02754674|7623677|FG000|NOT COMPLETED|Overall Study||6
6693325|NCT02754674|7623678|FG001|NOT COMPLETED|Overall Study||7
6693326|NCT02755090|7623686|FG000|STARTED|Overall Study||19
6693327|NCT02755090|7623687|FG001|STARTED|Overall Study||20
6693328|NCT02755090|7623686|FG000|COMPLETED|Overall Study||18
6693329|NCT02755090|7623687|FG001|COMPLETED|Overall Study||20
6693330|NCT02755090|7623686|FG000|NOT COMPLETED|Overall Study||1
6693331|NCT02755090|7623687|FG001|NOT COMPLETED|Overall Study||0
6693332|NCT02755116|7623695|FG000|STARTED|Overall Study||74
6693333|NCT02755116|7623696|FG001|STARTED|Overall Study||70
6693334|NCT02755116|7623695|FG000|COMPLETED|Overall Study||71
6693335|NCT02755116|7623696|FG001|COMPLETED|Overall Study||69
6693336|NCT02755116|7623695|FG000|NOT COMPLETED|Overall Study||3
6693337|NCT02755116|7623696|FG001|NOT COMPLETED|Overall Study||1
6693338|NCT02755129|7623702|FG000|STARTED|Overall Study||15
6693339|NCT02755129|7623702|FG000|COMPLETED|Overall Study||15
6693340|NCT02755129|7623702|FG000|NOT COMPLETED|Overall Study||0
6693341|NCT02755285|7623709|FG000|STARTED|Overall Study||20
6693342|NCT02755285|7623709|FG000|COMPLETED|Overall Study||20
6693343|NCT02755285|7623709|FG000|NOT COMPLETED|Overall Study||0
6693344|NCT02755649|7623716|FG000|STARTED|Overall Study||108
6693345|NCT02755649|7623717|FG001|STARTED|Overall Study||107
6693346|NCT02755649|7623718|FG002|STARTED|Overall Study||110
6693347|NCT02755649|7623716|FG000|Completed Treatment (Week 16)|Overall Study||107
6693348|NCT02755649|7623717|FG001|Completed Treatment (Week 16)|Overall Study||106
6693349|NCT02755649|7623718|FG002|Completed Treatment (Week 16)|Overall Study||109
6693350|NCT02755649|7623716|FG000|Completed Study (Week 28)|Overall Study||7
6693351|NCT02755649|7623717|FG001|Completed Study (Week 28)|Overall Study||8
6693352|NCT02755649|7623718|FG002|Completed Study (Week 28)|Overall Study||8
6693353|NCT02755649|7623716|FG000|COMPLETED|Overall Study||7
6693354|NCT02755649|7623717|FG001|COMPLETED|Overall Study||8
6693355|NCT02755649|7623718|FG002|COMPLETED|Overall Study||8
6258569|NCT03307785|7157844|FG000|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258570|NCT03307785|7157845|FG001|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258571|NCT03307785|7157846|FG002|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258572|NCT03307785|7157847|FG003|NOT COMPLETED|Part C: Up to 22.5 Months||6
6258573|NCT03307785|7157848|FG004|NOT COMPLETED|Part C: Up to 22.5 Months||7
6258574|NCT03307785|7157849|FG005|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258575|NCT03307785|7157850|FG006|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258576|NCT03307785|7157851|FG007|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258577|NCT03307785|7157852|FG008|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258578|NCT03307785|7157853|FG009|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258579|NCT03307785|7157854|FG010|NOT COMPLETED|Part C: Up to 22.5 Months||0
6258580|NCT03307785|7157844|FG000|STARTED|Part D: Up to 9.5 Months||0
6258581|NCT03307785|7157845|FG001|STARTED|Part D: Up to 9.5 Months||0
6258582|NCT03307785|7157846|FG002|STARTED|Part D: Up to 9.5 Months||0
6258583|NCT03307785|7157847|FG003|STARTED|Part D: Up to 9.5 Months||0
6258584|NCT03307785|7157848|FG004|STARTED|Part D: Up to 9.5 Months||0
6258585|NCT03307785|7157849|FG005|STARTED|Part D: Up to 9.5 Months||6
6258586|NCT03307785|7157850|FG006|STARTED|Part D: Up to 9.5 Months||0
6258587|NCT03307785|7157851|FG007|STARTED|Part D: Up to 9.5 Months||0
6258588|NCT03307785|7157852|FG008|STARTED|Part D: Up to 9.5 Months||0
6258589|NCT03307785|7157853|FG009|STARTED|Part D: Up to 9.5 Months||0
6258590|NCT03307785|7157854|FG010|STARTED|Part D: Up to 9.5 Months||0
6258591|NCT03307785|7157844|FG000|COMPLETED|Part D: Up to 9.5 Months||0
6258592|NCT03307785|7157845|FG001|COMPLETED|Part D: Up to 9.5 Months||0
6258593|NCT03307785|7157846|FG002|COMPLETED|Part D: Up to 9.5 Months||0
6258594|NCT03307785|7157847|FG003|COMPLETED|Part D: Up to 9.5 Months||0
6258595|NCT03307785|7157848|FG004|COMPLETED|Part D: Up to 9.5 Months||0
6258596|NCT03307785|7157849|FG005|COMPLETED|Part D: Up to 9.5 Months||3
6258597|NCT03307785|7157850|FG006|COMPLETED|Part D: Up to 9.5 Months||0
6258598|NCT03307785|7157851|FG007|COMPLETED|Part D: Up to 9.5 Months||0
6258599|NCT03307785|7157852|FG008|COMPLETED|Part D: Up to 9.5 Months||0
6258600|NCT03307785|7157853|FG009|COMPLETED|Part D: Up to 9.5 Months||0
6258601|NCT03307785|7157854|FG010|COMPLETED|Part D: Up to 9.5 Months||0
6258602|NCT03307785|7157844|FG000|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258603|NCT03307785|7157845|FG001|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258604|NCT03307785|7157846|FG002|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258605|NCT03307785|7157847|FG003|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258606|NCT03307785|7157848|FG004|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258607|NCT03307785|7157849|FG005|NOT COMPLETED|Part D: Up to 9.5 Months||3
6258608|NCT03307785|7157850|FG006|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258609|NCT03307785|7157851|FG007|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258610|NCT03307785|7157852|FG008|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258611|NCT03307785|7157853|FG009|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258612|NCT03307785|7157854|FG010|NOT COMPLETED|Part D: Up to 9.5 Months||0
6258613|NCT03307785|7157844|FG000|STARTED|Part E: Up to 4.4 Months||0
6258614|NCT03307785|7157845|FG001|STARTED|Part E: Up to 4.4 Months||0
6258615|NCT03307785|7157846|FG002|STARTED|Part E: Up to 4.4 Months||0
6693356|NCT02755649|7623716|FG000|NOT COMPLETED|Overall Study||101
6693357|NCT02755649|7623717|FG001|NOT COMPLETED|Overall Study||99
6693358|NCT02755649|7623718|FG002|NOT COMPLETED|Overall Study||102
6738763|NCT03285958|7667976|FG000|COMPLETED|Overall Study||28
6738764|NCT03285958|7667977|FG001|COMPLETED|Overall Study||23
6738765|NCT03285958|7667976|FG000|NOT COMPLETED|Overall Study||5
6693359|NCT02755805|7623728|FG000|STARTED|Overall Study||15
6693360|NCT02755805|7623729|FG001|STARTED|Overall Study||15
6693361|NCT02755805|7623728|FG000|COMPLETED|Overall Study||13
6693362|NCT02755805|7623729|FG001|COMPLETED|Overall Study||11
6693363|NCT02755805|7623728|FG000|NOT COMPLETED|Overall Study||2
6693364|NCT02755805|7623729|FG001|NOT COMPLETED|Overall Study||4
6693365|NCT02755818|7623739|FG000|STARTED|Overall Study||30
6693366|NCT02755818|7623740|FG001|STARTED|Overall Study||2
6693367|NCT02755818|7623741|FG002|STARTED|Overall Study||2
6693368|NCT02755818|7623742|FG003|STARTED|Overall Study||17
6693369|NCT02755818|7623739|FG000|COMPLETED|Overall Study||30
6693370|NCT02755818|7623740|FG001|COMPLETED|Overall Study||2
6693371|NCT02755818|7623741|FG002|COMPLETED|Overall Study||1
6693372|NCT02755818|7623742|FG003|COMPLETED|Overall Study||14
6693373|NCT02755818|7623739|FG000|NOT COMPLETED|Overall Study||0
6693374|NCT02755818|7623740|FG001|NOT COMPLETED|Overall Study||0
6693375|NCT02755818|7623741|FG002|NOT COMPLETED|Overall Study||1
6693376|NCT02755818|7623742|FG003|NOT COMPLETED|Overall Study||3
6693377|NCT02755831|7623756|FG000|STARTED|Overall Study||100
6693378|NCT02755831|7623757|FG001|STARTED|Overall Study||93
6693379|NCT02755831|7623756|FG000|COMPLETED|Overall Study||97
6693380|NCT02755831|7623757|FG001|COMPLETED|Overall Study||90
6693381|NCT02755831|7623756|FG000|NOT COMPLETED|Overall Study||3
6693382|NCT02755831|7623757|FG001|NOT COMPLETED|Overall Study||3
6693383|NCT02755935|7623763|FG000|STARTED|Overall Study||24
6693384|NCT02755935|7623763|FG000|COMPLETED|Overall Study||22
6693385|NCT02755935|7623763|FG000|NOT COMPLETED|Overall Study||2
6693386|NCT02756013|7623767|FG000|STARTED|Overall Study||3
6693387|NCT02756013|7623767|FG000|COMPLETED|Overall Study||1
6693388|NCT02756013|7623767|FG000|NOT COMPLETED|Overall Study||2
6693389|NCT02756078|7623771|FG000|STARTED|Period 1||85
6693390|NCT02756078|7623772|FG001|STARTED|Period 1||86
6693391|NCT02756078|7623771|FG000|COMPLETED|Period 1||76
6693392|NCT02756078|7623772|FG001|COMPLETED|Period 1||64
6693393|NCT02756078|7623771|FG000|NOT COMPLETED|Period 1||9
6693394|NCT02756078|7623772|FG001|NOT COMPLETED|Period 1||22
6693395|NCT02756078|7623771|FG000|STARTED|Period 2||76
6693396|NCT02756078|7623772|FG001|STARTED|Period 2||64
6693397|NCT02756078|7623771|FG000|COMPLETED|Period 2||70
6693398|NCT02756078|7623772|FG001|COMPLETED|Period 2||57
6693399|NCT02756078|7623771|FG000|NOT COMPLETED|Period 2||6
6693400|NCT02756078|7623772|FG001|NOT COMPLETED|Period 2||7
6693401|NCT02756182|7623778|FG000|STARTED|Overall Study||25
6693402|NCT02756182|7623778|FG000|COMPLETED|Overall Study||21
6693403|NCT02756182|7623778|FG000|NOT COMPLETED|Overall Study||4
6693404|NCT02756338|7623784|FG000|STARTED|Overall Study||77
6693405|NCT02756338|7623784|FG000|COMPLETED|Overall Study||72
6693406|NCT02756338|7623784|FG000|NOT COMPLETED|Overall Study||5
6693407|NCT02756351|7623790|FG000|STARTED|Overall Study||24
6693408|NCT02756351|7623791|FG001|STARTED|Overall Study||24
6693409|NCT02756351|7623790|FG000|COMPLETED|Overall Study||24
6693410|NCT02756351|7623791|FG001|COMPLETED|Overall Study||24
6693411|NCT02756351|7623790|FG000|NOT COMPLETED|Overall Study||0
6693412|NCT02756351|7623791|FG001|NOT COMPLETED|Overall Study||0
6693413|NCT02756364|7623800|FG000|STARTED|Overall Study||46
6693414|NCT02756364|7623801|FG001|STARTED|Overall Study||47
6693415|NCT02756364|7623802|FG002|STARTED|Overall Study||48
6693416|NCT02756364|7623800|FG000|Treated Participants|Overall Study||46
6693417|NCT02756364|7623801|FG001|Treated Participants|Overall Study||47
6693418|NCT02756364|7623802|FG002|Treated Participants|Overall Study||47
6693419|NCT02756364|7623800|FG000|COMPLETED|Overall Study||0
6693420|NCT02756364|7623801|FG001|COMPLETED|Overall Study||0
6693421|NCT02756364|7623802|FG002|COMPLETED|Overall Study||0
6693422|NCT02756364|7623800|FG000|NOT COMPLETED|Overall Study||46
6693423|NCT02756364|7623801|FG001|NOT COMPLETED|Overall Study||47
6693424|NCT02756364|7623802|FG002|NOT COMPLETED|Overall Study||48
6693425|NCT02756572|7623810|FG000|STARTED|Overall Study||30
6693426|NCT02756572|7623810|FG000|COMPLETED|Overall Study||30
6693427|NCT02756572|7623810|FG000|NOT COMPLETED|Overall Study||0
6693428|NCT02756624|7623821|FG000|STARTED|Overall Study||343
6693429|NCT02756624|7623822|FG001|STARTED|Overall Study||173
6693430|NCT02756624|7623821|FG000|COMPLETED|Overall Study||327
6693431|NCT02756624|7623822|FG001|COMPLETED|Overall Study||166
6693432|NCT02756624|7623821|FG000|NOT COMPLETED|Overall Study||16
6693433|NCT02756624|7623822|FG001|NOT COMPLETED|Overall Study||7
6693434|NCT02756637|7623830|FG000|STARTED|Overall Study||317
6693435|NCT02756637|7623831|FG001|STARTED|Overall Study||317
6693436|NCT02756637|7623830|FG000|Eligible for SWOG 8710|Overall Study||307
6693437|NCT02756637|7623831|FG001|Eligible for SWOG 8710|Overall Study||307
6693438|NCT02756637|7623830|FG000|Had NLR Value|Overall Study||263
6693439|NCT02756637|7623831|FG001|Had NLR Value|Overall Study||263
6693440|NCT02756637|7623830|FG000|Completed Curative Treatment|Overall Study||230
6693441|NCT02756637|7623831|FG001|Completed Curative Treatment|Overall Study||0
6693442|NCT02756637|7623830|FG000|COMPLETED|Overall Study||230
6693443|NCT02756637|7623831|FG001|COMPLETED|Overall Study||263
6693444|NCT02756637|7623830|FG000|NOT COMPLETED|Overall Study||87
6693445|NCT02756637|7623831|FG001|NOT COMPLETED|Overall Study||54
6693446|NCT02756650|7623837|FG000|STARTED|Overall Study||8
6693447|NCT02756650|7623837|FG000|COMPLETED|Overall Study||6
6693448|NCT02756650|7623837|FG000|NOT COMPLETED|Overall Study||2
6693449|NCT02756689|7623843|FG000|STARTED|Overall Study||64
6693450|NCT02756689|7623844|FG001|STARTED|Overall Study||65
6693451|NCT02756689|7623843|FG000|COMPLETED|Overall Study||64
6693452|NCT02756689|7623844|FG001|COMPLETED|Overall Study||65
6693453|NCT02756689|7623843|FG000|NOT COMPLETED|Overall Study||0
6693454|NCT02756689|7623844|FG001|NOT COMPLETED|Overall Study||0
6693455|NCT02756819|7623884|FG000|STARTED|Overall Study||1945
6693456|NCT02756819|7623884|FG000|Per-protocol Set (PPS)|Overall Study|Participants who were enrolled, received Edarbi® therapy and did not have major protocol deviations.|1724
6693457|NCT02756819|7623884|FG000|Safety Analysis Set (SAS)|Overall Study|Participants who received at least one dose of Edarbi® therapy and had any follow-up data.|1934
6258616|NCT03307785|7157847|FG003|STARTED|Part E: Up to 4.4 Months||0
6258617|NCT03307785|7157848|FG004|STARTED|Part E: Up to 4.4 Months||0
6258618|NCT03307785|7157849|FG005|STARTED|Part E: Up to 4.4 Months||0
6258619|NCT03307785|7157850|FG006|STARTED|Part E: Up to 4.4 Months||2
6258620|NCT03307785|7157851|FG007|STARTED|Part E: Up to 4.4 Months||0
6258621|NCT03307785|7157852|FG008|STARTED|Part E: Up to 4.4 Months||0
6258622|NCT03307785|7157853|FG009|STARTED|Part E: Up to 4.4 Months||0
6258623|NCT03307785|7157854|FG010|STARTED|Part E: Up to 4.4 Months||0
6258624|NCT03307785|7157844|FG000|COMPLETED|Part E: Up to 4.4 Months||0
6258625|NCT03307785|7157845|FG001|COMPLETED|Part E: Up to 4.4 Months||0
6258626|NCT03307785|7157846|FG002|COMPLETED|Part E: Up to 4.4 Months||0
6258627|NCT03307785|7157847|FG003|COMPLETED|Part E: Up to 4.4 Months||0
6258628|NCT03307785|7157848|FG004|COMPLETED|Part E: Up to 4.4 Months||0
6258629|NCT03307785|7157849|FG005|COMPLETED|Part E: Up to 4.4 Months||0
6258630|NCT03307785|7157850|FG006|COMPLETED|Part E: Up to 4.4 Months||0
6258631|NCT03307785|7157851|FG007|COMPLETED|Part E: Up to 4.4 Months||0
6258632|NCT03307785|7157852|FG008|COMPLETED|Part E: Up to 4.4 Months||0
6258633|NCT03307785|7157853|FG009|COMPLETED|Part E: Up to 4.4 Months||0
6258634|NCT03307785|7157854|FG010|COMPLETED|Part E: Up to 4.4 Months||0
6258635|NCT03307785|7157844|FG000|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258636|NCT03307785|7157845|FG001|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258637|NCT03307785|7157846|FG002|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258638|NCT03307785|7157847|FG003|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258639|NCT03307785|7157848|FG004|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258640|NCT03307785|7157849|FG005|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258641|NCT03307785|7157850|FG006|NOT COMPLETED|Part E: Up to 4.4 Months||2
6258642|NCT03307785|7157851|FG007|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258643|NCT03307785|7157852|FG008|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258644|NCT03307785|7157853|FG009|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258645|NCT03307785|7157854|FG010|NOT COMPLETED|Part E: Up to 4.4 Months||0
6258646|NCT03307785|7157844|FG000|STARTED|Part F: Up to 3.5 Months||0
6258647|NCT03307785|7157845|FG001|STARTED|Part F: Up to 3.5 Months||0
6258648|NCT03307785|7157846|FG002|STARTED|Part F: Up to 3.5 Months||0
6258649|NCT03307785|7157847|FG003|STARTED|Part F: Up to 3.5 Months||0
6258650|NCT03307785|7157848|FG004|STARTED|Part F: Up to 3.5 Months||0
6258651|NCT03307785|7157849|FG005|STARTED|Part F: Up to 3.5 Months||0
6258652|NCT03307785|7157850|FG006|STARTED|Part F: Up to 3.5 Months||0
6258653|NCT03307785|7157851|FG007|STARTED|Part F: Up to 3.5 Months||1
6258654|NCT03307785|7157852|FG008|STARTED|Part F: Up to 3.5 Months||0
6258655|NCT03307785|7157853|FG009|STARTED|Part F: Up to 3.5 Months||0
6258656|NCT03307785|7157854|FG010|STARTED|Part F: Up to 3.5 Months||0
6258657|NCT03307785|7157844|FG000|COMPLETED|Part F: Up to 3.5 Months||0
6258658|NCT03307785|7157845|FG001|COMPLETED|Part F: Up to 3.5 Months||0
6258659|NCT03307785|7157846|FG002|COMPLETED|Part F: Up to 3.5 Months||0
6258660|NCT03307785|7157847|FG003|COMPLETED|Part F: Up to 3.5 Months||0
6258661|NCT03307785|7157848|FG004|COMPLETED|Part F: Up to 3.5 Months||0
6258662|NCT03307785|7157849|FG005|COMPLETED|Part F: Up to 3.5 Months||0
6258663|NCT03307785|7157850|FG006|COMPLETED|Part F: Up to 3.5 Months||0
6258664|NCT03307785|7157851|FG007|COMPLETED|Part F: Up to 3.5 Months||0
6258665|NCT03307785|7157852|FG008|COMPLETED|Part F: Up to 3.5 Months||0
6258666|NCT03307785|7157853|FG009|COMPLETED|Part F: Up to 3.5 Months||0
6258667|NCT03307785|7157854|FG010|COMPLETED|Part F: Up to 3.5 Months||0
6258668|NCT03307785|7157844|FG000|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258669|NCT03307785|7157845|FG001|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258670|NCT03307785|7157846|FG002|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258671|NCT03307785|7157847|FG003|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258672|NCT03307785|7157848|FG004|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258673|NCT03307785|7157849|FG005|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258674|NCT03307785|7157850|FG006|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258675|NCT03307785|7157851|FG007|NOT COMPLETED|Part F: Up to 3.5 Months||1
6258676|NCT03307785|7157852|FG008|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258677|NCT03307785|7157853|FG009|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258678|NCT03307785|7157854|FG010|NOT COMPLETED|Part F: Up to 3.5 Months||0
6258679|NCT03307785|7157844|FG000|STARTED|Part G: Up to 24 Months||0
6258680|NCT03307785|7157845|FG001|STARTED|Part G: Up to 24 Months||0
6258681|NCT03307785|7157846|FG002|STARTED|Part G: Up to 24 Months||0
6258682|NCT03307785|7157847|FG003|STARTED|Part G: Up to 24 Months||0
6258683|NCT03307785|7157848|FG004|STARTED|Part G: Up to 24 Months||0
6258684|NCT03307785|7157849|FG005|STARTED|Part G: Up to 24 Months||0
6258685|NCT03307785|7157850|FG006|STARTED|Part G: Up to 24 Months||0
6258686|NCT03307785|7157851|FG007|STARTED|Part G: Up to 24 Months||0
6258687|NCT03307785|7157852|FG008|STARTED|Part G: Up to 24 Months||0
6258688|NCT03307785|7157853|FG009|STARTED|Part G: Up to 24 Months||0
6258689|NCT03307785|7157854|FG010|STARTED|Part G: Up to 24 Months||0
6258690|NCT03307785|7157844|FG000|COMPLETED|Part G: Up to 24 Months||0
6693458|NCT02756819|7623884|FG000|COMPLETED|Overall Study||1893
6693459|NCT02756819|7623884|FG000|NOT COMPLETED|Overall Study||52
6693460|NCT02756832|7623888|FG000|STARTED|Overall Study||1409
6693461|NCT02756832|7623888|FG000|Received Therapy|Overall Study||1393
6693462|NCT02756832|7623888|FG000|Included in Efficacy and Safety Analysis|Overall Study||1399
6693463|NCT02756832|7623888|FG000|COMPLETED|Overall Study||1356
6693464|NCT02756832|7623888|FG000|NOT COMPLETED|Overall Study||53
6693465|NCT02756910|7623892|FG000|STARTED|Overall Study||80
6693466|NCT02756910|7623892|FG000|COMPLETED|Overall Study||80
6693467|NCT02756910|7623892|FG000|NOT COMPLETED|Overall Study||0
6693468|NCT02756949|7623898|FG000|STARTED|Overall Study||181
6693469|NCT02756949|7623899|FG001|STARTED|Overall Study||172
6693470|NCT02756949|7623898|FG000|COMPLETED|Overall Study||181
6693471|NCT02756949|7623899|FG001|COMPLETED|Overall Study||164
6693472|NCT02756949|7623898|FG000|NOT COMPLETED|Overall Study||0
6693473|NCT02756949|7623899|FG001|NOT COMPLETED|Overall Study||8
6693474|NCT02757092|7623907|FG000|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
6693475|NCT02757092|7623908|FG001|STARTED|Overall Study|Random assignment was to encode subjects from opaque envelopes and sealed, on the day of discharge|18
6693476|NCT02757092|7623907|FG000|COMPLETED|Overall Study|All subjects completed the study|18
6693477|NCT02757092|7623908|FG001|COMPLETED|Overall Study|All subjects completed the study|18
6693478|NCT02757092|7623907|FG000|NOT COMPLETED|Overall Study||0
6693479|NCT02757092|7623908|FG001|NOT COMPLETED|Overall Study||0
6693480|NCT02757105|7623974|FG000|STARTED|Overall Study||75
6693481|NCT02757105|7623975|FG001|STARTED|Overall Study||52
6693482|NCT02757105|7623974|FG000|Treated|Overall Study||75
6693483|NCT02757105|7623975|FG001|Treated|Overall Study||51
6693484|NCT02757105|7623974|FG000|COMPLETED|Overall Study||63
6693485|NCT02757105|7623975|FG001|COMPLETED|Overall Study||41
6693486|NCT02757105|7623974|FG000|NOT COMPLETED|Overall Study||12
6693487|NCT02757105|7623975|FG001|NOT COMPLETED|Overall Study||11
6693488|NCT02757326|7623985|FG000|STARTED|Overall Study||3
6693489|NCT02757326|7623986|FG001|STARTED|Overall Study||4
6693490|NCT02757326|7623987|FG002|STARTED|Overall Study||6
6693491|NCT02757326|7623985|FG000|COMPLETED|Overall Study||3
6693492|NCT02757326|7623986|FG001|COMPLETED|Overall Study||4
6693493|NCT02757326|7623987|FG002|COMPLETED|Overall Study||6
6693494|NCT02757326|7623985|FG000|NOT COMPLETED|Overall Study||0
6258691|NCT03307785|7157845|FG001|COMPLETED|Part G: Up to 24 Months||0
6258692|NCT03307785|7157846|FG002|COMPLETED|Part G: Up to 24 Months||0
6258693|NCT03307785|7157847|FG003|COMPLETED|Part G: Up to 24 Months||0
6258694|NCT03307785|7157848|FG004|COMPLETED|Part G: Up to 24 Months||0
6258695|NCT03307785|7157849|FG005|COMPLETED|Part G: Up to 24 Months||0
6258696|NCT03307785|7157850|FG006|COMPLETED|Part G: Up to 24 Months||0
6258697|NCT03307785|7157851|FG007|COMPLETED|Part G: Up to 24 Months||0
6258698|NCT03307785|7157852|FG008|COMPLETED|Part G: Up to 24 Months||0
6258699|NCT03307785|7157853|FG009|COMPLETED|Part G: Up to 24 Months||0
6258700|NCT03307785|7157854|FG010|COMPLETED|Part G: Up to 24 Months||0
6258701|NCT03307785|7157844|FG000|NOT COMPLETED|Part G: Up to 24 Months||0
6258702|NCT03307785|7157845|FG001|NOT COMPLETED|Part G: Up to 24 Months||0
6258703|NCT03307785|7157846|FG002|NOT COMPLETED|Part G: Up to 24 Months||0
6258704|NCT03307785|7157847|FG003|NOT COMPLETED|Part G: Up to 24 Months||0
6258705|NCT03307785|7157848|FG004|NOT COMPLETED|Part G: Up to 24 Months||0
6258706|NCT03307785|7157849|FG005|NOT COMPLETED|Part G: Up to 24 Months||0
6258707|NCT03307785|7157850|FG006|NOT COMPLETED|Part G: Up to 24 Months||0
6258708|NCT03307785|7157851|FG007|NOT COMPLETED|Part G: Up to 24 Months||0
6258709|NCT03307785|7157852|FG008|NOT COMPLETED|Part G: Up to 24 Months||0
6258710|NCT03307785|7157853|FG009|NOT COMPLETED|Part G: Up to 24 Months||0
6258711|NCT03307785|7157854|FG010|NOT COMPLETED|Part G: Up to 24 Months||0
6258712|NCT03307785|7157844|FG000|STARTED|Part H: Up to 24 Months||0
6258713|NCT03307785|7157845|FG001|STARTED|Part H: Up to 24 Months||0
6258714|NCT03307785|7157846|FG002|STARTED|Part H: Up to 24 Months||0
6258715|NCT03307785|7157847|FG003|STARTED|Part H: Up to 24 Months||0
6258716|NCT03307785|7157848|FG004|STARTED|Part H: Up to 24 Months||0
6258717|NCT03307785|7157849|FG005|STARTED|Part H: Up to 24 Months||0
6258718|NCT03307785|7157850|FG006|STARTED|Part H: Up to 24 Months||0
6258719|NCT03307785|7157851|FG007|STARTED|Part H: Up to 24 Months||0
6258720|NCT03307785|7157852|FG008|STARTED|Part H: Up to 24 Months||0
6258721|NCT03307785|7157853|FG009|STARTED|Part H: Up to 24 Months||0
6258722|NCT03307785|7157854|FG010|STARTED|Part H: Up to 24 Months||0
6258723|NCT03307785|7157844|FG000|COMPLETED|Part H: Up to 24 Months||0
6258724|NCT03307785|7157845|FG001|COMPLETED|Part H: Up to 24 Months||0
6258725|NCT03307785|7157846|FG002|COMPLETED|Part H: Up to 24 Months||0
6258726|NCT03307785|7157847|FG003|COMPLETED|Part H: Up to 24 Months||0
6258727|NCT03307785|7157848|FG004|COMPLETED|Part H: Up to 24 Months||0
6258728|NCT03307785|7157849|FG005|COMPLETED|Part H: Up to 24 Months||0
6258729|NCT03307785|7157850|FG006|COMPLETED|Part H: Up to 24 Months||0
6258730|NCT03307785|7157851|FG007|COMPLETED|Part H: Up to 24 Months||0
6258731|NCT03307785|7157852|FG008|COMPLETED|Part H: Up to 24 Months||0
6258732|NCT03307785|7157853|FG009|COMPLETED|Part H: Up to 24 Months||0
6258733|NCT03307785|7157854|FG010|COMPLETED|Part H: Up to 24 Months||0
6258734|NCT03307785|7157844|FG000|NOT COMPLETED|Part H: Up to 24 Months||0
6258735|NCT03307785|7157845|FG001|NOT COMPLETED|Part H: Up to 24 Months||0
6258736|NCT03307785|7157846|FG002|NOT COMPLETED|Part H: Up to 24 Months||0
6258737|NCT03307785|7157847|FG003|NOT COMPLETED|Part H: Up to 24 Months||0
6258738|NCT03307785|7157848|FG004|NOT COMPLETED|Part H: Up to 24 Months||0
6693495|NCT02757326|7623986|FG001|NOT COMPLETED|Overall Study||0
6693496|NCT02757326|7623987|FG002|NOT COMPLETED|Overall Study||0
6693497|NCT02757352|7624002|FG000|STARTED|Double-Blind Period (Week 0 - Week 16)||105
6693498|NCT02757352|7624003|FG001|STARTED|Double-Blind Period (Week 0 - Week 16)||96
6693499|NCT02757352|7624004|FG002|STARTED|Double-Blind Period (Week 0 - Week 16)||102
6693500|NCT02757352|7624005|FG003|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6693501|NCT02757352|7624006|FG004|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6693502|NCT02757352|7624007|FG005|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6693503|NCT02757352|7624008|FG006|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6693504|NCT02757352|7624009|FG007|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6693505|NCT02757352|7624010|FG008|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6693506|NCT02757352|7624011|FG009|STARTED|Double-Blind Period (Week 0 - Week 16)||0
6693507|NCT02757352|7624002|FG000|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||104
6693508|NCT02757352|7624003|FG001|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||96
6693509|NCT02757352|7624004|FG002|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||102
6693510|NCT02757352|7624005|FG003|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6693511|NCT02757352|7624006|FG004|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6693512|NCT02757352|7624007|FG005|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6693513|NCT02757352|7624008|FG006|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6693514|NCT02757352|7624009|FG007|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6693515|NCT02757352|7624010|FG008|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6693516|NCT02757352|7624011|FG009|Received at Least One Dose of Study Drug|Double-Blind Period (Week 0 - Week 16)||0
6693517|NCT02757352|7624002|FG000|COMPLETED|Double-Blind Period (Week 0 - Week 16)||97
6693518|NCT02757352|7624003|FG001|COMPLETED|Double-Blind Period (Week 0 - Week 16)||95
6693519|NCT02757352|7624004|FG002|COMPLETED|Double-Blind Period (Week 0 - Week 16)||98
6693520|NCT02757352|7624005|FG003|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693521|NCT02757352|7624006|FG004|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693522|NCT02757352|7624007|FG005|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693523|NCT02757352|7624008|FG006|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693524|NCT02757352|7624009|FG007|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693525|NCT02757352|7624010|FG008|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693526|NCT02757352|7624011|FG009|COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693527|NCT02757352|7624002|FG000|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||8
6693528|NCT02757352|7624003|FG001|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||1
6693529|NCT02757352|7624004|FG002|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||4
6693530|NCT02757352|7624005|FG003|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693531|NCT02757352|7624006|FG004|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693532|NCT02757352|7624007|FG005|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6258739|NCT03307785|7157849|FG005|NOT COMPLETED|Part H: Up to 24 Months||0
6258740|NCT03307785|7157850|FG006|NOT COMPLETED|Part H: Up to 24 Months||0
6258741|NCT03307785|7157851|FG007|NOT COMPLETED|Part H: Up to 24 Months||0
6258742|NCT03307785|7157852|FG008|NOT COMPLETED|Part H: Up to 24 Months||0
6258743|NCT03307785|7157853|FG009|NOT COMPLETED|Part H: Up to 24 Months||0
6258744|NCT03307785|7157854|FG010|NOT COMPLETED|Part H: Up to 24 Months||0
6258745|NCT03307785|7157844|FG000|STARTED|Part I: Up to 24 Months||0
6258746|NCT03307785|7157845|FG001|STARTED|Part I: Up to 24 Months||0
6258747|NCT03307785|7157846|FG002|STARTED|Part I: Up to 24 Months||0
6258748|NCT03307785|7157847|FG003|STARTED|Part I: Up to 24 Months||0
6258749|NCT03307785|7157848|FG004|STARTED|Part I: Up to 24 Months||0
6258750|NCT03307785|7157849|FG005|STARTED|Part I: Up to 24 Months||0
6258751|NCT03307785|7157850|FG006|STARTED|Part I: Up to 24 Months||0
6258752|NCT03307785|7157851|FG007|STARTED|Part I: Up to 24 Months||0
6258753|NCT03307785|7157852|FG008|STARTED|Part I: Up to 24 Months||0
6258754|NCT03307785|7157853|FG009|STARTED|Part I: Up to 24 Months||0
6258755|NCT03307785|7157854|FG010|STARTED|Part I: Up to 24 Months||0
6258756|NCT03307785|7157844|FG000|COMPLETED|Part I: Up to 24 Months||0
6258757|NCT03307785|7157845|FG001|COMPLETED|Part I: Up to 24 Months||0
6258758|NCT03307785|7157846|FG002|COMPLETED|Part I: Up to 24 Months||0
6258759|NCT03307785|7157847|FG003|COMPLETED|Part I: Up to 24 Months||0
6258760|NCT03307785|7157848|FG004|COMPLETED|Part I: Up to 24 Months||0
6258761|NCT03307785|7157849|FG005|COMPLETED|Part I: Up to 24 Months||0
6258762|NCT03307785|7157850|FG006|COMPLETED|Part I: Up to 24 Months||0
6258763|NCT03307785|7157851|FG007|COMPLETED|Part I: Up to 24 Months||0
6258764|NCT03307785|7157852|FG008|COMPLETED|Part I: Up to 24 Months||0
6258765|NCT03307785|7157853|FG009|COMPLETED|Part I: Up to 24 Months||0
6258766|NCT03307785|7157854|FG010|COMPLETED|Part I: Up to 24 Months||0
6258767|NCT03307785|7157844|FG000|NOT COMPLETED|Part I: Up to 24 Months||0
6258768|NCT03307785|7157845|FG001|NOT COMPLETED|Part I: Up to 24 Months||0
6258769|NCT03307785|7157846|FG002|NOT COMPLETED|Part I: Up to 24 Months||0
6258770|NCT03307785|7157847|FG003|NOT COMPLETED|Part I: Up to 24 Months||0
6258771|NCT03307785|7157848|FG004|NOT COMPLETED|Part I: Up to 24 Months||0
6258772|NCT03307785|7157849|FG005|NOT COMPLETED|Part I: Up to 24 Months||0
6258773|NCT03307785|7157850|FG006|NOT COMPLETED|Part I: Up to 24 Months||0
6258774|NCT03307785|7157851|FG007|NOT COMPLETED|Part I: Up to 24 Months||0
6258775|NCT03307785|7157852|FG008|NOT COMPLETED|Part I: Up to 24 Months||0
6258776|NCT03307785|7157853|FG009|NOT COMPLETED|Part I: Up to 24 Months||0
6258777|NCT03307785|7157854|FG010|NOT COMPLETED|Part I: Up to 24 Months||0
6693533|NCT02757352|7624008|FG006|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693534|NCT02757352|7624009|FG007|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693535|NCT02757352|7624010|FG008|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693536|NCT02757352|7624011|FG009|NOT COMPLETED|Double-Blind Period (Week 0 - Week 16)||0
6693537|NCT02757352|7624002|FG000|STARTED|Double-Blind Period (Week 16 - Week 52)||97
6693538|NCT02757352|7624003|FG001|STARTED|Double-Blind Period (Week 16 - Week 52)||95
6693539|NCT02757352|7624004|FG002|STARTED|Double-Blind Period (Week 16 - Week 52)||98
6693540|NCT02757352|7624005|FG003|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6693541|NCT02757352|7624006|FG004|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6693542|NCT02757352|7624007|FG005|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6693543|NCT02757352|7624008|FG006|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6693544|NCT02757352|7624009|FG007|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6693545|NCT02757352|7624010|FG008|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6693546|NCT02757352|7624011|FG009|STARTED|Double-Blind Period (Week 16 - Week 52)||0
6693547|NCT02757352|7624002|FG000|COMPLETED|Double-Blind Period (Week 16 - Week 52)||34
6693548|NCT02757352|7624003|FG001|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
6693549|NCT02757352|7624004|FG002|COMPLETED|Double-Blind Period (Week 16 - Week 52)||52
6693550|NCT02757352|7624005|FG003|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693551|NCT02757352|7624006|FG004|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693552|NCT02757352|7624007|FG005|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693553|NCT02757352|7624008|FG006|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693554|NCT02757352|7624009|FG007|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693555|NCT02757352|7624010|FG008|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693556|NCT02757352|7624011|FG009|COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693557|NCT02757352|7624002|FG000|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||63
6693558|NCT02757352|7624003|FG001|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||43
6693559|NCT02757352|7624004|FG002|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||46
6693560|NCT02757352|7624005|FG003|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693561|NCT02757352|7624006|FG004|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693562|NCT02757352|7624007|FG005|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693563|NCT02757352|7624008|FG006|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693564|NCT02757352|7624009|FG007|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693565|NCT02757352|7624010|FG008|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693566|NCT02757352|7624011|FG009|NOT COMPLETED|Double-Blind Period (Week 16 - Week 52)||0
6693567|NCT02757352|7624002|FG000|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
6693568|NCT02757352|7624003|FG001|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
6693569|NCT02757352|7624004|FG002|STARTED|IR-Open Label Period (Week 16 - Week 52)|Participants continued with original assigned treatment without switching to open label ixeQ2W.|0
6693570|NCT02757352|7624005|FG003|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|62
6693571|NCT02757352|7624006|FG004|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|40
6693572|NCT02757352|7624007|FG005|STARTED|IR-Open Label Period (Week 16 - Week 52)|IR based on the investigator's opinion switched to ixekizumab open label 80 mg Q2W.|42
6693573|NCT02757352|7624008|FG006|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
6693574|NCT02757352|7624009|FG007|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
6693575|NCT02757352|7624010|FG008|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
6693576|NCT02757352|7624011|FG009|STARTED|IR-Open Label Period (Week 16 - Week 52)||0
6693577|NCT02757352|7624002|FG000|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6693578|NCT02757352|7624003|FG001|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6693579|NCT02757352|7624004|FG002|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6693580|NCT02757352|7624005|FG003|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||2
6693581|NCT02757352|7624006|FG004|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6693582|NCT02757352|7624007|FG005|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||3
6693583|NCT02757352|7624008|FG006|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6693584|NCT02757352|7624009|FG007|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6693585|NCT02757352|7624010|FG008|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6693586|NCT02757352|7624011|FG009|Initiated Other Biologic Rescue|IR-Open Label Period (Week 16 - Week 52)||0
6693587|NCT02757352|7624002|FG000|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693588|NCT02757352|7624003|FG001|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693589|NCT02757352|7624004|FG002|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693590|NCT02757352|7624005|FG003|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||55
6693591|NCT02757352|7624006|FG004|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||37
6693592|NCT02757352|7624007|FG005|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||35
6693593|NCT02757352|7624008|FG006|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693594|NCT02757352|7624009|FG007|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693595|NCT02757352|7624010|FG008|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693596|NCT02757352|7624011|FG009|COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693597|NCT02757352|7624002|FG000|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693598|NCT02757352|7624003|FG001|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693599|NCT02757352|7624004|FG002|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693600|NCT02757352|7624005|FG003|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
6693601|NCT02757352|7624006|FG004|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||3
6693602|NCT02757352|7624007|FG005|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||7
6693603|NCT02757352|7624008|FG006|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693604|NCT02757352|7624009|FG007|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693605|NCT02757352|7624010|FG008|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693606|NCT02757352|7624011|FG009|NOT COMPLETED|IR-Open Label Period (Week 16 - Week 52)||0
6693607|NCT02757352|7624002|FG000|STARTED|Follow-Up Period||0
6693608|NCT02757352|7624003|FG001|STARTED|Follow-Up Period||0
6693609|NCT02757352|7624004|FG002|STARTED|Follow-Up Period||0
6693610|NCT02757352|7624005|FG003|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
6693611|NCT02757352|7624006|FG004|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
6693612|NCT02757352|7624007|FG005|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|0
6693613|NCT02757352|7624008|FG006|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|3
6693614|NCT02757352|7624009|FG007|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|5
6693615|NCT02757352|7624010|FG008|STARTED|Follow-Up Period|Participants who completed the study were eligible to enroll in RHBY or enter follow up period.|28
6693616|NCT02757352|7624011|FG009|STARTED|Follow-Up Period||5
6693617|NCT02757352|7624002|FG000|COMPLETED|Follow-Up Period||0
6693618|NCT02757352|7624003|FG001|COMPLETED|Follow-Up Period||0
6693619|NCT02757352|7624004|FG002|COMPLETED|Follow-Up Period||0
6693620|NCT02757352|7624005|FG003|COMPLETED|Follow-Up Period||0
6693621|NCT02757352|7624006|FG004|COMPLETED|Follow-Up Period||0
6693622|NCT02757352|7624007|FG005|COMPLETED|Follow-Up Period||0
6693623|NCT02757352|7624008|FG006|COMPLETED|Follow-Up Period||2
6693624|NCT02757352|7624009|FG007|COMPLETED|Follow-Up Period||4
6693625|NCT02757352|7624010|FG008|COMPLETED|Follow-Up Period||18
6693626|NCT02757352|7624011|FG009|COMPLETED|Follow-Up Period||2
6693627|NCT02757352|7624002|FG000|NOT COMPLETED|Follow-Up Period||0
6693628|NCT02757352|7624003|FG001|NOT COMPLETED|Follow-Up Period||0
6693629|NCT02757352|7624004|FG002|NOT COMPLETED|Follow-Up Period||0
6693630|NCT02757352|7624005|FG003|NOT COMPLETED|Follow-Up Period||0
6693631|NCT02757352|7624006|FG004|NOT COMPLETED|Follow-Up Period||0
6693632|NCT02757352|7624007|FG005|NOT COMPLETED|Follow-Up Period||0
6693633|NCT02757352|7624008|FG006|NOT COMPLETED|Follow-Up Period||1
6693634|NCT02757352|7624009|FG007|NOT COMPLETED|Follow-Up Period||1
6693635|NCT02757352|7624010|FG008|NOT COMPLETED|Follow-Up Period||10
6693636|NCT02757352|7624011|FG009|NOT COMPLETED|Follow-Up Period||3
6693637|NCT02757430|7624042|FG000|STARTED|Overall Study||515
6693638|NCT02757430|7624042|FG000|Baseline Visits|Overall Study||503
6693639|NCT02757430|7624042|FG000|EP Mapping/Ablation Procedure|Overall Study||503
6693640|NCT02757430|7624042|FG000|COMPLETED|Overall Study|Subjects with pre-discharge visit were considered completed.|503
6693641|NCT02757430|7624042|FG000|NOT COMPLETED|Overall Study||12
6693642|NCT02757625|7624059|FG000|STARTED|Overall Study||14
6693643|NCT02757625|7624060|FG001|STARTED|Overall Study||18
6693644|NCT02757625|7624061|FG002|STARTED|Overall Study||19
6693645|NCT02757625|7624062|FG003|STARTED|Overall Study||12
6693646|NCT02757625|7624059|FG000|COMPLETED|Overall Study||14
6693647|NCT02757625|7624060|FG001|COMPLETED|Overall Study||18
6693648|NCT02757625|7624061|FG002|COMPLETED|Overall Study||17
6693649|NCT02757625|7624062|FG003|COMPLETED|Overall Study||12
6693650|NCT02757625|7624059|FG000|NOT COMPLETED|Overall Study||0
6693651|NCT02757625|7624060|FG001|NOT COMPLETED|Overall Study||0
6693652|NCT02757625|7624061|FG002|NOT COMPLETED|Overall Study||2
6693653|NCT02757625|7624062|FG003|NOT COMPLETED|Overall Study||0
6693654|NCT02757768|7624076|FG000|STARTED|Overall Study||356
6693655|NCT02757768|7624077|FG001|STARTED|Overall Study||359
6693656|NCT02757768|7624076|FG000|Treated|Overall Study||352
6693657|NCT02757768|7624077|FG001|Treated|Overall Study||354
6693658|NCT02757768|7624076|FG000|COMPLETED|Overall Study||323
6693659|NCT02757768|7624077|FG001|COMPLETED|Overall Study||331
6693660|NCT02757768|7624076|FG000|NOT COMPLETED|Overall Study||33
6693661|NCT02757768|7624077|FG001|NOT COMPLETED|Overall Study||28
6693662|NCT02757950|7624087|FG000|STARTED|Overall Study||1203
6693663|NCT02757950|7624088|FG001|STARTED|Overall Study||1259
6693664|NCT02757950|7624087|FG000|COMPLETED|Overall Study||1199
6693665|NCT02757950|7624088|FG001|COMPLETED|Overall Study||1248
6693666|NCT02757950|7624087|FG000|NOT COMPLETED|Overall Study||4
6693667|NCT02757950|7624088|FG001|NOT COMPLETED|Overall Study||11
6693668|NCT02757963|7624095|FG000|STARTED|Overall Study||1658
6693669|NCT02757963|7624095|FG000|COMPLETED|Overall Study||561
6693670|NCT02757963|7624095|FG000|NOT COMPLETED|Overall Study||1097
6693671|NCT02758119|7624112|FG000|STARTED|Overall Study||41
6693672|NCT02758119|7624113|FG001|STARTED|Overall Study||41
6693673|NCT02758119|7624112|FG000|COMPLETED|Overall Study||39
6258778|NCT03090737|7157875|FG000|STARTED|Overall Study||129
6693674|NCT02758119|7624113|FG001|COMPLETED|Overall Study||40
6693675|NCT02758119|7624112|FG000|NOT COMPLETED|Overall Study||2
6693676|NCT02758119|7624113|FG001|NOT COMPLETED|Overall Study||1
6693677|NCT02758171|7624123|FG000|STARTED|Treatment Period 1||28
6693678|NCT02758171|7624124|FG001|STARTED|Treatment Period 1||28
6693679|NCT02758171|7624123|FG000|COMPLETED|Treatment Period 1||28
6693680|NCT02758171|7624124|FG001|COMPLETED|Treatment Period 1||28
6693681|NCT02758171|7624123|FG000|NOT COMPLETED|Treatment Period 1||0
6693682|NCT02758171|7624124|FG001|NOT COMPLETED|Treatment Period 1||0
6693683|NCT02758171|7624123|FG000|STARTED|Wash-out||28
6693684|NCT02758171|7624124|FG001|STARTED|Wash-out||28
6693685|NCT02758171|7624123|FG000|COMPLETED|Wash-out||26
6693686|NCT02758171|7624124|FG001|COMPLETED|Wash-out||28
6693687|NCT02758171|7624123|FG000|NOT COMPLETED|Wash-out||2
6693688|NCT02758171|7624124|FG001|NOT COMPLETED|Wash-out||0
6693689|NCT02758171|7624123|FG000|STARTED|Treatment Period 2||26
6693690|NCT02758171|7624124|FG001|STARTED|Treatment Period 2||28
6693691|NCT02758171|7624123|FG000|COMPLETED|Treatment Period 2||26
6693692|NCT02758171|7624124|FG001|COMPLETED|Treatment Period 2||28
6693693|NCT02758171|7624123|FG000|NOT COMPLETED|Treatment Period 2||0
6693694|NCT02758171|7624124|FG001|NOT COMPLETED|Treatment Period 2||0
6693695|NCT02758210|7624130|FG000|STARTED|Overall Study||20
6693696|NCT02758210|7624130|FG000|COMPLETED|Overall Study||20
6693697|NCT02758210|7624130|FG000|NOT COMPLETED|Overall Study||0
6693698|NCT02758301|7624136|FG000|STARTED|Overall Study||104
6693699|NCT02758301|7624137|FG001|STARTED|Overall Study||8
6693700|NCT02758301|7624136|FG000|COMPLETED|Overall Study||70
6693701|NCT02758301|7624137|FG001|COMPLETED|Overall Study||0
6693702|NCT02758301|7624136|FG000|NOT COMPLETED|Overall Study||34
6693703|NCT02758301|7624137|FG001|NOT COMPLETED|Overall Study||8
6693704|NCT02758613|7624147|FG000|STARTED|Treatment||8
6693705|NCT02758613|7624148|FG001|STARTED|Treatment||8
6693706|NCT02758613|7624149|FG002|STARTED|Treatment||9
6693707|NCT02758613|7624150|FG003|STARTED|Treatment||8
6693708|NCT02758613|7624147|FG000|Received at Least One Dose of Study Drug|Treatment||8
6693709|NCT02758613|7624148|FG001|Received at Least One Dose of Study Drug|Treatment||8
6693710|NCT02758613|7624149|FG002|Received at Least One Dose of Study Drug|Treatment||9
6693711|NCT02758613|7624150|FG003|Received at Least One Dose of Study Drug|Treatment||8
6693712|NCT02758613|7624147|FG000|COMPLETED|Treatment||6
6693713|NCT02758613|7624148|FG001|COMPLETED|Treatment||8
6693714|NCT02758613|7624149|FG002|COMPLETED|Treatment||8
6693715|NCT02758613|7624150|FG003|COMPLETED|Treatment||8
6693716|NCT02758613|7624147|FG000|NOT COMPLETED|Treatment||2
6693717|NCT02758613|7624148|FG001|NOT COMPLETED|Treatment||0
6693718|NCT02758613|7624149|FG002|NOT COMPLETED|Treatment||1
6693719|NCT02758613|7624150|FG003|NOT COMPLETED|Treatment||0
6693720|NCT02758613|7624147|FG000|STARTED|Follow-up||6
6693721|NCT02758613|7624148|FG001|STARTED|Follow-up||8
6693722|NCT02758613|7624149|FG002|STARTED|Follow-up||8
6693723|NCT02758613|7624150|FG003|STARTED|Follow-up||8
6693724|NCT02758613|7624147|FG000|COMPLETED|Follow-up||6
6693725|NCT02758613|7624148|FG001|COMPLETED|Follow-up||8
6693726|NCT02758613|7624149|FG002|COMPLETED|Follow-up||8
6693727|NCT02758613|7624150|FG003|COMPLETED|Follow-up||8
6693728|NCT02758613|7624147|FG000|NOT COMPLETED|Follow-up||0
6693729|NCT02758613|7624148|FG001|NOT COMPLETED|Follow-up||0
6693730|NCT02758613|7624149|FG002|NOT COMPLETED|Follow-up||0
6693731|NCT02758613|7624150|FG003|NOT COMPLETED|Follow-up||0
6693732|NCT02758899|7624165|FG000|STARTED|Overall Study||11
6693733|NCT02758899|7624166|FG001|STARTED|Overall Study||10
6693734|NCT02758899|7624165|FG000|COMPLETED|Overall Study||9
6693735|NCT02758899|7624166|FG001|COMPLETED|Overall Study||9
6693736|NCT02758899|7624165|FG000|NOT COMPLETED|Overall Study||2
6693737|NCT02758899|7624166|FG001|NOT COMPLETED|Overall Study||1
6693738|NCT02759016|7624174|FG000|STARTED|Overall Study||4
6693739|NCT02759016|7624175|FG001|STARTED|Overall Study||3
6693740|NCT02759016|7624174|FG000|Treated With BI 836826 and Ibrutinib|Overall Study||3
6693741|NCT02759016|7624175|FG001|Treated With BI 836826 and Ibrutinib|Overall Study||3
6693742|NCT02759016|7624174|FG000|COMPLETED|Overall Study||0
6693743|NCT02759016|7624175|FG001|COMPLETED|Overall Study||0
6693744|NCT02759016|7624174|FG000|NOT COMPLETED|Overall Study||4
6693745|NCT02759016|7624175|FG001|NOT COMPLETED|Overall Study||3
6693746|NCT02759055|7624184|FG000|STARTED|Overall Study||12702
6693747|NCT02759055|7624185|FG001|STARTED|Overall Study||8962
6693748|NCT02759055|7624184|FG000|COMPLETED|Overall Study||10775
6693749|NCT02759055|7624185|FG001|COMPLETED|Overall Study||7454
6693750|NCT02759055|7624184|FG000|NOT COMPLETED|Overall Study||1927
6693751|NCT02759055|7624185|FG001|NOT COMPLETED|Overall Study||1508
6693752|NCT02759120|7624193|FG000|STARTED|Overall Study||254
6258779|NCT03090737|7157875|FG000|COMPLETED|Overall Study||98
6693753|NCT02759120|7624194|FG001|STARTED|Overall Study||259
6693754|NCT02759120|7624193|FG000|COMPLETED|Overall Study||169
6693755|NCT02759120|7624194|FG001|COMPLETED|Overall Study||180
6693756|NCT02759120|7624193|FG000|NOT COMPLETED|Overall Study||85
6693757|NCT02759120|7624194|FG001|NOT COMPLETED|Overall Study||79
6693758|NCT02759146|7624206|FG000|STARTED|Week 1-4||57
6693759|NCT02759146|7624207|FG001|STARTED|Week 1-4||36
6693760|NCT02759146|7624208|FG002|STARTED|Week 1-4||33
6693761|NCT02759146|7624209|FG003|STARTED|Week 1-4|One control participant could continue without the other after baseline.|44
6693762|NCT02759146|7624210|FG004|STARTED|Week 1-4||49
6693763|NCT02759146|7624211|FG005|STARTED|Week 1-4||30
6693764|NCT02759146|7624212|FG006|STARTED|Week 1-4||27
6693765|NCT02759146|7624206|FG000|COMPLETED|Week 1-4||56
6693766|NCT02759146|7624207|FG001|COMPLETED|Week 1-4||34
6693767|NCT02759146|7624208|FG002|COMPLETED|Week 1-4||32
6693768|NCT02759146|7624209|FG003|COMPLETED|Week 1-4||44
6693769|NCT02759146|7624210|FG004|COMPLETED|Week 1-4||49
6693770|NCT02759146|7624211|FG005|COMPLETED|Week 1-4||29
6693771|NCT02759146|7624212|FG006|COMPLETED|Week 1-4||26
6693772|NCT02759146|7624206|FG000|NOT COMPLETED|Week 1-4||1
6693773|NCT02759146|7624207|FG001|NOT COMPLETED|Week 1-4||2
6693774|NCT02759146|7624208|FG002|NOT COMPLETED|Week 1-4||1
6693775|NCT02759146|7624209|FG003|NOT COMPLETED|Week 1-4||0
6693776|NCT02759146|7624210|FG004|NOT COMPLETED|Week 1-4||0
6693777|NCT02759146|7624211|FG005|NOT COMPLETED|Week 1-4||1
6693778|NCT02759146|7624212|FG006|NOT COMPLETED|Week 1-4||1
6693779|NCT02759146|7624206|FG000|STARTED|Week 5-8||56
6693780|NCT02759146|7624207|FG001|STARTED|Week 5-8||34
6693781|NCT02759146|7624208|FG002|STARTED|Week 5-8||32
6693782|NCT02759146|7624209|FG003|STARTED|Week 5-8||44
6693783|NCT02759146|7624210|FG004|STARTED|Week 5-8||49
6693784|NCT02759146|7624211|FG005|STARTED|Week 5-8||29
6693785|NCT02759146|7624212|FG006|STARTED|Week 5-8||26
6693786|NCT02759146|7624206|FG000|COMPLETED|Week 5-8||46
6693787|NCT02759146|7624207|FG001|COMPLETED|Week 5-8||29
6693788|NCT02759146|7624208|FG002|COMPLETED|Week 5-8||22
6693789|NCT02759146|7624209|FG003|COMPLETED|Week 5-8||37
6693790|NCT02759146|7624210|FG004|COMPLETED|Week 5-8||44
6693791|NCT02759146|7624211|FG005|COMPLETED|Week 5-8||23
6693792|NCT02759146|7624212|FG006|COMPLETED|Week 5-8||20
6693793|NCT02759146|7624206|FG000|NOT COMPLETED|Week 5-8||10
6693794|NCT02759146|7624207|FG001|NOT COMPLETED|Week 5-8||5
6693795|NCT02759146|7624208|FG002|NOT COMPLETED|Week 5-8||10
6693796|NCT02759146|7624209|FG003|NOT COMPLETED|Week 5-8||7
6693797|NCT02759146|7624210|FG004|NOT COMPLETED|Week 5-8||5
6693798|NCT02759146|7624211|FG005|NOT COMPLETED|Week 5-8||6
6693799|NCT02759146|7624212|FG006|NOT COMPLETED|Week 5-8||6
6693800|NCT02759315|7624233|FG000|STARTED|Overall Study||69
6693801|NCT02759315|7624234|FG001|STARTED|Overall Study||29
6693802|NCT02759315|7624235|FG002|STARTED|Overall Study||39
6693803|NCT02759315|7624236|FG003|STARTED|Overall Study||20
6693804|NCT02759315|7624237|FG004|STARTED|Overall Study||3
6693805|NCT02759315|7624233|FG000|COMPLETED|Overall Study||65
6693806|NCT02759315|7624234|FG001|COMPLETED|Overall Study||28
6693807|NCT02759315|7624235|FG002|COMPLETED|Overall Study||29
6693808|NCT02759315|7624236|FG003|COMPLETED|Overall Study||19
6693809|NCT02759315|7624237|FG004|COMPLETED|Overall Study||2
6693810|NCT02759315|7624233|FG000|NOT COMPLETED|Overall Study||4
6693811|NCT02759315|7624234|FG001|NOT COMPLETED|Overall Study||1
6693812|NCT02759315|7624235|FG002|NOT COMPLETED|Overall Study||10
6693813|NCT02759315|7624236|FG003|NOT COMPLETED|Overall Study||1
6693814|NCT02759315|7624237|FG004|NOT COMPLETED|Overall Study||1
6693815|NCT02759354|7624255|FG000|STARTED|Overall Study||192
6693816|NCT02759354|7624256|FG001|STARTED|Overall Study||190
6693817|NCT02759354|7624257|FG002|STARTED|Overall Study||181
6693818|NCT02759354|7624258|FG003|STARTED|Overall Study||191
6693819|NCT02759354|7624255|FG000|COMPLETED|Overall Study||192
6693820|NCT02759354|7624256|FG001|COMPLETED|Overall Study||190
6693821|NCT02759354|7624257|FG002|COMPLETED|Overall Study||181
6693822|NCT02759354|7624258|FG003|COMPLETED|Overall Study||191
6693823|NCT02759354|7624255|FG000|NOT COMPLETED|Overall Study||0
6693824|NCT02759354|7624256|FG001|NOT COMPLETED|Overall Study||0
6693825|NCT02759354|7624257|FG002|NOT COMPLETED|Overall Study||0
6693826|NCT02759354|7624258|FG003|NOT COMPLETED|Overall Study||0
6693827|NCT02759471|7624270|FG000|STARTED|Overall Study||54
6693828|NCT02759471|7624270|FG000|COMPLETED|Overall Study||52
6693829|NCT02759471|7624270|FG000|NOT COMPLETED|Overall Study||2
6693830|NCT02759562|7624278|FG000|STARTED|Double-Blind Treatment Period (8 Weeks)||3
6693831|NCT02759562|7624279|FG001|STARTED|Double-Blind Treatment Period (8 Weeks)||3
6693832|NCT02759562|7624278|FG000|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
6693833|NCT02759562|7624279|FG001|COMPLETED|Double-Blind Treatment Period (8 Weeks)||3
6693834|NCT02759562|7624278|FG000|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
6693835|NCT02759562|7624279|FG001|NOT COMPLETED|Double-Blind Treatment Period (8 Weeks)||0
6693836|NCT02759562|7624278|FG000|STARTED|Open-Label Treatment Period||2
6693837|NCT02759562|7624279|FG001|STARTED|Open-Label Treatment Period||2
6693838|NCT02759562|7624278|FG000|COMPLETED|Open-Label Treatment Period||0
6693839|NCT02759562|7624279|FG001|COMPLETED|Open-Label Treatment Period||0
6693840|NCT02759562|7624278|FG000|NOT COMPLETED|Open-Label Treatment Period||2
6693841|NCT02759562|7624279|FG001|NOT COMPLETED|Open-Label Treatment Period||2
6693842|NCT02759575|7624286|FG000|STARTED|Overall Study||9
6693843|NCT02759575|7624286|FG000|COMPLETED|Overall Study||9
6693844|NCT02759575|7624286|FG000|NOT COMPLETED|Overall Study||0
6693845|NCT02759692|7624290|FG000|STARTED|Period 1||141
6693846|NCT02759692|7624291|FG001|STARTED|Period 1||142
6693847|NCT02759692|7624290|FG000|COMPLETED|Period 1||138
6693848|NCT02759692|7624291|FG001|COMPLETED|Period 1||140
6693849|NCT02759692|7624290|FG000|NOT COMPLETED|Period 1||3
6693850|NCT02759692|7624291|FG001|NOT COMPLETED|Period 1||2
6693851|NCT02759692|7624290|FG000|STARTED|Period 2||138
6693852|NCT02759692|7624291|FG001|STARTED|Period 2||140
6693853|NCT02759692|7624290|FG000|COMPLETED|Period 2||137
6693854|NCT02759692|7624291|FG001|COMPLETED|Period 2||139
6693855|NCT02759692|7624290|FG000|NOT COMPLETED|Period 2||1
6693856|NCT02759692|7624291|FG001|NOT COMPLETED|Period 2||1
6693857|NCT02759692|7624290|FG000|STARTED|Period 3||137
6693858|NCT02759692|7624291|FG001|STARTED|Period 3||139
6693859|NCT02759692|7624290|FG000|COMPLETED|Period 3||137
6693860|NCT02759692|7624291|FG001|COMPLETED|Period 3||139
6693861|NCT02759692|7624290|FG000|NOT COMPLETED|Period 3||0
6693862|NCT02759692|7624291|FG001|NOT COMPLETED|Period 3||0
6693863|NCT02759939|7624301|FG000|STARTED|Overall Study||1256
6693864|NCT02759939|7624302|FG001|STARTED|Overall Study||1143
6693865|NCT02759939|7624303|FG002|STARTED|Overall Study||1393
6693866|NCT02759939|7624304|FG003|STARTED|Overall Study||1246
6693867|NCT02759939|7624301|FG000|Analyzed at T1|Overall Study||1245
6693868|NCT02759939|7624302|FG001|Analyzed at T1|Overall Study||1141
6258780|NCT03090737|7157875|FG000|NOT COMPLETED|Overall Study||31
6258781|NCT03088826|7157881|FG000|STARTED|Overall Study||40
6258782|NCT03088826|7157882|FG001|STARTED|Overall Study||40
6258783|NCT03088826|7157881|FG000|COMPLETED|Overall Study||40
6258784|NCT03088826|7157882|FG001|COMPLETED|Overall Study||40
6258785|NCT03088826|7157881|FG000|NOT COMPLETED|Overall Study||0
6258786|NCT03088826|7157882|FG001|NOT COMPLETED|Overall Study||0
6258787|NCT03043872|7157891|FG000|STARTED|Overall Study||329
6258788|NCT03043872|7157892|FG001|STARTED|Overall Study||328
6258789|NCT03043872|7157893|FG002|STARTED|Overall Study||330
6258790|NCT03043872|7157891|FG000|Randomized and Included in Global Cohort Analysis|Overall Study||268
6258791|NCT03043872|7157892|FG001|Randomized and Included in Global Cohort Analysis|Overall Study||268
6258792|NCT03043872|7157893|FG002|Randomized and Included in Global Cohort Analysis|Overall Study||269
6258793|NCT03043872|7157891|FG000|Received Treatment in Global Cohort|Overall Study||266
6258794|NCT03043872|7157892|FG001|Received Treatment in Global Cohort|Overall Study||265
6258795|NCT03043872|7157893|FG002|Received Treatment in Global Cohort|Overall Study||266
6258796|NCT03043872|7157891|FG000|Randomized and Included in China Cohort Analysis|Overall Study||65
6258797|NCT03043872|7157892|FG001|Randomized and Included in China Cohort Analysis|Overall Study||61
6258798|NCT03043872|7157893|FG002|Randomized and Included in China Cohort Analysis|Overall Study||62
6258799|NCT03043872|7157891|FG000|Received Treatment in China Cohort|Overall Study||65
6258800|NCT03043872|7157892|FG001|Received Treatment in China Cohort|Overall Study||61
6258801|NCT03043872|7157893|FG002|Received Treatment in China Cohort|Overall Study||62
6258802|NCT03043872|7157891|FG000|Included in Both Cohorts (Global + China)|Overall Study||4
6258803|NCT03043872|7157892|FG001|Included in Both Cohorts (Global + China)|Overall Study||1
6258804|NCT03043872|7157893|FG002|Included in Both Cohorts (Global + China)|Overall Study||1
6258805|NCT03043872|7157891|FG000|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
6258806|NCT03043872|7157892|FG001|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||56
6258807|NCT03043872|7157893|FG002|Ongoing Study at Global Cohort Final Analysis Data Cut-off (DCO)|Overall Study||31
6258808|NCT03043872|7157891|FG000|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||16
6258809|NCT03043872|7157892|FG001|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||11
6258810|NCT03043872|7157893|FG002|Ongoing Study at China Cohort Second (Final) Analysis DCO|Overall Study||7
6258811|NCT03043872|7157891|FG000|COMPLETED|Overall Study||51
6258812|NCT03043872|7157892|FG001|COMPLETED|Overall Study||52
6258813|NCT03043872|7157893|FG002|COMPLETED|Overall Study||18
6258814|NCT03043872|7157891|FG000|NOT COMPLETED|Overall Study||278
6258815|NCT03043872|7157892|FG001|NOT COMPLETED|Overall Study||276
6258816|NCT03043872|7157893|FG002|NOT COMPLETED|Overall Study||312
6258817|NCT03034018|7157913|FG000|STARTED|Overall Study||30
6258818|NCT03034018|7157914|FG001|STARTED|Overall Study||30
6258819|NCT03034018|7157913|FG000|Initiated Assigned Treatment|Overall Study||27
6258820|NCT03034018|7157914|FG001|Initiated Assigned Treatment|Overall Study||29
6258821|NCT03034018|7157913|FG000|COMPLETED|Overall Study||25
6258822|NCT03034018|7157914|FG001|COMPLETED|Overall Study||28
6258823|NCT03034018|7157913|FG000|NOT COMPLETED|Overall Study||5
6258824|NCT03034018|7157914|FG001|NOT COMPLETED|Overall Study||2
6258825|NCT02750215|7157920|FG000|STARTED|Overall Study||20
6258826|NCT02750215|7157920|FG000|COMPLETED|Overall Study||20
6258827|NCT02750215|7157920|FG000|NOT COMPLETED|Overall Study||0
6258828|NCT02673333|7157924|FG000|STARTED|Overall Study||39
6258829|NCT02673333|7157924|FG000|COMPLETED|Overall Study||39
6258830|NCT02673333|7157924|FG000|NOT COMPLETED|Overall Study||0
6258831|NCT01984346|7157930|FG000|STARTED|Overall Study|Date of full approval was 8/22/13. Date of first treated patient was 01/08/14|115
6258832|NCT01984346|7157931|FG001|STARTED|Overall Study||55
6258833|NCT01984346|7157930|FG000|Treated|Overall Study||102
6258834|NCT01984346|7157931|FG001|Treated|Overall Study||51
6258835|NCT01984346|7157930|FG000|COMPLETED|Overall Study||98
6258836|NCT01984346|7157931|FG001|COMPLETED|Overall Study||50
6258837|NCT01984346|7157930|FG000|NOT COMPLETED|Overall Study||17
6602436|NCT02057081|7527443|FG000|NOT COMPLETED|Overall Study||90
6602437|NCT02057081|7527444|FG001|NOT COMPLETED|Overall Study||68
6602438|NCT02057198|7527453|FG000|STARTED|Overall Study||11
6602439|NCT02057198|7527454|FG001|STARTED|Overall Study||11
6602440|NCT02057198|7527455|FG002|STARTED|Overall Study||11
6602441|NCT02057198|7527453|FG000|COMPLETED|Overall Study||11
6602442|NCT02057198|7527454|FG001|COMPLETED|Overall Study||10
6602443|NCT02057198|7527455|FG002|COMPLETED|Overall Study||10
6602444|NCT02057198|7527453|FG000|NOT COMPLETED|Overall Study||0
6602445|NCT02057198|7527454|FG001|NOT COMPLETED|Overall Study||1
6602446|NCT02057198|7527455|FG002|NOT COMPLETED|Overall Study||1
6602447|NCT02057250|7527467|FG000|STARTED|AID Assessment Phase||56
6602448|NCT02057250|7527468|FG001|STARTED|AID Assessment Phase||53
6602449|NCT02057250|7527469|FG002|STARTED|AID Assessment Phase||52
6602450|NCT02057250|7527470|FG003|STARTED|AID Assessment Phase||56
6602451|NCT02057250|7527471|FG004|STARTED|AID Assessment Phase||0
6602452|NCT02057250|7527467|FG000|COMPLETED|AID Assessment Phase||52
6602453|NCT02057250|7527468|FG001|COMPLETED|AID Assessment Phase||50
6602454|NCT02057250|7527469|FG002|COMPLETED|AID Assessment Phase||45
6602455|NCT02057250|7527470|FG003|COMPLETED|AID Assessment Phase||54
6693869|NCT02759939|7624303|FG002|Analyzed at T1|Overall Study||1388
6693870|NCT02759939|7624304|FG003|Analyzed at T1|Overall Study||1244
6693871|NCT02759939|7624301|FG000|Eligible for T2 and T3|Overall Study||935
6693872|NCT02759939|7624302|FG001|Eligible for T2 and T3|Overall Study||962
6693873|NCT02759939|7624303|FG002|Eligible for T2 and T3|Overall Study||1022
6693874|NCT02759939|7624304|FG003|Eligible for T2 and T3|Overall Study||853
6693875|NCT02759939|7624301|FG000|Analyzed at T2 and/or T3|Overall Study||303
6693876|NCT02759939|7624302|FG001|Analyzed at T2 and/or T3|Overall Study||278
6693877|NCT02759939|7624303|FG002|Analyzed at T2 and/or T3|Overall Study||373
6693878|NCT02759939|7624304|FG003|Analyzed at T2 and/or T3|Overall Study||304
6693879|NCT02759939|7624301|FG000|Consented to T2 and T3|Overall Study||579
6693880|NCT02759939|7624302|FG001|Consented to T2 and T3|Overall Study||626
6693881|NCT02759939|7624303|FG002|Consented to T2 and T3|Overall Study||702
6693882|NCT02759939|7624304|FG003|Consented to T2 and T3|Overall Study||564
6693883|NCT02759939|7624301|FG000|COMPLETED|Overall Study||200
6693884|NCT02759939|7624302|FG001|COMPLETED|Overall Study||171
6693885|NCT02759939|7624303|FG002|COMPLETED|Overall Study||239
6693886|NCT02759939|7624304|FG003|COMPLETED|Overall Study||203
6693887|NCT02759939|7624301|FG000|NOT COMPLETED|Overall Study||1056
6693888|NCT02759939|7624302|FG001|NOT COMPLETED|Overall Study||972
6693889|NCT02759939|7624303|FG002|NOT COMPLETED|Overall Study||1154
6693890|NCT02759939|7624304|FG003|NOT COMPLETED|Overall Study||1043
6693891|NCT02760056|7624316|FG000|STARTED|Overall Study||10
6693892|NCT02760056|7624317|FG001|STARTED|Overall Study||5
6693893|NCT02760056|7624316|FG000|COMPLETED|Overall Study||10
6693894|NCT02760056|7624317|FG001|COMPLETED|Overall Study||5
6693895|NCT02760056|7624316|FG000|NOT COMPLETED|Overall Study||0
6693896|NCT02760056|7624317|FG001|NOT COMPLETED|Overall Study||0
6693897|NCT02760069|7624327|FG000|STARTED|Overall Study||40
6693898|NCT02760069|7624328|FG001|STARTED|Overall Study||41
6693899|NCT02760069|7624329|FG002|STARTED|Overall Study||41
6693900|NCT02760069|7624327|FG000|COMPLETED|Overall Study||40
6693901|NCT02760069|7624328|FG001|COMPLETED|Overall Study||40
6693902|NCT02760069|7624329|FG002|COMPLETED|Overall Study||40
6693903|NCT02760069|7624327|FG000|NOT COMPLETED|Overall Study||0
6693904|NCT02760069|7624328|FG001|NOT COMPLETED|Overall Study||1
6693905|NCT02760069|7624329|FG002|NOT COMPLETED|Overall Study||1
6693906|NCT02760264|7624341|FG000|STARTED|0.25 mg/kg/Day||12
6693907|NCT02760264|7624342|FG001|STARTED|0.25 mg/kg/Day||0
6693908|NCT02760264|7624343|FG002|STARTED|0.25 mg/kg/Day||0
6693909|NCT02760264|7624344|FG003|STARTED|0.25 mg/kg/Day||0
6693910|NCT02760264|7624341|FG000|COMPLETED|0.25 mg/kg/Day||12
6693911|NCT02760264|7624342|FG001|COMPLETED|0.25 mg/kg/Day||0
6693912|NCT02760264|7624343|FG002|COMPLETED|0.25 mg/kg/Day||0
6693913|NCT02760264|7624344|FG003|COMPLETED|0.25 mg/kg/Day||0
6693914|NCT02760264|7624341|FG000|NOT COMPLETED|0.25 mg/kg/Day||0
6693915|NCT02760264|7624342|FG001|NOT COMPLETED|0.25 mg/kg/Day||0
6693916|NCT02760264|7624343|FG002|NOT COMPLETED|0.25 mg/kg/Day||0
6693917|NCT02760264|7624344|FG003|NOT COMPLETED|0.25 mg/kg/Day||0
6693918|NCT02760264|7624341|FG000|STARTED|0.75 mg/kg/Day||0
6693919|NCT02760264|7624342|FG001|STARTED|0.75 mg/kg/Day||12
6693920|NCT02760264|7624343|FG002|STARTED|0.75 mg/kg/Day||0
6693921|NCT02760264|7624344|FG003|STARTED|0.75 mg/kg/Day||0
6693922|NCT02760264|7624341|FG000|COMPLETED|0.75 mg/kg/Day||0
6693923|NCT02760264|7624342|FG001|COMPLETED|0.75 mg/kg/Day||12
6693924|NCT02760264|7624343|FG002|COMPLETED|0.75 mg/kg/Day||0
6693925|NCT02760264|7624344|FG003|COMPLETED|0.75 mg/kg/Day||0
6693926|NCT02760264|7624341|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
6693927|NCT02760264|7624342|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
6693928|NCT02760264|7624343|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
6693929|NCT02760264|7624344|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
6693930|NCT02760264|7624341|FG000|STARTED|2.0 mg/kg/Day||0
6693931|NCT02760264|7624342|FG001|STARTED|2.0 mg/kg/Day||0
6693932|NCT02760264|7624343|FG002|STARTED|2.0 mg/kg/Day||12
6693933|NCT02760264|7624344|FG003|STARTED|2.0 mg/kg/Day||0
6693934|NCT02760264|7624341|FG000|COMPLETED|2.0 mg/kg/Day||0
6693935|NCT02760264|7624342|FG001|COMPLETED|2.0 mg/kg/Day||0
6693936|NCT02760264|7624343|FG002|COMPLETED|2.0 mg/kg/Day||12
6693937|NCT02760264|7624344|FG003|COMPLETED|2.0 mg/kg/Day||0
6693938|NCT02760264|7624341|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
6693939|NCT02760264|7624342|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
6693940|NCT02760264|7624343|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
6693941|NCT02760264|7624344|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
6693942|NCT02760264|7624341|FG000|STARTED|6.0 mg/kg/Day||0
6693943|NCT02760264|7624342|FG001|STARTED|6.0 mg/kg/Day||0
6693944|NCT02760264|7624343|FG002|STARTED|6.0 mg/kg/Day||0
6693945|NCT02760264|7624344|FG003|STARTED|6.0 mg/kg/Day||12
6693946|NCT02760264|7624341|FG000|COMPLETED|6.0 mg/kg/Day||0
6693947|NCT02760264|7624342|FG001|COMPLETED|6.0 mg/kg/Day||0
6693948|NCT02760264|7624343|FG002|COMPLETED|6.0 mg/kg/Day||0
6693949|NCT02760264|7624344|FG003|COMPLETED|6.0 mg/kg/Day||12
6693950|NCT02760264|7624341|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
6693951|NCT02760264|7624342|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
6693952|NCT02760264|7624343|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
6693953|NCT02760264|7624344|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
6693954|NCT02760277|7624359|FG000|STARTED|Vamorolone 0.25 mg/kg/Day||12
6693955|NCT02760277|7624360|FG001|STARTED|Vamorolone 0.25 mg/kg/Day||0
6693956|NCT02760277|7624361|FG002|STARTED|Vamorolone 0.25 mg/kg/Day||0
6693957|NCT02760277|7624362|FG003|STARTED|Vamorolone 0.25 mg/kg/Day||0
6693958|NCT02760277|7624359|FG000|COMPLETED|Vamorolone 0.25 mg/kg/Day||12
6693959|NCT02760277|7624360|FG001|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6693960|NCT02760277|7624361|FG002|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6693961|NCT02760277|7624362|FG003|COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6693962|NCT02760277|7624359|FG000|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6693963|NCT02760277|7624360|FG001|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6693964|NCT02760277|7624361|FG002|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6693965|NCT02760277|7624362|FG003|NOT COMPLETED|Vamorolone 0.25 mg/kg/Day||0
6693966|NCT02760277|7624359|FG000|STARTED|0.75 mg/kg/Day||0
6693967|NCT02760277|7624360|FG001|STARTED|0.75 mg/kg/Day||12
6693968|NCT02760277|7624361|FG002|STARTED|0.75 mg/kg/Day||0
6693969|NCT02760277|7624362|FG003|STARTED|0.75 mg/kg/Day||0
6693970|NCT02760277|7624359|FG000|COMPLETED|0.75 mg/kg/Day||0
6693971|NCT02760277|7624360|FG001|COMPLETED|0.75 mg/kg/Day||12
6693972|NCT02760277|7624361|FG002|COMPLETED|0.75 mg/kg/Day||0
6693973|NCT02760277|7624362|FG003|COMPLETED|0.75 mg/kg/Day||0
6693974|NCT02760277|7624359|FG000|NOT COMPLETED|0.75 mg/kg/Day||0
6693975|NCT02760277|7624360|FG001|NOT COMPLETED|0.75 mg/kg/Day||0
6693976|NCT02760277|7624361|FG002|NOT COMPLETED|0.75 mg/kg/Day||0
6693977|NCT02760277|7624362|FG003|NOT COMPLETED|0.75 mg/kg/Day||0
6693978|NCT02760277|7624359|FG000|STARTED|2.0 mg/kg/Day||0
6693979|NCT02760277|7624360|FG001|STARTED|2.0 mg/kg/Day||0
6693980|NCT02760277|7624361|FG002|STARTED|2.0 mg/kg/Day||12
6693981|NCT02760277|7624362|FG003|STARTED|2.0 mg/kg/Day||0
6693982|NCT02760277|7624359|FG000|COMPLETED|2.0 mg/kg/Day||0
6693983|NCT02760277|7624360|FG001|COMPLETED|2.0 mg/kg/Day||0
6693984|NCT02760277|7624361|FG002|COMPLETED|2.0 mg/kg/Day||12
6693985|NCT02760277|7624362|FG003|COMPLETED|2.0 mg/kg/Day||0
6693986|NCT02760277|7624359|FG000|NOT COMPLETED|2.0 mg/kg/Day||0
6693987|NCT02760277|7624360|FG001|NOT COMPLETED|2.0 mg/kg/Day||0
6693988|NCT02760277|7624361|FG002|NOT COMPLETED|2.0 mg/kg/Day||0
6693989|NCT02760277|7624362|FG003|NOT COMPLETED|2.0 mg/kg/Day||0
6693990|NCT02760277|7624359|FG000|STARTED|6.0 mg/kg/Day||0
6693991|NCT02760277|7624360|FG001|STARTED|6.0 mg/kg/Day||0
6693992|NCT02760277|7624361|FG002|STARTED|6.0 mg/kg/Day||0
6693993|NCT02760277|7624362|FG003|STARTED|6.0 mg/kg/Day||12
6693994|NCT02760277|7624359|FG000|COMPLETED|6.0 mg/kg/Day||0
6693995|NCT02760277|7624360|FG001|COMPLETED|6.0 mg/kg/Day||0
6693996|NCT02760277|7624361|FG002|COMPLETED|6.0 mg/kg/Day||0
6693997|NCT02760277|7624362|FG003|COMPLETED|6.0 mg/kg/Day||12
6693998|NCT02760277|7624359|FG000|NOT COMPLETED|6.0 mg/kg/Day||0
6693999|NCT02760277|7624360|FG001|NOT COMPLETED|6.0 mg/kg/Day||0
6694000|NCT02760277|7624361|FG002|NOT COMPLETED|6.0 mg/kg/Day||0
6694001|NCT02760277|7624362|FG003|NOT COMPLETED|6.0 mg/kg/Day||0
6694002|NCT02760368|7624375|FG000|STARTED|Overall Study||143
6694003|NCT02760368|7624376|FG001|STARTED|Overall Study||142
6694004|NCT02760368|7624377|FG002|STARTED|Overall Study||143
6694005|NCT02760368|7624375|FG000|COMPLETED|Overall Study||130
6694006|NCT02760368|7624376|FG001|COMPLETED|Overall Study||134
6694007|NCT02760368|7624377|FG002|COMPLETED|Overall Study||132
6694008|NCT02760368|7624375|FG000|NOT COMPLETED|Overall Study||13
6694009|NCT02760368|7624376|FG001|NOT COMPLETED|Overall Study||8
6694010|NCT02760368|7624377|FG002|NOT COMPLETED|Overall Study||11
6694011|NCT02760407|7624389|FG000|STARTED|Overall Study||479
6694012|NCT02760407|7624390|FG001|STARTED|Overall Study||464
6694013|NCT02760407|7624391|FG002|STARTED|Overall Study||462
6694014|NCT02760407|7624392|FG003|STARTED|Overall Study||243
6694015|NCT02760407|7624389|FG000|COMPLETED|Overall Study||443
6694016|NCT02760407|7624390|FG001|COMPLETED|Overall Study||421
6694017|NCT02760407|7624391|FG002|COMPLETED|Overall Study||412
6694018|NCT02760407|7624392|FG003|COMPLETED|Overall Study||207
6694019|NCT02760407|7624389|FG000|NOT COMPLETED|Overall Study||36
6694020|NCT02760407|7624390|FG001|NOT COMPLETED|Overall Study||43
6694021|NCT02760407|7624391|FG002|NOT COMPLETED|Overall Study||50
6694022|NCT02760407|7624392|FG003|NOT COMPLETED|Overall Study||36
6694023|NCT02760433|7624408|FG000|STARTED|Overall Study||161
6694024|NCT02760433|7624409|FG001|STARTED|Overall Study||138
6694025|NCT02760433|7624410|FG002|STARTED|Overall Study||26
6694026|NCT02760433|7624411|FG003|STARTED|Overall Study||32
6694027|NCT02760433|7624412|FG004|STARTED|Overall Study||11
6694028|NCT02760433|7624408|FG000|COMPLETED|Overall Study||134
6694029|NCT02760433|7624409|FG001|COMPLETED|Overall Study||128
6694030|NCT02760433|7624410|FG002|COMPLETED|Overall Study||25
6694031|NCT02760433|7624411|FG003|COMPLETED|Overall Study||30
6694032|NCT02760433|7624412|FG004|COMPLETED|Overall Study||1
6694033|NCT02760433|7624408|FG000|NOT COMPLETED|Overall Study||27
6694034|NCT02760433|7624409|FG001|NOT COMPLETED|Overall Study||10
6694035|NCT02760433|7624410|FG002|NOT COMPLETED|Overall Study||1
6694036|NCT02760433|7624411|FG003|NOT COMPLETED|Overall Study||2
6694037|NCT02760433|7624412|FG004|NOT COMPLETED|Overall Study||10
6694038|NCT02760654|7624431|FG000|STARTED|Overall Study||30
6694039|NCT02760654|7624432|FG001|STARTED|Overall Study||30
6694040|NCT02760654|7624431|FG000|COMPLETED|Overall Study||23
6694041|NCT02760654|7624432|FG001|COMPLETED|Overall Study||24
6694042|NCT02760654|7624431|FG000|NOT COMPLETED|Overall Study||7
6694043|NCT02760654|7624432|FG001|NOT COMPLETED|Overall Study||6
6694044|NCT02760810|7624438|FG000|STARTED|Overall Study||30
6694045|NCT02760810|7624438|FG000|COMPLETED|Overall Study||29
6694046|NCT02760810|7624438|FG000|NOT COMPLETED|Overall Study||1
6694047|NCT02760862|7624444|FG000|STARTED|Overall Study||25
6694048|NCT02760862|7624445|FG001|STARTED|Overall Study||25
6694049|NCT02760862|7624444|FG000|COMPLETED|Overall Study||25
6694050|NCT02760862|7624445|FG001|COMPLETED|Overall Study||25
6694051|NCT02760862|7624444|FG000|NOT COMPLETED|Overall Study||0
6694052|NCT02760862|7624445|FG001|NOT COMPLETED|Overall Study||0
6694053|NCT02760927|7624451|FG000|STARTED|Overall Study||4
6694054|NCT02760927|7624451|FG000|COMPLETED|Overall Study||3
6694055|NCT02760927|7624451|FG000|NOT COMPLETED|Overall Study||1
6694056|NCT02761252|7624458|FG000|STARTED|Overall Study||143
6694057|NCT02761252|7624459|FG001|STARTED|Overall Study||140
6694058|NCT02761252|7624460|FG002|STARTED|Overall Study||137
6694059|NCT02761252|7624458|FG000|COMPLETED|Overall Study||133
6694060|NCT02761252|7624459|FG001|COMPLETED|Overall Study||132
6694061|NCT02761252|7624460|FG002|COMPLETED|Overall Study||123
6694062|NCT02761252|7624458|FG000|NOT COMPLETED|Overall Study||10
6694063|NCT02761252|7624459|FG001|NOT COMPLETED|Overall Study||8
6694064|NCT02761252|7624460|FG002|NOT COMPLETED|Overall Study||14
6694065|NCT02761330|7624470|FG000|STARTED|Treatment Week 1||2
6694066|NCT02761330|7624471|FG001|STARTED|Treatment Week 1||3
6694067|NCT02761330|7624472|FG002|STARTED|Treatment Week 1||2
6694068|NCT02761330|7624473|FG003|STARTED|Treatment Week 1||3
6694069|NCT02761330|7624474|FG004|STARTED|Treatment Week 1||1
6694070|NCT02761330|7624475|FG005|STARTED|Treatment Week 1||3
6694071|NCT02761330|7624470|FG000|COMPLETED|Treatment Week 1||2
6694072|NCT02761330|7624471|FG001|COMPLETED|Treatment Week 1||3
6694073|NCT02761330|7624472|FG002|COMPLETED|Treatment Week 1||2
6694074|NCT02761330|7624473|FG003|COMPLETED|Treatment Week 1||2
6694075|NCT02761330|7624474|FG004|COMPLETED|Treatment Week 1||1
6694076|NCT02761330|7624475|FG005|COMPLETED|Treatment Week 1||2
6694077|NCT02761330|7624470|FG000|NOT COMPLETED|Treatment Week 1||0
6694078|NCT02761330|7624471|FG001|NOT COMPLETED|Treatment Week 1||0
6694079|NCT02761330|7624472|FG002|NOT COMPLETED|Treatment Week 1||0
6694080|NCT02761330|7624473|FG003|NOT COMPLETED|Treatment Week 1||1
6694081|NCT02761330|7624474|FG004|NOT COMPLETED|Treatment Week 1||0
6694082|NCT02761330|7624475|FG005|NOT COMPLETED|Treatment Week 1||1
6694083|NCT02761330|7624470|FG000|STARTED|Treatment Week 2||2
6694084|NCT02761330|7624471|FG001|STARTED|Treatment Week 2||3
6694085|NCT02761330|7624472|FG002|STARTED|Treatment Week 2||2
6694086|NCT02761330|7624473|FG003|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to withdraw.|1
6694087|NCT02761330|7624474|FG004|STARTED|Treatment Week 2||1
6694088|NCT02761330|7624475|FG005|STARTED|Treatment Week 2|1 pt. in this group completed Week 1, but did not begin Week 2 due to cancellation of treatment.|1
6694089|NCT02761330|7624470|FG000|COMPLETED|Treatment Week 2||2
6694090|NCT02761330|7624471|FG001|COMPLETED|Treatment Week 2||3
6694091|NCT02761330|7624472|FG002|COMPLETED|Treatment Week 2||2
6694092|NCT02761330|7624473|FG003|COMPLETED|Treatment Week 2||1
6694093|NCT02761330|7624474|FG004|COMPLETED|Treatment Week 2||1
6694094|NCT02761330|7624475|FG005|COMPLETED|Treatment Week 2||1
6694095|NCT02761330|7624470|FG000|NOT COMPLETED|Treatment Week 2||0
6694096|NCT02761330|7624471|FG001|NOT COMPLETED|Treatment Week 2||0
6694097|NCT02761330|7624472|FG002|NOT COMPLETED|Treatment Week 2||0
6694098|NCT02761330|7624473|FG003|NOT COMPLETED|Treatment Week 2||0
6694099|NCT02761330|7624474|FG004|NOT COMPLETED|Treatment Week 2||0
6694100|NCT02761330|7624475|FG005|NOT COMPLETED|Treatment Week 2||0
6694101|NCT02761629|7624491|FG000|STARTED|Overall Study||90
6694102|NCT02761629|7624492|FG001|STARTED|Overall Study||90
6694103|NCT02761629|7624491|FG000|Treated|Overall Study||82
6694104|NCT02761629|7624492|FG001|Treated|Overall Study||86
6694105|NCT02761629|7624491|FG000|COMPLETED|Overall Study||63
6694106|NCT02761629|7624492|FG001|COMPLETED|Overall Study||58
6694107|NCT02761629|7624491|FG000|NOT COMPLETED|Overall Study||27
6694108|NCT02761629|7624492|FG001|NOT COMPLETED|Overall Study||32
6694109|NCT02761642|7624498|FG000|STARTED|Overall Study||200
6694110|NCT02761642|7624498|FG000|Treated|Overall Study||197
6694111|NCT02761642|7624498|FG000|COMPLETED|Overall Study||130
6694112|NCT02761642|7624498|FG000|NOT COMPLETED|Overall Study||70
6694113|NCT02761733|7624506|FG000|STARTED|Overall Study||60
6694114|NCT02761733|7624507|FG001|STARTED|Overall Study||60
6694115|NCT02761733|7624508|FG002|STARTED|Overall Study||60
6694116|NCT02761733|7624509|FG003|STARTED|Overall Study||60
6694117|NCT02761733|7624506|FG000|9/30/2014|Overall Study||53
6694118|NCT02761733|7624507|FG001|9/30/2014|Overall Study||56
6694119|NCT02761733|7624508|FG002|9/30/2014|Overall Study||48
6694120|NCT02761733|7624509|FG003|9/30/2014|Overall Study||55
6694121|NCT02761733|7624506|FG000|3/31/2015|Overall Study||48
6694122|NCT02761733|7624507|FG001|3/31/2015|Overall Study||47
6694123|NCT02761733|7624508|FG002|3/31/2015|Overall Study||43
6694124|NCT02761733|7624509|FG003|3/31/2015|Overall Study||50
6694125|NCT02761733|7624506|FG000|9/30/2015|Overall Study||40
6694126|NCT02761733|7624507|FG001|9/30/2015|Overall Study||44
6694127|NCT02761733|7624508|FG002|9/30/2015|Overall Study||33
6694128|NCT02761733|7624509|FG003|9/30/2015|Overall Study||50
6694129|NCT02761733|7624506|FG000|COMPLETED|Overall Study||30
6694130|NCT02761733|7624507|FG001|COMPLETED|Overall Study||39
6694131|NCT02761733|7624508|FG002|COMPLETED|Overall Study||33
6694132|NCT02761733|7624509|FG003|COMPLETED|Overall Study||45
6694133|NCT02761733|7624506|FG000|NOT COMPLETED|Overall Study||30
6694134|NCT02761733|7624507|FG001|NOT COMPLETED|Overall Study||21
6694135|NCT02761733|7624508|FG002|NOT COMPLETED|Overall Study||27
6694136|NCT02761733|7624509|FG003|NOT COMPLETED|Overall Study||15
6694137|NCT02761915|7624525|FG000|STARTED|Overall Study||4
6694138|NCT02761915|7624526|FG001|STARTED|Overall Study||1
6694139|NCT02761915|7624527|FG002|STARTED|Overall Study||1
6694140|NCT02761915|7624528|FG003|STARTED|Overall Study||3
6694141|NCT02761915|7624529|FG004|STARTED|Overall Study||3
6694142|NCT02761915|7624530|FG005|STARTED|Overall Study||5
6694143|NCT02761915|7624525|FG000|Underwent Leukapheresis|Overall Study||4
6694144|NCT02761915|7624526|FG001|Underwent Leukapheresis|Overall Study||1
6694145|NCT02761915|7624527|FG002|Underwent Leukapheresis|Overall Study||1
6694146|NCT02761915|7624528|FG003|Underwent Leukapheresis|Overall Study||3
6694147|NCT02761915|7624529|FG004|Underwent Leukapheresis|Overall Study||3
6694148|NCT02761915|7624530|FG005|Underwent Leukapheresis|Overall Study||5
6694149|NCT02761915|7624525|FG000|Received Investigational Medicinal Product|Overall Study||4
6694150|NCT02761915|7624526|FG001|Received Investigational Medicinal Product|Overall Study||1
6694151|NCT02761915|7624527|FG002|Received Investigational Medicinal Product|Overall Study||1
6694152|NCT02761915|7624528|FG003|Received Investigational Medicinal Product|Overall Study||3
6694153|NCT02761915|7624529|FG004|Received Investigational Medicinal Product|Overall Study||3
6694154|NCT02761915|7624530|FG005|Received Investigational Medicinal Product|Overall Study||0
6694155|NCT02761915|7624525|FG000|COMPLETED|Overall Study||0
6694156|NCT02761915|7624526|FG001|COMPLETED|Overall Study||0
6694157|NCT02761915|7624527|FG002|COMPLETED|Overall Study||0
6694158|NCT02761915|7624528|FG003|COMPLETED|Overall Study||0
6694159|NCT02761915|7624529|FG004|COMPLETED|Overall Study||0
6694160|NCT02761915|7624530|FG005|COMPLETED|Overall Study||0
6694161|NCT02761915|7624525|FG000|NOT COMPLETED|Overall Study||4
6694162|NCT02761915|7624526|FG001|NOT COMPLETED|Overall Study||1
6694163|NCT02761915|7624527|FG002|NOT COMPLETED|Overall Study||1
6694164|NCT02761915|7624528|FG003|NOT COMPLETED|Overall Study||3
6694165|NCT02761915|7624529|FG004|NOT COMPLETED|Overall Study||3
6694166|NCT02761915|7624530|FG005|NOT COMPLETED|Overall Study||5
6694167|NCT02761967|7624550|FG000|STARTED|Overall Study||70
6694168|NCT02761967|7624551|FG001|STARTED|Overall Study||70
6694169|NCT02761967|7624550|FG000|COMPLETED|Overall Study||65
6694170|NCT02761967|7624551|FG001|COMPLETED|Overall Study||64
6694171|NCT02761967|7624550|FG000|NOT COMPLETED|Overall Study||5
6694172|NCT02761967|7624551|FG001|NOT COMPLETED|Overall Study||6
6694173|NCT02761980|7624564|FG000|STARTED|Overall Study||29
6694174|NCT02761980|7624565|FG001|STARTED|Overall Study||87
6694175|NCT02761980|7624566|FG002|STARTED|Overall Study||87
6694176|NCT02761980|7624567|FG003|STARTED|Overall Study||87
6694177|NCT02761980|7624564|FG000|COMPLETED|Overall Study||25
6694178|NCT02761980|7624565|FG001|COMPLETED|Overall Study||80
6694179|NCT02761980|7624566|FG002|COMPLETED|Overall Study||81
6694180|NCT02761980|7624567|FG003|COMPLETED|Overall Study||81
6694181|NCT02761980|7624564|FG000|NOT COMPLETED|Overall Study||4
6694182|NCT02761980|7624565|FG001|NOT COMPLETED|Overall Study||7
6694183|NCT02761980|7624566|FG002|NOT COMPLETED|Overall Study||6
6694184|NCT02761980|7624567|FG003|NOT COMPLETED|Overall Study||6
6694185|NCT02761993|7624580|FG000|STARTED|Overall Study||52
6694186|NCT02761993|7624581|FG001|STARTED|Overall Study||49
6694187|NCT02761993|7624582|FG002|STARTED|Overall Study||50
6694188|NCT02761993|7624580|FG000|COMPLETED|Overall Study||50
6258838|NCT01984346|7157931|FG001|NOT COMPLETED|Overall Study||5
6258839|NCT01828112|7157939|FG000|STARTED|Overall Study||115
6258840|NCT01828112|7157940|FG001|STARTED|Overall Study||116
6258841|NCT01828112|7157939|FG000|Entered Extension Treatment Phase|Overall Study||0
6258842|NCT01828112|7157940|FG001|Entered Extension Treatment Phase|Overall Study||74
6258843|NCT01828112|7157939|FG000|Entered Post-treatment Follow-up Phase|Overall Study||7
6258844|NCT01828112|7157940|FG001|Entered Post-treatment Follow-up Phase|Overall Study||5
6258845|NCT01828112|7157939|FG000|Entered Survival Follow-up Phase|Overall Study||61
6258846|NCT01828112|7157940|FG001|Entered Survival Follow-up Phase|Overall Study||19
6258847|NCT01828112|7157939|FG000|Discontinued From Study|Overall Study||14
6258848|NCT01828112|7157940|FG001|Discontinued From Study|Overall Study||10
6258849|NCT01828112|7157939|FG000|Untreated Patients|Overall Study||0
6258850|NCT01828112|7157940|FG001|Untreated Patients|Overall Study|untreated = did not receive study drug|3
6258851|NCT01828112|7157939|FG000|Untreated|Overall Study||0
6258852|NCT01828112|7157940|FG001|Untreated|Overall Study||3
6258853|NCT01828112|7157939|FG000|Treated|Overall Study||115
6258854|NCT01828112|7157940|FG001|Treated|Overall Study||113
6258855|NCT01828112|7157939|FG000|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
6258856|NCT01828112|7157940|FG001|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
6258857|NCT01828112|7157939|FG000|NOT COMPLETED|Overall Study||82
6258858|NCT01828112|7157940|FG001|NOT COMPLETED|Overall Study||108
6258859|NCT01750281|7157949|FG000|STARTED|Overall Study||43
6258860|NCT01750281|7157950|FG001|STARTED|Overall Study||85
6258861|NCT01750281|7157951|FG002|STARTED|Overall Study||84
6258862|NCT01750281|7157949|FG000|Received Treatment|Overall Study||43
6694189|NCT02761993|7624581|FG001|COMPLETED|Overall Study||43
6694190|NCT02761993|7624582|FG002|COMPLETED|Overall Study||46
6694191|NCT02761993|7624580|FG000|NOT COMPLETED|Overall Study||2
6694192|NCT02761993|7624581|FG001|NOT COMPLETED|Overall Study||6
6694193|NCT02761993|7624582|FG002|NOT COMPLETED|Overall Study||4
6694194|NCT02762071|7624592|FG000|STARTED|Overall Study||54
6694195|NCT02762071|7624593|FG001|STARTED|Overall Study||54
6694196|NCT02762071|7624592|FG000|COMPLETED|Overall Study||54
6694197|NCT02762071|7624593|FG001|COMPLETED|Overall Study||54
6694198|NCT02762071|7624592|FG000|NOT COMPLETED|Overall Study||0
6694199|NCT02762071|7624593|FG001|NOT COMPLETED|Overall Study||0
6694200|NCT02762084|7624603|FG000|STARTED|Overall Study||6
6694201|NCT02762084|7624604|FG001|STARTED|Overall Study||6
6694202|NCT02762084|7624605|FG002|STARTED|Overall Study||5
6694203|NCT02762084|7624603|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6694204|NCT02762084|7624604|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6694205|NCT02762084|7624605|FG002|Received at Least 1 Dose of Study Drug|Overall Study||5
6694206|NCT02762084|7624603|FG000|By Tumor Per Protocol Population (PP)|Overall Study||6
6694207|NCT02762084|7624604|FG001|By Tumor Per Protocol Population (PP)|Overall Study||6
6694208|NCT02762084|7624605|FG002|By Tumor Per Protocol Population (PP)|Overall Study||4
6694209|NCT02762084|7624603|FG000|COMPLETED|Overall Study||5
6694210|NCT02762084|7624604|FG001|COMPLETED|Overall Study||6
6694211|NCT02762084|7624605|FG002|COMPLETED|Overall Study||4
6694212|NCT02762084|7624603|FG000|NOT COMPLETED|Overall Study||1
6694213|NCT02762084|7624604|FG001|NOT COMPLETED|Overall Study||0
6694214|NCT02762084|7624605|FG002|NOT COMPLETED|Overall Study||1
6694215|NCT02762331|7624617|FG000|STARTED|Overall Study||4
6694216|NCT02762331|7624618|FG001|STARTED|Overall Study||2
6694217|NCT02762331|7624617|FG000|COMPLETED|Overall Study||4
6694218|NCT02762331|7624618|FG001|COMPLETED|Overall Study||2
6694219|NCT02762331|7624617|FG000|NOT COMPLETED|Overall Study||0
6694220|NCT02762331|7624618|FG001|NOT COMPLETED|Overall Study||0
6694221|NCT02762370|7624626|FG000|STARTED|Overall Study||18
6694222|NCT02762370|7624627|FG001|STARTED|Overall Study||15
6694223|NCT02762370|7624626|FG000|COMPLETED|Overall Study||17
6694224|NCT02762370|7624627|FG001|COMPLETED|Overall Study||15
6258863|NCT01750281|7157950|FG001|Received Treatment|Overall Study||84
6258864|NCT01750281|7157951|FG002|Received Treatment|Overall Study||84
6258865|NCT01750281|7157949|FG000|Did Not Receive Treatment|Overall Study||0
6258866|NCT01750281|7157950|FG001|Did Not Receive Treatment|Overall Study||1
6694225|NCT02762370|7624626|FG000|NOT COMPLETED|Overall Study||1
6694226|NCT02762370|7624627|FG001|NOT COMPLETED|Overall Study||0
6694227|NCT02762500|7624637|FG000|STARTED|Overall Study||62
6694228|NCT02762500|7624638|FG001|STARTED|Overall Study||62
6694229|NCT02762500|7624637|FG000|COMPLETED|Overall Study||60
6694230|NCT02762500|7624638|FG001|COMPLETED|Overall Study||59
6694231|NCT02762500|7624637|FG000|NOT COMPLETED|Overall Study||2
6694232|NCT02762500|7624638|FG001|NOT COMPLETED|Overall Study||3
6694233|NCT02762513|7624644|FG000|STARTED|Overall Study||28
6694234|NCT02762513|7624644|FG000|COMPLETED|Overall Study||28
6694235|NCT02762513|7624644|FG000|NOT COMPLETED|Overall Study||0
6694236|NCT02762565|7624648|FG000|STARTED|Overall Study||89
6694237|NCT02762565|7624648|FG000|COMPLETED|Overall Study||78
6694238|NCT02762565|7624648|FG000|NOT COMPLETED|Overall Study||11
6694239|NCT02762578|7624654|FG000|STARTED|Overall Study||361
6694240|NCT02762578|7624655|FG001|STARTED|Overall Study||182
6694241|NCT02762578|7624654|FG000|Exposed|Overall Study||360
6694242|NCT02762578|7624655|FG001|Exposed|Overall Study||181
6694243|NCT02762578|7624654|FG000|COMPLETED|Overall Study||346
6694244|NCT02762578|7624655|FG001|COMPLETED|Overall Study||172
6694245|NCT02762578|7624654|FG000|NOT COMPLETED|Overall Study||15
6694246|NCT02762578|7624655|FG001|NOT COMPLETED|Overall Study||10
6694247|NCT02762799|7624665|FG000|STARTED|Overall Study||18
6694248|NCT02762799|7624666|FG001|STARTED|Overall Study||18
6694249|NCT02762799|7624667|FG002|STARTED|Overall Study||12
6694250|NCT02762799|7624668|FG003|STARTED|Overall Study||12
6694251|NCT02762799|7624665|FG000|COMPLETED|Overall Study||18
6694252|NCT02762799|7624666|FG001|COMPLETED|Overall Study||18
6694253|NCT02762799|7624667|FG002|COMPLETED|Overall Study||11
6694254|NCT02762799|7624668|FG003|COMPLETED|Overall Study||12
6694255|NCT02762799|7624665|FG000|NOT COMPLETED|Overall Study||0
6694256|NCT02762799|7624666|FG001|NOT COMPLETED|Overall Study||0
6694257|NCT02762799|7624667|FG002|NOT COMPLETED|Overall Study||1
6694258|NCT02762799|7624668|FG003|NOT COMPLETED|Overall Study||0
6694259|NCT02762877|7624682|FG000|STARTED|Overall Study||121
6694260|NCT02762877|7624683|FG001|STARTED|Overall Study||19
6694261|NCT02762877|7624682|FG000|COMPLETED|Overall Study||121
6694262|NCT02762877|7624683|FG001|COMPLETED|Overall Study||19
6694263|NCT02762877|7624682|FG000|NOT COMPLETED|Overall Study||0
6694264|NCT02762877|7624683|FG001|NOT COMPLETED|Overall Study||0
6694265|NCT02762994|7624694|FG000|STARTED|Overall Study||31
6694266|NCT02762994|7624695|FG001|STARTED|Overall Study||31
6694267|NCT02762994|7624696|FG002|STARTED|Overall Study||30
6694268|NCT02762994|7624697|FG003|STARTED|Overall Study||28
6694269|NCT02762994|7624694|FG000|COMPLETED|Overall Study||30
6694270|NCT02762994|7624695|FG001|COMPLETED|Overall Study||30
6694271|NCT02762994|7624696|FG002|COMPLETED|Overall Study||28
6694272|NCT02762994|7624697|FG003|COMPLETED|Overall Study||26
6694273|NCT02762994|7624694|FG000|NOT COMPLETED|Overall Study||1
6694274|NCT02762994|7624695|FG001|NOT COMPLETED|Overall Study||1
6694275|NCT02762994|7624696|FG002|NOT COMPLETED|Overall Study||2
6694276|NCT02762994|7624697|FG003|NOT COMPLETED|Overall Study||2
6694277|NCT02763046|7624714|FG000|STARTED|Overall Study||71
6694278|NCT02763046|7624715|FG001|STARTED|Overall Study||70
6694279|NCT02763046|7624716|FG002|STARTED|Overall Study||70
6694280|NCT02763046|7624714|FG000|COMPLETED|Overall Study||62
6694281|NCT02763046|7624715|FG001|COMPLETED|Overall Study||65
6694282|NCT02763046|7624716|FG002|COMPLETED|Overall Study||62
6694283|NCT02763046|7624714|FG000|NOT COMPLETED|Overall Study||9
6694284|NCT02763046|7624715|FG001|NOT COMPLETED|Overall Study||5
6694285|NCT02763046|7624716|FG002|NOT COMPLETED|Overall Study||8
6694286|NCT02763124|7624730|FG000|STARTED|Overall Study||18
6694287|NCT02763124|7624730|FG000|COMPLETED|Overall Study||18
6694288|NCT02763124|7624730|FG000|NOT COMPLETED|Overall Study||0
6694289|NCT02763215|7624734|FG000|STARTED|Overall Study||64
6694290|NCT02763215|7624734|FG000|COMPLETED|Overall Study||57
6694291|NCT02763215|7624734|FG000|NOT COMPLETED|Overall Study||7
6694292|NCT02763254|7624738|FG000|STARTED|Overall Study||1
6694293|NCT02763254|7624738|FG000|COMPLETED|Overall Study||0
6694294|NCT02763254|7624738|FG000|NOT COMPLETED|Overall Study||1
6258867|NCT01750281|7157951|FG002|Did Not Receive Treatment|Overall Study||0
6258868|NCT01750281|7157949|FG000|COMPLETED|Overall Study||0
6258869|NCT01750281|7157950|FG001|COMPLETED|Overall Study||0
6258870|NCT01750281|7157951|FG002|COMPLETED|Overall Study||0
6258871|NCT01750281|7157949|FG000|NOT COMPLETED|Overall Study||43
6258872|NCT01750281|7157950|FG001|NOT COMPLETED|Overall Study||85
6258873|NCT01750281|7157951|FG002|NOT COMPLETED|Overall Study||84
6258874|NCT01353118|7157961|FG000|STARTED|Overall Study||21
6258875|NCT01353118|7157962|FG001|STARTED|Overall Study||20
6258876|NCT01353118|7157961|FG000|COMPLETED|Overall Study||21
6258877|NCT01353118|7157962|FG001|COMPLETED|Overall Study||20
6258878|NCT01353118|7157961|FG000|NOT COMPLETED|Overall Study||0
6258879|NCT01353118|7157962|FG001|NOT COMPLETED|Overall Study||0
6258880|NCT01252953|7157970|FG000|STARTED|Overall Study||15225
6258881|NCT01252953|7157971|FG001|STARTED|Overall Study||15224
6258882|NCT01252953|7157970|FG000|COMPLETED|Overall Study||15187
6258883|NCT01252953|7157971|FG001|COMPLETED|Overall Study||15186
6258884|NCT01252953|7157970|FG000|NOT COMPLETED|Overall Study||38
6258885|NCT01252953|7157971|FG001|NOT COMPLETED|Overall Study||38
6258886|NCT01012609|7157980|FG000|STARTED|Overall Study||21
6258887|NCT01012609|7157981|FG001|STARTED|Overall Study||26
6258888|NCT01012609|7157980|FG000|COMPLETED|Overall Study||20
6258889|NCT01012609|7157981|FG001|COMPLETED|Overall Study||25
6258890|NCT01012609|7157980|FG000|NOT COMPLETED|Overall Study||1
6258891|NCT01012609|7157981|FG001|NOT COMPLETED|Overall Study||1
6258892|NCT00920387|7157990|FG000|STARTED|Stage 1||8
6258893|NCT00920387|7157991|FG001|STARTED|Stage 1||4
6258894|NCT00920387|7157992|FG002|STARTED|Stage 1||0
6258895|NCT00920387|7157990|FG000|COMPLETED|Stage 1||7
6258896|NCT00920387|7157991|FG001|COMPLETED|Stage 1||4
6258897|NCT00920387|7157992|FG002|COMPLETED|Stage 1||0
6258898|NCT00920387|7157990|FG000|NOT COMPLETED|Stage 1||1
6258899|NCT00920387|7157991|FG001|NOT COMPLETED|Stage 1||0
6258900|NCT00920387|7157992|FG002|NOT COMPLETED|Stage 1||0
6258901|NCT00920387|7157990|FG000|STARTED|Stage 2||0
6258902|NCT00920387|7157991|FG001|STARTED|Stage 2||0
6258903|NCT00920387|7157992|FG002|STARTED|Stage 2||3
6258904|NCT00920387|7157990|FG000|COMPLETED|Stage 2||0
6258905|NCT00920387|7157991|FG001|COMPLETED|Stage 2||0
6258906|NCT00920387|7157992|FG002|COMPLETED|Stage 2||3
6258907|NCT00920387|7157990|FG000|NOT COMPLETED|Stage 2||0
6258908|NCT00920387|7157991|FG001|NOT COMPLETED|Stage 2||0
6258909|NCT00920387|7157992|FG002|NOT COMPLETED|Stage 2||0
6258910|NCT00494234|7158001|FG000|STARTED|Overall Study||27
6258911|NCT00494234|7158002|FG001|STARTED|Overall Study||27
6258912|NCT00494234|7158001|FG000|COMPLETED|Overall Study||12
6258913|NCT00494234|7158002|FG001|COMPLETED|Overall Study||17
6258914|NCT00494234|7158001|FG000|NOT COMPLETED|Overall Study||15
6258915|NCT00494234|7158002|FG001|NOT COMPLETED|Overall Study||10
6258916|NCT00458835|7158018|FG000|STARTED|Overall Study||5
6258917|NCT00458835|7158019|FG001|STARTED|Overall Study||5
6258918|NCT00458835|7158020|FG002|STARTED|Overall Study||5
6258919|NCT00458835|7158021|FG003|STARTED|Overall Study||5
6258920|NCT00458835|7158022|FG004|STARTED|Overall Study||5
6258921|NCT00458835|7158023|FG005|STARTED|Overall Study||5
6258922|NCT00458835|7158018|FG000|COMPLETED|Overall Study||5
6258923|NCT00458835|7158019|FG001|COMPLETED|Overall Study||5
6258924|NCT00458835|7158020|FG002|COMPLETED|Overall Study||5
6258925|NCT00458835|7158021|FG003|COMPLETED|Overall Study||5
6258926|NCT00458835|7158022|FG004|COMPLETED|Overall Study||5
6258927|NCT00458835|7158023|FG005|COMPLETED|Overall Study||4
6258928|NCT00458835|7158018|FG000|NOT COMPLETED|Overall Study||0
6258929|NCT00458835|7158019|FG001|NOT COMPLETED|Overall Study||0
6258930|NCT00458835|7158020|FG002|NOT COMPLETED|Overall Study||0
6258931|NCT00458835|7158021|FG003|NOT COMPLETED|Overall Study||0
6258932|NCT00458835|7158022|FG004|NOT COMPLETED|Overall Study||0
6258933|NCT00458835|7158023|FG005|NOT COMPLETED|Overall Study||1
6258934|NCT00403559|7158033|FG000|STARTED|Overall Study||56
6258935|NCT00403559|7158034|FG001|STARTED|Overall Study||56
6258936|NCT00403559|7158033|FG000|COMPLETED|Overall Study||52
6258937|NCT00403559|7158034|FG001|COMPLETED|Overall Study||52
6258938|NCT00403559|7158033|FG000|NOT COMPLETED|Overall Study||4
6258939|NCT00403559|7158034|FG001|NOT COMPLETED|Overall Study||4
6258940|NCT00353938|7158044|FG000|STARTED|Stage 1||9
6258941|NCT00353938|7158045|FG001|STARTED|Stage 1||5
6258942|NCT00353938|7158046|FG002|STARTED|Stage 1||0
6258943|NCT00353938|7158047|FG003|STARTED|Stage 1||0
6258944|NCT00353938|7158044|FG000|COMPLETED|Stage 1||8
6258945|NCT00353938|7158045|FG001|COMPLETED|Stage 1||5
6258946|NCT00353938|7158046|FG002|COMPLETED|Stage 1||0
6258947|NCT00353938|7158047|FG003|COMPLETED|Stage 1||0
6258948|NCT00353938|7158044|FG000|NOT COMPLETED|Stage 1||1
6258949|NCT00353938|7158045|FG001|NOT COMPLETED|Stage 1||0
6258950|NCT00353938|7158046|FG002|NOT COMPLETED|Stage 1||0
6258951|NCT00353938|7158047|FG003|NOT COMPLETED|Stage 1||0
6258952|NCT00353938|7158044|FG000|STARTED|Stage 2||0
6258953|NCT00353938|7158045|FG001|STARTED|Stage 2||0
6258954|NCT00353938|7158046|FG002|STARTED|Stage 2||4
6258955|NCT00353938|7158047|FG003|STARTED|Stage 2||0
6258956|NCT00353938|7158044|FG000|COMPLETED|Stage 2||0
6258957|NCT00353938|7158045|FG001|COMPLETED|Stage 2||0
6258958|NCT00353938|7158046|FG002|COMPLETED|Stage 2||4
6258959|NCT00353938|7158047|FG003|COMPLETED|Stage 2||0
6258960|NCT00353938|7158044|FG000|NOT COMPLETED|Stage 2||0
6258961|NCT00353938|7158045|FG001|NOT COMPLETED|Stage 2||0
6258962|NCT00353938|7158046|FG002|NOT COMPLETED|Stage 2||0
6694295|NCT02763566|7624746|FG000|STARTED|Overall Study||207
6694296|NCT02763566|7624747|FG001|STARTED|Overall Study||99
6694297|NCT02763566|7624748|FG002|STARTED|Overall Study||104
6694298|NCT02763566|7624749|FG003|STARTED|Overall Study||53
6694299|NCT02763566|7624746|FG000|COMPLETED|Overall Study||89
6694300|NCT02763566|7624747|FG001|COMPLETED|Overall Study||60
6694301|NCT02763566|7624748|FG002|COMPLETED|Overall Study||50
6694302|NCT02763566|7624749|FG003|COMPLETED|Overall Study||39
6694303|NCT02763566|7624746|FG000|NOT COMPLETED|Overall Study||118
6694304|NCT02763566|7624747|FG001|NOT COMPLETED|Overall Study||39
6694305|NCT02763566|7624748|FG002|NOT COMPLETED|Overall Study||54
6694306|NCT02763566|7624749|FG003|NOT COMPLETED|Overall Study||14
6694307|NCT02763579|7624765|FG000|STARTED|Overall Study||201
6694308|NCT02763579|7624766|FG001|STARTED|Overall Study||202
6694309|NCT02763579|7624765|FG000|COMPLETED|Overall Study||0
6694310|NCT02763579|7624766|FG001|COMPLETED|Overall Study||0
6694311|NCT02763579|7624765|FG000|NOT COMPLETED|Overall Study||201
6694312|NCT02763579|7624766|FG001|NOT COMPLETED|Overall Study||202
6694313|NCT02763644|7624774|FG000|STARTED|Overall Study||3
6694314|NCT02763644|7624775|FG001|STARTED|Overall Study||4
6694315|NCT02763644|7624774|FG000|COMPLETED|Overall Study||0
6694316|NCT02763644|7624775|FG001|COMPLETED|Overall Study||2
6694317|NCT02763644|7624774|FG000|NOT COMPLETED|Overall Study||3
6694318|NCT02763644|7624775|FG001|NOT COMPLETED|Overall Study||2
6694319|NCT02763826|7624790|FG000|STARTED|Part 1 Dose Escalation, 1 mA||3
6694320|NCT02763826|7624791|FG001|STARTED|Part 1 Dose Escalation, 1 mA||0
6694321|NCT02763826|7624792|FG002|STARTED|Part 1 Dose Escalation, 1 mA||0
6694322|NCT02763826|7624793|FG003|STARTED|Part 1 Dose Escalation, 1 mA||0
6694323|NCT02763826|7624794|FG004|STARTED|Part 1 Dose Escalation, 1 mA||0
6694324|NCT02763826|7624795|FG005|STARTED|Part 1 Dose Escalation, 1 mA||0
6694325|NCT02763826|7624796|FG006|STARTED|Part 1 Dose Escalation, 1 mA||0
6694326|NCT02763826|7624797|FG007|STARTED|Part 1 Dose Escalation, 1 mA||0
6694327|NCT02763826|7624790|FG000|COMPLETED|Part 1 Dose Escalation, 1 mA||3
6694328|NCT02763826|7624791|FG001|COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694329|NCT02763826|7624792|FG002|COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694330|NCT02763826|7624793|FG003|COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694331|NCT02763826|7624794|FG004|COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694332|NCT02763826|7624795|FG005|COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694333|NCT02763826|7624796|FG006|COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694334|NCT02763826|7624797|FG007|COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694335|NCT02763826|7624790|FG000|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694336|NCT02763826|7624791|FG001|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694337|NCT02763826|7624792|FG002|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694338|NCT02763826|7624793|FG003|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694339|NCT02763826|7624794|FG004|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694340|NCT02763826|7624795|FG005|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694341|NCT02763826|7624796|FG006|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694342|NCT02763826|7624797|FG007|NOT COMPLETED|Part 1 Dose Escalation, 1 mA||0
6694343|NCT02763826|7624790|FG000|STARTED|Part 1 Dose Escalation, 2 mA||0
6694344|NCT02763826|7624791|FG001|STARTED|Part 1 Dose Escalation, 2 mA||3
6258963|NCT00353938|7158047|FG003|NOT COMPLETED|Stage 2||0
6258964|NCT00353938|7158044|FG000|STARTED|Stage 3||0
6258965|NCT00353938|7158045|FG001|STARTED|Stage 3||0
6258966|NCT00353938|7158046|FG002|STARTED|Stage 3||0
6258967|NCT00353938|7158047|FG003|STARTED|Stage 3||3
6258968|NCT00353938|7158044|FG000|COMPLETED|Stage 3||0
6258969|NCT00353938|7158045|FG001|COMPLETED|Stage 3||0
6258970|NCT00353938|7158046|FG002|COMPLETED|Stage 3||0
6258971|NCT00353938|7158047|FG003|COMPLETED|Stage 3||3
6258972|NCT00353938|7158044|FG000|NOT COMPLETED|Stage 3||0
6258973|NCT00353938|7158045|FG001|NOT COMPLETED|Stage 3||0
6258974|NCT00353938|7158046|FG002|NOT COMPLETED|Stage 3||0
6258975|NCT00353938|7158047|FG003|NOT COMPLETED|Stage 3||0
6258976|NCT00176436|7158057|FG000|STARTED|Overall Study||20
6258977|NCT00176436|7158058|FG001|STARTED|Overall Study||17
6258978|NCT00176436|7158057|FG000|COMPLETED|Overall Study||14
6258979|NCT00176436|7158058|FG001|COMPLETED|Overall Study||12
6258980|NCT00176436|7158057|FG000|NOT COMPLETED|Overall Study||6
6258981|NCT00176436|7158058|FG001|NOT COMPLETED|Overall Study||5
6280154|NCT00151775|7180011|FG008|COMPLETED|Period 4: Open Label||0
6280155|NCT00151775|7180012|FG009|COMPLETED|Period 4: Open Label||83
6280156|NCT00151775|7180013|FG010|COMPLETED|Period 4: Open Label||57
6280157|NCT00151775|7180014|FG011|COMPLETED|Period 4: Open Label||0
6280158|NCT00151775|7180003|FG000|NOT COMPLETED|Period 4: Open Label||0
6280159|NCT00151775|7180004|FG001|NOT COMPLETED|Period 4: Open Label||0
6280160|NCT00151775|7180005|FG002|NOT COMPLETED|Period 4: Open Label||0
6280161|NCT00151775|7180006|FG003|NOT COMPLETED|Period 4: Open Label||0
6280162|NCT00151775|7180007|FG004|NOT COMPLETED|Period 4: Open Label||30
6280163|NCT00151775|7180008|FG005|NOT COMPLETED|Period 4: Open Label||0
6280164|NCT00151775|7180009|FG006|NOT COMPLETED|Period 4: Open Label||0
6694345|NCT02763826|7624792|FG002|STARTED|Part 1 Dose Escalation, 2 mA||0
6694346|NCT02763826|7624793|FG003|STARTED|Part 1 Dose Escalation, 2 mA||0
6694347|NCT02763826|7624794|FG004|STARTED|Part 1 Dose Escalation, 2 mA||0
6694348|NCT02763826|7624795|FG005|STARTED|Part 1 Dose Escalation, 2 mA||0
6694349|NCT02763826|7624796|FG006|STARTED|Part 1 Dose Escalation, 2 mA||0
6694350|NCT02763826|7624797|FG007|STARTED|Part 1 Dose Escalation, 2 mA||0
6694351|NCT02763826|7624790|FG000|COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694352|NCT02763826|7624791|FG001|COMPLETED|Part 1 Dose Escalation, 2 mA||3
6694353|NCT02763826|7624792|FG002|COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694354|NCT02763826|7624793|FG003|COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694355|NCT02763826|7624794|FG004|COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694356|NCT02763826|7624795|FG005|COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694357|NCT02763826|7624796|FG006|COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694358|NCT02763826|7624797|FG007|COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694359|NCT02763826|7624790|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694360|NCT02763826|7624791|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694361|NCT02763826|7624792|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694362|NCT02763826|7624793|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694363|NCT02763826|7624794|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694364|NCT02763826|7624795|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694365|NCT02763826|7624796|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694366|NCT02763826|7624797|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2 mA||0
6694367|NCT02763826|7624790|FG000|STARTED|Part 1 Dose Escalation, 2.5 mA||0
6694368|NCT02763826|7624791|FG001|STARTED|Part 1 Dose Escalation, 2.5 mA||0
6694369|NCT02763826|7624792|FG002|STARTED|Part 1 Dose Escalation, 2.5 mA||3
6694370|NCT02763826|7624793|FG003|STARTED|Part 1 Dose Escalation, 2.5 mA||0
6694371|NCT02763826|7624794|FG004|STARTED|Part 1 Dose Escalation, 2.5 mA||0
6694372|NCT02763826|7624795|FG005|STARTED|Part 1 Dose Escalation, 2.5 mA||0
6694373|NCT02763826|7624796|FG006|STARTED|Part 1 Dose Escalation, 2.5 mA||0
6694374|NCT02763826|7624797|FG007|STARTED|Part 1 Dose Escalation, 2.5 mA||0
6694375|NCT02763826|7624790|FG000|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694376|NCT02763826|7624791|FG001|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694377|NCT02763826|7624792|FG002|COMPLETED|Part 1 Dose Escalation, 2.5 mA||3
6694378|NCT02763826|7624793|FG003|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694379|NCT02763826|7624794|FG004|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694380|NCT02763826|7624795|FG005|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694381|NCT02763826|7624796|FG006|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694382|NCT02763826|7624797|FG007|COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694383|NCT02763826|7624790|FG000|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694384|NCT02763826|7624791|FG001|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694385|NCT02763826|7624792|FG002|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694386|NCT02763826|7624793|FG003|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694387|NCT02763826|7624794|FG004|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694388|NCT02763826|7624795|FG005|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694389|NCT02763826|7624796|FG006|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694390|NCT02763826|7624797|FG007|NOT COMPLETED|Part 1 Dose Escalation, 2.5 mA||0
6694391|NCT02763826|7624790|FG000|STARTED|Part 1 Dose Escalation, 3 mA||0
6694392|NCT02763826|7624791|FG001|STARTED|Part 1 Dose Escalation, 3 mA||0
6694393|NCT02763826|7624792|FG002|STARTED|Part 1 Dose Escalation, 3 mA||0
6694394|NCT02763826|7624793|FG003|STARTED|Part 1 Dose Escalation, 3 mA||3
6694395|NCT02763826|7624794|FG004|STARTED|Part 1 Dose Escalation, 3 mA||0
6694396|NCT02763826|7624795|FG005|STARTED|Part 1 Dose Escalation, 3 mA||0
6694397|NCT02763826|7624796|FG006|STARTED|Part 1 Dose Escalation, 3 mA||0
6694398|NCT02763826|7624797|FG007|STARTED|Part 1 Dose Escalation, 3 mA||0
6694399|NCT02763826|7624790|FG000|COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694400|NCT02763826|7624791|FG001|COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694401|NCT02763826|7624792|FG002|COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694402|NCT02763826|7624793|FG003|COMPLETED|Part 1 Dose Escalation, 3 mA||3
6694403|NCT02763826|7624794|FG004|COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694404|NCT02763826|7624795|FG005|COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694405|NCT02763826|7624796|FG006|COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694406|NCT02763826|7624797|FG007|COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694407|NCT02763826|7624790|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694408|NCT02763826|7624791|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694409|NCT02763826|7624792|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694410|NCT02763826|7624793|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694411|NCT02763826|7624794|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694412|NCT02763826|7624795|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694413|NCT02763826|7624796|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694414|NCT02763826|7624797|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3 mA||0
6694415|NCT02763826|7624790|FG000|STARTED|Part 1 Dose Escalation, 3.5 mA||0
6694416|NCT02763826|7624791|FG001|STARTED|Part 1 Dose Escalation, 3.5 mA||0
6694417|NCT02763826|7624792|FG002|STARTED|Part 1 Dose Escalation, 3.5 mA||0
6694418|NCT02763826|7624793|FG003|STARTED|Part 1 Dose Escalation, 3.5 mA||0
6694419|NCT02763826|7624794|FG004|STARTED|Part 1 Dose Escalation, 3.5 mA||3
6694420|NCT02763826|7624795|FG005|STARTED|Part 1 Dose Escalation, 3.5 mA||0
6694421|NCT02763826|7624796|FG006|STARTED|Part 1 Dose Escalation, 3.5 mA||0
6694422|NCT02763826|7624797|FG007|STARTED|Part 1 Dose Escalation, 3.5 mA||0
6694423|NCT02763826|7624790|FG000|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694424|NCT02763826|7624791|FG001|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694425|NCT02763826|7624792|FG002|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694426|NCT02763826|7624793|FG003|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694427|NCT02763826|7624794|FG004|COMPLETED|Part 1 Dose Escalation, 3.5 mA||3
6694428|NCT02763826|7624795|FG005|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694429|NCT02763826|7624796|FG006|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694430|NCT02763826|7624797|FG007|COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694431|NCT02763826|7624790|FG000|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694432|NCT02763826|7624791|FG001|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694433|NCT02763826|7624792|FG002|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694434|NCT02763826|7624793|FG003|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694435|NCT02763826|7624794|FG004|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694436|NCT02763826|7624795|FG005|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694437|NCT02763826|7624796|FG006|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694438|NCT02763826|7624797|FG007|NOT COMPLETED|Part 1 Dose Escalation, 3.5 mA||0
6694439|NCT02763826|7624790|FG000|STARTED|Part 1 Dose Escalation, 4 mA||0
6694440|NCT02763826|7624791|FG001|STARTED|Part 1 Dose Escalation, 4 mA||0
6694441|NCT02763826|7624792|FG002|STARTED|Part 1 Dose Escalation, 4 mA||0
6694442|NCT02763826|7624793|FG003|STARTED|Part 1 Dose Escalation, 4 mA||0
6694443|NCT02763826|7624794|FG004|STARTED|Part 1 Dose Escalation, 4 mA||0
6694444|NCT02763826|7624795|FG005|STARTED|Part 1 Dose Escalation, 4 mA||3
6694445|NCT02763826|7624796|FG006|STARTED|Part 1 Dose Escalation, 4 mA||0
6694446|NCT02763826|7624797|FG007|STARTED|Part 1 Dose Escalation, 4 mA||0
6694447|NCT02763826|7624790|FG000|COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694448|NCT02763826|7624791|FG001|COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694449|NCT02763826|7624792|FG002|COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694450|NCT02763826|7624793|FG003|COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694451|NCT02763826|7624794|FG004|COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694452|NCT02763826|7624795|FG005|COMPLETED|Part 1 Dose Escalation, 4 mA||3
6694453|NCT02763826|7624796|FG006|COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694454|NCT02763826|7624797|FG007|COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694455|NCT02763826|7624790|FG000|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694456|NCT02763826|7624791|FG001|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694457|NCT02763826|7624792|FG002|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694458|NCT02763826|7624793|FG003|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694459|NCT02763826|7624794|FG004|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694460|NCT02763826|7624795|FG005|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694461|NCT02763826|7624796|FG006|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694462|NCT02763826|7624797|FG007|NOT COMPLETED|Part 1 Dose Escalation, 4 mA||0
6694463|NCT02763826|7624790|FG000|STARTED|Part 2 Montage Effect, 1st Intervention||0
6694464|NCT02763826|7624791|FG001|STARTED|Part 2 Montage Effect, 1st Intervention||0
6694465|NCT02763826|7624792|FG002|STARTED|Part 2 Montage Effect, 1st Intervention||0
6694466|NCT02763826|7624793|FG003|STARTED|Part 2 Montage Effect, 1st Intervention||0
6694467|NCT02763826|7624794|FG004|STARTED|Part 2 Montage Effect, 1st Intervention||0
6694468|NCT02763826|7624795|FG005|STARTED|Part 2 Montage Effect, 1st Intervention||6
6694469|NCT02763826|7624796|FG006|STARTED|Part 2 Montage Effect, 1st Intervention||6
6694470|NCT02763826|7624797|FG007|STARTED|Part 2 Montage Effect, 1st Intervention||7
6694471|NCT02763826|7624790|FG000|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694472|NCT02763826|7624791|FG001|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694473|NCT02763826|7624792|FG002|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694474|NCT02763826|7624793|FG003|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694475|NCT02763826|7624794|FG004|COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694476|NCT02763826|7624795|FG005|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
6694477|NCT02763826|7624796|FG006|COMPLETED|Part 2 Montage Effect, 1st Intervention||6
6694478|NCT02763826|7624797|FG007|COMPLETED|Part 2 Montage Effect, 1st Intervention||7
6694479|NCT02763826|7624790|FG000|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694480|NCT02763826|7624791|FG001|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694481|NCT02763826|7624792|FG002|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694482|NCT02763826|7624793|FG003|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694483|NCT02763826|7624794|FG004|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694484|NCT02763826|7624795|FG005|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694485|NCT02763826|7624796|FG006|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694486|NCT02763826|7624797|FG007|NOT COMPLETED|Part 2 Montage Effect, 1st Intervention||0
6694487|NCT02763826|7624790|FG000|STARTED|Part 2 Montage Effect, 2nd Intervention||0
6694488|NCT02763826|7624791|FG001|STARTED|Part 2 Montage Effect, 2nd Intervention||0
6694489|NCT02763826|7624792|FG002|STARTED|Part 2 Montage Effect, 2nd Intervention||0
6694490|NCT02763826|7624793|FG003|STARTED|Part 2 Montage Effect, 2nd Intervention||0
6694491|NCT02763826|7624794|FG004|STARTED|Part 2 Montage Effect, 2nd Intervention||0
6694492|NCT02763826|7624795|FG005|STARTED|Part 2 Montage Effect, 2nd Intervention||6
6694493|NCT02763826|7624796|FG006|STARTED|Part 2 Montage Effect, 2nd Intervention||6
6694494|NCT02763826|7624797|FG007|STARTED|Part 2 Montage Effect, 2nd Intervention||6
6694495|NCT02763826|7624790|FG000|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694496|NCT02763826|7624791|FG001|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694497|NCT02763826|7624792|FG002|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694498|NCT02763826|7624793|FG003|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694499|NCT02763826|7624794|FG004|COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694500|NCT02763826|7624795|FG005|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
6694501|NCT02763826|7624796|FG006|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
6694502|NCT02763826|7624797|FG007|COMPLETED|Part 2 Montage Effect, 2nd Intervention||6
6694503|NCT02763826|7624790|FG000|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694504|NCT02763826|7624791|FG001|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694505|NCT02763826|7624792|FG002|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694506|NCT02763826|7624793|FG003|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694507|NCT02763826|7624794|FG004|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694508|NCT02763826|7624795|FG005|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694509|NCT02763826|7624796|FG006|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694510|NCT02763826|7624797|FG007|NOT COMPLETED|Part 2 Montage Effect, 2nd Intervention||0
6694511|NCT02763826|7624790|FG000|STARTED|Part 2 Montage Effect, 3rd Intervention||0
6694512|NCT02763826|7624791|FG001|STARTED|Part 2 Montage Effect, 3rd Intervention||0
6694513|NCT02763826|7624792|FG002|STARTED|Part 2 Montage Effect, 3rd Intervention||0
6694514|NCT02763826|7624793|FG003|STARTED|Part 2 Montage Effect, 3rd Intervention||0
6694515|NCT02763826|7624794|FG004|STARTED|Part 2 Montage Effect, 3rd Intervention||0
6694516|NCT02763826|7624795|FG005|STARTED|Part 2 Montage Effect, 3rd Intervention||6
6694517|NCT02763826|7624796|FG006|STARTED|Part 2 Montage Effect, 3rd Intervention||6
6694518|NCT02763826|7624797|FG007|STARTED|Part 2 Montage Effect, 3rd Intervention||6
6694519|NCT02763826|7624790|FG000|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694520|NCT02763826|7624791|FG001|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694521|NCT02763826|7624792|FG002|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694522|NCT02763826|7624793|FG003|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694523|NCT02763826|7624794|FG004|COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694524|NCT02763826|7624795|FG005|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
6694525|NCT02763826|7624796|FG006|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
6694526|NCT02763826|7624797|FG007|COMPLETED|Part 2 Montage Effect, 3rd Intervention||6
6694527|NCT02763826|7624790|FG000|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694528|NCT02763826|7624791|FG001|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694529|NCT02763826|7624792|FG002|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694530|NCT02763826|7624793|FG003|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694531|NCT02763826|7624794|FG004|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694532|NCT02763826|7624795|FG005|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694533|NCT02763826|7624796|FG006|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694534|NCT02763826|7624797|FG007|NOT COMPLETED|Part 2 Montage Effect, 3rd Intervention||0
6694535|NCT02763865|7624817|FG000|STARTED|Overall Study||5
6694536|NCT02763865|7624818|FG001|STARTED|Overall Study||5
6694537|NCT02763865|7624817|FG000|COMPLETED|Overall Study||5
6694538|NCT02763865|7624818|FG001|COMPLETED|Overall Study||5
6694539|NCT02763865|7624817|FG000|NOT COMPLETED|Overall Study||0
6694540|NCT02763865|7624818|FG001|NOT COMPLETED|Overall Study||0
6694541|NCT02764151|7624830|FG000|STARTED|Overall Study||2
6694542|NCT02764151|7624831|FG001|STARTED|Overall Study||4
6694543|NCT02764151|7624832|FG002|STARTED|Overall Study||3
6694544|NCT02764151|7624833|FG003|STARTED|Overall Study||8
6694545|NCT02764151|7624830|FG000|COMPLETED|Overall Study||2
6258982|NCT04749459|7158064|FG000|STARTED|Overall Study||14
6258983|NCT04749459|7158064|FG000|CSM Classic|Overall Study||12
6258984|NCT04749459|7158064|FG000|CSM Strawberry Flavor|Overall Study||10
6258985|NCT04749459|7158064|FG000|P2 Control Standard|Overall Study||14
6258986|NCT04749459|7158064|FG000|COMPLETED|Overall Study||14
6258987|NCT04749459|7158064|FG000|NOT COMPLETED|Overall Study||0
6259003|NCT04481035|7158092|FG000|STARTED|Period 1||3
6259004|NCT04481035|7158093|FG001|STARTED|Period 1||2
6259005|NCT04481035|7158092|FG000|COMPLETED|Period 1||3
6259006|NCT04481035|7158093|FG001|COMPLETED|Period 1||2
6259007|NCT04481035|7158092|FG000|NOT COMPLETED|Period 1||0
6259008|NCT04481035|7158093|FG001|NOT COMPLETED|Period 1||0
6259009|NCT04481035|7158092|FG000|STARTED|Period 2||3
6259010|NCT04481035|7158093|FG001|STARTED|Period 2||2
6259011|NCT04481035|7158092|FG000|COMPLETED|Period 2||3
6259012|NCT04481035|7158093|FG001|COMPLETED|Period 2||2
6259013|NCT04481035|7158092|FG000|NOT COMPLETED|Period 2||0
6259014|NCT04481035|7158093|FG001|NOT COMPLETED|Period 2||0
6259015|NCT04195958|7158099|FG000|STARTED|Overall Study||3
6259016|NCT04195958|7158099|FG000|COMPLETED|Overall Study||1
6259017|NCT04195958|7158099|FG000|NOT COMPLETED|Overall Study||2
6259018|NCT04191148|7158105|FG000|STARTED|Overall Study||24
6259019|NCT04191148|7158106|FG001|STARTED|Overall Study||12
6259020|NCT04191148|7158105|FG000|COMPLETED|Overall Study||22
6259021|NCT04191148|7158106|FG001|COMPLETED|Overall Study||12
6259022|NCT04191148|7158105|FG000|NOT COMPLETED|Overall Study||2
6259023|NCT04191148|7158106|FG001|NOT COMPLETED|Overall Study||0
6280165|NCT00151775|7180010|FG007|NOT COMPLETED|Period 4: Open Label||0
6280166|NCT00151775|7180011|FG008|NOT COMPLETED|Period 4: Open Label||0
6694546|NCT02764151|7624831|FG001|COMPLETED|Overall Study||4
6694547|NCT02764151|7624832|FG002|COMPLETED|Overall Study||3
6694548|NCT02764151|7624833|FG003|COMPLETED|Overall Study||5
6694549|NCT02764151|7624830|FG000|NOT COMPLETED|Overall Study||0
6694550|NCT02764151|7624831|FG001|NOT COMPLETED|Overall Study||0
6694551|NCT02764151|7624832|FG002|NOT COMPLETED|Overall Study||0
6694552|NCT02764151|7624833|FG003|NOT COMPLETED|Overall Study||3
6694553|NCT02764164|7624843|FG000|STARTED|Overall Study||1
6694554|NCT02764164|7624843|FG000|COMPLETED|Overall Study|Duration flexible up to 12mo, ended early (funding), 2 week time point achieved|1
6694555|NCT02764164|7624843|FG000|NOT COMPLETED|Overall Study||0
6694556|NCT02764190|7624849|FG000|STARTED|Overall Study||167
6280167|NCT00151775|7180012|FG009|NOT COMPLETED|Period 4: Open Label||21
6694557|NCT02764190|7624850|FG001|STARTED|Overall Study||135
6694558|NCT02764190|7624849|FG000|1 Day Follow-up|Overall Study||161
6694559|NCT02764190|7624850|FG001|1 Day Follow-up|Overall Study||131
6280168|NCT00151775|7180013|FG010|NOT COMPLETED|Period 4: Open Label||0
6694560|NCT02764190|7624849|FG000|3 Month Follow-up|Overall Study||156
6694561|NCT02764190|7624850|FG001|3 Month Follow-up|Overall Study||128
6694562|NCT02764190|7624849|FG000|6 Month Follow-up|Overall Study||155
6694563|NCT02764190|7624850|FG001|6 Month Follow-up|Overall Study||128
6694564|NCT02764190|7624849|FG000|12 Month Follow-up|Overall Study||150
6694565|NCT02764190|7624850|FG001|12 Month Follow-up|Overall Study||122
6694566|NCT02764190|7624849|FG000|COMPLETED|Overall Study||150
6694567|NCT02764190|7624850|FG001|COMPLETED|Overall Study||122
6694568|NCT02764190|7624849|FG000|NOT COMPLETED|Overall Study||17
6694569|NCT02764190|7624850|FG001|NOT COMPLETED|Overall Study||13
6694570|NCT02764229|7624856|FG000|STARTED|Overall Study||112
6694571|NCT02764229|7624856|FG000|COMPLETED|Overall Study||10
6694572|NCT02764229|7624856|FG000|NOT COMPLETED|Overall Study||102
6694573|NCT02764320|7624862|FG000|STARTED|Overall Study||361
6694574|NCT02764320|7624863|FG001|STARTED|Overall Study||359
6694575|NCT02764320|7624862|FG000|COMPLETED|Overall Study||310
6694576|NCT02764320|7624863|FG001|COMPLETED|Overall Study||310
6694577|NCT02764320|7624862|FG000|NOT COMPLETED|Overall Study||51
6694578|NCT02764320|7624863|FG001|NOT COMPLETED|Overall Study||49
6694579|NCT02764333|7624869|FG000|STARTED|Overall Study||29
6694580|NCT02764333|7624869|FG000|COMPLETED|Overall Study||28
6694581|NCT02764333|7624869|FG000|NOT COMPLETED|Overall Study||1
6694582|NCT02764385|7624875|FG000|STARTED|Overall Study||9145
6694583|NCT02764385|7624876|FG001|STARTED|Overall Study||6641
6694584|NCT02764385|7624875|FG000|COMPLETED|Overall Study||9145
6694585|NCT02764385|7624876|FG001|COMPLETED|Overall Study||6641
6694586|NCT02764385|7624875|FG000|NOT COMPLETED|Overall Study||0
6694587|NCT02764385|7624876|FG001|NOT COMPLETED|Overall Study||0
6694588|NCT02764697|7624882|FG000|STARTED|Overall Study||5
6694589|NCT02764697|7624882|FG000|COMPLETED|Overall Study||2
6694590|NCT02764697|7624882|FG000|NOT COMPLETED|Overall Study||3
6694591|NCT02764762|7624886|FG000|STARTED|Overall Study||55
6694592|NCT02764762|7624886|FG000|COMPLETED|Overall Study||46
6694593|NCT02764762|7624886|FG000|NOT COMPLETED|Overall Study||9
6694594|NCT02764775|7624890|FG000|STARTED|Overall Study|All 14 participants were assigned to the Headpod utilization group.|14
6694595|NCT02764775|7624890|FG000|COMPLETED|Overall Study||8
6694596|NCT02764775|7624890|FG000|NOT COMPLETED|Overall Study||6
6694597|NCT02764970|7624896|FG000|STARTED|Overall Study||65
6694598|NCT02764970|7624897|FG001|STARTED|Overall Study||47
6694599|NCT02764970|7624896|FG000|COMPLETED|Overall Study||65
6694600|NCT02764970|7624897|FG001|COMPLETED|Overall Study||47
6694601|NCT02764970|7624896|FG000|NOT COMPLETED|Overall Study||0
6694602|NCT02764970|7624897|FG001|NOT COMPLETED|Overall Study||0
6694603|NCT02765035|7624905|FG000|STARTED|First Intervention (90 Days)||5
6694604|NCT02765035|7624906|FG001|STARTED|First Intervention (90 Days)||8
6694605|NCT02765035|7624905|FG000|COMPLETED|First Intervention (90 Days)||4
6694606|NCT02765035|7624906|FG001|COMPLETED|First Intervention (90 Days)||7
6694607|NCT02765035|7624905|FG000|NOT COMPLETED|First Intervention (90 Days)||1
6694608|NCT02765035|7624906|FG001|NOT COMPLETED|First Intervention (90 Days)||1
6694609|NCT02765035|7624905|FG000|STARTED|Second Intervention (30 Days)||4
6694610|NCT02765035|7624906|FG001|STARTED|Second Intervention (30 Days)||7
6258988|NCT04702984|7158075|FG000|STARTED|Overall Study||39
6258989|NCT04702984|7158075|FG000|COMPLETED|Overall Study||38
6258990|NCT04702984|7158075|FG000|NOT COMPLETED|Overall Study||1
6258991|NCT04633564|7158083|FG000|STARTED|Period 1||335
6258992|NCT04633564|7158084|FG001|STARTED|Period 1||329
6258993|NCT04633564|7158083|FG000|COMPLETED|Period 1||227
6258994|NCT04633564|7158084|FG001|COMPLETED|Period 1||220
6258995|NCT04633564|7158083|FG000|NOT COMPLETED|Period 1||108
6258996|NCT04633564|7158084|FG001|NOT COMPLETED|Period 1||109
6258997|NCT04633564|7158083|FG000|STARTED|Period 2||200
6258998|NCT04633564|7158084|FG001|STARTED|Period 2||199
6258999|NCT04633564|7158083|FG000|COMPLETED|Period 2||107
6259000|NCT04633564|7158084|FG001|COMPLETED|Period 2||102
6259001|NCT04633564|7158083|FG000|NOT COMPLETED|Period 2||93
6259002|NCT04633564|7158084|FG001|NOT COMPLETED|Period 2||97
6259024|NCT04151628|7158116|FG000|STARTED|Overall Study||8
6259025|NCT04151628|7158117|FG001|STARTED|Overall Study||64
6259026|NCT04151628|7158116|FG000|COMPLETED|Overall Study||8
6259027|NCT04151628|7158117|FG001|COMPLETED|Overall Study||64
6259028|NCT04151628|7158116|FG000|NOT COMPLETED|Overall Study||0
6259029|NCT04151628|7158117|FG001|NOT COMPLETED|Overall Study||0
6259030|NCT04130802|7158125|FG000|STARTED|Overall Study||51
6259031|NCT04130802|7158126|FG001|STARTED|Overall Study||51
6259032|NCT04130802|7158127|FG002|STARTED|Overall Study||51
6259033|NCT04130802|7158125|FG000|COMPLETED|Overall Study||50
6259034|NCT04130802|7158126|FG001|COMPLETED|Overall Study||50
6259035|NCT04130802|7158127|FG002|COMPLETED|Overall Study||48
6259036|NCT04130802|7158125|FG000|NOT COMPLETED|Overall Study||1
6259037|NCT04130802|7158126|FG001|NOT COMPLETED|Overall Study||1
6259038|NCT04130802|7158127|FG002|NOT COMPLETED|Overall Study||3
6259039|NCT04105738|7158138|FG000|STARTED|Overall Study||13
6259040|NCT04105738|7158139|FG001|STARTED|Overall Study||0
6694611|NCT02765035|7624905|FG000|COMPLETED|Second Intervention (30 Days)||2
6694612|NCT02765035|7624906|FG001|COMPLETED|Second Intervention (30 Days)||5
6259041|NCT04105738|7158138|FG000|COMPLETED|Overall Study||13
6259042|NCT04105738|7158139|FG001|COMPLETED|Overall Study||0
6259043|NCT04105738|7158138|FG000|NOT COMPLETED|Overall Study||0
6259044|NCT04105738|7158139|FG001|NOT COMPLETED|Overall Study||0
6259045|NCT04022733|7158147|FG000|STARTED|Overall Study||67
6259046|NCT04022733|7158148|FG001|STARTED|Overall Study||67
6694613|NCT02765035|7624905|FG000|NOT COMPLETED|Second Intervention (30 Days)||2
6694614|NCT02765035|7624906|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
6694615|NCT02765100|7624915|FG000|STARTED|Overall Study||9
6694616|NCT02765100|7624916|FG001|STARTED|Overall Study||12
6694617|NCT02765100|7624915|FG000|COMPLETED|Overall Study||8
6694618|NCT02765100|7624916|FG001|COMPLETED|Overall Study||10
6694619|NCT02765100|7624915|FG000|NOT COMPLETED|Overall Study||1
6694620|NCT02765100|7624916|FG001|NOT COMPLETED|Overall Study||2
6694621|NCT02765165|7624929|FG000|STARTED|Treatment Period||3
6694622|NCT02765165|7624930|FG001|STARTED|Treatment Period||4
6694623|NCT02765165|7624931|FG002|STARTED|Treatment Period||3
6694624|NCT02765165|7624932|FG003|STARTED|Treatment Period||3
6694625|NCT02765165|7624933|FG004|STARTED|Treatment Period||6
6694626|NCT02765165|7624934|FG005|STARTED|Treatment Period||3
6694627|NCT02765165|7624935|FG006|STARTED|Treatment Period||4
6694628|NCT02765165|7624929|FG000|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
6694629|NCT02765165|7624930|FG001|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
6694630|NCT02765165|7624931|FG002|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
6694631|NCT02765165|7624932|FG003|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
6694632|NCT02765165|7624933|FG004|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
6694633|NCT02765165|7624934|FG005|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
6694634|NCT02765165|7624935|FG006|COMPLETED|Treatment Period|Open-ended design for participation until progression or other reason for withdrawal|0
6694635|NCT02765165|7624929|FG000|NOT COMPLETED|Treatment Period||3
6694636|NCT02765165|7624930|FG001|NOT COMPLETED|Treatment Period||4
6694637|NCT02765165|7624931|FG002|NOT COMPLETED|Treatment Period||3
6694638|NCT02765165|7624932|FG003|NOT COMPLETED|Treatment Period||3
6694639|NCT02765165|7624933|FG004|NOT COMPLETED|Treatment Period||6
6694640|NCT02765165|7624934|FG005|NOT COMPLETED|Treatment Period||3
6694641|NCT02765165|7624935|FG006|NOT COMPLETED|Treatment Period||4
6694642|NCT02765165|7624929|FG000|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
6694643|NCT02765165|7624930|FG001|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
6694644|NCT02765165|7624931|FG002|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
6694645|NCT02765165|7624932|FG003|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
6694646|NCT02765165|7624933|FG004|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
6694647|NCT02765165|7624934|FG005|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|3
6694648|NCT02765165|7624935|FG006|STARTED|Post-treatment Follow-up|Subjects who chose to enter follow-up, including long term follow-up for survival, after discontinuing treatment. Subjects were not required to enter follow-up.|1
6694649|NCT02765165|7624929|FG000|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
6694650|NCT02765165|7624930|FG001|COMPLETED|Post-treatment Follow-up||0
6694651|NCT02765165|7624931|FG002|COMPLETED|Post-treatment Follow-up||0
6694652|NCT02765165|7624932|FG003|COMPLETED|Post-treatment Follow-up||0
6694653|NCT02765165|7624933|FG004|COMPLETED|Post-treatment Follow-up|Open-ended follow-up|0
6694654|NCT02765165|7624934|FG005|COMPLETED|Post-treatment Follow-up||0
6694655|NCT02765165|7624935|FG006|COMPLETED|Post-treatment Follow-up||0
6694656|NCT02765165|7624929|FG000|NOT COMPLETED|Post-treatment Follow-up||1
6694657|NCT02765165|7624930|FG001|NOT COMPLETED|Post-treatment Follow-up||3
6694658|NCT02765165|7624931|FG002|NOT COMPLETED|Post-treatment Follow-up||3
6694659|NCT02765165|7624932|FG003|NOT COMPLETED|Post-treatment Follow-up||3
6694660|NCT02765165|7624933|FG004|NOT COMPLETED|Post-treatment Follow-up||3
6694661|NCT02765165|7624934|FG005|NOT COMPLETED|Post-treatment Follow-up||3
6694662|NCT02765165|7624935|FG006|NOT COMPLETED|Post-treatment Follow-up||1
6694663|NCT02765256|7624957|FG000|STARTED|Overall Study||4
6694664|NCT02765256|7624958|FG001|STARTED|Overall Study||4
6694665|NCT02765256|7624957|FG000|COMPLETED|Overall Study||4
6694666|NCT02765256|7624958|FG001|COMPLETED|Overall Study||4
6694667|NCT02765256|7624957|FG000|NOT COMPLETED|Overall Study||0
6694668|NCT02765256|7624958|FG001|NOT COMPLETED|Overall Study||0
6738766|NCT03285958|7667977|FG001|NOT COMPLETED|Overall Study||1
6738767|NCT03285984|7667984|FG000|STARTED|Overall Study||56
6738768|NCT03285984|7667984|FG000|Received Test Product 1|Overall Study||56
6738769|NCT03285984|7667984|FG000|Received Test Product 2|Overall Study||56
6738770|NCT03285984|7667984|FG000|Received Test Product 3|Overall Study||56
6738771|NCT03285984|7667984|FG000|Received Test Product 4|Overall Study||56
6738772|NCT03285984|7667984|FG000|COMPLETED|Overall Study||56
6738773|NCT03285984|7667984|FG000|NOT COMPLETED|Overall Study||0
6738774|NCT03286218|7667996|FG000|STARTED|Qualification Phase Period 1||48
6738775|NCT03286218|7667997|FG001|STARTED|Qualification Phase Period 1||48
6738776|NCT03286218|7667998|FG002|STARTED|Qualification Phase Period 1||0
6694669|NCT02765269|7624966|FG000|STARTED|Overall Study||25
6694670|NCT02765269|7624967|FG001|STARTED|Overall Study||21
6694671|NCT02765269|7624966|FG000|COMPLETED|Overall Study||25
6694672|NCT02765269|7624967|FG001|COMPLETED|Overall Study||21
6694673|NCT02765269|7624966|FG000|NOT COMPLETED|Overall Study||0
6694674|NCT02765269|7624967|FG001|NOT COMPLETED|Overall Study||0
6694675|NCT02765490|7624975|FG000|STARTED|Overall Study||183
6694676|NCT02765490|7624976|FG001|STARTED|Overall Study||182
6694677|NCT02765490|7624975|FG000|COMPLETED|Overall Study||182
6694678|NCT02765490|7624976|FG001|COMPLETED|Overall Study||179
6694679|NCT02765490|7624975|FG000|NOT COMPLETED|Overall Study||1
6694680|NCT02765490|7624976|FG001|NOT COMPLETED|Overall Study||3
6694681|NCT02766023|7624984|FG000|STARTED|Overall Study||152
6694682|NCT02766023|7624985|FG001|STARTED|Overall Study||76
6694683|NCT02766023|7624984|FG000|COMPLETED|Overall Study||122
6694684|NCT02766023|7624985|FG001|COMPLETED|Overall Study||59
6694685|NCT02766023|7624984|FG000|NOT COMPLETED|Overall Study||30
6694686|NCT02766023|7624985|FG001|NOT COMPLETED|Overall Study||17
6694687|NCT02766088|7624991|FG000|STARTED|Overall Study||850
6694688|NCT02766088|7624991|FG000|COMPLETED|Overall Study||344
6694689|NCT02766088|7624991|FG000|NOT COMPLETED|Overall Study||506
6694690|NCT02766244|7624995|FG000|STARTED|Overall Study||3
6694691|NCT02766244|7624995|FG000|COMPLETED|Overall Study||3
6694692|NCT02766244|7624995|FG000|NOT COMPLETED|Overall Study||0
6694693|NCT02766283|7625004|FG000|STARTED|Overall Study||843
6694694|NCT02766283|7625004|FG000|COMPLETED|Overall Study||816
6694695|NCT02766283|7625004|FG000|NOT COMPLETED|Overall Study||27
6694696|NCT02766374|7625014|FG000|STARTED|Overall Study||35
6694697|NCT02766374|7625015|FG001|STARTED|Overall Study||33
6694698|NCT02766374|7625014|FG000|COMPLETED|Overall Study||25
6694699|NCT02766374|7625015|FG001|COMPLETED|Overall Study||30
6694700|NCT02766374|7625014|FG000|NOT COMPLETED|Overall Study||10
6694701|NCT02766374|7625015|FG001|NOT COMPLETED|Overall Study||3
6694702|NCT02766400|7625023|FG000|STARTED|Overall Study||21
6694703|NCT02766400|7625024|FG001|STARTED|Overall Study||22
6694704|NCT02766400|7625023|FG000|COMPLETED|Overall Study||19
6694705|NCT02766400|7625024|FG001|COMPLETED|Overall Study||20
6694706|NCT02766400|7625023|FG000|NOT COMPLETED|Overall Study||2
6694707|NCT02766400|7625024|FG001|NOT COMPLETED|Overall Study||2
6694708|NCT02766517|7625033|FG000|STARTED|Overall Study||19
6694709|NCT02766517|7625034|FG001|STARTED|Overall Study||9
6694710|NCT02766517|7625035|FG002|STARTED|Overall Study||9
6694711|NCT02766517|7625033|FG000|COMPLETED|Overall Study||19
6694712|NCT02766517|7625034|FG001|COMPLETED|Overall Study||9
6694713|NCT02766517|7625035|FG002|COMPLETED|Overall Study||9
6694714|NCT02766517|7625033|FG000|NOT COMPLETED|Overall Study||0
6694715|NCT02766517|7625034|FG001|NOT COMPLETED|Overall Study||0
6694716|NCT02766517|7625035|FG002|NOT COMPLETED|Overall Study||0
6694717|NCT02766608|7625048|FG000|STARTED|Overall Study||655
6694718|NCT02766608|7625049|FG001|STARTED|Overall Study||637
6694719|NCT02766608|7625050|FG002|STARTED|Overall Study||644
6694720|NCT02766608|7625051|FG003|STARTED|Overall Study||206
6694721|NCT02766608|7625052|FG004|STARTED|Overall Study||219
6694722|NCT02766608|7625048|FG000|COMPLETED|Overall Study||576
6694723|NCT02766608|7625049|FG001|COMPLETED|Overall Study||567
6694724|NCT02766608|7625050|FG002|COMPLETED|Overall Study||554
6694725|NCT02766608|7625051|FG003|COMPLETED|Overall Study||169
6694726|NCT02766608|7625052|FG004|COMPLETED|Overall Study||190
6694727|NCT02766608|7625048|FG000|NOT COMPLETED|Overall Study||79
6694728|NCT02766608|7625049|FG001|NOT COMPLETED|Overall Study||70
6694729|NCT02766608|7625050|FG002|NOT COMPLETED|Overall Study||90
6694730|NCT02766608|7625051|FG003|NOT COMPLETED|Overall Study||37
6694731|NCT02766608|7625052|FG004|NOT COMPLETED|Overall Study||29
6694732|NCT02766673|7625067|FG000|STARTED|Overall Study||4
6694733|NCT02766673|7625068|FG001|STARTED|Overall Study||4
6694734|NCT02766673|7625069|FG002|STARTED|Overall Study||4
6694735|NCT02766673|7625070|FG003|STARTED|Overall Study||4
6694736|NCT02766673|7625071|FG004|STARTED|Overall Study||4
6694737|NCT02766673|7625072|FG005|STARTED|Overall Study||4
6694738|NCT02766673|7625067|FG000|COMPLETED|Overall Study||3
6694739|NCT02766673|7625068|FG001|COMPLETED|Overall Study||4
6694740|NCT02766673|7625069|FG002|COMPLETED|Overall Study||4
6694741|NCT02766673|7625070|FG003|COMPLETED|Overall Study||4
6694742|NCT02766673|7625071|FG004|COMPLETED|Overall Study||4
6694743|NCT02766673|7625072|FG005|COMPLETED|Overall Study||3
6694744|NCT02766673|7625067|FG000|NOT COMPLETED|Overall Study||1
6694745|NCT02766673|7625068|FG001|NOT COMPLETED|Overall Study||0
6694746|NCT02766673|7625069|FG002|NOT COMPLETED|Overall Study||0
6694747|NCT02766673|7625070|FG003|NOT COMPLETED|Overall Study||0
6694748|NCT02766673|7625071|FG004|NOT COMPLETED|Overall Study||0
6694749|NCT02766673|7625072|FG005|NOT COMPLETED|Overall Study||1
6694750|NCT02766777|7625080|FG000|STARTED|Overall Study||87
6694751|NCT02766777|7625080|FG000|Treated (Safety [SAF] Population)|Overall Study||87
6694752|NCT02766777|7625080|FG000|COMPLETED|Overall Study||53
6694753|NCT02766777|7625080|FG000|NOT COMPLETED|Overall Study||34
6694754|NCT02766907|7625086|FG000|STARTED|Overall Study||10
6694755|NCT02766907|7625087|FG001|STARTED|Overall Study||10
6694756|NCT02766907|7625086|FG000|COMPLETED|Overall Study||9
6694757|NCT02766907|7625087|FG001|COMPLETED|Overall Study||9
6694758|NCT02766907|7625086|FG000|NOT COMPLETED|Overall Study||1
6694759|NCT02766907|7625087|FG001|NOT COMPLETED|Overall Study||1
6694760|NCT02767011|7625095|FG000|STARTED|Overall Study||16
6694761|NCT02767011|7625096|FG001|STARTED|Overall Study||14
6694762|NCT02767011|7625095|FG000|COMPLETED|Overall Study||16
6694763|NCT02767011|7625096|FG001|COMPLETED|Overall Study||14
6694764|NCT02767011|7625095|FG000|NOT COMPLETED|Overall Study||0
6694765|NCT02767011|7625096|FG001|NOT COMPLETED|Overall Study||0
6694766|NCT02767128|7625102|FG000|STARTED|Overall Study||14
6694767|NCT02767128|7625102|FG000|Baseline|Overall Study||14
6694768|NCT02767128|7625102|FG000|Fer-In-Sol|Overall Study||14
6694769|NCT02767128|7625102|FG000|Shohl's + Fer-In-Sol|Overall Study||14
6694770|NCT02767128|7625102|FG000|Triferic|Overall Study||14
6694771|NCT02767128|7625102|FG000|Shohl's + Triferic After 10 Min|Overall Study||14
6694772|NCT02767128|7625102|FG000|Shohl's + Triferic Immediately|Overall Study||14
6694773|NCT02767128|7625102|FG000|COMPLETED|Overall Study||14
6694774|NCT02767128|7625102|FG000|NOT COMPLETED|Overall Study||0
6694775|NCT02767271|7625118|FG000|STARTED|Overall Study||15
6694776|NCT02767271|7625119|FG001|STARTED|Overall Study||15
6694777|NCT02767271|7625118|FG000|Safety Population|Overall Study||15
6694778|NCT02767271|7625119|FG001|Safety Population|Overall Study||15
6694779|NCT02767271|7625118|FG000|Pharmacokinetic Pedis (PKP) Population|Overall Study||15
6694780|NCT02767271|7625119|FG001|Pharmacokinetic Pedis (PKP) Population|Overall Study||0
6694781|NCT02767271|7625118|FG000|Pharmacokinetic Cruris (PKC) Population|Overall Study||0
6694782|NCT02767271|7625119|FG001|Pharmacokinetic Cruris (PKC) Population|Overall Study||15
6259047|NCT04022733|7158147|FG000|COMPLETED|Overall Study||64
6259048|NCT04022733|7158148|FG001|COMPLETED|Overall Study||64
6259049|NCT04022733|7158147|FG000|NOT COMPLETED|Overall Study||3
6259050|NCT04022733|7158148|FG001|NOT COMPLETED|Overall Study||3
6259051|NCT04021524|7158156|FG000|STARTED|Overall Study||25
6259052|NCT04021524|7158157|FG001|STARTED|Overall Study||25
6259053|NCT04021524|7158156|FG000|COMPLETED|Overall Study||25
6259054|NCT04021524|7158157|FG001|COMPLETED|Overall Study||24
6259055|NCT04021524|7158156|FG000|NOT COMPLETED|Overall Study||0
6259056|NCT04021524|7158157|FG001|NOT COMPLETED|Overall Study||1
6259057|NCT03963895|7158166|FG000|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
6259058|NCT03963895|7158167|FG001|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
6259059|NCT03963895|7158168|FG002|STARTED|Pre-dose Period (Study Days -7, -5, -2)||12
6259060|NCT03963895|7158166|FG000|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
6259061|NCT03963895|7158167|FG001|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
6259062|NCT03963895|7158168|FG002|COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||12
6259063|NCT03963895|7158166|FG000|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
6259064|NCT03963895|7158167|FG001|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
6259065|NCT03963895|7158168|FG002|NOT COMPLETED|Pre-dose Period (Study Days -7, -5, -2)||0
6259066|NCT03963895|7158166|FG000|STARTED|Dosing Period (Study Day 1)||12
6259067|NCT03963895|7158167|FG001|STARTED|Dosing Period (Study Day 1)||12
6259068|NCT03963895|7158168|FG002|STARTED|Dosing Period (Study Day 1)||12
6259069|NCT03963895|7158166|FG000|COMPLETED|Dosing Period (Study Day 1)||12
6259070|NCT03963895|7158167|FG001|COMPLETED|Dosing Period (Study Day 1)||12
6259071|NCT03963895|7158168|FG002|COMPLETED|Dosing Period (Study Day 1)||12
6259072|NCT03963895|7158166|FG000|NOT COMPLETED|Dosing Period (Study Day 1)||0
6259073|NCT03963895|7158167|FG001|NOT COMPLETED|Dosing Period (Study Day 1)||0
6259074|NCT03963895|7158168|FG002|NOT COMPLETED|Dosing Period (Study Day 1)||0
6259075|NCT03963895|7158166|FG000|STARTED|Recovery Period (Study Day 3)||12
6259076|NCT03963895|7158167|FG001|STARTED|Recovery Period (Study Day 3)||12
6259077|NCT03963895|7158168|FG002|STARTED|Recovery Period (Study Day 3)||12
6259078|NCT03963895|7158166|FG000|COMPLETED|Recovery Period (Study Day 3)||12
6259079|NCT03963895|7158167|FG001|COMPLETED|Recovery Period (Study Day 3)||12
6259080|NCT03963895|7158168|FG002|COMPLETED|Recovery Period (Study Day 3)||12
6259081|NCT03963895|7158166|FG000|NOT COMPLETED|Recovery Period (Study Day 3)||0
6259082|NCT03963895|7158167|FG001|NOT COMPLETED|Recovery Period (Study Day 3)||0
6259083|NCT03963895|7158168|FG002|NOT COMPLETED|Recovery Period (Study Day 3)||0
6259084|NCT03963895|7158166|FG000|STARTED|Follow-up Period (Study Day 14)||12
6259085|NCT03963895|7158167|FG001|STARTED|Follow-up Period (Study Day 14)||12
6259086|NCT03963895|7158168|FG002|STARTED|Follow-up Period (Study Day 14)||12
6259087|NCT03963895|7158166|FG000|COMPLETED|Follow-up Period (Study Day 14)||12
6259088|NCT03963895|7158167|FG001|COMPLETED|Follow-up Period (Study Day 14)||11
6259089|NCT03963895|7158168|FG002|COMPLETED|Follow-up Period (Study Day 14)||12
6259090|NCT03963895|7158166|FG000|NOT COMPLETED|Follow-up Period (Study Day 14)||0
6259091|NCT03963895|7158167|FG001|NOT COMPLETED|Follow-up Period (Study Day 14)||1
6259092|NCT03963895|7158168|FG002|NOT COMPLETED|Follow-up Period (Study Day 14)||0
6280169|NCT00151775|7180014|FG011|NOT COMPLETED|Period 4: Open Label||0
6280170|NCT00151814|7180058|FG000|STARTED|Overall Study||4
6280171|NCT00151814|7180059|FG001|STARTED|Overall Study||10
6280172|NCT00151814|7180060|FG002|STARTED|Overall Study||10
6280173|NCT00151814|7180058|FG000|COMPLETED|Overall Study||4
6280174|NCT00151814|7180059|FG001|COMPLETED|Overall Study||10
6280175|NCT00151814|7180060|FG002|COMPLETED|Overall Study||10
6280176|NCT00151814|7180058|FG000|NOT COMPLETED|Overall Study||0
6280177|NCT00151814|7180059|FG001|NOT COMPLETED|Overall Study||0
6280178|NCT00151814|7180060|FG002|NOT COMPLETED|Overall Study||0
6280179|NCT00151892|7180069|FG000|STARTED|Overall Study||416
6280180|NCT00151892|7180070|FG001|STARTED|Overall Study||413
6280181|NCT00151892|7180069|FG000|COMPLETED|Overall Study||340
6280182|NCT00151892|7180070|FG001|COMPLETED|Overall Study||330
6280183|NCT00151892|7180069|FG000|NOT COMPLETED|Overall Study||76
6280184|NCT00151892|7180070|FG001|NOT COMPLETED|Overall Study||83
6694783|NCT02767271|7625118|FG000|COMPLETED|Overall Study||15
6694784|NCT02767271|7625119|FG001|COMPLETED|Overall Study||15
6694785|NCT02767271|7625118|FG000|NOT COMPLETED|Overall Study||0
6694786|NCT02767271|7625119|FG001|NOT COMPLETED|Overall Study||0
6694787|NCT02767323|7625129|FG000|STARTED|Overall Study||83
6694788|NCT02767323|7625130|FG001|STARTED|Overall Study||42
6694789|NCT02767323|7625131|FG002|STARTED|Overall Study||58
6694790|NCT02767323|7625132|FG003|STARTED|Overall Study||1
6694791|NCT02767323|7625129|FG000|COMPLETED|Overall Study||49
6694792|NCT02767323|7625130|FG001|COMPLETED|Overall Study||17
6694793|NCT02767323|7625131|FG002|COMPLETED|Overall Study||28
6694794|NCT02767323|7625132|FG003|COMPLETED|Overall Study||1
6694795|NCT02767323|7625129|FG000|NOT COMPLETED|Overall Study||34
6694796|NCT02767323|7625130|FG001|NOT COMPLETED|Overall Study||25
6694797|NCT02767323|7625131|FG002|NOT COMPLETED|Overall Study||30
6694798|NCT02767323|7625132|FG003|NOT COMPLETED|Overall Study||0
6694799|NCT02767388|7625148|FG000|STARTED|Overall Study||15
6694800|NCT02767388|7625149|FG001|STARTED|Overall Study||15
6694801|NCT02767388|7625150|FG002|STARTED|Overall Study||15
6694802|NCT02767388|7625148|FG000|COMPLETED|Overall Study||8
6694803|NCT02767388|7625149|FG001|COMPLETED|Overall Study||10
6694804|NCT02767388|7625150|FG002|COMPLETED|Overall Study||12
6694805|NCT02767388|7625148|FG000|NOT COMPLETED|Overall Study||7
6694806|NCT02767388|7625149|FG001|NOT COMPLETED|Overall Study||5
6694807|NCT02767388|7625150|FG002|NOT COMPLETED|Overall Study||3
6694808|NCT02767427|7625160|FG000|STARTED|Overall Study||21
6694809|NCT02767427|7625161|FG001|STARTED|Overall Study||19
6694810|NCT02767427|7625160|FG000|COMPLETED|Overall Study||21
6694811|NCT02767427|7625161|FG001|COMPLETED|Overall Study||19
6694812|NCT02767427|7625160|FG000|NOT COMPLETED|Overall Study||0
6694813|NCT02767427|7625161|FG001|NOT COMPLETED|Overall Study||0
6694814|NCT02767492|7625169|FG000|STARTED|Overall Study||45
6694815|NCT02767492|7625170|FG001|STARTED|Overall Study||45
6694816|NCT02767492|7625169|FG000|COMPLETED|Overall Study||35
6694817|NCT02767492|7625170|FG001|COMPLETED|Overall Study||35
6694818|NCT02767492|7625169|FG000|NOT COMPLETED|Overall Study||10
6694819|NCT02767492|7625170|FG001|NOT COMPLETED|Overall Study||10
6694820|NCT02767609|7625176|FG000|STARTED|Overall Study||1
6694821|NCT02767609|7625176|FG000|COMPLETED|Overall Study||1
6694822|NCT02767609|7625176|FG000|NOT COMPLETED|Overall Study||0
6694823|NCT02767765|7625180|FG000|STARTED|Overall Study||61
6694824|NCT02767765|7625180|FG000|COMPLETED|Overall Study||50
6694825|NCT02767765|7625180|FG000|NOT COMPLETED|Overall Study||11
6694826|NCT02767843|7625184|FG000|STARTED|Overall Study||4
6694827|NCT02767843|7625184|FG000|COMPLETED|Overall Study||4
6694828|NCT02767843|7625184|FG000|NOT COMPLETED|Overall Study||0
6694829|NCT02767869|7625192|FG000|STARTED|Overall Study||12
6694830|NCT02767869|7625193|FG001|STARTED|Overall Study||12
6694831|NCT02767869|7625192|FG000|COMPLETED|Overall Study||12
6694832|NCT02767869|7625193|FG001|COMPLETED|Overall Study||12
6694833|NCT02767869|7625192|FG000|NOT COMPLETED|Overall Study||0
6694834|NCT02767869|7625193|FG001|NOT COMPLETED|Overall Study||0
6694835|NCT02767934|7625199|FG000|STARTED|Overall Study||12
6694836|NCT02767934|7625199|FG000|COMPLETED|Overall Study||12
6694837|NCT02767934|7625199|FG000|NOT COMPLETED|Overall Study||0
6694838|NCT02767947|7625206|FG000|STARTED|Overall Study||60
6694839|NCT02767947|7625207|FG001|STARTED|Overall Study||15
6694840|NCT02767947|7625206|FG000|Safety Population|Overall Study||60
6694841|NCT02767947|7625207|FG001|Safety Population|Overall Study||15
6694842|NCT02767947|7625206|FG000|Pharmacokinetic (PK) Population|Overall Study||12
6694843|NCT02767947|7625207|FG001|Pharmacokinetic (PK) Population|Overall Study||3
6694844|NCT02767947|7625206|FG000|COMPLETED|Overall Study||60
6694845|NCT02767947|7625207|FG001|COMPLETED|Overall Study||15
6694846|NCT02767947|7625206|FG000|NOT COMPLETED|Overall Study||0
6694847|NCT02767947|7625207|FG001|NOT COMPLETED|Overall Study||0
6694848|NCT02768103|7625213|FG000|STARTED|Overall Study||5
6694849|NCT02768103|7625213|FG000|COMPLETED|Overall Study||4
6694850|NCT02768103|7625213|FG000|NOT COMPLETED|Overall Study||1
6694851|NCT02768129|7625219|FG000|STARTED|Overall Study||11
6694852|NCT02768129|7625220|FG001|STARTED|Overall Study||10
6694853|NCT02768129|7625219|FG000|COMPLETED|Overall Study||11
6694854|NCT02768129|7625220|FG001|COMPLETED|Overall Study||10
6694855|NCT02768129|7625219|FG000|NOT COMPLETED|Overall Study||0
6694856|NCT02768129|7625220|FG001|NOT COMPLETED|Overall Study||0
6694857|NCT02768194|7625226|FG000|STARTED|Period 1||4
6694858|NCT02768194|7625227|FG001|STARTED|Period 1||4
6694859|NCT02768194|7625228|FG002|STARTED|Period 1||4
6694860|NCT02768194|7625229|FG003|STARTED|Period 1||4
6694861|NCT02768194|7625230|FG004|STARTED|Period 1||4
6694862|NCT02768194|7625231|FG005|STARTED|Period 1||4
6694863|NCT02768194|7625226|FG000|COMPLETED|Period 1||4
6694864|NCT02768194|7625227|FG001|COMPLETED|Period 1||4
6694865|NCT02768194|7625228|FG002|COMPLETED|Period 1||4
6694866|NCT02768194|7625229|FG003|COMPLETED|Period 1||3
6694867|NCT02768194|7625230|FG004|COMPLETED|Period 1||4
6694868|NCT02768194|7625231|FG005|COMPLETED|Period 1||4
6694869|NCT02768194|7625226|FG000|NOT COMPLETED|Period 1||0
6694870|NCT02768194|7625227|FG001|NOT COMPLETED|Period 1||0
6694871|NCT02768194|7625228|FG002|NOT COMPLETED|Period 1||0
6694872|NCT02768194|7625229|FG003|NOT COMPLETED|Period 1||1
6694873|NCT02768194|7625230|FG004|NOT COMPLETED|Period 1||0
6694874|NCT02768194|7625231|FG005|NOT COMPLETED|Period 1||0
6694875|NCT02768194|7625226|FG000|STARTED|Period 2||4
6694876|NCT02768194|7625227|FG001|STARTED|Period 2||4
6694877|NCT02768194|7625228|FG002|STARTED|Period 2||4
6694878|NCT02768194|7625229|FG003|STARTED|Period 2||3
6694879|NCT02768194|7625230|FG004|STARTED|Period 2||4
6694880|NCT02768194|7625231|FG005|STARTED|Period 2||4
6694881|NCT02768194|7625226|FG000|COMPLETED|Period 2||3
6694882|NCT02768194|7625227|FG001|COMPLETED|Period 2||4
6694883|NCT02768194|7625228|FG002|COMPLETED|Period 2||4
6694884|NCT02768194|7625229|FG003|COMPLETED|Period 2||3
6694885|NCT02768194|7625230|FG004|COMPLETED|Period 2||4
6694886|NCT02768194|7625231|FG005|COMPLETED|Period 2||4
6694887|NCT02768194|7625226|FG000|NOT COMPLETED|Period 2||1
6694888|NCT02768194|7625227|FG001|NOT COMPLETED|Period 2||0
6694889|NCT02768194|7625228|FG002|NOT COMPLETED|Period 2||0
6694890|NCT02768194|7625229|FG003|NOT COMPLETED|Period 2||0
6694891|NCT02768194|7625230|FG004|NOT COMPLETED|Period 2||0
6694892|NCT02768194|7625231|FG005|NOT COMPLETED|Period 2||0
6694893|NCT02768194|7625226|FG000|STARTED|Period 3||3
6694894|NCT02768194|7625227|FG001|STARTED|Period 3||4
6694895|NCT02768194|7625228|FG002|STARTED|Period 3||4
6694896|NCT02768194|7625229|FG003|STARTED|Period 3||3
6694897|NCT02768194|7625230|FG004|STARTED|Period 3||4
6694898|NCT02768194|7625231|FG005|STARTED|Period 3||4
6694899|NCT02768194|7625226|FG000|COMPLETED|Period 3||3
6694900|NCT02768194|7625227|FG001|COMPLETED|Period 3||3
6694901|NCT02768194|7625228|FG002|COMPLETED|Period 3||4
6694902|NCT02768194|7625229|FG003|COMPLETED|Period 3||3
6694903|NCT02768194|7625230|FG004|COMPLETED|Period 3||4
6694904|NCT02768194|7625231|FG005|COMPLETED|Period 3||4
6694905|NCT02768194|7625226|FG000|NOT COMPLETED|Period 3||0
6694906|NCT02768194|7625227|FG001|NOT COMPLETED|Period 3||1
6694907|NCT02768194|7625228|FG002|NOT COMPLETED|Period 3||0
6694908|NCT02768194|7625229|FG003|NOT COMPLETED|Period 3||0
6694909|NCT02768194|7625230|FG004|NOT COMPLETED|Period 3||0
6694910|NCT02768194|7625231|FG005|NOT COMPLETED|Period 3||0
6694911|NCT02768298|7625241|FG000|STARTED|Overall Study||103
6694912|NCT02768298|7625242|FG001|STARTED|Overall Study||98
6694913|NCT02768298|7625241|FG000|COMPLETED|Overall Study||99
6694914|NCT02768298|7625242|FG001|COMPLETED|Overall Study||91
6694915|NCT02768298|7625241|FG000|NOT COMPLETED|Overall Study||4
6694916|NCT02768298|7625242|FG001|NOT COMPLETED|Overall Study||7
6694917|NCT02768558|7625250|FG000|STARTED|Overall Study||3
6694918|NCT02768558|7625251|FG001|STARTED|Overall Study||5
6694919|NCT02768558|7625250|FG000|Eligible|Overall Study||3
6694920|NCT02768558|7625251|FG001|Eligible|Overall Study||5
6694921|NCT02768558|7625250|FG000|COMPLETED|Overall Study||3
6694922|NCT02768558|7625251|FG001|COMPLETED|Overall Study||5
6694923|NCT02768558|7625250|FG000|NOT COMPLETED|Overall Study||0
6694924|NCT02768558|7625251|FG001|NOT COMPLETED|Overall Study||0
6694925|NCT02768753|7625259|FG000|STARTED|Overall Study||30
6694926|NCT02768753|7625260|FG001|STARTED|Overall Study||30
6694927|NCT02768753|7625259|FG000|COMPLETED|Overall Study||30
6694928|NCT02768753|7625260|FG001|COMPLETED|Overall Study||30
6694929|NCT02768753|7625259|FG000|NOT COMPLETED|Overall Study||0
6694930|NCT02768753|7625260|FG001|NOT COMPLETED|Overall Study||0
6694931|NCT02768792|7625266|FG000|STARTED|Overall Study||38
6694932|NCT02768792|7625266|FG000|COMPLETED|Overall Study||37
6694933|NCT02768792|7625266|FG000|NOT COMPLETED|Overall Study||1
6694934|NCT02769065|7625300|FG000|STARTED|Overall Study||17
6694935|NCT02769065|7625301|FG001|STARTED|Overall Study||6
6694936|NCT02769065|7625302|FG002|STARTED|Overall Study||6
6694937|NCT02769065|7625303|FG003|STARTED|Overall Study||6
6694938|NCT02769065|7625304|FG004|STARTED|Overall Study||6
6694939|NCT02769065|7625305|FG005|STARTED|Overall Study||6
6694940|NCT02769065|7625306|FG006|STARTED|Overall Study||7
6694941|NCT02769065|7625307|FG007|STARTED|Overall Study||6
6694942|NCT02769065|7625308|FG008|STARTED|Overall Study||6
6694943|NCT02769065|7625309|FG009|STARTED|Overall Study||6
6694944|NCT02769065|7625310|FG010|STARTED|Overall Study||6
6694945|NCT02769065|7625311|FG011|STARTED|Overall Study||6
6694946|NCT02769065|7625312|FG012|STARTED|Overall Study||6
6694947|NCT02769065|7625313|FG013|STARTED|Overall Study||6
6694948|NCT02769065|7625314|FG014|STARTED|Overall Study||6
6694949|NCT02769065|7625315|FG015|STARTED|Overall Study||3
6694950|NCT02769065|7625316|FG016|STARTED|Overall Study||5
6694951|NCT02769065|7625317|FG017|STARTED|Overall Study||5
6694952|NCT02769065|7625318|FG018|STARTED|Overall Study||5
6694953|NCT02769065|7625319|FG019|STARTED|Overall Study||0
6694954|NCT02769065|7625320|FG020|STARTED|Overall Study||4
6694955|NCT02769065|7625321|FG021|STARTED|Overall Study||4
6694956|NCT02769065|7625322|FG022|STARTED|Overall Study||4
6694957|NCT02769065|7625323|FG023|STARTED|Overall Study||6
6694958|NCT02769065|7625324|FG024|STARTED|Overall Study||6
6694959|NCT02769065|7625325|FG025|STARTED|Overall Study||9
6694960|NCT02769065|7625326|FG026|STARTED|Overall Study||9
6694961|NCT02769065|7625327|FG027|STARTED|Overall Study||5
6694962|NCT02769065|7625328|FG028|STARTED|Overall Study||6
6694963|NCT02769065|7625329|FG029|STARTED|Overall Study||6
6694964|NCT02769065|7625300|FG000|COMPLETED|Overall Study||16
6694965|NCT02769065|7625301|FG001|COMPLETED|Overall Study||6
6694966|NCT02769065|7625302|FG002|COMPLETED|Overall Study||6
6694967|NCT02769065|7625303|FG003|COMPLETED|Overall Study||6
6694968|NCT02769065|7625304|FG004|COMPLETED|Overall Study||6
6694969|NCT02769065|7625305|FG005|COMPLETED|Overall Study||6
6694970|NCT02769065|7625306|FG006|COMPLETED|Overall Study||6
6694971|NCT02769065|7625307|FG007|COMPLETED|Overall Study||6
6694972|NCT02769065|7625308|FG008|COMPLETED|Overall Study||6
6694973|NCT02769065|7625309|FG009|COMPLETED|Overall Study||6
6694974|NCT02769065|7625310|FG010|COMPLETED|Overall Study||5
6694975|NCT02769065|7625311|FG011|COMPLETED|Overall Study||6
6694976|NCT02769065|7625312|FG012|COMPLETED|Overall Study||6
6694977|NCT02769065|7625313|FG013|COMPLETED|Overall Study||6
6694978|NCT02769065|7625314|FG014|COMPLETED|Overall Study||6
6694979|NCT02769065|7625315|FG015|COMPLETED|Overall Study||3
6694980|NCT02769065|7625316|FG016|COMPLETED|Overall Study||5
6259093|NCT03830359|7158176|FG000|STARTED|Overall Study||62
6259094|NCT03830359|7158176|FG000|COMPLETED|Overall Study||62
6259095|NCT03830359|7158176|FG000|NOT COMPLETED|Overall Study||0
6259096|NCT03675516|7158182|FG000|STARTED|Overall Study||6591
6259097|NCT03675516|7158183|FG001|STARTED|Overall Study||6591
6259098|NCT03675516|7158182|FG000|COMPLETED|Overall Study||6591
6259099|NCT03675516|7158183|FG001|COMPLETED|Overall Study||6591
6259100|NCT03675516|7158182|FG000|NOT COMPLETED|Overall Study||0
6259101|NCT03675516|7158183|FG001|NOT COMPLETED|Overall Study||0
6259102|NCT03605680|7158194|FG000|STARTED|SB Placebo Run-in Period (1 Week)||604
6259103|NCT03605680|7158195|FG001|STARTED|SB Placebo Run-in Period (1 Week)||0
6259104|NCT03605680|7158196|FG002|STARTED|SB Placebo Run-in Period (1 Week)||0
6259105|NCT03605680|7158197|FG003|STARTED|SB Placebo Run-in Period (1 Week)||0
6259106|NCT03605680|7158194|FG000|Treated|SB Placebo Run-in Period (1 Week)||584
6259107|NCT03605680|7158195|FG001|Treated|SB Placebo Run-in Period (1 Week)||0
6259108|NCT03605680|7158196|FG002|Treated|SB Placebo Run-in Period (1 Week)||0
6259109|NCT03605680|7158197|FG003|Treated|SB Placebo Run-in Period (1 Week)||0
6259110|NCT03605680|7158194|FG000|COMPLETED|SB Placebo Run-in Period (1 Week)||466
6259111|NCT03605680|7158195|FG001|COMPLETED|SB Placebo Run-in Period (1 Week)||0
6259112|NCT03605680|7158196|FG002|COMPLETED|SB Placebo Run-in Period (1 Week)||0
6259113|NCT03605680|7158197|FG003|COMPLETED|SB Placebo Run-in Period (1 Week)||0
6259114|NCT03605680|7158194|FG000|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||138
6259115|NCT03605680|7158195|FG001|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
6259116|NCT03605680|7158196|FG002|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
6259117|NCT03605680|7158197|FG003|NOT COMPLETED|SB Placebo Run-in Period (1 Week)||0
6259118|NCT03605680|7158194|FG000|STARTED|Double-blind Treatment Period (6 Weeks)||0
6259119|NCT03605680|7158195|FG001|STARTED|Double-blind Treatment Period (6 Weeks)||154
6259120|NCT03605680|7158196|FG002|STARTED|Double-blind Treatment Period (6 Weeks)||156
6259121|NCT03605680|7158197|FG003|STARTED|Double-blind Treatment Period (6 Weeks)||156
6259122|NCT03605680|7158194|FG000|COMPLETED|Double-blind Treatment Period (6 Weeks)||0
6259123|NCT03605680|7158195|FG001|COMPLETED|Double-blind Treatment Period (6 Weeks)||110
6259124|NCT03605680|7158196|FG002|COMPLETED|Double-blind Treatment Period (6 Weeks)||117
6259125|NCT03605680|7158197|FG003|COMPLETED|Double-blind Treatment Period (6 Weeks)||121
6259126|NCT03605680|7158194|FG000|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||0
6259127|NCT03605680|7158195|FG001|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||44
6259128|NCT03605680|7158196|FG002|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||39
6259129|NCT03605680|7158197|FG003|NOT COMPLETED|Double-blind Treatment Period (6 Weeks)||35
6259130|NCT03485950|7158208|FG000|STARTED|Overall Study||50
6259131|NCT03485950|7158209|FG001|STARTED|Overall Study||50
6259132|NCT03485950|7158208|FG000|COMPLETED|Overall Study||43
6259133|NCT03485950|7158209|FG001|COMPLETED|Overall Study||48
6259134|NCT03485950|7158208|FG000|NOT COMPLETED|Overall Study||7
6259135|NCT03485950|7158209|FG001|NOT COMPLETED|Overall Study||2
6259136|NCT03404518|7158217|FG000|STARTED|Overall Study||97
6259137|NCT03404518|7158218|FG001|STARTED|Overall Study||88
6259138|NCT03404518|7158217|FG000|COMPLETED|Overall Study||56
6259139|NCT03404518|7158218|FG001|COMPLETED|Overall Study||52
6259140|NCT03404518|7158217|FG000|NOT COMPLETED|Overall Study||41
6259141|NCT03404518|7158218|FG001|NOT COMPLETED|Overall Study||36
6259142|NCT03402841|7158224|FG000|STARTED|Overall Study||279
6259143|NCT03402841|7158224|FG000|COMPLETED|Overall Study||187
6259144|NCT03402841|7158224|FG000|NOT COMPLETED|Overall Study||92
6259145|NCT03370757|7158230|FG000|STARTED|Overall Study||20
6259146|NCT03370757|7158231|FG001|STARTED|Overall Study||28
6259147|NCT03370757|7158230|FG000|COMPLETED|Overall Study||20
6259148|NCT03370757|7158231|FG001|COMPLETED|Overall Study||26
6259149|NCT03370757|7158230|FG000|NOT COMPLETED|Overall Study||0
6259150|NCT03370757|7158231|FG001|NOT COMPLETED|Overall Study||2
6259151|NCT03303989|7158241|FG000|STARTED|Overall Study||24
6259152|NCT03303989|7158242|FG001|STARTED|Overall Study||11
6259153|NCT03303989|7158241|FG000|COMPLETED|Overall Study||22
6259154|NCT03303989|7158242|FG001|COMPLETED|Overall Study||10
6259155|NCT03303989|7158241|FG000|NOT COMPLETED|Overall Study||2
6259156|NCT03303989|7158242|FG001|NOT COMPLETED|Overall Study||1
6259157|NCT03289143|7158252|FG000|STARTED|Overall Study||135
6259158|NCT03289143|7158253|FG001|STARTED|Overall Study||94
6259159|NCT03289143|7158254|FG002|STARTED|Overall Study||136
6259160|NCT03289143|7158255|FG003|STARTED|Overall Study||92
6259161|NCT03289143|7158252|FG000|COMPLETED|Overall Study||1
6259162|NCT03289143|7158253|FG001|COMPLETED|Overall Study||0
6259163|NCT03289143|7158254|FG002|COMPLETED|Overall Study||2
6259164|NCT03289143|7158255|FG003|COMPLETED|Overall Study||0
6259165|NCT03289143|7158252|FG000|NOT COMPLETED|Overall Study||134
6259166|NCT03289143|7158253|FG001|NOT COMPLETED|Overall Study||94
6259167|NCT03289143|7158254|FG002|NOT COMPLETED|Overall Study||134
6259168|NCT03289143|7158255|FG003|NOT COMPLETED|Overall Study||92
6259169|NCT03156504|7158270|FG000|STARTED|Overall Study||75
6259170|NCT03156504|7158270|FG000|COMPLETED|Overall Study||74
6259171|NCT03156504|7158270|FG000|NOT COMPLETED|Overall Study||1
6694981|NCT02769065|7625317|FG017|COMPLETED|Overall Study||5
6694982|NCT02769065|7625318|FG018|COMPLETED|Overall Study||5
6694983|NCT02769065|7625319|FG019|COMPLETED|Overall Study||0
6694984|NCT02769065|7625320|FG020|COMPLETED|Overall Study||4
6694985|NCT02769065|7625321|FG021|COMPLETED|Overall Study||4
6694986|NCT02769065|7625322|FG022|COMPLETED|Overall Study||4
6694987|NCT02769065|7625323|FG023|COMPLETED|Overall Study||6
6694988|NCT02769065|7625324|FG024|COMPLETED|Overall Study||6
6694989|NCT02769065|7625325|FG025|COMPLETED|Overall Study||9
6694990|NCT02769065|7625326|FG026|COMPLETED|Overall Study||9
6694991|NCT02769065|7625327|FG027|COMPLETED|Overall Study||5
6694992|NCT02769065|7625328|FG028|COMPLETED|Overall Study||6
6694993|NCT02769065|7625329|FG029|COMPLETED|Overall Study||6
6694994|NCT02769065|7625300|FG000|NOT COMPLETED|Overall Study||1
6694995|NCT02769065|7625301|FG001|NOT COMPLETED|Overall Study||0
6694996|NCT02769065|7625302|FG002|NOT COMPLETED|Overall Study||0
6694997|NCT02769065|7625303|FG003|NOT COMPLETED|Overall Study||0
6694998|NCT02769065|7625304|FG004|NOT COMPLETED|Overall Study||0
6694999|NCT02769065|7625305|FG005|NOT COMPLETED|Overall Study||0
6695000|NCT02769065|7625306|FG006|NOT COMPLETED|Overall Study||1
6695001|NCT02769065|7625307|FG007|NOT COMPLETED|Overall Study||0
6695002|NCT02769065|7625308|FG008|NOT COMPLETED|Overall Study||0
6695003|NCT02769065|7625309|FG009|NOT COMPLETED|Overall Study||0
6695004|NCT02769065|7625310|FG010|NOT COMPLETED|Overall Study||1
6695005|NCT02769065|7625311|FG011|NOT COMPLETED|Overall Study||0
6695006|NCT02769065|7625312|FG012|NOT COMPLETED|Overall Study||0
6695007|NCT02769065|7625313|FG013|NOT COMPLETED|Overall Study||0
6695008|NCT02769065|7625314|FG014|NOT COMPLETED|Overall Study||0
6695009|NCT02769065|7625315|FG015|NOT COMPLETED|Overall Study||0
6695010|NCT02769065|7625316|FG016|NOT COMPLETED|Overall Study||0
6695011|NCT02769065|7625317|FG017|NOT COMPLETED|Overall Study||0
6695012|NCT02769065|7625318|FG018|NOT COMPLETED|Overall Study||0
6695013|NCT02769065|7625319|FG019|NOT COMPLETED|Overall Study||0
6695014|NCT02769065|7625320|FG020|NOT COMPLETED|Overall Study||0
6695015|NCT02769065|7625321|FG021|NOT COMPLETED|Overall Study||0
6695016|NCT02769065|7625322|FG022|NOT COMPLETED|Overall Study||0
6695017|NCT02769065|7625323|FG023|NOT COMPLETED|Overall Study||0
6695018|NCT02769065|7625324|FG024|NOT COMPLETED|Overall Study||0
6695019|NCT02769065|7625325|FG025|NOT COMPLETED|Overall Study||0
6695020|NCT02769065|7625326|FG026|NOT COMPLETED|Overall Study||0
6695021|NCT02769065|7625327|FG027|NOT COMPLETED|Overall Study||0
6695022|NCT02769065|7625328|FG028|NOT COMPLETED|Overall Study||0
6695023|NCT02769065|7625329|FG029|NOT COMPLETED|Overall Study||0
6695024|NCT02769247|7625426|FG000|STARTED|Overall Study||40
6695025|NCT02769247|7625427|FG001|STARTED|Overall Study||40
6695026|NCT02769247|7625428|FG002|STARTED|Overall Study||40
6695027|NCT02769247|7625429|FG003|STARTED|Overall Study||40
6695028|NCT02769247|7625426|FG000|COMPLETED|Overall Study|unable to insert IUD in one patient; 1 pt decided against study participation after enrollment|38
6695029|NCT02769247|7625427|FG001|COMPLETED|Overall Study||40
6695030|NCT02769247|7625428|FG002|COMPLETED|Overall Study|1 took non-study med after enrollment/randomization, before IUD insertion (excluded from study)|39
6695031|NCT02769247|7625429|FG003|COMPLETED|Overall Study|1 patient decided against study participation after enrollment/randomization|39
6695032|NCT02769247|7625426|FG000|NOT COMPLETED|Overall Study||2
6695033|NCT02769247|7625427|FG001|NOT COMPLETED|Overall Study||0
6695034|NCT02769247|7625428|FG002|NOT COMPLETED|Overall Study||1
6695035|NCT02769247|7625429|FG003|NOT COMPLETED|Overall Study||1
6695036|NCT02769312|7625445|FG000|STARTED|Double-Blind (0-2 Weeks)||25
6695037|NCT02769312|7625446|FG001|STARTED|Double-Blind (0-2 Weeks)||25
6695038|NCT02769312|7625445|FG000|COMPLETED|Double-Blind (0-2 Weeks)||23
6695039|NCT02769312|7625446|FG001|COMPLETED|Double-Blind (0-2 Weeks)||24
6695040|NCT02769312|7625445|FG000|NOT COMPLETED|Double-Blind (0-2 Weeks)||2
6695041|NCT02769312|7625446|FG001|NOT COMPLETED|Double-Blind (0-2 Weeks)||1
6695042|NCT02769312|7625445|FG000|STARTED|Unblinded (Optional 2-4 Weeks)|2 participants chose not to continue with the unblinded period.|21
6695043|NCT02769312|7625446|FG001|STARTED|Unblinded (Optional 2-4 Weeks)||24
6695044|NCT02769312|7625445|FG000|COMPLETED|Unblinded (Optional 2-4 Weeks)||20
6695045|NCT02769312|7625446|FG001|COMPLETED|Unblinded (Optional 2-4 Weeks)||23
6695046|NCT02769312|7625445|FG000|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
6695047|NCT02769312|7625446|FG001|NOT COMPLETED|Unblinded (Optional 2-4 Weeks)||1
6695048|NCT02769312|7625445|FG000|STARTED|Follow-up||23
6695049|NCT02769312|7625446|FG001|STARTED|Follow-up||24
6695050|NCT02769312|7625445|FG000|COMPLETED|Follow-up||22
6695051|NCT02769312|7625446|FG001|COMPLETED|Follow-up||23
6695052|NCT02769312|7625445|FG000|NOT COMPLETED|Follow-up||1
6695053|NCT02769312|7625446|FG001|NOT COMPLETED|Follow-up||1
6695054|NCT02769351|7625453|FG000|STARTED|Overall Study|SP|46
6695055|NCT02769351|7625453|FG000|COMPLETED|Overall Study|SP|4
6695056|NCT02769351|7625453|FG000|NOT COMPLETED|Overall Study||42
6695057|NCT02769442|7625460|FG000|STARTED|Overall Study||309
6695058|NCT02769442|7625461|FG001|STARTED|Overall Study||291
6695059|NCT02769442|7625460|FG000|COMPLETED|Overall Study||309
6695060|NCT02769442|7625461|FG001|COMPLETED|Overall Study||291
6695061|NCT02769442|7625460|FG000|NOT COMPLETED|Overall Study||0
6695062|NCT02769442|7625461|FG001|NOT COMPLETED|Overall Study||0
6695063|NCT02769481|7625469|FG000|STARTED|Overall Study||213
6695064|NCT02769481|7625470|FG001|STARTED|Overall Study||213
6695065|NCT02769481|7625469|FG000|Study Complete at Week 60|Overall Study||193
6695066|NCT02769481|7625470|FG001|Study Complete at Week 60|Overall Study||192
6695067|NCT02769481|7625469|FG000|COMPLETED|Overall Study||180
6695068|NCT02769481|7625470|FG001|COMPLETED|Overall Study||177
6695069|NCT02769481|7625469|FG000|NOT COMPLETED|Overall Study||33
6695070|NCT02769481|7625470|FG001|NOT COMPLETED|Overall Study||36
6695071|NCT02769624|7625476|FG000|STARTED|Overall Study||7
6695072|NCT02769624|7625477|FG001|STARTED|Overall Study||8
6695073|NCT02769624|7625476|FG000|COMPLETED|Overall Study||7
6695074|NCT02769624|7625477|FG001|COMPLETED|Overall Study||7
6695075|NCT02769624|7625476|FG000|NOT COMPLETED|Overall Study||0
6695076|NCT02769624|7625477|FG001|NOT COMPLETED|Overall Study||1
6695077|NCT02769702|7625483|FG000|STARTED|Overall Study||2
6695078|NCT02769702|7625483|FG000|COMPLETED|Overall Study||2
6695079|NCT02769702|7625483|FG000|NOT COMPLETED|Overall Study||0
6695080|NCT02769858|7625487|FG000|STARTED|Overall Study||10
6695081|NCT02769858|7625487|FG000|COMPLETED|Overall Study||8
6695082|NCT02769858|7625487|FG000|NOT COMPLETED|Overall Study||2
6695083|NCT02770014|7625491|FG000|STARTED|Plasma Genotyping||43
6695084|NCT02770014|7625491|FG000|COMPLETED|Plasma Genotyping||43
6695085|NCT02770014|7625491|FG000|NOT COMPLETED|Plasma Genotyping||0
6695086|NCT02770014|7625491|FG000|STARTED|EGFR Exon 19 Pos, Treated With Erlotinib|A total of 11 participants were found to have an activating EGFR mutation (exon 19 del or L858R).|11
6695087|NCT02770014|7625491|FG000|COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib|Of the 11 participants that had an activating EGFR mutation, 6 started erlotinib treatment.|6
6695088|NCT02770014|7625491|FG000|NOT COMPLETED|EGFR Exon 19 Pos, Treated With Erlotinib||5
6695089|NCT02770170|7625500|FG000|STARTED|Overall Study||21
6695090|NCT02770170|7625501|FG001|STARTED|Overall Study||20
6695091|NCT02770170|7625502|FG002|STARTED|Overall Study||40
6695092|NCT02770170|7625503|FG003|STARTED|Overall Study||40
6695093|NCT02770170|7625500|FG000|COMPLETED|Overall Study||14
6695094|NCT02770170|7625501|FG001|COMPLETED|Overall Study||17
6695095|NCT02770170|7625502|FG002|COMPLETED|Overall Study||35
6695096|NCT02770170|7625503|FG003|COMPLETED|Overall Study||33
6695097|NCT02770170|7625500|FG000|NOT COMPLETED|Overall Study||7
6695098|NCT02770170|7625501|FG001|NOT COMPLETED|Overall Study||3
6695099|NCT02770170|7625502|FG002|NOT COMPLETED|Overall Study||5
6695100|NCT02770170|7625503|FG003|NOT COMPLETED|Overall Study||7
6695101|NCT02770248|7625515|FG000|STARTED|Overall Study||62
6695102|NCT02770248|7625516|FG001|STARTED|Overall Study||63
6695103|NCT02770248|7625515|FG000|COMPLETED|Overall Study||62
6695104|NCT02770248|7625516|FG001|COMPLETED|Overall Study||61
6695105|NCT02770248|7625515|FG000|NOT COMPLETED|Overall Study||0
6695106|NCT02770248|7625516|FG001|NOT COMPLETED|Overall Study||2
6695107|NCT02770287|7625522|FG000|STARTED|Overall Study||11
6695108|NCT02770287|7625522|FG000|COMPLETED|Overall Study||11
6695109|NCT02770287|7625522|FG000|NOT COMPLETED|Overall Study||0
6695110|NCT02770365|7625532|FG000|STARTED|Overall Study||277
6695111|NCT02770365|7625533|FG001|STARTED|Overall Study||279
6695112|NCT02770365|7625534|FG002|STARTED|Overall Study||139
6695113|NCT02770365|7625532|FG000|COMPLETED|Overall Study||272
6695114|NCT02770365|7625533|FG001|COMPLETED|Overall Study||275
6695115|NCT02770365|7625534|FG002|COMPLETED|Overall Study||139
6695116|NCT02770365|7625532|FG000|NOT COMPLETED|Overall Study||5
6695117|NCT02770365|7625533|FG001|NOT COMPLETED|Overall Study||4
6695118|NCT02770365|7625534|FG002|NOT COMPLETED|Overall Study||0
6695119|NCT02770521|7625544|FG000|STARTED|Period One||4
6695120|NCT02770521|7625545|FG001|STARTED|Period One||4
6695121|NCT02770521|7625546|FG002|STARTED|Period One||2
6695122|NCT02770521|7625547|FG003|STARTED|Period One||2
6695123|NCT02770521|7625548|FG004|STARTED|Period One||2
6695124|NCT02770521|7625549|FG005|STARTED|Period One||9
6695125|NCT02770521|7625544|FG000|Received Study Drug|Period One||4
6695126|NCT02770521|7625545|FG001|Received Study Drug|Period One||4
6695127|NCT02770521|7625546|FG002|Received Study Drug|Period One||2
6695128|NCT02770521|7625547|FG003|Received Study Drug|Period One||2
6695129|NCT02770521|7625548|FG004|Received Study Drug|Period One||2
6695130|NCT02770521|7625549|FG005|Received Study Drug|Period One||9
6695131|NCT02770521|7625544|FG000|COMPLETED|Period One||4
6695132|NCT02770521|7625545|FG001|COMPLETED|Period One||4
6695133|NCT02770521|7625546|FG002|COMPLETED|Period One||2
6695134|NCT02770521|7625547|FG003|COMPLETED|Period One||2
6695135|NCT02770521|7625548|FG004|COMPLETED|Period One||2
6695136|NCT02770521|7625549|FG005|COMPLETED|Period One||9
6695137|NCT02770521|7625544|FG000|NOT COMPLETED|Period One||0
6695138|NCT02770521|7625545|FG001|NOT COMPLETED|Period One||0
6695139|NCT02770521|7625546|FG002|NOT COMPLETED|Period One||0
6695140|NCT02770521|7625547|FG003|NOT COMPLETED|Period One||0
6695141|NCT02770521|7625548|FG004|NOT COMPLETED|Period One||0
6695142|NCT02770521|7625549|FG005|NOT COMPLETED|Period One||0
6695143|NCT02770521|7625544|FG000|STARTED|Period Two||4
6695144|NCT02770521|7625545|FG001|STARTED|Period Two||4
6695145|NCT02770521|7625546|FG002|STARTED|Period Two||2
6695146|NCT02770521|7625547|FG003|STARTED|Period Two||2
6695147|NCT02770521|7625548|FG004|STARTED|Period Two||2
6695148|NCT02770521|7625549|FG005|STARTED|Period Two||9
6695149|NCT02770521|7625544|FG000|Received Study Drug|Period Two||4
6695150|NCT02770521|7625545|FG001|Received Study Drug|Period Two||4
6695151|NCT02770521|7625546|FG002|Received Study Drug|Period Two||2
6695152|NCT02770521|7625547|FG003|Received Study Drug|Period Two||2
6695153|NCT02770521|7625548|FG004|Received Study Drug|Period Two||2
6695154|NCT02770521|7625549|FG005|Received Study Drug|Period Two||9
6695155|NCT02770521|7625544|FG000|COMPLETED|Period Two||4
6695156|NCT02770521|7625545|FG001|COMPLETED|Period Two||4
6695157|NCT02770521|7625546|FG002|COMPLETED|Period Two||2
6695158|NCT02770521|7625547|FG003|COMPLETED|Period Two||2
6695159|NCT02770521|7625548|FG004|COMPLETED|Period Two||2
6695160|NCT02770521|7625549|FG005|COMPLETED|Period Two||9
6695161|NCT02770521|7625544|FG000|NOT COMPLETED|Period Two||0
6695162|NCT02770521|7625545|FG001|NOT COMPLETED|Period Two||0
6695163|NCT02770521|7625546|FG002|NOT COMPLETED|Period Two||0
6695164|NCT02770521|7625547|FG003|NOT COMPLETED|Period Two||0
6695165|NCT02770521|7625548|FG004|NOT COMPLETED|Period Two||0
6695166|NCT02770521|7625549|FG005|NOT COMPLETED|Period Two||0
6695167|NCT02770521|7625544|FG000|STARTED|Period Three|Not applicable. Part A only had two periods.|0
6695168|NCT02770521|7625545|FG001|STARTED|Period Three|Not applicable. Part A only had two periods.|0
6695169|NCT02770521|7625546|FG002|STARTED|Period Three||2
6695170|NCT02770521|7625547|FG003|STARTED|Period Three||2
6695171|NCT02770521|7625548|FG004|STARTED|Period Three||2
6695172|NCT02770521|7625549|FG005|STARTED|Period Three||9
6695173|NCT02770521|7625544|FG000|Received Study Drug|Period Three||0
6695174|NCT02770521|7625545|FG001|Received Study Drug|Period Three||0
6695175|NCT02770521|7625546|FG002|Received Study Drug|Period Three||2
6695176|NCT02770521|7625547|FG003|Received Study Drug|Period Three||2
6695177|NCT02770521|7625548|FG004|Received Study Drug|Period Three||2
6695178|NCT02770521|7625549|FG005|Received Study Drug|Period Three||9
6695179|NCT02770521|7625544|FG000|COMPLETED|Period Three||0
6695180|NCT02770521|7625545|FG001|COMPLETED|Period Three||0
6695181|NCT02770521|7625546|FG002|COMPLETED|Period Three||2
6695182|NCT02770521|7625547|FG003|COMPLETED|Period Three||2
6695183|NCT02770521|7625548|FG004|COMPLETED|Period Three||2
6695184|NCT02770521|7625549|FG005|COMPLETED|Period Three||9
6695185|NCT02770521|7625544|FG000|NOT COMPLETED|Period Three||0
6695186|NCT02770521|7625545|FG001|NOT COMPLETED|Period Three||0
6695187|NCT02770521|7625546|FG002|NOT COMPLETED|Period Three||0
6695188|NCT02770521|7625547|FG003|NOT COMPLETED|Period Three||0
6695189|NCT02770521|7625548|FG004|NOT COMPLETED|Period Three||0
6695190|NCT02770521|7625549|FG005|NOT COMPLETED|Period Three||0
6695191|NCT02770547|7625569|FG000|STARTED|Overall Study||16
6695192|NCT02770547|7625570|FG001|STARTED|Overall Study||16
6695193|NCT02770547|7625569|FG000|COMPLETED|Overall Study||15
6695194|NCT02770547|7625570|FG001|COMPLETED|Overall Study||15
6695195|NCT02770547|7625569|FG000|NOT COMPLETED|Overall Study||1
6695196|NCT02770547|7625570|FG001|NOT COMPLETED|Overall Study||1
6695197|NCT02770612|7625576|FG000|STARTED|Overall Study||51
6695198|NCT02770612|7625576|FG000|COMPLETED|Overall Study||50
6695199|NCT02770612|7625576|FG000|NOT COMPLETED|Overall Study||1
6695200|NCT02770625|7625580|FG000|STARTED|Overall Study||8
6695201|NCT02770625|7625580|FG000|COMPLETED|Overall Study||8
6695202|NCT02770625|7625580|FG000|NOT COMPLETED|Overall Study||0
6695203|NCT02770820|7625584|FG000|STARTED|Overall Study||7
6695204|NCT02770820|7625584|FG000|COMPLETED|Overall Study||4
6695205|NCT02770820|7625584|FG000|NOT COMPLETED|Overall Study||3
6259178|NCT03006926|7158285|FG000|STARTED|Overall Study||6
6259179|NCT03006926|7158286|FG001|STARTED|Overall Study||98
6259180|NCT03006926|7158285|FG000|COMPLETED|Overall Study||6
6259181|NCT03006926|7158286|FG001|COMPLETED|Overall Study||0
6259182|NCT03006926|7158285|FG000|NOT COMPLETED|Overall Study||0
6259183|NCT03006926|7158286|FG001|NOT COMPLETED|Overall Study||98
6259184|NCT02993926|7158294|FG000|STARTED|Enantone Treatment Phase||108
6259185|NCT02993926|7158295|FG001|STARTED|Enantone Treatment Phase||0
6259186|NCT02993926|7158296|FG002|STARTED|Enantone Treatment Phase||0
6259187|NCT02993926|7158294|FG000|COMPLETED|Enantone Treatment Phase||76
6259188|NCT02993926|7158295|FG001|COMPLETED|Enantone Treatment Phase||0
6259189|NCT02993926|7158296|FG002|COMPLETED|Enantone Treatment Phase||0
6259190|NCT02993926|7158294|FG000|NOT COMPLETED|Enantone Treatment Phase||32
6259191|NCT02993926|7158295|FG001|NOT COMPLETED|Enantone Treatment Phase||0
6259192|NCT02993926|7158296|FG002|NOT COMPLETED|Enantone Treatment Phase||0
6259193|NCT02993926|7158294|FG000|STARTED|Follow-Up Phase||0
6259194|NCT02993926|7158295|FG001|STARTED|Follow-Up Phase||44
6259195|NCT02993926|7158296|FG002|STARTED|Follow-Up Phase||26
6259196|NCT02993926|7158294|FG000|COMPLETED|Follow-Up Phase||0
6259197|NCT02993926|7158295|FG001|COMPLETED|Follow-Up Phase||44
6259198|NCT02993926|7158296|FG002|COMPLETED|Follow-Up Phase||26
6259199|NCT02993926|7158294|FG000|NOT COMPLETED|Follow-Up Phase||0
6259200|NCT02993926|7158295|FG001|NOT COMPLETED|Follow-Up Phase||0
6259201|NCT02993926|7158296|FG002|NOT COMPLETED|Follow-Up Phase||0
6259202|NCT02932579|7158308|FG000|STARTED|Overall Study||33
6259203|NCT02932579|7158309|FG001|STARTED|Overall Study||26
6695206|NCT02770846|7625590|FG000|STARTED|Overall Study||25
6695207|NCT02770846|7625591|FG001|STARTED|Overall Study||25
6695208|NCT02770846|7625590|FG000|COMPLETED|Overall Study||25
6695209|NCT02770846|7625591|FG001|COMPLETED|Overall Study||25
6695210|NCT02770846|7625590|FG000|NOT COMPLETED|Overall Study||0
6695211|NCT02770846|7625591|FG001|NOT COMPLETED|Overall Study||0
6259204|NCT02932579|7158308|FG000|COMPLETED|Overall Study||29
6259205|NCT02932579|7158309|FG001|COMPLETED|Overall Study||25
6259206|NCT02932579|7158308|FG000|NOT COMPLETED|Overall Study||4
6259207|NCT02932579|7158309|FG001|NOT COMPLETED|Overall Study||1
6259208|NCT02928224|7158319|FG000|STARTED|Overall Study||37
6259209|NCT02928224|7158320|FG001|STARTED|Overall Study||224
6259210|NCT02928224|7158321|FG002|STARTED|Overall Study||220
6695212|NCT02771093|7625601|FG000|STARTED|Overall Study||13
6695213|NCT02771093|7625602|FG001|STARTED|Overall Study||14
6695214|NCT02771093|7625601|FG000|COMPLETED|Overall Study||13
6695215|NCT02771093|7625602|FG001|COMPLETED|Overall Study||14
6695216|NCT02771093|7625601|FG000|NOT COMPLETED|Overall Study||0
6695217|NCT02771093|7625602|FG001|NOT COMPLETED|Overall Study||0
6695218|NCT02771145|7625608|FG000|STARTED|Overall Study||90
6695219|NCT02771145|7625608|FG000|COMPLETED|Overall Study||86
6695220|NCT02771145|7625608|FG000|NOT COMPLETED|Overall Study||4
6695221|NCT02771210|7625630|FG000|STARTED|Period 1||102
6695222|NCT02771210|7625631|FG001|STARTED|Period 1||102
6695223|NCT02771210|7625630|FG000|COMPLETED|Period 1||91
6695224|NCT02771210|7625631|FG001|COMPLETED|Period 1||84
6695225|NCT02771210|7625630|FG000|NOT COMPLETED|Period 1||11
6695226|NCT02771210|7625631|FG001|NOT COMPLETED|Period 1||18
6695227|NCT02771210|7625630|FG000|STARTED|Period 2||91
6695228|NCT02771210|7625631|FG001|STARTED|Period 2||84
6695229|NCT02771210|7625630|FG000|COMPLETED|Period 2||89
6695230|NCT02771210|7625631|FG001|COMPLETED|Period 2||81
6695231|NCT02771210|7625630|FG000|NOT COMPLETED|Period 2||2
6695232|NCT02771210|7625631|FG001|NOT COMPLETED|Period 2||3
6695233|NCT02771340|7625640|FG000|STARTED|Overall Study||2
6695234|NCT02771340|7625641|FG001|STARTED|Overall Study||3
6695235|NCT02771340|7625642|FG002|STARTED|Overall Study||5
6695236|NCT02771340|7625640|FG000|COMPLETED|Overall Study||2
6695237|NCT02771340|7625641|FG001|COMPLETED|Overall Study||3
6695238|NCT02771340|7625642|FG002|COMPLETED|Overall Study||5
6695239|NCT02771340|7625640|FG000|NOT COMPLETED|Overall Study||0
6695240|NCT02771340|7625641|FG001|NOT COMPLETED|Overall Study||0
6695241|NCT02771340|7625642|FG002|NOT COMPLETED|Overall Study||0
6695242|NCT02771366|7625652|FG000|STARTED|Period 1||15
6695243|NCT02771366|7625653|FG001|STARTED|Period 1||15
6695244|NCT02771366|7625652|FG000|COMPLETED|Period 1||15
6695245|NCT02771366|7625653|FG001|COMPLETED|Period 1||13
6695246|NCT02771366|7625652|FG000|NOT COMPLETED|Period 1||0
6695247|NCT02771366|7625653|FG001|NOT COMPLETED|Period 1||2
6695248|NCT02771366|7625652|FG000|STARTED|Period 2 (Crossover)||15
6695249|NCT02771366|7625653|FG001|STARTED|Period 2 (Crossover)||13
6695250|NCT02771366|7625652|FG000|COMPLETED|Period 2 (Crossover)||13
6695251|NCT02771366|7625653|FG001|COMPLETED|Period 2 (Crossover)||13
6695252|NCT02771366|7625652|FG000|NOT COMPLETED|Period 2 (Crossover)||2
6695253|NCT02771366|7625653|FG001|NOT COMPLETED|Period 2 (Crossover)||0
6695254|NCT02771522|7625660|FG000|STARTED|Overall Study|119 teeth imaged with the Calcivis System from 30 patients|30
6695255|NCT02771522|7625660|FG000|COMPLETED|Overall Study|87 teeth imaged with the Calcivis System fro 22 patients|22
6695256|NCT02771522|7625660|FG000|NOT COMPLETED|Overall Study||8
6695257|NCT02771574|7625674|FG000|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||3
6695258|NCT02771574|7625675|FG001|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695259|NCT02771574|7625676|FG002|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695260|NCT02771574|7625677|FG003|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695261|NCT02771574|7625678|FG004|STARTED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695262|NCT02771574|7625674|FG000|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||3
6695263|NCT02771574|7625675|FG001|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695264|NCT02771574|7625676|FG002|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695265|NCT02771574|7625677|FG003|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695266|NCT02771574|7625678|FG004|COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695267|NCT02771574|7625674|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695268|NCT02771574|7625675|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695269|NCT02771574|7625676|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695270|NCT02771574|7625677|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695271|NCT02771574|7625678|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 1 (3 Days)||0
6695272|NCT02771574|7625674|FG000|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695273|NCT02771574|7625675|FG001|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||5
6695274|NCT02771574|7625676|FG002|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695275|NCT02771574|7625677|FG003|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695276|NCT02771574|7625678|FG004|STARTED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695277|NCT02771574|7625674|FG000|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695278|NCT02771574|7625675|FG001|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||5
6695279|NCT02771574|7625676|FG002|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695280|NCT02771574|7625677|FG003|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695281|NCT02771574|7625678|FG004|COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695282|NCT02771574|7625674|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695283|NCT02771574|7625675|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695284|NCT02771574|7625676|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695285|NCT02771574|7625677|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695286|NCT02771574|7625678|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 2 (3 Days)||0
6695287|NCT02771574|7625674|FG000|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695288|NCT02771574|7625675|FG001|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695289|NCT02771574|7625676|FG002|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||3
6695290|NCT02771574|7625677|FG003|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695291|NCT02771574|7625678|FG004|STARTED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695292|NCT02771574|7625674|FG000|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695293|NCT02771574|7625675|FG001|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695294|NCT02771574|7625676|FG002|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||3
6695295|NCT02771574|7625677|FG003|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6738777|NCT03286218|7667999|FG003|STARTED|Qualification Phase Period 1||0
6695296|NCT02771574|7625678|FG004|COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695297|NCT02771574|7625674|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695298|NCT02771574|7625675|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695299|NCT02771574|7625676|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695300|NCT02771574|7625677|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695301|NCT02771574|7625678|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 3 (3 Days)||0
6695302|NCT02771574|7625674|FG000|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695303|NCT02771574|7625675|FG001|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695304|NCT02771574|7625676|FG002|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695305|NCT02771574|7625677|FG003|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||3
6695306|NCT02771574|7625678|FG004|STARTED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695307|NCT02771574|7625674|FG000|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695308|NCT02771574|7625675|FG001|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695309|NCT02771574|7625676|FG002|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695310|NCT02771574|7625677|FG003|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||3
6695311|NCT02771574|7625678|FG004|COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695312|NCT02771574|7625674|FG000|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695313|NCT02771574|7625675|FG001|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695314|NCT02771574|7625676|FG002|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695315|NCT02771574|7625677|FG003|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695316|NCT02771574|7625678|FG004|NOT COMPLETED|Lyo Avexitide Dose Level 4 (3 Days)||0
6695317|NCT02771574|7625674|FG000|STARTED|Liq Avexitide (3 Days)||0
6695318|NCT02771574|7625675|FG001|STARTED|Liq Avexitide (3 Days)||0
6695319|NCT02771574|7625676|FG002|STARTED|Liq Avexitide (3 Days)||0
6695320|NCT02771574|7625677|FG003|STARTED|Liq Avexitide (3 Days)||0
6695321|NCT02771574|7625678|FG004|STARTED|Liq Avexitide (3 Days)||5
6695322|NCT02771574|7625674|FG000|COMPLETED|Liq Avexitide (3 Days)||0
6695323|NCT02771574|7625675|FG001|COMPLETED|Liq Avexitide (3 Days)||0
6695324|NCT02771574|7625676|FG002|COMPLETED|Liq Avexitide (3 Days)||0
6695325|NCT02771574|7625677|FG003|COMPLETED|Liq Avexitide (3 Days)||0
6695326|NCT02771574|7625678|FG004|COMPLETED|Liq Avexitide (3 Days)||5
6695327|NCT02771574|7625674|FG000|NOT COMPLETED|Liq Avexitide (3 Days)||0
6695328|NCT02771574|7625675|FG001|NOT COMPLETED|Liq Avexitide (3 Days)||0
6695329|NCT02771574|7625676|FG002|NOT COMPLETED|Liq Avexitide (3 Days)||0
6695330|NCT02771574|7625677|FG003|NOT COMPLETED|Liq Avexitide (3 Days)||0
6695331|NCT02771574|7625678|FG004|NOT COMPLETED|Liq Avexitide (3 Days)||0
6695332|NCT02772302|7625695|FG000|STARTED|Overall Study||10
6695333|NCT02772302|7625696|FG001|STARTED|Overall Study||10
6695334|NCT02772302|7625695|FG000|COMPLETED|Overall Study||10
6695335|NCT02772302|7625696|FG001|COMPLETED|Overall Study||10
6695336|NCT02772302|7625695|FG000|NOT COMPLETED|Overall Study||0
6695337|NCT02772302|7625696|FG001|NOT COMPLETED|Overall Study||0
6695338|NCT02772432|7625704|FG000|STARTED|Overall Study||31
6695339|NCT02772432|7625705|FG001|STARTED|Overall Study||22
6695340|NCT02772432|7625704|FG000|COMPLETED|Overall Study||19
6695341|NCT02772432|7625705|FG001|COMPLETED|Overall Study||21
6695342|NCT02772432|7625704|FG000|NOT COMPLETED|Overall Study||12
6695343|NCT02772432|7625705|FG001|NOT COMPLETED|Overall Study||1
6695344|NCT02772666|7625711|FG000|STARTED|O-Glas Then SFT||44
6695345|NCT02772666|7625711|FG000|COMPLETED|O-Glas Then SFT||44
6695346|NCT02772666|7625711|FG000|NOT COMPLETED|O-Glas Then SFT||0
6695347|NCT02772666|7625711|FG000|STARTED|SFT Then O-Glass||44
6695348|NCT02772666|7625711|FG000|COMPLETED|SFT Then O-Glass||44
6695349|NCT02772666|7625711|FG000|NOT COMPLETED|SFT Then O-Glass||0
6695350|NCT02772757|7625719|FG000|STARTED|Overall Study||22
6695351|NCT02772757|7625720|FG001|STARTED|Overall Study||24
6695352|NCT02772757|7625721|FG002|STARTED|Overall Study||26
6695353|NCT02772757|7625719|FG000|COMPLETED|Overall Study||21
6695354|NCT02772757|7625720|FG001|COMPLETED|Overall Study||21
6695355|NCT02772757|7625721|FG002|COMPLETED|Overall Study||21
6695356|NCT02772757|7625719|FG000|NOT COMPLETED|Overall Study||1
6695357|NCT02772757|7625720|FG001|NOT COMPLETED|Overall Study||3
6695358|NCT02772757|7625721|FG002|NOT COMPLETED|Overall Study||5
6695359|NCT02772783|7625730|FG000|STARTED|Experimental Condition 1, 1 Day||8
6695360|NCT02772783|7625731|FG001|STARTED|Experimental Condition 1, 1 Day||7
6695361|NCT02772783|7625730|FG000|COMPLETED|Experimental Condition 1, 1 Day||8
6695362|NCT02772783|7625731|FG001|COMPLETED|Experimental Condition 1, 1 Day||7
6695363|NCT02772783|7625730|FG000|NOT COMPLETED|Experimental Condition 1, 1 Day||0
6695364|NCT02772783|7625731|FG001|NOT COMPLETED|Experimental Condition 1, 1 Day||0
6695365|NCT02772783|7625730|FG000|STARTED|Wash-out, 1 Week||8
6695366|NCT02772783|7625731|FG001|STARTED|Wash-out, 1 Week||7
6695367|NCT02772783|7625730|FG000|COMPLETED|Wash-out, 1 Week||8
6695368|NCT02772783|7625731|FG001|COMPLETED|Wash-out, 1 Week||7
6695369|NCT02772783|7625730|FG000|NOT COMPLETED|Wash-out, 1 Week||0
6695370|NCT02772783|7625731|FG001|NOT COMPLETED|Wash-out, 1 Week||0
6695371|NCT02772783|7625730|FG000|STARTED|Comparison Condition, 1 Day||8
6695372|NCT02772783|7625731|FG001|STARTED|Comparison Condition, 1 Day||7
6695373|NCT02772783|7625730|FG000|COMPLETED|Comparison Condition, 1 Day||8
6695374|NCT02772783|7625731|FG001|COMPLETED|Comparison Condition, 1 Day||7
6695375|NCT02772783|7625730|FG000|NOT COMPLETED|Comparison Condition, 1 Day||0
6695376|NCT02772783|7625731|FG001|NOT COMPLETED|Comparison Condition, 1 Day||0
6695377|NCT02772783|7625730|FG000|STARTED|Wash-out, 1 Week||8
6695378|NCT02772783|7625731|FG001|STARTED|Wash-out, 1 Week||7
6695379|NCT02772783|7625730|FG000|COMPLETED|Wash-out, 1 Week||8
6695380|NCT02772783|7625731|FG001|COMPLETED|Wash-out, 1 Week||7
6695381|NCT02772783|7625730|FG000|NOT COMPLETED|Wash-out, 1 Week||0
6695382|NCT02772783|7625731|FG001|NOT COMPLETED|Wash-out, 1 Week||0
6695383|NCT02772783|7625730|FG000|STARTED|Experimental Condition 2, 1 Day||8
6695384|NCT02772783|7625731|FG001|STARTED|Experimental Condition 2, 1 Day||7
6695385|NCT02772783|7625730|FG000|COMPLETED|Experimental Condition 2, 1 Day||8
6695386|NCT02772783|7625731|FG001|COMPLETED|Experimental Condition 2, 1 Day||7
6695387|NCT02772783|7625730|FG000|NOT COMPLETED|Experimental Condition 2, 1 Day||0
6259211|NCT02928224|7158322|FG003|STARTED|Overall Study||221
6259212|NCT02928224|7158319|FG000|COMPLETED|Overall Study||0
6259213|NCT02928224|7158320|FG001|COMPLETED|Overall Study||0
6259214|NCT02928224|7158321|FG002|COMPLETED|Overall Study||0
6259215|NCT02928224|7158322|FG003|COMPLETED|Overall Study||0
6259216|NCT02928224|7158319|FG000|NOT COMPLETED|Overall Study||37
6259217|NCT02928224|7158320|FG001|NOT COMPLETED|Overall Study||224
6259218|NCT02928224|7158321|FG002|NOT COMPLETED|Overall Study||220
6259219|NCT02928224|7158322|FG003|NOT COMPLETED|Overall Study||221
6259220|NCT02858154|7158337|FG000|STARTED|HFNC 3-4 Hours||9
6259221|NCT02858154|7158337|FG000|COMPLETED|HFNC 3-4 Hours||9
6259222|NCT02858154|7158337|FG000|NOT COMPLETED|HFNC 3-4 Hours||0
6259223|NCT02858154|7158337|FG000|STARTED|Clinically Ordered PSG/Low Flow Oxygen||9
6259224|NCT02858154|7158337|FG000|COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||9
6259225|NCT02858154|7158337|FG000|NOT COMPLETED|Clinically Ordered PSG/Low Flow Oxygen||0
6280185|NCT00151996|7180078|FG000|STARTED|Overall Study||42
6280186|NCT00151996|7180079|FG001|STARTED|Overall Study||33
6280187|NCT00151996|7180078|FG000|COMPLETED|Overall Study||37
6280188|NCT00151996|7180079|FG001|COMPLETED|Overall Study||26
6280189|NCT00151996|7180078|FG000|NOT COMPLETED|Overall Study||5
6280190|NCT00151996|7180079|FG001|NOT COMPLETED|Overall Study||7
6280191|NCT00152009|7180089|FG000|STARTED|Overall Study||87
6280192|NCT00152009|7180090|FG001|STARTED|Overall Study||86
6280193|NCT00152009|7180091|FG002|STARTED|Overall Study||86
6280194|NCT00152009|7180092|FG003|STARTED|Overall Study||86
6695388|NCT02772783|7625731|FG001|NOT COMPLETED|Experimental Condition 2, 1 Day||0
6695389|NCT02772809|7625739|FG000|STARTED|Overall Study||23
6695390|NCT02772809|7625739|FG000|COMPLETED|Overall Study||17
6695391|NCT02772809|7625739|FG000|NOT COMPLETED|Overall Study||6
6695392|NCT02772978|7625748|FG000|STARTED|Overall Study|First participant enrolled|10
6695393|NCT02772978|7625749|FG001|STARTED|Overall Study||9
6695394|NCT02772978|7625748|FG000|COMPLETED|Overall Study|Last participant enrolled|9
6695395|NCT02772978|7625749|FG001|COMPLETED|Overall Study||8
6280195|NCT00152009|7180089|FG000|COMPLETED|Overall Study||58
6280196|NCT00152009|7180090|FG001|COMPLETED|Overall Study||55
6280197|NCT00152009|7180091|FG002|COMPLETED|Overall Study||49
6280198|NCT00152009|7180092|FG003|COMPLETED|Overall Study||53
6280199|NCT00152009|7180089|FG000|NOT COMPLETED|Overall Study||29
6280200|NCT00152009|7180090|FG001|NOT COMPLETED|Overall Study||31
6695396|NCT02772978|7625748|FG000|NOT COMPLETED|Overall Study||1
6695397|NCT02772978|7625749|FG001|NOT COMPLETED|Overall Study||1
6695398|NCT02773368|7625756|FG000|STARTED|Overall Study||210
6695399|NCT02773368|7625757|FG001|STARTED|Overall Study||210
6695400|NCT02773368|7625756|FG000|Exposed|Overall Study||209
6695401|NCT02773368|7625757|FG001|Exposed|Overall Study||210
6695402|NCT02773368|7625756|FG000|COMPLETED|Overall Study||200
6695403|NCT02773368|7625757|FG001|COMPLETED|Overall Study||206
6695404|NCT02773368|7625756|FG000|NOT COMPLETED|Overall Study||10
6695405|NCT02773368|7625757|FG001|NOT COMPLETED|Overall Study||4
6695406|NCT02773446|7625769|FG000|STARTED|First Admission||7
6695407|NCT02773446|7625770|FG001|STARTED|First Admission||7
6695408|NCT02773446|7625771|FG002|STARTED|First Admission||7
6695409|NCT02773446|7625772|FG003|STARTED|First Admission||7
6695410|NCT02773446|7625773|FG004|STARTED|First Admission||0
6695411|NCT02773446|7625774|FG005|STARTED|First Admission||0
6695412|NCT02773446|7625769|FG000|COMPLETED|First Admission||6
6695413|NCT02773446|7625770|FG001|COMPLETED|First Admission||7
6695414|NCT02773446|7625771|FG002|COMPLETED|First Admission||7
6695415|NCT02773446|7625772|FG003|COMPLETED|First Admission||6
6695416|NCT02773446|7625773|FG004|COMPLETED|First Admission||0
6695417|NCT02773446|7625774|FG005|COMPLETED|First Admission||0
6695418|NCT02773446|7625769|FG000|NOT COMPLETED|First Admission||1
6695419|NCT02773446|7625770|FG001|NOT COMPLETED|First Admission||0
6695420|NCT02773446|7625771|FG002|NOT COMPLETED|First Admission||0
6695421|NCT02773446|7625772|FG003|NOT COMPLETED|First Admission||1
6695422|NCT02773446|7625773|FG004|NOT COMPLETED|First Admission||0
6695423|NCT02773446|7625774|FG005|NOT COMPLETED|First Admission||0
6695424|NCT02773446|7625769|FG000|STARTED|Second Admission||0
6695425|NCT02773446|7625770|FG001|STARTED|Second Admission||0
6695426|NCT02773446|7625771|FG002|STARTED|Second Admission||0
6695427|NCT02773446|7625772|FG003|STARTED|Second Admission||0
6695428|NCT02773446|7625773|FG004|STARTED|Second Admission||11
6695429|NCT02773446|7625774|FG005|STARTED|Second Admission||19
6695430|NCT02773446|7625769|FG000|COMPLETED|Second Admission||0
6695431|NCT02773446|7625770|FG001|COMPLETED|Second Admission||0
6695432|NCT02773446|7625771|FG002|COMPLETED|Second Admission||0
6695433|NCT02773446|7625772|FG003|COMPLETED|Second Admission||0
6695434|NCT02773446|7625773|FG004|COMPLETED|Second Admission||11
6695435|NCT02773446|7625774|FG005|COMPLETED|Second Admission||19
6695436|NCT02773446|7625769|FG000|NOT COMPLETED|Second Admission||0
6695437|NCT02773446|7625770|FG001|NOT COMPLETED|Second Admission||0
6695438|NCT02773446|7625771|FG002|NOT COMPLETED|Second Admission||0
6695439|NCT02773446|7625772|FG003|NOT COMPLETED|Second Admission||0
6695440|NCT02773446|7625773|FG004|NOT COMPLETED|Second Admission||0
6695441|NCT02773446|7625774|FG005|NOT COMPLETED|Second Admission||0
6695442|NCT02773537|7625794|FG000|STARTED|Overall Study||25
6695443|NCT02773537|7625795|FG001|STARTED|Overall Study||25
6695444|NCT02773537|7625796|FG002|STARTED|Overall Study||25
6695445|NCT02773537|7625794|FG000|COMPLETED|Overall Study||25
6695446|NCT02773537|7625795|FG001|COMPLETED|Overall Study||24
6695447|NCT02773537|7625796|FG002|COMPLETED|Overall Study||21
6695448|NCT02773537|7625794|FG000|NOT COMPLETED|Overall Study||0
6695449|NCT02773537|7625795|FG001|NOT COMPLETED|Overall Study||1
6695450|NCT02773537|7625796|FG002|NOT COMPLETED|Overall Study||4
6695451|NCT02773758|7625806|FG000|STARTED|Overall Study||71
6695452|NCT02773758|7625807|FG001|STARTED|Overall Study||70
6695453|NCT02773758|7625806|FG000|COMPLETED|Overall Study||71
6695454|NCT02773758|7625807|FG001|COMPLETED|Overall Study||70
6695455|NCT02773758|7625806|FG000|NOT COMPLETED|Overall Study||0
6695456|NCT02773758|7625807|FG001|NOT COMPLETED|Overall Study||0
6695457|NCT02773836|7625819|FG000|STARTED|Wave 1- Pre-TPD Implementation||1000
6695458|NCT02773836|7625820|FG001|STARTED|Wave 1- Pre-TPD Implementation||1003
6695459|NCT02773836|7625821|FG002|STARTED|Wave 1- Pre-TPD Implementation||1001
6695460|NCT02773836|7625822|FG003|STARTED|Wave 1- Pre-TPD Implementation||1001
6695461|NCT02773836|7625823|FG004|STARTED|Wave 1- Pre-TPD Implementation||1000
6695462|NCT02773836|7625824|FG005|STARTED|Wave 1- Pre-TPD Implementation||1006
6695463|NCT02773836|7625819|FG000|COMPLETED|Wave 1- Pre-TPD Implementation||1000
6695464|NCT02773836|7625820|FG001|COMPLETED|Wave 1- Pre-TPD Implementation||1003
6695465|NCT02773836|7625821|FG002|COMPLETED|Wave 1- Pre-TPD Implementation||1001
6695466|NCT02773836|7625822|FG003|COMPLETED|Wave 1- Pre-TPD Implementation||1001
6695467|NCT02773836|7625823|FG004|COMPLETED|Wave 1- Pre-TPD Implementation||1000
6695468|NCT02773836|7625824|FG005|COMPLETED|Wave 1- Pre-TPD Implementation||1006
6695469|NCT02773836|7625819|FG000|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6695470|NCT02773836|7625820|FG001|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6695471|NCT02773836|7625821|FG002|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6695472|NCT02773836|7625822|FG003|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6695473|NCT02773836|7625823|FG004|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6695474|NCT02773836|7625824|FG005|NOT COMPLETED|Wave 1- Pre-TPD Implementation||0
6695475|NCT02773836|7625819|FG000|STARTED|Wave 2- Post-TPD Implementation||1010
6695476|NCT02773836|7625820|FG001|STARTED|Wave 2- Post-TPD Implementation||1013
6259226|NCT02852967|7158347|FG000|STARTED|Overall Study||23
6259227|NCT02852967|7158348|FG001|STARTED|Overall Study||22
6695477|NCT02773836|7625821|FG002|STARTED|Wave 2- Post-TPD Implementation||1003
6695478|NCT02773836|7625822|FG003|STARTED|Wave 2- Post-TPD Implementation||1010
6695479|NCT02773836|7625823|FG004|STARTED|Wave 2- Post-TPD Implementation||1002
6695480|NCT02773836|7625824|FG005|STARTED|Wave 2- Post-TPD Implementation||998
6695481|NCT02773836|7625819|FG000|COMPLETED|Wave 2- Post-TPD Implementation||1010
6695482|NCT02773836|7625820|FG001|COMPLETED|Wave 2- Post-TPD Implementation||1013
6695483|NCT02773836|7625821|FG002|COMPLETED|Wave 2- Post-TPD Implementation||1003
6695484|NCT02773836|7625822|FG003|COMPLETED|Wave 2- Post-TPD Implementation||1010
6695485|NCT02773836|7625823|FG004|COMPLETED|Wave 2- Post-TPD Implementation||1002
6695486|NCT02773836|7625824|FG005|COMPLETED|Wave 2- Post-TPD Implementation||998
6695487|NCT02773836|7625819|FG000|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6695488|NCT02773836|7625820|FG001|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6695489|NCT02773836|7625821|FG002|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6695490|NCT02773836|7625822|FG003|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6695491|NCT02773836|7625823|FG004|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6695492|NCT02773836|7625824|FG005|NOT COMPLETED|Wave 2- Post-TPD Implementation||0
6695493|NCT02774213|7625844|FG000|STARTED|Overall Study||74
6695494|NCT02774213|7625844|FG000|COMPLETED|Overall Study||55
6695495|NCT02774213|7625844|FG000|NOT COMPLETED|Overall Study||19
6695496|NCT02774226|7625850|FG000|STARTED|Overall Study||8
6695497|NCT02774226|7625851|FG001|STARTED|Overall Study||7
6695498|NCT02774226|7625850|FG000|COMPLETED|Overall Study||8
6695499|NCT02774226|7625851|FG001|COMPLETED|Overall Study||7
6695500|NCT02774226|7625850|FG000|NOT COMPLETED|Overall Study||0
6695501|NCT02774226|7625851|FG001|NOT COMPLETED|Overall Study||0
6695502|NCT02774278|7625857|FG000|STARTED|Overall Study||264
6695503|NCT02774278|7625857|FG000|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
6695504|NCT02774278|7625857|FG000|COMPLETED|Overall Study||0
6695505|NCT02774278|7625857|FG000|NOT COMPLETED|Overall Study||264
6695506|NCT02774343|7625863|FG000|STARTED|Overall Study||15
6695507|NCT02774343|7625864|FG001|STARTED|Overall Study||15
6695508|NCT02774343|7625863|FG000|Received at Least One Capsule|Overall Study||12
6695509|NCT02774343|7625864|FG001|Received at Least One Capsule|Overall Study||14
6695510|NCT02774343|7625863|FG000|COMPLETED|Overall Study||9
6695511|NCT02774343|7625864|FG001|COMPLETED|Overall Study||12
6695512|NCT02774343|7625863|FG000|NOT COMPLETED|Overall Study||6
6695513|NCT02774343|7625864|FG001|NOT COMPLETED|Overall Study||3
6695514|NCT02774616|7625873|FG000|STARTED|Overall Study||95
6695515|NCT02774616|7625874|FG001|STARTED|Overall Study||167
6695516|NCT02774616|7625875|FG002|STARTED|Overall Study||16
6695517|NCT02774616|7625873|FG000|Died|Overall Study||6
6695518|NCT02774616|7625874|FG001|Died|Overall Study||3
6695519|NCT02774616|7625875|FG002|Died|Overall Study||1
6695520|NCT02774616|7625873|FG000|Withdrew Consent|Overall Study||3
6695521|NCT02774616|7625874|FG001|Withdrew Consent|Overall Study||3
6695522|NCT02774616|7625875|FG002|Withdrew Consent|Overall Study||0
6695523|NCT02774616|7625873|FG000|Lost to FU|Overall Study||2
6695524|NCT02774616|7625874|FG001|Lost to FU|Overall Study||0
6695525|NCT02774616|7625875|FG002|Lost to FU|Overall Study||0
6695526|NCT02774616|7625873|FG000|Device Explanted|Overall Study||2
6695527|NCT02774616|7625874|FG001|Device Explanted|Overall Study||1
6695528|NCT02774616|7625875|FG002|Device Explanted|Overall Study||1
6695529|NCT02774616|7625873|FG000|Other|Overall Study||2
6695530|NCT02774616|7625874|FG001|Other|Overall Study||4
6695531|NCT02774616|7625875|FG002|Other|Overall Study||1
6695532|NCT02774616|7625873|FG000|COMPLETED|Overall Study||80
6695533|NCT02774616|7625874|FG001|COMPLETED|Overall Study||156
6695534|NCT02774616|7625875|FG002|COMPLETED|Overall Study||13
6695535|NCT02774616|7625873|FG000|NOT COMPLETED|Overall Study||15
6695536|NCT02774616|7625874|FG001|NOT COMPLETED|Overall Study||11
6695537|NCT02774616|7625875|FG002|NOT COMPLETED|Overall Study||3
6695538|NCT02774681|7625885|FG000|STARTED|Treatment on Study||12
6695539|NCT02774681|7625885|FG000|Reached 1st Response/2 Cycles|Treatment on Study||10
6695540|NCT02774681|7625885|FG000|Went on to Start Cycle 3|Treatment on Study||5
6695541|NCT02774681|7625885|FG000|COMPLETED|Treatment on Study||5
6695542|NCT02774681|7625885|FG000|NOT COMPLETED|Treatment on Study||7
6695543|NCT02774681|7625885|FG000|STARTED|Follow-Up for 3 Years||12
6695544|NCT02774681|7625885|FG000|COMPLETED|Follow-Up for 3 Years||0
6695545|NCT02774681|7625885|FG000|NOT COMPLETED|Follow-Up for 3 Years||12
6695546|NCT02774798|7625892|FG000|STARTED|Overall Study||7
6695547|NCT02774798|7625893|FG001|STARTED|Overall Study||17
6695548|NCT02774798|7625894|FG002|STARTED|Overall Study||7
6695549|NCT02774798|7625892|FG000|COMPLETED|Overall Study||7
6695550|NCT02774798|7625893|FG001|COMPLETED|Overall Study||17
6695551|NCT02774798|7625894|FG002|COMPLETED|Overall Study||7
6695552|NCT02774798|7625892|FG000|NOT COMPLETED|Overall Study||0
6695553|NCT02774798|7625893|FG001|NOT COMPLETED|Overall Study||0
6695554|NCT02774798|7625894|FG002|NOT COMPLETED|Overall Study||0
6695555|NCT02774850|7625904|FG000|STARTED|Overall Study||610
6259228|NCT02852967|7158349|FG002|STARTED|Overall Study||21
6259229|NCT02852967|7158350|FG003|STARTED|Overall Study||26
6259230|NCT02852967|7158351|FG004|STARTED|Overall Study||18
6259231|NCT02852967|7158347|FG000|Completed Period 1: Double-blind|Overall Study||14
6259232|NCT02852967|7158348|FG001|Completed Period 1: Double-blind|Overall Study||15
6259233|NCT02852967|7158349|FG002|Completed Period 1: Double-blind|Overall Study||17
6259234|NCT02852967|7158350|FG003|Completed Period 1: Double-blind|Overall Study||16
6259235|NCT02852967|7158351|FG004|Completed Period 1: Double-blind|Overall Study||10
6259236|NCT02852967|7158347|FG000|Completed Period 2: Open-label|Overall Study||11
6259237|NCT02852967|7158348|FG001|Completed Period 2: Open-label|Overall Study||8
6259238|NCT02852967|7158349|FG002|Completed Period 2: Open-label|Overall Study||13
6259239|NCT02852967|7158350|FG003|Completed Period 2: Open-label|Overall Study||11
6259240|NCT02852967|7158351|FG004|Completed Period 2: Open-label|Overall Study||14
6259241|NCT02852967|7158347|FG000|COMPLETED|Overall Study||9
6259242|NCT02852967|7158348|FG001|COMPLETED|Overall Study||6
6259243|NCT02852967|7158349|FG002|COMPLETED|Overall Study||9
6259244|NCT02852967|7158350|FG003|COMPLETED|Overall Study||4
6259245|NCT02852967|7158351|FG004|COMPLETED|Overall Study||2
6695556|NCT02774850|7625904|FG000|Induction I|Overall Study||585
6695557|NCT02774850|7625904|FG000|Early Discharge Eligible at Induction I|Overall Study|24 of these patients were managed as outpatients. 252 were managed as inpatients.|276
6695558|NCT02774850|7625904|FG000|Induction II|Overall Study||564
6695559|NCT02774850|7625904|FG000|Early Discharge Eligible at Induction II|Overall Study|114 of these patients were managed as outpatients. 379 were managed as inpatients.|493
6695560|NCT02774850|7625904|FG000|Intensification I|Overall Study||476
6695561|NCT02774850|7625904|FG000|Early Discharge Eligible at Int I|Overall Study|104 of these patients were managed as outpatients. 270 were managed as inpatients.|374
6695562|NCT02774850|7625904|FG000|Intensification II|Overall Study||342
6695563|NCT02774850|7625904|FG000|Early Discharge Eligible at Int II|Overall Study|56 of these patients were managed as outpatients. 229 were managed as inpatients.|285
6695564|NCT02774850|7625904|FG000|Intensification III|Overall Study||48
6695565|NCT02774850|7625904|FG000|Early Discharge Eligible at Int III|Overall Study|7 of these patients were managed as outpatients. 37 were managed as inpatients.|44
6695566|NCT02774850|7625904|FG000|COMPLETED|Overall Study||575
6695567|NCT02774850|7625904|FG000|NOT COMPLETED|Overall Study||35
6695568|NCT02774941|7625912|FG000|STARTED|Overall Study||110
6695569|NCT02774941|7625913|FG001|STARTED|Overall Study||110
6695570|NCT02774941|7625912|FG000|Subjects Excluded|Overall Study||1
6695571|NCT02774941|7625913|FG001|Subjects Excluded|Overall Study||2
6695572|NCT02774941|7625912|FG000|COMPLETED|Overall Study||109
6695573|NCT02774941|7625913|FG001|COMPLETED|Overall Study||108
6695574|NCT02774941|7625912|FG000|NOT COMPLETED|Overall Study||1
6695575|NCT02774941|7625913|FG001|NOT COMPLETED|Overall Study||2
6695576|NCT02775240|7625919|FG000|STARTED|Overall Study||18
6695577|NCT02775240|7625919|FG000|Started Treatment A|Overall Study||18
6695578|NCT02775240|7625919|FG000|Started Treatment B|Overall Study||17
6695579|NCT02775240|7625919|FG000|COMPLETED|Overall Study||17
6695580|NCT02775240|7625919|FG000|NOT COMPLETED|Overall Study||1
6695581|NCT02775344|7625928|FG000|STARTED|Overall Study||40
6695582|NCT02775344|7625929|FG001|STARTED|Overall Study||40
6695583|NCT02775344|7625928|FG000|COMPLETED|Overall Study||37
6695584|NCT02775344|7625929|FG001|COMPLETED|Overall Study||38
6695585|NCT02775344|7625928|FG000|NOT COMPLETED|Overall Study||3
6695586|NCT02775344|7625929|FG001|NOT COMPLETED|Overall Study||2
6695587|NCT02775617|7625937|FG000|STARTED|Overall Study|Participants are seen at via a survey of the community. 92.6% of the resident population|653
6695588|NCT02775617|7625938|FG001|STARTED|Overall Study|Participants are seen at via a survey of the community. 88.9% of the resident population|638
6695589|NCT02775617|7625937|FG000|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 96.3% of the resident population|605
6695590|NCT02775617|7625938|FG001|COMPLETED|Overall Study|Participants are seen at via a survey of the community. 76.2% of the resident population|478
6695591|NCT02775617|7625937|FG000|NOT COMPLETED|Overall Study||48
6695592|NCT02775617|7625938|FG001|NOT COMPLETED|Overall Study||160
6695593|NCT02775864|7625948|FG000|STARTED|Overall Study||26014
6695594|NCT02775864|7625949|FG001|STARTED|Overall Study||31117
6695595|NCT02775864|7625950|FG002|STARTED|Overall Study||11941
6695596|NCT02775864|7625951|FG003|STARTED|Overall Study||12849
6695597|NCT02775864|7625948|FG000|COMPLETED|Overall Study||22772
6695598|NCT02775864|7625949|FG001|COMPLETED|Overall Study||26218
6695599|NCT02775864|7625950|FG002|COMPLETED|Overall Study||10081
6695600|NCT02775864|7625951|FG003|COMPLETED|Overall Study||10765
6695601|NCT02775864|7625948|FG000|NOT COMPLETED|Overall Study||3242
6695602|NCT02775864|7625949|FG001|NOT COMPLETED|Overall Study||4899
6695603|NCT02775864|7625950|FG002|NOT COMPLETED|Overall Study||1860
6695604|NCT02775864|7625951|FG003|NOT COMPLETED|Overall Study||2084
6695605|NCT02775903|7625966|FG000|STARTED|Overall Study||42
6695606|NCT02775903|7625967|FG001|STARTED|Overall Study||42
6695607|NCT02775903|7625968|FG002|STARTED|Overall Study||64
6695608|NCT02775903|7625969|FG003|STARTED|Overall Study||65
6695609|NCT02775903|7625966|FG000|Received Study Treatment|Overall Study||38
6695610|NCT02775903|7625967|FG001|Received Study Treatment|Overall Study||41
6695611|NCT02775903|7625968|FG002|Received Study Treatment|Overall Study||64
6695612|NCT02775903|7625969|FG003|Received Study Treatment|Overall Study||62
6695613|NCT02775903|7625966|FG000|COMPLETED|Overall Study||0
6695614|NCT02775903|7625967|FG001|COMPLETED|Overall Study||1
6695615|NCT02775903|7625968|FG002|COMPLETED|Overall Study||0
6695616|NCT02775903|7625969|FG003|COMPLETED|Overall Study||0
6695617|NCT02775903|7625966|FG000|NOT COMPLETED|Overall Study||42
6695618|NCT02775903|7625967|FG001|NOT COMPLETED|Overall Study||41
6695619|NCT02775903|7625968|FG002|NOT COMPLETED|Overall Study||64
6695620|NCT02775903|7625969|FG003|NOT COMPLETED|Overall Study||65
6695621|NCT02775916|7625985|FG000|STARTED|Overall Study||20
6695622|NCT02775916|7625986|FG001|STARTED|Overall Study||10
6695623|NCT02775916|7625985|FG000|COMPLETED|Overall Study||17
6695624|NCT02775916|7625986|FG001|COMPLETED|Overall Study||10
6695625|NCT02775916|7625985|FG000|NOT COMPLETED|Overall Study||3
6695626|NCT02775916|7625986|FG001|NOT COMPLETED|Overall Study||0
6695627|NCT02776033|7625995|FG000|STARTED|Overall Study||18
6695628|NCT02776033|7625996|FG001|STARTED|Overall Study||23
6695629|NCT02776033|7625997|FG002|STARTED|Overall Study||24
6695630|NCT02776033|7625995|FG000|COMPLETED|Overall Study||14
6695631|NCT02776033|7625996|FG001|COMPLETED|Overall Study||21
6695632|NCT02776033|7625997|FG002|COMPLETED|Overall Study||22
6695633|NCT02776033|7625995|FG000|NOT COMPLETED|Overall Study||4
6695634|NCT02776033|7625996|FG001|NOT COMPLETED|Overall Study||2
6695635|NCT02776033|7625997|FG002|NOT COMPLETED|Overall Study||2
6695636|NCT02776553|7626013|FG000|STARTED|Overall Study|One subject was eliminated for repeated hospitalizations.|9
6738778|NCT03286218|7668000|FG004|STARTED|Qualification Phase Period 1||0
6695637|NCT02776553|7626014|FG001|STARTED|Overall Study|Two subjects were eliminated for repeated hospitalizations.|8
6695638|NCT02776553|7626013|FG000|COMPLETED|Overall Study||6
6695639|NCT02776553|7626014|FG001|COMPLETED|Overall Study||5
6695640|NCT02776553|7626013|FG000|NOT COMPLETED|Overall Study||3
6695641|NCT02776553|7626014|FG001|NOT COMPLETED|Overall Study||3
6695642|NCT02776644|7626022|FG000|STARTED|Overall Study||1223
6695643|NCT02776644|7626023|FG001|STARTED|Overall Study||126
6695644|NCT02776644|7626022|FG000|COMPLETED|Overall Study||1223
6695645|NCT02776644|7626023|FG001|COMPLETED|Overall Study||126
6695646|NCT02776644|7626022|FG000|NOT COMPLETED|Overall Study||0
6695647|NCT02776644|7626023|FG001|NOT COMPLETED|Overall Study||0
6695648|NCT02776670|7626031|FG000|STARTED|Overall Study||117
6695649|NCT02776670|7626032|FG001|STARTED|Overall Study||114
6695650|NCT02776670|7626031|FG000|Full Analysis Set (FAS)|Overall Study||117
6695651|NCT02776670|7626032|FG001|Full Analysis Set (FAS)|Overall Study||114
6695652|NCT02776670|7626031|FG000|Per Protocol Analysis Set (PPS)|Overall Study||115
6695653|NCT02776670|7626032|FG001|Per Protocol Analysis Set (PPS)|Overall Study||113
6695654|NCT02776670|7626031|FG000|Safety Analysis Set|Overall Study||117
6695655|NCT02776670|7626032|FG001|Safety Analysis Set|Overall Study||114
6695656|NCT02776670|7626031|FG000|COMPLETED|Overall Study||117
6695657|NCT02776670|7626032|FG001|COMPLETED|Overall Study||108
6695658|NCT02776670|7626031|FG000|NOT COMPLETED|Overall Study||0
6695659|NCT02776670|7626032|FG001|NOT COMPLETED|Overall Study||6
6695660|NCT02776683|7626038|FG000|STARTED|Pre-switch Period|Assigned to trial medication or enrolled/treated|123
6695661|NCT02776683|7626039|FG001|STARTED|Pre-switch Period||0
6695662|NCT02776683|7626038|FG000|COMPLETED|Pre-switch Period|Entered into Switch Set|43
6695663|NCT02776683|7626039|FG001|COMPLETED|Pre-switch Period||0
6695664|NCT02776683|7626038|FG000|NOT COMPLETED|Pre-switch Period||80
6695665|NCT02776683|7626039|FG001|NOT COMPLETED|Pre-switch Period||0
6695666|NCT02776683|7626038|FG000|STARTED|Post-switch Period||0
6695667|NCT02776683|7626039|FG001|STARTED|Post-switch Period|Entered into Switch Set|43
6695668|NCT02776683|7626038|FG000|COMPLETED|Post-switch Period||0
6695669|NCT02776683|7626039|FG001|COMPLETED|Post-switch Period||0
6695670|NCT02776683|7626038|FG000|NOT COMPLETED|Post-switch Period||0
6695671|NCT02776683|7626039|FG001|NOT COMPLETED|Post-switch Period||43
6695672|NCT02776774|7626043|FG000|STARTED|Overall Study||91
6695673|NCT02776774|7626043|FG000|COMPLETED|Overall Study|Total after data cleaning|91
6695674|NCT02776774|7626043|FG000|NOT COMPLETED|Overall Study||0
6695675|NCT02776904|7626049|FG000|STARTED|Overall Study||281
6695676|NCT02776904|7626050|FG001|STARTED|Overall Study||46
6695677|NCT02776904|7626049|FG000|Gait Assessment|Overall Study||178
6695678|NCT02776904|7626050|FG001|Gait Assessment|Overall Study||32
6695679|NCT02776904|7626049|FG000|ImPACT|Overall Study||21
6695680|NCT02776904|7626050|FG001|ImPACT|Overall Study|ImPACT testing for the concussed subjects was completed for the clinical assessment (not research).|46
6695681|NCT02776904|7626049|FG000|COMPLETED|Overall Study||281
6695682|NCT02776904|7626050|FG001|COMPLETED|Overall Study||46
6695683|NCT02776904|7626049|FG000|NOT COMPLETED|Overall Study||0
6695684|NCT02776904|7626050|FG001|NOT COMPLETED|Overall Study||0
6695685|NCT02777021|7626065|FG000|STARTED|Overall Study||60
6695686|NCT02777021|7626066|FG001|STARTED|Overall Study||94
6695687|NCT02777021|7626065|FG000|COMPLETED|Overall Study||43
6695688|NCT02777021|7626066|FG001|COMPLETED|Overall Study||77
6695689|NCT02777021|7626065|FG000|NOT COMPLETED|Overall Study||17
6695690|NCT02777021|7626066|FG001|NOT COMPLETED|Overall Study||17
6695691|NCT02777086|7626074|FG000|STARTED|Overall Study||261
6695692|NCT02777086|7626075|FG001|STARTED|Overall Study||250
6695693|NCT02777086|7626074|FG000|COMPLETED|Overall Study||165
6695694|NCT02777086|7626075|FG001|COMPLETED|Overall Study||151
6695695|NCT02777086|7626074|FG000|NOT COMPLETED|Overall Study||96
6695696|NCT02777086|7626075|FG001|NOT COMPLETED|Overall Study||99
6695697|NCT02777125|7626083|FG000|STARTED|Overall Study||488
6695698|NCT02777125|7626084|FG001|STARTED|Overall Study||492
6695699|NCT02777125|7626083|FG000|COMPLETED|Overall Study||445
6695700|NCT02777125|7626084|FG001|COMPLETED|Overall Study||445
6695701|NCT02777125|7626083|FG000|NOT COMPLETED|Overall Study||43
6695702|NCT02777125|7626084|FG001|NOT COMPLETED|Overall Study||47
6695703|NCT02777242|7626091|FG000|STARTED|Overall Study||65
6695704|NCT02777242|7626091|FG000|COMPLETED|Overall Study||59
6695705|NCT02777242|7626091|FG000|NOT COMPLETED|Overall Study||6
6695706|NCT02777268|7626095|FG000|STARTED|Overall Study||16
6695707|NCT02777268|7626095|FG000|COMPLETED|Overall Study||16
6695708|NCT02777268|7626095|FG000|NOT COMPLETED|Overall Study||0
6695709|NCT02777333|7626119|FG000|STARTED|Overall Study||15
6695710|NCT02777333|7626120|FG001|STARTED|Overall Study||15
6695711|NCT02777333|7626119|FG000|COMPLETED|Overall Study||15
6695712|NCT02777333|7626120|FG001|COMPLETED|Overall Study||13
6695713|NCT02777333|7626119|FG000|NOT COMPLETED|Overall Study||0
6695714|NCT02777333|7626120|FG001|NOT COMPLETED|Overall Study||2
6738779|NCT03286218|7668001|FG005|STARTED|Qualification Phase Period 1||0
6738780|NCT03286218|7668002|FG006|STARTED|Qualification Phase Period 1||0
6738781|NCT03286218|7668003|FG007|STARTED|Qualification Phase Period 1||0
6738782|NCT03286218|7668004|FG008|STARTED|Qualification Phase Period 1||0
6738783|NCT03286218|7668005|FG009|STARTED|Qualification Phase Period 1||0
6738784|NCT03286218|7668006|FG010|STARTED|Qualification Phase Period 1||0
6738785|NCT03286218|7668007|FG011|STARTED|Qualification Phase Period 1||0
6738786|NCT03286218|7667996|FG000|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
6695715|NCT04952701|7626126|FG000|STARTED|Control Lens||63
6695716|NCT04952701|7626126|FG000|COMPLETED|Control Lens||59
6695717|NCT04952701|7626126|FG000|NOT COMPLETED|Control Lens||4
6695718|NCT04952701|7626126|FG000|STARTED|Test Lens||59
6695719|NCT04952701|7626126|FG000|COMPLETED|Test Lens||58
6695720|NCT04952701|7626126|FG000|NOT COMPLETED|Test Lens||1
6695721|NCT04350606|7626132|FG000|STARTED|Overall Study||3
6695722|NCT04350606|7626132|FG000|Treated|Overall Study||3
6695723|NCT04350606|7626132|FG000|Follow-up|Overall Study||3
6695724|NCT04350606|7626132|FG000|COMPLETED|Overall Study||3
6695725|NCT04350606|7626132|FG000|NOT COMPLETED|Overall Study||0
6695726|NCT04074161|7626139|FG000|STARTED|Overall Study||126
6695727|NCT04074161|7626140|FG001|STARTED|Overall Study||127
6695728|NCT04074161|7626141|FG002|STARTED|Overall Study||85
6695729|NCT04074161|7626139|FG000|Full Analysis Set|Overall Study||126
6695730|NCT04074161|7626140|FG001|Full Analysis Set|Overall Study||127
6695731|NCT04074161|7626141|FG002|Full Analysis Set|Overall Study||85
6695732|NCT04074161|7626139|FG000|Safety Analysis Set|Overall Study||126
6695733|NCT04074161|7626140|FG001|Safety Analysis Set|Overall Study||127
6695734|NCT04074161|7626141|FG002|Safety Analysis Set|Overall Study||85
6695735|NCT04074161|7626139|FG000|COMPLETED|Overall Study||120
6695736|NCT04074161|7626140|FG001|COMPLETED|Overall Study||118
6695737|NCT04074161|7626141|FG002|COMPLETED|Overall Study||81
6695738|NCT04074161|7626139|FG000|NOT COMPLETED|Overall Study||6
6695739|NCT04074161|7626140|FG001|NOT COMPLETED|Overall Study||9
6695740|NCT04074161|7626141|FG002|NOT COMPLETED|Overall Study||4
6695741|NCT04033432|7626149|FG000|STARTED|Overall Study||14
6695742|NCT04033432|7626149|FG000|Registered for Study|Overall Study||14
6695743|NCT04033432|7626149|FG000|Started Cycle 1|Overall Study||14
6695744|NCT04033432|7626149|FG000|Started Cycle 2|Overall Study||13
6695745|NCT04033432|7626149|FG000|Started Cycle 3|Overall Study||10
6695746|NCT04033432|7626149|FG000|Started Cycle 4|Overall Study||7
6695747|NCT04033432|7626149|FG000|Started Cycle 5|Overall Study||1
6695748|NCT04033432|7626149|FG000|Started Cycle 6|Overall Study||1
6695749|NCT04033432|7626149|FG000|Started Cycle 7+|Overall Study||1
6695750|NCT04033432|7626149|FG000|COMPLETED|Overall Study||1
6695751|NCT04033432|7626149|FG000|NOT COMPLETED|Overall Study||13
6695752|NCT04030247|7626154|FG000|STARTED|Overall Study||50
6695753|NCT04030247|7626154|FG000|COMPLETED|Overall Study||33
6695754|NCT04030247|7626154|FG000|NOT COMPLETED|Overall Study||17
6695755|NCT03893565|7626163|FG000|STARTED|Double-blind Induction Phase (10 Weeks)||27
6695756|NCT03893565|7626164|FG001|STARTED|Double-blind Induction Phase (10 Weeks)||48
6695757|NCT03893565|7626165|FG002|STARTED|Double-blind Induction Phase (10 Weeks)||11
6695758|NCT03893565|7626166|FG003|STARTED|Double-blind Induction Phase (10 Weeks)||10
6695759|NCT03893565|7626167|FG004|STARTED|Double-blind Induction Phase (10 Weeks)||8
6695760|NCT03893565|7626168|FG005|STARTED|Double-blind Induction Phase (10 Weeks)||0
6695761|NCT03893565|7626169|FG006|STARTED|Double-blind Induction Phase (10 Weeks)||0
6695762|NCT03893565|7626170|FG007|STARTED|Double-blind Induction Phase (10 Weeks)||0
6695763|NCT03893565|7626171|FG008|STARTED|Double-blind Induction Phase (10 Weeks)||0
6695764|NCT03893565|7626163|FG000|COMPLETED|Double-blind Induction Phase (10 Weeks)||21
6695765|NCT03893565|7626164|FG001|COMPLETED|Double-blind Induction Phase (10 Weeks)||32
6695766|NCT03893565|7626165|FG002|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
6695767|NCT03893565|7626166|FG003|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
6695768|NCT03893565|7626167|FG004|COMPLETED|Double-blind Induction Phase (10 Weeks)||1
6695769|NCT03893565|7626168|FG005|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
6695770|NCT03893565|7626169|FG006|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
6695771|NCT03893565|7626170|FG007|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
6695772|NCT03893565|7626171|FG008|COMPLETED|Double-blind Induction Phase (10 Weeks)||0
6695773|NCT03893565|7626163|FG000|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||6
6695774|NCT03893565|7626164|FG001|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||16
6695775|NCT03893565|7626165|FG002|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||10
6695776|NCT03893565|7626166|FG003|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||9
6695777|NCT03893565|7626167|FG004|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||7
6695778|NCT03893565|7626168|FG005|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
6695779|NCT03893565|7626169|FG006|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
6695780|NCT03893565|7626170|FG007|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
6695781|NCT03893565|7626171|FG008|NOT COMPLETED|Double-blind Induction Phase (10 Weeks)||0
6695782|NCT03893565|7626163|FG000|STARTED|Double-blind Extended Treatment(20weeks)||0
6695783|NCT03893565|7626164|FG001|STARTED|Double-blind Extended Treatment(20weeks)||0
6695784|NCT03893565|7626165|FG002|STARTED|Double-blind Extended Treatment(20weeks)||0
6695785|NCT03893565|7626166|FG003|STARTED|Double-blind Extended Treatment(20weeks)||0
6695786|NCT03893565|7626167|FG004|STARTED|Double-blind Extended Treatment(20weeks)||0
6695787|NCT03893565|7626168|FG005|STARTED|Double-blind Extended Treatment(20weeks)||5
6695788|NCT03893565|7626169|FG006|STARTED|Double-blind Extended Treatment(20weeks)||8
6695789|NCT03893565|7626170|FG007|STARTED|Double-blind Extended Treatment(20weeks)||0
6695790|NCT03893565|7626171|FG008|STARTED|Double-blind Extended Treatment(20weeks)||0
6695791|NCT03893565|7626163|FG000|COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695792|NCT03893565|7626164|FG001|COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695793|NCT03893565|7626165|FG002|COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695794|NCT03893565|7626166|FG003|COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695795|NCT03893565|7626167|FG004|COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695796|NCT03893565|7626168|FG005|COMPLETED|Double-blind Extended Treatment(20weeks)||2
6695797|NCT03893565|7626169|FG006|COMPLETED|Double-blind Extended Treatment(20weeks)||4
6695798|NCT03893565|7626170|FG007|COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695799|NCT03893565|7626171|FG008|COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695800|NCT03893565|7626163|FG000|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695801|NCT03893565|7626164|FG001|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695802|NCT03893565|7626165|FG002|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695803|NCT03893565|7626166|FG003|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695804|NCT03893565|7626167|FG004|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695805|NCT03893565|7626168|FG005|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||3
6695806|NCT03893565|7626169|FG006|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||4
6695807|NCT03893565|7626170|FG007|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695808|NCT03893565|7626171|FG008|NOT COMPLETED|Double-blind Extended Treatment(20weeks)||0
6695809|NCT03893565|7626163|FG000|STARTED|Open-label Induction Phase (10 Weeks)||0
6695810|NCT03893565|7626164|FG001|STARTED|Open-label Induction Phase (10 Weeks)||0
6695811|NCT03893565|7626165|FG002|STARTED|Open-label Induction Phase (10 Weeks)||0
6695812|NCT03893565|7626166|FG003|STARTED|Open-label Induction Phase (10 Weeks)||0
6695813|NCT03893565|7626167|FG004|STARTED|Open-label Induction Phase (10 Weeks)||0
6695814|NCT03893565|7626168|FG005|STARTED|Open-label Induction Phase (10 Weeks)||0
6695815|NCT03893565|7626169|FG006|STARTED|Open-label Induction Phase (10 Weeks)||0
6695816|NCT03893565|7626170|FG007|STARTED|Open-label Induction Phase (10 Weeks)||42
6695817|NCT03893565|7626171|FG008|STARTED|Open-label Induction Phase (10 Weeks)||0
6695818|NCT03893565|7626163|FG000|COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695819|NCT03893565|7626164|FG001|COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695820|NCT03893565|7626165|FG002|COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695821|NCT03893565|7626166|FG003|COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695822|NCT03893565|7626167|FG004|COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695823|NCT03893565|7626168|FG005|COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695824|NCT03893565|7626169|FG006|COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695825|NCT03893565|7626170|FG007|COMPLETED|Open-label Induction Phase (10 Weeks)||12
6695826|NCT03893565|7626171|FG008|COMPLETED|Open-label Induction Phase (10 Weeks)||0
6259246|NCT02852967|7158347|FG000|NOT COMPLETED|Overall Study||14
6259247|NCT02852967|7158348|FG001|NOT COMPLETED|Overall Study||16
6259248|NCT02852967|7158349|FG002|NOT COMPLETED|Overall Study||12
6259249|NCT02852967|7158350|FG003|NOT COMPLETED|Overall Study||22
6259250|NCT02852967|7158351|FG004|NOT COMPLETED|Overall Study||16
6259251|NCT02810418|7158378|FG000|STARTED|Arm A Dose Escalation||6
6259252|NCT02810418|7158379|FG001|STARTED|Arm A Dose Escalation||8
6259253|NCT02810418|7158380|FG002|STARTED|Arm A Dose Escalation||0
6259254|NCT02810418|7158381|FG003|STARTED|Arm A Dose Escalation||0
6259255|NCT02810418|7158382|FG004|STARTED|Arm A Dose Escalation||0
6259256|NCT02810418|7158383|FG005|STARTED|Arm A Dose Escalation||0
6259257|NCT02810418|7158384|FG006|STARTED|Arm A Dose Escalation||0
6259258|NCT02810418|7158378|FG000|COMPLETED|Arm A Dose Escalation||4
6259259|NCT02810418|7158379|FG001|COMPLETED|Arm A Dose Escalation||7
6259260|NCT02810418|7158380|FG002|COMPLETED|Arm A Dose Escalation||0
6259261|NCT02810418|7158381|FG003|COMPLETED|Arm A Dose Escalation||0
6259262|NCT02810418|7158382|FG004|COMPLETED|Arm A Dose Escalation||0
6259263|NCT02810418|7158383|FG005|COMPLETED|Arm A Dose Escalation||0
6259264|NCT02810418|7158384|FG006|COMPLETED|Arm A Dose Escalation||0
6259265|NCT02810418|7158378|FG000|NOT COMPLETED|Arm A Dose Escalation||2
6259266|NCT02810418|7158379|FG001|NOT COMPLETED|Arm A Dose Escalation||1
6259267|NCT02810418|7158380|FG002|NOT COMPLETED|Arm A Dose Escalation||0
6259268|NCT02810418|7158381|FG003|NOT COMPLETED|Arm A Dose Escalation||0
6259269|NCT02810418|7158382|FG004|NOT COMPLETED|Arm A Dose Escalation||0
6259270|NCT02810418|7158383|FG005|NOT COMPLETED|Arm A Dose Escalation||0
6259271|NCT02810418|7158384|FG006|NOT COMPLETED|Arm A Dose Escalation||0
6259272|NCT02810418|7158378|FG000|STARTED|Dose Expansion||0
6259273|NCT02810418|7158379|FG001|STARTED|Dose Expansion||8
6259274|NCT02810418|7158380|FG002|STARTED|Dose Expansion||6
6259275|NCT02810418|7158381|FG003|STARTED|Dose Expansion||0
6259276|NCT02810418|7158382|FG004|STARTED|Dose Expansion||0
6259277|NCT02810418|7158383|FG005|STARTED|Dose Expansion||0
6259278|NCT02810418|7158384|FG006|STARTED|Dose Expansion||0
6259279|NCT02810418|7158378|FG000|COMPLETED|Dose Expansion||0
6259280|NCT02810418|7158379|FG001|COMPLETED|Dose Expansion||7
6259281|NCT02810418|7158380|FG002|COMPLETED|Dose Expansion||3
6259282|NCT02810418|7158381|FG003|COMPLETED|Dose Expansion||0
6259283|NCT02810418|7158382|FG004|COMPLETED|Dose Expansion||0
6259284|NCT02810418|7158383|FG005|COMPLETED|Dose Expansion||0
6259285|NCT02810418|7158384|FG006|COMPLETED|Dose Expansion||0
6259286|NCT02810418|7158378|FG000|NOT COMPLETED|Dose Expansion||0
6259287|NCT02810418|7158379|FG001|NOT COMPLETED|Dose Expansion||1
6259288|NCT02810418|7158380|FG002|NOT COMPLETED|Dose Expansion||3
6259289|NCT02810418|7158381|FG003|NOT COMPLETED|Dose Expansion||0
6259290|NCT02810418|7158382|FG004|NOT COMPLETED|Dose Expansion||0
6259291|NCT02810418|7158383|FG005|NOT COMPLETED|Dose Expansion||0
6259292|NCT02810418|7158384|FG006|NOT COMPLETED|Dose Expansion||0
6259293|NCT02810418|7158378|FG000|STARTED|Arm B Dose Escalation||0
6259294|NCT02810418|7158379|FG001|STARTED|Arm B Dose Escalation||0
6259295|NCT02810418|7158380|FG002|STARTED|Arm B Dose Escalation||0
6259296|NCT02810418|7158381|FG003|STARTED|Arm B Dose Escalation||6
6695827|NCT03893565|7626163|FG000|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695828|NCT03893565|7626164|FG001|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695829|NCT03893565|7626165|FG002|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695830|NCT03893565|7626166|FG003|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
6391934|NCT00838682|7303884|FG001|STARTED|Overall Study||52
6391935|NCT00838682|7303883|FG000|COMPLETED|Overall Study||29
6391936|NCT00838682|7303884|FG001|COMPLETED|Overall Study||33
6391937|NCT00838682|7303883|FG000|NOT COMPLETED|Overall Study||25
6391938|NCT00838682|7303884|FG001|NOT COMPLETED|Overall Study||19
6391939|NCT00838695|7303892|FG000|STARTED|Overall Study||42
6695831|NCT03893565|7626167|FG004|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695832|NCT03893565|7626168|FG005|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695833|NCT03893565|7626169|FG006|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695834|NCT03893565|7626170|FG007|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||30
6695835|NCT03893565|7626171|FG008|NOT COMPLETED|Open-label Induction Phase (10 Weeks)||0
6695836|NCT03893565|7626163|FG000|STARTED|Open-label Extended Treatment (20 Weeks)||0
6695837|NCT03893565|7626164|FG001|STARTED|Open-label Extended Treatment (20 Weeks)||0
6695838|NCT03893565|7626165|FG002|STARTED|Open-label Extended Treatment (20 Weeks)||0
6695839|NCT03893565|7626166|FG003|STARTED|Open-label Extended Treatment (20 Weeks)||0
6695840|NCT03893565|7626167|FG004|STARTED|Open-label Extended Treatment (20 Weeks)||0
6695841|NCT03893565|7626168|FG005|STARTED|Open-label Extended Treatment (20 Weeks)||0
6695842|NCT03893565|7626169|FG006|STARTED|Open-label Extended Treatment (20 Weeks)||0
6695843|NCT03893565|7626170|FG007|STARTED|Open-label Extended Treatment (20 Weeks)||0
6695844|NCT03893565|7626171|FG008|STARTED|Open-label Extended Treatment (20 Weeks)||7
6695845|NCT03893565|7626163|FG000|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695846|NCT03893565|7626164|FG001|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695847|NCT03893565|7626165|FG002|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695848|NCT03893565|7626166|FG003|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695849|NCT03893565|7626167|FG004|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695850|NCT03893565|7626168|FG005|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695851|NCT03893565|7626169|FG006|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695852|NCT03893565|7626170|FG007|COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695853|NCT03893565|7626171|FG008|COMPLETED|Open-label Extended Treatment (20 Weeks)||3
6695854|NCT03893565|7626163|FG000|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695855|NCT03893565|7626164|FG001|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695856|NCT03893565|7626165|FG002|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695857|NCT03893565|7626166|FG003|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695858|NCT03893565|7626167|FG004|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695859|NCT03893565|7626168|FG005|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695860|NCT03893565|7626169|FG006|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695861|NCT03893565|7626170|FG007|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||0
6695862|NCT03893565|7626171|FG008|NOT COMPLETED|Open-label Extended Treatment (20 Weeks)||4
6695863|NCT03701516|7626190|FG000|STARTED|Period 1||131
6695864|NCT03701516|7626191|FG001|STARTED|Period 1||132
6695865|NCT03701516|7626190|FG000|COMPLETED|Period 1||127
6695866|NCT03701516|7626191|FG001|COMPLETED|Period 1||127
6695867|NCT03701516|7626190|FG000|NOT COMPLETED|Period 1||4
6695868|NCT03701516|7626191|FG001|NOT COMPLETED|Period 1||5
6695869|NCT03701516|7626190|FG000|STARTED|Period 2||127
6695870|NCT03701516|7626191|FG001|STARTED|Period 2||127
6695871|NCT03701516|7626190|FG000|COMPLETED|Period 2||126
6695872|NCT03701516|7626191|FG001|COMPLETED|Period 2||126
6695873|NCT03701516|7626190|FG000|NOT COMPLETED|Period 2||1
6695874|NCT03701516|7626191|FG001|NOT COMPLETED|Period 2||1
6259297|NCT02810418|7158382|FG004|STARTED|Arm B Dose Escalation||3
6259298|NCT02810418|7158383|FG005|STARTED|Arm B Dose Escalation||6
6259299|NCT02810418|7158384|FG006|STARTED|Arm B Dose Escalation||0
6259300|NCT02810418|7158378|FG000|COMPLETED|Arm B Dose Escalation||0
6259301|NCT02810418|7158379|FG001|COMPLETED|Arm B Dose Escalation||0
6259302|NCT02810418|7158380|FG002|COMPLETED|Arm B Dose Escalation||0
6259303|NCT02810418|7158381|FG003|COMPLETED|Arm B Dose Escalation||6
6259304|NCT02810418|7158382|FG004|COMPLETED|Arm B Dose Escalation||2
6259305|NCT02810418|7158383|FG005|COMPLETED|Arm B Dose Escalation||4
6259306|NCT02810418|7158384|FG006|COMPLETED|Arm B Dose Escalation||0
6259307|NCT02810418|7158378|FG000|NOT COMPLETED|Arm B Dose Escalation||0
6259308|NCT02810418|7158379|FG001|NOT COMPLETED|Arm B Dose Escalation||0
6259309|NCT02810418|7158380|FG002|NOT COMPLETED|Arm B Dose Escalation||0
6259310|NCT02810418|7158381|FG003|NOT COMPLETED|Arm B Dose Escalation||0
6259311|NCT02810418|7158382|FG004|NOT COMPLETED|Arm B Dose Escalation||1
6259312|NCT02810418|7158383|FG005|NOT COMPLETED|Arm B Dose Escalation||2
6259313|NCT02810418|7158384|FG006|NOT COMPLETED|Arm B Dose Escalation||0
6259314|NCT02810418|7158378|FG000|STARTED|Arm B Combination Therapy||0
6259315|NCT02810418|7158379|FG001|STARTED|Arm B Combination Therapy||0
6259316|NCT02810418|7158380|FG002|STARTED|Arm B Combination Therapy||0
6259317|NCT02810418|7158381|FG003|STARTED|Arm B Combination Therapy||0
6259318|NCT02810418|7158382|FG004|STARTED|Arm B Combination Therapy||0
6259319|NCT02810418|7158383|FG005|STARTED|Arm B Combination Therapy||0
6259320|NCT02810418|7158384|FG006|STARTED|Arm B Combination Therapy||5
6259321|NCT02810418|7158378|FG000|COMPLETED|Arm B Combination Therapy||0
6391940|NCT00838695|7303893|FG001|STARTED|Overall Study||64
6695875|NCT03692052|7626197|FG000|STARTED|Core Period (Day 1 to Week 24)||20
6695876|NCT03692052|7626197|FG000|COMPLETED|Core Period (Day 1 to Week 24)||19
6695877|NCT03692052|7626197|FG000|NOT COMPLETED|Core Period (Day 1 to Week 24)||1
6695878|NCT03692052|7626197|FG000|STARTED|Extension Period (Week 25 to 10 Years)||19
6695879|NCT03692052|7626197|FG000|COMPLETED|Extension Period (Week 25 to 10 Years)||0
6695880|NCT03692052|7626197|FG000|NOT COMPLETED|Extension Period (Week 25 to 10 Years)||19
6695881|NCT03650556|7626201|FG000|STARTED|Overall Study||224
6695882|NCT03650556|7626201|FG000|Ablation Procedure|Overall Study||223
6695883|NCT03650556|7626201|FG000|Pre-Discharge|Overall Study||223
6695884|NCT03650556|7626201|FG000|7-day Follow-Up|Overall Study||223
6695885|NCT03650556|7626201|FG000|3-month Follow-Up|Overall Study||210
6695886|NCT03650556|7626201|FG000|6-month Follow-up|Overall Study||197
6695887|NCT03650556|7626201|FG000|12-month Follow-Up|Overall Study||189
6695888|NCT03650556|7626201|FG000|15-month Follow-Up|Overall Study||187
6695889|NCT03650556|7626201|FG000|COMPLETED|Overall Study||187
6695890|NCT03650556|7626201|FG000|NOT COMPLETED|Overall Study||37
6695891|NCT03639311|7626208|FG000|STARTED|Overall Study||90
6695892|NCT03639311|7626209|FG001|STARTED|Overall Study||7
6695893|NCT03639311|7626208|FG000|COMPLETED|Overall Study||0
6695894|NCT03639311|7626209|FG001|COMPLETED|Overall Study||7
6695895|NCT03639311|7626208|FG000|NOT COMPLETED|Overall Study||90
6695896|NCT03639311|7626209|FG001|NOT COMPLETED|Overall Study||0
6695897|NCT03628716|7626220|FG000|STARTED|Overall Study||19
6695898|NCT03628716|7626221|FG001|STARTED|Overall Study||24
6695899|NCT03628716|7626220|FG000|COMPLETED|Overall Study||0
6695900|NCT03628716|7626221|FG001|COMPLETED|Overall Study||1
6695901|NCT03628716|7626220|FG000|NOT COMPLETED|Overall Study||19
6695902|NCT03628716|7626221|FG001|NOT COMPLETED|Overall Study||23
6695903|NCT03377699|7626231|FG000|STARTED|Overall Study||111
6695904|NCT03377699|7626232|FG001|STARTED|Overall Study||114
6695905|NCT03377699|7626231|FG000|Treated|Overall Study||110
6695906|NCT03377699|7626232|FG001|Treated|Overall Study||112
6695907|NCT03377699|7626231|FG000|SASpregnant|Overall Study||91
6695908|NCT03377699|7626232|FG001|SASpregnant|Overall Study||94
6695909|NCT03377699|7626231|FG000|FASpregnant|Overall Study||92
6695910|NCT03377699|7626232|FG001|FASpregnant|Overall Study||96
6695911|NCT03377699|7626231|FG000|COMPLETED|Overall Study||89
6695912|NCT03377699|7626232|FG001|COMPLETED|Overall Study||89
6695913|NCT03377699|7626231|FG000|NOT COMPLETED|Overall Study||22
6695914|NCT03377699|7626232|FG001|NOT COMPLETED|Overall Study||25
6695915|NCT03275350|7626242|FG000|STARTED|Overall Study||55
6695916|NCT03275350|7626243|FG001|STARTED|Overall Study||59
6695917|NCT03275350|7626242|FG000|COMPLETED|Overall Study||47
6695918|NCT03275350|7626243|FG001|COMPLETED|Overall Study||51
6695919|NCT03275350|7626242|FG000|NOT COMPLETED|Overall Study||8
6695920|NCT03275350|7626243|FG001|NOT COMPLETED|Overall Study||8
6695921|NCT03272347|7626254|FG000|STARTED|Overall Study||31
6695922|NCT03272347|7626255|FG001|STARTED|Overall Study||30
6695923|NCT03272347|7626256|FG002|STARTED|Overall Study||31
6695924|NCT03272347|7626257|FG003|STARTED|Overall Study||31
6695925|NCT03272347|7626254|FG000|Treated|Overall Study||29
6695926|NCT03272347|7626255|FG001|Treated|Overall Study||30
6695927|NCT03272347|7626256|FG002|Treated|Overall Study||31
6695928|NCT03272347|7626257|FG003|Treated|Overall Study||31
6695929|NCT03272347|7626254|FG000|COMPLETED|Overall Study||0
6695930|NCT03272347|7626255|FG001|COMPLETED|Overall Study||1
6695931|NCT03272347|7626256|FG002|COMPLETED|Overall Study||0
6695932|NCT03272347|7626257|FG003|COMPLETED|Overall Study||2
6695933|NCT03272347|7626254|FG000|NOT COMPLETED|Overall Study||31
6695934|NCT03272347|7626255|FG001|NOT COMPLETED|Overall Study||29
6695935|NCT03272347|7626256|FG002|NOT COMPLETED|Overall Study||31
6695936|NCT03272347|7626257|FG003|NOT COMPLETED|Overall Study||29
6695937|NCT03138369|7626269|FG000|STARTED|Overall Study||11
6695938|NCT03138369|7626270|FG001|STARTED|Overall Study||11
6695939|NCT03138369|7626269|FG000|COMPLETED|Overall Study||8
6695940|NCT03138369|7626270|FG001|COMPLETED|Overall Study||3
6695941|NCT03138369|7626269|FG000|NOT COMPLETED|Overall Study||3
6695942|NCT03138369|7626270|FG001|NOT COMPLETED|Overall Study||8
6695943|NCT02853305|7626280|FG000|STARTED|Overall Study||351
6695944|NCT02853305|7626281|FG001|STARTED|Overall Study||307
6695945|NCT02853305|7626282|FG002|STARTED|Overall Study||352
6695946|NCT02853305|7626280|FG000|Treated|Overall Study|Includes 2 participants randomized to Pembrolizumab alone|349
6695947|NCT02853305|7626281|FG001|Treated|Overall Study||302
6695948|NCT02853305|7626282|FG002|Treated|Overall Study||342
6695949|NCT02853305|7626280|FG000|COMPLETED|Overall Study||0
6695950|NCT02853305|7626281|FG001|COMPLETED|Overall Study||0
6695951|NCT02853305|7626282|FG002|COMPLETED|Overall Study||0
6695952|NCT02853305|7626280|FG000|NOT COMPLETED|Overall Study||351
6695953|NCT02853305|7626281|FG001|NOT COMPLETED|Overall Study||307
6695954|NCT02853305|7626282|FG002|NOT COMPLETED|Overall Study||352
6695955|NCT02758184|7626292|FG000|STARTED|Overall Study||11
6695956|NCT02758184|7626293|FG001|STARTED|Overall Study||10
6695957|NCT02758184|7626292|FG000|COMPLETED|Overall Study||11
6695958|NCT02758184|7626293|FG001|COMPLETED|Overall Study||10
6695959|NCT02758184|7626292|FG000|NOT COMPLETED|Overall Study||0
6695960|NCT02758184|7626293|FG001|NOT COMPLETED|Overall Study||0
6695961|NCT02677870|7626299|FG000|STARTED|Diet Treatment (4 Weeks)||4
6695962|NCT02677870|7626300|FG001|STARTED|Diet Treatment (4 Weeks)||3
6695963|NCT02677870|7626299|FG000|COMPLETED|Diet Treatment (4 Weeks)||4
6695964|NCT02677870|7626300|FG001|COMPLETED|Diet Treatment (4 Weeks)||3
6695965|NCT02677870|7626299|FG000|NOT COMPLETED|Diet Treatment (4 Weeks)||0
6695966|NCT02677870|7626300|FG001|NOT COMPLETED|Diet Treatment (4 Weeks)||0
6695967|NCT02677870|7626299|FG000|STARTED|First Saproterin Dihydrochloride tx||4
6695968|NCT02677870|7626300|FG001|STARTED|First Saproterin Dihydrochloride tx||3
6695969|NCT02677870|7626299|FG000|COMPLETED|First Saproterin Dihydrochloride tx||4
6695970|NCT02677870|7626300|FG001|COMPLETED|First Saproterin Dihydrochloride tx||3
6695971|NCT02677870|7626299|FG000|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
6695972|NCT02677870|7626300|FG001|NOT COMPLETED|First Saproterin Dihydrochloride tx||0
6695973|NCT02677870|7626299|FG000|STARTED|Washout (2 Weeks)||4
6695974|NCT02677870|7626300|FG001|STARTED|Washout (2 Weeks)||3
6695975|NCT02677870|7626299|FG000|COMPLETED|Washout (2 Weeks)||4
6695976|NCT02677870|7626300|FG001|COMPLETED|Washout (2 Weeks)||3
6695977|NCT02677870|7626299|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6695978|NCT02677870|7626300|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6695979|NCT02677870|7626299|FG000|STARTED|Second Saproterin Dihydrochloride tx||4
6695980|NCT02677870|7626300|FG001|STARTED|Second Saproterin Dihydrochloride tx||3
6695981|NCT02677870|7626299|FG000|COMPLETED|Second Saproterin Dihydrochloride tx||4
6695982|NCT02677870|7626300|FG001|COMPLETED|Second Saproterin Dihydrochloride tx||3
6695983|NCT02677870|7626299|FG000|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
6695984|NCT02677870|7626300|FG001|NOT COMPLETED|Second Saproterin Dihydrochloride tx||0
6695985|NCT02674750|7626311|FG000|STARTED|Overall Study||5
6695986|NCT02674750|7626312|FG001|STARTED|Overall Study||49
6695987|NCT02674750|7626313|FG002|STARTED|Overall Study||16
6695988|NCT02674750|7626311|FG000|COMPLETED|Overall Study||0
6695989|NCT02674750|7626312|FG001|COMPLETED|Overall Study||4
6695990|NCT02674750|7626313|FG002|COMPLETED|Overall Study||4
6695991|NCT02674750|7626311|FG000|NOT COMPLETED|Overall Study||5
6695992|NCT02674750|7626312|FG001|NOT COMPLETED|Overall Study||45
6695993|NCT02674750|7626313|FG002|NOT COMPLETED|Overall Study||12
6695994|NCT02440854|7626320|FG000|STARTED|Overall Study||80
6695995|NCT02440854|7626320|FG000|Analyzed|Overall Study||77
6695996|NCT02440854|7626320|FG000|COMPLETED|Overall Study||0
6695997|NCT02440854|7626320|FG000|NOT COMPLETED|Overall Study||80
6695998|NCT02367040|7626326|FG000|STARTED|Overall Study||307
6695999|NCT02367040|7626327|FG001|STARTED|Overall Study||151
6696000|NCT02367040|7626326|FG000|Received Treatment|Overall Study||304
6696001|NCT02367040|7626327|FG001|Received Treatment|Overall Study||149
6696002|NCT02367040|7626326|FG000|COMPLETED|Overall Study||70
6696003|NCT02367040|7626327|FG001|COMPLETED|Overall Study||29
6696004|NCT02367040|7626326|FG000|NOT COMPLETED|Overall Study||237
6696005|NCT02367040|7626327|FG001|NOT COMPLETED|Overall Study||122
6696036|NCT02278185|7626363|FG000|STARTED|Overall Study||10
6696037|NCT02278185|7626364|FG001|STARTED|Overall Study||9
6696038|NCT02278185|7626363|FG000|COMPLETED|Overall Study||7
6696039|NCT02278185|7626364|FG001|COMPLETED|Overall Study||7
6696040|NCT02278185|7626363|FG000|NOT COMPLETED|Overall Study||3
6696041|NCT02278185|7626364|FG001|NOT COMPLETED|Overall Study||2
6696042|NCT02154529|7626376|FG000|STARTED|Overall Study||4
6696043|NCT02154529|7626377|FG001|STARTED|Overall Study||3
6696044|NCT02154529|7626378|FG002|STARTED|Overall Study||8
6696045|NCT02154529|7626379|FG003|STARTED|Overall Study||2
6696046|NCT02154529|7626376|FG000|COMPLETED|Overall Study|Study terminated by sponsor|0
6696047|NCT02154529|7626377|FG001|COMPLETED|Overall Study|Study terminated by sponsor|0
6259322|NCT02810418|7158379|FG001|COMPLETED|Arm B Combination Therapy||0
6696048|NCT02154529|7626378|FG002|COMPLETED|Overall Study|Study terminated by sponsor|0
6696049|NCT02154529|7626379|FG003|COMPLETED|Overall Study|Study terminated by sponsor|0
6696050|NCT02154529|7626376|FG000|NOT COMPLETED|Overall Study||4
6696051|NCT02154529|7626377|FG001|NOT COMPLETED|Overall Study||3
6696052|NCT02154529|7626378|FG002|NOT COMPLETED|Overall Study||8
6696053|NCT02154529|7626379|FG003|NOT COMPLETED|Overall Study||2
6696054|NCT01590628|7626393|FG000|STARTED|Overall Study||13
6696055|NCT01590628|7626394|FG001|STARTED|Overall Study||3
6696056|NCT01590628|7626393|FG000|COMPLETED|Overall Study||11
6696057|NCT01590628|7626394|FG001|COMPLETED|Overall Study||3
6696058|NCT01590628|7626393|FG000|NOT COMPLETED|Overall Study||2
6696059|NCT01590628|7626394|FG001|NOT COMPLETED|Overall Study||0
6696060|NCT00788125|7626404|FG000|STARTED|Overall Study||7
6696061|NCT00788125|7626404|FG000|COMPLETED|Overall Study||1
6696062|NCT00788125|7626404|FG000|NOT COMPLETED|Overall Study||6
6738787|NCT03286218|7667997|FG001|Received at Least One Dose of Study Drug|Qualification Phase Period 1||47
6738788|NCT03286218|7667998|FG002|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738789|NCT03286218|7667999|FG003|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738790|NCT03286218|7668000|FG004|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738791|NCT03286218|7668001|FG005|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738792|NCT03286218|7668002|FG006|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738793|NCT03286218|7668003|FG007|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738794|NCT03286218|7668004|FG008|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738795|NCT03286218|7668005|FG009|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738796|NCT03286218|7668006|FG010|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738797|NCT03286218|7668007|FG011|Received at Least One Dose of Study Drug|Qualification Phase Period 1||0
6738798|NCT03286218|7667996|FG000|COMPLETED|Qualification Phase Period 1||47
6738799|NCT03286218|7667997|FG001|COMPLETED|Qualification Phase Period 1||47
6738800|NCT03286218|7667998|FG002|COMPLETED|Qualification Phase Period 1||0
6738801|NCT03286218|7667999|FG003|COMPLETED|Qualification Phase Period 1||0
6738802|NCT03286218|7668000|FG004|COMPLETED|Qualification Phase Period 1||0
6738803|NCT03286218|7668001|FG005|COMPLETED|Qualification Phase Period 1||0
6738804|NCT03286218|7668002|FG006|COMPLETED|Qualification Phase Period 1||0
6738805|NCT03286218|7668003|FG007|COMPLETED|Qualification Phase Period 1||0
6738806|NCT03286218|7668004|FG008|COMPLETED|Qualification Phase Period 1||0
6738807|NCT03286218|7668005|FG009|COMPLETED|Qualification Phase Period 1||0
6738808|NCT03286218|7668006|FG010|COMPLETED|Qualification Phase Period 1||0
6738809|NCT03286218|7668007|FG011|COMPLETED|Qualification Phase Period 1||0
6738810|NCT03286218|7667996|FG000|NOT COMPLETED|Qualification Phase Period 1||1
6738811|NCT03286218|7667997|FG001|NOT COMPLETED|Qualification Phase Period 1||1
6738812|NCT03286218|7667998|FG002|NOT COMPLETED|Qualification Phase Period 1||0
6738813|NCT03286218|7667999|FG003|NOT COMPLETED|Qualification Phase Period 1||0
6738814|NCT03286218|7668000|FG004|NOT COMPLETED|Qualification Phase Period 1||0
6738815|NCT03286218|7668001|FG005|NOT COMPLETED|Qualification Phase Period 1||0
6738816|NCT03286218|7668002|FG006|NOT COMPLETED|Qualification Phase Period 1||0
6738817|NCT03286218|7668003|FG007|NOT COMPLETED|Qualification Phase Period 1||0
6738818|NCT03286218|7668004|FG008|NOT COMPLETED|Qualification Phase Period 1||0
6738819|NCT03286218|7668005|FG009|NOT COMPLETED|Qualification Phase Period 1||0
6738820|NCT03286218|7668006|FG010|NOT COMPLETED|Qualification Phase Period 1||0
6738821|NCT03286218|7668007|FG011|NOT COMPLETED|Qualification Phase Period 1||0
6738822|NCT03286218|7667996|FG000|STARTED|Qualification Phase Period 2||47
6738823|NCT03286218|7667997|FG001|STARTED|Qualification Phase Period 2||47
6738824|NCT03286218|7667998|FG002|STARTED|Qualification Phase Period 2||0
6738825|NCT03286218|7667999|FG003|STARTED|Qualification Phase Period 2||0
6738826|NCT03286218|7668000|FG004|STARTED|Qualification Phase Period 2||0
6738827|NCT03286218|7668001|FG005|STARTED|Qualification Phase Period 2||0
6738828|NCT03286218|7668002|FG006|STARTED|Qualification Phase Period 2||0
6738829|NCT03286218|7668003|FG007|STARTED|Qualification Phase Period 2||0
6738830|NCT03286218|7668004|FG008|STARTED|Qualification Phase Period 2||0
6738831|NCT03286218|7668005|FG009|STARTED|Qualification Phase Period 2||0
6738832|NCT03286218|7668006|FG010|STARTED|Qualification Phase Period 2||0
6738833|NCT03286218|7668007|FG011|STARTED|Qualification Phase Period 2||0
6738834|NCT03286218|7667996|FG000|COMPLETED|Qualification Phase Period 2||30
6738835|NCT03286218|7667997|FG001|COMPLETED|Qualification Phase Period 2||28
6738836|NCT03286218|7667998|FG002|COMPLETED|Qualification Phase Period 2||0
6738837|NCT03286218|7667999|FG003|COMPLETED|Qualification Phase Period 2||0
6738838|NCT03286218|7668000|FG004|COMPLETED|Qualification Phase Period 2||0
6738839|NCT03286218|7668001|FG005|COMPLETED|Qualification Phase Period 2||0
6738840|NCT03286218|7668002|FG006|COMPLETED|Qualification Phase Period 2||0
6738841|NCT03286218|7668003|FG007|COMPLETED|Qualification Phase Period 2||0
6738842|NCT03286218|7668004|FG008|COMPLETED|Qualification Phase Period 2||0
6738843|NCT03286218|7668005|FG009|COMPLETED|Qualification Phase Period 2||0
6738844|NCT03286218|7668006|FG010|COMPLETED|Qualification Phase Period 2||0
6738845|NCT03286218|7668007|FG011|COMPLETED|Qualification Phase Period 2||0
6738846|NCT03286218|7667996|FG000|NOT COMPLETED|Qualification Phase Period 2||17
6738847|NCT03286218|7667997|FG001|NOT COMPLETED|Qualification Phase Period 2||19
6738848|NCT03286218|7667998|FG002|NOT COMPLETED|Qualification Phase Period 2||0
6738849|NCT03286218|7667999|FG003|NOT COMPLETED|Qualification Phase Period 2||0
6738850|NCT03286218|7668000|FG004|NOT COMPLETED|Qualification Phase Period 2||0
6738851|NCT03286218|7668001|FG005|NOT COMPLETED|Qualification Phase Period 2||0
6738852|NCT03286218|7668002|FG006|NOT COMPLETED|Qualification Phase Period 2||0
6696063|NCT02777554|7626410|FG000|STARTED|Overall Study||62
6696064|NCT02777554|7626411|FG001|STARTED|Overall Study||62
6696065|NCT02777554|7626412|FG002|STARTED|Overall Study||5
6696066|NCT02777554|7626413|FG003|STARTED|Overall Study||5
6696067|NCT02777554|7626414|FG004|STARTED|Overall Study||5
6696068|NCT02777554|7626415|FG005|STARTED|Overall Study||5
6696069|NCT02777554|7626410|FG000|COMPLETED|Overall Study||32
6696070|NCT02777554|7626411|FG001|COMPLETED|Overall Study||37
6696071|NCT02777554|7626412|FG002|COMPLETED|Overall Study||4
6696072|NCT02777554|7626413|FG003|COMPLETED|Overall Study||4
6696073|NCT02777554|7626414|FG004|COMPLETED|Overall Study||5
6696074|NCT02777554|7626415|FG005|COMPLETED|Overall Study||5
6696075|NCT02777554|7626410|FG000|NOT COMPLETED|Overall Study||30
6696076|NCT02777554|7626411|FG001|NOT COMPLETED|Overall Study||25
6696077|NCT02777554|7626412|FG002|NOT COMPLETED|Overall Study||1
6696078|NCT02777554|7626413|FG003|NOT COMPLETED|Overall Study||1
6696079|NCT02777554|7626414|FG004|NOT COMPLETED|Overall Study||0
6696080|NCT02777554|7626415|FG005|NOT COMPLETED|Overall Study||0
6696081|NCT02777749|7626438|FG000|STARTED|Overall Study||53
6696082|NCT02777749|7626439|FG001|STARTED|Overall Study||51
6696083|NCT02777749|7626440|FG002|STARTED|Overall Study||51
6696084|NCT02777749|7626438|FG000|COMPLETED|Overall Study||53
6696085|NCT02777749|7626439|FG001|COMPLETED|Overall Study||51
6696086|NCT02777749|7626440|FG002|COMPLETED|Overall Study||51
6696087|NCT02777749|7626438|FG000|NOT COMPLETED|Overall Study||0
6696088|NCT02777749|7626439|FG001|NOT COMPLETED|Overall Study||0
6696089|NCT02777749|7626440|FG002|NOT COMPLETED|Overall Study||0
6696090|NCT02777827|7626452|FG000|STARTED|Treatment Period 1||5
6696091|NCT02777827|7626453|FG001|STARTED|Treatment Period 1||5
6696092|NCT02777827|7626454|FG002|STARTED|Treatment Period 1||5
6696093|NCT02777827|7626455|FG003|STARTED|Treatment Period 1||5
6696094|NCT02777827|7626456|FG004|STARTED|Treatment Period 1||4
6696095|NCT02777827|7626457|FG005|STARTED|Treatment Period 1||6
6696096|NCT02777827|7626452|FG000|COMPLETED|Treatment Period 1||5
6696097|NCT02777827|7626453|FG001|COMPLETED|Treatment Period 1||5
6696098|NCT02777827|7626454|FG002|COMPLETED|Treatment Period 1||5
6696099|NCT02777827|7626455|FG003|COMPLETED|Treatment Period 1||5
6696100|NCT02777827|7626456|FG004|COMPLETED|Treatment Period 1||4
6696101|NCT02777827|7626457|FG005|COMPLETED|Treatment Period 1||6
6696102|NCT02777827|7626452|FG000|NOT COMPLETED|Treatment Period 1||0
6696103|NCT02777827|7626453|FG001|NOT COMPLETED|Treatment Period 1||0
6696104|NCT02777827|7626454|FG002|NOT COMPLETED|Treatment Period 1||0
6696105|NCT02777827|7626455|FG003|NOT COMPLETED|Treatment Period 1||0
6696106|NCT02777827|7626456|FG004|NOT COMPLETED|Treatment Period 1||0
6696107|NCT02777827|7626457|FG005|NOT COMPLETED|Treatment Period 1||0
6696108|NCT02777827|7626452|FG000|STARTED|Washout Between Periods 1 and 2||5
6696109|NCT02777827|7626453|FG001|STARTED|Washout Between Periods 1 and 2||5
6696110|NCT02777827|7626454|FG002|STARTED|Washout Between Periods 1 and 2||5
6696111|NCT02777827|7626455|FG003|STARTED|Washout Between Periods 1 and 2||5
6696112|NCT02777827|7626456|FG004|STARTED|Washout Between Periods 1 and 2||4
6696113|NCT02777827|7626457|FG005|STARTED|Washout Between Periods 1 and 2||6
6696114|NCT02777827|7626452|FG000|COMPLETED|Washout Between Periods 1 and 2||5
6696115|NCT02777827|7626453|FG001|COMPLETED|Washout Between Periods 1 and 2||5
6696116|NCT02777827|7626454|FG002|COMPLETED|Washout Between Periods 1 and 2||5
6696117|NCT02777827|7626455|FG003|COMPLETED|Washout Between Periods 1 and 2||5
6696118|NCT02777827|7626456|FG004|COMPLETED|Washout Between Periods 1 and 2||4
6696119|NCT02777827|7626457|FG005|COMPLETED|Washout Between Periods 1 and 2||6
6696120|NCT02777827|7626452|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
6696121|NCT02777827|7626453|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
6696122|NCT02777827|7626454|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
6696123|NCT02777827|7626455|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
6696124|NCT02777827|7626456|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
6696125|NCT02777827|7626457|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
6696126|NCT02777827|7626452|FG000|STARTED|Treatment Period 2||5
6696127|NCT02777827|7626453|FG001|STARTED|Treatment Period 2||5
6696128|NCT02777827|7626454|FG002|STARTED|Treatment Period 2||5
6696129|NCT02777827|7626455|FG003|STARTED|Treatment Period 2||5
6696130|NCT02777827|7626456|FG004|STARTED|Treatment Period 2||4
6696131|NCT02777827|7626457|FG005|STARTED|Treatment Period 2||6
6696132|NCT02777827|7626452|FG000|COMPLETED|Treatment Period 2||5
6696133|NCT02777827|7626453|FG001|COMPLETED|Treatment Period 2||5
6696134|NCT02777827|7626454|FG002|COMPLETED|Treatment Period 2||5
6696135|NCT02777827|7626455|FG003|COMPLETED|Treatment Period 2||5
6696136|NCT02777827|7626456|FG004|COMPLETED|Treatment Period 2||4
6696137|NCT02777827|7626457|FG005|COMPLETED|Treatment Period 2||6
6696138|NCT02777827|7626452|FG000|NOT COMPLETED|Treatment Period 2||0
6696139|NCT02777827|7626453|FG001|NOT COMPLETED|Treatment Period 2||0
6696140|NCT02777827|7626454|FG002|NOT COMPLETED|Treatment Period 2||0
6696141|NCT02777827|7626455|FG003|NOT COMPLETED|Treatment Period 2||0
6696142|NCT02777827|7626456|FG004|NOT COMPLETED|Treatment Period 2||0
6696143|NCT02777827|7626457|FG005|NOT COMPLETED|Treatment Period 2||0
6696144|NCT02777827|7626452|FG000|STARTED|Washout Between Periods 2 and 3||5
6696145|NCT02777827|7626453|FG001|STARTED|Washout Between Periods 2 and 3||5
6696146|NCT02777827|7626454|FG002|STARTED|Washout Between Periods 2 and 3||5
6696147|NCT02777827|7626455|FG003|STARTED|Washout Between Periods 2 and 3||5
6696148|NCT02777827|7626456|FG004|STARTED|Washout Between Periods 2 and 3||4
6696149|NCT02777827|7626457|FG005|STARTED|Washout Between Periods 2 and 3||6
6696150|NCT02777827|7626452|FG000|COMPLETED|Washout Between Periods 2 and 3||5
6696151|NCT02777827|7626453|FG001|COMPLETED|Washout Between Periods 2 and 3||5
6696152|NCT02777827|7626454|FG002|COMPLETED|Washout Between Periods 2 and 3||5
6696153|NCT02777827|7626455|FG003|COMPLETED|Washout Between Periods 2 and 3||5
6696154|NCT02777827|7626456|FG004|COMPLETED|Washout Between Periods 2 and 3||4
6696155|NCT02777827|7626457|FG005|COMPLETED|Washout Between Periods 2 and 3||6
6696156|NCT02777827|7626452|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
6696157|NCT02777827|7626453|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
6696158|NCT02777827|7626454|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
6696159|NCT02777827|7626455|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
6696160|NCT02777827|7626456|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
6696161|NCT02777827|7626457|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
6696162|NCT02777827|7626452|FG000|STARTED|Treatment Period 3||5
6696163|NCT02777827|7626453|FG001|STARTED|Treatment Period 3||5
6696164|NCT02777827|7626454|FG002|STARTED|Treatment Period 3||5
6696165|NCT02777827|7626455|FG003|STARTED|Treatment Period 3||5
6696166|NCT02777827|7626456|FG004|STARTED|Treatment Period 3||4
6696167|NCT02777827|7626457|FG005|STARTED|Treatment Period 3||6
6696168|NCT02777827|7626452|FG000|COMPLETED|Treatment Period 3||5
6696169|NCT02777827|7626453|FG001|COMPLETED|Treatment Period 3||5
6696170|NCT02777827|7626454|FG002|COMPLETED|Treatment Period 3||5
6696171|NCT02777827|7626455|FG003|COMPLETED|Treatment Period 3||5
6696172|NCT02777827|7626456|FG004|COMPLETED|Treatment Period 3||4
6696173|NCT02777827|7626457|FG005|COMPLETED|Treatment Period 3||6
6696174|NCT02777827|7626452|FG000|NOT COMPLETED|Treatment Period 3||0
6696175|NCT02777827|7626453|FG001|NOT COMPLETED|Treatment Period 3||0
6696176|NCT02777827|7626454|FG002|NOT COMPLETED|Treatment Period 3||0
6696177|NCT02777827|7626455|FG003|NOT COMPLETED|Treatment Period 3||0
6696178|NCT02777827|7626456|FG004|NOT COMPLETED|Treatment Period 3||0
6696179|NCT02777827|7626457|FG005|NOT COMPLETED|Treatment Period 3||0
6696180|NCT02777827|7626452|FG000|STARTED|Washout Between Periods 3 and 4||5
6696181|NCT02777827|7626453|FG001|STARTED|Washout Between Periods 3 and 4||5
6696182|NCT02777827|7626454|FG002|STARTED|Washout Between Periods 3 and 4||5
6696183|NCT02777827|7626455|FG003|STARTED|Washout Between Periods 3 and 4||5
6696184|NCT02777827|7626456|FG004|STARTED|Washout Between Periods 3 and 4||4
6696185|NCT02777827|7626457|FG005|STARTED|Washout Between Periods 3 and 4||6
6696186|NCT02777827|7626452|FG000|COMPLETED|Washout Between Periods 3 and 4||5
6696187|NCT02777827|7626453|FG001|COMPLETED|Washout Between Periods 3 and 4||5
6696188|NCT02777827|7626454|FG002|COMPLETED|Washout Between Periods 3 and 4||4
6696189|NCT02777827|7626455|FG003|COMPLETED|Washout Between Periods 3 and 4||5
6696190|NCT02777827|7626456|FG004|COMPLETED|Washout Between Periods 3 and 4||4
6696191|NCT02777827|7626457|FG005|COMPLETED|Washout Between Periods 3 and 4||6
6696192|NCT02777827|7626452|FG000|NOT COMPLETED|Washout Between Periods 3 and 4||0
6696193|NCT02777827|7626453|FG001|NOT COMPLETED|Washout Between Periods 3 and 4||0
6696194|NCT02777827|7626454|FG002|NOT COMPLETED|Washout Between Periods 3 and 4||1
6696195|NCT02777827|7626455|FG003|NOT COMPLETED|Washout Between Periods 3 and 4||0
6696196|NCT02777827|7626456|FG004|NOT COMPLETED|Washout Between Periods 3 and 4||0
6696197|NCT02777827|7626457|FG005|NOT COMPLETED|Washout Between Periods 3 and 4||0
6696198|NCT02777827|7626452|FG000|STARTED|Treatment Period 4||5
6696199|NCT02777827|7626453|FG001|STARTED|Treatment Period 4||5
6696200|NCT02777827|7626454|FG002|STARTED|Treatment Period 4||4
6696201|NCT02777827|7626455|FG003|STARTED|Treatment Period 4||5
6696202|NCT02777827|7626456|FG004|STARTED|Treatment Period 4||4
6696203|NCT02777827|7626457|FG005|STARTED|Treatment Period 4||6
6696204|NCT02777827|7626452|FG000|COMPLETED|Treatment Period 4||5
6696205|NCT02777827|7626453|FG001|COMPLETED|Treatment Period 4||5
6696206|NCT02777827|7626454|FG002|COMPLETED|Treatment Period 4||4
6696207|NCT02777827|7626455|FG003|COMPLETED|Treatment Period 4||5
6696208|NCT02777827|7626456|FG004|COMPLETED|Treatment Period 4||4
6696209|NCT02777827|7626457|FG005|COMPLETED|Treatment Period 4||6
6696210|NCT02777827|7626452|FG000|NOT COMPLETED|Treatment Period 4||0
6696211|NCT02777827|7626453|FG001|NOT COMPLETED|Treatment Period 4||0
6696212|NCT02777827|7626454|FG002|NOT COMPLETED|Treatment Period 4||0
6696213|NCT02777827|7626455|FG003|NOT COMPLETED|Treatment Period 4||0
6696214|NCT02777827|7626456|FG004|NOT COMPLETED|Treatment Period 4||0
6696215|NCT02777827|7626457|FG005|NOT COMPLETED|Treatment Period 4||0
6696216|NCT02777827|7626452|FG000|STARTED|Washout Between Periods 4 and 5||5
6696217|NCT02777827|7626453|FG001|STARTED|Washout Between Periods 4 and 5||5
6696218|NCT02777827|7626454|FG002|STARTED|Washout Between Periods 4 and 5||4
6696219|NCT02777827|7626455|FG003|STARTED|Washout Between Periods 4 and 5||5
6696220|NCT02777827|7626456|FG004|STARTED|Washout Between Periods 4 and 5||4
6696221|NCT02777827|7626457|FG005|STARTED|Washout Between Periods 4 and 5||6
6696222|NCT02777827|7626452|FG000|COMPLETED|Washout Between Periods 4 and 5||5
6696223|NCT02777827|7626453|FG001|COMPLETED|Washout Between Periods 4 and 5||5
6696224|NCT02777827|7626454|FG002|COMPLETED|Washout Between Periods 4 and 5||4
6696225|NCT02777827|7626455|FG003|COMPLETED|Washout Between Periods 4 and 5||5
6696226|NCT02777827|7626456|FG004|COMPLETED|Washout Between Periods 4 and 5||4
6696227|NCT02777827|7626457|FG005|COMPLETED|Washout Between Periods 4 and 5||6
6696228|NCT02777827|7626452|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
6696229|NCT02777827|7626453|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
6696230|NCT02777827|7626454|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
6696231|NCT02777827|7626455|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
6696232|NCT02777827|7626456|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
6696233|NCT02777827|7626457|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
6696234|NCT02777827|7626452|FG000|STARTED|Treatment Period 5||5
6696235|NCT02777827|7626453|FG001|STARTED|Treatment Period 5||5
6696236|NCT02777827|7626454|FG002|STARTED|Treatment Period 5||4
6696237|NCT02777827|7626455|FG003|STARTED|Treatment Period 5||5
6696238|NCT02777827|7626456|FG004|STARTED|Treatment Period 5||4
6696239|NCT02777827|7626457|FG005|STARTED|Treatment Period 5||6
6696240|NCT02777827|7626452|FG000|COMPLETED|Treatment Period 5||5
6696241|NCT02777827|7626453|FG001|COMPLETED|Treatment Period 5||5
6696242|NCT02777827|7626454|FG002|COMPLETED|Treatment Period 5||4
6696243|NCT02777827|7626455|FG003|COMPLETED|Treatment Period 5||5
6696244|NCT02777827|7626456|FG004|COMPLETED|Treatment Period 5||4
6696245|NCT02777827|7626457|FG005|COMPLETED|Treatment Period 5||6
6696246|NCT02777827|7626452|FG000|NOT COMPLETED|Treatment Period 5||0
6696247|NCT02777827|7626453|FG001|NOT COMPLETED|Treatment Period 5||0
6696248|NCT02777827|7626454|FG002|NOT COMPLETED|Treatment Period 5||0
6696249|NCT02777827|7626455|FG003|NOT COMPLETED|Treatment Period 5||0
6696250|NCT02777827|7626456|FG004|NOT COMPLETED|Treatment Period 5||0
6696251|NCT02777827|7626457|FG005|NOT COMPLETED|Treatment Period 5||0
6696252|NCT02777827|7626452|FG000|STARTED|Washout Between Periods 5 and 6||5
6696253|NCT02777827|7626453|FG001|STARTED|Washout Between Periods 5 and 6||5
6696254|NCT02777827|7626454|FG002|STARTED|Washout Between Periods 5 and 6||4
6696255|NCT02777827|7626455|FG003|STARTED|Washout Between Periods 5 and 6||5
6696256|NCT02777827|7626456|FG004|STARTED|Washout Between Periods 5 and 6||4
6696257|NCT02777827|7626457|FG005|STARTED|Washout Between Periods 5 and 6||6
6696258|NCT02777827|7626452|FG000|COMPLETED|Washout Between Periods 5 and 6||5
6696259|NCT02777827|7626453|FG001|COMPLETED|Washout Between Periods 5 and 6||5
6696260|NCT02777827|7626454|FG002|COMPLETED|Washout Between Periods 5 and 6||4
6696261|NCT02777827|7626455|FG003|COMPLETED|Washout Between Periods 5 and 6||5
6696262|NCT02777827|7626456|FG004|COMPLETED|Washout Between Periods 5 and 6||4
6696263|NCT02777827|7626457|FG005|COMPLETED|Washout Between Periods 5 and 6||6
6696264|NCT02777827|7626452|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
6696265|NCT02777827|7626453|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
6696266|NCT02777827|7626454|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
6696267|NCT02777827|7626455|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
6696268|NCT02777827|7626456|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
6696269|NCT02777827|7626457|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
6696270|NCT02777827|7626452|FG000|STARTED|Treatment Period 6||5
6696271|NCT02777827|7626453|FG001|STARTED|Treatment Period 6||5
6696272|NCT02777827|7626454|FG002|STARTED|Treatment Period 6||4
6696273|NCT02777827|7626455|FG003|STARTED|Treatment Period 6||5
6696274|NCT02777827|7626456|FG004|STARTED|Treatment Period 6||4
6696275|NCT02777827|7626457|FG005|STARTED|Treatment Period 6||6
6696276|NCT02777827|7626452|FG000|COMPLETED|Treatment Period 6||5
6696277|NCT02777827|7626453|FG001|COMPLETED|Treatment Period 6||5
6696278|NCT02777827|7626454|FG002|COMPLETED|Treatment Period 6||4
6696279|NCT02777827|7626455|FG003|COMPLETED|Treatment Period 6||5
6696280|NCT02777827|7626456|FG004|COMPLETED|Treatment Period 6||4
6696281|NCT02777827|7626457|FG005|COMPLETED|Treatment Period 6||6
6696282|NCT02777827|7626452|FG000|NOT COMPLETED|Treatment Period 6||0
6696283|NCT02777827|7626453|FG001|NOT COMPLETED|Treatment Period 6||0
6696284|NCT02777827|7626454|FG002|NOT COMPLETED|Treatment Period 6||0
6696285|NCT02777827|7626455|FG003|NOT COMPLETED|Treatment Period 6||0
6696286|NCT02777827|7626456|FG004|NOT COMPLETED|Treatment Period 6||0
6696287|NCT02777827|7626457|FG005|NOT COMPLETED|Treatment Period 6||0
6696288|NCT02777918|7626473|FG000|STARTED|Overall Study||53
6696289|NCT02777918|7626474|FG001|STARTED|Overall Study||47
6696290|NCT02777918|7626473|FG000|COMPLETED|Overall Study||50
6696291|NCT02777918|7626474|FG001|COMPLETED|Overall Study||43
6696292|NCT02777918|7626473|FG000|NOT COMPLETED|Overall Study||3
6696293|NCT02777918|7626474|FG001|NOT COMPLETED|Overall Study||4
6696294|NCT02777931|7626482|FG000|STARTED|Overall Study||49
6696295|NCT02777931|7626483|FG001|STARTED|Overall Study||52
6696296|NCT02777931|7626482|FG000|Safety Population|Overall Study||47
6696297|NCT02777931|7626483|FG001|Safety Population|Overall Study||50
6696298|NCT02777931|7626482|FG000|Modified Intent to Treat Population|Overall Study||46
6696299|NCT02777931|7626483|FG001|Modified Intent to Treat Population|Overall Study||50
6696300|NCT02777931|7626482|FG000|COMPLETED|Overall Study||37
6696301|NCT02777931|7626483|FG001|COMPLETED|Overall Study||39
6696302|NCT02777931|7626482|FG000|NOT COMPLETED|Overall Study||12
6696303|NCT02777931|7626483|FG001|NOT COMPLETED|Overall Study||13
6696304|NCT02777944|7626491|FG000|STARTED|Overall Study||157
6696305|NCT02777944|7626492|FG001|STARTED|Overall Study||156
6696306|NCT02777944|7626491|FG000|COMPLETED|Overall Study||157
6696307|NCT02777944|7626492|FG001|COMPLETED|Overall Study||156
6696308|NCT02777944|7626491|FG000|NOT COMPLETED|Overall Study||0
6696309|NCT02777944|7626492|FG001|NOT COMPLETED|Overall Study||0
6696310|NCT02777970|7626501|FG000|STARTED|Overall Study||261
6696311|NCT02777970|7626502|FG001|STARTED|Overall Study||262
6696312|NCT02777970|7626503|FG002|STARTED|Overall Study||131
6696313|NCT02777970|7626501|FG000|COMPLETED|Overall Study||260
6259323|NCT02810418|7158380|FG002|COMPLETED|Arm B Combination Therapy||0
6696314|NCT02777970|7626502|FG001|COMPLETED|Overall Study||261
6696315|NCT02777970|7626503|FG002|COMPLETED|Overall Study||131
6696316|NCT02777970|7626501|FG000|NOT COMPLETED|Overall Study||1
6696317|NCT02777970|7626502|FG001|NOT COMPLETED|Overall Study||1
6696318|NCT02777970|7626503|FG002|NOT COMPLETED|Overall Study||0
6696319|NCT02778074|7626515|FG000|STARTED|Overall Study||72
6696320|NCT02778074|7626516|FG001|STARTED|Overall Study||72
6696321|NCT02778074|7626515|FG000|COMPLETED|Overall Study||65
6696322|NCT02778074|7626516|FG001|COMPLETED|Overall Study||62
6696323|NCT02778074|7626515|FG000|NOT COMPLETED|Overall Study||7
6696324|NCT02778074|7626516|FG001|NOT COMPLETED|Overall Study||10
6696325|NCT02778100|7626524|FG000|STARTED|Period 1 (Common Cold)||18
6696326|NCT02778100|7626525|FG001|STARTED|Period 1 (Common Cold)||18
6696327|NCT02778100|7626524|FG000|COMPLETED|Period 1 (Common Cold)||17
6696328|NCT02778100|7626525|FG001|COMPLETED|Period 1 (Common Cold)||18
6696329|NCT02778100|7626524|FG000|NOT COMPLETED|Period 1 (Common Cold)||1
6696330|NCT02778100|7626525|FG001|NOT COMPLETED|Period 1 (Common Cold)||0
6696331|NCT02778100|7626524|FG000|STARTED|Period 2 (No Cold Symptoms)||17
6696332|NCT02778100|7626525|FG001|STARTED|Period 2 (No Cold Symptoms)|Cohort 2 only administered NG to participants with a common cold who are taking oxymetazoline.|0
6696333|NCT02778100|7626524|FG000|COMPLETED|Period 2 (No Cold Symptoms)||17
6696334|NCT02778100|7626525|FG001|COMPLETED|Period 2 (No Cold Symptoms)||0
6696335|NCT02778100|7626524|FG000|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
6696336|NCT02778100|7626525|FG001|NOT COMPLETED|Period 2 (No Cold Symptoms)||0
6696337|NCT02778113|7626533|FG000|STARTED|Study Period One||4
6696338|NCT02778113|7626534|FG001|STARTED|Study Period One||4
6696339|NCT02778113|7626535|FG002|STARTED|Study Period One||4
6696340|NCT02778113|7626536|FG003|STARTED|Study Period One||4
6696341|NCT02778113|7626533|FG000|Received Study Drug|Study Period One||4
6696342|NCT02778113|7626534|FG001|Received Study Drug|Study Period One||4
6696343|NCT02778113|7626535|FG002|Received Study Drug|Study Period One||4
6696344|NCT02778113|7626536|FG003|Received Study Drug|Study Period One||4
6696345|NCT02778113|7626533|FG000|COMPLETED|Study Period One||4
6696346|NCT02778113|7626534|FG001|COMPLETED|Study Period One||4
6696347|NCT02778113|7626535|FG002|COMPLETED|Study Period One||4
6696348|NCT02778113|7626536|FG003|COMPLETED|Study Period One||4
6696349|NCT02778113|7626533|FG000|NOT COMPLETED|Study Period One||0
6696350|NCT02778113|7626534|FG001|NOT COMPLETED|Study Period One||0
6696351|NCT02778113|7626535|FG002|NOT COMPLETED|Study Period One||0
6696352|NCT02778113|7626536|FG003|NOT COMPLETED|Study Period One||0
6696353|NCT02778113|7626533|FG000|STARTED|Study Period Two||4
6696354|NCT02778113|7626534|FG001|STARTED|Study Period Two||4
6696355|NCT02778113|7626535|FG002|STARTED|Study Period Two||4
6696356|NCT02778113|7626536|FG003|STARTED|Study Period Two||4
6696357|NCT02778113|7626533|FG000|Received Study Drug|Study Period Two||4
6696358|NCT02778113|7626534|FG001|Received Study Drug|Study Period Two||4
6696359|NCT02778113|7626535|FG002|Received Study Drug|Study Period Two||4
6696360|NCT02778113|7626536|FG003|Received Study Drug|Study Period Two||4
6696361|NCT02778113|7626533|FG000|COMPLETED|Study Period Two||4
6696362|NCT02778113|7626534|FG001|COMPLETED|Study Period Two||4
6696363|NCT02778113|7626535|FG002|COMPLETED|Study Period Two||4
6696364|NCT02778113|7626536|FG003|COMPLETED|Study Period Two||4
6696365|NCT02778113|7626533|FG000|NOT COMPLETED|Study Period Two||0
6696366|NCT02778113|7626534|FG001|NOT COMPLETED|Study Period Two||0
6696367|NCT02778113|7626535|FG002|NOT COMPLETED|Study Period Two||0
6696368|NCT02778113|7626536|FG003|NOT COMPLETED|Study Period Two||0
6696369|NCT02778113|7626533|FG000|STARTED|Study Period Three||4
6696370|NCT02778113|7626534|FG001|STARTED|Study Period Three||4
6696371|NCT02778113|7626535|FG002|STARTED|Study Period Three|One participant completed study period two, but did not enter study period three.|3
6696372|NCT02778113|7626536|FG003|STARTED|Study Period Three||4
6696373|NCT02778113|7626533|FG000|Received Study Drug|Study Period Three||4
6696374|NCT02778113|7626534|FG001|Received Study Drug|Study Period Three||4
6696375|NCT02778113|7626535|FG002|Received Study Drug|Study Period Three||3
6696376|NCT02778113|7626536|FG003|Received Study Drug|Study Period Three||4
6696377|NCT02778113|7626533|FG000|COMPLETED|Study Period Three||4
6696378|NCT02778113|7626534|FG001|COMPLETED|Study Period Three||4
6696379|NCT02778113|7626535|FG002|COMPLETED|Study Period Three||3
6696380|NCT02778113|7626536|FG003|COMPLETED|Study Period Three||4
6696381|NCT02778113|7626533|FG000|NOT COMPLETED|Study Period Three||0
6696382|NCT02778113|7626534|FG001|NOT COMPLETED|Study Period Three||0
6696383|NCT02778113|7626535|FG002|NOT COMPLETED|Study Period Three||0
6696384|NCT02778113|7626536|FG003|NOT COMPLETED|Study Period Three||0
6696385|NCT02778113|7626533|FG000|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|3
6696386|NCT02778113|7626534|FG001|STARTED|Study Period Four||4
6696387|NCT02778113|7626535|FG002|STARTED|Study Period Four|One participant completed study period three, but did not enter study period four.|2
6696388|NCT02778113|7626536|FG003|STARTED|Study Period Four||4
6696389|NCT02778113|7626533|FG000|Received Study Drug|Study Period Four||3
6696390|NCT02778113|7626534|FG001|Received Study Drug|Study Period Four||4
6696391|NCT02778113|7626535|FG002|Received Study Drug|Study Period Four||2
6696392|NCT02778113|7626536|FG003|Received Study Drug|Study Period Four||4
6696393|NCT02778113|7626533|FG000|COMPLETED|Study Period Four||3
6696394|NCT02778113|7626534|FG001|COMPLETED|Study Period Four||4
6696395|NCT02778113|7626535|FG002|COMPLETED|Study Period Four||2
6696396|NCT02778113|7626536|FG003|COMPLETED|Study Period Four||4
6696397|NCT02778113|7626533|FG000|NOT COMPLETED|Study Period Four||0
6696398|NCT02778113|7626534|FG001|NOT COMPLETED|Study Period Four||0
6696399|NCT02778113|7626535|FG002|NOT COMPLETED|Study Period Four||0
6696400|NCT02778113|7626536|FG003|NOT COMPLETED|Study Period Four||0
6696401|NCT02778152|7626548|FG000|STARTED|Overall Study||13
6696402|NCT02778152|7626548|FG000|COMPLETED|Overall Study||13
6696403|NCT02778152|7626548|FG000|NOT COMPLETED|Overall Study||0
6259324|NCT02810418|7158381|FG003|COMPLETED|Arm B Combination Therapy||0
6259325|NCT02810418|7158382|FG004|COMPLETED|Arm B Combination Therapy||0
6259326|NCT02810418|7158383|FG005|COMPLETED|Arm B Combination Therapy||0
6259327|NCT02810418|7158384|FG006|COMPLETED|Arm B Combination Therapy||5
6259328|NCT02810418|7158378|FG000|NOT COMPLETED|Arm B Combination Therapy||0
6259329|NCT02810418|7158379|FG001|NOT COMPLETED|Arm B Combination Therapy||0
6259330|NCT02810418|7158380|FG002|NOT COMPLETED|Arm B Combination Therapy||0
6259331|NCT02810418|7158381|FG003|NOT COMPLETED|Arm B Combination Therapy||0
6259332|NCT02810418|7158382|FG004|NOT COMPLETED|Arm B Combination Therapy||0
6259333|NCT02810418|7158383|FG005|NOT COMPLETED|Arm B Combination Therapy||0
6259334|NCT02810418|7158384|FG006|NOT COMPLETED|Arm B Combination Therapy||0
6259335|NCT02785991|7158447|FG000|STARTED|Overall Study||1742
6259336|NCT02785991|7158447|FG000|COMPLETED|Overall Study||1741
6259337|NCT02785991|7158447|FG000|NOT COMPLETED|Overall Study||1
6259338|NCT02781584|7158465|FG000|STARTED|Pre-treatment Phase||0
6259339|NCT02781584|7158466|FG001|STARTED|Pre-treatment Phase||0
6259340|NCT02781584|7158467|FG002|STARTED|Pre-treatment Phase||0
6259341|NCT02781584|7158468|FG003|STARTED|Pre-treatment Phase||0
6259342|NCT02781584|7158469|FG004|STARTED|Pre-treatment Phase||0
6259343|NCT02781584|7158470|FG005|STARTED|Pre-treatment Phase||0
6259344|NCT02781584|7158471|FG006|STARTED|Pre-treatment Phase||0
6259345|NCT02781584|7158472|FG007|STARTED|Pre-treatment Phase||0
6259346|NCT02781584|7158473|FG008|STARTED|Pre-treatment Phase||0
6259347|NCT02781584|7158474|FG009|STARTED|Pre-treatment Phase||15
6259348|NCT02781584|7158475|FG010|STARTED|Pre-treatment Phase||16
6259349|NCT02781584|7158476|FG011|STARTED|Pre-treatment Phase||33
6259350|NCT02781584|7158477|FG012|STARTED|Pre-treatment Phase||33
6259351|NCT02781584|7158465|FG000|COMPLETED|Pre-treatment Phase||0
6259352|NCT02781584|7158466|FG001|COMPLETED|Pre-treatment Phase||0
6259353|NCT02781584|7158467|FG002|COMPLETED|Pre-treatment Phase||0
6259354|NCT02781584|7158468|FG003|COMPLETED|Pre-treatment Phase||0
6259355|NCT02781584|7158469|FG004|COMPLETED|Pre-treatment Phase||0
6696404|NCT02778555|7626555|FG000|STARTED|Overall Study||186
6696405|NCT02778555|7626556|FG001|STARTED|Overall Study||209
6696406|NCT02778555|7626557|FG002|STARTED|Overall Study||318
6696407|NCT02778555|7626555|FG000|COMPLETED|Overall Study||131
6696408|NCT02778555|7626556|FG001|COMPLETED|Overall Study||177
6696409|NCT02778555|7626557|FG002|COMPLETED|Overall Study||211
6696410|NCT02778555|7626555|FG000|NOT COMPLETED|Overall Study||55
6696411|NCT02778555|7626556|FG001|NOT COMPLETED|Overall Study||32
6696412|NCT02778555|7626557|FG002|NOT COMPLETED|Overall Study||107
6696413|NCT02778867|7626567|FG000|STARTED|Phase 1||67
6696414|NCT02778867|7626568|FG001|STARTED|Phase 1||62
6696415|NCT02778867|7626569|FG002|STARTED|Phase 1||0
6696416|NCT02778867|7626570|FG003|STARTED|Phase 1||0
6696417|NCT02778867|7626567|FG000|COMPLETED|Phase 1||65
6696418|NCT02778867|7626568|FG001|COMPLETED|Phase 1||59
6696419|NCT02778867|7626569|FG002|COMPLETED|Phase 1||0
6696420|NCT02778867|7626570|FG003|COMPLETED|Phase 1||0
6696421|NCT02778867|7626567|FG000|NOT COMPLETED|Phase 1||2
6696422|NCT02778867|7626568|FG001|NOT COMPLETED|Phase 1||3
6696423|NCT02778867|7626569|FG002|NOT COMPLETED|Phase 1||0
6696424|NCT02778867|7626570|FG003|NOT COMPLETED|Phase 1||0
6696425|NCT02778867|7626567|FG000|STARTED|Phase 2|1FED non-responders from Phase 1 have the option to undergo 6FED in Phase 2|0
6696426|NCT02778867|7626568|FG001|STARTED|Phase 2|6FED non-responders from Phase 1 have the option to undergo SGC in Phase 2|0
6696427|NCT02778867|7626569|FG002|STARTED|Phase 2|Optional phase for 1FED non-responders|21
6696428|NCT02778867|7626570|FG003|STARTED|Phase 2|Optional phase for 6FED non-responders|11
6696429|NCT02778867|7626567|FG000|COMPLETED|Phase 2||0
6696430|NCT02778867|7626568|FG001|COMPLETED|Phase 2||0
6696431|NCT02778867|7626569|FG002|COMPLETED|Phase 2||20
6696432|NCT02778867|7626570|FG003|COMPLETED|Phase 2||9
6696433|NCT02778867|7626567|FG000|NOT COMPLETED|Phase 2||0
6696434|NCT02778867|7626568|FG001|NOT COMPLETED|Phase 2||0
6696435|NCT02778867|7626569|FG002|NOT COMPLETED|Phase 2||1
6696436|NCT02778867|7626570|FG003|NOT COMPLETED|Phase 2||2
6696437|NCT02778880|7626582|FG000|STARTED|Overall Study||45
6696438|NCT02778880|7626583|FG001|STARTED|Overall Study||45
6696439|NCT02778880|7626582|FG000|COMPLETED|Overall Study||44
6696440|NCT02778880|7626583|FG001|COMPLETED|Overall Study||42
6696441|NCT02778880|7626582|FG000|NOT COMPLETED|Overall Study||1
6696442|NCT02778880|7626583|FG001|NOT COMPLETED|Overall Study||3
6696443|NCT02778932|7626591|FG000|STARTED|Overall Study||74
6696444|NCT02778932|7626592|FG001|STARTED|Overall Study||74
6696445|NCT02778932|7626591|FG000|COMPLETED|Overall Study||74
6696446|NCT02778932|7626592|FG001|COMPLETED|Overall Study||74
6696447|NCT02778932|7626591|FG000|NOT COMPLETED|Overall Study||0
6696448|NCT02778932|7626592|FG001|NOT COMPLETED|Overall Study||0
6696449|NCT02779075|7626600|FG000|STARTED|Overall Study||16
6696450|NCT02779075|7626601|FG001|STARTED|Overall Study||13
6696451|NCT02779075|7626600|FG000|COMPLETED|Overall Study||14
6696452|NCT02779075|7626601|FG001|COMPLETED|Overall Study||10
6696453|NCT02779075|7626600|FG000|NOT COMPLETED|Overall Study||2
6696454|NCT02779075|7626601|FG001|NOT COMPLETED|Overall Study||3
6696455|NCT02779166|7626609|FG000|STARTED|Overall Study||50
6696456|NCT02779166|7626610|FG001|STARTED|Overall Study||48
6696457|NCT02779166|7626609|FG000|COMPLETED|Overall Study||50
6696458|NCT02779166|7626610|FG001|COMPLETED|Overall Study||48
6696459|NCT02779166|7626609|FG000|NOT COMPLETED|Overall Study||0
6696460|NCT02779166|7626610|FG001|NOT COMPLETED|Overall Study||0
6696461|NCT02779491|7626620|FG000|STARTED|Overall Study||32
6696462|NCT02779491|7626621|FG001|STARTED|Overall Study||27
6696463|NCT02779491|7626622|FG002|STARTED|Overall Study||18
6696464|NCT02779491|7626623|FG003|STARTED|Overall Study||17
6696465|NCT02779491|7626620|FG000|COMPLETED|Overall Study||32
6696466|NCT02779491|7626621|FG001|COMPLETED|Overall Study||26
6696467|NCT02779491|7626622|FG002|COMPLETED|Overall Study||17
6696468|NCT02779491|7626623|FG003|COMPLETED|Overall Study||15
6696469|NCT02779491|7626620|FG000|NOT COMPLETED|Overall Study||0
6696470|NCT02779491|7626621|FG001|NOT COMPLETED|Overall Study||1
6696471|NCT02779491|7626622|FG002|NOT COMPLETED|Overall Study||1
6696472|NCT02779491|7626623|FG003|NOT COMPLETED|Overall Study||2
6696473|NCT02779543|7626635|FG000|STARTED|Overall Study||100
6696474|NCT02779543|7626636|FG001|STARTED|Overall Study||100
6696475|NCT02779543|7626635|FG000|COMPLETED|Overall Study||100
6696476|NCT02779543|7626636|FG001|COMPLETED|Overall Study||100
6696477|NCT02779543|7626635|FG000|NOT COMPLETED|Overall Study||0
6696478|NCT02779543|7626636|FG001|NOT COMPLETED|Overall Study||0
6696479|NCT02780115|7626648|FG000|STARTED|Overall Study||28
6696480|NCT02780115|7626649|FG001|STARTED|Overall Study||30
6259356|NCT02781584|7158470|FG005|COMPLETED|Pre-treatment Phase||0
6696481|NCT02780115|7626650|FG002|STARTED|Overall Study||30
6696482|NCT02780115|7626651|FG003|STARTED|Overall Study||32
6696483|NCT02780115|7626652|FG004|STARTED|Overall Study||31
6696484|NCT02780115|7626648|FG000|COMPLETED|Overall Study||28
6696485|NCT02780115|7626649|FG001|COMPLETED|Overall Study||29
6696486|NCT02780115|7626650|FG002|COMPLETED|Overall Study||29
6696487|NCT02780115|7626651|FG003|COMPLETED|Overall Study||31
6696488|NCT02780115|7626652|FG004|COMPLETED|Overall Study||30
6696489|NCT02780115|7626648|FG000|NOT COMPLETED|Overall Study||0
6696490|NCT02780115|7626649|FG001|NOT COMPLETED|Overall Study||1
6696491|NCT02780115|7626650|FG002|NOT COMPLETED|Overall Study||1
6696492|NCT02780115|7626651|FG003|NOT COMPLETED|Overall Study||1
6696493|NCT02780115|7626652|FG004|NOT COMPLETED|Overall Study||1
6696494|NCT02780167|7626669|FG000|STARTED|Overall Study||56
6696495|NCT02780167|7626670|FG001|STARTED|Overall Study||49
6696496|NCT02780167|7626671|FG002|STARTED|Overall Study||51
6696497|NCT02780167|7626672|FG003|STARTED|Overall Study||56
6696498|NCT02780167|7626673|FG004|STARTED|Overall Study||55
6696499|NCT02780167|7626669|FG000|COMPLETED|Overall Study||28
6696500|NCT02780167|7626670|FG001|COMPLETED|Overall Study||27
6696501|NCT02780167|7626671|FG002|COMPLETED|Overall Study||27
6696502|NCT02780167|7626672|FG003|COMPLETED|Overall Study||37
6696503|NCT02780167|7626673|FG004|COMPLETED|Overall Study||38
6696504|NCT02780167|7626669|FG000|NOT COMPLETED|Overall Study||28
6696505|NCT02780167|7626670|FG001|NOT COMPLETED|Overall Study||22
6696506|NCT02780167|7626671|FG002|NOT COMPLETED|Overall Study||24
6696507|NCT02780167|7626672|FG003|NOT COMPLETED|Overall Study||19
6696508|NCT02780167|7626673|FG004|NOT COMPLETED|Overall Study||17
6696509|NCT02780349|7626685|FG000|STARTED|Overall Study||103
6696510|NCT02780349|7626685|FG000|COMPLETED|Overall Study||101
6696511|NCT02780349|7626685|FG000|NOT COMPLETED|Overall Study||2
6696512|NCT02780388|7626694|FG000|STARTED|Overall Study||15
6696513|NCT02780388|7626695|FG001|STARTED|Overall Study||8
6696514|NCT02780388|7626696|FG002|STARTED|Overall Study||10
6696515|NCT02780388|7626697|FG003|STARTED|Overall Study||12
6696516|NCT02780388|7626698|FG004|STARTED|Overall Study||12
6696517|NCT02780388|7626694|FG000|COMPLETED|Overall Study||14
6696518|NCT02780388|7626695|FG001|COMPLETED|Overall Study||6
6696519|NCT02780388|7626696|FG002|COMPLETED|Overall Study||10
6696520|NCT02780388|7626697|FG003|COMPLETED|Overall Study||12
6696521|NCT02780388|7626698|FG004|COMPLETED|Overall Study||12
6696522|NCT02780388|7626694|FG000|NOT COMPLETED|Overall Study||1
6696523|NCT02780388|7626695|FG001|NOT COMPLETED|Overall Study||2
6696524|NCT02780388|7626696|FG002|NOT COMPLETED|Overall Study||0
6696525|NCT02780388|7626697|FG003|NOT COMPLETED|Overall Study||0
6696526|NCT02780388|7626698|FG004|NOT COMPLETED|Overall Study||0
6696527|NCT02780622|7626714|FG000|STARTED|Treatment Period 1||10
6696528|NCT02780622|7626715|FG001|STARTED|Treatment Period 1||10
6696529|NCT02780622|7626714|FG000|COMPLETED|Treatment Period 1||10
6696530|NCT02780622|7626715|FG001|COMPLETED|Treatment Period 1||10
6696531|NCT02780622|7626714|FG000|NOT COMPLETED|Treatment Period 1||0
6696532|NCT02780622|7626715|FG001|NOT COMPLETED|Treatment Period 1||0
6696533|NCT02780622|7626714|FG000|STARTED|Treatment Period 2||10
6696534|NCT02780622|7626715|FG001|STARTED|Treatment Period 2||10
6696535|NCT02780622|7626714|FG000|COMPLETED|Treatment Period 2||10
6696536|NCT02780622|7626715|FG001|COMPLETED|Treatment Period 2||10
6696537|NCT02780622|7626714|FG000|NOT COMPLETED|Treatment Period 2||0
6696538|NCT02780622|7626715|FG001|NOT COMPLETED|Treatment Period 2||0
6696539|NCT02780661|7626722|FG000|STARTED|Period 1||10
6696540|NCT02780661|7626723|FG001|STARTED|Period 1||9
6696541|NCT02780661|7626722|FG000|COMPLETED|Period 1||10
6696542|NCT02780661|7626723|FG001|COMPLETED|Period 1||9
6696543|NCT02780661|7626722|FG000|NOT COMPLETED|Period 1||0
6696544|NCT02780661|7626723|FG001|NOT COMPLETED|Period 1||0
6696545|NCT02780661|7626722|FG000|STARTED|Wash Out Period||10
6696546|NCT02780661|7626723|FG001|STARTED|Wash Out Period||9
6696547|NCT02780661|7626722|FG000|COMPLETED|Wash Out Period||10
6696548|NCT02780661|7626723|FG001|COMPLETED|Wash Out Period||9
6696549|NCT02780661|7626722|FG000|NOT COMPLETED|Wash Out Period||0
6696550|NCT02780661|7626723|FG001|NOT COMPLETED|Wash Out Period||0
6696551|NCT02780661|7626722|FG000|STARTED|Period 2||10
6696552|NCT02780661|7626723|FG001|STARTED|Period 2||9
6696553|NCT02780661|7626722|FG000|COMPLETED|Period 2||10
6696554|NCT02780661|7626723|FG001|COMPLETED|Period 2||9
6696555|NCT02780661|7626722|FG000|NOT COMPLETED|Period 2||0
6696556|NCT02780661|7626723|FG001|NOT COMPLETED|Period 2||0
6696557|NCT02780687|7626732|FG000|STARTED|Overall Study||34
6696558|NCT02780687|7626733|FG001|STARTED|Overall Study||8
6696559|NCT02780687|7626732|FG000|COMPLETED|Overall Study||0
6696560|NCT02780687|7626733|FG001|COMPLETED|Overall Study||0
6696561|NCT02780687|7626732|FG000|NOT COMPLETED|Overall Study||34
6696562|NCT02780687|7626733|FG001|NOT COMPLETED|Overall Study||8
6696563|NCT02780700|7626738|FG000|STARTED|Overall Study||1
6696564|NCT02780700|7626738|FG000|COMPLETED|Overall Study||0
6696565|NCT02780700|7626738|FG000|NOT COMPLETED|Overall Study||1
6696566|NCT02780713|7626742|FG000|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 2.|14
6696567|NCT02780713|7626743|FG001|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 3.|0
6696568|NCT02780713|7626744|FG002|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 4.|0
6696569|NCT02780713|7626745|FG003|STARTED|Period 1: Variant A (100mg)|After washout period participants entered Treatment Period 5.|0
6696570|NCT02780713|7626746|FG004|STARTED|Period 1: Variant A (100mg)||0
6696571|NCT02780713|7626742|FG000|COMPLETED|Period 1: Variant A (100mg)||14
6696572|NCT02780713|7626743|FG001|COMPLETED|Period 1: Variant A (100mg)||0
6696573|NCT02780713|7626744|FG002|COMPLETED|Period 1: Variant A (100mg)||0
6696574|NCT02780713|7626745|FG003|COMPLETED|Period 1: Variant A (100mg)||0
6696575|NCT02780713|7626746|FG004|COMPLETED|Period 1: Variant A (100mg)||0
6259357|NCT02781584|7158471|FG006|COMPLETED|Pre-treatment Phase||0
6259358|NCT02781584|7158472|FG007|COMPLETED|Pre-treatment Phase||0
6259359|NCT02781584|7158473|FG008|COMPLETED|Pre-treatment Phase||0
6259360|NCT02781584|7158474|FG009|COMPLETED|Pre-treatment Phase||15
6696576|NCT02780713|7626742|FG000|NOT COMPLETED|Period 1: Variant A (100mg)||0
6696577|NCT02780713|7626743|FG001|NOT COMPLETED|Period 1: Variant A (100mg)||0
6696578|NCT02780713|7626744|FG002|NOT COMPLETED|Period 1: Variant A (100mg)||0
6696579|NCT02780713|7626745|FG003|NOT COMPLETED|Period 1: Variant A (100mg)||0
6696580|NCT02780713|7626746|FG004|NOT COMPLETED|Period 1: Variant A (100mg)||0
6696581|NCT02780713|7626742|FG000|STARTED|Period 2: Reference (100mg)||0
6696582|NCT02780713|7626743|FG001|STARTED|Period 2: Reference (100mg)||14
6696583|NCT02780713|7626744|FG002|STARTED|Period 2: Reference (100mg)||0
6696584|NCT02780713|7626745|FG003|STARTED|Period 2: Reference (100mg)||0
6696585|NCT02780713|7626746|FG004|STARTED|Period 2: Reference (100mg)||0
6696586|NCT02780713|7626742|FG000|COMPLETED|Period 2: Reference (100mg)||0
6696587|NCT02780713|7626743|FG001|COMPLETED|Period 2: Reference (100mg)||14
6696588|NCT02780713|7626744|FG002|COMPLETED|Period 2: Reference (100mg)||0
6259361|NCT02781584|7158475|FG010|COMPLETED|Pre-treatment Phase||16
6259362|NCT02781584|7158476|FG011|COMPLETED|Pre-treatment Phase||30
6259363|NCT02781584|7158477|FG012|COMPLETED|Pre-treatment Phase||32
6259364|NCT02781584|7158465|FG000|NOT COMPLETED|Pre-treatment Phase||0
6259365|NCT02781584|7158466|FG001|NOT COMPLETED|Pre-treatment Phase||0
6259366|NCT02781584|7158467|FG002|NOT COMPLETED|Pre-treatment Phase||0
6259367|NCT02781584|7158468|FG003|NOT COMPLETED|Pre-treatment Phase||0
6259368|NCT02781584|7158469|FG004|NOT COMPLETED|Pre-treatment Phase||0
6259369|NCT02781584|7158470|FG005|NOT COMPLETED|Pre-treatment Phase||0
6259370|NCT02781584|7158471|FG006|NOT COMPLETED|Pre-treatment Phase||0
6259371|NCT02781584|7158472|FG007|NOT COMPLETED|Pre-treatment Phase||0
6259372|NCT02781584|7158473|FG008|NOT COMPLETED|Pre-treatment Phase||0
6259373|NCT02781584|7158474|FG009|NOT COMPLETED|Pre-treatment Phase||0
6259374|NCT02781584|7158475|FG010|NOT COMPLETED|Pre-treatment Phase||0
6259375|NCT02781584|7158476|FG011|NOT COMPLETED|Pre-treatment Phase||3
6259376|NCT02781584|7158477|FG012|NOT COMPLETED|Pre-treatment Phase||1
6259377|NCT02781584|7158465|FG000|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
6259378|NCT02781584|7158466|FG001|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
6259379|NCT02781584|7158467|FG002|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
6259380|NCT02781584|7158468|FG003|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
6259381|NCT02781584|7158469|FG004|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
6259382|NCT02781584|7158470|FG005|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|20
6259383|NCT02781584|7158471|FG006|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
6259384|NCT02781584|7158472|FG007|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|10
6259385|NCT02781584|7158473|FG008|STARTED|Treatment Phase|Only participants in Cohorts 10-13 received pre-treatment.|13
6259386|NCT02781584|7158474|FG009|STARTED|Treatment Phase||15
6259387|NCT02781584|7158475|FG010|STARTED|Treatment Phase||16
6259388|NCT02781584|7158476|FG011|STARTED|Treatment Phase||30
6259389|NCT02781584|7158477|FG012|STARTED|Treatment Phase||32
6259390|NCT02781584|7158465|FG000|COMPLETED|Treatment Phase||10
6259391|NCT02781584|7158466|FG001|COMPLETED|Treatment Phase||10
6259392|NCT02781584|7158467|FG002|COMPLETED|Treatment Phase||10
6259393|NCT02781584|7158468|FG003|COMPLETED|Treatment Phase||20
6259394|NCT02781584|7158469|FG004|COMPLETED|Treatment Phase||20
6259395|NCT02781584|7158470|FG005|COMPLETED|Treatment Phase||19
6259396|NCT02781584|7158471|FG006|COMPLETED|Treatment Phase||10
6259397|NCT02781584|7158472|FG007|COMPLETED|Treatment Phase||9
6259398|NCT02781584|7158473|FG008|COMPLETED|Treatment Phase||13
6259399|NCT02781584|7158474|FG009|COMPLETED|Treatment Phase||15
6259400|NCT02781584|7158475|FG010|COMPLETED|Treatment Phase||15
6259401|NCT02781584|7158476|FG011|COMPLETED|Treatment Phase||28
6259402|NCT02781584|7158477|FG012|COMPLETED|Treatment Phase||32
6259403|NCT02781584|7158465|FG000|NOT COMPLETED|Treatment Phase||0
6259404|NCT02781584|7158466|FG001|NOT COMPLETED|Treatment Phase||0
6259405|NCT02781584|7158467|FG002|NOT COMPLETED|Treatment Phase||0
6259406|NCT02781584|7158468|FG003|NOT COMPLETED|Treatment Phase||0
6259407|NCT02781584|7158469|FG004|NOT COMPLETED|Treatment Phase||0
6259408|NCT02781584|7158470|FG005|NOT COMPLETED|Treatment Phase||1
6259409|NCT02781584|7158471|FG006|NOT COMPLETED|Treatment Phase||0
6259410|NCT02781584|7158472|FG007|NOT COMPLETED|Treatment Phase||1
6259411|NCT02781584|7158473|FG008|NOT COMPLETED|Treatment Phase||0
6259412|NCT02781584|7158474|FG009|NOT COMPLETED|Treatment Phase||0
6259413|NCT02781584|7158475|FG010|NOT COMPLETED|Treatment Phase||1
6259414|NCT02781584|7158476|FG011|NOT COMPLETED|Treatment Phase||2
6259415|NCT02781584|7158477|FG012|NOT COMPLETED|Treatment Phase||0
6259416|NCT02730130|7158505|FG000|STARTED|Overall Study||17
6259417|NCT02730130|7158505|FG000|COMPLETED|Overall Study||17
6259418|NCT02730130|7158505|FG000|NOT COMPLETED|Overall Study||0
6259419|NCT02714062|7158512|FG000|STARTED|Overall Study||14
6259420|NCT02714062|7158513|FG001|STARTED|Overall Study||15
6259421|NCT02714062|7158514|FG002|STARTED|Overall Study||13
6259422|NCT02714062|7158512|FG000|COMPLETED|Overall Study||13
6259423|NCT02714062|7158513|FG001|COMPLETED|Overall Study||14
6259424|NCT02714062|7158514|FG002|COMPLETED|Overall Study||10
6259425|NCT02714062|7158512|FG000|NOT COMPLETED|Overall Study||1
6259426|NCT02714062|7158513|FG001|NOT COMPLETED|Overall Study||1
6696589|NCT02780713|7626745|FG003|COMPLETED|Period 2: Reference (100mg)||0
6259427|NCT02714062|7158514|FG002|NOT COMPLETED|Overall Study||3
6259428|NCT02707055|7158526|FG000|STARTED|Phase 1||18
6259429|NCT02707055|7158527|FG001|STARTED|Phase 1||19
6259430|NCT02707055|7158526|FG000|COMPLETED|Phase 1||17
6259431|NCT02707055|7158527|FG001|COMPLETED|Phase 1||16
6259432|NCT02707055|7158526|FG000|NOT COMPLETED|Phase 1||1
6259433|NCT02707055|7158527|FG001|NOT COMPLETED|Phase 1||3
6259434|NCT02707055|7158526|FG000|STARTED|Washout Period||17
6696590|NCT02780713|7626746|FG004|COMPLETED|Period 2: Reference (100mg)||0
6696591|NCT02780713|7626742|FG000|NOT COMPLETED|Period 2: Reference (100mg)||0
6696592|NCT02780713|7626743|FG001|NOT COMPLETED|Period 2: Reference (100mg)||0
6696593|NCT02780713|7626744|FG002|NOT COMPLETED|Period 2: Reference (100mg)||0
6696594|NCT02780713|7626745|FG003|NOT COMPLETED|Period 2: Reference (100mg)||0
6696595|NCT02780713|7626746|FG004|NOT COMPLETED|Period 2: Reference (100mg)||0
6696596|NCT02780713|7626742|FG000|STARTED|Period 3: Variant B (100mg)||0
6696597|NCT02780713|7626743|FG001|STARTED|Period 3: Variant B (100mg)||0
6696598|NCT02780713|7626744|FG002|STARTED|Period 3: Variant B (100mg)||14
6696599|NCT02780713|7626745|FG003|STARTED|Period 3: Variant B (100mg)||0
6696600|NCT02780713|7626746|FG004|STARTED|Period 3: Variant B (100mg)||0
6696601|NCT02780713|7626742|FG000|COMPLETED|Period 3: Variant B (100mg)||0
6696602|NCT02780713|7626743|FG001|COMPLETED|Period 3: Variant B (100mg)||0
6696603|NCT02780713|7626744|FG002|COMPLETED|Period 3: Variant B (100mg)||12
6696604|NCT02780713|7626745|FG003|COMPLETED|Period 3: Variant B (100mg)||0
6696605|NCT02780713|7626746|FG004|COMPLETED|Period 3: Variant B (100mg)||0
6696606|NCT02780713|7626742|FG000|NOT COMPLETED|Period 3: Variant B (100mg)||0
6696607|NCT02780713|7626743|FG001|NOT COMPLETED|Period 3: Variant B (100mg)||0
6696608|NCT02780713|7626744|FG002|NOT COMPLETED|Period 3: Variant B (100mg)||2
6696609|NCT02780713|7626745|FG003|NOT COMPLETED|Period 3: Variant B (100mg)||0
6696610|NCT02780713|7626746|FG004|NOT COMPLETED|Period 3: Variant B (100mg)||0
6696611|NCT02780713|7626742|FG000|STARTED|Period 4: Variant C (100mg)||0
6696612|NCT02780713|7626743|FG001|STARTED|Period 4: Variant C (100mg)||0
6696613|NCT02780713|7626744|FG002|STARTED|Period 4: Variant C (100mg)||0
6696614|NCT02780713|7626745|FG003|STARTED|Period 4: Variant C (100mg)||12
6696615|NCT02780713|7626746|FG004|STARTED|Period 4: Variant C (100mg)||0
6696616|NCT02780713|7626742|FG000|COMPLETED|Period 4: Variant C (100mg)||0
6696617|NCT02780713|7626743|FG001|COMPLETED|Period 4: Variant C (100mg)||0
6696618|NCT02780713|7626744|FG002|COMPLETED|Period 4: Variant C (100mg)||0
6696619|NCT02780713|7626745|FG003|COMPLETED|Period 4: Variant C (100mg)||12
6696620|NCT02780713|7626746|FG004|COMPLETED|Period 4: Variant C (100mg)||0
6696621|NCT02780713|7626742|FG000|NOT COMPLETED|Period 4: Variant C (100mg)||0
6696622|NCT02780713|7626743|FG001|NOT COMPLETED|Period 4: Variant C (100mg)||0
6696623|NCT02780713|7626744|FG002|NOT COMPLETED|Period 4: Variant C (100mg)||0
6696624|NCT02780713|7626745|FG003|NOT COMPLETED|Period 4: Variant C (100mg)||0
6696625|NCT02780713|7626746|FG004|NOT COMPLETED|Period 4: Variant C (100mg)||0
6696626|NCT02780713|7626742|FG000|STARTED|Period 5: Variant B (300mg)||0
6696627|NCT02780713|7626743|FG001|STARTED|Period 5: Variant B (300mg)||0
6696628|NCT02780713|7626744|FG002|STARTED|Period 5: Variant B (300mg)||0
6696629|NCT02780713|7626745|FG003|STARTED|Period 5: Variant B (300mg)||0
6696630|NCT02780713|7626746|FG004|STARTED|Period 5: Variant B (300mg)||12
6696631|NCT02780713|7626742|FG000|COMPLETED|Period 5: Variant B (300mg)||0
6696632|NCT02780713|7626743|FG001|COMPLETED|Period 5: Variant B (300mg)||0
6696633|NCT02780713|7626744|FG002|COMPLETED|Period 5: Variant B (300mg)||0
6696634|NCT02780713|7626745|FG003|COMPLETED|Period 5: Variant B (300mg)||0
6696635|NCT02780713|7626746|FG004|COMPLETED|Period 5: Variant B (300mg)||12
6696636|NCT02780713|7626742|FG000|NOT COMPLETED|Period 5: Variant B (300mg)||0
6696637|NCT02780713|7626743|FG001|NOT COMPLETED|Period 5: Variant B (300mg)||0
6696638|NCT02780713|7626744|FG002|NOT COMPLETED|Period 5: Variant B (300mg)||0
6696639|NCT02780713|7626745|FG003|NOT COMPLETED|Period 5: Variant B (300mg)||0
6696640|NCT02780713|7626746|FG004|NOT COMPLETED|Period 5: Variant B (300mg)||0
6696641|NCT02780765|7626767|FG000|STARTED|Overall Study||30
6696642|NCT02780765|7626768|FG001|STARTED|Overall Study||30
6696643|NCT02780765|7626767|FG000|COMPLETED|Overall Study||30
6696644|NCT02780765|7626768|FG001|COMPLETED|Overall Study||30
6696645|NCT02780765|7626767|FG000|NOT COMPLETED|Overall Study||0
6696646|NCT02780765|7626768|FG001|NOT COMPLETED|Overall Study||0
6696647|NCT02780856|7626774|FG000|STARTED|Overall Study||110
6696648|NCT02780856|7626774|FG000|COMPLETED|Overall Study||109
6696649|NCT02780856|7626774|FG000|NOT COMPLETED|Overall Study||1
6696650|NCT02780869|7626783|FG000|STARTED|Overall Study||175
6696651|NCT02780869|7626784|FG001|STARTED|Overall Study||83
6696652|NCT02780869|7626783|FG000|COMPLETED|Overall Study||162
6696653|NCT02780869|7626784|FG001|COMPLETED|Overall Study||74
6696654|NCT02780869|7626783|FG000|NOT COMPLETED|Overall Study||13
6696655|NCT02780869|7626784|FG001|NOT COMPLETED|Overall Study||9
6696656|NCT02781051|7626790|FG000|STARTED|Overall Study||16
6696657|NCT02781051|7626790|FG000|COMPLETED|Overall Study||14
6696658|NCT02781051|7626790|FG000|NOT COMPLETED|Overall Study||2
6696659|NCT02781311|7626798|FG000|STARTED|Overall Study||74
6696660|NCT02781311|7626799|FG001|STARTED|Overall Study||83
6696661|NCT02781311|7626800|FG002|STARTED|Overall Study||12
6696662|NCT02781311|7626798|FG000|Safety Population (Treated)|Overall Study||73
6696663|NCT02781311|7626799|FG001|Safety Population (Treated)|Overall Study||81
6696664|NCT02781311|7626800|FG002|Safety Population (Treated)|Overall Study||12
6696665|NCT02781311|7626798|FG000|mITT Population|Overall Study||70
6696666|NCT02781311|7626799|FG001|mITT Population|Overall Study||78
6696667|NCT02781311|7626800|FG002|mITT Population|Overall Study||11
6696668|NCT02781311|7626798|FG000|COMPLETED|Overall Study||48
6696669|NCT02781311|7626799|FG001|COMPLETED|Overall Study||57
6696670|NCT02781311|7626800|FG002|COMPLETED|Overall Study||8
6696671|NCT02781311|7626798|FG000|NOT COMPLETED|Overall Study||26
6696672|NCT02781311|7626799|FG001|NOT COMPLETED|Overall Study||26
6696673|NCT02781311|7626800|FG002|NOT COMPLETED|Overall Study||4
6696674|NCT02781324|7626809|FG000|STARTED|Overall Study||33
6696675|NCT02781324|7626810|FG001|STARTED|Overall Study||33
6696676|NCT02781324|7626809|FG000|COMPLETED|Overall Study||31
6696677|NCT02781324|7626810|FG001|COMPLETED|Overall Study||31
6696678|NCT02781324|7626809|FG000|NOT COMPLETED|Overall Study||2
6696679|NCT02781324|7626810|FG001|NOT COMPLETED|Overall Study||2
6696680|NCT02781454|7626821|FG000|STARTED|Overall Study||8
6696681|NCT02781454|7626822|FG001|STARTED|Overall Study||6
6696682|NCT02781454|7626823|FG002|STARTED|Overall Study||6
6696683|NCT02781454|7626821|FG000|COMPLETED|Overall Study||8
6696684|NCT02781454|7626822|FG001|COMPLETED|Overall Study||6
6696685|NCT02781454|7626823|FG002|COMPLETED|Overall Study||5
6696686|NCT02781454|7626821|FG000|NOT COMPLETED|Overall Study||0
6696687|NCT02781454|7626822|FG001|NOT COMPLETED|Overall Study||0
6696688|NCT02781454|7626823|FG002|NOT COMPLETED|Overall Study||1
6696689|NCT02781480|7626834|FG000|STARTED|Overall Study||9
6696690|NCT02781480|7626835|FG001|STARTED|Overall Study||3
6696691|NCT02781480|7626836|FG002|STARTED|Overall Study||3
6696692|NCT02781480|7626834|FG000|COMPLETED|Overall Study||9
6696693|NCT02781480|7626835|FG001|COMPLETED|Overall Study||3
6696694|NCT02781480|7626836|FG002|COMPLETED|Overall Study||3
6696695|NCT02781480|7626834|FG000|NOT COMPLETED|Overall Study||0
6696696|NCT02781480|7626835|FG001|NOT COMPLETED|Overall Study||0
6696697|NCT02781480|7626836|FG002|NOT COMPLETED|Overall Study||0
6696698|NCT02781558|7626846|FG000|STARTED|Overall Study||101
6696699|NCT02781558|7626847|FG001|STARTED|Overall Study||103
6696700|NCT02781558|7626846|FG000|COMPLETED|Overall Study||98
6696701|NCT02781558|7626847|FG001|COMPLETED|Overall Study||101
6696702|NCT02781558|7626846|FG000|NOT COMPLETED|Overall Study||3
6696703|NCT02781558|7626847|FG001|NOT COMPLETED|Overall Study||2
6696704|NCT02781571|7626854|FG000|STARTED|Overall Study||79
6696705|NCT02781571|7626854|FG000|COMPLETED|Overall Study||79
6696706|NCT02781571|7626854|FG000|NOT COMPLETED|Overall Study||0
6696707|NCT02781610|7626862|FG000|STARTED|Overall Study||140
6696708|NCT02781610|7626863|FG001|STARTED|Overall Study||137
6696709|NCT02781610|7626864|FG002|STARTED|Overall Study||353
6696710|NCT02781610|7626865|FG003|STARTED|Overall Study||352
6696711|NCT02781610|7626862|FG000|COMPLETED|Overall Study||134
6696712|NCT02781610|7626863|FG001|COMPLETED|Overall Study||130
6696713|NCT02781610|7626864|FG002|COMPLETED|Overall Study||336
6696714|NCT02781610|7626865|FG003|COMPLETED|Overall Study||323
6696715|NCT02781610|7626862|FG000|NOT COMPLETED|Overall Study||6
6696716|NCT02781610|7626863|FG001|NOT COMPLETED|Overall Study||7
6696717|NCT02781610|7626864|FG002|NOT COMPLETED|Overall Study||17
6696718|NCT02781610|7626865|FG003|NOT COMPLETED|Overall Study||29
6696719|NCT02781649|7626878|FG000|STARTED|Overall Study|4 in this group had insufficient viral RNA for genotyping. They were treated as 1a|7
6696720|NCT02781649|7626879|FG001|STARTED|Overall Study||0
6696721|NCT02781649|7626880|FG002|STARTED|Overall Study||3
6696722|NCT02781649|7626878|FG000|COMPLETED|Overall Study||7
6696723|NCT02781649|7626879|FG001|COMPLETED|Overall Study||0
6696724|NCT02781649|7626880|FG002|COMPLETED|Overall Study||3
6696725|NCT02781649|7626878|FG000|NOT COMPLETED|Overall Study||0
6696726|NCT02781649|7626879|FG001|NOT COMPLETED|Overall Study||0
6696727|NCT02781649|7626880|FG002|NOT COMPLETED|Overall Study||0
6696728|NCT02781818|7626891|FG000|STARTED|Overall Study||20
6696729|NCT02781818|7626892|FG001|STARTED|Overall Study||18
6696730|NCT02781818|7626893|FG002|STARTED|Overall Study||17
6696731|NCT02781818|7626891|FG000|COMPLETED|Overall Study||16
6696732|NCT02781818|7626892|FG001|COMPLETED|Overall Study||16
6696733|NCT02781818|7626893|FG002|COMPLETED|Overall Study||16
6696734|NCT02781818|7626891|FG000|NOT COMPLETED|Overall Study||4
6696735|NCT02781818|7626892|FG001|NOT COMPLETED|Overall Study||2
6696736|NCT02781818|7626893|FG002|NOT COMPLETED|Overall Study||1
6696737|NCT02781844|7626905|FG000|STARTED|Treatment Period 1||5
6696738|NCT02781844|7626906|FG001|STARTED|Treatment Period 1||4
6696739|NCT02781844|7626907|FG002|STARTED|Treatment Period 1||4
6696740|NCT02781844|7626908|FG003|STARTED|Treatment Period 1||4
6696741|NCT02781844|7626909|FG004|STARTED|Treatment Period 1||4
6696742|NCT02781844|7626910|FG005|STARTED|Treatment Period 1||5
6696743|NCT02781844|7626911|FG006|STARTED|Treatment Period 1||4
6696744|NCT02781844|7626912|FG007|STARTED|Treatment Period 1||4
6696745|NCT02781844|7626905|FG000|COMPLETED|Treatment Period 1||5
6696746|NCT02781844|7626906|FG001|COMPLETED|Treatment Period 1||4
6696747|NCT02781844|7626907|FG002|COMPLETED|Treatment Period 1||4
6696748|NCT02781844|7626908|FG003|COMPLETED|Treatment Period 1||4
6696749|NCT02781844|7626909|FG004|COMPLETED|Treatment Period 1||4
6696750|NCT02781844|7626910|FG005|COMPLETED|Treatment Period 1||4
6696751|NCT02781844|7626911|FG006|COMPLETED|Treatment Period 1||4
6696752|NCT02781844|7626912|FG007|COMPLETED|Treatment Period 1||4
6696753|NCT02781844|7626905|FG000|NOT COMPLETED|Treatment Period 1||0
6696754|NCT02781844|7626906|FG001|NOT COMPLETED|Treatment Period 1||0
6696755|NCT02781844|7626907|FG002|NOT COMPLETED|Treatment Period 1||0
6696756|NCT02781844|7626908|FG003|NOT COMPLETED|Treatment Period 1||0
6696757|NCT02781844|7626909|FG004|NOT COMPLETED|Treatment Period 1||0
6696758|NCT02781844|7626910|FG005|NOT COMPLETED|Treatment Period 1||1
6696759|NCT02781844|7626911|FG006|NOT COMPLETED|Treatment Period 1||0
6696760|NCT02781844|7626912|FG007|NOT COMPLETED|Treatment Period 1||0
6696761|NCT02781844|7626905|FG000|STARTED|Treatment Period 2||5
6696762|NCT02781844|7626906|FG001|STARTED|Treatment Period 2||4
6696763|NCT02781844|7626907|FG002|STARTED|Treatment Period 2||4
6696764|NCT02781844|7626908|FG003|STARTED|Treatment Period 2||4
6696765|NCT02781844|7626909|FG004|STARTED|Treatment Period 2||4
6696766|NCT02781844|7626910|FG005|STARTED|Treatment Period 2||4
6696767|NCT02781844|7626911|FG006|STARTED|Treatment Period 2||4
6696768|NCT02781844|7626912|FG007|STARTED|Treatment Period 2||4
6696769|NCT02781844|7626905|FG000|COMPLETED|Treatment Period 2||5
6696770|NCT02781844|7626906|FG001|COMPLETED|Treatment Period 2||4
6696771|NCT02781844|7626907|FG002|COMPLETED|Treatment Period 2||4
6696772|NCT02781844|7626908|FG003|COMPLETED|Treatment Period 2||4
6696773|NCT02781844|7626909|FG004|COMPLETED|Treatment Period 2||4
6696774|NCT02781844|7626910|FG005|COMPLETED|Treatment Period 2||4
6696775|NCT02781844|7626911|FG006|COMPLETED|Treatment Period 2||4
6696776|NCT02781844|7626912|FG007|COMPLETED|Treatment Period 2||4
6696777|NCT02781844|7626905|FG000|NOT COMPLETED|Treatment Period 2||0
6696778|NCT02781844|7626906|FG001|NOT COMPLETED|Treatment Period 2||0
6696779|NCT02781844|7626907|FG002|NOT COMPLETED|Treatment Period 2||0
6696780|NCT02781844|7626908|FG003|NOT COMPLETED|Treatment Period 2||0
6696781|NCT02781844|7626909|FG004|NOT COMPLETED|Treatment Period 2||0
6696782|NCT02781844|7626910|FG005|NOT COMPLETED|Treatment Period 2||0
6696783|NCT02781844|7626911|FG006|NOT COMPLETED|Treatment Period 2||0
6696784|NCT02781844|7626912|FG007|NOT COMPLETED|Treatment Period 2||0
6696785|NCT02782065|7626928|FG000|STARTED|Overall Study||58
6696786|NCT02782065|7626928|FG000|COMPLETED|Overall Study||58
6696787|NCT02782065|7626928|FG000|NOT COMPLETED|Overall Study||0
6696788|NCT02782169|7626935|FG000|STARTED|Overall Study||56
6696789|NCT02782169|7626936|FG001|STARTED|Overall Study||54
6696790|NCT02782169|7626935|FG000|COMPLETED|Overall Study||55
6696791|NCT02782169|7626936|FG001|COMPLETED|Overall Study||52
6696792|NCT02782169|7626935|FG000|NOT COMPLETED|Overall Study||1
6696793|NCT02782169|7626936|FG001|NOT COMPLETED|Overall Study||2
6696794|NCT02782325|7626944|FG000|STARTED|Blinded FMT Treatment (up to 24 Weeks)||4
6696795|NCT02782325|7626945|FG001|STARTED|Blinded FMT Treatment (up to 24 Weeks)||2
6696796|NCT02782325|7626946|FG002|STARTED|Blinded FMT Treatment (up to 24 Weeks)||0
6696797|NCT02782325|7626944|FG000|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
6696798|NCT02782325|7626945|FG001|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
6696799|NCT02782325|7626946|FG002|COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
6696800|NCT02782325|7626944|FG000|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||4
6696801|NCT02782325|7626945|FG001|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||2
6696802|NCT02782325|7626946|FG002|NOT COMPLETED|Blinded FMT Treatment (up to 24 Weeks)||0
6696803|NCT02782325|7626944|FG000|STARTED|Open Label FMT Period (up to 24 Weeks)||0
6696804|NCT02782325|7626945|FG001|STARTED|Open Label FMT Period (up to 24 Weeks)||0
6696805|NCT02782325|7626946|FG002|STARTED|Open Label FMT Period (up to 24 Weeks)|1 participant decided to not participate in the open label period|5
6696806|NCT02782325|7626944|FG000|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
6696807|NCT02782325|7626945|FG001|COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
6696808|NCT02782325|7626946|FG002|COMPLETED|Open Label FMT Period (up to 24 Weeks)||1
6696809|NCT02782325|7626944|FG000|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
6696810|NCT02782325|7626945|FG001|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||0
6696811|NCT02782325|7626946|FG002|NOT COMPLETED|Open Label FMT Period (up to 24 Weeks)||4
6696812|NCT02782364|7626954|FG000|STARTED|Overall Study||18
6696813|NCT02782364|7626955|FG001|STARTED|Overall Study||18
6696814|NCT02782364|7626954|FG000|COMPLETED|Overall Study||18
6696815|NCT02782364|7626955|FG001|COMPLETED|Overall Study||18
6696816|NCT02782364|7626954|FG000|NOT COMPLETED|Overall Study||0
6696817|NCT02782364|7626955|FG001|NOT COMPLETED|Overall Study||0
6696818|NCT02782377|7626962|FG000|STARTED|Overall Study||40
6696819|NCT02782377|7626962|FG000|COMPLETED|Overall Study|data from five of the patients were excluded due to interpretation difficulties|35
6696820|NCT02782377|7626962|FG000|NOT COMPLETED|Overall Study||5
6696821|NCT02782676|7626967|FG000|STARTED|Overall Study||211
6696822|NCT02782676|7626968|FG001|STARTED|Overall Study||210
6696823|NCT02782676|7626967|FG000|COMPLETED|Overall Study||211
6696824|NCT02782676|7626968|FG001|COMPLETED|Overall Study||209
6696825|NCT02782676|7626967|FG000|NOT COMPLETED|Overall Study||0
6696826|NCT02782676|7626968|FG001|NOT COMPLETED|Overall Study||1
6696827|NCT02782741|7626976|FG000|STARTED|Blinded Treatment Period: up to Week 49||51
6696828|NCT02782741|7626977|FG001|STARTED|Blinded Treatment Period: up to Week 49||49
6696829|NCT02782741|7626976|FG000|Safety Population|Blinded Treatment Period: up to Week 49||51
6696830|NCT02782741|7626977|FG001|Safety Population|Blinded Treatment Period: up to Week 49||49
6696831|NCT02782741|7626976|FG000|COMPLETED|Blinded Treatment Period: up to Week 49||51
6696832|NCT02782741|7626977|FG001|COMPLETED|Blinded Treatment Period: up to Week 49||44
6696833|NCT02782741|7626976|FG000|NOT COMPLETED|Blinded Treatment Period: up to Week 49||0
6696834|NCT02782741|7626977|FG001|NOT COMPLETED|Blinded Treatment Period: up to Week 49||5
6696835|NCT02782741|7626976|FG000|STARTED|Open-label Long-term: Week 50 to 145||51
6696836|NCT02782741|7626977|FG001|STARTED|Open-label Long-term: Week 50 to 145||44
6696837|NCT02782741|7626976|FG000|Safety Population|Open-label Long-term: Week 50 to 145||51
6696838|NCT02782741|7626977|FG001|Safety Population|Open-label Long-term: Week 50 to 145||44
6696839|NCT02782741|7626976|FG000|COMPLETED|Open-label Long-term: Week 50 to 145||0
6696840|NCT02782741|7626977|FG001|COMPLETED|Open-label Long-term: Week 50 to 145||0
6696841|NCT02782741|7626976|FG000|NOT COMPLETED|Open-label Long-term: Week 50 to 145||51
6696842|NCT02782741|7626977|FG001|NOT COMPLETED|Open-label Long-term: Week 50 to 145||44
6696843|NCT02782780|7626989|FG000|STARTED|Overall Study||46
6696844|NCT02782780|7626990|FG001|STARTED|Overall Study||39
6696845|NCT02782780|7626989|FG000|COMPLETED|Overall Study||39
6696846|NCT02782780|7626990|FG001|COMPLETED|Overall Study||32
6696847|NCT02782780|7626989|FG000|NOT COMPLETED|Overall Study||7
6696848|NCT02782780|7626990|FG001|NOT COMPLETED|Overall Study||7
6696849|NCT02782923|7626996|FG000|STARTED|Overall Study||19
6696850|NCT02782923|7626996|FG000|COMPLETED|Overall Study||4
6696851|NCT02782923|7626996|FG000|NOT COMPLETED|Overall Study||15
6696852|NCT02783027|7627002|FG000|STARTED|Overall Study||39
6696853|NCT02783027|7627003|FG001|STARTED|Overall Study||44
6696854|NCT02783027|7627002|FG000|COMPLETED|Overall Study||16
6696855|NCT02783027|7627003|FG001|COMPLETED|Overall Study||27
6696856|NCT02783027|7627002|FG000|NOT COMPLETED|Overall Study||23
6696857|NCT02783027|7627003|FG001|NOT COMPLETED|Overall Study||17
6696858|NCT02783066|7627009|FG000|STARTED|Overall Study||16
6696859|NCT02783066|7627009|FG000|COMPLETED|Overall Study|complete 4-week pulseflow offloading wearing test|3
6696860|NCT02783066|7627009|FG000|NOT COMPLETED|Overall Study||13
6696861|NCT02783170|7627016|FG000|STARTED|Overall Study||43
6696862|NCT02783170|7627017|FG001|STARTED|Overall Study||38
6696863|NCT02783170|7627016|FG000|Safety Population|Overall Study|Added subject randomized to sequential but got simultaneous.|42
6696864|NCT02783170|7627017|FG001|Safety Population|Overall Study|Excluded sub. randomized but not vaccinated. Excluded sub. randomized to seq. but got simultaneous.|38
6696865|NCT02783170|7627016|FG000|COMPLETED|Overall Study||42
6696866|NCT02783170|7627017|FG001|COMPLETED|Overall Study||38
6696867|NCT02783170|7627016|FG000|NOT COMPLETED|Overall Study||1
6696868|NCT02783170|7627017|FG001|NOT COMPLETED|Overall Study||0
6696869|NCT02783443|7627026|FG000|STARTED|Overall Study||30
6696870|NCT02783443|7627027|FG001|STARTED|Overall Study||30
6696871|NCT02783443|7627026|FG000|COMPLETED|Overall Study||30
6696872|NCT02783443|7627027|FG001|COMPLETED|Overall Study||30
6696873|NCT02783443|7627026|FG000|NOT COMPLETED|Overall Study||0
6696874|NCT02783443|7627027|FG001|NOT COMPLETED|Overall Study||0
6696875|NCT02783469|7627033|FG000|STARTED|Overall Study||1915
6696876|NCT02783469|7627033|FG000|COMPLETED|Overall Study||1915
6696877|NCT02783469|7627033|FG000|NOT COMPLETED|Overall Study||0
6696878|NCT02783573|7627040|FG000|STARTED|Placebo-Controlled Treatment Period||562
6696879|NCT02783573|7627041|FG001|STARTED|Placebo-Controlled Treatment Period||590
6696880|NCT02783573|7627042|FG002|STARTED|Placebo-Controlled Treatment Period||570
6696881|NCT02783573|7627040|FG000|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||558
6696882|NCT02783573|7627041|FG001|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||588
6696883|NCT02783573|7627042|FG002|Received at Least 1 Dose of Study Drug|Placebo-Controlled Treatment Period||568
6696884|NCT02783573|7627040|FG000|COMPLETED|Placebo-Controlled Treatment Period||26
6696885|NCT02783573|7627041|FG001|COMPLETED|Placebo-Controlled Treatment Period||28
6696886|NCT02783573|7627042|FG002|COMPLETED|Placebo-Controlled Treatment Period||22
6696887|NCT02783573|7627040|FG000|NOT COMPLETED|Placebo-Controlled Treatment Period||536
6696888|NCT02783573|7627041|FG001|NOT COMPLETED|Placebo-Controlled Treatment Period||562
6696889|NCT02783573|7627042|FG002|NOT COMPLETED|Placebo-Controlled Treatment Period||548
6696890|NCT02783573|7627040|FG000|STARTED|Delayed-Start Period|Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.|0
6696891|NCT02783573|7627041|FG001|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|17
6696892|NCT02783573|7627042|FG002|STARTED|Delayed-Start Period|Participants completed period 1 may not have entered period 2 due to early termination of the study.|12
6696893|NCT02783573|7627040|FG000|Received at Least 1 Dose of Study Drug|Delayed-Start Period||0
6259435|NCT02707055|7158527|FG001|STARTED|Washout Period||16
6259436|NCT02707055|7158526|FG000|COMPLETED|Washout Period||17
6259437|NCT02707055|7158527|FG001|COMPLETED|Washout Period||16
6259438|NCT02707055|7158526|FG000|NOT COMPLETED|Washout Period||0
6259439|NCT02707055|7158527|FG001|NOT COMPLETED|Washout Period||0
6259440|NCT02707055|7158526|FG000|STARTED|Phase 2||17
6259441|NCT02707055|7158527|FG001|STARTED|Phase 2||16
6259442|NCT02707055|7158526|FG000|COMPLETED|Phase 2||16
6259443|NCT02707055|7158527|FG001|COMPLETED|Phase 2||14
6696894|NCT02783573|7627041|FG001|Received at Least 1 Dose of Study Drug|Delayed-Start Period||14
6259444|NCT02707055|7158526|FG000|NOT COMPLETED|Phase 2||1
6259445|NCT02707055|7158527|FG001|NOT COMPLETED|Phase 2||2
6259446|NCT02696759|7158533|FG000|STARTED|Overall Study||15
6259447|NCT02696759|7158533|FG000|COMPLETED|Overall Study||15
6259448|NCT02696759|7158533|FG000|NOT COMPLETED|Overall Study||0
6259449|NCT02673398|7158537|FG000|STARTED|Overall Study||25
6259450|NCT02673398|7158537|FG000|COMPLETED|Overall Study||25
6259451|NCT02673398|7158537|FG000|NOT COMPLETED|Overall Study||0
6259452|NCT02656290|7158541|FG000|STARTED|Overall Study||26
6696895|NCT02783573|7627042|FG002|Received at Least 1 Dose of Study Drug|Delayed-Start Period||12
6696896|NCT02783573|7627040|FG000|COMPLETED|Delayed-Start Period||0
6696897|NCT02783573|7627041|FG001|COMPLETED|Delayed-Start Period||0
6696898|NCT02783573|7627042|FG002|COMPLETED|Delayed-Start Period||0
6696899|NCT02783573|7627040|FG000|NOT COMPLETED|Delayed-Start Period||0
6696900|NCT02783573|7627041|FG001|NOT COMPLETED|Delayed-Start Period||17
6696901|NCT02783573|7627042|FG002|NOT COMPLETED|Delayed-Start Period||12
6696902|NCT02783599|7627053|FG000|STARTED|Overall Study||51
6696903|NCT02783599|7627053|FG000|Received At Least One Dose of Study Drug|Overall Study||51
6696904|NCT02783599|7627053|FG000|COMPLETED|Overall Study||11
6696905|NCT02783599|7627053|FG000|NOT COMPLETED|Overall Study||40
6696906|NCT02783729|7627068|FG000|STARTED|Overall Study||208
6696907|NCT02783729|7627069|FG001|STARTED|Overall Study||263
6696908|NCT02783729|7627070|FG002|STARTED|Overall Study||266
6696909|NCT02783729|7627071|FG003|STARTED|Overall Study||269
6696910|NCT02783729|7627068|FG000|COMPLETED|Overall Study||198
6696911|NCT02783729|7627069|FG001|COMPLETED|Overall Study||246
6696912|NCT02783729|7627070|FG002|COMPLETED|Overall Study||258
6696913|NCT02783729|7627071|FG003|COMPLETED|Overall Study||260
6696914|NCT02783729|7627068|FG000|NOT COMPLETED|Overall Study||10
6696915|NCT02783729|7627069|FG001|NOT COMPLETED|Overall Study||17
6696916|NCT02783729|7627070|FG002|NOT COMPLETED|Overall Study||8
6696917|NCT02783729|7627071|FG003|NOT COMPLETED|Overall Study||9
6696918|NCT02783768|7627086|FG000|STARTED|Overall Study||6
6696919|NCT02783768|7627087|FG001|STARTED|Overall Study||5
6696920|NCT02783768|7627086|FG000|COMPLETED|Overall Study||5
6696921|NCT02783768|7627087|FG001|COMPLETED|Overall Study||5
6696922|NCT02783768|7627086|FG000|NOT COMPLETED|Overall Study||1
6696923|NCT02783768|7627087|FG001|NOT COMPLETED|Overall Study||0
6696924|NCT02783820|7627097|FG000|STARTED|Overall Study||6
6696925|NCT02783820|7627098|FG001|STARTED|Overall Study||6
6696926|NCT02783820|7627099|FG002|STARTED|Overall Study||6
6696927|NCT02783820|7627100|FG003|STARTED|Overall Study||6
6696928|NCT02783820|7627097|FG000|COMPLETED|Overall Study||6
6696929|NCT02783820|7627098|FG001|COMPLETED|Overall Study||6
6696930|NCT02783820|7627099|FG002|COMPLETED|Overall Study||6
6696931|NCT02783820|7627100|FG003|COMPLETED|Overall Study||6
6696932|NCT02783820|7627097|FG000|NOT COMPLETED|Overall Study||0
6696933|NCT02783820|7627098|FG001|NOT COMPLETED|Overall Study||0
6696934|NCT02783820|7627099|FG002|NOT COMPLETED|Overall Study||0
6696935|NCT02783820|7627100|FG003|NOT COMPLETED|Overall Study||0
6696936|NCT02783898|7627112|FG000|STARTED|Overall Study||125
6696937|NCT02783898|7627113|FG001|STARTED|Overall Study||117
6696938|NCT02783898|7627112|FG000|COMPLETED|Overall Study||124
6696939|NCT02783898|7627113|FG001|COMPLETED|Overall Study||116
6696940|NCT02783898|7627112|FG000|NOT COMPLETED|Overall Study||1
6696941|NCT02783898|7627113|FG001|NOT COMPLETED|Overall Study||1
6696942|NCT02783911|7627123|FG000|STARTED|Overall Study||11
6696943|NCT02783911|7627124|FG001|STARTED|Overall Study||46
6696944|NCT02783911|7627123|FG000|COMPLETED|Overall Study||8
6696945|NCT02783911|7627124|FG001|COMPLETED|Overall Study||14
6696946|NCT02783911|7627123|FG000|NOT COMPLETED|Overall Study||3
6696947|NCT02783911|7627124|FG001|NOT COMPLETED|Overall Study||32
6696948|NCT02783950|7627132|FG000|STARTED|Overall Study||182
6696949|NCT02783950|7627133|FG001|STARTED|Overall Study||174
6696950|NCT02783950|7627132|FG000|COMPLETED|Overall Study||175
6696951|NCT02783950|7627133|FG001|COMPLETED|Overall Study||165
6696952|NCT02783950|7627132|FG000|NOT COMPLETED|Overall Study||7
6696953|NCT02783950|7627133|FG001|NOT COMPLETED|Overall Study||9
6696954|NCT02784106|7627141|FG000|STARTED|Double-Blind Treatment Period (12 Weeks)||32
6696955|NCT02784106|7627142|FG001|STARTED|Double-Blind Treatment Period (12 Weeks)||33
6696956|NCT02784106|7627143|FG002|STARTED|Double-Blind Treatment Period (12 Weeks)||0
6696957|NCT02784106|7627144|FG003|STARTED|Double-Blind Treatment Period (12 Weeks)||0
6696958|NCT02784106|7627141|FG000|COMPLETED|Double-Blind Treatment Period (12 Weeks)||24
6696959|NCT02784106|7627142|FG001|COMPLETED|Double-Blind Treatment Period (12 Weeks)||27
6696960|NCT02784106|7627143|FG002|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
6696961|NCT02784106|7627144|FG003|COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
6696962|NCT02784106|7627141|FG000|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||8
6696963|NCT02784106|7627142|FG001|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||6
6696964|NCT02784106|7627143|FG002|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
6696965|NCT02784106|7627144|FG003|NOT COMPLETED|Double-Blind Treatment Period (12 Weeks)||0
6696966|NCT02784106|7627141|FG000|STARTED|Open-Label Extension Period (26 Weeks)||0
6696967|NCT02784106|7627142|FG001|STARTED|Open-Label Extension Period (26 Weeks)||0
6696968|NCT02784106|7627143|FG002|STARTED|Open-Label Extension Period (26 Weeks)||18
6696969|NCT02784106|7627144|FG003|STARTED|Open-Label Extension Period (26 Weeks)||21
6696970|NCT02784106|7627141|FG000|COMPLETED|Open-Label Extension Period (26 Weeks)||0
6391941|NCT00838695|7303892|FG000|COMPLETED|Overall Study||42
6391942|NCT00838695|7303893|FG001|COMPLETED|Overall Study||64
6391943|NCT00838695|7303892|FG000|NOT COMPLETED|Overall Study||0
6696971|NCT02784106|7627142|FG001|COMPLETED|Open-Label Extension Period (26 Weeks)||0
6696972|NCT02784106|7627143|FG002|COMPLETED|Open-Label Extension Period (26 Weeks)||15
6696973|NCT02784106|7627144|FG003|COMPLETED|Open-Label Extension Period (26 Weeks)||19
6696974|NCT02784106|7627141|FG000|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
6696975|NCT02784106|7627142|FG001|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||0
6696976|NCT02784106|7627143|FG002|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||3
6391944|NCT00838695|7303893|FG001|NOT COMPLETED|Overall Study||0
6391945|NCT00838903|7303903|FG000|STARTED|Treatment Period (156 Weeks)||101
6391946|NCT00838903|7303904|FG001|STARTED|Treatment Period (156 Weeks)||302
6391947|NCT00838903|7303905|FG002|STARTED|Treatment Period (156 Weeks)||307
6391948|NCT00838903|7303906|FG003|STARTED|Treatment Period (156 Weeks)||302
6391949|NCT00838903|7303903|FG000|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
6391950|NCT00838903|7303904|FG001|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
6391951|NCT00838903|7303905|FG002|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
6391952|NCT00838903|7303906|FG003|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
6391953|NCT00838903|7303903|FG000|COMPLETED|Treatment Period (156 Weeks)||55
6391954|NCT00838903|7303904|FG001|COMPLETED|Treatment Period (156 Weeks)||190
6391955|NCT00838903|7303905|FG002|COMPLETED|Treatment Period (156 Weeks)||191
6391956|NCT00838903|7303906|FG003|COMPLETED|Treatment Period (156 Weeks)||192
6391957|NCT00838903|7303903|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||46
6391958|NCT00838903|7303904|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||112
6391959|NCT00838903|7303905|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||116
6391960|NCT00838903|7303906|FG003|NOT COMPLETED|Treatment Period (156 Weeks)||110
6391961|NCT00838903|7303903|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
6391962|NCT00838903|7303904|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
6391963|NCT00838903|7303905|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
6391964|NCT00838903|7303906|FG003|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
6391965|NCT00838903|7303903|FG000|COMPLETED|Follow-up Period (8 Weeks)||75
6391966|NCT00838903|7303904|FG001|COMPLETED|Follow-up Period (8 Weeks)||237
6391967|NCT00838903|7303905|FG002|COMPLETED|Follow-up Period (8 Weeks)||243
6391968|NCT00838903|7303906|FG003|COMPLETED|Follow-up Period (8 Weeks)||244
6391969|NCT00838903|7303903|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||26
6391970|NCT00838903|7303904|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||65
6391971|NCT00838903|7303905|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||64
6391972|NCT00838903|7303906|FG003|NOT COMPLETED|Follow-up Period (8 Weeks)||58
6391973|NCT00838916|7303918|FG000|STARTED|Treatment Period (156 Weeks)||504
6391974|NCT00838916|7303919|FG001|STARTED|Treatment Period (156 Weeks)||241
6391975|NCT00838916|7303918|FG000|COMPLETED|Treatment Period (156 Weeks)||308
6391976|NCT00838916|7303919|FG001|COMPLETED|Treatment Period (156 Weeks)||164
6391977|NCT00838916|7303918|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||196
6391978|NCT00838916|7303919|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||77
6391979|NCT00838916|7303918|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
6391980|NCT00838916|7303919|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
6391981|NCT00838916|7303918|FG000|COMPLETED|Follow-up Period (8 Weeks)||408
6391982|NCT00838916|7303919|FG001|COMPLETED|Follow-up Period (8 Weeks)||190
6391983|NCT00838916|7303918|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||96
6391984|NCT00838916|7303919|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||51
6391985|NCT00838929|7303928|FG000|STARTED|Overall Study||3
6391986|NCT00838929|7303929|FG001|STARTED|Overall Study||8
6391987|NCT00838929|7303930|FG002|STARTED|Overall Study||6
6391988|NCT00838929|7303928|FG000|COMPLETED|Overall Study||3
6391989|NCT00838929|7303929|FG001|COMPLETED|Overall Study||5
6391990|NCT00838929|7303930|FG002|COMPLETED|Overall Study||5
6391991|NCT00838929|7303928|FG000|NOT COMPLETED|Overall Study||0
6391992|NCT00838929|7303929|FG001|NOT COMPLETED|Overall Study||3
6391993|NCT00838929|7303930|FG002|NOT COMPLETED|Overall Study||1
6391994|NCT00839072|7303936|FG000|STARTED|First Intervention Period||12
6391995|NCT00839072|7303937|FG001|STARTED|First Intervention Period||12
6391996|NCT00839072|7303936|FG000|COMPLETED|First Intervention Period||10
6391997|NCT00839072|7303937|FG001|COMPLETED|First Intervention Period||11
6391998|NCT00839072|7303936|FG000|NOT COMPLETED|First Intervention Period||2
6391999|NCT00839072|7303937|FG001|NOT COMPLETED|First Intervention Period||1
6392000|NCT00839072|7303936|FG000|STARTED|Washout Period of 7 Days||10
6392001|NCT00839072|7303937|FG001|STARTED|Washout Period of 7 Days||11
6392002|NCT00839072|7303936|FG000|COMPLETED|Washout Period of 7 Days||10
6392003|NCT00839072|7303937|FG001|COMPLETED|Washout Period of 7 Days||11
6392004|NCT00839072|7303936|FG000|NOT COMPLETED|Washout Period of 7 Days||0
6392005|NCT00839072|7303937|FG001|NOT COMPLETED|Washout Period of 7 Days||0
6392006|NCT00839072|7303936|FG000|STARTED|Second Intervention Period||10
6392007|NCT00839072|7303937|FG001|STARTED|Second Intervention Period||11
6392008|NCT00839072|7303936|FG000|COMPLETED|Second Intervention Period||9
6392009|NCT00839072|7303937|FG001|COMPLETED|Second Intervention Period||11
6392010|NCT00839072|7303936|FG000|NOT COMPLETED|Second Intervention Period||1
6392011|NCT00839072|7303937|FG001|NOT COMPLETED|Second Intervention Period||0
6392012|NCT00839098|7303946|FG000|STARTED|Overall Study||3
6392013|NCT00839098|7303947|FG001|STARTED|Overall Study||12
6392014|NCT00839098|7303948|FG002|STARTED|Overall Study||13
6392015|NCT00839098|7303946|FG000|COMPLETED|Overall Study||1
6392016|NCT00839098|7303947|FG001|COMPLETED|Overall Study||11
6392017|NCT00839098|7303948|FG002|COMPLETED|Overall Study||6
6392018|NCT00839098|7303946|FG000|NOT COMPLETED|Overall Study||2
6392019|NCT00839098|7303947|FG001|NOT COMPLETED|Overall Study||1
6392020|NCT00839098|7303948|FG002|NOT COMPLETED|Overall Study||7
6392021|NCT00839241|7303958|FG000|STARTED|Overall Study||20
6392022|NCT00839241|7303959|FG001|STARTED|Overall Study||25
6392023|NCT00839241|7303958|FG000|COMPLETED|Overall Study||15
6392024|NCT00839241|7303959|FG001|COMPLETED|Overall Study||8
6392025|NCT00839241|7303958|FG000|NOT COMPLETED|Overall Study||5
6392026|NCT00839241|7303959|FG001|NOT COMPLETED|Overall Study||17
6392027|NCT00839254|7303973|FG000|STARTED|Overall Study||1849
6392028|NCT00839254|7303974|FG001|STARTED|Overall Study||1316
6392029|NCT00839254|7303975|FG002|STARTED|Overall Study||1069
6392030|NCT00839254|7303976|FG003|STARTED|Overall Study||859
6392031|NCT00839254|7303977|FG004|STARTED|Overall Study||241
6392032|NCT00839254|7303978|FG005|STARTED|Overall Study||204
6392033|NCT00839254|7303979|FG006|STARTED|Overall Study||368
6392034|NCT00839254|7303980|FG007|STARTED|Overall Study||271
6392035|NCT00839254|7303973|FG000|COMPLETED|Overall Study||1696
6392036|NCT00839254|7303974|FG001|COMPLETED|Overall Study||1224
6392037|NCT00839254|7303975|FG002|COMPLETED|Overall Study||979
6392038|NCT00839254|7303976|FG003|COMPLETED|Overall Study||797
6392039|NCT00839254|7303977|FG004|COMPLETED|Overall Study||204
6392040|NCT00839254|7303978|FG005|COMPLETED|Overall Study||178
6392041|NCT00839254|7303979|FG006|COMPLETED|Overall Study||340
6392042|NCT00839254|7303980|FG007|COMPLETED|Overall Study||256
6392043|NCT00839254|7303973|FG000|NOT COMPLETED|Overall Study||153
6392044|NCT00839254|7303974|FG001|NOT COMPLETED|Overall Study||92
6392045|NCT00839254|7303975|FG002|NOT COMPLETED|Overall Study||90
6392046|NCT00839254|7303976|FG003|NOT COMPLETED|Overall Study||62
6392047|NCT00839254|7303977|FG004|NOT COMPLETED|Overall Study||37
6392048|NCT00839254|7303978|FG005|NOT COMPLETED|Overall Study||26
6392049|NCT00839254|7303979|FG006|NOT COMPLETED|Overall Study||28
6392050|NCT00839254|7303980|FG007|NOT COMPLETED|Overall Study||15
6392051|NCT00839306|7304031|FG000|STARTED|Overall Study|Treated|60
6392052|NCT00839306|7304032|FG001|STARTED|Overall Study|Treated|177
6392053|NCT00839306|7304031|FG000|COMPLETED|Overall Study||35
6392054|NCT00839306|7304032|FG001|COMPLETED|Overall Study||134
6392055|NCT00839306|7304031|FG000|NOT COMPLETED|Overall Study||25
6392056|NCT00839306|7304032|FG001|NOT COMPLETED|Overall Study||43
6392057|NCT00839319|7304044|FG000|STARTED|Overall Study||8
6392058|NCT00839319|7304045|FG001|STARTED|Overall Study||8
6392059|NCT00839319|7304046|FG002|STARTED|Overall Study||8
6392060|NCT00839319|7304047|FG003|STARTED|Overall Study||8
6392061|NCT00839319|7304048|FG004|STARTED|Overall Study||8
6392062|NCT00839319|7304044|FG000|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
6392063|NCT00839319|7304045|FG001|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
6392064|NCT00839319|7304046|FG002|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
6392065|NCT00839319|7304047|FG003|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
6392066|NCT00839319|7304048|FG004|COMPLETED|Overall Study||8
6392067|NCT00839319|7304044|FG000|NOT COMPLETED|Overall Study||2
6392068|NCT00839319|7304045|FG001|NOT COMPLETED|Overall Study||1
6392069|NCT00839319|7304046|FG002|NOT COMPLETED|Overall Study||3
6392070|NCT00839319|7304047|FG003|NOT COMPLETED|Overall Study||3
6392071|NCT00839319|7304048|FG004|NOT COMPLETED|Overall Study||0
6392072|NCT00839332|7304063|FG000|STARTED|Phase 1||50
6392073|NCT00839332|7304064|FG001|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
6392074|NCT00839332|7304065|FG002|STARTED|Phase 1|Participants in Phase 2 did not participate in Phase 1.|0
6392075|NCT00839332|7304063|FG000|Received at Least 1 Dose of Study Drug|Phase 1||50
6392076|NCT00839332|7304064|FG001|Received at Least 1 Dose of Study Drug|Phase 1||0
6392077|NCT00839332|7304065|FG002|Received at Least 1 Dose of Study Drug|Phase 1||0
6392078|NCT00839332|7304063|FG000|COMPLETED|Phase 1||0
6392079|NCT00839332|7304064|FG001|COMPLETED|Phase 1||0
6392080|NCT00839332|7304065|FG002|COMPLETED|Phase 1||0
6392081|NCT00839332|7304063|FG000|NOT COMPLETED|Phase 1||50
6392082|NCT00839332|7304064|FG001|NOT COMPLETED|Phase 1||0
6392083|NCT00839332|7304065|FG002|NOT COMPLETED|Phase 1||0
6392084|NCT00839332|7304063|FG000|STARTED|Phase 2|Participants in Phase 1 did not participate in Phase 2.|0
6392085|NCT00839332|7304064|FG001|STARTED|Phase 2||68
6392086|NCT00839332|7304065|FG002|STARTED|Phase 2||39
6392087|NCT00839332|7304063|FG000|Received at Least 1 Dose of Study Drug|Phase 2||0
6392088|NCT00839332|7304064|FG001|Received at Least 1 Dose of Study Drug|Phase 2||65
6392089|NCT00839332|7304065|FG002|Received at Least 1 Dose of Study Drug|Phase 2||34
6392090|NCT00839332|7304063|FG000|COMPLETED|Phase 2||0
6392091|NCT00839332|7304064|FG001|COMPLETED|Phase 2||0
6392092|NCT00839332|7304065|FG002|COMPLETED|Phase 2||0
6392093|NCT00839332|7304063|FG000|NOT COMPLETED|Phase 2||0
6392094|NCT00839332|7304064|FG001|NOT COMPLETED|Phase 2||68
6392095|NCT00839332|7304065|FG002|NOT COMPLETED|Phase 2||39
6392096|NCT00839423|7304078|FG000|STARTED|Overall Study||105
6392097|NCT00839423|7304079|FG001|STARTED|Overall Study||108
6392098|NCT00839423|7304080|FG002|STARTED|Overall Study||100
6392099|NCT00839423|7304081|FG003|STARTED|Overall Study||113
6392100|NCT00839423|7304078|FG000|COMPLETED|Overall Study||87
6392101|NCT00839423|7304079|FG001|COMPLETED|Overall Study||98
6392102|NCT00839423|7304080|FG002|COMPLETED|Overall Study||82
6392103|NCT00839423|7304081|FG003|COMPLETED|Overall Study||93
6392104|NCT00839423|7304078|FG000|NOT COMPLETED|Overall Study||18
6392105|NCT00839423|7304079|FG001|NOT COMPLETED|Overall Study||10
6392106|NCT00839423|7304080|FG002|NOT COMPLETED|Overall Study||18
6392107|NCT00839423|7304081|FG003|NOT COMPLETED|Overall Study||20
6392108|NCT00839436|7304094|FG000|STARTED|Overall Study||3
6392109|NCT00839436|7304095|FG001|STARTED|Overall Study||5
6392110|NCT00839436|7304096|FG002|STARTED|Overall Study||1
6392111|NCT00839436|7304094|FG000|COMPLETED|Overall Study||2
6696977|NCT02784106|7627144|FG003|NOT COMPLETED|Open-Label Extension Period (26 Weeks)||2
6696978|NCT02784275|7627157|FG000|STARTED|Overall Study||16
6696979|NCT02784275|7627158|FG001|STARTED|Overall Study||16
6696980|NCT02784275|7627159|FG002|STARTED|Overall Study||17
6696981|NCT02784275|7627160|FG003|STARTED|Overall Study||15
6696982|NCT02784275|7627157|FG000|COMPLETED|Overall Study||15
6696983|NCT02784275|7627158|FG001|COMPLETED|Overall Study||16
6696984|NCT02784275|7627159|FG002|COMPLETED|Overall Study||16
6696985|NCT02784275|7627160|FG003|COMPLETED|Overall Study||14
6696986|NCT02784275|7627157|FG000|NOT COMPLETED|Overall Study||1
6696987|NCT02784275|7627158|FG001|NOT COMPLETED|Overall Study||0
6696988|NCT02784275|7627159|FG002|NOT COMPLETED|Overall Study||1
6696989|NCT02784275|7627160|FG003|NOT COMPLETED|Overall Study||1
6696990|NCT02784431|7627170|FG000|STARTED|Overall Study||20
6696991|NCT02784431|7627170|FG000|COMPLETED|Overall Study||0
6696992|NCT02784431|7627170|FG000|NOT COMPLETED|Overall Study||20
6696993|NCT02784444|7627178|FG000|STARTED|Overall Study||94
6696994|NCT02784444|7627179|FG001|STARTED|Overall Study||99
6696995|NCT02784444|7627180|FG002|STARTED|Overall Study||98
6696996|NCT02784444|7627181|FG003|STARTED|Overall Study||101
6696997|NCT02784444|7627178|FG000|COMPLETED|Overall Study||78
6696998|NCT02784444|7627179|FG001|COMPLETED|Overall Study||90
6696999|NCT02784444|7627180|FG002|COMPLETED|Overall Study||86
6697000|NCT02784444|7627181|FG003|COMPLETED|Overall Study||88
6697001|NCT02784444|7627178|FG000|NOT COMPLETED|Overall Study||16
6697002|NCT02784444|7627179|FG001|NOT COMPLETED|Overall Study||9
6697003|NCT02784444|7627180|FG002|NOT COMPLETED|Overall Study||12
6697004|NCT02784444|7627181|FG003|NOT COMPLETED|Overall Study||13
6697005|NCT02784548|7627191|FG000|STARTED|Overall Study||15
6697006|NCT02784548|7627191|FG000|COMPLETED|Overall Study||15
6697007|NCT02784548|7627191|FG000|NOT COMPLETED|Overall Study||0
6697008|NCT02784587|7627196|FG000|STARTED|Overall Study||25
6697009|NCT02784587|7627196|FG000|COMPLETED|Overall Study||25
6697010|NCT02784587|7627196|FG000|NOT COMPLETED|Overall Study||0
6697011|NCT02784613|7627200|FG000|STARTED|Overall Study||10
6697012|NCT02784613|7627200|FG000|COMPLETED|Overall Study||8
6697013|NCT02784613|7627200|FG000|NOT COMPLETED|Overall Study||2
6697014|NCT02784834|7627204|FG000|STARTED|Overall Study||2
6697015|NCT02784834|7627204|FG000|COMPLETED|Overall Study||1
6697016|NCT02784834|7627204|FG000|NOT COMPLETED|Overall Study||1
6697017|NCT02784925|7627208|FG000|STARTED|Overall Study||30
6697018|NCT02784925|7627208|FG000|COMPLETED|Overall Study||30
6697019|NCT02784925|7627208|FG000|NOT COMPLETED|Overall Study||0
6697020|NCT02785159|7627216|FG000|STARTED|Overall Study||62
6697021|NCT02785159|7627217|FG001|STARTED|Overall Study||58
6697022|NCT02785159|7627218|FG002|STARTED|Overall Study||15
6697023|NCT02785159|7627219|FG003|STARTED|Overall Study||17
6697024|NCT02785159|7627216|FG000|COMPLETED|Overall Study||51
6697025|NCT02785159|7627217|FG001|COMPLETED|Overall Study||45
6697026|NCT02785159|7627218|FG002|COMPLETED|Overall Study||12
6697027|NCT02785159|7627219|FG003|COMPLETED|Overall Study||14
6697028|NCT02785159|7627216|FG000|NOT COMPLETED|Overall Study||11
6697029|NCT02785159|7627217|FG001|NOT COMPLETED|Overall Study||13
6697030|NCT02785159|7627218|FG002|NOT COMPLETED|Overall Study||3
6697031|NCT02785159|7627219|FG003|NOT COMPLETED|Overall Study||3
6697032|NCT02785172|7627233|FG000|STARTED|Overall Study||61
6697033|NCT02785172|7627234|FG001|STARTED|Overall Study||63
6697034|NCT02785172|7627235|FG002|STARTED|Overall Study||16
6697035|NCT02785172|7627236|FG003|STARTED|Overall Study||14
6697036|NCT02785172|7627233|FG000|COMPLETED|Overall Study||61
6697037|NCT02785172|7627234|FG001|COMPLETED|Overall Study||62
6697038|NCT02785172|7627235|FG002|COMPLETED|Overall Study||15
6697039|NCT02785172|7627236|FG003|COMPLETED|Overall Study||14
6697040|NCT02785172|7627233|FG000|NOT COMPLETED|Overall Study||0
6697041|NCT02785172|7627234|FG001|NOT COMPLETED|Overall Study||1
6697042|NCT02785172|7627235|FG002|NOT COMPLETED|Overall Study||1
6697043|NCT02785172|7627236|FG003|NOT COMPLETED|Overall Study||0
6697044|NCT02785185|7627250|FG000|STARTED|Overall Study||60
6697045|NCT02785185|7627251|FG001|STARTED|Overall Study||57
6697046|NCT02785185|7627252|FG002|STARTED|Overall Study||17
6697047|NCT02785185|7627253|FG003|STARTED|Overall Study||16
6697048|NCT02785185|7627250|FG000|COMPLETED|Overall Study||59
6697049|NCT02785185|7627251|FG001|COMPLETED|Overall Study||56
6697050|NCT02785185|7627252|FG002|COMPLETED|Overall Study||15
6697051|NCT02785185|7627253|FG003|COMPLETED|Overall Study||16
6697052|NCT02785185|7627250|FG000|NOT COMPLETED|Overall Study||1
6697053|NCT02785185|7627251|FG001|NOT COMPLETED|Overall Study||1
6697054|NCT02785185|7627252|FG002|NOT COMPLETED|Overall Study||2
6697055|NCT02785185|7627253|FG003|NOT COMPLETED|Overall Study||0
6697056|NCT02785354|7627266|FG000|STARTED|Overall Study||27060
6697057|NCT02785354|7627267|FG001|STARTED|Overall Study||31388
6697058|NCT02785354|7627268|FG002|STARTED|Overall Study||44653
6697059|NCT02785354|7627266|FG000|COMPLETED|Overall Study||27060
6697060|NCT02785354|7627267|FG001|COMPLETED|Overall Study||31388
6697061|NCT02785354|7627268|FG002|COMPLETED|Overall Study||44653
6697062|NCT02785354|7627266|FG000|NOT COMPLETED|Overall Study||0
6697063|NCT02785354|7627267|FG001|NOT COMPLETED|Overall Study||0
6697064|NCT02785354|7627268|FG002|NOT COMPLETED|Overall Study||0
6697065|NCT02785406|7627279|FG000|STARTED|Overall Study||10
6697066|NCT02785406|7627280|FG001|STARTED|Overall Study||10
6697067|NCT02785406|7627279|FG000|Completed First Week|Overall Study||10
6697068|NCT02785406|7627280|FG001|Completed First Week|Overall Study||10
6697069|NCT02785406|7627279|FG000|Completed Second Week|Overall Study||10
6697070|NCT02785406|7627280|FG001|Completed Second Week|Overall Study||10
6697071|NCT02785406|7627279|FG000|COMPLETED|Overall Study||10
6697072|NCT02785406|7627280|FG001|COMPLETED|Overall Study||10
6697073|NCT02785406|7627279|FG000|NOT COMPLETED|Overall Study||0
6697074|NCT02785406|7627280|FG001|NOT COMPLETED|Overall Study||0
6697075|NCT02785432|7627288|FG000|STARTED|Overall Study||4
6697076|NCT02785432|7627289|FG001|STARTED|Overall Study||7
6697077|NCT02785432|7627288|FG000|COMPLETED|Overall Study||4
6697078|NCT02785432|7627289|FG001|COMPLETED|Overall Study||7
6697079|NCT02785432|7627288|FG000|NOT COMPLETED|Overall Study||0
6697080|NCT02785432|7627289|FG001|NOT COMPLETED|Overall Study||0
6697081|NCT02785458|7627297|FG000|STARTED|Baseline||526
6697082|NCT02785458|7627298|FG001|STARTED|Baseline||479
6697083|NCT02785458|7627297|FG000|COMPLETED|Baseline||526
6697084|NCT02785458|7627298|FG001|COMPLETED|Baseline||479
6697085|NCT02785458|7627297|FG000|NOT COMPLETED|Baseline||0
6697086|NCT02785458|7627298|FG001|NOT COMPLETED|Baseline||0
6697087|NCT02785458|7627297|FG000|STARTED|1 Month||526
6697088|NCT02785458|7627298|FG001|STARTED|1 Month||479
6697089|NCT02785458|7627297|FG000|COMPLETED|1 Month||443
6697090|NCT02785458|7627298|FG001|COMPLETED|1 Month||404
6697091|NCT02785458|7627297|FG000|NOT COMPLETED|1 Month||83
6697092|NCT02785458|7627298|FG001|NOT COMPLETED|1 Month||75
6697093|NCT02785458|7627297|FG000|STARTED|3 Months||443
6697094|NCT02785458|7627298|FG001|STARTED|3 Months||404
6697095|NCT02785458|7627297|FG000|COMPLETED|3 Months||315
6697096|NCT02785458|7627298|FG001|COMPLETED|3 Months||293
6697097|NCT02785458|7627297|FG000|NOT COMPLETED|3 Months||128
6697098|NCT02785458|7627298|FG001|NOT COMPLETED|3 Months||111
6697099|NCT02785588|7627304|FG000|STARTED|Phase 1: Initial Feasibility Assessment||49
6697100|NCT02785588|7627304|FG000|COMPLETED|Phase 1: Initial Feasibility Assessment||47
6697101|NCT02785588|7627304|FG000|NOT COMPLETED|Phase 1: Initial Feasibility Assessment||2
6259453|NCT02656290|7158541|FG000|1 Year|Overall Study|One subject missed the 1 year follow-up visit.|25
6259454|NCT02656290|7158541|FG000|2 Year|Overall Study||17
6259455|NCT02656290|7158541|FG000|3 Year|Overall Study||6
6259456|NCT02656290|7158541|FG000|COMPLETED|Overall Study||0
6259457|NCT02656290|7158541|FG000|NOT COMPLETED|Overall Study||26
6259458|NCT02652130|7158545|FG000|STARTED|Overall Study||32
6259459|NCT02652130|7158545|FG000|COMPLETED|Overall Study||31
6259460|NCT02652130|7158545|FG000|NOT COMPLETED|Overall Study||1
6259461|NCT02616393|7158552|FG000|STARTED|Overall Study||13
6259462|NCT02616393|7158553|FG001|STARTED|Overall Study||20
6259463|NCT02616393|7158554|FG002|STARTED|Overall Study||3
6259464|NCT02616393|7158552|FG000|COMPLETED|Overall Study||0
6259465|NCT02616393|7158553|FG001|COMPLETED|Overall Study||0
6259466|NCT02616393|7158554|FG002|COMPLETED|Overall Study||0
6259467|NCT02616393|7158552|FG000|NOT COMPLETED|Overall Study||13
6259468|NCT02616393|7158553|FG001|NOT COMPLETED|Overall Study||20
6259469|NCT02616393|7158554|FG002|NOT COMPLETED|Overall Study||3
6259470|NCT02602288|7158580|FG000|STARTED|End of Treatment/3 Month Follow-up||199
6259471|NCT02602288|7158581|FG001|STARTED|End of Treatment/3 Month Follow-up||197
6259472|NCT02602288|7158580|FG000|COMPLETED|End of Treatment/3 Month Follow-up||174
6259473|NCT02602288|7158581|FG001|COMPLETED|End of Treatment/3 Month Follow-up||179
6259474|NCT02602288|7158580|FG000|NOT COMPLETED|End of Treatment/3 Month Follow-up||25
6259475|NCT02602288|7158581|FG001|NOT COMPLETED|End of Treatment/3 Month Follow-up||18
6259476|NCT02602288|7158580|FG000|STARTED|12 Month Follow-up||174
6259477|NCT02602288|7158581|FG001|STARTED|12 Month Follow-up||179
6259478|NCT02602288|7158580|FG000|COMPLETED|12 Month Follow-up||172
6259479|NCT02602288|7158581|FG001|COMPLETED|12 Month Follow-up||175
6259480|NCT02602288|7158580|FG000|NOT COMPLETED|12 Month Follow-up||2
6259481|NCT02602288|7158581|FG001|NOT COMPLETED|12 Month Follow-up||4
6259482|NCT02577523|7158589|FG000|STARTED|Overall Study||19
6259483|NCT02577523|7158590|FG001|STARTED|Overall Study||19
6259484|NCT02577523|7158589|FG000|COMPLETED|Overall Study||16
6259485|NCT02577523|7158590|FG001|COMPLETED|Overall Study||17
6697102|NCT02785588|7627304|FG000|STARTED|Phase2 Controlled Image &Data Collection|Phase 2 participants represent newly enrolled participants.|5
6697103|NCT02785588|7627304|FG000|COMPLETED|Phase2 Controlled Image &Data Collection||5
6697104|NCT02785588|7627304|FG000|NOT COMPLETED|Phase2 Controlled Image &Data Collection||0
6697105|NCT02785770|7627308|FG000|STARTED|Intervention Period 1 (1 Day)||11
6259486|NCT02577523|7158589|FG000|NOT COMPLETED|Overall Study||3
6259487|NCT02577523|7158590|FG001|NOT COMPLETED|Overall Study||2
6259488|NCT02563002|7158598|FG000|STARTED|Overall Study||153
6259489|NCT02563002|7158599|FG001|STARTED|Overall Study||154
6697106|NCT02785770|7627309|FG001|STARTED|Intervention Period 1 (1 Day)||11
6697107|NCT02785770|7627310|FG002|STARTED|Intervention Period 1 (1 Day)||11
6697108|NCT02785770|7627311|FG003|STARTED|Intervention Period 1 (1 Day)||11
6697109|NCT02785770|7627308|FG000|COMPLETED|Intervention Period 1 (1 Day)||11
6697110|NCT02785770|7627309|FG001|COMPLETED|Intervention Period 1 (1 Day)||11
6697111|NCT02785770|7627310|FG002|COMPLETED|Intervention Period 1 (1 Day)||11
6259490|NCT02563002|7158598|FG000|Treated|Overall Study||153
6259491|NCT02563002|7158599|FG001|Treated|Overall Study||143
6259492|NCT02563002|7158598|FG000|Received Second Course of Pembrolizumab|Overall Study||8
6259493|NCT02563002|7158599|FG001|Received Second Course of Pembrolizumab|Overall Study||4
6259494|NCT02563002|7158598|FG000|Switched Over to Pembrolizumab|Overall Study||0
6697112|NCT02785770|7627311|FG003|COMPLETED|Intervention Period 1 (1 Day)||11
6697113|NCT02785770|7627308|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6697114|NCT02785770|7627309|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6697115|NCT02785770|7627310|FG002|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6697116|NCT02785770|7627311|FG003|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6697117|NCT02785770|7627308|FG000|STARTED|Washout Period 1 (7 Days)||11
6697118|NCT02785770|7627309|FG001|STARTED|Washout Period 1 (7 Days)||11
6697119|NCT02785770|7627310|FG002|STARTED|Washout Period 1 (7 Days)||11
6697120|NCT02785770|7627311|FG003|STARTED|Washout Period 1 (7 Days)||11
6697121|NCT02785770|7627308|FG000|COMPLETED|Washout Period 1 (7 Days)||11
6697122|NCT02785770|7627309|FG001|COMPLETED|Washout Period 1 (7 Days)||11
6697123|NCT02785770|7627310|FG002|COMPLETED|Washout Period 1 (7 Days)||11
6697124|NCT02785770|7627311|FG003|COMPLETED|Washout Period 1 (7 Days)||11
6697125|NCT02785770|7627308|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||0
6697126|NCT02785770|7627309|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||0
6697127|NCT02785770|7627310|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||0
6697128|NCT02785770|7627311|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||0
6697129|NCT02785770|7627308|FG000|STARTED|Intervention Period 2 (1 Day)||11
6697130|NCT02785770|7627309|FG001|STARTED|Intervention Period 2 (1 Day)||11
6697131|NCT02785770|7627310|FG002|STARTED|Intervention Period 2 (1 Day)||11
6697132|NCT02785770|7627311|FG003|STARTED|Intervention Period 2 (1 Day)||11
6697133|NCT02785770|7627308|FG000|COMPLETED|Intervention Period 2 (1 Day)||11
6697134|NCT02785770|7627309|FG001|COMPLETED|Intervention Period 2 (1 Day)||10
6697135|NCT02785770|7627310|FG002|COMPLETED|Intervention Period 2 (1 Day)||10
6697136|NCT02785770|7627311|FG003|COMPLETED|Intervention Period 2 (1 Day)||11
6697137|NCT02785770|7627308|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
6259495|NCT02563002|7158599|FG001|Switched Over to Pembrolizumab|Overall Study||56
6259496|NCT02563002|7158598|FG000|COMPLETED|Overall Study||0
6259497|NCT02563002|7158599|FG001|COMPLETED|Overall Study||0
6259498|NCT02563002|7158598|FG000|NOT COMPLETED|Overall Study||153
6259499|NCT02563002|7158599|FG001|NOT COMPLETED|Overall Study||154
6259500|NCT02461225|7158610|FG000|STARTED|Overall Study||19
6259501|NCT02461225|7158611|FG001|STARTED|Overall Study||11
6259502|NCT02461225|7158610|FG000|COMPLETED|Overall Study||19
6259503|NCT02461225|7158611|FG001|COMPLETED|Overall Study||11
6259504|NCT02461225|7158610|FG000|NOT COMPLETED|Overall Study||0
6259505|NCT02461225|7158611|FG001|NOT COMPLETED|Overall Study||0
6259506|NCT02427958|7158617|FG000|STARTED|Overall Study||307
6259507|NCT02427958|7158617|FG000|COMPLETED|Overall Study||283
6259508|NCT02427958|7158617|FG000|NOT COMPLETED|Overall Study||24
6259509|NCT02425826|7158623|FG000|STARTED|Placebo-controlled Phase (Week 0 - 16)||148
6259510|NCT02425826|7158624|FG001|STARTED|Placebo-controlled Phase (Week 0 - 16)||73
6259511|NCT02425826|7158625|FG002|STARTED|Placebo-controlled Phase (Week 0 - 16)||0
6259512|NCT02425826|7158623|FG000|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|147
6259513|NCT02425826|7158624|FG001|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)|ITT = includes participants who received at least one dose of study drug.|73
6259514|NCT02425826|7158625|FG002|Intent to Treat|Placebo-controlled Phase (Week 0 - 16)||0
6259515|NCT02425826|7158623|FG000|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|121
6259516|NCT02425826|7158624|FG001|COMPLETED|Placebo-controlled Phase (Week 0 - 16)|Completed = participants who completed Week 16|64
6259517|NCT02425826|7158625|FG002|COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
6259518|NCT02425826|7158623|FG000|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||27
6259519|NCT02425826|7158624|FG001|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||9
6259520|NCT02425826|7158625|FG002|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 16)||0
6259521|NCT02425826|7158623|FG000|STARTED|Apremilast Extension Phase (Weeks 16-52)||121
6259522|NCT02425826|7158624|FG001|STARTED|Apremilast Extension Phase (Weeks 16-52)||0
6259523|NCT02425826|7158625|FG002|STARTED|Apremilast Extension Phase (Weeks 16-52)||64
6259524|NCT02425826|7158623|FG000|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||121
6259525|NCT02425826|7158624|FG001|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||0
6259526|NCT02425826|7158625|FG002|Received Treatment|Apremilast Extension Phase (Weeks 16-52)||64
6259527|NCT02425826|7158623|FG000|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||86
6259528|NCT02425826|7158624|FG001|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
6259529|NCT02425826|7158625|FG002|COMPLETED|Apremilast Extension Phase (Weeks 16-52)||50
6259530|NCT02425826|7158623|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||35
6259531|NCT02425826|7158624|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||0
6259532|NCT02425826|7158625|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks 16-52)||14
6259533|NCT02425826|7158623|FG000|STARTED|Post-Treatment Observational Follow-Up||81
6259534|NCT02425826|7158624|FG001|STARTED|Post-Treatment Observational Follow-Up||0
6259535|NCT02425826|7158625|FG002|STARTED|Post-Treatment Observational Follow-Up||49
6259536|NCT02425826|7158623|FG000|COMPLETED|Post-Treatment Observational Follow-Up||80
6259537|NCT02425826|7158624|FG001|COMPLETED|Post-Treatment Observational Follow-Up||0
6259538|NCT02425826|7158625|FG002|COMPLETED|Post-Treatment Observational Follow-Up||49
6259539|NCT02425826|7158623|FG000|NOT COMPLETED|Post-Treatment Observational Follow-Up||1
6259540|NCT02425826|7158624|FG001|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
6259541|NCT02425826|7158625|FG002|NOT COMPLETED|Post-Treatment Observational Follow-Up||0
6259542|NCT02384239|7158637|FG000|STARTED|Overall Study||36
6259543|NCT02384239|7158638|FG001|STARTED|Overall Study||34
6697138|NCT02785770|7627309|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||1
6697139|NCT02785770|7627310|FG002|NOT COMPLETED|Intervention Period 2 (1 Day)||1
6697140|NCT02785770|7627311|FG003|NOT COMPLETED|Intervention Period 2 (1 Day)||0
6697141|NCT02785770|7627308|FG000|STARTED|Washout Period 2 (7 Days)||11
6697142|NCT02785770|7627309|FG001|STARTED|Washout Period 2 (7 Days)||10
6697143|NCT02785770|7627310|FG002|STARTED|Washout Period 2 (7 Days)||10
6697144|NCT02785770|7627311|FG003|STARTED|Washout Period 2 (7 Days)||11
6697145|NCT02785770|7627308|FG000|COMPLETED|Washout Period 2 (7 Days)||11
6697146|NCT02785770|7627309|FG001|COMPLETED|Washout Period 2 (7 Days)||10
6697147|NCT02785770|7627310|FG002|COMPLETED|Washout Period 2 (7 Days)||10
6697148|NCT02785770|7627311|FG003|COMPLETED|Washout Period 2 (7 Days)||11
6697149|NCT02785770|7627308|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6697150|NCT02785770|7627309|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6697151|NCT02785770|7627310|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6697152|NCT02785770|7627311|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6697153|NCT02785770|7627308|FG000|STARTED|Intervention Period 3 (1 Day)||11
6697154|NCT02785770|7627309|FG001|STARTED|Intervention Period 3 (1 Day)||10
6697155|NCT02785770|7627310|FG002|STARTED|Intervention Period 3 (1 Day)||10
6697156|NCT02785770|7627311|FG003|STARTED|Intervention Period 3 (1 Day)||11
6697157|NCT02785770|7627308|FG000|COMPLETED|Intervention Period 3 (1 Day)||11
6697158|NCT02785770|7627309|FG001|COMPLETED|Intervention Period 3 (1 Day)||10
6697159|NCT02785770|7627310|FG002|COMPLETED|Intervention Period 3 (1 Day)||10
6697160|NCT02785770|7627311|FG003|COMPLETED|Intervention Period 3 (1 Day)||10
6697161|NCT02785770|7627308|FG000|NOT COMPLETED|Intervention Period 3 (1 Day)||0
6697162|NCT02785770|7627309|FG001|NOT COMPLETED|Intervention Period 3 (1 Day)||0
6697163|NCT02785770|7627310|FG002|NOT COMPLETED|Intervention Period 3 (1 Day)||0
6697164|NCT02785770|7627311|FG003|NOT COMPLETED|Intervention Period 3 (1 Day)||1
6697165|NCT02785770|7627308|FG000|STARTED|Washout Period 3 (7 Days)||11
6697166|NCT02785770|7627309|FG001|STARTED|Washout Period 3 (7 Days)||10
6697167|NCT02785770|7627310|FG002|STARTED|Washout Period 3 (7 Days)||10
6697168|NCT02785770|7627311|FG003|STARTED|Washout Period 3 (7 Days)||10
6697169|NCT02785770|7627308|FG000|COMPLETED|Washout Period 3 (7 Days)||11
6697170|NCT02785770|7627309|FG001|COMPLETED|Washout Period 3 (7 Days)||10
6697171|NCT02785770|7627310|FG002|COMPLETED|Washout Period 3 (7 Days)||10
6697172|NCT02785770|7627311|FG003|COMPLETED|Washout Period 3 (7 Days)||10
6697173|NCT02785770|7627308|FG000|NOT COMPLETED|Washout Period 3 (7 Days)||0
6697174|NCT02785770|7627309|FG001|NOT COMPLETED|Washout Period 3 (7 Days)||0
6697175|NCT02785770|7627310|FG002|NOT COMPLETED|Washout Period 3 (7 Days)||0
6697176|NCT02785770|7627311|FG003|NOT COMPLETED|Washout Period 3 (7 Days)||0
6697177|NCT02785770|7627308|FG000|STARTED|Intervention Period 4 (1 Day)||11
6697178|NCT02785770|7627309|FG001|STARTED|Intervention Period 4 (1 Day)||10
6697179|NCT02785770|7627310|FG002|STARTED|Intervention Period 4 (1 Day)||10
6697180|NCT02785770|7627311|FG003|STARTED|Intervention Period 4 (1 Day)||10
6697181|NCT02785770|7627308|FG000|COMPLETED|Intervention Period 4 (1 Day)||11
6697182|NCT02785770|7627309|FG001|COMPLETED|Intervention Period 4 (1 Day)||10
6697183|NCT02785770|7627310|FG002|COMPLETED|Intervention Period 4 (1 Day)||10
6697184|NCT02785770|7627311|FG003|COMPLETED|Intervention Period 4 (1 Day)||10
6697185|NCT02785770|7627308|FG000|NOT COMPLETED|Intervention Period 4 (1 Day)||0
6697186|NCT02785770|7627309|FG001|NOT COMPLETED|Intervention Period 4 (1 Day)||0
6697187|NCT02785770|7627310|FG002|NOT COMPLETED|Intervention Period 4 (1 Day)||0
6697188|NCT02785770|7627311|FG003|NOT COMPLETED|Intervention Period 4 (1 Day)||0
6697189|NCT02785900|7627326|FG000|STARTED|Overall Study||117
6697190|NCT02785900|7627327|FG001|STARTED|Overall Study||123
6697191|NCT02785900|7627326|FG000|COMPLETED|Overall Study||0
6697192|NCT02785900|7627327|FG001|COMPLETED|Overall Study||0
6697193|NCT02785900|7627326|FG000|NOT COMPLETED|Overall Study||117
6697194|NCT02785900|7627327|FG001|NOT COMPLETED|Overall Study||123
6697195|NCT02785913|7627333|FG000|STARTED|Overall Study||26
6697196|NCT02785913|7627333|FG000|COMPLETED|Overall Study||0
6697197|NCT02785913|7627333|FG000|NOT COMPLETED|Overall Study||26
6697198|NCT02785939|7627340|FG000|STARTED|Overall Study||31
6697199|NCT02785939|7627341|FG001|STARTED|Overall Study||10
6697200|NCT02785939|7627340|FG000|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||0
6697201|NCT02785939|7627341|FG001|Participants Re-registered to Palbociclib After Progression on Docetaxel|Overall Study||1
6697202|NCT02785939|7627340|FG000|COMPLETED|Overall Study||0
6697203|NCT02785939|7627341|FG001|COMPLETED|Overall Study||0
6697204|NCT02785939|7627340|FG000|NOT COMPLETED|Overall Study||31
6697205|NCT02785939|7627341|FG001|NOT COMPLETED|Overall Study||10
6697206|NCT02786004|7627349|FG000|STARTED|Overall Study||14
6697207|NCT02786004|7627350|FG001|STARTED|Overall Study||10
6697208|NCT02786004|7627349|FG000|COMPLETED|Overall Study||14
6697209|NCT02786004|7627350|FG001|COMPLETED|Overall Study||9
6697210|NCT02786004|7627349|FG000|NOT COMPLETED|Overall Study||0
6697211|NCT02786004|7627350|FG001|NOT COMPLETED|Overall Study||1
6697212|NCT02786134|7627360|FG000|STARTED|Overall Study||25
6697213|NCT02786134|7627361|FG001|STARTED|Overall Study||25
6697214|NCT02786134|7627360|FG000|COMPLETED|Overall Study||25
6697215|NCT02786134|7627361|FG001|COMPLETED|Overall Study||25
6697216|NCT02786134|7627360|FG000|NOT COMPLETED|Overall Study||0
6697217|NCT02786134|7627361|FG001|NOT COMPLETED|Overall Study||0
6697218|NCT02786355|7627367|FG000|STARTED|Overall Study||35
6697219|NCT02786355|7627367|FG000|COMPLETED|Overall Study||35
6697220|NCT02786355|7627367|FG000|NOT COMPLETED|Overall Study||0
6697221|NCT02786719|7627374|FG000|STARTED|Overall Study||13
6697222|NCT02786719|7627374|FG000|COMPLETED|Overall Study||12
6697223|NCT02786719|7627374|FG000|NOT COMPLETED|Overall Study||1
6697224|NCT02786771|7627380|FG000|STARTED|Overall Study||63
6697225|NCT02786771|7627381|FG001|STARTED|Overall Study||62
6697226|NCT02786771|7627380|FG000|COMPLETED|Overall Study||53
6697227|NCT02786771|7627381|FG001|COMPLETED|Overall Study||56
6697228|NCT02786771|7627380|FG000|NOT COMPLETED|Overall Study||10
6697229|NCT02786771|7627381|FG001|NOT COMPLETED|Overall Study||6
6697230|NCT02786810|7627387|FG000|STARTED|Overall Study||10
6697231|NCT02786810|7627387|FG000|COMPLETED|Overall Study||10
6697232|NCT02786810|7627387|FG000|NOT COMPLETED|Overall Study||0
6697233|NCT02786836|7627391|FG000|STARTED|Overall Study||76
6697234|NCT02786836|7627391|FG000|Eligible Patients Enrolled Into the Stud|Overall Study||76
6697235|NCT02786836|7627391|FG000|COMPLETED|Overall Study||62
6697236|NCT02786836|7627391|FG000|NOT COMPLETED|Overall Study||14
6697237|NCT02786901|7627399|FG000|STARTED|Overall Study||199
6697238|NCT02786901|7627400|FG001|STARTED|Overall Study||201
6697239|NCT02786901|7627401|FG002|STARTED|Overall Study||200
6697240|NCT02786901|7627399|FG000|COMPLETED|Overall Study||122
6697241|NCT02786901|7627400|FG001|COMPLETED|Overall Study||145
6697242|NCT02786901|7627401|FG002|COMPLETED|Overall Study||159
6697243|NCT02786901|7627399|FG000|NOT COMPLETED|Overall Study||77
6697244|NCT02786901|7627400|FG001|NOT COMPLETED|Overall Study||56
6697245|NCT02786901|7627401|FG002|NOT COMPLETED|Overall Study||41
6697246|NCT02786927|7627409|FG000|STARTED|Overall Study||212
6697247|NCT02786927|7627409|FG000|COMPLETED|Overall Study||207
6697248|NCT02786927|7627409|FG000|NOT COMPLETED|Overall Study||5
6697249|NCT02786953|7627416|FG000|STARTED|Overall Study||20
6697250|NCT02786953|7627417|FG001|STARTED|Overall Study||19
6697251|NCT02786953|7627416|FG000|Baseline Teen Survey Data Completed|Overall Study||20
6697252|NCT02786953|7627417|FG001|Baseline Teen Survey Data Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
6697253|NCT02786953|7627416|FG000|Baseline Parent Survey Completed|Overall Study||20
6697254|NCT02786953|7627417|FG001|Baseline Parent Survey Completed|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
6697255|NCT02786953|7627416|FG000|Actigraph Data Complete|Overall Study||14
6697256|NCT02786953|7627417|FG001|Actigraph Data Complete|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|17
6697257|NCT02786953|7627416|FG000|A1C Data Baseline|Overall Study||20
6697258|NCT02786953|7627417|FG001|A1C Data Baseline|Overall Study|One participant withdrawn and data excluded due to becoming ineligible due to a new diagnosis|18
6697259|NCT02786953|7627416|FG000|Session 1 Completed|Overall Study||17
6697260|NCT02786953|7627417|FG001|Session 1 Completed|Overall Study||0
6697261|NCT02786953|7627416|FG000|Session 2 Completed|Overall Study||16
6697262|NCT02786953|7627417|FG001|Session 2 Completed|Overall Study||0
6697263|NCT02786953|7627416|FG000|Session 3 Completed|Overall Study||16
6697264|NCT02786953|7627417|FG001|Session 3 Completed|Overall Study||0
6697265|NCT02786953|7627416|FG000|3 Month Teen Survey Completed|Overall Study||17
6697266|NCT02786953|7627417|FG001|3 Month Teen Survey Completed|Overall Study||18
6697267|NCT02786953|7627416|FG000|3 Month Parent Survey Completed|Overall Study||17
6697268|NCT02786953|7627417|FG001|3 Month Parent Survey Completed|Overall Study||18
6697269|NCT02786953|7627416|FG000|A1C 3 Month|Overall Study||15
6697270|NCT02786953|7627417|FG001|A1C 3 Month|Overall Study||17
6259544|NCT02384239|7158637|FG000|COMPLETED|Overall Study||36
6259545|NCT02384239|7158638|FG001|COMPLETED|Overall Study||34
6259546|NCT02384239|7158637|FG000|NOT COMPLETED|Overall Study||0
6259547|NCT02384239|7158638|FG001|NOT COMPLETED|Overall Study||0
6259548|NCT02356705|7158648|FG000|STARTED|Overall Study||14
6259549|NCT02356705|7158649|FG001|STARTED|Overall Study||14
6259550|NCT02356705|7158650|FG002|STARTED|Overall Study||14
6259551|NCT02356705|7158648|FG000|COMPLETED|Overall Study||14
6259552|NCT02356705|7158649|FG001|COMPLETED|Overall Study||14
6259553|NCT02356705|7158650|FG002|COMPLETED|Overall Study||14
6259554|NCT02356705|7158648|FG000|NOT COMPLETED|Overall Study||0
6259555|NCT02356705|7158649|FG001|NOT COMPLETED|Overall Study||0
6259556|NCT02356705|7158650|FG002|NOT COMPLETED|Overall Study||0
6259557|NCT02353247|7158663|FG000|STARTED|Overall Study||30
6259558|NCT02353247|7158664|FG001|STARTED|Overall Study||23
6259559|NCT02353247|7158665|FG002|STARTED|Overall Study||35
6259560|NCT02353247|7158663|FG000|COMPLETED|Overall Study||21
6259561|NCT02353247|7158664|FG001|COMPLETED|Overall Study||18
6259562|NCT02353247|7158665|FG002|COMPLETED|Overall Study||0
6259563|NCT02353247|7158663|FG000|NOT COMPLETED|Overall Study||9
6259564|NCT02353247|7158664|FG001|NOT COMPLETED|Overall Study||5
6259565|NCT02353247|7158665|FG002|NOT COMPLETED|Overall Study||35
6259566|NCT02316002|7158679|FG000|STARTED|Overall Study||51
6259567|NCT02316002|7158679|FG000|COMPLETED|Overall Study||45
6259568|NCT02316002|7158679|FG000|NOT COMPLETED|Overall Study||6
6259569|NCT02315703|7158691|FG000|STARTED|Overall Study||50
6259570|NCT02315703|7158692|FG001|STARTED|Overall Study||49
6259571|NCT02315703|7158693|FG002|STARTED|Overall Study||49
6259572|NCT02315703|7158694|FG003|STARTED|Overall Study||48
6259573|NCT02315703|7158695|FG004|STARTED|Overall Study||49
6259574|NCT02315703|7158696|FG005|STARTED|Overall Study||49
6259575|NCT02315703|7158697|FG006|STARTED|Overall Study||50
6259576|NCT02315703|7158698|FG007|STARTED|Overall Study||49
6259577|NCT02315703|7158691|FG000|COMPLETED|Overall Study||44
6259578|NCT02315703|7158692|FG001|COMPLETED|Overall Study||39
6259579|NCT02315703|7158693|FG002|COMPLETED|Overall Study||44
6259580|NCT02315703|7158694|FG003|COMPLETED|Overall Study||39
6259581|NCT02315703|7158695|FG004|COMPLETED|Overall Study||41
6697271|NCT02786953|7627416|FG000|COMPLETED|Overall Study||17
6697272|NCT02786953|7627417|FG001|COMPLETED|Overall Study||18
6697273|NCT02786953|7627416|FG000|NOT COMPLETED|Overall Study||3
6697274|NCT02786953|7627417|FG001|NOT COMPLETED|Overall Study||1
6697275|NCT02787057|7627425|FG000|STARTED|Overall Study||40
6697276|NCT02787057|7627426|FG001|STARTED|Overall Study||40
6697277|NCT02787057|7627425|FG000|COMPLETED|Overall Study||40
6697278|NCT02787057|7627426|FG001|COMPLETED|Overall Study||40
6697279|NCT02787057|7627425|FG000|NOT COMPLETED|Overall Study||0
6697280|NCT02787057|7627426|FG001|NOT COMPLETED|Overall Study||0
6697281|NCT02787083|7627434|FG000|STARTED|Overall Study||4
6697282|NCT02787083|7627435|FG001|STARTED|Overall Study||5
6697283|NCT02787083|7627434|FG000|COMPLETED|Overall Study||1
6697284|NCT02787083|7627435|FG001|COMPLETED|Overall Study||3
6697285|NCT02787083|7627434|FG000|NOT COMPLETED|Overall Study||3
6697286|NCT02787083|7627435|FG001|NOT COMPLETED|Overall Study||2
6697287|NCT02787291|7627441|FG000|STARTED|Overall Study||227
6697288|NCT02787291|7627441|FG000|COMPLETED|Overall Study||227
6697289|NCT02787291|7627441|FG000|NOT COMPLETED|Overall Study||0
6697290|NCT02787304|7627449|FG000|STARTED|Overall Study||49
6697291|NCT02787304|7627450|FG001|STARTED|Overall Study|One subject was randomized and received 1 dose of study drug but withdrew from the study.|50
6697292|NCT02787304|7627451|FG002|STARTED|Overall Study||49
6697293|NCT02787304|7627452|FG003|STARTED|Overall Study||49
6697294|NCT02787304|7627449|FG000|COMPLETED|Overall Study||13
6697295|NCT02787304|7627450|FG001|COMPLETED|Overall Study||12
6697296|NCT02787304|7627451|FG002|COMPLETED|Overall Study||8
6697297|NCT02787304|7627452|FG003|COMPLETED|Overall Study||15
6697298|NCT02787304|7627449|FG000|NOT COMPLETED|Overall Study||36
6697299|NCT02787304|7627450|FG001|NOT COMPLETED|Overall Study||38
6697300|NCT02787304|7627451|FG002|NOT COMPLETED|Overall Study||41
6697301|NCT02787304|7627452|FG003|NOT COMPLETED|Overall Study||34
6697302|NCT02787564|7627464|FG000|STARTED|Overall Study||32
6259582|NCT02315703|7158696|FG005|COMPLETED|Overall Study||43
6259583|NCT02315703|7158697|FG006|COMPLETED|Overall Study||37
6259584|NCT02315703|7158698|FG007|COMPLETED|Overall Study||42
6259585|NCT02315703|7158691|FG000|NOT COMPLETED|Overall Study||6
6259586|NCT02315703|7158692|FG001|NOT COMPLETED|Overall Study||10
6259587|NCT02315703|7158693|FG002|NOT COMPLETED|Overall Study||5
6259588|NCT02315703|7158694|FG003|NOT COMPLETED|Overall Study||9
6259589|NCT02315703|7158695|FG004|NOT COMPLETED|Overall Study||8
6259590|NCT02315703|7158696|FG005|NOT COMPLETED|Overall Study||6
6259591|NCT02315703|7158697|FG006|NOT COMPLETED|Overall Study||13
6259592|NCT02315703|7158698|FG007|NOT COMPLETED|Overall Study||7
6280201|NCT00152009|7180091|FG002|NOT COMPLETED|Overall Study||37
6280202|NCT00152009|7180092|FG003|NOT COMPLETED|Overall Study||33
6280203|NCT00152464|7180104|FG000|STARTED|Overall Study||255
6280204|NCT00152464|7180105|FG001|STARTED|Overall Study||255
6280205|NCT00152464|7180104|FG000|COMPLETED|Overall Study||215
6280206|NCT00152464|7180105|FG001|COMPLETED|Overall Study||219
6280207|NCT00152464|7180104|FG000|NOT COMPLETED|Overall Study||40
6280208|NCT00152464|7180105|FG001|NOT COMPLETED|Overall Study||36
6280209|NCT00152516|7180111|FG000|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
6280210|NCT00152516|7180111|FG000|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
6280211|NCT00152516|7180111|FG000|NOT COMPLETED|Overall Study||75
6280212|NCT00152763|7180119|FG000|STARTED|Overall Study||77
6280213|NCT00152763|7180120|FG001|STARTED|Overall Study||19
6280214|NCT00152763|7180121|FG002|STARTED|Overall Study||20
6280215|NCT00152763|7180122|FG003|STARTED|Overall Study||77
6280216|NCT00152763|7180119|FG000|COMPLETED|Overall Study||67
6280217|NCT00152763|7180120|FG001|COMPLETED|Overall Study||14
6280218|NCT00152763|7180121|FG002|COMPLETED|Overall Study||16
6280219|NCT00152763|7180122|FG003|COMPLETED|Overall Study||63
6280220|NCT00152763|7180119|FG000|NOT COMPLETED|Overall Study||10
6280221|NCT00152763|7180120|FG001|NOT COMPLETED|Overall Study||5
6280222|NCT00152763|7180121|FG002|NOT COMPLETED|Overall Study||4
6280223|NCT00152763|7180122|FG003|NOT COMPLETED|Overall Study||14
6280224|NCT00152971|7180137|FG000|STARTED|Overall Study||857
6280225|NCT00152971|7180138|FG001|STARTED|Overall Study||871
6280226|NCT00152971|7180139|FG002|STARTED|Overall Study||868
6280227|NCT00152971|7180137|FG000|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
6280228|NCT00152971|7180138|FG001|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
6280229|NCT00152971|7180139|FG002|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
6280230|NCT00152971|7180137|FG000|NOT COMPLETED|Overall Study||51
6697303|NCT02787564|7627465|FG001|STARTED|Overall Study||29
6697304|NCT02787564|7627464|FG000|COMPLETED|Overall Study|n=12 food bank users; n=13 non-food bank users|25
6697305|NCT02787564|7627465|FG001|COMPLETED|Overall Study|n=12 food bank users; n=15 non-food bank users|27
6280231|NCT00152971|7180138|FG001|NOT COMPLETED|Overall Study||48
6280232|NCT00152971|7180139|FG002|NOT COMPLETED|Overall Study||49
6280233|NCT00152971|7180137|FG000|STARTED|Treatment||857
6280234|NCT00152971|7180138|FG001|STARTED|Treatment||871
6280235|NCT00152971|7180139|FG002|STARTED|Treatment||868
6280236|NCT00152971|7180137|FG000|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
6697306|NCT02787564|7627464|FG000|NOT COMPLETED|Overall Study||7
6697307|NCT02787564|7627465|FG001|NOT COMPLETED|Overall Study||2
6738853|NCT03286218|7668003|FG007|NOT COMPLETED|Qualification Phase Period 2||0
6697308|NCT02787655|7627473|FG000|STARTED|Overall Study||40
6697309|NCT02787655|7627474|FG001|STARTED|Overall Study||38
6697310|NCT02787655|7627473|FG000|COMPLETED|Overall Study||29
6697311|NCT02787655|7627474|FG001|COMPLETED|Overall Study||26
6697312|NCT02787655|7627473|FG000|NOT COMPLETED|Overall Study||11
6697313|NCT02787655|7627474|FG001|NOT COMPLETED|Overall Study||12
6697314|NCT02787681|7627480|FG000|STARTED|Overall Study||71
6697315|NCT02787681|7627480|FG000|COMPLETED|Overall Study||69
6697316|NCT02787681|7627480|FG000|NOT COMPLETED|Overall Study||2
6697317|NCT02787694|7627484|FG000|STARTED|Overall Study||22
6697318|NCT02787694|7627484|FG000|COMPLETED|Overall Study||17
6697319|NCT02787694|7627484|FG000|NOT COMPLETED|Overall Study||5
6697320|NCT02787863|7627496|FG000|STARTED|Overall Study||33
6697321|NCT02787863|7627497|FG001|STARTED|Overall Study||34
6697322|NCT02787863|7627498|FG002|STARTED|Overall Study||25
6697323|NCT02787863|7627499|FG003|STARTED|Overall Study||25
6697324|NCT02787863|7627500|FG004|STARTED|Overall Study||32
6697325|NCT02787863|7627501|FG005|STARTED|Overall Study||18
6697326|NCT02787863|7627502|FG006|STARTED|Overall Study||25
6697327|NCT02787863|7627503|FG007|STARTED|Overall Study||27
6697328|NCT02787863|7627496|FG000|1 Year After Vaccination|Overall Study||32
6697329|NCT02787863|7627497|FG001|1 Year After Vaccination|Overall Study||33
6697330|NCT02787863|7627498|FG002|1 Year After Vaccination|Overall Study||23
6697331|NCT02787863|7627499|FG003|1 Year After Vaccination|Overall Study||25
6697332|NCT02787863|7627500|FG004|1 Year After Vaccination|Overall Study||32
6697333|NCT02787863|7627501|FG005|1 Year After Vaccination|Overall Study||18
6697334|NCT02787863|7627502|FG006|1 Year After Vaccination|Overall Study||25
6697335|NCT02787863|7627503|FG007|1 Year After Vaccination|Overall Study||27
6697336|NCT02787863|7627496|FG000|4 Years After Vaccination|Overall Study||32
6697337|NCT02787863|7627497|FG001|4 Years After Vaccination|Overall Study||33
6697338|NCT02787863|7627498|FG002|4 Years After Vaccination|Overall Study||23
6697339|NCT02787863|7627499|FG003|4 Years After Vaccination|Overall Study||25
6697340|NCT02787863|7627500|FG004|4 Years After Vaccination|Overall Study||32
6697341|NCT02787863|7627501|FG005|4 Years After Vaccination|Overall Study||18
6697342|NCT02787863|7627502|FG006|4 Years After Vaccination|Overall Study||25
6697343|NCT02787863|7627503|FG007|4 Years After Vaccination|Overall Study||27
6697344|NCT02787863|7627496|FG000|COMPLETED|Overall Study||32
6697345|NCT02787863|7627497|FG001|COMPLETED|Overall Study||33
6697346|NCT02787863|7627498|FG002|COMPLETED|Overall Study||23
6697347|NCT02787863|7627499|FG003|COMPLETED|Overall Study||25
6697348|NCT02787863|7627500|FG004|COMPLETED|Overall Study||32
6697349|NCT02787863|7627501|FG005|COMPLETED|Overall Study||18
6697350|NCT02787863|7627502|FG006|COMPLETED|Overall Study||25
6697351|NCT02787863|7627503|FG007|COMPLETED|Overall Study||27
6697352|NCT02787863|7627496|FG000|NOT COMPLETED|Overall Study||1
6697353|NCT02787863|7627497|FG001|NOT COMPLETED|Overall Study||1
6697354|NCT02787863|7627498|FG002|NOT COMPLETED|Overall Study||2
6697355|NCT02787863|7627499|FG003|NOT COMPLETED|Overall Study||0
6697356|NCT02787863|7627500|FG004|NOT COMPLETED|Overall Study||0
6697357|NCT02787863|7627501|FG005|NOT COMPLETED|Overall Study||0
6697358|NCT02787863|7627502|FG006|NOT COMPLETED|Overall Study||0
6697359|NCT02787863|7627503|FG007|NOT COMPLETED|Overall Study||0
6697360|NCT02788019|7627546|FG000|STARTED|Overall Study||27
6697361|NCT02788019|7627547|FG001|STARTED|Overall Study||25
6697362|NCT02788019|7627546|FG000|COMPLETED|Overall Study||23
6697363|NCT02788019|7627547|FG001|COMPLETED|Overall Study||20
6697364|NCT02788019|7627546|FG000|NOT COMPLETED|Overall Study||4
6697365|NCT02788019|7627547|FG001|NOT COMPLETED|Overall Study||5
6697366|NCT02788097|7627555|FG000|STARTED|Overall Study||61
6697367|NCT02788097|7627556|FG001|STARTED|Overall Study||69
6697368|NCT02788097|7627555|FG000|COMPLETED|Overall Study||61
6697369|NCT02788097|7627556|FG001|COMPLETED|Overall Study||69
6697370|NCT02788097|7627555|FG000|NOT COMPLETED|Overall Study||0
6697371|NCT02788097|7627556|FG001|NOT COMPLETED|Overall Study||0
6697372|NCT02788175|7627562|FG000|STARTED|Overall Study||26
6697373|NCT02788175|7627562|FG000|Received Study Agent|Overall Study||20
6697374|NCT02788175|7627562|FG000|COMPLETED|Overall Study||13
6697375|NCT02788175|7627562|FG000|NOT COMPLETED|Overall Study||13
6697376|NCT02788188|7627573|FG000|STARTED|Overall Study||2
6697377|NCT02788188|7627574|FG001|STARTED|Overall Study||2
6697378|NCT02788188|7627575|FG002|STARTED|Overall Study||4
6697379|NCT02788188|7627576|FG003|STARTED|Overall Study||4
6697380|NCT02788188|7627577|FG004|STARTED|Overall Study||8
6697381|NCT02788188|7627578|FG005|STARTED|Overall Study||8
6697382|NCT02788188|7627579|FG006|STARTED|Overall Study||10
6697383|NCT02788188|7627573|FG000|COMPLETED|Overall Study||2
6697384|NCT02788188|7627574|FG001|COMPLETED|Overall Study||2
6697385|NCT02788188|7627575|FG002|COMPLETED|Overall Study||4
6697386|NCT02788188|7627576|FG003|COMPLETED|Overall Study||4
6697387|NCT02788188|7627577|FG004|COMPLETED|Overall Study||8
6697388|NCT02788188|7627578|FG005|COMPLETED|Overall Study||8
6697389|NCT02788188|7627579|FG006|COMPLETED|Overall Study||10
6697390|NCT02788188|7627573|FG000|NOT COMPLETED|Overall Study||0
6697391|NCT02788188|7627574|FG001|NOT COMPLETED|Overall Study||0
6697392|NCT02788188|7627575|FG002|NOT COMPLETED|Overall Study||0
6697393|NCT02788188|7627576|FG003|NOT COMPLETED|Overall Study||0
6697394|NCT02788188|7627577|FG004|NOT COMPLETED|Overall Study||0
6697395|NCT02788188|7627578|FG005|NOT COMPLETED|Overall Study||0
6697396|NCT02788188|7627579|FG006|NOT COMPLETED|Overall Study||0
6697397|NCT02788201|7627601|FG000|STARTED|Overall Study||1
6697398|NCT02788201|7627602|FG001|STARTED|Overall Study||1
6697399|NCT02788201|7627603|FG002|STARTED|Overall Study||1
6697400|NCT02788201|7627604|FG003|STARTED|Overall Study||1
6697401|NCT02788201|7627605|FG004|STARTED|Overall Study||1
6697402|NCT02788201|7627606|FG005|STARTED|Overall Study||3
6697403|NCT02788201|7627601|FG000|Did Not Start Treatment|Overall Study||0
6697404|NCT02788201|7627602|FG001|Did Not Start Treatment|Overall Study||0
6697405|NCT02788201|7627603|FG002|Did Not Start Treatment|Overall Study||0
6697406|NCT02788201|7627604|FG003|Did Not Start Treatment|Overall Study||0
6697407|NCT02788201|7627605|FG004|Did Not Start Treatment|Overall Study||0
6697408|NCT02788201|7627606|FG005|Did Not Start Treatment|Overall Study||3
6697409|NCT02788201|7627601|FG000|COMPLETED|Overall Study||0
6697410|NCT02788201|7627602|FG001|COMPLETED|Overall Study||0
6697411|NCT02788201|7627603|FG002|COMPLETED|Overall Study||0
6697412|NCT02788201|7627604|FG003|COMPLETED|Overall Study||0
6697413|NCT02788201|7627605|FG004|COMPLETED|Overall Study||1
6697414|NCT02788201|7627606|FG005|COMPLETED|Overall Study||0
6697415|NCT02788201|7627601|FG000|NOT COMPLETED|Overall Study||1
6697416|NCT02788201|7627602|FG001|NOT COMPLETED|Overall Study||1
6697417|NCT02788201|7627603|FG002|NOT COMPLETED|Overall Study||1
6697418|NCT02788201|7627604|FG003|NOT COMPLETED|Overall Study||1
6697419|NCT02788201|7627605|FG004|NOT COMPLETED|Overall Study||0
6697420|NCT02788201|7627606|FG005|NOT COMPLETED|Overall Study||3
6697421|NCT02788279|7627625|FG000|STARTED|Overall Study||90
6697422|NCT02788279|7627626|FG001|STARTED|Overall Study||183
6697423|NCT02788279|7627627|FG002|STARTED|Overall Study||90
6697424|NCT02788279|7627625|FG000|Received Treatment (Safety Population)|Overall Study||80
6697425|NCT02788279|7627626|FG001|Received Treatment (Safety Population)|Overall Study||179
6697426|NCT02788279|7627627|FG002|Received Treatment (Safety Population)|Overall Study||90
6697427|NCT02788279|7627625|FG000|Modified ITT Population|Overall Study||57
6697428|NCT02788279|7627626|FG001|Modified ITT Population|Overall Study||125
6697429|NCT02788279|7627627|FG002|Modified ITT Population|Overall Study||61
6697430|NCT02788279|7627625|FG000|COMPLETED|Overall Study||0
6697431|NCT02788279|7627626|FG001|COMPLETED|Overall Study||0
6697432|NCT02788279|7627627|FG002|COMPLETED|Overall Study||0
6697433|NCT02788279|7627625|FG000|NOT COMPLETED|Overall Study||90
6697434|NCT02788279|7627626|FG001|NOT COMPLETED|Overall Study||183
6697435|NCT02788279|7627627|FG002|NOT COMPLETED|Overall Study||90
6697436|NCT02788357|7627640|FG000|STARTED|Overall Study||6
6697437|NCT02788357|7627641|FG001|STARTED|Overall Study||6
6697438|NCT02788357|7627640|FG000|COMPLETED|Overall Study||3
6697439|NCT02788357|7627641|FG001|COMPLETED|Overall Study||6
6697440|NCT02788357|7627640|FG000|NOT COMPLETED|Overall Study||3
6697441|NCT02788357|7627641|FG001|NOT COMPLETED|Overall Study||0
6697442|NCT02788474|7627649|FG000|STARTED|Double Blind Treatment Period||231
6697443|NCT02788474|7627650|FG001|STARTED|Double Blind Treatment Period||116
6697444|NCT02788474|7627649|FG000|Treated|Double Blind Treatment Period||230
6697445|NCT02788474|7627650|FG001|Treated|Double Blind Treatment Period||116
6697446|NCT02788474|7627649|FG000|COMPLETED|Double Blind Treatment Period||221
6697447|NCT02788474|7627650|FG001|COMPLETED|Double Blind Treatment Period||112
6697448|NCT02788474|7627649|FG000|NOT COMPLETED|Double Blind Treatment Period||10
6697449|NCT02788474|7627650|FG001|NOT COMPLETED|Double Blind Treatment Period||4
6697450|NCT02788474|7627649|FG000|STARTED|Open Label Treatment Period||221
6697451|NCT02788474|7627650|FG001|STARTED|Open Label Treatment Period||112
6697452|NCT02788474|7627649|FG000|COMPLETED|Open Label Treatment Period||189
6697453|NCT02788474|7627650|FG001|COMPLETED|Open Label Treatment Period||100
6697454|NCT02788474|7627649|FG000|NOT COMPLETED|Open Label Treatment Period||32
6697455|NCT02788474|7627650|FG001|NOT COMPLETED|Open Label Treatment Period||12
6697456|NCT02788513|7627662|FG000|STARTED|Overall Study||123
6697457|NCT02788513|7627663|FG001|STARTED|Overall Study||122
6697458|NCT02788513|7627664|FG002|STARTED|Overall Study||122
6697459|NCT02788513|7627665|FG003|STARTED|Overall Study||123
6697460|NCT02788513|7627666|FG004|STARTED|Overall Study||120
6697461|NCT02788513|7627662|FG000|COMPLETED|Overall Study||114
6697462|NCT02788513|7627663|FG001|COMPLETED|Overall Study||114
6697463|NCT02788513|7627664|FG002|COMPLETED|Overall Study||114
6697464|NCT02788513|7627665|FG003|COMPLETED|Overall Study||117
6697465|NCT02788513|7627666|FG004|COMPLETED|Overall Study||115
6697466|NCT02788513|7627662|FG000|NOT COMPLETED|Overall Study||9
6697467|NCT02788513|7627663|FG001|NOT COMPLETED|Overall Study||8
6697468|NCT02788513|7627664|FG002|NOT COMPLETED|Overall Study||8
6697469|NCT02788513|7627665|FG003|NOT COMPLETED|Overall Study||6
6697470|NCT02788513|7627666|FG004|NOT COMPLETED|Overall Study||5
6697471|NCT02788656|7627680|FG000|STARTED|Overall Study||2
6697472|NCT02788656|7627681|FG001|STARTED|Overall Study||2
6697473|NCT02788656|7627680|FG000|COMPLETED|Overall Study||1
6697474|NCT02788656|7627681|FG001|COMPLETED|Overall Study||2
6697475|NCT02788656|7627680|FG000|NOT COMPLETED|Overall Study||1
6697476|NCT02788656|7627681|FG001|NOT COMPLETED|Overall Study||0
6697477|NCT02788747|7627690|FG000|STARTED|Overall Study||23
6697478|NCT02788747|7627691|FG001|STARTED|Overall Study||24
6697479|NCT02788747|7627692|FG002|STARTED|Overall Study||24
6697480|NCT02788747|7627690|FG000|COMPLETED|Overall Study||22
6697481|NCT02788747|7627691|FG001|COMPLETED|Overall Study||24
6697482|NCT02788747|7627692|FG002|COMPLETED|Overall Study||24
6697483|NCT02788747|7627690|FG000|NOT COMPLETED|Overall Study||1
6697484|NCT02788747|7627691|FG001|NOT COMPLETED|Overall Study||0
6697485|NCT02788747|7627692|FG002|NOT COMPLETED|Overall Study||0
6697486|NCT02788903|7627705|FG000|STARTED|Overall Study||567908
6697487|NCT02788903|7627706|FG001|STARTED|Overall Study||2054256
6697488|NCT02788903|7627705|FG000|COMPLETED|Overall Study||567908
6697489|NCT02788903|7627706|FG001|COMPLETED|Overall Study||2054256
6697490|NCT02788903|7627705|FG000|NOT COMPLETED|Overall Study||0
6697491|NCT02788903|7627706|FG001|NOT COMPLETED|Overall Study||0
6697492|NCT02789033|7627718|FG000|STARTED|Overall Study||17
6697493|NCT02789033|7627719|FG001|STARTED|Overall Study||17
6697494|NCT02789033|7627720|FG002|STARTED|Overall Study||17
6697495|NCT02789033|7627721|FG003|STARTED|Overall Study||17
6697496|NCT02789033|7627718|FG000|COMPLETED|Overall Study||15
6697497|NCT02789033|7627719|FG001|COMPLETED|Overall Study||15
6697498|NCT02789033|7627720|FG002|COMPLETED|Overall Study||16
6697499|NCT02789033|7627721|FG003|COMPLETED|Overall Study||15
6697500|NCT02789033|7627718|FG000|NOT COMPLETED|Overall Study||2
6697501|NCT02789033|7627719|FG001|NOT COMPLETED|Overall Study||2
6697502|NCT02789033|7627720|FG002|NOT COMPLETED|Overall Study||1
6697503|NCT02789033|7627721|FG003|NOT COMPLETED|Overall Study||2
6697504|NCT02789111|7627733|FG000|STARTED|Overall Study||24
6697505|NCT02789111|7627734|FG001|STARTED|Overall Study||25
6697506|NCT02789111|7627733|FG000|COMPLETED|Overall Study||23
6697507|NCT02789111|7627734|FG001|COMPLETED|Overall Study||21
6697508|NCT02789111|7627733|FG000|NOT COMPLETED|Overall Study||1
6697509|NCT02789111|7627734|FG001|NOT COMPLETED|Overall Study||4
6697510|NCT02789137|7627742|FG000|STARTED|Overall Study||111
6697511|NCT02789137|7627742|FG000|COMPLETED|Overall Study||53
6697512|NCT02789137|7627742|FG000|NOT COMPLETED|Overall Study||58
6697513|NCT02789176|7627751|FG000|STARTED|Overall Study||99
6697514|NCT02789176|7627752|FG001|STARTED|Overall Study||55
6697515|NCT02789176|7627753|FG002|STARTED|Overall Study||95
6697516|NCT02789176|7627754|FG003|STARTED|Overall Study||54
6697517|NCT02789176|7627751|FG000|COMPLETED|Overall Study||91
6697518|NCT02789176|7627752|FG001|COMPLETED|Overall Study||53
6697519|NCT02789176|7627753|FG002|COMPLETED|Overall Study||85
6697520|NCT02789176|7627754|FG003|COMPLETED|Overall Study||53
6697521|NCT02789176|7627751|FG000|NOT COMPLETED|Overall Study||8
6697522|NCT02789176|7627752|FG001|NOT COMPLETED|Overall Study||2
6697523|NCT02789176|7627753|FG002|NOT COMPLETED|Overall Study||10
6697524|NCT02789176|7627754|FG003|NOT COMPLETED|Overall Study||1
6697525|NCT02789410|7627766|FG000|STARTED|Overall Study||66
6697526|NCT02789410|7627767|FG001|STARTED|Overall Study||68
6697527|NCT02789410|7627766|FG000|COMPLETED|Overall Study||66
6697528|NCT02789410|7627767|FG001|COMPLETED|Overall Study||68
6697529|NCT02789410|7627766|FG000|NOT COMPLETED|Overall Study||0
6697530|NCT02789410|7627767|FG001|NOT COMPLETED|Overall Study||0
6697531|NCT02790073|7627773|FG000|STARTED|Overall Study||14
6697532|NCT02790073|7627773|FG000|COMPLETED|Overall Study||11
6259593|NCT02021071|7158718|FG000|STARTED|Overall Study||12
6259594|NCT02021071|7158719|FG001|STARTED|Overall Study||12
6259595|NCT02021071|7158718|FG000|COMPLETED|Overall Study||12
6259596|NCT02021071|7158719|FG001|COMPLETED|Overall Study||12
6259597|NCT02021071|7158718|FG000|NOT COMPLETED|Overall Study||0
6259598|NCT02021071|7158719|FG001|NOT COMPLETED|Overall Study||0
6259599|NCT02000622|7158728|FG000|STARTED|Overall Study||205
6259600|NCT02000622|7158729|FG001|STARTED|Overall Study||97
6259601|NCT02000622|7158728|FG000|COMPLETED|Overall Study||36
6259602|NCT02000622|7158729|FG001|COMPLETED|Overall Study||17
6259603|NCT02000622|7158728|FG000|NOT COMPLETED|Overall Study||169
6259604|NCT02000622|7158729|FG001|NOT COMPLETED|Overall Study||80
6259605|NCT01933932|7158737|FG000|STARTED|Overall Study||254
6259606|NCT01933932|7158738|FG001|STARTED|Overall Study||256
6259607|NCT01933932|7158737|FG000|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
6259608|NCT01933932|7158738|FG001|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
6259609|NCT01933932|7158737|FG000|NOT COMPLETED|Overall Study||184
6259610|NCT01933932|7158738|FG001|NOT COMPLETED|Overall Study||178
6259611|NCT01927068|7158746|FG000|STARTED|Overall Study||370
6259612|NCT01927068|7158747|FG001|STARTED|Overall Study||129
6259613|NCT01927068|7158746|FG000|COMPLETED|Overall Study||262
6259614|NCT01927068|7158747|FG001|COMPLETED|Overall Study||121
6259615|NCT01927068|7158746|FG000|NOT COMPLETED|Overall Study||108
6259616|NCT01927068|7158747|FG001|NOT COMPLETED|Overall Study||8
6259617|NCT01883817|7158756|FG000|STARTED|Overall Study||14
6259618|NCT01883817|7158757|FG001|STARTED|Overall Study||16
6259619|NCT01883817|7158756|FG000|COMPLETED|Overall Study||10
6259620|NCT01883817|7158757|FG001|COMPLETED|Overall Study||9
6259621|NCT01883817|7158756|FG000|NOT COMPLETED|Overall Study||4
6259622|NCT01883817|7158757|FG001|NOT COMPLETED|Overall Study||7
6259623|NCT01813435|7158765|FG000|STARTED|Overall Study|12 participants withdrew consent or objected to use further use of data|7980
6259624|NCT01813435|7158766|FG001|STARTED|Overall Study|11 participants withdrew consent or objected to use further use of data|7988
6259625|NCT01813435|7158765|FG000|COMPLETED|Overall Study||5810
6259626|NCT01813435|7158766|FG001|COMPLETED|Overall Study||6981
6697533|NCT02790073|7627773|FG000|NOT COMPLETED|Overall Study||3
6697534|NCT02790281|7627777|FG000|STARTED|Overall Study||33
6697535|NCT02790281|7627777|FG000|COMPLETED|Overall Study||33
6697536|NCT02790281|7627777|FG000|NOT COMPLETED|Overall Study||0
6697537|NCT02790437|7627783|FG000|STARTED|Overall Study||16
6697538|NCT02790437|7627784|FG001|STARTED|Overall Study||3
6697539|NCT02790437|7627783|FG000|COMPLETED|Overall Study||13
6697540|NCT02790437|7627784|FG001|COMPLETED|Overall Study||3
6697541|NCT02790437|7627783|FG000|NOT COMPLETED|Overall Study||3
6697542|NCT02790437|7627784|FG001|NOT COMPLETED|Overall Study||0
6697543|NCT02790463|7627799|FG000|STARTED|Overall Study||782
6697544|NCT02790463|7627800|FG001|STARTED|Overall Study||681
6697545|NCT02790463|7627799|FG000|COMPLETED|Overall Study||782
6697546|NCT02790463|7627800|FG001|COMPLETED|Overall Study||372
6697547|NCT02790463|7627799|FG000|NOT COMPLETED|Overall Study||0
6697548|NCT02790463|7627800|FG001|NOT COMPLETED|Overall Study||309
6697549|NCT02790606|7627806|FG000|STARTED|Overall Study||110
6697550|NCT02790606|7627806|FG000|COMPLETED|Overall Study||75
6697551|NCT02790606|7627806|FG000|NOT COMPLETED|Overall Study||35
6697552|NCT02790736|7627812|FG000|STARTED|Overall Study||5
6697553|NCT02790736|7627813|FG001|STARTED|Overall Study||1
6697554|NCT02790736|7627812|FG000|COMPLETED|Overall Study||5
6697555|NCT02790736|7627813|FG001|COMPLETED|Overall Study||1
6697556|NCT02790736|7627812|FG000|NOT COMPLETED|Overall Study||0
6697557|NCT02790736|7627813|FG001|NOT COMPLETED|Overall Study||0
6697558|NCT02790788|7627821|FG000|STARTED|Overall Study||46
6697559|NCT02790788|7627822|FG001|STARTED|Overall Study||54
6697560|NCT02790788|7627821|FG000|COMPLETED|Overall Study||46
6697561|NCT02790788|7627822|FG001|COMPLETED|Overall Study||54
6697562|NCT02790788|7627821|FG000|NOT COMPLETED|Overall Study||0
6697563|NCT02790788|7627822|FG001|NOT COMPLETED|Overall Study||0
6697564|NCT02791191|7627833|FG000|STARTED|Overall Study||55
6697565|NCT02791191|7627834|FG001|STARTED|Overall Study||128
6697566|NCT02791191|7627835|FG002|STARTED|Overall Study||133
6697567|NCT02791191|7627833|FG000|Received One Dose of Study Drug|Overall Study||55
6697568|NCT02791191|7627834|FG001|Received One Dose of Study Drug|Overall Study||127
6697569|NCT02791191|7627835|FG002|Received One Dose of Study Drug|Overall Study||133
6697570|NCT02791191|7627833|FG000|COMPLETED|Overall Study||17
6697571|NCT02791191|7627834|FG001|COMPLETED|Overall Study||17
6697572|NCT02791191|7627835|FG002|COMPLETED|Overall Study||13
6697573|NCT02791191|7627833|FG000|NOT COMPLETED|Overall Study||38
6697574|NCT02791191|7627834|FG001|NOT COMPLETED|Overall Study||111
6697575|NCT02791191|7627835|FG002|NOT COMPLETED|Overall Study||120
6697576|NCT02791269|7627845|FG000|STARTED|Overall Study||4
6697577|NCT02791269|7627846|FG001|STARTED|Overall Study||20
6697578|NCT02791269|7627845|FG000|COMPLETED|Overall Study||4
6697579|NCT02791269|7627846|FG001|COMPLETED|Overall Study||19
6697580|NCT02791269|7627845|FG000|NOT COMPLETED|Overall Study||0
6697581|NCT02791269|7627846|FG001|NOT COMPLETED|Overall Study||1
6697582|NCT02791308|7627857|FG000|STARTED|Overall Study||195
6697583|NCT02791308|7627858|FG001|STARTED|Overall Study||196
6697584|NCT02791308|7627859|FG002|STARTED|Overall Study||196
6697585|NCT02791308|7627857|FG000|COMPLETED|Overall Study||185
6697586|NCT02791308|7627858|FG001|COMPLETED|Overall Study||187
6697587|NCT02791308|7627859|FG002|COMPLETED|Overall Study||179
6697588|NCT02791308|7627857|FG000|NOT COMPLETED|Overall Study||10
6697589|NCT02791308|7627858|FG001|NOT COMPLETED|Overall Study||9
6697590|NCT02791308|7627859|FG002|NOT COMPLETED|Overall Study||17
6697591|NCT02791399|7627869|FG000|STARTED|Overall Study||136
6697592|NCT02791399|7627870|FG001|STARTED|Overall Study||150
6697593|NCT02791399|7627869|FG000|COMPLETED|Overall Study||123
6697594|NCT02791399|7627870|FG001|COMPLETED|Overall Study||135
6697595|NCT02791399|7627869|FG000|NOT COMPLETED|Overall Study||13
6697596|NCT02791399|7627870|FG001|NOT COMPLETED|Overall Study||15
6697597|NCT02791438|7627878|FG000|STARTED|Run-In Period||22
6697598|NCT02791438|7627879|FG001|STARTED|Run-In Period||5
6697599|NCT02791438|7627878|FG000|COMPLETED|Run-In Period||22
6697600|NCT02791438|7627879|FG001|COMPLETED|Run-In Period||5
6697601|NCT02791438|7627878|FG000|NOT COMPLETED|Run-In Period||0
6697602|NCT02791438|7627879|FG001|NOT COMPLETED|Run-In Period||0
6697603|NCT02791438|7627878|FG000|STARTED|Treatment Period||22
6697604|NCT02791438|7627879|FG001|STARTED|Treatment Period||5
6697605|NCT02791438|7627878|FG000|COMPLETED|Treatment Period||19
6697606|NCT02791438|7627879|FG001|COMPLETED|Treatment Period||4
6697607|NCT02791438|7627878|FG000|NOT COMPLETED|Treatment Period||3
6697608|NCT02791438|7627879|FG001|NOT COMPLETED|Treatment Period||1
6697609|NCT02791490|7627887|FG000|STARTED|Overall Study||229
6697610|NCT02791490|7627888|FG001|STARTED|Overall Study||229
6697611|NCT02791490|7627887|FG000|COMPLETED|Overall Study||226
6697612|NCT02791490|7627888|FG001|COMPLETED|Overall Study||221
6697613|NCT02791490|7627887|FG000|NOT COMPLETED|Overall Study||3
6697614|NCT02791490|7627888|FG001|NOT COMPLETED|Overall Study||8
6697615|NCT02791516|7627896|FG000|STARTED|Overall Study||33
6697616|NCT02791516|7627897|FG001|STARTED|Overall Study||34
6697617|NCT02791516|7627896|FG000|Completed 6-month Treatment Period|Overall Study||33
6697618|NCT02791516|7627897|FG001|Completed 6-month Treatment Period|Overall Study||33
6697619|NCT02791516|7627896|FG000|COMPLETED|Overall Study||32
6697620|NCT02791516|7627897|FG001|COMPLETED|Overall Study||33
6697621|NCT02791516|7627896|FG000|NOT COMPLETED|Overall Study||1
6697622|NCT02791516|7627897|FG001|NOT COMPLETED|Overall Study||1
6697623|NCT02791659|7627905|FG000|STARTED|Overall Study||27
6697624|NCT02791659|7627906|FG001|STARTED|Overall Study||28
6697625|NCT02791659|7627905|FG000|COMPLETED|Overall Study||27
6697626|NCT02791659|7627906|FG001|COMPLETED|Overall Study||27
6697627|NCT02791659|7627905|FG000|NOT COMPLETED|Overall Study||0
6697628|NCT02791659|7627906|FG001|NOT COMPLETED|Overall Study||1
6697629|NCT02791763|7627915|FG000|STARTED|Overall Study||149
6697630|NCT02791763|7627916|FG001|STARTED|Overall Study||150
6697631|NCT02791763|7627917|FG002|STARTED|Overall Study||56
6697632|NCT02791763|7627915|FG000|COMPLETED|Overall Study||111
6697633|NCT02791763|7627916|FG001|COMPLETED|Overall Study||113
6697634|NCT02791763|7627917|FG002|COMPLETED|Overall Study||43
6697635|NCT02791763|7627915|FG000|NOT COMPLETED|Overall Study||38
6697636|NCT02791763|7627916|FG001|NOT COMPLETED|Overall Study||37
6697637|NCT02791763|7627917|FG002|NOT COMPLETED|Overall Study||13
6697638|NCT02791893|7627936|FG000|STARTED|Blinded Phase||13
6697639|NCT02791893|7627937|FG001|STARTED|Blinded Phase||14
6697640|NCT02791893|7627936|FG000|COMPLETED|Blinded Phase||10
6697641|NCT02791893|7627937|FG001|COMPLETED|Blinded Phase||10
6697642|NCT02791893|7627936|FG000|NOT COMPLETED|Blinded Phase||3
6697643|NCT02791893|7627937|FG001|NOT COMPLETED|Blinded Phase||4
6697644|NCT02791893|7627936|FG000|STARTED|Open Label Phase||10
6697645|NCT02791893|7627937|FG001|STARTED|Open Label Phase||10
6697646|NCT02791893|7627936|FG000|COMPLETED|Open Label Phase||7
6697647|NCT02791893|7627937|FG001|COMPLETED|Open Label Phase||8
6697648|NCT02791893|7627936|FG000|NOT COMPLETED|Open Label Phase||3
6697649|NCT02791893|7627937|FG001|NOT COMPLETED|Open Label Phase||2
6697650|NCT02791906|7627945|FG000|STARTED|Overall Study||4
6697651|NCT02791906|7627946|FG001|STARTED|Overall Study||3
6697652|NCT02791906|7627945|FG000|COMPLETED|Overall Study||2
6697653|NCT02791906|7627946|FG001|COMPLETED|Overall Study||2
6697654|NCT02791906|7627945|FG000|NOT COMPLETED|Overall Study||2
6697655|NCT02791906|7627946|FG001|NOT COMPLETED|Overall Study||1
6697656|NCT02791945|7627956|FG000|STARTED|Overall Study||14
6697657|NCT02791945|7627957|FG001|STARTED|Overall Study||16
6697658|NCT02791945|7627956|FG000|COMPLETED|Overall Study||12
6697659|NCT02791945|7627957|FG001|COMPLETED|Overall Study||14
6697660|NCT02791945|7627956|FG000|NOT COMPLETED|Overall Study||2
6697661|NCT02791945|7627957|FG001|NOT COMPLETED|Overall Study||2
6697662|NCT02792049|7627965|FG000|STARTED|Overall Study||35
6697663|NCT02792049|7627966|FG001|STARTED|Overall Study||35
6697664|NCT02792049|7627965|FG000|COMPLETED|Overall Study||35
6697665|NCT02792049|7627966|FG001|COMPLETED|Overall Study||35
6697666|NCT02792049|7627965|FG000|NOT COMPLETED|Overall Study||0
6697667|NCT02792049|7627966|FG001|NOT COMPLETED|Overall Study||0
6697668|NCT02792062|7627980|FG000|STARTED|Intervention Period 1 (6 Days)||2
6697669|NCT02792062|7627981|FG001|STARTED|Intervention Period 1 (6 Days)||2
6697670|NCT02792062|7627982|FG002|STARTED|Intervention Period 1 (6 Days)||2
6697671|NCT02792062|7627983|FG003|STARTED|Intervention Period 1 (6 Days)||2
6697672|NCT02792062|7627984|FG004|STARTED|Intervention Period 1 (6 Days)||2
6697673|NCT02792062|7627985|FG005|STARTED|Intervention Period 1 (6 Days)||2
6697674|NCT02792062|7627980|FG000|COMPLETED|Intervention Period 1 (6 Days)||2
6697675|NCT02792062|7627981|FG001|COMPLETED|Intervention Period 1 (6 Days)||2
6697676|NCT02792062|7627982|FG002|COMPLETED|Intervention Period 1 (6 Days)||2
6697677|NCT02792062|7627983|FG003|COMPLETED|Intervention Period 1 (6 Days)||2
6697678|NCT02792062|7627984|FG004|COMPLETED|Intervention Period 1 (6 Days)||2
6697679|NCT02792062|7627985|FG005|COMPLETED|Intervention Period 1 (6 Days)||2
6697680|NCT02792062|7627980|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6697681|NCT02792062|7627981|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6697682|NCT02792062|7627982|FG002|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6697683|NCT02792062|7627983|FG003|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6697684|NCT02792062|7627984|FG004|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6697685|NCT02792062|7627985|FG005|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6697686|NCT02792062|7627980|FG000|STARTED|Washout Period (at Least 14 Days)||2
6697687|NCT02792062|7627981|FG001|STARTED|Washout Period (at Least 14 Days)||2
6697688|NCT02792062|7627982|FG002|STARTED|Washout Period (at Least 14 Days)||2
6697689|NCT02792062|7627983|FG003|STARTED|Washout Period (at Least 14 Days)||2
6697690|NCT02792062|7627984|FG004|STARTED|Washout Period (at Least 14 Days)||2
6697691|NCT02792062|7627985|FG005|STARTED|Washout Period (at Least 14 Days)||2
6697692|NCT02792062|7627980|FG000|COMPLETED|Washout Period (at Least 14 Days)||2
6697693|NCT02792062|7627981|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
6697694|NCT02792062|7627982|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
6697695|NCT02792062|7627983|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
6697696|NCT02792062|7627984|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
6697697|NCT02792062|7627985|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
6697698|NCT02792062|7627980|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697699|NCT02792062|7627981|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697700|NCT02792062|7627982|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697701|NCT02792062|7627983|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697702|NCT02792062|7627984|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697703|NCT02792062|7627985|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697704|NCT02792062|7627980|FG000|STARTED|Intervention Period 2 (6 Days)||2
6697705|NCT02792062|7627981|FG001|STARTED|Intervention Period 2 (6 Days)||2
6697706|NCT02792062|7627982|FG002|STARTED|Intervention Period 2 (6 Days)||2
6697707|NCT02792062|7627983|FG003|STARTED|Intervention Period 2 (6 Days)||2
6697708|NCT02792062|7627984|FG004|STARTED|Intervention Period 2 (6 Days)||2
6259627|NCT01813435|7158765|FG000|NOT COMPLETED|Overall Study||2170
6259628|NCT01813435|7158766|FG001|NOT COMPLETED|Overall Study||1007
6697709|NCT02792062|7627985|FG005|STARTED|Intervention Period 2 (6 Days)||2
6697710|NCT02792062|7627980|FG000|COMPLETED|Intervention Period 2 (6 Days)||2
6697711|NCT02792062|7627981|FG001|COMPLETED|Intervention Period 2 (6 Days)||2
6697712|NCT02792062|7627982|FG002|COMPLETED|Intervention Period 2 (6 Days)||2
6697713|NCT02792062|7627983|FG003|COMPLETED|Intervention Period 2 (6 Days)||2
6697714|NCT02792062|7627984|FG004|COMPLETED|Intervention Period 2 (6 Days)||2
6697715|NCT02792062|7627985|FG005|COMPLETED|Intervention Period 2 (6 Days)||2
6697716|NCT02792062|7627980|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6697717|NCT02792062|7627981|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6697718|NCT02792062|7627982|FG002|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6697719|NCT02792062|7627983|FG003|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6697720|NCT02792062|7627984|FG004|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6697721|NCT02792062|7627985|FG005|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6697722|NCT02792062|7627980|FG000|STARTED|Washout Period (at Least 14 Days)||2
6697723|NCT02792062|7627981|FG001|STARTED|Washout Period (at Least 14 Days)||2
6697724|NCT02792062|7627982|FG002|STARTED|Washout Period (at Least 14 Days)||2
6697725|NCT02792062|7627983|FG003|STARTED|Washout Period (at Least 14 Days)||2
6697726|NCT02792062|7627984|FG004|STARTED|Washout Period (at Least 14 Days)||2
6697727|NCT02792062|7627985|FG005|STARTED|Washout Period (at Least 14 Days)||2
6697728|NCT02792062|7627980|FG000|COMPLETED|Washout Period (at Least 14 Days)||1
6697729|NCT02792062|7627981|FG001|COMPLETED|Washout Period (at Least 14 Days)||2
6697730|NCT02792062|7627982|FG002|COMPLETED|Washout Period (at Least 14 Days)||2
6697731|NCT02792062|7627983|FG003|COMPLETED|Washout Period (at Least 14 Days)||2
6697732|NCT02792062|7627984|FG004|COMPLETED|Washout Period (at Least 14 Days)||2
6697733|NCT02792062|7627985|FG005|COMPLETED|Washout Period (at Least 14 Days)||2
6697734|NCT02792062|7627980|FG000|NOT COMPLETED|Washout Period (at Least 14 Days)||1
6697735|NCT02792062|7627981|FG001|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697736|NCT02792062|7627982|FG002|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697737|NCT02792062|7627983|FG003|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697738|NCT02792062|7627984|FG004|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697739|NCT02792062|7627985|FG005|NOT COMPLETED|Washout Period (at Least 14 Days)||0
6697740|NCT02792062|7627980|FG000|STARTED|Intervention Period 3 (6 Days)||1
6697741|NCT02792062|7627981|FG001|STARTED|Intervention Period 3 (6 Days)||2
6697742|NCT02792062|7627982|FG002|STARTED|Intervention Period 3 (6 Days)||2
6697743|NCT02792062|7627983|FG003|STARTED|Intervention Period 3 (6 Days)||2
6697744|NCT02792062|7627984|FG004|STARTED|Intervention Period 3 (6 Days)||2
6697745|NCT02792062|7627985|FG005|STARTED|Intervention Period 3 (6 Days)||2
6697746|NCT02792062|7627980|FG000|COMPLETED|Intervention Period 3 (6 Days)||1
6697747|NCT02792062|7627981|FG001|COMPLETED|Intervention Period 3 (6 Days)||2
6697748|NCT02792062|7627982|FG002|COMPLETED|Intervention Period 3 (6 Days)||2
6697749|NCT02792062|7627983|FG003|COMPLETED|Intervention Period 3 (6 Days)||2
6697750|NCT02792062|7627984|FG004|COMPLETED|Intervention Period 3 (6 Days)||2
6697751|NCT02792062|7627985|FG005|COMPLETED|Intervention Period 3 (6 Days)||2
6697752|NCT02792062|7627980|FG000|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6697753|NCT02792062|7627981|FG001|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6697754|NCT02792062|7627982|FG002|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6697755|NCT02792062|7627983|FG003|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6697756|NCT02792062|7627984|FG004|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6697757|NCT02792062|7627985|FG005|NOT COMPLETED|Intervention Period 3 (6 Days)||0
6697758|NCT02792192|7627997|FG000|STARTED|Overall Study||12
6697759|NCT02792192|7627998|FG001|STARTED|Overall Study||12
6697760|NCT02792192|7627999|FG002|STARTED|Overall Study||0
6697761|NCT02792192|7628000|FG003|STARTED|Overall Study||0
6697762|NCT02792192|7627997|FG000|COMPLETED|Overall Study||0
6697763|NCT02792192|7627998|FG001|COMPLETED|Overall Study||1
6697764|NCT02792192|7627999|FG002|COMPLETED|Overall Study||0
6697765|NCT02792192|7628000|FG003|COMPLETED|Overall Study||0
6697766|NCT02792192|7627997|FG000|NOT COMPLETED|Overall Study||12
6697767|NCT02792192|7627998|FG001|NOT COMPLETED|Overall Study||11
6697768|NCT02792192|7627999|FG002|NOT COMPLETED|Overall Study||0
6697769|NCT02792192|7628000|FG003|NOT COMPLETED|Overall Study||0
6697770|NCT02792218|7628013|FG000|STARTED|Overall Study||465
6697771|NCT02792218|7628014|FG001|STARTED|Overall Study||462
6697772|NCT02792218|7628013|FG000|COMPLETED|Overall Study||416
6697773|NCT02792218|7628014|FG001|COMPLETED|Overall Study||381
6697774|NCT02792218|7628013|FG000|NOT COMPLETED|Overall Study||49
6697775|NCT02792218|7628014|FG001|NOT COMPLETED|Overall Study||81
6697776|NCT02792231|7628022|FG000|STARTED|Overall Study||481
6697777|NCT02792231|7628023|FG001|STARTED|Overall Study||474
6697778|NCT02792231|7628022|FG000|COMPLETED|Overall Study||399
6697779|NCT02792231|7628023|FG001|COMPLETED|Overall Study||390
6697780|NCT02792231|7628022|FG000|NOT COMPLETED|Overall Study||82
6697781|NCT02792231|7628023|FG001|NOT COMPLETED|Overall Study||84
6697782|NCT02792504|7628029|FG000|STARTED|Overall Study||669
6697783|NCT02792504|7628029|FG000|Safety Analysis Set|Overall Study||639
6697784|NCT02792504|7628029|FG000|Efficacy Analysis Set|Overall Study||390
6697785|NCT02792504|7628029|FG000|COMPLETED|Overall Study||639
6697786|NCT02792504|7628029|FG000|NOT COMPLETED|Overall Study||30
6697787|NCT02792517|7628033|FG000|STARTED|Overall Study||41
6697788|NCT02792517|7628033|FG000|Received Erenumab|Overall Study||24
6697789|NCT02792517|7628033|FG000|COMPLETED|Overall Study||21
6697790|NCT02792517|7628033|FG000|NOT COMPLETED|Overall Study||20
6697791|NCT02792699|7628040|FG000|STARTED|Overall Study||104
6697792|NCT02792699|7628041|FG001|STARTED|Overall Study||104
6697793|NCT02792699|7628042|FG002|STARTED|Overall Study||103
6697794|NCT02792699|7628040|FG000|Received First Infusion of First Dose|Overall Study||104
6697795|NCT02792699|7628041|FG001|Received First Infusion of First Dose|Overall Study||104
6697796|NCT02792699|7628042|FG002|Received First Infusion of First Dose|Overall Study||103
6697797|NCT02792699|7628040|FG000|Received Second Infusion of First Dose|Overall Study||102
6697798|NCT02792699|7628041|FG001|Received Second Infusion of First Dose|Overall Study||103
6697799|NCT02792699|7628042|FG002|Received Second Infusion of First Dose|Overall Study||99
6697800|NCT02792699|7628040|FG000|Received First Infusion of Second Dose|Overall Study||97
6697801|NCT02792699|7628041|FG001|Received First Infusion of Second Dose|Overall Study||99
6697802|NCT02792699|7628042|FG002|Received First Infusion of Second Dose|Overall Study||95
6697803|NCT02792699|7628040|FG000|Received Second Infusion of Second Dose|Overall Study||97
6697804|NCT02792699|7628041|FG001|Received Second Infusion of Second Dose|Overall Study||99
6697805|NCT02792699|7628042|FG002|Received Second Infusion of Second Dose|Overall Study||93
6697806|NCT02792699|7628040|FG000|COMPLETED|Overall Study||95
6697807|NCT02792699|7628041|FG001|COMPLETED|Overall Study||94
6697808|NCT02792699|7628042|FG002|COMPLETED|Overall Study||93
6697809|NCT02792699|7628040|FG000|NOT COMPLETED|Overall Study||9
6697810|NCT02792699|7628041|FG001|NOT COMPLETED|Overall Study||10
6697811|NCT02792699|7628042|FG002|NOT COMPLETED|Overall Study||10
6697812|NCT02792777|7628059|FG000|STARTED|Overall Study||96
6697813|NCT02792777|7628060|FG001|STARTED|Overall Study||52
6697814|NCT02792777|7628059|FG000|COMPLETED|Overall Study||89
6697815|NCT02792777|7628060|FG001|COMPLETED|Overall Study||52
6697816|NCT02792777|7628059|FG000|NOT COMPLETED|Overall Study||7
6697817|NCT02792777|7628060|FG001|NOT COMPLETED|Overall Study||0
6697818|NCT02792829|7628075|FG000|STARTED|Treatment Period 1||10
6697819|NCT02792829|7628076|FG001|STARTED|Treatment Period 1||10
6697820|NCT02792829|7628077|FG002|STARTED|Treatment Period 1||5
6697821|NCT02792829|7628078|FG003|STARTED|Treatment Period 1||5
6259651|NCT01700439|7158799|FG000|STARTED|Overall Study||889
6259652|NCT01700439|7158799|FG000|Study Valve Group|Overall Study|Received the Edwards INTUITY surgical aortic heart valve.|839
6259653|NCT01700439|7158799|FG000|Discharge|Overall Study||831
6259654|NCT01700439|7158799|FG000|3 Month|Overall Study||778
6259655|NCT01700439|7158799|FG000|1 Year|Overall Study||573
6259656|NCT01700439|7158799|FG000|2 Year|Overall Study||215
6259657|NCT01700439|7158799|FG000|COMPLETED|Overall Study||0
6259658|NCT01700439|7158799|FG000|NOT COMPLETED|Overall Study||889
6259659|NCT01690299|7158807|FG000|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
6259660|NCT01690299|7158808|FG001|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
6259661|NCT01690299|7158809|FG002|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
6259662|NCT01690299|7158810|FG003|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
6259663|NCT01690299|7158811|FG004|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
6259664|NCT01690299|7158812|FG005|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
6259665|NCT01690299|7158807|FG000|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
6259666|NCT01690299|7158808|FG001|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
6259667|NCT01690299|7158809|FG002|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
6259668|NCT01690299|7158810|FG003|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
6259669|NCT01690299|7158811|FG004|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
6259670|NCT01690299|7158812|FG005|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
6259671|NCT01690299|7158807|FG000|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
6259672|NCT01690299|7158808|FG001|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
6259673|NCT01690299|7158809|FG002|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
6259674|NCT01690299|7158810|FG003|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6259675|NCT01690299|7158811|FG004|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6259676|NCT01690299|7158812|FG005|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6697822|NCT02792829|7628079|FG004|STARTED|Treatment Period 1||5
6697823|NCT02792829|7628080|FG005|STARTED|Treatment Period 1||5
6697824|NCT02792829|7628081|FG006|STARTED|Treatment Period 1||10
6697825|NCT02792829|7628082|FG007|STARTED|Treatment Period 1||10
6697826|NCT02792829|7628075|FG000|COMPLETED|Treatment Period 1||10
6697827|NCT02792829|7628076|FG001|COMPLETED|Treatment Period 1||10
6697828|NCT02792829|7628077|FG002|COMPLETED|Treatment Period 1||5
6697829|NCT02792829|7628078|FG003|COMPLETED|Treatment Period 1||5
6697830|NCT02792829|7628079|FG004|COMPLETED|Treatment Period 1||5
6697831|NCT02792829|7628080|FG005|COMPLETED|Treatment Period 1||5
6697832|NCT02792829|7628081|FG006|COMPLETED|Treatment Period 1||10
6697833|NCT02792829|7628082|FG007|COMPLETED|Treatment Period 1||10
6697834|NCT02792829|7628075|FG000|NOT COMPLETED|Treatment Period 1||0
6697835|NCT02792829|7628076|FG001|NOT COMPLETED|Treatment Period 1||0
6697836|NCT02792829|7628077|FG002|NOT COMPLETED|Treatment Period 1||0
6697837|NCT02792829|7628078|FG003|NOT COMPLETED|Treatment Period 1||0
6697838|NCT02792829|7628079|FG004|NOT COMPLETED|Treatment Period 1||0
6697839|NCT02792829|7628080|FG005|NOT COMPLETED|Treatment Period 1||0
6697840|NCT02792829|7628081|FG006|NOT COMPLETED|Treatment Period 1||0
6697841|NCT02792829|7628082|FG007|NOT COMPLETED|Treatment Period 1||0
6697842|NCT02792829|7628075|FG000|STARTED|Wash Out Period||10
6697843|NCT02792829|7628076|FG001|STARTED|Wash Out Period||10
6697844|NCT02792829|7628077|FG002|STARTED|Wash Out Period||5
6697845|NCT02792829|7628078|FG003|STARTED|Wash Out Period||5
6697846|NCT02792829|7628079|FG004|STARTED|Wash Out Period||5
6697847|NCT02792829|7628080|FG005|STARTED|Wash Out Period||5
6697848|NCT02792829|7628081|FG006|STARTED|Wash Out Period||10
6697849|NCT02792829|7628082|FG007|STARTED|Wash Out Period||10
6697850|NCT02792829|7628075|FG000|COMPLETED|Wash Out Period||10
6697851|NCT02792829|7628076|FG001|COMPLETED|Wash Out Period||10
6697852|NCT02792829|7628077|FG002|COMPLETED|Wash Out Period||5
6697853|NCT02792829|7628078|FG003|COMPLETED|Wash Out Period||5
6697854|NCT02792829|7628079|FG004|COMPLETED|Wash Out Period||5
6697855|NCT02792829|7628080|FG005|COMPLETED|Wash Out Period||5
6697856|NCT02792829|7628081|FG006|COMPLETED|Wash Out Period||10
6697857|NCT02792829|7628082|FG007|COMPLETED|Wash Out Period||10
6697858|NCT02792829|7628075|FG000|NOT COMPLETED|Wash Out Period||0
6697859|NCT02792829|7628076|FG001|NOT COMPLETED|Wash Out Period||0
6697860|NCT02792829|7628077|FG002|NOT COMPLETED|Wash Out Period||0
6697861|NCT02792829|7628078|FG003|NOT COMPLETED|Wash Out Period||0
6697862|NCT02792829|7628079|FG004|NOT COMPLETED|Wash Out Period||0
6697863|NCT02792829|7628080|FG005|NOT COMPLETED|Wash Out Period||0
6697864|NCT02792829|7628081|FG006|NOT COMPLETED|Wash Out Period||0
6697865|NCT02792829|7628082|FG007|NOT COMPLETED|Wash Out Period||0
6697866|NCT02792829|7628075|FG000|STARTED|Treatment Period 2||10
6697867|NCT02792829|7628076|FG001|STARTED|Treatment Period 2||10
6697868|NCT02792829|7628077|FG002|STARTED|Treatment Period 2||5
6697869|NCT02792829|7628078|FG003|STARTED|Treatment Period 2||5
6697870|NCT02792829|7628079|FG004|STARTED|Treatment Period 2||5
6697871|NCT02792829|7628080|FG005|STARTED|Treatment Period 2||5
6697872|NCT02792829|7628081|FG006|STARTED|Treatment Period 2||10
6697873|NCT02792829|7628082|FG007|STARTED|Treatment Period 2||10
6697874|NCT02792829|7628075|FG000|COMPLETED|Treatment Period 2||10
6697875|NCT02792829|7628076|FG001|COMPLETED|Treatment Period 2||9
6697876|NCT02792829|7628077|FG002|COMPLETED|Treatment Period 2||5
6697877|NCT02792829|7628078|FG003|COMPLETED|Treatment Period 2||5
6697878|NCT02792829|7628079|FG004|COMPLETED|Treatment Period 2||4
6697879|NCT02792829|7628080|FG005|COMPLETED|Treatment Period 2||5
6697880|NCT02792829|7628081|FG006|COMPLETED|Treatment Period 2||9
6697881|NCT02792829|7628082|FG007|COMPLETED|Treatment Period 2||8
6697882|NCT02792829|7628075|FG000|NOT COMPLETED|Treatment Period 2||0
6697883|NCT02792829|7628076|FG001|NOT COMPLETED|Treatment Period 2||1
6697884|NCT02792829|7628077|FG002|NOT COMPLETED|Treatment Period 2||0
6697885|NCT02792829|7628078|FG003|NOT COMPLETED|Treatment Period 2||0
6697886|NCT02792829|7628079|FG004|NOT COMPLETED|Treatment Period 2||1
6697887|NCT02792829|7628080|FG005|NOT COMPLETED|Treatment Period 2||0
6697888|NCT02792829|7628081|FG006|NOT COMPLETED|Treatment Period 2||1
6697889|NCT02792829|7628082|FG007|NOT COMPLETED|Treatment Period 2||2
6697890|NCT02792959|7628108|FG000|STARTED|Overall Study||11
6697891|NCT02792959|7628108|FG000|COMPLETED|Overall Study||10
6697892|NCT02792959|7628108|FG000|NOT COMPLETED|Overall Study||1
6697893|NCT02793128|7628112|FG000|STARTED|Overall Study||71
6697894|NCT02793128|7628112|FG000|COMPLETED|Overall Study||62
6697895|NCT02793128|7628112|FG000|NOT COMPLETED|Overall Study||9
6697896|NCT02793154|7628127|FG000|STARTED|Part A (Single Group-up to 12 Days)||4
6697897|NCT02793154|7628128|FG001|STARTED|Part A (Single Group-up to 12 Days)||0
6697898|NCT02793154|7628129|FG002|STARTED|Part A (Single Group-up to 12 Days)||0
6697899|NCT02793154|7628127|FG000|COMPLETED|Part A (Single Group-up to 12 Days)||4
6697900|NCT02793154|7628128|FG001|COMPLETED|Part A (Single Group-up to 12 Days)||0
6697901|NCT02793154|7628129|FG002|COMPLETED|Part A (Single Group-up to 12 Days)||0
6697902|NCT02793154|7628127|FG000|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
6697903|NCT02793154|7628128|FG001|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
6697904|NCT02793154|7628129|FG002|NOT COMPLETED|Part A (Single Group-up to 12 Days)||0
6697905|NCT02793154|7628127|FG000|STARTED|Part B (Parallel Group-up to 84 Days)||0
6697906|NCT02793154|7628128|FG001|STARTED|Part B (Parallel Group-up to 84 Days)||0
6697907|NCT02793154|7628129|FG002|STARTED|Part B (Parallel Group-up to 84 Days)||0
6697908|NCT02793154|7628127|FG000|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6697909|NCT02793154|7628128|FG001|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6697910|NCT02793154|7628129|FG002|COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6697911|NCT02793154|7628127|FG000|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6697912|NCT02793154|7628128|FG001|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6697913|NCT02793154|7628129|FG002|NOT COMPLETED|Part B (Parallel Group-up to 84 Days)||0
6697914|NCT02793232|7628146|FG000|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697915|NCT02793232|7628147|FG001|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697916|NCT02793232|7628148|FG002|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697917|NCT02793232|7628149|FG003|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697918|NCT02793232|7628150|FG004|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||7
6697919|NCT02793232|7628151|FG005|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||12
6697920|NCT02793232|7628152|FG006|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||9
6697921|NCT02793232|7628153|FG007|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697922|NCT02793232|7628154|FG008|STARTED|Period 1-Part A:5 Days; Part B,C:19 Days||8
6697923|NCT02793232|7628146|FG000|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697924|NCT02793232|7628147|FG001|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697925|NCT02793232|7628148|FG002|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697926|NCT02793232|7628149|FG003|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697927|NCT02793232|7628150|FG004|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||6
6697928|NCT02793232|7628151|FG005|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||12
6697929|NCT02793232|7628152|FG006|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
6697930|NCT02793232|7628153|FG007|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||2
6697931|NCT02793232|7628154|FG008|COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||8
6697932|NCT02793232|7628146|FG000|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6697933|NCT02793232|7628147|FG001|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6697934|NCT02793232|7628148|FG002|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6697935|NCT02793232|7628149|FG003|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6697936|NCT02793232|7628150|FG004|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
6697937|NCT02793232|7628151|FG005|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6697938|NCT02793232|7628152|FG006|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||1
6697939|NCT02793232|7628153|FG007|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6697940|NCT02793232|7628154|FG008|NOT COMPLETED|Period 1-Part A:5 Days; Part B,C:19 Days||0
6697941|NCT02793232|7628146|FG000|STARTED|Washout Period 1(Part A:at Least 10days)||2
6697942|NCT02793232|7628147|FG001|STARTED|Washout Period 1(Part A:at Least 10days)||2
6697943|NCT02793232|7628148|FG002|STARTED|Washout Period 1(Part A:at Least 10days)||2
6697944|NCT02793232|7628149|FG003|STARTED|Washout Period 1(Part A:at Least 10days)||2
6697945|NCT02793232|7628150|FG004|STARTED|Washout Period 1(Part A:at Least 10days)||0
6697946|NCT02793232|7628151|FG005|STARTED|Washout Period 1(Part A:at Least 10days)||0
6697947|NCT02793232|7628152|FG006|STARTED|Washout Period 1(Part A:at Least 10days)||0
6697948|NCT02793232|7628153|FG007|STARTED|Washout Period 1(Part A:at Least 10days)||0
6697949|NCT02793232|7628154|FG008|STARTED|Washout Period 1(Part A:at Least 10days)||0
6697950|NCT02793232|7628146|FG000|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
6697951|NCT02793232|7628147|FG001|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
6697952|NCT02793232|7628148|FG002|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
6697953|NCT02793232|7628149|FG003|COMPLETED|Washout Period 1(Part A:at Least 10days)||2
6697954|NCT02793232|7628150|FG004|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697955|NCT02793232|7628151|FG005|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697956|NCT02793232|7628152|FG006|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697957|NCT02793232|7628153|FG007|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697958|NCT02793232|7628154|FG008|COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697959|NCT02793232|7628146|FG000|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697960|NCT02793232|7628147|FG001|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697961|NCT02793232|7628148|FG002|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697962|NCT02793232|7628149|FG003|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697963|NCT02793232|7628150|FG004|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697964|NCT02793232|7628151|FG005|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697965|NCT02793232|7628152|FG006|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697966|NCT02793232|7628153|FG007|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697967|NCT02793232|7628154|FG008|NOT COMPLETED|Washout Period 1(Part A:at Least 10days)||0
6697968|NCT02793232|7628146|FG000|STARTED|Period 2 (Part A: 5 Days)||2
6697969|NCT02793232|7628147|FG001|STARTED|Period 2 (Part A: 5 Days)||2
6697970|NCT02793232|7628148|FG002|STARTED|Period 2 (Part A: 5 Days)||2
6697971|NCT02793232|7628149|FG003|STARTED|Period 2 (Part A: 5 Days)||2
6697972|NCT02793232|7628150|FG004|STARTED|Period 2 (Part A: 5 Days)||0
6697973|NCT02793232|7628151|FG005|STARTED|Period 2 (Part A: 5 Days)||0
6697974|NCT02793232|7628152|FG006|STARTED|Period 2 (Part A: 5 Days)||0
6697975|NCT02793232|7628153|FG007|STARTED|Period 2 (Part A: 5 Days)||0
6697976|NCT02793232|7628154|FG008|STARTED|Period 2 (Part A: 5 Days)||0
6697977|NCT02793232|7628146|FG000|COMPLETED|Period 2 (Part A: 5 Days)||2
6697978|NCT02793232|7628147|FG001|COMPLETED|Period 2 (Part A: 5 Days)||2
6697979|NCT02793232|7628148|FG002|COMPLETED|Period 2 (Part A: 5 Days)||2
6697980|NCT02793232|7628149|FG003|COMPLETED|Period 2 (Part A: 5 Days)||2
6697981|NCT02793232|7628150|FG004|COMPLETED|Period 2 (Part A: 5 Days)||0
6697982|NCT02793232|7628151|FG005|COMPLETED|Period 2 (Part A: 5 Days)||0
6697983|NCT02793232|7628152|FG006|COMPLETED|Period 2 (Part A: 5 Days)||0
6697984|NCT02793232|7628153|FG007|COMPLETED|Period 2 (Part A: 5 Days)||0
6697985|NCT02793232|7628154|FG008|COMPLETED|Period 2 (Part A: 5 Days)||0
6697986|NCT02793232|7628146|FG000|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697987|NCT02793232|7628147|FG001|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697988|NCT02793232|7628148|FG002|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697989|NCT02793232|7628149|FG003|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697990|NCT02793232|7628150|FG004|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697991|NCT02793232|7628151|FG005|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697992|NCT02793232|7628152|FG006|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697993|NCT02793232|7628153|FG007|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697994|NCT02793232|7628154|FG008|NOT COMPLETED|Period 2 (Part A: 5 Days)||0
6697995|NCT02793232|7628146|FG000|STARTED|Washout Period 2(Part A:at Least 10days)||2
6697996|NCT02793232|7628147|FG001|STARTED|Washout Period 2(Part A:at Least 10days)||2
6697997|NCT02793232|7628148|FG002|STARTED|Washout Period 2(Part A:at Least 10days)||2
6697998|NCT02793232|7628149|FG003|STARTED|Washout Period 2(Part A:at Least 10days)||2
6697999|NCT02793232|7628150|FG004|STARTED|Washout Period 2(Part A:at Least 10days)||0
6698000|NCT02793232|7628151|FG005|STARTED|Washout Period 2(Part A:at Least 10days)||0
6698001|NCT02793232|7628152|FG006|STARTED|Washout Period 2(Part A:at Least 10days)||0
6698002|NCT02793232|7628153|FG007|STARTED|Washout Period 2(Part A:at Least 10days)||0
6698003|NCT02793232|7628154|FG008|STARTED|Washout Period 2(Part A:at Least 10days)||0
6698004|NCT02793232|7628146|FG000|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
6698005|NCT02793232|7628147|FG001|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
6698006|NCT02793232|7628148|FG002|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
6698007|NCT02793232|7628149|FG003|COMPLETED|Washout Period 2(Part A:at Least 10days)||2
6698008|NCT02793232|7628150|FG004|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698009|NCT02793232|7628151|FG005|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698010|NCT02793232|7628152|FG006|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698011|NCT02793232|7628153|FG007|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698012|NCT02793232|7628154|FG008|COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698013|NCT02793232|7628146|FG000|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698014|NCT02793232|7628147|FG001|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698015|NCT02793232|7628148|FG002|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698016|NCT02793232|7628149|FG003|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698017|NCT02793232|7628150|FG004|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698018|NCT02793232|7628151|FG005|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698019|NCT02793232|7628152|FG006|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698020|NCT02793232|7628153|FG007|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698021|NCT02793232|7628154|FG008|NOT COMPLETED|Washout Period 2(Part A:at Least 10days)||0
6698022|NCT02793232|7628146|FG000|STARTED|Period 3 (Part A: 5 Days)||2
6698023|NCT02793232|7628147|FG001|STARTED|Period 3 (Part A: 5 Days)||2
6698024|NCT02793232|7628148|FG002|STARTED|Period 3 (Part A: 5 Days)||2
6698025|NCT02793232|7628149|FG003|STARTED|Period 3 (Part A: 5 Days)||2
6698026|NCT02793232|7628150|FG004|STARTED|Period 3 (Part A: 5 Days)||0
6698027|NCT02793232|7628151|FG005|STARTED|Period 3 (Part A: 5 Days)||0
6698028|NCT02793232|7628152|FG006|STARTED|Period 3 (Part A: 5 Days)||0
6698029|NCT02793232|7628153|FG007|STARTED|Period 3 (Part A: 5 Days)||0
6698030|NCT02793232|7628154|FG008|STARTED|Period 3 (Part A: 5 Days)||0
6698031|NCT02793232|7628146|FG000|COMPLETED|Period 3 (Part A: 5 Days)||2
6698032|NCT02793232|7628147|FG001|COMPLETED|Period 3 (Part A: 5 Days)||2
6698033|NCT02793232|7628148|FG002|COMPLETED|Period 3 (Part A: 5 Days)||2
6698034|NCT02793232|7628149|FG003|COMPLETED|Period 3 (Part A: 5 Days)||2
6698035|NCT02793232|7628150|FG004|COMPLETED|Period 3 (Part A: 5 Days)||0
6698036|NCT02793232|7628151|FG005|COMPLETED|Period 3 (Part A: 5 Days)||0
6698037|NCT02793232|7628152|FG006|COMPLETED|Period 3 (Part A: 5 Days)||0
6698038|NCT02793232|7628153|FG007|COMPLETED|Period 3 (Part A: 5 Days)||0
6698039|NCT02793232|7628154|FG008|COMPLETED|Period 3 (Part A: 5 Days)||0
6698040|NCT02793232|7628146|FG000|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698041|NCT02793232|7628147|FG001|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698042|NCT02793232|7628148|FG002|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698043|NCT02793232|7628149|FG003|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698044|NCT02793232|7628150|FG004|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698045|NCT02793232|7628151|FG005|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698046|NCT02793232|7628152|FG006|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698047|NCT02793232|7628153|FG007|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698048|NCT02793232|7628154|FG008|NOT COMPLETED|Period 3 (Part A: 5 Days)||0
6698049|NCT02793232|7628146|FG000|STARTED|Washout Period 3(Part A:at Least 10days)||2
6698050|NCT02793232|7628147|FG001|STARTED|Washout Period 3(Part A:at Least 10days)||2
6698051|NCT02793232|7628148|FG002|STARTED|Washout Period 3(Part A:at Least 10days)||2
6698052|NCT02793232|7628149|FG003|STARTED|Washout Period 3(Part A:at Least 10days)||2
6698053|NCT02793232|7628150|FG004|STARTED|Washout Period 3(Part A:at Least 10days)||0
6698054|NCT02793232|7628151|FG005|STARTED|Washout Period 3(Part A:at Least 10days)||0
6698055|NCT02793232|7628152|FG006|STARTED|Washout Period 3(Part A:at Least 10days)||0
6698056|NCT02793232|7628153|FG007|STARTED|Washout Period 3(Part A:at Least 10days)||0
6698057|NCT02793232|7628154|FG008|STARTED|Washout Period 3(Part A:at Least 10days)||0
6698058|NCT02793232|7628146|FG000|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
6698059|NCT02793232|7628147|FG001|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
6698060|NCT02793232|7628148|FG002|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
6698061|NCT02793232|7628149|FG003|COMPLETED|Washout Period 3(Part A:at Least 10days)||2
6698062|NCT02793232|7628150|FG004|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698063|NCT02793232|7628151|FG005|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698064|NCT02793232|7628152|FG006|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698065|NCT02793232|7628153|FG007|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698066|NCT02793232|7628154|FG008|COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698067|NCT02793232|7628146|FG000|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698068|NCT02793232|7628147|FG001|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698069|NCT02793232|7628148|FG002|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698070|NCT02793232|7628149|FG003|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698071|NCT02793232|7628150|FG004|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698072|NCT02793232|7628151|FG005|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698073|NCT02793232|7628152|FG006|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698074|NCT02793232|7628153|FG007|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698075|NCT02793232|7628154|FG008|NOT COMPLETED|Washout Period 3(Part A:at Least 10days)||0
6698076|NCT02793232|7628146|FG000|STARTED|Period 4 (Part A: 5 Days)||2
6698077|NCT02793232|7628147|FG001|STARTED|Period 4 (Part A: 5 Days)||2
6698078|NCT02793232|7628148|FG002|STARTED|Period 4 (Part A: 5 Days)||2
6698079|NCT02793232|7628149|FG003|STARTED|Period 4 (Part A: 5 Days)||2
6698080|NCT02793232|7628150|FG004|STARTED|Period 4 (Part A: 5 Days)||0
6698081|NCT02793232|7628151|FG005|STARTED|Period 4 (Part A: 5 Days)||0
6698082|NCT02793232|7628152|FG006|STARTED|Period 4 (Part A: 5 Days)||0
6698083|NCT02793232|7628153|FG007|STARTED|Period 4 (Part A: 5 Days)||0
6698084|NCT02793232|7628154|FG008|STARTED|Period 4 (Part A: 5 Days)||0
6698085|NCT02793232|7628146|FG000|COMPLETED|Period 4 (Part A: 5 Days)||2
6698086|NCT02793232|7628147|FG001|COMPLETED|Period 4 (Part A: 5 Days)||2
6698087|NCT02793232|7628148|FG002|COMPLETED|Period 4 (Part A: 5 Days)||2
6698088|NCT02793232|7628149|FG003|COMPLETED|Period 4 (Part A: 5 Days)||2
6698089|NCT02793232|7628150|FG004|COMPLETED|Period 4 (Part A: 5 Days)||0
6698090|NCT02793232|7628151|FG005|COMPLETED|Period 4 (Part A: 5 Days)||0
6698091|NCT02793232|7628152|FG006|COMPLETED|Period 4 (Part A: 5 Days)||0
6698092|NCT02793232|7628153|FG007|COMPLETED|Period 4 (Part A: 5 Days)||0
6698093|NCT02793232|7628154|FG008|COMPLETED|Period 4 (Part A: 5 Days)||0
6698094|NCT02793232|7628146|FG000|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698095|NCT02793232|7628147|FG001|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698096|NCT02793232|7628148|FG002|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698097|NCT02793232|7628149|FG003|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698098|NCT02793232|7628150|FG004|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698099|NCT02793232|7628151|FG005|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698100|NCT02793232|7628152|FG006|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698101|NCT02793232|7628153|FG007|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698102|NCT02793232|7628154|FG008|NOT COMPLETED|Period 4 (Part A: 5 Days)||0
6698103|NCT02793622|7628190|FG000|STARTED|Overall Study||391
6698104|NCT02793622|7628191|FG001|STARTED|Overall Study||391
6698105|NCT02793622|7628190|FG000|COMPLETED|Overall Study||338
6698106|NCT02793622|7628191|FG001|COMPLETED|Overall Study||349
6698107|NCT02793622|7628190|FG000|NOT COMPLETED|Overall Study||53
6698108|NCT02793622|7628191|FG001|NOT COMPLETED|Overall Study||42
6698109|NCT02793674|7628199|FG000|STARTED|Overall Study||9
6698110|NCT02793674|7628200|FG001|STARTED|Overall Study||12
6698111|NCT02793674|7628199|FG000|COMPLETED|Overall Study||9
6698112|NCT02793674|7628200|FG001|COMPLETED|Overall Study||12
6698113|NCT02793674|7628199|FG000|NOT COMPLETED|Overall Study||0
6698114|NCT02793674|7628200|FG001|NOT COMPLETED|Overall Study||0
6698115|NCT02793817|7628214|FG000|STARTED|Overall Study||261
6698116|NCT02793817|7628215|FG001|STARTED|Overall Study||259
6698117|NCT02793817|7628214|FG000|COMPLETED|Overall Study||258
6698118|NCT02793817|7628215|FG001|COMPLETED|Overall Study||254
6698119|NCT02793817|7628214|FG000|NOT COMPLETED|Overall Study||3
6698120|NCT02793817|7628215|FG001|NOT COMPLETED|Overall Study||5
6698121|NCT02793856|7628225|FG000|STARTED|Overall Study||2
6698122|NCT02793856|7628226|FG001|STARTED|Overall Study||4
6698123|NCT02793856|7628227|FG002|STARTED|Overall Study||3
6698124|NCT02793856|7628228|FG003|STARTED|Overall Study||3
6698125|NCT02793856|7628225|FG000|COMPLETED|Overall Study||2
6698126|NCT02793856|7628226|FG001|COMPLETED|Overall Study||4
6698127|NCT02793856|7628227|FG002|COMPLETED|Overall Study||3
6698128|NCT02793856|7628228|FG003|COMPLETED|Overall Study||3
6698129|NCT02793856|7628225|FG000|NOT COMPLETED|Overall Study||0
6698130|NCT02793856|7628226|FG001|NOT COMPLETED|Overall Study||0
6698131|NCT02793856|7628227|FG002|NOT COMPLETED|Overall Study||0
6698132|NCT02793856|7628228|FG003|NOT COMPLETED|Overall Study||0
6698133|NCT02793947|7628268|FG000|STARTED|Overall Study||47
6698134|NCT02793947|7628269|FG001|STARTED|Overall Study||55
6698135|NCT02793947|7628268|FG000|COMPLETED|Overall Study||45
6698136|NCT02793947|7628269|FG001|COMPLETED|Overall Study||50
6698137|NCT02793947|7628268|FG000|NOT COMPLETED|Overall Study||2
6698138|NCT02793947|7628269|FG001|NOT COMPLETED|Overall Study||5
6698139|NCT02794103|7628275|FG000|STARTED|Overall Study||18
6698140|NCT02794103|7628275|FG000|COMPLETED|Overall Study||15
6698141|NCT02794103|7628275|FG000|NOT COMPLETED|Overall Study||3
6698142|NCT02794207|7628281|FG000|STARTED|Overall Study||32
6698143|NCT02794207|7628282|FG001|STARTED|Overall Study||54
6698144|NCT02794207|7628281|FG000|COMPLETED|Overall Study||32
6698145|NCT02794207|7628282|FG001|COMPLETED|Overall Study||54
6698146|NCT02794207|7628281|FG000|NOT COMPLETED|Overall Study||0
6698147|NCT02794207|7628282|FG001|NOT COMPLETED|Overall Study||0
6698148|NCT02794246|7628287|FG000|STARTED|Overall Study||6
6698149|NCT02794246|7628287|FG000|Treated|Overall Study||3
6698150|NCT02794246|7628287|FG000|COMPLETED|Overall Study||0
6698151|NCT02794246|7628287|FG000|NOT COMPLETED|Overall Study||6
6698152|NCT02794441|7628293|FG000|STARTED|Overall Study||7
6698153|NCT02794441|7628294|FG001|STARTED|Overall Study||5
6698154|NCT02794441|7628293|FG000|COMPLETED|Overall Study||6
6698155|NCT02794441|7628294|FG001|COMPLETED|Overall Study||5
6698156|NCT02794441|7628293|FG000|NOT COMPLETED|Overall Study||1
6698157|NCT02794441|7628294|FG001|NOT COMPLETED|Overall Study||0
6698158|NCT02794480|7628302|FG000|STARTED|Period 1: Treatment Period 1 (28 Days)||80
6698159|NCT02794480|7628303|FG001|STARTED|Period 1: Treatment Period 1 (28 Days)||82
6698160|NCT02794480|7628304|FG002|STARTED|Period 1: Treatment Period 1 (28 Days)||81
6259677|NCT01690299|7158807|FG000|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
6259678|NCT01690299|7158808|FG001|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
6259679|NCT01690299|7158809|FG002|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
6259680|NCT01690299|7158810|FG003|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6259681|NCT01690299|7158811|FG004|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6259682|NCT01690299|7158812|FG005|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
6259683|NCT01690299|7158807|FG000|STARTED|Apremilast Extension Phase (Weeks16-104)||0
6259684|NCT01690299|7158808|FG001|STARTED|Apremilast Extension Phase (Weeks16-104)||0
6259685|NCT01690299|7158809|FG002|STARTED|Apremilast Extension Phase (Weeks16-104)||0
6259686|NCT01690299|7158810|FG003|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
6259687|NCT01690299|7158811|FG004|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
6259688|NCT01690299|7158812|FG005|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
6259689|NCT01690299|7158807|FG000|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
6259690|NCT01690299|7158808|FG001|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
6259691|NCT01690299|7158809|FG002|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
6259692|NCT01690299|7158810|FG003|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
6259693|NCT01690299|7158811|FG004|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
6259694|NCT01690299|7158812|FG005|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
6259695|NCT01690299|7158807|FG000|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6259696|NCT01690299|7158808|FG001|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6259697|NCT01690299|7158809|FG002|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6259698|NCT01690299|7158810|FG003|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
6259699|NCT01690299|7158811|FG004|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
6259700|NCT01690299|7158812|FG005|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
6259701|NCT01690299|7158807|FG000|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6259702|NCT01690299|7158808|FG001|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6259703|NCT01690299|7158809|FG002|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
6259704|NCT01690299|7158810|FG003|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
6259705|NCT01690299|7158811|FG004|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
6259706|NCT01690299|7158812|FG005|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
6259707|NCT01525329|7158835|FG000|STARTED|Overall Study||4
6259708|NCT01525329|7158836|FG001|STARTED|Overall Study||14
6259709|NCT01525329|7158835|FG000|COMPLETED|Overall Study||4
6259710|NCT01525329|7158836|FG001|COMPLETED|Overall Study||14
6259711|NCT01525329|7158835|FG000|NOT COMPLETED|Overall Study||0
6259712|NCT01525329|7158836|FG001|NOT COMPLETED|Overall Study||0
6259713|NCT01482286|7158850|FG000|STARTED|Overall Study||7
6259714|NCT01482286|7158851|FG001|STARTED|Overall Study||7
6259715|NCT01482286|7158852|FG002|STARTED|Overall Study||8
6259716|NCT01482286|7158853|FG003|STARTED|Overall Study||10
6259717|NCT01482286|7158850|FG000|COMPLETED|Overall Study||4
6259718|NCT01482286|7158851|FG001|COMPLETED|Overall Study||4
6259719|NCT01482286|7158852|FG002|COMPLETED|Overall Study||4
6259720|NCT01482286|7158853|FG003|COMPLETED|Overall Study||5
6259721|NCT01482286|7158850|FG000|NOT COMPLETED|Overall Study||3
6259722|NCT01482286|7158851|FG001|NOT COMPLETED|Overall Study||3
6259723|NCT01482286|7158852|FG002|NOT COMPLETED|Overall Study||4
6259724|NCT01482286|7158853|FG003|NOT COMPLETED|Overall Study||5
6259725|NCT01452152|7158866|FG000|STARTED|Overall Study||5
6259726|NCT01452152|7158867|FG001|STARTED|Overall Study||0
6259727|NCT01452152|7158868|FG002|STARTED|Overall Study||4
6259728|NCT01452152|7158866|FG000|COMPLETED|Overall Study||0
6259729|NCT01452152|7158867|FG001|COMPLETED|Overall Study||0
6259730|NCT01452152|7158868|FG002|COMPLETED|Overall Study||0
6259731|NCT01452152|7158866|FG000|NOT COMPLETED|Overall Study||5
6259732|NCT01452152|7158867|FG001|NOT COMPLETED|Overall Study||0
6259733|NCT01452152|7158868|FG002|NOT COMPLETED|Overall Study||4
6259734|NCT01420926|7158878|FG000|STARTED|Overall Study||82
6259735|NCT01420926|7158879|FG001|STARTED|Overall Study||81
6698161|NCT02794480|7628305|FG003|STARTED|Period 1: Treatment Period 1 (28 Days)||81
6698162|NCT02794480|7628302|FG000|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
6698163|NCT02794480|7628303|FG001|COMPLETED|Period 1: Treatment Period 1 (28 Days)||80
6698164|NCT02794480|7628304|FG002|COMPLETED|Period 1: Treatment Period 1 (28 Days)||79
6698165|NCT02794480|7628305|FG003|COMPLETED|Period 1: Treatment Period 1 (28 Days)||78
6698166|NCT02794480|7628302|FG000|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||0
6698167|NCT02794480|7628303|FG001|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
6698168|NCT02794480|7628304|FG002|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||2
6698169|NCT02794480|7628305|FG003|NOT COMPLETED|Period 1: Treatment Period 1 (28 Days)||3
6698170|NCT02794480|7628302|FG000|STARTED|Period 2: Treatment Period 2 (28 Days)||80
6698171|NCT02794480|7628303|FG001|STARTED|Period 2: Treatment Period 2 (28 Days)||80
6698172|NCT02794480|7628304|FG002|STARTED|Period 2: Treatment Period 2 (28 Days)||79
6698173|NCT02794480|7628305|FG003|STARTED|Period 2: Treatment Period 2 (28 Days)||78
6698174|NCT02794480|7628302|FG000|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
6698175|NCT02794480|7628303|FG001|COMPLETED|Period 2: Treatment Period 2 (28 Days)||80
6698176|NCT02794480|7628304|FG002|COMPLETED|Period 2: Treatment Period 2 (28 Days)||79
6698177|NCT02794480|7628305|FG003|COMPLETED|Period 2: Treatment Period 2 (28 Days)||77
6698178|NCT02794480|7628302|FG000|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
6698179|NCT02794480|7628303|FG001|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
6698180|NCT02794480|7628304|FG002|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||0
6698181|NCT02794480|7628305|FG003|NOT COMPLETED|Period 2: Treatment Period 2 (28 Days)||1
6698182|NCT02794597|7628315|FG000|STARTED|Overall Study||63
6698183|NCT02794597|7628316|FG001|STARTED|Overall Study||56
6698184|NCT02794597|7628315|FG000|COMPLETED|Overall Study||63
6698185|NCT02794597|7628316|FG001|COMPLETED|Overall Study||56
6698186|NCT02794597|7628315|FG000|NOT COMPLETED|Overall Study||0
6698187|NCT02794597|7628316|FG001|NOT COMPLETED|Overall Study||0
6698188|NCT02794727|7628325|FG000|STARTED|Overall Study||44
6698189|NCT02794727|7628326|FG001|STARTED|Overall Study||46
6698190|NCT02794727|7628327|FG002|STARTED|Overall Study||45
6698191|NCT02794727|7628325|FG000|COMPLETED|Overall Study||44
6698192|NCT02794727|7628326|FG001|COMPLETED|Overall Study||46
6698193|NCT02794727|7628327|FG002|COMPLETED|Overall Study||44
6698194|NCT02794727|7628325|FG000|NOT COMPLETED|Overall Study||0
6698195|NCT02794727|7628326|FG001|NOT COMPLETED|Overall Study||0
6698196|NCT02794727|7628327|FG002|NOT COMPLETED|Overall Study||1
6698197|NCT02794766|7628337|FG000|STARTED|Overall Study||15
6698198|NCT02794766|7628338|FG001|STARTED|Overall Study||15
6698199|NCT02794766|7628339|FG002|STARTED|Overall Study||15
6698200|NCT02794766|7628337|FG000|COMPLETED|Overall Study||15
6698201|NCT02794766|7628338|FG001|COMPLETED|Overall Study||15
6698202|NCT02794766|7628339|FG002|COMPLETED|Overall Study||14
6698203|NCT02794766|7628337|FG000|NOT COMPLETED|Overall Study||0
6698204|NCT02794766|7628338|FG001|NOT COMPLETED|Overall Study||0
6698205|NCT02794766|7628339|FG002|NOT COMPLETED|Overall Study||1
6698206|NCT02794844|7628347|FG000|STARTED|Overall Study||28
6698207|NCT02794844|7628347|FG000|COMPLETED|Overall Study||23
6698208|NCT02794844|7628347|FG000|NOT COMPLETED|Overall Study||5
6698209|NCT02794870|7628353|FG000|STARTED|Overall Study||22
6698210|NCT02794870|7628354|FG001|STARTED|Overall Study||11
6698211|NCT02794870|7628353|FG000|Received Inoculation|Overall Study||21
6698212|NCT02794870|7628354|FG001|Received Inoculation|Overall Study||11
6698213|NCT02794870|7628353|FG000|COMPLETED|Overall Study||20
6698214|NCT02794870|7628354|FG001|COMPLETED|Overall Study||11
6698215|NCT02794870|7628353|FG000|NOT COMPLETED|Overall Study||2
6698216|NCT02794870|7628354|FG001|NOT COMPLETED|Overall Study||0
6698217|NCT02794974|7628362|FG000|STARTED|Overall Study||14
6698218|NCT02794974|7628363|FG001|STARTED|Overall Study||15
6698219|NCT02794974|7628362|FG000|COMPLETED|Overall Study||14
6698220|NCT02794974|7628363|FG001|COMPLETED|Overall Study||14
6698221|NCT02794974|7628362|FG000|NOT COMPLETED|Overall Study||0
6698222|NCT02794974|7628363|FG001|NOT COMPLETED|Overall Study||1
6698223|NCT02795117|7628372|FG000|STARTED|Overall Study||193
6698224|NCT02795117|7628373|FG001|STARTED|Overall Study||193
6698225|NCT02795117|7628374|FG002|STARTED|Overall Study||100
6698226|NCT02795117|7628372|FG000|COMPLETED|Overall Study||175
6698227|NCT02795117|7628373|FG001|COMPLETED|Overall Study||166
6698228|NCT02795117|7628374|FG002|COMPLETED|Overall Study||88
6698229|NCT02795117|7628372|FG000|NOT COMPLETED|Overall Study||18
6698230|NCT02795117|7628373|FG001|NOT COMPLETED|Overall Study||27
6698231|NCT02795117|7628374|FG002|NOT COMPLETED|Overall Study||12
6698232|NCT02795767|7628385|FG000|STARTED|Overall Study||68
6698233|NCT02795767|7628386|FG001|STARTED|Overall Study||10
6698234|NCT02795767|7628387|FG002|STARTED|Overall Study||10
6698235|NCT02795767|7628385|FG000|Received at Least One Dose of Emicizumab|Overall Study||68
6698236|NCT02795767|7628386|FG001|Received at Least One Dose of Emicizumab|Overall Study||10
6698237|NCT02795767|7628387|FG002|Received at Least One Dose of Emicizumab|Overall Study||10
6698238|NCT02795767|7628385|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
6698239|NCT02795767|7628386|FG001|Dose Up-Titrated to 3 mg/kg QW|Overall Study||0
6698240|NCT02795767|7628387|FG002|Dose Up-Titrated to 3 mg/kg QW|Overall Study||3
6698241|NCT02795767|7628385|FG000|Completed 52 Weeks in Study|Overall Study||67
6698242|NCT02795767|7628386|FG001|Completed 52 Weeks in Study|Overall Study||10
6698243|NCT02795767|7628387|FG002|Completed 52 Weeks in Study|Overall Study||9
6698244|NCT02795767|7628385|FG000|COMPLETED|Overall Study||67
6698245|NCT02795767|7628386|FG001|COMPLETED|Overall Study||10
6698246|NCT02795767|7628387|FG002|COMPLETED|Overall Study||10
6698247|NCT02795767|7628385|FG000|NOT COMPLETED|Overall Study||1
6698248|NCT02795767|7628386|FG001|NOT COMPLETED|Overall Study||0
6698249|NCT02795767|7628387|FG002|NOT COMPLETED|Overall Study||0
6698250|NCT02795780|7628401|FG000|STARTED|Overall Study||25
6698251|NCT02795780|7628402|FG001|STARTED|Overall Study||54
6698252|NCT02795780|7628401|FG000|COMPLETED|Overall Study||25
6698253|NCT02795780|7628402|FG001|COMPLETED|Overall Study||54
6698254|NCT02795780|7628401|FG000|NOT COMPLETED|Overall Study||0
6698255|NCT02795780|7628402|FG001|NOT COMPLETED|Overall Study||0
6698256|NCT02795819|7628410|FG000|STARTED|Overall Study||0
6698257|NCT02795819|7628411|FG001|STARTED|Overall Study||6
6698258|NCT02795819|7628412|FG002|STARTED|Overall Study||0
6698259|NCT02795819|7628413|FG003|STARTED|Overall Study||0
6698260|NCT02795819|7628414|FG004|STARTED|Overall Study||0
6698261|NCT02795819|7628415|FG005|STARTED|Overall Study||0
6698262|NCT02795819|7628416|FG006|STARTED|Overall Study||0
6698263|NCT02795819|7628410|FG000|COMPLETED|Overall Study||0
6698264|NCT02795819|7628411|FG001|COMPLETED|Overall Study||6
6698265|NCT02795819|7628412|FG002|COMPLETED|Overall Study||0
6698266|NCT02795819|7628413|FG003|COMPLETED|Overall Study||0
6698267|NCT02795819|7628414|FG004|COMPLETED|Overall Study||0
6698268|NCT02795819|7628415|FG005|COMPLETED|Overall Study||0
6698269|NCT02795819|7628416|FG006|COMPLETED|Overall Study||0
6698270|NCT02795819|7628410|FG000|NOT COMPLETED|Overall Study||0
6698271|NCT02795819|7628411|FG001|NOT COMPLETED|Overall Study||0
6698272|NCT02795819|7628412|FG002|NOT COMPLETED|Overall Study||0
6698273|NCT02795819|7628413|FG003|NOT COMPLETED|Overall Study||0
6698274|NCT02795819|7628414|FG004|NOT COMPLETED|Overall Study||0
6698275|NCT02795819|7628415|FG005|NOT COMPLETED|Overall Study||0
6698276|NCT02795819|7628416|FG006|NOT COMPLETED|Overall Study||0
6259736|NCT01420926|7158878|FG000|COMPLETED|Overall Study||22
6259737|NCT01420926|7158879|FG001|COMPLETED|Overall Study||16
6259738|NCT01420926|7158878|FG000|NOT COMPLETED|Overall Study||60
6259739|NCT01420926|7158879|FG001|NOT COMPLETED|Overall Study||65
6259740|NCT01386385|7158890|FG000|STARTED|Phase I 40mg: Concurrent CRT||8
6259741|NCT01386385|7158891|FG001|STARTED|Phase I 40mg: Concurrent CRT||0
6259742|NCT01386385|7158892|FG002|STARTED|Phase I 40mg: Concurrent CRT||0
6259743|NCT01386385|7158893|FG003|STARTED|Phase I 40mg: Concurrent CRT||0
6259744|NCT01386385|7158894|FG004|STARTED|Phase I 40mg: Concurrent CRT||0
6259745|NCT01386385|7158895|FG005|STARTED|Phase I 40mg: Concurrent CRT||0
6259746|NCT01386385|7158896|FG006|STARTED|Phase I 40mg: Concurrent CRT||0
6259747|NCT01386385|7158897|FG007|STARTED|Phase I 40mg: Concurrent CRT||0
6259748|NCT01386385|7158890|FG000|COMPLETED|Phase I 40mg: Concurrent CRT||6
6259749|NCT01386385|7158891|FG001|COMPLETED|Phase I 40mg: Concurrent CRT||0
6259750|NCT01386385|7158892|FG002|COMPLETED|Phase I 40mg: Concurrent CRT||0
6259751|NCT01386385|7158893|FG003|COMPLETED|Phase I 40mg: Concurrent CRT||0
6259752|NCT01386385|7158894|FG004|COMPLETED|Phase I 40mg: Concurrent CRT||0
6259753|NCT01386385|7158895|FG005|COMPLETED|Phase I 40mg: Concurrent CRT||0
6259754|NCT01386385|7158896|FG006|COMPLETED|Phase I 40mg: Concurrent CRT||0
6259755|NCT01386385|7158897|FG007|COMPLETED|Phase I 40mg: Concurrent CRT||0
6259756|NCT01386385|7158890|FG000|NOT COMPLETED|Phase I 40mg: Concurrent CRT||2
6259757|NCT01386385|7158891|FG001|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
6259758|NCT01386385|7158892|FG002|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
6259759|NCT01386385|7158893|FG003|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
6259760|NCT01386385|7158894|FG004|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
6259761|NCT01386385|7158895|FG005|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
6259762|NCT01386385|7158896|FG006|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
6259763|NCT01386385|7158897|FG007|NOT COMPLETED|Phase I 40mg: Concurrent CRT||0
6259764|NCT01386385|7158890|FG000|STARTED|Phase I 40mg: Consolidation Therapy||0
6259765|NCT01386385|7158891|FG001|STARTED|Phase I 40mg: Consolidation Therapy||4
6259766|NCT01386385|7158892|FG002|STARTED|Phase I 40mg: Consolidation Therapy||0
6259767|NCT01386385|7158893|FG003|STARTED|Phase I 40mg: Consolidation Therapy||0
6259768|NCT01386385|7158894|FG004|STARTED|Phase I 40mg: Consolidation Therapy||0
6259769|NCT01386385|7158895|FG005|STARTED|Phase I 40mg: Consolidation Therapy||0
6259770|NCT01386385|7158896|FG006|STARTED|Phase I 40mg: Consolidation Therapy||0
6259771|NCT01386385|7158897|FG007|STARTED|Phase I 40mg: Consolidation Therapy||0
6259772|NCT01386385|7158890|FG000|COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259773|NCT01386385|7158891|FG001|COMPLETED|Phase I 40mg: Consolidation Therapy||4
6259774|NCT01386385|7158892|FG002|COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259775|NCT01386385|7158893|FG003|COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259776|NCT01386385|7158894|FG004|COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259777|NCT01386385|7158895|FG005|COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259778|NCT01386385|7158896|FG006|COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259779|NCT01386385|7158897|FG007|COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259780|NCT01386385|7158890|FG000|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259781|NCT01386385|7158891|FG001|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259782|NCT01386385|7158892|FG002|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259783|NCT01386385|7158893|FG003|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
6698277|NCT02795832|7628432|FG000|STARTED|Overall Study||8
6698278|NCT02795832|7628433|FG001|STARTED|Overall Study||4
6698279|NCT02795832|7628434|FG002|STARTED|Overall Study||8
6698280|NCT02795832|7628435|FG003|STARTED|Overall Study||3
6698281|NCT02795832|7628436|FG004|STARTED|Overall Study||20
6698282|NCT02795832|7628437|FG005|STARTED|Overall Study||10
6698283|NCT02795832|7628432|FG000|COMPLETED|Overall Study||8
6698284|NCT02795832|7628433|FG001|COMPLETED|Overall Study||4
6698285|NCT02795832|7628434|FG002|COMPLETED|Overall Study||8
6698286|NCT02795832|7628435|FG003|COMPLETED|Overall Study||3
6698287|NCT02795832|7628436|FG004|COMPLETED|Overall Study||20
6698288|NCT02795832|7628437|FG005|COMPLETED|Overall Study||7
6698289|NCT02795832|7628432|FG000|NOT COMPLETED|Overall Study||0
6698290|NCT02795832|7628433|FG001|NOT COMPLETED|Overall Study||0
6698291|NCT02795832|7628434|FG002|NOT COMPLETED|Overall Study||0
6698292|NCT02795832|7628435|FG003|NOT COMPLETED|Overall Study||0
6698293|NCT02795832|7628436|FG004|NOT COMPLETED|Overall Study||0
6698294|NCT02795832|7628437|FG005|NOT COMPLETED|Overall Study||3
6698295|NCT02796092|7628461|FG000|STARTED|Overall Study||50
6698296|NCT02796092|7628462|FG001|STARTED|Overall Study||50
6698297|NCT02796092|7628461|FG000|COMPLETED|Overall Study||50
6698298|NCT02796092|7628462|FG001|COMPLETED|Overall Study||50
6698299|NCT02796092|7628461|FG000|NOT COMPLETED|Overall Study||0
6698300|NCT02796092|7628462|FG001|NOT COMPLETED|Overall Study||0
6698301|NCT02796144|7628471|FG000|STARTED|Overall Study||23
6698302|NCT02796144|7628472|FG001|STARTED|Overall Study||24
6698303|NCT02796144|7628473|FG002|STARTED|Overall Study||24
6698304|NCT02796144|7628471|FG000|COMPLETED|Overall Study||18
6698305|NCT02796144|7628472|FG001|COMPLETED|Overall Study||21
6698306|NCT02796144|7628473|FG002|COMPLETED|Overall Study||18
6698307|NCT02796144|7628471|FG000|NOT COMPLETED|Overall Study||5
6698308|NCT02796144|7628472|FG001|NOT COMPLETED|Overall Study||3
6259784|NCT01386385|7158894|FG004|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259785|NCT01386385|7158895|FG005|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259786|NCT01386385|7158896|FG006|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259787|NCT01386385|7158897|FG007|NOT COMPLETED|Phase I 40mg: Consolidation Therapy||0
6259788|NCT01386385|7158890|FG000|STARTED|Phase I 80mg: Concurrent CRT||0
6259789|NCT01386385|7158891|FG001|STARTED|Phase I 80mg: Concurrent CRT||0
6259790|NCT01386385|7158892|FG002|STARTED|Phase I 80mg: Concurrent CRT||7
6259791|NCT01386385|7158893|FG003|STARTED|Phase I 80mg: Concurrent CRT||0
6259792|NCT01386385|7158894|FG004|STARTED|Phase I 80mg: Concurrent CRT||0
6259793|NCT01386385|7158895|FG005|STARTED|Phase I 80mg: Concurrent CRT||0
6259794|NCT01386385|7158896|FG006|STARTED|Phase I 80mg: Concurrent CRT||0
6259795|NCT01386385|7158897|FG007|STARTED|Phase I 80mg: Concurrent CRT||0
6259796|NCT01386385|7158890|FG000|COMPLETED|Phase I 80mg: Concurrent CRT||0
6259797|NCT01386385|7158891|FG001|COMPLETED|Phase I 80mg: Concurrent CRT||0
6259798|NCT01386385|7158892|FG002|COMPLETED|Phase I 80mg: Concurrent CRT||5
6259799|NCT01386385|7158893|FG003|COMPLETED|Phase I 80mg: Concurrent CRT||0
6259800|NCT01386385|7158894|FG004|COMPLETED|Phase I 80mg: Concurrent CRT||0
6259801|NCT01386385|7158895|FG005|COMPLETED|Phase I 80mg: Concurrent CRT||0
6259802|NCT01386385|7158896|FG006|COMPLETED|Phase I 80mg: Concurrent CRT||0
6259803|NCT01386385|7158897|FG007|COMPLETED|Phase I 80mg: Concurrent CRT||0
6259804|NCT01386385|7158890|FG000|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
6259805|NCT01386385|7158891|FG001|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
6259806|NCT01386385|7158892|FG002|NOT COMPLETED|Phase I 80mg: Concurrent CRT||2
6259807|NCT01386385|7158893|FG003|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
6259808|NCT01386385|7158894|FG004|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
6259809|NCT01386385|7158895|FG005|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
6259810|NCT01386385|7158896|FG006|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
6259811|NCT01386385|7158897|FG007|NOT COMPLETED|Phase I 80mg: Concurrent CRT||0
6259812|NCT01386385|7158890|FG000|STARTED|Phase I 80mg: Consolidation Therapy||0
6259813|NCT01386385|7158891|FG001|STARTED|Phase I 80mg: Consolidation Therapy||0
6259814|NCT01386385|7158892|FG002|STARTED|Phase I 80mg: Consolidation Therapy||0
6259815|NCT01386385|7158893|FG003|STARTED|Phase I 80mg: Consolidation Therapy||5
6259816|NCT01386385|7158894|FG004|STARTED|Phase I 80mg: Consolidation Therapy||0
6259817|NCT01386385|7158895|FG005|STARTED|Phase I 80mg: Consolidation Therapy||0
6259818|NCT01386385|7158896|FG006|STARTED|Phase I 80mg: Consolidation Therapy||0
6259819|NCT01386385|7158897|FG007|STARTED|Phase I 80mg: Consolidation Therapy||0
6259820|NCT01386385|7158890|FG000|COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259821|NCT01386385|7158891|FG001|COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259822|NCT01386385|7158892|FG002|COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259823|NCT01386385|7158893|FG003|COMPLETED|Phase I 80mg: Consolidation Therapy||5
6259824|NCT01386385|7158894|FG004|COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259825|NCT01386385|7158895|FG005|COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259826|NCT01386385|7158896|FG006|COMPLETED|Phase I 80mg: Consolidation Therapy||0
6698309|NCT02796144|7628473|FG002|NOT COMPLETED|Overall Study||6
6698310|NCT02796274|7628483|FG000|STARTED|Overall Study||219
6698311|NCT02796274|7628483|FG000|COMPLETED|Overall Study||219
6698312|NCT02796274|7628483|FG000|NOT COMPLETED|Overall Study||0
6698313|NCT02796300|7628489|FG000|STARTED|Overall Study||10
6698314|NCT02796300|7628490|FG001|STARTED|Overall Study||22
6698315|NCT02796300|7628489|FG000|COMPLETED|Overall Study||10
6698316|NCT02796300|7628490|FG001|COMPLETED|Overall Study||22
6698317|NCT02796300|7628489|FG000|NOT COMPLETED|Overall Study||0
6698318|NCT02796300|7628490|FG001|NOT COMPLETED|Overall Study||0
6698319|NCT02796352|7628496|FG000|STARTED|Overall Study||1
6259827|NCT01386385|7158897|FG007|COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259828|NCT01386385|7158890|FG000|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
6698320|NCT02796352|7628496|FG000|COMPLETED|Overall Study||1
6698321|NCT02796352|7628496|FG000|NOT COMPLETED|Overall Study||0
6698322|NCT02796560|7628502|FG000|STARTED|Overall Study||38
6698323|NCT02796560|7628503|FG001|STARTED|Overall Study||38
6698324|NCT02796560|7628502|FG000|COMPLETED|Overall Study||34
6698325|NCT02796560|7628503|FG001|COMPLETED|Overall Study||36
6698326|NCT02796560|7628502|FG000|NOT COMPLETED|Overall Study||4
6698327|NCT02796560|7628503|FG001|NOT COMPLETED|Overall Study||2
6698328|NCT02796625|7628509|FG000|STARTED|Overall Study||80
6698329|NCT02796625|7628509|FG000|COMPLETED|Overall Study||61
6698330|NCT02796625|7628509|FG000|NOT COMPLETED|Overall Study||19
6698331|NCT02796651|7628513|FG000|STARTED|Overall Study||132
6698332|NCT02796651|7628513|FG000|Formoterol Fumarate (FF) 6 μg|Overall Study||107
6698333|NCT02796651|7628513|FG000|Formoterol Fumarate (FF) 12 μg|Overall Study||121
6698334|NCT02796651|7628513|FG000|Formoterol Fumarate (FF) 24 μg|Overall Study||105
6698335|NCT02796651|7628513|FG000|Perforomist 20 μg|Overall Study||118
6698336|NCT02796651|7628513|FG000|Perforomist 40 μg|Overall Study||108
6698337|NCT02796651|7628513|FG000|Placebo (Lactose Monohydrate)|Overall Study||38
6698338|NCT02796651|7628513|FG000|COMPLETED|Overall Study||106
6698339|NCT02796651|7628513|FG000|NOT COMPLETED|Overall Study||26
6698340|NCT02796664|7628530|FG000|STARTED|Overall Study||29
6698341|NCT02796664|7628531|FG001|STARTED|Overall Study||29
6698342|NCT02796664|7628530|FG000|COMPLETED|Overall Study||28
6698343|NCT02796664|7628531|FG001|COMPLETED|Overall Study||24
6698344|NCT02796664|7628530|FG000|NOT COMPLETED|Overall Study||1
6698345|NCT02796664|7628531|FG001|NOT COMPLETED|Overall Study||5
6698346|NCT02796677|7628543|FG000|STARTED|Overall Study||317
6698347|NCT02796677|7628544|FG001|STARTED|Overall Study||478
6698348|NCT02796677|7628545|FG002|STARTED|Overall Study||320
6698349|NCT02796677|7628546|FG003|STARTED|Overall Study||479
6698350|NCT02796677|7628543|FG000|Completed Treatment and Follow-up|Overall Study||279
6698351|NCT02796677|7628544|FG001|Completed Treatment and Follow-up|Overall Study||405
6698352|NCT02796677|7628545|FG002|Completed Treatment and Follow-up|Overall Study||267
6698353|NCT02796677|7628546|FG003|Completed Treatment and Follow-up|Overall Study||403
6698354|NCT02796677|7628543|FG000|COMPLETED|Overall Study||279
6698355|NCT02796677|7628544|FG001|COMPLETED|Overall Study||405
6698356|NCT02796677|7628545|FG002|COMPLETED|Overall Study||267
6698357|NCT02796677|7628546|FG003|COMPLETED|Overall Study||405
6698358|NCT02796677|7628543|FG000|NOT COMPLETED|Overall Study||38
6698359|NCT02796677|7628544|FG001|NOT COMPLETED|Overall Study||73
6698360|NCT02796677|7628545|FG002|NOT COMPLETED|Overall Study||53
6698361|NCT02796677|7628546|FG003|NOT COMPLETED|Overall Study||74
6698362|NCT02796755|7628560|FG000|STARTED|Overall Study||15
6698363|NCT02796755|7628561|FG001|STARTED|Overall Study||15
6698364|NCT02796755|7628560|FG000|COMPLETED|Overall Study||13
6698365|NCT02796755|7628561|FG001|COMPLETED|Overall Study||15
6698366|NCT02796755|7628560|FG000|NOT COMPLETED|Overall Study||2
6698367|NCT02796755|7628561|FG001|NOT COMPLETED|Overall Study||0
6698368|NCT02796924|7628567|FG000|STARTED|Overall Study||10
6698369|NCT02796924|7628567|FG000|COMPLETED|Overall Study||10
6698370|NCT02796924|7628567|FG000|NOT COMPLETED|Overall Study||0
6698371|NCT02796963|7628575|FG000|STARTED|Overall Study||383
6698372|NCT02796963|7628576|FG001|STARTED|Overall Study||328
6698373|NCT02796963|7628577|FG002|STARTED|Overall Study||316
6698374|NCT02796963|7628578|FG003|STARTED|Overall Study||354
6698375|NCT02796963|7628575|FG000|First Follow up|Overall Study||293
6698376|NCT02796963|7628576|FG001|First Follow up|Overall Study||279
6698377|NCT02796963|7628577|FG002|First Follow up|Overall Study||257
6698378|NCT02796963|7628578|FG003|First Follow up|Overall Study||291
6698379|NCT02796963|7628575|FG000|Second Follow up|Overall Study||280
6698380|NCT02796963|7628576|FG001|Second Follow up|Overall Study||260
6698381|NCT02796963|7628577|FG002|Second Follow up|Overall Study||255
6698382|NCT02796963|7628578|FG003|Second Follow up|Overall Study||293
6698383|NCT02796963|7628575|FG000|Third Follow up|Overall Study||276
6698384|NCT02796963|7628576|FG001|Third Follow up|Overall Study||237
6698385|NCT02796963|7628577|FG002|Third Follow up|Overall Study||245
6698386|NCT02796963|7628578|FG003|Third Follow up|Overall Study||286
6698387|NCT02796963|7628575|FG000|Fourth Follow up|Overall Study||275
6698388|NCT02796963|7628576|FG001|Fourth Follow up|Overall Study||233
6698389|NCT02796963|7628577|FG002|Fourth Follow up|Overall Study||236
6698390|NCT02796963|7628578|FG003|Fourth Follow up|Overall Study||263
6698391|NCT02796963|7628575|FG000|HIV Sero Converted|Overall Study||19
6698392|NCT02796963|7628576|FG001|HIV Sero Converted|Overall Study||19
6698393|NCT02796963|7628577|FG002|HIV Sero Converted|Overall Study||11
6698394|NCT02796963|7628578|FG003|HIV Sero Converted|Overall Study||19
6698395|NCT02796963|7628575|FG000|COMPLETED|Overall Study||294
6698396|NCT02796963|7628576|FG001|COMPLETED|Overall Study||252
6698397|NCT02796963|7628577|FG002|COMPLETED|Overall Study||247
6698398|NCT02796963|7628578|FG003|COMPLETED|Overall Study||282
6698399|NCT02796963|7628575|FG000|NOT COMPLETED|Overall Study||89
6698400|NCT02796963|7628576|FG001|NOT COMPLETED|Overall Study||76
6698401|NCT02796963|7628577|FG002|NOT COMPLETED|Overall Study||69
6698402|NCT02796963|7628578|FG003|NOT COMPLETED|Overall Study||72
6698403|NCT02797054|7628591|FG000|STARTED|Post-test||387
6698404|NCT02797054|7628592|FG001|STARTED|Post-test||383
6698405|NCT02797054|7628593|FG002|STARTED|Post-test||435
6698406|NCT02797054|7628591|FG000|COMPLETED|Post-test||380
6698407|NCT02797054|7628592|FG001|COMPLETED|Post-test||372
6698408|NCT02797054|7628593|FG002|COMPLETED|Post-test||87
6698409|NCT02797054|7628591|FG000|NOT COMPLETED|Post-test||7
6698410|NCT02797054|7628592|FG001|NOT COMPLETED|Post-test||11
6698411|NCT02797054|7628593|FG002|NOT COMPLETED|Post-test||348
6698412|NCT02797054|7628591|FG000|STARTED|Follow-up||387
6698413|NCT02797054|7628592|FG001|STARTED|Follow-up||383
6698414|NCT02797054|7628593|FG002|STARTED|Follow-up||435
6698415|NCT02797054|7628591|FG000|COMPLETED|Follow-up||178
6698416|NCT02797054|7628592|FG001|COMPLETED|Follow-up||155
6698417|NCT02797054|7628593|FG002|COMPLETED|Follow-up||150
6698418|NCT02797054|7628591|FG000|NOT COMPLETED|Follow-up||209
6698419|NCT02797054|7628592|FG001|NOT COMPLETED|Follow-up||228
6698420|NCT02797054|7628593|FG002|NOT COMPLETED|Follow-up||285
6698421|NCT02797080|7628601|FG000|STARTED|Overall Study||38
6698422|NCT02797080|7628601|FG000|COMPLETED|Overall Study||36
6698423|NCT02797080|7628601|FG000|NOT COMPLETED|Overall Study||2
6698424|NCT02797132|7628605|FG000|STARTED|Part A (15 Days)||12
6698425|NCT02797132|7628605|FG000|Part A (<14 kg Weight)|Part A (15 Days)||4
6698426|NCT02797132|7628605|FG000|Part A (>=14 kg Weight)|Part A (15 Days)||8
6698427|NCT02797132|7628605|FG000|COMPLETED|Part A (15 Days)||11
6698428|NCT02797132|7628605|FG000|NOT COMPLETED|Part A (15 Days)||1
6698429|NCT02797132|7628605|FG000|STARTED|Part B (24 Weeks)|Participants from Part A may have participated in Part B.|60
6698430|NCT02797132|7628605|FG000|Part B (<14 kg Weight)|Part B (24 Weeks)||19
6698431|NCT02797132|7628605|FG000|Part B (>=14 kg Weight)|Part B (24 Weeks)||41
6698432|NCT02797132|7628605|FG000|COMPLETED|Part B (24 Weeks)||57
6698433|NCT02797132|7628605|FG000|NOT COMPLETED|Part B (24 Weeks)||3
6698434|NCT02797171|7628624|FG000|STARTED|Overall Study||23
6698435|NCT02797171|7628625|FG001|STARTED|Overall Study||23
6698436|NCT02797171|7628626|FG002|STARTED|Overall Study||7
6698437|NCT02797171|7628627|FG003|STARTED|Overall Study||16
6698438|NCT02797171|7628628|FG004|STARTED|Overall Study||10
6698439|NCT02797171|7628629|FG005|STARTED|Overall Study||1
6698440|NCT02797171|7628624|FG000|Safety Population|Overall Study||23
6698441|NCT02797171|7628625|FG001|Safety Population|Overall Study||23
6698442|NCT02797171|7628626|FG002|Safety Population|Overall Study||7
6698443|NCT02797171|7628627|FG003|Safety Population|Overall Study||16
6698444|NCT02797171|7628628|FG004|Safety Population|Overall Study||10
6698445|NCT02797171|7628629|FG005|Safety Population|Overall Study||1
6698446|NCT02797171|7628624|FG000|COMPLETED|Overall Study||19
6698447|NCT02797171|7628625|FG001|COMPLETED|Overall Study||21
6698448|NCT02797171|7628626|FG002|COMPLETED|Overall Study||5
6698449|NCT02797171|7628627|FG003|COMPLETED|Overall Study||15
6698450|NCT02797171|7628628|FG004|COMPLETED|Overall Study||8
6698451|NCT02797171|7628629|FG005|COMPLETED|Overall Study||0
6698452|NCT02797171|7628624|FG000|NOT COMPLETED|Overall Study||4
6698453|NCT02797171|7628625|FG001|NOT COMPLETED|Overall Study||2
6698454|NCT02797171|7628626|FG002|NOT COMPLETED|Overall Study||2
6698455|NCT02797171|7628627|FG003|NOT COMPLETED|Overall Study||1
6698456|NCT02797171|7628628|FG004|NOT COMPLETED|Overall Study||2
6259829|NCT01386385|7158891|FG001|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259830|NCT01386385|7158892|FG002|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259831|NCT01386385|7158893|FG003|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259832|NCT01386385|7158894|FG004|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259833|NCT01386385|7158895|FG005|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259834|NCT01386385|7158896|FG006|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259835|NCT01386385|7158897|FG007|NOT COMPLETED|Phase I 80mg: Consolidation Therapy||0
6259836|NCT01386385|7158890|FG000|STARTED|Phase I 120mg: Concurrent CRT||0
6259837|NCT01386385|7158891|FG001|STARTED|Phase I 120mg: Concurrent CRT||0
6259838|NCT01386385|7158892|FG002|STARTED|Phase I 120mg: Concurrent CRT||0
6259839|NCT01386385|7158893|FG003|STARTED|Phase I 120mg: Concurrent CRT||0
6259840|NCT01386385|7158894|FG004|STARTED|Phase I 120mg: Concurrent CRT||6
6259841|NCT01386385|7158895|FG005|STARTED|Phase I 120mg: Concurrent CRT||0
6259842|NCT01386385|7158896|FG006|STARTED|Phase I 120mg: Concurrent CRT||0
6259843|NCT01386385|7158897|FG007|STARTED|Phase I 120mg: Concurrent CRT||0
6259844|NCT01386385|7158890|FG000|COMPLETED|Phase I 120mg: Concurrent CRT||0
6259845|NCT01386385|7158891|FG001|COMPLETED|Phase I 120mg: Concurrent CRT||0
6259846|NCT01386385|7158892|FG002|COMPLETED|Phase I 120mg: Concurrent CRT||0
6259847|NCT01386385|7158893|FG003|COMPLETED|Phase I 120mg: Concurrent CRT||0
6259848|NCT01386385|7158894|FG004|COMPLETED|Phase I 120mg: Concurrent CRT||5
6259849|NCT01386385|7158895|FG005|COMPLETED|Phase I 120mg: Concurrent CRT||0
6259850|NCT01386385|7158896|FG006|COMPLETED|Phase I 120mg: Concurrent CRT||0
6259851|NCT01386385|7158897|FG007|COMPLETED|Phase I 120mg: Concurrent CRT||0
6259852|NCT01386385|7158890|FG000|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
6259853|NCT01386385|7158891|FG001|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
6259854|NCT01386385|7158892|FG002|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
6259855|NCT01386385|7158893|FG003|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
6259856|NCT01386385|7158894|FG004|NOT COMPLETED|Phase I 120mg: Concurrent CRT||1
6259857|NCT01386385|7158895|FG005|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
6259858|NCT01386385|7158896|FG006|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
6698457|NCT02797171|7628629|FG005|NOT COMPLETED|Overall Study||1
6698458|NCT02797522|7628654|FG000|STARTED|Overall Study||4
6698459|NCT02797522|7628655|FG001|STARTED|Overall Study||4
6698460|NCT02797522|7628656|FG002|STARTED|Overall Study||4
6698461|NCT02797522|7628657|FG003|STARTED|Overall Study||4
6698462|NCT02797522|7628658|FG004|STARTED|Overall Study||4
6698463|NCT02797522|7628659|FG005|STARTED|Overall Study||4
6698464|NCT02797522|7628660|FG006|STARTED|Overall Study||12
6698465|NCT02797522|7628661|FG007|STARTED|Overall Study||4
6698466|NCT02797522|7628662|FG008|STARTED|Overall Study||2
6698467|NCT02797522|7628663|FG009|STARTED|Overall Study||4
6259859|NCT01386385|7158897|FG007|NOT COMPLETED|Phase I 120mg: Concurrent CRT||0
6259860|NCT01386385|7158890|FG000|STARTED|Phase I 120mg: Consolidation Therapy||0
6698468|NCT02797522|7628664|FG010|STARTED|Overall Study||1
6698469|NCT02797522|7628654|FG000|COMPLETED|Overall Study||4
6698470|NCT02797522|7628655|FG001|COMPLETED|Overall Study||4
6698471|NCT02797522|7628656|FG002|COMPLETED|Overall Study||4
6698472|NCT02797522|7628657|FG003|COMPLETED|Overall Study||4
6698473|NCT02797522|7628658|FG004|COMPLETED|Overall Study||4
6698474|NCT02797522|7628659|FG005|COMPLETED|Overall Study||4
6698475|NCT02797522|7628660|FG006|COMPLETED|Overall Study||12
6698476|NCT02797522|7628661|FG007|COMPLETED|Overall Study||0
6698477|NCT02797522|7628662|FG008|COMPLETED|Overall Study||0
6698478|NCT02797522|7628663|FG009|COMPLETED|Overall Study||0
6698479|NCT02797522|7628664|FG010|COMPLETED|Overall Study||0
6698480|NCT02797522|7628654|FG000|NOT COMPLETED|Overall Study||0
6698481|NCT02797522|7628655|FG001|NOT COMPLETED|Overall Study||0
6698482|NCT02797522|7628656|FG002|NOT COMPLETED|Overall Study||0
6698483|NCT02797522|7628657|FG003|NOT COMPLETED|Overall Study||0
6698484|NCT02797522|7628658|FG004|NOT COMPLETED|Overall Study||0
6698485|NCT02797522|7628659|FG005|NOT COMPLETED|Overall Study||0
6698486|NCT02797522|7628660|FG006|NOT COMPLETED|Overall Study||0
6698487|NCT02797522|7628661|FG007|NOT COMPLETED|Overall Study||4
6698488|NCT02797522|7628662|FG008|NOT COMPLETED|Overall Study||2
6698489|NCT02797522|7628663|FG009|NOT COMPLETED|Overall Study||4
6698490|NCT02797522|7628664|FG010|NOT COMPLETED|Overall Study||1
6698491|NCT02797613|7628694|FG000|STARTED|Overall Study||55
6698492|NCT02797613|7628695|FG001|STARTED|Overall Study||55
6698493|NCT02797613|7628694|FG000|COMPLETED|Overall Study||55
6698494|NCT02797613|7628695|FG001|COMPLETED|Overall Study||55
6698495|NCT02797613|7628694|FG000|NOT COMPLETED|Overall Study||0
6698496|NCT02797613|7628695|FG001|NOT COMPLETED|Overall Study||0
6698497|NCT02797678|7628701|FG000|STARTED|Screening Phase||62
6698498|NCT02797678|7628702|FG001|STARTED|Screening Phase||0
6698499|NCT02797678|7628703|FG002|STARTED|Screening Phase||0
6698500|NCT02797678|7628704|FG003|STARTED|Screening Phase||0
6698501|NCT02797678|7628701|FG000|COMPLETED|Screening Phase||37
6698502|NCT02797678|7628702|FG001|COMPLETED|Screening Phase||0
6698503|NCT02797678|7628703|FG002|COMPLETED|Screening Phase||0
6698504|NCT02797678|7628704|FG003|COMPLETED|Screening Phase||0
6698505|NCT02797678|7628701|FG000|NOT COMPLETED|Screening Phase||25
6698506|NCT02797678|7628702|FG001|NOT COMPLETED|Screening Phase||0
6698507|NCT02797678|7628703|FG002|NOT COMPLETED|Screening Phase||0
6698508|NCT02797678|7628704|FG003|NOT COMPLETED|Screening Phase||0
6698509|NCT02797678|7628701|FG000|STARTED|First Intervention (5 Nights)||0
6698510|NCT02797678|7628702|FG001|STARTED|First Intervention (5 Nights)||20
6698511|NCT02797678|7628703|FG002|STARTED|First Intervention (5 Nights)||17
6698512|NCT02797678|7628704|FG003|STARTED|First Intervention (5 Nights)||0
6698513|NCT02797678|7628701|FG000|COMPLETED|First Intervention (5 Nights)||0
6698514|NCT02797678|7628702|FG001|COMPLETED|First Intervention (5 Nights)||19
6698515|NCT02797678|7628703|FG002|COMPLETED|First Intervention (5 Nights)||17
6698516|NCT02797678|7628704|FG003|COMPLETED|First Intervention (5 Nights)||0
6698517|NCT02797678|7628701|FG000|NOT COMPLETED|First Intervention (5 Nights)||0
6698518|NCT02797678|7628702|FG001|NOT COMPLETED|First Intervention (5 Nights)||1
6698519|NCT02797678|7628703|FG002|NOT COMPLETED|First Intervention (5 Nights)||0
6698520|NCT02797678|7628704|FG003|NOT COMPLETED|First Intervention (5 Nights)||0
6698521|NCT02797678|7628701|FG000|STARTED|Washout||0
6698522|NCT02797678|7628702|FG001|STARTED|Washout||19
6698523|NCT02797678|7628703|FG002|STARTED|Washout||17
6698524|NCT02797678|7628704|FG003|STARTED|Washout||0
6698525|NCT02797678|7628701|FG000|COMPLETED|Washout||0
6698526|NCT02797678|7628702|FG001|COMPLETED|Washout||19
6698527|NCT02797678|7628703|FG002|COMPLETED|Washout||17
6698528|NCT02797678|7628704|FG003|COMPLETED|Washout||0
6698529|NCT02797678|7628701|FG000|NOT COMPLETED|Washout||0
6698530|NCT02797678|7628702|FG001|NOT COMPLETED|Washout||0
6698531|NCT02797678|7628703|FG002|NOT COMPLETED|Washout||0
6698532|NCT02797678|7628704|FG003|NOT COMPLETED|Washout||0
6698533|NCT02797678|7628701|FG000|STARTED|Second Intervention (5 Nights)||0
6698534|NCT02797678|7628702|FG001|STARTED|Second Intervention (5 Nights)||19
6698535|NCT02797678|7628703|FG002|STARTED|Second Intervention (5 Nights)||17
6698536|NCT02797678|7628704|FG003|STARTED|Second Intervention (5 Nights)||0
6698537|NCT02797678|7628701|FG000|COMPLETED|Second Intervention (5 Nights)||0
6698538|NCT02797678|7628702|FG001|COMPLETED|Second Intervention (5 Nights)||19
6698539|NCT02797678|7628703|FG002|COMPLETED|Second Intervention (5 Nights)||16
6698540|NCT02797678|7628704|FG003|COMPLETED|Second Intervention (5 Nights)||0
6698541|NCT02797678|7628701|FG000|NOT COMPLETED|Second Intervention (5 Nights)||0
6698542|NCT02797678|7628702|FG001|NOT COMPLETED|Second Intervention (5 Nights)||0
6698543|NCT02797678|7628703|FG002|NOT COMPLETED|Second Intervention (5 Nights)||1
6698544|NCT02797678|7628704|FG003|NOT COMPLETED|Second Intervention (5 Nights)||0
6698545|NCT02797678|7628701|FG000|STARTED|Sub-Study||0
6698546|NCT02797678|7628702|FG001|STARTED|Sub-Study||0
6698547|NCT02797678|7628703|FG002|STARTED|Sub-Study||0
6698548|NCT02797678|7628704|FG003|STARTED|Sub-Study||9
6698549|NCT02797678|7628701|FG000|COMPLETED|Sub-Study||0
6698550|NCT02797678|7628702|FG001|COMPLETED|Sub-Study||0
6698551|NCT02797678|7628703|FG002|COMPLETED|Sub-Study||0
6698552|NCT02797678|7628704|FG003|COMPLETED|Sub-Study||9
6698553|NCT02797678|7628701|FG000|NOT COMPLETED|Sub-Study||0
6698554|NCT02797678|7628702|FG001|NOT COMPLETED|Sub-Study||0
6698555|NCT02797678|7628703|FG002|NOT COMPLETED|Sub-Study||0
6698556|NCT02797678|7628704|FG003|NOT COMPLETED|Sub-Study||0
6698557|NCT02797808|7628719|FG000|STARTED|Overall Study||23
6698558|NCT02797808|7628720|FG001|STARTED|Overall Study||18
6698559|NCT02797808|7628719|FG000|COMPLETED|Overall Study||16
6698560|NCT02797808|7628720|FG001|COMPLETED|Overall Study||15
6698561|NCT02797808|7628719|FG000|NOT COMPLETED|Overall Study||7
6698562|NCT02797808|7628720|FG001|NOT COMPLETED|Overall Study||3
6698563|NCT02797821|7628729|FG000|STARTED|Overall Study||8
6698564|NCT02797821|7628730|FG001|STARTED|Overall Study||10
6698565|NCT02797821|7628731|FG002|STARTED|Overall Study||9
6698566|NCT02797821|7628729|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6698567|NCT02797821|7628730|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
6698568|NCT02797821|7628731|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
6698569|NCT02797821|7628729|FG000|COMPLETED|Overall Study||8
6698570|NCT02797821|7628730|FG001|COMPLETED|Overall Study||10
6698571|NCT02797821|7628731|FG002|COMPLETED|Overall Study||9
6698572|NCT02797821|7628729|FG000|NOT COMPLETED|Overall Study||0
6698573|NCT02797821|7628730|FG001|NOT COMPLETED|Overall Study||0
6698574|NCT02797821|7628731|FG002|NOT COMPLETED|Overall Study||0
6698575|NCT02798211|7628742|FG000|STARTED|Period 1||103
6698576|NCT02798211|7628743|FG001|STARTED|Period 1||103
6698577|NCT02798211|7628744|FG002|STARTED|Period 1||52
6698578|NCT02798211|7628745|FG003|STARTED|Period 1||0
6698579|NCT02798211|7628746|FG004|STARTED|Period 1||0
6698580|NCT02798211|7628747|FG005|STARTED|Period 1||0
6698581|NCT02798211|7628742|FG000|COMPLETED|Period 1||97
6698582|NCT02798211|7628743|FG001|COMPLETED|Period 1||93
6698583|NCT02798211|7628744|FG002|COMPLETED|Period 1||46
6698584|NCT02798211|7628745|FG003|COMPLETED|Period 1||0
6698585|NCT02798211|7628746|FG004|COMPLETED|Period 1||0
6698586|NCT02798211|7628747|FG005|COMPLETED|Period 1||0
6698587|NCT02798211|7628742|FG000|NOT COMPLETED|Period 1||6
6698588|NCT02798211|7628743|FG001|NOT COMPLETED|Period 1||10
6698589|NCT02798211|7628744|FG002|NOT COMPLETED|Period 1||6
6698590|NCT02798211|7628745|FG003|NOT COMPLETED|Period 1||0
6698591|NCT02798211|7628746|FG004|NOT COMPLETED|Period 1||0
6698592|NCT02798211|7628747|FG005|NOT COMPLETED|Period 1||0
6698593|NCT02798211|7628742|FG000|STARTED|Period 2||97
6698594|NCT02798211|7628743|FG001|STARTED|Period 2||0
6698595|NCT02798211|7628744|FG002|STARTED|Period 2||0
6698596|NCT02798211|7628745|FG003|STARTED|Period 2||50
6698597|NCT02798211|7628746|FG004|STARTED|Period 2||42
6698598|NCT02798211|7628747|FG005|STARTED|Period 2||46
6698599|NCT02798211|7628742|FG000|COMPLETED|Period 2||83
6698600|NCT02798211|7628743|FG001|COMPLETED|Period 2||0
6698601|NCT02798211|7628744|FG002|COMPLETED|Period 2||0
6698602|NCT02798211|7628745|FG003|COMPLETED|Period 2||43
6698603|NCT02798211|7628746|FG004|COMPLETED|Period 2||34
6698604|NCT02798211|7628747|FG005|COMPLETED|Period 2||40
6698605|NCT02798211|7628742|FG000|NOT COMPLETED|Period 2||14
6698606|NCT02798211|7628743|FG001|NOT COMPLETED|Period 2||0
6698607|NCT02798211|7628744|FG002|NOT COMPLETED|Period 2||0
6698608|NCT02798211|7628745|FG003|NOT COMPLETED|Period 2||7
6698609|NCT02798211|7628746|FG004|NOT COMPLETED|Period 2||8
6698610|NCT02798211|7628747|FG005|NOT COMPLETED|Period 2||6
6698611|NCT02798289|7628759|FG000|STARTED|Overall Study||55
6698612|NCT02798289|7628759|FG000|COMPLETED|Overall Study||55
6698613|NCT02798289|7628759|FG000|NOT COMPLETED|Overall Study||0
6698614|NCT02798315|7628763|FG000|STARTED|Overall Study||40
6698615|NCT02798315|7628763|FG000|COMPLETED|Overall Study||39
6698616|NCT02798315|7628763|FG000|NOT COMPLETED|Overall Study||1
6738854|NCT03286218|7668004|FG008|NOT COMPLETED|Qualification Phase Period 2||0
6738855|NCT03286218|7668005|FG009|NOT COMPLETED|Qualification Phase Period 2||0
6738856|NCT03286218|7668006|FG010|NOT COMPLETED|Qualification Phase Period 2||0
6738857|NCT03286218|7668007|FG011|NOT COMPLETED|Qualification Phase Period 2||0
6738858|NCT03286218|7667996|FG000|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
6738859|NCT03286218|7667997|FG001|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase prior to entering the Treatment Phase.|0
6738860|NCT03286218|7667998|FG002|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6738861|NCT03286218|7667999|FG003|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6738862|NCT03286218|7668000|FG004|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
6738863|NCT03286218|7668001|FG005|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6738864|NCT03286218|7668002|FG006|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6738865|NCT03286218|7668003|FG007|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6738866|NCT03286218|7668004|FG008|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6738867|NCT03286218|7668005|FG009|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6738868|NCT03286218|7668006|FG010|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|5
6738869|NCT03286218|7668007|FG011|STARTED|Treatment Phase Period 1|Participants completed the Qualification Phase and crossed over to the Treatment Phase.|6
6738870|NCT03286218|7667996|FG000|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
6738871|NCT03286218|7667997|FG001|Received at Least One Dose of Study Drug|Treatment Phase Period 1||0
6738872|NCT03286218|7667998|FG002|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6738873|NCT03286218|7667999|FG003|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6698617|NCT02798354|7628770|FG000|STARTED|First Intervention Period||1184
6698618|NCT02798354|7628771|FG001|STARTED|First Intervention Period||2176
6698619|NCT02798354|7628772|FG002|STARTED|First Intervention Period||990
6698620|NCT02798354|7628770|FG000|Control Data Error 1|First Intervention Period||440
6698621|NCT02798354|7628771|FG001|Control Data Error 1|First Intervention Period||549
6698622|NCT02798354|7628772|FG002|Control Data Error 1|First Intervention Period||345
6698623|NCT02798354|7628770|FG000|Intervention Data Error 1|First Intervention Period||744
6698624|NCT02798354|7628771|FG001|Intervention Data Error 1|First Intervention Period||1627
6698625|NCT02798354|7628772|FG002|Intervention Data Error 1|First Intervention Period||645
6698626|NCT02798354|7628770|FG000|COMPLETED|First Intervention Period||1184
6698627|NCT02798354|7628771|FG001|COMPLETED|First Intervention Period||2176
6698628|NCT02798354|7628772|FG002|COMPLETED|First Intervention Period||990
6698629|NCT02798354|7628770|FG000|NOT COMPLETED|First Intervention Period||0
6698630|NCT02798354|7628771|FG001|NOT COMPLETED|First Intervention Period||0
6698631|NCT02798354|7628772|FG002|NOT COMPLETED|First Intervention Period||0
6698632|NCT02798354|7628770|FG000|STARTED|Second Intervention Period||2617
6698633|NCT02798354|7628771|FG001|STARTED|Second Intervention Period||1047
6698634|NCT02798354|7628772|FG002|STARTED|Second Intervention Period||1368
6698635|NCT02798354|7628770|FG000|Control Data Error 2|Second Intervention Period||1378
6698636|NCT02798354|7628771|FG001|Control Data Error 2|Second Intervention Period||593
6698637|NCT02798354|7628772|FG002|Control Data Error 2|Second Intervention Period||668
6698638|NCT02798354|7628770|FG000|Intervention Data Error 2|Second Intervention Period||1239
6698639|NCT02798354|7628771|FG001|Intervention Data Error 2|Second Intervention Period||454
6698640|NCT02798354|7628772|FG002|Intervention Data Error 2|Second Intervention Period||700
6698641|NCT02798354|7628770|FG000|COMPLETED|Second Intervention Period||2617
6698642|NCT02798354|7628771|FG001|COMPLETED|Second Intervention Period||1047
6698643|NCT02798354|7628772|FG002|COMPLETED|Second Intervention Period||1368
6698644|NCT02798354|7628770|FG000|NOT COMPLETED|Second Intervention Period||0
6698645|NCT02798354|7628771|FG001|NOT COMPLETED|Second Intervention Period||0
6698646|NCT02798354|7628772|FG002|NOT COMPLETED|Second Intervention Period||0
6698647|NCT02798354|7628770|FG000|STARTED|Third Intervention Period||746
6698648|NCT02798354|7628771|FG001|STARTED|Third Intervention Period||1010
6698649|NCT02798354|7628772|FG002|STARTED|Third Intervention Period||2715
6698650|NCT02798354|7628770|FG000|Control Data Error 3|Third Intervention Period||419
6698651|NCT02798354|7628771|FG001|Control Data Error 3|Third Intervention Period||620
6698652|NCT02798354|7628772|FG002|Control Data Error 3|Third Intervention Period||1467
6698653|NCT02798354|7628770|FG000|Intervention Data Error 3|Third Intervention Period||327
6698654|NCT02798354|7628771|FG001|Intervention Data Error 3|Third Intervention Period||390
6698655|NCT02798354|7628772|FG002|Intervention Data Error 3|Third Intervention Period||1248
6698656|NCT02798354|7628770|FG000|COMPLETED|Third Intervention Period||746
6698657|NCT02798354|7628771|FG001|COMPLETED|Third Intervention Period||1010
6698658|NCT02798354|7628772|FG002|COMPLETED|Third Intervention Period||2715
6698659|NCT02798354|7628770|FG000|NOT COMPLETED|Third Intervention Period||0
6698660|NCT02798354|7628771|FG001|NOT COMPLETED|Third Intervention Period||0
6698661|NCT02798354|7628772|FG002|NOT COMPLETED|Third Intervention Period||0
6698662|NCT02798380|7628786|FG000|STARTED|Overall Study||30
6698663|NCT02798380|7628786|FG000|COMPLETED|Overall Study||30
6698664|NCT02798380|7628786|FG000|NOT COMPLETED|Overall Study||0
6698665|NCT02798627|7628792|FG000|STARTED|Overall Study||27
6698666|NCT02798627|7628793|FG001|STARTED|Overall Study||28
6698667|NCT02798627|7628792|FG000|COMPLETED|Overall Study||27
6698668|NCT02798627|7628793|FG001|COMPLETED|Overall Study||28
6698669|NCT02798627|7628792|FG000|NOT COMPLETED|Overall Study||0
6698670|NCT02798627|7628793|FG001|NOT COMPLETED|Overall Study||0
6698671|NCT02798835|7628802|FG000|STARTED|Overall Study||60
6698672|NCT02798835|7628803|FG001|STARTED|Overall Study||60
6698673|NCT02798835|7628804|FG002|STARTED|Overall Study||60
6698674|NCT02798835|7628802|FG000|COMPLETED|Overall Study||60
6698675|NCT02798835|7628803|FG001|COMPLETED|Overall Study||60
6698676|NCT02798835|7628804|FG002|COMPLETED|Overall Study||57
6698677|NCT02798835|7628802|FG000|NOT COMPLETED|Overall Study||0
6698678|NCT02798835|7628803|FG001|NOT COMPLETED|Overall Study||0
6698679|NCT02798835|7628804|FG002|NOT COMPLETED|Overall Study||3
6698680|NCT02798861|7628812|FG000|STARTED|Overall Study||160
6698681|NCT02798861|7628812|FG000|COMPLETED|Overall Study||137
6698682|NCT02798861|7628812|FG000|NOT COMPLETED|Overall Study||23
6698683|NCT02798952|7628816|FG000|STARTED|Overall Study||302
6698684|NCT02798952|7628816|FG000|COMPLETED|Overall Study||302
6698685|NCT02798952|7628816|FG000|NOT COMPLETED|Overall Study||0
6698686|NCT02798978|7628827|FG000|STARTED|Part 1 (30 Days)||10
6698687|NCT02798978|7628828|FG001|STARTED|Part 1 (30 Days)||6
6698688|NCT02798978|7628829|FG002|STARTED|Part 1 (30 Days)||6
6698689|NCT02798978|7628830|FG003|STARTED|Part 1 (30 Days)||6
6698690|NCT02798978|7628831|FG004|STARTED|Part 1 (30 Days)||6
6698691|NCT02798978|7628832|FG005|STARTED|Part 1 (30 Days)||6
6698692|NCT02798978|7628833|FG006|STARTED|Part 1 (30 Days)||0
6698693|NCT02798978|7628827|FG000|COMPLETED|Part 1 (30 Days)||10
6698694|NCT02798978|7628828|FG001|COMPLETED|Part 1 (30 Days)||6
6698695|NCT02798978|7628829|FG002|COMPLETED|Part 1 (30 Days)||6
6698696|NCT02798978|7628830|FG003|COMPLETED|Part 1 (30 Days)||6
6698697|NCT02798978|7628831|FG004|COMPLETED|Part 1 (30 Days)||6
6698698|NCT02798978|7628832|FG005|COMPLETED|Part 1 (30 Days)||6
6698699|NCT02798978|7628833|FG006|COMPLETED|Part 1 (30 Days)||0
6698700|NCT02798978|7628827|FG000|NOT COMPLETED|Part 1 (30 Days)||0
6698701|NCT02798978|7628828|FG001|NOT COMPLETED|Part 1 (30 Days)||0
6698702|NCT02798978|7628829|FG002|NOT COMPLETED|Part 1 (30 Days)||0
6698703|NCT02798978|7628830|FG003|NOT COMPLETED|Part 1 (30 Days)||0
6698704|NCT02798978|7628831|FG004|NOT COMPLETED|Part 1 (30 Days)||0
6698705|NCT02798978|7628832|FG005|NOT COMPLETED|Part 1 (30 Days)||0
6698706|NCT02798978|7628833|FG006|NOT COMPLETED|Part 1 (30 Days)||0
6698707|NCT02798978|7628827|FG000|STARTED|Part 2 (45 Days)||0
6698708|NCT02798978|7628828|FG001|STARTED|Part 2 (45 Days)||0
6698709|NCT02798978|7628829|FG002|STARTED|Part 2 (45 Days)||0
6698710|NCT02798978|7628830|FG003|STARTED|Part 2 (45 Days)||0
6698711|NCT02798978|7628831|FG004|STARTED|Part 2 (45 Days)||0
6698712|NCT02798978|7628832|FG005|STARTED|Part 2 (45 Days)||0
6698713|NCT02798978|7628833|FG006|STARTED|Part 2 (45 Days)||0
6698714|NCT02798978|7628827|FG000|COMPLETED|Part 2 (45 Days)||0
6698715|NCT02798978|7628828|FG001|COMPLETED|Part 2 (45 Days)||0
6698716|NCT02798978|7628829|FG002|COMPLETED|Part 2 (45 Days)||0
6698717|NCT02798978|7628830|FG003|COMPLETED|Part 2 (45 Days)||0
6698718|NCT02798978|7628831|FG004|COMPLETED|Part 2 (45 Days)||0
6698719|NCT02798978|7628832|FG005|COMPLETED|Part 2 (45 Days)||0
6698720|NCT02798978|7628833|FG006|COMPLETED|Part 2 (45 Days)||0
6698721|NCT02798978|7628827|FG000|NOT COMPLETED|Part 2 (45 Days)||0
6698722|NCT02798978|7628828|FG001|NOT COMPLETED|Part 2 (45 Days)||0
6698723|NCT02798978|7628829|FG002|NOT COMPLETED|Part 2 (45 Days)||0
6698724|NCT02798978|7628830|FG003|NOT COMPLETED|Part 2 (45 Days)||0
6698725|NCT02798978|7628831|FG004|NOT COMPLETED|Part 2 (45 Days)||0
6698726|NCT02798978|7628832|FG005|NOT COMPLETED|Part 2 (45 Days)||0
6698727|NCT02798978|7628833|FG006|NOT COMPLETED|Part 2 (45 Days)||0
6698728|NCT02799069|7628858|FG000|STARTED|Overall Study||76
6698729|NCT02799069|7628859|FG001|STARTED|Overall Study||248
6698730|NCT02799069|7628860|FG002|STARTED|Overall Study||247
6698731|NCT02799069|7628858|FG000|ITT/Safety|Overall Study||76
6698732|NCT02799069|7628859|FG001|ITT/Safety|Overall Study||248
6698733|NCT02799069|7628860|FG002|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
6698734|NCT02799069|7628858|FG000|COMPLETED|Overall Study||68
6698735|NCT02799069|7628859|FG001|COMPLETED|Overall Study||241
6698736|NCT02799069|7628860|FG002|COMPLETED|Overall Study||240
6698737|NCT02799069|7628858|FG000|NOT COMPLETED|Overall Study||8
6698738|NCT02799069|7628859|FG001|NOT COMPLETED|Overall Study||7
6698739|NCT02799069|7628860|FG002|NOT COMPLETED|Overall Study||7
6698740|NCT02799082|7628870|FG000|STARTED|Overall Study||41
6698741|NCT02799082|7628871|FG001|STARTED|Overall Study||81
6698742|NCT02799082|7628870|FG000|COMPLETED|Overall Study||37
6698743|NCT02799082|7628871|FG001|COMPLETED|Overall Study||77
6698744|NCT02799082|7628870|FG000|NOT COMPLETED|Overall Study||4
6698745|NCT02799082|7628871|FG001|NOT COMPLETED|Overall Study||4
6698746|NCT02799290|7628880|FG000|STARTED|Overall Study||24
6698747|NCT02799290|7628881|FG001|STARTED|Overall Study||13
6698748|NCT02799290|7628882|FG002|STARTED|Overall Study||11
6698749|NCT02799290|7628880|FG000|COMPLETED|Overall Study||24
6698750|NCT02799290|7628881|FG001|COMPLETED|Overall Study||13
6698751|NCT02799290|7628882|FG002|COMPLETED|Overall Study||11
6698752|NCT02799290|7628880|FG000|NOT COMPLETED|Overall Study||0
6698753|NCT02799290|7628881|FG001|NOT COMPLETED|Overall Study||0
6698754|NCT02799290|7628882|FG002|NOT COMPLETED|Overall Study||0
6698755|NCT02799381|7628896|FG000|STARTED|Overall Study||33
6698756|NCT02799381|7628897|FG001|STARTED|Overall Study||28
6698757|NCT02799381|7628896|FG000|COMPLETED|Overall Study||29
6698758|NCT02799381|7628897|FG001|COMPLETED|Overall Study||25
6698759|NCT02799381|7628896|FG000|NOT COMPLETED|Overall Study||4
6698760|NCT02799381|7628897|FG001|NOT COMPLETED|Overall Study||3
6698761|NCT02799472|7628905|FG000|STARTED|Overall Study||11
6698762|NCT02799472|7628906|FG001|STARTED|Overall Study||28
6698763|NCT02799472|7628905|FG000|COMPLETED|Overall Study||7
6698764|NCT02799472|7628906|FG001|COMPLETED|Overall Study||23
6698765|NCT02799472|7628905|FG000|NOT COMPLETED|Overall Study||4
6698766|NCT02799472|7628906|FG001|NOT COMPLETED|Overall Study||5
6698767|NCT02799667|7628914|FG000|STARTED|Overall Study||55
6698768|NCT02799667|7628915|FG001|STARTED|Overall Study||55
6698769|NCT02799667|7628914|FG000|COMPLETED|Overall Study||54
6698770|NCT02799667|7628915|FG001|COMPLETED|Overall Study||54
6698771|NCT02799667|7628914|FG000|NOT COMPLETED|Overall Study||1
6698772|NCT02799667|7628915|FG001|NOT COMPLETED|Overall Study||1
6698773|NCT02799745|7628923|FG000|STARTED|Overall Study||114
6698774|NCT02799745|7628924|FG001|STARTED|Overall Study||113
6698775|NCT02799745|7628923|FG000|Treated|Overall Study||112
6698776|NCT02799745|7628924|FG001|Treated|Overall Study||113
6698777|NCT02799745|7628923|FG000|COMPLETED|Overall Study||58
6698778|NCT02799745|7628924|FG001|COMPLETED|Overall Study||42
6698779|NCT02799745|7628923|FG000|NOT COMPLETED|Overall Study||56
6698780|NCT02799745|7628924|FG001|NOT COMPLETED|Overall Study||71
6698781|NCT02799784|7628930|FG000|STARTED|Treatment Period 1 (TP1- 8 Weeks)||117
6698782|NCT02799784|7628931|FG001|STARTED|Treatment Period 1 (TP1- 8 Weeks)||119
6698783|NCT02799784|7628930|FG000|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||111
6698784|NCT02799784|7628931|FG001|COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||118
6698785|NCT02799784|7628930|FG000|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||6
6698786|NCT02799784|7628931|FG001|NOT COMPLETED|Treatment Period 1 (TP1- 8 Weeks)||1
6698787|NCT02799784|7628930|FG000|STARTED|Washout Period (3 Weeks)||111
6698788|NCT02799784|7628931|FG001|STARTED|Washout Period (3 Weeks)||118
6698789|NCT02799784|7628930|FG000|COMPLETED|Washout Period (3 Weeks)||111
6698790|NCT02799784|7628931|FG001|COMPLETED|Washout Period (3 Weeks)||118
6698791|NCT02799784|7628930|FG000|NOT COMPLETED|Washout Period (3 Weeks)||0
6698792|NCT02799784|7628931|FG001|NOT COMPLETED|Washout Period (3 Weeks)||0
6698793|NCT02799784|7628930|FG000|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||111
6698794|NCT02799784|7628931|FG001|STARTED|Treatment Period 2 (TP2 - 8 Weeks)||118
6698795|NCT02799784|7628930|FG000|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||110
6698796|NCT02799784|7628931|FG001|COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||115
6698797|NCT02799784|7628930|FG000|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||1
6698798|NCT02799784|7628931|FG001|NOT COMPLETED|Treatment Period 2 (TP2 - 8 Weeks)||3
6698799|NCT02800148|7628940|FG000|STARTED|Overall Study||224
6698800|NCT02800148|7628941|FG001|STARTED|Overall Study||224
6698801|NCT02800148|7628942|FG002|STARTED|Overall Study||219
6698802|NCT02800148|7628940|FG000|COMPLETED|Overall Study||199
6698803|NCT02800148|7628941|FG001|COMPLETED|Overall Study||204
6698804|NCT02800148|7628942|FG002|COMPLETED|Overall Study||194
6698805|NCT02800148|7628940|FG000|NOT COMPLETED|Overall Study||25
6698806|NCT02800148|7628941|FG001|NOT COMPLETED|Overall Study||20
6698807|NCT02800148|7628942|FG002|NOT COMPLETED|Overall Study||25
6698808|NCT02800213|7628952|FG000|STARTED|First Intervention||35
6698809|NCT02800213|7628953|FG001|STARTED|First Intervention||35
6698810|NCT02800213|7628952|FG000|COMPLETED|First Intervention||35
6698811|NCT02800213|7628953|FG001|COMPLETED|First Intervention||35
6698812|NCT02800213|7628952|FG000|NOT COMPLETED|First Intervention||0
6698813|NCT02800213|7628953|FG001|NOT COMPLETED|First Intervention||0
6698814|NCT02800213|7628952|FG000|STARTED|Second Intervention||35
6698815|NCT02800213|7628953|FG001|STARTED|Second Intervention||35
6259861|NCT01386385|7158891|FG001|STARTED|Phase I 120mg: Consolidation Therapy||0
6698816|NCT02800213|7628952|FG000|COMPLETED|Second Intervention||35
6698817|NCT02800213|7628953|FG001|COMPLETED|Second Intervention||35
6698818|NCT02800213|7628952|FG000|NOT COMPLETED|Second Intervention||0
6698819|NCT02800213|7628953|FG001|NOT COMPLETED|Second Intervention||0
6698820|NCT02800356|7628959|FG000|STARTED|Overall Study||20
6698821|NCT02800356|7628959|FG000|COMPLETED|Overall Study||20
6698822|NCT02800356|7628959|FG000|NOT COMPLETED|Overall Study||0
6698823|NCT02800642|7628963|FG000|STARTED|Overall Study||162
6698824|NCT02800642|7628963|FG000|COMPLETED|Overall Study||137
6698825|NCT02800642|7628963|FG000|NOT COMPLETED|Overall Study||25
6698826|NCT02800928|7628967|FG000|STARTED|Overall Study||9
6698827|NCT02800928|7628968|FG001|STARTED|Overall Study||8
6698828|NCT02800928|7628967|FG000|COMPLETED|Overall Study||7
6698829|NCT02800928|7628968|FG001|COMPLETED|Overall Study||6
6698830|NCT02800928|7628967|FG000|NOT COMPLETED|Overall Study||2
6698831|NCT02800928|7628968|FG001|NOT COMPLETED|Overall Study||2
6698832|NCT02801006|7628974|FG000|STARTED|Lens 1||22
6698833|NCT02801006|7628975|FG001|STARTED|Lens 1||19
6698834|NCT02801006|7628974|FG000|COMPLETED|Lens 1||22
6698835|NCT02801006|7628975|FG001|COMPLETED|Lens 1||19
6698836|NCT02801006|7628974|FG000|NOT COMPLETED|Lens 1||0
6698837|NCT02801006|7628975|FG001|NOT COMPLETED|Lens 1||0
6698838|NCT02801006|7628974|FG000|STARTED|Lens 2||22
6698839|NCT02801006|7628975|FG001|STARTED|Lens 2||19
6698840|NCT02801006|7628974|FG000|COMPLETED|Lens 2||22
6698841|NCT02801006|7628975|FG001|COMPLETED|Lens 2||19
6698842|NCT02801006|7628974|FG000|NOT COMPLETED|Lens 2||0
6698843|NCT02801006|7628975|FG001|NOT COMPLETED|Lens 2||0
6698844|NCT02801370|7628985|FG000|STARTED|Overall Study||130
6698845|NCT02801370|7628986|FG001|STARTED|Overall Study||132
6698846|NCT02801370|7628985|FG000|COMPLETED|Overall Study||123
6698847|NCT02801370|7628986|FG001|COMPLETED|Overall Study||132
6698848|NCT02801370|7628985|FG000|NOT COMPLETED|Overall Study||7
6698849|NCT02801370|7628986|FG001|NOT COMPLETED|Overall Study||0
6698850|NCT02801396|7628993|FG000|STARTED|Period 1||17
6698851|NCT02801396|7628994|FG001|STARTED|Period 1||17
6698852|NCT02801396|7628995|FG002|STARTED|Period 1||17
6698853|NCT02801396|7628996|FG003|STARTED|Period 1||16
6698854|NCT02801396|7628997|FG004|STARTED|Period 1||17
6698855|NCT02801396|7628998|FG005|STARTED|Period 1||17
6698856|NCT02801396|7628993|FG000|COMPLETED|Period 1||17
6698857|NCT02801396|7628994|FG001|COMPLETED|Period 1||17
6698858|NCT02801396|7628995|FG002|COMPLETED|Period 1||17
6698859|NCT02801396|7628996|FG003|COMPLETED|Period 1||16
6698860|NCT02801396|7628997|FG004|COMPLETED|Period 1||16
6698861|NCT02801396|7628998|FG005|COMPLETED|Period 1||17
6698862|NCT02801396|7628993|FG000|NOT COMPLETED|Period 1||0
6698863|NCT02801396|7628994|FG001|NOT COMPLETED|Period 1||0
6698864|NCT02801396|7628995|FG002|NOT COMPLETED|Period 1||0
6698865|NCT02801396|7628996|FG003|NOT COMPLETED|Period 1||0
6698866|NCT02801396|7628997|FG004|NOT COMPLETED|Period 1||1
6698867|NCT02801396|7628998|FG005|NOT COMPLETED|Period 1||0
6698868|NCT02801396|7628993|FG000|STARTED|Period 2||17
6698869|NCT02801396|7628994|FG001|STARTED|Period 2||17
6698870|NCT02801396|7628995|FG002|STARTED|Period 2||17
6698871|NCT02801396|7628996|FG003|STARTED|Period 2||16
6698872|NCT02801396|7628997|FG004|STARTED|Period 2||16
6698873|NCT02801396|7628998|FG005|STARTED|Period 2||17
6698874|NCT02801396|7628993|FG000|COMPLETED|Period 2||17
6698875|NCT02801396|7628994|FG001|COMPLETED|Period 2||17
6698876|NCT02801396|7628995|FG002|COMPLETED|Period 2||17
6698877|NCT02801396|7628996|FG003|COMPLETED|Period 2||16
6698878|NCT02801396|7628997|FG004|COMPLETED|Period 2||16
6698879|NCT02801396|7628998|FG005|COMPLETED|Period 2||17
6698880|NCT02801396|7628993|FG000|NOT COMPLETED|Period 2||0
6698881|NCT02801396|7628994|FG001|NOT COMPLETED|Period 2||0
6698882|NCT02801396|7628995|FG002|NOT COMPLETED|Period 2||0
6698883|NCT02801396|7628996|FG003|NOT COMPLETED|Period 2||0
6698884|NCT02801396|7628997|FG004|NOT COMPLETED|Period 2||0
6698885|NCT02801396|7628998|FG005|NOT COMPLETED|Period 2||0
6698886|NCT02801396|7628993|FG000|STARTED|Period 3||17
6698887|NCT02801396|7628994|FG001|STARTED|Period 3||17
6698888|NCT02801396|7628995|FG002|STARTED|Period 3||17
6698889|NCT02801396|7628996|FG003|STARTED|Period 3||16
6698890|NCT02801396|7628997|FG004|STARTED|Period 3||16
6698891|NCT02801396|7628998|FG005|STARTED|Period 3||17
6698892|NCT02801396|7628993|FG000|COMPLETED|Period 3||17
6698893|NCT02801396|7628994|FG001|COMPLETED|Period 3||17
6698894|NCT02801396|7628995|FG002|COMPLETED|Period 3||17
6698895|NCT02801396|7628996|FG003|COMPLETED|Period 3||16
6698896|NCT02801396|7628997|FG004|COMPLETED|Period 3||16
6259862|NCT01386385|7158892|FG002|STARTED|Phase I 120mg: Consolidation Therapy||0
6259863|NCT01386385|7158893|FG003|STARTED|Phase I 120mg: Consolidation Therapy||0
6259864|NCT01386385|7158894|FG004|STARTED|Phase I 120mg: Consolidation Therapy||0
6259865|NCT01386385|7158895|FG005|STARTED|Phase I 120mg: Consolidation Therapy||5
6259866|NCT01386385|7158896|FG006|STARTED|Phase I 120mg: Consolidation Therapy||0
6259867|NCT01386385|7158897|FG007|STARTED|Phase I 120mg: Consolidation Therapy||0
6259868|NCT01386385|7158890|FG000|COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259869|NCT01386385|7158891|FG001|COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259870|NCT01386385|7158892|FG002|COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259871|NCT01386385|7158893|FG003|COMPLETED|Phase I 120mg: Consolidation Therapy||0
6698897|NCT02801396|7628998|FG005|COMPLETED|Period 3||17
6698898|NCT02801396|7628993|FG000|NOT COMPLETED|Period 3||0
6698899|NCT02801396|7628994|FG001|NOT COMPLETED|Period 3||0
6698900|NCT02801396|7628995|FG002|NOT COMPLETED|Period 3||0
6698901|NCT02801396|7628996|FG003|NOT COMPLETED|Period 3||0
6698902|NCT02801396|7628997|FG004|NOT COMPLETED|Period 3||0
6698903|NCT02801396|7628998|FG005|NOT COMPLETED|Period 3||0
6698904|NCT02801578|7629006|FG000|STARTED|Overall Study||11
6698905|NCT02801578|7629006|FG000|COMPLETED|Overall Study||9
6698906|NCT02801578|7629006|FG000|NOT COMPLETED|Overall Study||2
6698907|NCT02801617|7629012|FG000|STARTED|Overall Study||51
6698908|NCT02801617|7629013|FG001|STARTED|Overall Study||56
6698909|NCT02801617|7629012|FG000|COMPLETED|Overall Study||49
6698910|NCT02801617|7629013|FG001|COMPLETED|Overall Study||50
6698911|NCT02801617|7629012|FG000|NOT COMPLETED|Overall Study||2
6698912|NCT02801617|7629013|FG001|NOT COMPLETED|Overall Study||6
6698913|NCT02801669|7629025|FG000|STARTED|Overall Study||492
6698914|NCT02801669|7629026|FG001|STARTED|Overall Study||492
6698915|NCT02801669|7629025|FG000|Received at Least 1 Dose of Study Drug|Overall Study||492
6698916|NCT02801669|7629026|FG001|Received at Least 1 Dose of Study Drug|Overall Study||490
6698917|NCT02801669|7629025|FG000|COMPLETED|Overall Study||341
6698918|NCT02801669|7629026|FG001|COMPLETED|Overall Study||340
6698919|NCT02801669|7629025|FG000|NOT COMPLETED|Overall Study||151
6698920|NCT02801669|7629026|FG001|NOT COMPLETED|Overall Study||152
6698921|NCT02801877|7629036|FG000|STARTED|Overall Study||74
6698922|NCT02801877|7629037|FG001|STARTED|Overall Study||75
6698923|NCT02801877|7629038|FG002|STARTED|Overall Study||76
6698924|NCT02801877|7629039|FG003|STARTED|Overall Study||76
6698925|NCT02801877|7629036|FG000|COMPLETED|Overall Study||71
6698926|NCT02801877|7629037|FG001|COMPLETED|Overall Study||74
6698927|NCT02801877|7629038|FG002|COMPLETED|Overall Study||70
6698928|NCT02801877|7629039|FG003|COMPLETED|Overall Study||76
6698929|NCT02801877|7629036|FG000|NOT COMPLETED|Overall Study||3
6698930|NCT02801877|7629037|FG001|NOT COMPLETED|Overall Study||1
6698931|NCT02801877|7629038|FG002|NOT COMPLETED|Overall Study||6
6698932|NCT02801877|7629039|FG003|NOT COMPLETED|Overall Study||0
6698933|NCT02801942|7629051|FG000|STARTED|Overall Study||12
6698934|NCT02801942|7629052|FG001|STARTED|Overall Study||10
6698935|NCT02801942|7629051|FG000|COMPLETED|Overall Study||12
6698936|NCT02801942|7629052|FG001|COMPLETED|Overall Study||10
6698937|NCT02801942|7629051|FG000|NOT COMPLETED|Overall Study||0
6698938|NCT02801942|7629052|FG001|NOT COMPLETED|Overall Study||0
6698939|NCT02802111|7629060|FG000|STARTED|First Intervention (5 Min of Drug)||12
6698940|NCT02802111|7629061|FG001|STARTED|First Intervention (5 Min of Drug)||12
6698941|NCT02802111|7629060|FG000|COMPLETED|First Intervention (5 Min of Drug)||12
6698942|NCT02802111|7629061|FG001|COMPLETED|First Intervention (5 Min of Drug)||12
6698943|NCT02802111|7629060|FG000|NOT COMPLETED|First Intervention (5 Min of Drug)||0
6698944|NCT02802111|7629061|FG001|NOT COMPLETED|First Intervention (5 Min of Drug)||0
6698945|NCT02802111|7629060|FG000|STARTED|Washout (4 Hours)||12
6698946|NCT02802111|7629061|FG001|STARTED|Washout (4 Hours)||12
6698947|NCT02802111|7629060|FG000|COMPLETED|Washout (4 Hours)||12
6698948|NCT02802111|7629061|FG001|COMPLETED|Washout (4 Hours)||12
6698949|NCT02802111|7629060|FG000|NOT COMPLETED|Washout (4 Hours)||0
6698950|NCT02802111|7629061|FG001|NOT COMPLETED|Washout (4 Hours)||0
6698951|NCT02802111|7629060|FG000|STARTED|Second Intervention (5 Min of Drug)||12
6698952|NCT02802111|7629061|FG001|STARTED|Second Intervention (5 Min of Drug)||12
6698953|NCT02802111|7629060|FG000|COMPLETED|Second Intervention (5 Min of Drug)||12
6698954|NCT02802111|7629061|FG001|COMPLETED|Second Intervention (5 Min of Drug)||12
6698955|NCT02802111|7629060|FG000|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
6698956|NCT02802111|7629061|FG001|NOT COMPLETED|Second Intervention (5 Min of Drug)||0
6698957|NCT02802241|7629071|FG000|STARTED|Overall Study||97
6698958|NCT02802241|7629072|FG001|STARTED|Overall Study||97
6698959|NCT02802241|7629073|FG002|STARTED|Overall Study||48
6698960|NCT02802241|7629074|FG003|STARTED|Overall Study||98
6698961|NCT02802241|7629071|FG000|Planned Analysis|Overall Study||89
6698962|NCT02802241|7629072|FG001|Planned Analysis|Overall Study||86
6698963|NCT02802241|7629073|FG002|Planned Analysis|Overall Study|Not included in primary analysis|0
6698964|NCT02802241|7629074|FG003|Planned Analysis|Overall Study||87
6698965|NCT02802241|7629071|FG000|COMPLETED|Overall Study||68
6698966|NCT02802241|7629072|FG001|COMPLETED|Overall Study||71
6698967|NCT02802241|7629073|FG002|COMPLETED|Overall Study|Not included in primary analysis|0
6698968|NCT02802241|7629074|FG003|COMPLETED|Overall Study||72
6698969|NCT02802241|7629071|FG000|NOT COMPLETED|Overall Study||29
6698970|NCT02802241|7629072|FG001|NOT COMPLETED|Overall Study||26
6698971|NCT02802241|7629073|FG002|NOT COMPLETED|Overall Study||48
6698972|NCT02802241|7629074|FG003|NOT COMPLETED|Overall Study||26
6698973|NCT02802319|7629086|FG000|STARTED|Overall Study||22
6698974|NCT02802319|7629087|FG001|STARTED|Overall Study||22
6698975|NCT02802319|7629086|FG000|COMPLETED|Overall Study||20
6698976|NCT02802319|7629087|FG001|COMPLETED|Overall Study||17
6698977|NCT02802319|7629086|FG000|NOT COMPLETED|Overall Study||2
6698978|NCT02802319|7629087|FG001|NOT COMPLETED|Overall Study||5
6698979|NCT02802345|7629095|FG000|STARTED|Overall Study||136
6698980|NCT02802345|7629096|FG001|STARTED|Overall Study||138
6698981|NCT02802345|7629095|FG000|Treated|Overall Study||136
6698982|NCT02802345|7629096|FG001|Treated|Overall Study||137
6698983|NCT02802345|7629095|FG000|COMPLETED|Overall Study||104
6698984|NCT02802345|7629096|FG001|COMPLETED|Overall Study||108
6698985|NCT02802345|7629095|FG000|NOT COMPLETED|Overall Study||32
6698986|NCT02802345|7629096|FG001|NOT COMPLETED|Overall Study||30
6698987|NCT02802449|7629104|FG000|STARTED|Overall Study||111
6698988|NCT02802449|7629105|FG001|STARTED|Overall Study||219
6698989|NCT02802449|7629104|FG000|COMPLETED|Overall Study||102
6602456|NCT02057250|7527471|FG004|COMPLETED|AID Assessment Phase||0
6602457|NCT02057250|7527467|FG000|NOT COMPLETED|AID Assessment Phase||4
6602458|NCT02057250|7527468|FG001|NOT COMPLETED|AID Assessment Phase||3
6602459|NCT02057250|7527469|FG002|NOT COMPLETED|AID Assessment Phase||7
6602460|NCT02057250|7527470|FG003|NOT COMPLETED|AID Assessment Phase||2
6602461|NCT02057250|7527471|FG004|NOT COMPLETED|AID Assessment Phase||0
6602462|NCT02057250|7527467|FG000|STARTED|Extension Phase||0
6602463|NCT02057250|7527468|FG001|STARTED|Extension Phase||0
6602464|NCT02057250|7527469|FG002|STARTED|Extension Phase||0
6602465|NCT02057250|7527470|FG003|STARTED|Extension Phase||0
6602466|NCT02057250|7527471|FG004|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
6698990|NCT02802449|7629105|FG001|COMPLETED|Overall Study||202
6698991|NCT02802449|7629104|FG000|NOT COMPLETED|Overall Study||9
6698992|NCT02802449|7629105|FG001|NOT COMPLETED|Overall Study||17
6698993|NCT02802501|7629114|FG000|STARTED|Double-blind (Up to Day 180)||50
6698994|NCT02802501|7629115|FG001|STARTED|Double-blind (Up to Day 180)||50
6698995|NCT02802501|7629116|FG002|STARTED|Double-blind (Up to Day 180)||50
6698996|NCT02802501|7629114|FG000|COMPLETED|Double-blind (Up to Day 180)||50
6698997|NCT02802501|7629115|FG001|COMPLETED|Double-blind (Up to Day 180)||50
6698998|NCT02802501|7629116|FG002|COMPLETED|Double-blind (Up to Day 180)||50
6698999|NCT02802501|7629114|FG000|NOT COMPLETED|Double-blind (Up to Day 180)||0
6699000|NCT02802501|7629115|FG001|NOT COMPLETED|Double-blind (Up to Day 180)||0
6699001|NCT02802501|7629116|FG002|NOT COMPLETED|Double-blind (Up to Day 180)||0
6699002|NCT02802501|7629114|FG000|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|6
6699003|NCT02802501|7629115|FG001|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|12
6699004|NCT02802501|7629116|FG002|STARTED|Open-Label (Day 180 to Day 195)|Participants who had no relapse prior to Day 180 received open-label Primaquine|26
6699005|NCT02802501|7629114|FG000|COMPLETED|Open-Label (Day 180 to Day 195)||6
6699006|NCT02802501|7629115|FG001|COMPLETED|Open-Label (Day 180 to Day 195)||12
6699007|NCT02802501|7629116|FG002|COMPLETED|Open-Label (Day 180 to Day 195)||26
6699008|NCT02802501|7629114|FG000|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
6699009|NCT02802501|7629115|FG001|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
6699010|NCT02802501|7629116|FG002|NOT COMPLETED|Open-Label (Day 180 to Day 195)||0
6699011|NCT02802514|7629129|FG000|STARTED|Session 1 (up to Day 8)||1
6699012|NCT02802514|7629130|FG001|STARTED|Session 1 (up to Day 8)||1
6699013|NCT02802514|7629131|FG002|STARTED|Session 1 (up to Day 8)||1
6699014|NCT02802514|7629132|FG003|STARTED|Session 1 (up to Day 8)||1
6699015|NCT02802514|7629129|FG000|COMPLETED|Session 1 (up to Day 8)||1
6699016|NCT02802514|7629130|FG001|COMPLETED|Session 1 (up to Day 8)||1
6699017|NCT02802514|7629131|FG002|COMPLETED|Session 1 (up to Day 8)||1
6699018|NCT02802514|7629132|FG003|COMPLETED|Session 1 (up to Day 8)||1
6699019|NCT02802514|7629129|FG000|NOT COMPLETED|Session 1 (up to Day 8)||0
6699020|NCT02802514|7629130|FG001|NOT COMPLETED|Session 1 (up to Day 8)||0
6699021|NCT02802514|7629131|FG002|NOT COMPLETED|Session 1 (up to Day 8)||0
6699022|NCT02802514|7629132|FG003|NOT COMPLETED|Session 1 (up to Day 8)||0
6699023|NCT02802514|7629129|FG000|STARTED|Wash Out Period (up to Week 9)||1
6699024|NCT02802514|7629130|FG001|STARTED|Wash Out Period (up to Week 9)||1
6699025|NCT02802514|7629131|FG002|STARTED|Wash Out Period (up to Week 9)||1
6699026|NCT02802514|7629132|FG003|STARTED|Wash Out Period (up to Week 9)||1
6699027|NCT02802514|7629129|FG000|COMPLETED|Wash Out Period (up to Week 9)||1
6699028|NCT02802514|7629130|FG001|COMPLETED|Wash Out Period (up to Week 9)||1
6699029|NCT02802514|7629131|FG002|COMPLETED|Wash Out Period (up to Week 9)||1
6699030|NCT02802514|7629132|FG003|COMPLETED|Wash Out Period (up to Week 9)||1
6699031|NCT02802514|7629129|FG000|NOT COMPLETED|Wash Out Period (up to Week 9)||0
6699032|NCT02802514|7629130|FG001|NOT COMPLETED|Wash Out Period (up to Week 9)||0
6699033|NCT02802514|7629131|FG002|NOT COMPLETED|Wash Out Period (up to Week 9)||0
6699034|NCT02802514|7629132|FG003|NOT COMPLETED|Wash Out Period (up to Week 9)||0
6699035|NCT02802514|7629129|FG000|STARTED|Session 2 (Up to Day 8)||1
6699036|NCT02802514|7629130|FG001|STARTED|Session 2 (Up to Day 8)||1
6699037|NCT02802514|7629131|FG002|STARTED|Session 2 (Up to Day 8)||1
6699038|NCT02802514|7629132|FG003|STARTED|Session 2 (Up to Day 8)||1
6699039|NCT02802514|7629129|FG000|COMPLETED|Session 2 (Up to Day 8)||1
6699040|NCT02802514|7629130|FG001|COMPLETED|Session 2 (Up to Day 8)||1
6699041|NCT02802514|7629131|FG002|COMPLETED|Session 2 (Up to Day 8)||1
6699042|NCT02802514|7629132|FG003|COMPLETED|Session 2 (Up to Day 8)||1
6699043|NCT02802514|7629129|FG000|NOT COMPLETED|Session 2 (Up to Day 8)||0
6699044|NCT02802514|7629130|FG001|NOT COMPLETED|Session 2 (Up to Day 8)||0
6699045|NCT02802514|7629131|FG002|NOT COMPLETED|Session 2 (Up to Day 8)||0
6699046|NCT02802514|7629132|FG003|NOT COMPLETED|Session 2 (Up to Day 8)||0
6699047|NCT02802735|7629148|FG000|STARTED|Overall Study||4
6699048|NCT02802735|7629149|FG001|STARTED|Overall Study||4
6699049|NCT02802735|7629150|FG002|STARTED|Overall Study||4
6699050|NCT02802735|7629151|FG003|STARTED|Overall Study||12
6699051|NCT02802735|7629152|FG004|STARTED|Overall Study||4
6699052|NCT02802735|7629148|FG000|COMPLETED|Overall Study||4
6699053|NCT02802735|7629149|FG001|COMPLETED|Overall Study||3
6699054|NCT02802735|7629150|FG002|COMPLETED|Overall Study||4
6699055|NCT02802735|7629151|FG003|COMPLETED|Overall Study||12
6699056|NCT02802735|7629152|FG004|COMPLETED|Overall Study||4
6699057|NCT02802735|7629148|FG000|NOT COMPLETED|Overall Study||0
6699058|NCT02802735|7629149|FG001|NOT COMPLETED|Overall Study||1
6699059|NCT02802735|7629150|FG002|NOT COMPLETED|Overall Study||0
6699060|NCT02802735|7629151|FG003|NOT COMPLETED|Overall Study||0
6699061|NCT02802735|7629152|FG004|NOT COMPLETED|Overall Study||0
6699062|NCT02802865|7629169|FG000|STARTED|Overall Study||35
6699063|NCT02802865|7629170|FG001|STARTED|Overall Study||35
6699064|NCT02802865|7629169|FG000|COMPLETED|Overall Study||34
6699065|NCT02802865|7629170|FG001|COMPLETED|Overall Study||33
6699066|NCT02802865|7629169|FG000|NOT COMPLETED|Overall Study||1
6699067|NCT02802865|7629170|FG001|NOT COMPLETED|Overall Study||2
6699068|NCT02802878|7629178|FG000|STARTED|Overall Study||21
6699069|NCT02802878|7629179|FG001|STARTED|Overall Study||21
6699070|NCT02802878|7629178|FG000|COMPLETED|Overall Study||17
6699071|NCT02802878|7629179|FG001|COMPLETED|Overall Study||18
6699072|NCT02802878|7629178|FG000|NOT COMPLETED|Overall Study||4
6699073|NCT02802878|7629179|FG001|NOT COMPLETED|Overall Study||3
6699074|NCT02803138|7629185|FG000|STARTED|Overall Study||236
6699075|NCT02803138|7629185|FG000|COMPLETED|Overall Study||166
6699076|NCT02803138|7629185|FG000|NOT COMPLETED|Overall Study||70
6699077|NCT02803164|7629193|FG000|STARTED|Overall Study||10
6699078|NCT02803164|7629194|FG001|STARTED|Overall Study||11
6699079|NCT02803164|7629193|FG000|COMPLETED|Overall Study||10
6699080|NCT02803164|7629194|FG001|COMPLETED|Overall Study||11
6699081|NCT02803164|7629193|FG000|NOT COMPLETED|Overall Study||0
6699082|NCT02803164|7629194|FG001|NOT COMPLETED|Overall Study||0
6699083|NCT02803229|7629204|FG000|STARTED|Overall Study||15
6699084|NCT02803229|7629205|FG001|STARTED|Overall Study||13
6699085|NCT02803229|7629204|FG000|COMPLETED|Overall Study||11
6699086|NCT02803229|7629205|FG001|COMPLETED|Overall Study||7
6699087|NCT02803229|7629204|FG000|NOT COMPLETED|Overall Study||4
6699088|NCT02803229|7629205|FG001|NOT COMPLETED|Overall Study||6
6699089|NCT02803580|7629211|FG000|STARTED|Overall Study||209
6699090|NCT02803580|7629211|FG000|COMPLETED|Overall Study||173
6699091|NCT02803580|7629211|FG000|NOT COMPLETED|Overall Study||36
6699092|NCT02803749|7629217|FG000|STARTED|Overall Study||17
6699093|NCT02803749|7629218|FG001|STARTED|Overall Study||4
6699094|NCT02803749|7629217|FG000|COMPLETED|Overall Study||12
6699095|NCT02803749|7629218|FG001|COMPLETED|Overall Study||4
6699096|NCT02803749|7629217|FG000|NOT COMPLETED|Overall Study||5
6699097|NCT02803749|7629218|FG001|NOT COMPLETED|Overall Study||0
6699098|NCT02804178|7629224|FG000|STARTED|Overall Study||10
6699099|NCT02804178|7629224|FG000|COMPLETED|Overall Study||9
6699100|NCT02804178|7629224|FG000|NOT COMPLETED|Overall Study||1
6699101|NCT02804399|7629228|FG000|STARTED|Period 1||12
6699102|NCT02804399|7629229|FG001|STARTED|Period 1||0
6699103|NCT02804399|7629228|FG000|COMPLETED|Period 1||12
6699104|NCT02804399|7629229|FG001|COMPLETED|Period 1||0
6699105|NCT02804399|7629228|FG000|NOT COMPLETED|Period 1||0
6699106|NCT02804399|7629229|FG001|NOT COMPLETED|Period 1||0
6699107|NCT02804399|7629228|FG000|STARTED|Washout Period at Least 10 Days||12
6699108|NCT02804399|7629229|FG001|STARTED|Washout Period at Least 10 Days||0
6699109|NCT02804399|7629228|FG000|COMPLETED|Washout Period at Least 10 Days||12
6699110|NCT02804399|7629229|FG001|COMPLETED|Washout Period at Least 10 Days||0
6699111|NCT02804399|7629228|FG000|NOT COMPLETED|Washout Period at Least 10 Days||0
6699112|NCT02804399|7629229|FG001|NOT COMPLETED|Washout Period at Least 10 Days||0
6699113|NCT02804399|7629228|FG000|STARTED|Period 2||0
6259872|NCT01386385|7158894|FG004|COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259873|NCT01386385|7158895|FG005|COMPLETED|Phase I 120mg: Consolidation Therapy||5
6259874|NCT01386385|7158896|FG006|COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259875|NCT01386385|7158897|FG007|COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259876|NCT01386385|7158890|FG000|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259877|NCT01386385|7158891|FG001|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259878|NCT01386385|7158892|FG002|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259879|NCT01386385|7158893|FG003|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259880|NCT01386385|7158894|FG004|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259881|NCT01386385|7158895|FG005|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259882|NCT01386385|7158896|FG006|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259883|NCT01386385|7158897|FG007|NOT COMPLETED|Phase I 120mg: Consolidation Therapy||0
6259884|NCT01386385|7158890|FG000|STARTED|Phase II Concurrent CRT||0
6259885|NCT01386385|7158891|FG001|STARTED|Phase II Concurrent CRT||0
6259886|NCT01386385|7158892|FG002|STARTED|Phase II Concurrent CRT||0
6259887|NCT01386385|7158893|FG003|STARTED|Phase II Concurrent CRT||0
6259888|NCT01386385|7158894|FG004|STARTED|Phase II Concurrent CRT||0
6259889|NCT01386385|7158895|FG005|STARTED|Phase II Concurrent CRT||0
6259890|NCT01386385|7158896|FG006|STARTED|Phase II Concurrent CRT||18
6259891|NCT01386385|7158897|FG007|STARTED|Phase II Concurrent CRT||13
6259892|NCT01386385|7158890|FG000|COMPLETED|Phase II Concurrent CRT||0
6259893|NCT01386385|7158891|FG001|COMPLETED|Phase II Concurrent CRT||0
6259894|NCT01386385|7158892|FG002|COMPLETED|Phase II Concurrent CRT||0
6259895|NCT01386385|7158893|FG003|COMPLETED|Phase II Concurrent CRT||0
6259896|NCT01386385|7158894|FG004|COMPLETED|Phase II Concurrent CRT||0
6259897|NCT01386385|7158895|FG005|COMPLETED|Phase II Concurrent CRT||0
6259898|NCT01386385|7158896|FG006|COMPLETED|Phase II Concurrent CRT||12
6259899|NCT01386385|7158897|FG007|COMPLETED|Phase II Concurrent CRT||10
6259900|NCT01386385|7158890|FG000|NOT COMPLETED|Phase II Concurrent CRT||0
6259901|NCT01386385|7158891|FG001|NOT COMPLETED|Phase II Concurrent CRT||0
6259902|NCT01386385|7158892|FG002|NOT COMPLETED|Phase II Concurrent CRT||0
6259903|NCT01386385|7158893|FG003|NOT COMPLETED|Phase II Concurrent CRT||0
6259904|NCT01386385|7158894|FG004|NOT COMPLETED|Phase II Concurrent CRT||0
6259905|NCT01386385|7158895|FG005|NOT COMPLETED|Phase II Concurrent CRT||0
6259906|NCT01386385|7158896|FG006|NOT COMPLETED|Phase II Concurrent CRT||6
6259907|NCT01386385|7158897|FG007|NOT COMPLETED|Phase II Concurrent CRT||3
6259908|NCT01386385|7158890|FG000|STARTED|Phase II: Consolidation Therapy||0
6259909|NCT01386385|7158891|FG001|STARTED|Phase II: Consolidation Therapy||0
6259910|NCT01386385|7158892|FG002|STARTED|Phase II: Consolidation Therapy||0
6259911|NCT01386385|7158893|FG003|STARTED|Phase II: Consolidation Therapy||0
6259912|NCT01386385|7158894|FG004|STARTED|Phase II: Consolidation Therapy||0
6259913|NCT01386385|7158895|FG005|STARTED|Phase II: Consolidation Therapy||0
6259914|NCT01386385|7158896|FG006|STARTED|Phase II: Consolidation Therapy||13
6699114|NCT02804399|7629229|FG001|STARTED|Period 2||12
6699115|NCT02804399|7629228|FG000|COMPLETED|Period 2||0
6699116|NCT02804399|7629229|FG001|COMPLETED|Period 2||11
6699117|NCT02804399|7629228|FG000|NOT COMPLETED|Period 2||0
6699118|NCT02804399|7629229|FG001|NOT COMPLETED|Period 2||1
6699119|NCT02804594|7629240|FG000|STARTED|Overall Study||10
6699120|NCT02804594|7629241|FG001|STARTED|Overall Study||5
6699121|NCT02804594|7629240|FG000|COMPLETED|Overall Study||10
6699122|NCT02804594|7629241|FG001|COMPLETED|Overall Study||5
6699123|NCT02804594|7629240|FG000|NOT COMPLETED|Overall Study||0
6699124|NCT02804594|7629241|FG001|NOT COMPLETED|Overall Study||0
6699125|NCT02804750|7629249|FG000|STARTED|Period 1||17
6699126|NCT02804750|7629250|FG001|STARTED|Period 1||18
6699127|NCT02804750|7629249|FG000|COMPLETED|Period 1||17
6699128|NCT02804750|7629250|FG001|COMPLETED|Period 1||15
6699129|NCT02804750|7629249|FG000|NOT COMPLETED|Period 1||0
6699130|NCT02804750|7629250|FG001|NOT COMPLETED|Period 1||3
6699131|NCT02804750|7629249|FG000|STARTED|Period 2||17
6699132|NCT02804750|7629250|FG001|STARTED|Period 2||15
6699133|NCT02804750|7629249|FG000|COMPLETED|Period 2||16
6699134|NCT02804750|7629250|FG001|COMPLETED|Period 2||15
6699135|NCT02804750|7629249|FG000|NOT COMPLETED|Period 2||1
6699136|NCT02804750|7629250|FG001|NOT COMPLETED|Period 2||0
6699137|NCT02804750|7629249|FG000|STARTED|Period 3||16
6699138|NCT02804750|7629250|FG001|STARTED|Period 3||15
6699139|NCT02804750|7629249|FG000|COMPLETED|Period 3||16
6699140|NCT02804750|7629250|FG001|COMPLETED|Period 3||13
6699141|NCT02804750|7629249|FG000|NOT COMPLETED|Period 3||0
6699142|NCT02804750|7629250|FG001|NOT COMPLETED|Period 3||2
6699143|NCT02804750|7629249|FG000|STARTED|Period 4|Per-protocol, Group 1 did not participate in Period 4.|0
6699144|NCT02804750|7629250|FG001|STARTED|Period 4|One participant completed Period 3 but did not start Period 4 due to a pre-scheduled surgery.|12
6699145|NCT02804750|7629249|FG000|COMPLETED|Period 4||0
6699146|NCT02804750|7629250|FG001|COMPLETED|Period 4||7
6699147|NCT02804750|7629249|FG000|NOT COMPLETED|Period 4||0
6699148|NCT02804750|7629250|FG001|NOT COMPLETED|Period 4||5
6699149|NCT02804763|7629262|FG000|STARTED|Double-Blind Period (Week 1 to Week 24)||45
6699150|NCT02804763|7629263|FG001|STARTED|Double-Blind Period (Week 1 to Week 24)||45
6699151|NCT02804763|7629264|FG002|STARTED|Double-Blind Period (Week 1 to Week 24)||45
6699152|NCT02804763|7629265|FG003|STARTED|Double-Blind Period (Week 1 to Week 24)||47
6699153|NCT02804763|7629262|FG000|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
6699154|NCT02804763|7629263|FG001|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
6699155|NCT02804763|7629264|FG002|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||44
6699156|NCT02804763|7629265|FG003|Completed Week 24|Double-Blind Period (Week 1 to Week 24)||45
6699157|NCT02804763|7629262|FG000|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
6699158|NCT02804763|7629263|FG001|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
6699159|NCT02804763|7629264|FG002|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||44
6699160|NCT02804763|7629265|FG003|Finished Wk24 Began Observational Period|Double-Blind Period (Week 1 to Week 24)||45
6699161|NCT02804763|7629262|FG000|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
6699162|NCT02804763|7629263|FG001|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
6699163|NCT02804763|7629264|FG002|COMPLETED|Double-Blind Period (Week 1 to Week 24)||44
6699164|NCT02804763|7629265|FG003|COMPLETED|Double-Blind Period (Week 1 to Week 24)||45
6699165|NCT02804763|7629262|FG000|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
6699166|NCT02804763|7629263|FG001|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
6699167|NCT02804763|7629264|FG002|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||1
6699168|NCT02804763|7629265|FG003|NOT COMPLETED|Double-Blind Period (Week 1 to Week 24)||2
6699169|NCT02804763|7629262|FG000|STARTED|Observational Period (Wk 24 to Wk 48)||44
6699170|NCT02804763|7629263|FG001|STARTED|Observational Period (Wk 24 to Wk 48)||44
6699171|NCT02804763|7629264|FG002|STARTED|Observational Period (Wk 24 to Wk 48)||44
6699172|NCT02804763|7629265|FG003|STARTED|Observational Period (Wk 24 to Wk 48)||45
6699173|NCT02804763|7629262|FG000|COMPLETED|Observational Period (Wk 24 to Wk 48)||38
6699174|NCT02804763|7629263|FG001|COMPLETED|Observational Period (Wk 24 to Wk 48)||43
6699175|NCT02804763|7629264|FG002|COMPLETED|Observational Period (Wk 24 to Wk 48)||41
6699176|NCT02804763|7629265|FG003|COMPLETED|Observational Period (Wk 24 to Wk 48)||42
6699177|NCT02804763|7629262|FG000|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||6
6699178|NCT02804763|7629263|FG001|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||1
6699179|NCT02804763|7629264|FG002|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
6699180|NCT02804763|7629265|FG003|NOT COMPLETED|Observational Period (Wk 24 to Wk 48)||3
6699181|NCT02805179|7629279|FG000|STARTED|Overall Study||26
6699182|NCT02805179|7629279|FG000|Eligible Patients That Started Dose-intensified Chemo-radiation|Overall Study||23
6699183|NCT02805179|7629279|FG000|Subset of Participants, Boosted to Both High B-value Diffusion and Perfusion|Overall Study||13
6699184|NCT02805179|7629279|FG000|COMPLETED|Overall Study||23
6699185|NCT02805179|7629279|FG000|NOT COMPLETED|Overall Study||3
6699186|NCT02805309|7629286|FG000|STARTED|Overall Study||18
6699187|NCT02805309|7629287|FG001|STARTED|Overall Study||17
6699188|NCT02805309|7629288|FG002|STARTED|Overall Study||19
6699189|NCT02805309|7629286|FG000|COMPLETED|Overall Study||16
6699190|NCT02805309|7629287|FG001|COMPLETED|Overall Study||13
6699191|NCT02805309|7629288|FG002|COMPLETED|Overall Study||16
6699192|NCT02805309|7629286|FG000|NOT COMPLETED|Overall Study||2
6699193|NCT02805309|7629287|FG001|NOT COMPLETED|Overall Study||4
6699194|NCT02805309|7629288|FG002|NOT COMPLETED|Overall Study||3
6699195|NCT02805647|7629298|FG000|STARTED|Overall Study|at the moment of submision|100
6699196|NCT02805647|7629299|FG001|STARTED|Overall Study|at the moment of submision|122
6699197|NCT02805647|7629298|FG000|COMPLETED|Overall Study|after laboratory tests|100
6699198|NCT02805647|7629299|FG001|COMPLETED|Overall Study|after laboratory tests|122
6699199|NCT02805647|7629298|FG000|NOT COMPLETED|Overall Study||0
6699200|NCT02805647|7629299|FG001|NOT COMPLETED|Overall Study||0
6699201|NCT02805660|7629312|FG000|STARTED|Overall Study||5
6699202|NCT02805660|7629313|FG001|STARTED|Overall Study||4
6699203|NCT02805660|7629314|FG002|STARTED|Overall Study||11
6699204|NCT02805660|7629315|FG003|STARTED|Overall Study||18
6699205|NCT02805660|7629316|FG004|STARTED|Overall Study||3
6699206|NCT02805660|7629317|FG005|STARTED|Overall Study||23
6699207|NCT02805660|7629318|FG006|STARTED|Overall Study||19
6699208|NCT02805660|7629312|FG000|COMPLETED|Overall Study||0
6699209|NCT02805660|7629313|FG001|COMPLETED|Overall Study||0
6699210|NCT02805660|7629314|FG002|COMPLETED|Overall Study||0
6699211|NCT02805660|7629315|FG003|COMPLETED|Overall Study||0
6699212|NCT02805660|7629316|FG004|COMPLETED|Overall Study||0
6699213|NCT02805660|7629317|FG005|COMPLETED|Overall Study||0
6699214|NCT02805660|7629318|FG006|COMPLETED|Overall Study||0
6699215|NCT02805660|7629312|FG000|NOT COMPLETED|Overall Study||5
6699216|NCT02805660|7629313|FG001|NOT COMPLETED|Overall Study||4
6699217|NCT02805660|7629314|FG002|NOT COMPLETED|Overall Study||11
6699218|NCT02805660|7629315|FG003|NOT COMPLETED|Overall Study||18
6699219|NCT02805660|7629316|FG004|NOT COMPLETED|Overall Study||3
6699220|NCT02805660|7629317|FG005|NOT COMPLETED|Overall Study||23
6699221|NCT02805660|7629318|FG006|NOT COMPLETED|Overall Study||19
6699222|NCT02805790|7629349|FG000|STARTED|First Intervention (4 Weeks)||14
6699223|NCT02805790|7629350|FG001|STARTED|First Intervention (4 Weeks)||16
6699224|NCT02805790|7629349|FG000|COMPLETED|First Intervention (4 Weeks)||14
6699225|NCT02805790|7629350|FG001|COMPLETED|First Intervention (4 Weeks)||16
6699226|NCT02805790|7629349|FG000|NOT COMPLETED|First Intervention (4 Weeks)||0
6699227|NCT02805790|7629350|FG001|NOT COMPLETED|First Intervention (4 Weeks)||0
6699228|NCT02805790|7629349|FG000|STARTED|Washout (4 Weeks)||14
6699229|NCT02805790|7629350|FG001|STARTED|Washout (4 Weeks)||16
6699230|NCT02805790|7629349|FG000|COMPLETED|Washout (4 Weeks)||14
6699231|NCT02805790|7629350|FG001|COMPLETED|Washout (4 Weeks)||16
6699232|NCT02805790|7629349|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6699233|NCT02805790|7629350|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6699234|NCT02805790|7629349|FG000|STARTED|Second Intervention (4 Weeks)||14
6699235|NCT02805790|7629350|FG001|STARTED|Second Intervention (4 Weeks)||16
6699236|NCT02805790|7629349|FG000|COMPLETED|Second Intervention (4 Weeks)||14
6699237|NCT02805790|7629350|FG001|COMPLETED|Second Intervention (4 Weeks)||15
6699238|NCT02805790|7629349|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||0
6699239|NCT02805790|7629350|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||1
6699240|NCT02805907|7629358|FG000|STARTED|Overall Study||56
6699241|NCT02805907|7629359|FG001|STARTED|Overall Study||56
6699242|NCT02805907|7629358|FG000|COMPLETED|Overall Study||53
6699243|NCT02805907|7629359|FG001|COMPLETED|Overall Study||53
6699244|NCT02805907|7629358|FG000|NOT COMPLETED|Overall Study||3
6699245|NCT02805907|7629359|FG001|NOT COMPLETED|Overall Study||3
6699246|NCT02805972|7629367|FG000|STARTED|Intervention Visit 1||23
6699247|NCT02805972|7629368|FG001|STARTED|Intervention Visit 1||18
6699248|NCT02805972|7629367|FG000|COMPLETED|Intervention Visit 1||23
6699249|NCT02805972|7629368|FG001|COMPLETED|Intervention Visit 1||18
6699250|NCT02805972|7629367|FG000|NOT COMPLETED|Intervention Visit 1||0
6699251|NCT02805972|7629368|FG001|NOT COMPLETED|Intervention Visit 1||0
6699252|NCT02805972|7629367|FG000|STARTED|Washout Period||23
6699253|NCT02805972|7629368|FG001|STARTED|Washout Period||18
6699254|NCT02805972|7629367|FG000|COMPLETED|Washout Period||20
6699255|NCT02805972|7629368|FG001|COMPLETED|Washout Period||18
6699256|NCT02805972|7629367|FG000|NOT COMPLETED|Washout Period||3
6699257|NCT02805972|7629368|FG001|NOT COMPLETED|Washout Period||0
6699258|NCT02805972|7629367|FG000|STARTED|Intervention Visit 2||20
6699259|NCT02805972|7629368|FG001|STARTED|Intervention Visit 2||18
6699260|NCT02805972|7629367|FG000|COMPLETED|Intervention Visit 2||20
6699261|NCT02805972|7629368|FG001|COMPLETED|Intervention Visit 2||18
6699262|NCT02805972|7629367|FG000|NOT COMPLETED|Intervention Visit 2||0
6699263|NCT02805972|7629368|FG001|NOT COMPLETED|Intervention Visit 2||0
6699264|NCT02806024|7629386|FG000|STARTED|Overall Study||7
6699265|NCT02806024|7629387|FG001|STARTED|Overall Study||7
6699266|NCT02806024|7629386|FG000|COMPLETED|Overall Study||6
6699267|NCT02806024|7629387|FG001|COMPLETED|Overall Study||5
6699268|NCT02806024|7629386|FG000|NOT COMPLETED|Overall Study||1
6699269|NCT02806024|7629387|FG001|NOT COMPLETED|Overall Study||2
6699270|NCT02806232|7629402|FG000|STARTED|Overall Study||60
6699271|NCT02806232|7629403|FG001|STARTED|Overall Study||60
6699272|NCT02806232|7629404|FG002|STARTED|Overall Study||60
6699273|NCT02806232|7629405|FG003|STARTED|Overall Study||60
6699274|NCT02806232|7629406|FG004|STARTED|Overall Study||60
6699275|NCT02806232|7629407|FG005|STARTED|Overall Study||60
6699276|NCT02806232|7629408|FG006|STARTED|Overall Study||60
6699277|NCT02806232|7629409|FG007|STARTED|Overall Study||20
6699278|NCT02806232|7629410|FG008|STARTED|Overall Study||4
6699279|NCT02806232|7629402|FG000|COMPLETED|Overall Study||59
6699280|NCT02806232|7629403|FG001|COMPLETED|Overall Study||56
6699281|NCT02806232|7629404|FG002|COMPLETED|Overall Study||59
6699282|NCT02806232|7629405|FG003|COMPLETED|Overall Study||60
6699283|NCT02806232|7629406|FG004|COMPLETED|Overall Study||58
6699284|NCT02806232|7629407|FG005|COMPLETED|Overall Study||58
6699285|NCT02806232|7629408|FG006|COMPLETED|Overall Study||60
6699286|NCT02806232|7629409|FG007|COMPLETED|Overall Study||20
6699287|NCT02806232|7629410|FG008|COMPLETED|Overall Study||4
6699288|NCT02806232|7629402|FG000|NOT COMPLETED|Overall Study||1
6699289|NCT02806232|7629403|FG001|NOT COMPLETED|Overall Study||4
6699290|NCT02806232|7629404|FG002|NOT COMPLETED|Overall Study||1
6699291|NCT02806232|7629405|FG003|NOT COMPLETED|Overall Study||0
6699292|NCT02806232|7629406|FG004|NOT COMPLETED|Overall Study||2
6699293|NCT02806232|7629407|FG005|NOT COMPLETED|Overall Study||2
6699294|NCT02806232|7629408|FG006|NOT COMPLETED|Overall Study||0
6699295|NCT02806232|7629409|FG007|NOT COMPLETED|Overall Study||0
6699296|NCT02806232|7629410|FG008|NOT COMPLETED|Overall Study||0
6699297|NCT02806414|7629430|FG000|STARTED|Overall Study||25
6699298|NCT02806414|7629430|FG000|COMPLETED|Overall Study||23
6699299|NCT02806414|7629430|FG000|NOT COMPLETED|Overall Study||2
6699300|NCT02806505|7629436|FG000|STARTED|Overall Study||38
6699301|NCT02806505|7629437|FG001|STARTED|Overall Study||43
6699302|NCT02806505|7629436|FG000|COMPLETED|Overall Study||28
6699303|NCT02806505|7629437|FG001|COMPLETED|Overall Study||32
6699304|NCT02806505|7629436|FG000|NOT COMPLETED|Overall Study||10
6699305|NCT02806505|7629437|FG001|NOT COMPLETED|Overall Study||11
6699306|NCT02806544|7629443|FG000|STARTED|Overall Study||35
6699307|NCT02806544|7629443|FG000|COMPLETED|Overall Study||31
6699308|NCT02806544|7629443|FG000|NOT COMPLETED|Overall Study||4
6699309|NCT02806713|7629449|FG000|STARTED|Overall Study||46
6699310|NCT02806713|7629450|FG001|STARTED|Overall Study||46
6699311|NCT02806713|7629449|FG000|COMPLETED|Overall Study||44
6699312|NCT02806713|7629450|FG001|COMPLETED|Overall Study||44
6699313|NCT02806713|7629449|FG000|NOT COMPLETED|Overall Study||2
6699314|NCT02806713|7629450|FG001|NOT COMPLETED|Overall Study||2
6259915|NCT01386385|7158897|FG007|STARTED|Phase II: Consolidation Therapy||10
6259916|NCT01386385|7158890|FG000|COMPLETED|Phase II: Consolidation Therapy||0
6259917|NCT01386385|7158891|FG001|COMPLETED|Phase II: Consolidation Therapy||0
6259918|NCT01386385|7158892|FG002|COMPLETED|Phase II: Consolidation Therapy||0
6259919|NCT01386385|7158893|FG003|COMPLETED|Phase II: Consolidation Therapy||0
6259920|NCT01386385|7158894|FG004|COMPLETED|Phase II: Consolidation Therapy||0
6259921|NCT01386385|7158895|FG005|COMPLETED|Phase II: Consolidation Therapy||0
6259922|NCT01386385|7158896|FG006|COMPLETED|Phase II: Consolidation Therapy||8
6259923|NCT01386385|7158897|FG007|COMPLETED|Phase II: Consolidation Therapy||8
6259924|NCT01386385|7158890|FG000|NOT COMPLETED|Phase II: Consolidation Therapy||0
6259925|NCT01386385|7158891|FG001|NOT COMPLETED|Phase II: Consolidation Therapy||0
6259926|NCT01386385|7158892|FG002|NOT COMPLETED|Phase II: Consolidation Therapy||0
6259927|NCT01386385|7158893|FG003|NOT COMPLETED|Phase II: Consolidation Therapy||0
6259928|NCT01386385|7158894|FG004|NOT COMPLETED|Phase II: Consolidation Therapy||0
6259929|NCT01386385|7158895|FG005|NOT COMPLETED|Phase II: Consolidation Therapy||0
6259930|NCT01386385|7158896|FG006|NOT COMPLETED|Phase II: Consolidation Therapy||5
6259931|NCT01386385|7158897|FG007|NOT COMPLETED|Phase II: Consolidation Therapy||2
6259932|NCT01358877|7158920|FG000|STARTED|Overall Study||2400
6259933|NCT01358877|7158921|FG001|STARTED|Overall Study||2404
6259934|NCT01358877|7158920|FG000|Did Not Receive Study Drug|Overall Study||22
6259935|NCT01358877|7158921|FG001|Did Not Receive Study Drug|Overall Study||13
6259936|NCT01358877|7158920|FG000|Received Study Drug (Safety Population)|Overall Study|24 placebo participants received at least 1 dose of pertuzumab and were included in pertuzumab arm.|2364
6259937|NCT01358877|7158921|FG001|Received Study Drug (Safety Population)|Overall Study|38 pertuzumab participants did not receive pertuzumab and were included in placebo arm.|2405
6259938|NCT01358877|7158920|FG000|COMPLETED|Overall Study||0
6259939|NCT01358877|7158921|FG001|COMPLETED|Overall Study||0
6259940|NCT01358877|7158920|FG000|NOT COMPLETED|Overall Study||2400
6259941|NCT01358877|7158921|FG001|NOT COMPLETED|Overall Study||2404
6259942|NCT01313351|7158927|FG000|STARTED|Overall Study||206
6259943|NCT01313351|7158927|FG000|COMPLETED|Overall Study||206
6259944|NCT01313351|7158927|FG000|NOT COMPLETED|Overall Study||0
6259945|NCT01267955|7158932|FG000|STARTED|Stage 1 (6 Months)||20
6259946|NCT01267955|7158932|FG000|COMPLETED|Stage 1 (6 Months)||17
6259947|NCT01267955|7158932|FG000|NOT COMPLETED|Stage 1 (6 Months)||3
6259948|NCT01267955|7158932|FG000|STARTED|Stage 2 (6 Months)||45
6259949|NCT01267955|7158932|FG000|COMPLETED|Stage 2 (6 Months)||39
6259950|NCT01267955|7158932|FG000|NOT COMPLETED|Stage 2 (6 Months)||6
6259951|NCT01256398|7158936|FG000|STARTED|Overall Study||66
6259952|NCT01256398|7158936|FG000|COMPLETED|Overall Study||65
6259953|NCT01256398|7158936|FG000|NOT COMPLETED|Overall Study||1
6259954|NCT01253070|7158940|FG000|STARTED|Overall Study||54
6259955|NCT01253070|7158940|FG000|COMPLETED|Overall Study||54
6259956|NCT01253070|7158940|FG000|NOT COMPLETED|Overall Study||0
6259957|NCT01232283|7158947|FG000|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
6259958|NCT01232283|7158948|FG001|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
6259959|NCT01232283|7158949|FG002|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6259960|NCT01232283|7158950|FG003|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6259961|NCT01232283|7158951|FG004|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6259962|NCT01232283|7158952|FG005|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6259963|NCT01232283|7158953|FG006|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6259964|NCT01232283|7158954|FG007|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6259965|NCT01232283|7158955|FG008|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6259966|NCT01232283|7158956|FG009|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
6281042|NCT00161473|7180920|FG001|STARTED|Overall Study||12
6699315|NCT02806726|7629456|FG000|STARTED|Overall Study|Subjects were treated contralaterally|7
6699316|NCT02806726|7629456|FG000|COMPLETED|Overall Study|Subjects were treated contralaterally|6
6699317|NCT02806726|7629456|FG000|NOT COMPLETED|Overall Study||1
6699318|NCT02806869|7629463|FG000|STARTED|First Intervention (1 Day)||24
6699319|NCT02806869|7629464|FG001|STARTED|First Intervention (1 Day)||24
6699320|NCT02806869|7629463|FG000|COMPLETED|First Intervention (1 Day)||13
6699321|NCT02806869|7629464|FG001|COMPLETED|First Intervention (1 Day)||12
6699322|NCT02806869|7629463|FG000|NOT COMPLETED|First Intervention (1 Day)||11
6699323|NCT02806869|7629464|FG001|NOT COMPLETED|First Intervention (1 Day)||12
6699324|NCT02806869|7629463|FG000|STARTED|Washout (7 Days)||7
6699325|NCT02806869|7629464|FG001|STARTED|Washout (7 Days)||7
6699326|NCT02806869|7629463|FG000|COMPLETED|Washout (7 Days)||7
6699327|NCT02806869|7629464|FG001|COMPLETED|Washout (7 Days)||7
6699328|NCT02806869|7629463|FG000|NOT COMPLETED|Washout (7 Days)||0
6699329|NCT02806869|7629464|FG001|NOT COMPLETED|Washout (7 Days)||0
6699330|NCT02806869|7629463|FG000|STARTED|Second Intervention (1 Day)||7
6699331|NCT02806869|7629464|FG001|STARTED|Second Intervention (1 Day)||7
6699332|NCT02806869|7629463|FG000|COMPLETED|Second Intervention (1 Day)||7
6699333|NCT02806869|7629464|FG001|COMPLETED|Second Intervention (1 Day)||5
6699334|NCT02806869|7629463|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6699335|NCT02806869|7629464|FG001|NOT COMPLETED|Second Intervention (1 Day)||2
6699336|NCT02806895|7629472|FG000|STARTED|Overall Study||17
6699337|NCT02806895|7629473|FG001|STARTED|Overall Study||17
6699338|NCT02806895|7629472|FG000|COMPLETED|Overall Study||16
6699339|NCT02806895|7629473|FG001|COMPLETED|Overall Study||17
6699340|NCT02806895|7629472|FG000|NOT COMPLETED|Overall Study||1
6699341|NCT02806895|7629473|FG001|NOT COMPLETED|Overall Study||0
6699342|NCT02806908|7629482|FG000|STARTED|Overall Study||11
6699343|NCT02806908|7629483|FG001|STARTED|Overall Study||13
6699344|NCT02806908|7629482|FG000|COMPLETED|Overall Study||10
6699345|NCT02806908|7629483|FG001|COMPLETED|Overall Study||12
6699346|NCT02806908|7629482|FG000|NOT COMPLETED|Overall Study||1
6699347|NCT02806908|7629483|FG001|NOT COMPLETED|Overall Study||1
6699348|NCT02806947|7629492|FG000|STARTED|Overall Study||58
6699349|NCT02806947|7629493|FG001|STARTED|Overall Study||64
6699350|NCT02806947|7629492|FG000|COMPLETED|Overall Study||53
6699351|NCT02806947|7629493|FG001|COMPLETED|Overall Study||63
6259967|NCT01232283|7158947|FG000|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
6259968|NCT01232283|7158948|FG001|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
6259969|NCT01232283|7158949|FG002|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6259970|NCT01232283|7158950|FG003|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6259971|NCT01232283|7158951|FG004|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6259972|NCT01232283|7158952|FG005|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6259973|NCT01232283|7158953|FG006|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6259974|NCT01232283|7158954|FG007|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6259975|NCT01232283|7158955|FG008|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6259976|NCT01232283|7158956|FG009|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
6259977|NCT01232283|7158947|FG000|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
6259978|NCT01232283|7158948|FG001|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
6259979|NCT01232283|7158949|FG002|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259980|NCT01232283|7158950|FG003|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259981|NCT01232283|7158951|FG004|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259982|NCT01232283|7158952|FG005|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259983|NCT01232283|7158953|FG006|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259984|NCT01232283|7158954|FG007|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259985|NCT01232283|7158955|FG008|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259986|NCT01232283|7158956|FG009|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259987|NCT01232283|7158947|FG000|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
6259988|NCT01232283|7158948|FG001|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
6259989|NCT01232283|7158949|FG002|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259990|NCT01232283|7158950|FG003|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259991|NCT01232283|7158951|FG004|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259992|NCT01232283|7158952|FG005|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259993|NCT01232283|7158953|FG006|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259994|NCT01232283|7158954|FG007|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259995|NCT01232283|7158955|FG008|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259996|NCT01232283|7158956|FG009|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
6259997|NCT01232283|7158947|FG000|STARTED|Maintenance Phase (Weeks16-32)||0
6259998|NCT01232283|7158948|FG001|STARTED|Maintenance Phase (Weeks16-32)||0
6259999|NCT01232283|7158949|FG002|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
6260000|NCT01232283|7158950|FG003|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
6260001|NCT01232283|7158951|FG004|STARTED|Maintenance Phase (Weeks16-32)||0
6260002|NCT01232283|7158952|FG005|STARTED|Maintenance Phase (Weeks16-32)||0
6260003|NCT01232283|7158953|FG006|STARTED|Maintenance Phase (Weeks16-32)||0
6699352|NCT02806947|7629492|FG000|NOT COMPLETED|Overall Study||5
6699353|NCT02806947|7629493|FG001|NOT COMPLETED|Overall Study||1
6699354|NCT02806973|7629499|FG000|STARTED|Period 1||8
6699355|NCT02806973|7629500|FG001|STARTED|Period 1||8
6699356|NCT02806973|7629501|FG002|STARTED|Period 1||8
6699357|NCT02806973|7629502|FG003|STARTED|Period 1||8
6699358|NCT02806973|7629499|FG000|COMPLETED|Period 1||8
6699359|NCT02806973|7629500|FG001|COMPLETED|Period 1||6
6699360|NCT02806973|7629501|FG002|COMPLETED|Period 1||7
6699361|NCT02806973|7629502|FG003|COMPLETED|Period 1||6
6699362|NCT02806973|7629499|FG000|NOT COMPLETED|Period 1||0
6699363|NCT02806973|7629500|FG001|NOT COMPLETED|Period 1||2
6699364|NCT02806973|7629501|FG002|NOT COMPLETED|Period 1||1
6699365|NCT02806973|7629502|FG003|NOT COMPLETED|Period 1||2
6699366|NCT02806973|7629499|FG000|STARTED|Period 2||8
6699367|NCT02806973|7629500|FG001|STARTED|Period 2||6
6699368|NCT02806973|7629501|FG002|STARTED|Period 2||7
6699369|NCT02806973|7629502|FG003|STARTED|Period 2||6
6699370|NCT02806973|7629499|FG000|COMPLETED|Period 2||8
6699371|NCT02806973|7629500|FG001|COMPLETED|Period 2||6
6699372|NCT02806973|7629501|FG002|COMPLETED|Period 2||7
6699373|NCT02806973|7629502|FG003|COMPLETED|Period 2||6
6699374|NCT02806973|7629499|FG000|NOT COMPLETED|Period 2||0
6699375|NCT02806973|7629500|FG001|NOT COMPLETED|Period 2||0
6699376|NCT02806973|7629501|FG002|NOT COMPLETED|Period 2||0
6699377|NCT02806973|7629502|FG003|NOT COMPLETED|Period 2||0
6699378|NCT02806973|7629499|FG000|STARTED|Period 3||8
6699379|NCT02806973|7629500|FG001|STARTED|Period 3||6
6699380|NCT02806973|7629501|FG002|STARTED|Period 3||7
6699381|NCT02806973|7629502|FG003|STARTED|Period 3||6
6699382|NCT02806973|7629499|FG000|COMPLETED|Period 3||8
6699383|NCT02806973|7629500|FG001|COMPLETED|Period 3||6
6699384|NCT02806973|7629501|FG002|COMPLETED|Period 3||6
6699385|NCT02806973|7629502|FG003|COMPLETED|Period 3||3
6699386|NCT02806973|7629499|FG000|NOT COMPLETED|Period 3||0
6699387|NCT02806973|7629500|FG001|NOT COMPLETED|Period 3||0
6699388|NCT02806973|7629501|FG002|NOT COMPLETED|Period 3||1
6699389|NCT02806973|7629502|FG003|NOT COMPLETED|Period 3||3
6699390|NCT02806973|7629499|FG000|STARTED|Period 4||8
6699391|NCT02806973|7629500|FG001|STARTED|Period 4||6
6699392|NCT02806973|7629501|FG002|STARTED|Period 4||6
6699393|NCT02806973|7629502|FG003|STARTED|Period 4||3
6699394|NCT02806973|7629499|FG000|COMPLETED|Period 4||8
6699395|NCT02806973|7629500|FG001|COMPLETED|Period 4||6
6699396|NCT02806973|7629501|FG002|COMPLETED|Period 4||6
6699397|NCT02806973|7629502|FG003|COMPLETED|Period 4||3
6699398|NCT02806973|7629499|FG000|NOT COMPLETED|Period 4||0
6699399|NCT02806973|7629500|FG001|NOT COMPLETED|Period 4||0
6699400|NCT02806973|7629501|FG002|NOT COMPLETED|Period 4||0
6699401|NCT02806973|7629502|FG003|NOT COMPLETED|Period 4||0
6699402|NCT02806986|7629512|FG000|STARTED|Treatment Stage 1||61
6699403|NCT02806986|7629512|FG000|COMPLETED|Treatment Stage 1||60
6699404|NCT02806986|7629512|FG000|NOT COMPLETED|Treatment Stage 1||1
6699405|NCT02806986|7629512|FG000|STARTED|Treatment Stage 2||60
6699406|NCT02806986|7629512|FG000|COMPLETED|Treatment Stage 2||55
6699407|NCT02806986|7629512|FG000|NOT COMPLETED|Treatment Stage 2||5
6699408|NCT02807259|7629522|FG000|STARTED|Baseline (3 Months)||405
6699409|NCT02807259|7629523|FG001|STARTED|Baseline (3 Months)||404
6699410|NCT02807259|7629522|FG000|COMPLETED|Baseline (3 Months)||328
6699411|NCT02807259|7629523|FG001|COMPLETED|Baseline (3 Months)||292
6699412|NCT02807259|7629522|FG000|NOT COMPLETED|Baseline (3 Months)||77
6699413|NCT02807259|7629523|FG001|NOT COMPLETED|Baseline (3 Months)||112
6699414|NCT02807259|7629522|FG000|STARTED|Midline (3 Months)||352
6699415|NCT02807259|7629523|FG001|STARTED|Midline (3 Months)||223
6699416|NCT02807259|7629522|FG000|COMPLETED|Midline (3 Months)||322
6699417|NCT02807259|7629523|FG001|COMPLETED|Midline (3 Months)||189
6699418|NCT02807259|7629522|FG000|NOT COMPLETED|Midline (3 Months)||30
6699419|NCT02807259|7629523|FG001|NOT COMPLETED|Midline (3 Months)||34
6699420|NCT02807259|7629522|FG000|STARTED|Endline (3 Months)||323
6699421|NCT02807259|7629523|FG001|STARTED|Endline (3 Months)||346
6699422|NCT02807259|7629522|FG000|COMPLETED|Endline (3 Months)||288
6699423|NCT02807259|7629523|FG001|COMPLETED|Endline (3 Months)||259
6699424|NCT02807259|7629522|FG000|NOT COMPLETED|Endline (3 Months)||35
6699425|NCT02807259|7629523|FG001|NOT COMPLETED|Endline (3 Months)||87
6699426|NCT02807376|7629533|FG000|STARTED|Overall Study||139
6699427|NCT02807376|7629534|FG001|STARTED|Overall Study||131
6699428|NCT02807376|7629533|FG000|COMPLETED|Overall Study||136
6699429|NCT02807376|7629534|FG001|COMPLETED|Overall Study||130
6699430|NCT02807376|7629533|FG000|NOT COMPLETED|Overall Study||3
6699431|NCT02807376|7629534|FG001|NOT COMPLETED|Overall Study||1
6699432|NCT02807402|7629540|FG000|STARTED|Overall Study||522
6699433|NCT02807402|7629540|FG000|COMPLETED|Overall Study||516
6699434|NCT02807402|7629540|FG000|NOT COMPLETED|Overall Study||6
6699435|NCT02807623|7629555|FG000|STARTED|Overall Study||98
6699436|NCT02807623|7629556|FG001|STARTED|Overall Study||100
6699437|NCT02807623|7629557|FG002|STARTED|Overall Study||102
6699438|NCT02807623|7629555|FG000|COMPLETED|Overall Study||75
6699439|NCT02807623|7629556|FG001|COMPLETED|Overall Study||79
6699440|NCT02807623|7629557|FG002|COMPLETED|Overall Study||79
6699441|NCT02807623|7629555|FG000|NOT COMPLETED|Overall Study||23
6699442|NCT02807623|7629556|FG001|NOT COMPLETED|Overall Study||21
6699443|NCT02807623|7629557|FG002|NOT COMPLETED|Overall Study||23
6699444|NCT02807844|7629584|FG000|STARTED|Overall Study||6
6699445|NCT02807844|7629585|FG001|STARTED|Overall Study||12
6699446|NCT02807844|7629586|FG002|STARTED|Overall Study||12
6699447|NCT02807844|7629587|FG003|STARTED|Overall Study||13
6699448|NCT02807844|7629588|FG004|STARTED|Overall Study||6
6699449|NCT02807844|7629589|FG005|STARTED|Overall Study||11
6699450|NCT02807844|7629590|FG006|STARTED|Overall Study||20
6699451|NCT02807844|7629591|FG007|STARTED|Overall Study||20
6699452|NCT02807844|7629592|FG008|STARTED|Overall Study||21
6699453|NCT02807844|7629593|FG009|STARTED|Overall Study||20
6699454|NCT02807844|7629584|FG000|COMPLETED|Overall Study||0
6699455|NCT02807844|7629585|FG001|COMPLETED|Overall Study||0
6699456|NCT02807844|7629586|FG002|COMPLETED|Overall Study||0
6699457|NCT02807844|7629587|FG003|COMPLETED|Overall Study||0
6699458|NCT02807844|7629588|FG004|COMPLETED|Overall Study||0
6699459|NCT02807844|7629589|FG005|COMPLETED|Overall Study||0
6699460|NCT02807844|7629590|FG006|COMPLETED|Overall Study||0
6699461|NCT02807844|7629591|FG007|COMPLETED|Overall Study||0
6699462|NCT02807844|7629592|FG008|COMPLETED|Overall Study||0
6699463|NCT02807844|7629593|FG009|COMPLETED|Overall Study||0
6699464|NCT02807844|7629584|FG000|NOT COMPLETED|Overall Study||6
6699465|NCT02807844|7629585|FG001|NOT COMPLETED|Overall Study||12
6699466|NCT02807844|7629586|FG002|NOT COMPLETED|Overall Study||12
6699467|NCT02807844|7629587|FG003|NOT COMPLETED|Overall Study||13
6699468|NCT02807844|7629588|FG004|NOT COMPLETED|Overall Study||6
6699469|NCT02807844|7629589|FG005|NOT COMPLETED|Overall Study||11
6699470|NCT02807844|7629590|FG006|NOT COMPLETED|Overall Study||20
6699471|NCT02807844|7629591|FG007|NOT COMPLETED|Overall Study||20
6699472|NCT02807844|7629592|FG008|NOT COMPLETED|Overall Study||21
6699473|NCT02807844|7629593|FG009|NOT COMPLETED|Overall Study||20
6699474|NCT02807857|7629619|FG000|STARTED|Enrolled Set||1415
6699475|NCT02807857|7629619|FG000|COMPLETED|Enrolled Set||864
6699476|NCT02807857|7629619|FG000|NOT COMPLETED|Enrolled Set||551
6699477|NCT02807857|7629619|FG000|STARTED|Follow-Up Set||864
6699478|NCT02807857|7629619|FG000|COMPLETED|Follow-Up Set||680
6699479|NCT02807857|7629619|FG000|NOT COMPLETED|Follow-Up Set||184
6699480|NCT02807948|7629629|FG000|STARTED|Overall Study||132
6699481|NCT02807948|7629630|FG001|STARTED|Overall Study||57
6699482|NCT02807948|7629629|FG000|COMPLETED|Overall Study||131
6699483|NCT02807948|7629630|FG001|COMPLETED|Overall Study||57
6699484|NCT02807948|7629629|FG000|NOT COMPLETED|Overall Study||1
6699485|NCT02807948|7629630|FG001|NOT COMPLETED|Overall Study||0
6699486|NCT02808052|7629638|FG000|STARTED|Overall Study||4
6699487|NCT02808052|7629639|FG001|STARTED|Overall Study||3
6699488|NCT02808052|7629640|FG002|STARTED|Overall Study||2
6699489|NCT02808052|7629638|FG000|COMPLETED|Overall Study||4
6699490|NCT02808052|7629639|FG001|COMPLETED|Overall Study||3
6699491|NCT02808052|7629640|FG002|COMPLETED|Overall Study||2
6699492|NCT02808052|7629638|FG000|NOT COMPLETED|Overall Study||0
6699493|NCT02808052|7629639|FG001|NOT COMPLETED|Overall Study||0
6699494|NCT02808052|7629640|FG002|NOT COMPLETED|Overall Study||0
6699495|NCT02808130|7629654|FG000|STARTED|Overall Study||15
6699496|NCT02808130|7629655|FG001|STARTED|Overall Study||15
6699497|NCT02808130|7629656|FG002|STARTED|Overall Study||15
6699498|NCT02808130|7629657|FG003|STARTED|Overall Study||15
6699499|NCT02808130|7629658|FG004|STARTED|Overall Study||15
6699500|NCT02808130|7629659|FG005|STARTED|Overall Study||15
6699501|NCT02808130|7629654|FG000|COMPLETED|Overall Study||15
6699502|NCT02808130|7629655|FG001|COMPLETED|Overall Study||15
6699503|NCT02808130|7629656|FG002|COMPLETED|Overall Study||15
6699504|NCT02808130|7629657|FG003|COMPLETED|Overall Study||15
6699505|NCT02808130|7629658|FG004|COMPLETED|Overall Study||15
6699506|NCT02808130|7629659|FG005|COMPLETED|Overall Study||15
6699507|NCT02808130|7629654|FG000|NOT COMPLETED|Overall Study||0
6699508|NCT02808130|7629655|FG001|NOT COMPLETED|Overall Study||0
6699509|NCT02808130|7629656|FG002|NOT COMPLETED|Overall Study||0
6699510|NCT02808130|7629657|FG003|NOT COMPLETED|Overall Study||0
6699511|NCT02808130|7629658|FG004|NOT COMPLETED|Overall Study||0
6699512|NCT02808130|7629659|FG005|NOT COMPLETED|Overall Study||0
6699513|NCT02808312|7629681|FG000|STARTED|Overall Study||10
6699514|NCT02808312|7629682|FG001|STARTED|Overall Study||10
6699515|NCT02808312|7629683|FG002|STARTED|Overall Study||17
6699516|NCT02808312|7629684|FG003|STARTED|Overall Study||10
6699517|NCT02808312|7629685|FG004|STARTED|Overall Study||10
6699518|NCT02808312|7629681|FG000|COMPLETED|Overall Study||10
6699519|NCT02808312|7629682|FG001|COMPLETED|Overall Study||10
6699520|NCT02808312|7629683|FG002|COMPLETED|Overall Study||16
6699521|NCT02808312|7629684|FG003|COMPLETED|Overall Study||10
6699522|NCT02808312|7629685|FG004|COMPLETED|Overall Study||10
6699523|NCT02808312|7629681|FG000|NOT COMPLETED|Overall Study||0
6699524|NCT02808312|7629682|FG001|NOT COMPLETED|Overall Study||0
6699525|NCT02808312|7629683|FG002|NOT COMPLETED|Overall Study||1
6699526|NCT02808312|7629684|FG003|NOT COMPLETED|Overall Study||0
6699527|NCT02808312|7629685|FG004|NOT COMPLETED|Overall Study||0
6699528|NCT02808338|7629702|FG000|STARTED|Screening||25
6699529|NCT02808338|7629702|FG000|COMPLETED|Screening||15
6699530|NCT02808338|7629702|FG000|NOT COMPLETED|Screening||10
6699531|NCT02808338|7629702|FG000|STARTED|Overnight In-lab Polysomonography||15
6699532|NCT02808338|7629702|FG000|Modified Philips BiPAP ASV|Overnight In-lab Polysomonography||13
6699533|NCT02808338|7629702|FG000|ResMed S7 VPAP Adapt|Overnight In-lab Polysomonography||13
6699534|NCT02808338|7629702|FG000|Philips BiPAP AutoSV Advanced System One|Overnight In-lab Polysomonography||12
6699535|NCT02808338|7629702|FG000|ResMed S9 VPAP Adapt|Overnight In-lab Polysomonography||12
6699536|NCT02808338|7629702|FG000|COMPLETED|Overnight In-lab Polysomonography||13
6699537|NCT02808338|7629702|FG000|NOT COMPLETED|Overnight In-lab Polysomonography||2
6699538|NCT02808338|7629702|FG000|STARTED|Take Home Period||13
6699539|NCT02808338|7629702|FG000|COMPLETED|Take Home Period||13
6699540|NCT02808338|7629702|FG000|NOT COMPLETED|Take Home Period||0
6699541|NCT02808429|7629716|FG000|STARTED|Overall Study||5
6699542|NCT02808429|7629717|FG001|STARTED|Overall Study||6
6699543|NCT02808429|7629718|FG002|STARTED|Overall Study||5
6699544|NCT02808429|7629716|FG000|COMPLETED|Overall Study||2
6699545|NCT02808429|7629717|FG001|COMPLETED|Overall Study||5
6699546|NCT02808429|7629718|FG002|COMPLETED|Overall Study||3
6699547|NCT02808429|7629716|FG000|NOT COMPLETED|Overall Study||3
6699548|NCT02808429|7629717|FG001|NOT COMPLETED|Overall Study||1
6699549|NCT02808429|7629718|FG002|NOT COMPLETED|Overall Study||2
6699550|NCT02808819|7629728|FG000|STARTED|Overall Study||220
6699551|NCT02808819|7629729|FG001|STARTED|Overall Study||226
6699552|NCT02808819|7629728|FG000|Treated|Overall Study||220
6699553|NCT02808819|7629729|FG001|Treated|Overall Study||226
6699554|NCT02808819|7629728|FG000|COMPLETED|Overall Study||189
6699555|NCT02808819|7629729|FG001|COMPLETED|Overall Study||195
6699556|NCT02808819|7629728|FG000|NOT COMPLETED|Overall Study||31
6699557|NCT02808819|7629729|FG001|NOT COMPLETED|Overall Study||31
6699558|NCT02808975|7629738|FG000|STARTED|Overall Study||103
6699559|NCT02808975|7629739|FG001|STARTED|Overall Study||103
6699560|NCT02808975|7629738|FG000|COMPLETED|Overall Study||81
6699561|NCT02808975|7629739|FG001|COMPLETED|Overall Study||84
6699562|NCT02808975|7629738|FG000|NOT COMPLETED|Overall Study||22
6699563|NCT02808975|7629739|FG001|NOT COMPLETED|Overall Study||19
6699564|NCT02809053|7629747|FG000|STARTED|Overall Study||157
6699565|NCT02809053|7629748|FG001|STARTED|Overall Study||158
6699566|NCT02809053|7629747|FG000|Completed Treatment|Overall Study||156
6699567|NCT02809053|7629748|FG001|Completed Treatment|Overall Study||156
6699568|NCT02809053|7629747|FG000|COMPLETED|Overall Study||150
6699569|NCT02809053|7629748|FG001|COMPLETED|Overall Study||152
6699570|NCT02809053|7629747|FG000|NOT COMPLETED|Overall Study||7
6699571|NCT02809053|7629748|FG001|NOT COMPLETED|Overall Study||6
6699572|NCT02809183|7629759|FG000|STARTED|Overall Study||25
6699573|NCT02809183|7629760|FG001|STARTED|Overall Study||25
6699574|NCT02809183|7629761|FG002|STARTED|Overall Study||25
6699575|NCT02809183|7629762|FG003|STARTED|Overall Study||26
6699576|NCT02809183|7629763|FG004|STARTED|Overall Study||6
6699577|NCT02809183|7629764|FG005|STARTED|Overall Study||28
6699578|NCT02809183|7629759|FG000|COMPLETED|Overall Study||25
6699579|NCT02809183|7629760|FG001|COMPLETED|Overall Study||25
6699580|NCT02809183|7629761|FG002|COMPLETED|Overall Study||25
6699581|NCT02809183|7629762|FG003|COMPLETED|Overall Study||26
6699582|NCT02809183|7629763|FG004|COMPLETED|Overall Study||6
6699583|NCT02809183|7629764|FG005|COMPLETED|Overall Study||28
6699584|NCT02809183|7629759|FG000|NOT COMPLETED|Overall Study||0
6699585|NCT02809183|7629760|FG001|NOT COMPLETED|Overall Study||0
6699586|NCT02809183|7629761|FG002|NOT COMPLETED|Overall Study||0
6699587|NCT02809183|7629762|FG003|NOT COMPLETED|Overall Study||0
6699588|NCT02809183|7629763|FG004|NOT COMPLETED|Overall Study||0
6699589|NCT02809183|7629764|FG005|NOT COMPLETED|Overall Study||0
6699590|NCT02809430|7629781|FG000|STARTED|Overall Study||90
6699591|NCT02809430|7629781|FG000|Failed 3-night run-in Because no Evidence of Obstructive Sleep Apnea|Overall Study|14 with CPAP < 3 hours, 5 without evidence of OSA, 9 with evidence of central or complex sleep apnea|28
6699592|NCT02809430|7629781|FG000|Stopped CPAP During Inpatient Rehabilitation|Overall Study|10 of 62 participants stopped CPAP after the run-in and prior to discharge from IPR|10
6699593|NCT02809430|7629781|FG000|COMPLETED|Overall Study||52
6699594|NCT02809430|7629781|FG000|NOT COMPLETED|Overall Study||38
6699595|NCT02809833|7629788|FG000|STARTED|Overall Study||850
6699596|NCT02809833|7629788|FG000|COMPLETED|Overall Study||550
6699597|NCT02809833|7629788|FG000|NOT COMPLETED|Overall Study||300
6699598|NCT02809846|7629794|FG000|STARTED|Overall Study||17
6699599|NCT02809846|7629795|FG001|STARTED|Overall Study||16
6699600|NCT02809846|7629794|FG000|COMPLETED|Overall Study||8
6699601|NCT02809846|7629795|FG001|COMPLETED|Overall Study||9
6699602|NCT02809846|7629794|FG000|NOT COMPLETED|Overall Study||9
6699603|NCT02809846|7629795|FG001|NOT COMPLETED|Overall Study||7
6699604|NCT02809859|7629801|FG000|STARTED|Overall Study||139
6699605|NCT02809859|7629801|FG000|COMPLETED|Overall Study||125
6699606|NCT02809859|7629801|FG000|NOT COMPLETED|Overall Study||14
6699607|NCT02809911|7629807|FG000|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
6699608|NCT02809911|7629808|FG001|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
6699609|NCT02809911|7629807|FG000|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
6699610|NCT02809911|7629808|FG001|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
6699611|NCT02809911|7629807|FG000|NOT COMPLETED|Overall Study||0
6699612|NCT02809911|7629808|FG001|NOT COMPLETED|Overall Study||0
6699613|NCT02809976|7629814|FG000|STARTED|Overall Study||11
6699614|NCT02809976|7629814|FG000|COMPLETED|Overall Study||9
6699615|NCT02809976|7629814|FG000|NOT COMPLETED|Overall Study||2
6699616|NCT02810327|7629820|FG000|STARTED|Overall Study||76
6699617|NCT02810327|7629821|FG001|STARTED|Overall Study||41
6699618|NCT02810327|7629820|FG000|COMPLETED|Overall Study||69
6699619|NCT02810327|7629821|FG001|COMPLETED|Overall Study||34
6699620|NCT02810327|7629820|FG000|NOT COMPLETED|Overall Study||7
6699621|NCT02810327|7629821|FG001|NOT COMPLETED|Overall Study||7
6699622|NCT02810340|7629830|FG000|STARTED|Overall Study||20
6699623|NCT02810340|7629831|FG001|STARTED|Overall Study||20
6699624|NCT02810340|7629832|FG002|STARTED|Overall Study||20
6699625|NCT02810340|7629830|FG000|COMPLETED|Overall Study||19
6699626|NCT02810340|7629831|FG001|COMPLETED|Overall Study||19
6699627|NCT02810340|7629832|FG002|COMPLETED|Overall Study||19
6699628|NCT02810340|7629830|FG000|NOT COMPLETED|Overall Study||1
6699629|NCT02810340|7629831|FG001|NOT COMPLETED|Overall Study||1
6699630|NCT02810340|7629832|FG002|NOT COMPLETED|Overall Study||1
6699631|NCT02810392|7629842|FG000|STARTED|Overall Study||9
6699632|NCT02810392|7629843|FG001|STARTED|Overall Study||10
6699633|NCT02810392|7629842|FG000|COMPLETED|Overall Study||8
6699634|NCT02810392|7629843|FG001|COMPLETED|Overall Study||9
6699635|NCT02810392|7629842|FG000|NOT COMPLETED|Overall Study||1
6699636|NCT02810392|7629843|FG001|NOT COMPLETED|Overall Study||1
6699637|NCT02810509|7629851|FG000|STARTED|Overall Study||584
6699638|NCT02810509|7629852|FG001|STARTED|Overall Study||1230
6699639|NCT02810509|7629851|FG000|COMPLETED|Overall Study||584
6699640|NCT02810509|7629852|FG001|COMPLETED|Overall Study||1230
6699641|NCT02810509|7629851|FG000|NOT COMPLETED|Overall Study||0
6699642|NCT02810509|7629852|FG001|NOT COMPLETED|Overall Study||0
6699643|NCT02810873|7629862|FG000|STARTED|Overall Study||6
6699644|NCT02810873|7629863|FG001|STARTED|Overall Study||13
6699645|NCT02810873|7629862|FG000|COMPLETED|Overall Study||6
6699646|NCT02810873|7629863|FG001|COMPLETED|Overall Study||13
6699647|NCT02810873|7629862|FG000|NOT COMPLETED|Overall Study||0
6699648|NCT02810873|7629863|FG001|NOT COMPLETED|Overall Study||0
6699649|NCT02810951|7629870|FG000|STARTED|Overall Study||6
6699650|NCT02810951|7629870|FG000|FCX-007 Injection|Overall Study||6
6260004|NCT01232283|7158954|FG007|STARTED|Maintenance Phase (Weeks16-32)||0
6260005|NCT01232283|7158955|FG008|STARTED|Maintenance Phase (Weeks16-32)||0
6260006|NCT01232283|7158956|FG009|STARTED|Maintenance Phase (Weeks16-32)||0
6260007|NCT01232283|7158947|FG000|COMPLETED|Maintenance Phase (Weeks16-32)||0
6260008|NCT01232283|7158948|FG001|COMPLETED|Maintenance Phase (Weeks16-32)||0
6260009|NCT01232283|7158949|FG002|COMPLETED|Maintenance Phase (Weeks16-32)||194
6260010|NCT01232283|7158950|FG003|COMPLETED|Maintenance Phase (Weeks16-32)||100
6260011|NCT01232283|7158951|FG004|COMPLETED|Maintenance Phase (Weeks16-32)||0
6260012|NCT01232283|7158952|FG005|COMPLETED|Maintenance Phase (Weeks16-32)||0
6260013|NCT01232283|7158953|FG006|COMPLETED|Maintenance Phase (Weeks16-32)||0
6260014|NCT01232283|7158954|FG007|COMPLETED|Maintenance Phase (Weeks16-32)||0
6260015|NCT01232283|7158955|FG008|COMPLETED|Maintenance Phase (Weeks16-32)||0
6260016|NCT01232283|7158956|FG009|COMPLETED|Maintenance Phase (Weeks16-32)||0
6260017|NCT01232283|7158947|FG000|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6260018|NCT01232283|7158948|FG001|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6260019|NCT01232283|7158949|FG002|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
6260020|NCT01232283|7158950|FG003|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
6260021|NCT01232283|7158951|FG004|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6260022|NCT01232283|7158952|FG005|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6260023|NCT01232283|7158953|FG006|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6260024|NCT01232283|7158954|FG007|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6260025|NCT01232283|7158955|FG008|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6260026|NCT01232283|7158956|FG009|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
6260027|NCT01232283|7158947|FG000|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260028|NCT01232283|7158948|FG001|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260029|NCT01232283|7158949|FG002|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260030|NCT01232283|7158950|FG003|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260031|NCT01232283|7158951|FG004|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
6260032|NCT01232283|7158952|FG005|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
6260033|NCT01232283|7158953|FG006|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
6260034|NCT01232283|7158954|FG007|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
6260035|NCT01232283|7158955|FG008|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6602467|NCT02057250|7527467|FG000|Treated|Extension Phase||0
6602468|NCT02057250|7527468|FG001|Treated|Extension Phase||0
6602469|NCT02057250|7527469|FG002|Treated|Extension Phase||0
6602470|NCT02057250|7527470|FG003|Treated|Extension Phase||0
6602471|NCT02057250|7527471|FG004|Treated|Extension Phase||188
6602472|NCT02057250|7527467|FG000|COMPLETED|Extension Phase||0
6602473|NCT02057250|7527468|FG001|COMPLETED|Extension Phase||0
6602474|NCT02057250|7527469|FG002|COMPLETED|Extension Phase||0
6602475|NCT02057250|7527470|FG003|COMPLETED|Extension Phase||0
6602476|NCT02057250|7527471|FG004|COMPLETED|Extension Phase||156
6602477|NCT02057250|7527467|FG000|NOT COMPLETED|Extension Phase||0
6602478|NCT02057250|7527468|FG001|NOT COMPLETED|Extension Phase||0
6602479|NCT02057250|7527469|FG002|NOT COMPLETED|Extension Phase||0
6602480|NCT02057250|7527470|FG003|NOT COMPLETED|Extension Phase||0
6602481|NCT02057250|7527471|FG004|NOT COMPLETED|Extension Phase||36
6602482|NCT02057393|7527483|FG000|STARTED|Overall Study||89
6602483|NCT02057393|7527483|FG000|COMPLETED|Overall Study||87
6602484|NCT02057393|7527483|FG000|NOT COMPLETED|Overall Study||2
6602485|NCT02057406|7527490|FG000|STARTED|Overall Study||36
6602486|NCT02057406|7527491|FG001|STARTED|Overall Study||36
6602487|NCT02057406|7527492|FG002|STARTED|Overall Study||36
6602488|NCT02057406|7527490|FG000|COMPLETED|Overall Study||35
6602489|NCT02057406|7527491|FG001|COMPLETED|Overall Study||33
6602490|NCT02057406|7527492|FG002|COMPLETED|Overall Study||32
6602491|NCT02057406|7527490|FG000|NOT COMPLETED|Overall Study||1
6602492|NCT02057406|7527491|FG001|NOT COMPLETED|Overall Study||3
6602493|NCT02057406|7527492|FG002|NOT COMPLETED|Overall Study||4
6602494|NCT02057458|7527500|FG000|STARTED|Recruited for Participation||8
6602495|NCT02057458|7527501|FG001|STARTED|Recruited for Participation||8
6602496|NCT02057458|7527502|FG002|STARTED|Recruited for Participation||3
6699651|NCT02810951|7629870|FG000|No FCX-007 Injection|Overall Study||6
6699652|NCT02810951|7629870|FG000|COMPLETED|Overall Study||5
6699653|NCT02810951|7629870|FG000|NOT COMPLETED|Overall Study||1
6699654|NCT02810964|7629878|FG000|STARTED|Placebo Run-In Phase (2 Weeks)||32
6699655|NCT02810964|7629879|FG001|STARTED|Placebo Run-In Phase (2 Weeks)||32
6699656|NCT02810964|7629878|FG000|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
6699657|NCT02810964|7629879|FG001|COMPLETED|Placebo Run-In Phase (2 Weeks)||32
6699658|NCT02810964|7629878|FG000|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
6699659|NCT02810964|7629879|FG001|NOT COMPLETED|Placebo Run-In Phase (2 Weeks)||0
6699660|NCT02810964|7629878|FG000|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
6699661|NCT02810964|7629879|FG001|STARTED|Double-Blind Treatment Phase (16 Weeks)||32
6699662|NCT02810964|7629878|FG000|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
6699663|NCT02810964|7629879|FG001|COMPLETED|Double-Blind Treatment Phase (16 Weeks)||29
6699664|NCT02810964|7629878|FG000|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
6699665|NCT02810964|7629879|FG001|NOT COMPLETED|Double-Blind Treatment Phase (16 Weeks)||3
6699666|NCT02811159|7629885|FG000|STARTED|Treatment Course 1||20
6699667|NCT02811159|7629885|FG000|COMPLETED|Treatment Course 1||19
6699668|NCT02811159|7629885|FG000|NOT COMPLETED|Treatment Course 1||1
6699669|NCT02811159|7629885|FG000|STARTED|Treatment Course 2|Not all participants who completed the Treatment Course 1 entered the Treatment Course 2.|4
6699670|NCT02811159|7629885|FG000|COMPLETED|Treatment Course 2||4
6699671|NCT02811159|7629885|FG000|NOT COMPLETED|Treatment Course 2||0
6699672|NCT02811302|7629889|FG000|STARTED|Overall Study||1495
6699673|NCT02811302|7629889|FG000|COMPLETED|Overall Study||1282
6699674|NCT02811302|7629889|FG000|NOT COMPLETED|Overall Study||213
6699675|NCT02811419|7629896|FG000|STARTED|Overall Study||369
6699676|NCT02811419|7629897|FG001|STARTED|Overall Study||371
6699677|NCT02811419|7629896|FG000|COMPLETED|Overall Study||357
6699678|NCT02811419|7629897|FG001|COMPLETED|Overall Study||358
6699679|NCT02811419|7629896|FG000|NOT COMPLETED|Overall Study||12
6699680|NCT02811419|7629897|FG001|NOT COMPLETED|Overall Study||13
6738874|NCT03286218|7668000|FG004|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
6738875|NCT03286218|7668001|FG005|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6738876|NCT03286218|7668002|FG006|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6738877|NCT03286218|7668003|FG007|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6738878|NCT03286218|7668004|FG008|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6738879|NCT03286218|7668005|FG009|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6738880|NCT03286218|7668006|FG010|Received at Least One Dose of Study Drug|Treatment Phase Period 1||5
6738881|NCT03286218|7668007|FG011|Received at Least One Dose of Study Drug|Treatment Phase Period 1||6
6738882|NCT03286218|7667996|FG000|COMPLETED|Treatment Phase Period 1||0
6738883|NCT03286218|7667997|FG001|COMPLETED|Treatment Phase Period 1||0
6738884|NCT03286218|7667998|FG002|COMPLETED|Treatment Phase Period 1||5
6738885|NCT03286218|7667999|FG003|COMPLETED|Treatment Phase Period 1||5
6738886|NCT03286218|7668000|FG004|COMPLETED|Treatment Phase Period 1||5
6738887|NCT03286218|7668001|FG005|COMPLETED|Treatment Phase Period 1||5
6738888|NCT03286218|7668002|FG006|COMPLETED|Treatment Phase Period 1||6
6738889|NCT03286218|7668003|FG007|COMPLETED|Treatment Phase Period 1||6
6738890|NCT03286218|7668004|FG008|COMPLETED|Treatment Phase Period 1||6
6738891|NCT03286218|7668005|FG009|COMPLETED|Treatment Phase Period 1||6
6738892|NCT03286218|7668006|FG010|COMPLETED|Treatment Phase Period 1||5
6738893|NCT03286218|7668007|FG011|COMPLETED|Treatment Phase Period 1||5
6738894|NCT03286218|7667996|FG000|NOT COMPLETED|Treatment Phase Period 1||0
6738895|NCT03286218|7667997|FG001|NOT COMPLETED|Treatment Phase Period 1||0
6738896|NCT03286218|7667998|FG002|NOT COMPLETED|Treatment Phase Period 1||1
6738897|NCT03286218|7667999|FG003|NOT COMPLETED|Treatment Phase Period 1||1
6738898|NCT03286218|7668000|FG004|NOT COMPLETED|Treatment Phase Period 1||0
6738899|NCT03286218|7668001|FG005|NOT COMPLETED|Treatment Phase Period 1||1
6738900|NCT03286218|7668002|FG006|NOT COMPLETED|Treatment Phase Period 1||0
6738901|NCT03286218|7668003|FG007|NOT COMPLETED|Treatment Phase Period 1||0
6738902|NCT03286218|7668004|FG008|NOT COMPLETED|Treatment Phase Period 1||0
6738903|NCT03286218|7668005|FG009|NOT COMPLETED|Treatment Phase Period 1||0
6738904|NCT03286218|7668006|FG010|NOT COMPLETED|Treatment Phase Period 1||0
6738905|NCT03286218|7668007|FG011|NOT COMPLETED|Treatment Phase Period 1||1
6738906|NCT03286218|7667996|FG000|STARTED|Treatment Phase Period 2||0
6738907|NCT03286218|7667997|FG001|STARTED|Treatment Phase Period 2||0
6738908|NCT03286218|7667998|FG002|STARTED|Treatment Phase Period 2||5
6738909|NCT03286218|7667999|FG003|STARTED|Treatment Phase Period 2||5
6738910|NCT03286218|7668000|FG004|STARTED|Treatment Phase Period 2||5
6738911|NCT03286218|7668001|FG005|STARTED|Treatment Phase Period 2||5
6738912|NCT03286218|7668002|FG006|STARTED|Treatment Phase Period 2||6
6738913|NCT03286218|7668003|FG007|STARTED|Treatment Phase Period 2||6
6738914|NCT03286218|7668004|FG008|STARTED|Treatment Phase Period 2||6
6738915|NCT03286218|7668005|FG009|STARTED|Treatment Phase Period 2||6
6738916|NCT03286218|7668006|FG010|STARTED|Treatment Phase Period 2||5
6738917|NCT03286218|7668007|FG011|STARTED|Treatment Phase Period 2||5
6738918|NCT03286218|7667996|FG000|COMPLETED|Treatment Phase Period 2||0
6738919|NCT03286218|7667997|FG001|COMPLETED|Treatment Phase Period 2||0
6738920|NCT03286218|7667998|FG002|COMPLETED|Treatment Phase Period 2||5
6738921|NCT03286218|7667999|FG003|COMPLETED|Treatment Phase Period 2||5
6738922|NCT03286218|7668000|FG004|COMPLETED|Treatment Phase Period 2||5
6738923|NCT03286218|7668001|FG005|COMPLETED|Treatment Phase Period 2||5
6738924|NCT03286218|7668002|FG006|COMPLETED|Treatment Phase Period 2||6
6738925|NCT03286218|7668003|FG007|COMPLETED|Treatment Phase Period 2||6
6738926|NCT03286218|7668004|FG008|COMPLETED|Treatment Phase Period 2||6
6738927|NCT03286218|7668005|FG009|COMPLETED|Treatment Phase Period 2||6
6738928|NCT03286218|7668006|FG010|COMPLETED|Treatment Phase Period 2||5
6738929|NCT03286218|7668007|FG011|COMPLETED|Treatment Phase Period 2||5
6738930|NCT03286218|7667996|FG000|NOT COMPLETED|Treatment Phase Period 2||0
6738931|NCT03286218|7667997|FG001|NOT COMPLETED|Treatment Phase Period 2||0
6738932|NCT03286218|7667998|FG002|NOT COMPLETED|Treatment Phase Period 2||0
6699681|NCT02811445|7629905|FG000|STARTED|Overall Study||18
6699682|NCT02811445|7629906|FG001|STARTED|Overall Study||11
6699683|NCT02811445|7629905|FG000|COMPLETED|Overall Study||18
6699684|NCT02811445|7629906|FG001|COMPLETED|Overall Study||11
6699685|NCT02811445|7629905|FG000|NOT COMPLETED|Overall Study||0
6699686|NCT02811445|7629906|FG001|NOT COMPLETED|Overall Study||0
6699687|NCT02811640|7629912|FG000|STARTED|Overall Study||12
6699688|NCT02811640|7629912|FG000|COMPLETED|Overall Study||10
6699689|NCT02811640|7629912|FG000|NOT COMPLETED|Overall Study||2
6699693|NCT02811965|7629925|FG000|STARTED|Overall Study||21
6699694|NCT02811965|7629925|FG000|COMPLETED|Overall Study||21
6699695|NCT02811965|7629925|FG000|NOT COMPLETED|Overall Study||0
6699696|NCT02812160|7629943|FG000|STARTED|Overall Study||187
6699697|NCT02812160|7629944|FG001|STARTED|Overall Study||101
6699698|NCT02812160|7629943|FG000|COMPLETED|Overall Study||187
6699699|NCT02812160|7629944|FG001|COMPLETED|Overall Study||101
6699700|NCT02812160|7629943|FG000|NOT COMPLETED|Overall Study||0
6699701|NCT02812160|7629944|FG001|NOT COMPLETED|Overall Study||0
6699702|NCT02812186|7629952|FG000|STARTED|Period 1||40
6699703|NCT02812186|7629953|FG001|STARTED|Period 1||39
6699704|NCT02812186|7629952|FG000|COMPLETED|Period 1||29
6699705|NCT02812186|7629953|FG001|COMPLETED|Period 1||24
6699706|NCT02812186|7629952|FG000|NOT COMPLETED|Period 1||11
6699707|NCT02812186|7629953|FG001|NOT COMPLETED|Period 1||15
6699708|NCT02812186|7629952|FG000|STARTED|Period 2||29
6699709|NCT02812186|7629953|FG001|STARTED|Period 2||24
6699710|NCT02812186|7629952|FG000|COMPLETED|Period 2||29
6699711|NCT02812186|7629953|FG001|COMPLETED|Period 2||24
6699712|NCT02812186|7629952|FG000|NOT COMPLETED|Period 2||0
6699713|NCT02812186|7629953|FG001|NOT COMPLETED|Period 2||0
6699714|NCT02812238|7629962|FG000|STARTED|First Intervention||19
6699715|NCT02812238|7629963|FG001|STARTED|First Intervention||19
6699716|NCT02812238|7629962|FG000|COMPLETED|First Intervention||18
6699717|NCT02812238|7629963|FG001|COMPLETED|First Intervention||19
6699718|NCT02812238|7629962|FG000|NOT COMPLETED|First Intervention||1
6699719|NCT02812238|7629963|FG001|NOT COMPLETED|First Intervention||0
6699720|NCT02812238|7629962|FG000|STARTED|Second Intervention||18
6699721|NCT02812238|7629963|FG001|STARTED|Second Intervention||19
6699722|NCT02812238|7629962|FG000|COMPLETED|Second Intervention||18
6699723|NCT02812238|7629963|FG001|COMPLETED|Second Intervention||18
6699724|NCT02812238|7629962|FG000|NOT COMPLETED|Second Intervention||0
6699725|NCT02812238|7629963|FG001|NOT COMPLETED|Second Intervention||1
6699726|NCT02812342|7629969|FG000|STARTED|Overall Study||10
6699727|NCT02812342|7629969|FG000|COMPLETED|Overall Study||10
6699728|NCT02812342|7629969|FG000|NOT COMPLETED|Overall Study||0
6699729|NCT02812771|7629973|FG000|STARTED|Overall Study||62
6699730|NCT02812771|7629973|FG000|COMPLETED|Overall Study||50
6699731|NCT02812771|7629973|FG000|NOT COMPLETED|Overall Study||12
6699732|NCT02813070|7629980|FG000|STARTED|Overall Study||28
6699733|NCT02813070|7629981|FG001|STARTED|Overall Study||23
6699734|NCT02813070|7629982|FG002|STARTED|Overall Study||36
6699735|NCT02813070|7629980|FG000|Treated (Safety Population)|Overall Study||25
6699736|NCT02813070|7629981|FG001|Treated (Safety Population)|Overall Study||20
6699737|NCT02813070|7629982|FG002|Treated (Safety Population)|Overall Study||25
6699738|NCT02813070|7629980|FG000|COMPLETED|Overall Study||25
6699739|NCT02813070|7629981|FG001|COMPLETED|Overall Study||20
6699740|NCT02813070|7629982|FG002|COMPLETED|Overall Study||25
6699741|NCT02813070|7629980|FG000|NOT COMPLETED|Overall Study||3
6699742|NCT02813070|7629981|FG001|NOT COMPLETED|Overall Study||3
6699743|NCT02813070|7629982|FG002|NOT COMPLETED|Overall Study||11
6699744|NCT02813265|7629991|FG000|STARTED|Overall Study||459
6699745|NCT02813265|7629992|FG001|STARTED|Overall Study||456
6699746|NCT02813265|7629991|FG000|COMPLETED|Overall Study||455
6699747|NCT02813265|7629992|FG001|COMPLETED|Overall Study||453
6699748|NCT02813265|7629991|FG000|NOT COMPLETED|Overall Study||4
6699749|NCT02813265|7629992|FG001|NOT COMPLETED|Overall Study||3
6699750|NCT02813421|7630000|FG000|STARTED|Overall Study||5
6699751|NCT02813421|7630001|FG001|STARTED|Overall Study||6
6699752|NCT02813421|7630000|FG000|COMPLETED|Overall Study||3
6699753|NCT02813421|7630001|FG001|COMPLETED|Overall Study||3
6699754|NCT02813421|7630000|FG000|NOT COMPLETED|Overall Study||2
6699755|NCT02813421|7630001|FG001|NOT COMPLETED|Overall Study||3
6699756|NCT02813473|7630007|FG000|STARTED|Overall Study||223
6699757|NCT02813473|7630007|FG000|COMPLETED|Overall Study||223
6699758|NCT02813473|7630007|FG000|NOT COMPLETED|Overall Study||0
6699759|NCT02813551|7630013|FG000|STARTED|Overall Study||59
6699760|NCT02813551|7630014|FG001|STARTED|Overall Study||59
6699761|NCT02813551|7630013|FG000|COMPLETED|Overall Study||58
6699762|NCT02813551|7630014|FG001|COMPLETED|Overall Study||57
6699763|NCT02813551|7630013|FG000|NOT COMPLETED|Overall Study||1
6699764|NCT02813551|7630014|FG001|NOT COMPLETED|Overall Study||2
6699765|NCT02813577|7630020|FG000|STARTED|Overall Study||4
6699766|NCT02813577|7630020|FG000|COMPLETED|Overall Study|Study was terminated and only some results at 1 month follow up are available.|0
6699767|NCT02813577|7630020|FG000|NOT COMPLETED|Overall Study||4
6699768|NCT02813681|7630027|FG000|STARTED|Overall Study||27
6699769|NCT02813681|7630028|FG001|STARTED|Overall Study||34
6699770|NCT02813681|7630029|FG002|STARTED|Overall Study||19
6699771|NCT02813681|7630027|FG000|COMPLETED|Overall Study||22
6699772|NCT02813681|7630028|FG001|COMPLETED|Overall Study||28
6699773|NCT02813681|7630029|FG002|COMPLETED|Overall Study||19
6699774|NCT02813681|7630027|FG000|NOT COMPLETED|Overall Study||5
6699775|NCT02813681|7630028|FG001|NOT COMPLETED|Overall Study||6
6699776|NCT02813681|7630029|FG002|NOT COMPLETED|Overall Study||0
6699777|NCT02813694|7630041|FG000|STARTED|Overall Study|Intent to Treat Analysis Set|370
6699778|NCT02813694|7630042|FG001|STARTED|Overall Study|Intent to Treat Analysis Set|368
6699779|NCT02813694|7630041|FG000|COMPLETED|Overall Study||353
6699780|NCT02813694|7630042|FG001|COMPLETED|Overall Study|Completed Study (Late Follow Up Assessment)|354
6699781|NCT02813694|7630041|FG000|NOT COMPLETED|Overall Study||17
6699782|NCT02813694|7630042|FG001|NOT COMPLETED|Overall Study||14
6699783|NCT02814175|7630050|FG000|STARTED|Part 1||122
6699784|NCT02814175|7630051|FG001|STARTED|Part 1||123
6699785|NCT02814175|7630052|FG002|STARTED|Part 1||0
6699786|NCT02814175|7630053|FG003|STARTED|Part 1||0
6699787|NCT02814175|7630054|FG004|STARTED|Part 1||0
6699788|NCT02814175|7630055|FG005|STARTED|Part 1||0
6699789|NCT02814175|7630050|FG000|COMPLETED|Part 1||110
6699790|NCT02814175|7630051|FG001|COMPLETED|Part 1||117
6699791|NCT02814175|7630052|FG002|COMPLETED|Part 1||0
6699792|NCT02814175|7630053|FG003|COMPLETED|Part 1||0
6699793|NCT02814175|7630054|FG004|COMPLETED|Part 1||0
6699794|NCT02814175|7630055|FG005|COMPLETED|Part 1||0
6699795|NCT02814175|7630050|FG000|NOT COMPLETED|Part 1||12
6699796|NCT02814175|7630051|FG001|NOT COMPLETED|Part 1||6
6699797|NCT02814175|7630052|FG002|NOT COMPLETED|Part 1||0
6699798|NCT02814175|7630053|FG003|NOT COMPLETED|Part 1||0
6699799|NCT02814175|7630054|FG004|NOT COMPLETED|Part 1||0
6699800|NCT02814175|7630055|FG005|NOT COMPLETED|Part 1||0
6699801|NCT02814175|7630050|FG000|STARTED|Part 2||0
6699802|NCT02814175|7630051|FG001|STARTED|Part 2||0
6699803|NCT02814175|7630052|FG002|STARTED|Part 2||15
6699804|NCT02814175|7630053|FG003|STARTED|Part 2||95
6699805|NCT02814175|7630054|FG004|STARTED|Part 2||54
6699806|NCT02814175|7630055|FG005|STARTED|Part 2||63
6699807|NCT02814175|7630050|FG000|COMPLETED|Part 2||0
6699808|NCT02814175|7630051|FG001|COMPLETED|Part 2||0
6699809|NCT02814175|7630052|FG002|COMPLETED|Part 2||15
6699810|NCT02814175|7630053|FG003|COMPLETED|Part 2||91
6699811|NCT02814175|7630054|FG004|COMPLETED|Part 2||52
6699812|NCT02814175|7630055|FG005|COMPLETED|Part 2||57
6699813|NCT02814175|7630050|FG000|NOT COMPLETED|Part 2||0
6699814|NCT02814175|7630051|FG001|NOT COMPLETED|Part 2||0
6699815|NCT02814175|7630052|FG002|NOT COMPLETED|Part 2||0
6699816|NCT02814175|7630053|FG003|NOT COMPLETED|Part 2||4
6699817|NCT02814175|7630054|FG004|NOT COMPLETED|Part 2||2
6699818|NCT02814175|7630055|FG005|NOT COMPLETED|Part 2||6
6699819|NCT02814227|7630069|FG000|STARTED|Overall Study||52
6699820|NCT02814227|7630069|FG000|COMPLETED|Overall Study||52
6699821|NCT02814227|7630069|FG000|NOT COMPLETED|Overall Study||0
6699822|NCT02814279|7630075|FG000|STARTED|Overall Study||21
6699823|NCT02814279|7630076|FG001|STARTED|Overall Study||21
6699824|NCT02814279|7630075|FG000|COMPLETED|Overall Study||21
6699825|NCT02814279|7630076|FG001|COMPLETED|Overall Study||21
6699826|NCT02814279|7630075|FG000|NOT COMPLETED|Overall Study||0
6699827|NCT02814279|7630076|FG001|NOT COMPLETED|Overall Study||0
6699828|NCT02814448|7630087|FG000|STARTED|Overall Study||27
6699829|NCT02814448|7630088|FG001|STARTED|Overall Study||24
6699830|NCT02814448|7630089|FG002|STARTED|Overall Study||26
6699831|NCT02814448|7630090|FG003|STARTED|Overall Study||25
6699832|NCT02814448|7630091|FG004|STARTED|Overall Study||28
6699833|NCT02814448|7630087|FG000|COMPLETED|Overall Study||27
6699834|NCT02814448|7630088|FG001|COMPLETED|Overall Study||24
6699835|NCT02814448|7630089|FG002|COMPLETED|Overall Study||25
6699836|NCT02814448|7630090|FG003|COMPLETED|Overall Study||25
6699837|NCT02814448|7630091|FG004|COMPLETED|Overall Study||26
6699838|NCT02814448|7630087|FG000|NOT COMPLETED|Overall Study||0
6699839|NCT02814448|7630088|FG001|NOT COMPLETED|Overall Study||0
6699840|NCT02814448|7630089|FG002|NOT COMPLETED|Overall Study||1
6699841|NCT02814448|7630090|FG003|NOT COMPLETED|Overall Study||0
6699842|NCT02814448|7630091|FG004|NOT COMPLETED|Overall Study||2
6699843|NCT02814565|7630105|FG000|STARTED|Overall Study||90
6699844|NCT02814565|7630106|FG001|STARTED|Overall Study||90
6699845|NCT02814565|7630105|FG000|COMPLETED|Overall Study||89
6699846|NCT02814565|7630106|FG001|COMPLETED|Overall Study||88
6699847|NCT02814565|7630105|FG000|NOT COMPLETED|Overall Study||1
6699848|NCT02814565|7630106|FG001|NOT COMPLETED|Overall Study||2
6699849|NCT02814643|7630114|FG000|STARTED|Overall Study||51
6699850|NCT02814643|7630115|FG001|STARTED|Overall Study||52
6699851|NCT02814643|7630114|FG000|COMPLETED|Overall Study||50
6699852|NCT02814643|7630115|FG001|COMPLETED|Overall Study||49
6699853|NCT02814643|7630114|FG000|NOT COMPLETED|Overall Study||1
6699854|NCT02814643|7630115|FG001|NOT COMPLETED|Overall Study||3
6699855|NCT02814656|7630125|FG000|STARTED|Overall Study||6
6699856|NCT02814656|7630126|FG001|STARTED|Overall Study||6
6699857|NCT02814656|7630127|FG002|STARTED|Overall Study||6
6699858|NCT02814656|7630128|FG003|STARTED|Overall Study||6
6699859|NCT02814656|7630125|FG000|COMPLETED|Overall Study||6
6699860|NCT02814656|7630126|FG001|COMPLETED|Overall Study||6
6699861|NCT02814656|7630127|FG002|COMPLETED|Overall Study||6
6699862|NCT02814656|7630128|FG003|COMPLETED|Overall Study||6
6699863|NCT02814656|7630125|FG000|NOT COMPLETED|Overall Study||0
6699864|NCT02814656|7630126|FG001|NOT COMPLETED|Overall Study||0
6699865|NCT02814656|7630127|FG002|NOT COMPLETED|Overall Study||0
6699866|NCT02814656|7630128|FG003|NOT COMPLETED|Overall Study||0
6699867|NCT02814838|7630140|FG000|STARTED|Overall Study||50
6699868|NCT02814838|7630141|FG001|STARTED|Overall Study||26
6699869|NCT02814838|7630140|FG000|COMPLETED|Overall Study||48
6699870|NCT02814838|7630141|FG001|COMPLETED|Overall Study||25
6699871|NCT02814838|7630140|FG000|NOT COMPLETED|Overall Study||2
6699872|NCT02814838|7630141|FG001|NOT COMPLETED|Overall Study||1
6699873|NCT02814890|7630149|FG000|STARTED|Overall Study||33
6699874|NCT02814890|7630150|FG001|STARTED|Overall Study||32
6699875|NCT02814890|7630149|FG000|COMPLETED|Overall Study||30
6699876|NCT02814890|7630150|FG001|COMPLETED|Overall Study||30
6699877|NCT02814890|7630149|FG000|NOT COMPLETED|Overall Study||3
6699878|NCT02814890|7630150|FG001|NOT COMPLETED|Overall Study||2
6699879|NCT02815293|7630165|FG000|STARTED|Overall Study||10
6699880|NCT02815293|7630166|FG001|STARTED|Overall Study||8
6699881|NCT02815293|7630167|FG002|STARTED|Overall Study||18
6699882|NCT02815293|7630165|FG000|COMPLETED|Overall Study||0
6699883|NCT02815293|7630166|FG001|COMPLETED|Overall Study||0
6699884|NCT02815293|7630167|FG002|COMPLETED|Overall Study||0
6699885|NCT02815293|7630165|FG000|NOT COMPLETED|Overall Study||10
6699886|NCT02815293|7630166|FG001|NOT COMPLETED|Overall Study||8
6699887|NCT02815293|7630167|FG002|NOT COMPLETED|Overall Study||18
6699888|NCT02815644|7630175|FG000|STARTED|Treatment Period 1 + Washout||11
6699889|NCT02815644|7630176|FG001|STARTED|Treatment Period 1 + Washout||11
6699890|NCT02815644|7630175|FG000|COMPLETED|Treatment Period 1 + Washout||11
6699891|NCT02815644|7630176|FG001|COMPLETED|Treatment Period 1 + Washout||11
6699892|NCT02815644|7630175|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
6699893|NCT02815644|7630176|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
6699894|NCT02815644|7630175|FG000|STARTED|Treatment Period 2||11
6699895|NCT02815644|7630176|FG001|STARTED|Treatment Period 2||11
6699896|NCT02815644|7630175|FG000|COMPLETED|Treatment Period 2||11
6699897|NCT02815644|7630176|FG001|COMPLETED|Treatment Period 2||11
6699898|NCT02815644|7630175|FG000|NOT COMPLETED|Treatment Period 2||0
6699899|NCT02815644|7630176|FG001|NOT COMPLETED|Treatment Period 2||0
6699900|NCT02815670|7630182|FG000|STARTED|Overall Study||1
6699901|NCT02815670|7630182|FG000|COMPLETED|Overall Study||0
6699902|NCT02815670|7630182|FG000|NOT COMPLETED|Overall Study||1
6699903|NCT02815709|7630191|FG000|STARTED|Overall Study||82
6699904|NCT02815709|7630192|FG001|STARTED|Overall Study||86
6699905|NCT02815709|7630193|FG002|STARTED|Overall Study||82
6699906|NCT02815709|7630194|FG003|STARTED|Overall Study||84
6699907|NCT02815709|7630195|FG004|STARTED|Overall Study||84
6699908|NCT02815709|7630191|FG000|Treated With Study Medication|Overall Study||76
6699909|NCT02815709|7630192|FG001|Treated With Study Medication|Overall Study||79
6699910|NCT02815709|7630193|FG002|Treated With Study Medication|Overall Study||79
6699911|NCT02815709|7630194|FG003|Treated With Study Medication|Overall Study||79
6699912|NCT02815709|7630195|FG004|Treated With Study Medication|Overall Study||76
6699913|NCT02815709|7630191|FG000|COMPLETED|Overall Study|Completed Study|75
6699914|NCT02815709|7630192|FG001|COMPLETED|Overall Study|Completed Study|78
6699915|NCT02815709|7630193|FG002|COMPLETED|Overall Study|Completed Study|75
6699916|NCT02815709|7630194|FG003|COMPLETED|Overall Study|Completed Study|76
6699917|NCT02815709|7630195|FG004|COMPLETED|Overall Study|Completed Study|74
6699918|NCT02815709|7630191|FG000|NOT COMPLETED|Overall Study||7
6699919|NCT02815709|7630192|FG001|NOT COMPLETED|Overall Study||8
6699920|NCT02815709|7630193|FG002|NOT COMPLETED|Overall Study||7
6699921|NCT02815709|7630194|FG003|NOT COMPLETED|Overall Study||8
6699922|NCT02815709|7630195|FG004|NOT COMPLETED|Overall Study||10
6699923|NCT02815735|7630208|FG000|STARTED|First Intervention (4 Weeks)||36
6699924|NCT02815735|7630209|FG001|STARTED|First Intervention (4 Weeks)||38
6699925|NCT02815735|7630208|FG000|COMPLETED|First Intervention (4 Weeks)||34
6699926|NCT02815735|7630209|FG001|COMPLETED|First Intervention (4 Weeks)||37
6699927|NCT02815735|7630208|FG000|NOT COMPLETED|First Intervention (4 Weeks)||2
6699928|NCT02815735|7630209|FG001|NOT COMPLETED|First Intervention (4 Weeks)||1
6699929|NCT02815735|7630208|FG000|STARTED|Second Intervention (4 Weeks)||34
6699930|NCT02815735|7630209|FG001|STARTED|Second Intervention (4 Weeks)||37
6699931|NCT02815735|7630208|FG000|COMPLETED|Second Intervention (4 Weeks)||33
6699932|NCT02815735|7630209|FG001|COMPLETED|Second Intervention (4 Weeks)||37
6699933|NCT02815735|7630208|FG000|NOT COMPLETED|Second Intervention (4 Weeks)||1
6699934|NCT02815735|7630209|FG001|NOT COMPLETED|Second Intervention (4 Weeks)||0
6699935|NCT02815982|7630228|FG000|STARTED|Overall Study||27
6699936|NCT02815982|7630229|FG001|STARTED|Overall Study||26
6699937|NCT02815982|7630230|FG002|STARTED|Overall Study||27
6699938|NCT02815982|7630231|FG003|STARTED|Overall Study||26
6699939|NCT02815982|7630228|FG000|COMPLETED|Overall Study||27
6699940|NCT02815982|7630229|FG001|COMPLETED|Overall Study||26
6699941|NCT02815982|7630230|FG002|COMPLETED|Overall Study||27
6699942|NCT02815982|7630231|FG003|COMPLETED|Overall Study||26
6699943|NCT02815982|7630228|FG000|NOT COMPLETED|Overall Study||0
6699944|NCT02815982|7630229|FG001|NOT COMPLETED|Overall Study||0
6699945|NCT02815982|7630230|FG002|NOT COMPLETED|Overall Study||0
6699946|NCT02815982|7630231|FG003|NOT COMPLETED|Overall Study||0
6699947|NCT02816138|7630243|FG000|STARTED|Overall Study||15
6699948|NCT02816138|7630243|FG000|COMPLETED|Overall Study||14
6699949|NCT02816138|7630243|FG000|NOT COMPLETED|Overall Study||1
6699950|NCT02816346|7630252|FG000|STARTED|Overall Study||10
6699951|NCT02816346|7630253|FG001|STARTED|Overall Study||10
6699952|NCT02816346|7630254|FG002|STARTED|Overall Study||10
6699953|NCT02816346|7630255|FG003|STARTED|Overall Study||10
6699954|NCT02816346|7630256|FG004|STARTED|Overall Study||16
6699955|NCT02816346|7630252|FG000|COMPLETED|Overall Study||10
6699956|NCT02816346|7630253|FG001|COMPLETED|Overall Study||10
6699957|NCT02816346|7630254|FG002|COMPLETED|Overall Study||10
6699958|NCT02816346|7630255|FG003|COMPLETED|Overall Study||10
6699959|NCT02816346|7630256|FG004|COMPLETED|Overall Study||16
6699960|NCT02816346|7630252|FG000|NOT COMPLETED|Overall Study||0
6699961|NCT02816346|7630253|FG001|NOT COMPLETED|Overall Study||0
6699962|NCT02816346|7630254|FG002|NOT COMPLETED|Overall Study||0
6699963|NCT02816346|7630255|FG003|NOT COMPLETED|Overall Study||0
6699964|NCT02816346|7630256|FG004|NOT COMPLETED|Overall Study||0
6699965|NCT02816398|7630268|FG000|STARTED|Overall Study||26
6699966|NCT02816398|7630268|FG000|COMPLETED|Overall Study||12
6699967|NCT02816398|7630268|FG000|NOT COMPLETED|Overall Study||14
6699968|NCT02816710|7630275|FG000|STARTED|Overall Study||38
6699969|NCT02816710|7630276|FG001|STARTED|Overall Study||38
6699970|NCT02816710|7630277|FG002|STARTED|Overall Study||36
6699971|NCT02816710|7630275|FG000|COMPLETED|Overall Study||34
6699972|NCT02816710|7630276|FG001|COMPLETED|Overall Study||35
6699973|NCT02816710|7630277|FG002|COMPLETED|Overall Study||29
6699974|NCT02816710|7630275|FG000|NOT COMPLETED|Overall Study||4
6699975|NCT02816710|7630276|FG001|NOT COMPLETED|Overall Study||3
6699976|NCT02816710|7630277|FG002|NOT COMPLETED|Overall Study||7
6699977|NCT02816723|7630290|FG000|STARTED|Overall Study||30
6699978|NCT02816723|7630291|FG001|STARTED|Overall Study||30
6699979|NCT02816723|7630290|FG000|COMPLETED|Overall Study||24
6699980|NCT02816723|7630291|FG001|COMPLETED|Overall Study||28
6699981|NCT02816723|7630290|FG000|NOT COMPLETED|Overall Study||6
6699982|NCT02816723|7630291|FG001|NOT COMPLETED|Overall Study||2
6699983|NCT02817087|7630299|FG000|STARTED|Overall Study||16
6699984|NCT02817087|7630300|FG001|STARTED|Overall Study||15
6699985|NCT02817087|7630299|FG000|COMPLETED|Overall Study|1 pt was withdrawn early d/t concurrent disease. One pt. withdrew ICF d/t transportation concerns|14
6699986|NCT02817087|7630300|FG001|COMPLETED|Overall Study||15
6699987|NCT02817087|7630299|FG000|NOT COMPLETED|Overall Study||2
6699988|NCT02817087|7630300|FG001|NOT COMPLETED|Overall Study||0
6699989|NCT02817516|7630310|FG000|STARTED|Overall Study||6
6699990|NCT02817516|7630311|FG001|STARTED|Overall Study||6
6699991|NCT02817516|7630312|FG002|STARTED|Overall Study||6
6699992|NCT02817516|7630313|FG003|STARTED|Overall Study||6
6699993|NCT02817516|7630310|FG000|COMPLETED|Overall Study||6
6699994|NCT02817516|7630311|FG001|COMPLETED|Overall Study||6
6699995|NCT02817516|7630312|FG002|COMPLETED|Overall Study||5
6699996|NCT02817516|7630313|FG003|COMPLETED|Overall Study||6
6699997|NCT02817516|7630310|FG000|NOT COMPLETED|Overall Study||0
6699998|NCT02817516|7630311|FG001|NOT COMPLETED|Overall Study||0
6699999|NCT02817516|7630312|FG002|NOT COMPLETED|Overall Study||1
6700000|NCT02817516|7630313|FG003|NOT COMPLETED|Overall Study||0
6700001|NCT02817555|7630328|FG000|STARTED|Overall Study||24
6700002|NCT02817555|7630329|FG001|STARTED|Overall Study||26
6700003|NCT02817555|7630328|FG000|COMPLETED|Overall Study||21
6700004|NCT02817555|7630329|FG001|COMPLETED|Overall Study||21
6700005|NCT02817555|7630328|FG000|NOT COMPLETED|Overall Study||3
6700006|NCT02817555|7630329|FG001|NOT COMPLETED|Overall Study||5
6700007|NCT02817594|7630335|FG000|STARTED|Overall Study||51
6700008|NCT02817594|7630335|FG000|Received Treatment|Overall Study||50
6700009|NCT02817594|7630335|FG000|COMPLETED|Overall Study||48
6700010|NCT02817594|7630335|FG000|NOT COMPLETED|Overall Study||3
6700011|NCT02817763|7630345|FG000|STARTED|Overall Study||20
6700012|NCT02817763|7630346|FG001|STARTED|Overall Study||20
6700013|NCT02817763|7630345|FG000|COMPLETED|Overall Study||20
6700014|NCT02817763|7630346|FG001|COMPLETED|Overall Study||20
6700015|NCT02817763|7630345|FG000|NOT COMPLETED|Overall Study||0
6700016|NCT02817763|7630346|FG001|NOT COMPLETED|Overall Study||0
6700017|NCT02817776|7630352|FG000|STARTED|Overall Study|33 excluded prior to procedure. 348 had study catheter inserted (Safety Population)|381
6700018|NCT02817776|7630352|FG000|COMPLETED|Overall Study||293
6700019|NCT02817776|7630352|FG000|NOT COMPLETED|Overall Study||88
6700020|NCT02817828|7630356|FG000|STARTED|Overall Study||1553
6700021|NCT02817828|7630356|FG000|COMPLETED|Overall Study||1218
6700022|NCT02817828|7630356|FG000|NOT COMPLETED|Overall Study||335
6700023|NCT02817841|7630365|FG000|STARTED|Overall Study||1864
6700024|NCT02817841|7630365|FG000|COMPLETED|Overall Study||1016
6700025|NCT02817841|7630365|FG000|NOT COMPLETED|Overall Study||848
6700026|NCT02817906|7630375|FG000|STARTED|Overall Study|87 patients were randomized but only 86 received study drug. The number completed and discontinued is based on the 86 patients that received study drug.|86
6700027|NCT02817906|7630376|FG001|STARTED|Overall Study|90 patients were randomized but only 89 received study drug. The number completed and discontinued is based on 89 patients that received study drug.|89
6700028|NCT02817906|7630375|FG000|COMPLETED|Overall Study||70
6700029|NCT02817906|7630376|FG001|COMPLETED|Overall Study||84
6700030|NCT02817906|7630375|FG000|NOT COMPLETED|Overall Study||16
6700031|NCT02817906|7630376|FG001|NOT COMPLETED|Overall Study||5
6700032|NCT02818036|7630384|FG000|STARTED|Overall Study||42
6700033|NCT02818036|7630385|FG001|STARTED|Overall Study||40
6700034|NCT02818036|7630384|FG000|COMPLETED|Overall Study||40
6700035|NCT02818036|7630385|FG001|COMPLETED|Overall Study||40
6700036|NCT02818036|7630384|FG000|NOT COMPLETED|Overall Study||2
6700037|NCT02818036|7630385|FG001|NOT COMPLETED|Overall Study||0
6700038|NCT02818114|7630391|FG000|STARTED|Overall Study||8
6700039|NCT02818114|7630391|FG000|COMPLETED|Overall Study||7
6700040|NCT02818114|7630391|FG000|NOT COMPLETED|Overall Study||1
6700041|NCT02818244|7630400|FG000|STARTED|Overall Study||25
6700042|NCT02818244|7630401|FG001|STARTED|Overall Study||25
6700043|NCT02818244|7630402|FG002|STARTED|Overall Study||25
6700044|NCT02818244|7630403|FG003|STARTED|Overall Study||25
6700045|NCT02818244|7630400|FG000|COMPLETED|Overall Study||25
6700046|NCT02818244|7630401|FG001|COMPLETED|Overall Study||25
6700047|NCT02818244|7630402|FG002|COMPLETED|Overall Study||25
6700048|NCT02818244|7630403|FG003|COMPLETED|Overall Study||25
6700049|NCT02818244|7630400|FG000|NOT COMPLETED|Overall Study||0
6700050|NCT02818244|7630401|FG001|NOT COMPLETED|Overall Study||0
6700051|NCT02818244|7630402|FG002|NOT COMPLETED|Overall Study||0
6700052|NCT02818244|7630403|FG003|NOT COMPLETED|Overall Study||0
6700053|NCT02818569|7630413|FG000|STARTED|Overall Study||8
6700054|NCT02818569|7630414|FG001|STARTED|Overall Study||7
6700055|NCT02818569|7630413|FG000|COMPLETED|Overall Study||8
6700056|NCT02818569|7630414|FG001|COMPLETED|Overall Study||7
6700057|NCT02818569|7630413|FG000|NOT COMPLETED|Overall Study||0
6700058|NCT02818569|7630414|FG001|NOT COMPLETED|Overall Study||0
6700059|NCT02818777|7630423|FG000|STARTED|Overall Study|The number of baseline participants was 13.|13
6700060|NCT02818777|7630423|FG000|COMPLETED|Overall Study||10
6700061|NCT02818777|7630423|FG000|NOT COMPLETED|Overall Study||3
6700062|NCT02818998|7630436|FG000|STARTED|Overall Study||155
6700063|NCT02818998|7630437|FG001|STARTED|Overall Study||154
6700064|NCT02818998|7630438|FG002|STARTED|Overall Study||154
6700065|NCT02818998|7630436|FG000|Completed Week 52 Visit|Overall Study||144
6700066|NCT02818998|7630437|FG001|Completed Week 52 Visit|Overall Study||146
6700067|NCT02818998|7630438|FG002|Completed Week 52 Visit|Overall Study||140
6700068|NCT02818998|7630436|FG000|COMPLETED|Overall Study||137
6700069|NCT02818998|7630437|FG001|COMPLETED|Overall Study||138
6700070|NCT02818998|7630438|FG002|COMPLETED|Overall Study||136
6700071|NCT02818998|7630436|FG000|NOT COMPLETED|Overall Study||18
6700072|NCT02818998|7630437|FG001|NOT COMPLETED|Overall Study||16
6700073|NCT02818998|7630438|FG002|NOT COMPLETED|Overall Study||18
6700074|NCT02819011|7630448|FG000|STARTED|Overall Study||22
6700075|NCT02819011|7630449|FG001|STARTED|Overall Study||22
6700076|NCT02819011|7630448|FG000|COMPLETED|Overall Study||15
6700077|NCT02819011|7630449|FG001|COMPLETED|Overall Study||17
6700078|NCT02819011|7630448|FG000|NOT COMPLETED|Overall Study||7
6700079|NCT02819011|7630449|FG001|NOT COMPLETED|Overall Study||5
6700080|NCT02819284|7630458|FG000|STARTED|Overall Study||452
6700081|NCT02819284|7630459|FG001|STARTED|Overall Study||453
6700082|NCT02819284|7630458|FG000|COMPLETED|Overall Study||447
6700083|NCT02819284|7630459|FG001|COMPLETED|Overall Study||448
6700084|NCT02819284|7630458|FG000|NOT COMPLETED|Overall Study||5
6700085|NCT02819284|7630459|FG001|NOT COMPLETED|Overall Study||5
6700086|NCT02819297|7630467|FG000|STARTED|Overall Study||299
6700087|NCT02819297|7630468|FG001|STARTED|Overall Study||304
6700088|NCT02819297|7630467|FG000|COMPLETED|Overall Study||239
6700089|NCT02819297|7630468|FG001|COMPLETED|Overall Study||252
6700090|NCT02819297|7630467|FG000|NOT COMPLETED|Overall Study||60
6700091|NCT02819297|7630468|FG001|NOT COMPLETED|Overall Study||52
6700092|NCT02819310|7630474|FG000|STARTED|Overall Study||330
6700093|NCT02819310|7630474|FG000|COMPLETED|Overall Study||221
6700094|NCT02819310|7630474|FG000|NOT COMPLETED|Overall Study||109
6700095|NCT02819323|7630481|FG000|STARTED|Overall Study||31
6700096|NCT02819323|7630482|FG001|STARTED|Overall Study||28
6700097|NCT02819323|7630483|FG002|STARTED|Overall Study||32
6700098|NCT02819323|7630481|FG000|COMPLETED|Overall Study||26
6700099|NCT02819323|7630482|FG001|COMPLETED|Overall Study||26
6700100|NCT02819323|7630483|FG002|COMPLETED|Overall Study||31
6700101|NCT02819323|7630481|FG000|NOT COMPLETED|Overall Study||5
6700102|NCT02819323|7630482|FG001|NOT COMPLETED|Overall Study||2
6700103|NCT02819323|7630483|FG002|NOT COMPLETED|Overall Study||1
6700104|NCT02819479|7630491|FG000|STARTED|Overall Study||10
6700105|NCT02819479|7630491|FG000|COMPLETED|Overall Study|2 subjects experienced recurrence of radiation necrosis requiring intervention at approx. month 11.|8
6700106|NCT02819479|7630491|FG000|NOT COMPLETED|Overall Study||2
6700107|NCT02819557|7630496|FG000|STARTED|Overall Study||14
6700108|NCT02819557|7630496|FG000|Safety Population|Overall Study||14
6700109|NCT02819557|7630496|FG000|Pharmacokinetics (PK) Population|Overall Study||14
6700110|NCT02819557|7630496|FG000|Evaluable Population|Overall Study||14
6700111|NCT02819557|7630496|FG000|COMPLETED|Overall Study||14
6700112|NCT02819557|7630496|FG000|NOT COMPLETED|Overall Study||0
6700113|NCT02819726|7630503|FG000|STARTED|Part A (All Participants)||98
6700114|NCT02819726|7630504|FG001|STARTED|Part A (All Participants)||98
6700115|NCT02819726|7630505|FG002|STARTED|Part A (All Participants)||98
6700116|NCT02819726|7630506|FG003|STARTED|Part A (All Participants)||0
6700117|NCT02819726|7630503|FG000|COMPLETED|Part A (All Participants)||92
6700118|NCT02819726|7630504|FG001|COMPLETED|Part A (All Participants)||88
6281043|NCT00161473|7180919|FG000|COMPLETED|Overall Study||7
6700119|NCT02819726|7630505|FG002|COMPLETED|Part A (All Participants)||87
6700120|NCT02819726|7630506|FG003|COMPLETED|Part A (All Participants)||0
6700121|NCT02819726|7630503|FG000|NOT COMPLETED|Part A (All Participants)||6
6700122|NCT02819726|7630504|FG001|NOT COMPLETED|Part A (All Participants)||10
6700123|NCT02819726|7630505|FG002|NOT COMPLETED|Part A (All Participants)||11
6700124|NCT02819726|7630506|FG003|NOT COMPLETED|Part A (All Participants)||0
6700125|NCT02819726|7630503|FG000|STARTED|Part B (All Participants)|19 participants who completed Part A were not eligible for Part B|73
6700126|NCT02819726|7630504|FG001|STARTED|Part B (All Participants)|18 participants completing Part A were not eligible for Part B|70
6700127|NCT02819726|7630505|FG002|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|39
6700128|NCT02819726|7630506|FG003|STARTED|Part B (All Participants)|5 participants completing Part A were ineligible for Part B.|38
6700129|NCT02819726|7630503|FG000|COMPLETED|Part B (All Participants)||70
6700130|NCT02819726|7630504|FG001|COMPLETED|Part B (All Participants)||68
6700131|NCT02819726|7630505|FG002|COMPLETED|Part B (All Participants)||35
6700132|NCT02819726|7630506|FG003|COMPLETED|Part B (All Participants)||36
6700133|NCT02819726|7630503|FG000|NOT COMPLETED|Part B (All Participants)||3
6700134|NCT02819726|7630504|FG001|NOT COMPLETED|Part B (All Participants)||2
6700135|NCT02819726|7630505|FG002|NOT COMPLETED|Part B (All Participants)||4
6700136|NCT02819726|7630506|FG003|NOT COMPLETED|Part B (All Participants)||2
6700137|NCT02819973|7630517|FG000|STARTED|Overall Study||114
6700138|NCT02819973|7630518|FG001|STARTED|Overall Study||114
6700139|NCT02819973|7630519|FG002|STARTED|Overall Study||115
6700140|NCT02819973|7630517|FG000|COMPLETED|Overall Study|2 withdrawn by request, 4 determined after randomization to be not eligible|108
6700141|NCT02819973|7630518|FG001|COMPLETED|Overall Study|3 determined after randomization to be not eligible|111
6700142|NCT02819973|7630519|FG002|COMPLETED|Overall Study|2 withdrawn by request, 2 determined after randomization to be not eligible|111
6700143|NCT02819973|7630517|FG000|NOT COMPLETED|Overall Study||6
6700144|NCT02819973|7630518|FG001|NOT COMPLETED|Overall Study||3
6700145|NCT02819973|7630519|FG002|NOT COMPLETED|Overall Study||4
6700146|NCT02820038|7630537|FG000|STARTED|Overall Study||78
6700147|NCT02820038|7630538|FG001|STARTED|Overall Study||77
6700148|NCT02820038|7630539|FG002|STARTED|Overall Study||65
6700149|NCT02820038|7630540|FG003|STARTED|Overall Study||66
6700150|NCT02820038|7630537|FG000|COMPLETED|Overall Study||68
6700151|NCT02820038|7630538|FG001|COMPLETED|Overall Study||52
6700152|NCT02820038|7630539|FG002|COMPLETED|Overall Study||60
6700153|NCT02820038|7630540|FG003|COMPLETED|Overall Study||44
6700154|NCT02820038|7630537|FG000|NOT COMPLETED|Overall Study||10
6700155|NCT02820038|7630538|FG001|NOT COMPLETED|Overall Study||25
6700156|NCT02820038|7630539|FG002|NOT COMPLETED|Overall Study||5
6700157|NCT02820038|7630540|FG003|NOT COMPLETED|Overall Study||22
6700158|NCT02820181|7630553|FG000|STARTED|Overall Study||30
6700159|NCT02820181|7630554|FG001|STARTED|Overall Study||30
6700160|NCT02820181|7630553|FG000|COMPLETED|Overall Study||30
6700161|NCT02820181|7630554|FG001|COMPLETED|Overall Study||30
6260036|NCT01232283|7158956|FG009|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260037|NCT01232283|7158947|FG000|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6260038|NCT01232283|7158948|FG001|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6260039|NCT01232283|7158949|FG002|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6260040|NCT01232283|7158950|FG003|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6260041|NCT01232283|7158951|FG004|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6260042|NCT01232283|7158952|FG005|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6260043|NCT01232283|7158953|FG006|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
6260044|NCT01232283|7158954|FG007|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
6260045|NCT01232283|7158955|FG008|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6260046|NCT01232283|7158956|FG009|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
6260047|NCT01232283|7158947|FG000|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260048|NCT01232283|7158948|FG001|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260049|NCT01232283|7158949|FG002|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260050|NCT01232283|7158950|FG003|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260051|NCT01232283|7158951|FG004|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
6260052|NCT01232283|7158952|FG005|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
6260053|NCT01232283|7158953|FG006|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
6260054|NCT01232283|7158954|FG007|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
6260055|NCT01232283|7158955|FG008|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260056|NCT01232283|7158956|FG009|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260057|NCT01232283|7158947|FG000|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260058|NCT01232283|7158948|FG001|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260059|NCT01232283|7158949|FG002|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260060|NCT01232283|7158950|FG003|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260061|NCT01232283|7158951|FG004|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
6260062|NCT01232283|7158952|FG005|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
6260063|NCT01232283|7158953|FG006|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
6260064|NCT01232283|7158954|FG007|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
6260065|NCT01232283|7158955|FG008|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260066|NCT01232283|7158956|FG009|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
6260067|NCT01232283|7158947|FG000|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6260068|NCT01232283|7158948|FG001|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6700162|NCT02820181|7630553|FG000|NOT COMPLETED|Overall Study||0
6700163|NCT02820181|7630554|FG001|NOT COMPLETED|Overall Study||0
6700164|NCT02820298|7630562|FG000|STARTED|Overall Study||13
6700165|NCT02820298|7630563|FG001|STARTED|Overall Study||12
6700166|NCT02820298|7630562|FG000|COMPLETED|Overall Study||12
6700167|NCT02820298|7630563|FG001|COMPLETED|Overall Study||10
6700168|NCT02820298|7630562|FG000|NOT COMPLETED|Overall Study||1
6700169|NCT02820298|7630563|FG001|NOT COMPLETED|Overall Study||2
6700170|NCT02820324|7630580|FG000|STARTED|Overall Study||78
6700171|NCT02820324|7630581|FG001|STARTED|Overall Study||82
6700172|NCT02820324|7630582|FG002|STARTED|Overall Study||82
6700173|NCT02820324|7630583|FG003|STARTED|Overall Study||82
6700174|NCT02820324|7630584|FG004|STARTED|Overall Study||83
6700175|NCT02820324|7630580|FG000|Treated With Study Medication|Overall Study||77
6700176|NCT02820324|7630581|FG001|Treated With Study Medication|Overall Study||80
6700177|NCT02820324|7630582|FG002|Treated With Study Medication|Overall Study||80
6700178|NCT02820324|7630583|FG003|Treated With Study Medication|Overall Study||81
6700179|NCT02820324|7630584|FG004|Treated With Study Medication|Overall Study||83
6700180|NCT02820324|7630580|FG000|COMPLETED|Overall Study||76
6700181|NCT02820324|7630581|FG001|COMPLETED|Overall Study||79
6700182|NCT02820324|7630582|FG002|COMPLETED|Overall Study||79
6700183|NCT02820324|7630583|FG003|COMPLETED|Overall Study||79
6700184|NCT02820324|7630584|FG004|COMPLETED|Overall Study||80
6700185|NCT02820324|7630580|FG000|NOT COMPLETED|Overall Study||2
6700186|NCT02820324|7630581|FG001|NOT COMPLETED|Overall Study||3
6700187|NCT02820324|7630582|FG002|NOT COMPLETED|Overall Study||3
6700188|NCT02820324|7630583|FG003|NOT COMPLETED|Overall Study||3
6700189|NCT02820324|7630584|FG004|NOT COMPLETED|Overall Study||3
6700190|NCT02820597|7630596|FG000|STARTED|Overall Study||27
6700191|NCT02820597|7630596|FG000|1-day Post Treatment|Overall Study||27
6700192|NCT02820597|7630596|FG000|7-day Post Treatment|Overall Study||27
6700193|NCT02820597|7630596|FG000|30-day Post Treatment|Overall Study||27
6700194|NCT02820597|7630596|FG000|90-day Post Treatment|Overall Study|2 participants missed the 90-day visit, 1 participant was lost to follow-up.|24
6700195|NCT02820597|7630596|FG000|180-day Post Treatment|Overall Study|3 participants missed the 180-day visit, 3 participants were lost to follow-up.|21
6700196|NCT02820597|7630596|FG000|COMPLETED|Overall Study|12 participants were lost to follow-up.|15
6700197|NCT02820597|7630596|FG000|NOT COMPLETED|Overall Study||12
6700198|NCT02820844|7630602|FG000|STARTED|Double-blinded (Up to 48 Weeks)||124
6700199|NCT02820844|7630603|FG001|STARTED|Double-blinded (Up to 48 Weeks)||124
6700200|NCT02820844|7630604|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
6700201|NCT02820844|7630605|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
6700202|NCT02820844|7630606|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
6700203|NCT02820844|7630607|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
6700204|NCT02820844|7630602|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||119
6700205|NCT02820844|7630603|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||115
6700206|NCT02820844|7630604|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6700207|NCT02820844|7630605|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6700208|NCT02820844|7630606|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6700209|NCT02820844|7630607|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6700210|NCT02820844|7630602|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||5
6700211|NCT02820844|7630603|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||9
6700212|NCT02820844|7630604|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6700213|NCT02820844|7630605|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6700214|NCT02820844|7630606|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6700215|NCT02820844|7630607|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6700216|NCT02820844|7630602|FG000|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700217|NCT02820844|7630603|FG001|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700218|NCT02820844|7630604|FG002|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||108
6700219|NCT02820844|7630605|FG003|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||88
6700220|NCT02820844|7630606|FG004|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700221|NCT02820844|7630607|FG005|STARTED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700222|NCT02820844|7630602|FG000|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700223|NCT02820844|7630603|FG001|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700224|NCT02820844|7630604|FG002|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||99
6700225|NCT02820844|7630605|FG003|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||84
6700226|NCT02820844|7630606|FG004|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700227|NCT02820844|7630607|FG005|COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700228|NCT02820844|7630602|FG000|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700229|NCT02820844|7630603|FG001|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700230|NCT02820844|7630604|FG002|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||9
6700231|NCT02820844|7630605|FG003|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||4
6700232|NCT02820844|7630606|FG004|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700233|NCT02820844|7630607|FG005|NOT COMPLETED|Open-label(2nd Treatment-Up to 48 Weeks)||0
6700234|NCT02820844|7630602|FG000|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700235|NCT02820844|7630603|FG001|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700236|NCT02820844|7630604|FG002|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700237|NCT02820844|7630605|FG003|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700238|NCT02820844|7630606|FG004|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||56
6700239|NCT02820844|7630607|FG005|STARTED|Open-label(3rd Treatment-Up to 48 Weeks)||43
6700240|NCT02820844|7630602|FG000|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700241|NCT02820844|7630603|FG001|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700242|NCT02820844|7630604|FG002|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700243|NCT02820844|7630605|FG003|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700244|NCT02820844|7630606|FG004|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||54
6700245|NCT02820844|7630607|FG005|COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||42
6700246|NCT02820844|7630602|FG000|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700247|NCT02820844|7630603|FG001|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700248|NCT02820844|7630604|FG002|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700249|NCT02820844|7630605|FG003|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||0
6700250|NCT02820844|7630606|FG004|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||2
6700251|NCT02820844|7630607|FG005|NOT COMPLETED|Open-label(3rd Treatment-Up to 48 Weeks)||1
6700252|NCT02820870|7630626|FG000|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
6700253|NCT02820870|7630627|FG001|STARTED|Before Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
6700254|NCT02820870|7630626|FG000|COMPLETED|Before Intervention||15
6700255|NCT02820870|7630627|FG001|COMPLETED|Before Intervention||28
6700256|NCT02820870|7630626|FG000|NOT COMPLETED|Before Intervention||0
6700257|NCT02820870|7630627|FG001|NOT COMPLETED|Before Intervention||0
6700258|NCT02820870|7630626|FG000|STARTED|Intervention||15
6700259|NCT02820870|7630627|FG001|STARTED|Intervention||28
6700260|NCT02820870|7630626|FG000|COMPLETED|Intervention||15
6700261|NCT02820870|7630627|FG001|COMPLETED|Intervention||28
6700262|NCT02820870|7630626|FG000|NOT COMPLETED|Intervention||0
6700263|NCT02820870|7630627|FG001|NOT COMPLETED|Intervention||0
6700264|NCT02820870|7630626|FG000|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|15
6700265|NCT02820870|7630627|FG001|STARTED|Post Intervention|These are a separate set of visits from the intervention period and have different visit numbers.|28
6700266|NCT02820870|7630626|FG000|COMPLETED|Post Intervention||15
6700267|NCT02820870|7630627|FG001|COMPLETED|Post Intervention||28
6700268|NCT02820870|7630626|FG000|NOT COMPLETED|Post Intervention||0
6700269|NCT02820870|7630627|FG001|NOT COMPLETED|Post Intervention||0
6700270|NCT02821104|7630635|FG000|STARTED|Overall Study||77
6700271|NCT02821104|7630635|FG000|COMPLETED|Overall Study||77
6700272|NCT02821104|7630635|FG000|NOT COMPLETED|Overall Study||0
6700273|NCT02821338|7630642|FG000|STARTED|Overall Study||15
6700274|NCT02821338|7630643|FG001|STARTED|Overall Study||15
6700275|NCT02821338|7630642|FG000|COMPLETED|Overall Study|12 out of 15 subjects assigned to Sequence 1 completed the study, and provided two data points.|12
6700276|NCT02821338|7630643|FG001|COMPLETED|Overall Study|13 out of 15 subjects assigned to Sequence 2 completed the study, and provided two data points.|13
6700277|NCT02821338|7630642|FG000|NOT COMPLETED|Overall Study||3
6700278|NCT02821338|7630643|FG001|NOT COMPLETED|Overall Study||2
6700279|NCT02821403|7630651|FG000|STARTED|"First Intervention (1 Month)"||40
6700280|NCT02821403|7630652|FG001|STARTED|"First Intervention (1 Month)"||40
6700281|NCT02821403|7630651|FG000|Used Clear Lens|"First Intervention (1 Month)"||13
6700282|NCT02821403|7630652|FG001|Used Clear Lens|"First Intervention (1 Month)"||13
6700283|NCT02821403|7630651|FG000|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
6700284|NCT02821403|7630652|FG001|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
6700285|NCT02821403|7630651|FG000|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
6700286|NCT02821403|7630652|FG001|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
6700287|NCT02821403|7630651|FG000|COMPLETED|"First Intervention (1 Month)"||40
6700288|NCT02821403|7630652|FG001|COMPLETED|"First Intervention (1 Month)"||40
6700289|NCT02821403|7630651|FG000|NOT COMPLETED|"First Intervention (1 Month)"||0
6700290|NCT02821403|7630652|FG001|NOT COMPLETED|"First Intervention (1 Month)"||0
6700291|NCT02821403|7630651|FG000|STARTED|"Second Intervention (1 Month)"||40
6700292|NCT02821403|7630652|FG001|STARTED|"Second Intervention (1 Month)"||40
6700293|NCT02821403|7630651|FG000|Used Clear Lens|"Second Intervention (1 Month)"||13
6700294|NCT02821403|7630652|FG001|Used Clear Lens|"Second Intervention (1 Month)"||14
6700295|NCT02821403|7630651|FG000|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
6700296|NCT02821403|7630652|FG001|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
6700297|NCT02821403|7630651|FG000|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
6700298|NCT02821403|7630652|FG001|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
6700299|NCT02821403|7630651|FG000|COMPLETED|"Second Intervention (1 Month)"||40
6700300|NCT02821403|7630652|FG001|COMPLETED|"Second Intervention (1 Month)"||40
6700301|NCT02821403|7630651|FG000|NOT COMPLETED|"Second Intervention (1 Month)"||0
6700302|NCT02821403|7630652|FG001|NOT COMPLETED|"Second Intervention (1 Month)"||0
6700303|NCT02821403|7630651|FG000|STARTED|"Third Intervention (1 Month)"||40
6700304|NCT02821403|7630652|FG001|STARTED|"Third Intervention (1 Month)"||40
6700305|NCT02821403|7630651|FG000|Used Clear Lens|"Third Intervention (1 Month)"||14
6700306|NCT02821403|7630652|FG001|Used Clear Lens|"Third Intervention (1 Month)"||13
6700307|NCT02821403|7630651|FG000|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
6700308|NCT02821403|7630652|FG001|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
6700309|NCT02821403|7630651|FG000|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
6700310|NCT02821403|7630652|FG001|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
6700311|NCT02821403|7630651|FG000|COMPLETED|"Third Intervention (1 Month)"||40
6700312|NCT02821403|7630652|FG001|COMPLETED|"Third Intervention (1 Month)"||40
6700313|NCT02821403|7630651|FG000|NOT COMPLETED|"Third Intervention (1 Month)"||0
6700314|NCT02821403|7630652|FG001|NOT COMPLETED|"Third Intervention (1 Month)"||0
6700315|NCT02821416|7630666|FG000|STARTED|Overall Study||23
6700316|NCT02821416|7630667|FG001|STARTED|Overall Study||23
6700317|NCT02821416|7630666|FG000|COMPLETED|Overall Study||20
6700318|NCT02821416|7630667|FG001|COMPLETED|Overall Study||22
6700319|NCT02821416|7630666|FG000|NOT COMPLETED|Overall Study||3
6700320|NCT02821416|7630667|FG001|NOT COMPLETED|Overall Study||1
6700321|NCT02821455|7630674|FG000|STARTED|Overall Study||19
6700322|NCT02821455|7630674|FG000|COMPLETED|Overall Study||19
6700323|NCT02821455|7630674|FG000|NOT COMPLETED|Overall Study||0
6700324|NCT02821715|7630678|FG000|STARTED|Overall Study||8
6700325|NCT02821715|7630679|FG001|STARTED|Overall Study||8
6700326|NCT02821715|7630680|FG002|STARTED|Overall Study||8
6700327|NCT02821715|7630681|FG003|STARTED|Overall Study||9
6700328|NCT02821715|7630682|FG004|STARTED|Overall Study||6
6700329|NCT02821715|7630683|FG005|STARTED|Overall Study||9
6700330|NCT02821715|7630678|FG000|COMPLETED|Overall Study||7
6700331|NCT02821715|7630679|FG001|COMPLETED|Overall Study||8
6700332|NCT02821715|7630680|FG002|COMPLETED|Overall Study||8
6700333|NCT02821715|7630681|FG003|COMPLETED|Overall Study||9
6700334|NCT02821715|7630682|FG004|COMPLETED|Overall Study||6
6700335|NCT02821715|7630683|FG005|COMPLETED|Overall Study||9
6700336|NCT02821715|7630678|FG000|NOT COMPLETED|Overall Study||1
6700337|NCT02821715|7630679|FG001|NOT COMPLETED|Overall Study||0
6700338|NCT02821715|7630680|FG002|NOT COMPLETED|Overall Study||0
6700339|NCT02821715|7630681|FG003|NOT COMPLETED|Overall Study||0
6700340|NCT02821715|7630682|FG004|NOT COMPLETED|Overall Study||0
6700341|NCT02821715|7630683|FG005|NOT COMPLETED|Overall Study||0
6700342|NCT02821819|7630691|FG000|STARTED|Overall Study||15
6700343|NCT02821819|7630691|FG000|COMPLETED|Overall Study||14
6700344|NCT02821819|7630691|FG000|NOT COMPLETED|Overall Study||1
6700345|NCT02821910|7630701|FG000|STARTED|Overall Study||7
6700346|NCT02821910|7630702|FG001|STARTED|Overall Study||8
6700347|NCT02821910|7630703|FG002|STARTED|Overall Study||10
6700348|NCT02821910|7630704|FG003|STARTED|Overall Study||10
6700349|NCT02821910|7630705|FG004|STARTED|Overall Study||7
6700350|NCT02821910|7630706|FG005|STARTED|Overall Study||8
6700351|NCT02821910|7630701|FG000|COMPLETED|Overall Study||6
6700352|NCT02821910|7630702|FG001|COMPLETED|Overall Study||8
6700353|NCT02821910|7630703|FG002|COMPLETED|Overall Study||8
6700354|NCT02821910|7630704|FG003|COMPLETED|Overall Study||10
6700355|NCT02821910|7630705|FG004|COMPLETED|Overall Study||7
6700356|NCT02821910|7630706|FG005|COMPLETED|Overall Study||7
6700357|NCT02821910|7630701|FG000|NOT COMPLETED|Overall Study||1
6700358|NCT02821910|7630702|FG001|NOT COMPLETED|Overall Study||0
6700359|NCT02821910|7630703|FG002|NOT COMPLETED|Overall Study||2
6700360|NCT02821910|7630704|FG003|NOT COMPLETED|Overall Study||0
6700361|NCT02821910|7630705|FG004|NOT COMPLETED|Overall Study||0
6700362|NCT02821910|7630706|FG005|NOT COMPLETED|Overall Study||1
6700363|NCT02821962|7630722|FG000|STARTED|Overall Study||19
6700364|NCT02821962|7630723|FG001|STARTED|Overall Study||21
6700365|NCT02821962|7630722|FG000|COMPLETED|Overall Study||17
6700366|NCT02821962|7630723|FG001|COMPLETED|Overall Study||21
6700367|NCT02821962|7630722|FG000|NOT COMPLETED|Overall Study||2
6700368|NCT02821962|7630723|FG001|NOT COMPLETED|Overall Study||0
6700369|NCT02822222|7630731|FG000|STARTED|Overall Study||16
6700370|NCT02822222|7630732|FG001|STARTED|Overall Study||6
6700371|NCT02822222|7630731|FG000|COMPLETED|Overall Study||15
6700372|NCT02822222|7630732|FG001|COMPLETED|Overall Study||6
6700373|NCT02822222|7630731|FG000|NOT COMPLETED|Overall Study||1
6700374|NCT02822222|7630732|FG001|NOT COMPLETED|Overall Study||0
6700375|NCT02822235|7630740|FG000|STARTED|Cross-sectional Phase (Day 1)||264
6700376|NCT02822235|7630741|FG001|STARTED|Cross-sectional Phase (Day 1)||143
6700377|NCT02822235|7630740|FG000|COMPLETED|Cross-sectional Phase (Day 1)||118
6700378|NCT02822235|7630741|FG001|COMPLETED|Cross-sectional Phase (Day 1)||36
6700379|NCT02822235|7630740|FG000|NOT COMPLETED|Cross-sectional Phase (Day 1)||146
6700380|NCT02822235|7630741|FG001|NOT COMPLETED|Cross-sectional Phase (Day 1)||107
6700381|NCT02822235|7630740|FG000|STARTED|Prospective Phase (Day 1 up to Month 12)||118
6700382|NCT02822235|7630741|FG001|STARTED|Prospective Phase (Day 1 up to Month 12)||36
6700383|NCT02822235|7630740|FG000|COMPLETED|Prospective Phase (Day 1 up to Month 12)||107
6700384|NCT02822235|7630741|FG001|COMPLETED|Prospective Phase (Day 1 up to Month 12)||34
6700385|NCT02822235|7630740|FG000|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||11
6700386|NCT02822235|7630741|FG001|NOT COMPLETED|Prospective Phase (Day 1 up to Month 12)||2
6700387|NCT02822287|7630754|FG000|STARTED|Overall Study||57
6700388|NCT02822287|7630754|FG000|COMPLETED|Overall Study||57
6700389|NCT02822287|7630754|FG000|NOT COMPLETED|Overall Study||0
6700390|NCT02822599|7630760|FG000|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
6700391|NCT02822599|7630761|FG001|STARTED|Overall Study|First subject enrolled on 6-1-17.|15
6700392|NCT02822599|7630760|FG000|COMPLETED|Overall Study||15
6700393|NCT02822599|7630761|FG001|COMPLETED|Overall Study||15
6700394|NCT02822599|7630760|FG000|NOT COMPLETED|Overall Study||0
6700395|NCT02822599|7630761|FG001|NOT COMPLETED|Overall Study||0
6700396|NCT02822612|7630772|FG000|STARTED|Overall Study||14
6700397|NCT02822612|7630773|FG001|STARTED|Overall Study||13
6700398|NCT02822612|7630774|FG002|STARTED|Overall Study||14
6700399|NCT02822612|7630775|FG003|STARTED|Overall Study||4
6700400|NCT02822612|7630776|FG004|STARTED|Overall Study||15
6700401|NCT02822612|7630772|FG000|COMPLETED|Overall Study||14
6700402|NCT02822612|7630773|FG001|COMPLETED|Overall Study||13
6700403|NCT02822612|7630774|FG002|COMPLETED|Overall Study||14
6700404|NCT02822612|7630775|FG003|COMPLETED|Overall Study||4
6700405|NCT02822612|7630776|FG004|COMPLETED|Overall Study||15
6700406|NCT02822612|7630772|FG000|NOT COMPLETED|Overall Study||0
6700407|NCT02822612|7630773|FG001|NOT COMPLETED|Overall Study||0
6700408|NCT02822612|7630774|FG002|NOT COMPLETED|Overall Study||0
6700409|NCT02822612|7630775|FG003|NOT COMPLETED|Overall Study||0
6700410|NCT02822612|7630776|FG004|NOT COMPLETED|Overall Study||0
6700411|NCT02822794|7630792|FG000|STARTED|Overall Study||57
6700412|NCT02822794|7630793|FG001|STARTED|Overall Study||60
6700413|NCT02822794|7630792|FG000|COMPLETED|Overall Study||56
6700414|NCT02822794|7630793|FG001|COMPLETED|Overall Study||60
6700415|NCT02822794|7630792|FG000|NOT COMPLETED|Overall Study||1
6700416|NCT02822794|7630793|FG001|NOT COMPLETED|Overall Study||0
6700417|NCT02822885|7630806|FG000|STARTED|Overall Study||70
6700418|NCT02822885|7630806|FG000|COMPLETED|Overall Study||70
6700419|NCT02822885|7630806|FG000|NOT COMPLETED|Overall Study||0
6700420|NCT02822950|7630810|FG000|STARTED|Overall Study||10
6700421|NCT02822950|7630810|FG000|COMPLETED|Overall Study||10
6700422|NCT02822950|7630810|FG000|NOT COMPLETED|Overall Study||0
6700423|NCT02823080|7630816|FG000|STARTED|Overall Study||24
6700424|NCT02823080|7630817|FG001|STARTED|Overall Study||24
6700425|NCT02823080|7630816|FG000|COMPLETED|Overall Study||24
6700426|NCT02823080|7630817|FG001|COMPLETED|Overall Study||24
6700427|NCT02823080|7630816|FG000|NOT COMPLETED|Overall Study||0
6700428|NCT02823080|7630817|FG001|NOT COMPLETED|Overall Study||0
6700429|NCT02823431|7630826|FG000|STARTED|Overall Study||11
6700430|NCT02823431|7630827|FG001|STARTED|Overall Study||12
6700431|NCT02823431|7630826|FG000|COMPLETED|Overall Study||11
6700432|NCT02823431|7630827|FG001|COMPLETED|Overall Study||12
6700433|NCT02823431|7630826|FG000|NOT COMPLETED|Overall Study||0
6700434|NCT02823431|7630827|FG001|NOT COMPLETED|Overall Study||0
6700435|NCT02823470|7630835|FG000|STARTED|Overall Study||9
6260069|NCT01232283|7158949|FG002|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6260070|NCT01232283|7158950|FG003|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6260071|NCT01232283|7158951|FG004|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6260072|NCT01232283|7158952|FG005|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6260073|NCT01232283|7158953|FG006|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6260074|NCT01232283|7158954|FG007|STARTED|Long-Term Extension Phase (Weeks 52-260)||0
6260075|NCT01232283|7158955|FG008|STARTED|Long-Term Extension Phase (Weeks 52-260)||137
6260076|NCT01232283|7158956|FG009|STARTED|Long-Term Extension Phase (Weeks 52-260)||80
6260077|NCT01232283|7158947|FG000|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260078|NCT01232283|7158948|FG001|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260079|NCT01232283|7158949|FG002|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260080|NCT01232283|7158950|FG003|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260081|NCT01232283|7158951|FG004|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260082|NCT01232283|7158952|FG005|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260083|NCT01232283|7158953|FG006|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260084|NCT01232283|7158954|FG007|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260085|NCT01232283|7158955|FG008|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||29
6260086|NCT01232283|7158956|FG009|COMPLETED|Long-Term Extension Phase (Weeks 52-260)||19
6260087|NCT01232283|7158947|FG000|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260088|NCT01232283|7158948|FG001|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260089|NCT01232283|7158949|FG002|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260090|NCT01232283|7158950|FG003|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260091|NCT01232283|7158951|FG004|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260092|NCT01232283|7158952|FG005|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260093|NCT01232283|7158953|FG006|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260094|NCT01232283|7158954|FG007|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||0
6260095|NCT01232283|7158955|FG008|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||108
6260096|NCT01232283|7158956|FG009|NOT COMPLETED|Long-Term Extension Phase (Weeks 52-260)||61
6260097|NCT01231516|7158980|FG000|STARTED|Double-blind Phase (Up to Week [Wk] 48)||360
6260098|NCT01231516|7158981|FG001|STARTED|Double-blind Phase (Up to Week [Wk] 48)||364
6260099|NCT01231516|7158980|FG000|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||357
6260100|NCT01231516|7158981|FG001|ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||362
6260101|NCT01231516|7158980|FG000|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||354
6260102|NCT01231516|7158981|FG001|Modified (m)ITT-E Population|Double-blind Phase (Up to Week [Wk] 48)||361
6260103|NCT01231516|7158980|FG000|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||299
6260104|NCT01231516|7158981|FG001|COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||283
6260105|NCT01231516|7158980|FG000|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||61
6260106|NCT01231516|7158981|FG001|NOT COMPLETED|Double-blind Phase (Up to Week [Wk] 48)||81
6260107|NCT01231516|7158980|FG000|STARTED|Open-label Phase:From Wk 48 up to Wk 480|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
6260108|NCT01231516|7158981|FG001|STARTED|Open-label Phase:From Wk 48 up to Wk 480|157 participants completed the Double-blind Phase but did not enter the Open-label Phase.|126
6260109|NCT01231516|7158980|FG000|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||227
6260110|NCT01231516|7158981|FG001|COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||109
6260111|NCT01231516|7158980|FG000|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||68
6260112|NCT01231516|7158981|FG001|NOT COMPLETED|Open-label Phase:From Wk 48 up to Wk 480||17
6260113|NCT01229943|7158989|FG000|STARTED|Overall Study||75
6700436|NCT02823470|7630836|FG001|STARTED|Overall Study||15
6700437|NCT02823470|7630835|FG000|COMPLETED|Overall Study||0
6700438|NCT02823470|7630836|FG001|COMPLETED|Overall Study||0
6700439|NCT02823470|7630835|FG000|NOT COMPLETED|Overall Study||9
6700440|NCT02823470|7630836|FG001|NOT COMPLETED|Overall Study||15
6700441|NCT02823600|7630845|FG000|STARTED|Overall Study||68
6700442|NCT02823600|7630845|FG000|COMPLETED|Overall Study||68
6700443|NCT02823600|7630845|FG000|NOT COMPLETED|Overall Study||0
6700444|NCT02823964|7630851|FG000|STARTED|Overall Study||25
6700445|NCT02823964|7630851|FG000|COMPLETED|Overall Study||20
6700446|NCT02823964|7630851|FG000|NOT COMPLETED|Overall Study||5
6700447|NCT02824224|7630857|FG000|STARTED|Overall Study||19
6700448|NCT02824224|7630858|FG001|STARTED|Overall Study||18
6700449|NCT02824224|7630857|FG000|COMPLETED|Overall Study||17
6700450|NCT02824224|7630858|FG001|COMPLETED|Overall Study||17
6700451|NCT02824224|7630857|FG000|NOT COMPLETED|Overall Study||2
6700452|NCT02824224|7630858|FG001|NOT COMPLETED|Overall Study||1
6700453|NCT02824432|7630866|FG000|STARTED|Overall Study||18
6700454|NCT02824432|7630867|FG001|STARTED|Overall Study||19
6700455|NCT02824432|7630866|FG000|COMPLETED|Overall Study||17
6700456|NCT02824432|7630867|FG001|COMPLETED|Overall Study||19
6700457|NCT02824432|7630866|FG000|NOT COMPLETED|Overall Study||1
6700458|NCT02824432|7630867|FG001|NOT COMPLETED|Overall Study||0
6700459|NCT02824562|7630875|FG000|STARTED|Overall Study||22
6700460|NCT02824562|7630876|FG001|STARTED|Overall Study||22
6700461|NCT02824562|7630875|FG000|COMPLETED|Overall Study||19
6700462|NCT02824562|7630876|FG001|COMPLETED|Overall Study||17
6700463|NCT02824562|7630875|FG000|NOT COMPLETED|Overall Study||3
6700464|NCT02824562|7630876|FG001|NOT COMPLETED|Overall Study||5
6700465|NCT02824913|7630884|FG000|STARTED|First Intervention (1 Day)||1
6700466|NCT02824913|7630885|FG001|STARTED|First Intervention (1 Day)||0
6700467|NCT02824913|7630884|FG000|COMPLETED|First Intervention (1 Day)|Only one subject was enrolled in the study and received both study treatments.|1
6700468|NCT02824913|7630885|FG001|COMPLETED|First Intervention (1 Day)||0
6700469|NCT02824913|7630884|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6700470|NCT02824913|7630885|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6700471|NCT02824913|7630884|FG000|STARTED|Washout (7-14 Days)||1
6700472|NCT02824913|7630885|FG001|STARTED|Washout (7-14 Days)||0
6700473|NCT02824913|7630884|FG000|COMPLETED|Washout (7-14 Days)||1
6700474|NCT02824913|7630885|FG001|COMPLETED|Washout (7-14 Days)||0
6700475|NCT02824913|7630884|FG000|NOT COMPLETED|Washout (7-14 Days)||0
6700476|NCT02824913|7630885|FG001|NOT COMPLETED|Washout (7-14 Days)||0
6700477|NCT02824913|7630884|FG000|STARTED|Second Intervention (1 Day)||1
6700478|NCT02824913|7630885|FG001|STARTED|Second Intervention (1 Day)||0
6700479|NCT02824913|7630884|FG000|COMPLETED|Second Intervention (1 Day)||1
6700480|NCT02824913|7630885|FG001|COMPLETED|Second Intervention (1 Day)||0
6700481|NCT02824913|7630884|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6700482|NCT02824913|7630885|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6700483|NCT02825212|7630893|FG000|STARTED|Overall Study||10
6700484|NCT02825212|7630893|FG000|COMPLETED|Overall Study||10
6700485|NCT02825212|7630893|FG000|NOT COMPLETED|Overall Study||0
6700486|NCT02825251|7630899|FG000|STARTED|Overall Study||236
6700487|NCT02825251|7630900|FG001|STARTED|Overall Study||236
6700488|NCT02825251|7630899|FG000|COMPLETED|Overall Study||233
6700489|NCT02825251|7630900|FG001|COMPLETED|Overall Study||230
6700490|NCT02825251|7630899|FG000|NOT COMPLETED|Overall Study||3
6700491|NCT02825251|7630900|FG001|NOT COMPLETED|Overall Study||6
6700492|NCT02825420|7630908|FG000|STARTED|Overall Study||131
6700493|NCT02825420|7630909|FG001|STARTED|Overall Study||89
6700494|NCT02825420|7630908|FG000|COMPLETED|Overall Study||88
6700495|NCT02825420|7630909|FG001|COMPLETED|Overall Study||72
6700496|NCT02825420|7630908|FG000|NOT COMPLETED|Overall Study||43
6700497|NCT02825420|7630909|FG001|NOT COMPLETED|Overall Study||17
6700498|NCT02825550|7630920|FG000|STARTED|Overall Study||13
6700499|NCT02825550|7630920|FG000|COMPLETED|Overall Study||12
6260114|NCT01229943|7158990|FG001|STARTED|Overall Study||75
6260115|NCT01229943|7158989|FG000|COMPLETED|Overall Study||57
6260116|NCT01229943|7158990|FG001|COMPLETED|Overall Study||58
6260117|NCT01229943|7158989|FG000|NOT COMPLETED|Overall Study||18
6260118|NCT01229943|7158990|FG001|NOT COMPLETED|Overall Study||17
6260119|NCT01194219|7159000|FG000|STARTED|Placebo-Controlled Phase Weeks 0-16||562
6260120|NCT01194219|7159001|FG001|STARTED|Placebo-Controlled Phase Weeks 0-16||282
6260121|NCT01194219|7159002|FG002|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6260122|NCT01194219|7159003|FG003|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6260123|NCT01194219|7159004|FG004|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6260124|NCT01194219|7159005|FG005|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6260125|NCT01194219|7159006|FG006|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6260126|NCT01194219|7159007|FG007|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6260127|NCT01194219|7159008|FG008|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6260128|NCT01194219|7159009|FG009|STARTED|Placebo-Controlled Phase Weeks 0-16||0
6260129|NCT01194219|7159000|FG000|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||560
6260130|NCT01194219|7159001|FG001|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||282
6260131|NCT01194219|7159002|FG002|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6260132|NCT01194219|7159003|FG003|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6260133|NCT01194219|7159004|FG004|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6260134|NCT01194219|7159005|FG005|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6260135|NCT01194219|7159006|FG006|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6260136|NCT01194219|7159007|FG007|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6260137|NCT01194219|7159008|FG008|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6260138|NCT01194219|7159009|FG009|Received Apremilast|Placebo-Controlled Phase Weeks 0-16||0
6260139|NCT01194219|7159000|FG000|COMPLETED|Placebo-Controlled Phase Weeks 0-16||503
6260140|NCT01194219|7159001|FG001|COMPLETED|Placebo-Controlled Phase Weeks 0-16||249
6260141|NCT01194219|7159002|FG002|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6700500|NCT02825550|7630920|FG000|NOT COMPLETED|Overall Study||1
6700501|NCT02825680|7630928|FG000|STARTED|Overall Study||82
6700502|NCT02825680|7630929|FG001|STARTED|Overall Study||55
6700503|NCT02825680|7630928|FG000|COMPLETED|Overall Study||82
6700504|NCT02825680|7630929|FG001|COMPLETED|Overall Study||39
6700505|NCT02825680|7630928|FG000|NOT COMPLETED|Overall Study||0
6700506|NCT02825680|7630929|FG001|NOT COMPLETED|Overall Study||16
6700507|NCT02825849|7630937|FG000|STARTED|Overall Study||22
6700508|NCT02825849|7630938|FG001|STARTED|Overall Study||5
6700509|NCT02825849|7630937|FG000|COMPLETED|Overall Study||22
6700510|NCT02825849|7630938|FG001|COMPLETED|Overall Study||5
6700511|NCT02825849|7630937|FG000|NOT COMPLETED|Overall Study||0
6700512|NCT02825849|7630938|FG001|NOT COMPLETED|Overall Study||0
6738933|NCT03286218|7667999|FG003|NOT COMPLETED|Treatment Phase Period 2||0
6738934|NCT03286218|7668000|FG004|NOT COMPLETED|Treatment Phase Period 2||0
6738935|NCT03286218|7668001|FG005|NOT COMPLETED|Treatment Phase Period 2||0
6738936|NCT03286218|7668002|FG006|NOT COMPLETED|Treatment Phase Period 2||0
6738937|NCT03286218|7668003|FG007|NOT COMPLETED|Treatment Phase Period 2||0
6738938|NCT03286218|7668004|FG008|NOT COMPLETED|Treatment Phase Period 2||0
6738939|NCT03286218|7668005|FG009|NOT COMPLETED|Treatment Phase Period 2||0
6738940|NCT03286218|7668006|FG010|NOT COMPLETED|Treatment Phase Period 2||0
6738941|NCT03286218|7668007|FG011|NOT COMPLETED|Treatment Phase Period 2||0
6738942|NCT03286218|7667996|FG000|STARTED|Treatment Phase Period 3||0
6738943|NCT03286218|7667997|FG001|STARTED|Treatment Phase Period 3||0
6738944|NCT03286218|7667998|FG002|STARTED|Treatment Phase Period 3||5
6738945|NCT03286218|7667999|FG003|STARTED|Treatment Phase Period 3||5
6738946|NCT03286218|7668000|FG004|STARTED|Treatment Phase Period 3||5
6738947|NCT03286218|7668001|FG005|STARTED|Treatment Phase Period 3||5
6738948|NCT03286218|7668002|FG006|STARTED|Treatment Phase Period 3||6
6738949|NCT03286218|7668003|FG007|STARTED|Treatment Phase Period 3||6
6738950|NCT03286218|7668004|FG008|STARTED|Treatment Phase Period 3||6
6738951|NCT03286218|7668005|FG009|STARTED|Treatment Phase Period 3||6
6738952|NCT03286218|7668006|FG010|STARTED|Treatment Phase Period 3||5
6738953|NCT03286218|7668007|FG011|STARTED|Treatment Phase Period 3||5
6738954|NCT03286218|7667996|FG000|COMPLETED|Treatment Phase Period 3||0
6738955|NCT03286218|7667997|FG001|COMPLETED|Treatment Phase Period 3||0
6738956|NCT03286218|7667998|FG002|COMPLETED|Treatment Phase Period 3||5
6738957|NCT03286218|7667999|FG003|COMPLETED|Treatment Phase Period 3||5
6738958|NCT03286218|7668000|FG004|COMPLETED|Treatment Phase Period 3||5
6738959|NCT03286218|7668001|FG005|COMPLETED|Treatment Phase Period 3||5
6738960|NCT03286218|7668002|FG006|COMPLETED|Treatment Phase Period 3||6
6738961|NCT03286218|7668003|FG007|COMPLETED|Treatment Phase Period 3||6
6738962|NCT03286218|7668004|FG008|COMPLETED|Treatment Phase Period 3||6
6738963|NCT03286218|7668005|FG009|COMPLETED|Treatment Phase Period 3||6
6738964|NCT03286218|7668006|FG010|COMPLETED|Treatment Phase Period 3||5
6738965|NCT03286218|7668007|FG011|COMPLETED|Treatment Phase Period 3||5
6738966|NCT03286218|7667996|FG000|NOT COMPLETED|Treatment Phase Period 3||0
6738967|NCT03286218|7667997|FG001|NOT COMPLETED|Treatment Phase Period 3||0
6738968|NCT03286218|7667998|FG002|NOT COMPLETED|Treatment Phase Period 3||0
6738969|NCT03286218|7667999|FG003|NOT COMPLETED|Treatment Phase Period 3||0
6738970|NCT03286218|7668000|FG004|NOT COMPLETED|Treatment Phase Period 3||0
6738971|NCT03286218|7668001|FG005|NOT COMPLETED|Treatment Phase Period 3||0
6738972|NCT03286218|7668002|FG006|NOT COMPLETED|Treatment Phase Period 3||0
6738973|NCT03286218|7668003|FG007|NOT COMPLETED|Treatment Phase Period 3||0
6738974|NCT03286218|7668004|FG008|NOT COMPLETED|Treatment Phase Period 3||0
6738975|NCT03286218|7668005|FG009|NOT COMPLETED|Treatment Phase Period 3||0
6738976|NCT03286218|7668006|FG010|NOT COMPLETED|Treatment Phase Period 3||0
6738977|NCT03286218|7668007|FG011|NOT COMPLETED|Treatment Phase Period 3||0
6738978|NCT03286218|7667996|FG000|STARTED|Treatment Phase Period 4||0
6738979|NCT03286218|7667997|FG001|STARTED|Treatment Phase Period 4||0
6738980|NCT03286218|7667998|FG002|STARTED|Treatment Phase Period 4||5
6738981|NCT03286218|7667999|FG003|STARTED|Treatment Phase Period 4||5
6738982|NCT03286218|7668000|FG004|STARTED|Treatment Phase Period 4||5
6738983|NCT03286218|7668001|FG005|STARTED|Treatment Phase Period 4||5
6738984|NCT03286218|7668002|FG006|STARTED|Treatment Phase Period 4||6
6738985|NCT03286218|7668003|FG007|STARTED|Treatment Phase Period 4||6
6738986|NCT03286218|7668004|FG008|STARTED|Treatment Phase Period 4||6
6738987|NCT03286218|7668005|FG009|STARTED|Treatment Phase Period 4||6
6738988|NCT03286218|7668006|FG010|STARTED|Treatment Phase Period 4||5
6738989|NCT03286218|7668007|FG011|STARTED|Treatment Phase Period 4||5
6738990|NCT03286218|7667996|FG000|COMPLETED|Treatment Phase Period 4||0
6738991|NCT03286218|7667997|FG001|COMPLETED|Treatment Phase Period 4||0
6738992|NCT03286218|7667998|FG002|COMPLETED|Treatment Phase Period 4||5
6738993|NCT03286218|7667999|FG003|COMPLETED|Treatment Phase Period 4||5
6738994|NCT03286218|7668000|FG004|COMPLETED|Treatment Phase Period 4||5
6738995|NCT03286218|7668001|FG005|COMPLETED|Treatment Phase Period 4||5
6738996|NCT03286218|7668002|FG006|COMPLETED|Treatment Phase Period 4||6
6738997|NCT03286218|7668003|FG007|COMPLETED|Treatment Phase Period 4||6
6738998|NCT03286218|7668004|FG008|COMPLETED|Treatment Phase Period 4||6
6738999|NCT03286218|7668005|FG009|COMPLETED|Treatment Phase Period 4||6
6739000|NCT03286218|7668006|FG010|COMPLETED|Treatment Phase Period 4||5
6739001|NCT03286218|7668007|FG011|COMPLETED|Treatment Phase Period 4||4
6739002|NCT03286218|7667996|FG000|NOT COMPLETED|Treatment Phase Period 4||0
6739003|NCT03286218|7667997|FG001|NOT COMPLETED|Treatment Phase Period 4||0
6739004|NCT03286218|7667998|FG002|NOT COMPLETED|Treatment Phase Period 4||0
6739005|NCT03286218|7667999|FG003|NOT COMPLETED|Treatment Phase Period 4||0
6739006|NCT03286218|7668000|FG004|NOT COMPLETED|Treatment Phase Period 4||0
6739007|NCT03286218|7668001|FG005|NOT COMPLETED|Treatment Phase Period 4||0
6739008|NCT03286218|7668002|FG006|NOT COMPLETED|Treatment Phase Period 4||0
6739009|NCT03286218|7668003|FG007|NOT COMPLETED|Treatment Phase Period 4||0
6700513|NCT02825966|7630944|FG000|STARTED|Overall Study||35
6700514|NCT02825966|7630944|FG000|COMPLETED|Overall Study||35
6700515|NCT02825966|7630944|FG000|NOT COMPLETED|Overall Study||0
6700516|NCT02825992|7630951|FG000|STARTED|Overall Study|The procedure was terminated for clinical reasons in 2 patients, therefore only 127 were treated.|129
6700517|NCT02825992|7630951|FG000|COMPLETED|Overall Study||121
6700518|NCT02825992|7630951|FG000|NOT COMPLETED|Overall Study||8
6700519|NCT02826421|7630965|FG000|STARTED|Overall Study||22
6700520|NCT02826421|7630966|FG001|STARTED|Overall Study||29
6700521|NCT02826421|7630967|FG002|STARTED|Overall Study||28
6700522|NCT02826421|7630968|FG003|STARTED|Overall Study||30
6700523|NCT02826421|7630965|FG000|Treated|Overall Study||19
6700524|NCT02826421|7630966|FG001|Treated|Overall Study||26
6700525|NCT02826421|7630967|FG002|Treated|Overall Study||26
6700526|NCT02826421|7630968|FG003|Treated|Overall Study||28
6700527|NCT02826421|7630965|FG000|COMPLETED|Overall Study||19
6700528|NCT02826421|7630966|FG001|COMPLETED|Overall Study||26
6700529|NCT02826421|7630967|FG002|COMPLETED|Overall Study||26
6700530|NCT02826421|7630968|FG003|COMPLETED|Overall Study||28
6700531|NCT02826421|7630965|FG000|NOT COMPLETED|Overall Study||3
6700532|NCT02826421|7630966|FG001|NOT COMPLETED|Overall Study||3
6700533|NCT02826421|7630967|FG002|NOT COMPLETED|Overall Study||2
6700534|NCT02826421|7630968|FG003|NOT COMPLETED|Overall Study||2
6700535|NCT02826603|7630981|FG000|STARTED|Overall Study||550
6700536|NCT02826603|7630982|FG001|STARTED|Overall Study||552
6700537|NCT02826603|7630981|FG000|COMPLETED|Overall Study||489
6700538|NCT02826603|7630982|FG001|COMPLETED|Overall Study||488
6700539|NCT02826603|7630981|FG000|NOT COMPLETED|Overall Study||61
6700540|NCT02826603|7630982|FG001|NOT COMPLETED|Overall Study||64
6700541|NCT02826694|7630991|FG000|STARTED|Overall Study||61
6700542|NCT02826694|7630992|FG001|STARTED|Overall Study||45
6700543|NCT02826694|7630991|FG000|Decision Group|Overall Study||41
6700544|NCT02826694|7630992|FG001|Decision Group|Overall Study||30
6700545|NCT02826694|7630991|FG000|Control Group|Overall Study||20
6700546|NCT02826694|7630992|FG001|Control Group|Overall Study||15
6700547|NCT02826694|7630991|FG000|COMPLETED|Overall Study||61
6700548|NCT02826694|7630992|FG001|COMPLETED|Overall Study||45
6700549|NCT02826694|7630991|FG000|NOT COMPLETED|Overall Study||0
6700550|NCT02826694|7630992|FG001|NOT COMPLETED|Overall Study||0
6700551|NCT02826798|7631005|FG000|STARTED|Overall Study||25
6700552|NCT02826798|7631006|FG001|STARTED|Overall Study||26
6700553|NCT02826798|7631007|FG002|STARTED|Overall Study||26
6700554|NCT02826798|7631008|FG003|STARTED|Overall Study||25
6700555|NCT02826798|7631009|FG004|STARTED|Overall Study||26
6700556|NCT02826798|7631005|FG000|COMPLETED|Overall Study||25
6700557|NCT02826798|7631006|FG001|COMPLETED|Overall Study||25
6700558|NCT02826798|7631007|FG002|COMPLETED|Overall Study||26
6700559|NCT02826798|7631008|FG003|COMPLETED|Overall Study||24
6700560|NCT02826798|7631009|FG004|COMPLETED|Overall Study||26
6700561|NCT02826798|7631005|FG000|NOT COMPLETED|Overall Study||0
6700562|NCT02826798|7631006|FG001|NOT COMPLETED|Overall Study||1
6700563|NCT02826798|7631007|FG002|NOT COMPLETED|Overall Study||0
6700564|NCT02826798|7631008|FG003|NOT COMPLETED|Overall Study||1
6700565|NCT02826798|7631009|FG004|NOT COMPLETED|Overall Study||0
6700566|NCT02827500|7631023|FG000|STARTED|Overall Study||52
6700567|NCT02827500|7631024|FG001|STARTED|Overall Study||52
6700568|NCT02827500|7631023|FG000|COMPLETED|Overall Study||33
6700569|NCT02827500|7631024|FG001|COMPLETED|Overall Study||45
6700570|NCT02827500|7631023|FG000|NOT COMPLETED|Overall Study||19
6700571|NCT02827500|7631024|FG001|NOT COMPLETED|Overall Study||7
6700572|NCT02827708|7631032|FG000|STARTED|Overall Study||163
6700573|NCT02827708|7631033|FG001|STARTED|Overall Study||161
6700574|NCT02827708|7631032|FG000|Full Analysis Set (FAS)|Overall Study||163
6700575|NCT02827708|7631033|FG001|Full Analysis Set (FAS)|Overall Study||161
6700576|NCT02827708|7631032|FG000|Safety Analysis Set (SAS)|Overall Study||163
6700577|NCT02827708|7631033|FG001|Safety Analysis Set (SAS)|Overall Study||161
6700578|NCT02827708|7631032|FG000|COMPLETED|Overall Study||158
6700579|NCT02827708|7631033|FG001|COMPLETED|Overall Study||156
6700580|NCT02827708|7631032|FG000|NOT COMPLETED|Overall Study||5
6700581|NCT02827708|7631033|FG001|NOT COMPLETED|Overall Study||5
6700582|NCT02828020|7631042|FG000|STARTED|Treatment Period||559
6700583|NCT02828020|7631043|FG001|STARTED|Treatment Period||556
6700584|NCT02828020|7631044|FG002|STARTED|Treatment Period||557
6700585|NCT02828020|7631042|FG000|Safety Population: Received Study Drug|Treatment Period||485
6700586|NCT02828020|7631043|FG001|Safety Population: Received Study Drug|Treatment Period||466
6700587|NCT02828020|7631044|FG002|Safety Population: Received Study Drug|Treatment Period||485
6700588|NCT02828020|7631042|FG000|COMPLETED|Treatment Period||479
6700589|NCT02828020|7631043|FG001|COMPLETED|Treatment Period||457
6700590|NCT02828020|7631044|FG002|COMPLETED|Treatment Period||479
6700591|NCT02828020|7631042|FG000|NOT COMPLETED|Treatment Period||80
6700592|NCT02828020|7631043|FG001|NOT COMPLETED|Treatment Period||99
6700593|NCT02828020|7631044|FG002|NOT COMPLETED|Treatment Period||78
6700594|NCT02828020|7631042|FG000|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
6700595|NCT02828020|7631043|FG001|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|458
6700596|NCT02828020|7631044|FG002|STARTED|Safety Follow-up Period|1 participant who did not complete the Treatment Period, was counted in the Safety Follow-up Period.|480
6700597|NCT02828020|7631042|FG000|COMPLETED|Safety Follow-up Period||460
6700598|NCT02828020|7631043|FG001|COMPLETED|Safety Follow-up Period||440
6700599|NCT02828020|7631044|FG002|COMPLETED|Safety Follow-up Period||461
6700600|NCT02828020|7631042|FG000|NOT COMPLETED|Safety Follow-up Period||20
6700601|NCT02828020|7631043|FG001|NOT COMPLETED|Safety Follow-up Period||18
6700602|NCT02828020|7631044|FG002|NOT COMPLETED|Safety Follow-up Period||19
6700603|NCT02828111|7631057|FG000|STARTED|Overall Study||6
6700604|NCT02828111|7631058|FG001|STARTED|Overall Study||6
6700605|NCT02828111|7631059|FG002|STARTED|Overall Study||6
6700606|NCT02828111|7631060|FG003|STARTED|Overall Study||6
6700607|NCT02828111|7631061|FG004|STARTED|Overall Study||12
6700608|NCT02828111|7631057|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6700609|NCT02828111|7631058|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6700610|NCT02828111|7631059|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6700611|NCT02828111|7631060|FG003|Received at Least 1 Dose of Study Drug|Overall Study||6
6700612|NCT02828111|7631061|FG004|Received at Least 1 Dose of Study Drug|Overall Study||12
6700613|NCT02828111|7631057|FG000|COMPLETED|Overall Study||6
6700614|NCT02828111|7631058|FG001|COMPLETED|Overall Study||6
6700615|NCT02828111|7631059|FG002|COMPLETED|Overall Study||4
6700616|NCT02828111|7631060|FG003|COMPLETED|Overall Study||5
6700617|NCT02828111|7631061|FG004|COMPLETED|Overall Study||11
6700618|NCT02828111|7631057|FG000|NOT COMPLETED|Overall Study||0
6700619|NCT02828111|7631058|FG001|NOT COMPLETED|Overall Study||0
6700620|NCT02828111|7631059|FG002|NOT COMPLETED|Overall Study||2
6700621|NCT02828111|7631060|FG003|NOT COMPLETED|Overall Study||1
6700622|NCT02828111|7631061|FG004|NOT COMPLETED|Overall Study||1
6700623|NCT02828137|7631085|FG000|STARTED|Overall Study||41
6700624|NCT02828137|7631086|FG001|STARTED|Overall Study||41
6700625|NCT02828137|7631087|FG002|STARTED|Overall Study||41
6700626|NCT02828137|7631085|FG000|COMPLETED|Overall Study||41
6700627|NCT02828137|7631086|FG001|COMPLETED|Overall Study||41
6700628|NCT02828137|7631087|FG002|COMPLETED|Overall Study||41
6700629|NCT02828137|7631085|FG000|NOT COMPLETED|Overall Study||0
6700630|NCT02828137|7631086|FG001|NOT COMPLETED|Overall Study||0
6700631|NCT02828137|7631087|FG002|NOT COMPLETED|Overall Study||0
6700632|NCT02828241|7631097|FG000|STARTED|Overall Study||38
6700633|NCT02828241|7631098|FG001|STARTED|Overall Study||23
6700634|NCT02828241|7631097|FG000|COMPLETED|Overall Study||30
6700635|NCT02828241|7631098|FG001|COMPLETED|Overall Study||21
6700636|NCT02828241|7631097|FG000|NOT COMPLETED|Overall Study||8
6700637|NCT02828241|7631098|FG001|NOT COMPLETED|Overall Study||2
6700638|NCT02828267|7631109|FG000|STARTED|Overall Study||10
6700639|NCT02828267|7631110|FG001|STARTED|Overall Study||21
6700640|NCT02828267|7631111|FG002|STARTED|Overall Study||24
6700641|NCT02828267|7631112|FG003|STARTED|Overall Study||20
6700642|NCT02828267|7631109|FG000|COMPLETED|Overall Study||10
6700643|NCT02828267|7631110|FG001|COMPLETED|Overall Study||21
6700644|NCT02828267|7631111|FG002|COMPLETED|Overall Study||24
6700645|NCT02828267|7631112|FG003|COMPLETED|Overall Study||20
6700646|NCT02828267|7631109|FG000|NOT COMPLETED|Overall Study||0
6700647|NCT02828267|7631110|FG001|NOT COMPLETED|Overall Study||0
6700648|NCT02828267|7631111|FG002|NOT COMPLETED|Overall Study||0
6700649|NCT02828267|7631112|FG003|NOT COMPLETED|Overall Study||0
6700650|NCT02828358|7631126|FG000|STARTED|Overall Study||56
6700651|NCT02828358|7631127|FG001|STARTED|Overall Study||22
6700652|NCT02828358|7631126|FG000|COMPLETED|Overall Study||11
6700653|NCT02828358|7631127|FG001|COMPLETED|Overall Study||0
6700654|NCT02828358|7631126|FG000|NOT COMPLETED|Overall Study||45
6700655|NCT02828358|7631127|FG001|NOT COMPLETED|Overall Study||22
6700656|NCT02828436|7631132|FG000|STARTED|Period 1||0
6700657|NCT02828436|7631133|FG001|STARTED|Period 1||9
6700658|NCT02828436|7631132|FG000|COMPLETED|Period 1||0
6700659|NCT02828436|7631133|FG001|COMPLETED|Period 1||5
6700660|NCT02828436|7631132|FG000|NOT COMPLETED|Period 1||0
6700661|NCT02828436|7631133|FG001|NOT COMPLETED|Period 1||4
6700662|NCT02828436|7631132|FG000|STARTED|Period 2||9
6700663|NCT02828436|7631133|FG001|STARTED|Period 2||0
6700664|NCT02828436|7631132|FG000|COMPLETED|Period 2||1
6700665|NCT02828436|7631133|FG001|COMPLETED|Period 2||0
6700666|NCT02828436|7631132|FG000|NOT COMPLETED|Period 2||8
6700667|NCT02828436|7631133|FG001|NOT COMPLETED|Period 2||0
6700668|NCT02828644|7631141|FG000|STARTED|Overall Study||88
6700669|NCT02828644|7631142|FG001|STARTED|Overall Study||87
6700670|NCT02828644|7631141|FG000|COMPLETED|Overall Study||65
6700671|NCT02828644|7631142|FG001|COMPLETED|Overall Study||65
6700672|NCT02828644|7631141|FG000|NOT COMPLETED|Overall Study||23
6700673|NCT02828644|7631142|FG001|NOT COMPLETED|Overall Study||22
6700674|NCT02829034|7631151|FG000|STARTED|Overall Study||14
6700675|NCT02829034|7631152|FG001|STARTED|Overall Study||8
6700676|NCT02829034|7631151|FG000|COMPLETED|Overall Study||9
6700677|NCT02829034|7631152|FG001|COMPLETED|Overall Study||6
6700678|NCT02829034|7631151|FG000|NOT COMPLETED|Overall Study||5
6700679|NCT02829034|7631152|FG001|NOT COMPLETED|Overall Study||2
6700680|NCT02829138|7631160|FG000|STARTED|Overall Study||29
6700681|NCT02829138|7631161|FG001|STARTED|Overall Study||28
6700682|NCT02829138|7631160|FG000|COMPLETED|Overall Study||28
6700683|NCT02829138|7631161|FG001|COMPLETED|Overall Study||28
6700684|NCT02829138|7631160|FG000|NOT COMPLETED|Overall Study||1
6700685|NCT02829138|7631161|FG001|NOT COMPLETED|Overall Study||0
6700686|NCT02829294|7631167|FG000|STARTED|Overall Study||19
6700687|NCT02829294|7631167|FG000|COMPLETED|Overall Study||19
6700688|NCT02829294|7631167|FG000|NOT COMPLETED|Overall Study||0
6700689|NCT02829307|7631173|FG000|STARTED|Overall Study||8
6700690|NCT02829307|7631173|FG000|COMPLETED|Overall Study||8
6700691|NCT02829307|7631173|FG000|NOT COMPLETED|Overall Study||0
6700692|NCT02829320|7631177|FG000|STARTED|Overall Study||28
6700693|NCT02829320|7631177|FG000|COMPLETED|Overall Study||28
6700694|NCT02829320|7631177|FG000|NOT COMPLETED|Overall Study||0
6700695|NCT02829463|7631190|FG000|STARTED|Overall Study||59
6700696|NCT02829463|7631191|FG001|STARTED|Overall Study||62
6700697|NCT02829463|7631190|FG000|COMPLETED|Overall Study||59
6700698|NCT02829463|7631191|FG001|COMPLETED|Overall Study||62
6700699|NCT02829463|7631190|FG000|NOT COMPLETED|Overall Study||0
6700700|NCT02829463|7631191|FG001|NOT COMPLETED|Overall Study||0
6700701|NCT02829775|7631197|FG000|STARTED|Overall Study||9
6700702|NCT02829775|7631197|FG000|COMPLETED|Overall Study||4
6700703|NCT02829775|7631197|FG000|NOT COMPLETED|Overall Study||5
6700704|NCT02829944|7631204|FG000|STARTED|Overall Study||44
6700705|NCT02829944|7631205|FG001|STARTED|Overall Study||40
6700706|NCT02829944|7631204|FG000|COMPLETED|Overall Study||38
6700707|NCT02829944|7631205|FG001|COMPLETED|Overall Study||33
6700708|NCT02829944|7631204|FG000|NOT COMPLETED|Overall Study||6
6700709|NCT02829944|7631205|FG001|NOT COMPLETED|Overall Study||7
6700710|NCT02829983|7631213|FG000|STARTED|Overall Study||20
6700711|NCT02829983|7631214|FG001|STARTED|Overall Study||20
6700712|NCT02829983|7631213|FG000|COMPLETED|Overall Study||20
6700713|NCT02829983|7631214|FG001|COMPLETED|Overall Study||20
6700714|NCT02829983|7631213|FG000|NOT COMPLETED|Overall Study||0
6700715|NCT02829983|7631214|FG001|NOT COMPLETED|Overall Study||0
6700716|NCT02829996|7631225|FG000|STARTED|Overall Study||39
6700717|NCT02829996|7631226|FG001|STARTED|Overall Study||39
6700718|NCT02829996|7631227|FG002|STARTED|Overall Study||40
6700719|NCT02829996|7631228|FG003|STARTED|Overall Study||41
6700720|NCT02829996|7631229|FG004|STARTED|Overall Study||42
6700721|NCT02829996|7631225|FG000|COMPLETED|Overall Study||38
6700722|NCT02829996|7631226|FG001|COMPLETED|Overall Study||39
6700723|NCT02829996|7631227|FG002|COMPLETED|Overall Study||40
6700724|NCT02829996|7631228|FG003|COMPLETED|Overall Study||41
6700725|NCT02829996|7631229|FG004|COMPLETED|Overall Study||42
6700726|NCT02829996|7631225|FG000|NOT COMPLETED|Overall Study||1
6700727|NCT02829996|7631226|FG001|NOT COMPLETED|Overall Study||0
6700728|NCT02829996|7631227|FG002|NOT COMPLETED|Overall Study||0
6700729|NCT02829996|7631228|FG003|NOT COMPLETED|Overall Study||0
6700730|NCT02829996|7631229|FG004|NOT COMPLETED|Overall Study||0
6700731|NCT02830074|7631243|FG000|STARTED|Overall Study||32
6700732|NCT02830074|7631244|FG001|STARTED|Overall Study||31
6700733|NCT02830074|7631243|FG000|COMPLETED|Overall Study||32
6700734|NCT02830074|7631244|FG001|COMPLETED|Overall Study||31
6700735|NCT02830074|7631243|FG000|NOT COMPLETED|Overall Study||0
6700736|NCT02830074|7631244|FG001|NOT COMPLETED|Overall Study||0
6700737|NCT02830087|7631257|FG000|STARTED|Overall Study||4
6700738|NCT02830087|7631258|FG001|STARTED|Overall Study||4
6700739|NCT02830087|7631259|FG002|STARTED|Overall Study||4
6700740|NCT02830087|7631260|FG003|STARTED|Overall Study||3
6700741|NCT02830087|7631261|FG004|STARTED|Overall Study||3
6700742|NCT02830087|7631262|FG005|STARTED|Overall Study||3
6700743|NCT02830087|7631257|FG000|COMPLETED|Overall Study||0
6700744|NCT02830087|7631258|FG001|COMPLETED|Overall Study||0
6700745|NCT02830087|7631259|FG002|COMPLETED|Overall Study||0
6700746|NCT02830087|7631260|FG003|COMPLETED|Overall Study||0
6700747|NCT02830087|7631261|FG004|COMPLETED|Overall Study||0
6700748|NCT02830087|7631262|FG005|COMPLETED|Overall Study||0
6700749|NCT02830087|7631257|FG000|NOT COMPLETED|Overall Study||4
6700750|NCT02830087|7631258|FG001|NOT COMPLETED|Overall Study||4
6700751|NCT02830087|7631259|FG002|NOT COMPLETED|Overall Study||4
6700752|NCT02830087|7631260|FG003|NOT COMPLETED|Overall Study||3
6700753|NCT02830087|7631261|FG004|NOT COMPLETED|Overall Study||3
6700754|NCT02830087|7631262|FG005|NOT COMPLETED|Overall Study||3
6700755|NCT02830438|7631276|FG000|STARTED|Overall Study||8
6700756|NCT02830438|7631276|FG000|COMPLETED|Overall Study||8
6700757|NCT02830438|7631276|FG000|NOT COMPLETED|Overall Study||0
6700758|NCT02830776|7631280|FG000|STARTED|Overall Study||15
6700759|NCT02830776|7631280|FG000|COMPLETED|Overall Study||14
6700760|NCT02830776|7631280|FG000|NOT COMPLETED|Overall Study||1
6700761|NCT02830880|7631285|FG000|STARTED|Overall Study||7
6700762|NCT02830880|7631285|FG000|Completed Visit After Cyle 1|Overall Study||7
6700763|NCT02830880|7631285|FG000|COMPLETED|Overall Study||4
6700764|NCT02830880|7631285|FG000|NOT COMPLETED|Overall Study||3
6700765|NCT02830893|7631291|FG000|STARTED|Overall Study||12
6700766|NCT02830893|7631292|FG001|STARTED|Overall Study||11
6700767|NCT02830893|7631291|FG000|COMPLETED|Overall Study||11
6700768|NCT02830893|7631292|FG001|COMPLETED|Overall Study||8
6700769|NCT02830893|7631291|FG000|NOT COMPLETED|Overall Study||1
6700770|NCT02830893|7631292|FG001|NOT COMPLETED|Overall Study||3
6700771|NCT02831257|7631298|FG000|STARTED|Overall Study||18
6700772|NCT02831257|7631298|FG000|COMPLETED|Overall Study||6
6700773|NCT02831257|7631298|FG000|NOT COMPLETED|Overall Study||12
6700774|NCT02831387|7631304|FG000|STARTED|Overall Study||23
6700775|NCT02831387|7631305|FG001|STARTED|Overall Study||24
6700776|NCT02831387|7631304|FG000|COMPLETED|Overall Study||22
6700777|NCT02831387|7631305|FG001|COMPLETED|Overall Study||22
6700778|NCT02831387|7631304|FG000|NOT COMPLETED|Overall Study||1
6700779|NCT02831387|7631305|FG001|NOT COMPLETED|Overall Study||2
6700780|NCT02831569|7631311|FG000|STARTED|Overall Study||80
6700781|NCT02831569|7631311|FG000|COMPLETED|Overall Study||80
6700782|NCT02831569|7631311|FG000|NOT COMPLETED|Overall Study||0
6700783|NCT02831660|7631315|FG000|STARTED|Overall Study||1
6700784|NCT02831660|7631315|FG000|COMPLETED|Overall Study||1
6700785|NCT02831660|7631315|FG000|NOT COMPLETED|Overall Study||0
6700786|NCT02831816|7631319|FG000|STARTED|Overall Study||640
6700787|NCT02831816|7631319|FG000|ZP|Overall Study||589
6700788|NCT02831816|7631319|FG000|CP|Overall Study||590
6700789|NCT02831816|7631319|FG000|Vehicle|Overall Study||131
6700790|NCT02831816|7631319|FG000|COMPLETED|Overall Study||640
6700791|NCT02831816|7631319|FG000|NOT COMPLETED|Overall Study||0
6700792|NCT02831855|7631330|FG000|STARTED|Open Label Phase (24 Weeks)||694
6700793|NCT02831855|7631331|FG001|STARTED|Open Label Phase (24 Weeks)||0
6700794|NCT02831855|7631332|FG002|STARTED|Open Label Phase (24 Weeks)||0
6700795|NCT02831855|7631330|FG000|COMPLETED|Open Label Phase (24 Weeks)||623
6700796|NCT02831855|7631331|FG001|COMPLETED|Open Label Phase (24 Weeks)||0
6700797|NCT02831855|7631332|FG002|COMPLETED|Open Label Phase (24 Weeks)||0
6700798|NCT02831855|7631330|FG000|NOT COMPLETED|Open Label Phase (24 Weeks)||71
6700799|NCT02831855|7631331|FG001|NOT COMPLETED|Open Label Phase (24 Weeks)||0
6700800|NCT02831855|7631332|FG002|NOT COMPLETED|Open Label Phase (24 Weeks)||0
6700801|NCT02831855|7631330|FG000|STARTED|Double Blind Phase (24 Weeks)||0
6700802|NCT02831855|7631331|FG001|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase.|267
6700803|NCT02831855|7631332|FG002|STARTED|Double Blind Phase (24 Weeks)|Only eligible participants from open label phase, were randomized into double blind phase. .|266
6700804|NCT02831855|7631330|FG000|Treated|Double Blind Phase (24 Weeks)||0
6700805|NCT02831855|7631331|FG001|Treated|Double Blind Phase (24 Weeks)||264
6700806|NCT02831855|7631332|FG002|Treated|Double Blind Phase (24 Weeks)||266
6700807|NCT02831855|7631330|FG000|COMPLETED|Double Blind Phase (24 Weeks)||0
6700808|NCT02831855|7631331|FG001|COMPLETED|Double Blind Phase (24 Weeks)||238
6700809|NCT02831855|7631332|FG002|COMPLETED|Double Blind Phase (24 Weeks)||247
6700810|NCT02831855|7631330|FG000|NOT COMPLETED|Double Blind Phase (24 Weeks)||0
6700811|NCT02831855|7631331|FG001|NOT COMPLETED|Double Blind Phase (24 Weeks)||29
6700812|NCT02831855|7631332|FG002|NOT COMPLETED|Double Blind Phase (24 Weeks)||19
6700813|NCT02831998|7631342|FG000|STARTED|Overall Study||440
6700814|NCT02831998|7631342|FG000|ZP|Overall Study||400
6700815|NCT02831998|7631342|FG000|CP|Overall Study||400
6700816|NCT02831998|7631342|FG000|Vehicle|Overall Study||80
6700817|NCT02831998|7631342|FG000|COMPLETED|Overall Study||440
6700818|NCT02831998|7631342|FG000|NOT COMPLETED|Overall Study||0
6700819|NCT02832037|7631358|FG000|STARTED|Overall Study||85
6700820|NCT02832037|7631359|FG001|STARTED|Overall Study||84
6700821|NCT02832037|7631360|FG002|STARTED|Overall Study||85
6700822|NCT02832037|7631361|FG003|STARTED|Overall Study||85
6700823|NCT02832037|7631362|FG004|STARTED|Overall Study||170
6700824|NCT02832037|7631358|FG000|COMPLETED|Overall Study||66
6700825|NCT02832037|7631359|FG001|COMPLETED|Overall Study||72
6700826|NCT02832037|7631360|FG002|COMPLETED|Overall Study||77
6700827|NCT02832037|7631361|FG003|COMPLETED|Overall Study||78
6700828|NCT02832037|7631362|FG004|COMPLETED|Overall Study||151
6700829|NCT02832037|7631358|FG000|NOT COMPLETED|Overall Study||19
6700830|NCT02832037|7631359|FG001|NOT COMPLETED|Overall Study||12
6700831|NCT02832037|7631360|FG002|NOT COMPLETED|Overall Study||8
6700832|NCT02832037|7631361|FG003|NOT COMPLETED|Overall Study||7
6700833|NCT02832037|7631362|FG004|NOT COMPLETED|Overall Study||19
6700834|NCT02832115|7631376|FG000|STARTED|Overall Study||48
6700835|NCT02832115|7631377|FG001|STARTED|Overall Study||52
6700836|NCT02832115|7631376|FG000|COMPLETED|Overall Study||48
6700837|NCT02832115|7631377|FG001|COMPLETED|Overall Study||52
6700838|NCT02832115|7631376|FG000|NOT COMPLETED|Overall Study||0
6700839|NCT02832115|7631377|FG001|NOT COMPLETED|Overall Study||0
6700840|NCT02832154|7631383|FG000|STARTED|Overall Study||43
6700841|NCT02832154|7631383|FG000|COMPLETED|Overall Study||43
6700842|NCT02832154|7631383|FG000|NOT COMPLETED|Overall Study||0
6700843|NCT02832284|7631387|FG000|STARTED|Overall Study||23
6700844|NCT02832284|7631387|FG000|COMPLETED|Overall Study||23
6700845|NCT02832284|7631387|FG000|NOT COMPLETED|Overall Study||0
6700846|NCT02832375|7631393|FG000|STARTED|Overall Study||121
6700847|NCT02832375|7631394|FG001|STARTED|Overall Study||121
6700848|NCT02832375|7631393|FG000|COMPLETED|Overall Study||119
6700849|NCT02832375|7631394|FG001|COMPLETED|Overall Study||121
6700850|NCT02832375|7631393|FG000|NOT COMPLETED|Overall Study||2
6700851|NCT02832375|7631394|FG001|NOT COMPLETED|Overall Study||0
6700852|NCT02832622|7631401|FG000|STARTED|Overall Study||2169
6700853|NCT02832622|7631401|FG000|COMPLETED|Overall Study||433
6700854|NCT02832622|7631401|FG000|NOT COMPLETED|Overall Study||1736
6700855|NCT02832674|7631406|FG000|STARTED|Overall Study||72
6700856|NCT02832674|7631406|FG000|COMPLETED|Overall Study||67
6700857|NCT02832674|7631406|FG000|NOT COMPLETED|Overall Study||5
6700858|NCT02833077|7631412|FG000|STARTED|Overall Study||144
6700859|NCT02833077|7631413|FG001|STARTED|Overall Study||48
6700860|NCT02833077|7631412|FG000|Participants Treated|Overall Study||144
6700861|NCT02833077|7631413|FG001|Participants Treated|Overall Study||38
6700862|NCT02833077|7631412|FG000|COMPLETED|Overall Study||127
6700863|NCT02833077|7631413|FG001|COMPLETED|Overall Study|Includes participants who completed the study but did not receive the optional treatment.|40
6700864|NCT02833077|7631412|FG000|NOT COMPLETED|Overall Study||17
6700865|NCT02833077|7631413|FG001|NOT COMPLETED|Overall Study||8
6700866|NCT02833337|7631420|FG000|STARTED|Overall Study||180
6700867|NCT02833337|7631420|FG000|COMPLETED|Overall Study||180
6700868|NCT02833337|7631420|FG000|NOT COMPLETED|Overall Study||0
6700869|NCT02833350|7631431|FG000|STARTED|Overall Study||40
6700870|NCT02833350|7631432|FG001|STARTED|Overall Study||109
6700871|NCT02833350|7631433|FG002|STARTED|Overall Study||110
6700872|NCT02833350|7631434|FG003|STARTED|Overall Study||110
6700873|NCT02833350|7631435|FG004|STARTED|Overall Study||111
6700874|NCT02833350|7631436|FG005|STARTED|Overall Study||49
6700875|NCT02833350|7631437|FG006|STARTED|Overall Study||49
6700876|NCT02833350|7631431|FG000|Randomized|Overall Study||40
6700877|NCT02833350|7631432|FG001|Randomized|Overall Study||109
6700878|NCT02833350|7631433|FG002|Randomized|Overall Study||110
6700879|NCT02833350|7631434|FG003|Randomized|Overall Study||110
6700880|NCT02833350|7631435|FG004|Randomized|Overall Study||111
6700881|NCT02833350|7631436|FG005|Randomized|Overall Study||48
6700882|NCT02833350|7631437|FG006|Randomized|Overall Study||50
6700883|NCT02833350|7631431|FG000|COMPLETED|Overall Study||37
6700884|NCT02833350|7631432|FG001|COMPLETED|Overall Study||100
6700885|NCT02833350|7631433|FG002|COMPLETED|Overall Study||102
6700886|NCT02833350|7631434|FG003|COMPLETED|Overall Study||102
6700887|NCT02833350|7631435|FG004|COMPLETED|Overall Study||108
6700888|NCT02833350|7631436|FG005|COMPLETED|Overall Study||48
6700889|NCT02833350|7631437|FG006|COMPLETED|Overall Study||44
6700890|NCT02833350|7631431|FG000|NOT COMPLETED|Overall Study||3
6700891|NCT02833350|7631432|FG001|NOT COMPLETED|Overall Study||9
6700892|NCT02833350|7631433|FG002|NOT COMPLETED|Overall Study||8
6700893|NCT02833350|7631434|FG003|NOT COMPLETED|Overall Study||8
6700894|NCT02833350|7631435|FG004|NOT COMPLETED|Overall Study||3
6700895|NCT02833350|7631436|FG005|NOT COMPLETED|Overall Study||1
6700896|NCT02833350|7631437|FG006|NOT COMPLETED|Overall Study||5
6700897|NCT02833415|7631458|FG000|STARTED|Overall Study||20
6700898|NCT02833415|7631459|FG001|STARTED|Overall Study||20
6700899|NCT02833415|7631458|FG000|COMPLETED|Overall Study||18
6700900|NCT02833415|7631459|FG001|COMPLETED|Overall Study||17
6700901|NCT02833415|7631458|FG000|NOT COMPLETED|Overall Study||2
6700902|NCT02833415|7631459|FG001|NOT COMPLETED|Overall Study||3
6700903|NCT02833844|7631467|FG000|STARTED|Double-Blind Period||157
6700904|NCT02833844|7631468|FG001|STARTED|Double-Blind Period||310
6700905|NCT02833844|7631467|FG000|Randomized and Treated|Double-Blind Period||157
6700906|NCT02833844|7631468|FG001|Randomized and Treated|Double-Blind Period||307
6700907|NCT02833844|7631467|FG000|COMPLETED|Double-Blind Period|completed double-blind period|155
6700908|NCT02833844|7631468|FG001|COMPLETED|Double-Blind Period|completed double-blind period|303
6700909|NCT02833844|7631467|FG000|NOT COMPLETED|Double-Blind Period||2
6700910|NCT02833844|7631468|FG001|NOT COMPLETED|Double-Blind Period||7
6700911|NCT02833844|7631467|FG000|STARTED|Open-Label Period|3 participants did not continue to open-label period|152
6700912|NCT02833844|7631468|FG001|STARTED|Open-Label Period||303
6700913|NCT02833844|7631467|FG000|Received Open-Label Study Drug|Open-Label Period||152
6700914|NCT02833844|7631468|FG001|Received Open-Label Study Drug|Open-Label Period||299
6700915|NCT02833844|7631467|FG000|COMPLETED|Open-Label Period||150
6700916|NCT02833844|7631468|FG001|COMPLETED|Open-Label Period||301
6700917|NCT02833844|7631467|FG000|NOT COMPLETED|Open-Label Period||2
6700918|NCT02833844|7631468|FG001|NOT COMPLETED|Open-Label Period||2
6700919|NCT02833857|7631476|FG000|STARTED|Overall Study||11
6700920|NCT02833857|7631476|FG000|COMPLETED|Overall Study||11
6700921|NCT02833857|7631476|FG000|NOT COMPLETED|Overall Study||0
6700922|NCT02833922|7631480|FG000|STARTED|Overall Study||718
6700923|NCT02833922|7631480|FG000|COMPLETED|Overall Study||336
6700924|NCT02833922|7631480|FG000|NOT COMPLETED|Overall Study||382
6700925|NCT02833948|7631486|FG000|STARTED|Overall Study||116
6700926|NCT02833948|7631487|FG001|STARTED|Overall Study||115
6260142|NCT01194219|7159003|FG003|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260143|NCT01194219|7159004|FG004|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260144|NCT01194219|7159005|FG005|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260145|NCT01194219|7159006|FG006|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260146|NCT01194219|7159007|FG007|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260147|NCT01194219|7159008|FG008|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260148|NCT01194219|7159009|FG009|COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260149|NCT01194219|7159000|FG000|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||59
6260150|NCT01194219|7159001|FG001|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||33
6260151|NCT01194219|7159002|FG002|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260152|NCT01194219|7159003|FG003|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260153|NCT01194219|7159004|FG004|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260154|NCT01194219|7159005|FG005|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260155|NCT01194219|7159006|FG006|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260156|NCT01194219|7159007|FG007|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260157|NCT01194219|7159008|FG008|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260158|NCT01194219|7159009|FG009|NOT COMPLETED|Placebo-Controlled Phase Weeks 0-16||0
6260159|NCT01194219|7159000|FG000|STARTED|Maintenance Phase Weeks16-32||0
6260160|NCT01194219|7159001|FG001|STARTED|Maintenance Phase Weeks16-32||0
6260161|NCT01194219|7159002|FG002|STARTED|Maintenance Phase Weeks16-32|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
6260162|NCT01194219|7159003|FG003|STARTED|Maintenance Phase Weeks16-32|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
6260163|NCT01194219|7159004|FG004|STARTED|Maintenance Phase Weeks16-32||0
6700927|NCT02833948|7631486|FG000|COMPLETED|Overall Study||101
6700928|NCT02833948|7631487|FG001|COMPLETED|Overall Study||97
6700929|NCT02833948|7631486|FG000|NOT COMPLETED|Overall Study||15
6700930|NCT02833948|7631487|FG001|NOT COMPLETED|Overall Study||18
6700931|NCT02833974|7631499|FG000|STARTED|Overall Study||14
6700932|NCT02833974|7631500|FG001|STARTED|Overall Study||22
6700933|NCT02833974|7631499|FG000|COMPLETED|Overall Study||13
6700934|NCT02833974|7631500|FG001|COMPLETED|Overall Study||19
6700935|NCT02833974|7631499|FG000|NOT COMPLETED|Overall Study||1
6700936|NCT02833974|7631500|FG001|NOT COMPLETED|Overall Study||3
6700937|NCT02834247|7631510|FG000|STARTED|Dose Escalation Phase||8
6700938|NCT02834247|7631511|FG001|STARTED|Dose Escalation Phase||11
6700939|NCT02834247|7631512|FG002|STARTED|Dose Escalation Phase||5
6700940|NCT02834247|7631513|FG003|STARTED|Dose Escalation Phase||0
6700941|NCT02834247|7631510|FG000|COMPLETED|Dose Escalation Phase||0
6700942|NCT02834247|7631511|FG001|COMPLETED|Dose Escalation Phase||0
6700943|NCT02834247|7631512|FG002|COMPLETED|Dose Escalation Phase||0
6700944|NCT02834247|7631513|FG003|COMPLETED|Dose Escalation Phase||0
6700945|NCT02834247|7631510|FG000|NOT COMPLETED|Dose Escalation Phase||8
6700946|NCT02834247|7631511|FG001|NOT COMPLETED|Dose Escalation Phase||11
6700947|NCT02834247|7631512|FG002|NOT COMPLETED|Dose Escalation Phase||5
6700948|NCT02834247|7631513|FG003|NOT COMPLETED|Dose Escalation Phase||0
6700949|NCT02834247|7631510|FG000|STARTED|Dose Expansion Phase||0
6700950|NCT02834247|7631511|FG001|STARTED|Dose Expansion Phase||0
6700951|NCT02834247|7631512|FG002|STARTED|Dose Expansion Phase||0
6700952|NCT02834247|7631513|FG003|STARTED|Dose Expansion Phase||17
6700953|NCT02834247|7631510|FG000|COMPLETED|Dose Expansion Phase||0
6700954|NCT02834247|7631511|FG001|COMPLETED|Dose Expansion Phase||0
6700955|NCT02834247|7631512|FG002|COMPLETED|Dose Expansion Phase||0
6700956|NCT02834247|7631513|FG003|COMPLETED|Dose Expansion Phase||0
6700957|NCT02834247|7631510|FG000|NOT COMPLETED|Dose Expansion Phase||0
6700958|NCT02834247|7631511|FG001|NOT COMPLETED|Dose Expansion Phase||0
6700959|NCT02834247|7631512|FG002|NOT COMPLETED|Dose Expansion Phase||0
6700960|NCT02834247|7631513|FG003|NOT COMPLETED|Dose Expansion Phase||17
6700961|NCT02834390|7631527|FG000|STARTED|Induction Phase||4
6700962|NCT02834390|7631528|FG001|STARTED|Induction Phase||3
6700963|NCT02834390|7631527|FG000|COMPLETED|Induction Phase||2
6700964|NCT02834390|7631528|FG001|COMPLETED|Induction Phase||1
6700965|NCT02834390|7631527|FG000|NOT COMPLETED|Induction Phase||2
6700966|NCT02834390|7631528|FG001|NOT COMPLETED|Induction Phase||2
6700967|NCT02834390|7631527|FG000|STARTED|Consolidation Phase||2
6700968|NCT02834390|7631528|FG001|STARTED|Consolidation Phase||1
6700969|NCT02834390|7631527|FG000|COMPLETED|Consolidation Phase||1
6700970|NCT02834390|7631528|FG001|COMPLETED|Consolidation Phase||0
6700971|NCT02834390|7631527|FG000|NOT COMPLETED|Consolidation Phase||1
6700972|NCT02834390|7631528|FG001|NOT COMPLETED|Consolidation Phase||1
6700973|NCT02834624|7631536|FG000|STARTED|Overall Study||15
6700974|NCT02834624|7631537|FG001|STARTED|Overall Study||15
6700975|NCT02834624|7631536|FG000|COMPLETED|Overall Study||15
6700976|NCT02834624|7631537|FG001|COMPLETED|Overall Study||15
6700977|NCT02834624|7631536|FG000|NOT COMPLETED|Overall Study||0
6700978|NCT02834624|7631537|FG001|NOT COMPLETED|Overall Study||0
6700979|NCT02834663|7631544|FG000|STARTED|Overall Study|Unit means the eye. One eye was included per patient|25
6700980|NCT02834663|7631544|FG000|COMPLETED|Overall Study|Unit means the eye. One eye was included per patient|25
6700981|NCT02834663|7631544|FG000|NOT COMPLETED|Overall Study||0
6700982|NCT02834806|7631562|FG000|STARTED|Overall Study||58
6700983|NCT02834806|7631562|FG000|COMPLETED|Overall Study||58
6700984|NCT02834806|7631562|FG000|NOT COMPLETED|Overall Study||0
6700985|NCT02834819|7631568|FG000|STARTED|Overall Study||9
6700986|NCT02834819|7631569|FG001|STARTED|Overall Study||9
6700987|NCT02834819|7631568|FG000|COMPLETED|Overall Study||4
6700988|NCT02834819|7631569|FG001|COMPLETED|Overall Study||9
6700989|NCT02834819|7631568|FG000|NOT COMPLETED|Overall Study||5
6700990|NCT02834819|7631569|FG001|NOT COMPLETED|Overall Study||0
6700991|NCT02835092|7631578|FG000|STARTED|Overall Study||66
6700992|NCT02835092|7631579|FG001|STARTED|Overall Study||65
6700993|NCT02835092|7631580|FG002|STARTED|Overall Study||67
6700994|NCT02835092|7631578|FG000|COMPLETED|Overall Study||63
6700995|NCT02835092|7631579|FG001|COMPLETED|Overall Study||57
6700996|NCT02835092|7631580|FG002|COMPLETED|Overall Study||64
6700997|NCT02835092|7631578|FG000|NOT COMPLETED|Overall Study||3
6700998|NCT02835092|7631579|FG001|NOT COMPLETED|Overall Study||8
6700999|NCT02835092|7631580|FG002|NOT COMPLETED|Overall Study||3
6701000|NCT02835274|7631590|FG000|STARTED|Overall Study||6
6701001|NCT02835274|7631591|FG001|STARTED|Overall Study||6
6701002|NCT02835274|7631590|FG000|COMPLETED|Overall Study||6
6701003|NCT02835274|7631591|FG001|COMPLETED|Overall Study||6
6701004|NCT02835274|7631590|FG000|NOT COMPLETED|Overall Study||0
6701005|NCT02835274|7631591|FG001|NOT COMPLETED|Overall Study||0
6701006|NCT02835339|7631599|FG000|STARTED|Overall Study||31
6701007|NCT02835339|7631600|FG001|STARTED|Overall Study||35
6701008|NCT02835339|7631599|FG000|COMPLETED|Overall Study||18
6701009|NCT02835339|7631600|FG001|COMPLETED|Overall Study||19
6701010|NCT02835339|7631599|FG000|NOT COMPLETED|Overall Study||13
6701011|NCT02835339|7631600|FG001|NOT COMPLETED|Overall Study||16
6701012|NCT02835495|7631608|FG000|STARTED|Overall Study|26 randomized, however, one had to withdraw pre-intervention initiation due to cancer diagnosis.|26
6701013|NCT02835495|7631609|FG001|STARTED|Overall Study||25
6701014|NCT02835495|7631608|FG000|Intervention Start|Overall Study||25
6701015|NCT02835495|7631609|FG001|Intervention Start|Overall Study||25
6701016|NCT02835495|7631608|FG000|COMPLETED|Overall Study||21
6701017|NCT02835495|7631609|FG001|COMPLETED|Overall Study||23
6701018|NCT02835495|7631608|FG000|NOT COMPLETED|Overall Study||5
6701019|NCT02835495|7631609|FG001|NOT COMPLETED|Overall Study||2
6701020|NCT02835625|7631619|FG000|STARTED|Overall Study||14734
6701021|NCT02835625|7631620|FG001|STARTED|Overall Study||14719
6701022|NCT02835625|7631619|FG000|COMPLETED|Overall Study||14734
6701023|NCT02835625|7631620|FG001|COMPLETED|Overall Study||14719
6701024|NCT02835625|7631619|FG000|NOT COMPLETED|Overall Study||0
6701025|NCT02835625|7631620|FG001|NOT COMPLETED|Overall Study||0
6701026|NCT02835677|7631627|FG000|STARTED|Overall Study||25
6701027|NCT02835677|7631627|FG000|COMPLETED|Overall Study||25
6701028|NCT02835677|7631627|FG000|NOT COMPLETED|Overall Study||0
6701029|NCT02835820|7631633|FG000|STARTED|Overall Study||7
6701030|NCT02835820|7631634|FG001|STARTED|Overall Study||10
6701031|NCT02835820|7631633|FG000|Baseline Screen (OGTT)|Overall Study||7
6701032|NCT02835820|7631634|FG001|Baseline Screen (OGTT)|Overall Study||7
6701033|NCT02835820|7631633|FG000|COMPLETED|Overall Study||7
6701034|NCT02835820|7631634|FG001|COMPLETED|Overall Study||7
6701035|NCT02835820|7631633|FG000|NOT COMPLETED|Overall Study||0
6701036|NCT02835820|7631634|FG001|NOT COMPLETED|Overall Study||3
6701037|NCT02835846|7631640|FG000|STARTED|Overall Study||35
6701038|NCT02835846|7631640|FG000|COMPLETED|Overall Study||24
6701039|NCT02835846|7631640|FG000|NOT COMPLETED|Overall Study||11
6701040|NCT02836496|7631646|FG000|STARTED|Overall Study||54
6701041|NCT02836496|7631647|FG001|STARTED|Overall Study||54
6701042|NCT02836496|7631646|FG000|COMPLETED|Overall Study||52
6701043|NCT02836496|7631647|FG001|COMPLETED|Overall Study||52
6701044|NCT02836496|7631646|FG000|NOT COMPLETED|Overall Study||2
6701045|NCT02836496|7631647|FG001|NOT COMPLETED|Overall Study||2
6701046|NCT02836613|7631655|FG000|STARTED|Overall Study||80
6701047|NCT02836613|7631656|FG001|STARTED|Overall Study||80
6701048|NCT02836613|7631655|FG000|COMPLETED|Overall Study||79
6701049|NCT02836613|7631656|FG001|COMPLETED|Overall Study||77
6701050|NCT02836613|7631655|FG000|NOT COMPLETED|Overall Study||1
6701051|NCT02836613|7631656|FG001|NOT COMPLETED|Overall Study||3
6701052|NCT02836652|7631664|FG000|STARTED|Overall Study||35
6701053|NCT02836652|7631665|FG001|STARTED|Overall Study||37
6701054|NCT02836652|7631664|FG000|As-treated Population|Overall Study||31
6701055|NCT02836652|7631665|FG001|As-treated Population|Overall Study||34
6701056|NCT02836652|7631664|FG000|COMPLETED|Overall Study||17
6701057|NCT02836652|7631665|FG001|COMPLETED|Overall Study||18
6701058|NCT02836652|7631664|FG000|NOT COMPLETED|Overall Study||18
6260164|NCT01194219|7159005|FG005|STARTED|Maintenance Phase Weeks16-32||0
6260165|NCT01194219|7159006|FG006|STARTED|Maintenance Phase Weeks16-32||0
6260166|NCT01194219|7159007|FG007|STARTED|Maintenance Phase Weeks16-32||0
6260167|NCT01194219|7159008|FG008|STARTED|Maintenance Phase Weeks16-32||0
6260168|NCT01194219|7159009|FG009|STARTED|Maintenance Phase Weeks16-32||0
6701059|NCT02836652|7631665|FG001|NOT COMPLETED|Overall Study||19
6701060|NCT02836769|7631671|FG000|STARTED|Overall Study||35
6701061|NCT02836769|7631671|FG000|Received Intervention|Overall Study||30
6701062|NCT02836769|7631671|FG000|Completed Post-test Assessment|Overall Study||21
6701063|NCT02836769|7631671|FG000|COMPLETED|Overall Study||20
6701064|NCT02836769|7631671|FG000|NOT COMPLETED|Overall Study||15
6701065|NCT02836873|7631677|FG000|STARTED|Overall Study||157
6701066|NCT02836873|7631678|FG001|STARTED|Overall Study||155
6701067|NCT02836873|7631677|FG000|COMPLETED|Overall Study||152
6701068|NCT02836873|7631678|FG001|COMPLETED|Overall Study||144
6701069|NCT02836873|7631677|FG000|NOT COMPLETED|Overall Study||5
6701070|NCT02836873|7631678|FG001|NOT COMPLETED|Overall Study||11
6701071|NCT02836990|7631686|FG000|STARTED|Overall Study||50
6701072|NCT02836990|7631687|FG001|STARTED|Overall Study||55
6701073|NCT02836990|7631686|FG000|COMPLETED|Overall Study||50
6701074|NCT02836990|7631687|FG001|COMPLETED|Overall Study||55
6701075|NCT02836990|7631686|FG000|NOT COMPLETED|Overall Study||0
6701076|NCT02836990|7631687|FG001|NOT COMPLETED|Overall Study||0
6701077|NCT02837237|7631695|FG000|STARTED|Overall Study||11
6701078|NCT02837237|7631695|FG000|COMPLETED|Overall Study||11
6701079|NCT02837237|7631695|FG000|NOT COMPLETED|Overall Study||0
6701080|NCT02837328|7631701|FG000|STARTED|Overall Study||29
6701081|NCT02837328|7631702|FG001|STARTED|Overall Study||30
6701082|NCT02837328|7631701|FG000|COMPLETED|Overall Study||29
6701083|NCT02837328|7631702|FG001|COMPLETED|Overall Study||30
6701084|NCT02837328|7631701|FG000|NOT COMPLETED|Overall Study||0
6701085|NCT02837328|7631702|FG001|NOT COMPLETED|Overall Study||0
6701086|NCT02837731|7631710|FG000|STARTED|Allocation||102
6701087|NCT02837731|7631711|FG001|STARTED|Allocation||48
6701088|NCT02837731|7631710|FG000|COMPLETED|Allocation||83
6701089|NCT02837731|7631711|FG001|COMPLETED|Allocation||41
6701090|NCT02837731|7631710|FG000|NOT COMPLETED|Allocation||19
6701091|NCT02837731|7631711|FG001|NOT COMPLETED|Allocation||7
6701092|NCT02837731|7631710|FG000|STARTED|Follow-up||83
6701093|NCT02837731|7631711|FG001|STARTED|Follow-up||41
6701094|NCT02837731|7631710|FG000|COMPLETED|Follow-up||83
6701095|NCT02837731|7631711|FG001|COMPLETED|Follow-up||41
6701096|NCT02837731|7631710|FG000|NOT COMPLETED|Follow-up||0
6701097|NCT02837731|7631711|FG001|NOT COMPLETED|Follow-up||0
6701098|NCT02837731|7631710|FG000|STARTED|Analysis||83
6701099|NCT02837731|7631711|FG001|STARTED|Analysis||41
6701100|NCT02837731|7631710|FG000|COMPLETED|Analysis||83
6701101|NCT02837731|7631711|FG001|COMPLETED|Analysis||41
6701102|NCT02837731|7631710|FG000|NOT COMPLETED|Analysis||0
6701103|NCT02837731|7631711|FG001|NOT COMPLETED|Analysis||0
6701104|NCT02837744|7631717|FG000|STARTED|Overall Study||70
6701105|NCT02837744|7631717|FG000|COMPLETED|Overall Study||70
6701106|NCT02837744|7631717|FG000|NOT COMPLETED|Overall Study||0
6701107|NCT02837913|7631723|FG000|STARTED|Overall Study||10
6701108|NCT02837913|7631724|FG001|STARTED|Overall Study||9
6701109|NCT02837913|7631723|FG000|COMPLETED|Overall Study||10
6701110|NCT02837913|7631724|FG001|COMPLETED|Overall Study||9
6701111|NCT02837913|7631723|FG000|NOT COMPLETED|Overall Study||0
6701112|NCT02837913|7631724|FG001|NOT COMPLETED|Overall Study||0
6701113|NCT02837952|7631732|FG000|STARTED|Overall Study||41
6701114|NCT02837952|7631733|FG001|STARTED|Overall Study||82
6701115|NCT02837952|7631732|FG000|COMPLETED|Overall Study||36
6701116|NCT02837952|7631733|FG001|COMPLETED|Overall Study||76
6701117|NCT02837952|7631732|FG000|NOT COMPLETED|Overall Study||5
6701118|NCT02837952|7631733|FG001|NOT COMPLETED|Overall Study||6
6701119|NCT02838017|7631741|FG000|STARTED|Overall Study||252
6701120|NCT02838017|7631742|FG001|STARTED|Overall Study||252
6701121|NCT02838017|7631741|FG000|COMPLETED|Overall Study||238
6701122|NCT02838017|7631742|FG001|COMPLETED|Overall Study||241
6701123|NCT02838017|7631741|FG000|NOT COMPLETED|Overall Study||14
6701124|NCT02838017|7631742|FG001|NOT COMPLETED|Overall Study||11
6701125|NCT02838134|7631750|FG000|STARTED|Overall Study||50
6701126|NCT02838134|7631751|FG001|STARTED|Overall Study||51
6701127|NCT02838134|7631750|FG000|COMPLETED|Overall Study||48
6701128|NCT02838134|7631751|FG001|COMPLETED|Overall Study||48
6701129|NCT02838134|7631750|FG000|NOT COMPLETED|Overall Study||2
6701130|NCT02838134|7631751|FG001|NOT COMPLETED|Overall Study||3
6701131|NCT02838407|7631757|FG000|STARTED|Overall Study||197
6701132|NCT02838407|7631757|FG000|COMPLETED|Overall Study||197
6701133|NCT02838407|7631757|FG000|NOT COMPLETED|Overall Study||0
6701134|NCT02838420|7631763|FG000|STARTED|Overall Study||125
6701135|NCT02838420|7631764|FG001|STARTED|Overall Study||62
6701136|NCT02838420|7631763|FG000|COMPLETED|Overall Study||0
6701137|NCT02838420|7631764|FG001|COMPLETED|Overall Study||0
6701138|NCT02838420|7631763|FG000|NOT COMPLETED|Overall Study||125
6701139|NCT02838420|7631764|FG001|NOT COMPLETED|Overall Study||62
6701140|NCT02838628|7631772|FG000|STARTED|Treatment and Follow-up Period||84
6701141|NCT02838628|7631773|FG001|STARTED|Treatment and Follow-up Period||84
6701142|NCT02838628|7631772|FG000|COMPLETED|Treatment and Follow-up Period||84
6701143|NCT02838628|7631773|FG001|COMPLETED|Treatment and Follow-up Period||84
6701144|NCT02838628|7631772|FG000|NOT COMPLETED|Treatment and Follow-up Period||0
6701145|NCT02838628|7631773|FG001|NOT COMPLETED|Treatment and Follow-up Period||0
6701146|NCT02838628|7631772|FG000|STARTED|Recurrence Follow-up Period||36
6701147|NCT02838628|7631773|FG001|STARTED|Recurrence Follow-up Period||27
6701148|NCT02838628|7631772|FG000|COMPLETED|Recurrence Follow-up Period||16
6701149|NCT02838628|7631773|FG001|COMPLETED|Recurrence Follow-up Period||10
6701150|NCT02838628|7631772|FG000|NOT COMPLETED|Recurrence Follow-up Period||20
6701151|NCT02838628|7631773|FG001|NOT COMPLETED|Recurrence Follow-up Period||17
6701152|NCT02838901|7631782|FG000|STARTED|Overall Study||9
6701153|NCT02838901|7631783|FG001|STARTED|Overall Study||9
6701154|NCT02838901|7631782|FG000|COMPLETED|Overall Study||7
6701155|NCT02838901|7631783|FG001|COMPLETED|Overall Study||7
6701156|NCT02838901|7631782|FG000|NOT COMPLETED|Overall Study||2
6701157|NCT02838901|7631783|FG001|NOT COMPLETED|Overall Study||2
6701158|NCT02839200|7631797|FG000|STARTED|Overall Study||60
6701159|NCT02839200|7631798|FG001|STARTED|Overall Study||59
6701160|NCT02839200|7631799|FG002|STARTED|Overall Study||60
6701161|NCT02839200|7631800|FG003|STARTED|Overall Study||61
6701162|NCT02839200|7631801|FG004|STARTED|Overall Study||60
6701163|NCT02839200|7631802|FG005|STARTED|Overall Study||60
6701164|NCT02839200|7631797|FG000|COMPLETED|Overall Study||56
6701165|NCT02839200|7631798|FG001|COMPLETED|Overall Study||58
6701166|NCT02839200|7631799|FG002|COMPLETED|Overall Study||59
6701167|NCT02839200|7631800|FG003|COMPLETED|Overall Study||61
6701168|NCT02839200|7631801|FG004|COMPLETED|Overall Study||58
6701169|NCT02839200|7631802|FG005|COMPLETED|Overall Study||59
6701170|NCT02839200|7631797|FG000|NOT COMPLETED|Overall Study||4
6701171|NCT02839200|7631798|FG001|NOT COMPLETED|Overall Study||1
6701172|NCT02839200|7631799|FG002|NOT COMPLETED|Overall Study||1
6701173|NCT02839200|7631800|FG003|NOT COMPLETED|Overall Study||0
6701174|NCT02839200|7631801|FG004|NOT COMPLETED|Overall Study||2
6701175|NCT02839200|7631802|FG005|NOT COMPLETED|Overall Study||1
6260169|NCT01194219|7159000|FG000|Received Apremilast|Maintenance Phase Weeks16-32||0
6260170|NCT01194219|7159001|FG001|Received Apremilast|Maintenance Phase Weeks16-32||0
6260171|NCT01194219|7159002|FG002|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|493
6260172|NCT01194219|7159003|FG003|Received Apremilast|Maintenance Phase Weeks16-32|1 participant elected not to participate at the time the first dose was dispensed.|244
6260173|NCT01194219|7159004|FG004|Received Apremilast|Maintenance Phase Weeks16-32||0
6260174|NCT01194219|7159005|FG005|Received Apremilast|Maintenance Phase Weeks16-32||0
6260175|NCT01194219|7159006|FG006|Received Apremilast|Maintenance Phase Weeks16-32||0
6260176|NCT01194219|7159007|FG007|Received Apremilast|Maintenance Phase Weeks16-32||0
6260177|NCT01194219|7159008|FG008|Received Apremilast|Maintenance Phase Weeks16-32||0
6260178|NCT01194219|7159009|FG009|Received Apremilast|Maintenance Phase Weeks16-32||0
6260179|NCT01194219|7159000|FG000|COMPLETED|Maintenance Phase Weeks16-32||0
6260180|NCT01194219|7159001|FG001|COMPLETED|Maintenance Phase Weeks16-32||0
6260181|NCT01194219|7159002|FG002|COMPLETED|Maintenance Phase Weeks16-32||424
6701176|NCT02839330|7631820|FG000|STARTED|Overall Study||804
6701177|NCT02839330|7631821|FG001|STARTED|Overall Study||799
6701178|NCT02839330|7631822|FG002|STARTED|Overall Study||795
6701179|NCT02839330|7631823|FG003|STARTED|Overall Study||798
6701180|NCT02839330|7631820|FG000|Exposed|Overall Study||804
6701181|NCT02839330|7631821|FG001|Exposed|Overall Study||797
6701182|NCT02839330|7631822|FG002|Exposed|Overall Study||793
6701183|NCT02839330|7631823|FG003|Exposed|Overall Study||797
6701184|NCT02839330|7631820|FG000|COMPLETED|Overall Study||746
6701185|NCT02839330|7631821|FG001|COMPLETED|Overall Study||741
6701186|NCT02839330|7631822|FG002|COMPLETED|Overall Study||747
6701187|NCT02839330|7631823|FG003|COMPLETED|Overall Study||747
6701188|NCT02839330|7631820|FG000|NOT COMPLETED|Overall Study||58
6701189|NCT02839330|7631821|FG001|NOT COMPLETED|Overall Study||58
6701190|NCT02839330|7631822|FG002|NOT COMPLETED|Overall Study||48
6701191|NCT02839330|7631823|FG003|NOT COMPLETED|Overall Study||51
6701192|NCT02839681|7631834|FG000|STARTED|Overall Study||2
6701193|NCT02839681|7631834|FG000|COMPLETED|Overall Study||0
6701194|NCT02839681|7631834|FG000|NOT COMPLETED|Overall Study||2
6701195|NCT02839746|7631838|FG000|STARTED|Overall Study||671
6701196|NCT02839746|7631838|FG000|COMPLETED|Overall Study||659
6701197|NCT02839746|7631838|FG000|NOT COMPLETED|Overall Study||12
6701198|NCT02839772|7631844|FG000|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
6701199|NCT02839772|7631845|FG001|STARTED|Overall Study||96
6701200|NCT02839772|7631844|FG000|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
6701201|NCT02839772|7631845|FG001|COMPLETED|Overall Study||96
6701202|NCT02839772|7631844|FG000|NOT COMPLETED|Overall Study||1
6701203|NCT02839772|7631845|FG001|NOT COMPLETED|Overall Study||0
6701204|NCT02839798|7631865|FG000|STARTED|Overall Study||6
6701205|NCT02839798|7631865|FG000|COMPLETED|Overall Study||4
6701206|NCT02839798|7631865|FG000|NOT COMPLETED|Overall Study||2
6701207|NCT02839876|7631871|FG000|STARTED|Overall Study||41
6701208|NCT02839876|7631872|FG001|STARTED|Overall Study||40
6701209|NCT02839876|7631871|FG000|COMPLETED|Overall Study||31
6701210|NCT02839876|7631872|FG001|COMPLETED|Overall Study||29
6701211|NCT02839876|7631871|FG000|NOT COMPLETED|Overall Study||10
6701212|NCT02839876|7631872|FG001|NOT COMPLETED|Overall Study||11
6701213|NCT02839889|7631880|FG000|STARTED|Randomization Period||2
6701214|NCT02839889|7631881|FG001|STARTED|Randomization Period||3
6701215|NCT02839889|7631880|FG000|COMPLETED|Randomization Period||2
6701216|NCT02839889|7631881|FG001|COMPLETED|Randomization Period||3
6701217|NCT02839889|7631880|FG000|NOT COMPLETED|Randomization Period||0
6701218|NCT02839889|7631881|FG001|NOT COMPLETED|Randomization Period||0
6701219|NCT02839889|7631880|FG000|STARTED|Open-Label Period||0
6701220|NCT02839889|7631881|FG001|STARTED|Open-Label Period||5
6701221|NCT02839889|7631880|FG000|COMPLETED|Open-Label Period||0
6701222|NCT02839889|7631881|FG001|COMPLETED|Open-Label Period||4
6701223|NCT02839889|7631880|FG000|NOT COMPLETED|Open-Label Period||0
6701224|NCT02839889|7631881|FG001|NOT COMPLETED|Open-Label Period||1
6701225|NCT02839902|7631889|FG000|STARTED|Overall Study||24
6701226|NCT02839902|7631890|FG001|STARTED|Overall Study||29
6701227|NCT02839902|7631889|FG000|COMPLETED|Overall Study||24
6701228|NCT02839902|7631890|FG001|COMPLETED|Overall Study||29
6701229|NCT02839902|7631889|FG000|NOT COMPLETED|Overall Study||0
6701230|NCT02839902|7631890|FG001|NOT COMPLETED|Overall Study||0
6701231|NCT02840097|7631899|FG000|STARTED|Overall Study||9
6701232|NCT02840097|7631900|FG001|STARTED|Overall Study||10
6701233|NCT02840097|7631901|FG002|STARTED|Overall Study||12
6701234|NCT02840097|7631899|FG000|COMPLETED|Overall Study||9
6701235|NCT02840097|7631900|FG001|COMPLETED|Overall Study||10
6701236|NCT02840097|7631901|FG002|COMPLETED|Overall Study||12
6701237|NCT02840097|7631899|FG000|NOT COMPLETED|Overall Study||0
6701238|NCT02840097|7631900|FG001|NOT COMPLETED|Overall Study||0
6701239|NCT02840097|7631901|FG002|NOT COMPLETED|Overall Study||0
6701240|NCT02840253|7631912|FG000|STARTED|Overall Study||23
6701241|NCT02840253|7631912|FG000|COMPLETED|Overall Study||19
6701242|NCT02840253|7631912|FG000|NOT COMPLETED|Overall Study||4
6701243|NCT02840461|7631919|FG000|STARTED|Overall Study||259
6701244|NCT02840461|7631920|FG001|STARTED|Overall Study||257
6701245|NCT02840461|7631921|FG002|STARTED|Overall Study||114
6701246|NCT02840461|7631919|FG000|COMPLETED|Overall Study||236
6701247|NCT02840461|7631920|FG001|COMPLETED|Overall Study||235
6701248|NCT02840461|7631921|FG002|COMPLETED|Overall Study||100
6701249|NCT02840461|7631919|FG000|NOT COMPLETED|Overall Study||23
6701250|NCT02840461|7631920|FG001|NOT COMPLETED|Overall Study||22
6701251|NCT02840461|7631921|FG002|NOT COMPLETED|Overall Study||14
6701252|NCT02840474|7631932|FG000|STARTED|Overall Study||7
6701253|NCT02840474|7631933|FG001|STARTED|Overall Study||9
6701254|NCT02840474|7631932|FG000|Received Study Product|Overall Study||7
6701255|NCT02840474|7631933|FG001|Received Study Product|Overall Study||9
6701256|NCT02840474|7631932|FG000|COMPLETED|Overall Study||6
6701257|NCT02840474|7631933|FG001|COMPLETED|Overall Study||9
6701258|NCT02840474|7631932|FG000|NOT COMPLETED|Overall Study||1
6701259|NCT02840474|7631933|FG001|NOT COMPLETED|Overall Study||0
6739010|NCT03286218|7668004|FG008|NOT COMPLETED|Treatment Phase Period 4||0
6739011|NCT03286218|7668005|FG009|NOT COMPLETED|Treatment Phase Period 4||0
6739012|NCT03286218|7668006|FG010|NOT COMPLETED|Treatment Phase Period 4||0
6739013|NCT03286218|7668007|FG011|NOT COMPLETED|Treatment Phase Period 4||1
6739014|NCT03286218|7667996|FG000|STARTED|Treatment Phase Period 5||0
6739015|NCT03286218|7667997|FG001|STARTED|Treatment Phase Period 5||0
6739016|NCT03286218|7667998|FG002|STARTED|Treatment Phase Period 5||5
6739017|NCT03286218|7667999|FG003|STARTED|Treatment Phase Period 5||5
6739018|NCT03286218|7668000|FG004|STARTED|Treatment Phase Period 5||5
6739019|NCT03286218|7668001|FG005|STARTED|Treatment Phase Period 5||5
6739020|NCT03286218|7668002|FG006|STARTED|Treatment Phase Period 5||6
6739021|NCT03286218|7668003|FG007|STARTED|Treatment Phase Period 5||6
6739022|NCT03286218|7668004|FG008|STARTED|Treatment Phase Period 5||6
6701260|NCT02840721|7631939|FG000|STARTED|Treatment Period||50
6701261|NCT02840721|7631939|FG000|COMPLETED|Treatment Period||49
6701262|NCT02840721|7631939|FG000|NOT COMPLETED|Treatment Period||1
6701263|NCT02840721|7631939|FG000|STARTED|Follow-Up||49
6701264|NCT02840721|7631939|FG000|COMPLETED|Follow-Up||42
6701265|NCT02840721|7631939|FG000|NOT COMPLETED|Follow-Up||7
6701266|NCT02840916|7631945|FG000|STARTED|Overall Study||33
6701267|NCT02840916|7631946|FG001|STARTED|Overall Study||33
6701268|NCT02840916|7631945|FG000|COMPLETED|Overall Study||32
6701269|NCT02840916|7631946|FG001|COMPLETED|Overall Study||30
6701270|NCT02840916|7631945|FG000|NOT COMPLETED|Overall Study||1
6701271|NCT02840916|7631946|FG001|NOT COMPLETED|Overall Study||3
6701272|NCT02841033|7631952|FG000|STARTED|Overall Study||22
6701273|NCT02841033|7631952|FG000|COMPLETED|Overall Study||22
6701274|NCT02841033|7631952|FG000|NOT COMPLETED|Overall Study||0
6701275|NCT02841046|7631958|FG000|STARTED|Overall Study||25
6701276|NCT02841046|7631959|FG001|STARTED|Overall Study||25
6701277|NCT02841046|7631958|FG000|COMPLETED|Overall Study||25
6260182|NCT01194219|7159003|FG003|COMPLETED|Maintenance Phase Weeks16-32||215
6260183|NCT01194219|7159004|FG004|COMPLETED|Maintenance Phase Weeks16-32||0
6260184|NCT01194219|7159005|FG005|COMPLETED|Maintenance Phase Weeks16-32||0
6260185|NCT01194219|7159006|FG006|COMPLETED|Maintenance Phase Weeks16-32||0
6260186|NCT01194219|7159007|FG007|COMPLETED|Maintenance Phase Weeks16-32||0
6260187|NCT01194219|7159008|FG008|COMPLETED|Maintenance Phase Weeks16-32||0
6260188|NCT01194219|7159009|FG009|COMPLETED|Maintenance Phase Weeks16-32||0
6260189|NCT01194219|7159000|FG000|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6260190|NCT01194219|7159001|FG001|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6260191|NCT01194219|7159002|FG002|NOT COMPLETED|Maintenance Phase Weeks16-32||70
6260192|NCT01194219|7159003|FG003|NOT COMPLETED|Maintenance Phase Weeks16-32||30
6701278|NCT02841046|7631959|FG001|COMPLETED|Overall Study||25
6701279|NCT02841046|7631958|FG000|NOT COMPLETED|Overall Study||0
6701280|NCT02841046|7631959|FG001|NOT COMPLETED|Overall Study||0
6701281|NCT02841189|7631965|FG000|STARTED|Overall Study||100
6701282|NCT02841189|7631965|FG000|COMPLETED|Overall Study||65
6701283|NCT02841189|7631965|FG000|NOT COMPLETED|Overall Study||35
6701284|NCT02841241|7631969|FG000|STARTED|Overall Study||7
6701285|NCT02841241|7631969|FG000|COMPLETED|Overall Study||7
6701286|NCT02841241|7631969|FG000|NOT COMPLETED|Overall Study||0
6701287|NCT02841267|7631976|FG000|STARTED|Lead-in (Untreated)||4
6701288|NCT02841267|7631977|FG001|STARTED|Lead-in (Untreated)||7
6701289|NCT02841267|7631978|FG002|STARTED|Lead-in (Untreated)||8
6701290|NCT02841267|7631976|FG000|COMPLETED|Lead-in (Untreated)||4
6701291|NCT02841267|7631977|FG001|COMPLETED|Lead-in (Untreated)||7
6701292|NCT02841267|7631978|FG002|COMPLETED|Lead-in (Untreated)||8
6701293|NCT02841267|7631976|FG000|NOT COMPLETED|Lead-in (Untreated)||0
6701294|NCT02841267|7631977|FG001|NOT COMPLETED|Lead-in (Untreated)||0
6701295|NCT02841267|7631978|FG002|NOT COMPLETED|Lead-in (Untreated)||0
6701296|NCT02841267|7631976|FG000|STARTED|Treatment Period|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
6701297|NCT02841267|7631977|FG001|STARTED|Treatment Period||7
6701298|NCT02841267|7631978|FG002|STARTED|Treatment Period||8
6701299|NCT02841267|7631976|FG000|COMPLETED|Treatment Period||4
6701300|NCT02841267|7631977|FG001|COMPLETED|Treatment Period||7
6701301|NCT02841267|7631978|FG002|COMPLETED|Treatment Period||8
6701302|NCT02841267|7631976|FG000|NOT COMPLETED|Treatment Period||0
6701303|NCT02841267|7631977|FG001|NOT COMPLETED|Treatment Period||0
6701304|NCT02841267|7631978|FG002|NOT COMPLETED|Treatment Period||0
6701305|NCT02841267|7631976|FG000|STARTED|Extension Study|Cohort 1 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 28 weeks.|4
6701306|NCT02841267|7631977|FG001|STARTED|Extension Study|Cohort 2 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 40 weeks.|6
6701307|NCT02841267|7631978|FG002|STARTED|Extension Study|Cohort 3 was invited to continue receiving 40mg/kg of study drug every 4 weeks for 24 weeks.|6
6701308|NCT02841267|7631976|FG000|COMPLETED|Extension Study||4
6701309|NCT02841267|7631977|FG001|COMPLETED|Extension Study||6
6701310|NCT02841267|7631978|FG002|COMPLETED|Extension Study||6
6701311|NCT02841267|7631976|FG000|NOT COMPLETED|Extension Study||0
6701312|NCT02841267|7631977|FG001|NOT COMPLETED|Extension Study||0
6701313|NCT02841267|7631978|FG002|NOT COMPLETED|Extension Study||0
6701314|NCT02841397|7631994|FG000|STARTED|Overall Study||50
6701315|NCT02841397|7631994|FG000|COMPLETED|Overall Study||48
6701316|NCT02841397|7631994|FG000|NOT COMPLETED|Overall Study||2
6701317|NCT02841449|7632000|FG000|STARTED|Overall Study||7
6701318|NCT02841449|7632001|FG001|STARTED|Overall Study||9
6701319|NCT02841449|7632000|FG000|COMPLETED|Overall Study||7
6701320|NCT02841449|7632001|FG001|COMPLETED|Overall Study||9
6701321|NCT02841449|7632000|FG000|NOT COMPLETED|Overall Study||0
6701322|NCT02841449|7632001|FG001|NOT COMPLETED|Overall Study||0
6701323|NCT02841709|7632007|FG000|STARTED|1st Intervention||12
6701324|NCT02841709|7632008|FG001|STARTED|1st Intervention||11
6701325|NCT02841709|7632009|FG002|STARTED|1st Intervention||12
6701326|NCT02841709|7632010|FG003|STARTED|1st Intervention||12
6701327|NCT02841709|7632011|FG004|STARTED|1st Intervention||11
6701328|NCT02841709|7632007|FG000|COMPLETED|1st Intervention||12
6701329|NCT02841709|7632008|FG001|COMPLETED|1st Intervention||11
6701330|NCT02841709|7632009|FG002|COMPLETED|1st Intervention||12
6701331|NCT02841709|7632010|FG003|COMPLETED|1st Intervention||12
6701332|NCT02841709|7632011|FG004|COMPLETED|1st Intervention||11
6701333|NCT02841709|7632007|FG000|NOT COMPLETED|1st Intervention||0
6701334|NCT02841709|7632008|FG001|NOT COMPLETED|1st Intervention||0
6701335|NCT02841709|7632009|FG002|NOT COMPLETED|1st Intervention||0
6701336|NCT02841709|7632010|FG003|NOT COMPLETED|1st Intervention||0
6701337|NCT02841709|7632011|FG004|NOT COMPLETED|1st Intervention||0
6701338|NCT02841709|7632007|FG000|STARTED|Washout Period 1||12
6701339|NCT02841709|7632008|FG001|STARTED|Washout Period 1||11
6701340|NCT02841709|7632009|FG002|STARTED|Washout Period 1||12
6701341|NCT02841709|7632010|FG003|STARTED|Washout Period 1||12
6701342|NCT02841709|7632011|FG004|STARTED|Washout Period 1||11
6701343|NCT02841709|7632007|FG000|COMPLETED|Washout Period 1||12
6701344|NCT02841709|7632008|FG001|COMPLETED|Washout Period 1||11
6701345|NCT02841709|7632009|FG002|COMPLETED|Washout Period 1||12
6701346|NCT02841709|7632010|FG003|COMPLETED|Washout Period 1||12
6701347|NCT02841709|7632011|FG004|COMPLETED|Washout Period 1||11
6701348|NCT02841709|7632007|FG000|NOT COMPLETED|Washout Period 1||0
6701349|NCT02841709|7632008|FG001|NOT COMPLETED|Washout Period 1||0
6701350|NCT02841709|7632009|FG002|NOT COMPLETED|Washout Period 1||0
6701351|NCT02841709|7632010|FG003|NOT COMPLETED|Washout Period 1||0
6701352|NCT02841709|7632011|FG004|NOT COMPLETED|Washout Period 1||0
6701353|NCT02841709|7632007|FG000|STARTED|2nd Intervention||12
6701354|NCT02841709|7632008|FG001|STARTED|2nd Intervention||11
6701355|NCT02841709|7632009|FG002|STARTED|2nd Intervention||12
6701356|NCT02841709|7632010|FG003|STARTED|2nd Intervention||12
6701357|NCT02841709|7632011|FG004|STARTED|2nd Intervention||11
6701358|NCT02841709|7632007|FG000|COMPLETED|2nd Intervention||12
6701359|NCT02841709|7632008|FG001|COMPLETED|2nd Intervention||11
6701360|NCT02841709|7632009|FG002|COMPLETED|2nd Intervention||12
6701361|NCT02841709|7632010|FG003|COMPLETED|2nd Intervention||12
6701362|NCT02841709|7632011|FG004|COMPLETED|2nd Intervention||11
6701363|NCT02841709|7632007|FG000|NOT COMPLETED|2nd Intervention||0
6701364|NCT02841709|7632008|FG001|NOT COMPLETED|2nd Intervention||0
6701365|NCT02841709|7632009|FG002|NOT COMPLETED|2nd Intervention||0
6701366|NCT02841709|7632010|FG003|NOT COMPLETED|2nd Intervention||0
6701367|NCT02841709|7632011|FG004|NOT COMPLETED|2nd Intervention||0
6701368|NCT02841709|7632007|FG000|STARTED|Washout Period 2||12
6701369|NCT02841709|7632008|FG001|STARTED|Washout Period 2||11
6701370|NCT02841709|7632009|FG002|STARTED|Washout Period 2||12
6701371|NCT02841709|7632010|FG003|STARTED|Washout Period 2||12
6701372|NCT02841709|7632011|FG004|STARTED|Washout Period 2||11
6701373|NCT02841709|7632007|FG000|COMPLETED|Washout Period 2||12
6701374|NCT02841709|7632008|FG001|COMPLETED|Washout Period 2||11
6701375|NCT02841709|7632009|FG002|COMPLETED|Washout Period 2||12
6701376|NCT02841709|7632010|FG003|COMPLETED|Washout Period 2||12
6701377|NCT02841709|7632011|FG004|COMPLETED|Washout Period 2||11
6701378|NCT02841709|7632007|FG000|NOT COMPLETED|Washout Period 2||0
6701379|NCT02841709|7632008|FG001|NOT COMPLETED|Washout Period 2||0
6701380|NCT02841709|7632009|FG002|NOT COMPLETED|Washout Period 2||0
6701381|NCT02841709|7632010|FG003|NOT COMPLETED|Washout Period 2||0
6701382|NCT02841709|7632011|FG004|NOT COMPLETED|Washout Period 2||0
6701383|NCT02841709|7632007|FG000|STARTED|3rd Intervention||12
6701384|NCT02841709|7632008|FG001|STARTED|3rd Intervention||11
6260193|NCT01194219|7159004|FG004|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6260194|NCT01194219|7159005|FG005|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6260195|NCT01194219|7159006|FG006|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6260196|NCT01194219|7159007|FG007|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6260197|NCT01194219|7159008|FG008|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6260198|NCT01194219|7159009|FG009|NOT COMPLETED|Maintenance Phase Weeks16-32||0
6260199|NCT01194219|7159000|FG000|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6260200|NCT01194219|7159001|FG001|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6260201|NCT01194219|7159002|FG002|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6260202|NCT01194219|7159003|FG003|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6260203|NCT01194219|7159004|FG004|STARTED|Randomized Withdrawal Phase-Weeks 32-52|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
6260204|NCT01194219|7159005|FG005|STARTED|Randomized Withdrawal Phase-Weeks 32-52|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
6260205|NCT01194219|7159006|FG006|STARTED|Randomized Withdrawal Phase-Weeks 32-52||245
6260206|NCT01194219|7159007|FG007|STARTED|Randomized Withdrawal Phase-Weeks 32-52||208
6260207|NCT01194219|7159008|FG008|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6260208|NCT01194219|7159009|FG009|STARTED|Randomized Withdrawal Phase-Weeks 32-52||0
6260209|NCT01194219|7159000|FG000|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6260210|NCT01194219|7159001|FG001|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6260211|NCT01194219|7159002|FG002|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6260212|NCT01194219|7159003|FG003|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6260213|NCT01194219|7159004|FG004|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6260214|NCT01194219|7159005|FG005|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6701385|NCT02841709|7632009|FG002|STARTED|3rd Intervention||12
6701386|NCT02841709|7632010|FG003|STARTED|3rd Intervention||12
6701387|NCT02841709|7632011|FG004|STARTED|3rd Intervention||11
6701388|NCT02841709|7632007|FG000|COMPLETED|3rd Intervention||12
6701389|NCT02841709|7632008|FG001|COMPLETED|3rd Intervention||11
6701390|NCT02841709|7632009|FG002|COMPLETED|3rd Intervention||12
6701391|NCT02841709|7632010|FG003|COMPLETED|3rd Intervention||12
6701392|NCT02841709|7632011|FG004|COMPLETED|3rd Intervention||11
6701393|NCT02841709|7632007|FG000|NOT COMPLETED|3rd Intervention||0
6701394|NCT02841709|7632008|FG001|NOT COMPLETED|3rd Intervention||0
6701395|NCT02841709|7632009|FG002|NOT COMPLETED|3rd Intervention||0
6701396|NCT02841709|7632010|FG003|NOT COMPLETED|3rd Intervention||0
6701397|NCT02841709|7632011|FG004|NOT COMPLETED|3rd Intervention||0
6701398|NCT02841709|7632007|FG000|STARTED|Washout Period 3||12
6701399|NCT02841709|7632008|FG001|STARTED|Washout Period 3||11
6701400|NCT02841709|7632009|FG002|STARTED|Washout Period 3||12
6701401|NCT02841709|7632010|FG003|STARTED|Washout Period 3||12
6701402|NCT02841709|7632011|FG004|STARTED|Washout Period 3||11
6701403|NCT02841709|7632007|FG000|COMPLETED|Washout Period 3||12
6701404|NCT02841709|7632008|FG001|COMPLETED|Washout Period 3||11
6701405|NCT02841709|7632009|FG002|COMPLETED|Washout Period 3||12
6701406|NCT02841709|7632010|FG003|COMPLETED|Washout Period 3||12
6701407|NCT02841709|7632011|FG004|COMPLETED|Washout Period 3||11
6701408|NCT02841709|7632007|FG000|NOT COMPLETED|Washout Period 3||0
6701409|NCT02841709|7632008|FG001|NOT COMPLETED|Washout Period 3||0
6701410|NCT02841709|7632009|FG002|NOT COMPLETED|Washout Period 3||0
6701411|NCT02841709|7632010|FG003|NOT COMPLETED|Washout Period 3||0
6701412|NCT02841709|7632011|FG004|NOT COMPLETED|Washout Period 3||0
6701413|NCT02841709|7632007|FG000|STARTED|4th Intervention||12
6701414|NCT02841709|7632008|FG001|STARTED|4th Intervention||11
6701415|NCT02841709|7632009|FG002|STARTED|4th Intervention||12
6701416|NCT02841709|7632010|FG003|STARTED|4th Intervention||12
6701417|NCT02841709|7632011|FG004|STARTED|4th Intervention||11
6701418|NCT02841709|7632007|FG000|COMPLETED|4th Intervention||12
6701419|NCT02841709|7632008|FG001|COMPLETED|4th Intervention||11
6701420|NCT02841709|7632009|FG002|COMPLETED|4th Intervention||12
6701421|NCT02841709|7632010|FG003|COMPLETED|4th Intervention||12
6701422|NCT02841709|7632011|FG004|COMPLETED|4th Intervention||11
6260215|NCT01194219|7159006|FG006|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||126
6260216|NCT01194219|7159007|FG007|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||91
6260217|NCT01194219|7159008|FG008|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6260218|NCT01194219|7159009|FG009|Received Topical + Light Therapy|Randomized Withdrawal Phase-Weeks 32-52||0
6260219|NCT01194219|7159000|FG000|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260220|NCT01194219|7159001|FG001|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260221|NCT01194219|7159002|FG002|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260222|NCT01194219|7159003|FG003|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260223|NCT01194219|7159004|FG004|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
6260224|NCT01194219|7159005|FG005|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
6260225|NCT01194219|7159006|FG006|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
6260226|NCT01194219|7159007|FG007|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
6260227|NCT01194219|7159008|FG008|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260228|NCT01194219|7159009|FG009|COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260229|NCT01194219|7159000|FG000|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260230|NCT01194219|7159001|FG001|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260231|NCT01194219|7159002|FG002|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260232|NCT01194219|7159003|FG003|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260233|NCT01194219|7159004|FG004|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
6260234|NCT01194219|7159005|FG005|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||4
6260235|NCT01194219|7159006|FG006|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||61
6260236|NCT01194219|7159007|FG007|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||45
6260237|NCT01194219|7159008|FG008|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260238|NCT01194219|7159009|FG009|NOT COMPLETED|Randomized Withdrawal Phase-Weeks 32-52||0
6260239|NCT01194219|7159000|FG000|STARTED|Long-Term Extension Weeks 52 to 260||0
6260240|NCT01194219|7159001|FG001|STARTED|Long-Term Extension Weeks 52 to 260||0
6260241|NCT01194219|7159002|FG002|STARTED|Long-Term Extension Weeks 52 to 260||0
6260242|NCT01194219|7159003|FG003|STARTED|Long-Term Extension Weeks 52 to 260||0
6260243|NCT01194219|7159004|FG004|STARTED|Long-Term Extension Weeks 52 to 260||0
6260244|NCT01194219|7159005|FG005|STARTED|Long-Term Extension Weeks 52 to 260||0
6260245|NCT01194219|7159006|FG006|STARTED|Long-Term Extension Weeks 52 to 260||0
6260246|NCT01194219|7159007|FG007|STARTED|Long-Term Extension Weeks 52 to 260||0
6260247|NCT01194219|7159008|FG008|STARTED|Long-Term Extension Weeks 52 to 260||306
6260248|NCT01194219|7159009|FG009|STARTED|Long-Term Extension Weeks 52 to 260||153
6260249|NCT01194219|7159000|FG000|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6260250|NCT01194219|7159001|FG001|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6260251|NCT01194219|7159002|FG002|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6260252|NCT01194219|7159003|FG003|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6260253|NCT01194219|7159004|FG004|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6260254|NCT01194219|7159005|FG005|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6260255|NCT01194219|7159006|FG006|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6701423|NCT02841709|7632007|FG000|NOT COMPLETED|4th Intervention||0
6701424|NCT02841709|7632008|FG001|NOT COMPLETED|4th Intervention||0
6701425|NCT02841709|7632009|FG002|NOT COMPLETED|4th Intervention||0
6701426|NCT02841709|7632010|FG003|NOT COMPLETED|4th Intervention||0
6701427|NCT02841709|7632011|FG004|NOT COMPLETED|4th Intervention||0
6701428|NCT02841709|7632007|FG000|STARTED|Washout Period 4||12
6701429|NCT02841709|7632008|FG001|STARTED|Washout Period 4||11
6701430|NCT02841709|7632009|FG002|STARTED|Washout Period 4||12
6701431|NCT02841709|7632010|FG003|STARTED|Washout Period 4||12
6701432|NCT02841709|7632011|FG004|STARTED|Washout Period 4||11
6701433|NCT02841709|7632007|FG000|COMPLETED|Washout Period 4||12
6701434|NCT02841709|7632008|FG001|COMPLETED|Washout Period 4||11
6701435|NCT02841709|7632009|FG002|COMPLETED|Washout Period 4||12
6701436|NCT02841709|7632010|FG003|COMPLETED|Washout Period 4||12
6701437|NCT02841709|7632011|FG004|COMPLETED|Washout Period 4||11
6701438|NCT02841709|7632007|FG000|NOT COMPLETED|Washout Period 4||0
6701439|NCT02841709|7632008|FG001|NOT COMPLETED|Washout Period 4||0
6701440|NCT02841709|7632009|FG002|NOT COMPLETED|Washout Period 4||0
6701441|NCT02841709|7632010|FG003|NOT COMPLETED|Washout Period 4||0
6701442|NCT02841709|7632011|FG004|NOT COMPLETED|Washout Period 4||0
6701443|NCT02841709|7632007|FG000|STARTED|5th Intervention||12
6701444|NCT02841709|7632008|FG001|STARTED|5th Intervention||11
6701445|NCT02841709|7632009|FG002|STARTED|5th Intervention||12
6701446|NCT02841709|7632010|FG003|STARTED|5th Intervention||12
6701447|NCT02841709|7632011|FG004|STARTED|5th Intervention||11
6701448|NCT02841709|7632007|FG000|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 1.|10
6701449|NCT02841709|7632008|FG001|COMPLETED|5th Intervention||11
6701450|NCT02841709|7632009|FG002|COMPLETED|5th Intervention||12
6701451|NCT02841709|7632010|FG003|COMPLETED|5th Intervention||12
6701452|NCT02841709|7632011|FG004|COMPLETED|5th Intervention|Note: In total, 2 subjects did not complete Sequence 5.|9
6701453|NCT02841709|7632007|FG000|NOT COMPLETED|5th Intervention||2
6701454|NCT02841709|7632008|FG001|NOT COMPLETED|5th Intervention||0
6701455|NCT02841709|7632009|FG002|NOT COMPLETED|5th Intervention||0
6701456|NCT02841709|7632010|FG003|NOT COMPLETED|5th Intervention||0
6701457|NCT02841709|7632011|FG004|NOT COMPLETED|5th Intervention||2
6701458|NCT02841787|7632027|FG000|STARTED|Overall Study||12
6701459|NCT02841787|7632028|FG001|STARTED|Overall Study||23
6701460|NCT02841787|7632029|FG002|STARTED|Overall Study||12
6701461|NCT02841787|7632027|FG000|COMPLETED|Overall Study||9
6701462|NCT02841787|7632028|FG001|COMPLETED|Overall Study||19
6701463|NCT02841787|7632029|FG002|COMPLETED|Overall Study||12
6701464|NCT02841787|7632027|FG000|NOT COMPLETED|Overall Study||3
6701465|NCT02841787|7632028|FG001|NOT COMPLETED|Overall Study||4
6701466|NCT02841787|7632029|FG002|NOT COMPLETED|Overall Study||0
6701467|NCT02842060|7632039|FG000|STARTED|Overall Study||120
6701468|NCT02842060|7632040|FG001|STARTED|Overall Study||60
6701469|NCT02842060|7632039|FG000|COMPLETED|Overall Study||120
6701470|NCT02842060|7632040|FG001|COMPLETED|Overall Study||60
6701471|NCT02842060|7632039|FG000|NOT COMPLETED|Overall Study||0
6701472|NCT02842060|7632040|FG001|NOT COMPLETED|Overall Study||0
6701473|NCT02842073|7632046|FG000|STARTED|Overall Study||12
6701474|NCT02842073|7632046|FG000|COMPLETED|Overall Study||11
6701475|NCT02842073|7632046|FG000|NOT COMPLETED|Overall Study||1
6701476|NCT02842086|7632052|FG000|STARTED|Overall Study||2700
6701477|NCT02842086|7632053|FG001|STARTED|Overall Study||2699
6701478|NCT02842086|7632052|FG000|COMPLETED|Overall Study||2156
6701479|NCT02842086|7632053|FG001|COMPLETED|Overall Study||2206
6701480|NCT02842086|7632052|FG000|NOT COMPLETED|Overall Study||544
6701481|NCT02842086|7632053|FG001|NOT COMPLETED|Overall Study||493
6701482|NCT02842151|7632059|FG000|STARTED|Overall Study||150
6701483|NCT02842151|7632059|FG000|COMPLETED|Overall Study||148
6701484|NCT02842151|7632059|FG000|NOT COMPLETED|Overall Study||2
6701485|NCT02842242|7632067|FG000|STARTED|Overall Study||11
6701486|NCT02842242|7632068|FG001|STARTED|Overall Study||10
6701487|NCT02842242|7632067|FG000|COMPLETED|Overall Study||10
6701488|NCT02842242|7632068|FG001|COMPLETED|Overall Study||10
6701489|NCT02842242|7632067|FG000|NOT COMPLETED|Overall Study||1
6701490|NCT02842242|7632068|FG001|NOT COMPLETED|Overall Study||0
6701491|NCT02842736|7632074|FG000|STARTED|Overall Study|Treated|242
6701492|NCT02842736|7632074|FG000|Known Month 12 Outcome|Overall Study||230
6701493|NCT02842736|7632074|FG000|24 Month Visit Performed|Overall Study||210
6701494|NCT02842736|7632074|FG000|COMPLETED|Overall Study|36 Month Visit Completed|201
6701495|NCT02842736|7632074|FG000|NOT COMPLETED|Overall Study||41
6701496|NCT02843178|7632082|FG000|STARTED|Overall Study||86
6701497|NCT02843178|7632083|FG001|STARTED|Overall Study||90
6701498|NCT02843178|7632084|FG002|STARTED|Overall Study||92
6701499|NCT02843178|7632085|FG003|STARTED|Overall Study||91
6701500|NCT02843178|7632082|FG000|COMPLETED|Overall Study||78
6701501|NCT02843178|7632083|FG001|COMPLETED|Overall Study||82
6701502|NCT02843178|7632084|FG002|COMPLETED|Overall Study||85
6701503|NCT02843178|7632085|FG003|COMPLETED|Overall Study||87
6701504|NCT02843178|7632082|FG000|NOT COMPLETED|Overall Study||8
6701505|NCT02843178|7632083|FG001|NOT COMPLETED|Overall Study||8
6701506|NCT02843178|7632084|FG002|NOT COMPLETED|Overall Study||7
6701507|NCT02843178|7632085|FG003|NOT COMPLETED|Overall Study||4
6701508|NCT02843529|7632097|FG000|STARTED|Overall Study||244
6701509|NCT02843529|7632098|FG001|STARTED|Overall Study||304
6701510|NCT02843529|7632097|FG000|COMPLETED|Overall Study||213
6701511|NCT02843529|7632098|FG001|COMPLETED|Overall Study||283
6701512|NCT02843529|7632097|FG000|NOT COMPLETED|Overall Study||31
6701513|NCT02843529|7632098|FG001|NOT COMPLETED|Overall Study||21
6701514|NCT02843659|7632107|FG000|STARTED|Overall Study||5
6701515|NCT02843659|7632108|FG001|STARTED|Overall Study||6
6701516|NCT02843659|7632109|FG002|STARTED|Overall Study||7
6701517|NCT02843659|7632107|FG000|COMPLETED|Overall Study||1
6701518|NCT02843659|7632108|FG001|COMPLETED|Overall Study||0
6701519|NCT02843659|7632109|FG002|COMPLETED|Overall Study||2
6701520|NCT02843659|7632107|FG000|NOT COMPLETED|Overall Study||4
6701521|NCT02843659|7632108|FG001|NOT COMPLETED|Overall Study||6
6701522|NCT02843659|7632109|FG002|NOT COMPLETED|Overall Study||5
6701523|NCT02844439|7632117|FG000|STARTED|Overall Study|"All Subjects with Glioblastoma:~24 subjects with EGFR-gene amplified + 16 subjects without EGFR gene-amplified nor EGFRvIII^pos"|40
6701524|NCT02844439|7632117|FG000|Subpopulation A (EGFR Gene Amplified Glioblastoma)|Overall Study||24
6701525|NCT02844439|7632117|FG000|Subpopulation B (EGFRvIII^Pos Glioblastoma)|Overall Study||11
6701526|NCT02844439|7632117|FG000|COMPLETED|Overall Study||0
6701527|NCT02844439|7632117|FG000|NOT COMPLETED|Overall Study||40
6701528|NCT02844543|7632128|FG000|STARTED|Overall Study||155
6701529|NCT02844543|7632128|FG000|COMPLETED|Overall Study||150
6701530|NCT02844543|7632128|FG000|NOT COMPLETED|Overall Study||5
6701531|NCT02844569|7632134|FG000|STARTED|Overall Study||12
6701532|NCT02844569|7632135|FG001|STARTED|Overall Study||12
6701533|NCT02844569|7632134|FG000|COMPLETED|Overall Study||12
6701534|NCT02844569|7632135|FG001|COMPLETED|Overall Study||12
6701535|NCT02844569|7632134|FG000|NOT COMPLETED|Overall Study||0
6701536|NCT02844569|7632135|FG001|NOT COMPLETED|Overall Study||0
6701537|NCT02844582|7632141|FG000|STARTED|Overall Study||2
6701538|NCT02844582|7632141|FG000|COMPLETED|Overall Study||2
6701539|NCT02844582|7632141|FG000|NOT COMPLETED|Overall Study||0
6701540|NCT02844920|7632145|FG000|STARTED|Overall Study||37
6701541|NCT02844920|7632145|FG000|Completed Without Evaluable Videos|Overall Study|Participants with completed the follow-up but without evaluable hysteroscopy videos|1
6701542|NCT02844920|7632145|FG000|Completed With Evaluable Videos|Overall Study|Participants with completed the follow-up and evaluable hysteroscopy videos|34
6701543|NCT02844920|7632145|FG000|Completed, Eval. Data, Opposing Fibroids|Overall Study|Participants with completed the follow-up, evaluable hysteroscopy videos, and opposing fibroids|6
6701544|NCT02844920|7632145|FG000|COMPLETED|Overall Study|Participants with completed the follow-up|35
6701545|NCT02844920|7632145|FG000|NOT COMPLETED|Overall Study||2
6701546|NCT02844998|7632152|FG000|STARTED|Overall Study||42
6701547|NCT02844998|7632153|FG001|STARTED|Overall Study||39
6701548|NCT02844998|7632154|FG002|STARTED|Overall Study||39
6701549|NCT02844998|7632152|FG000|COMPLETED|Overall Study||35
6701550|NCT02844998|7632153|FG001|COMPLETED|Overall Study||35
6701551|NCT02844998|7632154|FG002|COMPLETED|Overall Study||35
6701552|NCT02844998|7632152|FG000|NOT COMPLETED|Overall Study||7
6701553|NCT02844998|7632153|FG001|NOT COMPLETED|Overall Study||4
6701554|NCT02844998|7632154|FG002|NOT COMPLETED|Overall Study||4
6701555|NCT02845336|7632164|FG000|STARTED|Overall Study||6
6701556|NCT02845336|7632165|FG001|STARTED|Overall Study||1
6701557|NCT02845336|7632164|FG000|COMPLETED|Overall Study||1
6701558|NCT02845336|7632165|FG001|COMPLETED|Overall Study||0
6701559|NCT02845336|7632164|FG000|NOT COMPLETED|Overall Study||5
6701560|NCT02845336|7632165|FG001|NOT COMPLETED|Overall Study||1
6701561|NCT02845375|7632174|FG000|STARTED|Overall Study||13
6701562|NCT02845375|7632175|FG001|STARTED|Overall Study||14
6701563|NCT02845375|7632176|FG002|STARTED|Overall Study||13
6701564|NCT02845375|7632174|FG000|COMPLETED|Overall Study||12
6701565|NCT02845375|7632175|FG001|COMPLETED|Overall Study||12
6701566|NCT02845375|7632176|FG002|COMPLETED|Overall Study||12
6701567|NCT02845375|7632174|FG000|NOT COMPLETED|Overall Study||1
6701568|NCT02845375|7632175|FG001|NOT COMPLETED|Overall Study||2
6701569|NCT02845375|7632176|FG002|NOT COMPLETED|Overall Study||1
6701570|NCT02845674|7632186|FG000|STARTED|Overall Study||129
6701571|NCT02845674|7632187|FG001|STARTED|Overall Study||129
6701572|NCT02845674|7632186|FG000|COMPLETED|Overall Study||111
6701573|NCT02845674|7632187|FG001|COMPLETED|Overall Study||79
6701574|NCT02845674|7632186|FG000|NOT COMPLETED|Overall Study||18
6701575|NCT02845674|7632187|FG001|NOT COMPLETED|Overall Study||50
6701576|NCT02845700|7632195|FG000|STARTED|Baseline Appointment||6
6701577|NCT02845700|7632196|FG001|STARTED|Baseline Appointment||7
6701578|NCT02845700|7632195|FG000|COMPLETED|Baseline Appointment||6
6701579|NCT02845700|7632196|FG001|COMPLETED|Baseline Appointment||7
6701580|NCT02845700|7632195|FG000|NOT COMPLETED|Baseline Appointment||0
6701581|NCT02845700|7632196|FG001|NOT COMPLETED|Baseline Appointment||0
6701582|NCT02845700|7632195|FG000|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|5
6701583|NCT02845700|7632196|FG001|STARTED|Intervention Session 1|1 participant withdrew after completing the Baseline Appointment|6
6701584|NCT02845700|7632195|FG000|COMPLETED|Intervention Session 1||5
6701585|NCT02845700|7632196|FG001|COMPLETED|Intervention Session 1||6
6701586|NCT02845700|7632195|FG000|NOT COMPLETED|Intervention Session 1||0
6701587|NCT02845700|7632196|FG001|NOT COMPLETED|Intervention Session 1||0
6701588|NCT02845700|7632195|FG000|STARTED|Intervention Session 2||5
6701589|NCT02845700|7632196|FG001|STARTED|Intervention Session 2||6
6701590|NCT02845700|7632195|FG000|COMPLETED|Intervention Session 2||5
6701591|NCT02845700|7632196|FG001|COMPLETED|Intervention Session 2||6
6701592|NCT02845700|7632195|FG000|NOT COMPLETED|Intervention Session 2||0
6701593|NCT02845700|7632196|FG001|NOT COMPLETED|Intervention Session 2||0
6701594|NCT02845700|7632195|FG000|STARTED|Month 1 Follow-Up|3 participants withdrew after completing the Intervention 2 Appointment|2
6701595|NCT02845700|7632196|FG001|STARTED|Month 1 Follow-Up|2 participants withdrew after completing the Intervention 2 Appointment|4
6701596|NCT02845700|7632195|FG000|COMPLETED|Month 1 Follow-Up||2
6701597|NCT02845700|7632196|FG001|COMPLETED|Month 1 Follow-Up||4
6701598|NCT02845700|7632195|FG000|NOT COMPLETED|Month 1 Follow-Up||0
6701599|NCT02845700|7632196|FG001|NOT COMPLETED|Month 1 Follow-Up||0
6701600|NCT02845752|7632204|FG000|STARTED|First Intervention (7 Days)||7
6701601|NCT02845752|7632205|FG001|STARTED|First Intervention (7 Days)||7
6701602|NCT02845752|7632204|FG000|COMPLETED|First Intervention (7 Days)||7
6701603|NCT02845752|7632205|FG001|COMPLETED|First Intervention (7 Days)||7
6701604|NCT02845752|7632204|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6701605|NCT02845752|7632205|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6701606|NCT02845752|7632204|FG000|STARTED|Washout (14 Days)||7
6701607|NCT02845752|7632205|FG001|STARTED|Washout (14 Days)||7
6701608|NCT02845752|7632204|FG000|COMPLETED|Washout (14 Days)||7
6701609|NCT02845752|7632205|FG001|COMPLETED|Washout (14 Days)||7
6701610|NCT02845752|7632204|FG000|NOT COMPLETED|Washout (14 Days)||0
6701611|NCT02845752|7632205|FG001|NOT COMPLETED|Washout (14 Days)||0
6260256|NCT01194219|7159007|FG007|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||0
6260257|NCT01194219|7159008|FG008|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||304
6260258|NCT01194219|7159009|FG009|Received at Least 1 Dose of IP|Long-Term Extension Weeks 52 to 260||153
6260259|NCT01194219|7159000|FG000|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260260|NCT01194219|7159001|FG001|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260261|NCT01194219|7159002|FG002|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260262|NCT01194219|7159003|FG003|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260263|NCT01194219|7159004|FG004|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260264|NCT01194219|7159005|FG005|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260265|NCT01194219|7159006|FG006|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260266|NCT01194219|7159007|FG007|COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260267|NCT01194219|7159008|FG008|COMPLETED|Long-Term Extension Weeks 52 to 260||86
6260268|NCT01194219|7159009|FG009|COMPLETED|Long-Term Extension Weeks 52 to 260||41
6260269|NCT01194219|7159000|FG000|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260270|NCT01194219|7159001|FG001|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260271|NCT01194219|7159002|FG002|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260272|NCT01194219|7159003|FG003|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260273|NCT01194219|7159004|FG004|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260274|NCT01194219|7159005|FG005|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260275|NCT01194219|7159006|FG006|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260276|NCT01194219|7159007|FG007|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||0
6260277|NCT01194219|7159008|FG008|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||220
6260278|NCT01194219|7159009|FG009|NOT COMPLETED|Long-Term Extension Weeks 52 to 260||112
6260279|NCT01193842|7159037|FG000|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
6260280|NCT01193842|7159038|FG001|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260281|NCT01193842|7159039|FG002|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260282|NCT01193842|7159040|FG003|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260283|NCT01193842|7159041|FG004|STARTED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260284|NCT01193842|7159037|FG000|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||3
6260285|NCT01193842|7159038|FG001|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260286|NCT01193842|7159039|FG002|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260287|NCT01193842|7159040|FG003|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260288|NCT01193842|7159041|FG004|COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260289|NCT01193842|7159037|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260290|NCT01193842|7159038|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260291|NCT01193842|7159039|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260292|NCT01193842|7159040|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260293|NCT01193842|7159041|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, Dose Level (DL) 1||0
6260294|NCT01193842|7159037|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
6260295|NCT01193842|7159038|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 2||7
6260296|NCT01193842|7159039|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
6260297|NCT01193842|7159040|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
6260298|NCT01193842|7159041|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 2||0
6260299|NCT01193842|7159037|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6260300|NCT01193842|7159038|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||6
6260301|NCT01193842|7159039|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6260302|NCT01193842|7159040|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6260303|NCT01193842|7159041|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6260304|NCT01193842|7159037|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6260305|NCT01193842|7159038|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||1
6260306|NCT01193842|7159039|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6260307|NCT01193842|7159040|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6260308|NCT01193842|7159041|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 2||0
6260309|NCT01193842|7159037|FG000|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||4
6260310|NCT01193842|7159038|FG001|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260311|NCT01193842|7159039|FG002|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260312|NCT01193842|7159040|FG003|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260313|NCT01193842|7159041|FG004|STARTED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260314|NCT01193842|7159037|FG000|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||3
6701612|NCT02845752|7632204|FG000|STARTED|Second Intervention (7 Days)||7
6701613|NCT02845752|7632205|FG001|STARTED|Second Intervention (7 Days)||7
6701614|NCT02845752|7632204|FG000|COMPLETED|Second Intervention (7 Days)||7
6701615|NCT02845752|7632205|FG001|COMPLETED|Second Intervention (7 Days)||7
6701616|NCT02845752|7632204|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6701617|NCT02845752|7632205|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6701618|NCT02846233|7632213|FG000|STARTED|Overall Study||12
6701619|NCT02846233|7632214|FG001|STARTED|Overall Study||10
6701620|NCT02846233|7632213|FG000|COMPLETED|Overall Study||10
6701621|NCT02846233|7632214|FG001|COMPLETED|Overall Study||8
6701622|NCT02846233|7632213|FG000|NOT COMPLETED|Overall Study||2
6701623|NCT02846233|7632214|FG001|NOT COMPLETED|Overall Study||2
6701624|NCT02846324|7632224|FG000|STARTED|Overall Study||9
6701625|NCT02846324|7632225|FG001|STARTED|Overall Study||6
6701626|NCT02846324|7632226|FG002|STARTED|Overall Study||14
6701627|NCT02846324|7632227|FG003|STARTED|Overall Study||10
6701628|NCT02846324|7632224|FG000|Completed Study Treatment|Overall Study||7
6701629|NCT02846324|7632225|FG001|Completed Study Treatment|Overall Study||5
6701630|NCT02846324|7632226|FG002|Completed Study Treatment|Overall Study||11
6701631|NCT02846324|7632227|FG003|Completed Study Treatment|Overall Study||10
6701632|NCT02846324|7632224|FG000|COMPLETED|Overall Study||7
6701633|NCT02846324|7632225|FG001|COMPLETED|Overall Study||6
6701634|NCT02846324|7632226|FG002|COMPLETED|Overall Study||10
6701635|NCT02846324|7632227|FG003|COMPLETED|Overall Study||10
6701636|NCT02846324|7632224|FG000|NOT COMPLETED|Overall Study||2
6701637|NCT02846324|7632225|FG001|NOT COMPLETED|Overall Study||0
6701638|NCT02846324|7632226|FG002|NOT COMPLETED|Overall Study||4
6701639|NCT02846324|7632227|FG003|NOT COMPLETED|Overall Study||0
6701640|NCT02846415|7632248|FG000|STARTED|Overall Study||18
6701641|NCT02846415|7632249|FG001|STARTED|Overall Study||12
6701642|NCT02846415|7632248|FG000|COMPLETED|Overall Study||15
6701643|NCT02846415|7632249|FG001|COMPLETED|Overall Study||11
6701644|NCT02846415|7632248|FG000|NOT COMPLETED|Overall Study||3
6701645|NCT02846415|7632249|FG001|NOT COMPLETED|Overall Study||1
6701646|NCT02846558|7632259|FG000|STARTED|Overall Study||15
6701647|NCT02846558|7632260|FG001|STARTED|Overall Study||12
6701648|NCT02846558|7632261|FG002|STARTED|Overall Study||14
6701649|NCT02846558|7632262|FG003|STARTED|Overall Study||13
6701650|NCT02846558|7632259|FG000|Baseline Study Visit|Overall Study||10
6701651|NCT02846558|7632260|FG001|Baseline Study Visit|Overall Study||9
6701652|NCT02846558|7632261|FG002|Baseline Study Visit|Overall Study||14
6701653|NCT02846558|7632262|FG003|Baseline Study Visit|Overall Study||12
6701654|NCT02846558|7632259|FG000|3 Month Study Visit|Overall Study||7
6701655|NCT02846558|7632260|FG001|3 Month Study Visit|Overall Study||8
6701656|NCT02846558|7632261|FG002|3 Month Study Visit|Overall Study||12
6701657|NCT02846558|7632262|FG003|3 Month Study Visit|Overall Study||11
6701658|NCT02846558|7632259|FG000|COMPLETED|Overall Study||7
6701659|NCT02846558|7632260|FG001|COMPLETED|Overall Study||8
6701660|NCT02846558|7632261|FG002|COMPLETED|Overall Study||12
6701661|NCT02846558|7632262|FG003|COMPLETED|Overall Study||11
6701662|NCT02846558|7632259|FG000|NOT COMPLETED|Overall Study||8
6701663|NCT02846558|7632260|FG001|NOT COMPLETED|Overall Study||4
6701664|NCT02846558|7632261|FG002|NOT COMPLETED|Overall Study||2
6701665|NCT02846558|7632262|FG003|NOT COMPLETED|Overall Study||2
6701666|NCT02846714|7632279|FG000|STARTED|Overall Study||42
6701667|NCT02846714|7632279|FG000|COMPLETED|Overall Study||36
6701668|NCT02846714|7632279|FG000|NOT COMPLETED|Overall Study||6
6701669|NCT02846740|7632285|FG000|STARTED|Overall Study||15
6701670|NCT02846740|7632286|FG001|STARTED|Overall Study||15
6701671|NCT02846740|7632285|FG000|COMPLETED|Overall Study||15
6701672|NCT02846740|7632286|FG001|COMPLETED|Overall Study||14
6701673|NCT02846740|7632285|FG000|NOT COMPLETED|Overall Study||0
6701674|NCT02846740|7632286|FG001|NOT COMPLETED|Overall Study||1
6701675|NCT02846779|7632295|FG000|STARTED|Overall Study||2000
6701676|NCT02846779|7632296|FG001|STARTED|Overall Study||2000
6701677|NCT02846779|7632297|FG002|STARTED|Overall Study||2000
6701678|NCT02846779|7632295|FG000|COMPLETED|Overall Study||1861
6701679|NCT02846779|7632296|FG001|COMPLETED|Overall Study||1873
6701680|NCT02846779|7632297|FG002|COMPLETED|Overall Study||1862
6701681|NCT02846779|7632295|FG000|NOT COMPLETED|Overall Study||139
6701682|NCT02846779|7632296|FG001|NOT COMPLETED|Overall Study||127
6701683|NCT02846779|7632297|FG002|NOT COMPLETED|Overall Study||138
6701684|NCT02846792|7632305|FG000|STARTED|Overall Study||5
6701685|NCT02846792|7632305|FG000|COMPLETED|Overall Study||5
6701686|NCT02846792|7632305|FG000|NOT COMPLETED|Overall Study||0
6701687|NCT02847169|7632309|FG000|STARTED|First Intervention (1 Week)||15
6701688|NCT02847169|7632310|FG001|STARTED|First Intervention (1 Week)||15
6701689|NCT02847169|7632309|FG000|COMPLETED|First Intervention (1 Week)||15
6701690|NCT02847169|7632310|FG001|COMPLETED|First Intervention (1 Week)||15
6701691|NCT02847169|7632309|FG000|NOT COMPLETED|First Intervention (1 Week)||0
6701692|NCT02847169|7632310|FG001|NOT COMPLETED|First Intervention (1 Week)||0
6701693|NCT02847169|7632309|FG000|STARTED|Second Intervention (1 Week)||15
6701694|NCT02847169|7632310|FG001|STARTED|Second Intervention (1 Week)||15
6701695|NCT02847169|7632309|FG000|COMPLETED|Second Intervention (1 Week)||15
6701696|NCT02847169|7632310|FG001|COMPLETED|Second Intervention (1 Week)||15
6701697|NCT02847169|7632309|FG000|NOT COMPLETED|Second Intervention (1 Week)||0
6701698|NCT02847169|7632310|FG001|NOT COMPLETED|Second Intervention (1 Week)||0
6701699|NCT02847182|7632333|FG000|STARTED|Overall Study||119
6701700|NCT02847182|7632334|FG001|STARTED|Overall Study||61
6701701|NCT02847182|7632333|FG000|First Intervention (6 Months)|Overall Study||119
6701702|NCT02847182|7632334|FG001|First Intervention (6 Months)|Overall Study||61
6701703|NCT02847182|7632333|FG000|Second Intervention (6 Months)|Overall Study||61
6701704|NCT02847182|7632334|FG001|Second Intervention (6 Months)|Overall Study||119
6701705|NCT02847182|7632333|FG000|COMPLETED|Overall Study||119
6701706|NCT02847182|7632334|FG001|COMPLETED|Overall Study||60
6701707|NCT02847182|7632333|FG000|NOT COMPLETED|Overall Study||0
6701708|NCT02847182|7632334|FG001|NOT COMPLETED|Overall Study||1
6701709|NCT02847260|7632346|FG000|STARTED|Overall Study||39
6701710|NCT02847260|7632346|FG000|COMPLETED|Overall Study||32
6701711|NCT02847260|7632346|FG000|NOT COMPLETED|Overall Study||7
6701712|NCT02847494|7632352|FG000|STARTED|Overall Study||109
6701713|NCT02847494|7632353|FG001|STARTED|Overall Study||111
6701714|NCT02847494|7632352|FG000|COMPLETED|Overall Study||101
6701715|NCT02847494|7632353|FG001|COMPLETED|Overall Study||106
6701716|NCT02847494|7632352|FG000|NOT COMPLETED|Overall Study||8
6701717|NCT02847494|7632353|FG001|NOT COMPLETED|Overall Study||5
6701718|NCT02847650|7632361|FG000|STARTED|Overall Study||29
6701719|NCT02847650|7632362|FG001|STARTED|Overall Study||28
6701720|NCT02847650|7632361|FG000|COMPLETED|Overall Study||25
6701721|NCT02847650|7632362|FG001|COMPLETED|Overall Study||22
6701722|NCT02847650|7632361|FG000|NOT COMPLETED|Overall Study||4
6701723|NCT02847650|7632362|FG001|NOT COMPLETED|Overall Study||6
6701724|NCT02847858|7632370|FG000|STARTED|Overall Study||693
6701725|NCT02847858|7632371|FG001|STARTED|Overall Study||667
6701726|NCT02847858|7632370|FG000|COMPLETED|Overall Study||292
6701727|NCT02847858|7632371|FG001|COMPLETED|Overall Study||398
6701728|NCT02847858|7632370|FG000|NOT COMPLETED|Overall Study||401
6701729|NCT02847858|7632371|FG001|NOT COMPLETED|Overall Study||269
6701730|NCT02848079|7632382|FG000|STARTED|Overall Study||41
6701731|NCT02848079|7632382|FG000|Receieved Study Treatment|Overall Study||41
6701732|NCT02848079|7632382|FG000|Discontinued|Overall Study||41
6701733|NCT02848079|7632382|FG000|COMPLETED|Overall Study||41
6701734|NCT02848079|7632382|FG000|NOT COMPLETED|Overall Study||0
6701735|NCT02848222|7632389|FG000|STARTED|Overall Study||25
6701736|NCT02848222|7632390|FG001|STARTED|Overall Study||18
6701737|NCT02848222|7632391|FG002|STARTED|Overall Study||17
6701738|NCT02848222|7632389|FG000|COMPLETED|Overall Study||18
6701739|NCT02848222|7632390|FG001|COMPLETED|Overall Study||17
6701740|NCT02848222|7632391|FG002|COMPLETED|Overall Study||17
6701741|NCT02848222|7632389|FG000|NOT COMPLETED|Overall Study||7
6701742|NCT02848222|7632390|FG001|NOT COMPLETED|Overall Study||1
6701743|NCT02848222|7632391|FG002|NOT COMPLETED|Overall Study||0
6701744|NCT02848313|7632401|FG000|STARTED|Overall Study||21
6701745|NCT02848313|7632402|FG001|STARTED|Overall Study||19
6701746|NCT02848313|7632401|FG000|COMPLETED|Overall Study||18
6701747|NCT02848313|7632402|FG001|COMPLETED|Overall Study||15
6701748|NCT02848313|7632401|FG000|NOT COMPLETED|Overall Study||3
6701749|NCT02848313|7632402|FG001|NOT COMPLETED|Overall Study||4
6701750|NCT02848326|7632414|FG000|STARTED|Treatment Period||186
6701751|NCT02848326|7632415|FG001|STARTED|Treatment Period||94
6701752|NCT02848326|7632416|FG002|STARTED|Treatment Period||185
6701753|NCT02848326|7632417|FG003|STARTED|Treatment Period||187
6701754|NCT02848326|7632418|FG004|STARTED|Treatment Period||89
6701755|NCT02848326|7632419|FG005|STARTED|Treatment Period||93
6701756|NCT02848326|7632414|FG000|Safety Population: Received Study Drug|Treatment Period||186
6701757|NCT02848326|7632415|FG001|Safety Population: Received Study Drug|Treatment Period||93
6701758|NCT02848326|7632416|FG002|Safety Population: Received Study Drug|Treatment Period||183
6701759|NCT02848326|7632417|FG003|Safety Population: Received Study Drug|Treatment Period||186
6701760|NCT02848326|7632418|FG004|Safety Population: Received Study Drug|Treatment Period||86
6701761|NCT02848326|7632419|FG005|Safety Population: Received Study Drug|Treatment Period||91
6701762|NCT02848326|7632414|FG000|COMPLETED|Treatment Period||148
6701763|NCT02848326|7632415|FG001|COMPLETED|Treatment Period||80
6701764|NCT02848326|7632416|FG002|COMPLETED|Treatment Period||149
6701765|NCT02848326|7632417|FG003|COMPLETED|Treatment Period||164
6701766|NCT02848326|7632418|FG004|COMPLETED|Treatment Period||70
6701767|NCT02848326|7632419|FG005|COMPLETED|Treatment Period||73
6701768|NCT02848326|7632414|FG000|NOT COMPLETED|Treatment Period||38
6701769|NCT02848326|7632415|FG001|NOT COMPLETED|Treatment Period||14
6701770|NCT02848326|7632416|FG002|NOT COMPLETED|Treatment Period||36
6701771|NCT02848326|7632417|FG003|NOT COMPLETED|Treatment Period||23
6701772|NCT02848326|7632418|FG004|NOT COMPLETED|Treatment Period||19
6701773|NCT02848326|7632419|FG005|NOT COMPLETED|Treatment Period||20
6701774|NCT02848326|7632414|FG000|STARTED|Safety Follow-up Period||161
6701775|NCT02848326|7632415|FG001|STARTED|Safety Follow-up Period||84
6701776|NCT02848326|7632416|FG002|STARTED|Safety Follow-up Period||156
6701777|NCT02848326|7632417|FG003|STARTED|Safety Follow-up Period||169
6701778|NCT02848326|7632418|FG004|STARTED|Safety Follow-up Period||77
6701779|NCT02848326|7632419|FG005|STARTED|Safety Follow-up Period||82
6701780|NCT02848326|7632414|FG000|COMPLETED|Safety Follow-up Period||157
6701781|NCT02848326|7632415|FG001|COMPLETED|Safety Follow-up Period||83
6701782|NCT02848326|7632416|FG002|COMPLETED|Safety Follow-up Period||153
6701783|NCT02848326|7632417|FG003|COMPLETED|Safety Follow-up Period||169
6701784|NCT02848326|7632418|FG004|COMPLETED|Safety Follow-up Period||76
6701785|NCT02848326|7632419|FG005|COMPLETED|Safety Follow-up Period||77
6701786|NCT02848326|7632414|FG000|NOT COMPLETED|Safety Follow-up Period||4
6701787|NCT02848326|7632415|FG001|NOT COMPLETED|Safety Follow-up Period||1
6701788|NCT02848326|7632416|FG002|NOT COMPLETED|Safety Follow-up Period||3
6701789|NCT02848326|7632417|FG003|NOT COMPLETED|Safety Follow-up Period||0
6701790|NCT02848326|7632418|FG004|NOT COMPLETED|Safety Follow-up Period||1
6701791|NCT02848326|7632419|FG005|NOT COMPLETED|Safety Follow-up Period||5
6701792|NCT02848599|7632435|FG000|STARTED|Overall Study||42
6701793|NCT02848599|7632436|FG001|STARTED|Overall Study||44
6701794|NCT02848599|7632435|FG000|COMPLETED|Overall Study||35
6701795|NCT02848599|7632436|FG001|COMPLETED|Overall Study||35
6701796|NCT02848599|7632435|FG000|NOT COMPLETED|Overall Study||7
6701797|NCT02848599|7632436|FG001|NOT COMPLETED|Overall Study||9
6701798|NCT02848651|7632444|FG000|STARTED|Overall Study||153
6701799|NCT02848651|7632444|FG000|Received Treatment|Overall Study||152
6701800|NCT02848651|7632444|FG000|COMPLETED|Overall Study||47
6701801|NCT02848651|7632444|FG000|NOT COMPLETED|Overall Study||106
6701802|NCT02848664|7632464|FG000|STARTED|Overall Study||11
6701803|NCT02848664|7632464|FG000|COMPLETED|Overall Study||7
6701804|NCT02848664|7632464|FG000|NOT COMPLETED|Overall Study||4
6701805|NCT02848729|7632474|FG000|STARTED|Overall Study||27
6701806|NCT02848729|7632475|FG001|STARTED|Overall Study||23
6701807|NCT02848729|7632474|FG000|Per Protocol Population|Overall Study||11
6701808|NCT02848729|7632475|FG001|Per Protocol Population|Overall Study||11
6260315|NCT01193842|7159038|FG001|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6701809|NCT02848729|7632474|FG000|Safety Population|Overall Study||27
6701810|NCT02848729|7632475|FG001|Safety Population|Overall Study||23
6701811|NCT02848729|7632474|FG000|COMPLETED|Overall Study||11
6701812|NCT02848729|7632475|FG001|COMPLETED|Overall Study||12
6701813|NCT02848729|7632474|FG000|NOT COMPLETED|Overall Study||16
6701814|NCT02848729|7632475|FG001|NOT COMPLETED|Overall Study||11
6701815|NCT02848833|7632488|FG000|STARTED|Overall Study||3368
6701816|NCT02848833|7632488|FG000|COMPLETED|Overall Study||3231
6701817|NCT02848833|7632488|FG000|NOT COMPLETED|Overall Study||137
6701818|NCT02849080|7632494|FG000|STARTED|Main Phase: 0 - 52 Weeks||253
6701819|NCT02849080|7632495|FG001|STARTED|Main Phase: 0 - 52 Weeks||251
6701820|NCT02849080|7632496|FG002|STARTED|Main Phase: 0 - 52 Weeks||0
6701821|NCT02849080|7632497|FG003|STARTED|Main Phase: 0 - 52 Weeks||0
6701822|NCT02849080|7632494|FG000|Exposed|Main Phase: 0 - 52 Weeks||253
6701823|NCT02849080|7632495|FG001|Exposed|Main Phase: 0 - 52 Weeks||250
6701824|NCT02849080|7632496|FG002|Exposed|Main Phase: 0 - 52 Weeks||0
6701825|NCT02849080|7632497|FG003|Exposed|Main Phase: 0 - 52 Weeks||0
6701826|NCT02849080|7632494|FG000|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||253
6701827|NCT02849080|7632495|FG001|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||251
6701828|NCT02849080|7632496|FG002|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
6701829|NCT02849080|7632497|FG003|Full Analysis Set (FAS)|Main Phase: 0 - 52 Weeks||0
6701830|NCT02849080|7632494|FG000|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||253
6701831|NCT02849080|7632495|FG001|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||250
6701832|NCT02849080|7632496|FG002|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
6701833|NCT02849080|7632497|FG003|Safety Analysis Set (SAS)|Main Phase: 0 - 52 Weeks||0
6701834|NCT02849080|7632494|FG000|COMPLETED|Main Phase: 0 - 52 Weeks||241
6701835|NCT02849080|7632495|FG001|COMPLETED|Main Phase: 0 - 52 Weeks||244
6701836|NCT02849080|7632496|FG002|COMPLETED|Main Phase: 0 - 52 Weeks||0
6701837|NCT02849080|7632497|FG003|COMPLETED|Main Phase: 0 - 52 Weeks||0
6701838|NCT02849080|7632494|FG000|NOT COMPLETED|Main Phase: 0 - 52 Weeks||12
6701839|NCT02849080|7632495|FG001|NOT COMPLETED|Main Phase: 0 - 52 Weeks||7
6701840|NCT02849080|7632496|FG002|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
6701841|NCT02849080|7632497|FG003|NOT COMPLETED|Main Phase: 0 - 52 Weeks||0
6701842|NCT02849080|7632494|FG000|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|185
6701843|NCT02849080|7632495|FG001|STARTED|Extension Phase: 53 - 104 Weeks||0
6701844|NCT02849080|7632496|FG002|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|100
6701845|NCT02849080|7632497|FG003|STARTED|Extension Phase: 53 - 104 Weeks|Participants who had provided consent to continue in the extension phase started in this period.|98
6701846|NCT02849080|7632494|FG000|Exposed|Extension Phase: 53 - 104 Weeks||184
6701847|NCT02849080|7632495|FG001|Exposed|Extension Phase: 53 - 104 Weeks||0
6701848|NCT02849080|7632496|FG002|Exposed|Extension Phase: 53 - 104 Weeks||100
6701849|NCT02849080|7632497|FG003|Exposed|Extension Phase: 53 - 104 Weeks||97
6701850|NCT02849080|7632494|FG000|COMPLETED|Extension Phase: 53 - 104 Weeks||182
6701851|NCT02849080|7632495|FG001|COMPLETED|Extension Phase: 53 - 104 Weeks||0
6701852|NCT02849080|7632496|FG002|COMPLETED|Extension Phase: 53 - 104 Weeks||99
6701853|NCT02849080|7632497|FG003|COMPLETED|Extension Phase: 53 - 104 Weeks||98
6701854|NCT02849080|7632494|FG000|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||3
6701855|NCT02849080|7632495|FG001|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
6701856|NCT02849080|7632496|FG002|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||1
6701857|NCT02849080|7632497|FG003|NOT COMPLETED|Extension Phase: 53 - 104 Weeks||0
6701858|NCT02849184|7632511|FG000|STARTED|Overall Study||40
6701859|NCT02849184|7632512|FG001|STARTED|Overall Study||42
6701860|NCT02849184|7632511|FG000|COMPLETED|Overall Study||40
6701861|NCT02849184|7632512|FG001|COMPLETED|Overall Study||42
6701862|NCT02849184|7632511|FG000|NOT COMPLETED|Overall Study||0
6701863|NCT02849184|7632512|FG001|NOT COMPLETED|Overall Study||0
6701864|NCT02849418|7632520|FG000|STARTED|Double-blinded (Up to 48 Weeks)||10
6701865|NCT02849418|7632521|FG001|STARTED|Double-blinded (Up to 48 Weeks)||11
6701866|NCT02849418|7632522|FG002|STARTED|Double-blinded (Up to 48 Weeks)||0
6701867|NCT02849418|7632523|FG003|STARTED|Double-blinded (Up to 48 Weeks)||0
6701868|NCT02849418|7632524|FG004|STARTED|Double-blinded (Up to 48 Weeks)||0
6701869|NCT02849418|7632525|FG005|STARTED|Double-blinded (Up to 48 Weeks)||0
6701870|NCT02849418|7632520|FG000|COMPLETED|Double-blinded (Up to 48 Weeks)||10
6701871|NCT02849418|7632521|FG001|COMPLETED|Double-blinded (Up to 48 Weeks)||11
6701872|NCT02849418|7632522|FG002|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701873|NCT02849418|7632523|FG003|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701874|NCT02849418|7632524|FG004|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701875|NCT02849418|7632525|FG005|COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701876|NCT02849418|7632520|FG000|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701877|NCT02849418|7632521|FG001|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701878|NCT02849418|7632522|FG002|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701879|NCT02849418|7632523|FG003|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701880|NCT02849418|7632524|FG004|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701881|NCT02849418|7632525|FG005|NOT COMPLETED|Double-blinded (Up to 48 Weeks)||0
6701882|NCT02849418|7632520|FG000|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
6701883|NCT02849418|7632521|FG001|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
6701884|NCT02849418|7632522|FG002|STARTED|Open-label(2nd Treatment-Week 12 to 48)||10
6701885|NCT02849418|7632523|FG003|STARTED|Open-label(2nd Treatment-Week 12 to 48)||6
6701886|NCT02849418|7632524|FG004|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
6701887|NCT02849418|7632525|FG005|STARTED|Open-label(2nd Treatment-Week 12 to 48)||0
6701888|NCT02849418|7632520|FG000|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701889|NCT02849418|7632521|FG001|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701890|NCT02849418|7632522|FG002|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||10
6701891|NCT02849418|7632523|FG003|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||6
6701892|NCT02849418|7632524|FG004|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701893|NCT02849418|7632525|FG005|COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701894|NCT02849418|7632520|FG000|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701895|NCT02849418|7632521|FG001|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701896|NCT02849418|7632522|FG002|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701897|NCT02849418|7632523|FG003|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701898|NCT02849418|7632524|FG004|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701899|NCT02849418|7632525|FG005|NOT COMPLETED|Open-label(2nd Treatment-Week 12 to 48)||0
6701900|NCT02849418|7632520|FG000|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
6701901|NCT02849418|7632521|FG001|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
6701902|NCT02849418|7632522|FG002|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
6701903|NCT02849418|7632523|FG003|STARTED|Open-label(3rd Treatment-Week 12 to 48)||0
6701904|NCT02849418|7632524|FG004|STARTED|Open-label(3rd Treatment-Week 12 to 48)||5
6701905|NCT02849418|7632525|FG005|STARTED|Open-label(3rd Treatment-Week 12 to 48)||3
6701906|NCT02849418|7632520|FG000|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701907|NCT02849418|7632521|FG001|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701908|NCT02849418|7632522|FG002|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701909|NCT02849418|7632523|FG003|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6392112|NCT00839436|7304095|FG001|COMPLETED|Overall Study||4
6392113|NCT00839436|7304096|FG002|COMPLETED|Overall Study||0
6392114|NCT00839436|7304094|FG000|NOT COMPLETED|Overall Study||1
6392115|NCT00839436|7304095|FG001|NOT COMPLETED|Overall Study||1
6392116|NCT00839436|7304096|FG002|NOT COMPLETED|Overall Study||1
6701910|NCT02849418|7632524|FG004|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||5
6701911|NCT02849418|7632525|FG005|COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||3
6701912|NCT02849418|7632520|FG000|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701913|NCT02849418|7632521|FG001|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701914|NCT02849418|7632522|FG002|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701915|NCT02849418|7632523|FG003|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701916|NCT02849418|7632524|FG004|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701917|NCT02849418|7632525|FG005|NOT COMPLETED|Open-label(3rd Treatment-Week 12 to 48)||0
6701918|NCT02849509|7632544|FG000|STARTED|Overall Study||379
6701919|NCT02849509|7632545|FG001|STARTED|Overall Study||591
6701920|NCT02849509|7632546|FG002|STARTED|Overall Study||343
6701921|NCT02849509|7632544|FG000|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|289
6701922|NCT02849509|7632545|FG001|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|425
6701923|NCT02849509|7632546|FG002|COMPLETED|Overall Study|Not prematurely discontinued from Pradaxa or VKA|258
6701924|NCT02849509|7632544|FG000|NOT COMPLETED|Overall Study||90
6701925|NCT02849509|7632545|FG001|NOT COMPLETED|Overall Study||166
6701926|NCT02849509|7632546|FG002|NOT COMPLETED|Overall Study||85
6701927|NCT02849678|7632558|FG000|STARTED|Overall Study||20
6701928|NCT02849678|7632559|FG001|STARTED|Overall Study||24
6701929|NCT02849678|7632558|FG000|COMPLETED|Overall Study||17
6701930|NCT02849678|7632559|FG001|COMPLETED|Overall Study||18
6701931|NCT02849678|7632558|FG000|NOT COMPLETED|Overall Study||3
6701932|NCT02849678|7632559|FG001|NOT COMPLETED|Overall Study||6
6701933|NCT02849704|7632567|FG000|STARTED|Washout Period - CP Subj on PERT - 3days||11
6701934|NCT02849704|7632568|FG001|STARTED|Washout Period - CP Subj on PERT - 3days||0
6701935|NCT02849704|7632567|FG000|COMPLETED|Washout Period - CP Subj on PERT - 3days||11
6701936|NCT02849704|7632568|FG001|COMPLETED|Washout Period - CP Subj on PERT - 3days||0
6701937|NCT02849704|7632567|FG000|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
6701938|NCT02849704|7632568|FG001|NOT COMPLETED|Washout Period - CP Subj on PERT - 3days||0
6701939|NCT02849704|7632567|FG000|STARTED|Baseline Assessments - All Subj - 7 Days||24
6701940|NCT02849704|7632568|FG001|STARTED|Baseline Assessments - All Subj - 7 Days||24
6701941|NCT02849704|7632567|FG000|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
6701942|NCT02849704|7632568|FG001|COMPLETED|Baseline Assessments - All Subj - 7 Days||24
6701943|NCT02849704|7632567|FG000|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
6701944|NCT02849704|7632568|FG001|NOT COMPLETED|Baseline Assessments - All Subj - 7 Days||0
6701945|NCT02849704|7632567|FG000|STARTED|Assessment on PERT - CP Subj - 16 Days||24
6701946|NCT02849704|7632568|FG001|STARTED|Assessment on PERT - CP Subj - 16 Days||0
6701947|NCT02849704|7632567|FG000|COMPLETED|Assessment on PERT - CP Subj - 16 Days||21
6701948|NCT02849704|7632568|FG001|COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
6701949|NCT02849704|7632567|FG000|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||3
6701950|NCT02849704|7632568|FG001|NOT COMPLETED|Assessment on PERT - CP Subj - 16 Days||0
6701951|NCT02849938|7632580|FG000|STARTED|Overall Study||9
6701952|NCT02849938|7632581|FG001|STARTED|Overall Study||15
6701953|NCT02849938|7632580|FG000|COMPLETED|Overall Study||9
6701954|NCT02849938|7632581|FG001|COMPLETED|Overall Study||15
6701955|NCT02849938|7632580|FG000|NOT COMPLETED|Overall Study||0
6701956|NCT02849938|7632581|FG001|NOT COMPLETED|Overall Study||0
6701957|NCT02850068|7632587|FG000|STARTED|Overall Study||20
6701958|NCT02850068|7632587|FG000|COMPLETED|Overall Study||0
6701959|NCT02850068|7632587|FG000|NOT COMPLETED|Overall Study||20
6701960|NCT02850159|7632593|FG000|STARTED|Overall Study||16
6701961|NCT02850159|7632594|FG001|STARTED|Overall Study||16
6701962|NCT02850159|7632593|FG000|COMPLETED|Overall Study||16
6701963|NCT02850159|7632594|FG001|COMPLETED|Overall Study||16
6701964|NCT02850159|7632593|FG000|NOT COMPLETED|Overall Study||0
6701965|NCT02850159|7632594|FG001|NOT COMPLETED|Overall Study||0
6701966|NCT02850276|7632600|FG000|STARTED|Overall Study||76
6701967|NCT02850276|7632600|FG000|COMPLETED|Overall Study||15
6701968|NCT02850276|7632600|FG000|NOT COMPLETED|Overall Study||61
6701969|NCT02850601|7632607|FG000|STARTED|Overall Study||12
6701970|NCT02850601|7632608|FG001|STARTED|Overall Study||12
6701971|NCT02850601|7632607|FG000|COMPLETED|Overall Study||12
6701972|NCT02850601|7632608|FG001|COMPLETED|Overall Study||12
6701973|NCT02850601|7632607|FG000|NOT COMPLETED|Overall Study||0
6701974|NCT02850601|7632608|FG001|NOT COMPLETED|Overall Study||0
6701975|NCT02850965|7632616|FG000|STARTED|Overall Study||159
6701976|NCT02850965|7632617|FG001|STARTED|Overall Study||159
6701977|NCT02850965|7632616|FG000|Treated|Overall Study||159
6701978|NCT02850965|7632617|FG001|Treated|Overall Study||158
6701979|NCT02850965|7632616|FG000|COMPLETED|Overall Study||141
6701980|NCT02850965|7632617|FG001|COMPLETED|Overall Study||134
6701981|NCT02850965|7632616|FG000|NOT COMPLETED|Overall Study||18
6701982|NCT02850965|7632617|FG001|NOT COMPLETED|Overall Study||25
6701983|NCT02850978|7632623|FG000|STARTED|Overall Study||1335
6701984|NCT02850978|7632623|FG000|Case Report Form (CRF) Collected|Overall Study||1308
6701985|NCT02850978|7632623|FG000|Treated|Overall Study||1308
6701986|NCT02850978|7632623|FG000|COMPLETED|Overall Study||909
6701987|NCT02850978|7632623|FG000|NOT COMPLETED|Overall Study||426
6701988|NCT02851069|7632627|FG000|STARTED|Overall Study||65
6701989|NCT02851069|7632627|FG000|COMPLETED|Overall Study||59
6701990|NCT02851069|7632627|FG000|NOT COMPLETED|Overall Study||6
6701991|NCT02851108|7632634|FG000|STARTED|Overall Study||50
6701992|NCT02851108|7632635|FG001|STARTED|Overall Study||50
6701993|NCT02851108|7632634|FG000|COMPLETED|Overall Study||42
6701994|NCT02851108|7632635|FG001|COMPLETED|Overall Study||49
6701995|NCT02851108|7632634|FG000|NOT COMPLETED|Overall Study||8
6701996|NCT02851108|7632635|FG001|NOT COMPLETED|Overall Study||1
6701997|NCT02851615|7632643|FG000|STARTED|Overall Study||27
6701998|NCT02851615|7632644|FG001|STARTED|Overall Study||31
6701999|NCT02851615|7632643|FG000|COMPLETED|Overall Study||26
6702000|NCT02851615|7632644|FG001|COMPLETED|Overall Study||27
6702001|NCT02851615|7632643|FG000|NOT COMPLETED|Overall Study||1
6702002|NCT02851615|7632644|FG001|NOT COMPLETED|Overall Study||4
6702003|NCT02851823|7632651|FG000|STARTED|Overall Study||25
6702004|NCT02851823|7632651|FG000|1 Month|Overall Study||25
6702005|NCT02851823|7632651|FG000|3 Months|Overall Study||25
6702006|NCT02851823|7632651|FG000|COMPLETED|Overall Study||25
6702007|NCT02851823|7632651|FG000|NOT COMPLETED|Overall Study||0
6702008|NCT02852005|7632662|FG000|STARTED|Overall Study||4
6702009|NCT02852005|7632663|FG001|STARTED|Overall Study||4
6702010|NCT02852005|7632664|FG002|STARTED|Overall Study||6
6702011|NCT02852005|7632665|FG003|STARTED|Overall Study||6
6702012|NCT02852005|7632666|FG004|STARTED|Overall Study||7
6702013|NCT02852005|7632662|FG000|Month 0.5|Overall Study||3
6702014|NCT02852005|7632663|FG001|Month 0.5|Overall Study||4
6702015|NCT02852005|7632664|FG002|Month 0.5|Overall Study||6
6702016|NCT02852005|7632665|FG003|Month 0.5|Overall Study||6
6702017|NCT02852005|7632666|FG004|Month 0.5|Overall Study||7
6702018|NCT02852005|7632662|FG000|Month 4.5|Overall Study||3
6702019|NCT02852005|7632663|FG001|Month 4.5|Overall Study||4
6702020|NCT02852005|7632664|FG002|Month 4.5|Overall Study||6
6702021|NCT02852005|7632665|FG003|Month 4.5|Overall Study||6
6702022|NCT02852005|7632666|FG004|Month 4.5|Overall Study||7
6702023|NCT02852005|7632662|FG000|Month 10|Overall Study||3
6702024|NCT02852005|7632663|FG001|Month 10|Overall Study||3
6702025|NCT02852005|7632664|FG002|Month 10|Overall Study||6
6702026|NCT02852005|7632665|FG003|Month 10|Overall Study||5
6702027|NCT02852005|7632666|FG004|Month 10|Overall Study||7
6702028|NCT02852005|7632662|FG000|COMPLETED|Overall Study||3
6702029|NCT02852005|7632663|FG001|COMPLETED|Overall Study||4
6702030|NCT02852005|7632664|FG002|COMPLETED|Overall Study||6
6702031|NCT02852005|7632665|FG003|COMPLETED|Overall Study||6
6702032|NCT02852005|7632666|FG004|COMPLETED|Overall Study||6
6702033|NCT02852005|7632662|FG000|NOT COMPLETED|Overall Study||1
6702034|NCT02852005|7632663|FG001|NOT COMPLETED|Overall Study||0
6702035|NCT02852005|7632664|FG002|NOT COMPLETED|Overall Study||0
6702036|NCT02852005|7632665|FG003|NOT COMPLETED|Overall Study||0
6702037|NCT02852005|7632666|FG004|NOT COMPLETED|Overall Study||1
6702038|NCT02852265|7632682|FG000|STARTED|1-month Follow-up||10
6702039|NCT02852265|7632683|FG001|STARTED|1-month Follow-up||10
6702040|NCT02852265|7632682|FG000|COMPLETED|1-month Follow-up||10
6702041|NCT02852265|7632683|FG001|COMPLETED|1-month Follow-up||10
6702042|NCT02852265|7632682|FG000|NOT COMPLETED|1-month Follow-up||0
6702043|NCT02852265|7632683|FG001|NOT COMPLETED|1-month Follow-up||0
6702044|NCT02852265|7632682|FG000|STARTED|3-month Follow-up||10
6702045|NCT02852265|7632683|FG001|STARTED|3-month Follow-up||10
6702046|NCT02852265|7632682|FG000|COMPLETED|3-month Follow-up||9
6702047|NCT02852265|7632683|FG001|COMPLETED|3-month Follow-up||9
6702048|NCT02852265|7632682|FG000|NOT COMPLETED|3-month Follow-up||1
6702049|NCT02852265|7632683|FG001|NOT COMPLETED|3-month Follow-up||1
6702050|NCT02852265|7632682|FG000|STARTED|6-month Follow-up||9
6702051|NCT02852265|7632683|FG001|STARTED|6-month Follow-up||9
6702052|NCT02852265|7632682|FG000|COMPLETED|6-month Follow-up||9
6702053|NCT02852265|7632683|FG001|COMPLETED|6-month Follow-up||9
6702054|NCT02852265|7632682|FG000|NOT COMPLETED|6-month Follow-up||0
6702055|NCT02852265|7632683|FG001|NOT COMPLETED|6-month Follow-up||0
6702056|NCT02852330|7632693|FG000|STARTED|Overall Study||20
6702057|NCT02852330|7632693|FG000|COMPLETED|Overall Study||20
6702058|NCT02852330|7632693|FG000|NOT COMPLETED|Overall Study||0
6702059|NCT02852434|7632699|FG000|STARTED|Overall Study||36
6702060|NCT02852434|7632700|FG001|STARTED|Overall Study||36
6702061|NCT02852434|7632699|FG000|COMPLETED|Overall Study||34
6702062|NCT02852434|7632700|FG001|COMPLETED|Overall Study||35
6702063|NCT02852434|7632699|FG000|NOT COMPLETED|Overall Study||2
6702064|NCT02852434|7632700|FG001|NOT COMPLETED|Overall Study||1
6702065|NCT02853032|7632708|FG000|STARTED|Overall Study||60
6702066|NCT02853032|7632709|FG001|STARTED|Overall Study||59
6702067|NCT02853032|7632708|FG000|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|51
6702068|NCT02853032|7632709|FG001|COMPLETED|Overall Study|"Evaluable = 10 or more irTMS sessions Completers = 15 or more irTMS sessions"|56
6702069|NCT02853032|7632708|FG000|NOT COMPLETED|Overall Study||9
6702070|NCT02853032|7632709|FG001|NOT COMPLETED|Overall Study||3
6702071|NCT02853123|7632717|FG000|STARTED|Treatment Period 1||52
6702072|NCT02853123|7632718|FG001|STARTED|Treatment Period 1||54
6702073|NCT02853123|7632717|FG000|COMPLETED|Treatment Period 1||52
6702074|NCT02853123|7632718|FG001|COMPLETED|Treatment Period 1||51
6702075|NCT02853123|7632717|FG000|NOT COMPLETED|Treatment Period 1||0
6702076|NCT02853123|7632718|FG001|NOT COMPLETED|Treatment Period 1||3
6702077|NCT02853123|7632717|FG000|STARTED|Washout Period||52
6702078|NCT02853123|7632718|FG001|STARTED|Washout Period||51
6702079|NCT02853123|7632717|FG000|COMPLETED|Washout Period||51
6702080|NCT02853123|7632718|FG001|COMPLETED|Washout Period||48
6702081|NCT02853123|7632717|FG000|NOT COMPLETED|Washout Period||1
6702082|NCT02853123|7632718|FG001|NOT COMPLETED|Washout Period||3
6702083|NCT02853123|7632717|FG000|STARTED|Treatment Period 2||51
6702084|NCT02853123|7632718|FG001|STARTED|Treatment Period 2||48
6702085|NCT02853123|7632717|FG000|COMPLETED|Treatment Period 2||51
6702086|NCT02853123|7632718|FG001|COMPLETED|Treatment Period 2||48
6702087|NCT02853123|7632717|FG000|NOT COMPLETED|Treatment Period 2||0
6702088|NCT02853123|7632718|FG001|NOT COMPLETED|Treatment Period 2||0
6702089|NCT02853318|7632725|FG000|STARTED|Overall Study||40
6702090|NCT02853318|7632725|FG000|COMPLETED|Overall Study||39
6702091|NCT02853318|7632725|FG000|NOT COMPLETED|Overall Study||1
6702092|NCT02853435|7632732|FG000|STARTED|Part 1a, Period 1 (3 Days)||9
6702093|NCT02853435|7632733|FG001|STARTED|Part 1a, Period 1 (3 Days)||9
6702094|NCT02853435|7632734|FG002|STARTED|Part 1a, Period 1 (3 Days)||8
6702095|NCT02853435|7632735|FG003|STARTED|Part 1a, Period 1 (3 Days)||0
6702096|NCT02853435|7632736|FG004|STARTED|Part 1a, Period 1 (3 Days)||0
6702097|NCT02853435|7632737|FG005|STARTED|Part 1a, Period 1 (3 Days)||0
6702098|NCT02853435|7632732|FG000|COMPLETED|Part 1a, Period 1 (3 Days)||9
6702099|NCT02853435|7632733|FG001|COMPLETED|Part 1a, Period 1 (3 Days)||9
6702100|NCT02853435|7632734|FG002|COMPLETED|Part 1a, Period 1 (3 Days)||8
6702101|NCT02853435|7632735|FG003|COMPLETED|Part 1a, Period 1 (3 Days)||0
6702102|NCT02853435|7632736|FG004|COMPLETED|Part 1a, Period 1 (3 Days)||0
6702103|NCT02853435|7632737|FG005|COMPLETED|Part 1a, Period 1 (3 Days)||0
6702104|NCT02853435|7632732|FG000|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6702105|NCT02853435|7632733|FG001|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6702106|NCT02853435|7632734|FG002|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6702107|NCT02853435|7632735|FG003|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6702108|NCT02853435|7632736|FG004|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6702109|NCT02853435|7632737|FG005|NOT COMPLETED|Part 1a, Period 1 (3 Days)||0
6702110|NCT02853435|7632732|FG000|STARTED|Part 1a, Washout Period 1 (3 Days)||9
6260316|NCT01193842|7159039|FG002|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260317|NCT01193842|7159040|FG003|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260318|NCT01193842|7159041|FG004|COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260319|NCT01193842|7159037|FG000|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||1
6260320|NCT01193842|7159038|FG001|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260321|NCT01193842|7159039|FG002|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260322|NCT01193842|7159040|FG003|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260323|NCT01193842|7159041|FG004|NOT COMPLETED|Phase I: VR-DA-EPOCH, DL 1 (De-escalate)||0
6260324|NCT01193842|7159037|FG000|STARTED|Phase I: VR-CHOP, DL 1||0
6260325|NCT01193842|7159038|FG001|STARTED|Phase I: VR-CHOP, DL 1||0
6260326|NCT01193842|7159039|FG002|STARTED|Phase I: VR-CHOP, DL 1||2
6260327|NCT01193842|7159040|FG003|STARTED|Phase I: VR-CHOP, DL 1||0
6702111|NCT02853435|7632733|FG001|STARTED|Part 1a, Washout Period 1 (3 Days)||9
6702112|NCT02853435|7632734|FG002|STARTED|Part 1a, Washout Period 1 (3 Days)||8
6702113|NCT02853435|7632735|FG003|STARTED|Part 1a, Washout Period 1 (3 Days)||0
6702114|NCT02853435|7632736|FG004|STARTED|Part 1a, Washout Period 1 (3 Days)||0
6702115|NCT02853435|7632737|FG005|STARTED|Part 1a, Washout Period 1 (3 Days)||0
6702116|NCT02853435|7632732|FG000|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
6702117|NCT02853435|7632733|FG001|COMPLETED|Part 1a, Washout Period 1 (3 Days)||9
6702118|NCT02853435|7632734|FG002|COMPLETED|Part 1a, Washout Period 1 (3 Days)||8
6702119|NCT02853435|7632735|FG003|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702120|NCT02853435|7632736|FG004|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702121|NCT02853435|7632737|FG005|COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702122|NCT02853435|7632732|FG000|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702123|NCT02853435|7632733|FG001|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702124|NCT02853435|7632734|FG002|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702125|NCT02853435|7632735|FG003|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702126|NCT02853435|7632736|FG004|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702127|NCT02853435|7632737|FG005|NOT COMPLETED|Part 1a, Washout Period 1 (3 Days)||0
6702128|NCT02853435|7632732|FG000|STARTED|Part 1a, Period 2 (3 Days)||9
6702129|NCT02853435|7632733|FG001|STARTED|Part 1a, Period 2 (3 Days)||9
6702130|NCT02853435|7632734|FG002|STARTED|Part 1a, Period 2 (3 Days)||8
6702131|NCT02853435|7632735|FG003|STARTED|Part 1a, Period 2 (3 Days)||0
6702132|NCT02853435|7632736|FG004|STARTED|Part 1a, Period 2 (3 Days)||0
6702133|NCT02853435|7632737|FG005|STARTED|Part 1a, Period 2 (3 Days)||0
6702134|NCT02853435|7632732|FG000|COMPLETED|Part 1a, Period 2 (3 Days)||9
6702135|NCT02853435|7632733|FG001|COMPLETED|Part 1a, Period 2 (3 Days)||9
6702136|NCT02853435|7632734|FG002|COMPLETED|Part 1a, Period 2 (3 Days)||8
6702137|NCT02853435|7632735|FG003|COMPLETED|Part 1a, Period 2 (3 Days)||0
6702138|NCT02853435|7632736|FG004|COMPLETED|Part 1a, Period 2 (3 Days)||0
6702139|NCT02853435|7632737|FG005|COMPLETED|Part 1a, Period 2 (3 Days)||0
6702140|NCT02853435|7632732|FG000|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6702141|NCT02853435|7632733|FG001|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6702142|NCT02853435|7632734|FG002|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6702143|NCT02853435|7632735|FG003|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6702144|NCT02853435|7632736|FG004|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6702145|NCT02853435|7632737|FG005|NOT COMPLETED|Part 1a, Period 2 (3 Days)||0
6702146|NCT02853435|7632732|FG000|STARTED|Part 1a, Washout Period 2 (3 Days)||9
6702147|NCT02853435|7632733|FG001|STARTED|Part 1a, Washout Period 2 (3 Days)||9
6702148|NCT02853435|7632734|FG002|STARTED|Part 1a, Washout Period 2 (3 Days)||8
6702149|NCT02853435|7632735|FG003|STARTED|Part 1a, Washout Period 2 (3 Days)||0
6702150|NCT02853435|7632736|FG004|STARTED|Part 1a, Washout Period 2 (3 Days)||0
6702151|NCT02853435|7632737|FG005|STARTED|Part 1a, Washout Period 2 (3 Days)||0
6702152|NCT02853435|7632732|FG000|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
6702153|NCT02853435|7632733|FG001|COMPLETED|Part 1a, Washout Period 2 (3 Days)||9
6702154|NCT02853435|7632734|FG002|COMPLETED|Part 1a, Washout Period 2 (3 Days)||8
6702155|NCT02853435|7632735|FG003|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6702156|NCT02853435|7632736|FG004|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6702157|NCT02853435|7632737|FG005|COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6702158|NCT02853435|7632732|FG000|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6702159|NCT02853435|7632733|FG001|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6392117|NCT00839527|7304107|FG000|STARTED|Treatment Period (TP) (156 Weeks)||115
6392118|NCT00839527|7304108|FG001|STARTED|Treatment Period (TP) (156 Weeks)||277
6702160|NCT02853435|7632734|FG002|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6702161|NCT02853435|7632735|FG003|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6702162|NCT02853435|7632736|FG004|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6702163|NCT02853435|7632737|FG005|NOT COMPLETED|Part 1a, Washout Period 2 (3 Days)||0
6702164|NCT02853435|7632732|FG000|STARTED|Part 1a, Period 3 (3 Days)||9
6702165|NCT02853435|7632733|FG001|STARTED|Part 1a, Period 3 (3 Days)||9
6702166|NCT02853435|7632734|FG002|STARTED|Part 1a, Period 3 (3 Days)||8
6702167|NCT02853435|7632735|FG003|STARTED|Part 1a, Period 3 (3 Days)||0
6702168|NCT02853435|7632736|FG004|STARTED|Part 1a, Period 3 (3 Days)||0
6702169|NCT02853435|7632737|FG005|STARTED|Part 1a, Period 3 (3 Days)||0
6702170|NCT02853435|7632732|FG000|COMPLETED|Part 1a, Period 3 (3 Days)||9
6702171|NCT02853435|7632733|FG001|COMPLETED|Part 1a, Period 3 (3 Days)||9
6702172|NCT02853435|7632734|FG002|COMPLETED|Part 1a, Period 3 (3 Days)||8
6702173|NCT02853435|7632735|FG003|COMPLETED|Part 1a, Period 3 (3 Days)||0
6702174|NCT02853435|7632736|FG004|COMPLETED|Part 1a, Period 3 (3 Days)||0
6702175|NCT02853435|7632737|FG005|COMPLETED|Part 1a, Period 3 (3 Days)||0
6702176|NCT02853435|7632732|FG000|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6702177|NCT02853435|7632733|FG001|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6702178|NCT02853435|7632734|FG002|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6702179|NCT02853435|7632735|FG003|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6702180|NCT02853435|7632736|FG004|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6702181|NCT02853435|7632737|FG005|NOT COMPLETED|Part 1a, Period 3 (3 Days)||0
6702182|NCT02853435|7632732|FG000|STARTED|Part 2, Period 1 (3 Days)||0
6702183|NCT02853435|7632733|FG001|STARTED|Part 2, Period 1 (3 Days)||0
6702184|NCT02853435|7632734|FG002|STARTED|Part 2, Period 1 (3 Days)||0
6702185|NCT02853435|7632735|FG003|STARTED|Part 2, Period 1 (3 Days)||10
6702186|NCT02853435|7632736|FG004|STARTED|Part 2, Period 1 (3 Days)||0
6702187|NCT02853435|7632737|FG005|STARTED|Part 2, Period 1 (3 Days)||0
6702188|NCT02853435|7632732|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
6702189|NCT02853435|7632733|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
6702190|NCT02853435|7632734|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
6702191|NCT02853435|7632735|FG003|COMPLETED|Part 2, Period 1 (3 Days)||10
6702192|NCT02853435|7632736|FG004|COMPLETED|Part 2, Period 1 (3 Days)||0
6702193|NCT02853435|7632737|FG005|COMPLETED|Part 2, Period 1 (3 Days)||0
6702194|NCT02853435|7632732|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6702195|NCT02853435|7632733|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6702196|NCT02853435|7632734|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6702197|NCT02853435|7632735|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6702198|NCT02853435|7632736|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6702199|NCT02853435|7632737|FG005|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6702200|NCT02853435|7632732|FG000|STARTED|Part 2, Washout Period 1 (3 Days)||0
6702201|NCT02853435|7632733|FG001|STARTED|Part 2, Washout Period 1 (3 Days)||0
6702202|NCT02853435|7632734|FG002|STARTED|Part 2, Washout Period 1 (3 Days)||0
6702203|NCT02853435|7632735|FG003|STARTED|Part 2, Washout Period 1 (3 Days)||10
6702204|NCT02853435|7632736|FG004|STARTED|Part 2, Washout Period 1 (3 Days)||0
6702205|NCT02853435|7632737|FG005|STARTED|Part 2, Washout Period 1 (3 Days)||0
6702206|NCT02853435|7632732|FG000|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702207|NCT02853435|7632733|FG001|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702208|NCT02853435|7632734|FG002|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702209|NCT02853435|7632735|FG003|COMPLETED|Part 2, Washout Period 1 (3 Days)||10
6702210|NCT02853435|7632736|FG004|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702211|NCT02853435|7632737|FG005|COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702212|NCT02853435|7632732|FG000|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702213|NCT02853435|7632733|FG001|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702214|NCT02853435|7632734|FG002|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702215|NCT02853435|7632735|FG003|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702216|NCT02853435|7632736|FG004|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702217|NCT02853435|7632737|FG005|NOT COMPLETED|Part 2, Washout Period 1 (3 Days)||0
6702218|NCT02853435|7632732|FG000|STARTED|Part 2, Period 2 (3 Days)||0
6702219|NCT02853435|7632733|FG001|STARTED|Part 2, Period 2 (3 Days)||0
6702220|NCT02853435|7632734|FG002|STARTED|Part 2, Period 2 (3 Days)||0
6702221|NCT02853435|7632735|FG003|STARTED|Part 2, Period 2 (3 Days)||10
6702222|NCT02853435|7632736|FG004|STARTED|Part 2, Period 2 (3 Days)||0
6702223|NCT02853435|7632737|FG005|STARTED|Part 2, Period 2 (3 Days)||0
6702224|NCT02853435|7632732|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
6702225|NCT02853435|7632733|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
6702226|NCT02853435|7632734|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
6702227|NCT02853435|7632735|FG003|COMPLETED|Part 2, Period 2 (3 Days)||10
6702228|NCT02853435|7632736|FG004|COMPLETED|Part 2, Period 2 (3 Days)||0
6702229|NCT02853435|7632737|FG005|COMPLETED|Part 2, Period 2 (3 Days)||0
6702230|NCT02853435|7632732|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6260328|NCT01193842|7159041|FG004|STARTED|Phase I: VR-CHOP, DL 1||0
6260329|NCT01193842|7159037|FG000|COMPLETED|Phase I: VR-CHOP, DL 1||0
6260330|NCT01193842|7159038|FG001|COMPLETED|Phase I: VR-CHOP, DL 1||0
6260331|NCT01193842|7159039|FG002|COMPLETED|Phase I: VR-CHOP, DL 1||1
6260332|NCT01193842|7159040|FG003|COMPLETED|Phase I: VR-CHOP, DL 1||0
6260333|NCT01193842|7159041|FG004|COMPLETED|Phase I: VR-CHOP, DL 1||0
6260334|NCT01193842|7159037|FG000|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
6260335|NCT01193842|7159038|FG001|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
6260336|NCT01193842|7159039|FG002|NOT COMPLETED|Phase I: VR-CHOP, DL 1||1
6260337|NCT01193842|7159040|FG003|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
6260338|NCT01193842|7159041|FG004|NOT COMPLETED|Phase I: VR-CHOP, DL 1||0
6260339|NCT01193842|7159037|FG000|STARTED|Phase II: Randomized Groups||0
6260340|NCT01193842|7159038|FG001|STARTED|Phase II: Randomized Groups||0
6260341|NCT01193842|7159039|FG002|STARTED|Phase II: Randomized Groups||0
6260342|NCT01193842|7159040|FG003|STARTED|Phase II: Randomized Groups||45
6260343|NCT01193842|7159041|FG004|STARTED|Phase II: Randomized Groups||46
6260344|NCT01193842|7159037|FG000|COMPLETED|Phase II: Randomized Groups||0
6260345|NCT01193842|7159038|FG001|COMPLETED|Phase II: Randomized Groups||0
6260346|NCT01193842|7159039|FG002|COMPLETED|Phase II: Randomized Groups||0
6260347|NCT01193842|7159040|FG003|COMPLETED|Phase II: Randomized Groups||33
6260348|NCT01193842|7159041|FG004|COMPLETED|Phase II: Randomized Groups||36
6260349|NCT01193842|7159037|FG000|NOT COMPLETED|Phase II: Randomized Groups||0
6260350|NCT01193842|7159038|FG001|NOT COMPLETED|Phase II: Randomized Groups||0
6260351|NCT01193842|7159039|FG002|NOT COMPLETED|Phase II: Randomized Groups||0
6260352|NCT01193842|7159040|FG003|NOT COMPLETED|Phase II: Randomized Groups||12
6602497|NCT02057458|7527500|FG000|COMPLETED|Recruited for Participation||8
6602498|NCT02057458|7527501|FG001|COMPLETED|Recruited for Participation||8
6602499|NCT02057458|7527502|FG002|COMPLETED|Recruited for Participation||3
6602500|NCT02057458|7527500|FG000|NOT COMPLETED|Recruited for Participation||0
6602501|NCT02057458|7527501|FG001|NOT COMPLETED|Recruited for Participation||0
6602502|NCT02057458|7527502|FG002|NOT COMPLETED|Recruited for Participation||0
6602503|NCT02057458|7527500|FG000|STARTED|Met Inclusion Criteria||8
6602504|NCT02057458|7527501|FG001|STARTED|Met Inclusion Criteria||8
6602505|NCT02057458|7527502|FG002|STARTED|Met Inclusion Criteria||3
6602506|NCT02057458|7527500|FG000|COMPLETED|Met Inclusion Criteria||8
6602507|NCT02057458|7527501|FG001|COMPLETED|Met Inclusion Criteria||7
6602508|NCT02057458|7527502|FG002|COMPLETED|Met Inclusion Criteria||3
6602509|NCT02057458|7527500|FG000|NOT COMPLETED|Met Inclusion Criteria||0
6602510|NCT02057458|7527501|FG001|NOT COMPLETED|Met Inclusion Criteria||1
6602511|NCT02057458|7527502|FG002|NOT COMPLETED|Met Inclusion Criteria||0
6602512|NCT02057458|7527500|FG000|STARTED|Acute Study (1 Hour): First Intervention||8
6602513|NCT02057458|7527501|FG001|STARTED|Acute Study (1 Hour): First Intervention||7
6602514|NCT02057458|7527502|FG002|STARTED|Acute Study (1 Hour): First Intervention||0
6602515|NCT02057458|7527500|FG000|COMPLETED|Acute Study (1 Hour): First Intervention||6
6602516|NCT02057458|7527501|FG001|COMPLETED|Acute Study (1 Hour): First Intervention||7
6702231|NCT02853435|7632733|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6702232|NCT02853435|7632734|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6702233|NCT02853435|7632735|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6260353|NCT01193842|7159041|FG004|NOT COMPLETED|Phase II: Randomized Groups||10
6602517|NCT02057458|7527502|FG002|COMPLETED|Acute Study (1 Hour): First Intervention||0
6702234|NCT02853435|7632736|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6702235|NCT02853435|7632737|FG005|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6702236|NCT02853435|7632732|FG000|STARTED|Part 3, Period 1 (3 Days)||0
6702237|NCT02853435|7632733|FG001|STARTED|Part 3, Period 1 (3 Days)||0
6702238|NCT02853435|7632734|FG002|STARTED|Part 3, Period 1 (3 Days)||0
6702239|NCT02853435|7632735|FG003|STARTED|Part 3, Period 1 (3 Days)||0
6702240|NCT02853435|7632736|FG004|STARTED|Part 3, Period 1 (3 Days)||10
6702241|NCT02853435|7632737|FG005|STARTED|Part 3, Period 1 (3 Days)||2
6702242|NCT02853435|7632732|FG000|COMPLETED|Part 3, Period 1 (3 Days)||0
6702243|NCT02853435|7632733|FG001|COMPLETED|Part 3, Period 1 (3 Days)||0
6702244|NCT02853435|7632734|FG002|COMPLETED|Part 3, Period 1 (3 Days)||0
6702245|NCT02853435|7632735|FG003|COMPLETED|Part 3, Period 1 (3 Days)||0
6702246|NCT02853435|7632736|FG004|COMPLETED|Part 3, Period 1 (3 Days)||10
6702247|NCT02853435|7632737|FG005|COMPLETED|Part 3, Period 1 (3 Days)||2
6702248|NCT02853435|7632732|FG000|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6702249|NCT02853435|7632733|FG001|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6702250|NCT02853435|7632734|FG002|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6702251|NCT02853435|7632735|FG003|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6702252|NCT02853435|7632736|FG004|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6702253|NCT02853435|7632737|FG005|NOT COMPLETED|Part 3, Period 1 (3 Days)||0
6702254|NCT02853435|7632732|FG000|STARTED|Part 3, Washout Period 1 (3 Days)||0
6702255|NCT02853435|7632733|FG001|STARTED|Part 3, Washout Period 1 (3 Days)||0
6702256|NCT02853435|7632734|FG002|STARTED|Part 3, Washout Period 1 (3 Days)||0
6702257|NCT02853435|7632735|FG003|STARTED|Part 3, Washout Period 1 (3 Days)||0
6702258|NCT02853435|7632736|FG004|STARTED|Part 3, Washout Period 1 (3 Days)||10
6702259|NCT02853435|7632737|FG005|STARTED|Part 3, Washout Period 1 (3 Days)||2
6702260|NCT02853435|7632732|FG000|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702261|NCT02853435|7632733|FG001|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702262|NCT02853435|7632734|FG002|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702263|NCT02853435|7632735|FG003|COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702264|NCT02853435|7632736|FG004|COMPLETED|Part 3, Washout Period 1 (3 Days)||10
6702265|NCT02853435|7632737|FG005|COMPLETED|Part 3, Washout Period 1 (3 Days)||2
6702266|NCT02853435|7632732|FG000|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702267|NCT02853435|7632733|FG001|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702268|NCT02853435|7632734|FG002|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702269|NCT02853435|7632735|FG003|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702270|NCT02853435|7632736|FG004|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702271|NCT02853435|7632737|FG005|NOT COMPLETED|Part 3, Washout Period 1 (3 Days)||0
6702272|NCT02853435|7632732|FG000|STARTED|Part 3, Period 2 (3 Days)||0
6702273|NCT02853435|7632733|FG001|STARTED|Part 3, Period 2 (3 Days)||0
6702274|NCT02853435|7632734|FG002|STARTED|Part 3, Period 2 (3 Days)||0
6702275|NCT02853435|7632735|FG003|STARTED|Part 3, Period 2 (3 Days)||0
6702276|NCT02853435|7632736|FG004|STARTED|Part 3, Period 2 (3 Days)||10
6702277|NCT02853435|7632737|FG005|STARTED|Part 3, Period 2 (3 Days)||2
6702278|NCT02853435|7632732|FG000|COMPLETED|Part 3, Period 2 (3 Days)||0
6702279|NCT02853435|7632733|FG001|COMPLETED|Part 3, Period 2 (3 Days)||0
6702280|NCT02853435|7632734|FG002|COMPLETED|Part 3, Period 2 (3 Days)||0
6702281|NCT02853435|7632735|FG003|COMPLETED|Part 3, Period 2 (3 Days)||0
6702282|NCT02853435|7632736|FG004|COMPLETED|Part 3, Period 2 (3 Days)||10
6702283|NCT02853435|7632737|FG005|COMPLETED|Part 3, Period 2 (3 Days)||2
6702284|NCT02853435|7632732|FG000|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6702285|NCT02853435|7632733|FG001|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6702286|NCT02853435|7632734|FG002|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6702287|NCT02853435|7632735|FG003|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6702288|NCT02853435|7632736|FG004|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6702289|NCT02853435|7632737|FG005|NOT COMPLETED|Part 3, Period 2 (3 Days)||0
6702290|NCT02853435|7632732|FG000|STARTED|Part 3, Washout Period 2 (3 Days)||0
6702291|NCT02853435|7632733|FG001|STARTED|Part 3, Washout Period 2 (3 Days)||0
6702292|NCT02853435|7632734|FG002|STARTED|Part 3, Washout Period 2 (3 Days)||0
6702293|NCT02853435|7632735|FG003|STARTED|Part 3, Washout Period 2 (3 Days)||0
6702294|NCT02853435|7632736|FG004|STARTED|Part 3, Washout Period 2 (3 Days)||10
6702295|NCT02853435|7632737|FG005|STARTED|Part 3, Washout Period 2 (3 Days)||2
6702296|NCT02853435|7632732|FG000|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702297|NCT02853435|7632733|FG001|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702298|NCT02853435|7632734|FG002|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702299|NCT02853435|7632735|FG003|COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702300|NCT02853435|7632736|FG004|COMPLETED|Part 3, Washout Period 2 (3 Days)||9
6702301|NCT02853435|7632737|FG005|COMPLETED|Part 3, Washout Period 2 (3 Days)||2
6702302|NCT02853435|7632732|FG000|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702303|NCT02853435|7632733|FG001|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702304|NCT02853435|7632734|FG002|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702305|NCT02853435|7632735|FG003|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702306|NCT02853435|7632736|FG004|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||1
6702307|NCT02853435|7632737|FG005|NOT COMPLETED|Part 3, Washout Period 2 (3 Days)||0
6702308|NCT02853435|7632732|FG000|STARTED|Part 3, Period 3 (3 Days)||0
6702309|NCT02853435|7632733|FG001|STARTED|Part 3, Period 3 (3 Days)||0
6702310|NCT02853435|7632734|FG002|STARTED|Part 3, Period 3 (3 Days)||0
6702311|NCT02853435|7632735|FG003|STARTED|Part 3, Period 3 (3 Days)||0
6702312|NCT02853435|7632736|FG004|STARTED|Part 3, Period 3 (3 Days)||9
6702313|NCT02853435|7632737|FG005|STARTED|Part 3, Period 3 (3 Days)||2
6702314|NCT02853435|7632732|FG000|COMPLETED|Part 3, Period 3 (3 Days)||0
6702315|NCT02853435|7632733|FG001|COMPLETED|Part 3, Period 3 (3 Days)||0
6702316|NCT02853435|7632734|FG002|COMPLETED|Part 3, Period 3 (3 Days)||0
6702317|NCT02853435|7632735|FG003|COMPLETED|Part 3, Period 3 (3 Days)||0
6702318|NCT02853435|7632736|FG004|COMPLETED|Part 3, Period 3 (3 Days)||9
6702319|NCT02853435|7632737|FG005|COMPLETED|Part 3, Period 3 (3 Days)||2
6702320|NCT02853435|7632732|FG000|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6702321|NCT02853435|7632733|FG001|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6702322|NCT02853435|7632734|FG002|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6702323|NCT02853435|7632735|FG003|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6702324|NCT02853435|7632736|FG004|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6702325|NCT02853435|7632737|FG005|NOT COMPLETED|Part 3, Period 3 (3 Days)||0
6702326|NCT02853760|7632767|FG000|STARTED|First Intervention (3 Hours)||7
6702327|NCT02853760|7632768|FG001|STARTED|First Intervention (3 Hours)||10
6702328|NCT02853760|7632769|FG002|STARTED|First Intervention (3 Hours)||7
6702329|NCT02853760|7632770|FG003|STARTED|First Intervention (3 Hours)||8
6702330|NCT02853760|7632771|FG004|STARTED|First Intervention (3 Hours)||8
6702331|NCT02853760|7632772|FG005|STARTED|First Intervention (3 Hours)||7
6702332|NCT02853760|7632767|FG000|COMPLETED|First Intervention (3 Hours)||7
6702333|NCT02853760|7632768|FG001|COMPLETED|First Intervention (3 Hours)||10
6702334|NCT02853760|7632769|FG002|COMPLETED|First Intervention (3 Hours)||7
6702335|NCT02853760|7632770|FG003|COMPLETED|First Intervention (3 Hours)||8
6702336|NCT02853760|7632771|FG004|COMPLETED|First Intervention (3 Hours)||8
6702337|NCT02853760|7632772|FG005|COMPLETED|First Intervention (3 Hours)||7
6702338|NCT02853760|7632767|FG000|NOT COMPLETED|First Intervention (3 Hours)||0
6702339|NCT02853760|7632768|FG001|NOT COMPLETED|First Intervention (3 Hours)||0
6702340|NCT02853760|7632769|FG002|NOT COMPLETED|First Intervention (3 Hours)||0
6702341|NCT02853760|7632770|FG003|NOT COMPLETED|First Intervention (3 Hours)||0
6702342|NCT02853760|7632771|FG004|NOT COMPLETED|First Intervention (3 Hours)||0
6702343|NCT02853760|7632772|FG005|NOT COMPLETED|First Intervention (3 Hours)||0
6702344|NCT02853760|7632767|FG000|STARTED|Washout (1 Week)||7
6702345|NCT02853760|7632768|FG001|STARTED|Washout (1 Week)||10
6702346|NCT02853760|7632769|FG002|STARTED|Washout (1 Week)||7
6702347|NCT02853760|7632770|FG003|STARTED|Washout (1 Week)||8
6702348|NCT02853760|7632771|FG004|STARTED|Washout (1 Week)||8
6702349|NCT02853760|7632772|FG005|STARTED|Washout (1 Week)||7
6702350|NCT02853760|7632767|FG000|COMPLETED|Washout (1 Week)||7
6702351|NCT02853760|7632768|FG001|COMPLETED|Washout (1 Week)||10
6702352|NCT02853760|7632769|FG002|COMPLETED|Washout (1 Week)||6
6702353|NCT02853760|7632770|FG003|COMPLETED|Washout (1 Week)||6
6702354|NCT02853760|7632771|FG004|COMPLETED|Washout (1 Week)||8
6702355|NCT02853760|7632772|FG005|COMPLETED|Washout (1 Week)||5
6702356|NCT02853760|7632767|FG000|NOT COMPLETED|Washout (1 Week)||0
6702357|NCT02853760|7632768|FG001|NOT COMPLETED|Washout (1 Week)||0
6702358|NCT02853760|7632769|FG002|NOT COMPLETED|Washout (1 Week)||1
6702359|NCT02853760|7632770|FG003|NOT COMPLETED|Washout (1 Week)||2
6702360|NCT02853760|7632771|FG004|NOT COMPLETED|Washout (1 Week)||0
6702361|NCT02853760|7632772|FG005|NOT COMPLETED|Washout (1 Week)||2
6702362|NCT02853760|7632767|FG000|STARTED|Second Intervention (3 Hours)||7
6702363|NCT02853760|7632768|FG001|STARTED|Second Intervention (3 Hours)||10
6702364|NCT02853760|7632769|FG002|STARTED|Second Intervention (3 Hours)||6
6702365|NCT02853760|7632770|FG003|STARTED|Second Intervention (3 Hours)||6
6702366|NCT02853760|7632771|FG004|STARTED|Second Intervention (3 Hours)||8
6702367|NCT02853760|7632772|FG005|STARTED|Second Intervention (3 Hours)||5
6702368|NCT02853760|7632767|FG000|COMPLETED|Second Intervention (3 Hours)||7
6702369|NCT02853760|7632768|FG001|COMPLETED|Second Intervention (3 Hours)||10
6702370|NCT02853760|7632769|FG002|COMPLETED|Second Intervention (3 Hours)||6
6702371|NCT02853760|7632770|FG003|COMPLETED|Second Intervention (3 Hours)||6
6702372|NCT02853760|7632771|FG004|COMPLETED|Second Intervention (3 Hours)||8
6702373|NCT02853760|7632772|FG005|COMPLETED|Second Intervention (3 Hours)||5
6702374|NCT02853760|7632767|FG000|NOT COMPLETED|Second Intervention (3 Hours)||0
6702375|NCT02853760|7632768|FG001|NOT COMPLETED|Second Intervention (3 Hours)||0
6702376|NCT02853760|7632769|FG002|NOT COMPLETED|Second Intervention (3 Hours)||0
6702377|NCT02853760|7632770|FG003|NOT COMPLETED|Second Intervention (3 Hours)||0
6702378|NCT02853760|7632771|FG004|NOT COMPLETED|Second Intervention (3 Hours)||0
6702379|NCT02853760|7632772|FG005|NOT COMPLETED|Second Intervention (3 Hours)||0
6702380|NCT02853760|7632767|FG000|STARTED|Washout (1 Week)||7
6702381|NCT02853760|7632768|FG001|STARTED|Washout (1 Week)||10
6702382|NCT02853760|7632769|FG002|STARTED|Washout (1 Week)||6
6702383|NCT02853760|7632770|FG003|STARTED|Washout (1 Week)||6
6702384|NCT02853760|7632771|FG004|STARTED|Washout (1 Week)||8
6702385|NCT02853760|7632772|FG005|STARTED|Washout (1 Week)||5
6702386|NCT02853760|7632767|FG000|COMPLETED|Washout (1 Week)||7
6702387|NCT02853760|7632768|FG001|COMPLETED|Washout (1 Week)||10
6702388|NCT02853760|7632769|FG002|COMPLETED|Washout (1 Week)||6
6702389|NCT02853760|7632770|FG003|COMPLETED|Washout (1 Week)||6
6702390|NCT02853760|7632771|FG004|COMPLETED|Washout (1 Week)||8
6702391|NCT02853760|7632772|FG005|COMPLETED|Washout (1 Week)||5
6702392|NCT02853760|7632767|FG000|NOT COMPLETED|Washout (1 Week)||0
6702393|NCT02853760|7632768|FG001|NOT COMPLETED|Washout (1 Week)||0
6702394|NCT02853760|7632769|FG002|NOT COMPLETED|Washout (1 Week)||0
6702395|NCT02853760|7632770|FG003|NOT COMPLETED|Washout (1 Week)||0
6702396|NCT02853760|7632771|FG004|NOT COMPLETED|Washout (1 Week)||0
6702397|NCT02853760|7632772|FG005|NOT COMPLETED|Washout (1 Week)||0
6702398|NCT02853760|7632767|FG000|STARTED|Third Intervention (3 Hours)||7
6702399|NCT02853760|7632768|FG001|STARTED|Third Intervention (3 Hours)||10
6702400|NCT02853760|7632769|FG002|STARTED|Third Intervention (3 Hours)||6
6702401|NCT02853760|7632770|FG003|STARTED|Third Intervention (3 Hours)||6
6702402|NCT02853760|7632771|FG004|STARTED|Third Intervention (3 Hours)||8
6702403|NCT02853760|7632772|FG005|STARTED|Third Intervention (3 Hours)||5
6702404|NCT02853760|7632767|FG000|COMPLETED|Third Intervention (3 Hours)||7
6702405|NCT02853760|7632768|FG001|COMPLETED|Third Intervention (3 Hours)||10
6702406|NCT02853760|7632769|FG002|COMPLETED|Third Intervention (3 Hours)||6
6702407|NCT02853760|7632770|FG003|COMPLETED|Third Intervention (3 Hours)||6
6702408|NCT02853760|7632771|FG004|COMPLETED|Third Intervention (3 Hours)||8
6702409|NCT02853760|7632772|FG005|COMPLETED|Third Intervention (3 Hours)||5
6702410|NCT02853760|7632767|FG000|NOT COMPLETED|Third Intervention (3 Hours)||0
6702411|NCT02853760|7632768|FG001|NOT COMPLETED|Third Intervention (3 Hours)||0
6702412|NCT02853760|7632769|FG002|NOT COMPLETED|Third Intervention (3 Hours)||0
6702413|NCT02853760|7632770|FG003|NOT COMPLETED|Third Intervention (3 Hours)||0
6702414|NCT02853760|7632771|FG004|NOT COMPLETED|Third Intervention (3 Hours)||0
6702415|NCT02853760|7632772|FG005|NOT COMPLETED|Third Intervention (3 Hours)||0
6702416|NCT02853929|7632782|FG000|STARTED|Overall Study||270
6702417|NCT02853929|7632783|FG001|STARTED|Overall Study||281
6702418|NCT02853929|7632782|FG000|Vaccinated|Overall Study||263
6702419|NCT02853929|7632783|FG001|Vaccinated|Overall Study||277
6702420|NCT02853929|7632782|FG000|COMPLETED|Overall Study||259
6702421|NCT02853929|7632783|FG001|COMPLETED|Overall Study||277
6702422|NCT02853929|7632782|FG000|NOT COMPLETED|Overall Study||11
6702423|NCT02853929|7632783|FG001|NOT COMPLETED|Overall Study||4
6702424|NCT02854059|7632791|FG000|STARTED|Overall Study||2
6702425|NCT02854059|7632792|FG001|STARTED|Overall Study||0
6702426|NCT02854059|7632791|FG000|COMPLETED|Overall Study||2
6702427|NCT02854059|7632792|FG001|COMPLETED|Overall Study||0
6702428|NCT02854059|7632791|FG000|NOT COMPLETED|Overall Study||0
6702429|NCT02854059|7632792|FG001|NOT COMPLETED|Overall Study||0
6702430|NCT02854527|7632808|FG000|STARTED|Overall Study||3
6702431|NCT02854527|7632809|FG001|STARTED|Overall Study||3
6702432|NCT02854527|7632810|FG002|STARTED|Overall Study||3
6702433|NCT02854527|7632811|FG003|STARTED|Overall Study||3
6702434|NCT02854527|7632812|FG004|STARTED|Overall Study||3
6702435|NCT02854527|7632813|FG005|STARTED|Overall Study||3
6702436|NCT02854527|7632814|FG006|STARTED|Overall Study||3
6702437|NCT02854527|7632815|FG007|STARTED|Overall Study||3
6702438|NCT02854527|7632816|FG008|STARTED|Overall Study||3
6702439|NCT02854527|7632817|FG009|STARTED|Overall Study||3
6702440|NCT02854527|7632808|FG000|Received R1|Overall Study||3
6702441|NCT02854527|7632809|FG001|Received R1|Overall Study||3
6702442|NCT02854527|7632810|FG002|Received R1|Overall Study||3
6702443|NCT02854527|7632811|FG003|Received R1|Overall Study||2
6702444|NCT02854527|7632812|FG004|Received R1|Overall Study||2
6702445|NCT02854527|7632813|FG005|Received R1|Overall Study||3
6702446|NCT02854527|7632814|FG006|Received R1|Overall Study||3
6702447|NCT02854527|7632815|FG007|Received R1|Overall Study||3
6702448|NCT02854527|7632816|FG008|Received R1|Overall Study||3
6702449|NCT02854527|7632817|FG009|Received R1|Overall Study||3
6702450|NCT02854527|7632808|FG000|Received R2|Overall Study||3
6702451|NCT02854527|7632809|FG001|Received R2|Overall Study||3
6702452|NCT02854527|7632810|FG002|Received R2|Overall Study||3
6702453|NCT02854527|7632811|FG003|Received R2|Overall Study||3
6702454|NCT02854527|7632812|FG004|Received R2|Overall Study||3
6702455|NCT02854527|7632813|FG005|Received R2|Overall Study||3
6702456|NCT02854527|7632814|FG006|Received R2|Overall Study||3
6702457|NCT02854527|7632815|FG007|Received R2|Overall Study||3
6702458|NCT02854527|7632816|FG008|Received R2|Overall Study||3
6702459|NCT02854527|7632817|FG009|Received R2|Overall Study||3
6702460|NCT02854527|7632808|FG000|Received R3|Overall Study||3
6702461|NCT02854527|7632809|FG001|Received R3|Overall Study||3
6702462|NCT02854527|7632810|FG002|Received R3|Overall Study||3
6702463|NCT02854527|7632811|FG003|Received R3|Overall Study||2
6702464|NCT02854527|7632812|FG004|Received R3|Overall Study||3
6702465|NCT02854527|7632813|FG005|Received R3|Overall Study||3
6702466|NCT02854527|7632814|FG006|Received R3|Overall Study||3
6702467|NCT02854527|7632815|FG007|Received R3|Overall Study||3
6702468|NCT02854527|7632816|FG008|Received R3|Overall Study||3
6702469|NCT02854527|7632817|FG009|Received R3|Overall Study||3
6702470|NCT02854527|7632808|FG000|Received R4|Overall Study||3
6702471|NCT02854527|7632809|FG001|Received R4|Overall Study||3
6702472|NCT02854527|7632810|FG002|Received R4|Overall Study||3
6702473|NCT02854527|7632811|FG003|Received R4|Overall Study||2
6702474|NCT02854527|7632812|FG004|Received R4|Overall Study||3
6702475|NCT02854527|7632813|FG005|Received R4|Overall Study||3
6702476|NCT02854527|7632814|FG006|Received R4|Overall Study||3
6702477|NCT02854527|7632815|FG007|Received R4|Overall Study||3
6702478|NCT02854527|7632816|FG008|Received R4|Overall Study||3
6702479|NCT02854527|7632817|FG009|Received R4|Overall Study||3
6702480|NCT02854527|7632808|FG000|Received T|Overall Study||3
6702481|NCT02854527|7632809|FG001|Received T|Overall Study||3
6702482|NCT02854527|7632810|FG002|Received T|Overall Study||3
6702483|NCT02854527|7632811|FG003|Received T|Overall Study||2
6702484|NCT02854527|7632812|FG004|Received T|Overall Study||2
6702485|NCT02854527|7632813|FG005|Received T|Overall Study||3
6702486|NCT02854527|7632814|FG006|Received T|Overall Study||3
6702487|NCT02854527|7632815|FG007|Received T|Overall Study||3
6702488|NCT02854527|7632816|FG008|Received T|Overall Study||3
6702489|NCT02854527|7632817|FG009|Received T|Overall Study||3
6702490|NCT02854527|7632808|FG000|COMPLETED|Overall Study||3
6702491|NCT02854527|7632809|FG001|COMPLETED|Overall Study||3
6702492|NCT02854527|7632810|FG002|COMPLETED|Overall Study||3
6702493|NCT02854527|7632811|FG003|COMPLETED|Overall Study||2
6702494|NCT02854527|7632812|FG004|COMPLETED|Overall Study||2
6702495|NCT02854527|7632813|FG005|COMPLETED|Overall Study||3
6702496|NCT02854527|7632814|FG006|COMPLETED|Overall Study||3
6702497|NCT02854527|7632815|FG007|COMPLETED|Overall Study||3
6702498|NCT02854527|7632816|FG008|COMPLETED|Overall Study||3
6702499|NCT02854527|7632817|FG009|COMPLETED|Overall Study||3
6702500|NCT02854527|7632808|FG000|NOT COMPLETED|Overall Study||0
6702501|NCT02854527|7632809|FG001|NOT COMPLETED|Overall Study||0
6702502|NCT02854527|7632810|FG002|NOT COMPLETED|Overall Study||0
6702503|NCT02854527|7632811|FG003|NOT COMPLETED|Overall Study||1
6702504|NCT02854527|7632812|FG004|NOT COMPLETED|Overall Study||1
6702505|NCT02854527|7632813|FG005|NOT COMPLETED|Overall Study||0
6702506|NCT02854527|7632814|FG006|NOT COMPLETED|Overall Study||0
6702507|NCT02854527|7632815|FG007|NOT COMPLETED|Overall Study||0
6702508|NCT02854527|7632816|FG008|NOT COMPLETED|Overall Study||0
6702509|NCT02854527|7632817|FG009|NOT COMPLETED|Overall Study||0
6702510|NCT02854540|7632829|FG000|STARTED|Overall Study||13
6702511|NCT02854540|7632829|FG000|COMPLETED|Overall Study||11
6702512|NCT02854540|7632829|FG000|NOT COMPLETED|Overall Study||2
6702513|NCT02854605|7632838|FG000|STARTED|Overall Study||56
6702514|NCT02854605|7632839|FG001|STARTED|Overall Study||56
6702515|NCT02854605|7632840|FG002|STARTED|Overall Study||28
6702516|NCT02854605|7632838|FG000|COMPLETED|Overall Study||53
6702517|NCT02854605|7632839|FG001|COMPLETED|Overall Study||49
6702518|NCT02854605|7632840|FG002|COMPLETED|Overall Study||24
6702519|NCT02854605|7632838|FG000|NOT COMPLETED|Overall Study||3
6702520|NCT02854605|7632839|FG001|NOT COMPLETED|Overall Study||7
6702521|NCT02854605|7632840|FG002|NOT COMPLETED|Overall Study||4
6702522|NCT02854631|7632850|FG000|STARTED|Overall Study||52
6702523|NCT02854631|7632851|FG001|STARTED|Overall Study||52
6702524|NCT02854631|7632850|FG000|COMPLETED|Overall Study||26
6702525|NCT02854631|7632851|FG001|COMPLETED|Overall Study||37
6702526|NCT02854631|7632850|FG000|NOT COMPLETED|Overall Study||26
6702527|NCT02854631|7632851|FG001|NOT COMPLETED|Overall Study||15
6702528|NCT02854800|7632860|FG000|STARTED|Overall Study||32
6702529|NCT02854800|7632861|FG001|STARTED|Overall Study||28
6702530|NCT02854800|7632862|FG002|STARTED|Overall Study||14
6702531|NCT02854800|7632860|FG000|COMPLETED|Overall Study||12
6702532|NCT02854800|7632861|FG001|COMPLETED|Overall Study||15
6702533|NCT02854800|7632862|FG002|COMPLETED|Overall Study||8
6702534|NCT02854800|7632860|FG000|NOT COMPLETED|Overall Study||20
6702535|NCT02854800|7632861|FG001|NOT COMPLETED|Overall Study||13
6702536|NCT02854800|7632862|FG002|NOT COMPLETED|Overall Study||6
6702537|NCT02855086|7632875|FG000|STARTED|Overall Study||2
6702538|NCT02855086|7632876|FG001|STARTED|Overall Study||1
6702539|NCT02855086|7632875|FG000|COMPLETED|Overall Study||2
6702540|NCT02855086|7632876|FG001|COMPLETED|Overall Study||1
6702541|NCT02855086|7632875|FG000|NOT COMPLETED|Overall Study||0
6702542|NCT02855086|7632876|FG001|NOT COMPLETED|Overall Study||0
6702543|NCT02855164|7632890|FG000|STARTED|Parts A + B (Randomized Set)||14
6702544|NCT02855164|7632891|FG001|STARTED|Parts A + B (Randomized Set)||16
6702545|NCT02855164|7632892|FG002|STARTED|Parts A + B (Randomized Set)||37
6702546|NCT02855164|7632893|FG003|STARTED|Parts A + B (Randomized Set)||85
6702547|NCT02855164|7632894|FG004|STARTED|Parts A + B (Randomized Set)||46
6702548|NCT02855164|7632895|FG005|STARTED|Parts A + B (Randomized Set)||0
6702549|NCT02855164|7632896|FG006|STARTED|Parts A + B (Randomized Set)||0
6702550|NCT02855164|7632897|FG007|STARTED|Parts A + B (Randomized Set)||0
6702551|NCT02855164|7632890|FG000|COMPLETED|Parts A + B (Randomized Set)||14
6702552|NCT02855164|7632891|FG001|COMPLETED|Parts A + B (Randomized Set)||16
6702553|NCT02855164|7632892|FG002|COMPLETED|Parts A + B (Randomized Set)||36
6702554|NCT02855164|7632893|FG003|COMPLETED|Parts A + B (Randomized Set)||77
6702555|NCT02855164|7632894|FG004|COMPLETED|Parts A + B (Randomized Set)||45
6702556|NCT02855164|7632895|FG005|COMPLETED|Parts A + B (Randomized Set)||0
6702557|NCT02855164|7632896|FG006|COMPLETED|Parts A + B (Randomized Set)||0
6702558|NCT02855164|7632897|FG007|COMPLETED|Parts A + B (Randomized Set)||0
6702559|NCT02855164|7632890|FG000|NOT COMPLETED|Parts A + B (Randomized Set)||0
6702560|NCT02855164|7632891|FG001|NOT COMPLETED|Parts A + B (Randomized Set)||0
6702561|NCT02855164|7632892|FG002|NOT COMPLETED|Parts A + B (Randomized Set)||1
6702562|NCT02855164|7632893|FG003|NOT COMPLETED|Parts A + B (Randomized Set)||8
6702563|NCT02855164|7632894|FG004|NOT COMPLETED|Parts A + B (Randomized Set)||1
6702564|NCT02855164|7632895|FG005|NOT COMPLETED|Parts A + B (Randomized Set)||0
6702565|NCT02855164|7632896|FG006|NOT COMPLETED|Parts A + B (Randomized Set)||0
6702566|NCT02855164|7632897|FG007|NOT COMPLETED|Parts A + B (Randomized Set)||0
6702567|NCT02855164|7632890|FG000|STARTED|Part C (Randomized Set)||0
6702568|NCT02855164|7632891|FG001|STARTED|Part C (Randomized Set)||0
6702569|NCT02855164|7632892|FG002|STARTED|Part C (Randomized Set)||0
6702570|NCT02855164|7632893|FG003|STARTED|Part C (Randomized Set)||0
6702571|NCT02855164|7632894|FG004|STARTED|Part C (Randomized Set)||0
6702572|NCT02855164|7632895|FG005|STARTED|Part C (Randomized Set)||50
6702573|NCT02855164|7632896|FG006|STARTED|Part C (Randomized Set)||51
6702574|NCT02855164|7632897|FG007|STARTED|Part C (Randomized Set)||51
6702575|NCT02855164|7632890|FG000|COMPLETED|Part C (Randomized Set)||0
6702576|NCT02855164|7632891|FG001|COMPLETED|Part C (Randomized Set)||0
6702577|NCT02855164|7632892|FG002|COMPLETED|Part C (Randomized Set)||0
6702578|NCT02855164|7632893|FG003|COMPLETED|Part C (Randomized Set)||0
6702579|NCT02855164|7632894|FG004|COMPLETED|Part C (Randomized Set)||0
6702580|NCT02855164|7632895|FG005|COMPLETED|Part C (Randomized Set)||38
6702581|NCT02855164|7632896|FG006|COMPLETED|Part C (Randomized Set)||37
6702582|NCT02855164|7632897|FG007|COMPLETED|Part C (Randomized Set)||44
6702583|NCT02855164|7632890|FG000|NOT COMPLETED|Part C (Randomized Set)||0
6702584|NCT02855164|7632891|FG001|NOT COMPLETED|Part C (Randomized Set)||0
6702585|NCT02855164|7632892|FG002|NOT COMPLETED|Part C (Randomized Set)||0
6702586|NCT02855164|7632893|FG003|NOT COMPLETED|Part C (Randomized Set)||0
6702587|NCT02855164|7632894|FG004|NOT COMPLETED|Part C (Randomized Set)||0
6702588|NCT02855164|7632895|FG005|NOT COMPLETED|Part C (Randomized Set)||12
6702589|NCT02855164|7632896|FG006|NOT COMPLETED|Part C (Randomized Set)||14
6702590|NCT02855164|7632897|FG007|NOT COMPLETED|Part C (Randomized Set)||7
6702591|NCT02855281|7632935|FG000|STARTED|Overall Study||50
6702592|NCT02855281|7632935|FG000|COMPLETED|Overall Study||50
6702593|NCT02855281|7632935|FG000|NOT COMPLETED|Overall Study||0
6702594|NCT02855359|7632945|FG000|STARTED|Overall Study||11
6702595|NCT02855359|7632946|FG001|STARTED|Overall Study||13
6702596|NCT02855359|7632947|FG002|STARTED|Overall Study||0
6702597|NCT02855359|7632948|FG003|STARTED|Overall Study||0
6702598|NCT02855359|7632945|FG000|COMPLETED|Overall Study||0
6702599|NCT02855359|7632946|FG001|COMPLETED|Overall Study||0
6702600|NCT02855359|7632947|FG002|COMPLETED|Overall Study||0
6702601|NCT02855359|7632948|FG003|COMPLETED|Overall Study||0
6702602|NCT02855359|7632945|FG000|NOT COMPLETED|Overall Study||11
6702603|NCT02855359|7632946|FG001|NOT COMPLETED|Overall Study||13
6702604|NCT02855359|7632947|FG002|NOT COMPLETED|Overall Study||0
6702605|NCT02855359|7632948|FG003|NOT COMPLETED|Overall Study||0
6702606|NCT02855437|7632956|FG000|STARTED|Phase 1||23
6702607|NCT02855437|7632957|FG001|STARTED|Phase 1||21
6702608|NCT02855437|7632956|FG000|COMPLETED|Phase 1||21
6702609|NCT02855437|7632957|FG001|COMPLETED|Phase 1||19
6702610|NCT02855437|7632956|FG000|NOT COMPLETED|Phase 1||2
6702611|NCT02855437|7632957|FG001|NOT COMPLETED|Phase 1||2
6702612|NCT02855437|7632956|FG000|STARTED|Crossover Period (Same Day)||21
6702613|NCT02855437|7632957|FG001|STARTED|Crossover Period (Same Day)||19
6702614|NCT02855437|7632956|FG000|COMPLETED|Crossover Period (Same Day)||21
6702615|NCT02855437|7632957|FG001|COMPLETED|Crossover Period (Same Day)||19
6702616|NCT02855437|7632956|FG000|NOT COMPLETED|Crossover Period (Same Day)||0
6260354|NCT01064648|7159061|FG000|STARTED|Phase I Cohort1: Dose Level 1||7
6260355|NCT01064648|7159062|FG001|STARTED|Phase I Cohort1: Dose Level 1||0
6260356|NCT01064648|7159063|FG002|STARTED|Phase I Cohort1: Dose Level 1||0
6260357|NCT01064648|7159064|FG003|STARTED|Phase I Cohort1: Dose Level 1||0
6260358|NCT01064648|7159061|FG000|COMPLETED|Phase I Cohort1: Dose Level 1||0
6260359|NCT01064648|7159062|FG001|COMPLETED|Phase I Cohort1: Dose Level 1||0
6260360|NCT01064648|7159063|FG002|COMPLETED|Phase I Cohort1: Dose Level 1||0
6260361|NCT01064648|7159064|FG003|COMPLETED|Phase I Cohort1: Dose Level 1||0
6260362|NCT01064648|7159061|FG000|NOT COMPLETED|Phase I Cohort1: Dose Level 1||7
6260363|NCT01064648|7159062|FG001|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
6260364|NCT01064648|7159063|FG002|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
6260365|NCT01064648|7159064|FG003|NOT COMPLETED|Phase I Cohort1: Dose Level 1||0
6260366|NCT01064648|7159061|FG000|STARTED|Phase I Cohort 2: Dose Level 2||0
6260367|NCT01064648|7159062|FG001|STARTED|Phase I Cohort 2: Dose Level 2||13
6260368|NCT01064648|7159063|FG002|STARTED|Phase I Cohort 2: Dose Level 2||0
6260369|NCT01064648|7159064|FG003|STARTED|Phase I Cohort 2: Dose Level 2||0
6260370|NCT01064648|7159061|FG000|COMPLETED|Phase I Cohort 2: Dose Level 2||0
6260371|NCT01064648|7159062|FG001|COMPLETED|Phase I Cohort 2: Dose Level 2||0
6260372|NCT01064648|7159063|FG002|COMPLETED|Phase I Cohort 2: Dose Level 2||0
6260373|NCT01064648|7159064|FG003|COMPLETED|Phase I Cohort 2: Dose Level 2||0
6260374|NCT01064648|7159061|FG000|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
6260375|NCT01064648|7159062|FG001|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||13
6260376|NCT01064648|7159063|FG002|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
6260377|NCT01064648|7159064|FG003|NOT COMPLETED|Phase I Cohort 2: Dose Level 2||0
6260378|NCT01064648|7159061|FG000|STARTED|Phase II||0
6260379|NCT01064648|7159062|FG001|STARTED|Phase II||0
6260380|NCT01064648|7159063|FG002|STARTED|Phase II||49
6260381|NCT01064648|7159064|FG003|STARTED|Phase II||48
6260382|NCT01064648|7159061|FG000|COMPLETED|Phase II||0
6260383|NCT01064648|7159062|FG001|COMPLETED|Phase II||0
6260384|NCT01064648|7159063|FG002|COMPLETED|Phase II||0
6260385|NCT01064648|7159064|FG003|COMPLETED|Phase II||0
6260386|NCT01064648|7159061|FG000|NOT COMPLETED|Phase II||0
6260387|NCT01064648|7159062|FG001|NOT COMPLETED|Phase II||0
6260388|NCT01064648|7159063|FG002|NOT COMPLETED|Phase II||49
6260389|NCT01064648|7159064|FG003|NOT COMPLETED|Phase II||48
6260390|NCT00980538|7159077|FG000|STARTED|Overall Study||180
6260391|NCT00980538|7159077|FG000|COMPLETED|Overall Study||0
6702617|NCT02855437|7632957|FG001|NOT COMPLETED|Crossover Period (Same Day)||0
6702618|NCT02855437|7632956|FG000|STARTED|Phase 2||21
6702619|NCT02855437|7632957|FG001|STARTED|Phase 2||19
6702620|NCT02855437|7632956|FG000|COMPLETED|Phase 2||20
6702621|NCT02855437|7632957|FG001|COMPLETED|Phase 2||18
6702622|NCT02855437|7632956|FG000|NOT COMPLETED|Phase 2||1
6702623|NCT02855437|7632957|FG001|NOT COMPLETED|Phase 2||1
6702624|NCT02855450|7632966|FG000|STARTED|Overall Study||40
6702625|NCT02855450|7632967|FG001|STARTED|Overall Study||20
6260392|NCT00980538|7159077|FG000|NOT COMPLETED|Overall Study||180
6260393|NCT00855803|7159081|FG000|STARTED|Overall Study||35
6702626|NCT02855450|7632966|FG000|COMPLETED|Overall Study||35
6702627|NCT02855450|7632967|FG001|COMPLETED|Overall Study||20
6702628|NCT02855450|7632966|FG000|NOT COMPLETED|Overall Study||5
6702629|NCT02855450|7632967|FG001|NOT COMPLETED|Overall Study||0
6702630|NCT02855541|7632973|FG000|STARTED|Overall Study||25
6702631|NCT02855541|7632973|FG000|COMPLETED|Overall Study||21
6702632|NCT02855541|7632973|FG000|NOT COMPLETED|Overall Study||4
6702633|NCT02855567|7632979|FG000|STARTED|Overall Study||54
6702634|NCT02855567|7632980|FG001|STARTED|Overall Study||56
6702635|NCT02855567|7632979|FG000|COMPLETED|Overall Study||54
6702636|NCT02855567|7632980|FG001|COMPLETED|Overall Study||56
6702637|NCT02855567|7632979|FG000|NOT COMPLETED|Overall Study||0
6702638|NCT02855567|7632980|FG001|NOT COMPLETED|Overall Study||0
6702639|NCT02856035|7632986|FG000|STARTED|Overall Study||4
6702640|NCT02856035|7632986|FG000|COMPLETED|Overall Study||4
6702641|NCT02856035|7632986|FG000|NOT COMPLETED|Overall Study||0
6702642|NCT02856282|7632990|FG000|STARTED|Overall Study||46
6702643|NCT02856282|7632990|FG000|COMPLETED|Overall Study||45
6702644|NCT02856282|7632990|FG000|NOT COMPLETED|Overall Study||1
6702645|NCT02856490|7632997|FG000|STARTED|Overall Study||2
6702646|NCT02856490|7632998|FG001|STARTED|Overall Study||2
6702647|NCT02856490|7632999|FG002|STARTED|Overall Study||2
6702648|NCT02856490|7632997|FG000|COMPLETED|Overall Study||2
6702649|NCT02856490|7632998|FG001|COMPLETED|Overall Study||2
6702650|NCT02856490|7632999|FG002|COMPLETED|Overall Study||2
6702651|NCT02856490|7632997|FG000|NOT COMPLETED|Overall Study||0
6702652|NCT02856490|7632998|FG001|NOT COMPLETED|Overall Study||0
6702653|NCT02856490|7632999|FG002|NOT COMPLETED|Overall Study||0
6702654|NCT02856555|7633010|FG000|STARTED|Overall Study||51
6702655|NCT02856555|7633011|FG001|STARTED|Overall Study||50
6702656|NCT02856555|7633012|FG002|STARTED|Overall Study||26
6702657|NCT02856555|7633010|FG000|COMPLETED|Overall Study||46
6702658|NCT02856555|7633011|FG001|COMPLETED|Overall Study||46
6702659|NCT02856555|7633012|FG002|COMPLETED|Overall Study||26
6702660|NCT02856555|7633010|FG000|NOT COMPLETED|Overall Study||5
6702661|NCT02856555|7633011|FG001|NOT COMPLETED|Overall Study||4
6702662|NCT02856555|7633012|FG002|NOT COMPLETED|Overall Study||0
6702663|NCT02856802|7633022|FG000|STARTED|Double-Blind Treatment Period 1|4 of 54 randomized subjects did not start; 2 had no migraines, 1 withdrew, 1 lost to follow-up.|50
6702664|NCT02856802|7633023|FG001|STARTED|Double-Blind Treatment Period 1|10 of 53 randomized subjects did not start; 6 had no migraines, 3 withdrew, 1 sponsor terminated.|43
6702665|NCT02856802|7633022|FG000|COMPLETED|Double-Blind Treatment Period 1||48
6702666|NCT02856802|7633023|FG001|COMPLETED|Double-Blind Treatment Period 1||38
6702667|NCT02856802|7633022|FG000|NOT COMPLETED|Double-Blind Treatment Period 1||2
6702668|NCT02856802|7633023|FG001|NOT COMPLETED|Double-Blind Treatment Period 1||5
6702669|NCT02856802|7633022|FG000|STARTED|Double-Blind Treatment Period 2|6 of 43 re-randomized subjects did not start; 5 had no migraines, for 1 protocol deviation.|37
6702670|NCT02856802|7633023|FG001|STARTED|Double-Blind Treatment Period 2|5 of 43 re-randomized subjects did not start; 4 had no migraines, for 1 prohibited drug use.|38
6702671|NCT02856802|7633022|FG000|COMPLETED|Double-Blind Treatment Period 2||36
6702672|NCT02856802|7633023|FG001|COMPLETED|Double-Blind Treatment Period 2||38
6702673|NCT02856802|7633022|FG000|NOT COMPLETED|Double-Blind Treatment Period 2||1
6702674|NCT02856802|7633023|FG001|NOT COMPLETED|Double-Blind Treatment Period 2||0
6739023|NCT03286218|7668005|FG009|STARTED|Treatment Phase Period 5||6
6739024|NCT03286218|7668006|FG010|STARTED|Treatment Phase Period 5||5
6739025|NCT03286218|7668007|FG011|STARTED|Treatment Phase Period 5||4
6739026|NCT03286218|7667996|FG000|COMPLETED|Treatment Phase Period 5||0
6739027|NCT03286218|7667997|FG001|COMPLETED|Treatment Phase Period 5||0
6739028|NCT03286218|7667998|FG002|COMPLETED|Treatment Phase Period 5||5
6739029|NCT03286218|7667999|FG003|COMPLETED|Treatment Phase Period 5||5
6739030|NCT03286218|7668000|FG004|COMPLETED|Treatment Phase Period 5||5
6739031|NCT03286218|7668001|FG005|COMPLETED|Treatment Phase Period 5||5
6739032|NCT03286218|7668002|FG006|COMPLETED|Treatment Phase Period 5||6
6739033|NCT03286218|7668003|FG007|COMPLETED|Treatment Phase Period 5||6
6739034|NCT03286218|7668004|FG008|COMPLETED|Treatment Phase Period 5||6
6739035|NCT03286218|7668005|FG009|COMPLETED|Treatment Phase Period 5||6
6739036|NCT03286218|7668006|FG010|COMPLETED|Treatment Phase Period 5||5
6739037|NCT03286218|7668007|FG011|COMPLETED|Treatment Phase Period 5||4
6739038|NCT03286218|7667996|FG000|NOT COMPLETED|Treatment Phase Period 5||0
6739039|NCT03286218|7667997|FG001|NOT COMPLETED|Treatment Phase Period 5||0
6739040|NCT03286218|7667998|FG002|NOT COMPLETED|Treatment Phase Period 5||0
6739041|NCT03286218|7667999|FG003|NOT COMPLETED|Treatment Phase Period 5||0
6739042|NCT03286218|7668000|FG004|NOT COMPLETED|Treatment Phase Period 5||0
6739043|NCT03286218|7668001|FG005|NOT COMPLETED|Treatment Phase Period 5||0
6739044|NCT03286218|7668002|FG006|NOT COMPLETED|Treatment Phase Period 5||0
6739045|NCT03286218|7668003|FG007|NOT COMPLETED|Treatment Phase Period 5||0
6739046|NCT03286218|7668004|FG008|NOT COMPLETED|Treatment Phase Period 5||0
6739047|NCT03286218|7668005|FG009|NOT COMPLETED|Treatment Phase Period 5||0
6739048|NCT03286218|7668006|FG010|NOT COMPLETED|Treatment Phase Period 5||0
6739049|NCT03286218|7668007|FG011|NOT COMPLETED|Treatment Phase Period 5||0
6739050|NCT03286283|7668034|FG000|STARTED|Overall Study||55
6702675|NCT02856828|7633035|FG000|STARTED|Overall Study||2
6702676|NCT02856828|7633036|FG001|STARTED|Overall Study||3
6702677|NCT02856828|7633035|FG000|COMPLETED|Overall Study||2
6702678|NCT02856828|7633036|FG001|COMPLETED|Overall Study||3
6702679|NCT02856828|7633035|FG000|NOT COMPLETED|Overall Study||0
6260394|NCT00855803|7159081|FG000|COMPLETED|Overall Study||21
6260395|NCT00855803|7159081|FG000|NOT COMPLETED|Overall Study||14
6260396|NCT00792948|7159085|FG000|STARTED|Overall Study|Patients registered to induction/consolidation step|97
6260397|NCT00792948|7159085|FG000|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
6260398|NCT00792948|7159085|FG000|NOT COMPLETED|Overall Study||28
6260399|NCT00790803|7159092|FG000|STARTED|Overall Study||5
6260400|NCT00790803|7159092|FG000|COMPLETED|Overall Study||5
6260401|NCT00790803|7159092|FG000|NOT COMPLETED|Overall Study||0
6260402|NCT00740116|7159098|FG000|STARTED|Overall Study||50
6260403|NCT00740116|7159099|FG001|STARTED|Overall Study||50
6260404|NCT00740116|7159098|FG000|COMPLETED|Overall Study||48
6260405|NCT00740116|7159099|FG001|COMPLETED|Overall Study||45
6260406|NCT00740116|7159098|FG000|NOT COMPLETED|Overall Study||2
6260407|NCT00740116|7159099|FG001|NOT COMPLETED|Overall Study||5
6260408|NCT00565617|7159107|FG000|STARTED|Overall Study||6
6260409|NCT00565617|7159107|FG000|COMPLETED|Overall Study||5
6260410|NCT00565617|7159107|FG000|NOT COMPLETED|Overall Study||1
6260411|NCT00551616|7159113|FG000|STARTED|Overall Study||1104
6260412|NCT00551616|7159114|FG001|STARTED|Overall Study||1117
6260413|NCT00551616|7159113|FG000|COMPLETED|Overall Study||1056
6260414|NCT00551616|7159114|FG001|COMPLETED|Overall Study||1077
6260415|NCT00551616|7159113|FG000|NOT COMPLETED|Overall Study||48
6260416|NCT00551616|7159114|FG001|NOT COMPLETED|Overall Study||40
6260417|NCT00470704|7159122|FG000|STARTED|Overall Study||41
6260418|NCT00470704|7159123|FG001|STARTED|Overall Study||46
6260419|NCT00470704|7159122|FG000|Safety Population|Overall Study||41
6260420|NCT00470704|7159123|FG001|Safety Population|Overall Study||45
6260421|NCT00470704|7159122|FG000|Treated|Overall Study||40
6260422|NCT00470704|7159123|FG001|Treated|Overall Study||45
6260423|NCT00470704|7159122|FG000|COMPLETED|Overall Study||0
6260424|NCT00470704|7159123|FG001|COMPLETED|Overall Study||0
6260425|NCT00470704|7159122|FG000|NOT COMPLETED|Overall Study||41
6260426|NCT00470704|7159123|FG001|NOT COMPLETED|Overall Study||46
6260427|NCT00427193|7159131|FG000|STARTED|Overall Study||143
6260428|NCT00427193|7159132|FG001|STARTED|Overall Study||75
6260429|NCT00427193|7159131|FG000|COMPLETED|Overall Study||117
6260430|NCT00427193|7159132|FG001|COMPLETED|Overall Study||71
6260431|NCT00427193|7159131|FG000|NOT COMPLETED|Overall Study||26
6260432|NCT00427193|7159132|FG001|NOT COMPLETED|Overall Study||4
6260433|NCT00148733|7159142|FG000|STARTED|Overall Study||1314
6260434|NCT00148733|7159143|FG001|STARTED|Overall Study||1314
6260435|NCT00148733|7159142|FG000|COMPLETED|Overall Study||1300
6260436|NCT00148733|7159143|FG001|COMPLETED|Overall Study||1299
6260437|NCT00148733|7159142|FG000|NOT COMPLETED|Overall Study||14
6260438|NCT00148733|7159143|FG001|NOT COMPLETED|Overall Study||15
6260439|NCT00142584|7159151|FG000|STARTED|Overall Study||252
6260440|NCT00142584|7159152|FG001|STARTED|Overall Study||84
6260441|NCT00142584|7159151|FG000|COMPLETED|Overall Study||108
6260442|NCT00142584|7159152|FG001|COMPLETED|Overall Study||28
6260443|NCT00142584|7159151|FG000|NOT COMPLETED|Overall Study||144
6260444|NCT00142584|7159152|FG001|NOT COMPLETED|Overall Study||56
6280237|NCT00152971|7180138|FG001|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
6280238|NCT00152971|7180139|FG002|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
6280239|NCT00152971|7180137|FG000|NOT COMPLETED|Treatment||71
6280240|NCT00152971|7180138|FG001|NOT COMPLETED|Treatment||63
6280241|NCT00152971|7180139|FG002|NOT COMPLETED|Treatment||80
6280242|NCT00153062|7180151|FG000|STARTED|Overall Study||5086
6280243|NCT00153062|7180152|FG001|STARTED|Overall Study||5095
6280244|NCT00153062|7180153|FG002|STARTED|Overall Study||5060
6280245|NCT00153062|7180154|FG003|STARTED|Overall Study||5091
6280246|NCT00153062|7180151|FG000|COMPLETED|Overall Study||4699
6280247|NCT00153062|7180152|FG001|COMPLETED|Overall Study||4689
6280248|NCT00153062|7180153|FG002|COMPLETED|Overall Study||4645
6280249|NCT00153062|7180154|FG003|COMPLETED|Overall Study||4680
6280250|NCT00153062|7180151|FG000|NOT COMPLETED|Overall Study||387
6280251|NCT00153062|7180152|FG001|NOT COMPLETED|Overall Study||406
6280252|NCT00153062|7180153|FG002|NOT COMPLETED|Overall Study||415
6280253|NCT00153062|7180154|FG003|NOT COMPLETED|Overall Study||411
6280254|NCT00153101|7180169|FG000|STARTED|Overall Study||8502
6280255|NCT00153101|7180170|FG001|STARTED|Overall Study||8542
6280256|NCT00153101|7180171|FG002|STARTED|Overall Study||8576
6280257|NCT00153101|7180172|FG003|STARTED|Overall Study||2954
6280258|NCT00153101|7180173|FG004|STARTED|Overall Study||2972
6280259|NCT00153101|7180169|FG000|COMPLETED|Overall Study||8485
6280260|NCT00153101|7180170|FG001|COMPLETED|Overall Study||8524
6280261|NCT00153101|7180171|FG002|COMPLETED|Overall Study||8561
6280262|NCT00153101|7180172|FG003|COMPLETED|Overall Study||2946
6280263|NCT00153101|7180173|FG004|COMPLETED|Overall Study||2962
6280264|NCT00153101|7180169|FG000|NOT COMPLETED|Overall Study||17
6280265|NCT00153101|7180170|FG001|NOT COMPLETED|Overall Study||18
6280266|NCT00153101|7180171|FG002|NOT COMPLETED|Overall Study||15
6280267|NCT00153101|7180172|FG003|NOT COMPLETED|Overall Study||8
6280268|NCT00153101|7180173|FG004|NOT COMPLETED|Overall Study||10
6280269|NCT00153166|7180190|FG000|STARTED|Overall Study||11
6280270|NCT00153166|7180191|FG001|STARTED|Overall Study||37
6702680|NCT02856828|7633036|FG001|NOT COMPLETED|Overall Study||0
6702681|NCT02856880|7633050|FG000|STARTED|Overall Study||45
6702682|NCT02856880|7633050|FG000|Received Test Zinc-IPMP|Overall Study||44
6702683|NCT02856880|7633050|FG000|Received Test Zinc Non-IPMP|Overall Study||44
6702684|NCT02856880|7633050|FG000|Received Positive Control|Overall Study||45
6702685|NCT02856880|7633050|FG000|Received Non-SLS Negative Control|Overall Study||44
6702686|NCT02856880|7633050|FG000|Received SLS Negative Control|Overall Study||44
6702687|NCT02856880|7633050|FG000|COMPLETED|Overall Study||44
6702688|NCT02856880|7633050|FG000|NOT COMPLETED|Overall Study||1
6702689|NCT02857283|7633071|FG000|STARTED|First Exposure||8
6702690|NCT02857283|7633072|FG001|STARTED|First Exposure||7
6702691|NCT02857283|7633071|FG000|COMPLETED|First Exposure||7
6702692|NCT02857283|7633072|FG001|COMPLETED|First Exposure||7
6702693|NCT02857283|7633071|FG000|NOT COMPLETED|First Exposure||1
6702694|NCT02857283|7633072|FG001|NOT COMPLETED|First Exposure||0
6702695|NCT02857283|7633071|FG000|STARTED|Washout (2 Weeks)||7
6702696|NCT02857283|7633072|FG001|STARTED|Washout (2 Weeks)||7
6702697|NCT02857283|7633071|FG000|COMPLETED|Washout (2 Weeks)||7
6702698|NCT02857283|7633072|FG001|COMPLETED|Washout (2 Weeks)||7
6702699|NCT02857283|7633071|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6702700|NCT02857283|7633072|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6702701|NCT02857283|7633071|FG000|STARTED|Second Exposure||7
6702702|NCT02857283|7633072|FG001|STARTED|Second Exposure||7
6702703|NCT02857283|7633071|FG000|COMPLETED|Second Exposure||7
6702704|NCT02857283|7633072|FG001|COMPLETED|Second Exposure||7
6702705|NCT02857283|7633071|FG000|NOT COMPLETED|Second Exposure||0
6702706|NCT02857283|7633072|FG001|NOT COMPLETED|Second Exposure||0
6702707|NCT02857816|7633079|FG000|STARTED|Overall Study||154
6702708|NCT02857816|7633079|FG000|Subjects Qualified and Treated With PTNM|Overall Study||120
6702709|NCT02857816|7633079|FG000|COMPLETED|Overall Study||116
6702710|NCT02857816|7633079|FG000|NOT COMPLETED|Overall Study||38
6702711|NCT02858050|7633086|FG000|STARTED|Overall Study||20
6702712|NCT02858050|7633087|FG001|STARTED|Overall Study||20
6702713|NCT02858050|7633086|FG000|COMPLETED|Overall Study||20
6702714|NCT02858050|7633087|FG001|COMPLETED|Overall Study||20
6702715|NCT02858050|7633086|FG000|NOT COMPLETED|Overall Study||0
6702716|NCT02858050|7633087|FG001|NOT COMPLETED|Overall Study||0
6702717|NCT02858076|7633095|FG000|STARTED|Overall Study||100
6702718|NCT02858076|7633096|FG001|STARTED|Overall Study||105
6702719|NCT02858076|7633095|FG000|COMPLETED|Overall Study||90
6702720|NCT02858076|7633096|FG001|COMPLETED|Overall Study||87
6702721|NCT02858076|7633095|FG000|NOT COMPLETED|Overall Study||10
6702722|NCT02858076|7633096|FG001|NOT COMPLETED|Overall Study||18
6702723|NCT02858180|7633106|FG000|STARTED|Overall Study||10
6702724|NCT02858180|7633107|FG001|STARTED|Overall Study||5
6702725|NCT02858180|7633106|FG000|COMPLETED|Overall Study|Completed a 12-week course of therapy.|10
6702726|NCT02858180|7633107|FG001|COMPLETED|Overall Study|Completed a 12-week course of therapy.|3
6702727|NCT02858180|7633106|FG000|NOT COMPLETED|Overall Study||0
6702728|NCT02858180|7633107|FG001|NOT COMPLETED|Overall Study||2
6702729|NCT02858349|7633113|FG000|STARTED|Overall Study||10
6702730|NCT02858349|7633113|FG000|COMPLETED|Overall Study||10
6702731|NCT02858349|7633113|FG000|NOT COMPLETED|Overall Study||0
6702732|NCT02858362|7633120|FG000|STARTED|Overall Study||30
6702733|NCT02858362|7633121|FG001|STARTED|Overall Study||10
6702734|NCT02858362|7633122|FG002|STARTED|Overall Study||3
6702735|NCT02858362|7633120|FG000|Did Not Enter Extension Phase|Overall Study||1
6702736|NCT02858362|7633121|FG001|Did Not Enter Extension Phase|Overall Study||2
6702737|NCT02858362|7633122|FG002|Did Not Enter Extension Phase|Overall Study||0
6702738|NCT02858362|7633120|FG000|COMPLETED|Overall Study||28
6702739|NCT02858362|7633121|FG001|COMPLETED|Overall Study||9
6702740|NCT02858362|7633122|FG002|COMPLETED|Overall Study||0
6702741|NCT02858362|7633120|FG000|NOT COMPLETED|Overall Study||2
6702742|NCT02858362|7633121|FG001|NOT COMPLETED|Overall Study||1
6702743|NCT02858362|7633122|FG002|NOT COMPLETED|Overall Study||3
6702744|NCT02858401|7633142|FG000|STARTED|Overall Study||6
6702745|NCT02858401|7633143|FG001|STARTED|Overall Study||6
6702746|NCT02858401|7633144|FG002|STARTED|Overall Study||6
6702747|NCT02858401|7633145|FG003|STARTED|Overall Study||6
6702748|NCT02858401|7633146|FG004|STARTED|Overall Study||6
6702749|NCT02858401|7633147|FG005|STARTED|Overall Study||6
6702750|NCT02858401|7633148|FG006|STARTED|Overall Study||12
6702751|NCT02858401|7633142|FG000|COMPLETED|Overall Study||6
6702752|NCT02858401|7633143|FG001|COMPLETED|Overall Study||5
6702753|NCT02858401|7633144|FG002|COMPLETED|Overall Study||6
6702754|NCT02858401|7633145|FG003|COMPLETED|Overall Study||6
6702755|NCT02858401|7633146|FG004|COMPLETED|Overall Study||6
6702756|NCT02858401|7633147|FG005|COMPLETED|Overall Study||5
6702757|NCT02858401|7633148|FG006|COMPLETED|Overall Study||12
6702758|NCT02858401|7633142|FG000|NOT COMPLETED|Overall Study||0
6702759|NCT02858401|7633143|FG001|NOT COMPLETED|Overall Study||1
6702760|NCT02858401|7633144|FG002|NOT COMPLETED|Overall Study||0
6702761|NCT02858401|7633145|FG003|NOT COMPLETED|Overall Study||0
6702762|NCT02858401|7633146|FG004|NOT COMPLETED|Overall Study||0
6702763|NCT02858401|7633147|FG005|NOT COMPLETED|Overall Study||1
6702764|NCT02858401|7633148|FG006|NOT COMPLETED|Overall Study||0
6702765|NCT02858440|7633173|FG000|STARTED|Overall Study||235
6702766|NCT02858440|7633173|FG000|COMPLETED|Overall Study||223
6702767|NCT02858440|7633173|FG000|NOT COMPLETED|Overall Study||12
6702768|NCT02858492|7633181|FG000|STARTED|Overall Study||3
6702769|NCT02858492|7633182|FG001|STARTED|Overall Study||15
6702770|NCT02858492|7633183|FG002|STARTED|Overall Study||5
6702771|NCT02858492|7633184|FG003|STARTED|Overall Study||28
6702772|NCT02858492|7633181|FG000|COMPLETED|Overall Study||3
6702773|NCT02858492|7633182|FG001|COMPLETED|Overall Study||14
6702774|NCT02858492|7633183|FG002|COMPLETED|Overall Study||5
6702775|NCT02858492|7633184|FG003|COMPLETED|Overall Study||22
6702776|NCT02858492|7633181|FG000|NOT COMPLETED|Overall Study||0
6702777|NCT02858492|7633182|FG001|NOT COMPLETED|Overall Study||1
6702778|NCT02858492|7633183|FG002|NOT COMPLETED|Overall Study||0
6702779|NCT02858492|7633184|FG003|NOT COMPLETED|Overall Study||6
6702780|NCT02858713|7633198|FG000|STARTED|Overall Study||68
6702781|NCT02858713|7633199|FG001|STARTED|Overall Study||66
6702782|NCT02858713|7633198|FG000|COMPLETED|Overall Study||61
6702783|NCT02858713|7633199|FG001|COMPLETED|Overall Study||61
6702784|NCT02858713|7633198|FG000|NOT COMPLETED|Overall Study||7
6702785|NCT02858713|7633199|FG001|NOT COMPLETED|Overall Study||5
6702786|NCT02858726|7633213|FG000|STARTED|Overall Study||44
6702787|NCT02858726|7633214|FG001|STARTED|Overall Study||42
6702788|NCT02858726|7633215|FG002|STARTED|Overall Study||44
6702789|NCT02858726|7633216|FG003|STARTED|Overall Study||45
6702790|NCT02858726|7633213|FG000|COMPLETED|Overall Study||39
6702791|NCT02858726|7633214|FG001|COMPLETED|Overall Study||35
6702792|NCT02858726|7633215|FG002|COMPLETED|Overall Study||33
6702793|NCT02858726|7633216|FG003|COMPLETED|Overall Study||42
6702794|NCT02858726|7633213|FG000|NOT COMPLETED|Overall Study||5
6702795|NCT02858726|7633214|FG001|NOT COMPLETED|Overall Study||7
6702796|NCT02858726|7633215|FG002|NOT COMPLETED|Overall Study||11
6702797|NCT02858726|7633216|FG003|NOT COMPLETED|Overall Study||3
6702798|NCT02859142|7633232|FG000|STARTED|Overall Study||61
6702799|NCT02859142|7633233|FG001|STARTED|Overall Study||61
6702800|NCT02859142|7633232|FG000|COMPLETED|Overall Study||57
6702801|NCT02859142|7633233|FG001|COMPLETED|Overall Study||52
6702802|NCT02859142|7633232|FG000|NOT COMPLETED|Overall Study||4
6702803|NCT02859142|7633233|FG001|NOT COMPLETED|Overall Study||9
6702804|NCT02859246|7633239|FG000|STARTED|Overall Study|15 subjects were enrolled into study|15
6702805|NCT02859246|7633239|FG000|COMPLETED|Overall Study|10 subjects completed the study|10
6702806|NCT02859246|7633239|FG000|NOT COMPLETED|Overall Study||5
6702807|NCT02859324|7633247|FG000|STARTED|Overall Study||7
6702808|NCT02859324|7633248|FG001|STARTED|Overall Study||9
6702809|NCT02859324|7633249|FG002|STARTED|Overall Study||5
6702810|NCT02859324|7633247|FG000|COMPLETED|Overall Study||0
6702811|NCT02859324|7633248|FG001|COMPLETED|Overall Study||0
6702812|NCT02859324|7633249|FG002|COMPLETED|Overall Study||0
6702813|NCT02859324|7633247|FG000|NOT COMPLETED|Overall Study||7
6702814|NCT02859324|7633248|FG001|NOT COMPLETED|Overall Study||9
6702815|NCT02859324|7633249|FG002|NOT COMPLETED|Overall Study||5
6702816|NCT02859441|7633257|FG000|STARTED|Overall Study||3
6702817|NCT02859441|7633257|FG000|COMPLETED|Overall Study||3
6702818|NCT02859441|7633257|FG000|NOT COMPLETED|Overall Study||0
6702819|NCT02859454|7633278|FG000|STARTED|Overall Study||13
6702820|NCT02859454|7633278|FG000|COMPLETED|Overall Study||12
6702821|NCT02859454|7633278|FG000|NOT COMPLETED|Overall Study||1
6702822|NCT02859597|7633287|FG000|STARTED|Overall Study|started Dec 2016|22
6702823|NCT02859597|7633288|FG001|STARTED|Overall Study|Started Dec 2016|19
6702824|NCT02859597|7633287|FG000|COMPLETED|Overall Study|September 2018|22
6702825|NCT02859597|7633288|FG001|COMPLETED|Overall Study|September 2018|19
6702826|NCT02859597|7633287|FG000|NOT COMPLETED|Overall Study||0
6702827|NCT02859597|7633288|FG001|NOT COMPLETED|Overall Study||0
6702828|NCT02860130|7633298|FG000|STARTED|Overall Study||17
6702829|NCT02860130|7633299|FG001|STARTED|Overall Study||17
6702830|NCT02860130|7633298|FG000|COMPLETED|Overall Study||10
6702831|NCT02860130|7633299|FG001|COMPLETED|Overall Study||8
6702832|NCT02860130|7633298|FG000|NOT COMPLETED|Overall Study||7
6702833|NCT02860130|7633299|FG001|NOT COMPLETED|Overall Study||9
6702834|NCT02860286|7633307|FG000|STARTED|Overall Study||13
6702835|NCT02860286|7633308|FG001|STARTED|Overall Study||61
6702836|NCT02860286|7633307|FG000|COMPLETED|Overall Study||13
6702837|NCT02860286|7633308|FG001|COMPLETED|Overall Study||61
6702838|NCT02860286|7633307|FG000|NOT COMPLETED|Overall Study||0
6702839|NCT02860286|7633308|FG001|NOT COMPLETED|Overall Study||0
6702840|NCT02860507|7633325|FG000|STARTED|Overall Study||25
6702841|NCT02860507|7633326|FG001|STARTED|Overall Study||25
6702842|NCT02860507|7633325|FG000|COMPLETED|Overall Study||25
6702843|NCT02860507|7633326|FG001|COMPLETED|Overall Study||25
6702844|NCT02860507|7633325|FG000|NOT COMPLETED|Overall Study||0
6702845|NCT02860507|7633326|FG001|NOT COMPLETED|Overall Study||0
6702846|NCT02860546|7633332|FG000|STARTED|Overall Study||18
6702847|NCT02860546|7633332|FG000|COMPLETED|Overall Study||0
6702848|NCT02860546|7633332|FG000|NOT COMPLETED|Overall Study||18
6702849|NCT02860845|7633338|FG000|STARTED|Overall Study||24
6702850|NCT02860845|7633339|FG001|STARTED|Overall Study||24
6702851|NCT02860845|7633338|FG000|Analyzed Patients|Overall Study||22
6702852|NCT02860845|7633339|FG001|Analyzed Patients|Overall Study||23
6702853|NCT02860845|7633338|FG000|COMPLETED|Overall Study||22
6702854|NCT02860845|7633339|FG001|COMPLETED|Overall Study||23
6702855|NCT02860845|7633338|FG000|NOT COMPLETED|Overall Study||2
6702856|NCT02860845|7633339|FG001|NOT COMPLETED|Overall Study||1
6702857|NCT02860988|7633351|FG000|STARTED|Overall Study||201
6702858|NCT02860988|7633352|FG001|STARTED|Overall Study||200
6702859|NCT02860988|7633351|FG000|COMPLETED|Overall Study||117
6702860|NCT02860988|7633352|FG001|COMPLETED|Overall Study||94
6702861|NCT02860988|7633351|FG000|NOT COMPLETED|Overall Study||84
6702862|NCT02860988|7633352|FG001|NOT COMPLETED|Overall Study||106
6702863|NCT02861118|7633360|FG000|STARTED|Overall Study||194
6702864|NCT02861118|7633361|FG001|STARTED|Overall Study||116
6702865|NCT02861118|7633360|FG000|COMPLETED|Overall Study||194
6702866|NCT02861118|7633361|FG001|COMPLETED|Overall Study||116
6702867|NCT02861118|7633360|FG000|NOT COMPLETED|Overall Study||0
6702868|NCT02861118|7633361|FG001|NOT COMPLETED|Overall Study||0
6702869|NCT02861131|7633371|FG000|STARTED|Overall Study||100
6702870|NCT02861131|7633372|FG001|STARTED|Overall Study||100
6702871|NCT02861131|7633371|FG000|COMPLETED|Overall Study||100
6702872|NCT02861131|7633372|FG001|COMPLETED|Overall Study||100
6702873|NCT02861131|7633371|FG000|NOT COMPLETED|Overall Study||0
6260445|NCT04794803|7159162|FG000|STARTED|Overall Study||37
6260446|NCT04794803|7159163|FG001|STARTED|Overall Study||19
6260447|NCT04794803|7159162|FG000|FAS Population|Overall Study||36
6260448|NCT04794803|7159163|FG001|FAS Population|Overall Study||19
6260449|NCT04794803|7159162|FG000|Safety Set|Overall Study||36
6260450|NCT04794803|7159163|FG001|Safety Set|Overall Study||19
6260451|NCT04794803|7159162|FG000|Per Protocol Set|Overall Study||17
6260452|NCT04794803|7159163|FG001|Per Protocol Set|Overall Study||11
6260453|NCT04794803|7159162|FG000|COMPLETED|Overall Study||27
6260454|NCT04794803|7159163|FG001|COMPLETED|Overall Study||11
6260455|NCT04794803|7159162|FG000|NOT COMPLETED|Overall Study||10
6260456|NCT04794803|7159163|FG001|NOT COMPLETED|Overall Study||8
6260457|NCT04753710|7159171|FG000|STARTED|Overall||67
6260458|NCT04753710|7159172|FG001|STARTED|Overall||29
6260459|NCT04753710|7159171|FG000|COMPLETED|Overall||67
6260460|NCT04753710|7159172|FG001|COMPLETED|Overall||29
6260461|NCT04753710|7159171|FG000|NOT COMPLETED|Overall||0
6260462|NCT04753710|7159172|FG001|NOT COMPLETED|Overall||0
6260463|NCT04753710|7159171|FG000|STARTED|First Phase||27
6260464|NCT04753710|7159172|FG001|STARTED|First Phase||9
6260465|NCT04753710|7159171|FG000|COMPLETED|First Phase||27
6260466|NCT04753710|7159172|FG001|COMPLETED|First Phase||9
6260467|NCT04753710|7159171|FG000|NOT COMPLETED|First Phase||0
6260468|NCT04753710|7159172|FG001|NOT COMPLETED|First Phase||0
6260469|NCT04753710|7159171|FG000|STARTED|Second Phase||40
6260470|NCT04753710|7159172|FG001|STARTED|Second Phase||20
6260471|NCT04753710|7159171|FG000|COMPLETED|Second Phase||40
6260472|NCT04753710|7159172|FG001|COMPLETED|Second Phase||20
6260473|NCT04753710|7159171|FG000|NOT COMPLETED|Second Phase||0
6260474|NCT04753710|7159172|FG001|NOT COMPLETED|Second Phase||0
6260475|NCT04570605|7159180|FG000|STARTED|Overall Study||15
6260476|NCT04570605|7159181|FG001|STARTED|Overall Study||15
6260477|NCT04570605|7159180|FG000|COMPLETED|Overall Study||11
6260478|NCT04570605|7159181|FG001|COMPLETED|Overall Study||13
6260479|NCT04570605|7159180|FG000|NOT COMPLETED|Overall Study||4
6260480|NCT04570605|7159181|FG001|NOT COMPLETED|Overall Study||2
6260481|NCT04551898|7159191|FG000|STARTED|Overall Study||47
6260482|NCT04551898|7159192|FG001|STARTED|Overall Study||45
6260483|NCT04551898|7159193|FG002|STARTED|Overall Study||43
6260484|NCT04551898|7159194|FG003|STARTED|Overall Study||46
6260485|NCT04551898|7159191|FG000|COMPLETED|Overall Study||39
6260486|NCT04551898|7159192|FG001|COMPLETED|Overall Study||42
6260487|NCT04551898|7159193|FG002|COMPLETED|Overall Study||35
6260488|NCT04551898|7159194|FG003|COMPLETED|Overall Study||41
6260489|NCT04551898|7159191|FG000|NOT COMPLETED|Overall Study||8
6260490|NCT04551898|7159192|FG001|NOT COMPLETED|Overall Study||3
6260491|NCT04551898|7159193|FG002|NOT COMPLETED|Overall Study||8
6260492|NCT04551898|7159194|FG003|NOT COMPLETED|Overall Study||5
6260493|NCT04402866|7159216|FG000|STARTED|Overall Study||6
6260494|NCT04402866|7159217|FG001|STARTED|Overall Study||6
6260495|NCT04402866|7159218|FG002|STARTED|Overall Study||7
6260496|NCT04402866|7159219|FG003|STARTED|Overall Study||6
6260497|NCT04402866|7159220|FG004|STARTED|Overall Study||104
6260498|NCT04402866|7159221|FG005|STARTED|Overall Study||106
6260499|NCT04402866|7159216|FG000|Randomized and Treated With Study Drug|Overall Study||6
6260500|NCT04402866|7159217|FG001|Randomized and Treated With Study Drug|Overall Study||6
6260501|NCT04402866|7159218|FG002|Randomized and Treated With Study Drug|Overall Study||7
6260502|NCT04402866|7159219|FG003|Randomized and Treated With Study Drug|Overall Study||6
6260503|NCT04402866|7159220|FG004|Randomized and Treated With Study Drug|Overall Study||102
6260504|NCT04402866|7159221|FG005|Randomized and Treated With Study Drug|Overall Study||103
6260505|NCT04402866|7159216|FG000|COMPLETED|Overall Study||4
6260506|NCT04402866|7159217|FG001|COMPLETED|Overall Study||5
6260507|NCT04402866|7159218|FG002|COMPLETED|Overall Study||6
6260508|NCT04402866|7159219|FG003|COMPLETED|Overall Study||6
6260509|NCT04402866|7159220|FG004|COMPLETED|Overall Study||89
6260510|NCT04402866|7159221|FG005|COMPLETED|Overall Study||92
6260511|NCT04402866|7159216|FG000|NOT COMPLETED|Overall Study||2
6260512|NCT04402866|7159217|FG001|NOT COMPLETED|Overall Study||1
6260513|NCT04402866|7159218|FG002|NOT COMPLETED|Overall Study||1
6260514|NCT04402866|7159219|FG003|NOT COMPLETED|Overall Study||0
6260515|NCT04402866|7159220|FG004|NOT COMPLETED|Overall Study||15
6260516|NCT04402866|7159221|FG005|NOT COMPLETED|Overall Study||14
6260517|NCT04327388|7159234|FG000|STARTED|Overall Study||161
6260518|NCT04327388|7159235|FG001|STARTED|Overall Study||173
6260519|NCT04327388|7159236|FG002|STARTED|Overall Study||86
6702874|NCT02861131|7633372|FG001|NOT COMPLETED|Overall Study||0
6702875|NCT02861534|7633380|FG000|STARTED|Overall Study||2526
6260520|NCT04327388|7159234|FG000|Treated|Overall Study||159
6260521|NCT04327388|7159235|FG001|Treated|Overall Study||173
6260522|NCT04327388|7159236|FG002|Treated|Overall Study||84
6702876|NCT02861534|7633381|FG001|STARTED|Overall Study||2524
6702877|NCT02861534|7633380|FG000|Treated|Overall Study||2519
6702878|NCT02861534|7633381|FG001|Treated|Overall Study||2515
6702879|NCT02861534|7633380|FG000|COMPLETED|Overall Study||1952
6702880|NCT02861534|7633381|FG001|COMPLETED|Overall Study||1937
6702881|NCT02861534|7633380|FG000|NOT COMPLETED|Overall Study||574
6702882|NCT02861534|7633381|FG001|NOT COMPLETED|Overall Study||587
6702883|NCT02861586|7633395|FG000|STARTED|Overall Study||51
6702884|NCT02861586|7633396|FG001|STARTED|Overall Study||18
6702885|NCT02861586|7633397|FG002|STARTED|Overall Study||47
6702886|NCT02861586|7633398|FG003|STARTED|Overall Study||16
6702887|NCT02861586|7633399|FG004|STARTED|Overall Study||47
6702888|NCT02861586|7633400|FG005|STARTED|Overall Study||50
6702889|NCT02861586|7633401|FG006|STARTED|Overall Study||18
6702890|NCT02861586|7633402|FG007|STARTED|Overall Study||16
6702891|NCT02861586|7633395|FG000|COMPLETED|Overall Study||47
6702892|NCT02861586|7633396|FG001|COMPLETED|Overall Study||15
6702893|NCT02861586|7633397|FG002|COMPLETED|Overall Study||46
6702894|NCT02861586|7633398|FG003|COMPLETED|Overall Study||16
6702895|NCT02861586|7633399|FG004|COMPLETED|Overall Study||47
6702896|NCT02861586|7633400|FG005|COMPLETED|Overall Study||45
6702897|NCT02861586|7633401|FG006|COMPLETED|Overall Study||17
6702898|NCT02861586|7633402|FG007|COMPLETED|Overall Study||16
6702899|NCT02861586|7633395|FG000|NOT COMPLETED|Overall Study||4
6702900|NCT02861586|7633396|FG001|NOT COMPLETED|Overall Study||3
6702901|NCT02861586|7633397|FG002|NOT COMPLETED|Overall Study||1
6702902|NCT02861586|7633398|FG003|NOT COMPLETED|Overall Study||0
6702903|NCT02861586|7633399|FG004|NOT COMPLETED|Overall Study||0
6702904|NCT02861586|7633400|FG005|NOT COMPLETED|Overall Study||5
6702905|NCT02861586|7633401|FG006|NOT COMPLETED|Overall Study||1
6702906|NCT02861586|7633402|FG007|NOT COMPLETED|Overall Study||0
6702907|NCT02861664|7633427|FG000|STARTED|Overall Study||67
6702908|NCT02861664|7633428|FG001|STARTED|Overall Study||68
6702909|NCT02861664|7633427|FG000|COMPLETED|Overall Study||67
6702910|NCT02861664|7633428|FG001|COMPLETED|Overall Study||67
6702911|NCT02861664|7633427|FG000|NOT COMPLETED|Overall Study||0
6702912|NCT02861664|7633428|FG001|NOT COMPLETED|Overall Study||1
6702913|NCT02861807|7633436|FG000|STARTED|Overall Study||47
6702914|NCT02861807|7633437|FG001|STARTED|Overall Study||37
6702915|NCT02861807|7633436|FG000|Attended Post-treatment Assessment|Overall Study||34
6702916|NCT02861807|7633437|FG001|Attended Post-treatment Assessment|Overall Study||18
6702917|NCT02861807|7633436|FG000|Attended 2-month Follow-up|Overall Study||32
6702918|NCT02861807|7633437|FG001|Attended 2-month Follow-up|Overall Study||20
6702919|NCT02861807|7633436|FG000|COMPLETED|Overall Study||35
6702920|NCT02861807|7633437|FG001|COMPLETED|Overall Study||23
6702921|NCT02861807|7633436|FG000|NOT COMPLETED|Overall Study||12
6702922|NCT02861807|7633437|FG001|NOT COMPLETED|Overall Study||14
6702923|NCT02861937|7633446|FG000|STARTED|Overall Study||10
6702924|NCT02861937|7633447|FG001|STARTED|Overall Study||12
6702925|NCT02861937|7633448|FG002|STARTED|Overall Study||12
6702926|NCT02861937|7633446|FG000|COMPLETED|Overall Study||10
6702927|NCT02861937|7633447|FG001|COMPLETED|Overall Study||12
6702928|NCT02861937|7633448|FG002|COMPLETED|Overall Study||12
6702929|NCT02861937|7633446|FG000|NOT COMPLETED|Overall Study||0
6702930|NCT02861937|7633447|FG001|NOT COMPLETED|Overall Study||0
6702931|NCT02861937|7633448|FG002|NOT COMPLETED|Overall Study||0
6702932|NCT02862080|7633459|FG000|STARTED|7 Days Before Any Intervention||1
6702933|NCT02862080|7633460|FG001|STARTED|7 Days Before Any Intervention||1
6702934|NCT02862080|7633461|FG002|STARTED|7 Days Before Any Intervention||1
6702935|NCT02862080|7633462|FG003|STARTED|7 Days Before Any Intervention||1
6702936|NCT02862080|7633459|FG000|COMPLETED|7 Days Before Any Intervention||1
6702937|NCT02862080|7633460|FG001|COMPLETED|7 Days Before Any Intervention||1
6702938|NCT02862080|7633461|FG002|COMPLETED|7 Days Before Any Intervention||1
6702939|NCT02862080|7633462|FG003|COMPLETED|7 Days Before Any Intervention||1
6702940|NCT02862080|7633459|FG000|NOT COMPLETED|7 Days Before Any Intervention||0
6702941|NCT02862080|7633460|FG001|NOT COMPLETED|7 Days Before Any Intervention||0
6702942|NCT02862080|7633461|FG002|NOT COMPLETED|7 Days Before Any Intervention||0
6702943|NCT02862080|7633462|FG003|NOT COMPLETED|7 Days Before Any Intervention||0
6702944|NCT02862080|7633459|FG000|STARTED|3 Days Before Any Intervention||1
6702945|NCT02862080|7633460|FG001|STARTED|3 Days Before Any Intervention||1
6702946|NCT02862080|7633461|FG002|STARTED|3 Days Before Any Intervention||1
6702947|NCT02862080|7633462|FG003|STARTED|3 Days Before Any Intervention||1
6702948|NCT02862080|7633459|FG000|COMPLETED|3 Days Before Any Intervention||1
6702949|NCT02862080|7633460|FG001|COMPLETED|3 Days Before Any Intervention||1
6702950|NCT02862080|7633461|FG002|COMPLETED|3 Days Before Any Intervention||1
6702951|NCT02862080|7633462|FG003|COMPLETED|3 Days Before Any Intervention||1
6702952|NCT02862080|7633459|FG000|NOT COMPLETED|3 Days Before Any Intervention||0
6702953|NCT02862080|7633460|FG001|NOT COMPLETED|3 Days Before Any Intervention||0
6702954|NCT02862080|7633461|FG002|NOT COMPLETED|3 Days Before Any Intervention||0
6702955|NCT02862080|7633462|FG003|NOT COMPLETED|3 Days Before Any Intervention||0
6702956|NCT02862080|7633459|FG000|STARTED|Intervention 1 (1 Week)||1
6702957|NCT02862080|7633460|FG001|STARTED|Intervention 1 (1 Week)||1
6702958|NCT02862080|7633461|FG002|STARTED|Intervention 1 (1 Week)||1
6702959|NCT02862080|7633462|FG003|STARTED|Intervention 1 (1 Week)||1
6702960|NCT02862080|7633459|FG000|COMPLETED|Intervention 1 (1 Week)||1
6702961|NCT02862080|7633460|FG001|COMPLETED|Intervention 1 (1 Week)||1
6702962|NCT02862080|7633461|FG002|COMPLETED|Intervention 1 (1 Week)||1
6702963|NCT02862080|7633462|FG003|COMPLETED|Intervention 1 (1 Week)||1
6702964|NCT02862080|7633459|FG000|NOT COMPLETED|Intervention 1 (1 Week)||0
6702965|NCT02862080|7633460|FG001|NOT COMPLETED|Intervention 1 (1 Week)||0
6702966|NCT02862080|7633461|FG002|NOT COMPLETED|Intervention 1 (1 Week)||0
6702967|NCT02862080|7633462|FG003|NOT COMPLETED|Intervention 1 (1 Week)||0
6702968|NCT02862080|7633459|FG000|STARTED|Washout (1 Week)||1
6702969|NCT02862080|7633460|FG001|STARTED|Washout (1 Week)||1
6702970|NCT02862080|7633461|FG002|STARTED|Washout (1 Week)||1
6702971|NCT02862080|7633462|FG003|STARTED|Washout (1 Week)||1
6702972|NCT02862080|7633459|FG000|COMPLETED|Washout (1 Week)||1
6702973|NCT02862080|7633460|FG001|COMPLETED|Washout (1 Week)||1
6702974|NCT02862080|7633461|FG002|COMPLETED|Washout (1 Week)||1
6702975|NCT02862080|7633462|FG003|COMPLETED|Washout (1 Week)||1
6702976|NCT02862080|7633459|FG000|NOT COMPLETED|Washout (1 Week)||0
6702977|NCT02862080|7633460|FG001|NOT COMPLETED|Washout (1 Week)||0
6702978|NCT02862080|7633461|FG002|NOT COMPLETED|Washout (1 Week)||0
6702979|NCT02862080|7633462|FG003|NOT COMPLETED|Washout (1 Week)||0
6702980|NCT02862080|7633459|FG000|STARTED|Intervention 2 (1 Week)||1
6702981|NCT02862080|7633460|FG001|STARTED|Intervention 2 (1 Week)||1
6702982|NCT02862080|7633461|FG002|STARTED|Intervention 2 (1 Week)||1
6702983|NCT02862080|7633462|FG003|STARTED|Intervention 2 (1 Week)||1
6702984|NCT02862080|7633459|FG000|COMPLETED|Intervention 2 (1 Week)||1
6702985|NCT02862080|7633460|FG001|COMPLETED|Intervention 2 (1 Week)||1
6702986|NCT02862080|7633461|FG002|COMPLETED|Intervention 2 (1 Week)||1
6702987|NCT02862080|7633462|FG003|COMPLETED|Intervention 2 (1 Week)||1
6702988|NCT02862080|7633459|FG000|NOT COMPLETED|Intervention 2 (1 Week)||0
6702989|NCT02862080|7633460|FG001|NOT COMPLETED|Intervention 2 (1 Week)||0
6702990|NCT02862080|7633461|FG002|NOT COMPLETED|Intervention 2 (1 Week)||0
6702991|NCT02862080|7633462|FG003|NOT COMPLETED|Intervention 2 (1 Week)||0
6702992|NCT02862080|7633459|FG000|STARTED|Washout (1 Week)||1
6702993|NCT02862080|7633460|FG001|STARTED|Washout (1 Week)||1
6702994|NCT02862080|7633461|FG002|STARTED|Washout (1 Week)||1
6702995|NCT02862080|7633462|FG003|STARTED|Washout (1 Week)||1
6702996|NCT02862080|7633459|FG000|COMPLETED|Washout (1 Week)||1
6702997|NCT02862080|7633460|FG001|COMPLETED|Washout (1 Week)||1
6702998|NCT02862080|7633461|FG002|COMPLETED|Washout (1 Week)||1
6702999|NCT02862080|7633462|FG003|COMPLETED|Washout (1 Week)||1
6703000|NCT02862080|7633459|FG000|NOT COMPLETED|Washout (1 Week)||0
6703001|NCT02862080|7633460|FG001|NOT COMPLETED|Washout (1 Week)||0
6703002|NCT02862080|7633461|FG002|NOT COMPLETED|Washout (1 Week)||0
6703003|NCT02862080|7633462|FG003|NOT COMPLETED|Washout (1 Week)||0
6703004|NCT02862080|7633459|FG000|STARTED|Intervention 1 Again (1 Week)||1
6703005|NCT02862080|7633460|FG001|STARTED|Intervention 1 Again (1 Week)||1
6703006|NCT02862080|7633461|FG002|STARTED|Intervention 1 Again (1 Week)||1
6703007|NCT02862080|7633462|FG003|STARTED|Intervention 1 Again (1 Week)||1
6703008|NCT02862080|7633459|FG000|COMPLETED|Intervention 1 Again (1 Week)||1
6703009|NCT02862080|7633460|FG001|COMPLETED|Intervention 1 Again (1 Week)||1
6703010|NCT02862080|7633461|FG002|COMPLETED|Intervention 1 Again (1 Week)||1
6703011|NCT02862080|7633462|FG003|COMPLETED|Intervention 1 Again (1 Week)||1
6703012|NCT02862080|7633459|FG000|NOT COMPLETED|Intervention 1 Again (1 Week)||0
6703013|NCT02862080|7633460|FG001|NOT COMPLETED|Intervention 1 Again (1 Week)||0
6703014|NCT02862080|7633461|FG002|NOT COMPLETED|Intervention 1 Again (1 Week)||0
6703015|NCT02862080|7633462|FG003|NOT COMPLETED|Intervention 1 Again (1 Week)||0
6703016|NCT02862106|7633478|FG000|STARTED|Overall Study||183
6703017|NCT02862106|7633479|FG001|STARTED|Overall Study||26
6703018|NCT02862106|7633478|FG000|COMPLETED|Overall Study||145
6703019|NCT02862106|7633479|FG001|COMPLETED|Overall Study||20
6703020|NCT02862106|7633478|FG000|NOT COMPLETED|Overall Study||38
6703021|NCT02862106|7633479|FG001|NOT COMPLETED|Overall Study||6
6703022|NCT02862535|7633495|FG000|STARTED|Overall Study||9
6703023|NCT02862535|7633496|FG001|STARTED|Overall Study||6
6703024|NCT02862535|7633497|FG002|STARTED|Overall Study||10
6703025|NCT02862535|7633498|FG003|STARTED|Overall Study||11
6703026|NCT02862535|7633495|FG000|COMPLETED|Overall Study||0
6703027|NCT02862535|7633496|FG001|COMPLETED|Overall Study||0
6703028|NCT02862535|7633497|FG002|COMPLETED|Overall Study||0
6703029|NCT02862535|7633498|FG003|COMPLETED|Overall Study||0
6703030|NCT02862535|7633495|FG000|NOT COMPLETED|Overall Study||9
6703031|NCT02862535|7633496|FG001|NOT COMPLETED|Overall Study||6
6703032|NCT02862535|7633497|FG002|NOT COMPLETED|Overall Study||10
6703033|NCT02862535|7633498|FG003|NOT COMPLETED|Overall Study||11
6703034|NCT02862548|7633510|FG000|STARTED|Open-Label Phase||26
6703035|NCT02862548|7633511|FG001|STARTED|Open-Label Phase||25
6703036|NCT02862548|7633510|FG000|COMPLETED|Open-Label Phase||26
6703037|NCT02862548|7633511|FG001|COMPLETED|Open-Label Phase||24
6703038|NCT02862548|7633510|FG000|NOT COMPLETED|Open-Label Phase||0
6703039|NCT02862548|7633511|FG001|NOT COMPLETED|Open-Label Phase||1
6703040|NCT02862548|7633510|FG000|STARTED|Open-Label Extension Phase||26
6703041|NCT02862548|7633511|FG001|STARTED|Open-Label Extension Phase||24
6703042|NCT02862548|7633510|FG000|COMPLETED|Open-Label Extension Phase||0
6703043|NCT02862548|7633511|FG001|COMPLETED|Open-Label Extension Phase||0
6703044|NCT02862548|7633510|FG000|NOT COMPLETED|Open-Label Extension Phase||26
6703045|NCT02862548|7633511|FG001|NOT COMPLETED|Open-Label Extension Phase||24
6703046|NCT02862574|7633520|FG000|STARTED|Double-Blind Treatment Period||5
6703047|NCT02862574|7633521|FG001|STARTED|Double-Blind Treatment Period||5
6703048|NCT02862574|7633522|FG002|STARTED|Double-Blind Treatment Period||5
6703049|NCT02862574|7633520|FG000|COMPLETED|Double-Blind Treatment Period||2
6703050|NCT02862574|7633521|FG001|COMPLETED|Double-Blind Treatment Period||3
6703051|NCT02862574|7633522|FG002|COMPLETED|Double-Blind Treatment Period||1
6703052|NCT02862574|7633520|FG000|NOT COMPLETED|Double-Blind Treatment Period||3
6703053|NCT02862574|7633521|FG001|NOT COMPLETED|Double-Blind Treatment Period||2
6703054|NCT02862574|7633522|FG002|NOT COMPLETED|Double-Blind Treatment Period||4
6703055|NCT02862574|7633520|FG000|STARTED|Open-Label Treatment Period||2
6703056|NCT02862574|7633521|FG001|STARTED|Open-Label Treatment Period||3
6703057|NCT02862574|7633522|FG002|STARTED|Open-Label Treatment Period||1
6703058|NCT02862574|7633520|FG000|COMPLETED|Open-Label Treatment Period||0
6703059|NCT02862574|7633521|FG001|COMPLETED|Open-Label Treatment Period||0
6703060|NCT02862574|7633522|FG002|COMPLETED|Open-Label Treatment Period||0
6703061|NCT02862574|7633520|FG000|NOT COMPLETED|Open-Label Treatment Period||2
6703062|NCT02862574|7633521|FG001|NOT COMPLETED|Open-Label Treatment Period||3
6703063|NCT02862574|7633522|FG002|NOT COMPLETED|Open-Label Treatment Period||1
6703064|NCT02862600|7633531|FG000|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
6703065|NCT02862600|7633531|FG000|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
6703066|NCT02862600|7633531|FG000|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
6703067|NCT02862600|7633531|FG000|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
6703068|NCT02862600|7633531|FG000|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
6703069|NCT02862600|7633531|FG000|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
6703070|NCT02862730|7633537|FG000|STARTED|Tslim Training Visit (2 Weeks)||4
6703071|NCT02862730|7633538|FG001|STARTED|Tslim Training Visit (2 Weeks)||1
6703072|NCT02862730|7633539|FG002|STARTED|Tslim Training Visit (2 Weeks)||8
6703073|NCT02862730|7633540|FG003|STARTED|Tslim Training Visit (2 Weeks)||5
6703074|NCT02862730|7633541|FG004|STARTED|Tslim Training Visit (2 Weeks)||5
6703075|NCT02862730|7633542|FG005|STARTED|Tslim Training Visit (2 Weeks)||1
6703076|NCT02862730|7633543|FG006|STARTED|Tslim Training Visit (2 Weeks)||1
6703077|NCT02862730|7633537|FG000|COMPLETED|Tslim Training Visit (2 Weeks)||4
6703078|NCT02862730|7633538|FG001|COMPLETED|Tslim Training Visit (2 Weeks)||1
6260523|NCT04327388|7159234|FG000|Participants Who Received Second Dose|Overall Study||13
6260524|NCT04327388|7159235|FG001|Participants Who Received Second Dose|Overall Study||11
6260525|NCT04327388|7159236|FG002|Participants Who Received Second Dose|Overall Study||5
6260526|NCT04327388|7159234|FG000|COMPLETED|Overall Study||141
6260527|NCT04327388|7159235|FG001|COMPLETED|Overall Study||153
6260528|NCT04327388|7159236|FG002|COMPLETED|Overall Study||75
6260529|NCT04327388|7159234|FG000|NOT COMPLETED|Overall Study||20
6260530|NCT04327388|7159235|FG001|NOT COMPLETED|Overall Study||20
6260531|NCT04327388|7159236|FG002|NOT COMPLETED|Overall Study||11
6280271|NCT00153166|7180192|FG002|STARTED|Overall Study||28
6280272|NCT00153166|7180190|FG000|Received Atorvastatin and Pioglitazone|Overall Study||3
6280273|NCT00153166|7180191|FG001|Received Atorvastatin and Pioglitazone|Overall Study||9
6280274|NCT00153166|7180192|FG002|Received Atorvastatin and Pioglitazone|Overall Study||7
6280275|NCT00153166|7180190|FG000|Received Atorvastatin and Placebo|Overall Study||2
6280276|NCT00153166|7180191|FG001|Received Atorvastatin and Placebo|Overall Study||9
6280277|NCT00153166|7180192|FG002|Received Atorvastatin and Placebo|Overall Study||7
6280278|NCT00153166|7180190|FG000|Received Placebo and Pioglitazone|Overall Study||3
6280279|NCT00153166|7180191|FG001|Received Placebo and Pioglitazone|Overall Study||10
6280280|NCT00153166|7180192|FG002|Received Placebo and Pioglitazone|Overall Study||7
6280281|NCT00153166|7180190|FG000|Received Placebo and Placebo|Overall Study||3
6280282|NCT00153166|7180191|FG001|Received Placebo and Placebo|Overall Study||9
6280283|NCT00153166|7180192|FG002|Received Placebo and Placebo|Overall Study||7
6280284|NCT00153166|7180190|FG000|COMPLETED|Overall Study||11
6280285|NCT00153166|7180191|FG001|COMPLETED|Overall Study||37
6280286|NCT00153166|7180192|FG002|COMPLETED|Overall Study||28
6280287|NCT00153166|7180190|FG000|NOT COMPLETED|Overall Study||0
6280288|NCT00153166|7180191|FG001|NOT COMPLETED|Overall Study||0
6280289|NCT00153166|7180192|FG002|NOT COMPLETED|Overall Study||0
6280290|NCT00153179|7180203|FG000|STARTED|Study Visit Day 1||10
6280291|NCT00153179|7180204|FG001|STARTED|Study Visit Day 1||8
6280292|NCT00153179|7180205|FG002|STARTED|Study Visit Day 1||13
6280293|NCT00153179|7180206|FG003|STARTED|Study Visit Day 1||9
6280294|NCT00153179|7180203|FG000|COMPLETED|Study Visit Day 1||10
6280295|NCT00153179|7180204|FG001|COMPLETED|Study Visit Day 1||8
6280296|NCT00153179|7180205|FG002|COMPLETED|Study Visit Day 1||13
6280297|NCT00153179|7180206|FG003|COMPLETED|Study Visit Day 1||9
6280298|NCT00153179|7180203|FG000|NOT COMPLETED|Study Visit Day 1||0
6280299|NCT00153179|7180204|FG001|NOT COMPLETED|Study Visit Day 1||0
6280300|NCT00153179|7180205|FG002|NOT COMPLETED|Study Visit Day 1||0
6280301|NCT00153179|7180206|FG003|NOT COMPLETED|Study Visit Day 1||0
6280302|NCT00153179|7180203|FG000|STARTED|Study Visit Day 2||10
6280303|NCT00153179|7180204|FG001|STARTED|Study Visit Day 2||8
6280304|NCT00153179|7180205|FG002|STARTED|Study Visit Day 2||13
6280305|NCT00153179|7180206|FG003|STARTED|Study Visit Day 2||9
6280306|NCT00153179|7180203|FG000|COMPLETED|Study Visit Day 2||9
6703079|NCT02862730|7633539|FG002|COMPLETED|Tslim Training Visit (2 Weeks)||7
6703080|NCT02862730|7633540|FG003|COMPLETED|Tslim Training Visit (2 Weeks)||5
6703081|NCT02862730|7633541|FG004|COMPLETED|Tslim Training Visit (2 Weeks)||5
6703082|NCT02862730|7633542|FG005|COMPLETED|Tslim Training Visit (2 Weeks)||1
6280307|NCT00153179|7180204|FG001|COMPLETED|Study Visit Day 2||8
6703083|NCT02862730|7633543|FG006|COMPLETED|Tslim Training Visit (2 Weeks)||1
6703084|NCT02862730|7633537|FG000|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6703085|NCT02862730|7633538|FG001|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6703086|NCT02862730|7633539|FG002|NOT COMPLETED|Tslim Training Visit (2 Weeks)||1
6703087|NCT02862730|7633540|FG003|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6260532|NCT03982043|7159246|FG000|STARTED|Overall Study||43
6260533|NCT03982043|7159247|FG001|STARTED|Overall Study||4
6260534|NCT03982043|7159246|FG000|COMPLETED|Overall Study||43
6260535|NCT03982043|7159247|FG001|COMPLETED|Overall Study||4
6260536|NCT03982043|7159246|FG000|NOT COMPLETED|Overall Study||0
6260537|NCT03982043|7159247|FG001|NOT COMPLETED|Overall Study||0
6260538|NCT03860259|7159256|FG000|STARTED|Overall Study||25
6260539|NCT03860259|7159257|FG001|STARTED|Overall Study||25
6260540|NCT03860259|7159256|FG000|COMPLETED|Overall Study||19
6260541|NCT03860259|7159257|FG001|COMPLETED|Overall Study||20
6260542|NCT03860259|7159256|FG000|NOT COMPLETED|Overall Study||6
6260543|NCT03860259|7159257|FG001|NOT COMPLETED|Overall Study||5
6260544|NCT03767634|7159266|FG000|STARTED|Overall Study||62145
6260545|NCT03767634|7159267|FG001|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
6260546|NCT03767634|7159268|FG002|STARTED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
6260547|NCT03767634|7159266|FG000|COMPLETED|Overall Study||62145
6260548|NCT03767634|7159267|FG001|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|19080
6260549|NCT03767634|7159268|FG002|COMPLETED|Overall Study|8,146 neonates were included in the matched propensity score analysis|16282
6260550|NCT03767634|7159266|FG000|NOT COMPLETED|Overall Study||0
6260551|NCT03767634|7159267|FG001|NOT COMPLETED|Overall Study||0
6260552|NCT03767634|7159268|FG002|NOT COMPLETED|Overall Study||0
6260553|NCT03446573|7159279|FG000|STARTED|Overall Study||369
6260554|NCT03446573|7159280|FG001|STARTED|Overall Study||372
6260555|NCT03446573|7159279|FG000|COMPLETED|Overall Study||0
6260556|NCT03446573|7159280|FG001|COMPLETED|Overall Study||0
6260557|NCT03446573|7159279|FG000|NOT COMPLETED|Overall Study||369
6260558|NCT03446573|7159280|FG001|NOT COMPLETED|Overall Study||372
6260559|NCT03388138|7159291|FG000|STARTED|Overall Study||94
6260560|NCT03388138|7159292|FG001|STARTED|Overall Study||47
6260561|NCT03388138|7159291|FG000|COMPLETED|Overall Study||93
6260562|NCT03388138|7159292|FG001|COMPLETED|Overall Study||47
6260563|NCT03388138|7159291|FG000|NOT COMPLETED|Overall Study||1
6260564|NCT03388138|7159292|FG001|NOT COMPLETED|Overall Study||0
6260565|NCT03067610|7159298|FG000|STARTED|Overall Study||72
6260566|NCT03067610|7159298|FG000|COMPLETED|Overall Study||72
6260567|NCT03067610|7159298|FG000|NOT COMPLETED|Overall Study||0
6260568|NCT03027609|7159308|FG000|STARTED|Overall Study|Safety and ITT population|79
6260569|NCT03027609|7159309|FG001|STARTED|Overall Study|Safety and ITT population|79
6260570|NCT03027609|7159308|FG000|COMPLETED|Overall Study|Safety and ITT population|49
6260571|NCT03027609|7159309|FG001|COMPLETED|Overall Study|Safety and ITT population|62
6260572|NCT03027609|7159308|FG000|NOT COMPLETED|Overall Study||30
6260573|NCT03027609|7159309|FG001|NOT COMPLETED|Overall Study||17
6260574|NCT02993107|7159325|FG000|STARTED|Overall Study||113
6260575|NCT02993107|7159326|FG001|STARTED|Overall Study||120
6260576|NCT02993107|7159327|FG002|STARTED|Overall Study||50
6260577|NCT02993107|7159328|FG003|STARTED|Overall Study||35
6260578|NCT02993107|7159329|FG004|STARTED|Overall Study||34
6260579|NCT02993107|7159330|FG005|STARTED|Overall Study||36
6260580|NCT02993107|7159325|FG000|Adverse Event|Overall Study||12
6260581|NCT02993107|7159326|FG001|Adverse Event|Overall Study||4
6260582|NCT02993107|7159327|FG002|Adverse Event|Overall Study||1
6260583|NCT02993107|7159328|FG003|Adverse Event|Overall Study||1
6260584|NCT02993107|7159329|FG004|Adverse Event|Overall Study||3
6260585|NCT02993107|7159330|FG005|Adverse Event|Overall Study||5
6260586|NCT02993107|7159325|FG000|Physician Decision|Overall Study||1
6260587|NCT02993107|7159326|FG001|Physician Decision|Overall Study||0
6260588|NCT02993107|7159327|FG002|Physician Decision|Overall Study||1
6260589|NCT02993107|7159328|FG003|Physician Decision|Overall Study||0
6260590|NCT02993107|7159329|FG004|Physician Decision|Overall Study||0
6260591|NCT02993107|7159330|FG005|Physician Decision|Overall Study||0
6260592|NCT02993107|7159325|FG000|Withdrawal by Subject|Overall Study||32
6260593|NCT02993107|7159326|FG001|Withdrawal by Subject|Overall Study||7
6260594|NCT02993107|7159327|FG002|Withdrawal by Subject|Overall Study||7
6260595|NCT02993107|7159328|FG003|Withdrawal by Subject|Overall Study||3
6260596|NCT02993107|7159329|FG004|Withdrawal by Subject|Overall Study||6
6260597|NCT02993107|7159330|FG005|Withdrawal by Subject|Overall Study||2
6260598|NCT02993107|7159325|FG000|Lost to Follow-up|Overall Study||0
6260599|NCT02993107|7159326|FG001|Lost to Follow-up|Overall Study||1
6260600|NCT02993107|7159327|FG002|Lost to Follow-up|Overall Study||0
6260601|NCT02993107|7159328|FG003|Lost to Follow-up|Overall Study||0
6260602|NCT02993107|7159329|FG004|Lost to Follow-up|Overall Study||0
6260603|NCT02993107|7159330|FG005|Lost to Follow-up|Overall Study||1
6260604|NCT02993107|7159325|FG000|Sponsor Decision|Overall Study||4
6260605|NCT02993107|7159326|FG001|Sponsor Decision|Overall Study||0
6260606|NCT02993107|7159327|FG002|Sponsor Decision|Overall Study||1
6260607|NCT02993107|7159328|FG003|Sponsor Decision|Overall Study||1
6260608|NCT02993107|7159329|FG004|Sponsor Decision|Overall Study||0
6260609|NCT02993107|7159330|FG005|Sponsor Decision|Overall Study||4
6260610|NCT02993107|7159325|FG000|Protocol Deviation|Overall Study||0
6703088|NCT02862730|7633541|FG004|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6703089|NCT02862730|7633542|FG005|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6703090|NCT02862730|7633543|FG006|NOT COMPLETED|Tslim Training Visit (2 Weeks)||0
6703091|NCT02862730|7633537|FG000|STARTED|First Rest Period (1-12 Weeks)||4
6703092|NCT02862730|7633538|FG001|STARTED|First Rest Period (1-12 Weeks)||1
6703093|NCT02862730|7633539|FG002|STARTED|First Rest Period (1-12 Weeks)||7
6703094|NCT02862730|7633540|FG003|STARTED|First Rest Period (1-12 Weeks)||5
6703095|NCT02862730|7633541|FG004|STARTED|First Rest Period (1-12 Weeks)||5
6703096|NCT02862730|7633542|FG005|STARTED|First Rest Period (1-12 Weeks)||1
6703097|NCT02862730|7633543|FG006|STARTED|First Rest Period (1-12 Weeks)||1
6703098|NCT02862730|7633537|FG000|COMPLETED|First Rest Period (1-12 Weeks)||4
6703099|NCT02862730|7633538|FG001|COMPLETED|First Rest Period (1-12 Weeks)||1
6703100|NCT02862730|7633539|FG002|COMPLETED|First Rest Period (1-12 Weeks)||7
6703101|NCT02862730|7633540|FG003|COMPLETED|First Rest Period (1-12 Weeks)||5
6703102|NCT02862730|7633541|FG004|COMPLETED|First Rest Period (1-12 Weeks)||5
6703103|NCT02862730|7633542|FG005|COMPLETED|First Rest Period (1-12 Weeks)||1
6703104|NCT02862730|7633543|FG006|COMPLETED|First Rest Period (1-12 Weeks)||1
6703105|NCT02862730|7633537|FG000|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6703106|NCT02862730|7633538|FG001|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6703107|NCT02862730|7633539|FG002|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6703108|NCT02862730|7633540|FG003|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6703109|NCT02862730|7633541|FG004|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6703110|NCT02862730|7633542|FG005|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6703111|NCT02862730|7633543|FG006|NOT COMPLETED|First Rest Period (1-12 Weeks)||0
6703112|NCT02862730|7633537|FG000|STARTED|First Intervention (84 Hours)||4
6703113|NCT02862730|7633538|FG001|STARTED|First Intervention (84 Hours)||1
6703114|NCT02862730|7633539|FG002|STARTED|First Intervention (84 Hours)||7
6703115|NCT02862730|7633540|FG003|STARTED|First Intervention (84 Hours)||5
6703116|NCT02862730|7633541|FG004|STARTED|First Intervention (84 Hours)||5
6703117|NCT02862730|7633542|FG005|STARTED|First Intervention (84 Hours)||1
6703118|NCT02862730|7633543|FG006|STARTED|First Intervention (84 Hours)||1
6703119|NCT02862730|7633537|FG000|COMPLETED|First Intervention (84 Hours)||4
6703120|NCT02862730|7633538|FG001|COMPLETED|First Intervention (84 Hours)||1
6703121|NCT02862730|7633539|FG002|COMPLETED|First Intervention (84 Hours)||7
6703122|NCT02862730|7633540|FG003|COMPLETED|First Intervention (84 Hours)||5
6703123|NCT02862730|7633541|FG004|COMPLETED|First Intervention (84 Hours)||5
6703124|NCT02862730|7633542|FG005|COMPLETED|First Intervention (84 Hours)||1
6703125|NCT02862730|7633543|FG006|COMPLETED|First Intervention (84 Hours)||1
6703126|NCT02862730|7633537|FG000|NOT COMPLETED|First Intervention (84 Hours)||0
6703127|NCT02862730|7633538|FG001|NOT COMPLETED|First Intervention (84 Hours)||0
6703128|NCT02862730|7633539|FG002|NOT COMPLETED|First Intervention (84 Hours)||0
6703129|NCT02862730|7633540|FG003|NOT COMPLETED|First Intervention (84 Hours)||0
6703130|NCT02862730|7633541|FG004|NOT COMPLETED|First Intervention (84 Hours)||0
6703131|NCT02862730|7633542|FG005|NOT COMPLETED|First Intervention (84 Hours)||0
6703132|NCT02862730|7633543|FG006|NOT COMPLETED|First Intervention (84 Hours)||0
6703133|NCT02862730|7633537|FG000|STARTED|Second Rest Period (7-45 Days)||4
6703134|NCT02862730|7633538|FG001|STARTED|Second Rest Period (7-45 Days)||1
6703135|NCT02862730|7633539|FG002|STARTED|Second Rest Period (7-45 Days)||7
6703136|NCT02862730|7633540|FG003|STARTED|Second Rest Period (7-45 Days)||5
6703137|NCT02862730|7633541|FG004|STARTED|Second Rest Period (7-45 Days)||5
6703138|NCT02862730|7633542|FG005|STARTED|Second Rest Period (7-45 Days)||1
6703139|NCT02862730|7633543|FG006|STARTED|Second Rest Period (7-45 Days)||1
6703140|NCT02862730|7633537|FG000|COMPLETED|Second Rest Period (7-45 Days)||4
6703141|NCT02862730|7633538|FG001|COMPLETED|Second Rest Period (7-45 Days)||1
6703142|NCT02862730|7633539|FG002|COMPLETED|Second Rest Period (7-45 Days)||7
6703143|NCT02862730|7633540|FG003|COMPLETED|Second Rest Period (7-45 Days)||5
6703144|NCT02862730|7633541|FG004|COMPLETED|Second Rest Period (7-45 Days)||5
6703145|NCT02862730|7633542|FG005|COMPLETED|Second Rest Period (7-45 Days)||1
6703146|NCT02862730|7633543|FG006|COMPLETED|Second Rest Period (7-45 Days)||1
6703147|NCT02862730|7633537|FG000|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6703148|NCT02862730|7633538|FG001|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6703149|NCT02862730|7633539|FG002|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6703150|NCT02862730|7633540|FG003|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6703151|NCT02862730|7633541|FG004|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6703152|NCT02862730|7633542|FG005|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6703153|NCT02862730|7633543|FG006|NOT COMPLETED|Second Rest Period (7-45 Days)||0
6703154|NCT02862730|7633537|FG000|STARTED|Second Intervention (84 Hours)||4
6703155|NCT02862730|7633538|FG001|STARTED|Second Intervention (84 Hours)||1
6703156|NCT02862730|7633539|FG002|STARTED|Second Intervention (84 Hours)||7
6703157|NCT02862730|7633540|FG003|STARTED|Second Intervention (84 Hours)||5
6703158|NCT02862730|7633541|FG004|STARTED|Second Intervention (84 Hours)||5
6703159|NCT02862730|7633542|FG005|STARTED|Second Intervention (84 Hours)||1
6703160|NCT02862730|7633543|FG006|STARTED|Second Intervention (84 Hours)||1
6703161|NCT02862730|7633537|FG000|COMPLETED|Second Intervention (84 Hours)||3
6703162|NCT02862730|7633538|FG001|COMPLETED|Second Intervention (84 Hours)||1
6703163|NCT02862730|7633539|FG002|COMPLETED|Second Intervention (84 Hours)||7
6703164|NCT02862730|7633540|FG003|COMPLETED|Second Intervention (84 Hours)||5
6703165|NCT02862730|7633541|FG004|COMPLETED|Second Intervention (84 Hours)||5
6703166|NCT02862730|7633542|FG005|COMPLETED|Second Intervention (84 Hours)||1
6260611|NCT02993107|7159326|FG001|Protocol Deviation|Overall Study||0
6703167|NCT02862730|7633543|FG006|COMPLETED|Second Intervention (84 Hours)||1
6703168|NCT02862730|7633537|FG000|NOT COMPLETED|Second Intervention (84 Hours)||1
6703169|NCT02862730|7633538|FG001|NOT COMPLETED|Second Intervention (84 Hours)||0
6703170|NCT02862730|7633539|FG002|NOT COMPLETED|Second Intervention (84 Hours)||0
6703171|NCT02862730|7633540|FG003|NOT COMPLETED|Second Intervention (84 Hours)||0
6703172|NCT02862730|7633541|FG004|NOT COMPLETED|Second Intervention (84 Hours)||0
6703173|NCT02862730|7633542|FG005|NOT COMPLETED|Second Intervention (84 Hours)||0
6703174|NCT02862730|7633543|FG006|NOT COMPLETED|Second Intervention (84 Hours)||0
6703175|NCT02862730|7633537|FG000|STARTED|Third Rest Period (7-45 Days)||3
6703176|NCT02862730|7633538|FG001|STARTED|Third Rest Period (7-45 Days)||1
6703177|NCT02862730|7633539|FG002|STARTED|Third Rest Period (7-45 Days)||7
6703178|NCT02862730|7633540|FG003|STARTED|Third Rest Period (7-45 Days)||5
6703179|NCT02862730|7633541|FG004|STARTED|Third Rest Period (7-45 Days)||5
6703180|NCT02862730|7633542|FG005|STARTED|Third Rest Period (7-45 Days)||1
6703181|NCT02862730|7633543|FG006|STARTED|Third Rest Period (7-45 Days)||1
6703182|NCT02862730|7633537|FG000|COMPLETED|Third Rest Period (7-45 Days)||3
6703183|NCT02862730|7633538|FG001|COMPLETED|Third Rest Period (7-45 Days)||1
6703184|NCT02862730|7633539|FG002|COMPLETED|Third Rest Period (7-45 Days)||6
6703185|NCT02862730|7633540|FG003|COMPLETED|Third Rest Period (7-45 Days)||5
6703186|NCT02862730|7633541|FG004|COMPLETED|Third Rest Period (7-45 Days)||4
6703187|NCT02862730|7633542|FG005|COMPLETED|Third Rest Period (7-45 Days)||1
6703188|NCT02862730|7633543|FG006|COMPLETED|Third Rest Period (7-45 Days)||1
6703189|NCT02862730|7633537|FG000|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6703190|NCT02862730|7633538|FG001|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6703191|NCT02862730|7633539|FG002|NOT COMPLETED|Third Rest Period (7-45 Days)||1
6703192|NCT02862730|7633540|FG003|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6703193|NCT02862730|7633541|FG004|NOT COMPLETED|Third Rest Period (7-45 Days)||1
6703194|NCT02862730|7633542|FG005|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6703195|NCT02862730|7633543|FG006|NOT COMPLETED|Third Rest Period (7-45 Days)||0
6703196|NCT02862730|7633537|FG000|STARTED|Third Intervention (84 Hours)||3
6703197|NCT02862730|7633538|FG001|STARTED|Third Intervention (84 Hours)||1
6703198|NCT02862730|7633539|FG002|STARTED|Third Intervention (84 Hours)||6
6703199|NCT02862730|7633540|FG003|STARTED|Third Intervention (84 Hours)||5
6703200|NCT02862730|7633541|FG004|STARTED|Third Intervention (84 Hours)||4
6703201|NCT02862730|7633542|FG005|STARTED|Third Intervention (84 Hours)||1
6703202|NCT02862730|7633543|FG006|STARTED|Third Intervention (84 Hours)||1
6703203|NCT02862730|7633537|FG000|COMPLETED|Third Intervention (84 Hours)||3
6703204|NCT02862730|7633538|FG001|COMPLETED|Third Intervention (84 Hours)||1
6703205|NCT02862730|7633539|FG002|COMPLETED|Third Intervention (84 Hours)||6
6703206|NCT02862730|7633540|FG003|COMPLETED|Third Intervention (84 Hours)||4
6703207|NCT02862730|7633541|FG004|COMPLETED|Third Intervention (84 Hours)||4
6703208|NCT02862730|7633542|FG005|COMPLETED|Third Intervention (84 Hours)||1
6703209|NCT02862730|7633543|FG006|COMPLETED|Third Intervention (84 Hours)||1
6703210|NCT02862730|7633537|FG000|NOT COMPLETED|Third Intervention (84 Hours)||0
6703211|NCT02862730|7633538|FG001|NOT COMPLETED|Third Intervention (84 Hours)||0
6703212|NCT02862730|7633539|FG002|NOT COMPLETED|Third Intervention (84 Hours)||0
6703213|NCT02862730|7633540|FG003|NOT COMPLETED|Third Intervention (84 Hours)||1
6703214|NCT02862730|7633541|FG004|NOT COMPLETED|Third Intervention (84 Hours)||0
6703215|NCT02862730|7633542|FG005|NOT COMPLETED|Third Intervention (84 Hours)||0
6703216|NCT02862730|7633543|FG006|NOT COMPLETED|Third Intervention (84 Hours)||0
6703217|NCT02862730|7633537|FG000|STARTED|Fourth Rest Period (7-45 Days)||3
6703218|NCT02862730|7633538|FG001|STARTED|Fourth Rest Period (7-45 Days)||1
6703219|NCT02862730|7633539|FG002|STARTED|Fourth Rest Period (7-45 Days)||6
6703220|NCT02862730|7633540|FG003|STARTED|Fourth Rest Period (7-45 Days)||4
6703221|NCT02862730|7633541|FG004|STARTED|Fourth Rest Period (7-45 Days)||4
6703222|NCT02862730|7633542|FG005|STARTED|Fourth Rest Period (7-45 Days)||1
6703223|NCT02862730|7633543|FG006|STARTED|Fourth Rest Period (7-45 Days)||1
6703224|NCT02862730|7633537|FG000|COMPLETED|Fourth Rest Period (7-45 Days)||3
6703225|NCT02862730|7633538|FG001|COMPLETED|Fourth Rest Period (7-45 Days)||1
6703226|NCT02862730|7633539|FG002|COMPLETED|Fourth Rest Period (7-45 Days)||6
6703227|NCT02862730|7633540|FG003|COMPLETED|Fourth Rest Period (7-45 Days)||4
6703228|NCT02862730|7633541|FG004|COMPLETED|Fourth Rest Period (7-45 Days)||4
6703229|NCT02862730|7633542|FG005|COMPLETED|Fourth Rest Period (7-45 Days)||1
6703230|NCT02862730|7633543|FG006|COMPLETED|Fourth Rest Period (7-45 Days)||1
6703231|NCT02862730|7633537|FG000|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6703232|NCT02862730|7633538|FG001|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6703233|NCT02862730|7633539|FG002|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6703234|NCT02862730|7633540|FG003|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6703235|NCT02862730|7633541|FG004|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6703236|NCT02862730|7633542|FG005|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6703237|NCT02862730|7633543|FG006|NOT COMPLETED|Fourth Rest Period (7-45 Days)||0
6703238|NCT02862730|7633537|FG000|STARTED|Fourth Intervention (84 Hours)||3
6703239|NCT02862730|7633538|FG001|STARTED|Fourth Intervention (84 Hours)||1
6703240|NCT02862730|7633539|FG002|STARTED|Fourth Intervention (84 Hours)||6
6703241|NCT02862730|7633540|FG003|STARTED|Fourth Intervention (84 Hours)||4
6703242|NCT02862730|7633541|FG004|STARTED|Fourth Intervention (84 Hours)||4
6703243|NCT02862730|7633542|FG005|STARTED|Fourth Intervention (84 Hours)||1
6703244|NCT02862730|7633543|FG006|STARTED|Fourth Intervention (84 Hours)||1
6703245|NCT02862730|7633537|FG000|COMPLETED|Fourth Intervention (84 Hours)||3
6703246|NCT02862730|7633538|FG001|COMPLETED|Fourth Intervention (84 Hours)||1
6703247|NCT02862730|7633539|FG002|COMPLETED|Fourth Intervention (84 Hours)||6
6703248|NCT02862730|7633540|FG003|COMPLETED|Fourth Intervention (84 Hours)||4
6703249|NCT02862730|7633541|FG004|COMPLETED|Fourth Intervention (84 Hours)||4
6703250|NCT02862730|7633542|FG005|COMPLETED|Fourth Intervention (84 Hours)||1
6703251|NCT02862730|7633543|FG006|COMPLETED|Fourth Intervention (84 Hours)||1
6703252|NCT02862730|7633537|FG000|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6703253|NCT02862730|7633538|FG001|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6703254|NCT02862730|7633539|FG002|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6703255|NCT02862730|7633540|FG003|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6703256|NCT02862730|7633541|FG004|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6703257|NCT02862730|7633542|FG005|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6703258|NCT02862730|7633543|FG006|NOT COMPLETED|Fourth Intervention (84 Hours)||0
6703259|NCT02862912|7633560|FG000|STARTED|Overall Study||23
6703260|NCT02862912|7633561|FG001|STARTED|Overall Study||20
6260612|NCT02993107|7159327|FG002|Protocol Deviation|Overall Study||0
6260613|NCT02993107|7159328|FG003|Protocol Deviation|Overall Study||0
6260614|NCT02993107|7159329|FG004|Protocol Deviation|Overall Study||1
6260615|NCT02993107|7159330|FG005|Protocol Deviation|Overall Study||0
6260616|NCT02993107|7159325|FG000|Other Reasons|Overall Study||2
6260617|NCT02993107|7159326|FG001|Other Reasons|Overall Study||1
6260618|NCT02993107|7159327|FG002|Other Reasons|Overall Study||1
6260619|NCT02993107|7159328|FG003|Other Reasons|Overall Study||1
6260620|NCT02993107|7159329|FG004|Other Reasons|Overall Study||2
6260621|NCT02993107|7159330|FG005|Other Reasons|Overall Study||3
6260622|NCT02993107|7159325|FG000|COMPLETED|Overall Study||62
6260623|NCT02993107|7159326|FG001|COMPLETED|Overall Study||107
6260624|NCT02993107|7159327|FG002|COMPLETED|Overall Study||39
6260625|NCT02993107|7159328|FG003|COMPLETED|Overall Study||29
6260626|NCT02993107|7159329|FG004|COMPLETED|Overall Study||22
6260627|NCT02993107|7159330|FG005|COMPLETED|Overall Study||21
6260628|NCT02993107|7159325|FG000|NOT COMPLETED|Overall Study||51
6260629|NCT02993107|7159326|FG001|NOT COMPLETED|Overall Study||13
6260630|NCT02993107|7159327|FG002|NOT COMPLETED|Overall Study||11
6260631|NCT02993107|7159328|FG003|NOT COMPLETED|Overall Study||6
6260632|NCT02993107|7159329|FG004|NOT COMPLETED|Overall Study||12
6260633|NCT02993107|7159330|FG005|NOT COMPLETED|Overall Study||15
6260634|NCT02981082|7159358|FG000|STARTED|Overall Study||4
6260635|NCT02981082|7159359|FG001|STARTED|Overall Study||2
6260636|NCT02981082|7159358|FG000|COMPLETED|Overall Study||1
6260637|NCT02981082|7159359|FG001|COMPLETED|Overall Study||1
6260638|NCT02981082|7159358|FG000|NOT COMPLETED|Overall Study||3
6260639|NCT02981082|7159359|FG001|NOT COMPLETED|Overall Study||1
6260640|NCT02924129|7159367|FG000|STARTED|Overall Study||67
6260641|NCT02924129|7159368|FG001|STARTED|Overall Study||67
6260642|NCT02924129|7159367|FG000|COMPLETED|Overall Study||62
6260643|NCT02924129|7159368|FG001|COMPLETED|Overall Study||63
6260644|NCT02924129|7159367|FG000|NOT COMPLETED|Overall Study||5
6260645|NCT02924129|7159368|FG001|NOT COMPLETED|Overall Study||4
6260646|NCT02831673|7159376|FG000|STARTED|Overall Study||356
6260647|NCT02831673|7159377|FG001|STARTED|Overall Study||358
6260648|NCT02831673|7159376|FG000|COMPLETED|Overall Study||0
6260649|NCT02831673|7159377|FG001|COMPLETED|Overall Study||0
6260650|NCT02831673|7159376|FG000|NOT COMPLETED|Overall Study||356
6260651|NCT02831673|7159377|FG001|NOT COMPLETED|Overall Study||358
6260652|NCT02741700|7159385|FG000|STARTED|Overall Study||152
6260653|NCT02741700|7159386|FG001|STARTED|Overall Study||154
6260654|NCT02741700|7159385|FG000|COMPLETED|Overall Study||126
6260655|NCT02741700|7159386|FG001|COMPLETED|Overall Study||135
6260656|NCT02741700|7159385|FG000|NOT COMPLETED|Overall Study||26
6260657|NCT02741700|7159386|FG001|NOT COMPLETED|Overall Study||19
6260658|NCT02635776|7159394|FG000|STARTED|Overall Study||416
6260659|NCT02635776|7159395|FG001|STARTED|Overall Study||139
6260660|NCT02635776|7159394|FG000|COMPLETED|Overall Study||314
6260661|NCT02635776|7159395|FG001|COMPLETED|Overall Study||128
6260662|NCT02635776|7159394|FG000|NOT COMPLETED|Overall Study||102
6260663|NCT02635776|7159395|FG001|NOT COMPLETED|Overall Study||11
6260664|NCT02609724|7159406|FG000|STARTED|Overall Study||65
6260665|NCT02609724|7159407|FG001|STARTED|Overall Study||64
6260666|NCT02609724|7159408|FG002|STARTED|Overall Study||65
6260667|NCT02609724|7159406|FG000|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
6260668|NCT02609724|7159407|FG001|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||63
6260669|NCT02609724|7159408|FG002|Post Intensive Treatment Phase (= Primary Endpoint)|Overall Study||64
6260670|NCT02609724|7159406|FG000|COMPLETED|Overall Study|post follow-up phase|60
6260671|NCT02609724|7159407|FG001|COMPLETED|Overall Study|post follow-up phase|61
6260672|NCT02609724|7159408|FG002|COMPLETED|Overall Study|post follow-up phase|61
6260673|NCT02609724|7159406|FG000|NOT COMPLETED|Overall Study||5
6260674|NCT02609724|7159407|FG001|NOT COMPLETED|Overall Study||3
6260675|NCT02609724|7159408|FG002|NOT COMPLETED|Overall Study||4
6260676|NCT02359994|7159418|FG000|STARTED|Overall Population Study||161
6260677|NCT02359994|7159419|FG001|STARTED|Overall Population Study||163
6260678|NCT02359994|7159418|FG000|Treated|Overall Population Study||160
6260679|NCT02359994|7159419|FG001|Treated|Overall Population Study||162
6260680|NCT02359994|7159418|FG000|COMPLETED|Overall Population Study||156
6260681|NCT02359994|7159419|FG001|COMPLETED|Overall Population Study||155
6260682|NCT02359994|7159418|FG000|NOT COMPLETED|Overall Population Study||5
6703261|NCT02862912|7633560|FG000|COMPLETED|Overall Study||22
6703262|NCT02862912|7633561|FG001|COMPLETED|Overall Study||20
6703263|NCT02862912|7633560|FG000|NOT COMPLETED|Overall Study||1
6703264|NCT02862912|7633561|FG001|NOT COMPLETED|Overall Study||0
6703265|NCT02863198|7633571|FG000|STARTED|Overall Study||60
6703266|NCT02863198|7633572|FG001|STARTED|Overall Study||60
6703267|NCT02863198|7633571|FG000|COMPLETED|Overall Study||60
6703268|NCT02863198|7633572|FG001|COMPLETED|Overall Study||60
6703269|NCT02863198|7633571|FG000|NOT COMPLETED|Overall Study||0
6703270|NCT02863198|7633572|FG001|NOT COMPLETED|Overall Study||0
6703271|NCT02863263|7633580|FG000|STARTED|Overall Study||3
6703272|NCT02863263|7633581|FG001|STARTED|Overall Study||2
6703273|NCT02863263|7633580|FG000|COMPLETED|Overall Study||2
6703274|NCT02863263|7633581|FG001|COMPLETED|Overall Study||1
6703275|NCT02863263|7633580|FG000|NOT COMPLETED|Overall Study||1
6703276|NCT02863263|7633581|FG001|NOT COMPLETED|Overall Study||1
6703277|NCT02863289|7633587|FG000|STARTED|Overall Study|Study started on 01/11/2016, with 118 study participants.|118
6703278|NCT02863289|7633587|FG000|COMPLETED|Overall Study|Study completed on 01/03/2017, 35 study participants have returned the questionnaire.|35
6703279|NCT02863289|7633587|FG000|NOT COMPLETED|Overall Study||83
6703280|NCT02863328|7633594|FG000|STARTED|Overall Study||411
6703281|NCT02863328|7633595|FG001|STARTED|Overall Study||410
6703282|NCT02863328|7633594|FG000|Full Analysis Set (FAS)|Overall Study||411
6703283|NCT02863328|7633595|FG001|Full Analysis Set (FAS)|Overall Study||410
6703284|NCT02863328|7633594|FG000|Safety Analysis Set (SAS)|Overall Study||410
6703285|NCT02863328|7633595|FG001|Safety Analysis Set (SAS)|Overall Study||409
6703286|NCT02863328|7633594|FG000|COMPLETED|Overall Study||400
6703287|NCT02863328|7633595|FG001|COMPLETED|Overall Study||387
6703288|NCT02863328|7633594|FG000|NOT COMPLETED|Overall Study||11
6703289|NCT02863328|7633595|FG001|NOT COMPLETED|Overall Study||23
6703290|NCT02863354|7633603|FG000|STARTED|Year 1||23
6703291|NCT02863354|7633604|FG001|STARTED|Year 1||20
6703292|NCT02863354|7633603|FG000|COMPLETED|Year 1||19
6703293|NCT02863354|7633604|FG001|COMPLETED|Year 1||18
6703294|NCT02863354|7633603|FG000|NOT COMPLETED|Year 1||4
6703295|NCT02863354|7633604|FG001|NOT COMPLETED|Year 1||2
6703296|NCT02863354|7633603|FG000|STARTED|Year 2||19
6703297|NCT02863354|7633604|FG001|STARTED|Year 2||18
6703298|NCT02863354|7633603|FG000|COMPLETED|Year 2||17
6703299|NCT02863354|7633604|FG001|COMPLETED|Year 2||16
6703300|NCT02863354|7633603|FG000|NOT COMPLETED|Year 2||2
6703301|NCT02863354|7633604|FG001|NOT COMPLETED|Year 2||2
6703302|NCT02863419|7633613|FG000|STARTED|Overall Study||285
6703303|NCT02863419|7633614|FG001|STARTED|Overall Study||284
6703304|NCT02863419|7633615|FG002|STARTED|Overall Study||142
6703305|NCT02863419|7633613|FG000|Full Analysis Set (FAS)|Overall Study||285
6703306|NCT02863419|7633614|FG001|Full Analysis Set (FAS)|Overall Study||284
6703307|NCT02863419|7633615|FG002|Full Analysis Set (FAS)|Overall Study||142
6703308|NCT02863419|7633613|FG000|Safety Analysis Set (SAS)|Overall Study||285
6703309|NCT02863419|7633614|FG001|Safety Analysis Set (SAS)|Overall Study||284
6703310|NCT02863419|7633615|FG002|Safety Analysis Set (SAS)|Overall Study||142
6703311|NCT02863419|7633613|FG000|COMPLETED|Overall Study||277
6703312|NCT02863419|7633614|FG001|COMPLETED|Overall Study||274
6703313|NCT02863419|7633615|FG002|COMPLETED|Overall Study||134
6703314|NCT02863419|7633613|FG000|NOT COMPLETED|Overall Study||8
6703315|NCT02863419|7633614|FG001|NOT COMPLETED|Overall Study||10
6703316|NCT02863419|7633615|FG002|NOT COMPLETED|Overall Study||8
6703317|NCT02863575|7633626|FG000|STARTED|Overall Study||161
6703318|NCT02863575|7633627|FG001|STARTED|Overall Study||161
6703319|NCT02863575|7633628|FG002|STARTED|Overall Study||52
6703320|NCT02863575|7633626|FG000|COMPLETED|Overall Study||160
6703321|NCT02863575|7633627|FG001|COMPLETED|Overall Study||159
6703322|NCT02863575|7633628|FG002|COMPLETED|Overall Study||51
6703323|NCT02863575|7633626|FG000|NOT COMPLETED|Overall Study||1
6703324|NCT02863575|7633627|FG001|NOT COMPLETED|Overall Study||2
6703325|NCT02863575|7633628|FG002|NOT COMPLETED|Overall Study||1
6703326|NCT02864069|7633639|FG000|STARTED|Overall Study||18
6703327|NCT02864069|7633640|FG001|STARTED|Overall Study||13
6703328|NCT02864069|7633641|FG002|STARTED|Overall Study||21
6703329|NCT02864069|7633639|FG000|COMPLETED|Overall Study||12
6703330|NCT02864069|7633640|FG001|COMPLETED|Overall Study||5
6703331|NCT02864069|7633641|FG002|COMPLETED|Overall Study||13
6703332|NCT02864069|7633639|FG000|NOT COMPLETED|Overall Study||6
6703333|NCT02864069|7633640|FG001|NOT COMPLETED|Overall Study||8
6703334|NCT02864069|7633641|FG002|NOT COMPLETED|Overall Study||8
6703335|NCT02864082|7633651|FG000|STARTED|Overall Study||10
6703336|NCT02864082|7633652|FG001|STARTED|Overall Study||9
6703337|NCT02864082|7633651|FG000|COMPLETED|Overall Study||7
6703338|NCT02864082|7633652|FG001|COMPLETED|Overall Study||5
6703339|NCT02864082|7633651|FG000|NOT COMPLETED|Overall Study||3
6703340|NCT02864082|7633652|FG001|NOT COMPLETED|Overall Study||4
6703341|NCT02864316|7633674|FG000|STARTED|Overall Study||2
6703342|NCT02864316|7633675|FG001|STARTED|Overall Study||2
6703343|NCT02864316|7633674|FG000|COMPLETED|Overall Study||0
6703344|NCT02864316|7633675|FG001|COMPLETED|Overall Study||0
6703345|NCT02864316|7633674|FG000|NOT COMPLETED|Overall Study||2
6703346|NCT02864316|7633675|FG001|NOT COMPLETED|Overall Study||2
6703347|NCT02864342|7633683|FG000|STARTED|Overall Study||70
6703348|NCT02864342|7633684|FG001|STARTED|Overall Study||68
6703349|NCT02864342|7633683|FG000|Full Analysis Set (FAS)|Overall Study||70
6703350|NCT02864342|7633684|FG001|Full Analysis Set (FAS)|Overall Study||67
6703351|NCT02864342|7633683|FG000|COMPLETED|Overall Study||55
6703352|NCT02864342|7633684|FG001|COMPLETED|Overall Study||49
6703353|NCT02864342|7633683|FG000|NOT COMPLETED|Overall Study||15
6703354|NCT02864342|7633684|FG001|NOT COMPLETED|Overall Study||19
6703355|NCT02864355|7633693|FG000|STARTED|Overall Study||25
6703356|NCT02864355|7633694|FG001|STARTED|Overall Study||28
6703357|NCT02864355|7633693|FG000|COMPLETED|Overall Study||23
6703358|NCT02864355|7633694|FG001|COMPLETED|Overall Study||25
6703359|NCT02864355|7633693|FG000|NOT COMPLETED|Overall Study||2
6703360|NCT02864355|7633694|FG001|NOT COMPLETED|Overall Study||3
6703361|NCT02864368|7633705|FG000|STARTED|Overall Study||4
6703362|NCT02864368|7633706|FG001|STARTED|Overall Study||1
6703363|NCT02864368|7633707|FG002|STARTED|Overall Study||6
6703364|NCT02864368|7633708|FG003|STARTED|Overall Study||8
6703365|NCT02864368|7633709|FG004|STARTED|Overall Study||8
6703366|NCT02864368|7633705|FG000|COMPLETED|Overall Study||4
6703367|NCT02864368|7633706|FG001|COMPLETED|Overall Study||1
6703368|NCT02864368|7633707|FG002|COMPLETED|Overall Study||6
6703369|NCT02864368|7633708|FG003|COMPLETED|Overall Study||8
6703370|NCT02864368|7633709|FG004|COMPLETED|Overall Study||8
6703371|NCT02864368|7633705|FG000|NOT COMPLETED|Overall Study||0
6703372|NCT02864368|7633706|FG001|NOT COMPLETED|Overall Study||0
6703373|NCT02864368|7633707|FG002|NOT COMPLETED|Overall Study||0
6703374|NCT02864368|7633708|FG003|NOT COMPLETED|Overall Study||0
6703375|NCT02864368|7633709|FG004|NOT COMPLETED|Overall Study||0
6703376|NCT02864381|7633728|FG000|STARTED|Overall Study||72
6703377|NCT02864381|7633729|FG001|STARTED|Overall Study||72
6703378|NCT02864381|7633728|FG000|COMPLETED|Overall Study||0
6703379|NCT02864381|7633729|FG001|COMPLETED|Overall Study||0
6703380|NCT02864381|7633728|FG000|NOT COMPLETED|Overall Study||72
6703381|NCT02864381|7633729|FG001|NOT COMPLETED|Overall Study||72
6703382|NCT02864394|7633737|FG000|STARTED|Overall Study||213
6703383|NCT02864394|7633738|FG001|STARTED|Overall Study||212
6703384|NCT02864394|7633737|FG000|Treated|Overall Study||213
6703385|NCT02864394|7633738|FG001|Treated|Overall Study||198
6703386|NCT02864394|7633737|FG000|COMPLETED|Overall Study||0
6703387|NCT02864394|7633738|FG001|COMPLETED|Overall Study||0
6703388|NCT02864394|7633737|FG000|NOT COMPLETED|Overall Study||213
6703389|NCT02864394|7633738|FG001|NOT COMPLETED|Overall Study||212
6703390|NCT02864706|7633746|FG000|STARTED|Overall Study||48
6703391|NCT02864706|7633747|FG001|STARTED|Overall Study||47
6703392|NCT02864706|7633746|FG000|Safety Set|Overall Study||48
6703393|NCT02864706|7633747|FG001|Safety Set|Overall Study||47
6703394|NCT02864706|7633746|FG000|Intent to Treat|Overall Study||46
6703395|NCT02864706|7633747|FG001|Intent to Treat|Overall Study||47
6703396|NCT02864706|7633746|FG000|COMPLETED|Overall Study||48
6703397|NCT02864706|7633747|FG001|COMPLETED|Overall Study||47
6703398|NCT02864706|7633746|FG000|NOT COMPLETED|Overall Study||0
6703399|NCT02864706|7633747|FG001|NOT COMPLETED|Overall Study||0
6703400|NCT02864732|7633755|FG000|STARTED|Overall Study||15
6703401|NCT02864732|7633756|FG001|STARTED|Overall Study||15
6703402|NCT02864732|7633755|FG000|COMPLETED|Overall Study||13
6703403|NCT02864732|7633756|FG001|COMPLETED|Overall Study||13
6703404|NCT02864732|7633755|FG000|NOT COMPLETED|Overall Study||2
6703405|NCT02864732|7633756|FG001|NOT COMPLETED|Overall Study||2
6703406|NCT02865343|7633765|FG000|STARTED|Overall Study||6
6703407|NCT02865343|7633766|FG001|STARTED|Overall Study||5
6703408|NCT02865343|7633765|FG000|COMPLETED|Overall Study||6
6703409|NCT02865343|7633766|FG001|COMPLETED|Overall Study||3
6703410|NCT02865343|7633765|FG000|NOT COMPLETED|Overall Study||0
6703411|NCT02865343|7633766|FG001|NOT COMPLETED|Overall Study||2
6703412|NCT02865434|7633785|FG000|STARTED|Overall Study||3
6703413|NCT02865434|7633786|FG001|STARTED|Overall Study||3
6703414|NCT02865434|7633787|FG002|STARTED|Overall Study||3
6703415|NCT02865434|7633788|FG003|STARTED|Overall Study||3
6703416|NCT02865434|7633789|FG004|STARTED|Overall Study||3
6703417|NCT02865434|7633790|FG005|STARTED|Overall Study||3
6703418|NCT02865434|7633791|FG006|STARTED|Overall Study||3
6703419|NCT02865434|7633792|FG007|STARTED|Overall Study||3
6703420|NCT02865434|7633793|FG008|STARTED|Overall Study||3
6703421|NCT02865434|7633794|FG009|STARTED|Overall Study||6
6703422|NCT02865434|7633795|FG010|STARTED|Overall Study||6
6703423|NCT02865434|7633785|FG000|COMPLETED|Overall Study||3
6703424|NCT02865434|7633786|FG001|COMPLETED|Overall Study||3
6703425|NCT02865434|7633787|FG002|COMPLETED|Overall Study||3
6703426|NCT02865434|7633788|FG003|COMPLETED|Overall Study||3
6703427|NCT02865434|7633789|FG004|COMPLETED|Overall Study||3
6703428|NCT02865434|7633790|FG005|COMPLETED|Overall Study||3
6703429|NCT02865434|7633791|FG006|COMPLETED|Overall Study||3
6703430|NCT02865434|7633792|FG007|COMPLETED|Overall Study||3
6703431|NCT02865434|7633793|FG008|COMPLETED|Overall Study||3
6703432|NCT02865434|7633794|FG009|COMPLETED|Overall Study||6
6703433|NCT02865434|7633795|FG010|COMPLETED|Overall Study||6
6703434|NCT02865434|7633785|FG000|NOT COMPLETED|Overall Study||0
6703435|NCT02865434|7633786|FG001|NOT COMPLETED|Overall Study||0
6703436|NCT02865434|7633787|FG002|NOT COMPLETED|Overall Study||0
6703437|NCT02865434|7633788|FG003|NOT COMPLETED|Overall Study||0
6703438|NCT02865434|7633789|FG004|NOT COMPLETED|Overall Study||0
6703439|NCT02865434|7633790|FG005|NOT COMPLETED|Overall Study||0
6703440|NCT02865434|7633791|FG006|NOT COMPLETED|Overall Study||0
6703441|NCT02865434|7633792|FG007|NOT COMPLETED|Overall Study||0
6703442|NCT02865434|7633793|FG008|NOT COMPLETED|Overall Study||0
6703443|NCT02865434|7633794|FG009|NOT COMPLETED|Overall Study||0
6703444|NCT02865434|7633795|FG010|NOT COMPLETED|Overall Study||0
6703445|NCT02865499|7633825|FG000|STARTED|Baseline||8
6703446|NCT02865499|7633825|FG000|COMPLETED|Baseline||6
6703447|NCT02865499|7633825|FG000|NOT COMPLETED|Baseline||2
6703448|NCT02865499|7633825|FG000|STARTED|8 Weeks||6
6703449|NCT02865499|7633825|FG000|COMPLETED|8 Weeks||6
6703450|NCT02865499|7633825|FG000|NOT COMPLETED|8 Weeks||0
6703451|NCT02865499|7633825|FG000|STARTED|12 Weeks||6
6703452|NCT02865499|7633825|FG000|COMPLETED|12 Weeks||6
6703453|NCT02865499|7633825|FG000|NOT COMPLETED|12 Weeks||0
6703454|NCT02865538|7633834|FG000|STARTED|Overall Study||18
6703455|NCT02865538|7633835|FG001|STARTED|Overall Study||15
6703456|NCT02865538|7633836|FG002|STARTED|Overall Study||15
6703457|NCT02865538|7633837|FG003|STARTED|Overall Study||15
6703458|NCT02865538|7633838|FG004|STARTED|Overall Study||13
6703459|NCT02865538|7633834|FG000|COMPLETED|Overall Study||17
6703460|NCT02865538|7633835|FG001|COMPLETED|Overall Study||15
6703461|NCT02865538|7633836|FG002|COMPLETED|Overall Study||14
6703462|NCT02865538|7633837|FG003|COMPLETED|Overall Study||15
6703463|NCT02865538|7633838|FG004|COMPLETED|Overall Study||13
6703464|NCT02865538|7633834|FG000|NOT COMPLETED|Overall Study||1
6703465|NCT02865538|7633835|FG001|NOT COMPLETED|Overall Study||0
6703466|NCT02865538|7633836|FG002|NOT COMPLETED|Overall Study||1
6703467|NCT02865538|7633837|FG003|NOT COMPLETED|Overall Study||0
6703468|NCT02865538|7633838|FG004|NOT COMPLETED|Overall Study||0
6703469|NCT02865590|7633852|FG000|STARTED|Overall Study||8
6703470|NCT02865590|7633853|FG001|STARTED|Overall Study||8
6703471|NCT02865590|7633852|FG000|COMPLETED|Overall Study||8
6703472|NCT02865590|7633853|FG001|COMPLETED|Overall Study||8
6703473|NCT02865590|7633852|FG000|NOT COMPLETED|Overall Study||0
6703474|NCT02865590|7633853|FG001|NOT COMPLETED|Overall Study||0
6703475|NCT02865720|7633861|FG000|STARTED|Overall Study||0
6703476|NCT02865720|7633862|FG001|STARTED|Overall Study||8
6703477|NCT02865720|7633861|FG000|COMPLETED|Overall Study||0
6703478|NCT02865720|7633862|FG001|COMPLETED|Overall Study||8
6703479|NCT02865720|7633861|FG000|NOT COMPLETED|Overall Study||0
6703480|NCT02865720|7633862|FG001|NOT COMPLETED|Overall Study||0
6703481|NCT02865811|7633867|FG000|STARTED|Overall Study||26
6703482|NCT02865811|7633867|FG000|COMPLETED|Overall Study||26
6703483|NCT02865811|7633867|FG000|NOT COMPLETED|Overall Study||0
6703484|NCT02866175|7633874|FG000|STARTED|Overall Study||751
6703485|NCT02866175|7633875|FG001|STARTED|Overall Study||755
6703486|NCT02866175|7633874|FG000|COMPLETED|Overall Study||616
6703487|NCT02866175|7633875|FG001|COMPLETED|Overall Study||580
6703488|NCT02866175|7633874|FG000|NOT COMPLETED|Overall Study||135
6703489|NCT02866175|7633875|FG001|NOT COMPLETED|Overall Study||175
6703490|NCT02866643|7633884|FG000|STARTED|Overall Study||48
6703491|NCT02866643|7633885|FG001|STARTED|Overall Study||47
6703492|NCT02866643|7633884|FG000|Intent-to-Treat (ITT) Population|Overall Study||38
6703493|NCT02866643|7633885|FG001|Intent-to-Treat (ITT) Population|Overall Study||39
6703494|NCT02866643|7633884|FG000|Per Protocol Population|Overall Study||35
6703495|NCT02866643|7633885|FG001|Per Protocol Population|Overall Study||35
6703496|NCT02866643|7633884|FG000|COMPLETED|Overall Study||35
6703497|NCT02866643|7633885|FG001|COMPLETED|Overall Study||35
6703498|NCT02866643|7633884|FG000|NOT COMPLETED|Overall Study||13
6703499|NCT02866643|7633885|FG001|NOT COMPLETED|Overall Study||12
6703500|NCT02866942|7633891|FG000|STARTED|Overall Study||479
6703501|NCT02866942|7633891|FG000|COMPLETED|Overall Study||478
6703502|NCT02866942|7633891|FG000|NOT COMPLETED|Overall Study||1
6703503|NCT02867059|7633897|FG000|STARTED|Overall Study||7
6703504|NCT02867059|7633898|FG001|STARTED|Overall Study||10
6703505|NCT02867059|7633897|FG000|COMPLETED|Overall Study||7
6703506|NCT02867059|7633898|FG001|COMPLETED|Overall Study||8
6703507|NCT02867059|7633897|FG000|NOT COMPLETED|Overall Study||0
6703508|NCT02867059|7633898|FG001|NOT COMPLETED|Overall Study||2
6703509|NCT02867150|7633904|FG000|STARTED|Overall Study||58
6703510|NCT02867150|7633904|FG000|COMPLETED|Overall Study||58
6703511|NCT02867150|7633904|FG000|NOT COMPLETED|Overall Study||0
6703512|NCT02867163|7633908|FG000|STARTED|Overall Study||25
6703513|NCT02867163|7633908|FG000|COMPLETED|Overall Study||25
6703514|NCT02867163|7633908|FG000|NOT COMPLETED|Overall Study||0
6703515|NCT02867202|7633914|FG000|STARTED|Overall Study||83
6703516|NCT02867202|7633915|FG001|STARTED|Overall Study||88
6703517|NCT02867202|7633914|FG000|COMPLETED|Overall Study||62
6703518|NCT02867202|7633915|FG001|COMPLETED|Overall Study||56
6703519|NCT02867202|7633914|FG000|NOT COMPLETED|Overall Study||21
6703520|NCT02867202|7633915|FG001|NOT COMPLETED|Overall Study||32
6703521|NCT02867605|7633921|FG000|STARTED|Overall Study||20
6703522|NCT02867605|7633921|FG000|COMPLETED|Overall Study||20
6703523|NCT02867605|7633921|FG000|NOT COMPLETED|Overall Study||0
6703524|NCT02867618|7633938|FG000|STARTED|Overall Study||11
6703525|NCT02867618|7633938|FG000|COMPLETED|Overall Study||11
6703526|NCT02867618|7633938|FG000|NOT COMPLETED|Overall Study||0
6703527|NCT02867709|7633945|FG000|STARTED|Treatment Period||563
6703528|NCT02867709|7633946|FG001|STARTED|Treatment Period||561
6703529|NCT02867709|7633947|FG002|STARTED|Treatment Period||562
6703530|NCT02867709|7633945|FG000|Safety Population: Received Study Drug|Treatment Period||499
6703531|NCT02867709|7633946|FG001|Safety Population: Received Study Drug|Treatment Period||478
6703532|NCT02867709|7633947|FG002|Safety Population: Received Study Drug|Treatment Period||488
6703533|NCT02867709|7633945|FG000|COMPLETED|Treatment Period||493
6703534|NCT02867709|7633946|FG001|COMPLETED|Treatment Period||474
6703535|NCT02867709|7633947|FG002|COMPLETED|Treatment Period||487
6703536|NCT02867709|7633945|FG000|NOT COMPLETED|Treatment Period||70
6703537|NCT02867709|7633946|FG001|NOT COMPLETED|Treatment Period||87
6703538|NCT02867709|7633947|FG002|NOT COMPLETED|Treatment Period||75
6703539|NCT02867709|7633945|FG000|STARTED|Safety Follow-up Period||493
6703540|NCT02867709|7633946|FG001|STARTED|Safety Follow-up Period||474
6703541|NCT02867709|7633947|FG002|STARTED|Safety Follow-up Period||487
6703542|NCT02867709|7633945|FG000|COMPLETED|Safety Follow-up Period||482
6703543|NCT02867709|7633946|FG001|COMPLETED|Safety Follow-up Period||459
6703544|NCT02867709|7633947|FG002|COMPLETED|Safety Follow-up Period||473
6703545|NCT02867709|7633945|FG000|NOT COMPLETED|Safety Follow-up Period||11
6703546|NCT02867709|7633946|FG001|NOT COMPLETED|Safety Follow-up Period||15
6703547|NCT02867709|7633947|FG002|NOT COMPLETED|Safety Follow-up Period||14
6703548|NCT02867995|7633957|FG000|STARTED|Overall Study|Total patients consented|9
6703549|NCT02867995|7633958|FG001|STARTED|Overall Study|Total patients consented|30
6703550|NCT02867995|7633957|FG000|COMPLETED|Overall Study|Total patients completed|9
6703551|NCT02867995|7633958|FG001|COMPLETED|Overall Study|Total patients completed|27
6703552|NCT02867995|7633957|FG000|NOT COMPLETED|Overall Study||0
6703553|NCT02867995|7633958|FG001|NOT COMPLETED|Overall Study||3
6703554|NCT02868216|7633970|FG000|STARTED|Overall Study||43
6703555|NCT02868216|7633971|FG001|STARTED|Overall Study||47
6703556|NCT02868216|7633970|FG000|COMPLETED|Overall Study||35
6703557|NCT02868216|7633971|FG001|COMPLETED|Overall Study||41
6703558|NCT02868216|7633970|FG000|NOT COMPLETED|Overall Study||8
6703559|NCT02868216|7633971|FG001|NOT COMPLETED|Overall Study||6
6703560|NCT02868229|7633981|FG000|STARTED|Overall Study||12
6703561|NCT02868229|7633982|FG001|STARTED|Overall Study||16
6703562|NCT02868229|7633983|FG002|STARTED|Overall Study||16
6703563|NCT02868229|7633984|FG003|STARTED|Overall Study||17
6703564|NCT02868229|7633981|FG000|Intent to Treat (ITT) Population|Overall Study||12
6703565|NCT02868229|7633982|FG001|Intent to Treat (ITT) Population|Overall Study||16
6703566|NCT02868229|7633983|FG002|Intent to Treat (ITT) Population|Overall Study||16
6703567|NCT02868229|7633984|FG003|Intent to Treat (ITT) Population|Overall Study||17
6703568|NCT02868229|7633981|FG000|Pharmacodynamic (PD) Population|Overall Study||12
6703569|NCT02868229|7633982|FG001|Pharmacodynamic (PD) Population|Overall Study||16
6703570|NCT02868229|7633983|FG002|Pharmacodynamic (PD) Population|Overall Study||13
6703571|NCT02868229|7633984|FG003|Pharmacodynamic (PD) Population|Overall Study||12
6703572|NCT02868229|7633981|FG000|Pharmacokinetic (PK) Population|Overall Study||12
6703573|NCT02868229|7633982|FG001|Pharmacokinetic (PK) Population|Overall Study||16
6703574|NCT02868229|7633983|FG002|Pharmacokinetic (PK) Population|Overall Study||16
6703575|NCT02868229|7633984|FG003|Pharmacokinetic (PK) Population|Overall Study||17
6703576|NCT02868229|7633981|FG000|Safety Analysis Population|Overall Study||12
6703577|NCT02868229|7633982|FG001|Safety Analysis Population|Overall Study||16
6703578|NCT02868229|7633983|FG002|Safety Analysis Population|Overall Study||16
6703579|NCT02868229|7633984|FG003|Safety Analysis Population|Overall Study||17
6703580|NCT02868229|7633981|FG000|Maximum Tolerated Dose (MTD) Population|Overall Study||12
6703581|NCT02868229|7633982|FG001|Maximum Tolerated Dose (MTD) Population|Overall Study||16
6703582|NCT02868229|7633983|FG002|Maximum Tolerated Dose (MTD) Population|Overall Study||16
6703583|NCT02868229|7633984|FG003|Maximum Tolerated Dose (MTD) Population|Overall Study||16
6703584|NCT02868229|7633981|FG000|COMPLETED|Overall Study||11
6703585|NCT02868229|7633982|FG001|COMPLETED|Overall Study||16
6703586|NCT02868229|7633983|FG002|COMPLETED|Overall Study||15
6703587|NCT02868229|7633984|FG003|COMPLETED|Overall Study||12
6703588|NCT02868229|7633981|FG000|NOT COMPLETED|Overall Study||1
6703589|NCT02868229|7633982|FG001|NOT COMPLETED|Overall Study||0
6703590|NCT02868229|7633983|FG002|NOT COMPLETED|Overall Study||1
6703591|NCT02868229|7633984|FG003|NOT COMPLETED|Overall Study||5
6703592|NCT02868242|7633999|FG000|STARTED|Overall Study||19
6703593|NCT02868242|7633999|FG000|COMPLETED|Overall Study||19
6703594|NCT02868242|7633999|FG000|NOT COMPLETED|Overall Study||0
6703595|NCT02868281|7634007|FG000|STARTED|Overall Study||252
6703596|NCT02868281|7634008|FG001|STARTED|Overall Study||278
6703597|NCT02868281|7634007|FG000|COMPLETED|Overall Study||209
6703598|NCT02868281|7634008|FG001|COMPLETED|Overall Study||234
6703599|NCT02868281|7634007|FG000|NOT COMPLETED|Overall Study||43
6703600|NCT02868281|7634008|FG001|NOT COMPLETED|Overall Study||44
6703601|NCT02868554|7634017|FG000|STARTED|Overall Study||10
6703602|NCT02868554|7634018|FG001|STARTED|Overall Study||12
6703603|NCT02868554|7634019|FG002|STARTED|Overall Study||12
6703604|NCT02868554|7634017|FG000|COMPLETED|Overall Study||7
6703605|NCT02868554|7634018|FG001|COMPLETED|Overall Study||12
6703606|NCT02868554|7634019|FG002|COMPLETED|Overall Study||11
6703607|NCT02868554|7634017|FG000|NOT COMPLETED|Overall Study||3
6703608|NCT02868554|7634018|FG001|NOT COMPLETED|Overall Study||0
6703609|NCT02868554|7634019|FG002|NOT COMPLETED|Overall Study||1
6703610|NCT02869295|7634032|FG000|STARTED|Overall Study||4
6703611|NCT02869295|7634033|FG001|STARTED|Overall Study||11
6703612|NCT02869295|7634034|FG002|STARTED|Overall Study||6
6703613|NCT02869295|7634035|FG003|STARTED|Overall Study||6
6703614|NCT02869295|7634036|FG004|STARTED|Overall Study||1
6703615|NCT02869295|7634032|FG000|COMPLETED|Overall Study||0
6703616|NCT02869295|7634033|FG001|COMPLETED|Overall Study||0
6703617|NCT02869295|7634034|FG002|COMPLETED|Overall Study||0
6703618|NCT02869295|7634035|FG003|COMPLETED|Overall Study||0
6703619|NCT02869295|7634036|FG004|COMPLETED|Overall Study||0
6703620|NCT02869295|7634032|FG000|NOT COMPLETED|Overall Study||4
6703621|NCT02869295|7634033|FG001|NOT COMPLETED|Overall Study||11
6703622|NCT02869295|7634034|FG002|NOT COMPLETED|Overall Study||6
6703623|NCT02869295|7634035|FG003|NOT COMPLETED|Overall Study||6
6703624|NCT02869295|7634036|FG004|NOT COMPLETED|Overall Study||1
6703625|NCT02869334|7634050|FG000|STARTED|Overall Study||10
6703626|NCT02869334|7634051|FG001|STARTED|Overall Study||10
6703627|NCT02869334|7634050|FG000|COMPLETED|Overall Study||2
6703628|NCT02869334|7634051|FG001|COMPLETED|Overall Study||3
6703629|NCT02869334|7634050|FG000|NOT COMPLETED|Overall Study||8
6703630|NCT02869334|7634051|FG001|NOT COMPLETED|Overall Study||7
6703631|NCT02869438|7634059|FG000|STARTED|Overall Study||118
6703632|NCT02869438|7634060|FG001|STARTED|Overall Study||115
6703633|NCT02869438|7634059|FG000|COMPLETED|Overall Study||115
6703634|NCT02869438|7634060|FG001|COMPLETED|Overall Study||113
6703635|NCT02869438|7634059|FG000|NOT COMPLETED|Overall Study||3
6703636|NCT02869438|7634060|FG001|NOT COMPLETED|Overall Study||2
6703637|NCT02869451|7634066|FG000|STARTED|Overall Study||5
6703638|NCT02869451|7634066|FG000|COMPLETED|Overall Study||5
6703639|NCT02869451|7634066|FG000|NOT COMPLETED|Overall Study||0
6703640|NCT02869893|7634070|FG000|STARTED|Overall Study||57
6703641|NCT02869893|7634070|FG000|COMPLETED|Overall Study||50
6703642|NCT02869893|7634070|FG000|NOT COMPLETED|Overall Study||7
6703643|NCT02870101|7634075|FG000|STARTED|Overall Study||2767
6703644|NCT02870101|7634075|FG000|COMPLETED|Overall Study||2598
6703645|NCT02870101|7634075|FG000|NOT COMPLETED|Overall Study||169
6703646|NCT02870205|7634094|FG000|STARTED|Overall Study||294
6703647|NCT02870205|7634095|FG001|STARTED|Overall Study||294
6703648|NCT02870205|7634096|FG002|STARTED|Overall Study||294
6703649|NCT02870205|7634097|FG003|STARTED|Overall Study||294
6703650|NCT02870205|7634094|FG000|COMPLETED|Overall Study||284
6703651|NCT02870205|7634095|FG001|COMPLETED|Overall Study||289
6703652|NCT02870205|7634096|FG002|COMPLETED|Overall Study||287
6703653|NCT02870205|7634097|FG003|COMPLETED|Overall Study||287
6703654|NCT02870205|7634094|FG000|NOT COMPLETED|Overall Study||10
6703655|NCT02870205|7634095|FG001|NOT COMPLETED|Overall Study||5
6703656|NCT02870205|7634096|FG002|NOT COMPLETED|Overall Study||7
6703657|NCT02870205|7634097|FG003|NOT COMPLETED|Overall Study||7
6703658|NCT02870283|7634110|FG000|STARTED|Overall Study||38
6703659|NCT02870283|7634111|FG001|STARTED|Overall Study||35
6703660|NCT02870283|7634112|FG002|STARTED|Overall Study||34
6703661|NCT02870283|7634110|FG000|COMPLETED|Overall Study||35
6703662|NCT02870283|7634111|FG001|COMPLETED|Overall Study||26
6703663|NCT02870283|7634112|FG002|COMPLETED|Overall Study||15
6703664|NCT02870283|7634110|FG000|NOT COMPLETED|Overall Study||3
6703665|NCT02870283|7634111|FG001|NOT COMPLETED|Overall Study||9
6703666|NCT02870283|7634112|FG002|NOT COMPLETED|Overall Study||19
6703667|NCT02870309|7634120|FG000|STARTED|Overall Study||4
6703668|NCT02870309|7634120|FG000|COMPLETED|Overall Study||4
6703669|NCT02870309|7634120|FG000|NOT COMPLETED|Overall Study||0
6703670|NCT02870933|7634126|FG000|STARTED|Overall Study||15
6703671|NCT02870933|7634127|FG001|STARTED|Overall Study||15
6703672|NCT02870933|7634126|FG000|COMPLETED|Overall Study||13
6703673|NCT02870933|7634127|FG001|COMPLETED|Overall Study||13
6703674|NCT02870933|7634126|FG000|NOT COMPLETED|Overall Study||2
6703675|NCT02870933|7634127|FG001|NOT COMPLETED|Overall Study||2
6703676|NCT02870972|7634139|FG000|STARTED|Overall Study||18
6703677|NCT02870972|7634140|FG001|STARTED|Overall Study||14
6703678|NCT02870972|7634141|FG002|STARTED|Overall Study||14
6703679|NCT02870972|7634142|FG003|STARTED|Overall Study||7
6703680|NCT02870972|7634143|FG004|STARTED|Overall Study||22
6703681|NCT02870972|7634139|FG000|COMPLETED|Overall Study||17
6703682|NCT02870972|7634140|FG001|COMPLETED|Overall Study||14
6703683|NCT02870972|7634141|FG002|COMPLETED|Overall Study||14
6703684|NCT02870972|7634142|FG003|COMPLETED|Overall Study||7
6703685|NCT02870972|7634143|FG004|COMPLETED|Overall Study||22
6703686|NCT02870972|7634139|FG000|NOT COMPLETED|Overall Study||1
6703687|NCT02870972|7634140|FG001|NOT COMPLETED|Overall Study||0
6703688|NCT02870972|7634141|FG002|NOT COMPLETED|Overall Study||0
6703689|NCT02870972|7634142|FG003|NOT COMPLETED|Overall Study||0
6703690|NCT02870972|7634143|FG004|NOT COMPLETED|Overall Study||0
6703691|NCT02871011|7634159|FG000|STARTED|Overall Study||7
6703692|NCT02871011|7634160|FG001|STARTED|Overall Study||13
6703693|NCT02871011|7634159|FG000|COMPLETED|Overall Study||7
6703694|NCT02871011|7634160|FG001|COMPLETED|Overall Study||13
6703695|NCT02871011|7634159|FG000|NOT COMPLETED|Overall Study||0
6703696|NCT02871011|7634160|FG001|NOT COMPLETED|Overall Study||0
6703697|NCT02871128|7634169|FG000|STARTED|Overall Study||20
6703698|NCT02871128|7634170|FG001|STARTED|Overall Study||20
6703699|NCT02871128|7634171|FG002|STARTED|Overall Study||16
6703700|NCT02871128|7634169|FG000|COMPLETED|Overall Study||20
6703701|NCT02871128|7634170|FG001|COMPLETED|Overall Study||19
6703702|NCT02871128|7634171|FG002|COMPLETED|Overall Study||15
6703703|NCT02871128|7634169|FG000|NOT COMPLETED|Overall Study||0
6703704|NCT02871128|7634170|FG001|NOT COMPLETED|Overall Study||1
6703705|NCT02871128|7634171|FG002|NOT COMPLETED|Overall Study||1
6703706|NCT02871375|7634179|FG000|STARTED|Period 1, First 14 Days of Wear||89
6703707|NCT02871375|7634180|FG001|STARTED|Period 1, First 14 Days of Wear||77
6703708|NCT02871375|7634179|FG000|COMPLETED|Period 1, First 14 Days of Wear||89
6703709|NCT02871375|7634180|FG001|COMPLETED|Period 1, First 14 Days of Wear||76
6703710|NCT02871375|7634179|FG000|NOT COMPLETED|Period 1, First 14 Days of Wear||0
6703711|NCT02871375|7634180|FG001|NOT COMPLETED|Period 1, First 14 Days of Wear||1
6703712|NCT02871375|7634179|FG000|STARTED|Period 2, Second 14 Days of Wear||89
6703713|NCT02871375|7634180|FG001|STARTED|Period 2, Second 14 Days of Wear||76
6703714|NCT02871375|7634179|FG000|COMPLETED|Period 2, Second 14 Days of Wear||89
6703715|NCT02871375|7634180|FG001|COMPLETED|Period 2, Second 14 Days of Wear||76
6703716|NCT02871375|7634179|FG000|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6703717|NCT02871375|7634180|FG001|NOT COMPLETED|Period 2, Second 14 Days of Wear||0
6703718|NCT02871440|7634191|FG000|STARTED|Overall Study||12
6703719|NCT02871440|7634192|FG001|STARTED|Overall Study||13
6703720|NCT02871440|7634193|FG002|STARTED|Overall Study||15
6703721|NCT02871440|7634191|FG000|COMPLETED|Overall Study||12
6703722|NCT02871440|7634192|FG001|COMPLETED|Overall Study||13
6703723|NCT02871440|7634193|FG002|COMPLETED|Overall Study||15
6703724|NCT02871440|7634191|FG000|NOT COMPLETED|Overall Study||0
6703725|NCT02871440|7634192|FG001|NOT COMPLETED|Overall Study||0
6703726|NCT02871440|7634193|FG002|NOT COMPLETED|Overall Study||0
6703727|NCT02871479|7634207|FG000|STARTED|Overall Study||36
6703728|NCT02871479|7634208|FG001|STARTED|Overall Study||24
6703729|NCT02871479|7634209|FG002|STARTED|Overall Study||11
6703730|NCT02871479|7634207|FG000|COMPLETED|Overall Study||33
6703731|NCT02871479|7634208|FG001|COMPLETED|Overall Study||21
6703732|NCT02871479|7634209|FG002|COMPLETED|Overall Study||11
6703733|NCT02871479|7634207|FG000|NOT COMPLETED|Overall Study||3
6703734|NCT02871479|7634208|FG001|NOT COMPLETED|Overall Study||3
6703735|NCT02871479|7634209|FG002|NOT COMPLETED|Overall Study||0
6703736|NCT02871492|7634220|FG000|STARTED|Overall Study||73
6703737|NCT02871492|7634221|FG001|STARTED|Overall Study||73
6703738|NCT02871492|7634222|FG002|STARTED|Overall Study||77
6703739|NCT02871492|7634220|FG000|COMPLETED|Overall Study||67
6703740|NCT02871492|7634221|FG001|COMPLETED|Overall Study||70
6703741|NCT02871492|7634222|FG002|COMPLETED|Overall Study||71
6703742|NCT02871492|7634220|FG000|NOT COMPLETED|Overall Study||6
6703743|NCT02871492|7634221|FG001|NOT COMPLETED|Overall Study||3
6703744|NCT02871492|7634222|FG002|NOT COMPLETED|Overall Study||6
6703745|NCT02871570|7634232|FG000|STARTED|Overall Study||8
6703746|NCT02871570|7634233|FG001|STARTED|Overall Study||8
6703747|NCT02871570|7634232|FG000|COMPLETED|Overall Study||8
6703748|NCT02871570|7634233|FG001|COMPLETED|Overall Study||8
6703749|NCT02871570|7634232|FG000|NOT COMPLETED|Overall Study||0
6703750|NCT02871570|7634233|FG001|NOT COMPLETED|Overall Study||0
6703751|NCT02871635|7634241|FG000|STARTED|Overall Study||72
6703752|NCT02871635|7634242|FG001|STARTED|Overall Study||75
6703753|NCT02871635|7634241|FG000|COMPLETED|Overall Study||54
6703754|NCT02871635|7634242|FG001|COMPLETED|Overall Study||56
6703755|NCT02871635|7634241|FG000|NOT COMPLETED|Overall Study||18
6703756|NCT02871635|7634242|FG001|NOT COMPLETED|Overall Study||19
6739051|NCT03286283|7668034|FG000|COMPLETED|Overall Study||55
6739052|NCT03286283|7668034|FG000|NOT COMPLETED|Overall Study||0
6739053|NCT03286400|7668038|FG000|STARTED|Overall Study||127
6739054|NCT03286400|7668038|FG000|COMPLETED|Overall Study||102
6739055|NCT03286400|7668038|FG000|NOT COMPLETED|Overall Study||25
6739056|NCT03286465|7668044|FG000|STARTED|Overall Study||100
6739057|NCT03286465|7668045|FG001|STARTED|Overall Study||100
6739058|NCT03286465|7668044|FG000|COMPLETED|Overall Study||100
6739059|NCT03286465|7668045|FG001|COMPLETED|Overall Study||100
6739060|NCT03286465|7668044|FG000|NOT COMPLETED|Overall Study||0
6739061|NCT03286465|7668045|FG001|NOT COMPLETED|Overall Study||0
6739062|NCT03286543|7668053|FG000|STARTED|Consented||47
6739063|NCT03286543|7668054|FG001|STARTED|Consented||0
6739064|NCT03286543|7668055|FG002|STARTED|Consented||0
6739065|NCT03286543|7668053|FG000|Randomized|Consented||45
6739066|NCT03286543|7668054|FG001|Randomized|Consented||0
6739067|NCT03286543|7668055|FG002|Randomized|Consented||0
6739068|NCT03286543|7668053|FG000|Enrolled|Consented||41
6739069|NCT03286543|7668054|FG001|Enrolled|Consented||0
6739070|NCT03286543|7668055|FG002|Enrolled|Consented||0
6739071|NCT03286543|7668053|FG000|Intent to Treat Set|Consented||37
6739072|NCT03286543|7668054|FG001|Intent to Treat Set|Consented||0
6739073|NCT03286543|7668055|FG002|Intent to Treat Set|Consented||0
6739074|NCT03286543|7668053|FG000|Per Protocol Set|Consented||23
6739075|NCT03286543|7668054|FG001|Per Protocol Set|Consented||0
6739076|NCT03286543|7668055|FG002|Per Protocol Set|Consented||0
6739077|NCT03286543|7668053|FG000|COMPLETED|Consented||28
6739078|NCT03286543|7668054|FG001|COMPLETED|Consented||0
6739079|NCT03286543|7668055|FG002|COMPLETED|Consented||0
6739080|NCT03286543|7668053|FG000|NOT COMPLETED|Consented||19
6739081|NCT03286543|7668054|FG001|NOT COMPLETED|Consented||0
6739082|NCT03286543|7668055|FG002|NOT COMPLETED|Consented||0
6260683|NCT02359994|7159419|FG001|NOT COMPLETED|Overall Population Study||8
6739083|NCT03286543|7668053|FG000|STARTED|Study Enrollment||0
6739084|NCT03286543|7668054|FG001|STARTED|Study Enrollment||18
6739085|NCT03286543|7668055|FG002|STARTED|Study Enrollment||23
6739086|NCT03286543|7668053|FG000|Intent to Treat Set|Study Enrollment||0
6739087|NCT03286543|7668054|FG001|Intent to Treat Set|Study Enrollment||18
6739088|NCT03286543|7668055|FG002|Intent to Treat Set|Study Enrollment||19
6739089|NCT03286543|7668053|FG000|Per Protocol Set|Study Enrollment||0
6739090|NCT03286543|7668054|FG001|Per Protocol Set|Study Enrollment||7
6739091|NCT03286543|7668055|FG002|Per Protocol Set|Study Enrollment||16
6739092|NCT03286543|7668053|FG000|COMPLETED|Study Enrollment||0
6739093|NCT03286543|7668054|FG001|COMPLETED|Study Enrollment||12
6739094|NCT03286543|7668055|FG002|COMPLETED|Study Enrollment||16
6739095|NCT03286543|7668053|FG000|NOT COMPLETED|Study Enrollment||0
6739096|NCT03286543|7668054|FG001|NOT COMPLETED|Study Enrollment||6
6739097|NCT03286543|7668055|FG002|NOT COMPLETED|Study Enrollment||7
6739098|NCT03286751|7668061|FG000|STARTED|Period 1||7
6739099|NCT03286751|7668062|FG001|STARTED|Period 1||7
6739100|NCT03286751|7668063|FG002|STARTED|Period 1||7
6739101|NCT03286751|7668064|FG003|STARTED|Period 1||7
6703757|NCT02871739|7634254|FG000|STARTED|Overall Study||6
6703758|NCT02871739|7634255|FG001|STARTED|Overall Study||6
6703759|NCT02871739|7634256|FG002|STARTED|Overall Study||4
6703760|NCT02871739|7634257|FG003|STARTED|Overall Study||7
6703761|NCT02871739|7634254|FG000|Completed First SPI|Overall Study||3
6703762|NCT02871739|7634255|FG001|Completed First SPI|Overall Study||5
6703763|NCT02871739|7634256|FG002|Completed First SPI|Overall Study||4
6703764|NCT02871739|7634257|FG003|Completed First SPI|Overall Study||6
6703765|NCT02871739|7634254|FG000|Completed Second SPI|Overall Study||3
6703766|NCT02871739|7634255|FG001|Completed Second SPI|Overall Study||4
6703767|NCT02871739|7634256|FG002|Completed Second SPI|Overall Study||4
6703768|NCT02871739|7634257|FG003|Completed Second SPI|Overall Study||5
6703769|NCT02871739|7634254|FG000|Complete Final Survey|Overall Study||3
6703770|NCT02871739|7634255|FG001|Complete Final Survey|Overall Study||4
6703771|NCT02871739|7634256|FG002|Complete Final Survey|Overall Study||4
6703772|NCT02871739|7634257|FG003|Complete Final Survey|Overall Study||5
6703773|NCT02871739|7634254|FG000|COMPLETED|Overall Study||3
6260684|NCT02359994|7159418|FG000|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the PerClot group who completed either the 6 week or 3 month visit in the Overall Population Study.|85
6260685|NCT02359994|7159419|FG001|STARTED|Extended Oncology 24-Month Survival|Oncology subjects in the Arista group who completed either the 6 week or 3 month visit in the Overall Population Study.|93
6260686|NCT02359994|7159418|FG000|COMPLETED|Extended Oncology 24-Month Survival||65
6260687|NCT02359994|7159419|FG001|COMPLETED|Extended Oncology 24-Month Survival||72
6260688|NCT02359994|7159418|FG000|NOT COMPLETED|Extended Oncology 24-Month Survival||20
6260689|NCT02359994|7159419|FG001|NOT COMPLETED|Extended Oncology 24-Month Survival||21
6260690|NCT02336230|7159425|FG000|STARTED|Overall Study||55
6260691|NCT02336230|7159425|FG000|Full Analysis Set (FAS)|Overall Study||55
6260692|NCT02336230|7159425|FG000|Safety Analysis Population|Overall Study||54
6260693|NCT02336230|7159425|FG000|COMPLETED|Overall Study||42
6260694|NCT02336230|7159425|FG000|NOT COMPLETED|Overall Study||13
6260695|NCT02041533|7159431|FG000|STARTED|Overall Study||271
6260696|NCT02041533|7159432|FG001|STARTED|Overall Study||270
6260697|NCT02041533|7159431|FG000|Began Treatment|Overall Study||267
6260698|NCT02041533|7159432|FG001|Began Treatment|Overall Study||263
6260699|NCT02041533|7159431|FG000|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
6260700|NCT02041533|7159432|FG001|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
6260701|NCT02041533|7159431|FG000|NOT COMPLETED|Overall Study||228
6260702|NCT02041533|7159432|FG001|NOT COMPLETED|Overall Study||258
6260703|NCT02032823|7159440|FG000|STARTED|Overall Study||921
6260704|NCT02032823|7159441|FG001|STARTED|Overall Study||915
6260705|NCT02032823|7159440|FG000|COMPLETED|Overall Study||0
6260706|NCT02032823|7159441|FG001|COMPLETED|Overall Study||0
6260707|NCT02032823|7159440|FG000|NOT COMPLETED|Overall Study||921
6392119|NCT00839527|7304109|FG002|STARTED|Treatment Period (TP) (156 Weeks)||271
6392120|NCT00839527|7304107|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||55
6392121|NCT00839527|7304108|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||159
6392122|NCT00839527|7304109|FG002|COMPLETED|Treatment Period (TP) (156 Weeks)||152
6392123|NCT00839527|7304107|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
6703774|NCT02871739|7634255|FG001|COMPLETED|Overall Study||4
6703775|NCT02871739|7634256|FG002|COMPLETED|Overall Study||4
6703776|NCT02871739|7634257|FG003|COMPLETED|Overall Study||5
6703777|NCT02871739|7634254|FG000|NOT COMPLETED|Overall Study||3
6703778|NCT02871739|7634255|FG001|NOT COMPLETED|Overall Study||2
6703779|NCT02871739|7634256|FG002|NOT COMPLETED|Overall Study||0
6703780|NCT02871739|7634257|FG003|NOT COMPLETED|Overall Study||2
6703781|NCT02872012|7634272|FG000|STARTED|Overall Study||4
6703782|NCT02872012|7634273|FG001|STARTED|Overall Study||7
6703783|NCT02872012|7634274|FG002|STARTED|Overall Study||4
6703784|NCT02872012|7634275|FG003|STARTED|Overall Study||3
6703785|NCT02872012|7634276|FG004|STARTED|Overall Study||5
6703786|NCT02872012|7634272|FG000|COMPLETED|Overall Study||3
6703787|NCT02872012|7634273|FG001|COMPLETED|Overall Study||7
6703788|NCT02872012|7634274|FG002|COMPLETED|Overall Study||4
6703789|NCT02872012|7634275|FG003|COMPLETED|Overall Study||3
6703790|NCT02872012|7634276|FG004|COMPLETED|Overall Study||5
6703791|NCT02872012|7634272|FG000|NOT COMPLETED|Overall Study||1
6703792|NCT02872012|7634273|FG001|NOT COMPLETED|Overall Study||0
6703793|NCT02872012|7634274|FG002|NOT COMPLETED|Overall Study||0
6703794|NCT02872012|7634275|FG003|NOT COMPLETED|Overall Study||0
6703795|NCT02872012|7634276|FG004|NOT COMPLETED|Overall Study||0
6703796|NCT02872103|7634292|FG000|STARTED|Cycle 1||83
6703797|NCT02872103|7634293|FG001|STARTED|Cycle 1||39
6703798|NCT02872103|7634292|FG000|COMPLETED|Cycle 1||83
6703799|NCT02872103|7634293|FG001|COMPLETED|Cycle 1||38
6703800|NCT02872103|7634292|FG000|NOT COMPLETED|Cycle 1||0
6703801|NCT02872103|7634293|FG001|NOT COMPLETED|Cycle 1||1
6703802|NCT02872103|7634292|FG000|STARTED|Cycle 2-4||83
6703803|NCT02872103|7634293|FG001|STARTED|Cycle 2-4|1 subject withdrawn in Cycle 1|38
6703804|NCT02872103|7634292|FG000|COMPLETED|Cycle 2-4||81
6703805|NCT02872103|7634293|FG001|COMPLETED|Cycle 2-4||37
6703806|NCT02872103|7634292|FG000|NOT COMPLETED|Cycle 2-4||2
6703807|NCT02872103|7634293|FG001|NOT COMPLETED|Cycle 2-4||1
6703808|NCT02872142|7634301|FG000|STARTED|Overall Study||12
6703809|NCT02872142|7634301|FG000|COMPLETED|Overall Study||6
6703810|NCT02872142|7634301|FG000|NOT COMPLETED|Overall Study||6
6703811|NCT02872285|7634307|FG000|STARTED|Overall Study||22
6703812|NCT02872285|7634308|FG001|STARTED|Overall Study||11
6703813|NCT02872285|7634307|FG000|COMPLETED|Overall Study||17
6703814|NCT02872285|7634308|FG001|COMPLETED|Overall Study||9
6703815|NCT02872285|7634307|FG000|NOT COMPLETED|Overall Study||5
6703816|NCT02872285|7634308|FG001|NOT COMPLETED|Overall Study||2
6703817|NCT02872311|7634319|FG000|STARTED|Overall Study||59
6703818|NCT02872311|7634320|FG001|STARTED|Overall Study||60
6703819|NCT02872311|7634321|FG002|STARTED|Overall Study||20
6703820|NCT02872311|7634322|FG003|STARTED|Overall Study||20
6703821|NCT02872311|7634323|FG004|STARTED|Overall Study||20
6703822|NCT02872311|7634319|FG000|COMPLETED|Overall Study||55
6703823|NCT02872311|7634320|FG001|COMPLETED|Overall Study||58
6703824|NCT02872311|7634321|FG002|COMPLETED|Overall Study||19
6703825|NCT02872311|7634322|FG003|COMPLETED|Overall Study||20
6703826|NCT02872311|7634323|FG004|COMPLETED|Overall Study||20
6703827|NCT02872311|7634319|FG000|NOT COMPLETED|Overall Study||4
6703828|NCT02872311|7634320|FG001|NOT COMPLETED|Overall Study||2
6703829|NCT02872311|7634321|FG002|NOT COMPLETED|Overall Study||1
6703830|NCT02872311|7634322|FG003|NOT COMPLETED|Overall Study||0
6703831|NCT02872311|7634323|FG004|NOT COMPLETED|Overall Study||0
6703832|NCT02872857|7634353|FG000|STARTED|Phase 1||15
6703833|NCT02872857|7634354|FG001|STARTED|Phase 1||15
6703834|NCT02872857|7634355|FG002|STARTED|Phase 1||0
6703835|NCT02872857|7634356|FG003|STARTED|Phase 1||0
6703836|NCT02872857|7634353|FG000|COMPLETED|Phase 1||15
6703837|NCT02872857|7634354|FG001|COMPLETED|Phase 1||15
6703838|NCT02872857|7634355|FG002|COMPLETED|Phase 1||0
6703839|NCT02872857|7634356|FG003|COMPLETED|Phase 1||0
6703840|NCT02872857|7634353|FG000|NOT COMPLETED|Phase 1||0
6703841|NCT02872857|7634354|FG001|NOT COMPLETED|Phase 1||0
6703842|NCT02872857|7634355|FG002|NOT COMPLETED|Phase 1||0
6703843|NCT02872857|7634356|FG003|NOT COMPLETED|Phase 1||0
6703844|NCT02872857|7634353|FG000|STARTED|Phase 2||0
6703845|NCT02872857|7634354|FG001|STARTED|Phase 2||0
6703846|NCT02872857|7634355|FG002|STARTED|Phase 2||15
6703847|NCT02872857|7634356|FG003|STARTED|Phase 2||15
6703848|NCT02872857|7634353|FG000|COMPLETED|Phase 2||0
6703849|NCT02872857|7634354|FG001|COMPLETED|Phase 2||0
6703850|NCT02872857|7634355|FG002|COMPLETED|Phase 2||15
6703851|NCT02872857|7634356|FG003|COMPLETED|Phase 2||15
6703852|NCT02872857|7634353|FG000|NOT COMPLETED|Phase 2||0
6703853|NCT02872857|7634354|FG001|NOT COMPLETED|Phase 2||0
6703854|NCT02872857|7634355|FG002|NOT COMPLETED|Phase 2||0
6703855|NCT02872857|7634356|FG003|NOT COMPLETED|Phase 2||0
6703856|NCT02872909|7634364|FG000|STARTED|Overall Study||32
6703857|NCT02872909|7634365|FG001|STARTED|Overall Study||18
6703858|NCT02872909|7634364|FG000|COMPLETED|Overall Study||32
6703859|NCT02872909|7634365|FG001|COMPLETED|Overall Study||18
6703860|NCT02872909|7634364|FG000|NOT COMPLETED|Overall Study||0
6703861|NCT02872909|7634365|FG001|NOT COMPLETED|Overall Study||0
6703862|NCT02872935|7634373|FG000|STARTED|Overall Study||11
6703863|NCT02872935|7634374|FG001|STARTED|Overall Study||11
6703864|NCT02872935|7634373|FG000|COMPLETED|Overall Study||11
6703865|NCT02872935|7634374|FG001|COMPLETED|Overall Study|One subject consented but did no proceed with the study.|10
6703866|NCT02872935|7634373|FG000|NOT COMPLETED|Overall Study||0
6703867|NCT02872935|7634374|FG001|NOT COMPLETED|Overall Study||1
6703868|NCT02873104|7634382|FG000|STARTED|Overall Study||47
6703869|NCT02873104|7634383|FG001|STARTED|Overall Study||23
6703870|NCT02873104|7634382|FG000|COMPLETED|Overall Study||46
6703871|NCT02873104|7634383|FG001|COMPLETED|Overall Study||23
6703872|NCT02873104|7634382|FG000|NOT COMPLETED|Overall Study||1
6703873|NCT02873104|7634383|FG001|NOT COMPLETED|Overall Study||0
6703874|NCT02873208|7634389|FG000|STARTED|Overall Study||265
6703875|NCT02873208|7634389|FG000|COMPLETED|Overall Study||167
6703876|NCT02873208|7634389|FG000|NOT COMPLETED|Overall Study||98
6703877|NCT02873221|7634396|FG000|STARTED|Treatment Period||417
6703878|NCT02873221|7634397|FG001|STARTED|Treatment Period||417
6703879|NCT02873221|7634398|FG002|STARTED|Treatment Period||420
6703880|NCT02873221|7634396|FG000|Safety Population: Received Study Drug|Treatment Period||417
6703881|NCT02873221|7634397|FG001|Safety Population: Received Study Drug|Treatment Period||404
6703882|NCT02873221|7634398|FG002|Safety Population: Received Study Drug|Treatment Period||409
6703883|NCT02873221|7634396|FG000|COMPLETED|Treatment Period||329
6703884|NCT02873221|7634397|FG001|COMPLETED|Treatment Period||291
6703885|NCT02873221|7634398|FG002|COMPLETED|Treatment Period||315
6703886|NCT02873221|7634396|FG000|NOT COMPLETED|Treatment Period||88
6703887|NCT02873221|7634397|FG001|NOT COMPLETED|Treatment Period||126
6703888|NCT02873221|7634398|FG002|NOT COMPLETED|Treatment Period||105
6703889|NCT02873221|7634396|FG000|STARTED|Safety Follow-up Period||350
6703890|NCT02873221|7634397|FG001|STARTED|Safety Follow-up Period||356
6703891|NCT02873221|7634398|FG002|STARTED|Safety Follow-up Period||364
6703892|NCT02873221|7634396|FG000|COMPLETED|Safety Follow-up Period||343
6703893|NCT02873221|7634397|FG001|COMPLETED|Safety Follow-up Period||339
6703894|NCT02873221|7634398|FG002|COMPLETED|Safety Follow-up Period||350
6703895|NCT02873221|7634396|FG000|NOT COMPLETED|Safety Follow-up Period||7
6703896|NCT02873221|7634397|FG001|NOT COMPLETED|Safety Follow-up Period||17
6703897|NCT02873221|7634398|FG002|NOT COMPLETED|Safety Follow-up Period||14
6703898|NCT02873286|7634411|FG000|STARTED|Main Study||78
6703899|NCT02873286|7634412|FG001|STARTED|Main Study||89
6703900|NCT02873286|7634413|FG002|STARTED|Main Study||80
6703901|NCT02873286|7634414|FG003|STARTED|Main Study||90
6703902|NCT02873286|7634415|FG004|STARTED|Main Study||83
6703903|NCT02873286|7634411|FG000|COMPLETED|Main Study||76
6703904|NCT02873286|7634412|FG001|COMPLETED|Main Study||84
6703905|NCT02873286|7634413|FG002|COMPLETED|Main Study||78
6703906|NCT02873286|7634414|FG003|COMPLETED|Main Study||89
6703907|NCT02873286|7634415|FG004|COMPLETED|Main Study||81
6703908|NCT02873286|7634411|FG000|NOT COMPLETED|Main Study||2
6703909|NCT02873286|7634412|FG001|NOT COMPLETED|Main Study||5
6703910|NCT02873286|7634413|FG002|NOT COMPLETED|Main Study||2
6703911|NCT02873286|7634414|FG003|NOT COMPLETED|Main Study||1
6703912|NCT02873286|7634415|FG004|NOT COMPLETED|Main Study||2
6703913|NCT02873286|7634411|FG000|STARTED|Booster Substudy||43
6703914|NCT02873286|7634412|FG001|STARTED|Booster Substudy||0
6703915|NCT02873286|7634413|FG002|STARTED|Booster Substudy||45
6703916|NCT02873286|7634414|FG003|STARTED|Booster Substudy||0
6703917|NCT02873286|7634415|FG004|STARTED|Booster Substudy||0
6703918|NCT02873286|7634411|FG000|COMPLETED|Booster Substudy||43
6703919|NCT02873286|7634412|FG001|COMPLETED|Booster Substudy||0
6703920|NCT02873286|7634413|FG002|COMPLETED|Booster Substudy||45
6703921|NCT02873286|7634414|FG003|COMPLETED|Booster Substudy||0
6703922|NCT02873286|7634415|FG004|COMPLETED|Booster Substudy||0
6703923|NCT02873286|7634411|FG000|NOT COMPLETED|Booster Substudy||0
6703924|NCT02873286|7634412|FG001|NOT COMPLETED|Booster Substudy||0
6703925|NCT02873286|7634413|FG002|NOT COMPLETED|Booster Substudy||0
6703926|NCT02873286|7634414|FG003|NOT COMPLETED|Booster Substudy||0
6703927|NCT02873286|7634415|FG004|NOT COMPLETED|Booster Substudy||0
6703928|NCT02873338|7634430|FG000|STARTED|Overall Study||26
6703929|NCT02873338|7634431|FG001|STARTED|Overall Study||25
6703930|NCT02873338|7634432|FG002|STARTED|Overall Study||24
6703931|NCT02873338|7634430|FG000|COMPLETED|Overall Study||8
6703932|NCT02873338|7634431|FG001|COMPLETED|Overall Study||4
6703933|NCT02873338|7634432|FG002|COMPLETED|Overall Study||6
6703934|NCT02873338|7634430|FG000|NOT COMPLETED|Overall Study||18
6703935|NCT02873338|7634431|FG001|NOT COMPLETED|Overall Study||21
6703936|NCT02873338|7634432|FG002|NOT COMPLETED|Overall Study||18
6703937|NCT02873377|7634442|FG000|STARTED|Period 1: Enrollment||65
6703938|NCT02873377|7634443|FG001|STARTED|Period 1: Enrollment||69
6703939|NCT02873377|7634442|FG000|COMPLETED|Period 1: Enrollment||65
6703940|NCT02873377|7634443|FG001|COMPLETED|Period 1: Enrollment||69
6703941|NCT02873377|7634442|FG000|NOT COMPLETED|Period 1: Enrollment||0
6703942|NCT02873377|7634443|FG001|NOT COMPLETED|Period 1: Enrollment||0
6703943|NCT02873377|7634442|FG000|STARTED|Period Title 2: 3 Months Follow up||65
6703944|NCT02873377|7634443|FG001|STARTED|Period Title 2: 3 Months Follow up||69
6703945|NCT02873377|7634442|FG000|COMPLETED|Period Title 2: 3 Months Follow up||43
6703946|NCT02873377|7634443|FG001|COMPLETED|Period Title 2: 3 Months Follow up||47
6703947|NCT02873377|7634442|FG000|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
6703948|NCT02873377|7634443|FG001|NOT COMPLETED|Period Title 2: 3 Months Follow up||22
6703949|NCT02873377|7634442|FG000|STARTED|Period Title 3: 6 Months Follow up||65
6703950|NCT02873377|7634443|FG001|STARTED|Period Title 3: 6 Months Follow up||69
6703951|NCT02873377|7634442|FG000|COMPLETED|Period Title 3: 6 Months Follow up||50
6703952|NCT02873377|7634443|FG001|COMPLETED|Period Title 3: 6 Months Follow up||46
6703953|NCT02873377|7634442|FG000|NOT COMPLETED|Period Title 3: 6 Months Follow up||15
6703954|NCT02873377|7634443|FG001|NOT COMPLETED|Period Title 3: 6 Months Follow up||23
6703955|NCT02873429|7634452|FG000|STARTED|Baseline||109
6703956|NCT02873429|7634453|FG001|STARTED|Baseline||100
6703957|NCT02873429|7634452|FG000|COMPLETED|Baseline||109
6703958|NCT02873429|7634453|FG001|COMPLETED|Baseline||100
6703959|NCT02873429|7634452|FG000|NOT COMPLETED|Baseline||0
6703960|NCT02873429|7634453|FG001|NOT COMPLETED|Baseline||0
6703961|NCT02873429|7634452|FG000|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
6703962|NCT02873429|7634453|FG001|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
6703963|NCT02873429|7634452|FG000|COMPLETED|6-8 Weeks||95
6703964|NCT02873429|7634453|FG001|COMPLETED|6-8 Weeks||97
6703965|NCT02873429|7634452|FG000|NOT COMPLETED|6-8 Weeks||10
6703966|NCT02873429|7634453|FG001|NOT COMPLETED|6-8 Weeks||1
6703967|NCT02873429|7634452|FG000|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
6703968|NCT02873429|7634453|FG001|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
6703969|NCT02873429|7634452|FG000|COMPLETED|16 Weeks||100
6703970|NCT02873429|7634453|FG001|COMPLETED|16 Weeks||96
6703971|NCT02873429|7634452|FG000|NOT COMPLETED|16 Weeks||5
6703972|NCT02873429|7634453|FG001|NOT COMPLETED|16 Weeks||2
6703973|NCT02873481|7634461|FG000|STARTED|Overall Study||15
6703974|NCT02873481|7634462|FG001|STARTED|Overall Study||17
6703975|NCT02873481|7634461|FG000|COMPLETED|Overall Study||15
6703976|NCT02873481|7634462|FG001|COMPLETED|Overall Study||17
6703977|NCT02873481|7634461|FG000|NOT COMPLETED|Overall Study||0
6703978|NCT02873481|7634462|FG001|NOT COMPLETED|Overall Study||0
6703979|NCT02873585|7634468|FG000|STARTED|Overall Study||32
6703980|NCT02873585|7634468|FG000|COMPLETED|Overall Study||32
6703981|NCT02873585|7634468|FG000|NOT COMPLETED|Overall Study||0
6703982|NCT02873689|7634478|FG000|STARTED|Overall Study||109
6703983|NCT02873689|7634479|FG001|STARTED|Overall Study||108
6703984|NCT02873689|7634478|FG000|Treated|Overall Study||108
6703985|NCT02873689|7634479|FG001|Treated|Overall Study||107
6703986|NCT02873689|7634478|FG000|COMPLETED|Overall Study||102
6703987|NCT02873689|7634479|FG001|COMPLETED|Overall Study||103
6703988|NCT02873689|7634478|FG000|NOT COMPLETED|Overall Study||7
6703989|NCT02873689|7634479|FG001|NOT COMPLETED|Overall Study||5
6703990|NCT02873702|7634487|FG000|STARTED|Healing Period (up to Week 8)||20
6703991|NCT02873702|7634488|FG001|STARTED|Healing Period (up to Week 8)||17
6703992|NCT02873702|7634489|FG002|STARTED|Healing Period (up to Week 8)||0
6703993|NCT02873702|7634490|FG003|STARTED|Healing Period (up to Week 8)||0
6703994|NCT02873702|7634487|FG000|COMPLETED|Healing Period (up to Week 8)||19
6703995|NCT02873702|7634488|FG001|COMPLETED|Healing Period (up to Week 8)||16
6703996|NCT02873702|7634489|FG002|COMPLETED|Healing Period (up to Week 8)||0
6703997|NCT02873702|7634490|FG003|COMPLETED|Healing Period (up to Week 8)||0
6260708|NCT02032823|7159441|FG001|NOT COMPLETED|Overall Study||915
6260709|NCT01557751|7159447|FG000|STARTED|Overall Study||156
6260710|NCT01557751|7159447|FG000|COMPLETED|Overall Study||153
6260711|NCT01557751|7159447|FG000|NOT COMPLETED|Overall Study||3
6260712|NCT01363401|7159453|FG000|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
6260713|NCT01363401|7159454|FG001|STARTED|Overall Study||31
6260714|NCT01363401|7159453|FG000|COMPLETED|Overall Study||39
6260715|NCT01363401|7159454|FG001|COMPLETED|Overall Study||27
6260716|NCT01363401|7159453|FG000|NOT COMPLETED|Overall Study||2
6260717|NCT01363401|7159454|FG001|NOT COMPLETED|Overall Study||4
6260718|NCT00961064|7159460|FG000|STARTED|Overall Study||30
6260719|NCT00961064|7159460|FG000|COMPLETED|Overall Study||30
6260720|NCT00961064|7159460|FG000|NOT COMPLETED|Overall Study||0
6260721|NCT00848757|7159466|FG000|STARTED|Overall Study||65
6260722|NCT00848757|7159467|FG001|STARTED|Overall Study||65
6260723|NCT00848757|7159466|FG000|COMPLETED|Overall Study||61
6260724|NCT00848757|7159467|FG001|COMPLETED|Overall Study||61
6260725|NCT00848757|7159466|FG000|NOT COMPLETED|Overall Study||4
6260726|NCT00848757|7159467|FG001|NOT COMPLETED|Overall Study||4
6260727|NCT00378482|7159473|FG000|STARTED|Overall Study||37
6260728|NCT00378482|7159473|FG000|COMPLETED|Overall Study||6
6260729|NCT00378482|7159473|FG000|NOT COMPLETED|Overall Study||31
6280308|NCT00153179|7180205|FG002|COMPLETED|Study Visit Day 2||11
6280309|NCT00153179|7180206|FG003|COMPLETED|Study Visit Day 2||7
6280310|NCT00153179|7180203|FG000|NOT COMPLETED|Study Visit Day 2||1
6280311|NCT00153179|7180204|FG001|NOT COMPLETED|Study Visit Day 2||0
6280312|NCT00153179|7180205|FG002|NOT COMPLETED|Study Visit Day 2||2
6280313|NCT00153179|7180206|FG003|NOT COMPLETED|Study Visit Day 2||2
6280314|NCT00153803|7180216|FG000|STARTED|Concurrent Chemoradiation||123
6280315|NCT00153803|7180217|FG001|STARTED|Concurrent Chemoradiation||122
6280316|NCT00153803|7180216|FG000|Received Chemoradiation|Concurrent Chemoradiation||118
6602518|NCT02057458|7527500|FG000|NOT COMPLETED|Acute Study (1 Hour): First Intervention||2
6602519|NCT02057458|7527501|FG001|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
6602520|NCT02057458|7527502|FG002|NOT COMPLETED|Acute Study (1 Hour): First Intervention||0
6602521|NCT02057458|7527500|FG000|STARTED|Acute Study (1 Hour): Second Int.||6
6602522|NCT02057458|7527501|FG001|STARTED|Acute Study (1 Hour): Second Int.||7
6602523|NCT02057458|7527502|FG002|STARTED|Acute Study (1 Hour): Second Int.||0
6602524|NCT02057458|7527500|FG000|COMPLETED|Acute Study (1 Hour): Second Int.||6
6602525|NCT02057458|7527501|FG001|COMPLETED|Acute Study (1 Hour): Second Int.||7
6703998|NCT02873702|7634487|FG000|NOT COMPLETED|Healing Period (up to Week 8)||1
6703999|NCT02873702|7634488|FG001|NOT COMPLETED|Healing Period (up to Week 8)||1
6704000|NCT02873702|7634489|FG002|NOT COMPLETED|Healing Period (up to Week 8)||0
6704001|NCT02873702|7634490|FG003|NOT COMPLETED|Healing Period (up to Week 8)||0
6704002|NCT02873702|7634487|FG000|STARTED|Maintenance Period (up to Month 6)||0
6704003|NCT02873702|7634488|FG001|STARTED|Maintenance Period (up to Month 6)||0
6704004|NCT02873702|7634489|FG002|STARTED|Maintenance Period (up to Month 6)||8
6704005|NCT02873702|7634490|FG003|STARTED|Maintenance Period (up to Month 6)||8
6704006|NCT02873702|7634487|FG000|COMPLETED|Maintenance Period (up to Month 6)||0
6704007|NCT02873702|7634488|FG001|COMPLETED|Maintenance Period (up to Month 6)||0
6704008|NCT02873702|7634489|FG002|COMPLETED|Maintenance Period (up to Month 6)||1
6704009|NCT02873702|7634490|FG003|COMPLETED|Maintenance Period (up to Month 6)||6
6704010|NCT02873702|7634487|FG000|NOT COMPLETED|Maintenance Period (up to Month 6)||0
6704011|NCT02873702|7634488|FG001|NOT COMPLETED|Maintenance Period (up to Month 6)||0
6704012|NCT02873702|7634489|FG002|NOT COMPLETED|Maintenance Period (up to Month 6)||7
6704013|NCT02873702|7634490|FG003|NOT COMPLETED|Maintenance Period (up to Month 6)||2
6704014|NCT02873754|7634500|FG000|STARTED|Overall Study||11
6704015|NCT02873754|7634500|FG000|COMPLETED|Overall Study||5
6704016|NCT02873754|7634500|FG000|NOT COMPLETED|Overall Study||6
6704017|NCT02873923|7634504|FG000|STARTED|Overall Study||2846
6704018|NCT02873923|7634504|FG000|COMPLETED|Overall Study||2846
6704019|NCT02873923|7634504|FG000|NOT COMPLETED|Overall Study||0
6704020|NCT02873936|7634511|FG000|STARTED|Overall Study||148
6704021|NCT02873936|7634512|FG001|STARTED|Overall Study||153
6704022|NCT02873936|7634513|FG002|STARTED|Overall Study||148
6704023|NCT02873936|7634511|FG000|COMPLETED|Overall Study||135
6704024|NCT02873936|7634512|FG001|COMPLETED|Overall Study||130
6704025|NCT02873936|7634513|FG002|COMPLETED|Overall Study||116
6704026|NCT02873936|7634511|FG000|NOT COMPLETED|Overall Study||13
6704027|NCT02873936|7634512|FG001|NOT COMPLETED|Overall Study||23
6704028|NCT02873936|7634513|FG002|NOT COMPLETED|Overall Study||32
6704029|NCT02874066|7634521|FG000|STARTED|Overall Study||46
6704030|NCT02874066|7634521|FG000|COMPLETED|Overall Study||46
6704031|NCT02874066|7634521|FG000|NOT COMPLETED|Overall Study||0
6704032|NCT02874092|7634527|FG000|STARTED|Overall Study||7
6704033|NCT02874092|7634528|FG001|STARTED|Overall Study||2
6704034|NCT02874092|7634527|FG000|COMPLETED|Overall Study||7
6704035|NCT02874092|7634528|FG001|COMPLETED|Overall Study||2
6704036|NCT02874092|7634527|FG000|NOT COMPLETED|Overall Study||0
6704037|NCT02874092|7634528|FG001|NOT COMPLETED|Overall Study||0
6704038|NCT02874404|7634533|FG000|STARTED|Overall Study||13
6704039|NCT02874404|7634533|FG000|COMPLETED|Overall Study||13
6704040|NCT02874404|7634533|FG000|NOT COMPLETED|Overall Study||0
6704041|NCT02874534|7634540|FG000|STARTED|Overall Study||31
6704042|NCT02874534|7634541|FG001|STARTED|Overall Study||26
6704043|NCT02874534|7634540|FG000|COMPLETED|Overall Study||23
6704044|NCT02874534|7634541|FG001|COMPLETED|Overall Study||15
6704045|NCT02874534|7634540|FG000|NOT COMPLETED|Overall Study||8
6704046|NCT02874534|7634541|FG001|NOT COMPLETED|Overall Study||11
6704047|NCT02874794|7634549|FG000|STARTED|Overall Study||233
6704048|NCT02874794|7634550|FG001|STARTED|Overall Study||232
6704049|NCT02874794|7634549|FG000|COMPLETED|Overall Study||226
6704050|NCT02874794|7634550|FG001|COMPLETED|Overall Study||221
6704051|NCT02874794|7634549|FG000|NOT COMPLETED|Overall Study||7
6704052|NCT02874794|7634550|FG001|NOT COMPLETED|Overall Study||11
6704053|NCT02874846|7634561|FG000|STARTED|Overall Study||8
6704054|NCT02874846|7634562|FG001|STARTED|Overall Study||4
6704055|NCT02874846|7634561|FG000|COMPLETED|Overall Study||8
6704056|NCT02874846|7634562|FG001|COMPLETED|Overall Study||4
6704057|NCT02874846|7634561|FG000|NOT COMPLETED|Overall Study||0
6704058|NCT02874846|7634562|FG001|NOT COMPLETED|Overall Study||0
6260730|NCT03825393|7159479|FG000|STARTED|Overall Study||100
6260731|NCT03825393|7159480|FG001|STARTED|Overall Study||100
6260732|NCT03825393|7159479|FG000|COMPLETED|Overall Study||100
6260733|NCT03825393|7159480|FG001|COMPLETED|Overall Study||100
6260734|NCT03825393|7159479|FG000|NOT COMPLETED|Overall Study||0
6260735|NCT03825393|7159480|FG001|NOT COMPLETED|Overall Study||0
6260736|NCT03813719|7159488|FG000|STARTED|Overall Study||250
6260737|NCT03813719|7159488|FG000|COMPLETED|Overall Study||250
6260738|NCT03813719|7159488|FG000|NOT COMPLETED|Overall Study||0
6280317|NCT00153803|7180217|FG001|Received Chemoradiation|Concurrent Chemoradiation||117
6280318|NCT00153803|7180216|FG000|COMPLETED|Concurrent Chemoradiation||118
6280319|NCT00153803|7180217|FG001|COMPLETED|Concurrent Chemoradiation||117
6280320|NCT00153803|7180216|FG000|NOT COMPLETED|Concurrent Chemoradiation||5
6280321|NCT00153803|7180217|FG001|NOT COMPLETED|Concurrent Chemoradiation||5
6280322|NCT00153803|7180216|FG000|STARTED|Investigational Drug||118
6280323|NCT00153803|7180217|FG001|STARTED|Investigational Drug||117
6280324|NCT00153803|7180216|FG000|Investigational Drug Dispensed|Investigational Drug||77
6280325|NCT00153803|7180217|FG001|Investigational Drug Dispensed|Investigational Drug||75
6280326|NCT00153803|7180216|FG000|COMPLETED|Investigational Drug||77
6280327|NCT00153803|7180217|FG001|COMPLETED|Investigational Drug||75
6280328|NCT00153803|7180216|FG000|NOT COMPLETED|Investigational Drug||41
6280329|NCT00153803|7180217|FG001|NOT COMPLETED|Investigational Drug||42
6280330|NCT00153816|7180232|FG000|STARTED|Overall Study||415
6280331|NCT00153816|7180233|FG001|STARTED|Overall Study||419
6280332|NCT00153816|7180234|FG002|STARTED|Overall Study||420
6704059|NCT02874924|7634572|FG000|STARTED|Overall Study||14
6704060|NCT02874924|7634573|FG001|STARTED|Overall Study||14
6704061|NCT02874924|7634574|FG002|STARTED|Overall Study||6
6704062|NCT02874924|7634572|FG000|COMPLETED|Overall Study||11
6704063|NCT02874924|7634573|FG001|COMPLETED|Overall Study||14
6704064|NCT02874924|7634574|FG002|COMPLETED|Overall Study||6
6704065|NCT02874924|7634572|FG000|NOT COMPLETED|Overall Study||3
6704066|NCT02874924|7634573|FG001|NOT COMPLETED|Overall Study||0
6704067|NCT02874924|7634574|FG002|NOT COMPLETED|Overall Study||0
6704068|NCT02875028|7634584|FG000|STARTED|First Intervention (24 Hours)||8
6704069|NCT02875028|7634585|FG001|STARTED|First Intervention (24 Hours)||8
6704070|NCT02875028|7634584|FG000|COMPLETED|First Intervention (24 Hours)||8
6704071|NCT02875028|7634585|FG001|COMPLETED|First Intervention (24 Hours)||8
6704072|NCT02875028|7634584|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
6704073|NCT02875028|7634585|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
6704074|NCT02875028|7634584|FG000|STARTED|Washout Period||8
6704075|NCT02875028|7634585|FG001|STARTED|Washout Period||8
6704076|NCT02875028|7634584|FG000|COMPLETED|Washout Period||8
6704077|NCT02875028|7634585|FG001|COMPLETED|Washout Period||7
6704078|NCT02875028|7634584|FG000|NOT COMPLETED|Washout Period||0
6704079|NCT02875028|7634585|FG001|NOT COMPLETED|Washout Period||1
6704080|NCT02875028|7634584|FG000|STARTED|Second Intervention (24 Hours)||8
6704081|NCT02875028|7634585|FG001|STARTED|Second Intervention (24 Hours)||7
6704082|NCT02875028|7634584|FG000|COMPLETED|Second Intervention (24 Hours)||8
6704083|NCT02875028|7634585|FG001|COMPLETED|Second Intervention (24 Hours)||7
6704084|NCT02875028|7634584|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
6704085|NCT02875028|7634585|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
6704086|NCT02875080|7634596|FG000|STARTED|Overall Study||6
6704087|NCT02875080|7634597|FG001|STARTED|Overall Study||6
6704088|NCT02875080|7634598|FG002|STARTED|Overall Study||6
6704089|NCT02875080|7634596|FG000|COMPLETED|Overall Study||4
6704090|NCT02875080|7634597|FG001|COMPLETED|Overall Study||6
6704091|NCT02875080|7634598|FG002|COMPLETED|Overall Study||6
6704092|NCT02875080|7634596|FG000|NOT COMPLETED|Overall Study||2
6704093|NCT02875080|7634597|FG001|NOT COMPLETED|Overall Study||0
6704094|NCT02875080|7634598|FG002|NOT COMPLETED|Overall Study||0
6704095|NCT02875340|7634606|FG000|STARTED|Overall Study||8
6704096|NCT02875340|7634606|FG000|COMPLETED|Overall Study|No patients completed 6 months of continuous treatment|0
6704097|NCT02875340|7634606|FG000|NOT COMPLETED|Overall Study||8
6704098|NCT02875366|7634618|FG000|STARTED|Overall Study||36
6704099|NCT02875366|7634619|FG001|STARTED|Overall Study||34
6704100|NCT02875366|7634618|FG000|COMPLETED|Overall Study||36
6704101|NCT02875366|7634619|FG001|COMPLETED|Overall Study||31
6260739|NCT03798756|7159494|FG000|STARTED|Overall Study||9274
6260740|NCT03798756|7159494|FG000|COMPLETED|Overall Study||9274
6260741|NCT03798756|7159494|FG000|NOT COMPLETED|Overall Study||0
6260742|NCT03790917|7159499|FG000|STARTED|Overall Study||201
6260743|NCT03790917|7159499|FG000|COMPLETED|Overall Study||200
6260744|NCT03790917|7159499|FG000|NOT COMPLETED|Overall Study||1
6260745|NCT03790306|7159504|FG000|STARTED|Overall Study||207
6260746|NCT03790306|7159504|FG000|COMPLETED|Overall Study||207
6260747|NCT03790306|7159504|FG000|NOT COMPLETED|Overall Study||0
6260748|NCT03727373|7159509|FG000|STARTED|Overall Study||8
6260749|NCT03727373|7159509|FG000|COMPLETED|Overall Study||8
6260750|NCT03727373|7159509|FG000|NOT COMPLETED|Overall Study||0
6260751|NCT05017493|7159515|FG000|STARTED|Overall Study||483
6260752|NCT05017493|7159516|FG001|STARTED|Overall Study||178
6260753|NCT05017493|7159515|FG000|Treatment & Care|Overall Study||483
6260754|NCT05017493|7159516|FG001|Treatment & Care|Overall Study||178
6260755|NCT05017493|7159515|FG000|Follow up|Overall Study||483
6260756|NCT05017493|7159516|FG001|Follow up|Overall Study||178
6260757|NCT05017493|7159515|FG000|Mortality Check|Overall Study||483
6260758|NCT05017493|7159516|FG001|Mortality Check|Overall Study||178
6260759|NCT05017493|7159515|FG000|COMPLETED|Overall Study||361
6260760|NCT05017493|7159516|FG001|COMPLETED|Overall Study||178
6260761|NCT05017493|7159515|FG000|NOT COMPLETED|Overall Study||122
6260762|NCT05017493|7159516|FG001|NOT COMPLETED|Overall Study||0
6260763|NCT04870138|7159525|FG000|STARTED|Overall Study||5
6260764|NCT04870138|7159526|FG001|STARTED|Overall Study||5
6260765|NCT04870138|7159527|FG002|STARTED|Overall Study||6
6260766|NCT04870138|7159525|FG000|COMPLETED|Overall Study||5
6260767|NCT04870138|7159526|FG001|COMPLETED|Overall Study||5
6260768|NCT04870138|7159527|FG002|COMPLETED|Overall Study||6
6260769|NCT04870138|7159525|FG000|NOT COMPLETED|Overall Study||0
6260770|NCT04870138|7159526|FG001|NOT COMPLETED|Overall Study||0
6260771|NCT04870138|7159527|FG002|NOT COMPLETED|Overall Study||0
6260772|NCT04374149|7159540|FG000|STARTED|Overall Study||10
6260773|NCT04374149|7159541|FG001|STARTED|Overall Study||10
6260774|NCT04374149|7159540|FG000|COMPLETED|Overall Study||10
6260775|NCT04374149|7159541|FG001|COMPLETED|Overall Study||10
6260776|NCT04374149|7159540|FG000|NOT COMPLETED|Overall Study||0
6260777|NCT04374149|7159541|FG001|NOT COMPLETED|Overall Study||0
6704102|NCT02875366|7634618|FG000|NOT COMPLETED|Overall Study||0
6704103|NCT02875366|7634619|FG001|NOT COMPLETED|Overall Study||3
6704104|NCT02875392|7634627|FG000|STARTED|Overall Study||28
6704105|NCT02875392|7634628|FG001|STARTED|Overall Study||29
6704106|NCT02875392|7634627|FG000|COMPLETED|Overall Study||21
6704107|NCT02875392|7634628|FG001|COMPLETED|Overall Study||21
6704108|NCT02875392|7634627|FG000|NOT COMPLETED|Overall Study||7
6704109|NCT02875392|7634628|FG001|NOT COMPLETED|Overall Study||8
6704110|NCT02875613|7634634|FG000|STARTED|Overall Study||5
6260778|NCT04348500|7159549|FG000|STARTED|Overall Study||8
6704111|NCT02875613|7634634|FG000|COMPLETED|Overall Study||4
6704112|NCT02875613|7634634|FG000|NOT COMPLETED|Overall Study||1
6704113|NCT02875834|7634642|FG000|STARTED|Open-label Phase||267
6704114|NCT02875834|7634643|FG001|STARTED|Open-label Phase||0
6704115|NCT02875834|7634644|FG002|STARTED|Open-label Phase||0
6704116|NCT02875834|7634645|FG003|STARTED|Open-label Phase||0
6704117|NCT02875834|7634642|FG000|COMPLETED|Open-label Phase||260
6704118|NCT02875834|7634643|FG001|COMPLETED|Open-label Phase||0
6704119|NCT02875834|7634644|FG002|COMPLETED|Open-label Phase||0
6704120|NCT02875834|7634645|FG003|COMPLETED|Open-label Phase||0
6704121|NCT02875834|7634642|FG000|NOT COMPLETED|Open-label Phase||7
6704122|NCT02875834|7634643|FG001|NOT COMPLETED|Open-label Phase||0
6704123|NCT02875834|7634644|FG002|NOT COMPLETED|Open-label Phase||0
6704124|NCT02875834|7634645|FG003|NOT COMPLETED|Open-label Phase||0
6704125|NCT02875834|7634642|FG000|STARTED|Randomized Treatment Phase|No subjects were randomized in 10g TID group in RTP.|0
6704126|NCT02875834|7634643|FG001|STARTED|Randomized Treatment Phase|99 subjects were randomized in 5g QD group in RTP.|99
6704127|NCT02875834|7634644|FG002|STARTED|Randomized Treatment Phase|99 subjects were randomized in 10g QD group in RTP.|99
6704128|NCT02875834|7634645|FG003|STARTED|Randomized Treatment Phase|50 subjects were randomized in placebo group in RTP.|50
6704129|NCT02875834|7634642|FG000|COMPLETED|Randomized Treatment Phase||0
6704130|NCT02875834|7634643|FG001|COMPLETED|Randomized Treatment Phase||85
6704131|NCT02875834|7634644|FG002|COMPLETED|Randomized Treatment Phase||88
6704132|NCT02875834|7634645|FG003|COMPLETED|Randomized Treatment Phase||41
6704133|NCT02875834|7634642|FG000|NOT COMPLETED|Randomized Treatment Phase||0
6704134|NCT02875834|7634643|FG001|NOT COMPLETED|Randomized Treatment Phase||14
6704135|NCT02875834|7634644|FG002|NOT COMPLETED|Randomized Treatment Phase||11
6704136|NCT02875834|7634645|FG003|NOT COMPLETED|Randomized Treatment Phase||9
6704137|NCT02875977|7634657|FG000|STARTED|Overall Study||100
6704138|NCT02875977|7634658|FG001|STARTED|Overall Study||100
6704139|NCT02875977|7634657|FG000|COMPLETED|Overall Study||58
6704140|NCT02875977|7634658|FG001|COMPLETED|Overall Study||71
6704141|NCT02875977|7634657|FG000|NOT COMPLETED|Overall Study||42
6704142|NCT02875977|7634658|FG001|NOT COMPLETED|Overall Study||29
6704143|NCT02876055|7634667|FG000|STARTED|Overall Study||42
6704144|NCT02876055|7634668|FG001|STARTED|Overall Study||41
6704145|NCT02876055|7634669|FG002|STARTED|Overall Study||42
6704146|NCT02876055|7634667|FG000|COMPLETED|Overall Study||42
6704147|NCT02876055|7634668|FG001|COMPLETED|Overall Study||41
6704148|NCT02876055|7634669|FG002|COMPLETED|Overall Study||42
6704149|NCT02876055|7634667|FG000|NOT COMPLETED|Overall Study||0
6704150|NCT02876055|7634668|FG001|NOT COMPLETED|Overall Study||0
6704151|NCT02876055|7634669|FG002|NOT COMPLETED|Overall Study||0
6704152|NCT02876159|7634679|FG000|STARTED|Overall Study||10
6704153|NCT02876159|7634680|FG001|STARTED|Overall Study||10
6704154|NCT02876159|7634679|FG000|COMPLETED|Overall Study||10
6704155|NCT02876159|7634680|FG001|COMPLETED|Overall Study||10
6704156|NCT02876159|7634679|FG000|NOT COMPLETED|Overall Study||0
6704157|NCT02876159|7634680|FG001|NOT COMPLETED|Overall Study||0
6704158|NCT02876575|7634689|FG000|STARTED|Overall Study||48
6704159|NCT02876575|7634689|FG000|COMPLETED|Overall Study||48
6704160|NCT02876575|7634689|FG000|NOT COMPLETED|Overall Study||0
6704161|NCT02876601|7634698|FG000|STARTED|First Intervention (24 Hours)||8
6704162|NCT02876601|7634699|FG001|STARTED|First Intervention (24 Hours)||8
6704163|NCT02876601|7634700|FG002|STARTED|First Intervention (24 Hours)||2
6704164|NCT02876601|7634701|FG003|STARTED|First Intervention (24 Hours)||2
6704165|NCT02876601|7634698|FG000|COMPLETED|First Intervention (24 Hours)||8
6704166|NCT02876601|7634699|FG001|COMPLETED|First Intervention (24 Hours)||8
6704167|NCT02876601|7634700|FG002|COMPLETED|First Intervention (24 Hours)||2
6704168|NCT02876601|7634701|FG003|COMPLETED|First Intervention (24 Hours)||2
6704169|NCT02876601|7634698|FG000|NOT COMPLETED|First Intervention (24 Hours)||0
6704170|NCT02876601|7634699|FG001|NOT COMPLETED|First Intervention (24 Hours)||0
6704171|NCT02876601|7634700|FG002|NOT COMPLETED|First Intervention (24 Hours)||0
6704172|NCT02876601|7634701|FG003|NOT COMPLETED|First Intervention (24 Hours)||0
6704173|NCT02876601|7634698|FG000|STARTED|Washout (Minimum of 6 Weeks)||8
6704174|NCT02876601|7634699|FG001|STARTED|Washout (Minimum of 6 Weeks)||8
6704175|NCT02876601|7634700|FG002|STARTED|Washout (Minimum of 6 Weeks)||2
6704176|NCT02876601|7634701|FG003|STARTED|Washout (Minimum of 6 Weeks)||2
6704177|NCT02876601|7634698|FG000|COMPLETED|Washout (Minimum of 6 Weeks)||8
6704178|NCT02876601|7634699|FG001|COMPLETED|Washout (Minimum of 6 Weeks)||8
6704179|NCT02876601|7634700|FG002|COMPLETED|Washout (Minimum of 6 Weeks)||1
6704180|NCT02876601|7634701|FG003|COMPLETED|Washout (Minimum of 6 Weeks)||2
6704181|NCT02876601|7634698|FG000|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
6704182|NCT02876601|7634699|FG001|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
6704183|NCT02876601|7634700|FG002|NOT COMPLETED|Washout (Minimum of 6 Weeks)||1
6704184|NCT02876601|7634701|FG003|NOT COMPLETED|Washout (Minimum of 6 Weeks)||0
6704185|NCT02876601|7634698|FG000|STARTED|Second Intervention (24 Hours)||8
6704186|NCT02876601|7634699|FG001|STARTED|Second Intervention (24 Hours)||8
6704187|NCT02876601|7634700|FG002|STARTED|Second Intervention (24 Hours)||1
6704188|NCT02876601|7634701|FG003|STARTED|Second Intervention (24 Hours)||2
6704189|NCT02876601|7634698|FG000|COMPLETED|Second Intervention (24 Hours)||8
6704190|NCT02876601|7634699|FG001|COMPLETED|Second Intervention (24 Hours)||8
6704191|NCT02876601|7634700|FG002|COMPLETED|Second Intervention (24 Hours)||1
6704192|NCT02876601|7634701|FG003|COMPLETED|Second Intervention (24 Hours)||2
6704193|NCT02876601|7634698|FG000|NOT COMPLETED|Second Intervention (24 Hours)||0
6704194|NCT02876601|7634699|FG001|NOT COMPLETED|Second Intervention (24 Hours)||0
6704195|NCT02876601|7634700|FG002|NOT COMPLETED|Second Intervention (24 Hours)||0
6704196|NCT02876601|7634701|FG003|NOT COMPLETED|Second Intervention (24 Hours)||0
6704197|NCT02876757|7634748|FG000|STARTED|Overall Study||93197
6704198|NCT02876757|7634749|FG001|STARTED|Overall Study||93197
6704199|NCT02876757|7634748|FG000|COMPLETED|Overall Study||93197
6704200|NCT02876757|7634749|FG001|COMPLETED|Overall Study||93197
6704201|NCT02876757|7634748|FG000|NOT COMPLETED|Overall Study||0
6704202|NCT02876757|7634749|FG001|NOT COMPLETED|Overall Study||0
6704203|NCT02876887|7634757|FG000|STARTED|Overall Study||23
6704204|NCT02876887|7634758|FG001|STARTED|Overall Study||21
6704205|NCT02876887|7634757|FG000|COMPLETED|Overall Study||19
6704206|NCT02876887|7634758|FG001|COMPLETED|Overall Study||21
6704207|NCT02876887|7634757|FG000|NOT COMPLETED|Overall Study||4
6704208|NCT02876887|7634758|FG001|NOT COMPLETED|Overall Study||0
6704209|NCT02876900|7634767|FG000|STARTED|Overall Study||205
6704210|NCT02876900|7634768|FG001|STARTED|Overall Study||206
6704211|NCT02876900|7634769|FG002|STARTED|Overall Study||206
6704212|NCT02876900|7634767|FG000|COMPLETED|Overall Study||166
6704213|NCT02876900|7634768|FG001|COMPLETED|Overall Study||158
6704214|NCT02876900|7634769|FG002|COMPLETED|Overall Study||162
6704215|NCT02876900|7634767|FG000|NOT COMPLETED|Overall Study||39
6704216|NCT02876900|7634768|FG001|NOT COMPLETED|Overall Study||48
6704217|NCT02876900|7634769|FG002|NOT COMPLETED|Overall Study||44
6704218|NCT02876926|7634780|FG000|STARTED|Overall Study||21
6704219|NCT02876926|7634781|FG001|STARTED|Overall Study||22
6704220|NCT02876926|7634782|FG002|STARTED|Overall Study||22
6704221|NCT02876926|7634780|FG000|COMPLETED|Overall Study||3
6704222|NCT02876926|7634781|FG001|COMPLETED|Overall Study||3
6704223|NCT02876926|7634782|FG002|COMPLETED|Overall Study||2
6704224|NCT02876926|7634780|FG000|NOT COMPLETED|Overall Study||18
6704225|NCT02876926|7634781|FG001|NOT COMPLETED|Overall Study||19
6704226|NCT02876926|7634782|FG002|NOT COMPLETED|Overall Study||20
6704227|NCT02877004|7634793|FG000|STARTED|Overall Study||20
6704228|NCT02877004|7634794|FG001|STARTED|Overall Study||20
6704229|NCT02877004|7634795|FG002|STARTED|Overall Study||20
6704230|NCT02877004|7634793|FG000|COMPLETED|Overall Study||20
6704231|NCT02877004|7634794|FG001|COMPLETED|Overall Study||20
6704232|NCT02877004|7634795|FG002|COMPLETED|Overall Study||19
6704233|NCT02877004|7634793|FG000|NOT COMPLETED|Overall Study||0
6704234|NCT02877004|7634794|FG001|NOT COMPLETED|Overall Study||0
6704235|NCT02877004|7634795|FG002|NOT COMPLETED|Overall Study||1
6704236|NCT02877082|7634803|FG000|STARTED|Overall Study||5
6704237|NCT02877082|7634803|FG000|COMPLETED|Overall Study||0
6704238|NCT02877082|7634803|FG000|NOT COMPLETED|Overall Study||5
6704239|NCT02877095|7634809|FG000|STARTED|Overall Study|First patient enrolled 1/9/17.|20
6704240|NCT02877095|7634810|FG001|STARTED|Overall Study||20
6704241|NCT02877095|7634809|FG000|COMPLETED|Overall Study||20
6704242|NCT02877095|7634810|FG001|COMPLETED|Overall Study||20
6704243|NCT02877095|7634809|FG000|NOT COMPLETED|Overall Study||0
6704244|NCT02877095|7634810|FG001|NOT COMPLETED|Overall Study||0
6704245|NCT02877485|7634818|FG000|STARTED|Overall Study||22
6704246|NCT02877485|7634819|FG001|STARTED|Overall Study||20
6704247|NCT02877485|7634818|FG000|COMPLETED|Overall Study||22
6704248|NCT02877485|7634819|FG001|COMPLETED|Overall Study||20
6704249|NCT02877485|7634818|FG000|NOT COMPLETED|Overall Study||0
6704250|NCT02877485|7634819|FG001|NOT COMPLETED|Overall Study||0
6704251|NCT02877680|7634828|FG000|STARTED|Overall Study||55
6704252|NCT02877680|7634829|FG001|STARTED|Overall Study||25
6704253|NCT02877680|7634828|FG000|COMPLETED|Overall Study||54
6704254|NCT02877680|7634829|FG001|COMPLETED|Overall Study||24
6704255|NCT02877680|7634828|FG000|NOT COMPLETED|Overall Study||1
6704256|NCT02877680|7634829|FG001|NOT COMPLETED|Overall Study||1
6704257|NCT02877927|7634841|FG000|STARTED|Overall Study||368
6704258|NCT02877927|7634842|FG001|STARTED|Overall Study||367
6704259|NCT02877927|7634841|FG000|COMPLETED|Overall Study||314
6704260|NCT02877927|7634842|FG001|COMPLETED|Overall Study||310
6704261|NCT02877927|7634841|FG000|NOT COMPLETED|Overall Study||54
6704262|NCT02877927|7634842|FG001|NOT COMPLETED|Overall Study||57
6704263|NCT02878057|7634848|FG000|STARTED|Overall Study||30
6704264|NCT02878057|7634848|FG000|COMPLETED|Overall Study||26
6704265|NCT02878057|7634848|FG000|NOT COMPLETED|Overall Study||4
6704266|NCT02878213|7634852|FG000|STARTED|Overall Study||39
6704267|NCT02878213|7634852|FG000|COMPLETED|Overall Study||36
6704268|NCT02878213|7634852|FG000|NOT COMPLETED|Overall Study||3
6704269|NCT02878330|7634859|FG000|STARTED|Overall Study||484
6704270|NCT02878330|7634860|FG001|STARTED|Overall Study||969
6704271|NCT02878330|7634859|FG000|COMPLETED|Overall Study||455
6704272|NCT02878330|7634860|FG001|COMPLETED|Overall Study||913
6704273|NCT02878330|7634859|FG000|NOT COMPLETED|Overall Study||29
6704274|NCT02878330|7634860|FG001|NOT COMPLETED|Overall Study||56
6704275|NCT02878382|7634867|FG000|STARTED|Overall Study|total 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
6704276|NCT02878382|7634868|FG001|STARTED|Overall Study|otal 20 patients.split-scalp: 20 split -scalp received CAL-PDT and the other 20 received C-PDT|20
6704277|NCT02878382|7634867|FG000|COMPLETED|Overall Study||20
6704278|NCT02878382|7634868|FG001|COMPLETED|Overall Study||20
6704279|NCT02878382|7634867|FG000|NOT COMPLETED|Overall Study||0
6704280|NCT02878382|7634868|FG001|NOT COMPLETED|Overall Study||0
6704281|NCT02878486|7634878|FG000|STARTED|Overall Study||3
6704282|NCT02878486|7634879|FG001|STARTED|Overall Study||3
6704283|NCT02878486|7634878|FG000|COMPLETED|Overall Study||3
6704284|NCT02878486|7634879|FG001|COMPLETED|Overall Study||3
6704285|NCT02878486|7634878|FG000|NOT COMPLETED|Overall Study||0
6704286|NCT02878486|7634879|FG001|NOT COMPLETED|Overall Study||0
6704287|NCT02878590|7634885|FG000|STARTED|Overall Study||12
6704288|NCT02878590|7634885|FG000|COMPLETED|Overall Study||10
6704289|NCT02878590|7634885|FG000|NOT COMPLETED|Overall Study||2
6704290|NCT02879032|7634889|FG000|STARTED|Overall Study||130
6704291|NCT02879032|7634889|FG000|COMPLETED|Overall Study||130
6704292|NCT02879032|7634889|FG000|NOT COMPLETED|Overall Study||0
6704293|NCT02879318|7634897|FG000|STARTED|Overall Study||61
6704294|NCT02879318|7634898|FG001|STARTED|Overall Study||119
6704295|NCT02879318|7634897|FG000|COMPLETED|Overall Study||61
6704296|NCT02879318|7634898|FG001|COMPLETED|Overall Study||119
6704297|NCT02879318|7634897|FG000|NOT COMPLETED|Overall Study||0
6704298|NCT02879318|7634898|FG001|NOT COMPLETED|Overall Study||0
6704299|NCT02879383|7634908|FG000|STARTED|First 24 Weeks||39
6704300|NCT02879383|7634909|FG001|STARTED|First 24 Weeks||37
6704301|NCT02879383|7634910|FG002|STARTED|First 24 Weeks||17
6704302|NCT02879383|7634911|FG003|STARTED|First 24 Weeks||16
6704303|NCT02879383|7634908|FG000|COMPLETED|First 24 Weeks||39
6704304|NCT02879383|7634909|FG001|COMPLETED|First 24 Weeks||36
6704305|NCT02879383|7634910|FG002|COMPLETED|First 24 Weeks||17
6704306|NCT02879383|7634911|FG003|COMPLETED|First 24 Weeks||16
6704307|NCT02879383|7634908|FG000|NOT COMPLETED|First 24 Weeks||0
6704308|NCT02879383|7634909|FG001|NOT COMPLETED|First 24 Weeks||1
6704309|NCT02879383|7634910|FG002|NOT COMPLETED|First 24 Weeks||0
6704310|NCT02879383|7634911|FG003|NOT COMPLETED|First 24 Weeks||0
6704311|NCT02879383|7634908|FG000|STARTED|Second 24 Weeks (Crossover for Sham)||33
6704312|NCT02879383|7634909|FG001|STARTED|Second 24 Weeks (Crossover for Sham)||0
6704313|NCT02879383|7634910|FG002|STARTED|Second 24 Weeks (Crossover for Sham)||4
6704314|NCT02879383|7634911|FG003|STARTED|Second 24 Weeks (Crossover for Sham)||0
6704315|NCT02879383|7634908|FG000|COMPLETED|Second 24 Weeks (Crossover for Sham)||33
6704316|NCT02879383|7634909|FG001|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
6704317|NCT02879383|7634910|FG002|COMPLETED|Second 24 Weeks (Crossover for Sham)||4
6704318|NCT02879383|7634911|FG003|COMPLETED|Second 24 Weeks (Crossover for Sham)||0
6704319|NCT02879383|7634908|FG000|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
6704320|NCT02879383|7634909|FG001|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
6704321|NCT02879383|7634910|FG002|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
6704322|NCT02879383|7634911|FG003|NOT COMPLETED|Second 24 Weeks (Crossover for Sham)||0
6704323|NCT02879578|7634926|FG000|STARTED|Overall Study||33
6704324|NCT02879578|7634927|FG001|STARTED|Overall Study||41
6704325|NCT02879578|7634928|FG002|STARTED|Overall Study||81
6704326|NCT02879578|7634926|FG000|Safety Analysis Set|Overall Study||33
6704327|NCT02879578|7634927|FG001|Safety Analysis Set|Overall Study||40
6704328|NCT02879578|7634928|FG002|Safety Analysis Set|Overall Study||79
6704329|NCT02879578|7634926|FG000|COMPLETED|Overall Study||23
6704330|NCT02879578|7634927|FG001|COMPLETED|Overall Study||32
6704331|NCT02879578|7634928|FG002|COMPLETED|Overall Study||49
6704332|NCT02879578|7634926|FG000|NOT COMPLETED|Overall Study||10
6704333|NCT02879578|7634927|FG001|NOT COMPLETED|Overall Study||9
6704334|NCT02879578|7634928|FG002|NOT COMPLETED|Overall Study||32
6704335|NCT02879747|7634939|FG000|STARTED|Overall Study||27
6704336|NCT02879747|7634940|FG001|STARTED|Overall Study||38
6704337|NCT02879747|7634941|FG002|STARTED|Overall Study||33
6704338|NCT02879747|7634939|FG000|COMPLETED|Overall Study||23
6704339|NCT02879747|7634940|FG001|COMPLETED|Overall Study||32
6704340|NCT02879747|7634941|FG002|COMPLETED|Overall Study||31
6704341|NCT02879747|7634939|FG000|NOT COMPLETED|Overall Study||4
6704342|NCT02879747|7634940|FG001|NOT COMPLETED|Overall Study||6
6704343|NCT02879747|7634941|FG002|NOT COMPLETED|Overall Study||2
6704344|NCT02879812|7634960|FG000|STARTED|Overall Study||23370
6704345|NCT02879812|7634961|FG001|STARTED|Overall Study||22480
6704346|NCT02879812|7634960|FG000|COMPLETED|Overall Study||22153
6704347|NCT02879812|7634961|FG001|COMPLETED|Overall Study||21029
6704348|NCT02879812|7634960|FG000|NOT COMPLETED|Overall Study||1217
6704349|NCT02879812|7634961|FG001|NOT COMPLETED|Overall Study||1451
6704350|NCT02879994|7634967|FG000|STARTED|Overall Study||11
6704351|NCT02879994|7634967|FG000|COMPLETED|Overall Study||0
6704352|NCT02879994|7634967|FG000|NOT COMPLETED|Overall Study||11
6704353|NCT02880137|7634971|FG000|STARTED|Overall Study||36
6704354|NCT02880137|7634971|FG000|COMPLETED|Overall Study||36
6704355|NCT02880137|7634971|FG000|NOT COMPLETED|Overall Study||0
6704356|NCT02880176|7634977|FG000|STARTED|Overall Study||23
6704357|NCT02880176|7634978|FG001|STARTED|Overall Study||11
6704358|NCT02880176|7634977|FG000|Underwent Cystectomy|Overall Study||22
6704359|NCT02880176|7634978|FG001|Underwent Cystectomy|Overall Study||11
6704360|NCT02880176|7634977|FG000|Collected Postop Step Data|Overall Study||22
6704361|NCT02880176|7634978|FG001|Collected Postop Step Data|Overall Study||11
6704362|NCT02880176|7634977|FG000|Responded to 30 Day Survey|Overall Study||20
6704363|NCT02880176|7634978|FG001|Responded to 30 Day Survey|Overall Study||9
6704364|NCT02880176|7634977|FG000|COMPLETED|Overall Study||20
6704365|NCT02880176|7634978|FG001|COMPLETED|Overall Study||9
6704366|NCT02880176|7634977|FG000|NOT COMPLETED|Overall Study||3
6704367|NCT02880176|7634978|FG001|NOT COMPLETED|Overall Study||2
6704368|NCT02880189|7634984|FG000|STARTED|Overall Study||21
6704369|NCT02880189|7634984|FG000|COMPLETED|Overall Study||21
6704370|NCT02880189|7634984|FG000|NOT COMPLETED|Overall Study||0
6704371|NCT02880228|7634988|FG000|STARTED|Overall Study||11
6704372|NCT02880228|7634988|FG000|COMPLETED|Overall Study||11
6704373|NCT02880228|7634988|FG000|NOT COMPLETED|Overall Study||0
6704374|NCT02880254|7634994|FG000|STARTED|Overall Study||13
6704375|NCT02880254|7634995|FG001|STARTED|Overall Study||14
6704376|NCT02880254|7634994|FG000|COMPLETED|Overall Study||4
6704377|NCT02880254|7634995|FG001|COMPLETED|Overall Study||4
6704378|NCT02880254|7634994|FG000|NOT COMPLETED|Overall Study||9
6704379|NCT02880254|7634995|FG001|NOT COMPLETED|Overall Study||10
6704380|NCT02880475|7635003|FG000|STARTED|Overall Study||13
6704381|NCT02880475|7635004|FG001|STARTED|Overall Study||17
6704382|NCT02880475|7635003|FG000|COMPLETED|Overall Study||13
6704383|NCT02880475|7635004|FG001|COMPLETED|Overall Study||17
6704384|NCT02880475|7635003|FG000|NOT COMPLETED|Overall Study||0
6704385|NCT02880475|7635004|FG001|NOT COMPLETED|Overall Study||0
6704386|NCT02880514|7635012|FG000|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the treatment group|50
6704387|NCT02880514|7635013|FG001|STARTED|Overall Study|A total of 50 subjects with one sinus side assigned to the control group|50
6704388|NCT02880514|7635012|FG000|COMPLETED|Overall Study||50
6704389|NCT02880514|7635013|FG001|COMPLETED|Overall Study||50
6704390|NCT02880514|7635012|FG000|NOT COMPLETED|Overall Study||0
6704391|NCT02880514|7635013|FG001|NOT COMPLETED|Overall Study||0
6704392|NCT02880761|7635022|FG000|STARTED|Overall Study||103
6260779|NCT04348500|7159550|FG001|STARTED|Overall Study||9
6260780|NCT04348500|7159549|FG000|Treated|Overall Study||8
6260781|NCT04348500|7159550|FG001|Treated|Overall Study||8
6260782|NCT04348500|7159549|FG000|COMPLETED|Overall Study||6
6260783|NCT04348500|7159550|FG001|COMPLETED|Overall Study||6
6260784|NCT04348500|7159549|FG000|NOT COMPLETED|Overall Study||2
6260785|NCT04348500|7159550|FG001|NOT COMPLETED|Overall Study||3
6260786|NCT04347941|7159558|FG000|STARTED|Overall Study||12
6260787|NCT04347941|7159559|FG001|STARTED|Overall Study||12
6260788|NCT04347941|7159558|FG000|COMPLETED|Overall Study||12
6260789|NCT04347941|7159559|FG001|COMPLETED|Overall Study||12
6260790|NCT04347941|7159558|FG000|NOT COMPLETED|Overall Study||0
6260791|NCT04347941|7159559|FG001|NOT COMPLETED|Overall Study||0
6260792|NCT04308694|7159568|FG000|STARTED|Overall Study||20
6260793|NCT04308694|7159568|FG000|COMPLETED|Overall Study||16
6260794|NCT04308694|7159568|FG000|NOT COMPLETED|Overall Study||4
6260795|NCT03999411|7159575|FG000|STARTED|Overall Study||13
6260796|NCT03999411|7159576|FG001|STARTED|Overall Study||13
6260797|NCT03999411|7159577|FG002|STARTED|Overall Study||13
6704393|NCT02880761|7635023|FG001|STARTED|Overall Study||106
6704394|NCT02880761|7635022|FG000|COMPLETED|Overall Study||87
6704395|NCT02880761|7635023|FG001|COMPLETED|Overall Study||85
6704396|NCT02880761|7635022|FG000|NOT COMPLETED|Overall Study||16
6704397|NCT02880761|7635023|FG001|NOT COMPLETED|Overall Study||21
6704398|NCT02880852|7635029|FG000|STARTED|Overall Study||20
6704399|NCT02880852|7635029|FG000|COMPLETED|Overall Study||20
6704400|NCT02880852|7635029|FG000|NOT COMPLETED|Overall Study||0
6704401|NCT02880865|7635035|FG000|STARTED|Overall Study||314
6704402|NCT02880865|7635036|FG001|STARTED|Overall Study||314
6704403|NCT02880865|7635035|FG000|Received MMR Dose 1|Overall Study||314
6704404|NCT02880865|7635036|FG001|Received MMR Dose 1|Overall Study||314
6704405|NCT02880865|7635035|FG000|Received CD-JEV|Overall Study||314
6704406|NCT02880865|7635036|FG001|Received CD-JEV|Overall Study||309
6704407|NCT02880865|7635035|FG000|Received MMR Dose 2|Overall Study||313
6704408|NCT02880865|7635036|FG001|Received MMR Dose 2|Overall Study||311
6704409|NCT02880865|7635035|FG000|COMPLETED|Overall Study||313
6704410|NCT02880865|7635036|FG001|COMPLETED|Overall Study||311
6704411|NCT02880865|7635035|FG000|NOT COMPLETED|Overall Study||1
6704412|NCT02880865|7635036|FG001|NOT COMPLETED|Overall Study||3
6704413|NCT02881008|7635069|FG000|STARTED|Overall Study||8
6704414|NCT02881008|7635070|FG001|STARTED|Overall Study||8
6704415|NCT02881008|7635071|FG002|STARTED|Overall Study||8
6704416|NCT02881008|7635072|FG003|STARTED|Overall Study||8
6704417|NCT02881008|7635073|FG004|STARTED|Overall Study||8
6704418|NCT02881008|7635074|FG005|STARTED|Overall Study||8
6704419|NCT02881008|7635069|FG000|COMPLETED|Overall Study||8
6704420|NCT02881008|7635070|FG001|COMPLETED|Overall Study||8
6704421|NCT02881008|7635071|FG002|COMPLETED|Overall Study||8
6704422|NCT02881008|7635072|FG003|COMPLETED|Overall Study||8
6704423|NCT02881008|7635073|FG004|COMPLETED|Overall Study||8
6704424|NCT02881008|7635074|FG005|COMPLETED|Overall Study||8
6704425|NCT02881008|7635069|FG000|NOT COMPLETED|Overall Study||0
6704426|NCT02881008|7635070|FG001|NOT COMPLETED|Overall Study||0
6704427|NCT02881008|7635071|FG002|NOT COMPLETED|Overall Study||0
6704428|NCT02881008|7635072|FG003|NOT COMPLETED|Overall Study||0
6704429|NCT02881008|7635073|FG004|NOT COMPLETED|Overall Study||0
6704430|NCT02881008|7635074|FG005|NOT COMPLETED|Overall Study||0
6704431|NCT02881047|7635091|FG000|STARTED|Overall Study||8
6704432|NCT02881047|7635091|FG000|COMPLETED|Overall Study||6
6704433|NCT02881047|7635091|FG000|NOT COMPLETED|Overall Study||2
6704434|NCT02881112|7635095|FG000|STARTED|Overall Study||180
6704435|NCT02881112|7635095|FG000|COMPLETED|Overall Study||152
6704436|NCT02881112|7635095|FG000|NOT COMPLETED|Overall Study||28
6260798|NCT03999411|7159575|FG000|COMPLETED|Overall Study||12
6704437|NCT02881567|7635099|FG000|STARTED|Overall Study||41
6704438|NCT02881567|7635099|FG000|COMPLETED|Overall Study||23
6704439|NCT02881567|7635099|FG000|NOT COMPLETED|Overall Study||18
6704440|NCT02881658|7635105|FG000|STARTED|Overall Study||100
6704441|NCT02881658|7635106|FG001|STARTED|Overall Study||101
6704442|NCT02881658|7635105|FG000|COMPLETED|Overall Study||98
6704443|NCT02881658|7635106|FG001|COMPLETED|Overall Study||96
6704444|NCT02881658|7635105|FG000|NOT COMPLETED|Overall Study||2
6704445|NCT02881658|7635106|FG001|NOT COMPLETED|Overall Study||5
6704446|NCT02881775|7635114|FG000|STARTED|Baseline||11
6704447|NCT02881775|7635115|FG001|STARTED|Baseline||9
6704448|NCT02881775|7635114|FG000|COMPLETED|Baseline||11
6704449|NCT02881775|7635115|FG001|COMPLETED|Baseline||9
6704450|NCT02881775|7635114|FG000|NOT COMPLETED|Baseline||0
6704451|NCT02881775|7635115|FG001|NOT COMPLETED|Baseline||0
6704452|NCT02881775|7635114|FG000|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|9
6704453|NCT02881775|7635115|FG001|STARTED|First Intervention (1-hr Session)|Two participants dropped out prior to First Intervention (1-hr Session).|7
6704454|NCT02881775|7635114|FG000|COMPLETED|First Intervention (1-hr Session)||9
6704455|NCT02881775|7635115|FG001|COMPLETED|First Intervention (1-hr Session)||7
6704456|NCT02881775|7635114|FG000|NOT COMPLETED|First Intervention (1-hr Session)||0
6704457|NCT02881775|7635115|FG001|NOT COMPLETED|First Intervention (1-hr Session)||0
6704458|NCT02881775|7635114|FG000|STARTED|Washout (1 Week)||9
6704459|NCT02881775|7635115|FG001|STARTED|Washout (1 Week)||7
6704460|NCT02881775|7635114|FG000|COMPLETED|Washout (1 Week)||9
6704461|NCT02881775|7635115|FG001|COMPLETED|Washout (1 Week)||7
6704462|NCT02881775|7635114|FG000|NOT COMPLETED|Washout (1 Week)||0
6704463|NCT02881775|7635115|FG001|NOT COMPLETED|Washout (1 Week)||0
6704464|NCT02881775|7635114|FG000|STARTED|Second Intervention (1-Hour Session)||9
6704465|NCT02881775|7635115|FG001|STARTED|Second Intervention (1-Hour Session)||7
6704466|NCT02881775|7635114|FG000|COMPLETED|Second Intervention (1-Hour Session)||9
6704467|NCT02881775|7635115|FG001|COMPLETED|Second Intervention (1-Hour Session)||7
6704468|NCT02881775|7635114|FG000|NOT COMPLETED|Second Intervention (1-Hour Session)||0
6704469|NCT02881775|7635115|FG001|NOT COMPLETED|Second Intervention (1-Hour Session)||0
6704470|NCT02881840|7635121|FG000|STARTED|Overall Study||6
6704471|NCT02881840|7635121|FG000|COMPLETED|Overall Study||6
6704472|NCT02881840|7635121|FG000|NOT COMPLETED|Overall Study||0
6704473|NCT02881957|7635127|FG000|STARTED|Overall Study||136
6704474|NCT02881957|7635128|FG001|STARTED|Overall Study||138
6704475|NCT02881957|7635127|FG000|COMPLETED|Overall Study||133
6704476|NCT02881957|7635128|FG001|COMPLETED|Overall Study||134
6704477|NCT02881957|7635127|FG000|NOT COMPLETED|Overall Study||3
6704478|NCT02881957|7635128|FG001|NOT COMPLETED|Overall Study||4
6704479|NCT02881996|7635136|FG000|STARTED|Overall Study||45
6704480|NCT02881996|7635137|FG001|STARTED|Overall Study||45
6704481|NCT02881996|7635136|FG000|COMPLETED|Overall Study||39
6704482|NCT02881996|7635137|FG001|COMPLETED|Overall Study||43
6704483|NCT02881996|7635136|FG000|NOT COMPLETED|Overall Study||6
6704484|NCT02881996|7635137|FG001|NOT COMPLETED|Overall Study||2
6704485|NCT02882152|7635145|FG000|STARTED|Overall Study||20
6704486|NCT02882152|7635146|FG001|STARTED|Overall Study||20
6704487|NCT02882152|7635145|FG000|COMPLETED|Overall Study||19
6704488|NCT02882152|7635146|FG001|COMPLETED|Overall Study||20
6704489|NCT02882152|7635145|FG000|NOT COMPLETED|Overall Study||1
6704490|NCT02882152|7635146|FG001|NOT COMPLETED|Overall Study||0
6704491|NCT02882178|7635152|FG000|STARTED|Overall Study||18
6704492|NCT02882178|7635152|FG000|COMPLETED|Overall Study||18
6704493|NCT02882178|7635152|FG000|NOT COMPLETED|Overall Study||0
6704494|NCT02882633|7635158|FG000|STARTED|Overall Study||25
6704495|NCT02882633|7635159|FG001|STARTED|Overall Study||25
6704496|NCT02882633|7635158|FG000|COMPLETED|Overall Study||23
6704497|NCT02882633|7635159|FG001|COMPLETED|Overall Study||25
6704498|NCT02882633|7635158|FG000|NOT COMPLETED|Overall Study||2
6704499|NCT02882633|7635159|FG001|NOT COMPLETED|Overall Study||0
6704500|NCT02882711|7635165|FG000|STARTED|Overall Study||6
6704501|NCT02882711|7635165|FG000|COMPLETED|Overall Study||2
6704502|NCT02882711|7635165|FG000|NOT COMPLETED|Overall Study||4
6704503|NCT02882854|7635171|FG000|STARTED|Overall Study||40
6704504|NCT02882854|7635172|FG001|STARTED|Overall Study||44
6704505|NCT02882854|7635171|FG000|COMPLETED|Overall Study||39
6704506|NCT02882854|7635172|FG001|COMPLETED|Overall Study||41
6704507|NCT02882854|7635171|FG000|NOT COMPLETED|Overall Study||1
6704508|NCT02882854|7635172|FG001|NOT COMPLETED|Overall Study||3
6704509|NCT02883244|7635180|FG000|STARTED|Overall Study||24
6704510|NCT02883244|7635181|FG001|STARTED|Overall Study||26
6704511|NCT02883244|7635180|FG000|COMPLETED|Overall Study||24
6704512|NCT02883244|7635181|FG001|COMPLETED|Overall Study||25
6704513|NCT02883244|7635180|FG000|NOT COMPLETED|Overall Study||0
6704514|NCT02883244|7635181|FG001|NOT COMPLETED|Overall Study||1
6704515|NCT02883452|7635193|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
6704516|NCT02883452|7635194|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
6704517|NCT02883452|7635195|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
6704518|NCT02883452|7635196|FG003|STARTED|Overall Study|This cohort is only for Part 1.|8
6260799|NCT03999411|7159576|FG001|COMPLETED|Overall Study||11
6260800|NCT03999411|7159577|FG002|COMPLETED|Overall Study||13
6260801|NCT03999411|7159575|FG000|NOT COMPLETED|Overall Study||1
6260802|NCT03999411|7159576|FG001|NOT COMPLETED|Overall Study||2
6260803|NCT03999411|7159577|FG002|NOT COMPLETED|Overall Study||0
6260804|NCT03803605|7159586|FG000|STARTED|Overall Study||15
6260805|NCT03803605|7159586|FG000|Step 1: Participants With an RCI Measurement > 0.30 Per Million Cells|Overall Study||8
6260806|NCT03803605|7159586|FG000|Steps 2-4: Participants Receiving Study Intervention|Overall Study||8
6260807|NCT03803605|7159586|FG000|COMPLETED|Overall Study||8
6260808|NCT03803605|7159586|FG000|NOT COMPLETED|Overall Study||7
6260809|NCT03799198|7159593|FG000|STARTED|Overall Study||100
6739102|NCT03286751|7668065|FG004|STARTED|Period 1||7
6704519|NCT02883452|7635197|FG004|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|66
6704520|NCT02883452|7635198|FG005|STARTED|Overall Study|This arm is for Part 2. All of the patients in Part 2 were screened only for Part 2.|65
6704521|NCT02883452|7635193|FG000|COMPLETED|Overall Study||8
6704522|NCT02883452|7635194|FG001|COMPLETED|Overall Study||9
6704523|NCT02883452|7635195|FG002|COMPLETED|Overall Study||7
6704524|NCT02883452|7635196|FG003|COMPLETED|Overall Study||6
6704525|NCT02883452|7635197|FG004|COMPLETED|Overall Study||55
6704526|NCT02883452|7635198|FG005|COMPLETED|Overall Study||50
6704527|NCT02883452|7635193|FG000|NOT COMPLETED|Overall Study||5
6704528|NCT02883452|7635194|FG001|NOT COMPLETED|Overall Study||2
6704529|NCT02883452|7635195|FG002|NOT COMPLETED|Overall Study||5
6704530|NCT02883452|7635196|FG003|NOT COMPLETED|Overall Study||2
6704531|NCT02883452|7635197|FG004|NOT COMPLETED|Overall Study||11
6704532|NCT02883452|7635198|FG005|NOT COMPLETED|Overall Study||15
6704533|NCT02884089|7635213|FG000|STARTED|Period 1||11
6704534|NCT02884089|7635214|FG001|STARTED|Period 1||11
6704535|NCT02884089|7635215|FG002|STARTED|Period 1||9
6704536|NCT02884089|7635216|FG003|STARTED|Period 1||9
6704537|NCT02884089|7635213|FG000|Received at Least One Dose of Study Drug|Period 1||11
6704538|NCT02884089|7635214|FG001|Received at Least One Dose of Study Drug|Period 1||11
6704539|NCT02884089|7635215|FG002|Received at Least One Dose of Study Drug|Period 1||9
6704540|NCT02884089|7635216|FG003|Received at Least One Dose of Study Drug|Period 1||9
6704541|NCT02884089|7635213|FG000|COMPLETED|Period 1||9
6704542|NCT02884089|7635214|FG001|COMPLETED|Period 1||9
6704543|NCT02884089|7635215|FG002|COMPLETED|Period 1||9
6704544|NCT02884089|7635216|FG003|COMPLETED|Period 1||9
6704545|NCT02884089|7635213|FG000|NOT COMPLETED|Period 1||2
6704546|NCT02884089|7635214|FG001|NOT COMPLETED|Period 1||2
6704547|NCT02884089|7635215|FG002|NOT COMPLETED|Period 1||0
6704548|NCT02884089|7635216|FG003|NOT COMPLETED|Period 1||0
6704549|NCT02884089|7635213|FG000|STARTED|Washout Period 1||9
6704550|NCT02884089|7635214|FG001|STARTED|Washout Period 1||9
6704551|NCT02884089|7635215|FG002|STARTED|Washout Period 1||9
6704552|NCT02884089|7635216|FG003|STARTED|Washout Period 1||9
6704553|NCT02884089|7635213|FG000|COMPLETED|Washout Period 1||9
6704554|NCT02884089|7635214|FG001|COMPLETED|Washout Period 1||7
6704555|NCT02884089|7635215|FG002|COMPLETED|Washout Period 1||9
6704556|NCT02884089|7635216|FG003|COMPLETED|Washout Period 1||8
6704557|NCT02884089|7635213|FG000|NOT COMPLETED|Washout Period 1||0
6704558|NCT02884089|7635214|FG001|NOT COMPLETED|Washout Period 1||2
6704559|NCT02884089|7635215|FG002|NOT COMPLETED|Washout Period 1||0
6704560|NCT02884089|7635216|FG003|NOT COMPLETED|Washout Period 1||1
6704561|NCT02884089|7635213|FG000|STARTED|Period 2||9
6704562|NCT02884089|7635214|FG001|STARTED|Period 2||7
6704563|NCT02884089|7635215|FG002|STARTED|Period 2||9
6704564|NCT02884089|7635216|FG003|STARTED|Period 2||8
6704565|NCT02884089|7635213|FG000|COMPLETED|Period 2||8
6704566|NCT02884089|7635214|FG001|COMPLETED|Period 2||7
6704567|NCT02884089|7635215|FG002|COMPLETED|Period 2||9
6704568|NCT02884089|7635216|FG003|COMPLETED|Period 2||8
6704569|NCT02884089|7635213|FG000|NOT COMPLETED|Period 2||1
6704570|NCT02884089|7635214|FG001|NOT COMPLETED|Period 2||0
6704571|NCT02884089|7635215|FG002|NOT COMPLETED|Period 2||0
6704572|NCT02884089|7635216|FG003|NOT COMPLETED|Period 2||0
6704573|NCT02884089|7635213|FG000|STARTED|Washout Period 2||8
6704574|NCT02884089|7635214|FG001|STARTED|Washout Period 2||7
6704575|NCT02884089|7635215|FG002|STARTED|Washout Period 2||9
6704576|NCT02884089|7635216|FG003|STARTED|Washout Period 2||8
6704577|NCT02884089|7635213|FG000|COMPLETED|Washout Period 2||8
6704578|NCT02884089|7635214|FG001|COMPLETED|Washout Period 2||7
6704579|NCT02884089|7635215|FG002|COMPLETED|Washout Period 2||9
6704580|NCT02884089|7635216|FG003|COMPLETED|Washout Period 2||8
6704581|NCT02884089|7635213|FG000|NOT COMPLETED|Washout Period 2||0
6704582|NCT02884089|7635214|FG001|NOT COMPLETED|Washout Period 2||0
6704583|NCT02884089|7635215|FG002|NOT COMPLETED|Washout Period 2||0
6704584|NCT02884089|7635216|FG003|NOT COMPLETED|Washout Period 2||0
6704585|NCT02884089|7635213|FG000|STARTED|Period 3||8
6704586|NCT02884089|7635214|FG001|STARTED|Period 3||7
6704587|NCT02884089|7635215|FG002|STARTED|Period 3||9
6704588|NCT02884089|7635216|FG003|STARTED|Period 3||8
6704589|NCT02884089|7635213|FG000|COMPLETED|Period 3||8
6704590|NCT02884089|7635214|FG001|COMPLETED|Period 3||7
6704591|NCT02884089|7635215|FG002|COMPLETED|Period 3||8
6704592|NCT02884089|7635216|FG003|COMPLETED|Period 3||8
6704593|NCT02884089|7635213|FG000|NOT COMPLETED|Period 3||0
6704594|NCT02884089|7635214|FG001|NOT COMPLETED|Period 3||0
6704595|NCT02884089|7635215|FG002|NOT COMPLETED|Period 3||1
6704596|NCT02884089|7635216|FG003|NOT COMPLETED|Period 3||0
6704597|NCT02884089|7635213|FG000|STARTED|Washout Period 3||8
6704598|NCT02884089|7635214|FG001|STARTED|Washout Period 3||7
6704599|NCT02884089|7635215|FG002|STARTED|Washout Period 3||8
6704600|NCT02884089|7635216|FG003|STARTED|Washout Period 3||8
6704601|NCT02884089|7635213|FG000|COMPLETED|Washout Period 3||8
6704602|NCT02884089|7635214|FG001|COMPLETED|Washout Period 3||7
6704603|NCT02884089|7635215|FG002|COMPLETED|Washout Period 3||7
6704604|NCT02884089|7635216|FG003|COMPLETED|Washout Period 3||7
6704605|NCT02884089|7635213|FG000|NOT COMPLETED|Washout Period 3||0
6704606|NCT02884089|7635214|FG001|NOT COMPLETED|Washout Period 3||0
6704607|NCT02884089|7635215|FG002|NOT COMPLETED|Washout Period 3||1
6704608|NCT02884089|7635216|FG003|NOT COMPLETED|Washout Period 3||1
6704609|NCT02884089|7635213|FG000|STARTED|Period 4||8
6704610|NCT02884089|7635214|FG001|STARTED|Period 4||7
6704611|NCT02884089|7635215|FG002|STARTED|Period 4||7
6704612|NCT02884089|7635216|FG003|STARTED|Period 4||7
6704613|NCT02884089|7635213|FG000|COMPLETED|Period 4||7
6704614|NCT02884089|7635214|FG001|COMPLETED|Period 4||6
6704615|NCT02884089|7635215|FG002|COMPLETED|Period 4||7
6704616|NCT02884089|7635216|FG003|COMPLETED|Period 4||7
6704617|NCT02884089|7635213|FG000|NOT COMPLETED|Period 4||1
6704618|NCT02884089|7635214|FG001|NOT COMPLETED|Period 4||1
6704619|NCT02884089|7635215|FG002|NOT COMPLETED|Period 4||0
6704620|NCT02884089|7635216|FG003|NOT COMPLETED|Period 4||0
6704621|NCT02884089|7635213|FG000|STARTED|Follow-up Visit||7
6704622|NCT02884089|7635214|FG001|STARTED|Follow-up Visit||6
6704623|NCT02884089|7635215|FG002|STARTED|Follow-up Visit||7
6704624|NCT02884089|7635216|FG003|STARTED|Follow-up Visit||7
6704625|NCT02884089|7635213|FG000|COMPLETED|Follow-up Visit||6
6704626|NCT02884089|7635214|FG001|COMPLETED|Follow-up Visit||6
6704627|NCT02884089|7635215|FG002|COMPLETED|Follow-up Visit||7
6704628|NCT02884089|7635216|FG003|COMPLETED|Follow-up Visit||6
6704629|NCT02884089|7635213|FG000|NOT COMPLETED|Follow-up Visit||1
6704630|NCT02884089|7635214|FG001|NOT COMPLETED|Follow-up Visit||0
6704631|NCT02884089|7635215|FG002|NOT COMPLETED|Follow-up Visit||0
6704632|NCT02884089|7635216|FG003|NOT COMPLETED|Follow-up Visit||1
6704633|NCT02884414|7635226|FG000|STARTED|Overall Study||56
6704634|NCT02884414|7635226|FG000|COMPLETED|Overall Study||56
6704635|NCT02884414|7635226|FG000|NOT COMPLETED|Overall Study||0
6704636|NCT02884427|7635233|FG000|STARTED|Overall Study||48
6704637|NCT02884427|7635234|FG001|STARTED|Overall Study||52
6704638|NCT02884427|7635235|FG002|STARTED|Overall Study||50
6704639|NCT02884427|7635233|FG000|COMPLETED|Overall Study||48
6704640|NCT02884427|7635234|FG001|COMPLETED|Overall Study||52
6704641|NCT02884427|7635235|FG002|COMPLETED|Overall Study||50
6704642|NCT02884427|7635233|FG000|NOT COMPLETED|Overall Study||0
6704643|NCT02884427|7635234|FG001|NOT COMPLETED|Overall Study||0
6704644|NCT02884427|7635235|FG002|NOT COMPLETED|Overall Study||0
6704645|NCT02884492|7635245|FG000|STARTED|Overall Study||7
6704646|NCT02884492|7635246|FG001|STARTED|Overall Study||10
6704647|NCT02884492|7635245|FG000|COMPLETED|Overall Study||7
6704648|NCT02884492|7635246|FG001|COMPLETED|Overall Study||10
6704649|NCT02884492|7635245|FG000|NOT COMPLETED|Overall Study||0
6704650|NCT02884492|7635246|FG001|NOT COMPLETED|Overall Study||0
6704651|NCT02885012|7635254|FG000|STARTED|Overall Study||1
6704652|NCT02885012|7635255|FG001|STARTED|Overall Study||2
6704653|NCT02885012|7635254|FG000|COMPLETED|Overall Study||1
6704654|NCT02885012|7635255|FG001|COMPLETED|Overall Study||2
6704655|NCT02885012|7635254|FG000|NOT COMPLETED|Overall Study||0
6704656|NCT02885012|7635255|FG001|NOT COMPLETED|Overall Study||0
6704657|NCT02885025|7635265|FG000|STARTED|Overall Study||16
6704658|NCT02885025|7635266|FG001|STARTED|Overall Study||14
6704659|NCT02885025|7635267|FG002|STARTED|Overall Study||9
6704660|NCT02885025|7635268|FG003|STARTED|Overall Study||8
6704661|NCT02885025|7635265|FG000|COMPLETED|Overall Study||16
6704662|NCT02885025|7635266|FG001|COMPLETED|Overall Study||12
6704663|NCT02885025|7635267|FG002|COMPLETED|Overall Study||9
6704664|NCT02885025|7635268|FG003|COMPLETED|Overall Study||8
6704665|NCT02885025|7635265|FG000|NOT COMPLETED|Overall Study||0
6704666|NCT02885025|7635266|FG001|NOT COMPLETED|Overall Study||2
6704667|NCT02885025|7635267|FG002|NOT COMPLETED|Overall Study||0
6704668|NCT02885025|7635268|FG003|NOT COMPLETED|Overall Study||0
6704669|NCT02885181|7635286|FG000|STARTED|Overall Study||20
6704670|NCT02885181|7635287|FG001|STARTED|Overall Study||20
6704671|NCT02885181|7635288|FG002|STARTED|Overall Study||21
6704672|NCT02885181|7635289|FG003|STARTED|Overall Study||22
6704673|NCT02885181|7635286|FG000|COMPLETED|Overall Study||20
6704674|NCT02885181|7635287|FG001|COMPLETED|Overall Study||19
6704675|NCT02885181|7635288|FG002|COMPLETED|Overall Study||21
6704676|NCT02885181|7635289|FG003|COMPLETED|Overall Study||19
6704677|NCT02885181|7635286|FG000|NOT COMPLETED|Overall Study||0
6704678|NCT02885181|7635287|FG001|NOT COMPLETED|Overall Study||1
6704679|NCT02885181|7635288|FG002|NOT COMPLETED|Overall Study||0
6704680|NCT02885181|7635289|FG003|NOT COMPLETED|Overall Study||3
6704681|NCT02885246|7635303|FG000|STARTED|Overall Study||1839
6704682|NCT02885246|7635303|FG000|COMPLETED|Overall Study||1839
6704683|NCT02885246|7635303|FG000|NOT COMPLETED|Overall Study||0
6704684|NCT02885350|7635311|FG000|STARTED|Overall Study||20
6704685|NCT02885350|7635312|FG001|STARTED|Overall Study||20
6704686|NCT02885350|7635313|FG002|STARTED|Overall Study||20
6704687|NCT02885350|7635314|FG003|STARTED|Overall Study||20
6704688|NCT02885350|7635311|FG000|COMPLETED|Overall Study||20
6704689|NCT02885350|7635312|FG001|COMPLETED|Overall Study||20
6704690|NCT02885350|7635313|FG002|COMPLETED|Overall Study||20
6704691|NCT02885350|7635314|FG003|COMPLETED|Overall Study||20
6704692|NCT02885350|7635311|FG000|NOT COMPLETED|Overall Study||0
6704693|NCT02885350|7635312|FG001|NOT COMPLETED|Overall Study||0
6704694|NCT02885350|7635313|FG002|NOT COMPLETED|Overall Study||0
6704695|NCT02885350|7635314|FG003|NOT COMPLETED|Overall Study||0
6739103|NCT03286751|7668066|FG005|STARTED|Period 1||7
6739104|NCT03286751|7668061|FG000|Received at Least One Dose of Study Drug|Period 1||7
6739105|NCT03286751|7668062|FG001|Received at Least One Dose of Study Drug|Period 1||7
6739106|NCT03286751|7668063|FG002|Received at Least One Dose of Study Drug|Period 1||7
6739107|NCT03286751|7668064|FG003|Received at Least One Dose of Study Drug|Period 1||7
6739108|NCT03286751|7668065|FG004|Received at Least One Dose of Study Drug|Period 1||7
6739109|NCT03286751|7668066|FG005|Received at Least One Dose of Study Drug|Period 1||7
6739110|NCT03286751|7668061|FG000|COMPLETED|Period 1||7
6704696|NCT02885506|7635334|FG000|STARTED|Part A||6
6704697|NCT02885506|7635335|FG001|STARTED|Part A||6
6704698|NCT02885506|7635336|FG002|STARTED|Part A||6
6704699|NCT02885506|7635337|FG003|STARTED|Part A||6
6704700|NCT02885506|7635338|FG004|STARTED|Part A||6
6704701|NCT02885506|7635339|FG005|STARTED|Part A||6
6704702|NCT02885506|7635340|FG006|STARTED|Part A||6
6704703|NCT02885506|7635341|FG007|STARTED|Part A||14
6704704|NCT02885506|7635342|FG008|STARTED|Part A||0
6704705|NCT02885506|7635343|FG009|STARTED|Part A||0
6704706|NCT02885506|7635334|FG000|COMPLETED|Part A||6
6704707|NCT02885506|7635335|FG001|COMPLETED|Part A||6
6704708|NCT02885506|7635336|FG002|COMPLETED|Part A||6
6704709|NCT02885506|7635337|FG003|COMPLETED|Part A||6
6704710|NCT02885506|7635338|FG004|COMPLETED|Part A||6
6704711|NCT02885506|7635339|FG005|COMPLETED|Part A||6
6704712|NCT02885506|7635340|FG006|COMPLETED|Part A||6
6704713|NCT02885506|7635341|FG007|COMPLETED|Part A||14
6704714|NCT02885506|7635342|FG008|COMPLETED|Part A||0
6704715|NCT02885506|7635343|FG009|COMPLETED|Part A||0
6704716|NCT02885506|7635334|FG000|NOT COMPLETED|Part A||0
6704717|NCT02885506|7635335|FG001|NOT COMPLETED|Part A||0
6704718|NCT02885506|7635336|FG002|NOT COMPLETED|Part A||0
6704719|NCT02885506|7635337|FG003|NOT COMPLETED|Part A||0
6704720|NCT02885506|7635338|FG004|NOT COMPLETED|Part A||0
6704721|NCT02885506|7635339|FG005|NOT COMPLETED|Part A||0
6704722|NCT02885506|7635340|FG006|NOT COMPLETED|Part A||0
6704723|NCT02885506|7635341|FG007|NOT COMPLETED|Part A||0
6704724|NCT02885506|7635342|FG008|NOT COMPLETED|Part A||0
6704725|NCT02885506|7635343|FG009|NOT COMPLETED|Part A||0
6704726|NCT02885506|7635334|FG000|STARTED|Part B||0
6704727|NCT02885506|7635335|FG001|STARTED|Part B||0
6704728|NCT02885506|7635336|FG002|STARTED|Part B||0
6704729|NCT02885506|7635337|FG003|STARTED|Part B||0
6704730|NCT02885506|7635338|FG004|STARTED|Part B||0
6704731|NCT02885506|7635339|FG005|STARTED|Part B||0
6704732|NCT02885506|7635340|FG006|STARTED|Part B||0
6704733|NCT02885506|7635341|FG007|STARTED|Part B||0
6704734|NCT02885506|7635342|FG008|STARTED|Part B||4
6704735|NCT02885506|7635343|FG009|STARTED|Part B||4
6704736|NCT02885506|7635334|FG000|COMPLETED|Part B||0
6704737|NCT02885506|7635335|FG001|COMPLETED|Part B||0
6704738|NCT02885506|7635336|FG002|COMPLETED|Part B||0
6704739|NCT02885506|7635337|FG003|COMPLETED|Part B||0
6704740|NCT02885506|7635338|FG004|COMPLETED|Part B||0
6704741|NCT02885506|7635339|FG005|COMPLETED|Part B||0
6704742|NCT02885506|7635340|FG006|COMPLETED|Part B||0
6704743|NCT02885506|7635341|FG007|COMPLETED|Part B||0
6704744|NCT02885506|7635342|FG008|COMPLETED|Part B||4
6704745|NCT02885506|7635343|FG009|COMPLETED|Part B||4
6704746|NCT02885506|7635334|FG000|NOT COMPLETED|Part B||0
6704747|NCT02885506|7635335|FG001|NOT COMPLETED|Part B||0
6704748|NCT02885506|7635336|FG002|NOT COMPLETED|Part B||0
6704749|NCT02885506|7635337|FG003|NOT COMPLETED|Part B||0
6704750|NCT02885506|7635338|FG004|NOT COMPLETED|Part B||0
6704751|NCT02885506|7635339|FG005|NOT COMPLETED|Part B||0
6704752|NCT02885506|7635340|FG006|NOT COMPLETED|Part B||0
6704753|NCT02885506|7635341|FG007|NOT COMPLETED|Part B||0
6704754|NCT02885506|7635342|FG008|NOT COMPLETED|Part B||0
6704755|NCT02885506|7635343|FG009|NOT COMPLETED|Part B||0
6704756|NCT02885636|7635369|FG000|STARTED|Overall Study||15
6704757|NCT02885636|7635370|FG001|STARTED|Overall Study||15
6704758|NCT02885636|7635369|FG000|COMPLETED|Overall Study||15
6704759|NCT02885636|7635370|FG001|COMPLETED|Overall Study||15
6704760|NCT02885636|7635369|FG000|NOT COMPLETED|Overall Study||0
6704761|NCT02885636|7635370|FG001|NOT COMPLETED|Overall Study||0
6704762|NCT02886234|7635378|FG000|STARTED|Overall Study||20
6704763|NCT02886234|7635379|FG001|STARTED|Overall Study||24
6704764|NCT02886234|7635378|FG000|COMPLETED|Overall Study||20
6704765|NCT02886234|7635379|FG001|COMPLETED|Overall Study||22
6704766|NCT02886234|7635378|FG000|NOT COMPLETED|Overall Study||0
6704767|NCT02886234|7635379|FG001|NOT COMPLETED|Overall Study||2
6704768|NCT02886338|7635385|FG000|STARTED|Overall Study||10
6704769|NCT02886338|7635385|FG000|COMPLETED|Overall Study||9
6704770|NCT02886338|7635385|FG000|NOT COMPLETED|Overall Study||1
6704771|NCT02886494|7635391|FG000|STARTED|Overall Study||60
6704772|NCT02886494|7635392|FG001|STARTED|Overall Study||20
6704773|NCT02886494|7635391|FG000|COMPLETED|Overall Study||43
6704774|NCT02886494|7635392|FG001|COMPLETED|Overall Study||16
6704775|NCT02886494|7635391|FG000|NOT COMPLETED|Overall Study||17
6704776|NCT02886494|7635392|FG001|NOT COMPLETED|Overall Study||4
6704777|NCT02886624|7635401|FG000|STARTED|8-week Treatment||30
6704778|NCT02886624|7635401|FG000|COMPLETED|8-week Treatment||30
6704779|NCT02886624|7635401|FG000|NOT COMPLETED|8-week Treatment||0
6704780|NCT02886624|7635401|FG000|STARTED|12-week Post Treatment Follow-up||30
6704781|NCT02886624|7635401|FG000|COMPLETED|12-week Post Treatment Follow-up||29
6704782|NCT02886624|7635401|FG000|NOT COMPLETED|12-week Post Treatment Follow-up||1
6704783|NCT02886624|7635401|FG000|STARTED|48-week Post Treatment Follow-up||29
6704784|NCT02886624|7635401|FG000|COMPLETED|48-week Post Treatment Follow-up||28
6704785|NCT02886624|7635401|FG000|NOT COMPLETED|48-week Post Treatment Follow-up||1
6704786|NCT02886702|7635408|FG000|STARTED|Overall Study||284
6704787|NCT02886702|7635409|FG001|STARTED|Overall Study||286
6704788|NCT02886702|7635410|FG002|STARTED|Overall Study||285
6704789|NCT02886702|7635408|FG000|Modified Intent-to Treat (mITT)|Overall Study||263
6704790|NCT02886702|7635409|FG001|Modified Intent-to Treat (mITT)|Overall Study||266
6704791|NCT02886702|7635410|FG002|Modified Intent-to Treat (mITT)|Overall Study||275
6704792|NCT02886702|7635408|FG000|Per-Protocol Population (PP)|Overall Study||208
6704793|NCT02886702|7635409|FG001|Per-Protocol Population (PP)|Overall Study||209
6704794|NCT02886702|7635410|FG002|Per-Protocol Population (PP)|Overall Study||201
6704795|NCT02886702|7635408|FG000|COMPLETED|Overall Study||236
6704796|NCT02886702|7635409|FG001|COMPLETED|Overall Study||235
6704797|NCT02886702|7635410|FG002|COMPLETED|Overall Study||232
6704798|NCT02886702|7635408|FG000|NOT COMPLETED|Overall Study||48
6704799|NCT02886702|7635409|FG001|NOT COMPLETED|Overall Study||51
6704800|NCT02886702|7635410|FG002|NOT COMPLETED|Overall Study||53
6704801|NCT02886715|7635421|FG000|STARTED|Overall Study||442
6704802|NCT02886715|7635422|FG001|STARTED|Overall Study||445
6704803|NCT02886715|7635423|FG002|STARTED|Overall Study||223
6704804|NCT02886715|7635421|FG000|Modified ITT (mITT)|Overall Study||421
6704805|NCT02886715|7635422|FG001|Modified ITT (mITT)|Overall Study||418
6704806|NCT02886715|7635423|FG002|Modified ITT (mITT)|Overall Study||217
6704807|NCT02886715|7635421|FG000|Per Protocol (PP) Population|Overall Study||346
6704808|NCT02886715|7635422|FG001|Per Protocol (PP) Population|Overall Study||351
6704809|NCT02886715|7635423|FG002|Per Protocol (PP) Population|Overall Study||176
6704810|NCT02886715|7635421|FG000|COMPLETED|Overall Study||378
6704811|NCT02886715|7635422|FG001|COMPLETED|Overall Study||390
6704812|NCT02886715|7635423|FG002|COMPLETED|Overall Study||203
6704813|NCT02886715|7635421|FG000|NOT COMPLETED|Overall Study||64
6704814|NCT02886715|7635422|FG001|NOT COMPLETED|Overall Study||55
6704815|NCT02886715|7635423|FG002|NOT COMPLETED|Overall Study||20
6704816|NCT02886728|7635435|FG000|STARTED|Overall Study||417
6704817|NCT02886728|7635436|FG001|STARTED|Overall Study||207
6704818|NCT02886728|7635437|FG002|STARTED|Overall Study||210
6704819|NCT02886728|7635438|FG003|STARTED|Overall Study||418
6704820|NCT02886728|7635435|FG000|COMPLETED|Overall Study||345
6704821|NCT02886728|7635436|FG001|COMPLETED|Overall Study||175
6704822|NCT02886728|7635437|FG002|COMPLETED|Overall Study||174
6704823|NCT02886728|7635438|FG003|COMPLETED|Overall Study||331
6704824|NCT02886728|7635435|FG000|NOT COMPLETED|Overall Study||72
6704825|NCT02886728|7635436|FG001|NOT COMPLETED|Overall Study||32
6704826|NCT02886728|7635437|FG002|NOT COMPLETED|Overall Study||36
6704827|NCT02886728|7635438|FG003|NOT COMPLETED|Overall Study||87
6704828|NCT02886923|7635448|FG000|STARTED|Period 1||12
6704829|NCT02886923|7635449|FG001|STARTED|Period 1||11
6704830|NCT02886923|7635448|FG000|COMPLETED|Period 1||12
6704831|NCT02886923|7635449|FG001|COMPLETED|Period 1||11
6704832|NCT02886923|7635448|FG000|NOT COMPLETED|Period 1||0
6704833|NCT02886923|7635449|FG001|NOT COMPLETED|Period 1||0
6704834|NCT02886923|7635448|FG000|STARTED|Period 2||12
6704835|NCT02886923|7635449|FG001|STARTED|Period 2||11
6704836|NCT02886923|7635448|FG000|COMPLETED|Period 2||12
6704837|NCT02886923|7635449|FG001|COMPLETED|Period 2||11
6704838|NCT02886923|7635448|FG000|NOT COMPLETED|Period 2||0
6704839|NCT02886923|7635449|FG001|NOT COMPLETED|Period 2||0
6704840|NCT02887183|7635455|FG000|STARTED|Overall Study||795
6704841|NCT02887183|7635455|FG000|Full Analysis Set|Overall Study||794
6704842|NCT02887183|7635455|FG000|COMPLETED|Overall Study||654
6704843|NCT02887183|7635455|FG000|NOT COMPLETED|Overall Study||141
6704844|NCT02887404|7635461|FG000|STARTED|Overall Study||150
6704845|NCT02887404|7635462|FG001|STARTED|Overall Study||149
6704846|NCT02887404|7635461|FG000|COMPLETED|Overall Study||150
6704847|NCT02887404|7635462|FG001|COMPLETED|Overall Study||149
6704848|NCT02887404|7635461|FG000|NOT COMPLETED|Overall Study||0
6704849|NCT02887404|7635462|FG001|NOT COMPLETED|Overall Study||0
6704850|NCT02887521|7635471|FG000|STARTED|Overall Study||4
6704851|NCT02887521|7635472|FG001|STARTED|Overall Study||5
6704852|NCT02887521|7635471|FG000|COMPLETED|Overall Study||4
6704853|NCT02887521|7635472|FG001|COMPLETED|Overall Study||2
6704854|NCT02887521|7635471|FG000|NOT COMPLETED|Overall Study||0
6704855|NCT02887521|7635472|FG001|NOT COMPLETED|Overall Study||3
6704856|NCT02887989|7635480|FG000|STARTED|Overall Study||70
6704857|NCT02887989|7635481|FG001|STARTED|Overall Study||70
6704858|NCT02887989|7635480|FG000|COMPLETED|Overall Study||61
6704859|NCT02887989|7635481|FG001|COMPLETED|Overall Study||59
6704860|NCT02887989|7635480|FG000|NOT COMPLETED|Overall Study||9
6704861|NCT02887989|7635481|FG001|NOT COMPLETED|Overall Study||11
6704862|NCT02888080|7635489|FG000|STARTED|Overall Study||20
6704863|NCT02888080|7635490|FG001|STARTED|Overall Study||20
6704864|NCT02888080|7635489|FG000|COMPLETED|Overall Study||18
6704865|NCT02888080|7635490|FG001|COMPLETED|Overall Study||15
6704866|NCT02888080|7635489|FG000|NOT COMPLETED|Overall Study||2
6704867|NCT02888080|7635490|FG001|NOT COMPLETED|Overall Study||5
6704868|NCT02888093|7635498|FG000|STARTED|Overall Study||22
6704869|NCT02888093|7635499|FG001|STARTED|Overall Study||22
6704870|NCT02888093|7635498|FG000|COMPLETED|Overall Study||20
6704871|NCT02888093|7635499|FG001|COMPLETED|Overall Study||20
6704872|NCT02888093|7635498|FG000|NOT COMPLETED|Overall Study||2
6704873|NCT02888093|7635499|FG001|NOT COMPLETED|Overall Study||2
6704874|NCT02888106|7635513|FG000|STARTED|Overall Study||15
6704875|NCT02888106|7635514|FG001|STARTED|Overall Study||15
6704876|NCT02888106|7635515|FG002|STARTED|Overall Study||15
6704877|NCT02888106|7635516|FG003|STARTED|Overall Study||15
6704878|NCT02888106|7635517|FG004|STARTED|Overall Study||15
6704879|NCT02888106|7635518|FG005|STARTED|Overall Study||15
6704880|NCT02888106|7635513|FG000|COMPLETED|Overall Study||10
6704881|NCT02888106|7635514|FG001|COMPLETED|Overall Study||13
6704882|NCT02888106|7635515|FG002|COMPLETED|Overall Study||15
6704883|NCT02888106|7635516|FG003|COMPLETED|Overall Study||13
6704884|NCT02888106|7635517|FG004|COMPLETED|Overall Study||14
6704885|NCT02888106|7635518|FG005|COMPLETED|Overall Study||14
6704886|NCT02888106|7635513|FG000|NOT COMPLETED|Overall Study||5
6704887|NCT02888106|7635514|FG001|NOT COMPLETED|Overall Study||2
6704888|NCT02888106|7635515|FG002|NOT COMPLETED|Overall Study||0
6704889|NCT02888106|7635516|FG003|NOT COMPLETED|Overall Study||2
6704890|NCT02888106|7635517|FG004|NOT COMPLETED|Overall Study||1
6704891|NCT02888106|7635518|FG005|NOT COMPLETED|Overall Study||1
6704892|NCT02888171|7635540|FG000|STARTED|Overall Study||30
6704893|NCT02888171|7635541|FG001|STARTED|Overall Study||30
6704894|NCT02888171|7635540|FG000|COMPLETED|Overall Study||25
6704895|NCT02888171|7635541|FG001|COMPLETED|Overall Study||26
6704896|NCT02888171|7635540|FG000|NOT COMPLETED|Overall Study||5
6704897|NCT02888171|7635541|FG001|NOT COMPLETED|Overall Study||4
6704898|NCT02888665|7635550|FG000|STARTED|Overall Study||3
6704899|NCT02888665|7635551|FG001|STARTED|Overall Study||3
6704900|NCT02888665|7635552|FG002|STARTED|Overall Study||31
6704901|NCT02888665|7635550|FG000|COMPLETED|Overall Study||3
6704902|NCT02888665|7635551|FG001|COMPLETED|Overall Study||3
6704903|NCT02888665|7635552|FG002|COMPLETED|Overall Study||31
6704904|NCT02888665|7635550|FG000|NOT COMPLETED|Overall Study||0
6704905|NCT02888665|7635551|FG001|NOT COMPLETED|Overall Study||0
6704906|NCT02888665|7635552|FG002|NOT COMPLETED|Overall Study||0
6704907|NCT02888691|7635561|FG000|STARTED|First Intervention Period||7
6704908|NCT02888691|7635562|FG001|STARTED|First Intervention Period||7
6704909|NCT02888691|7635561|FG000|COMPLETED|First Intervention Period||6
6704910|NCT02888691|7635562|FG001|COMPLETED|First Intervention Period||7
6704911|NCT02888691|7635561|FG000|NOT COMPLETED|First Intervention Period||1
6704912|NCT02888691|7635562|FG001|NOT COMPLETED|First Intervention Period||0
6704913|NCT02888691|7635561|FG000|STARTED|Second Intervention Period|This is a cross-over study. Therefore starters does not necessarily equal completers of period 1.|7
6704914|NCT02888691|7635562|FG001|STARTED|Second Intervention Period||5
6704915|NCT02888691|7635561|FG000|COMPLETED|Second Intervention Period||7
6704916|NCT02888691|7635562|FG001|COMPLETED|Second Intervention Period||3
6704917|NCT02888691|7635561|FG000|NOT COMPLETED|Second Intervention Period||0
6704918|NCT02888691|7635562|FG001|NOT COMPLETED|Second Intervention Period||2
6704919|NCT02888756|7635571|FG000|STARTED|Vaccination Period||16
6704920|NCT02888756|7635572|FG001|STARTED|Vaccination Period||9
6704921|NCT02888756|7635573|FG002|STARTED|Vaccination Period||8
6704922|NCT02888756|7635571|FG000|COMPLETED|Vaccination Period||16
6704923|NCT02888756|7635572|FG001|COMPLETED|Vaccination Period||9
6704924|NCT02888756|7635573|FG002|COMPLETED|Vaccination Period||8
6704925|NCT02888756|7635571|FG000|NOT COMPLETED|Vaccination Period||0
6704926|NCT02888756|7635572|FG001|NOT COMPLETED|Vaccination Period||0
6704927|NCT02888756|7635573|FG002|NOT COMPLETED|Vaccination Period||0
6704928|NCT02888756|7635571|FG000|STARTED|Analytical Treatment Interruption||15
6704929|NCT02888756|7635572|FG001|STARTED|Analytical Treatment Interruption||9
6704930|NCT02888756|7635573|FG002|STARTED|Analytical Treatment Interruption||8
6704931|NCT02888756|7635571|FG000|COMPLETED|Analytical Treatment Interruption||5
6704932|NCT02888756|7635572|FG001|COMPLETED|Analytical Treatment Interruption||3
6704933|NCT02888756|7635573|FG002|COMPLETED|Analytical Treatment Interruption||3
6704934|NCT02888756|7635571|FG000|NOT COMPLETED|Analytical Treatment Interruption||10
6704935|NCT02888756|7635572|FG001|NOT COMPLETED|Analytical Treatment Interruption||6
6704936|NCT02888756|7635573|FG002|NOT COMPLETED|Analytical Treatment Interruption||5
6704937|NCT02889289|7635581|FG000|STARTED|Overall Study||1
6704938|NCT02889289|7635581|FG000|COMPLETED|Overall Study||1
6704939|NCT02889289|7635581|FG000|NOT COMPLETED|Overall Study||0
6704940|NCT02889393|7635587|FG000|STARTED|Overall Study||3
6704941|NCT02889393|7635588|FG001|STARTED|Overall Study||3
6704942|NCT02889393|7635587|FG000|COMPLETED|Overall Study||3
6704943|NCT02889393|7635588|FG001|COMPLETED|Overall Study||3
6704944|NCT02889393|7635587|FG000|NOT COMPLETED|Overall Study||0
6704945|NCT02889393|7635588|FG001|NOT COMPLETED|Overall Study||0
6704946|NCT02889510|7635595|FG000|STARTED|Overall Study||35
6704947|NCT02889510|7635596|FG001|STARTED|Overall Study||37
6704948|NCT02889510|7635595|FG000|COMPLETED|Overall Study||27
6704949|NCT02889510|7635596|FG001|COMPLETED|Overall Study||32
6704950|NCT02889510|7635595|FG000|NOT COMPLETED|Overall Study||8
6704951|NCT02889510|7635596|FG001|NOT COMPLETED|Overall Study||5
6704952|NCT02889562|7635604|FG000|STARTED|Overall Study||28
6704953|NCT02889562|7635605|FG001|STARTED|Overall Study||28
6704954|NCT02889562|7635604|FG000|COMPLETED|Overall Study||28
6704955|NCT02889562|7635605|FG001|COMPLETED|Overall Study||26
6704956|NCT02889562|7635604|FG000|NOT COMPLETED|Overall Study||0
6704957|NCT02889562|7635605|FG001|NOT COMPLETED|Overall Study||2
6704958|NCT02889796|7635615|FG000|STARTED|Overall Study||477
6704959|NCT02889796|7635616|FG001|STARTED|Overall Study||480
6704960|NCT02889796|7635617|FG002|STARTED|Overall Study||325
6704961|NCT02889796|7635618|FG003|STARTED|Overall Study||190
6704962|NCT02889796|7635619|FG004|STARTED|Overall Study||191
6704963|NCT02889796|7635620|FG005|STARTED|Overall Study||96
6704964|NCT02889796|7635615|FG000|COMPLETED|Overall Study||424
6704965|NCT02889796|7635616|FG001|COMPLETED|Overall Study||422
6704966|NCT02889796|7635617|FG002|COMPLETED|Overall Study||281
6704967|NCT02889796|7635618|FG003|COMPLETED|Overall Study||181
6704968|NCT02889796|7635619|FG004|COMPLETED|Overall Study||185
6704969|NCT02889796|7635620|FG005|COMPLETED|Overall Study|Completed 24 weeks of placebo treatment and not rerandomized to Filgotinib 200 mg or 100 mg groups|24
6704970|NCT02889796|7635615|FG000|NOT COMPLETED|Overall Study||53
6704971|NCT02889796|7635616|FG001|NOT COMPLETED|Overall Study||58
6704972|NCT02889796|7635617|FG002|NOT COMPLETED|Overall Study||44
6704973|NCT02889796|7635618|FG003|NOT COMPLETED|Overall Study||9
6704974|NCT02889796|7635619|FG004|NOT COMPLETED|Overall Study||6
6704975|NCT02889796|7635620|FG005|NOT COMPLETED|Overall Study||72
6260810|NCT03799198|7159594|FG001|STARTED|Overall Study||100
6260811|NCT03799198|7159593|FG000|Full Analysis Set (FAS)|Overall Study||100
6260812|NCT03799198|7159594|FG001|Full Analysis Set (FAS)|Overall Study||100
6260813|NCT03799198|7159593|FG000|COMPLETED|Overall Study||96
6260814|NCT03799198|7159594|FG001|COMPLETED|Overall Study||91
6260815|NCT03799198|7159593|FG000|NOT COMPLETED|Overall Study||4
6260816|NCT03799198|7159594|FG001|NOT COMPLETED|Overall Study||9
6260817|NCT03770728|7159604|FG000|STARTED|Overall Study||79
6260818|NCT03770728|7159605|FG001|STARTED|Overall Study||78
6260819|NCT03770728|7159606|FG002|STARTED|Overall Study||77
6260820|NCT03770728|7159607|FG003|STARTED|Overall Study||78
6260821|NCT03770728|7159604|FG000|Safety Population|Overall Study||79
6260822|NCT03770728|7159605|FG001|Safety Population|Overall Study||78
6260823|NCT03770728|7159606|FG002|Safety Population|Overall Study|For safety analysis, participants were included in the treatment group that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg group for safety analysis.|80
6260824|NCT03770728|7159607|FG003|Safety Population|Overall Study||75
6260825|NCT03770728|7159604|FG000|COMPLETED|Overall Study||41
6704976|NCT02889861|7635643|FG000|STARTED|Overall Study||3
6704977|NCT02889861|7635643|FG000|COMPLETED|Overall Study||1
6704978|NCT02889861|7635643|FG000|NOT COMPLETED|Overall Study||2
6704979|NCT02890303|7635652|FG000|STARTED|Overall Study||100
6704980|NCT02890303|7635652|FG000|COMPLETED|Overall Study||100
6704981|NCT02890303|7635652|FG000|NOT COMPLETED|Overall Study||0
6704982|NCT02890381|7635658|FG000|STARTED|Overall Study||11
6704983|NCT02890381|7635659|FG001|STARTED|Overall Study||6
6704984|NCT02890381|7635658|FG000|COMPLETED|Overall Study||11
6704985|NCT02890381|7635659|FG001|COMPLETED|Overall Study||6
6704986|NCT02890381|7635658|FG000|NOT COMPLETED|Overall Study||0
6704987|NCT02890381|7635659|FG001|NOT COMPLETED|Overall Study||0
6704988|NCT02890992|7635673|FG000|STARTED|12 Weeks Open-Label Dose Finding Period||4
6704989|NCT02890992|7635674|FG001|STARTED|12 Weeks Open-Label Dose Finding Period||6
6704990|NCT02890992|7635675|FG002|STARTED|12 Weeks Open-Label Dose Finding Period||4
6704991|NCT02890992|7635676|FG003|STARTED|12 Weeks Open-Label Dose Finding Period||6
6704992|NCT02890992|7635677|FG004|STARTED|12 Weeks Open-Label Dose Finding Period||6
6260826|NCT03770728|7159605|FG001|COMPLETED|Overall Study||47
6260827|NCT03770728|7159606|FG002|COMPLETED|Overall Study||45
6260828|NCT03770728|7159607|FG003|COMPLETED|Overall Study||43
6260829|NCT03770728|7159604|FG000|NOT COMPLETED|Overall Study||38
6260830|NCT03770728|7159605|FG001|NOT COMPLETED|Overall Study||31
6260831|NCT03770728|7159606|FG002|NOT COMPLETED|Overall Study||32
6260832|NCT03770728|7159607|FG003|NOT COMPLETED|Overall Study||35
6260833|NCT03760146|7159625|FG000|STARTED|Overall Study||1514
6260834|NCT03760146|7159626|FG001|STARTED|Overall Study||1495
6260835|NCT03760146|7159627|FG002|STARTED|Overall Study||334
6260836|NCT03760146|7159628|FG003|STARTED|Overall Study||111
6260837|NCT03760146|7159629|FG004|STARTED|Overall Study||336
6260838|NCT03760146|7159630|FG005|STARTED|Overall Study||112
6260839|NCT03760146|7159625|FG000|Evaluable 13-Matched Immunogenicity Population|Overall Study||1435
6260840|NCT03760146|7159626|FG001|Evaluable 13-Matched Immunogenicity Population|Overall Study||1420
6260841|NCT03760146|7159627|FG002|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
6260842|NCT03760146|7159628|FG003|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
6260843|NCT03760146|7159629|FG004|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
6260844|NCT03760146|7159630|FG005|Evaluable 13-Matched Immunogenicity Population|Overall Study||0
6260845|NCT03760146|7159625|FG000|Evaluable 7-Additional Immunogenicity Population|Overall Study||1433
6260846|NCT03760146|7159626|FG001|Evaluable 7-Additional Immunogenicity Population|Overall Study||1383
6260847|NCT03760146|7159627|FG002|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
6260848|NCT03760146|7159628|FG003|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
6260849|NCT03760146|7159629|FG004|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
6260850|NCT03760146|7159630|FG005|Evaluable 7-Additional Immunogenicity Population|Overall Study||0
6260851|NCT03760146|7159625|FG000|Vaccination 1|Overall Study||1507
6260852|NCT03760146|7159626|FG001|Vaccination 1|Overall Study||1490
6260853|NCT03760146|7159627|FG002|Vaccination 1|Overall Study||334
6260854|NCT03760146|7159628|FG003|Vaccination 1|Overall Study||111
6260855|NCT03760146|7159629|FG004|Vaccination 1|Overall Study||335
6260856|NCT03760146|7159630|FG005|Vaccination 1|Overall Study||112
6260857|NCT03760146|7159625|FG000|Vaccination 2|Overall Study||1461
6260858|NCT03760146|7159626|FG001|Vaccination 2|Overall Study||1446
6260859|NCT03760146|7159627|FG002|Vaccination 2|Overall Study||0
6260860|NCT03760146|7159628|FG003|Vaccination 2|Overall Study||0
6260861|NCT03760146|7159629|FG004|Vaccination 2|Overall Study||0
6260862|NCT03760146|7159630|FG005|Vaccination 2|Overall Study||0
6260863|NCT03760146|7159625|FG000|Safety Population|Overall Study||1507
6260864|NCT03760146|7159626|FG001|Safety Population|Overall Study||1490
6260865|NCT03760146|7159627|FG002|Safety Population|Overall Study||334
6260866|NCT03760146|7159628|FG003|Safety Population|Overall Study||111
6260867|NCT03760146|7159629|FG004|Safety Population|Overall Study||335
6260868|NCT03760146|7159630|FG005|Safety Population|Overall Study||112
6260869|NCT03760146|7159625|FG000|Evaluable-20 Immunogenicity Population|Overall Study|Only for 60-64 years of age.|946
6260870|NCT03760146|7159626|FG001|Evaluable-20 Immunogenicity Population|Overall Study||0
6260871|NCT03760146|7159627|FG002|Evaluable-20 Immunogenicity Population|Overall Study||321
6260872|NCT03760146|7159628|FG003|Evaluable-20 Immunogenicity Population|Overall Study||0
6260873|NCT03760146|7159629|FG004|Evaluable-20 Immunogenicity Population|Overall Study||317
6260874|NCT03760146|7159630|FG005|Evaluable-20 Immunogenicity Population|Overall Study||0
6260875|NCT03760146|7159625|FG000|COMPLETED|Overall Study||1418
6260876|NCT03760146|7159626|FG001|COMPLETED|Overall Study||1417
6260877|NCT03760146|7159627|FG002|COMPLETED|Overall Study||323
6260878|NCT03760146|7159628|FG003|COMPLETED|Overall Study||109
6260879|NCT03760146|7159629|FG004|COMPLETED|Overall Study||319
6260880|NCT03760146|7159630|FG005|COMPLETED|Overall Study||104
6260881|NCT03760146|7159625|FG000|NOT COMPLETED|Overall Study||96
6260882|NCT03760146|7159626|FG001|NOT COMPLETED|Overall Study||78
6260883|NCT03760146|7159627|FG002|NOT COMPLETED|Overall Study||11
6260884|NCT03760146|7159628|FG003|NOT COMPLETED|Overall Study||2
6260885|NCT03760146|7159629|FG004|NOT COMPLETED|Overall Study||17
6260886|NCT03760146|7159630|FG005|NOT COMPLETED|Overall Study||8
6260887|NCT03760081|7159650|FG000|STARTED|Overall Study||6
6260888|NCT03760081|7159651|FG001|STARTED|Overall Study||13
6260889|NCT03760081|7159650|FG000|COMPLETED|Overall Study||0
6260890|NCT03760081|7159651|FG001|COMPLETED|Overall Study||1
6260891|NCT03760081|7159650|FG000|NOT COMPLETED|Overall Study||6
6704993|NCT02890992|7635678|FG005|STARTED|12 Weeks Open-Label Dose Finding Period||5
6704994|NCT02890992|7635679|FG006|STARTED|12 Weeks Open-Label Dose Finding Period||6
6704995|NCT02890992|7635680|FG007|STARTED|12 Weeks Open-Label Dose Finding Period||5
6704996|NCT02890992|7635673|FG000|Treated|12 Weeks Open-Label Dose Finding Period||4
6704997|NCT02890992|7635674|FG001|Treated|12 Weeks Open-Label Dose Finding Period||6
6704998|NCT02890992|7635675|FG002|Treated|12 Weeks Open-Label Dose Finding Period||4
6704999|NCT02890992|7635676|FG003|Treated|12 Weeks Open-Label Dose Finding Period||6
6705000|NCT02890992|7635677|FG004|Treated|12 Weeks Open-Label Dose Finding Period||6
6705001|NCT02890992|7635678|FG005|Treated|12 Weeks Open-Label Dose Finding Period||5
6705002|NCT02890992|7635679|FG006|Treated|12 Weeks Open-Label Dose Finding Period||6
6705003|NCT02890992|7635680|FG007|Treated|12 Weeks Open-Label Dose Finding Period||5
6705004|NCT02890992|7635673|FG000|COMPLETED|12 Weeks Open-Label Dose Finding Period|Out of 4 participants, 3 participants entered into the open-label extension (OLE) period.|4
6705005|NCT02890992|7635674|FG001|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
6705006|NCT02890992|7635675|FG002|COMPLETED|12 Weeks Open-Label Dose Finding Period||4
6705007|NCT02890992|7635676|FG003|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
6705008|NCT02890992|7635677|FG004|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
6705009|NCT02890992|7635678|FG005|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
6705010|NCT02890992|7635679|FG006|COMPLETED|12 Weeks Open-Label Dose Finding Period||6
6705011|NCT02890992|7635680|FG007|COMPLETED|12 Weeks Open-Label Dose Finding Period||5
6705012|NCT02890992|7635673|FG000|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6705013|NCT02890992|7635674|FG001|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6705014|NCT02890992|7635675|FG002|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6705015|NCT02890992|7635676|FG003|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6260892|NCT03760081|7159651|FG001|NOT COMPLETED|Overall Study||12
6260893|NCT03737110|7159661|FG000|STARTED|Run-in (RI) Period||86
6260894|NCT03737110|7159662|FG001|STARTED|Run-in (RI) Period||0
6260895|NCT03737110|7159663|FG002|STARTED|Run-in (RI) Period||0
6260896|NCT03737110|7159661|FG000|Continue to RW Period|Run-in (RI) Period||61
6260897|NCT03737110|7159662|FG001|Continue to RW Period|Run-in (RI) Period||0
6260898|NCT03737110|7159663|FG002|Continue to RW Period|Run-in (RI) Period||0
6260899|NCT03737110|7159661|FG000|Continue Directly to LTE Period|Run-in (RI) Period||15
6260900|NCT03737110|7159662|FG001|Continue Directly to LTE Period|Run-in (RI) Period||0
6260901|NCT03737110|7159663|FG002|Continue Directly to LTE Period|Run-in (RI) Period||0
6260902|NCT03737110|7159661|FG000|COMPLETED|Run-in (RI) Period||76
6260903|NCT03737110|7159662|FG001|COMPLETED|Run-in (RI) Period||0
6260904|NCT03737110|7159663|FG002|COMPLETED|Run-in (RI) Period||0
6260905|NCT03737110|7159661|FG000|NOT COMPLETED|Run-in (RI) Period||10
6260906|NCT03737110|7159662|FG001|NOT COMPLETED|Run-in (RI) Period||0
6260907|NCT03737110|7159663|FG002|NOT COMPLETED|Run-in (RI) Period||0
6260908|NCT03737110|7159661|FG000|STARTED|Randomized Withdrawal (RW) Period||0
6260909|NCT03737110|7159662|FG001|STARTED|Randomized Withdrawal (RW) Period||30
6260910|NCT03737110|7159663|FG002|STARTED|Randomized Withdrawal (RW) Period||31
6260911|NCT03737110|7159661|FG000|COMPLETED|Randomized Withdrawal (RW) Period||0
6260912|NCT03737110|7159662|FG001|COMPLETED|Randomized Withdrawal (RW) Period||29
6260913|NCT03737110|7159663|FG002|COMPLETED|Randomized Withdrawal (RW) Period||30
6260914|NCT03737110|7159661|FG000|NOT COMPLETED|Randomized Withdrawal (RW) Period||0
6260915|NCT03737110|7159662|FG001|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
6260916|NCT03737110|7159663|FG002|NOT COMPLETED|Randomized Withdrawal (RW) Period||1
6260917|NCT03737110|7159661|FG000|STARTED|Long-Term Extension (LTE) Period|Participants who entered the LTE directly from RI after protocol-specified 22 adjudicated pericarditis recurrence events had accrued.|15
6260918|NCT03737110|7159662|FG001|STARTED|Long-Term Extension (LTE) Period|1 participant withdrew consent prior to entering LTE.|29
6260919|NCT03737110|7159663|FG002|STARTED|Long-Term Extension (LTE) Period||30
6260920|NCT03737110|7159661|FG000|COMPLETED|Long-Term Extension (LTE) Period||0
6260921|NCT03737110|7159662|FG001|COMPLETED|Long-Term Extension (LTE) Period||0
6260922|NCT03737110|7159663|FG002|COMPLETED|Long-Term Extension (LTE) Period||0
6260923|NCT03737110|7159661|FG000|NOT COMPLETED|Long-Term Extension (LTE) Period||15
6260924|NCT03737110|7159662|FG001|NOT COMPLETED|Long-Term Extension (LTE) Period||29
6260925|NCT03737110|7159663|FG002|NOT COMPLETED|Long-Term Extension (LTE) Period||30
6260926|NCT03713684|7159685|FG000|STARTED|Overall Study||92
6260927|NCT03713684|7159686|FG001|STARTED|Overall Study||92
6260928|NCT03713684|7159687|FG002|STARTED|Overall Study||93
6260929|NCT03713684|7159688|FG003|STARTED|Overall Study||93
6260930|NCT03713684|7159685|FG000|Safety Population|Overall Study||92
6260931|NCT03713684|7159686|FG001|Safety Population|Overall Study||92
6260932|NCT03713684|7159687|FG002|Safety Population|Overall Study|For safety analysis participants were included in the treatment arm that they were exposed for longer duration. 3 participants randomized to Efpeglenatide 6 mg arm received 4 mg dose for longer duration; and considered in Efpeglenatide 4 mg arm for safety analysis.|96
6260933|NCT03713684|7159688|FG003|Safety Population|Overall Study||90
6260934|NCT03713684|7159685|FG000|Completed 30-Week Core Treatment Period|Overall Study||50
6260935|NCT03713684|7159686|FG001|Completed 30-Week Core Treatment Period|Overall Study||52
6260936|NCT03713684|7159687|FG002|Completed 30-Week Core Treatment Period|Overall Study||51
6260937|NCT03713684|7159688|FG003|Completed 30-Week Core Treatment Period|Overall Study||49
6260938|NCT03713684|7159685|FG000|COMPLETED|Overall Study||6
6260939|NCT03713684|7159686|FG001|COMPLETED|Overall Study||5
6260940|NCT03713684|7159687|FG002|COMPLETED|Overall Study||5
6260941|NCT03713684|7159688|FG003|COMPLETED|Overall Study||6
6705016|NCT02890992|7635677|FG004|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6705017|NCT02890992|7635678|FG005|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6705018|NCT02890992|7635679|FG006|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6705019|NCT02890992|7635680|FG007|NOT COMPLETED|12 Weeks Open-Label Dose Finding Period||0
6705020|NCT02890992|7635673|FG000|STARTED|130 Weeks Open-Label Extension Period|3 participants from Open-Label Dose Finding Period (OLDFI) entered in OLE period.|3
6705021|NCT02890992|7635674|FG001|STARTED|130 Weeks Open-Label Extension Period||6
6705022|NCT02890992|7635675|FG002|STARTED|130 Weeks Open-Label Extension Period||4
6705023|NCT02890992|7635676|FG003|STARTED|130 Weeks Open-Label Extension Period||6
6705024|NCT02890992|7635677|FG004|STARTED|130 Weeks Open-Label Extension Period||6
6705025|NCT02890992|7635678|FG005|STARTED|130 Weeks Open-Label Extension Period||5
6705026|NCT02890992|7635679|FG006|STARTED|130 Weeks Open-Label Extension Period||6
6705027|NCT02890992|7635680|FG007|STARTED|130 Weeks Open-Label Extension Period||5
6705028|NCT02890992|7635673|FG000|Treated|130 Weeks Open-Label Extension Period||3
6705029|NCT02890992|7635674|FG001|Treated|130 Weeks Open-Label Extension Period||6
6705030|NCT02890992|7635675|FG002|Treated|130 Weeks Open-Label Extension Period||4
6705031|NCT02890992|7635676|FG003|Treated|130 Weeks Open-Label Extension Period||6
6705032|NCT02890992|7635677|FG004|Treated|130 Weeks Open-Label Extension Period||6
6705033|NCT02890992|7635678|FG005|Treated|130 Weeks Open-Label Extension Period||5
6705034|NCT02890992|7635679|FG006|Treated|130 Weeks Open-Label Extension Period||5
6705035|NCT02890992|7635680|FG007|Treated|130 Weeks Open-Label Extension Period||4
6705036|NCT02890992|7635673|FG000|COMPLETED|130 Weeks Open-Label Extension Period||3
6705037|NCT02890992|7635674|FG001|COMPLETED|130 Weeks Open-Label Extension Period||3
6705038|NCT02890992|7635675|FG002|COMPLETED|130 Weeks Open-Label Extension Period||4
6705039|NCT02890992|7635676|FG003|COMPLETED|130 Weeks Open-Label Extension Period||6
6705040|NCT02890992|7635677|FG004|COMPLETED|130 Weeks Open-Label Extension Period||6
6705041|NCT02890992|7635678|FG005|COMPLETED|130 Weeks Open-Label Extension Period||5
6705042|NCT02890992|7635679|FG006|COMPLETED|130 Weeks Open-Label Extension Period||5
6705043|NCT02890992|7635680|FG007|COMPLETED|130 Weeks Open-Label Extension Period||4
6705044|NCT02890992|7635673|FG000|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6705045|NCT02890992|7635674|FG001|NOT COMPLETED|130 Weeks Open-Label Extension Period||3
6705046|NCT02890992|7635675|FG002|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6705047|NCT02890992|7635676|FG003|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6705048|NCT02890992|7635677|FG004|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6705049|NCT02890992|7635678|FG005|NOT COMPLETED|130 Weeks Open-Label Extension Period||0
6705050|NCT02890992|7635679|FG006|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
6705051|NCT02890992|7635680|FG007|NOT COMPLETED|130 Weeks Open-Label Extension Period||1
6705052|NCT02891070|7635707|FG000|STARTED|Overall Study||110
6705053|NCT02891070|7635708|FG001|STARTED|Overall Study||114
6705054|NCT02891070|7635707|FG000|COMPLETED|Overall Study||100
6705055|NCT02891070|7635708|FG001|COMPLETED|Overall Study||106
6705056|NCT02891070|7635707|FG000|NOT COMPLETED|Overall Study||10
6705057|NCT02891070|7635708|FG001|NOT COMPLETED|Overall Study||8
6705058|NCT02891174|7635716|FG000|STARTED|First Intervention (24 Hours)||20
6705059|NCT02891174|7635717|FG001|STARTED|First Intervention (24 Hours)||23
6705060|NCT02891174|7635716|FG000|Received First Intervention|First Intervention (24 Hours)||19
6705061|NCT02891174|7635717|FG001|Received First Intervention|First Intervention (24 Hours)||18
6705062|NCT02891174|7635716|FG000|COMPLETED|First Intervention (24 Hours)||17
6705063|NCT02891174|7635717|FG001|COMPLETED|First Intervention (24 Hours)||10
6705064|NCT02891174|7635716|FG000|NOT COMPLETED|First Intervention (24 Hours)||3
6705065|NCT02891174|7635717|FG001|NOT COMPLETED|First Intervention (24 Hours)||13
6705066|NCT02891174|7635716|FG000|STARTED|Second Intervention (24 Hours)||17
6705067|NCT02891174|7635717|FG001|STARTED|Second Intervention (24 Hours)||10
6705068|NCT02891174|7635716|FG000|COMPLETED|Second Intervention (24 Hours)||11
6705069|NCT02891174|7635717|FG001|COMPLETED|Second Intervention (24 Hours)||3
6705070|NCT02891174|7635716|FG000|NOT COMPLETED|Second Intervention (24 Hours)||6
6705071|NCT02891174|7635717|FG001|NOT COMPLETED|Second Intervention (24 Hours)||7
6705072|NCT02891200|7635729|FG000|STARTED|Overall Study||145
6705073|NCT02891200|7635730|FG001|STARTED|Overall Study||147
6705074|NCT02891200|7635729|FG000|COMPLETED|Overall Study||103
6705075|NCT02891200|7635730|FG001|COMPLETED|Overall Study||98
6705076|NCT02891200|7635729|FG000|NOT COMPLETED|Overall Study||42
6705077|NCT02891200|7635730|FG001|NOT COMPLETED|Overall Study||49
6705078|NCT02891408|7635743|FG000|STARTED|Overall Study||10
6705079|NCT02891408|7635744|FG001|STARTED|Overall Study||10
6705080|NCT02891408|7635745|FG002|STARTED|Overall Study||14
6705081|NCT02891408|7635746|FG003|STARTED|Overall Study||10
6705082|NCT02891408|7635747|FG004|STARTED|Overall Study||10
6705083|NCT02891408|7635748|FG005|STARTED|Overall Study||10
6705084|NCT02891408|7635749|FG006|STARTED|Overall Study||10
6705085|NCT02891408|7635743|FG000|COMPLETED|Overall Study||10
6705086|NCT02891408|7635744|FG001|COMPLETED|Overall Study||10
6705087|NCT02891408|7635745|FG002|COMPLETED|Overall Study||13
6705088|NCT02891408|7635746|FG003|COMPLETED|Overall Study||10
6705089|NCT02891408|7635747|FG004|COMPLETED|Overall Study||10
6705090|NCT02891408|7635748|FG005|COMPLETED|Overall Study||10
6705091|NCT02891408|7635749|FG006|COMPLETED|Overall Study||10
6705092|NCT02891408|7635743|FG000|NOT COMPLETED|Overall Study||0
6705093|NCT02891408|7635744|FG001|NOT COMPLETED|Overall Study||0
6705094|NCT02891408|7635745|FG002|NOT COMPLETED|Overall Study||1
6705095|NCT02891408|7635746|FG003|NOT COMPLETED|Overall Study||0
6705096|NCT02891408|7635747|FG004|NOT COMPLETED|Overall Study||0
6705097|NCT02891408|7635748|FG005|NOT COMPLETED|Overall Study||0
6705098|NCT02891408|7635749|FG006|NOT COMPLETED|Overall Study||0
6705099|NCT02891629|7635777|FG000|STARTED|Overall Study||10
6705100|NCT02891629|7635778|FG001|STARTED|Overall Study||5
6705101|NCT02891629|7635777|FG000|COMPLETED|Overall Study||10
6705102|NCT02891629|7635778|FG001|COMPLETED|Overall Study||4
6705103|NCT02891629|7635777|FG000|NOT COMPLETED|Overall Study||0
6705104|NCT02891629|7635778|FG001|NOT COMPLETED|Overall Study||1
6705105|NCT02891681|7635787|FG000|STARTED|Overall Study||39
6705106|NCT02891681|7635788|FG001|STARTED|Overall Study||1
6705107|NCT02891681|7635789|FG002|STARTED|Overall Study||1
6705108|NCT02891681|7635787|FG000|COMPLETED|Overall Study||36
6705109|NCT02891681|7635788|FG001|COMPLETED|Overall Study||1
6705110|NCT02891681|7635789|FG002|COMPLETED|Overall Study||0
6705111|NCT02891681|7635787|FG000|NOT COMPLETED|Overall Study||3
6705112|NCT02891681|7635788|FG001|NOT COMPLETED|Overall Study||0
6705113|NCT02891681|7635789|FG002|NOT COMPLETED|Overall Study||1
6705114|NCT02891850|7635799|FG000|STARTED|Overall Study||111
6705115|NCT02891850|7635800|FG001|STARTED|Overall Study||114
6705116|NCT02891850|7635799|FG000|COMPLETED|Overall Study||104
6705117|NCT02891850|7635800|FG001|COMPLETED|Overall Study||107
6705118|NCT02891850|7635799|FG000|NOT COMPLETED|Overall Study||7
6705119|NCT02891850|7635800|FG001|NOT COMPLETED|Overall Study||7
6705120|NCT02891863|7635806|FG000|STARTED|Overall Study||9
6705121|NCT02891863|7635806|FG000|COMPLETED|Overall Study||9
6705122|NCT02891863|7635806|FG000|NOT COMPLETED|Overall Study||0
6705123|NCT02891915|7635812|FG000|STARTED|Overall Study||192
6705124|NCT02891915|7635813|FG001|STARTED|Overall Study||193
6705125|NCT02891915|7635812|FG000|COMPLETED|Overall Study||179
6705126|NCT02891915|7635813|FG001|COMPLETED|Overall Study||181
6705127|NCT02891915|7635812|FG000|NOT COMPLETED|Overall Study||13
6705128|NCT02891915|7635813|FG001|NOT COMPLETED|Overall Study||12
6705129|NCT02892019|7635821|FG000|STARTED|Overall Study||41
6705130|NCT02892019|7635822|FG001|STARTED|Overall Study||39
6705131|NCT02892019|7635821|FG000|COMPLETED|Overall Study||40
6705132|NCT02892019|7635822|FG001|COMPLETED|Overall Study||36
6705133|NCT02892019|7635821|FG000|NOT COMPLETED|Overall Study||1
6705134|NCT02892019|7635822|FG001|NOT COMPLETED|Overall Study||3
6705135|NCT02892110|7635830|FG000|STARTED|Overall Study||35
6705136|NCT02892110|7635831|FG001|STARTED|Overall Study||37
6705137|NCT02892110|7635830|FG000|COMPLETED|Overall Study||22
6705138|NCT02892110|7635831|FG001|COMPLETED|Overall Study||25
6705139|NCT02892110|7635830|FG000|NOT COMPLETED|Overall Study||13
6705140|NCT02892110|7635831|FG001|NOT COMPLETED|Overall Study||12
6705141|NCT02892344|7635839|FG000|STARTED|Overall Study||398
6705142|NCT02892344|7635840|FG001|STARTED|Overall Study||404
6705143|NCT02892344|7635839|FG000|Full Analysis Set|Overall Study||395
6705144|NCT02892344|7635840|FG001|Full Analysis Set|Overall Study||399
6705145|NCT02892344|7635839|FG000|COMPLETED|Overall Study||394
6705146|NCT02892344|7635840|FG001|COMPLETED|Overall Study||383
6705147|NCT02892344|7635839|FG000|NOT COMPLETED|Overall Study||4
6705148|NCT02892344|7635840|FG001|NOT COMPLETED|Overall Study||21
6705149|NCT02892409|7635848|FG000|STARTED|Overall Study||15
6705150|NCT02892409|7635849|FG001|STARTED|Overall Study||15
6705151|NCT02892409|7635848|FG000|COMPLETED|Overall Study||12
6705152|NCT02892409|7635849|FG001|COMPLETED|Overall Study||14
6705153|NCT02892409|7635848|FG000|NOT COMPLETED|Overall Study||3
6705154|NCT02892409|7635849|FG001|NOT COMPLETED|Overall Study||1
6705155|NCT02892422|7635855|FG000|STARTED|Overall Study|528 participants were enrolled, 524 from study 16159A and 4 from study 16323A|528
6705156|NCT02892422|7635855|FG000|COMPLETED|Overall Study||318
6705157|NCT02892422|7635855|FG000|NOT COMPLETED|Overall Study||210
6705158|NCT02892448|7635862|FG000|STARTED|Overall Study||12
6705159|NCT02892448|7635863|FG001|STARTED|Overall Study||12
6705160|NCT02892448|7635864|FG002|STARTED|Overall Study||11
6705161|NCT02892448|7635862|FG000|COMPLETED|Overall Study||10
6705162|NCT02892448|7635863|FG001|COMPLETED|Overall Study||10
6260942|NCT03713684|7159685|FG000|NOT COMPLETED|Overall Study||86
6260943|NCT03713684|7159686|FG001|NOT COMPLETED|Overall Study||87
6260944|NCT03713684|7159687|FG002|NOT COMPLETED|Overall Study||88
6260945|NCT03713684|7159688|FG003|NOT COMPLETED|Overall Study||87
6260946|NCT03644550|7159698|FG000|STARTED|Overall Study||18
6260947|NCT03644550|7159698|FG000|COMPLETED|Overall Study||0
6260948|NCT03644550|7159698|FG000|NOT COMPLETED|Overall Study||18
6260949|NCT03557970|7159705|FG000|STARTED|Overall Study||1
6260950|NCT03557970|7159706|FG001|STARTED|Overall Study||2
6260951|NCT03557970|7159705|FG000|COMPLETED|Overall Study||0
6705163|NCT02892448|7635864|FG002|COMPLETED|Overall Study||10
6705164|NCT02892448|7635862|FG000|NOT COMPLETED|Overall Study||2
6705165|NCT02892448|7635863|FG001|NOT COMPLETED|Overall Study||2
6705166|NCT02892448|7635864|FG002|NOT COMPLETED|Overall Study||1
6705167|NCT02892513|7635874|FG000|STARTED|Overall Study||28
6705168|NCT02892513|7635875|FG001|STARTED|Overall Study|did not receive allocated intervention = 1 (withdrew per participant request)|25
6705169|NCT02892513|7635874|FG000|COMPLETED|Overall Study|Discontinued intervention early = 5; excluded from analysis = 0|28
6705170|NCT02892513|7635875|FG001|COMPLETED|Overall Study|Discontinued intervention early = 6; excluded from analysis = 1|24
6705171|NCT02892513|7635874|FG000|NOT COMPLETED|Overall Study||0
6705172|NCT02892513|7635875|FG001|NOT COMPLETED|Overall Study||1
6260952|NCT03557970|7159706|FG001|COMPLETED|Overall Study||0
6260953|NCT03557970|7159705|FG000|NOT COMPLETED|Overall Study||1
6260954|NCT03557970|7159706|FG001|NOT COMPLETED|Overall Study||2
6705173|NCT02892734|7635881|FG000|STARTED|Treatment on Study||3
6705174|NCT02892734|7635881|FG000|Completed 1st Cycle/Response at 12 Weeks|Treatment on Study||1
6705175|NCT02892734|7635881|FG000|Went on to Start Cycle 2|Treatment on Study||1
6705176|NCT02892734|7635881|FG000|COMPLETED|Treatment on Study||1
6705177|NCT02892734|7635881|FG000|NOT COMPLETED|Treatment on Study||2
6705178|NCT02892734|7635881|FG000|STARTED|Follow up for 2 Years||3
6705179|NCT02892734|7635881|FG000|COMPLETED|Follow up for 2 Years||0
6705180|NCT02892734|7635881|FG000|NOT COMPLETED|Follow up for 2 Years||3
6705181|NCT02892760|7635885|FG000|STARTED|Overall Study||17
6705182|NCT02892760|7635885|FG000|Received Intervention|Overall Study||15
6705183|NCT02892760|7635885|FG000|COMPLETED|Overall Study||14
6705184|NCT02892760|7635885|FG000|NOT COMPLETED|Overall Study||3
6705185|NCT02893878|7635892|FG000|STARTED|Overall Study||13861
6705186|NCT02893878|7635893|FG001|STARTED|Overall Study||2295
6705187|NCT02893878|7635894|FG002|STARTED|Overall Study||3178
6705188|NCT02893878|7635892|FG000|COMPLETED|Overall Study||13861
6705189|NCT02893878|7635893|FG001|COMPLETED|Overall Study||2295
6705190|NCT02893878|7635894|FG002|COMPLETED|Overall Study||3178
6705191|NCT02893878|7635892|FG000|NOT COMPLETED|Overall Study||0
6705192|NCT02893878|7635893|FG001|NOT COMPLETED|Overall Study||0
6705193|NCT02893878|7635894|FG002|NOT COMPLETED|Overall Study||0
6705194|NCT02894502|7635908|FG000|STARTED|Baseline||155
6705195|NCT02894502|7635909|FG001|STARTED|Baseline||177
6705196|NCT02894502|7635910|FG002|STARTED|Baseline||178
6705197|NCT02894502|7635908|FG000|COMPLETED|Baseline||128
6705198|NCT02894502|7635909|FG001|COMPLETED|Baseline||145
6705199|NCT02894502|7635910|FG002|COMPLETED|Baseline||133
6705200|NCT02894502|7635908|FG000|NOT COMPLETED|Baseline||27
6705201|NCT02894502|7635909|FG001|NOT COMPLETED|Baseline||32
6705202|NCT02894502|7635910|FG002|NOT COMPLETED|Baseline||45
6705203|NCT02894502|7635908|FG000|STARTED|First Follow up||128
6705204|NCT02894502|7635909|FG001|STARTED|First Follow up||145
6705205|NCT02894502|7635910|FG002|STARTED|First Follow up||133
6705206|NCT02894502|7635908|FG000|COMPLETED|First Follow up||94
6705207|NCT02894502|7635909|FG001|COMPLETED|First Follow up||114
6705208|NCT02894502|7635910|FG002|COMPLETED|First Follow up||93
6705209|NCT02894502|7635908|FG000|NOT COMPLETED|First Follow up||34
6705210|NCT02894502|7635909|FG001|NOT COMPLETED|First Follow up||31
6705211|NCT02894502|7635910|FG002|NOT COMPLETED|First Follow up||40
6705212|NCT02894502|7635908|FG000|STARTED|Second Follow up||94
6705213|NCT02894502|7635909|FG001|STARTED|Second Follow up||114
6705214|NCT02894502|7635910|FG002|STARTED|Second Follow up||93
6705215|NCT02894502|7635908|FG000|COMPLETED|Second Follow up||79
6705216|NCT02894502|7635909|FG001|COMPLETED|Second Follow up||96
6705217|NCT02894502|7635910|FG002|COMPLETED|Second Follow up||79
6705218|NCT02894502|7635908|FG000|NOT COMPLETED|Second Follow up||15
6705219|NCT02894502|7635909|FG001|NOT COMPLETED|Second Follow up||18
6705220|NCT02894502|7635910|FG002|NOT COMPLETED|Second Follow up||14
6705221|NCT02894502|7635908|FG000|STARTED|Third Follow up||79
6705222|NCT02894502|7635909|FG001|STARTED|Third Follow up||96
6705223|NCT02894502|7635910|FG002|STARTED|Third Follow up||79
6705224|NCT02894502|7635908|FG000|COMPLETED|Third Follow up||73
6705225|NCT02894502|7635909|FG001|COMPLETED|Third Follow up||89
6705226|NCT02894502|7635910|FG002|COMPLETED|Third Follow up||76
6705227|NCT02894502|7635908|FG000|NOT COMPLETED|Third Follow up||6
6705228|NCT02894502|7635909|FG001|NOT COMPLETED|Third Follow up||7
6705229|NCT02894502|7635910|FG002|NOT COMPLETED|Third Follow up||3
6705230|NCT02894840|7635925|FG000|STARTED|Overall Study||20
6705231|NCT02894840|7635926|FG001|STARTED|Overall Study||20
6705232|NCT02894840|7635927|FG002|STARTED|Overall Study||200
6705233|NCT02894840|7635928|FG003|STARTED|Overall Study||100
6705234|NCT02894840|7635925|FG000|COMPLETED|Overall Study||19
6705235|NCT02894840|7635926|FG001|COMPLETED|Overall Study||20
6705236|NCT02894840|7635927|FG002|COMPLETED|Overall Study||197
6705237|NCT02894840|7635928|FG003|COMPLETED|Overall Study||100
6705238|NCT02894840|7635925|FG000|NOT COMPLETED|Overall Study||1
6705239|NCT02894840|7635926|FG001|NOT COMPLETED|Overall Study||0
6705240|NCT02894840|7635927|FG002|NOT COMPLETED|Overall Study||3
6705241|NCT02894840|7635928|FG003|NOT COMPLETED|Overall Study||0
6705242|NCT02895035|7635943|FG000|STARTED|Overall Study||23
6705243|NCT02895035|7635944|FG001|STARTED|Overall Study||36
6705244|NCT02895035|7635943|FG000|COMPLETED|Overall Study||18
6705245|NCT02895035|7635944|FG001|COMPLETED|Overall Study||24
6705246|NCT02895035|7635943|FG000|NOT COMPLETED|Overall Study||5
6705247|NCT02895035|7635944|FG001|NOT COMPLETED|Overall Study||12
6705248|NCT02895100|7635954|FG000|STARTED|Overall Study||25
6705249|NCT02895100|7635955|FG001|STARTED|Overall Study||25
6705250|NCT02895100|7635956|FG002|STARTED|Overall Study||23
6705251|NCT02895100|7635957|FG003|STARTED|Overall Study||25
6705252|NCT02895100|7635954|FG000|COMPLETED|Overall Study||14
6705253|NCT02895100|7635955|FG001|COMPLETED|Overall Study||14
6705254|NCT02895100|7635956|FG002|COMPLETED|Overall Study||15
6705255|NCT02895100|7635957|FG003|COMPLETED|Overall Study||15
6705256|NCT02895100|7635954|FG000|NOT COMPLETED|Overall Study||11
6705257|NCT02895100|7635955|FG001|NOT COMPLETED|Overall Study||11
6705258|NCT02895100|7635956|FG002|NOT COMPLETED|Overall Study||8
6705259|NCT02895100|7635957|FG003|NOT COMPLETED|Overall Study||10
6705260|NCT02895295|7635970|FG000|STARTED|Overall Study||384
6705261|NCT02895295|7635971|FG001|STARTED|Overall Study||410
6705262|NCT02895295|7635972|FG002|STARTED|Overall Study||391
6705263|NCT02895295|7635970|FG000|COMPLETED|Overall Study||313
6705264|NCT02895295|7635971|FG001|COMPLETED|Overall Study||316
6705265|NCT02895295|7635972|FG002|COMPLETED|Overall Study||299
6705266|NCT02895295|7635970|FG000|NOT COMPLETED|Overall Study||71
6705267|NCT02895295|7635971|FG001|NOT COMPLETED|Overall Study||94
6705268|NCT02895295|7635972|FG002|NOT COMPLETED|Overall Study||92
6705269|NCT02895347|7635982|FG000|STARTED|Overall Study||20
6705270|NCT02895347|7635983|FG001|STARTED|Overall Study||20
6705271|NCT02895347|7635982|FG000|COMPLETED|Overall Study||17
6705272|NCT02895347|7635983|FG001|COMPLETED|Overall Study||19
6705273|NCT02895347|7635982|FG000|NOT COMPLETED|Overall Study||3
6705274|NCT02895347|7635983|FG001|NOT COMPLETED|Overall Study||1
6705275|NCT02895360|7635996|FG000|STARTED|Phase 1 - 30 mg/m² Cohort||4
6705276|NCT02895360|7635997|FG001|STARTED|Phase 1 - 30 mg/m² Cohort||0
6705277|NCT02895360|7635998|FG002|STARTED|Phase 1 - 30 mg/m² Cohort||0
6705278|NCT02895360|7635999|FG003|STARTED|Phase 1 - 30 mg/m² Cohort||0
6705279|NCT02895360|7636000|FG004|STARTED|Phase 1 - 30 mg/m² Cohort||0
6705280|NCT02895360|7636001|FG005|STARTED|Phase 1 - 30 mg/m² Cohort||0
6705281|NCT02895360|7635996|FG000|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705282|NCT02895360|7635997|FG001|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705283|NCT02895360|7635998|FG002|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705284|NCT02895360|7635999|FG003|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705285|NCT02895360|7636000|FG004|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705286|NCT02895360|7636001|FG005|COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705287|NCT02895360|7635996|FG000|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||4
6705288|NCT02895360|7635997|FG001|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705289|NCT02895360|7635998|FG002|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705290|NCT02895360|7635999|FG003|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705291|NCT02895360|7636000|FG004|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705292|NCT02895360|7636001|FG005|NOT COMPLETED|Phase 1 - 30 mg/m² Cohort||0
6705293|NCT02895360|7635996|FG000|STARTED|Phase 1 - 45 mg/m² Cohort||0
6705294|NCT02895360|7635997|FG001|STARTED|Phase 1 - 45 mg/m² Cohort||3
6705295|NCT02895360|7635998|FG002|STARTED|Phase 1 - 45 mg/m² Cohort||0
6705296|NCT02895360|7635999|FG003|STARTED|Phase 1 - 45 mg/m² Cohort||0
6705297|NCT02895360|7636000|FG004|STARTED|Phase 1 - 45 mg/m² Cohort||0
6705298|NCT02895360|7636001|FG005|STARTED|Phase 1 - 45 mg/m² Cohort||0
6705299|NCT02895360|7635996|FG000|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705300|NCT02895360|7635997|FG001|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705301|NCT02895360|7635998|FG002|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705302|NCT02895360|7635999|FG003|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705303|NCT02895360|7636000|FG004|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705304|NCT02895360|7636001|FG005|COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705305|NCT02895360|7635996|FG000|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705306|NCT02895360|7635997|FG001|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||3
6705307|NCT02895360|7635998|FG002|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705308|NCT02895360|7635999|FG003|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705309|NCT02895360|7636000|FG004|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705310|NCT02895360|7636001|FG005|NOT COMPLETED|Phase 1 - 45 mg/m² Cohort||0
6705311|NCT02895360|7635996|FG000|STARTED|Phase 1 - 70 mg/m² Cohort||0
6705312|NCT02895360|7635997|FG001|STARTED|Phase 1 - 70 mg/m² Cohort||0
6705313|NCT02895360|7635998|FG002|STARTED|Phase 1 - 70 mg/m² Cohort||9
6705314|NCT02895360|7635999|FG003|STARTED|Phase 1 - 70 mg/m² Cohort||0
6705315|NCT02895360|7636000|FG004|STARTED|Phase 1 - 70 mg/m² Cohort||0
6705316|NCT02895360|7636001|FG005|STARTED|Phase 1 - 70 mg/m² Cohort||0
6705317|NCT02895360|7635996|FG000|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6260955|NCT03369197|7159714|FG000|STARTED|Overall Study||53
6260956|NCT03369197|7159715|FG001|STARTED|Overall Study||57
6260957|NCT03369197|7159714|FG000|COMPLETED|Overall Study||53
6260958|NCT03369197|7159715|FG001|COMPLETED|Overall Study||57
6260959|NCT03369197|7159714|FG000|NOT COMPLETED|Overall Study||0
6260960|NCT03369197|7159715|FG001|NOT COMPLETED|Overall Study||0
6260961|NCT03368196|7159721|FG000|STARTED|Overall Study||12
6260962|NCT03368196|7159721|FG000|COMPLETED|Overall Study||12
6260963|NCT03368196|7159721|FG000|NOT COMPLETED|Overall Study||0
6260964|NCT03022461|7159725|FG000|STARTED|Overall Study||25
6260965|NCT03022461|7159725|FG000|COMPLETED|Overall Study||22
6260966|NCT03022461|7159725|FG000|NOT COMPLETED|Overall Study||3
6260967|NCT02979587|7159730|FG000|STARTED|Overall Study||50
6260968|NCT02979587|7159730|FG000|Catheterized|Overall Study||50
6260969|NCT02979587|7159730|FG000|Implanted|Overall Study||50
6260970|NCT02979587|7159730|FG000|Implanted > 24 Hours|Overall Study||48
6260971|NCT02979587|7159730|FG000|COMPLETED|Overall Study||48
6260972|NCT02979587|7159730|FG000|NOT COMPLETED|Overall Study||2
6260973|NCT02964039|7159741|FG000|STARTED|Overall Study||18
6260974|NCT02964039|7159742|FG001|STARTED|Overall Study||18
6260975|NCT02964039|7159743|FG002|STARTED|Overall Study||18
6260976|NCT02964039|7159741|FG000|Received Allocated Intervention|Overall Study||15
6705318|NCT02895360|7635997|FG001|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705319|NCT02895360|7635998|FG002|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705320|NCT02895360|7635999|FG003|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705321|NCT02895360|7636000|FG004|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705322|NCT02895360|7636001|FG005|COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6260977|NCT02964039|7159742|FG001|Received Allocated Intervention|Overall Study||17
6260978|NCT02964039|7159743|FG002|Received Allocated Intervention|Overall Study||14
6260979|NCT02964039|7159741|FG000|COMPLETED|Overall Study||14
6260980|NCT02964039|7159742|FG001|COMPLETED|Overall Study||17
6260981|NCT02964039|7159743|FG002|COMPLETED|Overall Study||13
6260982|NCT02964039|7159741|FG000|NOT COMPLETED|Overall Study||4
6705323|NCT02895360|7635996|FG000|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705324|NCT02895360|7635997|FG001|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705325|NCT02895360|7635998|FG002|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||9
6705326|NCT02895360|7635999|FG003|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705327|NCT02895360|7636000|FG004|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705328|NCT02895360|7636001|FG005|NOT COMPLETED|Phase 1 - 70 mg/m² Cohort||0
6705329|NCT02895360|7635996|FG000|STARTED|Phase 1 - 90 mg/m² Cohort||0
6705330|NCT02895360|7635997|FG001|STARTED|Phase 1 - 90 mg/m² Cohort||0
6705331|NCT02895360|7635998|FG002|STARTED|Phase 1 - 90 mg/m² Cohort||0
6705332|NCT02895360|7635999|FG003|STARTED|Phase 1 - 90 mg/m² Cohort||4
6705333|NCT02895360|7636000|FG004|STARTED|Phase 1 - 90 mg/m² Cohort||0
6705334|NCT02895360|7636001|FG005|STARTED|Phase 1 - 90 mg/m² Cohort||0
6705335|NCT02895360|7635996|FG000|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705336|NCT02895360|7635997|FG001|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705337|NCT02895360|7635998|FG002|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705338|NCT02895360|7635999|FG003|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705339|NCT02895360|7636000|FG004|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705340|NCT02895360|7636001|FG005|COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705341|NCT02895360|7635996|FG000|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705342|NCT02895360|7635997|FG001|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705343|NCT02895360|7635998|FG002|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705344|NCT02895360|7635999|FG003|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||4
6705345|NCT02895360|7636000|FG004|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705346|NCT02895360|7636001|FG005|NOT COMPLETED|Phase 1 - 90 mg/m² Cohort||0
6705347|NCT02895360|7635996|FG000|STARTED|Phase 2a||0
6705348|NCT02895360|7635997|FG001|STARTED|Phase 2a||0
6705349|NCT02895360|7635998|FG002|STARTED|Phase 2a||0
6705350|NCT02895360|7635999|FG003|STARTED|Phase 2a||0
6705351|NCT02895360|7636000|FG004|STARTED|Phase 2a||11
6705352|NCT02895360|7636001|FG005|STARTED|Phase 2a||12
6705353|NCT02895360|7635996|FG000|COMPLETED|Phase 2a||0
6705354|NCT02895360|7635997|FG001|COMPLETED|Phase 2a||0
6705355|NCT02895360|7635998|FG002|COMPLETED|Phase 2a||0
6705356|NCT02895360|7635999|FG003|COMPLETED|Phase 2a||0
6705357|NCT02895360|7636000|FG004|COMPLETED|Phase 2a||0
6705358|NCT02895360|7636001|FG005|COMPLETED|Phase 2a||0
6705359|NCT02895360|7635996|FG000|NOT COMPLETED|Phase 2a||0
6705360|NCT02895360|7635997|FG001|NOT COMPLETED|Phase 2a||0
6705361|NCT02895360|7635998|FG002|NOT COMPLETED|Phase 2a||0
6705362|NCT02895360|7635999|FG003|NOT COMPLETED|Phase 2a||0
6705363|NCT02895360|7636000|FG004|NOT COMPLETED|Phase 2a||11
6705364|NCT02895360|7636001|FG005|NOT COMPLETED|Phase 2a||12
6705365|NCT02895945|7636035|FG000|STARTED|Overall Study||7
6705366|NCT02895945|7636036|FG001|STARTED|Overall Study||1
6705367|NCT02895945|7636035|FG000|SAS|Overall Study||7
6705368|NCT02895945|7636036|FG001|SAS|Overall Study||1
6705369|NCT02895945|7636035|FG000|FAS|Overall Study||7
6705370|NCT02895945|7636036|FG001|FAS|Overall Study||0
6705371|NCT02895945|7636035|FG000|COMPLETED|Overall Study||5
6705372|NCT02895945|7636036|FG001|COMPLETED|Overall Study||0
6705373|NCT02895945|7636035|FG000|NOT COMPLETED|Overall Study||2
6705374|NCT02895945|7636036|FG001|NOT COMPLETED|Overall Study||1
6705375|NCT02896075|7636042|FG000|STARTED|Overall Study||40
6705376|NCT02896075|7636042|FG000|Leg Soreness|Overall Study||40
6705377|NCT02896075|7636042|FG000|COMPLETED|Overall Study||40
6705378|NCT02896075|7636042|FG000|NOT COMPLETED|Overall Study||0
6705379|NCT02896127|7636051|FG000|STARTED|COMPLETED WEEK 52||305
6705380|NCT02896127|7636052|FG001|STARTED|COMPLETED WEEK 52|Includes participants originally assigned to placebo and switched to AIN457150 mg after Wk 16.|153
6705381|NCT02896127|7636051|FG000|COMPLETED|COMPLETED WEEK 52||278
6705382|NCT02896127|7636052|FG001|COMPLETED|COMPLETED WEEK 52||142
6705383|NCT02896127|7636051|FG000|NOT COMPLETED|COMPLETED WEEK 52||27
6705384|NCT02896127|7636052|FG001|NOT COMPLETED|COMPLETED WEEK 52||11
6705385|NCT02896127|7636051|FG000|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|280
6705386|NCT02896127|7636052|FG001|STARTED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|139
6705387|NCT02896127|7636051|FG000|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|276
6705388|NCT02896127|7636052|FG001|COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP|Participants enter follow-up if they exited before Wk 52 Thus numbers different from previous period|134
6705389|NCT02896127|7636051|FG000|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||4
6705390|NCT02896127|7636052|FG001|NOT COMPLETED|COMPLETED POST-TREATMENT FOLLOW UP||5
6705391|NCT02896296|7636058|FG000|STARTED|Overall Study||208
6705392|NCT02896296|7636058|FG000|COMPLETED|Overall Study||166
6705393|NCT02896296|7636058|FG000|NOT COMPLETED|Overall Study||42
6705394|NCT02896361|7636062|FG000|STARTED|First Intervention (2 Weeks)||9
6705395|NCT02896361|7636063|FG001|STARTED|First Intervention (2 Weeks)||10
6705396|NCT02896361|7636064|FG002|STARTED|First Intervention (2 Weeks)||8
6705397|NCT02896361|7636062|FG000|COMPLETED|First Intervention (2 Weeks)||9
6705398|NCT02896361|7636063|FG001|COMPLETED|First Intervention (2 Weeks)||10
6705399|NCT02896361|7636064|FG002|COMPLETED|First Intervention (2 Weeks)||8
6705400|NCT02896361|7636062|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6705401|NCT02896361|7636063|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
6705402|NCT02896361|7636064|FG002|NOT COMPLETED|First Intervention (2 Weeks)||0
6705403|NCT02896361|7636062|FG000|STARTED|Second Intervention (2 Weeks)||9
6705404|NCT02896361|7636063|FG001|STARTED|Second Intervention (2 Weeks)||10
6705405|NCT02896361|7636064|FG002|STARTED|Second Intervention (2 Weeks)||8
6705406|NCT02896361|7636062|FG000|COMPLETED|Second Intervention (2 Weeks)||9
6705407|NCT02896361|7636063|FG001|COMPLETED|Second Intervention (2 Weeks)||10
6705408|NCT02896361|7636064|FG002|COMPLETED|Second Intervention (2 Weeks)||8
6705409|NCT02896361|7636062|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6705410|NCT02896361|7636063|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6705411|NCT02896361|7636064|FG002|NOT COMPLETED|Second Intervention (2 Weeks)||0
6705412|NCT02896361|7636062|FG000|STARTED|Third Intervention (2 Weeks)||9
6705413|NCT02896361|7636063|FG001|STARTED|Third Intervention (2 Weeks)||10
6705414|NCT02896361|7636064|FG002|STARTED|Third Intervention (2 Weeks)||8
6705415|NCT02896361|7636062|FG000|COMPLETED|Third Intervention (2 Weeks)||8
6705416|NCT02896361|7636063|FG001|COMPLETED|Third Intervention (2 Weeks)||9
6705417|NCT02896361|7636064|FG002|COMPLETED|Third Intervention (2 Weeks)||8
6705418|NCT02896361|7636062|FG000|NOT COMPLETED|Third Intervention (2 Weeks)||1
6705419|NCT02896361|7636063|FG001|NOT COMPLETED|Third Intervention (2 Weeks)||1
6705420|NCT02896361|7636064|FG002|NOT COMPLETED|Third Intervention (2 Weeks)||0
6705421|NCT02896400|7636092|FG000|STARTED|Baseline||66
6705422|NCT02896400|7636093|FG001|STARTED|Baseline||66
6705423|NCT02896400|7636094|FG002|STARTED|Baseline||66
6705424|NCT02896400|7636095|FG003|STARTED|Baseline||66
6705425|NCT02896400|7636096|FG004|STARTED|Baseline||66
6705426|NCT02896400|7636097|FG005|STARTED|Baseline||66
6705427|NCT02896400|7636098|FG006|STARTED|Baseline||66
6705428|NCT02896400|7636099|FG007|STARTED|Baseline||66
6705429|NCT02896400|7636100|FG008|STARTED|Baseline||66
6705430|NCT02896400|7636101|FG009|STARTED|Baseline||66
6705431|NCT02896400|7636102|FG010|STARTED|Baseline||66
6705432|NCT02896400|7636103|FG011|STARTED|Baseline||66
6705433|NCT02896400|7636104|FG012|STARTED|Baseline||66
6705434|NCT02896400|7636105|FG013|STARTED|Baseline||66
6705435|NCT02896400|7636106|FG014|STARTED|Baseline||66
6705436|NCT02896400|7636107|FG015|STARTED|Baseline||66
6705437|NCT02896400|7636092|FG000|COMPLETED|Baseline||66
6705438|NCT02896400|7636093|FG001|COMPLETED|Baseline||66
6705439|NCT02896400|7636094|FG002|COMPLETED|Baseline||66
6705440|NCT02896400|7636095|FG003|COMPLETED|Baseline||66
6705441|NCT02896400|7636096|FG004|COMPLETED|Baseline||66
6705442|NCT02896400|7636097|FG005|COMPLETED|Baseline||66
6705443|NCT02896400|7636098|FG006|COMPLETED|Baseline||66
6705444|NCT02896400|7636099|FG007|COMPLETED|Baseline||66
6705445|NCT02896400|7636100|FG008|COMPLETED|Baseline||66
6705446|NCT02896400|7636101|FG009|COMPLETED|Baseline||66
6705447|NCT02896400|7636102|FG010|COMPLETED|Baseline||66
6705448|NCT02896400|7636103|FG011|COMPLETED|Baseline||66
6705449|NCT02896400|7636104|FG012|COMPLETED|Baseline||66
6705450|NCT02896400|7636105|FG013|COMPLETED|Baseline||66
6705451|NCT02896400|7636106|FG014|COMPLETED|Baseline||66
6705452|NCT02896400|7636107|FG015|COMPLETED|Baseline||66
6705453|NCT02896400|7636092|FG000|NOT COMPLETED|Baseline||0
6705454|NCT02896400|7636093|FG001|NOT COMPLETED|Baseline||0
6705455|NCT02896400|7636094|FG002|NOT COMPLETED|Baseline||0
6705456|NCT02896400|7636095|FG003|NOT COMPLETED|Baseline||0
6705457|NCT02896400|7636096|FG004|NOT COMPLETED|Baseline||0
6705458|NCT02896400|7636097|FG005|NOT COMPLETED|Baseline||0
6705459|NCT02896400|7636098|FG006|NOT COMPLETED|Baseline||0
6705460|NCT02896400|7636099|FG007|NOT COMPLETED|Baseline||0
6705461|NCT02896400|7636100|FG008|NOT COMPLETED|Baseline||0
6705462|NCT02896400|7636101|FG009|NOT COMPLETED|Baseline||0
6705463|NCT02896400|7636102|FG010|NOT COMPLETED|Baseline||0
6705464|NCT02896400|7636103|FG011|NOT COMPLETED|Baseline||0
6705465|NCT02896400|7636104|FG012|NOT COMPLETED|Baseline||0
6705466|NCT02896400|7636105|FG013|NOT COMPLETED|Baseline||0
6705467|NCT02896400|7636106|FG014|NOT COMPLETED|Baseline||0
6705468|NCT02896400|7636107|FG015|NOT COMPLETED|Baseline||0
6705469|NCT02896400|7636092|FG000|STARTED|1 Month Follow-up||66
6705470|NCT02896400|7636093|FG001|STARTED|1 Month Follow-up||66
6705471|NCT02896400|7636094|FG002|STARTED|1 Month Follow-up||66
6705472|NCT02896400|7636095|FG003|STARTED|1 Month Follow-up||66
6705473|NCT02896400|7636096|FG004|STARTED|1 Month Follow-up||66
6705474|NCT02896400|7636097|FG005|STARTED|1 Month Follow-up||66
6705475|NCT02896400|7636098|FG006|STARTED|1 Month Follow-up||66
6705476|NCT02896400|7636099|FG007|STARTED|1 Month Follow-up||66
6705477|NCT02896400|7636100|FG008|STARTED|1 Month Follow-up||66
6705478|NCT02896400|7636101|FG009|STARTED|1 Month Follow-up||66
6705479|NCT02896400|7636102|FG010|STARTED|1 Month Follow-up||66
6705480|NCT02896400|7636103|FG011|STARTED|1 Month Follow-up||66
6705481|NCT02896400|7636104|FG012|STARTED|1 Month Follow-up||66
6705482|NCT02896400|7636105|FG013|STARTED|1 Month Follow-up||66
6705483|NCT02896400|7636106|FG014|STARTED|1 Month Follow-up||66
6705484|NCT02896400|7636107|FG015|STARTED|1 Month Follow-up||66
6705485|NCT02896400|7636092|FG000|COMPLETED|1 Month Follow-up||59
6705486|NCT02896400|7636093|FG001|COMPLETED|1 Month Follow-up||59
6705487|NCT02896400|7636094|FG002|COMPLETED|1 Month Follow-up||61
6705488|NCT02896400|7636095|FG003|COMPLETED|1 Month Follow-up||58
6705489|NCT02896400|7636096|FG004|COMPLETED|1 Month Follow-up||57
6705490|NCT02896400|7636097|FG005|COMPLETED|1 Month Follow-up||60
6705491|NCT02896400|7636098|FG006|COMPLETED|1 Month Follow-up||61
6705492|NCT02896400|7636099|FG007|COMPLETED|1 Month Follow-up||60
6705493|NCT02896400|7636100|FG008|COMPLETED|1 Month Follow-up||62
6705494|NCT02896400|7636101|FG009|COMPLETED|1 Month Follow-up||59
6705495|NCT02896400|7636102|FG010|COMPLETED|1 Month Follow-up||61
6705496|NCT02896400|7636103|FG011|COMPLETED|1 Month Follow-up||61
6705497|NCT02896400|7636104|FG012|COMPLETED|1 Month Follow-up||63
6705498|NCT02896400|7636105|FG013|COMPLETED|1 Month Follow-up||62
6705499|NCT02896400|7636106|FG014|COMPLETED|1 Month Follow-up||65
6705500|NCT02896400|7636107|FG015|COMPLETED|1 Month Follow-up||63
6705501|NCT02896400|7636092|FG000|NOT COMPLETED|1 Month Follow-up||7
6705502|NCT02896400|7636093|FG001|NOT COMPLETED|1 Month Follow-up||7
6705503|NCT02896400|7636094|FG002|NOT COMPLETED|1 Month Follow-up||5
6705504|NCT02896400|7636095|FG003|NOT COMPLETED|1 Month Follow-up||8
6705505|NCT02896400|7636096|FG004|NOT COMPLETED|1 Month Follow-up||9
6705506|NCT02896400|7636097|FG005|NOT COMPLETED|1 Month Follow-up||6
6705507|NCT02896400|7636098|FG006|NOT COMPLETED|1 Month Follow-up||5
6705508|NCT02896400|7636099|FG007|NOT COMPLETED|1 Month Follow-up||6
6705509|NCT02896400|7636100|FG008|NOT COMPLETED|1 Month Follow-up||4
6705510|NCT02896400|7636101|FG009|NOT COMPLETED|1 Month Follow-up||7
6705511|NCT02896400|7636102|FG010|NOT COMPLETED|1 Month Follow-up||5
6705512|NCT02896400|7636103|FG011|NOT COMPLETED|1 Month Follow-up||5
6705513|NCT02896400|7636104|FG012|NOT COMPLETED|1 Month Follow-up||3
6705514|NCT02896400|7636105|FG013|NOT COMPLETED|1 Month Follow-up||4
6705515|NCT02896400|7636106|FG014|NOT COMPLETED|1 Month Follow-up||1
6705516|NCT02896400|7636107|FG015|NOT COMPLETED|1 Month Follow-up||3
6705517|NCT02896400|7636092|FG000|STARTED|3 Month Follow-up||66
6705518|NCT02896400|7636093|FG001|STARTED|3 Month Follow-up||66
6705519|NCT02896400|7636094|FG002|STARTED|3 Month Follow-up||66
6705520|NCT02896400|7636095|FG003|STARTED|3 Month Follow-up||66
6705521|NCT02896400|7636096|FG004|STARTED|3 Month Follow-up||66
6705522|NCT02896400|7636097|FG005|STARTED|3 Month Follow-up||66
6705523|NCT02896400|7636098|FG006|STARTED|3 Month Follow-up||66
6705524|NCT02896400|7636099|FG007|STARTED|3 Month Follow-up||66
6705525|NCT02896400|7636100|FG008|STARTED|3 Month Follow-up||66
6705526|NCT02896400|7636101|FG009|STARTED|3 Month Follow-up||66
6705527|NCT02896400|7636102|FG010|STARTED|3 Month Follow-up||66
6705528|NCT02896400|7636103|FG011|STARTED|3 Month Follow-up||66
6705529|NCT02896400|7636104|FG012|STARTED|3 Month Follow-up||66
6705530|NCT02896400|7636105|FG013|STARTED|3 Month Follow-up||66
6705531|NCT02896400|7636106|FG014|STARTED|3 Month Follow-up||66
6705532|NCT02896400|7636107|FG015|STARTED|3 Month Follow-up||65
6705533|NCT02896400|7636092|FG000|COMPLETED|3 Month Follow-up||60
6705534|NCT02896400|7636093|FG001|COMPLETED|3 Month Follow-up||63
6705535|NCT02896400|7636094|FG002|COMPLETED|3 Month Follow-up||60
6705536|NCT02896400|7636095|FG003|COMPLETED|3 Month Follow-up||55
6705537|NCT02896400|7636096|FG004|COMPLETED|3 Month Follow-up||54
6705538|NCT02896400|7636097|FG005|COMPLETED|3 Month Follow-up||60
6705539|NCT02896400|7636098|FG006|COMPLETED|3 Month Follow-up||62
6705540|NCT02896400|7636099|FG007|COMPLETED|3 Month Follow-up||63
6705541|NCT02896400|7636100|FG008|COMPLETED|3 Month Follow-up||60
6705542|NCT02896400|7636101|FG009|COMPLETED|3 Month Follow-up||61
6705543|NCT02896400|7636102|FG010|COMPLETED|3 Month Follow-up||60
6705544|NCT02896400|7636103|FG011|COMPLETED|3 Month Follow-up||60
6705545|NCT02896400|7636104|FG012|COMPLETED|3 Month Follow-up||63
6705546|NCT02896400|7636105|FG013|COMPLETED|3 Month Follow-up||60
6705547|NCT02896400|7636106|FG014|COMPLETED|3 Month Follow-up||62
6705548|NCT02896400|7636107|FG015|COMPLETED|3 Month Follow-up||63
6705549|NCT02896400|7636092|FG000|NOT COMPLETED|3 Month Follow-up||6
6705550|NCT02896400|7636093|FG001|NOT COMPLETED|3 Month Follow-up||3
6705551|NCT02896400|7636094|FG002|NOT COMPLETED|3 Month Follow-up||6
6705552|NCT02896400|7636095|FG003|NOT COMPLETED|3 Month Follow-up||11
6705553|NCT02896400|7636096|FG004|NOT COMPLETED|3 Month Follow-up||12
6705554|NCT02896400|7636097|FG005|NOT COMPLETED|3 Month Follow-up||6
6705555|NCT02896400|7636098|FG006|NOT COMPLETED|3 Month Follow-up||4
6705556|NCT02896400|7636099|FG007|NOT COMPLETED|3 Month Follow-up||3
6705557|NCT02896400|7636100|FG008|NOT COMPLETED|3 Month Follow-up||6
6705558|NCT02896400|7636101|FG009|NOT COMPLETED|3 Month Follow-up||5
6705559|NCT02896400|7636102|FG010|NOT COMPLETED|3 Month Follow-up||6
6705560|NCT02896400|7636103|FG011|NOT COMPLETED|3 Month Follow-up||6
6705561|NCT02896400|7636104|FG012|NOT COMPLETED|3 Month Follow-up||3
6705562|NCT02896400|7636105|FG013|NOT COMPLETED|3 Month Follow-up||6
6705563|NCT02896400|7636106|FG014|NOT COMPLETED|3 Month Follow-up||4
6705564|NCT02896400|7636107|FG015|NOT COMPLETED|3 Month Follow-up||2
6705565|NCT02896400|7636092|FG000|STARTED|Biochemical Verification at 3 Months||60
6705566|NCT02896400|7636093|FG001|STARTED|Biochemical Verification at 3 Months||63
6705567|NCT02896400|7636094|FG002|STARTED|Biochemical Verification at 3 Months||60
6705568|NCT02896400|7636095|FG003|STARTED|Biochemical Verification at 3 Months||55
6705569|NCT02896400|7636096|FG004|STARTED|Biochemical Verification at 3 Months||54
6705570|NCT02896400|7636097|FG005|STARTED|Biochemical Verification at 3 Months||60
6705571|NCT02896400|7636098|FG006|STARTED|Biochemical Verification at 3 Months||62
6705572|NCT02896400|7636099|FG007|STARTED|Biochemical Verification at 3 Months||63
6705573|NCT02896400|7636100|FG008|STARTED|Biochemical Verification at 3 Months||60
6705574|NCT02896400|7636101|FG009|STARTED|Biochemical Verification at 3 Months||61
6705575|NCT02896400|7636102|FG010|STARTED|Biochemical Verification at 3 Months||60
6705576|NCT02896400|7636103|FG011|STARTED|Biochemical Verification at 3 Months||60
6705577|NCT02896400|7636104|FG012|STARTED|Biochemical Verification at 3 Months||63
6705578|NCT02896400|7636105|FG013|STARTED|Biochemical Verification at 3 Months||60
6705579|NCT02896400|7636106|FG014|STARTED|Biochemical Verification at 3 Months||62
6705580|NCT02896400|7636107|FG015|STARTED|Biochemical Verification at 3 Months||63
6705581|NCT02896400|7636092|FG000|COMPLETED|Biochemical Verification at 3 Months||14
6705582|NCT02896400|7636093|FG001|COMPLETED|Biochemical Verification at 3 Months||15
6705583|NCT02896400|7636094|FG002|COMPLETED|Biochemical Verification at 3 Months||13
6705584|NCT02896400|7636095|FG003|COMPLETED|Biochemical Verification at 3 Months||14
6705585|NCT02896400|7636096|FG004|COMPLETED|Biochemical Verification at 3 Months||9
6705586|NCT02896400|7636097|FG005|COMPLETED|Biochemical Verification at 3 Months||11
6705587|NCT02896400|7636098|FG006|COMPLETED|Biochemical Verification at 3 Months||11
6705588|NCT02896400|7636099|FG007|COMPLETED|Biochemical Verification at 3 Months||14
6705589|NCT02896400|7636100|FG008|COMPLETED|Biochemical Verification at 3 Months||15
6705590|NCT02896400|7636101|FG009|COMPLETED|Biochemical Verification at 3 Months||8
6705591|NCT02896400|7636102|FG010|COMPLETED|Biochemical Verification at 3 Months||5
6705592|NCT02896400|7636103|FG011|COMPLETED|Biochemical Verification at 3 Months||19
6705593|NCT02896400|7636104|FG012|COMPLETED|Biochemical Verification at 3 Months||10
6705594|NCT02896400|7636105|FG013|COMPLETED|Biochemical Verification at 3 Months||12
6705595|NCT02896400|7636106|FG014|COMPLETED|Biochemical Verification at 3 Months||7
6705596|NCT02896400|7636107|FG015|COMPLETED|Biochemical Verification at 3 Months||6
6705597|NCT02896400|7636092|FG000|NOT COMPLETED|Biochemical Verification at 3 Months||46
6705598|NCT02896400|7636093|FG001|NOT COMPLETED|Biochemical Verification at 3 Months||48
6705599|NCT02896400|7636094|FG002|NOT COMPLETED|Biochemical Verification at 3 Months||47
6705600|NCT02896400|7636095|FG003|NOT COMPLETED|Biochemical Verification at 3 Months||41
6705601|NCT02896400|7636096|FG004|NOT COMPLETED|Biochemical Verification at 3 Months||45
6705602|NCT02896400|7636097|FG005|NOT COMPLETED|Biochemical Verification at 3 Months||49
6705603|NCT02896400|7636098|FG006|NOT COMPLETED|Biochemical Verification at 3 Months||51
6705604|NCT02896400|7636099|FG007|NOT COMPLETED|Biochemical Verification at 3 Months||49
6705605|NCT02896400|7636100|FG008|NOT COMPLETED|Biochemical Verification at 3 Months||45
6705606|NCT02896400|7636101|FG009|NOT COMPLETED|Biochemical Verification at 3 Months||53
6705607|NCT02896400|7636102|FG010|NOT COMPLETED|Biochemical Verification at 3 Months||55
6705608|NCT02896400|7636103|FG011|NOT COMPLETED|Biochemical Verification at 3 Months||41
6705609|NCT02896400|7636104|FG012|NOT COMPLETED|Biochemical Verification at 3 Months||53
6705610|NCT02896400|7636105|FG013|NOT COMPLETED|Biochemical Verification at 3 Months||48
6705611|NCT02896400|7636106|FG014|NOT COMPLETED|Biochemical Verification at 3 Months||55
6705612|NCT02896400|7636107|FG015|NOT COMPLETED|Biochemical Verification at 3 Months||57
6705613|NCT02896569|7636135|FG000|STARTED|Overall Study||25
6705614|NCT02896569|7636136|FG001|STARTED|Overall Study||24
6705615|NCT02896569|7636135|FG000|COMPLETED|Overall Study||21
6705616|NCT02896569|7636136|FG001|COMPLETED|Overall Study||19
6705617|NCT02896569|7636135|FG000|NOT COMPLETED|Overall Study||4
6705618|NCT02896569|7636136|FG001|NOT COMPLETED|Overall Study||5
6705619|NCT02896595|7636144|FG000|STARTED|Overall Study||50
6705620|NCT02896595|7636145|FG001|STARTED|Overall Study||50
6705621|NCT02896595|7636144|FG000|COMPLETED|Overall Study||50
6705622|NCT02896595|7636145|FG001|COMPLETED|Overall Study||50
6705623|NCT02896595|7636144|FG000|NOT COMPLETED|Overall Study||0
6705624|NCT02896595|7636145|FG001|NOT COMPLETED|Overall Study||0
6705625|NCT02896907|7636151|FG000|STARTED|Overall Study||8
6705626|NCT02896907|7636151|FG000|COMPLETED|Overall Study||8
6705627|NCT02896907|7636151|FG000|NOT COMPLETED|Overall Study||0
6705628|NCT02897115|7636157|FG000|STARTED|Overall Study||14
6705629|NCT02897115|7636158|FG001|STARTED|Overall Study||8
6705630|NCT02897115|7636157|FG000|COMPLETED|Overall Study||3
6705631|NCT02897115|7636158|FG001|COMPLETED|Overall Study||0
6705632|NCT02897115|7636157|FG000|NOT COMPLETED|Overall Study||11
6705633|NCT02897115|7636158|FG001|NOT COMPLETED|Overall Study||8
6705634|NCT02897141|7636166|FG000|STARTED|Overall Study||40
6705635|NCT02897141|7636167|FG001|STARTED|Overall Study||40
6705636|NCT02897141|7636166|FG000|COMPLETED|Overall Study||38
6705637|NCT02897141|7636167|FG001|COMPLETED|Overall Study||39
6705638|NCT02897141|7636166|FG000|NOT COMPLETED|Overall Study||2
6705639|NCT02897141|7636167|FG001|NOT COMPLETED|Overall Study||1
6705640|NCT02897349|7636186|FG000|STARTED|Overall Study||102
6705641|NCT02897349|7636187|FG001|STARTED|Overall Study||104
6705642|NCT02897349|7636186|FG000|COMPLETED|Overall Study||97
6705643|NCT02897349|7636187|FG001|COMPLETED|Overall Study||98
6705644|NCT02897349|7636186|FG000|NOT COMPLETED|Overall Study||5
6705645|NCT02897349|7636187|FG001|NOT COMPLETED|Overall Study||6
6705646|NCT02898077|7636195|FG000|STARTED|Overall Study||294
6705647|NCT02898077|7636196|FG001|STARTED|Overall Study||146
6705648|NCT02898077|7636195|FG000|Received at Least 1 Dose of Study Drug|Overall Study||293
6705649|NCT02898077|7636196|FG001|Received at Least 1 Dose of Study Drug|Overall Study||145
6705650|NCT02898077|7636195|FG000|COMPLETED|Overall Study||199
6705651|NCT02898077|7636196|FG001|COMPLETED|Overall Study||116
6705652|NCT02898077|7636195|FG000|NOT COMPLETED|Overall Study||95
6705653|NCT02898077|7636196|FG001|NOT COMPLETED|Overall Study||30
6705654|NCT02898103|7636204|FG000|STARTED|Overall Study||4
6705655|NCT02898103|7636205|FG001|STARTED|Overall Study||3
6705656|NCT02898103|7636204|FG000|COMPLETED|Overall Study||4
6705657|NCT02898103|7636205|FG001|COMPLETED|Overall Study||3
6705658|NCT02898103|7636204|FG000|NOT COMPLETED|Overall Study||0
6705659|NCT02898103|7636205|FG001|NOT COMPLETED|Overall Study||0
6705660|NCT02898116|7636215|FG000|STARTED|Overall Study||2
6705661|NCT02898116|7636215|FG000|COMPLETED|Overall Study||0
6260983|NCT02964039|7159742|FG001|NOT COMPLETED|Overall Study||1
6260984|NCT02964039|7159743|FG002|NOT COMPLETED|Overall Study||5
6260985|NCT02930889|7159751|FG000|STARTED|Overall Study||21
6260986|NCT02930889|7159751|FG000|COMPLETED|Overall Study||5
6260987|NCT02930889|7159751|FG000|NOT COMPLETED|Overall Study||16
6260988|NCT02919618|7159755|FG000|STARTED|Overall Study||19
6260989|NCT02919618|7159755|FG000|Primary Safety Endpoint (</=90 Days)|Overall Study||19
6260990|NCT02919618|7159755|FG000|Primary Efficacy Endpoint (6 Months)|Overall Study||18
6260991|NCT02919618|7159755|FG000|COMPLETED|Overall Study||18
6260992|NCT02919618|7159755|FG000|NOT COMPLETED|Overall Study||1
6260993|NCT02844946|7159772|FG000|STARTED|Overall Study||27
6260994|NCT02844946|7159773|FG001|STARTED|Overall Study||12
6260995|NCT02844946|7159772|FG000|COMPLETED|Overall Study||20
6260996|NCT02844946|7159773|FG001|COMPLETED|Overall Study||12
6260997|NCT02844946|7159772|FG000|NOT COMPLETED|Overall Study||7
6260998|NCT02844946|7159773|FG001|NOT COMPLETED|Overall Study||0
6260999|NCT02675114|7159781|FG000|STARTED|Overall Study||497
6261000|NCT02675114|7159782|FG001|STARTED|Overall Study||503
6261001|NCT02675114|7159781|FG000|As Treated|Overall Study||454
6261002|NCT02675114|7159782|FG001|As Treated|Overall Study||496
6261003|NCT02675114|7159781|FG000|Valve Implant|Overall Study||453
6261004|NCT02675114|7159782|FG001|Valve Implant|Overall Study||495
6261005|NCT02675114|7159781|FG000|COMPLETED|Overall Study||424
6261006|NCT02675114|7159782|FG001|COMPLETED|Overall Study||490
6261007|NCT02675114|7159781|FG000|NOT COMPLETED|Overall Study||73
6261008|NCT02675114|7159782|FG001|NOT COMPLETED|Overall Study||13
6261009|NCT02564796|7159790|FG000|STARTED|Overall Study||2
6261010|NCT02564796|7159791|FG001|STARTED|Overall Study||2
6261011|NCT02564796|7159790|FG000|COMPLETED|Overall Study||0
6261012|NCT02564796|7159791|FG001|COMPLETED|Overall Study||0
6261013|NCT02564796|7159790|FG000|NOT COMPLETED|Overall Study||2
6261014|NCT02564796|7159791|FG001|NOT COMPLETED|Overall Study||2
6261015|NCT02562716|7159799|FG000|STARTED|Overall Study||55
6261016|NCT02562716|7159800|FG001|STARTED|Overall Study||47
6261017|NCT02562716|7159799|FG000|Participants Assessed for AEs|Overall Study||53
6261018|NCT02562716|7159800|FG001|Participants Assessed for AEs|Overall Study||45
6261019|NCT02562716|7159799|FG000|COMPLETED|Overall Study||27
6261020|NCT02562716|7159800|FG001|COMPLETED|Overall Study||19
6705662|NCT02898116|7636215|FG000|NOT COMPLETED|Overall Study||2
6261021|NCT02562716|7159799|FG000|NOT COMPLETED|Overall Study||28
6261022|NCT02562716|7159800|FG001|NOT COMPLETED|Overall Study||28
6261023|NCT02211131|7159810|FG000|STARTED|Overall Study||74
6261024|NCT02211131|7159811|FG001|STARTED|Overall Study||76
6261025|NCT02211131|7159810|FG000|COMPLETED|Overall Study||0
6261026|NCT02211131|7159811|FG001|COMPLETED|Overall Study||0
6261027|NCT02211131|7159810|FG000|NOT COMPLETED|Overall Study||74
6261028|NCT02211131|7159811|FG001|NOT COMPLETED|Overall Study||76
6261029|NCT01803854|7159824|FG000|STARTED|Overall Study||1275
6261030|NCT01803854|7159824|FG000|COMPLETED|Overall Study||1275
6261031|NCT01803854|7159824|FG000|NOT COMPLETED|Overall Study||0
6261032|NCT01472081|7159835|FG000|STARTED|Overall Study||7
6261033|NCT01472081|7159836|FG001|STARTED|Overall Study||26
6261034|NCT01472081|7159837|FG002|STARTED|Overall Study||20
6261035|NCT01472081|7159838|FG003|STARTED|Overall Study||47
6261036|NCT01472081|7159839|FG004|STARTED|Overall Study||47
6261037|NCT01472081|7159840|FG005|STARTED|Overall Study||6
6261038|NCT01472081|7159835|FG000|COMPLETED|Overall Study||0
6261039|NCT01472081|7159836|FG001|COMPLETED|Overall Study||0
6261040|NCT01472081|7159837|FG002|COMPLETED|Overall Study||0
6261041|NCT01472081|7159838|FG003|COMPLETED|Overall Study||1
6261042|NCT01472081|7159839|FG004|COMPLETED|Overall Study||0
6261043|NCT01472081|7159840|FG005|COMPLETED|Overall Study||0
6705663|NCT02898454|7636222|FG000|STARTED|Overall Study||153
6705664|NCT02898454|7636223|FG001|STARTED|Overall Study||145
6705665|NCT02898454|7636224|FG002|STARTED|Overall Study||150
6739111|NCT03286751|7668062|FG001|COMPLETED|Period 1||7
6261044|NCT01472081|7159835|FG000|NOT COMPLETED|Overall Study||7
6261045|NCT01472081|7159836|FG001|NOT COMPLETED|Overall Study||26
6261046|NCT01472081|7159837|FG002|NOT COMPLETED|Overall Study||20
6261047|NCT01472081|7159838|FG003|NOT COMPLETED|Overall Study||46
6705666|NCT02898454|7636222|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
6705667|NCT02898454|7636223|FG001|Intent-to-Treat (ITT) Population|Overall Study||145
6705668|NCT02898454|7636224|FG002|Intent-to-Treat (ITT) Population|Overall Study||150
6705669|NCT02898454|7636222|FG000|Treated|Overall Study||152
6705670|NCT02898454|7636223|FG001|Treated|Overall Study||145
6705671|NCT02898454|7636224|FG002|Treated|Overall Study||150
6705672|NCT02898454|7636222|FG000|Safety Population|Overall Study|2 participants randomized to placebo received 1 dose of dupilumab:counted in 300 mg q2w then q4w arm|150
6705673|NCT02898454|7636223|FG001|Safety Population|Overall Study|1 randomized to dupilumab q2w arm received 1dose of placebo: counted in 300 mg q2w then q4w arm.|148
6705674|NCT02898454|7636224|FG002|Safety Population|Overall Study||149
6705675|NCT02898454|7636222|FG000|COMPLETED|Overall Study||136
6705676|NCT02898454|7636223|FG001|COMPLETED|Overall Study||140
6705677|NCT02898454|7636224|FG002|COMPLETED|Overall Study||144
6705678|NCT02898454|7636222|FG000|NOT COMPLETED|Overall Study||17
6705679|NCT02898454|7636223|FG001|NOT COMPLETED|Overall Study||5
6705680|NCT02898454|7636224|FG002|NOT COMPLETED|Overall Study||6
6705681|NCT02898597|7636239|FG000|STARTED|Overall Study||25
6705682|NCT02898597|7636240|FG001|STARTED|Overall Study||24
6705683|NCT02898597|7636239|FG000|COMPLETED|Overall Study||21
6705684|NCT02898597|7636240|FG001|COMPLETED|Overall Study||12
6705685|NCT02898597|7636239|FG000|NOT COMPLETED|Overall Study||4
6705686|NCT02898597|7636240|FG001|NOT COMPLETED|Overall Study||12
6705687|NCT02898662|7636248|FG000|STARTED|Overall Study||40
6705688|NCT02898662|7636249|FG001|STARTED|Overall Study||41
6705689|NCT02898662|7636248|FG000|Completed Treatment|Overall Study||25
6705690|NCT02898662|7636249|FG001|Completed Treatment|Overall Study||29
6705691|NCT02898662|7636248|FG000|COMPLETED|Overall Study||11
6705692|NCT02898662|7636249|FG001|COMPLETED|Overall Study||13
6705693|NCT02898662|7636248|FG000|NOT COMPLETED|Overall Study||29
6705694|NCT02898662|7636249|FG001|NOT COMPLETED|Overall Study||28
6705695|NCT02898740|7636257|FG000|STARTED|Overall Study||21
6705696|NCT02898740|7636258|FG001|STARTED|Overall Study||19
6705697|NCT02898740|7636257|FG000|COMPLETED|Overall Study||21
6705698|NCT02898740|7636258|FG001|COMPLETED|Overall Study||19
6705699|NCT02898740|7636257|FG000|NOT COMPLETED|Overall Study||0
6705700|NCT02898740|7636258|FG001|NOT COMPLETED|Overall Study||0
6705701|NCT02898974|7636266|FG000|STARTED|Overall Study||13
6705702|NCT02898974|7636267|FG001|STARTED|Overall Study||9
6705703|NCT02898974|7636266|FG000|COMPLETED|Overall Study||13
6705704|NCT02898974|7636267|FG001|COMPLETED|Overall Study||9
6705705|NCT02898974|7636266|FG000|NOT COMPLETED|Overall Study||0
6705706|NCT02898974|7636267|FG001|NOT COMPLETED|Overall Study||0
6705707|NCT02899156|7636275|FG000|STARTED|Overall Study||11
6705708|NCT02899156|7636276|FG001|STARTED|Overall Study||11
6705709|NCT02899156|7636275|FG000|COMPLETED|Overall Study||10
6705710|NCT02899156|7636276|FG001|COMPLETED|Overall Study||10
6705711|NCT02899156|7636275|FG000|NOT COMPLETED|Overall Study||1
6705712|NCT02899156|7636276|FG001|NOT COMPLETED|Overall Study||1
6705713|NCT02899195|7636282|FG000|STARTED|Concurrent Durvalumab||55
6705714|NCT02899195|7636282|FG000|COMPLETED|Concurrent Durvalumab||44
6705715|NCT02899195|7636282|FG000|NOT COMPLETED|Concurrent Durvalumab||11
6705716|NCT02899195|7636282|FG000|STARTED|Maintenance Durvalumab||44
6705717|NCT02899195|7636282|FG000|COMPLETED|Maintenance Durvalumab||10
6705718|NCT02899195|7636282|FG000|NOT COMPLETED|Maintenance Durvalumab||34
6705719|NCT02899338|7636288|FG000|STARTED|Overall Study||81
6705720|NCT02899338|7636289|FG001|STARTED|Overall Study||81
6705721|NCT02899338|7636288|FG000|COMPLETED|Overall Study||78
6705722|NCT02899338|7636289|FG001|COMPLETED|Overall Study||79
6705723|NCT02899338|7636288|FG000|NOT COMPLETED|Overall Study||3
6705724|NCT02899338|7636289|FG001|NOT COMPLETED|Overall Study||2
6705725|NCT02899377|7636297|FG000|STARTED|Overall Study||13
6705726|NCT02899377|7636298|FG001|STARTED|Overall Study||12
6705727|NCT02899377|7636297|FG000|COMPLETED|Overall Study||12
6705728|NCT02899377|7636298|FG001|COMPLETED|Overall Study||12
6705729|NCT02899377|7636297|FG000|NOT COMPLETED|Overall Study||1
6705730|NCT02899377|7636298|FG001|NOT COMPLETED|Overall Study||0
6705731|NCT02899650|7636309|FG000|STARTED|Overall Study||15
6705732|NCT02899650|7636310|FG001|STARTED|Overall Study||10
6705733|NCT02899650|7636311|FG002|STARTED|Overall Study||14
6705734|NCT02899650|7636312|FG003|STARTED|Overall Study|We were not able to recruit older unfit adults so this group was dropped from the study.|0
6705735|NCT02899650|7636309|FG000|COMPLETED|Overall Study||15
6705736|NCT02899650|7636310|FG001|COMPLETED|Overall Study||10
6705737|NCT02899650|7636311|FG002|COMPLETED|Overall Study||14
6705738|NCT02899650|7636312|FG003|COMPLETED|Overall Study||0
6705739|NCT02899650|7636309|FG000|NOT COMPLETED|Overall Study||0
6705740|NCT02899650|7636310|FG001|NOT COMPLETED|Overall Study||0
6705741|NCT02899650|7636311|FG002|NOT COMPLETED|Overall Study||0
6705742|NCT02899650|7636312|FG003|NOT COMPLETED|Overall Study||0
6705743|NCT02899689|7636323|FG000|STARTED|Overall Study||209
6705744|NCT02899689|7636324|FG001|STARTED|Overall Study||210
6705745|NCT02899689|7636323|FG000|COMPLETED|Overall Study||209
6705746|NCT02899689|7636324|FG001|COMPLETED|Overall Study||208
6705747|NCT02899689|7636323|FG000|NOT COMPLETED|Overall Study||0
6705748|NCT02899689|7636324|FG001|NOT COMPLETED|Overall Study||2
6705749|NCT02899884|7636330|FG000|STARTED|Overall Study||3765
6705750|NCT02899884|7636330|FG000|COMPLETED|Overall Study||3765
6705751|NCT02899884|7636330|FG000|NOT COMPLETED|Overall Study||0
6705752|NCT02899962|7636334|FG000|STARTED|Open-label Phase||650
6705753|NCT02899962|7636335|FG001|STARTED|Open-label Phase||0
6705754|NCT02899962|7636336|FG002|STARTED|Open-label Phase||0
6705755|NCT02899962|7636334|FG000|COMPLETED|Open-label Phase||623
6705756|NCT02899962|7636335|FG001|COMPLETED|Open-label Phase||0
6705757|NCT02899962|7636336|FG002|COMPLETED|Open-label Phase||0
6705758|NCT02899962|7636334|FG000|NOT COMPLETED|Open-label Phase||27
6705759|NCT02899962|7636335|FG001|NOT COMPLETED|Open-label Phase||0
6705760|NCT02899962|7636336|FG002|NOT COMPLETED|Open-label Phase||0
6705761|NCT02899962|7636334|FG000|STARTED|Maintenance Phase||0
6705762|NCT02899962|7636335|FG001|STARTED|Maintenance Phase||272
6705763|NCT02899962|7636336|FG002|STARTED|Maintenance Phase||273
6705764|NCT02899962|7636334|FG000|COMPLETED|Maintenance Phase||0
6705765|NCT02899962|7636335|FG001|COMPLETED|Maintenance Phase||131
6705766|NCT02899962|7636336|FG002|COMPLETED|Maintenance Phase||120
6705767|NCT02899962|7636334|FG000|NOT COMPLETED|Maintenance Phase||0
6705768|NCT02899962|7636335|FG001|NOT COMPLETED|Maintenance Phase||141
6705769|NCT02899962|7636336|FG002|NOT COMPLETED|Maintenance Phase||153
6705770|NCT02899988|7636347|FG000|STARTED|Induction Period (16 Weeks)||52
6705771|NCT02899988|7636348|FG001|STARTED|Induction Period (16 Weeks)||51
6705772|NCT02899988|7636349|FG002|STARTED|Induction Period (16 Weeks)||51
6705773|NCT02899988|7636350|FG003|STARTED|Induction Period (16 Weeks)||51
6705774|NCT02899988|7636351|FG004|STARTED|Induction Period (16 Weeks)||0
6705775|NCT02899988|7636352|FG005|STARTED|Induction Period (16 Weeks)||0
6705776|NCT02899988|7636353|FG006|STARTED|Induction Period (16 Weeks)||0
6705777|NCT02899988|7636354|FG007|STARTED|Induction Period (16 Weeks)||0
6705778|NCT02899988|7636355|FG008|STARTED|Induction Period (16 Weeks)||0
6705779|NCT02899988|7636356|FG009|STARTED|Induction Period (16 Weeks)||0
6705780|NCT02899988|7636357|FG010|STARTED|Induction Period (16 Weeks)||0
6705781|NCT02899988|7636347|FG000|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||52
6705782|NCT02899988|7636348|FG001|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
6705783|NCT02899988|7636349|FG002|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
6705784|NCT02899988|7636350|FG003|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||51
6705785|NCT02899988|7636351|FG004|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6705786|NCT02899988|7636352|FG005|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6705787|NCT02899988|7636353|FG006|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6705788|NCT02899988|7636354|FG007|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6705789|NCT02899988|7636355|FG008|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6705790|NCT02899988|7636356|FG009|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6705791|NCT02899988|7636357|FG010|Received at Least One Dose of Study Drug|Induction Period (16 Weeks)||0
6705792|NCT02899988|7636347|FG000|COMPLETED|Induction Period (16 Weeks)||50
6705793|NCT02899988|7636348|FG001|COMPLETED|Induction Period (16 Weeks)||49
6705794|NCT02899988|7636349|FG002|COMPLETED|Induction Period (16 Weeks)||51
6705795|NCT02899988|7636350|FG003|COMPLETED|Induction Period (16 Weeks)||49
6705796|NCT02899988|7636351|FG004|COMPLETED|Induction Period (16 Weeks)||0
6705797|NCT02899988|7636352|FG005|COMPLETED|Induction Period (16 Weeks)||0
6705798|NCT02899988|7636353|FG006|COMPLETED|Induction Period (16 Weeks)||0
6705799|NCT02899988|7636354|FG007|COMPLETED|Induction Period (16 Weeks)||0
6705800|NCT02899988|7636355|FG008|COMPLETED|Induction Period (16 Weeks)||0
6705801|NCT02899988|7636356|FG009|COMPLETED|Induction Period (16 Weeks)||0
6705802|NCT02899988|7636357|FG010|COMPLETED|Induction Period (16 Weeks)||0
6705803|NCT02899988|7636347|FG000|NOT COMPLETED|Induction Period (16 Weeks)||2
6705804|NCT02899988|7636348|FG001|NOT COMPLETED|Induction Period (16 Weeks)||2
6705805|NCT02899988|7636349|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
6705806|NCT02899988|7636350|FG003|NOT COMPLETED|Induction Period (16 Weeks)||2
6705807|NCT02899988|7636351|FG004|NOT COMPLETED|Induction Period (16 Weeks)||0
6705808|NCT02899988|7636352|FG005|NOT COMPLETED|Induction Period (16 Weeks)||0
6705809|NCT02899988|7636353|FG006|NOT COMPLETED|Induction Period (16 Weeks)||0
6705810|NCT02899988|7636354|FG007|NOT COMPLETED|Induction Period (16 Weeks)||0
6705811|NCT02899988|7636355|FG008|NOT COMPLETED|Induction Period (16 Weeks)||0
6261048|NCT01472081|7159839|FG004|NOT COMPLETED|Overall Study||47
6261049|NCT01472081|7159840|FG005|NOT COMPLETED|Overall Study||6
6261050|NCT01309672|7159853|FG000|STARTED|Overall Study||41
6261051|NCT01309672|7159853|FG000|Received Protocol Treatment|Overall Study||40
6261052|NCT01309672|7159853|FG000|COMPLETED|Overall Study||4
6261053|NCT01309672|7159853|FG000|NOT COMPLETED|Overall Study||37
6261054|NCT01131169|7159860|FG000|STARTED|Overall Study||47
6261055|NCT01131169|7159861|FG001|STARTED|Overall Study||19
6261056|NCT01131169|7159860|FG000|COMPLETED|Overall Study||47
6261057|NCT01131169|7159861|FG001|COMPLETED|Overall Study||19
6261058|NCT01131169|7159860|FG000|NOT COMPLETED|Overall Study||0
6261059|NCT01131169|7159861|FG001|NOT COMPLETED|Overall Study||0
6261060|NCT00774345|7159870|FG000|STARTED|Pre-treatment||160
6705812|NCT02899988|7636356|FG009|NOT COMPLETED|Induction Period (16 Weeks)||0
6705813|NCT02899988|7636357|FG010|NOT COMPLETED|Induction Period (16 Weeks)||0
6705814|NCT02899988|7636347|FG000|STARTED|Maintenance Period (88 Weeks)|No participants received placebo during maintenance period.|0
6705815|NCT02899988|7636348|FG001|STARTED|Maintenance Period (88 Weeks)|No participants received 30 mg mirikizumab Q8W in both induction and maintenance.|0
6705816|NCT02899988|7636349|FG002|STARTED|Maintenance Period (88 Weeks)|No participants received 100 mg mirikizumab Q8W in both induction and maintenance.|0
6705817|NCT02899988|7636350|FG003|STARTED|Maintenance Period (88 Weeks)||0
6705818|NCT02899988|7636351|FG004|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction period.|15
6705819|NCT02899988|7636352|FG005|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction period.|30
6705820|NCT02899988|7636353|FG006|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction period.|34
6705821|NCT02899988|7636354|FG007|STARTED|Maintenance Period (88 Weeks)|Participants received placebo during induction period.|50
6705822|NCT02899988|7636355|FG008|STARTED|Maintenance Period (88 Weeks)|Participants received 30 mg mirikizumab Q8W during induction arm.|34
6705823|NCT02899988|7636356|FG009|STARTED|Maintenance Period (88 Weeks)|Participants received 100 mg mirikizumab Q8W during induction arm.|21
6705824|NCT02899988|7636357|FG010|STARTED|Maintenance Period (88 Weeks)|Participants received 300 mg mirikizumab Q8W during induction arm.|15
6705825|NCT02899988|7636347|FG000|Rescue Participants|Maintenance Period (88 Weeks)||0
6705826|NCT02899988|7636348|FG001|Rescue Participants|Maintenance Period (88 Weeks)||0
6705827|NCT02899988|7636349|FG002|Rescue Participants|Maintenance Period (88 Weeks)||0
6705828|NCT02899988|7636350|FG003|Rescue Participants|Maintenance Period (88 Weeks)|In PRN not regaining ≥ PASI 90 after 3 consecutive doses of drug or have < PASI 50 after 1 dose.|10
6705829|NCT02899988|7636351|FG004|Rescue Participants|Maintenance Period (88 Weeks)||0
6705830|NCT02899988|7636352|FG005|Rescue Participants|Maintenance Period (88 Weeks)||0
6705831|NCT02899988|7636353|FG006|Rescue Participants|Maintenance Period (88 Weeks)||0
6705832|NCT02899988|7636354|FG007|Rescue Participants|Maintenance Period (88 Weeks)||0
6705833|NCT02899988|7636355|FG008|Rescue Participants|Maintenance Period (88 Weeks)||0
6705834|NCT02899988|7636356|FG009|Rescue Participants|Maintenance Period (88 Weeks)||0
6705835|NCT02899988|7636357|FG010|Rescue Participants|Maintenance Period (88 Weeks)||0
6705836|NCT02899988|7636347|FG000|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
6705837|NCT02899988|7636348|FG001|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
6705838|NCT02899988|7636349|FG002|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
6705839|NCT02899988|7636350|FG003|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||13
6705840|NCT02899988|7636351|FG004|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||9
6705841|NCT02899988|7636352|FG005|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||18
6705842|NCT02899988|7636353|FG006|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||26
6705843|NCT02899988|7636354|FG007|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||42
6705844|NCT02899988|7636355|FG008|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||24
6705845|NCT02899988|7636356|FG009|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||17
6705846|NCT02899988|7636357|FG010|Roll Over to AMAH (NCT03556202)|Maintenance Period (88 Weeks)||0
6705847|NCT02899988|7636347|FG000|COMPLETED|Maintenance Period (88 Weeks)||0
6705848|NCT02899988|7636348|FG001|COMPLETED|Maintenance Period (88 Weeks)||0
6705849|NCT02899988|7636349|FG002|COMPLETED|Maintenance Period (88 Weeks)||0
6705850|NCT02899988|7636350|FG003|COMPLETED|Maintenance Period (88 Weeks)||0
6705851|NCT02899988|7636351|FG004|COMPLETED|Maintenance Period (88 Weeks)||13
6705852|NCT02899988|7636352|FG005|COMPLETED|Maintenance Period (88 Weeks)||27
6705853|NCT02899988|7636353|FG006|COMPLETED|Maintenance Period (88 Weeks)||30
6705854|NCT02899988|7636354|FG007|COMPLETED|Maintenance Period (88 Weeks)||45
6705855|NCT02899988|7636355|FG008|COMPLETED|Maintenance Period (88 Weeks)||30
6705856|NCT02899988|7636356|FG009|COMPLETED|Maintenance Period (88 Weeks)||19
6705857|NCT02899988|7636357|FG010|COMPLETED|Maintenance Period (88 Weeks)||13
6705858|NCT02899988|7636347|FG000|NOT COMPLETED|Maintenance Period (88 Weeks)||0
6705859|NCT02899988|7636348|FG001|NOT COMPLETED|Maintenance Period (88 Weeks)||0
6705860|NCT02899988|7636349|FG002|NOT COMPLETED|Maintenance Period (88 Weeks)||0
6705861|NCT02899988|7636350|FG003|NOT COMPLETED|Maintenance Period (88 Weeks)||0
6705862|NCT02899988|7636351|FG004|NOT COMPLETED|Maintenance Period (88 Weeks)||2
6705863|NCT02899988|7636352|FG005|NOT COMPLETED|Maintenance Period (88 Weeks)||3
6705864|NCT02899988|7636353|FG006|NOT COMPLETED|Maintenance Period (88 Weeks)||4
6705865|NCT02899988|7636354|FG007|NOT COMPLETED|Maintenance Period (88 Weeks)||5
6705866|NCT02899988|7636355|FG008|NOT COMPLETED|Maintenance Period (88 Weeks)||4
6705867|NCT02899988|7636356|FG009|NOT COMPLETED|Maintenance Period (88 Weeks)||2
6705868|NCT02899988|7636357|FG010|NOT COMPLETED|Maintenance Period (88 Weeks)||2
6705869|NCT02899988|7636347|FG000|STARTED|Follow-Up (16 Weeks)||0
6705870|NCT02899988|7636348|FG001|STARTED|Follow-Up (16 Weeks)||0
6705871|NCT02899988|7636349|FG002|STARTED|Follow-Up (16 Weeks)||0
6705872|NCT02899988|7636350|FG003|STARTED|Follow-Up (16 Weeks)||0
6705873|NCT02899988|7636351|FG004|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
6705874|NCT02899988|7636352|FG005|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|4
6705875|NCT02899988|7636353|FG006|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
6705876|NCT02899988|7636354|FG007|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|3
6705877|NCT02899988|7636355|FG008|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|6
6705878|NCT02899988|7636356|FG009|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|2
6705879|NCT02899988|7636357|FG010|STARTED|Follow-Up (16 Weeks)|Not all participants that completed maintenance period continued to follow-up period.|0
6705880|NCT02899988|7636347|FG000|COMPLETED|Follow-Up (16 Weeks)||0
6705881|NCT02899988|7636348|FG001|COMPLETED|Follow-Up (16 Weeks)||0
6705882|NCT02899988|7636349|FG002|COMPLETED|Follow-Up (16 Weeks)||0
6705883|NCT02899988|7636350|FG003|COMPLETED|Follow-Up (16 Weeks)||0
6705884|NCT02899988|7636351|FG004|COMPLETED|Follow-Up (16 Weeks)||2
6705885|NCT02899988|7636352|FG005|COMPLETED|Follow-Up (16 Weeks)||4
6705886|NCT02899988|7636353|FG006|COMPLETED|Follow-Up (16 Weeks)||3
6705887|NCT02899988|7636354|FG007|COMPLETED|Follow-Up (16 Weeks)||3
6705888|NCT02899988|7636355|FG008|COMPLETED|Follow-Up (16 Weeks)||6
6705889|NCT02899988|7636356|FG009|COMPLETED|Follow-Up (16 Weeks)||2
6705890|NCT02899988|7636357|FG010|COMPLETED|Follow-Up (16 Weeks)||0
6705891|NCT02899988|7636347|FG000|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705892|NCT02899988|7636348|FG001|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705893|NCT02899988|7636349|FG002|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705894|NCT02899988|7636350|FG003|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705895|NCT02899988|7636351|FG004|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705896|NCT02899988|7636352|FG005|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705897|NCT02899988|7636353|FG006|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705898|NCT02899988|7636354|FG007|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705899|NCT02899988|7636355|FG008|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705900|NCT02899988|7636356|FG009|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705901|NCT02899988|7636357|FG010|NOT COMPLETED|Follow-Up (16 Weeks)||0
6705902|NCT02900092|7636389|FG000|STARTED|Overall Study||10
6705903|NCT02900092|7636389|FG000|COMPLETED|Overall Study||9
6705904|NCT02900092|7636389|FG000|NOT COMPLETED|Overall Study||1
6705905|NCT02900170|7636393|FG000|STARTED|Overall Study||8
6705906|NCT02900170|7636393|FG000|COMPLETED|Overall Study||0
6705907|NCT02900170|7636393|FG000|NOT COMPLETED|Overall Study||8
6705908|NCT02900378|7636399|FG000|STARTED|Randomization (Visit 2)||310
6705909|NCT02900378|7636400|FG001|STARTED|Randomization (Visit 2)||311
6705910|NCT02900378|7636399|FG000|COMPLETED|Randomization (Visit 2)||287
6705911|NCT02900378|7636400|FG001|COMPLETED|Randomization (Visit 2)||283
6705912|NCT02900378|7636399|FG000|NOT COMPLETED|Randomization (Visit 2)||23
6705913|NCT02900378|7636400|FG001|NOT COMPLETED|Randomization (Visit 2)||28
6705914|NCT02900378|7636399|FG000|STARTED|Treatment Phase||309
6705915|NCT02900378|7636400|FG001|STARTED|Treatment Phase||310
6705916|NCT02900378|7636399|FG000|Full Analysis Set|Treatment Phase||302
6705917|NCT02900378|7636400|FG001|Full Analysis Set|Treatment Phase||302
6705918|NCT02900378|7636399|FG000|COMPLETED|Treatment Phase||309
6705919|NCT02900378|7636400|FG001|COMPLETED|Treatment Phase||310
6705920|NCT02900378|7636399|FG000|NOT COMPLETED|Treatment Phase||0
6705921|NCT02900378|7636400|FG001|NOT COMPLETED|Treatment Phase||0
6705922|NCT02901054|7636406|FG000|STARTED|Overall Study|19 consented, 3 withdrew prior to intervention, 1 received study drug but surgery was cancelled.|19
6705923|NCT02901054|7636406|FG000|COMPLETED|Overall Study||15
6705924|NCT02901054|7636406|FG000|NOT COMPLETED|Overall Study||4
6705925|NCT02901080|7636410|FG000|STARTED|Overall Study||161
6705926|NCT02901080|7636410|FG000|COMPLETED|Overall Study||112
6705927|NCT02901080|7636410|FG000|NOT COMPLETED|Overall Study||49
6705928|NCT02901249|7636416|FG000|STARTED|Overall Study||68
6705929|NCT02901249|7636416|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|43
6705930|NCT02901249|7636416|FG000|NOT COMPLETED|Overall Study||25
6705931|NCT02901275|7636420|FG000|STARTED|Overall Study||29
6705932|NCT02901275|7636420|FG000|Placebo + Placebo|Overall Study||29
6705933|NCT02901275|7636420|FG000|Hydromorphone (Oral) 4mg + Placebo|Overall Study||29
6705934|NCT02901275|7636420|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 2.5mg|Overall Study||29
6705935|NCT02901275|7636420|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 5mg|Overall Study||29
6705936|NCT02901275|7636420|FG000|Hydromorphone (Oral) 4mg + Dronabinol (Oral) 10mg|Overall Study||29
6705937|NCT02901275|7636420|FG000|COMPLETED|Overall Study||29
6705938|NCT02901275|7636420|FG000|NOT COMPLETED|Overall Study||0
6705939|NCT02901431|7636440|FG000|STARTED|PK Part||12
6705940|NCT02901431|7636441|FG001|STARTED|PK Part||11
6705941|NCT02901431|7636442|FG002|STARTED|PK Part||15
6705942|NCT02901431|7636443|FG003|STARTED|PK Part||0
6705943|NCT02901431|7636444|FG004|STARTED|PK Part||0
6705944|NCT02901431|7636445|FG005|STARTED|PK Part||0
6705945|NCT02901431|7636446|FG006|STARTED|PK Part||0
6705946|NCT02901431|7636447|FG007|STARTED|PK Part||0
6705947|NCT02901431|7636448|FG008|STARTED|PK Part||0
6705948|NCT02901431|7636449|FG009|STARTED|PK Part||0
6705949|NCT02901431|7636450|FG010|STARTED|PK Part||0
6705950|NCT02901431|7636451|FG011|STARTED|PK Part||0
6705951|NCT02901431|7636452|FG012|STARTED|PK Part||0
6705952|NCT02901431|7636440|FG000|COMPLETED|PK Part||5
6705953|NCT02901431|7636441|FG001|COMPLETED|PK Part||5
6705954|NCT02901431|7636442|FG002|COMPLETED|PK Part||6
6705955|NCT02901431|7636443|FG003|COMPLETED|PK Part||0
6705956|NCT02901431|7636444|FG004|COMPLETED|PK Part||0
6705957|NCT02901431|7636445|FG005|COMPLETED|PK Part||0
6705958|NCT02901431|7636446|FG006|COMPLETED|PK Part||0
6705959|NCT02901431|7636447|FG007|COMPLETED|PK Part||0
6705960|NCT02901431|7636448|FG008|COMPLETED|PK Part||0
6705961|NCT02901431|7636449|FG009|COMPLETED|PK Part||0
6705962|NCT02901431|7636450|FG010|COMPLETED|PK Part||0
6705963|NCT02901431|7636451|FG011|COMPLETED|PK Part||0
6705964|NCT02901431|7636452|FG012|COMPLETED|PK Part||0
6705965|NCT02901431|7636440|FG000|NOT COMPLETED|PK Part||7
6705966|NCT02901431|7636441|FG001|NOT COMPLETED|PK Part||6
6705967|NCT02901431|7636442|FG002|NOT COMPLETED|PK Part||9
6705968|NCT02901431|7636443|FG003|NOT COMPLETED|PK Part||0
6705969|NCT02901431|7636444|FG004|NOT COMPLETED|PK Part||0
6705970|NCT02901431|7636445|FG005|NOT COMPLETED|PK Part||0
6705971|NCT02901431|7636446|FG006|NOT COMPLETED|PK Part||0
6705972|NCT02901431|7636447|FG007|NOT COMPLETED|PK Part||0
6705973|NCT02901431|7636448|FG008|NOT COMPLETED|PK Part||0
6705974|NCT02901431|7636449|FG009|NOT COMPLETED|PK Part||0
6705975|NCT02901431|7636450|FG010|NOT COMPLETED|PK Part||0
6705976|NCT02901431|7636451|FG011|NOT COMPLETED|PK Part||0
6705977|NCT02901431|7636452|FG012|NOT COMPLETED|PK Part||0
6705978|NCT02901431|7636440|FG000|STARTED|Main Treatment Part||0
6705979|NCT02901431|7636441|FG001|STARTED|Main Treatment Part||0
6705980|NCT02901431|7636442|FG002|STARTED|Main Treatment Part||0
6705981|NCT02901431|7636443|FG003|STARTED|Main Treatment Part||112
6705982|NCT02901431|7636444|FG004|STARTED|Main Treatment Part||57
6705983|NCT02901431|7636445|FG005|STARTED|Main Treatment Part||66
6705984|NCT02901431|7636446|FG006|STARTED|Main Treatment Part||66
6705985|NCT02901431|7636447|FG007|STARTED|Main Treatment Part||7
6705986|NCT02901431|7636448|FG008|STARTED|Main Treatment Part||0
6705987|NCT02901431|7636449|FG009|STARTED|Main Treatment Part||0
6705988|NCT02901431|7636450|FG010|STARTED|Main Treatment Part||0
6705989|NCT02901431|7636451|FG011|STARTED|Main Treatment Part||0
6705990|NCT02901431|7636452|FG012|STARTED|Main Treatment Part||0
6705991|NCT02901431|7636440|FG000|COMPLETED|Main Treatment Part||0
6705992|NCT02901431|7636441|FG001|COMPLETED|Main Treatment Part||0
6705993|NCT02901431|7636442|FG002|COMPLETED|Main Treatment Part||0
6705994|NCT02901431|7636443|FG003|COMPLETED|Main Treatment Part||86
6705995|NCT02901431|7636444|FG004|COMPLETED|Main Treatment Part||50
6705996|NCT02901431|7636445|FG005|COMPLETED|Main Treatment Part||54
6705997|NCT02901431|7636446|FG006|COMPLETED|Main Treatment Part||55
6705998|NCT02901431|7636447|FG007|COMPLETED|Main Treatment Part||7
6705999|NCT02901431|7636448|FG008|COMPLETED|Main Treatment Part||0
6706000|NCT02901431|7636449|FG009|COMPLETED|Main Treatment Part||0
6706001|NCT02901431|7636450|FG010|COMPLETED|Main Treatment Part||0
6706002|NCT02901431|7636451|FG011|COMPLETED|Main Treatment Part||0
6706003|NCT02901431|7636452|FG012|COMPLETED|Main Treatment Part||0
6706004|NCT02901431|7636440|FG000|NOT COMPLETED|Main Treatment Part||0
6706005|NCT02901431|7636441|FG001|NOT COMPLETED|Main Treatment Part||0
6706006|NCT02901431|7636442|FG002|NOT COMPLETED|Main Treatment Part||0
6706007|NCT02901431|7636443|FG003|NOT COMPLETED|Main Treatment Part||26
6706008|NCT02901431|7636444|FG004|NOT COMPLETED|Main Treatment Part||7
6706009|NCT02901431|7636445|FG005|NOT COMPLETED|Main Treatment Part||12
6706010|NCT02901431|7636446|FG006|NOT COMPLETED|Main Treatment Part||11
6706011|NCT02901431|7636447|FG007|NOT COMPLETED|Main Treatment Part||0
6706012|NCT02901431|7636448|FG008|NOT COMPLETED|Main Treatment Part||0
6706013|NCT02901431|7636449|FG009|NOT COMPLETED|Main Treatment Part||0
6706014|NCT02901431|7636450|FG010|NOT COMPLETED|Main Treatment Part||0
6706015|NCT02901431|7636451|FG011|NOT COMPLETED|Main Treatment Part||0
6706016|NCT02901431|7636452|FG012|NOT COMPLETED|Main Treatment Part||0
6706017|NCT02901431|7636440|FG000|STARTED|Open Label Part||0
6706018|NCT02901431|7636441|FG001|STARTED|Open Label Part||0
6706019|NCT02901431|7636442|FG002|STARTED|Open Label Part||0
6706020|NCT02901431|7636443|FG003|STARTED|Open Label Part||0
6706021|NCT02901431|7636444|FG004|STARTED|Open Label Part||0
6706022|NCT02901431|7636445|FG005|STARTED|Open Label Part||0
6706023|NCT02901431|7636446|FG006|STARTED|Open Label Part||0
6706024|NCT02901431|7636447|FG007|STARTED|Open Label Part||0
6706025|NCT02901431|7636448|FG008|STARTED|Open Label Part||68
6706026|NCT02901431|7636449|FG009|STARTED|Open Label Part||35
6706027|NCT02901431|7636450|FG010|STARTED|Open Label Part||40
6706028|NCT02901431|7636451|FG011|STARTED|Open Label Part||46
6261061|NCT00774345|7159871|FG001|STARTED|Pre-treatment||157
6261062|NCT00774345|7159870|FG000|COMPLETED|Pre-treatment||158
6261063|NCT00774345|7159871|FG001|COMPLETED|Pre-treatment||157
6261064|NCT00774345|7159870|FG000|NOT COMPLETED|Pre-treatment||2
6261065|NCT00774345|7159871|FG001|NOT COMPLETED|Pre-treatment||0
6261066|NCT00774345|7159870|FG000|STARTED|Treatment||158
6261067|NCT00774345|7159871|FG001|STARTED|Treatment||157
6261068|NCT00774345|7159870|FG000|Participants Escalated to 5mg|Treatment||129
6261069|NCT00774345|7159871|FG001|Participants Escalated to 5mg|Treatment||149
6261070|NCT00774345|7159870|FG000|Participants Escalated to 10mg|Treatment||68
6261071|NCT00774345|7159871|FG001|Participants Escalated to 10mg|Treatment||88
6261072|NCT00774345|7159870|FG000|COMPLETED|Treatment||0
6261073|NCT00774345|7159871|FG001|COMPLETED|Treatment||0
6261074|NCT00774345|7159870|FG000|NOT COMPLETED|Treatment||158
6261075|NCT00774345|7159871|FG001|NOT COMPLETED|Treatment||157
6280333|NCT00153816|7180235|FG003|STARTED|Overall Study||421
6280334|NCT00153816|7180236|FG004|STARTED|Overall Study||295
6280335|NCT00153816|7180237|FG005|STARTED|Overall Study||289
6706029|NCT02901431|7636452|FG012|STARTED|Open Label Part||5
6706030|NCT02901431|7636440|FG000|COMPLETED|Open Label Part||0
6706031|NCT02901431|7636441|FG001|COMPLETED|Open Label Part||0
6706032|NCT02901431|7636442|FG002|COMPLETED|Open Label Part||0
6706033|NCT02901431|7636443|FG003|COMPLETED|Open Label Part||0
6280336|NCT00153816|7180232|FG000|COMPLETED|Overall Study||383
6280337|NCT00153816|7180233|FG001|COMPLETED|Overall Study||387
6280338|NCT00153816|7180234|FG002|COMPLETED|Overall Study||388
6706034|NCT02901431|7636444|FG004|COMPLETED|Open Label Part||0
6706035|NCT02901431|7636445|FG005|COMPLETED|Open Label Part||0
6706036|NCT02901431|7636446|FG006|COMPLETED|Open Label Part||0
6706037|NCT02901431|7636447|FG007|COMPLETED|Open Label Part||0
6706038|NCT02901431|7636448|FG008|COMPLETED|Open Label Part||20
6706039|NCT02901431|7636449|FG009|COMPLETED|Open Label Part||11
6706040|NCT02901431|7636450|FG010|COMPLETED|Open Label Part||11
6706041|NCT02901431|7636451|FG011|COMPLETED|Open Label Part||7
6706042|NCT02901431|7636452|FG012|COMPLETED|Open Label Part||2
6706043|NCT02901431|7636440|FG000|NOT COMPLETED|Open Label Part||0
6706044|NCT02901431|7636441|FG001|NOT COMPLETED|Open Label Part||0
6706045|NCT02901431|7636442|FG002|NOT COMPLETED|Open Label Part||0
6706046|NCT02901431|7636443|FG003|NOT COMPLETED|Open Label Part||0
6706047|NCT02901431|7636444|FG004|NOT COMPLETED|Open Label Part||0
6706048|NCT02901431|7636445|FG005|NOT COMPLETED|Open Label Part||0
6706049|NCT02901431|7636446|FG006|NOT COMPLETED|Open Label Part||0
6706050|NCT02901431|7636447|FG007|NOT COMPLETED|Open Label Part||0
6706051|NCT02901431|7636448|FG008|NOT COMPLETED|Open Label Part||48
6706052|NCT02901431|7636449|FG009|NOT COMPLETED|Open Label Part||24
6706053|NCT02901431|7636450|FG010|NOT COMPLETED|Open Label Part||29
6706054|NCT02901431|7636451|FG011|NOT COMPLETED|Open Label Part||39
6706055|NCT02901431|7636452|FG012|NOT COMPLETED|Open Label Part||3
6706056|NCT02901899|7636477|FG000|STARTED|Reached 1st Response Assessment||45
6706057|NCT02901899|7636477|FG000|Registered|Reached 1st Response Assessment||45
6706058|NCT02901899|7636477|FG000|Started Treatment|Reached 1st Response Assessment||43
6706059|NCT02901899|7636477|FG000|Attempted 2 Cycles of Treatment/Reached First Response|Reached 1st Response Assessment||37
6706060|NCT02901899|7636477|FG000|COMPLETED|Reached 1st Response Assessment||37
6706061|NCT02901899|7636477|FG000|NOT COMPLETED|Reached 1st Response Assessment||8
6706062|NCT02901899|7636477|FG000|STARTED|Continued Treatment After 1st Response||37
6706063|NCT02901899|7636477|FG000|Went on to Start Cycle 3|Continued Treatment After 1st Response||21
6706064|NCT02901899|7636477|FG000|COMPLETED|Continued Treatment After 1st Response||21
6706065|NCT02901899|7636477|FG000|NOT COMPLETED|Continued Treatment After 1st Response||16
6706066|NCT02901899|7636477|FG000|STARTED|Follow up|All patients who receive at least one dose of study drug go into the follow up period.|43
6706067|NCT02901899|7636477|FG000|COMPLETED|Follow up||27
6706068|NCT02901899|7636477|FG000|NOT COMPLETED|Follow up||16
6706069|NCT02901951|7636481|FG000|STARTED|Overall Study||103
6706070|NCT02901951|7636481|FG000|COMPLETED|Overall Study||103
6706071|NCT02901951|7636481|FG000|NOT COMPLETED|Overall Study||0
6706072|NCT02902081|7636485|FG000|STARTED|Overall Study||38
6706073|NCT02902081|7636485|FG000|COMPLETED|Overall Study||38
6706074|NCT02902081|7636485|FG000|NOT COMPLETED|Overall Study||0
6706075|NCT02902146|7636495|FG000|STARTED|Overall Study||381
6706076|NCT02902146|7636496|FG001|STARTED|Overall Study||376
6706077|NCT02902146|7636495|FG000|COMPLETED|Overall Study||381
6706078|NCT02902146|7636496|FG001|COMPLETED|Overall Study||376
6706079|NCT02902146|7636495|FG000|NOT COMPLETED|Overall Study||0
6706080|NCT02902146|7636496|FG001|NOT COMPLETED|Overall Study||0
6706081|NCT02902172|7636504|FG000|STARTED|Overall Study||16
6706082|NCT02902172|7636505|FG001|STARTED|Overall Study||20
6706083|NCT02902172|7636504|FG000|COMPLETED|Overall Study||16
6706084|NCT02902172|7636505|FG001|COMPLETED|Overall Study||20
6706085|NCT02902172|7636504|FG000|NOT COMPLETED|Overall Study||0
6706086|NCT02902172|7636505|FG001|NOT COMPLETED|Overall Study||0
6706087|NCT02902237|7636512|FG000|STARTED|Overall Study||17
6706088|NCT02902237|7636512|FG000|COMPLETED|Overall Study|STUDY INITIATION: 2017 03 29, 1st Patient In, STUDY COMPLETION: 2019 11 05, Date of Study End|17
6706089|NCT02902237|7636512|FG000|NOT COMPLETED|Overall Study||0
6706090|NCT02902770|7636526|FG000|STARTED|Overall Study||50
6706091|NCT02902770|7636527|FG001|STARTED|Overall Study||50
6706092|NCT02902770|7636528|FG002|STARTED|Overall Study||50
6706093|NCT02902770|7636526|FG000|COMPLETED|Overall Study||50
6706094|NCT02902770|7636527|FG001|COMPLETED|Overall Study||50
6706095|NCT02902770|7636528|FG002|COMPLETED|Overall Study||50
6706096|NCT02902770|7636526|FG000|NOT COMPLETED|Overall Study||0
6706097|NCT02902770|7636527|FG001|NOT COMPLETED|Overall Study||0
6706098|NCT02902770|7636528|FG002|NOT COMPLETED|Overall Study||0
6739112|NCT03286751|7668063|FG002|COMPLETED|Period 1||7
6739113|NCT03286751|7668064|FG003|COMPLETED|Period 1||7
6739114|NCT03286751|7668065|FG004|COMPLETED|Period 1||7
6739115|NCT03286751|7668066|FG005|COMPLETED|Period 1||7
6739116|NCT03286751|7668061|FG000|NOT COMPLETED|Period 1||0
6739117|NCT03286751|7668062|FG001|NOT COMPLETED|Period 1||0
6739118|NCT03286751|7668063|FG002|NOT COMPLETED|Period 1||0
6739119|NCT03286751|7668064|FG003|NOT COMPLETED|Period 1||0
6739120|NCT03286751|7668065|FG004|NOT COMPLETED|Period 1||0
6739121|NCT03286751|7668066|FG005|NOT COMPLETED|Period 1||0
6739122|NCT03286751|7668061|FG000|STARTED|Washout Period 1||7
6739123|NCT03286751|7668062|FG001|STARTED|Washout Period 1||7
6739124|NCT03286751|7668063|FG002|STARTED|Washout Period 1||7
6739125|NCT03286751|7668064|FG003|STARTED|Washout Period 1||7
6739126|NCT03286751|7668065|FG004|STARTED|Washout Period 1||7
6739127|NCT03286751|7668066|FG005|STARTED|Washout Period 1||7
6739128|NCT03286751|7668061|FG000|COMPLETED|Washout Period 1||7
6739129|NCT03286751|7668062|FG001|COMPLETED|Washout Period 1||7
6739130|NCT03286751|7668063|FG002|COMPLETED|Washout Period 1||7
6739131|NCT03286751|7668064|FG003|COMPLETED|Washout Period 1||7
6739132|NCT03286751|7668065|FG004|COMPLETED|Washout Period 1||6
6739133|NCT03286751|7668066|FG005|COMPLETED|Washout Period 1||7
6739134|NCT03286751|7668061|FG000|NOT COMPLETED|Washout Period 1||0
6706099|NCT02902809|7636536|FG000|STARTED|Overall Study||28
6706100|NCT02902809|7636536|FG000|Treatment Received|Overall Study||28
6706101|NCT02902809|7636536|FG000|Treatment Completed|Overall Study||2
6706102|NCT02902809|7636536|FG000|COMPLETED|Overall Study||0
6706103|NCT02902809|7636536|FG000|NOT COMPLETED|Overall Study||28
6706104|NCT02902913|7636540|FG000|STARTED|Overall Study||9
6706105|NCT02902913|7636540|FG000|First Intervention (1 Day)|Overall Study||9
6706106|NCT02902913|7636540|FG000|Washout (7 Days)|Overall Study||9
6706107|NCT02902913|7636540|FG000|Second Intervention (1 Day)|Overall Study||9
6706108|NCT02902913|7636540|FG000|Washout (7 Days)|Overall Study||9
6706109|NCT02902913|7636540|FG000|Third Intervention (1 Day)|Overall Study||9
6706110|NCT02902913|7636540|FG000|Washout (7 Days)|Overall Study||9
6706111|NCT02902913|7636540|FG000|Ibuprofen (400mg)|Overall Study||9
6706112|NCT02902913|7636540|FG000|COMPLETED|Overall Study||9
6706113|NCT02902913|7636540|FG000|NOT COMPLETED|Overall Study||0
6706114|NCT02902965|7636548|FG000|STARTED|Overall Study||74
6706115|NCT02902965|7636548|FG000|COMPLETED|Overall Study||64
6706116|NCT02902965|7636548|FG000|NOT COMPLETED|Overall Study||10
6706117|NCT02903030|7636555|FG000|STARTED|First Intervention (8 Weeks)||8
6706118|NCT02903030|7636556|FG001|STARTED|First Intervention (8 Weeks)||5
6706119|NCT02903030|7636555|FG000|Received Intervention|First Intervention (8 Weeks)||6
6706120|NCT02903030|7636556|FG001|Received Intervention|First Intervention (8 Weeks)||4
6706121|NCT02903030|7636555|FG000|COMPLETED|First Intervention (8 Weeks)||6
6706122|NCT02903030|7636556|FG001|COMPLETED|First Intervention (8 Weeks)||4
6706123|NCT02903030|7636555|FG000|NOT COMPLETED|First Intervention (8 Weeks)||2
6706124|NCT02903030|7636556|FG001|NOT COMPLETED|First Intervention (8 Weeks)||1
6706125|NCT02903030|7636555|FG000|STARTED|Washout (3 Weeks)||6
6706126|NCT02903030|7636556|FG001|STARTED|Washout (3 Weeks)||4
6706127|NCT02903030|7636555|FG000|COMPLETED|Washout (3 Weeks)||6
6706128|NCT02903030|7636556|FG001|COMPLETED|Washout (3 Weeks)||4
6706129|NCT02903030|7636555|FG000|NOT COMPLETED|Washout (3 Weeks)||0
6706130|NCT02903030|7636556|FG001|NOT COMPLETED|Washout (3 Weeks)||0
6706131|NCT02903030|7636555|FG000|STARTED|Second Intervention (8 Weeks)||6
6706132|NCT02903030|7636556|FG001|STARTED|Second Intervention (8 Weeks)||4
6706133|NCT02903030|7636555|FG000|COMPLETED|Second Intervention (8 Weeks)||6
6706134|NCT02903030|7636556|FG001|COMPLETED|Second Intervention (8 Weeks)||4
6706135|NCT02903030|7636555|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||0
6706136|NCT02903030|7636556|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
6706137|NCT02903121|7636567|FG000|STARTED|Overall Study||57
6706138|NCT02903121|7636568|FG001|STARTED|Overall Study||52
6706139|NCT02903121|7636567|FG000|COMPLETED|Overall Study||34
6706140|NCT02903121|7636568|FG001|COMPLETED|Overall Study||38
6706141|NCT02903121|7636567|FG000|NOT COMPLETED|Overall Study||23
6706142|NCT02903121|7636568|FG001|NOT COMPLETED|Overall Study||14
6706143|NCT02903238|7636574|FG000|STARTED|Overall Study||21
6706144|NCT02903238|7636574|FG000|COMPLETED|Overall Study||17
6706145|NCT02903238|7636574|FG000|NOT COMPLETED|Overall Study||4
6706146|NCT02903368|7636581|FG000|STARTED|Overall Study||59
6706147|NCT02903368|7636582|FG001|STARTED|Overall Study||59
6706148|NCT02903368|7636581|FG000|COMPLETED|Overall Study||55
6706149|NCT02903368|7636582|FG001|COMPLETED|Overall Study||59
6706150|NCT02903368|7636581|FG000|NOT COMPLETED|Overall Study||4
6706151|NCT02903368|7636582|FG001|NOT COMPLETED|Overall Study||0
6706152|NCT02903394|7636593|FG000|STARTED|Overall Study||5
6706153|NCT02903394|7636594|FG001|STARTED|Overall Study||50
6706154|NCT02903394|7636593|FG000|COMPLETED|Overall Study||5
6706155|NCT02903394|7636594|FG001|COMPLETED|Overall Study||50
6706156|NCT02903394|7636593|FG000|NOT COMPLETED|Overall Study||0
6706157|NCT02903394|7636594|FG001|NOT COMPLETED|Overall Study||0
6706158|NCT02903407|7636603|FG000|STARTED|Overall Study||4
6706159|NCT02903407|7636604|FG001|STARTED|Overall Study||3
6706160|NCT02903407|7636603|FG000|COMPLETED|Overall Study||4
6706161|NCT02903407|7636604|FG001|COMPLETED|Overall Study||3
6706162|NCT02903407|7636603|FG000|NOT COMPLETED|Overall Study||0
6706163|NCT02903407|7636604|FG001|NOT COMPLETED|Overall Study||0
6706164|NCT02903420|7636610|FG000|STARTED|Overall Study||28
6706165|NCT02903420|7636610|FG000|COMPLETED|Overall Study||25
6706166|NCT02903420|7636610|FG000|NOT COMPLETED|Overall Study||3
6706167|NCT02903446|7636616|FG000|STARTED|Overall Study||10
6706168|NCT02903446|7636617|FG001|STARTED|Overall Study||10
6706169|NCT02903446|7636616|FG000|COMPLETED|Overall Study||10
6706170|NCT02903446|7636617|FG001|COMPLETED|Overall Study||10
6706171|NCT02903446|7636616|FG000|NOT COMPLETED|Overall Study||0
6706172|NCT02903446|7636617|FG001|NOT COMPLETED|Overall Study||0
6706173|NCT02903511|7636625|FG000|STARTED|Overall Study||26
6706174|NCT02903511|7636626|FG001|STARTED|Overall Study||25
6706175|NCT02903511|7636625|FG000|Received Intervention|Overall Study||25
6706176|NCT02903511|7636626|FG001|Received Intervention|Overall Study||25
6706177|NCT02903511|7636625|FG000|COMPLETED|Overall Study||22
6706178|NCT02903511|7636626|FG001|COMPLETED|Overall Study||23
6706179|NCT02903511|7636625|FG000|NOT COMPLETED|Overall Study||4
6706180|NCT02903511|7636626|FG001|NOT COMPLETED|Overall Study||2
6706181|NCT02903836|7636635|FG000|STARTED|Overall Study||74
6706182|NCT02903836|7636636|FG001|STARTED|Overall Study||73
6706183|NCT02903836|7636637|FG002|STARTED|Overall Study||77
6706184|NCT02903836|7636635|FG000|COMPLETED|Overall Study||71
6706185|NCT02903836|7636636|FG001|COMPLETED|Overall Study||69
6706186|NCT02903836|7636637|FG002|COMPLETED|Overall Study||73
6706187|NCT02903836|7636635|FG000|NOT COMPLETED|Overall Study||3
6706188|NCT02903836|7636636|FG001|NOT COMPLETED|Overall Study||4
6706189|NCT02903836|7636637|FG002|NOT COMPLETED|Overall Study||4
6706190|NCT02903966|7636647|FG000|STARTED|Part A (Day 1 to 43)||12
6706191|NCT02903966|7636648|FG001|STARTED|Part A (Day 1 to 43)||24
6706192|NCT02903966|7636647|FG000|COMPLETED|Part A (Day 1 to 43)||11
6706193|NCT02903966|7636648|FG001|COMPLETED|Part A (Day 1 to 43)||24
6706194|NCT02903966|7636647|FG000|NOT COMPLETED|Part A (Day 1 to 43)||1
6706195|NCT02903966|7636648|FG001|NOT COMPLETED|Part A (Day 1 to 43)||0
6706196|NCT02903966|7636647|FG000|STARTED|Part B (Day 44 to 112)||11
6706197|NCT02903966|7636648|FG001|STARTED|Part B (Day 44 to 112)||24
6706198|NCT02903966|7636647|FG000|COMPLETED|Part B (Day 44 to 112)||11
6706199|NCT02903966|7636648|FG001|COMPLETED|Part B (Day 44 to 112)||22
6706200|NCT02903966|7636647|FG000|NOT COMPLETED|Part B (Day 44 to 112)||0
6706201|NCT02903966|7636648|FG001|NOT COMPLETED|Part B (Day 44 to 112)||2
6706202|NCT02904057|7636662|FG000|STARTED|Overall Study||19
6706203|NCT02904057|7636663|FG001|STARTED|Overall Study||10
6706204|NCT02904057|7636662|FG000|COMPLETED|Overall Study||19
6706205|NCT02904057|7636663|FG001|COMPLETED|Overall Study||10
6706206|NCT02904057|7636662|FG000|NOT COMPLETED|Overall Study||0
6706207|NCT02904057|7636663|FG001|NOT COMPLETED|Overall Study||0
6706208|NCT02904096|7636671|FG000|STARTED|Overall Study||130
6706209|NCT02904096|7636672|FG001|STARTED|Overall Study||126
6261076|NCT00457951|7159880|FG000|STARTED|Overall Study||13
6261077|NCT00457951|7159881|FG001|STARTED|Overall Study||66
6706210|NCT02904096|7636671|FG000|COMPLETED|Overall Study||111
6706211|NCT02904096|7636672|FG001|COMPLETED|Overall Study||105
6706212|NCT02904096|7636671|FG000|NOT COMPLETED|Overall Study||19
6706213|NCT02904096|7636672|FG001|NOT COMPLETED|Overall Study||21
6706214|NCT02904200|7636678|FG000|STARTED|Overall Study|One pat. early terminated on own decision, due to travelling distance between home and hospital.|2
6706215|NCT02904200|7636679|FG001|STARTED|Overall Study|No statistical evaluation was performed because only 2 subjects were included in one arm.|0
6706216|NCT02904200|7636678|FG000|COMPLETED|Overall Study||1
6706217|NCT02904200|7636679|FG001|COMPLETED|Overall Study||0
6706218|NCT02904200|7636678|FG000|NOT COMPLETED|Overall Study||1
6706219|NCT02904200|7636679|FG001|NOT COMPLETED|Overall Study||0
6706220|NCT02904226|7636691|FG000|STARTED|Overall Study||40
6706221|NCT02904226|7636692|FG001|STARTED|Overall Study||31
6706222|NCT02904226|7636693|FG002|STARTED|Overall Study||30
6706223|NCT02904226|7636694|FG003|STARTED|Overall Study||100
6706224|NCT02904226|7636695|FG004|STARTED|Overall Study||11
6706225|NCT02904226|7636696|FG005|STARTED|Overall Study||0
6706226|NCT02904226|7636697|FG006|STARTED|Overall Study||6
6706227|NCT02904226|7636698|FG007|STARTED|Overall Study||0
6706228|NCT02904226|7636691|FG000|COMPLETED|Overall Study||0
6706229|NCT02904226|7636692|FG001|COMPLETED|Overall Study||2
6706230|NCT02904226|7636693|FG002|COMPLETED|Overall Study||0
6706231|NCT02904226|7636694|FG003|COMPLETED|Overall Study||4
6706232|NCT02904226|7636695|FG004|COMPLETED|Overall Study||0
6706233|NCT02904226|7636696|FG005|COMPLETED|Overall Study||0
6706234|NCT02904226|7636697|FG006|COMPLETED|Overall Study||0
6706235|NCT02904226|7636698|FG007|COMPLETED|Overall Study||0
6706236|NCT02904226|7636691|FG000|NOT COMPLETED|Overall Study||40
6706237|NCT02904226|7636692|FG001|NOT COMPLETED|Overall Study||29
6706238|NCT02904226|7636693|FG002|NOT COMPLETED|Overall Study||30
6706239|NCT02904226|7636694|FG003|NOT COMPLETED|Overall Study||96
6706240|NCT02904226|7636695|FG004|NOT COMPLETED|Overall Study||11
6706241|NCT02904226|7636696|FG005|NOT COMPLETED|Overall Study||0
6706242|NCT02904226|7636697|FG006|NOT COMPLETED|Overall Study||6
6706243|NCT02904226|7636698|FG007|NOT COMPLETED|Overall Study||0
6706244|NCT02904265|7636716|FG000|STARTED|Overall Study|Study closed due to only 3 participants recruited|1
6706245|NCT02904265|7636717|FG001|STARTED|Overall Study|Study closed due to only 3 participants recruited|2
6706246|NCT02904265|7636716|FG000|COMPLETED|Overall Study||0
6706247|NCT02904265|7636717|FG001|COMPLETED|Overall Study||0
6706248|NCT02904265|7636716|FG000|NOT COMPLETED|Overall Study||1
6706249|NCT02904265|7636717|FG001|NOT COMPLETED|Overall Study||2
6706250|NCT02904512|7636725|FG000|STARTED|Overall Study||9
6706251|NCT02904512|7636726|FG001|STARTED|Overall Study||7
6706252|NCT02904512|7636725|FG000|COMPLETED|Overall Study||6
6706253|NCT02904512|7636726|FG001|COMPLETED|Overall Study||7
6706254|NCT02904512|7636725|FG000|NOT COMPLETED|Overall Study||3
6706255|NCT02904512|7636726|FG001|NOT COMPLETED|Overall Study||0
6706256|NCT02904902|7636732|FG000|STARTED|Overall Study||15
6706257|NCT02904902|7636732|FG000|COMPLETED|Overall Study||14
6706258|NCT02904902|7636732|FG000|NOT COMPLETED|Overall Study||1
6706259|NCT02904915|7636738|FG000|STARTED|Overall Study||25
6706260|NCT02904915|7636739|FG001|STARTED|Overall Study||25
6706261|NCT02904915|7636738|FG000|COMPLETED|Overall Study||25
6706262|NCT02904915|7636739|FG001|COMPLETED|Overall Study||25
6706263|NCT02904915|7636738|FG000|NOT COMPLETED|Overall Study||0
6706264|NCT02904915|7636739|FG001|NOT COMPLETED|Overall Study||0
6706265|NCT02904954|7636747|FG000|STARTED|Neoadjuvant (Preoperative) to Surgery||30
6706266|NCT02904954|7636748|FG001|STARTED|Neoadjuvant (Preoperative) to Surgery||30
6706267|NCT02904954|7636747|FG000|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed 2 neoadjuvant cycles. Surgical resection was not performed in 4 participants.|26
6739135|NCT03286751|7668062|FG001|NOT COMPLETED|Washout Period 1||0
6706268|NCT02904954|7636748|FG001|COMPLETED|Neoadjuvant (Preoperative) to Surgery|30 participants completed the first neoadjuvant Durvalumab cycle combined with SBRT. Three subjects did not receive the 2nd cycle. Surgical resection was not performed in 4 participants.|26
6706269|NCT02904954|7636747|FG000|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
6706270|NCT02904954|7636748|FG001|NOT COMPLETED|Neoadjuvant (Preoperative) to Surgery||4
6706271|NCT02904954|7636747|FG000|STARTED|Adjuvant Durvalumab||26
6706272|NCT02904954|7636748|FG001|STARTED|Adjuvant Durvalumab||26
6706273|NCT02904954|7636747|FG000|COMPLETED|Adjuvant Durvalumab||5
6706274|NCT02904954|7636748|FG001|COMPLETED|Adjuvant Durvalumab||10
6706275|NCT02904954|7636747|FG000|NOT COMPLETED|Adjuvant Durvalumab||21
6706276|NCT02904954|7636748|FG001|NOT COMPLETED|Adjuvant Durvalumab||16
6706277|NCT02905006|7636762|FG000|STARTED|Overall Study||42
6706278|NCT02905006|7636763|FG001|STARTED|Overall Study||39
6706279|NCT02905006|7636764|FG002|STARTED|Overall Study||43
6706280|NCT02905006|7636765|FG003|STARTED|Overall Study||40
6706281|NCT02905006|7636766|FG004|STARTED|Overall Study||43
6706282|NCT02905006|7636767|FG005|STARTED|Overall Study||43
6706283|NCT02905006|7636762|FG000|Completed Treatment Period|Overall Study||37
6706284|NCT02905006|7636763|FG001|Completed Treatment Period|Overall Study||36
6706285|NCT02905006|7636764|FG002|Completed Treatment Period|Overall Study||38
6706286|NCT02905006|7636765|FG003|Completed Treatment Period|Overall Study||34
6706287|NCT02905006|7636766|FG004|Completed Treatment Period|Overall Study||40
6706288|NCT02905006|7636767|FG005|Completed Treatment Period|Overall Study||39
6706289|NCT02905006|7636762|FG000|Enrolled in Extension Study (PS0011)|Overall Study||38
6706290|NCT02905006|7636763|FG001|Enrolled in Extension Study (PS0011)|Overall Study||35
6706291|NCT02905006|7636764|FG002|Enrolled in Extension Study (PS0011)|Overall Study||39
6706292|NCT02905006|7636765|FG003|Enrolled in Extension Study (PS0011)|Overall Study||38
6706293|NCT02905006|7636766|FG004|Enrolled in Extension Study (PS0011)|Overall Study||42
6706294|NCT02905006|7636767|FG005|Enrolled in Extension Study (PS0011)|Overall Study||40
6706295|NCT02905006|7636762|FG000|Entered Safety Follow-up Period|Overall Study||4
6706296|NCT02905006|7636763|FG001|Entered Safety Follow-up Period|Overall Study||4
6706297|NCT02905006|7636764|FG002|Entered Safety Follow-up Period|Overall Study||4
6706298|NCT02905006|7636765|FG003|Entered Safety Follow-up Period|Overall Study||2
6706299|NCT02905006|7636766|FG004|Entered Safety Follow-up Period|Overall Study||1
6706300|NCT02905006|7636767|FG005|Entered Safety Follow-up Period|Overall Study||3
6706301|NCT02905006|7636762|FG000|COMPLETED|Overall Study||37
6706302|NCT02905006|7636763|FG001|COMPLETED|Overall Study||36
6706303|NCT02905006|7636764|FG002|COMPLETED|Overall Study||38
6706304|NCT02905006|7636765|FG003|COMPLETED|Overall Study||34
6706305|NCT02905006|7636766|FG004|COMPLETED|Overall Study||40
6706306|NCT02905006|7636767|FG005|COMPLETED|Overall Study||39
6706307|NCT02905006|7636762|FG000|NOT COMPLETED|Overall Study||5
6706308|NCT02905006|7636763|FG001|NOT COMPLETED|Overall Study||3
6706309|NCT02905006|7636764|FG002|NOT COMPLETED|Overall Study||5
6706310|NCT02905006|7636765|FG003|NOT COMPLETED|Overall Study||6
6706311|NCT02905006|7636766|FG004|NOT COMPLETED|Overall Study||3
6706312|NCT02905006|7636767|FG005|NOT COMPLETED|Overall Study||4
6706313|NCT02905149|7636807|FG000|STARTED|Overall Study||30
6706314|NCT02905149|7636808|FG001|STARTED|Overall Study||30
6706315|NCT02905149|7636807|FG000|COMPLETED|Overall Study||28
6706316|NCT02905149|7636808|FG001|COMPLETED|Overall Study||30
6706317|NCT02905149|7636807|FG000|NOT COMPLETED|Overall Study||2
6706318|NCT02905149|7636808|FG001|NOT COMPLETED|Overall Study||0
6706319|NCT02905266|7636816|FG000|STARTED|Treatment Phase Part 1||53
6706320|NCT02905266|7636817|FG001|STARTED|Treatment Phase Part 1||53
6706321|NCT02905266|7636816|FG000|COMPLETED|Treatment Phase Part 1||24
6706322|NCT02905266|7636817|FG001|COMPLETED|Treatment Phase Part 1||30
6706323|NCT02905266|7636816|FG000|NOT COMPLETED|Treatment Phase Part 1||29
6706324|NCT02905266|7636817|FG001|NOT COMPLETED|Treatment Phase Part 1||23
6706325|NCT02905266|7636816|FG000|STARTED|Transition From Part 1 to Part 2||24
6706326|NCT02905266|7636817|FG001|STARTED|Transition From Part 1 to Part 2||30
6706327|NCT02905266|7636816|FG000|COMPLETED|Transition From Part 1 to Part 2||20
6706328|NCT02905266|7636817|FG001|COMPLETED|Transition From Part 1 to Part 2||22
6706329|NCT02905266|7636816|FG000|NOT COMPLETED|Transition From Part 1 to Part 2||4
6706330|NCT02905266|7636817|FG001|NOT COMPLETED|Transition From Part 1 to Part 2||8
6706331|NCT02905266|7636816|FG000|STARTED|Maintenance Phase Part 2||20
6706332|NCT02905266|7636817|FG001|STARTED|Maintenance Phase Part 2||22
6706333|NCT02905266|7636816|FG000|COMPLETED|Maintenance Phase Part 2||8
6706334|NCT02905266|7636817|FG001|COMPLETED|Maintenance Phase Part 2||14
6706335|NCT02905266|7636816|FG000|NOT COMPLETED|Maintenance Phase Part 2||12
6706336|NCT02905266|7636817|FG001|NOT COMPLETED|Maintenance Phase Part 2||8
6706337|NCT02905331|7636825|FG000|STARTED|Placebo Controlled Period(Week[wk] 0-16)||16
6706338|NCT02905331|7636826|FG001|STARTED|Placebo Controlled Period(Week[wk] 0-16)||62
6706339|NCT02905331|7636827|FG002|STARTED|Placebo Controlled Period(Week[wk] 0-16)||0
6706340|NCT02905331|7636825|FG000|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||13
6706341|NCT02905331|7636826|FG001|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||61
6706342|NCT02905331|7636827|FG002|COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
6706343|NCT02905331|7636825|FG000|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||3
6706344|NCT02905331|7636826|FG001|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||1
6706345|NCT02905331|7636827|FG002|NOT COMPLETED|Placebo Controlled Period(Week[wk] 0-16)||0
6706346|NCT02905331|7636825|FG000|STARTED|Active Treatment and Follow up (wk16-40)||0
6706347|NCT02905331|7636826|FG001|STARTED|Active Treatment and Follow up (wk16-40)||61
6706348|NCT02905331|7636827|FG002|STARTED|Active Treatment and Follow up (wk16-40)||13
6706349|NCT02905331|7636825|FG000|COMPLETED|Active Treatment and Follow up (wk16-40)||0
6706350|NCT02905331|7636826|FG001|COMPLETED|Active Treatment and Follow up (wk16-40)||53
6706351|NCT02905331|7636827|FG002|COMPLETED|Active Treatment and Follow up (wk16-40)||13
6706352|NCT02905331|7636825|FG000|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
6706353|NCT02905331|7636826|FG001|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||8
6706354|NCT02905331|7636827|FG002|NOT COMPLETED|Active Treatment and Follow up (wk16-40)||0
6706355|NCT02905435|7636835|FG000|STARTED|Overall Study||14
6706356|NCT02905435|7636835|FG000|COMPLETED|Overall Study||7
6706357|NCT02905435|7636835|FG000|NOT COMPLETED|Overall Study||7
6706358|NCT02905825|7636840|FG000|STARTED|Overall Study||53
6706359|NCT02905825|7636840|FG000|COMPLETED|Overall Study||41
6706360|NCT02905825|7636840|FG000|NOT COMPLETED|Overall Study||12
6706361|NCT02905981|7636844|FG000|STARTED|Overall Study||1
6706362|NCT02905981|7636844|FG000|COMPLETED|Overall Study||0
6706363|NCT02905981|7636844|FG000|NOT COMPLETED|Overall Study||1
6706364|NCT02906358|7636850|FG000|STARTED|Overall Study||58
6706365|NCT02906358|7636851|FG001|STARTED|Overall Study||53
6706366|NCT02906358|7636850|FG000|Completed 3 Month Measures|Overall Study||36
6706367|NCT02906358|7636851|FG001|Completed 3 Month Measures|Overall Study||33
6706368|NCT02906358|7636850|FG000|COMPLETED|Overall Study||36
6706369|NCT02906358|7636851|FG001|COMPLETED|Overall Study||31
6706370|NCT02906358|7636850|FG000|NOT COMPLETED|Overall Study||22
6706371|NCT02906358|7636851|FG001|NOT COMPLETED|Overall Study||22
6706372|NCT02906566|7636859|FG000|STARTED|Overall Study||24
6706373|NCT02906566|7636860|FG001|STARTED|Overall Study||10
6706374|NCT02906566|7636859|FG000|COMPLETED|Overall Study||21
6706375|NCT02906566|7636860|FG001|COMPLETED|Overall Study||10
6706376|NCT02906566|7636859|FG000|NOT COMPLETED|Overall Study||3
6706377|NCT02906566|7636860|FG001|NOT COMPLETED|Overall Study||0
6706378|NCT02906579|7636868|FG000|STARTED|Overall Study||11
6706379|NCT02906579|7636868|FG000|Completed Cycle 1 (Placebo)|Overall Study||11
6706380|NCT02906579|7636868|FG000|Completed Cycle 2 (10 mg IW-1973)|Overall Study||11
6706381|NCT02906579|7636868|FG000|Completed Cycle 3 (20 mg IW-1973)|Overall Study||11
6706382|NCT02906579|7636868|FG000|Completed Cycle 4 (30 mg IW-1973)|Overall Study||10
6706383|NCT02906579|7636868|FG000|Completed Cycle 5 (40 mg IW-1973)|Overall Study||9
6706384|NCT02906579|7636868|FG000|Completed Cycle 6 (50 mg IW-1973)|Overall Study||9
6706385|NCT02906579|7636868|FG000|COMPLETED|Overall Study||9
6706386|NCT02906579|7636868|FG000|NOT COMPLETED|Overall Study||2
6706387|NCT02906644|7636890|FG000|STARTED|First 2 Weeks||31
6706388|NCT02906644|7636891|FG001|STARTED|First 2 Weeks||30
6706389|NCT02906644|7636890|FG000|COMPLETED|First 2 Weeks||30
6706390|NCT02906644|7636891|FG001|COMPLETED|First 2 Weeks||27
6706391|NCT02906644|7636890|FG000|NOT COMPLETED|First 2 Weeks||1
6706392|NCT02906644|7636891|FG001|NOT COMPLETED|First 2 Weeks||3
6706393|NCT02906644|7636890|FG000|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|30
6706394|NCT02906644|7636891|FG001|STARTED|Weeks 3 to 14|All participants receiving active Lorcaserin plus nicotine patches starting at the 2nd study visit.|27
6706395|NCT02906644|7636890|FG000|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|17
6706396|NCT02906644|7636891|FG001|Final Study Visit|Weeks 3 to 14|All participants receiving only 1 week of 14mg & 1 week of 7mg nicotine patches at this visit.|20
6706397|NCT02906644|7636890|FG000|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||14
6706398|NCT02906644|7636891|FG001|Follow-up (6 Months Post Quit Day)|Weeks 3 to 14||16
6706399|NCT02906644|7636890|FG000|COMPLETED|Weeks 3 to 14||14
6706400|NCT02906644|7636891|FG001|COMPLETED|Weeks 3 to 14||16
6706401|NCT02906644|7636890|FG000|NOT COMPLETED|Weeks 3 to 14||16
6706402|NCT02906644|7636891|FG001|NOT COMPLETED|Weeks 3 to 14||11
6706403|NCT02906670|7636908|FG000|STARTED|Cohort 1, QW||1
6706404|NCT02906670|7636909|FG001|STARTED|Cohort 1, QW||0
6706405|NCT02906670|7636910|FG002|STARTED|Cohort 1, QW||0
6706406|NCT02906670|7636911|FG003|STARTED|Cohort 1, QW||0
6706407|NCT02906670|7636912|FG004|STARTED|Cohort 1, QW||0
6706408|NCT02906670|7636913|FG005|STARTED|Cohort 1, QW||0
6706409|NCT02906670|7636914|FG006|STARTED|Cohort 1, QW||0
6706410|NCT02906670|7636915|FG007|STARTED|Cohort 1, QW||0
6706411|NCT02906670|7636916|FG008|STARTED|Cohort 1, QW||0
6706412|NCT02906670|7636917|FG009|STARTED|Cohort 1, QW||0
6706413|NCT02906670|7636908|FG000|COMPLETED|Cohort 1, QW||0
6706414|NCT02906670|7636909|FG001|COMPLETED|Cohort 1, QW||0
6706415|NCT02906670|7636910|FG002|COMPLETED|Cohort 1, QW||0
6706416|NCT02906670|7636911|FG003|COMPLETED|Cohort 1, QW||0
6706417|NCT02906670|7636912|FG004|COMPLETED|Cohort 1, QW||0
6706418|NCT02906670|7636913|FG005|COMPLETED|Cohort 1, QW||0
6706419|NCT02906670|7636914|FG006|COMPLETED|Cohort 1, QW||0
6706420|NCT02906670|7636915|FG007|COMPLETED|Cohort 1, QW||0
6706421|NCT02906670|7636916|FG008|COMPLETED|Cohort 1, QW||0
6706422|NCT02906670|7636917|FG009|COMPLETED|Cohort 1, QW||0
6706423|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 1, QW||1
6706424|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 1, QW||0
6706425|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 1, QW||0
6706426|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 1, QW||0
6706427|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 1, QW||0
6706428|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 1, QW||0
6706429|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 1, QW||0
6706430|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 1, QW||0
6261078|NCT00457951|7159882|FG002|STARTED|Overall Study||72
6261079|NCT00457951|7159880|FG000|COMPLETED|Overall Study||13
6602526|NCT02057458|7527502|FG002|COMPLETED|Acute Study (1 Hour): Second Int.||0
6602527|NCT02057458|7527500|FG000|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
6602528|NCT02057458|7527501|FG001|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
6602529|NCT02057458|7527502|FG002|NOT COMPLETED|Acute Study (1 Hour): Second Int.||0
6602530|NCT02057458|7527500|FG000|STARTED|Sub-Chronic Study (4 Weeks)||6
6602531|NCT02057458|7527501|FG001|STARTED|Sub-Chronic Study (4 Weeks)||7
6602532|NCT02057458|7527502|FG002|STARTED|Sub-Chronic Study (4 Weeks)||3
6602533|NCT02057458|7527500|FG000|COMPLETED|Sub-Chronic Study (4 Weeks)||5
6602534|NCT02057458|7527501|FG001|COMPLETED|Sub-Chronic Study (4 Weeks)||7
6602535|NCT02057458|7527502|FG002|COMPLETED|Sub-Chronic Study (4 Weeks)||3
6602536|NCT02057458|7527500|FG000|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||1
6602537|NCT02057458|7527501|FG001|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
6602538|NCT02057458|7527502|FG002|NOT COMPLETED|Sub-Chronic Study (4 Weeks)||0
6602539|NCT02057523|7527532|FG000|STARTED|Overall Study||2
6602540|NCT02057523|7527532|FG000|COMPLETED|Overall Study||0
6602541|NCT02057523|7527532|FG000|NOT COMPLETED|Overall Study||2
6602542|NCT02057549|7527538|FG000|STARTED|Overall Study||18
6602543|NCT02057549|7527539|FG001|STARTED|Overall Study||18
6602544|NCT02057549|7527538|FG000|COMPLETED|Overall Study||15
6602545|NCT02057549|7527539|FG001|COMPLETED|Overall Study||18
6602546|NCT02057549|7527538|FG000|NOT COMPLETED|Overall Study||3
6602547|NCT02057549|7527539|FG001|NOT COMPLETED|Overall Study||0
6625123|NCT02222922|7552720|FG008|STARTED|Overall Study||12
6625124|NCT02222922|7552712|FG000|Received Treatment|Overall Study||2
6625125|NCT02222922|7552713|FG001|Received Treatment|Overall Study||2
6625126|NCT02222922|7552714|FG002|Received Treatment|Overall Study||2
6625127|NCT02222922|7552715|FG003|Received Treatment|Overall Study||4
6625128|NCT02222922|7552716|FG004|Received Treatment|Overall Study||96
6625129|NCT02222922|7552717|FG005|Received Treatment|Overall Study||6
6625130|NCT02222922|7552718|FG006|Received Treatment|Overall Study||3
6625131|NCT02222922|7552719|FG007|Received Treatment|Overall Study||10
6625132|NCT02222922|7552720|FG008|Received Treatment|Overall Study||12
6625133|NCT02222922|7552712|FG000|COMPLETED|Overall Study||1
6625134|NCT02222922|7552713|FG001|COMPLETED|Overall Study||2
6625135|NCT02222922|7552714|FG002|COMPLETED|Overall Study||1
6625136|NCT02222922|7552715|FG003|COMPLETED|Overall Study||2
6625137|NCT02222922|7552716|FG004|COMPLETED|Overall Study||58
6625138|NCT02222922|7552717|FG005|COMPLETED|Overall Study||3
6625139|NCT02222922|7552718|FG006|COMPLETED|Overall Study||1
6625140|NCT02222922|7552719|FG007|COMPLETED|Overall Study||6
6625141|NCT02222922|7552720|FG008|COMPLETED|Overall Study||6
6625142|NCT02222922|7552712|FG000|NOT COMPLETED|Overall Study||1
6625143|NCT02222922|7552713|FG001|NOT COMPLETED|Overall Study||0
6625144|NCT02222922|7552714|FG002|NOT COMPLETED|Overall Study||1
6625145|NCT02222922|7552715|FG003|NOT COMPLETED|Overall Study||3
6625146|NCT02222922|7552716|FG004|NOT COMPLETED|Overall Study||38
6625147|NCT02222922|7552717|FG005|NOT COMPLETED|Overall Study||3
6625148|NCT02222922|7552718|FG006|NOT COMPLETED|Overall Study||2
6625149|NCT02222922|7552719|FG007|NOT COMPLETED|Overall Study||4
6625150|NCT02222922|7552720|FG008|NOT COMPLETED|Overall Study||6
6625151|NCT02223065|7552756|FG000|STARTED|Overall Study||18
6625152|NCT02223065|7552757|FG001|STARTED|Overall Study||18
6625153|NCT02223065|7552756|FG000|COMPLETED|Overall Study||18
6625154|NCT02223065|7552757|FG001|COMPLETED|Overall Study||18
6625155|NCT02223065|7552756|FG000|NOT COMPLETED|Overall Study||0
6625156|NCT02223065|7552757|FG001|NOT COMPLETED|Overall Study||0
6625157|NCT02223260|7552763|FG000|STARTED|Overall Study||8
6625158|NCT02223260|7552763|FG000|COMPLETED|Overall Study||8
6625159|NCT02223260|7552763|FG000|NOT COMPLETED|Overall Study||0
6625160|NCT02223338|7552769|FG000|STARTED|Overall Study||60
6625161|NCT02223338|7552770|FG001|STARTED|Overall Study||60
6625162|NCT02223338|7552769|FG000|COMPLETED|Overall Study||60
6625163|NCT02223338|7552770|FG001|COMPLETED|Overall Study||60
6625164|NCT02223338|7552769|FG000|NOT COMPLETED|Overall Study||0
6625165|NCT02223338|7552770|FG001|NOT COMPLETED|Overall Study||0
6625166|NCT02223351|7552778|FG000|STARTED|Overall Study||24
6625167|NCT02223351|7552779|FG001|STARTED|Overall Study||24
6625168|NCT02223351|7552778|FG000|First Intervention (8 Days)|Overall Study||24
6625169|NCT02223351|7552779|FG001|First Intervention (8 Days)|Overall Study||24
6625170|NCT02223351|7552778|FG000|Wasout (2weeks)|Overall Study||24
6625171|NCT02223351|7552779|FG001|Wasout (2weeks)|Overall Study||24
6625172|NCT02223351|7552778|FG000|Second Intervention (8 Days)|Overall Study||24
6625173|NCT02223351|7552779|FG001|Second Intervention (8 Days)|Overall Study||24
6625174|NCT02223351|7552778|FG000|COMPLETED|Overall Study||24
6625175|NCT02223351|7552779|FG001|COMPLETED|Overall Study||24
6625176|NCT02223351|7552778|FG000|NOT COMPLETED|Overall Study||0
6625177|NCT02223351|7552779|FG001|NOT COMPLETED|Overall Study||0
6625178|NCT02223364|7552796|FG000|STARTED|Overall Study||55
6625179|NCT02223364|7552797|FG001|STARTED|Overall Study||55
6625180|NCT02223364|7552798|FG002|STARTED|Overall Study||55
6625181|NCT02223364|7552796|FG000|COMPLETED|Overall Study||50
6625182|NCT02223364|7552797|FG001|COMPLETED|Overall Study||55
6625183|NCT02223364|7552798|FG002|COMPLETED|Overall Study||52
6625184|NCT02223364|7552796|FG000|NOT COMPLETED|Overall Study||5
6625185|NCT02223364|7552797|FG001|NOT COMPLETED|Overall Study||0
6625186|NCT02223364|7552798|FG002|NOT COMPLETED|Overall Study||3
6625187|NCT02223390|7552808|FG000|STARTED|Overall Study||32
6706431|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 1, QW||0
6706432|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 1, QW||0
6706433|NCT02906670|7636908|FG000|STARTED|Cohort 2, QW||0
6706434|NCT02906670|7636909|FG001|STARTED|Cohort 2, QW||1
6706435|NCT02906670|7636910|FG002|STARTED|Cohort 2, QW||0
6706436|NCT02906670|7636911|FG003|STARTED|Cohort 2, QW||0
6706437|NCT02906670|7636912|FG004|STARTED|Cohort 2, QW||0
6706438|NCT02906670|7636913|FG005|STARTED|Cohort 2, QW||0
6706439|NCT02906670|7636914|FG006|STARTED|Cohort 2, QW||0
6706440|NCT02906670|7636915|FG007|STARTED|Cohort 2, QW||0
6706441|NCT02906670|7636916|FG008|STARTED|Cohort 2, QW||0
6706442|NCT02906670|7636917|FG009|STARTED|Cohort 2, QW||0
6706443|NCT02906670|7636908|FG000|COMPLETED|Cohort 2, QW||0
6706444|NCT02906670|7636909|FG001|COMPLETED|Cohort 2, QW||0
6706445|NCT02906670|7636910|FG002|COMPLETED|Cohort 2, QW||0
6706446|NCT02906670|7636911|FG003|COMPLETED|Cohort 2, QW||0
6706447|NCT02906670|7636912|FG004|COMPLETED|Cohort 2, QW||0
6706448|NCT02906670|7636913|FG005|COMPLETED|Cohort 2, QW||0
6706449|NCT02906670|7636914|FG006|COMPLETED|Cohort 2, QW||0
6706450|NCT02906670|7636915|FG007|COMPLETED|Cohort 2, QW||0
6706451|NCT02906670|7636916|FG008|COMPLETED|Cohort 2, QW||0
6706452|NCT02906670|7636917|FG009|COMPLETED|Cohort 2, QW||0
6706453|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 2, QW||0
6706454|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 2, QW||1
6706455|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 2, QW||0
6706456|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 2, QW||0
6706457|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 2, QW||0
6706458|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 2, QW||0
6706459|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 2, QW||0
6706460|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 2, QW||0
6706461|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 2, QW||0
6706462|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 2, QW||0
6706463|NCT02906670|7636908|FG000|STARTED|Cohort 3, QW||0
6706464|NCT02906670|7636909|FG001|STARTED|Cohort 3, QW||0
6706465|NCT02906670|7636910|FG002|STARTED|Cohort 3, QW||4
6706466|NCT02906670|7636911|FG003|STARTED|Cohort 3, QW||0
6706467|NCT02906670|7636912|FG004|STARTED|Cohort 3, QW||0
6706468|NCT02906670|7636913|FG005|STARTED|Cohort 3, QW||0
6706469|NCT02906670|7636914|FG006|STARTED|Cohort 3, QW||0
6706470|NCT02906670|7636915|FG007|STARTED|Cohort 3, QW||0
6706471|NCT02906670|7636916|FG008|STARTED|Cohort 3, QW||0
6706472|NCT02906670|7636917|FG009|STARTED|Cohort 3, QW||0
6706473|NCT02906670|7636908|FG000|COMPLETED|Cohort 3, QW||0
6706474|NCT02906670|7636909|FG001|COMPLETED|Cohort 3, QW||0
6706475|NCT02906670|7636910|FG002|COMPLETED|Cohort 3, QW||0
6706476|NCT02906670|7636911|FG003|COMPLETED|Cohort 3, QW||0
6706477|NCT02906670|7636912|FG004|COMPLETED|Cohort 3, QW||0
6706478|NCT02906670|7636913|FG005|COMPLETED|Cohort 3, QW||0
6706479|NCT02906670|7636914|FG006|COMPLETED|Cohort 3, QW||0
6706480|NCT02906670|7636915|FG007|COMPLETED|Cohort 3, QW||0
6706481|NCT02906670|7636916|FG008|COMPLETED|Cohort 3, QW||0
6706482|NCT02906670|7636917|FG009|COMPLETED|Cohort 3, QW||0
6706483|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 3, QW||0
6706484|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 3, QW||0
6706485|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 3, QW||4
6706486|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 3, QW||0
6706487|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 3, QW||0
6706488|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 3, QW||0
6706489|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 3, QW||0
6706490|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 3, QW||0
6706491|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 3, QW||0
6706492|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 3, QW||0
6706493|NCT02906670|7636908|FG000|STARTED|Cohort 4, Q2W||0
6706494|NCT02906670|7636909|FG001|STARTED|Cohort 4, Q2W||0
6706495|NCT02906670|7636910|FG002|STARTED|Cohort 4, Q2W||0
6706496|NCT02906670|7636911|FG003|STARTED|Cohort 4, Q2W||0
6706497|NCT02906670|7636912|FG004|STARTED|Cohort 4, Q2W||0
6706498|NCT02906670|7636913|FG005|STARTED|Cohort 4, Q2W||3
6706499|NCT02906670|7636914|FG006|STARTED|Cohort 4, Q2W||0
6706500|NCT02906670|7636915|FG007|STARTED|Cohort 4, Q2W||0
6706501|NCT02906670|7636916|FG008|STARTED|Cohort 4, Q2W||0
6706502|NCT02906670|7636917|FG009|STARTED|Cohort 4, Q2W||0
6706503|NCT02906670|7636908|FG000|COMPLETED|Cohort 4, Q2W||0
6706504|NCT02906670|7636909|FG001|COMPLETED|Cohort 4, Q2W||0
6706505|NCT02906670|7636910|FG002|COMPLETED|Cohort 4, Q2W||0
6706506|NCT02906670|7636911|FG003|COMPLETED|Cohort 4, Q2W||0
6706507|NCT02906670|7636912|FG004|COMPLETED|Cohort 4, Q2W||0
6706508|NCT02906670|7636913|FG005|COMPLETED|Cohort 4, Q2W||0
6706509|NCT02906670|7636914|FG006|COMPLETED|Cohort 4, Q2W||0
6706510|NCT02906670|7636915|FG007|COMPLETED|Cohort 4, Q2W||0
6706511|NCT02906670|7636916|FG008|COMPLETED|Cohort 4, Q2W||0
6706512|NCT02906670|7636917|FG009|COMPLETED|Cohort 4, Q2W||0
6706513|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 4, Q2W||0
6706514|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 4, Q2W||0
6706515|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 4, Q2W||0
6706516|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 4, Q2W||0
6706517|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 4, Q2W||0
6706518|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 4, Q2W||3
6706519|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 4, Q2W||0
6706520|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 4, Q2W||0
6706521|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 4, Q2W||0
6706522|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 4, Q2W||0
6706523|NCT02906670|7636908|FG000|STARTED|Cohort 5, Q2W||0
6706524|NCT02906670|7636909|FG001|STARTED|Cohort 5, Q2W||0
6706525|NCT02906670|7636910|FG002|STARTED|Cohort 5, Q2W||0
6706526|NCT02906670|7636911|FG003|STARTED|Cohort 5, Q2W||0
6706527|NCT02906670|7636912|FG004|STARTED|Cohort 5, Q2W||0
6706528|NCT02906670|7636913|FG005|STARTED|Cohort 5, Q2W||0
6706529|NCT02906670|7636914|FG006|STARTED|Cohort 5, Q2W||7
6706530|NCT02906670|7636915|FG007|STARTED|Cohort 5, Q2W||0
6706531|NCT02906670|7636916|FG008|STARTED|Cohort 5, Q2W||0
6706532|NCT02906670|7636917|FG009|STARTED|Cohort 5, Q2W||0
6706533|NCT02906670|7636908|FG000|COMPLETED|Cohort 5, Q2W||0
6706534|NCT02906670|7636909|FG001|COMPLETED|Cohort 5, Q2W||0
6706535|NCT02906670|7636910|FG002|COMPLETED|Cohort 5, Q2W||0
6706536|NCT02906670|7636911|FG003|COMPLETED|Cohort 5, Q2W||0
6706537|NCT02906670|7636912|FG004|COMPLETED|Cohort 5, Q2W||0
6706538|NCT02906670|7636913|FG005|COMPLETED|Cohort 5, Q2W||0
6706539|NCT02906670|7636914|FG006|COMPLETED|Cohort 5, Q2W||0
6706540|NCT02906670|7636915|FG007|COMPLETED|Cohort 5, Q2W||0
6706541|NCT02906670|7636916|FG008|COMPLETED|Cohort 5, Q2W||0
6706542|NCT02906670|7636917|FG009|COMPLETED|Cohort 5, Q2W||0
6706543|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 5, Q2W||0
6706544|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 5, Q2W||0
6706545|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 5, Q2W||0
6706546|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 5, Q2W||0
6706547|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 5, Q2W||0
6706548|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 5, Q2W||0
6706549|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 5, Q2W||7
6706550|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 5, Q2W||0
6706551|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 5, Q2W||0
6706552|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 5, Q2W||0
6706553|NCT02906670|7636908|FG000|STARTED|Cohort 5P, Q2W||0
6706554|NCT02906670|7636909|FG001|STARTED|Cohort 5P, Q2W||0
6706555|NCT02906670|7636910|FG002|STARTED|Cohort 5P, Q2W||0
6706556|NCT02906670|7636911|FG003|STARTED|Cohort 5P, Q2W||0
6706557|NCT02906670|7636912|FG004|STARTED|Cohort 5P, Q2W||0
6706558|NCT02906670|7636913|FG005|STARTED|Cohort 5P, Q2W||0
6706559|NCT02906670|7636914|FG006|STARTED|Cohort 5P, Q2W||0
6706560|NCT02906670|7636915|FG007|STARTED|Cohort 5P, Q2W||3
6706561|NCT02906670|7636916|FG008|STARTED|Cohort 5P, Q2W||0
6706562|NCT02906670|7636917|FG009|STARTED|Cohort 5P, Q2W||0
6706563|NCT02906670|7636908|FG000|COMPLETED|Cohort 5P, Q2W||0
6706564|NCT02906670|7636909|FG001|COMPLETED|Cohort 5P, Q2W||0
6706565|NCT02906670|7636910|FG002|COMPLETED|Cohort 5P, Q2W||0
6706566|NCT02906670|7636911|FG003|COMPLETED|Cohort 5P, Q2W||0
6706567|NCT02906670|7636912|FG004|COMPLETED|Cohort 5P, Q2W||0
6706568|NCT02906670|7636913|FG005|COMPLETED|Cohort 5P, Q2W||0
6706569|NCT02906670|7636914|FG006|COMPLETED|Cohort 5P, Q2W||0
6706570|NCT02906670|7636915|FG007|COMPLETED|Cohort 5P, Q2W||0
6706571|NCT02906670|7636916|FG008|COMPLETED|Cohort 5P, Q2W||0
6706572|NCT02906670|7636917|FG009|COMPLETED|Cohort 5P, Q2W||0
6706573|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 5P, Q2W||0
6706574|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 5P, Q2W||0
6706575|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 5P, Q2W||0
6706576|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 5P, Q2W||0
6706577|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 5P, Q2W||0
6706578|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 5P, Q2W||0
6706579|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 5P, Q2W||0
6706580|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 5P, Q2W||3
6261080|NCT00457951|7159881|FG001|COMPLETED|Overall Study||50
6706581|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 5P, Q2W||0
6706582|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 5P, Q2W||0
6706583|NCT02906670|7636908|FG000|STARTED|Cohort 6P, Q2W||0
6706584|NCT02906670|7636909|FG001|STARTED|Cohort 6P, Q2W||0
6706585|NCT02906670|7636910|FG002|STARTED|Cohort 6P, Q2W||0
6706586|NCT02906670|7636911|FG003|STARTED|Cohort 6P, Q2W||0
6706587|NCT02906670|7636912|FG004|STARTED|Cohort 6P, Q2W||0
6706588|NCT02906670|7636913|FG005|STARTED|Cohort 6P, Q2W||0
6706589|NCT02906670|7636914|FG006|STARTED|Cohort 6P, Q2W||0
6706590|NCT02906670|7636915|FG007|STARTED|Cohort 6P, Q2W||0
6706591|NCT02906670|7636916|FG008|STARTED|Cohort 6P, Q2W||4
6706592|NCT02906670|7636917|FG009|STARTED|Cohort 6P, Q2W||0
6706593|NCT02906670|7636908|FG000|COMPLETED|Cohort 6P, Q2W||0
6706594|NCT02906670|7636909|FG001|COMPLETED|Cohort 6P, Q2W||0
6706595|NCT02906670|7636910|FG002|COMPLETED|Cohort 6P, Q2W||0
6706596|NCT02906670|7636911|FG003|COMPLETED|Cohort 6P, Q2W||0
6706597|NCT02906670|7636912|FG004|COMPLETED|Cohort 6P, Q2W||0
6706598|NCT02906670|7636913|FG005|COMPLETED|Cohort 6P, Q2W||0
6706599|NCT02906670|7636914|FG006|COMPLETED|Cohort 6P, Q2W||0
6706600|NCT02906670|7636915|FG007|COMPLETED|Cohort 6P, Q2W||0
6706601|NCT02906670|7636916|FG008|COMPLETED|Cohort 6P, Q2W||0
6706602|NCT02906670|7636917|FG009|COMPLETED|Cohort 6P, Q2W||0
6706603|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 6P, Q2W||0
6706604|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 6P, Q2W||0
6706605|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 6P, Q2W||0
6706606|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 6P, Q2W||0
6706607|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 6P, Q2W||0
6706608|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 6P, Q2W||0
6706609|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 6P, Q2W||0
6706610|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 6P, Q2W||0
6706611|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 6P, Q2W||4
6706612|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 6P, Q2W||0
6706613|NCT02906670|7636908|FG000|STARTED|Cohort 4P, QW||0
6706614|NCT02906670|7636909|FG001|STARTED|Cohort 4P, QW||0
6706615|NCT02906670|7636910|FG002|STARTED|Cohort 4P, QW||0
6706616|NCT02906670|7636911|FG003|STARTED|Cohort 4P, QW||3
6706617|NCT02906670|7636912|FG004|STARTED|Cohort 4P, QW||0
6706618|NCT02906670|7636913|FG005|STARTED|Cohort 4P, QW||0
6706619|NCT02906670|7636914|FG006|STARTED|Cohort 4P, QW||0
6706620|NCT02906670|7636915|FG007|STARTED|Cohort 4P, QW||0
6706621|NCT02906670|7636916|FG008|STARTED|Cohort 4P, QW||0
6261081|NCT00457951|7159882|FG002|COMPLETED|Overall Study||60
6261082|NCT00457951|7159880|FG000|NOT COMPLETED|Overall Study||0
6261083|NCT00457951|7159881|FG001|NOT COMPLETED|Overall Study||16
6261084|NCT00457951|7159882|FG002|NOT COMPLETED|Overall Study||12
6261085|NCT00345943|7159891|FG000|STARTED|Overall Study||38
6261086|NCT00345943|7159892|FG001|STARTED|Overall Study||33
6706622|NCT02906670|7636917|FG009|STARTED|Cohort 4P, QW||0
6706623|NCT02906670|7636908|FG000|COMPLETED|Cohort 4P, QW||0
6706624|NCT02906670|7636909|FG001|COMPLETED|Cohort 4P, QW||0
6706625|NCT02906670|7636910|FG002|COMPLETED|Cohort 4P, QW||0
6706626|NCT02906670|7636911|FG003|COMPLETED|Cohort 4P, QW||0
6706627|NCT02906670|7636912|FG004|COMPLETED|Cohort 4P, QW||0
6706628|NCT02906670|7636913|FG005|COMPLETED|Cohort 4P, QW||0
6706629|NCT02906670|7636914|FG006|COMPLETED|Cohort 4P, QW||0
6706630|NCT02906670|7636915|FG007|COMPLETED|Cohort 4P, QW||0
6706631|NCT02906670|7636916|FG008|COMPLETED|Cohort 4P, QW||0
6261087|NCT00345943|7159891|FG000|COMPLETED|Overall Study||33
6261088|NCT00345943|7159892|FG001|COMPLETED|Overall Study||28
6261089|NCT00345943|7159891|FG000|NOT COMPLETED|Overall Study||5
6261090|NCT00345943|7159892|FG001|NOT COMPLETED|Overall Study||5
6261091|NCT00258427|7159902|FG000|STARTED|Overall Study||3
6261092|NCT00258427|7159903|FG001|STARTED|Overall Study||8
6261093|NCT00258427|7159904|FG002|STARTED|Overall Study||2
6261094|NCT00258427|7159905|FG003|STARTED|Overall Study||1
6261095|NCT00258427|7159902|FG000|COMPLETED|Overall Study||3
6261096|NCT00258427|7159903|FG001|COMPLETED|Overall Study||8
6261097|NCT00258427|7159904|FG002|COMPLETED|Overall Study||2
6261098|NCT00258427|7159905|FG003|COMPLETED|Overall Study||1
6261099|NCT00258427|7159902|FG000|NOT COMPLETED|Overall Study||0
6261100|NCT00258427|7159903|FG001|NOT COMPLETED|Overall Study||0
6261101|NCT00258427|7159904|FG002|NOT COMPLETED|Overall Study||0
6261102|NCT00258427|7159905|FG003|NOT COMPLETED|Overall Study||0
6261103|NCT03722810|7159917|FG000|STARTED|Overall Study||157
6261104|NCT03722810|7159918|FG001|STARTED|Overall Study||160
6261105|NCT03722810|7159917|FG000|COMPLETED|Overall Study||150
6261106|NCT03722810|7159918|FG001|COMPLETED|Overall Study||156
6706632|NCT02906670|7636917|FG009|COMPLETED|Cohort 4P, QW||0
6706633|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 4P, QW||0
6706634|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 4P, QW||0
6706635|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 4P, QW||0
6706636|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 4P, QW||3
6706637|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 4P, QW||0
6706638|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 4P, QW||0
6706639|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 4P, QW||0
6706640|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 4P, QW||0
6706641|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 4P, QW||0
6706642|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 4P, QW||0
6706643|NCT02906670|7636908|FG000|STARTED|Cohort 7P, Q2W||0
6706644|NCT02906670|7636909|FG001|STARTED|Cohort 7P, Q2W||0
6706645|NCT02906670|7636910|FG002|STARTED|Cohort 7P, Q2W||0
6706646|NCT02906670|7636911|FG003|STARTED|Cohort 7P, Q2W||0
6261107|NCT03722810|7159917|FG000|NOT COMPLETED|Overall Study||7
6706647|NCT02906670|7636912|FG004|STARTED|Cohort 7P, Q2W||0
6706648|NCT02906670|7636913|FG005|STARTED|Cohort 7P, Q2W||0
6706649|NCT02906670|7636914|FG006|STARTED|Cohort 7P, Q2W||0
6706650|NCT02906670|7636915|FG007|STARTED|Cohort 7P, Q2W||0
6706651|NCT02906670|7636916|FG008|STARTED|Cohort 7P, Q2W||0
6706652|NCT02906670|7636917|FG009|STARTED|Cohort 7P, Q2W||3
6706653|NCT02906670|7636908|FG000|COMPLETED|Cohort 7P, Q2W||0
6706654|NCT02906670|7636909|FG001|COMPLETED|Cohort 7P, Q2W||0
6706655|NCT02906670|7636910|FG002|COMPLETED|Cohort 7P, Q2W||0
6706656|NCT02906670|7636911|FG003|COMPLETED|Cohort 7P, Q2W||0
6706657|NCT02906670|7636912|FG004|COMPLETED|Cohort 7P, Q2W||0
6706658|NCT02906670|7636913|FG005|COMPLETED|Cohort 7P, Q2W||0
6706659|NCT02906670|7636914|FG006|COMPLETED|Cohort 7P, Q2W||0
6706660|NCT02906670|7636915|FG007|COMPLETED|Cohort 7P, Q2W||0
6706661|NCT02906670|7636916|FG008|COMPLETED|Cohort 7P, Q2W||0
6706662|NCT02906670|7636917|FG009|COMPLETED|Cohort 7P, Q2W||0
6706663|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 7P, Q2W||0
6706664|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 7P, Q2W||0
6706665|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 7P, Q2W||0
6706666|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 7P, Q2W||0
6706667|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 7P, Q2W||0
6706668|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 7P, Q2W||0
6706669|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 7P, Q2W||0
6706670|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 7P, Q2W||0
6706671|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 7P, Q2W||0
6706672|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 7P, Q2W||3
6706673|NCT02906670|7636908|FG000|STARTED|Cohort 5P, QW||0
6706674|NCT02906670|7636909|FG001|STARTED|Cohort 5P, QW||0
6706675|NCT02906670|7636910|FG002|STARTED|Cohort 5P, QW||0
6706676|NCT02906670|7636911|FG003|STARTED|Cohort 5P, QW||0
6706677|NCT02906670|7636912|FG004|STARTED|Cohort 5P, QW||3
6706678|NCT02906670|7636913|FG005|STARTED|Cohort 5P, QW||0
6706679|NCT02906670|7636914|FG006|STARTED|Cohort 5P, QW||0
6706680|NCT02906670|7636915|FG007|STARTED|Cohort 5P, QW||0
6706681|NCT02906670|7636916|FG008|STARTED|Cohort 5P, QW||0
6706682|NCT02906670|7636917|FG009|STARTED|Cohort 5P, QW||0
6706683|NCT02906670|7636908|FG000|COMPLETED|Cohort 5P, QW||0
6706684|NCT02906670|7636909|FG001|COMPLETED|Cohort 5P, QW||0
6706685|NCT02906670|7636910|FG002|COMPLETED|Cohort 5P, QW||0
6706686|NCT02906670|7636911|FG003|COMPLETED|Cohort 5P, QW||0
6706687|NCT02906670|7636912|FG004|COMPLETED|Cohort 5P, QW||0
6706688|NCT02906670|7636913|FG005|COMPLETED|Cohort 5P, QW||0
6706689|NCT02906670|7636914|FG006|COMPLETED|Cohort 5P, QW||0
6706690|NCT02906670|7636915|FG007|COMPLETED|Cohort 5P, QW||0
6706691|NCT02906670|7636916|FG008|COMPLETED|Cohort 5P, QW||0
6706692|NCT02906670|7636917|FG009|COMPLETED|Cohort 5P, QW||0
6706693|NCT02906670|7636908|FG000|NOT COMPLETED|Cohort 5P, QW||0
6706694|NCT02906670|7636909|FG001|NOT COMPLETED|Cohort 5P, QW||0
6706695|NCT02906670|7636910|FG002|NOT COMPLETED|Cohort 5P, QW||0
6706696|NCT02906670|7636911|FG003|NOT COMPLETED|Cohort 5P, QW||0
6706697|NCT02906670|7636912|FG004|NOT COMPLETED|Cohort 5P, QW||3
6706698|NCT02906670|7636913|FG005|NOT COMPLETED|Cohort 5P, QW||0
6706699|NCT02906670|7636914|FG006|NOT COMPLETED|Cohort 5P, QW||0
6706700|NCT02906670|7636915|FG007|NOT COMPLETED|Cohort 5P, QW||0
6706701|NCT02906670|7636916|FG008|NOT COMPLETED|Cohort 5P, QW||0
6706702|NCT02906670|7636917|FG009|NOT COMPLETED|Cohort 5P, QW||0
6706703|NCT02906696|7636967|FG000|STARTED|Overall Study||8
6706704|NCT02906696|7636967|FG000|COMPLETED|Overall Study||8
6706705|NCT02906696|7636967|FG000|NOT COMPLETED|Overall Study||0
6706706|NCT02906709|7636973|FG000|STARTED|Phase A (Week 0 to Week 16)||123
6706707|NCT02906709|7636974|FG001|STARTED|Phase A (Week 0 to Week 16)||61
6706708|NCT02906709|7636973|FG000|COMPLETED|Phase A (Week 0 to Week 16)||122
6706709|NCT02906709|7636974|FG001|COMPLETED|Phase A (Week 0 to Week 16)||58
6706710|NCT02906709|7636973|FG000|NOT COMPLETED|Phase A (Week 0 to Week 16)||1
6706711|NCT02906709|7636974|FG001|NOT COMPLETED|Phase A (Week 0 to Week 16)||3
6706712|NCT02906709|7636973|FG000|STARTED|Phase B (Extension, Week 17 to Week 52)||122
6706713|NCT02906709|7636974|FG001|STARTED|Phase B (Extension, Week 17 to Week 52)||58
6706714|NCT02906709|7636973|FG000|COMPLETED|Phase B (Extension, Week 17 to Week 52)||117
6706715|NCT02906709|7636974|FG001|COMPLETED|Phase B (Extension, Week 17 to Week 52)||58
6706716|NCT02906709|7636973|FG000|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||5
6706717|NCT02906709|7636974|FG001|NOT COMPLETED|Phase B (Extension, Week 17 to Week 52)||0
6706718|NCT02906813|7636989|FG000|STARTED|Intervention Period 1 (3 Days)||3
6706719|NCT02906813|7636990|FG001|STARTED|Intervention Period 1 (3 Days)||3
6706720|NCT02906813|7636991|FG002|STARTED|Intervention Period 1 (3 Days)||3
6706721|NCT02906813|7636989|FG000|COMPLETED|Intervention Period 1 (3 Days)||3
6706722|NCT02906813|7636990|FG001|COMPLETED|Intervention Period 1 (3 Days)||3
6706723|NCT02906813|7636991|FG002|COMPLETED|Intervention Period 1 (3 Days)||3
6706724|NCT02906813|7636989|FG000|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6706725|NCT02906813|7636990|FG001|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6706726|NCT02906813|7636991|FG002|NOT COMPLETED|Intervention Period 1 (3 Days)||0
6706727|NCT02906813|7636989|FG000|STARTED|Washout Period 1 (at Least 3 Days)||3
6706728|NCT02906813|7636990|FG001|STARTED|Washout Period 1 (at Least 3 Days)||3
6706729|NCT02906813|7636991|FG002|STARTED|Washout Period 1 (at Least 3 Days)||3
6706730|NCT02906813|7636989|FG000|COMPLETED|Washout Period 1 (at Least 3 Days)||3
6706731|NCT02906813|7636990|FG001|COMPLETED|Washout Period 1 (at Least 3 Days)||3
6706732|NCT02906813|7636991|FG002|COMPLETED|Washout Period 1 (at Least 3 Days)||3
6706733|NCT02906813|7636989|FG000|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
6706734|NCT02906813|7636990|FG001|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
6706735|NCT02906813|7636991|FG002|NOT COMPLETED|Washout Period 1 (at Least 3 Days)||0
6706736|NCT02906813|7636989|FG000|STARTED|Intervention Period 2 (3 Days)||3
6706737|NCT02906813|7636990|FG001|STARTED|Intervention Period 2 (3 Days)||3
6706738|NCT02906813|7636991|FG002|STARTED|Intervention Period 2 (3 Days)||3
6706739|NCT02906813|7636989|FG000|COMPLETED|Intervention Period 2 (3 Days)||3
6706740|NCT02906813|7636990|FG001|COMPLETED|Intervention Period 2 (3 Days)||3
6706741|NCT02906813|7636991|FG002|COMPLETED|Intervention Period 2 (3 Days)||3
6706742|NCT02906813|7636989|FG000|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6706743|NCT02906813|7636990|FG001|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6706744|NCT02906813|7636991|FG002|NOT COMPLETED|Intervention Period 2 (3 Days)||0
6706745|NCT02906813|7636989|FG000|STARTED|Washout Period 2 (at Least 3 Days)||3
6706746|NCT02906813|7636990|FG001|STARTED|Washout Period 2 (at Least 3 Days)||3
6706747|NCT02906813|7636991|FG002|STARTED|Washout Period 2 (at Least 3 Days)||3
6706748|NCT02906813|7636989|FG000|COMPLETED|Washout Period 2 (at Least 3 Days)||3
6706749|NCT02906813|7636990|FG001|COMPLETED|Washout Period 2 (at Least 3 Days)||3
6706750|NCT02906813|7636991|FG002|COMPLETED|Washout Period 2 (at Least 3 Days)||3
6706751|NCT02906813|7636989|FG000|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
6706752|NCT02906813|7636990|FG001|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
6706753|NCT02906813|7636991|FG002|NOT COMPLETED|Washout Period 2 (at Least 3 Days)||0
6706754|NCT02906813|7636989|FG000|STARTED|Intervention Period 3 (3 Days)||3
6706755|NCT02906813|7636990|FG001|STARTED|Intervention Period 3 (3 Days)||3
6706756|NCT02906813|7636991|FG002|STARTED|Intervention Period 3 (3 Days)||3
6706757|NCT02906813|7636989|FG000|COMPLETED|Intervention Period 3 (3 Days)||3
6706758|NCT02906813|7636990|FG001|COMPLETED|Intervention Period 3 (3 Days)||3
6706759|NCT02906813|7636991|FG002|COMPLETED|Intervention Period 3 (3 Days)||3
6706760|NCT02906813|7636989|FG000|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6706761|NCT02906813|7636990|FG001|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6706762|NCT02906813|7636991|FG002|NOT COMPLETED|Intervention Period 3 (3 Days)||0
6706763|NCT02906917|7637001|FG000|STARTED|Initiation Period (Week 0-26)||267
6706764|NCT02906917|7637002|FG001|STARTED|Initiation Period (Week 0-26)||265
6706765|NCT02906917|7637001|FG000|Exposed|Initiation Period (Week 0-26)||265
6706766|NCT02906917|7637002|FG001|Exposed|Initiation Period (Week 0-26)||263
6706767|NCT02906917|7637001|FG000|COMPLETED|Initiation Period (Week 0-26)||261
6706768|NCT02906917|7637002|FG001|COMPLETED|Initiation Period (Week 0-26)||254
6706769|NCT02906917|7637001|FG000|NOT COMPLETED|Initiation Period (Week 0-26)||6
6706770|NCT02906917|7637002|FG001|NOT COMPLETED|Initiation Period (Week 0-26)||11
6706771|NCT02906917|7637001|FG000|STARTED|Intensification Period (Week 26-38)||261
6706772|NCT02906917|7637002|FG001|STARTED|Intensification Period (Week 26-38)||254
6706773|NCT02906917|7637001|FG000|COMPLETED|Intensification Period (Week 26-38)||252
6706774|NCT02906917|7637002|FG001|COMPLETED|Intensification Period (Week 26-38)||247
6706775|NCT02906917|7637001|FG000|NOT COMPLETED|Intensification Period (Week 26-38)||9
6706776|NCT02906917|7637002|FG001|NOT COMPLETED|Intensification Period (Week 26-38)||7
6706777|NCT02906930|7637012|FG000|STARTED|Overall Study||175
6706778|NCT02906930|7637013|FG001|STARTED|Overall Study||175
6706779|NCT02906930|7637014|FG002|STARTED|Overall Study||175
6706780|NCT02906930|7637015|FG003|STARTED|Overall Study||178
6706781|NCT02906930|7637012|FG000|Full Analysis Set (FAS)|Overall Study||175
6706782|NCT02906930|7637013|FG001|Full Analysis Set (FAS)|Overall Study||175
6706783|NCT02906930|7637014|FG002|Full Analysis Set (FAS)|Overall Study||175
6706784|NCT02906930|7637015|FG003|Full Analysis Set (FAS)|Overall Study||178
6706785|NCT02906930|7637012|FG000|Safety Analysis Set (SAS)|Overall Study||175
6706786|NCT02906930|7637013|FG001|Safety Analysis Set (SAS)|Overall Study||175
6706787|NCT02906930|7637014|FG002|Safety Analysis Set (SAS)|Overall Study||175
6706788|NCT02906930|7637015|FG003|Safety Analysis Set (SAS)|Overall Study||178
6706789|NCT02906930|7637012|FG000|COMPLETED|Overall Study||169
6706790|NCT02906930|7637013|FG001|COMPLETED|Overall Study||161
6706791|NCT02906930|7637014|FG002|COMPLETED|Overall Study||163
6706792|NCT02906930|7637015|FG003|COMPLETED|Overall Study||170
6706793|NCT02906930|7637012|FG000|NOT COMPLETED|Overall Study||6
6706794|NCT02906930|7637013|FG001|NOT COMPLETED|Overall Study||14
6706795|NCT02906930|7637014|FG002|NOT COMPLETED|Overall Study||12
6706796|NCT02906930|7637015|FG003|NOT COMPLETED|Overall Study||8
6706797|NCT02907073|7637028|FG000|STARTED|Overall Study||8
6706798|NCT02907073|7637029|FG001|STARTED|Overall Study||0
6706799|NCT02907073|7637030|FG002|STARTED|Overall Study||0
6706800|NCT02907073|7637028|FG000|COMPLETED|Overall Study||8
6706801|NCT02907073|7637029|FG001|COMPLETED|Overall Study||0
6706802|NCT02907073|7637030|FG002|COMPLETED|Overall Study||0
6706803|NCT02907073|7637028|FG000|NOT COMPLETED|Overall Study||0
6706804|NCT02907073|7637029|FG001|NOT COMPLETED|Overall Study||0
6706805|NCT02907073|7637030|FG002|NOT COMPLETED|Overall Study||0
6706806|NCT02907177|7637040|FG000|STARTED|Overall Study||68
6706807|NCT02907177|7637041|FG001|STARTED|Overall Study||68
6706808|NCT02907177|7637040|FG000|Treated|Overall Study||67
6261108|NCT03722810|7159918|FG001|NOT COMPLETED|Overall Study||4
6261109|NCT00000125|7159933|FG000|STARTED|Overall Study||819
6261110|NCT00000125|7159934|FG001|STARTED|Overall Study||817
6261111|NCT00000125|7159933|FG000|Completed OHTS Phase I, June 2002|Overall Study||706
6261112|NCT00000125|7159934|FG001|Completed OHTS Phase I, June 2002|Overall Study||702
6261113|NCT00000125|7159933|FG000|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
6261114|NCT00000125|7159934|FG001|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
6706809|NCT02907177|7637041|FG001|Treated|Overall Study||68
6706810|NCT02907177|7637040|FG000|Randomized Analysis Set|Overall Study||68
6706811|NCT02907177|7637041|FG001|Randomized Analysis Set|Overall Study||68
6706812|NCT02907177|7637040|FG000|COMPLETED|Overall Study||0
6261115|NCT00000125|7159933|FG000|NOT COMPLETED|Overall Study||239
6261116|NCT00000125|7159934|FG001|NOT COMPLETED|Overall Study||238
6261117|NCT00000134|7159943|FG000|STARTED|Overall Study||89
6261118|NCT00000134|7159944|FG001|STARTED|Overall Study||94
6261119|NCT00000134|7159945|FG002|STARTED|Overall Study||96
6261120|NCT00000134|7159943|FG000|COMPLETED|Overall Study||89
6261121|NCT00000134|7159944|FG001|COMPLETED|Overall Study||94
6261122|NCT00000134|7159945|FG002|COMPLETED|Overall Study||96
6261123|NCT00000134|7159943|FG000|NOT COMPLETED|Overall Study||0
6261124|NCT00000134|7159944|FG001|NOT COMPLETED|Overall Study||0
6261125|NCT00000134|7159945|FG002|NOT COMPLETED|Overall Study||0
6261126|NCT00000135|7159955|FG000|STARTED|Overall Study||104
6261127|NCT00000135|7159956|FG001|STARTED|Overall Study||105
6261128|NCT00000135|7159955|FG000|COMPLETED|Overall Study||77
6261129|NCT00000135|7159956|FG001|COMPLETED|Overall Study||91
6261130|NCT00000135|7159955|FG000|NOT COMPLETED|Overall Study||27
6261131|NCT00000135|7159956|FG001|NOT COMPLETED|Overall Study||14
6261132|NCT00000136|7159964|FG000|STARTED|Overall Study||107
6261133|NCT00000136|7159965|FG001|STARTED|Overall Study||127
6261134|NCT00000136|7159964|FG000|COMPLETED|Overall Study||107
6706813|NCT02907177|7637041|FG001|COMPLETED|Overall Study||0
6706814|NCT02907177|7637040|FG000|NOT COMPLETED|Overall Study||68
6706815|NCT02907177|7637041|FG001|NOT COMPLETED|Overall Study||68
6706816|NCT02907216|7637049|FG000|STARTED|Overall Study||147
6706817|NCT02907216|7637050|FG001|STARTED|Overall Study||145
6706818|NCT02907216|7637049|FG000|COMPLETED|Overall Study||146
6706819|NCT02907216|7637050|FG001|COMPLETED|Overall Study||144
6706820|NCT02907216|7637049|FG000|NOT COMPLETED|Overall Study||1
6706821|NCT02907216|7637050|FG001|NOT COMPLETED|Overall Study||1
6706822|NCT02907268|7637058|FG000|STARTED|Overall Study||5
6706823|NCT02907268|7637059|FG001|STARTED|Overall Study||5
6706824|NCT02907268|7637058|FG000|COMPLETED|Overall Study||5
6706825|NCT02907268|7637059|FG001|COMPLETED|Overall Study||5
6706826|NCT02907268|7637058|FG000|NOT COMPLETED|Overall Study||0
6706827|NCT02907268|7637059|FG001|NOT COMPLETED|Overall Study||0
6706828|NCT02907463|7637064|FG000|STARTED|Overall Study||280
6706829|NCT02907463|7637064|FG000|Enrolled Cohort|Overall Study||280
6706830|NCT02907463|7637064|FG000|Per Protocol Cohort|Overall Study||276
6706831|NCT02907463|7637064|FG000|COMPLETED|Overall Study||243
6706832|NCT02907463|7637064|FG000|NOT COMPLETED|Overall Study||37
6706833|NCT02907489|7637078|FG000|STARTED|Overall Study||42
6706834|NCT02907489|7637079|FG001|STARTED|Overall Study||42
6706835|NCT02907489|7637078|FG000|COMPLETED|Overall Study||40
6706836|NCT02907489|7637079|FG001|COMPLETED|Overall Study||41
6706837|NCT02907489|7637078|FG000|NOT COMPLETED|Overall Study||2
6706838|NCT02907489|7637079|FG001|NOT COMPLETED|Overall Study||1
6706839|NCT02907619|7637088|FG000|STARTED|Overall Study||19
6706840|NCT02907619|7637089|FG001|STARTED|Overall Study||20
6706841|NCT02907619|7637090|FG002|STARTED|Overall Study||20
6706842|NCT02907619|7637088|FG000|Received Treatment|Overall Study||19
6706843|NCT02907619|7637089|FG001|Received Treatment|Overall Study||20
6706844|NCT02907619|7637090|FG002|Received Treatment|Overall Study||20
6706845|NCT02907619|7637088|FG000|COMPLETED|Overall Study||0
6706846|NCT02907619|7637089|FG001|COMPLETED|Overall Study||0
6706847|NCT02907619|7637090|FG002|COMPLETED|Overall Study||0
6706848|NCT02907619|7637088|FG000|NOT COMPLETED|Overall Study||19
6706849|NCT02907619|7637089|FG001|NOT COMPLETED|Overall Study||20
6261135|NCT00000136|7159965|FG001|COMPLETED|Overall Study||127
6261136|NCT00000136|7159964|FG000|NOT COMPLETED|Overall Study||0
6261137|NCT00000136|7159965|FG001|NOT COMPLETED|Overall Study||0
6261138|NCT00000142|7159974|FG000|STARTED|Overall Study||26
6261139|NCT00000142|7159975|FG001|STARTED|Overall Study||26
6261140|NCT00000142|7159976|FG002|STARTED|Overall Study||12
6261141|NCT00000142|7159974|FG000|COMPLETED|Overall Study||26
6261142|NCT00000142|7159975|FG001|COMPLETED|Overall Study||26
6261143|NCT00000142|7159976|FG002|COMPLETED|Overall Study||12
6261144|NCT00000142|7159974|FG000|NOT COMPLETED|Overall Study||0
6261145|NCT00000142|7159975|FG001|NOT COMPLETED|Overall Study||0
6261146|NCT00000142|7159976|FG002|NOT COMPLETED|Overall Study||0
6261147|NCT00000143|7159986|FG000|STARTED|Overall Study||31
6261148|NCT00000143|7159987|FG001|STARTED|Overall Study||30
6261149|NCT00000143|7159986|FG000|COMPLETED|Overall Study||31
6261150|NCT00000143|7159987|FG001|COMPLETED|Overall Study||30
6261151|NCT00000143|7159986|FG000|NOT COMPLETED|Overall Study||0
6261152|NCT00000143|7159987|FG001|NOT COMPLETED|Overall Study||0
6261153|NCT00000371|7159995|FG000|STARTED|Overall Study||27
6261154|NCT00000371|7159996|FG001|STARTED|Overall Study||28
6261155|NCT00000371|7159995|FG000|COMPLETED|Overall Study||14
6261156|NCT00000371|7159996|FG001|COMPLETED|Overall Study||12
6261157|NCT00000371|7159995|FG000|NOT COMPLETED|Overall Study||13
6261158|NCT00000371|7159996|FG001|NOT COMPLETED|Overall Study||16
6261159|NCT00000378|7160004|FG000|STARTED|Overall Study||58
6261160|NCT00000378|7160005|FG001|STARTED|Overall Study||52
6261161|NCT00000378|7160004|FG000|COMPLETED|Overall Study||42
6261162|NCT00000378|7160005|FG001|COMPLETED|Overall Study||38
6261163|NCT00000378|7160004|FG000|NOT COMPLETED|Overall Study||16
6261164|NCT00000378|7160005|FG001|NOT COMPLETED|Overall Study||14
6261165|NCT00000392|7160013|FG000|STARTED|Overall Study||106
6706850|NCT02907619|7637090|FG002|NOT COMPLETED|Overall Study||20
6261166|NCT00000392|7160014|FG001|STARTED|Overall Study||109
6261167|NCT00000392|7160013|FG000|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
6280339|NCT00153816|7180235|FG003|COMPLETED|Overall Study||390
6706851|NCT02907814|7637102|FG000|STARTED|Overall Study||6
6706852|NCT02907814|7637103|FG001|STARTED|Overall Study||0
6706853|NCT02907814|7637102|FG000|COMPLETED|Overall Study||0
6706854|NCT02907814|7637103|FG001|COMPLETED|Overall Study||0
6706855|NCT02907814|7637102|FG000|NOT COMPLETED|Overall Study||6
6706856|NCT02907814|7637103|FG001|NOT COMPLETED|Overall Study||0
6706857|NCT02907892|7637111|FG000|STARTED|Overall Study||277
6706858|NCT02907892|7637112|FG001|STARTED|Overall Study||276
6706859|NCT02907892|7637111|FG000|COMPLETED|Overall Study||250
6706860|NCT02907892|7637112|FG001|COMPLETED|Overall Study||236
6706861|NCT02907892|7637111|FG000|NOT COMPLETED|Overall Study||27
6706862|NCT02907892|7637112|FG001|NOT COMPLETED|Overall Study||40
6706863|NCT02907918|7637118|FG000|STARTED|Overall Study||26
6706864|NCT02907918|7637118|FG000|COMPLETED|Overall Study||26
6706865|NCT02907918|7637118|FG000|NOT COMPLETED|Overall Study||0
6706866|NCT02908100|7637128|FG000|STARTED|Overall Study||86
6706867|NCT02908100|7637129|FG001|STARTED|Overall Study||87
6706868|NCT02908100|7637130|FG002|STARTED|Overall Study||87
6706869|NCT02908100|7637128|FG000|COMPLETED|Overall Study||63
6706870|NCT02908100|7637129|FG001|COMPLETED|Overall Study||66
6706871|NCT02908100|7637130|FG002|COMPLETED|Overall Study||66
6706872|NCT02908100|7637128|FG000|NOT COMPLETED|Overall Study||23
6706873|NCT02908100|7637129|FG001|NOT COMPLETED|Overall Study||21
6706874|NCT02908100|7637130|FG002|NOT COMPLETED|Overall Study||21
6706875|NCT02908178|7637144|FG000|STARTED|Overall Study|The sample prior to Mahalanobis matching.|2409
6706876|NCT02908178|7637145|FG001|STARTED|Overall Study|The sample prior to Mahalanobis matching.|13106
6706877|NCT02908178|7637146|FG002|STARTED|Overall Study|The sample prior to Mahalanobis matching.|1992
6706878|NCT02908178|7637147|FG003|STARTED|Overall Study|The sample prior to Mahalanobis matching.|10784
6706879|NCT02908178|7637144|FG000|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|2409
6706880|NCT02908178|7637145|FG001|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|4718
6706881|NCT02908178|7637146|FG002|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|1992
6706882|NCT02908178|7637147|FG003|COMPLETED|Overall Study|The sample after Mahalanobis matching; that is, the number in the main analyses.|3965
6706883|NCT02908178|7637144|FG000|NOT COMPLETED|Overall Study||0
6706884|NCT02908178|7637145|FG001|NOT COMPLETED|Overall Study||8388
6706885|NCT02908178|7637146|FG002|NOT COMPLETED|Overall Study||0
6706886|NCT02908178|7637147|FG003|NOT COMPLETED|Overall Study||6819
6706887|NCT02908347|7637158|FG000|STARTED|Overall Study||23
6706888|NCT02908347|7637159|FG001|STARTED|Overall Study||23
6706889|NCT02908347|7637158|FG000|COMPLETED|Overall Study||22
6706890|NCT02908347|7637159|FG001|COMPLETED|Overall Study||22
6706891|NCT02908347|7637158|FG000|NOT COMPLETED|Overall Study||1
6706892|NCT02908347|7637159|FG001|NOT COMPLETED|Overall Study||1
6706893|NCT02908464|7637181|FG000|STARTED|Overall Study||22
6706894|NCT02908464|7637182|FG001|STARTED|Overall Study||23
6706895|NCT02908464|7637181|FG000|COMPLETED|Overall Study||20
6706896|NCT02908464|7637182|FG001|COMPLETED|Overall Study||20
6706897|NCT02908464|7637181|FG000|NOT COMPLETED|Overall Study||2
6706898|NCT02908464|7637182|FG001|NOT COMPLETED|Overall Study||3
6706899|NCT02908490|7637191|FG000|STARTED|Overall Study||12
6706900|NCT02908490|7637192|FG001|STARTED|Overall Study||13
6706901|NCT02908490|7637191|FG000|COMPLETED|Overall Study||10
6706902|NCT02908490|7637192|FG001|COMPLETED|Overall Study||11
6706903|NCT02908490|7637191|FG000|NOT COMPLETED|Overall Study||2
6706904|NCT02908490|7637192|FG001|NOT COMPLETED|Overall Study||2
6706905|NCT02908529|7637198|FG000|STARTED|Overall Study||10
6706906|NCT02908529|7637199|FG001|STARTED|Overall Study||12
6706907|NCT02908529|7637198|FG000|COMPLETED|Overall Study||10
6706908|NCT02908529|7637199|FG001|COMPLETED|Overall Study||10
6706909|NCT02908529|7637198|FG000|NOT COMPLETED|Overall Study||0
6706910|NCT02908529|7637199|FG001|NOT COMPLETED|Overall Study||2
6706911|NCT02908620|7637211|FG000|STARTED|Overall Study||10
6706912|NCT02908620|7637212|FG001|STARTED|Overall Study||10
6706913|NCT02908620|7637213|FG002|STARTED|Overall Study||10
6706914|NCT02908620|7637214|FG003|STARTED|Overall Study||10
6706915|NCT02908620|7637211|FG000|COMPLETED|Overall Study||10
6706916|NCT02908620|7637212|FG001|COMPLETED|Overall Study||10
6706917|NCT02908620|7637213|FG002|COMPLETED|Overall Study||10
6706918|NCT02908620|7637214|FG003|COMPLETED|Overall Study||10
6706919|NCT02908620|7637211|FG000|NOT COMPLETED|Overall Study||0
6706920|NCT02908620|7637212|FG001|NOT COMPLETED|Overall Study||0
6706921|NCT02908620|7637213|FG002|NOT COMPLETED|Overall Study||0
6706922|NCT02908620|7637214|FG003|NOT COMPLETED|Overall Study||0
6706923|NCT02908841|7637230|FG000|STARTED|Overall Study||10
6706924|NCT02908841|7637231|FG001|STARTED|Overall Study||12
6706925|NCT02908841|7637230|FG000|COMPLETED|Overall Study||6
6706926|NCT02908841|7637231|FG001|COMPLETED|Overall Study||12
6706927|NCT02908841|7637230|FG000|NOT COMPLETED|Overall Study||4
6706928|NCT02908841|7637231|FG001|NOT COMPLETED|Overall Study||0
6706929|NCT02908880|7637237|FG000|STARTED|Overall Study|Subjects within the Primary Analysis Cohort that received the MANTA Device|263
6706930|NCT02908880|7637237|FG000|COMPLETED|Overall Study|Subjects within the Primary Analysis Cohort that completed all follow-up time points.|236
6706931|NCT02908880|7637237|FG000|NOT COMPLETED|Overall Study||27
6706932|NCT02909101|7637243|FG000|STARTED|Overall Study||29
6706933|NCT02909101|7637244|FG001|STARTED|Overall Study||29
6706934|NCT02909101|7637243|FG000|COMPLETED|Overall Study||28
6706935|NCT02909101|7637244|FG001|COMPLETED|Overall Study||28
6706936|NCT02909101|7637243|FG000|NOT COMPLETED|Overall Study||1
6706937|NCT02909101|7637244|FG001|NOT COMPLETED|Overall Study||1
6706938|NCT02909140|7637253|FG000|STARTED|Overall Study||0
6706939|NCT02909140|7637254|FG001|STARTED|Overall Study||2
6706940|NCT02909140|7637255|FG002|STARTED|Overall Study||0
6706941|NCT02909140|7637253|FG000|COMPLETED|Overall Study||0
6706942|NCT02909140|7637254|FG001|COMPLETED|Overall Study||2
6706943|NCT02909140|7637255|FG002|COMPLETED|Overall Study||0
6706944|NCT02909140|7637253|FG000|NOT COMPLETED|Overall Study||0
6706945|NCT02909140|7637254|FG001|NOT COMPLETED|Overall Study||0
6706946|NCT02909140|7637255|FG002|NOT COMPLETED|Overall Study||0
6706947|NCT02909153|7637268|FG000|STARTED|Overall Study||6
6706948|NCT02909153|7637269|FG001|STARTED|Overall Study||6
6706949|NCT02909153|7637270|FG002|STARTED|Overall Study||6
6706950|NCT02909153|7637271|FG003|STARTED|Overall Study||6
6706951|NCT02909153|7637272|FG004|STARTED|Overall Study||6
6706952|NCT02909153|7637268|FG000|Triferic in Dianeal PD Solution|Overall Study||6
6706953|NCT02909153|7637269|FG001|Triferic in Dianeal PD Solution|Overall Study||6
6706954|NCT02909153|7637270|FG002|Triferic in Dianeal PD Solution|Overall Study||6
6706955|NCT02909153|7637271|FG003|Triferic in Dianeal PD Solution|Overall Study||0
6706956|NCT02909153|7637272|FG004|Triferic in Dianeal PD Solution|Overall Study||0
6706957|NCT02909153|7637268|FG000|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
6706958|NCT02909153|7637269|FG001|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||5
6706959|NCT02909153|7637270|FG002|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
6706960|NCT02909153|7637271|FG003|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
6706961|NCT02909153|7637272|FG004|Triferic 6.6mg Fe Via 4hr IV Infusions|Overall Study||6
6706962|NCT02909153|7637268|FG000|Triferic in Extraneal PD Solution|Overall Study||0
6706963|NCT02909153|7637269|FG001|Triferic in Extraneal PD Solution|Overall Study||0
6706964|NCT02909153|7637270|FG002|Triferic in Extraneal PD Solution|Overall Study||0
6706965|NCT02909153|7637271|FG003|Triferic in Extraneal PD Solution|Overall Study||6
6706966|NCT02909153|7637272|FG004|Triferic in Extraneal PD Solution|Overall Study||6
6706967|NCT02909153|7637268|FG000|COMPLETED|Overall Study||6
6706968|NCT02909153|7637269|FG001|COMPLETED|Overall Study||5
6706969|NCT02909153|7637270|FG002|COMPLETED|Overall Study||6
6706970|NCT02909153|7637271|FG003|COMPLETED|Overall Study||6
6706971|NCT02909153|7637272|FG004|COMPLETED|Overall Study||6
6706972|NCT02909153|7637268|FG000|NOT COMPLETED|Overall Study||0
6706973|NCT02909153|7637269|FG001|NOT COMPLETED|Overall Study||1
6706974|NCT02909153|7637270|FG002|NOT COMPLETED|Overall Study||0
6706975|NCT02909153|7637271|FG003|NOT COMPLETED|Overall Study||0
6706976|NCT02909153|7637272|FG004|NOT COMPLETED|Overall Study||0
6706977|NCT02909439|7637286|FG000|STARTED|Overall Study||31
6706978|NCT02909439|7637287|FG001|STARTED|Overall Study||31
6706979|NCT02909439|7637286|FG000|COMPLETED|Overall Study||31
6706980|NCT02909439|7637287|FG001|COMPLETED|Overall Study||31
6706981|NCT02909439|7637286|FG000|NOT COMPLETED|Overall Study||0
6706982|NCT02909439|7637287|FG001|NOT COMPLETED|Overall Study||0
6706983|NCT02909504|7637293|FG000|STARTED|Overall Study||24
6706984|NCT02909504|7637293|FG000|COMPLETED|Overall Study||12
6706985|NCT02909504|7637293|FG000|NOT COMPLETED|Overall Study||12
6261168|NCT00000392|7160014|FG001|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
6261169|NCT00000392|7160013|FG000|NOT COMPLETED|Overall Study||40
6261170|NCT00000392|7160014|FG001|NOT COMPLETED|Overall Study||32
6261171|NCT00000479|7160024|FG000|STARTED|Overall Study||9968
6261172|NCT00000479|7160025|FG001|STARTED|Overall Study||9971
6261173|NCT00000479|7160026|FG002|STARTED|Overall Study||9966
6261174|NCT00000479|7160027|FG003|STARTED|Overall Study||9971
6261175|NCT00000479|7160024|FG000|COMPLETED|Overall Study||9968
6261176|NCT00000479|7160025|FG001|COMPLETED|Overall Study||9971
6261177|NCT00000479|7160026|FG002|COMPLETED|Overall Study||9966
6261178|NCT00000479|7160027|FG003|COMPLETED|Overall Study||9971
6261179|NCT00000479|7160024|FG000|NOT COMPLETED|Overall Study||0
6261180|NCT00000479|7160025|FG001|NOT COMPLETED|Overall Study||0
6261181|NCT00000479|7160026|FG002|NOT COMPLETED|Overall Study||0
6261182|NCT00000479|7160027|FG003|NOT COMPLETED|Overall Study||0
6261183|NCT00000575|7160040|FG000|STARTED|Overall Study||311
6261184|NCT00000575|7160041|FG001|STARTED|Overall Study||312
6602548|NCT02057575|7527549|FG000|STARTED|Overall Study||74
6602549|NCT02057575|7527550|FG001|STARTED|Overall Study||73
6602550|NCT02057575|7527551|FG002|STARTED|Overall Study||78
6602551|NCT02057575|7527552|FG003|STARTED|Overall Study||73
6602552|NCT02057575|7527549|FG000|COMPLETED|Overall Study||73
6602553|NCT02057575|7527550|FG001|COMPLETED|Overall Study||69
6602554|NCT02057575|7527551|FG002|COMPLETED|Overall Study||78
6602555|NCT02057575|7527552|FG003|COMPLETED|Overall Study||72
6602556|NCT02057575|7527549|FG000|NOT COMPLETED|Overall Study||1
6602557|NCT02057575|7527550|FG001|NOT COMPLETED|Overall Study||4
6706986|NCT02909764|7637300|FG000|STARTED|Overall Study||19
6706987|NCT02909764|7637301|FG001|STARTED|Overall Study||20
6706988|NCT02909764|7637300|FG000|COMPLETED|Overall Study||19
6706989|NCT02909764|7637301|FG001|COMPLETED|Overall Study||20
6706990|NCT02909764|7637300|FG000|NOT COMPLETED|Overall Study||0
6706991|NCT02909764|7637301|FG001|NOT COMPLETED|Overall Study||0
6706992|NCT02909907|7637312|FG000|STARTED|Overall Study||10
6706993|NCT02909907|7637313|FG001|STARTED|Overall Study||10
6706994|NCT02909907|7637312|FG000|COMPLETED|Overall Study||10
6706995|NCT02909907|7637313|FG001|COMPLETED|Overall Study||9
6706996|NCT02909907|7637312|FG000|NOT COMPLETED|Overall Study||0
6706997|NCT02909907|7637313|FG001|NOT COMPLETED|Overall Study||1
6706998|NCT02909959|7637321|FG000|STARTED|Overall Study||24
6706999|NCT02909959|7637322|FG001|STARTED|Overall Study||24
6707000|NCT02909959|7637321|FG000|COMPLETED|Overall Study||24
6707001|NCT02909959|7637322|FG001|COMPLETED|Overall Study||24
6707002|NCT02909959|7637321|FG000|NOT COMPLETED|Overall Study||0
6707003|NCT02909959|7637322|FG001|NOT COMPLETED|Overall Study||0
6707004|NCT02910011|7637328|FG000|STARTED|Overall Study||15
6707005|NCT02910011|7637328|FG000|COMPLETED|Overall Study||13
6707006|NCT02910011|7637328|FG000|NOT COMPLETED|Overall Study||2
6707007|NCT02910037|7637334|FG000|STARTED|Overall Study||214
6707008|NCT02910037|7637334|FG000|COMPLETED|Overall Study||204
6707009|NCT02910037|7637334|FG000|NOT COMPLETED|Overall Study||10
6707010|NCT02910063|7637354|FG000|STARTED|Phase 2||41
6707011|NCT02910063|7637355|FG001|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
6707012|NCT02910063|7637356|FG002|STARTED|Phase 2|Participants in this Phase 3 arm were not included in the Phase 2 period.|0
6707013|NCT02910063|7637354|FG000|Started Cycle 1|Phase 2||41
6707014|NCT02910063|7637355|FG001|Started Cycle 1|Phase 2||0
6707015|NCT02910063|7637356|FG002|Started Cycle 1|Phase 2||0
6707016|NCT02910063|7637354|FG000|Started Optional Cycle 2|Phase 2||4
6707017|NCT02910063|7637355|FG001|Started Optional Cycle 2|Phase 2||0
6707018|NCT02910063|7637356|FG002|Started Optional Cycle 2|Phase 2||0
6707019|NCT02910063|7637354|FG000|COMPLETED|Phase 2||13
6707020|NCT02910063|7637355|FG001|COMPLETED|Phase 2||0
6707021|NCT02910063|7637356|FG002|COMPLETED|Phase 2||0
6707022|NCT02910063|7637354|FG000|NOT COMPLETED|Phase 2||28
6707023|NCT02910063|7637355|FG001|NOT COMPLETED|Phase 2||0
6707024|NCT02910063|7637356|FG002|NOT COMPLETED|Phase 2||0
6707025|NCT02910063|7637354|FG000|STARTED|Phase 3|Participants in this Phase 2 arm were not included in the Phase 3 period.|0
6707026|NCT02910063|7637355|FG001|STARTED|Phase 3||0
6707027|NCT02910063|7637356|FG002|STARTED|Phase 3||0
6707028|NCT02910063|7637354|FG000|COMPLETED|Phase 3||0
6707029|NCT02910063|7637355|FG001|COMPLETED|Phase 3||0
6707030|NCT02910063|7637356|FG002|COMPLETED|Phase 3||0
6707031|NCT02910063|7637354|FG000|NOT COMPLETED|Phase 3||0
6707032|NCT02910063|7637355|FG001|NOT COMPLETED|Phase 3||0
6707033|NCT02910063|7637356|FG002|NOT COMPLETED|Phase 3||0
6707034|NCT02910089|7637367|FG000|STARTED|Overall Study|Patients allocated to intervention|700
6707035|NCT02910089|7637368|FG001|STARTED|Overall Study|Patients allocated to control|700
6707036|NCT02910089|7637367|FG000|COMPLETED|Overall Study|22 patients ineligible (3.1%)|678
6707037|NCT02910089|7637368|FG001|COMPLETED|Overall Study|16 Patients ineligible (2.3%)|684
6707038|NCT02910089|7637367|FG000|NOT COMPLETED|Overall Study||22
6707039|NCT02910089|7637368|FG001|NOT COMPLETED|Overall Study||16
6707040|NCT02910102|7637376|FG000|STARTED|Overall Study||21
6707041|NCT02910102|7637377|FG001|STARTED|Overall Study||17
6707042|NCT02910102|7637376|FG000|Safety Population|Overall Study||21
6707043|NCT02910102|7637377|FG001|Safety Population|Overall Study||17
6707044|NCT02910102|7637376|FG000|Intent to Treat (ITT) Population|Overall Study||21
6707045|NCT02910102|7637377|FG001|Intent to Treat (ITT) Population|Overall Study||17
6707046|NCT02910102|7637376|FG000|Per-Protocol Population|Overall Study||20
6707047|NCT02910102|7637377|FG001|Per-Protocol Population|Overall Study||17
6707048|NCT02910102|7637376|FG000|COMPLETED|Overall Study||21
6707049|NCT02910102|7637377|FG001|COMPLETED|Overall Study||17
6707050|NCT02910102|7637376|FG000|NOT COMPLETED|Overall Study||0
6707051|NCT02910102|7637377|FG001|NOT COMPLETED|Overall Study||0
6707052|NCT02910167|7637388|FG000|STARTED|Overall Study||360
6707053|NCT02910167|7637388|FG000|COMPLETED|Overall Study||341
6707054|NCT02910167|7637388|FG000|NOT COMPLETED|Overall Study||19
6707055|NCT02910362|7637394|FG000|STARTED|Overall Study||8
6707056|NCT02910362|7637395|FG001|STARTED|Overall Study||7
6707057|NCT02910362|7637394|FG000|COMPLETED|Overall Study||8
6707058|NCT02910362|7637395|FG001|COMPLETED|Overall Study||7
6707059|NCT02910362|7637394|FG000|NOT COMPLETED|Overall Study||0
6707060|NCT02910362|7637395|FG001|NOT COMPLETED|Overall Study||0
6261185|NCT00000575|7160042|FG002|STARTED|Overall Study||418
6261186|NCT00000575|7160040|FG000|COMPLETED|Overall Study||311
6261187|NCT00000575|7160041|FG001|COMPLETED|Overall Study||312
6261188|NCT00000575|7160042|FG002|COMPLETED|Overall Study||418
6261189|NCT00000575|7160040|FG000|NOT COMPLETED|Overall Study||0
6261190|NCT00000575|7160041|FG001|NOT COMPLETED|Overall Study||0
6261191|NCT00000575|7160042|FG002|NOT COMPLETED|Overall Study||0
6261192|NCT00000620|7160052|FG000|STARTED|Overall Study||1178
6261193|NCT00000620|7160053|FG001|STARTED|Overall Study||1193
6261194|NCT00000620|7160054|FG002|STARTED|Overall Study||1374
6261195|NCT00000620|7160055|FG003|STARTED|Overall Study||1383
6261196|NCT00000620|7160056|FG004|STARTED|Overall Study||1184
6261197|NCT00000620|7160057|FG005|STARTED|Overall Study||1178
6261198|NCT00000620|7160058|FG006|STARTED|Overall Study||1391
6261199|NCT00000620|7160059|FG007|STARTED|Overall Study||1370
6261200|NCT00000620|7160052|FG000|COMPLETED|Overall Study||1016
6707061|NCT02910466|7637401|FG000|STARTED|Overall Study||39
6707062|NCT02910466|7637401|FG000|Safety Set|Overall Study||39
6707063|NCT02910466|7637401|FG000|Treated|Overall Study||36
6707064|NCT02910466|7637401|FG000|COMPLETED|Overall Study||0
6707065|NCT02910466|7637401|FG000|NOT COMPLETED|Overall Study||39
6707066|NCT02910674|7637405|FG000|STARTED|Overall Study||102
6707067|NCT02910674|7637405|FG000|COMPLETED|Overall Study||102
6707068|NCT02910674|7637405|FG000|NOT COMPLETED|Overall Study||0
6707069|NCT02910713|7637410|FG000|STARTED|Overall Study||185
6707070|NCT02910713|7637410|FG000|Safety Population: Entered CAE|Overall Study||171
6707071|NCT02910713|7637410|FG000|COMPLETED|Overall Study|Completed=Completed both Intranasal and Extranasal applications.|143
6707072|NCT02910713|7637410|FG000|NOT COMPLETED|Overall Study||42
6707073|NCT02910739|7637417|FG000|STARTED|Overall Study||8
6707074|NCT02910739|7637418|FG001|STARTED|Overall Study||8
6707075|NCT02910739|7637419|FG002|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
6707076|NCT02910739|7637420|FG003|STARTED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
6707077|NCT02910739|7637417|FG000|COMPLETED|Overall Study||7
6707078|NCT02910739|7637418|FG001|COMPLETED|Overall Study||8
6707079|NCT02910739|7637419|FG002|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
6707080|NCT02910739|7637420|FG003|COMPLETED|Overall Study|Participants were not enrolled in Part II as the PK criterion from the Part I IA was not met.|0
6707081|NCT02910739|7637417|FG000|NOT COMPLETED|Overall Study||1
6707082|NCT02910739|7637418|FG001|NOT COMPLETED|Overall Study||0
6707083|NCT02910739|7637419|FG002|NOT COMPLETED|Overall Study||0
6707084|NCT02910739|7637420|FG003|NOT COMPLETED|Overall Study||0
6707085|NCT02911025|7637426|FG000|STARTED|Overall Study||13
6707086|NCT02911025|7637426|FG000|COMPLETED|Overall Study||10
6707087|NCT02911025|7637426|FG000|NOT COMPLETED|Overall Study||3
6707088|NCT02911116|7637432|FG000|STARTED|Overall Study||5
6707089|NCT02911116|7637433|FG001|STARTED|Overall Study||3
6707090|NCT02911116|7637432|FG000|COMPLETED|Overall Study||4
6707091|NCT02911116|7637433|FG001|COMPLETED|Overall Study||2
6707092|NCT02911116|7637432|FG000|NOT COMPLETED|Overall Study||1
6707093|NCT02911116|7637433|FG001|NOT COMPLETED|Overall Study||1
6707094|NCT02911285|7637441|FG000|STARTED|Overall Study||49
6707095|NCT02911285|7637442|FG001|STARTED|Overall Study||41
6707096|NCT02911285|7637441|FG000|COMPLETED|Overall Study||40
6707097|NCT02911285|7637442|FG001|COMPLETED|Overall Study||36
6707098|NCT02911285|7637441|FG000|NOT COMPLETED|Overall Study||9
6707099|NCT02911285|7637442|FG001|NOT COMPLETED|Overall Study||5
6707100|NCT02911324|7637454|FG000|STARTED|Overall Study||9
6707101|NCT02911324|7637455|FG001|STARTED|Overall Study||7
6707102|NCT02911324|7637454|FG000|COMPLETED|Overall Study||6
6707103|NCT02911324|7637455|FG001|COMPLETED|Overall Study||6
6707104|NCT02911324|7637454|FG000|NOT COMPLETED|Overall Study||3
6707105|NCT02911324|7637455|FG001|NOT COMPLETED|Overall Study||1
6707106|NCT02911519|7637464|FG000|STARTED|Overall Study||90
6707107|NCT02911519|7637465|FG001|STARTED|Overall Study||86
6707108|NCT02911519|7637464|FG000|COMPLETED|Overall Study||88
6707109|NCT02911519|7637465|FG001|COMPLETED|Overall Study||82
6707110|NCT02911519|7637464|FG000|NOT COMPLETED|Overall Study||2
6707111|NCT02911519|7637465|FG001|NOT COMPLETED|Overall Study||4
6707112|NCT02911688|7637473|FG000|STARTED|First Intervention||9
6707113|NCT02911688|7637474|FG001|STARTED|First Intervention||9
6707114|NCT02911688|7637473|FG000|Received Intervention|First Intervention||9
6707115|NCT02911688|7637474|FG001|Received Intervention|First Intervention||9
6707116|NCT02911688|7637473|FG000|COMPLETED|First Intervention||9
6707117|NCT02911688|7637474|FG001|COMPLETED|First Intervention||9
6707118|NCT02911688|7637473|FG000|NOT COMPLETED|First Intervention||0
6707119|NCT02911688|7637474|FG001|NOT COMPLETED|First Intervention||0
6707120|NCT02911688|7637473|FG000|STARTED|Washout||9
6707121|NCT02911688|7637474|FG001|STARTED|Washout||9
6707122|NCT02911688|7637473|FG000|COMPLETED|Washout||8
6707123|NCT02911688|7637474|FG001|COMPLETED|Washout||7
6707124|NCT02911688|7637473|FG000|NOT COMPLETED|Washout||1
6707125|NCT02911688|7637474|FG001|NOT COMPLETED|Washout||2
6707126|NCT02911688|7637473|FG000|STARTED|Second Intervention||8
6707127|NCT02911688|7637474|FG001|STARTED|Second Intervention||7
6707128|NCT02911688|7637473|FG000|COMPLETED|Second Intervention||8
6707129|NCT02911688|7637474|FG001|COMPLETED|Second Intervention||7
6707130|NCT02911688|7637473|FG000|NOT COMPLETED|Second Intervention||0
6707131|NCT02911688|7637474|FG001|NOT COMPLETED|Second Intervention||0
6707132|NCT02911753|7637485|FG000|STARTED|Overall Study||21
6707133|NCT02911753|7637486|FG001|STARTED|Overall Study||19
6707134|NCT02911753|7637487|FG002|STARTED|Overall Study||10
6707135|NCT02911753|7637485|FG000|COMPLETED|Overall Study||18
6707136|NCT02911753|7637486|FG001|COMPLETED|Overall Study||16
6707137|NCT02911753|7637487|FG002|COMPLETED|Overall Study||10
6707138|NCT02911753|7637485|FG000|NOT COMPLETED|Overall Study||3
6707139|NCT02911753|7637486|FG001|NOT COMPLETED|Overall Study||3
6707140|NCT02911753|7637487|FG002|NOT COMPLETED|Overall Study||0
6707141|NCT02911818|7637516|FG000|STARTED|52 Week Study||50
6707142|NCT02911818|7637517|FG001|STARTED|52 Week Study||50
6707143|NCT02911818|7637518|FG002|STARTED|52 Week Study||50
6707144|NCT02911818|7637519|FG003|STARTED|52 Week Study||0
6707145|NCT02911818|7637520|FG004|STARTED|52 Week Study||0
6707146|NCT02911818|7637516|FG000|COMPLETED|52 Week Study||46
6707147|NCT02911818|7637517|FG001|COMPLETED|52 Week Study||45
6707148|NCT02911818|7637518|FG002|COMPLETED|52 Week Study||46
6707149|NCT02911818|7637519|FG003|COMPLETED|52 Week Study||0
6707150|NCT02911818|7637520|FG004|COMPLETED|52 Week Study||0
6261201|NCT00000620|7160053|FG001|COMPLETED|Overall Study||1057
6261202|NCT00000620|7160054|FG002|COMPLETED|Overall Study||1204
6261203|NCT00000620|7160055|FG003|COMPLETED|Overall Study||1205
6261204|NCT00000620|7160056|FG004|COMPLETED|Overall Study||1049
6261205|NCT00000620|7160057|FG005|COMPLETED|Overall Study||1026
6261206|NCT00000620|7160058|FG006|COMPLETED|Overall Study||1242
6261207|NCT00000620|7160059|FG007|COMPLETED|Overall Study||1224
6261208|NCT00000620|7160052|FG000|NOT COMPLETED|Overall Study||162
6261209|NCT00000620|7160053|FG001|NOT COMPLETED|Overall Study||136
6261210|NCT00000620|7160054|FG002|NOT COMPLETED|Overall Study||170
6261211|NCT00000620|7160055|FG003|NOT COMPLETED|Overall Study||178
6261212|NCT00000620|7160056|FG004|NOT COMPLETED|Overall Study||135
6261213|NCT00000620|7160057|FG005|NOT COMPLETED|Overall Study||152
6261214|NCT00000620|7160058|FG006|NOT COMPLETED|Overall Study||149
6261215|NCT00000620|7160059|FG007|NOT COMPLETED|Overall Study||146
6261216|NCT00001151|7160071|FG000|STARTED|Overall Study||6
6261217|NCT00001151|7160071|FG000|COMPLETED|Overall Study||1
6261218|NCT00001151|7160071|FG000|NOT COMPLETED|Overall Study||5
6261219|NCT00001213|7160075|FG000|STARTED|Overall Study||328
6261220|NCT00001213|7160075|FG000|COMPLETED|Overall Study||310
6261221|NCT00001213|7160075|FG000|NOT COMPLETED|Overall Study||18
6261222|NCT00001262|7160082|FG000|STARTED|Overall Study||35
6261223|NCT00001262|7160083|FG001|STARTED|Overall Study||22
6261224|NCT00001262|7160084|FG002|STARTED|Overall Study||3
6261225|NCT00001262|7160082|FG000|COMPLETED|Overall Study||25
6261226|NCT00001262|7160083|FG001|COMPLETED|Overall Study||8
6261227|NCT00001262|7160084|FG002|COMPLETED|Overall Study||3
6261228|NCT00001262|7160082|FG000|NOT COMPLETED|Overall Study||10
6261229|NCT00001262|7160083|FG001|NOT COMPLETED|Overall Study||14
6261230|NCT00001262|7160084|FG002|NOT COMPLETED|Overall Study||0
6261231|NCT00001304|7160094|FG000|STARTED|Overall Study||13
6261232|NCT00001304|7160095|FG001|STARTED|Overall Study||14
6261233|NCT00001304|7160094|FG000|COMPLETED|Overall Study||13
6261234|NCT00001304|7160095|FG001|COMPLETED|Overall Study||14
6261235|NCT00001304|7160094|FG000|NOT COMPLETED|Overall Study||0
6261236|NCT00001304|7160095|FG001|NOT COMPLETED|Overall Study||0
6261237|NCT00001305|7160101|FG000|STARTED|Overall Study||42
6261238|NCT00001305|7160101|FG000|COMPLETED|Overall Study||42
6261239|NCT00001305|7160101|FG000|NOT COMPLETED|Overall Study||0
6261240|NCT00001566|7160105|FG000|STARTED|Overall Study||42
6261241|NCT00001566|7160105|FG000|Completed Immunotherapy|Overall Study||23
6602558|NCT02057575|7527551|FG002|NOT COMPLETED|Overall Study||0
6602559|NCT02057575|7527552|FG003|NOT COMPLETED|Overall Study||1
6602560|NCT02057640|7527564|FG000|STARTED|Weeks 1-4|1 extra participant accidentally treated at DL1 (in addition to initial 3).|4
6602561|NCT02057640|7527565|FG001|STARTED|Weeks 1-4||3
6602562|NCT02057640|7527564|FG000|COMPLETED|Weeks 1-4||4
6602563|NCT02057640|7527565|FG001|COMPLETED|Weeks 1-4||3
6602564|NCT02057640|7527564|FG000|NOT COMPLETED|Weeks 1-4||0
6602565|NCT02057640|7527565|FG001|NOT COMPLETED|Weeks 1-4||0
6602566|NCT02057640|7527564|FG000|STARTED|Phase II Portion of Study at DL2||0
6602567|NCT02057640|7527565|FG001|STARTED|Phase II Portion of Study at DL2||9
6602568|NCT02057640|7527564|FG000|COMPLETED|Phase II Portion of Study at DL2||0
6602569|NCT02057640|7527565|FG001|COMPLETED|Phase II Portion of Study at DL2||9
6602570|NCT02057640|7527564|FG000|NOT COMPLETED|Phase II Portion of Study at DL2||0
6602571|NCT02057640|7527565|FG001|NOT COMPLETED|Phase II Portion of Study at DL2||0
6602572|NCT02057666|7527574|FG000|STARTED|Double Blind Treatment Period||96
6602573|NCT02057666|7527575|FG001|STARTED|Double Blind Treatment Period||50
6602574|NCT02057666|7527574|FG000|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|0
6602575|NCT02057666|7527575|FG001|COMPLETED|Double Blind Treatment Period|Number of patients who continued into the open-label treatment period.|6
6602576|NCT02057666|7527574|FG000|NOT COMPLETED|Double Blind Treatment Period||96
6602577|NCT02057666|7527575|FG001|NOT COMPLETED|Double Blind Treatment Period||44
6602578|NCT02057666|7527574|FG000|STARTED|Open-Label Treatment Period||0
6602579|NCT02057666|7527575|FG001|STARTED|Open-Label Treatment Period||6
6602580|NCT02057666|7527574|FG000|COMPLETED|Open-Label Treatment Period||0
6602581|NCT02057666|7527575|FG001|COMPLETED|Open-Label Treatment Period||0
6602582|NCT02057666|7527574|FG000|NOT COMPLETED|Open-Label Treatment Period||0
6602583|NCT02057666|7527575|FG001|NOT COMPLETED|Open-Label Treatment Period||6
6602584|NCT02057692|7527585|FG000|STARTED|Overall Study||8
6602585|NCT02057692|7527586|FG001|STARTED|Overall Study||11
6602586|NCT02057692|7527587|FG002|STARTED|Overall Study||6
6602587|NCT02057692|7527588|FG003|STARTED|Overall Study||12
6602588|NCT02057692|7527585|FG000|COMPLETED|Overall Study||7
6602589|NCT02057692|7527586|FG001|COMPLETED|Overall Study||11
6602590|NCT02057692|7527587|FG002|COMPLETED|Overall Study||6
6602591|NCT02057692|7527588|FG003|COMPLETED|Overall Study||11
6602592|NCT02057692|7527585|FG000|NOT COMPLETED|Overall Study||1
6602593|NCT02057692|7527586|FG001|NOT COMPLETED|Overall Study||0
6602594|NCT02057692|7527587|FG002|NOT COMPLETED|Overall Study||0
6602595|NCT02057692|7527588|FG003|NOT COMPLETED|Overall Study||1
6602596|NCT02057718|7527606|FG000|STARTED|Completed Study Treatment Through Wk. 72||8
6602597|NCT02057718|7527607|FG001|STARTED|Completed Study Treatment Through Wk. 72||25
6261242|NCT00001566|7160105|FG000|COMPLETED|Overall Study||23
6261243|NCT00001566|7160105|FG000|NOT COMPLETED|Overall Study||19
6261244|NCT00001575|7160109|FG000|STARTED|Overall Study||87
6261245|NCT00001575|7160109|FG000|Treated|Overall Study||65
6707151|NCT02911818|7637516|FG000|NOT COMPLETED|52 Week Study||4
6707152|NCT02911818|7637517|FG001|NOT COMPLETED|52 Week Study||5
6707153|NCT02911818|7637518|FG002|NOT COMPLETED|52 Week Study||4
6707154|NCT02911818|7637519|FG003|NOT COMPLETED|52 Week Study||0
6707155|NCT02911818|7637520|FG004|NOT COMPLETED|52 Week Study||0
6707156|NCT02911818|7637516|FG000|STARTED|12 Week Extension Study||0
6707157|NCT02911818|7637517|FG001|STARTED|12 Week Extension Study||0
6707158|NCT02911818|7637518|FG002|STARTED|12 Week Extension Study||0
6707159|NCT02911818|7637519|FG003|STARTED|12 Week Extension Study||22
6707160|NCT02911818|7637520|FG004|STARTED|12 Week Extension Study||23
6707161|NCT02911818|7637516|FG000|COMPLETED|12 Week Extension Study||0
6707162|NCT02911818|7637517|FG001|COMPLETED|12 Week Extension Study||0
6707163|NCT02911818|7637518|FG002|COMPLETED|12 Week Extension Study||0
6707164|NCT02911818|7637519|FG003|COMPLETED|12 Week Extension Study||22
6707165|NCT02911818|7637520|FG004|COMPLETED|12 Week Extension Study||22
6707166|NCT02911818|7637516|FG000|NOT COMPLETED|12 Week Extension Study||0
6707167|NCT02911818|7637517|FG001|NOT COMPLETED|12 Week Extension Study||0
6707168|NCT02911818|7637518|FG002|NOT COMPLETED|12 Week Extension Study||0
6707169|NCT02911818|7637519|FG003|NOT COMPLETED|12 Week Extension Study||0
6707170|NCT02911818|7637520|FG004|NOT COMPLETED|12 Week Extension Study||1
6707171|NCT02911844|7637534|FG000|STARTED|Overall Study||5
6707172|NCT02911844|7637534|FG000|COMPLETED|Overall Study||5
6707173|NCT02911844|7637534|FG000|NOT COMPLETED|Overall Study||0
6707174|NCT02911857|7637541|FG000|STARTED|Overall Study||2
6707175|NCT02911857|7637542|FG001|STARTED|Overall Study||1
6707176|NCT02911857|7637543|FG002|STARTED|Overall Study||1
6707177|NCT02911857|7637541|FG000|COMPLETED|Overall Study||2
6707178|NCT02911857|7637542|FG001|COMPLETED|Overall Study||1
6707179|NCT02911857|7637543|FG002|COMPLETED|Overall Study||1
6707180|NCT02911857|7637541|FG000|NOT COMPLETED|Overall Study||0
6707181|NCT02911857|7637542|FG001|NOT COMPLETED|Overall Study||0
6707182|NCT02911857|7637543|FG002|NOT COMPLETED|Overall Study||0
6707183|NCT02911909|7637553|FG000|STARTED|Overall Study||4
6707184|NCT02911909|7637554|FG001|STARTED|Overall Study||3
6707185|NCT02911909|7637553|FG000|COMPLETED|Overall Study||2
6707186|NCT02911909|7637554|FG001|COMPLETED|Overall Study|No Data was obtained in the study group.|0
6707187|NCT02911909|7637553|FG000|NOT COMPLETED|Overall Study||2
6707188|NCT02911909|7637554|FG001|NOT COMPLETED|Overall Study||3
6707189|NCT02911922|7637562|FG000|STARTED|Overall Study||1
6707190|NCT02911922|7637563|FG001|STARTED|Overall Study||0
6707191|NCT02911922|7637562|FG000|COMPLETED|Overall Study||1
6707192|NCT02911922|7637563|FG001|COMPLETED|Overall Study||0
6707193|NCT02911922|7637562|FG000|NOT COMPLETED|Overall Study||0
6707194|NCT02911922|7637563|FG001|NOT COMPLETED|Overall Study||0
6707195|NCT02911948|7637573|FG000|STARTED|Overall Study||105
6707196|NCT02911948|7637574|FG001|STARTED|Overall Study||105
6707197|NCT02911948|7637573|FG000|COMPLETED|Overall Study||105
6707198|NCT02911948|7637574|FG001|COMPLETED|Overall Study||98
6707199|NCT02911948|7637573|FG000|NOT COMPLETED|Overall Study||0
6707200|NCT02911948|7637574|FG001|NOT COMPLETED|Overall Study||7
6707201|NCT02912195|7637582|FG000|STARTED|Overall Study||16
6707202|NCT02912195|7637583|FG001|STARTED|Overall Study||16
6707203|NCT02912195|7637582|FG000|COMPLETED|Overall Study||16
6707204|NCT02912195|7637583|FG001|COMPLETED|Overall Study||16
6707205|NCT02912195|7637582|FG000|NOT COMPLETED|Overall Study||0
6707206|NCT02912195|7637583|FG001|NOT COMPLETED|Overall Study||0
6707207|NCT02912364|7637589|FG000|STARTED|Treatment 1||23
6707208|NCT02912364|7637590|FG001|STARTED|Treatment 1||23
6707209|NCT02912364|7637589|FG000|Received Intervention|Treatment 1||18
6707210|NCT02912364|7637590|FG001|Received Intervention|Treatment 1||18
6707211|NCT02912364|7637589|FG000|COMPLETED|Treatment 1||13
6707212|NCT02912364|7637590|FG001|COMPLETED|Treatment 1||11
6707213|NCT02912364|7637589|FG000|NOT COMPLETED|Treatment 1||10
6707214|NCT02912364|7637590|FG001|NOT COMPLETED|Treatment 1||12
6707215|NCT02912364|7637589|FG000|STARTED|Washout Period||13
6707216|NCT02912364|7637590|FG001|STARTED|Washout Period||11
6707217|NCT02912364|7637589|FG000|COMPLETED|Washout Period||13
6707218|NCT02912364|7637590|FG001|COMPLETED|Washout Period||11
6707219|NCT02912364|7637589|FG000|NOT COMPLETED|Washout Period||0
6707220|NCT02912364|7637590|FG001|NOT COMPLETED|Washout Period||0
6707221|NCT02912364|7637589|FG000|STARTED|Treatment 2||13
6707222|NCT02912364|7637590|FG001|STARTED|Treatment 2||11
6707223|NCT02912364|7637589|FG000|Received Intervention|Treatment 2||12
6707224|NCT02912364|7637590|FG001|Received Intervention|Treatment 2||11
6707225|NCT02912364|7637589|FG000|COMPLETED|Treatment 2||12
6707226|NCT02912364|7637590|FG001|COMPLETED|Treatment 2||11
6707227|NCT02912364|7637589|FG000|NOT COMPLETED|Treatment 2||1
6707228|NCT02912364|7637590|FG001|NOT COMPLETED|Treatment 2||0
6707229|NCT02912455|7637601|FG000|STARTED|Overall Study||11
6707230|NCT02912455|7637602|FG001|STARTED|Overall Study||5
6707231|NCT02912455|7637601|FG000|COMPLETED|Overall Study||9
6707232|NCT02912455|7637602|FG001|COMPLETED|Overall Study||2
6707233|NCT02912455|7637601|FG000|NOT COMPLETED|Overall Study||2
6707234|NCT02912455|7637602|FG001|NOT COMPLETED|Overall Study||3
6707235|NCT02912468|7637610|FG000|STARTED|Overall Study||133
6707236|NCT02912468|7637611|FG001|STARTED|Overall Study||143
6707237|NCT02912468|7637610|FG000|Treated|Overall Study||133
6707238|NCT02912468|7637611|FG001|Treated|Overall Study||142
6707239|NCT02912468|7637610|FG000|Safety Population|Overall Study||132
6707240|NCT02912468|7637611|FG001|Safety Population|Overall Study||143
6707241|NCT02912468|7637610|FG000|COMPLETED|Overall Study||124
6707242|NCT02912468|7637611|FG001|COMPLETED|Overall Study||138
6707243|NCT02912468|7637610|FG000|NOT COMPLETED|Overall Study||9
6707244|NCT02912468|7637611|FG001|NOT COMPLETED|Overall Study||5
6707245|NCT02912650|7637622|FG000|STARTED|Overall Study||56
6707246|NCT02912650|7637623|FG001|STARTED|Overall Study||172
6707247|NCT02912650|7637624|FG002|STARTED|Overall Study||175
6707248|NCT02912650|7637625|FG003|STARTED|Overall Study||165
6707249|NCT02912650|7637622|FG000|COMPLETED|Overall Study||55
6707250|NCT02912650|7637623|FG001|COMPLETED|Overall Study||172
6707251|NCT02912650|7637624|FG002|COMPLETED|Overall Study||173
6707252|NCT02912650|7637625|FG003|COMPLETED|Overall Study||160
6707253|NCT02912650|7637622|FG000|NOT COMPLETED|Overall Study||1
6707254|NCT02912650|7637623|FG001|NOT COMPLETED|Overall Study||0
6707255|NCT02912650|7637624|FG002|NOT COMPLETED|Overall Study||2
6707256|NCT02912650|7637625|FG003|NOT COMPLETED|Overall Study||5
6707257|NCT02913105|7637638|FG000|STARTED|Overall Study||37
6707258|NCT02913105|7637639|FG001|STARTED|Overall Study||44
6707259|NCT02913105|7637640|FG002|STARTED|Overall Study||40
6707260|NCT02913105|7637638|FG000|COMPLETED|Overall Study||22
6707261|NCT02913105|7637639|FG001|COMPLETED|Overall Study||39
6707262|NCT02913105|7637640|FG002|COMPLETED|Overall Study||33
6707263|NCT02913105|7637638|FG000|NOT COMPLETED|Overall Study||15
6707264|NCT02913105|7637639|FG001|NOT COMPLETED|Overall Study||5
6707265|NCT02913105|7637640|FG002|NOT COMPLETED|Overall Study||7
6707266|NCT02913326|7637651|FG000|STARTED|Overall Study||60
6707267|NCT02913326|7637652|FG001|STARTED|Overall Study||60
6707268|NCT02913326|7637651|FG000|COMPLETED|Overall Study||59
6707269|NCT02913326|7637652|FG001|COMPLETED|Overall Study||58
6707270|NCT02913326|7637651|FG000|NOT COMPLETED|Overall Study||1
6707271|NCT02913326|7637652|FG001|NOT COMPLETED|Overall Study||2
6707272|NCT02913521|7637661|FG000|STARTED|Overall Study||316
6707273|NCT02913521|7637662|FG001|STARTED|Overall Study||312
6707274|NCT02913521|7637663|FG002|STARTED|Overall Study||306
6707275|NCT02913521|7637661|FG000|COMPLETED|Overall Study||263
6707276|NCT02913521|7637662|FG001|COMPLETED|Overall Study||262
6707277|NCT02913521|7637663|FG002|COMPLETED|Overall Study||261
6707278|NCT02913521|7637661|FG000|NOT COMPLETED|Overall Study||53
6707279|NCT02913521|7637662|FG001|NOT COMPLETED|Overall Study||50
6707280|NCT02913521|7637663|FG002|NOT COMPLETED|Overall Study||45
6707281|NCT02913924|7637673|FG000|STARTED|Overall Study||34
6707282|NCT02913924|7637674|FG001|STARTED|Overall Study||34
6707283|NCT02913924|7637673|FG000|COMPLETED|Overall Study||21
6707284|NCT02913924|7637674|FG001|COMPLETED|Overall Study||21
6707285|NCT02913924|7637673|FG000|NOT COMPLETED|Overall Study||13
6707286|NCT02913924|7637674|FG001|NOT COMPLETED|Overall Study||13
6739136|NCT03286751|7668063|FG002|NOT COMPLETED|Washout Period 1||0
6739137|NCT03286751|7668064|FG003|NOT COMPLETED|Washout Period 1||0
6739138|NCT03286751|7668065|FG004|NOT COMPLETED|Washout Period 1||1
6739139|NCT03286751|7668066|FG005|NOT COMPLETED|Washout Period 1||0
6739140|NCT03286751|7668061|FG000|STARTED|Period 2||7
6739141|NCT03286751|7668062|FG001|STARTED|Period 2||7
6739142|NCT03286751|7668063|FG002|STARTED|Period 2||7
6739143|NCT03286751|7668064|FG003|STARTED|Period 2||7
6739144|NCT03286751|7668065|FG004|STARTED|Period 2||6
6739145|NCT03286751|7668066|FG005|STARTED|Period 2||7
6739146|NCT03286751|7668061|FG000|COMPLETED|Period 2||7
6739147|NCT03286751|7668062|FG001|COMPLETED|Period 2||7
6739148|NCT03286751|7668063|FG002|COMPLETED|Period 2||7
6739149|NCT03286751|7668064|FG003|COMPLETED|Period 2||7
6739150|NCT03286751|7668065|FG004|COMPLETED|Period 2||6
6739151|NCT03286751|7668066|FG005|COMPLETED|Period 2||7
6739152|NCT03286751|7668061|FG000|NOT COMPLETED|Period 2||0
6739153|NCT03286751|7668062|FG001|NOT COMPLETED|Period 2||0
6739154|NCT03286751|7668063|FG002|NOT COMPLETED|Period 2||0
6739155|NCT03286751|7668064|FG003|NOT COMPLETED|Period 2||0
6739156|NCT03286751|7668065|FG004|NOT COMPLETED|Period 2||0
6739157|NCT03286751|7668066|FG005|NOT COMPLETED|Period 2||0
6739158|NCT03286751|7668061|FG000|STARTED|Washout Period 2||7
6739159|NCT03286751|7668062|FG001|STARTED|Washout Period 2||7
6739160|NCT03286751|7668063|FG002|STARTED|Washout Period 2||7
6739161|NCT03286751|7668064|FG003|STARTED|Washout Period 2||7
6739162|NCT03286751|7668065|FG004|STARTED|Washout Period 2||6
6739163|NCT03286751|7668066|FG005|STARTED|Washout Period 2||7
6739164|NCT03286751|7668061|FG000|COMPLETED|Washout Period 2||7
6739165|NCT03286751|7668062|FG001|COMPLETED|Washout Period 2||6
6739166|NCT03286751|7668063|FG002|COMPLETED|Washout Period 2||7
6739167|NCT03286751|7668064|FG003|COMPLETED|Washout Period 2||7
6739168|NCT03286751|7668065|FG004|COMPLETED|Washout Period 2||6
6739169|NCT03286751|7668066|FG005|COMPLETED|Washout Period 2||7
6739170|NCT03286751|7668061|FG000|NOT COMPLETED|Washout Period 2||0
6739171|NCT03286751|7668062|FG001|NOT COMPLETED|Washout Period 2||1
6739172|NCT03286751|7668063|FG002|NOT COMPLETED|Washout Period 2||0
6739173|NCT03286751|7668064|FG003|NOT COMPLETED|Washout Period 2||0
6739174|NCT03286751|7668065|FG004|NOT COMPLETED|Washout Period 2||0
6739175|NCT03286751|7668066|FG005|NOT COMPLETED|Washout Period 2||0
6739176|NCT03286751|7668061|FG000|STARTED|Period 3||7
6739177|NCT03286751|7668062|FG001|STARTED|Period 3||6
6739178|NCT03286751|7668063|FG002|STARTED|Period 3||7
6739179|NCT03286751|7668064|FG003|STARTED|Period 3||7
6739180|NCT03286751|7668065|FG004|STARTED|Period 3||6
6739181|NCT03286751|7668066|FG005|STARTED|Period 3||7
6739182|NCT03286751|7668061|FG000|COMPLETED|Period 3||7
6739183|NCT03286751|7668062|FG001|COMPLETED|Period 3||6
6739184|NCT03286751|7668063|FG002|COMPLETED|Period 3||7
6739185|NCT03286751|7668064|FG003|COMPLETED|Period 3||7
6739186|NCT03286751|7668065|FG004|COMPLETED|Period 3||6
6707287|NCT02914119|7637680|FG000|STARTED|Overall Study||30430
6707288|NCT02914119|7637680|FG000|COMPLETED|Overall Study||30430
6707289|NCT02914119|7637680|FG000|NOT COMPLETED|Overall Study||0
6707290|NCT02914132|7637684|FG000|STARTED|Overall Study||15
6707291|NCT02914132|7637684|FG000|COMPLETED|Overall Study||15
6707292|NCT02914132|7637684|FG000|NOT COMPLETED|Overall Study||0
6707293|NCT02914184|7637692|FG000|STARTED|Overall Study||400
6707294|NCT02914184|7637693|FG001|STARTED|Overall Study||396
6707295|NCT02914184|7637694|FG002|STARTED|Overall Study||402
6707296|NCT02914184|7637695|FG003|STARTED|Overall Study||402
6707297|NCT02914184|7637692|FG000|COMPLETED|Overall Study||386
6707298|NCT02914184|7637693|FG001|COMPLETED|Overall Study||383
6707299|NCT02914184|7637694|FG002|COMPLETED|Overall Study||385
6707300|NCT02914184|7637695|FG003|COMPLETED|Overall Study||391
6707301|NCT02914184|7637692|FG000|NOT COMPLETED|Overall Study||14
6707302|NCT02914184|7637693|FG001|NOT COMPLETED|Overall Study||13
6707303|NCT02914184|7637694|FG002|NOT COMPLETED|Overall Study||17
6707304|NCT02914184|7637695|FG003|NOT COMPLETED|Overall Study||11
6707305|NCT02914210|7637709|FG000|STARTED|Overall Study||153
6707306|NCT02914210|7637710|FG001|STARTED|Overall Study||153
6707307|NCT02914210|7637709|FG000|COMPLETED|Overall Study||143
6707308|NCT02914210|7637710|FG001|COMPLETED|Overall Study||144
6707309|NCT02914210|7637709|FG000|NOT COMPLETED|Overall Study||10
6707310|NCT02914210|7637710|FG001|NOT COMPLETED|Overall Study||9
6707311|NCT02914236|7637716|FG000|STARTED|Overall Study||50
6707312|NCT02914236|7637716|FG000|4-week Follow-up Visit|Overall Study||50
6707313|NCT02914236|7637716|FG000|12-week Follow-up Visit|Overall Study||50
6707314|NCT02914236|7637716|FG000|26-week Follow-up Visit|Overall Study||49
6707315|NCT02914236|7637716|FG000|COMPLETED|Overall Study||49
6707316|NCT02914236|7637716|FG000|NOT COMPLETED|Overall Study||1
6707317|NCT02914275|7637722|FG000|STARTED|Overall Study||1687
6707318|NCT02914275|7637723|FG001|STARTED|Overall Study||563
6707319|NCT02914275|7637722|FG000|Included in Clinical Database / FAS|Overall Study||1684
6707320|NCT02914275|7637723|FG001|Included in Clinical Database / FAS|Overall Study||563
6707321|NCT02914275|7637722|FG000|COMPLETED|Overall Study||1566
6707322|NCT02914275|7637723|FG001|COMPLETED|Overall Study||521
6707323|NCT02914275|7637722|FG000|NOT COMPLETED|Overall Study||121
6707324|NCT02914275|7637723|FG001|NOT COMPLETED|Overall Study||42
6707325|NCT02914457|7637733|FG000|STARTED|Overall Study||31
6707326|NCT02914457|7637733|FG000|COMPLETED|Overall Study|Subjects who completed electrophysiological study with analyzable data|25
6707327|NCT02914457|7637733|FG000|NOT COMPLETED|Overall Study||6
6707328|NCT02914509|7637739|FG000|STARTED|Overall Study||348
6707329|NCT02914509|7637740|FG001|STARTED|Overall Study||217
6707330|NCT02914509|7637739|FG000|COMPLETED|Overall Study||343
6707331|NCT02914509|7637740|FG001|COMPLETED|Overall Study||211
6707332|NCT02914509|7637739|FG000|NOT COMPLETED|Overall Study||5
6707333|NCT02914509|7637740|FG001|NOT COMPLETED|Overall Study||6
6707334|NCT02914522|7637754|FG000|STARTED|Induction Study: Up to Week 11||245
6707335|NCT02914522|7637755|FG001|STARTED|Induction Study: Up to Week 11||278
6707336|NCT02914522|7637756|FG002|STARTED|Induction Study: Up to Week 11||137
6707337|NCT02914522|7637757|FG003|STARTED|Induction Study: Up to Week 11||262
6707338|NCT02914522|7637758|FG004|STARTED|Induction Study: Up to Week 11||286
6707339|NCT02914522|7637759|FG005|STARTED|Induction Study: Up to Week 11||143
6707340|NCT02914522|7637760|FG006|STARTED|Induction Study: Up to Week 11||0
6707341|NCT02914522|7637761|FG007|STARTED|Induction Study: Up to Week 11||0
6707342|NCT02914522|7637762|FG008|STARTED|Induction Study: Up to Week 11||0
6707343|NCT02914522|7637763|FG009|STARTED|Induction Study: Up to Week 11||0
6707344|NCT02914522|7637764|FG010|STARTED|Induction Study: Up to Week 11||0
6707345|NCT02914522|7637754|FG000|COMPLETED|Induction Study: Up to Week 11||235
6707346|NCT02914522|7637755|FG001|COMPLETED|Induction Study: Up to Week 11||256
6707347|NCT02914522|7637756|FG002|COMPLETED|Induction Study: Up to Week 11||127
6707348|NCT02914522|7637757|FG003|COMPLETED|Induction Study: Up to Week 11||234
6707349|NCT02914522|7637758|FG004|COMPLETED|Induction Study: Up to Week 11||262
6707350|NCT02914522|7637759|FG005|COMPLETED|Induction Study: Up to Week 11||127
6707351|NCT02914522|7637760|FG006|COMPLETED|Induction Study: Up to Week 11||0
6707352|NCT02914522|7637761|FG007|COMPLETED|Induction Study: Up to Week 11||0
6707353|NCT02914522|7637762|FG008|COMPLETED|Induction Study: Up to Week 11||0
6707354|NCT02914522|7637763|FG009|COMPLETED|Induction Study: Up to Week 11||0
6707355|NCT02914522|7637764|FG010|COMPLETED|Induction Study: Up to Week 11||0
6707356|NCT02914522|7637754|FG000|NOT COMPLETED|Induction Study: Up to Week 11||10
6602598|NCT02057718|7527606|FG000|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||6
6602599|NCT02057718|7527607|FG001|Completed Study Treatment Through Week 72|Completed Study Treatment Through Wk. 72||16
6602600|NCT02057718|7527606|FG000|COMPLETED|Completed Study Treatment Through Wk. 72||6
6602601|NCT02057718|7527607|FG001|COMPLETED|Completed Study Treatment Through Wk. 72||16
6602602|NCT02057718|7527606|FG000|NOT COMPLETED|Completed Study Treatment Through Wk. 72||2
6602603|NCT02057718|7527607|FG001|NOT COMPLETED|Completed Study Treatment Through Wk. 72||9
6602604|NCT02057718|7527606|FG000|STARTED|Optional Follow-up Treatment Period||6
6602605|NCT02057718|7527607|FG001|STARTED|Optional Follow-up Treatment Period||16
6602606|NCT02057718|7527606|FG000|COMPLETED|Optional Follow-up Treatment Period||4
6602607|NCT02057718|7527607|FG001|COMPLETED|Optional Follow-up Treatment Period||8
6602608|NCT02057718|7527606|FG000|NOT COMPLETED|Optional Follow-up Treatment Period||2
6602609|NCT02057718|7527607|FG001|NOT COMPLETED|Optional Follow-up Treatment Period||8
6707357|NCT02914522|7637755|FG001|NOT COMPLETED|Induction Study: Up to Week 11||22
6707358|NCT02914522|7637756|FG002|NOT COMPLETED|Induction Study: Up to Week 11||10
6707359|NCT02914522|7637757|FG003|NOT COMPLETED|Induction Study: Up to Week 11||28
6707360|NCT02914522|7637758|FG004|NOT COMPLETED|Induction Study: Up to Week 11||24
6707361|NCT02914522|7637759|FG005|NOT COMPLETED|Induction Study: Up to Week 11||16
6707362|NCT02914522|7637760|FG006|NOT COMPLETED|Induction Study: Up to Week 11||0
6707363|NCT02914522|7637761|FG007|NOT COMPLETED|Induction Study: Up to Week 11||0
6707364|NCT02914522|7637762|FG008|NOT COMPLETED|Induction Study: Up to Week 11||0
6707365|NCT02914522|7637763|FG009|NOT COMPLETED|Induction Study: Up to Week 11||0
6707366|NCT02914522|7637764|FG010|NOT COMPLETED|Induction Study: Up to Week 11||0
6707367|NCT02914522|7637754|FG000|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
6707368|NCT02914522|7637755|FG001|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
6707369|NCT02914522|7637756|FG002|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
6707370|NCT02914522|7637757|FG003|STARTED|Maintenance Study: Week 11 to Week 58||0
6707371|NCT02914522|7637758|FG004|STARTED|Maintenance Study: Week 11 to Week 58||0
6707372|NCT02914522|7637759|FG005|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|0
6707373|NCT02914522|7637760|FG006|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|202
6707374|NCT02914522|7637761|FG007|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|99
6707375|NCT02914522|7637762|FG008|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|179
6707376|NCT02914522|7637763|FG009|STARTED|Maintenance Study: Week 11 to Week 58|Participants achieved either EBS remission/MCS response at Week 10 continued into Maintenance Study.|91
6707377|NCT02914522|7637764|FG010|STARTED|Maintenance Study: Week 11 to Week 58||93
6707378|NCT02914522|7637754|FG000|COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707379|NCT02914522|7637755|FG001|COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707380|NCT02914522|7637756|FG002|COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707381|NCT02914522|7637757|FG003|COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707382|NCT02914522|7637758|FG004|COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707383|NCT02914522|7637759|FG005|COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707384|NCT02914522|7637760|FG006|COMPLETED|Maintenance Study: Week 11 to Week 58||150
6707385|NCT02914522|7637761|FG007|COMPLETED|Maintenance Study: Week 11 to Week 58||41
6707386|NCT02914522|7637762|FG008|COMPLETED|Maintenance Study: Week 11 to Week 58||104
6707387|NCT02914522|7637763|FG009|COMPLETED|Maintenance Study: Week 11 to Week 58||42
6707388|NCT02914522|7637764|FG010|COMPLETED|Maintenance Study: Week 11 to Week 58||64
6707389|NCT02914522|7637754|FG000|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707390|NCT02914522|7637755|FG001|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707391|NCT02914522|7637756|FG002|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707392|NCT02914522|7637757|FG003|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707393|NCT02914522|7637758|FG004|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707394|NCT02914522|7637759|FG005|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||0
6707395|NCT02914522|7637760|FG006|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||52
6707396|NCT02914522|7637761|FG007|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||58
6707397|NCT02914522|7637762|FG008|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||75
6707398|NCT02914522|7637763|FG009|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||49
6707399|NCT02914522|7637764|FG010|NOT COMPLETED|Maintenance Study: Week 11 to Week 58||29
6707400|NCT02914548|7637794|FG000|STARTED|Overall Study||67
6707401|NCT02914548|7637795|FG001|STARTED|Overall Study||67
6707402|NCT02914548|7637796|FG002|STARTED|Overall Study||66
6707403|NCT02914548|7637794|FG000|COMPLETED|Overall Study||46
6707404|NCT02914548|7637795|FG001|COMPLETED|Overall Study||53
6707405|NCT02914548|7637796|FG002|COMPLETED|Overall Study||46
6707406|NCT02914548|7637794|FG000|NOT COMPLETED|Overall Study||21
6707407|NCT02914548|7637795|FG001|NOT COMPLETED|Overall Study||14
6707408|NCT02914548|7637796|FG002|NOT COMPLETED|Overall Study||20
6707409|NCT02914795|7637806|FG000|STARTED|Overall Study||77
6707410|NCT02914795|7637807|FG001|STARTED|Overall Study||22
6707411|NCT02914795|7637806|FG000|COMPLETED|Overall Study||77
6707412|NCT02914795|7637807|FG001|COMPLETED|Overall Study||22
6707413|NCT02914795|7637806|FG000|NOT COMPLETED|Overall Study||0
6707414|NCT02914795|7637807|FG001|NOT COMPLETED|Overall Study||0
6707415|NCT02914834|7637817|FG000|STARTED|Overall Study||12
6707416|NCT02914834|7637818|FG001|STARTED|Overall Study||15
6707417|NCT02914834|7637817|FG000|COMPLETED|Overall Study||11
6707418|NCT02914834|7637818|FG001|COMPLETED|Overall Study||13
6707419|NCT02914834|7637817|FG000|NOT COMPLETED|Overall Study||1
6707420|NCT02914834|7637818|FG001|NOT COMPLETED|Overall Study||2
6707453|NCT02915029|7637859|FG000|STARTED|Overall Study||63
6707454|NCT02915029|7637860|FG001|STARTED|Overall Study||62
6707455|NCT02915029|7637859|FG000|COMPLETED|Overall Study||50
6707456|NCT02915029|7637860|FG001|COMPLETED|Overall Study||48
6707457|NCT02915029|7637859|FG000|NOT COMPLETED|Overall Study||13
6707458|NCT02915029|7637860|FG001|NOT COMPLETED|Overall Study||14
6707459|NCT02915159|7637868|FG000|STARTED|Overall Study||92
6707460|NCT02915159|7637869|FG001|STARTED|Overall Study||95
6707461|NCT02915159|7637868|FG000|COMPLETED|Overall Study||81
6707462|NCT02915159|7637869|FG001|COMPLETED|Overall Study||87
6707463|NCT02915159|7637868|FG000|NOT COMPLETED|Overall Study||11
6707464|NCT02915159|7637869|FG001|NOT COMPLETED|Overall Study||8
6707465|NCT02915705|7637881|FG000|STARTED|Treatment Period||32
6707466|NCT02915705|7637882|FG001|STARTED|Treatment Period||29
6707467|NCT02915705|7637881|FG000|Completed Week 40|Treatment Period||32
6707468|NCT02915705|7637882|FG001|Completed Week 40|Treatment Period||29
6707469|NCT02915705|7637881|FG000|Completed Week 64|Treatment Period||32
6707470|NCT02915705|7637882|FG001|Completed Week 64|Treatment Period||29
6707471|NCT02915705|7637881|FG000|COMPLETED|Treatment Period||32
6707472|NCT02915705|7637882|FG001|COMPLETED|Treatment Period||29
6707473|NCT02915705|7637881|FG000|NOT COMPLETED|Treatment Period||0
6707474|NCT02915705|7637882|FG001|NOT COMPLETED|Treatment Period||0
6707475|NCT02915705|7637881|FG000|STARTED|Long Term Extension Period|6 participants did not enter the extension period|26
6707476|NCT02915705|7637882|FG001|STARTED|Long Term Extension Period|4 participants did not enter the extension period|25
6707477|NCT02915705|7637881|FG000|COMPLETED|Long Term Extension Period||26
6707478|NCT02915705|7637882|FG001|COMPLETED|Long Term Extension Period||25
6707479|NCT02915705|7637881|FG000|NOT COMPLETED|Long Term Extension Period||0
6707480|NCT02915705|7637882|FG001|NOT COMPLETED|Long Term Extension Period||0
6707481|NCT02915744|7637893|FG000|STARTED|Overall Study||92
6707482|NCT02915744|7637894|FG001|STARTED|Overall Study||86
6707483|NCT02915744|7637893|FG000|COMPLETED|Overall Study||13
6707484|NCT02915744|7637894|FG001|COMPLETED|Overall Study||9
6707485|NCT02915744|7637893|FG000|NOT COMPLETED|Overall Study||79
6707486|NCT02915744|7637894|FG001|NOT COMPLETED|Overall Study||77
6707487|NCT02915835|7637904|FG000|STARTED|Overall Study||9
6707488|NCT02915835|7637905|FG001|STARTED|Overall Study||8
6707489|NCT02915835|7637904|FG000|COMPLETED|Overall Study||8
6707490|NCT02915835|7637905|FG001|COMPLETED|Overall Study||7
6707491|NCT02915835|7637904|FG000|NOT COMPLETED|Overall Study||1
6707492|NCT02915835|7637905|FG001|NOT COMPLETED|Overall Study||1
6707493|NCT02915874|7637913|FG000|STARTED|Overall Study||44
6707494|NCT02915874|7637914|FG001|STARTED|Overall Study||28
6707495|NCT02915874|7637913|FG000|Week 6 Follow Up|Overall Study||41
6707496|NCT02915874|7637914|FG001|Week 6 Follow Up|Overall Study||26
6707497|NCT02915874|7637913|FG000|COMPLETED|Overall Study||38
6707498|NCT02915874|7637914|FG001|COMPLETED|Overall Study||22
6707499|NCT02915874|7637913|FG000|NOT COMPLETED|Overall Study||6
6707500|NCT02915874|7637914|FG001|NOT COMPLETED|Overall Study||6
6707501|NCT02915978|7637923|FG000|STARTED|Overall Study||15
6707502|NCT02915978|7637924|FG001|STARTED|Overall Study||15
6707503|NCT02915978|7637925|FG002|STARTED|Overall Study||15
6707504|NCT02915978|7637923|FG000|COMPLETED|Overall Study||13
6707505|NCT02915978|7637924|FG001|COMPLETED|Overall Study||14
6707506|NCT02915978|7637925|FG002|COMPLETED|Overall Study||15
6707507|NCT02915978|7637923|FG000|NOT COMPLETED|Overall Study||2
6707508|NCT02915978|7637924|FG001|NOT COMPLETED|Overall Study||1
6707509|NCT02915978|7637925|FG002|NOT COMPLETED|Overall Study||0
6707510|NCT02916056|7637933|FG000|STARTED|Overall Study||297
6707511|NCT02916056|7637933|FG000|COMPLETED|Overall Study||0
6707512|NCT02916056|7637933|FG000|NOT COMPLETED|Overall Study||297
6707513|NCT02916407|7637939|FG000|STARTED|Overall Study||28
6707514|NCT02916407|7637940|FG001|STARTED|Overall Study||28
6707515|NCT02916407|7637939|FG000|COMPLETED|Overall Study||28
6707516|NCT02916407|7637940|FG001|COMPLETED|Overall Study||28
6707517|NCT02916407|7637939|FG000|NOT COMPLETED|Overall Study||0
6707518|NCT02916407|7637940|FG001|NOT COMPLETED|Overall Study||0
6707519|NCT02916433|7637948|FG000|STARTED|Overall Study||3
6707520|NCT02916433|7637949|FG001|STARTED|Overall Study||2
6707521|NCT02916433|7637948|FG000|COMPLETED|Overall Study||1
6707522|NCT02916433|7637949|FG001|COMPLETED|Overall Study||2
6707523|NCT02916433|7637948|FG000|NOT COMPLETED|Overall Study||2
6707524|NCT02916433|7637949|FG001|NOT COMPLETED|Overall Study||0
6707525|NCT02916498|7637960|FG000|STARTED|First Intervention, 21 Days||2
6707526|NCT02916498|7637961|FG001|STARTED|First Intervention, 21 Days||4
6707527|NCT02916498|7637960|FG000|COMPLETED|First Intervention, 21 Days||2
6707528|NCT02916498|7637961|FG001|COMPLETED|First Intervention, 21 Days||4
6707529|NCT02916498|7637960|FG000|NOT COMPLETED|First Intervention, 21 Days||0
6707530|NCT02916498|7637961|FG001|NOT COMPLETED|First Intervention, 21 Days||0
6707531|NCT02916498|7637960|FG000|STARTED|Second Intervention, 21 Days||2
6707532|NCT02916498|7637961|FG001|STARTED|Second Intervention, 21 Days||4
6707533|NCT02916498|7637960|FG000|COMPLETED|Second Intervention, 21 Days||2
6707534|NCT02916498|7637961|FG001|COMPLETED|Second Intervention, 21 Days||4
6707535|NCT02916498|7637960|FG000|NOT COMPLETED|Second Intervention, 21 Days||0
6707536|NCT02916498|7637961|FG001|NOT COMPLETED|Second Intervention, 21 Days||0
6707537|NCT02916563|7637967|FG000|STARTED|Overall Study||50
6707538|NCT02916563|7637967|FG000|COMPLETED|Overall Study||50
6707539|NCT02916563|7637967|FG000|NOT COMPLETED|Overall Study||0
6707540|NCT02916693|7637971|FG000|STARTED|Overall Study||20
6707541|NCT02916693|7637971|FG000|COMPLETED|Overall Study||13
6707542|NCT02916693|7637971|FG000|NOT COMPLETED|Overall Study||7
6707543|NCT02916745|7637979|FG000|STARTED|Overall Study||5
6707544|NCT02916745|7637979|FG000|COMPLETED|Overall Study||5
6707545|NCT02916745|7637979|FG000|NOT COMPLETED|Overall Study||0
6707546|NCT02916927|7637985|FG000|STARTED|Overall Study||31
6707547|NCT02916927|7637986|FG001|STARTED|Overall Study||31
6707548|NCT02916927|7637985|FG000|Received Study Drug|Overall Study||31
6707549|NCT02916927|7637986|FG001|Received Study Drug|Overall Study||29
6707550|NCT02916927|7637985|FG000|COMPLETED|Overall Study||30
6707551|NCT02916927|7637986|FG001|COMPLETED|Overall Study|1 participant was in radiology for the 45 and 60 minute time points.|28
6707552|NCT02916927|7637985|FG000|NOT COMPLETED|Overall Study||1
6707553|NCT02916927|7637986|FG001|NOT COMPLETED|Overall Study||3
6707554|NCT02917031|7637995|FG000|STARTED|Overall Study||112
6707555|NCT02917031|7637996|FG001|STARTED|Overall Study||115
6707556|NCT02917031|7637997|FG002|STARTED|Overall Study||120
6707557|NCT02917031|7637995|FG000|COMPLETED|Overall Study||94
6707558|NCT02917031|7637996|FG001|COMPLETED|Overall Study||102
6707559|NCT02917031|7637997|FG002|COMPLETED|Overall Study||105
6707560|NCT02917031|7637995|FG000|NOT COMPLETED|Overall Study||18
6707561|NCT02917031|7637996|FG001|NOT COMPLETED|Overall Study||13
6707562|NCT02917031|7637997|FG002|NOT COMPLETED|Overall Study||15
6707563|NCT02917122|7638008|FG000|STARTED|Overall Study||8
6707564|NCT02917122|7638009|FG001|STARTED|Overall Study||7
6707565|NCT02917122|7638008|FG000|COMPLETED|Overall Study||8
6707566|NCT02917122|7638009|FG001|COMPLETED|Overall Study||7
6707567|NCT02917122|7638008|FG000|NOT COMPLETED|Overall Study||0
6707568|NCT02917122|7638009|FG001|NOT COMPLETED|Overall Study||0
6707569|NCT02917265|7638017|FG000|STARTED|Overall Study||5
6707570|NCT02917265|7638018|FG001|STARTED|Overall Study||2
6707571|NCT02917265|7638017|FG000|COMPLETED|Overall Study||3
6707572|NCT02917265|7638018|FG001|COMPLETED|Overall Study||2
6707573|NCT02917265|7638017|FG000|NOT COMPLETED|Overall Study||2
6707574|NCT02917265|7638018|FG001|NOT COMPLETED|Overall Study||0
6707575|NCT02917278|7638028|FG000|STARTED|Overall Study||10
6707576|NCT02917278|7638029|FG001|STARTED|Overall Study||9
6707577|NCT02917278|7638028|FG000|COMPLETED|Overall Study||9
6707578|NCT02917278|7638029|FG001|COMPLETED|Overall Study||9
6707579|NCT02917278|7638028|FG000|NOT COMPLETED|Overall Study||1
6707580|NCT02917278|7638029|FG001|NOT COMPLETED|Overall Study||0
6707581|NCT02917447|7638037|FG000|STARTED|Overall Study||51
6707582|NCT02917447|7638038|FG001|STARTED|Overall Study||51
6707583|NCT02917447|7638037|FG000|COMPLETED|Overall Study||44
6707584|NCT02917447|7638038|FG001|COMPLETED|Overall Study||48
6707585|NCT02917447|7638037|FG000|NOT COMPLETED|Overall Study||7
6707586|NCT02917447|7638038|FG001|NOT COMPLETED|Overall Study||3
6707587|NCT02917603|7638046|FG000|STARTED|Overall Study||20
6707588|NCT02917603|7638047|FG001|STARTED|Overall Study||20
6707589|NCT02917603|7638046|FG000|COMPLETED|Overall Study||19
6707590|NCT02917603|7638047|FG001|COMPLETED|Overall Study||16
6707591|NCT02917603|7638046|FG000|NOT COMPLETED|Overall Study||1
6707592|NCT02917603|7638047|FG001|NOT COMPLETED|Overall Study||4
6707593|NCT02917642|7638056|FG000|STARTED|Overall Study||25
6707594|NCT02917642|7638057|FG001|STARTED|Overall Study||25
6707595|NCT02917642|7638056|FG000|COMPLETED|Overall Study||25
6707596|NCT02917642|7638057|FG001|COMPLETED|Overall Study||25
6707597|NCT02917642|7638056|FG000|NOT COMPLETED|Overall Study||0
6707598|NCT02917642|7638057|FG001|NOT COMPLETED|Overall Study||0
6707599|NCT02917941|7638063|FG000|STARTED|Treatment Period||34
6707600|NCT02917941|7638063|FG000|COMPLETED|Treatment Period||10
6707601|NCT02917941|7638063|FG000|NOT COMPLETED|Treatment Period||24
6707602|NCT02917941|7638063|FG000|STARTED|Survival Follow-up Period||31
6707603|NCT02917941|7638063|FG000|COMPLETED|Survival Follow-up Period||26
6707604|NCT02917941|7638063|FG000|NOT COMPLETED|Survival Follow-up Period||5
6707605|NCT02918071|7638067|FG000|STARTED|Overall Study||121
6707606|NCT02918071|7638067|FG000|COMPLETED|Overall Study||118
6707607|NCT02918071|7638067|FG000|NOT COMPLETED|Overall Study||3
6707608|NCT02918097|7638071|FG000|STARTED|Overall Study||78
6707609|NCT02918097|7638071|FG000|COMPLETED|Overall Study|Primary and secondary outcomes are assessed just at the end of the protocol, not at each step|58
6707610|NCT02918097|7638071|FG000|NOT COMPLETED|Overall Study||20
6707611|NCT02918266|7638086|FG000|STARTED|Part 1||6
6707612|NCT02918266|7638087|FG001|STARTED|Part 1||0
6707613|NCT02918266|7638088|FG002|STARTED|Part 1||0
6707614|NCT02918266|7638089|FG003|STARTED|Part 1||0
6707615|NCT02918266|7638090|FG004|STARTED|Part 1||0
6707616|NCT02918266|7638091|FG005|STARTED|Part 1||0
6707617|NCT02918266|7638092|FG006|STARTED|Part 1||0
6707618|NCT02918266|7638093|FG007|STARTED|Part 1||0
6707619|NCT02918266|7638094|FG008|STARTED|Part 1||0
6707620|NCT02918266|7638095|FG009|STARTED|Part 1||0
6707621|NCT02918266|7638096|FG010|STARTED|Part 1||0
6707622|NCT02918266|7638086|FG000|COMPLETED|Part 1||6
6707623|NCT02918266|7638087|FG001|COMPLETED|Part 1||0
6707624|NCT02918266|7638088|FG002|COMPLETED|Part 1||0
6707625|NCT02918266|7638089|FG003|COMPLETED|Part 1||0
6707626|NCT02918266|7638090|FG004|COMPLETED|Part 1||0
6707627|NCT02918266|7638091|FG005|COMPLETED|Part 1||0
6707628|NCT02918266|7638092|FG006|COMPLETED|Part 1||0
6707629|NCT02918266|7638093|FG007|COMPLETED|Part 1||0
6707630|NCT02918266|7638094|FG008|COMPLETED|Part 1||0
6707631|NCT02918266|7638095|FG009|COMPLETED|Part 1||0
6707632|NCT02918266|7638096|FG010|COMPLETED|Part 1||0
6261246|NCT00001575|7160109|FG000|COMPLETED|Overall Study||42
6261247|NCT00001575|7160109|FG000|NOT COMPLETED|Overall Study||45
6261248|NCT00001586|7160115|FG000|STARTED|Overall Study||49
6261249|NCT00001586|7160116|FG001|STARTED|Overall Study||56
6261250|NCT00001586|7160115|FG000|COMPLETED|Overall Study||49
6261251|NCT00001586|7160116|FG001|COMPLETED|Overall Study||56
6261252|NCT00001586|7160115|FG000|NOT COMPLETED|Overall Study||0
6707633|NCT02918266|7638086|FG000|NOT COMPLETED|Part 1||0
6707634|NCT02918266|7638087|FG001|NOT COMPLETED|Part 1||0
6707635|NCT02918266|7638088|FG002|NOT COMPLETED|Part 1||0
6707636|NCT02918266|7638089|FG003|NOT COMPLETED|Part 1||0
6707637|NCT02918266|7638090|FG004|NOT COMPLETED|Part 1||0
6707638|NCT02918266|7638091|FG005|NOT COMPLETED|Part 1||0
6707639|NCT02918266|7638092|FG006|NOT COMPLETED|Part 1||0
6707640|NCT02918266|7638093|FG007|NOT COMPLETED|Part 1||0
6707641|NCT02918266|7638094|FG008|NOT COMPLETED|Part 1||0
6707642|NCT02918266|7638095|FG009|NOT COMPLETED|Part 1||0
6707643|NCT02918266|7638096|FG010|NOT COMPLETED|Part 1||0
6707644|NCT02918266|7638086|FG000|STARTED|Part 2: Intervention Period 1 (2 Days)||0
6707645|NCT02918266|7638087|FG001|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6707646|NCT02918266|7638088|FG002|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6707647|NCT02918266|7638089|FG003|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6261253|NCT00001586|7160116|FG001|NOT COMPLETED|Overall Study||0
6261254|NCT00001596|7160124|FG000|STARTED|Overall Study||23
6261255|NCT00001596|7160125|FG001|STARTED|Overall Study||12
6261256|NCT00001596|7160124|FG000|COMPLETED|Overall Study||6
6261257|NCT00001596|7160125|FG001|COMPLETED|Overall Study||2
6261258|NCT00001596|7160124|FG000|NOT COMPLETED|Overall Study||17
6261259|NCT00001596|7160125|FG001|NOT COMPLETED|Overall Study||10
6261260|NCT00001656|7160133|FG000|STARTED|Overall Study||13
6261261|NCT00001656|7160134|FG001|STARTED|Overall Study||12
6707648|NCT02918266|7638090|FG004|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6707649|NCT02918266|7638091|FG005|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6739187|NCT03286751|7668066|FG005|COMPLETED|Period 3||7
6707650|NCT02918266|7638092|FG006|STARTED|Part 2: Intervention Period 1 (2 Days)||2
6707651|NCT02918266|7638093|FG007|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6707652|NCT02918266|7638094|FG008|STARTED|Part 2: Intervention Period 1 (2 Days)||2
6707653|NCT02918266|7638095|FG009|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6707654|NCT02918266|7638096|FG010|STARTED|Part 2: Intervention Period 1 (2 Days)||1
6707655|NCT02918266|7638086|FG000|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707656|NCT02918266|7638087|FG001|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707657|NCT02918266|7638088|FG002|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707658|NCT02918266|7638089|FG003|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707659|NCT02918266|7638090|FG004|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707660|NCT02918266|7638091|FG005|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707661|NCT02918266|7638092|FG006|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707662|NCT02918266|7638093|FG007|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707663|NCT02918266|7638094|FG008|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707664|NCT02918266|7638095|FG009|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707665|NCT02918266|7638096|FG010|COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707666|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||0
6707667|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6707668|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6707669|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6707670|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6707671|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6707672|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
6707673|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6707674|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||2
6707675|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6707676|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Intervention Period 1 (2 Days)||1
6707677|NCT02918266|7638086|FG000|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707678|NCT02918266|7638087|FG001|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707679|NCT02918266|7638088|FG002|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707680|NCT02918266|7638089|FG003|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707681|NCT02918266|7638090|FG004|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707682|NCT02918266|7638091|FG005|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707683|NCT02918266|7638092|FG006|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707684|NCT02918266|7638093|FG007|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707685|NCT02918266|7638094|FG008|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707686|NCT02918266|7638095|FG009|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707687|NCT02918266|7638096|FG010|STARTED|Part 2: Washout Period 1 (3 Weeks)||0
6707688|NCT02918266|7638086|FG000|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707689|NCT02918266|7638087|FG001|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707690|NCT02918266|7638088|FG002|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707691|NCT02918266|7638089|FG003|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707692|NCT02918266|7638090|FG004|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707693|NCT02918266|7638091|FG005|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707694|NCT02918266|7638092|FG006|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707695|NCT02918266|7638093|FG007|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707696|NCT02918266|7638094|FG008|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707697|NCT02918266|7638095|FG009|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707698|NCT02918266|7638096|FG010|COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707699|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707700|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707701|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707702|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707703|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707704|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707705|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707706|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707707|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707708|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707709|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Washout Period 1 (3 Weeks)||0
6707710|NCT02918266|7638086|FG000|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707711|NCT02918266|7638087|FG001|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707712|NCT02918266|7638088|FG002|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707713|NCT02918266|7638089|FG003|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707714|NCT02918266|7638090|FG004|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707715|NCT02918266|7638091|FG005|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707716|NCT02918266|7638092|FG006|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707717|NCT02918266|7638093|FG007|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707718|NCT02918266|7638094|FG008|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707719|NCT02918266|7638095|FG009|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707720|NCT02918266|7638096|FG010|STARTED|Part 2: Intervention Period 2 (2 Days)||0
6707721|NCT02918266|7638086|FG000|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707722|NCT02918266|7638087|FG001|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6739188|NCT03286751|7668061|FG000|NOT COMPLETED|Period 3||0
6707723|NCT02918266|7638088|FG002|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707724|NCT02918266|7638089|FG003|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707725|NCT02918266|7638090|FG004|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707726|NCT02918266|7638091|FG005|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707727|NCT02918266|7638092|FG006|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707728|NCT02918266|7638093|FG007|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707729|NCT02918266|7638094|FG008|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707730|NCT02918266|7638095|FG009|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707731|NCT02918266|7638096|FG010|COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707732|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707733|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707734|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707735|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707736|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707737|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707738|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707739|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707740|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707741|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707742|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Intervention Period 2 (2 Days)||0
6707743|NCT02918266|7638086|FG000|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707744|NCT02918266|7638087|FG001|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707745|NCT02918266|7638088|FG002|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707746|NCT02918266|7638089|FG003|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707747|NCT02918266|7638090|FG004|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707748|NCT02918266|7638091|FG005|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707749|NCT02918266|7638092|FG006|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707750|NCT02918266|7638093|FG007|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707751|NCT02918266|7638094|FG008|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707752|NCT02918266|7638095|FG009|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707753|NCT02918266|7638096|FG010|STARTED|Part 2: Washout Period 2 (3 Weeks)||0
6707754|NCT02918266|7638086|FG000|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707755|NCT02918266|7638087|FG001|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707756|NCT02918266|7638088|FG002|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707757|NCT02918266|7638089|FG003|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707758|NCT02918266|7638090|FG004|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707759|NCT02918266|7638091|FG005|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707760|NCT02918266|7638092|FG006|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707761|NCT02918266|7638093|FG007|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707762|NCT02918266|7638094|FG008|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707763|NCT02918266|7638095|FG009|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707764|NCT02918266|7638096|FG010|COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707765|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707766|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707767|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707768|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707769|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707770|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707771|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707772|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707773|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707774|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707775|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Washout Period 2 (3 Weeks)||0
6707776|NCT02918266|7638086|FG000|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707777|NCT02918266|7638087|FG001|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707778|NCT02918266|7638088|FG002|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707779|NCT02918266|7638089|FG003|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707780|NCT02918266|7638090|FG004|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707781|NCT02918266|7638091|FG005|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707782|NCT02918266|7638092|FG006|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707783|NCT02918266|7638093|FG007|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707784|NCT02918266|7638094|FG008|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707785|NCT02918266|7638095|FG009|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707786|NCT02918266|7638096|FG010|STARTED|Part 2: Intervention Period 3 (2 Days)||0
6707787|NCT02918266|7638086|FG000|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707788|NCT02918266|7638087|FG001|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707789|NCT02918266|7638088|FG002|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707790|NCT02918266|7638089|FG003|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707791|NCT02918266|7638090|FG004|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707792|NCT02918266|7638091|FG005|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707793|NCT02918266|7638092|FG006|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707794|NCT02918266|7638093|FG007|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707795|NCT02918266|7638094|FG008|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6739189|NCT03286751|7668062|FG001|NOT COMPLETED|Period 3||0
6707796|NCT02918266|7638095|FG009|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707797|NCT02918266|7638096|FG010|COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707798|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707799|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707800|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707801|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707802|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707803|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707804|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707805|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707806|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707807|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707808|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Intervention Period 3 (2 Days)||0
6707809|NCT02918266|7638086|FG000|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707810|NCT02918266|7638087|FG001|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707811|NCT02918266|7638088|FG002|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707812|NCT02918266|7638089|FG003|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707813|NCT02918266|7638090|FG004|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707814|NCT02918266|7638091|FG005|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707815|NCT02918266|7638092|FG006|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707816|NCT02918266|7638093|FG007|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707817|NCT02918266|7638094|FG008|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707818|NCT02918266|7638095|FG009|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707819|NCT02918266|7638096|FG010|STARTED|Part 2: Washout Period 3 (3 Weeks)||0
6707820|NCT02918266|7638086|FG000|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707821|NCT02918266|7638087|FG001|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707822|NCT02918266|7638088|FG002|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707823|NCT02918266|7638089|FG003|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707824|NCT02918266|7638090|FG004|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707825|NCT02918266|7638091|FG005|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707826|NCT02918266|7638092|FG006|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707827|NCT02918266|7638093|FG007|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707828|NCT02918266|7638094|FG008|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707829|NCT02918266|7638095|FG009|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707830|NCT02918266|7638096|FG010|COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707831|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707832|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707833|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707834|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707835|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707836|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707837|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707838|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707839|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707840|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707841|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Washout Period 3 (3 Weeks)||0
6707842|NCT02918266|7638086|FG000|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707843|NCT02918266|7638087|FG001|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707844|NCT02918266|7638088|FG002|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707845|NCT02918266|7638089|FG003|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707846|NCT02918266|7638090|FG004|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707847|NCT02918266|7638091|FG005|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707848|NCT02918266|7638092|FG006|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707849|NCT02918266|7638093|FG007|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707850|NCT02918266|7638094|FG008|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707851|NCT02918266|7638095|FG009|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707852|NCT02918266|7638096|FG010|STARTED|Part 2: Intervention Period 4 (2 Days)||0
6707853|NCT02918266|7638086|FG000|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707854|NCT02918266|7638087|FG001|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707855|NCT02918266|7638088|FG002|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707856|NCT02918266|7638089|FG003|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707857|NCT02918266|7638090|FG004|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707858|NCT02918266|7638091|FG005|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707859|NCT02918266|7638092|FG006|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707860|NCT02918266|7638093|FG007|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707861|NCT02918266|7638094|FG008|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707862|NCT02918266|7638095|FG009|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707863|NCT02918266|7638096|FG010|COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707864|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707865|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707866|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707867|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707868|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707869|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6261262|NCT00001656|7160133|FG000|COMPLETED|Overall Study||12
6261263|NCT00001656|7160134|FG001|COMPLETED|Overall Study||12
6261264|NCT00001656|7160133|FG000|NOT COMPLETED|Overall Study||1
6261265|NCT00001656|7160134|FG001|NOT COMPLETED|Overall Study||0
6261266|NCT00001703|7160140|FG000|STARTED|Overall Study||6
6261267|NCT00001703|7160140|FG000|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
6261268|NCT00001703|7160140|FG000|COMPLETED|Overall Study||1
6261269|NCT00001703|7160140|FG000|NOT COMPLETED|Overall Study||5
6261270|NCT00001723|7160146|FG000|STARTED|Overall Study||100
6261271|NCT00001723|7160147|FG001|STARTED|Overall Study||100
6261272|NCT00001723|7160146|FG000|COMPLETED|Overall Study||87
6261273|NCT00001723|7160147|FG001|COMPLETED|Overall Study||84
6261274|NCT00001723|7160146|FG000|NOT COMPLETED|Overall Study||13
6261275|NCT00001723|7160147|FG001|NOT COMPLETED|Overall Study||16
6261276|NCT00001832|7160171|FG000|STARTED|Apheresis Period||170
6261277|NCT00001832|7160172|FG001|STARTED|Apheresis Period||0
6261278|NCT00001832|7160173|FG002|STARTED|Apheresis Period||0
6261279|NCT00001832|7160174|FG003|STARTED|Apheresis Period||0
6261280|NCT00001832|7160175|FG004|STARTED|Apheresis Period||0
6261281|NCT00001832|7160176|FG005|STARTED|Apheresis Period||0
6261282|NCT00001832|7160177|FG006|STARTED|Apheresis Period||0
6261283|NCT00001832|7160178|FG007|STARTED|Apheresis Period||0
6261284|NCT00001832|7160179|FG008|STARTED|Apheresis Period||0
6261285|NCT00001832|7160180|FG009|STARTED|Apheresis Period||0
6602610|NCT02057757|7527615|FG000|STARTED|Overall Study||131
6602611|NCT02057757|7527616|FG001|STARTED|Overall Study||129
6602612|NCT02057757|7527615|FG000|Intent to Treat|Overall Study||130
6602613|NCT02057757|7527616|FG001|Intent to Treat|Overall Study||127
6602614|NCT02057757|7527615|FG000|COMPLETED|Overall Study||117
6602615|NCT02057757|7527616|FG001|COMPLETED|Overall Study||121
6602616|NCT02057757|7527615|FG000|NOT COMPLETED|Overall Study||14
6602617|NCT02057757|7527616|FG001|NOT COMPLETED|Overall Study||8
6602618|NCT02057835|7527636|FG000|STARTED|Overall Study||8
6602619|NCT02057835|7527637|FG001|STARTED|Overall Study||6
6602620|NCT02057835|7527638|FG002|STARTED|Overall Study||6
6602621|NCT02057835|7527639|FG003|STARTED|Overall Study||6
6602622|NCT02057835|7527640|FG004|STARTED|Overall Study||6
6602623|NCT02057835|7527641|FG005|STARTED|Overall Study||8
6602624|NCT02057835|7527642|FG006|STARTED|Overall Study||6
6602625|NCT02057835|7527643|FG007|STARTED|Overall Study||6
6602626|NCT02057835|7527644|FG008|STARTED|Overall Study||6
6602627|NCT02057835|7527645|FG009|STARTED|Overall Study||6
6602628|NCT02057835|7527636|FG000|COMPLETED|Overall Study||8
6602629|NCT02057835|7527637|FG001|COMPLETED|Overall Study||4
6602630|NCT02057835|7527638|FG002|COMPLETED|Overall Study||6
6602631|NCT02057835|7527639|FG003|COMPLETED|Overall Study||6
6602632|NCT02057835|7527640|FG004|COMPLETED|Overall Study||6
6602633|NCT02057835|7527641|FG005|COMPLETED|Overall Study||8
6602634|NCT02057835|7527642|FG006|COMPLETED|Overall Study||6
6602635|NCT02057835|7527643|FG007|COMPLETED|Overall Study||6
6602636|NCT02057835|7527644|FG008|COMPLETED|Overall Study||6
6602637|NCT02057835|7527645|FG009|COMPLETED|Overall Study||6
6602638|NCT02057835|7527636|FG000|NOT COMPLETED|Overall Study||0
6602639|NCT02057835|7527637|FG001|NOT COMPLETED|Overall Study||2
6602640|NCT02057835|7527638|FG002|NOT COMPLETED|Overall Study||0
6602641|NCT02057835|7527639|FG003|NOT COMPLETED|Overall Study||0
6602642|NCT02057835|7527640|FG004|NOT COMPLETED|Overall Study||0
6602643|NCT02057835|7527641|FG005|NOT COMPLETED|Overall Study||0
6602644|NCT02057835|7527642|FG006|NOT COMPLETED|Overall Study||0
6602645|NCT02057835|7527643|FG007|NOT COMPLETED|Overall Study||0
6602646|NCT02057835|7527644|FG008|NOT COMPLETED|Overall Study||0
6602647|NCT02057835|7527645|FG009|NOT COMPLETED|Overall Study||0
6707870|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707871|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707872|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707873|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707874|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Intervention Period 4 (2 Days)||0
6707875|NCT02918266|7638086|FG000|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6261286|NCT00001832|7160181|FG010|STARTED|Apheresis Period||0
6261287|NCT00001832|7160182|FG011|STARTED|Apheresis Period||0
6261288|NCT00001832|7160183|FG012|STARTED|Apheresis Period||0
6261289|NCT00001832|7160184|FG013|STARTED|Apheresis Period||0
6261290|NCT00001832|7160185|FG014|STARTED|Apheresis Period||0
6602648|NCT02057939|7527674|FG000|STARTED|Overall Study||38
6602649|NCT02057939|7527674|FG000|COMPLETED|Overall Study||37
6602650|NCT02057939|7527674|FG000|NOT COMPLETED|Overall Study||1
6602651|NCT02057952|7527681|FG000|STARTED|Overall Study||51
6261291|NCT00001832|7160171|FG000|COMPLETED|Apheresis Period||110
6261292|NCT00001832|7160172|FG001|COMPLETED|Apheresis Period||0
6261293|NCT00001832|7160173|FG002|COMPLETED|Apheresis Period||0
6261294|NCT00001832|7160174|FG003|COMPLETED|Apheresis Period||0
6261295|NCT00001832|7160175|FG004|COMPLETED|Apheresis Period||0
6261296|NCT00001832|7160176|FG005|COMPLETED|Apheresis Period||0
6261297|NCT00001832|7160177|FG006|COMPLETED|Apheresis Period||0
6261298|NCT00001832|7160178|FG007|COMPLETED|Apheresis Period||0
6602652|NCT02057952|7527682|FG001|STARTED|Overall Study||49
6602653|NCT02057952|7527683|FG002|STARTED|Overall Study||50
6602654|NCT02057952|7527681|FG000|COMPLETED|Overall Study||43
6602655|NCT02057952|7527682|FG001|COMPLETED|Overall Study||39
6707876|NCT02918266|7638087|FG001|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707877|NCT02918266|7638088|FG002|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707878|NCT02918266|7638089|FG003|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707879|NCT02918266|7638090|FG004|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707880|NCT02918266|7638091|FG005|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707881|NCT02918266|7638092|FG006|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707882|NCT02918266|7638093|FG007|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707883|NCT02918266|7638094|FG008|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707884|NCT02918266|7638095|FG009|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707885|NCT02918266|7638096|FG010|STARTED|Part 2: Washout Period 4 (3 Weeks)||0
6707886|NCT02918266|7638086|FG000|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707887|NCT02918266|7638087|FG001|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707888|NCT02918266|7638088|FG002|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707889|NCT02918266|7638089|FG003|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707890|NCT02918266|7638090|FG004|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707891|NCT02918266|7638091|FG005|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707892|NCT02918266|7638092|FG006|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707893|NCT02918266|7638093|FG007|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707894|NCT02918266|7638094|FG008|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707895|NCT02918266|7638095|FG009|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707896|NCT02918266|7638096|FG010|COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707897|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707898|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707899|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707900|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707901|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707902|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707903|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707904|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707905|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707906|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707907|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Washout Period 4 (3 Weeks)||0
6707908|NCT02918266|7638086|FG000|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707909|NCT02918266|7638087|FG001|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707910|NCT02918266|7638088|FG002|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707911|NCT02918266|7638089|FG003|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707912|NCT02918266|7638090|FG004|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707913|NCT02918266|7638091|FG005|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6261299|NCT00001832|7160179|FG008|COMPLETED|Apheresis Period||0
6261300|NCT00001832|7160180|FG009|COMPLETED|Apheresis Period||0
6261301|NCT00001832|7160181|FG010|COMPLETED|Apheresis Period||0
6261302|NCT00001832|7160182|FG011|COMPLETED|Apheresis Period||0
6261303|NCT00001832|7160183|FG012|COMPLETED|Apheresis Period||0
6261304|NCT00001832|7160184|FG013|COMPLETED|Apheresis Period||0
6261305|NCT00001832|7160185|FG014|COMPLETED|Apheresis Period||0
6261306|NCT00001832|7160171|FG000|NOT COMPLETED|Apheresis Period||60
6261307|NCT00001832|7160172|FG001|NOT COMPLETED|Apheresis Period||0
6261308|NCT00001832|7160173|FG002|NOT COMPLETED|Apheresis Period||0
6261309|NCT00001832|7160174|FG003|NOT COMPLETED|Apheresis Period||0
6261310|NCT00001832|7160175|FG004|NOT COMPLETED|Apheresis Period||0
6261311|NCT00001832|7160176|FG005|NOT COMPLETED|Apheresis Period||0
6261312|NCT00001832|7160177|FG006|NOT COMPLETED|Apheresis Period||0
6261313|NCT00001832|7160178|FG007|NOT COMPLETED|Apheresis Period||0
6261314|NCT00001832|7160179|FG008|NOT COMPLETED|Apheresis Period||0
6261315|NCT00001832|7160180|FG009|NOT COMPLETED|Apheresis Period||0
6261316|NCT00001832|7160181|FG010|NOT COMPLETED|Apheresis Period||0
6261317|NCT00001832|7160182|FG011|NOT COMPLETED|Apheresis Period||0
6261318|NCT00001832|7160183|FG012|NOT COMPLETED|Apheresis Period||0
6261319|NCT00001832|7160184|FG013|NOT COMPLETED|Apheresis Period||0
6261320|NCT00001832|7160185|FG014|NOT COMPLETED|Apheresis Period||0
6261321|NCT00001832|7160171|FG000|STARTED|Treatment Period||0
6261322|NCT00001832|7160172|FG001|STARTED|Treatment Period||3
6261323|NCT00001832|7160173|FG002|STARTED|Treatment Period||3
6261324|NCT00001832|7160174|FG003|STARTED|Treatment Period||3
6261325|NCT00001832|7160175|FG004|STARTED|Treatment Period||6
6261326|NCT00001832|7160176|FG005|STARTED|Treatment Period||51
6261327|NCT00001832|7160177|FG006|STARTED|Treatment Period||4
6261328|NCT00001832|7160178|FG007|STARTED|Treatment Period||7
6261329|NCT00001832|7160179|FG008|STARTED|Treatment Period||8
6261330|NCT00001832|7160180|FG009|STARTED|Treatment Period||6
6261331|NCT00001832|7160181|FG010|STARTED|Treatment Period||1
6261332|NCT00001832|7160182|FG011|STARTED|Treatment Period||7
6261333|NCT00001832|7160183|FG012|STARTED|Treatment Period||6
6261334|NCT00001832|7160184|FG013|STARTED|Treatment Period||3
6261335|NCT00001832|7160185|FG014|STARTED|Treatment Period||2
6261336|NCT00001832|7160171|FG000|COMPLETED|Treatment Period||0
6261337|NCT00001832|7160172|FG001|COMPLETED|Treatment Period||3
6261338|NCT00001832|7160173|FG002|COMPLETED|Treatment Period||3
6261339|NCT00001832|7160174|FG003|COMPLETED|Treatment Period||3
6261340|NCT00001832|7160175|FG004|COMPLETED|Treatment Period||6
6261341|NCT00001832|7160176|FG005|COMPLETED|Treatment Period||50
6261342|NCT00001832|7160177|FG006|COMPLETED|Treatment Period||4
6707914|NCT02918266|7638092|FG006|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707915|NCT02918266|7638093|FG007|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707916|NCT02918266|7638094|FG008|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707917|NCT02918266|7638095|FG009|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707918|NCT02918266|7638096|FG010|STARTED|Part 2: Intervention Period 5 (2 Days)||0
6707919|NCT02918266|7638086|FG000|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707920|NCT02918266|7638087|FG001|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707921|NCT02918266|7638088|FG002|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707922|NCT02918266|7638089|FG003|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707923|NCT02918266|7638090|FG004|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707924|NCT02918266|7638091|FG005|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707925|NCT02918266|7638092|FG006|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707926|NCT02918266|7638093|FG007|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707927|NCT02918266|7638094|FG008|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707928|NCT02918266|7638095|FG009|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707929|NCT02918266|7638096|FG010|COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707930|NCT02918266|7638086|FG000|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707931|NCT02918266|7638087|FG001|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707932|NCT02918266|7638088|FG002|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707933|NCT02918266|7638089|FG003|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707934|NCT02918266|7638090|FG004|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6261343|NCT00001832|7160178|FG007|COMPLETED|Treatment Period||6
6261344|NCT00001832|7160179|FG008|COMPLETED|Treatment Period||8
6261345|NCT00001832|7160180|FG009|COMPLETED|Treatment Period||6
6261346|NCT00001832|7160181|FG010|COMPLETED|Treatment Period||1
6261347|NCT00001832|7160182|FG011|COMPLETED|Treatment Period||7
6261348|NCT00001832|7160183|FG012|COMPLETED|Treatment Period||6
6261349|NCT00001832|7160184|FG013|COMPLETED|Treatment Period||3
6261350|NCT00001832|7160185|FG014|COMPLETED|Treatment Period||2
6261351|NCT00001832|7160171|FG000|NOT COMPLETED|Treatment Period||0
6261352|NCT00001832|7160172|FG001|NOT COMPLETED|Treatment Period||0
6261353|NCT00001832|7160173|FG002|NOT COMPLETED|Treatment Period||0
6261354|NCT00001832|7160174|FG003|NOT COMPLETED|Treatment Period||0
6261355|NCT00001832|7160175|FG004|NOT COMPLETED|Treatment Period||0
6261356|NCT00001832|7160176|FG005|NOT COMPLETED|Treatment Period||1
6261357|NCT00001832|7160177|FG006|NOT COMPLETED|Treatment Period||0
6261358|NCT00001832|7160178|FG007|NOT COMPLETED|Treatment Period||1
6261359|NCT00001832|7160179|FG008|NOT COMPLETED|Treatment Period||0
6261360|NCT00001832|7160180|FG009|NOT COMPLETED|Treatment Period||0
6261361|NCT00001832|7160181|FG010|NOT COMPLETED|Treatment Period||0
6261362|NCT00001832|7160182|FG011|NOT COMPLETED|Treatment Period||0
6261363|NCT00001832|7160183|FG012|NOT COMPLETED|Treatment Period||0
6261364|NCT00001832|7160184|FG013|NOT COMPLETED|Treatment Period||0
6261365|NCT00001832|7160185|FG014|NOT COMPLETED|Treatment Period||0
6261366|NCT00001849|7160215|FG000|STARTED|Overall Study||68
6261367|NCT00001849|7160215|FG000|COMPLETED|Overall Study|Patients completed when an ectopic ACTH-secreting tumor was identified|54
6261368|NCT00001849|7160215|FG000|NOT COMPLETED|Overall Study||14
6261369|NCT00001880|7160228|FG000|STARTED|Overall Study||42
6261370|NCT00001880|7160228|FG000|COMPLETED|Overall Study||28
6261371|NCT00001880|7160228|FG000|NOT COMPLETED|Overall Study||14
6261372|NCT00001941|7160232|FG000|STARTED|Overall Study||3
6261373|NCT00001941|7160233|FG001|STARTED|Overall Study||5
6261374|NCT00001941|7160234|FG002|STARTED|Overall Study||3
6261375|NCT00001941|7160235|FG003|STARTED|Overall Study||3
6261376|NCT00001941|7160236|FG004|STARTED|Overall Study||20
6261377|NCT00001941|7160232|FG000|COMPLETED|Overall Study||3
6261378|NCT00001941|7160233|FG001|COMPLETED|Overall Study||5
6261379|NCT00001941|7160234|FG002|COMPLETED|Overall Study||3
6261380|NCT00001941|7160235|FG003|COMPLETED|Overall Study||3
6261381|NCT00001941|7160236|FG004|COMPLETED|Overall Study||19
6261382|NCT00001941|7160232|FG000|NOT COMPLETED|Overall Study||0
6261383|NCT00001941|7160233|FG001|NOT COMPLETED|Overall Study||0
6261384|NCT00001941|7160234|FG002|NOT COMPLETED|Overall Study||0
6261385|NCT00001941|7160235|FG003|NOT COMPLETED|Overall Study||0
6261386|NCT00001941|7160236|FG004|NOT COMPLETED|Overall Study||1
6261387|NCT00001959|7160241|FG000|STARTED|Overall Study||21
6261388|NCT00001959|7160241|FG000|COMPLETED|Overall Study||18
6261389|NCT00001959|7160241|FG000|NOT COMPLETED|Overall Study||3
6261390|NCT00001962|7160245|FG000|STARTED|Overall Study||100
6261391|NCT00001962|7160245|FG000|COMPLETED|Overall Study||72
6261392|NCT00001962|7160245|FG000|NOT COMPLETED|Overall Study||28
6261393|NCT00001984|7160249|FG000|STARTED|Overall Study||5
6261394|NCT00001984|7160249|FG000|COMPLETED|Overall Study||5
6261395|NCT00001984|7160249|FG000|NOT COMPLETED|Overall Study||0
6261396|NCT00002525|7160255|FG000|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
6707935|NCT02918266|7638091|FG005|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6261397|NCT00002525|7160256|FG001|STARTED|Overall Study||428
6261398|NCT00002525|7160255|FG000|Treated|Overall Study||419
6261399|NCT00002525|7160256|FG001|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
6261400|NCT00002525|7160255|FG000|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
6261401|NCT00002525|7160256|FG001|Dukes' B3 or C Stage|Overall Study||158
6261402|NCT00002525|7160255|FG000|Dukes' B2 Stage|Overall Study||150
6707936|NCT02918266|7638092|FG006|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707937|NCT02918266|7638093|FG007|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707938|NCT02918266|7638094|FG008|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707939|NCT02918266|7638095|FG009|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707940|NCT02918266|7638096|FG010|NOT COMPLETED|Part 2: Intervention Period 5 (2 Days)||0
6707941|NCT02918279|7638118|FG000|STARTED|Overall Study||125
6707942|NCT02918279|7638119|FG001|STARTED|Overall Study||126
6707943|NCT02918279|7638118|FG000|Full Analysis Set|Overall Study||125
6707944|NCT02918279|7638119|FG001|Full Analysis Set|Overall Study||126
6707945|NCT02918279|7638118|FG000|Safety Analysis Set|Overall Study||125
6707946|NCT02918279|7638119|FG001|Safety Analysis Set|Overall Study||126
6707947|NCT02918279|7638118|FG000|COMPLETED|Overall Study||112
6707948|NCT02918279|7638119|FG001|COMPLETED|Overall Study||103
6707949|NCT02918279|7638118|FG000|NOT COMPLETED|Overall Study||13
6707950|NCT02918279|7638119|FG001|NOT COMPLETED|Overall Study||23
6707951|NCT02918318|7638129|FG000|STARTED|Double-blind Induction Phase: 4 Weeks||41
6707952|NCT02918318|7638130|FG001|STARTED|Double-blind Induction Phase: 4 Weeks||40
6707953|NCT02918318|7638131|FG002|STARTED|Double-blind Induction Phase: 4 Weeks||41
6707954|NCT02918318|7638132|FG003|STARTED|Double-blind Induction Phase: 4 Weeks||80
6707955|NCT02918318|7638133|FG004|STARTED|Double-blind Induction Phase: 4 Weeks||0
6707956|NCT02918318|7638129|FG000|Responders|Double-blind Induction Phase: 4 Weeks||13
6707957|NCT02918318|7638130|FG001|Responders|Double-blind Induction Phase: 4 Weeks||11
6707958|NCT02918318|7638131|FG002|Responders|Double-blind Induction Phase: 4 Weeks||17
6707959|NCT02918318|7638132|FG003|Responders|Double-blind Induction Phase: 4 Weeks||27
6707960|NCT02918318|7638133|FG004|Responders|Double-blind Induction Phase: 4 Weeks||0
6707961|NCT02918318|7638129|FG000|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
6707962|NCT02918318|7638130|FG001|COMPLETED|Double-blind Induction Phase: 4 Weeks||33
6707963|NCT02918318|7638131|FG002|COMPLETED|Double-blind Induction Phase: 4 Weeks||39
6707964|NCT02918318|7638132|FG003|COMPLETED|Double-blind Induction Phase: 4 Weeks||72
6707965|NCT02918318|7638133|FG004|COMPLETED|Double-blind Induction Phase: 4 Weeks||0
6707966|NCT02918318|7638129|FG000|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
6707967|NCT02918318|7638130|FG001|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||7
6707968|NCT02918318|7638131|FG002|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||2
6707969|NCT02918318|7638132|FG003|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||8
6707970|NCT02918318|7638133|FG004|NOT COMPLETED|Double-blind Induction Phase: 4 Weeks||0
6707971|NCT02918318|7638129|FG000|STARTED|Double-blind Follow-up Phase: 4 Weeks||27
6707972|NCT02918318|7638130|FG001|STARTED|Double-blind Follow-up Phase: 4 Weeks||28
6707973|NCT02918318|7638131|FG002|STARTED|Double-blind Follow-up Phase: 4 Weeks||24
6707974|NCT02918318|7638132|FG003|STARTED|Double-blind Follow-up Phase: 4 Weeks||53
6707975|NCT02918318|7638133|FG004|STARTED|Double-blind Follow-up Phase: 4 Weeks||0
6707976|NCT02918318|7638129|FG000|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||26
6707977|NCT02918318|7638130|FG001|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||28
6707978|NCT02918318|7638131|FG002|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||23
6707979|NCT02918318|7638132|FG003|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||50
6707980|NCT02918318|7638133|FG004|COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
6707981|NCT02918318|7638129|FG000|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
6707982|NCT02918318|7638130|FG001|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
6707983|NCT02918318|7638131|FG002|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||1
6707984|NCT02918318|7638132|FG003|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||3
6707985|NCT02918318|7638133|FG004|NOT COMPLETED|Double-blind Follow-up Phase: 4 Weeks||0
6707986|NCT02918318|7638129|FG000|STARTED|Posttreatment Phase: Up to 24 Weeks||13
6707987|NCT02918318|7638130|FG001|STARTED|Posttreatment Phase: Up to 24 Weeks||11
6707988|NCT02918318|7638131|FG002|STARTED|Posttreatment Phase: Up to 24 Weeks||17
6707989|NCT02918318|7638132|FG003|STARTED|Posttreatment Phase: Up to 24 Weeks||27
6707990|NCT02918318|7638133|FG004|STARTED|Posttreatment Phase: Up to 24 Weeks||0
6707991|NCT02918318|7638129|FG000|COMPLETED|Posttreatment Phase: Up to 24 Weeks||12
6707992|NCT02918318|7638130|FG001|COMPLETED|Posttreatment Phase: Up to 24 Weeks||8
6707993|NCT02918318|7638131|FG002|COMPLETED|Posttreatment Phase: Up to 24 Weeks||16
6707994|NCT02918318|7638132|FG003|COMPLETED|Posttreatment Phase: Up to 24 Weeks||25
6707995|NCT02918318|7638133|FG004|COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
6707996|NCT02918318|7638129|FG000|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
6707997|NCT02918318|7638130|FG001|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||3
6707998|NCT02918318|7638131|FG002|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||1
6707999|NCT02918318|7638132|FG003|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||2
6708000|NCT02918318|7638133|FG004|NOT COMPLETED|Posttreatment Phase: Up to 24 Weeks||0
6708001|NCT02918318|7638129|FG000|STARTED|Open Label Treatment Phase: 4 Weeks||0
6708002|NCT02918318|7638130|FG001|STARTED|Open Label Treatment Phase: 4 Weeks||0
6708003|NCT02918318|7638131|FG002|STARTED|Open Label Treatment Phase: 4 Weeks||0
6708004|NCT02918318|7638132|FG003|STARTED|Open Label Treatment Phase: 4 Weeks||0
6708005|NCT02918318|7638133|FG004|STARTED|Open Label Treatment Phase: 4 Weeks||48
6708006|NCT02918318|7638129|FG000|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6708007|NCT02918318|7638130|FG001|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6708008|NCT02918318|7638131|FG002|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6708009|NCT02918318|7638132|FG003|COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6708010|NCT02918318|7638133|FG004|COMPLETED|Open Label Treatment Phase: 4 Weeks||47
6708011|NCT02918318|7638129|FG000|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6708012|NCT02918318|7638130|FG001|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6708013|NCT02918318|7638131|FG002|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6708014|NCT02918318|7638132|FG003|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||0
6708015|NCT02918318|7638133|FG004|NOT COMPLETED|Open Label Treatment Phase: 4 Weeks||1
6708016|NCT02918318|7638129|FG000|STARTED|Open Label Follow-up Phase: 4 Weeks||0
6708017|NCT02918318|7638130|FG001|STARTED|Open Label Follow-up Phase: 4 Weeks||0
6708018|NCT02918318|7638131|FG002|STARTED|Open Label Follow-up Phase: 4 Weeks||0
6708019|NCT02918318|7638132|FG003|STARTED|Open Label Follow-up Phase: 4 Weeks||0
6708020|NCT02918318|7638133|FG004|STARTED|Open Label Follow-up Phase: 4 Weeks||48
6708021|NCT02918318|7638129|FG000|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6708022|NCT02918318|7638130|FG001|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6708023|NCT02918318|7638131|FG002|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6708024|NCT02918318|7638132|FG003|COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6708025|NCT02918318|7638133|FG004|COMPLETED|Open Label Follow-up Phase: 4 Weeks||47
6708026|NCT02918318|7638129|FG000|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6708027|NCT02918318|7638130|FG001|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6708028|NCT02918318|7638131|FG002|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6708029|NCT02918318|7638132|FG003|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||0
6708030|NCT02918318|7638133|FG004|NOT COMPLETED|Open Label Follow-up Phase: 4 Weeks||1
6708031|NCT02918357|7638154|FG000|STARTED|Overall Study||385
6708032|NCT02918357|7638154|FG000|Investigational Drug Administration|Overall Study||385
6708033|NCT02918357|7638154|FG000|PET/CT Scan|Overall Study||385
6708034|NCT02918357|7638154|FG000|COMPLETED|Overall Study||385
6708035|NCT02918357|7638154|FG000|NOT COMPLETED|Overall Study||0
6708036|NCT02918396|7638179|FG000|STARTED|Overall Study||2
6708037|NCT02918396|7638180|FG001|STARTED|Overall Study||1
6708038|NCT02918396|7638181|FG002|STARTED|Overall Study||2
6708039|NCT02918396|7638179|FG000|COMPLETED|Overall Study||2
6708040|NCT02918396|7638180|FG001|COMPLETED|Overall Study||1
6708041|NCT02918396|7638181|FG002|COMPLETED|Overall Study||2
6708042|NCT02918396|7638179|FG000|NOT COMPLETED|Overall Study||0
6708043|NCT02918396|7638180|FG001|NOT COMPLETED|Overall Study||0
6708044|NCT02918396|7638181|FG002|NOT COMPLETED|Overall Study||0
6708045|NCT02918552|7638191|FG000|STARTED|Overall Study||7
6708046|NCT02918552|7638192|FG001|STARTED|Overall Study||8
6261403|NCT00002525|7160256|FG001|Dukes' B2 Stage|Overall Study||139
6261404|NCT00002525|7160255|FG000|COMPLETED|Overall Study||241
6261405|NCT00002525|7160256|FG001|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
6261406|NCT00002525|7160255|FG000|NOT COMPLETED|Overall Study||186
6261407|NCT00002525|7160256|FG001|NOT COMPLETED|Overall Study||0
6261408|NCT00002540|7160266|FG000|STARTED|Overall Study||38345
6261409|NCT00002540|7160267|FG001|STARTED|Overall Study||38340
6261410|NCT00002540|7160266|FG000|COMPLETED|Overall Study||37544
6261411|NCT00002540|7160267|FG001|COMPLETED|Overall Study||35876
6261412|NCT00002540|7160266|FG000|NOT COMPLETED|Overall Study||801
6261413|NCT00002540|7160267|FG001|NOT COMPLETED|Overall Study||2464
6261414|NCT00002558|7160275|FG000|STARTED|Overall Study||92
6261415|NCT00002558|7160276|FG001|STARTED|Overall Study||16
6261416|NCT00002558|7160275|FG000|COMPLETED|Overall Study||92
6261417|NCT00002558|7160276|FG001|COMPLETED|Overall Study||15
6261418|NCT00002558|7160275|FG000|NOT COMPLETED|Overall Study||0
6261419|NCT00002558|7160276|FG001|NOT COMPLETED|Overall Study||1
6261420|NCT00002597|7160284|FG000|STARTED|Overall Study||1013
6261421|NCT00002597|7160285|FG001|STARTED|Overall Study||1015
6261422|NCT00002597|7160284|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
6261423|NCT00002597|7160285|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
6261424|NCT00002597|7160284|FG000|NOT COMPLETED|Overall Study||26
6261425|NCT00002597|7160285|FG001|NOT COMPLETED|Overall Study||23
6708047|NCT02918552|7638191|FG000|COMPLETED|Overall Study||6
6708048|NCT02918552|7638192|FG001|COMPLETED|Overall Study||6
6708049|NCT02918552|7638191|FG000|NOT COMPLETED|Overall Study||1
6708050|NCT02918552|7638192|FG001|NOT COMPLETED|Overall Study||2
6708051|NCT02918617|7638207|FG000|STARTED|Overall Study||21
6708052|NCT02918617|7638208|FG001|STARTED|Overall Study||20
6708053|NCT02918617|7638209|FG002|STARTED|Overall Study||22
6708054|NCT02918617|7638210|FG003|STARTED|Overall Study||22
6708055|NCT02918617|7638211|FG004|STARTED|Overall Study||24
6708056|NCT02918617|7638212|FG005|STARTED|Overall Study||20
6708057|NCT02918617|7638213|FG006|STARTED|Overall Study||22
6708058|NCT02918617|7638214|FG007|STARTED|Overall Study||26
6708059|NCT02918617|7638215|FG008|STARTED|Overall Study||26
6708060|NCT02918617|7638207|FG000|COMPLETED|Overall Study||20
6708061|NCT02918617|7638208|FG001|COMPLETED|Overall Study||20
6708062|NCT02918617|7638209|FG002|COMPLETED|Overall Study||19
6708063|NCT02918617|7638210|FG003|COMPLETED|Overall Study||22
6708064|NCT02918617|7638211|FG004|COMPLETED|Overall Study||24
6708065|NCT02918617|7638212|FG005|COMPLETED|Overall Study||20
6261426|NCT00002601|7160291|FG000|STARTED|Overall Study||13
6261427|NCT00002601|7160291|FG000|COMPLETED|Overall Study||13
6261428|NCT00002601|7160291|FG000|NOT COMPLETED|Overall Study||0
6708066|NCT02918617|7638213|FG006|COMPLETED|Overall Study||22
6708067|NCT02918617|7638214|FG007|COMPLETED|Overall Study||25
6708068|NCT02918617|7638215|FG008|COMPLETED|Overall Study||26
6708069|NCT02918617|7638207|FG000|NOT COMPLETED|Overall Study||1
6708070|NCT02918617|7638208|FG001|NOT COMPLETED|Overall Study||0
6708071|NCT02918617|7638209|FG002|NOT COMPLETED|Overall Study||3
6708072|NCT02918617|7638210|FG003|NOT COMPLETED|Overall Study||0
6708073|NCT02918617|7638211|FG004|NOT COMPLETED|Overall Study||0
6708074|NCT02918617|7638212|FG005|NOT COMPLETED|Overall Study||0
6708075|NCT02918617|7638213|FG006|NOT COMPLETED|Overall Study||0
6708076|NCT02918617|7638214|FG007|NOT COMPLETED|Overall Study||1
6708077|NCT02918617|7638215|FG008|NOT COMPLETED|Overall Study||0
6708078|NCT02918630|7638237|FG000|STARTED|Overall Study||4
6708079|NCT02918630|7638238|FG001|STARTED|Overall Study||3
6708080|NCT02918630|7638237|FG000|COMPLETED|Overall Study||4
6708081|NCT02918630|7638238|FG001|COMPLETED|Overall Study||3
6708082|NCT02918630|7638237|FG000|NOT COMPLETED|Overall Study||0
6708083|NCT02918630|7638238|FG001|NOT COMPLETED|Overall Study||0
6708084|NCT02918656|7638247|FG000|STARTED|Overall Study||54
6708085|NCT02918656|7638248|FG001|STARTED|Overall Study||60
6708086|NCT02918656|7638249|FG002|STARTED|Overall Study||57
6708087|NCT02918656|7638247|FG000|COMPLETED|Overall Study||54
6708088|NCT02918656|7638248|FG001|COMPLETED|Overall Study||60
6708089|NCT02918656|7638249|FG002|COMPLETED|Overall Study||57
6708090|NCT02918656|7638247|FG000|NOT COMPLETED|Overall Study||0
6708091|NCT02918656|7638248|FG001|NOT COMPLETED|Overall Study||0
6708092|NCT02918656|7638249|FG002|NOT COMPLETED|Overall Study||0
6708093|NCT02918669|7638257|FG000|STARTED|Overall Study||12
6708094|NCT02918669|7638257|FG000|COMPLETED|Overall Study||8
6708095|NCT02918669|7638257|FG000|NOT COMPLETED|Overall Study||4
6708096|NCT02918721|7638261|FG000|STARTED|Overall Study||70
6708097|NCT02918721|7638261|FG000|COMPLETED|Overall Study||70
6708098|NCT02918721|7638261|FG000|NOT COMPLETED|Overall Study||0
6708099|NCT02918773|7638268|FG000|STARTED|Overall Study||11
6708100|NCT02918773|7638269|FG001|STARTED|Overall Study||11
6708101|NCT02918773|7638268|FG000|COMPLETED|Overall Study||11
6708102|NCT02918773|7638269|FG001|COMPLETED|Overall Study||11
6708103|NCT02918773|7638268|FG000|NOT COMPLETED|Overall Study||0
6708104|NCT02918773|7638269|FG001|NOT COMPLETED|Overall Study||0
6708105|NCT02918851|7638279|FG000|STARTED|Overall Study||14
6708106|NCT02918851|7638280|FG001|STARTED|Overall Study||14
6708107|NCT02918851|7638281|FG002|STARTED|Overall Study||14
6708108|NCT02918851|7638279|FG000|COMPLETED|Overall Study||10
6708109|NCT02918851|7638280|FG001|COMPLETED|Overall Study||10
6708110|NCT02918851|7638281|FG002|COMPLETED|Overall Study||10
6708111|NCT02918851|7638279|FG000|NOT COMPLETED|Overall Study||4
6708112|NCT02918851|7638280|FG001|NOT COMPLETED|Overall Study||4
6708113|NCT02918851|7638281|FG002|NOT COMPLETED|Overall Study||4
6708114|NCT02918877|7638291|FG000|STARTED|Overall Study||24
6708115|NCT02918877|7638292|FG001|STARTED|Overall Study||25
6708116|NCT02918877|7638291|FG000|COMPLETED|Overall Study||18
6708117|NCT02918877|7638292|FG001|COMPLETED|Overall Study||22
6708118|NCT02918877|7638291|FG000|NOT COMPLETED|Overall Study||6
6708119|NCT02918877|7638292|FG001|NOT COMPLETED|Overall Study||3
6708120|NCT02918968|7638300|FG000|STARTED|1st Line AAT||102
6708121|NCT02918968|7638301|FG001|STARTED|1st Line AAT||104
6708122|NCT02918968|7638300|FG000|Maintained 1st Line AAT Without Progression|1st Line AAT||25
6708123|NCT02918968|7638301|FG001|Maintained 1st Line AAT Without Progression|1st Line AAT||8
6708124|NCT02918968|7638300|FG000|COMPLETED|1st Line AAT||73
6708125|NCT02918968|7638301|FG001|COMPLETED|1st Line AAT||93
6708126|NCT02918968|7638300|FG000|NOT COMPLETED|1st Line AAT||29
6708127|NCT02918968|7638301|FG001|NOT COMPLETED|1st Line AAT||11
6708128|NCT02918968|7638300|FG000|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|48
6708129|NCT02918968|7638301|FG001|STARTED|2nd Line AAT|Participants who maintained 1st line AAT without progression did not enter 2nd line AAT|85
6708130|NCT02918968|7638300|FG000|COMPLETED|2nd Line AAT||23
6708131|NCT02918968|7638301|FG001|COMPLETED|2nd Line AAT||73
6708132|NCT02918968|7638300|FG000|NOT COMPLETED|2nd Line AAT||25
6708133|NCT02918968|7638301|FG001|NOT COMPLETED|2nd Line AAT||12
6708134|NCT02919007|7638309|FG000|STARTED|Overall Study||25
6708135|NCT02919007|7638309|FG000|COMPLETED|Overall Study||25
6708136|NCT02919007|7638309|FG000|NOT COMPLETED|Overall Study||0
6708137|NCT02919111|7638313|FG000|STARTED|Overall Study||299
6708138|NCT02919111|7638313|FG000|COMPLETED|Overall Study||299
6708139|NCT02919111|7638313|FG000|NOT COMPLETED|Overall Study||0
6708140|NCT02919267|7638321|FG000|STARTED|Overall Study||10
6708141|NCT02919267|7638322|FG001|STARTED|Overall Study||12
6708142|NCT02919267|7638323|FG002|STARTED|Overall Study||13
6708143|NCT02919267|7638324|FG003|STARTED|Overall Study||14
6708144|NCT02919267|7638321|FG000|COMPLETED|Overall Study||10
6708145|NCT02919267|7638322|FG001|COMPLETED|Overall Study||9
6708146|NCT02919267|7638323|FG002|COMPLETED|Overall Study||10
6708147|NCT02919267|7638324|FG003|COMPLETED|Overall Study||10
6708148|NCT02919267|7638321|FG000|NOT COMPLETED|Overall Study||0
6708149|NCT02919267|7638322|FG001|NOT COMPLETED|Overall Study||3
6708150|NCT02919267|7638323|FG002|NOT COMPLETED|Overall Study||3
6708151|NCT02919267|7638324|FG003|NOT COMPLETED|Overall Study||4
6708152|NCT02919423|7638336|FG000|STARTED|Overall Study||6
6708153|NCT02919423|7638337|FG001|STARTED|Overall Study||25
6708154|NCT02919423|7638336|FG000|COMPLETED|Overall Study||4
6708155|NCT02919423|7638337|FG001|COMPLETED|Overall Study||16
6708156|NCT02919423|7638336|FG000|NOT COMPLETED|Overall Study||2
6708157|NCT02919423|7638337|FG001|NOT COMPLETED|Overall Study||9
6708158|NCT02919475|7638348|FG000|STARTED|Overall Study||52
6708159|NCT02919475|7638349|FG001|STARTED|Overall Study||52
6708160|NCT02919475|7638350|FG002|STARTED|Overall Study||52
6708161|NCT02919475|7638351|FG003|STARTED|Overall Study||51
6708162|NCT02919475|7638352|FG004|STARTED|Overall Study||52
6708163|NCT02919475|7638348|FG000|Started Dosing|Overall Study||51
6708164|NCT02919475|7638349|FG001|Started Dosing|Overall Study||52
6708165|NCT02919475|7638350|FG002|Started Dosing|Overall Study||52
6708166|NCT02919475|7638351|FG003|Started Dosing|Overall Study||51
6708167|NCT02919475|7638352|FG004|Started Dosing|Overall Study||52
6708168|NCT02919475|7638348|FG000|COMPLETED|Overall Study||46
6708169|NCT02919475|7638349|FG001|COMPLETED|Overall Study||44
6708170|NCT02919475|7638350|FG002|COMPLETED|Overall Study||47
6708171|NCT02919475|7638351|FG003|COMPLETED|Overall Study||38
6708172|NCT02919475|7638352|FG004|COMPLETED|Overall Study||48
6708173|NCT02919475|7638348|FG000|NOT COMPLETED|Overall Study||6
6708174|NCT02919475|7638349|FG001|NOT COMPLETED|Overall Study||8
6708175|NCT02919475|7638350|FG002|NOT COMPLETED|Overall Study||5
6708176|NCT02919475|7638351|FG003|NOT COMPLETED|Overall Study||13
6708177|NCT02919475|7638352|FG004|NOT COMPLETED|Overall Study||4
6708178|NCT02919657|7638364|FG000|STARTED|Overall Study|10 Participants|10
6708179|NCT02919657|7638365|FG001|STARTED|Overall Study|10 Participants|10
6708180|NCT02919657|7638364|FG000|COMPLETED|Overall Study|completed with the same initial 10 participants|10
6708181|NCT02919657|7638365|FG001|COMPLETED|Overall Study|completed with the same initial 10 participants|10
6708182|NCT02919657|7638364|FG000|NOT COMPLETED|Overall Study||0
6708183|NCT02919657|7638365|FG001|NOT COMPLETED|Overall Study||0
6708184|NCT02919696|7638373|FG000|STARTED|Overall Study||12
6708185|NCT02919696|7638374|FG001|STARTED|Overall Study||14
6708186|NCT02919696|7638373|FG000|Received at Least One Dose of Study Drug|Overall Study||12
6708187|NCT02919696|7638374|FG001|Received at Least One Dose of Study Drug|Overall Study||13
6708188|NCT02919696|7638373|FG000|PK 100 mg Abemaciclib Dose|Overall Study||5
6708189|NCT02919696|7638374|FG001|PK 100 mg Abemaciclib Dose|Overall Study||0
6708190|NCT02919696|7638373|FG000|PK 150 mg Abemaciclib Dose|Overall Study||0
6708191|NCT02919696|7638374|FG001|PK 150 mg Abemaciclib Dose|Overall Study||2
6708192|NCT02919696|7638373|FG000|Death On Treatment|Overall Study||1
6708193|NCT02919696|7638374|FG001|Death On Treatment|Overall Study||0
6708194|NCT02919696|7638373|FG000|Progressive Disease|Overall Study||7
6708195|NCT02919696|7638374|FG001|Progressive Disease|Overall Study||9
6708196|NCT02919696|7638373|FG000|COMPLETED|Overall Study||8
6708197|NCT02919696|7638374|FG001|COMPLETED|Overall Study||9
6708198|NCT02919696|7638373|FG000|NOT COMPLETED|Overall Study||4
6708199|NCT02919696|7638374|FG001|NOT COMPLETED|Overall Study||5
6708200|NCT02919761|7638386|FG000|STARTED|Part 1: Open Label||259
6708201|NCT02919761|7638387|FG001|STARTED|Part 1: Open Label|Part 2 Blinded groups were not evaluated as such during Part 1|0
6708202|NCT02919761|7638388|FG002|STARTED|Part 1: Open Label||0
6708203|NCT02919761|7638386|FG000|mITT Population|Part 1: Open Label||259
6708204|NCT02919761|7638387|FG001|mITT Population|Part 1: Open Label||0
6708205|NCT02919761|7638388|FG002|mITT Population|Part 1: Open Label||0
6708206|NCT02919761|7638386|FG000|Safety Population|Part 1: Open Label||259
6708207|NCT02919761|7638387|FG001|Safety Population|Part 1: Open Label||0
6708208|NCT02919761|7638388|FG002|Safety Population|Part 1: Open Label||0
6708209|NCT02919761|7638386|FG000|Per Protocol Population|Part 1: Open Label||236
6708210|NCT02919761|7638387|FG001|Per Protocol Population|Part 1: Open Label||0
6708211|NCT02919761|7638388|FG002|Per Protocol Population|Part 1: Open Label||0
6708212|NCT02919761|7638386|FG000|COMPLETED|Part 1: Open Label||235
6708213|NCT02919761|7638387|FG001|COMPLETED|Part 1: Open Label||0
6708214|NCT02919761|7638388|FG002|COMPLETED|Part 1: Open Label||0
6708215|NCT02919761|7638386|FG000|NOT COMPLETED|Part 1: Open Label||24
6708216|NCT02919761|7638387|FG001|NOT COMPLETED|Part 1: Open Label||0
6708217|NCT02919761|7638388|FG002|NOT COMPLETED|Part 1: Open Label||0
6708218|NCT02919761|7638386|FG000|STARTED|Part 2: Double-blind|154 of the original Part 1 participants continued to Part 2, randomized to Acthar or placebo|0
6708219|NCT02919761|7638387|FG001|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive Acthar for an additional 12 weeks in Part 2|77
6708220|NCT02919761|7638388|FG002|STARTED|Part 2: Double-blind|77 participants who completed Part 1 were to receive placebo for an additional 12 weeks in Part 2|77
6708221|NCT02919761|7638386|FG000|Safety Population|Part 2: Double-blind||0
6708222|NCT02919761|7638387|FG001|Safety Population|Part 2: Double-blind||77
6708223|NCT02919761|7638388|FG002|Safety Population|Part 2: Double-blind||77
6708224|NCT02919761|7638386|FG000|mITT Population|Part 2: Double-blind||0
6708225|NCT02919761|7638387|FG001|mITT Population|Part 2: Double-blind||77
6708226|NCT02919761|7638388|FG002|mITT Population|Part 2: Double-blind||76
6708227|NCT02919761|7638386|FG000|Per Protocol Population|Part 2: Double-blind||0
6708228|NCT02919761|7638387|FG001|Per Protocol Population|Part 2: Double-blind||76
6708229|NCT02919761|7638388|FG002|Per Protocol Population|Part 2: Double-blind||73
6708230|NCT02919761|7638386|FG000|COMPLETED|Part 2: Double-blind||0
6708231|NCT02919761|7638387|FG001|COMPLETED|Part 2: Double-blind||71
6708232|NCT02919761|7638388|FG002|COMPLETED|Part 2: Double-blind||56
6708233|NCT02919761|7638386|FG000|NOT COMPLETED|Part 2: Double-blind||0
6708234|NCT02919761|7638387|FG001|NOT COMPLETED|Part 2: Double-blind||6
6708235|NCT02919761|7638388|FG002|NOT COMPLETED|Part 2: Double-blind||21
6708236|NCT02919813|7638401|FG000|STARTED|Overall Study||14
6708237|NCT02919813|7638402|FG001|STARTED|Overall Study||17
6708238|NCT02919813|7638401|FG000|COMPLETED|Overall Study||14
6708239|NCT02919813|7638402|FG001|COMPLETED|Overall Study||17
6708240|NCT02919813|7638401|FG000|NOT COMPLETED|Overall Study||0
6708241|NCT02919813|7638402|FG001|NOT COMPLETED|Overall Study||0
6708242|NCT02919826|7638410|FG000|STARTED|Overall Study||10
6708243|NCT02919826|7638411|FG001|STARTED|Overall Study||10
6708244|NCT02919826|7638410|FG000|COMPLETED|Overall Study||10
6708245|NCT02919826|7638411|FG001|COMPLETED|Overall Study||8
6708246|NCT02919826|7638410|FG000|NOT COMPLETED|Overall Study||0
6708247|NCT02919826|7638411|FG001|NOT COMPLETED|Overall Study||2
6708248|NCT02919995|7638425|FG000|STARTED|Overall Study||1
6708249|NCT02919995|7638426|FG001|STARTED|Overall Study||2
6708250|NCT02919995|7638427|FG002|STARTED|Overall Study||2
6708251|NCT02919995|7638428|FG003|STARTED|Overall Study||2
6708252|NCT02919995|7638429|FG004|STARTED|Overall Study||1
6708253|NCT02919995|7638430|FG005|STARTED|Overall Study||2
6708254|NCT02919995|7638425|FG000|COMPLETED|Overall Study||1
6708255|NCT02919995|7638426|FG001|COMPLETED|Overall Study||2
6708256|NCT02919995|7638427|FG002|COMPLETED|Overall Study||2
6708257|NCT02919995|7638428|FG003|COMPLETED|Overall Study||2
6708258|NCT02919995|7638429|FG004|COMPLETED|Overall Study||1
6708259|NCT02919995|7638430|FG005|COMPLETED|Overall Study||1
6708260|NCT02919995|7638425|FG000|NOT COMPLETED|Overall Study||0
6708261|NCT02919995|7638426|FG001|NOT COMPLETED|Overall Study||0
6708262|NCT02919995|7638427|FG002|NOT COMPLETED|Overall Study||0
6708263|NCT02919995|7638428|FG003|NOT COMPLETED|Overall Study||0
6708264|NCT02919995|7638429|FG004|NOT COMPLETED|Overall Study||0
6708265|NCT02919995|7638430|FG005|NOT COMPLETED|Overall Study||1
6708266|NCT02920476|7638438|FG000|STARTED|Overall Study||4
6708267|NCT02920476|7638438|FG000|COMPLETED|Overall Study||3
6708268|NCT02920476|7638438|FG000|NOT COMPLETED|Overall Study||1
6708269|NCT02920528|7638445|FG000|STARTED|Overall Study||35
6708270|NCT02920528|7638446|FG001|STARTED|Overall Study||36
6708271|NCT02920528|7638447|FG002|STARTED|Overall Study||35
6708272|NCT02920528|7638445|FG000|COMPLETED|Overall Study||32
6708273|NCT02920528|7638446|FG001|COMPLETED|Overall Study||35
6708274|NCT02920528|7638447|FG002|COMPLETED|Overall Study||30
6708275|NCT02920528|7638445|FG000|NOT COMPLETED|Overall Study||3
6708276|NCT02920528|7638446|FG001|NOT COMPLETED|Overall Study||1
6708277|NCT02920528|7638447|FG002|NOT COMPLETED|Overall Study||5
6708278|NCT02920749|7638459|FG000|STARTED|Overall Study||30
6708279|NCT02920749|7638460|FG001|STARTED|Overall Study||30
6708280|NCT02920749|7638461|FG002|STARTED|Overall Study||30
6708281|NCT02920749|7638462|FG003|STARTED|Overall Study||30
6708282|NCT02920749|7638459|FG000|COMPLETED|Overall Study||30
6708283|NCT02920749|7638460|FG001|COMPLETED|Overall Study||30
6708284|NCT02920749|7638461|FG002|COMPLETED|Overall Study||30
6708285|NCT02920749|7638462|FG003|COMPLETED|Overall Study||30
6708286|NCT02920749|7638459|FG000|NOT COMPLETED|Overall Study||0
6708287|NCT02920749|7638460|FG001|NOT COMPLETED|Overall Study||0
6708288|NCT02920749|7638461|FG002|NOT COMPLETED|Overall Study||0
6708289|NCT02920749|7638462|FG003|NOT COMPLETED|Overall Study||0
6708290|NCT02920918|7638478|FG000|STARTED|Overall Study||17
6708291|NCT02920918|7638479|FG001|STARTED|Overall Study||19
6708292|NCT02920918|7638478|FG000|COMPLETED|Overall Study||17
6708293|NCT02920918|7638479|FG001|COMPLETED|Overall Study||19
6708294|NCT02920918|7638478|FG000|NOT COMPLETED|Overall Study||0
6708295|NCT02920918|7638479|FG001|NOT COMPLETED|Overall Study||0
6708296|NCT02920957|7638485|FG000|STARTED|First Intervention : 1 Month||46
6708297|NCT02920957|7638486|FG001|STARTED|First Intervention : 1 Month||41
6708298|NCT02920957|7638485|FG000|COMPLETED|First Intervention : 1 Month||42
6708299|NCT02920957|7638486|FG001|COMPLETED|First Intervention : 1 Month||41
6708300|NCT02920957|7638485|FG000|NOT COMPLETED|First Intervention : 1 Month||4
6708301|NCT02920957|7638486|FG001|NOT COMPLETED|First Intervention : 1 Month||0
6708302|NCT02920957|7638485|FG000|STARTED|Second Intervention: 1 Month||42
6708303|NCT02920957|7638486|FG001|STARTED|Second Intervention: 1 Month||41
6708304|NCT02920957|7638485|FG000|COMPLETED|Second Intervention: 1 Month||42
6708305|NCT02920957|7638486|FG001|COMPLETED|Second Intervention: 1 Month||40
6708306|NCT02920957|7638485|FG000|NOT COMPLETED|Second Intervention: 1 Month||0
6708307|NCT02920957|7638486|FG001|NOT COMPLETED|Second Intervention: 1 Month||1
6708308|NCT02920970|7638503|FG000|STARTED|First Intervention||38
6708309|NCT02920970|7638504|FG001|STARTED|First Intervention||32
6708310|NCT02920970|7638503|FG000|COMPLETED|First Intervention||38
6602656|NCT02057952|7527683|FG002|COMPLETED|Overall Study||28
6602657|NCT02057952|7527681|FG000|NOT COMPLETED|Overall Study||8
6602658|NCT02057952|7527682|FG001|NOT COMPLETED|Overall Study||10
6602659|NCT02057952|7527683|FG002|NOT COMPLETED|Overall Study||22
6602660|NCT02058069|7527691|FG000|STARTED|Overall Study||100
6602661|NCT02058069|7527691|FG000|COMPLETED|Overall Study||89
6602662|NCT02058069|7527691|FG000|NOT COMPLETED|Overall Study||11
6602663|NCT02058095|7527697|FG000|STARTED|Overall Study||15
6602664|NCT02058095|7527698|FG001|STARTED|Overall Study||7
6602665|NCT02058095|7527697|FG000|COMPLETED|Overall Study||14
6602666|NCT02058095|7527698|FG001|COMPLETED|Overall Study||7
6602667|NCT02058095|7527697|FG000|NOT COMPLETED|Overall Study||1
6602668|NCT02058095|7527698|FG001|NOT COMPLETED|Overall Study||0
6602669|NCT02058108|7527706|FG000|STARTED|Overall Study||43
6602670|NCT02058108|7527707|FG001|STARTED|Overall Study||10
6708311|NCT02920970|7638504|FG001|COMPLETED|First Intervention||30
6708312|NCT02920970|7638503|FG000|NOT COMPLETED|First Intervention||0
6708313|NCT02920970|7638504|FG001|NOT COMPLETED|First Intervention||2
6708314|NCT02920970|7638503|FG000|STARTED|Second Intervention||38
6708315|NCT02920970|7638504|FG001|STARTED|Second Intervention||30
6708316|NCT02920970|7638503|FG000|COMPLETED|Second Intervention||37
6708317|NCT02920970|7638504|FG001|COMPLETED|Second Intervention||30
6708318|NCT02920970|7638503|FG000|NOT COMPLETED|Second Intervention||1
6708319|NCT02920970|7638504|FG001|NOT COMPLETED|Second Intervention||0
6708320|NCT02920983|7638512|FG000|STARTED|Dispense 1||8
6708321|NCT02920983|7638513|FG001|STARTED|Dispense 1||10
6708322|NCT02920983|7638514|FG002|STARTED|Dispense 1||7
6708323|NCT02920983|7638515|FG003|STARTED|Dispense 1||6
6708324|NCT02920983|7638516|FG004|STARTED|Dispense 1||13
6708325|NCT02920983|7638517|FG005|STARTED|Dispense 1||7
6708326|NCT02920983|7638512|FG000|COMPLETED|Dispense 1||8
6708327|NCT02920983|7638513|FG001|COMPLETED|Dispense 1||10
6708328|NCT02920983|7638514|FG002|COMPLETED|Dispense 1||7
6708329|NCT02920983|7638515|FG003|COMPLETED|Dispense 1||6
6708330|NCT02920983|7638516|FG004|COMPLETED|Dispense 1||12
6708331|NCT02920983|7638517|FG005|COMPLETED|Dispense 1||7
6708332|NCT02920983|7638512|FG000|NOT COMPLETED|Dispense 1||0
6708333|NCT02920983|7638513|FG001|NOT COMPLETED|Dispense 1||0
6708334|NCT02920983|7638514|FG002|NOT COMPLETED|Dispense 1||0
6708335|NCT02920983|7638515|FG003|NOT COMPLETED|Dispense 1||0
6708336|NCT02920983|7638516|FG004|NOT COMPLETED|Dispense 1||1
6708337|NCT02920983|7638517|FG005|NOT COMPLETED|Dispense 1||0
6708338|NCT02920983|7638512|FG000|STARTED|Dispense 2||8
6708339|NCT02920983|7638513|FG001|STARTED|Dispense 2||10
6708340|NCT02920983|7638514|FG002|STARTED|Dispense 2||7
6708341|NCT02920983|7638515|FG003|STARTED|Dispense 2||6
6708342|NCT02920983|7638516|FG004|STARTED|Dispense 2||13
6708343|NCT02920983|7638517|FG005|STARTED|Dispense 2||7
6708344|NCT02920983|7638512|FG000|COMPLETED|Dispense 2||7
6708345|NCT02920983|7638513|FG001|COMPLETED|Dispense 2||10
6708346|NCT02920983|7638514|FG002|COMPLETED|Dispense 2||7
6708347|NCT02920983|7638515|FG003|COMPLETED|Dispense 2||6
6708348|NCT02920983|7638516|FG004|COMPLETED|Dispense 2||12
6708349|NCT02920983|7638517|FG005|COMPLETED|Dispense 2||7
6708350|NCT02920983|7638512|FG000|NOT COMPLETED|Dispense 2||1
6708351|NCT02920983|7638513|FG001|NOT COMPLETED|Dispense 2||0
6708352|NCT02920983|7638514|FG002|NOT COMPLETED|Dispense 2||0
6708353|NCT02920983|7638515|FG003|NOT COMPLETED|Dispense 2||0
6708354|NCT02920983|7638516|FG004|NOT COMPLETED|Dispense 2||1
6708355|NCT02920983|7638517|FG005|NOT COMPLETED|Dispense 2||0
6708356|NCT02920983|7638512|FG000|STARTED|Dispense 3||8
6708357|NCT02920983|7638513|FG001|STARTED|Dispense 3||10
6708358|NCT02920983|7638514|FG002|STARTED|Dispense 3||7
6708359|NCT02920983|7638515|FG003|STARTED|Dispense 3||6
6708360|NCT02920983|7638516|FG004|STARTED|Dispense 3||13
6708361|NCT02920983|7638517|FG005|STARTED|Dispense 3||7
6708362|NCT02920983|7638512|FG000|COMPLETED|Dispense 3||7
6708363|NCT02920983|7638513|FG001|COMPLETED|Dispense 3||9
6708364|NCT02920983|7638514|FG002|COMPLETED|Dispense 3||7
6708365|NCT02920983|7638515|FG003|COMPLETED|Dispense 3||6
6708366|NCT02920983|7638516|FG004|COMPLETED|Dispense 3||12
6708367|NCT02920983|7638517|FG005|COMPLETED|Dispense 3||7
6708368|NCT02920983|7638512|FG000|NOT COMPLETED|Dispense 3||1
6708369|NCT02920983|7638513|FG001|NOT COMPLETED|Dispense 3||1
6708370|NCT02920983|7638514|FG002|NOT COMPLETED|Dispense 3||0
6708371|NCT02920983|7638515|FG003|NOT COMPLETED|Dispense 3||0
6708372|NCT02920983|7638516|FG004|NOT COMPLETED|Dispense 3||1
6708373|NCT02920983|7638517|FG005|NOT COMPLETED|Dispense 3||0
6708374|NCT02921061|7638525|FG000|STARTED|Overall Study||28
6708375|NCT02921061|7638525|FG000|COMPLETED|Overall Study||28
6708376|NCT02921061|7638525|FG000|NOT COMPLETED|Overall Study||0
6708377|NCT02921087|7638531|FG000|STARTED|Overall Study||12
6708378|NCT02921087|7638532|FG001|STARTED|Overall Study||11
6708379|NCT02921087|7638531|FG000|COMPLETED|Overall Study||12
6708380|NCT02921087|7638532|FG001|COMPLETED|Overall Study|One subject dropped out prior to 1 week of lens wear while wearing the control lens (lens 1).|10
6708381|NCT02921087|7638531|FG000|NOT COMPLETED|Overall Study||0
6708382|NCT02921087|7638532|FG001|NOT COMPLETED|Overall Study||1
6708383|NCT02921295|7638548|FG000|STARTED|Sidekicks||1
6708384|NCT02921295|7638548|FG000|COMPLETED|Sidekicks||1
6708385|NCT02921295|7638548|FG000|NOT COMPLETED|Sidekicks||0
6708386|NCT02921295|7638548|FG000|STARTED|Conventional Prostheses||1
6708387|NCT02921295|7638548|FG000|COMPLETED|Conventional Prostheses||1
6708388|NCT02921295|7638548|FG000|NOT COMPLETED|Conventional Prostheses||0
6708389|NCT02921386|7638557|FG000|STARTED|Sequence A: Fasting||18
6708390|NCT02921386|7638557|FG000|COMPLETED|Sequence A: Fasting||18
6708391|NCT02921386|7638557|FG000|NOT COMPLETED|Sequence A: Fasting||0
6708392|NCT02921386|7638557|FG000|STARTED|Sequence B: 15 g Fat Breakfast||18
6708393|NCT02921386|7638557|FG000|COMPLETED|Sequence B: 15 g Fat Breakfast||18
6708394|NCT02921386|7638557|FG000|NOT COMPLETED|Sequence B: 15 g Fat Breakfast||0
6708395|NCT02921386|7638557|FG000|STARTED|Sequence C: 30 g Fat Breakfast||18
6708396|NCT02921386|7638557|FG000|COMPLETED|Sequence C: 30 g Fat Breakfast||18
6708397|NCT02921386|7638557|FG000|NOT COMPLETED|Sequence C: 30 g Fat Breakfast||0
6708398|NCT02921386|7638557|FG000|STARTED|Sequence D: 45 g Fat Breakfast||18
6708399|NCT02921386|7638557|FG000|COMPLETED|Sequence D: 45 g Fat Breakfast||18
6708400|NCT02921386|7638557|FG000|NOT COMPLETED|Sequence D: 45 g Fat Breakfast||0
6708401|NCT02921386|7638557|FG000|STARTED|Sequence E: FDA High Fat Breakfast||18
6708402|NCT02921386|7638557|FG000|COMPLETED|Sequence E: FDA High Fat Breakfast||18
6708403|NCT02921386|7638557|FG000|NOT COMPLETED|Sequence E: FDA High Fat Breakfast||0
6708404|NCT02921412|7638565|FG000|STARTED|Overall Study||36
6708405|NCT02921412|7638565|FG000|COMPLETED|Overall Study||36
6708406|NCT02921412|7638565|FG000|NOT COMPLETED|Overall Study||0
6708407|NCT02921425|7638576|FG000|STARTED|Overall Study||47
6739190|NCT03286751|7668063|FG002|NOT COMPLETED|Period 3||0
6708408|NCT02921425|7638576|FG000|Second Visit|Overall Study|Participants had to wear an accelerometer and make entries into their PHR over the previous 7 days.|47
6708409|NCT02921425|7638576|FG000|COMPLETED|Overall Study||38
6708410|NCT02921425|7638576|FG000|NOT COMPLETED|Overall Study||9
6708411|NCT02921490|7638580|FG000|STARTED|Overall Study||10
6708412|NCT02921490|7638580|FG000|COMPLETED|Overall Study||10
6708413|NCT02921490|7638580|FG000|NOT COMPLETED|Overall Study||0
6708414|NCT02921737|7638584|FG000|STARTED|Overall Study||7
6708415|NCT02921737|7638584|FG000|COMPLETED|Overall Study||7
6708416|NCT02921737|7638584|FG000|NOT COMPLETED|Overall Study||0
6708417|NCT02921750|7638590|FG000|STARTED|Overall Study||124
6708418|NCT02921750|7638591|FG001|STARTED|Overall Study||124
6708419|NCT02921750|7638590|FG000|Intention to Treat (ITT)|Overall Study||122
6708420|NCT02921750|7638591|FG001|Intention to Treat (ITT)|Overall Study||123
6708421|NCT02921750|7638590|FG000|Per Protocol (PP)|Overall Study||100
6708422|NCT02921750|7638591|FG001|Per Protocol (PP)|Overall Study||107
6708423|NCT02921750|7638590|FG000|Completed 6 Weeks Follow-up (PP)|Overall Study||97
6708424|NCT02921750|7638591|FG001|Completed 6 Weeks Follow-up (PP)|Overall Study||104
6708425|NCT02921750|7638590|FG000|Subgroup Followed for 24 Weeks (ITT)|Overall Study||35
6708426|NCT02921750|7638591|FG001|Subgroup Followed for 24 Weeks (ITT)|Overall Study||40
6708427|NCT02921750|7638590|FG000|Subgroup Followed for 24 Weeks (PP)|Overall Study||19
6708428|NCT02921750|7638591|FG001|Subgroup Followed for 24 Weeks (PP)|Overall Study||36
6708429|NCT02921750|7638590|FG000|COMPLETED|Overall Study||115
6708430|NCT02921750|7638591|FG001|COMPLETED|Overall Study||113
6708431|NCT02921750|7638590|FG000|NOT COMPLETED|Overall Study||9
6708432|NCT02921750|7638591|FG001|NOT COMPLETED|Overall Study||11
6708433|NCT02921841|7638602|FG000|STARTED|Overall Study||68
6708434|NCT02921841|7638603|FG001|STARTED|Overall Study||57
6708435|NCT02921841|7638602|FG000|COMPLETED|Overall Study||52
6708436|NCT02921841|7638603|FG001|COMPLETED|Overall Study||44
6708437|NCT02921841|7638602|FG000|NOT COMPLETED|Overall Study||16
6708438|NCT02921841|7638603|FG001|NOT COMPLETED|Overall Study||13
6708439|NCT02922153|7638611|FG000|STARTED|Overall Study||65
6708440|NCT02922153|7638612|FG001|STARTED|Overall Study||19
6708441|NCT02922153|7638611|FG000|COMPLETED|Overall Study||55
6708442|NCT02922153|7638612|FG001|COMPLETED|Overall Study||17
6708443|NCT02922153|7638611|FG000|NOT COMPLETED|Overall Study||10
6708444|NCT02922153|7638612|FG001|NOT COMPLETED|Overall Study||2
6708445|NCT02922582|7638622|FG000|STARTED|Overall Study||4
6708446|NCT02922582|7638623|FG001|STARTED|Overall Study||4
6708447|NCT02922582|7638624|FG002|STARTED|Overall Study||4
6708448|NCT02922582|7638625|FG003|STARTED|Overall Study||4
6708449|NCT02922582|7638622|FG000|COMPLETED|Overall Study||4
6708450|NCT02922582|7638623|FG001|COMPLETED|Overall Study||3
6708451|NCT02922582|7638624|FG002|COMPLETED|Overall Study||4
6708452|NCT02922582|7638625|FG003|COMPLETED|Overall Study||4
6708453|NCT02922582|7638622|FG000|NOT COMPLETED|Overall Study||0
6708454|NCT02922582|7638623|FG001|NOT COMPLETED|Overall Study||1
6708455|NCT02922582|7638624|FG002|NOT COMPLETED|Overall Study||0
6708456|NCT02922582|7638625|FG003|NOT COMPLETED|Overall Study||0
6708457|NCT02922634|7638635|FG000|STARTED|Overall Study||229
6708458|NCT02922634|7638635|FG000|COMPLETED|Overall Study||219
6708459|NCT02922634|7638635|FG000|NOT COMPLETED|Overall Study||10
6708460|NCT02922738|7638648|FG000|STARTED|Overall Study|158 patients and 17 providers|175
6708461|NCT02922738|7638649|FG001|STARTED|Overall Study|275 patients and 15 providers|290
6708462|NCT02922738|7638648|FG000|COMPLETED|Overall Study||175
6708463|NCT02922738|7638649|FG001|COMPLETED|Overall Study||290
6708464|NCT02922738|7638648|FG000|NOT COMPLETED|Overall Study||0
6708465|NCT02922738|7638649|FG001|NOT COMPLETED|Overall Study||0
6708466|NCT02922868|7638659|FG000|STARTED|Overall Study||30
6708467|NCT02922868|7638660|FG001|STARTED|Overall Study||30
6708468|NCT02922868|7638659|FG000|COMPLETED|Overall Study||30
6708469|NCT02922868|7638660|FG001|COMPLETED|Overall Study||30
6708470|NCT02922868|7638659|FG000|NOT COMPLETED|Overall Study||0
6708471|NCT02922868|7638660|FG001|NOT COMPLETED|Overall Study||0
6708472|NCT02922959|7638668|FG000|STARTED|Overall Study||40
6708473|NCT02922959|7638669|FG001|STARTED|Overall Study||40
6708474|NCT02922959|7638668|FG000|3 Weeks|Overall Study|n=38 (95.0%)|38
6708475|NCT02922959|7638669|FG001|3 Weeks|Overall Study|n=36 (90.0%)|36
6708476|NCT02922959|7638668|FG000|3 Months|Overall Study|n=35 (87.5%)|35
6708477|NCT02922959|7638669|FG001|3 Months|Overall Study|n=31 (77.5%)|31
6708478|NCT02922959|7638668|FG000|6 Months|Overall Study|n=28 (70.0%)|28
6708479|NCT02922959|7638669|FG001|6 Months|Overall Study|n=30 (75.0%)|30
6708480|NCT02922959|7638668|FG000|12 Months|Overall Study|n=21 (52.5%)|21
6708481|NCT02922959|7638669|FG001|12 Months|Overall Study|n=23 (57.5%)|23
6708482|NCT02922959|7638668|FG000|COMPLETED|Overall Study||21
6708483|NCT02922959|7638669|FG001|COMPLETED|Overall Study||23
6708484|NCT02922959|7638668|FG000|NOT COMPLETED|Overall Study||19
6708485|NCT02922959|7638669|FG001|NOT COMPLETED|Overall Study||17
6708486|NCT02923115|7638681|FG000|STARTED|Overall Study||12
6708487|NCT02923115|7638682|FG001|STARTED|Overall Study||16
6708488|NCT02923115|7638683|FG002|STARTED|Overall Study||23
6708489|NCT02923115|7638684|FG003|STARTED|Overall Study||23
6708490|NCT02923115|7638685|FG004|STARTED|Overall Study||22
6708491|NCT02923115|7638686|FG005|STARTED|Overall Study||38
6392124|NCT00839527|7304108|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
6392125|NCT00839527|7304109|FG002|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
6708492|NCT02923115|7638681|FG000|Treated|Overall Study||12
6708493|NCT02923115|7638682|FG001|Treated|Overall Study||16
6392126|NCT00839527|7304107|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
6602671|NCT02058108|7527706|FG000|Switched to Telbivudine After Week 24|Overall Study||0
6602672|NCT02058108|7527707|FG001|Switched to Telbivudine After Week 24|Overall Study||5
6708494|NCT02923115|7638683|FG002|Treated|Overall Study||20
6708495|NCT02923115|7638684|FG003|Treated|Overall Study||22
6261429|NCT00002651|7160299|FG000|STARTED|Induction||3040
6261430|NCT00002651|7160300|FG001|STARTED|Induction||0
6261431|NCT00002651|7160301|FG002|STARTED|Induction||0
6261432|NCT00002651|7160299|FG000|Eligible|Induction||2950
6261433|NCT00002651|7160300|FG001|Eligible|Induction||0
6261434|NCT00002651|7160301|FG002|Eligible|Induction||0
6261435|NCT00002651|7160299|FG000|Eligible and Began Protocol Therapy|Induction||2950
6261436|NCT00002651|7160300|FG001|Eligible and Began Protocol Therapy|Induction||0
6261437|NCT00002651|7160301|FG002|Eligible and Began Protocol Therapy|Induction||0
6261438|NCT00002651|7160299|FG000|COMPLETED|Induction||1697
6261439|NCT00002651|7160300|FG001|COMPLETED|Induction||0
6261440|NCT00002651|7160301|FG002|COMPLETED|Induction||0
6261441|NCT00002651|7160299|FG000|NOT COMPLETED|Induction||1343
6261442|NCT00002651|7160300|FG001|NOT COMPLETED|Induction||0
6261443|NCT00002651|7160301|FG002|NOT COMPLETED|Induction||0
6261444|NCT00002651|7160299|FG000|STARTED|Consolidation and Randomization||0
6261445|NCT00002651|7160300|FG001|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
6261446|NCT00002651|7160301|FG002|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
6261447|NCT00002651|7160299|FG000|Eligible|Consolidation and Randomization||0
6261448|NCT00002651|7160300|FG001|Eligible|Consolidation and Randomization||765
6261449|NCT00002651|7160301|FG002|Eligible|Consolidation and Randomization||770
6261450|NCT00002651|7160299|FG000|Assessable for Toxicity|Consolidation and Randomization||0
6261451|NCT00002651|7160300|FG001|Assessable for Toxicity|Consolidation and Randomization||732
6261452|NCT00002651|7160301|FG002|Assessable for Toxicity|Consolidation and Randomization||702
6261453|NCT00002651|7160299|FG000|COMPLETED|Consolidation and Randomization||0
6261454|NCT00002651|7160300|FG001|COMPLETED|Consolidation and Randomization||29
6261455|NCT00002651|7160301|FG002|COMPLETED|Consolidation and Randomization||22
6261456|NCT00002651|7160299|FG000|NOT COMPLETED|Consolidation and Randomization||0
6261457|NCT00002651|7160300|FG001|NOT COMPLETED|Consolidation and Randomization||838
6261458|NCT00002651|7160301|FG002|NOT COMPLETED|Consolidation and Randomization||860
6261459|NCT00002766|7160311|FG000|STARTED|Overall Study||81
6261460|NCT00002766|7160312|FG001|STARTED|Overall Study||89
6261461|NCT00002766|7160311|FG000|COMPLETED|Overall Study||78
6261462|NCT00002766|7160312|FG001|COMPLETED|Overall Study||85
6261463|NCT00002766|7160311|FG000|NOT COMPLETED|Overall Study||3
6261464|NCT00002766|7160312|FG001|NOT COMPLETED|Overall Study||4
6261465|NCT00002842|7160318|FG000|STARTED|Overall Study||49
6261466|NCT00002842|7160318|FG000|COMPLETED|Overall Study||22
6261467|NCT00002842|7160318|FG000|NOT COMPLETED|Overall Study||27
6261468|NCT00002850|7160325|FG000|STARTED|Overall Study||69
6261469|NCT00002850|7160326|FG001|STARTED|Overall Study||76
6261470|NCT00002850|7160327|FG002|STARTED|Overall Study||67
6261471|NCT00002850|7160325|FG000|COMPLETED|Overall Study||64
6261472|NCT00002850|7160326|FG001|COMPLETED|Overall Study||74
6261473|NCT00002850|7160327|FG002|COMPLETED|Overall Study||63
6261474|NCT00002850|7160325|FG000|NOT COMPLETED|Overall Study||5
6261475|NCT00002850|7160326|FG001|NOT COMPLETED|Overall Study||2
6261476|NCT00002850|7160327|FG002|NOT COMPLETED|Overall Study||4
6261477|NCT00002931|7160335|FG000|STARTED|Overall Study||48
6261478|NCT00002931|7160335|FG000|COMPLETED|Overall Study||46
6261479|NCT00002931|7160335|FG000|NOT COMPLETED|Overall Study||2
6261480|NCT00003138|7160341|FG000|STARTED|Step 1||61
6261481|NCT00003138|7160342|FG001|STARTED|Step 1||57
6261482|NCT00003138|7160341|FG000|Patients With Complete Data|Step 1||57
6261483|NCT00003138|7160342|FG001|Patients With Complete Data|Step 1||53
6261484|NCT00003138|7160341|FG000|Treated|Step 1||56
6261485|NCT00003138|7160342|FG001|Treated|Step 1||53
6261486|NCT00003138|7160341|FG000|Eligible and Treated|Step 1||52
6261487|NCT00003138|7160342|FG001|Eligible and Treated|Step 1||50
6261488|NCT00003138|7160341|FG000|Patients With QOL Data at 4 Months|Step 1||42
6261489|NCT00003138|7160342|FG001|Patients With QOL Data at 4 Months|Step 1||42
6261490|NCT00003138|7160341|FG000|Patients With Transfusion Data|Step 1||37
6261491|NCT00003138|7160342|FG001|Patients With Transfusion Data|Step 1||42
6261492|NCT00003138|7160341|FG000|COMPLETED|Step 1||0
6261493|NCT00003138|7160342|FG001|COMPLETED|Step 1||0
6261494|NCT00003138|7160341|FG000|NOT COMPLETED|Step 1||61
6261495|NCT00003138|7160342|FG001|NOT COMPLETED|Step 1||57
6261496|NCT00003138|7160341|FG000|STARTED|Step 2 (Cross Over)||26
6261497|NCT00003138|7160342|FG001|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
6261498|NCT00003138|7160341|FG000|COMPLETED|Step 2 (Cross Over)||0
6261499|NCT00003138|7160342|FG001|COMPLETED|Step 2 (Cross Over)||0
6261500|NCT00003138|7160341|FG000|NOT COMPLETED|Step 2 (Cross Over)||26
6261501|NCT00003138|7160342|FG001|NOT COMPLETED|Step 2 (Cross Over)||0
6261502|NCT00003138|7160341|FG000|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
6602673|NCT02058108|7527706|FG000|COMPLETED|Overall Study||2
6602674|NCT02058108|7527707|FG001|COMPLETED|Overall Study||0
6602675|NCT02058108|7527706|FG000|NOT COMPLETED|Overall Study||41
6602676|NCT02058108|7527707|FG001|NOT COMPLETED|Overall Study||10
6602677|NCT02058147|7527718|FG000|STARTED|Overall Study||469
6708496|NCT02923115|7638685|FG004|Treated|Overall Study||17
6708497|NCT02923115|7638686|FG005|Treated|Overall Study||38
6708498|NCT02923115|7638681|FG000|COMPLETED|Overall Study||12
6708499|NCT02923115|7638682|FG001|COMPLETED|Overall Study||15
6708500|NCT02923115|7638683|FG002|COMPLETED|Overall Study||20
6708501|NCT02923115|7638684|FG003|COMPLETED|Overall Study||21
6708502|NCT02923115|7638685|FG004|COMPLETED|Overall Study||17
6708503|NCT02923115|7638686|FG005|COMPLETED|Overall Study||38
6708504|NCT02923115|7638681|FG000|NOT COMPLETED|Overall Study||0
6708505|NCT02923115|7638682|FG001|NOT COMPLETED|Overall Study||1
6708506|NCT02923115|7638683|FG002|NOT COMPLETED|Overall Study||3
6708507|NCT02923115|7638684|FG003|NOT COMPLETED|Overall Study||2
6708508|NCT02923115|7638685|FG004|NOT COMPLETED|Overall Study||5
6708509|NCT02923115|7638686|FG005|NOT COMPLETED|Overall Study||0
6708510|NCT02923167|7638700|FG000|STARTED|Overall Study||6
6708511|NCT02923167|7638700|FG000|COMPLETED|Overall Study||4
6261503|NCT00003138|7160342|FG001|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
6261504|NCT00003138|7160341|FG000|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
6261505|NCT00003138|7160342|FG001|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
6261506|NCT00003138|7160341|FG000|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
6261507|NCT00003138|7160342|FG001|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
6261508|NCT00003138|7160341|FG000|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
6261509|NCT00003138|7160342|FG001|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
6261510|NCT00003138|7160341|FG000|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
6261511|NCT00003138|7160342|FG001|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
6261512|NCT00003138|7160341|FG000|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
6261513|NCT00003138|7160342|FG001|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
6261514|NCT00003138|7160341|FG000|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
6261515|NCT00003138|7160342|FG001|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
6261516|NCT00003199|7160351|FG000|STARTED|Overall Study||50
6261517|NCT00003199|7160351|FG000|COMPLETED|Overall Study||28
6261518|NCT00003199|7160351|FG000|NOT COMPLETED|Overall Study||22
6261519|NCT00003222|7160357|FG000|STARTED|Overall Study||13
6261520|NCT00003222|7160358|FG001|STARTED|Overall Study||28
6261521|NCT00003222|7160357|FG000|COMPLETED|Overall Study||13
6261522|NCT00003222|7160358|FG001|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
6261523|NCT00003222|7160357|FG000|NOT COMPLETED|Overall Study||0
6261524|NCT00003222|7160358|FG001|NOT COMPLETED|Overall Study||1
6261525|NCT00003224|7160370|FG000|STARTED|Overall Study||4
6261526|NCT00003224|7160371|FG001|STARTED|Overall Study||5
6261527|NCT00003224|7160372|FG002|STARTED|Overall Study||4
6261528|NCT00003224|7160373|FG003|STARTED|Overall Study||2
6261529|NCT00003224|7160374|FG004|STARTED|Overall Study||4
6261530|NCT00003224|7160375|FG005|STARTED|Overall Study||3
6261531|NCT00003224|7160370|FG000|COMPLETED|Overall Study||4
6261532|NCT00003224|7160371|FG001|COMPLETED|Overall Study||5
6261533|NCT00003224|7160372|FG002|COMPLETED|Overall Study||4
6261534|NCT00003224|7160373|FG003|COMPLETED|Overall Study||2
6261535|NCT00003224|7160374|FG004|COMPLETED|Overall Study||4
6261536|NCT00003224|7160375|FG005|COMPLETED|Overall Study||3
6261537|NCT00003224|7160370|FG000|NOT COMPLETED|Overall Study||0
6261538|NCT00003224|7160371|FG001|NOT COMPLETED|Overall Study||0
6261539|NCT00003224|7160372|FG002|NOT COMPLETED|Overall Study||0
6261540|NCT00003224|7160373|FG003|NOT COMPLETED|Overall Study||0
6261541|NCT00003224|7160374|FG004|NOT COMPLETED|Overall Study||0
6261542|NCT00003224|7160375|FG005|NOT COMPLETED|Overall Study||0
6261543|NCT00003270|7160387|FG000|STARTED|Overall Study||20
6261544|NCT00003270|7160387|FG000|COMPLETED|Overall Study||20
6261545|NCT00003270|7160387|FG000|NOT COMPLETED|Overall Study||0
6280340|NCT00153816|7180236|FG004|COMPLETED|Overall Study||278
6280341|NCT00153816|7180237|FG005|COMPLETED|Overall Study||262
6280342|NCT00153816|7180232|FG000|NOT COMPLETED|Overall Study||32
6280343|NCT00153816|7180233|FG001|NOT COMPLETED|Overall Study||32
6280344|NCT00153816|7180234|FG002|NOT COMPLETED|Overall Study||32
6708512|NCT02923167|7638700|FG000|NOT COMPLETED|Overall Study||2
6708513|NCT02923180|7638705|FG000|STARTED|Overall Study||32
6708514|NCT02923180|7638705|FG000|COMPLETED|Overall Study||6
6708515|NCT02923180|7638705|FG000|NOT COMPLETED|Overall Study||26
6708516|NCT02923245|7638711|FG000|STARTED|Overall Study||60
6708517|NCT02923245|7638712|FG001|STARTED|Overall Study||60
6280345|NCT00153816|7180235|FG003|NOT COMPLETED|Overall Study||31
6280346|NCT00153816|7180236|FG004|NOT COMPLETED|Overall Study||17
6280347|NCT00153816|7180237|FG005|NOT COMPLETED|Overall Study||27
6280348|NCT00153842|7180253|FG000|STARTED|Overall Study||26
6280349|NCT00153842|7180254|FG001|STARTED|Overall Study||7
6280350|NCT00153842|7180253|FG000|COMPLETED|Overall Study||26
6280351|NCT00153842|7180254|FG001|COMPLETED|Overall Study||7
6280352|NCT00153842|7180253|FG000|NOT COMPLETED|Overall Study||0
6280353|NCT00153842|7180254|FG001|NOT COMPLETED|Overall Study||0
6280354|NCT00153920|7180262|FG000|STARTED|Overall Study||66
6708518|NCT02923245|7638711|FG000|COMPLETED|Overall Study||58
6708519|NCT02923245|7638712|FG001|COMPLETED|Overall Study||59
6708520|NCT02923245|7638711|FG000|NOT COMPLETED|Overall Study||2
6708521|NCT02923245|7638712|FG001|NOT COMPLETED|Overall Study||1
6708522|NCT02923271|7638721|FG000|STARTED|Overall Study||18
6708523|NCT02923271|7638722|FG001|STARTED|Overall Study||16
6708524|NCT02923271|7638721|FG000|COMPLETED|Overall Study||10
6708525|NCT02923271|7638722|FG001|COMPLETED|Overall Study||14
6708526|NCT02923271|7638721|FG000|NOT COMPLETED|Overall Study||8
6708527|NCT02923271|7638722|FG001|NOT COMPLETED|Overall Study||2
6708528|NCT02923349|7638735|FG000|STARTED|Overall Study||4
6708529|NCT02923349|7638736|FG001|STARTED|Overall Study||4
6708530|NCT02923349|7638737|FG002|STARTED|Overall Study||22
6708531|NCT02923349|7638738|FG003|STARTED|Overall Study||18
6708532|NCT02923349|7638739|FG004|STARTED|Overall Study||23
6708533|NCT02923349|7638740|FG005|STARTED|Overall Study||12
6708534|NCT02923349|7638741|FG006|STARTED|Overall Study||4
6708535|NCT02923349|7638735|FG000|COMPLETED|Overall Study||0
6708536|NCT02923349|7638736|FG001|COMPLETED|Overall Study||0
6708537|NCT02923349|7638737|FG002|COMPLETED|Overall Study||5
6708538|NCT02923349|7638738|FG003|COMPLETED|Overall Study||2
6708539|NCT02923349|7638739|FG004|COMPLETED|Overall Study||4
6708540|NCT02923349|7638740|FG005|COMPLETED|Overall Study||5
6708541|NCT02923349|7638741|FG006|COMPLETED|Overall Study||1
6708542|NCT02923349|7638735|FG000|NOT COMPLETED|Overall Study||4
6708543|NCT02923349|7638736|FG001|NOT COMPLETED|Overall Study||4
6708544|NCT02923349|7638737|FG002|NOT COMPLETED|Overall Study||17
6708545|NCT02923349|7638738|FG003|NOT COMPLETED|Overall Study||16
6708546|NCT02923349|7638739|FG004|NOT COMPLETED|Overall Study||19
6708547|NCT02923349|7638740|FG005|NOT COMPLETED|Overall Study||7
6708548|NCT02923349|7638741|FG006|NOT COMPLETED|Overall Study||3
6708549|NCT02923427|7638759|FG000|STARTED|Overall Study||55
6708550|NCT02923427|7638760|FG001|STARTED|Overall Study||57
6708551|NCT02923427|7638759|FG000|COMPLETED|Overall Study|"The reasons:~n= 2 Convert to Laparotomy n=1 Desaturation n=1 LMA-S can not be placed"|51
6708552|NCT02923427|7638760|FG001|COMPLETED|Overall Study|"The reasons:~n = 2 Convert to Laparotomy"|55
6708553|NCT02923427|7638759|FG000|NOT COMPLETED|Overall Study||4
6708554|NCT02923427|7638760|FG001|NOT COMPLETED|Overall Study||2
6708555|NCT02923895|7638768|FG000|STARTED|Overall Study||97
6708556|NCT02923895|7638769|FG001|STARTED|Overall Study||95
6708557|NCT02923895|7638768|FG000|COMPLETED|Overall Study||97
6708558|NCT02923895|7638769|FG001|COMPLETED|Overall Study||95
6708559|NCT02923895|7638768|FG000|NOT COMPLETED|Overall Study||0
6708560|NCT02923895|7638769|FG001|NOT COMPLETED|Overall Study||0
6708561|NCT02923921|7638777|FG000|STARTED|Overall Study||283
6708562|NCT02923921|7638778|FG001|STARTED|Overall Study||284
6708563|NCT02923921|7638777|FG000|Received at Least 1 Dose of Study Drug|Overall Study||278
6708564|NCT02923921|7638778|FG001|Received at Least 1 Dose of Study Drug|Overall Study||251
6708565|NCT02923921|7638777|FG000|Safety Population|Overall Study||278
6708566|NCT02923921|7638778|FG001|Safety Population|Overall Study||251
6708567|NCT02923921|7638777|FG000|COMPLETED|Overall Study||230
6708568|NCT02923921|7638778|FG001|COMPLETED|Overall Study||227
6708569|NCT02923921|7638777|FG000|NOT COMPLETED|Overall Study||53
6708570|NCT02923921|7638778|FG001|NOT COMPLETED|Overall Study||57
6708571|NCT02924051|7638786|FG000|STARTED|Overall Study||82
6708572|NCT02924051|7638787|FG001|STARTED|Overall Study||106
6708573|NCT02924051|7638786|FG000|COMPLETED|Overall Study||81
6708574|NCT02924051|7638787|FG001|COMPLETED|Overall Study||97
6708575|NCT02924051|7638786|FG000|NOT COMPLETED|Overall Study||1
6708576|NCT02924051|7638787|FG001|NOT COMPLETED|Overall Study||9
6708577|NCT02924350|7638797|FG000|STARTED|Overall Study||102
6708578|NCT02924350|7638798|FG001|STARTED|Overall Study||102
6708579|NCT02924350|7638797|FG000|COMPLETED|Overall Study||102
6708580|NCT02924350|7638798|FG001|COMPLETED|Overall Study||100
6708581|NCT02924350|7638797|FG000|NOT COMPLETED|Overall Study||0
6708582|NCT02924350|7638798|FG001|NOT COMPLETED|Overall Study||2
6708583|NCT02924428|7638806|FG000|STARTED|Overall Study||20
6708584|NCT02924428|7638807|FG001|STARTED|Overall Study||19
6708585|NCT02924428|7638806|FG000|COMPLETED|Overall Study||16
6708586|NCT02924428|7638807|FG001|COMPLETED|Overall Study||14
6708587|NCT02924428|7638806|FG000|NOT COMPLETED|Overall Study||4
6708588|NCT02924428|7638807|FG001|NOT COMPLETED|Overall Study||5
6708589|NCT02924688|7638819|FG000|STARTED|Overall Study||407
6708590|NCT02924688|7638820|FG001|STARTED|Overall Study||405
6708591|NCT02924688|7638821|FG002|STARTED|Overall Study||406
6708592|NCT02924688|7638822|FG003|STARTED|Overall Study||406
6708593|NCT02924688|7638823|FG004|STARTED|Overall Study||404
6708594|NCT02924688|7638824|FG005|STARTED|Overall Study||408
6708595|NCT02924688|7638819|FG000|COMPLETED|Overall Study||374
6708596|NCT02924688|7638820|FG001|COMPLETED|Overall Study||374
6708597|NCT02924688|7638821|FG002|COMPLETED|Overall Study||383
6708598|NCT02924688|7638822|FG003|COMPLETED|Overall Study||378
6708599|NCT02924688|7638823|FG004|COMPLETED|Overall Study||381
6708600|NCT02924688|7638824|FG005|COMPLETED|Overall Study||384
6708601|NCT02924688|7638819|FG000|NOT COMPLETED|Overall Study||33
6708602|NCT02924688|7638820|FG001|NOT COMPLETED|Overall Study||31
6708603|NCT02924688|7638821|FG002|NOT COMPLETED|Overall Study||23
6708604|NCT02924688|7638822|FG003|NOT COMPLETED|Overall Study||28
6708605|NCT02924688|7638823|FG004|NOT COMPLETED|Overall Study||23
6708606|NCT02924688|7638824|FG005|NOT COMPLETED|Overall Study||24
6739191|NCT03286751|7668064|FG003|NOT COMPLETED|Period 3||0
6739192|NCT03286751|7668065|FG004|NOT COMPLETED|Period 3||0
6739193|NCT03286751|7668066|FG005|NOT COMPLETED|Period 3||0
6739194|NCT03286751|7668061|FG000|STARTED|Washout Period 3||7
6739195|NCT03286751|7668062|FG001|STARTED|Washout Period 3||6
6739196|NCT03286751|7668063|FG002|STARTED|Washout Period 3||7
6739197|NCT03286751|7668064|FG003|STARTED|Washout Period 3||7
6739198|NCT03286751|7668065|FG004|STARTED|Washout Period 3||6
6739199|NCT03286751|7668066|FG005|STARTED|Washout Period 3||7
6739200|NCT03286751|7668061|FG000|COMPLETED|Washout Period 3||7
6708607|NCT02924883|7638843|FG000|STARTED|Overall Study||133
6708608|NCT02924883|7638844|FG001|STARTED|Overall Study||69
6708609|NCT02924883|7638843|FG000|COMPLETED|Overall Study||0
6708610|NCT02924883|7638844|FG001|COMPLETED|Overall Study||0
6708611|NCT02924883|7638843|FG000|NOT COMPLETED|Overall Study||133
6708612|NCT02924883|7638844|FG001|NOT COMPLETED|Overall Study||69
6708613|NCT02925078|7638854|FG000|STARTED|Overall Study||14
6708614|NCT02925078|7638855|FG001|STARTED|Overall Study||16
6708615|NCT02925078|7638854|FG000|COMPLETED|Overall Study||13
6708616|NCT02925078|7638855|FG001|COMPLETED|Overall Study||13
6708617|NCT02925078|7638854|FG000|NOT COMPLETED|Overall Study||1
6708618|NCT02925078|7638855|FG001|NOT COMPLETED|Overall Study||3
6708619|NCT02925117|7638865|FG000|STARTED|Period 1 (Weeks 0 - 16)||41
6708620|NCT02925117|7638866|FG001|STARTED|Period 1 (Weeks 0 - 16)||42
6708621|NCT02925117|7638867|FG002|STARTED|Period 1 (Weeks 0 - 16)||42
6708622|NCT02925117|7638868|FG003|STARTED|Period 1 (Weeks 0 - 16)||42
6708623|NCT02925117|7638869|FG004|STARTED|Period 1 (Weeks 0 - 16)||0
6708624|NCT02925117|7638870|FG005|STARTED|Period 1 (Weeks 0 - 16)||0
6708625|NCT02925117|7638871|FG006|STARTED|Period 1 (Weeks 0 - 16)||0
6708626|NCT02925117|7638872|FG007|STARTED|Period 1 (Weeks 0 - 16)||0
6708627|NCT02925117|7638873|FG008|STARTED|Period 1 (Weeks 0 - 16)||0
6708628|NCT02925117|7638874|FG009|STARTED|Period 1 (Weeks 0 - 16)||0
6708629|NCT02925117|7638875|FG010|STARTED|Period 1 (Weeks 0 - 16)||0
6708630|NCT02925117|7638876|FG011|STARTED|Period 1 (Weeks 0 - 16)||0
6708631|NCT02925117|7638865|FG000|Received Treatment|Period 1 (Weeks 0 - 16)||40
6708632|NCT02925117|7638866|FG001|Received Treatment|Period 1 (Weeks 0 - 16)||42
6708633|NCT02925117|7638867|FG002|Received Treatment|Period 1 (Weeks 0 - 16)||42
6708634|NCT02925117|7638868|FG003|Received Treatment|Period 1 (Weeks 0 - 16)||42
6708635|NCT02925117|7638869|FG004|Received Treatment|Period 1 (Weeks 0 - 16)||0
6708636|NCT02925117|7638870|FG005|Received Treatment|Period 1 (Weeks 0 - 16)||0
6708637|NCT02925117|7638871|FG006|Received Treatment|Period 1 (Weeks 0 - 16)||0
6708638|NCT02925117|7638872|FG007|Received Treatment|Period 1 (Weeks 0 - 16)||0
6708639|NCT02925117|7638873|FG008|Received Treatment|Period 1 (Weeks 0 - 16)||0
6708640|NCT02925117|7638874|FG009|Received Treatment|Period 1 (Weeks 0 - 16)||0
6708641|NCT02925117|7638875|FG010|Received Treatment|Period 1 (Weeks 0 - 16)||0
6708642|NCT02925117|7638876|FG011|Received Treatment|Period 1 (Weeks 0 - 16)||0
6708643|NCT02925117|7638865|FG000|COMPLETED|Period 1 (Weeks 0 - 16)||23
6708644|NCT02925117|7638866|FG001|COMPLETED|Period 1 (Weeks 0 - 16)||31
6708645|NCT02925117|7638867|FG002|COMPLETED|Period 1 (Weeks 0 - 16)||37
6708646|NCT02925117|7638868|FG003|COMPLETED|Period 1 (Weeks 0 - 16)||39
6708647|NCT02925117|7638869|FG004|COMPLETED|Period 1 (Weeks 0 - 16)||0
6708648|NCT02925117|7638870|FG005|COMPLETED|Period 1 (Weeks 0 - 16)||0
6708649|NCT02925117|7638871|FG006|COMPLETED|Period 1 (Weeks 0 - 16)||0
6708650|NCT02925117|7638872|FG007|COMPLETED|Period 1 (Weeks 0 - 16)||0
6708651|NCT02925117|7638873|FG008|COMPLETED|Period 1 (Weeks 0 - 16)||0
6708652|NCT02925117|7638874|FG009|COMPLETED|Period 1 (Weeks 0 - 16)||0
6708653|NCT02925117|7638875|FG010|COMPLETED|Period 1 (Weeks 0 - 16)||0
6708654|NCT02925117|7638876|FG011|COMPLETED|Period 1 (Weeks 0 - 16)||0
6708655|NCT02925117|7638865|FG000|NOT COMPLETED|Period 1 (Weeks 0 - 16)||18
6708656|NCT02925117|7638866|FG001|NOT COMPLETED|Period 1 (Weeks 0 - 16)||11
6708657|NCT02925117|7638867|FG002|NOT COMPLETED|Period 1 (Weeks 0 - 16)||5
6708658|NCT02925117|7638868|FG003|NOT COMPLETED|Period 1 (Weeks 0 - 16)||3
6708659|NCT02925117|7638869|FG004|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6708660|NCT02925117|7638870|FG005|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6708661|NCT02925117|7638871|FG006|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6708662|NCT02925117|7638872|FG007|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6708663|NCT02925117|7638873|FG008|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6708664|NCT02925117|7638874|FG009|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6708665|NCT02925117|7638875|FG010|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6708666|NCT02925117|7638876|FG011|NOT COMPLETED|Period 1 (Weeks 0 - 16)||0
6708667|NCT02925117|7638865|FG000|STARTED|Period 2 (Weeks 16 - 88)||0
6708668|NCT02925117|7638866|FG001|STARTED|Period 2 (Weeks 16 - 88)||0
6708669|NCT02925117|7638867|FG002|STARTED|Period 2 (Weeks 16 - 88)||0
6708670|NCT02925117|7638868|FG003|STARTED|Period 2 (Weeks 16 - 88)||0
6708671|NCT02925117|7638869|FG004|STARTED|Period 2 (Weeks 16 - 88)||10
6708672|NCT02925117|7638870|FG005|STARTED|Period 2 (Weeks 16 - 88)||10
6708673|NCT02925117|7638871|FG006|STARTED|Period 2 (Weeks 16 - 88)||15
6708674|NCT02925117|7638872|FG007|STARTED|Period 2 (Weeks 16 - 88)||16
6708675|NCT02925117|7638873|FG008|STARTED|Period 2 (Weeks 16 - 88)||19
6708676|NCT02925117|7638874|FG009|STARTED|Period 2 (Weeks 16 - 88)||18
6708677|NCT02925117|7638875|FG010|STARTED|Period 2 (Weeks 16 - 88)||19
6708678|NCT02925117|7638876|FG011|STARTED|Period 2 (Weeks 16 - 88)||19
6708679|NCT02925117|7638865|FG000|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
6708680|NCT02925117|7638866|FG001|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
6708681|NCT02925117|7638867|FG002|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
6708682|NCT02925117|7638868|FG003|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||0
6708683|NCT02925117|7638869|FG004|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||8
6708684|NCT02925117|7638870|FG005|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||1
6708685|NCT02925117|7638871|FG006|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||13
6708686|NCT02925117|7638872|FG007|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
6708687|NCT02925117|7638873|FG008|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||17
6708688|NCT02925117|7638874|FG009|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||12
6708689|NCT02925117|7638875|FG010|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||14
6708690|NCT02925117|7638876|FG011|Rescued to Upadacitinib 30 mg|Period 2 (Weeks 16 - 88)||4
6708691|NCT02925117|7638865|FG000|COMPLETED|Period 2 (Weeks 16 - 88)||0
6708692|NCT02925117|7638866|FG001|COMPLETED|Period 2 (Weeks 16 - 88)||0
6708693|NCT02925117|7638867|FG002|COMPLETED|Period 2 (Weeks 16 - 88)||0
6708694|NCT02925117|7638868|FG003|COMPLETED|Period 2 (Weeks 16 - 88)||0
6708695|NCT02925117|7638869|FG004|COMPLETED|Period 2 (Weeks 16 - 88)||8
6708696|NCT02925117|7638870|FG005|COMPLETED|Period 2 (Weeks 16 - 88)||5
6708697|NCT02925117|7638871|FG006|COMPLETED|Period 2 (Weeks 16 - 88)||9
6708698|NCT02925117|7638872|FG007|COMPLETED|Period 2 (Weeks 16 - 88)||11
6708699|NCT02925117|7638873|FG008|COMPLETED|Period 2 (Weeks 16 - 88)||13
6708700|NCT02925117|7638874|FG009|COMPLETED|Period 2 (Weeks 16 - 88)||12
6708701|NCT02925117|7638875|FG010|COMPLETED|Period 2 (Weeks 16 - 88)||11
6708702|NCT02925117|7638876|FG011|COMPLETED|Period 2 (Weeks 16 - 88)||14
6708703|NCT02925117|7638865|FG000|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
6708704|NCT02925117|7638866|FG001|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
6708705|NCT02925117|7638867|FG002|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
6708706|NCT02925117|7638868|FG003|NOT COMPLETED|Period 2 (Weeks 16 - 88)||0
6708707|NCT02925117|7638869|FG004|NOT COMPLETED|Period 2 (Weeks 16 - 88)||2
6708708|NCT02925117|7638870|FG005|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
6708709|NCT02925117|7638871|FG006|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
6708710|NCT02925117|7638872|FG007|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
6708711|NCT02925117|7638873|FG008|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
6261546|NCT04617860|7160394|FG000|STARTED|Overall Study||8
6261547|NCT04617860|7160395|FG001|STARTED|Overall Study||10
6261548|NCT04617860|7160396|FG002|STARTED|Overall Study||18
6261549|NCT04617860|7160394|FG000|Dose Modified to 8 mg|Overall Study||8
6261550|NCT04617860|7160395|FG001|Dose Modified to 8 mg|Overall Study||1
6261551|NCT04617860|7160396|FG002|Dose Modified to 8 mg|Overall Study||0
6261552|NCT04617860|7160394|FG000|Dose Modified to 16 mg|Overall Study||8
6261553|NCT04617860|7160395|FG001|Dose Modified to 16 mg|Overall Study||9
6261554|NCT04617860|7160396|FG002|Dose Modified to 16 mg|Overall Study||8
6261555|NCT04617860|7160394|FG000|Dose Modified to 32 mg|Overall Study||2
6261556|NCT04617860|7160395|FG001|Dose Modified to 32 mg|Overall Study||4
6261557|NCT04617860|7160396|FG002|Dose Modified to 32 mg|Overall Study||11
6261558|NCT04617860|7160394|FG000|COMPLETED|Overall Study||0
6261559|NCT04617860|7160395|FG001|COMPLETED|Overall Study||0
6261560|NCT04617860|7160396|FG002|COMPLETED|Overall Study||0
6261561|NCT04617860|7160394|FG000|NOT COMPLETED|Overall Study||8
6261562|NCT04617860|7160395|FG001|NOT COMPLETED|Overall Study||10
6261563|NCT04617860|7160396|FG002|NOT COMPLETED|Overall Study||18
6261564|NCT04617847|7160408|FG000|STARTED|Overall Study||3
6261565|NCT04617847|7160409|FG001|STARTED|Overall Study||24
6261566|NCT04617847|7160408|FG000|Dose Modified to 16 mg WVE-120101|Overall Study||3
6261567|NCT04617847|7160409|FG001|Dose Modified to 16 mg WVE-120101|Overall Study||1
6261568|NCT04617847|7160408|FG000|Dose Modified to 32 mg WVE-120101|Overall Study||0
6261569|NCT04617847|7160409|FG001|Dose Modified to 32 mg WVE-120101|Overall Study||5
6261570|NCT04617847|7160408|FG000|COMPLETED|Overall Study||0
6261571|NCT04617847|7160409|FG001|COMPLETED|Overall Study||0
6261572|NCT04617847|7160408|FG000|NOT COMPLETED|Overall Study||3
6261573|NCT04617847|7160409|FG001|NOT COMPLETED|Overall Study||24
6261574|NCT04426318|7160419|FG000|STARTED|Overall Study||346
6261575|NCT04426318|7160420|FG001|STARTED|Overall Study||320
6261576|NCT04426318|7160419|FG000|Failed Attention Checks|Overall Study||4
6261577|NCT04426318|7160420|FG001|Failed Attention Checks|Overall Study||6
6261578|NCT04426318|7160419|FG000|Downloaded HMP App|Overall Study||329
6261579|NCT04426318|7160420|FG001|Downloaded HMP App|Overall Study||0
6261580|NCT04426318|7160419|FG000|Completed T2 Assessment|Overall Study||281
6261581|NCT04426318|7160420|FG001|Completed T2 Assessment|Overall Study||280
6261582|NCT04426318|7160419|FG000|Completed T3 Assessment|Overall Study||261
6261583|NCT04426318|7160420|FG001|Completed T3 Assessment|Overall Study||274
6261584|NCT04426318|7160419|FG000|Completed T4 Assessment|Overall Study||261
6261585|NCT04426318|7160420|FG001|Completed T4 Assessment|Overall Study||275
6261586|NCT04426318|7160419|FG000|Completed T5 Assessment|Overall Study||284
6261587|NCT04426318|7160420|FG001|Completed T5 Assessment|Overall Study||293
6261588|NCT04426318|7160419|FG000|Completed T6 Assessment|Overall Study||286
6261589|NCT04426318|7160420|FG001|Completed T6 Assessment|Overall Study||293
6261590|NCT04426318|7160419|FG000|Final Intent to Treat Sample|Overall Study||344
6261591|NCT04426318|7160420|FG001|Final Intent to Treat Sample|Overall Study||318
6261592|NCT04426318|7160419|FG000|COMPLETED|Overall Study||344
6261593|NCT04426318|7160420|FG001|COMPLETED|Overall Study||318
6261594|NCT04426318|7160419|FG000|NOT COMPLETED|Overall Study||2
6261595|NCT04426318|7160420|FG001|NOT COMPLETED|Overall Study||2
6261596|NCT04255381|7160426|FG000|STARTED|Overall Study||20
6261597|NCT04255381|7160426|FG000|COMPLETED|Overall Study||20
6261598|NCT04255381|7160426|FG000|NOT COMPLETED|Overall Study||0
6261599|NCT04063657|7160432|FG000|STARTED|Overall Study||1
6261600|NCT04063657|7160433|FG001|STARTED|Overall Study||0
6261601|NCT04063657|7160432|FG000|COMPLETED|Overall Study||0
6261602|NCT04063657|7160433|FG001|COMPLETED|Overall Study||0
6261603|NCT04063657|7160432|FG000|NOT COMPLETED|Overall Study||1
6261604|NCT04063657|7160433|FG001|NOT COMPLETED|Overall Study||0
6261605|NCT04042623|7160439|FG000|STARTED|Overall Study||1
6261606|NCT04042623|7160439|FG000|COMPLETED|Overall Study||0
6261607|NCT04042623|7160439|FG000|NOT COMPLETED|Overall Study||1
6261608|NCT03882047|7160446|FG000|STARTED|Overall Study||104
6708712|NCT02925117|7638874|FG009|NOT COMPLETED|Period 2 (Weeks 16 - 88)||6
6708713|NCT02925117|7638875|FG010|NOT COMPLETED|Period 2 (Weeks 16 - 88)||8
6708714|NCT02925117|7638876|FG011|NOT COMPLETED|Period 2 (Weeks 16 - 88)||5
6708715|NCT02925143|7638898|FG000|STARTED|Overall Study||6525
6708716|NCT02925143|7638898|FG000|Participants Receiving Depolarizing Neuromuscular Blocking Agent (NMBA) (Succinylcholine)|Overall Study||3099
6708717|NCT02925143|7638898|FG000|Participants Receiving Non-depolarizing Neuromuscular Blocking Agent (NMBA)|Overall Study||3426
6708718|NCT02925143|7638898|FG000|COMPLETED|Overall Study||6525
6708719|NCT02925143|7638898|FG000|NOT COMPLETED|Overall Study||0
6708720|NCT02925312|7638904|FG000|STARTED|Overall Study||125
6708721|NCT02925312|7638905|FG001|STARTED|Overall Study||294
6708722|NCT02925312|7638904|FG000|COMPLETED|Overall Study||98
6708723|NCT02925312|7638905|FG001|COMPLETED|Overall Study||294
6708724|NCT02925312|7638904|FG000|NOT COMPLETED|Overall Study||27
6708725|NCT02925312|7638905|FG001|NOT COMPLETED|Overall Study||0
6261609|NCT03882047|7160447|FG001|STARTED|Overall Study||105
6261610|NCT03882047|7160448|FG002|STARTED|Overall Study||104
6261611|NCT03882047|7160446|FG000|Treated|Overall Study||104
6261612|NCT03882047|7160447|FG001|Treated|Overall Study||104
6261613|NCT03882047|7160448|FG002|Treated|Overall Study||103
6261614|NCT03882047|7160446|FG000|COMPLETED|Overall Study||98
6261615|NCT03882047|7160447|FG001|COMPLETED|Overall Study||95
6261616|NCT03882047|7160448|FG002|COMPLETED|Overall Study||88
6261617|NCT03882047|7160446|FG000|NOT COMPLETED|Overall Study||6
6261618|NCT03882047|7160447|FG001|NOT COMPLETED|Overall Study||10
6261619|NCT03882047|7160448|FG002|NOT COMPLETED|Overall Study||16
6261620|NCT03879772|7160461|FG000|STARTED|Overall Study||137
6261621|NCT03879772|7160462|FG001|STARTED|Overall Study||135
6261622|NCT03879772|7160463|FG002|STARTED|Overall Study||133
6261623|NCT03879772|7160464|FG003|STARTED|Overall Study||138
6261624|NCT03879772|7160465|FG004|STARTED|Overall Study||136
6261625|NCT03879772|7160461|FG000|COMPLETED|Overall Study||133
6261626|NCT03879772|7160462|FG001|COMPLETED|Overall Study||132
6261627|NCT03879772|7160463|FG002|COMPLETED|Overall Study||123
6261628|NCT03879772|7160464|FG003|COMPLETED|Overall Study||130
6261629|NCT03879772|7160465|FG004|COMPLETED|Overall Study||128
6261630|NCT03879772|7160461|FG000|NOT COMPLETED|Overall Study||4
6261631|NCT03879772|7160462|FG001|NOT COMPLETED|Overall Study||3
6261632|NCT03879772|7160463|FG002|NOT COMPLETED|Overall Study||10
6261633|NCT03879772|7160464|FG003|NOT COMPLETED|Overall Study||8
6261634|NCT03879772|7160465|FG004|NOT COMPLETED|Overall Study||8
6261635|NCT03861559|7160479|FG000|STARTED|Overall Study||101
6261636|NCT03861559|7160480|FG001|STARTED|Overall Study||100
6261637|NCT03861559|7160479|FG000|COMPLETED|Overall Study||99
6261638|NCT03861559|7160480|FG001|COMPLETED|Overall Study||95
6261639|NCT03861559|7160479|FG000|NOT COMPLETED|Overall Study||2
6261640|NCT03861559|7160480|FG001|NOT COMPLETED|Overall Study||5
6261641|NCT03855228|7160490|FG000|STARTED|Overall Study||169
6261642|NCT03855228|7160491|FG001|STARTED|Overall Study||176
6261643|NCT03855228|7160492|FG002|STARTED|Overall Study||182
6261644|NCT03855228|7160493|FG003|STARTED|Overall Study||177
6261645|NCT03855228|7160490|FG000|Treated|Overall Study||169
6261646|NCT03855228|7160491|FG001|Treated|Overall Study||176
6261647|NCT03855228|7160492|FG002|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|181
6261648|NCT03855228|7160493|FG003|Treated|Overall Study|1 participant immediately dropped out prior to starting study intervention.|176
6261649|NCT03855228|7160490|FG000|COMPLETED|Overall Study||166
6261650|NCT03855228|7160491|FG001|COMPLETED|Overall Study||167
6261651|NCT03855228|7160492|FG002|COMPLETED|Overall Study||174
6261652|NCT03855228|7160493|FG003|COMPLETED|Overall Study||158
6261653|NCT03855228|7160490|FG000|NOT COMPLETED|Overall Study||3
6261654|NCT03855228|7160491|FG001|NOT COMPLETED|Overall Study||9
6261655|NCT03855228|7160492|FG002|NOT COMPLETED|Overall Study||8
6261656|NCT03855228|7160493|FG003|NOT COMPLETED|Overall Study||19
6261657|NCT03855189|7160506|FG000|STARTED|Overall Study||113
6261658|NCT03855189|7160507|FG001|STARTED|Overall Study||116
6261659|NCT03855189|7160508|FG002|STARTED|Overall Study||116
6261660|NCT03855189|7160506|FG000|Treated|Overall Study|Does not include 1 participant who received first dose but was excluded from safety analysis.|112
6261661|NCT03855189|7160507|FG001|Treated|Overall Study||116
6261662|NCT03855189|7160508|FG002|Treated|Overall Study||116
6261663|NCT03855189|7160506|FG000|COMPLETED|Overall Study||103
6261664|NCT03855189|7160507|FG001|COMPLETED|Overall Study||109
6261665|NCT03855189|7160508|FG002|COMPLETED|Overall Study||110
6261666|NCT03855189|7160506|FG000|NOT COMPLETED|Overall Study||10
6261667|NCT03855189|7160507|FG001|NOT COMPLETED|Overall Study||7
6602678|NCT02058147|7527719|FG001|STARTED|Overall Study||467
6602679|NCT02058147|7527720|FG002|STARTED|Overall Study||234
6602680|NCT02058147|7527718|FG000|Treated|Overall Study||469
6602681|NCT02058147|7527719|FG001|Treated|Overall Study||467
6602682|NCT02058147|7527720|FG002|Treated|Overall Study||233
6602683|NCT02058147|7527718|FG000|COMPLETED|Overall Study||440
6602684|NCT02058147|7527719|FG001|COMPLETED|Overall Study||440
6602685|NCT02058147|7527720|FG002|COMPLETED|Overall Study||205
6602686|NCT02058147|7527718|FG000|NOT COMPLETED|Overall Study||29
6602687|NCT02058147|7527719|FG001|NOT COMPLETED|Overall Study||27
6602688|NCT02058147|7527720|FG002|NOT COMPLETED|Overall Study||29
6602689|NCT02058160|7527730|FG000|STARTED|Overall Study||367
6602690|NCT02058160|7527731|FG001|STARTED|Overall Study||369
6602691|NCT02058160|7527730|FG000|Treated|Overall Study||365
6602692|NCT02058160|7527731|FG001|Treated|Overall Study||365
6602693|NCT02058160|7527730|FG000|COMPLETED|Overall Study||336
6708726|NCT02925403|7638913|FG000|STARTED|Overall Study||8
6708727|NCT02925403|7638914|FG001|STARTED|Overall Study||5
6708728|NCT02925403|7638913|FG000|COMPLETED|Overall Study||8
6708729|NCT02925403|7638914|FG001|COMPLETED|Overall Study||4
6708730|NCT02925403|7638913|FG000|NOT COMPLETED|Overall Study||0
6708731|NCT02925403|7638914|FG001|NOT COMPLETED|Overall Study||1
6708732|NCT02925455|7638922|FG000|STARTED|Overall Study||9
6708733|NCT02925455|7638923|FG001|STARTED|Overall Study||6
6708734|NCT02925455|7638922|FG000|COMPLETED|Overall Study||7
6708735|NCT02925455|7638923|FG001|COMPLETED|Overall Study||6
6708736|NCT02925455|7638922|FG000|NOT COMPLETED|Overall Study||2
6708737|NCT02925455|7638923|FG001|NOT COMPLETED|Overall Study||0
6708738|NCT02925494|7638933|FG000|STARTED|Treatment Period||59
6708739|NCT02925494|7638934|FG001|STARTED|Treatment Period||58
6708740|NCT02925494|7638935|FG002|STARTED|Treatment Period||98
6708741|NCT02925494|7638936|FG003|STARTED|Treatment Period||218
6708742|NCT02925494|7638933|FG000|COMPLETED|Treatment Period||50
6708743|NCT02925494|7638934|FG001|COMPLETED|Treatment Period||43
6708744|NCT02925494|7638935|FG002|COMPLETED|Treatment Period||79
6708745|NCT02925494|7638936|FG003|COMPLETED|Treatment Period||182
6708746|NCT02925494|7638933|FG000|NOT COMPLETED|Treatment Period||9
6708747|NCT02925494|7638934|FG001|NOT COMPLETED|Treatment Period||15
6708748|NCT02925494|7638935|FG002|NOT COMPLETED|Treatment Period||19
6708749|NCT02925494|7638936|FG003|NOT COMPLETED|Treatment Period||36
6708750|NCT02925494|7638933|FG000|STARTED|Post-Treatment Follow-Up Period||54
6708751|NCT02925494|7638934|FG001|STARTED|Post-Treatment Follow-Up Period||47
6708752|NCT02925494|7638935|FG002|STARTED|Post-Treatment Follow-Up Period||88
6708753|NCT02925494|7638936|FG003|STARTED|Post-Treatment Follow-Up Period||184
6708754|NCT02925494|7638933|FG000|COMPLETED|Post-Treatment Follow-Up Period||40
6708755|NCT02925494|7638934|FG001|COMPLETED|Post-Treatment Follow-Up Period||37
6708756|NCT02925494|7638935|FG002|COMPLETED|Post-Treatment Follow-Up Period||64
6708757|NCT02925494|7638936|FG003|COMPLETED|Post-Treatment Follow-Up Period||134
6708758|NCT02925494|7638933|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||14
6708759|NCT02925494|7638934|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||10
6708760|NCT02925494|7638935|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||24
6708761|NCT02925494|7638936|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||50
6708762|NCT02925611|7638949|FG000|STARTED|Overall Study||30
6708763|NCT02925611|7638950|FG001|STARTED|Overall Study||30
6708764|NCT02925611|7638949|FG000|COMPLETED|Overall Study||30
6708765|NCT02925611|7638950|FG001|COMPLETED|Overall Study||30
6708766|NCT02925611|7638949|FG000|NOT COMPLETED|Overall Study||0
6708767|NCT02925611|7638950|FG001|NOT COMPLETED|Overall Study||0
6708768|NCT02925741|7638958|FG000|STARTED|Overall Study||1637
6708769|NCT02925741|7638959|FG001|STARTED|Overall Study||1706
6708770|NCT02925741|7638958|FG000|COMPLETED|Overall Study||1626
6708771|NCT02925741|7638959|FG001|COMPLETED|Overall Study||1706
6708772|NCT02925741|7638958|FG000|NOT COMPLETED|Overall Study||11
6708773|NCT02925741|7638959|FG001|NOT COMPLETED|Overall Study||0
6708774|NCT02925858|7638970|FG000|STARTED|Overall Study||42
6708775|NCT02925858|7638971|FG001|STARTED|Overall Study||38
6708776|NCT02925858|7638970|FG000|COMPLETED|Overall Study||42
6708777|NCT02925858|7638971|FG001|COMPLETED|Overall Study||38
6708778|NCT02925858|7638970|FG000|NOT COMPLETED|Overall Study||0
6708779|NCT02925858|7638971|FG001|NOT COMPLETED|Overall Study||0
6708780|NCT02925923|7638979|FG000|STARTED|Overall Study||50
6708781|NCT02925923|7638980|FG001|STARTED|Overall Study||50
6708782|NCT02925923|7638979|FG000|COMPLETED|Overall Study||50
6708783|NCT02925923|7638980|FG001|COMPLETED|Overall Study||48
6261668|NCT03855189|7160508|FG002|NOT COMPLETED|Overall Study||6
6280355|NCT00153920|7180262|FG000|Eligible and Treated|Overall Study||64
6280356|NCT00153920|7180262|FG000|COMPLETED|Overall Study||36
6280357|NCT00153920|7180262|FG000|NOT COMPLETED|Overall Study||30
6280358|NCT00153985|7180266|FG000|STARTED|Overall Study||2
6280359|NCT00153985|7180266|FG000|COMPLETED|Overall Study||2
6280360|NCT00153985|7180266|FG000|NOT COMPLETED|Overall Study||0
6280361|NCT00154063|7180272|FG000|STARTED|Overall Study||104
6280362|NCT00154063|7180273|FG001|STARTED|Overall Study||102
6280363|NCT00154063|7180272|FG000|COMPLETED|Overall Study||92
6280364|NCT00154063|7180273|FG001|COMPLETED|Overall Study||80
6280365|NCT00154063|7180272|FG000|NOT COMPLETED|Overall Study||12
6708784|NCT02925923|7638979|FG000|NOT COMPLETED|Overall Study||0
6708785|NCT02925923|7638980|FG001|NOT COMPLETED|Overall Study||2
6708786|NCT02926027|7638988|FG000|STARTED|Overall Study||40
6708787|NCT02926027|7638989|FG001|STARTED|Overall Study||40
6708788|NCT02926027|7638988|FG000|COMPLETED|Overall Study||31
6708789|NCT02926027|7638989|FG001|COMPLETED|Overall Study||37
6708790|NCT02926027|7638988|FG000|NOT COMPLETED|Overall Study||9
6708791|NCT02926027|7638989|FG001|NOT COMPLETED|Overall Study||3
6708792|NCT02926209|7638995|FG000|STARTED|Study Cohort|Training cohort patients Aer-O-Scope as first followed by a conventional colonoscopy|42
6708793|NCT02926209|7638996|FG001|STARTED|Study Cohort||37
6708794|NCT02926209|7638995|FG000|COMPLETED|Study Cohort||41
6708795|NCT02926209|7638996|FG001|COMPLETED|Study Cohort||37
6708796|NCT02926209|7638995|FG000|NOT COMPLETED|Study Cohort||1
6708797|NCT02926209|7638996|FG001|NOT COMPLETED|Study Cohort||0
6708798|NCT02926209|7638995|FG000|STARTED|Training Cohort - First Patients||20
6708799|NCT02926209|7638996|FG001|STARTED|Training Cohort - First Patients||0
6280366|NCT00154063|7180273|FG001|NOT COMPLETED|Overall Study||22
6280367|NCT00154102|7180285|FG000|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
6708800|NCT02926209|7638995|FG000|COMPLETED|Training Cohort - First Patients||20
6708801|NCT02926209|7638996|FG001|COMPLETED|Training Cohort - First Patients||0
6708802|NCT02926209|7638995|FG000|NOT COMPLETED|Training Cohort - First Patients||0
6708803|NCT02926209|7638996|FG001|NOT COMPLETED|Training Cohort - First Patients||0
6708804|NCT02926573|7639005|FG000|STARTED|Overall Study||55
6708805|NCT02926573|7639006|FG001|STARTED|Overall Study||55
6708806|NCT02926573|7639005|FG000|COMPLETED|Overall Study||44
6708807|NCT02926573|7639006|FG001|COMPLETED|Overall Study||46
6708808|NCT02926573|7639005|FG000|NOT COMPLETED|Overall Study||11
6708809|NCT02926573|7639006|FG001|NOT COMPLETED|Overall Study||9
6708810|NCT02926677|7639015|FG000|STARTED|Overall Study||25
6708811|NCT02926677|7639016|FG001|STARTED|Overall Study||22
6708812|NCT02926677|7639017|FG002|STARTED|Overall Study||26
6708813|NCT02926677|7639015|FG000|COMPLETED|Overall Study||8
6708814|NCT02926677|7639016|FG001|COMPLETED|Overall Study||8
6708815|NCT02926677|7639017|FG002|COMPLETED|Overall Study||6
6708816|NCT02926677|7639015|FG000|NOT COMPLETED|Overall Study||17
6708817|NCT02926677|7639016|FG001|NOT COMPLETED|Overall Study||14
6708818|NCT02926677|7639017|FG002|NOT COMPLETED|Overall Study||20
6708819|NCT02926937|7639029|FG000|STARTED|Overall Study||150
6708820|NCT02926937|7639030|FG001|STARTED|Overall Study||142
6708821|NCT02926937|7639031|FG002|STARTED|Overall Study||107
6708822|NCT02926937|7639029|FG000|COMPLETED|Overall Study||131
6708823|NCT02926937|7639030|FG001|COMPLETED|Overall Study||127
6708824|NCT02926937|7639031|FG002|COMPLETED|Overall Study||96
6708825|NCT02926937|7639029|FG000|NOT COMPLETED|Overall Study||19
6708826|NCT02926937|7639030|FG001|NOT COMPLETED|Overall Study||15
6261669|NCT03764631|7160518|FG000|STARTED|Overall Study||751
6261670|NCT03764631|7160519|FG001|STARTED|Overall Study||751
6261671|NCT03764631|7160518|FG000|COMPLETED|Overall Study||710
6261672|NCT03764631|7160519|FG001|COMPLETED|Overall Study||698
6261673|NCT03764631|7160518|FG000|NOT COMPLETED|Overall Study||41
6261674|NCT03764631|7160519|FG001|NOT COMPLETED|Overall Study||53
6261675|NCT03764072|7160531|FG000|STARTED|Overall Study||46
6261676|NCT03764072|7160532|FG001|STARTED|Overall Study||42
6261677|NCT03764072|7160533|FG002|STARTED|Overall Study||44
6261678|NCT03764072|7160534|FG003|STARTED|Overall Study||45
6261679|NCT03764072|7160535|FG004|STARTED|Overall Study||46
6261680|NCT03764072|7160536|FG005|STARTED|Overall Study||27
6261681|NCT03764072|7160531|FG000|COMPLETED|Overall Study||46
6261682|NCT03764072|7160532|FG001|COMPLETED|Overall Study||42
6261683|NCT03764072|7160533|FG002|COMPLETED|Overall Study||43
6261684|NCT03764072|7160534|FG003|COMPLETED|Overall Study||45
6261685|NCT03764072|7160535|FG004|COMPLETED|Overall Study||45
6261686|NCT03764072|7160536|FG005|COMPLETED|Overall Study||26
6261687|NCT03764072|7160531|FG000|NOT COMPLETED|Overall Study||0
6261688|NCT03764072|7160532|FG001|NOT COMPLETED|Overall Study||0
6261689|NCT03764072|7160533|FG002|NOT COMPLETED|Overall Study||1
6261690|NCT03764072|7160534|FG003|NOT COMPLETED|Overall Study||0
6261691|NCT03764072|7160535|FG004|NOT COMPLETED|Overall Study||1
6261692|NCT03764072|7160536|FG005|NOT COMPLETED|Overall Study||1
6261693|NCT03645408|7160557|FG000|STARTED|Overall Study||1
6261694|NCT03645408|7160558|FG001|STARTED|Overall Study||2
6261695|NCT03645408|7160557|FG000|COMPLETED|Overall Study||1
6261696|NCT03645408|7160558|FG001|COMPLETED|Overall Study||2
6261697|NCT03645408|7160557|FG000|NOT COMPLETED|Overall Study||0
6261698|NCT03645408|7160558|FG001|NOT COMPLETED|Overall Study||0
6261699|NCT03578809|7160568|FG000|STARTED|Overall Study||94
6261700|NCT03578809|7160569|FG001|STARTED|Overall Study||185
6261701|NCT03578809|7160570|FG002|STARTED|Overall Study||112
6261702|NCT03578809|7160571|FG003|STARTED|Overall Study||202
6261703|NCT03578809|7160568|FG000|Treated|Overall Study||90
6261704|NCT03578809|7160569|FG001|Treated|Overall Study||179
6261705|NCT03578809|7160570|FG002|Treated|Overall Study||111
6261706|NCT03578809|7160571|FG003|Treated|Overall Study||195
6261707|NCT03578809|7160568|FG000|COMPLETED|Overall Study||88
6261708|NCT03578809|7160569|FG001|COMPLETED|Overall Study||171
6261709|NCT03578809|7160570|FG002|COMPLETED|Overall Study||108
6261710|NCT03578809|7160571|FG003|COMPLETED|Overall Study||193
6261711|NCT03578809|7160568|FG000|NOT COMPLETED|Overall Study||6
6261712|NCT03578809|7160569|FG001|NOT COMPLETED|Overall Study||14
6261713|NCT03578809|7160570|FG002|NOT COMPLETED|Overall Study||4
6261714|NCT03578809|7160571|FG003|NOT COMPLETED|Overall Study||9
6261715|NCT03571204|7160587|FG000|STARTED|Overall Study||8
6261716|NCT03571204|7160588|FG001|STARTED|Overall Study||8
6261717|NCT03571204|7160589|FG002|STARTED|Overall Study||5
6261718|NCT03571204|7160587|FG000|COMPLETED|Overall Study||7
6261719|NCT03571204|7160588|FG001|COMPLETED|Overall Study||6
6261720|NCT03571204|7160589|FG002|COMPLETED|Overall Study||5
6261721|NCT03571204|7160587|FG000|NOT COMPLETED|Overall Study||1
6261722|NCT03571204|7160588|FG001|NOT COMPLETED|Overall Study||2
6261723|NCT03571204|7160589|FG002|NOT COMPLETED|Overall Study||0
6261724|NCT03523091|7160600|FG000|STARTED|Overall Study||1
6261725|NCT03523091|7160601|FG001|STARTED|Overall Study||5
6261726|NCT03523091|7160600|FG000|COMPLETED|Overall Study||0
6261727|NCT03523091|7160601|FG001|COMPLETED|Overall Study||1
6261728|NCT03523091|7160600|FG000|NOT COMPLETED|Overall Study||1
6261729|NCT03523091|7160601|FG001|NOT COMPLETED|Overall Study||4
6280368|NCT00154102|7180286|FG001|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
6708827|NCT02926937|7639031|FG002|NOT COMPLETED|Overall Study||11
6708828|NCT02926950|7639042|FG000|STARTED|Overall Study||259
6708829|NCT02926950|7639043|FG001|STARTED|Overall Study||259
6708830|NCT02926950|7639042|FG000|COMPLETED|Overall Study||210
6708831|NCT02926950|7639043|FG001|COMPLETED|Overall Study||211
6708832|NCT02926950|7639042|FG000|NOT COMPLETED|Overall Study||49
6708833|NCT02926950|7639043|FG001|NOT COMPLETED|Overall Study||48
6708834|NCT02927080|7639060|FG000|STARTED|Overall Study||6
6708835|NCT02927080|7639061|FG001|STARTED|Overall Study||6
6708836|NCT02927080|7639062|FG002|STARTED|Overall Study||6
6708837|NCT02927080|7639063|FG003|STARTED|Overall Study||6
6708838|NCT02927080|7639064|FG004|STARTED|Overall Study||7
6708839|NCT02927080|7639065|FG005|STARTED|Overall Study||6
6708840|NCT02927080|7639066|FG006|STARTED|Overall Study||15
6708841|NCT02927080|7639067|FG007|STARTED|Overall Study||14
6708842|NCT02927080|7639068|FG008|STARTED|Overall Study||15
6708843|NCT02927080|7639069|FG009|STARTED|Overall Study||14
6708844|NCT02927080|7639060|FG000|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
6708845|NCT02927080|7639061|FG001|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
6708846|NCT02927080|7639062|FG002|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
6708847|NCT02927080|7639063|FG003|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
6708848|NCT02927080|7639064|FG004|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
6708849|NCT02927080|7639065|FG005|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||0
6708850|NCT02927080|7639066|FG006|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
6708851|NCT02927080|7639067|FG007|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||13
6708852|NCT02927080|7639068|FG008|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||14
6708853|NCT02927080|7639069|FG009|Open-Label Extension From Part 2 Double Blind-Placebo Controlled|Overall Study||12
6708854|NCT02927080|7639060|FG000|COMPLETED|Overall Study||6
6708855|NCT02927080|7639061|FG001|COMPLETED|Overall Study||5
6708856|NCT02927080|7639062|FG002|COMPLETED|Overall Study||6
6708857|NCT02927080|7639063|FG003|COMPLETED|Overall Study||6
6708858|NCT02927080|7639064|FG004|COMPLETED|Overall Study||6
6708859|NCT02927080|7639065|FG005|COMPLETED|Overall Study||6
6708860|NCT02927080|7639066|FG006|COMPLETED|Overall Study||7
6708861|NCT02927080|7639067|FG007|COMPLETED|Overall Study||5
6708862|NCT02927080|7639068|FG008|COMPLETED|Overall Study||12
6708863|NCT02927080|7639069|FG009|COMPLETED|Overall Study||7
6708864|NCT02927080|7639060|FG000|NOT COMPLETED|Overall Study||0
6708865|NCT02927080|7639061|FG001|NOT COMPLETED|Overall Study||1
6708866|NCT02927080|7639062|FG002|NOT COMPLETED|Overall Study||0
6708867|NCT02927080|7639063|FG003|NOT COMPLETED|Overall Study||0
6708868|NCT02927080|7639064|FG004|NOT COMPLETED|Overall Study||1
6708869|NCT02927080|7639065|FG005|NOT COMPLETED|Overall Study||0
6708870|NCT02927080|7639066|FG006|NOT COMPLETED|Overall Study||8
6708871|NCT02927080|7639067|FG007|NOT COMPLETED|Overall Study||9
6708872|NCT02927080|7639068|FG008|NOT COMPLETED|Overall Study||3
6708873|NCT02927080|7639069|FG009|NOT COMPLETED|Overall Study||7
6708874|NCT02927171|7639116|FG000|STARTED|Overall Study||53
6708875|NCT02927171|7639117|FG001|STARTED|Overall Study||51
6708876|NCT02927171|7639116|FG000|COMPLETED|Overall Study||53
6708877|NCT02927171|7639117|FG001|COMPLETED|Overall Study||50
6708878|NCT02927171|7639116|FG000|NOT COMPLETED|Overall Study||0
6708879|NCT02927171|7639117|FG001|NOT COMPLETED|Overall Study||1
6708880|NCT02927223|7639123|FG000|STARTED|Overall Study||6
6708881|NCT02927223|7639123|FG000|COMPLETED|Overall Study||6
6708882|NCT02927223|7639123|FG000|NOT COMPLETED|Overall Study||0
6708883|NCT02927301|7639129|FG000|STARTED|Overall Study||181
6708884|NCT02927301|7639129|FG000|COMPLETED|Overall Study||171
6708885|NCT02927301|7639129|FG000|NOT COMPLETED|Overall Study||10
6708886|NCT02927327|7639135|FG000|STARTED|Overall Study||30
6708887|NCT02927327|7639136|FG001|STARTED|Overall Study||31
6708888|NCT02927327|7639135|FG000|COMPLETED|Overall Study||30
6708889|NCT02927327|7639136|FG001|COMPLETED|Overall Study||31
6708890|NCT02927327|7639135|FG000|NOT COMPLETED|Overall Study||0
6708891|NCT02927327|7639136|FG001|NOT COMPLETED|Overall Study||0
6708892|NCT02927366|7639144|FG000|STARTED|Overall Study||6
6708893|NCT02927366|7639145|FG001|STARTED|Overall Study||2
6708894|NCT02927366|7639144|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||6
6708895|NCT02927366|7639145|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||2
6708896|NCT02927366|7639144|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||4
6708897|NCT02927366|7639145|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6708898|NCT02927366|7639144|FG000|COMPLETED|Overall Study||4
6708899|NCT02927366|7639145|FG001|COMPLETED|Overall Study||2
6708900|NCT02927366|7639144|FG000|NOT COMPLETED|Overall Study||2
6708901|NCT02927366|7639145|FG001|NOT COMPLETED|Overall Study||0
6708902|NCT02927431|7639154|FG000|STARTED|Overall Study||2
6708903|NCT02927431|7639155|FG001|STARTED|Overall Study||4
6708904|NCT02927431|7639156|FG002|STARTED|Overall Study||4
6708905|NCT02927431|7639154|FG000|COMPLETED|Overall Study||2
6708906|NCT02927431|7639155|FG001|COMPLETED|Overall Study||4
6708907|NCT02927431|7639156|FG002|COMPLETED|Overall Study||3
6708908|NCT02927431|7639154|FG000|NOT COMPLETED|Overall Study||0
6708909|NCT02927431|7639155|FG001|NOT COMPLETED|Overall Study||0
6708910|NCT02927431|7639156|FG002|NOT COMPLETED|Overall Study||1
6708911|NCT02927457|7639168|FG000|STARTED|Overall Study||0
6708912|NCT02927457|7639169|FG001|STARTED|Overall Study||11
6708913|NCT02927457|7639168|FG000|COMPLETED|Overall Study||0
6708914|NCT02927457|7639169|FG001|COMPLETED|Overall Study||11
6708915|NCT02927457|7639168|FG000|NOT COMPLETED|Overall Study||0
6708916|NCT02927457|7639169|FG001|NOT COMPLETED|Overall Study||0
6708917|NCT02927639|7639181|FG000|STARTED|Overall Study||83
6708918|NCT02927639|7639182|FG001|STARTED|Overall Study|1 subj was inadvertently enrolled in another interventional study just before enrolling so removed.|82
6708919|NCT02927639|7639181|FG000|COMPLETED|Overall Study||10
6708920|NCT02927639|7639182|FG001|COMPLETED|Overall Study||13
6708921|NCT02927639|7639181|FG000|NOT COMPLETED|Overall Study||73
6708922|NCT02927639|7639182|FG001|NOT COMPLETED|Overall Study||69
6708923|NCT02927795|7639188|FG000|STARTED|Overall Study||257
6708924|NCT02927795|7639188|FG000|Treated|Overall Study||253
6708925|NCT02927795|7639188|FG000|COMPLETED|Overall Study||234
6708926|NCT02927795|7639188|FG000|NOT COMPLETED|Overall Study||23
6708927|NCT02927834|7639195|FG000|STARTED|Overall Study||8
6708928|NCT02927834|7639196|FG001|STARTED|Overall Study||8
6708929|NCT02927834|7639197|FG002|STARTED|Overall Study||8
6708930|NCT02927834|7639195|FG000|COMPLETED|Overall Study||7
6708931|NCT02927834|7639196|FG001|COMPLETED|Overall Study||6
6708932|NCT02927834|7639197|FG002|COMPLETED|Overall Study||6
6708933|NCT02927834|7639195|FG000|NOT COMPLETED|Overall Study||1
6708934|NCT02927834|7639196|FG001|NOT COMPLETED|Overall Study||2
6708935|NCT02927834|7639197|FG002|NOT COMPLETED|Overall Study||2
6708936|NCT02927873|7639211|FG000|STARTED|Overall Study||11
6708937|NCT02927873|7639212|FG001|STARTED|Overall Study||14
6708938|NCT02927873|7639213|FG002|STARTED|Overall Study||18
6708939|NCT02927873|7639214|FG003|STARTED|Overall Study||11
6708940|NCT02927873|7639215|FG004|STARTED|Overall Study||11
6708941|NCT02927873|7639216|FG005|STARTED|Overall Study||17
6708942|NCT02927873|7639211|FG000|COMPLETED|Overall Study||9
6708943|NCT02927873|7639212|FG001|COMPLETED|Overall Study||11
6708944|NCT02927873|7639213|FG002|COMPLETED|Overall Study||18
6708945|NCT02927873|7639214|FG003|COMPLETED|Overall Study||11
6708946|NCT02927873|7639215|FG004|COMPLETED|Overall Study||11
6708947|NCT02927873|7639216|FG005|COMPLETED|Overall Study||16
6708948|NCT02927873|7639211|FG000|NOT COMPLETED|Overall Study||2
6708949|NCT02927873|7639212|FG001|NOT COMPLETED|Overall Study||3
6708950|NCT02927873|7639213|FG002|NOT COMPLETED|Overall Study||0
6708951|NCT02927873|7639214|FG003|NOT COMPLETED|Overall Study||0
6708952|NCT02927873|7639215|FG004|NOT COMPLETED|Overall Study||0
6708953|NCT02927873|7639216|FG005|NOT COMPLETED|Overall Study||1
6708954|NCT02927925|7639230|FG000|STARTED|Overall Study||32
6708955|NCT02927925|7639230|FG000|COMPLETED|Overall Study||0
6708956|NCT02927925|7639230|FG000|NOT COMPLETED|Overall Study||32
6708957|NCT02928029|7639236|FG000|STARTED|Overall Study||3
6708958|NCT02928029|7639237|FG001|STARTED|Overall Study||4
6708959|NCT02928029|7639236|FG000|COMPLETED|Overall Study||0
6708960|NCT02928029|7639237|FG001|COMPLETED|Overall Study||0
6708961|NCT02928029|7639236|FG000|NOT COMPLETED|Overall Study||3
6708962|NCT02928029|7639237|FG001|NOT COMPLETED|Overall Study||4
6708963|NCT02928055|7639246|FG000|STARTED|Overall Study||8
6708964|NCT02928055|7639247|FG001|STARTED|Overall Study||8
6708965|NCT02928055|7639248|FG002|STARTED|Overall Study||7
6708966|NCT02928055|7639246|FG000|End of Treatment|Overall Study||8
6708967|NCT02928055|7639247|FG001|End of Treatment|Overall Study||8
6708968|NCT02928055|7639248|FG002|End of Treatment|Overall Study||6
6708969|NCT02928055|7639246|FG000|1 Month Follow up|Overall Study||7
6708970|NCT02928055|7639247|FG001|1 Month Follow up|Overall Study||7
6708971|NCT02928055|7639248|FG002|1 Month Follow up|Overall Study||6
6708972|NCT02928055|7639246|FG000|2 Month Follow up|Overall Study||6
6708973|NCT02928055|7639247|FG001|2 Month Follow up|Overall Study||7
6708974|NCT02928055|7639248|FG002|2 Month Follow up|Overall Study||5
6708975|NCT02928055|7639246|FG000|3 Month Follow up|Overall Study||5
6708976|NCT02928055|7639247|FG001|3 Month Follow up|Overall Study||6
6708977|NCT02928055|7639248|FG002|3 Month Follow up|Overall Study||5
6708978|NCT02928055|7639246|FG000|COMPLETED|Overall Study||5
6708979|NCT02928055|7639247|FG001|COMPLETED|Overall Study||6
6708980|NCT02928055|7639248|FG002|COMPLETED|Overall Study||5
6708981|NCT02928055|7639246|FG000|NOT COMPLETED|Overall Study||3
6708982|NCT02928055|7639247|FG001|NOT COMPLETED|Overall Study||2
6708983|NCT02928055|7639248|FG002|NOT COMPLETED|Overall Study||2
6708984|NCT02928380|7639256|FG000|STARTED|Period 1||13
6708985|NCT02928380|7639257|FG001|STARTED|Period 1||14
6708986|NCT02928380|7639258|FG002|STARTED|Period 1||14
6708987|NCT02928380|7639259|FG003|STARTED|Period 1||14
6708988|NCT02928380|7639260|FG004|STARTED|Period 1||14
6708989|NCT02928380|7639261|FG005|STARTED|Period 1||14
6708990|NCT02928380|7639256|FG000|COMPLETED|Period 1||13
6708991|NCT02928380|7639257|FG001|COMPLETED|Period 1||14
6708992|NCT02928380|7639258|FG002|COMPLETED|Period 1||14
6708993|NCT02928380|7639259|FG003|COMPLETED|Period 1||14
6708994|NCT02928380|7639260|FG004|COMPLETED|Period 1||14
6708995|NCT02928380|7639261|FG005|COMPLETED|Period 1||14
6708996|NCT02928380|7639256|FG000|NOT COMPLETED|Period 1||0
6708997|NCT02928380|7639257|FG001|NOT COMPLETED|Period 1||0
6708998|NCT02928380|7639258|FG002|NOT COMPLETED|Period 1||0
6708999|NCT02928380|7639259|FG003|NOT COMPLETED|Period 1||0
6709000|NCT02928380|7639260|FG004|NOT COMPLETED|Period 1||0
6709001|NCT02928380|7639261|FG005|NOT COMPLETED|Period 1||0
6709002|NCT02928380|7639256|FG000|STARTED|Wash Out Period 1||13
6709003|NCT02928380|7639257|FG001|STARTED|Wash Out Period 1||14
6709004|NCT02928380|7639258|FG002|STARTED|Wash Out Period 1||14
6709005|NCT02928380|7639259|FG003|STARTED|Wash Out Period 1||14
6709006|NCT02928380|7639260|FG004|STARTED|Wash Out Period 1||14
6709007|NCT02928380|7639261|FG005|STARTED|Wash Out Period 1||14
6709008|NCT02928380|7639256|FG000|COMPLETED|Wash Out Period 1||13
6709009|NCT02928380|7639257|FG001|COMPLETED|Wash Out Period 1||14
6709010|NCT02928380|7639258|FG002|COMPLETED|Wash Out Period 1||14
6709011|NCT02928380|7639259|FG003|COMPLETED|Wash Out Period 1||14
6709012|NCT02928380|7639260|FG004|COMPLETED|Wash Out Period 1||14
6709013|NCT02928380|7639261|FG005|COMPLETED|Wash Out Period 1||14
6709014|NCT02928380|7639256|FG000|NOT COMPLETED|Wash Out Period 1||0
6709015|NCT02928380|7639257|FG001|NOT COMPLETED|Wash Out Period 1||0
6709016|NCT02928380|7639258|FG002|NOT COMPLETED|Wash Out Period 1||0
6709017|NCT02928380|7639259|FG003|NOT COMPLETED|Wash Out Period 1||0
6709018|NCT02928380|7639260|FG004|NOT COMPLETED|Wash Out Period 1||0
6709019|NCT02928380|7639261|FG005|NOT COMPLETED|Wash Out Period 1||0
6709020|NCT02928380|7639256|FG000|STARTED|Period 2||13
6709021|NCT02928380|7639257|FG001|STARTED|Period 2||14
6709022|NCT02928380|7639258|FG002|STARTED|Period 2||14
6709023|NCT02928380|7639259|FG003|STARTED|Period 2||14
6709024|NCT02928380|7639260|FG004|STARTED|Period 2||14
6709025|NCT02928380|7639261|FG005|STARTED|Period 2||14
6709026|NCT02928380|7639256|FG000|COMPLETED|Period 2||13
6709027|NCT02928380|7639257|FG001|COMPLETED|Period 2||14
6709028|NCT02928380|7639258|FG002|COMPLETED|Period 2||14
6709029|NCT02928380|7639259|FG003|COMPLETED|Period 2||14
6709030|NCT02928380|7639260|FG004|COMPLETED|Period 2||14
6709031|NCT02928380|7639261|FG005|COMPLETED|Period 2||14
6709032|NCT02928380|7639256|FG000|NOT COMPLETED|Period 2||0
6709033|NCT02928380|7639257|FG001|NOT COMPLETED|Period 2||0
6709034|NCT02928380|7639258|FG002|NOT COMPLETED|Period 2||0
6709035|NCT02928380|7639259|FG003|NOT COMPLETED|Period 2||0
6709036|NCT02928380|7639260|FG004|NOT COMPLETED|Period 2||0
6709037|NCT02928380|7639261|FG005|NOT COMPLETED|Period 2||0
6709038|NCT02928380|7639256|FG000|STARTED|Wash Out Period 2||13
6709039|NCT02928380|7639257|FG001|STARTED|Wash Out Period 2||14
6709040|NCT02928380|7639258|FG002|STARTED|Wash Out Period 2||14
6709041|NCT02928380|7639259|FG003|STARTED|Wash Out Period 2||14
6709042|NCT02928380|7639260|FG004|STARTED|Wash Out Period 2||14
6709043|NCT02928380|7639261|FG005|STARTED|Wash Out Period 2||14
6709044|NCT02928380|7639256|FG000|COMPLETED|Wash Out Period 2||13
6709045|NCT02928380|7639257|FG001|COMPLETED|Wash Out Period 2||14
6709046|NCT02928380|7639258|FG002|COMPLETED|Wash Out Period 2||14
6709047|NCT02928380|7639259|FG003|COMPLETED|Wash Out Period 2||14
6709048|NCT02928380|7639260|FG004|COMPLETED|Wash Out Period 2||14
6709049|NCT02928380|7639261|FG005|COMPLETED|Wash Out Period 2||14
6709050|NCT02928380|7639256|FG000|NOT COMPLETED|Wash Out Period 2||0
6709051|NCT02928380|7639257|FG001|NOT COMPLETED|Wash Out Period 2||0
6709052|NCT02928380|7639258|FG002|NOT COMPLETED|Wash Out Period 2||0
6709053|NCT02928380|7639259|FG003|NOT COMPLETED|Wash Out Period 2||0
6709054|NCT02928380|7639260|FG004|NOT COMPLETED|Wash Out Period 2||0
6709055|NCT02928380|7639261|FG005|NOT COMPLETED|Wash Out Period 2||0
6709056|NCT02928380|7639256|FG000|STARTED|Period 3||13
6709057|NCT02928380|7639257|FG001|STARTED|Period 3||14
6709058|NCT02928380|7639258|FG002|STARTED|Period 3||14
6709059|NCT02928380|7639259|FG003|STARTED|Period 3||14
6709060|NCT02928380|7639260|FG004|STARTED|Period 3||14
6709061|NCT02928380|7639261|FG005|STARTED|Period 3||14
6709062|NCT02928380|7639256|FG000|COMPLETED|Period 3||13
6709063|NCT02928380|7639257|FG001|COMPLETED|Period 3||14
6709064|NCT02928380|7639258|FG002|COMPLETED|Period 3||14
6709065|NCT02928380|7639259|FG003|COMPLETED|Period 3||14
6709066|NCT02928380|7639260|FG004|COMPLETED|Period 3||14
6709067|NCT02928380|7639261|FG005|COMPLETED|Period 3||14
6709068|NCT02928380|7639256|FG000|NOT COMPLETED|Period 3||0
6709069|NCT02928380|7639257|FG001|NOT COMPLETED|Period 3||0
6709070|NCT02928380|7639258|FG002|NOT COMPLETED|Period 3||0
6709071|NCT02928380|7639259|FG003|NOT COMPLETED|Period 3||0
6709072|NCT02928380|7639260|FG004|NOT COMPLETED|Period 3||0
6709073|NCT02928380|7639261|FG005|NOT COMPLETED|Period 3||0
6709074|NCT02928536|7639272|FG000|STARTED|Overall Study||11902
6709075|NCT02928536|7639272|FG000|COMPLETED|Overall Study||11902
6709076|NCT02928536|7639272|FG000|NOT COMPLETED|Overall Study||0
6709077|NCT02928770|7639276|FG000|STARTED|Overall Study||32
6709078|NCT02928770|7639276|FG000|COMPLETED|Overall Study||30
6709079|NCT02928770|7639276|FG000|NOT COMPLETED|Overall Study||2
6709080|NCT02928848|7639282|FG000|STARTED|Arm 1||9
6709081|NCT02928848|7639283|FG001|STARTED|Arm 1||7
6709082|NCT02928848|7639282|FG000|COMPLETED|Arm 1||9
6709083|NCT02928848|7639283|FG001|COMPLETED|Arm 1||6
6709084|NCT02928848|7639282|FG000|NOT COMPLETED|Arm 1||0
6709085|NCT02928848|7639283|FG001|NOT COMPLETED|Arm 1||1
6709086|NCT02928848|7639282|FG000|STARTED|Arm 2||9
6709087|NCT02928848|7639283|FG001|STARTED|Arm 2||6
6709088|NCT02928848|7639282|FG000|COMPLETED|Arm 2||8
6709089|NCT02928848|7639283|FG001|COMPLETED|Arm 2||6
6709090|NCT02928848|7639282|FG000|NOT COMPLETED|Arm 2||1
6709091|NCT02928848|7639283|FG001|NOT COMPLETED|Arm 2||0
6709092|NCT02928952|7639293|FG000|STARTED|Overall Study||65
6709093|NCT02928952|7639294|FG001|STARTED|Overall Study||67
6709094|NCT02928952|7639293|FG000|COMPLETED|Overall Study||55
6709095|NCT02928952|7639294|FG001|COMPLETED|Overall Study||60
6709096|NCT02928952|7639293|FG000|NOT COMPLETED|Overall Study||10
6709097|NCT02928952|7639294|FG001|NOT COMPLETED|Overall Study||7
6709098|NCT02929329|7639302|FG000|STARTED|Overall Study||4112
6709099|NCT02929329|7639303|FG001|STARTED|Overall Study||4120
6709100|NCT02929329|7639302|FG000|Received Treatment|Overall Study||4101
6709101|NCT02929329|7639303|FG001|Received Treatment|Overall Study||4110
6739201|NCT03286751|7668062|FG001|COMPLETED|Washout Period 3||6
6709102|NCT02929329|7639302|FG000|COMPLETED|Overall Study|7 participants in this group who discontinued the study had unknown vital status at the end of study|3008
6709103|NCT02929329|7639303|FG001|COMPLETED|Overall Study|9 participants in this group who discontinued the study had unknown vital status at the end of study|3028
6709104|NCT02929329|7639302|FG000|NOT COMPLETED|Overall Study||1104
6709105|NCT02929329|7639303|FG001|NOT COMPLETED|Overall Study||1092
6709106|NCT02929407|7639313|FG000|STARTED|Overall Study||4
6709107|NCT02929407|7639313|FG000|COMPLETED|Overall Study||3
6709108|NCT02929407|7639313|FG000|NOT COMPLETED|Overall Study||1
6709109|NCT02929498|7639320|FG000|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||5
6709110|NCT02929498|7639321|FG001|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
6709111|NCT02929498|7639322|FG002|STARTED|Part 1: Dose Confirmation (Upto 2 Years)||0
6709112|NCT02929498|7639320|FG000|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6709113|NCT02929498|7639321|FG001|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6709114|NCT02929498|7639322|FG002|COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6709115|NCT02929498|7639320|FG000|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||5
6709116|NCT02929498|7639321|FG001|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6709117|NCT02929498|7639322|FG002|NOT COMPLETED|Part 1: Dose Confirmation (Upto 2 Years)||0
6709118|NCT02929498|7639320|FG000|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709119|NCT02929498|7639321|FG001|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709120|NCT02929498|7639322|FG002|STARTED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709121|NCT02929498|7639320|FG000|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709122|NCT02929498|7639321|FG001|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709123|NCT02929498|7639322|FG002|COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709124|NCT02929498|7639320|FG000|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709125|NCT02929498|7639321|FG001|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709126|NCT02929498|7639322|FG002|NOT COMPLETED|Part 2 : Dose Expansion (Upto 2.5 Years)||0
6709127|NCT02929667|7639330|FG000|STARTED|Overall Study||11
6709128|NCT02929667|7639331|FG001|STARTED|Overall Study||11
6709129|NCT02929667|7639330|FG000|COMPLETED|Overall Study||11
6709130|NCT02929667|7639331|FG001|COMPLETED|Overall Study||11
6709131|NCT02929667|7639330|FG000|NOT COMPLETED|Overall Study||0
6709132|NCT02929667|7639331|FG001|NOT COMPLETED|Overall Study||0
6709133|NCT02929823|7639342|FG000|STARTED|Overall Study||42
6709134|NCT02929823|7639343|FG001|STARTED|Overall Study||46
6709135|NCT02929823|7639344|FG002|STARTED|Overall Study||42
6709136|NCT02929823|7639342|FG000|COMPLETED|Overall Study||39
6709137|NCT02929823|7639343|FG001|COMPLETED|Overall Study||40
6709138|NCT02929823|7639344|FG002|COMPLETED|Overall Study||38
6709139|NCT02929823|7639342|FG000|NOT COMPLETED|Overall Study||3
6709140|NCT02929823|7639343|FG001|NOT COMPLETED|Overall Study||6
6709141|NCT02929823|7639344|FG002|NOT COMPLETED|Overall Study||4
6709142|NCT02929979|7639354|FG000|STARTED|Overall Study||52
6709143|NCT02929979|7639355|FG001|STARTED|Overall Study||38
6709144|NCT02929979|7639354|FG000|COMPLETED|Overall Study||25
6709145|NCT02929979|7639355|FG001|COMPLETED|Overall Study||28
6709146|NCT02929979|7639354|FG000|NOT COMPLETED|Overall Study||27
6709147|NCT02929979|7639355|FG001|NOT COMPLETED|Overall Study||10
6709148|NCT02930005|7639364|FG000|STARTED|Overall Study||2
6709149|NCT02930005|7639365|FG001|STARTED|Overall Study||6
6709150|NCT02930005|7639364|FG000|Completed 2 Weeks|Overall Study||2
6709151|NCT02930005|7639365|FG001|Completed 2 Weeks|Overall Study||2
6709152|NCT02930005|7639364|FG000|COMPLETED|Overall Study||1
6709153|NCT02930005|7639365|FG001|COMPLETED|Overall Study||1
6709154|NCT02930005|7639364|FG000|NOT COMPLETED|Overall Study||1
6709155|NCT02930005|7639365|FG001|NOT COMPLETED|Overall Study||5
6709156|NCT02930018|7639373|FG000|STARTED|Overall Study||556
6709157|NCT02930018|7639374|FG001|STARTED|Overall Study||549
6709158|NCT02930018|7639373|FG000|COMPLETED|Overall Study||550
6709159|NCT02930018|7639374|FG001|COMPLETED|Overall Study||546
6709160|NCT02930018|7639373|FG000|NOT COMPLETED|Overall Study||6
6709161|NCT02930018|7639374|FG001|NOT COMPLETED|Overall Study||3
6709162|NCT02930174|7639382|FG000|STARTED|Overall Study||12
6709163|NCT02930174|7639383|FG001|STARTED|Overall Study||8
6709164|NCT02930174|7639382|FG000|COMPLETED|Overall Study||12
6709165|NCT02930174|7639383|FG001|COMPLETED|Overall Study||8
6709166|NCT02930174|7639382|FG000|NOT COMPLETED|Overall Study||0
6709167|NCT02930174|7639383|FG001|NOT COMPLETED|Overall Study||0
6709168|NCT02930226|7639397|FG000|STARTED|Overall Study||4
6709169|NCT02930226|7639398|FG001|STARTED|Overall Study||4
6709170|NCT02930226|7639399|FG002|STARTED|Overall Study||4
6709171|NCT02930226|7639400|FG003|STARTED|Overall Study||4
6709172|NCT02930226|7639401|FG004|STARTED|Overall Study||4
6709173|NCT02930226|7639402|FG005|STARTED|Overall Study||4
6709174|NCT02930226|7639397|FG000|COMPLETED|Overall Study||4
6709175|NCT02930226|7639398|FG001|COMPLETED|Overall Study||4
6709176|NCT02930226|7639399|FG002|COMPLETED|Overall Study||4
6709177|NCT02930226|7639400|FG003|COMPLETED|Overall Study||4
6709178|NCT02930226|7639401|FG004|COMPLETED|Overall Study||3
6709179|NCT02930226|7639402|FG005|COMPLETED|Overall Study||4
6709180|NCT02930226|7639397|FG000|NOT COMPLETED|Overall Study||0
6709181|NCT02930226|7639398|FG001|NOT COMPLETED|Overall Study||0
6709182|NCT02930226|7639399|FG002|NOT COMPLETED|Overall Study||0
6709183|NCT02930226|7639400|FG003|NOT COMPLETED|Overall Study||0
6709184|NCT02930226|7639401|FG004|NOT COMPLETED|Overall Study||1
6709185|NCT02930226|7639402|FG005|NOT COMPLETED|Overall Study||0
6709186|NCT02930343|7639420|FG000|STARTED|Overall Study||68
6709187|NCT02930343|7639421|FG001|STARTED|Overall Study||68
6709188|NCT02930343|7639420|FG000|COMPLETED|Overall Study||59
6709189|NCT02930343|7639421|FG001|COMPLETED|Overall Study||61
6709190|NCT02930343|7639420|FG000|NOT COMPLETED|Overall Study||9
6709191|NCT02930343|7639421|FG001|NOT COMPLETED|Overall Study||7
6709192|NCT02930590|7639427|FG000|STARTED|First Intervention (2 Hours)||3
6709193|NCT02930590|7639428|FG001|STARTED|First Intervention (2 Hours)||3
6709194|NCT02930590|7639429|FG002|STARTED|First Intervention (2 Hours)||3
6709195|NCT02930590|7639430|FG003|STARTED|First Intervention (2 Hours)||2
6709196|NCT02930590|7639431|FG004|STARTED|First Intervention (2 Hours)||2
6709197|NCT02930590|7639432|FG005|STARTED|First Intervention (2 Hours)||2
6709198|NCT02930590|7639427|FG000|COMPLETED|First Intervention (2 Hours)||3
6709199|NCT02930590|7639428|FG001|COMPLETED|First Intervention (2 Hours)||3
6709200|NCT02930590|7639429|FG002|COMPLETED|First Intervention (2 Hours)||3
6709201|NCT02930590|7639430|FG003|COMPLETED|First Intervention (2 Hours)||2
6709202|NCT02930590|7639431|FG004|COMPLETED|First Intervention (2 Hours)||2
6709203|NCT02930590|7639432|FG005|COMPLETED|First Intervention (2 Hours)||2
6709204|NCT02930590|7639427|FG000|NOT COMPLETED|First Intervention (2 Hours)||0
6709205|NCT02930590|7639428|FG001|NOT COMPLETED|First Intervention (2 Hours)||0
6709206|NCT02930590|7639429|FG002|NOT COMPLETED|First Intervention (2 Hours)||0
6709207|NCT02930590|7639430|FG003|NOT COMPLETED|First Intervention (2 Hours)||0
6709208|NCT02930590|7639431|FG004|NOT COMPLETED|First Intervention (2 Hours)||0
6709209|NCT02930590|7639432|FG005|NOT COMPLETED|First Intervention (2 Hours)||0
6709210|NCT02930590|7639427|FG000|STARTED|Second Intervention (2 Hours)||3
6709211|NCT02930590|7639428|FG001|STARTED|Second Intervention (2 Hours)||3
6709212|NCT02930590|7639429|FG002|STARTED|Second Intervention (2 Hours)||3
6709213|NCT02930590|7639430|FG003|STARTED|Second Intervention (2 Hours)||2
6709214|NCT02930590|7639431|FG004|STARTED|Second Intervention (2 Hours)||2
6709215|NCT02930590|7639432|FG005|STARTED|Second Intervention (2 Hours)||2
6709216|NCT02930590|7639427|FG000|COMPLETED|Second Intervention (2 Hours)||3
6709217|NCT02930590|7639428|FG001|COMPLETED|Second Intervention (2 Hours)||3
6709218|NCT02930590|7639429|FG002|COMPLETED|Second Intervention (2 Hours)||3
6709219|NCT02930590|7639430|FG003|COMPLETED|Second Intervention (2 Hours)||2
6709220|NCT02930590|7639431|FG004|COMPLETED|Second Intervention (2 Hours)||2
6709221|NCT02930590|7639432|FG005|COMPLETED|Second Intervention (2 Hours)||2
6709222|NCT02930590|7639427|FG000|NOT COMPLETED|Second Intervention (2 Hours)||0
6709223|NCT02930590|7639428|FG001|NOT COMPLETED|Second Intervention (2 Hours)||0
6709224|NCT02930590|7639429|FG002|NOT COMPLETED|Second Intervention (2 Hours)||0
6709225|NCT02930590|7639430|FG003|NOT COMPLETED|Second Intervention (2 Hours)||0
6709226|NCT02930590|7639431|FG004|NOT COMPLETED|Second Intervention (2 Hours)||0
6709227|NCT02930590|7639432|FG005|NOT COMPLETED|Second Intervention (2 Hours)||0
6709228|NCT02930590|7639427|FG000|STARTED|Third Intervention (2 Hours)||3
6709229|NCT02930590|7639428|FG001|STARTED|Third Intervention (2 Hours)||3
6709230|NCT02930590|7639429|FG002|STARTED|Third Intervention (2 Hours)||3
6709231|NCT02930590|7639430|FG003|STARTED|Third Intervention (2 Hours)||2
6709232|NCT02930590|7639431|FG004|STARTED|Third Intervention (2 Hours)||2
6709233|NCT02930590|7639432|FG005|STARTED|Third Intervention (2 Hours)||2
6709234|NCT02930590|7639427|FG000|COMPLETED|Third Intervention (2 Hours)||3
6709235|NCT02930590|7639428|FG001|COMPLETED|Third Intervention (2 Hours)||3
6709236|NCT02930590|7639429|FG002|COMPLETED|Third Intervention (2 Hours)||3
6709237|NCT02930590|7639430|FG003|COMPLETED|Third Intervention (2 Hours)||2
6709238|NCT02930590|7639431|FG004|COMPLETED|Third Intervention (2 Hours)||2
6709239|NCT02930590|7639432|FG005|COMPLETED|Third Intervention (2 Hours)||2
6709240|NCT02930590|7639427|FG000|NOT COMPLETED|Third Intervention (2 Hours)||0
6709241|NCT02930590|7639428|FG001|NOT COMPLETED|Third Intervention (2 Hours)||0
6709242|NCT02930590|7639429|FG002|NOT COMPLETED|Third Intervention (2 Hours)||0
6709243|NCT02930590|7639430|FG003|NOT COMPLETED|Third Intervention (2 Hours)||0
6709244|NCT02930590|7639431|FG004|NOT COMPLETED|Third Intervention (2 Hours)||0
6709245|NCT02930590|7639432|FG005|NOT COMPLETED|Third Intervention (2 Hours)||0
6709246|NCT02930824|7639446|FG000|STARTED|Overall Study||62
6709247|NCT02930824|7639447|FG001|STARTED|Overall Study||63
6709248|NCT02930824|7639448|FG002|STARTED|Overall Study||30
6709249|NCT02930824|7639449|FG003|STARTED|Overall Study||30
6709250|NCT02930824|7639446|FG000|COMPLETED|Overall Study||56
6709251|NCT02930824|7639447|FG001|COMPLETED|Overall Study||57
6709252|NCT02930824|7639448|FG002|COMPLETED|Overall Study||20
6709253|NCT02930824|7639449|FG003|COMPLETED|Overall Study||23
6709254|NCT02930824|7639446|FG000|NOT COMPLETED|Overall Study||6
6709255|NCT02930824|7639447|FG001|NOT COMPLETED|Overall Study||6
6602694|NCT02058160|7527731|FG001|COMPLETED|Overall Study||355
6602695|NCT02058160|7527730|FG000|NOT COMPLETED|Overall Study||31
6602696|NCT02058160|7527731|FG001|NOT COMPLETED|Overall Study||14
6602697|NCT02058251|7527739|FG000|STARTED|Overall Study||35
6602698|NCT02058251|7527740|FG001|STARTED|Overall Study||38
6602699|NCT02058251|7527739|FG000|COMPLETED|Overall Study||35
6602700|NCT02058251|7527740|FG001|COMPLETED|Overall Study||38
6602701|NCT02058251|7527739|FG000|NOT COMPLETED|Overall Study||0
6602702|NCT02058251|7527740|FG001|NOT COMPLETED|Overall Study||0
6602703|NCT02058290|7527748|FG000|STARTED|Overall Study||77
6602704|NCT02058290|7527749|FG001|STARTED|Overall Study||45
6602705|NCT02058290|7527748|FG000|COMPLETED|Overall Study||66
6602706|NCT02058290|7527749|FG001|COMPLETED|Overall Study||36
6602707|NCT02058290|7527748|FG000|NOT COMPLETED|Overall Study||11
6709256|NCT02930824|7639448|FG002|NOT COMPLETED|Overall Study||10
6709257|NCT02930824|7639449|FG003|NOT COMPLETED|Overall Study||7
6709258|NCT02930837|7639465|FG000|STARTED|Overall Study|Started are treated patients|120
6709259|NCT02930837|7639465|FG000|COMPLETED|Overall Study|Completed the trial|108
6709260|NCT02930837|7639465|FG000|NOT COMPLETED|Overall Study||12
6709261|NCT02930941|7639471|FG000|STARTED|Overall Study||17
6709262|NCT02930941|7639472|FG001|STARTED|Overall Study||18
6709263|NCT02930941|7639471|FG000|COMPLETED|Overall Study||16
6709264|NCT02930941|7639472|FG001|COMPLETED|Overall Study||16
6709265|NCT02930941|7639471|FG000|NOT COMPLETED|Overall Study||1
6709266|NCT02930941|7639472|FG001|NOT COMPLETED|Overall Study||2
6709267|NCT02930980|7639482|FG000|STARTED|Overall Study||43
6709268|NCT02930980|7639482|FG000|COMPLETED|Overall Study||43
6709269|NCT02930980|7639482|FG000|NOT COMPLETED|Overall Study||0
6709270|NCT02931045|7639488|FG000|STARTED|Overall Study||30
6709271|NCT02931045|7639489|FG001|STARTED|Overall Study||30
6709272|NCT02931045|7639488|FG000|COMPLETED|Overall Study||27
6709273|NCT02931045|7639489|FG001|COMPLETED|Overall Study||28
6261730|NCT03503474|7160609|FG000|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a positive test result at the coordinating laboratory. There is no intervention as this is an observational study only.|103
6261731|NCT03503474|7160610|FG001|STARTED|Overall Study|The number of participant with a diarrhoeal sample that returned a negative test result at the coordinating laboratory. There is no intervention as this is an observational study only.|3050
6261732|NCT03503474|7160609|FG000|COMPLETED|Overall Study||103
6261733|NCT03503474|7160610|FG001|COMPLETED|Overall Study||3050
6261734|NCT03503474|7160609|FG000|NOT COMPLETED|Overall Study||0
6261735|NCT03503474|7160610|FG001|NOT COMPLETED|Overall Study||0
6261736|NCT03476317|7160619|FG000|STARTED|Overall Study|Group 1 study was not completed|0
6261737|NCT03476317|7160620|FG001|STARTED|Overall Study|Group 1 study was not completed|0
6261738|NCT03476317|7160621|FG002|STARTED|Overall Study||10
6261739|NCT03476317|7160619|FG000|COMPLETED|Overall Study|Group 1 study was not completed|0
6261740|NCT03476317|7160620|FG001|COMPLETED|Overall Study|Group 1 study was not completed|0
6261741|NCT03476317|7160621|FG002|COMPLETED|Overall Study||10
6261742|NCT03476317|7160619|FG000|NOT COMPLETED|Overall Study||0
6261743|NCT03476317|7160620|FG001|NOT COMPLETED|Overall Study||0
6261744|NCT03476317|7160621|FG002|NOT COMPLETED|Overall Study||0
6261745|NCT03391960|7160629|FG000|STARTED|Overall Study|Units were not assessed for this Arm/Group. Data was collected from the health care worker surveys for the retrospective study to monitor compliance with the scrub-the-hub protocol (signed informed consent and were enrolled)|165
6261746|NCT03391960|7160630|FG001|STARTED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
6261747|NCT03391960|7160629|FG000|COMPLETED|Overall Study||165
6261748|NCT03391960|7160630|FG001|COMPLETED|Overall Study|No individual patient was recruited into the study. Data was collected from the compliance audits to monitor compliance with the disinfecting barrier cap protocol.|
6261749|NCT03391960|7160629|FG000|NOT COMPLETED|Overall Study||0
6261750|NCT03391960|7160630|FG001|NOT COMPLETED|Overall Study||
6261751|NCT03362190|7160649|FG000|STARTED|Overall Study||10
6261752|NCT03362190|7160650|FG001|STARTED|Overall Study||10
6261753|NCT03362190|7160651|FG002|STARTED|Overall Study||22
6261754|NCT03362190|7160652|FG003|STARTED|Overall Study||22
6261755|NCT03362190|7160649|FG000|COMPLETED|Overall Study||10
6261756|NCT03362190|7160650|FG001|COMPLETED|Overall Study||10
6261757|NCT03362190|7160651|FG002|COMPLETED|Overall Study||22
6261758|NCT03362190|7160652|FG003|COMPLETED|Overall Study||20
6261759|NCT03362190|7160649|FG000|NOT COMPLETED|Overall Study||0
6261760|NCT03362190|7160650|FG001|NOT COMPLETED|Overall Study||0
6261761|NCT03362190|7160651|FG002|NOT COMPLETED|Overall Study||0
6261762|NCT03362190|7160652|FG003|NOT COMPLETED|Overall Study||2
6261763|NCT03338790|7160669|FG000|STARTED|Overall Study||88
6261764|NCT03338790|7160670|FG001|STARTED|Overall Study||71
6261765|NCT03338790|7160671|FG002|STARTED|Overall Study||84
6261766|NCT03338790|7160672|FG003|STARTED|Overall Study||49
6261767|NCT03338790|7160669|FG000|COMPLETED|Overall Study||4
6261768|NCT03338790|7160670|FG001|COMPLETED|Overall Study||4
6261769|NCT03338790|7160671|FG002|COMPLETED|Overall Study||8
6261770|NCT03338790|7160672|FG003|COMPLETED|Overall Study||4
6261771|NCT03338790|7160669|FG000|NOT COMPLETED|Overall Study||84
6261772|NCT03338790|7160670|FG001|NOT COMPLETED|Overall Study||67
6261773|NCT03338790|7160671|FG002|NOT COMPLETED|Overall Study||76
6261774|NCT03338790|7160672|FG003|NOT COMPLETED|Overall Study||45
6280369|NCT00154102|7180285|FG000|COMPLETED|Overall Study||592
6280370|NCT00154102|7180286|FG001|COMPLETED|Overall Study||597
6280371|NCT00154102|7180285|FG000|NOT COMPLETED|Overall Study||7
6280372|NCT00154102|7180286|FG001|NOT COMPLETED|Overall Study||2
6280373|NCT00154284|7180294|FG000|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
6280374|NCT00154284|7180295|FG001|STARTED|Overall Study||55
6280375|NCT00154284|7180294|FG000|Intent to Treat (ITT) Population|Overall Study||57
6280376|NCT00154284|7180295|FG001|Intent to Treat (ITT) Population|Overall Study||53
6280377|NCT00154284|7180294|FG000|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
6280378|NCT00154284|7180295|FG001|COMPLETED|Overall Study||42
6280379|NCT00154284|7180294|FG000|NOT COMPLETED|Overall Study||7
6709274|NCT02931045|7639488|FG000|NOT COMPLETED|Overall Study||3
6280380|NCT00154284|7180295|FG001|NOT COMPLETED|Overall Study||13
6709275|NCT02931045|7639489|FG001|NOT COMPLETED|Overall Study||2
6709276|NCT02931253|7639497|FG000|STARTED|Overall Study||2
6709277|NCT02931253|7639498|FG001|STARTED|Overall Study||4
6709278|NCT02931253|7639497|FG000|COMPLETED|Overall Study||2
6709279|NCT02931253|7639498|FG001|COMPLETED|Overall Study||4
6709280|NCT02931253|7639497|FG000|NOT COMPLETED|Overall Study||0
6709281|NCT02931253|7639498|FG001|NOT COMPLETED|Overall Study||0
6709282|NCT02931396|7639506|FG000|STARTED|Overall Study||10
6709283|NCT02931396|7639507|FG001|STARTED|Overall Study||10
6709284|NCT02931396|7639506|FG000|COMPLETED|Overall Study||5
6709285|NCT02931396|7639507|FG001|COMPLETED|Overall Study||10
6709286|NCT02931396|7639506|FG000|NOT COMPLETED|Overall Study||5
6709287|NCT02931396|7639507|FG001|NOT COMPLETED|Overall Study||0
6709288|NCT02931539|7639515|FG000|STARTED|Period 1: Treatment Phase||117
6709289|NCT02931539|7639516|FG001|STARTED|Period 1: Treatment Phase||235
6709290|NCT02931539|7639517|FG002|STARTED|Period 1: Treatment Phase||0
6709291|NCT02931539|7639515|FG000|Treated Participants|Period 1: Treatment Phase||116
6709292|NCT02931539|7639516|FG001|Treated Participants|Period 1: Treatment Phase||234
6709293|NCT02931539|7639517|FG002|Treated Participants|Period 1: Treatment Phase||0
6709294|NCT02931539|7639515|FG000|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||56
6709295|NCT02931539|7639516|FG001|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
6709296|NCT02931539|7639517|FG002|IAT (Ganciclovir/ Valganciclovir)|Period 1: Treatment Phase||0
6709297|NCT02931539|7639515|FG000|IAT (Foscarnet)|Period 1: Treatment Phase||47
6709298|NCT02931539|7639516|FG001|IAT (Foscarnet)|Period 1: Treatment Phase||0
6709299|NCT02931539|7639517|FG002|IAT (Foscarnet)|Period 1: Treatment Phase||0
6709300|NCT02931539|7639515|FG000|IAT (Cidofovir)|Period 1: Treatment Phase||6
6709301|NCT02931539|7639516|FG001|IAT (Cidofovir)|Period 1: Treatment Phase||0
6709302|NCT02931539|7639517|FG002|IAT (Cidofovir)|Period 1: Treatment Phase||0
6709303|NCT02931539|7639515|FG000|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||7
6709304|NCT02931539|7639516|FG001|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
6709305|NCT02931539|7639517|FG002|IAT (Foscarnet + Valganciclovir/Ganciclovir)|Period 1: Treatment Phase||0
6709306|NCT02931539|7639515|FG000|COMPLETED|Period 1: Treatment Phase||58
6709307|NCT02931539|7639516|FG001|COMPLETED|Period 1: Treatment Phase||199
6709308|NCT02931539|7639517|FG002|COMPLETED|Period 1: Treatment Phase||0
6709309|NCT02931539|7639515|FG000|NOT COMPLETED|Period 1: Treatment Phase||59
6709310|NCT02931539|7639516|FG001|NOT COMPLETED|Period 1: Treatment Phase||36
6709311|NCT02931539|7639517|FG002|NOT COMPLETED|Period 1: Treatment Phase||0
6709312|NCT02931539|7639515|FG000|STARTED|Period 2: Maribavir Rescue Therapy||0
6709313|NCT02931539|7639516|FG001|STARTED|Period 2: Maribavir Rescue Therapy||0
6709314|NCT02931539|7639517|FG002|STARTED|Period 2: Maribavir Rescue Therapy||22
6709315|NCT02931539|7639515|FG000|COMPLETED|Period 2: Maribavir Rescue Therapy||0
6709316|NCT02931539|7639516|FG001|COMPLETED|Period 2: Maribavir Rescue Therapy||0
6709317|NCT02931539|7639517|FG002|COMPLETED|Period 2: Maribavir Rescue Therapy||20
6709318|NCT02931539|7639515|FG000|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
6709319|NCT02931539|7639516|FG001|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||0
6709320|NCT02931539|7639517|FG002|NOT COMPLETED|Period 2: Maribavir Rescue Therapy||2
6709321|NCT02931565|7639532|FG000|STARTED|Overall Study||2
6709322|NCT02931565|7639533|FG001|STARTED|Overall Study||7
6709323|NCT02931565|7639532|FG000|COMPLETED|Overall Study||2
6709324|NCT02931565|7639533|FG001|COMPLETED|Overall Study||7
6709325|NCT02931565|7639532|FG000|NOT COMPLETED|Overall Study||0
6709326|NCT02931565|7639533|FG001|NOT COMPLETED|Overall Study||0
6709327|NCT02931838|7639546|FG000|STARTED|Overall Study||45
6709328|NCT02931838|7639547|FG001|STARTED|Overall Study||44
6709329|NCT02931838|7639548|FG002|STARTED|Overall Study||44
6709330|NCT02931838|7639549|FG003|STARTED|Overall Study||45
6709331|NCT02931838|7639550|FG004|STARTED|Overall Study||45
6709332|NCT02931838|7639551|FG005|STARTED|Overall Study||44
6709333|NCT02931838|7639546|FG000|COMPLETED|Overall Study||31
6709334|NCT02931838|7639547|FG001|COMPLETED|Overall Study||34
6709335|NCT02931838|7639548|FG002|COMPLETED|Overall Study||36
6709336|NCT02931838|7639549|FG003|COMPLETED|Overall Study||42
6709337|NCT02931838|7639550|FG004|COMPLETED|Overall Study||39
6709338|NCT02931838|7639551|FG005|COMPLETED|Overall Study||42
6709339|NCT02931838|7639546|FG000|NOT COMPLETED|Overall Study||14
6709340|NCT02931838|7639547|FG001|NOT COMPLETED|Overall Study||10
6709341|NCT02931838|7639548|FG002|NOT COMPLETED|Overall Study||8
6709342|NCT02931838|7639549|FG003|NOT COMPLETED|Overall Study||3
6709343|NCT02931838|7639550|FG004|NOT COMPLETED|Overall Study||6
6709344|NCT02931838|7639551|FG005|NOT COMPLETED|Overall Study||2
6709345|NCT02932228|7639572|FG000|STARTED|Overall Study||150
6709346|NCT02932228|7639573|FG001|STARTED|Overall Study||433
6709347|NCT02932228|7639572|FG000|COMPLETED|Overall Study||140
6709348|NCT02932228|7639573|FG001|COMPLETED|Overall Study||405
6709349|NCT02932228|7639572|FG000|NOT COMPLETED|Overall Study||10
6709350|NCT02932228|7639573|FG001|NOT COMPLETED|Overall Study||28
6709351|NCT02932267|7639581|FG000|STARTED|Overall Study||50
6709352|NCT02932267|7639581|FG000|COMPLETED|Overall Study||42
6709353|NCT02932267|7639581|FG000|NOT COMPLETED|Overall Study||8
6709354|NCT02932306|7639587|FG000|STARTED|Overall Study||406
6709355|NCT02932306|7639588|FG001|STARTED|Overall Study||414
6709356|NCT02932306|7639587|FG000|Intent-to-treat (ITT) Population|Overall Study||406
6709357|NCT02932306|7639588|FG001|Intent-to-treat (ITT) Population|Overall Study||414
6709358|NCT02932306|7639587|FG000|Safety Population|Overall Study||378
6709359|NCT02932306|7639588|FG001|Safety Population|Overall Study||385
6709360|NCT02932306|7639587|FG000|COMPLETED|Overall Study||338
6709361|NCT02932306|7639588|FG001|COMPLETED|Overall Study||337
6709362|NCT02932306|7639587|FG000|NOT COMPLETED|Overall Study||68
6709363|NCT02932306|7639588|FG001|NOT COMPLETED|Overall Study||77
6709364|NCT02932462|7639596|FG000|STARTED|Overall Study||184
6709365|NCT02932462|7639597|FG001|STARTED|Overall Study||189
6709366|NCT02932462|7639596|FG000|COMPLETED|Overall Study||177
6709367|NCT02932462|7639597|FG001|COMPLETED|Overall Study||176
6709368|NCT02932462|7639596|FG000|NOT COMPLETED|Overall Study||7
6709369|NCT02932462|7639597|FG001|NOT COMPLETED|Overall Study||13
6709370|NCT02932787|7639605|FG000|STARTED|Overall Study||22
6709371|NCT02932787|7639606|FG001|STARTED|Overall Study||9
6709372|NCT02932787|7639605|FG000|COMPLETED|Overall Study||22
6709373|NCT02932787|7639606|FG001|COMPLETED|Overall Study||9
6709374|NCT02932787|7639605|FG000|NOT COMPLETED|Overall Study||0
6709375|NCT02932787|7639606|FG001|NOT COMPLETED|Overall Study||0
6709376|NCT02932878|7639617|FG000|STARTED|Overall Study||15
6709377|NCT02932878|7639618|FG001|STARTED|Overall Study||1
6709378|NCT02932878|7639617|FG000|COMPLETED|Overall Study||13
6709379|NCT02932878|7639618|FG001|COMPLETED|Overall Study||0
6709380|NCT02932878|7639617|FG000|NOT COMPLETED|Overall Study||2
6709381|NCT02932878|7639618|FG001|NOT COMPLETED|Overall Study||1
6709382|NCT02932891|7639624|FG000|STARTED|Overall Study||28
6709383|NCT02932891|7639624|FG000|COMPLETED|Overall Study||24
6709384|NCT02932891|7639624|FG000|NOT COMPLETED|Overall Study||4
6709385|NCT02932904|7639632|FG000|STARTED|Overall Study||92
6709386|NCT02932904|7639633|FG001|STARTED|Overall Study||85
6709387|NCT02932904|7639634|FG002|STARTED|Overall Study||91
6709388|NCT02932904|7639635|FG003|STARTED|Overall Study||93
6709389|NCT02932904|7639632|FG000|Treated|Overall Study||91
6709390|NCT02932904|7639633|FG001|Treated|Overall Study||84
6709391|NCT02932904|7639634|FG002|Treated|Overall Study||91
6709392|NCT02932904|7639635|FG003|Treated|Overall Study||91
6709393|NCT02932904|7639632|FG000|COMPLETED|Overall Study||76
6709394|NCT02932904|7639633|FG001|COMPLETED|Overall Study||67
6709395|NCT02932904|7639634|FG002|COMPLETED|Overall Study||68
6709396|NCT02932904|7639635|FG003|COMPLETED|Overall Study||79
6709397|NCT02932904|7639632|FG000|NOT COMPLETED|Overall Study||16
6709398|NCT02932904|7639633|FG001|NOT COMPLETED|Overall Study||18
6709399|NCT02932904|7639634|FG002|NOT COMPLETED|Overall Study||23
6709400|NCT02932904|7639635|FG003|NOT COMPLETED|Overall Study||14
6709401|NCT02932943|7639650|FG000|STARTED|Overall Study||227
6709402|NCT02932943|7639651|FG001|STARTED|Overall Study||231
6709403|NCT02932943|7639650|FG000|COMPLETED|Overall Study||222
6709404|NCT02932943|7639651|FG001|COMPLETED|Overall Study||224
6709405|NCT02932943|7639650|FG000|NOT COMPLETED|Overall Study||5
6709406|NCT02932943|7639651|FG001|NOT COMPLETED|Overall Study||7
6709407|NCT02933034|7639657|FG000|STARTED|Overall Study||33
6709408|NCT02933034|7639657|FG000|Received Both MEMRI and DEMRI Scans|Overall Study||24
6709409|NCT02933034|7639657|FG000|COMPLETED|Overall Study||24
6709410|NCT02933034|7639657|FG000|NOT COMPLETED|Overall Study||9
6709411|NCT02933060|7639663|FG000|STARTED|Overall Study||25
6709412|NCT02933060|7639664|FG001|STARTED|Overall Study||25
6709413|NCT02933060|7639663|FG000|COMPLETED|Overall Study||25
6709414|NCT02933060|7639664|FG001|COMPLETED|Overall Study||24
6709415|NCT02933060|7639663|FG000|NOT COMPLETED|Overall Study||0
6709416|NCT02933060|7639664|FG001|NOT COMPLETED|Overall Study||1
6709417|NCT02933320|7639674|FG000|STARTED|Overall Study||13
6709418|NCT02933320|7639675|FG001|STARTED|Overall Study||1
6709419|NCT02933320|7639676|FG002|STARTED|Overall Study|Trial terminated early|0
6709420|NCT02933320|7639677|FG003|STARTED|Overall Study|Trial terminated early|0
6709421|NCT02933320|7639674|FG000|COMPLETED|Overall Study||13
6709422|NCT02933320|7639675|FG001|COMPLETED|Overall Study||1
6709423|NCT02933320|7639676|FG002|COMPLETED|Overall Study||0
6709424|NCT02933320|7639677|FG003|COMPLETED|Overall Study||0
6709425|NCT02933320|7639674|FG000|NOT COMPLETED|Overall Study||0
6709426|NCT02933320|7639675|FG001|NOT COMPLETED|Overall Study||0
6709427|NCT02933320|7639676|FG002|NOT COMPLETED|Overall Study||0
6709428|NCT02933320|7639677|FG003|NOT COMPLETED|Overall Study||0
6709429|NCT02933372|7639689|FG000|STARTED|Overall Study||15
6709430|NCT02933372|7639690|FG001|STARTED|Overall Study||10
6709431|NCT02933372|7639689|FG000|COMPLETED|Overall Study||15
6709432|NCT02933372|7639690|FG001|COMPLETED|Overall Study||10
6709433|NCT02933372|7639689|FG000|NOT COMPLETED|Overall Study||0
6709434|NCT02933372|7639690|FG001|NOT COMPLETED|Overall Study||0
6709435|NCT02933450|7639698|FG000|STARTED|Overall Study||20
6709436|NCT02933450|7639699|FG001|STARTED|Overall Study||23
6709437|NCT02933450|7639698|FG000|COMPLETED|Overall Study||15
6709438|NCT02933450|7639699|FG001|COMPLETED|Overall Study||15
6709439|NCT02933450|7639698|FG000|NOT COMPLETED|Overall Study||5
6709440|NCT02933450|7639699|FG001|NOT COMPLETED|Overall Study||8
6709441|NCT02933476|7639705|FG000|STARTED|Overall Study||5
6709442|NCT02933476|7639705|FG000|COMPLETED|Overall Study||5
6709443|NCT02933476|7639705|FG000|NOT COMPLETED|Overall Study||0
6709444|NCT02933489|7639711|FG000|STARTED|Overall Study||757
6709445|NCT02933489|7639712|FG001|STARTED|Overall Study||759
6709446|NCT02933489|7639711|FG000|DBTperformed|Overall Study||726
6709447|NCT02933489|7639712|FG001|DBTperformed|Overall Study||737
6709448|NCT02933489|7639711|FG000|AB MR Performed|Overall Study||713
6709449|NCT02933489|7639712|FG001|AB MR Performed|Overall Study||733
6709450|NCT02933489|7639711|FG000|COMPLETED|Overall Study||713
6709451|NCT02933489|7639712|FG001|COMPLETED|Overall Study||731
6709452|NCT02933489|7639711|FG000|NOT COMPLETED|Overall Study||44
6709453|NCT02933489|7639712|FG001|NOT COMPLETED|Overall Study||28
6709454|NCT02933502|7639723|FG000|STARTED|Overall Study||3
6709455|NCT02933502|7639723|FG000|COMPLETED|Overall Study||3
6709456|NCT02933502|7639723|FG000|NOT COMPLETED|Overall Study||0
6709457|NCT02933528|7639727|FG000|STARTED|Overall Study||24
6709458|NCT02933528|7639727|FG000|COMPLETED|Overall Study||22
6709459|NCT02933528|7639727|FG000|NOT COMPLETED|Overall Study||2
6709460|NCT02933866|7639733|FG000|STARTED|Overall Study||186
6709461|NCT02933866|7639734|FG001|STARTED|Overall Study||185
6709462|NCT02933866|7639733|FG000|COMPLETED|Overall Study||174
6709463|NCT02933866|7639734|FG001|COMPLETED|Overall Study||176
6709464|NCT02933866|7639733|FG000|NOT COMPLETED|Overall Study||12
6709465|NCT02933866|7639734|FG001|NOT COMPLETED|Overall Study||9
6709466|NCT02933879|7639743|FG000|STARTED|Overall Study||64
6709467|NCT02933879|7639744|FG001|STARTED|Overall Study||62
6709468|NCT02933879|7639745|FG002|STARTED|Overall Study||58
6709469|NCT02933879|7639743|FG000|COMPLETED|Overall Study||48
6709470|NCT02933879|7639744|FG001|COMPLETED|Overall Study||48
6709471|NCT02933879|7639745|FG002|COMPLETED|Overall Study||41
6709472|NCT02933879|7639743|FG000|NOT COMPLETED|Overall Study||16
6709473|NCT02933879|7639744|FG001|NOT COMPLETED|Overall Study||14
6709474|NCT02933879|7639745|FG002|NOT COMPLETED|Overall Study||17
6709475|NCT02934178|7639757|FG000|STARTED|Received Vaccination 1||12
6709476|NCT02934178|7639758|FG001|STARTED|Received Vaccination 1||4
6709477|NCT02934178|7639757|FG000|COMPLETED|Received Vaccination 1||12
6709478|NCT02934178|7639758|FG001|COMPLETED|Received Vaccination 1||4
6709479|NCT02934178|7639757|FG000|NOT COMPLETED|Received Vaccination 1||0
6709480|NCT02934178|7639758|FG001|NOT COMPLETED|Received Vaccination 1||0
6709481|NCT02934178|7639757|FG000|STARTED|Received Vaccination 2||12
6709482|NCT02934178|7639758|FG001|STARTED|Received Vaccination 2||4
6709483|NCT02934178|7639757|FG000|COMPLETED|Received Vaccination 2||12
6709484|NCT02934178|7639758|FG001|COMPLETED|Received Vaccination 2||3
6709485|NCT02934178|7639757|FG000|NOT COMPLETED|Received Vaccination 2||0
6709486|NCT02934178|7639758|FG001|NOT COMPLETED|Received Vaccination 2||1
6709487|NCT02934178|7639757|FG000|STARTED|Received Vaccination 3||12
6709488|NCT02934178|7639758|FG001|STARTED|Received Vaccination 3||3
6709489|NCT02934178|7639757|FG000|COMPLETED|Received Vaccination 3||11
6709490|NCT02934178|7639758|FG001|COMPLETED|Received Vaccination 3||3
6709491|NCT02934178|7639757|FG000|NOT COMPLETED|Received Vaccination 3||1
6709492|NCT02934178|7639758|FG001|NOT COMPLETED|Received Vaccination 3||0
6709493|NCT02934191|7639767|FG000|STARTED|Overall Study||87
6709494|NCT02934191|7639768|FG001|STARTED|Overall Study||85
6709495|NCT02934191|7639767|FG000|COMPLETED|Overall Study||87
6709496|NCT02934191|7639768|FG001|COMPLETED|Overall Study||85
6709497|NCT02934191|7639767|FG000|NOT COMPLETED|Overall Study||0
6709498|NCT02934191|7639768|FG001|NOT COMPLETED|Overall Study||0
6709499|NCT02934347|7639776|FG000|STARTED|Overall Study||374
6709500|NCT02934347|7639777|FG001|STARTED|Overall Study||407
6709501|NCT02934347|7639776|FG000|COMPLETED|Overall Study||374
6709502|NCT02934347|7639777|FG001|COMPLETED|Overall Study||407
6709503|NCT02934347|7639776|FG000|NOT COMPLETED|Overall Study||0
6709504|NCT02934347|7639777|FG001|NOT COMPLETED|Overall Study||0
6709505|NCT02934555|7639785|FG000|STARTED|Overall Study||23
6709506|NCT02934555|7639786|FG001|STARTED|Overall Study||25
6709507|NCT02934555|7639785|FG000|COMPLETED|Overall Study||21
6709508|NCT02934555|7639786|FG001|COMPLETED|Overall Study||22
6709509|NCT02934555|7639785|FG000|NOT COMPLETED|Overall Study||2
6709510|NCT02934555|7639786|FG001|NOT COMPLETED|Overall Study||3
6709511|NCT02934698|7639792|FG000|STARTED|Overall Study||2
6709512|NCT02934698|7639792|FG000|COMPLETED|Overall Study||2
6709513|NCT02934698|7639792|FG000|NOT COMPLETED|Overall Study||0
6709514|NCT02935036|7639798|FG000|STARTED|Overall Study||147
6709515|NCT02935036|7639799|FG001|STARTED|Overall Study||147
6709516|NCT02935036|7639798|FG000|COMPLETED|Overall Study||137
6709517|NCT02935036|7639799|FG001|COMPLETED|Overall Study||136
6709518|NCT02935036|7639798|FG000|NOT COMPLETED|Overall Study||10
6709519|NCT02935036|7639799|FG001|NOT COMPLETED|Overall Study||11
6709520|NCT02935062|7639808|FG000|STARTED|Overall Study||8
6709521|NCT02935062|7639809|FG001|STARTED|Overall Study||8
6709522|NCT02935062|7639810|FG002|STARTED|Overall Study||8
6709523|NCT02935062|7639808|FG000|COMPLETED|Overall Study||8
6709524|NCT02935062|7639809|FG001|COMPLETED|Overall Study||8
6709525|NCT02935062|7639810|FG002|COMPLETED|Overall Study||8
6709526|NCT02935062|7639808|FG000|NOT COMPLETED|Overall Study||0
6709527|NCT02935062|7639809|FG001|NOT COMPLETED|Overall Study||0
6709528|NCT02935062|7639810|FG002|NOT COMPLETED|Overall Study||0
6709529|NCT02935088|7639818|FG000|STARTED|Overall Study||2217
6709530|NCT02935088|7639818|FG000|COMPLETED|Overall Study||2115
6709531|NCT02935088|7639818|FG000|NOT COMPLETED|Overall Study||102
6709532|NCT02935179|7639831|FG000|STARTED|Overall Study||30
6709533|NCT02935179|7639832|FG001|STARTED|Overall Study||30
6709534|NCT02935179|7639831|FG000|COMPLETED|Overall Study||29
6709535|NCT02935179|7639832|FG001|COMPLETED|Overall Study||29
6709536|NCT02935179|7639831|FG000|NOT COMPLETED|Overall Study||1
6709537|NCT02935179|7639832|FG001|NOT COMPLETED|Overall Study||1
6709538|NCT02935192|7639840|FG000|STARTED|Overall Study|312 subjects were included in the Full Protocol Analysis because 8 withdrew without getting product.|320
6709539|NCT02935192|7639841|FG001|STARTED|Overall Study|156 subjects were included in the Full Protocol Analysis because 4 withdrew without getting product.|160
6709540|NCT02935192|7639840|FG000|Received Vaccine/Placebo|Overall Study||312
6709541|NCT02935192|7639841|FG001|Received Vaccine/Placebo|Overall Study||156
6709542|NCT02935192|7639840|FG000|COMPLETED|Overall Study||312
6709543|NCT02935192|7639841|FG001|COMPLETED|Overall Study||156
6709544|NCT02935192|7639840|FG000|NOT COMPLETED|Overall Study||8
6709545|NCT02935192|7639841|FG001|NOT COMPLETED|Overall Study||4
6709546|NCT02935452|7639849|FG000|STARTED|Overall Study||30
6709547|NCT02935452|7639850|FG001|STARTED|Overall Study||30
6709548|NCT02935452|7639849|FG000|COMPLETED|Overall Study||27
6709549|NCT02935452|7639850|FG001|COMPLETED|Overall Study||29
6709550|NCT02935452|7639849|FG000|NOT COMPLETED|Overall Study||3
6709551|NCT02935452|7639850|FG001|NOT COMPLETED|Overall Study||1
6709552|NCT02935543|7639856|FG000|STARTED|Overall Study||1
6709553|NCT02935543|7639856|FG000|COMPLETED|Overall Study||1
6709554|NCT02935543|7639856|FG000|NOT COMPLETED|Overall Study||0
6739202|NCT03286751|7668063|FG002|COMPLETED|Washout Period 3||7
6739203|NCT03286751|7668064|FG003|COMPLETED|Washout Period 3||7
6739204|NCT03286751|7668065|FG004|COMPLETED|Washout Period 3||6
6739205|NCT03286751|7668066|FG005|COMPLETED|Washout Period 3||7
6739206|NCT03286751|7668061|FG000|NOT COMPLETED|Washout Period 3||0
6739207|NCT03286751|7668062|FG001|NOT COMPLETED|Washout Period 3||0
6739208|NCT03286751|7668063|FG002|NOT COMPLETED|Washout Period 3||0
6739209|NCT03286751|7668064|FG003|NOT COMPLETED|Washout Period 3||0
6739210|NCT03286751|7668065|FG004|NOT COMPLETED|Washout Period 3||0
6739211|NCT03286751|7668066|FG005|NOT COMPLETED|Washout Period 3||0
6739212|NCT03286751|7668061|FG000|STARTED|Period 4||7
6739213|NCT03286751|7668062|FG001|STARTED|Period 4||6
6739214|NCT03286751|7668063|FG002|STARTED|Period 4||7
6739215|NCT03286751|7668064|FG003|STARTED|Period 4||7
6739216|NCT03286751|7668065|FG004|STARTED|Period 4||6
6739217|NCT03286751|7668066|FG005|STARTED|Period 4||7
6739218|NCT03286751|7668061|FG000|COMPLETED|Period 4||7
6739219|NCT03286751|7668062|FG001|COMPLETED|Period 4||6
6739220|NCT03286751|7668063|FG002|COMPLETED|Period 4||7
6739221|NCT03286751|7668064|FG003|COMPLETED|Period 4||7
6739222|NCT03286751|7668065|FG004|COMPLETED|Period 4||6
6739223|NCT03286751|7668066|FG005|COMPLETED|Period 4||7
6739224|NCT03286751|7668061|FG000|NOT COMPLETED|Period 4||0
6739225|NCT03286751|7668062|FG001|NOT COMPLETED|Period 4||0
6739226|NCT03286751|7668063|FG002|NOT COMPLETED|Period 4||0
6739227|NCT03286751|7668064|FG003|NOT COMPLETED|Period 4||0
6739228|NCT03286751|7668065|FG004|NOT COMPLETED|Period 4||0
6739229|NCT03286751|7668066|FG005|NOT COMPLETED|Period 4||0
6739230|NCT03286751|7668061|FG000|STARTED|Washout Period 4||7
6739231|NCT03286751|7668062|FG001|STARTED|Washout Period 4||6
6739232|NCT03286751|7668063|FG002|STARTED|Washout Period 4||7
6739233|NCT03286751|7668064|FG003|STARTED|Washout Period 4||7
6739234|NCT03286751|7668065|FG004|STARTED|Washout Period 4||6
6739235|NCT03286751|7668066|FG005|STARTED|Washout Period 4||7
6739236|NCT03286751|7668061|FG000|COMPLETED|Washout Period 4||7
6739237|NCT03286751|7668062|FG001|COMPLETED|Washout Period 4||6
6739238|NCT03286751|7668063|FG002|COMPLETED|Washout Period 4||7
6739239|NCT03286751|7668064|FG003|COMPLETED|Washout Period 4||7
6739240|NCT03286751|7668065|FG004|COMPLETED|Washout Period 4||6
6739241|NCT03286751|7668066|FG005|COMPLETED|Washout Period 4||7
6739242|NCT03286751|7668061|FG000|NOT COMPLETED|Washout Period 4||0
6739243|NCT03286751|7668062|FG001|NOT COMPLETED|Washout Period 4||0
6739244|NCT03286751|7668063|FG002|NOT COMPLETED|Washout Period 4||0
6739245|NCT03286751|7668064|FG003|NOT COMPLETED|Washout Period 4||0
6739246|NCT03286751|7668065|FG004|NOT COMPLETED|Washout Period 4||0
6739247|NCT03286751|7668066|FG005|NOT COMPLETED|Washout Period 4||0
6739248|NCT03286751|7668061|FG000|STARTED|Period 5||7
6739249|NCT03286751|7668062|FG001|STARTED|Period 5||6
6739250|NCT03286751|7668063|FG002|STARTED|Period 5||7
6739251|NCT03286751|7668064|FG003|STARTED|Period 5||7
6739252|NCT03286751|7668065|FG004|STARTED|Period 5||6
6739253|NCT03286751|7668066|FG005|STARTED|Period 5||7
6261775|NCT03252522|7160684|FG000|STARTED|Overall Study||78
6261776|NCT03252522|7160685|FG001|STARTED|Overall Study||57
6261777|NCT03252522|7160686|FG002|STARTED|Overall Study||0
6261778|NCT03252522|7160684|FG000|COMPLETED|Overall Study||69
6261779|NCT03252522|7160685|FG001|COMPLETED|Overall Study||54
6261780|NCT03252522|7160686|FG002|COMPLETED|Overall Study||0
6261781|NCT03252522|7160684|FG000|NOT COMPLETED|Overall Study||9
6261782|NCT03252522|7160685|FG001|NOT COMPLETED|Overall Study||3
6261783|NCT03252522|7160686|FG002|NOT COMPLETED|Overall Study||0
6739254|NCT03286751|7668061|FG000|COMPLETED|Period 5||7
6739255|NCT03286751|7668062|FG001|COMPLETED|Period 5||6
6739256|NCT03286751|7668063|FG002|COMPLETED|Period 5||7
6739257|NCT03286751|7668064|FG003|COMPLETED|Period 5||7
6739258|NCT03286751|7668065|FG004|COMPLETED|Period 5||6
6739259|NCT03286751|7668066|FG005|COMPLETED|Period 5||7
6739260|NCT03286751|7668061|FG000|NOT COMPLETED|Period 5||0
6739261|NCT03286751|7668062|FG001|NOT COMPLETED|Period 5||0
6739262|NCT03286751|7668063|FG002|NOT COMPLETED|Period 5||0
6739263|NCT03286751|7668064|FG003|NOT COMPLETED|Period 5||0
6739264|NCT03286751|7668065|FG004|NOT COMPLETED|Period 5||0
6739265|NCT03286751|7668066|FG005|NOT COMPLETED|Period 5||0
6261784|NCT03235544|7160701|FG000|STARTED|Overall Study||12
6261785|NCT03235544|7160702|FG001|STARTED|Overall Study||41
6261786|NCT03235544|7160703|FG002|STARTED|Overall Study||31
6261787|NCT03235544|7160704|FG003|STARTED|Overall Study||77
6739266|NCT03286751|7668061|FG000|STARTED|Washout Period 5||7
6739267|NCT03286751|7668062|FG001|STARTED|Washout Period 5||6
6739268|NCT03286751|7668063|FG002|STARTED|Washout Period 5||7
6739269|NCT03286751|7668064|FG003|STARTED|Washout Period 5||7
6739270|NCT03286751|7668065|FG004|STARTED|Washout Period 5||6
6739271|NCT03286751|7668066|FG005|STARTED|Washout Period 5||7
6709555|NCT02935673|7639863|FG000|STARTED|Overall Study||16
6709556|NCT02935673|7639864|FG001|STARTED|Overall Study||27
6709557|NCT02935673|7639865|FG002|STARTED|Overall Study||6
6709558|NCT02935673|7639863|FG000|COMPLETED|Overall Study||15
6709559|NCT02935673|7639864|FG001|COMPLETED|Overall Study||24
6709560|NCT02935673|7639865|FG002|COMPLETED|Overall Study||6
6261788|NCT03235544|7160701|FG000|COMPLETED|Overall Study||0
6261789|NCT03235544|7160702|FG001|COMPLETED|Overall Study||0
6261790|NCT03235544|7160703|FG002|COMPLETED|Overall Study||0
6261791|NCT03235544|7160704|FG003|COMPLETED|Overall Study||0
6261792|NCT03235544|7160701|FG000|NOT COMPLETED|Overall Study||12
6261793|NCT03235544|7160702|FG001|NOT COMPLETED|Overall Study||41
6261794|NCT03235544|7160703|FG002|NOT COMPLETED|Overall Study||31
6261795|NCT03235544|7160704|FG003|NOT COMPLETED|Overall Study||77
6261796|NCT03225833|7160721|FG000|STARTED|Overall Study||16
6261797|NCT03225833|7160722|FG001|STARTED|Overall Study||9
6261798|NCT03225833|7160723|FG002|STARTED|Overall Study||9
6261799|NCT03225833|7160724|FG003|STARTED|Overall Study||9
6261800|NCT03225833|7160725|FG004|STARTED|Overall Study||8
6261801|NCT03225833|7160726|FG005|STARTED|Overall Study||10
6261802|NCT03225833|7160721|FG000|Single Dose Period Only|Overall Study||1
6261803|NCT03225833|7160722|FG001|Single Dose Period Only|Overall Study||1
6261804|NCT03225833|7160723|FG002|Single Dose Period Only|Overall Study||2
6261805|NCT03225833|7160724|FG003|Single Dose Period Only|Overall Study||0
6261806|NCT03225833|7160725|FG004|Single Dose Period Only|Overall Study||0
6261807|NCT03225833|7160726|FG005|Single Dose Period Only|Overall Study||4
6261808|NCT03225833|7160721|FG000|Multiple Dose Period Only|Overall Study||0
6261809|NCT03225833|7160722|FG001|Multiple Dose Period Only|Overall Study||0
6261810|NCT03225833|7160723|FG002|Multiple Dose Period Only|Overall Study||0
6261811|NCT03225833|7160724|FG003|Multiple Dose Period Only|Overall Study||0
6261812|NCT03225833|7160725|FG004|Multiple Dose Period Only|Overall Study||0
6261813|NCT03225833|7160726|FG005|Multiple Dose Period Only|Overall Study||1
6261814|NCT03225833|7160721|FG000|Single Dose and Multiple Dose Periods|Overall Study||15
6261815|NCT03225833|7160722|FG001|Single Dose and Multiple Dose Periods|Overall Study||8
6261816|NCT03225833|7160723|FG002|Single Dose and Multiple Dose Periods|Overall Study||7
6261817|NCT03225833|7160724|FG003|Single Dose and Multiple Dose Periods|Overall Study||9
6261818|NCT03225833|7160725|FG004|Single Dose and Multiple Dose Periods|Overall Study||8
6261819|NCT03225833|7160726|FG005|Single Dose and Multiple Dose Periods|Overall Study||5
6261820|NCT03225833|7160721|FG000|COMPLETED|Overall Study||11
6261821|NCT03225833|7160722|FG001|COMPLETED|Overall Study||8
6261822|NCT03225833|7160723|FG002|COMPLETED|Overall Study||7
6261823|NCT03225833|7160724|FG003|COMPLETED|Overall Study||9
6261824|NCT03225833|7160725|FG004|COMPLETED|Overall Study||7
6261825|NCT03225833|7160726|FG005|COMPLETED|Overall Study||0
6261826|NCT03225833|7160721|FG000|NOT COMPLETED|Overall Study||5
6261827|NCT03225833|7160722|FG001|NOT COMPLETED|Overall Study||1
6261828|NCT03225833|7160723|FG002|NOT COMPLETED|Overall Study||2
6261829|NCT03225833|7160724|FG003|NOT COMPLETED|Overall Study||0
6261830|NCT03225833|7160725|FG004|NOT COMPLETED|Overall Study||1
6261831|NCT03225833|7160726|FG005|NOT COMPLETED|Overall Study||10
6261832|NCT03167242|7160757|FG000|STARTED|Overall Study||12
6261833|NCT03167242|7160758|FG001|STARTED|Overall Study||51
6261834|NCT03167242|7160759|FG002|STARTED|Overall Study||51
6261835|NCT03167242|7160760|FG003|STARTED|Overall Study||51
6261836|NCT03167242|7160761|FG004|STARTED|Overall Study||54
6261837|NCT03167242|7160762|FG005|STARTED|Overall Study||51
6261838|NCT03167242|7160763|FG006|STARTED|Overall Study||52
6261839|NCT03167242|7160764|FG007|STARTED|Overall Study||27
6261840|NCT03167242|7160765|FG008|STARTED|Overall Study||53
6261841|NCT03167242|7160766|FG009|STARTED|Overall Study||53
6261842|NCT03167242|7160767|FG010|STARTED|Overall Study||45
6261843|NCT03167242|7160768|FG011|STARTED|Overall Study||24
6261844|NCT03167242|7160757|FG000|Full Analysis Set (FAS)|Overall Study||12
6261845|NCT03167242|7160758|FG001|Full Analysis Set (FAS)|Overall Study||51
6261846|NCT03167242|7160759|FG002|Full Analysis Set (FAS)|Overall Study||51
6261847|NCT03167242|7160760|FG003|Full Analysis Set (FAS)|Overall Study||51
6261848|NCT03167242|7160761|FG004|Full Analysis Set (FAS)|Overall Study||54
6261849|NCT03167242|7160762|FG005|Full Analysis Set (FAS)|Overall Study||51
6261850|NCT03167242|7160763|FG006|Full Analysis Set (FAS)|Overall Study||52
6261851|NCT03167242|7160764|FG007|Full Analysis Set (FAS)|Overall Study||27
6261852|NCT03167242|7160765|FG008|Full Analysis Set (FAS)|Overall Study||52
6261853|NCT03167242|7160766|FG009|Full Analysis Set (FAS)|Overall Study||53
6261854|NCT03167242|7160767|FG010|Full Analysis Set (FAS)|Overall Study||45
6261855|NCT03167242|7160768|FG011|Full Analysis Set (FAS)|Overall Study||24
6261856|NCT03167242|7160757|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||12
6261857|NCT03167242|7160758|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study||47
6261858|NCT03167242|7160759|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study||51
6261859|NCT03167242|7160760|FG003|Pharmacokinetics (PK) Analysis Set|Overall Study||46
6261860|NCT03167242|7160761|FG004|Pharmacokinetics (PK) Analysis Set|Overall Study||48
6261861|NCT03167242|7160762|FG005|Pharmacokinetics (PK) Analysis Set|Overall Study||46
6261862|NCT03167242|7160763|FG006|Pharmacokinetics (PK) Analysis Set|Overall Study||45
6261863|NCT03167242|7160764|FG007|Pharmacokinetics (PK) Analysis Set|Overall Study||24
6261864|NCT03167242|7160765|FG008|Pharmacokinetics (PK) Analysis Set|Overall Study||48
6261865|NCT03167242|7160766|FG009|Pharmacokinetics (PK) Analysis Set|Overall Study||46
6261866|NCT03167242|7160767|FG010|Pharmacokinetics (PK) Analysis Set|Overall Study||41
6709561|NCT02935673|7639863|FG000|NOT COMPLETED|Overall Study||1
6709562|NCT02935673|7639864|FG001|NOT COMPLETED|Overall Study||3
6709563|NCT02935673|7639865|FG002|NOT COMPLETED|Overall Study||0
6709564|NCT02935699|7639877|FG000|STARTED|Overall Study||127
6709565|NCT02935699|7639878|FG001|STARTED|Overall Study||135
6709566|NCT02935699|7639877|FG000|COMPLETED|Overall Study||127
6709567|NCT02935699|7639878|FG001|COMPLETED|Overall Study||135
6709568|NCT02935699|7639877|FG000|NOT COMPLETED|Overall Study||0
6709569|NCT02935699|7639878|FG001|NOT COMPLETED|Overall Study||0
6709570|NCT02935738|7639888|FG000|STARTED|Overall Study||67
6709571|NCT02935738|7639889|FG001|STARTED|Overall Study||74
6709572|NCT02935738|7639890|FG002|STARTED|Overall Study||47
6709573|NCT02935738|7639891|FG003|STARTED|Overall Study||53
6709574|NCT02935738|7639888|FG000|COMPLETED|Overall Study||50
6709575|NCT02935738|7639889|FG001|COMPLETED|Overall Study||53
6709576|NCT02935738|7639890|FG002|COMPLETED|Overall Study||46
6709577|NCT02935738|7639891|FG003|COMPLETED|Overall Study||48
6709578|NCT02935738|7639888|FG000|NOT COMPLETED|Overall Study||17
6709579|NCT02935738|7639889|FG001|NOT COMPLETED|Overall Study||21
6709580|NCT02935738|7639890|FG002|NOT COMPLETED|Overall Study||1
6709581|NCT02935738|7639891|FG003|NOT COMPLETED|Overall Study||5
6709582|NCT02935842|7639905|FG000|STARTED|Testing and Therapy Period 1||8
6709583|NCT02935842|7639906|FG001|STARTED|Testing and Therapy Period 1||6
6709584|NCT02935842|7639907|FG002|STARTED|Testing and Therapy Period 1||6
6709585|NCT02935842|7639908|FG003|STARTED|Testing and Therapy Period 1|Due to limited staff capacity, HC have only been included in the final tranche.|0
6709586|NCT02935842|7639905|FG000|COMPLETED|Testing and Therapy Period 1||8
6709587|NCT02935842|7639906|FG001|COMPLETED|Testing and Therapy Period 1||6
6709588|NCT02935842|7639907|FG002|COMPLETED|Testing and Therapy Period 1||6
6709589|NCT02935842|7639908|FG003|COMPLETED|Testing and Therapy Period 1||0
6709590|NCT02935842|7639905|FG000|NOT COMPLETED|Testing and Therapy Period 1||0
6709591|NCT02935842|7639906|FG001|NOT COMPLETED|Testing and Therapy Period 1||0
6709592|NCT02935842|7639907|FG002|NOT COMPLETED|Testing and Therapy Period 1||0
6709593|NCT02935842|7639908|FG003|NOT COMPLETED|Testing and Therapy Period 1||0
6709594|NCT02935842|7639905|FG000|STARTED|Testing and Therapy Period 2||8
6709595|NCT02935842|7639906|FG001|STARTED|Testing and Therapy Period 2||6
6709596|NCT02935842|7639907|FG002|STARTED|Testing and Therapy Period 2||6
6709597|NCT02935842|7639908|FG003|STARTED|Testing and Therapy Period 2|Due to limited staff capacity, HC have only been included in the final tranche.|0
6709598|NCT02935842|7639905|FG000|COMPLETED|Testing and Therapy Period 2||6
6709599|NCT02935842|7639906|FG001|COMPLETED|Testing and Therapy Period 2||6
6709600|NCT02935842|7639907|FG002|COMPLETED|Testing and Therapy Period 2||6
6709601|NCT02935842|7639908|FG003|COMPLETED|Testing and Therapy Period 2||0
6709602|NCT02935842|7639905|FG000|NOT COMPLETED|Testing and Therapy Period 2||2
6709603|NCT02935842|7639906|FG001|NOT COMPLETED|Testing and Therapy Period 2||0
6709604|NCT02935842|7639907|FG002|NOT COMPLETED|Testing and Therapy Period 2||0
6709605|NCT02935842|7639908|FG003|NOT COMPLETED|Testing and Therapy Period 2||0
6709606|NCT02935842|7639905|FG000|STARTED|Testing and Therapy Period 3||6
6709607|NCT02935842|7639906|FG001|STARTED|Testing and Therapy Period 3||6
6709608|NCT02935842|7639907|FG002|STARTED|Testing and Therapy Period 3||6
6709609|NCT02935842|7639908|FG003|STARTED|Testing and Therapy Period 3|HC received no interventions. They have only been tested at BL, 4 Weeks and 6 Months.|18
6709610|NCT02935842|7639905|FG000|COMPLETED|Testing and Therapy Period 3||3
6709611|NCT02935842|7639906|FG001|COMPLETED|Testing and Therapy Period 3||2
6709612|NCT02935842|7639907|FG002|COMPLETED|Testing and Therapy Period 3||1
6709613|NCT02935842|7639908|FG003|COMPLETED|Testing and Therapy Period 3||17
6709614|NCT02935842|7639905|FG000|NOT COMPLETED|Testing and Therapy Period 3||3
6709615|NCT02935842|7639906|FG001|NOT COMPLETED|Testing and Therapy Period 3||4
6709616|NCT02935842|7639907|FG002|NOT COMPLETED|Testing and Therapy Period 3||5
6709617|NCT02935842|7639908|FG003|NOT COMPLETED|Testing and Therapy Period 3||1
6709618|NCT02935894|7639925|FG000|STARTED|Overall Study||14
6709619|NCT02935894|7639925|FG000|COMPLETED|Overall Study||13
6709620|NCT02935894|7639925|FG000|NOT COMPLETED|Overall Study||1
6709621|NCT02936037|7639931|FG000|STARTED|Double-Blind Treatment Period||316
6709622|NCT02936037|7639932|FG001|STARTED|Double-Blind Treatment Period||326
6709623|NCT02936037|7639931|FG000|COMPLETED|Double-Blind Treatment Period||267
6709624|NCT02936037|7639932|FG001|COMPLETED|Double-Blind Treatment Period||261
6709625|NCT02936037|7639931|FG000|NOT COMPLETED|Double-Blind Treatment Period||49
6709626|NCT02936037|7639932|FG001|NOT COMPLETED|Double-Blind Treatment Period||65
6709627|NCT02936037|7639931|FG000|STARTED|Open Label Extension||0
6709628|NCT02936037|7639932|FG001|STARTED|Open Label Extension||528
6709629|NCT02936037|7639931|FG000|COMPLETED|Open Label Extension||0
6709630|NCT02936037|7639932|FG001|COMPLETED|Open Label Extension||518
6709631|NCT02936037|7639931|FG000|NOT COMPLETED|Open Label Extension||0
6709632|NCT02936037|7639932|FG001|NOT COMPLETED|Open Label Extension||10
6709633|NCT02936076|7639940|FG000|STARTED|Overall Study||25
6709634|NCT02936076|7639941|FG001|STARTED|Overall Study||24
6709635|NCT02936076|7639940|FG000|COMPLETED|Overall Study||19
6709636|NCT02936076|7639941|FG001|COMPLETED|Overall Study||20
6709637|NCT02936076|7639940|FG000|NOT COMPLETED|Overall Study||6
6709638|NCT02936076|7639941|FG001|NOT COMPLETED|Overall Study||4
6709639|NCT02936479|7639947|FG000|STARTED|Overall Study||1
6709640|NCT02936479|7639947|FG000|COMPLETED|Overall Study||1
6709641|NCT02936479|7639947|FG000|NOT COMPLETED|Overall Study||0
6739272|NCT03286751|7668061|FG000|COMPLETED|Washout Period 5||7
6709642|NCT02936635|7639953|FG000|STARTED|Overall Study||115
6709643|NCT02936635|7639954|FG001|STARTED|Overall Study||165
6709644|NCT02936635|7639953|FG000|COMPLETED|Overall Study||0
6709645|NCT02936635|7639954|FG001|COMPLETED|Overall Study||0
6709646|NCT02936635|7639953|FG000|NOT COMPLETED|Overall Study||115
6709647|NCT02936635|7639954|FG001|NOT COMPLETED|Overall Study||165
6709648|NCT02936648|7639960|FG000|STARTED|Overall Study||2209
6709649|NCT02936648|7639960|FG000|COMPLETED|Overall Study||2209
6709650|NCT02936648|7639960|FG000|NOT COMPLETED|Overall Study||0
6709651|NCT02936869|7639966|FG000|STARTED|Overall Study||104
6709652|NCT02936869|7639967|FG001|STARTED|Overall Study||103
6709653|NCT02936869|7639966|FG000|COMPLETED|Overall Study||102
6709654|NCT02936869|7639967|FG001|COMPLETED|Overall Study||98
6709655|NCT02936869|7639966|FG000|NOT COMPLETED|Overall Study||2
6709656|NCT02936869|7639967|FG001|NOT COMPLETED|Overall Study||5
6709657|NCT02937116|7639986|FG000|STARTED|Overall Study||3
6709658|NCT02937116|7639987|FG001|STARTED|Overall Study||3
6709659|NCT02937116|7639988|FG002|STARTED|Overall Study||3
6709660|NCT02937116|7639989|FG003|STARTED|Overall Study||3
6709661|NCT02937116|7639990|FG004|STARTED|Overall Study||22
6709662|NCT02937116|7639991|FG005|STARTED|Overall Study||87
6709663|NCT02937116|7639992|FG006|STARTED|Overall Study||37
6709664|NCT02937116|7639993|FG007|STARTED|Overall Study||21
6709665|NCT02937116|7639994|FG008|STARTED|Overall Study||20
6709666|NCT02937116|7639995|FG009|STARTED|Overall Study||20
6709667|NCT02937116|7639996|FG010|STARTED|Overall Study||7
6709668|NCT02937116|7639997|FG011|STARTED|Overall Study||7
6709669|NCT02937116|7639986|FG000|COMPLETED|Overall Study||0
6709670|NCT02937116|7639987|FG001|COMPLETED|Overall Study||0
6709671|NCT02937116|7639988|FG002|COMPLETED|Overall Study||0
6709672|NCT02937116|7639989|FG003|COMPLETED|Overall Study||0
6709673|NCT02937116|7639990|FG004|COMPLETED|Overall Study||0
6709674|NCT02937116|7639991|FG005|COMPLETED|Overall Study||0
6709675|NCT02937116|7639992|FG006|COMPLETED|Overall Study||0
6709676|NCT02937116|7639993|FG007|COMPLETED|Overall Study||0
6709677|NCT02937116|7639994|FG008|COMPLETED|Overall Study||0
6709678|NCT02937116|7639995|FG009|COMPLETED|Overall Study||0
6709679|NCT02937116|7639996|FG010|COMPLETED|Overall Study||0
6709680|NCT02937116|7639997|FG011|COMPLETED|Overall Study||0
6709681|NCT02937116|7639986|FG000|NOT COMPLETED|Overall Study||3
6709682|NCT02937116|7639987|FG001|NOT COMPLETED|Overall Study||3
6709683|NCT02937116|7639988|FG002|NOT COMPLETED|Overall Study||3
6709684|NCT02937116|7639989|FG003|NOT COMPLETED|Overall Study||3
6709685|NCT02937116|7639990|FG004|NOT COMPLETED|Overall Study||22
6709686|NCT02937116|7639991|FG005|NOT COMPLETED|Overall Study||87
6709687|NCT02937116|7639992|FG006|NOT COMPLETED|Overall Study||37
6709688|NCT02937116|7639993|FG007|NOT COMPLETED|Overall Study||21
6709689|NCT02937116|7639994|FG008|NOT COMPLETED|Overall Study||20
6709690|NCT02937116|7639995|FG009|NOT COMPLETED|Overall Study||20
6709691|NCT02937116|7639996|FG010|NOT COMPLETED|Overall Study||7
6709692|NCT02937116|7639997|FG011|NOT COMPLETED|Overall Study||7
6709693|NCT02937168|7640023|FG000|STARTED|PET/CT Screening Period (21 Days)||5
6709694|NCT02937168|7640024|FG001|STARTED|PET/CT Screening Period (21 Days)||0
6709695|NCT02937168|7640025|FG002|STARTED|PET/CT Screening Period (21 Days)||0
6709696|NCT02937168|7640023|FG000|COMPLETED|PET/CT Screening Period (21 Days)||5
6261867|NCT03167242|7160768|FG011|Pharmacokinetics (PK) Analysis Set|Overall Study||24
6261868|NCT03167242|7160757|FG000|Per-Protocol Set (PPS)|Overall Study||12
6261869|NCT03167242|7160758|FG001|Per-Protocol Set (PPS)|Overall Study||50
6261870|NCT03167242|7160759|FG002|Per-Protocol Set (PPS)|Overall Study||48
6261871|NCT03167242|7160760|FG003|Per-Protocol Set (PPS)|Overall Study||48
6261872|NCT03167242|7160761|FG004|Per-Protocol Set (PPS)|Overall Study||47
6261873|NCT03167242|7160762|FG005|Per-Protocol Set (PPS)|Overall Study||44
6261874|NCT03167242|7160763|FG006|Per-Protocol Set (PPS)|Overall Study||43
6261875|NCT03167242|7160764|FG007|Per-Protocol Set (PPS)|Overall Study||25
6261876|NCT03167242|7160765|FG008|Per-Protocol Set (PPS)|Overall Study||48
6261877|NCT03167242|7160766|FG009|Per-Protocol Set (PPS)|Overall Study||46
6261878|NCT03167242|7160767|FG010|Per-Protocol Set (PPS)|Overall Study||40
6261879|NCT03167242|7160768|FG011|Per-Protocol Set (PPS)|Overall Study||22
6261880|NCT03167242|7160757|FG000|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
6261881|NCT03167242|7160758|FG001|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
6261882|NCT03167242|7160759|FG002|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
6261883|NCT03167242|7160760|FG003|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
6261884|NCT03167242|7160761|FG004|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||6
6261885|NCT03167242|7160762|FG005|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||12
6261886|NCT03167242|7160763|FG006|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||5
6709697|NCT02937168|7640024|FG001|COMPLETED|PET/CT Screening Period (21 Days)||0
6709698|NCT02937168|7640025|FG002|COMPLETED|PET/CT Screening Period (21 Days)||0
6709699|NCT02937168|7640023|FG000|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
6709700|NCT02937168|7640024|FG001|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
6709701|NCT02937168|7640025|FG002|NOT COMPLETED|PET/CT Screening Period (21 Days)||0
6709702|NCT02937168|7640023|FG000|STARTED|Double-Blind Treatment Period (6 Weeks)||0
6709703|NCT02937168|7640024|FG001|STARTED|Double-Blind Treatment Period (6 Weeks)||0
6709704|NCT02937168|7640025|FG002|STARTED|Double-Blind Treatment Period (6 Weeks)||0
6709705|NCT02937168|7640023|FG000|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6709706|NCT02937168|7640024|FG001|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6709707|NCT02937168|7640025|FG002|COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6709708|NCT02937168|7640023|FG000|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6709709|NCT02937168|7640024|FG001|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6709710|NCT02937168|7640025|FG002|NOT COMPLETED|Double-Blind Treatment Period (6 Weeks)||0
6709711|NCT02937194|7640033|FG000|STARTED|1-year Followup||294
6709712|NCT02937194|7640034|FG001|STARTED|1-year Followup||286
6709713|NCT02937194|7640033|FG000|COMPLETED|1-year Followup||223
6709714|NCT02937194|7640034|FG001|COMPLETED|1-year Followup||218
6709715|NCT02937194|7640033|FG000|NOT COMPLETED|1-year Followup||71
6709716|NCT02937194|7640034|FG001|NOT COMPLETED|1-year Followup||68
6709717|NCT02937194|7640033|FG000|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
6709718|NCT02937194|7640034|FG001|STARTED|2-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
6709719|NCT02937194|7640033|FG000|COMPLETED|2-years Followup||216
6709720|NCT02937194|7640034|FG001|COMPLETED|2-years Followup||208
6709721|NCT02937194|7640033|FG000|NOT COMPLETED|2-years Followup||78
6709722|NCT02937194|7640034|FG001|NOT COMPLETED|2-years Followup||78
6709723|NCT02937194|7640033|FG000|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 294 for each follow-up.|294
6709724|NCT02937194|7640034|FG001|STARTED|3-years Followup|The researchers contacted all the participants recruited/enrolled at baseline at each follow-up regardless if they had participated in the previous follow-up or not. So the number started equals 286 for each follow-up.|286
6709725|NCT02937194|7640033|FG000|COMPLETED|3-years Followup||228
6709726|NCT02937194|7640034|FG001|COMPLETED|3-years Followup||208
6709727|NCT02937194|7640033|FG000|NOT COMPLETED|3-years Followup||66
6709728|NCT02937194|7640034|FG001|NOT COMPLETED|3-years Followup||78
6709729|NCT02937350|7640043|FG000|STARTED|Overall Study||43
6709730|NCT02937350|7640044|FG001|STARTED|Overall Study||25
6709731|NCT02937350|7640045|FG002|STARTED|Overall Study||20
6709732|NCT02937350|7640043|FG000|COMPLETED|Overall Study||43
6709733|NCT02937350|7640044|FG001|COMPLETED|Overall Study||24
6709734|NCT02937350|7640045|FG002|COMPLETED|Overall Study||20
6709735|NCT02937350|7640043|FG000|NOT COMPLETED|Overall Study||0
6709736|NCT02937350|7640044|FG001|NOT COMPLETED|Overall Study||1
6709737|NCT02937350|7640045|FG002|NOT COMPLETED|Overall Study||0
6709738|NCT02937454|7640053|FG000|STARTED|Overall Study||567
6709739|NCT02937454|7640054|FG001|STARTED|Overall Study||565
6709740|NCT02937454|7640053|FG000|Started Treatment|Overall Study||559
6709741|NCT02937454|7640054|FG001|Started Treatment|Overall Study||551
6709742|NCT02937454|7640053|FG000|COMPLETED|Overall Study||427
6709743|NCT02937454|7640054|FG001|COMPLETED|Overall Study||437
6709744|NCT02937454|7640053|FG000|NOT COMPLETED|Overall Study||140
6709745|NCT02937454|7640054|FG001|NOT COMPLETED|Overall Study||128
6709746|NCT02937506|7640063|FG000|STARTED|Overall Study||300
6709747|NCT02937506|7640064|FG001|STARTED|Overall Study||300
6709748|NCT02937506|7640063|FG000|COMPLETED|Overall Study||300
6709749|NCT02937506|7640064|FG001|COMPLETED|Overall Study||300
6709750|NCT02937506|7640063|FG000|NOT COMPLETED|Overall Study||0
6709751|NCT02937506|7640064|FG001|NOT COMPLETED|Overall Study||0
6709752|NCT02937545|7640072|FG000|STARTED|Overall Study||69
6709753|NCT02937545|7640073|FG001|STARTED|Overall Study||85
6709754|NCT02937545|7640074|FG002|STARTED|Overall Study||15
6709755|NCT02937545|7640075|FG003|STARTED|Overall Study||21
6709756|NCT02937545|7640072|FG000|COMPLETED|Overall Study||67
6709757|NCT02937545|7640073|FG001|COMPLETED|Overall Study||83
6709758|NCT02937545|7640074|FG002|COMPLETED|Overall Study||9
6709759|NCT02937545|7640075|FG003|COMPLETED|Overall Study||14
6709760|NCT02937545|7640072|FG000|NOT COMPLETED|Overall Study||2
6261887|NCT03167242|7160764|FG007|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
6261888|NCT03167242|7160765|FG008|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
6261889|NCT03167242|7160766|FG009|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
6261890|NCT03167242|7160767|FG010|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
6261891|NCT03167242|7160768|FG011|Rich Pharmacokinetics (PK) Analysis Subset|Overall Study||0
6261892|NCT03167242|7160757|FG000|COMPLETED|Overall Study||12
6261893|NCT03167242|7160758|FG001|COMPLETED|Overall Study||50
6261894|NCT03167242|7160759|FG002|COMPLETED|Overall Study||48
6261895|NCT03167242|7160760|FG003|COMPLETED|Overall Study||50
6261896|NCT03167242|7160761|FG004|COMPLETED|Overall Study||53
6261897|NCT03167242|7160762|FG005|COMPLETED|Overall Study||49
6261898|NCT03167242|7160763|FG006|COMPLETED|Overall Study||50
6261899|NCT03167242|7160764|FG007|COMPLETED|Overall Study||26
6261900|NCT03167242|7160765|FG008|COMPLETED|Overall Study||52
6261901|NCT03167242|7160766|FG009|COMPLETED|Overall Study||53
6261902|NCT03167242|7160767|FG010|COMPLETED|Overall Study||43
6261903|NCT03167242|7160768|FG011|COMPLETED|Overall Study||23
6261904|NCT03167242|7160757|FG000|NOT COMPLETED|Overall Study||0
6261905|NCT03167242|7160758|FG001|NOT COMPLETED|Overall Study||1
6261906|NCT03167242|7160759|FG002|NOT COMPLETED|Overall Study||3
6261907|NCT03167242|7160760|FG003|NOT COMPLETED|Overall Study||1
6261908|NCT03167242|7160761|FG004|NOT COMPLETED|Overall Study||1
6261909|NCT03167242|7160762|FG005|NOT COMPLETED|Overall Study||2
6709761|NCT02937545|7640073|FG001|NOT COMPLETED|Overall Study||2
6709762|NCT02937545|7640074|FG002|NOT COMPLETED|Overall Study||6
6709763|NCT02937545|7640075|FG003|NOT COMPLETED|Overall Study||7
6709764|NCT02937558|7640088|FG000|STARTED|Double-blind Phase||3
6709765|NCT02937558|7640089|FG001|STARTED|Double-blind Phase||2
6709766|NCT02937558|7640088|FG000|COMPLETED|Double-blind Phase||3
6709767|NCT02937558|7640089|FG001|COMPLETED|Double-blind Phase||2
6709768|NCT02937558|7640088|FG000|NOT COMPLETED|Double-blind Phase||0
6709769|NCT02937558|7640089|FG001|NOT COMPLETED|Double-blind Phase||0
6709770|NCT02937558|7640088|FG000|STARTED|Open-label Phase||5
6709771|NCT02937558|7640089|FG001|STARTED|Open-label Phase||0
6709772|NCT02937558|7640088|FG000|COMPLETED|Open-label Phase||5
6709773|NCT02937558|7640089|FG001|COMPLETED|Open-label Phase||0
6709774|NCT02937558|7640088|FG000|NOT COMPLETED|Open-label Phase||0
6709775|NCT02937558|7640089|FG001|NOT COMPLETED|Open-label Phase||0
6709776|NCT02937584|7640096|FG000|STARTED|Period 1||11
6709777|NCT02937584|7640097|FG001|STARTED|Period 1||12
6709778|NCT02937584|7640096|FG000|COMPLETED|Period 1||10
6709779|NCT02937584|7640097|FG001|COMPLETED|Period 1||10
6709780|NCT02937584|7640096|FG000|NOT COMPLETED|Period 1||1
6709781|NCT02937584|7640097|FG001|NOT COMPLETED|Period 1||2
6709782|NCT02937584|7640096|FG000|STARTED|Washout||10
6709783|NCT02937584|7640097|FG001|STARTED|Washout||10
6709784|NCT02937584|7640096|FG000|COMPLETED|Washout||10
6709785|NCT02937584|7640097|FG001|COMPLETED|Washout||9
6709786|NCT02937584|7640096|FG000|NOT COMPLETED|Washout||0
6709787|NCT02937584|7640097|FG001|NOT COMPLETED|Washout||1
6709788|NCT02937584|7640096|FG000|STARTED|Period 2||10
6709789|NCT02937584|7640097|FG001|STARTED|Period 2||9
6709790|NCT02937584|7640096|FG000|COMPLETED|Period 2||10
6709791|NCT02937584|7640097|FG001|COMPLETED|Period 2||9
6709792|NCT02937584|7640096|FG000|NOT COMPLETED|Period 2||0
6709793|NCT02937584|7640097|FG001|NOT COMPLETED|Period 2||0
6709794|NCT02937623|7640105|FG000|STARTED|Overall Study||60
6709795|NCT02937623|7640106|FG001|STARTED|Overall Study||60
6709796|NCT02937623|7640105|FG000|COMPLETED|Overall Study||60
6709797|NCT02937623|7640106|FG001|COMPLETED|Overall Study||60
6709798|NCT02937623|7640105|FG000|NOT COMPLETED|Overall Study||0
6709799|NCT02937623|7640106|FG001|NOT COMPLETED|Overall Study||0
6709800|NCT02937636|7640114|FG000|STARTED|Overall Study||63
6709801|NCT02937636|7640115|FG001|STARTED|Overall Study||65
6709802|NCT02937636|7640114|FG000|COMPLETED|Overall Study||60
6709803|NCT02937636|7640115|FG001|COMPLETED|Overall Study||63
6709804|NCT02937636|7640114|FG000|NOT COMPLETED|Overall Study||3
6709805|NCT02937636|7640115|FG001|NOT COMPLETED|Overall Study||2
6709806|NCT02937701|7640124|FG000|STARTED|Day 1 to Week 22||279
6709807|NCT02937701|7640125|FG001|STARTED|Day 1 to Week 22||279
6709808|NCT02937701|7640126|FG002|STARTED|Day 1 to Week 22||0
6709809|NCT02937701|7640127|FG003|STARTED|Day 1 to Week 22||0
6709810|NCT02937701|7640128|FG004|STARTED|Day 1 to Week 22||0
6709811|NCT02937701|7640124|FG000|Received Treatment|Day 1 to Week 22||278
6709812|NCT02937701|7640125|FG001|Received Treatment|Day 1 to Week 22||278
6709813|NCT02937701|7640126|FG002|Received Treatment|Day 1 to Week 22||0
6709814|NCT02937701|7640127|FG003|Received Treatment|Day 1 to Week 22||0
6709815|NCT02937701|7640128|FG004|Received Treatment|Day 1 to Week 22||0
6709816|NCT02937701|7640124|FG000|COMPLETED|Day 1 to Week 22||244
6709817|NCT02937701|7640125|FG001|COMPLETED|Day 1 to Week 22||240
6709818|NCT02937701|7640126|FG002|COMPLETED|Day 1 to Week 22||0
6709819|NCT02937701|7640127|FG003|COMPLETED|Day 1 to Week 22||0
6709820|NCT02937701|7640128|FG004|COMPLETED|Day 1 to Week 22||0
6709821|NCT02937701|7640124|FG000|NOT COMPLETED|Day 1 to Week 22||35
6709822|NCT02937701|7640125|FG001|NOT COMPLETED|Day 1 to Week 22||39
6709823|NCT02937701|7640126|FG002|NOT COMPLETED|Day 1 to Week 22||0
6709824|NCT02937701|7640127|FG003|NOT COMPLETED|Day 1 to Week 22||0
6709825|NCT02937701|7640128|FG004|NOT COMPLETED|Day 1 to Week 22||0
6709826|NCT02937701|7640124|FG000|STARTED|Week 22 to Week 50||0
6709827|NCT02937701|7640125|FG001|STARTED|Week 22 to Week 50||0
6709828|NCT02937701|7640126|FG002|STARTED|Week 22 to Week 50||244
6709829|NCT02937701|7640127|FG003|STARTED|Week 22 to Week 50||121
6709830|NCT02937701|7640128|FG004|STARTED|Week 22 to Week 50||119
6709831|NCT02937701|7640124|FG000|COMPLETED|Week 22 to Week 50||0
6709832|NCT02937701|7640125|FG001|COMPLETED|Week 22 to Week 50||0
6709833|NCT02937701|7640126|FG002|COMPLETED|Week 22 to Week 50||212
6709834|NCT02937701|7640127|FG003|COMPLETED|Week 22 to Week 50||113
6709835|NCT02937701|7640128|FG004|COMPLETED|Week 22 to Week 50||110
6709836|NCT02937701|7640124|FG000|NOT COMPLETED|Week 22 to Week 50||0
6709837|NCT02937701|7640125|FG001|NOT COMPLETED|Week 22 to Week 50||0
6709838|NCT02937701|7640126|FG002|NOT COMPLETED|Week 22 to Week 50||32
6709839|NCT02937701|7640127|FG003|NOT COMPLETED|Week 22 to Week 50||8
6709840|NCT02937701|7640128|FG004|NOT COMPLETED|Week 22 to Week 50||9
6709841|NCT02937740|7640142|FG000|STARTED|BID for 90 Days, 22 mg/Day||24
6709842|NCT02937740|7640143|FG001|STARTED|BID for 90 Days, 22 mg/Day||93
6709843|NCT02937740|7640142|FG000|COMPLETED|BID for 90 Days, 22 mg/Day||19
6709844|NCT02937740|7640143|FG001|COMPLETED|BID for 90 Days, 22 mg/Day||62
6709845|NCT02937740|7640142|FG000|NOT COMPLETED|BID for 90 Days, 22 mg/Day||5
6709846|NCT02937740|7640143|FG001|NOT COMPLETED|BID for 90 Days, 22 mg/Day||31
6709847|NCT02937740|7640142|FG000|STARTED|Uptitrated to TID on Day 90 for 30 Days||13
6709848|NCT02937740|7640143|FG001|STARTED|Uptitrated to TID on Day 90 for 30 Days||17
6709849|NCT02937740|7640142|FG000|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||12
6709850|NCT02937740|7640143|FG001|COMPLETED|Uptitrated to TID on Day 90 for 30 Days||15
6709851|NCT02937740|7640142|FG000|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||1
6709852|NCT02937740|7640143|FG001|NOT COMPLETED|Uptitrated to TID on Day 90 for 30 Days||2
6709853|NCT02937870|7640155|FG000|STARTED|Overall Study||23
6709854|NCT02937870|7640155|FG000|Received Test Adhesive 1|Overall Study||21
6709855|NCT02937870|7640155|FG000|Received Test Adhesive 2|Overall Study||22
6709856|NCT02937870|7640155|FG000|Received Positive Control Adhesive|Overall Study||21
6261910|NCT03167242|7160763|FG006|NOT COMPLETED|Overall Study||2
6261911|NCT03167242|7160764|FG007|NOT COMPLETED|Overall Study||1
6261912|NCT03167242|7160765|FG008|NOT COMPLETED|Overall Study||1
6261913|NCT03167242|7160766|FG009|NOT COMPLETED|Overall Study||0
6261914|NCT03167242|7160767|FG010|NOT COMPLETED|Overall Study||2
6261915|NCT03167242|7160768|FG011|NOT COMPLETED|Overall Study||1
6261916|NCT03144674|7160808|FG000|STARTED|Overall Study||4
6261917|NCT03144674|7160809|FG001|STARTED|Overall Study||6
6261918|NCT03144674|7160810|FG002|STARTED|Overall Study||28
6261919|NCT03144674|7160811|FG003|STARTED|Overall Study||72
6261920|NCT03144674|7160808|FG000|COMPLETED|Overall Study||0
6261921|NCT03144674|7160809|FG001|COMPLETED|Overall Study||0
6261922|NCT03144674|7160810|FG002|COMPLETED|Overall Study||0
6261923|NCT03144674|7160811|FG003|COMPLETED|Overall Study||0
6261924|NCT03144674|7160808|FG000|NOT COMPLETED|Overall Study||4
6261925|NCT03144674|7160809|FG001|NOT COMPLETED|Overall Study||6
6261926|NCT03144674|7160810|FG002|NOT COMPLETED|Overall Study||28
6261927|NCT03144674|7160811|FG003|NOT COMPLETED|Overall Study||72
6261928|NCT03137537|7160828|FG000|STARTED|Overall Study||12
6261929|NCT03137537|7160829|FG001|STARTED|Overall Study||11
6261930|NCT03137537|7160828|FG000|COMPLETED|Overall Study||12
6261931|NCT03137537|7160829|FG001|COMPLETED|Overall Study||10
6261932|NCT03137537|7160828|FG000|NOT COMPLETED|Overall Study||0
6261933|NCT03137537|7160829|FG001|NOT COMPLETED|Overall Study||1
6261934|NCT03126019|7160837|FG000|STARTED|Overall Study||23
6261935|NCT03126019|7160838|FG001|STARTED|Overall Study||103
6261936|NCT03126019|7160837|FG000|COMPLETED|Overall Study||0
6261937|NCT03126019|7160838|FG001|COMPLETED|Overall Study||0
6261938|NCT03126019|7160837|FG000|NOT COMPLETED|Overall Study||23
6261939|NCT03126019|7160838|FG001|NOT COMPLETED|Overall Study||103
6261940|NCT03113383|7160845|FG000|STARTED|Overall Study||4
6261941|NCT03113383|7160846|FG001|STARTED|Overall Study||0
6261942|NCT03113383|7160845|FG000|COMPLETED|Overall Study||0
6261943|NCT03113383|7160846|FG001|COMPLETED|Overall Study||0
6261944|NCT03113383|7160845|FG000|NOT COMPLETED|Overall Study||4
6261945|NCT03113383|7160846|FG001|NOT COMPLETED|Overall Study||0
6261946|NCT03057106|7160854|FG000|STARTED|Overall Study|1 patient refused the treatment|149
6261947|NCT03057106|7160855|FG001|STARTED|Overall Study|3 patients refused the treatment|148
6261948|NCT03057106|7160854|FG000|COMPLETED|Overall Study||149
6261949|NCT03057106|7160855|FG001|COMPLETED|Overall Study||148
6261950|NCT03057106|7160854|FG000|NOT COMPLETED|Overall Study||0
6261951|NCT03057106|7160855|FG001|NOT COMPLETED|Overall Study||0
6261952|NCT03028896|7160863|FG000|STARTED|Overall Study||66
6261953|NCT03028896|7160864|FG001|STARTED|Overall Study||66
6261954|NCT03028896|7160863|FG000|COMPLETED|Overall Study||63
6261955|NCT03028896|7160864|FG001|COMPLETED|Overall Study||66
6261956|NCT03028896|7160863|FG000|NOT COMPLETED|Overall Study||3
6261957|NCT03028896|7160864|FG001|NOT COMPLETED|Overall Study||0
6261958|NCT03008369|7160870|FG000|STARTED|Overall Study||3
6261959|NCT03008369|7160870|FG000|COMPLETED|Overall Study||3
6261960|NCT03008369|7160870|FG000|NOT COMPLETED|Overall Study||0
6261961|NCT02978326|7160877|FG000|STARTED|Part A (Up to 75 Days)||1
6261962|NCT02978326|7160878|FG001|STARTED|Part A (Up to 75 Days)||0
6261963|NCT02978326|7160879|FG002|STARTED|Part A (Up to 75 Days)||0
6261964|NCT02978326|7160877|FG000|COMPLETED|Part A (Up to 75 Days)||1
6261965|NCT02978326|7160878|FG001|COMPLETED|Part A (Up to 75 Days)||0
6261966|NCT02978326|7160879|FG002|COMPLETED|Part A (Up to 75 Days)||0
6261967|NCT02978326|7160877|FG000|NOT COMPLETED|Part A (Up to 75 Days)||0
6261968|NCT02978326|7160878|FG001|NOT COMPLETED|Part A (Up to 75 Days)||0
6261969|NCT02978326|7160879|FG002|NOT COMPLETED|Part A (Up to 75 Days)||0
6261970|NCT02978326|7160877|FG000|STARTED|Part B (Up to 45 Days)||0
6261971|NCT02978326|7160878|FG001|STARTED|Part B (Up to 45 Days)||76
6261972|NCT02978326|7160879|FG002|STARTED|Part B (Up to 45 Days)||77
6261973|NCT02978326|7160877|FG000|Received Study Drug|Part B (Up to 45 Days)||0
6261974|NCT02978326|7160878|FG001|Received Study Drug|Part B (Up to 45 Days)||73
6261975|NCT02978326|7160879|FG002|Received Study Drug|Part B (Up to 45 Days)|Two participants were randomized to placebo but received at least 1 dose of SAGE-217 in error and were included in the SAGE-217 group for 'Received Study Drug' and for 'Safety Analysis'.|78
6261976|NCT02978326|7160877|FG000|Safety Set (Part B)|Part B (Up to 45 Days)||0
6261977|NCT02978326|7160878|FG001|Safety Set (Part B)|Part B (Up to 45 Days)||73
6602708|NCT02058290|7527749|FG001|NOT COMPLETED|Overall Study||9
6602709|NCT02058368|7527757|FG000|STARTED|Overall Study||302
6602710|NCT02058368|7527758|FG001|STARTED|Overall Study||305
6602711|NCT02058368|7527757|FG000|COMPLETED|Overall Study||261
6602712|NCT02058368|7527758|FG001|COMPLETED|Overall Study||251
6602713|NCT02058368|7527757|FG000|NOT COMPLETED|Overall Study||41
6602714|NCT02058368|7527758|FG001|NOT COMPLETED|Overall Study||54
6261978|NCT02978326|7160879|FG002|Safety Set (Part B)|Part B (Up to 45 Days)||78
6261979|NCT02978326|7160877|FG000|Efficacy Set (Part B)|Part B (Up to 45 Days)||0
6261980|NCT02978326|7160878|FG001|Efficacy Set (Part B)|Part B (Up to 45 Days)||74
6261981|NCT02978326|7160879|FG002|Efficacy Set (Part B)|Part B (Up to 45 Days)||76
6261982|NCT02978326|7160877|FG000|COMPLETED|Part B (Up to 45 Days)||0
6261983|NCT02978326|7160878|FG001|COMPLETED|Part B (Up to 45 Days)||69
6261984|NCT02978326|7160879|FG002|COMPLETED|Part B (Up to 45 Days)||73
6602715|NCT02058498|7527764|FG000|STARTED|Overall Study||12
6709857|NCT02937870|7640155|FG000|Received no Adhesive|Overall Study||20
6709858|NCT02937870|7640155|FG000|COMPLETED|Overall Study||20
6709859|NCT02937870|7640155|FG000|NOT COMPLETED|Overall Study||3
6709860|NCT02938052|7640169|FG000|STARTED|Overall Study||10
6709861|NCT02938052|7640169|FG000|COMPLETED|Overall Study||10
6709862|NCT02938052|7640169|FG000|NOT COMPLETED|Overall Study||0
6709863|NCT02938169|7640178|FG000|STARTED|Overall Study||15
6709864|NCT02938169|7640179|FG001|STARTED|Overall Study||15
6709865|NCT02938169|7640180|FG002|STARTED|Overall Study||15
6709866|NCT02938169|7640181|FG003|STARTED|Overall Study||15
6709867|NCT02938169|7640178|FG000|COMPLETED|Overall Study||13
6709868|NCT02938169|7640179|FG001|COMPLETED|Overall Study||13
6709869|NCT02938169|7640180|FG002|COMPLETED|Overall Study||10
6709870|NCT02938169|7640181|FG003|COMPLETED|Overall Study||12
6709871|NCT02938169|7640178|FG000|NOT COMPLETED|Overall Study||2
6709872|NCT02938169|7640179|FG001|NOT COMPLETED|Overall Study||2
6709873|NCT02938169|7640180|FG002|NOT COMPLETED|Overall Study||5
6709874|NCT02938169|7640181|FG003|NOT COMPLETED|Overall Study||3
6709875|NCT02938494|7640202|FG000|STARTED|Overall Study||69
6709876|NCT02938494|7640203|FG001|STARTED|Overall Study||72
6709877|NCT02938494|7640204|FG002|STARTED|Overall Study||34
6709878|NCT02938494|7640205|FG003|STARTED|Overall Study||35
6709879|NCT02938494|7640202|FG000|COMPLETED|Overall Study||65
6709880|NCT02938494|7640203|FG001|COMPLETED|Overall Study||63
6709881|NCT02938494|7640204|FG002|COMPLETED|Overall Study||30
6709882|NCT02938494|7640205|FG003|COMPLETED|Overall Study||31
6709883|NCT02938494|7640202|FG000|NOT COMPLETED|Overall Study||4
6709884|NCT02938494|7640203|FG001|NOT COMPLETED|Overall Study||9
6709885|NCT02938494|7640204|FG002|NOT COMPLETED|Overall Study||4
6709886|NCT02938494|7640205|FG003|NOT COMPLETED|Overall Study||4
6709887|NCT02938520|7640216|FG000|STARTED|Overall Study||283
6709888|NCT02938520|7640217|FG001|STARTED|Overall Study||283
6709889|NCT02938520|7640216|FG000|COMPLETED|Overall Study||0
6709890|NCT02938520|7640217|FG001|COMPLETED|Overall Study||0
6709891|NCT02938520|7640216|FG000|NOT COMPLETED|Overall Study||283
6709892|NCT02938520|7640217|FG001|NOT COMPLETED|Overall Study||283
6709893|NCT02938585|7640230|FG000|STARTED|Overall Study||9
6709894|NCT02938585|7640231|FG001|STARTED|Overall Study||33
6709895|NCT02938585|7640232|FG002|STARTED|Overall Study||11
6709896|NCT02938585|7640233|FG003|STARTED|Overall Study||15
6709897|NCT02938585|7640230|FG000|Exposed to Prophylaxis Regimen|Overall Study||9
6709898|NCT02938585|7640231|FG001|Exposed to Prophylaxis Regimen|Overall Study||31
6709899|NCT02938585|7640232|FG002|Exposed to Prophylaxis Regimen|Overall Study||11
6709900|NCT02938585|7640233|FG003|Exposed to Prophylaxis Regimen|Overall Study||12
6709901|NCT02938585|7640230|FG000|Exposed to On-demand Regimen|Overall Study||1
6709902|NCT02938585|7640231|FG001|Exposed to On-demand Regimen|Overall Study||7
6709903|NCT02938585|7640232|FG002|Exposed to On-demand Regimen|Overall Study||1
6709904|NCT02938585|7640233|FG003|Exposed to On-demand Regimen|Overall Study||8
6709905|NCT02938585|7640230|FG000|COMPLETED|Overall Study||9
6709906|NCT02938585|7640231|FG001|COMPLETED|Overall Study||32
6709907|NCT02938585|7640232|FG002|COMPLETED|Overall Study||11
6709908|NCT02938585|7640233|FG003|COMPLETED|Overall Study||10
6709909|NCT02938585|7640230|FG000|NOT COMPLETED|Overall Study||0
6709910|NCT02938585|7640231|FG001|NOT COMPLETED|Overall Study||1
6709911|NCT02938585|7640232|FG002|NOT COMPLETED|Overall Study||0
6709912|NCT02938585|7640233|FG003|NOT COMPLETED|Overall Study||5
6709913|NCT02938949|7640259|FG000|STARTED|Overall Study||10
6709914|NCT02938949|7640260|FG001|STARTED|Overall Study||10
6709915|NCT02938949|7640259|FG000|COMPLETED|Overall Study||10
6709916|NCT02938949|7640260|FG001|COMPLETED|Overall Study||10
6709917|NCT02938949|7640259|FG000|NOT COMPLETED|Overall Study||0
6709918|NCT02938949|7640260|FG001|NOT COMPLETED|Overall Study||0
6709919|NCT02939014|7640268|FG000|STARTED|Overall Study||30
6709920|NCT02939014|7640269|FG001|STARTED|Overall Study||9
6709921|NCT02939014|7640268|FG000|COMPLETED|Overall Study||25
6709922|NCT02939014|7640269|FG001|COMPLETED|Overall Study||6
6709923|NCT02939014|7640268|FG000|NOT COMPLETED|Overall Study||5
6709924|NCT02939014|7640269|FG001|NOT COMPLETED|Overall Study||3
6709925|NCT02939079|7640278|FG000|STARTED|Overall Study||25
6709926|NCT02939079|7640279|FG001|STARTED|Overall Study||25
6709927|NCT02939079|7640278|FG000|COMPLETED|Overall Study||21
6709928|NCT02939079|7640279|FG001|COMPLETED|Overall Study||20
6709929|NCT02939079|7640278|FG000|NOT COMPLETED|Overall Study||4
6709930|NCT02939079|7640279|FG001|NOT COMPLETED|Overall Study||5
6709931|NCT02939105|7640285|FG000|STARTED|Overall Study||15
6709932|NCT02939105|7640285|FG000|COMPLETED|Overall Study||15
6709933|NCT02939105|7640285|FG000|NOT COMPLETED|Overall Study||0
6709934|NCT02939131|7640292|FG000|STARTED|Overall Study|One additional site in the COMB-R group withdrew prior to the start of participant enrollment.|81
6709935|NCT02939131|7640293|FG001|STARTED|Overall Study||75
6709936|NCT02939131|7640292|FG000|Week 24 Visit|Overall Study|These are the numbers still on study at week 24|74
6709937|NCT02939131|7640293|FG001|Week 24 Visit|Overall Study||72
6709938|NCT02939131|7640292|FG000|COMPLETED|Overall Study||70
6709939|NCT02939131|7640293|FG001|COMPLETED|Overall Study||66
6709940|NCT02939131|7640292|FG000|NOT COMPLETED|Overall Study||11
6709941|NCT02939131|7640293|FG001|NOT COMPLETED|Overall Study||9
6709942|NCT02939170|7640302|FG000|STARTED|Overall Study||40
6709943|NCT02939170|7640303|FG001|STARTED|Overall Study||40
6709944|NCT02939170|7640302|FG000|COMPLETED|Overall Study||40
6709945|NCT02939170|7640303|FG001|COMPLETED|Overall Study||40
6709946|NCT02939170|7640302|FG000|NOT COMPLETED|Overall Study||0
6709947|NCT02939170|7640303|FG001|NOT COMPLETED|Overall Study||0
6709948|NCT02939326|7640318|FG000|STARTED|Overall Study||7
6709949|NCT02939326|7640319|FG001|STARTED|Overall Study||5
6709950|NCT02939326|7640320|FG002|STARTED|Overall Study||5
6709951|NCT02939326|7640321|FG003|STARTED|Overall Study||5
6709952|NCT02939326|7640322|FG004|STARTED|Overall Study||5
6709953|NCT02939326|7640323|FG005|STARTED|Overall Study||5
6709954|NCT02939326|7640324|FG006|STARTED|Overall Study||5
6709955|NCT02939326|7640325|FG007|STARTED|Overall Study||5
6709956|NCT02939326|7640318|FG000|COMPLETED|Overall Study||7
6709957|NCT02939326|7640319|FG001|COMPLETED|Overall Study||5
6709958|NCT02939326|7640320|FG002|COMPLETED|Overall Study||5
6709959|NCT02939326|7640321|FG003|COMPLETED|Overall Study||5
6709960|NCT02939326|7640322|FG004|COMPLETED|Overall Study||5
6709961|NCT02939326|7640323|FG005|COMPLETED|Overall Study||5
6709962|NCT02939326|7640324|FG006|COMPLETED|Overall Study||5
6709963|NCT02939326|7640325|FG007|COMPLETED|Overall Study||5
6709964|NCT02939326|7640318|FG000|NOT COMPLETED|Overall Study||0
6709965|NCT02939326|7640319|FG001|NOT COMPLETED|Overall Study||0
6709966|NCT02939326|7640320|FG002|NOT COMPLETED|Overall Study||0
6709967|NCT02939326|7640321|FG003|NOT COMPLETED|Overall Study||0
6709968|NCT02939326|7640322|FG004|NOT COMPLETED|Overall Study||0
6709969|NCT02939326|7640323|FG005|NOT COMPLETED|Overall Study||0
6709970|NCT02939326|7640324|FG006|NOT COMPLETED|Overall Study||0
6709971|NCT02939326|7640325|FG007|NOT COMPLETED|Overall Study||0
6709972|NCT02939560|7640343|FG000|STARTED|Overall Study||13
6709973|NCT02939560|7640343|FG000|COMPLETED|Overall Study||10
6709974|NCT02939560|7640343|FG000|NOT COMPLETED|Overall Study||3
6709975|NCT02939599|7640349|FG000|STARTED|Overall Study||3
6709976|NCT02939599|7640350|FG001|STARTED|Overall Study||2
6709977|NCT02939599|7640349|FG000|COMPLETED|Overall Study||0
6709978|NCT02939599|7640350|FG001|COMPLETED|Overall Study||0
6709979|NCT02939599|7640349|FG000|NOT COMPLETED|Overall Study||3
6709980|NCT02939599|7640350|FG001|NOT COMPLETED|Overall Study||2
6709981|NCT02939651|7640357|FG000|STARTED|Overall Study||21
6709982|NCT02939651|7640357|FG000|COMPLETED|Overall Study||21
6709983|NCT02939651|7640357|FG000|NOT COMPLETED|Overall Study||0
6709984|NCT02939716|7640361|FG000|STARTED|Overall Study||3
6709985|NCT02939716|7640362|FG001|STARTED|Overall Study||3
6709986|NCT02939716|7640363|FG002|STARTED|Overall Study||3
6709987|NCT02939716|7640364|FG003|STARTED|Overall Study||3
6709988|NCT02939716|7640365|FG004|STARTED|Overall Study||3
6709989|NCT02939716|7640366|FG005|STARTED|Overall Study||3
6709990|NCT02939716|7640361|FG000|COMPLETED|Overall Study||3
6709991|NCT02939716|7640362|FG001|COMPLETED|Overall Study||3
6709992|NCT02939716|7640363|FG002|COMPLETED|Overall Study||3
6709993|NCT02939716|7640364|FG003|COMPLETED|Overall Study||2
6709994|NCT02939716|7640365|FG004|COMPLETED|Overall Study||2
6709995|NCT02939716|7640366|FG005|COMPLETED|Overall Study||2
6709996|NCT02939716|7640361|FG000|NOT COMPLETED|Overall Study||0
6709997|NCT02939716|7640362|FG001|NOT COMPLETED|Overall Study||0
6709998|NCT02939716|7640363|FG002|NOT COMPLETED|Overall Study||0
6709999|NCT02939716|7640364|FG003|NOT COMPLETED|Overall Study||1
6710000|NCT02939716|7640365|FG004|NOT COMPLETED|Overall Study||1
6710001|NCT02939716|7640366|FG005|NOT COMPLETED|Overall Study||1
6710002|NCT02939781|7640383|FG000|STARTED|Overall Study||12
6710003|NCT02939781|7640383|FG000|COMPLETED|Overall Study||3
6710004|NCT02939781|7640383|FG000|NOT COMPLETED|Overall Study||9
6710005|NCT02939937|7640390|FG000|STARTED|Overall Study|5 patients had drug reaction and 1 patient excluded from study,|21
6710006|NCT02939937|7640391|FG001|STARTED|Overall Study|3 patients excluded from study|50
6710007|NCT02939937|7640390|FG000|COMPLETED|Overall Study||15
6710008|NCT02939937|7640391|FG001|COMPLETED|Overall Study||47
6710009|NCT02939937|7640390|FG000|NOT COMPLETED|Overall Study||6
6710010|NCT02939937|7640391|FG001|NOT COMPLETED|Overall Study||3
6710011|NCT02939950|7640399|FG000|STARTED|Overall Study||406
6710012|NCT02939950|7640400|FG001|STARTED|Overall Study||410
6710013|NCT02939950|7640399|FG000|Dispensed the Assigned Lenses|Overall Study||405
6710014|NCT02939950|7640400|FG001|Dispensed the Assigned Lenses|Overall Study||410
6710015|NCT02939950|7640399|FG000|Eligible at Baseline|Overall Study||403
6710016|NCT02939950|7640400|FG001|Eligible at Baseline|Overall Study||402
6710017|NCT02939950|7640399|FG000|COMPLETED|Overall Study||340
6710018|NCT02939950|7640400|FG001|COMPLETED|Overall Study||329
6710019|NCT02939950|7640399|FG000|NOT COMPLETED|Overall Study||66
6710020|NCT02939950|7640400|FG001|NOT COMPLETED|Overall Study||81
6710021|NCT02940249|7640406|FG000|STARTED|Overall Study||34
6710022|NCT02940249|7640406|FG000|COMPLETED|Overall Study||30
6710023|NCT02940249|7640406|FG000|NOT COMPLETED|Overall Study||4
6710024|NCT02940327|7640416|FG000|STARTED|Overall Study||24
6710025|NCT02940327|7640416|FG000|COMPLETED|Overall Study||24
6710026|NCT02940327|7640416|FG000|NOT COMPLETED|Overall Study||0
6710027|NCT02940392|7640421|FG000|STARTED|Overall Study||15
6710028|NCT02940392|7640421|FG000|COMPLETED|Overall Study||7
6710029|NCT02940392|7640421|FG000|NOT COMPLETED|Overall Study||8
6710036|NCT02940574|7640436|FG000|STARTED|From Study Start to 1-month Follow-up||22
6710037|NCT02940574|7640437|FG001|STARTED|From Study Start to 1-month Follow-up||18
6710038|NCT02940574|7640436|FG000|COMPLETED|From Study Start to 1-month Follow-up|Discontinued intervention (N=1): self-termination unrelated to treatment|21
6710039|NCT02940574|7640437|FG001|COMPLETED|From Study Start to 1-month Follow-up|All participants completed, but data from 1 participant was not included in analyses.|18
6710040|NCT02940574|7640436|FG000|NOT COMPLETED|From Study Start to 1-month Follow-up||1
6710041|NCT02940574|7640437|FG001|NOT COMPLETED|From Study Start to 1-month Follow-up||0
6710042|NCT02940574|7640436|FG000|STARTED|1-year Follow-up||21
6710043|NCT02940574|7640437|FG001|STARTED|1-year Follow-up||18
6710044|NCT02940574|7640436|FG000|COMPLETED|1-year Follow-up||18
6710045|NCT02940574|7640437|FG001|COMPLETED|1-year Follow-up||14
6710046|NCT02940574|7640436|FG000|NOT COMPLETED|1-year Follow-up||3
6710047|NCT02940574|7640437|FG001|NOT COMPLETED|1-year Follow-up||4
6710048|NCT02940626|7640449|FG000|STARTED|Overall Study||77
6710049|NCT02940626|7640450|FG001|STARTED|Overall Study||78
6710050|NCT02940626|7640449|FG000|Randomized Into Primary Prevention Study|Overall Study||77
6710051|NCT02940626|7640450|FG001|Randomized Into Primary Prevention Study|Overall Study||77
6710052|NCT02940626|7640449|FG000|Randomized Into Treatment Sub-study|Overall Study||0
6710053|NCT02940626|7640450|FG001|Randomized Into Treatment Sub-study|Overall Study||1
6710054|NCT02940626|7640449|FG000|Received Study Treatment|Overall Study||77
6710055|NCT02940626|7640450|FG001|Received Study Treatment|Overall Study||77
6710056|NCT02940626|7640449|FG000|Completed Through Study Day 22|Overall Study||42
6710057|NCT02940626|7640450|FG001|Completed Through Study Day 22|Overall Study||49
6710058|NCT02940626|7640449|FG000|COMPLETED|Overall Study||30
6710059|NCT02940626|7640450|FG001|COMPLETED|Overall Study||43
6710060|NCT02940626|7640449|FG000|NOT COMPLETED|Overall Study||47
6710061|NCT02940626|7640450|FG001|NOT COMPLETED|Overall Study||35
6710062|NCT02940691|7640458|FG000|STARTED|Overall Study||32
6710063|NCT02940691|7640458|FG000|COMPLETED|Overall Study||26
6710064|NCT02940691|7640458|FG000|NOT COMPLETED|Overall Study||6
6710065|NCT02940730|7640465|FG000|STARTED|Intervention 1||10
6710066|NCT02940730|7640466|FG001|STARTED|Intervention 1||0
6710067|NCT02940730|7640465|FG000|Received Intervention|Intervention 1||10
6710068|NCT02940730|7640466|FG001|Received Intervention|Intervention 1||0
6710069|NCT02940730|7640465|FG000|COMPLETED|Intervention 1||10
6710070|NCT02940730|7640466|FG001|COMPLETED|Intervention 1||0
6710071|NCT02940730|7640465|FG000|NOT COMPLETED|Intervention 1||0
6710072|NCT02940730|7640466|FG001|NOT COMPLETED|Intervention 1||0
6710073|NCT02940730|7640465|FG000|STARTED|Intervention 2||10
6710074|NCT02940730|7640466|FG001|STARTED|Intervention 2||0
6710075|NCT02940730|7640465|FG000|Received Intervention|Intervention 2||3
6710076|NCT02940730|7640466|FG001|Received Intervention|Intervention 2||0
6710077|NCT02940730|7640465|FG000|COMPLETED|Intervention 2||3
6710078|NCT02940730|7640466|FG001|COMPLETED|Intervention 2||0
6710079|NCT02940730|7640465|FG000|NOT COMPLETED|Intervention 2||7
6710080|NCT02940730|7640466|FG001|NOT COMPLETED|Intervention 2||0
6710081|NCT02940860|7640474|FG000|STARTED|Overall Study||1027
6710082|NCT02940860|7640475|FG001|STARTED|Overall Study||511
6710083|NCT02940860|7640474|FG000|COMPLETED|Overall Study||971
6710084|NCT02940860|7640475|FG001|COMPLETED|Overall Study||476
6710085|NCT02940860|7640474|FG000|NOT COMPLETED|Overall Study||56
6710086|NCT02940860|7640475|FG001|NOT COMPLETED|Overall Study||35
6710087|NCT02940886|7640485|FG000|STARTED|Overall Study|Intention-to-treat analysis set included 1009 subjects, safety analysis set included 989 subjects.|1009
6710088|NCT02940886|7640486|FG001|STARTED|Overall Study|Intention-to-treat analysis set included 503 subjects, safety analysis set included 494 subjects.|503
6710089|NCT02940886|7640485|FG000|Safety Analysis Set|Overall Study||989
6710090|NCT02940886|7640486|FG001|Safety Analysis Set|Overall Study||494
6710091|NCT02940886|7640485|FG000|COMPLETED|Overall Study||907
6710092|NCT02940886|7640486|FG001|COMPLETED|Overall Study||449
6710093|NCT02940886|7640485|FG000|NOT COMPLETED|Overall Study||102
6710094|NCT02940886|7640486|FG001|NOT COMPLETED|Overall Study||54
6710095|NCT02941523|7640496|FG000|STARTED|Monotherapy|8 received NOX66 400 mg monotherapy and combination therapy with carboplatin.|8
6710096|NCT02941523|7640497|FG001|STARTED|Monotherapy||8
6710097|NCT02941523|7640496|FG000|COMPLETED|Monotherapy||8
6710098|NCT02941523|7640497|FG001|COMPLETED|Monotherapy||7
6710099|NCT02941523|7640496|FG000|NOT COMPLETED|Monotherapy||0
6710100|NCT02941523|7640497|FG001|NOT COMPLETED|Monotherapy||1
6710101|NCT02941523|7640496|FG000|STARTED|Carboplatin Combination Therapy|All continued to combination therapy|8
6710102|NCT02941523|7640497|FG001|STARTED|Carboplatin Combination Therapy|7 continued to combination therapy; 3 started combination therapy only|10
6710103|NCT02941523|7640496|FG000|COMPLETED|Carboplatin Combination Therapy||3
6710104|NCT02941523|7640497|FG001|COMPLETED|Carboplatin Combination Therapy||6
6710105|NCT02941523|7640496|FG000|NOT COMPLETED|Carboplatin Combination Therapy||5
6710106|NCT02941523|7640497|FG001|NOT COMPLETED|Carboplatin Combination Therapy||4
6710107|NCT02941614|7640513|FG000|STARTED|Overall Study||744
6710108|NCT02941614|7640514|FG001|STARTED|Overall Study||692
6710109|NCT02941614|7640513|FG000|COMPLETED|Overall Study||603
6710110|NCT02941614|7640514|FG001|COMPLETED|Overall Study||446
6710111|NCT02941614|7640513|FG000|NOT COMPLETED|Overall Study||141
6710112|NCT02941614|7640514|FG001|NOT COMPLETED|Overall Study||246
6710113|NCT02941627|7640522|FG000|STARTED|Overall Study|Among 53 patients enrolled: 1 passed away after the informed consent completion, 1 was not implanted for surgical failure, and 1 for cholesteatoma discovered during surgical procedure. This last patient was included in safety analysis as defined in the protocol. Therefore, among 53 patients enrolled 51 were evaluated for safety outcomes, and 50 were successfully implanted and complete the study.|53
6710114|NCT02941627|7640522|FG000|Clinical Safety on Overall Participants|Overall Study||51
6710115|NCT02941627|7640522|FG000|Clinical Efficiency on English Speaking Participants|Overall Study|Among the 50 patients successfully implanted 33 English speaking participant complete speech performance measure.|33
6710116|NCT02941627|7640522|FG000|COMPLETED|Overall Study||50
6710117|NCT02941627|7640522|FG000|NOT COMPLETED|Overall Study||3
6710118|NCT02941640|7640536|FG000|STARTED|Overall Study||30
6710119|NCT02941640|7640537|FG001|STARTED|Overall Study||30
6710120|NCT02941640|7640538|FG002|STARTED|Overall Study||30
6710121|NCT02941640|7640539|FG003|STARTED|Overall Study||30
6710122|NCT02941640|7640536|FG000|COMPLETED|Overall Study||30
6710123|NCT02941640|7640537|FG001|COMPLETED|Overall Study||30
6710124|NCT02941640|7640538|FG002|COMPLETED|Overall Study||30
6710125|NCT02941640|7640539|FG003|COMPLETED|Overall Study||30
6710126|NCT02941640|7640536|FG000|NOT COMPLETED|Overall Study||0
6710127|NCT02941640|7640537|FG001|NOT COMPLETED|Overall Study||0
6710128|NCT02941640|7640538|FG002|NOT COMPLETED|Overall Study||0
6710129|NCT02941640|7640539|FG003|NOT COMPLETED|Overall Study||0
6710130|NCT02941692|7640551|FG000|STARTED|Overall Study||32
6710131|NCT02941692|7640552|FG001|STARTED|Overall Study||34
6710132|NCT02941692|7640551|FG000|COMPLETED|Overall Study||32
6710133|NCT02941692|7640552|FG001|COMPLETED|Overall Study||34
6710134|NCT02941692|7640551|FG000|NOT COMPLETED|Overall Study||0
6710135|NCT02941692|7640552|FG001|NOT COMPLETED|Overall Study||0
6710136|NCT02942160|7640558|FG000|STARTED|Overall Study|Observation Phase prior to open-label treatment phase|259
6710137|NCT02942160|7640558|FG000|EN3835-202 Participants|Overall Study|Observation Phase Completed|222
6710138|NCT02942160|7640558|FG000|EN3835 Treated Subjects in EN3835-202|Overall Study|EN3835 Treated Participants in EN3835-202 Started|200
6710139|NCT02942160|7640558|FG000|COMPLETED|Overall Study|EN3835 Treated Participants in EN3835-202 Completed|156
6710140|NCT02942160|7640558|FG000|NOT COMPLETED|Overall Study||103
6710141|NCT02942264|7640575|FG000|STARTED|Phase 1 MTD Finding Stage||6
6710142|NCT02942264|7640576|FG001|STARTED|Phase 1 MTD Finding Stage||13
6710143|NCT02942264|7640577|FG002|STARTED|Phase 1 MTD Finding Stage||3
6710144|NCT02942264|7640578|FG003|STARTED|Phase 1 MTD Finding Stage||6
6710145|NCT02942264|7640579|FG004|STARTED|Phase 1 MTD Finding Stage||3
6710146|NCT02942264|7640580|FG005|STARTED|Phase 1 MTD Finding Stage||2
6710147|NCT02942264|7640581|FG006|STARTED|Phase 1 MTD Finding Stage||7
6710148|NCT02942264|7640582|FG007|STARTED|Phase 1 MTD Finding Stage||0
6710149|NCT02942264|7640583|FG008|STARTED|Phase 1 MTD Finding Stage||0
6710150|NCT02942264|7640575|FG000|COMPLETED|Phase 1 MTD Finding Stage||6
6710151|NCT02942264|7640576|FG001|COMPLETED|Phase 1 MTD Finding Stage||12
6710152|NCT02942264|7640577|FG002|COMPLETED|Phase 1 MTD Finding Stage||3
6710153|NCT02942264|7640578|FG003|COMPLETED|Phase 1 MTD Finding Stage||6
6710154|NCT02942264|7640579|FG004|COMPLETED|Phase 1 MTD Finding Stage||3
6710155|NCT02942264|7640580|FG005|COMPLETED|Phase 1 MTD Finding Stage||2
6710156|NCT02942264|7640581|FG006|COMPLETED|Phase 1 MTD Finding Stage||6
6710157|NCT02942264|7640582|FG007|COMPLETED|Phase 1 MTD Finding Stage||0
6710158|NCT02942264|7640583|FG008|COMPLETED|Phase 1 MTD Finding Stage||0
6710159|NCT02942264|7640575|FG000|NOT COMPLETED|Phase 1 MTD Finding Stage||0
6710160|NCT02942264|7640576|FG001|NOT COMPLETED|Phase 1 MTD Finding Stage||1
6710161|NCT02942264|7640577|FG002|NOT COMPLETED|Phase 1 MTD Finding Stage||0
6710162|NCT02942264|7640578|FG003|NOT COMPLETED|Phase 1 MTD Finding Stage||0
6710163|NCT02942264|7640579|FG004|NOT COMPLETED|Phase 1 MTD Finding Stage||0
6710164|NCT02942264|7640580|FG005|NOT COMPLETED|Phase 1 MTD Finding Stage||0
6710165|NCT02942264|7640581|FG006|NOT COMPLETED|Phase 1 MTD Finding Stage||1
6710166|NCT02942264|7640582|FG007|NOT COMPLETED|Phase 1 MTD Finding Stage||0
6710167|NCT02942264|7640583|FG008|NOT COMPLETED|Phase 1 MTD Finding Stage||0
6710168|NCT02942264|7640575|FG000|STARTED|Phase 1 Cohort Expansion Stage||0
6710169|NCT02942264|7640576|FG001|STARTED|Phase 1 Cohort Expansion Stage||0
6710170|NCT02942264|7640577|FG002|STARTED|Phase 1 Cohort Expansion Stage||0
6710171|NCT02942264|7640578|FG003|STARTED|Phase 1 Cohort Expansion Stage||0
6710172|NCT02942264|7640579|FG004|STARTED|Phase 1 Cohort Expansion Stage||0
6710173|NCT02942264|7640580|FG005|STARTED|Phase 1 Cohort Expansion Stage||0
6710174|NCT02942264|7640581|FG006|STARTED|Phase 1 Cohort Expansion Stage||0
6710175|NCT02942264|7640582|FG007|STARTED|Phase 1 Cohort Expansion Stage||6
6710176|NCT02942264|7640583|FG008|STARTED|Phase 1 Cohort Expansion Stage||7
6710177|NCT02942264|7640575|FG000|COMPLETED|Phase 1 Cohort Expansion Stage||0
6710178|NCT02942264|7640576|FG001|COMPLETED|Phase 1 Cohort Expansion Stage||0
6710179|NCT02942264|7640577|FG002|COMPLETED|Phase 1 Cohort Expansion Stage||0
6710180|NCT02942264|7640578|FG003|COMPLETED|Phase 1 Cohort Expansion Stage||0
6710181|NCT02942264|7640579|FG004|COMPLETED|Phase 1 Cohort Expansion Stage||0
6710182|NCT02942264|7640580|FG005|COMPLETED|Phase 1 Cohort Expansion Stage||0
6710183|NCT02942264|7640581|FG006|COMPLETED|Phase 1 Cohort Expansion Stage||0
6710184|NCT02942264|7640582|FG007|COMPLETED|Phase 1 Cohort Expansion Stage||6
6710185|NCT02942264|7640583|FG008|COMPLETED|Phase 1 Cohort Expansion Stage||6
6710186|NCT02942264|7640575|FG000|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
6710187|NCT02942264|7640576|FG001|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
6710188|NCT02942264|7640577|FG002|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
6710189|NCT02942264|7640578|FG003|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
6710190|NCT02942264|7640579|FG004|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
6710191|NCT02942264|7640580|FG005|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
6710192|NCT02942264|7640581|FG006|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
6710193|NCT02942264|7640582|FG007|NOT COMPLETED|Phase 1 Cohort Expansion Stage||0
6710194|NCT02942264|7640583|FG008|NOT COMPLETED|Phase 1 Cohort Expansion Stage||1
6710195|NCT02942407|7640610|FG000|STARTED|Overall Study||82
6710196|NCT02942407|7640611|FG001|STARTED|Overall Study||72
6710197|NCT02942407|7640610|FG000|COMPLETED|Overall Study||56
6710198|NCT02942407|7640611|FG001|COMPLETED|Overall Study||48
6710199|NCT02942407|7640610|FG000|NOT COMPLETED|Overall Study||26
6710200|NCT02942407|7640611|FG001|NOT COMPLETED|Overall Study||24
6710201|NCT02942485|7640627|FG000|STARTED|Overall Study||7
6710202|NCT02942485|7640628|FG001|STARTED|Overall Study||1
6710203|NCT02942485|7640627|FG000|COMPLETED|Overall Study||6
6710204|NCT02942485|7640628|FG001|COMPLETED|Overall Study||1
6710205|NCT02942485|7640627|FG000|NOT COMPLETED|Overall Study||1
6710206|NCT02942485|7640628|FG001|NOT COMPLETED|Overall Study||0
6710207|NCT02942576|7640636|FG000|STARTED|Overall Study||405
6710208|NCT02942576|7640637|FG001|STARTED|Overall Study||197
6710209|NCT02942576|7640636|FG000|COMPLETED|Overall Study||359
6710210|NCT02942576|7640637|FG001|COMPLETED|Overall Study||174
6710211|NCT02942576|7640636|FG000|NOT COMPLETED|Overall Study||46
6710212|NCT02942576|7640637|FG001|NOT COMPLETED|Overall Study||23
6710213|NCT02942654|7640643|FG000|STARTED|Period 1||16
6710214|NCT02942654|7640644|FG001|STARTED|Period 1||16
6710215|NCT02942654|7640643|FG000|Received at Least 1 Dose of Study Drug|Period 1||16
6710216|NCT02942654|7640644|FG001|Received at Least 1 Dose of Study Drug|Period 1||16
6710217|NCT02942654|7640643|FG000|COMPLETED|Period 1||16
6710218|NCT02942654|7640644|FG001|COMPLETED|Period 1||16
6710219|NCT02942654|7640643|FG000|NOT COMPLETED|Period 1||0
6710220|NCT02942654|7640644|FG001|NOT COMPLETED|Period 1||0
6710221|NCT02942654|7640643|FG000|STARTED|Washout||16
6710222|NCT02942654|7640644|FG001|STARTED|Washout||16
6710223|NCT02942654|7640643|FG000|COMPLETED|Washout||16
6710224|NCT02942654|7640644|FG001|COMPLETED|Washout||16
6710225|NCT02942654|7640643|FG000|NOT COMPLETED|Washout||0
6710226|NCT02942654|7640644|FG001|NOT COMPLETED|Washout||0
6710227|NCT02942654|7640643|FG000|STARTED|Period 2||16
6710228|NCT02942654|7640644|FG001|STARTED|Period 2||16
6710229|NCT02942654|7640643|FG000|COMPLETED|Period 2||16
6710230|NCT02942654|7640644|FG001|COMPLETED|Period 2||16
6710231|NCT02942654|7640643|FG000|NOT COMPLETED|Period 2||0
6710232|NCT02942654|7640644|FG001|NOT COMPLETED|Period 2||0
6710233|NCT02942771|7640655|FG000|STARTED|Overall Study||9
6710234|NCT02942771|7640656|FG001|STARTED|Overall Study||6
6710235|NCT02942771|7640657|FG002|STARTED|Overall Study||6
6261985|NCT02978326|7160877|FG000|NOT COMPLETED|Part B (Up to 45 Days)||0
6261986|NCT02978326|7160878|FG001|NOT COMPLETED|Part B (Up to 45 Days)||7
6261987|NCT02978326|7160879|FG002|NOT COMPLETED|Part B (Up to 45 Days)||4
6261988|NCT02970929|7160889|FG000|STARTED|Overall Study||157
6261989|NCT02970929|7160889|FG000|Subjects Who Received Study Medication|Overall Study||156
6261990|NCT02970929|7160889|FG000|COMPLETED|Overall Study||105
6261991|NCT02970929|7160889|FG000|NOT COMPLETED|Overall Study||52
6261992|NCT02963493|7160895|FG000|STARTED|Overall Study||157
6261993|NCT02963493|7160895|FG000|COMPLETED|Overall Study||157
6261994|NCT02963493|7160895|FG000|NOT COMPLETED|Overall Study||0
6261995|NCT02899078|7160906|FG000|STARTED|Overall Study||31
6261996|NCT02899078|7160906|FG000|COMPLETED|Overall Study||28
6261997|NCT02899078|7160906|FG000|NOT COMPLETED|Overall Study||3
6261998|NCT02873975|7160913|FG000|STARTED|Overall Study||8
6261999|NCT02873975|7160914|FG001|STARTED|Overall Study||10
6262000|NCT02873975|7160915|FG002|STARTED|Overall Study||9
6262001|NCT02873975|7160913|FG000|COMPLETED|Overall Study||8
6262002|NCT02873975|7160914|FG001|COMPLETED|Overall Study||10
6262003|NCT02873975|7160915|FG002|COMPLETED|Overall Study||9
6262004|NCT02873975|7160913|FG000|NOT COMPLETED|Overall Study||0
6262005|NCT02873975|7160914|FG001|NOT COMPLETED|Overall Study||0
6262006|NCT02873975|7160915|FG002|NOT COMPLETED|Overall Study||0
6262007|NCT02797951|7160923|FG000|STARTED|Overall Study||165
6262008|NCT02797951|7160923|FG000|Received at Least One Dose of Study Drug|Overall Study||164
6262009|NCT02797951|7160923|FG000|COMPLETED|Overall Study||116
6262010|NCT02797951|7160923|FG000|NOT COMPLETED|Overall Study||49
6262011|NCT02753751|7160929|FG000|STARTED|Overall Study||2971
6262012|NCT02753751|7160930|FG001|STARTED|Overall Study||3059
6262013|NCT02753751|7160929|FG000|COMPLETED|Overall Study||2971
6262014|NCT02753751|7160930|FG001|COMPLETED|Overall Study||3059
6262015|NCT02753751|7160929|FG000|NOT COMPLETED|Overall Study||0
6262016|NCT02753751|7160930|FG001|NOT COMPLETED|Overall Study||0
6262017|NCT02748057|7160938|FG000|STARTED|Overall Study||114
6262018|NCT02748057|7160939|FG001|STARTED|Overall Study||21
6262019|NCT02748057|7160938|FG000|COMPLETED|Overall Study||109
6262020|NCT02748057|7160939|FG001|COMPLETED|Overall Study||19
6262021|NCT02748057|7160938|FG000|NOT COMPLETED|Overall Study||5
6262022|NCT02748057|7160939|FG001|NOT COMPLETED|Overall Study||2
6262023|NCT02741271|7160947|FG000|STARTED|Overall Study||91
6262024|NCT02741271|7160948|FG001|STARTED|Overall Study||90
6262025|NCT02741271|7160947|FG000|COMPLETED|Overall Study||89
6262026|NCT02741271|7160948|FG001|COMPLETED|Overall Study||88
6262027|NCT02741271|7160947|FG000|NOT COMPLETED|Overall Study||2
6262028|NCT02741271|7160948|FG001|NOT COMPLETED|Overall Study||2
6262029|NCT02741245|7160961|FG000|STARTED|Overall Study||35
6262030|NCT02741245|7160962|FG001|STARTED|Overall Study||72
6262031|NCT02741245|7160963|FG002|STARTED|Overall Study||71
6262032|NCT02741245|7160964|FG003|STARTED|Overall Study||71
6262033|NCT02741245|7160965|FG004|STARTED|Overall Study||72
6262034|NCT02741245|7160961|FG000|COMPLETED|Overall Study||35
6262035|NCT02741245|7160962|FG001|COMPLETED|Overall Study||71
6262036|NCT02741245|7160963|FG002|COMPLETED|Overall Study||71
6262037|NCT02741245|7160964|FG003|COMPLETED|Overall Study||67
6262038|NCT02741245|7160965|FG004|COMPLETED|Overall Study||70
6262039|NCT02741245|7160961|FG000|NOT COMPLETED|Overall Study||0
6262040|NCT02741245|7160962|FG001|NOT COMPLETED|Overall Study||1
6262041|NCT02741245|7160963|FG002|NOT COMPLETED|Overall Study||0
6262042|NCT02741245|7160964|FG003|NOT COMPLETED|Overall Study||4
6262043|NCT02741245|7160965|FG004|NOT COMPLETED|Overall Study||2
6280381|NCT00154297|7180305|FG000|STARTED|Overall Study|Randomized population.|65
6280382|NCT00154297|7180306|FG001|STARTED|Overall Study|Randomized population.|74
6280383|NCT00154297|7180305|FG000|COMPLETED|Overall Study|Completed study by 12 month.|57
6280384|NCT00154297|7180306|FG001|COMPLETED|Overall Study|Completed study by 12 month.|67
6280385|NCT00154297|7180305|FG000|NOT COMPLETED|Overall Study||8
6280386|NCT00154297|7180306|FG001|NOT COMPLETED|Overall Study||7
6280387|NCT00154310|7180314|FG000|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
6280388|NCT00154310|7180315|FG001|STARTED|Overall Study||145
6280389|NCT00154310|7180314|FG000|COMPLETED|Overall Study||118
6710236|NCT02942771|7640658|FG003|STARTED|Overall Study||6
6710237|NCT02942771|7640659|FG004|STARTED|Overall Study||8
6710238|NCT02942771|7640655|FG000|COMPLETED|Overall Study||6
6710239|NCT02942771|7640656|FG001|COMPLETED|Overall Study||6
6710240|NCT02942771|7640657|FG002|COMPLETED|Overall Study||6
6710241|NCT02942771|7640658|FG003|COMPLETED|Overall Study||6
6710242|NCT02942771|7640659|FG004|COMPLETED|Overall Study||4
6710243|NCT02942771|7640655|FG000|NOT COMPLETED|Overall Study||3
6710244|NCT02942771|7640656|FG001|NOT COMPLETED|Overall Study||0
6710245|NCT02942771|7640657|FG002|NOT COMPLETED|Overall Study||0
6710246|NCT02942771|7640658|FG003|NOT COMPLETED|Overall Study||0
6710247|NCT02942771|7640659|FG004|NOT COMPLETED|Overall Study||4
6710248|NCT02942979|7640673|FG000|STARTED|Step 0||108
6710249|NCT02942979|7640674|FG001|STARTED|Step 0||0
6710250|NCT02942979|7640673|FG000|COMPLETED|Step 0||108
6710251|NCT02942979|7640674|FG001|COMPLETED|Step 0|This is a stepped wedge design - all participants received both MISSION Implementation as Usual and Facilitation|0
6710252|NCT02942979|7640673|FG000|NOT COMPLETED|Step 0||0
6710253|NCT02942979|7640674|FG001|NOT COMPLETED|Step 0||0
6710254|NCT02942979|7640673|FG000|STARTED|Step 1||15
6710255|NCT02942979|7640674|FG001|STARTED|Step 1||93
6710256|NCT02942979|7640673|FG000|COMPLETED|Step 1||15
6710257|NCT02942979|7640674|FG001|COMPLETED|Step 1||93
6710258|NCT02942979|7640673|FG000|NOT COMPLETED|Step 1||0
6710259|NCT02942979|7640674|FG001|NOT COMPLETED|Step 1||0
6710260|NCT02942979|7640673|FG000|STARTED|Step 2||0
6710261|NCT02942979|7640674|FG001|STARTED|Step 2||108
6710262|NCT02942979|7640673|FG000|COMPLETED|Step 2||0
6710263|NCT02942979|7640674|FG001|COMPLETED|Step 2||108
6710264|NCT02942979|7640673|FG000|NOT COMPLETED|Step 2||0
6710265|NCT02942979|7640674|FG001|NOT COMPLETED|Step 2||0
6710266|NCT02943070|7640680|FG000|STARTED|Overall Study||50
6710267|NCT02943070|7640680|FG000|COMPLETED|Overall Study||7
6710268|NCT02943070|7640680|FG000|NOT COMPLETED|Overall Study||43
6710269|NCT02943096|7640693|FG000|STARTED|Overall Study||3
6710270|NCT02943096|7640694|FG001|STARTED|Overall Study||3
6710271|NCT02943096|7640693|FG000|COMPLETED|Overall Study||3
6710272|NCT02943096|7640694|FG001|COMPLETED|Overall Study||2
6710273|NCT02943096|7640693|FG000|NOT COMPLETED|Overall Study||0
6710274|NCT02943096|7640694|FG001|NOT COMPLETED|Overall Study||1
6710275|NCT02943213|7640700|FG000|STARTED|Treatment Period 1||20
6710276|NCT02943213|7640700|FG000|COMPLETED|Treatment Period 1||20
6710277|NCT02943213|7640700|FG000|NOT COMPLETED|Treatment Period 1||0
6710278|NCT02943213|7640700|FG000|STARTED|Treatment Period 2||20
6710279|NCT02943213|7640700|FG000|COMPLETED|Treatment Period 2||20
6710280|NCT02943213|7640700|FG000|NOT COMPLETED|Treatment Period 2||0
6710281|NCT02943226|7640708|FG000|STARTED|Overall Study||31
6710282|NCT02943226|7640709|FG001|STARTED|Overall Study||30
6710283|NCT02943226|7640708|FG000|COMPLETED|Overall Study||31
6710284|NCT02943226|7640709|FG001|COMPLETED|Overall Study||30
6710285|NCT02943226|7640708|FG000|NOT COMPLETED|Overall Study||0
6710286|NCT02943226|7640709|FG001|NOT COMPLETED|Overall Study||0
6710287|NCT02943447|7640718|FG000|STARTED|Blinded Study Phase||28
6710288|NCT02943447|7640719|FG001|STARTED|Blinded Study Phase||30
6710289|NCT02943447|7640720|FG002|STARTED|Blinded Study Phase||13
6262044|NCT02688608|7160977|FG000|STARTED|Overall Study||6
6262045|NCT02688608|7160977|FG000|COMPLETED|Overall Study||5
6262046|NCT02688608|7160977|FG000|NOT COMPLETED|Overall Study||1
6262047|NCT02675231|7160984|FG000|STARTED|Overall Study||79
6262048|NCT02675231|7160985|FG001|STARTED|Overall Study||79
6262049|NCT02675231|7160986|FG002|STARTED|Overall Study||79
6262050|NCT02675231|7160984|FG000|Received at Least One Dose of Drug|Overall Study||78
6262051|NCT02675231|7160985|FG001|Received at Least One Dose of Drug|Overall Study||77
6262052|NCT02675231|7160986|FG002|Received at Least One Dose of Drug|Overall Study||72
6262053|NCT02675231|7160984|FG000|COMPLETED|Overall Study||53
6262054|NCT02675231|7160985|FG001|COMPLETED|Overall Study||43
6262055|NCT02675231|7160986|FG002|COMPLETED|Overall Study||53
6262056|NCT02675231|7160984|FG000|NOT COMPLETED|Overall Study||26
6262057|NCT02675231|7160985|FG001|NOT COMPLETED|Overall Study||36
6262058|NCT02675231|7160986|FG002|NOT COMPLETED|Overall Study||26
6262059|NCT02634268|7160997|FG000|STARTED|Overall Study||346
6262060|NCT02634268|7160998|FG001|STARTED|Overall Study||338
6262061|NCT02634268|7160997|FG000|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|287
6262062|NCT02634268|7160998|FG001|COMPLETED|Overall Study|In-person visit completion = 267 for both groups. Some participants completed only surveys because of Covid-19 restrictions.|291
6262063|NCT02634268|7160997|FG000|NOT COMPLETED|Overall Study||59
6262064|NCT02634268|7160998|FG001|NOT COMPLETED|Overall Study||47
6710290|NCT02943447|7640718|FG000|COMPLETED|Blinded Study Phase||23
6710291|NCT02943447|7640719|FG001|COMPLETED|Blinded Study Phase||28
6710292|NCT02943447|7640720|FG002|COMPLETED|Blinded Study Phase||12
6710293|NCT02943447|7640718|FG000|NOT COMPLETED|Blinded Study Phase||5
6710294|NCT02943447|7640719|FG001|NOT COMPLETED|Blinded Study Phase||2
6710295|NCT02943447|7640720|FG002|NOT COMPLETED|Blinded Study Phase||1
6710296|NCT02943447|7640718|FG000|STARTED|Open-Label Extension Phase||23
6710297|NCT02943447|7640719|FG001|STARTED|Open-Label Extension Phase||28
6710298|NCT02943447|7640720|FG002|STARTED|Open-Label Extension Phase||12
6710299|NCT02943447|7640718|FG000|COMPLETED|Open-Label Extension Phase||5
6262065|NCT02605967|7161006|FG000|STARTED|Overall Study||82
6262066|NCT02605967|7161007|FG001|STARTED|Overall Study||40
6262067|NCT02605967|7161006|FG000|Safety Set|Overall Study||82
6262068|NCT02605967|7161007|FG001|Safety Set|Overall Study||39
6262069|NCT02605967|7161006|FG000|Crossover to Spartalizumab|Overall Study||0
6710300|NCT02943447|7640719|FG001|COMPLETED|Open-Label Extension Phase||3
6710301|NCT02943447|7640720|FG002|COMPLETED|Open-Label Extension Phase||2
6710302|NCT02943447|7640718|FG000|NOT COMPLETED|Open-Label Extension Phase||18
6710303|NCT02943447|7640719|FG001|NOT COMPLETED|Open-Label Extension Phase||25
6710304|NCT02943447|7640720|FG002|NOT COMPLETED|Open-Label Extension Phase||10
6710305|NCT02943460|7640740|FG000|STARTED|Blinded Study Phase||22
6710306|NCT02943460|7640741|FG001|STARTED|Blinded Study Phase||20
6710307|NCT02943460|7640742|FG002|STARTED|Blinded Study Phase||10
6710308|NCT02943460|7640740|FG000|COMPLETED|Blinded Study Phase||19
6710309|NCT02943460|7640741|FG001|COMPLETED|Blinded Study Phase||19
6710310|NCT02943460|7640742|FG002|COMPLETED|Blinded Study Phase||10
6710311|NCT02943460|7640740|FG000|NOT COMPLETED|Blinded Study Phase||3
6710312|NCT02943460|7640741|FG001|NOT COMPLETED|Blinded Study Phase||1
6710313|NCT02943460|7640742|FG002|NOT COMPLETED|Blinded Study Phase||0
6710314|NCT02943460|7640740|FG000|STARTED|Open Label Extension (OLE) Phase||19
6710315|NCT02943460|7640741|FG001|STARTED|Open Label Extension (OLE) Phase|1 participant completed the Blinded Study Phase, but did not continue in the OLE Phase.|18
6710316|NCT02943460|7640742|FG002|STARTED|Open Label Extension (OLE) Phase||10
6710317|NCT02943460|7640740|FG000|COMPLETED|Open Label Extension (OLE) Phase||14
6710318|NCT02943460|7640741|FG001|COMPLETED|Open Label Extension (OLE) Phase||11
6710319|NCT02943460|7640742|FG002|COMPLETED|Open Label Extension (OLE) Phase||8
6710320|NCT02943460|7640740|FG000|NOT COMPLETED|Open Label Extension (OLE) Phase||5
6710321|NCT02943460|7640741|FG001|NOT COMPLETED|Open Label Extension (OLE) Phase||7
6710322|NCT02943460|7640742|FG002|NOT COMPLETED|Open Label Extension (OLE) Phase||2
6710323|NCT02943473|7640751|FG000|STARTED|Overall Study||9
6710324|NCT02943473|7640751|FG000|COMPLETED|Overall Study||3
6710325|NCT02943473|7640751|FG000|NOT COMPLETED|Overall Study||6
6710326|NCT02943499|7640757|FG000|STARTED|Overall Study||41
6710327|NCT02943499|7640758|FG001|STARTED|Overall Study||39
6710328|NCT02943499|7640757|FG000|COMPLETED|Overall Study||34
6710329|NCT02943499|7640758|FG001|COMPLETED|Overall Study||34
6710330|NCT02943499|7640757|FG000|NOT COMPLETED|Overall Study||7
6710331|NCT02943499|7640758|FG001|NOT COMPLETED|Overall Study||5
6710332|NCT02943564|7640767|FG000|STARTED|Overall Study||217
6710333|NCT02943564|7640768|FG001|STARTED|Overall Study||211
6710334|NCT02943564|7640769|FG002|STARTED|Overall Study||210
6710335|NCT02943564|7640767|FG000|Responder|Overall Study||83
6710336|NCT02943564|7640768|FG001|Responder|Overall Study||77
6710337|NCT02943564|7640769|FG002|Responder|Overall Study||77
6710338|NCT02943564|7640767|FG000|Non-Responder|Overall Study||134
6710339|NCT02943564|7640768|FG001|Non-Responder|Overall Study||134
6710340|NCT02943564|7640769|FG002|Non-Responder|Overall Study||133
6710341|NCT02943564|7640767|FG000|COMPLETED|Overall Study||207
6710342|NCT02943564|7640768|FG001|COMPLETED|Overall Study||198
6710343|NCT02943564|7640769|FG002|COMPLETED|Overall Study||201
6710344|NCT02943564|7640767|FG000|NOT COMPLETED|Overall Study||10
6710345|NCT02943564|7640768|FG001|NOT COMPLETED|Overall Study||13
6710346|NCT02943564|7640769|FG002|NOT COMPLETED|Overall Study||9
6710347|NCT02943577|7640779|FG000|STARTED|Overall Study||209
6710348|NCT02943577|7640780|FG001|STARTED|Overall Study||206
6710349|NCT02943577|7640779|FG000|COMPLETED|Overall Study||204
6710350|NCT02943577|7640780|FG001|COMPLETED|Overall Study||201
6710351|NCT02943577|7640779|FG000|NOT COMPLETED|Overall Study||5
6710352|NCT02943577|7640780|FG001|NOT COMPLETED|Overall Study||5
6710353|NCT02943668|7640786|FG000|STARTED|Overall Study||2
6710354|NCT02943668|7640786|FG000|COMPLETED|Overall Study||1
6710355|NCT02943668|7640786|FG000|NOT COMPLETED|Overall Study||1
6710356|NCT02943941|7640793|FG000|STARTED|Overall Study||16
6710357|NCT02943941|7640793|FG000|COMPLETED|Overall Study||16
6710358|NCT02943941|7640793|FG000|NOT COMPLETED|Overall Study||0
6710359|NCT02944383|7640801|FG000|STARTED|Overall Study||30
6710360|NCT02944383|7640802|FG001|STARTED|Overall Study||30
6710361|NCT02944383|7640803|FG002|STARTED|Overall Study||31
6710362|NCT02944383|7640801|FG000|COMPLETED|Overall Study||29
6710363|NCT02944383|7640802|FG001|COMPLETED|Overall Study||30
6710364|NCT02944383|7640803|FG002|COMPLETED|Overall Study||30
6710365|NCT02944383|7640801|FG000|NOT COMPLETED|Overall Study||1
6710366|NCT02944383|7640802|FG001|NOT COMPLETED|Overall Study||0
6710367|NCT02944383|7640803|FG002|NOT COMPLETED|Overall Study||1
6710368|NCT02944448|7640815|FG000|STARTED|Overall Study||316
6710369|NCT02944448|7640816|FG001|STARTED|Overall Study||160
6710370|NCT02944448|7640815|FG000|COMPLETED|Overall Study||227
6710371|NCT02944448|7640816|FG001|COMPLETED|Overall Study||136
6710372|NCT02944448|7640815|FG000|NOT COMPLETED|Overall Study||89
6710373|NCT02944448|7640816|FG001|NOT COMPLETED|Overall Study||24
6710374|NCT02944461|7640823|FG000|STARTED|Overall Study||20
6710375|NCT02944461|7640823|FG000|COMPLETED|Overall Study||15
6710376|NCT02944461|7640823|FG000|NOT COMPLETED|Overall Study||5
6710377|NCT02944565|7640827|FG000|STARTED|Overall Study||28
6710378|NCT02944565|7640827|FG000|COMPLETED|Overall Study||28
6710379|NCT02944565|7640827|FG000|NOT COMPLETED|Overall Study||0
6710380|NCT02944656|7640834|FG000|STARTED|Overall Study||57
6710381|NCT02944656|7640835|FG001|STARTED|Overall Study||57
6710382|NCT02944656|7640834|FG000|Completed Procedure Day|Overall Study||54
6710383|NCT02944656|7640835|FG001|Completed Procedure Day|Overall Study||57
6710384|NCT02944656|7640834|FG000|Completed Day 1 Follow up|Overall Study||47
6710385|NCT02944656|7640835|FG001|Completed Day 1 Follow up|Overall Study||47
6710386|NCT02944656|7640834|FG000|COMPLETED|Overall Study||47
6710387|NCT02944656|7640835|FG001|COMPLETED|Overall Study||47
6710388|NCT02944656|7640834|FG000|NOT COMPLETED|Overall Study||10
6710389|NCT02944656|7640835|FG001|NOT COMPLETED|Overall Study||10
6710390|NCT02944968|7640841|FG000|STARTED|Overall Study||51
6710391|NCT02944968|7640841|FG000|COMPLETED|Overall Study||48
6710392|NCT02944968|7640841|FG000|NOT COMPLETED|Overall Study||3
6710393|NCT02945046|7640848|FG000|STARTED|Overall Study||59
6710394|NCT02945046|7640849|FG001|STARTED|Overall Study||55
6710395|NCT02945046|7640850|FG002|STARTED|Overall Study||55
6710396|NCT02945046|7640848|FG000|Safety Analysis Set|Overall Study||59
6710397|NCT02945046|7640849|FG001|Safety Analysis Set|Overall Study||55
6710398|NCT02945046|7640850|FG002|Safety Analysis Set|Overall Study||55
6710399|NCT02945046|7640848|FG000|Full Analysis Set|Overall Study||57
6710400|NCT02945046|7640849|FG001|Full Analysis Set|Overall Study||53
6710401|NCT02945046|7640850|FG002|Full Analysis Set|Overall Study||55
6710402|NCT02945046|7640848|FG000|COMPLETED|Overall Study||46
6710403|NCT02945046|7640849|FG001|COMPLETED|Overall Study||42
6710404|NCT02945046|7640850|FG002|COMPLETED|Overall Study||40
6710405|NCT02945046|7640848|FG000|NOT COMPLETED|Overall Study||13
6710406|NCT02945046|7640849|FG001|NOT COMPLETED|Overall Study||13
6710407|NCT02945046|7640850|FG002|NOT COMPLETED|Overall Study||15
6710408|NCT02945150|7640858|FG000|STARTED|Overall Study||8
6710409|NCT02945150|7640858|FG000|SVR12|Overall Study||8
6710410|NCT02945150|7640858|FG000|COMPLETED|Overall Study||8
6710411|NCT02945150|7640858|FG000|NOT COMPLETED|Overall Study||0
6710412|NCT02945254|7640864|FG000|STARTED|Overall Study||10
6710413|NCT02945254|7640865|FG001|STARTED|Overall Study||10
6710414|NCT02945254|7640864|FG000|COMPLETED|Overall Study||8
6710415|NCT02945254|7640865|FG001|COMPLETED|Overall Study||10
6710416|NCT02945254|7640864|FG000|NOT COMPLETED|Overall Study||2
6710417|NCT02945254|7640865|FG001|NOT COMPLETED|Overall Study||0
6710418|NCT02945410|7640877|FG000|STARTED|Intervention 1 (5 Days)||3
6710419|NCT02945410|7640878|FG001|STARTED|Intervention 1 (5 Days)||4
6710420|NCT02945410|7640879|FG002|STARTED|Intervention 1 (5 Days)||2
6710421|NCT02945410|7640880|FG003|STARTED|Intervention 1 (5 Days)||3
6710422|NCT02945410|7640881|FG004|STARTED|Intervention 1 (5 Days)||2
6710423|NCT02945410|7640882|FG005|STARTED|Intervention 1 (5 Days)||1
6710424|NCT02945410|7640877|FG000|COMPLETED|Intervention 1 (5 Days)||2
6710425|NCT02945410|7640878|FG001|COMPLETED|Intervention 1 (5 Days)||1
6710426|NCT02945410|7640879|FG002|COMPLETED|Intervention 1 (5 Days)||2
6710427|NCT02945410|7640880|FG003|COMPLETED|Intervention 1 (5 Days)||3
6710428|NCT02945410|7640881|FG004|COMPLETED|Intervention 1 (5 Days)||2
6710429|NCT02945410|7640882|FG005|COMPLETED|Intervention 1 (5 Days)||0
6710430|NCT02945410|7640877|FG000|NOT COMPLETED|Intervention 1 (5 Days)||1
6710431|NCT02945410|7640878|FG001|NOT COMPLETED|Intervention 1 (5 Days)||3
6710432|NCT02945410|7640879|FG002|NOT COMPLETED|Intervention 1 (5 Days)||0
6710433|NCT02945410|7640880|FG003|NOT COMPLETED|Intervention 1 (5 Days)||0
6710434|NCT02945410|7640881|FG004|NOT COMPLETED|Intervention 1 (5 Days)||0
6710435|NCT02945410|7640882|FG005|NOT COMPLETED|Intervention 1 (5 Days)||1
6710436|NCT02945410|7640877|FG000|STARTED|Washout 1 (14 Days)||2
6710437|NCT02945410|7640878|FG001|STARTED|Washout 1 (14 Days)||1
6710438|NCT02945410|7640879|FG002|STARTED|Washout 1 (14 Days)||2
6710439|NCT02945410|7640880|FG003|STARTED|Washout 1 (14 Days)||3
6710440|NCT02945410|7640881|FG004|STARTED|Washout 1 (14 Days)||2
6710441|NCT02945410|7640882|FG005|STARTED|Washout 1 (14 Days)||0
6710442|NCT02945410|7640877|FG000|COMPLETED|Washout 1 (14 Days)||2
6710443|NCT02945410|7640878|FG001|COMPLETED|Washout 1 (14 Days)||1
6710444|NCT02945410|7640879|FG002|COMPLETED|Washout 1 (14 Days)||0
6710445|NCT02945410|7640880|FG003|COMPLETED|Washout 1 (14 Days)||3
6710446|NCT02945410|7640881|FG004|COMPLETED|Washout 1 (14 Days)||1
6710447|NCT02945410|7640882|FG005|COMPLETED|Washout 1 (14 Days)||0
6710448|NCT02945410|7640877|FG000|NOT COMPLETED|Washout 1 (14 Days)||0
6710449|NCT02945410|7640878|FG001|NOT COMPLETED|Washout 1 (14 Days)||0
6710450|NCT02945410|7640879|FG002|NOT COMPLETED|Washout 1 (14 Days)||2
6710451|NCT02945410|7640880|FG003|NOT COMPLETED|Washout 1 (14 Days)||0
6710452|NCT02945410|7640881|FG004|NOT COMPLETED|Washout 1 (14 Days)||1
6710453|NCT02945410|7640882|FG005|NOT COMPLETED|Washout 1 (14 Days)||0
6710454|NCT02945410|7640877|FG000|STARTED|Intervention 2 (5 Days)||2
6710455|NCT02945410|7640878|FG001|STARTED|Intervention 2 (5 Days)||1
6710456|NCT02945410|7640879|FG002|STARTED|Intervention 2 (5 Days)||0
6710457|NCT02945410|7640880|FG003|STARTED|Intervention 2 (5 Days)||3
6710458|NCT02945410|7640881|FG004|STARTED|Intervention 2 (5 Days)||1
6710459|NCT02945410|7640882|FG005|STARTED|Intervention 2 (5 Days)||0
6710460|NCT02945410|7640877|FG000|COMPLETED|Intervention 2 (5 Days)||2
6710461|NCT02945410|7640878|FG001|COMPLETED|Intervention 2 (5 Days)||1
6710462|NCT02945410|7640879|FG002|COMPLETED|Intervention 2 (5 Days)||0
6710463|NCT02945410|7640880|FG003|COMPLETED|Intervention 2 (5 Days)||3
6710464|NCT02945410|7640881|FG004|COMPLETED|Intervention 2 (5 Days)||1
6710465|NCT02945410|7640882|FG005|COMPLETED|Intervention 2 (5 Days)||0
6710466|NCT02945410|7640877|FG000|NOT COMPLETED|Intervention 2 (5 Days)||0
6710467|NCT02945410|7640878|FG001|NOT COMPLETED|Intervention 2 (5 Days)||0
6710468|NCT02945410|7640879|FG002|NOT COMPLETED|Intervention 2 (5 Days)||0
6710469|NCT02945410|7640880|FG003|NOT COMPLETED|Intervention 2 (5 Days)||0
6710470|NCT02945410|7640881|FG004|NOT COMPLETED|Intervention 2 (5 Days)||0
6710471|NCT02945410|7640882|FG005|NOT COMPLETED|Intervention 2 (5 Days)||0
6710472|NCT02945410|7640877|FG000|STARTED|Washout 2 (14 Days)||2
6710473|NCT02945410|7640878|FG001|STARTED|Washout 2 (14 Days)||1
6710474|NCT02945410|7640879|FG002|STARTED|Washout 2 (14 Days)||0
6710475|NCT02945410|7640880|FG003|STARTED|Washout 2 (14 Days)||3
6710476|NCT02945410|7640881|FG004|STARTED|Washout 2 (14 Days)||1
6710477|NCT02945410|7640882|FG005|STARTED|Washout 2 (14 Days)||0
6710478|NCT02945410|7640877|FG000|COMPLETED|Washout 2 (14 Days)||2
6710479|NCT02945410|7640878|FG001|COMPLETED|Washout 2 (14 Days)||1
6710480|NCT02945410|7640879|FG002|COMPLETED|Washout 2 (14 Days)||0
6710481|NCT02945410|7640880|FG003|COMPLETED|Washout 2 (14 Days)||3
6710482|NCT02945410|7640881|FG004|COMPLETED|Washout 2 (14 Days)||1
6710483|NCT02945410|7640882|FG005|COMPLETED|Washout 2 (14 Days)||0
6710484|NCT02945410|7640877|FG000|NOT COMPLETED|Washout 2 (14 Days)||0
6710485|NCT02945410|7640878|FG001|NOT COMPLETED|Washout 2 (14 Days)||0
6710486|NCT02945410|7640879|FG002|NOT COMPLETED|Washout 2 (14 Days)||0
6710487|NCT02945410|7640880|FG003|NOT COMPLETED|Washout 2 (14 Days)||0
6710488|NCT02945410|7640881|FG004|NOT COMPLETED|Washout 2 (14 Days)||0
6710489|NCT02945410|7640882|FG005|NOT COMPLETED|Washout 2 (14 Days)||0
6710490|NCT02945410|7640877|FG000|STARTED|Intervention 3 (5 Days)||2
6710491|NCT02945410|7640878|FG001|STARTED|Intervention 3 (5 Days)||1
6710492|NCT02945410|7640879|FG002|STARTED|Intervention 3 (5 Days)||0
6710493|NCT02945410|7640880|FG003|STARTED|Intervention 3 (5 Days)||3
6710494|NCT02945410|7640881|FG004|STARTED|Intervention 3 (5 Days)||1
6710495|NCT02945410|7640882|FG005|STARTED|Intervention 3 (5 Days)||0
6710496|NCT02945410|7640877|FG000|COMPLETED|Intervention 3 (5 Days)||2
6710497|NCT02945410|7640878|FG001|COMPLETED|Intervention 3 (5 Days)||1
6710498|NCT02945410|7640879|FG002|COMPLETED|Intervention 3 (5 Days)||0
6710499|NCT02945410|7640880|FG003|COMPLETED|Intervention 3 (5 Days)||3
6710500|NCT02945410|7640881|FG004|COMPLETED|Intervention 3 (5 Days)||1
6710501|NCT02945410|7640882|FG005|COMPLETED|Intervention 3 (5 Days)||0
6710502|NCT02945410|7640877|FG000|NOT COMPLETED|Intervention 3 (5 Days)||0
6710503|NCT02945410|7640878|FG001|NOT COMPLETED|Intervention 3 (5 Days)||0
6710504|NCT02945410|7640879|FG002|NOT COMPLETED|Intervention 3 (5 Days)||0
6710505|NCT02945410|7640880|FG003|NOT COMPLETED|Intervention 3 (5 Days)||0
6710506|NCT02945410|7640881|FG004|NOT COMPLETED|Intervention 3 (5 Days)||0
6710507|NCT02945410|7640882|FG005|NOT COMPLETED|Intervention 3 (5 Days)||0
6710508|NCT02945553|7640892|FG000|STARTED|Overall Study||14
6710509|NCT02945553|7640893|FG001|STARTED|Overall Study||11
6710510|NCT02945553|7640892|FG000|COMPLETED|Overall Study|Included in analysis for primary aim.|11
6710511|NCT02945553|7640893|FG001|COMPLETED|Overall Study|Included in analysis for primary aim.|9
6710512|NCT02945553|7640892|FG000|NOT COMPLETED|Overall Study||3
6710513|NCT02945553|7640893|FG001|NOT COMPLETED|Overall Study||2
6710514|NCT02945657|7640903|FG000|STARTED|Overall Study||32
6710515|NCT02945657|7640903|FG000|COMPLETED|Overall Study||28
6710516|NCT02945657|7640903|FG000|NOT COMPLETED|Overall Study||4
6710517|NCT02946021|7640910|FG000|STARTED|Overall Study||6
6710518|NCT02946021|7640911|FG001|STARTED|Overall Study||5
6710519|NCT02946021|7640910|FG000|COMPLETED|Overall Study||6
6710520|NCT02946021|7640911|FG001|COMPLETED|Overall Study||5
6710521|NCT02946021|7640910|FG000|NOT COMPLETED|Overall Study||0
6710522|NCT02946021|7640911|FG001|NOT COMPLETED|Overall Study||0
6710523|NCT02946034|7640917|FG000|STARTED|Overall Study||10
6710524|NCT02946034|7640917|FG000|COMPLETED|Overall Study||10
6710525|NCT02946034|7640917|FG000|NOT COMPLETED|Overall Study||0
6710526|NCT02946073|7640927|FG000|STARTED|Titration Phase||811
6710527|NCT02946073|7640928|FG001|STARTED|Titration Phase||0
6710528|NCT02946073|7640929|FG002|STARTED|Titration Phase||98
6710529|NCT02946073|7640930|FG003|STARTED|Titration Phase||0
6710530|NCT02946073|7640927|FG000|COMPLETED|Titration Phase||222
6710531|NCT02946073|7640928|FG001|COMPLETED|Titration Phase||0
6710532|NCT02946073|7640929|FG002|COMPLETED|Titration Phase||75
6262070|NCT02605967|7161007|FG001|Crossover to Spartalizumab|Overall Study||27
6262071|NCT02605967|7161006|FG000|COMPLETED|Overall Study||0
6262072|NCT02605967|7161007|FG001|COMPLETED|Overall Study||0
6262073|NCT02605967|7161006|FG000|NOT COMPLETED|Overall Study||82
6262074|NCT02605967|7161007|FG001|NOT COMPLETED|Overall Study||40
6262075|NCT02584634|7161019|FG000|STARTED|Overall Study||12
6262076|NCT02584634|7161020|FG001|STARTED|Overall Study||31
6262077|NCT02584634|7161019|FG000|COMPLETED|Overall Study||0
6262078|NCT02584634|7161020|FG001|COMPLETED|Overall Study||0
6262079|NCT02584634|7161019|FG000|NOT COMPLETED|Overall Study||12
6262080|NCT02584634|7161020|FG001|NOT COMPLETED|Overall Study||31
6262081|NCT02581137|7161029|FG000|STARTED|Overall Study||26
6262082|NCT02581137|7161029|FG000|COMPLETED|Overall Study||22
6262083|NCT02581137|7161029|FG000|NOT COMPLETED|Overall Study||4
6262084|NCT02570503|7161035|FG000|STARTED|Overall Study||34
6262085|NCT02570503|7161036|FG001|STARTED|Overall Study||30
6262086|NCT02570503|7161035|FG000|COMPLETED|Overall Study||34
6262087|NCT02570503|7161036|FG001|COMPLETED|Overall Study||30
6262088|NCT02570503|7161035|FG000|NOT COMPLETED|Overall Study||0
6262089|NCT02570503|7161036|FG001|NOT COMPLETED|Overall Study||0
6262090|NCT02553265|7161042|FG000|STARTED|Enrollment||9
6262091|NCT02553265|7161043|FG001|STARTED|Enrollment||7
6262092|NCT02553265|7161044|FG002|STARTED|Enrollment||6
6262093|NCT02553265|7161042|FG000|COMPLETED|Enrollment||9
6262094|NCT02553265|7161043|FG001|COMPLETED|Enrollment||7
6262095|NCT02553265|7161044|FG002|COMPLETED|Enrollment||5
6262096|NCT02553265|7161042|FG000|NOT COMPLETED|Enrollment||0
6710533|NCT02946073|7640930|FG003|COMPLETED|Titration Phase||0
6710534|NCT02946073|7640927|FG000|NOT COMPLETED|Titration Phase||589
6710535|NCT02946073|7640928|FG001|NOT COMPLETED|Titration Phase||0
6710536|NCT02946073|7640929|FG002|NOT COMPLETED|Titration Phase||23
6710537|NCT02946073|7640930|FG003|NOT COMPLETED|Titration Phase||0
6710538|NCT02946073|7640927|FG000|STARTED|Double Blind Phase||112
6710539|NCT02946073|7640928|FG001|STARTED|Double Blind Phase||110
6710540|NCT02946073|7640929|FG002|STARTED|Double Blind Phase||0
6710541|NCT02946073|7640930|FG003|STARTED|Double Blind Phase||0
6710542|NCT02946073|7640927|FG000|COMPLETED|Double Blind Phase||88
6710543|NCT02946073|7640928|FG001|COMPLETED|Double Blind Phase||70
6710544|NCT02946073|7640929|FG002|COMPLETED|Double Blind Phase||0
6710545|NCT02946073|7640930|FG003|COMPLETED|Double Blind Phase||0
6710546|NCT02946073|7640927|FG000|NOT COMPLETED|Double Blind Phase||24
6710547|NCT02946073|7640928|FG001|NOT COMPLETED|Double Blind Phase||40
6710548|NCT02946073|7640929|FG002|NOT COMPLETED|Double Blind Phase||0
6710549|NCT02946073|7640930|FG003|NOT COMPLETED|Double Blind Phase||0
6710550|NCT02946073|7640927|FG000|STARTED|Open Label Phase||0
6710551|NCT02946073|7640928|FG001|STARTED|Open Label Phase||0
6710552|NCT02946073|7640929|FG002|STARTED|Open Label Phase||75
6710553|NCT02946073|7640930|FG003|STARTED|Open Label Phase||57
6710554|NCT02946073|7640927|FG000|COMPLETED|Open Label Phase||0
6710555|NCT02946073|7640928|FG001|COMPLETED|Open Label Phase||0
6710556|NCT02946073|7640929|FG002|COMPLETED|Open Label Phase||54
6710557|NCT02946073|7640930|FG003|COMPLETED|Open Label Phase||44
6710558|NCT02946073|7640927|FG000|NOT COMPLETED|Open Label Phase||0
6710559|NCT02946073|7640928|FG001|NOT COMPLETED|Open Label Phase||0
6710560|NCT02946073|7640929|FG002|NOT COMPLETED|Open Label Phase||21
6710561|NCT02946073|7640930|FG003|NOT COMPLETED|Open Label Phase||13
6710562|NCT02946229|7640949|FG000|STARTED|Overall Study||142
6710563|NCT02946229|7640949|FG000|COMPLETED|Overall Study||142
6710564|NCT02946229|7640949|FG000|NOT COMPLETED|Overall Study||0
6710565|NCT02946385|7640959|FG000|STARTED|Overall Study||126
6710566|NCT02946385|7640960|FG001|STARTED|Overall Study||127
6710567|NCT02946385|7640961|FG002|STARTED|Overall Study||99
6710568|NCT02946385|7640962|FG003|STARTED|Overall Study||74
6710569|NCT02946385|7640963|FG004|STARTED|Overall Study||101
6710570|NCT02946385|7640964|FG005|STARTED|Overall Study||77
6710571|NCT02946385|7640959|FG000|COMPLETED|Overall Study||126
6710572|NCT02946385|7640960|FG001|COMPLETED|Overall Study||127
6710573|NCT02946385|7640961|FG002|COMPLETED|Overall Study||96
6710574|NCT02946385|7640962|FG003|COMPLETED|Overall Study||74
6710575|NCT02946385|7640963|FG004|COMPLETED|Overall Study||99
6710576|NCT02946385|7640964|FG005|COMPLETED|Overall Study||76
6710577|NCT02946385|7640959|FG000|NOT COMPLETED|Overall Study||0
6710578|NCT02946385|7640960|FG001|NOT COMPLETED|Overall Study||0
6710579|NCT02946385|7640961|FG002|NOT COMPLETED|Overall Study||3
6710580|NCT02946385|7640962|FG003|NOT COMPLETED|Overall Study||0
6710581|NCT02946385|7640963|FG004|NOT COMPLETED|Overall Study||2
6710582|NCT02946385|7640964|FG005|NOT COMPLETED|Overall Study||1
6710583|NCT02946463|7640986|FG000|STARTED|Primary Evaluation Period||125
6710584|NCT02946463|7640987|FG001|STARTED|Primary Evaluation Period||121
6710585|NCT02946463|7640986|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||125
6710586|NCT02946463|7640987|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||121
6710587|NCT02946463|7640986|FG000|COMPLETED|Primary Evaluation Period||125
6710588|NCT02946463|7640987|FG001|COMPLETED|Primary Evaluation Period||119
6710589|NCT02946463|7640986|FG000|NOT COMPLETED|Primary Evaluation Period||0
6710590|NCT02946463|7640987|FG001|NOT COMPLETED|Primary Evaluation Period||2
6710591|NCT02946463|7640986|FG000|STARTED|Extension Period||124
6710592|NCT02946463|7640987|FG001|STARTED|Extension Period||119
6710593|NCT02946463|7640986|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||124
6710594|NCT02946463|7640987|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||119
6710595|NCT02946463|7640986|FG000|COMPLETED|Extension Period||0
6710596|NCT02946463|7640987|FG001|COMPLETED|Extension Period||0
6710597|NCT02946463|7640986|FG000|NOT COMPLETED|Extension Period||124
6262097|NCT02553265|7161043|FG001|NOT COMPLETED|Enrollment||0
6262098|NCT02553265|7161044|FG002|NOT COMPLETED|Enrollment||1
6262099|NCT02553265|7161042|FG000|STARTED|First Intervention (28 Days)||9
6262100|NCT02553265|7161043|FG001|STARTED|First Intervention (28 Days)||7
6262101|NCT02553265|7161044|FG002|STARTED|First Intervention (28 Days)||5
6710598|NCT02946463|7640987|FG001|NOT COMPLETED|Extension Period||119
6710599|NCT02946489|7640993|FG000|STARTED|Overall Study||8
6710600|NCT02946489|7640993|FG000|COMPLETED|Overall Study||8
6710601|NCT02946489|7640993|FG000|NOT COMPLETED|Overall Study||0
6710602|NCT02946515|7640999|FG000|STARTED|Overall Study||22
6710603|NCT02946515|7641000|FG001|STARTED|Overall Study||22
6710604|NCT02946515|7640999|FG000|COMPLETED|Overall Study||20
6710605|NCT02946515|7641000|FG001|COMPLETED|Overall Study||21
6710606|NCT02946515|7640999|FG000|NOT COMPLETED|Overall Study||2
6710607|NCT02946515|7641000|FG001|NOT COMPLETED|Overall Study||1
6710608|NCT02946580|7641008|FG000|STARTED|Overall Study||28
6710609|NCT02946580|7641009|FG001|STARTED|Overall Study||25
6710610|NCT02946580|7641008|FG000|COMPLETED|Overall Study||27
6710611|NCT02946580|7641009|FG001|COMPLETED|Overall Study||20
6710612|NCT02946580|7641008|FG000|NOT COMPLETED|Overall Study||1
6710613|NCT02946580|7641009|FG001|NOT COMPLETED|Overall Study||5
6710614|NCT02946892|7641015|FG000|STARTED|First Intervention (12 Weeks)||11
6710615|NCT02946892|7641016|FG001|STARTED|First Intervention (12 Weeks)||15
6710616|NCT02946892|7641015|FG000|COMPLETED|First Intervention (12 Weeks)||11
6710617|NCT02946892|7641016|FG001|COMPLETED|First Intervention (12 Weeks)||14
6710618|NCT02946892|7641015|FG000|NOT COMPLETED|First Intervention (12 Weeks)||0
6710619|NCT02946892|7641016|FG001|NOT COMPLETED|First Intervention (12 Weeks)||1
6710620|NCT02946892|7641015|FG000|STARTED|Washout (6 Weeks)||11
6710621|NCT02946892|7641016|FG001|STARTED|Washout (6 Weeks)||14
6710622|NCT02946892|7641015|FG000|COMPLETED|Washout (6 Weeks)||9
6710623|NCT02946892|7641016|FG001|COMPLETED|Washout (6 Weeks)||14
6710624|NCT02946892|7641015|FG000|NOT COMPLETED|Washout (6 Weeks)||2
6710625|NCT02946892|7641016|FG001|NOT COMPLETED|Washout (6 Weeks)||0
6710626|NCT02946892|7641015|FG000|STARTED|Second Intervention||9
6710627|NCT02946892|7641016|FG001|STARTED|Second Intervention||14
6710628|NCT02946892|7641015|FG000|COMPLETED|Second Intervention||9
6710629|NCT02946892|7641016|FG001|COMPLETED|Second Intervention||14
6710630|NCT02946892|7641015|FG000|NOT COMPLETED|Second Intervention||0
6710631|NCT02946892|7641016|FG001|NOT COMPLETED|Second Intervention||0
6710632|NCT02946918|7641024|FG000|STARTED|Overall Study||6
6710633|NCT02946918|7641025|FG001|STARTED|Overall Study||8
6710634|NCT02946918|7641024|FG000|COMPLETED|Overall Study||5
6710635|NCT02946918|7641025|FG001|COMPLETED|Overall Study||5
6262102|NCT02553265|7161042|FG000|COMPLETED|First Intervention (28 Days)||8
6262103|NCT02553265|7161043|FG001|COMPLETED|First Intervention (28 Days)||7
6262104|NCT02553265|7161044|FG002|COMPLETED|First Intervention (28 Days)||4
6262105|NCT02553265|7161042|FG000|NOT COMPLETED|First Intervention (28 Days)||1
6262106|NCT02553265|7161043|FG001|NOT COMPLETED|First Intervention (28 Days)||0
6262107|NCT02553265|7161044|FG002|NOT COMPLETED|First Intervention (28 Days)||1
6262108|NCT02553265|7161042|FG000|STARTED|Second Intervention (28 Days)||8
6262109|NCT02553265|7161043|FG001|STARTED|Second Intervention (28 Days)||7
6262110|NCT02553265|7161044|FG002|STARTED|Second Intervention (28 Days)||4
6262111|NCT02553265|7161042|FG000|COMPLETED|Second Intervention (28 Days)||7
6262112|NCT02553265|7161043|FG001|COMPLETED|Second Intervention (28 Days)||7
6262113|NCT02553265|7161044|FG002|COMPLETED|Second Intervention (28 Days)||4
6262114|NCT02553265|7161042|FG000|NOT COMPLETED|Second Intervention (28 Days)||1
6262115|NCT02553265|7161043|FG001|NOT COMPLETED|Second Intervention (28 Days)||0
6262116|NCT02553265|7161044|FG002|NOT COMPLETED|Second Intervention (28 Days)||0
6262117|NCT02553265|7161042|FG000|STARTED|Third Intervention (28 Days)||7
6262118|NCT02553265|7161043|FG001|STARTED|Third Intervention (28 Days)||7
6262119|NCT02553265|7161044|FG002|STARTED|Third Intervention (28 Days)||4
6262120|NCT02553265|7161042|FG000|COMPLETED|Third Intervention (28 Days)||6
6262121|NCT02553265|7161043|FG001|COMPLETED|Third Intervention (28 Days)||7
6262122|NCT02553265|7161044|FG002|COMPLETED|Third Intervention (28 Days)||3
6262123|NCT02553265|7161042|FG000|NOT COMPLETED|Third Intervention (28 Days)||1
6262124|NCT02553265|7161043|FG001|NOT COMPLETED|Third Intervention (28 Days)||0
6262125|NCT02553265|7161044|FG002|NOT COMPLETED|Third Intervention (28 Days)||1
6262126|NCT02550288|7161060|FG000|STARTED|Overall Study||35
6262127|NCT02550288|7161061|FG001|STARTED|Overall Study||68
6262128|NCT02550288|7161062|FG002|STARTED|Overall Study||69
6262129|NCT02550288|7161063|FG003|STARTED|Overall Study||68
6262130|NCT02550288|7161064|FG004|STARTED|Overall Study||69
6262131|NCT02550288|7161060|FG000|COMPLETED|Overall Study||33
6262132|NCT02550288|7161061|FG001|COMPLETED|Overall Study||65
6262133|NCT02550288|7161062|FG002|COMPLETED|Overall Study||68
6262134|NCT02550288|7161063|FG003|COMPLETED|Overall Study||65
6262135|NCT02550288|7161064|FG004|COMPLETED|Overall Study||66
6262136|NCT02550288|7161060|FG000|NOT COMPLETED|Overall Study||2
6262137|NCT02550288|7161061|FG001|NOT COMPLETED|Overall Study||3
6262138|NCT02550288|7161062|FG002|NOT COMPLETED|Overall Study||1
6262139|NCT02550288|7161063|FG003|NOT COMPLETED|Overall Study||3
6262140|NCT02550288|7161064|FG004|NOT COMPLETED|Overall Study||3
6262141|NCT02510040|7161079|FG000|STARTED|Overall Study||81
6262142|NCT02510040|7161080|FG001|STARTED|Overall Study||114
6262143|NCT02510040|7161081|FG002|STARTED|Overall Study||22
6262144|NCT02510040|7161079|FG000|COMPLETED|Overall Study||63
6262145|NCT02510040|7161080|FG001|COMPLETED|Overall Study||111
6262146|NCT02510040|7161081|FG002|COMPLETED|Overall Study||21
6262147|NCT02510040|7161079|FG000|NOT COMPLETED|Overall Study||18
6262148|NCT02510040|7161080|FG001|NOT COMPLETED|Overall Study||3
6262149|NCT02510040|7161081|FG002|NOT COMPLETED|Overall Study||1
6262150|NCT02499328|7161109|FG000|STARTED|Overall Study||4
6262151|NCT02499328|7161110|FG001|STARTED|Overall Study||7
6262152|NCT02499328|7161111|FG002|STARTED|Overall Study||10
6262153|NCT02499328|7161112|FG003|STARTED|Overall Study||11
6262154|NCT02499328|7161113|FG004|STARTED|Overall Study||15
6262155|NCT02499328|7161114|FG005|STARTED|Overall Study||9
6262156|NCT02499328|7161115|FG006|STARTED|Overall Study||7
6262157|NCT02499328|7161116|FG007|STARTED|Overall Study||6
6262158|NCT02499328|7161117|FG008|STARTED|Overall Study||14
6262159|NCT02499328|7161118|FG009|STARTED|Overall Study||24
6262160|NCT02499328|7161119|FG010|STARTED|Overall Study||20
6262161|NCT02499328|7161120|FG011|STARTED|Overall Study||54
6262162|NCT02499328|7161121|FG012|STARTED|Overall Study||25
6262163|NCT02499328|7161122|FG013|STARTED|Overall Study||17
6262164|NCT02499328|7161123|FG014|STARTED|Overall Study||10
6262165|NCT02499328|7161124|FG015|STARTED|Overall Study||1
6262166|NCT02499328|7161125|FG016|STARTED|Overall Study||1
6262167|NCT02499328|7161126|FG017|STARTED|Overall Study||55
6262168|NCT02499328|7161127|FG018|STARTED|Overall Study||50
6710636|NCT02946918|7641024|FG000|NOT COMPLETED|Overall Study||1
6710637|NCT02946918|7641025|FG001|NOT COMPLETED|Overall Study||3
6710638|NCT02947984|7641033|FG000|STARTED|Overall Study||22
6710639|NCT02947984|7641034|FG001|STARTED|Overall Study||22
6710640|NCT02947984|7641033|FG000|COMPLETED|Overall Study||22
6710641|NCT02947984|7641034|FG001|COMPLETED|Overall Study||22
6710642|NCT02947984|7641033|FG000|NOT COMPLETED|Overall Study||0
6710643|NCT02947984|7641034|FG001|NOT COMPLETED|Overall Study||0
6710644|NCT02947997|7641040|FG000|STARTED|Overall Study||4
6710645|NCT02947997|7641040|FG000|COMPLETED|Overall Study||4
6710646|NCT02947997|7641040|FG000|NOT COMPLETED|Overall Study||0
6710647|NCT02948257|7641044|FG000|STARTED|Overall Study||52
6710648|NCT02948257|7641044|FG000|COMPLETED|Overall Study||52
6710649|NCT02948257|7641044|FG000|NOT COMPLETED|Overall Study||0
6710650|NCT02948426|7641052|FG000|STARTED|Overall Study||3
6710651|NCT02948426|7641053|FG001|STARTED|Overall Study||6
6710652|NCT02948426|7641054|FG002|STARTED|Overall Study||3
6710653|NCT02948426|7641055|FG003|STARTED|Overall Study||6
6710654|NCT02948426|7641052|FG000|COMPLETED|Overall Study||3
6710655|NCT02948426|7641053|FG001|COMPLETED|Overall Study||6
6710656|NCT02948426|7641054|FG002|COMPLETED|Overall Study||3
6710657|NCT02948426|7641055|FG003|COMPLETED|Overall Study||6
6710658|NCT02948426|7641052|FG000|NOT COMPLETED|Overall Study||0
6710659|NCT02948426|7641053|FG001|NOT COMPLETED|Overall Study||0
6710660|NCT02948426|7641054|FG002|NOT COMPLETED|Overall Study||0
6710661|NCT02948426|7641055|FG003|NOT COMPLETED|Overall Study||0
6710662|NCT02948582|7641067|FG000|STARTED|Treatment Period 1||7
6710663|NCT02948582|7641068|FG001|STARTED|Treatment Period 1||7
6710664|NCT02948582|7641069|FG002|STARTED|Treatment Period 1||7
6710665|NCT02948582|7641070|FG003|STARTED|Treatment Period 1||7
6710666|NCT02948582|7641071|FG004|STARTED|Treatment Period 1||7
6710667|NCT02948582|7641072|FG005|STARTED|Treatment Period 1||7
6710668|NCT02948582|7641067|FG000|COMPLETED|Treatment Period 1||7
6710669|NCT02948582|7641068|FG001|COMPLETED|Treatment Period 1||7
6710670|NCT02948582|7641069|FG002|COMPLETED|Treatment Period 1||7
6710671|NCT02948582|7641070|FG003|COMPLETED|Treatment Period 1||7
6710672|NCT02948582|7641071|FG004|COMPLETED|Treatment Period 1||7
6710673|NCT02948582|7641072|FG005|COMPLETED|Treatment Period 1||7
6710674|NCT02948582|7641067|FG000|NOT COMPLETED|Treatment Period 1||0
6710675|NCT02948582|7641068|FG001|NOT COMPLETED|Treatment Period 1||0
6710676|NCT02948582|7641069|FG002|NOT COMPLETED|Treatment Period 1||0
6710677|NCT02948582|7641070|FG003|NOT COMPLETED|Treatment Period 1||0
6710678|NCT02948582|7641071|FG004|NOT COMPLETED|Treatment Period 1||0
6710679|NCT02948582|7641072|FG005|NOT COMPLETED|Treatment Period 1||0
6710680|NCT02948582|7641067|FG000|STARTED|Washout Period 1||7
6710681|NCT02948582|7641068|FG001|STARTED|Washout Period 1||7
6710682|NCT02948582|7641069|FG002|STARTED|Washout Period 1||7
6710683|NCT02948582|7641070|FG003|STARTED|Washout Period 1||7
6710684|NCT02948582|7641071|FG004|STARTED|Washout Period 1||7
6710685|NCT02948582|7641072|FG005|STARTED|Washout Period 1||7
6710686|NCT02948582|7641067|FG000|COMPLETED|Washout Period 1||7
6710687|NCT02948582|7641068|FG001|COMPLETED|Washout Period 1||5
6710688|NCT02948582|7641069|FG002|COMPLETED|Washout Period 1||7
6710689|NCT02948582|7641070|FG003|COMPLETED|Washout Period 1||7
6710690|NCT02948582|7641071|FG004|COMPLETED|Washout Period 1||7
6710691|NCT02948582|7641072|FG005|COMPLETED|Washout Period 1||6
6710692|NCT02948582|7641067|FG000|NOT COMPLETED|Washout Period 1||0
6710693|NCT02948582|7641068|FG001|NOT COMPLETED|Washout Period 1||2
6710694|NCT02948582|7641069|FG002|NOT COMPLETED|Washout Period 1||0
6710695|NCT02948582|7641070|FG003|NOT COMPLETED|Washout Period 1||0
6710696|NCT02948582|7641071|FG004|NOT COMPLETED|Washout Period 1||0
6710697|NCT02948582|7641072|FG005|NOT COMPLETED|Washout Period 1||1
6710698|NCT02948582|7641067|FG000|STARTED|Treatment Period 2||7
6710699|NCT02948582|7641068|FG001|STARTED|Treatment Period 2||5
6710700|NCT02948582|7641069|FG002|STARTED|Treatment Period 2||7
6710701|NCT02948582|7641070|FG003|STARTED|Treatment Period 2||7
6710702|NCT02948582|7641071|FG004|STARTED|Treatment Period 2||7
6710703|NCT02948582|7641072|FG005|STARTED|Treatment Period 2||6
6710704|NCT02948582|7641067|FG000|COMPLETED|Treatment Period 2||7
6710705|NCT02948582|7641068|FG001|COMPLETED|Treatment Period 2||5
6710706|NCT02948582|7641069|FG002|COMPLETED|Treatment Period 2||7
6710707|NCT02948582|7641070|FG003|COMPLETED|Treatment Period 2||7
6710708|NCT02948582|7641071|FG004|COMPLETED|Treatment Period 2||7
6710709|NCT02948582|7641072|FG005|COMPLETED|Treatment Period 2||6
6710710|NCT02948582|7641067|FG000|NOT COMPLETED|Treatment Period 2||0
6710711|NCT02948582|7641068|FG001|NOT COMPLETED|Treatment Period 2||0
6710712|NCT02948582|7641069|FG002|NOT COMPLETED|Treatment Period 2||0
6710713|NCT02948582|7641070|FG003|NOT COMPLETED|Treatment Period 2||0
6710714|NCT02948582|7641071|FG004|NOT COMPLETED|Treatment Period 2||0
6710715|NCT02948582|7641072|FG005|NOT COMPLETED|Treatment Period 2||0
6710716|NCT02948582|7641067|FG000|STARTED|Washout Period 2||7
6710717|NCT02948582|7641068|FG001|STARTED|Washout Period 2||5
6710718|NCT02948582|7641069|FG002|STARTED|Washout Period 2||7
6710719|NCT02948582|7641070|FG003|STARTED|Washout Period 2||7
6710720|NCT02948582|7641071|FG004|STARTED|Washout Period 2||7
6710721|NCT02948582|7641072|FG005|STARTED|Washout Period 2||6
6710722|NCT02948582|7641067|FG000|COMPLETED|Washout Period 2||7
6710723|NCT02948582|7641068|FG001|COMPLETED|Washout Period 2||4
6710724|NCT02948582|7641069|FG002|COMPLETED|Washout Period 2||7
6710725|NCT02948582|7641070|FG003|COMPLETED|Washout Period 2||6
6710726|NCT02948582|7641071|FG004|COMPLETED|Washout Period 2||7
6710727|NCT02948582|7641072|FG005|COMPLETED|Washout Period 2||6
6710728|NCT02948582|7641067|FG000|NOT COMPLETED|Washout Period 2||0
6710729|NCT02948582|7641068|FG001|NOT COMPLETED|Washout Period 2||1
6710730|NCT02948582|7641069|FG002|NOT COMPLETED|Washout Period 2||0
6710731|NCT02948582|7641070|FG003|NOT COMPLETED|Washout Period 2||1
6710732|NCT02948582|7641071|FG004|NOT COMPLETED|Washout Period 2||0
6710733|NCT02948582|7641072|FG005|NOT COMPLETED|Washout Period 2||0
6710734|NCT02948582|7641067|FG000|STARTED|Treatment Period 3||7
6710735|NCT02948582|7641068|FG001|STARTED|Treatment Period 3||4
6710736|NCT02948582|7641069|FG002|STARTED|Treatment Period 3||7
6710737|NCT02948582|7641070|FG003|STARTED|Treatment Period 3||6
6710738|NCT02948582|7641071|FG004|STARTED|Treatment Period 3||7
6710739|NCT02948582|7641072|FG005|STARTED|Treatment Period 3||6
6710740|NCT02948582|7641067|FG000|COMPLETED|Treatment Period 3||7
6710741|NCT02948582|7641068|FG001|COMPLETED|Treatment Period 3||4
6710742|NCT02948582|7641069|FG002|COMPLETED|Treatment Period 3||7
6710743|NCT02948582|7641070|FG003|COMPLETED|Treatment Period 3||6
6710744|NCT02948582|7641071|FG004|COMPLETED|Treatment Period 3||7
6710745|NCT02948582|7641072|FG005|COMPLETED|Treatment Period 3||6
6710746|NCT02948582|7641067|FG000|NOT COMPLETED|Treatment Period 3||0
6710747|NCT02948582|7641068|FG001|NOT COMPLETED|Treatment Period 3||0
6710748|NCT02948582|7641069|FG002|NOT COMPLETED|Treatment Period 3||0
6710749|NCT02948582|7641070|FG003|NOT COMPLETED|Treatment Period 3||0
6710750|NCT02948582|7641071|FG004|NOT COMPLETED|Treatment Period 3||0
6710751|NCT02948582|7641072|FG005|NOT COMPLETED|Treatment Period 3||0
6710752|NCT02948582|7641067|FG000|STARTED|Washout Period 3||7
6710753|NCT02948582|7641068|FG001|STARTED|Washout Period 3||4
6710754|NCT02948582|7641069|FG002|STARTED|Washout Period 3||7
6710755|NCT02948582|7641070|FG003|STARTED|Washout Period 3||6
6710756|NCT02948582|7641071|FG004|STARTED|Washout Period 3||7
6710757|NCT02948582|7641072|FG005|STARTED|Washout Period 3||6
6710758|NCT02948582|7641067|FG000|COMPLETED|Washout Period 3||7
6710759|NCT02948582|7641068|FG001|COMPLETED|Washout Period 3||4
6710760|NCT02948582|7641069|FG002|COMPLETED|Washout Period 3||7
6710761|NCT02948582|7641070|FG003|COMPLETED|Washout Period 3||6
6710762|NCT02948582|7641071|FG004|COMPLETED|Washout Period 3||7
6710763|NCT02948582|7641072|FG005|COMPLETED|Washout Period 3||6
6710764|NCT02948582|7641067|FG000|NOT COMPLETED|Washout Period 3||0
6710765|NCT02948582|7641068|FG001|NOT COMPLETED|Washout Period 3||0
6710766|NCT02948582|7641069|FG002|NOT COMPLETED|Washout Period 3||0
6710767|NCT02948582|7641070|FG003|NOT COMPLETED|Washout Period 3||0
6710768|NCT02948582|7641071|FG004|NOT COMPLETED|Washout Period 3||0
6710769|NCT02948582|7641072|FG005|NOT COMPLETED|Washout Period 3||0
6710770|NCT02948582|7641067|FG000|STARTED|Treatment Period 4||7
6710771|NCT02948582|7641068|FG001|STARTED|Treatment Period 4||4
6710772|NCT02948582|7641069|FG002|STARTED|Treatment Period 4||7
6710773|NCT02948582|7641070|FG003|STARTED|Treatment Period 4||6
6710774|NCT02948582|7641071|FG004|STARTED|Treatment Period 4||7
6710775|NCT02948582|7641072|FG005|STARTED|Treatment Period 4||6
6710776|NCT02948582|7641067|FG000|COMPLETED|Treatment Period 4||7
6710777|NCT02948582|7641068|FG001|COMPLETED|Treatment Period 4||4
6710778|NCT02948582|7641069|FG002|COMPLETED|Treatment Period 4||7
6710779|NCT02948582|7641070|FG003|COMPLETED|Treatment Period 4||6
6710780|NCT02948582|7641071|FG004|COMPLETED|Treatment Period 4||7
6710781|NCT02948582|7641072|FG005|COMPLETED|Treatment Period 4||6
6710782|NCT02948582|7641067|FG000|NOT COMPLETED|Treatment Period 4||0
6710783|NCT02948582|7641068|FG001|NOT COMPLETED|Treatment Period 4||0
6710784|NCT02948582|7641069|FG002|NOT COMPLETED|Treatment Period 4||0
6710785|NCT02948582|7641070|FG003|NOT COMPLETED|Treatment Period 4||0
6710786|NCT02948582|7641071|FG004|NOT COMPLETED|Treatment Period 4||0
6710787|NCT02948582|7641072|FG005|NOT COMPLETED|Treatment Period 4||0
6710788|NCT02948582|7641067|FG000|STARTED|Washout Period 4||7
6710789|NCT02948582|7641068|FG001|STARTED|Washout Period 4||4
6710790|NCT02948582|7641069|FG002|STARTED|Washout Period 4||7
6710791|NCT02948582|7641070|FG003|STARTED|Washout Period 4||6
6710792|NCT02948582|7641071|FG004|STARTED|Washout Period 4||7
6710793|NCT02948582|7641072|FG005|STARTED|Washout Period 4||6
6710794|NCT02948582|7641067|FG000|COMPLETED|Washout Period 4||6
6710795|NCT02948582|7641068|FG001|COMPLETED|Washout Period 4||4
6710796|NCT02948582|7641069|FG002|COMPLETED|Washout Period 4||6
6710797|NCT02948582|7641070|FG003|COMPLETED|Washout Period 4||6
6710798|NCT02948582|7641071|FG004|COMPLETED|Washout Period 4||7
6710799|NCT02948582|7641072|FG005|COMPLETED|Washout Period 4||6
6710800|NCT02948582|7641067|FG000|NOT COMPLETED|Washout Period 4||1
6710801|NCT02948582|7641068|FG001|NOT COMPLETED|Washout Period 4||0
6710802|NCT02948582|7641069|FG002|NOT COMPLETED|Washout Period 4||1
6710803|NCT02948582|7641070|FG003|NOT COMPLETED|Washout Period 4||0
6710804|NCT02948582|7641071|FG004|NOT COMPLETED|Washout Period 4||0
6710805|NCT02948582|7641072|FG005|NOT COMPLETED|Washout Period 4||0
6710806|NCT02948582|7641067|FG000|STARTED|Treatment Period 5||6
6710807|NCT02948582|7641068|FG001|STARTED|Treatment Period 5||4
6710808|NCT02948582|7641069|FG002|STARTED|Treatment Period 5||6
6710809|NCT02948582|7641070|FG003|STARTED|Treatment Period 5||6
6710810|NCT02948582|7641071|FG004|STARTED|Treatment Period 5||7
6710811|NCT02948582|7641072|FG005|STARTED|Treatment Period 5||6
6710812|NCT02948582|7641067|FG000|COMPLETED|Treatment Period 5||6
6710813|NCT02948582|7641068|FG001|COMPLETED|Treatment Period 5||4
6710814|NCT02948582|7641069|FG002|COMPLETED|Treatment Period 5||6
6710815|NCT02948582|7641070|FG003|COMPLETED|Treatment Period 5||6
6710816|NCT02948582|7641071|FG004|COMPLETED|Treatment Period 5||7
6710817|NCT02948582|7641072|FG005|COMPLETED|Treatment Period 5||6
6710818|NCT02948582|7641067|FG000|NOT COMPLETED|Treatment Period 5||0
6710819|NCT02948582|7641068|FG001|NOT COMPLETED|Treatment Period 5||0
6710820|NCT02948582|7641069|FG002|NOT COMPLETED|Treatment Period 5||0
6710821|NCT02948582|7641070|FG003|NOT COMPLETED|Treatment Period 5||0
6710822|NCT02948582|7641071|FG004|NOT COMPLETED|Treatment Period 5||0
6710823|NCT02948582|7641072|FG005|NOT COMPLETED|Treatment Period 5||0
6710824|NCT02948582|7641067|FG000|STARTED|Washout Period 5||6
6710825|NCT02948582|7641068|FG001|STARTED|Washout Period 5||4
6710826|NCT02948582|7641069|FG002|STARTED|Washout Period 5||6
6710827|NCT02948582|7641070|FG003|STARTED|Washout Period 5||6
6710828|NCT02948582|7641071|FG004|STARTED|Washout Period 5||7
6710829|NCT02948582|7641072|FG005|STARTED|Washout Period 5||6
6710830|NCT02948582|7641067|FG000|COMPLETED|Washout Period 5||6
6710831|NCT02948582|7641068|FG001|COMPLETED|Washout Period 5||4
6710832|NCT02948582|7641069|FG002|COMPLETED|Washout Period 5||6
6710833|NCT02948582|7641070|FG003|COMPLETED|Washout Period 5||6
6710834|NCT02948582|7641071|FG004|COMPLETED|Washout Period 5||7
6710835|NCT02948582|7641072|FG005|COMPLETED|Washout Period 5||6
6710836|NCT02948582|7641067|FG000|NOT COMPLETED|Washout Period 5||0
6710837|NCT02948582|7641068|FG001|NOT COMPLETED|Washout Period 5||0
6710838|NCT02948582|7641069|FG002|NOT COMPLETED|Washout Period 5||0
6710839|NCT02948582|7641070|FG003|NOT COMPLETED|Washout Period 5||0
6710840|NCT02948582|7641071|FG004|NOT COMPLETED|Washout Period 5||0
6710841|NCT02948582|7641072|FG005|NOT COMPLETED|Washout Period 5||0
6710842|NCT02948582|7641067|FG000|STARTED|Treatment Period 6||6
6710843|NCT02948582|7641068|FG001|STARTED|Treatment Period 6||4
6710844|NCT02948582|7641069|FG002|STARTED|Treatment Period 6||6
6710845|NCT02948582|7641070|FG003|STARTED|Treatment Period 6||6
6710846|NCT02948582|7641071|FG004|STARTED|Treatment Period 6||7
6710847|NCT02948582|7641072|FG005|STARTED|Treatment Period 6||6
6710848|NCT02948582|7641067|FG000|COMPLETED|Treatment Period 6||6
6710849|NCT02948582|7641068|FG001|COMPLETED|Treatment Period 6||4
6710850|NCT02948582|7641069|FG002|COMPLETED|Treatment Period 6||6
6710851|NCT02948582|7641070|FG003|COMPLETED|Treatment Period 6||6
6710852|NCT02948582|7641071|FG004|COMPLETED|Treatment Period 6||7
6710853|NCT02948582|7641072|FG005|COMPLETED|Treatment Period 6||6
6710854|NCT02948582|7641067|FG000|NOT COMPLETED|Treatment Period 6||0
6710855|NCT02948582|7641068|FG001|NOT COMPLETED|Treatment Period 6||0
6710856|NCT02948582|7641069|FG002|NOT COMPLETED|Treatment Period 6||0
6710857|NCT02948582|7641070|FG003|NOT COMPLETED|Treatment Period 6||0
6710858|NCT02948582|7641071|FG004|NOT COMPLETED|Treatment Period 6||0
6710859|NCT02948582|7641072|FG005|NOT COMPLETED|Treatment Period 6||0
6710860|NCT02948582|7641067|FG000|STARTED|Wshout Period 6||6
6710861|NCT02948582|7641068|FG001|STARTED|Wshout Period 6||4
6710862|NCT02948582|7641069|FG002|STARTED|Wshout Period 6||6
6710863|NCT02948582|7641070|FG003|STARTED|Wshout Period 6||6
6710864|NCT02948582|7641071|FG004|STARTED|Wshout Period 6||7
6710865|NCT02948582|7641072|FG005|STARTED|Wshout Period 6||6
6710866|NCT02948582|7641067|FG000|COMPLETED|Wshout Period 6||6
6710867|NCT02948582|7641068|FG001|COMPLETED|Wshout Period 6||4
6710868|NCT02948582|7641069|FG002|COMPLETED|Wshout Period 6||6
6710869|NCT02948582|7641070|FG003|COMPLETED|Wshout Period 6||6
6710870|NCT02948582|7641071|FG004|COMPLETED|Wshout Period 6||7
6710871|NCT02948582|7641072|FG005|COMPLETED|Wshout Period 6||6
6710872|NCT02948582|7641067|FG000|NOT COMPLETED|Wshout Period 6||0
6710873|NCT02948582|7641068|FG001|NOT COMPLETED|Wshout Period 6||0
6710874|NCT02948582|7641069|FG002|NOT COMPLETED|Wshout Period 6||0
6710875|NCT02948582|7641070|FG003|NOT COMPLETED|Wshout Period 6||0
6710876|NCT02948582|7641071|FG004|NOT COMPLETED|Wshout Period 6||0
6710877|NCT02948582|7641072|FG005|NOT COMPLETED|Wshout Period 6||0
6710878|NCT02948634|7641088|FG000|STARTED|Overall Study||17
6710879|NCT02948634|7641089|FG001|STARTED|Overall Study||11
6710880|NCT02948634|7641088|FG000|COMPLETED|Overall Study||7
6710881|NCT02948634|7641089|FG001|COMPLETED|Overall Study||9
6710882|NCT02948634|7641088|FG000|NOT COMPLETED|Overall Study||10
6710883|NCT02948634|7641089|FG001|NOT COMPLETED|Overall Study||2
6739273|NCT03286751|7668062|FG001|COMPLETED|Washout Period 5||6
6739274|NCT03286751|7668063|FG002|COMPLETED|Washout Period 5||7
6739275|NCT03286751|7668064|FG003|COMPLETED|Washout Period 5||7
6739276|NCT03286751|7668065|FG004|COMPLETED|Washout Period 5||5
6739277|NCT03286751|7668066|FG005|COMPLETED|Washout Period 5||7
6739278|NCT03286751|7668061|FG000|NOT COMPLETED|Washout Period 5||0
6739279|NCT03286751|7668062|FG001|NOT COMPLETED|Washout Period 5||0
6739280|NCT03286751|7668063|FG002|NOT COMPLETED|Washout Period 5||0
6739281|NCT03286751|7668064|FG003|NOT COMPLETED|Washout Period 5||0
6739282|NCT03286751|7668065|FG004|NOT COMPLETED|Washout Period 5||1
6739283|NCT03286751|7668066|FG005|NOT COMPLETED|Washout Period 5||0
6739284|NCT03286751|7668061|FG000|STARTED|Period 6||7
6739285|NCT03286751|7668062|FG001|STARTED|Period 6||6
6739286|NCT03286751|7668063|FG002|STARTED|Period 6||7
6739287|NCT03286751|7668064|FG003|STARTED|Period 6||7
6739288|NCT03286751|7668065|FG004|STARTED|Period 6||5
6739289|NCT03286751|7668066|FG005|STARTED|Period 6||7
6739290|NCT03286751|7668061|FG000|COMPLETED|Period 6||7
6739291|NCT03286751|7668062|FG001|COMPLETED|Period 6||6
6739292|NCT03286751|7668063|FG002|COMPLETED|Period 6||7
6739293|NCT03286751|7668064|FG003|COMPLETED|Period 6||7
6739294|NCT03286751|7668065|FG004|COMPLETED|Period 6||5
6739295|NCT03286751|7668066|FG005|COMPLETED|Period 6||7
6739296|NCT03286751|7668061|FG000|NOT COMPLETED|Period 6||0
6739297|NCT03286751|7668062|FG001|NOT COMPLETED|Period 6||0
6739298|NCT03286751|7668063|FG002|NOT COMPLETED|Period 6||0
6739299|NCT03286751|7668064|FG003|NOT COMPLETED|Period 6||0
6710884|NCT02948777|7641095|FG000|STARTED|Overall Study||14
6710885|NCT02948777|7641095|FG000|COMPLETED|Overall Study||13
6710886|NCT02948777|7641095|FG000|NOT COMPLETED|Overall Study||1
6710887|NCT02948829|7641100|FG000|STARTED|Overall Study||200
6710888|NCT02948829|7641100|FG000|COMPLETED|Overall Study||0
6710889|NCT02948829|7641100|FG000|NOT COMPLETED|Overall Study||200
6710890|NCT02949011|7641122|FG000|STARTED|Overall Study||730
6710891|NCT02949011|7641123|FG001|STARTED|Overall Study||729
6710892|NCT02949011|7641124|FG002|STARTED|Overall Study||725
6710893|NCT02949011|7641122|FG000|Received Study Drug|Overall Study||728
6710894|NCT02949011|7641123|FG001|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|728
6710895|NCT02949011|7641124|FG002|Received Study Drug|Overall Study|Includes one participant who received baloxavir marboxil in error|722
6710896|NCT02949011|7641122|FG000|Intention to Treat Infected Population|Overall Study||388
6710897|NCT02949011|7641123|FG001|Intention to Treat Infected Population|Overall Study||386
6710898|NCT02949011|7641124|FG002|Intention to Treat Infected Population|Overall Study||389
6710899|NCT02949011|7641122|FG000|COMPLETED|Overall Study||697
6710900|NCT02949011|7641123|FG001|COMPLETED|Overall Study||695
6710901|NCT02949011|7641124|FG002|COMPLETED|Overall Study||683
6710902|NCT02949011|7641122|FG000|NOT COMPLETED|Overall Study||33
6710903|NCT02949011|7641123|FG001|NOT COMPLETED|Overall Study||34
6710904|NCT02949011|7641124|FG002|NOT COMPLETED|Overall Study||42
6710905|NCT02949024|7641134|FG000|STARTED|Overall Study||10
6710906|NCT02949024|7641135|FG001|STARTED|Overall Study||10
6710907|NCT02949024|7641134|FG000|COMPLETED|Overall Study||10
6710908|NCT02949024|7641135|FG001|COMPLETED|Overall Study||9
6710909|NCT02949024|7641134|FG000|NOT COMPLETED|Overall Study||0
6710910|NCT02949024|7641135|FG001|NOT COMPLETED|Overall Study||1
6710911|NCT02949141|7641143|FG000|STARTED|Overall Study||62
6710912|NCT02949141|7641143|FG000|COMPLETED|Overall Study||62
6710913|NCT02949141|7641143|FG000|NOT COMPLETED|Overall Study||0
6710914|NCT02949219|7641150|FG000|STARTED|Overall Study||41
6710915|NCT02949219|7641150|FG000|COMPLETED|Overall Study||40
6710916|NCT02949219|7641150|FG000|NOT COMPLETED|Overall Study||1
6710917|NCT02949271|7641156|FG000|STARTED|Overall Study||90
6710918|NCT02949271|7641157|FG001|STARTED|Overall Study||89
6710919|NCT02949271|7641156|FG000|COMPLETED|Overall Study||61
6710920|NCT02949271|7641157|FG001|COMPLETED|Overall Study||59
6710921|NCT02949271|7641156|FG000|NOT COMPLETED|Overall Study||29
6710922|NCT02949271|7641157|FG001|NOT COMPLETED|Overall Study||30
6710923|NCT02949362|7641165|FG000|STARTED|Retrospective Period||24
6710924|NCT02949362|7641166|FG001|STARTED|Retrospective Period||5
6710925|NCT02949362|7641167|FG002|STARTED|Retrospective Period||0
6710926|NCT02949362|7641168|FG003|STARTED|Retrospective Period||0
6710927|NCT02949362|7641165|FG000|COMPLETED|Retrospective Period||20
6710928|NCT02949362|7641166|FG001|COMPLETED|Retrospective Period||4
6710929|NCT02949362|7641167|FG002|COMPLETED|Retrospective Period||0
6710930|NCT02949362|7641168|FG003|COMPLETED|Retrospective Period||0
6710931|NCT02949362|7641165|FG000|NOT COMPLETED|Retrospective Period||4
6710932|NCT02949362|7641166|FG001|NOT COMPLETED|Retrospective Period||1
6710933|NCT02949362|7641167|FG002|NOT COMPLETED|Retrospective Period||0
6710934|NCT02949362|7641168|FG003|NOT COMPLETED|Retrospective Period||0
6710935|NCT02949362|7641165|FG000|STARTED|Prospective Period||0
6710936|NCT02949362|7641166|FG001|STARTED|Prospective Period||0
6710937|NCT02949362|7641167|FG002|STARTED|Prospective Period|Participants were enrolled from retrospective period.|5
6710938|NCT02949362|7641168|FG003|STARTED|Prospective Period|Participants were enrolled from retrospective period.|19
6710939|NCT02949362|7641165|FG000|COMPLETED|Prospective Period||0
6710940|NCT02949362|7641166|FG001|COMPLETED|Prospective Period||0
6710941|NCT02949362|7641167|FG002|COMPLETED|Prospective Period||4
6710942|NCT02949362|7641168|FG003|COMPLETED|Prospective Period||15
6710943|NCT02949362|7641165|FG000|NOT COMPLETED|Prospective Period||0
6710944|NCT02949362|7641166|FG001|NOT COMPLETED|Prospective Period||0
6710945|NCT02949362|7641167|FG002|NOT COMPLETED|Prospective Period||1
6710946|NCT02949362|7641168|FG003|NOT COMPLETED|Prospective Period||4
6710947|NCT02949518|7641182|FG000|STARTED|Overall Study||28
6710948|NCT02949518|7641183|FG001|STARTED|Overall Study||28
6710949|NCT02949518|7641182|FG000|COMPLETED|Overall Study||25
6710950|NCT02949518|7641183|FG001|COMPLETED|Overall Study||26
6710951|NCT02949518|7641182|FG000|NOT COMPLETED|Overall Study||3
6710952|NCT02949518|7641183|FG001|NOT COMPLETED|Overall Study||2
6710953|NCT02949674|7641194|FG000|STARTED|Overall Study||31
6710954|NCT02949674|7641195|FG001|STARTED|Overall Study||31
6710955|NCT02949674|7641196|FG002|STARTED|Overall Study||31
6710956|NCT02949674|7641194|FG000|COMPLETED|Overall Study||31
6710957|NCT02949674|7641195|FG001|COMPLETED|Overall Study||31
6710958|NCT02949674|7641196|FG002|COMPLETED|Overall Study||31
6710959|NCT02949674|7641194|FG000|NOT COMPLETED|Overall Study||0
6710960|NCT02949674|7641195|FG001|NOT COMPLETED|Overall Study||0
6710961|NCT02949674|7641196|FG002|NOT COMPLETED|Overall Study||0
6710962|NCT02949908|7641204|FG000|STARTED|Overall Study||2
6710963|NCT02949908|7641204|FG000|COMPLETED|Overall Study||0
6710964|NCT02949908|7641204|FG000|NOT COMPLETED|Overall Study||2
6710965|NCT02949921|7641210|FG000|STARTED|Overall Study||10
6710966|NCT02949921|7641211|FG001|STARTED|Overall Study||10
6710967|NCT02949921|7641210|FG000|COMPLETED|Overall Study||10
6710968|NCT02949921|7641211|FG001|COMPLETED|Overall Study||10
6710969|NCT02949921|7641210|FG000|NOT COMPLETED|Overall Study||0
6710970|NCT02949921|7641211|FG001|NOT COMPLETED|Overall Study||0
6710971|NCT02949973|7641217|FG000|STARTED|Overall Study||10
6710972|NCT02949973|7641217|FG000|COMPLETED|Overall Study||9
6710973|NCT02949973|7641217|FG000|NOT COMPLETED|Overall Study||1
6710974|NCT02950025|7641223|FG000|STARTED|Overall Study||2
6710975|NCT02950025|7641224|FG001|STARTED|Overall Study||3
6710976|NCT02950025|7641223|FG000|COMPLETED|Overall Study||2
6710977|NCT02950025|7641224|FG001|COMPLETED|Overall Study||3
6710978|NCT02950025|7641223|FG000|NOT COMPLETED|Overall Study||0
6710979|NCT02950025|7641224|FG001|NOT COMPLETED|Overall Study||0
6710980|NCT02950467|7641230|FG000|STARTED|Open-label Treatment||18
6710981|NCT02950467|7641230|FG000|COMPLETED|Open-label Treatment|1 participant completed study period but missed some visits due to an adverse event (AE).|18
6710982|NCT02950467|7641230|FG000|NOT COMPLETED|Open-label Treatment||0
6710983|NCT02950467|7641230|FG000|STARTED|3-month Follow-up||18
6710984|NCT02950467|7641230|FG000|COMPLETED|3-month Follow-up|All participants completed the safety follow-up assessment, but not all completed outcomes measures.|18
6710985|NCT02950467|7641230|FG000|NOT COMPLETED|3-month Follow-up||0
6710986|NCT02950545|7641240|FG000|STARTED|Session 1 (70 Minutes)||9
6710987|NCT02950545|7641241|FG001|STARTED|Session 1 (70 Minutes)||9
6710988|NCT02950545|7641242|FG002|STARTED|Session 1 (70 Minutes)||7
6710989|NCT02950545|7641243|FG003|STARTED|Session 1 (70 Minutes)||8
6710990|NCT02950545|7641244|FG004|STARTED|Session 1 (70 Minutes)||8
6710991|NCT02950545|7641245|FG005|STARTED|Session 1 (70 Minutes)||10
6710992|NCT02950545|7641240|FG000|COMPLETED|Session 1 (70 Minutes)||9
6710993|NCT02950545|7641241|FG001|COMPLETED|Session 1 (70 Minutes)||9
6710994|NCT02950545|7641242|FG002|COMPLETED|Session 1 (70 Minutes)||7
6710995|NCT02950545|7641243|FG003|COMPLETED|Session 1 (70 Minutes)||8
6710996|NCT02950545|7641244|FG004|COMPLETED|Session 1 (70 Minutes)||8
6710997|NCT02950545|7641245|FG005|COMPLETED|Session 1 (70 Minutes)||9
6710998|NCT02950545|7641240|FG000|NOT COMPLETED|Session 1 (70 Minutes)||0
6710999|NCT02950545|7641241|FG001|NOT COMPLETED|Session 1 (70 Minutes)||0
6711000|NCT02950545|7641242|FG002|NOT COMPLETED|Session 1 (70 Minutes)||0
6711001|NCT02950545|7641243|FG003|NOT COMPLETED|Session 1 (70 Minutes)||0
6711002|NCT02950545|7641244|FG004|NOT COMPLETED|Session 1 (70 Minutes)||0
6711003|NCT02950545|7641245|FG005|NOT COMPLETED|Session 1 (70 Minutes)||1
6711004|NCT02950545|7641240|FG000|STARTED|Washout 1 (5 Minutes)||9
6711005|NCT02950545|7641241|FG001|STARTED|Washout 1 (5 Minutes)||9
6711006|NCT02950545|7641242|FG002|STARTED|Washout 1 (5 Minutes)||7
6711007|NCT02950545|7641243|FG003|STARTED|Washout 1 (5 Minutes)||8
6711008|NCT02950545|7641244|FG004|STARTED|Washout 1 (5 Minutes)||8
6711009|NCT02950545|7641245|FG005|STARTED|Washout 1 (5 Minutes)||9
6711010|NCT02950545|7641240|FG000|COMPLETED|Washout 1 (5 Minutes)||8
6711011|NCT02950545|7641241|FG001|COMPLETED|Washout 1 (5 Minutes)||9
6711012|NCT02950545|7641242|FG002|COMPLETED|Washout 1 (5 Minutes)||7
6711013|NCT02950545|7641243|FG003|COMPLETED|Washout 1 (5 Minutes)||7
6711014|NCT02950545|7641244|FG004|COMPLETED|Washout 1 (5 Minutes)||8
6711015|NCT02950545|7641245|FG005|COMPLETED|Washout 1 (5 Minutes)||8
6711016|NCT02950545|7641240|FG000|NOT COMPLETED|Washout 1 (5 Minutes)||1
6711017|NCT02950545|7641241|FG001|NOT COMPLETED|Washout 1 (5 Minutes)||0
6711018|NCT02950545|7641242|FG002|NOT COMPLETED|Washout 1 (5 Minutes)||0
6711019|NCT02950545|7641243|FG003|NOT COMPLETED|Washout 1 (5 Minutes)||1
6711020|NCT02950545|7641244|FG004|NOT COMPLETED|Washout 1 (5 Minutes)||0
6711021|NCT02950545|7641245|FG005|NOT COMPLETED|Washout 1 (5 Minutes)||1
6711022|NCT02950545|7641240|FG000|STARTED|Session 2 (70 Minutes)||8
6711023|NCT02950545|7641241|FG001|STARTED|Session 2 (70 Minutes)||9
6711024|NCT02950545|7641242|FG002|STARTED|Session 2 (70 Minutes)||7
6711025|NCT02950545|7641243|FG003|STARTED|Session 2 (70 Minutes)||7
6711026|NCT02950545|7641244|FG004|STARTED|Session 2 (70 Minutes)||8
6711027|NCT02950545|7641245|FG005|STARTED|Session 2 (70 Minutes)||8
6711028|NCT02950545|7641240|FG000|COMPLETED|Session 2 (70 Minutes)||8
6711029|NCT02950545|7641241|FG001|COMPLETED|Session 2 (70 Minutes)||9
6711030|NCT02950545|7641242|FG002|COMPLETED|Session 2 (70 Minutes)||7
6711031|NCT02950545|7641243|FG003|COMPLETED|Session 2 (70 Minutes)||7
6711032|NCT02950545|7641244|FG004|COMPLETED|Session 2 (70 Minutes)||7
6711033|NCT02950545|7641245|FG005|COMPLETED|Session 2 (70 Minutes)||8
6711034|NCT02950545|7641240|FG000|NOT COMPLETED|Session 2 (70 Minutes)||0
6711035|NCT02950545|7641241|FG001|NOT COMPLETED|Session 2 (70 Minutes)||0
6711036|NCT02950545|7641242|FG002|NOT COMPLETED|Session 2 (70 Minutes)||0
6711037|NCT02950545|7641243|FG003|NOT COMPLETED|Session 2 (70 Minutes)||0
6711038|NCT02950545|7641244|FG004|NOT COMPLETED|Session 2 (70 Minutes)||1
6711039|NCT02950545|7641245|FG005|NOT COMPLETED|Session 2 (70 Minutes)||0
6711040|NCT02950545|7641240|FG000|STARTED|Washout 2 (5 Minutes)||8
6711041|NCT02950545|7641241|FG001|STARTED|Washout 2 (5 Minutes)||9
6711042|NCT02950545|7641242|FG002|STARTED|Washout 2 (5 Minutes)||7
6711043|NCT02950545|7641243|FG003|STARTED|Washout 2 (5 Minutes)||7
6711044|NCT02950545|7641244|FG004|STARTED|Washout 2 (5 Minutes)||7
6711045|NCT02950545|7641245|FG005|STARTED|Washout 2 (5 Minutes)||8
6711046|NCT02950545|7641240|FG000|COMPLETED|Washout 2 (5 Minutes)||7
6711047|NCT02950545|7641241|FG001|COMPLETED|Washout 2 (5 Minutes)||9
6711048|NCT02950545|7641242|FG002|COMPLETED|Washout 2 (5 Minutes)||7
6711049|NCT02950545|7641243|FG003|COMPLETED|Washout 2 (5 Minutes)||7
6711050|NCT02950545|7641244|FG004|COMPLETED|Washout 2 (5 Minutes)||7
6711051|NCT02950545|7641245|FG005|COMPLETED|Washout 2 (5 Minutes)||8
6711052|NCT02950545|7641240|FG000|NOT COMPLETED|Washout 2 (5 Minutes)||1
6711053|NCT02950545|7641241|FG001|NOT COMPLETED|Washout 2 (5 Minutes)||0
6711054|NCT02950545|7641242|FG002|NOT COMPLETED|Washout 2 (5 Minutes)||0
6711055|NCT02950545|7641243|FG003|NOT COMPLETED|Washout 2 (5 Minutes)||0
6711056|NCT02950545|7641244|FG004|NOT COMPLETED|Washout 2 (5 Minutes)||0
6711057|NCT02950545|7641245|FG005|NOT COMPLETED|Washout 2 (5 Minutes)||0
6711058|NCT02950545|7641240|FG000|STARTED|Session 3 (70 Minutes)||7
6711059|NCT02950545|7641241|FG001|STARTED|Session 3 (70 Minutes)||9
6711060|NCT02950545|7641242|FG002|STARTED|Session 3 (70 Minutes)||7
6711061|NCT02950545|7641243|FG003|STARTED|Session 3 (70 Minutes)||7
6711062|NCT02950545|7641244|FG004|STARTED|Session 3 (70 Minutes)||7
6711063|NCT02950545|7641245|FG005|STARTED|Session 3 (70 Minutes)||8
6711064|NCT02950545|7641240|FG000|COMPLETED|Session 3 (70 Minutes)||7
6711065|NCT02950545|7641241|FG001|COMPLETED|Session 3 (70 Minutes)||9
6711066|NCT02950545|7641242|FG002|COMPLETED|Session 3 (70 Minutes)||7
6711067|NCT02950545|7641243|FG003|COMPLETED|Session 3 (70 Minutes)||7
6711068|NCT02950545|7641244|FG004|COMPLETED|Session 3 (70 Minutes)||7
6711069|NCT02950545|7641245|FG005|COMPLETED|Session 3 (70 Minutes)||7
6711070|NCT02950545|7641240|FG000|NOT COMPLETED|Session 3 (70 Minutes)||0
6711071|NCT02950545|7641241|FG001|NOT COMPLETED|Session 3 (70 Minutes)||0
6711072|NCT02950545|7641242|FG002|NOT COMPLETED|Session 3 (70 Minutes)||0
6711073|NCT02950545|7641243|FG003|NOT COMPLETED|Session 3 (70 Minutes)||0
6711074|NCT02950545|7641244|FG004|NOT COMPLETED|Session 3 (70 Minutes)||0
6711075|NCT02950545|7641245|FG005|NOT COMPLETED|Session 3 (70 Minutes)||1
6711076|NCT02950558|7641253|FG000|STARTED|Overall Study||8
6711077|NCT02950558|7641254|FG001|STARTED|Overall Study||6
6711078|NCT02950558|7641253|FG000|12 Month Pain Questionnaire|Overall Study||6
6711079|NCT02950558|7641254|FG001|12 Month Pain Questionnaire|Overall Study||6
6711080|NCT02950558|7641253|FG000|COMPLETED|Overall Study||6
6711081|NCT02950558|7641254|FG001|COMPLETED|Overall Study||6
6711082|NCT02950558|7641253|FG000|NOT COMPLETED|Overall Study||2
6711083|NCT02950558|7641254|FG001|NOT COMPLETED|Overall Study||0
6711084|NCT02950753|7641263|FG000|STARTED|Overall Study||15
6711085|NCT02950753|7641264|FG001|STARTED|Overall Study||15
6711086|NCT02950753|7641263|FG000|COMPLETED|Overall Study||15
6711087|NCT02950753|7641264|FG001|COMPLETED|Overall Study||15
6711088|NCT02950753|7641263|FG000|NOT COMPLETED|Overall Study||0
6711089|NCT02950753|7641264|FG001|NOT COMPLETED|Overall Study||0
6711090|NCT02950831|7641270|FG000|STARTED|Overall Study||27
6711091|NCT02950831|7641270|FG000|Complete Trial|Overall Study||26
6711092|NCT02950831|7641270|FG000|Permanent Implant|Overall Study||20
6711093|NCT02950831|7641270|FG000|4 Week Follow up|Overall Study||20
6711094|NCT02950831|7641270|FG000|8 Weeks Follow up|Overall Study||19
6711095|NCT02950831|7641270|FG000|COMPLETED|Overall Study||18
6711096|NCT02950831|7641270|FG000|NOT COMPLETED|Overall Study||9
6711097|NCT02951143|7641280|FG000|STARTED|Overall Study||97
6711098|NCT02951143|7641281|FG001|STARTED|Overall Study||41
6711099|NCT02951143|7641282|FG002|STARTED|Overall Study||47
6711100|NCT02951143|7641283|FG003|STARTED|Overall Study||39
6711101|NCT02951143|7641284|FG004|STARTED|Overall Study||37
6711102|NCT02951143|7641285|FG005|STARTED|Overall Study||44
6711103|NCT02951143|7641280|FG000|COMPLETED|Overall Study||36
6711104|NCT02951143|7641281|FG001|COMPLETED|Overall Study||32
6711105|NCT02951143|7641282|FG002|COMPLETED|Overall Study||29
6711106|NCT02951143|7641283|FG003|COMPLETED|Overall Study||30
6711107|NCT02951143|7641284|FG004|COMPLETED|Overall Study||31
6711108|NCT02951143|7641285|FG005|COMPLETED|Overall Study||29
6711109|NCT02951143|7641280|FG000|NOT COMPLETED|Overall Study||61
6711110|NCT02951143|7641281|FG001|NOT COMPLETED|Overall Study||9
6711111|NCT02951143|7641282|FG002|NOT COMPLETED|Overall Study||18
6711112|NCT02951143|7641283|FG003|NOT COMPLETED|Overall Study||9
6711113|NCT02951143|7641284|FG004|NOT COMPLETED|Overall Study||6
6711114|NCT02951143|7641285|FG005|NOT COMPLETED|Overall Study||15
6711115|NCT02951156|7641302|FG000|STARTED|Overall Study||9
6711116|NCT02951156|7641303|FG001|STARTED|Overall Study||9
6711117|NCT02951156|7641304|FG002|STARTED|Overall Study||11
6711118|NCT02951156|7641302|FG000|COMPLETED|Overall Study||0
6711119|NCT02951156|7641303|FG001|COMPLETED|Overall Study||0
6711120|NCT02951156|7641304|FG002|COMPLETED|Overall Study||1
6711121|NCT02951156|7641302|FG000|NOT COMPLETED|Overall Study||9
6711122|NCT02951156|7641303|FG001|NOT COMPLETED|Overall Study||9
6711123|NCT02951156|7641304|FG002|NOT COMPLETED|Overall Study||10
6711124|NCT02951182|7641319|FG000|STARTED|Overall Study||11
6711125|NCT02951182|7641320|FG001|STARTED|Overall Study||9
6711126|NCT02951182|7641321|FG002|STARTED|Overall Study||9
6711127|NCT02951182|7641322|FG003|STARTED|Overall Study||18
6711128|NCT02951182|7641323|FG004|STARTED|Overall Study||6
6711129|NCT02951182|7641324|FG005|STARTED|Overall Study||20
6711130|NCT02951182|7641319|FG000|COMPLETED|Overall Study||11
6711131|NCT02951182|7641320|FG001|COMPLETED|Overall Study||9
6711132|NCT02951182|7641321|FG002|COMPLETED|Overall Study||9
6711133|NCT02951182|7641322|FG003|COMPLETED|Overall Study||18
6711134|NCT02951182|7641323|FG004|COMPLETED|Overall Study||6
6711135|NCT02951182|7641324|FG005|COMPLETED|Overall Study||20
6711136|NCT02951182|7641319|FG000|NOT COMPLETED|Overall Study||0
6711137|NCT02951182|7641320|FG001|NOT COMPLETED|Overall Study||0
6711138|NCT02951182|7641321|FG002|NOT COMPLETED|Overall Study||0
6711139|NCT02951182|7641322|FG003|NOT COMPLETED|Overall Study||0
6711140|NCT02951182|7641323|FG004|NOT COMPLETED|Overall Study||0
6711141|NCT02951182|7641324|FG005|NOT COMPLETED|Overall Study||0
6711142|NCT02951195|7641352|FG000|STARTED|Overall Study||8
6711143|NCT02951195|7641353|FG001|STARTED|Overall Study||6
6711144|NCT02951195|7641354|FG002|STARTED|Overall Study||10
6711145|NCT02951195|7641355|FG003|STARTED|Overall Study||10
6711146|NCT02951195|7641356|FG004|STARTED|Overall Study||4
6711147|NCT02951195|7641357|FG005|STARTED|Overall Study||10
6711148|NCT02951195|7641358|FG006|STARTED|Overall Study||7
6711149|NCT02951195|7641359|FG007|STARTED|Overall Study||21
6711150|NCT02951195|7641352|FG000|COMPLETED|Overall Study||8
6711151|NCT02951195|7641353|FG001|COMPLETED|Overall Study||6
6711152|NCT02951195|7641354|FG002|COMPLETED|Overall Study||10
6711153|NCT02951195|7641355|FG003|COMPLETED|Overall Study||10
6711154|NCT02951195|7641356|FG004|COMPLETED|Overall Study||4
6711155|NCT02951195|7641357|FG005|COMPLETED|Overall Study||10
6711156|NCT02951195|7641358|FG006|COMPLETED|Overall Study||7
6711157|NCT02951195|7641359|FG007|COMPLETED|Overall Study||21
6711158|NCT02951195|7641352|FG000|NOT COMPLETED|Overall Study||0
6711159|NCT02951195|7641353|FG001|NOT COMPLETED|Overall Study||0
6711160|NCT02951195|7641354|FG002|NOT COMPLETED|Overall Study||0
6711161|NCT02951195|7641355|FG003|NOT COMPLETED|Overall Study||0
6711162|NCT02951195|7641356|FG004|NOT COMPLETED|Overall Study||0
6711163|NCT02951195|7641357|FG005|NOT COMPLETED|Overall Study||0
6711164|NCT02951195|7641358|FG006|NOT COMPLETED|Overall Study||0
6711165|NCT02951195|7641359|FG007|NOT COMPLETED|Overall Study||0
6711166|NCT02951273|7641387|FG000|STARTED|Overall Study||30
6711167|NCT02951273|7641387|FG000|COMPLETED|Overall Study||27
6711168|NCT02951273|7641387|FG000|NOT COMPLETED|Overall Study||3
6711169|NCT02951312|7641395|FG000|STARTED|Study Part 1||6
6711170|NCT02951312|7641396|FG001|STARTED|Study Part 1||6
6711171|NCT02951312|7641397|FG002|STARTED|Study Part 1||0
6711172|NCT02951312|7641398|FG003|STARTED|Study Part 1||0
6711173|NCT02951312|7641395|FG000|COMPLETED|Study Part 1||6
6711174|NCT02951312|7641396|FG001|COMPLETED|Study Part 1||6
6711175|NCT02951312|7641397|FG002|COMPLETED|Study Part 1||0
6711176|NCT02951312|7641398|FG003|COMPLETED|Study Part 1||0
6711177|NCT02951312|7641395|FG000|NOT COMPLETED|Study Part 1||0
6711178|NCT02951312|7641396|FG001|NOT COMPLETED|Study Part 1||0
6711179|NCT02951312|7641397|FG002|NOT COMPLETED|Study Part 1||0
6711180|NCT02951312|7641398|FG003|NOT COMPLETED|Study Part 1||0
6711181|NCT02951312|7641395|FG000|STARTED|Study Part 2||0
6711182|NCT02951312|7641396|FG001|STARTED|Study Part 2||0
6711183|NCT02951312|7641397|FG002|STARTED|Study Part 2||6
6711184|NCT02951312|7641398|FG003|STARTED|Study Part 2||6
6711185|NCT02951312|7641395|FG000|COMPLETED|Study Part 2||0
6711186|NCT02951312|7641396|FG001|COMPLETED|Study Part 2||0
6711187|NCT02951312|7641397|FG002|COMPLETED|Study Part 2||6
6711188|NCT02951312|7641398|FG003|COMPLETED|Study Part 2||6
6711189|NCT02951312|7641395|FG000|NOT COMPLETED|Study Part 2||0
6711190|NCT02951312|7641396|FG001|NOT COMPLETED|Study Part 2||0
6711191|NCT02951312|7641397|FG002|NOT COMPLETED|Study Part 2||0
6711192|NCT02951312|7641398|FG003|NOT COMPLETED|Study Part 2||0
6711193|NCT02951351|7641420|FG000|STARTED|Overall Study||19
6711194|NCT02951351|7641421|FG001|STARTED|Overall Study||17
6711195|NCT02951351|7641420|FG000|COMPLETED|Overall Study||19
6711196|NCT02951351|7641421|FG001|COMPLETED|Overall Study||17
6711197|NCT02951351|7641420|FG000|NOT COMPLETED|Overall Study||0
6711198|NCT02951351|7641421|FG001|NOT COMPLETED|Overall Study||0
6711199|NCT02951429|7641429|FG000|STARTED|Overall Study||88
6711200|NCT02951429|7641430|FG001|STARTED|Overall Study||89
6711201|NCT02951429|7641429|FG000|COMPLETED|Overall Study||16
6711202|NCT02951429|7641430|FG001|COMPLETED|Overall Study||6
6711203|NCT02951429|7641429|FG000|NOT COMPLETED|Overall Study||72
6711204|NCT02951429|7641430|FG001|NOT COMPLETED|Overall Study||83
6711205|NCT02951533|7641438|FG000|STARTED|Part I (Week 0 Through Week 24)||60
6711206|NCT02951533|7641439|FG001|STARTED|Part I (Week 0 Through Week 24)||59
6711207|NCT02951533|7641440|FG002|STARTED|Part I (Week 0 Through Week 24)||0
6711208|NCT02951533|7641438|FG000|Treated|Part I (Week 0 Through Week 24)||60
6711209|NCT02951533|7641439|FG001|Treated|Part I (Week 0 Through Week 24)||58
6711210|NCT02951533|7641440|FG002|Treated|Part I (Week 0 Through Week 24)||0
6711211|NCT02951533|7641438|FG000|COMPLETED|Part I (Week 0 Through Week 24)||56
6711212|NCT02951533|7641439|FG001|COMPLETED|Part I (Week 0 Through Week 24)||36
6711213|NCT02951533|7641440|FG002|COMPLETED|Part I (Week 0 Through Week 24)||0
6711214|NCT02951533|7641438|FG000|NOT COMPLETED|Part I (Week 0 Through Week 24)||4
6711215|NCT02951533|7641439|FG001|NOT COMPLETED|Part I (Week 0 Through Week 24)||23
6711216|NCT02951533|7641440|FG002|NOT COMPLETED|Part I (Week 0 Through Week 24)||0
6711217|NCT02951533|7641438|FG000|STARTED|Part IIa (Week 24 Through Week 32)||56
6711218|NCT02951533|7641439|FG001|STARTED|Part IIa (Week 24 Through Week 32)|1 participant did not sign informed consent form (ICF) for Study Part II but completed Study Part I.|35
6711219|NCT02951533|7641440|FG002|STARTED|Part IIa (Week 24 Through Week 32)||0
6711220|NCT02951533|7641438|FG000|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||54
6711221|NCT02951533|7641439|FG001|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||14
6711222|NCT02951533|7641440|FG002|PASI 75 Responder at Week 32|Part IIa (Week 24 Through Week 32)||0
6711223|NCT02951533|7641438|FG000|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||1
6711224|NCT02951533|7641439|FG001|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||20
6711225|NCT02951533|7641440|FG002|PASI 75 Non-responder at Week 32|Part IIa (Week 24 Through Week 32)||0
6711226|NCT02951533|7641438|FG000|COMPLETED|Part IIa (Week 24 Through Week 32)||55
6711227|NCT02951533|7641439|FG001|COMPLETED|Part IIa (Week 24 Through Week 32)||34
6711228|NCT02951533|7641440|FG002|COMPLETED|Part IIa (Week 24 Through Week 32)||0
6711229|NCT02951533|7641438|FG000|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
6711230|NCT02951533|7641439|FG001|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||1
6711231|NCT02951533|7641440|FG002|NOT COMPLETED|Part IIa (Week 24 Through Week 32)||0
6711232|NCT02951533|7641438|FG000|STARTED|Part IIb (Week 32 Through Week 56)||55
6711233|NCT02951533|7641439|FG001|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in the FAE group, 14 PASI 75 responders remained on FAE treatment.|14
6711234|NCT02951533|7641440|FG002|STARTED|Part IIb (Week 32 Through Week 56)|Out of 34 participants in FAE group, 20 PASI 75 non-responders switched to GUS group.|20
6711235|NCT02951533|7641438|FG000|COMPLETED|Part IIb (Week 32 Through Week 56)||54
6711236|NCT02951533|7641439|FG001|COMPLETED|Part IIb (Week 32 Through Week 56)||10
6711237|NCT02951533|7641440|FG002|COMPLETED|Part IIb (Week 32 Through Week 56)||20
6711238|NCT02951533|7641438|FG000|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||1
6711239|NCT02951533|7641439|FG001|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||4
6711240|NCT02951533|7641440|FG002|NOT COMPLETED|Part IIb (Week 32 Through Week 56)||0
6711241|NCT02951533|7641438|FG000|STARTED|Part III (Week 64 Through Week 100)|18 participants were not eligible to enter Part III.|36
6711242|NCT02951533|7641439|FG001|STARTED|Part III (Week 64 Through Week 100)|10 participants in the FAE group were not eligible to enter Part III.|0
6711243|NCT02951533|7641440|FG002|STARTED|Part III (Week 64 Through Week 100)|8 participants were not eligible to enter Part III.|12
6711244|NCT02951533|7641438|FG000|COMPLETED|Part III (Week 64 Through Week 100)||32
6711245|NCT02951533|7641439|FG001|COMPLETED|Part III (Week 64 Through Week 100)||0
6711246|NCT02951533|7641440|FG002|COMPLETED|Part III (Week 64 Through Week 100)||10
6711247|NCT02951533|7641438|FG000|NOT COMPLETED|Part III (Week 64 Through Week 100)||4
6711248|NCT02951533|7641439|FG001|NOT COMPLETED|Part III (Week 64 Through Week 100)||0
6711249|NCT02951533|7641440|FG002|NOT COMPLETED|Part III (Week 64 Through Week 100)||2
6711250|NCT02951702|7641459|FG000|STARTED|Overall Study||34
6711251|NCT02951702|7641460|FG001|STARTED|Overall Study||17
6711252|NCT02951702|7641459|FG000|COMPLETED|Overall Study||34
6711253|NCT02951702|7641460|FG001|COMPLETED|Overall Study||17
6711254|NCT02951702|7641459|FG000|NOT COMPLETED|Overall Study||0
6711255|NCT02951702|7641460|FG001|NOT COMPLETED|Overall Study||0
6711256|NCT02951780|7641475|FG000|STARTED|Period 1||3
6711257|NCT02951780|7641476|FG001|STARTED|Period 1||2
6711258|NCT02951780|7641477|FG002|STARTED|Period 1||3
6711259|NCT02951780|7641478|FG003|STARTED|Period 1||3
6711260|NCT02951780|7641479|FG004|STARTED|Period 1||2
6711261|NCT02951780|7641480|FG005|STARTED|Period 1||3
6711262|NCT02951780|7641481|FG006|STARTED|Period 1||2
6711263|NCT02951780|7641482|FG007|STARTED|Period 1||3
6711264|NCT02951780|7641483|FG008|STARTED|Period 1||2
6711265|NCT02951780|7641475|FG000|COMPLETED|Period 1||3
6711266|NCT02951780|7641476|FG001|COMPLETED|Period 1||2
6711267|NCT02951780|7641477|FG002|COMPLETED|Period 1||3
6711268|NCT02951780|7641478|FG003|COMPLETED|Period 1||2
6711269|NCT02951780|7641479|FG004|COMPLETED|Period 1||2
6711270|NCT02951780|7641480|FG005|COMPLETED|Period 1||3
6711271|NCT02951780|7641481|FG006|COMPLETED|Period 1||2
6711272|NCT02951780|7641482|FG007|COMPLETED|Period 1||2
6711273|NCT02951780|7641483|FG008|COMPLETED|Period 1||2
6711274|NCT02951780|7641475|FG000|NOT COMPLETED|Period 1||0
6711275|NCT02951780|7641476|FG001|NOT COMPLETED|Period 1||0
6711276|NCT02951780|7641477|FG002|NOT COMPLETED|Period 1||0
6711277|NCT02951780|7641478|FG003|NOT COMPLETED|Period 1||1
6711278|NCT02951780|7641479|FG004|NOT COMPLETED|Period 1||0
6711279|NCT02951780|7641480|FG005|NOT COMPLETED|Period 1||0
6711280|NCT02951780|7641481|FG006|NOT COMPLETED|Period 1||0
6711281|NCT02951780|7641482|FG007|NOT COMPLETED|Period 1||1
6711282|NCT02951780|7641483|FG008|NOT COMPLETED|Period 1||0
6711283|NCT02951780|7641475|FG000|STARTED|Period 2||3
6711284|NCT02951780|7641476|FG001|STARTED|Period 2||2
6711285|NCT02951780|7641477|FG002|STARTED|Period 2||3
6711286|NCT02951780|7641478|FG003|STARTED|Period 2||2
6711287|NCT02951780|7641479|FG004|STARTED|Period 2||2
6711288|NCT02951780|7641480|FG005|STARTED|Period 2||3
6711289|NCT02951780|7641481|FG006|STARTED|Period 2||2
6711290|NCT02951780|7641482|FG007|STARTED|Period 2||2
6711291|NCT02951780|7641483|FG008|STARTED|Period 2||2
6711292|NCT02951780|7641475|FG000|COMPLETED|Period 2||3
6711293|NCT02951780|7641476|FG001|COMPLETED|Period 2||2
6711294|NCT02951780|7641477|FG002|COMPLETED|Period 2||3
6711295|NCT02951780|7641478|FG003|COMPLETED|Period 2||2
6711296|NCT02951780|7641479|FG004|COMPLETED|Period 2||2
6711297|NCT02951780|7641480|FG005|COMPLETED|Period 2||3
6711298|NCT02951780|7641481|FG006|COMPLETED|Period 2||2
6711299|NCT02951780|7641482|FG007|COMPLETED|Period 2||1
6711300|NCT02951780|7641483|FG008|COMPLETED|Period 2||2
6711301|NCT02951780|7641475|FG000|NOT COMPLETED|Period 2||0
6711302|NCT02951780|7641476|FG001|NOT COMPLETED|Period 2||0
6711303|NCT02951780|7641477|FG002|NOT COMPLETED|Period 2||0
6711304|NCT02951780|7641478|FG003|NOT COMPLETED|Period 2||0
6711305|NCT02951780|7641479|FG004|NOT COMPLETED|Period 2||0
6711306|NCT02951780|7641480|FG005|NOT COMPLETED|Period 2||0
6711307|NCT02951780|7641481|FG006|NOT COMPLETED|Period 2||0
6711308|NCT02951780|7641482|FG007|NOT COMPLETED|Period 2||1
6711309|NCT02951780|7641483|FG008|NOT COMPLETED|Period 2||0
6711310|NCT02951780|7641475|FG000|STARTED|Period 3||3
6711311|NCT02951780|7641476|FG001|STARTED|Period 3||2
6711312|NCT02951780|7641477|FG002|STARTED|Period 3||3
6711313|NCT02951780|7641478|FG003|STARTED|Period 3||2
6711314|NCT02951780|7641479|FG004|STARTED|Period 3||2
6711315|NCT02951780|7641480|FG005|STARTED|Period 3||3
6711316|NCT02951780|7641481|FG006|STARTED|Period 3||2
6711317|NCT02951780|7641482|FG007|STARTED|Period 3||1
6711318|NCT02951780|7641483|FG008|STARTED|Period 3||2
6711319|NCT02951780|7641475|FG000|COMPLETED|Period 3||3
6711320|NCT02951780|7641476|FG001|COMPLETED|Period 3||2
6262169|NCT02499328|7161109|FG000|COMPLETED|Overall Study||0
6262170|NCT02499328|7161110|FG001|COMPLETED|Overall Study||0
6262171|NCT02499328|7161111|FG002|COMPLETED|Overall Study||0
6262172|NCT02499328|7161112|FG003|COMPLETED|Overall Study||0
6262173|NCT02499328|7161113|FG004|COMPLETED|Overall Study||0
6262174|NCT02499328|7161114|FG005|COMPLETED|Overall Study||0
6262175|NCT02499328|7161115|FG006|COMPLETED|Overall Study||0
6262176|NCT02499328|7161116|FG007|COMPLETED|Overall Study||0
6262177|NCT02499328|7161117|FG008|COMPLETED|Overall Study||0
6262178|NCT02499328|7161118|FG009|COMPLETED|Overall Study||0
6262179|NCT02499328|7161119|FG010|COMPLETED|Overall Study||0
6262180|NCT02499328|7161120|FG011|COMPLETED|Overall Study||0
6262181|NCT02499328|7161121|FG012|COMPLETED|Overall Study||0
6262182|NCT02499328|7161122|FG013|COMPLETED|Overall Study||0
6262183|NCT02499328|7161123|FG014|COMPLETED|Overall Study||0
6262184|NCT02499328|7161124|FG015|COMPLETED|Overall Study||0
6262185|NCT02499328|7161125|FG016|COMPLETED|Overall Study||0
6262186|NCT02499328|7161126|FG017|COMPLETED|Overall Study||0
6262187|NCT02499328|7161127|FG018|COMPLETED|Overall Study||1
6262188|NCT02499328|7161109|FG000|NOT COMPLETED|Overall Study||4
6262189|NCT02499328|7161110|FG001|NOT COMPLETED|Overall Study||7
6262190|NCT02499328|7161111|FG002|NOT COMPLETED|Overall Study||10
6262191|NCT02499328|7161112|FG003|NOT COMPLETED|Overall Study||11
6262192|NCT02499328|7161113|FG004|NOT COMPLETED|Overall Study||15
6262193|NCT02499328|7161114|FG005|NOT COMPLETED|Overall Study||9
6262194|NCT02499328|7161115|FG006|NOT COMPLETED|Overall Study||7
6262195|NCT02499328|7161116|FG007|NOT COMPLETED|Overall Study||6
6262196|NCT02499328|7161117|FG008|NOT COMPLETED|Overall Study||14
6262197|NCT02499328|7161118|FG009|NOT COMPLETED|Overall Study||24
6262198|NCT02499328|7161119|FG010|NOT COMPLETED|Overall Study||20
6262199|NCT02499328|7161120|FG011|NOT COMPLETED|Overall Study||54
6262200|NCT02499328|7161121|FG012|NOT COMPLETED|Overall Study||25
6262201|NCT02499328|7161122|FG013|NOT COMPLETED|Overall Study||17
6262202|NCT02499328|7161123|FG014|NOT COMPLETED|Overall Study||10
6262203|NCT02499328|7161124|FG015|NOT COMPLETED|Overall Study||1
6262204|NCT02499328|7161125|FG016|NOT COMPLETED|Overall Study||1
6262205|NCT02499328|7161126|FG017|NOT COMPLETED|Overall Study||55
6262206|NCT02499328|7161127|FG018|NOT COMPLETED|Overall Study||49
6262207|NCT02463981|7161212|FG000|STARTED|Overall Study||21
6262208|NCT02463981|7161213|FG001|STARTED|Overall Study||16
6262209|NCT02463981|7161212|FG000|COMPLETED|Overall Study||18
6262210|NCT02463981|7161213|FG001|COMPLETED|Overall Study||14
6262211|NCT02463981|7161212|FG000|NOT COMPLETED|Overall Study||3
6262212|NCT02463981|7161213|FG001|NOT COMPLETED|Overall Study||2
6711321|NCT02951780|7641477|FG002|COMPLETED|Period 3||3
6711322|NCT02951780|7641478|FG003|COMPLETED|Period 3||2
6711323|NCT02951780|7641479|FG004|COMPLETED|Period 3||2
6711324|NCT02951780|7641480|FG005|COMPLETED|Period 3||3
6711325|NCT02951780|7641481|FG006|COMPLETED|Period 3||2
6711326|NCT02951780|7641482|FG007|COMPLETED|Period 3||1
6711327|NCT02951780|7641483|FG008|COMPLETED|Period 3||2
6711328|NCT02951780|7641475|FG000|NOT COMPLETED|Period 3||0
6711329|NCT02951780|7641476|FG001|NOT COMPLETED|Period 3||0
6711330|NCT02951780|7641477|FG002|NOT COMPLETED|Period 3||0
6711331|NCT02951780|7641478|FG003|NOT COMPLETED|Period 3||0
6711332|NCT02951780|7641479|FG004|NOT COMPLETED|Period 3||0
6711333|NCT02951780|7641480|FG005|NOT COMPLETED|Period 3||0
6711334|NCT02951780|7641481|FG006|NOT COMPLETED|Period 3||0
6711335|NCT02951780|7641482|FG007|NOT COMPLETED|Period 3||0
6711336|NCT02951780|7641483|FG008|NOT COMPLETED|Period 3||0
6711337|NCT02951819|7641505|FG000|STARTED|Overall Study||87
6711338|NCT02951819|7641506|FG001|STARTED|Overall Study||14
6711339|NCT02951819|7641505|FG000|Treated|Overall Study||86
6711340|NCT02951819|7641506|FG001|Treated|Overall Study||14
6711341|NCT02951819|7641505|FG000|COMPLETED|Overall Study||59
6711342|NCT02951819|7641506|FG001|COMPLETED|Overall Study||7
6711343|NCT02951819|7641505|FG000|NOT COMPLETED|Overall Study||28
6711344|NCT02951819|7641506|FG001|NOT COMPLETED|Overall Study||7
6711345|NCT02951884|7641515|FG000|STARTED|Overall Study||0
6711346|NCT02951884|7641516|FG001|STARTED|Overall Study||1
6711347|NCT02951884|7641517|FG002|STARTED|Overall Study||1
6711348|NCT02951884|7641515|FG000|COMPLETED|Overall Study||0
6711349|NCT02951884|7641516|FG001|COMPLETED|Overall Study||1
6711350|NCT02951884|7641517|FG002|COMPLETED|Overall Study||1
6711351|NCT02951884|7641515|FG000|NOT COMPLETED|Overall Study||0
6711352|NCT02951884|7641516|FG001|NOT COMPLETED|Overall Study||0
6711353|NCT02951884|7641517|FG002|NOT COMPLETED|Overall Study||0
6711354|NCT02951988|7641528|FG000|STARTED|Open-Label Treatment Period||1304
6711355|NCT02951988|7641529|FG001|STARTED|Open-Label Treatment Period||0
6711356|NCT02951988|7641530|FG002|STARTED|Open-Label Treatment Period||0
6711357|NCT02951988|7641531|FG003|STARTED|Open-Label Treatment Period||0
6711358|NCT02951988|7641528|FG000|COMPLETED|Open-Label Treatment Period||1056
6711359|NCT02951988|7641529|FG001|COMPLETED|Open-Label Treatment Period||0
6711360|NCT02951988|7641530|FG002|COMPLETED|Open-Label Treatment Period||0
6711361|NCT02951988|7641531|FG003|COMPLETED|Open-Label Treatment Period||0
6711362|NCT02951988|7641528|FG000|NOT COMPLETED|Open-Label Treatment Period||248
6711363|NCT02951988|7641529|FG001|NOT COMPLETED|Open-Label Treatment Period||0
6711364|NCT02951988|7641530|FG002|NOT COMPLETED|Open-Label Treatment Period||0
6711365|NCT02951988|7641531|FG003|NOT COMPLETED|Open-Label Treatment Period||0
6711366|NCT02951988|7641528|FG000|STARTED|Double-Blind Treatment Period||0
6711367|NCT02951988|7641529|FG001|STARTED|Double-Blind Treatment Period||202
6711368|NCT02951988|7641530|FG002|STARTED|Double-Blind Treatment Period||202
6711369|NCT02951988|7641531|FG003|STARTED|Double-Blind Treatment Period||200
6711370|NCT02951988|7641528|FG000|COMPLETED|Double-Blind Treatment Period||0
6711371|NCT02951988|7641529|FG001|COMPLETED|Double-Blind Treatment Period||101
6711372|NCT02951988|7641530|FG002|COMPLETED|Double-Blind Treatment Period||101
6711373|NCT02951988|7641531|FG003|COMPLETED|Double-Blind Treatment Period||85
6711374|NCT02951988|7641528|FG000|NOT COMPLETED|Double-Blind Treatment Period||0
6711375|NCT02951988|7641529|FG001|NOT COMPLETED|Double-Blind Treatment Period||101
6711376|NCT02951988|7641530|FG002|NOT COMPLETED|Double-Blind Treatment Period||101
6711377|NCT02951988|7641531|FG003|NOT COMPLETED|Double-Blind Treatment Period||115
6711378|NCT02952001|7641543|FG000|STARTED|Overall Study||28
6711379|NCT02952001|7641544|FG001|STARTED|Overall Study||5
6711380|NCT02952001|7641543|FG000|COMPLETED|Overall Study||14
6711381|NCT02952001|7641544|FG001|COMPLETED|Overall Study||2
6711382|NCT02952001|7641543|FG000|NOT COMPLETED|Overall Study||14
6711383|NCT02952001|7641544|FG001|NOT COMPLETED|Overall Study||3
6711384|NCT02952261|7641553|FG000|STARTED|Overall Study||100
6711385|NCT02952261|7641554|FG001|STARTED|Overall Study||100
6711386|NCT02952261|7641553|FG000|COMPLETED|Overall Study||95
6711387|NCT02952261|7641554|FG001|COMPLETED|Overall Study||95
6262213|NCT02460224|7161248|FG000|STARTED|Overall Study||17
6262214|NCT02460224|7161249|FG001|STARTED|Overall Study||12
6262215|NCT02460224|7161250|FG002|STARTED|Overall Study||6
6262216|NCT02460224|7161251|FG003|STARTED|Overall Study||6
6262217|NCT02460224|7161252|FG004|STARTED|Overall Study||6
6262218|NCT02460224|7161253|FG005|STARTED|Overall Study||30
6262219|NCT02460224|7161254|FG006|STARTED|Overall Study||30
6262220|NCT02460224|7161255|FG007|STARTED|Overall Study||5
6262221|NCT02460224|7161256|FG008|STARTED|Overall Study||6
6262222|NCT02460224|7161257|FG009|STARTED|Overall Study||11
6262223|NCT02460224|7161258|FG010|STARTED|Overall Study||5
6262224|NCT02460224|7161259|FG011|STARTED|Overall Study||6
6262225|NCT02460224|7161260|FG012|STARTED|Overall Study||6
6262226|NCT02460224|7161261|FG013|STARTED|Overall Study||6
6262227|NCT02460224|7161262|FG014|STARTED|Overall Study||5
6262228|NCT02460224|7161263|FG015|STARTED|Overall Study||6
6262229|NCT02460224|7161264|FG016|STARTED|Overall Study||20
6262230|NCT02460224|7161265|FG017|STARTED|Overall Study||6
6262231|NCT02460224|7161266|FG018|STARTED|Overall Study||12
6262232|NCT02460224|7161267|FG019|STARTED|Overall Study||7
6262233|NCT02460224|7161268|FG020|STARTED|Overall Study||6
6262234|NCT02460224|7161269|FG021|STARTED|Overall Study||12
6262235|NCT02460224|7161270|FG022|STARTED|Overall Study||6
6262236|NCT02460224|7161271|FG023|STARTED|Overall Study||11
6262237|NCT02460224|7161272|FG024|STARTED|Overall Study||6
6262238|NCT02460224|7161273|FG025|STARTED|Overall Study||6
6262239|NCT02460224|7161274|FG026|STARTED|Overall Study||121
6262240|NCT02460224|7161275|FG027|STARTED|Overall Study||21
6262241|NCT02460224|7161276|FG028|STARTED|Overall Study||93
6280390|NCT00154310|7180315|FG001|COMPLETED|Overall Study||117
6711388|NCT02952261|7641553|FG000|NOT COMPLETED|Overall Study||5
6711389|NCT02952261|7641554|FG001|NOT COMPLETED|Overall Study||5
6711390|NCT02952313|7641560|FG000|STARTED|Primary Endpoint||113
6711391|NCT02952313|7641560|FG000|6 Months|Primary Endpoint||106
6711392|NCT02952313|7641560|FG000|COMPLETED|Primary Endpoint||106
6711393|NCT02952313|7641560|FG000|NOT COMPLETED|Primary Endpoint||7
6711394|NCT02952313|7641560|FG000|STARTED|Long-term Follow-up||107
6711395|NCT02952313|7641560|FG000|12-Month|Long-term Follow-up||93
6711396|NCT02952313|7641560|FG000|18-Month|Long-term Follow-up||79
6711397|NCT02952313|7641560|FG000|COMPLETED|Long-term Follow-up||75
6711398|NCT02952313|7641560|FG000|NOT COMPLETED|Long-term Follow-up||32
6711399|NCT02952586|7641567|FG000|STARTED|Lead-In Phase (7 Days)||350
6711400|NCT02952586|7641568|FG001|STARTED|Lead-In Phase (7 Days)||347
6711401|NCT02952586|7641567|FG000|Safety Analysis Set|Lead-In Phase (7 Days)||348
6711402|NCT02952586|7641568|FG001|Safety Analysis Set|Lead-In Phase (7 Days)||344
6711403|NCT02952586|7641567|FG000|COMPLETED|Lead-In Phase (7 Days)||345
6711404|NCT02952586|7641568|FG001|COMPLETED|Lead-In Phase (7 Days)||343
6711405|NCT02952586|7641567|FG000|NOT COMPLETED|Lead-In Phase (7 Days)||5
6711406|NCT02952586|7641568|FG001|NOT COMPLETED|Lead-In Phase (7 Days)||4
6711407|NCT02952586|7641567|FG000|STARTED|CRT for Avelumab or Placebo (63 Days)||345
6711408|NCT02952586|7641568|FG001|STARTED|CRT for Avelumab or Placebo (63 Days)|All participants who did not withdraw from study after Lead-In phase, entered into CRT phase.|340
6711409|NCT02952586|7641567|FG000|COMPLETED|CRT for Avelumab or Placebo (63 Days)||312
6711410|NCT02952586|7641568|FG001|COMPLETED|CRT for Avelumab or Placebo (63 Days)||313
6711411|NCT02952586|7641567|FG000|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||33
6711412|NCT02952586|7641568|FG001|NOT COMPLETED|CRT for Avelumab or Placebo (63 Days)||27
6711413|NCT02952586|7641567|FG000|STARTED|CRT for Cisplatin (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
6711414|NCT02952586|7641568|FG001|STARTED|CRT for Cisplatin (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
6711415|NCT02952586|7641567|FG000|COMPLETED|CRT for Cisplatin (63 Days)||234
6711416|NCT02952586|7641568|FG001|COMPLETED|CRT for Cisplatin (63 Days)||236
6711417|NCT02952586|7641567|FG000|NOT COMPLETED|CRT for Cisplatin (63 Days)||111
6711418|NCT02952586|7641568|FG001|NOT COMPLETED|CRT for Cisplatin (63 Days)||104
6711419|NCT02952586|7641567|FG000|STARTED|CRT for IMRT (63 Days)|Avelumab, Cisplatin, and IMRT were treatments in CRT phase.|345
6711420|NCT02952586|7641568|FG001|STARTED|CRT for IMRT (63 Days)|Placebo, Cisplatin, and IMRT were treatments in CRT phase.|340
6711421|NCT02952586|7641567|FG000|COMPLETED|CRT for IMRT (63 Days)||322
6711422|NCT02952586|7641568|FG001|COMPLETED|CRT for IMRT (63 Days)||320
6711423|NCT02952586|7641567|FG000|NOT COMPLETED|CRT for IMRT (63 Days)||23
6711424|NCT02952586|7641568|FG001|NOT COMPLETED|CRT for IMRT (63 Days)||20
6711425|NCT02952586|7641567|FG000|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|291
6711426|NCT02952586|7641568|FG001|STARTED|Maintenance Phase (12 Months)|All participants who did not withdraw from study after CRT phases, entered into maintenance phase.|304
6711427|NCT02952586|7641567|FG000|COMPLETED|Maintenance Phase (12 Months)||139
6711428|NCT02952586|7641568|FG001|COMPLETED|Maintenance Phase (12 Months)||177
6711429|NCT02952586|7641567|FG000|NOT COMPLETED|Maintenance Phase (12 Months)||152
6711430|NCT02952586|7641568|FG001|NOT COMPLETED|Maintenance Phase (12 Months)||127
6711431|NCT02952586|7641567|FG000|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|266
6711432|NCT02952586|7641568|FG001|STARTED|Follow-Up Phase (90 Days)|Participants who did not withdraw study after previous phases, entered in short-term follow up phase.|284
6711433|NCT02952586|7641567|FG000|COMPLETED|Follow-Up Phase (90 Days)||208
6711434|NCT02952586|7641568|FG001|COMPLETED|Follow-Up Phase (90 Days)||216
6711435|NCT02952586|7641567|FG000|NOT COMPLETED|Follow-Up Phase (90 Days)||58
6711436|NCT02952586|7641568|FG001|NOT COMPLETED|Follow-Up Phase (90 Days)||68
6711437|NCT02952586|7641567|FG000|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|247
6711438|NCT02952586|7641568|FG001|STARTED|LT Follow-up (up to 45 Months)|Participants who did not withdraw study after previous phases, entered in long-term follow up phase.|237
6711439|NCT02952586|7641567|FG000|COMPLETED|LT Follow-up (up to 45 Months)||0
6711440|NCT02952586|7641568|FG001|COMPLETED|LT Follow-up (up to 45 Months)||0
6711441|NCT02952586|7641567|FG000|NOT COMPLETED|LT Follow-up (up to 45 Months)||247
6711442|NCT02952586|7641568|FG001|NOT COMPLETED|LT Follow-up (up to 45 Months)||237
6711443|NCT02952820|7641578|FG000|STARTED|Placebo-Controlled Treatment (6 Months)||325
6711444|NCT02952820|7641579|FG001|STARTED|Placebo-Controlled Treatment (6 Months)||323
6711445|NCT02952820|7641580|FG002|STARTED|Placebo-Controlled Treatment (6 Months)||323
6711446|NCT02952820|7641578|FG000|Treated|Placebo-Controlled Treatment (6 Months)||321
6711447|NCT02952820|7641579|FG001|Treated|Placebo-Controlled Treatment (6 Months)||319
6711448|NCT02952820|7641580|FG002|Treated|Placebo-Controlled Treatment (6 Months)||319
6711449|NCT02952820|7641578|FG000|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||319
6711450|NCT02952820|7641579|FG001|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
6711451|NCT02952820|7641580|FG002|Safety Analysis Set|Placebo-Controlled Treatment (6 Months)||314
6711452|NCT02952820|7641578|FG000|COMPLETED|Placebo-Controlled Treatment (6 Months)||261
6711453|NCT02952820|7641579|FG001|COMPLETED|Placebo-Controlled Treatment (6 Months)||254
6711454|NCT02952820|7641580|FG002|COMPLETED|Placebo-Controlled Treatment (6 Months)||235
6711455|NCT02952820|7641578|FG000|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||64
6711456|NCT02952820|7641579|FG001|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||69
6711457|NCT02952820|7641580|FG002|NOT COMPLETED|Placebo-Controlled Treatment (6 Months)||88
6711458|NCT02952820|7641578|FG000|STARTED|Active Treatment Period (6 Months)|Participants from Placebo were re-randomized to Lemborexant 5 mg and Lemborexant 10 mg.|0
6711459|NCT02952820|7641579|FG001|STARTED|Active Treatment Period (6 Months)||384
6711460|NCT02952820|7641580|FG002|STARTED|Active Treatment Period (6 Months)||352
6711461|NCT02952820|7641578|FG000|COMPLETED|Active Treatment Period (6 Months)||0
6711462|NCT02952820|7641579|FG001|COMPLETED|Active Treatment Period (6 Months)||346
6711463|NCT02952820|7641580|FG002|COMPLETED|Active Treatment Period (6 Months)||321
6711464|NCT02952820|7641578|FG000|NOT COMPLETED|Active Treatment Period (6 Months)||0
6711465|NCT02952820|7641579|FG001|NOT COMPLETED|Active Treatment Period (6 Months)||38
6711466|NCT02952820|7641580|FG002|NOT COMPLETED|Active Treatment Period (6 Months)||31
6711467|NCT02952872|7641607|FG000|STARTED|Overall Study||22
6711468|NCT02952872|7641608|FG001|STARTED|Overall Study||22
6711469|NCT02952872|7641609|FG002|STARTED|Overall Study||22
6711470|NCT02952872|7641610|FG003|STARTED|Overall Study||22
6711471|NCT02952872|7641611|FG004|STARTED|Overall Study||22
6711472|NCT02952872|7641612|FG005|STARTED|Overall Study||21
6711473|NCT02952872|7641613|FG006|STARTED|Overall Study||22
6711474|NCT02952872|7641614|FG007|STARTED|Overall Study||21
6711475|NCT02952872|7641615|FG008|STARTED|Overall Study||22
6711476|NCT02952872|7641616|FG009|STARTED|Overall Study||22
6711477|NCT02952872|7641617|FG010|STARTED|Overall Study||23
6711478|NCT02952872|7641618|FG011|STARTED|Overall Study||22
6711479|NCT02952872|7641619|FG012|STARTED|Overall Study||22
6711480|NCT02952872|7641620|FG013|STARTED|Overall Study||22
6711481|NCT02952872|7641621|FG014|STARTED|Overall Study||22
6711482|NCT02952872|7641622|FG015|STARTED|Overall Study||23
6711483|NCT02952872|7641607|FG000|COMPLETED|Overall Study||22
6711484|NCT02952872|7641608|FG001|COMPLETED|Overall Study||22
6711485|NCT02952872|7641609|FG002|COMPLETED|Overall Study||22
6711486|NCT02952872|7641610|FG003|COMPLETED|Overall Study||22
6711487|NCT02952872|7641611|FG004|COMPLETED|Overall Study||22
6711488|NCT02952872|7641612|FG005|COMPLETED|Overall Study||21
6711489|NCT02952872|7641613|FG006|COMPLETED|Overall Study||22
6711490|NCT02952872|7641614|FG007|COMPLETED|Overall Study||21
6711491|NCT02952872|7641615|FG008|COMPLETED|Overall Study||22
6711492|NCT02952872|7641616|FG009|COMPLETED|Overall Study||22
6711493|NCT02952872|7641617|FG010|COMPLETED|Overall Study||23
6711494|NCT02952872|7641618|FG011|COMPLETED|Overall Study||22
6711495|NCT02952872|7641619|FG012|COMPLETED|Overall Study||22
6711496|NCT02952872|7641620|FG013|COMPLETED|Overall Study||22
6711497|NCT02952872|7641621|FG014|COMPLETED|Overall Study||22
6711498|NCT02952872|7641622|FG015|COMPLETED|Overall Study||23
6711499|NCT02952872|7641607|FG000|NOT COMPLETED|Overall Study||0
6711500|NCT02952872|7641608|FG001|NOT COMPLETED|Overall Study||0
6711501|NCT02952872|7641609|FG002|NOT COMPLETED|Overall Study||0
6711502|NCT02952872|7641610|FG003|NOT COMPLETED|Overall Study||0
6711503|NCT02952872|7641611|FG004|NOT COMPLETED|Overall Study||0
6711504|NCT02952872|7641612|FG005|NOT COMPLETED|Overall Study||0
6711505|NCT02952872|7641613|FG006|NOT COMPLETED|Overall Study||0
6711506|NCT02952872|7641614|FG007|NOT COMPLETED|Overall Study||0
6711507|NCT02952872|7641615|FG008|NOT COMPLETED|Overall Study||0
6711508|NCT02952872|7641616|FG009|NOT COMPLETED|Overall Study||0
6711509|NCT02952872|7641617|FG010|NOT COMPLETED|Overall Study||0
6711510|NCT02952872|7641618|FG011|NOT COMPLETED|Overall Study||0
6711511|NCT02952872|7641619|FG012|NOT COMPLETED|Overall Study||0
6711512|NCT02952872|7641620|FG013|NOT COMPLETED|Overall Study||0
6711513|NCT02952872|7641621|FG014|NOT COMPLETED|Overall Study||0
6711514|NCT02952872|7641622|FG015|NOT COMPLETED|Overall Study||0
6711515|NCT02952898|7641659|FG000|STARTED|Overall Study||220
6711516|NCT02952898|7641660|FG001|STARTED|Overall Study||221
6711517|NCT02952898|7641661|FG002|STARTED|Overall Study||224
6711518|NCT02952898|7641659|FG000|COMPLETED|Overall Study||198
6711519|NCT02952898|7641660|FG001|COMPLETED|Overall Study||202
6711520|NCT02952898|7641661|FG002|COMPLETED|Overall Study||209
6711521|NCT02952898|7641659|FG000|NOT COMPLETED|Overall Study||22
6711522|NCT02952898|7641660|FG001|NOT COMPLETED|Overall Study||19
6711523|NCT02952898|7641661|FG002|NOT COMPLETED|Overall Study||15
6711524|NCT02953262|7641673|FG000|STARTED|Overall Study||68
6711525|NCT02953262|7641674|FG001|STARTED|Overall Study||69
6711526|NCT02953262|7641675|FG002|STARTED|Overall Study||68
6711527|NCT02953262|7641676|FG003|STARTED|Overall Study||70
6711528|NCT02953262|7641673|FG000|COMPLETED|Overall Study||65
6711529|NCT02953262|7641674|FG001|COMPLETED|Overall Study||63
6711530|NCT02953262|7641675|FG002|COMPLETED|Overall Study||65
6711531|NCT02953262|7641676|FG003|COMPLETED|Overall Study||67
6711532|NCT02953262|7641673|FG000|NOT COMPLETED|Overall Study||3
6711533|NCT02953262|7641674|FG001|NOT COMPLETED|Overall Study||6
6711534|NCT02953262|7641675|FG002|NOT COMPLETED|Overall Study||3
6711535|NCT02953262|7641676|FG003|NOT COMPLETED|Overall Study||3
6711536|NCT02953314|7641692|FG000|STARTED|Overall Study||13
6711537|NCT02953314|7641693|FG001|STARTED|Overall Study||70
6711538|NCT02953314|7641692|FG000|COMPLETED|Overall Study||13
6711539|NCT02953314|7641693|FG001|COMPLETED|Overall Study||67
6711540|NCT02953314|7641692|FG000|NOT COMPLETED|Overall Study||0
6711541|NCT02953314|7641693|FG001|NOT COMPLETED|Overall Study||3
6711542|NCT02953418|7641699|FG000|STARTED|Overall Study||34
6711543|NCT02953418|7641699|FG000|COMPLETED|Overall Study||34
6711544|NCT02953418|7641699|FG000|NOT COMPLETED|Overall Study||0
6711545|NCT02953548|7641703|FG000|STARTED|Overall Study||5
6711546|NCT02953548|7641704|FG001|STARTED|Overall Study||4
6711547|NCT02953548|7641703|FG000|COMPLETED|Overall Study||5
6711548|NCT02953548|7641704|FG001|COMPLETED|Overall Study||4
6711549|NCT02953548|7641703|FG000|NOT COMPLETED|Overall Study||0
6711550|NCT02953548|7641704|FG001|NOT COMPLETED|Overall Study||0
6711551|NCT02953561|7641711|FG000|STARTED|Overall Study||19
6711552|NCT02953561|7641711|FG000|COMPLETED|Overall Study||19
6711553|NCT02953561|7641711|FG000|NOT COMPLETED|Overall Study||0
6711554|NCT02953639|7641718|FG000|STARTED|Overall Study||81
6711555|NCT02953639|7641719|FG001|STARTED|Overall Study||54
6711556|NCT02953639|7641720|FG002|STARTED|Overall Study||78
6711557|NCT02953639|7641718|FG000|COMPLETED|Overall Study||61
6711558|NCT02953639|7641719|FG001|COMPLETED|Overall Study||40
6711559|NCT02953639|7641720|FG002|COMPLETED|Overall Study||62
6711560|NCT02953639|7641718|FG000|NOT COMPLETED|Overall Study||20
6711561|NCT02953639|7641719|FG001|NOT COMPLETED|Overall Study||14
6711562|NCT02953639|7641720|FG002|NOT COMPLETED|Overall Study||16
6711563|NCT02953678|7641730|FG000|STARTED|Overall Study||71
6711564|NCT02953678|7641730|FG000|COMPLETED|Overall Study||0
6711565|NCT02953678|7641730|FG000|NOT COMPLETED|Overall Study||71
6711566|NCT02953782|7641743|FG000|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
6711567|NCT02953782|7641744|FG001|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||3
6711568|NCT02953782|7641745|FG002|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||9
6711569|NCT02953782|7641746|FG003|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||8
6711570|NCT02953782|7641747|FG004|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||6
6711571|NCT02953782|7641748|FG005|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711572|NCT02953782|7641749|FG006|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711573|NCT02953782|7641750|FG007|STARTED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711574|NCT02953782|7641743|FG000|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711575|NCT02953782|7641744|FG001|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711576|NCT02953782|7641745|FG002|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711577|NCT02953782|7641746|FG003|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711578|NCT02953782|7641747|FG004|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711579|NCT02953782|7641748|FG005|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711580|NCT02953782|7641749|FG006|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711581|NCT02953782|7641750|FG007|COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711582|NCT02953782|7641743|FG000|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
6711583|NCT02953782|7641744|FG001|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||3
6711584|NCT02953782|7641745|FG002|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||9
6711585|NCT02953782|7641746|FG003|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||8
6711586|NCT02953782|7641747|FG004|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||6
6711587|NCT02953782|7641748|FG005|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711588|NCT02953782|7641749|FG006|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711589|NCT02953782|7641750|FG007|NOT COMPLETED|Phase 1b (Maximum Duration: 14.3 Months)||0
6711590|NCT02953782|7641743|FG000|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711591|NCT02953782|7641744|FG001|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711592|NCT02953782|7641745|FG002|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711593|NCT02953782|7641746|FG003|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711594|NCT02953782|7641747|FG004|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711595|NCT02953782|7641748|FG005|STARTED|Phase 2 (Maximum Duration: 11.1 Months)|11 participants were included in safety run-in to evaluate DLT. 9 out of 11 were evaluable for DLT.|16
6711596|NCT02953782|7641749|FG006|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
6711597|NCT02953782|7641750|FG007|STARTED|Phase 2 (Maximum Duration: 11.1 Months)||15
6711598|NCT02953782|7641743|FG000|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711599|NCT02953782|7641744|FG001|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711600|NCT02953782|7641745|FG002|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711601|NCT02953782|7641746|FG003|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711602|NCT02953782|7641747|FG004|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711603|NCT02953782|7641748|FG005|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711604|NCT02953782|7641749|FG006|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711605|NCT02953782|7641750|FG007|COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711606|NCT02953782|7641743|FG000|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711607|NCT02953782|7641744|FG001|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711608|NCT02953782|7641745|FG002|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6262242|NCT02460224|7161248|FG000|Rest of the World Patients in the Dose Escalation Part|Overall Study||13
6262243|NCT02460224|7161249|FG001|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
6262244|NCT02460224|7161250|FG002|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262245|NCT02460224|7161251|FG003|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262246|NCT02460224|7161252|FG004|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262247|NCT02460224|7161253|FG005|Rest of the World Patients in the Dose Escalation Part|Overall Study||25
6262248|NCT02460224|7161254|FG006|Rest of the World Patients in the Dose Escalation Part|Overall Study||24
6262249|NCT02460224|7161255|FG007|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
6262250|NCT02460224|7161256|FG008|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262251|NCT02460224|7161257|FG009|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
6262252|NCT02460224|7161258|FG010|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
6262253|NCT02460224|7161259|FG011|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262254|NCT02460224|7161260|FG012|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262255|NCT02460224|7161261|FG013|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262256|NCT02460224|7161262|FG014|Rest of the World Patients in the Dose Escalation Part|Overall Study||5
6262257|NCT02460224|7161263|FG015|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262258|NCT02460224|7161264|FG016|Rest of the World Patients in the Dose Escalation Part|Overall Study||20
6262259|NCT02460224|7161265|FG017|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6711609|NCT02953782|7641746|FG003|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711610|NCT02953782|7641747|FG004|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||0
6711611|NCT02953782|7641748|FG005|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||16
6711612|NCT02953782|7641749|FG006|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
6711613|NCT02953782|7641750|FG007|NOT COMPLETED|Phase 2 (Maximum Duration: 11.1 Months)||15
6711614|NCT02953821|7641773|FG000|STARTED|Overall Study||86
6711615|NCT02953821|7641774|FG001|STARTED|Overall Study||86
6711616|NCT02953821|7641773|FG000|Safety Population|Overall Study||86
6711617|NCT02953821|7641774|FG001|Safety Population|Overall Study||86
6711618|NCT02953821|7641773|FG000|Modified Intent to Treat (mITT) Populati|Overall Study||85
6711619|NCT02953821|7641774|FG001|Modified Intent to Treat (mITT) Populati|Overall Study||84
6711620|NCT02953821|7641773|FG000|Per Protocol (PP) Population|Overall Study||72
6711621|NCT02953821|7641774|FG001|Per Protocol (PP) Population|Overall Study||75
6711622|NCT02953821|7641773|FG000|Completed Week 16 Visit|Overall Study||76
6711623|NCT02953821|7641774|FG001|Completed Week 16 Visit|Overall Study||77
6711624|NCT02953821|7641773|FG000|Completed Study Treatment (Week 24)|Overall Study||73
6711625|NCT02953821|7641774|FG001|Completed Study Treatment (Week 24)|Overall Study||76
6711626|NCT02953821|7641773|FG000|COMPLETED|Overall Study||71
6711627|NCT02953821|7641774|FG001|COMPLETED|Overall Study||73
6711628|NCT02953821|7641773|FG000|NOT COMPLETED|Overall Study||15
6711629|NCT02953821|7641774|FG001|NOT COMPLETED|Overall Study||13
6711630|NCT02953860|7641782|FG000|STARTED|Overall Study||32
6711631|NCT02953860|7641782|FG000|COMPLETED|Overall Study||32
6711632|NCT02953860|7641782|FG000|NOT COMPLETED|Overall Study||0
6711633|NCT02953873|7641786|FG000|STARTED|Overall Study||25
6711634|NCT02953873|7641786|FG000|COMPLETED|Overall Study||25
6711635|NCT02953873|7641786|FG000|NOT COMPLETED|Overall Study||0
6711636|NCT02953886|7641790|FG000|STARTED|Overall Study||20
6262260|NCT02460224|7161266|FG018|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
6262261|NCT02460224|7161267|FG019|Rest of the World Patients in the Dose Escalation Part|Overall Study||7
6262262|NCT02460224|7161268|FG020|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262263|NCT02460224|7161269|FG021|Rest of the World Patients in the Dose Escalation Part|Overall Study||12
6262264|NCT02460224|7161270|FG022|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262265|NCT02460224|7161271|FG023|Rest of the World Patients in the Dose Escalation Part|Overall Study||11
6262266|NCT02460224|7161272|FG024|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262267|NCT02460224|7161273|FG025|Rest of the World Patients in the Dose Escalation Part|Overall Study||6
6262268|NCT02460224|7161274|FG026|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
6262269|NCT02460224|7161275|FG027|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
6262270|NCT02460224|7161276|FG028|Rest of the World Patients in the Dose Escalation Part|Overall Study||0
6262271|NCT02460224|7161248|FG000|Japanese Patients in the Dose Escalation Part|Overall Study||4
6262272|NCT02460224|7161249|FG001|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262273|NCT02460224|7161250|FG002|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262274|NCT02460224|7161251|FG003|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262275|NCT02460224|7161252|FG004|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262276|NCT02460224|7161253|FG005|Japanese Patients in the Dose Escalation Part|Overall Study||5
6262277|NCT02460224|7161254|FG006|Japanese Patients in the Dose Escalation Part|Overall Study||6
6262278|NCT02460224|7161255|FG007|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262279|NCT02460224|7161256|FG008|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262280|NCT02460224|7161257|FG009|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262281|NCT02460224|7161258|FG010|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262282|NCT02460224|7161259|FG011|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262283|NCT02460224|7161260|FG012|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262284|NCT02460224|7161261|FG013|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262285|NCT02460224|7161262|FG014|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262286|NCT02460224|7161263|FG015|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262287|NCT02460224|7161264|FG016|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262288|NCT02460224|7161265|FG017|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262289|NCT02460224|7161266|FG018|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262290|NCT02460224|7161267|FG019|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262291|NCT02460224|7161268|FG020|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262292|NCT02460224|7161269|FG021|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262293|NCT02460224|7161270|FG022|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262294|NCT02460224|7161271|FG023|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262295|NCT02460224|7161272|FG024|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262296|NCT02460224|7161273|FG025|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262297|NCT02460224|7161274|FG026|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262298|NCT02460224|7161275|FG027|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262299|NCT02460224|7161276|FG028|Japanese Patients in the Dose Escalation Part|Overall Study||0
6262300|NCT02460224|7161248|FG000|COMPLETED|Overall Study||0
6262301|NCT02460224|7161249|FG001|COMPLETED|Overall Study||0
6262302|NCT02460224|7161250|FG002|COMPLETED|Overall Study||0
6711637|NCT02953886|7641790|FG000|COMPLETED|Overall Study||20
6711638|NCT02953886|7641790|FG000|NOT COMPLETED|Overall Study||0
6711639|NCT02953938|7641796|FG000|STARTED|Overall Study||29
6711640|NCT02953938|7641797|FG001|STARTED|Overall Study||30
6711641|NCT02953938|7641796|FG000|COMPLETED|Overall Study||28
6711642|NCT02953938|7641797|FG001|COMPLETED|Overall Study||28
6711643|NCT02953938|7641796|FG000|NOT COMPLETED|Overall Study||1
6711644|NCT02953938|7641797|FG001|NOT COMPLETED|Overall Study||2
6711645|NCT02954172|7641806|FG000|STARTED|Overall Study||226
6711646|NCT02954172|7641807|FG001|STARTED|Overall Study||224
6711647|NCT02954172|7641806|FG000|COMPLETED|Overall Study||220
6711648|NCT02954172|7641807|FG001|COMPLETED|Overall Study||221
6711649|NCT02954172|7641806|FG000|NOT COMPLETED|Overall Study||6
6711650|NCT02954172|7641807|FG001|NOT COMPLETED|Overall Study||3
6711651|NCT02954198|7641816|FG000|STARTED|Overall Study||20
6711652|NCT02954198|7641817|FG001|STARTED|Overall Study||20
6711653|NCT02954198|7641816|FG000|COMPLETED|Overall Study||20
6711654|NCT02954198|7641817|FG001|COMPLETED|Overall Study||20
6711655|NCT02954198|7641816|FG000|NOT COMPLETED|Overall Study||0
6711656|NCT02954198|7641817|FG001|NOT COMPLETED|Overall Study||0
6711657|NCT02954354|7641826|FG000|STARTED|Overall Study||612
6711658|NCT02954354|7641827|FG001|STARTED|Overall Study||310
6711659|NCT02954354|7641828|FG002|STARTED|Overall Study||514
6711660|NCT02954354|7641826|FG000|Received Study Drug|Overall Study||610
6711661|NCT02954354|7641827|FG001|Received Study Drug|Overall Study||309
6711662|NCT02954354|7641828|FG002|Received Study Drug|Overall Study||513
6711663|NCT02954354|7641826|FG000|Intention to Treat Infected Population|Overall Study||456
6711664|NCT02954354|7641827|FG001|Intention to Treat Infected Population|Overall Study||231
6711665|NCT02954354|7641828|FG002|Intention to Treat Infected Population|Overall Study||377
6711666|NCT02954354|7641826|FG000|COMPLETED|Overall Study||578
6711667|NCT02954354|7641827|FG001|COMPLETED|Overall Study||290
6711668|NCT02954354|7641828|FG002|COMPLETED|Overall Study||498
6711669|NCT02954354|7641826|FG000|NOT COMPLETED|Overall Study||34
6262303|NCT02460224|7161251|FG003|COMPLETED|Overall Study||0
6262304|NCT02460224|7161252|FG004|COMPLETED|Overall Study||0
6262305|NCT02460224|7161253|FG005|COMPLETED|Overall Study||0
6262306|NCT02460224|7161254|FG006|COMPLETED|Overall Study||0
6262307|NCT02460224|7161255|FG007|COMPLETED|Overall Study||0
6262308|NCT02460224|7161256|FG008|COMPLETED|Overall Study||0
6262309|NCT02460224|7161257|FG009|COMPLETED|Overall Study||0
6262310|NCT02460224|7161258|FG010|COMPLETED|Overall Study||0
6262311|NCT02460224|7161259|FG011|COMPLETED|Overall Study||0
6262312|NCT02460224|7161260|FG012|COMPLETED|Overall Study||0
6262313|NCT02460224|7161261|FG013|COMPLETED|Overall Study||0
6262314|NCT02460224|7161262|FG014|COMPLETED|Overall Study||0
6262315|NCT02460224|7161263|FG015|COMPLETED|Overall Study||0
6262316|NCT02460224|7161264|FG016|COMPLETED|Overall Study||0
6262317|NCT02460224|7161265|FG017|COMPLETED|Overall Study||0
6262318|NCT02460224|7161266|FG018|COMPLETED|Overall Study||0
6262319|NCT02460224|7161267|FG019|COMPLETED|Overall Study||0
6262320|NCT02460224|7161268|FG020|COMPLETED|Overall Study||0
6262321|NCT02460224|7161269|FG021|COMPLETED|Overall Study||0
6262322|NCT02460224|7161270|FG022|COMPLETED|Overall Study||0
6262323|NCT02460224|7161271|FG023|COMPLETED|Overall Study||0
6262324|NCT02460224|7161272|FG024|COMPLETED|Overall Study||0
6262325|NCT02460224|7161273|FG025|COMPLETED|Overall Study||0
6262326|NCT02460224|7161274|FG026|COMPLETED|Overall Study||0
6262327|NCT02460224|7161275|FG027|COMPLETED|Overall Study||0
6262328|NCT02460224|7161276|FG028|COMPLETED|Overall Study||0
6262329|NCT02460224|7161248|FG000|NOT COMPLETED|Overall Study||17
6262330|NCT02460224|7161249|FG001|NOT COMPLETED|Overall Study||12
6262331|NCT02460224|7161250|FG002|NOT COMPLETED|Overall Study||6
6262332|NCT02460224|7161251|FG003|NOT COMPLETED|Overall Study||6
6262333|NCT02460224|7161252|FG004|NOT COMPLETED|Overall Study||6
6262334|NCT02460224|7161253|FG005|NOT COMPLETED|Overall Study||30
6262335|NCT02460224|7161254|FG006|NOT COMPLETED|Overall Study||30
6262336|NCT02460224|7161255|FG007|NOT COMPLETED|Overall Study||5
6262337|NCT02460224|7161256|FG008|NOT COMPLETED|Overall Study||6
6262338|NCT02460224|7161257|FG009|NOT COMPLETED|Overall Study||11
6262339|NCT02460224|7161258|FG010|NOT COMPLETED|Overall Study||5
6262340|NCT02460224|7161259|FG011|NOT COMPLETED|Overall Study||6
6262341|NCT02460224|7161260|FG012|NOT COMPLETED|Overall Study||6
6262342|NCT02460224|7161261|FG013|NOT COMPLETED|Overall Study||6
6262343|NCT02460224|7161262|FG014|NOT COMPLETED|Overall Study||5
6262344|NCT02460224|7161263|FG015|NOT COMPLETED|Overall Study||6
6262345|NCT02460224|7161264|FG016|NOT COMPLETED|Overall Study||20
6262346|NCT02460224|7161265|FG017|NOT COMPLETED|Overall Study||6
6262347|NCT02460224|7161266|FG018|NOT COMPLETED|Overall Study||12
6262348|NCT02460224|7161267|FG019|NOT COMPLETED|Overall Study||7
6262349|NCT02460224|7161268|FG020|NOT COMPLETED|Overall Study||6
6262350|NCT02460224|7161269|FG021|NOT COMPLETED|Overall Study||12
6262351|NCT02460224|7161270|FG022|NOT COMPLETED|Overall Study||6
6262352|NCT02460224|7161271|FG023|NOT COMPLETED|Overall Study||11
6262353|NCT02460224|7161272|FG024|NOT COMPLETED|Overall Study||6
6262354|NCT02460224|7161273|FG025|NOT COMPLETED|Overall Study||6
6262355|NCT02460224|7161274|FG026|NOT COMPLETED|Overall Study||121
6711670|NCT02954354|7641827|FG001|NOT COMPLETED|Overall Study||20
6711671|NCT02954354|7641828|FG002|NOT COMPLETED|Overall Study||16
6711672|NCT02954458|7641842|FG000|STARTED|Overall Study||7
6711673|NCT02954458|7641843|FG001|STARTED|Overall Study||3
6262356|NCT02460224|7161275|FG027|NOT COMPLETED|Overall Study||21
6262357|NCT02460224|7161276|FG028|NOT COMPLETED|Overall Study||93
6711674|NCT02954458|7641844|FG002|STARTED|Overall Study||1
6711675|NCT02954458|7641845|FG003|STARTED|Overall Study||50
6711676|NCT02954458|7641842|FG000|COMPLETED|Overall Study||6
6711677|NCT02954458|7641843|FG001|COMPLETED|Overall Study||3
6711678|NCT02954458|7641844|FG002|COMPLETED|Overall Study||0
6711679|NCT02954458|7641845|FG003|COMPLETED|Overall Study||38
6711680|NCT02954458|7641842|FG000|NOT COMPLETED|Overall Study||1
6711681|NCT02954458|7641843|FG001|NOT COMPLETED|Overall Study||0
6711682|NCT02954458|7641844|FG002|NOT COMPLETED|Overall Study||1
6711683|NCT02954458|7641845|FG003|NOT COMPLETED|Overall Study||12
6711684|NCT02954575|7641859|FG000|STARTED|Overall Study||57
6711685|NCT02954575|7641859|FG000|Received Treatment|Overall Study||55
6711686|NCT02954575|7641859|FG000|SAF Population|Overall Study||55
6711687|NCT02954575|7641859|FG000|FAS Population|Overall Study||55
6711688|NCT02954575|7641859|FG000|PP Population|Overall Study||52
6711689|NCT02954575|7641859|FG000|PK Population|Overall Study||21
6711690|NCT02954575|7641859|FG000|SURG Population|Overall Study||1
6711691|NCT02954575|7641859|FG000|COMPLETED|Overall Study||54
6711692|NCT02954575|7641859|FG000|NOT COMPLETED|Overall Study||3
6711693|NCT02954601|7641871|FG000|STARTED|First Intervention (Five Days)||11
6711694|NCT02954601|7641872|FG001|STARTED|First Intervention (Five Days)||6
6711695|NCT02954601|7641873|FG002|STARTED|First Intervention (Five Days)||8
6711696|NCT02954601|7641874|FG003|STARTED|First Intervention (Five Days)||7
6711697|NCT02954601|7641871|FG000|COMPLETED|First Intervention (Five Days)||11
6711698|NCT02954601|7641872|FG001|COMPLETED|First Intervention (Five Days)||6
6711699|NCT02954601|7641873|FG002|COMPLETED|First Intervention (Five Days)||7
6711700|NCT02954601|7641874|FG003|COMPLETED|First Intervention (Five Days)||7
6711701|NCT02954601|7641871|FG000|NOT COMPLETED|First Intervention (Five Days)||0
6711702|NCT02954601|7641872|FG001|NOT COMPLETED|First Intervention (Five Days)||0
6711703|NCT02954601|7641873|FG002|NOT COMPLETED|First Intervention (Five Days)||1
6711704|NCT02954601|7641874|FG003|NOT COMPLETED|First Intervention (Five Days)||0
6711705|NCT02954601|7641871|FG000|STARTED|Second Intervention (Five Days)||11
6711706|NCT02954601|7641872|FG001|STARTED|Second Intervention (Five Days)||6
6711707|NCT02954601|7641873|FG002|STARTED|Second Intervention (Five Days)||8
6711708|NCT02954601|7641874|FG003|STARTED|Second Intervention (Five Days)||6
6711709|NCT02954601|7641871|FG000|COMPLETED|Second Intervention (Five Days)||11
6711710|NCT02954601|7641872|FG001|COMPLETED|Second Intervention (Five Days)||6
6711711|NCT02954601|7641873|FG002|COMPLETED|Second Intervention (Five Days)||8
6711712|NCT02954601|7641874|FG003|COMPLETED|Second Intervention (Five Days)||6
6711713|NCT02954601|7641871|FG000|NOT COMPLETED|Second Intervention (Five Days)||0
6711714|NCT02954601|7641872|FG001|NOT COMPLETED|Second Intervention (Five Days)||0
6711715|NCT02954601|7641873|FG002|NOT COMPLETED|Second Intervention (Five Days)||0
6711716|NCT02954601|7641874|FG003|NOT COMPLETED|Second Intervention (Five Days)||0
6711717|NCT02954601|7641871|FG000|STARTED|Third Intervention (Five Days)||9
6711718|NCT02954601|7641872|FG001|STARTED|Third Intervention (Five Days)||8
6711719|NCT02954601|7641873|FG002|STARTED|Third Intervention (Five Days)||6
6711720|NCT02954601|7641874|FG003|STARTED|Third Intervention (Five Days)||8
6711721|NCT02954601|7641871|FG000|COMPLETED|Third Intervention (Five Days)||9
6711722|NCT02954601|7641872|FG001|COMPLETED|Third Intervention (Five Days)||8
6711723|NCT02954601|7641873|FG002|COMPLETED|Third Intervention (Five Days)||6
6711724|NCT02954601|7641874|FG003|COMPLETED|Third Intervention (Five Days)||8
6711725|NCT02954601|7641871|FG000|NOT COMPLETED|Third Intervention (Five Days)||0
6711726|NCT02954601|7641872|FG001|NOT COMPLETED|Third Intervention (Five Days)||0
6711727|NCT02954601|7641873|FG002|NOT COMPLETED|Third Intervention (Five Days)||0
6711728|NCT02954601|7641874|FG003|NOT COMPLETED|Third Intervention (Five Days)||0
6711729|NCT02954653|7641886|FG000|STARTED|Overall Study||4
6711730|NCT02954653|7641887|FG001|STARTED|Overall Study||4
6711731|NCT02954653|7641888|FG002|STARTED|Overall Study|No participants were enrolled in this arm.|0
6711732|NCT02954653|7641889|FG003|STARTED|Overall Study|No participants were enrolled in this arm.|0
6711733|NCT02954653|7641890|FG004|STARTED|Overall Study|No participants were enrolled in this arm.|0
6711734|NCT02954653|7641891|FG005|STARTED|Overall Study|No participants were enrolled in this arm.|0
6711735|NCT02954653|7641892|FG006|STARTED|Overall Study|No participants were enrolled in this arm.|0
6711736|NCT02954653|7641893|FG007|STARTED|Overall Study|No participants were enrolled in this arm.|0
6711737|NCT02954653|7641894|FG008|STARTED|Overall Study|No participants were enrolled in this arm.|0
6711738|NCT02954653|7641886|FG000|Received Treatment|Overall Study||3
6711739|NCT02954653|7641887|FG001|Received Treatment|Overall Study||4
6711740|NCT02954653|7641888|FG002|Received Treatment|Overall Study||0
6711741|NCT02954653|7641889|FG003|Received Treatment|Overall Study||0
6711742|NCT02954653|7641890|FG004|Received Treatment|Overall Study||0
6711743|NCT02954653|7641891|FG005|Received Treatment|Overall Study||0
6711744|NCT02954653|7641892|FG006|Received Treatment|Overall Study||0
6711745|NCT02954653|7641893|FG007|Received Treatment|Overall Study||0
6711746|NCT02954653|7641894|FG008|Received Treatment|Overall Study||0
6711747|NCT02954653|7641886|FG000|COMPLETED|Overall Study||0
6711748|NCT02954653|7641887|FG001|COMPLETED|Overall Study||1
6711749|NCT02954653|7641888|FG002|COMPLETED|Overall Study||0
6711750|NCT02954653|7641889|FG003|COMPLETED|Overall Study||0
6711751|NCT02954653|7641890|FG004|COMPLETED|Overall Study||0
6711752|NCT02954653|7641891|FG005|COMPLETED|Overall Study||0
6711753|NCT02954653|7641892|FG006|COMPLETED|Overall Study||0
6711754|NCT02954653|7641893|FG007|COMPLETED|Overall Study||0
6711755|NCT02954653|7641894|FG008|COMPLETED|Overall Study||0
6262358|NCT02460159|7161350|FG000|STARTED|Overall Study||117
6711756|NCT02954653|7641886|FG000|NOT COMPLETED|Overall Study||4
6711757|NCT02954653|7641887|FG001|NOT COMPLETED|Overall Study||3
6711758|NCT02954653|7641888|FG002|NOT COMPLETED|Overall Study||0
6711759|NCT02954653|7641889|FG003|NOT COMPLETED|Overall Study||0
6711760|NCT02954653|7641890|FG004|NOT COMPLETED|Overall Study||0
6711761|NCT02954653|7641891|FG005|NOT COMPLETED|Overall Study||0
6711762|NCT02954653|7641892|FG006|NOT COMPLETED|Overall Study||0
6711763|NCT02954653|7641893|FG007|NOT COMPLETED|Overall Study||0
6711764|NCT02954653|7641894|FG008|NOT COMPLETED|Overall Study||0
6711765|NCT02954848|7641908|FG000|STARTED|Overall Study||245
6711766|NCT02954848|7641909|FG001|STARTED|Overall Study||239
6711767|NCT02954848|7641908|FG000|Treated|Overall Study||245
6711768|NCT02954848|7641909|FG001|Treated|Overall Study||238
6711769|NCT02954848|7641908|FG000|COMPLETED|Overall Study||243
6711770|NCT02954848|7641909|FG001|COMPLETED|Overall Study||234
6711771|NCT02954848|7641908|FG000|NOT COMPLETED|Overall Study||2
6711772|NCT02954848|7641909|FG001|NOT COMPLETED|Overall Study||5
6711773|NCT02954887|7641915|FG000|STARTED|Overall Study||9
6711774|NCT02954887|7641915|FG000|COMPLETED|Overall Study||2
6711775|NCT02954887|7641915|FG000|NOT COMPLETED|Overall Study||7
6711776|NCT02955069|7641921|FG000|STARTED|Overall Study||95
6711777|NCT02955069|7641922|FG001|STARTED|Overall Study||21
6711778|NCT02955069|7641921|FG000|Full Analysis Set (FAS)|Overall Study||95
6711779|NCT02955069|7641922|FG001|Full Analysis Set (FAS)|Overall Study||21
6711780|NCT02955069|7641921|FG000|Safety Set|Overall Study||95
6711781|NCT02955069|7641922|FG001|Safety Set|Overall Study||21
6711782|NCT02955069|7641921|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||94
6711783|NCT02955069|7641922|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||18
6711784|NCT02955069|7641921|FG000|Immunogenicity (IG) Prevalence Set|Overall Study||94
6711785|NCT02955069|7641922|FG001|Immunogenicity (IG) Prevalence Set|Overall Study||21
6711786|NCT02955069|7641921|FG000|IG Incidence Set|Overall Study||84
6711787|NCT02955069|7641922|FG001|IG Incidence Set|Overall Study||17
6711788|NCT02955069|7641921|FG000|COMPLETED|Overall Study||0
6711789|NCT02955069|7641922|FG001|COMPLETED|Overall Study||0
6711790|NCT02955069|7641921|FG000|NOT COMPLETED|Overall Study||95
6711791|NCT02955069|7641922|FG001|NOT COMPLETED|Overall Study||21
6711792|NCT02955147|7641930|FG000|STARTED|Overall Study||13
6711793|NCT02955147|7641930|FG000|COMPLETED|Overall Study||13
6711794|NCT02955147|7641930|FG000|NOT COMPLETED|Overall Study||0
6711795|NCT02955186|7641936|FG000|STARTED|Overall Study||33
6711796|NCT02955186|7641937|FG001|STARTED|Overall Study||17
6711797|NCT02955186|7641936|FG000|COMPLETED|Overall Study||26
6711798|NCT02955186|7641937|FG001|COMPLETED|Overall Study||15
6711799|NCT02955186|7641936|FG000|NOT COMPLETED|Overall Study||7
6711800|NCT02955186|7641937|FG001|NOT COMPLETED|Overall Study||2
6711801|NCT02955212|7641945|FG000|STARTED|Period 1: Double-blind Treatment Period||169
6711802|NCT02955212|7641946|FG001|STARTED|Period 1: Double-blind Treatment Period||169
6711803|NCT02955212|7641945|FG000|COMPLETED|Period 1: Double-blind Treatment Period||153
6711804|NCT02955212|7641946|FG001|COMPLETED|Period 1: Double-blind Treatment Period||157
6711805|NCT02955212|7641945|FG000|NOT COMPLETED|Period 1: Double-blind Treatment Period||16
6711806|NCT02955212|7641946|FG001|NOT COMPLETED|Period 1: Double-blind Treatment Period||12
6711807|NCT02955212|7641945|FG000|STARTED|Period 2: Open-label Extension||153
6711808|NCT02955212|7641946|FG001|STARTED|Period 2: Open-label Extension||157
6711809|NCT02955212|7641945|FG000|COMPLETED|Period 2: Open-label Extension||136
6711810|NCT02955212|7641946|FG001|COMPLETED|Period 2: Open-label Extension||139
6711811|NCT02955212|7641945|FG000|NOT COMPLETED|Period 2: Open-label Extension||17
6711812|NCT02955212|7641946|FG001|NOT COMPLETED|Period 2: Open-label Extension||18
6711813|NCT02955329|7641953|FG000|STARTED|Tobacco Arm||8
6711814|NCT02955329|7641953|FG000|COMPLETED|Tobacco Arm||8
6711815|NCT02955329|7641953|FG000|NOT COMPLETED|Tobacco Arm||0
6711816|NCT02955329|7641953|FG000|STARTED|Cannabis Arm||8
6711817|NCT02955329|7641953|FG000|COMPLETED|Cannabis Arm||8
6711818|NCT02955329|7641953|FG000|NOT COMPLETED|Cannabis Arm||0
6262359|NCT02460159|7161351|FG001|STARTED|Overall Study||18
6262360|NCT02460159|7161350|FG000|COMPLETED|Overall Study||111
6262361|NCT02460159|7161351|FG001|COMPLETED|Overall Study||17
6262362|NCT02460159|7161350|FG000|NOT COMPLETED|Overall Study||6
6602716|NCT02058498|7527764|FG000|6 Weeks|Overall Study||8
6711819|NCT02955329|7641953|FG000|STARTED|Combined Cannabis and Tobacco Arm||8
6262363|NCT02460159|7161351|FG001|NOT COMPLETED|Overall Study||1
6602717|NCT02058498|7527764|FG000|COMPLETED|Overall Study||8
6602718|NCT02058498|7527764|FG000|NOT COMPLETED|Overall Study||4
6602719|NCT02058511|7527768|FG000|STARTED|Overall Study||24
6602720|NCT02058511|7527768|FG000|COMPLETED|Overall Study||24
6602721|NCT02058511|7527768|FG000|NOT COMPLETED|Overall Study||0
6602722|NCT02058563|7527774|FG000|STARTED|Overall Study||454
6602723|NCT02058563|7527775|FG001|STARTED|Overall Study||457
6602724|NCT02058563|7527774|FG000|COMPLETED|Overall Study||426
6602725|NCT02058563|7527775|FG001|COMPLETED|Overall Study||433
6602726|NCT02058563|7527774|FG000|NOT COMPLETED|Overall Study||28
6602727|NCT02058563|7527775|FG001|NOT COMPLETED|Overall Study||24
6602728|NCT02058589|7527783|FG000|STARTED|Overall Study||132
6602729|NCT02058589|7527784|FG001|STARTED|Overall Study||132
6602730|NCT02058589|7527783|FG000|COMPLETED|Overall Study||130
6711820|NCT02955329|7641953|FG000|COMPLETED|Combined Cannabis and Tobacco Arm||8
6711821|NCT02955329|7641953|FG000|NOT COMPLETED|Combined Cannabis and Tobacco Arm||0
6711822|NCT02956044|7641964|FG000|STARTED|Overall Study||18
6711823|NCT02956044|7641965|FG001|STARTED|Overall Study||18
6711824|NCT02956044|7641966|FG002|STARTED|Overall Study||18
6711825|NCT02956044|7641964|FG000|COMPLETED|Overall Study||18
6711826|NCT02956044|7641965|FG001|COMPLETED|Overall Study||18
6711827|NCT02956044|7641966|FG002|COMPLETED|Overall Study||18
6711828|NCT02956044|7641964|FG000|NOT COMPLETED|Overall Study||0
6711829|NCT02956044|7641965|FG001|NOT COMPLETED|Overall Study||0
6711830|NCT02956044|7641966|FG002|NOT COMPLETED|Overall Study||0
6711831|NCT02956057|7641994|FG000|STARTED|Overall Study||174
6711832|NCT02956057|7641995|FG001|STARTED|Overall Study||174
6711833|NCT02956057|7641996|FG002|STARTED|Overall Study||174
6711834|NCT02956057|7641997|FG003|STARTED|Overall Study||174
6711835|NCT02956057|7641998|FG004|STARTED|Overall Study||174
6711836|NCT02956057|7641999|FG005|STARTED|Overall Study||174
6711837|NCT02956057|7641994|FG000|COMPLETED|Overall Study||160
6711838|NCT02956057|7641995|FG001|COMPLETED|Overall Study||162
6711839|NCT02956057|7641996|FG002|COMPLETED|Overall Study||166
6711840|NCT02956057|7641997|FG003|COMPLETED|Overall Study||159
6711841|NCT02956057|7641998|FG004|COMPLETED|Overall Study||169
6711842|NCT02956057|7641999|FG005|COMPLETED|Overall Study||157
6711843|NCT02956057|7641994|FG000|NOT COMPLETED|Overall Study||14
6711844|NCT02956057|7641995|FG001|NOT COMPLETED|Overall Study||12
6711845|NCT02956057|7641996|FG002|NOT COMPLETED|Overall Study||8
6711846|NCT02956057|7641997|FG003|NOT COMPLETED|Overall Study||15
6711847|NCT02956057|7641998|FG004|NOT COMPLETED|Overall Study||5
6711848|NCT02956057|7641999|FG005|NOT COMPLETED|Overall Study||17
6711849|NCT02956070|7642015|FG000|STARTED|Overall Study||35
6711850|NCT02956070|7642016|FG001|STARTED|Overall Study||35
6711851|NCT02956070|7642015|FG000|COMPLETED|Overall Study||35
6711852|NCT02956070|7642016|FG001|COMPLETED|Overall Study||35
6711853|NCT02956070|7642015|FG000|NOT COMPLETED|Overall Study||0
6711854|NCT02956070|7642016|FG001|NOT COMPLETED|Overall Study||0
6711855|NCT02956122|7642022|FG000|STARTED|Overall Study||1
6711856|NCT02956122|7642022|FG000|COMPLETED|Overall Study||1
6711857|NCT02956122|7642022|FG000|NOT COMPLETED|Overall Study||0
6711858|NCT02956278|7642036|FG000|STARTED|Overall Study||15
6711859|NCT02956278|7642037|FG001|STARTED|Overall Study||9
6711860|NCT02956278|7642038|FG002|STARTED|Overall Study||3
6711861|NCT02956278|7642036|FG000|COMPLETED|Overall Study||9
6711862|NCT02956278|7642037|FG001|COMPLETED|Overall Study||7
6711863|NCT02956278|7642038|FG002|COMPLETED|Overall Study||3
6711864|NCT02956278|7642036|FG000|NOT COMPLETED|Overall Study||6
6711865|NCT02956278|7642037|FG001|NOT COMPLETED|Overall Study||2
6711866|NCT02956278|7642038|FG002|NOT COMPLETED|Overall Study||0
6711867|NCT02956460|7642048|FG000|STARTED|Lens 1||30
6711868|NCT02956460|7642049|FG001|STARTED|Lens 1||34
6711869|NCT02956460|7642048|FG000|COMPLETED|Lens 1||29
6711870|NCT02956460|7642049|FG001|COMPLETED|Lens 1||34
6711871|NCT02956460|7642048|FG000|NOT COMPLETED|Lens 1||1
6711872|NCT02956460|7642049|FG001|NOT COMPLETED|Lens 1||0
6711873|NCT02956460|7642048|FG000|STARTED|Lens 2||29
6711874|NCT02956460|7642049|FG001|STARTED|Lens 2||34
6711875|NCT02956460|7642048|FG000|COMPLETED|Lens 2||29
6711876|NCT02956460|7642049|FG001|COMPLETED|Lens 2||34
6711877|NCT02956460|7642048|FG000|NOT COMPLETED|Lens 2||0
6711878|NCT02956460|7642049|FG001|NOT COMPLETED|Lens 2||0
6711879|NCT02956486|7642057|FG000|STARTED|Core Phase||1108
6711880|NCT02956486|7642058|FG001|STARTED|Core Phase||1104
6711881|NCT02956486|7642059|FG002|STARTED|Core Phase||0
6711882|NCT02956486|7642057|FG000|Treated|Core Phase||1108
6711883|NCT02956486|7642058|FG001|Treated|Core Phase||1101
6711884|NCT02956486|7642059|FG002|Treated|Core Phase||0
6711885|NCT02956486|7642057|FG000|Safety Analysis Set (SAS)|Core Phase||1105
6711886|NCT02956486|7642058|FG001|Safety Analysis Set (SAS)|Core Phase||1099
6711887|NCT02956486|7642059|FG002|Safety Analysis Set (SAS)|Core Phase||0
6711888|NCT02956486|7642057|FG000|Full Analysis Set (FAS)|Core Phase||1084
6711889|NCT02956486|7642058|FG001|Full Analysis Set (FAS)|Core Phase||1062
6711890|NCT02956486|7642059|FG002|Full Analysis Set (FAS)|Core Phase||0
6711891|NCT02956486|7642057|FG000|COMPLETED|Core Phase||29
6711892|NCT02956486|7642058|FG001|COMPLETED|Core Phase||32
6711893|NCT02956486|7642059|FG002|COMPLETED|Core Phase||0
6711894|NCT02956486|7642057|FG000|NOT COMPLETED|Core Phase||1079
6711895|NCT02956486|7642058|FG001|NOT COMPLETED|Core Phase||1072
6711896|NCT02956486|7642059|FG002|NOT COMPLETED|Core Phase||0
6711897|NCT02956486|7642057|FG000|STARTED|Extension Phase||0
6711898|NCT02956486|7642058|FG001|STARTED|Extension Phase||0
6711899|NCT02956486|7642059|FG002|STARTED|Extension Phase|Eligible participants who completed core and consented for extension phase, entered extension phase.|19
6711900|NCT02956486|7642057|FG000|Treated|Extension Phase||0
6711901|NCT02956486|7642058|FG001|Treated|Extension Phase||0
6711902|NCT02956486|7642059|FG002|Treated|Extension Phase||18
6711903|NCT02956486|7642057|FG000|Safety Analysis Set (SAS)|Extension Phase||0
6711904|NCT02956486|7642058|FG001|Safety Analysis Set (SAS)|Extension Phase||0
6711905|NCT02956486|7642059|FG002|Safety Analysis Set (SAS)|Extension Phase||18
6711906|NCT02956486|7642057|FG000|COMPLETED|Extension Phase||0
6711907|NCT02956486|7642058|FG001|COMPLETED|Extension Phase||0
6711908|NCT02956486|7642059|FG002|COMPLETED|Extension Phase||0
6711909|NCT02956486|7642057|FG000|NOT COMPLETED|Extension Phase||0
6711910|NCT02956486|7642058|FG001|NOT COMPLETED|Extension Phase||0
6711911|NCT02956486|7642059|FG002|NOT COMPLETED|Extension Phase||19
6711912|NCT02956616|7642070|FG000|STARTED|Overall Study||58
6711913|NCT02956616|7642071|FG001|STARTED|Overall Study||60
6711914|NCT02956616|7642070|FG000|COMPLETED|Overall Study||58
6711915|NCT02956616|7642071|FG001|COMPLETED|Overall Study||60
6711916|NCT02956616|7642070|FG000|NOT COMPLETED|Overall Study||0
6711917|NCT02956616|7642071|FG001|NOT COMPLETED|Overall Study||0
6711918|NCT02956629|7642083|FG000|STARTED|Overall Study||78
6711919|NCT02956629|7642084|FG001|STARTED|Overall Study||47
6711920|NCT02956629|7642085|FG002|STARTED|Overall Study||61
6711921|NCT02956629|7642086|FG003|STARTED|Overall Study||56
6711922|NCT02956629|7642087|FG004|STARTED|Overall Study||18
6711923|NCT02956629|7642088|FG005|STARTED|Overall Study||22
6711924|NCT02956629|7642083|FG000|COMPLETED|Overall Study||73
6711925|NCT02956629|7642084|FG001|COMPLETED|Overall Study||41
6711926|NCT02956629|7642085|FG002|COMPLETED|Overall Study||57
6711927|NCT02956629|7642086|FG003|COMPLETED|Overall Study||55
6711928|NCT02956629|7642087|FG004|COMPLETED|Overall Study||18
6711929|NCT02956629|7642088|FG005|COMPLETED|Overall Study||21
6711930|NCT02956629|7642083|FG000|NOT COMPLETED|Overall Study||5
6711931|NCT02956629|7642084|FG001|NOT COMPLETED|Overall Study||6
6711932|NCT02956629|7642085|FG002|NOT COMPLETED|Overall Study||4
6711933|NCT02956629|7642086|FG003|NOT COMPLETED|Overall Study||1
6711934|NCT02956629|7642087|FG004|NOT COMPLETED|Overall Study||0
6711935|NCT02956629|7642088|FG005|NOT COMPLETED|Overall Study||1
6711936|NCT02956746|7642106|FG000|STARTED|Overall Study||40
6711937|NCT02956746|7642107|FG001|STARTED|Overall Study||40
6711938|NCT02956746|7642108|FG002|STARTED|Overall Study||42
6711939|NCT02956746|7642109|FG003|STARTED|Overall Study||42
6711940|NCT02956746|7642106|FG000|COMPLETED|Overall Study||38
6711941|NCT02956746|7642107|FG001|COMPLETED|Overall Study||37
6711942|NCT02956746|7642108|FG002|COMPLETED|Overall Study||36
6711943|NCT02956746|7642109|FG003|COMPLETED|Overall Study||38
6711944|NCT02956746|7642106|FG000|NOT COMPLETED|Overall Study||2
6711945|NCT02956746|7642107|FG001|NOT COMPLETED|Overall Study||3
6711946|NCT02956746|7642108|FG002|NOT COMPLETED|Overall Study||6
6711947|NCT02956746|7642109|FG003|NOT COMPLETED|Overall Study||4
6711948|NCT02956837|7642124|FG000|STARTED|Overall Study||100
6711949|NCT02956837|7642125|FG001|STARTED|Overall Study||99
6711950|NCT02956837|7642126|FG002|STARTED|Overall Study||99
6711951|NCT02956837|7642127|FG003|STARTED|Overall Study||102
6711952|NCT02956837|7642124|FG000|COMPLETED|Overall Study||100
6711953|NCT02956837|7642125|FG001|COMPLETED|Overall Study||96
6711954|NCT02956837|7642126|FG002|COMPLETED|Overall Study||97
6711955|NCT02956837|7642127|FG003|COMPLETED|Overall Study||99
6711956|NCT02956837|7642124|FG000|NOT COMPLETED|Overall Study||0
6711957|NCT02956837|7642125|FG001|NOT COMPLETED|Overall Study||3
6711958|NCT02956837|7642126|FG002|NOT COMPLETED|Overall Study||2
6711959|NCT02956837|7642127|FG003|NOT COMPLETED|Overall Study||3
6711960|NCT02956967|7642140|FG000|STARTED|Overall Study||171
6711961|NCT02956967|7642140|FG000|COMPLETED|Overall Study||123
6711962|NCT02956967|7642140|FG000|NOT COMPLETED|Overall Study||48
6711963|NCT02957123|7642144|FG000|STARTED|Overall Study||30
6711964|NCT02957123|7642144|FG000|COMPLETED|Overall Study||30
6711965|NCT02957123|7642144|FG000|NOT COMPLETED|Overall Study||0
6711966|NCT02957136|7642150|FG000|STARTED|Overall Study||95
6711967|NCT02957136|7642151|FG001|STARTED|Overall Study||99
6711968|NCT02957136|7642150|FG000|COMPLETED|Overall Study||93
6711969|NCT02957136|7642151|FG001|COMPLETED|Overall Study||98
6711970|NCT02957136|7642150|FG000|NOT COMPLETED|Overall Study||2
6711971|NCT02957136|7642151|FG001|NOT COMPLETED|Overall Study||1
6711972|NCT02957305|7642159|FG000|STARTED|Overall Study||106
6711973|NCT02957305|7642160|FG001|STARTED|Overall Study||105
6711974|NCT02957305|7642159|FG000|COMPLETED|Overall Study||106
6711975|NCT02957305|7642160|FG001|COMPLETED|Overall Study||105
6711976|NCT02957305|7642159|FG000|NOT COMPLETED|Overall Study||0
6711977|NCT02957305|7642160|FG001|NOT COMPLETED|Overall Study||0
6711978|NCT02957331|7642168|FG000|STARTED|Overall Study||14
6711979|NCT02957331|7642169|FG001|STARTED|Overall Study||12
6711980|NCT02957331|7642168|FG000|COMPLETED|Overall Study||13
6711981|NCT02957331|7642169|FG001|COMPLETED|Overall Study||12
6711982|NCT02957331|7642168|FG000|NOT COMPLETED|Overall Study||1
6711983|NCT02957331|7642169|FG001|NOT COMPLETED|Overall Study||0
6711984|NCT02957357|7642177|FG000|STARTED|Overall Study||10479
6711985|NCT02957357|7642178|FG001|STARTED|Overall Study||835
6711986|NCT02957357|7642177|FG000|COMPLETED|Overall Study||10479
6711987|NCT02957357|7642178|FG001|COMPLETED|Overall Study||835
6711988|NCT02957357|7642177|FG000|NOT COMPLETED|Overall Study||0
6711989|NCT02957357|7642178|FG001|NOT COMPLETED|Overall Study||0
6711990|NCT02957682|7642193|FG000|STARTED|Overall Study||1088
6711991|NCT02957682|7642194|FG001|STARTED|Overall Study||1088
6711992|NCT02957682|7642193|FG000|Randomized and Treated|Overall Study||1085
6711993|NCT02957682|7642194|FG001|Randomized and Treated|Overall Study||1086
6711994|NCT02957682|7642193|FG000|COMPLETED|Overall Study||890
6711995|NCT02957682|7642194|FG001|COMPLETED|Overall Study||919
6711996|NCT02957682|7642193|FG000|NOT COMPLETED|Overall Study||198
6711997|NCT02957682|7642194|FG001|NOT COMPLETED|Overall Study||169
6711998|NCT02957747|7642202|FG000|STARTED|Overall Study||76
6711999|NCT02957747|7642203|FG001|STARTED|Overall Study||77
6712000|NCT02957747|7642202|FG000|COMPLETED|Overall Study||66
6712001|NCT02957747|7642203|FG001|COMPLETED|Overall Study||69
6712002|NCT02957747|7642202|FG000|NOT COMPLETED|Overall Study||10
6712003|NCT02957747|7642203|FG001|NOT COMPLETED|Overall Study||8
6712004|NCT02957942|7642212|FG000|STARTED|Overall Study||7
6712005|NCT02957942|7642213|FG001|STARTED|Overall Study|7 healthy individuals were recruited as control; 6 were recruited for practicing experiment details.|13
6712006|NCT02957942|7642212|FG000|COMPLETED|Overall Study||7
6712007|NCT02957942|7642213|FG001|COMPLETED|Overall Study||6
6712008|NCT02957942|7642212|FG000|NOT COMPLETED|Overall Study||0
6712009|NCT02957942|7642213|FG001|NOT COMPLETED|Overall Study||7
6712010|NCT02958267|7642221|FG000|STARTED|Enrollment||17
6712011|NCT02958267|7642222|FG001|STARTED|Enrollment||15
6712012|NCT02958267|7642221|FG000|COMPLETED|Enrollment||17
6712013|NCT02958267|7642222|FG001|COMPLETED|Enrollment||15
6712014|NCT02958267|7642221|FG000|NOT COMPLETED|Enrollment||0
6712015|NCT02958267|7642222|FG001|NOT COMPLETED|Enrollment||0
6712016|NCT02958267|7642221|FG000|STARTED|Enrollment to Actual Treatment Complete||17
6712017|NCT02958267|7642222|FG001|STARTED|Enrollment to Actual Treatment Complete||15
6712018|NCT02958267|7642221|FG000|COMPLETED|Enrollment to Actual Treatment Complete||15
6712019|NCT02958267|7642222|FG001|COMPLETED|Enrollment to Actual Treatment Complete||15
6712020|NCT02958267|7642221|FG000|NOT COMPLETED|Enrollment to Actual Treatment Complete||2
6712021|NCT02958267|7642222|FG001|NOT COMPLETED|Enrollment to Actual Treatment Complete||0
6712022|NCT02958267|7642221|FG000|STARTED|Follow-up Visits||15
6712023|NCT02958267|7642222|FG001|STARTED|Follow-up Visits||15
6712024|NCT02958267|7642221|FG000|3 Month Follow-up|Follow-up Visits||15
6712025|NCT02958267|7642222|FG001|3 Month Follow-up|Follow-up Visits||15
6712026|NCT02958267|7642221|FG000|6 Month Follow-up|Follow-up Visits||14
6712027|NCT02958267|7642222|FG001|6 Month Follow-up|Follow-up Visits||14
6712028|NCT02958267|7642221|FG000|12 Month Follow-up|Follow-up Visits||13
6712029|NCT02958267|7642222|FG001|12 Month Follow-up|Follow-up Visits||14
6712030|NCT02958267|7642221|FG000|COMPLETED|Follow-up Visits||13
6712031|NCT02958267|7642222|FG001|COMPLETED|Follow-up Visits||14
6712032|NCT02958267|7642221|FG000|NOT COMPLETED|Follow-up Visits||2
6712033|NCT02958267|7642222|FG001|NOT COMPLETED|Follow-up Visits||1
6712034|NCT02958345|7642230|FG000|STARTED|Overall Study||14
6712035|NCT02958345|7642231|FG001|STARTED|Overall Study||14
6712036|NCT02958345|7642230|FG000|COMPLETED|Overall Study||13
6712037|NCT02958345|7642231|FG001|COMPLETED|Overall Study||13
6712038|NCT02958345|7642230|FG000|NOT COMPLETED|Overall Study||1
6712039|NCT02958345|7642231|FG001|NOT COMPLETED|Overall Study||1
6712040|NCT02958527|7642237|FG000|STARTED|Overall Study||1408
6712041|NCT02958527|7642237|FG000|COMPLETED|Overall Study||1396
6712042|NCT02958527|7642237|FG000|NOT COMPLETED|Overall Study||12
6712043|NCT02958553|7642250|FG000|STARTED|Phase I, 1st Visit -Passive Prosthesis||8
6712044|NCT02958553|7642250|FG000|COMPLETED|Phase I, 1st Visit -Passive Prosthesis||8
6712045|NCT02958553|7642250|FG000|NOT COMPLETED|Phase I, 1st Visit -Passive Prosthesis||0
6712046|NCT02958553|7642250|FG000|STARTED|Phase I, 2nd Visit -Fitted With emPOWER||8
6712047|NCT02958553|7642250|FG000|COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||8
6712048|NCT02958553|7642250|FG000|NOT COMPLETED|Phase I, 2nd Visit -Fitted With emPOWER||0
6712049|NCT02958553|7642250|FG000|STARTED|Phase I, 3rd Visit -2 Week emPOWER FU||8
6712050|NCT02958553|7642250|FG000|COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||7
6712051|NCT02958553|7642250|FG000|NOT COMPLETED|Phase I, 3rd Visit -2 Week emPOWER FU||1
6712052|NCT02958553|7642250|FG000|STARTED|Phase II, 4th Visit -3 Month emPOWER FU|Only 4 subjects started Phase II of the study. Phase II was optional per protocol.|7
6712053|NCT02958553|7642250|FG000|COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||4
6712054|NCT02958553|7642250|FG000|NOT COMPLETED|Phase II, 4th Visit -3 Month emPOWER FU||3
6712055|NCT02958553|7642250|FG000|STARTED|Phase II, 5th Visit -Crossover Visit||4
6712056|NCT02958553|7642250|FG000|COMPLETED|Phase II, 5th Visit -Crossover Visit||4
6712057|NCT02958553|7642250|FG000|NOT COMPLETED|Phase II, 5th Visit -Crossover Visit||0
6712058|NCT02958553|7642250|FG000|STARTED|Phase II, 6th Visit -6 Month emPOWER FU||4
6712059|NCT02958553|7642250|FG000|COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
6712060|NCT02958553|7642250|FG000|NOT COMPLETED|Phase II, 6th Visit -6 Month emPOWER FU||2
6712061|NCT02958553|7642250|FG000|STARTED|Phase II, 7th Visit -12 Month emPOWER FU||2
6712062|NCT02958553|7642250|FG000|COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||2
6712063|NCT02958553|7642250|FG000|NOT COMPLETED|Phase II, 7th Visit -12 Month emPOWER FU||0
6712064|NCT02958787|7642255|FG000|STARTED|Overall Study||135
6712065|NCT02958787|7642255|FG000|COMPLETED|Overall Study||135
6712066|NCT02958787|7642255|FG000|NOT COMPLETED|Overall Study||0
6712067|NCT02958826|7642261|FG000|STARTED|Overall Study||80
6712068|NCT02958826|7642262|FG001|STARTED|Overall Study||80
6712069|NCT02958826|7642261|FG000|COMPLETED|Overall Study||80
6712070|NCT02958826|7642262|FG001|COMPLETED|Overall Study||80
6712071|NCT02958826|7642261|FG000|NOT COMPLETED|Overall Study||0
6712072|NCT02958826|7642262|FG001|NOT COMPLETED|Overall Study||0
6712073|NCT02958956|7642272|FG000|STARTED|Overall Study||38190
6712074|NCT02958956|7642273|FG001|STARTED|Overall Study||198317
6712075|NCT02958956|7642272|FG000|COMPLETED|Overall Study||38190
6712076|NCT02958956|7642273|FG001|COMPLETED|Overall Study||198317
6712077|NCT02958956|7642272|FG000|NOT COMPLETED|Overall Study||0
6712078|NCT02958956|7642273|FG001|NOT COMPLETED|Overall Study||0
6712079|NCT02958969|7642280|FG000|STARTED|Overall Study||50
6712080|NCT02958969|7642280|FG000|COMPLETED|Overall Study||50
6712081|NCT02958969|7642280|FG000|NOT COMPLETED|Overall Study||0
6712082|NCT02958982|7642295|FG000|STARTED|Cohort 1: 25 mg in SAD Study||1
6712083|NCT02958982|7642296|FG001|STARTED|Cohort 1: 25 mg in SAD Study||3
6712084|NCT02958982|7642297|FG002|STARTED|Cohort 1: 25 mg in SAD Study||0
6712085|NCT02958982|7642298|FG003|STARTED|Cohort 1: 25 mg in SAD Study||0
6712086|NCT02958982|7642299|FG004|STARTED|Cohort 1: 25 mg in SAD Study||0
6712087|NCT02958982|7642300|FG005|STARTED|Cohort 1: 25 mg in SAD Study||0
6712088|NCT02958982|7642301|FG006|STARTED|Cohort 1: 25 mg in SAD Study||0
6712089|NCT02958982|7642302|FG007|STARTED|Cohort 1: 25 mg in SAD Study||0
6712090|NCT02958982|7642303|FG008|STARTED|Cohort 1: 25 mg in SAD Study||0
6712091|NCT02958982|7642304|FG009|STARTED|Cohort 1: 25 mg in SAD Study||0
6712092|NCT02958982|7642305|FG010|STARTED|Cohort 1: 25 mg in SAD Study||0
6712093|NCT02958982|7642295|FG000|COMPLETED|Cohort 1: 25 mg in SAD Study||1
6712094|NCT02958982|7642296|FG001|COMPLETED|Cohort 1: 25 mg in SAD Study||3
6712095|NCT02958982|7642297|FG002|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712096|NCT02958982|7642298|FG003|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712097|NCT02958982|7642299|FG004|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712098|NCT02958982|7642300|FG005|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712099|NCT02958982|7642301|FG006|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712100|NCT02958982|7642302|FG007|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712101|NCT02958982|7642303|FG008|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712102|NCT02958982|7642304|FG009|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712103|NCT02958982|7642305|FG010|COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712104|NCT02958982|7642295|FG000|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712105|NCT02958982|7642296|FG001|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712106|NCT02958982|7642297|FG002|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712107|NCT02958982|7642298|FG003|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712108|NCT02958982|7642299|FG004|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712109|NCT02958982|7642300|FG005|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712110|NCT02958982|7642301|FG006|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712111|NCT02958982|7642302|FG007|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712112|NCT02958982|7642303|FG008|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712113|NCT02958982|7642304|FG009|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712114|NCT02958982|7642305|FG010|NOT COMPLETED|Cohort 1: 25 mg in SAD Study||0
6712115|NCT02958982|7642295|FG000|STARTED|Cohort 2: 50 mg in SAD Study||2
6712116|NCT02958982|7642296|FG001|STARTED|Cohort 2: 50 mg in SAD Study||0
6712117|NCT02958982|7642297|FG002|STARTED|Cohort 2: 50 mg in SAD Study||4
6712118|NCT02958982|7642298|FG003|STARTED|Cohort 2: 50 mg in SAD Study||0
6712119|NCT02958982|7642299|FG004|STARTED|Cohort 2: 50 mg in SAD Study||0
6712120|NCT02958982|7642300|FG005|STARTED|Cohort 2: 50 mg in SAD Study||0
6712121|NCT02958982|7642301|FG006|STARTED|Cohort 2: 50 mg in SAD Study||0
6712122|NCT02958982|7642302|FG007|STARTED|Cohort 2: 50 mg in SAD Study||0
6712123|NCT02958982|7642303|FG008|STARTED|Cohort 2: 50 mg in SAD Study||0
6712124|NCT02958982|7642304|FG009|STARTED|Cohort 2: 50 mg in SAD Study||0
6712125|NCT02958982|7642305|FG010|STARTED|Cohort 2: 50 mg in SAD Study||0
6712126|NCT02958982|7642295|FG000|COMPLETED|Cohort 2: 50 mg in SAD Study||2
6712127|NCT02958982|7642296|FG001|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712128|NCT02958982|7642297|FG002|COMPLETED|Cohort 2: 50 mg in SAD Study||4
6712129|NCT02958982|7642298|FG003|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712130|NCT02958982|7642299|FG004|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712131|NCT02958982|7642300|FG005|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712132|NCT02958982|7642301|FG006|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712133|NCT02958982|7642302|FG007|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712134|NCT02958982|7642303|FG008|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712135|NCT02958982|7642304|FG009|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712136|NCT02958982|7642305|FG010|COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712137|NCT02958982|7642295|FG000|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712138|NCT02958982|7642296|FG001|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712139|NCT02958982|7642297|FG002|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712140|NCT02958982|7642298|FG003|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712141|NCT02958982|7642299|FG004|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712142|NCT02958982|7642300|FG005|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712143|NCT02958982|7642301|FG006|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712144|NCT02958982|7642302|FG007|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712145|NCT02958982|7642303|FG008|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712146|NCT02958982|7642304|FG009|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712147|NCT02958982|7642305|FG010|NOT COMPLETED|Cohort 2: 50 mg in SAD Study||0
6712148|NCT02958982|7642295|FG000|STARTED|Cohort 3: 100 mg in SAD Study||2
6712149|NCT02958982|7642296|FG001|STARTED|Cohort 3: 100 mg in SAD Study||0
6712150|NCT02958982|7642297|FG002|STARTED|Cohort 3: 100 mg in SAD Study||0
6712151|NCT02958982|7642298|FG003|STARTED|Cohort 3: 100 mg in SAD Study||4
6712152|NCT02958982|7642299|FG004|STARTED|Cohort 3: 100 mg in SAD Study||0
6712153|NCT02958982|7642300|FG005|STARTED|Cohort 3: 100 mg in SAD Study||0
6712154|NCT02958982|7642301|FG006|STARTED|Cohort 3: 100 mg in SAD Study||0
6712155|NCT02958982|7642302|FG007|STARTED|Cohort 3: 100 mg in SAD Study||0
6712156|NCT02958982|7642303|FG008|STARTED|Cohort 3: 100 mg in SAD Study||0
6712157|NCT02958982|7642304|FG009|STARTED|Cohort 3: 100 mg in SAD Study||0
6712158|NCT02958982|7642305|FG010|STARTED|Cohort 3: 100 mg in SAD Study||0
6712159|NCT02958982|7642295|FG000|COMPLETED|Cohort 3: 100 mg in SAD Study||2
6712160|NCT02958982|7642296|FG001|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712161|NCT02958982|7642297|FG002|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712162|NCT02958982|7642298|FG003|COMPLETED|Cohort 3: 100 mg in SAD Study||4
6712163|NCT02958982|7642299|FG004|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712164|NCT02958982|7642300|FG005|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712165|NCT02958982|7642301|FG006|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712166|NCT02958982|7642302|FG007|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712167|NCT02958982|7642303|FG008|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712168|NCT02958982|7642304|FG009|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712169|NCT02958982|7642305|FG010|COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712170|NCT02958982|7642295|FG000|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712171|NCT02958982|7642296|FG001|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712172|NCT02958982|7642297|FG002|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712173|NCT02958982|7642298|FG003|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712174|NCT02958982|7642299|FG004|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712175|NCT02958982|7642300|FG005|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712176|NCT02958982|7642301|FG006|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712177|NCT02958982|7642302|FG007|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712178|NCT02958982|7642303|FG008|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712179|NCT02958982|7642304|FG009|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712180|NCT02958982|7642305|FG010|NOT COMPLETED|Cohort 3: 100 mg in SAD Study||0
6712181|NCT02958982|7642295|FG000|STARTED|Cohort 4: 200 mg in SAD Study||2
6712182|NCT02958982|7642296|FG001|STARTED|Cohort 4: 200 mg in SAD Study||0
6712183|NCT02958982|7642297|FG002|STARTED|Cohort 4: 200 mg in SAD Study||0
6712184|NCT02958982|7642298|FG003|STARTED|Cohort 4: 200 mg in SAD Study||0
6712185|NCT02958982|7642299|FG004|STARTED|Cohort 4: 200 mg in SAD Study||6
6712186|NCT02958982|7642300|FG005|STARTED|Cohort 4: 200 mg in SAD Study||0
6712187|NCT02958982|7642301|FG006|STARTED|Cohort 4: 200 mg in SAD Study||0
6712188|NCT02958982|7642302|FG007|STARTED|Cohort 4: 200 mg in SAD Study||0
6712189|NCT02958982|7642303|FG008|STARTED|Cohort 4: 200 mg in SAD Study||0
6712190|NCT02958982|7642304|FG009|STARTED|Cohort 4: 200 mg in SAD Study||0
6712191|NCT02958982|7642305|FG010|STARTED|Cohort 4: 200 mg in SAD Study||0
6712192|NCT02958982|7642295|FG000|COMPLETED|Cohort 4: 200 mg in SAD Study||2
6712193|NCT02958982|7642296|FG001|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712194|NCT02958982|7642297|FG002|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712195|NCT02958982|7642298|FG003|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712196|NCT02958982|7642299|FG004|COMPLETED|Cohort 4: 200 mg in SAD Study||6
6712197|NCT02958982|7642300|FG005|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712198|NCT02958982|7642301|FG006|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712199|NCT02958982|7642302|FG007|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712200|NCT02958982|7642303|FG008|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712201|NCT02958982|7642304|FG009|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712202|NCT02958982|7642305|FG010|COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712203|NCT02958982|7642295|FG000|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712204|NCT02958982|7642296|FG001|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712205|NCT02958982|7642297|FG002|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712206|NCT02958982|7642298|FG003|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712207|NCT02958982|7642299|FG004|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712208|NCT02958982|7642300|FG005|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712209|NCT02958982|7642301|FG006|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712210|NCT02958982|7642302|FG007|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712211|NCT02958982|7642303|FG008|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712212|NCT02958982|7642304|FG009|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712213|NCT02958982|7642305|FG010|NOT COMPLETED|Cohort 4: 200 mg in SAD Study||0
6712214|NCT02958982|7642295|FG000|STARTED|Cohort 5: 400 mg in SAD Study||2
6712215|NCT02958982|7642296|FG001|STARTED|Cohort 5: 400 mg in SAD Study||0
6712216|NCT02958982|7642297|FG002|STARTED|Cohort 5: 400 mg in SAD Study||0
6712217|NCT02958982|7642298|FG003|STARTED|Cohort 5: 400 mg in SAD Study||0
6712218|NCT02958982|7642299|FG004|STARTED|Cohort 5: 400 mg in SAD Study||0
6712219|NCT02958982|7642300|FG005|STARTED|Cohort 5: 400 mg in SAD Study||6
6712220|NCT02958982|7642301|FG006|STARTED|Cohort 5: 400 mg in SAD Study||0
6712221|NCT02958982|7642302|FG007|STARTED|Cohort 5: 400 mg in SAD Study||0
6712222|NCT02958982|7642303|FG008|STARTED|Cohort 5: 400 mg in SAD Study||0
6712223|NCT02958982|7642304|FG009|STARTED|Cohort 5: 400 mg in SAD Study||0
6712224|NCT02958982|7642305|FG010|STARTED|Cohort 5: 400 mg in SAD Study||0
6712225|NCT02958982|7642295|FG000|COMPLETED|Cohort 5: 400 mg in SAD Study||2
6712226|NCT02958982|7642296|FG001|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712227|NCT02958982|7642297|FG002|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712228|NCT02958982|7642298|FG003|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712229|NCT02958982|7642299|FG004|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712230|NCT02958982|7642300|FG005|COMPLETED|Cohort 5: 400 mg in SAD Study||6
6262364|NCT02457910|7161363|FG000|STARTED|Overall Study||3
6262365|NCT02457910|7161364|FG001|STARTED|Overall Study|In dose escalation, two patients receiving the 4 mg dose of taselisib were removed for toxicities|5
6262366|NCT02457910|7161365|FG002|STARTED|Overall Study||3
6262367|NCT02457910|7161366|FG003|STARTED|Overall Study||2
6262368|NCT02457910|7161367|FG004|STARTED|Overall Study|3 participants crossed over to enzalutamide and taselisib|5
6262369|NCT02457910|7161368|FG005|STARTED|Overall Study||12
6262370|NCT02457910|7161363|FG000|COMPLETED|Overall Study||0
6262371|NCT02457910|7161364|FG001|COMPLETED|Overall Study||0
6262372|NCT02457910|7161365|FG002|COMPLETED|Overall Study||0
6262373|NCT02457910|7161366|FG003|COMPLETED|Overall Study||0
6262374|NCT02457910|7161367|FG004|COMPLETED|Overall Study||0
6262375|NCT02457910|7161368|FG005|COMPLETED|Overall Study||1
6262376|NCT02457910|7161363|FG000|NOT COMPLETED|Overall Study||3
6262377|NCT02457910|7161364|FG001|NOT COMPLETED|Overall Study||5
6262378|NCT02457910|7161365|FG002|NOT COMPLETED|Overall Study||3
6262379|NCT02457910|7161366|FG003|NOT COMPLETED|Overall Study||2
6262380|NCT02457910|7161367|FG004|NOT COMPLETED|Overall Study||5
6262381|NCT02457910|7161368|FG005|NOT COMPLETED|Overall Study||11
6262382|NCT02407236|7161393|FG000|STARTED|Induction Study (8 Weeks)||319
6712231|NCT02958982|7642301|FG006|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712232|NCT02958982|7642302|FG007|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712233|NCT02958982|7642303|FG008|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712234|NCT02958982|7642304|FG009|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712235|NCT02958982|7642305|FG010|COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712236|NCT02958982|7642295|FG000|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712237|NCT02958982|7642296|FG001|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712238|NCT02958982|7642297|FG002|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712239|NCT02958982|7642298|FG003|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712240|NCT02958982|7642299|FG004|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712241|NCT02958982|7642300|FG005|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712242|NCT02958982|7642301|FG006|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712243|NCT02958982|7642302|FG007|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712244|NCT02958982|7642303|FG008|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712245|NCT02958982|7642304|FG009|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712246|NCT02958982|7642305|FG010|NOT COMPLETED|Cohort 5: 400 mg in SAD Study||0
6712247|NCT02958982|7642295|FG000|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712248|NCT02958982|7642296|FG001|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712249|NCT02958982|7642297|FG002|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712250|NCT02958982|7642298|FG003|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712251|NCT02958982|7642299|FG004|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712252|NCT02958982|7642300|FG005|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712253|NCT02958982|7642301|FG006|STARTED|Cohort 1 : 25 mg in MAD Study||2
6262383|NCT02407236|7161394|FG001|STARTED|Induction Study (8 Weeks)||320
6262384|NCT02407236|7161395|FG002|STARTED|Induction Study (8 Weeks)||322
6262385|NCT02407236|7161396|FG003|STARTED|Induction Study (8 Weeks)||0
6262386|NCT02407236|7161397|FG004|STARTED|Induction Study (8 Weeks)||0
6262387|NCT02407236|7161398|FG005|STARTED|Induction Study (8 Weeks)||0
6262388|NCT02407236|7161399|FG006|STARTED|Induction Study (8 Weeks)||0
6262389|NCT02407236|7161400|FG007|STARTED|Induction Study (8 Weeks)||0
6262390|NCT02407236|7161393|FG000|Clinical Response at IS Week 8|Induction Study (8 Weeks)||103
6262391|NCT02407236|7161394|FG001|Clinical Response at IS Week 8|Induction Study (8 Weeks)||172
6262392|NCT02407236|7161395|FG002|Clinical Response at IS Week 8|Induction Study (8 Weeks)||208
6262393|NCT02407236|7161396|FG003|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6262394|NCT02407236|7161397|FG004|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6262395|NCT02407236|7161398|FG005|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6262396|NCT02407236|7161399|FG006|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6262397|NCT02407236|7161400|FG007|Clinical Response at IS Week 8|Induction Study (8 Weeks)||0
6262398|NCT02407236|7161393|FG000|Clinical Response at IS Week 16|Induction Study (8 Weeks)||143
6262399|NCT02407236|7161394|FG001|Clinical Response at IS Week 16|Induction Study (8 Weeks)||90
6262400|NCT02407236|7161395|FG002|Clinical Response at IS Week 16|Induction Study (8 Weeks)||67
6262401|NCT02407236|7161396|FG003|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6262402|NCT02407236|7161397|FG004|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6262403|NCT02407236|7161398|FG005|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6262404|NCT02407236|7161399|FG006|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6262405|NCT02407236|7161400|FG007|Clinical Response at IS Week 16|Induction Study (8 Weeks)||0
6262406|NCT02407236|7161393|FG000|Completed Safety Follow-up|Induction Study (8 Weeks)|17 participants from Induction Week (IW)- 8 and 33 participants from IW- 16.|50
6262407|NCT02407236|7161394|FG001|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 37 from IW- 16.|47
6262408|NCT02407236|7161395|FG002|Completed Safety Follow-up|Induction Study (8 Weeks)|10 participants from IW- 8 and 22 from IW- 16.|32
6262409|NCT02407236|7161396|FG003|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6262410|NCT02407236|7161397|FG004|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6262411|NCT02407236|7161398|FG005|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6262412|NCT02407236|7161399|FG006|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6262413|NCT02407236|7161400|FG007|Completed Safety Follow-up|Induction Study (8 Weeks)||0
6262414|NCT02407236|7161393|FG000|Safety Analysis Set|Induction Study (8 Weeks)||319
6262415|NCT02407236|7161394|FG001|Safety Analysis Set|Induction Study (8 Weeks)|1 participant of ustekinumab 130mg never had drug, 2 participants planned to 6 mg/kg but had 130mg.|321
6262416|NCT02407236|7161395|FG002|Safety Analysis Set|Induction Study (8 Weeks)||320
6262417|NCT02407236|7161396|FG003|Safety Analysis Set|Induction Study (8 Weeks)||0
6262418|NCT02407236|7161397|FG004|Safety Analysis Set|Induction Study (8 Weeks)||0
6262419|NCT02407236|7161398|FG005|Safety Analysis Set|Induction Study (8 Weeks)||0
6602731|NCT02058589|7527784|FG001|COMPLETED|Overall Study||130
6602732|NCT02058589|7527783|FG000|NOT COMPLETED|Overall Study||2
6602733|NCT02058589|7527784|FG001|NOT COMPLETED|Overall Study||2
6602734|NCT02058628|7527794|FG000|STARTED|Overall Study||111
6602735|NCT02058628|7527795|FG001|STARTED|Overall Study||110
6602736|NCT02058628|7527794|FG000|COMPLETED|Overall Study||104
6602737|NCT02058628|7527795|FG001|COMPLETED|Overall Study||102
6602738|NCT02058628|7527794|FG000|NOT COMPLETED|Overall Study||7
6602739|NCT02058628|7527795|FG001|NOT COMPLETED|Overall Study||8
6602740|NCT02058836|7527806|FG000|STARTED|Overall Study||4
6602741|NCT02058836|7527807|FG001|STARTED|Overall Study||4
6602742|NCT02058836|7527806|FG000|COMPLETED|Overall Study||3
6602743|NCT02058836|7527807|FG001|COMPLETED|Overall Study||3
6602744|NCT02058836|7527806|FG000|NOT COMPLETED|Overall Study||1
6602745|NCT02058836|7527807|FG001|NOT COMPLETED|Overall Study||1
6712254|NCT02958982|7642302|FG007|STARTED|Cohort 1 : 25 mg in MAD Study||6
6712255|NCT02958982|7642303|FG008|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712256|NCT02958982|7642304|FG009|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712257|NCT02958982|7642305|FG010|STARTED|Cohort 1 : 25 mg in MAD Study||0
6712258|NCT02958982|7642295|FG000|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712259|NCT02958982|7642296|FG001|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712260|NCT02958982|7642297|FG002|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712261|NCT02958982|7642298|FG003|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712262|NCT02958982|7642299|FG004|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712263|NCT02958982|7642300|FG005|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712264|NCT02958982|7642301|FG006|COMPLETED|Cohort 1 : 25 mg in MAD Study||2
6712265|NCT02958982|7642302|FG007|COMPLETED|Cohort 1 : 25 mg in MAD Study||6
6712266|NCT02958982|7642303|FG008|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712267|NCT02958982|7642304|FG009|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712268|NCT02958982|7642305|FG010|COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712269|NCT02958982|7642295|FG000|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712270|NCT02958982|7642296|FG001|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712271|NCT02958982|7642297|FG002|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712272|NCT02958982|7642298|FG003|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712273|NCT02958982|7642299|FG004|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712274|NCT02958982|7642300|FG005|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712275|NCT02958982|7642301|FG006|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712276|NCT02958982|7642302|FG007|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712277|NCT02958982|7642303|FG008|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712278|NCT02958982|7642304|FG009|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712279|NCT02958982|7642305|FG010|NOT COMPLETED|Cohort 1 : 25 mg in MAD Study||0
6712280|NCT02958982|7642295|FG000|STARTED|Cohort 2: 100 mg in MAD Study||0
6712281|NCT02958982|7642296|FG001|STARTED|Cohort 2: 100 mg in MAD Study||0
6712282|NCT02958982|7642297|FG002|STARTED|Cohort 2: 100 mg in MAD Study||0
6712283|NCT02958982|7642298|FG003|STARTED|Cohort 2: 100 mg in MAD Study||0
6712284|NCT02958982|7642299|FG004|STARTED|Cohort 2: 100 mg in MAD Study||0
6712285|NCT02958982|7642300|FG005|STARTED|Cohort 2: 100 mg in MAD Study||0
6712286|NCT02958982|7642301|FG006|STARTED|Cohort 2: 100 mg in MAD Study||2
6712287|NCT02958982|7642302|FG007|STARTED|Cohort 2: 100 mg in MAD Study||0
6712288|NCT02958982|7642303|FG008|STARTED|Cohort 2: 100 mg in MAD Study||6
6712289|NCT02958982|7642304|FG009|STARTED|Cohort 2: 100 mg in MAD Study||0
6712290|NCT02958982|7642305|FG010|STARTED|Cohort 2: 100 mg in MAD Study||0
6712291|NCT02958982|7642295|FG000|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712292|NCT02958982|7642296|FG001|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712293|NCT02958982|7642297|FG002|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712294|NCT02958982|7642298|FG003|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712295|NCT02958982|7642299|FG004|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712296|NCT02958982|7642300|FG005|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712297|NCT02958982|7642301|FG006|COMPLETED|Cohort 2: 100 mg in MAD Study||2
6712298|NCT02958982|7642302|FG007|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712299|NCT02958982|7642303|FG008|COMPLETED|Cohort 2: 100 mg in MAD Study||6
6712300|NCT02958982|7642304|FG009|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712301|NCT02958982|7642305|FG010|COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712302|NCT02958982|7642295|FG000|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712303|NCT02958982|7642296|FG001|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712304|NCT02958982|7642297|FG002|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712305|NCT02958982|7642298|FG003|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712306|NCT02958982|7642299|FG004|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712307|NCT02958982|7642300|FG005|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712308|NCT02958982|7642301|FG006|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712309|NCT02958982|7642302|FG007|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712310|NCT02958982|7642303|FG008|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712311|NCT02958982|7642304|FG009|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712312|NCT02958982|7642305|FG010|NOT COMPLETED|Cohort 2: 100 mg in MAD Study||0
6712313|NCT02958982|7642295|FG000|STARTED|Cohort 3: 400 mg in MAD Study||0
6712314|NCT02958982|7642296|FG001|STARTED|Cohort 3: 400 mg in MAD Study||0
6712315|NCT02958982|7642297|FG002|STARTED|Cohort 3: 400 mg in MAD Study||0
6712316|NCT02958982|7642298|FG003|STARTED|Cohort 3: 400 mg in MAD Study||0
6712317|NCT02958982|7642299|FG004|STARTED|Cohort 3: 400 mg in MAD Study||0
6712318|NCT02958982|7642300|FG005|STARTED|Cohort 3: 400 mg in MAD Study||0
6712319|NCT02958982|7642301|FG006|STARTED|Cohort 3: 400 mg in MAD Study||2
6712320|NCT02958982|7642302|FG007|STARTED|Cohort 3: 400 mg in MAD Study||0
6712321|NCT02958982|7642303|FG008|STARTED|Cohort 3: 400 mg in MAD Study||0
6712322|NCT02958982|7642304|FG009|STARTED|Cohort 3: 400 mg in MAD Study||6
6712323|NCT02958982|7642305|FG010|STARTED|Cohort 3: 400 mg in MAD Study||0
6712324|NCT02958982|7642295|FG000|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712325|NCT02958982|7642296|FG001|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712326|NCT02958982|7642297|FG002|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712327|NCT02958982|7642298|FG003|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712328|NCT02958982|7642299|FG004|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712329|NCT02958982|7642300|FG005|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712330|NCT02958982|7642301|FG006|COMPLETED|Cohort 3: 400 mg in MAD Study||2
6712331|NCT02958982|7642302|FG007|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712332|NCT02958982|7642303|FG008|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712333|NCT02958982|7642304|FG009|COMPLETED|Cohort 3: 400 mg in MAD Study||6
6712334|NCT02958982|7642305|FG010|COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712335|NCT02958982|7642295|FG000|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712336|NCT02958982|7642296|FG001|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712337|NCT02958982|7642297|FG002|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712338|NCT02958982|7642298|FG003|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712339|NCT02958982|7642299|FG004|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712340|NCT02958982|7642300|FG005|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712341|NCT02958982|7642301|FG006|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712342|NCT02958982|7642302|FG007|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712343|NCT02958982|7642303|FG008|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712344|NCT02958982|7642304|FG009|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712345|NCT02958982|7642305|FG010|NOT COMPLETED|Cohort 3: 400 mg in MAD Study||0
6712346|NCT02958982|7642295|FG000|STARTED|Proof of Concept Study||0
6712347|NCT02958982|7642296|FG001|STARTED|Proof of Concept Study||0
6712348|NCT02958982|7642297|FG002|STARTED|Proof of Concept Study||0
6712349|NCT02958982|7642298|FG003|STARTED|Proof of Concept Study||0
6712350|NCT02958982|7642299|FG004|STARTED|Proof of Concept Study||0
6712351|NCT02958982|7642300|FG005|STARTED|Proof of Concept Study||0
6712352|NCT02958982|7642301|FG006|STARTED|Proof of Concept Study||0
6712353|NCT02958982|7642302|FG007|STARTED|Proof of Concept Study||0
6712354|NCT02958982|7642303|FG008|STARTED|Proof of Concept Study||0
6712355|NCT02958982|7642304|FG009|STARTED|Proof of Concept Study||0
6712356|NCT02958982|7642305|FG010|STARTED|Proof of Concept Study||1
6712357|NCT02958982|7642295|FG000|COMPLETED|Proof of Concept Study||0
6712358|NCT02958982|7642296|FG001|COMPLETED|Proof of Concept Study||0
6712359|NCT02958982|7642297|FG002|COMPLETED|Proof of Concept Study||0
6712360|NCT02958982|7642298|FG003|COMPLETED|Proof of Concept Study||0
6712361|NCT02958982|7642299|FG004|COMPLETED|Proof of Concept Study||0
6712362|NCT02958982|7642300|FG005|COMPLETED|Proof of Concept Study||0
6712363|NCT02958982|7642301|FG006|COMPLETED|Proof of Concept Study||0
6712364|NCT02958982|7642302|FG007|COMPLETED|Proof of Concept Study||0
6712365|NCT02958982|7642303|FG008|COMPLETED|Proof of Concept Study||0
6712366|NCT02958982|7642304|FG009|COMPLETED|Proof of Concept Study||0
6712367|NCT02958982|7642305|FG010|COMPLETED|Proof of Concept Study||1
6712368|NCT02958982|7642295|FG000|NOT COMPLETED|Proof of Concept Study||0
6712369|NCT02958982|7642296|FG001|NOT COMPLETED|Proof of Concept Study||0
6712370|NCT02958982|7642297|FG002|NOT COMPLETED|Proof of Concept Study||0
6712371|NCT02958982|7642298|FG003|NOT COMPLETED|Proof of Concept Study||0
6712372|NCT02958982|7642299|FG004|NOT COMPLETED|Proof of Concept Study||0
6712373|NCT02958982|7642300|FG005|NOT COMPLETED|Proof of Concept Study||0
6712374|NCT02958982|7642301|FG006|NOT COMPLETED|Proof of Concept Study||0
6712375|NCT02958982|7642302|FG007|NOT COMPLETED|Proof of Concept Study||0
6262420|NCT02407236|7161399|FG006|Safety Analysis Set|Induction Study (8 Weeks)||0
6262421|NCT02407236|7161400|FG007|Safety Analysis Set|Induction Study (8 Weeks)||0
6262422|NCT02407236|7161393|FG000|Non-responders at Week 8|Induction Study (8 Weeks)||184
6262423|NCT02407236|7161394|FG001|Non-responders at Week 8|Induction Study (8 Weeks)||132
6262424|NCT02407236|7161395|FG002|Non-responders at Week 8|Induction Study (8 Weeks)||101
6262425|NCT02407236|7161396|FG003|Non-responders at Week 8|Induction Study (8 Weeks)||0
6262426|NCT02407236|7161397|FG004|Non-responders at Week 8|Induction Study (8 Weeks)||0
6262427|NCT02407236|7161398|FG005|Non-responders at Week 8|Induction Study (8 Weeks)||0
6262428|NCT02407236|7161399|FG006|Non-responders at Week 8|Induction Study (8 Weeks)||0
6262429|NCT02407236|7161400|FG007|Non-responders at Week 8|Induction Study (8 Weeks)||0
6262430|NCT02407236|7161393|FG000|COMPLETED|Induction Study (8 Weeks)||296
6262431|NCT02407236|7161394|FG001|COMPLETED|Induction Study (8 Weeks)||309
6262432|NCT02407236|7161395|FG002|COMPLETED|Induction Study (8 Weeks)||307
6262433|NCT02407236|7161396|FG003|COMPLETED|Induction Study (8 Weeks)||0
6262434|NCT02407236|7161397|FG004|COMPLETED|Induction Study (8 Weeks)||0
6262435|NCT02407236|7161398|FG005|COMPLETED|Induction Study (8 Weeks)||0
6262436|NCT02407236|7161399|FG006|COMPLETED|Induction Study (8 Weeks)||0
6262437|NCT02407236|7161400|FG007|COMPLETED|Induction Study (8 Weeks)||0
6262438|NCT02407236|7161393|FG000|NOT COMPLETED|Induction Study (8 Weeks)||23
6262439|NCT02407236|7161394|FG001|NOT COMPLETED|Induction Study (8 Weeks)||11
6262440|NCT02407236|7161395|FG002|NOT COMPLETED|Induction Study (8 Weeks)||15
6262441|NCT02407236|7161396|FG003|NOT COMPLETED|Induction Study (8 Weeks)||0
6262442|NCT02407236|7161397|FG004|NOT COMPLETED|Induction Study (8 Weeks)||0
6262443|NCT02407236|7161398|FG005|NOT COMPLETED|Induction Study (8 Weeks)||0
6262444|NCT02407236|7161399|FG006|NOT COMPLETED|Induction Study (8 Weeks)||0
6262445|NCT02407236|7161400|FG007|NOT COMPLETED|Induction Study (8 Weeks)||0
6262446|NCT02407236|7161393|FG000|STARTED|Maintenance Study (44 Weeks)||0
6262447|NCT02407236|7161394|FG001|STARTED|Maintenance Study (44 Weeks)||0
6262448|NCT02407236|7161395|FG002|STARTED|Maintenance Study (44 Weeks)||0
6262449|NCT02407236|7161396|FG003|STARTED|Maintenance Study (44 Weeks)||175
6262450|NCT02407236|7161397|FG004|STARTED|Maintenance Study (44 Weeks)||172
6262451|NCT02407236|7161398|FG005|STARTED|Maintenance Study (44 Weeks)||176
6262452|NCT02407236|7161399|FG006|STARTED|Maintenance Study (44 Weeks)||103
6262453|NCT02407236|7161400|FG007|STARTED|Maintenance Study (44 Weeks)||157
6262454|NCT02407236|7161393|FG000|COMPLETED|Maintenance Study (44 Weeks)||0
6262455|NCT02407236|7161394|FG001|COMPLETED|Maintenance Study (44 Weeks)||0
6712376|NCT02958982|7642303|FG008|NOT COMPLETED|Proof of Concept Study||0
6712377|NCT02958982|7642304|FG009|NOT COMPLETED|Proof of Concept Study||0
6712378|NCT02958982|7642305|FG010|NOT COMPLETED|Proof of Concept Study||0
6712379|NCT02958995|7642340|FG000|STARTED|Overall Study||2630666
6712380|NCT02958995|7642341|FG001|STARTED|Overall Study||107495
6712381|NCT02958995|7642340|FG000|COMPLETED|Overall Study||2630666
6712382|NCT02958995|7642341|FG001|COMPLETED|Overall Study||107495
6712383|NCT02958995|7642340|FG000|NOT COMPLETED|Overall Study||0
6712384|NCT02958995|7642341|FG001|NOT COMPLETED|Overall Study||0
6712385|NCT02959138|7642350|FG000|STARTED|Overall Study||10
6712386|NCT02959138|7642351|FG001|STARTED|Overall Study||10
6712387|NCT02959138|7642352|FG002|STARTED|Overall Study||16
6712388|NCT02959138|7642350|FG000|COMPLETED|Overall Study||10
6712389|NCT02959138|7642351|FG001|COMPLETED|Overall Study||9
6712390|NCT02959138|7642352|FG002|COMPLETED|Overall Study||16
6712391|NCT02959138|7642350|FG000|NOT COMPLETED|Overall Study||0
6712392|NCT02959138|7642351|FG001|NOT COMPLETED|Overall Study||1
6712393|NCT02959138|7642352|FG002|NOT COMPLETED|Overall Study||0
6712394|NCT02959177|7642367|FG000|STARTED|Double-Blind Treatment Phase||115
6712395|NCT02959177|7642368|FG001|STARTED|Double-Blind Treatment Phase||114
6712396|NCT02959177|7642369|FG002|STARTED|Double-Blind Treatment Phase||230
6712397|NCT02959177|7642367|FG000|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||115
6712398|NCT02959177|7642368|FG001|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||114
6712399|NCT02959177|7642369|FG002|Received at Least 1 Dose of Study Drug|Double-Blind Treatment Phase||230
6712400|NCT02959177|7642367|FG000|COMPLETED|Double-Blind Treatment Phase||104
6712401|NCT02959177|7642368|FG001|COMPLETED|Double-Blind Treatment Phase||111
6712402|NCT02959177|7642369|FG002|COMPLETED|Double-Blind Treatment Phase||225
6712403|NCT02959177|7642367|FG000|NOT COMPLETED|Double-Blind Treatment Phase||11
6712404|NCT02959177|7642368|FG001|NOT COMPLETED|Double-Blind Treatment Phase||3
6712405|NCT02959177|7642369|FG002|NOT COMPLETED|Double-Blind Treatment Phase||5
6712406|NCT02959177|7642367|FG000|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
6712407|NCT02959177|7642368|FG001|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|52
6712408|NCT02959177|7642369|FG002|STARTED|Follow-up Post Treatment Phase|Not all participants entered Post Treatment Follow-up Phase|100
6712409|NCT02959177|7642367|FG000|COMPLETED|Follow-up Post Treatment Phase||51
6712410|NCT02959177|7642368|FG001|COMPLETED|Follow-up Post Treatment Phase||51
6712411|NCT02959177|7642369|FG002|COMPLETED|Follow-up Post Treatment Phase||98
6712412|NCT02959177|7642367|FG000|NOT COMPLETED|Follow-up Post Treatment Phase||1
6712413|NCT02959177|7642368|FG001|NOT COMPLETED|Follow-up Post Treatment Phase||1
6712414|NCT02959177|7642369|FG002|NOT COMPLETED|Follow-up Post Treatment Phase||2
6712415|NCT02959190|7642387|FG000|STARTED|Open Label||120
6712416|NCT02959190|7642388|FG001|STARTED|Open Label||126
6712417|NCT02959190|7642389|FG002|STARTED|Open Label||32
6712418|NCT02959190|7642390|FG003|STARTED|Open Label||33
6262456|NCT02407236|7161395|FG002|COMPLETED|Maintenance Study (44 Weeks)||0
6262457|NCT02407236|7161396|FG003|COMPLETED|Maintenance Study (44 Weeks)||165
6262458|NCT02407236|7161397|FG004|COMPLETED|Maintenance Study (44 Weeks)||161
6262459|NCT02407236|7161398|FG005|COMPLETED|Maintenance Study (44 Weeks)||168
6262460|NCT02407236|7161399|FG006|COMPLETED|Maintenance Study (44 Weeks)||94
6262461|NCT02407236|7161400|FG007|COMPLETED|Maintenance Study (44 Weeks)||149
6262462|NCT02407236|7161393|FG000|NOT COMPLETED|Maintenance Study (44 Weeks)||0
6262463|NCT02407236|7161394|FG001|NOT COMPLETED|Maintenance Study (44 Weeks)||0
6262464|NCT02407236|7161395|FG002|NOT COMPLETED|Maintenance Study (44 Weeks)||0
6262465|NCT02407236|7161396|FG003|NOT COMPLETED|Maintenance Study (44 Weeks)||10
6262466|NCT02407236|7161397|FG004|NOT COMPLETED|Maintenance Study (44 Weeks)||11
6262467|NCT02407236|7161398|FG005|NOT COMPLETED|Maintenance Study (44 Weeks)||8
6262468|NCT02407236|7161399|FG006|NOT COMPLETED|Maintenance Study (44 Weeks)||9
6262469|NCT02407236|7161400|FG007|NOT COMPLETED|Maintenance Study (44 Weeks)||8
6262470|NCT02320396|7161420|FG000|STARTED|Overall Study||224
6262471|NCT02320396|7161421|FG001|STARTED|Overall Study||225
6262472|NCT02320396|7161420|FG000|Treated (Full Analysis Set)|Overall Study||223
6262473|NCT02320396|7161421|FG001|Treated (Full Analysis Set)|Overall Study||225
6712419|NCT02959190|7642387|FG000|Received at Least 1 Dose of Study Drug|Open Label||120
6712420|NCT02959190|7642388|FG001|Received at Least 1 Dose of Study Drug|Open Label||126
6712421|NCT02959190|7642389|FG002|Received at Least 1 Dose of Study Drug|Open Label||32
6712422|NCT02959190|7642390|FG003|Received at Least 1 Dose of Study Drug|Open Label||33
6712423|NCT02959190|7642387|FG000|120mg/120mg Galcanezumab - EM|Open Label||58
6712424|NCT02959190|7642388|FG001|120mg/120mg Galcanezumab - EM|Open Label||0
6712425|NCT02959190|7642389|FG002|120mg/120mg Galcanezumab - EM|Open Label||0
6712426|NCT02959190|7642390|FG003|120mg/120mg Galcanezumab - EM|Open Label||0
6712427|NCT02959190|7642387|FG000|240mg/240mg Galcanezumab - EM|Open Label||0
6712428|NCT02959190|7642388|FG001|240mg/240mg Galcanezumab - EM|Open Label||62
6712429|NCT02959190|7642389|FG002|240mg/240mg Galcanezumab - EM|Open Label||0
6712430|NCT02959190|7642390|FG003|240mg/240mg Galcanezumab - EM|Open Label||0
6712431|NCT02959190|7642387|FG000|Placebo/ 120mg Galcanezumab - EM|Open Label||62
6712432|NCT02959190|7642388|FG001|Placebo/ 120mg Galcanezumab - EM|Open Label||0
6712433|NCT02959190|7642389|FG002|Placebo/ 120mg Galcanezumab - EM|Open Label||0
6712434|NCT02959190|7642390|FG003|Placebo/ 120mg Galcanezumab - EM|Open Label||0
6712435|NCT02959190|7642387|FG000|Placebo/ 240mg Galcanezumab - EM|Open Label||0
6712436|NCT02959190|7642388|FG001|Placebo/ 240mg Galcanezumab - EM|Open Label||64
6712437|NCT02959190|7642389|FG002|Placebo/ 240mg Galcanezumab - EM|Open Label||0
6712438|NCT02959190|7642390|FG003|Placebo/ 240mg Galcanezumab - EM|Open Label||0
6712439|NCT02959190|7642387|FG000|COMPLETED|Open Label||113
6712440|NCT02959190|7642388|FG001|COMPLETED|Open Label||110
6712441|NCT02959190|7642389|FG002|COMPLETED|Open Label||28
6712442|NCT02959190|7642390|FG003|COMPLETED|Open Label||27
6712443|NCT02959190|7642387|FG000|NOT COMPLETED|Open Label||7
6712444|NCT02959190|7642388|FG001|NOT COMPLETED|Open Label||16
6712445|NCT02959190|7642389|FG002|NOT COMPLETED|Open Label||4
6712446|NCT02959190|7642390|FG003|NOT COMPLETED|Open Label||6
6712447|NCT02959190|7642387|FG000|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|117
6712448|NCT02959190|7642388|FG001|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|120
6712449|NCT02959190|7642389|FG002|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
6712450|NCT02959190|7642390|FG003|STARTED|Post Treatment Follow Up|Participants who discontinued open-label treatment phase had an option to enter post treatment phase|32
6712451|NCT02959190|7642387|FG000|COMPLETED|Post Treatment Follow Up||114
6712452|NCT02959190|7642388|FG001|COMPLETED|Post Treatment Follow Up||119
6712453|NCT02959190|7642389|FG002|COMPLETED|Post Treatment Follow Up||31
6712454|NCT02959190|7642390|FG003|COMPLETED|Post Treatment Follow Up||32
6712455|NCT02959190|7642387|FG000|NOT COMPLETED|Post Treatment Follow Up||3
6712456|NCT02959190|7642388|FG001|NOT COMPLETED|Post Treatment Follow Up||1
6712457|NCT02959190|7642389|FG002|NOT COMPLETED|Post Treatment Follow Up||1
6712458|NCT02959190|7642390|FG003|NOT COMPLETED|Post Treatment Follow Up||0
6739300|NCT03286751|7668065|FG004|NOT COMPLETED|Period 6||0
6739301|NCT03286751|7668066|FG005|NOT COMPLETED|Period 6||0
6739302|NCT03286829|7668084|FG000|STARTED|Overall Study||15
6739303|NCT03286829|7668085|FG001|STARTED|Overall Study||15
6739304|NCT03286829|7668086|FG002|STARTED|Overall Study||15
6739305|NCT03286829|7668087|FG003|STARTED|Overall Study||15
6739306|NCT03286829|7668084|FG000|COMPLETED|Overall Study||15
6739307|NCT03286829|7668085|FG001|COMPLETED|Overall Study||15
6739308|NCT03286829|7668086|FG002|COMPLETED|Overall Study||15
6739309|NCT03286829|7668087|FG003|COMPLETED|Overall Study||15
6739310|NCT03286829|7668084|FG000|NOT COMPLETED|Overall Study||0
6739311|NCT03286829|7668085|FG001|NOT COMPLETED|Overall Study||0
6739312|NCT03286829|7668086|FG002|NOT COMPLETED|Overall Study||0
6739313|NCT03286829|7668087|FG003|NOT COMPLETED|Overall Study||0
6739314|NCT03287219|7668101|FG000|STARTED|Overall Study||24
6739315|NCT03287219|7668102|FG001|STARTED|Overall Study||90
6739316|NCT03287219|7668101|FG000|COMPLETED|Overall Study||24
6739317|NCT03287219|7668102|FG001|COMPLETED|Overall Study||88
6739318|NCT03287219|7668101|FG000|NOT COMPLETED|Overall Study||0
6739319|NCT03287219|7668102|FG001|NOT COMPLETED|Overall Study||2
6739320|NCT03287310|7668147|FG000|STARTED|Overall Study||12
6739321|NCT03287310|7668148|FG001|STARTED|Overall Study||6
6739322|NCT03287310|7668149|FG002|STARTED|Overall Study||6
6739323|NCT03287310|7668150|FG003|STARTED|Overall Study||9
6739324|NCT03287310|7668151|FG004|STARTED|Overall Study||9
6739325|NCT03287310|7668152|FG005|STARTED|Overall Study||6
6739326|NCT03287310|7668147|FG000|COMPLETED|Overall Study||12
6739327|NCT03287310|7668148|FG001|COMPLETED|Overall Study||6
6739328|NCT03287310|7668149|FG002|COMPLETED|Overall Study||6
6739329|NCT03287310|7668150|FG003|COMPLETED|Overall Study||9
6739330|NCT03287310|7668151|FG004|COMPLETED|Overall Study||9
6739331|NCT03287310|7668152|FG005|COMPLETED|Overall Study||6
6739332|NCT03287310|7668147|FG000|NOT COMPLETED|Overall Study||0
6739333|NCT03287310|7668148|FG001|NOT COMPLETED|Overall Study||0
6739334|NCT03287310|7668149|FG002|NOT COMPLETED|Overall Study||0
6739335|NCT03287310|7668150|FG003|NOT COMPLETED|Overall Study||0
6739336|NCT03287310|7668151|FG004|NOT COMPLETED|Overall Study||0
6739337|NCT03287310|7668152|FG005|NOT COMPLETED|Overall Study||0
6739338|NCT03287622|7668176|FG000|STARTED|Overall Study||356
6739339|NCT03287622|7668177|FG001|STARTED|Overall Study||356
6739340|NCT03287622|7668176|FG000|Sub-randomized to Nudge/NoNudge|Overall Study||253
6739341|NCT03287622|7668177|FG001|Sub-randomized to Nudge/NoNudge|Overall Study||266
6739342|NCT03287622|7668176|FG000|COMPLETED|Overall Study||298
6739343|NCT03287622|7668177|FG001|COMPLETED|Overall Study||308
6739344|NCT03287622|7668176|FG000|NOT COMPLETED|Overall Study||58
6739345|NCT03287622|7668177|FG001|NOT COMPLETED|Overall Study||48
6739346|NCT03287635|7668190|FG000|STARTED|Overall Study||19
6739347|NCT03287635|7668190|FG000|COMPLETED|Overall Study||12
6739348|NCT03287635|7668190|FG000|NOT COMPLETED|Overall Study||7
6739349|NCT03287674|7668194|FG000|STARTED|Overall Study||7
6739350|NCT03287674|7668194|FG000|All Treated With TILs|Overall Study||6
6739351|NCT03287674|7668194|FG000|COMPLETED|Overall Study||6
6739352|NCT03287674|7668194|FG000|NOT COMPLETED|Overall Study||1
6739353|NCT03287791|7668202|FG000|STARTED|Overall Study||312
6739354|NCT03287791|7668203|FG001|STARTED|Overall Study||312
6739355|NCT03287791|7668204|FG002|STARTED|Overall Study||300
6739356|NCT03287791|7668202|FG000|Safety Population|Overall Study||306
6739357|NCT03287791|7668203|FG001|Safety Population|Overall Study||297
6739358|NCT03287791|7668204|FG002|Safety Population|Overall Study||291
6739359|NCT03287791|7668202|FG000|mITT Population|Overall Study||291
6739360|NCT03287791|7668203|FG001|mITT Population|Overall Study||291
6739361|NCT03287791|7668204|FG002|mITT Population|Overall Study||283
6739362|NCT03287791|7668202|FG000|PP Population|Overall Study||262
6712459|NCT02959307|7642411|FG000|STARTED|Phase 1||18
6712460|NCT02959307|7642412|FG001|STARTED|Phase 1||31
6712461|NCT02959307|7642411|FG000|COMPLETED|Phase 1||15
6712462|NCT02959307|7642412|FG001|COMPLETED|Phase 1||23
6712463|NCT02959307|7642411|FG000|NOT COMPLETED|Phase 1||3
6712464|NCT02959307|7642412|FG001|NOT COMPLETED|Phase 1||8
6712465|NCT02959307|7642411|FG000|STARTED|Phase 2|This group is increased as those in sham were re-randomized to sham or NIR.|28
6712466|NCT02959307|7642412|FG001|STARTED|Phase 2|This group is decreased as those in sham were re-randomized to sham or NIR.|10
6712467|NCT02959307|7642411|FG000|COMPLETED|Phase 2||26
6712468|NCT02959307|7642412|FG001|COMPLETED|Phase 2||10
6712469|NCT02959307|7642411|FG000|NOT COMPLETED|Phase 2||2
6712470|NCT02959307|7642412|FG001|NOT COMPLETED|Phase 2||0
6712471|NCT02959437|7642422|FG000|STARTED|Overall Study||62
6712472|NCT02959437|7642423|FG001|STARTED|Overall Study||8
6712473|NCT02959437|7642424|FG002|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
6712474|NCT02959437|7642425|FG003|STARTED|Overall Study|Due to early termination of the trial Treatment groups B and C were not dosed.|0
6712475|NCT02959437|7642422|FG000|COMPLETED|Overall Study||0
6712476|NCT02959437|7642423|FG001|COMPLETED|Overall Study||0
6712477|NCT02959437|7642424|FG002|COMPLETED|Overall Study||0
6712478|NCT02959437|7642425|FG003|COMPLETED|Overall Study||0
6712479|NCT02959437|7642422|FG000|NOT COMPLETED|Overall Study||62
6712480|NCT02959437|7642423|FG001|NOT COMPLETED|Overall Study||8
6712481|NCT02959437|7642424|FG002|NOT COMPLETED|Overall Study||0
6712482|NCT02959437|7642425|FG003|NOT COMPLETED|Overall Study||0
6712483|NCT02959671|7642436|FG000|STARTED|Overall Study||34
6712484|NCT02959671|7642436|FG000|COMPLETED|Overall Study||29
6712485|NCT02959671|7642436|FG000|NOT COMPLETED|Overall Study||5
6712486|NCT02959814|7642440|FG000|STARTED|Overall Study|22-02-2017|329
6712487|NCT02959814|7642440|FG000|COMPLETED|Overall Study|17-10-2017|272
6712488|NCT02959814|7642440|FG000|NOT COMPLETED|Overall Study||57
6712489|NCT02959827|7642445|FG000|STARTED|Overall Study||2320
6712490|NCT02959827|7642445|FG000|COMPLETED|Overall Study||2320
6712491|NCT02959827|7642445|FG000|NOT COMPLETED|Overall Study||0
6712492|NCT02959840|7642456|FG000|STARTED|Overall Study||60
6712493|NCT02959840|7642457|FG001|STARTED|Overall Study||60
6712494|NCT02959840|7642458|FG002|STARTED|Overall Study||60
6712495|NCT02959840|7642456|FG000|COMPLETED|Overall Study||60
6712496|NCT02959840|7642457|FG001|COMPLETED|Overall Study||60
6712497|NCT02959840|7642458|FG002|COMPLETED|Overall Study||60
6712498|NCT02959840|7642456|FG000|NOT COMPLETED|Overall Study||0
6712499|NCT02959840|7642457|FG001|NOT COMPLETED|Overall Study||0
6712500|NCT02959840|7642458|FG002|NOT COMPLETED|Overall Study||0
6712501|NCT02959853|7642468|FG000|STARTED|Overall Study||11
6712502|NCT02959853|7642469|FG001|STARTED|Overall Study||12
6712503|NCT02959853|7642468|FG000|COMPLETED|Overall Study||7
6712504|NCT02959853|7642469|FG001|COMPLETED|Overall Study||10
6712505|NCT02959853|7642468|FG000|NOT COMPLETED|Overall Study||4
6712506|NCT02959853|7642469|FG001|NOT COMPLETED|Overall Study||2
6712507|NCT02959866|7642476|FG000|STARTED|Overall Study||59
6712508|NCT02959866|7642476|FG000|Telephone Interview at 1 Month Follow-up|Overall Study||59
6712509|NCT02959866|7642476|FG000|COMPLETED|Overall Study||58
6712510|NCT02959866|7642476|FG000|NOT COMPLETED|Overall Study||1
6712511|NCT02959892|7642483|FG000|STARTED|Overall Study||6
6712512|NCT02959892|7642484|FG001|STARTED|Overall Study||6
6712513|NCT02959892|7642483|FG000|COMPLETED|Overall Study||5
6712514|NCT02959892|7642484|FG001|COMPLETED|Overall Study||5
6712515|NCT02959892|7642483|FG000|NOT COMPLETED|Overall Study||1
6712516|NCT02959892|7642484|FG001|NOT COMPLETED|Overall Study||1
6712517|NCT02959970|7642492|FG000|STARTED|Overall Study||17
6712518|NCT02959970|7642493|FG001|STARTED|Overall Study||83
6712519|NCT02959970|7642492|FG000|COMPLETED|Overall Study||15
6712520|NCT02959970|7642493|FG001|COMPLETED|Overall Study||76
6712521|NCT02959970|7642492|FG000|NOT COMPLETED|Overall Study||2
6712522|NCT02959970|7642493|FG001|NOT COMPLETED|Overall Study||7
6712523|NCT02959983|7642503|FG000|STARTED|Overall Study||172
6712524|NCT02959983|7642504|FG001|STARTED|Overall Study||174
6712525|NCT02959983|7642503|FG000|COMPLETED|Overall Study||146
6712526|NCT02959983|7642504|FG001|COMPLETED|Overall Study||149
6712527|NCT02959983|7642503|FG000|NOT COMPLETED|Overall Study||26
6712528|NCT02959983|7642504|FG001|NOT COMPLETED|Overall Study||25
6712529|NCT02959996|7642512|FG000|STARTED|Overall Study||40
6712530|NCT02959996|7642513|FG001|STARTED|Overall Study||39
6712531|NCT02959996|7642512|FG000|COMPLETED|Overall Study||40
6712532|NCT02959996|7642513|FG001|COMPLETED|Overall Study||39
6712533|NCT02959996|7642512|FG000|NOT COMPLETED|Overall Study||0
6712534|NCT02959996|7642513|FG001|NOT COMPLETED|Overall Study||0
6712535|NCT02960217|7642521|FG000|STARTED|Maintenance Phase: Treatment Period 1||22
6712536|NCT02960217|7642522|FG001|STARTED|Maintenance Phase: Treatment Period 1||21
6712537|NCT02960217|7642521|FG000|COMPLETED|Maintenance Phase: Treatment Period 1||21
6712538|NCT02960217|7642522|FG001|COMPLETED|Maintenance Phase: Treatment Period 1||21
6712539|NCT02960217|7642521|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 1||1
6712540|NCT02960217|7642522|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 1||0
6712541|NCT02960217|7642521|FG000|STARTED|Maintenance Phase: Crossover Washout||21
6712542|NCT02960217|7642522|FG001|STARTED|Maintenance Phase: Crossover Washout||21
6712543|NCT02960217|7642521|FG000|COMPLETED|Maintenance Phase: Crossover Washout||21
6712544|NCT02960217|7642522|FG001|COMPLETED|Maintenance Phase: Crossover Washout||21
6712545|NCT02960217|7642521|FG000|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
6712546|NCT02960217|7642522|FG001|NOT COMPLETED|Maintenance Phase: Crossover Washout||0
6712547|NCT02960217|7642521|FG000|STARTED|Maintenance Phase: Treatment Period 2||21
6712548|NCT02960217|7642522|FG001|STARTED|Maintenance Phase: Treatment Period 2||21
6712549|NCT02960217|7642521|FG000|COMPLETED|Maintenance Phase: Treatment Period 2||20
6712550|NCT02960217|7642522|FG001|COMPLETED|Maintenance Phase: Treatment Period 2||18
6712551|NCT02960217|7642521|FG000|NOT COMPLETED|Maintenance Phase: Treatment Period 2||1
6712552|NCT02960217|7642522|FG001|NOT COMPLETED|Maintenance Phase: Treatment Period 2||3
6712553|NCT02960217|7642521|FG000|STARTED|Open-Label Extension Phase||20
6712554|NCT02960217|7642522|FG001|STARTED|Open-Label Extension Phase|5 participants completed the double blind period but did not continue in the open label period.|13
6712555|NCT02960217|7642521|FG000|COMPLETED|Open-Label Extension Phase||0
6712556|NCT02960217|7642522|FG001|COMPLETED|Open-Label Extension Phase||0
6712557|NCT02960217|7642521|FG000|NOT COMPLETED|Open-Label Extension Phase||20
6712558|NCT02960217|7642522|FG001|NOT COMPLETED|Open-Label Extension Phase||13
6712559|NCT02960295|7642532|FG000|STARTED|Overall Study||10
6712560|NCT02960295|7642532|FG000|COMPLETED|Overall Study||10
6712561|NCT02960295|7642532|FG000|NOT COMPLETED|Overall Study||0
6712562|NCT02960438|7642541|FG000|STARTED|Treatment Phase (Double-blind): 24 Weeks||56
6712563|NCT02960438|7642542|FG001|STARTED|Treatment Phase (Double-blind): 24 Weeks||29
6712564|NCT02960438|7642543|FG002|STARTED|Treatment Phase (Double-blind): 24 Weeks||54
6712565|NCT02960438|7642544|FG003|STARTED|Treatment Phase (Double-blind): 24 Weeks||55
6712566|NCT02960438|7642541|FG000|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
6712567|NCT02960438|7642542|FG001|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||28
6712568|NCT02960438|7642543|FG002|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
6712569|NCT02960438|7642544|FG003|Treated Participants|Treatment Phase (Double-blind): 24 Weeks||54
6712570|NCT02960438|7642541|FG000|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||47
6712571|NCT02960438|7642542|FG001|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||26
6712572|NCT02960438|7642543|FG002|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||50
6712573|NCT02960438|7642544|FG003|COMPLETED|Treatment Phase (Double-blind): 24 Weeks||46
6712574|NCT02960438|7642541|FG000|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
6712575|NCT02960438|7642542|FG001|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||3
6712576|NCT02960438|7642543|FG002|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||4
6712577|NCT02960438|7642544|FG003|NOT COMPLETED|Treatment Phase (Double-blind): 24 Weeks||9
6712578|NCT02960438|7642541|FG000|STARTED|Extension Phase (Open-label): 80 Weeks||47
6712579|NCT02960438|7642542|FG001|STARTED|Extension Phase (Open-label): 80 Weeks||26
6712580|NCT02960438|7642543|FG002|STARTED|Extension Phase (Open-label): 80 Weeks||50
6712581|NCT02960438|7642544|FG003|STARTED|Extension Phase (Open-label): 80 Weeks||46
6712582|NCT02960438|7642541|FG000|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
6712583|NCT02960438|7642542|FG001|COMPLETED|Extension Phase (Open-label): 80 Weeks||17
6712584|NCT02960438|7642543|FG002|COMPLETED|Extension Phase (Open-label): 80 Weeks||36
6712585|NCT02960438|7642544|FG003|COMPLETED|Extension Phase (Open-label): 80 Weeks||35
6712586|NCT02960438|7642541|FG000|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
6712587|NCT02960438|7642542|FG001|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||9
6712588|NCT02960438|7642543|FG002|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||14
6712589|NCT02960438|7642544|FG003|NOT COMPLETED|Extension Phase (Open-label): 80 Weeks||11
6712590|NCT02960490|7642564|FG000|STARTED|Treatment Phase(Double-blind): 12 Weeks||34
6712591|NCT02960490|7642565|FG001|STARTED|Treatment Phase(Double-blind): 12 Weeks||32
6712592|NCT02960490|7642566|FG002|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
6712593|NCT02960490|7642567|FG003|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
6712594|NCT02960490|7642568|FG004|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
6712595|NCT02960490|7642569|FG005|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
6712596|NCT02960490|7642570|FG006|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
6712597|NCT02960490|7642571|FG007|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
6712598|NCT02960490|7642572|FG008|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
6712599|NCT02960490|7642573|FG009|STARTED|Treatment Phase(Double-blind): 12 Weeks||0
6712600|NCT02960490|7642564|FG000|Treated|Treatment Phase(Double-blind): 12 Weeks||33
6712601|NCT02960490|7642565|FG001|Treated|Treatment Phase(Double-blind): 12 Weeks||31
6712602|NCT02960490|7642566|FG002|Treated|Treatment Phase(Double-blind): 12 Weeks||0
6712603|NCT02960490|7642567|FG003|Treated|Treatment Phase(Double-blind): 12 Weeks||0
6712604|NCT02960490|7642568|FG004|Treated|Treatment Phase(Double-blind): 12 Weeks||0
6712605|NCT02960490|7642569|FG005|Treated|Treatment Phase(Double-blind): 12 Weeks||0
6712606|NCT02960490|7642570|FG006|Treated|Treatment Phase(Double-blind): 12 Weeks||0
6712607|NCT02960490|7642571|FG007|Treated|Treatment Phase(Double-blind): 12 Weeks||0
6712608|NCT02960490|7642572|FG008|Treated|Treatment Phase(Double-blind): 12 Weeks||0
6712609|NCT02960490|7642573|FG009|Treated|Treatment Phase(Double-blind): 12 Weeks||0
6712610|NCT02960490|7642564|FG000|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||33
6712611|NCT02960490|7642565|FG001|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||31
6712612|NCT02960490|7642566|FG002|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712613|NCT02960490|7642567|FG003|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712614|NCT02960490|7642568|FG004|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712615|NCT02960490|7642569|FG005|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712616|NCT02960490|7642570|FG006|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
6739363|NCT03287791|7668203|FG001|PP Population|Overall Study||259
6712617|NCT02960490|7642571|FG007|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712618|NCT02960490|7642572|FG008|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712619|NCT02960490|7642573|FG009|Full Analysis Set (FAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712620|NCT02960490|7642564|FG000|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||33
6712621|NCT02960490|7642565|FG001|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||31
6712622|NCT02960490|7642566|FG002|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712623|NCT02960490|7642567|FG003|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712624|NCT02960490|7642568|FG004|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712625|NCT02960490|7642569|FG005|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712626|NCT02960490|7642570|FG006|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712627|NCT02960490|7642571|FG007|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712628|NCT02960490|7642572|FG008|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712629|NCT02960490|7642573|FG009|Safety Analysis Set (SAS)|Treatment Phase(Double-blind): 12 Weeks||0
6712630|NCT02960490|7642564|FG000|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||29
6712631|NCT02960490|7642565|FG001|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||26
6712632|NCT02960490|7642566|FG002|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712633|NCT02960490|7642567|FG003|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712634|NCT02960490|7642568|FG004|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712635|NCT02960490|7642569|FG005|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712636|NCT02960490|7642570|FG006|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712637|NCT02960490|7642571|FG007|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712638|NCT02960490|7642572|FG008|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712639|NCT02960490|7642573|FG009|COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712640|NCT02960490|7642564|FG000|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||5
6712641|NCT02960490|7642565|FG001|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||6
6712642|NCT02960490|7642566|FG002|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712643|NCT02960490|7642567|FG003|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712644|NCT02960490|7642568|FG004|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712645|NCT02960490|7642569|FG005|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712646|NCT02960490|7642570|FG006|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712647|NCT02960490|7642571|FG007|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712648|NCT02960490|7642572|FG008|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712649|NCT02960490|7642573|FG009|NOT COMPLETED|Treatment Phase(Double-blind): 12 Weeks||0
6712650|NCT02960490|7642564|FG000|STARTED|Re-randomized Participants: 12 Weeks||0
6712651|NCT02960490|7642565|FG001|STARTED|Re-randomized Participants: 12 Weeks||0
6712652|NCT02960490|7642566|FG002|STARTED|Re-randomized Participants: 12 Weeks||15
6712653|NCT02960490|7642567|FG003|STARTED|Re-randomized Participants: 12 Weeks||14
6712654|NCT02960490|7642568|FG004|STARTED|Re-randomized Participants: 12 Weeks||14
6712655|NCT02960490|7642569|FG005|STARTED|Re-randomized Participants: 12 Weeks||12
6712656|NCT02960490|7642570|FG006|STARTED|Re-randomized Participants: 12 Weeks||0
6712657|NCT02960490|7642571|FG007|STARTED|Re-randomized Participants: 12 Weeks||0
6712658|NCT02960490|7642572|FG008|STARTED|Re-randomized Participants: 12 Weeks||0
6712659|NCT02960490|7642573|FG009|STARTED|Re-randomized Participants: 12 Weeks||0
6712660|NCT02960490|7642564|FG000|Treated|Re-randomized Participants: 12 Weeks||0
6712661|NCT02960490|7642565|FG001|Treated|Re-randomized Participants: 12 Weeks||0
6712662|NCT02960490|7642566|FG002|Treated|Re-randomized Participants: 12 Weeks||15
6712663|NCT02960490|7642567|FG003|Treated|Re-randomized Participants: 12 Weeks||14
6712664|NCT02960490|7642568|FG004|Treated|Re-randomized Participants: 12 Weeks||14
6712665|NCT02960490|7642569|FG005|Treated|Re-randomized Participants: 12 Weeks||12
6712666|NCT02960490|7642570|FG006|Treated|Re-randomized Participants: 12 Weeks||0
6712667|NCT02960490|7642571|FG007|Treated|Re-randomized Participants: 12 Weeks||0
6712668|NCT02960490|7642572|FG008|Treated|Re-randomized Participants: 12 Weeks||0
6712669|NCT02960490|7642573|FG009|Treated|Re-randomized Participants: 12 Weeks||0
6712670|NCT02960490|7642564|FG000|FAS|Re-randomized Participants: 12 Weeks||0
6712671|NCT02960490|7642565|FG001|FAS|Re-randomized Participants: 12 Weeks||0
6712672|NCT02960490|7642566|FG002|FAS|Re-randomized Participants: 12 Weeks||15
6712673|NCT02960490|7642567|FG003|FAS|Re-randomized Participants: 12 Weeks||14
6712674|NCT02960490|7642568|FG004|FAS|Re-randomized Participants: 12 Weeks||14
6712675|NCT02960490|7642569|FG005|FAS|Re-randomized Participants: 12 Weeks||12
6712676|NCT02960490|7642570|FG006|FAS|Re-randomized Participants: 12 Weeks||0
6712677|NCT02960490|7642571|FG007|FAS|Re-randomized Participants: 12 Weeks||0
6712678|NCT02960490|7642572|FG008|FAS|Re-randomized Participants: 12 Weeks||0
6712679|NCT02960490|7642573|FG009|FAS|Re-randomized Participants: 12 Weeks||0
6712680|NCT02960490|7642564|FG000|SAS|Re-randomized Participants: 12 Weeks||0
6712681|NCT02960490|7642565|FG001|SAS|Re-randomized Participants: 12 Weeks||0
6712682|NCT02960490|7642566|FG002|SAS|Re-randomized Participants: 12 Weeks||15
6712683|NCT02960490|7642567|FG003|SAS|Re-randomized Participants: 12 Weeks||14
6712684|NCT02960490|7642568|FG004|SAS|Re-randomized Participants: 12 Weeks||14
6712685|NCT02960490|7642569|FG005|SAS|Re-randomized Participants: 12 Weeks||12
6712686|NCT02960490|7642570|FG006|SAS|Re-randomized Participants: 12 Weeks||0
6712687|NCT02960490|7642571|FG007|SAS|Re-randomized Participants: 12 Weeks||0
6712688|NCT02960490|7642572|FG008|SAS|Re-randomized Participants: 12 Weeks||0
6712689|NCT02960490|7642573|FG009|SAS|Re-randomized Participants: 12 Weeks||0
6712690|NCT02960490|7642564|FG000|COMPLETED|Re-randomized Participants: 12 Weeks||0
6712691|NCT02960490|7642565|FG001|COMPLETED|Re-randomized Participants: 12 Weeks||0
6712692|NCT02960490|7642566|FG002|COMPLETED|Re-randomized Participants: 12 Weeks||13
6712693|NCT02960490|7642567|FG003|COMPLETED|Re-randomized Participants: 12 Weeks||12
6712694|NCT02960490|7642568|FG004|COMPLETED|Re-randomized Participants: 12 Weeks||13
6712695|NCT02960490|7642569|FG005|COMPLETED|Re-randomized Participants: 12 Weeks||10
6712696|NCT02960490|7642570|FG006|COMPLETED|Re-randomized Participants: 12 Weeks||0
6712697|NCT02960490|7642571|FG007|COMPLETED|Re-randomized Participants: 12 Weeks||0
6712698|NCT02960490|7642572|FG008|COMPLETED|Re-randomized Participants: 12 Weeks||0
6712699|NCT02960490|7642573|FG009|COMPLETED|Re-randomized Participants: 12 Weeks||0
6712700|NCT02960490|7642564|FG000|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
6712701|NCT02960490|7642565|FG001|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
6712702|NCT02960490|7642566|FG002|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
6712703|NCT02960490|7642567|FG003|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
6712704|NCT02960490|7642568|FG004|NOT COMPLETED|Re-randomized Participants: 12 Weeks||1
6712705|NCT02960490|7642569|FG005|NOT COMPLETED|Re-randomized Participants: 12 Weeks||2
6712706|NCT02960490|7642570|FG006|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
6712707|NCT02960490|7642571|FG007|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
6712708|NCT02960490|7642572|FG008|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
6712709|NCT02960490|7642573|FG009|NOT COMPLETED|Re-randomized Participants: 12 Weeks||0
6712710|NCT02960490|7642564|FG000|STARTED|Extension Phase(Open-label): 80 Weeks||0
6712711|NCT02960490|7642565|FG001|STARTED|Extension Phase(Open-label): 80 Weeks||0
6712712|NCT02960490|7642566|FG002|STARTED|Extension Phase(Open-label): 80 Weeks||0
6712713|NCT02960490|7642567|FG003|STARTED|Extension Phase(Open-label): 80 Weeks||0
6712714|NCT02960490|7642568|FG004|STARTED|Extension Phase(Open-label): 80 Weeks||0
6712715|NCT02960490|7642569|FG005|STARTED|Extension Phase(Open-label): 80 Weeks||0
6712716|NCT02960490|7642570|FG006|STARTED|Extension Phase(Open-label): 80 Weeks||13
6712717|NCT02960490|7642571|FG007|STARTED|Extension Phase(Open-label): 80 Weeks|One Participant who completed Core Treatment Phase (Placebo Then E6011 400 mg arm) had inadequate therapeutic effect at Week 24, hence did not started Extension phase.|11
6712718|NCT02960490|7642572|FG008|STARTED|Extension Phase(Open-label): 80 Weeks||13
6712719|NCT02960490|7642573|FG009|STARTED|Extension Phase(Open-label): 80 Weeks||10
6712720|NCT02960490|7642564|FG000|Treated|Extension Phase(Open-label): 80 Weeks||0
6712721|NCT02960490|7642565|FG001|Treated|Extension Phase(Open-label): 80 Weeks||0
6712722|NCT02960490|7642566|FG002|Treated|Extension Phase(Open-label): 80 Weeks||0
6712723|NCT02960490|7642567|FG003|Treated|Extension Phase(Open-label): 80 Weeks||0
6712724|NCT02960490|7642568|FG004|Treated|Extension Phase(Open-label): 80 Weeks||0
6712725|NCT02960490|7642569|FG005|Treated|Extension Phase(Open-label): 80 Weeks||0
6712726|NCT02960490|7642570|FG006|Treated|Extension Phase(Open-label): 80 Weeks||13
6712727|NCT02960490|7642571|FG007|Treated|Extension Phase(Open-label): 80 Weeks||11
6712728|NCT02960490|7642572|FG008|Treated|Extension Phase(Open-label): 80 Weeks||13
6712729|NCT02960490|7642573|FG009|Treated|Extension Phase(Open-label): 80 Weeks||10
6712730|NCT02960490|7642564|FG000|FAS|Extension Phase(Open-label): 80 Weeks||0
6712731|NCT02960490|7642565|FG001|FAS|Extension Phase(Open-label): 80 Weeks||0
6712732|NCT02960490|7642566|FG002|FAS|Extension Phase(Open-label): 80 Weeks||0
6712733|NCT02960490|7642567|FG003|FAS|Extension Phase(Open-label): 80 Weeks||0
6712734|NCT02960490|7642568|FG004|FAS|Extension Phase(Open-label): 80 Weeks||0
6712735|NCT02960490|7642569|FG005|FAS|Extension Phase(Open-label): 80 Weeks||0
6712736|NCT02960490|7642570|FG006|FAS|Extension Phase(Open-label): 80 Weeks||13
6712737|NCT02960490|7642571|FG007|FAS|Extension Phase(Open-label): 80 Weeks||11
6712738|NCT02960490|7642572|FG008|FAS|Extension Phase(Open-label): 80 Weeks||13
6712739|NCT02960490|7642573|FG009|FAS|Extension Phase(Open-label): 80 Weeks||10
6712740|NCT02960490|7642564|FG000|SAS|Extension Phase(Open-label): 80 Weeks||0
6712741|NCT02960490|7642565|FG001|SAS|Extension Phase(Open-label): 80 Weeks||0
6712742|NCT02960490|7642566|FG002|SAS|Extension Phase(Open-label): 80 Weeks||0
6712743|NCT02960490|7642567|FG003|SAS|Extension Phase(Open-label): 80 Weeks||0
6712744|NCT02960490|7642568|FG004|SAS|Extension Phase(Open-label): 80 Weeks||0
6712745|NCT02960490|7642569|FG005|SAS|Extension Phase(Open-label): 80 Weeks||0
6712746|NCT02960490|7642570|FG006|SAS|Extension Phase(Open-label): 80 Weeks||13
6712747|NCT02960490|7642571|FG007|SAS|Extension Phase(Open-label): 80 Weeks||11
6712748|NCT02960490|7642572|FG008|SAS|Extension Phase(Open-label): 80 Weeks||13
6712749|NCT02960490|7642573|FG009|SAS|Extension Phase(Open-label): 80 Weeks||10
6712750|NCT02960490|7642564|FG000|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712751|NCT02960490|7642565|FG001|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712752|NCT02960490|7642566|FG002|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712753|NCT02960490|7642567|FG003|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712754|NCT02960490|7642568|FG004|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712755|NCT02960490|7642569|FG005|COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712756|NCT02960490|7642570|FG006|COMPLETED|Extension Phase(Open-label): 80 Weeks||4
6712757|NCT02960490|7642571|FG007|COMPLETED|Extension Phase(Open-label): 80 Weeks||5
6712758|NCT02960490|7642572|FG008|COMPLETED|Extension Phase(Open-label): 80 Weeks||9
6712759|NCT02960490|7642573|FG009|COMPLETED|Extension Phase(Open-label): 80 Weeks||3
6712760|NCT02960490|7642564|FG000|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712761|NCT02960490|7642565|FG001|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712762|NCT02960490|7642566|FG002|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712763|NCT02960490|7642567|FG003|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712764|NCT02960490|7642568|FG004|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712765|NCT02960490|7642569|FG005|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||0
6712766|NCT02960490|7642570|FG006|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||9
6712767|NCT02960490|7642571|FG007|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||6
6712768|NCT02960490|7642572|FG008|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||4
6712769|NCT02960490|7642573|FG009|NOT COMPLETED|Extension Phase(Open-label): 80 Weeks||7
6712770|NCT02960854|7642597|FG000|STARTED|Overall Study||15
6712771|NCT02960854|7642598|FG001|STARTED|Overall Study||16
6712772|NCT02960854|7642597|FG000|COMPLETED|Overall Study||8
6712773|NCT02960854|7642598|FG001|COMPLETED|Overall Study||7
6712774|NCT02960854|7642597|FG000|NOT COMPLETED|Overall Study||7
6712775|NCT02960854|7642598|FG001|NOT COMPLETED|Overall Study||9
6712788|NCT02961062|7642622|FG000|STARTED|Overall Study||20
6712789|NCT02961062|7642623|FG001|STARTED|Overall Study||20
6712790|NCT02961062|7642622|FG000|COMPLETED|Overall Study||20
6712791|NCT02961062|7642623|FG001|COMPLETED|Overall Study||20
6712792|NCT02961062|7642622|FG000|NOT COMPLETED|Overall Study||0
6712793|NCT02961062|7642623|FG001|NOT COMPLETED|Overall Study||0
6712794|NCT02961218|7642631|FG000|STARTED|Overall Study||25
6712795|NCT02961218|7642632|FG001|STARTED|Overall Study||24
6712796|NCT02961218|7642631|FG000|Safety Analysis Set|Overall Study||25
6712797|NCT02961218|7642632|FG001|Safety Analysis Set|Overall Study||24
6712798|NCT02961218|7642631|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study||25
6712799|NCT02961218|7642632|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
6712800|NCT02961218|7642631|FG000|Primary PD Analysis Set|Overall Study||25
6712801|NCT02961218|7642632|FG001|Primary PD Analysis Set|Overall Study||24
6712802|NCT02961218|7642631|FG000|COMPLETED|Overall Study||22
6712803|NCT02961218|7642632|FG001|COMPLETED|Overall Study||19
6712804|NCT02961218|7642631|FG000|NOT COMPLETED|Overall Study||3
6712805|NCT02961218|7642632|FG001|NOT COMPLETED|Overall Study||5
6712806|NCT02961244|7642642|FG000|STARTED|Overall Study||64
6712807|NCT02961244|7642643|FG001|STARTED|Overall Study||64
6712808|NCT02961244|7642642|FG000|Patients Excluded During Randomization|Overall Study||0
6712809|NCT02961244|7642643|FG001|Patients Excluded During Randomization|Overall Study||1
6712810|NCT02961244|7642642|FG000|COMPLETED|Overall Study||63
6712811|NCT02961244|7642643|FG001|COMPLETED|Overall Study||55
6712812|NCT02961244|7642642|FG000|NOT COMPLETED|Overall Study||1
6712813|NCT02961244|7642643|FG001|NOT COMPLETED|Overall Study||9
6712814|NCT02961374|7642649|FG000|STARTED|Overall Study||46
6712815|NCT02961374|7642649|FG000|COMPLETED|Overall Study||42
6712816|NCT02961374|7642649|FG000|NOT COMPLETED|Overall Study||4
6712817|NCT02961751|7642653|FG000|STARTED|Overall Study||211
6712818|NCT02961751|7642653|FG000|COMPLETED|Overall Study||196
6712819|NCT02961751|7642653|FG000|NOT COMPLETED|Overall Study||15
6712820|NCT02961764|7642659|FG000|STARTED|Overall Study||160
6712821|NCT02961764|7642660|FG001|STARTED|Overall Study||153
6712822|NCT02961764|7642659|FG000|COMPLETED|Overall Study||121
6712823|NCT02961764|7642660|FG001|COMPLETED|Overall Study||128
6712824|NCT02961764|7642659|FG000|NOT COMPLETED|Overall Study||39
6712825|NCT02961764|7642660|FG001|NOT COMPLETED|Overall Study||25
6712826|NCT02961790|7642670|FG000|STARTED|Overall Study||50
6712827|NCT02961790|7642671|FG001|STARTED|Overall Study||51
6712828|NCT02961790|7642672|FG002|STARTED|Overall Study||24
6712829|NCT02961790|7642673|FG003|STARTED|Overall Study||25
6712830|NCT02961790|7642670|FG000|COMPLETED|Overall Study||35
6712831|NCT02961790|7642671|FG001|COMPLETED|Overall Study||40
6712832|NCT02961790|7642672|FG002|COMPLETED|Overall Study||18
6712833|NCT02961790|7642673|FG003|COMPLETED|Overall Study||20
6712834|NCT02961790|7642670|FG000|NOT COMPLETED|Overall Study||15
6712835|NCT02961790|7642671|FG001|NOT COMPLETED|Overall Study||11
6712836|NCT02961790|7642672|FG002|NOT COMPLETED|Overall Study||6
6712837|NCT02961790|7642673|FG003|NOT COMPLETED|Overall Study||5
6712838|NCT02961894|7642684|FG000|STARTED|Overall Study||121
6712839|NCT02961894|7642684|FG000|COMPLETED|Overall Study||121
6712840|NCT02961894|7642684|FG000|NOT COMPLETED|Overall Study||0
6712841|NCT02961920|7642690|FG000|STARTED|Overall Study||25
6712842|NCT02961920|7642691|FG001|STARTED|Overall Study||25
6712843|NCT02961920|7642690|FG000|COMPLETED|Overall Study||24
6712844|NCT02961920|7642691|FG001|COMPLETED|Overall Study||24
6712845|NCT02961920|7642690|FG000|NOT COMPLETED|Overall Study||1
6712846|NCT02961920|7642691|FG001|NOT COMPLETED|Overall Study||1
6712847|NCT02961946|7642700|FG000|STARTED|Overall Study||66
6712848|NCT02961946|7642701|FG001|STARTED|Overall Study||66
6712849|NCT02961946|7642702|FG002|STARTED|Overall Study||66
6712850|NCT02961946|7642700|FG000|COMPLETED|Overall Study||66
6712851|NCT02961946|7642701|FG001|COMPLETED|Overall Study||66
6712852|NCT02961946|7642702|FG002|COMPLETED|Overall Study||66
6712853|NCT02961946|7642700|FG000|NOT COMPLETED|Overall Study||0
6712854|NCT02961946|7642701|FG001|NOT COMPLETED|Overall Study||0
6712855|NCT02961946|7642702|FG002|NOT COMPLETED|Overall Study||0
6712856|NCT02962284|7642712|FG000|STARTED|Overall Study||9
6712857|NCT02962284|7642713|FG001|STARTED|Overall Study||11
6712858|NCT02962284|7642712|FG000|COMPLETED|Overall Study||4
6712859|NCT02962284|7642713|FG001|COMPLETED|Overall Study||8
6712860|NCT02962284|7642712|FG000|NOT COMPLETED|Overall Study||5
6712861|NCT02962284|7642713|FG001|NOT COMPLETED|Overall Study||3
6712862|NCT02962427|7642723|FG000|STARTED|Overall Study||3
6712863|NCT02962427|7642724|FG001|STARTED|Overall Study||1
6712864|NCT02962427|7642723|FG000|COMPLETED|Overall Study||3
6712865|NCT02962427|7642724|FG001|COMPLETED|Overall Study||1
6712866|NCT02962427|7642723|FG000|NOT COMPLETED|Overall Study||0
6712867|NCT02962427|7642724|FG001|NOT COMPLETED|Overall Study||0
6712868|NCT02962609|7642734|FG000|STARTED|Overall Study||38
6712869|NCT02962609|7642735|FG001|STARTED|Overall Study||42
6712870|NCT02962609|7642734|FG000|COMPLETED|Overall Study||38
6712871|NCT02962609|7642735|FG001|COMPLETED|Overall Study||42
6712872|NCT02962609|7642734|FG000|NOT COMPLETED|Overall Study||0
6712873|NCT02962609|7642735|FG001|NOT COMPLETED|Overall Study||0
6712874|NCT02962648|7642741|FG000|STARTED|Overall Study||103
6712875|NCT02962648|7642741|FG000|COMPLETED|Overall Study||94
6712876|NCT02962648|7642741|FG000|NOT COMPLETED|Overall Study||9
6712877|NCT02962674|7642745|FG000|STARTED|Overall Study|"Although a total of 49 subjects were consented to participate in the study, three (3) of those subjects are not included in the study analysis as they did not actually receive treatment. These 3 subjects could not be treated because of their anatomy and therefore are considered treatment attempts. The final enrollment number (treated subjects only)is 46 subjects."|49
6712878|NCT02962674|7642745|FG000|3 Month Endpoint|Overall Study|All treated subjects that completed the 3-month endpoint visit per protocol.|46
6712879|NCT02962674|7642745|FG000|12 Month Durability|Overall Study|All subjects that completed the 12-month follow-up visit per protocol.|46
6712880|NCT02962674|7642745|FG000|24 Month Durability|Overall Study|All subjects that completed the 24-month follow-up visit. Note that at the time of study termination, all subjects would have reached this milestone.|32
6712881|NCT02962674|7642745|FG000|36 Month Durability|Overall Study|All subjects that completed the 36-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|18
6712882|NCT02962674|7642745|FG000|48 Month Durability|Overall Study|All subjects that completed the 48-month follow-up visit. Note that at the time of study termination, not all subjects would have reached this milestone depending on time of enrollment.|4
6712883|NCT02962674|7642745|FG000|COMPLETED|Overall Study|Study was terminated by sponsor prior to reaching 60 Month study completion mainly due to COVID-19 effects on subject follow-up.|0
6712884|NCT02962674|7642745|FG000|NOT COMPLETED|Overall Study||49
6712885|NCT02962687|7642753|FG000|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
6712886|NCT02962687|7642754|FG001|STARTED|Overall Study|This number represents 20 dyads (1 Veteran and 1 caregiver in each dyad)|40
6712887|NCT02962687|7642753|FG000|COMPLETED|Overall Study|This number represents 15 dyads (1 Veteran and 1 caregiver in each dyad)|30
6712888|NCT02962687|7642754|FG001|COMPLETED|Overall Study|This number represents 16 dyads (1 Veteran and 1 caregiver in each dyad)|32
6712889|NCT02962687|7642753|FG000|NOT COMPLETED|Overall Study||10
6712890|NCT02962687|7642754|FG001|NOT COMPLETED|Overall Study||8
6712891|NCT02962739|7642762|FG000|STARTED|Overall Study||6
6712892|NCT02962739|7642763|FG001|STARTED|Overall Study||7
6712893|NCT02962739|7642764|FG002|STARTED|Overall Study||7
6712894|NCT02962739|7642765|FG003|STARTED|Overall Study||6
6712895|NCT02962739|7642766|FG004|STARTED|Overall Study||6
6712896|NCT02962739|7642767|FG005|STARTED|Overall Study||6
6712897|NCT02962739|7642762|FG000|COMPLETED|Overall Study||6
6712898|NCT02962739|7642763|FG001|COMPLETED|Overall Study||6
6712899|NCT02962739|7642764|FG002|COMPLETED|Overall Study||6
6712900|NCT02962739|7642765|FG003|COMPLETED|Overall Study||6
6712901|NCT02962739|7642766|FG004|COMPLETED|Overall Study||5
6712902|NCT02962739|7642767|FG005|COMPLETED|Overall Study||6
6712903|NCT02962739|7642762|FG000|NOT COMPLETED|Overall Study||0
6712904|NCT02962739|7642763|FG001|NOT COMPLETED|Overall Study||1
6712905|NCT02962739|7642764|FG002|NOT COMPLETED|Overall Study||1
6712906|NCT02962739|7642765|FG003|NOT COMPLETED|Overall Study||0
6712907|NCT02962739|7642766|FG004|NOT COMPLETED|Overall Study||1
6712908|NCT02962739|7642767|FG005|NOT COMPLETED|Overall Study||0
6712909|NCT02962765|7642773|FG000|STARTED|Overall Study||78
6712910|NCT02962765|7642773|FG000|FAS Population|Overall Study||78
6712911|NCT02962765|7642773|FG000|SAF Population|Overall Study||78
6712912|NCT02962765|7642773|FG000|Prophylactic Treatment Group|Overall Study||77
6712913|NCT02962765|7642773|FG000|On Demand Treatment Group|Overall Study||2
6712914|NCT02962765|7642773|FG000|SURG Population|Overall Study||4
6712915|NCT02962765|7642773|FG000|COMPLETED|Overall Study||61
6712916|NCT02962765|7642773|FG000|NOT COMPLETED|Overall Study||17
6712917|NCT02962882|7642784|FG000|STARTED|Overall Study||50
6712918|NCT02962882|7642784|FG000|COMPLETED|Overall Study||14
6712919|NCT02962882|7642784|FG000|NOT COMPLETED|Overall Study||36
6712920|NCT02962908|7642793|FG000|STARTED|Overall Study||58
6712921|NCT02962908|7642794|FG001|STARTED|Overall Study||58
6262474|NCT02320396|7161420|FG000|COMPLETED|Overall Study||220
6262475|NCT02320396|7161421|FG001|COMPLETED|Overall Study||221
6262476|NCT02320396|7161420|FG000|NOT COMPLETED|Overall Study||4
6262477|NCT02320396|7161421|FG001|NOT COMPLETED|Overall Study||4
6262478|NCT02282345|7161429|FG000|STARTED|Overall Study||13
6262479|NCT02282345|7161430|FG001|STARTED|Overall Study||20
6262480|NCT02282345|7161429|FG000|COMPLETED|Overall Study||13
6262481|NCT02282345|7161430|FG001|COMPLETED|Overall Study||19
6262482|NCT02282345|7161429|FG000|NOT COMPLETED|Overall Study||0
6262483|NCT02282345|7161430|FG001|NOT COMPLETED|Overall Study||1
6262484|NCT02230410|7161439|FG000|STARTED|Overall Study||18
6712922|NCT02962908|7642795|FG002|STARTED|Overall Study||32
6712923|NCT02962908|7642796|FG003|STARTED|Overall Study||27
6712924|NCT02962908|7642793|FG000|COMPLETED|Overall Study||58
6712925|NCT02962908|7642794|FG001|COMPLETED|Overall Study||50
6712926|NCT02962908|7642795|FG002|COMPLETED|Overall Study||32
6712927|NCT02962908|7642796|FG003|COMPLETED|Overall Study||24
6712928|NCT02962908|7642793|FG000|NOT COMPLETED|Overall Study||0
6712929|NCT02962908|7642794|FG001|NOT COMPLETED|Overall Study||8
6712930|NCT02962908|7642795|FG002|NOT COMPLETED|Overall Study||0
6712931|NCT02962908|7642796|FG003|NOT COMPLETED|Overall Study||3
6712932|NCT02962934|7642814|FG000|STARTED|Overall Study||12
6712933|NCT02962934|7642815|FG001|STARTED|Overall Study||6
6712934|NCT02962934|7642814|FG000|COMPLETED|Overall Study||12
6712935|NCT02962934|7642815|FG001|COMPLETED|Overall Study||6
6712936|NCT02962934|7642814|FG000|NOT COMPLETED|Overall Study||0
6712937|NCT02962934|7642815|FG001|NOT COMPLETED|Overall Study||0
6712938|NCT02962960|7642824|FG000|STARTED|Overall Study||14
6712939|NCT02962960|7642825|FG001|STARTED|Overall Study||13
6712940|NCT02962960|7642826|FG002|STARTED|Overall Study||9
6712941|NCT02962960|7642824|FG000|COMPLETED|Overall Study||11
6712942|NCT02962960|7642825|FG001|COMPLETED|Overall Study||11
6712943|NCT02962960|7642826|FG002|COMPLETED|Overall Study||9
6712944|NCT02962960|7642824|FG000|NOT COMPLETED|Overall Study||3
6712945|NCT02962960|7642825|FG001|NOT COMPLETED|Overall Study||2
6712946|NCT02962960|7642826|FG002|NOT COMPLETED|Overall Study||0
6712947|NCT02963311|7642836|FG000|STARTED|Overall Study||9
6712948|NCT02963311|7642836|FG000|COMPLETED|Overall Study||4
6712949|NCT02963311|7642836|FG000|NOT COMPLETED|Overall Study||5
6262485|NCT02230410|7161439|FG000|COMPLETED|Overall Study||15
6262486|NCT02230410|7161439|FG000|NOT COMPLETED|Overall Study||3
6262487|NCT02053246|7161443|FG000|STARTED|Overall Study||11
6262488|NCT02053246|7161443|FG000|COMPLETED|Overall Study||7
6262489|NCT02053246|7161443|FG000|NOT COMPLETED|Overall Study||4
6262490|NCT02005471|7161449|FG000|STARTED|Overall Study||195
6262491|NCT02005471|7161450|FG001|STARTED|Overall Study||194
6262492|NCT02005471|7161449|FG000|Treated|Overall Study||188
6262493|NCT02005471|7161450|FG001|Treated|Overall Study||194
6262494|NCT02005471|7161449|FG000|COMPLETED|Overall Study||0
6262495|NCT02005471|7161450|FG001|COMPLETED|Overall Study||0
6262496|NCT02005471|7161449|FG000|NOT COMPLETED|Overall Study||195
6262497|NCT02005471|7161450|FG001|NOT COMPLETED|Overall Study||194
6262498|NCT01980940|7161467|FG000|STARTED|Overall Study||5
6262499|NCT01980940|7161468|FG001|STARTED|Overall Study||5
6262500|NCT01980940|7161469|FG002|STARTED|Overall Study||5
6262501|NCT01980940|7161470|FG003|STARTED|Overall Study||3
6262502|NCT01980940|7161471|FG004|STARTED|Overall Study||2
6262503|NCT01980940|7161472|FG005|STARTED|Overall Study||2
6262504|NCT01980940|7161473|FG006|STARTED|Overall Study||24
6262505|NCT01980940|7161474|FG007|STARTED|Overall Study||24
6262506|NCT01980940|7161467|FG000|Treated|Overall Study||5
6262507|NCT01980940|7161468|FG001|Treated|Overall Study||5
6262508|NCT01980940|7161469|FG002|Treated|Overall Study||5
6262509|NCT01980940|7161470|FG003|Treated|Overall Study||3
6262510|NCT01980940|7161471|FG004|Treated|Overall Study||2
6262511|NCT01980940|7161472|FG005|Treated|Overall Study||2
6262512|NCT01980940|7161473|FG006|Treated|Overall Study||24
6262513|NCT01980940|7161474|FG007|Treated|Overall Study||24
6262514|NCT01980940|7161467|FG000|COMPLETED|Overall Study||5
6262515|NCT01980940|7161468|FG001|COMPLETED|Overall Study||5
6262516|NCT01980940|7161469|FG002|COMPLETED|Overall Study||5
6262517|NCT01980940|7161470|FG003|COMPLETED|Overall Study||3
6262518|NCT01980940|7161471|FG004|COMPLETED|Overall Study||2
6262519|NCT01980940|7161472|FG005|COMPLETED|Overall Study||0
6262520|NCT01980940|7161473|FG006|COMPLETED|Overall Study||24
6712950|NCT02963376|7642844|FG000|STARTED|Overall Study||6
6712951|NCT02963376|7642845|FG001|STARTED|Overall Study||2
6712952|NCT02963376|7642846|FG002|STARTED|Overall Study||6
6712953|NCT02963376|7642847|FG003|STARTED|Overall Study||2
6712954|NCT02963376|7642848|FG004|STARTED|Overall Study||6
6712955|NCT02963376|7642849|FG005|STARTED|Overall Study||2
6712956|NCT02963376|7642844|FG000|COMPLETED|Overall Study||6
6712957|NCT02963376|7642845|FG001|COMPLETED|Overall Study||2
6712958|NCT02963376|7642846|FG002|COMPLETED|Overall Study||6
6262521|NCT01980940|7161474|FG007|COMPLETED|Overall Study||24
6262522|NCT01980940|7161467|FG000|NOT COMPLETED|Overall Study||0
6262523|NCT01980940|7161468|FG001|NOT COMPLETED|Overall Study||0
6712959|NCT02963376|7642847|FG003|COMPLETED|Overall Study||2
6712960|NCT02963376|7642848|FG004|COMPLETED|Overall Study||6
6712961|NCT02963376|7642849|FG005|COMPLETED|Overall Study||2
6712962|NCT02963376|7642844|FG000|NOT COMPLETED|Overall Study||0
6712963|NCT02963376|7642845|FG001|NOT COMPLETED|Overall Study||0
6712964|NCT02963376|7642846|FG002|NOT COMPLETED|Overall Study||0
6712965|NCT02963376|7642847|FG003|NOT COMPLETED|Overall Study||0
6712966|NCT02963376|7642848|FG004|NOT COMPLETED|Overall Study||0
6712967|NCT02963376|7642849|FG005|NOT COMPLETED|Overall Study||0
6712968|NCT02963441|7642871|FG000|STARTED|Overall Study||900
6712969|NCT02963441|7642871|FG000|COMPLETED|Overall Study||819
6712970|NCT02963441|7642871|FG000|NOT COMPLETED|Overall Study||81
6712971|NCT02963506|7642881|FG000|STARTED|Double-Blind Period||60
6712972|NCT02963506|7642882|FG001|STARTED|Double-Blind Period||61
6712973|NCT02963506|7642883|FG002|STARTED|Double-Blind Period||61
6712974|NCT02963506|7642884|FG003|STARTED|Double-Blind Period||60
6712975|NCT02963506|7642885|FG004|STARTED|Double-Blind Period||61
6712976|NCT02963506|7642886|FG005|STARTED|Double-Blind Period||0
6712977|NCT02963506|7642887|FG006|STARTED|Double-Blind Period||0
6712978|NCT02963506|7642888|FG007|STARTED|Double-Blind Period||0
6712979|NCT02963506|7642889|FG008|STARTED|Double-Blind Period||0
6712980|NCT02963506|7642890|FG009|STARTED|Double-Blind Period||0
6712981|NCT02963506|7642891|FG010|STARTED|Double-Blind Period||0
6712982|NCT02963506|7642892|FG011|STARTED|Double-Blind Period||0
6712983|NCT02963506|7642893|FG012|STARTED|Double-Blind Period||0
6712984|NCT02963506|7642881|FG000|Completed Double-Blind Period|Double-Blind Period||60
6712985|NCT02963506|7642882|FG001|Completed Double-Blind Period|Double-Blind Period||59
6712986|NCT02963506|7642883|FG002|Completed Double-Blind Period|Double-Blind Period||59
6712987|NCT02963506|7642884|FG003|Completed Double-Blind Period|Double-Blind Period||58
6712988|NCT02963506|7642885|FG004|Completed Double-Blind Period|Double-Blind Period||61
6712989|NCT02963506|7642886|FG005|Completed Double-Blind Period|Double-Blind Period||0
6712990|NCT02963506|7642887|FG006|Completed Double-Blind Period|Double-Blind Period||0
6712991|NCT02963506|7642888|FG007|Completed Double-Blind Period|Double-Blind Period||0
6712992|NCT02963506|7642889|FG008|Completed Double-Blind Period|Double-Blind Period||0
6712993|NCT02963506|7642890|FG009|Completed Double-Blind Period|Double-Blind Period||0
6712994|NCT02963506|7642891|FG010|Completed Double-Blind Period|Double-Blind Period||0
6712995|NCT02963506|7642892|FG011|Completed Double-Blind Period|Double-Blind Period||0
6712996|NCT02963506|7642893|FG012|Completed Double-Blind Period|Double-Blind Period||0
6712997|NCT02963506|7642881|FG000|Completed Week 12 - Started Dose-Blind|Double-Blind Period||60
6712998|NCT02963506|7642882|FG001|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
6712999|NCT02963506|7642883|FG002|Completed Week 12 - Started Dose-Blind|Double-Blind Period||59
6713000|NCT02963506|7642884|FG003|Completed Week 12 - Started Dose-Blind|Double-Blind Period||58
6713001|NCT02963506|7642885|FG004|Completed Week 12 - Started Dose-Blind|Double-Blind Period||61
6713002|NCT02963506|7642886|FG005|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
6713003|NCT02963506|7642887|FG006|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
6713004|NCT02963506|7642888|FG007|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
6713005|NCT02963506|7642889|FG008|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
6713006|NCT02963506|7642890|FG009|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
6713007|NCT02963506|7642891|FG010|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
6713008|NCT02963506|7642892|FG011|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
6713009|NCT02963506|7642893|FG012|Completed Week 12 - Started Dose-Blind|Double-Blind Period||0
6713010|NCT02963506|7642881|FG000|COMPLETED|Double-Blind Period||60
6713011|NCT02963506|7642882|FG001|COMPLETED|Double-Blind Period||58
6713012|NCT02963506|7642883|FG002|COMPLETED|Double-Blind Period||59
6713013|NCT02963506|7642884|FG003|COMPLETED|Double-Blind Period||58
6713014|NCT02963506|7642885|FG004|COMPLETED|Double-Blind Period||61
6713015|NCT02963506|7642886|FG005|COMPLETED|Double-Blind Period||0
6713016|NCT02963506|7642887|FG006|COMPLETED|Double-Blind Period||0
6713017|NCT02963506|7642888|FG007|COMPLETED|Double-Blind Period||0
6713018|NCT02963506|7642889|FG008|COMPLETED|Double-Blind Period||0
6713019|NCT02963506|7642890|FG009|COMPLETED|Double-Blind Period||0
6713020|NCT02963506|7642891|FG010|COMPLETED|Double-Blind Period||0
6713021|NCT02963506|7642892|FG011|COMPLETED|Double-Blind Period||0
6713022|NCT02963506|7642893|FG012|COMPLETED|Double-Blind Period||0
6713023|NCT02963506|7642881|FG000|NOT COMPLETED|Double-Blind Period||0
6713024|NCT02963506|7642882|FG001|NOT COMPLETED|Double-Blind Period||3
6713025|NCT02963506|7642883|FG002|NOT COMPLETED|Double-Blind Period||2
6713026|NCT02963506|7642884|FG003|NOT COMPLETED|Double-Blind Period||2
6713027|NCT02963506|7642885|FG004|NOT COMPLETED|Double-Blind Period||0
6713028|NCT02963506|7642886|FG005|NOT COMPLETED|Double-Blind Period||0
6713029|NCT02963506|7642887|FG006|NOT COMPLETED|Double-Blind Period||0
6713030|NCT02963506|7642888|FG007|NOT COMPLETED|Double-Blind Period||0
6713031|NCT02963506|7642889|FG008|NOT COMPLETED|Double-Blind Period||0
6713032|NCT02963506|7642890|FG009|NOT COMPLETED|Double-Blind Period||0
6713033|NCT02963506|7642891|FG010|NOT COMPLETED|Double-Blind Period||0
6713034|NCT02963506|7642892|FG011|NOT COMPLETED|Double-Blind Period||0
6713035|NCT02963506|7642893|FG012|NOT COMPLETED|Double-Blind Period||0
6713036|NCT02963506|7642881|FG000|STARTED|Dose-Blind Period||0
6713037|NCT02963506|7642882|FG001|STARTED|Dose-Blind Period||0
6713038|NCT02963506|7642883|FG002|STARTED|Dose-Blind Period||0
6713039|NCT02963506|7642884|FG003|STARTED|Dose-Blind Period||0
6713040|NCT02963506|7642885|FG004|STARTED|Dose-Blind Period||0
6713041|NCT02963506|7642886|FG005|STARTED|Dose-Blind Period||24
6713042|NCT02963506|7642887|FG006|STARTED|Dose-Blind Period||36
6713043|NCT02963506|7642888|FG007|STARTED|Dose-Blind Period||31
6713044|NCT02963506|7642889|FG008|STARTED|Dose-Blind Period||27
6713045|NCT02963506|7642890|FG009|STARTED|Dose-Blind Period||34
6713046|NCT02963506|7642891|FG010|STARTED|Dose-Blind Period||25
6713047|NCT02963506|7642892|FG011|STARTED|Dose-Blind Period||58
6713048|NCT02963506|7642893|FG012|STARTED|Dose-Blind Period||61
6713049|NCT02963506|7642881|FG000|COMPLETED|Dose-Blind Period||0
6713050|NCT02963506|7642882|FG001|COMPLETED|Dose-Blind Period||0
6713051|NCT02963506|7642883|FG002|COMPLETED|Dose-Blind Period||0
6713052|NCT02963506|7642884|FG003|COMPLETED|Dose-Blind Period||0
6713053|NCT02963506|7642885|FG004|COMPLETED|Dose-Blind Period||0
6713054|NCT02963506|7642886|FG005|COMPLETED|Dose-Blind Period||20
6713055|NCT02963506|7642887|FG006|COMPLETED|Dose-Blind Period||31
6713056|NCT02963506|7642888|FG007|COMPLETED|Dose-Blind Period||26
6713057|NCT02963506|7642889|FG008|COMPLETED|Dose-Blind Period||24
6713058|NCT02963506|7642890|FG009|COMPLETED|Dose-Blind Period||30
6713059|NCT02963506|7642891|FG010|COMPLETED|Dose-Blind Period||24
6713060|NCT02963506|7642892|FG011|COMPLETED|Dose-Blind Period||56
6713061|NCT02963506|7642893|FG012|COMPLETED|Dose-Blind Period||54
6713062|NCT02963506|7642881|FG000|NOT COMPLETED|Dose-Blind Period||0
6713063|NCT02963506|7642882|FG001|NOT COMPLETED|Dose-Blind Period||0
6713064|NCT02963506|7642883|FG002|NOT COMPLETED|Dose-Blind Period||0
6713065|NCT02963506|7642884|FG003|NOT COMPLETED|Dose-Blind Period||0
6713066|NCT02963506|7642885|FG004|NOT COMPLETED|Dose-Blind Period||0
6713067|NCT02963506|7642886|FG005|NOT COMPLETED|Dose-Blind Period||4
6713068|NCT02963506|7642887|FG006|NOT COMPLETED|Dose-Blind Period||5
6713069|NCT02963506|7642888|FG007|NOT COMPLETED|Dose-Blind Period||5
6713070|NCT02963506|7642889|FG008|NOT COMPLETED|Dose-Blind Period||3
6713071|NCT02963506|7642890|FG009|NOT COMPLETED|Dose-Blind Period||4
6713072|NCT02963506|7642891|FG010|NOT COMPLETED|Dose-Blind Period||1
6713073|NCT02963506|7642892|FG011|NOT COMPLETED|Dose-Blind Period||2
6713074|NCT02963506|7642893|FG012|NOT COMPLETED|Dose-Blind Period||7
6713075|NCT02963597|7642912|FG000|STARTED|Overall Study||10
6713076|NCT02963597|7642913|FG001|STARTED|Overall Study||11
6713077|NCT02963597|7642912|FG000|COMPLETED|Overall Study||10
6713078|NCT02963597|7642913|FG001|COMPLETED|Overall Study||11
6713079|NCT02963597|7642912|FG000|NOT COMPLETED|Overall Study||0
6713080|NCT02963597|7642913|FG001|NOT COMPLETED|Overall Study||0
6713081|NCT02963701|7642921|FG000|STARTED|Period 1 (Including Washout) (2 Days)||28
6713082|NCT02963701|7642922|FG001|STARTED|Period 1 (Including Washout) (2 Days)||28
6713083|NCT02963701|7642921|FG000|COMPLETED|Period 1 (Including Washout) (2 Days)|One subject withdrawn from the study after period 1|27
6713084|NCT02963701|7642922|FG001|COMPLETED|Period 1 (Including Washout) (2 Days)||28
6713085|NCT02963701|7642921|FG000|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||1
6713086|NCT02963701|7642922|FG001|NOT COMPLETED|Period 1 (Including Washout) (2 Days)||0
6713087|NCT02963701|7642921|FG000|STARTED|Period 2 (2 Days)||27
6713088|NCT02963701|7642922|FG001|STARTED|Period 2 (2 Days)||28
6713089|NCT02963701|7642921|FG000|COMPLETED|Period 2 (2 Days)||27
6713090|NCT02963701|7642922|FG001|COMPLETED|Period 2 (2 Days)||28
6713091|NCT02963701|7642921|FG000|NOT COMPLETED|Period 2 (2 Days)||0
6713092|NCT02963701|7642922|FG001|NOT COMPLETED|Period 2 (2 Days)||0
6713093|NCT02963922|7642930|FG000|STARTED|Overall Study||198
6713094|NCT02963922|7642931|FG001|STARTED|Overall Study||198
6713095|NCT02963922|7642930|FG000|COMPLETED|Overall Study||166
6713096|NCT02963922|7642931|FG001|COMPLETED|Overall Study||168
6713097|NCT02963922|7642930|FG000|NOT COMPLETED|Overall Study||32
6713098|NCT02963922|7642931|FG001|NOT COMPLETED|Overall Study||30
6713099|NCT02963935|7642939|FG000|STARTED|Overall Study||142
6713100|NCT02963935|7642940|FG001|STARTED|Overall Study||140
6713101|NCT02963935|7642939|FG000|COMPLETED|Overall Study||114
6713102|NCT02963935|7642940|FG001|COMPLETED|Overall Study||103
6713103|NCT02963935|7642939|FG000|NOT COMPLETED|Overall Study||28
6713104|NCT02963935|7642940|FG001|NOT COMPLETED|Overall Study||37
6713105|NCT02963974|7642946|FG000|STARTED|Overall Study||20
6713106|NCT02963974|7642946|FG000|COMPLETED|Overall Study||19
6713107|NCT02963974|7642946|FG000|NOT COMPLETED|Overall Study||1
6713108|NCT02963987|7642950|FG000|STARTED|First Intervention Period||31
6713109|NCT02963987|7642951|FG001|STARTED|First Intervention Period||19
6713110|NCT02963987|7642950|FG000|COMPLETED|First Intervention Period||31
6713111|NCT02963987|7642951|FG001|COMPLETED|First Intervention Period||19
6713112|NCT02963987|7642950|FG000|NOT COMPLETED|First Intervention Period||0
6713113|NCT02963987|7642951|FG001|NOT COMPLETED|First Intervention Period||0
6713114|NCT02963987|7642950|FG000|STARTED|Second Intervention Period||31
6713115|NCT02963987|7642951|FG001|STARTED|Second Intervention Period||19
6713116|NCT02963987|7642950|FG000|COMPLETED|Second Intervention Period||31
6713117|NCT02963987|7642951|FG001|COMPLETED|Second Intervention Period||19
6713118|NCT02963987|7642950|FG000|NOT COMPLETED|Second Intervention Period||0
6713119|NCT02963987|7642951|FG001|NOT COMPLETED|Second Intervention Period||0
6713120|NCT02964234|7642961|FG000|STARTED|Overall Study||76
6713121|NCT02964234|7642962|FG001|STARTED|Overall Study||69
6713122|NCT02964234|7642961|FG000|COMPLETED|Overall Study||54
6713123|NCT02964234|7642962|FG001|COMPLETED|Overall Study||56
6713124|NCT02964234|7642961|FG000|NOT COMPLETED|Overall Study||22
6713125|NCT02964234|7642962|FG001|NOT COMPLETED|Overall Study||13
6713126|NCT02964247|7642970|FG000|STARTED|Overall Study||203
6713127|NCT02964247|7642971|FG001|STARTED|Overall Study||100
6713128|NCT02964247|7642970|FG000|Exposed to Trial Product|Overall Study||202
6713129|NCT02964247|7642971|FG001|Exposed to Trial Product|Overall Study||100
6713130|NCT02964247|7642970|FG000|COMPLETED|Overall Study||200
6713131|NCT02964247|7642971|FG001|COMPLETED|Overall Study||98
6713132|NCT02964247|7642970|FG000|NOT COMPLETED|Overall Study||3
6713133|NCT02964247|7642971|FG001|NOT COMPLETED|Overall Study||2
6713134|NCT02964312|7642977|FG000|STARTED|Overall Study||166
6713135|NCT02964312|7642977|FG000|1-Month Follow-up|Overall Study||164
6602746|NCT02058849|7527815|FG000|STARTED|Overall Study||11
6713136|NCT02964312|7642977|FG000|3-Month Follow-up|Overall Study||159
6713137|NCT02964312|7642977|FG000|6-Month Follow-up|Overall Study||152
6713138|NCT02964312|7642977|FG000|12-Month Follow-up|Overall Study||139
6713139|NCT02964312|7642977|FG000|18-Month Follow-up|Overall Study||112
6713140|NCT02964312|7642977|FG000|24-Month Follow-up|Overall Study||102
6713141|NCT02964312|7642977|FG000|COMPLETED|Overall Study||102
6713142|NCT02964312|7642977|FG000|NOT COMPLETED|Overall Study||64
6713143|NCT02964325|7642986|FG000|STARTED|Overall Study||164
6713144|NCT02964325|7642987|FG001|STARTED|Overall Study||166
6713145|NCT02964325|7642986|FG000|Full Analysis Set|Overall Study||164
6713146|NCT02964325|7642987|FG001|Full Analysis Set|Overall Study||166
6713147|NCT02964325|7642986|FG000|Modified Intent-to-Treat|Overall Study||145
6713148|NCT02964325|7642987|FG001|Modified Intent-to-Treat|Overall Study||152
6713149|NCT02964325|7642986|FG000|Safety Set|Overall Study||141
6713150|NCT02964325|7642987|FG001|Safety Set|Overall Study||161
6713151|NCT02964325|7642986|FG000|COMPLETED|Overall Study||143
6713152|NCT02964325|7642987|FG001|COMPLETED|Overall Study||143
6713153|NCT02964325|7642986|FG000|NOT COMPLETED|Overall Study||21
6713154|NCT02964325|7642987|FG001|NOT COMPLETED|Overall Study||23
6713155|NCT02964338|7642996|FG000|STARTED|Overall Study||84
6713156|NCT02964338|7642997|FG001|STARTED|Overall Study||88
6713157|NCT02964338|7642998|FG002|STARTED|Overall Study||87
6713158|NCT02964338|7642996|FG000|Safety Analysis Set|Overall Study||83
6713159|NCT02964338|7642997|FG001|Safety Analysis Set|Overall Study||88
6713160|NCT02964338|7642998|FG002|Safety Analysis Set|Overall Study||87
6713161|NCT02964338|7642996|FG000|Full Analysis Set|Overall Study||81
6713162|NCT02964338|7642997|FG001|Full Analysis Set|Overall Study||86
6713163|NCT02964338|7642998|FG002|Full Analysis Set|Overall Study||87
6713164|NCT02964338|7642996|FG000|COMPLETED|Overall Study||67
6713165|NCT02964338|7642997|FG001|COMPLETED|Overall Study||64
6713166|NCT02964338|7642998|FG002|COMPLETED|Overall Study||68
6713167|NCT02964338|7642996|FG000|NOT COMPLETED|Overall Study||17
6713168|NCT02964338|7642997|FG001|NOT COMPLETED|Overall Study||24
6713169|NCT02964338|7642998|FG002|NOT COMPLETED|Overall Study||19
6713170|NCT02964416|7643008|FG000|STARTED|Overall Study||39
6713171|NCT02964416|7643009|FG001|STARTED|Overall Study||41
6713172|NCT02964416|7643008|FG000|COMPLETED|Overall Study||38
6713173|NCT02964416|7643009|FG001|COMPLETED|Overall Study||41
6713174|NCT02964416|7643008|FG000|NOT COMPLETED|Overall Study||1
6713175|NCT02964416|7643009|FG001|NOT COMPLETED|Overall Study||0
6713176|NCT02964767|7643018|FG000|STARTED|Overall Study||171
6713177|NCT02964767|7643019|FG001|STARTED|Overall Study||48
6713178|NCT02964767|7643018|FG000|COMPLETED|Overall Study||171
6713179|NCT02964767|7643019|FG001|COMPLETED|Overall Study||48
6713180|NCT02964767|7643018|FG000|NOT COMPLETED|Overall Study||0
6713181|NCT02964767|7643019|FG001|NOT COMPLETED|Overall Study||0
6713182|NCT02964910|7643028|FG000|STARTED|Overall Study||235
6713183|NCT02964910|7643029|FG001|STARTED|Overall Study||240
6713184|NCT02964910|7643028|FG000|COMPLETED|Overall Study||192
6713185|NCT02964910|7643029|FG001|COMPLETED|Overall Study||196
6713186|NCT02964910|7643028|FG000|NOT COMPLETED|Overall Study||43
6713187|NCT02964910|7643029|FG001|NOT COMPLETED|Overall Study||44
6713188|NCT02965144|7643037|FG000|STARTED|Overall Study||13
6713189|NCT02965144|7643037|FG000|COMPLETED|Overall Study||13
6713190|NCT02965144|7643037|FG000|NOT COMPLETED|Overall Study||0
6713191|NCT02965378|7643046|FG000|STARTED|Overall Study||25
6713192|NCT02965378|7643047|FG001|STARTED|Overall Study||9
6713193|NCT02965378|7643046|FG000|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||0
6713194|NCT02965378|7643047|FG001|Participants on Docetaxel Re-registered to AZD4547 After Progression.|Overall Study||2
6713195|NCT02965378|7643046|FG000|COMPLETED|Overall Study||0
6713196|NCT02965378|7643047|FG001|COMPLETED|Overall Study||0
6713197|NCT02965378|7643046|FG000|NOT COMPLETED|Overall Study||25
6713198|NCT02965378|7643047|FG001|NOT COMPLETED|Overall Study||9
6713199|NCT02965456|7643055|FG000|STARTED|Overall Study||413
6713200|NCT02965456|7643056|FG001|STARTED|Overall Study||407
6713201|NCT02965456|7643055|FG000|Intent-to-treat (ITT) Population|Overall Study||413
6713202|NCT02965456|7643056|FG001|Intent-to-treat (ITT) Population|Overall Study||407
6713203|NCT02965456|7643055|FG000|Safety Population|Overall Study||389
6602747|NCT02058849|7527816|FG001|STARTED|Overall Study||2
6602748|NCT02058849|7527815|FG000|COMPLETED|Overall Study||4
6602749|NCT02058849|7527816|FG001|COMPLETED|Overall Study||1
6602750|NCT02058849|7527815|FG000|NOT COMPLETED|Overall Study||7
6602751|NCT02058849|7527816|FG001|NOT COMPLETED|Overall Study||1
6602752|NCT02058940|7527822|FG000|STARTED|Overall Study||8
6602753|NCT02058940|7527822|FG000|COMPLETED|Overall Study||7
6602754|NCT02058940|7527822|FG000|NOT COMPLETED|Overall Study||1
6602755|NCT02058966|7527826|FG000|STARTED|Open-Label Methamphetamine||19
6602756|NCT02058966|7527826|FG000|Received Methamphetamine|Open-Label Methamphetamine||18
6602757|NCT02058966|7527826|FG000|COMPLETED|Open-Label Methamphetamine||18
6602758|NCT02058966|7527826|FG000|NOT COMPLETED|Open-Label Methamphetamine||1
6602759|NCT02058966|7527826|FG000|STARTED|First Intervention||15
6602760|NCT02058966|7527826|FG000|Received Placebo-Placebo|First Intervention||3
6602761|NCT02058966|7527826|FG000|Received Placebo-Meth|First Intervention||4
6602762|NCT02058966|7527826|FG000|Received Entacapone-Placebo|First Intervention||2
6602763|NCT02058966|7527826|FG000|Received Entacapone-Meth|First Intervention||5
6602764|NCT02058966|7527826|FG000|COMPLETED|First Intervention||14
6602765|NCT02058966|7527826|FG000|NOT COMPLETED|First Intervention||1
6713204|NCT02965456|7643056|FG001|Safety Population|Overall Study||398
6713205|NCT02965456|7643055|FG000|COMPLETED|Overall Study||342
6713206|NCT02965456|7643056|FG001|COMPLETED|Overall Study||364
6713207|NCT02965456|7643055|FG000|NOT COMPLETED|Overall Study||71
6713208|NCT02965456|7643056|FG001|NOT COMPLETED|Overall Study||43
6713209|NCT02965534|7643062|FG000|STARTED|Overall Study|test period: 14 days with each test glasses|45
6713210|NCT02965534|7643063|FG001|STARTED|Overall Study|test period: 14 days with each test glasses|55
6713211|NCT02965534|7643062|FG000|COMPLETED|Overall Study||45
6713212|NCT02965534|7643063|FG001|COMPLETED|Overall Study||55
6713213|NCT02965534|7643062|FG000|NOT COMPLETED|Overall Study||0
6713214|NCT02965534|7643063|FG001|NOT COMPLETED|Overall Study||0
6713215|NCT02965573|7643072|FG000|STARTED|Overall Study||12
6713216|NCT02965573|7643073|FG001|STARTED|Overall Study||12
6713217|NCT02965573|7643072|FG000|COMPLETED|Overall Study||11
6713218|NCT02965573|7643073|FG001|COMPLETED|Overall Study||12
6262524|NCT01980940|7161469|FG002|NOT COMPLETED|Overall Study||0
6262525|NCT01980940|7161470|FG003|NOT COMPLETED|Overall Study||0
6262526|NCT01980940|7161471|FG004|NOT COMPLETED|Overall Study||0
6262527|NCT01980940|7161472|FG005|NOT COMPLETED|Overall Study||2
6262528|NCT01980940|7161473|FG006|NOT COMPLETED|Overall Study||0
6262529|NCT01980940|7161474|FG007|NOT COMPLETED|Overall Study||0
6262530|NCT01923298|7161498|FG000|STARTED|Overall Study||14
6262531|NCT01923298|7161498|FG000|COMPLETED|Overall Study||14
6262532|NCT01923298|7161498|FG000|NOT COMPLETED|Overall Study||0
6262533|NCT01918033|7161505|FG000|STARTED|Overall Study||203
6262534|NCT01918033|7161506|FG001|STARTED|Overall Study||203
6262535|NCT01918033|7161507|FG002|STARTED|Overall Study||202
6262536|NCT01918033|7161505|FG000|Treated|Overall Study|One randomized participant did not receive study drug.|202
6262537|NCT01918033|7161506|FG001|Treated|Overall Study||203
6262538|NCT01918033|7161507|FG002|Treated|Overall Study|One randomized participant did not receive study drug.|201
6262539|NCT01918033|7161505|FG000|COMPLETED|Overall Study||198
6262540|NCT01918033|7161506|FG001|COMPLETED|Overall Study||201
6262541|NCT01918033|7161507|FG002|COMPLETED|Overall Study||199
6262542|NCT01918033|7161505|FG000|NOT COMPLETED|Overall Study||5
6262543|NCT01918033|7161506|FG001|NOT COMPLETED|Overall Study||2
6262544|NCT01918033|7161507|FG002|NOT COMPLETED|Overall Study||3
6262545|NCT01916980|7161517|FG000|STARTED|Overall Study||65
6262546|NCT01916980|7161518|FG001|STARTED|Overall Study||29
6262547|NCT01916980|7161517|FG000|COMPLETED|Overall Study||58
6262548|NCT01916980|7161518|FG001|COMPLETED|Overall Study||25
6262549|NCT01916980|7161517|FG000|NOT COMPLETED|Overall Study||7
6262550|NCT01916980|7161518|FG001|NOT COMPLETED|Overall Study||4
6262551|NCT01916967|7161527|FG000|STARTED|Overall Study||80
6262552|NCT01916967|7161528|FG001|STARTED|Overall Study||79
6262553|NCT01916967|7161529|FG002|STARTED|Overall Study||80
6262554|NCT01916967|7161527|FG000|COMPLETED|Overall Study||80
6262555|NCT01916967|7161528|FG001|COMPLETED|Overall Study||78
6262556|NCT01916967|7161529|FG002|COMPLETED|Overall Study||71
6262557|NCT01916967|7161527|FG000|NOT COMPLETED|Overall Study||0
6262558|NCT01916967|7161528|FG001|NOT COMPLETED|Overall Study||1
6262559|NCT01916967|7161529|FG002|NOT COMPLETED|Overall Study||9
6262560|NCT01910402|7161541|FG000|STARTED|Randomized Phase||248
6262561|NCT01910402|7161542|FG001|STARTED|Randomized Phase||247
6262562|NCT01910402|7161541|FG000|COMPLETED|Randomized Phase||206
6262563|NCT01910402|7161542|FG001|COMPLETED|Randomized Phase||192
6262564|NCT01910402|7161541|FG000|NOT COMPLETED|Randomized Phase||42
6262565|NCT01910402|7161542|FG001|NOT COMPLETED|Randomized Phase||55
6262566|NCT01910402|7161541|FG000|STARTED|Continuation Phase||120
6262567|NCT01910402|7161542|FG001|STARTED|Continuation Phase||0
6262568|NCT01910402|7161541|FG000|COMPLETED|Continuation Phase||30
6262569|NCT01910402|7161542|FG001|COMPLETED|Continuation Phase||0
6262570|NCT01910402|7161541|FG000|NOT COMPLETED|Continuation Phase||90
6262571|NCT01910402|7161542|FG001|NOT COMPLETED|Continuation Phase||0
6262572|NCT01893320|7161552|FG000|STARTED|Overall Study||7
6262573|NCT01893320|7161553|FG001|STARTED|Overall Study||59
6262574|NCT01893320|7161552|FG000|COMPLETED|Overall Study||7
6262575|NCT01893320|7161553|FG001|COMPLETED|Overall Study||59
6262576|NCT01893320|7161552|FG000|NOT COMPLETED|Overall Study||0
6262577|NCT01893320|7161553|FG001|NOT COMPLETED|Overall Study||0
6262578|NCT01870401|7161561|FG000|STARTED|Overall Study||287
6262579|NCT01870401|7161562|FG001|STARTED|Overall Study||155
6262580|NCT01870401|7161561|FG000|COMPLETED|Overall Study||137
6262581|NCT01870401|7161562|FG001|COMPLETED|Overall Study||59
6262582|NCT01870401|7161561|FG000|NOT COMPLETED|Overall Study||150
6262583|NCT01870401|7161562|FG001|NOT COMPLETED|Overall Study||96
6262584|NCT01867606|7161572|FG000|STARTED|Overall Study||26
6262585|NCT01867606|7161573|FG001|STARTED|Overall Study||32
6262586|NCT01867606|7161572|FG000|COMPLETED|Overall Study||16
6262587|NCT01867606|7161573|FG001|COMPLETED|Overall Study||17
6262588|NCT01867606|7161572|FG000|NOT COMPLETED|Overall Study||10
6262589|NCT01867606|7161573|FG001|NOT COMPLETED|Overall Study||15
6262590|NCT01857063|7161587|FG000|STARTED|Period 1 (7 Days)||110
6262591|NCT01857063|7161588|FG001|STARTED|Period 1 (7 Days)||110
6262592|NCT01857063|7161587|FG000|COMPLETED|Period 1 (7 Days)||108
6262593|NCT01857063|7161588|FG001|COMPLETED|Period 1 (7 Days)||106
6262594|NCT01857063|7161587|FG000|NOT COMPLETED|Period 1 (7 Days)||2
6262595|NCT01857063|7161588|FG001|NOT COMPLETED|Period 1 (7 Days)||4
6262596|NCT01857063|7161587|FG000|STARTED|Period 2 (7 Days)||108
6262597|NCT01857063|7161588|FG001|STARTED|Period 2 (7 Days)||106
6262598|NCT01857063|7161587|FG000|COMPLETED|Period 2 (7 Days)||104
6713219|NCT02965573|7643072|FG000|NOT COMPLETED|Overall Study||1
6713220|NCT02965573|7643073|FG001|NOT COMPLETED|Overall Study||0
6713221|NCT02965599|7643081|FG000|STARTED|Overall Study||2
6713222|NCT02965599|7643082|FG001|STARTED|Overall Study||1
6713223|NCT02965599|7643081|FG000|COMPLETED|Overall Study||1
6713224|NCT02965599|7643082|FG001|COMPLETED|Overall Study||1
6713225|NCT02965599|7643081|FG000|NOT COMPLETED|Overall Study||1
6713226|NCT02965599|7643082|FG001|NOT COMPLETED|Overall Study||0
6713227|NCT02965781|7643092|FG000|STARTED|Overall Study||46
6713228|NCT02965781|7643093|FG001|STARTED|Overall Study||46
6713229|NCT02965781|7643094|FG002|STARTED|Overall Study||47
6713230|NCT02965781|7643092|FG000|COMPLETED|Overall Study||46
6713231|NCT02965781|7643093|FG001|COMPLETED|Overall Study||46
6713232|NCT02965781|7643094|FG002|COMPLETED|Overall Study||47
6713233|NCT02965781|7643092|FG000|NOT COMPLETED|Overall Study||0
6713234|NCT02965781|7643093|FG001|NOT COMPLETED|Overall Study||0
6713235|NCT02965781|7643094|FG002|NOT COMPLETED|Overall Study||0
6713236|NCT02965820|7643102|FG000|STARTED|Period 1, First 30 Days||59
6713237|NCT02965820|7643103|FG001|STARTED|Period 1, First 30 Days||62
6713238|NCT02965820|7643102|FG000|COMPLETED|Period 1, First 30 Days||59
6713239|NCT02965820|7643103|FG001|COMPLETED|Period 1, First 30 Days||62
6713240|NCT02965820|7643102|FG000|NOT COMPLETED|Period 1, First 30 Days||0
6713241|NCT02965820|7643103|FG001|NOT COMPLETED|Period 1, First 30 Days||0
6713242|NCT02965820|7643102|FG000|STARTED|Period 2, Second 30 Days|One subject discontinued due to an AE after completion of Period 1 but before beginning Period 2.|58
6713243|NCT02965820|7643103|FG001|STARTED|Period 2, Second 30 Days||62
6713244|NCT02965820|7643102|FG000|COMPLETED|Period 2, Second 30 Days||57
6713245|NCT02965820|7643103|FG001|COMPLETED|Period 2, Second 30 Days||61
6713246|NCT02965820|7643102|FG000|NOT COMPLETED|Period 2, Second 30 Days||1
6713247|NCT02965820|7643103|FG001|NOT COMPLETED|Period 2, Second 30 Days||1
6713248|NCT02965833|7643109|FG000|STARTED|Period 1, First 30 Days of Wear||67
6262599|NCT01857063|7161588|FG001|COMPLETED|Period 2 (7 Days)||104
6262600|NCT01857063|7161587|FG000|NOT COMPLETED|Period 2 (7 Days)||4
6262601|NCT01857063|7161588|FG001|NOT COMPLETED|Period 2 (7 Days)||2
6262602|NCT01854268|7161594|FG000|STARTED|Overall Study||25
6262603|NCT01854268|7161594|FG000|COMPLETED|Overall Study||25
6262604|NCT01854268|7161594|FG000|NOT COMPLETED|Overall Study||0
6262605|NCT01852812|7161601|FG000|STARTED|Overall Study||51
6262606|NCT01852812|7161602|FG001|STARTED|Overall Study||18
6262607|NCT01852812|7161603|FG002|STARTED|Overall Study||18
6262608|NCT01852812|7161601|FG000|COMPLETED|Overall Study||51
6262609|NCT01852812|7161602|FG001|COMPLETED|Overall Study||17
6262610|NCT01852812|7161603|FG002|COMPLETED|Overall Study||17
6262611|NCT01852812|7161601|FG000|NOT COMPLETED|Overall Study||0
6262612|NCT01852812|7161602|FG001|NOT COMPLETED|Overall Study||1
6262613|NCT01852812|7161603|FG002|NOT COMPLETED|Overall Study||1
6262614|NCT01844986|7161613|FG000|STARTED|Overall Study||260
6262615|NCT01844986|7161614|FG001|STARTED|Overall Study||131
6262616|NCT01844986|7161613|FG000|COMPLETED|Overall Study||183
6262617|NCT01844986|7161614|FG001|COMPLETED|Overall Study||91
6262618|NCT01844986|7161613|FG000|NOT COMPLETED|Overall Study||77
6262619|NCT01844986|7161614|FG001|NOT COMPLETED|Overall Study||40
6262620|NCT01828021|7161620|FG000|STARTED|Overall Study||25
6262621|NCT01828021|7161620|FG000|COMPLETED|Overall Study||0
6262622|NCT01828021|7161620|FG000|NOT COMPLETED|Overall Study||25
6262623|NCT01709318|7161631|FG000|STARTED|Overall Study||82
6262624|NCT01709318|7161632|FG001|STARTED|Overall Study||85
6262625|NCT01709318|7161633|FG002|STARTED|Overall Study||77
6262626|NCT01709318|7161634|FG003|STARTED|Overall Study||78
6262627|NCT01709318|7161635|FG004|STARTED|Overall Study||78
6262628|NCT01709318|7161636|FG005|STARTED|Overall Study||84
6262629|NCT01709318|7161637|FG006|STARTED|Overall Study||182
6262630|NCT01709318|7161631|FG000|Treated|Overall Study||79
6262631|NCT01709318|7161632|FG001|Treated|Overall Study||85
6262632|NCT01709318|7161633|FG002|Treated|Overall Study||78
6713249|NCT02965833|7643110|FG001|STARTED|Period 1, First 30 Days of Wear||54
6713250|NCT02965833|7643109|FG000|COMPLETED|Period 1, First 30 Days of Wear||64
6713251|NCT02965833|7643110|FG001|COMPLETED|Period 1, First 30 Days of Wear||52
6713252|NCT02965833|7643109|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
6713253|NCT02965833|7643110|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||2
6713254|NCT02965833|7643109|FG000|STARTED|Period 2, Second 30 Days of Wear||64
6713255|NCT02965833|7643110|FG001|STARTED|Period 2, Second 30 Days of Wear||52
6713256|NCT02965833|7643109|FG000|COMPLETED|Period 2, Second 30 Days of Wear||62
6713257|NCT02965833|7643110|FG001|COMPLETED|Period 2, Second 30 Days of Wear||52
6713258|NCT02965833|7643109|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
6713259|NCT02965833|7643110|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
6713260|NCT02965924|7643116|FG000|STARTED|Overall Study||20
6713261|NCT02965924|7643116|FG000|COMPLETED|Overall Study||20
6713262|NCT02965924|7643116|FG000|NOT COMPLETED|Overall Study||0
6713263|NCT02965989|7643122|FG000|STARTED|Overall Study||26
6713264|NCT02965989|7643123|FG001|STARTED|Overall Study||22
6262633|NCT01709318|7161634|FG003|Treated|Overall Study||77
6262634|NCT01709318|7161635|FG004|Treated|Overall Study||77
6262635|NCT01709318|7161636|FG005|Treated|Overall Study||86
6262636|NCT01709318|7161637|FG006|Treated|Overall Study||178
6262637|NCT01709318|7161631|FG000|COMPLETED|Overall Study||73
6262638|NCT01709318|7161632|FG001|COMPLETED|Overall Study||78
6262639|NCT01709318|7161633|FG002|COMPLETED|Overall Study||71
6262640|NCT01709318|7161634|FG003|COMPLETED|Overall Study||72
6262641|NCT01709318|7161635|FG004|COMPLETED|Overall Study||74
6262642|NCT01709318|7161636|FG005|COMPLETED|Overall Study||80
6262643|NCT01709318|7161637|FG006|COMPLETED|Overall Study||171
6262644|NCT01709318|7161631|FG000|NOT COMPLETED|Overall Study||9
6262645|NCT01709318|7161632|FG001|NOT COMPLETED|Overall Study||7
6262646|NCT01709318|7161633|FG002|NOT COMPLETED|Overall Study||6
6262647|NCT01709318|7161634|FG003|NOT COMPLETED|Overall Study||6
6262648|NCT01709318|7161635|FG004|NOT COMPLETED|Overall Study||4
6262649|NCT01709318|7161636|FG005|NOT COMPLETED|Overall Study||4
6262650|NCT01709318|7161637|FG006|NOT COMPLETED|Overall Study||11
6262651|NCT01698918|7161653|FG000|STARTED|First Line Treatment (Core+Extension)||202
6262652|NCT01698918|7161653|FG000|Dexamethasone Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||11
6262653|NCT01698918|7161653|FG000|Standard of Care Randomized Set (Stomatitis Sub-study)|First Line Treatment (Core+Extension)||13
6262654|NCT01698918|7161653|FG000|COMPLETED|First Line Treatment (Core+Extension)||29
6262655|NCT01698918|7161653|FG000|NOT COMPLETED|First Line Treatment (Core+Extension)||173
6262656|NCT01698918|7161653|FG000|STARTED|Second Line Treatment (Core+Extension)||53
6262657|NCT01698918|7161653|FG000|COMPLETED|Second Line Treatment (Core+Extension)||7
6262658|NCT01698918|7161653|FG000|NOT COMPLETED|Second Line Treatment (Core+Extension)||46
6262659|NCT01673620|7161667|FG000|STARTED|Overall Study||47
6262660|NCT01673620|7161668|FG001|STARTED|Overall Study||22
6262661|NCT01673620|7161667|FG000|COMPLETED|Overall Study||46
6262662|NCT01673620|7161668|FG001|COMPLETED|Overall Study||22
6262663|NCT01673620|7161667|FG000|NOT COMPLETED|Overall Study||1
6262664|NCT01673620|7161668|FG001|NOT COMPLETED|Overall Study||0
6262665|NCT01660243|7161678|FG000|STARTED|Overall Study||10
6262666|NCT01660243|7161679|FG001|STARTED|Overall Study||13
6262667|NCT01660243|7161680|FG002|STARTED|Overall Study||11
6262668|NCT01660243|7161681|FG003|STARTED|Overall Study||11
6262669|NCT01660243|7161678|FG000|COMPLETED|Overall Study||8
6262670|NCT01660243|7161679|FG001|COMPLETED|Overall Study||13
6262671|NCT01660243|7161680|FG002|COMPLETED|Overall Study||9
6262672|NCT01660243|7161681|FG003|COMPLETED|Overall Study||10
6262673|NCT01660243|7161678|FG000|NOT COMPLETED|Overall Study||2
6262674|NCT01660243|7161679|FG001|NOT COMPLETED|Overall Study||0
6262675|NCT01660243|7161680|FG002|NOT COMPLETED|Overall Study||2
6262676|NCT01660243|7161681|FG003|NOT COMPLETED|Overall Study||1
6262677|NCT01617187|7161695|FG000|STARTED|Randomization Through Start Treatment|Randomized|98
6262678|NCT01617187|7161696|FG001|STARTED|Randomization Through Start Treatment|Randomized|113
6262679|NCT01617187|7161697|FG002|STARTED|Randomization Through Start Treatment|Randomized|46
6262680|NCT01617187|7161698|FG003|STARTED|Randomization Through Start Treatment|Randomized|103
6262681|NCT01617187|7161695|FG000|COMPLETED|Randomization Through Start Treatment||97
6262682|NCT01617187|7161696|FG001|COMPLETED|Randomization Through Start Treatment||113
6262683|NCT01617187|7161697|FG002|COMPLETED|Randomization Through Start Treatment||46
6262684|NCT01617187|7161698|FG003|COMPLETED|Randomization Through Start Treatment||101
6262685|NCT01617187|7161695|FG000|NOT COMPLETED|Randomization Through Start Treatment||1
6262686|NCT01617187|7161696|FG001|NOT COMPLETED|Randomization Through Start Treatment||0
6262687|NCT01617187|7161697|FG002|NOT COMPLETED|Randomization Through Start Treatment||0
6262688|NCT01617187|7161698|FG003|NOT COMPLETED|Randomization Through Start Treatment||2
6262689|NCT01617187|7161695|FG000|STARTED|Treatment Through Study Completion|Treated|97
6262690|NCT01617187|7161696|FG001|STARTED|Treatment Through Study Completion|Treated|113
6262691|NCT01617187|7161697|FG002|STARTED|Treatment Through Study Completion|Treated|46
6262692|NCT01617187|7161698|FG003|STARTED|Treatment Through Study Completion|Treated|101
6262693|NCT01617187|7161695|FG000|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
6262694|NCT01617187|7161696|FG001|COMPLETED|Treatment Through Study Completion||102
6262695|NCT01617187|7161697|FG002|COMPLETED|Treatment Through Study Completion||41
6262696|NCT01617187|7161698|FG003|COMPLETED|Treatment Through Study Completion||91
6713265|NCT02965989|7643122|FG000|COMPLETED|Overall Study||26
6713266|NCT02965989|7643123|FG001|COMPLETED|Overall Study||22
6713267|NCT02965989|7643122|FG000|NOT COMPLETED|Overall Study||0
6713268|NCT02965989|7643123|FG001|NOT COMPLETED|Overall Study||0
6713269|NCT02966002|7643135|FG000|STARTED|Overall Study||9
6713270|NCT02966002|7643135|FG000|COMPLETED|Overall Study||5
6713271|NCT02966002|7643135|FG000|NOT COMPLETED|Overall Study||4
6713272|NCT02966015|7643141|FG000|STARTED|Inclusion Visit||95
6713273|NCT02966015|7643142|FG001|STARTED|Inclusion Visit||58
6713274|NCT02966015|7643141|FG000|COMPLETED|Inclusion Visit||87
6713275|NCT02966015|7643142|FG001|COMPLETED|Inclusion Visit||55
6713276|NCT02966015|7643141|FG000|NOT COMPLETED|Inclusion Visit||8
6713277|NCT02966015|7643142|FG001|NOT COMPLETED|Inclusion Visit||3
6713278|NCT02966015|7643141|FG000|STARTED|Test Period||87
6713279|NCT02966015|7643142|FG001|STARTED|Test Period||55
6713280|NCT02966015|7643141|FG000|COMPLETED|Test Period||87
6713281|NCT02966015|7643142|FG001|COMPLETED|Test Period||55
6713282|NCT02966015|7643141|FG000|NOT COMPLETED|Test Period||0
6713283|NCT02966015|7643142|FG001|NOT COMPLETED|Test Period||0
6713284|NCT02966028|7643151|FG000|STARTED|Overall Study||92
6713285|NCT02966028|7643152|FG001|STARTED|Overall Study||91
6713286|NCT02966028|7643153|FG002|STARTED|Overall Study||91
6713287|NCT02966028|7643151|FG000|COMPLETED|Overall Study||68
6713288|NCT02966028|7643152|FG001|COMPLETED|Overall Study||57
6713289|NCT02966028|7643153|FG002|COMPLETED|Overall Study||60
6713290|NCT02966028|7643151|FG000|NOT COMPLETED|Overall Study||24
6713291|NCT02966028|7643152|FG001|NOT COMPLETED|Overall Study||34
6713292|NCT02966028|7643153|FG002|NOT COMPLETED|Overall Study||31
6713293|NCT02966275|7643165|FG000|STARTED|Overall Study||10
6713294|NCT02966275|7643165|FG000|COMPLETED|Overall Study||10
6713295|NCT02966275|7643165|FG000|NOT COMPLETED|Overall Study||0
6713296|NCT02966314|7643174|FG000|STARTED|Overall Study||5
6713297|NCT02966314|7643175|FG001|STARTED|Overall Study||5
6713298|NCT02966314|7643174|FG000|COMPLETED|Overall Study||4
6713299|NCT02966314|7643175|FG001|COMPLETED|Overall Study||5
6713300|NCT02966314|7643174|FG000|NOT COMPLETED|Overall Study||1
6713301|NCT02966314|7643175|FG001|NOT COMPLETED|Overall Study||0
6713302|NCT02966340|7643181|FG000|STARTED|Overall Study||37
6713303|NCT02966340|7643182|FG001|STARTED|Overall Study||33
6713304|NCT02966340|7643181|FG000|COMPLETED|Overall Study||34
6713305|NCT02966340|7643182|FG001|COMPLETED|Overall Study||30
6713306|NCT02966340|7643181|FG000|NOT COMPLETED|Overall Study||3
6713307|NCT02966340|7643182|FG001|NOT COMPLETED|Overall Study||3
6713308|NCT02966353|7643188|FG000|STARTED|Overall Study||51
6713309|NCT02966353|7643188|FG000|Completed After Data Cutoff|Overall Study||1
6713310|NCT02966353|7643188|FG000|COMPLETED|Overall Study||29
6713311|NCT02966353|7643188|FG000|NOT COMPLETED|Overall Study||22
6713312|NCT02966509|7643194|FG000|STARTED|Baseline Satisfaction Survey||105
6713313|NCT02966509|7643195|FG001|STARTED|Baseline Satisfaction Survey||108
6713314|NCT02966509|7643194|FG000|COMPLETED|Baseline Satisfaction Survey||101
6713315|NCT02966509|7643195|FG001|COMPLETED|Baseline Satisfaction Survey||101
6713316|NCT02966509|7643194|FG000|NOT COMPLETED|Baseline Satisfaction Survey||4
6713317|NCT02966509|7643195|FG001|NOT COMPLETED|Baseline Satisfaction Survey||7
6713318|NCT02966509|7643194|FG000|STARTED|6 Month Satisfaction Decision Survey||105
6713319|NCT02966509|7643195|FG001|STARTED|6 Month Satisfaction Decision Survey||108
6713320|NCT02966509|7643194|FG000|COMPLETED|6 Month Satisfaction Decision Survey||80
6713321|NCT02966509|7643195|FG001|COMPLETED|6 Month Satisfaction Decision Survey||77
6713322|NCT02966509|7643194|FG000|NOT COMPLETED|6 Month Satisfaction Decision Survey||25
6713323|NCT02966509|7643195|FG001|NOT COMPLETED|6 Month Satisfaction Decision Survey||31
6713324|NCT02966509|7643194|FG000|STARTED|6 Month Satisfaction Survey||105
6713325|NCT02966509|7643195|FG001|STARTED|6 Month Satisfaction Survey||108
6713326|NCT02966509|7643194|FG000|COMPLETED|6 Month Satisfaction Survey||58
6713327|NCT02966509|7643195|FG001|COMPLETED|6 Month Satisfaction Survey||60
6713328|NCT02966509|7643194|FG000|NOT COMPLETED|6 Month Satisfaction Survey||47
6713329|NCT02966509|7643195|FG001|NOT COMPLETED|6 Month Satisfaction Survey||48
6713330|NCT02966509|7643194|FG000|STARTED|6-Month Utilization and Cost||105
6713331|NCT02966509|7643195|FG001|STARTED|6-Month Utilization and Cost||108
6713332|NCT02966509|7643194|FG000|COMPLETED|6-Month Utilization and Cost||105
6262697|NCT01617187|7161695|FG000|NOT COMPLETED|Treatment Through Study Completion||11
6262698|NCT01617187|7161696|FG001|NOT COMPLETED|Treatment Through Study Completion||11
6602766|NCT02058966|7527826|FG000|STARTED|Second Intervention||13
6602767|NCT02058966|7527826|FG000|Received Placebo-Placebo|Second Intervention||2
6602768|NCT02058966|7527826|FG000|Received Placebo-Meth|Second Intervention||2
6602769|NCT02058966|7527826|FG000|Received Entacapone-Placebo|Second Intervention||6
6602770|NCT02058966|7527826|FG000|Received Entacapone-Meth|Second Intervention||3
6602771|NCT02058966|7527826|FG000|COMPLETED|Second Intervention||13
6602772|NCT02058966|7527826|FG000|NOT COMPLETED|Second Intervention||0
6602773|NCT02058966|7527826|FG000|STARTED|Third Intervention||12
6713333|NCT02966509|7643195|FG001|COMPLETED|6-Month Utilization and Cost||108
6713334|NCT02966509|7643194|FG000|NOT COMPLETED|6-Month Utilization and Cost||0
6713335|NCT02966509|7643195|FG001|NOT COMPLETED|6-Month Utilization and Cost||0
6713336|NCT02966509|7643194|FG000|STARTED|15-Month Utilization and Cost||105
6713337|NCT02966509|7643195|FG001|STARTED|15-Month Utilization and Cost||108
6713338|NCT02966509|7643194|FG000|COMPLETED|15-Month Utilization and Cost||105
6713339|NCT02966509|7643195|FG001|COMPLETED|15-Month Utilization and Cost||108
6713340|NCT02966509|7643194|FG000|NOT COMPLETED|15-Month Utilization and Cost||0
6713341|NCT02966509|7643195|FG001|NOT COMPLETED|15-Month Utilization and Cost||0
6713342|NCT02966509|7643194|FG000|STARTED|End of Life Utilization and Cost 6 Month||105
6713343|NCT02966509|7643195|FG001|STARTED|End of Life Utilization and Cost 6 Month||108
6713344|NCT02966509|7643194|FG000|COMPLETED|End of Life Utilization and Cost 6 Month||36
6713345|NCT02966509|7643195|FG001|COMPLETED|End of Life Utilization and Cost 6 Month||33
6713346|NCT02966509|7643194|FG000|NOT COMPLETED|End of Life Utilization and Cost 6 Month||69
6713347|NCT02966509|7643195|FG001|NOT COMPLETED|End of Life Utilization and Cost 6 Month||75
6713348|NCT02966509|7643194|FG000|STARTED|End of Life Utilization and Cost 15month||105
6713349|NCT02966509|7643195|FG001|STARTED|End of Life Utilization and Cost 15month||108
6713350|NCT02966509|7643194|FG000|COMPLETED|End of Life Utilization and Cost 15month||60
6713351|NCT02966509|7643195|FG001|COMPLETED|End of Life Utilization and Cost 15month||60
6713352|NCT02966509|7643194|FG000|NOT COMPLETED|End of Life Utilization and Cost 15month||45
6713353|NCT02966509|7643195|FG001|NOT COMPLETED|End of Life Utilization and Cost 15month||48
6713354|NCT02966795|7643203|FG000|STARTED|Overall Study||23
6713355|NCT02966795|7643204|FG001|STARTED|Overall Study||61
6713356|NCT02966795|7643203|FG000|COMPLETED|Overall Study||23
6713357|NCT02966795|7643204|FG001|COMPLETED|Overall Study||60
6713358|NCT02966795|7643203|FG000|NOT COMPLETED|Overall Study||0
6713359|NCT02966795|7643204|FG001|NOT COMPLETED|Overall Study||1
6713360|NCT02966834|7643215|FG000|STARTED|Main Study Period (Up to 12 Weeks)||36
6713361|NCT02966834|7643216|FG001|STARTED|Main Study Period (Up to 12 Weeks)||16
6713362|NCT02966834|7643217|FG002|STARTED|Main Study Period (Up to 12 Weeks)||23
6713363|NCT02966834|7643218|FG003|STARTED|Main Study Period (Up to 12 Weeks)||27
6713364|NCT02966834|7643219|FG004|STARTED|Main Study Period (Up to 12 Weeks)||23
6713365|NCT02966834|7643220|FG005|STARTED|Main Study Period (Up to 12 Weeks)||22
6713366|NCT02966834|7643215|FG000|COMPLETED|Main Study Period (Up to 12 Weeks)||35
6713367|NCT02966834|7643216|FG001|COMPLETED|Main Study Period (Up to 12 Weeks)||16
6713368|NCT02966834|7643217|FG002|COMPLETED|Main Study Period (Up to 12 Weeks)||19
6713369|NCT02966834|7643218|FG003|COMPLETED|Main Study Period (Up to 12 Weeks)||19
6713370|NCT02966834|7643219|FG004|COMPLETED|Main Study Period (Up to 12 Weeks)||22
6713371|NCT02966834|7643220|FG005|COMPLETED|Main Study Period (Up to 12 Weeks)||17
6713372|NCT02966834|7643215|FG000|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
6713373|NCT02966834|7643216|FG001|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||0
6713374|NCT02966834|7643217|FG002|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||4
6713375|NCT02966834|7643218|FG003|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||8
6713376|NCT02966834|7643219|FG004|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||1
6713377|NCT02966834|7643220|FG005|NOT COMPLETED|Main Study Period (Up to 12 Weeks)||5
6713378|NCT02966834|7643215|FG000|STARTED|Final Study Period (Up to 4 Weeks)||35
6713379|NCT02966834|7643216|FG001|STARTED|Final Study Period (Up to 4 Weeks)||16
6713380|NCT02966834|7643217|FG002|STARTED|Final Study Period (Up to 4 Weeks)||19
6713381|NCT02966834|7643218|FG003|STARTED|Final Study Period (Up to 4 Weeks)||19
6713382|NCT02966834|7643219|FG004|STARTED|Final Study Period (Up to 4 Weeks)|One participant did not enter Final Study Period.|21
6713383|NCT02966834|7643220|FG005|STARTED|Final Study Period (Up to 4 Weeks)||17
6713384|NCT02966834|7643215|FG000|COMPLETED|Final Study Period (Up to 4 Weeks)||35
6713385|NCT02966834|7643216|FG001|COMPLETED|Final Study Period (Up to 4 Weeks)||16
6713386|NCT02966834|7643217|FG002|COMPLETED|Final Study Period (Up to 4 Weeks)||19
6713387|NCT02966834|7643218|FG003|COMPLETED|Final Study Period (Up to 4 Weeks)||19
6713388|NCT02966834|7643219|FG004|COMPLETED|Final Study Period (Up to 4 Weeks)||21
6713389|NCT02966834|7643220|FG005|COMPLETED|Final Study Period (Up to 4 Weeks)||17
6713390|NCT02966834|7643215|FG000|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
6713391|NCT02966834|7643216|FG001|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
6713392|NCT02966834|7643217|FG002|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
6713393|NCT02966834|7643218|FG003|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
6713394|NCT02966834|7643219|FG004|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
6713395|NCT02966834|7643220|FG005|NOT COMPLETED|Final Study Period (Up to 4 Weeks)||0
6713396|NCT02966834|7643215|FG000|STARTED|Follow-up (Up to 4 Weeks)||35
6713397|NCT02966834|7643216|FG001|STARTED|Follow-up (Up to 4 Weeks)||16
6713398|NCT02966834|7643217|FG002|STARTED|Follow-up (Up to 4 Weeks)|4 participants discontinued study treatment in Main study period and directly entered follow-up.|23
6713399|NCT02966834|7643218|FG003|STARTED|Follow-up (Up to 4 Weeks)|8 participants discontinued study treatment in Main Study period and directly entered follow-up.|27
6713400|NCT02966834|7643219|FG004|STARTED|Follow-up (Up to 4 Weeks)|1 participant who completed main study period directly entered follow-up in this arm|22
6713401|NCT02966834|7643220|FG005|STARTED|Follow-up (Up to 4 Weeks)|5 participants discontinued study treatment in Main study period and directly entered follow-up|22
6713402|NCT02966834|7643215|FG000|COMPLETED|Follow-up (Up to 4 Weeks)||35
6713403|NCT02966834|7643216|FG001|COMPLETED|Follow-up (Up to 4 Weeks)||16
6713404|NCT02966834|7643217|FG002|COMPLETED|Follow-up (Up to 4 Weeks)||22
6713405|NCT02966834|7643218|FG003|COMPLETED|Follow-up (Up to 4 Weeks)||22
6713406|NCT02966834|7643219|FG004|COMPLETED|Follow-up (Up to 4 Weeks)||22
6713407|NCT02966834|7643220|FG005|COMPLETED|Follow-up (Up to 4 Weeks)||21
6713408|NCT02966834|7643215|FG000|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
6713409|NCT02966834|7643216|FG001|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
6713410|NCT02966834|7643217|FG002|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
6713411|NCT02966834|7643218|FG003|NOT COMPLETED|Follow-up (Up to 4 Weeks)||5
6713412|NCT02966834|7643219|FG004|NOT COMPLETED|Follow-up (Up to 4 Weeks)||0
6713413|NCT02966834|7643220|FG005|NOT COMPLETED|Follow-up (Up to 4 Weeks)||1
6713414|NCT02967016|7643271|FG000|STARTED|Overall Study||25
6713415|NCT02967016|7643272|FG001|STARTED|Overall Study||25
6713416|NCT02967016|7643271|FG000|COMPLETED|Overall Study||25
6713417|NCT02967016|7643272|FG001|COMPLETED|Overall Study||25
6713418|NCT02967016|7643271|FG000|NOT COMPLETED|Overall Study||0
6713419|NCT02967016|7643272|FG001|NOT COMPLETED|Overall Study||0
6713420|NCT02967055|7643278|FG000|STARTED|Overall Study|Assessed for eligibility|54
6713421|NCT02967055|7643278|FG000|In-person Screening|Overall Study||14
6713422|NCT02967055|7643278|FG000|Enrolled|Overall Study|Enrolled|9
6713423|NCT02967055|7643278|FG000|Completed 4 Week Follow-up Visit|Overall Study||8
6713424|NCT02967055|7643278|FG000|COMPLETED|Overall Study||5
6713425|NCT02967055|7643278|FG000|NOT COMPLETED|Overall Study||49
6713426|NCT02967354|7643287|FG000|STARTED|Overall Study||8
6713427|NCT02967354|7643288|FG001|STARTED|Overall Study||7
6713428|NCT02967354|7643289|FG002|STARTED|Overall Study||9
6713429|NCT02967354|7643290|FG003|STARTED|Overall Study||7
6713430|NCT02967354|7643291|FG004|STARTED|Overall Study||8
6713431|NCT02967354|7643287|FG000|COMPLETED|Overall Study||8
6713432|NCT02967354|7643288|FG001|COMPLETED|Overall Study||7
6713433|NCT02967354|7643289|FG002|COMPLETED|Overall Study||9
6713434|NCT02967354|7643290|FG003|COMPLETED|Overall Study||7
6713435|NCT02967354|7643291|FG004|COMPLETED|Overall Study||8
6713436|NCT02967354|7643287|FG000|NOT COMPLETED|Overall Study||0
6713437|NCT02967354|7643288|FG001|NOT COMPLETED|Overall Study||0
6713438|NCT02967354|7643289|FG002|NOT COMPLETED|Overall Study||0
6713439|NCT02967354|7643290|FG003|NOT COMPLETED|Overall Study||0
6713440|NCT02967354|7643291|FG004|NOT COMPLETED|Overall Study||0
6713441|NCT02967367|7643308|FG000|STARTED|Overall Study||36
6713442|NCT02967367|7643308|FG000|COMPLETED|Overall Study||22
6713443|NCT02967367|7643308|FG000|NOT COMPLETED|Overall Study||14
6713444|NCT02967393|7643314|FG000|STARTED|Overall Study||20
6713445|NCT02967393|7643315|FG001|STARTED|Overall Study||20
6713446|NCT02967393|7643314|FG000|COMPLETED|Overall Study||20
6713447|NCT02967393|7643315|FG001|COMPLETED|Overall Study||20
6713448|NCT02967393|7643314|FG000|NOT COMPLETED|Overall Study||0
6713449|NCT02967393|7643315|FG001|NOT COMPLETED|Overall Study||0
6713450|NCT02967458|7643323|FG000|STARTED|Overall Study||55
6713451|NCT02967458|7643323|FG000|COMPLETED|Overall Study||55
6713452|NCT02967458|7643323|FG000|NOT COMPLETED|Overall Study||0
6713453|NCT02967510|7643332|FG000|STARTED|Overall Study||70
6713454|NCT02967510|7643333|FG001|STARTED|Overall Study||70
6713455|NCT02967510|7643334|FG002|STARTED|Overall Study||72
6713456|NCT02967510|7643335|FG003|STARTED|Overall Study||71
6713457|NCT02967510|7643332|FG000|COMPLETED|Overall Study||66
6713458|NCT02967510|7643333|FG001|COMPLETED|Overall Study||67
6713459|NCT02967510|7643334|FG002|COMPLETED|Overall Study||65
6713460|NCT02967510|7643335|FG003|COMPLETED|Overall Study||63
6713461|NCT02967510|7643332|FG000|NOT COMPLETED|Overall Study||4
6713462|NCT02967510|7643333|FG001|NOT COMPLETED|Overall Study||3
6713463|NCT02967510|7643334|FG002|NOT COMPLETED|Overall Study||7
6713464|NCT02967510|7643335|FG003|NOT COMPLETED|Overall Study||8
6713465|NCT02967562|7643347|FG000|STARTED|Overall Study||32
6713466|NCT02967562|7643348|FG001|STARTED|Overall Study||31
6713467|NCT02967562|7643347|FG000|COMPLETED|Overall Study||30
6713468|NCT02967562|7643348|FG001|COMPLETED|Overall Study||30
6713469|NCT02967562|7643347|FG000|NOT COMPLETED|Overall Study||2
6713470|NCT02967562|7643348|FG001|NOT COMPLETED|Overall Study||1
6713471|NCT02967679|7643354|FG000|STARTED|Overall Study||15
6713472|NCT02967679|7643354|FG000|COMPLETED|Overall Study||14
6713473|NCT02967679|7643354|FG000|NOT COMPLETED|Overall Study||1
6713474|NCT02967991|7643358|FG000|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
6713475|NCT02967991|7643359|FG001|STARTED|Overall Study|First Intervention: 10 minutes Washout: 1 minute Second Intervention: 10 minutes|10
6713476|NCT02967991|7643358|FG000|COMPLETED|Overall Study||10
6713477|NCT02967991|7643359|FG001|COMPLETED|Overall Study||10
6713478|NCT02967991|7643358|FG000|NOT COMPLETED|Overall Study||0
6713479|NCT02967991|7643359|FG001|NOT COMPLETED|Overall Study||0
6713480|NCT02968004|7643371|FG000|STARTED|Overall Study||109
6713481|NCT02968004|7643372|FG001|STARTED|Overall Study||115
6713482|NCT02968004|7643371|FG000|COMPLETED|Overall Study||108
6713483|NCT02968004|7643372|FG001|COMPLETED|Overall Study||114
6713484|NCT02968004|7643371|FG000|NOT COMPLETED|Overall Study||1
6713485|NCT02968004|7643372|FG001|NOT COMPLETED|Overall Study||1
6713486|NCT02968134|7643378|FG000|STARTED|Overall Study||8
6713487|NCT02968134|7643378|FG000|COMPLETED|Overall Study||8
6713488|NCT02968134|7643378|FG000|NOT COMPLETED|Overall Study||0
6713489|NCT02968173|7643382|FG000|STARTED|Overall Study||50
6713490|NCT02968173|7643382|FG000|COMPLETED|Overall Study||49
6713491|NCT02968173|7643382|FG000|NOT COMPLETED|Overall Study||1
6713492|NCT02968277|7643390|FG000|STARTED|Overall Study||10
6713493|NCT02968277|7643391|FG001|STARTED|Overall Study||7
6713494|NCT02968277|7643392|FG002|STARTED|Overall Study||13
6713495|NCT02968277|7643390|FG000|COMPLETED|Overall Study||10
6713496|NCT02968277|7643391|FG001|COMPLETED|Overall Study||7
6713497|NCT02968277|7643392|FG002|COMPLETED|Overall Study||13
6713498|NCT02968277|7643390|FG000|NOT COMPLETED|Overall Study||0
6713499|NCT02968277|7643391|FG001|NOT COMPLETED|Overall Study||0
6713500|NCT02968277|7643392|FG002|NOT COMPLETED|Overall Study||0
6713501|NCT02968368|7643406|FG000|STARTED|Double Blind Phase||111
6713502|NCT02968368|7643407|FG001|STARTED|Double Blind Phase||56
6713503|NCT02968368|7643406|FG000|COMPLETED|Double Blind Phase||90
6713504|NCT02968368|7643407|FG001|COMPLETED|Double Blind Phase||39
6713505|NCT02968368|7643406|FG000|NOT COMPLETED|Double Blind Phase||21
6713506|NCT02968368|7643407|FG001|NOT COMPLETED|Double Blind Phase||17
6713507|NCT02968368|7643406|FG000|STARTED|Open Label Phase||86
6713508|NCT02968368|7643407|FG001|STARTED|Open Label Phase||39
6713509|NCT02968368|7643406|FG000|COMPLETED|Open Label Phase||67
6713510|NCT02968368|7643407|FG001|COMPLETED|Open Label Phase||25
6713511|NCT02968368|7643406|FG000|NOT COMPLETED|Open Label Phase||19
6713512|NCT02968368|7643407|FG001|NOT COMPLETED|Open Label Phase||14
6713513|NCT02968420|7643418|FG000|STARTED|Overall Study||6
6713514|NCT02968420|7643419|FG001|STARTED|Overall Study||6
6713515|NCT02968420|7643420|FG002|STARTED|Overall Study||6
6713516|NCT02968420|7643418|FG000|COMPLETED|Overall Study||6
6713517|NCT02968420|7643419|FG001|COMPLETED|Overall Study||6
6713518|NCT02968420|7643420|FG002|COMPLETED|Overall Study||6
6713519|NCT02968420|7643418|FG000|NOT COMPLETED|Overall Study||0
6713520|NCT02968420|7643419|FG001|NOT COMPLETED|Overall Study||0
6713521|NCT02968420|7643420|FG002|NOT COMPLETED|Overall Study||0
6713522|NCT02968433|7643428|FG000|STARTED|Overall Study||16
6713523|NCT02968433|7643428|FG000|COMPLETED|Overall Study||15
6713524|NCT02968433|7643428|FG000|NOT COMPLETED|Overall Study||1
6713525|NCT02968576|7643438|FG000|STARTED|Overall Study||11
6713526|NCT02968576|7643439|FG001|STARTED|Overall Study||14
6713527|NCT02968576|7643438|FG000|COMPLETED|Overall Study||11
6713528|NCT02968576|7643439|FG001|COMPLETED|Overall Study||13
6713529|NCT02968576|7643438|FG000|NOT COMPLETED|Overall Study||0
6713530|NCT02968576|7643439|FG001|NOT COMPLETED|Overall Study||1
6713531|NCT02968758|7643445|FG000|STARTED|Overall Study||797
6713532|NCT02968758|7643446|FG001|STARTED|Overall Study||1664
6713533|NCT02968758|7643445|FG000|COMPLETED|Overall Study||797
6713534|NCT02968758|7643446|FG001|COMPLETED|Overall Study||1664
6713535|NCT02968758|7643445|FG000|NOT COMPLETED|Overall Study||0
6713536|NCT02968758|7643446|FG001|NOT COMPLETED|Overall Study||0
6713537|NCT02968914|7643453|FG000|STARTED|Overall Study||90
6713538|NCT02968914|7643454|FG001|STARTED|Overall Study||90
6713539|NCT02968914|7643453|FG000|COMPLETED|Overall Study||90
6713540|NCT02968914|7643454|FG001|COMPLETED|Overall Study||90
6713541|NCT02968914|7643453|FG000|NOT COMPLETED|Overall Study||0
6713542|NCT02968914|7643454|FG001|NOT COMPLETED|Overall Study||0
6713543|NCT02968979|7643460|FG000|STARTED|Overall Study||539
6713544|NCT02968979|7643460|FG000|COMPLETED|Overall Study|This cross-sectional study had only 1 visit.|531
6713545|NCT02968979|7643460|FG000|NOT COMPLETED|Overall Study||8
6739364|NCT03287791|7668204|FG002|PP Population|Overall Study||245
6739365|NCT03287791|7668202|FG000|COMPLETED|Overall Study||280
6739366|NCT03287791|7668203|FG001|COMPLETED|Overall Study||276
6739367|NCT03287791|7668204|FG002|COMPLETED|Overall Study||264
6739368|NCT03287791|7668202|FG000|NOT COMPLETED|Overall Study||32
6739369|NCT03287791|7668203|FG001|NOT COMPLETED|Overall Study||36
6739370|NCT03287791|7668204|FG002|NOT COMPLETED|Overall Study||36
6739371|NCT03287804|7668212|FG000|STARTED|Overall Study||12
6739372|NCT03287804|7668212|FG000|Leukaperesed|Overall Study||12
6739373|NCT03287804|7668212|FG000|Started Pre-conditioning Therapy|Overall Study||11
6739374|NCT03287804|7668212|FG000|Received Study Treatment|Overall Study||11
6739375|NCT03287804|7668212|FG000|COMPLETED|Overall Study||1
6739376|NCT03287804|7668212|FG000|NOT COMPLETED|Overall Study||11
6739377|NCT03287869|7668219|FG000|STARTED|Overall Study||188
6739378|NCT03287869|7668220|FG001|STARTED|Overall Study||193
6739379|NCT03287869|7668219|FG000|Analyzed For Safety (Safety Sample)|Overall Study||184
6739380|NCT03287869|7668220|FG001|Analyzed For Safety (Safety Sample)|Overall Study||184
6739381|NCT03287869|7668219|FG000|COMPLETED|Overall Study||105
6739382|NCT03287869|7668220|FG001|COMPLETED|Overall Study||100
6739383|NCT03287869|7668219|FG000|NOT COMPLETED|Overall Study||83
6739384|NCT03287869|7668220|FG001|NOT COMPLETED|Overall Study||93
6739385|NCT03288714|7668228|FG000|STARTED|Overall Study||59
6739386|NCT03288714|7668229|FG001|STARTED|Overall Study||62
6739387|NCT03288714|7668228|FG000|COMPLETED|Overall Study||49
6739388|NCT03288714|7668229|FG001|COMPLETED|Overall Study||59
6739389|NCT03288714|7668228|FG000|NOT COMPLETED|Overall Study||10
6739390|NCT03288714|7668229|FG001|NOT COMPLETED|Overall Study||3
6739391|NCT03288779|7668237|FG000|STARTED|Overall Study||6
6739392|NCT03288779|7668237|FG000|COMPLETED|Overall Study||3
6739393|NCT03288779|7668237|FG000|NOT COMPLETED|Overall Study||3
6739394|NCT03288987|7668243|FG000|STARTED|Overall Study||82
6739395|NCT03288987|7668244|FG001|STARTED|Overall Study||44
6739396|NCT03288987|7668243|FG000|Patients Receiving Medication|Overall Study||80
6739397|NCT03288987|7668244|FG001|Patients Receiving Medication|Overall Study||44
6739398|NCT03288987|7668243|FG000|COMPLETED|Overall Study|Per protocol population|72
6739399|NCT03288987|7668244|FG001|COMPLETED|Overall Study|Per protocol population|40
6739400|NCT03288987|7668243|FG000|NOT COMPLETED|Overall Study||10
6739401|NCT03288987|7668244|FG001|NOT COMPLETED|Overall Study||4
6739402|NCT03289052|7668253|FG000|STARTED|Overall Study||20
6739403|NCT03289052|7668254|FG001|STARTED|Overall Study||111
6739404|NCT03289052|7668255|FG002|STARTED|Overall Study||37
6739405|NCT03289052|7668253|FG000|COMPLETED|Overall Study||20
6739406|NCT03289052|7668254|FG001|COMPLETED|Overall Study||108
6739407|NCT03289052|7668255|FG002|COMPLETED|Overall Study||32
6739408|NCT03289052|7668253|FG000|NOT COMPLETED|Overall Study||0
6739409|NCT03289052|7668254|FG001|NOT COMPLETED|Overall Study||3
6739410|NCT03289052|7668255|FG002|NOT COMPLETED|Overall Study||5
6739411|NCT03289208|7668266|FG000|STARTED|Overall Study||11
6739412|NCT03289208|7668267|FG001|STARTED|Overall Study||8
6739413|NCT03289208|7668268|FG002|STARTED|Overall Study||11
6739414|NCT03289208|7668266|FG000|COMPLETED|Overall Study||10
6713546|NCT02968992|7643512|FG000|STARTED|Overall Study||18
6713547|NCT02968992|7643513|FG001|STARTED|Overall Study||18
6713548|NCT02968992|7643512|FG000|COMPLETED|Overall Study||18
6713549|NCT02968992|7643513|FG001|COMPLETED|Overall Study||17
6713550|NCT02968992|7643512|FG000|NOT COMPLETED|Overall Study||0
6713551|NCT02968992|7643513|FG001|NOT COMPLETED|Overall Study||1
6713552|NCT02969018|7643527|FG000|STARTED|Overall Study||25
6713553|NCT02969018|7643528|FG001|STARTED|Overall Study||29
6713554|NCT02969018|7643529|FG002|STARTED|Overall Study||26
6713555|NCT02969018|7643530|FG003|STARTED|Overall Study||25
6713556|NCT02969018|7643531|FG004|STARTED|Overall Study||29
6713557|NCT02969018|7643532|FG005|STARTED|Overall Study||25
6713558|NCT02969018|7643533|FG006|STARTED|Overall Study||30
6713559|NCT02969018|7643534|FG007|STARTED|Overall Study||23
6713560|NCT02969018|7643527|FG000|COMPLETED|Overall Study||21
6713561|NCT02969018|7643528|FG001|COMPLETED|Overall Study||21
6713562|NCT02969018|7643529|FG002|COMPLETED|Overall Study||20
6713563|NCT02969018|7643530|FG003|COMPLETED|Overall Study||20
6713564|NCT02969018|7643531|FG004|COMPLETED|Overall Study||27
6713565|NCT02969018|7643532|FG005|COMPLETED|Overall Study||17
6713566|NCT02969018|7643533|FG006|COMPLETED|Overall Study||22
6713567|NCT02969018|7643534|FG007|COMPLETED|Overall Study||16
6713568|NCT02969018|7643527|FG000|NOT COMPLETED|Overall Study||4
6713569|NCT02969018|7643528|FG001|NOT COMPLETED|Overall Study||8
6713570|NCT02969018|7643529|FG002|NOT COMPLETED|Overall Study||6
6713571|NCT02969018|7643530|FG003|NOT COMPLETED|Overall Study||5
6713572|NCT02969018|7643531|FG004|NOT COMPLETED|Overall Study||2
6713573|NCT02969018|7643532|FG005|NOT COMPLETED|Overall Study||8
6713574|NCT02969018|7643533|FG006|NOT COMPLETED|Overall Study||8
6713575|NCT02969018|7643534|FG007|NOT COMPLETED|Overall Study||7
6713576|NCT02969031|7643557|FG000|STARTED|Enrolled and Randomized||73
6713577|NCT02969031|7643558|FG001|STARTED|Enrolled and Randomized||75
6713578|NCT02969031|7643557|FG000|COMPLETED|Enrolled and Randomized||73
6713579|NCT02969031|7643558|FG001|COMPLETED|Enrolled and Randomized||75
6713580|NCT02969031|7643557|FG000|NOT COMPLETED|Enrolled and Randomized||0
6713581|NCT02969031|7643558|FG001|NOT COMPLETED|Enrolled and Randomized||0
6713582|NCT02969031|7643557|FG000|STARTED|Collection of Baseline Surveys||73
6713583|NCT02969031|7643558|FG001|STARTED|Collection of Baseline Surveys||75
6713584|NCT02969031|7643557|FG000|COMPLETED|Collection of Baseline Surveys||34
6713585|NCT02969031|7643558|FG001|COMPLETED|Collection of Baseline Surveys||23
6713586|NCT02969031|7643557|FG000|NOT COMPLETED|Collection of Baseline Surveys||39
6713587|NCT02969031|7643558|FG001|NOT COMPLETED|Collection of Baseline Surveys||52
6713588|NCT02969031|7643557|FG000|STARTED|Collection of Baseline Recordings||34
6713589|NCT02969031|7643558|FG001|STARTED|Collection of Baseline Recordings||23
6713590|NCT02969031|7643557|FG000|COMPLETED|Collection of Baseline Recordings||22
6713591|NCT02969031|7643558|FG001|COMPLETED|Collection of Baseline Recordings||18
6713592|NCT02969031|7643557|FG000|NOT COMPLETED|Collection of Baseline Recordings||12
6713593|NCT02969031|7643558|FG001|NOT COMPLETED|Collection of Baseline Recordings||5
6713594|NCT02969031|7643557|FG000|STARTED|Completed Intervention||22
6713595|NCT02969031|7643558|FG001|STARTED|Completed Intervention||18
6713596|NCT02969031|7643557|FG000|COMPLETED|Completed Intervention||15
6713597|NCT02969031|7643558|FG001|COMPLETED|Completed Intervention||14
6713598|NCT02969031|7643557|FG000|NOT COMPLETED|Completed Intervention||7
6713599|NCT02969031|7643558|FG001|NOT COMPLETED|Completed Intervention||4
6713600|NCT02969031|7643557|FG000|STARTED|Collection of Follow-Up Surveys||15
6713601|NCT02969031|7643558|FG001|STARTED|Collection of Follow-Up Surveys||14
6713602|NCT02969031|7643557|FG000|COMPLETED|Collection of Follow-Up Surveys||15
6713603|NCT02969031|7643558|FG001|COMPLETED|Collection of Follow-Up Surveys||12
6713604|NCT02969031|7643557|FG000|NOT COMPLETED|Collection of Follow-Up Surveys||0
6713605|NCT02969031|7643558|FG001|NOT COMPLETED|Collection of Follow-Up Surveys||2
6713606|NCT02969031|7643557|FG000|STARTED|Collection of Follow-Up Recordings||15
6713607|NCT02969031|7643558|FG001|STARTED|Collection of Follow-Up Recordings||12
6713608|NCT02969031|7643557|FG000|COMPLETED|Collection of Follow-Up Recordings||15
6713609|NCT02969031|7643558|FG001|COMPLETED|Collection of Follow-Up Recordings||12
6713610|NCT02969031|7643557|FG000|NOT COMPLETED|Collection of Follow-Up Recordings||0
6713611|NCT02969031|7643558|FG001|NOT COMPLETED|Collection of Follow-Up Recordings||0
6713612|NCT02969031|7643557|FG000|STARTED|Completed and Analyzed||15
6713613|NCT02969031|7643558|FG001|STARTED|Completed and Analyzed||12
6713614|NCT02969031|7643557|FG000|COMPLETED|Completed and Analyzed||15
6713615|NCT02969031|7643558|FG001|COMPLETED|Completed and Analyzed||12
6713616|NCT02969031|7643557|FG000|NOT COMPLETED|Completed and Analyzed||0
6713617|NCT02969031|7643558|FG001|NOT COMPLETED|Completed and Analyzed||0
6713618|NCT02969044|7643566|FG000|STARTED|Overall Study||42
6713619|NCT02969044|7643567|FG001|STARTED|Overall Study||28
6713620|NCT02969044|7643566|FG000|COMPLETED|Overall Study||37
6713621|NCT02969044|7643567|FG001|COMPLETED|Overall Study||22
6713622|NCT02969044|7643566|FG000|NOT COMPLETED|Overall Study||5
6713623|NCT02969044|7643567|FG001|NOT COMPLETED|Overall Study||6
6713624|NCT02969187|7643575|FG000|STARTED|Overall Study||63
6713625|NCT02969187|7643576|FG001|STARTED|Overall Study||63
6713626|NCT02969187|7643575|FG000|COMPLETED|Overall Study||51
6713627|NCT02969187|7643576|FG001|COMPLETED|Overall Study||50
6713628|NCT02969187|7643575|FG000|NOT COMPLETED|Overall Study||12
6713629|NCT02969187|7643576|FG001|NOT COMPLETED|Overall Study||13
6713630|NCT02969317|7643584|FG000|STARTED|Overall Study||12
6713631|NCT02969317|7643584|FG000|COMPLETED|Overall Study||12
6713632|NCT02969317|7643584|FG000|NOT COMPLETED|Overall Study||0
6713633|NCT02969356|7643589|FG000|STARTED|Overall Study||157
6713634|NCT02969356|7643589|FG000|Intent-to-Treat (ITT) Population|Overall Study||153
6713635|NCT02969356|7643589|FG000|COMPLETED|Overall Study||134
6713636|NCT02969356|7643589|FG000|NOT COMPLETED|Overall Study||23
6713637|NCT02969382|7643595|FG000|STARTED|Overall Study||125
6713638|NCT02969382|7643596|FG001|STARTED|Overall Study||120
6713639|NCT02969382|7643595|FG000|Subjects Continued Into Extension Study|Overall Study||79
6713640|NCT02969382|7643596|FG001|Subjects Continued Into Extension Study|Overall Study||78
6713641|NCT02969382|7643595|FG000|COMPLETED|Overall Study||99
6713642|NCT02969382|7643596|FG001|COMPLETED|Overall Study||94
6713643|NCT02969382|7643595|FG000|NOT COMPLETED|Overall Study||26
6713644|NCT02969382|7643596|FG001|NOT COMPLETED|Overall Study||26
6713645|NCT02969408|7643602|FG000|STARTED|Overall Study||397
6713646|NCT02969408|7643602|FG000|Used ABS eMDPI at Least Once|Overall Study||370
6713647|NCT02969408|7643602|FG000|COMPLETED|Overall Study||381
6262699|NCT01617187|7161697|FG002|NOT COMPLETED|Treatment Through Study Completion||5
6262700|NCT01617187|7161698|FG003|NOT COMPLETED|Treatment Through Study Completion||10
6262701|NCT01611883|7161710|FG000|STARTED|Overall Study||75
6262702|NCT01611883|7161711|FG001|STARTED|Overall Study||77
6262703|NCT01611883|7161710|FG000|COMPLETED|Overall Study||74
6262704|NCT01611883|7161711|FG001|COMPLETED|Overall Study||76
6262705|NCT01611883|7161710|FG000|NOT COMPLETED|Overall Study||1
6262706|NCT01611883|7161711|FG001|NOT COMPLETED|Overall Study||1
6262707|NCT01572675|7161719|FG000|STARTED|Overall Study||268
6262708|NCT01572675|7161720|FG001|STARTED|Overall Study||279
6262709|NCT01572675|7161719|FG000|COMPLETED|Overall Study||31
6262710|NCT01572675|7161720|FG001|COMPLETED|Overall Study||56
6262711|NCT01572675|7161719|FG000|NOT COMPLETED|Overall Study||237
6262712|NCT01572675|7161720|FG001|NOT COMPLETED|Overall Study||223
6262713|NCT01554163|7161741|FG000|STARTED|Overall Study||120
6262714|NCT01554163|7161742|FG001|STARTED|Overall Study||119
6262715|NCT01554163|7161741|FG000|Number Treated|Overall Study||119
6262716|NCT01554163|7161742|FG001|Number Treated|Overall Study||119
6262717|NCT01554163|7161741|FG000|COMPLETED|Overall Study||112
6262718|NCT01554163|7161742|FG001|COMPLETED|Overall Study||109
6262719|NCT01554163|7161741|FG000|NOT COMPLETED|Overall Study||8
6262720|NCT01554163|7161742|FG001|NOT COMPLETED|Overall Study||10
6262721|NCT01502371|7161753|FG000|STARTED|Overall Study||120
6262722|NCT01502371|7161754|FG001|STARTED|Overall Study||113
6262723|NCT01502371|7161755|FG002|STARTED|Overall Study||108
6262724|NCT01502371|7161756|FG003|STARTED|Overall Study||125
6262725|NCT01502371|7161757|FG004|STARTED|Overall Study||112
6262726|NCT01502371|7161753|FG000|COMPLETED|Overall Study||79
6262727|NCT01502371|7161754|FG001|COMPLETED|Overall Study||81
6262728|NCT01502371|7161755|FG002|COMPLETED|Overall Study||83
6262729|NCT01502371|7161756|FG003|COMPLETED|Overall Study||88
6262730|NCT01502371|7161757|FG004|COMPLETED|Overall Study||60
6262731|NCT01502371|7161753|FG000|NOT COMPLETED|Overall Study||41
6262732|NCT01502371|7161754|FG001|NOT COMPLETED|Overall Study||32
6262733|NCT01502371|7161755|FG002|NOT COMPLETED|Overall Study||25
6262734|NCT01502371|7161756|FG003|NOT COMPLETED|Overall Study||37
6262735|NCT01502371|7161757|FG004|NOT COMPLETED|Overall Study||52
6262736|NCT01490190|7161770|FG000|STARTED|Overall Study||252
6262737|NCT01490190|7161770|FG000|COMPLETED|Overall Study||204
6262738|NCT01490190|7161770|FG000|NOT COMPLETED|Overall Study||48
6280391|NCT00154310|7180314|FG000|NOT COMPLETED|Overall Study||37
6280392|NCT00154310|7180315|FG001|NOT COMPLETED|Overall Study||28
6280393|NCT00154375|7180323|FG000|STARTED|Overall Study||120
6280394|NCT00154375|7180324|FG001|STARTED|Overall Study||120
6280395|NCT00154375|7180323|FG000|Discontinued Study Treatment|Overall Study||111
6280396|NCT00154375|7180324|FG001|Discontinued Study Treatment|Overall Study||104
6280397|NCT00154375|7180323|FG000|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
6280398|NCT00154375|7180324|FG001|Not Exposed to Study Treatment|Overall Study||2
6280399|NCT00154375|7180323|FG000|COMPLETED|Overall Study||7
6280400|NCT00154375|7180324|FG001|COMPLETED|Overall Study||14
6280401|NCT00154375|7180323|FG000|NOT COMPLETED|Overall Study||113
6280402|NCT00154375|7180324|FG001|NOT COMPLETED|Overall Study||106
6280403|NCT00154466|7180334|FG000|STARTED|Overall Study||20
6280404|NCT00154466|7180335|FG001|STARTED|Overall Study||19
6280405|NCT00154466|7180336|FG002|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
6280406|NCT00154466|7180334|FG000|COMPLETED|Overall Study||20
6280407|NCT00154466|7180335|FG001|COMPLETED|Overall Study||19
6280408|NCT00154466|7180336|FG002|COMPLETED|Overall Study||19
6280409|NCT00154466|7180334|FG000|NOT COMPLETED|Overall Study||0
6280410|NCT00154466|7180335|FG001|NOT COMPLETED|Overall Study||0
6280411|NCT00154466|7180336|FG002|NOT COMPLETED|Overall Study||0
6280412|NCT00156013|7180346|FG000|STARTED|Overall Study||33
6280413|NCT00156013|7180346|FG000|COMPLETED|Overall Study||31
6713648|NCT02969408|7643602|FG000|NOT COMPLETED|Overall Study||16
6713649|NCT02969421|7643608|FG000|STARTED|Overall Study||33
6713650|NCT02969421|7643609|FG001|STARTED|Overall Study||33
6713651|NCT02969421|7643608|FG000|COMPLETED|Overall Study||33
6713652|NCT02969421|7643609|FG001|COMPLETED|Overall Study||33
6713653|NCT02969421|7643608|FG000|NOT COMPLETED|Overall Study||0
6713654|NCT02969421|7643609|FG001|NOT COMPLETED|Overall Study||0
6280414|NCT00156013|7180346|FG000|NOT COMPLETED|Overall Study||2
6280415|NCT00156247|7180352|FG000|STARTED|Overall Study||9
6713655|NCT02969499|7643615|FG000|STARTED|Overall Study||33
6713656|NCT02969499|7643615|FG000|COMPLETED|Overall Study||33
6713657|NCT02969499|7643615|FG000|NOT COMPLETED|Overall Study||0
6713658|NCT02969525|7643624|FG000|STARTED|Double-Blind Period||42
6713659|NCT02969525|7643625|FG001|STARTED|Double-Blind Period||41
6713660|NCT02969525|7643626|FG002|STARTED|Double-Blind Period||41
6713661|NCT02969525|7643627|FG003|STARTED|Double-Blind Period||41
6713662|NCT02969525|7643628|FG004|STARTED|Double-Blind Period||41
6713663|NCT02969525|7643629|FG005|STARTED|Double-Blind Period||0
6713664|NCT02969525|7643630|FG006|STARTED|Double-Blind Period||0
6713665|NCT02969525|7643631|FG007|STARTED|Double-Blind Period||0
6713666|NCT02969525|7643632|FG008|STARTED|Double-Blind Period||0
6713667|NCT02969525|7643633|FG009|STARTED|Double-Blind Period||0
6713668|NCT02969525|7643634|FG010|STARTED|Double-Blind Period||0
6713669|NCT02969525|7643635|FG011|STARTED|Double-Blind Period||0
6713670|NCT02969525|7643624|FG000|Completed Double-Blind Period|Double-Blind Period||42
6713671|NCT02969525|7643625|FG001|Completed Double-Blind Period|Double-Blind Period||41
6713672|NCT02969525|7643626|FG002|Completed Double-Blind Period|Double-Blind Period||40
6713673|NCT02969525|7643627|FG003|Completed Double-Blind Period|Double-Blind Period||39
6713674|NCT02969525|7643628|FG004|Completed Double-Blind Period|Double-Blind Period||41
6713675|NCT02969525|7643629|FG005|Completed Double-Blind Period|Double-Blind Period||0
6713676|NCT02969525|7643630|FG006|Completed Double-Blind Period|Double-Blind Period||0
6713677|NCT02969525|7643631|FG007|Completed Double-Blind Period|Double-Blind Period||0
6713678|NCT02969525|7643632|FG008|Completed Double-Blind Period|Double-Blind Period||0
6713679|NCT02969525|7643633|FG009|Completed Double-Blind Period|Double-Blind Period||0
6713680|NCT02969525|7643634|FG010|Completed Double-Blind Period|Double-Blind Period||0
6713681|NCT02969525|7643635|FG011|Completed Double-Blind Period|Double-Blind Period||0
6713682|NCT02969525|7643624|FG000|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
6713683|NCT02969525|7643625|FG001|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
6713684|NCT02969525|7643626|FG002|Completed Wk12 and Started Dose-Blind|Double-Blind Period||40
6713685|NCT02969525|7643627|FG003|Completed Wk12 and Started Dose-Blind|Double-Blind Period||37
6713686|NCT02969525|7643628|FG004|Completed Wk12 and Started Dose-Blind|Double-Blind Period||41
6713687|NCT02969525|7643629|FG005|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
6713688|NCT02969525|7643630|FG006|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
6713689|NCT02969525|7643631|FG007|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
6713690|NCT02969525|7643632|FG008|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
6713691|NCT02969525|7643633|FG009|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
6713692|NCT02969525|7643634|FG010|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
6713693|NCT02969525|7643635|FG011|Completed Wk12 and Started Dose-Blind|Double-Blind Period||0
6713694|NCT02969525|7643624|FG000|COMPLETED|Double-Blind Period||40
6713695|NCT02969525|7643625|FG001|COMPLETED|Double-Blind Period||41
6713696|NCT02969525|7643626|FG002|COMPLETED|Double-Blind Period||40
6713697|NCT02969525|7643627|FG003|COMPLETED|Double-Blind Period||37
6713698|NCT02969525|7643628|FG004|COMPLETED|Double-Blind Period||41
6713699|NCT02969525|7643629|FG005|COMPLETED|Double-Blind Period||0
6713700|NCT02969525|7643630|FG006|COMPLETED|Double-Blind Period||0
6713701|NCT02969525|7643631|FG007|COMPLETED|Double-Blind Period||0
6713702|NCT02969525|7643632|FG008|COMPLETED|Double-Blind Period||0
6713703|NCT02969525|7643633|FG009|COMPLETED|Double-Blind Period||0
6713704|NCT02969525|7643634|FG010|COMPLETED|Double-Blind Period||0
6713705|NCT02969525|7643635|FG011|COMPLETED|Double-Blind Period||0
6713706|NCT02969525|7643624|FG000|NOT COMPLETED|Double-Blind Period||2
6713707|NCT02969525|7643625|FG001|NOT COMPLETED|Double-Blind Period||0
6713708|NCT02969525|7643626|FG002|NOT COMPLETED|Double-Blind Period||1
6713709|NCT02969525|7643627|FG003|NOT COMPLETED|Double-Blind Period||4
6713710|NCT02969525|7643628|FG004|NOT COMPLETED|Double-Blind Period||0
6713711|NCT02969525|7643629|FG005|NOT COMPLETED|Double-Blind Period||0
6713712|NCT02969525|7643630|FG006|NOT COMPLETED|Double-Blind Period||0
6713713|NCT02969525|7643631|FG007|NOT COMPLETED|Double-Blind Period||0
6713714|NCT02969525|7643632|FG008|NOT COMPLETED|Double-Blind Period||0
6713715|NCT02969525|7643633|FG009|NOT COMPLETED|Double-Blind Period||0
6713716|NCT02969525|7643634|FG010|NOT COMPLETED|Double-Blind Period||0
6713717|NCT02969525|7643635|FG011|NOT COMPLETED|Double-Blind Period||0
6713718|NCT02969525|7643624|FG000|STARTED|Dose-Blind Period||0
6713719|NCT02969525|7643625|FG001|STARTED|Dose-Blind Period||0
6713720|NCT02969525|7643626|FG002|STARTED|Dose-Blind Period||0
6713721|NCT02969525|7643627|FG003|STARTED|Dose-Blind Period||0
6713722|NCT02969525|7643628|FG004|STARTED|Dose-Blind Period||0
6713723|NCT02969525|7643629|FG005|STARTED|Dose-Blind Period||20
6713724|NCT02969525|7643630|FG006|STARTED|Dose-Blind Period||20
6713725|NCT02969525|7643631|FG007|STARTED|Dose-Blind Period||22
6713726|NCT02969525|7643632|FG008|STARTED|Dose-Blind Period||19
6713727|NCT02969525|7643633|FG009|STARTED|Dose-Blind Period||37
6713728|NCT02969525|7643634|FG010|STARTED|Dose-Blind Period||40
6713729|NCT02969525|7643635|FG011|STARTED|Dose-Blind Period||41
6713730|NCT02969525|7643624|FG000|COMPLETED|Dose-Blind Period||0
6713731|NCT02969525|7643625|FG001|COMPLETED|Dose-Blind Period||0
6713732|NCT02969525|7643626|FG002|COMPLETED|Dose-Blind Period||0
6713733|NCT02969525|7643627|FG003|COMPLETED|Dose-Blind Period||0
6713734|NCT02969525|7643628|FG004|COMPLETED|Dose-Blind Period||0
6713735|NCT02969525|7643629|FG005|COMPLETED|Dose-Blind Period||20
6713736|NCT02969525|7643630|FG006|COMPLETED|Dose-Blind Period||18
6713737|NCT02969525|7643631|FG007|COMPLETED|Dose-Blind Period||22
6713738|NCT02969525|7643632|FG008|COMPLETED|Dose-Blind Period||18
6713739|NCT02969525|7643633|FG009|COMPLETED|Dose-Blind Period||34
6713740|NCT02969525|7643634|FG010|COMPLETED|Dose-Blind Period||38
6713741|NCT02969525|7643635|FG011|COMPLETED|Dose-Blind Period||39
6713742|NCT02969525|7643624|FG000|NOT COMPLETED|Dose-Blind Period||0
6713743|NCT02969525|7643625|FG001|NOT COMPLETED|Dose-Blind Period||0
6713744|NCT02969525|7643626|FG002|NOT COMPLETED|Dose-Blind Period||0
6713745|NCT02969525|7643627|FG003|NOT COMPLETED|Dose-Blind Period||0
6713746|NCT02969525|7643628|FG004|NOT COMPLETED|Dose-Blind Period||0
6713747|NCT02969525|7643629|FG005|NOT COMPLETED|Dose-Blind Period||0
6713748|NCT02969525|7643630|FG006|NOT COMPLETED|Dose-Blind Period||2
6713749|NCT02969525|7643631|FG007|NOT COMPLETED|Dose-Blind Period||0
6713750|NCT02969525|7643632|FG008|NOT COMPLETED|Dose-Blind Period||1
6713751|NCT02969525|7643633|FG009|NOT COMPLETED|Dose-Blind Period||3
6713752|NCT02969525|7643634|FG010|NOT COMPLETED|Dose-Blind Period||2
6713753|NCT02969525|7643635|FG011|NOT COMPLETED|Dose-Blind Period||2
6713754|NCT02969590|7643657|FG000|STARTED|Screening Period||5
6713755|NCT02969590|7643658|FG001|STARTED|Screening Period||0
6713756|NCT02969590|7643659|FG002|STARTED|Screening Period||0
6713757|NCT02969590|7643657|FG000|COMPLETED|Screening Period||4
6713758|NCT02969590|7643658|FG001|COMPLETED|Screening Period||0
6713759|NCT02969590|7643659|FG002|COMPLETED|Screening Period||0
6713760|NCT02969590|7643657|FG000|NOT COMPLETED|Screening Period||1
6713761|NCT02969590|7643658|FG001|NOT COMPLETED|Screening Period||0
6713762|NCT02969590|7643659|FG002|NOT COMPLETED|Screening Period||0
6713763|NCT02969590|7643657|FG000|STARTED|Treatment Period 1||0
6713764|NCT02969590|7643658|FG001|STARTED|Treatment Period 1||2
6713765|NCT02969590|7643659|FG002|STARTED|Treatment Period 1||2
6713766|NCT02969590|7643657|FG000|COMPLETED|Treatment Period 1||0
6713767|NCT02969590|7643658|FG001|COMPLETED|Treatment Period 1||2
6713768|NCT02969590|7643659|FG002|COMPLETED|Treatment Period 1||2
6713769|NCT02969590|7643657|FG000|NOT COMPLETED|Treatment Period 1||0
6713770|NCT02969590|7643658|FG001|NOT COMPLETED|Treatment Period 1||0
6262739|NCT01471340|7161776|FG000|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5868
6262740|NCT01471340|7161777|FG001|STARTED|Overall Study|This value corresponds to randomized participants who received at least of dose of study medication|5861
6262741|NCT01471340|7161776|FG000|COMPLETED|Overall Study||5862
6262742|NCT01471340|7161777|FG001|COMPLETED|Overall Study||5855
6262743|NCT01471340|7161776|FG000|NOT COMPLETED|Overall Study||6
6262744|NCT01471340|7161777|FG001|NOT COMPLETED|Overall Study||6
6262745|NCT01462370|7161783|FG000|STARTED|Overall Study||69
6262746|NCT01462370|7161784|FG001|STARTED|Overall Study||70
6713771|NCT02969590|7643659|FG002|NOT COMPLETED|Treatment Period 1||0
6713772|NCT02969590|7643657|FG000|STARTED|Treatment Period 2||0
6713773|NCT02969590|7643658|FG001|STARTED|Treatment Period 2||2
6713774|NCT02969590|7643659|FG002|STARTED|Treatment Period 2||2
6713775|NCT02969590|7643657|FG000|COMPLETED|Treatment Period 2||0
6713776|NCT02969590|7643658|FG001|COMPLETED|Treatment Period 2||2
6713777|NCT02969590|7643659|FG002|COMPLETED|Treatment Period 2||2
6713778|NCT02969590|7643657|FG000|NOT COMPLETED|Treatment Period 2||0
6713779|NCT02969590|7643658|FG001|NOT COMPLETED|Treatment Period 2||0
6713780|NCT02969590|7643659|FG002|NOT COMPLETED|Treatment Period 2||0
6713781|NCT02969655|7643671|FG000|STARTED|Overall Study||136
6713782|NCT02969655|7643672|FG001|STARTED|Overall Study||135
6713783|NCT02969655|7643671|FG000|COMPLETED|Overall Study||115
6713784|NCT02969655|7643672|FG001|COMPLETED|Overall Study||120
6713785|NCT02969655|7643671|FG000|NOT COMPLETED|Overall Study||21
6713786|NCT02969655|7643672|FG001|NOT COMPLETED|Overall Study||15
6713787|NCT02969707|7643681|FG000|STARTED|Overall Study||49
6713788|NCT02969707|7643682|FG001|STARTED|Overall Study||52
6713789|NCT02969707|7643681|FG000|COMPLETED|Overall Study||41
6713790|NCT02969707|7643682|FG001|COMPLETED|Overall Study||44
6713791|NCT02969707|7643681|FG000|NOT COMPLETED|Overall Study||8
6713792|NCT02969707|7643682|FG001|NOT COMPLETED|Overall Study||8
6713793|NCT02969863|7643693|FG000|STARTED|Overall Study||4
6713794|NCT02969863|7643694|FG001|STARTED|Overall Study||4
6713795|NCT02969863|7643695|FG002|STARTED|Overall Study||4
6713796|NCT02969863|7643696|FG003|STARTED|Overall Study||4
6713797|NCT02969863|7643697|FG004|STARTED|Overall Study||4
6713798|NCT02969863|7643698|FG005|STARTED|Overall Study||4
6713799|NCT02969863|7643693|FG000|COMPLETED|Overall Study||3
6713800|NCT02969863|7643694|FG001|COMPLETED|Overall Study||4
6713801|NCT02969863|7643695|FG002|COMPLETED|Overall Study||4
6713802|NCT02969863|7643696|FG003|COMPLETED|Overall Study||4
6713803|NCT02969863|7643697|FG004|COMPLETED|Overall Study||4
6713804|NCT02969863|7643698|FG005|COMPLETED|Overall Study||4
6713805|NCT02969863|7643693|FG000|NOT COMPLETED|Overall Study||1
6713806|NCT02969863|7643694|FG001|NOT COMPLETED|Overall Study||0
6713807|NCT02969863|7643695|FG002|NOT COMPLETED|Overall Study||0
6713808|NCT02969863|7643696|FG003|NOT COMPLETED|Overall Study||0
6713809|NCT02969863|7643697|FG004|NOT COMPLETED|Overall Study||0
6713810|NCT02969863|7643698|FG005|NOT COMPLETED|Overall Study||0
6713811|NCT02969876|7643712|FG000|STARTED|Overall Study||2
6713812|NCT02969876|7643712|FG000|COMPLETED|Overall Study||2
6713813|NCT02969876|7643712|FG000|NOT COMPLETED|Overall Study||0
6713814|NCT02970006|7643717|FG000|STARTED|Overall Study||15
6713815|NCT02970006|7643717|FG000|COMPLETED|Overall Study||14
6713816|NCT02970006|7643717|FG000|NOT COMPLETED|Overall Study||1
6713817|NCT02970032|7643721|FG000|STARTED|Standard Heparin Dose||20
6713818|NCT02970032|7643721|FG000|COMPLETED|Standard Heparin Dose||20
6713819|NCT02970032|7643721|FG000|NOT COMPLETED|Standard Heparin Dose||0
6713820|NCT02970032|7643721|FG000|STARTED|Real Time Heparin Dose Adjustment||20
6739415|NCT03289208|7668267|FG001|COMPLETED|Overall Study||8
6713821|NCT02970032|7643721|FG000|COMPLETED|Real Time Heparin Dose Adjustment||20
6713822|NCT02970032|7643721|FG000|NOT COMPLETED|Real Time Heparin Dose Adjustment||0
6713823|NCT02970162|7643728|FG000|STARTED|Overall Study||13
6713824|NCT02970162|7643729|FG001|STARTED|Overall Study||13
6713825|NCT02970162|7643728|FG000|COMPLETED|Overall Study||13
6713826|NCT02970162|7643729|FG001|COMPLETED|Overall Study||13
6713827|NCT02970162|7643728|FG000|NOT COMPLETED|Overall Study||0
6713828|NCT02970162|7643729|FG001|NOT COMPLETED|Overall Study||0
6713829|NCT02970292|7643737|FG000|STARTED|Overall Study||198
6713830|NCT02970292|7643738|FG001|STARTED|Overall Study||198
6713831|NCT02970292|7643737|FG000|COMPLETED|Overall Study||174
6713832|NCT02970292|7643738|FG001|COMPLETED|Overall Study||190
6713833|NCT02970292|7643737|FG000|NOT COMPLETED|Overall Study||24
6713834|NCT02970292|7643738|FG001|NOT COMPLETED|Overall Study||8
6713835|NCT02970305|7643746|FG000|STARTED|Overall Study||201
6713836|NCT02970305|7643747|FG001|STARTED|Overall Study||202
6713837|NCT02970305|7643746|FG000|COMPLETED|Overall Study||172
6713838|NCT02970305|7643747|FG001|COMPLETED|Overall Study||174
6713839|NCT02970305|7643746|FG000|NOT COMPLETED|Overall Study||29
6713840|NCT02970305|7643747|FG001|NOT COMPLETED|Overall Study||28
6713841|NCT02970422|7643753|FG000|STARTED|Overall Study||200
6713842|NCT02970422|7643753|FG000|COMPLETED|Overall Study||200
6713843|NCT02970422|7643753|FG000|NOT COMPLETED|Overall Study||0
6713844|NCT02970552|7643778|FG000|STARTED|Overall Study||70
6713845|NCT02970552|7643779|FG001|STARTED|Overall Study||70
6713846|NCT02970552|7643778|FG000|COMPLETED|Overall Study||67
6713847|NCT02970552|7643779|FG001|COMPLETED|Overall Study||67
6713848|NCT02970552|7643778|FG000|NOT COMPLETED|Overall Study||3
6713849|NCT02970552|7643779|FG001|NOT COMPLETED|Overall Study||3
6713850|NCT02970669|7643791|FG000|STARTED|Double-blind Period||70
6713851|NCT02970669|7643792|FG001|STARTED|Double-blind Period||70
6713852|NCT02970669|7643791|FG000|COMPLETED|Double-blind Period||62
6713853|NCT02970669|7643792|FG001|COMPLETED|Double-blind Period||64
6713854|NCT02970669|7643791|FG000|NOT COMPLETED|Double-blind Period||8
6713855|NCT02970669|7643792|FG001|NOT COMPLETED|Double-blind Period||6
6713856|NCT02970669|7643791|FG000|STARTED|Open-label Period||62
6713857|NCT02970669|7643792|FG001|STARTED|Open-label Period||64
6713858|NCT02970669|7643791|FG000|COMPLETED|Open-label Period||58
6713859|NCT02970669|7643792|FG001|COMPLETED|Open-label Period||62
6713860|NCT02970669|7643791|FG000|NOT COMPLETED|Open-label Period||4
6713861|NCT02970669|7643792|FG001|NOT COMPLETED|Open-label Period||2
6713862|NCT02970812|7643802|FG000|STARTED|Overall Study||30
6713863|NCT02970812|7643803|FG001|STARTED|Overall Study||30
6713864|NCT02970812|7643802|FG000|COMPLETED|Overall Study||22
6713865|NCT02970812|7643803|FG001|COMPLETED|Overall Study||28
6713866|NCT02970812|7643802|FG000|NOT COMPLETED|Overall Study||8
6713867|NCT02970812|7643803|FG001|NOT COMPLETED|Overall Study||2
6713868|NCT02970942|7643813|FG000|STARTED|Overall Study||80
6713869|NCT02970942|7643814|FG001|STARTED|Overall Study||78
6713870|NCT02970942|7643815|FG002|STARTED|Overall Study||82
6713871|NCT02970942|7643816|FG003|STARTED|Overall Study||80
6713872|NCT02970942|7643813|FG000|Full Analysis Set|Overall Study||80
6713873|NCT02970942|7643814|FG001|Full Analysis Set|Overall Study||78
6713874|NCT02970942|7643815|FG002|Full Analysis Set|Overall Study||82
6713875|NCT02970942|7643816|FG003|Full Analysis Set|Overall Study||80
6713876|NCT02970942|7643813|FG000|Safety Analysis Set|Overall Study||80
6713877|NCT02970942|7643814|FG001|Safety Analysis Set|Overall Study||78
6713878|NCT02970942|7643815|FG002|Safety Analysis Set|Overall Study||81
6713879|NCT02970942|7643816|FG003|Safety Analysis Set|Overall Study||80
6713880|NCT02970942|7643813|FG000|Exposed|Overall Study||80
6713881|NCT02970942|7643814|FG001|Exposed|Overall Study||78
6713882|NCT02970942|7643815|FG002|Exposed|Overall Study||81
6713883|NCT02970942|7643816|FG003|Exposed|Overall Study||80
6713884|NCT02970942|7643813|FG000|COMPLETED|Overall Study||76
6713885|NCT02970942|7643814|FG001|COMPLETED|Overall Study||72
6713886|NCT02970942|7643815|FG002|COMPLETED|Overall Study||77
6262747|NCT01462370|7161783|FG000|COMPLETED|Overall Study||68
6262748|NCT01462370|7161784|FG001|COMPLETED|Overall Study||65
6262749|NCT01462370|7161783|FG000|NOT COMPLETED|Overall Study||1
6262750|NCT01462370|7161784|FG001|NOT COMPLETED|Overall Study||5
6262751|NCT01436253|7161790|FG000|STARTED|Overall Study||2196
6262752|NCT01436253|7161790|FG000|COMPLETED|Overall Study||1897
6262753|NCT01436253|7161790|FG000|NOT COMPLETED|Overall Study||299
6262754|NCT01414192|7161798|FG000|STARTED|Overall Study||490
6262755|NCT01414192|7161799|FG001|STARTED|Overall Study||575
6262756|NCT01414192|7161800|FG002|STARTED|Overall Study||424
6262757|NCT01414192|7161801|FG003|STARTED|Overall Study||1726
6262758|NCT01414192|7161798|FG000|COMPLETED|Overall Study||490
6262759|NCT01414192|7161799|FG001|COMPLETED|Overall Study||575
6262760|NCT01414192|7161800|FG002|COMPLETED|Overall Study||424
6262761|NCT01414192|7161801|FG003|COMPLETED|Overall Study||1726
6262762|NCT01414192|7161798|FG000|NOT COMPLETED|Overall Study||0
6262763|NCT01414192|7161799|FG001|NOT COMPLETED|Overall Study||0
6262764|NCT01414192|7161800|FG002|NOT COMPLETED|Overall Study||0
6713887|NCT02970942|7643816|FG003|COMPLETED|Overall Study||77
6713888|NCT02970942|7643813|FG000|NOT COMPLETED|Overall Study||4
6713889|NCT02970942|7643814|FG001|NOT COMPLETED|Overall Study||6
6262765|NCT01414192|7161801|FG003|NOT COMPLETED|Overall Study||0
6713890|NCT02970942|7643815|FG002|NOT COMPLETED|Overall Study||5
6713891|NCT02970942|7643816|FG003|NOT COMPLETED|Overall Study||3
6713892|NCT02971007|7643829|FG000|STARTED|Overall Study||46
6713893|NCT02971007|7643830|FG001|STARTED|Overall Study||45
6713894|NCT02971007|7643831|FG002|STARTED|Overall Study||46
6713895|NCT02971007|7643829|FG000|COMPLETED|Overall Study||44
6713896|NCT02971007|7643830|FG001|COMPLETED|Overall Study||42
6713897|NCT02971007|7643831|FG002|COMPLETED|Overall Study||45
6713898|NCT02971007|7643829|FG000|NOT COMPLETED|Overall Study||2
6713899|NCT02971007|7643830|FG001|NOT COMPLETED|Overall Study||3
6713900|NCT02971007|7643831|FG002|NOT COMPLETED|Overall Study||1
6713901|NCT02971163|7643841|FG000|STARTED|Overall Study||24
6713902|NCT02971163|7643842|FG001|STARTED|Overall Study||26
6713903|NCT02971163|7643841|FG000|COMPLETED|Overall Study||20
6713904|NCT02971163|7643842|FG001|COMPLETED|Overall Study||24
6713905|NCT02971163|7643841|FG000|NOT COMPLETED|Overall Study||4
6713906|NCT02971163|7643842|FG001|NOT COMPLETED|Overall Study||2
6713907|NCT02971202|7643851|FG000|STARTED|Overall Study||12
6713908|NCT02971202|7643852|FG001|STARTED|Overall Study||10
6713909|NCT02971202|7643853|FG002|STARTED|Overall Study||11
6713910|NCT02971202|7643851|FG000|Started Study|Overall Study||11
6713911|NCT02971202|7643852|FG001|Started Study|Overall Study||10
6713912|NCT02971202|7643853|FG002|Started Study|Overall Study||10
6713913|NCT02971202|7643851|FG000|COMPLETED|Overall Study||10
6713914|NCT02971202|7643852|FG001|COMPLETED|Overall Study||10
6713915|NCT02971202|7643853|FG002|COMPLETED|Overall Study||10
6713916|NCT02971202|7643851|FG000|NOT COMPLETED|Overall Study||2
6713917|NCT02971202|7643852|FG001|NOT COMPLETED|Overall Study||0
6713918|NCT02971202|7643853|FG002|NOT COMPLETED|Overall Study||1
6713919|NCT02971228|7643861|FG000|STARTED|Overall Study||1
6713920|NCT02971228|7643862|FG001|STARTED|Overall Study||7
6713921|NCT02971228|7643863|FG002|STARTED|Overall Study||5
6713922|NCT02971228|7643864|FG003|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
6713923|NCT02971228|7643865|FG004|STARTED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
6713924|NCT02971228|7643861|FG000|Randomized and Treated|Overall Study||0
6713925|NCT02971228|7643862|FG001|Randomized and Treated|Overall Study||7
6713926|NCT02971228|7643863|FG002|Randomized and Treated|Overall Study||5
6713927|NCT02971228|7643864|FG003|Randomized and Treated|Overall Study||0
6713928|NCT02971228|7643865|FG004|Randomized and Treated|Overall Study||0
6713929|NCT02971228|7643861|FG000|COMPLETED|Overall Study||0
6713930|NCT02971228|7643862|FG001|COMPLETED|Overall Study||5
6713931|NCT02971228|7643863|FG002|COMPLETED|Overall Study||5
6262766|NCT01390415|7161817|FG000|STARTED|Overall Study||99
6262767|NCT01390415|7161818|FG001|STARTED|Overall Study||37
6262768|NCT01390415|7161817|FG000|COMPLETED|Overall Study||99
6262769|NCT01390415|7161818|FG001|COMPLETED|Overall Study||37
6262770|NCT01390415|7161817|FG000|NOT COMPLETED|Overall Study||0
6262771|NCT01390415|7161818|FG001|NOT COMPLETED|Overall Study||0
6262772|NCT01381679|7161824|FG000|STARTED|Overall Study||1682
6262773|NCT01381679|7161824|FG000|COMPLETED|Overall Study||794
6262774|NCT01381679|7161824|FG000|NOT COMPLETED|Overall Study||888
6262775|NCT01370603|7161830|FG000|STARTED|Period 1||164
6262776|NCT01370603|7161831|FG001|STARTED|Period 1||164
6262777|NCT01370603|7161830|FG000|COMPLETED|Period 1||150
6262778|NCT01370603|7161831|FG001|COMPLETED|Period 1||154
6262779|NCT01370603|7161830|FG000|NOT COMPLETED|Period 1||14
6262780|NCT01370603|7161831|FG001|NOT COMPLETED|Period 1||10
6262781|NCT01370603|7161830|FG000|STARTED|Crossover Washout||150
6262782|NCT01370603|7161831|FG001|STARTED|Crossover Washout||154
6262783|NCT01370603|7161830|FG000|COMPLETED|Crossover Washout||141
6262784|NCT01370603|7161831|FG001|COMPLETED|Crossover Washout||150
6262785|NCT01370603|7161830|FG000|NOT COMPLETED|Crossover Washout||9
6262786|NCT01370603|7161831|FG001|NOT COMPLETED|Crossover Washout||4
6262787|NCT01370603|7161830|FG000|STARTED|Period 2||141
6262788|NCT01370603|7161831|FG001|STARTED|Period 2||150
6262789|NCT01370603|7161830|FG000|COMPLETED|Period 2||138
6262790|NCT01370603|7161831|FG001|COMPLETED|Period 2||146
6262791|NCT01370603|7161830|FG000|NOT COMPLETED|Period 2||3
6262792|NCT01370603|7161831|FG001|NOT COMPLETED|Period 2||4
6262793|NCT01370590|7161839|FG000|STARTED|Period 1||203
6262794|NCT01370590|7161840|FG001|STARTED|Period 1||203
6262795|NCT01370590|7161839|FG000|COMPLETED|Period 1||187
6262796|NCT01370590|7161840|FG001|COMPLETED|Period 1||192
6262797|NCT01370590|7161839|FG000|NOT COMPLETED|Period 1||16
6262798|NCT01370590|7161840|FG001|NOT COMPLETED|Period 1||11
6262799|NCT01370590|7161839|FG000|STARTED|Crossover Washout Period||187
6262800|NCT01370590|7161840|FG001|STARTED|Crossover Washout Period||192
6262801|NCT01370590|7161839|FG000|COMPLETED|Crossover Washout Period||181
6262802|NCT01370590|7161840|FG001|COMPLETED|Crossover Washout Period||186
6262803|NCT01370590|7161839|FG000|NOT COMPLETED|Crossover Washout Period||6
6262804|NCT01370590|7161840|FG001|NOT COMPLETED|Crossover Washout Period||6
6262805|NCT01370590|7161839|FG000|STARTED|Period 2||181
6262806|NCT01370590|7161840|FG001|STARTED|Period 2||186
6262807|NCT01370590|7161839|FG000|COMPLETED|Period 2||180
6262808|NCT01370590|7161840|FG001|COMPLETED|Period 2||184
6713932|NCT02971228|7643864|FG003|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
6713933|NCT02971228|7643865|FG004|COMPLETED|Overall Study|Due to iLet unavailability, trial was stopped upon completion of Part 1. Part 2 was not conducted.|0
6713934|NCT02971228|7643861|FG000|NOT COMPLETED|Overall Study||1
6713935|NCT02971228|7643862|FG001|NOT COMPLETED|Overall Study||2
6262809|NCT01370590|7161839|FG000|NOT COMPLETED|Period 2||1
6262810|NCT01370590|7161840|FG001|NOT COMPLETED|Period 2||2
6262811|NCT01368185|7161846|FG000|STARTED|Overall Study||1705
6262812|NCT01368185|7161846|FG000|COMPLETED|Overall Study||1705
6713936|NCT02971228|7643863|FG002|NOT COMPLETED|Overall Study||0
6713937|NCT02971228|7643864|FG003|NOT COMPLETED|Overall Study||0
6713938|NCT02971228|7643865|FG004|NOT COMPLETED|Overall Study||0
6713939|NCT02971293|7643876|FG000|STARTED|Overall Study||42
6713940|NCT02971293|7643876|FG000|COMPLETED|Overall Study||31
6713941|NCT02971293|7643876|FG000|NOT COMPLETED|Overall Study||11
6713942|NCT02971488|7643884|FG000|STARTED|Overall Study||529
6713943|NCT02971488|7643884|FG000|COMPLETED|Overall Study||529
6713944|NCT02971488|7643884|FG000|NOT COMPLETED|Overall Study||0
6713945|NCT02971605|7643891|FG000|STARTED|Overall Study||13
6713946|NCT02971605|7643891|FG000|COMPLETED|Overall Study||12
6713947|NCT02971605|7643891|FG000|NOT COMPLETED|Overall Study||1
6713948|NCT02971631|7643897|FG000|STARTED|First Intervention - One Day||3
6713949|NCT02971631|7643898|FG001|STARTED|First Intervention - One Day||2
6713950|NCT02971631|7643897|FG000|COMPLETED|First Intervention - One Day||3
6713951|NCT02971631|7643898|FG001|COMPLETED|First Intervention - One Day||2
6713952|NCT02971631|7643897|FG000|NOT COMPLETED|First Intervention - One Day||0
6713953|NCT02971631|7643898|FG001|NOT COMPLETED|First Intervention - One Day||0
6713954|NCT02971631|7643897|FG000|STARTED|Second Intervention - One Day||3
6713955|NCT02971631|7643898|FG001|STARTED|Second Intervention - One Day||2
6713956|NCT02971631|7643897|FG000|COMPLETED|Second Intervention - One Day||3
6713957|NCT02971631|7643898|FG001|COMPLETED|Second Intervention - One Day||2
6713958|NCT02971631|7643897|FG000|NOT COMPLETED|Second Intervention - One Day||0
6713959|NCT02971631|7643898|FG001|NOT COMPLETED|Second Intervention - One Day||0
6713960|NCT02971670|7643909|FG000|STARTED|Overall Study||13
6713961|NCT02971670|7643910|FG001|STARTED|Overall Study||2
6713962|NCT02971670|7643911|FG002|STARTED|Overall Study||5
6713963|NCT02971670|7643912|FG003|STARTED|Overall Study||3
6713964|NCT02971670|7643909|FG000|COMPLETED|Overall Study||9
6713965|NCT02971670|7643910|FG001|COMPLETED|Overall Study||1
6713966|NCT02971670|7643911|FG002|COMPLETED|Overall Study||4
6713967|NCT02971670|7643912|FG003|COMPLETED|Overall Study||1
6713968|NCT02971670|7643909|FG000|NOT COMPLETED|Overall Study||4
6713969|NCT02971670|7643910|FG001|NOT COMPLETED|Overall Study||1
6713970|NCT02971670|7643911|FG002|NOT COMPLETED|Overall Study||1
6713971|NCT02971670|7643912|FG003|NOT COMPLETED|Overall Study||2
6713972|NCT02971735|7643924|FG000|STARTED|Overall Study||30
6713973|NCT02971735|7643925|FG001|STARTED|Overall Study||30
6713974|NCT02971735|7643924|FG000|COMPLETED|Overall Study||30
6713975|NCT02971735|7643925|FG001|COMPLETED|Overall Study||30
6713976|NCT02971735|7643924|FG000|NOT COMPLETED|Overall Study||0
6713977|NCT02971735|7643925|FG001|NOT COMPLETED|Overall Study||0
6713978|NCT02971800|7643931|FG000|STARTED|Overall Study||37
6713979|NCT02971800|7643931|FG000|COMPLETED|Overall Study||30
6713980|NCT02971800|7643931|FG000|NOT COMPLETED|Overall Study||7
6713981|NCT02972242|7643937|FG000|STARTED|Overall Study||82
6713982|NCT02972242|7643938|FG001|STARTED|Overall Study||93
6713983|NCT02972242|7643937|FG000|COMPLETED|Overall Study||81
6713984|NCT02972242|7643938|FG001|COMPLETED|Overall Study||93
6713985|NCT02972242|7643937|FG000|NOT COMPLETED|Overall Study||1
6713986|NCT02972242|7643938|FG001|NOT COMPLETED|Overall Study||0
6713987|NCT02972359|7643944|FG000|STARTED|Overall Study||318
6713988|NCT02972359|7643944|FG000|COMPLETED|Overall Study||247
6713989|NCT02972359|7643944|FG000|NOT COMPLETED|Overall Study||71
6713990|NCT02972502|7643950|FG000|STARTED|Overall Study||35
6713991|NCT02972502|7643951|FG001|STARTED|Overall Study||31
6713992|NCT02972502|7643950|FG000|COMPLETED|Overall Study||31
6713993|NCT02972502|7643951|FG001|COMPLETED|Overall Study||29
6713994|NCT02972502|7643950|FG000|NOT COMPLETED|Overall Study||4
6713995|NCT02972502|7643951|FG001|NOT COMPLETED|Overall Study||2
6713996|NCT02972515|7643957|FG000|STARTED|Overall Study||166
6713997|NCT02972515|7643957|FG000|COMPLETED|Overall Study||88
6713998|NCT02972515|7643957|FG000|NOT COMPLETED|Overall Study||78
6713999|NCT02972554|7643963|FG000|STARTED|Overall Study||44
6714000|NCT02972554|7643964|FG001|STARTED|Overall Study||48
6714001|NCT02972554|7643963|FG000|COMPLETED|Overall Study||44
6714002|NCT02972554|7643964|FG001|COMPLETED|Overall Study||48
6714003|NCT02972554|7643963|FG000|NOT COMPLETED|Overall Study||0
6714004|NCT02972554|7643964|FG001|NOT COMPLETED|Overall Study||0
6714005|NCT02972632|7643970|FG000|STARTED|Overall Study||123
6714006|NCT02972632|7643970|FG000|Safety Analysis Set|Overall Study||122
6714007|NCT02972632|7643970|FG000|COMPLETED|Overall Study||106
6714008|NCT02972632|7643970|FG000|NOT COMPLETED|Overall Study||17
6714009|NCT02972658|7643978|FG000|STARTED|Overall Study||76
6714010|NCT02972658|7643979|FG001|STARTED|Overall Study||139
6714011|NCT02972658|7643980|FG002|STARTED|Overall Study||75
6714012|NCT02972658|7643981|FG003|STARTED|Overall Study||131
6714013|NCT02972658|7643978|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
6714014|NCT02972658|7643979|FG001|Received at Least 1 Dose of Study Drug|Overall Study||139
6714015|NCT02972658|7643980|FG002|Received at Least 1 Dose of Study Drug|Overall Study||74
6714016|NCT02972658|7643981|FG003|Received at Least 1 Dose of Study Drug|Overall Study||131
6714017|NCT02972658|7643978|FG000|COMPLETED|Overall Study||0
6714018|NCT02972658|7643979|FG001|COMPLETED|Overall Study|"1 participant was incorrectly marked as Completed rather than study terminated by Sponsor."|1
6714019|NCT02972658|7643980|FG002|COMPLETED|Overall Study||0
6714020|NCT02972658|7643981|FG003|COMPLETED|Overall Study||0
6714021|NCT02972658|7643978|FG000|NOT COMPLETED|Overall Study||76
6714022|NCT02972658|7643979|FG001|NOT COMPLETED|Overall Study||138
6714023|NCT02972658|7643980|FG002|NOT COMPLETED|Overall Study||75
6714024|NCT02972658|7643981|FG003|NOT COMPLETED|Overall Study||131
6714025|NCT02973048|7643993|FG000|STARTED|Overall Study||20
6714026|NCT02973048|7643994|FG001|STARTED|Overall Study||20
6714027|NCT02973048|7643993|FG000|COMPLETED|Overall Study||19
6714028|NCT02973048|7643994|FG001|COMPLETED|Overall Study||17
6714029|NCT02973048|7643993|FG000|NOT COMPLETED|Overall Study||1
6714030|NCT02973048|7643994|FG001|NOT COMPLETED|Overall Study||3
6714031|NCT02973087|7644002|FG000|STARTED|Overall Study||13
6714032|NCT02973087|7644003|FG001|STARTED|Overall Study||10
6714033|NCT02973087|7644002|FG000|COMPLETED|Overall Study||9
6714034|NCT02973087|7644003|FG001|COMPLETED|Overall Study||8
6714035|NCT02973087|7644002|FG000|NOT COMPLETED|Overall Study||4
6714036|NCT02973087|7644003|FG001|NOT COMPLETED|Overall Study||2
6714037|NCT02973100|7644014|FG000|STARTED|Overall Study||82
6714038|NCT02973100|7644015|FG001|STARTED|Overall Study||81
6714039|NCT02973100|7644016|FG002|STARTED|Overall Study||79
6714040|NCT02973100|7644017|FG003|STARTED|Overall Study||76
6714041|NCT02973100|7644014|FG000|Received at Least 1 Dose of Study Drug|Overall Study||81
6714042|NCT02973100|7644015|FG001|Received at Least 1 Dose of Study Drug|Overall Study||81
6714043|NCT02973100|7644016|FG002|Received at Least 1 Dose of Study Drug|Overall Study||79
6714044|NCT02973100|7644017|FG003|Received at Least 1 Dose of Study Drug|Overall Study||76
6714045|NCT02973100|7644014|FG000|COMPLETED|Overall Study||75
6714046|NCT02973100|7644015|FG001|COMPLETED|Overall Study||73
6714047|NCT02973100|7644016|FG002|COMPLETED|Overall Study||75
6714048|NCT02973100|7644017|FG003|COMPLETED|Overall Study||69
6714049|NCT02973100|7644014|FG000|NOT COMPLETED|Overall Study||7
6714050|NCT02973100|7644015|FG001|NOT COMPLETED|Overall Study||8
6714051|NCT02973100|7644016|FG002|NOT COMPLETED|Overall Study||4
6714052|NCT02973100|7644017|FG003|NOT COMPLETED|Overall Study||7
6714053|NCT02973438|7644034|FG000|STARTED|First Treatment Session (4 Days)||2
6714054|NCT02973438|7644035|FG001|STARTED|First Treatment Session (4 Days)||1
6714055|NCT02973438|7644036|FG002|STARTED|First Treatment Session (4 Days)||2
6714056|NCT02973438|7644037|FG003|STARTED|First Treatment Session (4 Days)||1
6714057|NCT02973438|7644034|FG000|COMPLETED|First Treatment Session (4 Days)||2
6714058|NCT02973438|7644035|FG001|COMPLETED|First Treatment Session (4 Days)||1
6714059|NCT02973438|7644036|FG002|COMPLETED|First Treatment Session (4 Days)||2
6714060|NCT02973438|7644037|FG003|COMPLETED|First Treatment Session (4 Days)||1
6714061|NCT02973438|7644034|FG000|NOT COMPLETED|First Treatment Session (4 Days)||0
6714062|NCT02973438|7644035|FG001|NOT COMPLETED|First Treatment Session (4 Days)||0
6714063|NCT02973438|7644036|FG002|NOT COMPLETED|First Treatment Session (4 Days)||0
6714064|NCT02973438|7644037|FG003|NOT COMPLETED|First Treatment Session (4 Days)||0
6714065|NCT02973438|7644034|FG000|STARTED|Washout (Three Weeks)||2
6714066|NCT02973438|7644035|FG001|STARTED|Washout (Three Weeks)||1
6714067|NCT02973438|7644036|FG002|STARTED|Washout (Three Weeks)||2
6714068|NCT02973438|7644037|FG003|STARTED|Washout (Three Weeks)||1
6714069|NCT02973438|7644034|FG000|COMPLETED|Washout (Three Weeks)||2
6714070|NCT02973438|7644035|FG001|COMPLETED|Washout (Three Weeks)||1
6714071|NCT02973438|7644036|FG002|COMPLETED|Washout (Three Weeks)||2
6714072|NCT02973438|7644037|FG003|COMPLETED|Washout (Three Weeks)||1
6714073|NCT02973438|7644034|FG000|NOT COMPLETED|Washout (Three Weeks)||0
6714074|NCT02973438|7644035|FG001|NOT COMPLETED|Washout (Three Weeks)||0
6714075|NCT02973438|7644036|FG002|NOT COMPLETED|Washout (Three Weeks)||0
6714076|NCT02973438|7644037|FG003|NOT COMPLETED|Washout (Three Weeks)||0
6714077|NCT02973438|7644034|FG000|STARTED|Second Treatment Session (4 Days)||2
6714078|NCT02973438|7644035|FG001|STARTED|Second Treatment Session (4 Days)||1
6714079|NCT02973438|7644036|FG002|STARTED|Second Treatment Session (4 Days)||2
6714080|NCT02973438|7644037|FG003|STARTED|Second Treatment Session (4 Days)||1
6714081|NCT02973438|7644034|FG000|COMPLETED|Second Treatment Session (4 Days)||2
6714082|NCT02973438|7644035|FG001|COMPLETED|Second Treatment Session (4 Days)||1
6714083|NCT02973438|7644036|FG002|COMPLETED|Second Treatment Session (4 Days)||2
6714084|NCT02973438|7644037|FG003|COMPLETED|Second Treatment Session (4 Days)||1
6714085|NCT02973438|7644034|FG000|NOT COMPLETED|Second Treatment Session (4 Days)||0
6714086|NCT02973438|7644035|FG001|NOT COMPLETED|Second Treatment Session (4 Days)||0
6714087|NCT02973438|7644036|FG002|NOT COMPLETED|Second Treatment Session (4 Days)||0
6714088|NCT02973438|7644037|FG003|NOT COMPLETED|Second Treatment Session (4 Days)||0
6714089|NCT02973477|7644050|FG000|STARTED|First Intervention||19
6714090|NCT02973477|7644051|FG001|STARTED|First Intervention||26
6714091|NCT02973477|7644050|FG000|COMPLETED|First Intervention||19
6714092|NCT02973477|7644051|FG001|COMPLETED|First Intervention||24
6714093|NCT02973477|7644050|FG000|NOT COMPLETED|First Intervention||0
6714094|NCT02973477|7644051|FG001|NOT COMPLETED|First Intervention||2
6714095|NCT02973477|7644050|FG000|STARTED|Washout||19
6714096|NCT02973477|7644051|FG001|STARTED|Washout||24
6714097|NCT02973477|7644050|FG000|COMPLETED|Washout||18
6714098|NCT02973477|7644051|FG001|COMPLETED|Washout||24
6714099|NCT02973477|7644050|FG000|NOT COMPLETED|Washout||1
6714100|NCT02973477|7644051|FG001|NOT COMPLETED|Washout||0
6714101|NCT02973477|7644050|FG000|STARTED|Second Intervention||18
6714102|NCT02973477|7644051|FG001|STARTED|Second Intervention||24
6714103|NCT02973477|7644050|FG000|COMPLETED|Second Intervention||17
6714104|NCT02973477|7644051|FG001|COMPLETED|Second Intervention||24
6714105|NCT02973477|7644050|FG000|NOT COMPLETED|Second Intervention||1
6714106|NCT02973477|7644051|FG001|NOT COMPLETED|Second Intervention||0
6714107|NCT02973503|7644063|FG000|STARTED|Overall Study||117
6714108|NCT02973503|7644063|FG000|COMPLETED|Overall Study||117
6714109|NCT02973503|7644063|FG000|NOT COMPLETED|Overall Study||0
6714110|NCT02973516|7644074|FG000|STARTED|Overall Study||30
6714111|NCT02973516|7644075|FG001|STARTED|Overall Study||10
6714112|NCT02973516|7644074|FG000|COMPLETED|Overall Study||30
6714113|NCT02973516|7644075|FG001|COMPLETED|Overall Study||10
6714114|NCT02973516|7644074|FG000|NOT COMPLETED|Overall Study||0
6714115|NCT02973516|7644075|FG001|NOT COMPLETED|Overall Study||0
6714116|NCT02973802|7644081|FG000|STARTED|Overall Study||12
6714117|NCT02973802|7644081|FG000|COMPLETED|Overall Study||10
6714118|NCT02973802|7644081|FG000|NOT COMPLETED|Overall Study||2
6714119|NCT02974010|7644090|FG000|STARTED|Overall Study||12
6714120|NCT02974010|7644091|FG001|STARTED|Overall Study||5
6714121|NCT02974010|7644092|FG002|STARTED|Overall Study||4
6714122|NCT02974010|7644093|FG003|STARTED|Overall Study||1
6714123|NCT02974010|7644090|FG000|COMPLETED|Overall Study||6
6714124|NCT02974010|7644091|FG001|COMPLETED|Overall Study||2
6714125|NCT02974010|7644092|FG002|COMPLETED|Overall Study||2
6714126|NCT02974010|7644093|FG003|COMPLETED|Overall Study||1
6714127|NCT02974010|7644090|FG000|NOT COMPLETED|Overall Study||6
6714128|NCT02974010|7644091|FG001|NOT COMPLETED|Overall Study||3
6714129|NCT02974010|7644092|FG002|NOT COMPLETED|Overall Study||2
6714130|NCT02974010|7644093|FG003|NOT COMPLETED|Overall Study||0
6714131|NCT02974088|7644105|FG000|STARTED|Overall Study||23
6714132|NCT02974088|7644106|FG001|STARTED|Overall Study||24
6714133|NCT02974088|7644105|FG000|COMPLETED|Overall Study||23
6714134|NCT02974088|7644106|FG001|COMPLETED|Overall Study|Nurse left without notice and took CRFs and data for 2 subjects.|21
6714135|NCT02974088|7644105|FG000|NOT COMPLETED|Overall Study||0
6714136|NCT02974088|7644106|FG001|NOT COMPLETED|Overall Study||3
6714137|NCT02974114|7644115|FG000|STARTED|Overall Study||6
6714138|NCT02974114|7644116|FG001|STARTED|Overall Study||7
6714139|NCT02974114|7644117|FG002|STARTED|Overall Study||8
6714140|NCT02974114|7644115|FG000|COMPLETED|Overall Study||6
6714141|NCT02974114|7644116|FG001|COMPLETED|Overall Study||6
6714142|NCT02974114|7644117|FG002|COMPLETED|Overall Study||6
6714143|NCT02974114|7644115|FG000|NOT COMPLETED|Overall Study||0
6714144|NCT02974114|7644116|FG001|NOT COMPLETED|Overall Study||1
6714145|NCT02974114|7644117|FG002|NOT COMPLETED|Overall Study||2
6714146|NCT02974140|7644127|FG000|STARTED|Overall Study||39
6714147|NCT02974140|7644127|FG000|CRS (Left or Right Eye)|Overall Study||38
6714148|NCT02974140|7644127|FG000|Manual (Fellow Eye)|Overall Study||38
6714149|NCT02974140|7644127|FG000|COMPLETED|Overall Study||0
6714150|NCT02974140|7644127|FG000|NOT COMPLETED|Overall Study||39
6714151|NCT02974153|7644137|FG000|STARTED|Overall Study||374
6714152|NCT02974153|7644138|FG001|STARTED|Overall Study||372
6714153|NCT02974153|7644139|FG002|STARTED|Overall Study||375
6714154|NCT02974153|7644137|FG000|Participants Treated|Overall Study||350
6714155|NCT02974153|7644138|FG001|Participants Treated|Overall Study||356
6714156|NCT02974153|7644139|FG002|Participants Treated|Overall Study||366
6714157|NCT02974153|7644137|FG000|COMPLETED|Overall Study||322
6714158|NCT02974153|7644138|FG001|COMPLETED|Overall Study||324
6714159|NCT02974153|7644139|FG002|COMPLETED|Overall Study||325
6714160|NCT02974153|7644137|FG000|NOT COMPLETED|Overall Study||52
6714161|NCT02974153|7644138|FG001|NOT COMPLETED|Overall Study||48
6714162|NCT02974153|7644139|FG002|NOT COMPLETED|Overall Study||50
6714163|NCT02974296|7644149|FG000|STARTED|Overall Study||10
6714164|NCT02974296|7644150|FG001|STARTED|Overall Study||23
6714165|NCT02974296|7644149|FG000|COMPLETED|Overall Study||10
6714166|NCT02974296|7644150|FG001|COMPLETED|Overall Study||22
6714167|NCT02974296|7644149|FG000|NOT COMPLETED|Overall Study||0
6714168|NCT02974296|7644150|FG001|NOT COMPLETED|Overall Study||1
6714169|NCT02974543|7644158|FG000|STARTED|Overall Study||11
6714170|NCT02974543|7644159|FG001|STARTED|Overall Study||10
6714171|NCT02974543|7644158|FG000|Began Washout Period|Overall Study||10
6714172|NCT02974543|7644159|FG001|Began Washout Period|Overall Study||10
6714173|NCT02974543|7644158|FG000|Began Crossover Assignment|Overall Study||10
6714174|NCT02974543|7644159|FG001|Began Crossover Assignment|Overall Study||10
6714175|NCT02974543|7644158|FG000|COMPLETED|Overall Study||10
6714176|NCT02974543|7644159|FG001|COMPLETED|Overall Study||10
6714177|NCT02974543|7644158|FG000|NOT COMPLETED|Overall Study||1
6714178|NCT02974543|7644159|FG001|NOT COMPLETED|Overall Study||0
6714179|NCT02974634|7644175|FG000|STARTED|Overall Study||106
6714180|NCT02974634|7644176|FG001|STARTED|Overall Study||110
6714181|NCT02974634|7644175|FG000|COMPLETED|Overall Study||78
6714182|NCT02974634|7644176|FG001|COMPLETED|Overall Study||89
6714183|NCT02974634|7644175|FG000|NOT COMPLETED|Overall Study||28
6714184|NCT02974634|7644176|FG001|NOT COMPLETED|Overall Study||21
6714185|NCT02974842|7644183|FG000|STARTED|Overall Study|Participants|50
6714186|NCT02974842|7644183|FG000|COMPLETED|Overall Study||42
6714187|NCT02974842|7644183|FG000|NOT COMPLETED|Overall Study||8
6714188|NCT02974855|7644191|FG000|STARTED|Overall Study||7
6714189|NCT02974855|7644192|FG001|STARTED|Overall Study||6
6714190|NCT02974855|7644193|FG002|STARTED|Overall Study||6
6714191|NCT02974855|7644194|FG003|STARTED|Overall Study||7
6714192|NCT02974855|7644191|FG000|COMPLETED|Overall Study||7
6714193|NCT02974855|7644192|FG001|COMPLETED|Overall Study||5
6714194|NCT02974855|7644193|FG002|COMPLETED|Overall Study||6
6714195|NCT02974855|7644194|FG003|COMPLETED|Overall Study||6
6714196|NCT02974855|7644191|FG000|NOT COMPLETED|Overall Study||0
6714197|NCT02974855|7644192|FG001|NOT COMPLETED|Overall Study||1
6714198|NCT02974855|7644193|FG002|NOT COMPLETED|Overall Study||0
6714199|NCT02974855|7644194|FG003|NOT COMPLETED|Overall Study||1
6714200|NCT02974868|7644211|FG000|STARTED|Initial 24-Week Treatment Period (TP)||24
6714201|NCT02974868|7644212|FG001|STARTED|Initial 24-Week Treatment Period (TP)||23
6714202|NCT02974868|7644213|FG002|STARTED|Initial 24-Week Treatment Period (TP)||48
6714203|NCT02974868|7644214|FG003|STARTED|Initial 24-Week Treatment Period (TP)||47
6714204|NCT02974868|7644211|FG000|COMPLETED|Initial 24-Week Treatment Period (TP)||20
6714205|NCT02974868|7644212|FG001|COMPLETED|Initial 24-Week Treatment Period (TP)||14
6714206|NCT02974868|7644213|FG002|COMPLETED|Initial 24-Week Treatment Period (TP)||45
6714207|NCT02974868|7644214|FG003|COMPLETED|Initial 24-Week Treatment Period (TP)||35
6714208|NCT02974868|7644211|FG000|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||4
6714209|NCT02974868|7644212|FG001|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||9
6714210|NCT02974868|7644213|FG002|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||3
6714211|NCT02974868|7644214|FG003|NOT COMPLETED|Initial 24-Week Treatment Period (TP)||12
6714212|NCT02974868|7644211|FG000|STARTED|Single-Blind Extension (SBE) Period||17
6714213|NCT02974868|7644212|FG001|STARTED|Single-Blind Extension (SBE) Period||12
6714214|NCT02974868|7644213|FG002|STARTED|Single-Blind Extension (SBE) Period||38
6714215|NCT02974868|7644214|FG003|STARTED|Single-Blind Extension (SBE) Period||29
6714216|NCT02974868|7644211|FG000|COMPLETED|Single-Blind Extension (SBE) Period||15
6714217|NCT02974868|7644212|FG001|COMPLETED|Single-Blind Extension (SBE) Period||11
6714218|NCT02974868|7644213|FG002|COMPLETED|Single-Blind Extension (SBE) Period||27
6714219|NCT02974868|7644214|FG003|COMPLETED|Single-Blind Extension (SBE) Period||23
6714220|NCT02974868|7644211|FG000|NOT COMPLETED|Single-Blind Extension (SBE) Period||2
6714221|NCT02974868|7644212|FG001|NOT COMPLETED|Single-Blind Extension (SBE) Period||1
6714222|NCT02974868|7644213|FG002|NOT COMPLETED|Single-Blind Extension (SBE) Period||11
6714223|NCT02974868|7644214|FG003|NOT COMPLETED|Single-Blind Extension (SBE) Period||6
6714224|NCT02974868|7644211|FG000|STARTED|Cross-Over Extension (COE) Period||7
6714225|NCT02974868|7644212|FG001|STARTED|Cross-Over Extension (COE) Period||2
6714226|NCT02974868|7644213|FG002|STARTED|Cross-Over Extension (COE) Period||11
6714227|NCT02974868|7644214|FG003|STARTED|Cross-Over Extension (COE) Period||3
6714228|NCT02974868|7644211|FG000|COMPLETED|Cross-Over Extension (COE) Period||5
6714229|NCT02974868|7644212|FG001|COMPLETED|Cross-Over Extension (COE) Period||1
6714230|NCT02974868|7644213|FG002|COMPLETED|Cross-Over Extension (COE) Period||8
6714231|NCT02974868|7644214|FG003|COMPLETED|Cross-Over Extension (COE) Period||3
6714232|NCT02974868|7644211|FG000|NOT COMPLETED|Cross-Over Extension (COE) Period||2
6714233|NCT02974868|7644212|FG001|NOT COMPLETED|Cross-Over Extension (COE) Period||1
6714234|NCT02974868|7644213|FG002|NOT COMPLETED|Cross-Over Extension (COE) Period||3
6714235|NCT02974868|7644214|FG003|NOT COMPLETED|Cross-Over Extension (COE) Period||0
6714236|NCT02975206|7644258|FG000|STARTED|Overall Study||161
6714237|NCT02975206|7644259|FG001|STARTED|Overall Study||161
6714238|NCT02975206|7644260|FG002|STARTED|Overall Study||162
6714239|NCT02975206|7644258|FG000|COMPLETED|Overall Study||134
6714240|NCT02975206|7644259|FG001|COMPLETED|Overall Study||144
6714241|NCT02975206|7644260|FG002|COMPLETED|Overall Study||145
6714242|NCT02975206|7644258|FG000|NOT COMPLETED|Overall Study||27
6714243|NCT02975206|7644259|FG001|NOT COMPLETED|Overall Study||17
6714244|NCT02975206|7644260|FG002|NOT COMPLETED|Overall Study||17
6714245|NCT02975297|7644270|FG000|STARTED|Overall Study||41
6714246|NCT02975297|7644271|FG001|STARTED|Overall Study||41
6714247|NCT02975297|7644270|FG000|COMPLETED|Overall Study||34
6714248|NCT02975297|7644271|FG001|COMPLETED|Overall Study||35
6714249|NCT02975297|7644270|FG000|NOT COMPLETED|Overall Study||7
6714250|NCT02975297|7644271|FG001|NOT COMPLETED|Overall Study||6
6714251|NCT02975336|7644281|FG000|STARTED|DBPC (52 Weeks)||117
6714252|NCT02975336|7644282|FG001|STARTED|DBPC (52 Weeks)||118
6714253|NCT02975336|7644283|FG002|STARTED|DBPC (52 Weeks)||117
6714254|NCT02975336|7644284|FG003|STARTED|DBPC (52 Weeks)||117
6714255|NCT02975336|7644285|FG004|STARTED|DBPC (52 Weeks)||0
6714256|NCT02975336|7644286|FG005|STARTED|DBPC (52 Weeks)||0
6714257|NCT02975336|7644287|FG006|STARTED|DBPC (52 Weeks)||0
6714258|NCT02975336|7644288|FG007|STARTED|DBPC (52 Weeks)||0
6714259|NCT02975336|7644281|FG000|COMPLETED|DBPC (52 Weeks)||85
6714260|NCT02975336|7644282|FG001|COMPLETED|DBPC (52 Weeks)||89
6714261|NCT02975336|7644283|FG002|COMPLETED|DBPC (52 Weeks)||90
6714262|NCT02975336|7644284|FG003|COMPLETED|DBPC (52 Weeks)||84
6714263|NCT02975336|7644285|FG004|COMPLETED|DBPC (52 Weeks)||0
6714264|NCT02975336|7644286|FG005|COMPLETED|DBPC (52 Weeks)||0
6262813|NCT01368185|7161846|FG000|NOT COMPLETED|Overall Study||0
6262814|NCT01349907|7161852|FG000|STARTED|Overall Study|Enrolled and Treated|241
6262815|NCT01349907|7161853|FG001|STARTED|Overall Study|Enrolled and Treated|81
6262816|NCT01349907|7161852|FG000|COMPLETED|Overall Study||102
6262817|NCT01349907|7161853|FG001|COMPLETED|Overall Study||38
6262818|NCT01349907|7161852|FG000|NOT COMPLETED|Overall Study||139
6262819|NCT01349907|7161853|FG001|NOT COMPLETED|Overall Study||43
6262820|NCT01345786|7161863|FG000|STARTED|Overall Study|Number randomized|41
6262821|NCT01345786|7161864|FG001|STARTED|Overall Study|Number randomized|41
6262822|NCT01345786|7161865|FG002|STARTED|Overall Study|Number randomized|38
6262823|NCT01345786|7161866|FG003|STARTED|Overall Study|Number randomized|38
6262824|NCT01345786|7161863|FG000|Treated|Overall Study||41
6262825|NCT01345786|7161864|FG001|Treated|Overall Study||41
6262826|NCT01345786|7161865|FG002|Treated|Overall Study||37
6262827|NCT01345786|7161866|FG003|Treated|Overall Study||37
6262828|NCT01345786|7161863|FG000|COMPLETED|Overall Study||35
6262829|NCT01345786|7161864|FG001|COMPLETED|Overall Study||33
6262830|NCT01345786|7161865|FG002|COMPLETED|Overall Study||33
6262831|NCT01345786|7161866|FG003|COMPLETED|Overall Study||35
6262832|NCT01345786|7161863|FG000|NOT COMPLETED|Overall Study||6
6262833|NCT01345786|7161864|FG001|NOT COMPLETED|Overall Study||8
6714265|NCT02975336|7644287|FG006|COMPLETED|DBPC (52 Weeks)||0
6714266|NCT02975336|7644288|FG007|COMPLETED|DBPC (52 Weeks)||0
6714267|NCT02975336|7644281|FG000|NOT COMPLETED|DBPC (52 Weeks)||32
6714268|NCT02975336|7644282|FG001|NOT COMPLETED|DBPC (52 Weeks)||29
6714269|NCT02975336|7644283|FG002|NOT COMPLETED|DBPC (52 Weeks)||27
6714270|NCT02975336|7644284|FG003|NOT COMPLETED|DBPC (52 Weeks)||33
6714271|NCT02975336|7644285|FG004|NOT COMPLETED|DBPC (52 Weeks)||0
6714272|NCT02975336|7644286|FG005|NOT COMPLETED|DBPC (52 Weeks)||0
6714273|NCT02975336|7644287|FG006|NOT COMPLETED|DBPC (52 Weeks)||0
6714274|NCT02975336|7644288|FG007|NOT COMPLETED|DBPC (52 Weeks)||0
6714275|NCT02975336|7644281|FG000|STARTED|LTE (104 Weeks)||0
6714276|NCT02975336|7644282|FG001|STARTED|LTE (104 Weeks)||0
6714277|NCT02975336|7644283|FG002|STARTED|LTE (104 Weeks)||0
6714278|NCT02975336|7644284|FG003|STARTED|LTE (104 Weeks)||0
6714279|NCT02975336|7644285|FG004|STARTED|LTE (104 Weeks)||62
6714280|NCT02975336|7644286|FG005|STARTED|LTE (104 Weeks)||69
6714281|NCT02975336|7644287|FG006|STARTED|LTE (104 Weeks)||80
6714282|NCT02975336|7644288|FG007|STARTED|LTE (104 Weeks)||72
6714283|NCT02975336|7644281|FG000|COMPLETED|LTE (104 Weeks)||0
6714284|NCT02975336|7644282|FG001|COMPLETED|LTE (104 Weeks)||0
6714285|NCT02975336|7644283|FG002|COMPLETED|LTE (104 Weeks)||0
6714286|NCT02975336|7644284|FG003|COMPLETED|LTE (104 Weeks)||0
6714287|NCT02975336|7644285|FG004|COMPLETED|LTE (104 Weeks)||0
6714288|NCT02975336|7644286|FG005|COMPLETED|LTE (104 Weeks)||0
6714289|NCT02975336|7644287|FG006|COMPLETED|LTE (104 Weeks)||0
6714290|NCT02975336|7644288|FG007|COMPLETED|LTE (104 Weeks)||0
6714291|NCT02975336|7644281|FG000|NOT COMPLETED|LTE (104 Weeks)||0
6714292|NCT02975336|7644282|FG001|NOT COMPLETED|LTE (104 Weeks)||0
6714293|NCT02975336|7644283|FG002|NOT COMPLETED|LTE (104 Weeks)||0
6714294|NCT02975336|7644284|FG003|NOT COMPLETED|LTE (104 Weeks)||0
6714295|NCT02975336|7644285|FG004|NOT COMPLETED|LTE (104 Weeks)||62
6714296|NCT02975336|7644286|FG005|NOT COMPLETED|LTE (104 Weeks)||69
6714297|NCT02975336|7644287|FG006|NOT COMPLETED|LTE (104 Weeks)||80
6714298|NCT02975336|7644288|FG007|NOT COMPLETED|LTE (104 Weeks)||72
6714299|NCT02975349|7644307|FG000|STARTED|Active Treatment Period (24 Weeks)||54
6714300|NCT02975349|7644308|FG001|STARTED|Active Treatment Period (24 Weeks)||0
6714301|NCT02975349|7644309|FG002|STARTED|Active Treatment Period (24 Weeks)||52
6714302|NCT02975349|7644310|FG003|STARTED|Active Treatment Period (24 Weeks)||53
6714303|NCT02975349|7644311|FG004|STARTED|Active Treatment Period (24 Weeks)||54
6714304|NCT02975349|7644312|FG005|STARTED|Active Treatment Period (24 Weeks)||54
6714305|NCT02975349|7644307|FG000|COMPLETED|Active Treatment Period (24 Weeks)||49
6714306|NCT02975349|7644308|FG001|COMPLETED|Active Treatment Period (24 Weeks)||0
6714307|NCT02975349|7644309|FG002|COMPLETED|Active Treatment Period (24 Weeks)||47
6714308|NCT02975349|7644310|FG003|COMPLETED|Active Treatment Period (24 Weeks)||48
6714309|NCT02975349|7644311|FG004|COMPLETED|Active Treatment Period (24 Weeks)||48
6714310|NCT02975349|7644312|FG005|COMPLETED|Active Treatment Period (24 Weeks)||52
6714311|NCT02975349|7644307|FG000|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
6714312|NCT02975349|7644308|FG001|NOT COMPLETED|Active Treatment Period (24 Weeks)||0
6714313|NCT02975349|7644309|FG002|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
6714314|NCT02975349|7644310|FG003|NOT COMPLETED|Active Treatment Period (24 Weeks)||5
6714315|NCT02975349|7644311|FG004|NOT COMPLETED|Active Treatment Period (24 Weeks)||6
6714316|NCT02975349|7644312|FG005|NOT COMPLETED|Active Treatment Period (24 Weeks)||2
6714317|NCT02975349|7644307|FG000|STARTED|Blinded Extension Period (24 Weeks)||0
6714318|NCT02975349|7644308|FG001|STARTED|Blinded Extension Period (24 Weeks)||49
6714319|NCT02975349|7644309|FG002|STARTED|Blinded Extension Period (24 Weeks)||47
6714320|NCT02975349|7644310|FG003|STARTED|Blinded Extension Period (24 Weeks)||48
6714321|NCT02975349|7644311|FG004|STARTED|Blinded Extension Period (24 Weeks)||48
6714322|NCT02975349|7644312|FG005|STARTED|Blinded Extension Period (24 Weeks)||52
6714323|NCT02975349|7644307|FG000|COMPLETED|Blinded Extension Period (24 Weeks)||0
6714324|NCT02975349|7644308|FG001|COMPLETED|Blinded Extension Period (24 Weeks)||42
6714325|NCT02975349|7644309|FG002|COMPLETED|Blinded Extension Period (24 Weeks)||43
6714326|NCT02975349|7644310|FG003|COMPLETED|Blinded Extension Period (24 Weeks)||44
6714327|NCT02975349|7644311|FG004|COMPLETED|Blinded Extension Period (24 Weeks)||46
6262834|NCT01345786|7161865|FG002|NOT COMPLETED|Overall Study||5
6262835|NCT01345786|7161866|FG003|NOT COMPLETED|Overall Study||3
6262836|NCT01306929|7161876|FG000|STARTED|Overall Study||134
6262837|NCT01306929|7161876|FG000|COMPLETED|Overall Study||40
6262838|NCT01306929|7161876|FG000|NOT COMPLETED|Overall Study||94
6262839|NCT01294696|7161882|FG000|STARTED|Overall Study||1261
6262840|NCT01294696|7161882|FG000|COMPLETED|Overall Study||1187
6262841|NCT01294696|7161882|FG000|NOT COMPLETED|Overall Study||74
6262842|NCT01277822|7161889|FG000|STARTED|Overall Study||168
6262843|NCT01277822|7161890|FG001|STARTED|Overall Study||166
6262844|NCT01277822|7161889|FG000|COMPLETED|Overall Study||153
6262845|NCT01277822|7161890|FG001|COMPLETED|Overall Study||155
6262846|NCT01277822|7161889|FG000|NOT COMPLETED|Overall Study||15
6262847|NCT01277822|7161890|FG001|NOT COMPLETED|Overall Study||11
6262848|NCT01261247|7161896|FG000|STARTED|Overall Study||41
6262849|NCT01261247|7161896|FG000|COMPLETED|Overall Study||39
6262850|NCT01261247|7161896|FG000|NOT COMPLETED|Overall Study||2
6262851|NCT01244763|7161906|FG000|STARTED|Overall Study||24
6602774|NCT02058966|7527826|FG000|Received Placebo-Placebo|Third Intervention||4
6714328|NCT02975349|7644312|FG005|COMPLETED|Blinded Extension Period (24 Weeks)||52
6714329|NCT02975349|7644307|FG000|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
6714330|NCT02975349|7644308|FG001|NOT COMPLETED|Blinded Extension Period (24 Weeks)||7
6714331|NCT02975349|7644309|FG002|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
6714332|NCT02975349|7644310|FG003|NOT COMPLETED|Blinded Extension Period (24 Weeks)||4
6714333|NCT02975349|7644311|FG004|NOT COMPLETED|Blinded Extension Period (24 Weeks)||2
6714334|NCT02975349|7644312|FG005|NOT COMPLETED|Blinded Extension Period (24 Weeks)||0
6714335|NCT02975557|7644334|FG000|STARTED|Overall Study||4
6714336|NCT02975557|7644335|FG001|STARTED|Overall Study||5
6714337|NCT02975557|7644336|FG002|STARTED|Overall Study||6
6714338|NCT02975557|7644334|FG000|COMPLETED|Overall Study||3
6714339|NCT02975557|7644335|FG001|COMPLETED|Overall Study||2
6714340|NCT02975557|7644336|FG002|COMPLETED|Overall Study||5
6714341|NCT02975557|7644334|FG000|NOT COMPLETED|Overall Study||1
6714342|NCT02975557|7644335|FG001|NOT COMPLETED|Overall Study||3
6714343|NCT02975557|7644336|FG002|NOT COMPLETED|Overall Study||1
6714344|NCT02975804|7644346|FG000|STARTED|Overall Study||9
6714345|NCT02975804|7644347|FG001|STARTED|Overall Study||9
6714346|NCT02975804|7644346|FG000|COMPLETED|Overall Study||9
6714347|NCT02975804|7644347|FG001|COMPLETED|Overall Study||9
6714348|NCT02975804|7644346|FG000|NOT COMPLETED|Overall Study||0
6714349|NCT02975804|7644347|FG001|NOT COMPLETED|Overall Study||0
6714350|NCT02975973|7644357|FG000|STARTED|Overall Study||1
6714351|NCT02975973|7644358|FG001|STARTED|Overall Study||2
6714352|NCT02975973|7644359|FG002|STARTED|Overall Study||1
6714353|NCT02975973|7644360|FG003|STARTED|Overall Study||4
6714354|NCT02975973|7644357|FG000|COMPLETED|Overall Study||0
6714355|NCT02975973|7644358|FG001|COMPLETED|Overall Study||1
6714356|NCT02975973|7644359|FG002|COMPLETED|Overall Study||0
6714357|NCT02975973|7644360|FG003|COMPLETED|Overall Study||4
6714358|NCT02975973|7644357|FG000|NOT COMPLETED|Overall Study||1
6714359|NCT02975973|7644358|FG001|NOT COMPLETED|Overall Study||1
6714360|NCT02975973|7644359|FG002|NOT COMPLETED|Overall Study||1
6714361|NCT02975973|7644360|FG003|NOT COMPLETED|Overall Study||0
6714362|NCT02976103|7644372|FG000|STARTED|Overall Study||67
6714363|NCT02976103|7644373|FG001|STARTED|Overall Study||72
6714364|NCT02976103|7644372|FG000|COMPLETED|Overall Study|54 participants answered final (T3) questionnaire|54
6714365|NCT02976103|7644373|FG001|COMPLETED|Overall Study|64 participants answered final (T3 questionnaire)|64
6714366|NCT02976103|7644372|FG000|NOT COMPLETED|Overall Study||13
6714367|NCT02976103|7644373|FG001|NOT COMPLETED|Overall Study||8
6714368|NCT02976181|7644380|FG000|STARTED|Overall Study||113
6714369|NCT02976181|7644380|FG000|COMPLETED|Overall Study||112
6714370|NCT02976181|7644380|FG000|NOT COMPLETED|Overall Study||1
6714371|NCT02976519|7644392|FG000|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6714372|NCT02976519|7644393|FG001|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6714373|NCT02976519|7644394|FG002|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6714374|NCT02976519|7644395|FG003|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6714375|NCT02976519|7644396|FG004|STARTED|Treatment Period 1 (Part 1 and Part 2)||8
6714376|NCT02976519|7644397|FG005|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
6714377|NCT02976519|7644398|FG006|STARTED|Treatment Period 1 (Part 1 and Part 2)||12
6714378|NCT02976519|7644392|FG000|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
6714379|NCT02976519|7644393|FG001|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
6714380|NCT02976519|7644394|FG002|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
6714381|NCT02976519|7644395|FG003|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||7
6714382|NCT02976519|7644396|FG004|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||8
6714383|NCT02976519|7644397|FG005|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
6714384|NCT02976519|7644398|FG006|COMPLETED|Treatment Period 1 (Part 1 and Part 2)||12
6714385|NCT02976519|7644392|FG000|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6714386|NCT02976519|7644393|FG001|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
6714387|NCT02976519|7644394|FG002|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6714388|NCT02976519|7644395|FG003|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||1
6714389|NCT02976519|7644396|FG004|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6714390|NCT02976519|7644397|FG005|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6714391|NCT02976519|7644398|FG006|NOT COMPLETED|Treatment Period 1 (Part 1 and Part 2)||0
6714392|NCT02976519|7644392|FG000|STARTED|Wash-out Period (Part 2 Only)||0
6714393|NCT02976519|7644393|FG001|STARTED|Wash-out Period (Part 2 Only)||0
6714394|NCT02976519|7644394|FG002|STARTED|Wash-out Period (Part 2 Only)||0
6714395|NCT02976519|7644395|FG003|STARTED|Wash-out Period (Part 2 Only)||0
6714396|NCT02976519|7644396|FG004|STARTED|Wash-out Period (Part 2 Only)||0
6714397|NCT02976519|7644397|FG005|STARTED|Wash-out Period (Part 2 Only)||12
6714398|NCT02976519|7644398|FG006|STARTED|Wash-out Period (Part 2 Only)||12
6714399|NCT02976519|7644392|FG000|COMPLETED|Wash-out Period (Part 2 Only)||0
6714400|NCT02976519|7644393|FG001|COMPLETED|Wash-out Period (Part 2 Only)||0
6714401|NCT02976519|7644394|FG002|COMPLETED|Wash-out Period (Part 2 Only)||0
6714402|NCT02976519|7644395|FG003|COMPLETED|Wash-out Period (Part 2 Only)||0
6714403|NCT02976519|7644396|FG004|COMPLETED|Wash-out Period (Part 2 Only)||0
6714404|NCT02976519|7644397|FG005|COMPLETED|Wash-out Period (Part 2 Only)||12
6714405|NCT02976519|7644398|FG006|COMPLETED|Wash-out Period (Part 2 Only)||10
6714406|NCT02976519|7644392|FG000|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6714407|NCT02976519|7644393|FG001|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6714408|NCT02976519|7644394|FG002|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6714409|NCT02976519|7644395|FG003|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6714410|NCT02976519|7644396|FG004|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6714411|NCT02976519|7644397|FG005|NOT COMPLETED|Wash-out Period (Part 2 Only)||0
6714412|NCT02976519|7644398|FG006|NOT COMPLETED|Wash-out Period (Part 2 Only)||2
6714413|NCT02976519|7644392|FG000|STARTED|Treatment Period 2 (Part 2 Only)||0
6714414|NCT02976519|7644393|FG001|STARTED|Treatment Period 2 (Part 2 Only)||0
6714415|NCT02976519|7644394|FG002|STARTED|Treatment Period 2 (Part 2 Only)||0
6714416|NCT02976519|7644395|FG003|STARTED|Treatment Period 2 (Part 2 Only)||0
6714417|NCT02976519|7644396|FG004|STARTED|Treatment Period 2 (Part 2 Only)||0
6714418|NCT02976519|7644397|FG005|STARTED|Treatment Period 2 (Part 2 Only)||12
6714419|NCT02976519|7644398|FG006|STARTED|Treatment Period 2 (Part 2 Only)||10
6714420|NCT02976519|7644392|FG000|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714421|NCT02976519|7644393|FG001|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714422|NCT02976519|7644394|FG002|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714423|NCT02976519|7644395|FG003|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714424|NCT02976519|7644396|FG004|COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714425|NCT02976519|7644397|FG005|COMPLETED|Treatment Period 2 (Part 2 Only)||12
6714426|NCT02976519|7644398|FG006|COMPLETED|Treatment Period 2 (Part 2 Only)||9
6714427|NCT02976519|7644392|FG000|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714428|NCT02976519|7644393|FG001|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714429|NCT02976519|7644394|FG002|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714430|NCT02976519|7644395|FG003|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714431|NCT02976519|7644396|FG004|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714432|NCT02976519|7644397|FG005|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||0
6714433|NCT02976519|7644398|FG006|NOT COMPLETED|Treatment Period 2 (Part 2 Only)||1
6714434|NCT02977507|7644418|FG000|STARTED|Overall Study||8
6714435|NCT02977507|7644419|FG001|STARTED|Overall Study||10
6262852|NCT01244763|7161907|FG001|STARTED|Overall Study||24
6262853|NCT01244763|7161908|FG002|STARTED|Overall Study||24
6262854|NCT01244763|7161909|FG003|STARTED|Overall Study||24
6262855|NCT01244763|7161910|FG004|STARTED|Overall Study||24
6262856|NCT01244763|7161911|FG005|STARTED|Overall Study||25
6262857|NCT01244763|7161906|FG000|Safety Population|Overall Study||24
6262858|NCT01244763|7161907|FG001|Safety Population|Overall Study||24
6262859|NCT01244763|7161908|FG002|Safety Population|Overall Study||24
6262860|NCT01244763|7161909|FG003|Safety Population|Overall Study||24
6262861|NCT01244763|7161910|FG004|Safety Population|Overall Study||24
6262862|NCT01244763|7161911|FG005|Safety Population|Overall Study||25
6262863|NCT01244763|7161906|FG000|Efficacy Evaluable (EE) Population|Overall Study||23
6262864|NCT01244763|7161907|FG001|Efficacy Evaluable (EE) Population|Overall Study||24
6262865|NCT01244763|7161908|FG002|Efficacy Evaluable (EE) Population|Overall Study||23
6262866|NCT01244763|7161909|FG003|Efficacy Evaluable (EE) Population|Overall Study||24
6262867|NCT01244763|7161910|FG004|Efficacy Evaluable (EE) Population|Overall Study||24
6262868|NCT01244763|7161911|FG005|Efficacy Evaluable (EE) Population|Overall Study||25
6262869|NCT01244763|7161906|FG000|COMPLETED|Overall Study||21
6262870|NCT01244763|7161907|FG001|COMPLETED|Overall Study||21
6262871|NCT01244763|7161908|FG002|COMPLETED|Overall Study||22
6262872|NCT01244763|7161909|FG003|COMPLETED|Overall Study||23
6262873|NCT01244763|7161910|FG004|COMPLETED|Overall Study||21
6262874|NCT01244763|7161911|FG005|COMPLETED|Overall Study||21
6262875|NCT01244763|7161906|FG000|NOT COMPLETED|Overall Study||3
6262876|NCT01244763|7161907|FG001|NOT COMPLETED|Overall Study||3
6262877|NCT01244763|7161908|FG002|NOT COMPLETED|Overall Study||2
6262878|NCT01244763|7161909|FG003|NOT COMPLETED|Overall Study||1
6262879|NCT01244763|7161910|FG004|NOT COMPLETED|Overall Study||3
6262880|NCT01244763|7161911|FG005|NOT COMPLETED|Overall Study||4
6262881|NCT01208207|7161928|FG000|STARTED|Part I||702
6262882|NCT01208207|7161929|FG001|STARTED|Part I||156
6262883|NCT01208207|7161930|FG002|STARTED|Part I||157
6262884|NCT01208207|7161931|FG003|STARTED|Part I||0
6262885|NCT01208207|7161932|FG004|STARTED|Part I||0
6262886|NCT01208207|7161933|FG005|STARTED|Part I||0
6262887|NCT01208207|7161934|FG006|STARTED|Part I||0
6262888|NCT01208207|7161928|FG000|COMPLETED|Part I||632
6262889|NCT01208207|7161929|FG001|COMPLETED|Part I||145
6262890|NCT01208207|7161930|FG002|COMPLETED|Part I||142
6262891|NCT01208207|7161931|FG003|COMPLETED|Part I||0
6262892|NCT01208207|7161932|FG004|COMPLETED|Part I||0
6262893|NCT01208207|7161933|FG005|COMPLETED|Part I||0
6262894|NCT01208207|7161934|FG006|COMPLETED|Part I||0
6262895|NCT01208207|7161928|FG000|NOT COMPLETED|Part I||70
6262896|NCT01208207|7161929|FG001|NOT COMPLETED|Part I||11
6262897|NCT01208207|7161930|FG002|NOT COMPLETED|Part I||15
6262898|NCT01208207|7161931|FG003|NOT COMPLETED|Part I||0
6262899|NCT01208207|7161932|FG004|NOT COMPLETED|Part I||0
6262900|NCT01208207|7161933|FG005|NOT COMPLETED|Part I||0
6262901|NCT01208207|7161934|FG006|NOT COMPLETED|Part I||0
6262902|NCT01208207|7161928|FG000|STARTED|Part II||0
6262903|NCT01208207|7161929|FG001|STARTED|Part II||0
6262904|NCT01208207|7161930|FG002|STARTED|Part II||0
6262905|NCT01208207|7161931|FG003|STARTED|Part II||314
6262906|NCT01208207|7161932|FG004|STARTED|Part II||318
6262907|NCT01208207|7161933|FG005|STARTED|Part II||145
6262908|NCT01208207|7161934|FG006|STARTED|Part II||142
6262909|NCT01208207|7161928|FG000|COMPLETED|Part II||0
6262910|NCT01208207|7161929|FG001|COMPLETED|Part II||0
6262911|NCT01208207|7161930|FG002|COMPLETED|Part II||0
6262912|NCT01208207|7161931|FG003|COMPLETED|Part II||282
6262913|NCT01208207|7161932|FG004|COMPLETED|Part II||295
6262914|NCT01208207|7161933|FG005|COMPLETED|Part II||129
6262915|NCT01208207|7161934|FG006|COMPLETED|Part II||131
6262916|NCT01208207|7161928|FG000|NOT COMPLETED|Part II||0
6262917|NCT01208207|7161929|FG001|NOT COMPLETED|Part II||0
6714436|NCT02977507|7644418|FG000|COMPLETED|Overall Study||6
6714437|NCT02977507|7644419|FG001|COMPLETED|Overall Study||10
6714438|NCT02977507|7644418|FG000|NOT COMPLETED|Overall Study||2
6714439|NCT02977507|7644419|FG001|NOT COMPLETED|Overall Study||0
6714440|NCT02977572|7644428|FG000|STARTED|Overall Study||58
6714441|NCT02977572|7644429|FG001|STARTED|Overall Study||56
6714442|NCT02977572|7644428|FG000|COMPLETED|Overall Study||56
6714443|NCT02977572|7644429|FG001|COMPLETED|Overall Study||54
6714444|NCT02977572|7644428|FG000|NOT COMPLETED|Overall Study||2
6714445|NCT02977572|7644429|FG001|NOT COMPLETED|Overall Study||2
6714446|NCT02978157|7644441|FG000|STARTED|Overall Study||52
6714447|NCT02978157|7644442|FG001|STARTED|Overall Study||50
6714448|NCT02978157|7644441|FG000|COMPLETED|Overall Study||52
6714449|NCT02978157|7644442|FG001|COMPLETED|Overall Study||50
6714450|NCT02978157|7644441|FG000|NOT COMPLETED|Overall Study||0
6714451|NCT02978157|7644442|FG001|NOT COMPLETED|Overall Study||0
6714452|NCT02978183|7644450|FG000|STARTED|Overall Study||34
6714453|NCT02978183|7644451|FG001|STARTED|Overall Study||36
6714454|NCT02978183|7644450|FG000|COMPLETED|Overall Study||34
6714455|NCT02978183|7644451|FG001|COMPLETED|Overall Study||36
6714456|NCT02978183|7644450|FG000|NOT COMPLETED|Overall Study||0
6714457|NCT02978183|7644451|FG001|NOT COMPLETED|Overall Study||0
6714458|NCT02978339|7644457|FG000|STARTED|Overall Study||15
6714459|NCT02978339|7644457|FG000|COMPLETED|Overall Study||15
6714460|NCT02978339|7644457|FG000|NOT COMPLETED|Overall Study||0
6714461|NCT02978417|7644463|FG000|STARTED|Overall Study||5
6714462|NCT02978417|7644464|FG001|STARTED|Overall Study||5
6714463|NCT02978417|7644463|FG000|COMPLETED|Overall Study||3
6714464|NCT02978417|7644464|FG001|COMPLETED|Overall Study||3
6714465|NCT02978417|7644463|FG000|NOT COMPLETED|Overall Study||2
6714466|NCT02978417|7644464|FG001|NOT COMPLETED|Overall Study||2
6714467|NCT02978508|7644472|FG000|STARTED|Overall Study||70
6714468|NCT02978508|7644473|FG001|STARTED|Overall Study||70
6714469|NCT02978508|7644472|FG000|COMPLETED|Overall Study||70
6714470|NCT02978508|7644473|FG001|COMPLETED|Overall Study||70
6714471|NCT02978508|7644472|FG000|NOT COMPLETED|Overall Study||0
6714472|NCT02978508|7644473|FG001|NOT COMPLETED|Overall Study||0
6714473|NCT02979054|7644481|FG000|STARTED|Overall Study||71
6714474|NCT02979054|7644482|FG001|STARTED|Overall Study||64
6714475|NCT02979054|7644481|FG000|COMPLETED|Overall Study||71
6714476|NCT02979054|7644482|FG001|COMPLETED|Overall Study||64
6714477|NCT02979054|7644481|FG000|NOT COMPLETED|Overall Study||0
6714478|NCT02979054|7644482|FG001|NOT COMPLETED|Overall Study||0
6714479|NCT02979197|7644491|FG000|STARTED|Overall Study||48
6714480|NCT02979197|7644492|FG001|STARTED|Overall Study||49
6714481|NCT02979197|7644493|FG002|STARTED|Overall Study||8
6714482|NCT02979197|7644491|FG000|COMPLETED|Overall Study||44
6714483|NCT02979197|7644492|FG001|COMPLETED|Overall Study||45
6714484|NCT02979197|7644493|FG002|COMPLETED|Overall Study||8
6714485|NCT02979197|7644491|FG000|NOT COMPLETED|Overall Study||4
6714486|NCT02979197|7644492|FG001|NOT COMPLETED|Overall Study||4
6714487|NCT02979197|7644493|FG002|NOT COMPLETED|Overall Study||0
6714488|NCT02979249|7644501|FG000|STARTED|Overall Study||16
6714489|NCT02979249|7644501|FG000|COMPLETED|Overall Study||10
6714490|NCT02979249|7644501|FG000|NOT COMPLETED|Overall Study||6
6714491|NCT02979262|7644507|FG000|STARTED|Overall Study||33
6714492|NCT02979262|7644508|FG001|STARTED|Overall Study||29
6714493|NCT02979262|7644507|FG000|Received Allocated Intervention|Overall Study||30
6714494|NCT02979262|7644508|FG001|Received Allocated Intervention|Overall Study||27
6714495|NCT02979262|7644507|FG000|COMPLETED|Overall Study||21
6714496|NCT02979262|7644508|FG001|COMPLETED|Overall Study||20
6714497|NCT02979262|7644507|FG000|NOT COMPLETED|Overall Study||12
6714498|NCT02979262|7644508|FG001|NOT COMPLETED|Overall Study||9
6714499|NCT02979301|7644516|FG000|STARTED|Overall Study||11
6714500|NCT02979301|7644517|FG001|STARTED|Overall Study||11
6714501|NCT02979301|7644516|FG000|COMPLETED|Overall Study||10
6714502|NCT02979301|7644517|FG001|COMPLETED|Overall Study||11
6714503|NCT02979301|7644516|FG000|NOT COMPLETED|Overall Study||1
6714504|NCT02979301|7644517|FG001|NOT COMPLETED|Overall Study||0
6714505|NCT02979431|7644527|FG000|STARTED|Overall Study||44
6714506|NCT02979431|7644528|FG001|STARTED|Overall Study||46
6714507|NCT02979431|7644529|FG002|STARTED|Overall Study||45
6714508|NCT02979431|7644530|FG003|STARTED|Overall Study||45
6262918|NCT01208207|7161930|FG002|NOT COMPLETED|Part II||0
6262919|NCT01208207|7161931|FG003|NOT COMPLETED|Part II||32
6714509|NCT02979431|7644527|FG000|Included in the mITT Population|Overall Study||42
6714510|NCT02979431|7644528|FG001|Included in the mITT Population|Overall Study||45
6714511|NCT02979431|7644529|FG002|Included in the mITT Population|Overall Study||43
6714512|NCT02979431|7644530|FG003|Included in the mITT Population|Overall Study||45
6714513|NCT02979431|7644527|FG000|Included in the Safety Population|Overall Study||40
6714514|NCT02979431|7644528|FG001|Included in the Safety Population|Overall Study||45
6714515|NCT02979431|7644529|FG002|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 6.0 mg/kg|44
6714516|NCT02979431|7644530|FG003|Included in the Safety Population|Overall Study|Includes a subject that was randomized to placebo but received a dose of ALX-0171 9.0 mg/kg|46
6714517|NCT02979431|7644527|FG000|COMPLETED|Overall Study||40
6714518|NCT02979431|7644528|FG001|COMPLETED|Overall Study||44
6714519|NCT02979431|7644529|FG002|COMPLETED|Overall Study||43
6714520|NCT02979431|7644530|FG003|COMPLETED|Overall Study||44
6714521|NCT02979431|7644527|FG000|NOT COMPLETED|Overall Study||4
6714522|NCT02979431|7644528|FG001|NOT COMPLETED|Overall Study||2
6714523|NCT02979431|7644529|FG002|NOT COMPLETED|Overall Study||2
6262920|NCT01208207|7161932|FG004|NOT COMPLETED|Part II||23
6262921|NCT01208207|7161933|FG005|NOT COMPLETED|Part II||16
6262922|NCT01208207|7161934|FG006|NOT COMPLETED|Part II||11
6262923|NCT01208181|7161959|FG000|STARTED|Part 1||818
6262924|NCT01208181|7161960|FG001|STARTED|Part 1||468
6262925|NCT01208181|7161961|FG002|STARTED|Part 1||0
6262926|NCT01208181|7161962|FG003|STARTED|Part 1||0
6262927|NCT01208181|7161963|FG004|STARTED|Part 1||118
6262928|NCT01208181|7161959|FG000|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
6262929|NCT01208181|7161960|FG001|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
6262930|NCT01208181|7161961|FG002|COMPLETED|Part 1||0
6262931|NCT01208181|7161962|FG003|COMPLETED|Part 1||0
6262932|NCT01208181|7161963|FG004|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
6262933|NCT01208181|7161959|FG000|NOT COMPLETED|Part 1||99
6714524|NCT02979431|7644530|FG003|NOT COMPLETED|Overall Study||1
6714525|NCT02979444|7644543|FG000|STARTED|Overall Study||405
6714526|NCT02979444|7644544|FG001|STARTED|Overall Study||310
6714527|NCT02979444|7644545|FG002|STARTED|Overall Study||159
6714528|NCT02979444|7644543|FG000|COMPLETED|Overall Study||382
6714529|NCT02979444|7644544|FG001|COMPLETED|Overall Study||293
6714530|NCT02979444|7644545|FG002|COMPLETED|Overall Study||149
6714531|NCT02979444|7644543|FG000|NOT COMPLETED|Overall Study||23
6714532|NCT02979444|7644544|FG001|NOT COMPLETED|Overall Study||17
6714533|NCT02979444|7644545|FG002|NOT COMPLETED|Overall Study||10
6714534|NCT02979522|7644555|FG000|STARTED|Period 1: Phase 1||8
6714535|NCT02979522|7644556|FG001|STARTED|Period 1: Phase 1||0
6714536|NCT02979522|7644555|FG000|COMPLETED|Period 1: Phase 1||8
6714537|NCT02979522|7644556|FG001|COMPLETED|Period 1: Phase 1||0
6714538|NCT02979522|7644555|FG000|NOT COMPLETED|Period 1: Phase 1||0
6714539|NCT02979522|7644556|FG001|NOT COMPLETED|Period 1: Phase 1||0
6714540|NCT02979522|7644555|FG000|STARTED|Period 2: Phase 2||0
6714541|NCT02979522|7644556|FG001|STARTED|Period 2: Phase 2|Participants treated in Phase 1 entered Phase 2 along with additional participants enrolled in Phase 2.|59
6714542|NCT02979522|7644555|FG000|COMPLETED|Period 2: Phase 2||0
6714543|NCT02979522|7644556|FG001|COMPLETED|Period 2: Phase 2||59
6714544|NCT02979522|7644555|FG000|NOT COMPLETED|Period 2: Phase 2||0
6714545|NCT02979522|7644556|FG001|NOT COMPLETED|Period 2: Phase 2||0
6714546|NCT02979613|7644564|FG000|STARTED|Double-Blind Phase||245
6714547|NCT02979613|7644565|FG001|STARTED|Double-Blind Phase||245
6714548|NCT02979613|7644564|FG000|COMPLETED|Double-Blind Phase||235
6714549|NCT02979613|7644565|FG001|COMPLETED|Double-Blind Phase||237
6714550|NCT02979613|7644564|FG000|NOT COMPLETED|Double-Blind Phase||10
6714551|NCT02979613|7644565|FG001|NOT COMPLETED|Double-Blind Phase||8
6714552|NCT02979613|7644564|FG000|STARTED|Open-Label Extension (OLE) Phase||235
6714553|NCT02979613|7644565|FG001|STARTED|Open-Label Extension (OLE) Phase||237
6714554|NCT02979613|7644564|FG000|COMPLETED|Open-Label Extension (OLE) Phase||232
6714555|NCT02979613|7644565|FG001|COMPLETED|Open-Label Extension (OLE) Phase||231
6714556|NCT02979613|7644564|FG000|NOT COMPLETED|Open-Label Extension (OLE) Phase||3
6714557|NCT02979613|7644565|FG001|NOT COMPLETED|Open-Label Extension (OLE) Phase||6
6714558|NCT02979626|7644575|FG000|STARTED|Overall Study||313
6714559|NCT02979626|7644576|FG001|STARTED|Overall Study||98
6714560|NCT02979626|7644575|FG000|COMPLETED|Overall Study||313
6714561|NCT02979626|7644576|FG001|COMPLETED|Overall Study||98
6714562|NCT02979626|7644575|FG000|NOT COMPLETED|Overall Study||0
6714563|NCT02979626|7644576|FG001|NOT COMPLETED|Overall Study||0
6714564|NCT02979639|7644582|FG000|STARTED|Overall Study||401
6714565|NCT02979639|7644582|FG000|COMPLETED|Overall Study||387
6714566|NCT02979639|7644582|FG000|NOT COMPLETED|Overall Study||14
6714567|NCT02979899|7644588|FG000|STARTED|Overall Study||64
6714568|NCT02979899|7644589|FG001|STARTED|Overall Study||64
6714569|NCT02979899|7644588|FG000|COMPLETED|Overall Study||64
6714570|NCT02979899|7644589|FG001|COMPLETED|Overall Study||64
6714571|NCT02979899|7644588|FG000|NOT COMPLETED|Overall Study||0
6714572|NCT02979899|7644589|FG001|NOT COMPLETED|Overall Study||0
6714573|NCT02979925|7644597|FG000|STARTED|Overall Study||28
6714574|NCT02979925|7644598|FG001|STARTED|Overall Study||29
6714575|NCT02979925|7644597|FG000|COMPLETED|Overall Study||28
6714576|NCT02979925|7644598|FG001|COMPLETED|Overall Study||23
6714577|NCT02979925|7644597|FG000|NOT COMPLETED|Overall Study||0
6714578|NCT02979925|7644598|FG001|NOT COMPLETED|Overall Study||6
6714579|NCT02980042|7644606|FG000|STARTED|Overall Study||100
6714580|NCT02980042|7644607|FG001|STARTED|Overall Study||100
6714581|NCT02980042|7644606|FG000|COMPLETED|Overall Study|All 100 subjects completed their Week 24 infusion. 7 subjects did not complete the 12 month visit.|93
6714582|NCT02980042|7644607|FG001|COMPLETED|Overall Study||100
6714583|NCT02980042|7644606|FG000|NOT COMPLETED|Overall Study||7
6714584|NCT02980042|7644607|FG001|NOT COMPLETED|Overall Study||0
6714585|NCT02980107|7644627|FG000|STARTED|Overall Study||105
6714586|NCT02980107|7644628|FG001|STARTED|Overall Study||107
6714587|NCT02980107|7644627|FG000|COMPLETED|Overall Study||54
6714588|NCT02980107|7644628|FG001|COMPLETED|Overall Study||45
6714589|NCT02980107|7644627|FG000|NOT COMPLETED|Overall Study||51
6714590|NCT02980107|7644628|FG001|NOT COMPLETED|Overall Study||62
6714591|NCT02980133|7644638|FG000|STARTED|Overall Study||209
6714592|NCT02980133|7644639|FG001|STARTED|Overall Study||211
6714593|NCT02980133|7644640|FG002|STARTED|Overall Study||210
6714594|NCT02980133|7644641|FG003|STARTED|Overall Study||211
6714595|NCT02980133|7644638|FG000|Received at Least 1 Dose of Study Drug|Overall Study||209
6714596|NCT02980133|7644639|FG001|Received at Least 1 Dose of Study Drug|Overall Study||211
6714597|NCT02980133|7644640|FG002|Received at Least 1 Dose of Study Drug|Overall Study||208
6714598|NCT02980133|7644641|FG003|Received at Least 1 Dose of Study Drug|Overall Study||211
6714599|NCT02980133|7644638|FG000|COMPLETED|Overall Study||202
6714600|NCT02980133|7644639|FG001|COMPLETED|Overall Study||206
6714601|NCT02980133|7644640|FG002|COMPLETED|Overall Study||203
6714602|NCT02980133|7644641|FG003|COMPLETED|Overall Study||205
6714603|NCT02980133|7644638|FG000|NOT COMPLETED|Overall Study||7
6714604|NCT02980133|7644639|FG001|NOT COMPLETED|Overall Study||5
6714605|NCT02980133|7644640|FG002|NOT COMPLETED|Overall Study||7
6714606|NCT02980133|7644641|FG003|NOT COMPLETED|Overall Study||6
6714607|NCT02980211|7644654|FG000|STARTED|Overall Study||17
6714608|NCT02980211|7644654|FG000|COMPLETED|Overall Study||17
6714609|NCT02980211|7644654|FG000|NOT COMPLETED|Overall Study||0
6714610|NCT02980224|7644660|FG000|STARTED|Overall Study||89
6714611|NCT02980224|7644661|FG001|STARTED|Overall Study||91
6714612|NCT02980224|7644660|FG000|COMPLETED|Overall Study||85
6714613|NCT02980224|7644661|FG001|COMPLETED|Overall Study||88
6714614|NCT02980224|7644660|FG000|NOT COMPLETED|Overall Study||4
6714615|NCT02980224|7644661|FG001|NOT COMPLETED|Overall Study||3
6714616|NCT02980523|7644672|FG000|STARTED|Overall Study||30
6714617|NCT02980523|7644673|FG001|STARTED|Overall Study||30
6714618|NCT02980523|7644674|FG002|STARTED|Overall Study||30
6714619|NCT02980523|7644675|FG003|STARTED|Overall Study||30
6714620|NCT02980523|7644676|FG004|STARTED|Overall Study||30
6714621|NCT02980523|7644672|FG000|COMPLETED|Overall Study||27
6714622|NCT02980523|7644673|FG001|COMPLETED|Overall Study||19
6714623|NCT02980523|7644674|FG002|COMPLETED|Overall Study||24
6714624|NCT02980523|7644675|FG003|COMPLETED|Overall Study||21
6714625|NCT02980523|7644676|FG004|COMPLETED|Overall Study||20
6714626|NCT02980523|7644672|FG000|NOT COMPLETED|Overall Study||3
6714627|NCT02980523|7644673|FG001|NOT COMPLETED|Overall Study||11
6714628|NCT02980523|7644674|FG002|NOT COMPLETED|Overall Study||6
6714629|NCT02980523|7644675|FG003|NOT COMPLETED|Overall Study||9
6714630|NCT02980523|7644676|FG004|NOT COMPLETED|Overall Study||10
6739416|NCT03289208|7668268|FG002|COMPLETED|Overall Study||11
6739417|NCT03289208|7668266|FG000|NOT COMPLETED|Overall Study||1
6739418|NCT03289208|7668267|FG001|NOT COMPLETED|Overall Study||0
6739419|NCT03289208|7668268|FG002|NOT COMPLETED|Overall Study||0
6739420|NCT03289234|7668279|FG000|STARTED|Overall Study||8
6739421|NCT03289234|7668280|FG001|STARTED|Overall Study||6
6739422|NCT03289234|7668281|FG002|STARTED|Overall Study||8
6739423|NCT03289234|7668279|FG000|COMPLETED|Overall Study||8
6739424|NCT03289234|7668280|FG001|COMPLETED|Overall Study||6
6739425|NCT03289234|7668281|FG002|COMPLETED|Overall Study||8
6739426|NCT03289234|7668279|FG000|NOT COMPLETED|Overall Study||0
6739427|NCT03289234|7668280|FG001|NOT COMPLETED|Overall Study||0
6739428|NCT03289234|7668281|FG002|NOT COMPLETED|Overall Study||0
6739429|NCT03289455|7668292|FG000|STARTED|Overall Study||4
6739430|NCT03289455|7668293|FG001|STARTED|Overall Study||5
6739431|NCT03289455|7668294|FG002|STARTED|Overall Study||6
6739432|NCT03289455|7668292|FG000|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
6739433|NCT03289455|7668293|FG001|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
6739434|NCT03289455|7668294|FG002|COMPLETED|Overall Study|Completed = Received AUTO3 infusion and completed 24 months visit|0
6739435|NCT03289455|7668292|FG000|NOT COMPLETED|Overall Study||4
6739436|NCT03289455|7668293|FG001|NOT COMPLETED|Overall Study||5
6739437|NCT03289455|7668294|FG002|NOT COMPLETED|Overall Study||6
6739438|NCT03289481|7668305|FG000|STARTED|Overall Study||6
6739439|NCT03289481|7668306|FG001|STARTED|Overall Study||7
6739440|NCT03289481|7668305|FG000|COMPLETED|Overall Study||4
6739441|NCT03289481|7668306|FG001|COMPLETED|Overall Study||5
6739442|NCT03289481|7668305|FG000|NOT COMPLETED|Overall Study||2
6739443|NCT03289481|7668306|FG001|NOT COMPLETED|Overall Study||2
6739444|NCT03289533|7668313|FG000|STARTED|Overall Study||22
6739445|NCT03289533|7668313|FG000|COMPLETED|Overall Study||0
6739446|NCT03289533|7668313|FG000|NOT COMPLETED|Overall Study||22
6739447|NCT03289676|7668319|FG000|STARTED|Overall Study||27
6739448|NCT03289676|7668320|FG001|STARTED|Overall Study||26
6739449|NCT03289676|7668319|FG000|COMPLETED|Overall Study||23
6739450|NCT03289676|7668320|FG001|COMPLETED|Overall Study|Received 80% of the allotted intervention|25
6739451|NCT03289676|7668319|FG000|NOT COMPLETED|Overall Study||4
6739452|NCT03289676|7668320|FG001|NOT COMPLETED|Overall Study||1
6739453|NCT03289858|7668328|FG000|STARTED|Overall Study||27
6739454|NCT03289858|7668329|FG001|STARTED|Overall Study||28
6739455|NCT03289858|7668328|FG000|COMPLETED|Overall Study||25
6739456|NCT03289858|7668329|FG001|COMPLETED|Overall Study||28
6739457|NCT03289858|7668328|FG000|NOT COMPLETED|Overall Study||2
6739458|NCT03289858|7668329|FG001|NOT COMPLETED|Overall Study||0
6739459|NCT03290027|7668337|FG000|STARTED|Overall Study||277
6739460|NCT03290027|7668338|FG001|STARTED|Overall Study||273
6739461|NCT03290027|7668337|FG000|COMPLETED|Overall Study||219
6739462|NCT03290027|7668338|FG001|COMPLETED|Overall Study||228
6739463|NCT03290027|7668337|FG000|NOT COMPLETED|Overall Study||58
6739464|NCT03290027|7668338|FG001|NOT COMPLETED|Overall Study||45
6739465|NCT03290300|7668344|FG000|STARTED|Overall Study||39
6739466|NCT03290300|7668344|FG000|COMPLETED|Overall Study||36
6739467|NCT03290300|7668344|FG000|NOT COMPLETED|Overall Study||3
6739468|NCT03290378|7668356|FG000|STARTED|Overall Study||140
6739469|NCT03290378|7668357|FG001|STARTED|Overall Study||133
6739470|NCT03290378|7668358|FG002|STARTED|Overall Study||136
6739471|NCT03290378|7668356|FG000|COMPLETED|Overall Study||137
6714631|NCT02980601|7644693|FG000|STARTED|Overall Study||6
6714632|NCT02980601|7644694|FG001|STARTED|Overall Study||4
6714633|NCT02980601|7644693|FG000|COMPLETED|Overall Study||1
6714634|NCT02980601|7644694|FG001|COMPLETED|Overall Study||1
6714635|NCT02980601|7644693|FG000|NOT COMPLETED|Overall Study||5
6714636|NCT02980601|7644694|FG001|NOT COMPLETED|Overall Study||3
6714637|NCT02980692|7644705|FG000|STARTED|Overall Study||78
6714638|NCT02980692|7644706|FG001|STARTED|Overall Study||79
6714639|NCT02980692|7644707|FG002|STARTED|Overall Study||77
6714640|NCT02980692|7644708|FG003|STARTED|Overall Study||78
6714641|NCT02980692|7644709|FG004|STARTED|Overall Study||79
6714642|NCT02980692|7644705|FG000|COMPLETED|Overall Study||69
6714643|NCT02980692|7644706|FG001|COMPLETED|Overall Study||73
6714644|NCT02980692|7644707|FG002|COMPLETED|Overall Study||65
6714645|NCT02980692|7644708|FG003|COMPLETED|Overall Study||69
6714646|NCT02980692|7644709|FG004|COMPLETED|Overall Study||68
6714647|NCT02980692|7644705|FG000|NOT COMPLETED|Overall Study||9
6714648|NCT02980692|7644706|FG001|NOT COMPLETED|Overall Study||6
6714649|NCT02980692|7644707|FG002|NOT COMPLETED|Overall Study||12
6714650|NCT02980692|7644708|FG003|NOT COMPLETED|Overall Study||9
6714651|NCT02980692|7644709|FG004|NOT COMPLETED|Overall Study||11
6714652|NCT02980705|7644724|FG000|STARTED|Overall Study||50
6714653|NCT02980705|7644725|FG001|STARTED|Overall Study||51
6714654|NCT02980705|7644724|FG000|COMPLETED|Overall Study||42
6714655|NCT02980705|7644725|FG001|COMPLETED|Overall Study||40
6714656|NCT02980705|7644724|FG000|NOT COMPLETED|Overall Study||8
6714657|NCT02980705|7644725|FG001|NOT COMPLETED|Overall Study||11
6714658|NCT02980783|7644732|FG000|STARTED|Overall Study||53
6714659|NCT02980783|7644732|FG000|COMPLETED|Overall Study||52
6714660|NCT02980783|7644732|FG000|NOT COMPLETED|Overall Study||1
6714661|NCT02980874|7644738|FG000|STARTED|Overall Study||231
6714662|NCT02980874|7644739|FG001|STARTED|Overall Study||229
6714663|NCT02980874|7644738|FG000|COMPLETED|Overall Study||128
6714664|NCT02980874|7644739|FG001|COMPLETED|Overall Study||127
6714665|NCT02980874|7644738|FG000|NOT COMPLETED|Overall Study||103
6714666|NCT02980874|7644739|FG001|NOT COMPLETED|Overall Study||102
6714667|NCT02980978|7644747|FG000|STARTED|Overall Study||60
6714668|NCT02980978|7644748|FG001|STARTED|Overall Study||58
6714669|NCT02980978|7644747|FG000|COMPLETED|Overall Study||54
6714670|NCT02980978|7644748|FG001|COMPLETED|Overall Study||50
6714671|NCT02980978|7644747|FG000|NOT COMPLETED|Overall Study||6
6714672|NCT02980978|7644748|FG001|NOT COMPLETED|Overall Study||8
6714673|NCT02981342|7644758|FG000|STARTED|Overall Study||7
6714674|NCT02981342|7644759|FG001|STARTED|Overall Study||33
6714675|NCT02981342|7644760|FG002|STARTED|Overall Study||33
6714676|NCT02981342|7644761|FG003|STARTED|Overall Study||33
6714677|NCT02981342|7644758|FG000|Received at Least One Dose of Study Drug|Overall Study||7
6714678|NCT02981342|7644759|FG001|Received at Least One Dose of Study Drug|Overall Study||32
6714679|NCT02981342|7644760|FG002|Received at Least One Dose of Study Drug|Overall Study||33
6714680|NCT02981342|7644761|FG003|Received at Least One Dose of Study Drug|Overall Study||26
6714681|NCT02981342|7644758|FG000|COMPLETED|Overall Study||7
6714682|NCT02981342|7644759|FG001|COMPLETED|Overall Study||22
6714683|NCT02981342|7644760|FG002|COMPLETED|Overall Study||20
6714684|NCT02981342|7644761|FG003|COMPLETED|Overall Study||19
6714685|NCT02981342|7644758|FG000|NOT COMPLETED|Overall Study||0
6714686|NCT02981342|7644759|FG001|NOT COMPLETED|Overall Study||11
6714687|NCT02981342|7644760|FG002|NOT COMPLETED|Overall Study||13
6714688|NCT02981342|7644761|FG003|NOT COMPLETED|Overall Study||14
6714689|NCT02981368|7644775|FG000|STARTED|Overall Study||268
6714690|NCT02981368|7644776|FG001|STARTED|Overall Study||117
6262934|NCT01208181|7161960|FG001|NOT COMPLETED|Part 1||55
6262935|NCT01208181|7161961|FG002|NOT COMPLETED|Part 1||0
6262936|NCT01208181|7161962|FG003|NOT COMPLETED|Part 1||0
6262937|NCT01208181|7161963|FG004|NOT COMPLETED|Part 1||22
6262938|NCT01208181|7161959|FG000|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
6262939|NCT01208181|7161960|FG001|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
6262940|NCT01208181|7161961|FG002|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
6262941|NCT01208181|7161962|FG003|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
6262942|NCT01208181|7161963|FG004|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
6262943|NCT01208181|7161959|FG000|COMPLETED|Part 2||0
6262944|NCT01208181|7161960|FG001|COMPLETED|Part 2||0
6262945|NCT01208181|7161961|FG002|COMPLETED|Part 2||334
6262946|NCT01208181|7161962|FG003|COMPLETED|Part 2||343
6262947|NCT01208181|7161963|FG004|COMPLETED|Part 2||0
6262948|NCT01208181|7161959|FG000|NOT COMPLETED|Part 2||0
6262949|NCT01208181|7161960|FG001|NOT COMPLETED|Part 2||0
6262950|NCT01208181|7161961|FG002|NOT COMPLETED|Part 2||16
6262951|NCT01208181|7161962|FG003|NOT COMPLETED|Part 2||20
6262952|NCT01208181|7161963|FG004|NOT COMPLETED|Part 2||0
6262953|NCT01206517|7161986|FG000|STARTED|Overall Study||6
6714691|NCT02981368|7644775|FG000|COMPLETED|Overall Study||248
6714692|NCT02981368|7644776|FG001|COMPLETED|Overall Study||102
6714693|NCT02981368|7644775|FG000|NOT COMPLETED|Overall Study||20
6714694|NCT02981368|7644776|FG001|NOT COMPLETED|Overall Study||15
6714695|NCT02981524|7644809|FG000|STARTED|Overall Study||17
6714696|NCT02981524|7644809|FG000|COMPLETED|Overall Study||0
6714697|NCT02981524|7644809|FG000|NOT COMPLETED|Overall Study||17
6714698|NCT02981602|7644818|FG000|STARTED|Overall Study||6
6714699|NCT02981602|7644819|FG001|STARTED|Overall Study||12
6714700|NCT02981602|7644820|FG002|STARTED|Overall Study||6
6714701|NCT02981602|7644821|FG003|STARTED|Overall Study||5
6714702|NCT02981602|7644822|FG004|STARTED|Overall Study||2
6714703|NCT02981602|7644818|FG000|COMPLETED|Overall Study||6
6714704|NCT02981602|7644819|FG001|COMPLETED|Overall Study||12
6714705|NCT02981602|7644820|FG002|COMPLETED|Overall Study||6
6714706|NCT02981602|7644821|FG003|COMPLETED|Overall Study||4
6714707|NCT02981602|7644822|FG004|COMPLETED|Overall Study||2
6714708|NCT02981602|7644818|FG000|NOT COMPLETED|Overall Study||0
6714709|NCT02981602|7644819|FG001|NOT COMPLETED|Overall Study||0
6714710|NCT02981602|7644820|FG002|NOT COMPLETED|Overall Study||0
6714711|NCT02981602|7644821|FG003|NOT COMPLETED|Overall Study||1
6714712|NCT02981602|7644822|FG004|NOT COMPLETED|Overall Study||0
6714713|NCT02981953|7644835|FG000|STARTED|Overall Study||40
6714714|NCT02981953|7644835|FG000|COMPLETED|Overall Study||29
6714715|NCT02981953|7644835|FG000|NOT COMPLETED|Overall Study||11
6714716|NCT02982018|7644841|FG000|STARTED|Overall Study||67
6714717|NCT02982018|7644842|FG001|STARTED|Overall Study||64
6714718|NCT02982018|7644841|FG000|COMPLETED|Overall Study||62
6714719|NCT02982018|7644842|FG001|COMPLETED|Overall Study||61
6714720|NCT02982018|7644841|FG000|NOT COMPLETED|Overall Study||5
6714721|NCT02982018|7644842|FG001|NOT COMPLETED|Overall Study||3
6714722|NCT02982187|7644850|FG000|STARTED|Overall Study||20
6714723|NCT02982187|7644851|FG001|STARTED|Overall Study||20
6714724|NCT02982187|7644852|FG002|STARTED|Overall Study||20
6714725|NCT02982187|7644853|FG003|STARTED|Overall Study||20
6714726|NCT02982187|7644854|FG004|STARTED|Overall Study||20
6714727|NCT02982187|7644855|FG005|STARTED|Overall Study||20
6714728|NCT02982187|7644856|FG006|STARTED|Overall Study||20
6714729|NCT02982187|7644857|FG007|STARTED|Overall Study||20
6714730|NCT02982187|7644850|FG000|COMPLETED|Overall Study||20
6714731|NCT02982187|7644851|FG001|COMPLETED|Overall Study||20
6714732|NCT02982187|7644852|FG002|COMPLETED|Overall Study||20
6714733|NCT02982187|7644853|FG003|COMPLETED|Overall Study||20
6714734|NCT02982187|7644854|FG004|COMPLETED|Overall Study||20
6714735|NCT02982187|7644855|FG005|COMPLETED|Overall Study||20
6714736|NCT02982187|7644856|FG006|COMPLETED|Overall Study||19
6714737|NCT02982187|7644857|FG007|COMPLETED|Overall Study||20
6714738|NCT02982187|7644850|FG000|NOT COMPLETED|Overall Study||0
6714739|NCT02982187|7644851|FG001|NOT COMPLETED|Overall Study||0
6714740|NCT02982187|7644852|FG002|NOT COMPLETED|Overall Study||0
6714741|NCT02982187|7644853|FG003|NOT COMPLETED|Overall Study||0
6714742|NCT02982187|7644854|FG004|NOT COMPLETED|Overall Study||0
6714743|NCT02982187|7644855|FG005|NOT COMPLETED|Overall Study||0
6714744|NCT02982187|7644856|FG006|NOT COMPLETED|Overall Study||1
6714745|NCT02982187|7644857|FG007|NOT COMPLETED|Overall Study||0
6714746|NCT02982213|7644869|FG000|STARTED|Overall Study||75
6714747|NCT02982213|7644870|FG001|STARTED|Overall Study||75
6714748|NCT02982213|7644869|FG000|COMPLETED|Overall Study||70
6714749|NCT02982213|7644870|FG001|COMPLETED|Overall Study||74
6714750|NCT02982213|7644869|FG000|NOT COMPLETED|Overall Study||5
6714751|NCT02982213|7644870|FG001|NOT COMPLETED|Overall Study||1
6714752|NCT02982239|7644878|FG000|STARTED|Overall Study||20
6714753|NCT02982239|7644879|FG001|STARTED|Overall Study||20
6714754|NCT02982239|7644878|FG000|COMPLETED|Overall Study||17
6714755|NCT02982239|7644879|FG001|COMPLETED|Overall Study||18
6714756|NCT02982239|7644878|FG000|NOT COMPLETED|Overall Study||3
6714757|NCT02982239|7644879|FG001|NOT COMPLETED|Overall Study||2
6714758|NCT02982590|7644888|FG000|STARTED|Overall Study||13
6714759|NCT02982590|7644889|FG001|STARTED|Overall Study||14
6714760|NCT02982590|7644888|FG000|COMPLETED|Overall Study||9
6714761|NCT02982590|7644889|FG001|COMPLETED|Overall Study||13
6714762|NCT02982590|7644888|FG000|NOT COMPLETED|Overall Study||4
6714763|NCT02982590|7644889|FG001|NOT COMPLETED|Overall Study||1
6714764|NCT02982772|7644897|FG000|STARTED|Enrollment||245
6714765|NCT02982772|7644898|FG001|STARTED|Enrollment||243
6714766|NCT02982772|7644897|FG000|COMPLETED|Enrollment||245
6714767|NCT02982772|7644898|FG001|COMPLETED|Enrollment||243
6714768|NCT02982772|7644897|FG000|NOT COMPLETED|Enrollment||0
6714769|NCT02982772|7644898|FG001|NOT COMPLETED|Enrollment||0
6714770|NCT02982772|7644897|FG000|STARTED|Intervention||245
6714771|NCT02982772|7644898|FG001|STARTED|Intervention||243
6714772|NCT02982772|7644897|FG000|COMPLETED|Intervention||226
6714773|NCT02982772|7644898|FG001|COMPLETED|Intervention||230
6714774|NCT02982772|7644897|FG000|NOT COMPLETED|Intervention||19
6714775|NCT02982772|7644898|FG001|NOT COMPLETED|Intervention||13
6714776|NCT02982772|7644897|FG000|STARTED|1M Follow-Up||226
6714777|NCT02982772|7644898|FG001|STARTED|1M Follow-Up||230
6714778|NCT02982772|7644897|FG000|COMPLETED|1M Follow-Up||205
6714779|NCT02982772|7644898|FG001|COMPLETED|1M Follow-Up||212
6714780|NCT02982772|7644897|FG000|NOT COMPLETED|1M Follow-Up||21
6714781|NCT02982772|7644898|FG001|NOT COMPLETED|1M Follow-Up||18
6714782|NCT02982772|7644897|FG000|STARTED|3M Follow-Up||205
6714783|NCT02982772|7644898|FG001|STARTED|3M Follow-Up||212
6714784|NCT02982772|7644897|FG000|COMPLETED|3M Follow-Up||188
6714785|NCT02982772|7644898|FG001|COMPLETED|3M Follow-Up||201
6714786|NCT02982772|7644897|FG000|NOT COMPLETED|3M Follow-Up||17
6714787|NCT02982772|7644898|FG001|NOT COMPLETED|3M Follow-Up||11
6714788|NCT02982772|7644897|FG000|STARTED|6M Follow-Up||188
6714789|NCT02982772|7644898|FG001|STARTED|6M Follow-Up||201
6714790|NCT02982772|7644897|FG000|COMPLETED|6M Follow-Up||177
6714791|NCT02982772|7644898|FG001|COMPLETED|6M Follow-Up||192
6714792|NCT02982772|7644897|FG000|NOT COMPLETED|6M Follow-Up||11
6714793|NCT02982772|7644898|FG001|NOT COMPLETED|6M Follow-Up||9
6714794|NCT02982772|7644897|FG000|STARTED|12M Follow-Up||177
6714795|NCT02982772|7644898|FG001|STARTED|12M Follow-Up||192
6714796|NCT02982772|7644897|FG000|COMPLETED|12M Follow-Up||166
6714797|NCT02982772|7644898|FG001|COMPLETED|12M Follow-Up||187
6714798|NCT02982772|7644897|FG000|NOT COMPLETED|12M Follow-Up||11
6714799|NCT02982772|7644898|FG001|NOT COMPLETED|12M Follow-Up||5
6714800|NCT02982863|7644911|FG000|STARTED|Overall Study||5745
6714801|NCT02982863|7644912|FG001|STARTED|Overall Study||16745
6714802|NCT02982863|7644913|FG002|STARTED|Overall Study||13238
6714803|NCT02982863|7644914|FG003|STARTED|Overall Study||10158
6714804|NCT02982863|7644915|FG004|STARTED|Overall Study||2760
6714805|NCT02982863|7644911|FG000|COMPLETED|Overall Study||4936
6714806|NCT02982863|7644912|FG001|COMPLETED|Overall Study||12484
6714807|NCT02982863|7644913|FG002|COMPLETED|Overall Study||11386
6714808|NCT02982863|7644914|FG003|COMPLETED|Overall Study||8758
6714809|NCT02982863|7644915|FG004|COMPLETED|Overall Study||2268
6714810|NCT02982863|7644911|FG000|NOT COMPLETED|Overall Study||809
6714811|NCT02982863|7644912|FG001|NOT COMPLETED|Overall Study||4261
6714812|NCT02982863|7644913|FG002|NOT COMPLETED|Overall Study||1852
6714813|NCT02982863|7644914|FG003|NOT COMPLETED|Overall Study||1400
6714814|NCT02982863|7644915|FG004|NOT COMPLETED|Overall Study||492
6714815|NCT02982928|7644931|FG000|STARTED|Overall Study||11
6714816|NCT02982928|7644931|FG000|COMPLETED|Overall Study||11
6714817|NCT02982928|7644931|FG000|NOT COMPLETED|Overall Study||0
6714818|NCT02982954|7644939|FG000|STARTED|Treatment Period||106
6714819|NCT02982954|7644940|FG001|STARTED|Treatment Period||52
6714820|NCT02982954|7644941|FG002|STARTED|Treatment Period||28
6714821|NCT02982954|7644942|FG003|STARTED|Treatment Period||25
6714822|NCT02982954|7644939|FG000|COMPLETED|Treatment Period||0
6714823|NCT02982954|7644940|FG001|COMPLETED|Treatment Period||0
6714824|NCT02982954|7644941|FG002|COMPLETED|Treatment Period||0
6714825|NCT02982954|7644942|FG003|COMPLETED|Treatment Period||0
6714826|NCT02982954|7644939|FG000|NOT COMPLETED|Treatment Period||106
6714827|NCT02982954|7644940|FG001|NOT COMPLETED|Treatment Period||52
6714828|NCT02982954|7644941|FG002|NOT COMPLETED|Treatment Period||28
6714829|NCT02982954|7644942|FG003|NOT COMPLETED|Treatment Period||25
6714830|NCT02982954|7644939|FG000|STARTED|Continuing in Study||106
6714831|NCT02982954|7644940|FG001|STARTED|Continuing in Study||52
6714832|NCT02982954|7644941|FG002|STARTED|Continuing in Study||28
6714833|NCT02982954|7644942|FG003|STARTED|Continuing in Study||25
6714834|NCT02982954|7644939|FG000|COMPLETED|Continuing in Study||52
6714835|NCT02982954|7644940|FG001|COMPLETED|Continuing in Study||19
6714836|NCT02982954|7644941|FG002|COMPLETED|Continuing in Study||17
6714837|NCT02982954|7644942|FG003|COMPLETED|Continuing in Study||7
6714838|NCT02982954|7644939|FG000|NOT COMPLETED|Continuing in Study||54
6714839|NCT02982954|7644940|FG001|NOT COMPLETED|Continuing in Study||33
6714840|NCT02982954|7644941|FG002|NOT COMPLETED|Continuing in Study||11
6714841|NCT02982954|7644942|FG003|NOT COMPLETED|Continuing in Study||18
6714842|NCT02983058|7644954|FG000|STARTED|Overall Study||7
6714843|NCT02983058|7644955|FG001|STARTED|Overall Study||5
6714844|NCT02983058|7644954|FG000|COMPLETED|Overall Study||2
6714845|NCT02983058|7644955|FG001|COMPLETED|Overall Study||2
6714846|NCT02983058|7644954|FG000|NOT COMPLETED|Overall Study||5
6714847|NCT02983058|7644955|FG001|NOT COMPLETED|Overall Study||3
6714848|NCT02983227|7644963|FG000|STARTED|Overall Study||410
6714849|NCT02983227|7644964|FG001|STARTED|Overall Study||86
6714850|NCT02983227|7644963|FG000|COMPLETED|Overall Study||351
6714851|NCT02983227|7644964|FG001|COMPLETED|Overall Study||72
6714852|NCT02983227|7644963|FG000|NOT COMPLETED|Overall Study||59
6714853|NCT02983227|7644964|FG001|NOT COMPLETED|Overall Study||14
6714854|NCT02983305|7644972|FG000|STARTED|Overall Study||12
6714855|NCT02983305|7644973|FG001|STARTED|Overall Study||10
6714856|NCT02983305|7644972|FG000|COMPLETED|Overall Study||10
6714857|NCT02983305|7644973|FG001|COMPLETED|Overall Study||10
6714858|NCT02983305|7644972|FG000|NOT COMPLETED|Overall Study||2
6714859|NCT02983305|7644973|FG001|NOT COMPLETED|Overall Study||0
6714860|NCT02983448|7644979|FG000|STARTED|Overall Study||12
6714861|NCT02983448|7644980|FG001|STARTED|Overall Study||12
6714862|NCT02983448|7644979|FG000|COMPLETED|Overall Study||12
6714863|NCT02983448|7644980|FG001|COMPLETED|Overall Study||12
6714864|NCT02983448|7644979|FG000|NOT COMPLETED|Overall Study||0
6714865|NCT02983448|7644980|FG001|NOT COMPLETED|Overall Study||0
6714866|NCT02983552|7644992|FG000|STARTED|Overall Study||69
6714867|NCT02983552|7644993|FG001|STARTED|Overall Study||69
6714868|NCT02983552|7644994|FG002|STARTED|Overall Study||92
6714869|NCT02983552|7644995|FG003|STARTED|Overall Study||90
6714870|NCT02983552|7644992|FG000|4 Week Visit|Overall Study||69
6714871|NCT02983552|7644993|FG001|4 Week Visit|Overall Study||67
6714872|NCT02983552|7644994|FG002|4 Week Visit|Overall Study||85
6714873|NCT02983552|7644995|FG003|4 Week Visit|Overall Study||84
6714874|NCT02983552|7644992|FG000|8 Week Visit|Overall Study||67
6714875|NCT02983552|7644993|FG001|8 Week Visit|Overall Study||68
6714876|NCT02983552|7644994|FG002|8 Week Visit|Overall Study||85
6714877|NCT02983552|7644995|FG003|8 Week Visit|Overall Study||84
6714878|NCT02983552|7644992|FG000|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
6714879|NCT02983552|7644993|FG001|16 Week Visit|Overall Study||66
6739472|NCT03290378|7668357|FG001|COMPLETED|Overall Study||123
6739473|NCT03290378|7668358|FG002|COMPLETED|Overall Study||120
6714880|NCT02983552|7644994|FG002|16 Week Visit|Overall Study|The 16 week visit was elective for those who were originally assigned to continued spectacle correction. After completing 8 weeks of continued spectacle correction, participants were able to complete 8 weeks of binocular therapy. Values are not provided for the binocular computer game treatment cohorts as this visit was not applicable.|0
6714881|NCT02983552|7644995|FG003|16 Week Visit|Overall Study||72
6714882|NCT02983552|7644992|FG000|COMPLETED|Overall Study||69
6714883|NCT02983552|7644993|FG001|COMPLETED|Overall Study||67
6714884|NCT02983552|7644994|FG002|COMPLETED|Overall Study||92
6714885|NCT02983552|7644995|FG003|COMPLETED|Overall Study||90
6714886|NCT02983552|7644992|FG000|NOT COMPLETED|Overall Study||0
6714887|NCT02983552|7644993|FG001|NOT COMPLETED|Overall Study||2
6714888|NCT02983552|7644994|FG002|NOT COMPLETED|Overall Study||0
6714889|NCT02983552|7644995|FG003|NOT COMPLETED|Overall Study||0
6714890|NCT02983604|7645013|FG000|STARTED|Overall Study||4
6714891|NCT02983604|7645014|FG001|STARTED|Overall Study||3
6714892|NCT02983604|7645015|FG002|STARTED|Overall Study||4
6714893|NCT02983604|7645016|FG003|STARTED|Overall Study||3
6714894|NCT02983604|7645013|FG000|COMPLETED|Overall Study||4
6714895|NCT02983604|7645014|FG001|COMPLETED|Overall Study||3
6714896|NCT02983604|7645015|FG002|COMPLETED|Overall Study||3
6714897|NCT02983604|7645016|FG003|COMPLETED|Overall Study||3
6714898|NCT02983604|7645013|FG000|NOT COMPLETED|Overall Study||0
6714899|NCT02983604|7645014|FG001|NOT COMPLETED|Overall Study||0
6714900|NCT02983604|7645015|FG002|NOT COMPLETED|Overall Study||1
6714901|NCT02983604|7645016|FG003|NOT COMPLETED|Overall Study||0
6714902|NCT02983825|7645026|FG000|STARTED|Overall Study|Of 21 enrolled subjects, 9 became ineligible for between consent and intervention|12
6714903|NCT02983825|7645026|FG000|COMPLETED|Overall Study|Of 12 subjects starting intervention, 3 met specified stopping critieria|9
6714904|NCT02983825|7645026|FG000|NOT COMPLETED|Overall Study||3
6714905|NCT02983877|7645030|FG000|STARTED|Overall Study||38
6714906|NCT02983877|7645030|FG000|COMPLETED|Overall Study||38
6714907|NCT02983877|7645030|FG000|NOT COMPLETED|Overall Study||0
6714908|NCT02983981|7645035|FG000|STARTED|Overall Study||20
6714909|NCT02983981|7645035|FG000|COMPLETED|Overall Study||20
6714910|NCT02983981|7645035|FG000|NOT COMPLETED|Overall Study||0
6714911|NCT02984267|7645041|FG000|STARTED|Overall Study||8
6714912|NCT02984267|7645042|FG001|STARTED|Overall Study||10
6714913|NCT02984267|7645041|FG000|COMPLETED|Overall Study||7
6714914|NCT02984267|7645042|FG001|COMPLETED|Overall Study||9
6714915|NCT02984267|7645041|FG000|NOT COMPLETED|Overall Study||1
6714916|NCT02984267|7645042|FG001|NOT COMPLETED|Overall Study||1
6714917|NCT02984644|7645050|FG000|STARTED|Overall Study||20
6714918|NCT02984644|7645051|FG001|STARTED|Overall Study||10
6714919|NCT02984644|7645050|FG000|COMPLETED|Overall Study||20
6714920|NCT02984644|7645051|FG001|COMPLETED|Overall Study||10
6714921|NCT02984644|7645050|FG000|NOT COMPLETED|Overall Study||0
6714922|NCT02984644|7645051|FG001|NOT COMPLETED|Overall Study||0
6714923|NCT02984683|7645080|FG000|STARTED|Overall Study||11
6714924|NCT02984683|7645081|FG001|STARTED|Overall Study||12
6714925|NCT02984683|7645080|FG000|COMPLETED|Overall Study||0
6714926|NCT02984683|7645081|FG001|COMPLETED|Overall Study||0
6714927|NCT02984683|7645080|FG000|NOT COMPLETED|Overall Study||11
6262954|NCT01206517|7161987|FG001|STARTED|Overall Study||6
6262955|NCT01206517|7161988|FG002|STARTED|Overall Study||6
6262956|NCT01206517|7161989|FG003|STARTED|Overall Study||4
6262957|NCT01206517|7161990|FG004|STARTED|Overall Study||4
6262958|NCT01206517|7161991|FG005|STARTED|Overall Study||4
6262959|NCT01206517|7161986|FG000|COMPLETED|Overall Study||6
6262960|NCT01206517|7161987|FG001|COMPLETED|Overall Study||6
6262961|NCT01206517|7161988|FG002|COMPLETED|Overall Study||4
6262962|NCT01206517|7161989|FG003|COMPLETED|Overall Study||4
6262963|NCT01206517|7161990|FG004|COMPLETED|Overall Study||3
6262964|NCT01206517|7161991|FG005|COMPLETED|Overall Study||4
6262965|NCT01206517|7161986|FG000|NOT COMPLETED|Overall Study||0
6262966|NCT01206517|7161987|FG001|NOT COMPLETED|Overall Study||0
6262967|NCT01206517|7161988|FG002|NOT COMPLETED|Overall Study||2
6262968|NCT01206517|7161989|FG003|NOT COMPLETED|Overall Study||0
6262969|NCT01206517|7161990|FG004|NOT COMPLETED|Overall Study||1
6262970|NCT01206517|7161991|FG005|NOT COMPLETED|Overall Study||0
6262971|NCT01190267|7162004|FG000|STARTED|Overall Study||196
6262972|NCT01190267|7162005|FG001|STARTED|Overall Study||8
6262973|NCT01190267|7162004|FG000|COMPLETED|Overall Study||155
6262974|NCT01190267|7162005|FG001|COMPLETED|Overall Study||4
6262975|NCT01190267|7162004|FG000|NOT COMPLETED|Overall Study||41
6262976|NCT01190267|7162005|FG001|NOT COMPLETED|Overall Study||4
6262977|NCT01190254|7162014|FG000|STARTED|Overall Study||102
6262978|NCT01190254|7162015|FG001|STARTED|Overall Study||98
6262979|NCT01190254|7162016|FG002|STARTED|Overall Study||106
6262980|NCT01190254|7162014|FG000|Treated|Overall Study||102
6262981|NCT01190254|7162015|FG001|Treated|Overall Study||98
6262982|NCT01190254|7162016|FG002|Treated|Overall Study||106
6262983|NCT01190254|7162014|FG000|COMPLETED|Overall Study||81
6262984|NCT01190254|7162015|FG001|COMPLETED|Overall Study||81
6262985|NCT01190254|7162016|FG002|COMPLETED|Overall Study||84
6262986|NCT01190254|7162014|FG000|NOT COMPLETED|Overall Study||21
6262987|NCT01190254|7162015|FG001|NOT COMPLETED|Overall Study||17
6262988|NCT01190254|7162016|FG002|NOT COMPLETED|Overall Study||22
6714928|NCT02984683|7645081|FG001|NOT COMPLETED|Overall Study||12
6739474|NCT03290378|7668356|FG000|NOT COMPLETED|Overall Study||3
6262989|NCT01154036|7162027|FG000|STARTED|Phase I||120
6262990|NCT01154036|7162028|FG001|STARTED|Phase I||483
6262991|NCT01154036|7162029|FG002|STARTED|Phase I||944
6714929|NCT02984709|7645089|FG000|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
6714930|NCT02984709|7645090|FG001|STARTED|Overall Study|We enrolled 24 adolescent-parent dyads.|24
6714931|NCT02984709|7645089|FG000|COMPLETED|Overall Study||24
6714932|NCT02984709|7645090|FG001|COMPLETED|Overall Study||24
6714933|NCT02984709|7645089|FG000|NOT COMPLETED|Overall Study||0
6714934|NCT02984709|7645090|FG001|NOT COMPLETED|Overall Study||0
6714935|NCT02984878|7645100|FG000|STARTED|Overall Study||30
6714936|NCT02984878|7645101|FG001|STARTED|Overall Study||41
6714937|NCT02984878|7645100|FG000|COMPLETED|Overall Study||30
6714938|NCT02984878|7645101|FG001|COMPLETED|Overall Study||41
6714939|NCT02984878|7645100|FG000|NOT COMPLETED|Overall Study||0
6714940|NCT02984878|7645101|FG001|NOT COMPLETED|Overall Study||0
6714941|NCT02984943|7645110|FG000|STARTED|Overall Study||14
6714942|NCT02984943|7645110|FG000|COMPLETED|Overall Study||10
6714943|NCT02984943|7645110|FG000|NOT COMPLETED|Overall Study||4
6714944|NCT02984982|7645116|FG000|STARTED|Overall Study||102
6714945|NCT02984982|7645117|FG001|STARTED|Overall Study||104
6262992|NCT01154036|7162030|FG003|STARTED|Phase I||0
6262993|NCT01154036|7162031|FG004|STARTED|Phase I||0
6262994|NCT01154036|7162032|FG005|STARTED|Phase I||0
6262995|NCT01154036|7162033|FG006|STARTED|Phase I||0
6262996|NCT01154036|7162034|FG007|STARTED|Phase I||0
6262997|NCT01154036|7162027|FG000|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
6262998|NCT01154036|7162028|FG001|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
6714946|NCT02984982|7645116|FG000|Treated|Overall Study||102
6714947|NCT02984982|7645117|FG001|Treated|Overall Study||103
6714948|NCT02984982|7645116|FG000|COMPLETED|Overall Study||94
6714949|NCT02984982|7645117|FG001|COMPLETED|Overall Study||94
6714950|NCT02984982|7645116|FG000|NOT COMPLETED|Overall Study||8
6714951|NCT02984982|7645117|FG001|NOT COMPLETED|Overall Study||10
6714952|NCT02984995|7645126|FG000|STARTED|Overall Study||34
6714953|NCT02984995|7645127|FG001|STARTED|Overall Study||3
6714954|NCT02984995|7645126|FG000|COMPLETED|Overall Study||9
6714955|NCT02984995|7645127|FG001|COMPLETED|Overall Study||0
6714956|NCT02984995|7645126|FG000|NOT COMPLETED|Overall Study||25
6714957|NCT02984995|7645127|FG001|NOT COMPLETED|Overall Study||3
6714958|NCT02985021|7645139|FG000|STARTED|Overall Study||2
6714959|NCT02985021|7645139|FG000|COMPLETED|Overall Study||1
6714960|NCT02985021|7645139|FG000|NOT COMPLETED|Overall Study||1
6714961|NCT02985398|7645143|FG000|STARTED|Overall Study||128
6714962|NCT02985398|7645143|FG000|Participants Treated|Overall Study||128
6714963|NCT02985398|7645143|FG000|COMPLETED|Overall Study||106
6714964|NCT02985398|7645143|FG000|NOT COMPLETED|Overall Study||22
6714965|NCT02985450|7645147|FG000|STARTED|Overall Study||82
6714966|NCT02985450|7645147|FG000|COMPLETED|Overall Study||75
6714967|NCT02985450|7645147|FG000|NOT COMPLETED|Overall Study||7
6714968|NCT02985710|7645156|FG000|STARTED|Overall Study||69
6714969|NCT02985710|7645157|FG001|STARTED|Overall Study||33
6714970|NCT02985710|7645156|FG000|COMPLETED|Overall Study||65
6714971|NCT02985710|7645157|FG001|COMPLETED|Overall Study||33
6714972|NCT02985710|7645156|FG000|NOT COMPLETED|Overall Study||4
6714973|NCT02985710|7645157|FG001|NOT COMPLETED|Overall Study||0
6714974|NCT02985827|7645165|FG000|STARTED|Overall Study||33
6714975|NCT02985827|7645166|FG001|STARTED|Overall Study||15
6714976|NCT02985827|7645165|FG000|COMPLETED|Overall Study||33
6714977|NCT02985827|7645166|FG001|COMPLETED|Overall Study||15
6714978|NCT02985827|7645165|FG000|NOT COMPLETED|Overall Study||0
6714979|NCT02985827|7645166|FG001|NOT COMPLETED|Overall Study||0
6714980|NCT02985879|7645175|FG000|STARTED|Overall Study||126
6714981|NCT02985879|7645176|FG001|STARTED|Overall Study||127
6714982|NCT02985879|7645177|FG002|STARTED|Overall Study||125
6714983|NCT02985879|7645175|FG000|COMPLETED|Overall Study||50
6714984|NCT02985879|7645176|FG001|COMPLETED|Overall Study||52
6714985|NCT02985879|7645177|FG002|COMPLETED|Overall Study||48
6714986|NCT02985879|7645175|FG000|NOT COMPLETED|Overall Study||76
6714987|NCT02985879|7645176|FG001|NOT COMPLETED|Overall Study||75
6714988|NCT02985879|7645177|FG002|NOT COMPLETED|Overall Study||77
6714989|NCT02985996|7645196|FG000|STARTED|Overall Study||5
6714990|NCT02985996|7645197|FG001|STARTED|Overall Study||8
6714991|NCT02985996|7645198|FG002|STARTED|Overall Study||10
6714992|NCT02985996|7645199|FG003|STARTED|Overall Study||7
6714993|NCT02985996|7645200|FG004|STARTED|Overall Study||9
6714994|NCT02985996|7645196|FG000|COMPLETED|Overall Study||5
6714995|NCT02985996|7645197|FG001|COMPLETED|Overall Study||7
6714996|NCT02985996|7645198|FG002|COMPLETED|Overall Study||9
6714997|NCT02985996|7645199|FG003|COMPLETED|Overall Study||7
6714998|NCT02985996|7645200|FG004|COMPLETED|Overall Study||9
6714999|NCT02985996|7645196|FG000|NOT COMPLETED|Overall Study||0
6715000|NCT02985996|7645197|FG001|NOT COMPLETED|Overall Study||1
6715001|NCT02985996|7645198|FG002|NOT COMPLETED|Overall Study||1
6715002|NCT02985996|7645199|FG003|NOT COMPLETED|Overall Study||0
6715003|NCT02985996|7645200|FG004|NOT COMPLETED|Overall Study||0
6715004|NCT02986074|7645216|FG000|STARTED|First Trial Period||26
6715005|NCT02986074|7645217|FG001|STARTED|First Trial Period||29
6715006|NCT02986074|7645218|FG002|STARTED|First Trial Period||0
6715007|NCT02986074|7645219|FG003|STARTED|First Trial Period||0
6715008|NCT02986074|7645216|FG000|COMPLETED|First Trial Period||25
6715009|NCT02986074|7645217|FG001|COMPLETED|First Trial Period||29
6715010|NCT02986074|7645218|FG002|COMPLETED|First Trial Period||0
6715011|NCT02986074|7645219|FG003|COMPLETED|First Trial Period||0
6715012|NCT02986074|7645216|FG000|NOT COMPLETED|First Trial Period||1
6715013|NCT02986074|7645217|FG001|NOT COMPLETED|First Trial Period||0
6715014|NCT02986074|7645218|FG002|NOT COMPLETED|First Trial Period||0
6262999|NCT01154036|7162029|FG002|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
6263000|NCT01154036|7162030|FG003|COMPLETED|Phase I||0
6263001|NCT01154036|7162031|FG004|COMPLETED|Phase I||0
6263002|NCT01154036|7162032|FG005|COMPLETED|Phase I||0
6263003|NCT01154036|7162033|FG006|COMPLETED|Phase I||0
6263004|NCT01154036|7162034|FG007|COMPLETED|Phase I||0
6263005|NCT01154036|7162027|FG000|NOT COMPLETED|Phase I||3
6263006|NCT01154036|7162028|FG001|NOT COMPLETED|Phase I||28
6263007|NCT01154036|7162029|FG002|NOT COMPLETED|Phase I||56
6263008|NCT01154036|7162030|FG003|NOT COMPLETED|Phase I||0
6263009|NCT01154036|7162031|FG004|NOT COMPLETED|Phase I||0
6263010|NCT01154036|7162032|FG005|NOT COMPLETED|Phase I||0
6263011|NCT01154036|7162033|FG006|NOT COMPLETED|Phase I||0
6263012|NCT01154036|7162034|FG007|NOT COMPLETED|Phase I||0
6263013|NCT01154036|7162027|FG000|STARTED|Phase II||0
6263014|NCT01154036|7162028|FG001|STARTED|Phase II||0
6263015|NCT01154036|7162029|FG002|STARTED|Phase II||0
6263016|NCT01154036|7162030|FG003|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
6263017|NCT01154036|7162031|FG004|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
6263018|NCT01154036|7162032|FG005|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
6263019|NCT01154036|7162033|FG006|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
6263020|NCT01154036|7162034|FG007|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
6263021|NCT01154036|7162027|FG000|COMPLETED|Phase II||0
6263022|NCT01154036|7162028|FG001|COMPLETED|Phase II||0
6263023|NCT01154036|7162029|FG002|COMPLETED|Phase II||0
6263024|NCT01154036|7162030|FG003|COMPLETED|Phase II||27
6263025|NCT01154036|7162031|FG004|COMPLETED|Phase II||116
6263026|NCT01154036|7162032|FG005|COMPLETED|Phase II||121
6263027|NCT01154036|7162033|FG006|COMPLETED|Phase II||225
6263028|NCT01154036|7162034|FG007|COMPLETED|Phase II||200
6263029|NCT01154036|7162027|FG000|NOT COMPLETED|Phase II||0
6263030|NCT01154036|7162028|FG001|NOT COMPLETED|Phase II||0
6263031|NCT01154036|7162029|FG002|NOT COMPLETED|Phase II||0
6263032|NCT01154036|7162030|FG003|NOT COMPLETED|Phase II||1
6263033|NCT01154036|7162031|FG004|NOT COMPLETED|Phase II||8
6263034|NCT01154036|7162032|FG005|NOT COMPLETED|Phase II||5
6263035|NCT01154036|7162033|FG006|NOT COMPLETED|Phase II||9
6263036|NCT01154036|7162034|FG007|NOT COMPLETED|Phase II||6
6263037|NCT01101464|7162056|FG000|STARTED|Day 1 Through AM Dose of Day 5||4
6263038|NCT01101464|7162057|FG001|STARTED|Day 1 Through AM Dose of Day 5||4
6263039|NCT01101464|7162056|FG000|COMPLETED|Day 1 Through AM Dose of Day 5||4
6715015|NCT02986074|7645219|FG003|NOT COMPLETED|First Trial Period||0
6715016|NCT02986074|7645216|FG000|STARTED|Second Trial Period||25
6715017|NCT02986074|7645217|FG001|STARTED|Second Trial Period||29
6715018|NCT02986074|7645218|FG002|STARTED|Second Trial Period||0
6715019|NCT02986074|7645219|FG003|STARTED|Second Trial Period||0
6715020|NCT02986074|7645216|FG000|COMPLETED|Second Trial Period||25
6715021|NCT02986074|7645217|FG001|COMPLETED|Second Trial Period||29
6715022|NCT02986074|7645218|FG002|COMPLETED|Second Trial Period||0
6715023|NCT02986074|7645219|FG003|COMPLETED|Second Trial Period||0
6715024|NCT02986074|7645216|FG000|NOT COMPLETED|Second Trial Period||0
6715025|NCT02986074|7645217|FG001|NOT COMPLETED|Second Trial Period||0
6715026|NCT02986074|7645218|FG002|NOT COMPLETED|Second Trial Period||0
6715027|NCT02986074|7645219|FG003|NOT COMPLETED|Second Trial Period||0
6715028|NCT02986074|7645216|FG000|STARTED|Follow up Period||0
6715029|NCT02986074|7645217|FG001|STARTED|Follow up Period||0
6715030|NCT02986074|7645218|FG002|STARTED|Follow up Period||21
6715031|NCT02986074|7645219|FG003|STARTED|Follow up Period||22
6715032|NCT02986074|7645216|FG000|3 Month Follow up|Follow up Period||0
6715033|NCT02986074|7645217|FG001|3 Month Follow up|Follow up Period||0
6715034|NCT02986074|7645218|FG002|3 Month Follow up|Follow up Period||21
6715035|NCT02986074|7645219|FG003|3 Month Follow up|Follow up Period||21
6715036|NCT02986074|7645216|FG000|6 Month Follow up|Follow up Period||0
6715037|NCT02986074|7645217|FG001|6 Month Follow up|Follow up Period||0
6715038|NCT02986074|7645218|FG002|6 Month Follow up|Follow up Period||21
6715039|NCT02986074|7645219|FG003|6 Month Follow up|Follow up Period||20
6715040|NCT02986074|7645216|FG000|COMPLETED|Follow up Period||0
6715041|NCT02986074|7645217|FG001|COMPLETED|Follow up Period||0
6715042|NCT02986074|7645218|FG002|COMPLETED|Follow up Period||20
6715043|NCT02986074|7645219|FG003|COMPLETED|Follow up Period||19
6715044|NCT02986074|7645216|FG000|NOT COMPLETED|Follow up Period||0
6715045|NCT02986074|7645217|FG001|NOT COMPLETED|Follow up Period||0
6715046|NCT02986074|7645218|FG002|NOT COMPLETED|Follow up Period||1
6715047|NCT02986074|7645219|FG003|NOT COMPLETED|Follow up Period||3
6715048|NCT02986139|7645226|FG000|STARTED|Overall Study||56
6715049|NCT02986139|7645227|FG001|STARTED|Overall Study||55
6715050|NCT02986139|7645226|FG000|Received Etanercept|Overall Study||56
6715051|NCT02986139|7645227|FG001|Received Etanercept|Overall Study||53
6715052|NCT02986139|7645226|FG000|COMPLETED|Overall Study||55
6715053|NCT02986139|7645227|FG001|COMPLETED|Overall Study||51
6715054|NCT02986139|7645226|FG000|NOT COMPLETED|Overall Study||1
6715055|NCT02986139|7645227|FG001|NOT COMPLETED|Overall Study||4
6715056|NCT02986282|7645237|FG000|STARTED|Overall Study||115
6715057|NCT02986282|7645237|FG000|COMPLETED|Overall Study||99
6715058|NCT02986282|7645237|FG000|NOT COMPLETED|Overall Study||16
6715059|NCT02986373|7645241|FG000|STARTED|Overall Study||145
6715060|NCT02986373|7645241|FG000|COMPLETED|Overall Study||106
6715061|NCT02986373|7645241|FG000|NOT COMPLETED|Overall Study||39
6715062|NCT02986711|7645247|FG000|STARTED|Overall Study||78
6715063|NCT02986711|7645248|FG001|STARTED|Overall Study||80
6715064|NCT02986711|7645247|FG000|COMPLETED|Overall Study||70
6715065|NCT02986711|7645248|FG001|COMPLETED|Overall Study||70
6715066|NCT02986711|7645247|FG000|NOT COMPLETED|Overall Study||8
6715067|NCT02986711|7645248|FG001|NOT COMPLETED|Overall Study||10
6715068|NCT02986802|7645258|FG000|STARTED|Overall Study||1360
6715069|NCT02986802|7645259|FG001|STARTED|Overall Study||2839
6715070|NCT02986802|7645260|FG002|STARTED|Overall Study||1873
6715071|NCT02986802|7645261|FG003|STARTED|Overall Study||83060
6715072|NCT02986802|7645258|FG000|COMPLETED|Overall Study||1360
6715073|NCT02986802|7645259|FG001|COMPLETED|Overall Study||2839
6715074|NCT02986802|7645260|FG002|COMPLETED|Overall Study||1873
6715075|NCT02986802|7645261|FG003|COMPLETED|Overall Study||83060
6715076|NCT02986802|7645258|FG000|NOT COMPLETED|Overall Study||0
6715077|NCT02986802|7645259|FG001|NOT COMPLETED|Overall Study||0
6715078|NCT02986802|7645260|FG002|NOT COMPLETED|Overall Study||0
6715079|NCT02986802|7645261|FG003|NOT COMPLETED|Overall Study||0
6715080|NCT02986854|7645274|FG000|STARTED|Overall Study||301
6715081|NCT02986854|7645275|FG001|STARTED|Overall Study||300
6715082|NCT02986854|7645276|FG002|STARTED|Overall Study||100
6715083|NCT02986854|7645274|FG000|COMPLETED|Overall Study||298
6715084|NCT02986854|7645275|FG001|COMPLETED|Overall Study||288
6715085|NCT02986854|7645276|FG002|COMPLETED|Overall Study||97
6715086|NCT02986854|7645274|FG000|NOT COMPLETED|Overall Study||3
6715087|NCT02986854|7645275|FG001|NOT COMPLETED|Overall Study||12
6715088|NCT02986854|7645276|FG002|NOT COMPLETED|Overall Study||3
6715089|NCT02986958|7645288|FG000|STARTED|Overall Study||49
6715090|NCT02986958|7645289|FG001|STARTED|Overall Study||44
6715091|NCT02986958|7645288|FG000|COMPLETED|Overall Study||49
6715092|NCT02986958|7645289|FG001|COMPLETED|Overall Study||44
6715093|NCT02986958|7645288|FG000|NOT COMPLETED|Overall Study||0
6715094|NCT02986958|7645289|FG001|NOT COMPLETED|Overall Study||0
6715095|NCT02987205|7645295|FG000|STARTED|Overall Study||163
6715096|NCT02987205|7645295|FG000|Treated - Bilateral NLF Injection|Overall Study||163
6715097|NCT02987205|7645295|FG000|COMPLETED|Overall Study|Treatment is bilateral, subject lost to Restylane AE was lost to further Revanesse Ultra treatment|159
6715098|NCT02987205|7645295|FG000|NOT COMPLETED|Overall Study||4
6715099|NCT02987231|7645303|FG000|STARTED|Overall Study||30
6715100|NCT02987231|7645304|FG001|STARTED|Overall Study||30
6715101|NCT02987231|7645303|FG000|COMPLETED|Overall Study||30
6715102|NCT02987231|7645304|FG001|COMPLETED|Overall Study||30
6715103|NCT02987231|7645303|FG000|NOT COMPLETED|Overall Study||0
6715104|NCT02987231|7645304|FG001|NOT COMPLETED|Overall Study||0
6715105|NCT02987374|7645310|FG000|STARTED|Overall Study||10
6715106|NCT02987374|7645310|FG000|COMPLETED|Overall Study||10
6715107|NCT02987374|7645310|FG000|NOT COMPLETED|Overall Study||0
6715108|NCT02987621|7645314|FG000|STARTED|Overall Study||7
6715109|NCT02987621|7645315|FG001|STARTED|Overall Study||7
6715110|NCT02987621|7645314|FG000|COMPLETED|Overall Study||7
6715111|NCT02987621|7645315|FG001|COMPLETED|Overall Study||7
6715112|NCT02987621|7645314|FG000|NOT COMPLETED|Overall Study||0
6715113|NCT02987621|7645315|FG001|NOT COMPLETED|Overall Study||0
6715114|NCT02987660|7645325|FG000|STARTED|Overall Study||10
6715115|NCT02987660|7645326|FG001|STARTED|Overall Study||10
6715116|NCT02987660|7645325|FG000|COMPLETED|Overall Study||0
6715117|NCT02987660|7645326|FG001|COMPLETED|Overall Study||0
6715118|NCT02987660|7645325|FG000|NOT COMPLETED|Overall Study||10
6715119|NCT02987660|7645326|FG001|NOT COMPLETED|Overall Study||10
6715120|NCT02987829|7645338|FG000|STARTED|Overall Study||1
6715121|NCT02987829|7645339|FG001|STARTED|Overall Study||1
6715122|NCT02987829|7645340|FG002|STARTED|Overall Study||2
6715123|NCT02987829|7645341|FG003|STARTED|Overall Study||7
6715124|NCT02987829|7645342|FG004|STARTED|Overall Study||51
6715125|NCT02987829|7645343|FG005|STARTED|Overall Study||10
6715126|NCT02987829|7645338|FG000|COMPLETED|Overall Study||1
6715127|NCT02987829|7645339|FG001|COMPLETED|Overall Study||1
6715128|NCT02987829|7645340|FG002|COMPLETED|Overall Study||2
6715129|NCT02987829|7645341|FG003|COMPLETED|Overall Study||7
6715130|NCT02987829|7645342|FG004|COMPLETED|Overall Study||51
6715131|NCT02987829|7645343|FG005|COMPLETED|Overall Study||10
6715132|NCT02987829|7645338|FG000|NOT COMPLETED|Overall Study||0
6715133|NCT02987829|7645339|FG001|NOT COMPLETED|Overall Study||0
6715134|NCT02987829|7645340|FG002|NOT COMPLETED|Overall Study||0
6715135|NCT02987829|7645341|FG003|NOT COMPLETED|Overall Study||0
6715136|NCT02987829|7645342|FG004|NOT COMPLETED|Overall Study||0
6715137|NCT02987829|7645343|FG005|NOT COMPLETED|Overall Study||0
6715138|NCT02987868|7645360|FG000|STARTED|First Intervention||8
6715139|NCT02987868|7645361|FG001|STARTED|First Intervention||8
6715140|NCT02987868|7645360|FG000|COMPLETED|First Intervention||8
6715141|NCT02987868|7645361|FG001|COMPLETED|First Intervention||8
6715142|NCT02987868|7645360|FG000|NOT COMPLETED|First Intervention||0
6715143|NCT02987868|7645361|FG001|NOT COMPLETED|First Intervention||0
6715144|NCT02987868|7645360|FG000|STARTED|Wash Out Period 1 Week||8
6715145|NCT02987868|7645361|FG001|STARTED|Wash Out Period 1 Week||8
6715146|NCT02987868|7645360|FG000|COMPLETED|Wash Out Period 1 Week||8
6715147|NCT02987868|7645361|FG001|COMPLETED|Wash Out Period 1 Week||8
6715148|NCT02987868|7645360|FG000|NOT COMPLETED|Wash Out Period 1 Week||0
6715149|NCT02987868|7645361|FG001|NOT COMPLETED|Wash Out Period 1 Week||0
6715150|NCT02987868|7645360|FG000|STARTED|Second Intervention||8
6715151|NCT02987868|7645361|FG001|STARTED|Second Intervention||8
6715152|NCT02987868|7645360|FG000|COMPLETED|Second Intervention||8
6715153|NCT02987868|7645361|FG001|COMPLETED|Second Intervention||8
6715154|NCT02987868|7645360|FG000|NOT COMPLETED|Second Intervention||0
6715155|NCT02987868|7645361|FG001|NOT COMPLETED|Second Intervention||0
6715159|NCT02987972|7645374|FG000|STARTED|Overall Study||351
6263040|NCT01101464|7162057|FG001|COMPLETED|Day 1 Through AM Dose of Day 5||4
6263041|NCT01101464|7162056|FG000|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
6263042|NCT01101464|7162057|FG001|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
6263043|NCT01101464|7162056|FG000|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
6263044|NCT01101464|7162057|FG001|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
6715160|NCT02987972|7645375|FG001|STARTED|Overall Study||350
6715161|NCT02987972|7645376|FG002|STARTED|Overall Study||350
6715162|NCT02987972|7645374|FG000|Vaccination 1|Overall Study||350
6715163|NCT02987972|7645375|FG001|Vaccination 1|Overall Study||347
6715164|NCT02987972|7645376|FG002|Vaccination 1|Overall Study||347
6715165|NCT02987972|7645374|FG000|Vaccination 2|Overall Study||333
6715166|NCT02987972|7645375|FG001|Vaccination 2|Overall Study||335
6715167|NCT02987972|7645376|FG002|Vaccination 2|Overall Study||335
6715168|NCT02987972|7645374|FG000|Vaccination 3|Overall Study||330
6715169|NCT02987972|7645375|FG001|Vaccination 3|Overall Study||331
6715170|NCT02987972|7645376|FG002|Vaccination 3|Overall Study||332
6715171|NCT02987972|7645374|FG000|Vaccination 4|Overall Study||310
6715172|NCT02987972|7645375|FG001|Vaccination 4|Overall Study||306
6715173|NCT02987972|7645376|FG002|Vaccination 4|Overall Study||311
6715174|NCT02987972|7645374|FG000|COMPLETED|Overall Study||308
6715175|NCT02987972|7645375|FG001|COMPLETED|Overall Study||305
6715176|NCT02987972|7645376|FG002|COMPLETED|Overall Study||308
6715177|NCT02987972|7645374|FG000|NOT COMPLETED|Overall Study||43
6715178|NCT02987972|7645375|FG001|NOT COMPLETED|Overall Study||45
6715179|NCT02987972|7645376|FG002|NOT COMPLETED|Overall Study||42
6715180|NCT02988050|7645386|FG000|STARTED|Overall Study||30
6715181|NCT02988050|7645387|FG001|STARTED|Overall Study||30
6715182|NCT02988050|7645386|FG000|COMPLETED|Overall Study||30
6715183|NCT02988050|7645387|FG001|COMPLETED|Overall Study||30
6715184|NCT02988050|7645386|FG000|NOT COMPLETED|Overall Study||0
6715185|NCT02988050|7645387|FG001|NOT COMPLETED|Overall Study||0
6715186|NCT02988115|7645395|FG000|STARTED|Overall Study||234
6715187|NCT02988115|7645396|FG001|STARTED|Overall Study||111
6715188|NCT02988115|7645395|FG000|COMPLETED|Overall Study||220
6715189|NCT02988115|7645396|FG001|COMPLETED|Overall Study||107
6715190|NCT02988115|7645395|FG000|NOT COMPLETED|Overall Study||14
6715191|NCT02988115|7645396|FG001|NOT COMPLETED|Overall Study||4
6715192|NCT02988193|7645404|FG000|STARTED|Overall Study||12
6715193|NCT02988193|7645405|FG001|STARTED|Overall Study||16
6715194|NCT02988193|7645404|FG000|COMPLETED|Overall Study||12
6715195|NCT02988193|7645405|FG001|COMPLETED|Overall Study||16
6715196|NCT02988193|7645404|FG000|NOT COMPLETED|Overall Study||0
6715197|NCT02988193|7645405|FG001|NOT COMPLETED|Overall Study||0
6715198|NCT02988219|7645413|FG000|STARTED|Overall Study||25
6715199|NCT02988219|7645414|FG001|STARTED|Overall Study||25
6715200|NCT02988219|7645413|FG000|COMPLETED|Overall Study||24
6715201|NCT02988219|7645414|FG001|COMPLETED|Overall Study||22
6715202|NCT02988219|7645413|FG000|NOT COMPLETED|Overall Study||1
6715203|NCT02988219|7645414|FG001|NOT COMPLETED|Overall Study||3
6715204|NCT02988349|7645422|FG000|STARTED|Overall Study||21
6715205|NCT02988349|7645423|FG001|STARTED|Overall Study||21
6715206|NCT02988349|7645422|FG000|COMPLETED|Overall Study||21
6715207|NCT02988349|7645423|FG001|COMPLETED|Overall Study||21
6715208|NCT02988349|7645422|FG000|NOT COMPLETED|Overall Study||0
6715209|NCT02988349|7645423|FG001|NOT COMPLETED|Overall Study||0
6715210|NCT02988622|7645429|FG000|STARTED|Overall Study||100
6715211|NCT02988622|7645429|FG000|COMPLETED|Overall Study||83
6715212|NCT02988622|7645429|FG000|NOT COMPLETED|Overall Study||17
6715213|NCT02988843|7645435|FG000|STARTED|Overall Study||1
6715214|NCT02988843|7645435|FG000|COMPLETED|Overall Study||1
6715215|NCT02988843|7645435|FG000|NOT COMPLETED|Overall Study||0
6715216|NCT02988856|7645439|FG000|STARTED|Overall Study||11
6715217|NCT02988856|7645439|FG000|COMPLETED|Overall Study||8
6715218|NCT02988856|7645439|FG000|NOT COMPLETED|Overall Study||3
6715219|NCT02988882|7645445|FG000|STARTED|Overall Study||44
6715220|NCT02988882|7645446|FG001|STARTED|Overall Study||42
6715221|NCT02988882|7645445|FG000|COMPLETED|Overall Study||41
6715222|NCT02988882|7645446|FG001|COMPLETED|Overall Study||40
6715223|NCT02988882|7645445|FG000|NOT COMPLETED|Overall Study||3
6715224|NCT02988882|7645446|FG001|NOT COMPLETED|Overall Study||2
6715225|NCT02988986|7645452|FG000|STARTED|Overall Study||28
6715226|NCT02988986|7645452|FG000|COMPLETED|Overall Study||25
6715227|NCT02988986|7645452|FG000|NOT COMPLETED|Overall Study||3
6715228|NCT02989168|7645459|FG000|STARTED|Overall Study||11
6715229|NCT02989168|7645460|FG001|STARTED|Overall Study||3
6715230|NCT02989168|7645459|FG000|COMPLETED|Overall Study||7
6715231|NCT02989168|7645460|FG001|COMPLETED|Overall Study||0
6715232|NCT02989168|7645459|FG000|NOT COMPLETED|Overall Study||4
6715233|NCT02989168|7645460|FG001|NOT COMPLETED|Overall Study||3
6715234|NCT02989246|7645468|FG000|STARTED|Overall Study||32
6715235|NCT02989246|7645468|FG000|COMPLETED|Overall Study||32
6715236|NCT02989246|7645468|FG000|NOT COMPLETED|Overall Study||0
6715237|NCT02989389|7645482|FG000|STARTED|Period 1||3
6715238|NCT02989389|7645483|FG001|STARTED|Period 1||4
6715239|NCT02989389|7645484|FG002|STARTED|Period 1||3
6715240|NCT02989389|7645485|FG003|STARTED|Period 1||3
6715241|NCT02989389|7645486|FG004|STARTED|Period 1||3
6715242|NCT02989389|7645487|FG005|STARTED|Period 1||3
6715243|NCT02989389|7645488|FG006|STARTED|Period 1||6
6715244|NCT02989389|7645489|FG007|STARTED|Period 1||5
6715245|NCT02989389|7645490|FG008|STARTED|Period 1||6
6715246|NCT02989389|7645491|FG009|STARTED|Period 1||6
6715247|NCT02989389|7645482|FG000|Received at Least 1 Dose of Study Drug|Period 1||3
6715248|NCT02989389|7645483|FG001|Received at Least 1 Dose of Study Drug|Period 1||4
6715249|NCT02989389|7645484|FG002|Received at Least 1 Dose of Study Drug|Period 1||3
6715250|NCT02989389|7645485|FG003|Received at Least 1 Dose of Study Drug|Period 1||3
6715251|NCT02989389|7645486|FG004|Received at Least 1 Dose of Study Drug|Period 1||3
6715252|NCT02989389|7645487|FG005|Received at Least 1 Dose of Study Drug|Period 1||3
6715253|NCT02989389|7645488|FG006|Received at Least 1 Dose of Study Drug|Period 1||6
6715254|NCT02989389|7645489|FG007|Received at Least 1 Dose of Study Drug|Period 1||5
6715255|NCT02989389|7645490|FG008|Received at Least 1 Dose of Study Drug|Period 1||6
6715256|NCT02989389|7645491|FG009|Received at Least 1 Dose of Study Drug|Period 1||6
6715257|NCT02989389|7645482|FG000|COMPLETED|Period 1||3
6715258|NCT02989389|7645483|FG001|COMPLETED|Period 1||3
6715259|NCT02989389|7645484|FG002|COMPLETED|Period 1||3
6715260|NCT02989389|7645485|FG003|COMPLETED|Period 1||3
6715261|NCT02989389|7645486|FG004|COMPLETED|Period 1||3
6715262|NCT02989389|7645487|FG005|COMPLETED|Period 1||3
6715263|NCT02989389|7645488|FG006|COMPLETED|Period 1||6
6715264|NCT02989389|7645489|FG007|COMPLETED|Period 1||5
6715265|NCT02989389|7645490|FG008|COMPLETED|Period 1||5
6715266|NCT02989389|7645491|FG009|COMPLETED|Period 1||6
6715267|NCT02989389|7645482|FG000|NOT COMPLETED|Period 1||0
6715268|NCT02989389|7645483|FG001|NOT COMPLETED|Period 1||1
6715269|NCT02989389|7645484|FG002|NOT COMPLETED|Period 1||0
6715270|NCT02989389|7645485|FG003|NOT COMPLETED|Period 1||0
6715271|NCT02989389|7645486|FG004|NOT COMPLETED|Period 1||0
6715272|NCT02989389|7645487|FG005|NOT COMPLETED|Period 1||0
6715273|NCT02989389|7645488|FG006|NOT COMPLETED|Period 1||0
6715274|NCT02989389|7645489|FG007|NOT COMPLETED|Period 1||0
6715275|NCT02989389|7645490|FG008|NOT COMPLETED|Period 1||1
6715276|NCT02989389|7645491|FG009|NOT COMPLETED|Period 1||0
6715277|NCT02989389|7645482|FG000|STARTED|Period 2||3
6715278|NCT02989389|7645483|FG001|STARTED|Period 2||3
6715279|NCT02989389|7645484|FG002|STARTED|Period 2||3
6715280|NCT02989389|7645485|FG003|STARTED|Period 2||3
6715281|NCT02989389|7645486|FG004|STARTED|Period 2||3
6715282|NCT02989389|7645487|FG005|STARTED|Period 2||3
6715283|NCT02989389|7645488|FG006|STARTED|Period 2|Part B was planned as a single period study.|0
6715284|NCT02989389|7645489|FG007|STARTED|Period 2|Part B was planned as a single period study.|0
6715285|NCT02989389|7645490|FG008|STARTED|Period 2|Part B was planned as a single period study.|0
6715286|NCT02989389|7645491|FG009|STARTED|Period 2|Part B was planned as a single period study.|0
6715287|NCT02989389|7645482|FG000|COMPLETED|Period 2||3
6715288|NCT02989389|7645483|FG001|COMPLETED|Period 2||3
6715289|NCT02989389|7645484|FG002|COMPLETED|Period 2||3
6715290|NCT02989389|7645485|FG003|COMPLETED|Period 2||3
6715291|NCT02989389|7645486|FG004|COMPLETED|Period 2||3
6715292|NCT02989389|7645487|FG005|COMPLETED|Period 2||3
6715293|NCT02989389|7645488|FG006|COMPLETED|Period 2||0
6715294|NCT02989389|7645489|FG007|COMPLETED|Period 2||0
6715295|NCT02989389|7645490|FG008|COMPLETED|Period 2||0
6715296|NCT02989389|7645491|FG009|COMPLETED|Period 2||0
6715297|NCT02989389|7645482|FG000|NOT COMPLETED|Period 2||0
6715298|NCT02989389|7645483|FG001|NOT COMPLETED|Period 2||0
6715299|NCT02989389|7645484|FG002|NOT COMPLETED|Period 2||0
6715300|NCT02989389|7645485|FG003|NOT COMPLETED|Period 2||0
6715301|NCT02989389|7645486|FG004|NOT COMPLETED|Period 2||0
6715302|NCT02989389|7645487|FG005|NOT COMPLETED|Period 2||0
6715303|NCT02989389|7645488|FG006|NOT COMPLETED|Period 2||0
6715304|NCT02989389|7645489|FG007|NOT COMPLETED|Period 2||0
6715305|NCT02989389|7645490|FG008|NOT COMPLETED|Period 2||0
6715306|NCT02989389|7645491|FG009|NOT COMPLETED|Period 2||0
6715307|NCT02989389|7645482|FG000|STARTED|Period 3||3
6715308|NCT02989389|7645483|FG001|STARTED|Period 3||3
6715309|NCT02989389|7645484|FG002|STARTED|Period 3||3
6715310|NCT02989389|7645485|FG003|STARTED|Period 3||3
6715311|NCT02989389|7645486|FG004|STARTED|Period 3||3
6715312|NCT02989389|7645487|FG005|STARTED|Period 3||3
6715313|NCT02989389|7645488|FG006|STARTED|Period 3||0
6715314|NCT02989389|7645489|FG007|STARTED|Period 3||0
6715315|NCT02989389|7645490|FG008|STARTED|Period 3||0
6715316|NCT02989389|7645491|FG009|STARTED|Period 3||0
6715317|NCT02989389|7645482|FG000|COMPLETED|Period 3||3
6715318|NCT02989389|7645483|FG001|COMPLETED|Period 3||3
6715319|NCT02989389|7645484|FG002|COMPLETED|Period 3||3
6715320|NCT02989389|7645485|FG003|COMPLETED|Period 3||3
6715321|NCT02989389|7645486|FG004|COMPLETED|Period 3||3
6715322|NCT02989389|7645487|FG005|COMPLETED|Period 3||3
6715323|NCT02989389|7645488|FG006|COMPLETED|Period 3||0
6715324|NCT02989389|7645489|FG007|COMPLETED|Period 3||0
6715325|NCT02989389|7645490|FG008|COMPLETED|Period 3||0
6715326|NCT02989389|7645491|FG009|COMPLETED|Period 3||0
6715327|NCT02989389|7645482|FG000|NOT COMPLETED|Period 3||0
6715328|NCT02989389|7645483|FG001|NOT COMPLETED|Period 3||0
6715329|NCT02989389|7645484|FG002|NOT COMPLETED|Period 3||0
6715330|NCT02989389|7645485|FG003|NOT COMPLETED|Period 3||0
6715331|NCT02989389|7645486|FG004|NOT COMPLETED|Period 3||0
6715332|NCT02989389|7645487|FG005|NOT COMPLETED|Period 3||0
6715333|NCT02989389|7645488|FG006|NOT COMPLETED|Period 3||0
6715334|NCT02989389|7645489|FG007|NOT COMPLETED|Period 3||0
6715335|NCT02989389|7645490|FG008|NOT COMPLETED|Period 3||0
6715336|NCT02989389|7645491|FG009|NOT COMPLETED|Period 3||0
6715337|NCT02989493|7645533|FG000|STARTED|Overall Study||29
6715338|NCT02989493|7645534|FG001|STARTED|Overall Study||32
6715339|NCT02989493|7645533|FG000|COMPLETED|Overall Study||29
6715340|NCT02989493|7645534|FG001|COMPLETED|Overall Study||32
6715341|NCT02989493|7645533|FG000|NOT COMPLETED|Overall Study||0
6715342|NCT02989493|7645534|FG001|NOT COMPLETED|Overall Study||0
6715343|NCT02989545|7645540|FG000|STARTED|Control Period - no Intervention||20
6715344|NCT02989545|7645540|FG000|COMPLETED|Control Period - no Intervention||20
6715345|NCT02989545|7645540|FG000|NOT COMPLETED|Control Period - no Intervention||0
6715346|NCT02989545|7645540|FG000|STARTED|Treatment Period - Anal Tape Provided||20
6715347|NCT02989545|7645540|FG000|COMPLETED|Treatment Period - Anal Tape Provided||20
6715348|NCT02989545|7645540|FG000|NOT COMPLETED|Treatment Period - Anal Tape Provided||0
6715349|NCT02989610|7645548|FG000|STARTED|Overall Study||234
6715350|NCT02989610|7645548|FG000|COMPLETED|Overall Study||195
6715351|NCT02989610|7645548|FG000|NOT COMPLETED|Overall Study||39
6715352|NCT02989649|7645552|FG000|STARTED|Overall Study||593
6715353|NCT02989649|7645552|FG000|Started But Not Treated|Overall Study||84
6715354|NCT02989649|7645552|FG000|Eligible to Enter Into Treatment Period|Overall Study||509
6715355|NCT02989649|7645552|FG000|COMPLETED|Overall Study||173
6715356|NCT02989649|7645552|FG000|NOT COMPLETED|Overall Study||420
6715357|NCT02989714|7645556|FG000|STARTED|Overall Study||13
6715358|NCT02989714|7645556|FG000|Started Nivolumab|Overall Study||12
6263045|NCT01101464|7162056|FG000|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
6715359|NCT02989714|7645556|FG000|COMPLETED|Overall Study||12
6715360|NCT02989714|7645556|FG000|NOT COMPLETED|Overall Study||1
6715361|NCT02989727|7645565|FG000|STARTED|Overall Study||46
6715362|NCT02989727|7645566|FG001|STARTED|Overall Study||44
6715363|NCT02989727|7645567|FG002|STARTED|Overall Study||30
6715364|NCT02989727|7645568|FG003|STARTED|Overall Study||30
6715365|NCT02989727|7645565|FG000|COMPLETED|Overall Study||46
6715366|NCT02989727|7645566|FG001|COMPLETED|Overall Study||44
6715367|NCT02989727|7645567|FG002|COMPLETED|Overall Study||30
6715368|NCT02989727|7645568|FG003|COMPLETED|Overall Study||30
6715369|NCT02989727|7645565|FG000|NOT COMPLETED|Overall Study||0
6715370|NCT02989727|7645566|FG001|NOT COMPLETED|Overall Study||0
6715371|NCT02989727|7645567|FG002|NOT COMPLETED|Overall Study||0
6715372|NCT02989727|7645568|FG003|NOT COMPLETED|Overall Study||0
6715373|NCT02989805|7645578|FG000|STARTED|Overall Study||160
6715374|NCT02989805|7645579|FG001|STARTED|Overall Study||166
6715375|NCT02989805|7645578|FG000|COMPLETED|Overall Study||154
6715376|NCT02989805|7645579|FG001|COMPLETED|Overall Study||162
6715377|NCT02989805|7645578|FG000|NOT COMPLETED|Overall Study||6
6715378|NCT02989805|7645579|FG001|NOT COMPLETED|Overall Study||4
6715379|NCT02990000|7645587|FG000|STARTED|Overall Study|155 patients were randomly assigned to the Pragmatic Match condition|155
6715380|NCT02990000|7645588|FG001|STARTED|Overall Study|133 patients were randomly assigned to the Scientific Match condition|133
6715381|NCT02990000|7645587|FG000|Begin Treatment|Overall Study|119 Pragmatic Match patients actually began treatment (attended at least 1 session)|119
6715382|NCT02990000|7645588|FG001|Begin Treatment|Overall Study|99 Scientifically Matched patients actually began treatment (attended at least one session)|99
6715383|NCT02990000|7645587|FG000|COMPLETED|Overall Study|119 patients provided naturalistic treatment data and were included in analyses|119
6715384|NCT02990000|7645588|FG001|COMPLETED|Overall Study|99 patients provided naturalistic treatment data and were included in analyses|99
6715385|NCT02990000|7645587|FG000|NOT COMPLETED|Overall Study||36
6715386|NCT02990000|7645588|FG001|NOT COMPLETED|Overall Study||34
6715387|NCT02990910|7645596|FG000|STARTED|Overall Study||140
6715388|NCT02990910|7645597|FG001|STARTED|Overall Study||140
6715389|NCT02990910|7645596|FG000|COMPLETED|Overall Study||134
6715390|NCT02990910|7645597|FG001|COMPLETED|Overall Study||130
6715391|NCT02990910|7645596|FG000|NOT COMPLETED|Overall Study||6
6715392|NCT02990910|7645597|FG001|NOT COMPLETED|Overall Study||10
6715393|NCT02991040|7645603|FG000|STARTED|Overall Study||100
6715394|NCT02991040|7645603|FG000|COMPLETED|Overall Study||96
6715395|NCT02991040|7645603|FG000|NOT COMPLETED|Overall Study||4
6715396|NCT02991118|7645611|FG000|STARTED|Overall Study||257
6715397|NCT02991118|7645612|FG001|STARTED|Overall Study||522
6715398|NCT02991118|7645611|FG000|COMPLETED|Overall Study||250
6715399|NCT02991118|7645612|FG001|COMPLETED|Overall Study||490
6715400|NCT02991118|7645611|FG000|NOT COMPLETED|Overall Study||7
6715401|NCT02991118|7645612|FG001|NOT COMPLETED|Overall Study||32
6715402|NCT02991729|7645620|FG000|STARTED|Overall Study||105
6715403|NCT02991729|7645621|FG001|STARTED|Overall Study||92
6715404|NCT02991729|7645620|FG000|COMPLETED|Overall Study||105
6715405|NCT02991729|7645621|FG001|COMPLETED|Overall Study||92
6715406|NCT02991729|7645620|FG000|NOT COMPLETED|Overall Study||0
6715407|NCT02991729|7645621|FG001|NOT COMPLETED|Overall Study||0
6715408|NCT02991820|7645631|FG000|STARTED|Overall Study||12
6715409|NCT02991820|7645632|FG001|STARTED|Overall Study||31
6715410|NCT02991820|7645631|FG000|COMPLETED|Overall Study||12
6715411|NCT02991820|7645632|FG001|COMPLETED|Overall Study||31
6715412|NCT02991820|7645631|FG000|NOT COMPLETED|Overall Study||0
6715413|NCT02991820|7645632|FG001|NOT COMPLETED|Overall Study||0
6715414|NCT02991859|7645657|FG000|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715415|NCT02991859|7645658|FG001|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6715416|NCT02991859|7645659|FG002|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715417|NCT02991859|7645660|FG003|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715418|NCT02991859|7645661|FG004|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6715419|NCT02991859|7645662|FG005|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6715420|NCT02991859|7645663|FG006|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715421|NCT02991859|7645664|FG007|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715422|NCT02991859|7645665|FG008|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715423|NCT02991859|7645666|FG009|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715424|NCT02991859|7645667|FG010|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715425|NCT02991859|7645668|FG011|STARTED|Period 1,Escalation Phase 1,Upto Day 7||2
6715426|NCT02991859|7645669|FG012|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
6715427|NCT02991859|7645670|FG013|STARTED|Period 1,Escalation Phase 1,Upto Day 7||7
6715428|NCT02991859|7645671|FG014|STARTED|Period 1,Escalation Phase 1,Upto Day 7||6
6715429|NCT02991859|7645672|FG015|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6715430|NCT02991859|7645673|FG016|STARTED|Period 1,Escalation Phase 1,Upto Day 7||3
6715431|NCT02991859|7645657|FG000|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715432|NCT02991859|7645658|FG001|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715433|NCT02991859|7645659|FG002|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715434|NCT02991859|7645660|FG003|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715435|NCT02991859|7645661|FG004|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715436|NCT02991859|7645662|FG005|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
6715437|NCT02991859|7645663|FG006|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715438|NCT02991859|7645664|FG007|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715439|NCT02991859|7645665|FG008|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715440|NCT02991859|7645666|FG009|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715441|NCT02991859|7645667|FG010|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715442|NCT02991859|7645668|FG011|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||2
6715443|NCT02991859|7645669|FG012|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
6715444|NCT02991859|7645670|FG013|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||7
6715445|NCT02991859|7645671|FG014|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||6
6715446|NCT02991859|7645672|FG015|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
6715447|NCT02991859|7645673|FG016|COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||3
6715448|NCT02991859|7645657|FG000|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6739475|NCT03290378|7668357|FG001|NOT COMPLETED|Overall Study||10
6715449|NCT02991859|7645658|FG001|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
6715450|NCT02991859|7645659|FG002|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715451|NCT02991859|7645660|FG003|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715452|NCT02991859|7645661|FG004|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||1
6715453|NCT02991859|7645662|FG005|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715454|NCT02991859|7645663|FG006|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715455|NCT02991859|7645664|FG007|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715456|NCT02991859|7645665|FG008|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715457|NCT02991859|7645666|FG009|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715458|NCT02991859|7645667|FG010|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715459|NCT02991859|7645668|FG011|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715460|NCT02991859|7645669|FG012|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715461|NCT02991859|7645670|FG013|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715462|NCT02991859|7645671|FG014|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715463|NCT02991859|7645672|FG015|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715464|NCT02991859|7645673|FG016|NOT COMPLETED|Period 1,Escalation Phase 1,Upto Day 7||0
6715465|NCT02991859|7645657|FG000|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715466|NCT02991859|7645658|FG001|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715467|NCT02991859|7645659|FG002|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715468|NCT02991859|7645660|FG003|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715469|NCT02991859|7645661|FG004|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715470|NCT02991859|7645662|FG005|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
6715471|NCT02991859|7645663|FG006|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715472|NCT02991859|7645664|FG007|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715473|NCT02991859|7645665|FG008|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715474|NCT02991859|7645666|FG009|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715475|NCT02991859|7645667|FG010|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715476|NCT02991859|7645668|FG011|STARTED|Period 1,Escalation Phase2,Upto Day 14||2
6715477|NCT02991859|7645669|FG012|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
6715478|NCT02991859|7645670|FG013|STARTED|Period 1,Escalation Phase2,Upto Day 14||7
6715479|NCT02991859|7645671|FG014|STARTED|Period 1,Escalation Phase2,Upto Day 14||6
6715480|NCT02991859|7645672|FG015|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
6715481|NCT02991859|7645673|FG016|STARTED|Period 1,Escalation Phase2,Upto Day 14||3
6715482|NCT02991859|7645657|FG000|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6263046|NCT01101464|7162057|FG001|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
6263047|NCT01101464|7162056|FG000|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
6263048|NCT01101464|7162057|FG001|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
6263049|NCT01098071|7162065|FG000|STARTED|Overall Study||34
6263050|NCT01098071|7162065|FG000|COMPLETED|Overall Study||19
6263051|NCT01098071|7162065|FG000|NOT COMPLETED|Overall Study||15
6263052|NCT01077830|7162071|FG000|STARTED|Overall Study||677
6263053|NCT01077830|7162072|FG001|STARTED|Overall Study||682
6263054|NCT01077830|7162071|FG000|COMPLETED|Overall Study||677
6263055|NCT01077830|7162072|FG001|COMPLETED|Overall Study||682
6263056|NCT01077830|7162071|FG000|NOT COMPLETED|Overall Study||0
6263057|NCT01077830|7162072|FG001|NOT COMPLETED|Overall Study||0
6263058|NCT01070966|7162078|FG000|STARTED|Participants for Safety Evaluation||2089
6263059|NCT01070966|7162078|FG000|COMPLETED|Participants for Safety Evaluation||2011
6263060|NCT01070966|7162078|FG000|NOT COMPLETED|Participants for Safety Evaluation||78
6263061|NCT01070966|7162078|FG000|STARTED|Participants for Efficacy Evaluation||2011
6715483|NCT02991859|7645658|FG001|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715484|NCT02991859|7645659|FG002|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715485|NCT02991859|7645660|FG003|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715486|NCT02991859|7645661|FG004|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715487|NCT02991859|7645662|FG005|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
6715488|NCT02991859|7645663|FG006|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715489|NCT02991859|7645664|FG007|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715490|NCT02991859|7645665|FG008|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715491|NCT02991859|7645666|FG009|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715492|NCT02991859|7645667|FG010|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715493|NCT02991859|7645668|FG011|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||2
6715494|NCT02991859|7645669|FG012|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
6263062|NCT01070966|7162078|FG000|COMPLETED|Participants for Efficacy Evaluation||1929
6263063|NCT01070966|7162078|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||82
6263064|NCT01070953|7162089|FG000|STARTED|Participants for Safety Evaluation||4467
6263065|NCT01070953|7162089|FG000|COMPLETED|Participants for Safety Evaluation||3536
6263066|NCT01070953|7162089|FG000|NOT COMPLETED|Participants for Safety Evaluation||931
6263067|NCT01070953|7162089|FG000|STARTED|Participants for Efficacy Evaluation||3536
6263068|NCT01070953|7162089|FG000|COMPLETED|Participants for Efficacy Evaluation||3309
6263069|NCT01070953|7162089|FG000|NOT COMPLETED|Participants for Efficacy Evaluation||227
6263070|NCT01030341|7162099|FG000|STARTED|Overall Study|45 participants met all enrollment criteria by completing the screening and run-in phases|45
6263071|NCT01030341|7162099|FG000|COMPLETED|Overall Study|42 participants completed the study|42
6715495|NCT02991859|7645670|FG013|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||7
6715496|NCT02991859|7645671|FG014|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||6
6715497|NCT02991859|7645672|FG015|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
6715498|NCT02991859|7645673|FG016|COMPLETED|Period 1,Escalation Phase2,Upto Day 14||3
6715499|NCT02991859|7645657|FG000|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715500|NCT02991859|7645658|FG001|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715501|NCT02991859|7645659|FG002|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715502|NCT02991859|7645660|FG003|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715503|NCT02991859|7645661|FG004|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715504|NCT02991859|7645662|FG005|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715505|NCT02991859|7645663|FG006|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715506|NCT02991859|7645664|FG007|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715507|NCT02991859|7645665|FG008|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715508|NCT02991859|7645666|FG009|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715509|NCT02991859|7645667|FG010|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715510|NCT02991859|7645668|FG011|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715511|NCT02991859|7645669|FG012|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715512|NCT02991859|7645670|FG013|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715513|NCT02991859|7645671|FG014|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715514|NCT02991859|7645672|FG015|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715515|NCT02991859|7645673|FG016|NOT COMPLETED|Period 1,Escalation Phase2,Upto Day 14||0
6715516|NCT02991859|7645657|FG000|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715517|NCT02991859|7645658|FG001|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715518|NCT02991859|7645659|FG002|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715519|NCT02991859|7645660|FG003|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715520|NCT02991859|7645661|FG004|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715521|NCT02991859|7645662|FG005|STARTED|Period1, Escalation Phase3, Upto Day21||3
6715522|NCT02991859|7645663|FG006|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715523|NCT02991859|7645664|FG007|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715524|NCT02991859|7645665|FG008|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715525|NCT02991859|7645666|FG009|STARTED|Period1, Escalation Phase3, Upto Day21||2
6263072|NCT01030341|7162099|FG000|NOT COMPLETED|Overall Study||3
6263073|NCT00979901|7162107|FG000|STARTED|Overall Study||352
6263074|NCT00979901|7162108|FG001|STARTED|Overall Study||348
6263075|NCT00979901|7162109|FG002|STARTED|Overall Study||602
6263076|NCT00979901|7162110|FG003|STARTED|Overall Study||275
6263077|NCT00979901|7162107|FG000|COMPLETED|Overall Study||334
6263078|NCT00979901|7162108|FG001|COMPLETED|Overall Study||336
6263079|NCT00979901|7162109|FG002|COMPLETED|Overall Study||573
6263080|NCT00979901|7162110|FG003|COMPLETED|Overall Study||159
6263081|NCT00979901|7162107|FG000|NOT COMPLETED|Overall Study||18
6263082|NCT00979901|7162108|FG001|NOT COMPLETED|Overall Study||12
6263083|NCT00979901|7162109|FG002|NOT COMPLETED|Overall Study||29
6263084|NCT00979901|7162110|FG003|NOT COMPLETED|Overall Study||116
6263094|NCT00963599|7162136|FG000|STARTED|Overall Study||149
6263095|NCT00963599|7162137|FG001|STARTED|Overall Study||155
6263096|NCT00963599|7162138|FG002|STARTED|Overall Study||301
6263097|NCT00963599|7162139|FG003|STARTED|Overall Study||302
6263098|NCT00963599|7162136|FG000|COMPLETED|Overall Study||143
6263099|NCT00963599|7162137|FG001|COMPLETED|Overall Study||149
6263100|NCT00963599|7162138|FG002|COMPLETED|Overall Study||292
6263101|NCT00963599|7162139|FG003|COMPLETED|Overall Study||288
6263102|NCT00963599|7162136|FG000|NOT COMPLETED|Overall Study||6
6263103|NCT00963599|7162137|FG001|NOT COMPLETED|Overall Study||6
6263104|NCT00963599|7162138|FG002|NOT COMPLETED|Overall Study||9
6263105|NCT00963599|7162139|FG003|NOT COMPLETED|Overall Study||14
6263106|NCT00954915|7162149|FG000|STARTED|Overall Study||1
6263107|NCT00954915|7162149|FG000|COMPLETED|Overall Study||1
6263108|NCT00954915|7162149|FG000|NOT COMPLETED|Overall Study||0
6263109|NCT00953680|7162154|FG000|STARTED|Period 1||38
6263110|NCT00953680|7162155|FG001|STARTED|Period 1||39
6263111|NCT00953680|7162154|FG000|COMPLETED|Period 1||38
6263112|NCT00953680|7162155|FG001|COMPLETED|Period 1||38
6263113|NCT00953680|7162154|FG000|NOT COMPLETED|Period 1||0
6263114|NCT00953680|7162155|FG001|NOT COMPLETED|Period 1||1
6263115|NCT00953680|7162154|FG000|STARTED|Period 2||38
6263116|NCT00953680|7162155|FG001|STARTED|Period 2||38
6263117|NCT00953680|7162154|FG000|COMPLETED|Period 2||38
6263118|NCT00953680|7162155|FG001|COMPLETED|Period 2||38
6263119|NCT00953680|7162154|FG000|NOT COMPLETED|Period 2||0
6263120|NCT00953680|7162155|FG001|NOT COMPLETED|Period 2||0
6263121|NCT00945035|7162161|FG000|STARTED|Period 1||18
6263122|NCT00945035|7162162|FG001|STARTED|Period 1||18
6263123|NCT00945035|7162161|FG000|COMPLETED|Period 1||18
6263124|NCT00945035|7162162|FG001|COMPLETED|Period 1||18
6263125|NCT00945035|7162161|FG000|NOT COMPLETED|Period 1||0
6263126|NCT00945035|7162162|FG001|NOT COMPLETED|Period 1||0
6263127|NCT00945035|7162161|FG000|STARTED|Period 2||18
6263128|NCT00945035|7162162|FG001|STARTED|Period 2||18
6715526|NCT02991859|7645667|FG010|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715527|NCT02991859|7645668|FG011|STARTED|Period1, Escalation Phase3, Upto Day21||2
6715528|NCT02991859|7645669|FG012|STARTED|Period1, Escalation Phase3, Upto Day21||7
6715529|NCT02991859|7645670|FG013|STARTED|Period1, Escalation Phase3, Upto Day21||7
6715530|NCT02991859|7645671|FG014|STARTED|Period1, Escalation Phase3, Upto Day21||6
6715531|NCT02991859|7645672|FG015|STARTED|Period1, Escalation Phase3, Upto Day21||3
6715532|NCT02991859|7645673|FG016|STARTED|Period1, Escalation Phase3, Upto Day21||3
6715533|NCT02991859|7645657|FG000|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715534|NCT02991859|7645658|FG001|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715535|NCT02991859|7645659|FG002|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715536|NCT02991859|7645660|FG003|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715537|NCT02991859|7645661|FG004|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715538|NCT02991859|7645662|FG005|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
6715539|NCT02991859|7645663|FG006|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715540|NCT02991859|7645664|FG007|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715541|NCT02991859|7645665|FG008|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715542|NCT02991859|7645666|FG009|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715543|NCT02991859|7645667|FG010|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715544|NCT02991859|7645668|FG011|COMPLETED|Period1, Escalation Phase3, Upto Day21||2
6715545|NCT02991859|7645669|FG012|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
6715546|NCT02991859|7645670|FG013|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
6715547|NCT02991859|7645671|FG014|COMPLETED|Period1, Escalation Phase3, Upto Day21||6
6715548|NCT02991859|7645672|FG015|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
6715549|NCT02991859|7645673|FG016|COMPLETED|Period1, Escalation Phase3, Upto Day21||3
6715550|NCT02991859|7645657|FG000|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715551|NCT02991859|7645658|FG001|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715552|NCT02991859|7645659|FG002|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715553|NCT02991859|7645660|FG003|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715554|NCT02991859|7645661|FG004|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715555|NCT02991859|7645662|FG005|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715556|NCT02991859|7645663|FG006|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715557|NCT02991859|7645664|FG007|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715558|NCT02991859|7645665|FG008|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715559|NCT02991859|7645666|FG009|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715560|NCT02991859|7645667|FG010|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715561|NCT02991859|7645668|FG011|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715562|NCT02991859|7645669|FG012|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
6715563|NCT02991859|7645670|FG013|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||1
6715564|NCT02991859|7645671|FG014|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715565|NCT02991859|7645672|FG015|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715566|NCT02991859|7645673|FG016|NOT COMPLETED|Period1, Escalation Phase3, Upto Day21||0
6715567|NCT02991859|7645657|FG000|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715568|NCT02991859|7645658|FG001|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715569|NCT02991859|7645659|FG002|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715570|NCT02991859|7645660|FG003|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715571|NCT02991859|7645661|FG004|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715572|NCT02991859|7645662|FG005|STARTED|Period1, Escalation Phase4, Upto Day28|1 Par completed Phase 3 did not enter Phase 4|2
6715573|NCT02991859|7645663|FG006|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715574|NCT02991859|7645664|FG007|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715575|NCT02991859|7645665|FG008|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715576|NCT02991859|7645666|FG009|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715577|NCT02991859|7645667|FG010|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715578|NCT02991859|7645668|FG011|STARTED|Period1, Escalation Phase4, Upto Day28||2
6715579|NCT02991859|7645669|FG012|STARTED|Period1, Escalation Phase4, Upto Day28||6
6715580|NCT02991859|7645670|FG013|STARTED|Period1, Escalation Phase4, Upto Day28||6
6715581|NCT02991859|7645671|FG014|STARTED|Period1, Escalation Phase4, Upto Day28||6
6715582|NCT02991859|7645672|FG015|STARTED|Period1, Escalation Phase4, Upto Day28||3
6715583|NCT02991859|7645673|FG016|STARTED|Period1, Escalation Phase4, Upto Day28||3
6715584|NCT02991859|7645657|FG000|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715585|NCT02991859|7645658|FG001|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715586|NCT02991859|7645659|FG002|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715587|NCT02991859|7645660|FG003|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715588|NCT02991859|7645661|FG004|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715589|NCT02991859|7645662|FG005|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715590|NCT02991859|7645663|FG006|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715591|NCT02991859|7645664|FG007|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715592|NCT02991859|7645665|FG008|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715593|NCT02991859|7645666|FG009|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715594|NCT02991859|7645667|FG010|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715595|NCT02991859|7645668|FG011|COMPLETED|Period1, Escalation Phase4, Upto Day28||2
6715596|NCT02991859|7645669|FG012|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
6715597|NCT02991859|7645670|FG013|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
6715598|NCT02991859|7645671|FG014|COMPLETED|Period1, Escalation Phase4, Upto Day28||6
6715599|NCT02991859|7645672|FG015|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
6715600|NCT02991859|7645673|FG016|COMPLETED|Period1, Escalation Phase4, Upto Day28||3
6715601|NCT02991859|7645657|FG000|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715602|NCT02991859|7645658|FG001|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715603|NCT02991859|7645659|FG002|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715604|NCT02991859|7645660|FG003|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715605|NCT02991859|7645661|FG004|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715606|NCT02991859|7645662|FG005|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715607|NCT02991859|7645663|FG006|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715608|NCT02991859|7645664|FG007|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715609|NCT02991859|7645665|FG008|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715610|NCT02991859|7645666|FG009|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715611|NCT02991859|7645667|FG010|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715612|NCT02991859|7645668|FG011|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715613|NCT02991859|7645669|FG012|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715614|NCT02991859|7645670|FG013|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715615|NCT02991859|7645671|FG014|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715616|NCT02991859|7645672|FG015|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715617|NCT02991859|7645673|FG016|NOT COMPLETED|Period1, Escalation Phase4, Upto Day28||0
6715618|NCT02991859|7645657|FG000|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715619|NCT02991859|7645658|FG001|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715620|NCT02991859|7645659|FG002|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715621|NCT02991859|7645660|FG003|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715622|NCT02991859|7645661|FG004|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715623|NCT02991859|7645662|FG005|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715624|NCT02991859|7645663|FG006|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715625|NCT02991859|7645664|FG007|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715626|NCT02991859|7645665|FG008|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715627|NCT02991859|7645666|FG009|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715628|NCT02991859|7645667|FG010|STARTED|Period1, Escalation Phase5, Upto Day35|1 participant did not enter Esc Phase 5, and was not withdrawn|1
6715629|NCT02991859|7645668|FG011|STARTED|Period1, Escalation Phase5, Upto Day35||2
6715630|NCT02991859|7645669|FG012|STARTED|Period1, Escalation Phase5, Upto Day35||6
6715631|NCT02991859|7645670|FG013|STARTED|Period1, Escalation Phase5, Upto Day35||6
6715632|NCT02991859|7645671|FG014|STARTED|Period1, Escalation Phase5, Upto Day35||6
6715633|NCT02991859|7645672|FG015|STARTED|Period1, Escalation Phase5, Upto Day35||3
6715634|NCT02991859|7645673|FG016|STARTED|Period1, Escalation Phase5, Upto Day35||3
6715635|NCT02991859|7645657|FG000|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715636|NCT02991859|7645658|FG001|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715637|NCT02991859|7645659|FG002|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715638|NCT02991859|7645660|FG003|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715639|NCT02991859|7645661|FG004|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715640|NCT02991859|7645662|FG005|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715641|NCT02991859|7645663|FG006|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715642|NCT02991859|7645664|FG007|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715643|NCT02991859|7645665|FG008|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715644|NCT02991859|7645666|FG009|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715645|NCT02991859|7645667|FG010|COMPLETED|Period1, Escalation Phase5, Upto Day35||1
6715646|NCT02991859|7645668|FG011|COMPLETED|Period1, Escalation Phase5, Upto Day35||2
6715647|NCT02991859|7645669|FG012|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
6715648|NCT02991859|7645670|FG013|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
6715649|NCT02991859|7645671|FG014|COMPLETED|Period1, Escalation Phase5, Upto Day35||6
6715650|NCT02991859|7645672|FG015|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
6715651|NCT02991859|7645673|FG016|COMPLETED|Period1, Escalation Phase5, Upto Day35||3
6715652|NCT02991859|7645657|FG000|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715653|NCT02991859|7645658|FG001|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715654|NCT02991859|7645659|FG002|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715655|NCT02991859|7645660|FG003|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715656|NCT02991859|7645661|FG004|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715657|NCT02991859|7645662|FG005|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715658|NCT02991859|7645663|FG006|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715659|NCT02991859|7645664|FG007|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715660|NCT02991859|7645665|FG008|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715661|NCT02991859|7645666|FG009|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715662|NCT02991859|7645667|FG010|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715663|NCT02991859|7645668|FG011|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715664|NCT02991859|7645669|FG012|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715665|NCT02991859|7645670|FG013|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715666|NCT02991859|7645671|FG014|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715667|NCT02991859|7645672|FG015|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715668|NCT02991859|7645673|FG016|NOT COMPLETED|Period1, Escalation Phase5, Upto Day35||0
6715669|NCT02991859|7645657|FG000|STARTED|Wash Out, Up to Day 77||2
6263129|NCT00945035|7162161|FG000|COMPLETED|Period 2||18
6715670|NCT02991859|7645658|FG001|STARTED|Wash Out, Up to Day 77||2
6715671|NCT02991859|7645659|FG002|STARTED|Wash Out, Up to Day 77||2
6715672|NCT02991859|7645660|FG003|STARTED|Wash Out, Up to Day 77||2
6715673|NCT02991859|7645661|FG004|STARTED|Wash Out, Up to Day 77||2
6715674|NCT02991859|7645662|FG005|STARTED|Wash Out, Up to Day 77||2
6715675|NCT02991859|7645663|FG006|STARTED|Wash Out, Up to Day 77||2
6715676|NCT02991859|7645664|FG007|STARTED|Wash Out, Up to Day 77||2
6715677|NCT02991859|7645665|FG008|STARTED|Wash Out, Up to Day 77||2
6715678|NCT02991859|7645666|FG009|STARTED|Wash Out, Up to Day 77||2
6715679|NCT02991859|7645667|FG010|STARTED|Wash Out, Up to Day 77||1
6715680|NCT02991859|7645668|FG011|STARTED|Wash Out, Up to Day 77||2
6715681|NCT02991859|7645669|FG012|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6715682|NCT02991859|7645670|FG013|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6715683|NCT02991859|7645671|FG014|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6715684|NCT02991859|7645672|FG015|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6715685|NCT02991859|7645673|FG016|STARTED|Wash Out, Up to Day 77|Participants did not enter washout and Period 2|0
6715686|NCT02991859|7645657|FG000|COMPLETED|Wash Out, Up to Day 77||2
6715687|NCT02991859|7645658|FG001|COMPLETED|Wash Out, Up to Day 77||2
6715688|NCT02991859|7645659|FG002|COMPLETED|Wash Out, Up to Day 77||2
6715689|NCT02991859|7645660|FG003|COMPLETED|Wash Out, Up to Day 77||2
6715690|NCT02991859|7645661|FG004|COMPLETED|Wash Out, Up to Day 77||2
6715691|NCT02991859|7645662|FG005|COMPLETED|Wash Out, Up to Day 77||1
6715692|NCT02991859|7645663|FG006|COMPLETED|Wash Out, Up to Day 77||2
6715693|NCT02991859|7645664|FG007|COMPLETED|Wash Out, Up to Day 77||2
6715694|NCT02991859|7645665|FG008|COMPLETED|Wash Out, Up to Day 77||2
6715695|NCT02991859|7645666|FG009|COMPLETED|Wash Out, Up to Day 77||1
6715696|NCT02991859|7645667|FG010|COMPLETED|Wash Out, Up to Day 77||1
6715697|NCT02991859|7645668|FG011|COMPLETED|Wash Out, Up to Day 77||2
6715698|NCT02991859|7645669|FG012|COMPLETED|Wash Out, Up to Day 77||0
6715699|NCT02991859|7645670|FG013|COMPLETED|Wash Out, Up to Day 77||0
6715700|NCT02991859|7645671|FG014|COMPLETED|Wash Out, Up to Day 77||0
6715701|NCT02991859|7645672|FG015|COMPLETED|Wash Out, Up to Day 77||0
6715702|NCT02991859|7645673|FG016|COMPLETED|Wash Out, Up to Day 77||0
6715703|NCT02991859|7645657|FG000|NOT COMPLETED|Wash Out, Up to Day 77||0
6715704|NCT02991859|7645658|FG001|NOT COMPLETED|Wash Out, Up to Day 77||0
6715705|NCT02991859|7645659|FG002|NOT COMPLETED|Wash Out, Up to Day 77||0
6715706|NCT02991859|7645660|FG003|NOT COMPLETED|Wash Out, Up to Day 77||0
6715707|NCT02991859|7645661|FG004|NOT COMPLETED|Wash Out, Up to Day 77||0
6715708|NCT02991859|7645662|FG005|NOT COMPLETED|Wash Out, Up to Day 77||1
6715709|NCT02991859|7645663|FG006|NOT COMPLETED|Wash Out, Up to Day 77||0
6715710|NCT02991859|7645664|FG007|NOT COMPLETED|Wash Out, Up to Day 77||0
6715711|NCT02991859|7645665|FG008|NOT COMPLETED|Wash Out, Up to Day 77||0
6715712|NCT02991859|7645666|FG009|NOT COMPLETED|Wash Out, Up to Day 77||1
6715713|NCT02991859|7645667|FG010|NOT COMPLETED|Wash Out, Up to Day 77||0
6715714|NCT02991859|7645668|FG011|NOT COMPLETED|Wash Out, Up to Day 77||0
6715715|NCT02991859|7645669|FG012|NOT COMPLETED|Wash Out, Up to Day 77||0
6715716|NCT02991859|7645670|FG013|NOT COMPLETED|Wash Out, Up to Day 77||0
6715717|NCT02991859|7645671|FG014|NOT COMPLETED|Wash Out, Up to Day 77||0
6715718|NCT02991859|7645672|FG015|NOT COMPLETED|Wash Out, Up to Day 77||0
6715719|NCT02991859|7645673|FG016|NOT COMPLETED|Wash Out, Up to Day 77||0
6715720|NCT02991859|7645657|FG000|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6715721|NCT02991859|7645658|FG001|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6715722|NCT02991859|7645659|FG002|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6715723|NCT02991859|7645660|FG003|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6715724|NCT02991859|7645661|FG004|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6715725|NCT02991859|7645662|FG005|STARTED|Period2, Escalation Phase1, Upto Day 84||1
6715726|NCT02991859|7645663|FG006|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6263130|NCT00945035|7162162|FG001|COMPLETED|Period 2||18
6263131|NCT00945035|7162161|FG000|NOT COMPLETED|Period 2||0
6263132|NCT00945035|7162162|FG001|NOT COMPLETED|Period 2||0
6263133|NCT00943852|7162168|FG000|STARTED|First Period of Treatment Intervention||2
6263134|NCT00943852|7162169|FG001|STARTED|First Period of Treatment Intervention||1
6263135|NCT00943852|7162170|FG002|STARTED|First Period of Treatment Intervention||1
6263136|NCT00943852|7162171|FG003|STARTED|First Period of Treatment Intervention||2
6263137|NCT00943852|7162172|FG004|STARTED|First Period of Treatment Intervention||1
6263138|NCT00943852|7162173|FG005|STARTED|First Period of Treatment Intervention||1
6263139|NCT00943852|7162174|FG006|STARTED|First Period of Treatment Intervention||2
6263140|NCT00943852|7162175|FG007|STARTED|First Period of Treatment Intervention||1
6263141|NCT00943852|7162176|FG008|STARTED|First Period of Treatment Intervention||1
6263142|NCT00943852|7162177|FG009|STARTED|First Period of Treatment Intervention||1
6263143|NCT00943852|7162168|FG000|COMPLETED|First Period of Treatment Intervention||2
6263144|NCT00943852|7162169|FG001|COMPLETED|First Period of Treatment Intervention||1
6263145|NCT00943852|7162170|FG002|COMPLETED|First Period of Treatment Intervention||1
6263146|NCT00943852|7162171|FG003|COMPLETED|First Period of Treatment Intervention||2
6263147|NCT00943852|7162172|FG004|COMPLETED|First Period of Treatment Intervention||1
6263148|NCT00943852|7162173|FG005|COMPLETED|First Period of Treatment Intervention||1
6263149|NCT00943852|7162174|FG006|COMPLETED|First Period of Treatment Intervention||2
6263150|NCT00943852|7162175|FG007|COMPLETED|First Period of Treatment Intervention||1
6263151|NCT00943852|7162176|FG008|COMPLETED|First Period of Treatment Intervention||1
6715727|NCT02991859|7645664|FG007|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6715728|NCT02991859|7645665|FG008|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6715729|NCT02991859|7645666|FG009|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par directly entered into Period 2, Esc 1|2
6715730|NCT02991859|7645667|FG010|STARTED|Period2, Escalation Phase1, Upto Day 84|1 Par cont in P2 Esc 1 insteadP1 Esc 5, was not withdrawn|2
6715731|NCT02991859|7645668|FG011|STARTED|Period2, Escalation Phase1, Upto Day 84||2
6715732|NCT02991859|7645669|FG012|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6715733|NCT02991859|7645670|FG013|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6715734|NCT02991859|7645671|FG014|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6715735|NCT02991859|7645672|FG015|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6715736|NCT02991859|7645673|FG016|STARTED|Period2, Escalation Phase1, Upto Day 84||0
6715737|NCT02991859|7645657|FG000|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715738|NCT02991859|7645658|FG001|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715739|NCT02991859|7645659|FG002|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715740|NCT02991859|7645660|FG003|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715741|NCT02991859|7645661|FG004|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715742|NCT02991859|7645662|FG005|COMPLETED|Period2, Escalation Phase1, Upto Day 84||1
6715743|NCT02991859|7645663|FG006|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715744|NCT02991859|7645664|FG007|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715745|NCT02991859|7645665|FG008|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715746|NCT02991859|7645666|FG009|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715747|NCT02991859|7645667|FG010|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715748|NCT02991859|7645668|FG011|COMPLETED|Period2, Escalation Phase1, Upto Day 84||2
6715749|NCT02991859|7645669|FG012|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715750|NCT02991859|7645670|FG013|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715751|NCT02991859|7645671|FG014|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715752|NCT02991859|7645672|FG015|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715753|NCT02991859|7645673|FG016|COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715754|NCT02991859|7645657|FG000|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715755|NCT02991859|7645658|FG001|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715756|NCT02991859|7645659|FG002|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715757|NCT02991859|7645660|FG003|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715758|NCT02991859|7645661|FG004|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715759|NCT02991859|7645662|FG005|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715760|NCT02991859|7645663|FG006|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715761|NCT02991859|7645664|FG007|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715762|NCT02991859|7645665|FG008|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715763|NCT02991859|7645666|FG009|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715764|NCT02991859|7645667|FG010|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715765|NCT02991859|7645668|FG011|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715766|NCT02991859|7645669|FG012|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715767|NCT02991859|7645670|FG013|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6263152|NCT00943852|7162177|FG009|COMPLETED|First Period of Treatment Intervention||1
6263153|NCT00943852|7162168|FG000|NOT COMPLETED|First Period of Treatment Intervention||0
6263154|NCT00943852|7162169|FG001|NOT COMPLETED|First Period of Treatment Intervention||0
6263155|NCT00943852|7162170|FG002|NOT COMPLETED|First Period of Treatment Intervention||0
6263156|NCT00943852|7162171|FG003|NOT COMPLETED|First Period of Treatment Intervention||0
6715768|NCT02991859|7645671|FG014|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715769|NCT02991859|7645672|FG015|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715770|NCT02991859|7645673|FG016|NOT COMPLETED|Period2, Escalation Phase1, Upto Day 84||0
6715771|NCT02991859|7645657|FG000|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715772|NCT02991859|7645658|FG001|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715773|NCT02991859|7645659|FG002|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715774|NCT02991859|7645660|FG003|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715775|NCT02991859|7645661|FG004|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715776|NCT02991859|7645662|FG005|STARTED|Period2, Escalation Phase2, Upto Day 91||1
6715777|NCT02991859|7645663|FG006|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715778|NCT02991859|7645664|FG007|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715779|NCT02991859|7645665|FG008|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715780|NCT02991859|7645666|FG009|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715781|NCT02991859|7645667|FG010|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715782|NCT02991859|7645668|FG011|STARTED|Period2, Escalation Phase2, Upto Day 91||2
6715783|NCT02991859|7645669|FG012|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6715784|NCT02991859|7645670|FG013|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6715785|NCT02991859|7645671|FG014|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6715786|NCT02991859|7645672|FG015|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6715787|NCT02991859|7645673|FG016|STARTED|Period2, Escalation Phase2, Upto Day 91||0
6715788|NCT02991859|7645657|FG000|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715789|NCT02991859|7645658|FG001|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715790|NCT02991859|7645659|FG002|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715791|NCT02991859|7645660|FG003|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715792|NCT02991859|7645661|FG004|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715793|NCT02991859|7645662|FG005|COMPLETED|Period2, Escalation Phase2, Upto Day 91||1
6715794|NCT02991859|7645663|FG006|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715795|NCT02991859|7645664|FG007|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715796|NCT02991859|7645665|FG008|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715797|NCT02991859|7645666|FG009|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715798|NCT02991859|7645667|FG010|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715799|NCT02991859|7645668|FG011|COMPLETED|Period2, Escalation Phase2, Upto Day 91||2
6715800|NCT02991859|7645669|FG012|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715801|NCT02991859|7645670|FG013|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715802|NCT02991859|7645671|FG014|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715803|NCT02991859|7645672|FG015|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715804|NCT02991859|7645673|FG016|COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715805|NCT02991859|7645657|FG000|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715806|NCT02991859|7645658|FG001|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715807|NCT02991859|7645659|FG002|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715808|NCT02991859|7645660|FG003|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715809|NCT02991859|7645661|FG004|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715810|NCT02991859|7645662|FG005|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715811|NCT02991859|7645663|FG006|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715812|NCT02991859|7645664|FG007|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715813|NCT02991859|7645665|FG008|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715814|NCT02991859|7645666|FG009|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715815|NCT02991859|7645667|FG010|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715816|NCT02991859|7645668|FG011|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715817|NCT02991859|7645669|FG012|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715818|NCT02991859|7645670|FG013|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715819|NCT02991859|7645671|FG014|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715820|NCT02991859|7645672|FG015|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715821|NCT02991859|7645673|FG016|NOT COMPLETED|Period2, Escalation Phase2, Upto Day 91||0
6715822|NCT02991859|7645657|FG000|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715823|NCT02991859|7645658|FG001|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715824|NCT02991859|7645659|FG002|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715825|NCT02991859|7645660|FG003|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715826|NCT02991859|7645661|FG004|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715827|NCT02991859|7645662|FG005|STARTED|Period2, Escalation Phase3, Upto Day 98||1
6715828|NCT02991859|7645663|FG006|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715829|NCT02991859|7645664|FG007|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715830|NCT02991859|7645665|FG008|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715831|NCT02991859|7645666|FG009|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715832|NCT02991859|7645667|FG010|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6392127|NCT00839527|7304108|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
6392128|NCT00839527|7304109|FG002|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
6392129|NCT00839527|7304107|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
6392130|NCT00839527|7304108|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
6392131|NCT00839527|7304109|FG002|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
6392132|NCT00839527|7304107|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
6392133|NCT00839527|7304108|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
6392134|NCT00839527|7304109|FG002|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
6392135|NCT00839540|7304122|FG000|STARTED|Overall Study||8
6392136|NCT00839540|7304123|FG001|STARTED|Overall Study||8
6392137|NCT00839540|7304124|FG002|STARTED|Overall Study||5
6392138|NCT00839540|7304122|FG000|COMPLETED|Overall Study||8
6392139|NCT00839540|7304123|FG001|COMPLETED|Overall Study||8
6392140|NCT00839540|7304124|FG002|COMPLETED|Overall Study||5
6392141|NCT00839540|7304122|FG000|NOT COMPLETED|Overall Study||0
6392142|NCT00839540|7304123|FG001|NOT COMPLETED|Overall Study||0
6392143|NCT00839540|7304124|FG002|NOT COMPLETED|Overall Study||0
6715833|NCT02991859|7645668|FG011|STARTED|Period2, Escalation Phase3, Upto Day 98||2
6715834|NCT02991859|7645669|FG012|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6715835|NCT02991859|7645670|FG013|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6715836|NCT02991859|7645671|FG014|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6715837|NCT02991859|7645672|FG015|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6715838|NCT02991859|7645673|FG016|STARTED|Period2, Escalation Phase3, Upto Day 98||0
6715839|NCT02991859|7645657|FG000|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715840|NCT02991859|7645658|FG001|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715841|NCT02991859|7645659|FG002|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715842|NCT02991859|7645660|FG003|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715843|NCT02991859|7645661|FG004|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715844|NCT02991859|7645662|FG005|COMPLETED|Period2, Escalation Phase3, Upto Day 98||1
6715845|NCT02991859|7645663|FG006|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715846|NCT02991859|7645664|FG007|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715847|NCT02991859|7645665|FG008|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715848|NCT02991859|7645666|FG009|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715849|NCT02991859|7645667|FG010|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6392144|NCT00839800|7304134|FG000|STARTED|Overall Study||1049
6392145|NCT00839800|7304135|FG001|STARTED|Overall Study||1042
6392146|NCT00839800|7304134|FG000|COMPLETED|Overall Study||956
6392147|NCT00839800|7304135|FG001|COMPLETED|Overall Study||932
6392148|NCT00839800|7304134|FG000|NOT COMPLETED|Overall Study||93
6392149|NCT00839800|7304135|FG001|NOT COMPLETED|Overall Study||110
6392150|NCT00839852|7304141|FG000|STARTED|Overall Study||93
6392151|NCT00839852|7304141|FG000|COMPLETED|Overall Study||46
6392152|NCT00839852|7304141|FG000|NOT COMPLETED|Overall Study||47
6392153|NCT00839917|7304147|FG000|STARTED|Overall Study||13
6392154|NCT00839917|7304148|FG001|STARTED|Overall Study||17
6392155|NCT00839917|7304147|FG000|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
6392156|NCT00839917|7304148|FG001|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
6715850|NCT02991859|7645668|FG011|COMPLETED|Period2, Escalation Phase3, Upto Day 98||2
6715851|NCT02991859|7645669|FG012|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715852|NCT02991859|7645670|FG013|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715853|NCT02991859|7645671|FG014|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715854|NCT02991859|7645672|FG015|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715855|NCT02991859|7645673|FG016|COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715856|NCT02991859|7645657|FG000|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715857|NCT02991859|7645658|FG001|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715858|NCT02991859|7645659|FG002|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715859|NCT02991859|7645660|FG003|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715860|NCT02991859|7645661|FG004|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715861|NCT02991859|7645662|FG005|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715862|NCT02991859|7645663|FG006|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715863|NCT02991859|7645664|FG007|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715864|NCT02991859|7645665|FG008|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715865|NCT02991859|7645666|FG009|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715866|NCT02991859|7645667|FG010|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715867|NCT02991859|7645668|FG011|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715868|NCT02991859|7645669|FG012|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715869|NCT02991859|7645670|FG013|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715870|NCT02991859|7645671|FG014|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715871|NCT02991859|7645672|FG015|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715872|NCT02991859|7645673|FG016|NOT COMPLETED|Period2, Escalation Phase3, Upto Day 98||0
6715873|NCT02991859|7645657|FG000|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715874|NCT02991859|7645658|FG001|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715875|NCT02991859|7645659|FG002|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715876|NCT02991859|7645660|FG003|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715877|NCT02991859|7645661|FG004|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715878|NCT02991859|7645662|FG005|STARTED|Period2, Escalation Phase4, Upto Day 105||1
6715879|NCT02991859|7645663|FG006|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715880|NCT02991859|7645664|FG007|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715881|NCT02991859|7645665|FG008|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715882|NCT02991859|7645666|FG009|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715883|NCT02991859|7645667|FG010|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715884|NCT02991859|7645668|FG011|STARTED|Period2, Escalation Phase4, Upto Day 105||2
6715885|NCT02991859|7645669|FG012|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6715886|NCT02991859|7645670|FG013|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6715887|NCT02991859|7645671|FG014|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6715888|NCT02991859|7645672|FG015|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6715889|NCT02991859|7645673|FG016|STARTED|Period2, Escalation Phase4, Upto Day 105||0
6715890|NCT02991859|7645657|FG000|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715891|NCT02991859|7645658|FG001|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715892|NCT02991859|7645659|FG002|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715893|NCT02991859|7645660|FG003|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715894|NCT02991859|7645661|FG004|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715895|NCT02991859|7645662|FG005|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
6715896|NCT02991859|7645663|FG006|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715897|NCT02991859|7645664|FG007|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6392157|NCT00839917|7304147|FG000|NOT COMPLETED|Overall Study||1
6715898|NCT02991859|7645665|FG008|COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
6715899|NCT02991859|7645666|FG009|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715900|NCT02991859|7645667|FG010|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715901|NCT02991859|7645668|FG011|COMPLETED|Period2, Escalation Phase4, Upto Day 105||2
6715902|NCT02991859|7645669|FG012|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715903|NCT02991859|7645670|FG013|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715904|NCT02991859|7645671|FG014|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715905|NCT02991859|7645672|FG015|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715906|NCT02991859|7645673|FG016|COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715907|NCT02991859|7645657|FG000|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715908|NCT02991859|7645658|FG001|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715909|NCT02991859|7645659|FG002|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715910|NCT02991859|7645660|FG003|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715911|NCT02991859|7645661|FG004|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715912|NCT02991859|7645662|FG005|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715913|NCT02991859|7645663|FG006|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715914|NCT02991859|7645664|FG007|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715915|NCT02991859|7645665|FG008|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||1
6715916|NCT02991859|7645666|FG009|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715917|NCT02991859|7645667|FG010|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715918|NCT02991859|7645668|FG011|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715919|NCT02991859|7645669|FG012|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715920|NCT02991859|7645670|FG013|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715921|NCT02991859|7645671|FG014|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715922|NCT02991859|7645672|FG015|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715923|NCT02991859|7645673|FG016|NOT COMPLETED|Period2, Escalation Phase4, Upto Day 105||0
6715924|NCT02991859|7645657|FG000|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715925|NCT02991859|7645658|FG001|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715926|NCT02991859|7645659|FG002|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715927|NCT02991859|7645660|FG003|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715928|NCT02991859|7645661|FG004|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715929|NCT02991859|7645662|FG005|STARTED|Period2,Escalation Phase5,Upto Day 112||1
6715930|NCT02991859|7645663|FG006|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715931|NCT02991859|7645664|FG007|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715932|NCT02991859|7645665|FG008|STARTED|Period2,Escalation Phase5,Upto Day 112||1
6715933|NCT02991859|7645666|FG009|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715934|NCT02991859|7645667|FG010|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715935|NCT02991859|7645668|FG011|STARTED|Period2,Escalation Phase5,Upto Day 112||2
6715936|NCT02991859|7645669|FG012|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6715937|NCT02991859|7645670|FG013|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6715938|NCT02991859|7645671|FG014|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6715939|NCT02991859|7645672|FG015|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6715940|NCT02991859|7645673|FG016|STARTED|Period2,Escalation Phase5,Upto Day 112||0
6715941|NCT02991859|7645657|FG000|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715942|NCT02991859|7645658|FG001|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715943|NCT02991859|7645659|FG002|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715944|NCT02991859|7645660|FG003|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715945|NCT02991859|7645661|FG004|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715946|NCT02991859|7645662|FG005|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
6715947|NCT02991859|7645663|FG006|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715948|NCT02991859|7645664|FG007|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715949|NCT02991859|7645665|FG008|COMPLETED|Period2,Escalation Phase5,Upto Day 112||1
6715950|NCT02991859|7645666|FG009|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715951|NCT02991859|7645667|FG010|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715952|NCT02991859|7645668|FG011|COMPLETED|Period2,Escalation Phase5,Upto Day 112||2
6715953|NCT02991859|7645669|FG012|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715954|NCT02991859|7645670|FG013|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715955|NCT02991859|7645671|FG014|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715956|NCT02991859|7645672|FG015|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715957|NCT02991859|7645673|FG016|COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715958|NCT02991859|7645657|FG000|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715959|NCT02991859|7645658|FG001|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715960|NCT02991859|7645659|FG002|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715961|NCT02991859|7645660|FG003|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715962|NCT02991859|7645661|FG004|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715963|NCT02991859|7645662|FG005|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715964|NCT02991859|7645663|FG006|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715965|NCT02991859|7645664|FG007|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715966|NCT02991859|7645665|FG008|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715967|NCT02991859|7645666|FG009|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715968|NCT02991859|7645667|FG010|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6739476|NCT03290378|7668358|FG002|NOT COMPLETED|Overall Study||16
6715969|NCT02991859|7645668|FG011|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715970|NCT02991859|7645669|FG012|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715971|NCT02991859|7645670|FG013|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715972|NCT02991859|7645671|FG014|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715973|NCT02991859|7645672|FG015|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715974|NCT02991859|7645673|FG016|NOT COMPLETED|Period2,Escalation Phase5,Upto Day 112||0
6715975|NCT02991898|7645748|FG000|STARTED|Overall Study||3
6715976|NCT02991898|7645748|FG000|COMPLETED|Overall Study||3
6715977|NCT02991898|7645748|FG000|NOT COMPLETED|Overall Study||0
6715978|NCT02992067|7645752|FG000|STARTED|Overall Study||359
6715979|NCT02992067|7645752|FG000|COMPLETED|Overall Study||359
6715980|NCT02992067|7645752|FG000|NOT COMPLETED|Overall Study||0
6715981|NCT02992132|7645759|FG000|STARTED|Overall Study||40
6715982|NCT02992132|7645760|FG001|STARTED|Overall Study||35
6715983|NCT02992132|7645761|FG002|STARTED|Overall Study||36
6715984|NCT02992132|7645759|FG000|COMPLETED|Overall Study||27
6715985|NCT02992132|7645760|FG001|COMPLETED|Overall Study||27
6715986|NCT02992132|7645761|FG002|COMPLETED|Overall Study||29
6715987|NCT02992132|7645759|FG000|NOT COMPLETED|Overall Study||13
6715988|NCT02992132|7645760|FG001|NOT COMPLETED|Overall Study||8
6715989|NCT02992132|7645761|FG002|NOT COMPLETED|Overall Study||7
6715990|NCT02992197|7645771|FG000|STARTED|Overall Study||110
6715991|NCT02992197|7645772|FG001|STARTED|Overall Study||110
6715992|NCT02992197|7645771|FG000|COMPLETED|Overall Study||99
6715993|NCT02992197|7645772|FG001|COMPLETED|Overall Study||103
6715994|NCT02992197|7645771|FG000|NOT COMPLETED|Overall Study||11
6715995|NCT02992197|7645772|FG001|NOT COMPLETED|Overall Study||7
6715996|NCT02992236|7645780|FG000|STARTED|Overall Study||8
6715997|NCT02992236|7645781|FG001|STARTED|Overall Study||8
6715998|NCT02992236|7645780|FG000|COMPLETED|Overall Study||8
6715999|NCT02992236|7645781|FG001|COMPLETED|Overall Study||8
6716000|NCT02992236|7645780|FG000|NOT COMPLETED|Overall Study||0
6716001|NCT02992236|7645781|FG001|NOT COMPLETED|Overall Study||0
6716002|NCT02992288|7645795|FG000|STARTED|Overall Study||106
6716003|NCT02992288|7645796|FG001|STARTED|Overall Study||37
6716004|NCT02992288|7645797|FG002|STARTED|Overall Study||70
6716005|NCT02992288|7645798|FG003|STARTED|Overall Study||73
6716006|NCT02992288|7645799|FG004|STARTED|Overall Study||69
6716007|NCT02992288|7645800|FG005|STARTED|Overall Study||72
6716008|NCT02992288|7645795|FG000|Treated|Overall Study||106
6716009|NCT02992288|7645796|FG001|Treated|Overall Study||37
6716010|NCT02992288|7645797|FG002|Treated|Overall Study||70
6716011|NCT02992288|7645798|FG003|Treated|Overall Study||72
6716012|NCT02992288|7645799|FG004|Treated|Overall Study||69
6716013|NCT02992288|7645800|FG005|Treated|Overall Study||72
6716014|NCT02992288|7645795|FG000|COMPLETED|Overall Study||89
6716015|NCT02992288|7645796|FG001|COMPLETED|Overall Study||32
6716016|NCT02992288|7645797|FG002|COMPLETED|Overall Study||63
6716017|NCT02992288|7645798|FG003|COMPLETED|Overall Study||64
6716018|NCT02992288|7645799|FG004|COMPLETED|Overall Study||61
6716019|NCT02992288|7645800|FG005|COMPLETED|Overall Study||59
6716020|NCT02992288|7645795|FG000|NOT COMPLETED|Overall Study||17
6716021|NCT02992288|7645796|FG001|NOT COMPLETED|Overall Study||5
6716022|NCT02992288|7645797|FG002|NOT COMPLETED|Overall Study||7
6716023|NCT02992288|7645798|FG003|NOT COMPLETED|Overall Study||9
6716024|NCT02992288|7645799|FG004|NOT COMPLETED|Overall Study||8
6716025|NCT02992288|7645800|FG005|NOT COMPLETED|Overall Study||13
6716026|NCT02992691|7645814|FG000|STARTED|Overall Study||56
6716027|NCT02992691|7645814|FG000|Received Test Product 1|Overall Study||55
6716028|NCT02992691|7645814|FG000|Received Test Product 2|Overall Study||55
6716029|NCT02992691|7645814|FG000|Received Test Product 3|Overall Study||52
6716030|NCT02992691|7645814|FG000|Received Positive Control|Overall Study||55
6716031|NCT02992691|7645814|FG000|Received Negative Control|Overall Study||55
6716032|NCT02992691|7645814|FG000|COMPLETED|Overall Study||53
6716033|NCT02992691|7645814|FG000|NOT COMPLETED|Overall Study||3
6716034|NCT02992899|7645831|FG000|STARTED|Overall Study||27
6716035|NCT02992899|7645832|FG001|STARTED|Overall Study||29
6716036|NCT02992899|7645831|FG000|COMPLETED|Overall Study||25
6716037|NCT02992899|7645832|FG001|COMPLETED|Overall Study||26
6716038|NCT02992899|7645831|FG000|NOT COMPLETED|Overall Study||2
6716039|NCT02992899|7645832|FG001|NOT COMPLETED|Overall Study||3
6716040|NCT02993224|7645838|FG000|STARTED|Core Phase - Period 1||148
6716041|NCT02993224|7645838|FG000|COMPLETED|Core Phase - Period 1||140
6716042|NCT02993224|7645838|FG000|NOT COMPLETED|Core Phase - Period 1||8
6716043|NCT02993224|7645838|FG000|STARTED|Core Phase- Period 2||140
6716044|NCT02993224|7645838|FG000|COMPLETED|Core Phase- Period 2||136
6716045|NCT02993224|7645838|FG000|NOT COMPLETED|Core Phase- Period 2||4
6716046|NCT02993224|7645838|FG000|STARTED|Extension Phase||116
6716047|NCT02993224|7645838|FG000|COMPLETED|Extension Phase||80
6716048|NCT02993224|7645838|FG000|NOT COMPLETED|Extension Phase||36
6716049|NCT02993250|7645846|FG000|STARTED|Overall Study||22
6716050|NCT02993250|7645847|FG001|STARTED|Overall Study||11
6716051|NCT02993250|7645846|FG000|COMPLETED|Overall Study||22
6716052|NCT02993250|7645847|FG001|COMPLETED|Overall Study||10
6716053|NCT02993250|7645846|FG000|NOT COMPLETED|Overall Study||0
6716054|NCT02993250|7645847|FG001|NOT COMPLETED|Overall Study||1
6716055|NCT02993302|7645855|FG000|STARTED|Overall Study||13
6716056|NCT02993302|7645856|FG001|STARTED|Overall Study||12
6716057|NCT02993302|7645855|FG000|COMPLETED|Overall Study||13
6716058|NCT02993302|7645856|FG001|COMPLETED|Overall Study||12
6716059|NCT02993302|7645855|FG000|NOT COMPLETED|Overall Study||0
6716060|NCT02993302|7645856|FG001|NOT COMPLETED|Overall Study||0
6716061|NCT02993445|7645864|FG000|STARTED|First Intervention (5 Minutes)||6
6716062|NCT02993445|7645865|FG001|STARTED|First Intervention (5 Minutes)||5
6716063|NCT02993445|7645864|FG000|COMPLETED|First Intervention (5 Minutes)||6
6716064|NCT02993445|7645865|FG001|COMPLETED|First Intervention (5 Minutes)||5
6716065|NCT02993445|7645864|FG000|NOT COMPLETED|First Intervention (5 Minutes)||0
6716066|NCT02993445|7645865|FG001|NOT COMPLETED|First Intervention (5 Minutes)||0
6716067|NCT02993445|7645864|FG000|STARTED|Washout (2 Weeks)||6
6716068|NCT02993445|7645865|FG001|STARTED|Washout (2 Weeks)||5
6716069|NCT02993445|7645864|FG000|COMPLETED|Washout (2 Weeks)||6
6716070|NCT02993445|7645865|FG001|COMPLETED|Washout (2 Weeks)||5
6716071|NCT02993445|7645864|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6716072|NCT02993445|7645865|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6716073|NCT02993445|7645864|FG000|STARTED|Second Intervention (5 Mins)||6
6716074|NCT02993445|7645865|FG001|STARTED|Second Intervention (5 Mins)||5
6716075|NCT02993445|7645864|FG000|COMPLETED|Second Intervention (5 Mins)||6
6716076|NCT02993445|7645865|FG001|COMPLETED|Second Intervention (5 Mins)||5
6716077|NCT02993445|7645864|FG000|NOT COMPLETED|Second Intervention (5 Mins)||0
6716078|NCT02993445|7645865|FG001|NOT COMPLETED|Second Intervention (5 Mins)||0
6739477|NCT03290768|7668366|FG000|STARTED|Overall Study||358
6739478|NCT03290768|7668366|FG000|COMPLETED|Overall Study||193
6739479|NCT03290768|7668366|FG000|NOT COMPLETED|Overall Study||165
6739480|NCT03291041|7668372|FG000|STARTED|Overall Study||13
6739481|NCT03291041|7668373|FG001|STARTED|Overall Study||12
6739482|NCT03291041|7668372|FG000|COMPLETED|Overall Study||13
6739483|NCT03291041|7668373|FG001|COMPLETED|Overall Study||12
6739484|NCT03291041|7668372|FG000|NOT COMPLETED|Overall Study||0
6739485|NCT03291041|7668373|FG001|NOT COMPLETED|Overall Study||0
6739486|NCT03291080|7668381|FG000|STARTED|First Cycle (2 Weeks)||11
6739487|NCT03291080|7668382|FG001|STARTED|First Cycle (2 Weeks)||9
6739488|NCT03291080|7668381|FG000|COMPLETED|First Cycle (2 Weeks)||11
6739489|NCT03291080|7668382|FG001|COMPLETED|First Cycle (2 Weeks)||9
6739490|NCT03291080|7668381|FG000|NOT COMPLETED|First Cycle (2 Weeks)||0
6739491|NCT03291080|7668382|FG001|NOT COMPLETED|First Cycle (2 Weeks)||0
6739492|NCT03291080|7668381|FG000|STARTED|Washout (2 Weeks)||11
6739493|NCT03291080|7668382|FG001|STARTED|Washout (2 Weeks)||9
6739494|NCT03291080|7668381|FG000|COMPLETED|Washout (2 Weeks)||11
6739495|NCT03291080|7668382|FG001|COMPLETED|Washout (2 Weeks)||9
6739496|NCT03291080|7668381|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6739497|NCT03291080|7668382|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6739498|NCT03291080|7668381|FG000|STARTED|Second Cylcle (2 Weeks)||9
6739499|NCT03291080|7668382|FG001|STARTED|Second Cylcle (2 Weeks)||11
6739500|NCT03291080|7668381|FG000|COMPLETED|Second Cylcle (2 Weeks)||8
6739501|NCT03291080|7668382|FG001|COMPLETED|Second Cylcle (2 Weeks)||11
6739502|NCT03291080|7668381|FG000|NOT COMPLETED|Second Cylcle (2 Weeks)||1
6739503|NCT03291080|7668382|FG001|NOT COMPLETED|Second Cylcle (2 Weeks)||0
6716079|NCT02993471|7645871|FG000|STARTED|Period 1 (Drug Cocktail)||28
6716080|NCT02993471|7645871|FG000|Received at Least 1 Dose of Study Drug|Period 1 (Drug Cocktail)||28
6716081|NCT02993471|7645871|FG000|COMPLETED|Period 1 (Drug Cocktail)||28
6716082|NCT02993471|7645871|FG000|NOT COMPLETED|Period 1 (Drug Cocktail)||0
6716083|NCT02993471|7645871|FG000|STARTED|Period 2 (Drug Cocktail + Ixekizumab)||28
6716084|NCT02993471|7645871|FG000|Received at Least 1 Dose of Study Drug|Period 2 (Drug Cocktail + Ixekizumab)||27
6716085|NCT02993471|7645871|FG000|COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||26
6716086|NCT02993471|7645871|FG000|NOT COMPLETED|Period 2 (Drug Cocktail + Ixekizumab)||2
6716087|NCT02993783|7645895|FG000|STARTED|Overall Study||8
6716088|NCT02993783|7645896|FG001|STARTED|Overall Study||9
6716089|NCT02993783|7645895|FG000|COMPLETED|Overall Study||2
6716090|NCT02993783|7645896|FG001|COMPLETED|Overall Study||0
6716091|NCT02993783|7645895|FG000|NOT COMPLETED|Overall Study||6
6716092|NCT02993783|7645896|FG001|NOT COMPLETED|Overall Study||9
6716093|NCT02994056|7645902|FG000|STARTED|Overall Study||32
6716094|NCT02994056|7645902|FG000|COMPLETED|Overall Study||23
6716095|NCT02994056|7645902|FG000|NOT COMPLETED|Overall Study||9
6716096|NCT02994108|7645917|FG000|STARTED|Intervention Messages||74
6716097|NCT02994108|7645918|FG001|STARTED|Intervention Messages||76
6716098|NCT02994108|7645917|FG000|COMPLETED|Intervention Messages||72
6716099|NCT02994108|7645918|FG001|COMPLETED|Intervention Messages||76
6716100|NCT02994108|7645917|FG000|NOT COMPLETED|Intervention Messages||2
6716101|NCT02994108|7645918|FG001|NOT COMPLETED|Intervention Messages||0
6716102|NCT02994108|7645917|FG000|STARTED|Phase 1 Assessment||72
6716103|NCT02994108|7645918|FG001|STARTED|Phase 1 Assessment||76
6716104|NCT02994108|7645917|FG000|COMPLETED|Phase 1 Assessment||67
6716105|NCT02994108|7645918|FG001|COMPLETED|Phase 1 Assessment||73
6716106|NCT02994108|7645917|FG000|NOT COMPLETED|Phase 1 Assessment||5
6716107|NCT02994108|7645918|FG001|NOT COMPLETED|Phase 1 Assessment||3
6716108|NCT02994108|7645917|FG000|STARTED|Phase 2 Assessment||72
6716109|NCT02994108|7645918|FG001|STARTED|Phase 2 Assessment||76
6716110|NCT02994108|7645917|FG000|COMPLETED|Phase 2 Assessment||63
6716111|NCT02994108|7645918|FG001|COMPLETED|Phase 2 Assessment||69
6716112|NCT02994108|7645917|FG000|NOT COMPLETED|Phase 2 Assessment||9
6716113|NCT02994108|7645918|FG001|NOT COMPLETED|Phase 2 Assessment||7
6716114|NCT02994238|7645927|FG000|STARTED|Overall Study||125
6716115|NCT02994238|7645928|FG001|STARTED|Overall Study||127
6716116|NCT02994238|7645927|FG000|COMPLETED|Overall Study||125
6716117|NCT02994238|7645928|FG001|COMPLETED|Overall Study||127
6716118|NCT02994238|7645927|FG000|NOT COMPLETED|Overall Study||0
6716119|NCT02994238|7645928|FG001|NOT COMPLETED|Overall Study||0
6716120|NCT02994394|7645936|FG000|STARTED|Period 1 (Days 1 to 3)||14
6716121|NCT02994394|7645937|FG001|STARTED|Period 1 (Days 1 to 3)||14
6716122|NCT02994394|7645938|FG002|STARTED|Period 1 (Days 1 to 3)||14
6716123|NCT02994394|7645939|FG003|STARTED|Period 1 (Days 1 to 3)||14
6716124|NCT02994394|7645940|FG004|STARTED|Period 1 (Days 1 to 3)||14
6716125|NCT02994394|7645941|FG005|STARTED|Period 1 (Days 1 to 3)||14
6716126|NCT02994394|7645936|FG000|COMPLETED|Period 1 (Days 1 to 3)||14
6716127|NCT02994394|7645937|FG001|COMPLETED|Period 1 (Days 1 to 3)||14
6716128|NCT02994394|7645938|FG002|COMPLETED|Period 1 (Days 1 to 3)||13
6716129|NCT02994394|7645939|FG003|COMPLETED|Period 1 (Days 1 to 3)||14
6716130|NCT02994394|7645940|FG004|COMPLETED|Period 1 (Days 1 to 3)||14
6716131|NCT02994394|7645941|FG005|COMPLETED|Period 1 (Days 1 to 3)||14
6716132|NCT02994394|7645936|FG000|NOT COMPLETED|Period 1 (Days 1 to 3)||0
6716133|NCT02994394|7645937|FG001|NOT COMPLETED|Period 1 (Days 1 to 3)||0
6716134|NCT02994394|7645938|FG002|NOT COMPLETED|Period 1 (Days 1 to 3)||1
6716135|NCT02994394|7645939|FG003|NOT COMPLETED|Period 1 (Days 1 to 3)||0
6716136|NCT02994394|7645940|FG004|NOT COMPLETED|Period 1 (Days 1 to 3)||0
6716137|NCT02994394|7645941|FG005|NOT COMPLETED|Period 1 (Days 1 to 3)||0
6716138|NCT02994394|7645936|FG000|STARTED|Period 2 (Days 4 to 6)||14
6716139|NCT02994394|7645937|FG001|STARTED|Period 2 (Days 4 to 6)||14
6716140|NCT02994394|7645938|FG002|STARTED|Period 2 (Days 4 to 6)||13
6716141|NCT02994394|7645939|FG003|STARTED|Period 2 (Days 4 to 6)||14
6716142|NCT02994394|7645940|FG004|STARTED|Period 2 (Days 4 to 6)||14
6716143|NCT02994394|7645941|FG005|STARTED|Period 2 (Days 4 to 6)||14
6716144|NCT02994394|7645936|FG000|COMPLETED|Period 2 (Days 4 to 6)||14
6716145|NCT02994394|7645937|FG001|COMPLETED|Period 2 (Days 4 to 6)||13
6716146|NCT02994394|7645938|FG002|COMPLETED|Period 2 (Days 4 to 6)||13
6716147|NCT02994394|7645939|FG003|COMPLETED|Period 2 (Days 4 to 6)||14
6716148|NCT02994394|7645940|FG004|COMPLETED|Period 2 (Days 4 to 6)||13
6716149|NCT02994394|7645941|FG005|COMPLETED|Period 2 (Days 4 to 6)||14
6716150|NCT02994394|7645936|FG000|NOT COMPLETED|Period 2 (Days 4 to 6)||0
6716151|NCT02994394|7645937|FG001|NOT COMPLETED|Period 2 (Days 4 to 6)||1
6716152|NCT02994394|7645938|FG002|NOT COMPLETED|Period 2 (Days 4 to 6)||0
6716153|NCT02994394|7645939|FG003|NOT COMPLETED|Period 2 (Days 4 to 6)||0
6716154|NCT02994394|7645940|FG004|NOT COMPLETED|Period 2 (Days 4 to 6)||1
6716155|NCT02994394|7645941|FG005|NOT COMPLETED|Period 2 (Days 4 to 6)||0
6716156|NCT02994394|7645936|FG000|STARTED|Period 3 (Days 7 and 8)||14
6716157|NCT02994394|7645937|FG001|STARTED|Period 3 (Days 7 and 8)||13
6716158|NCT02994394|7645938|FG002|STARTED|Period 3 (Days 7 and 8)||13
6716159|NCT02994394|7645939|FG003|STARTED|Period 3 (Days 7 and 8)||14
6263157|NCT00943852|7162172|FG004|NOT COMPLETED|First Period of Treatment Intervention||0
6716160|NCT02994394|7645940|FG004|STARTED|Period 3 (Days 7 and 8)||13
6716161|NCT02994394|7645941|FG005|STARTED|Period 3 (Days 7 and 8)||14
6716162|NCT02994394|7645936|FG000|COMPLETED|Period 3 (Days 7 and 8)||14
6716163|NCT02994394|7645937|FG001|COMPLETED|Period 3 (Days 7 and 8)||13
6716164|NCT02994394|7645938|FG002|COMPLETED|Period 3 (Days 7 and 8)||13
6716165|NCT02994394|7645939|FG003|COMPLETED|Period 3 (Days 7 and 8)||14
6716166|NCT02994394|7645940|FG004|COMPLETED|Period 3 (Days 7 and 8)||13
6716167|NCT02994394|7645941|FG005|COMPLETED|Period 3 (Days 7 and 8)||14
6716168|NCT02994394|7645936|FG000|NOT COMPLETED|Period 3 (Days 7 and 8)||0
6716169|NCT02994394|7645937|FG001|NOT COMPLETED|Period 3 (Days 7 and 8)||0
6716170|NCT02994394|7645938|FG002|NOT COMPLETED|Period 3 (Days 7 and 8)||0
6716171|NCT02994394|7645939|FG003|NOT COMPLETED|Period 3 (Days 7 and 8)||0
6716172|NCT02994394|7645940|FG004|NOT COMPLETED|Period 3 (Days 7 and 8)||0
6716173|NCT02994394|7645941|FG005|NOT COMPLETED|Period 3 (Days 7 and 8)||0
6716174|NCT02994654|7645955|FG000|STARTED|Overall Study||12
6716175|NCT02994654|7645955|FG000|COMPLETED|Overall Study||11
6716176|NCT02994654|7645955|FG000|NOT COMPLETED|Overall Study||1
6716177|NCT02994732|7645960|FG000|STARTED|Overall Study|All subjects entered clinic on January 11, 2017|6
6716178|NCT02994732|7645960|FG000|COMPLETED|Overall Study|All subjects were discharged from the clinic by Jan 24, 2017|6
6716179|NCT02994732|7645960|FG000|NOT COMPLETED|Overall Study||0
6716180|NCT02994940|7645967|FG000|STARTED|Overall Study||37
6716181|NCT02994940|7645968|FG001|STARTED|Overall Study||37
6263158|NCT00943852|7162173|FG005|NOT COMPLETED|First Period of Treatment Intervention||0
6263159|NCT00943852|7162174|FG006|NOT COMPLETED|First Period of Treatment Intervention||0
6263160|NCT00943852|7162175|FG007|NOT COMPLETED|First Period of Treatment Intervention||0
6263161|NCT00943852|7162176|FG008|NOT COMPLETED|First Period of Treatment Intervention||0
6263162|NCT00943852|7162177|FG009|NOT COMPLETED|First Period of Treatment Intervention||0
6263163|NCT00943852|7162168|FG000|STARTED|Washout Period After Period 1 Treatment||2
6263164|NCT00943852|7162169|FG001|STARTED|Washout Period After Period 1 Treatment||1
6263165|NCT00943852|7162170|FG002|STARTED|Washout Period After Period 1 Treatment||1
6263166|NCT00943852|7162171|FG003|STARTED|Washout Period After Period 1 Treatment||2
6263167|NCT00943852|7162172|FG004|STARTED|Washout Period After Period 1 Treatment||1
6263168|NCT00943852|7162173|FG005|STARTED|Washout Period After Period 1 Treatment||1
6263169|NCT00943852|7162174|FG006|STARTED|Washout Period After Period 1 Treatment||2
6263170|NCT00943852|7162175|FG007|STARTED|Washout Period After Period 1 Treatment||1
6263171|NCT00943852|7162176|FG008|STARTED|Washout Period After Period 1 Treatment||1
6263172|NCT00943852|7162177|FG009|STARTED|Washout Period After Period 1 Treatment||1
6263173|NCT00943852|7162168|FG000|COMPLETED|Washout Period After Period 1 Treatment||2
6263174|NCT00943852|7162169|FG001|COMPLETED|Washout Period After Period 1 Treatment||1
6263175|NCT00943852|7162170|FG002|COMPLETED|Washout Period After Period 1 Treatment||1
6263176|NCT00943852|7162171|FG003|COMPLETED|Washout Period After Period 1 Treatment||1
6263177|NCT00943852|7162172|FG004|COMPLETED|Washout Period After Period 1 Treatment||1
6263178|NCT00943852|7162173|FG005|COMPLETED|Washout Period After Period 1 Treatment||1
6263179|NCT00943852|7162174|FG006|COMPLETED|Washout Period After Period 1 Treatment||2
6263180|NCT00943852|7162175|FG007|COMPLETED|Washout Period After Period 1 Treatment||1
6263181|NCT00943852|7162176|FG008|COMPLETED|Washout Period After Period 1 Treatment||1
6263182|NCT00943852|7162177|FG009|COMPLETED|Washout Period After Period 1 Treatment||1
6263183|NCT00943852|7162168|FG000|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263184|NCT00943852|7162169|FG001|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263185|NCT00943852|7162170|FG002|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263186|NCT00943852|7162171|FG003|NOT COMPLETED|Washout Period After Period 1 Treatment||1
6263187|NCT00943852|7162172|FG004|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263188|NCT00943852|7162173|FG005|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263189|NCT00943852|7162174|FG006|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263190|NCT00943852|7162175|FG007|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263191|NCT00943852|7162176|FG008|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263192|NCT00943852|7162177|FG009|NOT COMPLETED|Washout Period After Period 1 Treatment||0
6263193|NCT00943852|7162168|FG000|STARTED|Second Period of Treatment Intervention||2
6263194|NCT00943852|7162169|FG001|STARTED|Second Period of Treatment Intervention||1
6263195|NCT00943852|7162170|FG002|STARTED|Second Period of Treatment Intervention||1
6263196|NCT00943852|7162171|FG003|STARTED|Second Period of Treatment Intervention||1
6263197|NCT00943852|7162172|FG004|STARTED|Second Period of Treatment Intervention||1
6263198|NCT00943852|7162173|FG005|STARTED|Second Period of Treatment Intervention||1
6263199|NCT00943852|7162174|FG006|STARTED|Second Period of Treatment Intervention||2
6263200|NCT00943852|7162175|FG007|STARTED|Second Period of Treatment Intervention||1
6263201|NCT00943852|7162176|FG008|STARTED|Second Period of Treatment Intervention||1
6263202|NCT00943852|7162177|FG009|STARTED|Second Period of Treatment Intervention||1
6263203|NCT00943852|7162168|FG000|COMPLETED|Second Period of Treatment Intervention||2
6263204|NCT00943852|7162169|FG001|COMPLETED|Second Period of Treatment Intervention||1
6263205|NCT00943852|7162170|FG002|COMPLETED|Second Period of Treatment Intervention||1
6263206|NCT00943852|7162171|FG003|COMPLETED|Second Period of Treatment Intervention||1
6263207|NCT00943852|7162172|FG004|COMPLETED|Second Period of Treatment Intervention||1
6263208|NCT00943852|7162173|FG005|COMPLETED|Second Period of Treatment Intervention||1
6263209|NCT00943852|7162174|FG006|COMPLETED|Second Period of Treatment Intervention||2
6263210|NCT00943852|7162175|FG007|COMPLETED|Second Period of Treatment Intervention||1
6263211|NCT00943852|7162176|FG008|COMPLETED|Second Period of Treatment Intervention||1
6716182|NCT02994940|7645967|FG000|COMPLETED|Overall Study||30
6716183|NCT02994940|7645968|FG001|COMPLETED|Overall Study||36
6716184|NCT02994940|7645967|FG000|NOT COMPLETED|Overall Study||7
6716185|NCT02994940|7645968|FG001|NOT COMPLETED|Overall Study||1
6716186|NCT02994979|7645976|FG000|STARTED|Overall Study||114
6716187|NCT02994979|7645977|FG001|STARTED|Overall Study||105
6716188|NCT02994979|7645976|FG000|COMPLETED|Overall Study||114
6716189|NCT02994979|7645977|FG001|COMPLETED|Overall Study||105
6716190|NCT02994979|7645976|FG000|NOT COMPLETED|Overall Study||0
6716191|NCT02994979|7645977|FG001|NOT COMPLETED|Overall Study||0
6716192|NCT02995915|7645985|FG000|STARTED|Overall Study||30
6716193|NCT02995915|7645986|FG001|STARTED|Overall Study||15
6716194|NCT02995915|7645985|FG000|COMPLETED|Overall Study||30
6716195|NCT02995915|7645986|FG001|COMPLETED|Overall Study||15
6716196|NCT02995915|7645985|FG000|NOT COMPLETED|Overall Study||0
6716197|NCT02995915|7645986|FG001|NOT COMPLETED|Overall Study||0
6716198|NCT02995980|7645992|FG000|STARTED|Overall Study||128
6716199|NCT02995980|7645992|FG000|COMPLETED|Overall Study||114
6716200|NCT02995980|7645992|FG000|NOT COMPLETED|Overall Study||14
6716201|NCT02996097|7645997|FG000|STARTED|Overall Study||30
6716202|NCT02996097|7645998|FG001|STARTED|Overall Study||30
6716203|NCT02996097|7645997|FG000|Per Protocol Population|Overall Study||22
6716204|NCT02996097|7645998|FG001|Per Protocol Population|Overall Study||22
6716205|NCT02996097|7645997|FG000|COMPLETED|Overall Study||19
6716206|NCT02996097|7645998|FG001|COMPLETED|Overall Study||19
6716207|NCT02996097|7645997|FG000|NOT COMPLETED|Overall Study||11
6716208|NCT02996097|7645998|FG001|NOT COMPLETED|Overall Study||11
6263212|NCT00943852|7162177|FG009|COMPLETED|Second Period of Treatment Intervention||1
6263213|NCT00943852|7162168|FG000|NOT COMPLETED|Second Period of Treatment Intervention||0
6263214|NCT00943852|7162169|FG001|NOT COMPLETED|Second Period of Treatment Intervention||0
6263215|NCT00943852|7162170|FG002|NOT COMPLETED|Second Period of Treatment Intervention||0
6716209|NCT02996448|7646003|FG000|STARTED|Overall Study||3
6716210|NCT02996448|7646003|FG000|COMPLETED|Overall Study||0
6716211|NCT02996448|7646003|FG000|NOT COMPLETED|Overall Study||3
6716212|NCT02996474|7646008|FG000|STARTED|Overall Study||10
6716213|NCT02996474|7646008|FG000|COMPLETED|Overall Study||5
6716214|NCT02996474|7646008|FG000|NOT COMPLETED|Overall Study||5
6716215|NCT02996500|7646018|FG000|STARTED|Overall Study||39
6716216|NCT02996500|7646019|FG001|STARTED|Overall Study||43
6716217|NCT02996500|7646020|FG002|STARTED|Overall Study||39
6716218|NCT02996500|7646021|FG003|STARTED|Overall Study||50
6716219|NCT02996500|7646022|FG004|STARTED|Overall Study||50
6716220|NCT02996500|7646023|FG005|STARTED|Overall Study||48
6716221|NCT02996500|7646018|FG000|COMPLETED|Overall Study||31
6716222|NCT02996500|7646019|FG001|COMPLETED|Overall Study||42
6716223|NCT02996500|7646020|FG002|COMPLETED|Overall Study||29
6716224|NCT02996500|7646021|FG003|COMPLETED|Overall Study||46
6716225|NCT02996500|7646022|FG004|COMPLETED|Overall Study||45
6716226|NCT02996500|7646023|FG005|COMPLETED|Overall Study||44
6716227|NCT02996500|7646018|FG000|NOT COMPLETED|Overall Study||8
6716228|NCT02996500|7646019|FG001|NOT COMPLETED|Overall Study||1
6716229|NCT02996500|7646020|FG002|NOT COMPLETED|Overall Study||10
6716230|NCT02996500|7646021|FG003|NOT COMPLETED|Overall Study||4
6716231|NCT02996500|7646022|FG004|NOT COMPLETED|Overall Study||5
6716232|NCT02996500|7646023|FG005|NOT COMPLETED|Overall Study||4
6716233|NCT02996591|7646043|FG000|STARTED|Overall Study||18
6716234|NCT02996591|7646044|FG001|STARTED|Overall Study||18
6716235|NCT02996591|7646043|FG000|COMPLETED|Overall Study||18
6716236|NCT02996591|7646044|FG001|COMPLETED|Overall Study||18
6716237|NCT02996591|7646043|FG000|NOT COMPLETED|Overall Study||0
6716238|NCT02996591|7646044|FG001|NOT COMPLETED|Overall Study||0
6716239|NCT02996682|7646052|FG000|STARTED|Overall Study||51
6716240|NCT02996682|7646053|FG001|STARTED|Overall Study||51
6716241|NCT02996682|7646052|FG000|COMPLETED|Overall Study||51
6716242|NCT02996682|7646053|FG001|COMPLETED|Overall Study||48
6716243|NCT02996682|7646052|FG000|NOT COMPLETED|Overall Study||0
6716244|NCT02996682|7646053|FG001|NOT COMPLETED|Overall Study||3
6716245|NCT02996864|7646061|FG000|STARTED|Overall Study||150
6716246|NCT02996864|7646062|FG001|STARTED|Overall Study||150
6716247|NCT02996864|7646061|FG000|COMPLETED|Overall Study||142
6716248|NCT02996864|7646062|FG001|COMPLETED|Overall Study||136
6716249|NCT02996864|7646061|FG000|NOT COMPLETED|Overall Study||8
6716250|NCT02996864|7646062|FG001|NOT COMPLETED|Overall Study||14
6716251|NCT02996968|7646070|FG000|STARTED|Overall Study||79
6716252|NCT02996968|7646071|FG001|STARTED|Overall Study||79
6716253|NCT02996968|7646070|FG000|COMPLETED|Overall Study||78
6716254|NCT02996968|7646071|FG001|COMPLETED|Overall Study||79
6716255|NCT02996968|7646070|FG000|NOT COMPLETED|Overall Study||1
6716256|NCT02996968|7646071|FG001|NOT COMPLETED|Overall Study||0
6716257|NCT02997085|7646080|FG000|STARTED|Overall Study||34
6716258|NCT02997085|7646081|FG001|STARTED|Overall Study||35
6716259|NCT02997085|7646082|FG002|STARTED|Overall Study||34
6716260|NCT02997085|7646080|FG000|COMPLETED|Overall Study||34
6716261|NCT02997085|7646081|FG001|COMPLETED|Overall Study||35
6716262|NCT02997085|7646082|FG002|COMPLETED|Overall Study||34
6716263|NCT02997085|7646080|FG000|NOT COMPLETED|Overall Study||0
6716264|NCT02997085|7646081|FG001|NOT COMPLETED|Overall Study||0
6716265|NCT02997085|7646082|FG002|NOT COMPLETED|Overall Study||0
6716266|NCT02997163|7646093|FG000|STARTED|Overall Study||9
6716267|NCT02997163|7646094|FG001|STARTED|Overall Study||9
6716268|NCT02997163|7646095|FG002|STARTED|Overall Study||8
6716269|NCT02997163|7646096|FG003|STARTED|Overall Study||8
6716270|NCT02997163|7646093|FG000|COMPLETED|Overall Study||8
6716271|NCT02997163|7646094|FG001|COMPLETED|Overall Study||9
6716272|NCT02997163|7646095|FG002|COMPLETED|Overall Study||8
6716273|NCT02997163|7646096|FG003|COMPLETED|Overall Study||7
6716274|NCT02997163|7646093|FG000|NOT COMPLETED|Overall Study||1
6716275|NCT02997163|7646094|FG001|NOT COMPLETED|Overall Study||0
6716276|NCT02997163|7646095|FG002|NOT COMPLETED|Overall Study||0
6716277|NCT02997163|7646096|FG003|NOT COMPLETED|Overall Study||1
6263216|NCT00943852|7162171|FG003|NOT COMPLETED|Second Period of Treatment Intervention||0
6263217|NCT00943852|7162172|FG004|NOT COMPLETED|Second Period of Treatment Intervention||0
6263218|NCT00943852|7162173|FG005|NOT COMPLETED|Second Period of Treatment Intervention||0
6263219|NCT00943852|7162174|FG006|NOT COMPLETED|Second Period of Treatment Intervention||0
6263220|NCT00943852|7162175|FG007|NOT COMPLETED|Second Period of Treatment Intervention||0
6263221|NCT00943852|7162176|FG008|NOT COMPLETED|Second Period of Treatment Intervention||0
6263222|NCT00943852|7162177|FG009|NOT COMPLETED|Second Period of Treatment Intervention||0
6263223|NCT00943852|7162168|FG000|STARTED|Washout Period After Period 2 Treatment||2
6263224|NCT00943852|7162169|FG001|STARTED|Washout Period After Period 2 Treatment||1
6263225|NCT00943852|7162170|FG002|STARTED|Washout Period After Period 2 Treatment||1
6263226|NCT00943852|7162171|FG003|STARTED|Washout Period After Period 2 Treatment||1
6263227|NCT00943852|7162172|FG004|STARTED|Washout Period After Period 2 Treatment||1
6263228|NCT00943852|7162173|FG005|STARTED|Washout Period After Period 2 Treatment||1
6263229|NCT00943852|7162174|FG006|STARTED|Washout Period After Period 2 Treatment||2
6263230|NCT00943852|7162175|FG007|STARTED|Washout Period After Period 2 Treatment||1
6263231|NCT00943852|7162176|FG008|STARTED|Washout Period After Period 2 Treatment||1
6263232|NCT00943852|7162177|FG009|STARTED|Washout Period After Period 2 Treatment||1
6263233|NCT00943852|7162168|FG000|COMPLETED|Washout Period After Period 2 Treatment||2
6263234|NCT00943852|7162169|FG001|COMPLETED|Washout Period After Period 2 Treatment||1
6263235|NCT00943852|7162170|FG002|COMPLETED|Washout Period After Period 2 Treatment||1
6263236|NCT00943852|7162171|FG003|COMPLETED|Washout Period After Period 2 Treatment||1
6263237|NCT00943852|7162172|FG004|COMPLETED|Washout Period After Period 2 Treatment||1
6263238|NCT00943852|7162173|FG005|COMPLETED|Washout Period After Period 2 Treatment||0
6263239|NCT00943852|7162174|FG006|COMPLETED|Washout Period After Period 2 Treatment||2
6263240|NCT00943852|7162175|FG007|COMPLETED|Washout Period After Period 2 Treatment||1
6263241|NCT00943852|7162176|FG008|COMPLETED|Washout Period After Period 2 Treatment||1
6263242|NCT00943852|7162177|FG009|COMPLETED|Washout Period After Period 2 Treatment||1
6263243|NCT00943852|7162168|FG000|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263244|NCT00943852|7162169|FG001|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263245|NCT00943852|7162170|FG002|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263246|NCT00943852|7162171|FG003|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263247|NCT00943852|7162172|FG004|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263248|NCT00943852|7162173|FG005|NOT COMPLETED|Washout Period After Period 2 Treatment||1
6263249|NCT00943852|7162174|FG006|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263250|NCT00943852|7162175|FG007|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263251|NCT00943852|7162176|FG008|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263252|NCT00943852|7162177|FG009|NOT COMPLETED|Washout Period After Period 2 Treatment||0
6263253|NCT00943852|7162168|FG000|STARTED|Third Period of Treatment Intervention||2
6263254|NCT00943852|7162169|FG001|STARTED|Third Period of Treatment Intervention||1
6263255|NCT00943852|7162170|FG002|STARTED|Third Period of Treatment Intervention||1
6263256|NCT00943852|7162171|FG003|STARTED|Third Period of Treatment Intervention||1
6263257|NCT00943852|7162172|FG004|STARTED|Third Period of Treatment Intervention||1
6263258|NCT00943852|7162173|FG005|STARTED|Third Period of Treatment Intervention||0
6263259|NCT00943852|7162174|FG006|STARTED|Third Period of Treatment Intervention||2
6263260|NCT00943852|7162175|FG007|STARTED|Third Period of Treatment Intervention||1
6263261|NCT00943852|7162176|FG008|STARTED|Third Period of Treatment Intervention||1
6263262|NCT00943852|7162177|FG009|STARTED|Third Period of Treatment Intervention||1
6263263|NCT00943852|7162168|FG000|COMPLETED|Third Period of Treatment Intervention||2
6263264|NCT00943852|7162169|FG001|COMPLETED|Third Period of Treatment Intervention||1
6263265|NCT00943852|7162170|FG002|COMPLETED|Third Period of Treatment Intervention||1
6263266|NCT00943852|7162171|FG003|COMPLETED|Third Period of Treatment Intervention||1
6263267|NCT00943852|7162172|FG004|COMPLETED|Third Period of Treatment Intervention||1
6263268|NCT00943852|7162173|FG005|COMPLETED|Third Period of Treatment Intervention||0
6263269|NCT00943852|7162174|FG006|COMPLETED|Third Period of Treatment Intervention||2
6263270|NCT00943852|7162175|FG007|COMPLETED|Third Period of Treatment Intervention||1
6263271|NCT00943852|7162176|FG008|COMPLETED|Third Period of Treatment Intervention||1
6263272|NCT00943852|7162177|FG009|COMPLETED|Third Period of Treatment Intervention||1
6263273|NCT00943852|7162168|FG000|NOT COMPLETED|Third Period of Treatment Intervention||0
6263274|NCT00943852|7162169|FG001|NOT COMPLETED|Third Period of Treatment Intervention||0
6263275|NCT00943852|7162170|FG002|NOT COMPLETED|Third Period of Treatment Intervention||0
6263276|NCT00943852|7162171|FG003|NOT COMPLETED|Third Period of Treatment Intervention||0
6263277|NCT00943852|7162172|FG004|NOT COMPLETED|Third Period of Treatment Intervention||0
6263278|NCT00943852|7162173|FG005|NOT COMPLETED|Third Period of Treatment Intervention||0
6263279|NCT00943852|7162174|FG006|NOT COMPLETED|Third Period of Treatment Intervention||0
6263280|NCT00943852|7162175|FG007|NOT COMPLETED|Third Period of Treatment Intervention||0
6263281|NCT00943852|7162176|FG008|NOT COMPLETED|Third Period of Treatment Intervention||0
6263282|NCT00943852|7162177|FG009|NOT COMPLETED|Third Period of Treatment Intervention||0
6263283|NCT00943852|7162168|FG000|STARTED|Washout Period After Period 3 Treatment||2
6263284|NCT00943852|7162169|FG001|STARTED|Washout Period After Period 3 Treatment||1
6716278|NCT02997176|7646110|FG000|STARTED|Overall Study||7
6716279|NCT02997176|7646111|FG001|STARTED|Overall Study||10
6716280|NCT02997176|7646112|FG002|STARTED|Overall Study||5
6716281|NCT02997176|7646113|FG003|STARTED|Overall Study||16
6716282|NCT02997176|7646110|FG000|COMPLETED|Overall Study||6
6716283|NCT02997176|7646111|FG001|COMPLETED|Overall Study||8
6716284|NCT02997176|7646112|FG002|COMPLETED|Overall Study||3
6716285|NCT02997176|7646113|FG003|COMPLETED|Overall Study||5
6716286|NCT02997176|7646110|FG000|NOT COMPLETED|Overall Study||1
6716287|NCT02997176|7646111|FG001|NOT COMPLETED|Overall Study||2
6716288|NCT02997176|7646112|FG002|NOT COMPLETED|Overall Study||2
6716289|NCT02997176|7646113|FG003|NOT COMPLETED|Overall Study||11
6716290|NCT02997722|7646125|FG000|STARTED|Overall Study||3
6716291|NCT02997722|7646126|FG001|STARTED|Overall Study||1
6716292|NCT02997722|7646125|FG000|COMPLETED|Overall Study||3
6716293|NCT02997722|7646126|FG001|COMPLETED|Overall Study||1
6716294|NCT02997722|7646125|FG000|NOT COMPLETED|Overall Study||0
6716295|NCT02997722|7646126|FG001|NOT COMPLETED|Overall Study||0
6716296|NCT02997735|7646134|FG000|STARTED|Overall Study||233
6716297|NCT02997735|7646135|FG001|STARTED|Overall Study||251
6716298|NCT02997735|7646134|FG000|COMPLETED|Overall Study||233
6716299|NCT02997735|7646135|FG001|COMPLETED|Overall Study||251
6716300|NCT02997735|7646134|FG000|NOT COMPLETED|Overall Study||0
6716301|NCT02997735|7646135|FG001|NOT COMPLETED|Overall Study||0
6716302|NCT02997904|7646143|FG000|STARTED|Overall Study||51
6716303|NCT02997904|7646144|FG001|STARTED|Overall Study||49
6716304|NCT02997904|7646143|FG000|COMPLETED|Overall Study||51
6716305|NCT02997904|7646144|FG001|COMPLETED|Overall Study||49
6716306|NCT02997904|7646143|FG000|NOT COMPLETED|Overall Study||0
6716307|NCT02997904|7646144|FG001|NOT COMPLETED|Overall Study||0
6716308|NCT02998021|7646156|FG000|STARTED|Overall Study||8
6716309|NCT02998021|7646157|FG001|STARTED|Overall Study||2
6716310|NCT02998021|7646156|FG000|COMPLETED|Overall Study||5
6716311|NCT02998021|7646157|FG001|COMPLETED|Overall Study||0
6716312|NCT02998021|7646156|FG000|NOT COMPLETED|Overall Study||3
6716313|NCT02998021|7646157|FG001|NOT COMPLETED|Overall Study||2
6716314|NCT02998151|7646163|FG000|STARTED|Overall Study||29
6716315|NCT02998151|7646163|FG000|Placebo|Overall Study|Two participants withdrew from the study before receiving placebo.|27
6716316|NCT02998151|7646163|FG000|Acamprosate|Overall Study|Every participant received acamprosate prior to acamprosate's discontinuance.|16
6716317|NCT02998151|7646163|FG000|Lovastatin|Overall Study|All participants received lovastatin.|29
6716318|NCT02998151|7646163|FG000|Minocycline|Overall Study|Two participants withdrew from the study before receiving minocycline.|27
6263285|NCT00943852|7162170|FG002|STARTED|Washout Period After Period 3 Treatment||1
6263286|NCT00943852|7162171|FG003|STARTED|Washout Period After Period 3 Treatment||1
6263287|NCT00943852|7162172|FG004|STARTED|Washout Period After Period 3 Treatment||1
6263288|NCT00943852|7162173|FG005|STARTED|Washout Period After Period 3 Treatment||0
6263289|NCT00943852|7162174|FG006|STARTED|Washout Period After Period 3 Treatment||2
6263290|NCT00943852|7162175|FG007|STARTED|Washout Period After Period 3 Treatment||1
6263291|NCT00943852|7162176|FG008|STARTED|Washout Period After Period 3 Treatment||1
6263292|NCT00943852|7162177|FG009|STARTED|Washout Period After Period 3 Treatment||1
6263293|NCT00943852|7162168|FG000|COMPLETED|Washout Period After Period 3 Treatment||2
6263294|NCT00943852|7162169|FG001|COMPLETED|Washout Period After Period 3 Treatment||1
6263295|NCT00943852|7162170|FG002|COMPLETED|Washout Period After Period 3 Treatment||1
6263296|NCT00943852|7162171|FG003|COMPLETED|Washout Period After Period 3 Treatment||1
6263297|NCT00943852|7162172|FG004|COMPLETED|Washout Period After Period 3 Treatment||1
6263298|NCT00943852|7162173|FG005|COMPLETED|Washout Period After Period 3 Treatment||0
6263299|NCT00943852|7162174|FG006|COMPLETED|Washout Period After Period 3 Treatment||1
6263300|NCT00943852|7162175|FG007|COMPLETED|Washout Period After Period 3 Treatment||1
6263301|NCT00943852|7162176|FG008|COMPLETED|Washout Period After Period 3 Treatment||1
6263302|NCT00943852|7162177|FG009|COMPLETED|Washout Period After Period 3 Treatment||1
6263303|NCT00943852|7162168|FG000|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263304|NCT00943852|7162169|FG001|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263305|NCT00943852|7162170|FG002|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263306|NCT00943852|7162171|FG003|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263307|NCT00943852|7162172|FG004|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263308|NCT00943852|7162173|FG005|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263309|NCT00943852|7162174|FG006|NOT COMPLETED|Washout Period After Period 3 Treatment||1
6263310|NCT00943852|7162175|FG007|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263311|NCT00943852|7162176|FG008|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263312|NCT00943852|7162177|FG009|NOT COMPLETED|Washout Period After Period 3 Treatment||0
6263313|NCT00943852|7162168|FG000|STARTED|Fourth Period of Treatment Intervention||2
6263314|NCT00943852|7162169|FG001|STARTED|Fourth Period of Treatment Intervention||1
6263315|NCT00943852|7162170|FG002|STARTED|Fourth Period of Treatment Intervention||1
6263316|NCT00943852|7162171|FG003|STARTED|Fourth Period of Treatment Intervention||1
6263317|NCT00943852|7162172|FG004|STARTED|Fourth Period of Treatment Intervention||1
6263318|NCT00943852|7162173|FG005|STARTED|Fourth Period of Treatment Intervention||0
6263319|NCT00943852|7162174|FG006|STARTED|Fourth Period of Treatment Intervention||1
6263320|NCT00943852|7162175|FG007|STARTED|Fourth Period of Treatment Intervention||1
6716319|NCT02998151|7646163|FG000|Baclofen|Overall Study|All 13 remaining participants received baclofen after acamprosate was discontinued. Five participants were re-enrolled to receive baclofen.|18
6739504|NCT03291197|7668389|FG000|STARTED|Overall Study||5
6716320|NCT02998151|7646163|FG000|COMPLETED|Overall Study|Acamprosate was discontinued mid-study due to undetectable serum levels and replaced with baclofen. Participants who already completed acamprosate were given the option to re-enroll and receive baclofen. Five participants received all 5 interventions; 26 received 4+ interventions.|5
6716321|NCT02998151|7646163|FG000|NOT COMPLETED|Overall Study||24
6716322|NCT02998541|7646178|FG000|STARTED|Overall Study||86
6716323|NCT02998541|7646179|FG001|STARTED|Overall Study||90
6716324|NCT02998541|7646180|FG002|STARTED|Overall Study||43
6716325|NCT02998541|7646178|FG000|COMPLETED|Overall Study||78
6716326|NCT02998541|7646179|FG001|COMPLETED|Overall Study||81
6716327|NCT02998541|7646180|FG002|COMPLETED|Overall Study||37
6716328|NCT02998541|7646178|FG000|NOT COMPLETED|Overall Study||8
6716329|NCT02998541|7646179|FG001|NOT COMPLETED|Overall Study||9
6716330|NCT02998541|7646180|FG002|NOT COMPLETED|Overall Study||6
6716331|NCT02998554|7646190|FG000|STARTED|Overall Study||79
6716332|NCT02998554|7646191|FG001|STARTED|Overall Study||77
6716333|NCT02998554|7646190|FG000|COMPLETED|Overall Study||68
6716334|NCT02998554|7646191|FG001|COMPLETED|Overall Study||66
6716335|NCT02998554|7646190|FG000|NOT COMPLETED|Overall Study||11
6716336|NCT02998554|7646191|FG001|NOT COMPLETED|Overall Study||11
6716337|NCT02998671|7646204|FG000|STARTED|Period 1||21
6716338|NCT02998671|7646205|FG001|STARTED|Period 1||13
6716339|NCT02998671|7646206|FG002|STARTED|Period 1||6
6716340|NCT02998671|7646207|FG003|STARTED|Period 1||8
6716341|NCT02998671|7646208|FG004|STARTED|Period 1||4
6716342|NCT02998671|7646204|FG000|COMPLETED|Period 1||17
6716343|NCT02998671|7646205|FG001|COMPLETED|Period 1||10
6716344|NCT02998671|7646206|FG002|COMPLETED|Period 1||6
6716345|NCT02998671|7646207|FG003|COMPLETED|Period 1||8
6716346|NCT02998671|7646208|FG004|COMPLETED|Period 1||0
6716347|NCT02998671|7646204|FG000|NOT COMPLETED|Period 1||4
6716348|NCT02998671|7646205|FG001|NOT COMPLETED|Period 1||3
6716349|NCT02998671|7646206|FG002|NOT COMPLETED|Period 1||0
6716350|NCT02998671|7646207|FG003|NOT COMPLETED|Period 1||0
6716351|NCT02998671|7646208|FG004|NOT COMPLETED|Period 1||4
6716352|NCT02998671|7646204|FG000|STARTED|Period 2||17
6716353|NCT02998671|7646205|FG001|STARTED|Period 2||10
6716354|NCT02998671|7646206|FG002|STARTED|Period 2||6
6716355|NCT02998671|7646207|FG003|STARTED|Period 2||8
6716356|NCT02998671|7646208|FG004|STARTED|Period 2||0
6716357|NCT02998671|7646204|FG000|COMPLETED|Period 2||14
6716358|NCT02998671|7646205|FG001|COMPLETED|Period 2||3
6716359|NCT02998671|7646206|FG002|COMPLETED|Period 2||5
6716360|NCT02998671|7646207|FG003|COMPLETED|Period 2||4
6716361|NCT02998671|7646208|FG004|COMPLETED|Period 2||0
6716362|NCT02998671|7646204|FG000|NOT COMPLETED|Period 2||3
6716363|NCT02998671|7646205|FG001|NOT COMPLETED|Period 2||7
6716364|NCT02998671|7646206|FG002|NOT COMPLETED|Period 2||1
6716365|NCT02998671|7646207|FG003|NOT COMPLETED|Period 2||4
6716366|NCT02998671|7646208|FG004|NOT COMPLETED|Period 2||0
6716367|NCT02998684|7646230|FG000|STARTED|Overall Study||7
6716368|NCT02998684|7646231|FG001|STARTED|Overall Study||7
6716369|NCT02998684|7646230|FG000|COMPLETED|Overall Study||4
6716370|NCT02998684|7646231|FG001|COMPLETED|Overall Study||6
6716371|NCT02998684|7646230|FG000|NOT COMPLETED|Overall Study||3
6716372|NCT02998684|7646231|FG001|NOT COMPLETED|Overall Study||1
6716373|NCT02998996|7646243|FG000|STARTED|Overall Study||36
6716374|NCT02998996|7646244|FG001|STARTED|Overall Study||35
6716375|NCT02998996|7646245|FG002|STARTED|Overall Study||36
6716376|NCT02998996|7646246|FG003|STARTED|Overall Study||18
6716377|NCT02998996|7646247|FG004|STARTED|Overall Study||18
6716378|NCT02998996|7646248|FG005|STARTED|Overall Study||19
6716379|NCT02998996|7646243|FG000|COMPLETED|Overall Study||36
6716380|NCT02998996|7646244|FG001|COMPLETED|Overall Study||34
6716381|NCT02998996|7646245|FG002|COMPLETED|Overall Study||35
6716382|NCT02998996|7646246|FG003|COMPLETED|Overall Study||18
6716383|NCT02998996|7646247|FG004|COMPLETED|Overall Study||17
6716384|NCT02998996|7646248|FG005|COMPLETED|Overall Study||19
6716385|NCT02998996|7646243|FG000|NOT COMPLETED|Overall Study||0
6716386|NCT02998996|7646244|FG001|NOT COMPLETED|Overall Study||1
6716387|NCT02998996|7646245|FG002|NOT COMPLETED|Overall Study||1
6716388|NCT02998996|7646246|FG003|NOT COMPLETED|Overall Study||0
6716389|NCT02998996|7646247|FG004|NOT COMPLETED|Overall Study||1
6716390|NCT02998996|7646248|FG005|NOT COMPLETED|Overall Study||0
6716391|NCT02999100|7646268|FG000|STARTED|Part 1 (up to 15 Days)||9
6716392|NCT02999100|7646269|FG001|STARTED|Part 1 (up to 15 Days)||8
6716393|NCT02999100|7646270|FG002|STARTED|Part 1 (up to 15 Days)||0
6716394|NCT02999100|7646271|FG003|STARTED|Part 1 (up to 15 Days)||0
6716395|NCT02999100|7646272|FG004|STARTED|Part 1 (up to 15 Days)||0
6716396|NCT02999100|7646273|FG005|STARTED|Part 1 (up to 15 Days)||0
6716397|NCT02999100|7646268|FG000|COMPLETED|Part 1 (up to 15 Days)||9
6716398|NCT02999100|7646269|FG001|COMPLETED|Part 1 (up to 15 Days)||7
6716399|NCT02999100|7646270|FG002|COMPLETED|Part 1 (up to 15 Days)||0
6716400|NCT02999100|7646271|FG003|COMPLETED|Part 1 (up to 15 Days)||0
6716401|NCT02999100|7646272|FG004|COMPLETED|Part 1 (up to 15 Days)||0
6716402|NCT02999100|7646273|FG005|COMPLETED|Part 1 (up to 15 Days)||0
6280416|NCT00156247|7180352|FG000|COMPLETED|Overall Study||5
6716403|NCT02999100|7646268|FG000|NOT COMPLETED|Part 1 (up to 15 Days)||0
6716404|NCT02999100|7646269|FG001|NOT COMPLETED|Part 1 (up to 15 Days)||1
6716405|NCT02999100|7646270|FG002|NOT COMPLETED|Part 1 (up to 15 Days)||0
6716406|NCT02999100|7646271|FG003|NOT COMPLETED|Part 1 (up to 15 Days)||0
6716407|NCT02999100|7646272|FG004|NOT COMPLETED|Part 1 (up to 15 Days)||0
6716408|NCT02999100|7646273|FG005|NOT COMPLETED|Part 1 (up to 15 Days)||0
6716409|NCT02999100|7646268|FG000|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
6716410|NCT02999100|7646269|FG001|STARTED|Part 2 (Day 1): Dosing Session 1|Participants from Part 1 did not enter Part 2|0
6716411|NCT02999100|7646270|FG002|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|5
6716412|NCT02999100|7646271|FG003|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
6716413|NCT02999100|7646272|FG004|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
6716414|NCT02999100|7646273|FG005|STARTED|Part 2 (Day 1): Dosing Session 1|New participants were enrolled in Part 2 of study|3
6716415|NCT02999100|7646268|FG000|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6716416|NCT02999100|7646269|FG001|COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6716417|NCT02999100|7646270|FG002|COMPLETED|Part 2 (Day 1): Dosing Session 1||4
6716418|NCT02999100|7646271|FG003|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
6716419|NCT02999100|7646272|FG004|COMPLETED|Part 2 (Day 1): Dosing Session 1||3
6716420|NCT02999100|7646273|FG005|COMPLETED|Part 2 (Day 1): Dosing Session 1||2
6716421|NCT02999100|7646268|FG000|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6716422|NCT02999100|7646269|FG001|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6716423|NCT02999100|7646270|FG002|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
6716424|NCT02999100|7646271|FG003|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6716425|NCT02999100|7646272|FG004|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||0
6716426|NCT02999100|7646273|FG005|NOT COMPLETED|Part 2 (Day 1): Dosing Session 1||1
6716427|NCT02999100|7646268|FG000|STARTED|Part 2 (Day 14): Dosing Session 2||0
6716428|NCT02999100|7646269|FG001|STARTED|Part 2 (Day 14): Dosing Session 2||0
6716429|NCT02999100|7646270|FG002|STARTED|Part 2 (Day 14): Dosing Session 2||4
6716430|NCT02999100|7646271|FG003|STARTED|Part 2 (Day 14): Dosing Session 2||3
6716431|NCT02999100|7646272|FG004|STARTED|Part 2 (Day 14): Dosing Session 2||3
6716432|NCT02999100|7646273|FG005|STARTED|Part 2 (Day 14): Dosing Session 2||2
6716433|NCT02999100|7646268|FG000|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6716434|NCT02999100|7646269|FG001|COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6716435|NCT02999100|7646270|FG002|COMPLETED|Part 2 (Day 14): Dosing Session 2||4
6716436|NCT02999100|7646271|FG003|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
6716437|NCT02999100|7646272|FG004|COMPLETED|Part 2 (Day 14): Dosing Session 2||3
6716438|NCT02999100|7646273|FG005|COMPLETED|Part 2 (Day 14): Dosing Session 2||2
6716439|NCT02999100|7646268|FG000|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6716440|NCT02999100|7646269|FG001|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6716441|NCT02999100|7646270|FG002|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6716442|NCT02999100|7646271|FG003|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6716443|NCT02999100|7646272|FG004|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6716444|NCT02999100|7646273|FG005|NOT COMPLETED|Part 2 (Day 14): Dosing Session 2||0
6716445|NCT02999178|7646297|FG000|STARTED|Overall Study||332
6716446|NCT02999178|7646298|FG001|STARTED|Overall Study||331
6716447|NCT02999178|7646297|FG000|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|218
6716448|NCT02999178|7646298|FG001|COMPLETED|Overall Study|On treatment at analysis cut-off date, 12-August-2019|231
6716449|NCT02999178|7646297|FG000|NOT COMPLETED|Overall Study||114
6716450|NCT02999178|7646298|FG001|NOT COMPLETED|Overall Study||100
6716451|NCT02999191|7646307|FG000|STARTED|Treatment Period 1 [1 Day]||6
6716452|NCT02999191|7646308|FG001|STARTED|Treatment Period 1 [1 Day]||6
6716453|NCT02999191|7646309|FG002|STARTED|Treatment Period 1 [1 Day]||6
6716454|NCT02999191|7646307|FG000|COMPLETED|Treatment Period 1 [1 Day]||6
6716455|NCT02999191|7646308|FG001|COMPLETED|Treatment Period 1 [1 Day]||6
6716456|NCT02999191|7646309|FG002|COMPLETED|Treatment Period 1 [1 Day]||6
6716457|NCT02999191|7646307|FG000|NOT COMPLETED|Treatment Period 1 [1 Day]||0
6716458|NCT02999191|7646308|FG001|NOT COMPLETED|Treatment Period 1 [1 Day]||0
6716459|NCT02999191|7646309|FG002|NOT COMPLETED|Treatment Period 1 [1 Day]||0
6716460|NCT02999191|7646307|FG000|STARTED|Wash-out Period 1 [21 Days]||6
6716461|NCT02999191|7646308|FG001|STARTED|Wash-out Period 1 [21 Days]||6
6716462|NCT02999191|7646309|FG002|STARTED|Wash-out Period 1 [21 Days]||6
6716463|NCT02999191|7646307|FG000|COMPLETED|Wash-out Period 1 [21 Days]||6
6716464|NCT02999191|7646308|FG001|COMPLETED|Wash-out Period 1 [21 Days]||5
6716465|NCT02999191|7646309|FG002|COMPLETED|Wash-out Period 1 [21 Days]||6
6716466|NCT02999191|7646307|FG000|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
6716467|NCT02999191|7646308|FG001|NOT COMPLETED|Wash-out Period 1 [21 Days]||1
6716468|NCT02999191|7646309|FG002|NOT COMPLETED|Wash-out Period 1 [21 Days]||0
6716469|NCT02999191|7646307|FG000|STARTED|Treatment Period 2 [1 Day]||6
6716470|NCT02999191|7646308|FG001|STARTED|Treatment Period 2 [1 Day]||5
6716471|NCT02999191|7646309|FG002|STARTED|Treatment Period 2 [1 Day]||6
6716472|NCT02999191|7646307|FG000|COMPLETED|Treatment Period 2 [1 Day]||6
6716473|NCT02999191|7646308|FG001|COMPLETED|Treatment Period 2 [1 Day]||5
6716474|NCT02999191|7646309|FG002|COMPLETED|Treatment Period 2 [1 Day]||6
6716475|NCT02999191|7646307|FG000|NOT COMPLETED|Treatment Period 2 [1 Day]||0
6716476|NCT02999191|7646308|FG001|NOT COMPLETED|Treatment Period 2 [1 Day]||0
6716477|NCT02999191|7646309|FG002|NOT COMPLETED|Treatment Period 2 [1 Day]||0
6716478|NCT02999191|7646307|FG000|STARTED|Wash-out Period 2 [21 Days]||6
6716479|NCT02999191|7646308|FG001|STARTED|Wash-out Period 2 [21 Days]||5
6716480|NCT02999191|7646309|FG002|STARTED|Wash-out Period 2 [21 Days]||6
6716481|NCT02999191|7646307|FG000|COMPLETED|Wash-out Period 2 [21 Days]||6
6716482|NCT02999191|7646308|FG001|COMPLETED|Wash-out Period 2 [21 Days]||5
6716483|NCT02999191|7646309|FG002|COMPLETED|Wash-out Period 2 [21 Days]||6
6716484|NCT02999191|7646307|FG000|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
6716485|NCT02999191|7646308|FG001|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
6716486|NCT02999191|7646309|FG002|NOT COMPLETED|Wash-out Period 2 [21 Days]||0
6716487|NCT02999191|7646307|FG000|STARTED|Treatment Period 3 [1 Day]||6
6716488|NCT02999191|7646308|FG001|STARTED|Treatment Period 3 [1 Day]||6
6716489|NCT02999191|7646309|FG002|STARTED|Treatment Period 3 [1 Day]||6
6716490|NCT02999191|7646307|FG000|COMPLETED|Treatment Period 3 [1 Day]||6
6716491|NCT02999191|7646308|FG001|COMPLETED|Treatment Period 3 [1 Day]||6
6716492|NCT02999191|7646309|FG002|COMPLETED|Treatment Period 3 [1 Day]||6
6716493|NCT02999191|7646307|FG000|NOT COMPLETED|Treatment Period 3 [1 Day]||0
6716494|NCT02999191|7646308|FG001|NOT COMPLETED|Treatment Period 3 [1 Day]||0
6716495|NCT02999191|7646309|FG002|NOT COMPLETED|Treatment Period 3 [1 Day]||0
6716496|NCT02999672|7646319|FG000|STARTED|Overall Study||13
6716497|NCT02999672|7646320|FG001|STARTED|Overall Study||7
6716498|NCT02999672|7646319|FG000|COMPLETED|Overall Study||0
6716499|NCT02999672|7646320|FG001|COMPLETED|Overall Study||0
6716500|NCT02999672|7646319|FG000|NOT COMPLETED|Overall Study||13
6716501|NCT02999672|7646320|FG001|NOT COMPLETED|Overall Study||7
6716502|NCT02999763|7646326|FG000|STARTED|Overall Study||70
6716503|NCT02999763|7646326|FG000|COMPLETED|Overall Study||58
6716504|NCT02999763|7646326|FG000|NOT COMPLETED|Overall Study||12
6716505|NCT03000010|7646332|FG000|STARTED|Overall Study||21
6716506|NCT03000010|7646333|FG001|STARTED|Overall Study||20
6716507|NCT03000010|7646332|FG000|COMPLETED|Overall Study||21
6716508|NCT03000010|7646333|FG001|COMPLETED|Overall Study||20
6716509|NCT03000010|7646332|FG000|NOT COMPLETED|Overall Study||0
6716510|NCT03000010|7646333|FG001|NOT COMPLETED|Overall Study||0
6716511|NCT03000075|7646342|FG000|STARTED|Part A||58
6716512|NCT03000075|7646343|FG001|STARTED|Part A||58
6716513|NCT03000075|7646344|FG002|STARTED|Part A||55
6716514|NCT03000075|7646345|FG003|STARTED|Part A||0
6716515|NCT03000075|7646346|FG004|STARTED|Part A||0
6716516|NCT03000075|7646347|FG005|STARTED|Part A||0
6716517|NCT03000075|7646348|FG006|STARTED|Part A||0
6716518|NCT03000075|7646342|FG000|COMPLETED|Part A||54
6716519|NCT03000075|7646343|FG001|COMPLETED|Part A||58
6716520|NCT03000075|7646344|FG002|COMPLETED|Part A||55
6716521|NCT03000075|7646345|FG003|COMPLETED|Part A||0
6716522|NCT03000075|7646346|FG004|COMPLETED|Part A||0
6716523|NCT03000075|7646347|FG005|COMPLETED|Part A||0
6716524|NCT03000075|7646348|FG006|COMPLETED|Part A||0
6716525|NCT03000075|7646342|FG000|NOT COMPLETED|Part A||4
6716526|NCT03000075|7646343|FG001|NOT COMPLETED|Part A||0
6716527|NCT03000075|7646344|FG002|NOT COMPLETED|Part A||0
6716528|NCT03000075|7646345|FG003|NOT COMPLETED|Part A||0
6716529|NCT03000075|7646346|FG004|NOT COMPLETED|Part A||0
6716530|NCT03000075|7646347|FG005|NOT COMPLETED|Part A||0
6716531|NCT03000075|7646348|FG006|NOT COMPLETED|Part A||0
6716532|NCT03000075|7646342|FG000|STARTED|Part B||0
6716533|NCT03000075|7646343|FG001|STARTED|Part B||0
6716534|NCT03000075|7646344|FG002|STARTED|Part B||0
6716535|NCT03000075|7646345|FG003|STARTED|Part B|Participants who received placebo in Part A received risankizumab 75 mg in Part B|27
6716536|NCT03000075|7646346|FG004|STARTED|Part B|Participants who received placebo in Part A received risankizumab 150 mg in Part B|27
6716537|NCT03000075|7646347|FG005|STARTED|Part B|Participants who received risankizumab 75 mg in Part A received risankizumab 75 mg in Part B|58
6716538|NCT03000075|7646348|FG006|STARTED|Part B|Participants who received risankizumab 150 mg in Part A received risankizumab 150 mg in Part B|55
6716539|NCT03000075|7646342|FG000|COMPLETED|Part B||0
6716540|NCT03000075|7646343|FG001|COMPLETED|Part B||0
6716541|NCT03000075|7646344|FG002|COMPLETED|Part B||0
6716542|NCT03000075|7646345|FG003|COMPLETED|Part B||27
6716543|NCT03000075|7646346|FG004|COMPLETED|Part B||26
6716544|NCT03000075|7646347|FG005|COMPLETED|Part B||56
6716545|NCT03000075|7646348|FG006|COMPLETED|Part B||54
6716546|NCT03000075|7646342|FG000|NOT COMPLETED|Part B||0
6716547|NCT03000075|7646343|FG001|NOT COMPLETED|Part B||0
6716548|NCT03000075|7646344|FG002|NOT COMPLETED|Part B||0
6716549|NCT03000075|7646345|FG003|NOT COMPLETED|Part B||0
6716550|NCT03000075|7646346|FG004|NOT COMPLETED|Part B||1
6716551|NCT03000075|7646347|FG005|NOT COMPLETED|Part B||2
6716552|NCT03000075|7646348|FG006|NOT COMPLETED|Part B||1
6716553|NCT03000088|7646366|FG000|STARTED|Overall Study||70
6716554|NCT03000088|7646367|FG001|STARTED|Overall Study||70
6716555|NCT03000088|7646366|FG000|COMPLETED|Overall Study||70
6716556|NCT03000088|7646367|FG001|COMPLETED|Overall Study||70
6716557|NCT03000088|7646366|FG000|NOT COMPLETED|Overall Study||0
6716558|NCT03000088|7646367|FG001|NOT COMPLETED|Overall Study||0
6716559|NCT03000166|7646375|FG000|STARTED|Overall Study||25
6716560|NCT03000166|7646376|FG001|STARTED|Overall Study||22
6716561|NCT03000166|7646375|FG000|COMPLETED|Overall Study||25
6716562|NCT03000166|7646376|FG001|COMPLETED|Overall Study||19
6716563|NCT03000166|7646375|FG000|NOT COMPLETED|Overall Study||0
6716564|NCT03000166|7646376|FG001|NOT COMPLETED|Overall Study||3
6716565|NCT03000283|7646383|FG000|STARTED|Overall Study||7
6716566|NCT03000283|7646383|FG000|COMPLETED|Overall Study||7
6716567|NCT03000283|7646383|FG000|NOT COMPLETED|Overall Study||0
6716568|NCT03000309|7646387|FG000|STARTED|Overall Study||20
6716569|NCT03000309|7646387|FG000|COMPLETED|Overall Study||19
6716570|NCT03000309|7646387|FG000|NOT COMPLETED|Overall Study||1
6716571|NCT03000348|7646397|FG000|STARTED|Overall Study||17
6716572|NCT03000348|7646398|FG001|STARTED|Overall Study||11
6716573|NCT03000348|7646399|FG002|STARTED|Overall Study||15
6716574|NCT03000348|7646400|FG003|STARTED|Overall Study||15
6716575|NCT03000348|7646401|FG004|STARTED|Overall Study||16
6716576|NCT03000348|7646402|FG005|STARTED|Overall Study||15
6716577|NCT03000348|7646397|FG000|Day 14 Treatment Period|Overall Study||17
6716578|NCT03000348|7646398|FG001|Day 14 Treatment Period|Overall Study||10
6716579|NCT03000348|7646399|FG002|Day 14 Treatment Period|Overall Study||13
6716580|NCT03000348|7646400|FG003|Day 14 Treatment Period|Overall Study||14
6716581|NCT03000348|7646401|FG004|Day 14 Treatment Period|Overall Study||13
6716582|NCT03000348|7646402|FG005|Day 14 Treatment Period|Overall Study||14
6716583|NCT03000348|7646397|FG000|COMPLETED|Overall Study||14
6716584|NCT03000348|7646398|FG001|COMPLETED|Overall Study||7
6716585|NCT03000348|7646399|FG002|COMPLETED|Overall Study||11
6716586|NCT03000348|7646400|FG003|COMPLETED|Overall Study||12
6716587|NCT03000348|7646401|FG004|COMPLETED|Overall Study||11
6716588|NCT03000348|7646402|FG005|COMPLETED|Overall Study||13
6716589|NCT03000348|7646397|FG000|NOT COMPLETED|Overall Study||3
6716590|NCT03000348|7646398|FG001|NOT COMPLETED|Overall Study||4
6716591|NCT03000348|7646399|FG002|NOT COMPLETED|Overall Study||4
6716592|NCT03000348|7646400|FG003|NOT COMPLETED|Overall Study||3
6716593|NCT03000348|7646401|FG004|NOT COMPLETED|Overall Study||5
6263321|NCT00943852|7162176|FG008|STARTED|Fourth Period of Treatment Intervention||1
6263322|NCT00943852|7162177|FG009|STARTED|Fourth Period of Treatment Intervention||1
6263323|NCT00943852|7162168|FG000|COMPLETED|Fourth Period of Treatment Intervention||2
6263324|NCT00943852|7162169|FG001|COMPLETED|Fourth Period of Treatment Intervention||1
6263325|NCT00943852|7162170|FG002|COMPLETED|Fourth Period of Treatment Intervention||1
6263326|NCT00943852|7162171|FG003|COMPLETED|Fourth Period of Treatment Intervention||1
6263327|NCT00943852|7162172|FG004|COMPLETED|Fourth Period of Treatment Intervention||1
6263328|NCT00943852|7162173|FG005|COMPLETED|Fourth Period of Treatment Intervention||0
6263329|NCT00943852|7162174|FG006|COMPLETED|Fourth Period of Treatment Intervention||1
6263330|NCT00943852|7162175|FG007|COMPLETED|Fourth Period of Treatment Intervention||1
6263331|NCT00943852|7162176|FG008|COMPLETED|Fourth Period of Treatment Intervention||1
6263332|NCT00943852|7162177|FG009|COMPLETED|Fourth Period of Treatment Intervention||1
6263333|NCT00943852|7162168|FG000|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263334|NCT00943852|7162169|FG001|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263335|NCT00943852|7162170|FG002|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263336|NCT00943852|7162171|FG003|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263337|NCT00943852|7162172|FG004|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263338|NCT00943852|7162173|FG005|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263339|NCT00943852|7162174|FG006|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263340|NCT00943852|7162175|FG007|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263341|NCT00943852|7162176|FG008|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6602775|NCT02058966|7527826|FG000|Received Placebo-Meth|Third Intervention||4
6602776|NCT02058966|7527826|FG000|Received Entacapone-Placebo|Third Intervention||1
6602777|NCT02058966|7527826|FG000|Received Entacapone-Meth|Third Intervention||3
6602778|NCT02058966|7527826|FG000|COMPLETED|Third Intervention||12
6602779|NCT02058966|7527826|FG000|NOT COMPLETED|Third Intervention||0
6602780|NCT02058966|7527826|FG000|STARTED|Fourth Intervention||12
6602781|NCT02058966|7527826|FG000|Received Placebo-Placebo|Fourth Intervention||4
6602782|NCT02058966|7527826|FG000|Received Placebo-Meth|Fourth Intervention||3
6602783|NCT02058966|7527826|FG000|Received Entacapone-Placebo|Fourth Intervention||3
6602784|NCT02058966|7527826|FG000|Received Entacapone-Meth|Fourth Intervention||2
6602785|NCT02058966|7527826|FG000|COMPLETED|Fourth Intervention||12
6602786|NCT02058966|7527826|FG000|NOT COMPLETED|Fourth Intervention||0
6602787|NCT02058992|7527838|FG000|STARTED|Overall Study||3339
6602788|NCT02058992|7527838|FG000|COMPLETED|Overall Study||3223
6602789|NCT02058992|7527838|FG000|NOT COMPLETED|Overall Study||116
6602790|NCT02059005|7527844|FG000|STARTED|Overall Study||49
6602791|NCT02059005|7527845|FG001|STARTED|Overall Study||48
6602792|NCT02059005|7527844|FG000|3 Month Assessment|Overall Study||37
6602793|NCT02059005|7527845|FG001|3 Month Assessment|Overall Study||33
6602794|NCT02059005|7527844|FG000|6 Month Assessment|Overall Study||29
6602795|NCT02059005|7527845|FG001|6 Month Assessment|Overall Study||24
6602796|NCT02059005|7527844|FG000|COMPLETED|Overall Study||29
6602797|NCT02059005|7527845|FG001|COMPLETED|Overall Study||24
6602798|NCT02059005|7527844|FG000|NOT COMPLETED|Overall Study||20
6602799|NCT02059005|7527845|FG001|NOT COMPLETED|Overall Study||24
6602800|NCT02059057|7527853|FG000|STARTED|Overall Study||102
6602801|NCT02059057|7527853|FG000|COMPLETED|Overall Study||87
6602802|NCT02059057|7527853|FG000|NOT COMPLETED|Overall Study||15
6602803|NCT02059070|7527860|FG000|STARTED|Overall Study||19
6602804|NCT02059070|7527861|FG001|STARTED|Overall Study||20
6602805|NCT02059070|7527860|FG000|COMPLETED|Overall Study||14
6602806|NCT02059070|7527861|FG001|COMPLETED|Overall Study||16
6602807|NCT02059070|7527860|FG000|NOT COMPLETED|Overall Study||5
6602808|NCT02059070|7527861|FG001|NOT COMPLETED|Overall Study||4
6602809|NCT02059135|7527869|FG000|STARTED|Maternal Follow-up (ITT Population)||62
6602810|NCT02059135|7527870|FG001|STARTED|Maternal Follow-up (ITT Population)||58
6602811|NCT02059135|7527869|FG000|COMPLETED|Maternal Follow-up (ITT Population)||59
6602812|NCT02059135|7527870|FG001|COMPLETED|Maternal Follow-up (ITT Population)||51
6602813|NCT02059135|7527869|FG000|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
6602814|NCT02059135|7527870|FG001|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
6602815|NCT02059135|7527869|FG000|STARTED|Neonatal Follow-up (Safety Population)||60
6602816|NCT02059135|7527870|FG001|STARTED|Neonatal Follow-up (Safety Population)||54
6716594|NCT03000348|7646402|FG005|NOT COMPLETED|Overall Study||2
6716595|NCT03000452|7646419|FG000|STARTED|Treatment Period||18
6716596|NCT03000452|7646419|FG000|COMPLETED|Treatment Period||0
6716597|NCT03000452|7646419|FG000|NOT COMPLETED|Treatment Period||18
6716598|NCT03000452|7646419|FG000|STARTED|Follow-Up Period|1 participant died in Cycle 1 due to PD prior to evaluation.|17
6716599|NCT03000452|7646419|FG000|COMPLETED|Follow-Up Period||10
6716600|NCT03000452|7646419|FG000|NOT COMPLETED|Follow-Up Period||7
6716601|NCT03000608|7646425|FG000|STARTED|Overall Study||46
6716602|NCT03000608|7646426|FG001|STARTED|Overall Study||23
6716603|NCT03000608|7646425|FG000|COMPLETED|Overall Study||40
6716604|NCT03000608|7646426|FG001|COMPLETED|Overall Study||19
6716605|NCT03000608|7646425|FG000|NOT COMPLETED|Overall Study||6
6716606|NCT03000608|7646426|FG001|NOT COMPLETED|Overall Study||4
6716607|NCT03000673|7646436|FG000|STARTED|Overall Study||7
6716608|NCT03000673|7646437|FG001|STARTED|Overall Study||9
6716609|NCT03000673|7646438|FG002|STARTED|Overall Study||7
6716610|NCT03000673|7646439|FG003|STARTED|Overall Study||9
6716611|NCT03000673|7646436|FG000|COMPLETED|Overall Study||6
6716612|NCT03000673|7646437|FG001|COMPLETED|Overall Study||9
6716613|NCT03000673|7646438|FG002|COMPLETED|Overall Study||7
6716614|NCT03000673|7646439|FG003|COMPLETED|Overall Study||9
6716615|NCT03000673|7646436|FG000|NOT COMPLETED|Overall Study||1
6716616|NCT03000673|7646437|FG001|NOT COMPLETED|Overall Study||0
6716617|NCT03000673|7646438|FG002|NOT COMPLETED|Overall Study||0
6716618|NCT03000673|7646439|FG003|NOT COMPLETED|Overall Study||0
6716619|NCT03000686|7646452|FG000|STARTED|Part 1, Period 1 (1 Day)||5
6716620|NCT03000686|7646453|FG001|STARTED|Part 1, Period 1 (1 Day)||6
6716621|NCT03000686|7646454|FG002|STARTED|Part 1, Period 1 (1 Day)||0
6716622|NCT03000686|7646455|FG003|STARTED|Part 1, Period 1 (1 Day)||0
6716623|NCT03000686|7646452|FG000|COMPLETED|Part 1, Period 1 (1 Day)||5
6716624|NCT03000686|7646453|FG001|COMPLETED|Part 1, Period 1 (1 Day)||5
6716625|NCT03000686|7646454|FG002|COMPLETED|Part 1, Period 1 (1 Day)||0
6716626|NCT03000686|7646455|FG003|COMPLETED|Part 1, Period 1 (1 Day)||0
6716627|NCT03000686|7646452|FG000|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6716628|NCT03000686|7646453|FG001|NOT COMPLETED|Part 1, Period 1 (1 Day)||1
6716629|NCT03000686|7646454|FG002|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6716630|NCT03000686|7646455|FG003|NOT COMPLETED|Part 1, Period 1 (1 Day)||0
6716631|NCT03000686|7646452|FG000|STARTED|Part 1, Wash-out (Up to 14 Days)||5
6716632|NCT03000686|7646453|FG001|STARTED|Part 1, Wash-out (Up to 14 Days)||5
6716633|NCT03000686|7646454|FG002|STARTED|Part 1, Wash-out (Up to 14 Days)||0
6716634|NCT03000686|7646455|FG003|STARTED|Part 1, Wash-out (Up to 14 Days)||0
6716635|NCT03000686|7646452|FG000|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
6716636|NCT03000686|7646453|FG001|COMPLETED|Part 1, Wash-out (Up to 14 Days)||5
6716637|NCT03000686|7646454|FG002|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6716638|NCT03000686|7646455|FG003|COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6716639|NCT03000686|7646452|FG000|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6716640|NCT03000686|7646453|FG001|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6716641|NCT03000686|7646454|FG002|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6716642|NCT03000686|7646455|FG003|NOT COMPLETED|Part 1, Wash-out (Up to 14 Days)||0
6716643|NCT03000686|7646452|FG000|STARTED|Part 1, Period 2 (1 Day)||5
6716644|NCT03000686|7646453|FG001|STARTED|Part 1, Period 2 (1 Day)||5
6716645|NCT03000686|7646454|FG002|STARTED|Part 1, Period 2 (1 Day)||0
6716646|NCT03000686|7646455|FG003|STARTED|Part 1, Period 2 (1 Day)||0
6716647|NCT03000686|7646452|FG000|COMPLETED|Part 1, Period 2 (1 Day)||5
6716648|NCT03000686|7646453|FG001|COMPLETED|Part 1, Period 2 (1 Day)||5
6716649|NCT03000686|7646454|FG002|COMPLETED|Part 1, Period 2 (1 Day)||0
6716650|NCT03000686|7646455|FG003|COMPLETED|Part 1, Period 2 (1 Day)||0
6716651|NCT03000686|7646452|FG000|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6716652|NCT03000686|7646453|FG001|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6716653|NCT03000686|7646454|FG002|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6716654|NCT03000686|7646455|FG003|NOT COMPLETED|Part 1, Period 2 (1 Day)||0
6716655|NCT03000686|7646452|FG000|STARTED|Part 2, Period 1 (1 Day)||0
6716656|NCT03000686|7646453|FG001|STARTED|Part 2, Period 1 (1 Day)||0
6716657|NCT03000686|7646454|FG002|STARTED|Part 2, Period 1 (1 Day)||3
6716658|NCT03000686|7646455|FG003|STARTED|Part 2, Period 1 (1 Day)||3
6716659|NCT03000686|7646452|FG000|COMPLETED|Part 2, Period 1 (1 Day)||0
6716660|NCT03000686|7646453|FG001|COMPLETED|Part 2, Period 1 (1 Day)||0
6716661|NCT03000686|7646454|FG002|COMPLETED|Part 2, Period 1 (1 Day)||3
6716662|NCT03000686|7646455|FG003|COMPLETED|Part 2, Period 1 (1 Day)||3
6716663|NCT03000686|7646452|FG000|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6716664|NCT03000686|7646453|FG001|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6716665|NCT03000686|7646454|FG002|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6716666|NCT03000686|7646455|FG003|NOT COMPLETED|Part 2, Period 1 (1 Day)||0
6716667|NCT03000686|7646452|FG000|STARTED|Part 2, Wash-out (Up to 14 Days)||0
6716668|NCT03000686|7646453|FG001|STARTED|Part 2, Wash-out (Up to 14 Days)||0
6716669|NCT03000686|7646454|FG002|STARTED|Part 2, Wash-out (Up to 14 Days)||3
6716670|NCT03000686|7646455|FG003|STARTED|Part 2, Wash-out (Up to 14 Days)||3
6716671|NCT03000686|7646452|FG000|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6716672|NCT03000686|7646453|FG001|COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6716673|NCT03000686|7646454|FG002|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
6716674|NCT03000686|7646455|FG003|COMPLETED|Part 2, Wash-out (Up to 14 Days)||3
6716675|NCT03000686|7646452|FG000|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6716676|NCT03000686|7646453|FG001|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6716677|NCT03000686|7646454|FG002|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6716678|NCT03000686|7646455|FG003|NOT COMPLETED|Part 2, Wash-out (Up to 14 Days)||0
6716679|NCT03000686|7646452|FG000|STARTED|Part 2, Period 2 (1 Day)||0
6716680|NCT03000686|7646453|FG001|STARTED|Part 2, Period 2 (1 Day)||0
6716681|NCT03000686|7646454|FG002|STARTED|Part 2, Period 2 (1 Day)||3
6716682|NCT03000686|7646455|FG003|STARTED|Part 2, Period 2 (1 Day)||3
6716683|NCT03000686|7646452|FG000|COMPLETED|Part 2, Period 2 (1 Day)||0
6716684|NCT03000686|7646453|FG001|COMPLETED|Part 2, Period 2 (1 Day)||0
6716685|NCT03000686|7646454|FG002|COMPLETED|Part 2, Period 2 (1 Day)||3
6716686|NCT03000686|7646455|FG003|COMPLETED|Part 2, Period 2 (1 Day)||3
6716687|NCT03000686|7646452|FG000|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6716688|NCT03000686|7646453|FG001|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6716689|NCT03000686|7646454|FG002|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6716690|NCT03000686|7646455|FG003|NOT COMPLETED|Part 2, Period 2 (1 Day)||0
6716691|NCT03001076|7646469|FG000|STARTED|Overall Study||88
6716692|NCT03001076|7646470|FG001|STARTED|Overall Study||181
6716693|NCT03001076|7646469|FG000|COMPLETED|Overall Study||81
6716694|NCT03001076|7646470|FG001|COMPLETED|Overall Study||176
6716695|NCT03001076|7646469|FG000|NOT COMPLETED|Overall Study||7
6716696|NCT03001076|7646470|FG001|NOT COMPLETED|Overall Study||5
6716697|NCT03001219|7646478|FG000|STARTED|Proof of Concept||37
6716698|NCT03001219|7646479|FG001|STARTED|Proof of Concept||72
6716699|NCT03001219|7646478|FG000|COMPLETED|Proof of Concept||35
6716700|NCT03001219|7646479|FG001|COMPLETED|Proof of Concept||65
6716701|NCT03001219|7646478|FG000|NOT COMPLETED|Proof of Concept||2
6716702|NCT03001219|7646479|FG001|NOT COMPLETED|Proof of Concept||7
6716703|NCT03001219|7646478|FG000|STARTED|Extension Period Analysis||9
6716704|NCT03001219|7646479|FG001|STARTED|Extension Period Analysis||97
6716705|NCT03001219|7646478|FG000|COMPLETED|Extension Period Analysis||4
6716706|NCT03001219|7646479|FG001|COMPLETED|Extension Period Analysis||52
6716707|NCT03001219|7646478|FG000|NOT COMPLETED|Extension Period Analysis||5
6716708|NCT03001219|7646479|FG001|NOT COMPLETED|Extension Period Analysis||45
6716709|NCT03001258|7646493|FG000|STARTED|Overall Study||765
6716710|NCT03001258|7646494|FG001|STARTED|Overall Study||751
6716711|NCT03001258|7646495|FG002|STARTED|Overall Study||485
6716712|NCT03001258|7646493|FG000|COMPLETED|Overall Study||765
6716713|NCT03001258|7646494|FG001|COMPLETED|Overall Study||751
6716714|NCT03001258|7646495|FG002|COMPLETED|Overall Study||485
6716715|NCT03001258|7646493|FG000|NOT COMPLETED|Overall Study||0
6716716|NCT03001258|7646494|FG001|NOT COMPLETED|Overall Study||0
6716717|NCT03001258|7646495|FG002|NOT COMPLETED|Overall Study||0
6716718|NCT03001453|7646505|FG000|STARTED|Overall Study||50
6716719|NCT03001453|7646506|FG001|STARTED|Overall Study||57
6716720|NCT03001453|7646505|FG000|COMPLETED|Overall Study||50
6716721|NCT03001453|7646506|FG001|COMPLETED|Overall Study||57
6716722|NCT03001453|7646505|FG000|NOT COMPLETED|Overall Study||0
6716723|NCT03001453|7646506|FG001|NOT COMPLETED|Overall Study||0
6716724|NCT03001557|7646517|FG000|STARTED|Core Phase||12
6716725|NCT03001557|7646518|FG001|STARTED|Core Phase||12
6716726|NCT03001557|7646519|FG002|STARTED|Core Phase||14
6716727|NCT03001557|7646520|FG003|STARTED|Core Phase||13
6716728|NCT03001557|7646521|FG004|STARTED|Core Phase||12
6716729|NCT03001557|7646522|FG005|STARTED|Core Phase||0
6716730|NCT03001557|7646523|FG006|STARTED|Core Phase||0
6716731|NCT03001557|7646524|FG007|STARTED|Core Phase||0
6716732|NCT03001557|7646517|FG000|Treated|Core Phase||12
6716733|NCT03001557|7646518|FG001|Treated|Core Phase||12
6716734|NCT03001557|7646519|FG002|Treated|Core Phase||13
6716735|NCT03001557|7646520|FG003|Treated|Core Phase||13
6716736|NCT03001557|7646521|FG004|Treated|Core Phase||12
6716737|NCT03001557|7646522|FG005|Treated|Core Phase||0
6716738|NCT03001557|7646523|FG006|Treated|Core Phase||0
6716739|NCT03001557|7646524|FG007|Treated|Core Phase||0
6716740|NCT03001557|7646517|FG000|COMPLETED|Core Phase||12
6716741|NCT03001557|7646518|FG001|COMPLETED|Core Phase||12
6716742|NCT03001557|7646519|FG002|COMPLETED|Core Phase||13
6716743|NCT03001557|7646520|FG003|COMPLETED|Core Phase||13
6716744|NCT03001557|7646521|FG004|COMPLETED|Core Phase||12
6716745|NCT03001557|7646522|FG005|COMPLETED|Core Phase||0
6716746|NCT03001557|7646523|FG006|COMPLETED|Core Phase||0
6716747|NCT03001557|7646524|FG007|COMPLETED|Core Phase||0
6716748|NCT03001557|7646517|FG000|NOT COMPLETED|Core Phase||0
6716749|NCT03001557|7646518|FG001|NOT COMPLETED|Core Phase||0
6716750|NCT03001557|7646519|FG002|NOT COMPLETED|Core Phase||1
6716751|NCT03001557|7646520|FG003|NOT COMPLETED|Core Phase||0
6716752|NCT03001557|7646521|FG004|NOT COMPLETED|Core Phase||0
6716753|NCT03001557|7646522|FG005|NOT COMPLETED|Core Phase||0
6716754|NCT03001557|7646523|FG006|NOT COMPLETED|Core Phase||0
6716755|NCT03001557|7646524|FG007|NOT COMPLETED|Core Phase||0
6716756|NCT03001557|7646517|FG000|STARTED|Extension Phase||0
6716757|NCT03001557|7646518|FG001|STARTED|Extension Phase||0
6716758|NCT03001557|7646519|FG002|STARTED|Extension Phase||0
6716759|NCT03001557|7646520|FG003|STARTED|Extension Phase||0
6716760|NCT03001557|7646521|FG004|STARTED|Extension Phase||0
6716761|NCT03001557|7646522|FG005|STARTED|Extension Phase||5
6716762|NCT03001557|7646523|FG006|STARTED|Extension Phase||14
6716763|NCT03001557|7646524|FG007|STARTED|Extension Phase||6
6716764|NCT03001557|7646517|FG000|COMPLETED|Extension Phase||0
6716765|NCT03001557|7646518|FG001|COMPLETED|Extension Phase||0
6716766|NCT03001557|7646519|FG002|COMPLETED|Extension Phase||0
6716767|NCT03001557|7646520|FG003|COMPLETED|Extension Phase||0
6716768|NCT03001557|7646521|FG004|COMPLETED|Extension Phase||0
6716769|NCT03001557|7646522|FG005|COMPLETED|Extension Phase||0
6716770|NCT03001557|7646523|FG006|COMPLETED|Extension Phase||0
6716771|NCT03001557|7646524|FG007|COMPLETED|Extension Phase||0
6716772|NCT03001557|7646517|FG000|NOT COMPLETED|Extension Phase||0
6716773|NCT03001557|7646518|FG001|NOT COMPLETED|Extension Phase||0
6716774|NCT03001557|7646519|FG002|NOT COMPLETED|Extension Phase||0
6716775|NCT03001557|7646520|FG003|NOT COMPLETED|Extension Phase||0
6716776|NCT03001557|7646521|FG004|NOT COMPLETED|Extension Phase||0
6716777|NCT03001557|7646522|FG005|NOT COMPLETED|Extension Phase||5
6716778|NCT03001557|7646523|FG006|NOT COMPLETED|Extension Phase||14
6716779|NCT03001557|7646524|FG007|NOT COMPLETED|Extension Phase||6
6716780|NCT03001674|7646548|FG000|STARTED|Overall Study||10
6716781|NCT03001674|7646549|FG001|STARTED|Overall Study||5
6716782|NCT03001674|7646548|FG000|COMPLETED|Overall Study||10
6716783|NCT03001674|7646549|FG001|COMPLETED|Overall Study||5
6716784|NCT03001674|7646548|FG000|NOT COMPLETED|Overall Study||0
6716785|NCT03001674|7646549|FG001|NOT COMPLETED|Overall Study||0
6716786|NCT03001778|7646557|FG000|STARTED|Overall Study||21
6716787|NCT03001778|7646558|FG001|STARTED|Overall Study||46
6716788|NCT03001778|7646557|FG000|COMPLETED|Overall Study||21
6716789|NCT03001778|7646558|FG001|COMPLETED|Overall Study||46
6716790|NCT03001778|7646557|FG000|NOT COMPLETED|Overall Study||0
6716791|NCT03001778|7646558|FG001|NOT COMPLETED|Overall Study||0
6716792|NCT03001843|7646566|FG000|STARTED|Overall Study||27
6716793|NCT03001843|7646567|FG001|STARTED|Overall Study||27
6716794|NCT03001843|7646566|FG000|COMPLETED|Overall Study||27
6716795|NCT03001843|7646567|FG001|COMPLETED|Overall Study||27
6716796|NCT03001843|7646566|FG000|NOT COMPLETED|Overall Study||0
6716797|NCT03001843|7646567|FG001|NOT COMPLETED|Overall Study||0
6716798|NCT03002012|7646575|FG000|STARTED|Overall Study||11
6716799|NCT03002012|7646576|FG001|STARTED|Overall Study||11
6716800|NCT03002012|7646575|FG000|COMPLETED|Overall Study||11
6716801|NCT03002012|7646576|FG001|COMPLETED|Overall Study||11
6716802|NCT03002012|7646575|FG000|NOT COMPLETED|Overall Study||0
6716803|NCT03002012|7646576|FG001|NOT COMPLETED|Overall Study||0
6716804|NCT03002038|7646584|FG000|STARTED|Overall Study||46
6716805|NCT03002038|7646585|FG001|STARTED|Overall Study||40
6716806|NCT03002038|7646584|FG000|COMPLETED|Overall Study||35
6716807|NCT03002038|7646585|FG001|COMPLETED|Overall Study||33
6716808|NCT03002038|7646584|FG000|NOT COMPLETED|Overall Study||11
6716809|NCT03002038|7646585|FG001|NOT COMPLETED|Overall Study||7
6716810|NCT03002077|7646591|FG000|STARTED|Overall Study||617
6716811|NCT03002077|7646591|FG000|COMPLETED|Overall Study||179
6716812|NCT03002077|7646591|FG000|NOT COMPLETED|Overall Study||438
6716813|NCT03002194|7646595|FG000|STARTED|Overall Study||48
6716814|NCT03002194|7646595|FG000|COMPLETED|Overall Study||38
6716815|NCT03002194|7646595|FG000|NOT COMPLETED|Overall Study||10
6716816|NCT03002311|7646601|FG000|STARTED|Overall Study||147
6716817|NCT03002311|7646602|FG001|STARTED|Overall Study||180
6716818|NCT03002311|7646601|FG000|COMPLETED|Overall Study||128
6716819|NCT03002311|7646602|FG001|COMPLETED|Overall Study||150
6716820|NCT03002311|7646601|FG000|NOT COMPLETED|Overall Study||19
6716821|NCT03002311|7646602|FG001|NOT COMPLETED|Overall Study||30
6716822|NCT03002454|7646608|FG000|STARTED|Overall Study||4
6716823|NCT03002454|7646608|FG000|COMPLETED|Overall Study||4
6716824|NCT03002454|7646608|FG000|NOT COMPLETED|Overall Study||0
6716825|NCT03002506|7646613|FG000|STARTED|Overall Study||6
6716826|NCT03002506|7646613|FG000|COMPLETED|Overall Study||6
6716827|NCT03002506|7646613|FG000|NOT COMPLETED|Overall Study||0
6716828|NCT03002610|7646620|FG000|STARTED|Overall Study||24
6716829|NCT03002610|7646621|FG001|STARTED|Overall Study||50
6716830|NCT03002610|7646622|FG002|STARTED|Overall Study||34
6716831|NCT03002610|7646620|FG000|COMPLETED|Overall Study||18
6716832|NCT03002610|7646621|FG001|COMPLETED|Overall Study||25
6716833|NCT03002610|7646622|FG002|COMPLETED|Overall Study||21
6716834|NCT03002610|7646620|FG000|NOT COMPLETED|Overall Study||6
6716835|NCT03002610|7646621|FG001|NOT COMPLETED|Overall Study||25
6716836|NCT03002610|7646622|FG002|NOT COMPLETED|Overall Study||13
6716837|NCT03002623|7646632|FG000|STARTED|Overall Study||4
6716838|NCT03002623|7646633|FG001|STARTED|Overall Study||3
6716839|NCT03002623|7646632|FG000|COMPLETED|Overall Study||2
6716840|NCT03002623|7646633|FG001|COMPLETED|Overall Study||2
6716841|NCT03002623|7646632|FG000|NOT COMPLETED|Overall Study||2
6716842|NCT03002623|7646633|FG001|NOT COMPLETED|Overall Study||1
6716843|NCT03002753|7646643|FG000|STARTED|First Randomization||10
6716844|NCT03002753|7646644|FG001|STARTED|First Randomization||12
6716845|NCT03002753|7646645|FG002|STARTED|First Randomization||21
6716846|NCT03002753|7646643|FG000|COMPLETED|First Randomization||9
6716847|NCT03002753|7646644|FG001|COMPLETED|First Randomization||11
6716848|NCT03002753|7646645|FG002|COMPLETED|First Randomization||21
6716849|NCT03002753|7646643|FG000|NOT COMPLETED|First Randomization||1
6716850|NCT03002753|7646644|FG001|NOT COMPLETED|First Randomization||1
6716851|NCT03002753|7646645|FG002|NOT COMPLETED|First Randomization||0
6716852|NCT03002753|7646643|FG000|STARTED|Second Randomization (Re-randomization)||11
6716853|NCT03002753|7646644|FG001|STARTED|Second Randomization (Re-randomization)||10
6716854|NCT03002753|7646645|FG002|STARTED|Second Randomization (Re-randomization)||0
6716855|NCT03002753|7646643|FG000|COMPLETED|Second Randomization (Re-randomization)||11
6716856|NCT03002753|7646644|FG001|COMPLETED|Second Randomization (Re-randomization)||9
6716857|NCT03002753|7646645|FG002|COMPLETED|Second Randomization (Re-randomization)||0
6716858|NCT03002753|7646643|FG000|NOT COMPLETED|Second Randomization (Re-randomization)||0
6716859|NCT03002753|7646644|FG001|NOT COMPLETED|Second Randomization (Re-randomization)||1
6716860|NCT03002753|7646645|FG002|NOT COMPLETED|Second Randomization (Re-randomization)||0
6716861|NCT03002818|7646653|FG000|STARTED|Overall Study||41
6716862|NCT03002818|7646653|FG000|COMPLETED|Overall Study||40
6716863|NCT03002818|7646653|FG000|NOT COMPLETED|Overall Study||1
6716864|NCT03002974|7646660|FG000|STARTED|Overall Study||55
6716865|NCT03002974|7646661|FG001|STARTED|Overall Study||56
6716866|NCT03002974|7646662|FG002|STARTED|Overall Study||54
6716867|NCT03002974|7646660|FG000|Intention To Treat Populatio|Overall Study||55
6716868|NCT03002974|7646661|FG001|Intention To Treat Populatio|Overall Study||56
6716869|NCT03002974|7646662|FG002|Intention To Treat Populatio|Overall Study||54
6716870|NCT03002974|7646660|FG000|Safety Population|Overall Study||54
6716871|NCT03002974|7646661|FG001|Safety Population|Overall Study||55
6716872|NCT03002974|7646662|FG002|Safety Population|Overall Study||52
6716873|NCT03002974|7646660|FG000|COMPLETED|Overall Study||35
6716874|NCT03002974|7646661|FG001|COMPLETED|Overall Study||40
6716875|NCT03002974|7646662|FG002|COMPLETED|Overall Study||36
6716876|NCT03002974|7646660|FG000|NOT COMPLETED|Overall Study||20
6716877|NCT03002974|7646661|FG001|NOT COMPLETED|Overall Study||16
6716878|NCT03002974|7646662|FG002|NOT COMPLETED|Overall Study||18
6716879|NCT03003000|7646673|FG000|STARTED|Overall Study||126
6716880|NCT03003000|7646674|FG001|STARTED|Overall Study||253
6716881|NCT03003000|7646675|FG002|STARTED|Overall Study||256
6716882|NCT03003000|7646673|FG000|COMPLETED|Overall Study||121
6716883|NCT03003000|7646674|FG001|COMPLETED|Overall Study||249
6716884|NCT03003000|7646675|FG002|COMPLETED|Overall Study||251
6716885|NCT03003000|7646673|FG000|NOT COMPLETED|Overall Study||5
6716886|NCT03003000|7646674|FG001|NOT COMPLETED|Overall Study||4
6716887|NCT03003000|7646675|FG002|NOT COMPLETED|Overall Study||5
6716888|NCT03003130|7646685|FG000|STARTED|Overall Study||88
6716889|NCT03003130|7646686|FG001|STARTED|Overall Study||87
6716890|NCT03003130|7646685|FG000|COMPLETED|Overall Study||80
6716891|NCT03003130|7646686|FG001|COMPLETED|Overall Study||80
6716892|NCT03003130|7646685|FG000|NOT COMPLETED|Overall Study||8
6716893|NCT03003130|7646686|FG001|NOT COMPLETED|Overall Study||7
6716894|NCT03003390|7646694|FG000|STARTED|Overall Study||27
6716895|NCT03003390|7646695|FG001|STARTED|Overall Study||24
6716896|NCT03003390|7646694|FG000|COMPLETED|Overall Study||23
6716897|NCT03003390|7646695|FG001|COMPLETED|Overall Study||24
6716898|NCT03003390|7646694|FG000|NOT COMPLETED|Overall Study||4
6716899|NCT03003390|7646695|FG001|NOT COMPLETED|Overall Study||0
6716900|NCT03003494|7646706|FG000|STARTED|Overall Study||306
6716901|NCT03003494|7646706|FG000|COMPLETED|Overall Study||278
6716902|NCT03003494|7646706|FG000|NOT COMPLETED|Overall Study||28
6716903|NCT03003676|7646712|FG000|STARTED|Overall Study||9
6716904|NCT03003676|7646713|FG001|STARTED|Overall Study||12
6716905|NCT03003676|7646712|FG000|COMPLETED|Overall Study||3
6716906|NCT03003676|7646713|FG001|COMPLETED|Overall Study||4
6716907|NCT03003676|7646712|FG000|NOT COMPLETED|Overall Study||6
6716908|NCT03003676|7646713|FG001|NOT COMPLETED|Overall Study||8
6716909|NCT03003793|7646723|FG000|STARTED|Overall Study||16
6716910|NCT03003793|7646724|FG001|STARTED|Overall Study||16
6716911|NCT03003793|7646723|FG000|COMPLETED|Overall Study||16
6716912|NCT03003793|7646724|FG001|COMPLETED|Overall Study||16
6716913|NCT03003793|7646723|FG000|NOT COMPLETED|Overall Study||0
6716914|NCT03003793|7646724|FG001|NOT COMPLETED|Overall Study||0
6716915|NCT03003949|7646732|FG000|STARTED|Overall Study||40
6716916|NCT03003949|7646733|FG001|STARTED|Overall Study||42
6716917|NCT03003949|7646732|FG000|Week 8|Overall Study||40
6716918|NCT03003949|7646733|FG001|Week 8|Overall Study||42
6716919|NCT03003949|7646732|FG000|Week 16|Overall Study||38
6716920|NCT03003949|7646733|FG001|Week 16|Overall Study||35
6716921|NCT03003949|7646732|FG000|Week 20|Overall Study||35
6716922|NCT03003949|7646733|FG001|Week 20|Overall Study||33
6716923|NCT03003949|7646732|FG000|Week 24|Overall Study||35
6716924|NCT03003949|7646733|FG001|Week 24|Overall Study||32
6716925|NCT03003949|7646732|FG000|COMPLETED|Overall Study||35
6716926|NCT03003949|7646733|FG001|COMPLETED|Overall Study||32
6716927|NCT03003949|7646732|FG000|NOT COMPLETED|Overall Study||5
6716928|NCT03003949|7646733|FG001|NOT COMPLETED|Overall Study||10
6716929|NCT03004469|7646742|FG000|STARTED|Overall Study||189
6716930|NCT03004469|7646743|FG001|STARTED|Overall Study||184
6263342|NCT00943852|7162177|FG009|NOT COMPLETED|Fourth Period of Treatment Intervention||0
6263343|NCT00943852|7162168|FG000|STARTED|Washout Period After Period 4 Treatment||2
6263344|NCT00943852|7162169|FG001|STARTED|Washout Period After Period 4 Treatment||1
6263345|NCT00943852|7162170|FG002|STARTED|Washout Period After Period 4 Treatment||1
6263346|NCT00943852|7162171|FG003|STARTED|Washout Period After Period 4 Treatment||1
6263347|NCT00943852|7162172|FG004|STARTED|Washout Period After Period 4 Treatment||1
6263348|NCT00943852|7162173|FG005|STARTED|Washout Period After Period 4 Treatment||0
6263349|NCT00943852|7162174|FG006|STARTED|Washout Period After Period 4 Treatment||1
6263350|NCT00943852|7162175|FG007|STARTED|Washout Period After Period 4 Treatment||1
6263351|NCT00943852|7162176|FG008|STARTED|Washout Period After Period 4 Treatment||1
6263352|NCT00943852|7162177|FG009|STARTED|Washout Period After Period 4 Treatment||1
6263353|NCT00943852|7162168|FG000|COMPLETED|Washout Period After Period 4 Treatment||1
6263354|NCT00943852|7162169|FG001|COMPLETED|Washout Period After Period 4 Treatment||1
6263355|NCT00943852|7162170|FG002|COMPLETED|Washout Period After Period 4 Treatment||0
6263356|NCT00943852|7162171|FG003|COMPLETED|Washout Period After Period 4 Treatment||0
6263357|NCT00943852|7162172|FG004|COMPLETED|Washout Period After Period 4 Treatment||1
6263358|NCT00943852|7162173|FG005|COMPLETED|Washout Period After Period 4 Treatment||0
6263359|NCT00943852|7162174|FG006|COMPLETED|Washout Period After Period 4 Treatment||0
6263360|NCT00943852|7162175|FG007|COMPLETED|Washout Period After Period 4 Treatment||0
6263361|NCT00943852|7162176|FG008|COMPLETED|Washout Period After Period 4 Treatment||1
6263362|NCT00943852|7162177|FG009|COMPLETED|Washout Period After Period 4 Treatment||1
6263363|NCT00943852|7162168|FG000|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6263364|NCT00943852|7162169|FG001|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6263365|NCT00943852|7162170|FG002|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6263366|NCT00943852|7162171|FG003|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6263367|NCT00943852|7162172|FG004|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6263368|NCT00943852|7162173|FG005|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6263369|NCT00943852|7162174|FG006|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6263370|NCT00943852|7162175|FG007|NOT COMPLETED|Washout Period After Period 4 Treatment||1
6263371|NCT00943852|7162176|FG008|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6263372|NCT00943852|7162177|FG009|NOT COMPLETED|Washout Period After Period 4 Treatment||0
6263373|NCT00943852|7162168|FG000|STARTED|Fifth Period of Treatment Intervention||1
6263374|NCT00943852|7162169|FG001|STARTED|Fifth Period of Treatment Intervention||1
6263375|NCT00943852|7162170|FG002|STARTED|Fifth Period of Treatment Intervention||0
6263376|NCT00943852|7162171|FG003|STARTED|Fifth Period of Treatment Intervention||0
6263377|NCT00943852|7162172|FG004|STARTED|Fifth Period of Treatment Intervention||1
6263378|NCT00943852|7162173|FG005|STARTED|Fifth Period of Treatment Intervention||0
6263379|NCT00943852|7162174|FG006|STARTED|Fifth Period of Treatment Intervention||0
6263380|NCT00943852|7162175|FG007|STARTED|Fifth Period of Treatment Intervention||0
6263381|NCT00943852|7162176|FG008|STARTED|Fifth Period of Treatment Intervention||1
6263382|NCT00943852|7162177|FG009|STARTED|Fifth Period of Treatment Intervention||1
6263383|NCT00943852|7162168|FG000|COMPLETED|Fifth Period of Treatment Intervention||1
6263384|NCT00943852|7162169|FG001|COMPLETED|Fifth Period of Treatment Intervention||1
6263385|NCT00943852|7162170|FG002|COMPLETED|Fifth Period of Treatment Intervention||0
6716931|NCT03004469|7646744|FG002|STARTED|Overall Study||85
6716932|NCT03004469|7646742|FG000|COMPLETED|Overall Study||128
6716933|NCT03004469|7646743|FG001|COMPLETED|Overall Study||135
6716934|NCT03004469|7646744|FG002|COMPLETED|Overall Study||60
6716935|NCT03004469|7646742|FG000|NOT COMPLETED|Overall Study||61
6716936|NCT03004469|7646743|FG001|NOT COMPLETED|Overall Study||49
6716937|NCT03004469|7646744|FG002|NOT COMPLETED|Overall Study||25
6716938|NCT03004534|7646753|FG000|STARTED|Overall Study||36
6716939|NCT03004534|7646753|FG000|COMPLETED|Overall Study||36
6716940|NCT03004534|7646753|FG000|NOT COMPLETED|Overall Study||0
6716941|NCT03004638|7646763|FG000|STARTED|Overall Study||6
6716942|NCT03004638|7646764|FG001|STARTED|Overall Study||6
6716943|NCT03004638|7646765|FG002|STARTED|Overall Study||6
6716944|NCT03004638|7646766|FG003|STARTED|Overall Study||6
6716945|NCT03004638|7646767|FG004|STARTED|Overall Study||1
6716946|NCT03004638|7646768|FG005|STARTED|Overall Study||7
6716947|NCT03004638|7646763|FG000|COMPLETED|Overall Study||6
6716948|NCT03004638|7646764|FG001|COMPLETED|Overall Study||6
6716949|NCT03004638|7646765|FG002|COMPLETED|Overall Study||6
6716950|NCT03004638|7646766|FG003|COMPLETED|Overall Study||6
6716951|NCT03004638|7646767|FG004|COMPLETED|Overall Study||1
6716952|NCT03004638|7646768|FG005|COMPLETED|Overall Study||7
6716953|NCT03004638|7646763|FG000|NOT COMPLETED|Overall Study||0
6716954|NCT03004638|7646764|FG001|NOT COMPLETED|Overall Study||0
6716955|NCT03004638|7646765|FG002|NOT COMPLETED|Overall Study||0
6716956|NCT03004638|7646766|FG003|NOT COMPLETED|Overall Study||0
6716957|NCT03004638|7646767|FG004|NOT COMPLETED|Overall Study||0
6716958|NCT03004638|7646768|FG005|NOT COMPLETED|Overall Study||0
6716959|NCT03004846|7646789|FG000|STARTED|Part A (Up to 14 Weeks)||8
6716960|NCT03004846|7646790|FG001|STARTED|Part A (Up to 14 Weeks)||0
6716961|NCT03004846|7646791|FG002|STARTED|Part A (Up to 14 Weeks)||0
6716962|NCT03004846|7646789|FG000|COMPLETED|Part A (Up to 14 Weeks)||8
6716963|NCT03004846|7646790|FG001|COMPLETED|Part A (Up to 14 Weeks)||0
6716964|NCT03004846|7646791|FG002|COMPLETED|Part A (Up to 14 Weeks)||0
6716965|NCT03004846|7646789|FG000|NOT COMPLETED|Part A (Up to 14 Weeks)||0
6716966|NCT03004846|7646790|FG001|NOT COMPLETED|Part A (Up to 14 Weeks)||0
6716967|NCT03004846|7646791|FG002|NOT COMPLETED|Part A (Up to 14 Weeks)||0
6716968|NCT03004846|7646789|FG000|STARTED|Part B (Up to 14 Weeks)||0
6716969|NCT03004846|7646790|FG001|STARTED|Part B (Up to 14 Weeks)||0
6716970|NCT03004846|7646791|FG002|STARTED|Part B (Up to 14 Weeks)||0
6716971|NCT03004846|7646789|FG000|COMPLETED|Part B (Up to 14 Weeks)||0
6716972|NCT03004846|7646790|FG001|COMPLETED|Part B (Up to 14 Weeks)||0
6716973|NCT03004846|7646791|FG002|COMPLETED|Part B (Up to 14 Weeks)||0
6716974|NCT03004846|7646789|FG000|NOT COMPLETED|Part B (Up to 14 Weeks)||0
6716975|NCT03004846|7646790|FG001|NOT COMPLETED|Part B (Up to 14 Weeks)||0
6716976|NCT03004846|7646791|FG002|NOT COMPLETED|Part B (Up to 14 Weeks)||0
6716977|NCT03004911|7646802|FG000|STARTED|Overall Study||20
6716978|NCT03004911|7646803|FG001|STARTED|Overall Study||20
6716979|NCT03004911|7646802|FG000|COMPLETED|Overall Study||19
6716980|NCT03004911|7646803|FG001|COMPLETED|Overall Study||17
6716981|NCT03004911|7646802|FG000|NOT COMPLETED|Overall Study||1
6716982|NCT03004911|7646803|FG001|NOT COMPLETED|Overall Study||3
6716983|NCT03004924|7646812|FG000|STARTED|Overall Study||324
6716984|NCT03004924|7646813|FG001|STARTED|Overall Study||108
6716985|NCT03004924|7646814|FG002|STARTED|Overall Study||321
6716986|NCT03004924|7646812|FG000|COMPLETED|Overall Study||297
6716987|NCT03004924|7646813|FG001|COMPLETED|Overall Study||94
6716988|NCT03004924|7646814|FG002|COMPLETED|Overall Study||293
6716989|NCT03004924|7646812|FG000|NOT COMPLETED|Overall Study||27
6716990|NCT03004924|7646813|FG001|NOT COMPLETED|Overall Study||14
6716991|NCT03004924|7646814|FG002|NOT COMPLETED|Overall Study||28
6716992|NCT03005041|7646823|FG000|STARTED|Period 1||28
6716993|NCT03005041|7646824|FG001|STARTED|Period 1||27
6716994|NCT03005041|7646823|FG000|COMPLETED|Period 1||28
6716995|NCT03005041|7646824|FG001|COMPLETED|Period 1||27
6716996|NCT03005041|7646823|FG000|NOT COMPLETED|Period 1||0
6716997|NCT03005041|7646824|FG001|NOT COMPLETED|Period 1||0
6716998|NCT03005041|7646823|FG000|STARTED|Washout Period 1||28
6716999|NCT03005041|7646824|FG001|STARTED|Washout Period 1||27
6717000|NCT03005041|7646823|FG000|COMPLETED|Washout Period 1||28
6602817|NCT02059135|7527869|FG000|COMPLETED|Neonatal Follow-up (Safety Population)||56
6717001|NCT03005041|7646824|FG001|COMPLETED|Washout Period 1||27
6717002|NCT03005041|7646823|FG000|NOT COMPLETED|Washout Period 1||0
6717003|NCT03005041|7646824|FG001|NOT COMPLETED|Washout Period 1||0
6717004|NCT03005041|7646823|FG000|STARTED|Period 2||28
6717005|NCT03005041|7646824|FG001|STARTED|Period 2||27
6717006|NCT03005041|7646823|FG000|COMPLETED|Period 2||28
6717007|NCT03005041|7646824|FG001|COMPLETED|Period 2||27
6717008|NCT03005041|7646823|FG000|NOT COMPLETED|Period 2||0
6717009|NCT03005041|7646824|FG001|NOT COMPLETED|Period 2||0
6717010|NCT03005054|7646830|FG000|STARTED|Overall Study||3
6717011|NCT03005054|7646830|FG000|COMPLETED|Overall Study||3
6717012|NCT03005054|7646830|FG000|NOT COMPLETED|Overall Study||0
6717013|NCT03005067|7646836|FG000|STARTED|Overall Study||90
6717014|NCT03005067|7646837|FG001|STARTED|Overall Study||81
6717015|NCT03005067|7646836|FG000|COMPLETED|Overall Study||80
6717016|NCT03005067|7646837|FG001|COMPLETED|Overall Study||74
6717017|NCT03005067|7646836|FG000|NOT COMPLETED|Overall Study||10
6717018|NCT03005067|7646837|FG001|NOT COMPLETED|Overall Study||7
6717019|NCT03005106|7646843|FG000|STARTED|Overall Study||71
6717020|NCT03005106|7646843|FG000|Completed Month 3 Visit|Overall Study||64
6717021|NCT03005106|7646843|FG000|Completed Month 12 Visit|Overall Study||51
6717022|NCT03005106|7646843|FG000|COMPLETED|Overall Study||51
6717023|NCT03005106|7646843|FG000|NOT COMPLETED|Overall Study||20
6717024|NCT03005288|7646849|FG000|STARTED|Overall Study||39
6717025|NCT03005288|7646850|FG001|STARTED|Overall Study||39
6717026|NCT03005288|7646849|FG000|Safety Analysis Set|Overall Study||37
6717027|NCT03005288|7646850|FG001|Safety Analysis Set|Overall Study||38
6717028|NCT03005288|7646849|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
6717029|NCT03005288|7646850|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|PK samples were only obtained and evaluated for subjects treated with BYM338.|0
6717030|NCT03005288|7646849|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|One subject was excluded due to a protocol deviation.|36
6717031|NCT03005288|7646850|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|Two subjects were excluded due to protocol deviations.|36
6717032|NCT03005288|7646849|FG000|COMPLETED|Overall Study||27
6717033|NCT03005288|7646850|FG001|COMPLETED|Overall Study||31
6717034|NCT03005288|7646849|FG000|NOT COMPLETED|Overall Study||12
6717035|NCT03005288|7646850|FG001|NOT COMPLETED|Overall Study||8
6717036|NCT03006341|7646860|FG000|STARTED|Overall Study||26199
6717037|NCT03006341|7646861|FG001|STARTED|Overall Study||70071
6717038|NCT03006341|7646862|FG002|STARTED|Overall Study||32595
6717039|NCT03006341|7646863|FG003|STARTED|Overall Study||11322
6717040|NCT03006341|7646860|FG000|COMPLETED|Overall Study||1130
6717041|NCT03006341|7646861|FG001|COMPLETED|Overall Study||2566
6717042|NCT03006341|7646862|FG002|COMPLETED|Overall Study||1602
6717043|NCT03006341|7646863|FG003|COMPLETED|Overall Study||637
6717044|NCT03006341|7646860|FG000|NOT COMPLETED|Overall Study||25069
6717045|NCT03006341|7646861|FG001|NOT COMPLETED|Overall Study||67505
6717046|NCT03006341|7646862|FG002|NOT COMPLETED|Overall Study||30993
6717047|NCT03006341|7646863|FG003|NOT COMPLETED|Overall Study||10685
6717048|NCT03006393|7646873|FG000|STARTED|Overall Study||21
6263386|NCT00943852|7162171|FG003|COMPLETED|Fifth Period of Treatment Intervention||0
6263387|NCT00943852|7162172|FG004|COMPLETED|Fifth Period of Treatment Intervention||1
6263388|NCT00943852|7162173|FG005|COMPLETED|Fifth Period of Treatment Intervention||0
6263389|NCT00943852|7162174|FG006|COMPLETED|Fifth Period of Treatment Intervention||0
6263390|NCT00943852|7162175|FG007|COMPLETED|Fifth Period of Treatment Intervention||0
6263391|NCT00943852|7162176|FG008|COMPLETED|Fifth Period of Treatment Intervention||1
6263392|NCT00943852|7162177|FG009|COMPLETED|Fifth Period of Treatment Intervention||1
6263393|NCT00943852|7162168|FG000|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263394|NCT00943852|7162169|FG001|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263395|NCT00943852|7162170|FG002|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263396|NCT00943852|7162171|FG003|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263397|NCT00943852|7162172|FG004|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263398|NCT00943852|7162173|FG005|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263399|NCT00943852|7162174|FG006|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263400|NCT00943852|7162175|FG007|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263401|NCT00943852|7162176|FG008|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263402|NCT00943852|7162177|FG009|NOT COMPLETED|Fifth Period of Treatment Intervention||0
6263403|NCT00927953|7162189|FG000|STARTED|Overall Study||6
6263404|NCT00927953|7162190|FG001|STARTED|Overall Study||7
6263405|NCT00927953|7162189|FG000|COMPLETED|Overall Study||4
6263406|NCT00927953|7162190|FG001|COMPLETED|Overall Study||6
6263407|NCT00927953|7162189|FG000|NOT COMPLETED|Overall Study||2
6263408|NCT00927953|7162190|FG001|NOT COMPLETED|Overall Study||1
6263409|NCT00909389|7162197|FG000|STARTED|Overall Study||4748
6263410|NCT00909389|7162197|FG000|COMPLETED|Overall Study||4615
6263411|NCT00909389|7162197|FG000|NOT COMPLETED|Overall Study||133
6263412|NCT00820027|7162205|FG000|STARTED|Overall Study||224
6263413|NCT00820027|7162206|FG001|STARTED|Overall Study||230
6263414|NCT00820027|7162207|FG002|STARTED|Overall Study||224
6263415|NCT00820027|7162208|FG003|STARTED|Overall Study||98
6263416|NCT00820027|7162205|FG000|COMPLETED|Overall Study||198
6263417|NCT00820027|7162206|FG001|COMPLETED|Overall Study||216
6263418|NCT00820027|7162207|FG002|COMPLETED|Overall Study||203
6263419|NCT00820027|7162208|FG003|COMPLETED|Overall Study||85
6263420|NCT00820027|7162205|FG000|NOT COMPLETED|Overall Study||26
6263421|NCT00820027|7162206|FG001|NOT COMPLETED|Overall Study||14
6263422|NCT00820027|7162207|FG002|NOT COMPLETED|Overall Study||21
6263423|NCT00820027|7162208|FG003|NOT COMPLETED|Overall Study||13
6263424|NCT00788710|7162222|FG000|STARTED|Overall Study||144
6263425|NCT00788710|7162223|FG001|STARTED|Overall Study||142
6263426|NCT00788710|7162224|FG002|STARTED|Overall Study||144
6263427|NCT00788710|7162222|FG000|COMPLETED|Overall Study||139
6263428|NCT00788710|7162223|FG001|COMPLETED|Overall Study||134
6263429|NCT00788710|7162224|FG002|COMPLETED|Overall Study||138
6263430|NCT00788710|7162222|FG000|NOT COMPLETED|Overall Study||5
6263431|NCT00788710|7162223|FG001|NOT COMPLETED|Overall Study||8
6263432|NCT00788710|7162224|FG002|NOT COMPLETED|Overall Study||6
6263433|NCT00783224|7162236|FG000|STARTED|Overall Study||32
6263434|NCT00783224|7162237|FG001|STARTED|Overall Study||34
6263435|NCT00783224|7162238|FG002|STARTED|Overall Study||143
6263436|NCT00783224|7162239|FG003|STARTED|Overall Study||142
6263437|NCT00783224|7162236|FG000|COMPLETED|Overall Study||32
6263438|NCT00783224|7162237|FG001|COMPLETED|Overall Study||34
6263439|NCT00783224|7162238|FG002|COMPLETED|Overall Study||142
6263440|NCT00783224|7162239|FG003|COMPLETED|Overall Study||140
6263441|NCT00783224|7162236|FG000|NOT COMPLETED|Overall Study||0
6263442|NCT00783224|7162237|FG001|NOT COMPLETED|Overall Study||0
6263443|NCT00783224|7162238|FG002|NOT COMPLETED|Overall Study||1
6717049|NCT03006393|7646874|FG001|STARTED|Overall Study||21
6717050|NCT03006393|7646873|FG000|COMPLETED|Overall Study||20
6717051|NCT03006393|7646874|FG001|COMPLETED|Overall Study||18
6717052|NCT03006393|7646873|FG000|NOT COMPLETED|Overall Study||1
6717053|NCT03006393|7646874|FG001|NOT COMPLETED|Overall Study||3
6717054|NCT03006458|7646880|FG000|STARTED|First Intervention||14
6717055|NCT03006458|7646881|FG001|STARTED|First Intervention||10
6717056|NCT03006458|7646880|FG000|COMPLETED|First Intervention||14
6717057|NCT03006458|7646881|FG001|COMPLETED|First Intervention||7
6717058|NCT03006458|7646880|FG000|NOT COMPLETED|First Intervention||0
6717059|NCT03006458|7646881|FG001|NOT COMPLETED|First Intervention||3
6717060|NCT03006458|7646880|FG000|STARTED|Second Intervention||14
6717061|NCT03006458|7646881|FG001|STARTED|Second Intervention||10
6717062|NCT03006458|7646880|FG000|COMPLETED|Second Intervention||14
6717063|NCT03006458|7646881|FG001|COMPLETED|Second Intervention||10
6717064|NCT03006458|7646880|FG000|NOT COMPLETED|Second Intervention||0
6717065|NCT03006458|7646881|FG001|NOT COMPLETED|Second Intervention||0
6717066|NCT03006471|7646889|FG000|STARTED|Overall Study||15
6717067|NCT03006471|7646890|FG001|STARTED|Overall Study||15
6717068|NCT03006471|7646889|FG000|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
6717069|NCT03006471|7646890|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawal|13
6717070|NCT03006471|7646889|FG000|NOT COMPLETED|Overall Study||2
6717071|NCT03006471|7646890|FG001|NOT COMPLETED|Overall Study||2
6717072|NCT03006562|7646898|FG000|STARTED|Overall Study||251
6717073|NCT03006562|7646899|FG001|STARTED|Overall Study||250
6717074|NCT03006562|7646898|FG000|Voluntary Ultrasound at 30 Days|Overall Study||141
6717075|NCT03006562|7646899|FG001|Voluntary Ultrasound at 30 Days|Overall Study||137
6717076|NCT03006562|7646898|FG000|COMPLETED|Overall Study||251
6717077|NCT03006562|7646899|FG001|COMPLETED|Overall Study||249
6717078|NCT03006562|7646898|FG000|NOT COMPLETED|Overall Study||0
6717079|NCT03006562|7646899|FG001|NOT COMPLETED|Overall Study||1
6717080|NCT03006848|7646905|FG000|STARTED|Overall Study||18
6717081|NCT03006848|7646905|FG000|COMPLETED|Overall Study||0
6717082|NCT03006848|7646905|FG000|NOT COMPLETED|Overall Study||18
6717083|NCT03006887|7646916|FG000|STARTED|Overall Study||6
6717084|NCT03006887|7646916|FG000|COMPLETED|Overall Study||5
6717085|NCT03006887|7646916|FG000|NOT COMPLETED|Overall Study||1
6717086|NCT03007225|7646922|FG000|STARTED|Overall Study|Followed up for at least 6 months after DEB TACE|25
6717087|NCT03007225|7646923|FG001|STARTED|Overall Study|followed up for at least 6 months after TACE|25
6717088|NCT03007225|7646922|FG000|COMPLETED|Overall Study||25
6717089|NCT03007225|7646923|FG001|COMPLETED|Overall Study||25
6717090|NCT03007225|7646922|FG000|NOT COMPLETED|Overall Study||0
6717091|NCT03007225|7646923|FG001|NOT COMPLETED|Overall Study||0
6717092|NCT03007394|7646931|FG000|STARTED|Overall Study||118
6717093|NCT03007394|7646932|FG001|STARTED|Overall Study||154
6717094|NCT03007394|7646931|FG000|COMPLETED|Overall Study||91
6717095|NCT03007394|7646932|FG001|COMPLETED|Overall Study||91
6717096|NCT03007394|7646931|FG000|NOT COMPLETED|Overall Study||27
6717097|NCT03007394|7646932|FG001|NOT COMPLETED|Overall Study||63
6717098|NCT03007472|7646938|FG000|STARTED|Overall Study||96
6717099|NCT03007472|7646938|FG000|COMPLETED|Overall Study||91
6717100|NCT03007472|7646938|FG000|NOT COMPLETED|Overall Study||5
6717101|NCT03007953|7646944|FG000|STARTED|Overall Study||73
6717102|NCT03007953|7646945|FG001|STARTED|Overall Study||78
6717103|NCT03007953|7646944|FG000|COMPLETED|Overall Study||57
6717104|NCT03007953|7646945|FG001|COMPLETED|Overall Study||65
6717105|NCT03007953|7646944|FG000|NOT COMPLETED|Overall Study||16
6717106|NCT03007953|7646945|FG001|NOT COMPLETED|Overall Study||13
6717107|NCT03007966|7646953|FG000|STARTED|Overall Study||30
6717108|NCT03007966|7646954|FG001|STARTED|Overall Study||30
6717109|NCT03007966|7646953|FG000|COMPLETED|Overall Study||29
6717110|NCT03007966|7646954|FG001|COMPLETED|Overall Study||30
6263444|NCT00783224|7162239|FG003|NOT COMPLETED|Overall Study||2
6263445|NCT00780403|7162248|FG000|STARTED|First Intervention||109
6263446|NCT00780403|7162249|FG001|STARTED|First Intervention||111
6263447|NCT00780403|7162248|FG000|COMPLETED|First Intervention||109
6263448|NCT00780403|7162249|FG001|COMPLETED|First Intervention||111
6263449|NCT00780403|7162248|FG000|NOT COMPLETED|First Intervention||0
6263450|NCT00780403|7162249|FG001|NOT COMPLETED|First Intervention||0
6263451|NCT00780403|7162248|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
6263452|NCT00780403|7162249|FG001|STARTED|Interval Between Doses (8-10 Minutes)||111
6263453|NCT00780403|7162248|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
6263454|NCT00780403|7162249|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||111
6263455|NCT00780403|7162248|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
6263456|NCT00780403|7162249|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
6717111|NCT03007966|7646953|FG000|NOT COMPLETED|Overall Study||1
6717112|NCT03007966|7646954|FG001|NOT COMPLETED|Overall Study||0
6717113|NCT03008070|7646964|FG000|STARTED|Overall Study||83
6717114|NCT03008070|7646965|FG001|STARTED|Overall Study||83
6717115|NCT03008070|7646966|FG002|STARTED|Overall Study||81
6717116|NCT03008070|7646964|FG000|COMPLETED|Overall Study||77
6717117|NCT03008070|7646965|FG001|COMPLETED|Overall Study||77
6717118|NCT03008070|7646966|FG002|COMPLETED|Overall Study||74
6717119|NCT03008070|7646964|FG000|NOT COMPLETED|Overall Study||6
6717120|NCT03008070|7646965|FG001|NOT COMPLETED|Overall Study||6
6717121|NCT03008070|7646966|FG002|NOT COMPLETED|Overall Study||7
6739505|NCT03291197|7668389|FG000|COMPLETED|Overall Study||5
6739506|NCT03291197|7668389|FG000|NOT COMPLETED|Overall Study||0
6739507|NCT03291288|7668397|FG000|STARTED|Drug-drug Interaction Phase||32
6739508|NCT03291288|7668398|FG001|STARTED|Drug-drug Interaction Phase||0
6739509|NCT03291288|7668397|FG000|COMPLETED|Drug-drug Interaction Phase||26
6739510|NCT03291288|7668398|FG001|COMPLETED|Drug-drug Interaction Phase||0
6739511|NCT03291288|7668397|FG000|NOT COMPLETED|Drug-drug Interaction Phase||6
6263457|NCT00780403|7162248|FG000|STARTED|Second Intervention||109
6263458|NCT00780403|7162249|FG001|STARTED|Second Intervention||111
6717122|NCT03008174|7646978|FG000|STARTED|Overall Study||10
6717123|NCT03008174|7646979|FG001|STARTED|Overall Study||10
6717124|NCT03008174|7646978|FG000|COMPLETED|Overall Study||7
6717125|NCT03008174|7646979|FG001|COMPLETED|Overall Study||6
6717126|NCT03008174|7646978|FG000|NOT COMPLETED|Overall Study||3
6717127|NCT03008174|7646979|FG001|NOT COMPLETED|Overall Study||4
6717128|NCT03008213|7646985|FG000|STARTED|Overall Study||1
6717129|NCT03008213|7646985|FG000|COMPLETED|Overall Study||1
6717130|NCT03008213|7646985|FG000|NOT COMPLETED|Overall Study||0
6717131|NCT03008460|7646991|FG000|STARTED|Overall Study||126
6717132|NCT03008460|7646992|FG001|STARTED|Overall Study||124
6717133|NCT03008460|7646991|FG000|COMPLETED|Overall Study||119
6717134|NCT03008460|7646992|FG001|COMPLETED|Overall Study||110
6717135|NCT03008460|7646991|FG000|NOT COMPLETED|Overall Study||7
6717136|NCT03008460|7646992|FG001|NOT COMPLETED|Overall Study||14
6717137|NCT03008590|7647000|FG000|STARTED|Overall Study||14
6717138|NCT03008590|7647001|FG001|STARTED|Overall Study||15
6717139|NCT03008590|7647000|FG000|COMPLETED|Overall Study||11
6717140|NCT03008590|7647001|FG001|COMPLETED|Overall Study||12
6717141|NCT03008590|7647000|FG000|NOT COMPLETED|Overall Study||3
6717142|NCT03008590|7647001|FG001|NOT COMPLETED|Overall Study||3
6717143|NCT03008707|7647009|FG000|STARTED|Overall Study||28
6717144|NCT03008707|7647010|FG001|STARTED|Overall Study||38
6717145|NCT03008707|7647009|FG000|COMPLETED|Overall Study||28
6717146|NCT03008707|7647010|FG001|COMPLETED|Overall Study||38
6717147|NCT03008707|7647009|FG000|NOT COMPLETED|Overall Study||0
6717148|NCT03008707|7647010|FG001|NOT COMPLETED|Overall Study||0
6717149|NCT03008837|7647018|FG000|STARTED|Overall Study||12
6717150|NCT03008837|7647019|FG001|STARTED|Overall Study||9
6717151|NCT03008837|7647018|FG000|COMPLETED|Overall Study||9
6717152|NCT03008837|7647019|FG001|COMPLETED|Overall Study||5
6717153|NCT03008837|7647018|FG000|NOT COMPLETED|Overall Study||3
6717154|NCT03008837|7647019|FG001|NOT COMPLETED|Overall Study||4
6717155|NCT03008889|7647030|FG000|STARTED|Overall Study||1
6717156|NCT03008889|7647031|FG001|STARTED|Overall Study||1
6717157|NCT03008889|7647030|FG000|COMPLETED|Overall Study||1
6717158|NCT03008889|7647031|FG001|COMPLETED|Overall Study||1
6717159|NCT03008889|7647030|FG000|NOT COMPLETED|Overall Study||0
6717160|NCT03008889|7647031|FG001|NOT COMPLETED|Overall Study||0
6717161|NCT03008915|7647038|FG000|STARTED|Treatment 1||8
6717162|NCT03008915|7647039|FG001|STARTED|Treatment 1||7
6717163|NCT03008915|7647038|FG000|COMPLETED|Treatment 1||8
6717164|NCT03008915|7647039|FG001|COMPLETED|Treatment 1||6
6717165|NCT03008915|7647038|FG000|NOT COMPLETED|Treatment 1||0
6717166|NCT03008915|7647039|FG001|NOT COMPLETED|Treatment 1||1
6717167|NCT03008915|7647038|FG000|STARTED|Treatment 2||8
6717168|NCT03008915|7647039|FG001|STARTED|Treatment 2||6
6717169|NCT03008915|7647038|FG000|COMPLETED|Treatment 2||8
6717170|NCT03008915|7647039|FG001|COMPLETED|Treatment 2||6
6717171|NCT03008915|7647038|FG000|NOT COMPLETED|Treatment 2||0
6717172|NCT03008915|7647039|FG001|NOT COMPLETED|Treatment 2||0
6717173|NCT03009162|7647048|FG000|STARTED|Overall Study||8
6717174|NCT03009162|7647049|FG001|STARTED|Overall Study||8
6717175|NCT03009162|7647048|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6717176|NCT03009162|7647049|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
6717177|NCT03009162|7647048|FG000|COMPLETED|Overall Study||8
6717178|NCT03009162|7647049|FG001|COMPLETED|Overall Study||8
6717179|NCT03009162|7647048|FG000|NOT COMPLETED|Overall Study||0
6717180|NCT03009162|7647049|FG001|NOT COMPLETED|Overall Study||0
6717181|NCT03009396|7647055|FG000|STARTED|Overall Study||16
6717182|NCT03009396|7647056|FG001|STARTED|Overall Study||38
6717183|NCT03009396|7647055|FG000|COMPLETED|Overall Study||9
6717184|NCT03009396|7647056|FG001|COMPLETED|Overall Study||21
6717185|NCT03009396|7647055|FG000|NOT COMPLETED|Overall Study||7
6717186|NCT03009396|7647056|FG001|NOT COMPLETED|Overall Study||17
6717187|NCT03010137|7647065|FG000|STARTED|Overall Study||15
6717188|NCT03010137|7647066|FG001|STARTED|Overall Study||15
6717189|NCT03010137|7647065|FG000|COMPLETED|Overall Study||15
6717190|NCT03010137|7647066|FG001|COMPLETED|Overall Study||15
6717191|NCT03010137|7647065|FG000|NOT COMPLETED|Overall Study||0
6717192|NCT03010137|7647066|FG001|NOT COMPLETED|Overall Study||0
6717193|NCT03010254|7647074|FG000|STARTED|Overall Study||159
6717194|NCT03010254|7647075|FG001|STARTED|Overall Study||123
6717195|NCT03010254|7647074|FG000|Attempted Implantation|Overall Study||156
6717196|NCT03010254|7647075|FG001|Attempted Implantation|Overall Study||120
6717197|NCT03010254|7647074|FG000|Successful Implantation|Overall Study||156
6717198|NCT03010254|7647075|FG001|Successful Implantation|Overall Study||120
6717199|NCT03010254|7647074|FG000|COMPLETED|Overall Study||152
6717200|NCT03010254|7647075|FG001|COMPLETED|Overall Study||118
6717201|NCT03010254|7647074|FG000|NOT COMPLETED|Overall Study||7
6717202|NCT03010254|7647075|FG001|NOT COMPLETED|Overall Study||5
6717203|NCT03010462|7647090|FG000|STARTED|Overall Study||31
6717204|NCT03010462|7647091|FG001|STARTED|Overall Study||29
6717205|NCT03010462|7647090|FG000|COMPLETED|Overall Study|1 subject withdrew consent before baseline visit. 2 subjects completed treatment but were lost during follow-up|28
6717206|NCT03010462|7647091|FG001|COMPLETED|Overall Study|1 subject withdrew consent prior to baseline visit|28
6717207|NCT03010462|7647090|FG000|NOT COMPLETED|Overall Study||3
6717208|NCT03010462|7647091|FG001|NOT COMPLETED|Overall Study||1
6717209|NCT03010488|7647099|FG000|STARTED|Overall Study||22
6717210|NCT03010488|7647100|FG001|STARTED|Overall Study||22
6717211|NCT03010488|7647099|FG000|COMPLETED|Overall Study||17
6717212|NCT03010488|7647100|FG001|COMPLETED|Overall Study||15
6717213|NCT03010488|7647099|FG000|NOT COMPLETED|Overall Study||5
6717214|NCT03010488|7647100|FG001|NOT COMPLETED|Overall Study||7
6717215|NCT03010501|7647106|FG000|STARTED|Study Week 1||9
6717216|NCT03010501|7647107|FG001|STARTED|Study Week 1||15
6717217|NCT03010501|7647108|FG002|STARTED|Study Week 1||7
6717218|NCT03010501|7647109|FG003|STARTED|Study Week 1||7
6717219|NCT03010501|7647110|FG004|STARTED|Study Week 1||7
6717220|NCT03010501|7647111|FG005|STARTED|Study Week 1||11
6717221|NCT03010501|7647106|FG000|COMPLETED|Study Week 1||7
6717222|NCT03010501|7647107|FG001|COMPLETED|Study Week 1||14
6717223|NCT03010501|7647108|FG002|COMPLETED|Study Week 1||7
6717224|NCT03010501|7647109|FG003|COMPLETED|Study Week 1||5
6717225|NCT03010501|7647110|FG004|COMPLETED|Study Week 1||7
6717226|NCT03010501|7647111|FG005|COMPLETED|Study Week 1||11
6717227|NCT03010501|7647106|FG000|NOT COMPLETED|Study Week 1||2
6717228|NCT03010501|7647107|FG001|NOT COMPLETED|Study Week 1||1
6717229|NCT03010501|7647108|FG002|NOT COMPLETED|Study Week 1||0
6717230|NCT03010501|7647109|FG003|NOT COMPLETED|Study Week 1||2
6717231|NCT03010501|7647110|FG004|NOT COMPLETED|Study Week 1||0
6717232|NCT03010501|7647111|FG005|NOT COMPLETED|Study Week 1||0
6717233|NCT03010501|7647106|FG000|STARTED|Study Week 2||7
6717234|NCT03010501|7647107|FG001|STARTED|Study Week 2||14
6717235|NCT03010501|7647108|FG002|STARTED|Study Week 2||7
6717236|NCT03010501|7647109|FG003|STARTED|Study Week 2||5
6717237|NCT03010501|7647110|FG004|STARTED|Study Week 2||7
6717238|NCT03010501|7647111|FG005|STARTED|Study Week 2||11
6717239|NCT03010501|7647106|FG000|COMPLETED|Study Week 2||7
6717240|NCT03010501|7647107|FG001|COMPLETED|Study Week 2||14
6717241|NCT03010501|7647108|FG002|COMPLETED|Study Week 2||7
6717242|NCT03010501|7647109|FG003|COMPLETED|Study Week 2||5
6717243|NCT03010501|7647110|FG004|COMPLETED|Study Week 2||7
6717244|NCT03010501|7647111|FG005|COMPLETED|Study Week 2||11
6717245|NCT03010501|7647106|FG000|NOT COMPLETED|Study Week 2||0
6717246|NCT03010501|7647107|FG001|NOT COMPLETED|Study Week 2||0
6717247|NCT03010501|7647108|FG002|NOT COMPLETED|Study Week 2||0
6717248|NCT03010501|7647109|FG003|NOT COMPLETED|Study Week 2||0
6717249|NCT03010501|7647110|FG004|NOT COMPLETED|Study Week 2||0
6717250|NCT03010501|7647111|FG005|NOT COMPLETED|Study Week 2||0
6717251|NCT03010501|7647106|FG000|STARTED|Study Week 3||7
6717252|NCT03010501|7647107|FG001|STARTED|Study Week 3||14
6717253|NCT03010501|7647108|FG002|STARTED|Study Week 3||7
6717254|NCT03010501|7647109|FG003|STARTED|Study Week 3||5
6717255|NCT03010501|7647110|FG004|STARTED|Study Week 3||7
6717256|NCT03010501|7647111|FG005|STARTED|Study Week 3||11
6717257|NCT03010501|7647106|FG000|COMPLETED|Study Week 3||7
6717258|NCT03010501|7647107|FG001|COMPLETED|Study Week 3||14
6717259|NCT03010501|7647108|FG002|COMPLETED|Study Week 3||7
6717260|NCT03010501|7647109|FG003|COMPLETED|Study Week 3||4
6717261|NCT03010501|7647110|FG004|COMPLETED|Study Week 3||7
6717262|NCT03010501|7647111|FG005|COMPLETED|Study Week 3||11
6717263|NCT03010501|7647106|FG000|NOT COMPLETED|Study Week 3||0
6717264|NCT03010501|7647107|FG001|NOT COMPLETED|Study Week 3||0
6717265|NCT03010501|7647108|FG002|NOT COMPLETED|Study Week 3||0
6717266|NCT03010501|7647109|FG003|NOT COMPLETED|Study Week 3||1
6717267|NCT03010501|7647110|FG004|NOT COMPLETED|Study Week 3||0
6717268|NCT03010501|7647111|FG005|NOT COMPLETED|Study Week 3||0
6717269|NCT03010527|7647122|FG000|STARTED|Overall Study||15
6717270|NCT03010527|7647123|FG001|STARTED|Overall Study||111
6717271|NCT03010527|7647124|FG002|STARTED|Overall Study||91
6717272|NCT03010527|7647122|FG000|COMPLETED|Overall Study||15
6717273|NCT03010527|7647123|FG001|COMPLETED|Overall Study||92
6717274|NCT03010527|7647124|FG002|COMPLETED|Overall Study||75
6717275|NCT03010527|7647122|FG000|NOT COMPLETED|Overall Study||0
6717276|NCT03010527|7647123|FG001|NOT COMPLETED|Overall Study||19
6717277|NCT03010527|7647124|FG002|NOT COMPLETED|Overall Study||16
6717278|NCT03010631|7647145|FG000|STARTED|Cohort 1||18
6717279|NCT03010631|7647146|FG001|STARTED|Cohort 1||17
6717280|NCT03010631|7647147|FG002|STARTED|Cohort 1||0
6717281|NCT03010631|7647148|FG003|STARTED|Cohort 1||0
6717282|NCT03010631|7647145|FG000|COMPLETED|Cohort 1||14
6717283|NCT03010631|7647146|FG001|COMPLETED|Cohort 1||17
6717284|NCT03010631|7647147|FG002|COMPLETED|Cohort 1||0
6717285|NCT03010631|7647148|FG003|COMPLETED|Cohort 1||0
6717286|NCT03010631|7647145|FG000|NOT COMPLETED|Cohort 1||4
6717287|NCT03010631|7647146|FG001|NOT COMPLETED|Cohort 1||0
6717288|NCT03010631|7647147|FG002|NOT COMPLETED|Cohort 1||0
6717289|NCT03010631|7647148|FG003|NOT COMPLETED|Cohort 1||0
6717290|NCT03010631|7647145|FG000|STARTED|Cohort 2||0
6717291|NCT03010631|7647146|FG001|STARTED|Cohort 2||0
6717292|NCT03010631|7647147|FG002|STARTED|Cohort 2|New participants were enrolled for Cohort 2|7
6717293|NCT03010631|7647148|FG003|STARTED|Cohort 2||7
6717294|NCT03010631|7647145|FG000|COMPLETED|Cohort 2||0
6717295|NCT03010631|7647146|FG001|COMPLETED|Cohort 2||0
6717296|NCT03010631|7647147|FG002|COMPLETED|Cohort 2||7
6717297|NCT03010631|7647148|FG003|COMPLETED|Cohort 2||7
6717298|NCT03010631|7647145|FG000|NOT COMPLETED|Cohort 2||0
6717299|NCT03010631|7647146|FG001|NOT COMPLETED|Cohort 2||0
6717300|NCT03010631|7647147|FG002|NOT COMPLETED|Cohort 2||0
6717301|NCT03010631|7647148|FG003|NOT COMPLETED|Cohort 2||0
6717302|NCT03010683|7647164|FG000|STARTED|Overall Study||30
6717303|NCT03010683|7647165|FG001|STARTED|Overall Study||30
6717304|NCT03010683|7647164|FG000|COMPLETED|Overall Study||30
6717305|NCT03010683|7647165|FG001|COMPLETED|Overall Study||30
6717306|NCT03010683|7647164|FG000|NOT COMPLETED|Overall Study||0
6717307|NCT03010683|7647165|FG001|NOT COMPLETED|Overall Study||0
6717308|NCT03010800|7647173|FG000|STARTED|Initial Assignment||4
6717309|NCT03010800|7647174|FG001|STARTED|Initial Assignment||4
6717310|NCT03010800|7647173|FG000|COMPLETED|Initial Assignment||4
6717311|NCT03010800|7647174|FG001|COMPLETED|Initial Assignment||4
6717312|NCT03010800|7647173|FG000|NOT COMPLETED|Initial Assignment||0
6717313|NCT03010800|7647174|FG001|NOT COMPLETED|Initial Assignment||0
6717314|NCT03010800|7647173|FG000|STARTED|Cross Over||4
6717315|NCT03010800|7647174|FG001|STARTED|Cross Over||4
6717316|NCT03010800|7647173|FG000|COMPLETED|Cross Over||4
6717317|NCT03010800|7647174|FG001|COMPLETED|Cross Over||4
6717318|NCT03010800|7647173|FG000|NOT COMPLETED|Cross Over||0
6717319|NCT03010800|7647174|FG001|NOT COMPLETED|Cross Over||0
6717320|NCT03011099|7647182|FG000|STARTED|Overall Study||6
6717321|NCT03011099|7647183|FG001|STARTED|Overall Study||5
6717322|NCT03011099|7647182|FG000|COMPLETED|Overall Study||6
6717323|NCT03011099|7647183|FG001|COMPLETED|Overall Study||3
6717324|NCT03011099|7647182|FG000|NOT COMPLETED|Overall Study||0
6717325|NCT03011099|7647183|FG001|NOT COMPLETED|Overall Study||2
6717326|NCT03011333|7647198|FG000|STARTED|Overall Study||12
6717327|NCT03011333|7647199|FG001|STARTED|Overall Study||27
6717328|NCT03011333|7647200|FG002|STARTED|Overall Study||25
6717329|NCT03011333|7647201|FG003|STARTED|Overall Study||47
6717330|NCT03011333|7647202|FG004|STARTED|Overall Study||50
6717331|NCT03011333|7647203|FG005|STARTED|Overall Study||41
6717332|NCT03011333|7647204|FG006|STARTED|Overall Study||41
6717333|NCT03011333|7647198|FG000|COMPLETED|Overall Study||12
6717334|NCT03011333|7647199|FG001|COMPLETED|Overall Study||26
6717335|NCT03011333|7647200|FG002|COMPLETED|Overall Study||25
6717336|NCT03011333|7647201|FG003|COMPLETED|Overall Study||46
6717337|NCT03011333|7647202|FG004|COMPLETED|Overall Study||46
6717338|NCT03011333|7647203|FG005|COMPLETED|Overall Study||37
6717339|NCT03011333|7647204|FG006|COMPLETED|Overall Study||36
6717340|NCT03011333|7647198|FG000|NOT COMPLETED|Overall Study||0
6717341|NCT03011333|7647199|FG001|NOT COMPLETED|Overall Study||1
6717342|NCT03011333|7647200|FG002|NOT COMPLETED|Overall Study||0
6717343|NCT03011333|7647201|FG003|NOT COMPLETED|Overall Study||1
6717344|NCT03011333|7647202|FG004|NOT COMPLETED|Overall Study||4
6263459|NCT00780403|7162248|FG000|COMPLETED|Second Intervention||109
6263460|NCT00780403|7162249|FG001|COMPLETED|Second Intervention||111
6263461|NCT00780403|7162248|FG000|NOT COMPLETED|Second Intervention||0
6263462|NCT00780403|7162249|FG001|NOT COMPLETED|Second Intervention||0
6263463|NCT00779116|7162256|FG000|STARTED|First Intervention||109
6263464|NCT00779116|7162257|FG001|STARTED|First Intervention||108
6263465|NCT00779116|7162256|FG000|COMPLETED|First Intervention||109
6263466|NCT00779116|7162257|FG001|COMPLETED|First Intervention||108
6263467|NCT00779116|7162256|FG000|NOT COMPLETED|First Intervention||0
6263468|NCT00779116|7162257|FG001|NOT COMPLETED|First Intervention||0
6263469|NCT00779116|7162256|FG000|STARTED|Interval Between Doses (8-10 Minutes)||109
6263470|NCT00779116|7162257|FG001|STARTED|Interval Between Doses (8-10 Minutes)||108
6263471|NCT00779116|7162256|FG000|COMPLETED|Interval Between Doses (8-10 Minutes)||109
6263472|NCT00779116|7162257|FG001|COMPLETED|Interval Between Doses (8-10 Minutes)||108
6263473|NCT00779116|7162256|FG000|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
6263474|NCT00779116|7162257|FG001|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
6263475|NCT00779116|7162256|FG000|STARTED|Second Intervention||109
6263476|NCT00779116|7162257|FG001|STARTED|Second Intervention||108
6263477|NCT00779116|7162256|FG000|COMPLETED|Second Intervention||109
6263478|NCT00779116|7162257|FG001|COMPLETED|Second Intervention||108
6263479|NCT00779116|7162256|FG000|NOT COMPLETED|Second Intervention||0
6263480|NCT00779116|7162257|FG001|NOT COMPLETED|Second Intervention||0
6263481|NCT00778700|7162268|FG000|STARTED|Overall Study||50
6263482|NCT00778700|7162269|FG001|STARTED|Overall Study||51
6263483|NCT00778700|7162270|FG002|STARTED|Overall Study||49
6263484|NCT00778700|7162271|FG003|STARTED|Overall Study||49
6263485|NCT00778700|7162268|FG000|COMPLETED|Overall Study||32
6263486|NCT00778700|7162269|FG001|COMPLETED|Overall Study||44
6263487|NCT00778700|7162270|FG002|COMPLETED|Overall Study||43
6263488|NCT00778700|7162271|FG003|COMPLETED|Overall Study||36
6263489|NCT00778700|7162268|FG000|NOT COMPLETED|Overall Study||18
6263490|NCT00778700|7162269|FG001|NOT COMPLETED|Overall Study||7
6263491|NCT00778700|7162270|FG002|NOT COMPLETED|Overall Study||6
6263492|NCT00778700|7162271|FG003|NOT COMPLETED|Overall Study||13
6263493|NCT00764478|7162288|FG000|STARTED|Overall Study||122
6263494|NCT00764478|7162289|FG001|STARTED|Overall Study||119
6263495|NCT00764478|7162290|FG002|STARTED|Overall Study||126
6263496|NCT00764478|7162288|FG000|COMPLETED|Overall Study||107
6263497|NCT00764478|7162289|FG001|COMPLETED|Overall Study||97
6263498|NCT00764478|7162290|FG002|COMPLETED|Overall Study||118
6263499|NCT00764478|7162288|FG000|NOT COMPLETED|Overall Study||15
6717345|NCT03011333|7647203|FG005|NOT COMPLETED|Overall Study||4
6717346|NCT03011333|7647204|FG006|NOT COMPLETED|Overall Study||5
6717347|NCT03011840|7647222|FG000|STARTED|Overall Study||232
6717348|NCT03011840|7647223|FG001|STARTED|Overall Study||217
6717349|NCT03011840|7647222|FG000|COMPLETED|Overall Study||232
6717350|NCT03011840|7647223|FG001|COMPLETED|Overall Study||196
6717351|NCT03011840|7647222|FG000|NOT COMPLETED|Overall Study||0
6717352|NCT03011840|7647223|FG001|NOT COMPLETED|Overall Study||21
6717353|NCT03011892|7647235|FG000|STARTED|Double Blind (DB) Period||52
6717354|NCT03011892|7647236|FG001|STARTED|Double Blind (DB) Period||51
6717355|NCT03011892|7647237|FG002|STARTED|Double Blind (DB) Period||51
6717356|NCT03011892|7647238|FG003|STARTED|Double Blind (DB) Period||51
6717357|NCT03011892|7647239|FG004|STARTED|Double Blind (DB) Period||52
6717358|NCT03011892|7647240|FG005|STARTED|Double Blind (DB) Period||50
6717359|NCT03011892|7647241|FG006|STARTED|Double Blind (DB) Period||0
6717360|NCT03011892|7647242|FG007|STARTED|Double Blind (DB) Period||0
6717361|NCT03011892|7647243|FG008|STARTED|Double Blind (DB) Period||0
6717362|NCT03011892|7647244|FG009|STARTED|Double Blind (DB) Period||0
6717363|NCT03011892|7647245|FG010|STARTED|Double Blind (DB) Period||0
6717364|NCT03011892|7647246|FG011|STARTED|Double Blind (DB) Period||0
6263500|NCT00764478|7162289|FG001|NOT COMPLETED|Overall Study||22
6263501|NCT00764478|7162290|FG002|NOT COMPLETED|Overall Study||8
6263502|NCT00761527|7162298|FG000|STARTED|Overall Study||2980
6263503|NCT00761527|7162298|FG000|Received One Dose of Study Medication|Overall Study||2978
6263504|NCT00761527|7162298|FG000|COMPLETED|Overall Study||2958
6263505|NCT00761527|7162298|FG000|NOT COMPLETED|Overall Study||22
6263506|NCT00757627|7162302|FG000|STARTED|Overall Study||500
6263507|NCT00757627|7162302|FG000|COMPLETED|Overall Study||419
6263508|NCT00757627|7162302|FG000|NOT COMPLETED|Overall Study||81
6263509|NCT00756938|7162314|FG000|STARTED|12-week Base Study||33
6263510|NCT00756938|7162315|FG001|STARTED|12-week Base Study||34
6263511|NCT00756938|7162316|FG002|STARTED|12-week Base Study||34
6263512|NCT00756938|7162317|FG003|STARTED|12-week Base Study||0
6263513|NCT00756938|7162314|FG000|COMPLETED|12-week Base Study||31
6263514|NCT00756938|7162315|FG001|COMPLETED|12-week Base Study||34
6263515|NCT00756938|7162316|FG002|COMPLETED|12-week Base Study||32
6263516|NCT00756938|7162317|FG003|COMPLETED|12-week Base Study||0
6263517|NCT00756938|7162314|FG000|NOT COMPLETED|12-week Base Study||2
6263518|NCT00756938|7162315|FG001|NOT COMPLETED|12-week Base Study||0
6263519|NCT00756938|7162316|FG002|NOT COMPLETED|12-week Base Study||2
6263520|NCT00756938|7162317|FG003|NOT COMPLETED|12-week Base Study||0
6263521|NCT00756938|7162314|FG000|STARTED|Optional Extension||0
6263522|NCT00756938|7162315|FG001|STARTED|Optional Extension||0
6263523|NCT00756938|7162316|FG002|STARTED|Optional Extension||0
6263524|NCT00756938|7162317|FG003|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
6263525|NCT00756938|7162314|FG000|COMPLETED|Optional Extension||0
6263526|NCT00756938|7162315|FG001|COMPLETED|Optional Extension||0
6263527|NCT00756938|7162316|FG002|COMPLETED|Optional Extension||0
6263528|NCT00756938|7162317|FG003|COMPLETED|Optional Extension||53
6263529|NCT00756938|7162314|FG000|NOT COMPLETED|Optional Extension||0
6263530|NCT00756938|7162315|FG001|NOT COMPLETED|Optional Extension||0
6263531|NCT00756938|7162316|FG002|NOT COMPLETED|Optional Extension||0
6263532|NCT00756938|7162317|FG003|NOT COMPLETED|Optional Extension||37
6263533|NCT00746590|7162335|FG000|STARTED|Overall Study||1
6263534|NCT00746590|7162335|FG000|COMPLETED|Overall Study||0
6263535|NCT00746590|7162335|FG000|NOT COMPLETED|Overall Study||1
6263536|NCT00730132|7162339|FG000|STARTED|Overall Study||712
6263537|NCT00730132|7162339|FG000|COMPLETED|Overall Study||557
6263538|NCT00730132|7162339|FG000|NOT COMPLETED|Overall Study||155
6263539|NCT00728416|7162348|FG000|STARTED|Overall Study||168
6263540|NCT00728416|7162349|FG001|STARTED|Overall Study||165
6263541|NCT00728416|7162348|FG000|COMPLETED|Overall Study||166
6263542|NCT00728416|7162349|FG001|COMPLETED|Overall Study||163
6263543|NCT00728416|7162348|FG000|NOT COMPLETED|Overall Study||2
6263544|NCT00728416|7162349|FG001|NOT COMPLETED|Overall Study||2
6263545|NCT00724477|7162355|FG000|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
6263546|NCT00724477|7162355|FG000|COMPLETED|Overall Study||1663
6263547|NCT00724477|7162355|FG000|NOT COMPLETED|Overall Study||0
6263548|NCT00723736|7162359|FG000|STARTED|Overall Study||100
6263549|NCT00723736|7162359|FG000|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
6263550|NCT00723736|7162359|FG000|NOT COMPLETED|Overall Study||1
6263551|NCT00705081|7162365|FG000|STARTED|Overall Study||255
6263552|NCT00705081|7162366|FG001|STARTED|Overall Study||198
6263553|NCT00705081|7162365|FG000|COMPLETED|Overall Study||255
6263554|NCT00705081|7162366|FG001|COMPLETED|Overall Study||198
6263555|NCT00705081|7162365|FG000|NOT COMPLETED|Overall Study||0
6263556|NCT00705081|7162366|FG001|NOT COMPLETED|Overall Study||0
6263557|NCT00704769|7162372|FG000|STARTED|Overall Study||591
6263558|NCT00704769|7162372|FG000|COMPLETED|Overall Study||591
6263559|NCT00704769|7162372|FG000|NOT COMPLETED|Overall Study||0
6602818|NCT02059135|7527870|FG001|COMPLETED|Neonatal Follow-up (Safety Population)||50
6602819|NCT02059135|7527869|FG000|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
6602820|NCT02059135|7527870|FG001|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
6602821|NCT02059148|7527878|FG000|STARTED|Treatment 1||4
6602822|NCT02059148|7527879|FG001|STARTED|Treatment 1||4
6602823|NCT02059148|7527880|FG002|STARTED|Treatment 1||4
6602824|NCT02059148|7527881|FG003|STARTED|Treatment 1||4
6602825|NCT02059148|7527882|FG004|STARTED|Treatment 1||4
6602826|NCT02059148|7527883|FG005|STARTED|Treatment 1||4
6602827|NCT02059148|7527878|FG000|COMPLETED|Treatment 1||4
6602828|NCT02059148|7527879|FG001|COMPLETED|Treatment 1||4
6602829|NCT02059148|7527880|FG002|COMPLETED|Treatment 1||4
6602830|NCT02059148|7527881|FG003|COMPLETED|Treatment 1||4
6602831|NCT02059148|7527882|FG004|COMPLETED|Treatment 1||4
6602832|NCT02059148|7527883|FG005|COMPLETED|Treatment 1||3
6602833|NCT02059148|7527878|FG000|NOT COMPLETED|Treatment 1||0
6717365|NCT03011892|7647235|FG000|Treated in DB Period|Double Blind (DB) Period||52
6717366|NCT03011892|7647236|FG001|Treated in DB Period|Double Blind (DB) Period||51
6717367|NCT03011892|7647237|FG002|Treated in DB Period|Double Blind (DB) Period||51
6717368|NCT03011892|7647238|FG003|Treated in DB Period|Double Blind (DB) Period||51
6717369|NCT03011892|7647239|FG004|Treated in DB Period|Double Blind (DB) Period||51
6717370|NCT03011892|7647240|FG005|Treated in DB Period|Double Blind (DB) Period||50
6717371|NCT03011892|7647241|FG006|Treated in DB Period|Double Blind (DB) Period||0
6717372|NCT03011892|7647242|FG007|Treated in DB Period|Double Blind (DB) Period||0
6717373|NCT03011892|7647243|FG008|Treated in DB Period|Double Blind (DB) Period||0
6717374|NCT03011892|7647244|FG009|Treated in DB Period|Double Blind (DB) Period||0
6717375|NCT03011892|7647245|FG010|Treated in DB Period|Double Blind (DB) Period||0
6717376|NCT03011892|7647246|FG011|Treated in DB Period|Double Blind (DB) Period||0
6717377|NCT03011892|7647235|FG000|Completed Treatment Through Week 4|Double Blind (DB) Period||44
6717378|NCT03011892|7647236|FG001|Completed Treatment Through Week 4|Double Blind (DB) Period||46
6717379|NCT03011892|7647237|FG002|Completed Treatment Through Week 4|Double Blind (DB) Period||48
6717380|NCT03011892|7647238|FG003|Completed Treatment Through Week 4|Double Blind (DB) Period||47
6717381|NCT03011892|7647239|FG004|Completed Treatment Through Week 4|Double Blind (DB) Period||49
6717382|NCT03011892|7647240|FG005|Completed Treatment Through Week 4|Double Blind (DB) Period||49
6717383|NCT03011892|7647241|FG006|Completed Treatment Through Week 4|Double Blind (DB) Period||0
6717384|NCT03011892|7647242|FG007|Completed Treatment Through Week 4|Double Blind (DB) Period||0
6717385|NCT03011892|7647243|FG008|Completed Treatment Through Week 4|Double Blind (DB) Period||0
6717386|NCT03011892|7647244|FG009|Completed Treatment Through Week 4|Double Blind (DB) Period||0
6717387|NCT03011892|7647245|FG010|Completed Treatment Through Week 4|Double Blind (DB) Period||0
6717388|NCT03011892|7647246|FG011|Completed Treatment Through Week 4|Double Blind (DB) Period||0
6717389|NCT03011892|7647235|FG000|COMPLETED|Double Blind (DB) Period||41
6717390|NCT03011892|7647236|FG001|COMPLETED|Double Blind (DB) Period||41
6717391|NCT03011892|7647237|FG002|COMPLETED|Double Blind (DB) Period||45
6717392|NCT03011892|7647238|FG003|COMPLETED|Double Blind (DB) Period||44
6717393|NCT03011892|7647239|FG004|COMPLETED|Double Blind (DB) Period||45
6717394|NCT03011892|7647240|FG005|COMPLETED|Double Blind (DB) Period||45
6717395|NCT03011892|7647241|FG006|COMPLETED|Double Blind (DB) Period||0
6717396|NCT03011892|7647242|FG007|COMPLETED|Double Blind (DB) Period||0
6717397|NCT03011892|7647243|FG008|COMPLETED|Double Blind (DB) Period||0
6717398|NCT03011892|7647244|FG009|COMPLETED|Double Blind (DB) Period||0
6717399|NCT03011892|7647245|FG010|COMPLETED|Double Blind (DB) Period||0
6717400|NCT03011892|7647246|FG011|COMPLETED|Double Blind (DB) Period||0
6717401|NCT03011892|7647235|FG000|NOT COMPLETED|Double Blind (DB) Period||11
6717402|NCT03011892|7647236|FG001|NOT COMPLETED|Double Blind (DB) Period||10
6717403|NCT03011892|7647237|FG002|NOT COMPLETED|Double Blind (DB) Period||6
6717404|NCT03011892|7647238|FG003|NOT COMPLETED|Double Blind (DB) Period||7
6717405|NCT03011892|7647239|FG004|NOT COMPLETED|Double Blind (DB) Period||7
6717406|NCT03011892|7647240|FG005|NOT COMPLETED|Double Blind (DB) Period||5
6717407|NCT03011892|7647241|FG006|NOT COMPLETED|Double Blind (DB) Period||0
6717408|NCT03011892|7647242|FG007|NOT COMPLETED|Double Blind (DB) Period||0
6717409|NCT03011892|7647243|FG008|NOT COMPLETED|Double Blind (DB) Period||0
6717410|NCT03011892|7647244|FG009|NOT COMPLETED|Double Blind (DB) Period||0
6717411|NCT03011892|7647245|FG010|NOT COMPLETED|Double Blind (DB) Period||0
6717412|NCT03011892|7647246|FG011|NOT COMPLETED|Double Blind (DB) Period||0
6717413|NCT03011892|7647235|FG000|STARTED|Open Label (OL) Period||0
6717414|NCT03011892|7647236|FG001|STARTED|Open Label (OL) Period||0
6717415|NCT03011892|7647237|FG002|STARTED|Open Label (OL) Period||0
6717416|NCT03011892|7647238|FG003|STARTED|Open Label (OL) Period||0
6717417|NCT03011892|7647239|FG004|STARTED|Open Label (OL) Period||0
6717418|NCT03011892|7647240|FG005|STARTED|Open Label (OL) Period||0
6717419|NCT03011892|7647241|FG006|STARTED|Open Label (OL) Period||41
6717420|NCT03011892|7647242|FG007|STARTED|Open Label (OL) Period||40
6717421|NCT03011892|7647243|FG008|STARTED|Open Label (OL) Period||45
6717422|NCT03011892|7647244|FG009|STARTED|Open Label (OL) Period||41
6717423|NCT03011892|7647245|FG010|STARTED|Open Label (OL) Period||42
6717424|NCT03011892|7647246|FG011|STARTED|Open Label (OL) Period||43
6717425|NCT03011892|7647235|FG000|COMPLETED|Open Label (OL) Period||0
6717426|NCT03011892|7647236|FG001|COMPLETED|Open Label (OL) Period||0
6717427|NCT03011892|7647237|FG002|COMPLETED|Open Label (OL) Period||0
6717428|NCT03011892|7647238|FG003|COMPLETED|Open Label (OL) Period||0
6717429|NCT03011892|7647239|FG004|COMPLETED|Open Label (OL) Period||0
6717430|NCT03011892|7647240|FG005|COMPLETED|Open Label (OL) Period||0
6717431|NCT03011892|7647241|FG006|COMPLETED|Open Label (OL) Period||34
6717432|NCT03011892|7647242|FG007|COMPLETED|Open Label (OL) Period||37
6717433|NCT03011892|7647243|FG008|COMPLETED|Open Label (OL) Period||43
6717434|NCT03011892|7647244|FG009|COMPLETED|Open Label (OL) Period||41
6717435|NCT03011892|7647245|FG010|COMPLETED|Open Label (OL) Period||40
6717436|NCT03011892|7647246|FG011|COMPLETED|Open Label (OL) Period||40
6717437|NCT03011892|7647235|FG000|NOT COMPLETED|Open Label (OL) Period||0
6717438|NCT03011892|7647236|FG001|NOT COMPLETED|Open Label (OL) Period||0
6717439|NCT03011892|7647237|FG002|NOT COMPLETED|Open Label (OL) Period||0
6717440|NCT03011892|7647238|FG003|NOT COMPLETED|Open Label (OL) Period||0
6717441|NCT03011892|7647239|FG004|NOT COMPLETED|Open Label (OL) Period||0
6717442|NCT03011892|7647240|FG005|NOT COMPLETED|Open Label (OL) Period||0
6717443|NCT03011892|7647241|FG006|NOT COMPLETED|Open Label (OL) Period||7
6717444|NCT03011892|7647242|FG007|NOT COMPLETED|Open Label (OL) Period||3
6717445|NCT03011892|7647243|FG008|NOT COMPLETED|Open Label (OL) Period||2
6717446|NCT03011892|7647244|FG009|NOT COMPLETED|Open Label (OL) Period||0
6717447|NCT03011892|7647245|FG010|NOT COMPLETED|Open Label (OL) Period||2
6717448|NCT03011892|7647246|FG011|NOT COMPLETED|Open Label (OL) Period||3
6717449|NCT03012061|7647276|FG000|STARTED|Overall Study||143
6717450|NCT03012061|7647277|FG001|STARTED|Overall Study||139
6717451|NCT03012061|7647278|FG002|STARTED|Overall Study||139
6717452|NCT03012061|7647276|FG000|COMPLETED|Overall Study||137
6717453|NCT03012061|7647277|FG001|COMPLETED|Overall Study||130
6717454|NCT03012061|7647278|FG002|COMPLETED|Overall Study||131
6717455|NCT03012061|7647276|FG000|NOT COMPLETED|Overall Study||6
6717456|NCT03012061|7647277|FG001|NOT COMPLETED|Overall Study||9
6717457|NCT03012061|7647278|FG002|NOT COMPLETED|Overall Study||8
6717458|NCT03012191|7647289|FG000|STARTED|Overall Study||2
6717459|NCT03012191|7647290|FG001|STARTED|Overall Study||2
6717460|NCT03012191|7647291|FG002|STARTED|Overall Study||2
6717461|NCT03012191|7647289|FG000|COMPLETED|Overall Study||2
6717462|NCT03012191|7647290|FG001|COMPLETED|Overall Study||2
6717463|NCT03012191|7647291|FG002|COMPLETED|Overall Study||2
6717464|NCT03012191|7647289|FG000|NOT COMPLETED|Overall Study||0
6717465|NCT03012191|7647290|FG001|NOT COMPLETED|Overall Study||0
6717466|NCT03012191|7647291|FG002|NOT COMPLETED|Overall Study||0
6717467|NCT03012334|7647310|FG000|STARTED|Period 1||9
6717468|NCT03012334|7647311|FG001|STARTED|Period 1||9
6717469|NCT03012334|7647312|FG002|STARTED|Period 1||9
6717470|NCT03012334|7647313|FG003|STARTED|Period 1||9
6717471|NCT03012334|7647314|FG004|STARTED|Period 1||9
6717472|NCT03012334|7647315|FG005|STARTED|Period 1||9
6717473|NCT03012334|7647316|FG006|STARTED|Period 1||9
6717474|NCT03012334|7647317|FG007|STARTED|Period 1||9
6717475|NCT03012334|7647318|FG008|STARTED|Period 1||9
6717476|NCT03012334|7647319|FG009|STARTED|Period 1||9
6717477|NCT03012334|7647310|FG000|COMPLETED|Period 1||9
6717478|NCT03012334|7647311|FG001|COMPLETED|Period 1||9
6717479|NCT03012334|7647312|FG002|COMPLETED|Period 1||9
6717480|NCT03012334|7647313|FG003|COMPLETED|Period 1||9
6717481|NCT03012334|7647314|FG004|COMPLETED|Period 1||9
6717482|NCT03012334|7647315|FG005|COMPLETED|Period 1||9
6717483|NCT03012334|7647316|FG006|COMPLETED|Period 1||9
6717484|NCT03012334|7647317|FG007|COMPLETED|Period 1||9
6717485|NCT03012334|7647318|FG008|COMPLETED|Period 1||9
6717486|NCT03012334|7647319|FG009|COMPLETED|Period 1||8
6717487|NCT03012334|7647310|FG000|NOT COMPLETED|Period 1||0
6717488|NCT03012334|7647311|FG001|NOT COMPLETED|Period 1||0
6717489|NCT03012334|7647312|FG002|NOT COMPLETED|Period 1||0
6717490|NCT03012334|7647313|FG003|NOT COMPLETED|Period 1||0
6717491|NCT03012334|7647314|FG004|NOT COMPLETED|Period 1||0
6717492|NCT03012334|7647315|FG005|NOT COMPLETED|Period 1||0
6717493|NCT03012334|7647316|FG006|NOT COMPLETED|Period 1||0
6717494|NCT03012334|7647317|FG007|NOT COMPLETED|Period 1||0
6717495|NCT03012334|7647318|FG008|NOT COMPLETED|Period 1||0
6717496|NCT03012334|7647319|FG009|NOT COMPLETED|Period 1||1
6717497|NCT03012334|7647310|FG000|STARTED|Period 2||9
6717498|NCT03012334|7647311|FG001|STARTED|Period 2||9
6717499|NCT03012334|7647312|FG002|STARTED|Period 2||9
6717500|NCT03012334|7647313|FG003|STARTED|Period 2||9
6717501|NCT03012334|7647314|FG004|STARTED|Period 2||9
6717502|NCT03012334|7647315|FG005|STARTED|Period 2||9
6717503|NCT03012334|7647316|FG006|STARTED|Period 2||9
6717504|NCT03012334|7647317|FG007|STARTED|Period 2||9
6717505|NCT03012334|7647318|FG008|STARTED|Period 2||9
6717506|NCT03012334|7647319|FG009|STARTED|Period 2||8
6717507|NCT03012334|7647310|FG000|COMPLETED|Period 2||9
6717508|NCT03012334|7647311|FG001|COMPLETED|Period 2||8
6717509|NCT03012334|7647312|FG002|COMPLETED|Period 2||8
6717510|NCT03012334|7647313|FG003|COMPLETED|Period 2||9
6717511|NCT03012334|7647314|FG004|COMPLETED|Period 2||9
6717512|NCT03012334|7647315|FG005|COMPLETED|Period 2||9
6717513|NCT03012334|7647316|FG006|COMPLETED|Period 2||9
6717514|NCT03012334|7647317|FG007|COMPLETED|Period 2||8
6717515|NCT03012334|7647318|FG008|COMPLETED|Period 2||9
6717516|NCT03012334|7647319|FG009|COMPLETED|Period 2||8
6717517|NCT03012334|7647310|FG000|NOT COMPLETED|Period 2||0
6717518|NCT03012334|7647311|FG001|NOT COMPLETED|Period 2||1
6717519|NCT03012334|7647312|FG002|NOT COMPLETED|Period 2||1
6717520|NCT03012334|7647313|FG003|NOT COMPLETED|Period 2||0
6717521|NCT03012334|7647314|FG004|NOT COMPLETED|Period 2||0
6717522|NCT03012334|7647315|FG005|NOT COMPLETED|Period 2||0
6717523|NCT03012334|7647316|FG006|NOT COMPLETED|Period 2||0
6717524|NCT03012334|7647317|FG007|NOT COMPLETED|Period 2||1
6717525|NCT03012334|7647318|FG008|NOT COMPLETED|Period 2||0
6717526|NCT03012334|7647319|FG009|NOT COMPLETED|Period 2||0
6717527|NCT03012334|7647310|FG000|STARTED|Period 3||9
6717528|NCT03012334|7647311|FG001|STARTED|Period 3||8
6717529|NCT03012334|7647312|FG002|STARTED|Period 3||8
6717530|NCT03012334|7647313|FG003|STARTED|Period 3||9
6717531|NCT03012334|7647314|FG004|STARTED|Period 3||9
6717532|NCT03012334|7647315|FG005|STARTED|Period 3||9
6717533|NCT03012334|7647316|FG006|STARTED|Period 3||9
6717534|NCT03012334|7647317|FG007|STARTED|Period 3||8
6717535|NCT03012334|7647318|FG008|STARTED|Period 3||9
6717536|NCT03012334|7647319|FG009|STARTED|Period 3||8
6717537|NCT03012334|7647310|FG000|COMPLETED|Period 3||9
6717538|NCT03012334|7647311|FG001|COMPLETED|Period 3||8
6717539|NCT03012334|7647312|FG002|COMPLETED|Period 3||8
6717540|NCT03012334|7647313|FG003|COMPLETED|Period 3||9
6717541|NCT03012334|7647314|FG004|COMPLETED|Period 3||9
6717542|NCT03012334|7647315|FG005|COMPLETED|Period 3||9
6717543|NCT03012334|7647316|FG006|COMPLETED|Period 3||9
6717544|NCT03012334|7647317|FG007|COMPLETED|Period 3||8
6717545|NCT03012334|7647318|FG008|COMPLETED|Period 3||9
6717546|NCT03012334|7647319|FG009|COMPLETED|Period 3||8
6717547|NCT03012334|7647310|FG000|NOT COMPLETED|Period 3||0
6717548|NCT03012334|7647311|FG001|NOT COMPLETED|Period 3||0
6717549|NCT03012334|7647312|FG002|NOT COMPLETED|Period 3||0
6717550|NCT03012334|7647313|FG003|NOT COMPLETED|Period 3||0
6717551|NCT03012334|7647314|FG004|NOT COMPLETED|Period 3||0
6717552|NCT03012334|7647315|FG005|NOT COMPLETED|Period 3||0
6717553|NCT03012334|7647316|FG006|NOT COMPLETED|Period 3||0
6717554|NCT03012334|7647317|FG007|NOT COMPLETED|Period 3||0
6717555|NCT03012334|7647318|FG008|NOT COMPLETED|Period 3||0
6717556|NCT03012334|7647319|FG009|NOT COMPLETED|Period 3||0
6717557|NCT03012334|7647310|FG000|STARTED|Period 4||9
6717558|NCT03012334|7647311|FG001|STARTED|Period 4||8
6717559|NCT03012334|7647312|FG002|STARTED|Period 4||8
6717560|NCT03012334|7647313|FG003|STARTED|Period 4||9
6717561|NCT03012334|7647314|FG004|STARTED|Period 4||9
6717562|NCT03012334|7647315|FG005|STARTED|Period 4||9
6717563|NCT03012334|7647316|FG006|STARTED|Period 4||9
6717564|NCT03012334|7647317|FG007|STARTED|Period 4||8
6717565|NCT03012334|7647318|FG008|STARTED|Period 4||9
6717566|NCT03012334|7647319|FG009|STARTED|Period 4||8
6717567|NCT03012334|7647310|FG000|COMPLETED|Period 4||9
6717568|NCT03012334|7647311|FG001|COMPLETED|Period 4||8
6717569|NCT03012334|7647312|FG002|COMPLETED|Period 4||8
6717570|NCT03012334|7647313|FG003|COMPLETED|Period 4||9
6717571|NCT03012334|7647314|FG004|COMPLETED|Period 4||9
6717572|NCT03012334|7647315|FG005|COMPLETED|Period 4||9
6717573|NCT03012334|7647316|FG006|COMPLETED|Period 4||8
6717574|NCT03012334|7647317|FG007|COMPLETED|Period 4||8
6717575|NCT03012334|7647318|FG008|COMPLETED|Period 4||8
6717576|NCT03012334|7647319|FG009|COMPLETED|Period 4||8
6717577|NCT03012334|7647310|FG000|NOT COMPLETED|Period 4||0
6717578|NCT03012334|7647311|FG001|NOT COMPLETED|Period 4||0
6717579|NCT03012334|7647312|FG002|NOT COMPLETED|Period 4||0
6717580|NCT03012334|7647313|FG003|NOT COMPLETED|Period 4||0
6717581|NCT03012334|7647314|FG004|NOT COMPLETED|Period 4||0
6717582|NCT03012334|7647315|FG005|NOT COMPLETED|Period 4||0
6717583|NCT03012334|7647316|FG006|NOT COMPLETED|Period 4||1
6717584|NCT03012334|7647317|FG007|NOT COMPLETED|Period 4||0
6263560|NCT00704535|7162376|FG000|STARTED|Overall Study||4105
6263561|NCT00704535|7162376|FG000|COMPLETED|Overall Study||3959
6263562|NCT00704535|7162376|FG000|NOT COMPLETED|Overall Study||146
6263563|NCT00694369|7162385|FG000|STARTED|Overall Study||46
6263564|NCT00694369|7162386|FG001|STARTED|Overall Study||191
6263565|NCT00694369|7162387|FG002|STARTED|Overall Study||97
6263566|NCT00694369|7162388|FG003|STARTED|Overall Study||192
6263567|NCT00694369|7162389|FG004|STARTED|Overall Study||62
6263568|NCT00694369|7162385|FG000|COMPLETED|Overall Study||45
6263569|NCT00694369|7162386|FG001|COMPLETED|Overall Study||188
6263570|NCT00694369|7162387|FG002|COMPLETED|Overall Study||95
6263571|NCT00694369|7162388|FG003|COMPLETED|Overall Study||189
6263572|NCT00694369|7162389|FG004|COMPLETED|Overall Study||56
6263573|NCT00694369|7162385|FG000|NOT COMPLETED|Overall Study||1
6263574|NCT00694369|7162386|FG001|NOT COMPLETED|Overall Study||3
6263575|NCT00694369|7162387|FG002|NOT COMPLETED|Overall Study||2
6263576|NCT00694369|7162388|FG003|NOT COMPLETED|Overall Study||3
6263577|NCT00694369|7162389|FG004|NOT COMPLETED|Overall Study||6
6263578|NCT00671528|7162404|FG000|STARTED|Overall Study||1
6263579|NCT00671528|7162405|FG001|STARTED|Overall Study||1
6263580|NCT00671528|7162406|FG002|STARTED|Overall Study||1
6717585|NCT03012334|7647318|FG008|NOT COMPLETED|Period 4||1
6717586|NCT03012334|7647319|FG009|NOT COMPLETED|Period 4||0
6717587|NCT03012334|7647310|FG000|STARTED|Period 5||9
6717588|NCT03012334|7647311|FG001|STARTED|Period 5||8
6717589|NCT03012334|7647312|FG002|STARTED|Period 5||8
6717590|NCT03012334|7647313|FG003|STARTED|Period 5||9
6717591|NCT03012334|7647314|FG004|STARTED|Period 5||9
6717592|NCT03012334|7647315|FG005|STARTED|Period 5||9
6717593|NCT03012334|7647316|FG006|STARTED|Period 5||8
6717594|NCT03012334|7647317|FG007|STARTED|Period 5||8
6717595|NCT03012334|7647318|FG008|STARTED|Period 5||8
6717596|NCT03012334|7647319|FG009|STARTED|Period 5||8
6717597|NCT03012334|7647310|FG000|COMPLETED|Period 5||9
6717598|NCT03012334|7647311|FG001|COMPLETED|Period 5||8
6717599|NCT03012334|7647312|FG002|COMPLETED|Period 5||8
6717600|NCT03012334|7647313|FG003|COMPLETED|Period 5||9
6717601|NCT03012334|7647314|FG004|COMPLETED|Period 5||9
6717602|NCT03012334|7647315|FG005|COMPLETED|Period 5||9
6717603|NCT03012334|7647316|FG006|COMPLETED|Period 5||8
6717604|NCT03012334|7647317|FG007|COMPLETED|Period 5||8
6717605|NCT03012334|7647318|FG008|COMPLETED|Period 5||8
6717606|NCT03012334|7647319|FG009|COMPLETED|Period 5||8
6717607|NCT03012334|7647310|FG000|NOT COMPLETED|Period 5||0
6717608|NCT03012334|7647311|FG001|NOT COMPLETED|Period 5||0
6717609|NCT03012334|7647312|FG002|NOT COMPLETED|Period 5||0
6717610|NCT03012334|7647313|FG003|NOT COMPLETED|Period 5||0
6717611|NCT03012334|7647314|FG004|NOT COMPLETED|Period 5||0
6717612|NCT03012334|7647315|FG005|NOT COMPLETED|Period 5||0
6717613|NCT03012334|7647316|FG006|NOT COMPLETED|Period 5||0
6717614|NCT03012334|7647317|FG007|NOT COMPLETED|Period 5||0
6717615|NCT03012334|7647318|FG008|NOT COMPLETED|Period 5||0
6717616|NCT03012334|7647319|FG009|NOT COMPLETED|Period 5||0
6717617|NCT03012477|7647332|FG000|STARTED|Overall Study||34
6717618|NCT03012477|7647332|FG000|COMPLETED|Overall Study||34
6717619|NCT03012477|7647332|FG000|NOT COMPLETED|Overall Study||0
6717620|NCT03012594|7647336|FG000|STARTED|Overall Study||12
6717621|NCT03012594|7647336|FG000|COMPLETED|Overall Study||9
6717622|NCT03012594|7647336|FG000|NOT COMPLETED|Overall Study||3
6717623|NCT03012828|7647346|FG000|STARTED|Overall Study||10
6717624|NCT03012828|7647347|FG001|STARTED|Overall Study||10
6717625|NCT03012828|7647348|FG002|STARTED|Overall Study||10
6717626|NCT03012828|7647349|FG003|STARTED|Overall Study||10
6717627|NCT03012828|7647350|FG004|STARTED|Overall Study||10
6717628|NCT03012828|7647351|FG005|STARTED|Overall Study||10
6717629|NCT03012828|7647346|FG000|COMPLETED|Overall Study||9
6717630|NCT03012828|7647347|FG001|COMPLETED|Overall Study||10
6717631|NCT03012828|7647348|FG002|COMPLETED|Overall Study||8
6717632|NCT03012828|7647349|FG003|COMPLETED|Overall Study||10
6717633|NCT03012828|7647350|FG004|COMPLETED|Overall Study||8
6717634|NCT03012828|7647351|FG005|COMPLETED|Overall Study||8
6717635|NCT03012828|7647346|FG000|NOT COMPLETED|Overall Study||1
6717636|NCT03012828|7647347|FG001|NOT COMPLETED|Overall Study||0
6717637|NCT03012828|7647348|FG002|NOT COMPLETED|Overall Study||2
6717638|NCT03012828|7647349|FG003|NOT COMPLETED|Overall Study||0
6717639|NCT03012828|7647350|FG004|NOT COMPLETED|Overall Study||2
6717640|NCT03012828|7647351|FG005|NOT COMPLETED|Overall Study||2
6717641|NCT03012841|7647367|FG000|STARTED|Overall Study||165
6717642|NCT03012841|7647368|FG001|STARTED|Overall Study||21
6717643|NCT03012841|7647367|FG000|COMPLETED|Overall Study||145
6717644|NCT03012841|7647368|FG001|COMPLETED|Overall Study||0
6717645|NCT03012841|7647367|FG000|NOT COMPLETED|Overall Study||20
6717646|NCT03012841|7647368|FG001|NOT COMPLETED|Overall Study||21
6717647|NCT03013985|7647375|FG000|STARTED|Overall Study||108
6717648|NCT03013985|7647376|FG001|STARTED|Overall Study||103
6717649|NCT03013985|7647375|FG000|COMPLETED|Overall Study||92
6717650|NCT03013985|7647376|FG001|COMPLETED|Overall Study||84
6717651|NCT03013985|7647375|FG000|NOT COMPLETED|Overall Study||16
6717652|NCT03013985|7647376|FG001|NOT COMPLETED|Overall Study||19
6717653|NCT03014011|7647382|FG000|STARTED|First Intervention||14
6717654|NCT03014011|7647383|FG001|STARTED|First Intervention||13
6717655|NCT03014011|7647382|FG000|COMPLETED|First Intervention||13
6717656|NCT03014011|7647383|FG001|COMPLETED|First Intervention||13
6717657|NCT03014011|7647382|FG000|NOT COMPLETED|First Intervention||1
6717658|NCT03014011|7647383|FG001|NOT COMPLETED|First Intervention||0
6717659|NCT03014011|7647382|FG000|STARTED|Washout||13
6717660|NCT03014011|7647383|FG001|STARTED|Washout||13
6717661|NCT03014011|7647382|FG000|COMPLETED|Washout||12
6717662|NCT03014011|7647383|FG001|COMPLETED|Washout||13
6717663|NCT03014011|7647382|FG000|NOT COMPLETED|Washout||1
6717664|NCT03014011|7647383|FG001|NOT COMPLETED|Washout||0
6717665|NCT03014011|7647382|FG000|STARTED|Second Intervention||12
6717666|NCT03014011|7647383|FG001|STARTED|Second Intervention||13
6717667|NCT03014011|7647382|FG000|COMPLETED|Second Intervention||12
6717668|NCT03014011|7647383|FG001|COMPLETED|Second Intervention||13
6717669|NCT03014011|7647382|FG000|NOT COMPLETED|Second Intervention||0
6717670|NCT03014011|7647383|FG001|NOT COMPLETED|Second Intervention||0
6717671|NCT03014180|7647389|FG000|STARTED|Overall Study||60
6717672|NCT03014180|7647389|FG000|COMPLETED|Overall Study||58
6717673|NCT03014180|7647389|FG000|NOT COMPLETED|Overall Study||2
6717674|NCT03014206|7647397|FG000|STARTED|Overall Study||696
6717675|NCT03014206|7647397|FG000|COMPLETED|Overall Study||684
6717676|NCT03014206|7647397|FG000|NOT COMPLETED|Overall Study||12
6717677|NCT03014453|7647401|FG000|STARTED|Overall Study||187
6717678|NCT03014453|7647401|FG000|COMPLETED|Overall Study||116
6717679|NCT03014453|7647401|FG000|NOT COMPLETED|Overall Study||71
6717680|NCT03014479|7647407|FG000|STARTED|Overall Study||110
6717681|NCT03014479|7647408|FG001|STARTED|Overall Study||109
6717682|NCT03014479|7647407|FG000|COMPLETED|Overall Study||110
6717683|NCT03014479|7647408|FG001|COMPLETED|Overall Study||105
6717684|NCT03014479|7647407|FG000|NOT COMPLETED|Overall Study||0
6717685|NCT03014479|7647408|FG001|NOT COMPLETED|Overall Study||4
6717686|NCT03014492|7647416|FG000|STARTED|Overall Study||44
6717687|NCT03014492|7647417|FG001|STARTED|Overall Study||28
6717688|NCT03014492|7647416|FG000|COMPLETED|Overall Study||44
6717689|NCT03014492|7647417|FG001|COMPLETED|Overall Study||28
6717690|NCT03014492|7647416|FG000|NOT COMPLETED|Overall Study||0
6717691|NCT03014492|7647417|FG001|NOT COMPLETED|Overall Study||0
6717692|NCT03014674|7647426|FG000|STARTED|Overall Study||85
6717693|NCT03014674|7647427|FG001|STARTED|Overall Study||79
6717694|NCT03014674|7647428|FG002|STARTED|Overall Study||80
6717695|NCT03014674|7647426|FG000|COMPLETED|Overall Study||84
6717696|NCT03014674|7647427|FG001|COMPLETED|Overall Study||79
6717697|NCT03014674|7647428|FG002|COMPLETED|Overall Study||80
6717698|NCT03014674|7647426|FG000|NOT COMPLETED|Overall Study||1
6717699|NCT03014674|7647427|FG001|NOT COMPLETED|Overall Study||0
6717700|NCT03014674|7647428|FG002|NOT COMPLETED|Overall Study||0
6717701|NCT03014700|7647438|FG000|STARTED|Overall Study||30
6717702|NCT03014700|7647439|FG001|STARTED|Overall Study||30
6717703|NCT03014700|7647438|FG000|COMPLETED|Overall Study||25
6717704|NCT03014700|7647439|FG001|COMPLETED|Overall Study||29
6717705|NCT03014700|7647438|FG000|NOT COMPLETED|Overall Study||5
6717706|NCT03014700|7647439|FG001|NOT COMPLETED|Overall Study||1
6717707|NCT03015116|7647448|FG000|STARTED|Overall Study||38
6717708|NCT03015116|7647449|FG001|STARTED|Overall Study||38
6717709|NCT03015116|7647450|FG002|STARTED|Overall Study||38
6717710|NCT03015116|7647448|FG000|COMPLETED|Overall Study||31
6717711|NCT03015116|7647449|FG001|COMPLETED|Overall Study||36
6717712|NCT03015116|7647450|FG002|COMPLETED|Overall Study||36
6717713|NCT03015116|7647448|FG000|NOT COMPLETED|Overall Study||7
6717714|NCT03015116|7647449|FG001|NOT COMPLETED|Overall Study||2
6717715|NCT03015116|7647450|FG002|NOT COMPLETED|Overall Study||2
6717716|NCT03015181|7647467|FG000|STARTED|Overall Study||4
6717717|NCT03015181|7647468|FG001|STARTED|Overall Study||3
6717718|NCT03015181|7647469|FG002|STARTED|Overall Study||3
6717719|NCT03015181|7647470|FG003|STARTED|Overall Study||3
6717720|NCT03015181|7647471|FG004|STARTED|Overall Study||3
6717721|NCT03015181|7647472|FG005|STARTED|Overall Study||5
6717722|NCT03015181|7647473|FG006|STARTED|Overall Study||5
6717723|NCT03015181|7647467|FG000|Received VRC07-523LS Per Protocol|Overall Study||3
6717724|NCT03015181|7647468|FG001|Received VRC07-523LS Per Protocol|Overall Study||3
6717725|NCT03015181|7647469|FG002|Received VRC07-523LS Per Protocol|Overall Study||3
6717726|NCT03015181|7647470|FG003|Received VRC07-523LS Per Protocol|Overall Study||3
6717727|NCT03015181|7647471|FG004|Received VRC07-523LS Per Protocol|Overall Study||3
6717728|NCT03015181|7647472|FG005|Received VRC07-523LS Per Protocol|Overall Study||4
6717729|NCT03015181|7647473|FG006|Received VRC07-523LS Per Protocol|Overall Study||4
6717730|NCT03015181|7647467|FG000|Discontinued VRC07-523LS Administrations|Overall Study|One Group 1 subject decided not to receive the VRC07-523LS infusion|1
6717731|NCT03015181|7647468|FG001|Discontinued VRC07-523LS Administrations|Overall Study||0
6717732|NCT03015181|7647469|FG002|Discontinued VRC07-523LS Administrations|Overall Study||0
6717733|NCT03015181|7647470|FG003|Discontinued VRC07-523LS Administrations|Overall Study||0
6717734|NCT03015181|7647471|FG004|Discontinued VRC07-523LS Administrations|Overall Study||0
6717735|NCT03015181|7647472|FG005|Discontinued VRC07-523LS Administrations|Overall Study|One Group 6 subject received only 1 of 3 scheduled doses prior to withdrawing from the study|1
6717736|NCT03015181|7647473|FG006|Discontinued VRC07-523LS Administrations|Overall Study|One Group 7 subject received only 1 of 3 scheduled doses due to an unrelated intercurrent illness|1
6717737|NCT03015181|7647467|FG000|COMPLETED|Overall Study||3
6717738|NCT03015181|7647468|FG001|COMPLETED|Overall Study||3
6717739|NCT03015181|7647469|FG002|COMPLETED|Overall Study||3
6717740|NCT03015181|7647470|FG003|COMPLETED|Overall Study||3
6717741|NCT03015181|7647471|FG004|COMPLETED|Overall Study||3
6717742|NCT03015181|7647472|FG005|COMPLETED|Overall Study|Group 6 subject who received only 1 dose chose to withdraw from study after the first administration|4
6717743|NCT03015181|7647473|FG006|COMPLETED|Overall Study|Group 7 subject who received only 1 dose was withdrawn after unrelated intercurrent illness resolved|4
6717744|NCT03015181|7647467|FG000|NOT COMPLETED|Overall Study||1
6717745|NCT03015181|7647468|FG001|NOT COMPLETED|Overall Study||0
6717746|NCT03015181|7647469|FG002|NOT COMPLETED|Overall Study||0
6717747|NCT03015181|7647470|FG003|NOT COMPLETED|Overall Study||0
6717748|NCT03015181|7647471|FG004|NOT COMPLETED|Overall Study||0
6717749|NCT03015181|7647472|FG005|NOT COMPLETED|Overall Study||1
6717750|NCT03015181|7647473|FG006|NOT COMPLETED|Overall Study||1
6717751|NCT03015220|7647513|FG000|STARTED|Overall Study||131
6717752|NCT03015220|7647514|FG001|STARTED|Overall Study||132
6717753|NCT03015220|7647515|FG002|STARTED|Overall Study||130
6717754|NCT03015220|7647516|FG003|STARTED|Overall Study||65
6717755|NCT03015220|7647513|FG000|Full Analysis Set (FAS)|Overall Study||131
6717756|NCT03015220|7647514|FG001|Full Analysis Set (FAS)|Overall Study||132
6717757|NCT03015220|7647515|FG002|Full Analysis Set (FAS)|Overall Study||130
6717758|NCT03015220|7647516|FG003|Full Analysis Set (FAS)|Overall Study||65
6717759|NCT03015220|7647513|FG000|Safety Analysis Set (SAS)|Overall Study||131
6717760|NCT03015220|7647514|FG001|Safety Analysis Set (SAS)|Overall Study||132
6717761|NCT03015220|7647515|FG002|Safety Analysis Set (SAS)|Overall Study||130
6717762|NCT03015220|7647516|FG003|Safety Analysis Set (SAS)|Overall Study||65
6717763|NCT03015220|7647513|FG000|COMPLETED|Overall Study||128
6717764|NCT03015220|7647514|FG001|COMPLETED|Overall Study||130
6717765|NCT03015220|7647515|FG002|COMPLETED|Overall Study||127
6717766|NCT03015220|7647516|FG003|COMPLETED|Overall Study||63
6717767|NCT03015220|7647513|FG000|NOT COMPLETED|Overall Study||3
6717768|NCT03015220|7647514|FG001|NOT COMPLETED|Overall Study||2
6717769|NCT03015220|7647515|FG002|NOT COMPLETED|Overall Study||3
6602834|NCT02059148|7527879|FG001|NOT COMPLETED|Treatment 1||0
6602835|NCT02059148|7527880|FG002|NOT COMPLETED|Treatment 1||0
6717770|NCT03015220|7647516|FG003|NOT COMPLETED|Overall Study||2
6717771|NCT03015363|7647526|FG000|STARTED|Overall Study||37
6717772|NCT03015363|7647526|FG000|COMPLETED|Overall Study||20
6717773|NCT03015363|7647526|FG000|NOT COMPLETED|Overall Study||17
6602836|NCT02059148|7527881|FG003|NOT COMPLETED|Treatment 1||0
6717774|NCT03015532|7647538|FG000|STARTED|Overall Study||20
6717775|NCT03015532|7647539|FG001|STARTED|Overall Study||22
6717776|NCT03015532|7647540|FG002|STARTED|Overall Study||11
6717777|NCT03015532|7647541|FG003|STARTED|Overall Study||10
6717778|NCT03015532|7647542|FG004|STARTED|Overall Study||58
6717779|NCT03015532|7647543|FG005|STARTED|Overall Study||56
6717780|NCT03015532|7647544|FG006|STARTED|Overall Study||53
6717781|NCT03015532|7647545|FG007|STARTED|Overall Study||55
6717782|NCT03015532|7647538|FG000|COMPLETED|Overall Study||20
6717783|NCT03015532|7647539|FG001|COMPLETED|Overall Study||22
6717784|NCT03015532|7647540|FG002|COMPLETED|Overall Study||11
6717785|NCT03015532|7647541|FG003|COMPLETED|Overall Study||10
6717786|NCT03015532|7647542|FG004|COMPLETED|Overall Study||58
6717787|NCT03015532|7647543|FG005|COMPLETED|Overall Study||54
6717788|NCT03015532|7647544|FG006|COMPLETED|Overall Study||51
6717789|NCT03015532|7647545|FG007|COMPLETED|Overall Study||55
6717790|NCT03015532|7647538|FG000|NOT COMPLETED|Overall Study||0
6717791|NCT03015532|7647539|FG001|NOT COMPLETED|Overall Study||0
6717792|NCT03015532|7647540|FG002|NOT COMPLETED|Overall Study||0
6717793|NCT03015532|7647541|FG003|NOT COMPLETED|Overall Study||0
6717794|NCT03015532|7647542|FG004|NOT COMPLETED|Overall Study||0
6717795|NCT03015532|7647543|FG005|NOT COMPLETED|Overall Study||2
6717796|NCT03015532|7647544|FG006|NOT COMPLETED|Overall Study||2
6717797|NCT03015532|7647545|FG007|NOT COMPLETED|Overall Study||0
6717798|NCT03015649|7647565|FG000|STARTED|Overall Study||34
6717799|NCT03015649|7647565|FG000|COMPLETED|Overall Study||34
6717800|NCT03015649|7647565|FG000|NOT COMPLETED|Overall Study||0
6717801|NCT03015961|7647571|FG000|STARTED|Overall Study||18
6717802|NCT03015961|7647572|FG001|STARTED|Overall Study||20
6717803|NCT03015961|7647571|FG000|COMPLETED|Overall Study||18
6717804|NCT03015961|7647572|FG001|COMPLETED|Overall Study||18
6717805|NCT03015961|7647571|FG000|NOT COMPLETED|Overall Study||0
6717806|NCT03015961|7647572|FG001|NOT COMPLETED|Overall Study||2
6717807|NCT03016078|7647578|FG000|STARTED|Overall Study||21
6717808|NCT03016078|7647578|FG000|COMPLETED|Overall Study||19
6717809|NCT03016078|7647578|FG000|NOT COMPLETED|Overall Study||2
6717810|NCT03016325|7647590|FG000|STARTED|Treatment Period||48
6717811|NCT03016325|7647591|FG001|STARTED|Treatment Period||49
6717812|NCT03016325|7647592|FG002|STARTED|Treatment Period||71
6717813|NCT03016325|7647593|FG003|STARTED|Treatment Period||71
6717814|NCT03016325|7647594|FG004|STARTED|Treatment Period||72
6717815|NCT03016325|7647595|FG005|STARTED|Treatment Period||6
6717816|NCT03016325|7647596|FG006|STARTED|Treatment Period||6
6717817|NCT03016325|7647597|FG007|STARTED|Treatment Period||6
6717818|NCT03016325|7647590|FG000|COMPLETED|Treatment Period||48
6717819|NCT03016325|7647591|FG001|COMPLETED|Treatment Period||48
6717820|NCT03016325|7647592|FG002|COMPLETED|Treatment Period||70
6717821|NCT03016325|7647593|FG003|COMPLETED|Treatment Period||71
6717822|NCT03016325|7647594|FG004|COMPLETED|Treatment Period||70
6717823|NCT03016325|7647595|FG005|COMPLETED|Treatment Period||6
6717824|NCT03016325|7647596|FG006|COMPLETED|Treatment Period||6
6717825|NCT03016325|7647597|FG007|COMPLETED|Treatment Period||6
6717826|NCT03016325|7647590|FG000|NOT COMPLETED|Treatment Period||0
6717827|NCT03016325|7647591|FG001|NOT COMPLETED|Treatment Period||1
6717828|NCT03016325|7647592|FG002|NOT COMPLETED|Treatment Period||1
6717829|NCT03016325|7647593|FG003|NOT COMPLETED|Treatment Period||0
6717830|NCT03016325|7647594|FG004|NOT COMPLETED|Treatment Period||2
6717831|NCT03016325|7647595|FG005|NOT COMPLETED|Treatment Period||0
6717832|NCT03016325|7647596|FG006|NOT COMPLETED|Treatment Period||0
6717833|NCT03016325|7647597|FG007|NOT COMPLETED|Treatment Period||0
6717834|NCT03016325|7647590|FG000|STARTED|32-Day Follow-Up Period||48
6717835|NCT03016325|7647591|FG001|STARTED|32-Day Follow-Up Period||49
6717836|NCT03016325|7647592|FG002|STARTED|32-Day Follow-Up Period||71
6717837|NCT03016325|7647593|FG003|STARTED|32-Day Follow-Up Period||71
6717838|NCT03016325|7647594|FG004|STARTED|32-Day Follow-Up Period||72
6717839|NCT03016325|7647595|FG005|STARTED|32-Day Follow-Up Period||6
6717840|NCT03016325|7647596|FG006|STARTED|32-Day Follow-Up Period||6
6717841|NCT03016325|7647597|FG007|STARTED|32-Day Follow-Up Period||6
6717842|NCT03016325|7647590|FG000|COMPLETED|32-Day Follow-Up Period||44
6717843|NCT03016325|7647591|FG001|COMPLETED|32-Day Follow-Up Period||47
6717844|NCT03016325|7647592|FG002|COMPLETED|32-Day Follow-Up Period||62
6717845|NCT03016325|7647593|FG003|COMPLETED|32-Day Follow-Up Period||63
6717846|NCT03016325|7647594|FG004|COMPLETED|32-Day Follow-Up Period||64
6717847|NCT03016325|7647595|FG005|COMPLETED|32-Day Follow-Up Period||6
6717848|NCT03016325|7647596|FG006|COMPLETED|32-Day Follow-Up Period||5
6717849|NCT03016325|7647597|FG007|COMPLETED|32-Day Follow-Up Period||6
6717850|NCT03016325|7647590|FG000|NOT COMPLETED|32-Day Follow-Up Period||4
6717851|NCT03016325|7647591|FG001|NOT COMPLETED|32-Day Follow-Up Period||2
6717852|NCT03016325|7647592|FG002|NOT COMPLETED|32-Day Follow-Up Period||9
6717853|NCT03016325|7647593|FG003|NOT COMPLETED|32-Day Follow-Up Period||8
6717854|NCT03016325|7647594|FG004|NOT COMPLETED|32-Day Follow-Up Period||8
6717855|NCT03016325|7647595|FG005|NOT COMPLETED|32-Day Follow-Up Period||0
6717856|NCT03016325|7647596|FG006|NOT COMPLETED|32-Day Follow-Up Period||1
6717857|NCT03016325|7647597|FG007|NOT COMPLETED|32-Day Follow-Up Period||0
6717858|NCT03016325|7647590|FG000|STARTED|182-Day Follow-Up Period||48
6717859|NCT03016325|7647591|FG001|STARTED|182-Day Follow-Up Period||49
6717860|NCT03016325|7647592|FG002|STARTED|182-Day Follow-Up Period||71
6717861|NCT03016325|7647593|FG003|STARTED|182-Day Follow-Up Period||71
6717862|NCT03016325|7647594|FG004|STARTED|182-Day Follow-Up Period||72
6717863|NCT03016325|7647595|FG005|STARTED|182-Day Follow-Up Period||6
6717864|NCT03016325|7647596|FG006|STARTED|182-Day Follow-Up Period||6
6717865|NCT03016325|7647597|FG007|STARTED|182-Day Follow-Up Period||6
6717866|NCT03016325|7647590|FG000|COMPLETED|182-Day Follow-Up Period||44
6717867|NCT03016325|7647591|FG001|COMPLETED|182-Day Follow-Up Period||45
6717868|NCT03016325|7647592|FG002|COMPLETED|182-Day Follow-Up Period||60
6717869|NCT03016325|7647593|FG003|COMPLETED|182-Day Follow-Up Period||58
6717870|NCT03016325|7647594|FG004|COMPLETED|182-Day Follow-Up Period||60
6717871|NCT03016325|7647595|FG005|COMPLETED|182-Day Follow-Up Period||1
6717872|NCT03016325|7647596|FG006|COMPLETED|182-Day Follow-Up Period||2
6717873|NCT03016325|7647597|FG007|COMPLETED|182-Day Follow-Up Period||1
6717874|NCT03016325|7647590|FG000|NOT COMPLETED|182-Day Follow-Up Period||4
6717875|NCT03016325|7647591|FG001|NOT COMPLETED|182-Day Follow-Up Period||4
6717876|NCT03016325|7647592|FG002|NOT COMPLETED|182-Day Follow-Up Period||11
6717877|NCT03016325|7647593|FG003|NOT COMPLETED|182-Day Follow-Up Period||13
6717878|NCT03016325|7647594|FG004|NOT COMPLETED|182-Day Follow-Up Period||12
6717879|NCT03016325|7647595|FG005|NOT COMPLETED|182-Day Follow-Up Period||5
6717880|NCT03016325|7647596|FG006|NOT COMPLETED|182-Day Follow-Up Period||4
6717881|NCT03016325|7647597|FG007|NOT COMPLETED|182-Day Follow-Up Period||5
6717882|NCT03016403|7647622|FG000|STARTED|Baseline||139
6717883|NCT03016403|7647623|FG001|STARTED|Baseline||147
6717884|NCT03016403|7647624|FG002|STARTED|Baseline||118
6717885|NCT03016403|7647625|FG003|STARTED|Baseline||131
6717886|NCT03016403|7647622|FG000|COMPLETED|Baseline||123
6717887|NCT03016403|7647623|FG001|COMPLETED|Baseline||120
6717888|NCT03016403|7647624|FG002|COMPLETED|Baseline||107
6717889|NCT03016403|7647625|FG003|COMPLETED|Baseline||97
6717890|NCT03016403|7647622|FG000|NOT COMPLETED|Baseline||16
6717891|NCT03016403|7647623|FG001|NOT COMPLETED|Baseline||27
6717892|NCT03016403|7647624|FG002|NOT COMPLETED|Baseline||11
6717893|NCT03016403|7647625|FG003|NOT COMPLETED|Baseline||34
6717894|NCT03016403|7647622|FG000|STARTED|6-week Follow-up|Anyone who had at least 1 follow-up after baseline.|123
6717895|NCT03016403|7647623|FG001|STARTED|6-week Follow-up||120
6717896|NCT03016403|7647624|FG002|STARTED|6-week Follow-up||107
6717897|NCT03016403|7647625|FG003|STARTED|6-week Follow-up||97
6717898|NCT03016403|7647622|FG000|COMPLETED|6-week Follow-up||120
6717899|NCT03016403|7647623|FG001|COMPLETED|6-week Follow-up||107
6717900|NCT03016403|7647624|FG002|COMPLETED|6-week Follow-up||103
6717901|NCT03016403|7647625|FG003|COMPLETED|6-week Follow-up||88
6717902|NCT03016403|7647622|FG000|NOT COMPLETED|6-week Follow-up||3
6717903|NCT03016403|7647623|FG001|NOT COMPLETED|6-week Follow-up||13
6717904|NCT03016403|7647624|FG002|NOT COMPLETED|6-week Follow-up||4
6717905|NCT03016403|7647625|FG003|NOT COMPLETED|6-week Follow-up||9
6717906|NCT03016403|7647622|FG000|STARTED|3-month Follow-up and 6-month Follow-up||120
6717907|NCT03016403|7647623|FG001|STARTED|3-month Follow-up and 6-month Follow-up||107
6717908|NCT03016403|7647624|FG002|STARTED|3-month Follow-up and 6-month Follow-up||103
6263581|NCT00671528|7162404|FG000|COMPLETED|Overall Study||1
6263582|NCT00671528|7162405|FG001|COMPLETED|Overall Study||1
6263583|NCT00671528|7162406|FG002|COMPLETED|Overall Study||1
6263584|NCT00671528|7162404|FG000|NOT COMPLETED|Overall Study||0
6263585|NCT00671528|7162405|FG001|NOT COMPLETED|Overall Study||0
6263586|NCT00671528|7162406|FG002|NOT COMPLETED|Overall Study||0
6263587|NCT00667823|7162414|FG000|STARTED|Overall Study||550
6263588|NCT00667823|7162414|FG000|COMPLETED|Overall Study||334
6263589|NCT00667823|7162414|FG000|NOT COMPLETED|Overall Study||216
6263590|NCT00652327|7162420|FG000|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
6263591|NCT00652327|7162421|FG001|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
6263592|NCT00652327|7162420|FG000|COMPLETED|Overall Study||42
6263593|NCT00652327|7162421|FG001|COMPLETED|Overall Study||36
6263594|NCT00652327|7162420|FG000|NOT COMPLETED|Overall Study||0
6263595|NCT00652327|7162421|FG001|NOT COMPLETED|Overall Study||5
6263596|NCT00604500|7162427|FG000|STARTED|Overall Study||272
6263597|NCT00604500|7162427|FG000|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
6263598|NCT00604500|7162427|FG000|NOT COMPLETED|Overall Study||11
6263599|NCT00568178|7162433|FG000|STARTED|Double Blind Base Study||122
6263600|NCT00568178|7162434|FG001|STARTED|Double Blind Base Study||124
6263601|NCT00568178|7162435|FG002|STARTED|Double Blind Base Study||30
6263602|NCT00568178|7162436|FG003|STARTED|Double Blind Base Study||30
6263603|NCT00568178|7162437|FG004|STARTED|Double Blind Base Study||0
6263604|NCT00568178|7162438|FG005|STARTED|Double Blind Base Study||0
6263605|NCT00568178|7162433|FG000|COMPLETED|Double Blind Base Study||116
6263606|NCT00568178|7162434|FG001|COMPLETED|Double Blind Base Study||118
6263607|NCT00568178|7162435|FG002|COMPLETED|Double Blind Base Study||29
6263608|NCT00568178|7162436|FG003|COMPLETED|Double Blind Base Study||25
6263609|NCT00568178|7162437|FG004|COMPLETED|Double Blind Base Study||0
6263610|NCT00568178|7162438|FG005|COMPLETED|Double Blind Base Study||0
6263611|NCT00568178|7162433|FG000|NOT COMPLETED|Double Blind Base Study||6
6263612|NCT00568178|7162434|FG001|NOT COMPLETED|Double Blind Base Study||6
6263613|NCT00568178|7162435|FG002|NOT COMPLETED|Double Blind Base Study||1
6263614|NCT00568178|7162436|FG003|NOT COMPLETED|Double Blind Base Study||5
6263615|NCT00568178|7162437|FG004|NOT COMPLETED|Double Blind Base Study||0
6263616|NCT00568178|7162438|FG005|NOT COMPLETED|Double Blind Base Study||0
6263617|NCT00568178|7162433|FG000|STARTED|Open Label Extension||0
6263618|NCT00568178|7162434|FG001|STARTED|Open Label Extension||0
6263619|NCT00568178|7162435|FG002|STARTED|Open Label Extension||0
6717909|NCT03016403|7647625|FG003|STARTED|3-month Follow-up and 6-month Follow-up||88
6717910|NCT03016403|7647622|FG000|COMPLETED|3-month Follow-up and 6-month Follow-up||108
6717911|NCT03016403|7647623|FG001|COMPLETED|3-month Follow-up and 6-month Follow-up||96
6717912|NCT03016403|7647624|FG002|COMPLETED|3-month Follow-up and 6-month Follow-up||95
6717913|NCT03016403|7647625|FG003|COMPLETED|3-month Follow-up and 6-month Follow-up||81
6717914|NCT03016403|7647622|FG000|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||12
6717915|NCT03016403|7647623|FG001|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||11
6717916|NCT03016403|7647624|FG002|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||8
6717917|NCT03016403|7647625|FG003|NOT COMPLETED|3-month Follow-up and 6-month Follow-up||7
6717918|NCT03016598|7647639|FG000|STARTED|Overall Study||18
6717919|NCT03016598|7647640|FG001|STARTED|Overall Study||22
6717920|NCT03016598|7647639|FG000|COMPLETED|Overall Study||18
6717921|NCT03016598|7647640|FG001|COMPLETED|Overall Study||20
6717922|NCT03016598|7647639|FG000|NOT COMPLETED|Overall Study||0
6717923|NCT03016598|7647640|FG001|NOT COMPLETED|Overall Study||2
6717924|NCT03017079|7647648|FG000|STARTED|Overall Study||20
6717925|NCT03017079|7647649|FG001|STARTED|Overall Study||20
6717926|NCT03017079|7647648|FG000|COMPLETED|Overall Study||14
6717927|NCT03017079|7647649|FG001|COMPLETED|Overall Study||14
6717928|NCT03017079|7647648|FG000|NOT COMPLETED|Overall Study||6
6717929|NCT03017079|7647649|FG001|NOT COMPLETED|Overall Study||6
6717930|NCT03017235|7647664|FG000|STARTED|Overall Study||456
6717931|NCT03017235|7647665|FG001|STARTED|Overall Study||461
6717932|NCT03017235|7647664|FG000|COMPLETED|Overall Study||444
6717933|NCT03017235|7647665|FG001|COMPLETED|Overall Study||447
6717934|NCT03017235|7647664|FG000|NOT COMPLETED|Overall Study||12
6717935|NCT03017235|7647665|FG001|NOT COMPLETED|Overall Study||14
6717936|NCT03017261|7647671|FG000|STARTED|6 Week Follow up||115
6717937|NCT03017261|7647671|FG000|COMPLETED|6 Week Follow up||115
6717938|NCT03017261|7647671|FG000|NOT COMPLETED|6 Week Follow up||0
6717939|NCT03017261|7647671|FG000|STARTED|3 Month Follow up||115
6717940|NCT03017261|7647671|FG000|COMPLETED|3 Month Follow up|1 failed to compete 3M imaging so only 114 have 3M data for tibial slope and KSS Objective Score.|115
6717941|NCT03017261|7647671|FG000|NOT COMPLETED|3 Month Follow up||0
6717942|NCT03017261|7647671|FG000|STARTED|6 Month Follow up||115
6717943|NCT03017261|7647671|FG000|COMPLETED|6 Month Follow up||106
6717944|NCT03017261|7647671|FG000|NOT COMPLETED|6 Month Follow up||9
6717945|NCT03017261|7647671|FG000|STARTED|12 Month Follow up||106
6717946|NCT03017261|7647671|FG000|COMPLETED|12 Month Follow up|1 failed to compete 12M imaging so only 58 have 12M data for KSS Objective Score.|59
6717947|NCT03017261|7647671|FG000|NOT COMPLETED|12 Month Follow up||47
6717948|NCT03017508|7647677|FG000|STARTED|Overall Study||12
6717949|NCT03017508|7647678|FG001|STARTED|Overall Study||10
6717950|NCT03017508|7647677|FG000|First Intervention (1 Day)|Overall Study||12
6717951|NCT03017508|7647678|FG001|First Intervention (1 Day)|Overall Study||10
6717952|NCT03017508|7647677|FG000|Washout (2-10 Days)|Overall Study||12
6717953|NCT03017508|7647678|FG001|Washout (2-10 Days)|Overall Study||10
6717954|NCT03017508|7647677|FG000|Second Intervention (1 Day)|Overall Study||12
6717955|NCT03017508|7647678|FG001|Second Intervention (1 Day)|Overall Study||10
6717956|NCT03017508|7647677|FG000|COMPLETED|Overall Study||12
6717957|NCT03017508|7647678|FG001|COMPLETED|Overall Study||10
6717958|NCT03017508|7647677|FG000|NOT COMPLETED|Overall Study||0
6717959|NCT03017508|7647678|FG001|NOT COMPLETED|Overall Study||0
6717960|NCT03017612|7647684|FG000|STARTED|Overall Study||13
6717961|NCT03017612|7647684|FG000|COMPLETED|Overall Study||11
6717962|NCT03017612|7647684|FG000|NOT COMPLETED|Overall Study||2
6717963|NCT03017846|7647688|FG000|STARTED|Overall Study||30
6717964|NCT03017846|7647688|FG000|COMPLETED|Overall Study||25
6717965|NCT03017846|7647688|FG000|NOT COMPLETED|Overall Study||5
6717966|NCT03017924|7647696|FG000|STARTED|Overall Study||12
6717967|NCT03017924|7647697|FG001|STARTED|Overall Study||11
6717968|NCT03017924|7647696|FG000|COMPLETED|Overall Study||10
6717969|NCT03017924|7647697|FG001|COMPLETED|Overall Study||8
6717970|NCT03017924|7647696|FG000|NOT COMPLETED|Overall Study||2
6717971|NCT03017924|7647697|FG001|NOT COMPLETED|Overall Study||3
6717972|NCT03017937|7647705|FG000|STARTED|Overall Study||155
6717973|NCT03017937|7647705|FG000|COMPLETED|Overall Study||155
6717974|NCT03017937|7647705|FG000|NOT COMPLETED|Overall Study||0
6717975|NCT03018028|7647715|FG000|STARTED|Overall Study||49
6717976|NCT03018028|7647716|FG001|STARTED|Overall Study||49
6717977|NCT03018028|7647717|FG002|STARTED|Overall Study||48
6717978|NCT03018028|7647718|FG003|STARTED|Overall Study||48
6717979|NCT03018028|7647719|FG004|STARTED|Overall Study||49
6717980|NCT03018028|7647715|FG000|Full Analysis Set (FAS)|Overall Study||49
6717981|NCT03018028|7647716|FG001|Full Analysis Set (FAS)|Overall Study||49
6717982|NCT03018028|7647717|FG002|Full Analysis Set (FAS)|Overall Study||48
6717983|NCT03018028|7647718|FG003|Full Analysis Set (FAS)|Overall Study||48
6717984|NCT03018028|7647719|FG004|Full Analysis Set (FAS)|Overall Study||49
6717985|NCT03018028|7647715|FG000|Safety Analysis Set (SAS)|Overall Study||49
6717986|NCT03018028|7647716|FG001|Safety Analysis Set (SAS)|Overall Study||49
6717987|NCT03018028|7647717|FG002|Safety Analysis Set (SAS)|Overall Study||48
6717988|NCT03018028|7647718|FG003|Safety Analysis Set (SAS)|Overall Study||48
6717989|NCT03018028|7647719|FG004|Safety Analysis Set (SAS)|Overall Study||49
6717990|NCT03018028|7647715|FG000|COMPLETED|Overall Study||46
6717991|NCT03018028|7647716|FG001|COMPLETED|Overall Study||49
6717992|NCT03018028|7647717|FG002|COMPLETED|Overall Study||47
6717993|NCT03018028|7647718|FG003|COMPLETED|Overall Study||46
6717994|NCT03018028|7647719|FG004|COMPLETED|Overall Study||49
6717995|NCT03018028|7647715|FG000|NOT COMPLETED|Overall Study||3
6717996|NCT03018028|7647716|FG001|NOT COMPLETED|Overall Study||0
6717997|NCT03018028|7647717|FG002|NOT COMPLETED|Overall Study||1
6717998|NCT03018028|7647718|FG003|NOT COMPLETED|Overall Study||2
6717999|NCT03018028|7647719|FG004|NOT COMPLETED|Overall Study||0
6718000|NCT03018106|7647733|FG000|STARTED|Overall Study||0
6718001|NCT03018106|7647734|FG001|STARTED|Overall Study||1
6718002|NCT03018106|7647733|FG000|COMPLETED|Overall Study||0
6718003|NCT03018106|7647734|FG001|COMPLETED|Overall Study||0
6718004|NCT03018106|7647733|FG000|NOT COMPLETED|Overall Study||0
6718005|NCT03018106|7647734|FG001|NOT COMPLETED|Overall Study||1
6718006|NCT03018223|7647738|FG000|STARTED|Overall Study||32
6718007|NCT03018223|7647738|FG000|COMPLETED|Overall Study||32
6718008|NCT03018223|7647738|FG000|NOT COMPLETED|Overall Study||0
6718009|NCT03018249|7647744|FG000|STARTED|Overall Study||25
6718010|NCT03018249|7647745|FG001|STARTED|Overall Study||25
6718011|NCT03018249|7647744|FG000|COMPLETED|Overall Study||23
6718012|NCT03018249|7647745|FG001|COMPLETED|Overall Study||23
6718013|NCT03018249|7647744|FG000|NOT COMPLETED|Overall Study||2
6718014|NCT03018249|7647745|FG001|NOT COMPLETED|Overall Study||2
6718015|NCT03018340|7647753|FG000|STARTED|Overall Study||52
6718016|NCT03018340|7647754|FG001|STARTED|Overall Study||155
6718017|NCT03018340|7647753|FG000|COMPLETED|Overall Study||44
6718018|NCT03018340|7647754|FG001|COMPLETED|Overall Study||125
6718019|NCT03018340|7647753|FG000|NOT COMPLETED|Overall Study||8
6718020|NCT03018340|7647754|FG001|NOT COMPLETED|Overall Study||30
6718021|NCT03018691|7647767|FG000|STARTED|Overall Study||24
6718022|NCT03018691|7647768|FG001|STARTED|Overall Study||25
6718023|NCT03018691|7647769|FG002|STARTED|Overall Study||24
6718024|NCT03018691|7647767|FG000|COMPLETED|Overall Study||22
6718025|NCT03018691|7647768|FG001|COMPLETED|Overall Study||24
6718026|NCT03018691|7647769|FG002|COMPLETED|Overall Study||17
6718027|NCT03018691|7647767|FG000|NOT COMPLETED|Overall Study||2
6718028|NCT03018691|7647768|FG001|NOT COMPLETED|Overall Study||1
6718029|NCT03018691|7647769|FG002|NOT COMPLETED|Overall Study||7
6718030|NCT03018925|7647779|FG000|STARTED|Overall Study||15
6718031|NCT03018925|7647779|FG000|COMPLETED|Overall Study||15
6718032|NCT03018925|7647779|FG000|NOT COMPLETED|Overall Study||0
6718033|NCT03018938|7647806|FG000|STARTED|Overall Study||404
6718034|NCT03018938|7647807|FG001|STARTED|Overall Study||410
6718035|NCT03018938|7647806|FG000|Received at Least 1 Dose of Study Drug|Overall Study||404
6718036|NCT03018938|7647807|FG001|Received at Least 1 Dose of Study Drug|Overall Study||410
6718037|NCT03018938|7647806|FG000|COMPLETED|Overall Study||338
6718038|NCT03018938|7647807|FG001|COMPLETED|Overall Study||325
6718039|NCT03018938|7647806|FG000|NOT COMPLETED|Overall Study||66
6718040|NCT03018938|7647807|FG001|NOT COMPLETED|Overall Study||85
6718041|NCT03019055|7647817|FG000|STARTED|Overall Study||0
6718042|NCT03019055|7647818|FG001|STARTED|Overall Study||3
6718043|NCT03019055|7647819|FG002|STARTED|Overall Study||3
6718044|NCT03019055|7647820|FG003|STARTED|Overall Study||20
6718045|NCT03019055|7647817|FG000|COMPLETED|Overall Study||0
6718046|NCT03019055|7647818|FG001|COMPLETED|Overall Study||3
6718047|NCT03019055|7647819|FG002|COMPLETED|Overall Study||3
6718048|NCT03019055|7647820|FG003|COMPLETED|Overall Study||20
6718049|NCT03019055|7647817|FG000|NOT COMPLETED|Overall Study||0
6718050|NCT03019055|7647818|FG001|NOT COMPLETED|Overall Study||0
6718051|NCT03019055|7647819|FG002|NOT COMPLETED|Overall Study||0
6718052|NCT03019055|7647820|FG003|NOT COMPLETED|Overall Study||0
6718053|NCT03019107|7647832|FG000|STARTED|Overall Study||1
6718054|NCT03019107|7647833|FG001|STARTED|Overall Study||0
6718055|NCT03019107|7647832|FG000|COMPLETED|Overall Study||1
6718056|NCT03019107|7647833|FG001|COMPLETED|Overall Study||0
6718057|NCT03019107|7647832|FG000|NOT COMPLETED|Overall Study||0
6718058|NCT03019107|7647833|FG001|NOT COMPLETED|Overall Study||0
6718059|NCT03019289|7647848|FG000|STARTED|Overall Study||5
6718060|NCT03019289|7647849|FG001|STARTED|Overall Study||1
6718061|NCT03019289|7647850|FG002|STARTED|Overall Study||3
6718062|NCT03019289|7647851|FG003|STARTED|Overall Study||2
6718063|NCT03019289|7647852|FG004|STARTED|Overall Study||1
6718064|NCT03019289|7647853|FG005|STARTED|Overall Study||1
6718065|NCT03019289|7647854|FG006|STARTED|Overall Study||3
6718066|NCT03019289|7647855|FG007|STARTED|Overall Study||4
6718067|NCT03019289|7647856|FG008|STARTED|Overall Study||3
6718068|NCT03019289|7647848|FG000|COMPLETED|Overall Study||3
6718069|NCT03019289|7647849|FG001|COMPLETED|Overall Study||1
6718070|NCT03019289|7647850|FG002|COMPLETED|Overall Study||3
6718071|NCT03019289|7647851|FG003|COMPLETED|Overall Study||2
6718072|NCT03019289|7647852|FG004|COMPLETED|Overall Study||1
6718073|NCT03019289|7647853|FG005|COMPLETED|Overall Study||1
6718074|NCT03019289|7647854|FG006|COMPLETED|Overall Study||3
6718075|NCT03019289|7647855|FG007|COMPLETED|Overall Study||4
6718076|NCT03019289|7647856|FG008|COMPLETED|Overall Study||2
6718077|NCT03019289|7647848|FG000|NOT COMPLETED|Overall Study||2
6718078|NCT03019289|7647849|FG001|NOT COMPLETED|Overall Study||0
6718079|NCT03019289|7647850|FG002|NOT COMPLETED|Overall Study||0
6718080|NCT03019289|7647851|FG003|NOT COMPLETED|Overall Study||0
6718081|NCT03019289|7647852|FG004|NOT COMPLETED|Overall Study||0
6718082|NCT03019289|7647853|FG005|NOT COMPLETED|Overall Study||0
6718083|NCT03019289|7647854|FG006|NOT COMPLETED|Overall Study||0
6718084|NCT03019289|7647855|FG007|NOT COMPLETED|Overall Study||0
6718085|NCT03019289|7647856|FG008|NOT COMPLETED|Overall Study||1
6718086|NCT03019406|7647881|FG000|STARTED|PAP: up to 25 Weeks||6
6718087|NCT03019406|7647882|FG001|STARTED|PAP: up to 25 Weeks||5
6718088|NCT03019406|7647883|FG002|STARTED|PAP: up to 25 Weeks||5
6718089|NCT03019406|7647884|FG003|STARTED|PAP: up to 25 Weeks||6
6718090|NCT03019406|7647881|FG000|Treated|PAP: up to 25 Weeks||6
6718091|NCT03019406|7647882|FG001|Treated|PAP: up to 25 Weeks||5
6718092|NCT03019406|7647883|FG002|Treated|PAP: up to 25 Weeks||5
6718093|NCT03019406|7647884|FG003|Treated|PAP: up to 25 Weeks||6
6718094|NCT03019406|7647881|FG000|COMPLETED|PAP: up to 25 Weeks||6
6718095|NCT03019406|7647882|FG001|COMPLETED|PAP: up to 25 Weeks||5
6718096|NCT03019406|7647883|FG002|COMPLETED|PAP: up to 25 Weeks||5
6718097|NCT03019406|7647884|FG003|COMPLETED|PAP: up to 25 Weeks||6
6718098|NCT03019406|7647881|FG000|NOT COMPLETED|PAP: up to 25 Weeks||0
6718099|NCT03019406|7647882|FG001|NOT COMPLETED|PAP: up to 25 Weeks||0
6718100|NCT03019406|7647883|FG002|NOT COMPLETED|PAP: up to 25 Weeks||0
6718101|NCT03019406|7647884|FG003|NOT COMPLETED|PAP: up to 25 Weeks||0
6718102|NCT03019406|7647881|FG000|STARTED|ETP: Ongoing From Week 26||6
6718103|NCT03019406|7647882|FG001|STARTED|ETP: Ongoing From Week 26||5
6718104|NCT03019406|7647883|FG002|STARTED|ETP: Ongoing From Week 26||5
6718105|NCT03019406|7647884|FG003|STARTED|ETP: Ongoing From Week 26|Participants who completed PAP and accepted to receive avalglucosidase alfa treatment in ETP.|3
6718106|NCT03019406|7647881|FG000|COMPLETED|ETP: Ongoing From Week 26||0
6718107|NCT03019406|7647882|FG001|COMPLETED|ETP: Ongoing From Week 26||0
6718108|NCT03019406|7647883|FG002|COMPLETED|ETP: Ongoing From Week 26||0
6718109|NCT03019406|7647884|FG003|COMPLETED|ETP: Ongoing From Week 26||0
6718110|NCT03019406|7647881|FG000|NOT COMPLETED|ETP: Ongoing From Week 26||6
6718111|NCT03019406|7647882|FG001|NOT COMPLETED|ETP: Ongoing From Week 26||5
6718112|NCT03019406|7647883|FG002|NOT COMPLETED|ETP: Ongoing From Week 26||5
6718113|NCT03019406|7647884|FG003|NOT COMPLETED|ETP: Ongoing From Week 26||3
6718114|NCT03019458|7647899|FG000|STARTED|Overall Study||24
6718115|NCT03019458|7647900|FG001|STARTED|Overall Study||26
6718116|NCT03019458|7647899|FG000|COMPLETED|Overall Study||24
6602837|NCT02059148|7527882|FG004|NOT COMPLETED|Treatment 1||0
6602838|NCT02059148|7527883|FG005|NOT COMPLETED|Treatment 1||1
6602839|NCT02059148|7527878|FG000|STARTED|Treatment 2||4
6602840|NCT02059148|7527879|FG001|STARTED|Treatment 2||4
6602841|NCT02059148|7527880|FG002|STARTED|Treatment 2||4
6602842|NCT02059148|7527881|FG003|STARTED|Treatment 2||4
6602843|NCT02059148|7527882|FG004|STARTED|Treatment 2||4
6602844|NCT02059148|7527883|FG005|STARTED|Treatment 2||3
6602845|NCT02059148|7527878|FG000|COMPLETED|Treatment 2||4
6602846|NCT02059148|7527879|FG001|COMPLETED|Treatment 2||4
6602847|NCT02059148|7527880|FG002|COMPLETED|Treatment 2||4
6718117|NCT03019458|7647900|FG001|COMPLETED|Overall Study||25
6718118|NCT03019458|7647899|FG000|NOT COMPLETED|Overall Study||0
6718119|NCT03019458|7647900|FG001|NOT COMPLETED|Overall Study||1
6718120|NCT03019549|7647908|FG000|STARTED|Period 1||42
6718121|NCT03019549|7647908|FG000|Received 1 Dose of Study Drug|Period 1||42
6718122|NCT03019549|7647908|FG000|COMPLETED|Period 1||42
6718123|NCT03019549|7647908|FG000|NOT COMPLETED|Period 1||0
6718124|NCT03019549|7647908|FG000|STARTED|Washout||42
6718125|NCT03019549|7647908|FG000|COMPLETED|Washout||31
6718126|NCT03019549|7647908|FG000|NOT COMPLETED|Washout||11
6718127|NCT03019549|7647908|FG000|STARTED|Period 2||31
6718128|NCT03019549|7647908|FG000|Received at Least 1 Dose of Study Drug|Period 2||29
6718129|NCT03019549|7647908|FG000|COMPLETED|Period 2||26
6718130|NCT03019549|7647908|FG000|NOT COMPLETED|Period 2||5
6718131|NCT03019627|7647919|FG000|STARTED|Overall Study||100
6718132|NCT03019627|7647920|FG001|STARTED|Overall Study||50
6718133|NCT03019627|7647919|FG000|COMPLETED|Overall Study||85
6718134|NCT03019627|7647920|FG001|COMPLETED|Overall Study||42
6718135|NCT03019627|7647919|FG000|NOT COMPLETED|Overall Study||15
6718136|NCT03019627|7647920|FG001|NOT COMPLETED|Overall Study||8
6718137|NCT03019744|7647928|FG000|STARTED|Overall Study||38
6718138|NCT03019744|7647929|FG001|STARTED|Overall Study||44
6718139|NCT03019744|7647928|FG000|COMPLETED|Overall Study||32
6718140|NCT03019744|7647929|FG001|COMPLETED|Overall Study||36
6718141|NCT03019744|7647928|FG000|NOT COMPLETED|Overall Study||6
6718142|NCT03019744|7647929|FG001|NOT COMPLETED|Overall Study||8
6718143|NCT03019783|7647937|FG000|STARTED|Overall Study||29
6718144|NCT03019783|7647938|FG001|STARTED|Overall Study||31
6718145|NCT03019783|7647937|FG000|COMPLETED|Overall Study||29
6718146|NCT03019783|7647938|FG001|COMPLETED|Overall Study||31
6718147|NCT03019783|7647937|FG000|NOT COMPLETED|Overall Study||0
6718148|NCT03019783|7647938|FG001|NOT COMPLETED|Overall Study||0
6718149|NCT03019796|7647944|FG000|STARTED|First Intervention Drug Tests||20
6718150|NCT03019796|7647945|FG001|STARTED|First Intervention Drug Tests||20
6602848|NCT02059148|7527881|FG003|COMPLETED|Treatment 2||4
6602849|NCT02059148|7527882|FG004|COMPLETED|Treatment 2||4
6718151|NCT03019796|7647944|FG000|COMPLETED|First Intervention Drug Tests||20
6718152|NCT03019796|7647945|FG001|COMPLETED|First Intervention Drug Tests||20
6718153|NCT03019796|7647944|FG000|NOT COMPLETED|First Intervention Drug Tests||0
6718154|NCT03019796|7647945|FG001|NOT COMPLETED|First Intervention Drug Tests||0
6718155|NCT03019796|7647944|FG000|STARTED|Second Intervention Training (4 Months)||20
6718156|NCT03019796|7647945|FG001|STARTED|Second Intervention Training (4 Months)||20
6718157|NCT03019796|7647944|FG000|COMPLETED|Second Intervention Training (4 Months)||19
6718158|NCT03019796|7647945|FG001|COMPLETED|Second Intervention Training (4 Months)||19
6718159|NCT03019796|7647944|FG000|NOT COMPLETED|Second Intervention Training (4 Months)||1
6718160|NCT03019796|7647945|FG001|NOT COMPLETED|Second Intervention Training (4 Months)||1
6718161|NCT03019796|7647944|FG000|STARTED|Third Intervention Drug Test||19
6718162|NCT03019796|7647945|FG001|STARTED|Third Intervention Drug Test||19
6718163|NCT03019796|7647944|FG000|COMPLETED|Third Intervention Drug Test||19
6718164|NCT03019796|7647945|FG001|COMPLETED|Third Intervention Drug Test||19
6718165|NCT03019796|7647944|FG000|NOT COMPLETED|Third Intervention Drug Test||0
6718166|NCT03019796|7647945|FG001|NOT COMPLETED|Third Intervention Drug Test||0
6718167|NCT03019887|7647952|FG000|STARTED|Overall Study||139
6718168|NCT03019887|7647952|FG000|COMPLETED|Overall Study||130
6718169|NCT03019887|7647952|FG000|NOT COMPLETED|Overall Study||9
6718170|NCT03019939|7647956|FG000|STARTED|Overall Study||65
6718171|NCT03019939|7647956|FG000|COMPLETED|Overall Study||65
6718172|NCT03019939|7647956|FG000|NOT COMPLETED|Overall Study||0
6718173|NCT03019965|7647962|FG000|STARTED|Overall Study||211
6718174|NCT03019965|7647963|FG001|STARTED|Overall Study||215
6718175|NCT03019965|7647962|FG000|COMPLETED|Overall Study||201
6718176|NCT03019965|7647963|FG001|COMPLETED|Overall Study||202
6718177|NCT03019965|7647962|FG000|NOT COMPLETED|Overall Study||10
6718178|NCT03019965|7647963|FG001|NOT COMPLETED|Overall Study||13
6718179|NCT03020004|7647969|FG000|STARTED|Overall Study||70
6718180|NCT03020004|7647969|FG000|COMPLETED|Overall Study||69
6718181|NCT03020004|7647969|FG000|NOT COMPLETED|Overall Study||1
6718182|NCT03020069|7647975|FG000|STARTED|Overall Study||9
6718183|NCT03020069|7647976|FG001|STARTED|Overall Study||4
6718184|NCT03020069|7647975|FG000|COMPLETED|Overall Study||9
6718185|NCT03020069|7647976|FG001|COMPLETED|Overall Study||3
6718186|NCT03020069|7647975|FG000|NOT COMPLETED|Overall Study||0
6718187|NCT03020069|7647976|FG001|NOT COMPLETED|Overall Study||1
6718188|NCT03020082|7647982|FG000|STARTED|Overall Study||141
6718189|NCT03020082|7647982|FG000|COMPLETED|Overall Study||138
6718190|NCT03020082|7647982|FG000|NOT COMPLETED|Overall Study||3
6718191|NCT03020095|7647986|FG000|STARTED|Overall Study||38
6718192|NCT03020095|7647986|FG000|COMPLETED|Overall Study||37
6718193|NCT03020095|7647986|FG000|NOT COMPLETED|Overall Study||1
6718194|NCT03020407|7647992|FG000|STARTED|Overall Study||105
6718195|NCT03020407|7647993|FG001|STARTED|Overall Study||106
6718196|NCT03020407|7647992|FG000|COMPLETED|Overall Study||101
6718197|NCT03020407|7647993|FG001|COMPLETED|Overall Study||101
6718198|NCT03020407|7647992|FG000|NOT COMPLETED|Overall Study||4
6718199|NCT03020407|7647993|FG001|NOT COMPLETED|Overall Study||5
6718200|NCT03020472|7647999|FG000|STARTED|Overall Study||6
6718201|NCT03020472|7647999|FG000|COMPLETED|Overall Study||6
6718202|NCT03020472|7647999|FG000|NOT COMPLETED|Overall Study||0
6718203|NCT03020498|7648006|FG000|STARTED|Overall Study||14
6718204|NCT03020498|7648007|FG001|STARTED|Overall Study||41
6718205|NCT03020498|7648008|FG002|STARTED|Overall Study||36
6718206|NCT03020498|7648006|FG000|COMPLETED|Overall Study||14
6718207|NCT03020498|7648007|FG001|COMPLETED|Overall Study||38
6718208|NCT03020498|7648008|FG002|COMPLETED|Overall Study||36
6718209|NCT03020498|7648006|FG000|NOT COMPLETED|Overall Study||0
6718210|NCT03020498|7648007|FG001|NOT COMPLETED|Overall Study||3
6718211|NCT03020498|7648008|FG002|NOT COMPLETED|Overall Study||0
6718212|NCT03020524|7648019|FG000|STARTED|Overall Study||3
6718213|NCT03020524|7648020|FG001|STARTED|Overall Study||3
6718214|NCT03020524|7648021|FG002|STARTED|Overall Study||3
6718215|NCT03020524|7648019|FG000|COMPLETED|Overall Study||3
6718216|NCT03020524|7648020|FG001|COMPLETED|Overall Study||3
6718217|NCT03020524|7648021|FG002|COMPLETED|Overall Study||3
6718218|NCT03020524|7648019|FG000|NOT COMPLETED|Overall Study||0
6718219|NCT03020524|7648020|FG001|NOT COMPLETED|Overall Study||0
6718220|NCT03020524|7648021|FG002|NOT COMPLETED|Overall Study||0
6718221|NCT03020537|7648031|FG000|STARTED|Overall Study||1
6718222|NCT03020537|7648032|FG001|STARTED|Overall Study||7
6718223|NCT03020537|7648031|FG000|COMPLETED|Overall Study||1
6718224|NCT03020537|7648032|FG001|COMPLETED|Overall Study||7
6718225|NCT03020537|7648031|FG000|NOT COMPLETED|Overall Study||0
6718226|NCT03020537|7648032|FG001|NOT COMPLETED|Overall Study||0
6718227|NCT03020550|7648040|FG000|STARTED|Overall Study||8
6718228|NCT03020550|7648041|FG001|STARTED|Overall Study||16
6718229|NCT03020550|7648040|FG000|COMPLETED|Overall Study||8
6718230|NCT03020550|7648041|FG001|COMPLETED|Overall Study||16
6718231|NCT03020550|7648040|FG000|NOT COMPLETED|Overall Study||0
6718232|NCT03020550|7648041|FG001|NOT COMPLETED|Overall Study||0
6718233|NCT03020576|7648049|FG000|STARTED|Overall Study||15
6718234|NCT03020576|7648050|FG001|STARTED|Overall Study||16
6718235|NCT03020576|7648049|FG000|COMPLETED|Overall Study||14
6718236|NCT03020576|7648050|FG001|COMPLETED|Overall Study||14
6718237|NCT03020576|7648049|FG000|NOT COMPLETED|Overall Study||1
6718238|NCT03020576|7648050|FG001|NOT COMPLETED|Overall Study||2
6718239|NCT03020615|7648059|FG000|STARTED|Overall Study||26
6718240|NCT03020615|7648060|FG001|STARTED|Overall Study||25
6718241|NCT03020615|7648061|FG002|STARTED|Overall Study||7
6718242|NCT03020615|7648059|FG000|COMPLETED|Overall Study||19
6718243|NCT03020615|7648060|FG001|COMPLETED|Overall Study||23
6718244|NCT03020615|7648061|FG002|COMPLETED|Overall Study||0
6718245|NCT03020615|7648059|FG000|NOT COMPLETED|Overall Study||7
6718246|NCT03020615|7648060|FG001|NOT COMPLETED|Overall Study||2
6718247|NCT03020615|7648061|FG002|NOT COMPLETED|Overall Study||7
6718248|NCT03020641|7648074|FG000|STARTED|Overall Study||50
6718249|NCT03020641|7648075|FG001|STARTED|Overall Study||50
6718250|NCT03020641|7648074|FG000|COMPLETED|Overall Study||48
6718251|NCT03020641|7648075|FG001|COMPLETED|Overall Study||47
6718252|NCT03020641|7648074|FG000|NOT COMPLETED|Overall Study||2
6718253|NCT03020641|7648075|FG001|NOT COMPLETED|Overall Study||3
6718254|NCT03020719|7648086|FG000|STARTED|Overall Study||30
6718255|NCT03020719|7648087|FG001|STARTED|Overall Study||30
6718256|NCT03020719|7648086|FG000|COMPLETED|Overall Study||30
6718257|NCT03020719|7648087|FG001|COMPLETED|Overall Study||28
6718258|NCT03020719|7648086|FG000|NOT COMPLETED|Overall Study||0
6718259|NCT03020719|7648087|FG001|NOT COMPLETED|Overall Study||2
6718260|NCT03020745|7648101|FG000|STARTED|Part 1 (Up to 60 Days)||3
6718261|NCT03020745|7648102|FG001|STARTED|Part 1 (Up to 60 Days)||3
6718262|NCT03020745|7648103|FG002|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
6718263|NCT03020745|7648104|FG003|STARTED|Part 1 (Up to 60 Days)||6
6718264|NCT03020745|7648105|FG004|STARTED|Part 1 (Up to 60 Days)|No participants were enrolled in this arm as per decision made by the dose escalation committee.|0
6718265|NCT03020745|7648106|FG005|STARTED|Part 1 (Up to 60 Days)||0
6718266|NCT03020745|7648107|FG006|STARTED|Part 1 (Up to 60 Days)||0
6718267|NCT03020745|7648108|FG007|STARTED|Part 1 (Up to 60 Days)||0
6718268|NCT03020745|7648109|FG008|STARTED|Part 1 (Up to 60 Days)||0
6718269|NCT03020745|7648110|FG009|STARTED|Part 1 (Up to 60 Days)||0
6718270|NCT03020745|7648101|FG000|COMPLETED|Part 1 (Up to 60 Days)||3
6718271|NCT03020745|7648102|FG001|COMPLETED|Part 1 (Up to 60 Days)||3
6718272|NCT03020745|7648103|FG002|COMPLETED|Part 1 (Up to 60 Days)||0
6718273|NCT03020745|7648104|FG003|COMPLETED|Part 1 (Up to 60 Days)||6
6718274|NCT03020745|7648105|FG004|COMPLETED|Part 1 (Up to 60 Days)||0
6718275|NCT03020745|7648106|FG005|COMPLETED|Part 1 (Up to 60 Days)||0
6718276|NCT03020745|7648107|FG006|COMPLETED|Part 1 (Up to 60 Days)||0
6718277|NCT03020745|7648108|FG007|COMPLETED|Part 1 (Up to 60 Days)||0
6718278|NCT03020745|7648109|FG008|COMPLETED|Part 1 (Up to 60 Days)||0
6718279|NCT03020745|7648110|FG009|COMPLETED|Part 1 (Up to 60 Days)||0
6718280|NCT03020745|7648101|FG000|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718281|NCT03020745|7648102|FG001|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718282|NCT03020745|7648103|FG002|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718283|NCT03020745|7648104|FG003|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718284|NCT03020745|7648105|FG004|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718285|NCT03020745|7648106|FG005|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718286|NCT03020745|7648107|FG006|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718287|NCT03020745|7648108|FG007|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718288|NCT03020745|7648109|FG008|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718289|NCT03020745|7648110|FG009|NOT COMPLETED|Part 1 (Up to 60 Days)||0
6718290|NCT03020745|7648101|FG000|STARTED|Part 2 (Up to 169 Days)||0
6718291|NCT03020745|7648102|FG001|STARTED|Part 2 (Up to 169 Days)||0
6718292|NCT03020745|7648103|FG002|STARTED|Part 2 (Up to 169 Days)||0
6718293|NCT03020745|7648104|FG003|STARTED|Part 2 (Up to 169 Days)||0
6718294|NCT03020745|7648105|FG004|STARTED|Part 2 (Up to 169 Days)||0
6718295|NCT03020745|7648106|FG005|STARTED|Part 2 (Up to 169 Days)||10
6718296|NCT03020745|7648107|FG006|STARTED|Part 2 (Up to 169 Days)||6
6718297|NCT03020745|7648108|FG007|STARTED|Part 2 (Up to 169 Days)||20
6718298|NCT03020745|7648109|FG008|STARTED|Part 2 (Up to 169 Days)||15
6718299|NCT03020745|7648110|FG009|STARTED|Part 2 (Up to 169 Days)||15
6718300|NCT03020745|7648101|FG000|COMPLETED|Part 2 (Up to 169 Days)||0
6718301|NCT03020745|7648102|FG001|COMPLETED|Part 2 (Up to 169 Days)||0
6718302|NCT03020745|7648103|FG002|COMPLETED|Part 2 (Up to 169 Days)||0
6718303|NCT03020745|7648104|FG003|COMPLETED|Part 2 (Up to 169 Days)||0
6718304|NCT03020745|7648105|FG004|COMPLETED|Part 2 (Up to 169 Days)||0
6718305|NCT03020745|7648106|FG005|COMPLETED|Part 2 (Up to 169 Days)||10
6718306|NCT03020745|7648107|FG006|COMPLETED|Part 2 (Up to 169 Days)||6
6718307|NCT03020745|7648108|FG007|COMPLETED|Part 2 (Up to 169 Days)||19
6718308|NCT03020745|7648109|FG008|COMPLETED|Part 2 (Up to 169 Days)||14
6718309|NCT03020745|7648110|FG009|COMPLETED|Part 2 (Up to 169 Days)||15
6718310|NCT03020745|7648101|FG000|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6718311|NCT03020745|7648102|FG001|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6718312|NCT03020745|7648103|FG002|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6718313|NCT03020745|7648104|FG003|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6718314|NCT03020745|7648105|FG004|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6718315|NCT03020745|7648106|FG005|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6718316|NCT03020745|7648107|FG006|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6718317|NCT03020745|7648108|FG007|NOT COMPLETED|Part 2 (Up to 169 Days)||1
6718318|NCT03020745|7648109|FG008|NOT COMPLETED|Part 2 (Up to 169 Days)||1
6718319|NCT03020745|7648110|FG009|NOT COMPLETED|Part 2 (Up to 169 Days)||0
6718320|NCT03020745|7648101|FG000|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6718321|NCT03020745|7648102|FG001|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6718322|NCT03020745|7648103|FG002|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6718323|NCT03020745|7648104|FG003|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6718324|NCT03020745|7648105|FG004|STARTED|Part 2:Optional FU (Up to 450 Days)||0
6718325|NCT03020745|7648106|FG005|STARTED|Part 2:Optional FU (Up to 450 Days)||10
6718326|NCT03020745|7648107|FG006|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant didn't enter into optional follow-up period.|5
6718327|NCT03020745|7648108|FG007|STARTED|Part 2:Optional FU (Up to 450 Days)|2 participants didn't enter into optional follow-up period.|17
6718328|NCT03020745|7648109|FG008|STARTED|Part 2:Optional FU (Up to 450 Days)|1 participant did not enter into optional follow-up period|13
6718329|NCT03020745|7648110|FG009|STARTED|Part 2:Optional FU (Up to 450 Days)||15
6718330|NCT03020745|7648101|FG000|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718331|NCT03020745|7648102|FG001|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718332|NCT03020745|7648103|FG002|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718333|NCT03020745|7648104|FG003|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718334|NCT03020745|7648105|FG004|COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718335|NCT03020745|7648106|FG005|COMPLETED|Part 2:Optional FU (Up to 450 Days)||9
6718336|NCT03020745|7648107|FG006|COMPLETED|Part 2:Optional FU (Up to 450 Days)||5
6718337|NCT03020745|7648108|FG007|COMPLETED|Part 2:Optional FU (Up to 450 Days)||17
6718338|NCT03020745|7648109|FG008|COMPLETED|Part 2:Optional FU (Up to 450 Days)||10
6718339|NCT03020745|7648110|FG009|COMPLETED|Part 2:Optional FU (Up to 450 Days)||15
6718340|NCT03020745|7648101|FG000|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718341|NCT03020745|7648102|FG001|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718342|NCT03020745|7648103|FG002|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718343|NCT03020745|7648104|FG003|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718344|NCT03020745|7648105|FG004|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718345|NCT03020745|7648106|FG005|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||1
6718346|NCT03020745|7648107|FG006|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718347|NCT03020745|7648108|FG007|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718348|NCT03020745|7648109|FG008|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||3
6718349|NCT03020745|7648110|FG009|NOT COMPLETED|Part 2:Optional FU (Up to 450 Days)||0
6718350|NCT03020888|7648134|FG000|STARTED|Overall Study||120
6718351|NCT03020888|7648134|FG000|COMPLETED|Overall Study||107
6718352|NCT03020888|7648134|FG000|NOT COMPLETED|Overall Study||13
6718353|NCT03020966|7648140|FG000|STARTED|Overall Study||77
6718354|NCT03020966|7648141|FG001|STARTED|Overall Study||77
6718355|NCT03020966|7648140|FG000|COMPLETED|Overall Study||75
6718356|NCT03020966|7648141|FG001|COMPLETED|Overall Study||77
6718357|NCT03020966|7648140|FG000|NOT COMPLETED|Overall Study||2
6718358|NCT03020966|7648141|FG001|NOT COMPLETED|Overall Study||0
6718359|NCT03020992|7648147|FG000|STARTED|Overall Study||89
6718360|NCT03020992|7648147|FG000|COMPLETED|Overall Study||83
6718361|NCT03020992|7648147|FG000|NOT COMPLETED|Overall Study||6
6718362|NCT03021005|7648154|FG000|STARTED|Overall Study||102
6718363|NCT03021005|7648155|FG001|STARTED|Overall Study||98
6718364|NCT03021005|7648154|FG000|COMPLETED|Overall Study||63
6718365|NCT03021005|7648155|FG001|COMPLETED|Overall Study||72
6718366|NCT03021005|7648154|FG000|NOT COMPLETED|Overall Study||39
6718367|NCT03021005|7648155|FG001|NOT COMPLETED|Overall Study||26
6718368|NCT03021018|7648164|FG000|STARTED|Overall Study||16
6718369|NCT03021018|7648165|FG001|STARTED|Overall Study||15
6718370|NCT03021018|7648166|FG002|STARTED|Overall Study||15
6718371|NCT03021018|7648164|FG000|COMPLETED|Overall Study||14
6718372|NCT03021018|7648165|FG001|COMPLETED|Overall Study||15
6718373|NCT03021018|7648166|FG002|COMPLETED|Overall Study||15
6718374|NCT03021018|7648164|FG000|NOT COMPLETED|Overall Study||2
6718375|NCT03021018|7648165|FG001|NOT COMPLETED|Overall Study||0
6718376|NCT03021018|7648166|FG002|NOT COMPLETED|Overall Study||0
6718377|NCT03021187|7648178|FG000|STARTED|Overall Study||184
6718378|NCT03021187|7648179|FG001|STARTED|Overall Study||182
6718379|NCT03021187|7648180|FG002|STARTED|Overall Study||181
6718380|NCT03021187|7648181|FG003|STARTED|Overall Study||184
6718381|NCT03021187|7648178|FG000|Exposed|Overall Study||184
6718382|NCT03021187|7648179|FG001|Exposed|Overall Study||181
6718383|NCT03021187|7648180|FG002|Exposed|Overall Study||181
6718384|NCT03021187|7648181|FG003|Exposed|Overall Study||184
6718385|NCT03021187|7648178|FG000|Full Analysis Set (FAS)|Overall Study||184
6718386|NCT03021187|7648179|FG001|Full Analysis Set (FAS)|Overall Study||182
6718387|NCT03021187|7648180|FG002|Full Analysis Set (FAS)|Overall Study||181
6718388|NCT03021187|7648181|FG003|Full Analysis Set (FAS)|Overall Study||184
6718389|NCT03021187|7648178|FG000|Safety Analysis Set (SAS)|Overall Study||184
6718390|NCT03021187|7648179|FG001|Safety Analysis Set (SAS)|Overall Study||181
6718391|NCT03021187|7648180|FG002|Safety Analysis Set (SAS)|Overall Study||181
6718392|NCT03021187|7648181|FG003|Safety Analysis Set (SAS)|Overall Study||184
6718393|NCT03021187|7648178|FG000|COMPLETED|Overall Study||174
6718394|NCT03021187|7648179|FG001|COMPLETED|Overall Study||173
6718395|NCT03021187|7648180|FG002|COMPLETED|Overall Study||175
6718396|NCT03021187|7648181|FG003|COMPLETED|Overall Study||175
6718397|NCT03021187|7648178|FG000|NOT COMPLETED|Overall Study||10
6718398|NCT03021187|7648179|FG001|NOT COMPLETED|Overall Study||9
6718399|NCT03021187|7648180|FG002|NOT COMPLETED|Overall Study||6
6718400|NCT03021187|7648181|FG003|NOT COMPLETED|Overall Study||9
6739512|NCT03291288|7668398|FG001|NOT COMPLETED|Drug-drug Interaction Phase||0
6739513|NCT03291288|7668397|FG000|STARTED|Pexidartinib Only|This is a crossover trial; participants who completed Part 1 continued to Part 2.|0
6739514|NCT03291288|7668398|FG001|STARTED|Pexidartinib Only||26
6739515|NCT03291288|7668397|FG000|COMPLETED|Pexidartinib Only||0
6718401|NCT03021265|7648191|FG000|STARTED|Overall Study||676
6718402|NCT03021265|7648191|FG000|COMPLETED|Overall Study||554
6718403|NCT03021265|7648191|FG000|NOT COMPLETED|Overall Study||122
6718404|NCT03021304|7648195|FG000|STARTED|Overall Study||56
6718405|NCT03021304|7648195|FG000|COMPLETED|Overall Study||55
6718406|NCT03021304|7648195|FG000|NOT COMPLETED|Overall Study||1
6718407|NCT03021343|7648201|FG000|STARTED|Overall Study||179
6718408|NCT03021343|7648202|FG001|STARTED|Overall Study||181
6718409|NCT03021343|7648201|FG000|COMPLETED|Overall Study||174
6718410|NCT03021343|7648202|FG001|COMPLETED|Overall Study||174
6718411|NCT03021343|7648201|FG000|NOT COMPLETED|Overall Study||5
6718412|NCT03021343|7648202|FG001|NOT COMPLETED|Overall Study||7
6718413|NCT03021499|7648210|FG000|STARTED|Overall Study||179
6718414|NCT03021499|7648211|FG001|STARTED|Overall Study||178
6718415|NCT03021499|7648210|FG000|Week 24|Overall Study||167
6718416|NCT03021499|7648211|FG001|Week 24|Overall Study||162
6718417|NCT03021499|7648210|FG000|Week 52|Overall Study||162
6718418|NCT03021499|7648211|FG001|Week 52|Overall Study||147
6718419|NCT03021499|7648210|FG000|COMPLETED|Overall Study||163
6718420|NCT03021499|7648211|FG001|COMPLETED|Overall Study||147
6718421|NCT03021499|7648210|FG000|NOT COMPLETED|Overall Study||16
6718422|NCT03021499|7648211|FG001|NOT COMPLETED|Overall Study||31
6718423|NCT03021538|7648221|FG000|STARTED|Overall Study||6
6718424|NCT03021538|7648222|FG001|STARTED|Overall Study||7
6718425|NCT03021538|7648221|FG000|COMPLETED|Overall Study||6
6718426|NCT03021538|7648222|FG001|COMPLETED|Overall Study||7
6718427|NCT03021538|7648221|FG000|NOT COMPLETED|Overall Study||0
6718428|NCT03021538|7648222|FG001|NOT COMPLETED|Overall Study||0
6718429|NCT03021564|7648230|FG000|STARTED|Overall Study||120
6718430|NCT03021564|7648231|FG001|STARTED|Overall Study||557
6718431|NCT03021564|7648230|FG000|COMPLETED|Overall Study||36
6718432|NCT03021564|7648231|FG001|COMPLETED|Overall Study||89
6718433|NCT03021564|7648230|FG000|NOT COMPLETED|Overall Study||84
6718434|NCT03021564|7648231|FG001|NOT COMPLETED|Overall Study||468
6718435|NCT03021642|7648241|FG000|STARTED|Treatment Period 1 (Day 1)||12
6718436|NCT03021642|7648242|FG001|STARTED|Treatment Period 1 (Day 1)||12
6718437|NCT03021642|7648241|FG000|COMPLETED|Treatment Period 1 (Day 1)||12
6718438|NCT03021642|7648242|FG001|COMPLETED|Treatment Period 1 (Day 1)||12
6718439|NCT03021642|7648241|FG000|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6718440|NCT03021642|7648242|FG001|NOT COMPLETED|Treatment Period 1 (Day 1)||0
6718441|NCT03021642|7648241|FG000|STARTED|Washout Period (21 Days)||12
6718442|NCT03021642|7648242|FG001|STARTED|Washout Period (21 Days)||12
6718443|NCT03021642|7648241|FG000|COMPLETED|Washout Period (21 Days)||11
6718444|NCT03021642|7648242|FG001|COMPLETED|Washout Period (21 Days)||11
6718445|NCT03021642|7648241|FG000|NOT COMPLETED|Washout Period (21 Days)||1
6718446|NCT03021642|7648242|FG001|NOT COMPLETED|Washout Period (21 Days)||1
6718447|NCT03021642|7648241|FG000|STARTED|Treatment Period 2 (Day 22)||11
6718448|NCT03021642|7648242|FG001|STARTED|Treatment Period 2 (Day 22)||11
6718449|NCT03021642|7648241|FG000|COMPLETED|Treatment Period 2 (Day 22)||11
6718450|NCT03021642|7648242|FG001|COMPLETED|Treatment Period 2 (Day 22)||11
6718451|NCT03021642|7648241|FG000|NOT COMPLETED|Treatment Period 2 (Day 22)||0
6718452|NCT03021642|7648242|FG001|NOT COMPLETED|Treatment Period 2 (Day 22)||0
6718453|NCT03021668|7648250|FG000|STARTED|Overall Study||62
6718454|NCT03021668|7648251|FG001|STARTED|Overall Study||62
6718455|NCT03021668|7648250|FG000|COMPLETED|Overall Study||62
6718456|NCT03021668|7648251|FG001|COMPLETED|Overall Study||61
6718457|NCT03021668|7648250|FG000|NOT COMPLETED|Overall Study||0
6718458|NCT03021668|7648251|FG001|NOT COMPLETED|Overall Study||1
6718459|NCT03021759|7648260|FG000|STARTED|Overall Study||1566
6718460|NCT03021759|7648261|FG001|STARTED|Overall Study||1743
6718461|NCT03021759|7648262|FG002|STARTED|Overall Study||1465
6718462|NCT03021759|7648260|FG000|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1566
6718463|NCT03021759|7648261|FG001|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1743
6718464|NCT03021759|7648262|FG002|COMPLETED|Overall Study|32 primary care physicians were randomized to this arm and analyzed.|1465
6718465|NCT03021759|7648260|FG000|NOT COMPLETED|Overall Study||0
6718466|NCT03021759|7648261|FG001|NOT COMPLETED|Overall Study||0
6718467|NCT03021759|7648262|FG002|NOT COMPLETED|Overall Study||0
6718468|NCT03022045|7648272|FG000|STARTED|Overall Study||9
6718469|NCT03022045|7648273|FG001|STARTED|Overall Study||8
6718470|NCT03022045|7648272|FG000|COMPLETED|Overall Study||8
6718471|NCT03022045|7648273|FG001|COMPLETED|Overall Study||6
6718472|NCT03022045|7648272|FG000|NOT COMPLETED|Overall Study||1
6718473|NCT03022045|7648273|FG001|NOT COMPLETED|Overall Study||2
6718474|NCT03022084|7648285|FG000|STARTED|Overall Study||29
6718475|NCT03022084|7648286|FG001|STARTED|Overall Study||32
6718476|NCT03022084|7648285|FG000|COMPLETED|Overall Study||27
6718477|NCT03022084|7648286|FG001|COMPLETED|Overall Study||29
6718478|NCT03022084|7648285|FG000|NOT COMPLETED|Overall Study||2
6718479|NCT03022084|7648286|FG001|NOT COMPLETED|Overall Study||3
6718480|NCT03022370|7648296|FG000|STARTED|Overall Study||677
6718481|NCT03022370|7648297|FG001|STARTED|Overall Study||674
6718482|NCT03022370|7648296|FG000|COMPLETED|Overall Study||497
6718483|NCT03022370|7648297|FG001|COMPLETED|Overall Study||553
6718484|NCT03022370|7648296|FG000|NOT COMPLETED|Overall Study||180
6718485|NCT03022370|7648297|FG001|NOT COMPLETED|Overall Study||121
6718486|NCT03022396|7648313|FG000|STARTED|Overall Study||16
6718487|NCT03022396|7648314|FG001|STARTED|Overall Study||14
6718488|NCT03022396|7648315|FG002|STARTED|Overall Study||10
6718489|NCT03022396|7648316|FG003|STARTED|Overall Study||20
6718490|NCT03022396|7648317|FG004|STARTED|Overall Study||14
6718491|NCT03022396|7648318|FG005|STARTED|Overall Study||8
6718492|NCT03022396|7648313|FG000|COMPLETED|Overall Study||16
6718493|NCT03022396|7648314|FG001|COMPLETED|Overall Study||14
6718494|NCT03022396|7648315|FG002|COMPLETED|Overall Study||10
6718495|NCT03022396|7648316|FG003|COMPLETED|Overall Study||20
6718496|NCT03022396|7648317|FG004|COMPLETED|Overall Study||14
6718497|NCT03022396|7648318|FG005|COMPLETED|Overall Study||8
6718498|NCT03022396|7648313|FG000|NOT COMPLETED|Overall Study||0
6718499|NCT03022396|7648314|FG001|NOT COMPLETED|Overall Study||0
6718500|NCT03022396|7648315|FG002|NOT COMPLETED|Overall Study||0
6718501|NCT03022396|7648316|FG003|NOT COMPLETED|Overall Study||0
6718502|NCT03022396|7648317|FG004|NOT COMPLETED|Overall Study||0
6718503|NCT03022396|7648318|FG005|NOT COMPLETED|Overall Study||0
6718504|NCT03022422|7648338|FG000|STARTED|Overall Study||8
6718505|NCT03022422|7648339|FG001|STARTED|Overall Study||10
6718506|NCT03022422|7648340|FG002|STARTED|Overall Study||23
6718507|NCT03022422|7648341|FG003|STARTED|Overall Study||12
6718508|NCT03022422|7648342|FG004|STARTED|Overall Study||5
6718509|NCT03022422|7648343|FG005|STARTED|Overall Study||5
6718510|NCT03022422|7648338|FG000|COMPLETED|Overall Study||8
6718511|NCT03022422|7648339|FG001|COMPLETED|Overall Study||10
6718512|NCT03022422|7648340|FG002|COMPLETED|Overall Study||20
6718513|NCT03022422|7648341|FG003|COMPLETED|Overall Study||12
6718514|NCT03022422|7648342|FG004|COMPLETED|Overall Study||5
6718515|NCT03022422|7648343|FG005|COMPLETED|Overall Study||5
6718516|NCT03022422|7648338|FG000|NOT COMPLETED|Overall Study||0
6718517|NCT03022422|7648339|FG001|NOT COMPLETED|Overall Study||0
6718518|NCT03022422|7648340|FG002|NOT COMPLETED|Overall Study||3
6718519|NCT03022422|7648341|FG003|NOT COMPLETED|Overall Study||0
6718520|NCT03022422|7648342|FG004|NOT COMPLETED|Overall Study||0
6718521|NCT03022422|7648343|FG005|NOT COMPLETED|Overall Study||0
6718522|NCT03022435|7648364|FG000|STARTED|Overall Study||5
6718523|NCT03022435|7648365|FG001|STARTED|Overall Study||5
6718524|NCT03022435|7648366|FG002|STARTED|Overall Study||6
6718525|NCT03022435|7648367|FG003|STARTED|Overall Study||3
6718526|NCT03022435|7648368|FG004|STARTED|Overall Study||3
6718527|NCT03022435|7648364|FG000|COMPLETED|Overall Study||5
6718528|NCT03022435|7648365|FG001|COMPLETED|Overall Study||5
6718529|NCT03022435|7648366|FG002|COMPLETED|Overall Study||6
6718530|NCT03022435|7648367|FG003|COMPLETED|Overall Study||3
6718531|NCT03022435|7648368|FG004|COMPLETED|Overall Study||3
6718532|NCT03022435|7648364|FG000|NOT COMPLETED|Overall Study||0
6718533|NCT03022435|7648365|FG001|NOT COMPLETED|Overall Study||0
6718534|NCT03022435|7648366|FG002|NOT COMPLETED|Overall Study||0
6718535|NCT03022435|7648367|FG003|NOT COMPLETED|Overall Study||0
6718536|NCT03022435|7648368|FG004|NOT COMPLETED|Overall Study||0
6718537|NCT03022526|7648385|FG000|STARTED|Overall Study||31
6718538|NCT03022526|7648386|FG001|STARTED|Overall Study||30
6718539|NCT03022526|7648385|FG000|COMPLETED|Overall Study||21
6718540|NCT03022526|7648386|FG001|COMPLETED|Overall Study||25
6718541|NCT03022526|7648385|FG000|NOT COMPLETED|Overall Study||10
6718542|NCT03022526|7648386|FG001|NOT COMPLETED|Overall Study||5
6718543|NCT03022617|7648392|FG000|STARTED|Overall Study||12
6718544|NCT03022617|7648392|FG000|COMPLETED|Overall Study||6
6718545|NCT03022617|7648392|FG000|NOT COMPLETED|Overall Study||6
6718546|NCT03022630|7648398|FG000|STARTED|Overall Study||31
6718547|NCT03022630|7648399|FG001|STARTED|Overall Study||32
6718548|NCT03022630|7648398|FG000|COMPLETED|Overall Study||22
6718549|NCT03022630|7648399|FG001|COMPLETED|Overall Study||20
6718550|NCT03022630|7648398|FG000|NOT COMPLETED|Overall Study||9
6718551|NCT03022630|7648399|FG001|NOT COMPLETED|Overall Study||12
6718552|NCT03022799|7648423|FG000|STARTED|Overall Study||6
6718553|NCT03022799|7648424|FG001|STARTED|Overall Study||6
6718554|NCT03022799|7648425|FG002|STARTED|Overall Study||6
6718555|NCT03022799|7648426|FG003|STARTED|Overall Study||6
6718556|NCT03022799|7648427|FG004|STARTED|Overall Study||6
6718557|NCT03022799|7648428|FG005|STARTED|Overall Study||6
6718558|NCT03022799|7648429|FG006|STARTED|Overall Study||12
6718559|NCT03022799|7648430|FG007|STARTED|Overall Study||6
6718560|NCT03022799|7648431|FG008|STARTED|Overall Study||6
6718561|NCT03022799|7648432|FG009|STARTED|Overall Study||6
6718562|NCT03022799|7648433|FG010|STARTED|Overall Study||6
6718563|NCT03022799|7648434|FG011|STARTED|Overall Study||6
6718564|NCT03022799|7648435|FG012|STARTED|Overall Study||10
6718565|NCT03022799|7648423|FG000|COMPLETED|Overall Study||6
6718566|NCT03022799|7648424|FG001|COMPLETED|Overall Study||6
6718567|NCT03022799|7648425|FG002|COMPLETED|Overall Study||6
6718568|NCT03022799|7648426|FG003|COMPLETED|Overall Study||6
6718569|NCT03022799|7648427|FG004|COMPLETED|Overall Study||6
6718570|NCT03022799|7648428|FG005|COMPLETED|Overall Study||6
6718571|NCT03022799|7648429|FG006|COMPLETED|Overall Study||12
6718572|NCT03022799|7648430|FG007|COMPLETED|Overall Study||6
6718573|NCT03022799|7648431|FG008|COMPLETED|Overall Study||6
6718574|NCT03022799|7648432|FG009|COMPLETED|Overall Study||5
6718575|NCT03022799|7648433|FG010|COMPLETED|Overall Study||5
6718576|NCT03022799|7648434|FG011|COMPLETED|Overall Study||6
6718577|NCT03022799|7648435|FG012|COMPLETED|Overall Study||10
6718578|NCT03022799|7648423|FG000|NOT COMPLETED|Overall Study||0
6718579|NCT03022799|7648424|FG001|NOT COMPLETED|Overall Study||0
6718580|NCT03022799|7648425|FG002|NOT COMPLETED|Overall Study||0
6718581|NCT03022799|7648426|FG003|NOT COMPLETED|Overall Study||0
6718582|NCT03022799|7648427|FG004|NOT COMPLETED|Overall Study||0
6718583|NCT03022799|7648428|FG005|NOT COMPLETED|Overall Study||0
6718584|NCT03022799|7648429|FG006|NOT COMPLETED|Overall Study||0
6718585|NCT03022799|7648430|FG007|NOT COMPLETED|Overall Study||0
6718586|NCT03022799|7648431|FG008|NOT COMPLETED|Overall Study||0
6718587|NCT03022799|7648432|FG009|NOT COMPLETED|Overall Study||1
6718588|NCT03022799|7648433|FG010|NOT COMPLETED|Overall Study||1
6718589|NCT03022799|7648434|FG011|NOT COMPLETED|Overall Study||0
6718590|NCT03022799|7648435|FG012|NOT COMPLETED|Overall Study||0
6718591|NCT03022916|7648480|FG000|STARTED|Overall Study||5
6718592|NCT03022916|7648481|FG001|STARTED|Overall Study||5
6718593|NCT03022916|7648482|FG002|STARTED|Overall Study||5
6718594|NCT03022916|7648483|FG003|STARTED|Overall Study||5
6718595|NCT03022916|7648480|FG000|Nail Polish|Overall Study||5
6718596|NCT03022916|7648481|FG001|Nail Polish|Overall Study||5
6718597|NCT03022916|7648482|FG002|Nail Polish|Overall Study||5
6718598|NCT03022916|7648483|FG003|Nail Polish|Overall Study||5
6718599|NCT03022916|7648480|FG000|Nail Polish, Base Coat|Overall Study||5
6718600|NCT03022916|7648481|FG001|Nail Polish, Base Coat|Overall Study||5
6718601|NCT03022916|7648482|FG002|Nail Polish, Base Coat|Overall Study||5
6718602|NCT03022916|7648483|FG003|Nail Polish, Base Coat|Overall Study||5
6718603|NCT03022916|7648480|FG000|Nail Polish, Top Coat|Overall Study||5
6718604|NCT03022916|7648481|FG001|Nail Polish, Top Coat|Overall Study||5
6718605|NCT03022916|7648482|FG002|Nail Polish, Top Coat|Overall Study||5
6718606|NCT03022916|7648483|FG003|Nail Polish, Top Coat|Overall Study||5
6718607|NCT03022916|7648480|FG000|COMPLETED|Overall Study||5
6718608|NCT03022916|7648481|FG001|COMPLETED|Overall Study||5
6718609|NCT03022916|7648482|FG002|COMPLETED|Overall Study||5
6718610|NCT03022916|7648483|FG003|COMPLETED|Overall Study||5
6718611|NCT03022916|7648480|FG000|NOT COMPLETED|Overall Study||0
6718612|NCT03022916|7648481|FG001|NOT COMPLETED|Overall Study||0
6718613|NCT03022916|7648482|FG002|NOT COMPLETED|Overall Study||0
6718614|NCT03022916|7648483|FG003|NOT COMPLETED|Overall Study||0
6718615|NCT03022981|7648493|FG000|STARTED|Overall Study||102
6718616|NCT03022981|7648494|FG001|STARTED|Overall Study||73
6718617|NCT03022981|7648495|FG002|STARTED|Overall Study||41
6718618|NCT03022981|7648493|FG000|Participated in PK Lead-in (PKL) Phase|Overall Study|All 17 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|17
6718619|NCT03022981|7648494|FG001|Participated in PK Lead-in (PKL) Phase|Overall Study|All 20 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|20
6718620|NCT03022981|7648495|FG002|Participated in PK Lead-in (PKL) Phase|Overall Study|All 19 participants completed treatment in the PK Lead-in phase and continued into treatment phase.|19
6718621|NCT03022981|7648493|FG000|COMPLETED|Overall Study||96
6718622|NCT03022981|7648494|FG001|COMPLETED|Overall Study||69
6718623|NCT03022981|7648495|FG002|COMPLETED|Overall Study||35
6718624|NCT03022981|7648493|FG000|NOT COMPLETED|Overall Study||6
6718625|NCT03022981|7648494|FG001|NOT COMPLETED|Overall Study||4
6718626|NCT03022981|7648495|FG002|NOT COMPLETED|Overall Study||6
6718627|NCT03023137|7648515|FG000|STARTED|Overall Study||178
6718628|NCT03023137|7648516|FG001|STARTED|Overall Study||171
6718629|NCT03023137|7648515|FG000|COMPLETED|Overall Study||174
6718630|NCT03023137|7648516|FG001|COMPLETED|Overall Study||162
6718631|NCT03023137|7648515|FG000|NOT COMPLETED|Overall Study||4
6718632|NCT03023137|7648516|FG001|NOT COMPLETED|Overall Study||9
6718633|NCT03023176|7648523|FG000|STARTED|Overall Study||20
6718634|NCT03023176|7648523|FG000|COMPLETED|Overall Study||20
6718635|NCT03023176|7648523|FG000|NOT COMPLETED|Overall Study||0
6718636|NCT03023397|7648530|FG000|STARTED|Run-In||8
6718637|NCT03023397|7648531|FG001|STARTED|Run-In||3
6718638|NCT03023397|7648532|FG002|STARTED|Run-In||1
6718639|NCT03023397|7648530|FG000|COMPLETED|Run-In||6
6718640|NCT03023397|7648531|FG001|COMPLETED|Run-In||3
6718641|NCT03023397|7648532|FG002|COMPLETED|Run-In||1
6718642|NCT03023397|7648530|FG000|NOT COMPLETED|Run-In||2
6718643|NCT03023397|7648531|FG001|NOT COMPLETED|Run-In||0
6718644|NCT03023397|7648532|FG002|NOT COMPLETED|Run-In||0
6718645|NCT03023397|7648530|FG000|STARTED|Main Study||6
6718646|NCT03023397|7648531|FG001|STARTED|Main Study||3
6718647|NCT03023397|7648532|FG002|STARTED|Main Study||1
6718648|NCT03023397|7648530|FG000|COMPLETED|Main Study||6
6718649|NCT03023397|7648531|FG001|COMPLETED|Main Study||3
6718650|NCT03023397|7648532|FG002|COMPLETED|Main Study||1
6718651|NCT03023397|7648530|FG000|NOT COMPLETED|Main Study||0
6718652|NCT03023397|7648531|FG001|NOT COMPLETED|Main Study||0
6718653|NCT03023397|7648532|FG002|NOT COMPLETED|Main Study||0
6718654|NCT03023423|7648544|FG000|STARTED|Overall Study||7
6718655|NCT03023423|7648545|FG001|STARTED|Overall Study||46
6718656|NCT03023423|7648546|FG002|STARTED|Overall Study||46
6718657|NCT03023423|7648544|FG000|Treated|Overall Study||7
6718658|NCT03023423|7648545|FG001|Treated|Overall Study||44
6718659|NCT03023423|7648546|FG002|Treated|Overall Study||44
6718660|NCT03023423|7648544|FG000|Crossover From Atezo to Dara + Atezo|Overall Study||0
6718661|NCT03023423|7648545|FG001|Crossover From Atezo to Dara + Atezo|Overall Study|Participants who met crossover eligibility criteria entered to Dara + Atezo arm.|8
6718662|NCT03023423|7648546|FG002|Crossover From Atezo to Dara + Atezo|Overall Study||0
6718663|NCT03023423|7648544|FG000|COMPLETED|Overall Study||0
6718664|NCT03023423|7648545|FG001|COMPLETED|Overall Study||0
6718665|NCT03023423|7648546|FG002|COMPLETED|Overall Study||0
6718666|NCT03023423|7648544|FG000|NOT COMPLETED|Overall Study||7
6718667|NCT03023423|7648545|FG001|NOT COMPLETED|Overall Study||46
6718668|NCT03023423|7648546|FG002|NOT COMPLETED|Overall Study||46
6718669|NCT03023488|7648558|FG000|STARTED|Overall Study||46
6718670|NCT03023488|7648558|FG000|COMPLETED|Overall Study||46
6718671|NCT03023488|7648558|FG000|NOT COMPLETED|Overall Study||0
6718672|NCT03023553|7648570|FG000|STARTED|Overall Study||4
6718673|NCT03023553|7648571|FG001|STARTED|Overall Study||9
6718674|NCT03023553|7648570|FG000|COMPLETED|Overall Study||4
6718675|NCT03023553|7648571|FG001|COMPLETED|Overall Study||8
6718676|NCT03023553|7648570|FG000|NOT COMPLETED|Overall Study||0
6718677|NCT03023553|7648571|FG001|NOT COMPLETED|Overall Study||1
6718678|NCT03023683|7648579|FG000|STARTED|Overall Study||0
6718679|NCT03023683|7648580|FG001|STARTED|Overall Study||18
6718680|NCT03023683|7648579|FG000|COMPLETED|Overall Study||0
6718681|NCT03023683|7648580|FG001|COMPLETED|Overall Study||17
6718682|NCT03023683|7648579|FG000|NOT COMPLETED|Overall Study||0
6718683|NCT03023683|7648580|FG001|NOT COMPLETED|Overall Study||1
6718684|NCT03023709|7648588|FG000|STARTED|Overall Study||3
6718685|NCT03023709|7648589|FG001|STARTED|Overall Study||0
6718686|NCT03023709|7648588|FG000|COMPLETED|Overall Study||3
6718687|NCT03023709|7648589|FG001|COMPLETED|Overall Study||0
6718688|NCT03023709|7648588|FG000|NOT COMPLETED|Overall Study||0
6718689|NCT03023709|7648589|FG001|NOT COMPLETED|Overall Study||0
6718690|NCT03023722|7648597|FG000|STARTED|Overall Study||18
6718691|NCT03023722|7648597|FG000|COMPLETED|Overall Study||14
6718692|NCT03023722|7648597|FG000|NOT COMPLETED|Overall Study||4
6718693|NCT03023826|7648601|FG000|STARTED|Period 1||4
6718694|NCT03023826|7648602|FG001|STARTED|Period 1||4
6718695|NCT03023826|7648603|FG002|STARTED|Period 1||5
6718696|NCT03023826|7648604|FG003|STARTED|Period 1||4
6718697|NCT03023826|7648605|FG004|STARTED|Period 1||4
6718698|NCT03023826|7648606|FG005|STARTED|Period 1||5
6718699|NCT03023826|7648601|FG000|Received at Least One Dose of Study Drug|Period 1||4
6718700|NCT03023826|7648602|FG001|Received at Least One Dose of Study Drug|Period 1||4
6718701|NCT03023826|7648603|FG002|Received at Least One Dose of Study Drug|Period 1||5
6718702|NCT03023826|7648604|FG003|Received at Least One Dose of Study Drug|Period 1||4
6718703|NCT03023826|7648605|FG004|Received at Least One Dose of Study Drug|Period 1||4
6718704|NCT03023826|7648606|FG005|Received at Least One Dose of Study Drug|Period 1||5
6718705|NCT03023826|7648601|FG000|COMPLETED|Period 1||4
6718706|NCT03023826|7648602|FG001|COMPLETED|Period 1||4
6718707|NCT03023826|7648603|FG002|COMPLETED|Period 1||5
6718708|NCT03023826|7648604|FG003|COMPLETED|Period 1||4
6718709|NCT03023826|7648605|FG004|COMPLETED|Period 1||3
6718710|NCT03023826|7648606|FG005|COMPLETED|Period 1||5
6718711|NCT03023826|7648601|FG000|NOT COMPLETED|Period 1||0
6718712|NCT03023826|7648602|FG001|NOT COMPLETED|Period 1||0
6718713|NCT03023826|7648603|FG002|NOT COMPLETED|Period 1||0
6718714|NCT03023826|7648604|FG003|NOT COMPLETED|Period 1||0
6718715|NCT03023826|7648605|FG004|NOT COMPLETED|Period 1||1
6718716|NCT03023826|7648606|FG005|NOT COMPLETED|Period 1||0
6718717|NCT03023826|7648601|FG000|STARTED|Period 2||4
6718718|NCT03023826|7648602|FG001|STARTED|Period 2||4
6718719|NCT03023826|7648603|FG002|STARTED|Period 2||5
6718720|NCT03023826|7648604|FG003|STARTED|Period 2||4
6718721|NCT03023826|7648605|FG004|STARTED|Period 2||3
6718722|NCT03023826|7648606|FG005|STARTED|Period 2||5
6718723|NCT03023826|7648601|FG000|COMPLETED|Period 2||4
6718724|NCT03023826|7648602|FG001|COMPLETED|Period 2||4
6718725|NCT03023826|7648603|FG002|COMPLETED|Period 2||5
6718726|NCT03023826|7648604|FG003|COMPLETED|Period 2||4
6718727|NCT03023826|7648605|FG004|COMPLETED|Period 2||3
6718728|NCT03023826|7648606|FG005|COMPLETED|Period 2||5
6718729|NCT03023826|7648601|FG000|NOT COMPLETED|Period 2||0
6718730|NCT03023826|7648602|FG001|NOT COMPLETED|Period 2||0
6718731|NCT03023826|7648603|FG002|NOT COMPLETED|Period 2||0
6718732|NCT03023826|7648604|FG003|NOT COMPLETED|Period 2||0
6718733|NCT03023826|7648605|FG004|NOT COMPLETED|Period 2||0
6718734|NCT03023826|7648606|FG005|NOT COMPLETED|Period 2||0
6718735|NCT03023826|7648601|FG000|STARTED|Period 3||4
6718736|NCT03023826|7648602|FG001|STARTED|Period 3||4
6718737|NCT03023826|7648603|FG002|STARTED|Period 3||5
6718738|NCT03023826|7648604|FG003|STARTED|Period 3||4
6718739|NCT03023826|7648605|FG004|STARTED|Period 3||3
6718740|NCT03023826|7648606|FG005|STARTED|Period 3||5
6718741|NCT03023826|7648601|FG000|COMPLETED|Period 3||4
6718742|NCT03023826|7648602|FG001|COMPLETED|Period 3||4
6718743|NCT03023826|7648603|FG002|COMPLETED|Period 3||5
6718744|NCT03023826|7648604|FG003|COMPLETED|Period 3||4
6718745|NCT03023826|7648605|FG004|COMPLETED|Period 3||3
6718746|NCT03023826|7648606|FG005|COMPLETED|Period 3||5
6263620|NCT00568178|7162436|FG003|STARTED|Open Label Extension||0
6263621|NCT00568178|7162437|FG004|STARTED|Open Label Extension||134
6263622|NCT00568178|7162438|FG005|STARTED|Open Label Extension||134
6263623|NCT00568178|7162433|FG000|COMPLETED|Open Label Extension||0
6263624|NCT00568178|7162434|FG001|COMPLETED|Open Label Extension||0
6602850|NCT02059148|7527883|FG005|COMPLETED|Treatment 2||3
6602851|NCT02059148|7527878|FG000|NOT COMPLETED|Treatment 2||0
6602852|NCT02059148|7527879|FG001|NOT COMPLETED|Treatment 2||0
6602853|NCT02059148|7527880|FG002|NOT COMPLETED|Treatment 2||0
6602854|NCT02059148|7527881|FG003|NOT COMPLETED|Treatment 2||0
6602855|NCT02059148|7527882|FG004|NOT COMPLETED|Treatment 2||0
6602856|NCT02059148|7527883|FG005|NOT COMPLETED|Treatment 2||0
6602857|NCT02059148|7527878|FG000|STARTED|Treatment 3||4
6602858|NCT02059148|7527879|FG001|STARTED|Treatment 3||4
6602859|NCT02059148|7527880|FG002|STARTED|Treatment 3||4
6602860|NCT02059148|7527881|FG003|STARTED|Treatment 3||4
6718747|NCT03023826|7648601|FG000|NOT COMPLETED|Period 3||0
6718748|NCT03023826|7648602|FG001|NOT COMPLETED|Period 3||0
6718749|NCT03023826|7648603|FG002|NOT COMPLETED|Period 3||0
6718750|NCT03023826|7648604|FG003|NOT COMPLETED|Period 3||0
6718751|NCT03023826|7648605|FG004|NOT COMPLETED|Period 3||0
6718752|NCT03023826|7648606|FG005|NOT COMPLETED|Period 3||0
6718753|NCT03023878|7648614|FG000|STARTED|Pre-Study Run-In Period||47
6718754|NCT03023878|7648614|FG000|COMPLETED|Pre-Study Run-In Period||30
6718755|NCT03023878|7648614|FG000|NOT COMPLETED|Pre-Study Run-In Period||17
6718756|NCT03023878|7648614|FG000|STARTED|Between Run-In and Treatment Periods||30
6718757|NCT03023878|7648614|FG000|COMPLETED|Between Run-In and Treatment Periods||28
6718758|NCT03023878|7648614|FG000|NOT COMPLETED|Between Run-In and Treatment Periods||2
6718759|NCT03023878|7648614|FG000|STARTED|Treatment Period||28
6718760|NCT03023878|7648614|FG000|Started Cycle 1|Treatment Period||28
6718761|NCT03023878|7648614|FG000|Started Cycle 2|Treatment Period||11
6718762|NCT03023878|7648614|FG000|COMPLETED|Treatment Period||25
6718763|NCT03023878|7648614|FG000|NOT COMPLETED|Treatment Period||3
6718764|NCT03023878|7648614|FG000|STARTED|Long Term Follow-Up Period||28
6718765|NCT03023878|7648614|FG000|COMPLETED|Long Term Follow-Up Period||26
6718766|NCT03023878|7648614|FG000|NOT COMPLETED|Long Term Follow-Up Period||2
6718767|NCT03023891|7648618|FG000|STARTED|Overall Study||18
6718768|NCT03023891|7648618|FG000|COMPLETED|Overall Study||18
6718769|NCT03023891|7648618|FG000|NOT COMPLETED|Overall Study||0
6718770|NCT03024112|7648624|FG000|STARTED|Overall Study||25
6718771|NCT03024112|7648625|FG001|STARTED|Overall Study||26
6718772|NCT03024112|7648624|FG000|COMPLETED|Overall Study||18
6718773|NCT03024112|7648625|FG001|COMPLETED|Overall Study||26
6718774|NCT03024112|7648624|FG000|NOT COMPLETED|Overall Study||7
6718775|NCT03024112|7648625|FG001|NOT COMPLETED|Overall Study||0
6718776|NCT03024606|7648633|FG000|STARTED|Overall Study||23
6718777|NCT03024606|7648634|FG001|STARTED|Overall Study||26
6718778|NCT03024606|7648633|FG000|COMPLETED|Overall Study||14
6718779|NCT03024606|7648634|FG001|COMPLETED|Overall Study||16
6718780|NCT03024606|7648633|FG000|NOT COMPLETED|Overall Study||9
6718781|NCT03024606|7648634|FG001|NOT COMPLETED|Overall Study||10
6718782|NCT03024970|7648640|FG000|STARTED|First Intervention||34
6718783|NCT03024970|7648641|FG001|STARTED|First Intervention||38
6718784|NCT03024970|7648640|FG000|COMPLETED|First Intervention||33
6718785|NCT03024970|7648641|FG001|COMPLETED|First Intervention||38
6718786|NCT03024970|7648640|FG000|NOT COMPLETED|First Intervention||1
6718787|NCT03024970|7648641|FG001|NOT COMPLETED|First Intervention||0
6718788|NCT03024970|7648640|FG000|STARTED|Second Intervention||33
6718789|NCT03024970|7648641|FG001|STARTED|Second Intervention||38
6718790|NCT03024970|7648640|FG000|COMPLETED|Second Intervention||32
6718791|NCT03024970|7648641|FG001|COMPLETED|Second Intervention||38
6718792|NCT03024970|7648640|FG000|NOT COMPLETED|Second Intervention||1
6718793|NCT03024970|7648641|FG001|NOT COMPLETED|Second Intervention||0
6718794|NCT03025217|7648647|FG000|STARTED|Overall Study||31
6718795|NCT03025217|7648647|FG000|COMPLETED|Overall Study||27
6718796|NCT03025217|7648647|FG000|NOT COMPLETED|Overall Study||4
6718797|NCT03025945|7648653|FG000|STARTED|Overall Study||331
6718798|NCT03025945|7648654|FG001|STARTED|Overall Study||331
6718799|NCT03025945|7648653|FG000|COMPLETED|Overall Study||331
6718800|NCT03025945|7648654|FG001|COMPLETED|Overall Study||331
6718801|NCT03025945|7648653|FG000|NOT COMPLETED|Overall Study||0
6718802|NCT03025945|7648654|FG001|NOT COMPLETED|Overall Study||0
6718803|NCT03026075|7648660|FG000|STARTED|Overall Study||47
6718804|NCT03026075|7648660|FG000|COMPLETED|Overall Study||46
6718805|NCT03026075|7648660|FG000|NOT COMPLETED|Overall Study||1
6718806|NCT03026088|7648664|FG000|STARTED|Overall Study||20
6718807|NCT03026088|7648664|FG000|COMPLETED|Overall Study||0
6718808|NCT03026088|7648664|FG000|NOT COMPLETED|Overall Study||20
6718809|NCT03026166|7648670|FG000|STARTED|Overall Study||30
6718810|NCT03026166|7648671|FG001|STARTED|Overall Study||12
6718811|NCT03026166|7648670|FG000|COMPLETED|Overall Study||0
6718812|NCT03026166|7648671|FG001|COMPLETED|Overall Study||0
6718813|NCT03026166|7648670|FG000|NOT COMPLETED|Overall Study||30
6718814|NCT03026166|7648671|FG001|NOT COMPLETED|Overall Study||12
6718815|NCT03026257|7648683|FG000|STARTED|Overall Study||60
6718816|NCT03026257|7648684|FG001|STARTED|Overall Study||64
6718817|NCT03026257|7648685|FG002|STARTED|Overall Study||34
6718818|NCT03026257|7648686|FG003|STARTED|Overall Study||25
6718819|NCT03026257|7648687|FG004|STARTED|Overall Study||23
6718820|NCT03026257|7648688|FG005|STARTED|Overall Study||46
6718821|NCT03026257|7648683|FG000|Treated|Overall Study||58
6718822|NCT03026257|7648684|FG001|Treated|Overall Study||65
6718823|NCT03026257|7648685|FG002|Treated|Overall Study||35
6718824|NCT03026257|7648686|FG003|Treated|Overall Study||24
6718825|NCT03026257|7648687|FG004|Treated|Overall Study||23
6718826|NCT03026257|7648688|FG005|Treated|Overall Study||47
6718827|NCT03026257|7648683|FG000|COMPLETED|Overall Study||54
6718828|NCT03026257|7648684|FG001|COMPLETED|Overall Study||63
6718829|NCT03026257|7648685|FG002|COMPLETED|Overall Study||34
6718830|NCT03026257|7648686|FG003|COMPLETED|Overall Study||24
6718831|NCT03026257|7648687|FG004|COMPLETED|Overall Study||22
6718832|NCT03026257|7648688|FG005|COMPLETED|Overall Study||46
6718833|NCT03026257|7648683|FG000|NOT COMPLETED|Overall Study||6
6718834|NCT03026257|7648684|FG001|NOT COMPLETED|Overall Study||1
6718835|NCT03026257|7648685|FG002|NOT COMPLETED|Overall Study||0
6718836|NCT03026257|7648686|FG003|NOT COMPLETED|Overall Study||1
6718837|NCT03026257|7648687|FG004|NOT COMPLETED|Overall Study||1
6718838|NCT03026257|7648688|FG005|NOT COMPLETED|Overall Study||0
6718839|NCT03026283|7648702|FG000|STARTED|CCTA Diagnosis||586
6718840|NCT03026283|7648703|FG001|STARTED|CCTA Diagnosis||0
6718841|NCT03026283|7648704|FG002|STARTED|CCTA Diagnosis||0
6718842|NCT03026283|7648705|FG003|STARTED|CCTA Diagnosis||0
6718843|NCT03026283|7648706|FG004|STARTED|CCTA Diagnosis||0
6718844|NCT03026283|7648707|FG005|STARTED|CCTA Diagnosis||0
6718845|NCT03026283|7648708|FG006|STARTED|CCTA Diagnosis||0
6718846|NCT03026283|7648709|FG007|STARTED|CCTA Diagnosis||0
6718847|NCT03026283|7648702|FG000|COMPLETED|CCTA Diagnosis||572
6718848|NCT03026283|7648703|FG001|COMPLETED|CCTA Diagnosis||0
6718849|NCT03026283|7648704|FG002|COMPLETED|CCTA Diagnosis||0
6718850|NCT03026283|7648705|FG003|COMPLETED|CCTA Diagnosis||0
6718851|NCT03026283|7648706|FG004|COMPLETED|CCTA Diagnosis||0
6718852|NCT03026283|7648707|FG005|COMPLETED|CCTA Diagnosis||0
6718853|NCT03026283|7648708|FG006|COMPLETED|CCTA Diagnosis||0
6718854|NCT03026283|7648709|FG007|COMPLETED|CCTA Diagnosis||0
6718855|NCT03026283|7648702|FG000|NOT COMPLETED|CCTA Diagnosis||14
6718856|NCT03026283|7648703|FG001|NOT COMPLETED|CCTA Diagnosis||0
6718857|NCT03026283|7648704|FG002|NOT COMPLETED|CCTA Diagnosis||0
6718858|NCT03026283|7648705|FG003|NOT COMPLETED|CCTA Diagnosis||0
6718859|NCT03026283|7648706|FG004|NOT COMPLETED|CCTA Diagnosis||0
6718860|NCT03026283|7648707|FG005|NOT COMPLETED|CCTA Diagnosis||0
6718861|NCT03026283|7648708|FG006|NOT COMPLETED|CCTA Diagnosis||0
6718862|NCT03026283|7648709|FG007|NOT COMPLETED|CCTA Diagnosis||0
6718863|NCT03026283|7648702|FG000|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6718864|NCT03026283|7648703|FG001|STARTED|Optimal Medical Care/FFR-CT Diagnosis||289
6718865|NCT03026283|7648704|FG002|STARTED|Optimal Medical Care/FFR-CT Diagnosis||280
6718866|NCT03026283|7648705|FG003|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6718867|NCT03026283|7648706|FG004|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6718868|NCT03026283|7648707|FG005|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6718869|NCT03026283|7648708|FG006|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6718870|NCT03026283|7648709|FG007|STARTED|Optimal Medical Care/FFR-CT Diagnosis||0
6718871|NCT03026283|7648702|FG000|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718872|NCT03026283|7648703|FG001|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||286
6718873|NCT03026283|7648704|FG002|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||265
6718874|NCT03026283|7648705|FG003|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718875|NCT03026283|7648706|FG004|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718876|NCT03026283|7648707|FG005|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718877|NCT03026283|7648708|FG006|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718878|NCT03026283|7648709|FG007|COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718879|NCT03026283|7648702|FG000|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718880|NCT03026283|7648703|FG001|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||3
6718881|NCT03026283|7648704|FG002|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||15
6718882|NCT03026283|7648705|FG003|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718883|NCT03026283|7648706|FG004|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718884|NCT03026283|7648707|FG005|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718885|NCT03026283|7648708|FG006|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718886|NCT03026283|7648709|FG007|NOT COMPLETED|Optimal Medical Care/FFR-CT Diagnosis||0
6718887|NCT03026283|7648702|FG000|STARTED|Optimal Care/Stress Test/ICA||0
6718888|NCT03026283|7648703|FG001|STARTED|Optimal Care/Stress Test/ICA||0
6718889|NCT03026283|7648704|FG002|STARTED|Optimal Care/Stress Test/ICA||0
6718890|NCT03026283|7648705|FG003|STARTED|Optimal Care/Stress Test/ICA||128
6718891|NCT03026283|7648706|FG004|STARTED|Optimal Care/Stress Test/ICA||52
6718892|NCT03026283|7648707|FG005|STARTED|Optimal Care/Stress Test/ICA||101
6718893|NCT03026283|7648708|FG006|STARTED|Optimal Care/Stress Test/ICA||0
6718894|NCT03026283|7648709|FG007|STARTED|Optimal Care/Stress Test/ICA||0
6718895|NCT03026283|7648702|FG000|COMPLETED|Optimal Care/Stress Test/ICA||0
6718896|NCT03026283|7648703|FG001|COMPLETED|Optimal Care/Stress Test/ICA||0
6718897|NCT03026283|7648704|FG002|COMPLETED|Optimal Care/Stress Test/ICA||0
6718898|NCT03026283|7648705|FG003|COMPLETED|Optimal Care/Stress Test/ICA||108
6718899|NCT03026283|7648706|FG004|COMPLETED|Optimal Care/Stress Test/ICA||14
6718900|NCT03026283|7648707|FG005|COMPLETED|Optimal Care/Stress Test/ICA||73
6718901|NCT03026283|7648708|FG006|COMPLETED|Optimal Care/Stress Test/ICA||0
6718902|NCT03026283|7648709|FG007|COMPLETED|Optimal Care/Stress Test/ICA||0
6718903|NCT03026283|7648702|FG000|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6718904|NCT03026283|7648703|FG001|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6718905|NCT03026283|7648704|FG002|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6718906|NCT03026283|7648705|FG003|NOT COMPLETED|Optimal Care/Stress Test/ICA||20
6718907|NCT03026283|7648706|FG004|NOT COMPLETED|Optimal Care/Stress Test/ICA||38
6718908|NCT03026283|7648707|FG005|NOT COMPLETED|Optimal Care/Stress Test/ICA||28
6718909|NCT03026283|7648708|FG006|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6718910|NCT03026283|7648709|FG007|NOT COMPLETED|Optimal Care/Stress Test/ICA||0
6718911|NCT03026283|7648702|FG000|STARTED|Optimal Care/ICA Diagnostic Cath||0
6718912|NCT03026283|7648703|FG001|STARTED|Optimal Care/ICA Diagnostic Cath||0
6718913|NCT03026283|7648704|FG002|STARTED|Optimal Care/ICA Diagnostic Cath||0
6718914|NCT03026283|7648705|FG003|STARTED|Optimal Care/ICA Diagnostic Cath||0
6718915|NCT03026283|7648706|FG004|STARTED|Optimal Care/ICA Diagnostic Cath||0
6718916|NCT03026283|7648707|FG005|STARTED|Optimal Care/ICA Diagnostic Cath||0
6718917|NCT03026283|7648708|FG006|STARTED|Optimal Care/ICA Diagnostic Cath||21
6718918|NCT03026283|7648709|FG007|STARTED|Optimal Care/ICA Diagnostic Cath||0
6718919|NCT03026283|7648702|FG000|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718920|NCT03026283|7648703|FG001|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718921|NCT03026283|7648704|FG002|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718922|NCT03026283|7648705|FG003|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718923|NCT03026283|7648706|FG004|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718924|NCT03026283|7648707|FG005|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718925|NCT03026283|7648708|FG006|COMPLETED|Optimal Care/ICA Diagnostic Cath||21
6718926|NCT03026283|7648709|FG007|COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718927|NCT03026283|7648702|FG000|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718928|NCT03026283|7648703|FG001|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718929|NCT03026283|7648704|FG002|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718930|NCT03026283|7648705|FG003|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718931|NCT03026283|7648706|FG004|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718932|NCT03026283|7648707|FG005|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718933|NCT03026283|7648708|FG006|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718934|NCT03026283|7648709|FG007|NOT COMPLETED|Optimal Care/ICA Diagnostic Cath||0
6718935|NCT03026530|7648724|FG000|STARTED|Overall Study||100
6718936|NCT03026530|7648725|FG001|STARTED|Overall Study||100
6718937|NCT03026530|7648724|FG000|COMPLETED|Overall Study||79
6718938|NCT03026530|7648725|FG001|COMPLETED|Overall Study||71
6718939|NCT03026530|7648724|FG000|NOT COMPLETED|Overall Study||21
6718940|NCT03026530|7648725|FG001|NOT COMPLETED|Overall Study||29
6718941|NCT03026556|7648734|FG000|STARTED|Overall Study||12763
6718942|NCT03026556|7648735|FG001|STARTED|Overall Study||17177
6718943|NCT03026556|7648736|FG002|STARTED|Overall Study||12594
6718944|NCT03026556|7648734|FG000|COMPLETED|Overall Study||12763
6718945|NCT03026556|7648735|FG001|COMPLETED|Overall Study||17177
6718946|NCT03026556|7648736|FG002|COMPLETED|Overall Study||12594
6718947|NCT03026556|7648734|FG000|NOT COMPLETED|Overall Study||0
6718948|NCT03026556|7648735|FG001|NOT COMPLETED|Overall Study||0
6718949|NCT03026556|7648736|FG002|NOT COMPLETED|Overall Study||0
6718950|NCT03026777|7648747|FG000|STARTED|Overall Study||168
6718951|NCT03026777|7648748|FG001|STARTED|Overall Study||169
6718952|NCT03026777|7648747|FG000|COMPLETED|Overall Study||168
6718953|NCT03026777|7648748|FG001|COMPLETED|Overall Study||169
6718954|NCT03026777|7648747|FG000|NOT COMPLETED|Overall Study||0
6718955|NCT03026777|7648748|FG001|NOT COMPLETED|Overall Study||0
6718956|NCT03026803|7648754|FG000|STARTED|Overall Study||4
6718957|NCT03026803|7648754|FG000|COMPLETED|Overall Study||4
6718958|NCT03026803|7648754|FG000|NOT COMPLETED|Overall Study||0
6718959|NCT03027466|7648762|FG000|STARTED|Overall Study||2027
6718960|NCT03027466|7648763|FG001|STARTED|Overall Study||1984
6718961|NCT03027466|7648764|FG002|STARTED|Overall Study||1903
6718962|NCT03027466|7648765|FG003|STARTED|Overall Study||1985
6718963|NCT03027466|7648762|FG000|COMPLETED|Overall Study||158
6718964|NCT03027466|7648763|FG001|COMPLETED|Overall Study||165
6718965|NCT03027466|7648764|FG002|COMPLETED|Overall Study||160
6718966|NCT03027466|7648765|FG003|COMPLETED|Overall Study||164
6718967|NCT03027466|7648762|FG000|NOT COMPLETED|Overall Study||1869
6718968|NCT03027466|7648763|FG001|NOT COMPLETED|Overall Study||1819
6718969|NCT03027466|7648764|FG002|NOT COMPLETED|Overall Study||1743
6718970|NCT03027466|7648765|FG003|NOT COMPLETED|Overall Study||1821
6718971|NCT03027557|7648778|FG000|STARTED|Overall Study||15
6718972|NCT03027557|7648779|FG001|STARTED|Overall Study||16
6718973|NCT03027557|7648780|FG002|STARTED|Overall Study||15
6718974|NCT03027557|7648778|FG000|COMPLETED|Overall Study||14
6718975|NCT03027557|7648779|FG001|COMPLETED|Overall Study||16
6718976|NCT03027557|7648780|FG002|COMPLETED|Overall Study||15
6718977|NCT03027557|7648778|FG000|NOT COMPLETED|Overall Study||1
6718978|NCT03027557|7648779|FG001|NOT COMPLETED|Overall Study||0
6718979|NCT03027557|7648780|FG002|NOT COMPLETED|Overall Study||0
6718980|NCT03027661|7648790|FG000|STARTED|Overall Study||20
6718981|NCT03027661|7648791|FG001|STARTED|Overall Study||21
6263625|NCT00568178|7162435|FG002|COMPLETED|Open Label Extension||0
6263626|NCT00568178|7162436|FG003|COMPLETED|Open Label Extension||0
6263627|NCT00568178|7162437|FG004|COMPLETED|Open Label Extension||55
6263628|NCT00568178|7162438|FG005|COMPLETED|Open Label Extension||54
6263629|NCT00568178|7162433|FG000|NOT COMPLETED|Open Label Extension||0
6263630|NCT00568178|7162434|FG001|NOT COMPLETED|Open Label Extension||0
6263631|NCT00568178|7162435|FG002|NOT COMPLETED|Open Label Extension||0
6263632|NCT00568178|7162436|FG003|NOT COMPLETED|Open Label Extension||0
6263633|NCT00568178|7162437|FG004|NOT COMPLETED|Open Label Extension||79
6263634|NCT00568178|7162438|FG005|NOT COMPLETED|Open Label Extension||80
6263635|NCT00549848|7162455|FG000|STARTED|Overall Study||206
6718982|NCT03027661|7648790|FG000|COMPLETED|Overall Study||20
6718983|NCT03027661|7648791|FG001|COMPLETED|Overall Study||21
6718984|NCT03027661|7648790|FG000|NOT COMPLETED|Overall Study||0
6718985|NCT03027661|7648791|FG001|NOT COMPLETED|Overall Study||0
6718986|NCT03028012|7648800|FG000|STARTED|Overall Study||4
6718987|NCT03028012|7648801|FG001|STARTED|Overall Study||3
6718988|NCT03028012|7648802|FG002|STARTED|Overall Study||3
6718989|NCT03028012|7648800|FG000|COMPLETED|Overall Study||2
6718990|NCT03028012|7648801|FG001|COMPLETED|Overall Study||0
6263636|NCT00549848|7162456|FG001|STARTED|Overall Study||208
6263637|NCT00549848|7162457|FG002|STARTED|Overall Study||184
6263638|NCT00549848|7162455|FG000|COMPLETED|Overall Study||194
6718991|NCT03028012|7648802|FG002|COMPLETED|Overall Study||0
6718992|NCT03028012|7648800|FG000|NOT COMPLETED|Overall Study||2
6718993|NCT03028012|7648801|FG001|NOT COMPLETED|Overall Study||3
6718994|NCT03028012|7648802|FG002|NOT COMPLETED|Overall Study||3
6718995|NCT03028025|7648813|FG000|STARTED|Overall Study||90
6718996|NCT03028025|7648814|FG001|STARTED|Overall Study||94
6718997|NCT03028025|7648813|FG000|COMPLETED|Overall Study||87
6718998|NCT03028025|7648814|FG001|COMPLETED|Overall Study||93
6718999|NCT03028025|7648813|FG000|NOT COMPLETED|Overall Study||3
6719000|NCT03028025|7648814|FG001|NOT COMPLETED|Overall Study||1
6719001|NCT03028103|7648822|FG000|STARTED|Overall Study||16
6719002|NCT03028103|7648823|FG001|STARTED|Overall Study||16
6719003|NCT03028103|7648822|FG000|COMPLETED|Overall Study||16
6719004|NCT03028103|7648823|FG001|COMPLETED|Overall Study||16
6719005|NCT03028103|7648822|FG000|NOT COMPLETED|Overall Study||0
6719006|NCT03028103|7648823|FG001|NOT COMPLETED|Overall Study||0
6719007|NCT03028129|7648835|FG000|STARTED|Overall Study||258
6719008|NCT03028129|7648836|FG001|STARTED|Overall Study||209
6719009|NCT03028129|7648835|FG000|COMPLETED|Overall Study||132
6719010|NCT03028129|7648836|FG001|COMPLETED|Overall Study||122
6719011|NCT03028129|7648835|FG000|NOT COMPLETED|Overall Study||126
6719012|NCT03028129|7648836|FG001|NOT COMPLETED|Overall Study||87
6719013|NCT03028142|7648842|FG000|STARTED|Overall Study||5
6719014|NCT03028142|7648843|FG001|STARTED|Overall Study||5
6719015|NCT03028142|7648844|FG002|STARTED|Overall Study||6
6719016|NCT03028142|7648845|FG003|STARTED|Overall Study||4
6719017|NCT03028142|7648846|FG004|STARTED|Overall Study||6
6719018|NCT03028142|7648847|FG005|STARTED|Overall Study||4
6719019|NCT03028142|7648842|FG000|COMPLETED|Overall Study||4
6719020|NCT03028142|7648843|FG001|COMPLETED|Overall Study||4
6719021|NCT03028142|7648844|FG002|COMPLETED|Overall Study||6
6719022|NCT03028142|7648845|FG003|COMPLETED|Overall Study||4
6263639|NCT00549848|7162456|FG001|COMPLETED|Overall Study||188
6263640|NCT00549848|7162457|FG002|COMPLETED|Overall Study||133
6263641|NCT00549848|7162455|FG000|NOT COMPLETED|Overall Study||12
6263642|NCT00549848|7162456|FG001|NOT COMPLETED|Overall Study||20
6263643|NCT00549848|7162457|FG002|NOT COMPLETED|Overall Study||51
6263644|NCT00545844|7162473|FG000|STARTED|Overall Study||313
6263645|NCT00545844|7162473|FG000|COMPLETED|Overall Study||301
6263646|NCT00545844|7162473|FG000|NOT COMPLETED|Overall Study||12
6263647|NCT00511433|7162481|FG000|STARTED|Overall Study||32
6263648|NCT00511433|7162482|FG001|STARTED|Overall Study||16
6263649|NCT00511433|7162481|FG000|COMPLETED|Overall Study||26
6263650|NCT00511433|7162482|FG001|COMPLETED|Overall Study||15
6263651|NCT00511433|7162481|FG000|NOT COMPLETED|Overall Study||6
6263652|NCT00511433|7162482|FG001|NOT COMPLETED|Overall Study||1
6263653|NCT00511355|7162492|FG000|STARTED|Overall Study||60
6263654|NCT00511355|7162493|FG001|STARTED|Overall Study||61
6263655|NCT00511355|7162492|FG000|COMPLETED|Overall Study||53
6263656|NCT00511355|7162493|FG001|COMPLETED|Overall Study||52
6263657|NCT00511355|7162492|FG000|NOT COMPLETED|Overall Study||7
6263658|NCT00511355|7162493|FG001|NOT COMPLETED|Overall Study||9
6263659|NCT00511342|7162503|FG000|STARTED|Overall Study||56
6263660|NCT00511342|7162504|FG001|STARTED|Overall Study||54
6263661|NCT00511342|7162503|FG000|COMPLETED|Overall Study||43
6263662|NCT00511342|7162504|FG001|COMPLETED|Overall Study||32
6263663|NCT00511342|7162503|FG000|NOT COMPLETED|Overall Study||13
6263664|NCT00511342|7162504|FG001|NOT COMPLETED|Overall Study||22
6263665|NCT00511199|7162512|FG000|STARTED|Overall Study||1591
6263666|NCT00511199|7162513|FG001|STARTED|Overall Study||535
6263667|NCT00511199|7162512|FG000|COMPLETED|Overall Study||1142
6263668|NCT00511199|7162513|FG001|COMPLETED|Overall Study||410
6263669|NCT00511199|7162512|FG000|NOT COMPLETED|Overall Study||449
6263670|NCT00511199|7162513|FG001|NOT COMPLETED|Overall Study||125
6263671|NCT00491504|7162525|FG000|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
6263672|NCT00491504|7162526|FG001|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
6263673|NCT00491504|7162527|FG002|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
6263674|NCT00491504|7162528|FG003|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
6263675|NCT00491504|7162525|FG000|COMPLETED|Overall Study||77
6263676|NCT00491504|7162526|FG001|COMPLETED|Overall Study||77
6263677|NCT00491504|7162527|FG002|COMPLETED|Overall Study||74
6263678|NCT00491504|7162528|FG003|COMPLETED|Overall Study||73
6263679|NCT00491504|7162525|FG000|NOT COMPLETED|Overall Study||0
6263680|NCT00491504|7162526|FG001|NOT COMPLETED|Overall Study||1
6263681|NCT00491504|7162527|FG002|NOT COMPLETED|Overall Study||4
6263682|NCT00491504|7162528|FG003|NOT COMPLETED|Overall Study||4
6263683|NCT00468312|7162538|FG000|STARTED|Overall Study||220
6263684|NCT00468312|7162539|FG001|STARTED|Overall Study||209
6263685|NCT00468312|7162538|FG000|COMPLETED|Overall Study||216
6263686|NCT00468312|7162539|FG001|COMPLETED|Overall Study||204
6263687|NCT00468312|7162538|FG000|NOT COMPLETED|Overall Study||4
6263688|NCT00468312|7162539|FG001|NOT COMPLETED|Overall Study||5
6263689|NCT00453063|7162547|FG000|STARTED|Overall Study||211
6263690|NCT00453063|7162548|FG001|STARTED|Overall Study||215
6263691|NCT00453063|7162547|FG000|COMPLETED|Overall Study||208
6263692|NCT00453063|7162548|FG001|COMPLETED|Overall Study||212
6263693|NCT00453063|7162547|FG000|NOT COMPLETED|Overall Study||3
6263694|NCT00453063|7162548|FG001|NOT COMPLETED|Overall Study||3
6263695|NCT00447603|7162554|FG000|STARTED|Screening||40
6263696|NCT00447603|7162555|FG001|STARTED|Screening||0
6263697|NCT00447603|7162556|FG002|STARTED|Screening||0
6263698|NCT00447603|7162554|FG000|COMPLETED|Screening||19
6263699|NCT00447603|7162555|FG001|COMPLETED|Screening||0
6263700|NCT00447603|7162556|FG002|COMPLETED|Screening||0
6719023|NCT03028142|7648846|FG004|COMPLETED|Overall Study||5
6719024|NCT03028142|7648847|FG005|COMPLETED|Overall Study||3
6719025|NCT03028142|7648842|FG000|NOT COMPLETED|Overall Study||1
6719026|NCT03028142|7648843|FG001|NOT COMPLETED|Overall Study||1
6719027|NCT03028142|7648844|FG002|NOT COMPLETED|Overall Study||0
6719028|NCT03028142|7648845|FG003|NOT COMPLETED|Overall Study||0
6719029|NCT03028142|7648846|FG004|NOT COMPLETED|Overall Study||1
6719030|NCT03028142|7648847|FG005|NOT COMPLETED|Overall Study||1
6719031|NCT03028220|7648858|FG000|STARTED|Overall Study||20
6719032|NCT03028220|7648859|FG001|STARTED|Overall Study||20
6719033|NCT03028220|7648858|FG000|COMPLETED|Overall Study||20
6719034|NCT03028220|7648859|FG001|COMPLETED|Overall Study||20
6719035|NCT03028220|7648858|FG000|NOT COMPLETED|Overall Study||0
6719036|NCT03028220|7648859|FG001|NOT COMPLETED|Overall Study||0
6719037|NCT03028324|7648865|FG000|STARTED|Overall Study||4
6719038|NCT03028324|7648865|FG000|COMPLETED|Overall Study||4
6719039|NCT03028324|7648865|FG000|NOT COMPLETED|Overall Study||0
6719040|NCT03028363|7648871|FG000|STARTED|Overall Study||498
6719041|NCT03028363|7648872|FG001|STARTED|Overall Study||261
6719042|NCT03028363|7648871|FG000|COMPLETED|Overall Study||420
6719043|NCT03028363|7648872|FG001|COMPLETED|Overall Study||228
6719044|NCT03028363|7648871|FG000|NOT COMPLETED|Overall Study||78
6719045|NCT03028363|7648872|FG001|NOT COMPLETED|Overall Study||33
6719046|NCT03028415|7648880|FG000|STARTED|Overall Study||39
6263701|NCT00447603|7162554|FG000|NOT COMPLETED|Screening||21
6263702|NCT00447603|7162555|FG001|NOT COMPLETED|Screening||0
6263703|NCT00447603|7162556|FG002|NOT COMPLETED|Screening||0
6263704|NCT00447603|7162554|FG000|STARTED|Filter Period||0
6263705|NCT00447603|7162555|FG001|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
6263706|NCT00447603|7162556|FG002|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
6263707|NCT00447603|7162554|FG000|COMPLETED|Filter Period||0
6263708|NCT00447603|7162555|FG001|COMPLETED|Filter Period||0
6263709|NCT00447603|7162556|FG002|COMPLETED|Filter Period||0
6263710|NCT00447603|7162554|FG000|NOT COMPLETED|Filter Period||0
6263711|NCT00447603|7162555|FG001|NOT COMPLETED|Filter Period||4
6263712|NCT00447603|7162556|FG002|NOT COMPLETED|Filter Period||15
6263713|NCT00442351|7162566|FG000|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
6263714|NCT00442351|7162567|FG001|STARTED|Overall Study||9
6263715|NCT00442351|7162566|FG000|COMPLETED|Overall Study||10
6263716|NCT00442351|7162567|FG001|COMPLETED|Overall Study||3
6263717|NCT00442351|7162566|FG000|NOT COMPLETED|Overall Study||7
6263718|NCT00442351|7162567|FG001|NOT COMPLETED|Overall Study||6
6263719|NCT00423488|7162575|FG000|STARTED|Overall Study||42
6263720|NCT00423488|7162576|FG001|STARTED|Overall Study||51
6263721|NCT00423488|7162575|FG000|COMPLETED|Overall Study||37
6263722|NCT00423488|7162576|FG001|COMPLETED|Overall Study||50
6263723|NCT00423488|7162575|FG000|NOT COMPLETED|Overall Study||5
6263724|NCT00423488|7162576|FG001|NOT COMPLETED|Overall Study||1
6263725|NCT00413972|7162586|FG000|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
6263726|NCT00413972|7162587|FG001|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
6263727|NCT00413972|7162588|FG002|STARTED|Overall Study||98
6263728|NCT00413972|7162589|FG003|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
6263729|NCT00413972|7162586|FG000|COMPLETED|Overall Study||91
6263730|NCT00413972|7162587|FG001|COMPLETED|Overall Study||90
6263731|NCT00413972|7162588|FG002|COMPLETED|Overall Study||88
6263732|NCT00413972|7162589|FG003|COMPLETED|Overall Study||95
6263733|NCT00413972|7162586|FG000|NOT COMPLETED|Overall Study||7
6263734|NCT00413972|7162587|FG001|NOT COMPLETED|Overall Study||8
6263735|NCT00413972|7162588|FG002|NOT COMPLETED|Overall Study||10
6263736|NCT00413972|7162589|FG003|NOT COMPLETED|Overall Study||3
6263737|NCT00413062|7162601|FG000|STARTED|Overall Study||1666
6263738|NCT00413062|7162602|FG001|STARTED|Overall Study||554
6263739|NCT00413062|7162601|FG000|COMPLETED|Overall Study||988
6263740|NCT00413062|7162602|FG001|COMPLETED|Overall Study||344
6263741|NCT00413062|7162601|FG000|NOT COMPLETED|Overall Study||678
6263742|NCT00413062|7162602|FG001|NOT COMPLETED|Overall Study||210
6263743|NCT00391170|7162612|FG000|STARTED|Overall Study||27
6263744|NCT00391170|7162613|FG001|STARTED|Overall Study||27
6263745|NCT00391170|7162612|FG000|COMPLETED|Overall Study||21
6263746|NCT00391170|7162613|FG001|COMPLETED|Overall Study||23
6263747|NCT00391170|7162612|FG000|NOT COMPLETED|Overall Study||6
6263748|NCT00391170|7162613|FG001|NOT COMPLETED|Overall Study||4
6263749|NCT00359138|7162622|FG000|STARTED|Overall Study||12
6263750|NCT00359138|7162623|FG001|STARTED|Overall Study||12
6263751|NCT00359138|7162624|FG002|STARTED|Overall Study||12
6263752|NCT00359138|7162622|FG000|COMPLETED|Overall Study||12
6263753|NCT00359138|7162623|FG001|COMPLETED|Overall Study||12
6263754|NCT00359138|7162624|FG002|COMPLETED|Overall Study||12
6263755|NCT00359138|7162622|FG000|NOT COMPLETED|Overall Study||0
6263756|NCT00359138|7162623|FG001|NOT COMPLETED|Overall Study||0
6263757|NCT00359138|7162624|FG002|NOT COMPLETED|Overall Study||0
6263758|NCT00350701|7162635|FG000|STARTED|Overall Study||17
6263759|NCT00350701|7162636|FG001|STARTED|Overall Study||17
6263760|NCT00350701|7162637|FG002|STARTED|Overall Study||15
6263761|NCT00350701|7162635|FG000|COMPLETED|Overall Study||17
6263762|NCT00350701|7162636|FG001|COMPLETED|Overall Study||17
6263763|NCT00350701|7162637|FG002|COMPLETED|Overall Study||15
6719047|NCT03028415|7648881|FG001|STARTED|Overall Study||17
6719048|NCT03028415|7648880|FG000|Modified Intention-to-treat (mITT) Population|Overall Study||39
6719049|NCT03028415|7648881|FG001|Modified Intention-to-treat (mITT) Population|Overall Study||17
6719050|NCT03028415|7648880|FG000|COMPLETED|Overall Study||31
6719051|NCT03028415|7648881|FG001|COMPLETED|Overall Study||14
6719052|NCT03028415|7648880|FG000|NOT COMPLETED|Overall Study||8
6719053|NCT03028415|7648881|FG001|NOT COMPLETED|Overall Study||3
6719054|NCT03028467|7648892|FG000|STARTED|Overall Study||4
6719055|NCT03028467|7648893|FG001|STARTED|Overall Study||3
6719056|NCT03028467|7648894|FG002|STARTED|Overall Study||4
6719057|NCT03028467|7648895|FG003|STARTED|Overall Study||4
6719058|NCT03028467|7648892|FG000|COMPLETED|Overall Study||4
6719059|NCT03028467|7648893|FG001|COMPLETED|Overall Study||3
6719060|NCT03028467|7648894|FG002|COMPLETED|Overall Study||4
6719061|NCT03028467|7648895|FG003|COMPLETED|Overall Study||4
6719062|NCT03028467|7648892|FG000|NOT COMPLETED|Overall Study||0
6719063|NCT03028467|7648893|FG001|NOT COMPLETED|Overall Study||0
6719064|NCT03028467|7648894|FG002|NOT COMPLETED|Overall Study||0
6719065|NCT03028467|7648895|FG003|NOT COMPLETED|Overall Study||0
6719066|NCT03028636|7648908|FG000|STARTED|Overall Study||17
6719067|NCT03028636|7648908|FG000|COMPLETED|Overall Study||11
6719068|NCT03028636|7648908|FG000|NOT COMPLETED|Overall Study||6
6719069|NCT03028870|7648921|FG000|STARTED|Overall Study||74
6719070|NCT03028870|7648922|FG001|STARTED|Overall Study||67
6719071|NCT03028870|7648923|FG002|STARTED|Overall Study||76
6719072|NCT03028870|7648924|FG003|STARTED|Overall Study||74
6719073|NCT03028870|7648921|FG000|COMPLETED|Overall Study||57
6719074|NCT03028870|7648922|FG001|COMPLETED|Overall Study||57
6719075|NCT03028870|7648923|FG002|COMPLETED|Overall Study||60
6719076|NCT03028870|7648924|FG003|COMPLETED|Overall Study||65
6719077|NCT03028870|7648921|FG000|NOT COMPLETED|Overall Study||17
6719078|NCT03028870|7648922|FG001|NOT COMPLETED|Overall Study||10
6719079|NCT03028870|7648923|FG002|NOT COMPLETED|Overall Study||16
6719080|NCT03028870|7648924|FG003|NOT COMPLETED|Overall Study||9
6719081|NCT03028974|7648939|FG000|STARTED|2014-2015||1
6719082|NCT03028974|7648940|FG001|STARTED|2014-2015||0
6719083|NCT03028974|7648941|FG002|STARTED|2014-2015||0
6719084|NCT03028974|7648942|FG003|STARTED|2014-2015||3
6719085|NCT03028974|7648943|FG004|STARTED|2014-2015||0
6719086|NCT03028974|7648944|FG005|STARTED|2014-2015||11
6719087|NCT03028974|7648945|FG006|STARTED|2014-2015||13
6719088|NCT03028974|7648939|FG000|COMPLETED|2014-2015||1
6719089|NCT03028974|7648940|FG001|COMPLETED|2014-2015||0
6719090|NCT03028974|7648941|FG002|COMPLETED|2014-2015||0
6719091|NCT03028974|7648942|FG003|COMPLETED|2014-2015||3
6719092|NCT03028974|7648943|FG004|COMPLETED|2014-2015||0
6719093|NCT03028974|7648944|FG005|COMPLETED|2014-2015|2 participants did not continue to the next period.|11
6719094|NCT03028974|7648945|FG006|COMPLETED|2014-2015|13 participants did not continue to the next period.|13
6719095|NCT03028974|7648939|FG000|NOT COMPLETED|2014-2015||0
6719096|NCT03028974|7648940|FG001|NOT COMPLETED|2014-2015||0
6719097|NCT03028974|7648941|FG002|NOT COMPLETED|2014-2015||0
6719098|NCT03028974|7648942|FG003|NOT COMPLETED|2014-2015||0
6719099|NCT03028974|7648943|FG004|NOT COMPLETED|2014-2015||0
6719100|NCT03028974|7648944|FG005|NOT COMPLETED|2014-2015||0
6719101|NCT03028974|7648945|FG006|NOT COMPLETED|2014-2015||0
6719102|NCT03028974|7648939|FG000|STARTED|2015-2016||0
6719103|NCT03028974|7648940|FG001|STARTED|2015-2016||0
6719104|NCT03028974|7648941|FG002|STARTED|2015-2016||0
6263764|NCT00350701|7162635|FG000|NOT COMPLETED|Overall Study||0
6263765|NCT00350701|7162636|FG001|NOT COMPLETED|Overall Study||0
6263766|NCT00350701|7162637|FG002|NOT COMPLETED|Overall Study||0
6263767|NCT00319449|7162647|FG000|STARTED|Overall Study||10
6263768|NCT00319449|7162648|FG001|STARTED|Overall Study||12
6719105|NCT03028974|7648942|FG003|STARTED|2015-2016|One participant joined from Group A, 2 new were enrolled.|6
6719106|NCT03028974|7648943|FG004|STARTED|2015-2016||0
6719107|NCT03028974|7648944|FG005|STARTED|2015-2016|10 new participants were enrolled; 4 subjects switched from Group G.|14
6719108|NCT03028974|7648945|FG006|STARTED|2015-2016|11 new participants were enrolled; 9 subjects switched from Group F.|20
6719109|NCT03028974|7648939|FG000|COMPLETED|2015-2016||0
6719110|NCT03028974|7648940|FG001|COMPLETED|2015-2016||0
6719111|NCT03028974|7648941|FG002|COMPLETED|2015-2016||0
6719112|NCT03028974|7648942|FG003|COMPLETED|2015-2016|3 participants did not continue to the next period. 1 Participant returned in period 4 (2017-2018).|6
6719113|NCT03028974|7648943|FG004|COMPLETED|2015-2016||0
6719114|NCT03028974|7648944|FG005|COMPLETED|2015-2016|14 participants did not continue to the next period.|14
6719115|NCT03028974|7648945|FG006|COMPLETED|2015-2016|20 participants did not continue to the next period.|20
6719116|NCT03028974|7648939|FG000|NOT COMPLETED|2015-2016||0
6719117|NCT03028974|7648940|FG001|NOT COMPLETED|2015-2016||0
6719118|NCT03028974|7648941|FG002|NOT COMPLETED|2015-2016||0
6719119|NCT03028974|7648942|FG003|NOT COMPLETED|2015-2016||0
6719120|NCT03028974|7648943|FG004|NOT COMPLETED|2015-2016||0
6719121|NCT03028974|7648944|FG005|NOT COMPLETED|2015-2016||0
6719122|NCT03028974|7648945|FG006|NOT COMPLETED|2015-2016||0
6719123|NCT03028974|7648939|FG000|STARTED|2016-2017||0
6719124|NCT03028974|7648940|FG001|STARTED|2016-2017||0
6719125|NCT03028974|7648941|FG002|STARTED|2016-2017||0
6719126|NCT03028974|7648942|FG003|STARTED|2016-2017|1 new participant was enrolled.|4
6719127|NCT03028974|7648943|FG004|STARTED|2016-2017|2 new participants were enrolled.|2
6719128|NCT03028974|7648944|FG005|STARTED|2016-2017||0
6719129|NCT03028974|7648945|FG006|STARTED|2016-2017|18 new participants were enrolled.|18
6719130|NCT03028974|7648939|FG000|COMPLETED|2016-2017||0
6719131|NCT03028974|7648940|FG001|COMPLETED|2016-2017||0
6719132|NCT03028974|7648941|FG002|COMPLETED|2016-2017||0
6719133|NCT03028974|7648942|FG003|COMPLETED|2016-2017||4
6263769|NCT00319449|7162647|FG000|COMPLETED|Overall Study||8
6263770|NCT00319449|7162648|FG001|COMPLETED|Overall Study||12
6739516|NCT03291288|7668398|FG001|COMPLETED|Pexidartinib Only||24
6719134|NCT03028974|7648943|FG004|COMPLETED|2016-2017|2 participants did not continue to the next period|2
6719135|NCT03028974|7648944|FG005|COMPLETED|2016-2017||0
6719136|NCT03028974|7648945|FG006|COMPLETED|2016-2017|18 participants did not continue to the next period.|18
6719137|NCT03028974|7648939|FG000|NOT COMPLETED|2016-2017||0
6719138|NCT03028974|7648940|FG001|NOT COMPLETED|2016-2017||0
6719139|NCT03028974|7648941|FG002|NOT COMPLETED|2016-2017||0
6719140|NCT03028974|7648942|FG003|NOT COMPLETED|2016-2017||0
6719141|NCT03028974|7648943|FG004|NOT COMPLETED|2016-2017||0
6719142|NCT03028974|7648944|FG005|NOT COMPLETED|2016-2017||0
6719143|NCT03028974|7648945|FG006|NOT COMPLETED|2016-2017||0
6719144|NCT03028974|7648939|FG000|STARTED|2017-2018||0
6719145|NCT03028974|7648940|FG001|STARTED|2017-2018||0
6719146|NCT03028974|7648941|FG002|STARTED|2017-2018||0
6719147|NCT03028974|7648942|FG003|STARTED|2017-2018||5
6719148|NCT03028974|7648943|FG004|STARTED|2017-2018||0
6719149|NCT03028974|7648944|FG005|STARTED|2017-2018||0
6719150|NCT03028974|7648945|FG006|STARTED|2017-2018|5 new participants were enrolled.|5
6719151|NCT03028974|7648939|FG000|COMPLETED|2017-2018||0
6719152|NCT03028974|7648940|FG001|COMPLETED|2017-2018||0
6719153|NCT03028974|7648941|FG002|COMPLETED|2017-2018||0
6719154|NCT03028974|7648942|FG003|COMPLETED|2017-2018||5
6719155|NCT03028974|7648943|FG004|COMPLETED|2017-2018||0
6719156|NCT03028974|7648944|FG005|COMPLETED|2017-2018||0
6719157|NCT03028974|7648945|FG006|COMPLETED|2017-2018||5
6719158|NCT03028974|7648939|FG000|NOT COMPLETED|2017-2018||0
6719159|NCT03028974|7648940|FG001|NOT COMPLETED|2017-2018||0
6719160|NCT03028974|7648941|FG002|NOT COMPLETED|2017-2018||0
6719161|NCT03028974|7648942|FG003|NOT COMPLETED|2017-2018||0
6719162|NCT03028974|7648943|FG004|NOT COMPLETED|2017-2018||0
6719163|NCT03028974|7648944|FG005|NOT COMPLETED|2017-2018||0
6719164|NCT03028974|7648945|FG006|NOT COMPLETED|2017-2018||0
6719165|NCT03028987|7648960|FG000|STARTED|Overall Study||5
6719166|NCT03028987|7648961|FG001|STARTED|Overall Study||5
6719167|NCT03028987|7648960|FG000|COMPLETED|Overall Study||5
6719168|NCT03028987|7648961|FG001|COMPLETED|Overall Study||5
6719169|NCT03028987|7648960|FG000|NOT COMPLETED|Overall Study||0
6719170|NCT03028987|7648961|FG001|NOT COMPLETED|Overall Study||0
6719171|NCT03029091|7648969|FG000|STARTED|Overall Study||8
6719172|NCT03029091|7648970|FG001|STARTED|Overall Study||7
6719173|NCT03029091|7648969|FG000|COMPLETED|Overall Study||8
6719174|NCT03029091|7648970|FG001|COMPLETED|Overall Study||7
6719175|NCT03029091|7648969|FG000|NOT COMPLETED|Overall Study||0
6719176|NCT03029091|7648970|FG001|NOT COMPLETED|Overall Study||0
6719177|NCT03029143|7648978|FG000|STARTED|Lead-in Period (6 Weeks)||278
6719178|NCT03029143|7648979|FG001|STARTED|Lead-in Period (6 Weeks)||0
6719179|NCT03029143|7648980|FG002|STARTED|Lead-in Period (6 Weeks)||0
6719180|NCT03029143|7648978|FG000|COMPLETED|Lead-in Period (6 Weeks)||109
6719181|NCT03029143|7648979|FG001|COMPLETED|Lead-in Period (6 Weeks)||0
6719182|NCT03029143|7648980|FG002|COMPLETED|Lead-in Period (6 Weeks)||0
6719183|NCT03029143|7648978|FG000|NOT COMPLETED|Lead-in Period (6 Weeks)||169
6719184|NCT03029143|7648979|FG001|NOT COMPLETED|Lead-in Period (6 Weeks)||0
6719185|NCT03029143|7648980|FG002|NOT COMPLETED|Lead-in Period (6 Weeks)||0
6719186|NCT03029143|7648978|FG000|STARTED|Randomized Treatment Period (24 Weeks)||0
6719187|NCT03029143|7648979|FG001|STARTED|Randomized Treatment Period (24 Weeks)||54
6719188|NCT03029143|7648980|FG002|STARTED|Randomized Treatment Period (24 Weeks)||55
6719189|NCT03029143|7648978|FG000|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
6719190|NCT03029143|7648979|FG001|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)|One participant was randomized to Randomized Treatment Period: Standard Treatment Arm, but was not treated and was thus included in the Lead-in failure vedolizumab arm for the Safety Analysis Set (N=170).|1
6719191|NCT03029143|7648980|FG002|Not Treated Post Randomization|Randomized Treatment Period (24 Weeks)||0
6719192|NCT03029143|7648978|FG000|Safety Population|Randomized Treatment Period (24 Weeks)||0
6719193|NCT03029143|7648979|FG001|Safety Population|Randomized Treatment Period (24 Weeks)||53
6719194|NCT03029143|7648980|FG002|Safety Population|Randomized Treatment Period (24 Weeks)|Regimen A = 28 Regimen B = 27|55
6719195|NCT03029143|7648978|FG000|COMPLETED|Randomized Treatment Period (24 Weeks)||0
6719196|NCT03029143|7648979|FG001|COMPLETED|Randomized Treatment Period (24 Weeks)||31
6719197|NCT03029143|7648980|FG002|COMPLETED|Randomized Treatment Period (24 Weeks)||31
6719198|NCT03029143|7648978|FG000|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||0
6719199|NCT03029143|7648979|FG001|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||23
6719200|NCT03029143|7648980|FG002|NOT COMPLETED|Randomized Treatment Period (24 Weeks)||24
6719201|NCT03029208|7648991|FG000|STARTED|Overall Study||157
6719202|NCT03029208|7648992|FG001|STARTED|Overall Study||155
6719203|NCT03029208|7648991|FG000|COMPLETED|Overall Study||155
6719204|NCT03029208|7648992|FG001|COMPLETED|Overall Study||151
6719205|NCT03029208|7648991|FG000|NOT COMPLETED|Overall Study||2
6719206|NCT03029208|7648992|FG001|NOT COMPLETED|Overall Study||4
6719207|NCT03029247|7649009|FG000|STARTED|Acute Challenge 1 (Day 1)||45
6719208|NCT03029247|7649010|FG001|STARTED|Acute Challenge 1 (Day 1)||43
6719209|NCT03029247|7649009|FG000|COMPLETED|Acute Challenge 1 (Day 1)||45
6719210|NCT03029247|7649010|FG001|COMPLETED|Acute Challenge 1 (Day 1)||43
6719211|NCT03029247|7649009|FG000|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
6719212|NCT03029247|7649010|FG001|NOT COMPLETED|Acute Challenge 1 (Day 1)||0
6719213|NCT03029247|7649009|FG000|STARTED|Hgb Maintenance Phase (8 Weeks)||45
6719214|NCT03029247|7649010|FG001|STARTED|Hgb Maintenance Phase (8 Weeks)||43
6719215|NCT03029247|7649009|FG000|COMPLETED|Hgb Maintenance Phase (8 Weeks)||32
6719216|NCT03029247|7649010|FG001|COMPLETED|Hgb Maintenance Phase (8 Weeks)||36
6719217|NCT03029247|7649009|FG000|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||13
6719218|NCT03029247|7649010|FG001|NOT COMPLETED|Hgb Maintenance Phase (8 Weeks)||7
6719219|NCT03029247|7649009|FG000|STARTED|Acute Challenge 2 (Day 57)||32
6719220|NCT03029247|7649010|FG001|STARTED|Acute Challenge 2 (Day 57)||36
6719221|NCT03029247|7649009|FG000|COMPLETED|Acute Challenge 2 (Day 57)||32
6719222|NCT03029247|7649010|FG001|COMPLETED|Acute Challenge 2 (Day 57)||36
6719223|NCT03029247|7649009|FG000|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
6719224|NCT03029247|7649010|FG001|NOT COMPLETED|Acute Challenge 2 (Day 57)||0
6719225|NCT03029247|7649009|FG000|STARTED|Follow-up Period (14 Days)||32
6719226|NCT03029247|7649010|FG001|STARTED|Follow-up Period (14 Days)||36
6719227|NCT03029247|7649009|FG000|COMPLETED|Follow-up Period (14 Days)||32
6719228|NCT03029247|7649010|FG001|COMPLETED|Follow-up Period (14 Days)||36
6719229|NCT03029247|7649009|FG000|NOT COMPLETED|Follow-up Period (14 Days)||0
6719230|NCT03029247|7649010|FG001|NOT COMPLETED|Follow-up Period (14 Days)||0
6719231|NCT03029585|7649018|FG000|STARTED|Overall Study||7
6719232|NCT03029585|7649019|FG001|STARTED|Overall Study||3
6719233|NCT03029585|7649018|FG000|COMPLETED|Overall Study||5
6719234|NCT03029585|7649019|FG001|COMPLETED|Overall Study||2
6719235|NCT03029585|7649018|FG000|NOT COMPLETED|Overall Study||2
6719236|NCT03029585|7649019|FG001|NOT COMPLETED|Overall Study||1
6719237|NCT03029624|7649025|FG000|STARTED|Overall Study||46
6719238|NCT03029624|7649025|FG000|Primary Endpoint (3 Months)|Overall Study||44
6719239|NCT03029624|7649025|FG000|COMPLETED|Overall Study||41
6719240|NCT03029624|7649025|FG000|NOT COMPLETED|Overall Study||5
6719241|NCT03029650|7649031|FG000|STARTED|First Intervention (3 - 6 Days)|More subjects not enrolled after consent in other group leaving uneven number.|14
6719242|NCT03029650|7649032|FG001|STARTED|First Intervention (3 - 6 Days)||12
6719243|NCT03029650|7649031|FG000|COMPLETED|First Intervention (3 - 6 Days)||14
6719244|NCT03029650|7649032|FG001|COMPLETED|First Intervention (3 - 6 Days)||12
6719245|NCT03029650|7649031|FG000|NOT COMPLETED|First Intervention (3 - 6 Days)||0
6719246|NCT03029650|7649032|FG001|NOT COMPLETED|First Intervention (3 - 6 Days)||0
6719247|NCT03029650|7649031|FG000|STARTED|Washout (1 Week)||14
6719248|NCT03029650|7649032|FG001|STARTED|Washout (1 Week)||12
6719249|NCT03029650|7649031|FG000|COMPLETED|Washout (1 Week)||13
6719250|NCT03029650|7649032|FG001|COMPLETED|Washout (1 Week)||10
6719251|NCT03029650|7649031|FG000|NOT COMPLETED|Washout (1 Week)||1
6719252|NCT03029650|7649032|FG001|NOT COMPLETED|Washout (1 Week)||2
6719253|NCT03029650|7649031|FG000|STARTED|2nd Intervention (3 - 6 Days)||13
6719254|NCT03029650|7649032|FG001|STARTED|2nd Intervention (3 - 6 Days)||10
6719255|NCT03029650|7649031|FG000|COMPLETED|2nd Intervention (3 - 6 Days)||13
6719256|NCT03029650|7649032|FG001|COMPLETED|2nd Intervention (3 - 6 Days)||10
6719257|NCT03029650|7649031|FG000|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
6719258|NCT03029650|7649032|FG001|NOT COMPLETED|2nd Intervention (3 - 6 Days)||0
6719259|NCT03029715|7649044|FG000|STARTED|Overall Study||50
6719260|NCT03029715|7649045|FG001|STARTED|Overall Study||50
6719261|NCT03029715|7649044|FG000|COMPLETED|Overall Study||50
6719262|NCT03029715|7649045|FG001|COMPLETED|Overall Study||50
6719263|NCT03029715|7649044|FG000|NOT COMPLETED|Overall Study||0
6719264|NCT03029715|7649045|FG001|NOT COMPLETED|Overall Study||0
6719265|NCT03029780|7649053|FG000|STARTED|Overall Study||52
6719266|NCT03029780|7649054|FG001|STARTED|Overall Study||52
6719267|NCT03029780|7649053|FG000|COMPLETED|Overall Study||46
6719268|NCT03029780|7649054|FG001|COMPLETED|Overall Study||41
6719269|NCT03029780|7649053|FG000|NOT COMPLETED|Overall Study||6
6719270|NCT03029780|7649054|FG001|NOT COMPLETED|Overall Study||11
6719271|NCT03029819|7649062|FG000|STARTED|Overall Study||33
6719272|NCT03029819|7649063|FG001|STARTED|Overall Study||39
6719273|NCT03029819|7649062|FG000|COMPLETED|Overall Study||30
6719274|NCT03029819|7649063|FG001|COMPLETED|Overall Study||33
6719275|NCT03029819|7649062|FG000|NOT COMPLETED|Overall Study||3
6719276|NCT03029819|7649063|FG001|NOT COMPLETED|Overall Study||6
6719277|NCT03029988|7649072|FG000|STARTED|Overall Study||3
6719278|NCT03029988|7649072|FG000|COMPLETED|Overall Study||3
6719279|NCT03029988|7649072|FG000|NOT COMPLETED|Overall Study||0
6719280|NCT03030183|7649077|FG000|STARTED|Overall Study||3
6719281|NCT03030183|7649077|FG000|COMPLETED|Overall Study||3
6719282|NCT03030183|7649077|FG000|NOT COMPLETED|Overall Study||0
6719283|NCT03030599|7649081|FG000|STARTED|Open Label Treatment and Titration||201
6719284|NCT03030599|7649082|FG001|STARTED|Open Label Treatment and Titration||0
6719285|NCT03030599|7649083|FG002|STARTED|Open Label Treatment and Titration||0
6739517|NCT03291288|7668397|FG000|NOT COMPLETED|Pexidartinib Only||0
6719286|NCT03030599|7649081|FG000|COMPLETED|Open Label Treatment and Titration||155
6719287|NCT03030599|7649082|FG001|COMPLETED|Open Label Treatment and Titration||0
6719288|NCT03030599|7649083|FG002|COMPLETED|Open Label Treatment and Titration||0
6719289|NCT03030599|7649081|FG000|NOT COMPLETED|Open Label Treatment and Titration||46
6719290|NCT03030599|7649082|FG001|NOT COMPLETED|Open Label Treatment and Titration||0
6719291|NCT03030599|7649083|FG002|NOT COMPLETED|Open Label Treatment and Titration||0
6719292|NCT03030599|7649081|FG000|STARTED|Stable Dose|149 subjects of the 201 entered the Stable Dose Period. Of those subjects, 136 were randomized.|149
6719293|NCT03030599|7649082|FG001|STARTED|Stable Dose||0
6719294|NCT03030599|7649083|FG002|STARTED|Stable Dose||0
6719295|NCT03030599|7649081|FG000|COMPLETED|Stable Dose||144
6719296|NCT03030599|7649082|FG001|COMPLETED|Stable Dose||0
6719297|NCT03030599|7649083|FG002|COMPLETED|Stable Dose||0
6719298|NCT03030599|7649081|FG000|NOT COMPLETED|Stable Dose||5
6719299|NCT03030599|7649082|FG001|NOT COMPLETED|Stable Dose||0
6719300|NCT03030599|7649083|FG002|NOT COMPLETED|Stable Dose||0
6719301|NCT03030599|7649081|FG000|STARTED|Double Blind Randomized Withdrawal||0
6719302|NCT03030599|7649082|FG001|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|69
6719303|NCT03030599|7649083|FG002|STARTED|Double Blind Randomized Withdrawal|134 of the 136 subjects randomized received at least 1 dose of study drug in the DB RWP.|67
6719304|NCT03030599|7649081|FG000|COMPLETED|Double Blind Randomized Withdrawal||0
6719305|NCT03030599|7649082|FG001|COMPLETED|Double Blind Randomized Withdrawal||69
6719306|NCT03030599|7649083|FG002|COMPLETED|Double Blind Randomized Withdrawal||59
6719307|NCT03030599|7649081|FG000|NOT COMPLETED|Double Blind Randomized Withdrawal||0
6719308|NCT03030599|7649082|FG001|NOT COMPLETED|Double Blind Randomized Withdrawal||0
6719309|NCT03030599|7649083|FG002|NOT COMPLETED|Double Blind Randomized Withdrawal||8
6719310|NCT03030599|7649081|FG000|STARTED|Open-label Extension||74
6719311|NCT03030599|7649082|FG001|STARTED|Open-label Extension||0
6719312|NCT03030599|7649083|FG002|STARTED|Open-label Extension||0
6719313|NCT03030599|7649081|FG000|COMPLETED|Open-label Extension||67
6719314|NCT03030599|7649082|FG001|COMPLETED|Open-label Extension||0
6719315|NCT03030599|7649083|FG002|COMPLETED|Open-label Extension||0
6719316|NCT03030599|7649081|FG000|NOT COMPLETED|Open-label Extension||7
6719317|NCT03030599|7649082|FG001|NOT COMPLETED|Open-label Extension||0
6719318|NCT03030599|7649083|FG002|NOT COMPLETED|Open-label Extension||0
6719319|NCT03030638|7649097|FG000|STARTED|Overall Study||1386
6719320|NCT03030638|7649098|FG001|STARTED|Overall Study||1841
6719321|NCT03030638|7649099|FG002|STARTED|Overall Study||1712
6719322|NCT03030638|7649100|FG003|STARTED|Overall Study||6406
6719323|NCT03030638|7649101|FG004|STARTED|Overall Study||696
6719324|NCT03030638|7649102|FG005|STARTED|Overall Study||1592
6719325|NCT03030638|7649103|FG006|STARTED|Overall Study||364
6719326|NCT03030638|7649104|FG007|STARTED|Overall Study||127
6719327|NCT03030638|7649097|FG000|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||372
6719328|NCT03030638|7649098|FG001|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||636
6719329|NCT03030638|7649099|FG002|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6719330|NCT03030638|7649100|FG003|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6719331|NCT03030638|7649101|FG004|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6719332|NCT03030638|7649102|FG005|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6719333|NCT03030638|7649103|FG006|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6719334|NCT03030638|7649104|FG007|PHARMO-GP (Sub-set of PHARMO Overall)|Overall Study||0
6719335|NCT03030638|7649097|FG000|COMPLETED|Overall Study||1386
6719336|NCT03030638|7649098|FG001|COMPLETED|Overall Study||1841
6719337|NCT03030638|7649099|FG002|COMPLETED|Overall Study||1712
6719338|NCT03030638|7649100|FG003|COMPLETED|Overall Study||6406
6719339|NCT03030638|7649101|FG004|COMPLETED|Overall Study||696
6719340|NCT03030638|7649102|FG005|COMPLETED|Overall Study||1592
6719341|NCT03030638|7649103|FG006|COMPLETED|Overall Study||364
6719342|NCT03030638|7649104|FG007|COMPLETED|Overall Study||127
6719343|NCT03030638|7649097|FG000|NOT COMPLETED|Overall Study||0
6719344|NCT03030638|7649098|FG001|NOT COMPLETED|Overall Study||0
6719345|NCT03030638|7649099|FG002|NOT COMPLETED|Overall Study||0
6719346|NCT03030638|7649100|FG003|NOT COMPLETED|Overall Study||0
6719347|NCT03030638|7649101|FG004|NOT COMPLETED|Overall Study||0
6719348|NCT03030638|7649102|FG005|NOT COMPLETED|Overall Study||0
6719349|NCT03030638|7649103|FG006|NOT COMPLETED|Overall Study||0
6719350|NCT03030638|7649104|FG007|NOT COMPLETED|Overall Study||0
6719351|NCT03030989|7649126|FG000|STARTED|Overall Study||21
6719352|NCT03030989|7649127|FG001|STARTED|Overall Study||29
6719353|NCT03030989|7649126|FG000|COMPLETED|Overall Study||9
6719354|NCT03030989|7649127|FG001|COMPLETED|Overall Study||15
6719355|NCT03030989|7649126|FG000|NOT COMPLETED|Overall Study||12
6719356|NCT03030989|7649127|FG001|NOT COMPLETED|Overall Study||14
6719357|NCT03031431|7649133|FG000|STARTED|Overall Study||130
6719358|NCT03031431|7649133|FG000|COMPLETED|Overall Study||129
6719359|NCT03031431|7649133|FG000|NOT COMPLETED|Overall Study||1
6719360|NCT03031496|7649137|FG000|STARTED|Period 1||21
6719361|NCT03031496|7649138|FG001|STARTED|Period 1||21
6719362|NCT03031496|7649137|FG000|COMPLETED|Period 1||19
6719363|NCT03031496|7649138|FG001|COMPLETED|Period 1||19
6719364|NCT03031496|7649137|FG000|NOT COMPLETED|Period 1||2
6719365|NCT03031496|7649138|FG001|NOT COMPLETED|Period 1||2
6719366|NCT03031496|7649137|FG000|STARTED|Period 2||19
6719367|NCT03031496|7649138|FG001|STARTED|Period 2||19
6719368|NCT03031496|7649137|FG000|COMPLETED|Period 2||19
6719369|NCT03031496|7649138|FG001|COMPLETED|Period 2||19
6719370|NCT03031496|7649137|FG000|NOT COMPLETED|Period 2||0
6719371|NCT03031496|7649138|FG001|NOT COMPLETED|Period 2||0
6719372|NCT03031678|7649144|FG000|STARTED|Overall Study||50
6719373|NCT03031678|7649144|FG000|EAS Test Condition Complete|Overall Study||39
6719374|NCT03031678|7649144|FG000|CI Alone Test Condition Complete|Overall Study||10
6719375|NCT03031678|7649144|FG000|COMPLETED|Overall Study||49
6719376|NCT03031678|7649144|FG000|NOT COMPLETED|Overall Study||1
6719377|NCT03031795|7649154|FG000|STARTED|Overall Study||35
6719378|NCT03031795|7649155|FG001|STARTED|Overall Study||36
6719379|NCT03031795|7649154|FG000|COMPLETED|Overall Study||35
6719380|NCT03031795|7649155|FG001|COMPLETED|Overall Study||35
6719381|NCT03031795|7649154|FG000|NOT COMPLETED|Overall Study||0
6719382|NCT03031795|7649155|FG001|NOT COMPLETED|Overall Study||1
6719383|NCT03031899|7649161|FG000|STARTED|Overall Study||27
6719384|NCT03031899|7649161|FG000|COMPLETED|Overall Study||25
6719385|NCT03031899|7649161|FG000|NOT COMPLETED|Overall Study||2
6719386|NCT03031938|7649171|FG000|STARTED|Overall Study||2
6719387|NCT03031938|7649172|FG001|STARTED|Overall Study||2
6719388|NCT03031938|7649171|FG000|COMPLETED|Overall Study||1
6719389|NCT03031938|7649172|FG001|COMPLETED|Overall Study||2
6719390|NCT03031938|7649171|FG000|NOT COMPLETED|Overall Study||1
6719391|NCT03031938|7649172|FG001|NOT COMPLETED|Overall Study||0
6719392|NCT03032263|7649180|FG000|STARTED|Overall Study||6
6719393|NCT03032263|7649181|FG001|STARTED|Overall Study||6
6719394|NCT03032263|7649180|FG000|COMPLETED|Overall Study||6
6719395|NCT03032263|7649181|FG001|COMPLETED|Overall Study||6
6719396|NCT03032263|7649180|FG000|NOT COMPLETED|Overall Study||0
6719397|NCT03032263|7649181|FG001|NOT COMPLETED|Overall Study||0
6719398|NCT03032380|7649189|FG000|STARTED|Overall Study||148
6719399|NCT03032380|7649190|FG001|STARTED|Overall Study||152
6719400|NCT03032380|7649189|FG000|Received Treatment|Overall Study||148
6719401|NCT03032380|7649190|FG001|Received Treatment|Overall Study||150
6719402|NCT03032380|7649189|FG000|COMPLETED|Overall Study||106
6719403|NCT03032380|7649190|FG001|COMPLETED|Overall Study||112
6719404|NCT03032380|7649189|FG000|NOT COMPLETED|Overall Study||42
6719405|NCT03032380|7649190|FG001|NOT COMPLETED|Overall Study||40
6719406|NCT03032393|7649198|FG000|STARTED|Overall Study||15
6719407|NCT03032393|7649199|FG001|STARTED|Overall Study||15
6719408|NCT03032393|7649198|FG000|COMPLETED|Overall Study||15
6719409|NCT03032393|7649199|FG001|COMPLETED|Overall Study||15
6719410|NCT03032393|7649198|FG000|NOT COMPLETED|Overall Study||0
6719411|NCT03032393|7649199|FG001|NOT COMPLETED|Overall Study||0
6719412|NCT03032523|7649207|FG000|STARTED|Overall Study||15
6719413|NCT03032523|7649208|FG001|STARTED|Overall Study||6
6719414|NCT03032523|7649207|FG000|COMPLETED|Overall Study||12
6719415|NCT03032523|7649208|FG001|COMPLETED|Overall Study||4
6719416|NCT03032523|7649207|FG000|NOT COMPLETED|Overall Study||3
6719417|NCT03032523|7649208|FG001|NOT COMPLETED|Overall Study||2
6719418|NCT03032965|7649217|FG000|STARTED|Overall Study||61
6719419|NCT03032965|7649218|FG001|STARTED|Overall Study||68
6719420|NCT03032965|7649217|FG000|COMPLETED|Overall Study||61
6719421|NCT03032965|7649218|FG001|COMPLETED|Overall Study||68
6719422|NCT03032965|7649217|FG000|NOT COMPLETED|Overall Study||0
6719423|NCT03032965|7649218|FG001|NOT COMPLETED|Overall Study||0
6719424|NCT03033108|7649227|FG000|STARTED|Overall Study||7
6719425|NCT03033108|7649228|FG001|STARTED|Overall Study||9
6719426|NCT03033108|7649229|FG002|STARTED|Overall Study||7
6719427|NCT03033108|7649227|FG000|COMPLETED|Overall Study||7
6719428|NCT03033108|7649228|FG001|COMPLETED|Overall Study||8
6719429|NCT03033108|7649229|FG002|COMPLETED|Overall Study||7
6719430|NCT03033108|7649227|FG000|NOT COMPLETED|Overall Study||0
6719431|NCT03033108|7649228|FG001|NOT COMPLETED|Overall Study||1
6719432|NCT03033108|7649229|FG002|NOT COMPLETED|Overall Study||0
6719433|NCT03033134|7649239|FG000|STARTED|Overall Study||42
6719434|NCT03033134|7649240|FG001|STARTED|Overall Study||12
6719435|NCT03033134|7649239|FG000|6-month Primary Endpoints|Overall Study||42
6719436|NCT03033134|7649240|FG001|6-month Primary Endpoints|Overall Study||12
6719437|NCT03033134|7649239|FG000|COMPLETED|Overall Study||0
6719438|NCT03033134|7649240|FG001|COMPLETED|Overall Study||0
6719439|NCT03033134|7649239|FG000|NOT COMPLETED|Overall Study||42
6719440|NCT03033134|7649240|FG001|NOT COMPLETED|Overall Study||12
6719441|NCT03033394|7649248|FG000|STARTED|Completed Sampling||65
6719442|NCT03033394|7649248|FG000|COMPLETED|Completed Sampling||65
6719443|NCT03033394|7649248|FG000|NOT COMPLETED|Completed Sampling||0
6719444|NCT03033394|7649248|FG000|STARTED|Completed Pharmacokinetic Analysis||65
6719445|NCT03033394|7649248|FG000|COMPLETED|Completed Pharmacokinetic Analysis||59
6719446|NCT03033394|7649248|FG000|NOT COMPLETED|Completed Pharmacokinetic Analysis||6
6719447|NCT03033394|7649248|FG000|STARTED|Completed Final Analysis||59
6719448|NCT03033394|7649248|FG000|COMPLETED|Completed Final Analysis||58
6719449|NCT03033394|7649248|FG000|NOT COMPLETED|Completed Final Analysis||1
6719450|NCT03033511|7649259|FG000|STARTED|Overall Study||376
6719451|NCT03033511|7649260|FG001|STARTED|Overall Study||372
6719452|NCT03033511|7649259|FG000|COMPLETED|Overall Study||376
6719453|NCT03033511|7649260|FG001|COMPLETED|Overall Study||372
6719454|NCT03033511|7649259|FG000|NOT COMPLETED|Overall Study||0
6719455|NCT03033511|7649260|FG001|NOT COMPLETED|Overall Study||0
6719456|NCT03033745|7649269|FG000|STARTED|Overall Study||15
6263771|NCT00319449|7162647|FG000|NOT COMPLETED|Overall Study||2
6719457|NCT03033745|7649270|FG001|STARTED|Overall Study||18
6719458|NCT03033745|7649271|FG002|STARTED|Overall Study||16
6719459|NCT03033745|7649269|FG000|COMPLETED|Overall Study||14
6719460|NCT03033745|7649270|FG001|COMPLETED|Overall Study||17
6719461|NCT03033745|7649271|FG002|COMPLETED|Overall Study||14
6719462|NCT03033745|7649269|FG000|NOT COMPLETED|Overall Study||1
6719463|NCT03033745|7649270|FG001|NOT COMPLETED|Overall Study||1
6719464|NCT03033745|7649271|FG002|NOT COMPLETED|Overall Study||2
6719465|NCT03033784|7649288|FG000|STARTED|Overall Study||9
6719466|NCT03033784|7649289|FG001|STARTED|Overall Study||2
6719467|NCT03033784|7649290|FG002|STARTED|Overall Study||4
6719468|NCT03033784|7649291|FG003|STARTED|Overall Study||4
6719469|NCT03033784|7649292|FG004|STARTED|Overall Study||3
6719470|NCT03033784|7649293|FG005|STARTED|Overall Study||2
6719471|NCT03033784|7649294|FG006|STARTED|Overall Study||2
6719472|NCT03033784|7649295|FG007|STARTED|Overall Study||2
6719473|NCT03033784|7649296|FG008|STARTED|Overall Study||1
6719474|NCT03033784|7649297|FG009|STARTED|Overall Study||1
6719475|NCT03033784|7649298|FG010|STARTED|Overall Study||1
6719476|NCT03033784|7649299|FG011|STARTED|Overall Study||1
6719477|NCT03033784|7649300|FG012|STARTED|Overall Study||19
6719478|NCT03033784|7649288|FG000|Clinical Visit 2|Overall Study||9
6719479|NCT03033784|7649289|FG001|Clinical Visit 2|Overall Study||2
6719480|NCT03033784|7649290|FG002|Clinical Visit 2|Overall Study||4
6719481|NCT03033784|7649291|FG003|Clinical Visit 2|Overall Study||4
6719482|NCT03033784|7649292|FG004|Clinical Visit 2|Overall Study||3
6719483|NCT03033784|7649293|FG005|Clinical Visit 2|Overall Study||2
6719484|NCT03033784|7649294|FG006|Clinical Visit 2|Overall Study||2
6719485|NCT03033784|7649295|FG007|Clinical Visit 2|Overall Study||2
6719486|NCT03033784|7649296|FG008|Clinical Visit 2|Overall Study||1
6719487|NCT03033784|7649297|FG009|Clinical Visit 2|Overall Study||1
6719488|NCT03033784|7649298|FG010|Clinical Visit 2|Overall Study||1
6719489|NCT03033784|7649299|FG011|Clinical Visit 2|Overall Study||1
6719490|NCT03033784|7649300|FG012|Clinical Visit 2|Overall Study||17
6719491|NCT03033784|7649288|FG000|Clinical Visit 3|Overall Study||9
6719492|NCT03033784|7649289|FG001|Clinical Visit 3|Overall Study||1
6719493|NCT03033784|7649290|FG002|Clinical Visit 3|Overall Study||4
6719494|NCT03033784|7649291|FG003|Clinical Visit 3|Overall Study||4
6719495|NCT03033784|7649292|FG004|Clinical Visit 3|Overall Study||3
6719496|NCT03033784|7649293|FG005|Clinical Visit 3|Overall Study||2
6719497|NCT03033784|7649294|FG006|Clinical Visit 3|Overall Study||2
6719498|NCT03033784|7649295|FG007|Clinical Visit 3|Overall Study||2
6719499|NCT03033784|7649296|FG008|Clinical Visit 3|Overall Study||1
6719500|NCT03033784|7649297|FG009|Clinical Visit 3|Overall Study||1
6719501|NCT03033784|7649298|FG010|Clinical Visit 3|Overall Study||1
6719502|NCT03033784|7649299|FG011|Clinical Visit 3|Overall Study||1
6719503|NCT03033784|7649300|FG012|Clinical Visit 3|Overall Study||0
6719504|NCT03033784|7649288|FG000|Clinical Visit 4|Overall Study||9
6263772|NCT00319449|7162648|FG001|NOT COMPLETED|Overall Study||0
6263773|NCT00305344|7162654|FG000|STARTED|Overall Study||23
6263774|NCT00305344|7162654|FG000|COMPLETED|Overall Study||23
6263775|NCT00305344|7162654|FG000|NOT COMPLETED|Overall Study||0
6263776|NCT00289887|7162660|FG000|STARTED|Overall Study||127
6263777|NCT00289887|7162661|FG001|STARTED|Overall Study||134
6263778|NCT00289887|7162660|FG000|COMPLETED|Overall Study||105
6263779|NCT00289887|7162661|FG001|COMPLETED|Overall Study||105
6263780|NCT00289887|7162660|FG000|NOT COMPLETED|Overall Study||22
6263781|NCT00289887|7162661|FG001|NOT COMPLETED|Overall Study||29
6263782|NCT00281320|7162669|FG000|STARTED|Overall Study||61
6263783|NCT00281320|7162670|FG001|STARTED|Overall Study||61
6263784|NCT00281320|7162669|FG000|COMPLETED|Overall Study||36
6263785|NCT00281320|7162670|FG001|COMPLETED|Overall Study||40
6263786|NCT00281320|7162669|FG000|NOT COMPLETED|Overall Study||25
6263787|NCT00281320|7162670|FG001|NOT COMPLETED|Overall Study||21
6263788|NCT00276016|7162688|FG000|STARTED|Intervention 1||7
6263789|NCT00276016|7162689|FG001|STARTED|Intervention 1||7
6263790|NCT00276016|7162690|FG002|STARTED|Intervention 1||7
6263791|NCT00276016|7162691|FG003|STARTED|Intervention 1||6
6263792|NCT00276016|7162692|FG004|STARTED|Intervention 1||6
6263793|NCT00276016|7162693|FG005|STARTED|Intervention 1||6
6263794|NCT00276016|7162688|FG000|COMPLETED|Intervention 1||7
6263795|NCT00276016|7162689|FG001|COMPLETED|Intervention 1||6
6263796|NCT00276016|7162690|FG002|COMPLETED|Intervention 1||7
6263797|NCT00276016|7162691|FG003|COMPLETED|Intervention 1||6
6263798|NCT00276016|7162692|FG004|COMPLETED|Intervention 1||6
6263799|NCT00276016|7162693|FG005|COMPLETED|Intervention 1||6
6263800|NCT00276016|7162688|FG000|NOT COMPLETED|Intervention 1||0
6263801|NCT00276016|7162689|FG001|NOT COMPLETED|Intervention 1||1
6263802|NCT00276016|7162690|FG002|NOT COMPLETED|Intervention 1||0
6263803|NCT00276016|7162691|FG003|NOT COMPLETED|Intervention 1||0
6263804|NCT00276016|7162692|FG004|NOT COMPLETED|Intervention 1||0
6719505|NCT03033784|7649289|FG001|Clinical Visit 4|Overall Study||1
6719506|NCT03033784|7649290|FG002|Clinical Visit 4|Overall Study||4
6719507|NCT03033784|7649291|FG003|Clinical Visit 4|Overall Study||4
6719508|NCT03033784|7649292|FG004|Clinical Visit 4|Overall Study||3
6263805|NCT00276016|7162693|FG005|NOT COMPLETED|Intervention 1||0
6263806|NCT00276016|7162688|FG000|STARTED|Wash Out 1||7
6263807|NCT00276016|7162689|FG001|STARTED|Wash Out 1||6
6263808|NCT00276016|7162690|FG002|STARTED|Wash Out 1||7
6719509|NCT03033784|7649293|FG005|Clinical Visit 4|Overall Study||2
6719510|NCT03033784|7649294|FG006|Clinical Visit 4|Overall Study||2
6719511|NCT03033784|7649295|FG007|Clinical Visit 4|Overall Study||2
6719512|NCT03033784|7649296|FG008|Clinical Visit 4|Overall Study||1
6263809|NCT00276016|7162691|FG003|STARTED|Wash Out 1||6
6263810|NCT00276016|7162692|FG004|STARTED|Wash Out 1||6
6263811|NCT00276016|7162693|FG005|STARTED|Wash Out 1||6
6719513|NCT03033784|7649297|FG009|Clinical Visit 4|Overall Study||1
6719514|NCT03033784|7649298|FG010|Clinical Visit 4|Overall Study||1
6719515|NCT03033784|7649299|FG011|Clinical Visit 4|Overall Study||1
6719516|NCT03033784|7649300|FG012|Clinical Visit 4|Overall Study||0
6719517|NCT03033784|7649288|FG000|COMPLETED|Overall Study||9
6719518|NCT03033784|7649289|FG001|COMPLETED|Overall Study||1
6719519|NCT03033784|7649290|FG002|COMPLETED|Overall Study||4
6719520|NCT03033784|7649291|FG003|COMPLETED|Overall Study||4
6719521|NCT03033784|7649292|FG004|COMPLETED|Overall Study||3
6719522|NCT03033784|7649293|FG005|COMPLETED|Overall Study||2
6719523|NCT03033784|7649294|FG006|COMPLETED|Overall Study||2
6719524|NCT03033784|7649295|FG007|COMPLETED|Overall Study||2
6719525|NCT03033784|7649296|FG008|COMPLETED|Overall Study||1
6719526|NCT03033784|7649297|FG009|COMPLETED|Overall Study||1
6719527|NCT03033784|7649298|FG010|COMPLETED|Overall Study||1
6719528|NCT03033784|7649299|FG011|COMPLETED|Overall Study||1
6719529|NCT03033784|7649300|FG012|COMPLETED|Overall Study||17
6719530|NCT03033784|7649288|FG000|NOT COMPLETED|Overall Study||0
6719531|NCT03033784|7649289|FG001|NOT COMPLETED|Overall Study||1
6719532|NCT03033784|7649290|FG002|NOT COMPLETED|Overall Study||0
6719533|NCT03033784|7649291|FG003|NOT COMPLETED|Overall Study||0
6719534|NCT03033784|7649292|FG004|NOT COMPLETED|Overall Study||0
6719535|NCT03033784|7649293|FG005|NOT COMPLETED|Overall Study||0
6719536|NCT03033784|7649294|FG006|NOT COMPLETED|Overall Study||0
6719537|NCT03033784|7649295|FG007|NOT COMPLETED|Overall Study||0
6719538|NCT03033784|7649296|FG008|NOT COMPLETED|Overall Study||0
6719539|NCT03033784|7649297|FG009|NOT COMPLETED|Overall Study||0
6719540|NCT03033784|7649298|FG010|NOT COMPLETED|Overall Study||0
6719541|NCT03033784|7649299|FG011|NOT COMPLETED|Overall Study||0
6719542|NCT03033784|7649300|FG012|NOT COMPLETED|Overall Study||2
6719543|NCT03034044|7649311|FG000|STARTED|Overall Study||106
6719544|NCT03034044|7649311|FG000|Received Xyntha|Overall Study||105
6719545|NCT03034044|7649311|FG000|COMPLETED|Overall Study||105
6719546|NCT03034044|7649311|FG000|NOT COMPLETED|Overall Study||1
6719547|NCT03034057|7649315|FG000|STARTED|Overall Study||169
6719548|NCT03034057|7649315|FG000|COMPLETED|Overall Study||114
6719549|NCT03034057|7649315|FG000|NOT COMPLETED|Overall Study||55
6719550|NCT03034135|7649319|FG000|STARTED|Overall Study||23
6719551|NCT03034135|7649319|FG000|COMPLETED|Overall Study||21
6719552|NCT03034135|7649319|FG000|NOT COMPLETED|Overall Study||2
6719553|NCT03034460|7649325|FG000|STARTED|Overall Study||48
6719554|NCT03034460|7649326|FG001|STARTED|Overall Study||22
6719555|NCT03034460|7649325|FG000|COMPLETED|Overall Study||45
6719556|NCT03034460|7649326|FG001|COMPLETED|Overall Study||19
6719557|NCT03034460|7649325|FG000|NOT COMPLETED|Overall Study||3
6719558|NCT03034460|7649326|FG001|NOT COMPLETED|Overall Study||3
6739518|NCT03291288|7668398|FG001|NOT COMPLETED|Pexidartinib Only||2
6739519|NCT03291379|7668412|FG000|STARTED|Overall Study||8
6739520|NCT03291379|7668412|FG000|COMPLETED|Overall Study||8
6739521|NCT03291379|7668412|FG000|NOT COMPLETED|Overall Study||0
6739522|NCT03291613|7668417|FG000|STARTED|Overall Study||13
6739523|NCT03291613|7668417|FG000|COMPLETED|Overall Study||12
6739524|NCT03291613|7668417|FG000|NOT COMPLETED|Overall Study||1
6739525|NCT03292016|7668427|FG000|STARTED|First Intervention||1
6739526|NCT03292016|7668428|FG001|STARTED|First Intervention||1
6739527|NCT03292016|7668429|FG002|STARTED|First Intervention||2
6739528|NCT03292016|7668430|FG003|STARTED|First Intervention||1
6739529|NCT03292016|7668431|FG004|STARTED|First Intervention||1
6739530|NCT03292016|7668432|FG005|STARTED|First Intervention||2
6739531|NCT03292016|7668427|FG000|COMPLETED|First Intervention||1
6739532|NCT03292016|7668428|FG001|COMPLETED|First Intervention||1
6263812|NCT00276016|7162688|FG000|COMPLETED|Wash Out 1||7
6263813|NCT00276016|7162689|FG001|COMPLETED|Wash Out 1||6
6263814|NCT00276016|7162690|FG002|COMPLETED|Wash Out 1||7
6263815|NCT00276016|7162691|FG003|COMPLETED|Wash Out 1||6
6263816|NCT00276016|7162692|FG004|COMPLETED|Wash Out 1||6
6263817|NCT00276016|7162693|FG005|COMPLETED|Wash Out 1||6
6263818|NCT00276016|7162688|FG000|NOT COMPLETED|Wash Out 1||0
6263819|NCT00276016|7162689|FG001|NOT COMPLETED|Wash Out 1||0
6263820|NCT00276016|7162690|FG002|NOT COMPLETED|Wash Out 1||0
6263821|NCT00276016|7162691|FG003|NOT COMPLETED|Wash Out 1||0
6263822|NCT00276016|7162692|FG004|NOT COMPLETED|Wash Out 1||0
6263823|NCT00276016|7162693|FG005|NOT COMPLETED|Wash Out 1||0
6263824|NCT00276016|7162688|FG000|STARTED|Intervention 2||7
6263825|NCT00276016|7162689|FG001|STARTED|Intervention 2||6
6263826|NCT00276016|7162690|FG002|STARTED|Intervention 2||7
6263827|NCT00276016|7162691|FG003|STARTED|Intervention 2||6
6263828|NCT00276016|7162692|FG004|STARTED|Intervention 2||6
6263829|NCT00276016|7162693|FG005|STARTED|Intervention 2||6
6263830|NCT00276016|7162688|FG000|COMPLETED|Intervention 2||7
6263831|NCT00276016|7162689|FG001|COMPLETED|Intervention 2||6
6263832|NCT00276016|7162690|FG002|COMPLETED|Intervention 2||7
6263833|NCT00276016|7162691|FG003|COMPLETED|Intervention 2||6
6263834|NCT00276016|7162692|FG004|COMPLETED|Intervention 2||6
6263835|NCT00276016|7162693|FG005|COMPLETED|Intervention 2||6
6263836|NCT00276016|7162688|FG000|NOT COMPLETED|Intervention 2||0
6263837|NCT00276016|7162689|FG001|NOT COMPLETED|Intervention 2||0
6263838|NCT00276016|7162690|FG002|NOT COMPLETED|Intervention 2||0
6263839|NCT00276016|7162691|FG003|NOT COMPLETED|Intervention 2||0
6263840|NCT00276016|7162692|FG004|NOT COMPLETED|Intervention 2||0
6263841|NCT00276016|7162693|FG005|NOT COMPLETED|Intervention 2||0
6739533|NCT03292016|7668429|FG002|COMPLETED|First Intervention||2
6739534|NCT03292016|7668430|FG003|COMPLETED|First Intervention||1
6719559|NCT03034577|7649338|FG000|STARTED|Overall Study||175
6719560|NCT03034577|7649339|FG001|STARTED|Overall Study||175
6719561|NCT03034577|7649338|FG000|COMPLETED|Overall Study||144
6719562|NCT03034577|7649339|FG001|COMPLETED|Overall Study||140
6719563|NCT03034577|7649338|FG000|NOT COMPLETED|Overall Study||31
6719564|NCT03034577|7649339|FG001|NOT COMPLETED|Overall Study||35
6719565|NCT03034772|7649349|FG000|STARTED|Overall Study||27
6719566|NCT03034772|7649350|FG001|STARTED|Overall Study||25
6719567|NCT03034772|7649349|FG000|COMPLETED|Overall Study||27
6719568|NCT03034772|7649350|FG001|COMPLETED|Overall Study||23
6719569|NCT03034772|7649349|FG000|NOT COMPLETED|Overall Study||0
6719570|NCT03034772|7649350|FG001|NOT COMPLETED|Overall Study||2
6719571|NCT03034915|7649359|FG000|STARTED|Overall Study||812
6719572|NCT03034915|7649360|FG001|STARTED|Overall Study||804
6719573|NCT03034915|7649361|FG002|STARTED|Overall Study||809
6719574|NCT03034915|7649359|FG000|COMPLETED|Overall Study||717
6719575|NCT03034915|7649360|FG001|COMPLETED|Overall Study||650
6719576|NCT03034915|7649361|FG002|COMPLETED|Overall Study||683
6719577|NCT03034915|7649359|FG000|NOT COMPLETED|Overall Study||95
6719578|NCT03034915|7649360|FG001|NOT COMPLETED|Overall Study||154
6719579|NCT03034915|7649361|FG002|NOT COMPLETED|Overall Study||126
6719580|NCT03034928|7649369|FG000|STARTED|Period 1, First 2 Hours of Wear||8
6719581|NCT03034928|7649370|FG001|STARTED|Period 1, First 2 Hours of Wear||8
6719582|NCT03034928|7649371|FG002|STARTED|Period 1, First 2 Hours of Wear||9
6719583|NCT03034928|7649372|FG003|STARTED|Period 1, First 2 Hours of Wear||8
6719584|NCT03034928|7649369|FG000|COMPLETED|Period 1, First 2 Hours of Wear||8
6719585|NCT03034928|7649370|FG001|COMPLETED|Period 1, First 2 Hours of Wear||8
6719586|NCT03034928|7649371|FG002|COMPLETED|Period 1, First 2 Hours of Wear||9
6719587|NCT03034928|7649372|FG003|COMPLETED|Period 1, First 2 Hours of Wear||8
6719588|NCT03034928|7649369|FG000|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
6719589|NCT03034928|7649370|FG001|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
6719590|NCT03034928|7649371|FG002|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
6719591|NCT03034928|7649372|FG003|NOT COMPLETED|Period 1, First 2 Hours of Wear||0
6719592|NCT03034928|7649369|FG000|STARTED|Washout Period Between Lens Wear||8
6719593|NCT03034928|7649370|FG001|STARTED|Washout Period Between Lens Wear||8
6719594|NCT03034928|7649371|FG002|STARTED|Washout Period Between Lens Wear||9
6719595|NCT03034928|7649372|FG003|STARTED|Washout Period Between Lens Wear||8
6719596|NCT03034928|7649369|FG000|COMPLETED|Washout Period Between Lens Wear||8
6719597|NCT03034928|7649370|FG001|COMPLETED|Washout Period Between Lens Wear||8
6719598|NCT03034928|7649371|FG002|COMPLETED|Washout Period Between Lens Wear||9
6719599|NCT03034928|7649372|FG003|COMPLETED|Washout Period Between Lens Wear||8
6719600|NCT03034928|7649369|FG000|NOT COMPLETED|Washout Period Between Lens Wear||0
6719601|NCT03034928|7649370|FG001|NOT COMPLETED|Washout Period Between Lens Wear||0
6719602|NCT03034928|7649371|FG002|NOT COMPLETED|Washout Period Between Lens Wear||0
6719603|NCT03034928|7649372|FG003|NOT COMPLETED|Washout Period Between Lens Wear||0
6719604|NCT03034928|7649369|FG000|STARTED|Period 2, Second 2 Hours of Wear||8
6719605|NCT03034928|7649370|FG001|STARTED|Period 2, Second 2 Hours of Wear||8
6719606|NCT03034928|7649371|FG002|STARTED|Period 2, Second 2 Hours of Wear||9
6719607|NCT03034928|7649372|FG003|STARTED|Period 2, Second 2 Hours of Wear||8
6719608|NCT03034928|7649369|FG000|COMPLETED|Period 2, Second 2 Hours of Wear||8
6719609|NCT03034928|7649370|FG001|COMPLETED|Period 2, Second 2 Hours of Wear||8
6719610|NCT03034928|7649371|FG002|COMPLETED|Period 2, Second 2 Hours of Wear||9
6719611|NCT03034928|7649372|FG003|COMPLETED|Period 2, Second 2 Hours of Wear||8
6719612|NCT03034928|7649369|FG000|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
6719613|NCT03034928|7649370|FG001|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
6719614|NCT03034928|7649371|FG002|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
6719615|NCT03034928|7649372|FG003|NOT COMPLETED|Period 2, Second 2 Hours of Wear||0
6719616|NCT03034954|7649383|FG000|STARTED|Overall Study||21
6719617|NCT03034954|7649384|FG001|STARTED|Overall Study||21
6719618|NCT03034954|7649383|FG000|COMPLETED|Overall Study||20
6719619|NCT03034954|7649384|FG001|COMPLETED|Overall Study||21
6719620|NCT03034954|7649383|FG000|NOT COMPLETED|Overall Study||1
6719621|NCT03034954|7649384|FG001|NOT COMPLETED|Overall Study||0
6719622|NCT03034967|7649396|FG000|STARTED|Overall Study||102
6719623|NCT03034967|7649397|FG001|STARTED|Overall Study||102
6719624|NCT03034967|7649398|FG002|STARTED|Overall Study||103
6719625|NCT03034967|7649399|FG003|STARTED|Overall Study||103
6719626|NCT03034967|7649400|FG004|STARTED|Overall Study||102
6719627|NCT03034967|7649401|FG005|STARTED|Overall Study||102
6719628|NCT03034967|7649396|FG000|COMPLETED|Overall Study||88
6719629|NCT03034967|7649397|FG001|COMPLETED|Overall Study||97
6719630|NCT03034967|7649398|FG002|COMPLETED|Overall Study||90
6719631|NCT03034967|7649399|FG003|COMPLETED|Overall Study||92
6719632|NCT03034967|7649400|FG004|COMPLETED|Overall Study||88
6719633|NCT03034967|7649401|FG005|COMPLETED|Overall Study||87
6719634|NCT03034967|7649396|FG000|NOT COMPLETED|Overall Study||14
6719635|NCT03034967|7649397|FG001|NOT COMPLETED|Overall Study||5
6719636|NCT03034967|7649398|FG002|NOT COMPLETED|Overall Study||13
6719637|NCT03034967|7649399|FG003|NOT COMPLETED|Overall Study||11
6719638|NCT03034967|7649400|FG004|NOT COMPLETED|Overall Study||14
6719639|NCT03034967|7649401|FG005|NOT COMPLETED|Overall Study||15
6719640|NCT03035032|7649420|FG000|STARTED|Overall Study||107
6719641|NCT03035032|7649420|FG000|COMPLETED|Overall Study||64
6719642|NCT03035032|7649420|FG000|NOT COMPLETED|Overall Study||43
6719643|NCT03035318|7649429|FG000|STARTED|Overall Study||24
6719644|NCT03035318|7649430|FG001|STARTED|Overall Study||25
6719645|NCT03035318|7649431|FG002|STARTED|Overall Study||25
6719646|NCT03035318|7649432|FG003|STARTED|Overall Study||25
6719647|NCT03035318|7649433|FG004|STARTED|Overall Study||27
6719648|NCT03035318|7649429|FG000|COMPLETED|Overall Study||22
6719649|NCT03035318|7649430|FG001|COMPLETED|Overall Study||21
6719650|NCT03035318|7649431|FG002|COMPLETED|Overall Study||21
6719651|NCT03035318|7649432|FG003|COMPLETED|Overall Study||23
6719652|NCT03035318|7649433|FG004|COMPLETED|Overall Study||20
6719653|NCT03035318|7649429|FG000|NOT COMPLETED|Overall Study||2
6719654|NCT03035318|7649430|FG001|NOT COMPLETED|Overall Study||4
6719655|NCT03035318|7649431|FG002|NOT COMPLETED|Overall Study||4
6719656|NCT03035318|7649432|FG003|NOT COMPLETED|Overall Study||2
6719657|NCT03035318|7649433|FG004|NOT COMPLETED|Overall Study||7
6719658|NCT03035487|7649445|FG000|STARTED|Overall Study||9
6719659|NCT03035487|7649445|FG000|COMPLETED|Overall Study||9
6719660|NCT03035487|7649445|FG000|NOT COMPLETED|Overall Study||0
6719661|NCT03035708|7649451|FG000|STARTED|Overall Study||23
6719662|NCT03035708|7649452|FG001|STARTED|Overall Study||24
6719663|NCT03035708|7649451|FG000|COMPLETED|Overall Study||19
6719664|NCT03035708|7649452|FG001|COMPLETED|Overall Study||13
6719665|NCT03035708|7649451|FG000|NOT COMPLETED|Overall Study||4
6719666|NCT03035708|7649452|FG001|NOT COMPLETED|Overall Study||11
6719667|NCT03035760|7649465|FG000|STARTED|First Intervention - 10/7 Days Follow-up||8
6719668|NCT03035760|7649466|FG001|STARTED|First Intervention - 10/7 Days Follow-up||8
6719669|NCT03035760|7649467|FG002|STARTED|First Intervention - 10/7 Days Follow-up||8
6719670|NCT03035760|7649468|FG003|STARTED|First Intervention - 10/7 Days Follow-up||6
6719671|NCT03035760|7649469|FG004|STARTED|First Intervention - 10/7 Days Follow-up||6
6719672|NCT03035760|7649465|FG000|COMPLETED|First Intervention - 10/7 Days Follow-up||8
6719673|NCT03035760|7649466|FG001|COMPLETED|First Intervention - 10/7 Days Follow-up||8
6719674|NCT03035760|7649467|FG002|COMPLETED|First Intervention - 10/7 Days Follow-up||8
6719675|NCT03035760|7649468|FG003|COMPLETED|First Intervention - 10/7 Days Follow-up||6
6719676|NCT03035760|7649469|FG004|COMPLETED|First Intervention - 10/7 Days Follow-up||6
6719677|NCT03035760|7649465|FG000|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6719678|NCT03035760|7649466|FG001|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6719679|NCT03035760|7649467|FG002|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6719680|NCT03035760|7649468|FG003|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6719681|NCT03035760|7649469|FG004|NOT COMPLETED|First Intervention - 10/7 Days Follow-up||0
6719682|NCT03035760|7649465|FG000|STARTED|Second Intervention - 7 Days Follow-up||0
6719683|NCT03035760|7649466|FG001|STARTED|Second Intervention - 7 Days Follow-up||0
6719684|NCT03035760|7649467|FG002|STARTED|Second Intervention - 7 Days Follow-up||0
6719685|NCT03035760|7649468|FG003|STARTED|Second Intervention - 7 Days Follow-up||6
6719686|NCT03035760|7649469|FG004|STARTED|Second Intervention - 7 Days Follow-up||6
6719687|NCT03035760|7649465|FG000|COMPLETED|Second Intervention - 7 Days Follow-up||0
6719688|NCT03035760|7649466|FG001|COMPLETED|Second Intervention - 7 Days Follow-up||0
6719689|NCT03035760|7649467|FG002|COMPLETED|Second Intervention - 7 Days Follow-up||0
6719690|NCT03035760|7649468|FG003|COMPLETED|Second Intervention - 7 Days Follow-up||6
6719691|NCT03035760|7649469|FG004|COMPLETED|Second Intervention - 7 Days Follow-up||6
6719692|NCT03035760|7649465|FG000|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6719693|NCT03035760|7649466|FG001|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6719694|NCT03035760|7649467|FG002|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6719695|NCT03035760|7649468|FG003|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6719696|NCT03035760|7649469|FG004|NOT COMPLETED|Second Intervention - 7 Days Follow-up||0
6719697|NCT03035864|7649484|FG000|STARTED|Treatment Period||120
6719698|NCT03035864|7649485|FG001|STARTED|Treatment Period||60
6719699|NCT03035864|7649484|FG000|COMPLETED|Treatment Period||116
6719700|NCT03035864|7649485|FG001|COMPLETED|Treatment Period||59
6719701|NCT03035864|7649484|FG000|NOT COMPLETED|Treatment Period||4
6719702|NCT03035864|7649485|FG001|NOT COMPLETED|Treatment Period||1
6719703|NCT03035864|7649484|FG000|STARTED|Follow-up Period||116
6719704|NCT03035864|7649485|FG001|STARTED|Follow-up Period||59
6719705|NCT03035864|7649484|FG000|COMPLETED|Follow-up Period||105
6719706|NCT03035864|7649485|FG001|COMPLETED|Follow-up Period||55
6719707|NCT03035864|7649484|FG000|NOT COMPLETED|Follow-up Period||11
6719708|NCT03035864|7649485|FG001|NOT COMPLETED|Follow-up Period||4
6719709|NCT03035916|7649494|FG000|STARTED|Overall Study||30
6719710|NCT03035916|7649495|FG001|STARTED|Overall Study||30
6719711|NCT03035916|7649496|FG002|STARTED|Overall Study||31
6719712|NCT03035916|7649494|FG000|COMPLETED|Overall Study||30
6719713|NCT03035916|7649495|FG001|COMPLETED|Overall Study||28
6719714|NCT03035916|7649496|FG002|COMPLETED|Overall Study||31
6719715|NCT03035916|7649494|FG000|NOT COMPLETED|Overall Study||0
6719716|NCT03035916|7649495|FG001|NOT COMPLETED|Overall Study||2
6719717|NCT03035916|7649496|FG002|NOT COMPLETED|Overall Study||0
6719718|NCT03035929|7649504|FG000|STARTED|Overall Study||10
6719719|NCT03035929|7649504|FG000|COMPLETED|Overall Study||10
6719720|NCT03035929|7649504|FG000|NOT COMPLETED|Overall Study||0
6719721|NCT03035942|7649512|FG000|STARTED|Overall Study||45
6719722|NCT03035942|7649513|FG001|STARTED|Overall Study||45
6719723|NCT03035942|7649514|FG002|STARTED|Overall Study||45
6719724|NCT03035942|7649512|FG000|COMPLETED|Overall Study||37
6719725|NCT03035942|7649513|FG001|COMPLETED|Overall Study||41
6719726|NCT03035942|7649514|FG002|COMPLETED|Overall Study||40
6719727|NCT03035942|7649512|FG000|NOT COMPLETED|Overall Study||8
6719728|NCT03035942|7649513|FG001|NOT COMPLETED|Overall Study||4
6719729|NCT03035942|7649514|FG002|NOT COMPLETED|Overall Study||5
6719730|NCT03035955|7649526|FG000|STARTED|Overall Study||10
6719731|NCT03035955|7649527|FG001|STARTED|Overall Study||10
6719732|NCT03035955|7649526|FG000|COMPLETED|Overall Study||9
6719733|NCT03035955|7649527|FG001|COMPLETED|Overall Study||9
6719734|NCT03035955|7649526|FG000|NOT COMPLETED|Overall Study||1
6719735|NCT03035955|7649527|FG001|NOT COMPLETED|Overall Study||1
6719736|NCT03036072|7649535|FG000|STARTED|Overall Study||12
6719737|NCT03036072|7649536|FG001|STARTED|Overall Study||13
6719738|NCT03036072|7649535|FG000|COMPLETED|Overall Study||12
6719739|NCT03036072|7649536|FG001|COMPLETED|Overall Study||10
6719740|NCT03036072|7649535|FG000|NOT COMPLETED|Overall Study||0
6719741|NCT03036072|7649536|FG001|NOT COMPLETED|Overall Study||3
6719742|NCT03036124|7649544|FG000|STARTED|Overall Study||2373
6719743|NCT03036124|7649545|FG001|STARTED|Overall Study||2371
6719744|NCT03036124|7649544|FG000|COMPLETED|Overall Study||2368
6719745|NCT03036124|7649545|FG001|COMPLETED|Overall Study||2365
6719746|NCT03036124|7649544|FG000|NOT COMPLETED|Overall Study||5
6719747|NCT03036124|7649545|FG001|NOT COMPLETED|Overall Study||6
6719748|NCT03036150|7649553|FG000|STARTED|Overall Study||2152
6719749|NCT03036150|7649554|FG001|STARTED|Overall Study||2152
6719750|NCT03036150|7649553|FG000|COMPLETED|Overall Study||2142
6719751|NCT03036150|7649554|FG001|COMPLETED|Overall Study||2147
6719752|NCT03036150|7649553|FG000|NOT COMPLETED|Overall Study||10
6719753|NCT03036150|7649554|FG001|NOT COMPLETED|Overall Study||5
6719754|NCT03036163|7649567|FG000|STARTED|Overall Study||6
6719755|NCT03036163|7649568|FG001|STARTED|Overall Study||6
6719756|NCT03036163|7649569|FG002|STARTED|Overall Study||6
6719757|NCT03036163|7649570|FG003|STARTED|Overall Study||6
6719758|NCT03036163|7649571|FG004|STARTED|Overall Study||6
6719759|NCT03036163|7649572|FG005|STARTED|Overall Study||5
6719760|NCT03036163|7649573|FG006|STARTED|Overall Study||5
6719761|NCT03036163|7649567|FG000|COMPLETED|Overall Study||6
6719762|NCT03036163|7649568|FG001|COMPLETED|Overall Study||6
6719763|NCT03036163|7649569|FG002|COMPLETED|Overall Study||6
6719764|NCT03036163|7649570|FG003|COMPLETED|Overall Study||6
6719765|NCT03036163|7649571|FG004|COMPLETED|Overall Study||6
6719766|NCT03036163|7649572|FG005|COMPLETED|Overall Study||5
6719767|NCT03036163|7649573|FG006|COMPLETED|Overall Study||5
6719768|NCT03036163|7649567|FG000|NOT COMPLETED|Overall Study||0
6719769|NCT03036163|7649568|FG001|NOT COMPLETED|Overall Study||0
6719770|NCT03036163|7649569|FG002|NOT COMPLETED|Overall Study||0
6719771|NCT03036163|7649570|FG003|NOT COMPLETED|Overall Study||0
6719772|NCT03036163|7649571|FG004|NOT COMPLETED|Overall Study||0
6719773|NCT03036163|7649572|FG005|NOT COMPLETED|Overall Study||0
6719774|NCT03036163|7649573|FG006|NOT COMPLETED|Overall Study||0
6719775|NCT03036215|7649591|FG000|STARTED|Overall Study||41
6719776|NCT03036215|7649592|FG001|STARTED|Overall Study||39
6719777|NCT03036215|7649591|FG000|COMPLETED|Overall Study||39
6719778|NCT03036215|7649592|FG001|COMPLETED|Overall Study||36
6719779|NCT03036215|7649591|FG000|NOT COMPLETED|Overall Study||2
6719780|NCT03036215|7649592|FG001|NOT COMPLETED|Overall Study||3
6719781|NCT03036293|7649605|FG000|STARTED|Overall Study||127
6719782|NCT03036293|7649606|FG001|STARTED|Overall Study||67
6719783|NCT03036293|7649607|FG002|STARTED|Overall Study||131
6719784|NCT03036293|7649608|FG003|STARTED|Overall Study||65
6719785|NCT03036293|7649605|FG000|COMPLETED|Overall Study||126
6719786|NCT03036293|7649606|FG001|COMPLETED|Overall Study||64
6719787|NCT03036293|7649607|FG002|COMPLETED|Overall Study||130
6719788|NCT03036293|7649608|FG003|COMPLETED|Overall Study||64
6719789|NCT03036293|7649605|FG000|NOT COMPLETED|Overall Study||1
6719790|NCT03036293|7649606|FG001|NOT COMPLETED|Overall Study||3
6719791|NCT03036293|7649607|FG002|NOT COMPLETED|Overall Study||1
6719792|NCT03036293|7649608|FG003|NOT COMPLETED|Overall Study||1
6719793|NCT03036384|7649620|FG000|STARTED|Overall Study||4
6719794|NCT03036384|7649621|FG001|STARTED|Overall Study||4
6719795|NCT03036384|7649622|FG002|STARTED|Overall Study||4
6719796|NCT03036384|7649623|FG003|STARTED|Overall Study||4
6719797|NCT03036384|7649624|FG004|STARTED|Overall Study||4
6719798|NCT03036384|7649625|FG005|STARTED|Overall Study||4
6719799|NCT03036384|7649626|FG006|STARTED|Overall Study||4
6719800|NCT03036384|7649627|FG007|STARTED|Overall Study||4
6719801|NCT03036384|7649628|FG008|STARTED|Overall Study||4
6719802|NCT03036384|7649629|FG009|STARTED|Overall Study||4
6719803|NCT03036384|7649620|FG000|COMPLETED|Overall Study||4
6719804|NCT03036384|7649621|FG001|COMPLETED|Overall Study||4
6719805|NCT03036384|7649622|FG002|COMPLETED|Overall Study||4
6719806|NCT03036384|7649623|FG003|COMPLETED|Overall Study||4
6719807|NCT03036384|7649624|FG004|COMPLETED|Overall Study||4
6719808|NCT03036384|7649625|FG005|COMPLETED|Overall Study||4
6719809|NCT03036384|7649626|FG006|COMPLETED|Overall Study||4
6719810|NCT03036384|7649627|FG007|COMPLETED|Overall Study||4
6719811|NCT03036384|7649628|FG008|COMPLETED|Overall Study||4
6719812|NCT03036384|7649629|FG009|COMPLETED|Overall Study||4
6719813|NCT03036384|7649620|FG000|NOT COMPLETED|Overall Study||0
6719814|NCT03036384|7649621|FG001|NOT COMPLETED|Overall Study||0
6719815|NCT03036384|7649622|FG002|NOT COMPLETED|Overall Study||0
6719816|NCT03036384|7649623|FG003|NOT COMPLETED|Overall Study||0
6719817|NCT03036384|7649624|FG004|NOT COMPLETED|Overall Study||0
6719818|NCT03036384|7649625|FG005|NOT COMPLETED|Overall Study||0
6719819|NCT03036384|7649626|FG006|NOT COMPLETED|Overall Study||0
6719820|NCT03036384|7649627|FG007|NOT COMPLETED|Overall Study||0
6719821|NCT03036384|7649628|FG008|NOT COMPLETED|Overall Study||0
6719822|NCT03036384|7649629|FG009|NOT COMPLETED|Overall Study||0
6719823|NCT03036813|7649650|FG000|STARTED|Overall Study||92
6719824|NCT03036813|7649651|FG001|STARTED|Overall Study||90
6719825|NCT03036813|7649652|FG002|STARTED|Overall Study||92
6719826|NCT03036813|7649650|FG000|COMPLETED|Overall Study||70
6719827|NCT03036813|7649651|FG001|COMPLETED|Overall Study||63
6719828|NCT03036813|7649652|FG002|COMPLETED|Overall Study||66
6719829|NCT03036813|7649650|FG000|NOT COMPLETED|Overall Study||22
6719830|NCT03036813|7649651|FG001|NOT COMPLETED|Overall Study||27
6719831|NCT03036813|7649652|FG002|NOT COMPLETED|Overall Study||26
6719832|NCT03036839|7649666|FG000|STARTED|Overall Study||45
6719833|NCT03036839|7649667|FG001|STARTED|Overall Study||31
6719834|NCT03036839|7649668|FG002|STARTED|Overall Study||19
6719835|NCT03036839|7649666|FG000|COMPLETED|Overall Study||42
6719836|NCT03036839|7649667|FG001|COMPLETED|Overall Study||31
6719837|NCT03036839|7649668|FG002|COMPLETED|Overall Study||14
6719838|NCT03036839|7649666|FG000|NOT COMPLETED|Overall Study||3
6719839|NCT03036839|7649667|FG001|NOT COMPLETED|Overall Study||0
6719840|NCT03036839|7649668|FG002|NOT COMPLETED|Overall Study||5
6719841|NCT03036852|7649682|FG000|STARTED|Overall Study||59
6719842|NCT03036852|7649682|FG000|COMPLETED|Overall Study||53
6719843|NCT03036852|7649682|FG000|NOT COMPLETED|Overall Study||6
6719844|NCT03037203|7649696|FG000|STARTED|Overall Study||28
6719845|NCT03037203|7649697|FG001|STARTED|Overall Study||28
6719846|NCT03037203|7649698|FG002|STARTED|Overall Study||10
6719847|NCT03037203|7649696|FG000|COMPLETED|Overall Study||27
6719848|NCT03037203|7649697|FG001|COMPLETED|Overall Study||26
6719849|NCT03037203|7649698|FG002|COMPLETED|Overall Study||9
6719850|NCT03037203|7649696|FG000|NOT COMPLETED|Overall Study||1
6719851|NCT03037203|7649697|FG001|NOT COMPLETED|Overall Study||2
6719852|NCT03037203|7649698|FG002|NOT COMPLETED|Overall Study||1
6719853|NCT03037281|7649718|FG000|STARTED|Overall Study||6
6719854|NCT03037281|7649719|FG001|STARTED|Overall Study||8
6719855|NCT03037281|7649718|FG000|COMPLETED|Overall Study||6
6719856|NCT03037281|7649719|FG001|COMPLETED|Overall Study||8
6719857|NCT03037281|7649718|FG000|NOT COMPLETED|Overall Study||0
6719858|NCT03037281|7649719|FG001|NOT COMPLETED|Overall Study||0
6719859|NCT03037307|7649730|FG000|STARTED|Period 1||7
6719860|NCT03037307|7649731|FG001|STARTED|Period 1||7
6719861|NCT03037307|7649732|FG002|STARTED|Period 1||8
6719862|NCT03037307|7649733|FG003|STARTED|Period 1||7
6719863|NCT03037307|7649734|FG004|STARTED|Period 1||7
6719864|NCT03037307|7649735|FG005|STARTED|Period 1||8
6719865|NCT03037307|7649730|FG000|COMPLETED|Period 1||7
6719866|NCT03037307|7649731|FG001|COMPLETED|Period 1||7
6719867|NCT03037307|7649732|FG002|COMPLETED|Period 1||8
6719868|NCT03037307|7649733|FG003|COMPLETED|Period 1||6
6719869|NCT03037307|7649734|FG004|COMPLETED|Period 1||7
6719870|NCT03037307|7649735|FG005|COMPLETED|Period 1||8
6719871|NCT03037307|7649730|FG000|NOT COMPLETED|Period 1||0
6719872|NCT03037307|7649731|FG001|NOT COMPLETED|Period 1||0
6719873|NCT03037307|7649732|FG002|NOT COMPLETED|Period 1||0
6719874|NCT03037307|7649733|FG003|NOT COMPLETED|Period 1||1
6719875|NCT03037307|7649734|FG004|NOT COMPLETED|Period 1||0
6719876|NCT03037307|7649735|FG005|NOT COMPLETED|Period 1||0
6719877|NCT03037307|7649730|FG000|STARTED|Wash Out Period 1||7
6719878|NCT03037307|7649731|FG001|STARTED|Wash Out Period 1||7
6719879|NCT03037307|7649732|FG002|STARTED|Wash Out Period 1||8
6719880|NCT03037307|7649733|FG003|STARTED|Wash Out Period 1||6
6719881|NCT03037307|7649734|FG004|STARTED|Wash Out Period 1||7
6719882|NCT03037307|7649735|FG005|STARTED|Wash Out Period 1||8
6719883|NCT03037307|7649730|FG000|COMPLETED|Wash Out Period 1||7
6719884|NCT03037307|7649731|FG001|COMPLETED|Wash Out Period 1||7
6719885|NCT03037307|7649732|FG002|COMPLETED|Wash Out Period 1||8
6719886|NCT03037307|7649733|FG003|COMPLETED|Wash Out Period 1||6
6719887|NCT03037307|7649734|FG004|COMPLETED|Wash Out Period 1||7
6719888|NCT03037307|7649735|FG005|COMPLETED|Wash Out Period 1||8
6719889|NCT03037307|7649730|FG000|NOT COMPLETED|Wash Out Period 1||0
6719890|NCT03037307|7649731|FG001|NOT COMPLETED|Wash Out Period 1||0
6719891|NCT03037307|7649732|FG002|NOT COMPLETED|Wash Out Period 1||0
6719892|NCT03037307|7649733|FG003|NOT COMPLETED|Wash Out Period 1||0
6719893|NCT03037307|7649734|FG004|NOT COMPLETED|Wash Out Period 1||0
6719894|NCT03037307|7649735|FG005|NOT COMPLETED|Wash Out Period 1||0
6719895|NCT03037307|7649730|FG000|STARTED|Period 2||7
6719896|NCT03037307|7649731|FG001|STARTED|Period 2||7
6719897|NCT03037307|7649732|FG002|STARTED|Period 2||8
6719898|NCT03037307|7649733|FG003|STARTED|Period 2||6
6719899|NCT03037307|7649734|FG004|STARTED|Period 2||7
6719900|NCT03037307|7649735|FG005|STARTED|Period 2||8
6719901|NCT03037307|7649730|FG000|COMPLETED|Period 2||7
6719902|NCT03037307|7649731|FG001|COMPLETED|Period 2||7
6719903|NCT03037307|7649732|FG002|COMPLETED|Period 2||8
6719904|NCT03037307|7649733|FG003|COMPLETED|Period 2||6
6719905|NCT03037307|7649734|FG004|COMPLETED|Period 2||7
6719906|NCT03037307|7649735|FG005|COMPLETED|Period 2||8
6719907|NCT03037307|7649730|FG000|NOT COMPLETED|Period 2||0
6719908|NCT03037307|7649731|FG001|NOT COMPLETED|Period 2||0
6719909|NCT03037307|7649732|FG002|NOT COMPLETED|Period 2||0
6719910|NCT03037307|7649733|FG003|NOT COMPLETED|Period 2||0
6719911|NCT03037307|7649734|FG004|NOT COMPLETED|Period 2||0
6719912|NCT03037307|7649735|FG005|NOT COMPLETED|Period 2||0
6719913|NCT03037307|7649730|FG000|STARTED|Wash Out Period 2||7
6719914|NCT03037307|7649731|FG001|STARTED|Wash Out Period 2||7
6719915|NCT03037307|7649732|FG002|STARTED|Wash Out Period 2||8
6719916|NCT03037307|7649733|FG003|STARTED|Wash Out Period 2||6
6719917|NCT03037307|7649734|FG004|STARTED|Wash Out Period 2||7
6719918|NCT03037307|7649735|FG005|STARTED|Wash Out Period 2||8
6719919|NCT03037307|7649730|FG000|COMPLETED|Wash Out Period 2||7
6719920|NCT03037307|7649731|FG001|COMPLETED|Wash Out Period 2||7
6719921|NCT03037307|7649732|FG002|COMPLETED|Wash Out Period 2||8
6719922|NCT03037307|7649733|FG003|COMPLETED|Wash Out Period 2||6
6719923|NCT03037307|7649734|FG004|COMPLETED|Wash Out Period 2||7
6719924|NCT03037307|7649735|FG005|COMPLETED|Wash Out Period 2||8
6719925|NCT03037307|7649730|FG000|NOT COMPLETED|Wash Out Period 2||0
6719926|NCT03037307|7649731|FG001|NOT COMPLETED|Wash Out Period 2||0
6719927|NCT03037307|7649732|FG002|NOT COMPLETED|Wash Out Period 2||0
6263842|NCT00276016|7162688|FG000|STARTED|Wash Out 2||7
6263843|NCT00276016|7162689|FG001|STARTED|Wash Out 2||6
6263844|NCT00276016|7162690|FG002|STARTED|Wash Out 2||7
6263845|NCT00276016|7162691|FG003|STARTED|Wash Out 2||6
6263846|NCT00276016|7162692|FG004|STARTED|Wash Out 2||6
6263847|NCT00276016|7162693|FG005|STARTED|Wash Out 2||6
6263848|NCT00276016|7162688|FG000|COMPLETED|Wash Out 2||7
6263849|NCT00276016|7162689|FG001|COMPLETED|Wash Out 2||6
6263850|NCT00276016|7162690|FG002|COMPLETED|Wash Out 2||7
6263851|NCT00276016|7162691|FG003|COMPLETED|Wash Out 2||6
6263852|NCT00276016|7162692|FG004|COMPLETED|Wash Out 2||6
6263853|NCT00276016|7162693|FG005|COMPLETED|Wash Out 2||6
6263854|NCT00276016|7162688|FG000|NOT COMPLETED|Wash Out 2||0
6263855|NCT00276016|7162689|FG001|NOT COMPLETED|Wash Out 2||0
6263856|NCT00276016|7162690|FG002|NOT COMPLETED|Wash Out 2||0
6263857|NCT00276016|7162691|FG003|NOT COMPLETED|Wash Out 2||0
6263858|NCT00276016|7162692|FG004|NOT COMPLETED|Wash Out 2||0
6263859|NCT00276016|7162693|FG005|NOT COMPLETED|Wash Out 2||0
6263860|NCT00276016|7162688|FG000|STARTED|Intervention 3||7
6263861|NCT00276016|7162689|FG001|STARTED|Intervention 3||6
6263862|NCT00276016|7162690|FG002|STARTED|Intervention 3||7
6263863|NCT00276016|7162691|FG003|STARTED|Intervention 3||6
6263864|NCT00276016|7162692|FG004|STARTED|Intervention 3||6
6263865|NCT00276016|7162693|FG005|STARTED|Intervention 3||6
6263866|NCT00276016|7162688|FG000|COMPLETED|Intervention 3||7
6263867|NCT00276016|7162689|FG001|COMPLETED|Intervention 3||6
6263868|NCT00276016|7162690|FG002|COMPLETED|Intervention 3||7
6263869|NCT00276016|7162691|FG003|COMPLETED|Intervention 3||6
6263870|NCT00276016|7162692|FG004|COMPLETED|Intervention 3||6
6263871|NCT00276016|7162693|FG005|COMPLETED|Intervention 3||6
6263872|NCT00276016|7162688|FG000|NOT COMPLETED|Intervention 3||0
6263873|NCT00276016|7162689|FG001|NOT COMPLETED|Intervention 3||0
6263874|NCT00276016|7162690|FG002|NOT COMPLETED|Intervention 3||0
6263875|NCT00276016|7162691|FG003|NOT COMPLETED|Intervention 3||0
6263876|NCT00276016|7162692|FG004|NOT COMPLETED|Intervention 3||0
6263877|NCT00276016|7162693|FG005|NOT COMPLETED|Intervention 3||0
6280417|NCT00156247|7180352|FG000|NOT COMPLETED|Overall Study||4
6280418|NCT00156390|7180358|FG000|STARTED|Overall Study||110
6280419|NCT00156390|7180359|FG001|STARTED|Overall Study||77
6280420|NCT00156390|7180358|FG000|COMPLETED|Overall Study||96
6280421|NCT00156390|7180359|FG001|COMPLETED|Overall Study||69
6280422|NCT00156390|7180358|FG000|NOT COMPLETED|Overall Study||14
6280423|NCT00156390|7180359|FG001|NOT COMPLETED|Overall Study||8
6280424|NCT00156533|7180370|FG000|STARTED|Overall Study||5
6280425|NCT00156533|7180371|FG001|STARTED|Overall Study||5
6280426|NCT00156533|7180372|FG002|STARTED|Overall Study||5
6280427|NCT00156533|7180373|FG003|STARTED|Overall Study||5
6280428|NCT00156533|7180370|FG000|COMPLETED|Overall Study||3
6280429|NCT00156533|7180371|FG001|COMPLETED|Overall Study||3
6280430|NCT00156533|7180372|FG002|COMPLETED|Overall Study||3
6280431|NCT00156533|7180373|FG003|COMPLETED|Overall Study||3
6280432|NCT00156533|7180370|FG000|NOT COMPLETED|Overall Study||2
6280433|NCT00156533|7180371|FG001|NOT COMPLETED|Overall Study||2
6280434|NCT00156533|7180372|FG002|NOT COMPLETED|Overall Study||2
6280435|NCT00156533|7180373|FG003|NOT COMPLETED|Overall Study||2
6280436|NCT00156715|7180385|FG000|STARTED|Overall Study||23
6280437|NCT00156715|7180385|FG000|COMPLETED|Overall Study||16
6280438|NCT00156715|7180385|FG000|NOT COMPLETED|Overall Study||7
6280439|NCT00156819|7180392|FG000|STARTED|Overall Study||169
6280440|NCT00156819|7180393|FG001|STARTED|Overall Study||166
6280441|NCT00156819|7180394|FG002|STARTED|Overall Study||165
6280442|NCT00156819|7180392|FG000|COMPLETED|Overall Study||168
6280443|NCT00156819|7180393|FG001|COMPLETED|Overall Study||165
6280444|NCT00156819|7180394|FG002|COMPLETED|Overall Study||162
6280445|NCT00156819|7180392|FG000|NOT COMPLETED|Overall Study||1
6280446|NCT00156819|7180393|FG001|NOT COMPLETED|Overall Study||1
6280447|NCT00156819|7180394|FG002|NOT COMPLETED|Overall Study||3
6280448|NCT00156910|7180404|FG000|STARTED|Double-Blind Phase (DB)||341
6280449|NCT00156910|7180405|FG001|STARTED|Double-Blind Phase (DB)||338
6280450|NCT00156910|7180404|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
6280451|NCT00156910|7180405|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
6280452|NCT00156910|7180404|FG000|NOT COMPLETED|Double-Blind Phase (DB)||45
6280453|NCT00156910|7180405|FG001|NOT COMPLETED|Double-Blind Phase (DB)||43
6280454|NCT00156910|7180404|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
6280455|NCT00156910|7180405|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
6280456|NCT00156910|7180404|FG000|COMPLETED|Open-Label Phase (OL)||252
6280457|NCT00156910|7180405|FG001|COMPLETED|Open-Label Phase (OL)||231
6280458|NCT00156910|7180404|FG000|NOT COMPLETED|Open-Label Phase (OL)||33
6280459|NCT00156910|7180405|FG001|NOT COMPLETED|Open-Label Phase (OL)||55
6280460|NCT00156923|7180413|FG000|STARTED|Overall Study||56
6280461|NCT00156923|7180414|FG001|STARTED|Overall Study||52
6280462|NCT00156923|7180413|FG000|COMPLETED|Overall Study||22
6719928|NCT03037307|7649733|FG003|NOT COMPLETED|Wash Out Period 2||0
6719929|NCT03037307|7649734|FG004|NOT COMPLETED|Wash Out Period 2||0
6719930|NCT03037307|7649735|FG005|NOT COMPLETED|Wash Out Period 2||0
6719931|NCT03037307|7649730|FG000|STARTED|Period 3||7
6719932|NCT03037307|7649731|FG001|STARTED|Period 3||7
6719933|NCT03037307|7649732|FG002|STARTED|Period 3||8
6719934|NCT03037307|7649733|FG003|STARTED|Period 3||6
6719935|NCT03037307|7649734|FG004|STARTED|Period 3||7
6719936|NCT03037307|7649735|FG005|STARTED|Period 3||8
6719937|NCT03037307|7649730|FG000|COMPLETED|Period 3||7
6719938|NCT03037307|7649731|FG001|COMPLETED|Period 3||7
6719939|NCT03037307|7649732|FG002|COMPLETED|Period 3||8
6719940|NCT03037307|7649733|FG003|COMPLETED|Period 3||6
6719941|NCT03037307|7649734|FG004|COMPLETED|Period 3||7
6719942|NCT03037307|7649735|FG005|COMPLETED|Period 3||8
6719943|NCT03037307|7649730|FG000|NOT COMPLETED|Period 3||0
6719944|NCT03037307|7649731|FG001|NOT COMPLETED|Period 3||0
6719945|NCT03037307|7649732|FG002|NOT COMPLETED|Period 3||0
6719946|NCT03037307|7649733|FG003|NOT COMPLETED|Period 3||0
6719947|NCT03037307|7649734|FG004|NOT COMPLETED|Period 3||0
6719948|NCT03037307|7649735|FG005|NOT COMPLETED|Period 3||0
6719949|NCT03037489|7649746|FG000|STARTED|Overall Study||46
6719950|NCT03037489|7649747|FG001|STARTED|Overall Study||4
6719951|NCT03037489|7649746|FG000|COMPLETED|Overall Study||39
6719952|NCT03037489|7649747|FG001|COMPLETED|Overall Study||4
6719953|NCT03037489|7649746|FG000|NOT COMPLETED|Overall Study||7
6719954|NCT03037489|7649747|FG001|NOT COMPLETED|Overall Study||0
6719955|NCT03037541|7649755|FG000|STARTED|Overall Study||30
6719956|NCT03037541|7649756|FG001|STARTED|Overall Study||30
6719957|NCT03037541|7649755|FG000|COMPLETED|Overall Study||30
6719958|NCT03037541|7649756|FG001|COMPLETED|Overall Study||30
6719959|NCT03037541|7649755|FG000|NOT COMPLETED|Overall Study||0
6719960|NCT03037541|7649756|FG001|NOT COMPLETED|Overall Study||0
6719961|NCT03037580|7649764|FG000|STARTED|Overall Study||41
6719962|NCT03037580|7649765|FG001|STARTED|Overall Study||43
6719963|NCT03037580|7649764|FG000|COMPLETED|Overall Study||25
6719964|NCT03037580|7649765|FG001|COMPLETED|Overall Study||27
6719965|NCT03037580|7649764|FG000|NOT COMPLETED|Overall Study||16
6719966|NCT03037580|7649765|FG001|NOT COMPLETED|Overall Study||16
6719967|NCT03037619|7649773|FG000|STARTED|Overall Study||8
6719968|NCT03037619|7649774|FG001|STARTED|Overall Study|8 participants and 7 buddies|15
6719969|NCT03037619|7649773|FG000|COMPLETED|Overall Study||8
6719970|NCT03037619|7649774|FG001|COMPLETED|Overall Study|7 participants and 7 buddies|14
6719971|NCT03037619|7649773|FG000|NOT COMPLETED|Overall Study||0
6719972|NCT03037619|7649774|FG001|NOT COMPLETED|Overall Study||1
6719973|NCT03037905|7649782|FG000|STARTED|Overall Study||50
6719974|NCT03037905|7649783|FG001|STARTED|Overall Study||50
6719975|NCT03037905|7649782|FG000|COMPLETED|Overall Study||50
6719976|NCT03037905|7649783|FG001|COMPLETED|Overall Study||50
6719977|NCT03037905|7649782|FG000|NOT COMPLETED|Overall Study||0
6719978|NCT03037905|7649783|FG001|NOT COMPLETED|Overall Study||0
6719979|NCT03037983|7649793|FG000|STARTED|Overall Study||5
6719980|NCT03037983|7649794|FG001|STARTED|Overall Study||4
6719981|NCT03037983|7649793|FG000|COMPLETED|Overall Study||5
6719982|NCT03037983|7649794|FG001|COMPLETED|Overall Study||4
6719983|NCT03037983|7649793|FG000|NOT COMPLETED|Overall Study||0
6719984|NCT03037983|7649794|FG001|NOT COMPLETED|Overall Study||0
6719985|NCT03038113|7649814|FG000|STARTED|Overall Study||8
6719986|NCT03038113|7649815|FG001|STARTED|Overall Study||8
6719987|NCT03038113|7649816|FG002|STARTED|Overall Study||8
6719988|NCT03038113|7649817|FG003|STARTED|Overall Study||8
6719989|NCT03038113|7649818|FG004|STARTED|Overall Study||8
6719990|NCT03038113|7649819|FG005|STARTED|Overall Study||8
6719991|NCT03038113|7649820|FG006|STARTED|Overall Study||12
6719992|NCT03038113|7649821|FG007|STARTED|Overall Study||6
6719993|NCT03038113|7649822|FG008|STARTED|Overall Study||7
6719994|NCT03038113|7649823|FG009|STARTED|Overall Study||6
6719995|NCT03038113|7649824|FG010|STARTED|Overall Study||14
6719996|NCT03038113|7649825|FG011|STARTED|Overall Study||7
6719997|NCT03038113|7649826|FG012|STARTED|Overall Study||4
6719998|NCT03038113|7649827|FG013|STARTED|Overall Study||15
6719999|NCT03038113|7649814|FG000|COMPLETED|Overall Study||8
6720000|NCT03038113|7649815|FG001|COMPLETED|Overall Study||8
6720001|NCT03038113|7649816|FG002|COMPLETED|Overall Study||7
6720002|NCT03038113|7649817|FG003|COMPLETED|Overall Study||8
6720003|NCT03038113|7649818|FG004|COMPLETED|Overall Study||8
6720004|NCT03038113|7649819|FG005|COMPLETED|Overall Study||8
6720005|NCT03038113|7649820|FG006|COMPLETED|Overall Study||11
6720006|NCT03038113|7649821|FG007|COMPLETED|Overall Study||6
6720007|NCT03038113|7649822|FG008|COMPLETED|Overall Study||7
6720008|NCT03038113|7649823|FG009|COMPLETED|Overall Study||6
6720009|NCT03038113|7649824|FG010|COMPLETED|Overall Study||14
6720010|NCT03038113|7649825|FG011|COMPLETED|Overall Study||7
6720011|NCT03038113|7649826|FG012|COMPLETED|Overall Study||4
6720012|NCT03038113|7649827|FG013|COMPLETED|Overall Study||14
6720013|NCT03038113|7649814|FG000|NOT COMPLETED|Overall Study||0
6720014|NCT03038113|7649815|FG001|NOT COMPLETED|Overall Study||0
6720015|NCT03038113|7649816|FG002|NOT COMPLETED|Overall Study||1
6720016|NCT03038113|7649817|FG003|NOT COMPLETED|Overall Study||0
6720017|NCT03038113|7649818|FG004|NOT COMPLETED|Overall Study||0
6720018|NCT03038113|7649819|FG005|NOT COMPLETED|Overall Study||0
6720019|NCT03038113|7649820|FG006|NOT COMPLETED|Overall Study||1
6720020|NCT03038113|7649821|FG007|NOT COMPLETED|Overall Study||0
6720021|NCT03038113|7649822|FG008|NOT COMPLETED|Overall Study||0
6720022|NCT03038113|7649823|FG009|NOT COMPLETED|Overall Study||0
6720023|NCT03038113|7649824|FG010|NOT COMPLETED|Overall Study||0
6720024|NCT03038113|7649825|FG011|NOT COMPLETED|Overall Study||0
6720025|NCT03038113|7649826|FG012|NOT COMPLETED|Overall Study||0
6720026|NCT03038113|7649827|FG013|NOT COMPLETED|Overall Study||1
6720027|NCT03038126|7649876|FG000|STARTED|Overall Study||63
6720028|NCT03038126|7649877|FG001|STARTED|Overall Study||55
6720029|NCT03038126|7649876|FG000|COMPLETED|Overall Study||54
6720030|NCT03038126|7649877|FG001|COMPLETED|Overall Study||51
6720031|NCT03038126|7649876|FG000|NOT COMPLETED|Overall Study||9
6720032|NCT03038126|7649877|FG001|NOT COMPLETED|Overall Study||4
6720033|NCT03038308|7649883|FG000|STARTED|Overall Study||15
6720034|NCT03038308|7649883|FG000|COMPLETED|Overall Study||11
6720035|NCT03038308|7649883|FG000|NOT COMPLETED|Overall Study||4
6720036|NCT03038399|7649891|FG000|STARTED|Overall Study||11
6720037|NCT03038399|7649892|FG001|STARTED|Overall Study||12
6720038|NCT03038399|7649893|FG002|STARTED|Overall Study||12
6720039|NCT03038399|7649894|FG003|STARTED|Overall Study||11
6720040|NCT03038399|7649891|FG000|COMPLETED|Overall Study||10
6720041|NCT03038399|7649892|FG001|COMPLETED|Overall Study||11
6720042|NCT03038399|7649893|FG002|COMPLETED|Overall Study||11
6720043|NCT03038399|7649894|FG003|COMPLETED|Overall Study|Subjects escalated from lower dose groups|9
6720044|NCT03038399|7649891|FG000|NOT COMPLETED|Overall Study||1
6720045|NCT03038399|7649892|FG001|NOT COMPLETED|Overall Study||1
6720046|NCT03038399|7649893|FG002|NOT COMPLETED|Overall Study||1
6720047|NCT03038399|7649894|FG003|NOT COMPLETED|Overall Study||2
6720048|NCT03038620|7649908|FG000|STARTED|Overall Study||92
6720049|NCT03038620|7649909|FG001|STARTED|Overall Study||93
6720050|NCT03038620|7649908|FG000|COMPLETED|Overall Study||73
6720051|NCT03038620|7649909|FG001|COMPLETED|Overall Study||55
6720052|NCT03038620|7649908|FG000|NOT COMPLETED|Overall Study||19
6720053|NCT03038620|7649909|FG001|NOT COMPLETED|Overall Study||38
6720054|NCT03038815|7649917|FG000|STARTED|Controll Condition, 1 Hour||10
6720055|NCT03038815|7649918|FG001|STARTED|Controll Condition, 1 Hour||10
6720056|NCT03038815|7649917|FG000|COMPLETED|Controll Condition, 1 Hour||10
6720057|NCT03038815|7649918|FG001|COMPLETED|Controll Condition, 1 Hour||10
6720058|NCT03038815|7649917|FG000|NOT COMPLETED|Controll Condition, 1 Hour||0
6720059|NCT03038815|7649918|FG001|NOT COMPLETED|Controll Condition, 1 Hour||0
6720060|NCT03038815|7649917|FG000|STARTED|Intervention 1, 1 Hour||10
6720061|NCT03038815|7649918|FG001|STARTED|Intervention 1, 1 Hour||10
6720062|NCT03038815|7649917|FG000|COMPLETED|Intervention 1, 1 Hour||10
6720063|NCT03038815|7649918|FG001|COMPLETED|Intervention 1, 1 Hour||10
6720064|NCT03038815|7649917|FG000|NOT COMPLETED|Intervention 1, 1 Hour||0
6720065|NCT03038815|7649918|FG001|NOT COMPLETED|Intervention 1, 1 Hour||0
6720066|NCT03038815|7649917|FG000|STARTED|Intervention 2, 1 Hour||10
6720067|NCT03038815|7649918|FG001|STARTED|Intervention 2, 1 Hour||10
6720068|NCT03038815|7649917|FG000|COMPLETED|Intervention 2, 1 Hour||10
6720069|NCT03038815|7649918|FG001|COMPLETED|Intervention 2, 1 Hour||10
6720070|NCT03038815|7649917|FG000|NOT COMPLETED|Intervention 2, 1 Hour||0
6720071|NCT03038815|7649918|FG001|NOT COMPLETED|Intervention 2, 1 Hour||0
6720072|NCT03038867|7649927|FG000|STARTED|Overall Study||37
6720073|NCT03038867|7649928|FG001|STARTED|Overall Study||32
6720074|NCT03038867|7649927|FG000|COMPLETED|Overall Study||37
6720075|NCT03038867|7649928|FG001|COMPLETED|Overall Study||32
6720076|NCT03038867|7649927|FG000|NOT COMPLETED|Overall Study||0
6720077|NCT03038867|7649928|FG001|NOT COMPLETED|Overall Study||0
6720078|NCT03038880|7649937|FG000|STARTED|Overall Study||24
6720079|NCT03038880|7649938|FG001|STARTED|Overall Study||31
6720080|NCT03038880|7649939|FG002|STARTED|Overall Study||16
6720081|NCT03038880|7649937|FG000|COMPLETED|Overall Study||21
6720082|NCT03038880|7649938|FG001|COMPLETED|Overall Study||28
6720083|NCT03038880|7649939|FG002|COMPLETED|Overall Study||16
6720084|NCT03038880|7649937|FG000|NOT COMPLETED|Overall Study||3
6720085|NCT03038880|7649938|FG001|NOT COMPLETED|Overall Study||3
6720086|NCT03038880|7649939|FG002|NOT COMPLETED|Overall Study||0
6263878|NCT00265343|7162704|FG000|STARTED|Overall Study||134
6263879|NCT00265343|7162705|FG001|STARTED|Overall Study||172
6263880|NCT00265343|7162704|FG000|COMPLETED|Overall Study||113
6263881|NCT00265343|7162705|FG001|COMPLETED|Overall Study||153
6263882|NCT00265343|7162704|FG000|NOT COMPLETED|Overall Study||21
6263883|NCT00265343|7162705|FG001|NOT COMPLETED|Overall Study||19
6263884|NCT00264147|7162716|FG000|STARTED|Treatment I Period||161
6263885|NCT00264147|7162717|FG001|STARTED|Treatment I Period||154
6263886|NCT00264147|7162718|FG002|STARTED|Treatment I Period||151
6263887|NCT00264147|7162719|FG003|STARTED|Treatment I Period||140
6263888|NCT00264147|7162720|FG004|STARTED|Treatment I Period||155
6263889|NCT00264147|7162721|FG005|STARTED|Treatment I Period||0
6263890|NCT00264147|7162716|FG000|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
6263891|NCT00264147|7162717|FG001|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
6263892|NCT00264147|7162718|FG002|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
6280463|NCT00156923|7180414|FG001|COMPLETED|Overall Study||20
6720087|NCT03039023|7649952|FG000|STARTED|Overall Study||19
6720088|NCT03039023|7649953|FG001|STARTED|Overall Study||20
6720089|NCT03039023|7649954|FG002|STARTED|Overall Study||17
6720090|NCT03039023|7649955|FG003|STARTED|Overall Study||20
6720091|NCT03039023|7649956|FG004|STARTED|Overall Study||10
6720092|NCT03039023|7649952|FG000|COMPLETED|Overall Study||18
6720093|NCT03039023|7649953|FG001|COMPLETED|Overall Study||20
6720094|NCT03039023|7649954|FG002|COMPLETED|Overall Study||16
6720095|NCT03039023|7649955|FG003|COMPLETED|Overall Study||18
6720096|NCT03039023|7649956|FG004|COMPLETED|Overall Study||10
6720097|NCT03039023|7649952|FG000|NOT COMPLETED|Overall Study||1
6720098|NCT03039023|7649953|FG001|NOT COMPLETED|Overall Study||0
6720099|NCT03039023|7649954|FG002|NOT COMPLETED|Overall Study||1
6720100|NCT03039023|7649955|FG003|NOT COMPLETED|Overall Study||2
6720101|NCT03039023|7649956|FG004|NOT COMPLETED|Overall Study||0
6720102|NCT03039088|7649970|FG000|STARTED|Overall Study||192
6720103|NCT03039088|7649971|FG001|STARTED|Overall Study||316
6720104|NCT03039088|7649970|FG000|COMPLETED|Overall Study||192
6720105|NCT03039088|7649971|FG001|COMPLETED|Overall Study||316
6720106|NCT03039088|7649970|FG000|NOT COMPLETED|Overall Study||0
6720107|NCT03039088|7649971|FG001|NOT COMPLETED|Overall Study||0
6720108|NCT03039179|7649979|FG000|STARTED|Overall Study||38
6720109|NCT03039179|7649980|FG001|STARTED|Overall Study||42
6720110|NCT03039179|7649979|FG000|COMPLETED|Overall Study||38
6720111|NCT03039179|7649980|FG001|COMPLETED|Overall Study||42
6720112|NCT03039179|7649979|FG000|NOT COMPLETED|Overall Study||0
6720113|NCT03039179|7649980|FG001|NOT COMPLETED|Overall Study||0
6720114|NCT03039192|7649988|FG000|STARTED|Overall Study||112
6720115|NCT03039192|7649989|FG001|STARTED|Overall Study||114
6720116|NCT03039192|7649988|FG000|Treated|Overall Study||112
6720117|NCT03039192|7649989|FG001|Treated|Overall Study||113
6720118|NCT03039192|7649988|FG000|COMPLETED|Overall Study||80
6720119|NCT03039192|7649989|FG001|COMPLETED|Overall Study||84
6720120|NCT03039192|7649988|FG000|NOT COMPLETED|Overall Study||32
6720121|NCT03039192|7649989|FG001|NOT COMPLETED|Overall Study||30
6720122|NCT03039283|7649995|FG000|STARTED|Overall Study||162
6720123|NCT03039283|7649995|FG000|COMPLETED|Overall Study||160
6720124|NCT03039283|7649995|FG000|NOT COMPLETED|Overall Study||2
6720125|NCT03039543|7650001|FG000|STARTED|Overall Study||54
6720126|NCT03039543|7650002|FG001|STARTED|Overall Study||54
6720127|NCT03039543|7650001|FG000|COMPLETED|Overall Study||53
6720128|NCT03039543|7650002|FG001|COMPLETED|Overall Study||51
6720129|NCT03039543|7650001|FG000|NOT COMPLETED|Overall Study||1
6720130|NCT03039543|7650002|FG001|NOT COMPLETED|Overall Study||3
6720131|NCT03039569|7650010|FG000|STARTED|Overall Study||40
6720132|NCT03039569|7650011|FG001|STARTED|Overall Study||39
6720133|NCT03039569|7650010|FG000|COMPLETED|Overall Study||35
6720134|NCT03039569|7650011|FG001|COMPLETED|Overall Study||35
6720135|NCT03039569|7650010|FG000|NOT COMPLETED|Overall Study||5
6720136|NCT03039569|7650011|FG001|NOT COMPLETED|Overall Study||4
6720137|NCT03039621|7650020|FG000|STARTED|Overall Study||143
6720138|NCT03039621|7650021|FG001|STARTED|Overall Study||144
6720139|NCT03039621|7650020|FG000|COMPLETED|Overall Study||131
6720140|NCT03039621|7650021|FG001|COMPLETED|Overall Study||128
6720141|NCT03039621|7650020|FG000|NOT COMPLETED|Overall Study||12
6720142|NCT03039621|7650021|FG001|NOT COMPLETED|Overall Study||16
6720143|NCT03039686|7650030|FG000|STARTED|Double-blind Period||56
6720144|NCT03039686|7650031|FG001|STARTED|Double-blind Period||55
6720145|NCT03039686|7650032|FG002|STARTED|Double-blind Period||55
6720146|NCT03039686|7650030|FG000|COMPLETED|Double-blind Period||29
6720147|NCT03039686|7650031|FG001|COMPLETED|Double-blind Period||26
6720148|NCT03039686|7650032|FG002|COMPLETED|Double-blind Period||32
6720149|NCT03039686|7650030|FG000|NOT COMPLETED|Double-blind Period||27
6720150|NCT03039686|7650031|FG001|NOT COMPLETED|Double-blind Period||29
6720151|NCT03039686|7650032|FG002|NOT COMPLETED|Double-blind Period||23
6720152|NCT03039686|7650030|FG000|STARTED|Open Label Period|Double-blind (DB) placebo participants switched to RO7239361 (RO) for the open label phase.|0
6720153|NCT03039686|7650031|FG001|STARTED|Open Label Period|14 DB placebo participants switched to the RO Low Dose for the open-label phase.|38
6720154|NCT03039686|7650032|FG002|STARTED|Open Label Period|13 DB placebo participants switched to the RO High Dose for the open-label phase.|42
6720155|NCT03039686|7650030|FG000|Completed DB, Did Not Start OL|Open Label Period||2
6720156|NCT03039686|7650031|FG001|Completed DB, Did Not Start OL|Open Label Period||2
6720157|NCT03039686|7650032|FG002|Completed DB, Did Not Start OL|Open Label Period||3
6720158|NCT03039686|7650030|FG000|COMPLETED|Open Label Period||0
6720159|NCT03039686|7650031|FG001|COMPLETED|Open Label Period||0
6720160|NCT03039686|7650032|FG002|COMPLETED|Open Label Period||0
6720161|NCT03039686|7650030|FG000|NOT COMPLETED|Open Label Period||0
6720162|NCT03039686|7650031|FG001|NOT COMPLETED|Open Label Period||38
6720163|NCT03039686|7650032|FG002|NOT COMPLETED|Open Label Period||42
6720164|NCT03039699|7650052|FG000|STARTED|Overall Study||127
6720165|NCT03039699|7650053|FG001|STARTED|Overall Study||132
6720166|NCT03039699|7650052|FG000|COMPLETED|Overall Study||105
6720167|NCT03039699|7650053|FG001|COMPLETED|Overall Study||97
6720168|NCT03039699|7650052|FG000|NOT COMPLETED|Overall Study||22
6720169|NCT03039699|7650053|FG001|NOT COMPLETED|Overall Study||35
6720170|NCT03039738|7650061|FG000|STARTED|Overall Study||206
6720171|NCT03039738|7650062|FG001|STARTED|Overall Study|This arm did not initiate. The study was terminated following the completion of the telemetry phase.|0
6720172|NCT03039738|7650061|FG000|COMPLETED|Overall Study||152
6720173|NCT03039738|7650062|FG001|COMPLETED|Overall Study||0
6720174|NCT03039738|7650061|FG000|NOT COMPLETED|Overall Study||54
6720175|NCT03039738|7650062|FG001|NOT COMPLETED|Overall Study||0
6720176|NCT03040011|7650071|FG000|STARTED|Received Randomized Study Intervention||25
6720177|NCT03040011|7650072|FG001|STARTED|Received Randomized Study Intervention||25
6720178|NCT03040011|7650073|FG002|STARTED|Received Randomized Study Intervention||25
6720179|NCT03040011|7650071|FG000|COMPLETED|Received Randomized Study Intervention||25
6720180|NCT03040011|7650072|FG001|COMPLETED|Received Randomized Study Intervention||25
6720181|NCT03040011|7650073|FG002|COMPLETED|Received Randomized Study Intervention||25
6720182|NCT03040011|7650071|FG000|NOT COMPLETED|Received Randomized Study Intervention||0
6720183|NCT03040011|7650072|FG001|NOT COMPLETED|Received Randomized Study Intervention||0
6720184|NCT03040011|7650073|FG002|NOT COMPLETED|Received Randomized Study Intervention||0
6720185|NCT03040011|7650071|FG000|STARTED|Primary Outcome Follow Up||25
6720186|NCT03040011|7650072|FG001|STARTED|Primary Outcome Follow Up||25
6720187|NCT03040011|7650073|FG002|STARTED|Primary Outcome Follow Up||25
6720188|NCT03040011|7650071|FG000|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for four patients|21
6720189|NCT03040011|7650072|FG001|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
6720190|NCT03040011|7650073|FG002|COMPLETED|Primary Outcome Follow Up|Postoperative day one pain score not available for one patient|24
6720191|NCT03040011|7650071|FG000|NOT COMPLETED|Primary Outcome Follow Up||4
6720192|NCT03040011|7650072|FG001|NOT COMPLETED|Primary Outcome Follow Up||1
6720193|NCT03040011|7650073|FG002|NOT COMPLETED|Primary Outcome Follow Up||1
6720194|NCT03040024|7650084|FG000|STARTED|Overall Study||21
6720195|NCT03040024|7650085|FG001|STARTED|Overall Study||26
6720196|NCT03040024|7650086|FG002|STARTED|Overall Study||24
6720197|NCT03040024|7650084|FG000|COMPLETED|Overall Study||21
6720198|NCT03040024|7650085|FG001|COMPLETED|Overall Study||24
6720199|NCT03040024|7650086|FG002|COMPLETED|Overall Study||23
6720200|NCT03040024|7650084|FG000|NOT COMPLETED|Overall Study||0
6720201|NCT03040024|7650085|FG001|NOT COMPLETED|Overall Study||2
6720202|NCT03040024|7650086|FG002|NOT COMPLETED|Overall Study||1
6720203|NCT03040154|7650096|FG000|STARTED|Overall Study||110
6720204|NCT03040154|7650097|FG001|STARTED|Overall Study||105
6720205|NCT03040154|7650096|FG000|COMPLETED|Overall Study||110
6720206|NCT03040154|7650097|FG001|COMPLETED|Overall Study||105
6720207|NCT03040154|7650096|FG000|NOT COMPLETED|Overall Study||0
6720208|NCT03040154|7650097|FG001|NOT COMPLETED|Overall Study||0
6720209|NCT03040336|7650105|FG000|STARTED|Overall Study||10
6720210|NCT03040336|7650106|FG001|STARTED|Overall Study||7
6720211|NCT03040336|7650105|FG000|COMPLETED|Overall Study||7
6720212|NCT03040336|7650106|FG001|COMPLETED|Overall Study||4
6720213|NCT03040336|7650105|FG000|NOT COMPLETED|Overall Study||3
6720214|NCT03040336|7650106|FG001|NOT COMPLETED|Overall Study||3
6720215|NCT03040362|7650113|FG000|STARTED|Overall Study||8
6720216|NCT03040362|7650113|FG000|Received at Least 1dose of Study Drug|Overall Study||8
6720217|NCT03040362|7650113|FG000|COMPLETED|Overall Study||8
6720218|NCT03040362|7650113|FG000|NOT COMPLETED|Overall Study||0
6720219|NCT03040414|7650119|FG000|STARTED|Overall Study||57
6720220|NCT03040414|7650120|FG001|STARTED|Overall Study||56
6720221|NCT03040414|7650119|FG000|Completed Period 1|Overall Study||56
6720222|NCT03040414|7650120|FG001|Completed Period 1|Overall Study||55
6720223|NCT03040414|7650119|FG000|Started Period 2|Overall Study||56
6720224|NCT03040414|7650120|FG001|Started Period 2|Overall Study||55
6720225|NCT03040414|7650119|FG000|COMPLETED|Overall Study||56
6720226|NCT03040414|7650120|FG001|COMPLETED|Overall Study||55
6720227|NCT03040414|7650119|FG000|NOT COMPLETED|Overall Study||1
6720228|NCT03040414|7650120|FG001|NOT COMPLETED|Overall Study||1
6720229|NCT03040427|7650129|FG000|STARTED|Overall Study||2
6720230|NCT03040427|7650130|FG001|STARTED|Overall Study||6
6720231|NCT03040427|7650131|FG002|STARTED|Overall Study||4
6720232|NCT03040427|7650129|FG000|COMPLETED|Overall Study||2
6720233|NCT03040427|7650130|FG001|COMPLETED|Overall Study||6
6720234|NCT03040427|7650131|FG002|COMPLETED|Overall Study||4
6720235|NCT03040427|7650129|FG000|NOT COMPLETED|Overall Study||0
6720236|NCT03040427|7650130|FG001|NOT COMPLETED|Overall Study||0
6720237|NCT03040427|7650131|FG002|NOT COMPLETED|Overall Study||0
6720238|NCT03040466|7650141|FG000|STARTED|Overall Study||65
6720239|NCT03040466|7650142|FG001|STARTED|Overall Study||115
6720240|NCT03040466|7650141|FG000|COMPLETED|Overall Study||65
6720241|NCT03040466|7650142|FG001|COMPLETED|Overall Study||115
6720242|NCT03040466|7650141|FG000|NOT COMPLETED|Overall Study||0
6720243|NCT03040466|7650142|FG001|NOT COMPLETED|Overall Study||0
6720244|NCT03040479|7650151|FG000|STARTED|Overall Study||8
6720245|NCT03040479|7650152|FG001|STARTED|Overall Study||8
6720246|NCT03040479|7650153|FG002|STARTED|Overall Study||8
6720247|NCT03040479|7650151|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6720248|NCT03040479|7650152|FG001|Received at Least 1 Dose of Study Drug|Overall Study||8
6720249|NCT03040479|7650153|FG002|Received at Least 1 Dose of Study Drug|Overall Study||8
6720250|NCT03040479|7650151|FG000|COMPLETED|Overall Study||8
6720251|NCT03040479|7650152|FG001|COMPLETED|Overall Study||8
6720252|NCT03040479|7650153|FG002|COMPLETED|Overall Study||8
6720253|NCT03040479|7650151|FG000|NOT COMPLETED|Overall Study||0
6720254|NCT03040479|7650152|FG001|NOT COMPLETED|Overall Study||0
6720255|NCT03040479|7650153|FG002|NOT COMPLETED|Overall Study||0
6720256|NCT03040674|7650163|FG000|STARTED|Overall Study||489
6720257|NCT03040674|7650163|FG000|Participants Completing 3 Month Survey|Overall Study||351
6720258|NCT03040674|7650163|FG000|Participants Completing 6 Month Survey|Overall Study||241
6720259|NCT03040674|7650163|FG000|COMPLETED|Overall Study||241
6720260|NCT03040674|7650163|FG000|NOT COMPLETED|Overall Study||248
6720261|NCT03040687|7650171|FG000|STARTED|Overall Study||20
6720262|NCT03040687|7650172|FG001|STARTED|Overall Study||20
6720263|NCT03040687|7650173|FG002|STARTED|Overall Study||20
6720264|NCT03040687|7650171|FG000|COMPLETED|Overall Study||19
6720265|NCT03040687|7650172|FG001|COMPLETED|Overall Study||20
6720266|NCT03040687|7650173|FG002|COMPLETED|Overall Study||20
6720267|NCT03040687|7650171|FG000|NOT COMPLETED|Overall Study||1
6720268|NCT03040687|7650172|FG001|NOT COMPLETED|Overall Study||0
6392158|NCT00839917|7304148|FG001|NOT COMPLETED|Overall Study||1
6392159|NCT00839956|7304154|FG000|STARTED|Overall Study||31
6392160|NCT00839956|7304154|FG000|COMPLETED|Overall Study||19
6720269|NCT03040687|7650173|FG002|NOT COMPLETED|Overall Study||0
6720270|NCT03040713|7650181|FG000|STARTED|Overall Study||16
6720271|NCT03040713|7650181|FG000|COMPLETED|Overall Study||13
6720272|NCT03040713|7650181|FG000|NOT COMPLETED|Overall Study||3
6720273|NCT03040804|7650185|FG000|STARTED|Overall Study||2
6720274|NCT03040804|7650185|FG000|COMPLETED|Overall Study||2
6720275|NCT03040804|7650185|FG000|NOT COMPLETED|Overall Study||0
6720276|NCT03040986|7650191|FG000|STARTED|Overall Study||6
6720277|NCT03040986|7650192|FG001|STARTED|Overall Study||2
6392161|NCT00839956|7304154|FG000|NOT COMPLETED|Overall Study||12
6720278|NCT03040986|7650191|FG000|COMPLETED|Overall Study||0
6720279|NCT03040986|7650192|FG001|COMPLETED|Overall Study||0
6720280|NCT03040986|7650191|FG000|NOT COMPLETED|Overall Study||6
6720281|NCT03040986|7650192|FG001|NOT COMPLETED|Overall Study||2
6720282|NCT03041025|7650203|FG000|STARTED|Overall Study||8
6720283|NCT03041025|7650204|FG001|STARTED|Overall Study||3
6720284|NCT03041025|7650205|FG002|STARTED|Overall Study||24
6720285|NCT03041025|7650203|FG000|COMPLETED|Overall Study||7
6720286|NCT03041025|7650204|FG001|COMPLETED|Overall Study||3
6720287|NCT03041025|7650205|FG002|COMPLETED|Overall Study||22
6720288|NCT03041025|7650203|FG000|NOT COMPLETED|Overall Study||1
6720289|NCT03041025|7650204|FG001|NOT COMPLETED|Overall Study||0
6720290|NCT03041025|7650205|FG002|NOT COMPLETED|Overall Study||2
6720291|NCT03041038|7650218|FG000|STARTED|Overall Study||11
6720292|NCT03041038|7650219|FG001|STARTED|Overall Study||9
6720293|NCT03041038|7650218|FG000|Week 16|Overall Study||10
6720294|NCT03041038|7650219|FG001|Week 16|Overall Study||8
6720295|NCT03041038|7650218|FG000|Week 32|Overall Study||9
6720296|NCT03041038|7650219|FG001|Week 32|Overall Study||8
6720297|NCT03041038|7650218|FG000|COMPLETED|Overall Study||5
6720298|NCT03041038|7650219|FG001|COMPLETED|Overall Study||7
6720299|NCT03041038|7650218|FG000|NOT COMPLETED|Overall Study||6
6720300|NCT03041038|7650219|FG001|NOT COMPLETED|Overall Study||2
6720301|NCT03041090|7650229|FG000|STARTED|Overall Study||109
6720302|NCT03041090|7650230|FG001|STARTED|Overall Study||24
6720303|NCT03041090|7650229|FG000|COMPLETED|Overall Study||109
6720304|NCT03041090|7650230|FG001|COMPLETED|Overall Study|3 consented subjects in the dynamic arm were not included in analysis due to technical errors.|21
6720305|NCT03041090|7650229|FG000|NOT COMPLETED|Overall Study||0
6720306|NCT03041090|7650230|FG001|NOT COMPLETED|Overall Study||3
6720307|NCT03041116|7650238|FG000|STARTED|Double-blind||41
6720308|NCT03041116|7650239|FG001|STARTED|Double-blind||43
6720309|NCT03041116|7650238|FG000|Received at Least 1 Dose of Study Drug|Double-blind||41
6720310|NCT03041116|7650239|FG001|Received at Least 1 Dose of Study Drug|Double-blind||43
6720311|NCT03041116|7650238|FG000|COMPLETED|Double-blind||41
6720312|NCT03041116|7650239|FG001|COMPLETED|Double-blind||37
6720313|NCT03041116|7650238|FG000|NOT COMPLETED|Double-blind||0
6720314|NCT03041116|7650239|FG001|NOT COMPLETED|Double-blind||6
6720315|NCT03041116|7650238|FG000|STARTED|Open-label||41
6720316|NCT03041116|7650239|FG001|STARTED|Open-label||37
6720317|NCT03041116|7650238|FG000|Received At Least 1 Dose of Study Drug|Open-label||41
6720318|NCT03041116|7650239|FG001|Received At Least 1 Dose of Study Drug|Open-label||37
6720319|NCT03041116|7650238|FG000|COMPLETED|Open-label||0
6720320|NCT03041116|7650239|FG001|COMPLETED|Open-label||0
6720321|NCT03041116|7650238|FG000|NOT COMPLETED|Open-label||41
6720322|NCT03041116|7650239|FG001|NOT COMPLETED|Open-label||37
6720323|NCT03041181|7650251|FG000|STARTED|Overall Study||1
6720324|NCT03041181|7650252|FG001|STARTED|Overall Study||2
6720325|NCT03041181|7650251|FG000|COMPLETED|Overall Study||0
6720326|NCT03041181|7650252|FG001|COMPLETED|Overall Study||0
6720327|NCT03041181|7650251|FG000|NOT COMPLETED|Overall Study||1
6720328|NCT03041181|7650252|FG001|NOT COMPLETED|Overall Study||2
6720329|NCT03041298|7650258|FG000|STARTED|Overall Study||1537
6720330|NCT03041298|7650258|FG000|COMPLETED|Overall Study||1537
6720331|NCT03041298|7650258|FG000|NOT COMPLETED|Overall Study||0
6720332|NCT03041441|7650262|FG000|STARTED|Overall Study||5
6720333|NCT03041441|7650262|FG000|COMPLETED|Overall Study||3
6720334|NCT03041441|7650262|FG000|NOT COMPLETED|Overall Study||2
6720335|NCT03041467|7650269|FG000|STARTED|Overall Study||170
6720336|NCT03041467|7650270|FG001|STARTED|Overall Study||160
6720337|NCT03041467|7650269|FG000|COMPLETED|Overall Study||0
6720338|NCT03041467|7650270|FG001|COMPLETED|Overall Study||0
6263893|NCT00264147|7162719|FG003|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
6263894|NCT00264147|7162720|FG004|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
6263895|NCT00264147|7162721|FG005|COMPLETED|Treatment I Period||0
6263896|NCT00264147|7162716|FG000|NOT COMPLETED|Treatment I Period||98
6263897|NCT00264147|7162717|FG001|NOT COMPLETED|Treatment I Period||83
6263898|NCT00264147|7162718|FG002|NOT COMPLETED|Treatment I Period||77
6263899|NCT00264147|7162719|FG003|NOT COMPLETED|Treatment I Period||72
6263900|NCT00264147|7162720|FG004|NOT COMPLETED|Treatment I Period||56
6263901|NCT00264147|7162721|FG005|NOT COMPLETED|Treatment I Period||0
6263902|NCT00264147|7162716|FG000|STARTED|Treatment II Period||0
6263903|NCT00264147|7162717|FG001|STARTED|Treatment II Period||0
6263904|NCT00264147|7162718|FG002|STARTED|Treatment II Period||0
6263905|NCT00264147|7162719|FG003|STARTED|Treatment II Period||0
6263906|NCT00264147|7162720|FG004|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
6263907|NCT00264147|7162721|FG005|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
6263908|NCT00264147|7162716|FG000|COMPLETED|Treatment II Period||0
6263909|NCT00264147|7162717|FG001|COMPLETED|Treatment II Period||0
6263910|NCT00264147|7162718|FG002|COMPLETED|Treatment II Period||0
6263911|NCT00264147|7162719|FG003|COMPLETED|Treatment II Period||0
6720339|NCT03041467|7650269|FG000|NOT COMPLETED|Overall Study||170
6720340|NCT03041467|7650270|FG001|NOT COMPLETED|Overall Study||160
6720341|NCT03041636|7650278|FG000|STARTED|Overall Study||1
6720342|NCT03041636|7650278|FG000|COMPLETED|Overall Study||1
6720343|NCT03041636|7650278|FG000|NOT COMPLETED|Overall Study||0
6720344|NCT03041792|7650284|FG000|STARTED|Overall Study||32
6720345|NCT03041792|7650285|FG001|STARTED|Overall Study||29
6720346|NCT03041792|7650284|FG000|Received Treatment|Overall Study||32
6720347|NCT03041792|7650285|FG001|Received Treatment|Overall Study||28
6720348|NCT03041792|7650284|FG000|COMPLETED|Overall Study||28
6720349|NCT03041792|7650285|FG001|COMPLETED|Overall Study||26
6720350|NCT03041792|7650284|FG000|NOT COMPLETED|Overall Study||4
6720351|NCT03041792|7650285|FG001|NOT COMPLETED|Overall Study||3
6720352|NCT03041896|7650295|FG000|STARTED|Overall Study||1486
6720353|NCT03041896|7650296|FG001|STARTED|Overall Study||1009
6720354|NCT03041896|7650297|FG002|STARTED|Overall Study||2299
6720355|NCT03041896|7650298|FG003|STARTED|Overall Study||256
6720356|NCT03041896|7650295|FG000|COMPLETED|Overall Study||1486
6720357|NCT03041896|7650296|FG001|COMPLETED|Overall Study||1009
6720358|NCT03041896|7650297|FG002|COMPLETED|Overall Study||2236
6720359|NCT03041896|7650298|FG003|COMPLETED|Overall Study||253
6720360|NCT03041896|7650295|FG000|NOT COMPLETED|Overall Study||0
6720361|NCT03041896|7650296|FG001|NOT COMPLETED|Overall Study||0
6720362|NCT03041896|7650297|FG002|NOT COMPLETED|Overall Study||63
6720363|NCT03041896|7650298|FG003|NOT COMPLETED|Overall Study||3
6720364|NCT03041909|7650315|FG000|STARTED|Overall Study||3
6720365|NCT03041909|7650316|FG001|STARTED|Overall Study||1
6720366|NCT03041909|7650317|FG002|STARTED|Overall Study||1
6720367|NCT03041909|7650315|FG000|COMPLETED|Overall Study||3
6720368|NCT03041909|7650316|FG001|COMPLETED|Overall Study||1
6720369|NCT03041909|7650317|FG002|COMPLETED|Overall Study||1
6720370|NCT03041909|7650315|FG000|NOT COMPLETED|Overall Study||0
6720371|NCT03041909|7650316|FG001|NOT COMPLETED|Overall Study||0
6720372|NCT03041909|7650317|FG002|NOT COMPLETED|Overall Study||0
6720373|NCT03042299|7650327|FG000|STARTED|Intervention Period 1 (6 Days)||7
6720374|NCT03042299|7650328|FG001|STARTED|Intervention Period 1 (6 Days)||7
6720375|NCT03042299|7650327|FG000|COMPLETED|Intervention Period 1 (6 Days)||7
6720376|NCT03042299|7650328|FG001|COMPLETED|Intervention Period 1 (6 Days)||7
6720377|NCT03042299|7650327|FG000|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6720378|NCT03042299|7650328|FG001|NOT COMPLETED|Intervention Period 1 (6 Days)||0
6720379|NCT03042299|7650327|FG000|STARTED|Washout Period (at Least 6 Days)||7
6720380|NCT03042299|7650328|FG001|STARTED|Washout Period (at Least 6 Days)||7
6720381|NCT03042299|7650327|FG000|COMPLETED|Washout Period (at Least 6 Days)||7
6720382|NCT03042299|7650328|FG001|COMPLETED|Washout Period (at Least 6 Days)||7
6720383|NCT03042299|7650327|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||0
6720384|NCT03042299|7650328|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||0
6720385|NCT03042299|7650327|FG000|STARTED|Intervention Period 2 (6 Days)||7
6720386|NCT03042299|7650328|FG001|STARTED|Intervention Period 2 (6 Days)||7
6720387|NCT03042299|7650327|FG000|COMPLETED|Intervention Period 2 (6 Days)||7
6720388|NCT03042299|7650328|FG001|COMPLETED|Intervention Period 2 (6 Days)||7
6720389|NCT03042299|7650327|FG000|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6720390|NCT03042299|7650328|FG001|NOT COMPLETED|Intervention Period 2 (6 Days)||0
6720391|NCT03042312|7650336|FG000|STARTED|Overall Study||28
6720392|NCT03042312|7650337|FG001|STARTED|Overall Study||43
6720393|NCT03042312|7650336|FG000|Safety Population|Overall Study||23
6720394|NCT03042312|7650337|FG001|Safety Population|Overall Study||41
6720395|NCT03042312|7650336|FG000|COMPLETED|Overall Study||18
6720396|NCT03042312|7650337|FG001|COMPLETED|Overall Study||31
6720397|NCT03042312|7650336|FG000|NOT COMPLETED|Overall Study||10
6720398|NCT03042312|7650337|FG001|NOT COMPLETED|Overall Study||12
6720399|NCT03042559|7650345|FG000|STARTED|Overall Study||22
6720400|NCT03042559|7650346|FG001|STARTED|Overall Study||21
6720401|NCT03042559|7650345|FG000|COMPLETED|Overall Study||21
6720402|NCT03042559|7650346|FG001|COMPLETED|Overall Study||20
6720403|NCT03042559|7650345|FG000|NOT COMPLETED|Overall Study||1
6720404|NCT03042559|7650346|FG001|NOT COMPLETED|Overall Study||1
6720405|NCT03042702|7650352|FG000|STARTED|Overall Study||2
6720406|NCT03042702|7650352|FG000|COMPLETED|Overall Study||2
6720407|NCT03042702|7650352|FG000|NOT COMPLETED|Overall Study||0
6720408|NCT03042715|7650357|FG000|STARTED|Overall Study||6
6720409|NCT03042715|7650357|FG000|COMPLETED|Overall Study||5
6720410|NCT03042715|7650357|FG000|NOT COMPLETED|Overall Study||1
6720411|NCT03042767|7650363|FG000|STARTED|Overall Study||12
6720412|NCT03042767|7650364|FG001|STARTED|Overall Study||13
6720413|NCT03042767|7650363|FG000|COMPLETED|Overall Study||11
6720414|NCT03042767|7650364|FG001|COMPLETED|Overall Study||11
6720415|NCT03042767|7650363|FG000|NOT COMPLETED|Overall Study||1
6720416|NCT03042767|7650364|FG001|NOT COMPLETED|Overall Study||2
6720417|NCT03042910|7650370|FG000|STARTED|Overall Study||38
6720418|NCT03042910|7650370|FG000|Treated|Overall Study||37
6720419|NCT03042910|7650370|FG000|COMPLETED|Overall Study||31
6720420|NCT03042910|7650370|FG000|NOT COMPLETED|Overall Study||7
6720421|NCT03043079|7650377|FG000|STARTED|Overall Study||21
6720422|NCT03043079|7650378|FG001|STARTED|Overall Study||14
6720423|NCT03043079|7650379|FG002|STARTED|Overall Study||10
6720424|NCT03043079|7650377|FG000|COMPLETED|Overall Study||21
6720425|NCT03043079|7650378|FG001|COMPLETED|Overall Study||14
6720426|NCT03043079|7650379|FG002|COMPLETED|Overall Study||10
6720427|NCT03043079|7650377|FG000|NOT COMPLETED|Overall Study||0
6720428|NCT03043079|7650378|FG001|NOT COMPLETED|Overall Study||0
6720429|NCT03043079|7650379|FG002|NOT COMPLETED|Overall Study||0
6720430|NCT03043105|7650388|FG000|STARTED|Overall Study||25
6720431|NCT03043105|7650388|FG000|COMPLETED|Overall Study||25
6720432|NCT03043105|7650388|FG000|NOT COMPLETED|Overall Study||0
6720433|NCT03043274|7650394|FG000|STARTED|Overall Study||13
6720434|NCT03043274|7650395|FG001|STARTED|Overall Study||10
6720435|NCT03043274|7650394|FG000|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|13
6720436|NCT03043274|7650395|FG001|COMPLETED|Overall Study|The study was terminated because of slow recruitment.|9
6720437|NCT03043274|7650394|FG000|NOT COMPLETED|Overall Study||0
6720438|NCT03043274|7650395|FG001|NOT COMPLETED|Overall Study||1
6720439|NCT03043365|7650403|FG000|STARTED|Weeks 0 to Week 8||20
6720440|NCT03043365|7650404|FG001|STARTED|Weeks 0 to Week 8||17
6263912|NCT00264147|7162720|FG004|COMPLETED|Treatment II Period||147
6263913|NCT00264147|7162721|FG005|COMPLETED|Treatment II Period||116
6263914|NCT00264147|7162716|FG000|NOT COMPLETED|Treatment II Period||0
6263915|NCT00264147|7162717|FG001|NOT COMPLETED|Treatment II Period||0
6263916|NCT00264147|7162718|FG002|NOT COMPLETED|Treatment II Period||0
6263917|NCT00264147|7162719|FG003|NOT COMPLETED|Treatment II Period||0
6263918|NCT00264147|7162720|FG004|NOT COMPLETED|Treatment II Period||33
6263919|NCT00264147|7162721|FG005|NOT COMPLETED|Treatment II Period||33
6263920|NCT00202878|7162737|FG000|STARTED|Overall Study||9067
6263921|NCT00202878|7162738|FG001|STARTED|Overall Study||9077
6263922|NCT00202878|7162737|FG000|COMPLETED|Overall Study||6868
6263923|NCT00202878|7162738|FG001|COMPLETED|Overall Study||6860
6263924|NCT00202878|7162737|FG000|NOT COMPLETED|Overall Study||2199
6263925|NCT00202878|7162738|FG001|NOT COMPLETED|Overall Study||2217
6263926|NCT00174265|7162746|FG000|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
6263927|NCT00174265|7162747|FG001|STARTED|Overall Study||110
6263928|NCT00174265|7162746|FG000|COMPLETED|Overall Study||57
6263929|NCT00174265|7162747|FG001|COMPLETED|Overall Study||89
6263930|NCT00174265|7162746|FG000|NOT COMPLETED|Overall Study||29
6263931|NCT00174265|7162747|FG001|NOT COMPLETED|Overall Study||21
6263932|NCT00159783|7162756|FG000|STARTED|Overall Study||32
6263933|NCT00159783|7162757|FG001|STARTED|Overall Study||79
6263934|NCT00159783|7162758|FG002|STARTED|Overall Study||107
6263935|NCT00159783|7162756|FG000|COMPLETED|Overall Study||13
6263936|NCT00159783|7162757|FG001|COMPLETED|Overall Study||52
6263937|NCT00159783|7162758|FG002|COMPLETED|Overall Study||68
6263938|NCT00159783|7162756|FG000|NOT COMPLETED|Overall Study||19
6263939|NCT00159783|7162757|FG001|NOT COMPLETED|Overall Study||27
6263940|NCT00159783|7162758|FG002|NOT COMPLETED|Overall Study||39
6263941|NCT00114101|7162769|FG000|STARTED|Overall Study||231
6263942|NCT00114101|7162770|FG001|STARTED|Overall Study||229
6263943|NCT00114101|7162769|FG000|COMPLETED|Overall Study||231
6263944|NCT00114101|7162770|FG001|COMPLETED|Overall Study||229
6263945|NCT00114101|7162769|FG000|NOT COMPLETED|Overall Study||0
6263946|NCT00114101|7162770|FG001|NOT COMPLETED|Overall Study||0
6263947|NCT00092677|7162780|FG000|STARTED|Overall Study||944
6263948|NCT00092677|7162781|FG001|STARTED|Overall Study||929
6263949|NCT00092677|7162780|FG000|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
6263950|NCT00092677|7162781|FG001|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
6263951|NCT00092677|7162780|FG000|NOT COMPLETED|Overall Study||5
6263952|NCT00092677|7162781|FG001|NOT COMPLETED|Overall Study||11
6263953|NCT00090259|7162789|FG000|STARTED|Overall Study||1913
6263954|NCT00090259|7162790|FG001|STARTED|Overall Study||1921
6263955|NCT00090259|7162789|FG000|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
6263956|NCT00090259|7162790|FG001|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
6263957|NCT00090259|7162789|FG000|NOT COMPLETED|Overall Study||62
6263958|NCT00090259|7162790|FG001|NOT COMPLETED|Overall Study||48
6263959|NCT00003298|7162796|FG000|STARTED|Step 1 (Neoadjuvant Therapy)||39
6263960|NCT00003298|7162796|FG000|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
6263961|NCT00003298|7162796|FG000|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
6263962|NCT00003298|7162796|FG000|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
6263963|NCT00003298|7162796|FG000|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
6263964|NCT00003298|7162796|FG000|STARTED|Surgery||35
6263965|NCT00003298|7162796|FG000|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
6263966|NCT00003298|7162796|FG000|NOT COMPLETED|Surgery||7
6263967|NCT00003298|7162796|FG000|STARTED|Re-register to Step 2 After Surgery||28
6263968|NCT00003298|7162796|FG000|COMPLETED|Re-register to Step 2 After Surgery||10
6263969|NCT00003298|7162796|FG000|NOT COMPLETED|Re-register to Step 2 After Surgery||18
6263970|NCT00003298|7162796|FG000|STARTED|Step 2 (Adjuvant Therapy)||10
6263971|NCT00003298|7162796|FG000|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
6263972|NCT00003298|7162796|FG000|COMPLETED|Step 2 (Adjuvant Therapy)||4
6263973|NCT00003298|7162796|FG000|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
6263974|NCT00003377|7162806|FG000|STARTED|Period I||3
6263975|NCT00003377|7162807|FG001|STARTED|Period I||3
6263976|NCT00003377|7162808|FG002|STARTED|Period I||3
6263977|NCT00003377|7162809|FG003|STARTED|Period I||3
6263978|NCT00003377|7162810|FG004|STARTED|Period I||0
6263979|NCT00003377|7162806|FG000|COMPLETED|Period I||3
6263980|NCT00003377|7162807|FG001|COMPLETED|Period I||3
6263981|NCT00003377|7162808|FG002|COMPLETED|Period I||2
6263982|NCT00003377|7162809|FG003|COMPLETED|Period I||2
6263983|NCT00003377|7162810|FG004|COMPLETED|Period I||0
6263984|NCT00003377|7162806|FG000|NOT COMPLETED|Period I||0
6263985|NCT00003377|7162807|FG001|NOT COMPLETED|Period I||0
6263986|NCT00003377|7162808|FG002|NOT COMPLETED|Period I||1
6263987|NCT00003377|7162809|FG003|NOT COMPLETED|Period I||1
6263988|NCT00003377|7162810|FG004|NOT COMPLETED|Period I||0
6280464|NCT00156923|7180413|FG000|NOT COMPLETED|Overall Study||34
6720441|NCT03043365|7650403|FG000|COMPLETED|Weeks 0 to Week 8||17
6720442|NCT03043365|7650404|FG001|COMPLETED|Weeks 0 to Week 8||14
6720443|NCT03043365|7650403|FG000|NOT COMPLETED|Weeks 0 to Week 8||3
6720444|NCT03043365|7650404|FG001|NOT COMPLETED|Weeks 0 to Week 8||3
6720445|NCT03043365|7650403|FG000|STARTED|Week 8 to Week 16 - Washout Period||17
6720446|NCT03043365|7650404|FG001|STARTED|Week 8 to Week 16 - Washout Period||14
6720447|NCT03043365|7650403|FG000|COMPLETED|Week 8 to Week 16 - Washout Period||16
6720448|NCT03043365|7650404|FG001|COMPLETED|Week 8 to Week 16 - Washout Period||14
6720449|NCT03043365|7650403|FG000|NOT COMPLETED|Week 8 to Week 16 - Washout Period||1
6720450|NCT03043365|7650404|FG001|NOT COMPLETED|Week 8 to Week 16 - Washout Period||0
6720451|NCT03043365|7650403|FG000|STARTED|Week 16 to Week 24||16
6720452|NCT03043365|7650404|FG001|STARTED|Week 16 to Week 24||14
6720453|NCT03043365|7650403|FG000|COMPLETED|Week 16 to Week 24||16
6720454|NCT03043365|7650404|FG001|COMPLETED|Week 16 to Week 24||14
6720455|NCT03043365|7650403|FG000|NOT COMPLETED|Week 16 to Week 24||0
6720456|NCT03043365|7650404|FG001|NOT COMPLETED|Week 16 to Week 24||0
6720457|NCT03043534|7650414|FG000|STARTED|Overall Study||15
6720458|NCT03043534|7650415|FG001|STARTED|Overall Study||14
6720459|NCT03043534|7650414|FG000|COMPLETED|Overall Study||15
6720460|NCT03043534|7650415|FG001|COMPLETED|Overall Study||14
6720461|NCT03043534|7650414|FG000|NOT COMPLETED|Overall Study||0
6720462|NCT03043534|7650415|FG001|NOT COMPLETED|Overall Study||0
6720463|NCT03043560|7650423|FG000|STARTED|Overall Study||21
6720464|NCT03043560|7650424|FG001|STARTED|Overall Study||24
6720465|NCT03043560|7650423|FG000|COMPLETED|Overall Study||20
6720466|NCT03043560|7650424|FG001|COMPLETED|Overall Study||21
6720467|NCT03043560|7650423|FG000|NOT COMPLETED|Overall Study||1
6720468|NCT03043560|7650424|FG001|NOT COMPLETED|Overall Study||3
6720469|NCT03043651|7650430|FG000|STARTED|Overall Study||48
6720470|NCT03043651|7650430|FG000|COMPLETED|Overall Study||0
6720471|NCT03043651|7650430|FG000|NOT COMPLETED|Overall Study||48
6720472|NCT03043885|7650438|FG000|STARTED|Overall Study||10
6720473|NCT03043885|7650439|FG001|STARTED|Overall Study||10
6720474|NCT03043885|7650440|FG002|STARTED|Overall Study||10
6263989|NCT00003377|7162806|FG000|STARTED|Period II|Patients participated at this dose level only in Period I.|0
6263990|NCT00003377|7162807|FG001|STARTED|Period II|Patients participated at this dose level only in Period I.|0
6263991|NCT00003377|7162808|FG002|STARTED|Period II|Patients participated at this dose level only in Period I.|0
6263992|NCT00003377|7162809|FG003|STARTED|Period II|Patients participated at this dose level only in Period I.|0
6263993|NCT00003377|7162810|FG004|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
6263994|NCT00003377|7162806|FG000|COMPLETED|Period II||0
6263995|NCT00003377|7162807|FG001|COMPLETED|Period II||0
6263996|NCT00003377|7162808|FG002|COMPLETED|Period II||0
6263997|NCT00003377|7162809|FG003|COMPLETED|Period II||0
6263998|NCT00003377|7162810|FG004|COMPLETED|Period II||16
6263999|NCT00003377|7162806|FG000|NOT COMPLETED|Period II||0
6264000|NCT00003377|7162807|FG001|NOT COMPLETED|Period II||0
6720475|NCT03043885|7650441|FG003|STARTED|Overall Study||10
6720476|NCT03043885|7650438|FG000|COMPLETED|Overall Study||10
6720477|NCT03043885|7650439|FG001|COMPLETED|Overall Study||10
6264001|NCT00003377|7162808|FG002|NOT COMPLETED|Period II||0
6264002|NCT00003377|7162809|FG003|NOT COMPLETED|Period II||0
6264003|NCT00003377|7162810|FG004|NOT COMPLETED|Period II||1
6264004|NCT00003389|7162825|FG000|STARTED|Overall Study||428
6264005|NCT00003389|7162826|FG001|STARTED|Overall Study||426
6264006|NCT00003389|7162825|FG000|Treated Pts w/ Toxicity Data Available|Overall Study||414
6264007|NCT00003389|7162826|FG001|Treated Pts w/ Toxicity Data Available|Overall Study||422
6264008|NCT00003389|7162825|FG000|Eligible Patients|Overall Study||395
6264009|NCT00003389|7162826|FG001|Eligible Patients|Overall Study||399
6264010|NCT00003389|7162825|FG000|COMPLETED|Overall Study||330
6264011|NCT00003389|7162826|FG001|COMPLETED|Overall Study||366
6264012|NCT00003389|7162825|FG000|NOT COMPLETED|Overall Study||98
6264013|NCT00003389|7162826|FG001|NOT COMPLETED|Overall Study||60
6264014|NCT00003404|7162832|FG000|STARTED|Overall Study||46
6264015|NCT00003404|7162832|FG000|COMPLETED|Overall Study||46
6264016|NCT00003404|7162832|FG000|NOT COMPLETED|Overall Study||0
6264017|NCT00003453|7162837|FG000|STARTED|Overall Study||6
6264018|NCT00003453|7162837|FG000|COMPLETED|Overall Study|One patient was not evaluable|5
6264019|NCT00003453|7162837|FG000|NOT COMPLETED|Overall Study||1
6264020|NCT00003456|7162841|FG000|STARTED|Overall Study||40
6264021|NCT00003456|7162841|FG000|COMPLETED|Overall Study||32
6264022|NCT00003456|7162841|FG000|NOT COMPLETED|Overall Study||8
6264023|NCT00003457|7162845|FG000|STARTED|Overall Study||40
6264024|NCT00003457|7162845|FG000|COMPLETED|Overall Study||31
6264025|NCT00003457|7162845|FG000|NOT COMPLETED|Overall Study||9
6264026|NCT00003459|7162849|FG000|STARTED|Overall Study||40
6264027|NCT00003459|7162849|FG000|COMPLETED|Overall Study|Nine patients were not evaluable.|31
6264028|NCT00003459|7162849|FG000|NOT COMPLETED|Overall Study||9
6264029|NCT00003460|7162853|FG000|STARTED|Overall Study||13
6264030|NCT00003460|7162853|FG000|COMPLETED|Overall Study|One patient was not evaluable.|12
6264031|NCT00003460|7162853|FG000|NOT COMPLETED|Overall Study||1
6264032|NCT00003468|7162857|FG000|STARTED|Overall Study||11
6264033|NCT00003468|7162857|FG000|COMPLETED|Overall Study|Two patients were not evaluable.|9
6720478|NCT03043885|7650440|FG002|COMPLETED|Overall Study||10
6264034|NCT00003468|7162857|FG000|NOT COMPLETED|Overall Study||2
6264035|NCT00003469|7162861|FG000|STARTED|Overall Study||4
6264036|NCT00003469|7162861|FG000|COMPLETED|Overall Study||4
6720479|NCT03043885|7650441|FG003|COMPLETED|Overall Study||10
6720480|NCT03043885|7650438|FG000|NOT COMPLETED|Overall Study||0
6720481|NCT03043885|7650439|FG001|NOT COMPLETED|Overall Study||0
6720482|NCT03043885|7650440|FG002|NOT COMPLETED|Overall Study||0
6720483|NCT03043885|7650441|FG003|NOT COMPLETED|Overall Study||0
6720484|NCT03044028|7650454|FG000|STARTED|Overall Study||22
6720485|NCT03044028|7650455|FG001|STARTED|Overall Study||22
6720486|NCT03044028|7650456|FG002|STARTED|Overall Study||22
6720487|NCT03044028|7650454|FG000|COMPLETED|Overall Study||12
6720488|NCT03044028|7650455|FG001|COMPLETED|Overall Study||12
6720489|NCT03044028|7650456|FG002|COMPLETED|Overall Study||22
6720490|NCT03044028|7650454|FG000|NOT COMPLETED|Overall Study||10
6720491|NCT03044028|7650455|FG001|NOT COMPLETED|Overall Study||10
6720492|NCT03044028|7650456|FG002|NOT COMPLETED|Overall Study||0
6720493|NCT03044106|7650465|FG000|STARTED|Visit 1||22
6720494|NCT03044106|7650466|FG001|STARTED|Visit 1||22
6720495|NCT03044106|7650465|FG000|COMPLETED|Visit 1||22
6720496|NCT03044106|7650466|FG001|COMPLETED|Visit 1||22
6720497|NCT03044106|7650465|FG000|NOT COMPLETED|Visit 1||0
6720498|NCT03044106|7650466|FG001|NOT COMPLETED|Visit 1||0
6720499|NCT03044106|7650465|FG000|STARTED|Washout (1 Week)||22
6720500|NCT03044106|7650466|FG001|STARTED|Washout (1 Week)||22
6720501|NCT03044106|7650465|FG000|COMPLETED|Washout (1 Week)||22
6720502|NCT03044106|7650466|FG001|COMPLETED|Washout (1 Week)||20
6720503|NCT03044106|7650465|FG000|NOT COMPLETED|Washout (1 Week)||0
6720504|NCT03044106|7650466|FG001|NOT COMPLETED|Washout (1 Week)||2
6720505|NCT03044106|7650465|FG000|STARTED|Visit 2||22
6720506|NCT03044106|7650466|FG001|STARTED|Visit 2||20
6720507|NCT03044106|7650465|FG000|COMPLETED|Visit 2||22
6720508|NCT03044106|7650466|FG001|COMPLETED|Visit 2||20
6720509|NCT03044106|7650465|FG000|NOT COMPLETED|Visit 2||0
6720510|NCT03044106|7650466|FG001|NOT COMPLETED|Visit 2||0
6720511|NCT03044197|7650481|FG000|STARTED|Overall Study||12
6720512|NCT03044197|7650482|FG001|STARTED|Overall Study||12
6720513|NCT03044197|7650481|FG000|COMPLETED|Overall Study||9
6720514|NCT03044197|7650482|FG001|COMPLETED|Overall Study||11
6720515|NCT03044197|7650481|FG000|NOT COMPLETED|Overall Study||3
6720516|NCT03044197|7650482|FG001|NOT COMPLETED|Overall Study||1
6720517|NCT03044249|7650490|FG000|STARTED|Overall Study||42
6720518|NCT03044249|7650491|FG001|STARTED|Overall Study||39
6720519|NCT03044249|7650490|FG000|Received at Least One Dose of Study Drug|Overall Study||42
6720520|NCT03044249|7650491|FG001|Received at Least One Dose of Study Drug|Overall Study||39
6720521|NCT03044249|7650490|FG000|COMPLETED|Overall Study||32
6720522|NCT03044249|7650491|FG001|COMPLETED|Overall Study||25
6720523|NCT03044249|7650490|FG000|NOT COMPLETED|Overall Study||10
6720524|NCT03044249|7650491|FG001|NOT COMPLETED|Overall Study||14
6720525|NCT03044353|7650505|FG000|STARTED|Overall Study||6
6720526|NCT03044353|7650506|FG001|STARTED|Overall Study||1
6720527|NCT03044353|7650507|FG002|STARTED|Overall Study|No participant was enrolled in Group-3 due to early termination of the study.|0
6720528|NCT03044353|7650505|FG000|COMPLETED|Overall Study||6
6720529|NCT03044353|7650506|FG001|COMPLETED|Overall Study||0
6720530|NCT03044353|7650507|FG002|COMPLETED|Overall Study||0
6720531|NCT03044353|7650505|FG000|NOT COMPLETED|Overall Study||0
6720532|NCT03044353|7650506|FG001|NOT COMPLETED|Overall Study||1
6720533|NCT03044353|7650507|FG002|NOT COMPLETED|Overall Study||0
6739535|NCT03292016|7668431|FG004|COMPLETED|First Intervention||1
6739536|NCT03292016|7668432|FG005|COMPLETED|First Intervention||2
6739537|NCT03292016|7668427|FG000|NOT COMPLETED|First Intervention||0
6739538|NCT03292016|7668428|FG001|NOT COMPLETED|First Intervention||0
6739539|NCT03292016|7668429|FG002|NOT COMPLETED|First Intervention||0
6739540|NCT03292016|7668430|FG003|NOT COMPLETED|First Intervention||0
6739541|NCT03292016|7668431|FG004|NOT COMPLETED|First Intervention||0
6739542|NCT03292016|7668432|FG005|NOT COMPLETED|First Intervention||0
6739543|NCT03292016|7668427|FG000|STARTED|First Washout||1
6739544|NCT03292016|7668428|FG001|STARTED|First Washout||1
6739545|NCT03292016|7668429|FG002|STARTED|First Washout||2
6739546|NCT03292016|7668430|FG003|STARTED|First Washout||1
6739547|NCT03292016|7668431|FG004|STARTED|First Washout||1
6739548|NCT03292016|7668432|FG005|STARTED|First Washout||2
6739549|NCT03292016|7668427|FG000|COMPLETED|First Washout||1
6739550|NCT03292016|7668428|FG001|COMPLETED|First Washout||1
6739551|NCT03292016|7668429|FG002|COMPLETED|First Washout||2
6739552|NCT03292016|7668430|FG003|COMPLETED|First Washout||1
6739553|NCT03292016|7668431|FG004|COMPLETED|First Washout||1
6739554|NCT03292016|7668432|FG005|COMPLETED|First Washout||2
6739555|NCT03292016|7668427|FG000|NOT COMPLETED|First Washout||0
6739556|NCT03292016|7668428|FG001|NOT COMPLETED|First Washout||0
6739557|NCT03292016|7668429|FG002|NOT COMPLETED|First Washout||0
6739558|NCT03292016|7668430|FG003|NOT COMPLETED|First Washout||0
6739559|NCT03292016|7668431|FG004|NOT COMPLETED|First Washout||0
6739560|NCT03292016|7668432|FG005|NOT COMPLETED|First Washout||0
6739561|NCT03292016|7668427|FG000|STARTED|Second Intervention||1
6739562|NCT03292016|7668428|FG001|STARTED|Second Intervention||1
6739563|NCT03292016|7668429|FG002|STARTED|Second Intervention||2
6739564|NCT03292016|7668430|FG003|STARTED|Second Intervention||1
6739565|NCT03292016|7668431|FG004|STARTED|Second Intervention||1
6739566|NCT03292016|7668432|FG005|STARTED|Second Intervention||2
6739567|NCT03292016|7668427|FG000|COMPLETED|Second Intervention||1
6739568|NCT03292016|7668428|FG001|COMPLETED|Second Intervention||1
6739569|NCT03292016|7668429|FG002|COMPLETED|Second Intervention||2
6739570|NCT03292016|7668430|FG003|COMPLETED|Second Intervention||1
6739571|NCT03292016|7668431|FG004|COMPLETED|Second Intervention||1
6720534|NCT03044418|7650514|FG000|STARTED|Overall Study||30
6720535|NCT03044418|7650514|FG000|COMPLETED|Overall Study||30
6720536|NCT03044418|7650514|FG000|NOT COMPLETED|Overall Study||0
6720537|NCT03044431|7650518|FG000|STARTED|Overall Study||207
6720538|NCT03044431|7650518|FG000|COMPLETED|Overall Study||148
6720539|NCT03044431|7650518|FG000|NOT COMPLETED|Overall Study||59
6720540|NCT03044574|7650524|FG000|STARTED|Overall Study||204
6720541|NCT03044574|7650525|FG001|STARTED|Overall Study||203
6720542|NCT03044574|7650524|FG000|Inpatient Period|Overall Study||204
6720543|NCT03044574|7650525|FG001|Inpatient Period|Overall Study||203
6720544|NCT03044574|7650524|FG000|30 Days After Surgery|Overall Study||193
6720545|NCT03044574|7650525|FG001|30 Days After Surgery|Overall Study||194
6720546|NCT03044574|7650524|FG000|180 Days After Surgery|Overall Study||167
6720547|NCT03044574|7650525|FG001|180 Days After Surgery|Overall Study||158
6720548|NCT03044574|7650524|FG000|COMPLETED|Overall Study||167
6720549|NCT03044574|7650525|FG001|COMPLETED|Overall Study||158
6720550|NCT03044574|7650524|FG000|NOT COMPLETED|Overall Study||37
6720551|NCT03044574|7650525|FG001|NOT COMPLETED|Overall Study||45
6720552|NCT03044691|7650533|FG000|STARTED|Overall Study||0
6720553|NCT03044691|7650534|FG001|STARTED|Overall Study||84
6720554|NCT03044691|7650533|FG000|COMPLETED|Overall Study||0
6264037|NCT00003469|7162861|FG000|NOT COMPLETED|Overall Study||0
6264038|NCT00003470|7162865|FG000|STARTED|Overall Study||27
6264039|NCT00003470|7162865|FG000|COMPLETED|Overall Study||21
6264040|NCT00003470|7162865|FG000|NOT COMPLETED|Overall Study||6
6264041|NCT00003471|7162869|FG000|STARTED|Overall Study||7
6264042|NCT00003471|7162869|FG000|COMPLETED|Overall Study||3
6264043|NCT00003471|7162869|FG000|NOT COMPLETED|Overall Study||4
6264044|NCT00003472|7162873|FG000|STARTED|Overall Study||13
6264045|NCT00003472|7162873|FG000|COMPLETED|Overall Study||10
6264046|NCT00003472|7162873|FG000|NOT COMPLETED|Overall Study||3
6264047|NCT00003473|7162877|FG000|STARTED|Overall Study||20
6264048|NCT00003473|7162877|FG000|COMPLETED|Overall Study||17
6264049|NCT00003473|7162877|FG000|NOT COMPLETED|Overall Study||3
6264050|NCT00003474|7162881|FG000|STARTED|Overall Study||40
6264051|NCT00003474|7162881|FG000|COMPLETED|Overall Study||26
6264052|NCT00003474|7162881|FG000|NOT COMPLETED|Overall Study||14
6264053|NCT00003475|7162885|FG000|STARTED|Overall Study||40
6264054|NCT00003475|7162885|FG000|COMPLETED|Overall Study||27
6264055|NCT00003475|7162885|FG000|NOT COMPLETED|Overall Study||13
6264056|NCT00003476|7162890|FG000|STARTED|Overall Study||8
6264057|NCT00003476|7162890|FG000|COMPLETED|Overall Study||7
6264058|NCT00003476|7162890|FG000|NOT COMPLETED|Overall Study||1
6264059|NCT00003477|7162894|FG000|STARTED|Overall Study||12
6264060|NCT00003477|7162894|FG000|COMPLETED|Overall Study||8
6264061|NCT00003477|7162894|FG000|NOT COMPLETED|Overall Study||4
6264062|NCT00003483|7162898|FG000|STARTED|Overall Study||3
6264063|NCT00003483|7162898|FG000|COMPLETED|Overall Study||2
6264064|NCT00003483|7162898|FG000|NOT COMPLETED|Overall Study||1
6264065|NCT00003487|7162902|FG000|STARTED|Overall Study||8
6264066|NCT00003487|7162902|FG000|COMPLETED|Overall Study||6
6264067|NCT00003487|7162902|FG000|NOT COMPLETED|Overall Study||2
6264068|NCT00003492|7162906|FG000|STARTED|Overall Study||9
6264069|NCT00003492|7162906|FG000|COMPLETED|Overall Study||3
6264070|NCT00003492|7162906|FG000|NOT COMPLETED|Overall Study||6
6264071|NCT00003498|7162910|FG000|STARTED|Overall Study||5
6264072|NCT00003498|7162910|FG000|COMPLETED|Overall Study||1
6264073|NCT00003498|7162910|FG000|NOT COMPLETED|Overall Study||4
6264074|NCT00003499|7162914|FG000|STARTED|Overall Study||31
6264075|NCT00003499|7162914|FG000|COMPLETED|Overall Study||23
6264076|NCT00003499|7162914|FG000|NOT COMPLETED|Overall Study||8
6264077|NCT00003508|7162918|FG000|STARTED|Overall Study||8
6264078|NCT00003508|7162918|FG000|COMPLETED|Overall Study||3
6264079|NCT00003508|7162918|FG000|NOT COMPLETED|Overall Study||5
6264080|NCT00003509|7162922|FG000|STARTED|Overall Study||13
6264081|NCT00003509|7162922|FG000|COMPLETED|Overall Study||8
6264082|NCT00003509|7162922|FG000|NOT COMPLETED|Overall Study||5
6264083|NCT00003511|7162926|FG000|STARTED|Overall Study||5
6264084|NCT00003511|7162926|FG000|COMPLETED|Overall Study||1
6264085|NCT00003511|7162926|FG000|NOT COMPLETED|Overall Study||4
6264086|NCT00003526|7162930|FG000|STARTED|Overall Study||8
6602861|NCT02059148|7527882|FG004|STARTED|Treatment 3||4
6602862|NCT02059148|7527883|FG005|STARTED|Treatment 3||3
6602863|NCT02059148|7527878|FG000|COMPLETED|Treatment 3||4
6602864|NCT02059148|7527879|FG001|COMPLETED|Treatment 3||4
6602865|NCT02059148|7527880|FG002|COMPLETED|Treatment 3||4
6602866|NCT02059148|7527881|FG003|COMPLETED|Treatment 3||4
6602867|NCT02059148|7527882|FG004|COMPLETED|Treatment 3||4
6602868|NCT02059148|7527883|FG005|COMPLETED|Treatment 3||3
6602869|NCT02059148|7527878|FG000|NOT COMPLETED|Treatment 3||0
6602870|NCT02059148|7527879|FG001|NOT COMPLETED|Treatment 3||0
6602871|NCT02059148|7527880|FG002|NOT COMPLETED|Treatment 3||0
6264087|NCT00003526|7162930|FG000|COMPLETED|Overall Study||2
6264088|NCT00003526|7162930|FG000|NOT COMPLETED|Overall Study||6
6264089|NCT00003531|7162934|FG000|STARTED|Overall Study||15
6264090|NCT00003531|7162934|FG000|COMPLETED|Overall Study||5
6264091|NCT00003531|7162934|FG000|NOT COMPLETED|Overall Study||10
6264092|NCT00003535|7162938|FG000|STARTED|Overall Study||9
6264093|NCT00003535|7162938|FG000|COMPLETED|Overall Study||4
6264094|NCT00003535|7162938|FG000|NOT COMPLETED|Overall Study||5
6264095|NCT00003537|7162942|FG000|STARTED|Overall Study||19
6264096|NCT00003537|7162942|FG000|COMPLETED|Overall Study||18
6602872|NCT02059148|7527881|FG003|NOT COMPLETED|Treatment 3||0
6720555|NCT03044691|7650534|FG001|COMPLETED|Overall Study||84
6720556|NCT03044691|7650533|FG000|NOT COMPLETED|Overall Study||0
6720557|NCT03044691|7650534|FG001|NOT COMPLETED|Overall Study||0
6720558|NCT03044730|7650540|FG000|STARTED|3 Cycles of Pembro + Capecitab||30
6720559|NCT03044730|7650540|FG000|Attempted Cycle 1|3 Cycles of Pembro + Capecitab||30
6720560|NCT03044730|7650540|FG000|Attempted Cycle 2|3 Cycles of Pembro + Capecitab||28
6720561|NCT03044730|7650540|FG000|Attempted Cycle 3|3 Cycles of Pembro + Capecitab||26
6720562|NCT03044730|7650540|FG000|COMPLETED|3 Cycles of Pembro + Capecitab||26
6720563|NCT03044730|7650540|FG000|NOT COMPLETED|3 Cycles of Pembro + Capecitab||4
6720564|NCT03044730|7650540|FG000|STARTED|Cycles 4 and Beyond||26
6720565|NCT03044730|7650540|FG000|Assessed for Cycle 4|Cycles 4 and Beyond||26
6720566|NCT03044730|7650540|FG000|Started Cycle 4|Cycles 4 and Beyond||20
6720567|NCT03044730|7650540|FG000|Went on to Cycle 5 and Beyond|Cycles 4 and Beyond||16
6720568|NCT03044730|7650540|FG000|COMPLETED|Cycles 4 and Beyond||16
6720569|NCT03044730|7650540|FG000|NOT COMPLETED|Cycles 4 and Beyond||10
6720570|NCT03044730|7650540|FG000|STARTED|On Follow-up for 2 Years||29
6720571|NCT03044730|7650540|FG000|COMPLETED|On Follow-up for 2 Years||4
6720572|NCT03044730|7650540|FG000|NOT COMPLETED|On Follow-up for 2 Years||25
6720573|NCT03044886|7650548|FG000|STARTED|Overall Study||120
6720574|NCT03044886|7650549|FG001|STARTED|Overall Study||120
6720575|NCT03044886|7650550|FG002|STARTED|Overall Study||120
6720576|NCT03044886|7650548|FG000|COMPLETED|Overall Study||105
6720577|NCT03044886|7650549|FG001|COMPLETED|Overall Study||110
6720578|NCT03044886|7650550|FG002|COMPLETED|Overall Study||108
6720579|NCT03044886|7650548|FG000|NOT COMPLETED|Overall Study||15
6720580|NCT03044886|7650549|FG001|NOT COMPLETED|Overall Study||10
6720581|NCT03044886|7650550|FG002|NOT COMPLETED|Overall Study||12
6720582|NCT03045081|7650560|FG000|STARTED|Overall Study||51
6720583|NCT03045081|7650561|FG001|STARTED|Overall Study||48
6720584|NCT03045081|7650560|FG000|COMPLETED|Overall Study||45
6720585|NCT03045081|7650561|FG001|COMPLETED|Overall Study||37
6720586|NCT03045081|7650560|FG000|NOT COMPLETED|Overall Study||6
6720587|NCT03045081|7650561|FG001|NOT COMPLETED|Overall Study||11
6720588|NCT03045302|7650567|FG000|STARTED|Overall Study||4
6720589|NCT03045302|7650567|FG000|COMPLETED|Overall Study||3
6720590|NCT03045302|7650567|FG000|NOT COMPLETED|Overall Study||1
6720591|NCT03045328|7650571|FG000|STARTED|Overall Study||22
6720592|NCT03045328|7650571|FG000|COMPLETED|Overall Study||20
6720593|NCT03045328|7650571|FG000|NOT COMPLETED|Overall Study||2
6720594|NCT03045809|7650575|FG000|STARTED|Overall Study||705
6720595|NCT03045809|7650575|FG000|Attended an Additional Visit (if Needed)|Overall Study|(only if needed, for medical follow-up, to complete study procedures, or to report adverse events).|51
6720596|NCT03045809|7650575|FG000|COMPLETED|Overall Study||705
6720597|NCT03045809|7650575|FG000|NOT COMPLETED|Overall Study||0
6720598|NCT03045861|7650585|FG000|STARTED|Part A (Up to 10 Days)||0
6720599|NCT03045861|7650586|FG001|STARTED|Part A (Up to 10 Days)||0
6720600|NCT03045861|7650587|FG002|STARTED|Part A (Up to 10 Days)||10
6720601|NCT03045861|7650588|FG003|STARTED|Part A (Up to 10 Days)||0
6720602|NCT03045861|7650585|FG000|COMPLETED|Part A (Up to 10 Days)||0
6720603|NCT03045861|7650586|FG001|COMPLETED|Part A (Up to 10 Days)||0
6720604|NCT03045861|7650587|FG002|COMPLETED|Part A (Up to 10 Days)||10
6720605|NCT03045861|7650588|FG003|COMPLETED|Part A (Up to 10 Days)||0
6720606|NCT03045861|7650585|FG000|NOT COMPLETED|Part A (Up to 10 Days)||0
6720607|NCT03045861|7650586|FG001|NOT COMPLETED|Part A (Up to 10 Days)||0
6720608|NCT03045861|7650587|FG002|NOT COMPLETED|Part A (Up to 10 Days)||0
6720609|NCT03045861|7650588|FG003|NOT COMPLETED|Part A (Up to 10 Days)||0
6720610|NCT03045861|7650585|FG000|STARTED|Part B (Up to 10 Days)||7
6720611|NCT03045861|7650586|FG001|STARTED|Part B (Up to 10 Days)||8
6720612|NCT03045861|7650587|FG002|STARTED|Part B (Up to 10 Days)||0
6720613|NCT03045861|7650588|FG003|STARTED|Part B (Up to 10 Days)||8
6720614|NCT03045861|7650585|FG000|COMPLETED|Part B (Up to 10 Days)||7
6720615|NCT03045861|7650586|FG001|COMPLETED|Part B (Up to 10 Days)||8
6720616|NCT03045861|7650587|FG002|COMPLETED|Part B (Up to 10 Days)||0
6720617|NCT03045861|7650588|FG003|COMPLETED|Part B (Up to 10 Days)||8
6720618|NCT03045861|7650585|FG000|NOT COMPLETED|Part B (Up to 10 Days)||0
6720619|NCT03045861|7650586|FG001|NOT COMPLETED|Part B (Up to 10 Days)||0
6720620|NCT03045861|7650587|FG002|NOT COMPLETED|Part B (Up to 10 Days)||0
6720621|NCT03045861|7650588|FG003|NOT COMPLETED|Part B (Up to 10 Days)||0
6720622|NCT03045887|7650609|FG000|STARTED|Part A, Period (1 Day)||7
6720623|NCT03045887|7650610|FG001|STARTED|Part A, Period (1 Day)||4
6720624|NCT03045887|7650611|FG002|STARTED|Part A, Period (1 Day)||5
6720625|NCT03045887|7650612|FG003|STARTED|Part A, Period (1 Day)||5
6720626|NCT03045887|7650613|FG004|STARTED|Part A, Period (1 Day)||4
6720627|NCT03045887|7650614|FG005|STARTED|Part A, Period (1 Day)||4
6720628|NCT03045887|7650615|FG006|STARTED|Part A, Period (1 Day)||4
6720629|NCT03045887|7650616|FG007|STARTED|Part A, Period (1 Day)||4
6720630|NCT03045887|7650617|FG008|STARTED|Part A, Period (1 Day)||0
6720631|NCT03045887|7650618|FG009|STARTED|Part A, Period (1 Day)||0
6720632|NCT03045887|7650609|FG000|COMPLETED|Part A, Period (1 Day)||7
6720633|NCT03045887|7650610|FG001|COMPLETED|Part A, Period (1 Day)||4
6720634|NCT03045887|7650611|FG002|COMPLETED|Part A, Period (1 Day)||5
6720635|NCT03045887|7650612|FG003|COMPLETED|Part A, Period (1 Day)||5
6720636|NCT03045887|7650613|FG004|COMPLETED|Part A, Period (1 Day)||4
6720637|NCT03045887|7650614|FG005|COMPLETED|Part A, Period (1 Day)||4
6720638|NCT03045887|7650615|FG006|COMPLETED|Part A, Period (1 Day)||4
6720639|NCT03045887|7650616|FG007|COMPLETED|Part A, Period (1 Day)||4
6720640|NCT03045887|7650617|FG008|COMPLETED|Part A, Period (1 Day)||0
6720641|NCT03045887|7650618|FG009|COMPLETED|Part A, Period (1 Day)||0
6720642|NCT03045887|7650609|FG000|NOT COMPLETED|Part A, Period (1 Day)||0
6720643|NCT03045887|7650610|FG001|NOT COMPLETED|Part A, Period (1 Day)||0
6720644|NCT03045887|7650611|FG002|NOT COMPLETED|Part A, Period (1 Day)||0
6720645|NCT03045887|7650612|FG003|NOT COMPLETED|Part A, Period (1 Day)||0
6720646|NCT03045887|7650613|FG004|NOT COMPLETED|Part A, Period (1 Day)||0
6720647|NCT03045887|7650614|FG005|NOT COMPLETED|Part A, Period (1 Day)||0
6720648|NCT03045887|7650615|FG006|NOT COMPLETED|Part A, Period (1 Day)||0
6720649|NCT03045887|7650616|FG007|NOT COMPLETED|Part A, Period (1 Day)||0
6720650|NCT03045887|7650617|FG008|NOT COMPLETED|Part A, Period (1 Day)||0
6720651|NCT03045887|7650618|FG009|NOT COMPLETED|Part A, Period (1 Day)||0
6720652|NCT03045887|7650609|FG000|STARTED|Part A,Washout Period 1(4 Weeks)||7
6720653|NCT03045887|7650610|FG001|STARTED|Part A,Washout Period 1(4 Weeks)||4
6720654|NCT03045887|7650611|FG002|STARTED|Part A,Washout Period 1(4 Weeks)||5
6720655|NCT03045887|7650612|FG003|STARTED|Part A,Washout Period 1(4 Weeks)||5
6720656|NCT03045887|7650613|FG004|STARTED|Part A,Washout Period 1(4 Weeks)||4
6720657|NCT03045887|7650614|FG005|STARTED|Part A,Washout Period 1(4 Weeks)||4
6720658|NCT03045887|7650615|FG006|STARTED|Part A,Washout Period 1(4 Weeks)||4
6720659|NCT03045887|7650616|FG007|STARTED|Part A,Washout Period 1(4 Weeks)||4
6720660|NCT03045887|7650617|FG008|STARTED|Part A,Washout Period 1(4 Weeks)||0
6720661|NCT03045887|7650618|FG009|STARTED|Part A,Washout Period 1(4 Weeks)||0
6720662|NCT03045887|7650609|FG000|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6720663|NCT03045887|7650610|FG001|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6720664|NCT03045887|7650611|FG002|COMPLETED|Part A,Washout Period 1(4 Weeks)||5
6720665|NCT03045887|7650612|FG003|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6720666|NCT03045887|7650613|FG004|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6720667|NCT03045887|7650614|FG005|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6720668|NCT03045887|7650615|FG006|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6720669|NCT03045887|7650616|FG007|COMPLETED|Part A,Washout Period 1(4 Weeks)||4
6720670|NCT03045887|7650617|FG008|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720671|NCT03045887|7650618|FG009|COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720672|NCT03045887|7650609|FG000|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||3
6720673|NCT03045887|7650610|FG001|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720674|NCT03045887|7650611|FG002|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720675|NCT03045887|7650612|FG003|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||1
6720676|NCT03045887|7650613|FG004|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720677|NCT03045887|7650614|FG005|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720678|NCT03045887|7650615|FG006|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720679|NCT03045887|7650616|FG007|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720680|NCT03045887|7650617|FG008|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720681|NCT03045887|7650618|FG009|NOT COMPLETED|Part A,Washout Period 1(4 Weeks)||0
6720682|NCT03045887|7650609|FG000|STARTED|Part A, Period 2 (1 Day)||4
6720683|NCT03045887|7650610|FG001|STARTED|Part A, Period 2 (1 Day)||4
6720684|NCT03045887|7650611|FG002|STARTED|Part A, Period 2 (1 Day)||5
6720685|NCT03045887|7650612|FG003|STARTED|Part A, Period 2 (1 Day)||4
6720686|NCT03045887|7650613|FG004|STARTED|Part A, Period 2 (1 Day)||4
6720687|NCT03045887|7650614|FG005|STARTED|Part A, Period 2 (1 Day)||4
6720688|NCT03045887|7650615|FG006|STARTED|Part A, Period 2 (1 Day)||4
6720689|NCT03045887|7650616|FG007|STARTED|Part A, Period 2 (1 Day)||4
6720690|NCT03045887|7650617|FG008|STARTED|Part A, Period 2 (1 Day)||0
6720691|NCT03045887|7650618|FG009|STARTED|Part A, Period 2 (1 Day)||0
6720692|NCT03045887|7650609|FG000|COMPLETED|Part A, Period 2 (1 Day)||3
6720693|NCT03045887|7650610|FG001|COMPLETED|Part A, Period 2 (1 Day)||4
6720694|NCT03045887|7650611|FG002|COMPLETED|Part A, Period 2 (1 Day)||5
6720695|NCT03045887|7650612|FG003|COMPLETED|Part A, Period 2 (1 Day)||4
6720696|NCT03045887|7650613|FG004|COMPLETED|Part A, Period 2 (1 Day)||4
6720697|NCT03045887|7650614|FG005|COMPLETED|Part A, Period 2 (1 Day)||4
6720698|NCT03045887|7650615|FG006|COMPLETED|Part A, Period 2 (1 Day)||4
6720699|NCT03045887|7650616|FG007|COMPLETED|Part A, Period 2 (1 Day)||4
6720700|NCT03045887|7650617|FG008|COMPLETED|Part A, Period 2 (1 Day)||0
6720701|NCT03045887|7650618|FG009|COMPLETED|Part A, Period 2 (1 Day)||0
6720702|NCT03045887|7650609|FG000|NOT COMPLETED|Part A, Period 2 (1 Day)||1
6720703|NCT03045887|7650610|FG001|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720704|NCT03045887|7650611|FG002|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720705|NCT03045887|7650612|FG003|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720706|NCT03045887|7650613|FG004|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720707|NCT03045887|7650614|FG005|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720708|NCT03045887|7650615|FG006|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720709|NCT03045887|7650616|FG007|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720710|NCT03045887|7650617|FG008|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720711|NCT03045887|7650618|FG009|NOT COMPLETED|Part A, Period 2 (1 Day)||0
6720712|NCT03045887|7650609|FG000|STARTED|Part A,Washout Period 2 (4 Weeks)||3
6720713|NCT03045887|7650610|FG001|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6720714|NCT03045887|7650611|FG002|STARTED|Part A,Washout Period 2 (4 Weeks)||5
6720715|NCT03045887|7650612|FG003|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6720716|NCT03045887|7650613|FG004|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6720717|NCT03045887|7650614|FG005|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6720718|NCT03045887|7650615|FG006|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6720719|NCT03045887|7650616|FG007|STARTED|Part A,Washout Period 2 (4 Weeks)||4
6720720|NCT03045887|7650617|FG008|STARTED|Part A,Washout Period 2 (4 Weeks)||0
6720721|NCT03045887|7650618|FG009|STARTED|Part A,Washout Period 2 (4 Weeks)||0
6720722|NCT03045887|7650609|FG000|COMPLETED|Part A,Washout Period 2 (4 Weeks)||3
6720723|NCT03045887|7650610|FG001|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6720724|NCT03045887|7650611|FG002|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6720725|NCT03045887|7650612|FG003|COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
6720726|NCT03045887|7650613|FG004|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6720727|NCT03045887|7650614|FG005|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6720728|NCT03045887|7650615|FG006|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6720729|NCT03045887|7650616|FG007|COMPLETED|Part A,Washout Period 2 (4 Weeks)||4
6720730|NCT03045887|7650617|FG008|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720731|NCT03045887|7650618|FG009|COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720732|NCT03045887|7650609|FG000|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720733|NCT03045887|7650610|FG001|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720734|NCT03045887|7650611|FG002|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||1
6720735|NCT03045887|7650612|FG003|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||2
6720736|NCT03045887|7650613|FG004|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720737|NCT03045887|7650614|FG005|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720738|NCT03045887|7650615|FG006|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720739|NCT03045887|7650616|FG007|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720740|NCT03045887|7650617|FG008|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6264097|NCT00003537|7162942|FG000|NOT COMPLETED|Overall Study||1
6264098|NCT00003590|7162946|FG000|STARTED|Overall Study||29
6264099|NCT00003590|7162946|FG000|Eligible|Overall Study||28
6264100|NCT00003590|7162946|FG000|Eligible and Began Protocol Therapy|Overall Study||28
6264101|NCT00003590|7162946|FG000|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
6264102|NCT00003590|7162946|FG000|NOT COMPLETED|Overall Study||22
6264103|NCT00003631|7162953|FG000|STARTED|Overall Study||50
6264104|NCT00003631|7162954|FG001|STARTED|Overall Study||44
6264105|NCT00003631|7162955|FG002|STARTED|Overall Study||24
6264106|NCT00003631|7162953|FG000|COMPLETED|Overall Study||47
6264107|NCT00003631|7162954|FG001|COMPLETED|Overall Study||43
6264108|NCT00003631|7162955|FG002|COMPLETED|Overall Study||15
6264109|NCT00003631|7162953|FG000|NOT COMPLETED|Overall Study||3
6264110|NCT00003631|7162954|FG001|NOT COMPLETED|Overall Study||1
6264111|NCT00003631|7162955|FG002|NOT COMPLETED|Overall Study||9
6264112|NCT00003641|7162965|FG000|STARTED|Overall Study||569
6264113|NCT00003641|7162966|FG001|STARTED|Overall Study||581
6264114|NCT00003641|7162965|FG000|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
6264115|NCT00003641|7162966|FG001|Treated|Overall Study||569
6264116|NCT00003641|7162965|FG000|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
6264117|NCT00003641|7162966|FG001|Toxicity Assessed|Overall Study||568
6264118|NCT00003641|7162965|FG000|COMPLETED|Overall Study||0
6264119|NCT00003641|7162966|FG001|COMPLETED|Overall Study||407
6264120|NCT00003641|7162965|FG000|NOT COMPLETED|Overall Study||569
6264121|NCT00003641|7162966|FG001|NOT COMPLETED|Overall Study||174
6264122|NCT00003644|7162974|FG000|STARTED|Overall Study||289
6264123|NCT00003644|7162975|FG001|STARTED|Overall Study||282
6264124|NCT00003644|7162974|FG000|COMPLETED|Overall Study||274
6264125|NCT00003644|7162975|FG001|COMPLETED|Overall Study||268
6264126|NCT00003644|7162974|FG000|NOT COMPLETED|Overall Study||15
6264127|NCT00003644|7162975|FG001|NOT COMPLETED|Overall Study||14
6264128|NCT00003645|7162985|FG000|STARTED|Overall Study||30
6264129|NCT00003645|7162986|FG001|STARTED|Overall Study||34
6264130|NCT00003645|7162985|FG000|COMPLETED|Overall Study||18
6264131|NCT00003645|7162986|FG001|COMPLETED|Overall Study||22
6264132|NCT00003645|7162985|FG000|NOT COMPLETED|Overall Study||12
6264133|NCT00003645|7162986|FG001|NOT COMPLETED|Overall Study||12
6264134|NCT00003659|7162994|FG000|STARTED|Overall Study||39
6264135|NCT00003659|7162994|FG000|COMPLETED|Overall Study||36
6264136|NCT00003659|7162994|FG000|NOT COMPLETED|Overall Study||3
6264137|NCT00003702|7163000|FG000|STARTED|Overall Study||120
6264138|NCT00003702|7163001|FG001|STARTED|Overall Study||120
6264139|NCT00003702|7163000|FG000|COMPLETED|Overall Study||107
6264140|NCT00003702|7163001|FG001|COMPLETED|Overall Study||109
6264141|NCT00003702|7163000|FG000|NOT COMPLETED|Overall Study||13
6264142|NCT00003702|7163001|FG001|NOT COMPLETED|Overall Study||11
6264143|NCT00003782|7163011|FG000|STARTED|Overall Study||1783
6264144|NCT00003782|7163012|FG001|STARTED|Overall Study||1784
6264145|NCT00003782|7163013|FG002|STARTED|Overall Study||1784
6264146|NCT00003782|7163011|FG000|COMPLETED|Overall Study||1753
6720741|NCT03045887|7650618|FG009|NOT COMPLETED|Part A,Washout Period 2 (4 Weeks)||0
6720742|NCT03045887|7650609|FG000|STARTED|Part A, Period 3 (1 Day)||3
6720743|NCT03045887|7650610|FG001|STARTED|Part A, Period 3 (1 Day)||4
6720744|NCT03045887|7650611|FG002|STARTED|Part A, Period 3 (1 Day)||4
6720745|NCT03045887|7650612|FG003|STARTED|Part A, Period 3 (1 Day)||2
6720746|NCT03045887|7650613|FG004|STARTED|Part A, Period 3 (1 Day)||4
6720747|NCT03045887|7650614|FG005|STARTED|Part A, Period 3 (1 Day)||4
6720748|NCT03045887|7650615|FG006|STARTED|Part A, Period 3 (1 Day)||4
6720749|NCT03045887|7650616|FG007|STARTED|Part A, Period 3 (1 Day)||4
6720750|NCT03045887|7650617|FG008|STARTED|Part A, Period 3 (1 Day)||0
6720751|NCT03045887|7650618|FG009|STARTED|Part A, Period 3 (1 Day)||0
6720752|NCT03045887|7650609|FG000|COMPLETED|Part A, Period 3 (1 Day)||3
6720753|NCT03045887|7650610|FG001|COMPLETED|Part A, Period 3 (1 Day)||4
6720754|NCT03045887|7650611|FG002|COMPLETED|Part A, Period 3 (1 Day)||4
6720755|NCT03045887|7650612|FG003|COMPLETED|Part A, Period 3 (1 Day)||2
6720756|NCT03045887|7650613|FG004|COMPLETED|Part A, Period 3 (1 Day)||4
6720757|NCT03045887|7650614|FG005|COMPLETED|Part A, Period 3 (1 Day)||4
6720758|NCT03045887|7650615|FG006|COMPLETED|Part A, Period 3 (1 Day)||4
6720759|NCT03045887|7650616|FG007|COMPLETED|Part A, Period 3 (1 Day)||4
6720760|NCT03045887|7650617|FG008|COMPLETED|Part A, Period 3 (1 Day)||0
6720761|NCT03045887|7650618|FG009|COMPLETED|Part A, Period 3 (1 Day)||0
6720762|NCT03045887|7650609|FG000|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720763|NCT03045887|7650610|FG001|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720764|NCT03045887|7650611|FG002|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720765|NCT03045887|7650612|FG003|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720766|NCT03045887|7650613|FG004|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720767|NCT03045887|7650614|FG005|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720768|NCT03045887|7650615|FG006|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720769|NCT03045887|7650616|FG007|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720770|NCT03045887|7650617|FG008|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720771|NCT03045887|7650618|FG009|NOT COMPLETED|Part A, Period 3 (1 Day)||0
6720772|NCT03045887|7650609|FG000|STARTED|Part B (14 Days)||0
6720773|NCT03045887|7650610|FG001|STARTED|Part B (14 Days)||0
6720774|NCT03045887|7650611|FG002|STARTED|Part B (14 Days)||0
6720775|NCT03045887|7650612|FG003|STARTED|Part B (14 Days)||0
6720776|NCT03045887|7650613|FG004|STARTED|Part B (14 Days)||0
6720777|NCT03045887|7650614|FG005|STARTED|Part B (14 Days)||0
6720778|NCT03045887|7650615|FG006|STARTED|Part B (14 Days)||0
6720779|NCT03045887|7650616|FG007|STARTED|Part B (14 Days)||0
6720780|NCT03045887|7650617|FG008|STARTED|Part B (14 Days)||3
6720781|NCT03045887|7650618|FG009|STARTED|Part B (14 Days)||9
6720782|NCT03045887|7650609|FG000|COMPLETED|Part B (14 Days)||0
6720783|NCT03045887|7650610|FG001|COMPLETED|Part B (14 Days)||0
6264147|NCT00003782|7163012|FG001|COMPLETED|Overall Study||1753
6264148|NCT00003782|7163013|FG002|COMPLETED|Overall Study||1758
6264149|NCT00003782|7163011|FG000|NOT COMPLETED|Overall Study||30
6264150|NCT00003782|7163012|FG001|NOT COMPLETED|Overall Study||31
6264151|NCT00003782|7163013|FG002|NOT COMPLETED|Overall Study||26
6264152|NCT00003816|7163026|FG000|STARTED|Overall Study||55
6264153|NCT00003816|7163027|FG001|STARTED|Overall Study||69
6264154|NCT00003816|7163028|FG002|STARTED|Overall Study||199
6264155|NCT00003816|7163029|FG003|STARTED|Overall Study||23
6264156|NCT00003816|7163030|FG004|STARTED|Overall Study||15
6264157|NCT00003816|7163026|FG000|COMPLETED|Overall Study||55
6264158|NCT00003816|7163027|FG001|COMPLETED|Overall Study||69
6264159|NCT00003816|7163028|FG002|COMPLETED|Overall Study||199
6264160|NCT00003816|7163029|FG003|COMPLETED|Overall Study||23
6264161|NCT00003816|7163030|FG004|COMPLETED|Overall Study||15
6264162|NCT00003816|7163026|FG000|NOT COMPLETED|Overall Study||0
6264163|NCT00003816|7163027|FG001|NOT COMPLETED|Overall Study||0
6264164|NCT00003816|7163028|FG002|NOT COMPLETED|Overall Study||0
6264165|NCT00003816|7163029|FG003|NOT COMPLETED|Overall Study||0
6264166|NCT00003816|7163030|FG004|NOT COMPLETED|Overall Study||0
6264167|NCT00003820|7163042|FG000|STARTED|Cycle 1 (Initial Treatment)||23
6264168|NCT00003820|7163043|FG001|STARTED|Cycle 1 (Initial Treatment)||16
6264169|NCT00003820|7163042|FG000|COMPLETED|Cycle 1 (Initial Treatment)||23
6264170|NCT00003820|7163043|FG001|COMPLETED|Cycle 1 (Initial Treatment)||16
6264171|NCT00003820|7163042|FG000|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
6720784|NCT03045887|7650611|FG002|COMPLETED|Part B (14 Days)||0
6720785|NCT03045887|7650612|FG003|COMPLETED|Part B (14 Days)||0
6720786|NCT03045887|7650613|FG004|COMPLETED|Part B (14 Days)||0
6720787|NCT03045887|7650614|FG005|COMPLETED|Part B (14 Days)||0
6720788|NCT03045887|7650615|FG006|COMPLETED|Part B (14 Days)||0
6720789|NCT03045887|7650616|FG007|COMPLETED|Part B (14 Days)||0
6720790|NCT03045887|7650617|FG008|COMPLETED|Part B (14 Days)||3
6720791|NCT03045887|7650618|FG009|COMPLETED|Part B (14 Days)||9
6720792|NCT03045887|7650609|FG000|NOT COMPLETED|Part B (14 Days)||0
6720793|NCT03045887|7650610|FG001|NOT COMPLETED|Part B (14 Days)||0
6720794|NCT03045887|7650611|FG002|NOT COMPLETED|Part B (14 Days)||0
6720795|NCT03045887|7650612|FG003|NOT COMPLETED|Part B (14 Days)||0
6720796|NCT03045887|7650613|FG004|NOT COMPLETED|Part B (14 Days)||0
6720797|NCT03045887|7650614|FG005|NOT COMPLETED|Part B (14 Days)||0
6720798|NCT03045887|7650615|FG006|NOT COMPLETED|Part B (14 Days)||0
6264172|NCT00003820|7163043|FG001|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
6720799|NCT03045887|7650616|FG007|NOT COMPLETED|Part B (14 Days)||0
6264173|NCT00003820|7163042|FG000|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
6280465|NCT00156923|7180414|FG001|NOT COMPLETED|Overall Study||32
6720800|NCT03045887|7650617|FG008|NOT COMPLETED|Part B (14 Days)||0
6720801|NCT03045887|7650618|FG009|NOT COMPLETED|Part B (14 Days)||0
6720802|NCT03045926|7650645|FG000|STARTED|Overall Study||35
6720803|NCT03045926|7650645|FG000|COMPLETED|Overall Study||35
6720804|NCT03045926|7650645|FG000|NOT COMPLETED|Overall Study||0
6720805|NCT03046056|7650652|FG000|STARTED|Overall Study||28
6720806|NCT03046056|7650653|FG001|STARTED|Overall Study||32
6720807|NCT03046056|7650654|FG002|STARTED|Overall Study||18
6720808|NCT03046056|7650652|FG000|COMPLETED|Overall Study||16
6720809|NCT03046056|7650653|FG001|COMPLETED|Overall Study||16
6720810|NCT03046056|7650654|FG002|COMPLETED|Overall Study||11
6720811|NCT03046056|7650652|FG000|NOT COMPLETED|Overall Study||12
6720812|NCT03046056|7650653|FG001|NOT COMPLETED|Overall Study||16
6720813|NCT03046056|7650654|FG002|NOT COMPLETED|Overall Study||7
6720814|NCT03046212|7650664|FG000|STARTED|Overall Study||15
6720815|NCT03046212|7650665|FG001|STARTED|Overall Study||15
6720816|NCT03046212|7650664|FG000|COMPLETED|Overall Study||15
6720817|NCT03046212|7650665|FG001|COMPLETED|Overall Study||15
6720818|NCT03046212|7650664|FG000|NOT COMPLETED|Overall Study||0
6720819|NCT03046212|7650665|FG001|NOT COMPLETED|Overall Study||0
6720820|NCT03046225|7650673|FG000|STARTED|Overall Study||13
6720821|NCT03046225|7650674|FG001|STARTED|Overall Study||13
6720822|NCT03046225|7650673|FG000|COMPLETED|Overall Study||13
6720823|NCT03046225|7650674|FG001|COMPLETED|Overall Study||13
6720824|NCT03046225|7650673|FG000|NOT COMPLETED|Overall Study||0
6720825|NCT03046225|7650674|FG001|NOT COMPLETED|Overall Study||0
6720826|NCT03046446|7650680|FG000|STARTED|Overall Study||208
6720827|NCT03046446|7650680|FG000|Second Injection|Overall Study||179
6720828|NCT03046446|7650680|FG000|Completed at Week 12|Overall Study||10
6720829|NCT03046446|7650680|FG000|Completed at Week 24|Overall Study||6
6720830|NCT03046446|7650680|FG000|Completed at Week 52|Overall Study||133
6720831|NCT03046446|7650680|FG000|COMPLETED|Overall Study||149
6720832|NCT03046446|7650680|FG000|NOT COMPLETED|Overall Study||59
6720833|NCT03046472|7650686|FG000|STARTED|Overall Study||33
6720834|NCT03046472|7650687|FG001|STARTED|Overall Study||17
6720835|NCT03046472|7650686|FG000|COMPLETED|Overall Study||33
6720836|NCT03046472|7650687|FG001|COMPLETED|Overall Study||17
6720837|NCT03046472|7650686|FG000|NOT COMPLETED|Overall Study||0
6720838|NCT03046472|7650687|FG001|NOT COMPLETED|Overall Study||0
6720839|NCT03046966|7650695|FG000|STARTED|Overall Study||51
6720840|NCT03046966|7650696|FG001|STARTED|Overall Study||51
6720841|NCT03046966|7650695|FG000|COMPLETED|Overall Study||51
6720842|NCT03046966|7650696|FG001|COMPLETED|Overall Study||51
6720843|NCT03046966|7650695|FG000|NOT COMPLETED|Overall Study||0
6720844|NCT03046966|7650696|FG001|NOT COMPLETED|Overall Study||0
6720845|NCT03047174|7650704|FG000|STARTED|Overall Study||28
6720846|NCT03047174|7650705|FG001|STARTED|Overall Study||29
6720847|NCT03047174|7650704|FG000|COMPLETED|Overall Study||9
6720848|NCT03047174|7650705|FG001|COMPLETED|Overall Study||27
6720849|NCT03047174|7650704|FG000|NOT COMPLETED|Overall Study||19
6720850|NCT03047174|7650705|FG001|NOT COMPLETED|Overall Study||2
6720851|NCT03047447|7650728|FG000|STARTED|Overall Study||10
6720852|NCT03047447|7650729|FG001|STARTED|Overall Study||10
6720853|NCT03047447|7650730|FG002|STARTED|Overall Study||10
6720854|NCT03047447|7650728|FG000|COMPLETED|Overall Study||10
6720855|NCT03047447|7650729|FG001|COMPLETED|Overall Study||10
6720856|NCT03047447|7650730|FG002|COMPLETED|Overall Study||10
6720857|NCT03047447|7650728|FG000|NOT COMPLETED|Overall Study||0
6720858|NCT03047447|7650729|FG001|NOT COMPLETED|Overall Study||0
6720859|NCT03047447|7650730|FG002|NOT COMPLETED|Overall Study||0
6720860|NCT03047551|7650743|FG000|STARTED|Overall Study||319
6720861|NCT03047551|7650744|FG001|STARTED|Overall Study||315
6720862|NCT03047551|7650743|FG000|COMPLETED|Overall Study||317
6720863|NCT03047551|7650744|FG001|COMPLETED|Overall Study||312
6720864|NCT03047551|7650743|FG000|NOT COMPLETED|Overall Study||2
6720865|NCT03047551|7650744|FG001|NOT COMPLETED|Overall Study||3
6720866|NCT03047720|7650752|FG000|STARTED|First Intervention (6weeks)||12
6720867|NCT03047720|7650753|FG001|STARTED|First Intervention (6weeks)||0
6720868|NCT03047720|7650752|FG000|COMPLETED|First Intervention (6weeks)||5
6720869|NCT03047720|7650753|FG001|COMPLETED|First Intervention (6weeks)||0
6720870|NCT03047720|7650752|FG000|NOT COMPLETED|First Intervention (6weeks)||7
6720871|NCT03047720|7650753|FG001|NOT COMPLETED|First Intervention (6weeks)||0
6720872|NCT03047720|7650752|FG000|STARTED|Second Intervention (6weeks)||0
6720873|NCT03047720|7650753|FG001|STARTED|Second Intervention (6weeks)||0
6720874|NCT03047720|7650752|FG000|COMPLETED|Second Intervention (6weeks)||0
6720875|NCT03047720|7650753|FG001|COMPLETED|Second Intervention (6weeks)||0
6720876|NCT03047720|7650752|FG000|NOT COMPLETED|Second Intervention (6weeks)||0
6720877|NCT03047720|7650753|FG001|NOT COMPLETED|Second Intervention (6weeks)||0
6720878|NCT03047980|7650759|FG000|STARTED|Overall Study||10
6720879|NCT03047980|7650759|FG000|COMPLETED|Overall Study||9
6720880|NCT03047980|7650759|FG000|NOT COMPLETED|Overall Study||1
6720881|NCT03048006|7650763|FG000|STARTED|Overall Study||44456
6720882|NCT03048006|7650763|FG000|COMPLETED|Overall Study||44456
6720883|NCT03048006|7650763|FG000|NOT COMPLETED|Overall Study||0
6720884|NCT03048058|7650769|FG000|STARTED|Overall Study||10
6720885|NCT03048058|7650770|FG001|STARTED|Overall Study||10
6720886|NCT03048058|7650769|FG000|COMPLETED|Overall Study||6
6720887|NCT03048058|7650770|FG001|COMPLETED|Overall Study||6
6720888|NCT03048058|7650769|FG000|NOT COMPLETED|Overall Study||4
6720889|NCT03048058|7650770|FG001|NOT COMPLETED|Overall Study||4
6720890|NCT03048383|7650779|FG000|STARTED|Overall Study||28
6720891|NCT03048383|7650780|FG001|STARTED|Overall Study||21
6720892|NCT03048383|7650781|FG002|STARTED|Overall Study||22
6720893|NCT03048383|7650779|FG000|COMPLETED|Overall Study||15
6720894|NCT03048383|7650780|FG001|COMPLETED|Overall Study||13
6720895|NCT03048383|7650781|FG002|COMPLETED|Overall Study||10
6720896|NCT03048383|7650779|FG000|NOT COMPLETED|Overall Study||13
6720897|NCT03048383|7650780|FG001|NOT COMPLETED|Overall Study||8
6720898|NCT03048383|7650781|FG002|NOT COMPLETED|Overall Study||12
6720899|NCT03048500|7650789|FG000|STARTED|2 Cycles of Treatment||17
6720900|NCT03048500|7650789|FG000|Attempted 1st Cycle|2 Cycles of Treatment||17
6720901|NCT03048500|7650789|FG000|Attempted 2nd Cycle|2 Cycles of Treatment||16
6720902|NCT03048500|7650789|FG000|COMPLETED|2 Cycles of Treatment||16
6720903|NCT03048500|7650789|FG000|NOT COMPLETED|2 Cycles of Treatment||1
6720904|NCT03048500|7650789|FG000|STARTED|Reached 1st Response/Continued Treatment||16
6720905|NCT03048500|7650789|FG000|Assessed for First Response|Reached 1st Response/Continued Treatment||16
6720906|NCT03048500|7650789|FG000|Went on to Cycle 3 and Beyond|Reached 1st Response/Continued Treatment||9
6720907|NCT03048500|7650789|FG000|COMPLETED|Reached 1st Response/Continued Treatment||9
6720908|NCT03048500|7650789|FG000|NOT COMPLETED|Reached 1st Response/Continued Treatment||7
6720909|NCT03048500|7650789|FG000|STARTED|Follow up for 3 Years|1 patient died whilst on study.|16
6720910|NCT03048500|7650789|FG000|COMPLETED|Follow up for 3 Years||0
6720911|NCT03048500|7650789|FG000|NOT COMPLETED|Follow up for 3 Years||16
6720912|NCT03048747|7650793|FG000|STARTED|Overall Study||16
6720913|NCT03048747|7650793|FG000|COMPLETED|Overall Study||11
6720914|NCT03048747|7650793|FG000|NOT COMPLETED|Overall Study||5
6720915|NCT03049215|7650800|FG000|STARTED|Overall Study||1
6720916|NCT03049215|7650801|FG001|STARTED|Overall Study||0
6720917|NCT03049215|7650800|FG000|COMPLETED|Overall Study||1
6720918|NCT03049215|7650801|FG001|COMPLETED|Overall Study||0
6720919|NCT03049215|7650800|FG000|NOT COMPLETED|Overall Study||0
6720920|NCT03049215|7650801|FG001|NOT COMPLETED|Overall Study||0
6720921|NCT03049280|7650807|FG000|STARTED|Overall Study||33
6720922|NCT03049280|7650807|FG000|COMPLETED|Overall Study||32
6720923|NCT03049280|7650807|FG000|NOT COMPLETED|Overall Study||1
6720924|NCT03049488|7650819|FG000|STARTED|Overall Study||15
6720925|NCT03049488|7650820|FG001|STARTED|Overall Study||15
6720926|NCT03049488|7650821|FG002|STARTED|Overall Study||20
6720927|NCT03049488|7650822|FG003|STARTED|Overall Study||15
6720928|NCT03049488|7650823|FG004|STARTED|Overall Study||15
6720929|NCT03049488|7650824|FG005|STARTED|Overall Study||15
6720930|NCT03049488|7650819|FG000|Received First Product Administration|Overall Study||15
6720931|NCT03049488|7650820|FG001|Received First Product Administration|Overall Study||15
6720932|NCT03049488|7650821|FG002|Received First Product Administration|Overall Study||20
6720933|NCT03049488|7650822|FG003|Received First Product Administration|Overall Study||15
6720934|NCT03049488|7650823|FG004|Received First Product Administration|Overall Study||15
6720935|NCT03049488|7650824|FG005|Received First Product Administration|Overall Study||15
6720936|NCT03049488|7650819|FG000|Received Optional Second Dose|Overall Study||10
6720937|NCT03049488|7650820|FG001|Received Optional Second Dose|Overall Study||11
6720938|NCT03049488|7650821|FG002|Received Optional Second Dose|Overall Study||11
6720939|NCT03049488|7650822|FG003|Received Optional Second Dose|Overall Study||9
6720940|NCT03049488|7650823|FG004|Received Optional Second Dose|Overall Study||11
6720941|NCT03049488|7650824|FG005|Received Optional Second Dose|Overall Study||10
6720942|NCT03049488|7650819|FG000|COMPLETED|Overall Study||13
6720943|NCT03049488|7650820|FG001|COMPLETED|Overall Study||13
6720944|NCT03049488|7650821|FG002|COMPLETED|Overall Study||20
6720945|NCT03049488|7650822|FG003|COMPLETED|Overall Study||13
6720946|NCT03049488|7650823|FG004|COMPLETED|Overall Study||13
6720947|NCT03049488|7650824|FG005|COMPLETED|Overall Study||15
6720948|NCT03049488|7650819|FG000|NOT COMPLETED|Overall Study||2
6720949|NCT03049488|7650820|FG001|NOT COMPLETED|Overall Study||2
6720950|NCT03049488|7650821|FG002|NOT COMPLETED|Overall Study||0
6720951|NCT03049488|7650822|FG003|NOT COMPLETED|Overall Study||2
6720952|NCT03049488|7650823|FG004|NOT COMPLETED|Overall Study||2
6720953|NCT03049488|7650824|FG005|NOT COMPLETED|Overall Study||0
6720954|NCT03049501|7650841|FG000|STARTED|Overall Study||123
6720955|NCT03049501|7650842|FG001|STARTED|Overall Study||121
6720956|NCT03049501|7650841|FG000|6 Month Follow up|Overall Study||107
6720957|NCT03049501|7650842|FG001|6 Month Follow up|Overall Study||91
6720958|NCT03049501|7650841|FG000|12 Month Follow up|Overall Study||101
6720959|NCT03049501|7650842|FG001|12 Month Follow up|Overall Study||92
6720960|NCT03049501|7650841|FG000|COMPLETED|Overall Study||101
6720961|NCT03049501|7650842|FG001|COMPLETED|Overall Study||92
6720962|NCT03049501|7650841|FG000|NOT COMPLETED|Overall Study||22
6720963|NCT03049501|7650842|FG001|NOT COMPLETED|Overall Study||29
6720964|NCT03049748|7650850|FG000|STARTED|Overall Study||20
6720965|NCT03049748|7650851|FG001|STARTED|Overall Study||20
6720966|NCT03049748|7650850|FG000|COMPLETED|Overall Study||16
6720967|NCT03049748|7650851|FG001|COMPLETED|Overall Study||14
6720968|NCT03049748|7650850|FG000|NOT COMPLETED|Overall Study||4
6720969|NCT03049748|7650851|FG001|NOT COMPLETED|Overall Study||6
6720970|NCT03049852|7650860|FG000|STARTED|Overall Study||24
6720971|NCT03049852|7650861|FG001|STARTED|Overall Study||25
6720972|NCT03049852|7650862|FG002|STARTED|Overall Study||26
6720973|NCT03049852|7650860|FG000|COMPLETED|Overall Study||24
6720974|NCT03049852|7650861|FG001|COMPLETED|Overall Study||24
6720975|NCT03049852|7650862|FG002|COMPLETED|Overall Study||26
6720976|NCT03049852|7650860|FG000|NOT COMPLETED|Overall Study||0
6720977|NCT03049852|7650861|FG001|NOT COMPLETED|Overall Study||1
6720978|NCT03049852|7650862|FG002|NOT COMPLETED|Overall Study||0
6720979|NCT03049917|7650877|FG000|STARTED|Overall Study||90
6720980|NCT03049917|7650878|FG001|STARTED|Overall Study||89
6720981|NCT03049917|7650879|FG002|STARTED|Overall Study||93
6720982|NCT03049917|7650880|FG003|STARTED|Overall Study||92
6720983|NCT03049917|7650881|FG004|STARTED|Overall Study||88
6720984|NCT03049917|7650877|FG000|COMPLETED|Overall Study||31
6720985|NCT03049917|7650878|FG001|COMPLETED|Overall Study||31
6720986|NCT03049917|7650879|FG002|COMPLETED|Overall Study||44
6720987|NCT03049917|7650880|FG003|COMPLETED|Overall Study||51
6720988|NCT03049917|7650881|FG004|COMPLETED|Overall Study||54
6720989|NCT03049917|7650877|FG000|NOT COMPLETED|Overall Study||59
6720990|NCT03049917|7650878|FG001|NOT COMPLETED|Overall Study||58
6720991|NCT03049917|7650879|FG002|NOT COMPLETED|Overall Study||49
6720992|NCT03049917|7650880|FG003|NOT COMPLETED|Overall Study||41
6720993|NCT03049917|7650881|FG004|NOT COMPLETED|Overall Study||34
6720994|NCT03050203|7650917|FG000|STARTED|Overall Study||19
6720995|NCT03050203|7650918|FG001|STARTED|Overall Study||18
6720996|NCT03050203|7650917|FG000|COMPLETED|Overall Study||19
6720997|NCT03050203|7650918|FG001|COMPLETED|Overall Study||18
6720998|NCT03050203|7650917|FG000|NOT COMPLETED|Overall Study||0
6720999|NCT03050203|7650918|FG001|NOT COMPLETED|Overall Study||0
6721000|NCT03050216|7650924|FG000|STARTED|Overall Study||8
6721001|NCT03050216|7650924|FG000|COMPLETED|Overall Study||8
6721002|NCT03050216|7650924|FG000|NOT COMPLETED|Overall Study||0
6721003|NCT03050294|7650932|FG000|STARTED|Overall Study||6
6721004|NCT03050294|7650933|FG001|STARTED|Overall Study||6
6721005|NCT03050294|7650934|FG002|STARTED|Overall Study||6
6721006|NCT03050294|7650935|FG003|STARTED|Overall Study||6
6721007|NCT03050294|7650932|FG000|COMPLETED|Overall Study||6
6721008|NCT03050294|7650933|FG001|COMPLETED|Overall Study||6
6721009|NCT03050294|7650934|FG002|COMPLETED|Overall Study||6
6721010|NCT03050294|7650935|FG003|COMPLETED|Overall Study||6
6721011|NCT03050294|7650932|FG000|NOT COMPLETED|Overall Study||0
6721012|NCT03050294|7650933|FG001|NOT COMPLETED|Overall Study||0
6721013|NCT03050294|7650934|FG002|NOT COMPLETED|Overall Study||0
6721014|NCT03050294|7650935|FG003|NOT COMPLETED|Overall Study||0
6721015|NCT03050307|7650947|FG000|STARTED|Overall Study||115
6721016|NCT03050307|7650948|FG001|STARTED|Overall Study||119
6721017|NCT03050307|7650947|FG000|COMPLETED|Overall Study||107
6721018|NCT03050307|7650948|FG001|COMPLETED|Overall Study||110
6721019|NCT03050307|7650947|FG000|NOT COMPLETED|Overall Study||8
6721020|NCT03050307|7650948|FG001|NOT COMPLETED|Overall Study||9
6721021|NCT03050320|7650958|FG000|STARTED|Overall Study||21
6721022|NCT03050320|7650959|FG001|STARTED|Overall Study||22
6721023|NCT03050320|7650958|FG000|COMPLETED|Overall Study||20
6721024|NCT03050320|7650959|FG001|COMPLETED|Overall Study||21
6721025|NCT03050320|7650958|FG000|NOT COMPLETED|Overall Study||1
6721026|NCT03050320|7650959|FG001|NOT COMPLETED|Overall Study||1
6721027|NCT03050359|7650967|FG000|STARTED|Overall Study||265
6264174|NCT00003820|7163043|FG001|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
6264175|NCT00003820|7163042|FG000|COMPLETED|Cycle 2 (Maintenance Treatment)||0
6264176|NCT00003820|7163043|FG001|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
6264177|NCT00003820|7163042|FG000|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
6264178|NCT00003820|7163043|FG001|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
6264179|NCT00003820|7163042|FG000|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
6264180|NCT00003820|7163043|FG001|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
6264181|NCT00003820|7163042|FG000|COMPLETED|Cycle 3 (Maintenance Treatment)||0
6264182|NCT00003820|7163043|FG001|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
6721028|NCT03050359|7650968|FG001|STARTED|Overall Study||268
6721029|NCT03050359|7650967|FG000|COMPLETED|Overall Study||248
6721030|NCT03050359|7650968|FG001|COMPLETED|Overall Study||248
6721031|NCT03050359|7650967|FG000|NOT COMPLETED|Overall Study||17
6721032|NCT03050359|7650968|FG001|NOT COMPLETED|Overall Study||20
6721033|NCT03050372|7650976|FG000|STARTED|Adaptation Night (Night #1 PSG)||6
6721034|NCT03050372|7650977|FG001|STARTED|Adaptation Night (Night #1 PSG)||6
6721035|NCT03050372|7650976|FG000|COMPLETED|Adaptation Night (Night #1 PSG)|N=1 subject removed from study due to mild sleep apnea during adaptation night|5
6721036|NCT03050372|7650977|FG001|COMPLETED|Adaptation Night (Night #1 PSG)||6
6721037|NCT03050372|7650976|FG000|NOT COMPLETED|Adaptation Night (Night #1 PSG)||1
6721038|NCT03050372|7650977|FG001|NOT COMPLETED|Adaptation Night (Night #1 PSG)||0
6721039|NCT03050372|7650976|FG000|STARTED|First Intervention (Nights #2 and #3)||5
6721040|NCT03050372|7650977|FG001|STARTED|First Intervention (Nights #2 and #3)||6
6721041|NCT03050372|7650976|FG000|COMPLETED|First Intervention (Nights #2 and #3)||5
6721042|NCT03050372|7650977|FG001|COMPLETED|First Intervention (Nights #2 and #3)||6
6721043|NCT03050372|7650976|FG000|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
6721044|NCT03050372|7650977|FG001|NOT COMPLETED|First Intervention (Nights #2 and #3)||0
6721045|NCT03050372|7650976|FG000|STARTED|Second Intervention (Nights #4 and #5)||5
6721046|NCT03050372|7650977|FG001|STARTED|Second Intervention (Nights #4 and #5)||6
6721047|NCT03050372|7650976|FG000|COMPLETED|Second Intervention (Nights #4 and #5)||5
6721048|NCT03050372|7650977|FG001|COMPLETED|Second Intervention (Nights #4 and #5)|N=1 subject (blind only broken after double-blind analysis) moved out off State; lost to study|5
6721049|NCT03050372|7650976|FG000|NOT COMPLETED|Second Intervention (Nights #4 and #5)||0
6721050|NCT03050372|7650977|FG001|NOT COMPLETED|Second Intervention (Nights #4 and #5)||1
6721051|NCT03050450|7650987|FG000|STARTED|Overall Study||6
6721052|NCT03050450|7650988|FG001|STARTED|Overall Study||0
6721053|NCT03050450|7650989|FG002|STARTED|Overall Study||0
6721054|NCT03050450|7650990|FG003|STARTED|Overall Study||0
6721055|NCT03050450|7650991|FG004|STARTED|Overall Study||0
6721056|NCT03050450|7650987|FG000|COMPLETED|Overall Study||5
6721057|NCT03050450|7650988|FG001|COMPLETED|Overall Study||0
6721058|NCT03050450|7650989|FG002|COMPLETED|Overall Study||0
6721059|NCT03050450|7650990|FG003|COMPLETED|Overall Study||0
6721060|NCT03050450|7650991|FG004|COMPLETED|Overall Study||0
6721061|NCT03050450|7650987|FG000|NOT COMPLETED|Overall Study||1
6721062|NCT03050450|7650988|FG001|NOT COMPLETED|Overall Study||0
6721063|NCT03050450|7650989|FG002|NOT COMPLETED|Overall Study||0
6721064|NCT03050450|7650990|FG003|NOT COMPLETED|Overall Study||0
6721065|NCT03050450|7650991|FG004|NOT COMPLETED|Overall Study||0
6721066|NCT03050541|7651006|FG000|STARTED|Overall Study||28
6721067|NCT03050541|7651007|FG001|STARTED|Overall Study||28
6721068|NCT03050541|7651008|FG002|STARTED|Overall Study||28
6721069|NCT03050541|7651006|FG000|COMPLETED|Overall Study||20
6721070|NCT03050541|7651007|FG001|COMPLETED|Overall Study||20
6721071|NCT03050541|7651008|FG002|COMPLETED|Overall Study||20
6721072|NCT03050541|7651006|FG000|NOT COMPLETED|Overall Study||8
6721073|NCT03050541|7651007|FG001|NOT COMPLETED|Overall Study||8
6721074|NCT03050541|7651008|FG002|NOT COMPLETED|Overall Study||8
6721075|NCT03050619|7651022|FG000|STARTED|Overall Study||129
6721076|NCT03050619|7651023|FG001|STARTED|Overall Study||3926
6721077|NCT03050619|7651024|FG002|STARTED|Overall Study||6416
6721078|NCT03050619|7651025|FG003|STARTED|Overall Study||14007
6721079|NCT03050619|7651026|FG004|STARTED|Overall Study||6079
6721080|NCT03050619|7651027|FG005|STARTED|Overall Study||1351
6721081|NCT03050619|7651022|FG000|COMPLETED|Overall Study||129
6721082|NCT03050619|7651023|FG001|COMPLETED|Overall Study||3926
6721083|NCT03050619|7651024|FG002|COMPLETED|Overall Study||6416
6721084|NCT03050619|7651025|FG003|COMPLETED|Overall Study||14007
6721085|NCT03050619|7651026|FG004|COMPLETED|Overall Study||6079
6721086|NCT03050619|7651027|FG005|COMPLETED|Overall Study||1351
6721087|NCT03050619|7651022|FG000|NOT COMPLETED|Overall Study||0
6721088|NCT03050619|7651023|FG001|NOT COMPLETED|Overall Study||0
6721089|NCT03050619|7651024|FG002|NOT COMPLETED|Overall Study||0
6721090|NCT03050619|7651025|FG003|NOT COMPLETED|Overall Study||0
6721091|NCT03050619|7651026|FG004|NOT COMPLETED|Overall Study||0
6721092|NCT03050619|7651027|FG005|NOT COMPLETED|Overall Study||0
6721093|NCT03050697|7651041|FG000|STARTED|Overall Study||12
6721094|NCT03050697|7651041|FG000|COMPLETED|Overall Study||12
6721095|NCT03050697|7651041|FG000|NOT COMPLETED|Overall Study||0
6721096|NCT03050775|7651059|FG000|STARTED|Overall Study||35
6721097|NCT03050775|7651060|FG001|STARTED|Overall Study||35
6721098|NCT03050775|7651059|FG000|COMPLETED|Overall Study||35
6721099|NCT03050775|7651060|FG001|COMPLETED|Overall Study||35
6721100|NCT03050775|7651059|FG000|NOT COMPLETED|Overall Study||0
6721101|NCT03050775|7651060|FG001|NOT COMPLETED|Overall Study||0
6721102|NCT03050801|7651072|FG000|STARTED|Experiment 1||3
6721103|NCT03050801|7651073|FG001|STARTED|Experiment 1||13
6721104|NCT03050801|7651074|FG002|STARTED|Experiment 1||8
6721105|NCT03050801|7651075|FG003|STARTED|Experiment 1||0
6721106|NCT03050801|7651076|FG004|STARTED|Experiment 1||0
6721107|NCT03050801|7651077|FG005|STARTED|Experiment 1||0
6721108|NCT03050801|7651072|FG000|COMPLETED|Experiment 1||3
6721109|NCT03050801|7651073|FG001|COMPLETED|Experiment 1||6
6721110|NCT03050801|7651074|FG002|COMPLETED|Experiment 1||6
6721111|NCT03050801|7651075|FG003|COMPLETED|Experiment 1||0
6721112|NCT03050801|7651076|FG004|COMPLETED|Experiment 1||0
6721113|NCT03050801|7651077|FG005|COMPLETED|Experiment 1||0
6721114|NCT03050801|7651072|FG000|NOT COMPLETED|Experiment 1||0
6721115|NCT03050801|7651073|FG001|NOT COMPLETED|Experiment 1||7
6721116|NCT03050801|7651074|FG002|NOT COMPLETED|Experiment 1||2
6721117|NCT03050801|7651075|FG003|NOT COMPLETED|Experiment 1||0
6721118|NCT03050801|7651076|FG004|NOT COMPLETED|Experiment 1||0
6721119|NCT03050801|7651077|FG005|NOT COMPLETED|Experiment 1||0
6721120|NCT03050801|7651072|FG000|STARTED|Experiment 2||0
6721121|NCT03050801|7651073|FG001|STARTED|Experiment 2||0
6721122|NCT03050801|7651074|FG002|STARTED|Experiment 2||0
6721123|NCT03050801|7651075|FG003|STARTED|Experiment 2||21
6721124|NCT03050801|7651076|FG004|STARTED|Experiment 2||19
6721125|NCT03050801|7651077|FG005|STARTED|Experiment 2|Experiment 2 (Prefrontal Cortex Stimulation) was terminated early due to adverse events (intolerance of stimulation) in 2 of 4 participants.|4
6721126|NCT03050801|7651072|FG000|COMPLETED|Experiment 2||0
6721127|NCT03050801|7651073|FG001|COMPLETED|Experiment 2||0
6721128|NCT03050801|7651074|FG002|COMPLETED|Experiment 2||0
6721129|NCT03050801|7651075|FG003|COMPLETED|Experiment 2||15
6721130|NCT03050801|7651076|FG004|COMPLETED|Experiment 2||15
6721131|NCT03050801|7651077|FG005|COMPLETED|Experiment 2||2
6721132|NCT03050801|7651072|FG000|NOT COMPLETED|Experiment 2||0
6721133|NCT03050801|7651073|FG001|NOT COMPLETED|Experiment 2||0
6721134|NCT03050801|7651074|FG002|NOT COMPLETED|Experiment 2||0
6721135|NCT03050801|7651075|FG003|NOT COMPLETED|Experiment 2||6
6721136|NCT03050801|7651076|FG004|NOT COMPLETED|Experiment 2||4
6721137|NCT03050801|7651077|FG005|NOT COMPLETED|Experiment 2||2
6721138|NCT03050918|7651096|FG000|STARTED|Overall Study||1534
6721139|NCT03050918|7651097|FG001|STARTED|Overall Study||1520
6721140|NCT03050918|7651096|FG000|COMPLETED|Overall Study||1534
6721141|NCT03050918|7651097|FG001|COMPLETED|Overall Study||1520
6721142|NCT03050918|7651096|FG000|NOT COMPLETED|Overall Study||0
6721143|NCT03050918|7651097|FG001|NOT COMPLETED|Overall Study||0
6721144|NCT03051100|7651105|FG000|STARTED|Overall Study||20
6264183|NCT00003820|7163042|FG000|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
6264184|NCT00003820|7163043|FG001|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
6264185|NCT00003820|7163042|FG000|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
6264186|NCT00003820|7163043|FG001|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
6264187|NCT00003820|7163042|FG000|COMPLETED|Cycle 4 (Maintenance Treatment)||0
6264188|NCT00003820|7163043|FG001|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
6264189|NCT00003820|7163042|FG000|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
6264190|NCT00003820|7163043|FG001|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
6264191|NCT00003830|7163051|FG000|STARTED|Overall Study||2807
6264192|NCT00003830|7163052|FG001|STARTED|Overall Study||2804
6264193|NCT00003830|7163051|FG000|COMPLETED|Overall Study||1975
6264194|NCT00003830|7163052|FG001|COMPLETED|Overall Study||2011
6264195|NCT00003830|7163051|FG000|NOT COMPLETED|Overall Study||832
6264196|NCT00003830|7163052|FG001|NOT COMPLETED|Overall Study||793
6264197|NCT00003869|7163062|FG000|STARTED|Overall Study||94
6264198|NCT00003869|7163063|FG001|STARTED|Overall Study||92
6264199|NCT00003869|7163062|FG000|COMPLETED|Overall Study||53
6264200|NCT00003869|7163063|FG001|COMPLETED|Overall Study||80
6264201|NCT00003869|7163062|FG000|NOT COMPLETED|Overall Study||41
6264202|NCT00003869|7163063|FG001|NOT COMPLETED|Overall Study||12
6264203|NCT00003875|7163069|FG000|STARTED|Overall Study||30
6264204|NCT00003875|7163069|FG000|COMPLETED|Overall Study||29
6264205|NCT00003875|7163069|FG000|NOT COMPLETED|Overall Study||1
6264206|NCT00003895|7163075|FG000|STARTED|Overall Study||18
6264207|NCT00003895|7163076|FG001|STARTED|Overall Study||18
6264208|NCT00003895|7163075|FG000|COMPLETED|Overall Study||11
6264209|NCT00003895|7163076|FG001|COMPLETED|Overall Study||14
6264210|NCT00003895|7163075|FG000|NOT COMPLETED|Overall Study||7
6264211|NCT00003895|7163076|FG001|NOT COMPLETED|Overall Study||4
6264212|NCT00003896|7163082|FG000|STARTED|Overall Study||68
6264213|NCT00003896|7163082|FG000|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
6264214|NCT00003896|7163082|FG000|COMPLETED|Overall Study||39
6264215|NCT00003896|7163082|FG000|NOT COMPLETED|Overall Study||29
6264216|NCT00003901|7163087|FG000|STARTED|Overall Study||1047
6721145|NCT03051100|7651106|FG001|STARTED|Overall Study||43
6721146|NCT03051100|7651105|FG000|COMPLETED|Overall Study||19
6721147|NCT03051100|7651106|FG001|COMPLETED|Overall Study||43
6721148|NCT03051100|7651105|FG000|NOT COMPLETED|Overall Study||1
6721149|NCT03051100|7651106|FG001|NOT COMPLETED|Overall Study||0
6264217|NCT00003901|7163087|FG000|COMPLETED|Overall Study||1030
6264218|NCT00003901|7163087|FG000|NOT COMPLETED|Overall Study||17
6721150|NCT03051165|7651112|FG000|STARTED|Overall Study||13
6721151|NCT03051165|7651112|FG000|Completed Some Baseline Assessments|Overall Study||1
6721152|NCT03051165|7651112|FG000|Completed Some Day 105 Assessments|Overall Study||1
6264219|NCT00003907|7163096|FG000|STARTED|Overall Study||19
6721153|NCT03051165|7651112|FG000|Began HGNS Treatment Withdrawal|Overall Study||0
6721154|NCT03051165|7651112|FG000|Completed Some Day 137 Assessments|Overall Study||0
6721155|NCT03051165|7651112|FG000|COMPLETED|Overall Study||0
6721156|NCT03051165|7651112|FG000|NOT COMPLETED|Overall Study||13
6721157|NCT03051256|7651119|FG000|STARTED|Overall Study||19
6721158|NCT03051256|7651120|FG001|STARTED|Overall Study||21
6721159|NCT03051256|7651121|FG002|STARTED|Overall Study||22
6721160|NCT03051256|7651119|FG000|COMPLETED|Overall Study||19
6721161|NCT03051256|7651120|FG001|COMPLETED|Overall Study||21
6721162|NCT03051256|7651121|FG002|COMPLETED|Overall Study||21
6721163|NCT03051256|7651119|FG000|NOT COMPLETED|Overall Study||0
6721164|NCT03051256|7651120|FG001|NOT COMPLETED|Overall Study||0
6721165|NCT03051256|7651121|FG002|NOT COMPLETED|Overall Study||1
6721166|NCT03051607|7651130|FG000|STARTED|Overall Study||66
6721167|NCT03051607|7651130|FG000|COMPLETED|Overall Study||0
6721168|NCT03051607|7651130|FG000|NOT COMPLETED|Overall Study||66
6721169|NCT03051620|7651134|FG000|STARTED|Overall Study||142
6721170|NCT03051620|7651134|FG000|COMPLETED|Overall Study||124
6721171|NCT03051620|7651134|FG000|NOT COMPLETED|Overall Study||18
6721172|NCT03051633|7651140|FG000|STARTED|Overall Study||342
6721173|NCT03051633|7651141|FG001|STARTED|Overall Study||186
6721174|NCT03051633|7651140|FG000|COMPLETED|Overall Study||249
6721175|NCT03051633|7651141|FG001|COMPLETED|Overall Study||179
6721176|NCT03051633|7651140|FG000|NOT COMPLETED|Overall Study||93
6721177|NCT03051633|7651141|FG001|NOT COMPLETED|Overall Study||7
6721178|NCT03051646|7651149|FG000|STARTED|Overall Study||6
6721179|NCT03051646|7651150|FG001|STARTED|Overall Study||6
6721180|NCT03051646|7651149|FG000|COMPLETED|Overall Study||6
6721181|NCT03051646|7651150|FG001|COMPLETED|Overall Study||6
6721182|NCT03051646|7651149|FG000|NOT COMPLETED|Overall Study||0
6721183|NCT03051646|7651150|FG001|NOT COMPLETED|Overall Study||0
6721184|NCT03051672|7651158|FG000|STARTED|Overall Study||8
6721185|NCT03051672|7651158|FG000|Began Treatment|Overall Study||8
6721186|NCT03051672|7651158|FG000|COMPLETED|Overall Study||8
6721187|NCT03051672|7651158|FG000|NOT COMPLETED|Overall Study||0
6721188|NCT03052257|7651165|FG000|STARTED|Overall Study||100
6721189|NCT03052257|7651166|FG001|STARTED|Overall Study||100
6721190|NCT03052257|7651165|FG000|COMPLETED|Overall Study||95
6721191|NCT03052257|7651166|FG001|COMPLETED|Overall Study||97
6721192|NCT03052257|7651165|FG000|NOT COMPLETED|Overall Study||5
6721193|NCT03052257|7651166|FG001|NOT COMPLETED|Overall Study||3
6721194|NCT03052322|7651174|FG000|STARTED|Overall Study||143
6721195|NCT03052322|7651175|FG001|STARTED|Overall Study||145
6721196|NCT03052322|7651174|FG000|COMPLETED|Overall Study||122
6721197|NCT03052322|7651175|FG001|COMPLETED|Overall Study||113
6721198|NCT03052322|7651174|FG000|NOT COMPLETED|Overall Study||21
6721199|NCT03052322|7651175|FG001|NOT COMPLETED|Overall Study||32
6721200|NCT03052426|7651184|FG000|STARTED|Overall Study||6
6721201|NCT03052426|7651185|FG001|STARTED|Overall Study||6
6721202|NCT03052426|7651186|FG002|STARTED|Overall Study||6
6721203|NCT03052426|7651184|FG000|COMPLETED|Overall Study||4
6721204|NCT03052426|7651185|FG001|COMPLETED|Overall Study||5
6721205|NCT03052426|7651186|FG002|COMPLETED|Overall Study||5
6721206|NCT03052426|7651184|FG000|NOT COMPLETED|Overall Study||2
6721207|NCT03052426|7651185|FG001|NOT COMPLETED|Overall Study||1
6721208|NCT03052426|7651186|FG002|NOT COMPLETED|Overall Study||1
6721209|NCT03052517|7651202|FG000|STARTED|Overall Study||1093
6721210|NCT03052517|7651203|FG001|STARTED|Overall Study||1085
6721211|NCT03052517|7651204|FG002|STARTED|Overall Study||360
6721212|NCT03052517|7651202|FG000|Safety Set (SAF)|Overall Study|One patient received placebo. This patient was not included in QAW039 150 mg group in the SAF|1092
6721213|NCT03052517|7651203|FG001|Safety Set (SAF)|Overall Study|One patient had no treatment administered and thus was excluded from the SAF|1084
6721214|NCT03052517|7651204|FG002|Safety Set (SAF)|Overall Study|One patient in QAW039 150 mg group received placebo and was included in the placebo group in the SAF|361
6721215|NCT03052517|7651202|FG000|COMPLETED|Overall Study||76
6721216|NCT03052517|7651203|FG001|COMPLETED|Overall Study||71
6721217|NCT03052517|7651204|FG002|COMPLETED|Overall Study||32
6721218|NCT03052517|7651202|FG000|NOT COMPLETED|Overall Study||1017
6721219|NCT03052517|7651203|FG001|NOT COMPLETED|Overall Study||1014
6721220|NCT03052517|7651204|FG002|NOT COMPLETED|Overall Study||328
6721221|NCT03052530|7651212|FG000|STARTED|Overall Study||61
6721222|NCT03052530|7651212|FG000|COMPLETED|Overall Study||61
6721223|NCT03052530|7651212|FG000|NOT COMPLETED|Overall Study||0
6721224|NCT03052725|7651218|FG000|STARTED|Overall Study||194
6721225|NCT03052725|7651219|FG001|STARTED|Overall Study||197
6721226|NCT03052725|7651218|FG000|Safety Analysis Set|Overall Study||194
6721227|NCT03052725|7651219|FG001|Safety Analysis Set|Overall Study||196
6721228|NCT03052725|7651218|FG000|COMPLETED|Overall Study||46
6721229|NCT03052725|7651219|FG001|COMPLETED|Overall Study||47
6721230|NCT03052725|7651218|FG000|NOT COMPLETED|Overall Study||148
6721231|NCT03052725|7651219|FG001|NOT COMPLETED|Overall Study||150
6721232|NCT03052751|7651226|FG000|STARTED|Dosing Period 1||22
6721233|NCT03052751|7651227|FG001|STARTED|Dosing Period 1||21
6721234|NCT03052751|7651228|FG002|STARTED|Dosing Period 1||0
6721235|NCT03052751|7651229|FG003|STARTED|Dosing Period 1||0
6721236|NCT03052751|7651230|FG004|STARTED|Dosing Period 1||0
6721237|NCT03052751|7651231|FG005|STARTED|Dosing Period 1||0
6721238|NCT03052751|7651226|FG000|Completed Period 1|Dosing Period 1||22
6721239|NCT03052751|7651227|FG001|Completed Period 1|Dosing Period 1||21
6721240|NCT03052751|7651228|FG002|Completed Period 1|Dosing Period 1||0
6721241|NCT03052751|7651229|FG003|Completed Period 1|Dosing Period 1||0
6721242|NCT03052751|7651230|FG004|Completed Period 1|Dosing Period 1||0
6721243|NCT03052751|7651231|FG005|Completed Period 1|Dosing Period 1||0
6721244|NCT03052751|7651226|FG000|Completed Period 1 and Started Period 2|Dosing Period 1||22
6721245|NCT03052751|7651227|FG001|Completed Period 1 and Started Period 2|Dosing Period 1||20
6721246|NCT03052751|7651228|FG002|Completed Period 1 and Started Period 2|Dosing Period 1||0
6721247|NCT03052751|7651229|FG003|Completed Period 1 and Started Period 2|Dosing Period 1||0
6721248|NCT03052751|7651230|FG004|Completed Period 1 and Started Period 2|Dosing Period 1||0
6721249|NCT03052751|7651231|FG005|Completed Period 1 and Started Period 2|Dosing Period 1||0
6721250|NCT03052751|7651226|FG000|COMPLETED|Dosing Period 1||22
6721251|NCT03052751|7651227|FG001|COMPLETED|Dosing Period 1||20
6721252|NCT03052751|7651228|FG002|COMPLETED|Dosing Period 1||0
6721253|NCT03052751|7651229|FG003|COMPLETED|Dosing Period 1||0
6721254|NCT03052751|7651230|FG004|COMPLETED|Dosing Period 1||0
6721255|NCT03052751|7651231|FG005|COMPLETED|Dosing Period 1||0
6721256|NCT03052751|7651226|FG000|NOT COMPLETED|Dosing Period 1||0
6721257|NCT03052751|7651227|FG001|NOT COMPLETED|Dosing Period 1||1
6721258|NCT03052751|7651228|FG002|NOT COMPLETED|Dosing Period 1||0
6721259|NCT03052751|7651229|FG003|NOT COMPLETED|Dosing Period 1||0
6721260|NCT03052751|7651230|FG004|NOT COMPLETED|Dosing Period 1||0
6264220|NCT00003907|7163097|FG001|STARTED|Overall Study||31
6264221|NCT00003907|7163096|FG000|Eligible|Overall Study||18
6264222|NCT00003907|7163097|FG001|Eligible|Overall Study||29
6264223|NCT00003907|7163096|FG000|Received Protocol Therapy (Treated)|Overall Study||18
6264224|NCT00003907|7163097|FG001|Received Protocol Therapy (Treated)|Overall Study||31
6264225|NCT00003907|7163096|FG000|Eligible and Treated|Overall Study||17
6264226|NCT00003907|7163097|FG001|Eligible and Treated|Overall Study||29
6264227|NCT00003907|7163096|FG000|COMPLETED|Overall Study||6
6264228|NCT00003907|7163097|FG001|COMPLETED|Overall Study||8
6264229|NCT00003907|7163096|FG000|NOT COMPLETED|Overall Study||13
6264230|NCT00003907|7163097|FG001|NOT COMPLETED|Overall Study||23
6264231|NCT00003910|7163103|FG000|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
6264232|NCT00003910|7163104|FG001|STARTED|Step 1||0
6264233|NCT00003910|7163103|FG000|COMPLETED|Step 1||55
6264234|NCT00003910|7163104|FG001|COMPLETED|Step 1||0
6264235|NCT00003910|7163103|FG000|NOT COMPLETED|Step 1||0
6264236|NCT00003910|7163104|FG001|NOT COMPLETED|Step 1||0
6264237|NCT00003910|7163103|FG000|STARTED|Step 2||0
6264238|NCT00003910|7163104|FG001|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
6264239|NCT00003910|7163103|FG000|COMPLETED|Step 2||0
6264240|NCT00003910|7163104|FG001|COMPLETED|Step 2||16
6264241|NCT00003910|7163103|FG000|NOT COMPLETED|Step 2||0
6264242|NCT00003910|7163104|FG001|NOT COMPLETED|Step 2||0
6264243|NCT00004031|7163112|FG000|STARTED|Overall Study||128
6264244|NCT00004031|7163113|FG001|STARTED|Overall Study||125
6264245|NCT00004031|7163112|FG000|Assessed for Adverse Events|Overall Study||123
6264246|NCT00004031|7163113|FG001|Assessed for Adverse Events|Overall Study||113
6264247|NCT00004031|7163112|FG000|COMPLETED|Overall Study||103
6264248|NCT00004031|7163113|FG001|COMPLETED|Overall Study||104
6264249|NCT00004031|7163112|FG000|NOT COMPLETED|Overall Study||25
6264250|NCT00004031|7163113|FG001|NOT COMPLETED|Overall Study||21
6264251|NCT00004054|7163123|FG000|STARTED|Overall Study||197
6264252|NCT00004054|7163124|FG001|STARTED|Overall Study||200
6264253|NCT00004054|7163123|FG000|COMPLETED|Overall Study||197
6264254|NCT00004054|7163124|FG001|COMPLETED|Overall Study||200
6264255|NCT00004054|7163123|FG000|NOT COMPLETED|Overall Study||0
6264256|NCT00004054|7163124|FG001|NOT COMPLETED|Overall Study||0
6264257|NCT00004088|7163130|FG000|STARTED|Overall Study||77
6264258|NCT00004088|7163130|FG000|COMPLETED|Overall Study||68
6264259|NCT00004088|7163130|FG000|NOT COMPLETED|Overall Study||9
6264260|NCT00004092|7163136|FG000|STARTED|Overall Study||21
6264261|NCT00004092|7163137|FG001|STARTED|Overall Study||51
6264262|NCT00004092|7163136|FG000|COMPLETED|Overall Study||21
6264263|NCT00004092|7163137|FG001|COMPLETED|Overall Study||51
6264264|NCT00004092|7163136|FG000|NOT COMPLETED|Overall Study||0
6264265|NCT00004092|7163137|FG001|NOT COMPLETED|Overall Study||0
6264266|NCT00004124|7163145|FG000|STARTED|Overall Study||481
6264267|NCT00004124|7163146|FG001|STARTED|Overall Study||480
6264268|NCT00004124|7163145|FG000|COMPLETED|Overall Study||469
6264269|NCT00004124|7163146|FG001|COMPLETED|Overall Study||460
6264270|NCT00004124|7163145|FG000|NOT COMPLETED|Overall Study||12
6264271|NCT00004124|7163146|FG001|NOT COMPLETED|Overall Study||20
6264272|NCT00004143|7163152|FG000|STARTED|Overall Study||2
6264273|NCT00004143|7163152|FG000|COMPLETED|Overall Study||2
6264274|NCT00004143|7163152|FG000|NOT COMPLETED|Overall Study||0
6264275|NCT00004146|7163156|FG000|STARTED|Overall Study||55
6264276|NCT00004146|7163156|FG000|COMPLETED|Overall Study||55
6264277|NCT00004146|7163156|FG000|NOT COMPLETED|Overall Study||0
6264278|NCT00004228|7163169|FG000|STARTED|Overall Study||60
6264279|NCT00004228|7163170|FG001|STARTED|Overall Study||66
6264280|NCT00004228|7163171|FG002|STARTED|Overall Study||65
6264281|NCT00004228|7163172|FG003|STARTED|Overall Study||13
6264282|NCT00004228|7163173|FG004|STARTED|Overall Study||67
6264283|NCT00004228|7163174|FG005|STARTED|Overall Study||65
6264284|NCT00004228|7163175|FG006|STARTED|Overall Study||57
6264285|NCT00004228|7163169|FG000|COMPLETED|Overall Study||51
6264286|NCT00004228|7163170|FG001|COMPLETED|Overall Study||51
6264287|NCT00004228|7163171|FG002|COMPLETED|Overall Study||46
6264288|NCT00004228|7163172|FG003|COMPLETED|Overall Study||6
6264289|NCT00004228|7163173|FG004|COMPLETED|Overall Study||51
6264290|NCT00004228|7163174|FG005|COMPLETED|Overall Study||51
6264291|NCT00004228|7163175|FG006|COMPLETED|Overall Study||45
6721261|NCT03052751|7651231|FG005|NOT COMPLETED|Dosing Period 1||0
6721262|NCT03052751|7651226|FG000|STARTED|Dosing Period 2||0
6721263|NCT03052751|7651227|FG001|STARTED|Dosing Period 2||0
6721264|NCT03052751|7651228|FG002|STARTED|Dosing Period 2||11
6721265|NCT03052751|7651229|FG003|STARTED|Dosing Period 2||11
6721266|NCT03052751|7651230|FG004|STARTED|Dosing Period 2||10
6721267|NCT03052751|7651231|FG005|STARTED|Dosing Period 2||10
6721268|NCT03052751|7651226|FG000|COMPLETED|Dosing Period 2||0
6721269|NCT03052751|7651227|FG001|COMPLETED|Dosing Period 2||0
6721270|NCT03052751|7651228|FG002|COMPLETED|Dosing Period 2||8
6264292|NCT00004228|7163169|FG000|NOT COMPLETED|Overall Study||9
6264293|NCT00004228|7163170|FG001|NOT COMPLETED|Overall Study||15
6264294|NCT00004228|7163171|FG002|NOT COMPLETED|Overall Study||19
6264295|NCT00004228|7163172|FG003|NOT COMPLETED|Overall Study||7
6264296|NCT00004228|7163173|FG004|NOT COMPLETED|Overall Study||16
6264297|NCT00004228|7163174|FG005|NOT COMPLETED|Overall Study||14
6264298|NCT00004228|7163175|FG006|NOT COMPLETED|Overall Study||12
6264299|NCT00004259|7163196|FG000|STARTED|Overall Study||98
6264300|NCT00004259|7163197|FG001|STARTED|Overall Study||103
6264301|NCT00004259|7163198|FG002|STARTED|Overall Study||15
6264302|NCT00004259|7163199|FG003|STARTED|Overall Study||14
6264303|NCT00004259|7163196|FG000|COMPLETED|Overall Study||97
6264304|NCT00004259|7163197|FG001|COMPLETED|Overall Study||99
6264305|NCT00004259|7163198|FG002|COMPLETED|Overall Study||15
6264306|NCT00004259|7163199|FG003|COMPLETED|Overall Study||14
6264307|NCT00004259|7163196|FG000|NOT COMPLETED|Overall Study||1
6264308|NCT00004259|7163197|FG001|NOT COMPLETED|Overall Study||4
6264309|NCT00004259|7163198|FG002|NOT COMPLETED|Overall Study||0
6264310|NCT00004259|7163199|FG003|NOT COMPLETED|Overall Study||0
6264311|NCT00004412|7163215|FG000|STARTED|Randomized Period||11
6264312|NCT00004412|7163216|FG001|STARTED|Randomized Period||12
6264313|NCT00004412|7163217|FG002|STARTED|Randomized Period||0
6264314|NCT00004412|7163215|FG000|COMPLETED|Randomized Period||8
6264315|NCT00004412|7163216|FG001|COMPLETED|Randomized Period||12
6264316|NCT00004412|7163217|FG002|COMPLETED|Randomized Period||0
6264317|NCT00004412|7163215|FG000|NOT COMPLETED|Randomized Period||3
6264318|NCT00004412|7163216|FG001|NOT COMPLETED|Randomized Period||0
6264319|NCT00004412|7163217|FG002|NOT COMPLETED|Randomized Period||0
6264320|NCT00004412|7163215|FG000|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
6264321|NCT00004412|7163216|FG001|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
6264322|NCT00004412|7163217|FG002|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
6264323|NCT00004412|7163215|FG000|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
6264324|NCT00004412|7163216|FG001|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
6264325|NCT00004412|7163217|FG002|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
6264326|NCT00004412|7163215|FG000|NOT COMPLETED|Crossover Period||0
6264327|NCT00004412|7163216|FG001|NOT COMPLETED|Crossover Period||0
6264328|NCT00004412|7163217|FG002|NOT COMPLETED|Crossover Period||0
6264329|NCT00004418|7163223|FG000|STARTED|Overall Study||126
6264330|NCT00004418|7163223|FG000|COMPLETED|Overall Study|The definition of completed is until the subject wished to stop taking the oil.|126
6264331|NCT00004418|7163223|FG000|NOT COMPLETED|Overall Study||0
6264332|NCT00004445|7163227|FG000|STARTED|Overall Study||18
6264333|NCT00004445|7163227|FG000|COMPLETED|Overall Study||15
6264334|NCT00004445|7163227|FG000|NOT COMPLETED|Overall Study||3
6264335|NCT00004500|7163233|FG000|STARTED|Overall Study||38
6264336|NCT00004500|7163234|FG001|STARTED|Overall Study||31
6264337|NCT00004500|7163233|FG000|1 Year Follow-Up|Overall Study||24
6264338|NCT00004500|7163234|FG001|1 Year Follow-Up|Overall Study||24
6264339|NCT00004500|7163233|FG000|COMPLETED|Overall Study||38
6264340|NCT00004500|7163234|FG001|COMPLETED|Overall Study||31
6264341|NCT00004500|7163233|FG000|NOT COMPLETED|Overall Study||0
6264342|NCT00004500|7163234|FG001|NOT COMPLETED|Overall Study||0
6264343|NCT00004547|7163243|FG000|STARTED|Overall Study||83
6264344|NCT00004547|7163244|FG001|STARTED|Overall Study||48
6264345|NCT00004547|7163245|FG002|STARTED|Overall Study||57
6264346|NCT00004547|7163243|FG000|Not Evaluable|Overall Study||21
6264347|NCT00004547|7163244|FG001|Not Evaluable|Overall Study||9
6264348|NCT00004547|7163245|FG002|Not Evaluable|Overall Study||23
6264349|NCT00004547|7163243|FG000|COMPLETED|Overall Study||61
6264350|NCT00004547|7163244|FG001|COMPLETED|Overall Study||39
6264351|NCT00004547|7163245|FG002|COMPLETED|Overall Study||35
6264352|NCT00004547|7163243|FG000|NOT COMPLETED|Overall Study||22
6264353|NCT00004547|7163244|FG001|NOT COMPLETED|Overall Study||9
6264354|NCT00004547|7163245|FG002|NOT COMPLETED|Overall Study||22
6264355|NCT00004562|7163256|FG000|STARTED|Overall Study||1101
6264356|NCT00004562|7163257|FG001|STARTED|Overall Study||1100
6264357|NCT00004562|7163256|FG000|COMPLETED|Overall Study||999
6264358|NCT00004562|7163257|FG001|COMPLETED|Overall Study||1009
6264359|NCT00004562|7163256|FG000|NOT COMPLETED|Overall Study||102
6264360|NCT00004562|7163257|FG001|NOT COMPLETED|Overall Study||91
6264361|NCT00004563|7163265|FG000|STARTED|Overall Study||79
6264362|NCT00004563|7163266|FG001|STARTED|Overall Study||79
6264363|NCT00004563|7163265|FG000|COMPLETED|Overall Study||54
6264364|NCT00004563|7163266|FG001|COMPLETED|Overall Study||55
6721271|NCT03052751|7651229|FG003|COMPLETED|Dosing Period 2||11
6721272|NCT03052751|7651230|FG004|COMPLETED|Dosing Period 2||10
6721273|NCT03052751|7651231|FG005|COMPLETED|Dosing Period 2||10
6721274|NCT03052751|7651226|FG000|NOT COMPLETED|Dosing Period 2||0
6721275|NCT03052751|7651227|FG001|NOT COMPLETED|Dosing Period 2||0
6721276|NCT03052751|7651228|FG002|NOT COMPLETED|Dosing Period 2||3
6721277|NCT03052751|7651229|FG003|NOT COMPLETED|Dosing Period 2||0
6721278|NCT03052751|7651230|FG004|NOT COMPLETED|Dosing Period 2||0
6721279|NCT03052751|7651231|FG005|NOT COMPLETED|Dosing Period 2||0
6721280|NCT03052751|7651226|FG000|STARTED|Observation Period||22
6721281|NCT03052751|7651227|FG001|STARTED|Observation Period||21
6721282|NCT03052751|7651228|FG002|STARTED|Observation Period||11
6721283|NCT03052751|7651229|FG003|STARTED|Observation Period||11
6721284|NCT03052751|7651230|FG004|STARTED|Observation Period||10
6721285|NCT03052751|7651231|FG005|STARTED|Observation Period||10
6721286|NCT03052751|7651226|FG000|COMPLETED|Observation Period||22
6721287|NCT03052751|7651227|FG001|COMPLETED|Observation Period||21
6721288|NCT03052751|7651228|FG002|COMPLETED|Observation Period||11
6721289|NCT03052751|7651229|FG003|COMPLETED|Observation Period||11
6721290|NCT03052751|7651230|FG004|COMPLETED|Observation Period||9
6721291|NCT03052751|7651231|FG005|COMPLETED|Observation Period||10
6721292|NCT03052751|7651226|FG000|NOT COMPLETED|Observation Period||0
6721293|NCT03052751|7651227|FG001|NOT COMPLETED|Observation Period||0
6721294|NCT03052751|7651228|FG002|NOT COMPLETED|Observation Period||0
6721295|NCT03052751|7651229|FG003|NOT COMPLETED|Observation Period||0
6721296|NCT03052751|7651230|FG004|NOT COMPLETED|Observation Period||1
6721297|NCT03052751|7651231|FG005|NOT COMPLETED|Observation Period||0
6721298|NCT03052764|7651243|FG000|STARTED|Double-Blind Treatment Period||80
6721299|NCT03052764|7651244|FG001|STARTED|Double-Blind Treatment Period||40
6721300|NCT03052764|7651243|FG000|mITT|Double-Blind Treatment Period||78
6721301|NCT03052764|7651244|FG001|mITT|Double-Blind Treatment Period||39
6721302|NCT03052764|7651243|FG000|COMPLETED|Double-Blind Treatment Period||70
6721303|NCT03052764|7651244|FG001|COMPLETED|Double-Blind Treatment Period||37
6721304|NCT03052764|7651243|FG000|NOT COMPLETED|Double-Blind Treatment Period||10
6721305|NCT03052764|7651244|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
6721306|NCT03052764|7651243|FG000|STARTED|Open-Label Re-Treatment Period||58
6721307|NCT03052764|7651244|FG001|STARTED|Open-Label Re-Treatment Period||33
6721308|NCT03052764|7651243|FG000|COMPLETED|Open-Label Re-Treatment Period||58
6721309|NCT03052764|7651244|FG001|COMPLETED|Open-Label Re-Treatment Period||33
6721310|NCT03052764|7651243|FG000|NOT COMPLETED|Open-Label Re-Treatment Period||0
6721311|NCT03052764|7651244|FG001|NOT COMPLETED|Open-Label Re-Treatment Period||0
6721312|NCT03052816|7651254|FG000|STARTED|Overall Study||33
6721313|NCT03052816|7651255|FG001|STARTED|Overall Study||33
6721314|NCT03052816|7651254|FG000|COMPLETED|Overall Study||30
6721315|NCT03052816|7651255|FG001|COMPLETED|Overall Study||33
6721316|NCT03052816|7651254|FG000|NOT COMPLETED|Overall Study||3
6721317|NCT03052816|7651255|FG001|NOT COMPLETED|Overall Study||0
6721318|NCT03052959|7651265|FG000|STARTED|Overall Study||59
6721319|NCT03052959|7651266|FG001|STARTED|Overall Study||66
6721320|NCT03052959|7651265|FG000|COMPLETED|Overall Study||55
6721321|NCT03052959|7651266|FG001|COMPLETED|Overall Study||61
6721322|NCT03052959|7651265|FG000|NOT COMPLETED|Overall Study||4
6721323|NCT03052959|7651266|FG001|NOT COMPLETED|Overall Study||5
6721324|NCT03052972|7651275|FG000|STARTED|Overall Study||18
6721325|NCT03052972|7651276|FG001|STARTED|Overall Study||5
6721326|NCT03052972|7651275|FG000|COMPLETED|Overall Study||18
6721327|NCT03052972|7651276|FG001|COMPLETED|Overall Study||5
6721328|NCT03052972|7651275|FG000|NOT COMPLETED|Overall Study||0
6721329|NCT03052972|7651276|FG001|NOT COMPLETED|Overall Study||0
6721330|NCT03053050|7651286|FG000|STARTED|Randomized Phase||324
6721331|NCT03053050|7651287|FG001|STARTED|Randomized Phase||323
6721332|NCT03053050|7651288|FG002|STARTED|Randomized Phase||161
6721333|NCT03053050|7651289|FG003|STARTED|Randomized Phase||0
6721334|NCT03053050|7651286|FG000|COMPLETED|Randomized Phase||0
6721335|NCT03053050|7651287|FG001|COMPLETED|Randomized Phase||0
6721336|NCT03053050|7651288|FG002|COMPLETED|Randomized Phase||0
6721337|NCT03053050|7651289|FG003|COMPLETED|Randomized Phase||0
6721338|NCT03053050|7651286|FG000|NOT COMPLETED|Randomized Phase||324
6721339|NCT03053050|7651287|FG001|NOT COMPLETED|Randomized Phase||323
6721340|NCT03053050|7651288|FG002|NOT COMPLETED|Randomized Phase||161
6721341|NCT03053050|7651289|FG003|NOT COMPLETED|Randomized Phase||0
6721342|NCT03053050|7651286|FG000|STARTED|Open-label Phase||0
6721343|NCT03053050|7651287|FG001|STARTED|Open-label Phase||0
6721344|NCT03053050|7651288|FG002|STARTED|Open-label Phase||0
6721345|NCT03053050|7651289|FG003|STARTED|Open-label Phase|Participants with hepatic clinical event or progression to cirrhosis had option to go into OL Phase.|99
6721346|NCT03053050|7651286|FG000|COMPLETED|Open-label Phase||0
6721347|NCT03053050|7651287|FG001|COMPLETED|Open-label Phase||0
6721348|NCT03053050|7651288|FG002|COMPLETED|Open-label Phase||0
6721349|NCT03053050|7651289|FG003|COMPLETED|Open-label Phase||0
6721350|NCT03053050|7651286|FG000|NOT COMPLETED|Open-label Phase||0
6721351|NCT03053050|7651287|FG001|NOT COMPLETED|Open-label Phase||0
6721352|NCT03053050|7651288|FG002|NOT COMPLETED|Open-label Phase||0
6721353|NCT03053050|7651289|FG003|NOT COMPLETED|Open-label Phase||99
6721354|NCT03053063|7651301|FG000|STARTED|Randomized Phase||355
6721355|NCT03053063|7651302|FG001|STARTED|Randomized Phase||354
6721356|NCT03053063|7651303|FG002|STARTED|Randomized Phase||174
6721357|NCT03053063|7651304|FG003|STARTED|Randomized Phase||0
6721358|NCT03053063|7651301|FG000|COMPLETED|Randomized Phase||0
6721359|NCT03053063|7651302|FG001|COMPLETED|Randomized Phase||0
6721360|NCT03053063|7651303|FG002|COMPLETED|Randomized Phase||0
6721361|NCT03053063|7651304|FG003|COMPLETED|Randomized Phase||0
6721362|NCT03053063|7651301|FG000|NOT COMPLETED|Randomized Phase||355
6721363|NCT03053063|7651302|FG001|NOT COMPLETED|Randomized Phase||354
6721364|NCT03053063|7651303|FG002|NOT COMPLETED|Randomized Phase||174
6721365|NCT03053063|7651304|FG003|NOT COMPLETED|Randomized Phase||0
6721366|NCT03053063|7651301|FG000|STARTED|Open-Label Phase||0
6721367|NCT03053063|7651302|FG001|STARTED|Open-Label Phase||0
6721368|NCT03053063|7651303|FG002|STARTED|Open-Label Phase||0
6721369|NCT03053063|7651304|FG003|STARTED|Open-Label Phase|Participants who experienced a hepatic clinical event had the option to roll over into the OL Phase.|23
6721370|NCT03053063|7651301|FG000|COMPLETED|Open-Label Phase||0
6721371|NCT03053063|7651302|FG001|COMPLETED|Open-Label Phase||0
6721372|NCT03053063|7651303|FG002|COMPLETED|Open-Label Phase||0
6721373|NCT03053063|7651304|FG003|COMPLETED|Open-Label Phase||0
6721374|NCT03053063|7651301|FG000|NOT COMPLETED|Open-Label Phase||0
6721375|NCT03053063|7651302|FG001|NOT COMPLETED|Open-Label Phase||0
6721376|NCT03053063|7651303|FG002|NOT COMPLETED|Open-Label Phase||0
6721377|NCT03053063|7651304|FG003|NOT COMPLETED|Open-Label Phase||23
6721378|NCT03053102|7651313|FG000|STARTED|Study Part 1: 28-Day Treatment||10
6721379|NCT03053102|7651313|FG000|Received at Least 1 Dose of Study Drug|Study Part 1: 28-Day Treatment||10
6721380|NCT03053102|7651313|FG000|COMPLETED|Study Part 1: 28-Day Treatment||10
6721381|NCT03053102|7651313|FG000|NOT COMPLETED|Study Part 1: 28-Day Treatment||0
6721382|NCT03053102|7651313|FG000|STARTED|Study Part 2: 84-Day Treatment||10
6721383|NCT03053102|7651313|FG000|COMPLETED|Study Part 2: 84-Day Treatment||8
6721384|NCT03053102|7651313|FG000|NOT COMPLETED|Study Part 2: 84-Day Treatment||2
6721385|NCT03053180|7651318|FG000|STARTED|Overall Study||60
6721386|NCT03053180|7651318|FG000|COMPLETED|Overall Study||59
6721387|NCT03053180|7651318|FG000|NOT COMPLETED|Overall Study||1
6721388|NCT03053271|7651322|FG000|STARTED|Overall Study||4
6721389|NCT03053271|7651322|FG000|COMPLETED|Overall Study|All completed the open-label dose escalation, but did not meet criteria for randomization|0
6721390|NCT03053271|7651322|FG000|NOT COMPLETED|Overall Study||4
6721391|NCT03053401|7651328|FG000|STARTED|Overall Study||26
6721392|NCT03053401|7651329|FG001|STARTED|Overall Study||26
6721393|NCT03053401|7651328|FG000|COMPLETED|Overall Study||26
6721394|NCT03053401|7651329|FG001|COMPLETED|Overall Study||26
6721395|NCT03053401|7651328|FG000|NOT COMPLETED|Overall Study||0
6721396|NCT03053401|7651329|FG001|NOT COMPLETED|Overall Study||0
6721397|NCT03053427|7651338|FG000|STARTED|Overall Study||186
6721398|NCT03053427|7651339|FG001|STARTED|Overall Study||189
6721399|NCT03053427|7651338|FG000|COMPLETED|Overall Study||173
6721400|NCT03053427|7651339|FG001|COMPLETED|Overall Study||173
6721401|NCT03053427|7651338|FG000|NOT COMPLETED|Overall Study||13
6721402|NCT03053427|7651339|FG001|NOT COMPLETED|Overall Study||16
6721403|NCT03053492|7651347|FG000|STARTED|Overall Study||33
6721404|NCT03053492|7651348|FG001|STARTED|Overall Study||33
6721405|NCT03053492|7651347|FG000|COMPLETED|Overall Study||25
6721406|NCT03053492|7651348|FG001|COMPLETED|Overall Study||27
6721407|NCT03053492|7651347|FG000|NOT COMPLETED|Overall Study||8
6721408|NCT03053492|7651348|FG001|NOT COMPLETED|Overall Study||6
6721409|NCT03054051|7651356|FG000|STARTED|Overall Study||30
6721410|NCT03054051|7651357|FG001|STARTED|Overall Study||30
6721411|NCT03054051|7651356|FG000|COMPLETED|Overall Study||30
6721412|NCT03054051|7651357|FG001|COMPLETED|Overall Study||30
6721413|NCT03054051|7651356|FG000|NOT COMPLETED|Overall Study||0
6721414|NCT03054051|7651357|FG001|NOT COMPLETED|Overall Study||0
6721415|NCT03054064|7651365|FG000|STARTED|Overall Study||48
6721416|NCT03054064|7651365|FG000|Screen Failure|Overall Study||2
6721417|NCT03054064|7651365|FG000|COMPLETED|Overall Study||42
6721418|NCT03054064|7651365|FG000|NOT COMPLETED|Overall Study||6
6721419|NCT03054077|7651371|FG000|STARTED|Overall Study||12
6721420|NCT03054077|7651372|FG001|STARTED|Overall Study||12
6721421|NCT03054077|7651371|FG000|COMPLETED|Overall Study||12
6721422|NCT03054077|7651372|FG001|COMPLETED|Overall Study||12
6721423|NCT03054077|7651371|FG000|NOT COMPLETED|Overall Study||0
6721424|NCT03054077|7651372|FG001|NOT COMPLETED|Overall Study||0
6721425|NCT03054103|7651381|FG000|STARTED|Overall Study||41
6721426|NCT03054103|7651382|FG001|STARTED|Overall Study||29
6721427|NCT03054103|7651383|FG002|STARTED|Overall Study||35
6721428|NCT03054103|7651381|FG000|COMPLETED|Overall Study||41
6721429|NCT03054103|7651382|FG001|COMPLETED|Overall Study||29
6721430|NCT03054103|7651383|FG002|COMPLETED|Overall Study||35
6721431|NCT03054103|7651381|FG000|NOT COMPLETED|Overall Study||0
6721432|NCT03054103|7651382|FG001|NOT COMPLETED|Overall Study||0
6721433|NCT03054103|7651383|FG002|NOT COMPLETED|Overall Study||0
6721434|NCT03054337|7651397|FG000|STARTED|Primary Efficacy Period (6 Weeks)||12
6721435|NCT03054337|7651398|FG001|STARTED|Primary Efficacy Period (6 Weeks)||12
6721436|NCT03054337|7651399|FG002|STARTED|Primary Efficacy Period (6 Weeks)||13
6721437|NCT03054337|7651400|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
6721438|NCT03054337|7651401|FG004|STARTED|Primary Efficacy Period (6 Weeks)||4
6721439|NCT03054337|7651402|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
6721440|NCT03054337|7651397|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||12
6721441|NCT03054337|7651398|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||12
6721442|NCT03054337|7651399|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
6721443|NCT03054337|7651400|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||5
6721444|NCT03054337|7651401|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||4
6721445|NCT03054337|7651402|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||5
6721446|NCT03054337|7651397|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
6721447|NCT03054337|7651398|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
6721448|NCT03054337|7651399|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
6721449|NCT03054337|7651400|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
6721450|NCT03054337|7651401|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
6721451|NCT03054337|7651402|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||0
6721452|NCT03054337|7651397|FG000|STARTED|Dose Adjustment and Maintenance Period||12
6721453|NCT03054337|7651398|FG001|STARTED|Dose Adjustment and Maintenance Period||12
6721454|NCT03054337|7651399|FG002|STARTED|Dose Adjustment and Maintenance Period||13
6721455|NCT03054337|7651400|FG003|STARTED|Dose Adjustment and Maintenance Period||5
6721456|NCT03054337|7651401|FG004|STARTED|Dose Adjustment and Maintenance Period||4
6721457|NCT03054337|7651402|FG005|STARTED|Dose Adjustment and Maintenance Period||5
6721458|NCT03054337|7651397|FG000|COMPLETED|Dose Adjustment and Maintenance Period||11
6721459|NCT03054337|7651398|FG001|COMPLETED|Dose Adjustment and Maintenance Period||10
6721460|NCT03054337|7651399|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
6721461|NCT03054337|7651400|FG003|COMPLETED|Dose Adjustment and Maintenance Period||5
6721462|NCT03054337|7651401|FG004|COMPLETED|Dose Adjustment and Maintenance Period||4
6721463|NCT03054337|7651402|FG005|COMPLETED|Dose Adjustment and Maintenance Period||4
6721464|NCT03054337|7651397|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
6721465|NCT03054337|7651398|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||2
6721466|NCT03054337|7651399|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
6721467|NCT03054337|7651400|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
6721468|NCT03054337|7651401|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
6721469|NCT03054337|7651402|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
6721470|NCT03054350|7651435|FG000|STARTED|Primary Efficacy Period (6 Weeks)||15
6721471|NCT03054350|7651436|FG001|STARTED|Primary Efficacy Period (6 Weeks)||15
6721472|NCT03054350|7651437|FG002|STARTED|Primary Efficacy Period (6 Weeks)||15
6721473|NCT03054350|7651438|FG003|STARTED|Primary Efficacy Period (6 Weeks)||5
6721474|NCT03054350|7651439|FG004|STARTED|Primary Efficacy Period (6 Weeks)||5
6721475|NCT03054350|7651440|FG005|STARTED|Primary Efficacy Period (6 Weeks)||5
6721476|NCT03054350|7651435|FG000|COMPLETED|Primary Efficacy Period (6 Weeks)||11
6721477|NCT03054350|7651436|FG001|COMPLETED|Primary Efficacy Period (6 Weeks)||13
6721478|NCT03054350|7651437|FG002|COMPLETED|Primary Efficacy Period (6 Weeks)||13
6721479|NCT03054350|7651438|FG003|COMPLETED|Primary Efficacy Period (6 Weeks)||3
6721480|NCT03054350|7651439|FG004|COMPLETED|Primary Efficacy Period (6 Weeks)||1
6721481|NCT03054350|7651440|FG005|COMPLETED|Primary Efficacy Period (6 Weeks)||2
6721482|NCT03054350|7651435|FG000|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
6721483|NCT03054350|7651436|FG001|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
6721484|NCT03054350|7651437|FG002|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
6721485|NCT03054350|7651438|FG003|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||2
6721486|NCT03054350|7651439|FG004|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||4
6721487|NCT03054350|7651440|FG005|NOT COMPLETED|Primary Efficacy Period (6 Weeks)||3
6721488|NCT03054350|7651435|FG000|STARTED|Dose Adjustment and Maintenance Period||11
6721489|NCT03054350|7651436|FG001|STARTED|Dose Adjustment and Maintenance Period||13
6721490|NCT03054350|7651437|FG002|STARTED|Dose Adjustment and Maintenance Period||13
6721491|NCT03054350|7651438|FG003|STARTED|Dose Adjustment and Maintenance Period||3
6721492|NCT03054350|7651439|FG004|STARTED|Dose Adjustment and Maintenance Period||1
6721493|NCT03054350|7651440|FG005|STARTED|Dose Adjustment and Maintenance Period||2
6721494|NCT03054350|7651435|FG000|COMPLETED|Dose Adjustment and Maintenance Period||10
6721495|NCT03054350|7651436|FG001|COMPLETED|Dose Adjustment and Maintenance Period||13
6721496|NCT03054350|7651437|FG002|COMPLETED|Dose Adjustment and Maintenance Period||12
6721497|NCT03054350|7651438|FG003|COMPLETED|Dose Adjustment and Maintenance Period||2
6721498|NCT03054350|7651439|FG004|COMPLETED|Dose Adjustment and Maintenance Period||1
6721499|NCT03054350|7651440|FG005|COMPLETED|Dose Adjustment and Maintenance Period||2
6721500|NCT03054350|7651435|FG000|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
6721501|NCT03054350|7651436|FG001|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
6721502|NCT03054350|7651437|FG002|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
6721503|NCT03054350|7651438|FG003|NOT COMPLETED|Dose Adjustment and Maintenance Period||1
6721504|NCT03054350|7651439|FG004|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
6721505|NCT03054350|7651440|FG005|NOT COMPLETED|Dose Adjustment and Maintenance Period||0
6721506|NCT03054428|7651474|FG000|STARTED|Overall Study||85
6721507|NCT03054428|7651475|FG001|STARTED|Overall Study||84
6721508|NCT03054428|7651476|FG002|STARTED|Overall Study||82
6721509|NCT03054428|7651474|FG000|Completed Wk 16 End of Treatment (EOT)|Overall Study||80
6721510|NCT03054428|7651475|FG001|Completed Wk 16 End of Treatment (EOT)|Overall Study||81
6721511|NCT03054428|7651476|FG002|Completed Wk 16 End of Treatment (EOT)|Overall Study||79
6721512|NCT03054428|7651474|FG000|Completed Week 28 (End of Study)|Overall Study||2
6721513|NCT03054428|7651475|FG001|Completed Week 28 (End of Study)|Overall Study||4
6721514|NCT03054428|7651476|FG002|Completed Week 28 (End of Study)|Overall Study||3
6721515|NCT03054428|7651474|FG000|COMPLETED|Overall Study||2
6721516|NCT03054428|7651475|FG001|COMPLETED|Overall Study||4
6721517|NCT03054428|7651476|FG002|COMPLETED|Overall Study||3
6721518|NCT03054428|7651474|FG000|NOT COMPLETED|Overall Study||83
6721519|NCT03054428|7651475|FG001|NOT COMPLETED|Overall Study||80
6721520|NCT03054428|7651476|FG002|NOT COMPLETED|Overall Study||79
6721521|NCT03054506|7651487|FG000|STARTED|Overall Study||20
6721522|NCT03054506|7651488|FG001|STARTED|Overall Study||11
6721523|NCT03054506|7651489|FG002|STARTED|Overall Study||9
6721524|NCT03054506|7651487|FG000|COMPLETED|Overall Study||19
6721525|NCT03054506|7651488|FG001|COMPLETED|Overall Study||11
6721526|NCT03054506|7651489|FG002|COMPLETED|Overall Study||9
6721527|NCT03054506|7651487|FG000|NOT COMPLETED|Overall Study||1
6721528|NCT03054506|7651488|FG001|NOT COMPLETED|Overall Study||0
6721529|NCT03054506|7651489|FG002|NOT COMPLETED|Overall Study||0
6721530|NCT03054649|7651497|FG000|STARTED|Overall Study||27
6721531|NCT03054649|7651498|FG001|STARTED|Overall Study||27
6721532|NCT03054649|7651497|FG000|COMPLETED|Overall Study||27
6721533|NCT03054649|7651498|FG001|COMPLETED|Overall Study||27
6721534|NCT03054649|7651497|FG000|NOT COMPLETED|Overall Study||0
6721535|NCT03054649|7651498|FG001|NOT COMPLETED|Overall Study||0
6721536|NCT03054740|7651529|FG000|STARTED|Overall Study||15
6721537|NCT03054740|7651530|FG001|STARTED|Overall Study||15
6721538|NCT03054740|7651529|FG000|COMPLETED|Overall Study||15
6721539|NCT03054740|7651530|FG001|COMPLETED|Overall Study||15
6721540|NCT03054740|7651529|FG000|NOT COMPLETED|Overall Study||0
6264365|NCT00004563|7163265|FG000|NOT COMPLETED|Overall Study||25
6264366|NCT00004563|7163266|FG001|NOT COMPLETED|Overall Study||24
6264367|NCT00004635|7163274|FG000|STARTED|Period One||79
6264368|NCT00004635|7163275|FG001|STARTED|Period One||80
6264369|NCT00004635|7163274|FG000|Received Treatment|Period One||73
6264370|NCT00004635|7163275|FG001|Received Treatment|Period One||75
6264371|NCT00004635|7163274|FG000|COMPLETED|Period One||73
6264372|NCT00004635|7163275|FG001|COMPLETED|Period One||74
6264373|NCT00004635|7163274|FG000|NOT COMPLETED|Period One||6
6264374|NCT00004635|7163275|FG001|NOT COMPLETED|Period One||6
6264375|NCT00004635|7163274|FG000|STARTED|Period Two||44
6264376|NCT00004635|7163275|FG001|STARTED|Period Two||59
6264377|NCT00004635|7163274|FG000|COMPLETED|Period Two||38
6264378|NCT00004635|7163275|FG001|COMPLETED|Period Two||50
6264379|NCT00004635|7163274|FG000|NOT COMPLETED|Period Two||6
6264380|NCT00004635|7163275|FG001|NOT COMPLETED|Period Two||9
6264381|NCT00004732|7163286|FG000|STARTED|Overall Study||1262
6264382|NCT00004732|7163287|FG001|STARTED|Overall Study||1240
6264383|NCT00004732|7163286|FG000|COMPLETED|Overall Study||1193
6264384|NCT00004732|7163287|FG001|COMPLETED|Overall Study||1129
6264385|NCT00004732|7163286|FG000|NOT COMPLETED|Overall Study||69
6264386|NCT00004732|7163287|FG001|NOT COMPLETED|Overall Study||111
6264387|NCT00004859|7163297|FG000|STARTED|Overall Study||295
6264388|NCT00004859|7163298|FG001|STARTED|Overall Study||294
6264389|NCT00004859|7163297|FG000|Eligible|Overall Study||275
6264390|NCT00004859|7163298|FG001|Eligible|Overall Study||271
6264391|NCT00004859|7163297|FG000|Treated|Overall Study||289
6264392|NCT00004859|7163298|FG001|Treated|Overall Study||289
6264393|NCT00004859|7163297|FG000|Treated and Having Toxicity Data|Overall Study||289
6264394|NCT00004859|7163298|FG001|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
6264395|NCT00004859|7163297|FG000|COMPLETED|Overall Study||177
6264396|NCT00004859|7163298|FG001|COMPLETED|Overall Study||12
6264397|NCT00004859|7163297|FG000|NOT COMPLETED|Overall Study||118
6264398|NCT00004859|7163298|FG001|NOT COMPLETED|Overall Study||282
6264399|NCT00004888|7163308|FG000|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
6264400|NCT00004888|7163309|FG001|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
6264401|NCT00004888|7163308|FG000|COMPLETED|Overall Study||27
6264402|NCT00004888|7163309|FG001|COMPLETED|Overall Study||22
6264403|NCT00004888|7163308|FG000|NOT COMPLETED|Overall Study||11
6264404|NCT00004888|7163309|FG001|NOT COMPLETED|Overall Study||24
6264405|NCT00004978|7163317|FG000|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
6264406|NCT00004978|7163318|FG001|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
6264407|NCT00004978|7163317|FG000|COMPLETED|Overall Study||1846
6264408|NCT00004978|7163318|FG001|COMPLETED|Overall Study||1790
6264409|NCT00004978|7163317|FG000|NOT COMPLETED|Overall Study||244
6264410|NCT00004978|7163318|FG001|NOT COMPLETED|Overall Study||270
6264411|NCT00004980|7163326|FG000|STARTED|Overall Study||27
6264412|NCT00004980|7163327|FG001|STARTED|Overall Study||23
6264413|NCT00004980|7163326|FG000|COMPLETED|Overall Study||25
6264414|NCT00004980|7163327|FG001|COMPLETED|Overall Study||21
6264415|NCT00004980|7163326|FG000|NOT COMPLETED|Overall Study||2
6264416|NCT00004980|7163327|FG001|NOT COMPLETED|Overall Study||2
6264417|NCT00005044|7163335|FG000|STARTED|Overall Study||790
6264418|NCT00005044|7163336|FG001|STARTED|Overall Study||789
6264419|NCT00005044|7163335|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|752
6264420|NCT00005044|7163336|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|737
6264421|NCT00005044|7163335|FG000|NOT COMPLETED|Overall Study||38
6264422|NCT00005044|7163336|FG001|NOT COMPLETED|Overall Study||52
6264423|NCT00005047|7163346|FG000|STARTED|Overall Study||58
6264424|NCT00005047|7163347|FG001|STARTED|Overall Study||56
6264425|NCT00005047|7163348|FG002|STARTED|Overall Study||227
6264426|NCT00005047|7163349|FG003|STARTED|Overall Study||158
6264427|NCT00005047|7163346|FG000|COMPLETED|Overall Study||39
6264428|NCT00005047|7163347|FG001|COMPLETED|Overall Study||56
6264429|NCT00005047|7163348|FG002|COMPLETED|Overall Study||227
6264430|NCT00005047|7163349|FG003|COMPLETED|Overall Study||158
6264431|NCT00005047|7163346|FG000|NOT COMPLETED|Overall Study||19
6264432|NCT00005047|7163347|FG001|NOT COMPLETED|Overall Study||0
6264433|NCT00005047|7163348|FG002|NOT COMPLETED|Overall Study||0
6264434|NCT00005047|7163349|FG003|NOT COMPLETED|Overall Study||0
6721541|NCT03054740|7651530|FG001|NOT COMPLETED|Overall Study||0
6721542|NCT03054805|7651539|FG000|STARTED|Overall Study||58
6721543|NCT03054805|7651540|FG001|STARTED|Overall Study||51
6721544|NCT03054805|7651541|FG002|STARTED|Overall Study||44
6721545|NCT03054805|7651539|FG000|COMPLETED|Overall Study||42
6721546|NCT03054805|7651540|FG001|COMPLETED|Overall Study||41
6721547|NCT03054805|7651541|FG002|COMPLETED|Overall Study||42
6721548|NCT03054805|7651539|FG000|NOT COMPLETED|Overall Study||16
6721549|NCT03054805|7651540|FG001|NOT COMPLETED|Overall Study||10
6721550|NCT03054805|7651541|FG002|NOT COMPLETED|Overall Study||2
6721551|NCT03054844|7651551|FG000|STARTED|Overall Study||28
6721552|NCT03054844|7651552|FG001|STARTED|Overall Study||27
6721553|NCT03054844|7651551|FG000|COMPLETED|Overall Study||25
6721554|NCT03054844|7651552|FG001|COMPLETED|Overall Study||26
6721555|NCT03054844|7651551|FG000|NOT COMPLETED|Overall Study||3
6721556|NCT03054844|7651552|FG001|NOT COMPLETED|Overall Study||1
6721557|NCT03054857|7651560|FG000|STARTED|Overall Study||50
6721558|NCT03054857|7651561|FG001|STARTED|Overall Study||50
6721559|NCT03054857|7651560|FG000|COMPLETED|Overall Study||49
6721560|NCT03054857|7651561|FG001|COMPLETED|Overall Study||50
6721561|NCT03054857|7651560|FG000|NOT COMPLETED|Overall Study||1
6721562|NCT03054857|7651561|FG001|NOT COMPLETED|Overall Study||0
6721563|NCT03054870|7651571|FG000|STARTED|Day of Ventilation Imaging|16 of 226 enrolled subjects were withdrawn from the study prior to receiving Technegas and were not included in further study assessments.|210
6721564|NCT03054870|7651571|FG000|COMPLETED|Day of Ventilation Imaging||205
6721565|NCT03054870|7651571|FG000|NOT COMPLETED|Day of Ventilation Imaging||5
6721566|NCT03054870|7651571|FG000|STARTED|24-hour Follow-up|24-hour follow-up was omitted from Protocol Amendment 1, so 92 subjects enrolled under Amendment 1 not included.|118
6721567|NCT03054870|7651571|FG000|COMPLETED|24-hour Follow-up||118
6721568|NCT03054870|7651571|FG000|NOT COMPLETED|24-hour Follow-up||0
6721569|NCT03054870|7651571|FG000|STARTED|Blinded Read of Images|At time of study termination, 200 subjects had completed the blinded read assessments. The decision to terminate was based on the positive results of an unplanned interim analysis of these blind read data by a third party statistician.|200
6721570|NCT03054870|7651571|FG000|COMPLETED|Blinded Read of Images||200
6721571|NCT03054870|7651571|FG000|NOT COMPLETED|Blinded Read of Images||0
6721572|NCT03054922|7651589|FG000|STARTED|Overall Study||20
6721573|NCT03054922|7651590|FG001|STARTED|Overall Study||19
6721574|NCT03054922|7651591|FG002|STARTED|Overall Study||20
6721575|NCT03054922|7651589|FG000|COMPLETED|Overall Study||20
6721576|NCT03054922|7651590|FG001|COMPLETED|Overall Study||19
6721577|NCT03054922|7651591|FG002|COMPLETED|Overall Study||20
6721578|NCT03054922|7651589|FG000|NOT COMPLETED|Overall Study||0
6721579|NCT03054922|7651590|FG001|NOT COMPLETED|Overall Study||0
6721580|NCT03054922|7651591|FG002|NOT COMPLETED|Overall Study||0
6721581|NCT03055000|7651602|FG000|STARTED|Overall Study||16
6721582|NCT03055000|7651603|FG001|STARTED|Overall Study||17
6721583|NCT03055000|7651604|FG002|STARTED|Overall Study||16
6721584|NCT03055000|7651602|FG000|COMPLETED|Overall Study||16
6721585|NCT03055000|7651603|FG001|COMPLETED|Overall Study||17
6721586|NCT03055000|7651604|FG002|COMPLETED|Overall Study||16
6721587|NCT03055000|7651602|FG000|NOT COMPLETED|Overall Study||0
6721588|NCT03055000|7651603|FG001|NOT COMPLETED|Overall Study||0
6721589|NCT03055000|7651604|FG002|NOT COMPLETED|Overall Study||0
6721590|NCT03055156|7651614|FG000|STARTED|Overall Study||281
6721591|NCT03055156|7651615|FG001|STARTED|Overall Study||273
6721592|NCT03055156|7651614|FG000|COMPLETED|Overall Study||281
6721593|NCT03055156|7651615|FG001|COMPLETED|Overall Study||273
6721594|NCT03055156|7651614|FG000|NOT COMPLETED|Overall Study||0
6721595|NCT03055156|7651615|FG001|NOT COMPLETED|Overall Study||0
6721596|NCT03055195|7651623|FG000|STARTED|Overall Study||16
6721597|NCT03055195|7651624|FG001|STARTED|Overall Study||18
6721598|NCT03055195|7651623|FG000|COMPLETED|Overall Study||4
6721599|NCT03055195|7651624|FG001|COMPLETED|Overall Study||4
6721600|NCT03055195|7651623|FG000|NOT COMPLETED|Overall Study||12
6721601|NCT03055195|7651624|FG001|NOT COMPLETED|Overall Study||14
6721602|NCT03055221|7651630|FG000|STARTED|Overall Study||16
6721603|NCT03055221|7651630|FG000|COMPLETED|Overall Study||0
6721604|NCT03055221|7651630|FG000|NOT COMPLETED|Overall Study||16
6721605|NCT03055260|7651636|FG000|STARTED|Overall Study||8
6721606|NCT03055260|7651637|FG001|STARTED|Overall Study||0
6721607|NCT03055260|7651636|FG000|COMPLETED|Overall Study||7
6721608|NCT03055260|7651637|FG001|COMPLETED|Overall Study||0
6721609|NCT03055260|7651636|FG000|NOT COMPLETED|Overall Study||1
6721610|NCT03055260|7651637|FG001|NOT COMPLETED|Overall Study||0
6721611|NCT03055338|7651646|FG000|STARTED|Overall Study||90
6721612|NCT03055338|7651647|FG001|STARTED|Overall Study||45
6721613|NCT03055338|7651648|FG002|STARTED|Overall Study||89
6721614|NCT03055338|7651646|FG000|COMPLETED|Overall Study||72
6721615|NCT03055338|7651647|FG001|COMPLETED|Overall Study||34
6721616|NCT03055338|7651648|FG002|COMPLETED|Overall Study||77
6721617|NCT03055338|7651646|FG000|NOT COMPLETED|Overall Study||18
6721618|NCT03055338|7651647|FG001|NOT COMPLETED|Overall Study||11
6721619|NCT03055338|7651648|FG002|NOT COMPLETED|Overall Study||12
6721620|NCT03055494|7651658|FG000|STARTED|Overall Study||54
6721621|NCT03055494|7651659|FG001|STARTED|Overall Study||28
6721622|NCT03055494|7651658|FG000|COMPLETED|Overall Study||44
6721623|NCT03055494|7651659|FG001|COMPLETED|Overall Study||27
6721624|NCT03055494|7651658|FG000|NOT COMPLETED|Overall Study||10
6721625|NCT03055494|7651659|FG001|NOT COMPLETED|Overall Study||1
6721626|NCT03055624|7651666|FG000|STARTED|Overall Study||9
6721627|NCT03055624|7651666|FG000|COMPLETED|Overall Study||0
6721628|NCT03055624|7651666|FG000|NOT COMPLETED|Overall Study||9
6264435|NCT00005669|7163361|FG000|STARTED|Overall Study||53
6721629|NCT03055650|7651670|FG000|STARTED|Overall Study||30
6721630|NCT03055650|7651670|FG000|COMPLETED|Overall Study||30
6721631|NCT03055650|7651670|FG000|NOT COMPLETED|Overall Study||0
6721632|NCT03055806|7651678|FG000|STARTED|Overall Study||48
6721633|NCT03055806|7651679|FG001|STARTED|Overall Study||48
6721634|NCT03055806|7651680|FG002|STARTED|Overall Study||71
6721635|NCT03055806|7651681|FG003|STARTED|Overall Study||72
6721636|NCT03055806|7651678|FG000|COMPLETED|Overall Study||42
6721637|NCT03055806|7651679|FG001|COMPLETED|Overall Study||41
6721638|NCT03055806|7651680|FG002|COMPLETED|Overall Study||58
6721639|NCT03055806|7651681|FG003|COMPLETED|Overall Study||57
6721640|NCT03055806|7651678|FG000|NOT COMPLETED|Overall Study||6
6721641|NCT03055806|7651679|FG001|NOT COMPLETED|Overall Study||7
6721642|NCT03055806|7651680|FG002|NOT COMPLETED|Overall Study||13
6721643|NCT03055806|7651681|FG003|NOT COMPLETED|Overall Study||15
6721644|NCT03055832|7651693|FG000|STARTED|Baseline||71
6721645|NCT03055832|7651694|FG001|STARTED|Baseline||71
6721646|NCT03055832|7651693|FG000|COMPLETED|Baseline||71
6721647|NCT03055832|7651694|FG001|COMPLETED|Baseline||71
6721648|NCT03055832|7651693|FG000|NOT COMPLETED|Baseline||0
6721649|NCT03055832|7651694|FG001|NOT COMPLETED|Baseline||0
6721650|NCT03055832|7651693|FG000|STARTED|Immediately Post-Procedure (Hour 1)||71
6721651|NCT03055832|7651694|FG001|STARTED|Immediately Post-Procedure (Hour 1)||71
6721652|NCT03055832|7651693|FG000|COMPLETED|Immediately Post-Procedure (Hour 1)||71
6721653|NCT03055832|7651694|FG001|COMPLETED|Immediately Post-Procedure (Hour 1)||71
6721654|NCT03055832|7651693|FG000|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
6721655|NCT03055832|7651694|FG001|NOT COMPLETED|Immediately Post-Procedure (Hour 1)||0
6721656|NCT03055832|7651693|FG000|STARTED|Day 1||71
6721657|NCT03055832|7651694|FG001|STARTED|Day 1||71
6721658|NCT03055832|7651693|FG000|COMPLETED|Day 1||71
6721659|NCT03055832|7651694|FG001|COMPLETED|Day 1||71
6721660|NCT03055832|7651693|FG000|NOT COMPLETED|Day 1||0
6721661|NCT03055832|7651694|FG001|NOT COMPLETED|Day 1||0
6721662|NCT03055832|7651693|FG000|STARTED|Week 2||71
6721663|NCT03055832|7651694|FG001|STARTED|Week 2||71
6721664|NCT03055832|7651693|FG000|COMPLETED|Week 2||70
6721665|NCT03055832|7651694|FG001|COMPLETED|Week 2||71
6721666|NCT03055832|7651693|FG000|NOT COMPLETED|Week 2||1
6721667|NCT03055832|7651694|FG001|NOT COMPLETED|Week 2||0
6721668|NCT03055832|7651693|FG000|STARTED|Week 4||70
6721669|NCT03055832|7651694|FG001|STARTED|Week 4||71
6721670|NCT03055832|7651693|FG000|COMPLETED|Week 4||70
6721671|NCT03055832|7651694|FG001|COMPLETED|Week 4||71
6721672|NCT03055832|7651693|FG000|NOT COMPLETED|Week 4||0
6721673|NCT03055832|7651694|FG001|NOT COMPLETED|Week 4||0
6721674|NCT03055858|7651714|FG000|STARTED|Overall Study||200
6721675|NCT03055858|7651714|FG000|IDE Cohort|Overall Study||50
6721676|NCT03055858|7651714|FG000|CAP Cohort|Overall Study||150
6721677|NCT03055858|7651714|FG000|COMPLETED|Overall Study||194
6721678|NCT03055858|7651714|FG000|NOT COMPLETED|Overall Study||6
6721679|NCT03055897|7651718|FG000|STARTED|Overall Study||15
6264436|NCT00005669|7163362|FG001|STARTED|Overall Study||47
6264437|NCT00005669|7163361|FG000|COMPLETED|Overall Study||45
6264438|NCT00005669|7163362|FG001|COMPLETED|Overall Study||40
6264439|NCT00005669|7163361|FG000|NOT COMPLETED|Overall Study||8
6264440|NCT00005669|7163362|FG001|NOT COMPLETED|Overall Study||7
6264441|NCT00005803|7163368|FG000|STARTED|Overall Study||76
6264442|NCT00005803|7163368|FG000|COMPLETED|Overall Study||54
6264443|NCT00005803|7163368|FG000|NOT COMPLETED|Overall Study||22
6264444|NCT00005879|7163377|FG000|STARTED|Overall Study||101
6264445|NCT00005879|7163378|FG001|STARTED|Overall Study||98
6264446|NCT00005879|7163377|FG000|COMPLETED|Overall Study||93
6264447|NCT00005879|7163378|FG001|COMPLETED|Overall Study||88
6264448|NCT00005879|7163377|FG000|NOT COMPLETED|Overall Study||8
6264449|NCT00005879|7163378|FG001|NOT COMPLETED|Overall Study||10
6264450|NCT00005901|7163386|FG000|STARTED|Overall Study||19
6264451|NCT00005901|7163387|FG001|STARTED|Overall Study||15
6264452|NCT00005901|7163386|FG000|COMPLETED|Overall Study||19
6264453|NCT00005901|7163387|FG001|COMPLETED|Overall Study||15
6264454|NCT00005901|7163386|FG000|NOT COMPLETED|Overall Study||0
6264455|NCT00005901|7163387|FG001|NOT COMPLETED|Overall Study||0
6264456|NCT00005906|7163393|FG000|STARTED|Overall Study||4
6264457|NCT00005906|7163393|FG000|COMPLETED|Overall Study||1
6264458|NCT00005906|7163393|FG000|NOT COMPLETED|Overall Study||3
6721680|NCT03055897|7651718|FG000|COMPLETED|Overall Study||15
6721681|NCT03055897|7651718|FG000|NOT COMPLETED|Overall Study||0
6721682|NCT03055936|7651726|FG000|STARTED|Overall Study||14
6721683|NCT03055936|7651727|FG001|STARTED|Overall Study||14
6721684|NCT03055936|7651728|FG002|STARTED|Overall Study||14
6721685|NCT03055936|7651729|FG003|STARTED|Overall Study||14
6721686|NCT03055936|7651726|FG000|COMPLETED|Overall Study||12
6264459|NCT00005908|7163397|FG000|STARTED|Overall Study||10
6264460|NCT00005908|7163398|FG001|STARTED|Overall Study||20
6264461|NCT00005908|7163397|FG000|COMPLETED|Overall Study||9
6721687|NCT03055936|7651727|FG001|COMPLETED|Overall Study||13
6721688|NCT03055936|7651728|FG002|COMPLETED|Overall Study||12
6721689|NCT03055936|7651729|FG003|COMPLETED|Overall Study||13
6721690|NCT03055936|7651726|FG000|NOT COMPLETED|Overall Study||2
6721691|NCT03055936|7651727|FG001|NOT COMPLETED|Overall Study||1
6721692|NCT03055936|7651728|FG002|NOT COMPLETED|Overall Study||2
6721693|NCT03055936|7651729|FG003|NOT COMPLETED|Overall Study||1
6721694|NCT03055988|7651763|FG000|STARTED|Period 1||38
6721695|NCT03055988|7651764|FG001|STARTED|Period 1||38
6721696|NCT03055988|7651763|FG000|COMPLETED|Period 1||37
6721697|NCT03055988|7651764|FG001|COMPLETED|Period 1||33
6721698|NCT03055988|7651763|FG000|NOT COMPLETED|Period 1||1
6721699|NCT03055988|7651764|FG001|NOT COMPLETED|Period 1||5
6721700|NCT03055988|7651763|FG000|STARTED|Period 2||37
6721701|NCT03055988|7651764|FG001|STARTED|Period 2||33
6721702|NCT03055988|7651763|FG000|COMPLETED|Period 2||36
6264462|NCT00005908|7163398|FG001|COMPLETED|Overall Study||20
6264463|NCT00005908|7163397|FG000|NOT COMPLETED|Overall Study||1
6264464|NCT00005908|7163398|FG001|NOT COMPLETED|Overall Study||0
6264465|NCT00005937|7163407|FG000|STARTED|Overall Study||42
6264466|NCT00005937|7163407|FG000|COMPLETED|Overall Study||37
6264467|NCT00005937|7163407|FG000|NOT COMPLETED|Overall Study||5
6264468|NCT00005947|7163413|FG000|STARTED|Overall Study||82
6264469|NCT00005947|7163414|FG001|STARTED|Overall Study||45
6264470|NCT00005947|7163413|FG000|COMPLETED|Overall Study||25
6264471|NCT00005947|7163414|FG001|COMPLETED|Overall Study||4
6264472|NCT00005947|7163413|FG000|NOT COMPLETED|Overall Study||57
6264473|NCT00005947|7163414|FG001|NOT COMPLETED|Overall Study||41
6264474|NCT00005957|7163424|FG000|STARTED|Overall Study||916
6264475|NCT00005957|7163425|FG001|STARTED|Overall Study||916
6264476|NCT00005957|7163424|FG000|COMPLETED|Overall Study||908
6264477|NCT00005957|7163425|FG001|COMPLETED|Overall Study||888
6264478|NCT00005957|7163424|FG000|NOT COMPLETED|Overall Study||8
6264479|NCT00005957|7163425|FG001|NOT COMPLETED|Overall Study||28
6264480|NCT00006011|7163434|FG000|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
6264481|NCT00006011|7163435|FG001|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
6264482|NCT00006011|7163436|FG002|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
6264483|NCT00006011|7163434|FG000|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
6264484|NCT00006011|7163435|FG001|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
6264485|NCT00006011|7163436|FG002|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
6264486|NCT00006011|7163434|FG000|NOT COMPLETED|Overall Study||65
6264487|NCT00006011|7163435|FG001|NOT COMPLETED|Overall Study||77
6264488|NCT00006011|7163436|FG002|NOT COMPLETED|Overall Study||73
6264489|NCT00006046|7163447|FG000|STARTED|Overall Study||7
6264490|NCT00006046|7163448|FG001|STARTED|Overall Study||0
6264491|NCT00006046|7163449|FG002|STARTED|Overall Study||0
6264492|NCT00006046|7163450|FG003|STARTED|Overall Study||0
6264493|NCT00006046|7163451|FG004|STARTED|Overall Study||0
6264494|NCT00006046|7163447|FG000|COMPLETED|Overall Study||2
6264495|NCT00006046|7163448|FG001|COMPLETED|Overall Study||0
6264496|NCT00006046|7163449|FG002|COMPLETED|Overall Study||0
6264497|NCT00006046|7163450|FG003|COMPLETED|Overall Study||0
6264498|NCT00006046|7163451|FG004|COMPLETED|Overall Study||0
6264499|NCT00006046|7163447|FG000|NOT COMPLETED|Overall Study||5
6264500|NCT00006046|7163448|FG001|NOT COMPLETED|Overall Study||0
6264501|NCT00006046|7163449|FG002|NOT COMPLETED|Overall Study||0
6264502|NCT00006046|7163450|FG003|NOT COMPLETED|Overall Study||0
6264503|NCT00006046|7163451|FG004|NOT COMPLETED|Overall Study||0
6264504|NCT00006099|7163465|FG000|STARTED|Overall Study||1
6264505|NCT00006099|7163466|FG001|STARTED|Overall Study||0
6264506|NCT00006099|7163465|FG000|COMPLETED|Overall Study||1
6264507|NCT00006099|7163466|FG001|COMPLETED|Overall Study||0
6264508|NCT00006099|7163465|FG000|NOT COMPLETED|Overall Study||0
6264509|NCT00006099|7163466|FG001|NOT COMPLETED|Overall Study||0
6264510|NCT00006101|7163474|FG000|STARTED|Overall Study||38
6264511|NCT00006101|7163475|FG001|STARTED|Overall Study||38
6264512|NCT00006101|7163474|FG000|COMPLETED|Overall Study||33
6264513|NCT00006101|7163475|FG001|COMPLETED|Overall Study||33
6264514|NCT00006101|7163474|FG000|NOT COMPLETED|Overall Study||5
6264515|NCT00006101|7163475|FG001|NOT COMPLETED|Overall Study||5
6264516|NCT00006110|7163483|FG000|STARTED|Overall Study||52
6264517|NCT00006110|7163484|FG001|STARTED|Overall Study||30
6264518|NCT00006110|7163483|FG000|COMPLETED|Overall Study||52
6264519|NCT00006110|7163484|FG001|COMPLETED|Overall Study||30
6264520|NCT00006110|7163483|FG000|NOT COMPLETED|Overall Study||0
6264521|NCT00006110|7163484|FG001|NOT COMPLETED|Overall Study||0
6264522|NCT00006151|7163498|FG000|STARTED|Overall Study||30
6264523|NCT00006151|7163499|FG001|STARTED|Overall Study||30
6264524|NCT00006151|7163498|FG000|COMPLETED|Overall Study||17
6264525|NCT00006151|7163499|FG001|COMPLETED|Overall Study||16
6264526|NCT00006151|7163498|FG000|NOT COMPLETED|Overall Study||13
6264527|NCT00006151|7163499|FG001|NOT COMPLETED|Overall Study||14
6264528|NCT00006156|7163507|FG000|STARTED|Overall Study||42
6264529|NCT00006156|7163508|FG001|STARTED|Overall Study||7
6264530|NCT00006156|7163507|FG000|COMPLETED|Overall Study||42
6264531|NCT00006156|7163508|FG001|COMPLETED|Overall Study||7
6264532|NCT00006156|7163507|FG000|NOT COMPLETED|Overall Study||0
6264533|NCT00006156|7163508|FG001|NOT COMPLETED|Overall Study||0
6264534|NCT00006164|7163515|FG000|STARTED|Overall Study||517
6264535|NCT00006164|7163516|FG001|STARTED|Overall Study||533
6264536|NCT00006164|7163515|FG000|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
6264537|NCT00006164|7163516|FG001|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
6264538|NCT00006164|7163515|FG000|NOT COMPLETED|Overall Study||70
6264539|NCT00006164|7163516|FG001|NOT COMPLETED|Overall Study||81
6721703|NCT03055988|7651764|FG001|COMPLETED|Period 2||31
6721704|NCT03055988|7651763|FG000|NOT COMPLETED|Period 2||1
6721705|NCT03055988|7651764|FG001|NOT COMPLETED|Period 2||2
6721706|NCT03056040|7651772|FG000|STARTED|Primary Evaluation Period||97
6721707|NCT03056040|7651773|FG001|STARTED|Primary Evaluation Period||98
6721708|NCT03056040|7651772|FG000|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||97
6721709|NCT03056040|7651773|FG001|Received at Least 1 Dose of Study Drug|Primary Evaluation Period||98
6721710|NCT03056040|7651772|FG000|COMPLETED|Primary Evaluation Period||96
6721711|NCT03056040|7651773|FG001|COMPLETED|Primary Evaluation Period||95
6721712|NCT03056040|7651772|FG000|NOT COMPLETED|Primary Evaluation Period||1
6721713|NCT03056040|7651773|FG001|NOT COMPLETED|Primary Evaluation Period||3
6721714|NCT03056040|7651772|FG000|STARTED|Extension Period||96
6721715|NCT03056040|7651773|FG001|STARTED|Extension Period||95
6721716|NCT03056040|7651772|FG000|Received at Least 1 Dose of Ravulizumab|Extension Period||96
6721717|NCT03056040|7651773|FG001|Received at Least 1 Dose of Ravulizumab|Extension Period||95
6721718|NCT03056040|7651772|FG000|COMPLETED|Extension Period||0
6721719|NCT03056040|7651773|FG001|COMPLETED|Extension Period||0
6721720|NCT03056040|7651772|FG000|NOT COMPLETED|Extension Period||96
6721721|NCT03056040|7651773|FG001|NOT COMPLETED|Extension Period||95
6721722|NCT03056144|7651779|FG000|STARTED|Overall Study||1
6721723|NCT03056144|7651779|FG000|COMPLETED|Overall Study||1
6721724|NCT03056144|7651779|FG000|NOT COMPLETED|Overall Study||0
6721725|NCT03056300|7651783|FG000|STARTED|Overall Study||50
6721726|NCT03056300|7651783|FG000|COMPLETED|Overall Study||47
6721727|NCT03056300|7651783|FG000|NOT COMPLETED|Overall Study||3
6721728|NCT03056352|7651787|FG000|STARTED|Overall Study||21
6721729|NCT03056352|7651787|FG000|COMPLETED|Overall Study||20
6721730|NCT03056352|7651787|FG000|NOT COMPLETED|Overall Study||1
6721731|NCT03056456|7651791|FG000|STARTED|Period 1||6
6721732|NCT03056456|7651792|FG001|STARTED|Period 1||6
6721733|NCT03056456|7651793|FG002|STARTED|Period 1||6
6721734|NCT03056456|7651794|FG003|STARTED|Period 1||6
6721735|NCT03056456|7651791|FG000|Received One Dose of Study Drug|Period 1||6
6721736|NCT03056456|7651792|FG001|Received One Dose of Study Drug|Period 1||6
6721737|NCT03056456|7651793|FG002|Received One Dose of Study Drug|Period 1||6
6721738|NCT03056456|7651794|FG003|Received One Dose of Study Drug|Period 1||6
6721739|NCT03056456|7651791|FG000|COMPLETED|Period 1||6
6721740|NCT03056456|7651792|FG001|COMPLETED|Period 1||6
6721741|NCT03056456|7651793|FG002|COMPLETED|Period 1||6
6721742|NCT03056456|7651794|FG003|COMPLETED|Period 1||6
6721743|NCT03056456|7651791|FG000|NOT COMPLETED|Period 1||0
6721744|NCT03056456|7651792|FG001|NOT COMPLETED|Period 1||0
6721745|NCT03056456|7651793|FG002|NOT COMPLETED|Period 1||0
6721746|NCT03056456|7651794|FG003|NOT COMPLETED|Period 1||0
6721747|NCT03056456|7651791|FG000|STARTED|Period 2||6
6721748|NCT03056456|7651792|FG001|STARTED|Period 2||6
6721749|NCT03056456|7651793|FG002|STARTED|Period 2||6
6721750|NCT03056456|7651794|FG003|STARTED|Period 2||6
6721751|NCT03056456|7651791|FG000|COMPLETED|Period 2||6
6721752|NCT03056456|7651792|FG001|COMPLETED|Period 2||6
6721753|NCT03056456|7651793|FG002|COMPLETED|Period 2||6
6721754|NCT03056456|7651794|FG003|COMPLETED|Period 2||6
6721755|NCT03056456|7651791|FG000|NOT COMPLETED|Period 2||0
6721756|NCT03056456|7651792|FG001|NOT COMPLETED|Period 2||0
6721757|NCT03056456|7651793|FG002|NOT COMPLETED|Period 2||0
6721758|NCT03056456|7651794|FG003|NOT COMPLETED|Period 2||0
6721759|NCT03056456|7651791|FG000|STARTED|Period 3||6
6721760|NCT03056456|7651792|FG001|STARTED|Period 3||6
6721761|NCT03056456|7651793|FG002|STARTED|Period 3||6
6721762|NCT03056456|7651794|FG003|STARTED|Period 3||6
6721763|NCT03056456|7651791|FG000|COMPLETED|Period 3||6
6721764|NCT03056456|7651792|FG001|COMPLETED|Period 3||6
6721765|NCT03056456|7651793|FG002|COMPLETED|Period 3||6
6721766|NCT03056456|7651794|FG003|COMPLETED|Period 3||6
6721767|NCT03056456|7651791|FG000|NOT COMPLETED|Period 3||0
6721768|NCT03056456|7651792|FG001|NOT COMPLETED|Period 3||0
6721769|NCT03056456|7651793|FG002|NOT COMPLETED|Period 3||0
6721770|NCT03056456|7651794|FG003|NOT COMPLETED|Period 3||0
6721771|NCT03056456|7651791|FG000|STARTED|Period 4||6
6721772|NCT03056456|7651792|FG001|STARTED|Period 4||6
6721773|NCT03056456|7651793|FG002|STARTED|Period 4||6
6721774|NCT03056456|7651794|FG003|STARTED|Period 4|Participant deviated from 1 week maximum between consecutive periods and did not start Period 4.|5
6721775|NCT03056456|7651791|FG000|COMPLETED|Period 4||6
6721776|NCT03056456|7651792|FG001|COMPLETED|Period 4||6
6721777|NCT03056456|7651793|FG002|COMPLETED|Period 4||6
6721778|NCT03056456|7651794|FG003|COMPLETED|Period 4||5
6721779|NCT03056456|7651791|FG000|NOT COMPLETED|Period 4||0
6721780|NCT03056456|7651792|FG001|NOT COMPLETED|Period 4||0
6721781|NCT03056456|7651793|FG002|NOT COMPLETED|Period 4||0
6721782|NCT03056456|7651794|FG003|NOT COMPLETED|Period 4||0
6721783|NCT03056573|7651809|FG000|STARTED|Overall Study||45
6721784|NCT03056573|7651810|FG001|STARTED|Overall Study||19
6721785|NCT03056573|7651809|FG000|COMPLETED|Overall Study||40
6721786|NCT03056573|7651810|FG001|COMPLETED|Overall Study||14
6721787|NCT03056573|7651809|FG000|NOT COMPLETED|Overall Study||5
6721788|NCT03056573|7651810|FG001|NOT COMPLETED|Overall Study||5
6721789|NCT03056690|7651818|FG000|STARTED|Overall Study||95
6721790|NCT03056690|7651819|FG001|STARTED|Overall Study||91
6721791|NCT03056690|7651818|FG000|Treated|Overall Study||94
6721792|NCT03056690|7651819|FG001|Treated|Overall Study||90
6721793|NCT03056690|7651818|FG000|COMPLETED|Overall Study||81
6721794|NCT03056690|7651819|FG001|COMPLETED|Overall Study||75
6721795|NCT03056690|7651818|FG000|NOT COMPLETED|Overall Study||14
6721796|NCT03056690|7651819|FG001|NOT COMPLETED|Overall Study||16
6721797|NCT03057132|7651825|FG000|STARTED|Overall Study||1
6721798|NCT03057132|7651825|FG000|COMPLETED|Overall Study||1
6721799|NCT03057132|7651825|FG000|NOT COMPLETED|Overall Study||0
6721800|NCT03057366|7651830|FG000|STARTED|Part A||8
6721801|NCT03057366|7651831|FG001|STARTED|Part A||0
6721802|NCT03057366|7651832|FG002|STARTED|Part A||0
6721803|NCT03057366|7651830|FG000|COMPLETED|Part A||8
6721804|NCT03057366|7651831|FG001|COMPLETED|Part A||0
6721805|NCT03057366|7651832|FG002|COMPLETED|Part A||0
6721806|NCT03057366|7651830|FG000|NOT COMPLETED|Part A||0
6721807|NCT03057366|7651831|FG001|NOT COMPLETED|Part A||0
6721808|NCT03057366|7651832|FG002|NOT COMPLETED|Part A||0
6721809|NCT03057366|7651830|FG000|STARTED|Part B||0
6721810|NCT03057366|7651831|FG001|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|5
6721811|NCT03057366|7651832|FG002|STARTED|Part B|Participants completed Part A, met eligibility criteria, and provided consent for Part B.|2
6721812|NCT03057366|7651830|FG000|COMPLETED|Part B||0
6721813|NCT03057366|7651831|FG001|COMPLETED|Part B||5
6721814|NCT03057366|7651832|FG002|COMPLETED|Part B||2
6721815|NCT03057366|7651830|FG000|NOT COMPLETED|Part B||0
6721816|NCT03057366|7651831|FG001|NOT COMPLETED|Part B||0
6721817|NCT03057366|7651832|FG002|NOT COMPLETED|Part B||0
6721818|NCT03057496|7651842|FG000|STARTED|Overall Study||49
6721819|NCT03057496|7651842|FG000|Started Home-use Trial|Overall Study||36
6721820|NCT03057496|7651842|FG000|COMPLETED|Overall Study||31
6721821|NCT03057496|7651842|FG000|NOT COMPLETED|Overall Study||18
6721822|NCT03057613|7651848|FG000|STARTED|Overall Study||18
6721823|NCT03057613|7651848|FG000|COMPLETED|Overall Study||18
6721824|NCT03057613|7651848|FG000|NOT COMPLETED|Overall Study||0
6721825|NCT03057704|7651854|FG000|STARTED|Overall Study||25
6721826|NCT03057704|7651855|FG001|STARTED|Overall Study||25
6721827|NCT03057704|7651854|FG000|COMPLETED|Overall Study||25
6721828|NCT03057704|7651855|FG001|COMPLETED|Overall Study||25
6721829|NCT03057704|7651854|FG000|NOT COMPLETED|Overall Study||0
6721830|NCT03057704|7651855|FG001|NOT COMPLETED|Overall Study||0
6721831|NCT03057977|7651863|FG000|STARTED|Discontinuation From Treatment||1867
6721832|NCT03057977|7651864|FG001|STARTED|Discontinuation From Treatment||1863
6721833|NCT03057977|7651863|FG000|Treated|Discontinuation From Treatment||1863
6721834|NCT03057977|7651864|FG001|Treated|Discontinuation From Treatment||1863
6721835|NCT03057977|7651863|FG000|COMPLETED|Discontinuation From Treatment||1352
6721836|NCT03057977|7651864|FG001|COMPLETED|Discontinuation From Treatment||1381
6721837|NCT03057977|7651863|FG000|NOT COMPLETED|Discontinuation From Treatment||515
6721838|NCT03057977|7651864|FG001|NOT COMPLETED|Discontinuation From Treatment||482
6721839|NCT03057977|7651863|FG000|STARTED|Discontinuation From Trial||1867
6721840|NCT03057977|7651864|FG001|STARTED|Discontinuation From Trial||1863
6721841|NCT03057977|7651863|FG000|Treated|Discontinuation From Trial||1863
6721842|NCT03057977|7651864|FG001|Treated|Discontinuation From Trial||1863
6721843|NCT03057977|7651863|FG000|COMPLETED|Discontinuation From Trial||1847
6721844|NCT03057977|7651864|FG001|COMPLETED|Discontinuation From Trial||1841
6721845|NCT03057977|7651863|FG000|NOT COMPLETED|Discontinuation From Trial||20
6721846|NCT03057977|7651864|FG001|NOT COMPLETED|Discontinuation From Trial||22
6721847|NCT03058679|7651872|FG000|STARTED|Baseline to Week 6|3 randomized to SCD withdrew before starting diet;2 randomized pts w/ baseline sCDAI<150 excluded.|99
6721848|NCT03058679|7651873|FG001|STARTED|Baseline to Week 6|Due to an error 1 participant was randomized with a baseline sCDAI<150. This pt was excluded.|92
6721849|NCT03058679|7651872|FG000|COMPLETED|Baseline to Week 6||81
6721850|NCT03058679|7651873|FG001|COMPLETED|Baseline to Week 6||77
6721851|NCT03058679|7651872|FG000|NOT COMPLETED|Baseline to Week 6||18
6721852|NCT03058679|7651873|FG001|NOT COMPLETED|Baseline to Week 6||15
6721853|NCT03058679|7651872|FG000|STARTED|Week 6 to Week 12||81
6721854|NCT03058679|7651873|FG001|STARTED|Week 6 to Week 12||77
6721855|NCT03058679|7651872|FG000|COMPLETED|Week 6 to Week 12||61
6721856|NCT03058679|7651873|FG001|COMPLETED|Week 6 to Week 12||60
6721857|NCT03058679|7651872|FG000|NOT COMPLETED|Week 6 to Week 12||20
6721858|NCT03058679|7651873|FG001|NOT COMPLETED|Week 6 to Week 12||17
6721859|NCT03058692|7651881|FG000|STARTED|Overall Study||61
6721860|NCT03058692|7651882|FG001|STARTED|Overall Study||59
6721861|NCT03058692|7651881|FG000|COMPLETED|Overall Study||58
6721862|NCT03058692|7651882|FG001|COMPLETED|Overall Study||57
6721863|NCT03058692|7651881|FG000|NOT COMPLETED|Overall Study||3
6721864|NCT03058692|7651882|FG001|NOT COMPLETED|Overall Study||2
6721865|NCT03058991|7651892|FG000|STARTED|Overall Study||39
6721866|NCT03058991|7651893|FG001|STARTED|Overall Study||32
6721867|NCT03058991|7651894|FG002|STARTED|Overall Study||37
6721868|NCT03058991|7651892|FG000|1-Week Follow Up|Overall Study||23
6721869|NCT03058991|7651893|FG001|1-Week Follow Up|Overall Study||27
6721870|NCT03058991|7651894|FG002|1-Week Follow Up|Overall Study||28
6721871|NCT03058991|7651892|FG000|COMPLETED|Overall Study||21
6721872|NCT03058991|7651893|FG001|COMPLETED|Overall Study||20
6721873|NCT03058991|7651894|FG002|COMPLETED|Overall Study||25
6721874|NCT03058991|7651892|FG000|NOT COMPLETED|Overall Study||18
6721875|NCT03058991|7651893|FG001|NOT COMPLETED|Overall Study||12
6721876|NCT03058991|7651894|FG002|NOT COMPLETED|Overall Study||12
6721877|NCT03059810|7651902|FG000|STARTED|Overall Study||63
6721878|NCT03059810|7651902|FG000|COMPLETED|Overall Study||63
6721879|NCT03059810|7651902|FG000|NOT COMPLETED|Overall Study||0
6721880|NCT03059901|7651908|FG000|STARTED|Overall Study||30
6721881|NCT03059901|7651909|FG001|STARTED|Overall Study||30
6721882|NCT03059901|7651908|FG000|COMPLETED|Overall Study||26
6721883|NCT03059901|7651909|FG001|COMPLETED|Overall Study||28
6721884|NCT03059901|7651908|FG000|NOT COMPLETED|Overall Study||4
6721885|NCT03059901|7651909|FG001|NOT COMPLETED|Overall Study||2
6721886|NCT03060447|7651917|FG000|STARTED|Overall Study||17
6721887|NCT03060447|7651918|FG001|STARTED|Overall Study||8
6721888|NCT03060447|7651917|FG000|COMPLETED|Overall Study||15
6721889|NCT03060447|7651918|FG001|COMPLETED|Overall Study||8
6721890|NCT03060447|7651917|FG000|NOT COMPLETED|Overall Study||2
6721891|NCT03060447|7651918|FG001|NOT COMPLETED|Overall Study||0
6721892|NCT03060486|7651930|FG000|STARTED|Overall Study||15
6721893|NCT03060486|7651930|FG000|COMPLETED|Overall Study||15
6721894|NCT03060486|7651930|FG000|NOT COMPLETED|Overall Study||0
6721895|NCT03060512|7651936|FG000|STARTED|Overall Study||137
6721896|NCT03060512|7651937|FG001|STARTED|Overall Study||139
6721897|NCT03060512|7651936|FG000|Treated With Movantik|Overall Study||136
6721898|NCT03060512|7651937|FG001|Treated With Movantik|Overall Study||135
6721899|NCT03060512|7651936|FG000|Treated With PEG 3350|Overall Study||130
6721900|NCT03060512|7651937|FG001|Treated With PEG 3350|Overall Study||138
6721901|NCT03060512|7651936|FG000|COMPLETED|Overall Study||130
6721902|NCT03060512|7651937|FG001|COMPLETED|Overall Study||130
6721903|NCT03060512|7651936|FG000|NOT COMPLETED|Overall Study||7
6721904|NCT03060512|7651937|FG001|NOT COMPLETED|Overall Study||9
6721905|NCT03060551|7651948|FG000|STARTED|Overall Study||20
6721906|NCT03060551|7651948|FG000|COMPLETED|Overall Study||18
6721907|NCT03060551|7651948|FG000|NOT COMPLETED|Overall Study||2
6721908|NCT03060759|7651954|FG000|STARTED|Overall Study||20
6721909|NCT03060759|7651955|FG001|STARTED|Overall Study||15
6721910|NCT03060759|7651954|FG000|COMPLETED|Overall Study||15
6721911|NCT03060759|7651955|FG001|COMPLETED|Overall Study||12
6721912|NCT03060759|7651954|FG000|NOT COMPLETED|Overall Study||5
6721913|NCT03060759|7651955|FG001|NOT COMPLETED|Overall Study||3
6721914|NCT03061097|7651963|FG000|STARTED|Overall Study||4
6721915|NCT03061097|7651964|FG001|STARTED|Overall Study||3
6721916|NCT03061097|7651963|FG000|COMPLETED|Overall Study||4
6721917|NCT03061097|7651964|FG001|COMPLETED|Overall Study||0
6721918|NCT03061097|7651963|FG000|NOT COMPLETED|Overall Study||0
6721919|NCT03061097|7651964|FG001|NOT COMPLETED|Overall Study||3
6721920|NCT03061175|7651972|FG000|STARTED|Baseline||47
6721921|NCT03061175|7651973|FG001|STARTED|Baseline||47
6721922|NCT03061175|7651972|FG000|COMPLETED|Baseline||46
6721923|NCT03061175|7651973|FG001|COMPLETED|Baseline||47
6721924|NCT03061175|7651972|FG000|NOT COMPLETED|Baseline||1
6721925|NCT03061175|7651973|FG001|NOT COMPLETED|Baseline||0
6721926|NCT03061175|7651972|FG000|STARTED|Followup 1 at 2-4 Weeks Post-surgery|1 Participant dropped out of the study before the follow-up survey was to be sent|45
6721927|NCT03061175|7651973|FG001|STARTED|Followup 1 at 2-4 Weeks Post-surgery||47
6721928|NCT03061175|7651972|FG000|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|39 participants completed the follow-up survey out of the 45 who were sent the survey|39
6721929|NCT03061175|7651973|FG001|COMPLETED|Followup 1 at 2-4 Weeks Post-surgery|44 participants completed the follow-up survey out of the 47 who were sent the survey|44
6721930|NCT03061175|7651972|FG000|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||6
6721931|NCT03061175|7651973|FG001|NOT COMPLETED|Followup 1 at 2-4 Weeks Post-surgery||3
6721932|NCT03061175|7651972|FG000|STARTED|Followup 2 at 6 Months|Participants who skipped the first follow-up survey were still sent the second FU survey|45
6721933|NCT03061175|7651973|FG001|STARTED|Followup 2 at 6 Months|1 participant withdrew from the study in between the 1st and 2nd follow-up survey so only 46 sent|46
6721934|NCT03061175|7651972|FG000|COMPLETED|Followup 2 at 6 Months|41 participants completed the 2nd follow-up survey out of the 45 who were sent the survey|41
6721935|NCT03061175|7651973|FG001|COMPLETED|Followup 2 at 6 Months|39 participants completed the follow-up survey out of the 46 who were sent the survey|39
6721936|NCT03061175|7651972|FG000|NOT COMPLETED|Followup 2 at 6 Months||4
6264540|NCT00006170|7163526|FG000|STARTED|Overall Study||106
6264541|NCT00006170|7163527|FG001|STARTED|Overall Study||87
6264542|NCT00006170|7163528|FG002|STARTED|Overall Study||89
6264543|NCT00006170|7163529|FG003|STARTED|Overall Study||67
6264544|NCT00006170|7163526|FG000|COMPLETED|Overall Study||57
6264545|NCT00006170|7163527|FG001|COMPLETED|Overall Study||37
6264546|NCT00006170|7163528|FG002|COMPLETED|Overall Study||46
6264547|NCT00006170|7163529|FG003|COMPLETED|Overall Study||28
6264548|NCT00006170|7163526|FG000|NOT COMPLETED|Overall Study||49
6264549|NCT00006170|7163527|FG001|NOT COMPLETED|Overall Study||50
6264550|NCT00006170|7163528|FG002|NOT COMPLETED|Overall Study||43
6264551|NCT00006170|7163529|FG003|NOT COMPLETED|Overall Study||39
6280466|NCT00156936|7180422|FG000|STARTED|Overall Study||92
6280467|NCT00156936|7180423|FG001|STARTED|Overall Study||16
6280468|NCT00156936|7180422|FG000|COMPLETED|Overall Study||20
6280469|NCT00156936|7180423|FG001|COMPLETED|Overall Study||5
6280470|NCT00156936|7180422|FG000|NOT COMPLETED|Overall Study||72
6280471|NCT00156936|7180423|FG001|NOT COMPLETED|Overall Study||11
6280472|NCT00157014|7180433|FG000|STARTED|Overall Study||52
6280473|NCT00157014|7180434|FG001|STARTED|Overall Study||46
6280474|NCT00157014|7180435|FG002|STARTED|Overall Study||5
6280475|NCT00157014|7180436|FG003|STARTED|Overall Study||6
6280476|NCT00157014|7180433|FG000|COMPLETED|Overall Study||45
6280477|NCT00157014|7180434|FG001|COMPLETED|Overall Study||41
6280478|NCT00157014|7180435|FG002|COMPLETED|Overall Study||4
6280479|NCT00157014|7180436|FG003|COMPLETED|Overall Study||5
6280480|NCT00157014|7180433|FG000|NOT COMPLETED|Overall Study||7
6280481|NCT00157014|7180434|FG001|NOT COMPLETED|Overall Study||5
6721937|NCT03061175|7651973|FG001|NOT COMPLETED|Followup 2 at 6 Months||7
6721938|NCT03061188|7651983|FG000|STARTED|Completed 1st Cycle||0
6721939|NCT03061188|7651984|FG001|STARTED|Completed 1st Cycle||3
6721940|NCT03061188|7651985|FG002|STARTED|Completed 1st Cycle||6
6721941|NCT03061188|7651986|FG003|STARTED|Completed 1st Cycle||6
6721942|NCT03061188|7651983|FG000|COMPLETED|Completed 1st Cycle||0
6721943|NCT03061188|7651984|FG001|COMPLETED|Completed 1st Cycle||3
6721944|NCT03061188|7651985|FG002|COMPLETED|Completed 1st Cycle||6
6721945|NCT03061188|7651986|FG003|COMPLETED|Completed 1st Cycle||6
6721946|NCT03061188|7651983|FG000|NOT COMPLETED|Completed 1st Cycle||0
6721947|NCT03061188|7651984|FG001|NOT COMPLETED|Completed 1st Cycle||0
6721948|NCT03061188|7651985|FG002|NOT COMPLETED|Completed 1st Cycle||0
6721949|NCT03061188|7651986|FG003|NOT COMPLETED|Completed 1st Cycle||0
6721950|NCT03061188|7651983|FG000|STARTED|Went on to Cycle 2 and Beyond||0
6721951|NCT03061188|7651984|FG001|STARTED|Went on to Cycle 2 and Beyond||3
6721952|NCT03061188|7651985|FG002|STARTED|Went on to Cycle 2 and Beyond||6
6721953|NCT03061188|7651986|FG003|STARTED|Went on to Cycle 2 and Beyond||6
6721954|NCT03061188|7651983|FG000|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||0
6721955|NCT03061188|7651984|FG001|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||3
6721956|NCT03061188|7651985|FG002|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
6721957|NCT03061188|7651986|FG003|Received Dose of Study Drugs|Went on to Cycle 2 and Beyond||5
6721958|NCT03061188|7651983|FG000|COMPLETED|Went on to Cycle 2 and Beyond||0
6721959|NCT03061188|7651984|FG001|COMPLETED|Went on to Cycle 2 and Beyond||3
6721960|NCT03061188|7651985|FG002|COMPLETED|Went on to Cycle 2 and Beyond||5
6721961|NCT03061188|7651986|FG003|COMPLETED|Went on to Cycle 2 and Beyond||5
6721962|NCT03061188|7651983|FG000|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
6721963|NCT03061188|7651984|FG001|NOT COMPLETED|Went on to Cycle 2 and Beyond||0
6721964|NCT03061188|7651985|FG002|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
6721965|NCT03061188|7651986|FG003|NOT COMPLETED|Went on to Cycle 2 and Beyond||1
6721966|NCT03061188|7651983|FG000|STARTED|On Follow-up for 3 Years||0
6721967|NCT03061188|7651984|FG001|STARTED|On Follow-up for 3 Years||3
6721968|NCT03061188|7651985|FG002|STARTED|On Follow-up for 3 Years|Patients who received at least one dose of study drug go into follow-up.|6
6721969|NCT03061188|7651986|FG003|STARTED|On Follow-up for 3 Years|Patients who receive at least one dose of study drug go into follow-up.|6
6721970|NCT03061188|7651983|FG000|COMPLETED|On Follow-up for 3 Years||0
6721971|NCT03061188|7651984|FG001|COMPLETED|On Follow-up for 3 Years||0
6721972|NCT03061188|7651985|FG002|COMPLETED|On Follow-up for 3 Years||1
6721973|NCT03061188|7651986|FG003|COMPLETED|On Follow-up for 3 Years||1
6721974|NCT03061188|7651983|FG000|NOT COMPLETED|On Follow-up for 3 Years||0
6264558|NCT04323800|7163547|FG000|STARTED|Overall Study||87
6264559|NCT04323800|7163548|FG001|STARTED|Overall Study||93
6264560|NCT04323800|7163547|FG000|COMPLETED|Overall Study||81
6264561|NCT04323800|7163548|FG001|COMPLETED|Overall Study||87
6264562|NCT04323800|7163547|FG000|NOT COMPLETED|Overall Study||6
6264563|NCT04323800|7163548|FG001|NOT COMPLETED|Overall Study||6
6264564|NCT04279925|7163556|FG000|STARTED|Overall Study||4
6264565|NCT04279925|7163557|FG001|STARTED|Overall Study||5
6264566|NCT04279925|7163556|FG000|COMPLETED|Overall Study||4
6264567|NCT04279925|7163557|FG001|COMPLETED|Overall Study||5
6264568|NCT04279925|7163556|FG000|NOT COMPLETED|Overall Study||0
6264569|NCT04279925|7163557|FG001|NOT COMPLETED|Overall Study||0
6264570|NCT04110145|7163568|FG000|STARTED|Double-Blind Treatment Period (4 Weeks)||7
6264571|NCT04110145|7163569|FG001|STARTED|Double-Blind Treatment Period (4 Weeks)||7
6264572|NCT04110145|7163570|FG002|STARTED|Double-Blind Treatment Period (4 Weeks)||6
6264573|NCT04110145|7163571|FG003|STARTED|Double-Blind Treatment Period (4 Weeks)||7
6264574|NCT04110145|7163572|FG004|STARTED|Double-Blind Treatment Period (4 Weeks)||8
6602873|NCT02059148|7527882|FG004|NOT COMPLETED|Treatment 3||0
6602874|NCT02059148|7527883|FG005|NOT COMPLETED|Treatment 3||0
6602875|NCT02059161|7527896|FG000|STARTED|Overall Study||245
6602876|NCT02059161|7527897|FG001|STARTED|Overall Study||263
6602877|NCT02059161|7527896|FG000|Treated|Overall Study||241
6602878|NCT02059161|7527897|FG001|Treated|Overall Study||258
6602879|NCT02059161|7527896|FG000|COMPLETED|Overall Study||196
6602880|NCT02059161|7527897|FG001|COMPLETED|Overall Study||222
6602881|NCT02059161|7527896|FG000|NOT COMPLETED|Overall Study||49
6602882|NCT02059161|7527897|FG001|NOT COMPLETED|Overall Study||41
6602883|NCT02059174|7527903|FG000|STARTED|Period 1||37
6602884|NCT02059174|7527904|FG001|STARTED|Period 1||39
6602885|NCT02059174|7527903|FG000|COMPLETED|Period 1||37
6602886|NCT02059174|7527904|FG001|COMPLETED|Period 1||37
6602887|NCT02059174|7527903|FG000|NOT COMPLETED|Period 1||0
6602888|NCT02059174|7527904|FG001|NOT COMPLETED|Period 1||2
6602889|NCT02059174|7527903|FG000|STARTED|Period 2||37
6602890|NCT02059174|7527904|FG001|STARTED|Period 2||37
6602891|NCT02059174|7527903|FG000|COMPLETED|Period 2||36
6602892|NCT02059174|7527904|FG001|COMPLETED|Period 2||35
6602893|NCT02059174|7527903|FG000|NOT COMPLETED|Period 2||1
6721975|NCT03061188|7651984|FG001|NOT COMPLETED|On Follow-up for 3 Years||3
6721976|NCT03061188|7651985|FG002|NOT COMPLETED|On Follow-up for 3 Years||5
6721977|NCT03061188|7651986|FG003|NOT COMPLETED|On Follow-up for 3 Years||5
6602894|NCT02059174|7527904|FG001|NOT COMPLETED|Period 2||2
6602895|NCT02059174|7527903|FG000|STARTED|Period 3||36
6602896|NCT02059174|7527904|FG001|STARTED|Period 3||35
6602897|NCT02059174|7527903|FG000|COMPLETED|Period 3||35
6602898|NCT02059174|7527904|FG001|COMPLETED|Period 3||35
6602899|NCT02059174|7527903|FG000|NOT COMPLETED|Period 3||1
6721978|NCT03061214|7652004|FG000|STARTED|Overall Study||288
6721979|NCT03061214|7652005|FG001|STARTED|Overall Study||290
6721980|NCT03061214|7652006|FG002|STARTED|Overall Study||290
6721981|NCT03061214|7652004|FG000|Exposed|Overall Study||287
6721982|NCT03061214|7652005|FG001|Exposed|Overall Study||290
6721983|NCT03061214|7652006|FG002|Exposed|Overall Study||290
6721984|NCT03061214|7652004|FG000|Full Analysis Set (FAS)|Overall Study||288
6721985|NCT03061214|7652005|FG001|Full Analysis Set (FAS)|Overall Study||290
6721986|NCT03061214|7652006|FG002|Full Analysis Set (FAS)|Overall Study||290
6721987|NCT03061214|7652004|FG000|Safety Analysis Set (SAS)|Overall Study||287
6721988|NCT03061214|7652005|FG001|Safety Analysis Set (SAS)|Overall Study||290
6721989|NCT03061214|7652006|FG002|Safety Analysis Set (SAS)|Overall Study||290
6721990|NCT03061214|7652004|FG000|COMPLETED|Overall Study||263
6721991|NCT03061214|7652005|FG001|COMPLETED|Overall Study||262
6721992|NCT03061214|7652006|FG002|COMPLETED|Overall Study||280
6721993|NCT03061214|7652004|FG000|NOT COMPLETED|Overall Study||25
6721994|NCT03061214|7652005|FG001|NOT COMPLETED|Overall Study||28
6721995|NCT03061214|7652006|FG002|NOT COMPLETED|Overall Study||10
6721996|NCT03061331|7652016|FG000|STARTED|Treatment Period 1 (8 Weeks)||10
6721997|NCT03061331|7652017|FG001|STARTED|Treatment Period 1 (8 Weeks)||10
6721998|NCT03061331|7652016|FG000|COMPLETED|Treatment Period 1 (8 Weeks)||10
6721999|NCT03061331|7652017|FG001|COMPLETED|Treatment Period 1 (8 Weeks)||10
6722000|NCT03061331|7652016|FG000|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
6722001|NCT03061331|7652017|FG001|NOT COMPLETED|Treatment Period 1 (8 Weeks)||0
6722002|NCT03061331|7652016|FG000|STARTED|Washout Period (8 Weeks)||10
6722003|NCT03061331|7652017|FG001|STARTED|Washout Period (8 Weeks)||10
6722004|NCT03061331|7652016|FG000|COMPLETED|Washout Period (8 Weeks)||8
6722005|NCT03061331|7652017|FG001|COMPLETED|Washout Period (8 Weeks)||9
6722006|NCT03061331|7652016|FG000|NOT COMPLETED|Washout Period (8 Weeks)||2
6722007|NCT03061331|7652017|FG001|NOT COMPLETED|Washout Period (8 Weeks)||1
6722008|NCT03061331|7652016|FG000|STARTED|Treatment Period 2 (8 Weeks)||8
6722009|NCT03061331|7652017|FG001|STARTED|Treatment Period 2 (8 Weeks)||9
6722010|NCT03061331|7652016|FG000|COMPLETED|Treatment Period 2 (8 Weeks)||8
6722011|NCT03061331|7652017|FG001|COMPLETED|Treatment Period 2 (8 Weeks)||9
6722012|NCT03061331|7652016|FG000|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6722013|NCT03061331|7652017|FG001|NOT COMPLETED|Treatment Period 2 (8 Weeks)||0
6722014|NCT03061513|7652025|FG000|STARTED|Overall Study||6
6722015|NCT03061513|7652026|FG001|STARTED|Overall Study||5
6722016|NCT03061513|7652025|FG000|COMPLETED|Overall Study||6
6722017|NCT03061513|7652026|FG001|COMPLETED|Overall Study||4
6722018|NCT03061513|7652025|FG000|NOT COMPLETED|Overall Study||0
6722019|NCT03061513|7652026|FG001|NOT COMPLETED|Overall Study||1
6722020|NCT03061812|7652034|FG000|STARTED|Overall Study||148
6722021|NCT03061812|7652035|FG001|STARTED|Overall Study||296
6722022|NCT03061812|7652034|FG000|COMPLETED|Overall Study||148
6722023|NCT03061812|7652035|FG001|COMPLETED|Overall Study||296
6722024|NCT03061812|7652034|FG000|NOT COMPLETED|Overall Study||0
6722025|NCT03061812|7652035|FG001|NOT COMPLETED|Overall Study||0
6722026|NCT03062228|7652041|FG000|STARTED|Overall Study||162
6722027|NCT03062228|7652041|FG000|COMPLETED|Overall Study||162
6722028|NCT03062228|7652041|FG000|NOT COMPLETED|Overall Study||0
6722029|NCT03062267|7652047|FG000|STARTED|Overall Study||12
6722030|NCT03062267|7652048|FG001|STARTED|Overall Study||37
6722031|NCT03062267|7652047|FG000|COMPLETED|Overall Study||10
6722032|NCT03062267|7652048|FG001|COMPLETED|Overall Study||32
6722033|NCT03062267|7652047|FG000|NOT COMPLETED|Overall Study||2
6722034|NCT03062267|7652048|FG001|NOT COMPLETED|Overall Study||5
6722035|NCT03062488|7652057|FG000|STARTED|Overall Study||51
6722036|NCT03062488|7652058|FG001|STARTED|Overall Study||51
6722037|NCT03062488|7652059|FG002|STARTED|Overall Study||41
6722038|NCT03062488|7652057|FG000|COMPLETED|Overall Study||51
6722039|NCT03062488|7652058|FG001|COMPLETED|Overall Study||51
6722040|NCT03062488|7652059|FG002|COMPLETED|Overall Study||41
6722041|NCT03062488|7652057|FG000|NOT COMPLETED|Overall Study||0
6722042|NCT03062488|7652058|FG001|NOT COMPLETED|Overall Study||0
6722043|NCT03062488|7652059|FG002|NOT COMPLETED|Overall Study||0
6722044|NCT03062605|7652069|FG000|STARTED|Overall Study||25
6722045|NCT03062605|7652070|FG001|STARTED|Overall Study||23
6722046|NCT03062605|7652069|FG000|COMPLETED|Overall Study||14
6722047|NCT03062605|7652070|FG001|COMPLETED|Overall Study||13
6722048|NCT03062605|7652069|FG000|NOT COMPLETED|Overall Study||11
6722049|NCT03062605|7652070|FG001|NOT COMPLETED|Overall Study||10
6722050|NCT03062891|7652078|FG000|STARTED|Overall Study||99
6722051|NCT03062891|7652079|FG001|STARTED|Overall Study||100
6722052|NCT03062891|7652078|FG000|Mid-intervention|Overall Study||68
6722053|NCT03062891|7652079|FG001|Mid-intervention|Overall Study||74
6722054|NCT03062891|7652078|FG000|End of Intervention|Overall Study||67
6722055|NCT03062891|7652079|FG001|End of Intervention|Overall Study||78
6722056|NCT03062891|7652078|FG000|Followup|Overall Study||47
6722057|NCT03062891|7652079|FG001|Followup|Overall Study||62
6722058|NCT03062891|7652078|FG000|COMPLETED|Overall Study||47
6722059|NCT03062891|7652079|FG001|COMPLETED|Overall Study||62
6722060|NCT03062891|7652078|FG000|NOT COMPLETED|Overall Study||52
6722061|NCT03062891|7652079|FG001|NOT COMPLETED|Overall Study||38
6722062|NCT03062917|7652091|FG000|STARTED|Overall Study||32
6722063|NCT03062917|7652092|FG001|STARTED|Overall Study||51
6722064|NCT03062917|7652093|FG002|STARTED|Overall Study||49
6722065|NCT03062917|7652094|FG003|STARTED|Overall Study||20
6722066|NCT03062917|7652095|FG004|STARTED|Overall Study||0
6722067|NCT03062917|7652091|FG000|COMPLETED|Overall Study||32
6722068|NCT03062917|7652092|FG001|COMPLETED|Overall Study||51
6722069|NCT03062917|7652093|FG002|COMPLETED|Overall Study||49
6722070|NCT03062917|7652094|FG003|COMPLETED|Overall Study||20
6722071|NCT03062917|7652095|FG004|COMPLETED|Overall Study||0
6722072|NCT03062917|7652091|FG000|NOT COMPLETED|Overall Study||0
6722073|NCT03062917|7652092|FG001|NOT COMPLETED|Overall Study||0
6722074|NCT03062917|7652093|FG002|NOT COMPLETED|Overall Study||0
6722075|NCT03062917|7652094|FG003|NOT COMPLETED|Overall Study||0
6722076|NCT03062917|7652095|FG004|NOT COMPLETED|Overall Study||0
6722077|NCT03063086|7652106|FG000|STARTED|Overall Study||19
6722078|NCT03063086|7652107|FG001|STARTED|Overall Study||20
6722079|NCT03063086|7652108|FG002|STARTED|Overall Study||18
6722080|NCT03063086|7652109|FG003|STARTED|Overall Study||20
6722081|NCT03063086|7652110|FG004|STARTED|Overall Study||20
6722082|NCT03063086|7652111|FG005|STARTED|Overall Study||19
6722083|NCT03063086|7652106|FG000|COMPLETED|Overall Study||16
6722084|NCT03063086|7652107|FG001|COMPLETED|Overall Study||19
6722085|NCT03063086|7652108|FG002|COMPLETED|Overall Study||17
6722086|NCT03063086|7652109|FG003|COMPLETED|Overall Study||17
6722087|NCT03063086|7652110|FG004|COMPLETED|Overall Study||20
6722088|NCT03063086|7652111|FG005|COMPLETED|Overall Study||18
6722089|NCT03063086|7652106|FG000|NOT COMPLETED|Overall Study||3
6722090|NCT03063086|7652107|FG001|NOT COMPLETED|Overall Study||1
6722091|NCT03063086|7652108|FG002|NOT COMPLETED|Overall Study||1
6722092|NCT03063086|7652109|FG003|NOT COMPLETED|Overall Study||3
6722093|NCT03063086|7652110|FG004|NOT COMPLETED|Overall Study||0
6722094|NCT03063086|7652111|FG005|NOT COMPLETED|Overall Study||1
6722095|NCT03063125|7652120|FG000|STARTED|Overall Study||25
6722096|NCT03063125|7652120|FG000|COMPLETED|Overall Study||23
6722097|NCT03063125|7652120|FG000|NOT COMPLETED|Overall Study||2
6722098|NCT03063255|7652126|FG000|STARTED|Overall Study||30
6722099|NCT03063255|7652127|FG001|STARTED|Overall Study||30
6722100|NCT03063255|7652126|FG000|COMPLETED|Overall Study||29
6722101|NCT03063255|7652127|FG001|COMPLETED|Overall Study||30
6722102|NCT03063255|7652126|FG000|NOT COMPLETED|Overall Study||1
6722103|NCT03063255|7652127|FG001|NOT COMPLETED|Overall Study||0
6722104|NCT03063294|7652135|FG000|STARTED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
6722105|NCT03063294|7652136|FG001|STARTED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
6722106|NCT03063294|7652135|FG000|COMPLETED|Overall Study|2463 equals the sum of 1241 cross-sectional survey respondents at baseline and 1222 at follow-up.|2463
6722107|NCT03063294|7652136|FG001|COMPLETED|Overall Study|2502 equals the sum of 1243 cross-sectional survey respondents at baseline and 1259 at follow-up.|2502
6722108|NCT03063294|7652135|FG000|NOT COMPLETED|Overall Study||0
6722109|NCT03063294|7652136|FG001|NOT COMPLETED|Overall Study||0
6722110|NCT03063385|7652144|FG000|STARTED|Overall Study||330
6722111|NCT03063385|7652145|FG001|STARTED|Overall Study||330
6722112|NCT03063385|7652144|FG000|3-month Follow-up|Overall Study||257
6722113|NCT03063385|7652145|FG001|3-month Follow-up|Overall Study||259
6722114|NCT03063385|7652144|FG000|6-month Follow-up|Overall Study||265
6722115|NCT03063385|7652145|FG001|6-month Follow-up|Overall Study||259
6722116|NCT03063385|7652144|FG000|12-month Follow-up|Overall Study||243
6722117|NCT03063385|7652145|FG001|12-month Follow-up|Overall Study||254
6722118|NCT03063385|7652144|FG000|COMPLETED|Overall Study||243
6722119|NCT03063385|7652145|FG001|COMPLETED|Overall Study||254
6722120|NCT03063385|7652144|FG000|NOT COMPLETED|Overall Study||87
6722121|NCT03063385|7652145|FG001|NOT COMPLETED|Overall Study||76
6722122|NCT03063437|7652153|FG000|STARTED|Overall Study||4
6722123|NCT03063437|7652154|FG001|STARTED|Overall Study||5
6722124|NCT03063437|7652153|FG000|COMPLETED|Overall Study||4
6722125|NCT03063437|7652154|FG001|COMPLETED|Overall Study||5
6722126|NCT03063437|7652153|FG000|NOT COMPLETED|Overall Study||0
6722127|NCT03063437|7652154|FG001|NOT COMPLETED|Overall Study||0
6722128|NCT03063476|7652160|FG000|STARTED|Overall Study||2
6722129|NCT03063476|7652160|FG000|COMPLETED|Overall Study||2
6722130|NCT03063476|7652160|FG000|NOT COMPLETED|Overall Study||0
6722131|NCT03064152|7652166|FG000|STARTED|Overall Study||26
6722132|NCT03064152|7652167|FG001|STARTED|Overall Study||23
6722133|NCT03064152|7652166|FG000|COMPLETED|Overall Study||26
6264575|NCT04110145|7163568|FG000|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
6264576|NCT04110145|7163569|FG001|COMPLETED|Double-Blind Treatment Period (4 Weeks)||7
6264577|NCT04110145|7163570|FG002|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
6264578|NCT04110145|7163571|FG003|COMPLETED|Double-Blind Treatment Period (4 Weeks)||6
6264579|NCT04110145|7163572|FG004|COMPLETED|Double-Blind Treatment Period (4 Weeks)||8
6264580|NCT04110145|7163568|FG000|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
6264581|NCT04110145|7163569|FG001|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
6264582|NCT04110145|7163570|FG002|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
6264583|NCT04110145|7163571|FG003|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||1
6264584|NCT04110145|7163572|FG004|NOT COMPLETED|Double-Blind Treatment Period (4 Weeks)||0
6264585|NCT04110145|7163568|FG000|STARTED|Post-Treatment Period (1 Week)||7
6722134|NCT03064152|7652167|FG001|COMPLETED|Overall Study||23
6722135|NCT03064152|7652166|FG000|NOT COMPLETED|Overall Study||0
6722136|NCT03064152|7652167|FG001|NOT COMPLETED|Overall Study||0
6722137|NCT03064438|7652175|FG000|STARTED|Overall Study||27
6722138|NCT03064438|7652176|FG001|STARTED|Overall Study||13
6722139|NCT03064438|7652175|FG000|COMPLETED|Overall Study||26
6722140|NCT03064438|7652176|FG001|COMPLETED|Overall Study||12
6722141|NCT03064438|7652175|FG000|NOT COMPLETED|Overall Study||1
6722142|NCT03064438|7652176|FG001|NOT COMPLETED|Overall Study||1
6722143|NCT03064451|7652182|FG000|STARTED|Overall Study||60
6722144|NCT03064451|7652182|FG000|Safety Population|Overall Study||52
6722145|NCT03064451|7652182|FG000|COMPLETED|Overall Study||46
6722146|NCT03064451|7652182|FG000|NOT COMPLETED|Overall Study||14
6722147|NCT03064841|7652186|FG000|STARTED|Overall Study||1537
6722148|NCT03064841|7652186|FG000|COMPLETED|Overall Study||1520
6722149|NCT03064841|7652186|FG000|NOT COMPLETED|Overall Study||17
6722150|NCT03065023|7652194|FG000|STARTED|Overall Study||3
6722151|NCT03065023|7652195|FG001|STARTED|Overall Study||3
6722152|NCT03065023|7652196|FG002|STARTED|Overall Study||3
6722153|NCT03065023|7652197|FG003|STARTED|Overall Study||6
6722154|NCT03065023|7652198|FG004|STARTED|Overall Study|Group B not started for business reasons.|0
6722155|NCT03065023|7652194|FG000|COMPLETED|Overall Study||1
6722156|NCT03065023|7652195|FG001|COMPLETED|Overall Study||1
6722157|NCT03065023|7652196|FG002|COMPLETED|Overall Study||2
6722158|NCT03065023|7652197|FG003|COMPLETED|Overall Study||3
6722159|NCT03065023|7652198|FG004|COMPLETED|Overall Study||0
6722160|NCT03065023|7652194|FG000|NOT COMPLETED|Overall Study||2
6722161|NCT03065023|7652195|FG001|NOT COMPLETED|Overall Study||2
6722162|NCT03065023|7652196|FG002|NOT COMPLETED|Overall Study||1
6722163|NCT03065023|7652197|FG003|NOT COMPLETED|Overall Study||3
6722164|NCT03065023|7652198|FG004|NOT COMPLETED|Overall Study||0
6722165|NCT03065075|7652210|FG000|STARTED|Overall Study||76
6722166|NCT03065075|7652211|FG001|STARTED|Overall Study||76
6722167|NCT03065075|7652210|FG000|Intent-to-treat Analysis|Overall Study||72
6722168|NCT03065075|7652211|FG001|Intent-to-treat Analysis|Overall Study||74
6722169|NCT03065075|7652210|FG000|As-treated Analysis|Overall Study||69
6722170|NCT03065075|7652211|FG001|As-treated Analysis|Overall Study||77
6722171|NCT03065075|7652210|FG000|COMPLETED|Overall Study||76
6722172|NCT03065075|7652211|FG001|COMPLETED|Overall Study||76
6722173|NCT03065075|7652210|FG000|NOT COMPLETED|Overall Study||0
6722174|NCT03065075|7652211|FG001|NOT COMPLETED|Overall Study||0
6722175|NCT03065179|7652217|FG000|STARTED|Overall Study||25
6722176|NCT03065179|7652217|FG000|COMPLETED|Overall Study||25
6722177|NCT03065179|7652217|FG000|NOT COMPLETED|Overall Study||0
6722178|NCT03065205|7652221|FG000|STARTED|Overall Study||65
6722179|NCT03065205|7652221|FG000|COMPLETED|Overall Study||53
6722180|NCT03065205|7652221|FG000|NOT COMPLETED|Overall Study||12
6722181|NCT03065283|7652228|FG000|STARTED|Overall Study||50
6722182|NCT03065283|7652229|FG001|STARTED|Overall Study||25
6722183|NCT03065283|7652228|FG000|COMPLETED|Overall Study||50
6722184|NCT03065283|7652229|FG001|COMPLETED|Overall Study||25
6722185|NCT03065283|7652228|FG000|NOT COMPLETED|Overall Study||0
6722186|NCT03065283|7652229|FG001|NOT COMPLETED|Overall Study||0
6722187|NCT03065400|7652235|FG000|STARTED|Overall Study||10
6722188|NCT03065400|7652235|FG000|COMPLETED|Overall Study||0
6722189|NCT03065400|7652235|FG000|NOT COMPLETED|Overall Study||10
6722190|NCT03065530|7652243|FG000|STARTED|Overall Study||30
6722191|NCT03065530|7652244|FG001|STARTED|Overall Study||30
6722192|NCT03065530|7652245|FG002|STARTED|Overall Study||30
6722193|NCT03065530|7652246|FG003|STARTED|Overall Study||30
6722194|NCT03065530|7652243|FG000|COMPLETED|Overall Study||28
6722195|NCT03065530|7652244|FG001|COMPLETED|Overall Study||29
6722196|NCT03065530|7652245|FG002|COMPLETED|Overall Study||29
6722197|NCT03065530|7652246|FG003|COMPLETED|Overall Study||28
6722198|NCT03065530|7652243|FG000|NOT COMPLETED|Overall Study||2
6722199|NCT03065530|7652244|FG001|NOT COMPLETED|Overall Study||1
6722200|NCT03065530|7652245|FG002|NOT COMPLETED|Overall Study||1
6722201|NCT03065530|7652246|FG003|NOT COMPLETED|Overall Study||2
6722202|NCT03065647|7652266|FG000|STARTED|Overall Study||3
6722203|NCT03065647|7652267|FG001|STARTED|Overall Study||12
6722204|NCT03065647|7652266|FG000|COMPLETED|Overall Study||3
6722205|NCT03065647|7652267|FG001|COMPLETED|Overall Study||12
6722206|NCT03065647|7652266|FG000|NOT COMPLETED|Overall Study||0
6722207|NCT03065647|7652267|FG001|NOT COMPLETED|Overall Study||0
6722208|NCT03066102|7652273|FG000|STARTED|Overall Study||30
6722209|NCT03066102|7652273|FG000|COMPLETED|Overall Study||30
6722210|NCT03066102|7652273|FG000|NOT COMPLETED|Overall Study||0
6722211|NCT03066193|7652277|FG000|STARTED|Overall Study||17
6722212|NCT03066193|7652277|FG000|COMPLETED|Overall Study||16
6722213|NCT03066193|7652277|FG000|NOT COMPLETED|Overall Study||1
6722214|NCT03066609|7652284|FG000|STARTED|INDUCTION||136
6722215|NCT03066609|7652285|FG001|STARTED|INDUCTION||272
6722216|NCT03066609|7652286|FG002|STARTED|INDUCTION||135
6722217|NCT03066609|7652287|FG003|STARTED|INDUCTION||0
6722218|NCT03066609|7652284|FG000|COMPLETED|INDUCTION||134
6722219|NCT03066609|7652285|FG001|COMPLETED|INDUCTION||270
6722220|NCT03066609|7652286|FG002|COMPLETED|INDUCTION||133
6722221|NCT03066609|7652287|FG003|COMPLETED|INDUCTION||0
6722222|NCT03066609|7652284|FG000|NOT COMPLETED|INDUCTION||2
6722223|NCT03066609|7652285|FG001|NOT COMPLETED|INDUCTION||2
6722224|NCT03066609|7652286|FG002|NOT COMPLETED|INDUCTION||2
6722225|NCT03066609|7652287|FG003|NOT COMPLETED|INDUCTION||0
6722226|NCT03066609|7652284|FG000|STARTED|MAINTENANCE||134
6722227|NCT03066609|7652285|FG001|STARTED|MAINTENANCE||270
6722228|NCT03066609|7652286|FG002|STARTED|MAINTENANCE||4
6722229|NCT03066609|7652287|FG003|STARTED|MAINTENANCE||129
6722230|NCT03066609|7652284|FG000|COMPLETED|MAINTENANCE||127
6722231|NCT03066609|7652285|FG001|COMPLETED|MAINTENANCE||266
6722232|NCT03066609|7652286|FG002|COMPLETED|MAINTENANCE||2
6722233|NCT03066609|7652287|FG003|COMPLETED|MAINTENANCE||126
6722234|NCT03066609|7652284|FG000|NOT COMPLETED|MAINTENANCE||7
6722235|NCT03066609|7652285|FG001|NOT COMPLETED|MAINTENANCE||4
6722236|NCT03066609|7652286|FG002|NOT COMPLETED|MAINTENANCE||2
6264586|NCT04110145|7163569|FG001|STARTED|Post-Treatment Period (1 Week)||7
6264587|NCT04110145|7163570|FG002|STARTED|Post-Treatment Period (1 Week)||5
6264588|NCT04110145|7163571|FG003|STARTED|Post-Treatment Period (1 Week)||6
6264589|NCT04110145|7163572|FG004|STARTED|Post-Treatment Period (1 Week)||8
6264590|NCT04110145|7163568|FG000|COMPLETED|Post-Treatment Period (1 Week)||7
6264591|NCT04110145|7163569|FG001|COMPLETED|Post-Treatment Period (1 Week)||7
6264592|NCT04110145|7163570|FG002|COMPLETED|Post-Treatment Period (1 Week)||5
6264593|NCT04110145|7163571|FG003|COMPLETED|Post-Treatment Period (1 Week)||6
6264594|NCT04110145|7163572|FG004|COMPLETED|Post-Treatment Period (1 Week)||8
6264595|NCT04110145|7163568|FG000|NOT COMPLETED|Post-Treatment Period (1 Week)||0
6264596|NCT04110145|7163569|FG001|NOT COMPLETED|Post-Treatment Period (1 Week)||0
6264597|NCT04110145|7163570|FG002|NOT COMPLETED|Post-Treatment Period (1 Week)||0
6264598|NCT04110145|7163571|FG003|NOT COMPLETED|Post-Treatment Period (1 Week)||0
6264599|NCT04110145|7163572|FG004|NOT COMPLETED|Post-Treatment Period (1 Week)||0
6264600|NCT03986866|7163586|FG000|STARTED|Overall Study||55
6264601|NCT03986866|7163587|FG001|STARTED|Overall Study||55
6264602|NCT03986866|7163586|FG000|COMPLETED|Overall Study||53
6264603|NCT03986866|7163587|FG001|COMPLETED|Overall Study||50
6264604|NCT03986866|7163586|FG000|NOT COMPLETED|Overall Study||2
6264605|NCT03986866|7163587|FG001|NOT COMPLETED|Overall Study||5
6264606|NCT03636269|7163595|FG000|STARTED|Period 1: Double-blind Phase||235
6264607|NCT03636269|7163596|FG001|STARTED|Period 1: Double-blind Phase||236
6264608|NCT03636269|7163597|FG002|STARTED|Period 1: Double-blind Phase||0
6264609|NCT03636269|7163595|FG000|COMPLETED|Period 1: Double-blind Phase||206
6264610|NCT03636269|7163596|FG001|COMPLETED|Period 1: Double-blind Phase||223
6264611|NCT03636269|7163597|FG002|COMPLETED|Period 1: Double-blind Phase||0
6264612|NCT03636269|7163595|FG000|NOT COMPLETED|Period 1: Double-blind Phase||29
6264613|NCT03636269|7163596|FG001|NOT COMPLETED|Period 1: Double-blind Phase||13
6264614|NCT03636269|7163597|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
6264615|NCT03636269|7163595|FG000|STARTED|Period 2: Open-label Phase||0
6264616|NCT03636269|7163596|FG001|STARTED|Period 2: Open-label Phase||0
6264617|NCT03636269|7163597|FG002|STARTED|Period 2: Open-label Phase||399
6264618|NCT03636269|7163595|FG000|COMPLETED|Period 2: Open-label Phase||0
6264619|NCT03636269|7163596|FG001|COMPLETED|Period 2: Open-label Phase||0
6264620|NCT03636269|7163597|FG002|COMPLETED|Period 2: Open-label Phase||5
6264621|NCT03636269|7163595|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
6264622|NCT03636269|7163596|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
6264623|NCT03636269|7163597|FG002|NOT COMPLETED|Period 2: Open-label Phase||394
6264624|NCT03527264|7163610|FG000|STARTED|Overall Study||3
6264625|NCT03527264|7163611|FG001|STARTED|Overall Study||1
6264626|NCT03527264|7163612|FG002|STARTED|Overall Study||0
6264627|NCT03527264|7163613|FG003|STARTED|Overall Study||0
6264628|NCT03527264|7163610|FG000|COMPLETED|Overall Study||3
6264629|NCT03527264|7163611|FG001|COMPLETED|Overall Study||1
6264630|NCT03527264|7163612|FG002|COMPLETED|Overall Study||0
6264631|NCT03527264|7163613|FG003|COMPLETED|Overall Study||0
6264632|NCT03527264|7163610|FG000|NOT COMPLETED|Overall Study||0
6264633|NCT03527264|7163611|FG001|NOT COMPLETED|Overall Study||0
6264634|NCT03527264|7163612|FG002|NOT COMPLETED|Overall Study||0
6264635|NCT03527264|7163613|FG003|NOT COMPLETED|Overall Study||0
6264636|NCT03447314|7163637|FG000|STARTED|Part 1 (Up to 27 Months)||9
6264637|NCT03447314|7163638|FG001|STARTED|Part 1 (Up to 27 Months)||6
6264638|NCT03447314|7163639|FG002|STARTED|Part 1 (Up to 27 Months)||9
6264639|NCT03447314|7163640|FG003|STARTED|Part 1 (Up to 27 Months)||4
6264640|NCT03447314|7163641|FG004|STARTED|Part 1 (Up to 27 Months)||2
6264641|NCT03447314|7163642|FG005|STARTED|Part 1 (Up to 27 Months)||6
6264642|NCT03447314|7163643|FG006|STARTED|Part 1 (Up to 27 Months)||5
6264643|NCT03447314|7163644|FG007|STARTED|Part 1 (Up to 27 Months)||0
6264644|NCT03447314|7163645|FG008|STARTED|Part 1 (Up to 27 Months)||0
6264645|NCT03447314|7163646|FG009|STARTED|Part 1 (Up to 27 Months)||0
6264646|NCT03447314|7163647|FG010|STARTED|Part 1 (Up to 27 Months)||7
6264647|NCT03447314|7163648|FG011|STARTED|Part 1 (Up to 27 Months)||6
6264648|NCT03447314|7163649|FG012|STARTED|Part 1 (Up to 27 Months)||0
6264649|NCT03447314|7163650|FG013|STARTED|Part 1 (Up to 27 Months)||0
6264650|NCT03447314|7163651|FG014|STARTED|Part 1 (Up to 27 Months)||0
6264651|NCT03447314|7163652|FG015|STARTED|Part 1 (Up to 27 Months)||0
6264652|NCT03447314|7163653|FG016|STARTED|Part 1 (Up to 27 Months)||0
6264653|NCT03447314|7163654|FG017|STARTED|Part 1 (Up to 27 Months)||0
6264654|NCT03447314|7163637|FG000|COMPLETED|Part 1 (Up to 27 Months)||0
6264655|NCT03447314|7163638|FG001|COMPLETED|Part 1 (Up to 27 Months)||0
6264656|NCT03447314|7163639|FG002|COMPLETED|Part 1 (Up to 27 Months)||0
6722237|NCT03066609|7652287|FG003|NOT COMPLETED|MAINTENANCE||3
6722238|NCT03066609|7652284|FG000|STARTED|OVERALL STUDY||136
6722239|NCT03066609|7652285|FG001|STARTED|OVERALL STUDY||272
6722240|NCT03066609|7652286|FG002|STARTED|OVERALL STUDY||6
6722241|NCT03066609|7652287|FG003|STARTED|OVERALL STUDY||129
6722242|NCT03066609|7652284|FG000|COMPLETED|OVERALL STUDY||126
6722243|NCT03066609|7652285|FG001|COMPLETED|OVERALL STUDY||264
6722244|NCT03066609|7652286|FG002|COMPLETED|OVERALL STUDY||2
6722245|NCT03066609|7652287|FG003|COMPLETED|OVERALL STUDY||124
6722246|NCT03066609|7652284|FG000|NOT COMPLETED|OVERALL STUDY||10
6722247|NCT03066609|7652285|FG001|NOT COMPLETED|OVERALL STUDY||8
6722248|NCT03066609|7652286|FG002|NOT COMPLETED|OVERALL STUDY||4
6722249|NCT03066609|7652287|FG003|NOT COMPLETED|OVERALL STUDY||5
6722250|NCT03066778|7652300|FG000|STARTED|Overall Study||228
6722251|NCT03066778|7652301|FG001|STARTED|Overall Study||225
6722252|NCT03066778|7652300|FG000|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
6722253|NCT03066778|7652301|FG001|Treated|Overall Study|1 participant randomized to the pembrolizumab+etoposide arm was treated with placebo+etoposide.|223
6722254|NCT03066778|7652300|FG000|COMPLETED|Overall Study||0
6722255|NCT03066778|7652301|FG001|COMPLETED|Overall Study||0
6722256|NCT03066778|7652300|FG000|NOT COMPLETED|Overall Study||228
6722257|NCT03066778|7652301|FG001|NOT COMPLETED|Overall Study||225
6722258|NCT03066804|7652309|FG000|STARTED|Overall Study||1286
6722259|NCT03066804|7652310|FG001|STARTED|Overall Study||1286
6722260|NCT03066804|7652309|FG000|COMPLETED|Overall Study||1235
6722261|NCT03066804|7652310|FG001|COMPLETED|Overall Study||1236
6722262|NCT03066804|7652309|FG000|NOT COMPLETED|Overall Study||51
6722263|NCT03066804|7652310|FG001|NOT COMPLETED|Overall Study||50
6722264|NCT03066830|7652319|FG000|STARTED|Overall Study||254
6722265|NCT03066830|7652320|FG001|STARTED|Overall Study||253
6722266|NCT03066830|7652319|FG000|COMPLETED|Overall Study||221
6722267|NCT03066830|7652320|FG001|COMPLETED|Overall Study||231
6722268|NCT03066830|7652319|FG000|NOT COMPLETED|Overall Study||33
6722269|NCT03066830|7652320|FG001|NOT COMPLETED|Overall Study||22
6722270|NCT03066947|7652327|FG000|STARTED|Overall Study||24
6722271|NCT03066947|7652327|FG000|COMPLETED|Overall Study||14
6722272|NCT03066947|7652327|FG000|NOT COMPLETED|Overall Study||10
6722273|NCT03066999|7652334|FG000|STARTED|Overall Study||2
6722274|NCT03066999|7652335|FG001|STARTED|Overall Study||3
6722275|NCT03066999|7652334|FG000|COMPLETED|Overall Study||2
6722276|NCT03066999|7652335|FG001|COMPLETED|Overall Study||1
6722277|NCT03066999|7652334|FG000|NOT COMPLETED|Overall Study||0
6722278|NCT03066999|7652335|FG001|NOT COMPLETED|Overall Study||2
6722279|NCT03067129|7652346|FG000|STARTED|Overall Study||47
6722280|NCT03067129|7652347|FG001|STARTED|Overall Study||29
6722281|NCT03067129|7652348|FG002|STARTED|Overall Study||27
6722282|NCT03067129|7652349|FG003|STARTED|Overall Study||24
6722283|NCT03067129|7652346|FG000|COMPLETED|Overall Study||2
6722284|NCT03067129|7652347|FG001|COMPLETED|Overall Study||1
6722285|NCT03067129|7652348|FG002|COMPLETED|Overall Study||0
6722286|NCT03067129|7652349|FG003|COMPLETED|Overall Study||0
6722287|NCT03067129|7652346|FG000|NOT COMPLETED|Overall Study||45
6722288|NCT03067129|7652347|FG001|NOT COMPLETED|Overall Study||28
6722289|NCT03067129|7652348|FG002|NOT COMPLETED|Overall Study||27
6722290|NCT03067129|7652349|FG003|NOT COMPLETED|Overall Study||24
6722291|NCT03067311|7652369|FG000|STARTED|Overall Study||19
6722292|NCT03067311|7652370|FG001|STARTED|Overall Study||19
6722293|NCT03067311|7652369|FG000|COMPLETED|Overall Study||17
6722294|NCT03067311|7652370|FG001|COMPLETED|Overall Study||17
6722295|NCT03067311|7652369|FG000|NOT COMPLETED|Overall Study||2
6722296|NCT03067311|7652370|FG001|NOT COMPLETED|Overall Study||2
6722297|NCT03067441|7652378|FG000|STARTED|Overall Study||492
6722298|NCT03067441|7652379|FG001|STARTED|Overall Study||970
6722299|NCT03067441|7652378|FG000|COMPLETED|Overall Study||459
6722300|NCT03067441|7652379|FG001|COMPLETED|Overall Study||913
6722301|NCT03067441|7652378|FG000|NOT COMPLETED|Overall Study||33
6722302|NCT03067441|7652379|FG001|NOT COMPLETED|Overall Study||57
6722303|NCT03067506|7652388|FG000|STARTED|Overall Study||30
6722304|NCT03067506|7652388|FG000|COMPLETED|Overall Study||30
6722305|NCT03067506|7652388|FG000|NOT COMPLETED|Overall Study||0
6722306|NCT03067948|7652392|FG000|STARTED|Overall Study||32
6722307|NCT03067948|7652392|FG000|COMPLETED|Overall Study||32
6722308|NCT03067948|7652392|FG000|NOT COMPLETED|Overall Study||0
6722309|NCT03067987|7652398|FG000|STARTED|Overall Study||50
6722310|NCT03067987|7652399|FG001|STARTED|Overall Study||53
6722311|NCT03067987|7652398|FG000|COMPLETED|Overall Study||40
6722312|NCT03067987|7652399|FG001|COMPLETED|Overall Study||40
6722313|NCT03067987|7652398|FG000|NOT COMPLETED|Overall Study||10
6722314|NCT03067987|7652399|FG001|NOT COMPLETED|Overall Study||13
6722315|NCT03068091|7652405|FG000|STARTED|Overall Study||25
6722316|NCT03068091|7652405|FG000|COMPLETED|Overall Study||24
6722317|NCT03068091|7652405|FG000|NOT COMPLETED|Overall Study||1
6722318|NCT03068312|7652412|FG000|STARTED|Overall Study||19
6722319|NCT03068312|7652413|FG001|STARTED|Overall Study||19
6722320|NCT03068312|7652412|FG000|COMPLETED|Overall Study||19
6722321|NCT03068312|7652413|FG001|COMPLETED|Overall Study||19
6722322|NCT03068312|7652412|FG000|NOT COMPLETED|Overall Study||0
6722323|NCT03068312|7652413|FG001|NOT COMPLETED|Overall Study||0
6722324|NCT03068455|7652421|FG000|STARTED|Pre-treatment Period||920
6722325|NCT03068455|7652422|FG001|STARTED|Pre-treatment Period||924
6722326|NCT03068455|7652421|FG000|COMPLETED|Pre-treatment Period||916
6722327|NCT03068455|7652422|FG001|COMPLETED|Pre-treatment Period||917
6722328|NCT03068455|7652421|FG000|NOT COMPLETED|Pre-treatment Period||4
6722329|NCT03068455|7652422|FG001|NOT COMPLETED|Pre-treatment Period||7
6722330|NCT03068455|7652421|FG000|STARTED|Treatment Period||916
6722331|NCT03068455|7652422|FG001|STARTED|Treatment Period||917
6722332|NCT03068455|7652421|FG000|COMPLETED|Treatment Period||364
6722333|NCT03068455|7652422|FG001|COMPLETED|Treatment Period||561
6722334|NCT03068455|7652421|FG000|NOT COMPLETED|Treatment Period||552
6722335|NCT03068455|7652422|FG001|NOT COMPLETED|Treatment Period||356
6722336|NCT03068468|7652430|FG000|STARTED|Placebo-Controlled Period||166
6722337|NCT03068468|7652431|FG001|STARTED|Placebo-Controlled Period||324
6722338|NCT03068468|7652432|FG002|STARTED|Placebo-Controlled Period||0
6722339|NCT03068468|7652433|FG003|STARTED|Placebo-Controlled Period||0
6722340|NCT03068468|7652430|FG000|Treated|Placebo-Controlled Period||165
6722341|NCT03068468|7652431|FG001|Treated|Placebo-Controlled Period||321
6722342|NCT03068468|7652432|FG002|Treated|Placebo-Controlled Period||0
6722343|NCT03068468|7652433|FG003|Treated|Placebo-Controlled Period||0
6722344|NCT03068468|7652430|FG000|COMPLETED|Placebo-Controlled Period||144
6722345|NCT03068468|7652431|FG001|COMPLETED|Placebo-Controlled Period||279
6722346|NCT03068468|7652432|FG002|COMPLETED|Placebo-Controlled Period||0
6722347|NCT03068468|7652433|FG003|COMPLETED|Placebo-Controlled Period||0
6722348|NCT03068468|7652430|FG000|NOT COMPLETED|Placebo-Controlled Period||22
6722349|NCT03068468|7652431|FG001|NOT COMPLETED|Placebo-Controlled Period||45
6722350|NCT03068468|7652432|FG002|NOT COMPLETED|Placebo-Controlled Period||0
6722351|NCT03068468|7652433|FG003|NOT COMPLETED|Placebo-Controlled Period||0
6722352|NCT03068468|7652430|FG000|STARTED|Open-Label Extension Period||0
6722353|NCT03068468|7652431|FG001|STARTED|Open-Label Extension Period||0
6722354|NCT03068468|7652432|FG002|STARTED|Open-Label Extension Period|4 participants did not enter OLE period.|140
6722355|NCT03068468|7652433|FG003|STARTED|Open-Label Extension Period|3 participants did not enter OLE period.|276
6722356|NCT03068468|7652430|FG000|COMPLETED|Open-Label Extension Period||0
6722357|NCT03068468|7652431|FG001|COMPLETED|Open-Label Extension Period||0
6722358|NCT03068468|7652432|FG002|COMPLETED|Open-Label Extension Period||0
6722359|NCT03068468|7652433|FG003|COMPLETED|Open-Label Extension Period||0
6722360|NCT03068468|7652430|FG000|NOT COMPLETED|Open-Label Extension Period||0
6722361|NCT03068468|7652431|FG001|NOT COMPLETED|Open-Label Extension Period||0
6722362|NCT03068468|7652432|FG002|NOT COMPLETED|Open-Label Extension Period||140
6722363|NCT03068468|7652433|FG003|NOT COMPLETED|Open-Label Extension Period||276
6722364|NCT03068611|7652443|FG000|STARTED|Overall Study||61
6722365|NCT03068611|7652444|FG001|STARTED|Overall Study||58
6722366|NCT03068611|7652443|FG000|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|30
6722367|NCT03068611|7652444|FG001|COMPLETED|Overall Study|This is the number of participants followed through 6 months from enrollment.|33
6722368|NCT03068611|7652443|FG000|NOT COMPLETED|Overall Study||31
6722369|NCT03068611|7652444|FG001|NOT COMPLETED|Overall Study||25
6722370|NCT03068715|7652452|FG000|STARTED|Overall Study||15
6722371|NCT03068715|7652453|FG001|STARTED|Overall Study||15
6722372|NCT03068715|7652452|FG000|COMPLETED|Overall Study||14
6722373|NCT03068715|7652453|FG001|COMPLETED|Overall Study||15
6722374|NCT03068715|7652452|FG000|NOT COMPLETED|Overall Study||1
6722375|NCT03068715|7652453|FG001|NOT COMPLETED|Overall Study||0
6722376|NCT03068754|7652463|FG000|STARTED|Randomized Treatment Period (RTP)||95
6722377|NCT03068754|7652464|FG001|STARTED|Randomized Treatment Period (RTP)||48
6722378|NCT03068754|7652465|FG002|STARTED|Randomized Treatment Period (RTP)|OLE Arms were not included during the RTP|0
6722379|NCT03068754|7652466|FG003|STARTED|Randomized Treatment Period (RTP)||0
6722380|NCT03068754|7652463|FG000|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||95
6722381|NCT03068754|7652464|FG001|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||48
6722382|NCT03068754|7652465|FG002|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
6722383|NCT03068754|7652466|FG003|Intention to Treat (ITT) Population|Randomized Treatment Period (RTP)||0
6722384|NCT03068754|7652463|FG000|Safety Population|Randomized Treatment Period (RTP)||95
6722385|NCT03068754|7652464|FG001|Safety Population|Randomized Treatment Period (RTP)||47
6722386|NCT03068754|7652465|FG002|Safety Population|Randomized Treatment Period (RTP)||0
6722387|NCT03068754|7652466|FG003|Safety Population|Randomized Treatment Period (RTP)||0
6722388|NCT03068754|7652463|FG000|Modified ITT (mITT)|Randomized Treatment Period (RTP)||93
6722389|NCT03068754|7652464|FG001|Modified ITT (mITT)|Randomized Treatment Period (RTP)||46
6722390|NCT03068754|7652465|FG002|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
6722391|NCT03068754|7652466|FG003|Modified ITT (mITT)|Randomized Treatment Period (RTP)||0
6722392|NCT03068754|7652463|FG000|Completed Taper|Randomized Treatment Period (RTP)||58
6722393|NCT03068754|7652464|FG001|Completed Taper|Randomized Treatment Period (RTP)||28
6722394|NCT03068754|7652465|FG002|Completed Taper|Randomized Treatment Period (RTP)||0
6722395|NCT03068754|7652466|FG003|Completed Taper|Randomized Treatment Period (RTP)||0
6722396|NCT03068754|7652463|FG000|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||28
6722397|NCT03068754|7652464|FG001|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||9
6722398|NCT03068754|7652465|FG002|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
6722399|NCT03068754|7652466|FG003|Completed 36 Weeks of Treatment|Randomized Treatment Period (RTP)||0
6722400|NCT03068754|7652463|FG000|Completed RTP|Randomized Treatment Period (RTP)||27
6722401|NCT03068754|7652464|FG001|Completed RTP|Randomized Treatment Period (RTP)||9
6722402|NCT03068754|7652465|FG002|Completed RTP|Randomized Treatment Period (RTP)||0
6264657|NCT03447314|7163640|FG003|COMPLETED|Part 1 (Up to 27 Months)||0
6722403|NCT03068754|7652466|FG003|Completed RTP|Randomized Treatment Period (RTP)||0
6722404|NCT03068754|7652463|FG000|Enrolled in OLE Period|Randomized Treatment Period (RTP)||25
6722405|NCT03068754|7652464|FG001|Enrolled in OLE Period|Randomized Treatment Period (RTP)||8
6722406|NCT03068754|7652465|FG002|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
6722407|NCT03068754|7652466|FG003|Enrolled in OLE Period|Randomized Treatment Period (RTP)||0
6722408|NCT03068754|7652463|FG000|COMPLETED|Randomized Treatment Period (RTP)||28
6722409|NCT03068754|7652464|FG001|COMPLETED|Randomized Treatment Period (RTP)||9
6722410|NCT03068754|7652465|FG002|COMPLETED|Randomized Treatment Period (RTP)||0
6722411|NCT03068754|7652466|FG003|COMPLETED|Randomized Treatment Period (RTP)||0
6722412|NCT03068754|7652463|FG000|NOT COMPLETED|Randomized Treatment Period (RTP)||67
6264658|NCT03447314|7163641|FG004|COMPLETED|Part 1 (Up to 27 Months)||0
6264659|NCT03447314|7163642|FG005|COMPLETED|Part 1 (Up to 27 Months)||0
6264660|NCT03447314|7163643|FG006|COMPLETED|Part 1 (Up to 27 Months)||0
6264661|NCT03447314|7163644|FG007|COMPLETED|Part 1 (Up to 27 Months)||0
6264662|NCT03447314|7163645|FG008|COMPLETED|Part 1 (Up to 27 Months)||0
6264663|NCT03447314|7163646|FG009|COMPLETED|Part 1 (Up to 27 Months)||0
6264664|NCT03447314|7163647|FG010|COMPLETED|Part 1 (Up to 27 Months)||0
6264665|NCT03447314|7163648|FG011|COMPLETED|Part 1 (Up to 27 Months)||0
6264666|NCT03447314|7163649|FG012|COMPLETED|Part 1 (Up to 27 Months)||0
6264667|NCT03447314|7163650|FG013|COMPLETED|Part 1 (Up to 27 Months)||0
6264668|NCT03447314|7163651|FG014|COMPLETED|Part 1 (Up to 27 Months)||0
6264669|NCT03447314|7163652|FG015|COMPLETED|Part 1 (Up to 27 Months)||0
6264670|NCT03447314|7163653|FG016|COMPLETED|Part 1 (Up to 27 Months)||0
6264671|NCT03447314|7163654|FG017|COMPLETED|Part 1 (Up to 27 Months)||0
6264672|NCT03447314|7163637|FG000|NOT COMPLETED|Part 1 (Up to 27 Months)||9
6264673|NCT03447314|7163638|FG001|NOT COMPLETED|Part 1 (Up to 27 Months)||6
6264674|NCT03447314|7163639|FG002|NOT COMPLETED|Part 1 (Up to 27 Months)||9
6264675|NCT03447314|7163640|FG003|NOT COMPLETED|Part 1 (Up to 27 Months)||4
6264676|NCT03447314|7163641|FG004|NOT COMPLETED|Part 1 (Up to 27 Months)||2
6264677|NCT03447314|7163642|FG005|NOT COMPLETED|Part 1 (Up to 27 Months)||6
6264678|NCT03447314|7163643|FG006|NOT COMPLETED|Part 1 (Up to 27 Months)||5
6264679|NCT03447314|7163644|FG007|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264680|NCT03447314|7163645|FG008|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264681|NCT03447314|7163646|FG009|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264682|NCT03447314|7163647|FG010|NOT COMPLETED|Part 1 (Up to 27 Months)||7
6264683|NCT03447314|7163648|FG011|NOT COMPLETED|Part 1 (Up to 27 Months)||6
6264684|NCT03447314|7163649|FG012|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264685|NCT03447314|7163650|FG013|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264686|NCT03447314|7163651|FG014|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264687|NCT03447314|7163652|FG015|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264688|NCT03447314|7163653|FG016|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264689|NCT03447314|7163654|FG017|NOT COMPLETED|Part 1 (Up to 27 Months)||0
6264690|NCT03447314|7163637|FG000|STARTED|Part 2 (Up to 27 Months)||0
6264691|NCT03447314|7163638|FG001|STARTED|Part 2 (Up to 27 Months)||0
6264692|NCT03447314|7163639|FG002|STARTED|Part 2 (Up to 27 Months)||0
6264693|NCT03447314|7163640|FG003|STARTED|Part 2 (Up to 27 Months)||0
6264694|NCT03447314|7163641|FG004|STARTED|Part 2 (Up to 27 Months)||0
6264695|NCT03447314|7163642|FG005|STARTED|Part 2 (Up to 27 Months)||0
6264696|NCT03447314|7163643|FG006|STARTED|Part 2 (Up to 27 Months)||0
6264697|NCT03447314|7163644|FG007|STARTED|Part 2 (Up to 27 Months)||0
6264698|NCT03447314|7163645|FG008|STARTED|Part 2 (Up to 27 Months)||0
6264699|NCT03447314|7163646|FG009|STARTED|Part 2 (Up to 27 Months)||0
6264700|NCT03447314|7163647|FG010|STARTED|Part 2 (Up to 27 Months)||0
6264701|NCT03447314|7163648|FG011|STARTED|Part 2 (Up to 27 Months)||0
6264702|NCT03447314|7163649|FG012|STARTED|Part 2 (Up to 27 Months)||0
6264703|NCT03447314|7163650|FG013|STARTED|Part 2 (Up to 27 Months)||0
6264704|NCT03447314|7163651|FG014|STARTED|Part 2 (Up to 27 Months)||0
6264705|NCT03447314|7163652|FG015|STARTED|Part 2 (Up to 27 Months)||0
6264706|NCT03447314|7163653|FG016|STARTED|Part 2 (Up to 27 Months)||0
6264707|NCT03447314|7163654|FG017|STARTED|Part 2 (Up to 27 Months)||0
6264708|NCT03447314|7163637|FG000|COMPLETED|Part 2 (Up to 27 Months)||0
6264709|NCT03447314|7163638|FG001|COMPLETED|Part 2 (Up to 27 Months)||0
6264710|NCT03447314|7163639|FG002|COMPLETED|Part 2 (Up to 27 Months)||0
6264711|NCT03447314|7163640|FG003|COMPLETED|Part 2 (Up to 27 Months)||0
6264712|NCT03447314|7163641|FG004|COMPLETED|Part 2 (Up to 27 Months)||0
6264713|NCT03447314|7163642|FG005|COMPLETED|Part 2 (Up to 27 Months)||0
6264714|NCT03447314|7163643|FG006|COMPLETED|Part 2 (Up to 27 Months)||0
6264715|NCT03447314|7163644|FG007|COMPLETED|Part 2 (Up to 27 Months)||0
6264716|NCT03447314|7163645|FG008|COMPLETED|Part 2 (Up to 27 Months)||0
6264717|NCT03447314|7163646|FG009|COMPLETED|Part 2 (Up to 27 Months)||0
6264718|NCT03447314|7163647|FG010|COMPLETED|Part 2 (Up to 27 Months)||0
6264719|NCT03447314|7163648|FG011|COMPLETED|Part 2 (Up to 27 Months)||0
6264720|NCT03447314|7163649|FG012|COMPLETED|Part 2 (Up to 27 Months)||0
6264721|NCT03447314|7163650|FG013|COMPLETED|Part 2 (Up to 27 Months)||0
6264722|NCT03447314|7163651|FG014|COMPLETED|Part 2 (Up to 27 Months)||0
6264723|NCT03447314|7163652|FG015|COMPLETED|Part 2 (Up to 27 Months)||0
6264724|NCT03447314|7163653|FG016|COMPLETED|Part 2 (Up to 27 Months)||0
6264725|NCT03447314|7163654|FG017|COMPLETED|Part 2 (Up to 27 Months)||0
6264726|NCT03447314|7163637|FG000|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264727|NCT03447314|7163638|FG001|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264728|NCT03447314|7163639|FG002|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6722413|NCT03068754|7652464|FG001|NOT COMPLETED|Randomized Treatment Period (RTP)||39
6722414|NCT03068754|7652465|FG002|NOT COMPLETED|Randomized Treatment Period (RTP)||0
6722415|NCT03068754|7652466|FG003|NOT COMPLETED|Randomized Treatment Period (RTP)||0
6722416|NCT03068754|7652463|FG000|STARTED|Open Label Extension Period (OLE)|RTP arms were not included during the OLE period|0
6722417|NCT03068754|7652464|FG001|STARTED|Open Label Extension Period (OLE)||0
6722418|NCT03068754|7652465|FG002|STARTED|Open Label Extension Period (OLE)||25
6722419|NCT03068754|7652466|FG003|STARTED|Open Label Extension Period (OLE)||8
6722420|NCT03068754|7652463|FG000|Completed Taper|Open Label Extension Period (OLE)||0
6722421|NCT03068754|7652464|FG001|Completed Taper|Open Label Extension Period (OLE)||0
6722422|NCT03068754|7652465|FG002|Completed Taper|Open Label Extension Period (OLE)||19
6722423|NCT03068754|7652466|FG003|Completed Taper|Open Label Extension Period (OLE)||7
6722424|NCT03068754|7652463|FG000|Completed OLE Period|Open Label Extension Period (OLE)||0
6722425|NCT03068754|7652464|FG001|Completed OLE Period|Open Label Extension Period (OLE)||0
6722426|NCT03068754|7652465|FG002|Completed OLE Period|Open Label Extension Period (OLE)||3
6722427|NCT03068754|7652466|FG003|Completed OLE Period|Open Label Extension Period (OLE)||2
6722428|NCT03068754|7652463|FG000|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
6722429|NCT03068754|7652464|FG001|Completed Treatment in OLE|Open Label Extension Period (OLE)||0
6722430|NCT03068754|7652465|FG002|Completed Treatment in OLE|Open Label Extension Period (OLE)||4
6722431|NCT03068754|7652466|FG003|Completed Treatment in OLE|Open Label Extension Period (OLE)||2
6722432|NCT03068754|7652463|FG000|COMPLETED|Open Label Extension Period (OLE)||0
6722433|NCT03068754|7652464|FG001|COMPLETED|Open Label Extension Period (OLE)||0
6722434|NCT03068754|7652465|FG002|COMPLETED|Open Label Extension Period (OLE)||4
6722435|NCT03068754|7652466|FG003|COMPLETED|Open Label Extension Period (OLE)||2
6722436|NCT03068754|7652463|FG000|NOT COMPLETED|Open Label Extension Period (OLE)||0
6722437|NCT03068754|7652464|FG001|NOT COMPLETED|Open Label Extension Period (OLE)||0
6722438|NCT03068754|7652465|FG002|NOT COMPLETED|Open Label Extension Period (OLE)||21
6722439|NCT03068754|7652466|FG003|NOT COMPLETED|Open Label Extension Period (OLE)||6
6722440|NCT03068767|7652478|FG000|STARTED|Overall Study|from August 2017 to September 2018|75
6722441|NCT03068767|7652479|FG001|STARTED|Overall Study|from August 2017 to September 2018|74
6722442|NCT03068767|7652478|FG000|COMPLETED|Overall Study|December 2018|65
6722443|NCT03068767|7652479|FG001|COMPLETED|Overall Study|December 2018|71
6722444|NCT03068767|7652478|FG000|NOT COMPLETED|Overall Study||10
6722445|NCT03068767|7652479|FG001|NOT COMPLETED|Overall Study||3
6722446|NCT03068897|7652489|FG000|STARTED|Overall Study||80
6722447|NCT03068897|7652490|FG001|STARTED|Overall Study||80
6722448|NCT03068897|7652491|FG002|STARTED|Overall Study||80
6722449|NCT03068897|7652492|FG003|STARTED|Overall Study||80
6722450|NCT03068897|7652489|FG000|COMPLETED|Overall Study||76
6722451|NCT03068897|7652490|FG001|COMPLETED|Overall Study||76
6722452|NCT03068897|7652491|FG002|COMPLETED|Overall Study||79
6722453|NCT03068897|7652492|FG003|COMPLETED|Overall Study||74
6722454|NCT03068897|7652489|FG000|NOT COMPLETED|Overall Study||4
6722455|NCT03068897|7652490|FG001|NOT COMPLETED|Overall Study||4
6722456|NCT03068897|7652491|FG002|NOT COMPLETED|Overall Study||1
6722457|NCT03068897|7652492|FG003|NOT COMPLETED|Overall Study||6
6722458|NCT03068949|7652506|FG000|STARTED|Overall Study||113
6722459|NCT03068949|7652507|FG001|STARTED|Overall Study||102
6722460|NCT03068949|7652508|FG002|STARTED|Overall Study||122
6722461|NCT03068949|7652509|FG003|STARTED|Overall Study||76
6722462|NCT03068949|7652506|FG000|COMPLETED|Overall Study||105
6722463|NCT03068949|7652507|FG001|COMPLETED|Overall Study||90
6722464|NCT03068949|7652508|FG002|COMPLETED|Overall Study||113
6722465|NCT03068949|7652509|FG003|COMPLETED|Overall Study||63
6722466|NCT03068949|7652506|FG000|NOT COMPLETED|Overall Study||8
6722467|NCT03068949|7652507|FG001|NOT COMPLETED|Overall Study||12
6722468|NCT03068949|7652508|FG002|NOT COMPLETED|Overall Study||9
6722469|NCT03068949|7652509|FG003|NOT COMPLETED|Overall Study||13
6722470|NCT03069313|7652519|FG000|STARTED|Overall Study||41
6722471|NCT03069313|7652519|FG000|COMPLETED|Overall Study||36
6722472|NCT03069313|7652519|FG000|NOT COMPLETED|Overall Study||5
6722473|NCT03069352|7652525|FG000|STARTED|Overall Study||68
6722474|NCT03069352|7652526|FG001|STARTED|Overall Study||143
6722475|NCT03069352|7652525|FG000|Received Treatment|Overall Study||68
6722476|NCT03069352|7652526|FG001|Received Treatment|Overall Study||142
6722477|NCT03069352|7652525|FG000|COMPLETED|Overall Study||56
6722478|NCT03069352|7652526|FG001|COMPLETED|Overall Study||103
6722479|NCT03069352|7652525|FG000|NOT COMPLETED|Overall Study||12
6722480|NCT03069352|7652526|FG001|NOT COMPLETED|Overall Study||40
6722481|NCT03069365|7652532|FG000|STARTED|Overall Study||101
6722482|NCT03069365|7652532|FG000|COMPLETED|Overall Study||100
6722483|NCT03069365|7652532|FG000|NOT COMPLETED|Overall Study||1
6722484|NCT03069482|7652538|FG000|STARTED|Overall Study||34
6722485|NCT03069482|7652539|FG001|STARTED|Overall Study||29
6722486|NCT03069482|7652538|FG000|COMPLETED|Overall Study||33
6722487|NCT03069482|7652539|FG001|COMPLETED|Overall Study||28
6722488|NCT03069482|7652538|FG000|NOT COMPLETED|Overall Study||1
6722489|NCT03069482|7652539|FG001|NOT COMPLETED|Overall Study||1
6722490|NCT03069677|7652550|FG000|STARTED|Overall Study||80
6722491|NCT03069677|7652551|FG001|STARTED|Overall Study||80
6722492|NCT03069677|7652550|FG000|COMPLETED|Overall Study||77
6722493|NCT03069677|7652551|FG001|COMPLETED|Overall Study||77
6722494|NCT03069677|7652550|FG000|NOT COMPLETED|Overall Study||3
6722495|NCT03069677|7652551|FG001|NOT COMPLETED|Overall Study||3
6722496|NCT03069716|7652559|FG000|STARTED|Run-in Period (2 Weeks)||49
6722497|NCT03069716|7652560|FG001|STARTED|Run-in Period (2 Weeks)||0
6722498|NCT03069716|7652561|FG002|STARTED|Run-in Period (2 Weeks)||0
6722499|NCT03069716|7652559|FG000|COMPLETED|Run-in Period (2 Weeks)||42
6722500|NCT03069716|7652560|FG001|COMPLETED|Run-in Period (2 Weeks)||0
6722501|NCT03069716|7652561|FG002|COMPLETED|Run-in Period (2 Weeks)||0
6722502|NCT03069716|7652559|FG000|NOT COMPLETED|Run-in Period (2 Weeks)||7
6722503|NCT03069716|7652560|FG001|NOT COMPLETED|Run-in Period (2 Weeks)||0
6722504|NCT03069716|7652561|FG002|NOT COMPLETED|Run-in Period (2 Weeks)||0
6722505|NCT03069716|7652559|FG000|STARTED|Randomized Treatment||0
6722506|NCT03069716|7652560|FG001|STARTED|Randomized Treatment||20
6722507|NCT03069716|7652561|FG002|STARTED|Randomized Treatment||22
6722508|NCT03069716|7652559|FG000|COMPLETED|Randomized Treatment||0
6722509|NCT03069716|7652560|FG001|COMPLETED|Randomized Treatment||18
6722510|NCT03069716|7652561|FG002|COMPLETED|Randomized Treatment||22
6722511|NCT03069716|7652559|FG000|NOT COMPLETED|Randomized Treatment||0
6722512|NCT03069716|7652560|FG001|NOT COMPLETED|Randomized Treatment||2
6722513|NCT03069716|7652561|FG002|NOT COMPLETED|Randomized Treatment||0
6722514|NCT03069989|7652570|FG000|STARTED|Dosing Period 1 (Up to 2 Days)||3
6722515|NCT03069989|7652571|FG001|STARTED|Dosing Period 1 (Up to 2 Days)||5
6722516|NCT03069989|7652570|FG000|COMPLETED|Dosing Period 1 (Up to 2 Days)||3
6722517|NCT03069989|7652571|FG001|COMPLETED|Dosing Period 1 (Up to 2 Days)||5
6722518|NCT03069989|7652570|FG000|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
6722519|NCT03069989|7652571|FG001|NOT COMPLETED|Dosing Period 1 (Up to 2 Days)||0
6722520|NCT03069989|7652570|FG000|STARTED|Wash Out Period (Up to 28 Days))||3
6722521|NCT03069989|7652571|FG001|STARTED|Wash Out Period (Up to 28 Days))||5
6722522|NCT03069989|7652570|FG000|COMPLETED|Wash Out Period (Up to 28 Days))||3
6722523|NCT03069989|7652571|FG001|COMPLETED|Wash Out Period (Up to 28 Days))||5
6722524|NCT03069989|7652570|FG000|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
6722525|NCT03069989|7652571|FG001|NOT COMPLETED|Wash Out Period (Up to 28 Days))||0
6722526|NCT03069989|7652570|FG000|STARTED|Dosing Period 2 (Up to 16 Days)||3
6722527|NCT03069989|7652571|FG001|STARTED|Dosing Period 2 (Up to 16 Days)||5
6722528|NCT03069989|7652570|FG000|COMPLETED|Dosing Period 2 (Up to 16 Days)||2
6722529|NCT03069989|7652571|FG001|COMPLETED|Dosing Period 2 (Up to 16 Days)||5
6722530|NCT03069989|7652570|FG000|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||1
6722531|NCT03069989|7652571|FG001|NOT COMPLETED|Dosing Period 2 (Up to 16 Days)||0
6722532|NCT03070171|7652580|FG000|STARTED|Treatment Period 1 + Washout||80
6722533|NCT03070171|7652581|FG001|STARTED|Treatment Period 1 + Washout||80
6722534|NCT03070171|7652580|FG000|COMPLETED|Treatment Period 1 + Washout||80
6722535|NCT03070171|7652581|FG001|COMPLETED|Treatment Period 1 + Washout||80
6722536|NCT03070171|7652580|FG000|NOT COMPLETED|Treatment Period 1 + Washout||0
6722537|NCT03070171|7652581|FG001|NOT COMPLETED|Treatment Period 1 + Washout||0
6722538|NCT03070171|7652580|FG000|STARTED|Treatment Period 2 + Washout||80
6722539|NCT03070171|7652581|FG001|STARTED|Treatment Period 2 + Washout||80
6722540|NCT03070171|7652580|FG000|COMPLETED|Treatment Period 2 + Washout||80
6722541|NCT03070171|7652581|FG001|COMPLETED|Treatment Period 2 + Washout||79
6722542|NCT03070171|7652580|FG000|NOT COMPLETED|Treatment Period 2 + Washout||0
6722543|NCT03070171|7652581|FG001|NOT COMPLETED|Treatment Period 2 + Washout||1
6722544|NCT03070171|7652580|FG000|STARTED|Treatment Period 3 + Washout||80
6722545|NCT03070171|7652581|FG001|STARTED|Treatment Period 3 + Washout||79
6722546|NCT03070171|7652580|FG000|COMPLETED|Treatment Period 3 + Washout||80
6722547|NCT03070171|7652581|FG001|COMPLETED|Treatment Period 3 + Washout||79
6722548|NCT03070171|7652580|FG000|NOT COMPLETED|Treatment Period 3 + Washout||0
6722549|NCT03070171|7652581|FG001|NOT COMPLETED|Treatment Period 3 + Washout||0
6722550|NCT03070171|7652580|FG000|STARTED|Treatment Period 4 + Washout||80
6722551|NCT03070171|7652581|FG001|STARTED|Treatment Period 4 + Washout||79
6722552|NCT03070171|7652580|FG000|COMPLETED|Treatment Period 4 + Washout||80
6722553|NCT03070171|7652581|FG001|COMPLETED|Treatment Period 4 + Washout||78
6722554|NCT03070171|7652580|FG000|NOT COMPLETED|Treatment Period 4 + Washout||0
6722555|NCT03070171|7652581|FG001|NOT COMPLETED|Treatment Period 4 + Washout||1
6722556|NCT03070236|7652589|FG000|STARTED|Overall Study||912
6722557|NCT03070236|7652589|FG000|Guideline Concordant Care (GCC) Arm|Overall Study||538
6722558|NCT03070236|7652589|FG000|Active Surveillance (AS) Arm|Overall Study||374
6722559|NCT03070236|7652589|FG000|COMPLETED|Overall Study||912
6722560|NCT03070236|7652589|FG000|NOT COMPLETED|Overall Study||0
6722561|NCT03070431|7652594|FG000|STARTED|Overall Study||44
6722562|NCT03070431|7652594|FG000|COMPLETED|Overall Study||40
6722563|NCT03070431|7652594|FG000|NOT COMPLETED|Overall Study||4
6722564|NCT03070470|7652609|FG000|STARTED|Overall Study||10
6722565|NCT03070470|7652610|FG001|STARTED|Overall Study||10
6722566|NCT03070470|7652611|FG002|STARTED|Overall Study||10
6722567|NCT03070470|7652612|FG003|STARTED|Overall Study||10
6722568|NCT03070470|7652613|FG004|STARTED|Overall Study||10
6722569|NCT03070470|7652614|FG005|STARTED|Overall Study||10
6722570|NCT03070470|7652609|FG000|COMPLETED|Overall Study||10
6722571|NCT03070470|7652610|FG001|COMPLETED|Overall Study||9
6722572|NCT03070470|7652611|FG002|COMPLETED|Overall Study||10
6722573|NCT03070470|7652612|FG003|COMPLETED|Overall Study||10
6722574|NCT03070470|7652613|FG004|COMPLETED|Overall Study||10
6722575|NCT03070470|7652614|FG005|COMPLETED|Overall Study||8
6722576|NCT03070470|7652609|FG000|NOT COMPLETED|Overall Study||0
6722577|NCT03070470|7652610|FG001|NOT COMPLETED|Overall Study||1
6722578|NCT03070470|7652611|FG002|NOT COMPLETED|Overall Study||0
6722579|NCT03070470|7652612|FG003|NOT COMPLETED|Overall Study||0
6722580|NCT03070470|7652613|FG004|NOT COMPLETED|Overall Study||0
6722581|NCT03070470|7652614|FG005|NOT COMPLETED|Overall Study||2
6722582|NCT03070483|7652630|FG000|STARTED|Overall Study||5
6722583|NCT03070483|7652630|FG000|COMPLETED|Overall Study||3
6722584|NCT03070483|7652630|FG000|NOT COMPLETED|Overall Study||2
6722585|NCT03070548|7652635|FG000|STARTED|Overall Study||6
6722586|NCT03070548|7652635|FG000|COMPLETED|Overall Study||6
6722587|NCT03070548|7652635|FG000|NOT COMPLETED|Overall Study||0
6722588|NCT03070730|7652642|FG000|STARTED|Overall Study||0
6722589|NCT03070730|7652643|FG001|STARTED|Overall Study||0
6722590|NCT03070730|7652644|FG002|STARTED|Overall Study||0
6722591|NCT03070730|7652642|FG000|COMPLETED|Overall Study||0
6722592|NCT03070730|7652643|FG001|COMPLETED|Overall Study||0
6722593|NCT03070730|7652644|FG002|COMPLETED|Overall Study||0
6722594|NCT03070730|7652642|FG000|NOT COMPLETED|Overall Study||0
6722595|NCT03070730|7652643|FG001|NOT COMPLETED|Overall Study||0
6722596|NCT03070730|7652644|FG002|NOT COMPLETED|Overall Study||0
6739572|NCT03292016|7668432|FG005|COMPLETED|Second Intervention||2
6739573|NCT03292016|7668427|FG000|NOT COMPLETED|Second Intervention||0
6739574|NCT03292016|7668428|FG001|NOT COMPLETED|Second Intervention||0
6739575|NCT03292016|7668429|FG002|NOT COMPLETED|Second Intervention||0
6739576|NCT03292016|7668430|FG003|NOT COMPLETED|Second Intervention||0
6739577|NCT03292016|7668431|FG004|NOT COMPLETED|Second Intervention||0
6739578|NCT03292016|7668432|FG005|NOT COMPLETED|Second Intervention||0
6739579|NCT03292016|7668427|FG000|STARTED|Second Washout||1
6739580|NCT03292016|7668428|FG001|STARTED|Second Washout||1
6739581|NCT03292016|7668429|FG002|STARTED|Second Washout||2
6739582|NCT03292016|7668430|FG003|STARTED|Second Washout||1
6739583|NCT03292016|7668431|FG004|STARTED|Second Washout||1
6739584|NCT03292016|7668432|FG005|STARTED|Second Washout||2
6739585|NCT03292016|7668427|FG000|COMPLETED|Second Washout||1
6739586|NCT03292016|7668428|FG001|COMPLETED|Second Washout||0
6739587|NCT03292016|7668429|FG002|COMPLETED|Second Washout||2
6739588|NCT03292016|7668430|FG003|COMPLETED|Second Washout||1
6739589|NCT03292016|7668431|FG004|COMPLETED|Second Washout||1
6739590|NCT03292016|7668432|FG005|COMPLETED|Second Washout||2
6739591|NCT03292016|7668427|FG000|NOT COMPLETED|Second Washout||0
6739592|NCT03292016|7668428|FG001|NOT COMPLETED|Second Washout||1
6739593|NCT03292016|7668429|FG002|NOT COMPLETED|Second Washout||0
6739594|NCT03292016|7668430|FG003|NOT COMPLETED|Second Washout||0
6739595|NCT03292016|7668431|FG004|NOT COMPLETED|Second Washout||0
6739596|NCT03292016|7668432|FG005|NOT COMPLETED|Second Washout||0
6739597|NCT03292016|7668427|FG000|STARTED|Third Intervention||1
6739598|NCT03292016|7668428|FG001|STARTED|Third Intervention||0
6739599|NCT03292016|7668429|FG002|STARTED|Third Intervention||2
6739600|NCT03292016|7668430|FG003|STARTED|Third Intervention||1
6739601|NCT03292016|7668431|FG004|STARTED|Third Intervention||1
6739602|NCT03292016|7668432|FG005|STARTED|Third Intervention||2
6739603|NCT03292016|7668427|FG000|COMPLETED|Third Intervention||1
6739604|NCT03292016|7668428|FG001|COMPLETED|Third Intervention||0
6739605|NCT03292016|7668429|FG002|COMPLETED|Third Intervention||2
6739606|NCT03292016|7668430|FG003|COMPLETED|Third Intervention||1
6739607|NCT03292016|7668431|FG004|COMPLETED|Third Intervention||1
6739608|NCT03292016|7668432|FG005|COMPLETED|Third Intervention||2
6739609|NCT03292016|7668427|FG000|NOT COMPLETED|Third Intervention||0
6739610|NCT03292016|7668428|FG001|NOT COMPLETED|Third Intervention||0
6739611|NCT03292016|7668429|FG002|NOT COMPLETED|Third Intervention||0
6739612|NCT03292016|7668430|FG003|NOT COMPLETED|Third Intervention||0
6739613|NCT03292016|7668431|FG004|NOT COMPLETED|Third Intervention||0
6739614|NCT03292016|7668432|FG005|NOT COMPLETED|Third Intervention||0
6739615|NCT03292406|7668443|FG000|STARTED|Overall Study||30
6739616|NCT03292406|7668444|FG001|STARTED|Overall Study||28
6739617|NCT03292406|7668445|FG002|STARTED|Overall Study||28
6739618|NCT03292406|7668443|FG000|Participants Treated|Overall Study||30
6739619|NCT03292406|7668444|FG001|Participants Treated|Overall Study||28
6739620|NCT03292406|7668445|FG002|Participants Treated|Overall Study||27
6739621|NCT03292406|7668443|FG000|COMPLETED|Overall Study||17
6739622|NCT03292406|7668444|FG001|COMPLETED|Overall Study||15
6739623|NCT03292406|7668445|FG002|COMPLETED|Overall Study||15
6739624|NCT03292406|7668443|FG000|NOT COMPLETED|Overall Study||13
6739625|NCT03292406|7668444|FG001|NOT COMPLETED|Overall Study||13
6739626|NCT03292406|7668445|FG002|NOT COMPLETED|Overall Study||13
6739627|NCT03292432|7668455|FG000|STARTED|Overall Study||46
6739628|NCT03292432|7668456|FG001|STARTED|Overall Study||43
6739629|NCT03292432|7668455|FG000|Started Study Intervention|Overall Study||45
6739630|NCT03292432|7668456|FG001|Started Study Intervention|Overall Study||43
6739631|NCT03292432|7668455|FG000|COMPLETED|Overall Study||31
6739632|NCT03292432|7668456|FG001|COMPLETED|Overall Study||32
6739633|NCT03292432|7668455|FG000|NOT COMPLETED|Overall Study||15
6739634|NCT03292432|7668456|FG001|NOT COMPLETED|Overall Study||11
6739635|NCT03292562|7668464|FG000|STARTED|Overall Study||35
6739636|NCT03292562|7668465|FG001|STARTED|Overall Study||31
6739637|NCT03292562|7668464|FG000|COMPLETED|Overall Study||29
6739638|NCT03292562|7668465|FG001|COMPLETED|Overall Study||30
6739639|NCT03292562|7668464|FG000|NOT COMPLETED|Overall Study||6
6739640|NCT03292562|7668465|FG001|NOT COMPLETED|Overall Study||1
6739641|NCT03292614|7668471|FG000|STARTED|Overall Study||25
6739642|NCT03292614|7668471|FG000|COMPLETED|Overall Study||25
6739643|NCT03292614|7668471|FG000|NOT COMPLETED|Overall Study||0
6739644|NCT03292640|7668477|FG000|STARTED|Overall Study||275
6739645|NCT03292640|7668478|FG001|STARTED|Overall Study||272
6722597|NCT03070782|7652658|FG000|STARTED|Overall Study||48
6722598|NCT03070782|7652659|FG001|STARTED|Overall Study||48
6722599|NCT03070782|7652660|FG002|STARTED|Overall Study||47
6722600|NCT03070782|7652661|FG003|STARTED|Overall Study||48
6722601|NCT03070782|7652662|FG004|STARTED|Overall Study||48
6722602|NCT03070782|7652663|FG005|STARTED|Overall Study||47
6722603|NCT03070782|7652658|FG000|COMPLETED|Overall Study||41
6722604|NCT03070782|7652659|FG001|COMPLETED|Overall Study||47
6722605|NCT03070782|7652660|FG002|COMPLETED|Overall Study||43
6722606|NCT03070782|7652661|FG003|COMPLETED|Overall Study||43
6722607|NCT03070782|7652662|FG004|COMPLETED|Overall Study||36
6722608|NCT03070782|7652663|FG005|COMPLETED|Overall Study||40
6722609|NCT03070782|7652658|FG000|NOT COMPLETED|Overall Study||7
6722610|NCT03070782|7652659|FG001|NOT COMPLETED|Overall Study||1
6722611|NCT03070782|7652660|FG002|NOT COMPLETED|Overall Study||4
6722612|NCT03070782|7652661|FG003|NOT COMPLETED|Overall Study||5
6722613|NCT03070782|7652662|FG004|NOT COMPLETED|Overall Study||12
6722614|NCT03070782|7652663|FG005|NOT COMPLETED|Overall Study||7
6722615|NCT03070964|7652677|FG000|STARTED|Overall Study||14
6722616|NCT03070964|7652677|FG000|COMPLETED|Overall Study||0
6722617|NCT03070964|7652677|FG000|NOT COMPLETED|Overall Study||14
6722618|NCT03071094|7652683|FG000|STARTED|Overall Study||7
6722619|NCT03071094|7652684|FG001|STARTED|Overall Study||5
6722620|NCT03071094|7652683|FG000|COMPLETED|Overall Study||5
6722621|NCT03071094|7652684|FG001|COMPLETED|Overall Study||4
6722622|NCT03071094|7652683|FG000|NOT COMPLETED|Overall Study||2
6722623|NCT03071094|7652684|FG001|NOT COMPLETED|Overall Study||1
6722624|NCT03071263|7652692|FG000|STARTED|Overall Study||147
6722625|NCT03071263|7652693|FG001|STARTED|Overall Study||148
6722626|NCT03071263|7652692|FG000|COMPLETED|Overall Study||144
6722627|NCT03071263|7652693|FG001|COMPLETED|Overall Study||141
6722628|NCT03071263|7652692|FG000|NOT COMPLETED|Overall Study||3
6722629|NCT03071263|7652693|FG001|NOT COMPLETED|Overall Study||7
6722630|NCT03071276|7652699|FG000|STARTED|Overall Study||37
6722631|NCT03071276|7652699|FG000|COMPLETED|Overall Study||22
6722632|NCT03071276|7652699|FG000|NOT COMPLETED|Overall Study||15
6722633|NCT03071744|7652703|FG000|STARTED|Overall Study||6
6722634|NCT03071744|7652703|FG000|COMPLETED|Overall Study||4
6722635|NCT03071744|7652703|FG000|NOT COMPLETED|Overall Study||2
6722636|NCT03071887|7652707|FG000|STARTED|Overall Study||13
6722637|NCT03071887|7652707|FG000|COMPLETED|Overall Study||7
6722638|NCT03071887|7652707|FG000|NOT COMPLETED|Overall Study||6
6722639|NCT03072160|7652713|FG000|STARTED|Overall Study||13
6722640|NCT03072160|7652714|FG001|STARTED|Overall Study||4
6722641|NCT03072160|7652713|FG000|COMPLETED|Overall Study||2
6722642|NCT03072160|7652714|FG001|COMPLETED|Overall Study||0
6722643|NCT03072160|7652713|FG000|NOT COMPLETED|Overall Study||11
6722644|NCT03072160|7652714|FG001|NOT COMPLETED|Overall Study||4
6722645|NCT03072186|7652752|FG000|STARTED|Overall Study||23
6722646|NCT03072186|7652752|FG000|COMPLETED|Overall Study||17
6722647|NCT03072186|7652752|FG000|NOT COMPLETED|Overall Study||6
6722648|NCT03072550|7652756|FG000|STARTED|Overall Study||26
6722649|NCT03072550|7652756|FG000|COMPLETED|Overall Study||24
6722650|NCT03072550|7652756|FG000|NOT COMPLETED|Overall Study||2
6722651|NCT03072602|7652762|FG000|STARTED|Overall Study||39
6722652|NCT03072602|7652763|FG001|STARTED|Overall Study||42
6722653|NCT03072602|7652762|FG000|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
6722654|NCT03072602|7652763|FG001|Total Participant Screened for the Purpose of Eligibilty|Overall Study||47
6722655|NCT03072602|7652762|FG000|Ineligible Participants|Overall Study||8
6722656|NCT03072602|7652763|FG001|Ineligible Participants|Overall Study||5
6722657|NCT03072602|7652762|FG000|Participant Received Standardized Meals|Overall Study||39
6722658|NCT03072602|7652763|FG001|Participant Received Standardized Meals|Overall Study||42
6722659|NCT03072602|7652762|FG000|Study Dropouts|Overall Study||4
6722660|NCT03072602|7652763|FG001|Study Dropouts|Overall Study||3
6722661|NCT03072602|7652762|FG000|Participants Returned for Glucose Challenge Protocol|Overall Study||35
6722662|NCT03072602|7652763|FG001|Participants Returned for Glucose Challenge Protocol|Overall Study||39
6722663|NCT03072602|7652762|FG000|Unable to Complete the Protocol|Overall Study||1
6722664|NCT03072602|7652763|FG001|Unable to Complete the Protocol|Overall Study||1
6722665|NCT03072602|7652762|FG000|COMPLETED|Overall Study||34
6722666|NCT03072602|7652763|FG001|COMPLETED|Overall Study||38
6722667|NCT03072602|7652762|FG000|NOT COMPLETED|Overall Study||5
6722668|NCT03072602|7652763|FG001|NOT COMPLETED|Overall Study||4
6722669|NCT03072719|7652771|FG000|STARTED|Overall Study||60
6722670|NCT03072719|7652772|FG001|STARTED|Overall Study||60
6722671|NCT03072719|7652771|FG000|COMPLETED|Overall Study||59
6722672|NCT03072719|7652772|FG001|COMPLETED|Overall Study||59
6722673|NCT03072719|7652771|FG000|NOT COMPLETED|Overall Study||1
6722674|NCT03072719|7652772|FG001|NOT COMPLETED|Overall Study||1
6722675|NCT03072732|7652780|FG000|STARTED|Overall Study||20
6722676|NCT03072732|7652781|FG001|STARTED|Overall Study||20
6722677|NCT03072732|7652780|FG000|COMPLETED|Overall Study||20
6722678|NCT03072732|7652781|FG001|COMPLETED|Overall Study||20
6722679|NCT03072732|7652780|FG000|NOT COMPLETED|Overall Study||0
6722680|NCT03072732|7652781|FG001|NOT COMPLETED|Overall Study||0
6722681|NCT03072875|7652787|FG000|STARTED|Overall Study||26
6722682|NCT03072875|7652787|FG000|COMPLETED|Overall Study||25
6722683|NCT03072875|7652787|FG000|NOT COMPLETED|Overall Study||1
6722684|NCT03072953|7652792|FG000|STARTED|Overall Study||2
6722685|NCT03072953|7652792|FG000|COMPLETED|Overall Study||2
6722686|NCT03072953|7652792|FG000|NOT COMPLETED|Overall Study||0
6722687|NCT03073005|7652800|FG000|STARTED|Overall Study||33
6722688|NCT03073005|7652801|FG001|STARTED|Overall Study||37
6722689|NCT03073005|7652802|FG002|STARTED|Overall Study||36
6722690|NCT03073005|7652803|FG003|STARTED|Overall Study||37
6722691|NCT03073005|7652800|FG000|Received Initial Training|Overall Study|29 pairs (29 patients plus their caregivers)|29
6722692|NCT03073005|7652801|FG001|Received Initial Training|Overall Study||29
6722693|NCT03073005|7652802|FG002|Received Initial Training|Overall Study|33 pairs (33 patients plus their caregivers)|33
6722694|NCT03073005|7652803|FG003|Received Initial Training|Overall Study||33
6722695|NCT03073005|7652800|FG000|COMPLETED|Overall Study|25 pairs (25 patients plus their caregivers)|25
6722696|NCT03073005|7652801|FG001|COMPLETED|Overall Study||25
6722697|NCT03073005|7652802|FG002|COMPLETED|Overall Study|24 pairs (24 patients plus their caregivers)|24
6722698|NCT03073005|7652803|FG003|COMPLETED|Overall Study||24
6722699|NCT03073005|7652800|FG000|NOT COMPLETED|Overall Study||8
6722700|NCT03073005|7652801|FG001|NOT COMPLETED|Overall Study||12
6722701|NCT03073005|7652802|FG002|NOT COMPLETED|Overall Study||12
6722702|NCT03073005|7652803|FG003|NOT COMPLETED|Overall Study||13
6722703|NCT03073109|7652818|FG000|STARTED|Overall Study||100
6722704|NCT03073109|7652819|FG001|STARTED|Overall Study||70
6722705|NCT03073109|7652818|FG000|COMPLETED|Overall Study||90
6722706|NCT03073109|7652819|FG001|COMPLETED|Overall Study||68
6722707|NCT03073109|7652818|FG000|NOT COMPLETED|Overall Study||10
6722708|NCT03073109|7652819|FG001|NOT COMPLETED|Overall Study||2
6722709|NCT03073148|7652841|FG000|STARTED|Overall Study||21
6722710|NCT03073148|7652842|FG001|STARTED|Overall Study||10
6722711|NCT03073148|7652843|FG002|STARTED|Overall Study||4
6722712|NCT03073148|7652841|FG000|COMPLETED|Overall Study||21
6722713|NCT03073148|7652842|FG001|COMPLETED|Overall Study||10
6722714|NCT03073148|7652843|FG002|COMPLETED|Overall Study||0
6722715|NCT03073148|7652841|FG000|NOT COMPLETED|Overall Study||0
6722716|NCT03073148|7652842|FG001|NOT COMPLETED|Overall Study||0
6722717|NCT03073148|7652843|FG002|NOT COMPLETED|Overall Study||4
6722718|NCT03073200|7652854|FG000|STARTED|Double Blind Treatment Period||56
6722719|NCT03073200|7652855|FG001|STARTED|Double Blind Treatment Period||115
6722720|NCT03073200|7652856|FG002|STARTED|Double Blind Treatment Period||30
6722721|NCT03073200|7652857|FG003|STARTED|Double Blind Treatment Period||0
6722722|NCT03073200|7652858|FG004|STARTED|Double Blind Treatment Period||0
6722723|NCT03073200|7652859|FG005|STARTED|Double Blind Treatment Period||0
6722724|NCT03073200|7652860|FG006|STARTED|Double Blind Treatment Period||0
6722725|NCT03073200|7652861|FG007|STARTED|Double Blind Treatment Period||0
6722726|NCT03073200|7652862|FG008|STARTED|Double Blind Treatment Period||0
6722727|NCT03073200|7652863|FG009|STARTED|Double Blind Treatment Period||0
6722728|NCT03073200|7652864|FG010|STARTED|Double Blind Treatment Period||0
6722729|NCT03073200|7652865|FG011|STARTED|Double Blind Treatment Period||0
6722730|NCT03073200|7652866|FG012|STARTED|Double Blind Treatment Period||0
6722731|NCT03073200|7652867|FG013|STARTED|Double Blind Treatment Period||0
6722732|NCT03073200|7652868|FG014|STARTED|Double Blind Treatment Period||0
6722733|NCT03073200|7652854|FG000|Participants in Etanercept Approved Countries|Double Blind Treatment Period||19
6722734|NCT03073200|7652855|FG001|Participants in Etanercept Approved Countries|Double Blind Treatment Period||38
6722735|NCT03073200|7652856|FG002|Participants in Etanercept Approved Countries|Double Blind Treatment Period||30
6722736|NCT03073200|7652857|FG003|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722737|NCT03073200|7652858|FG004|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722738|NCT03073200|7652859|FG005|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722739|NCT03073200|7652860|FG006|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722740|NCT03073200|7652861|FG007|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722741|NCT03073200|7652862|FG008|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722742|NCT03073200|7652863|FG009|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722743|NCT03073200|7652864|FG010|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722744|NCT03073200|7652865|FG011|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722745|NCT03073200|7652866|FG012|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722746|NCT03073200|7652867|FG013|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722747|NCT03073200|7652868|FG014|Participants in Etanercept Approved Countries|Double Blind Treatment Period||0
6722748|NCT03073200|7652854|FG000|COMPLETED|Double Blind Treatment Period||54
6722749|NCT03073200|7652855|FG001|COMPLETED|Double Blind Treatment Period||114
6722750|NCT03073200|7652856|FG002|COMPLETED|Double Blind Treatment Period||30
6722751|NCT03073200|7652857|FG003|COMPLETED|Double Blind Treatment Period||0
6722752|NCT03073200|7652858|FG004|COMPLETED|Double Blind Treatment Period||0
6722753|NCT03073200|7652859|FG005|COMPLETED|Double Blind Treatment Period||0
6722754|NCT03073200|7652860|FG006|COMPLETED|Double Blind Treatment Period||0
6722755|NCT03073200|7652861|FG007|COMPLETED|Double Blind Treatment Period||0
6722756|NCT03073200|7652862|FG008|COMPLETED|Double Blind Treatment Period||0
6722757|NCT03073200|7652863|FG009|COMPLETED|Double Blind Treatment Period||0
6722758|NCT03073200|7652864|FG010|COMPLETED|Double Blind Treatment Period||0
6722759|NCT03073200|7652865|FG011|COMPLETED|Double Blind Treatment Period||0
6722760|NCT03073200|7652866|FG012|COMPLETED|Double Blind Treatment Period||0
6722761|NCT03073200|7652867|FG013|COMPLETED|Double Blind Treatment Period||0
6722762|NCT03073200|7652868|FG014|COMPLETED|Double Blind Treatment Period||0
6722763|NCT03073200|7652854|FG000|NOT COMPLETED|Double Blind Treatment Period||2
6722764|NCT03073200|7652855|FG001|NOT COMPLETED|Double Blind Treatment Period||1
6722765|NCT03073200|7652856|FG002|NOT COMPLETED|Double Blind Treatment Period||0
6722766|NCT03073200|7652857|FG003|NOT COMPLETED|Double Blind Treatment Period||0
6722767|NCT03073200|7652858|FG004|NOT COMPLETED|Double Blind Treatment Period||0
6722768|NCT03073200|7652859|FG005|NOT COMPLETED|Double Blind Treatment Period||0
6722769|NCT03073200|7652860|FG006|NOT COMPLETED|Double Blind Treatment Period||0
6264729|NCT03447314|7163640|FG003|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264730|NCT03447314|7163641|FG004|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264731|NCT03447314|7163642|FG005|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264732|NCT03447314|7163643|FG006|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264733|NCT03447314|7163644|FG007|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264734|NCT03447314|7163645|FG008|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264735|NCT03447314|7163646|FG009|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264736|NCT03447314|7163647|FG010|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264737|NCT03447314|7163648|FG011|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264738|NCT03447314|7163649|FG012|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264739|NCT03447314|7163650|FG013|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264740|NCT03447314|7163651|FG014|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264741|NCT03447314|7163652|FG015|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264742|NCT03447314|7163653|FG016|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264743|NCT03447314|7163654|FG017|NOT COMPLETED|Part 2 (Up to 27 Months)||0
6264744|NCT03422653|7163697|FG000|STARTED|Period 1: Double-blind Phase||189
6264745|NCT03422653|7163698|FG001|STARTED|Period 1: Double-blind Phase||189
6264746|NCT03422653|7163699|FG002|STARTED|Period 1: Double-blind Phase||0
6264747|NCT03422653|7163697|FG000|COMPLETED|Period 1: Double-blind Phase||162
6264748|NCT03422653|7163698|FG001|COMPLETED|Period 1: Double-blind Phase||170
6264749|NCT03422653|7163699|FG002|COMPLETED|Period 1: Double-blind Phase||0
6264750|NCT03422653|7163697|FG000|NOT COMPLETED|Period 1: Double-blind Phase||27
6264751|NCT03422653|7163698|FG001|NOT COMPLETED|Period 1: Double-blind Phase||19
6264752|NCT03422653|7163699|FG002|NOT COMPLETED|Period 1: Double-blind Phase||0
6264753|NCT03422653|7163697|FG000|STARTED|Period 2: Open-label Phase||0
6264754|NCT03422653|7163698|FG001|STARTED|Period 2: Open-label Phase||0
6264755|NCT03422653|7163699|FG002|STARTED|Period 2: Open-label Phase||313
6264756|NCT03422653|7163697|FG000|COMPLETED|Period 2: Open-label Phase||0
6264757|NCT03422653|7163698|FG001|COMPLETED|Period 2: Open-label Phase||0
6264758|NCT03422653|7163699|FG002|COMPLETED|Period 2: Open-label Phase||189
6264759|NCT03422653|7163697|FG000|NOT COMPLETED|Period 2: Open-label Phase||0
6264760|NCT03422653|7163698|FG001|NOT COMPLETED|Period 2: Open-label Phase||0
6264761|NCT03422653|7163699|FG002|NOT COMPLETED|Period 2: Open-label Phase||124
6264762|NCT03320330|7163711|FG000|STARTED|Overall Study||6
6264763|NCT03320330|7163712|FG001|STARTED|Overall Study||6
6264764|NCT03320330|7163713|FG002|STARTED|Overall Study||14
6264765|NCT03320330|7163711|FG000|COMPLETED|Overall Study||0
6602900|NCT02059174|7527904|FG001|NOT COMPLETED|Period 3||0
6602901|NCT02059174|7527903|FG000|STARTED|Period 4||35
6602902|NCT02059174|7527904|FG001|STARTED|Period 4||35
6602903|NCT02059174|7527903|FG000|COMPLETED|Period 4||35
6602904|NCT02059174|7527904|FG001|COMPLETED|Period 4||35
6602905|NCT02059174|7527903|FG000|NOT COMPLETED|Period 4||0
6602906|NCT02059174|7527904|FG001|NOT COMPLETED|Period 4||0
6602907|NCT02059187|7527912|FG000|STARTED|Overall Study||265
6602908|NCT02059187|7527913|FG001|STARTED|Overall Study||266
6602909|NCT02059187|7527912|FG000|COMPLETED|Overall Study||240
6602910|NCT02059187|7527913|FG001|COMPLETED|Overall Study||244
6602911|NCT02059187|7527912|FG000|NOT COMPLETED|Overall Study||25
6602912|NCT02059187|7527913|FG001|NOT COMPLETED|Overall Study||22
6602913|NCT02059213|7527921|FG000|STARTED|Overall Study||20
6602914|NCT02059213|7527922|FG001|STARTED|Overall Study||42
6602915|NCT02059213|7527921|FG000|Initiated Treatment|Overall Study||20
6602916|NCT02059213|7527922|FG001|Initiated Treatment|Overall Study||40
6602917|NCT02059213|7527921|FG000|COMPLETED|Overall Study||20
6602918|NCT02059213|7527922|FG001|COMPLETED|Overall Study||40
6602919|NCT02059213|7527921|FG000|NOT COMPLETED|Overall Study||0
6602920|NCT02059213|7527922|FG001|NOT COMPLETED|Overall Study||2
6602921|NCT02059239|7527933|FG000|STARTED|Overall Study||18
6602922|NCT02059239|7527934|FG001|STARTED|Overall Study||16
6602923|NCT02059239|7527933|FG000|COMPLETED|Overall Study||16
6602924|NCT02059239|7527934|FG001|COMPLETED|Overall Study||13
6602925|NCT02059239|7527933|FG000|NOT COMPLETED|Overall Study||2
6602926|NCT02059239|7527934|FG001|NOT COMPLETED|Overall Study||3
6602927|NCT02059278|7527943|FG000|STARTED|Overall Study||165
6602928|NCT02059278|7527944|FG001|STARTED|Overall Study||170
6602929|NCT02059278|7527943|FG000|COMPLETED|Overall Study||162
6602930|NCT02059278|7527944|FG001|COMPLETED|Overall Study||166
6602931|NCT02059278|7527943|FG000|NOT COMPLETED|Overall Study||3
6602932|NCT02059278|7527944|FG001|NOT COMPLETED|Overall Study||4
6602933|NCT02059291|7527959|FG000|STARTED|Epoch 2||31
6602934|NCT02059291|7527960|FG001|STARTED|Epoch 2||32
6602935|NCT02059291|7527961|FG002|STARTED|Epoch 2||37
6602936|NCT02059291|7527962|FG003|STARTED|Epoch 2||35
6602937|NCT02059291|7527963|FG004|STARTED|Epoch 2||22
6602938|NCT02059291|7527964|FG005|STARTED|Epoch 2||24
6602939|NCT02059291|7527965|FG006|STARTED|Epoch 2||2
6602940|NCT02059291|7527966|FG007|STARTED|Epoch 2||2
6602941|NCT02059291|7527967|FG008|STARTED|Epoch 2|This Epoch 3 group is shown in Epoch 2 to account for the 203 patients enrolled in the study.|18
6722770|NCT03073200|7652861|FG007|NOT COMPLETED|Double Blind Treatment Period||0
6722771|NCT03073200|7652862|FG008|NOT COMPLETED|Double Blind Treatment Period||0
6722772|NCT03073200|7652863|FG009|NOT COMPLETED|Double Blind Treatment Period||0
6722773|NCT03073200|7652864|FG010|NOT COMPLETED|Double Blind Treatment Period||0
6722774|NCT03073200|7652865|FG011|NOT COMPLETED|Double Blind Treatment Period||0
6722775|NCT03073200|7652866|FG012|NOT COMPLETED|Double Blind Treatment Period||0
6722776|NCT03073200|7652867|FG013|NOT COMPLETED|Double Blind Treatment Period||0
6722777|NCT03073200|7652868|FG014|NOT COMPLETED|Double Blind Treatment Period||0
6722778|NCT03073200|7652854|FG000|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
6722779|NCT03073200|7652855|FG001|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
6722780|NCT03073200|7652856|FG002|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|0
6722781|NCT03073200|7652857|FG003|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|53
6722782|NCT03073200|7652858|FG004|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|113
6722783|NCT03073200|7652859|FG005|STARTED|Open-Label Maintenance Period|This period is to report Maintenance Period participants.|28
6722784|NCT03073200|7652860|FG006|STARTED|Open-Label Maintenance Period||0
6722785|NCT03073200|7652861|FG007|STARTED|Open-Label Maintenance Period||0
6264766|NCT03320330|7163712|FG001|COMPLETED|Overall Study||1
6264767|NCT03320330|7163713|FG002|COMPLETED|Overall Study||0
6264768|NCT03320330|7163711|FG000|NOT COMPLETED|Overall Study||6
6264769|NCT03320330|7163712|FG001|NOT COMPLETED|Overall Study||5
6264770|NCT03320330|7163713|FG002|NOT COMPLETED|Overall Study||14
6264771|NCT03271151|7163724|FG000|STARTED|Overall Study||80
6264772|NCT03271151|7163725|FG001|STARTED|Overall Study||80
6264773|NCT03271151|7163724|FG000|COMPLETED|Overall Study||78
6264774|NCT03271151|7163725|FG001|COMPLETED|Overall Study||77
6264775|NCT03271151|7163724|FG000|NOT COMPLETED|Overall Study||2
6264776|NCT03271151|7163725|FG001|NOT COMPLETED|Overall Study||3
6264777|NCT03141177|7163734|FG000|STARTED|Overall Study||323
6264778|NCT03141177|7163735|FG001|STARTED|Overall Study||50
6264779|NCT03141177|7163736|FG002|STARTED|Overall Study||328
6264780|NCT03141177|7163734|FG000|Treated|Overall Study||320
6264781|NCT03141177|7163735|FG001|Treated|Overall Study||50
6264782|NCT03141177|7163736|FG002|Treated|Overall Study||320
6264783|NCT03141177|7163734|FG000|COMPLETED|Overall Study||242
6264784|NCT03141177|7163735|FG001|COMPLETED|Overall Study||34
6264785|NCT03141177|7163736|FG002|COMPLETED|Overall Study||210
6264786|NCT03141177|7163734|FG000|NOT COMPLETED|Overall Study||81
6264787|NCT03141177|7163735|FG001|NOT COMPLETED|Overall Study||16
6264788|NCT03141177|7163736|FG002|NOT COMPLETED|Overall Study||118
6264789|NCT03117049|7163747|FG000|STARTED|Overall Study||275
6264790|NCT03117049|7163748|FG001|STARTED|Overall Study||275
6264791|NCT03117049|7163747|FG000|COMPLETED|Overall Study||74
6264792|NCT03117049|7163748|FG001|COMPLETED|Overall Study||44
6264793|NCT03117049|7163747|FG000|NOT COMPLETED|Overall Study||201
6264794|NCT03117049|7163748|FG001|NOT COMPLETED|Overall Study||231
6264795|NCT03023813|7163757|FG000|STARTED|Overall Study||39
6264796|NCT03023813|7163758|FG001|STARTED|Overall Study||34
6264797|NCT03023813|7163759|FG002|STARTED|Overall Study||31
6264798|NCT03023813|7163757|FG000|COMPLETED|Overall Study||38
6264799|NCT03023813|7163758|FG001|COMPLETED|Overall Study||32
6264800|NCT03023813|7163759|FG002|COMPLETED|Overall Study||31
6264801|NCT03023813|7163757|FG000|NOT COMPLETED|Overall Study||1
6264802|NCT03023813|7163758|FG001|NOT COMPLETED|Overall Study||2
6264803|NCT03023813|7163759|FG002|NOT COMPLETED|Overall Study||0
6264804|NCT02993822|7163772|FG000|STARTED|Overall Study||79
6264805|NCT02993822|7163773|FG001|STARTED|Overall Study||78
6264806|NCT02993822|7163774|FG002|STARTED|Overall Study||79
6264807|NCT02993822|7163775|FG003|STARTED|Overall Study||79
6264808|NCT02993822|7163772|FG000|COMPLETED|Overall Study||69
6264809|NCT02993822|7163773|FG001|COMPLETED|Overall Study||74
6264810|NCT02993822|7163774|FG002|COMPLETED|Overall Study||69
6264811|NCT02993822|7163775|FG003|COMPLETED|Overall Study||75
6264812|NCT02993822|7163772|FG000|NOT COMPLETED|Overall Study||10
6264813|NCT02993822|7163773|FG001|NOT COMPLETED|Overall Study||4
6264814|NCT02993822|7163774|FG002|NOT COMPLETED|Overall Study||10
6264815|NCT02993822|7163775|FG003|NOT COMPLETED|Overall Study||4
6264816|NCT02924324|7163787|FG000|STARTED|Overall Study||28
6264817|NCT02924324|7163788|FG001|STARTED|Overall Study||28
6264818|NCT02924324|7163787|FG000|COMPLETED|Overall Study||28
6264819|NCT02924324|7163788|FG001|COMPLETED|Overall Study||28
6264820|NCT02924324|7163787|FG000|NOT COMPLETED|Overall Study||0
6264821|NCT02924324|7163788|FG001|NOT COMPLETED|Overall Study||0
6264822|NCT02828917|7163794|FG000|STARTED|Overall Study||104
6264823|NCT02828917|7163794|FG000|COMPLETED|Overall Study||104
6264824|NCT02828917|7163794|FG000|NOT COMPLETED|Overall Study||0
6264825|NCT02753127|7163800|FG000|STARTED|Overall Study||624
6264826|NCT02753127|7163801|FG001|STARTED|Overall Study||629
6264827|NCT02753127|7163800|FG000|Discontinued Due to Death|Overall Study||507
6264828|NCT02753127|7163801|FG001|Discontinued Due to Death|Overall Study||499
6264829|NCT02753127|7163800|FG000|Completion of Survival Follow-Up Due to Study Completion|Overall Study||64
6264830|NCT02753127|7163801|FG001|Completion of Survival Follow-Up Due to Study Completion|Overall Study||62
6264831|NCT02753127|7163800|FG000|COMPLETED|Overall Study||571
6264832|NCT02753127|7163801|FG001|COMPLETED|Overall Study||561
6264833|NCT02753127|7163800|FG000|NOT COMPLETED|Overall Study||53
6264834|NCT02753127|7163801|FG001|NOT COMPLETED|Overall Study||68
6722786|NCT03073200|7652862|FG008|STARTED|Open-Label Maintenance Period||0
6722787|NCT03073200|7652863|FG009|STARTED|Open-Label Maintenance Period||0
6722788|NCT03073200|7652864|FG010|STARTED|Open-Label Maintenance Period||0
6722789|NCT03073200|7652865|FG011|STARTED|Open-Label Maintenance Period||0
6722790|NCT03073200|7652866|FG012|STARTED|Open-Label Maintenance Period||0
6722791|NCT03073200|7652867|FG013|STARTED|Open-Label Maintenance Period||0
6722792|NCT03073200|7652868|FG014|STARTED|Open-Label Maintenance Period||0
6722793|NCT03073200|7652854|FG000|COMPLETED|Open-Label Maintenance Period||0
6722794|NCT03073200|7652855|FG001|COMPLETED|Open-Label Maintenance Period||0
6722795|NCT03073200|7652856|FG002|COMPLETED|Open-Label Maintenance Period||0
6722796|NCT03073200|7652857|FG003|COMPLETED|Open-Label Maintenance Period||49
6722797|NCT03073200|7652858|FG004|COMPLETED|Open-Label Maintenance Period||109
6722798|NCT03073200|7652859|FG005|COMPLETED|Open-Label Maintenance Period||28
6722799|NCT03073200|7652860|FG006|COMPLETED|Open-Label Maintenance Period||0
6722800|NCT03073200|7652861|FG007|COMPLETED|Open-Label Maintenance Period||0
6722801|NCT03073200|7652862|FG008|COMPLETED|Open-Label Maintenance Period||0
6722802|NCT03073200|7652863|FG009|COMPLETED|Open-Label Maintenance Period||0
6722803|NCT03073200|7652864|FG010|COMPLETED|Open-Label Maintenance Period||0
6722804|NCT03073200|7652865|FG011|COMPLETED|Open-Label Maintenance Period||0
6722805|NCT03073200|7652866|FG012|COMPLETED|Open-Label Maintenance Period||0
6722806|NCT03073200|7652867|FG013|COMPLETED|Open-Label Maintenance Period||0
6722807|NCT03073200|7652868|FG014|COMPLETED|Open-Label Maintenance Period||0
6722808|NCT03073200|7652854|FG000|NOT COMPLETED|Open-Label Maintenance Period||0
6722809|NCT03073200|7652855|FG001|NOT COMPLETED|Open-Label Maintenance Period||0
6722810|NCT03073200|7652856|FG002|NOT COMPLETED|Open-Label Maintenance Period||0
6722811|NCT03073200|7652857|FG003|NOT COMPLETED|Open-Label Maintenance Period||4
6722812|NCT03073200|7652858|FG004|NOT COMPLETED|Open-Label Maintenance Period||4
6722813|NCT03073200|7652859|FG005|NOT COMPLETED|Open-Label Maintenance Period||0
6722814|NCT03073200|7652860|FG006|NOT COMPLETED|Open-Label Maintenance Period||0
6722815|NCT03073200|7652861|FG007|NOT COMPLETED|Open-Label Maintenance Period||0
6722816|NCT03073200|7652862|FG008|NOT COMPLETED|Open-Label Maintenance Period||0
6722817|NCT03073200|7652863|FG009|NOT COMPLETED|Open-Label Maintenance Period||0
6722818|NCT03073200|7652864|FG010|NOT COMPLETED|Open-Label Maintenance Period||0
6722819|NCT03073200|7652865|FG011|NOT COMPLETED|Open-Label Maintenance Period||0
6722820|NCT03073200|7652866|FG012|NOT COMPLETED|Open-Label Maintenance Period||0
6722821|NCT03073200|7652867|FG013|NOT COMPLETED|Open-Label Maintenance Period||0
6722822|NCT03073200|7652868|FG014|NOT COMPLETED|Open-Label Maintenance Period||0
6722823|NCT03073200|7652854|FG000|STARTED|Extension Period||0
6722824|NCT03073200|7652855|FG001|STARTED|Extension Period||0
6722825|NCT03073200|7652856|FG002|STARTED|Extension Period||0
6722826|NCT03073200|7652857|FG003|STARTED|Extension Period|This period is to report Extension Period participants.|0
6722827|NCT03073200|7652858|FG004|STARTED|Extension Period|This period is to report Extension Period participants.|0
6722828|NCT03073200|7652859|FG005|STARTED|Extension Period|This period is to report Extension Period participants.|0
6722829|NCT03073200|7652860|FG006|STARTED|Extension Period|This period is to report Extension Period participants.|34
6722830|NCT03073200|7652861|FG007|STARTED|Extension Period|This period is to report Extension Period participants.|68
6722831|NCT03073200|7652862|FG008|STARTED|Extension Period|This period is to report Extension Period participants.|9
6722832|NCT03073200|7652863|FG009|STARTED|Extension Period||0
6722833|NCT03073200|7652864|FG010|STARTED|Extension Period||0
6722834|NCT03073200|7652865|FG011|STARTED|Extension Period||0
6722835|NCT03073200|7652866|FG012|STARTED|Extension Period||0
6722836|NCT03073200|7652867|FG013|STARTED|Extension Period||0
6722837|NCT03073200|7652868|FG014|STARTED|Extension Period||0
6722838|NCT03073200|7652854|FG000|COMPLETED|Extension Period||0
6722839|NCT03073200|7652855|FG001|COMPLETED|Extension Period||0
6722840|NCT03073200|7652856|FG002|COMPLETED|Extension Period||0
6722841|NCT03073200|7652857|FG003|COMPLETED|Extension Period||0
6722842|NCT03073200|7652858|FG004|COMPLETED|Extension Period||0
6722843|NCT03073200|7652859|FG005|COMPLETED|Extension Period||0
6722844|NCT03073200|7652860|FG006|COMPLETED|Extension Period||31
6722845|NCT03073200|7652861|FG007|COMPLETED|Extension Period||62
6722846|NCT03073200|7652862|FG008|COMPLETED|Extension Period||7
6722847|NCT03073200|7652863|FG009|COMPLETED|Extension Period||0
6722848|NCT03073200|7652864|FG010|COMPLETED|Extension Period||0
6722849|NCT03073200|7652865|FG011|COMPLETED|Extension Period||0
6722850|NCT03073200|7652866|FG012|COMPLETED|Extension Period||0
6722851|NCT03073200|7652867|FG013|COMPLETED|Extension Period||0
6722852|NCT03073200|7652868|FG014|COMPLETED|Extension Period||0
6722853|NCT03073200|7652854|FG000|NOT COMPLETED|Extension Period||0
6722854|NCT03073200|7652855|FG001|NOT COMPLETED|Extension Period||0
6722855|NCT03073200|7652856|FG002|NOT COMPLETED|Extension Period||0
6722856|NCT03073200|7652857|FG003|NOT COMPLETED|Extension Period||0
6722857|NCT03073200|7652858|FG004|NOT COMPLETED|Extension Period||0
6722858|NCT03073200|7652859|FG005|NOT COMPLETED|Extension Period||0
6722859|NCT03073200|7652860|FG006|NOT COMPLETED|Extension Period||3
6722860|NCT03073200|7652861|FG007|NOT COMPLETED|Extension Period||6
6722861|NCT03073200|7652862|FG008|NOT COMPLETED|Extension Period||2
6722862|NCT03073200|7652863|FG009|NOT COMPLETED|Extension Period||0
6722863|NCT03073200|7652864|FG010|NOT COMPLETED|Extension Period||0
6722864|NCT03073200|7652865|FG011|NOT COMPLETED|Extension Period||0
6722865|NCT03073200|7652866|FG012|NOT COMPLETED|Extension Period||0
6722866|NCT03073200|7652867|FG013|NOT COMPLETED|Extension Period||0
6722867|NCT03073200|7652868|FG014|NOT COMPLETED|Extension Period||0
6722868|NCT03073200|7652854|FG000|STARTED|Randomized Withdrawal Period||0
6722869|NCT03073200|7652855|FG001|STARTED|Randomized Withdrawal Period||0
6722870|NCT03073200|7652856|FG002|STARTED|Randomized Withdrawal Period||0
6722871|NCT03073200|7652857|FG003|STARTED|Randomized Withdrawal Period||0
6722872|NCT03073200|7652858|FG004|STARTED|Randomized Withdrawal Period||0
6722873|NCT03073200|7652859|FG005|STARTED|Randomized Withdrawal Period||0
6722874|NCT03073200|7652860|FG006|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
6722875|NCT03073200|7652861|FG007|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
6722876|NCT03073200|7652862|FG008|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|0
6722877|NCT03073200|7652863|FG009|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
6722878|NCT03073200|7652864|FG010|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|34
6722879|NCT03073200|7652865|FG011|STARTED|Randomized Withdrawal Period|This period is to report randomized withdrawal period participants.|33
6722880|NCT03073200|7652866|FG012|STARTED|Randomized Withdrawal Period||0
6722881|NCT03073200|7652867|FG013|STARTED|Randomized Withdrawal Period||0
6722882|NCT03073200|7652868|FG014|STARTED|Randomized Withdrawal Period||0
6722883|NCT03073200|7652854|FG000|COMPLETED|Randomized Withdrawal Period||0
6722884|NCT03073200|7652855|FG001|COMPLETED|Randomized Withdrawal Period||0
6722885|NCT03073200|7652856|FG002|COMPLETED|Randomized Withdrawal Period||0
6722886|NCT03073200|7652857|FG003|COMPLETED|Randomized Withdrawal Period||0
6722887|NCT03073200|7652858|FG004|COMPLETED|Randomized Withdrawal Period||0
6722888|NCT03073200|7652859|FG005|COMPLETED|Randomized Withdrawal Period||0
6722889|NCT03073200|7652860|FG006|COMPLETED|Randomized Withdrawal Period||0
6722890|NCT03073200|7652861|FG007|COMPLETED|Randomized Withdrawal Period||0
6722891|NCT03073200|7652862|FG008|COMPLETED|Randomized Withdrawal Period||0
6722892|NCT03073200|7652863|FG009|COMPLETED|Randomized Withdrawal Period||33
6722893|NCT03073200|7652864|FG010|COMPLETED|Randomized Withdrawal Period||32
6722894|NCT03073200|7652865|FG011|COMPLETED|Randomized Withdrawal Period||30
6722895|NCT03073200|7652866|FG012|COMPLETED|Randomized Withdrawal Period||0
6722896|NCT03073200|7652867|FG013|COMPLETED|Randomized Withdrawal Period||0
6722897|NCT03073200|7652868|FG014|COMPLETED|Randomized Withdrawal Period||0
6722898|NCT03073200|7652854|FG000|NOT COMPLETED|Randomized Withdrawal Period||0
6722899|NCT03073200|7652855|FG001|NOT COMPLETED|Randomized Withdrawal Period||0
6722900|NCT03073200|7652856|FG002|NOT COMPLETED|Randomized Withdrawal Period||0
6722901|NCT03073200|7652857|FG003|NOT COMPLETED|Randomized Withdrawal Period||0
6722902|NCT03073200|7652858|FG004|NOT COMPLETED|Randomized Withdrawal Period||0
6722903|NCT03073200|7652859|FG005|NOT COMPLETED|Randomized Withdrawal Period||0
6722904|NCT03073200|7652860|FG006|NOT COMPLETED|Randomized Withdrawal Period||0
6722905|NCT03073200|7652861|FG007|NOT COMPLETED|Randomized Withdrawal Period||0
6722906|NCT03073200|7652862|FG008|NOT COMPLETED|Randomized Withdrawal Period||0
6722907|NCT03073200|7652863|FG009|NOT COMPLETED|Randomized Withdrawal Period||0
6722908|NCT03073200|7652864|FG010|NOT COMPLETED|Randomized Withdrawal Period||2
6722909|NCT03073200|7652865|FG011|NOT COMPLETED|Randomized Withdrawal Period||3
6722910|NCT03073200|7652866|FG012|NOT COMPLETED|Randomized Withdrawal Period||0
6722911|NCT03073200|7652867|FG013|NOT COMPLETED|Randomized Withdrawal Period||0
6722912|NCT03073200|7652868|FG014|NOT COMPLETED|Randomized Withdrawal Period||0
6722913|NCT03073200|7652854|FG000|STARTED|Post-Treatment Follow-Up Period||0
6722914|NCT03073200|7652855|FG001|STARTED|Post-Treatment Follow-Up Period||0
6722915|NCT03073200|7652856|FG002|STARTED|Post-Treatment Follow-Up Period||0
6722916|NCT03073200|7652857|FG003|STARTED|Post-Treatment Follow-Up Period||0
6722917|NCT03073200|7652858|FG004|STARTED|Post-Treatment Follow-Up Period||0
6722918|NCT03073200|7652859|FG005|STARTED|Post-Treatment Follow-Up Period||0
6722919|NCT03073200|7652860|FG006|STARTED|Post-Treatment Follow-Up Period||0
6722920|NCT03073200|7652861|FG007|STARTED|Post-Treatment Follow-Up Period||0
6722921|NCT03073200|7652862|FG008|STARTED|Post-Treatment Follow-Up Period||0
6722922|NCT03073200|7652863|FG009|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
6722923|NCT03073200|7652864|FG010|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
6722924|NCT03073200|7652865|FG011|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|0
6722925|NCT03073200|7652866|FG012|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|6
6722926|NCT03073200|7652867|FG013|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|166
6722927|NCT03073200|7652868|FG014|STARTED|Post-Treatment Follow-Up Period|This period is to report Follow-Up period participants.|2
6722928|NCT03073200|7652854|FG000|COMPLETED|Post-Treatment Follow-Up Period||0
6722929|NCT03073200|7652855|FG001|COMPLETED|Post-Treatment Follow-Up Period||0
6722930|NCT03073200|7652856|FG002|COMPLETED|Post-Treatment Follow-Up Period||0
6722931|NCT03073200|7652857|FG003|COMPLETED|Post-Treatment Follow-Up Period||0
6722932|NCT03073200|7652858|FG004|COMPLETED|Post-Treatment Follow-Up Period||0
6722933|NCT03073200|7652859|FG005|COMPLETED|Post-Treatment Follow-Up Period||0
6722934|NCT03073200|7652860|FG006|COMPLETED|Post-Treatment Follow-Up Period||0
6722935|NCT03073200|7652861|FG007|COMPLETED|Post-Treatment Follow-Up Period||0
6722936|NCT03073200|7652862|FG008|COMPLETED|Post-Treatment Follow-Up Period||0
6722937|NCT03073200|7652863|FG009|COMPLETED|Post-Treatment Follow-Up Period||0
6722938|NCT03073200|7652864|FG010|COMPLETED|Post-Treatment Follow-Up Period||0
6722939|NCT03073200|7652865|FG011|COMPLETED|Post-Treatment Follow-Up Period||0
6722940|NCT03073200|7652866|FG012|COMPLETED|Post-Treatment Follow-Up Period||6
6722941|NCT03073200|7652867|FG013|COMPLETED|Post-Treatment Follow-Up Period||139
6722942|NCT03073200|7652868|FG014|COMPLETED|Post-Treatment Follow-Up Period||1
6722943|NCT03073200|7652854|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722944|NCT03073200|7652855|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722945|NCT03073200|7652856|FG002|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722946|NCT03073200|7652857|FG003|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722947|NCT03073200|7652858|FG004|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722948|NCT03073200|7652859|FG005|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722949|NCT03073200|7652860|FG006|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722950|NCT03073200|7652861|FG007|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722951|NCT03073200|7652862|FG008|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722952|NCT03073200|7652863|FG009|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722953|NCT03073200|7652864|FG010|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722954|NCT03073200|7652865|FG011|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722955|NCT03073200|7652866|FG012|NOT COMPLETED|Post-Treatment Follow-Up Period||0
6722956|NCT03073200|7652867|FG013|NOT COMPLETED|Post-Treatment Follow-Up Period||27
6722957|NCT03073200|7652868|FG014|NOT COMPLETED|Post-Treatment Follow-Up Period||1
6722958|NCT03073213|7652893|FG000|STARTED|Single Dose Period||12
6722959|NCT03073213|7652894|FG001|STARTED|Single Dose Period||0
6722960|NCT03073213|7652895|FG002|STARTED|Single Dose Period||0
6722961|NCT03073213|7652893|FG000|COMPLETED|Single Dose Period||12
6722962|NCT03073213|7652894|FG001|COMPLETED|Single Dose Period||0
6722963|NCT03073213|7652895|FG002|COMPLETED|Single Dose Period||0
6722964|NCT03073213|7652893|FG000|NOT COMPLETED|Single Dose Period||0
6722965|NCT03073213|7652894|FG001|NOT COMPLETED|Single Dose Period||0
6722966|NCT03073213|7652895|FG002|NOT COMPLETED|Single Dose Period||0
6722967|NCT03073213|7652893|FG000|STARTED|Multiple Dose Period||0
6722968|NCT03073213|7652894|FG001|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|14
6722969|NCT03073213|7652895|FG002|STARTED|Multiple Dose Period|Participants who completed single dose had option to enroll into multiple dose.|15
6722970|NCT03073213|7652893|FG000|Participants Enrolled From Single Dose|Multiple Dose Period||0
6722971|NCT03073213|7652894|FG001|Participants Enrolled From Single Dose|Multiple Dose Period||7
6722972|NCT03073213|7652895|FG002|Participants Enrolled From Single Dose|Multiple Dose Period||2
6722973|NCT03073213|7652893|FG000|COMPLETED|Multiple Dose Period||0
6722974|NCT03073213|7652894|FG001|COMPLETED|Multiple Dose Period||14
6722975|NCT03073213|7652895|FG002|COMPLETED|Multiple Dose Period||14
6722976|NCT03073213|7652893|FG000|NOT COMPLETED|Multiple Dose Period||0
6722977|NCT03073213|7652894|FG001|NOT COMPLETED|Multiple Dose Period||0
6722978|NCT03073213|7652895|FG002|NOT COMPLETED|Multiple Dose Period||1
6264835|NCT02744430|7163817|FG000|STARTED|Overall Study||17
6264836|NCT02744430|7163818|FG001|STARTED|Overall Study||16
6264837|NCT02744430|7163817|FG000|COMPLETED|Overall Study||17
6264838|NCT02744430|7163818|FG001|COMPLETED|Overall Study||16
6264839|NCT02744430|7163817|FG000|NOT COMPLETED|Overall Study||0
6264840|NCT02744430|7163818|FG001|NOT COMPLETED|Overall Study||0
6264841|NCT02460198|7163826|FG000|STARTED|Overall Study||61
6264842|NCT02460198|7163827|FG001|STARTED|Overall Study||63
6264843|NCT02460198|7163826|FG000|COMPLETED|Overall Study||0
6264844|NCT02460198|7163827|FG001|COMPLETED|Overall Study||0
6264845|NCT02460198|7163826|FG000|NOT COMPLETED|Overall Study||61
6264846|NCT02460198|7163827|FG001|NOT COMPLETED|Overall Study||63
6264847|NCT02421939|7163837|FG000|STARTED|Overall Study||247
6264848|NCT02421939|7163838|FG001|STARTED|Overall Study||124
6264849|NCT02421939|7163837|FG000|Treated|Overall Study||246
6264850|NCT02421939|7163838|FG001|Treated|Overall Study||109
6264851|NCT02421939|7163837|FG000|COMPLETED|Overall Study||38
6264852|NCT02421939|7163838|FG001|COMPLETED|Overall Study||0
6264853|NCT02421939|7163837|FG000|NOT COMPLETED|Overall Study||209
6264854|NCT02421939|7163838|FG001|NOT COMPLETED|Overall Study||124
6264855|NCT02260869|7163846|FG000|STARTED|Overall Study||38
6264856|NCT02260869|7163847|FG001|STARTED|Overall Study||37
6264857|NCT02260869|7163846|FG000|COMPLETED|Overall Study||31
6264858|NCT02260869|7163847|FG001|COMPLETED|Overall Study||29
6264859|NCT02260869|7163846|FG000|NOT COMPLETED|Overall Study||7
6264860|NCT02260869|7163847|FG001|NOT COMPLETED|Overall Study||8
6264861|NCT02255838|7163853|FG000|STARTED|Overall Study||6
6264862|NCT02255838|7163854|FG001|STARTED|Overall Study||6
6602942|NCT02059291|7527968|FG009|STARTED|Epoch 2||0
6602943|NCT02059291|7527969|FG010|STARTED|Epoch 2||0
6602944|NCT02059291|7527970|FG011|STARTED|Epoch 2||0
6602945|NCT02059291|7527971|FG012|STARTED|Epoch 2||0
6602946|NCT02059291|7527972|FG013|STARTED|Epoch 2||0
6602947|NCT02059291|7527973|FG014|STARTED|Epoch 2||0
6602948|NCT02059291|7527974|FG015|STARTED|Epoch 2||0
6602949|NCT02059291|7527975|FG016|STARTED|Epoch 2||0
6602950|NCT02059291|7527976|FG017|STARTED|Epoch 2||0
6602951|NCT02059291|7527977|FG018|STARTED|Epoch 2||0
6602952|NCT02059291|7527978|FG019|STARTED|Epoch 2||0
6602953|NCT02059291|7527979|FG020|STARTED|Epoch 2||0
6602954|NCT02059291|7527980|FG021|STARTED|Epoch 2||0
6602955|NCT02059291|7527981|FG022|STARTED|Epoch 2||0
6602956|NCT02059291|7527982|FG023|STARTED|Epoch 2||0
6602957|NCT02059291|7527983|FG024|STARTED|Epoch 2||0
6602958|NCT02059291|7527959|FG000|COMPLETED|Epoch 2||31
6602959|NCT02059291|7527960|FG001|COMPLETED|Epoch 2||31
6602960|NCT02059291|7527961|FG002|COMPLETED|Epoch 2||36
6722979|NCT03073486|7652906|FG000|STARTED|Overall Study||493
6722980|NCT03073486|7652907|FG001|STARTED|Overall Study||251
6722981|NCT03073486|7652906|FG000|COMPLETED|Overall Study||405
6722982|NCT03073486|7652907|FG001|COMPLETED|Overall Study||207
6722983|NCT03073486|7652906|FG000|NOT COMPLETED|Overall Study||88
6722984|NCT03073486|7652907|FG001|NOT COMPLETED|Overall Study||44
6722985|NCT03073759|7652915|FG000|STARTED|Overall Study||2
6264863|NCT02255838|7163853|FG000|COMPLETED|Overall Study||6
6264864|NCT02255838|7163854|FG001|COMPLETED|Overall Study||6
6264865|NCT02255838|7163853|FG000|NOT COMPLETED|Overall Study||0
6264866|NCT02255838|7163854|FG001|NOT COMPLETED|Overall Study||0
6264867|NCT02151526|7163864|FG000|STARTED|Overall Study||3
6264868|NCT02151526|7163865|FG001|STARTED|Overall Study||4
6264869|NCT02151526|7163864|FG000|COMPLETED|Overall Study||3
6264870|NCT02151526|7163865|FG001|COMPLETED|Overall Study||4
6264871|NCT02151526|7163864|FG000|NOT COMPLETED|Overall Study||0
6264872|NCT02151526|7163865|FG001|NOT COMPLETED|Overall Study||0
6264873|NCT02119468|7163875|FG000|STARTED|Overall Study||7
6264874|NCT02119468|7163876|FG001|STARTED|Overall Study||25
6264875|NCT02119468|7163875|FG000|COMPLETED|Overall Study||7
6264876|NCT02119468|7163876|FG001|COMPLETED|Overall Study||25
6264877|NCT02119468|7163875|FG000|NOT COMPLETED|Overall Study||0
6264878|NCT02119468|7163876|FG001|NOT COMPLETED|Overall Study||0
6264879|NCT01960530|7163883|FG000|STARTED|Overall Study||14
6264880|NCT01960530|7163883|FG000|COMPLETED|Overall Study||14
6264881|NCT01960530|7163883|FG000|NOT COMPLETED|Overall Study||0
6264882|NCT01892722|7163900|FG000|STARTED|Overall Study||107
6264883|NCT01892722|7163901|FG001|STARTED|Overall Study||108
6264884|NCT01892722|7163900|FG000|Full Analysis Set|Overall Study||107
6264885|NCT01892722|7163901|FG001|Full Analysis Set|Overall Study||107
6264886|NCT01892722|7163900|FG000|COMPLETED|Overall Study||100
6264887|NCT01892722|7163901|FG001|COMPLETED|Overall Study||88
6264888|NCT01892722|7163900|FG000|NOT COMPLETED|Overall Study||7
6264889|NCT01892722|7163901|FG001|NOT COMPLETED|Overall Study||20
6264890|NCT01516216|7163909|FG000|STARTED|Overall Study||70
6264891|NCT01516216|7163910|FG001|STARTED|Overall Study||69
6264892|NCT01516216|7163909|FG000|AE Evaluable|Overall Study||67
6264893|NCT01516216|7163910|FG001|AE Evaluable|Overall Study||68
6264894|NCT01516216|7163909|FG000|Response Evaluable|Overall Study||62
6264895|NCT01516216|7163910|FG001|Response Evaluable|Overall Study||66
6264896|NCT01516216|7163909|FG000|COMPLETED|Overall Study||0
6264897|NCT01516216|7163910|FG001|COMPLETED|Overall Study||0
6264898|NCT01516216|7163909|FG000|NOT COMPLETED|Overall Study||70
6264899|NCT01516216|7163910|FG001|NOT COMPLETED|Overall Study||69
6264900|NCT00519818|7163918|FG000|STARTED|Overall Study||14
6264901|NCT00519818|7163918|FG000|COMPLETED|Overall Study||14
6264902|NCT00519818|7163918|FG000|NOT COMPLETED|Overall Study||0
6264903|NCT00381641|7163926|FG000|STARTED|Overall Study||38
6264904|NCT00381641|7163927|FG001|STARTED|Overall Study||25
6264905|NCT00381641|7163926|FG000|COMPLETED|Overall Study||38
6264906|NCT00381641|7163927|FG001|COMPLETED|Overall Study||23
6264907|NCT00381641|7163926|FG000|NOT COMPLETED|Overall Study||0
6264908|NCT00381641|7163927|FG001|NOT COMPLETED|Overall Study||2
6280482|NCT00157014|7180435|FG002|NOT COMPLETED|Overall Study||1
6280483|NCT00157014|7180436|FG003|NOT COMPLETED|Overall Study||1
6280484|NCT00157157|7180446|FG000|STARTED|Overall Study||55
6280485|NCT00157157|7180446|FG000|COMPLETED|Overall Study||44
6280486|NCT00157157|7180446|FG000|NOT COMPLETED|Overall Study||11
6280487|NCT00157196|7180457|FG000|STARTED|Overall Study||22
6280488|NCT00157196|7180457|FG000|COMPLETED|Overall Study||13
6280489|NCT00157196|7180457|FG000|NOT COMPLETED|Overall Study||9
6280490|NCT00157209|7180463|FG000|STARTED|Overall Study||88
6280491|NCT00157209|7180464|FG001|STARTED|Overall Study||83
6280492|NCT00157209|7180463|FG000|COMPLETED|Overall Study||78
6280493|NCT00157209|7180464|FG001|COMPLETED|Overall Study||83
6280494|NCT00157209|7180463|FG000|NOT COMPLETED|Overall Study||10
6280495|NCT00157209|7180464|FG001|NOT COMPLETED|Overall Study||0
6280496|NCT00157248|7180474|FG000|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
6280497|NCT00157248|7180475|FG001|STARTED|Overall Study||89
6280498|NCT00157248|7180476|FG002|STARTED|Overall Study||50
6280499|NCT00157248|7180477|FG003|STARTED|Overall Study||124
6280500|NCT00157248|7180474|FG000|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
6280501|NCT00157248|7180475|FG001|COMPLETED|Overall Study||52
6280502|NCT00157248|7180476|FG002|COMPLETED|Overall Study||29
6280503|NCT00157248|7180477|FG003|COMPLETED|Overall Study||77
6280504|NCT00157248|7180474|FG000|NOT COMPLETED|Overall Study||48
6280505|NCT00157248|7180475|FG001|NOT COMPLETED|Overall Study||37
6280506|NCT00157248|7180476|FG002|NOT COMPLETED|Overall Study||21
6280507|NCT00157248|7180477|FG003|NOT COMPLETED|Overall Study||47
6281038|NCT00161382|7180911|FG001|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
6722986|NCT03073759|7652916|FG001|STARTED|Overall Study||2
6722987|NCT03073759|7652915|FG000|COMPLETED|Overall Study||2
6722988|NCT03073759|7652916|FG001|COMPLETED|Overall Study||2
6722989|NCT03073759|7652915|FG000|NOT COMPLETED|Overall Study||0
6722990|NCT03073759|7652916|FG001|NOT COMPLETED|Overall Study||0
6722991|NCT03073798|7652923|FG000|STARTED|Overall Study||12
6722992|NCT03073798|7652923|FG000|COMPLETED|Overall Study||10
6722993|NCT03073798|7652923|FG000|NOT COMPLETED|Overall Study||2
6722994|NCT03073876|7652930|FG000|STARTED|Overall Study||12
6722995|NCT03073876|7652931|FG001|STARTED|Overall Study||11
6722996|NCT03073876|7652930|FG000|COMPLETED|Overall Study||12
6722997|NCT03073876|7652931|FG001|COMPLETED|Overall Study||11
6722998|NCT03073876|7652930|FG000|NOT COMPLETED|Overall Study||0
6722999|NCT03073876|7652931|FG001|NOT COMPLETED|Overall Study||0
6723000|NCT03074162|7652948|FG000|STARTED|Period 1 Including Washout 1||8
6723001|NCT03074162|7652949|FG001|STARTED|Period 1 Including Washout 1||8
6723002|NCT03074162|7652950|FG002|STARTED|Period 1 Including Washout 1||8
6723003|NCT03074162|7652951|FG003|STARTED|Period 1 Including Washout 1||8
6723004|NCT03074162|7652952|FG004|STARTED|Period 1 Including Washout 1||8
6723005|NCT03074162|7652953|FG005|STARTED|Period 1 Including Washout 1||8
6723006|NCT03074162|7652948|FG000|COMPLETED|Period 1 Including Washout 1||8
6723007|NCT03074162|7652949|FG001|COMPLETED|Period 1 Including Washout 1||8
6723008|NCT03074162|7652950|FG002|COMPLETED|Period 1 Including Washout 1||7
6723009|NCT03074162|7652951|FG003|COMPLETED|Period 1 Including Washout 1||8
6723010|NCT03074162|7652952|FG004|COMPLETED|Period 1 Including Washout 1||8
6723011|NCT03074162|7652953|FG005|COMPLETED|Period 1 Including Washout 1||8
6723012|NCT03074162|7652948|FG000|NOT COMPLETED|Period 1 Including Washout 1||0
6723013|NCT03074162|7652949|FG001|NOT COMPLETED|Period 1 Including Washout 1||0
6723014|NCT03074162|7652950|FG002|NOT COMPLETED|Period 1 Including Washout 1||1
6723015|NCT03074162|7652951|FG003|NOT COMPLETED|Period 1 Including Washout 1||0
6723016|NCT03074162|7652952|FG004|NOT COMPLETED|Period 1 Including Washout 1||0
6723017|NCT03074162|7652953|FG005|NOT COMPLETED|Period 1 Including Washout 1||0
6723018|NCT03074162|7652948|FG000|STARTED|Period 2 Including Washout 2||8
6723019|NCT03074162|7652949|FG001|STARTED|Period 2 Including Washout 2||8
6723020|NCT03074162|7652950|FG002|STARTED|Period 2 Including Washout 2||7
6723021|NCT03074162|7652951|FG003|STARTED|Period 2 Including Washout 2||8
6723022|NCT03074162|7652952|FG004|STARTED|Period 2 Including Washout 2||8
6723023|NCT03074162|7652953|FG005|STARTED|Period 2 Including Washout 2||8
6723024|NCT03074162|7652948|FG000|COMPLETED|Period 2 Including Washout 2||8
6723025|NCT03074162|7652949|FG001|COMPLETED|Period 2 Including Washout 2||8
6723026|NCT03074162|7652950|FG002|COMPLETED|Period 2 Including Washout 2||6
6723027|NCT03074162|7652951|FG003|COMPLETED|Period 2 Including Washout 2||8
6723028|NCT03074162|7652952|FG004|COMPLETED|Period 2 Including Washout 2||8
6723029|NCT03074162|7652953|FG005|COMPLETED|Period 2 Including Washout 2||7
6723030|NCT03074162|7652948|FG000|NOT COMPLETED|Period 2 Including Washout 2||0
6723031|NCT03074162|7652949|FG001|NOT COMPLETED|Period 2 Including Washout 2||0
6723032|NCT03074162|7652950|FG002|NOT COMPLETED|Period 2 Including Washout 2||1
6723033|NCT03074162|7652951|FG003|NOT COMPLETED|Period 2 Including Washout 2||0
6723034|NCT03074162|7652952|FG004|NOT COMPLETED|Period 2 Including Washout 2||0
6723035|NCT03074162|7652953|FG005|NOT COMPLETED|Period 2 Including Washout 2||1
6723036|NCT03074162|7652948|FG000|STARTED|Period 3||8
6723037|NCT03074162|7652949|FG001|STARTED|Period 3||8
6723038|NCT03074162|7652950|FG002|STARTED|Period 3||6
6723039|NCT03074162|7652951|FG003|STARTED|Period 3||8
6723040|NCT03074162|7652952|FG004|STARTED|Period 3||8
6723041|NCT03074162|7652953|FG005|STARTED|Period 3||7
6723042|NCT03074162|7652948|FG000|COMPLETED|Period 3||7
6723043|NCT03074162|7652949|FG001|COMPLETED|Period 3||8
6723044|NCT03074162|7652950|FG002|COMPLETED|Period 3||6
6723045|NCT03074162|7652951|FG003|COMPLETED|Period 3||8
6723046|NCT03074162|7652952|FG004|COMPLETED|Period 3||7
6723047|NCT03074162|7652953|FG005|COMPLETED|Period 3||7
6723048|NCT03074162|7652948|FG000|NOT COMPLETED|Period 3||1
6723049|NCT03074162|7652949|FG001|NOT COMPLETED|Period 3||0
6723050|NCT03074162|7652950|FG002|NOT COMPLETED|Period 3||0
6723051|NCT03074162|7652951|FG003|NOT COMPLETED|Period 3||0
6723052|NCT03074162|7652952|FG004|NOT COMPLETED|Period 3||1
6723053|NCT03074162|7652953|FG005|NOT COMPLETED|Period 3||0
6723054|NCT03074331|7652961|FG000|STARTED|Overall Study||130
6723055|NCT03074331|7652961|FG000|COMPLETED|Overall Study||123
6723056|NCT03074331|7652961|FG000|NOT COMPLETED|Overall Study||7
6723057|NCT03074409|7652967|FG000|STARTED|Overall Study||41
6723058|NCT03074409|7652968|FG001|STARTED|Overall Study||42
6723059|NCT03074409|7652967|FG000|COMPLETED|Overall Study||37
6723060|NCT03074409|7652968|FG001|COMPLETED|Overall Study||38
6723061|NCT03074409|7652967|FG000|NOT COMPLETED|Overall Study||4
6723062|NCT03074409|7652968|FG001|NOT COMPLETED|Overall Study||4
6723063|NCT03074500|7652977|FG000|STARTED|Overall Study||11
6723064|NCT03074500|7652978|FG001|STARTED|Overall Study||11
6723065|NCT03074500|7652979|FG002|STARTED|Overall Study||11
6723066|NCT03074500|7652977|FG000|COMPLETED|Overall Study||10
6723067|NCT03074500|7652978|FG001|COMPLETED|Overall Study||10
6723068|NCT03074500|7652979|FG002|COMPLETED|Overall Study||10
6723069|NCT03074500|7652977|FG000|NOT COMPLETED|Overall Study||1
6723070|NCT03074500|7652978|FG001|NOT COMPLETED|Overall Study||1
6723071|NCT03074500|7652979|FG002|NOT COMPLETED|Overall Study||1
6723072|NCT03074630|7652989|FG000|STARTED|Overall Study||12
6723073|NCT03074630|7652989|FG000|COMPLETED|Overall Study||11
6723074|NCT03074630|7652989|FG000|NOT COMPLETED|Overall Study||1
6723075|NCT03074682|7652997|FG000|STARTED|Overall Study||18
6723076|NCT03074682|7652998|FG001|STARTED|Overall Study||18
6723077|NCT03074682|7652999|FG002|STARTED|Overall Study||18
6723078|NCT03074682|7652997|FG000|COMPLETED|Overall Study||18
6723079|NCT03074682|7652998|FG001|COMPLETED|Overall Study||18
6723080|NCT03074682|7652999|FG002|COMPLETED|Overall Study||18
6723081|NCT03074682|7652997|FG000|NOT COMPLETED|Overall Study||0
6723082|NCT03074682|7652998|FG001|NOT COMPLETED|Overall Study||0
6723083|NCT03074682|7652999|FG002|NOT COMPLETED|Overall Study||0
6723084|NCT03075085|7653009|FG000|STARTED|Overall Study||352
6723085|NCT03075085|7653010|FG001|STARTED|Overall Study||344
6723086|NCT03075085|7653009|FG000|COMPLETED|Overall Study||247
6723087|NCT03075085|7653010|FG001|COMPLETED|Overall Study||232
6723088|NCT03075085|7653009|FG000|NOT COMPLETED|Overall Study||105
6723089|NCT03075085|7653010|FG001|NOT COMPLETED|Overall Study||112
6723090|NCT03075163|7653018|FG000|STARTED|Overall Study||150
6723091|NCT03075163|7653019|FG001|STARTED|Overall Study||150
6723092|NCT03075163|7653018|FG000|COMPLETED|Overall Study||12
6723093|NCT03075163|7653019|FG001|COMPLETED|Overall Study||12
6723094|NCT03075163|7653018|FG000|NOT COMPLETED|Overall Study||138
6723095|NCT03075163|7653019|FG001|NOT COMPLETED|Overall Study||138
6723096|NCT03075267|7653028|FG000|STARTED|Overall Study||32
6723097|NCT03075267|7653029|FG001|STARTED|Overall Study||32
6723098|NCT03075267|7653030|FG002|STARTED|Overall Study||32
6723099|NCT03075267|7653028|FG000|COMPLETED|Overall Study||31
6723100|NCT03075267|7653029|FG001|COMPLETED|Overall Study||32
6723101|NCT03075267|7653030|FG002|COMPLETED|Overall Study||32
6723102|NCT03075267|7653028|FG000|NOT COMPLETED|Overall Study||1
6723103|NCT03075267|7653029|FG001|NOT COMPLETED|Overall Study||0
6264909|NCT00006178|7163933|FG000|STARTED|Overall Study||12
6264910|NCT00006178|7163933|FG000|COMPLETED|Overall Study||12
6264911|NCT00006178|7163933|FG000|NOT COMPLETED|Overall Study||0
6264912|NCT00006184|7163939|FG000|STARTED|Overall Study||10
6264913|NCT00006184|7163940|FG001|STARTED|Overall Study||10
6264914|NCT00006184|7163939|FG000|COMPLETED|Overall Study||9
6264915|NCT00006184|7163940|FG001|COMPLETED|Overall Study||10
6264916|NCT00006184|7163939|FG000|NOT COMPLETED|Overall Study||1
6264917|NCT00006184|7163940|FG001|NOT COMPLETED|Overall Study||0
6264918|NCT00006227|7163946|FG000|STARTED|Overall Study||31
6264919|NCT00006227|7163946|FG000|COMPLETED|Overall Study||31
6264920|NCT00006227|7163946|FG000|NOT COMPLETED|Overall Study||0
6264921|NCT00006237|7163952|FG000|STARTED|Overall Study||212
6264922|NCT00006237|7163953|FG001|STARTED|Overall Study||220
6264923|NCT00006237|7163952|FG000|Eligible|Overall Study||203
6264924|NCT00006237|7163953|FG001|Eligible|Overall Study||200
6264925|NCT00006237|7163952|FG000|Eligible and Treated|Overall Study||203
6264926|NCT00006237|7163953|FG001|Eligible and Treated|Overall Study||199
6264927|NCT00006237|7163952|FG000|COMPLETED|Overall Study||87
6264928|NCT00006237|7163953|FG001|COMPLETED|Overall Study||159
6264929|NCT00006237|7163952|FG000|NOT COMPLETED|Overall Study||125
6264930|NCT00006237|7163953|FG001|NOT COMPLETED|Overall Study||61
6264931|NCT00006244|7163962|FG000|STARTED|Overall Study||36
6264932|NCT00006244|7163962|FG000|COMPLETED|Overall Study||36
6264933|NCT00006244|7163962|FG000|NOT COMPLETED|Overall Study||0
6264934|NCT00006289|7163968|FG000|STARTED|First Intervention (5 Weeks)||11
6264935|NCT00006289|7163969|FG001|STARTED|First Intervention (5 Weeks)||10
6264936|NCT00006289|7163968|FG000|COMPLETED|First Intervention (5 Weeks)||10
6264937|NCT00006289|7163969|FG001|COMPLETED|First Intervention (5 Weeks)||10
6264938|NCT00006289|7163968|FG000|NOT COMPLETED|First Intervention (5 Weeks)||1
6264939|NCT00006289|7163969|FG001|NOT COMPLETED|First Intervention (5 Weeks)||0
6264940|NCT00006289|7163968|FG000|STARTED|Washout (>= 1 Week)||10
6264941|NCT00006289|7163969|FG001|STARTED|Washout (>= 1 Week)||10
6264942|NCT00006289|7163968|FG000|COMPLETED|Washout (>= 1 Week)||10
6264943|NCT00006289|7163969|FG001|COMPLETED|Washout (>= 1 Week)||10
6264944|NCT00006289|7163968|FG000|NOT COMPLETED|Washout (>= 1 Week)||0
6264945|NCT00006289|7163969|FG001|NOT COMPLETED|Washout (>= 1 Week)||0
6264946|NCT00006289|7163968|FG000|STARTED|Second Intervention (5 Weeks)||10
6264947|NCT00006289|7163969|FG001|STARTED|Second Intervention (5 Weeks)||10
6264948|NCT00006289|7163968|FG000|COMPLETED|Second Intervention (5 Weeks)||9
6264949|NCT00006289|7163969|FG001|COMPLETED|Second Intervention (5 Weeks)||9
6264950|NCT00006289|7163968|FG000|NOT COMPLETED|Second Intervention (5 Weeks)||1
6264951|NCT00006289|7163969|FG001|NOT COMPLETED|Second Intervention (5 Weeks)||1
6264952|NCT00006305|7163989|FG000|STARTED|Overall Study||592
6264953|NCT00006305|7163990|FG001|STARTED|Overall Study||584
6264954|NCT00006305|7163991|FG002|STARTED|Overall Study||593
6264955|NCT00006305|7163992|FG003|STARTED|Overall Study||599
6264956|NCT00006305|7163989|FG000|COMPLETED|Overall Study||575
6264957|NCT00006305|7163990|FG001|COMPLETED|Overall Study||574
6264958|NCT00006305|7163991|FG002|COMPLETED|Overall Study||578
6264959|NCT00006305|7163992|FG003|COMPLETED|Overall Study||585
6264960|NCT00006305|7163989|FG000|NOT COMPLETED|Overall Study||17
6264961|NCT00006305|7163990|FG001|NOT COMPLETED|Overall Study||10
6264962|NCT00006305|7163991|FG002|NOT COMPLETED|Overall Study||15
6264963|NCT00006305|7163992|FG003|NOT COMPLETED|Overall Study||14
6264964|NCT00006389|7164002|FG000|STARTED|Overall Study||12
6264965|NCT00006389|7164002|FG000|COMPLETED|Overall Study||11
6264966|NCT00006389|7164002|FG000|NOT COMPLETED|Overall Study||1
6723104|NCT03075267|7653030|FG002|NOT COMPLETED|Overall Study||0
6723105|NCT03075410|7653047|FG000|STARTED|Part A-Period 1 (14 Days)||2
6723106|NCT03075410|7653048|FG001|STARTED|Part A-Period 1 (14 Days)||1
6723107|NCT03075410|7653049|FG002|STARTED|Part A-Period 1 (14 Days)||2
6723108|NCT03075410|7653050|FG003|STARTED|Part A-Period 1 (14 Days)||1
6723109|NCT03075410|7653051|FG004|STARTED|Part A-Period 1 (14 Days)||2
6723110|NCT03075410|7653052|FG005|STARTED|Part A-Period 1 (14 Days)||1
6723111|NCT03075410|7653053|FG006|STARTED|Part A-Period 1 (14 Days)||0
6723112|NCT03075410|7653054|FG007|STARTED|Part A-Period 1 (14 Days)||0
6723113|NCT03075410|7653055|FG008|STARTED|Part A-Period 1 (14 Days)||0
6723114|NCT03075410|7653047|FG000|COMPLETED|Part A-Period 1 (14 Days)||2
6723115|NCT03075410|7653048|FG001|COMPLETED|Part A-Period 1 (14 Days)||1
6723116|NCT03075410|7653049|FG002|COMPLETED|Part A-Period 1 (14 Days)||2
6723117|NCT03075410|7653050|FG003|COMPLETED|Part A-Period 1 (14 Days)||1
6723118|NCT03075410|7653051|FG004|COMPLETED|Part A-Period 1 (14 Days)||2
6723119|NCT03075410|7653052|FG005|COMPLETED|Part A-Period 1 (14 Days)||1
6723120|NCT03075410|7653053|FG006|COMPLETED|Part A-Period 1 (14 Days)||0
6723121|NCT03075410|7653054|FG007|COMPLETED|Part A-Period 1 (14 Days)||0
6723122|NCT03075410|7653055|FG008|COMPLETED|Part A-Period 1 (14 Days)||0
6723123|NCT03075410|7653047|FG000|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723124|NCT03075410|7653048|FG001|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723125|NCT03075410|7653049|FG002|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723126|NCT03075410|7653050|FG003|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723127|NCT03075410|7653051|FG004|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723128|NCT03075410|7653052|FG005|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723129|NCT03075410|7653053|FG006|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723130|NCT03075410|7653054|FG007|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723131|NCT03075410|7653055|FG008|NOT COMPLETED|Part A-Period 1 (14 Days)||0
6723132|NCT03075410|7653047|FG000|STARTED|Part A-Washout Period 1 (14 Days)||2
6723133|NCT03075410|7653048|FG001|STARTED|Part A-Washout Period 1 (14 Days)||1
6723134|NCT03075410|7653049|FG002|STARTED|Part A-Washout Period 1 (14 Days)||2
6723135|NCT03075410|7653050|FG003|STARTED|Part A-Washout Period 1 (14 Days)||1
6723136|NCT03075410|7653051|FG004|STARTED|Part A-Washout Period 1 (14 Days)||2
6723137|NCT03075410|7653052|FG005|STARTED|Part A-Washout Period 1 (14 Days)||1
6723138|NCT03075410|7653053|FG006|STARTED|Part A-Washout Period 1 (14 Days)||0
6723139|NCT03075410|7653054|FG007|STARTED|Part A-Washout Period 1 (14 Days)||0
6723140|NCT03075410|7653055|FG008|STARTED|Part A-Washout Period 1 (14 Days)||0
6723141|NCT03075410|7653047|FG000|COMPLETED|Part A-Washout Period 1 (14 Days)||2
6723142|NCT03075410|7653048|FG001|COMPLETED|Part A-Washout Period 1 (14 Days)||1
6723143|NCT03075410|7653049|FG002|COMPLETED|Part A-Washout Period 1 (14 Days)||2
6723144|NCT03075410|7653050|FG003|COMPLETED|Part A-Washout Period 1 (14 Days)||1
6723145|NCT03075410|7653051|FG004|COMPLETED|Part A-Washout Period 1 (14 Days)||2
6723146|NCT03075410|7653052|FG005|COMPLETED|Part A-Washout Period 1 (14 Days)||1
6723147|NCT03075410|7653053|FG006|COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723148|NCT03075410|7653054|FG007|COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723149|NCT03075410|7653055|FG008|COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723150|NCT03075410|7653047|FG000|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723151|NCT03075410|7653048|FG001|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723152|NCT03075410|7653049|FG002|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723153|NCT03075410|7653050|FG003|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723154|NCT03075410|7653051|FG004|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723155|NCT03075410|7653052|FG005|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723156|NCT03075410|7653053|FG006|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723157|NCT03075410|7653054|FG007|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723158|NCT03075410|7653055|FG008|NOT COMPLETED|Part A-Washout Period 1 (14 Days)||0
6723159|NCT03075410|7653047|FG000|STARTED|Part A-Period 2 (14 Days)||2
6723160|NCT03075410|7653048|FG001|STARTED|Part A-Period 2 (14 Days)||1
6723161|NCT03075410|7653049|FG002|STARTED|Part A-Period 2 (14 Days)||2
6723162|NCT03075410|7653050|FG003|STARTED|Part A-Period 2 (14 Days)||1
6723163|NCT03075410|7653051|FG004|STARTED|Part A-Period 2 (14 Days)||2
6723164|NCT03075410|7653052|FG005|STARTED|Part A-Period 2 (14 Days)||1
6723165|NCT03075410|7653053|FG006|STARTED|Part A-Period 2 (14 Days)||0
6723166|NCT03075410|7653054|FG007|STARTED|Part A-Period 2 (14 Days)||0
6723167|NCT03075410|7653055|FG008|STARTED|Part A-Period 2 (14 Days)||0
6723168|NCT03075410|7653047|FG000|COMPLETED|Part A-Period 2 (14 Days)||1
6723169|NCT03075410|7653048|FG001|COMPLETED|Part A-Period 2 (14 Days)||1
6723170|NCT03075410|7653049|FG002|COMPLETED|Part A-Period 2 (14 Days)||1
6723171|NCT03075410|7653050|FG003|COMPLETED|Part A-Period 2 (14 Days)||1
6723172|NCT03075410|7653051|FG004|COMPLETED|Part A-Period 2 (14 Days)||2
6723173|NCT03075410|7653052|FG005|COMPLETED|Part A-Period 2 (14 Days)||1
6723174|NCT03075410|7653053|FG006|COMPLETED|Part A-Period 2 (14 Days)||0
6723175|NCT03075410|7653054|FG007|COMPLETED|Part A-Period 2 (14 Days)||0
6723176|NCT03075410|7653055|FG008|COMPLETED|Part A-Period 2 (14 Days)||0
6723177|NCT03075410|7653047|FG000|NOT COMPLETED|Part A-Period 2 (14 Days)||1
6723178|NCT03075410|7653048|FG001|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6723179|NCT03075410|7653049|FG002|NOT COMPLETED|Part A-Period 2 (14 Days)||1
6723180|NCT03075410|7653050|FG003|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6723181|NCT03075410|7653051|FG004|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6723182|NCT03075410|7653052|FG005|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6723183|NCT03075410|7653053|FG006|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6723184|NCT03075410|7653054|FG007|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6723185|NCT03075410|7653055|FG008|NOT COMPLETED|Part A-Period 2 (14 Days)||0
6723186|NCT03075410|7653047|FG000|STARTED|Part A-Washout Period 2 (14 Days)||1
6723187|NCT03075410|7653048|FG001|STARTED|Part A-Washout Period 2 (14 Days)||1
6723188|NCT03075410|7653049|FG002|STARTED|Part A-Washout Period 2 (14 Days)||1
6723189|NCT03075410|7653050|FG003|STARTED|Part A-Washout Period 2 (14 Days)||1
6723190|NCT03075410|7653051|FG004|STARTED|Part A-Washout Period 2 (14 Days)||2
6723191|NCT03075410|7653052|FG005|STARTED|Part A-Washout Period 2 (14 Days)||1
6723192|NCT03075410|7653053|FG006|STARTED|Part A-Washout Period 2 (14 Days)||0
6723193|NCT03075410|7653054|FG007|STARTED|Part A-Washout Period 2 (14 Days)||0
6723194|NCT03075410|7653055|FG008|STARTED|Part A-Washout Period 2 (14 Days)||0
6723195|NCT03075410|7653047|FG000|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6723196|NCT03075410|7653048|FG001|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6723197|NCT03075410|7653049|FG002|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6723198|NCT03075410|7653050|FG003|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6723199|NCT03075410|7653051|FG004|COMPLETED|Part A-Washout Period 2 (14 Days)||2
6723200|NCT03075410|7653052|FG005|COMPLETED|Part A-Washout Period 2 (14 Days)||1
6723201|NCT03075410|7653053|FG006|COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723202|NCT03075410|7653054|FG007|COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723203|NCT03075410|7653055|FG008|COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723204|NCT03075410|7653047|FG000|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723205|NCT03075410|7653048|FG001|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723206|NCT03075410|7653049|FG002|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723207|NCT03075410|7653050|FG003|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723208|NCT03075410|7653051|FG004|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723209|NCT03075410|7653052|FG005|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723210|NCT03075410|7653053|FG006|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723211|NCT03075410|7653054|FG007|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723212|NCT03075410|7653055|FG008|NOT COMPLETED|Part A-Washout Period 2 (14 Days)||0
6723213|NCT03075410|7653047|FG000|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
6723214|NCT03075410|7653048|FG001|STARTED|Part A-Period 3 (14 Days)||1
6723215|NCT03075410|7653049|FG002|STARTED|Part A-Period 3 (14 Days)|Participants who withdrew in Period 2 were replaced (2 new participants entered Part A period 3).|2
6723216|NCT03075410|7653050|FG003|STARTED|Part A-Period 3 (14 Days)||1
6723217|NCT03075410|7653051|FG004|STARTED|Part A-Period 3 (14 Days)||2
6723218|NCT03075410|7653052|FG005|STARTED|Part A-Period 3 (14 Days)||1
6723219|NCT03075410|7653053|FG006|STARTED|Part A-Period 3 (14 Days)||0
6723220|NCT03075410|7653054|FG007|STARTED|Part A-Period 3 (14 Days)||0
6723221|NCT03075410|7653055|FG008|STARTED|Part A-Period 3 (14 Days)||0
6723222|NCT03075410|7653047|FG000|COMPLETED|Part A-Period 3 (14 Days)||1
6723223|NCT03075410|7653048|FG001|COMPLETED|Part A-Period 3 (14 Days)||1
6723224|NCT03075410|7653049|FG002|COMPLETED|Part A-Period 3 (14 Days)||2
6723225|NCT03075410|7653050|FG003|COMPLETED|Part A-Period 3 (14 Days)||1
6723226|NCT03075410|7653051|FG004|COMPLETED|Part A-Period 3 (14 Days)||2
6723227|NCT03075410|7653052|FG005|COMPLETED|Part A-Period 3 (14 Days)||1
6723228|NCT03075410|7653053|FG006|COMPLETED|Part A-Period 3 (14 Days)||0
6723229|NCT03075410|7653054|FG007|COMPLETED|Part A-Period 3 (14 Days)||0
6723230|NCT03075410|7653055|FG008|COMPLETED|Part A-Period 3 (14 Days)||0
6723231|NCT03075410|7653047|FG000|NOT COMPLETED|Part A-Period 3 (14 Days)||1
6723232|NCT03075410|7653048|FG001|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6723233|NCT03075410|7653049|FG002|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6723234|NCT03075410|7653050|FG003|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6723235|NCT03075410|7653051|FG004|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6723236|NCT03075410|7653052|FG005|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6723237|NCT03075410|7653053|FG006|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6723238|NCT03075410|7653054|FG007|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6723239|NCT03075410|7653055|FG008|NOT COMPLETED|Part A-Period 3 (14 Days)||0
6723240|NCT03075410|7653047|FG000|STARTED|Part A-Washout Period 3 (14 Days)||1
6723241|NCT03075410|7653048|FG001|STARTED|Part A-Washout Period 3 (14 Days)||1
6723242|NCT03075410|7653049|FG002|STARTED|Part A-Washout Period 3 (14 Days)||2
6723243|NCT03075410|7653050|FG003|STARTED|Part A-Washout Period 3 (14 Days)||1
6723244|NCT03075410|7653051|FG004|STARTED|Part A-Washout Period 3 (14 Days)||2
6723245|NCT03075410|7653052|FG005|STARTED|Part A-Washout Period 3 (14 Days)||1
6723246|NCT03075410|7653053|FG006|STARTED|Part A-Washout Period 3 (14 Days)||0
6723247|NCT03075410|7653054|FG007|STARTED|Part A-Washout Period 3 (14 Days)||0
6723248|NCT03075410|7653055|FG008|STARTED|Part A-Washout Period 3 (14 Days)||0
6723249|NCT03075410|7653047|FG000|COMPLETED|Part A-Washout Period 3 (14 Days)||1
6723250|NCT03075410|7653048|FG001|COMPLETED|Part A-Washout Period 3 (14 Days)||1
6723251|NCT03075410|7653049|FG002|COMPLETED|Part A-Washout Period 3 (14 Days)||2
6723252|NCT03075410|7653050|FG003|COMPLETED|Part A-Washout Period 3 (14 Days)||1
6723253|NCT03075410|7653051|FG004|COMPLETED|Part A-Washout Period 3 (14 Days)||2
6723254|NCT03075410|7653052|FG005|COMPLETED|Part A-Washout Period 3 (14 Days)||1
6723255|NCT03075410|7653053|FG006|COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723256|NCT03075410|7653054|FG007|COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723257|NCT03075410|7653055|FG008|COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723258|NCT03075410|7653047|FG000|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723259|NCT03075410|7653048|FG001|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723260|NCT03075410|7653049|FG002|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723261|NCT03075410|7653050|FG003|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723262|NCT03075410|7653051|FG004|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723263|NCT03075410|7653052|FG005|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723264|NCT03075410|7653053|FG006|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723265|NCT03075410|7653054|FG007|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723266|NCT03075410|7653055|FG008|NOT COMPLETED|Part A-Washout Period 3 (14 Days)||0
6723267|NCT03075410|7653047|FG000|STARTED|Part A-Period 4 (14 Days)||1
6723268|NCT03075410|7653048|FG001|STARTED|Part A-Period 4 (14 Days)||1
6723269|NCT03075410|7653049|FG002|STARTED|Part A-Period 4 (14 Days)||2
6723270|NCT03075410|7653050|FG003|STARTED|Part A-Period 4 (14 Days)||1
6723271|NCT03075410|7653051|FG004|STARTED|Part A-Period 4 (14 Days)||2
6723272|NCT03075410|7653052|FG005|STARTED|Part A-Period 4 (14 Days)||1
6723273|NCT03075410|7653053|FG006|STARTED|Part A-Period 4 (14 Days)||0
6723274|NCT03075410|7653054|FG007|STARTED|Part A-Period 4 (14 Days)||0
6723275|NCT03075410|7653055|FG008|STARTED|Part A-Period 4 (14 Days)||0
6723276|NCT03075410|7653047|FG000|COMPLETED|Part A-Period 4 (14 Days)||1
6723277|NCT03075410|7653048|FG001|COMPLETED|Part A-Period 4 (14 Days)||1
6723278|NCT03075410|7653049|FG002|COMPLETED|Part A-Period 4 (14 Days)||2
6723279|NCT03075410|7653050|FG003|COMPLETED|Part A-Period 4 (14 Days)||1
6723280|NCT03075410|7653051|FG004|COMPLETED|Part A-Period 4 (14 Days)||2
6723281|NCT03075410|7653052|FG005|COMPLETED|Part A-Period 4 (14 Days)||1
6723282|NCT03075410|7653053|FG006|COMPLETED|Part A-Period 4 (14 Days)||0
6723283|NCT03075410|7653054|FG007|COMPLETED|Part A-Period 4 (14 Days)||0
6723284|NCT03075410|7653055|FG008|COMPLETED|Part A-Period 4 (14 Days)||0
6723285|NCT03075410|7653047|FG000|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723286|NCT03075410|7653048|FG001|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723287|NCT03075410|7653049|FG002|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723288|NCT03075410|7653050|FG003|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723289|NCT03075410|7653051|FG004|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723290|NCT03075410|7653052|FG005|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723291|NCT03075410|7653053|FG006|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723292|NCT03075410|7653054|FG007|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723293|NCT03075410|7653055|FG008|NOT COMPLETED|Part A-Period 4 (14 Days)||0
6723294|NCT03075410|7653047|FG000|STARTED|Part B (up to 28 Days)||0
6723295|NCT03075410|7653048|FG001|STARTED|Part B (up to 28 Days)||0
6723296|NCT03075410|7653049|FG002|STARTED|Part B (up to 28 Days)||0
6723297|NCT03075410|7653050|FG003|STARTED|Part B (up to 28 Days)||0
6723298|NCT03075410|7653051|FG004|STARTED|Part B (up to 28 Days)||0
6723299|NCT03075410|7653052|FG005|STARTED|Part B (up to 28 Days)||0
6723300|NCT03075410|7653053|FG006|STARTED|Part B (up to 28 Days)||4
6723301|NCT03075410|7653054|FG007|STARTED|Part B (up to 28 Days)||7
6723302|NCT03075410|7653055|FG008|STARTED|Part B (up to 28 Days)||8
6723303|NCT03075410|7653047|FG000|COMPLETED|Part B (up to 28 Days)||0
6723304|NCT03075410|7653048|FG001|COMPLETED|Part B (up to 28 Days)||0
6723305|NCT03075410|7653049|FG002|COMPLETED|Part B (up to 28 Days)||0
6723306|NCT03075410|7653050|FG003|COMPLETED|Part B (up to 28 Days)||0
6723307|NCT03075410|7653051|FG004|COMPLETED|Part B (up to 28 Days)||0
6723308|NCT03075410|7653052|FG005|COMPLETED|Part B (up to 28 Days)||0
6723309|NCT03075410|7653053|FG006|COMPLETED|Part B (up to 28 Days)||4
6723310|NCT03075410|7653054|FG007|COMPLETED|Part B (up to 28 Days)||7
6723311|NCT03075410|7653055|FG008|COMPLETED|Part B (up to 28 Days)||8
6723312|NCT03075410|7653047|FG000|NOT COMPLETED|Part B (up to 28 Days)||0
6723313|NCT03075410|7653048|FG001|NOT COMPLETED|Part B (up to 28 Days)||0
6723314|NCT03075410|7653049|FG002|NOT COMPLETED|Part B (up to 28 Days)||0
6723315|NCT03075410|7653050|FG003|NOT COMPLETED|Part B (up to 28 Days)||0
6723316|NCT03075410|7653051|FG004|NOT COMPLETED|Part B (up to 28 Days)||0
6723317|NCT03075410|7653052|FG005|NOT COMPLETED|Part B (up to 28 Days)||0
6723318|NCT03075410|7653053|FG006|NOT COMPLETED|Part B (up to 28 Days)||0
6723319|NCT03075410|7653054|FG007|NOT COMPLETED|Part B (up to 28 Days)||0
6723320|NCT03075410|7653055|FG008|NOT COMPLETED|Part B (up to 28 Days)||0
6723321|NCT03075449|7653079|FG000|STARTED|Overall Study||170
6723322|NCT03075449|7653079|FG000|COMPLETED|Overall Study||170
6723323|NCT03075449|7653079|FG000|NOT COMPLETED|Overall Study||0
6723324|NCT03075501|7653085|FG000|STARTED|Overall Study||89
6723325|NCT03075501|7653086|FG001|STARTED|Overall Study||44
6723326|NCT03075501|7653085|FG000|COMPLETED|Overall Study||74
6723327|NCT03075501|7653086|FG001|COMPLETED|Overall Study||35
6723328|NCT03075501|7653085|FG000|NOT COMPLETED|Overall Study||15
6723329|NCT03075501|7653086|FG001|NOT COMPLETED|Overall Study||9
6723330|NCT03075553|7653093|FG000|STARTED|Overall Study||12
6723331|NCT03075553|7653093|FG000|COMPLETED|Overall Study||12
6723332|NCT03075553|7653093|FG000|NOT COMPLETED|Overall Study||0
6723333|NCT03075644|7653099|FG000|STARTED|Overall Study||16
6723334|NCT03075644|7653100|FG001|STARTED|Overall Study||46
6723335|NCT03075644|7653099|FG000|Full Analysis Set (FAS)|Overall Study||16
6723336|NCT03075644|7653100|FG001|Full Analysis Set (FAS)|Overall Study||46
6723337|NCT03075644|7653099|FG000|Safety Analysis Set (SAS)|Overall Study||16
6723338|NCT03075644|7653100|FG001|Safety Analysis Set (SAS)|Overall Study||46
6723339|NCT03075644|7653099|FG000|COMPLETED|Overall Study||15
6723340|NCT03075644|7653100|FG001|COMPLETED|Overall Study||45
6723341|NCT03075644|7653099|FG000|NOT COMPLETED|Overall Study||1
6723342|NCT03075644|7653100|FG001|NOT COMPLETED|Overall Study||1
6723343|NCT03075761|7653109|FG000|STARTED|Overall Study||11
6723344|NCT03075761|7653110|FG001|STARTED|Overall Study||12
6723345|NCT03075761|7653109|FG000|COMPLETED|Overall Study||10
6723346|NCT03075761|7653110|FG001|COMPLETED|Overall Study||6
6723347|NCT03075761|7653109|FG000|NOT COMPLETED|Overall Study||1
6723348|NCT03075761|7653110|FG001|NOT COMPLETED|Overall Study||6
6723349|NCT03075839|7653121|FG000|STARTED|Overall Study||33
6723350|NCT03075839|7653121|FG000|COMPLETED|Overall Study||29
6723351|NCT03075839|7653121|FG000|NOT COMPLETED|Overall Study||4
6723352|NCT03075878|7653125|FG000|STARTED|Overall Study||8
6723353|NCT03075878|7653125|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6723354|NCT03075878|7653125|FG000|COMPLETED|Overall Study||7
6723355|NCT03075878|7653125|FG000|NOT COMPLETED|Overall Study||1
6723356|NCT03075891|7653131|FG000|STARTED|Overall Study||135
6723357|NCT03075891|7653132|FG001|STARTED|Overall Study||138
6723358|NCT03075891|7653131|FG000|COMPLETED|Overall Study||126
6723359|NCT03075891|7653132|FG001|COMPLETED|Overall Study||125
6723360|NCT03075891|7653131|FG000|NOT COMPLETED|Overall Study||9
6723361|NCT03075891|7653132|FG001|NOT COMPLETED|Overall Study||13
6723362|NCT03075904|7653140|FG000|STARTED|Overall Study||8
6723363|NCT03075904|7653140|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6723364|NCT03075904|7653140|FG000|COMPLETED|Overall Study||4
6723365|NCT03075904|7653140|FG000|NOT COMPLETED|Overall Study||4
6723366|NCT03076190|7653146|FG000|STARTED|Overall Study||50
6723367|NCT03076190|7653147|FG001|STARTED|Overall Study||77
6723368|NCT03076190|7653146|FG000|COMPLETED|Overall Study||32
6723369|NCT03076190|7653147|FG001|COMPLETED|Overall Study||36
6723370|NCT03076190|7653146|FG000|NOT COMPLETED|Overall Study||18
6723371|NCT03076190|7653147|FG001|NOT COMPLETED|Overall Study||41
6723372|NCT03076333|7653156|FG000|STARTED|Overall Study||3
6723373|NCT03076333|7653156|FG000|COMPLETED|Overall Study||3
6723374|NCT03076333|7653156|FG000|NOT COMPLETED|Overall Study||0
6723375|NCT03076359|7653162|FG000|STARTED|Overall Study||170
6723376|NCT03076359|7653163|FG001|STARTED|Overall Study||150
6723377|NCT03076359|7653162|FG000|COMPLETED|Overall Study||170
6723378|NCT03076359|7653163|FG001|COMPLETED|Overall Study||150
6723379|NCT03076359|7653162|FG000|NOT COMPLETED|Overall Study||0
6723380|NCT03076359|7653163|FG001|NOT COMPLETED|Overall Study||0
6723381|NCT03076515|7653173|FG000|STARTED|Overall Study||58
6723382|NCT03076515|7653174|FG001|STARTED|Overall Study||62
6723383|NCT03076515|7653173|FG000|COMPLETED|Overall Study||33
6723384|NCT03076515|7653174|FG001|COMPLETED|Overall Study||33
6723385|NCT03076515|7653173|FG000|NOT COMPLETED|Overall Study||25
6723386|NCT03076515|7653174|FG001|NOT COMPLETED|Overall Study||29
6723387|NCT03076970|7653180|FG000|STARTED|Period 1||7
6723388|NCT03076970|7653181|FG001|STARTED|Period 1||7
6723389|NCT03076970|7653182|FG002|STARTED|Period 1||7
6723390|NCT03076970|7653183|FG003|STARTED|Period 1||7
6723391|NCT03076970|7653184|FG004|STARTED|Period 1||7
6723392|NCT03076970|7653185|FG005|STARTED|Period 1||7
6723393|NCT03076970|7653180|FG000|Received at Least 1 Dose of Study Drug|Period 1||7
6723394|NCT03076970|7653181|FG001|Received at Least 1 Dose of Study Drug|Period 1||7
6723395|NCT03076970|7653182|FG002|Received at Least 1 Dose of Study Drug|Period 1||7
6723396|NCT03076970|7653183|FG003|Received at Least 1 Dose of Study Drug|Period 1||7
6723397|NCT03076970|7653184|FG004|Received at Least 1 Dose of Study Drug|Period 1||7
6723398|NCT03076970|7653185|FG005|Received at Least 1 Dose of Study Drug|Period 1||7
6723399|NCT03076970|7653180|FG000|COMPLETED|Period 1||7
6723400|NCT03076970|7653181|FG001|COMPLETED|Period 1||7
6723401|NCT03076970|7653182|FG002|COMPLETED|Period 1||7
6723402|NCT03076970|7653183|FG003|COMPLETED|Period 1||7
6723403|NCT03076970|7653184|FG004|COMPLETED|Period 1||7
6723404|NCT03076970|7653185|FG005|COMPLETED|Period 1||7
6723405|NCT03076970|7653180|FG000|NOT COMPLETED|Period 1||0
6723406|NCT03076970|7653181|FG001|NOT COMPLETED|Period 1||0
6723407|NCT03076970|7653182|FG002|NOT COMPLETED|Period 1||0
6723408|NCT03076970|7653183|FG003|NOT COMPLETED|Period 1||0
6723409|NCT03076970|7653184|FG004|NOT COMPLETED|Period 1||0
6723410|NCT03076970|7653185|FG005|NOT COMPLETED|Period 1||0
6723411|NCT03076970|7653180|FG000|STARTED|Washout Period 1||7
6723412|NCT03076970|7653181|FG001|STARTED|Washout Period 1||7
6723413|NCT03076970|7653182|FG002|STARTED|Washout Period 1||7
6723414|NCT03076970|7653183|FG003|STARTED|Washout Period 1||7
6723415|NCT03076970|7653184|FG004|STARTED|Washout Period 1||7
6723416|NCT03076970|7653185|FG005|STARTED|Washout Period 1||7
6723417|NCT03076970|7653180|FG000|COMPLETED|Washout Period 1||7
6723418|NCT03076970|7653181|FG001|COMPLETED|Washout Period 1||7
6723419|NCT03076970|7653182|FG002|COMPLETED|Washout Period 1||7
6723420|NCT03076970|7653183|FG003|COMPLETED|Washout Period 1||7
6723421|NCT03076970|7653184|FG004|COMPLETED|Washout Period 1||7
6723422|NCT03076970|7653185|FG005|COMPLETED|Washout Period 1||7
6723423|NCT03076970|7653180|FG000|NOT COMPLETED|Washout Period 1||0
6723424|NCT03076970|7653181|FG001|NOT COMPLETED|Washout Period 1||0
6723425|NCT03076970|7653182|FG002|NOT COMPLETED|Washout Period 1||0
6723426|NCT03076970|7653183|FG003|NOT COMPLETED|Washout Period 1||0
6723427|NCT03076970|7653184|FG004|NOT COMPLETED|Washout Period 1||0
6723428|NCT03076970|7653185|FG005|NOT COMPLETED|Washout Period 1||0
6723429|NCT03076970|7653180|FG000|STARTED|Period 2||7
6723430|NCT03076970|7653181|FG001|STARTED|Period 2||7
6723431|NCT03076970|7653182|FG002|STARTED|Period 2||7
6723432|NCT03076970|7653183|FG003|STARTED|Period 2||7
6723433|NCT03076970|7653184|FG004|STARTED|Period 2||7
6723434|NCT03076970|7653185|FG005|STARTED|Period 2||7
6723435|NCT03076970|7653180|FG000|COMPLETED|Period 2||7
6723436|NCT03076970|7653181|FG001|COMPLETED|Period 2||7
6723437|NCT03076970|7653182|FG002|COMPLETED|Period 2||7
6723438|NCT03076970|7653183|FG003|COMPLETED|Period 2||7
6723439|NCT03076970|7653184|FG004|COMPLETED|Period 2||7
6723440|NCT03076970|7653185|FG005|COMPLETED|Period 2||7
6723441|NCT03076970|7653180|FG000|NOT COMPLETED|Period 2||0
6723442|NCT03076970|7653181|FG001|NOT COMPLETED|Period 2||0
6723443|NCT03076970|7653182|FG002|NOT COMPLETED|Period 2||0
6723444|NCT03076970|7653183|FG003|NOT COMPLETED|Period 2||0
6723445|NCT03076970|7653184|FG004|NOT COMPLETED|Period 2||0
6723446|NCT03076970|7653185|FG005|NOT COMPLETED|Period 2||0
6723447|NCT03076970|7653180|FG000|STARTED|Washout Period 2||7
6723448|NCT03076970|7653181|FG001|STARTED|Washout Period 2||7
6723449|NCT03076970|7653182|FG002|STARTED|Washout Period 2||7
6723450|NCT03076970|7653183|FG003|STARTED|Washout Period 2||7
6723451|NCT03076970|7653184|FG004|STARTED|Washout Period 2||7
6723452|NCT03076970|7653185|FG005|STARTED|Washout Period 2||7
6723453|NCT03076970|7653180|FG000|COMPLETED|Washout Period 2||7
6723454|NCT03076970|7653181|FG001|COMPLETED|Washout Period 2||7
6723455|NCT03076970|7653182|FG002|COMPLETED|Washout Period 2||7
6723456|NCT03076970|7653183|FG003|COMPLETED|Washout Period 2||7
6723457|NCT03076970|7653184|FG004|COMPLETED|Washout Period 2||6
6723458|NCT03076970|7653185|FG005|COMPLETED|Washout Period 2||7
6723459|NCT03076970|7653180|FG000|NOT COMPLETED|Washout Period 2||0
6723460|NCT03076970|7653181|FG001|NOT COMPLETED|Washout Period 2||0
6723461|NCT03076970|7653182|FG002|NOT COMPLETED|Washout Period 2||0
6723462|NCT03076970|7653183|FG003|NOT COMPLETED|Washout Period 2||0
6723463|NCT03076970|7653184|FG004|NOT COMPLETED|Washout Period 2||1
6723464|NCT03076970|7653185|FG005|NOT COMPLETED|Washout Period 2||0
6723465|NCT03076970|7653180|FG000|STARTED|Period 3||7
6723466|NCT03076970|7653181|FG001|STARTED|Period 3||7
6723467|NCT03076970|7653182|FG002|STARTED|Period 3||7
6723468|NCT03076970|7653183|FG003|STARTED|Period 3||7
6723469|NCT03076970|7653184|FG004|STARTED|Period 3||6
6723470|NCT03076970|7653185|FG005|STARTED|Period 3||7
6723471|NCT03076970|7653180|FG000|COMPLETED|Period 3||7
6723472|NCT03076970|7653181|FG001|COMPLETED|Period 3||7
6723473|NCT03076970|7653182|FG002|COMPLETED|Period 3||7
6723474|NCT03076970|7653183|FG003|COMPLETED|Period 3||7
6723475|NCT03076970|7653184|FG004|COMPLETED|Period 3||5
6723476|NCT03076970|7653185|FG005|COMPLETED|Period 3||6
6723477|NCT03076970|7653180|FG000|NOT COMPLETED|Period 3||0
6723478|NCT03076970|7653181|FG001|NOT COMPLETED|Period 3||0
6723479|NCT03076970|7653182|FG002|NOT COMPLETED|Period 3||0
6723480|NCT03076970|7653183|FG003|NOT COMPLETED|Period 3||0
6723481|NCT03076970|7653184|FG004|NOT COMPLETED|Period 3||1
6723482|NCT03076970|7653185|FG005|NOT COMPLETED|Period 3||1
6723483|NCT03076970|7653180|FG000|STARTED|Washout Period 3||7
6723484|NCT03076970|7653181|FG001|STARTED|Washout Period 3||7
6723485|NCT03076970|7653182|FG002|STARTED|Washout Period 3||7
6723486|NCT03076970|7653183|FG003|STARTED|Washout Period 3||7
6723487|NCT03076970|7653184|FG004|STARTED|Washout Period 3||5
6723488|NCT03076970|7653185|FG005|STARTED|Washout Period 3||6
6723489|NCT03076970|7653180|FG000|COMPLETED|Washout Period 3||7
6723490|NCT03076970|7653181|FG001|COMPLETED|Washout Period 3||7
6723491|NCT03076970|7653182|FG002|COMPLETED|Washout Period 3||7
6723492|NCT03076970|7653183|FG003|COMPLETED|Washout Period 3||7
6723493|NCT03076970|7653184|FG004|COMPLETED|Washout Period 3||5
6723494|NCT03076970|7653185|FG005|COMPLETED|Washout Period 3||6
6723495|NCT03076970|7653180|FG000|NOT COMPLETED|Washout Period 3||0
6723496|NCT03076970|7653181|FG001|NOT COMPLETED|Washout Period 3||0
6723497|NCT03076970|7653182|FG002|NOT COMPLETED|Washout Period 3||0
6723498|NCT03076970|7653183|FG003|NOT COMPLETED|Washout Period 3||0
6723499|NCT03076970|7653184|FG004|NOT COMPLETED|Washout Period 3||0
6723500|NCT03076970|7653185|FG005|NOT COMPLETED|Washout Period 3||0
6723501|NCT03076983|7653198|FG000|STARTED|Overall Study||55
6723502|NCT03076983|7653199|FG001|STARTED|Overall Study||25
6723503|NCT03076983|7653198|FG000|COMPLETED|Overall Study||55
6723504|NCT03076983|7653199|FG001|COMPLETED|Overall Study||25
6723505|NCT03076983|7653198|FG000|NOT COMPLETED|Overall Study||0
6723506|NCT03076983|7653199|FG001|NOT COMPLETED|Overall Study||0
6723507|NCT03076996|7653205|FG000|STARTED|Overall Study||41
6723508|NCT03076996|7653205|FG000|COMPLETED|Overall Study||35
6723509|NCT03076996|7653205|FG000|NOT COMPLETED|Overall Study||6
6723510|NCT03077165|7653215|FG000|STARTED|Overall Study||21
6723511|NCT03077165|7653216|FG001|STARTED|Overall Study||22
6723512|NCT03077165|7653217|FG002|STARTED|Overall Study||20
6723513|NCT03077165|7653218|FG003|STARTED|Overall Study||19
6723514|NCT03077165|7653219|FG004|STARTED|Overall Study||19
6723515|NCT03077165|7653220|FG005|STARTED|Overall Study||20
6723516|NCT03077165|7653215|FG000|COMPLETED|Overall Study||20
6723517|NCT03077165|7653216|FG001|COMPLETED|Overall Study||22
6723518|NCT03077165|7653217|FG002|COMPLETED|Overall Study||20
6723519|NCT03077165|7653218|FG003|COMPLETED|Overall Study||19
6723520|NCT03077165|7653219|FG004|COMPLETED|Overall Study||16
6723521|NCT03077165|7653220|FG005|COMPLETED|Overall Study||20
6723522|NCT03077165|7653215|FG000|NOT COMPLETED|Overall Study||1
6723523|NCT03077165|7653216|FG001|NOT COMPLETED|Overall Study||0
6723524|NCT03077165|7653217|FG002|NOT COMPLETED|Overall Study||0
6723525|NCT03077165|7653218|FG003|NOT COMPLETED|Overall Study||0
6723526|NCT03077165|7653219|FG004|NOT COMPLETED|Overall Study||3
6723527|NCT03077165|7653220|FG005|NOT COMPLETED|Overall Study||0
6723528|NCT03077607|7653236|FG000|STARTED|Period 1 (15 Days)||19
6723529|NCT03077607|7653237|FG001|STARTED|Period 1 (15 Days)||17
6723530|NCT03077607|7653236|FG000|Treated (With Any Study Drug)|Period 1 (15 Days)||19
6723531|NCT03077607|7653237|FG001|Treated (With Any Study Drug)|Period 1 (15 Days)||17
6723532|NCT03077607|7653236|FG000|Received Talazoparib|Period 1 (15 Days)||19
6723533|NCT03077607|7653237|FG001|Received Talazoparib|Period 1 (15 Days)||17
6723534|NCT03077607|7653236|FG000|COMPLETED|Period 1 (15 Days)||17
6723535|NCT03077607|7653237|FG001|COMPLETED|Period 1 (15 Days)||17
6723536|NCT03077607|7653236|FG000|NOT COMPLETED|Period 1 (15 Days)||2
6723537|NCT03077607|7653237|FG001|NOT COMPLETED|Period 1 (15 Days)||0
6264967|NCT00006392|7164011|FG000|STARTED|Overall Study||8904
6264968|NCT00006392|7164012|FG001|STARTED|Overall Study||8910
6264969|NCT00006392|7164013|FG002|STARTED|Overall Study||8863
6264970|NCT00006392|7164014|FG003|STARTED|Overall Study||8856
6264971|NCT00006392|7164011|FG000|COMPLETED|Overall Study||8737
6264972|NCT00006392|7164012|FG001|COMPLETED|Overall Study||8752
6264973|NCT00006392|7164013|FG002|COMPLETED|Overall Study||8703
6264974|NCT00006392|7164014|FG003|COMPLETED|Overall Study||8696
6264975|NCT00006392|7164011|FG000|NOT COMPLETED|Overall Study||167
6264976|NCT00006392|7164012|FG001|NOT COMPLETED|Overall Study||158
6264977|NCT00006392|7164013|FG002|NOT COMPLETED|Overall Study||160
6264978|NCT00006392|7164014|FG003|NOT COMPLETED|Overall Study||160
6264979|NCT00006400|7164026|FG000|STARTED|Overall Study||96
6264980|NCT00006400|7164027|FG001|STARTED|Overall Study||97
6264981|NCT00006400|7164026|FG000|COMPLETED|Overall Study||83
6264982|NCT00006400|7164027|FG001|COMPLETED|Overall Study||84
6264983|NCT00006400|7164026|FG000|NOT COMPLETED|Overall Study||13
6264984|NCT00006400|7164027|FG001|NOT COMPLETED|Overall Study||13
6264985|NCT00006409|7164039|FG000|STARTED|Baseline||865
6264986|NCT00006409|7164040|FG001|STARTED|Baseline||856
6264987|NCT00006409|7164041|FG002|STARTED|Baseline||0
6264988|NCT00006409|7164042|FG003|STARTED|Baseline||0
6264989|NCT00006409|7164043|FG004|STARTED|Baseline||0
6264990|NCT00006409|7164044|FG005|STARTED|Baseline||0
6264991|NCT00006409|7164039|FG000|COMPLETED|Baseline||817
6264992|NCT00006409|7164040|FG001|COMPLETED|Baseline||786
6264993|NCT00006409|7164041|FG002|COMPLETED|Baseline||0
6264994|NCT00006409|7164042|FG003|COMPLETED|Baseline||0
6264995|NCT00006409|7164043|FG004|COMPLETED|Baseline||0
6264996|NCT00006409|7164044|FG005|COMPLETED|Baseline||0
6264997|NCT00006409|7164039|FG000|NOT COMPLETED|Baseline||48
6264998|NCT00006409|7164040|FG001|NOT COMPLETED|Baseline||70
6264999|NCT00006409|7164041|FG002|NOT COMPLETED|Baseline||0
6265000|NCT00006409|7164042|FG003|NOT COMPLETED|Baseline||0
6265001|NCT00006409|7164043|FG004|NOT COMPLETED|Baseline||0
6265002|NCT00006409|7164044|FG005|NOT COMPLETED|Baseline||0
6265003|NCT00006409|7164039|FG000|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
6265004|NCT00006409|7164040|FG001|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
6265005|NCT00006409|7164041|FG002|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
6265006|NCT00006409|7164042|FG003|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
6265007|NCT00006409|7164043|FG004|STARTED|Post-2 Year Intervention||0
6265008|NCT00006409|7164044|FG005|STARTED|Post-2 Year Intervention||0
6265009|NCT00006409|7164039|FG000|COMPLETED|Post-2 Year Intervention||0
6265010|NCT00006409|7164040|FG001|COMPLETED|Post-2 Year Intervention||0
6265011|NCT00006409|7164041|FG002|COMPLETED|Post-2 Year Intervention||1540
6265012|NCT00006409|7164042|FG003|COMPLETED|Post-2 Year Intervention||1545
6265013|NCT00006409|7164043|FG004|COMPLETED|Post-2 Year Intervention||0
6265014|NCT00006409|7164044|FG005|COMPLETED|Post-2 Year Intervention||0
6265015|NCT00006409|7164039|FG000|NOT COMPLETED|Post-2 Year Intervention||0
6265016|NCT00006409|7164040|FG001|NOT COMPLETED|Post-2 Year Intervention||0
6265017|NCT00006409|7164041|FG002|NOT COMPLETED|Post-2 Year Intervention||251
6265018|NCT00006409|7164042|FG003|NOT COMPLETED|Post-2 Year Intervention||168
6265019|NCT00006409|7164043|FG004|NOT COMPLETED|Post-2 Year Intervention||0
6265020|NCT00006409|7164044|FG005|NOT COMPLETED|Post-2 Year Intervention||0
6265021|NCT00006409|7164039|FG000|STARTED|Post-3 Year Intervention||0
6265022|NCT00006409|7164040|FG001|STARTED|Post-3 Year Intervention||0
6265023|NCT00006409|7164041|FG002|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
6265024|NCT00006409|7164042|FG003|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
6265025|NCT00006409|7164043|FG004|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
6265026|NCT00006409|7164044|FG005|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
6265027|NCT00006409|7164039|FG000|COMPLETED|Post-3 Year Intervention||0
6265028|NCT00006409|7164040|FG001|COMPLETED|Post-3 Year Intervention||0
6265029|NCT00006409|7164041|FG002|COMPLETED|Post-3 Year Intervention||0
6265030|NCT00006409|7164042|FG003|COMPLETED|Post-3 Year Intervention||0
6265031|NCT00006409|7164043|FG004|COMPLETED|Post-3 Year Intervention||1664
6265032|NCT00006409|7164044|FG005|COMPLETED|Post-3 Year Intervention||1714
6265033|NCT00006409|7164039|FG000|NOT COMPLETED|Post-3 Year Intervention||0
6265034|NCT00006409|7164040|FG001|NOT COMPLETED|Post-3 Year Intervention||0
6265035|NCT00006409|7164041|FG002|NOT COMPLETED|Post-3 Year Intervention||0
6265036|NCT00006409|7164042|FG003|NOT COMPLETED|Post-3 Year Intervention||0
6265037|NCT00006409|7164043|FG004|NOT COMPLETED|Post-3 Year Intervention||62
6265038|NCT00006409|7164044|FG005|NOT COMPLETED|Post-3 Year Intervention||62
6265039|NCT00006411|7164060|FG000|STARTED|Overall Study||707
6265040|NCT00006411|7164061|FG001|STARTED|Overall Study||383
6265041|NCT00006411|7164060|FG000|COMPLETED|Overall Study||707
6265042|NCT00006411|7164061|FG001|COMPLETED|Overall Study||383
6265043|NCT00006411|7164060|FG000|NOT COMPLETED|Overall Study||0
6265044|NCT00006411|7164061|FG001|NOT COMPLETED|Overall Study||0
6265045|NCT00006489|7164071|FG000|STARTED|Overall Study||42
6265046|NCT00006489|7164072|FG001|STARTED|Overall Study||40
6265047|NCT00006489|7164073|FG002|STARTED|Overall Study||40
6723538|NCT03077607|7653236|FG000|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
6723539|NCT03077607|7653237|FG001|STARTED|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
6723540|NCT03077607|7653236|FG000|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
6723541|NCT03077607|7653237|FG001|Treated (With Any Study Drug)|Period 2 (Arm A:21 Days; Arm B:23 Days)||17
6723542|NCT03077607|7653236|FG000|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
6723543|NCT03077607|7653237|FG001|Received Talazoparib|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
6723544|NCT03077607|7653236|FG000|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||14
6723545|NCT03077607|7653237|FG001|COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||15
6723546|NCT03077607|7653236|FG000|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||3
6723547|NCT03077607|7653237|FG001|NOT COMPLETED|Period 2 (Arm A:21 Days; Arm B:23 Days)||2
6723548|NCT03077646|7653257|FG000|STARTED|Overall Study||76
6723549|NCT03077646|7653258|FG001|STARTED|Overall Study||75
6723550|NCT03077646|7653259|FG002|STARTED|Overall Study||74
6723551|NCT03077646|7653257|FG000|COMPLETED|Overall Study|Of these 47, there were 25 paired samples for primary outcome|47
6723552|NCT03077646|7653258|FG001|COMPLETED|Overall Study|Of these 45, there were 27 paired samples for primary outcome|45
6723553|NCT03077646|7653259|FG002|COMPLETED|Overall Study|Of these 43, there were 20 paired samples for primary outcome|43
6723554|NCT03077646|7653257|FG000|NOT COMPLETED|Overall Study||29
6723555|NCT03077646|7653258|FG001|NOT COMPLETED|Overall Study||30
6723556|NCT03077646|7653259|FG002|NOT COMPLETED|Overall Study||31
6723557|NCT03077659|7653270|FG000|STARTED|Overall Study||3
6723558|NCT03077659|7653271|FG001|STARTED|Overall Study||3
6723559|NCT03077659|7653272|FG002|STARTED|Overall Study||10
6723560|NCT03077659|7653270|FG000|COMPLETED|Overall Study||3
6723561|NCT03077659|7653271|FG001|COMPLETED|Overall Study||3
6723562|NCT03077659|7653272|FG002|COMPLETED|Overall Study||9
6723563|NCT03077659|7653270|FG000|NOT COMPLETED|Overall Study||0
6723564|NCT03077659|7653271|FG001|NOT COMPLETED|Overall Study||0
6723565|NCT03077659|7653272|FG002|NOT COMPLETED|Overall Study||1
6723566|NCT03077711|7653285|FG000|STARTED|Overall Study||47
6723567|NCT03077711|7653286|FG001|STARTED|Overall Study||45
6723568|NCT03077711|7653285|FG000|COMPLETED|Overall Study||43
6723569|NCT03077711|7653286|FG001|COMPLETED|Overall Study||43
6723570|NCT03077711|7653285|FG000|NOT COMPLETED|Overall Study||4
6723571|NCT03077711|7653286|FG001|NOT COMPLETED|Overall Study||2
6723572|NCT03077724|7653296|FG000|STARTED|Overall Study||14
6723573|NCT03077724|7653297|FG001|STARTED|Overall Study||14
6723574|NCT03077724|7653296|FG000|COMPLETED|Overall Study||6
6723575|NCT03077724|7653297|FG001|COMPLETED|Overall Study||12
6723576|NCT03077724|7653296|FG000|NOT COMPLETED|Overall Study||8
6723577|NCT03077724|7653297|FG001|NOT COMPLETED|Overall Study||2
6723578|NCT03077893|7653305|FG000|STARTED|Overall Study||18
6723579|NCT03077893|7653306|FG001|STARTED|Overall Study||19
6723580|NCT03077893|7653305|FG000|COMPLETED|Overall Study||14
6723581|NCT03077893|7653306|FG001|COMPLETED|Overall Study||16
6723582|NCT03077893|7653305|FG000|NOT COMPLETED|Overall Study||4
6723583|NCT03077893|7653306|FG001|NOT COMPLETED|Overall Study||3
6723584|NCT03077919|7653315|FG000|STARTED|Overall Study||74
6723585|NCT03077919|7653316|FG001|STARTED|Overall Study||39
6723586|NCT03077919|7653315|FG000|Week 2 Visit|Overall Study||74
6723587|NCT03077919|7653316|FG001|Week 2 Visit|Overall Study||39
6723588|NCT03077919|7653315|FG000|Week 4 Visit|Overall Study||73
6723589|NCT03077919|7653316|FG001|Week 4 Visit|Overall Study||38
6723590|NCT03077919|7653315|FG000|Week 6 Visit|Overall Study||73
6723591|NCT03077919|7653316|FG001|Week 6 Visit|Overall Study||38
6723592|NCT03077919|7653315|FG000|Week 8 Visit|Overall Study||71
6723593|NCT03077919|7653316|FG001|Week 8 Visit|Overall Study||38
6723594|NCT03077919|7653315|FG000|Final CAPS|Overall Study||70
6723595|NCT03077919|7653316|FG001|Final CAPS|Overall Study||38
6723596|NCT03077919|7653315|FG000|COMPLETED|Overall Study||70
6723597|NCT03077919|7653316|FG001|COMPLETED|Overall Study||38
6723598|NCT03077919|7653315|FG000|NOT COMPLETED|Overall Study||4
6723599|NCT03077919|7653316|FG001|NOT COMPLETED|Overall Study||1
6723600|NCT03078075|7653324|FG000|STARTED|Overall Study||111
6723601|NCT03078075|7653325|FG001|STARTED|Overall Study||114
6723602|NCT03078075|7653326|FG002|STARTED|Overall Study||59
6723603|NCT03078075|7653327|FG003|STARTED|Overall Study||10
6723604|NCT03078075|7653328|FG004|STARTED|Overall Study||109
6723605|NCT03078075|7653324|FG000|COMPLETED|Overall Study||106
6723606|NCT03078075|7653325|FG001|COMPLETED|Overall Study||103
6723607|NCT03078075|7653326|FG002|COMPLETED|Overall Study||19
6265048|NCT00006489|7164074|FG003|STARTED|Overall Study||43
6265049|NCT00006489|7164071|FG000|COMPLETED|Overall Study||29
6265050|NCT00006489|7164072|FG001|COMPLETED|Overall Study||26
6265051|NCT00006489|7164073|FG002|COMPLETED|Overall Study||25
6265052|NCT00006489|7164074|FG003|COMPLETED|Overall Study||32
6265053|NCT00006489|7164071|FG000|NOT COMPLETED|Overall Study||13
6265054|NCT00006489|7164072|FG001|NOT COMPLETED|Overall Study||14
6265055|NCT00006489|7164073|FG002|NOT COMPLETED|Overall Study||15
6265056|NCT00006489|7164074|FG003|NOT COMPLETED|Overall Study||11
6265057|NCT00006604|7164091|FG000|STARTED|Overall Study||6
6265058|NCT00006604|7164092|FG001|STARTED|Overall Study||2
6723608|NCT03078075|7653327|FG003|COMPLETED|Overall Study||9
6723609|NCT03078075|7653328|FG004|COMPLETED|Overall Study||78
6723610|NCT03078075|7653324|FG000|NOT COMPLETED|Overall Study||5
6723611|NCT03078075|7653325|FG001|NOT COMPLETED|Overall Study||11
6265059|NCT00006604|7164093|FG002|STARTED|Overall Study||5
6265060|NCT00006604|7164094|FG003|STARTED|Overall Study||6
6723612|NCT03078075|7653326|FG002|NOT COMPLETED|Overall Study||40
6723613|NCT03078075|7653327|FG003|NOT COMPLETED|Overall Study||1
6723614|NCT03078075|7653328|FG004|NOT COMPLETED|Overall Study||31
6723615|NCT03078127|7653354|FG000|STARTED|First Intervention||4
6723616|NCT03078127|7653355|FG001|STARTED|First Intervention||3
6723617|NCT03078127|7653356|FG002|STARTED|First Intervention||3
6723618|NCT03078127|7653354|FG000|COMPLETED|First Intervention||4
6723619|NCT03078127|7653355|FG001|COMPLETED|First Intervention||3
6723620|NCT03078127|7653356|FG002|COMPLETED|First Intervention||3
6723621|NCT03078127|7653354|FG000|NOT COMPLETED|First Intervention||0
6723622|NCT03078127|7653355|FG001|NOT COMPLETED|First Intervention||0
6723623|NCT03078127|7653356|FG002|NOT COMPLETED|First Intervention||0
6723624|NCT03078127|7653354|FG000|STARTED|Washout (3-21 Days)||4
6723625|NCT03078127|7653355|FG001|STARTED|Washout (3-21 Days)||3
6723626|NCT03078127|7653356|FG002|STARTED|Washout (3-21 Days)||3
6723627|NCT03078127|7653354|FG000|COMPLETED|Washout (3-21 Days)||4
6723628|NCT03078127|7653355|FG001|COMPLETED|Washout (3-21 Days)||3
6723629|NCT03078127|7653356|FG002|COMPLETED|Washout (3-21 Days)||3
6723630|NCT03078127|7653354|FG000|NOT COMPLETED|Washout (3-21 Days)||0
6723631|NCT03078127|7653355|FG001|NOT COMPLETED|Washout (3-21 Days)||0
6723632|NCT03078127|7653356|FG002|NOT COMPLETED|Washout (3-21 Days)||0
6723633|NCT03078127|7653354|FG000|STARTED|Second Intervention||4
6723634|NCT03078127|7653355|FG001|STARTED|Second Intervention||3
6723635|NCT03078127|7653356|FG002|STARTED|Second Intervention||3
6723636|NCT03078127|7653354|FG000|COMPLETED|Second Intervention||4
6723637|NCT03078127|7653355|FG001|COMPLETED|Second Intervention||3
6723638|NCT03078127|7653356|FG002|COMPLETED|Second Intervention||3
6723639|NCT03078127|7653354|FG000|NOT COMPLETED|Second Intervention||0
6723640|NCT03078127|7653355|FG001|NOT COMPLETED|Second Intervention||0
6723641|NCT03078127|7653356|FG002|NOT COMPLETED|Second Intervention||0
6723642|NCT03078127|7653354|FG000|STARTED|Washout (3-21 Days)||4
6723643|NCT03078127|7653355|FG001|STARTED|Washout (3-21 Days)||3
6723644|NCT03078127|7653356|FG002|STARTED|Washout (3-21 Days)||3
6723645|NCT03078127|7653354|FG000|COMPLETED|Washout (3-21 Days)||4
6723646|NCT03078127|7653355|FG001|COMPLETED|Washout (3-21 Days)||3
6723647|NCT03078127|7653356|FG002|COMPLETED|Washout (3-21 Days)||3
6723648|NCT03078127|7653354|FG000|NOT COMPLETED|Washout (3-21 Days)||0
6723649|NCT03078127|7653355|FG001|NOT COMPLETED|Washout (3-21 Days)||0
6723650|NCT03078127|7653356|FG002|NOT COMPLETED|Washout (3-21 Days)||0
6723651|NCT03078127|7653354|FG000|STARTED|Third Intervention||4
6723652|NCT03078127|7653355|FG001|STARTED|Third Intervention||3
6723653|NCT03078127|7653356|FG002|STARTED|Third Intervention||3
6723654|NCT03078127|7653354|FG000|COMPLETED|Third Intervention||4
6723655|NCT03078127|7653355|FG001|COMPLETED|Third Intervention||3
6723656|NCT03078127|7653356|FG002|COMPLETED|Third Intervention||3
6723657|NCT03078127|7653354|FG000|NOT COMPLETED|Third Intervention||0
6723658|NCT03078127|7653355|FG001|NOT COMPLETED|Third Intervention||0
6723659|NCT03078127|7653356|FG002|NOT COMPLETED|Third Intervention||0
6723660|NCT03078504|7653367|FG000|STARTED|Overall Study||6
6723661|NCT03078504|7653367|FG000|COMPLETED|Overall Study||6
6723662|NCT03078504|7653367|FG000|NOT COMPLETED|Overall Study||0
6723663|NCT03078556|7653373|FG000|STARTED|Treatment Period 1 (4 Days)||39
6723664|NCT03078556|7653374|FG001|STARTED|Treatment Period 1 (4 Days)||39
6723665|NCT03078556|7653375|FG002|STARTED|Treatment Period 1 (4 Days)||38
6723666|NCT03078556|7653376|FG003|STARTED|Treatment Period 1 (4 Days)||38
6723667|NCT03078556|7653373|FG000|COMPLETED|Treatment Period 1 (4 Days)||39
6723668|NCT03078556|7653374|FG001|COMPLETED|Treatment Period 1 (4 Days)||38
6723669|NCT03078556|7653375|FG002|COMPLETED|Treatment Period 1 (4 Days)||38
6723670|NCT03078556|7653376|FG003|COMPLETED|Treatment Period 1 (4 Days)||38
6723671|NCT03078556|7653373|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6723672|NCT03078556|7653374|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||1
6723673|NCT03078556|7653375|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6723674|NCT03078556|7653376|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6723675|NCT03078556|7653373|FG000|STARTED|Washout Period 1 (7 Days)||39
6723676|NCT03078556|7653374|FG001|STARTED|Washout Period 1 (7 Days)||38
6723677|NCT03078556|7653375|FG002|STARTED|Washout Period 1 (7 Days)||38
6723678|NCT03078556|7653376|FG003|STARTED|Washout Period 1 (7 Days)||38
6723679|NCT03078556|7653373|FG000|COMPLETED|Washout Period 1 (7 Days)||37
6723680|NCT03078556|7653374|FG001|COMPLETED|Washout Period 1 (7 Days)||36
6723681|NCT03078556|7653375|FG002|COMPLETED|Washout Period 1 (7 Days)||37
6723682|NCT03078556|7653376|FG003|COMPLETED|Washout Period 1 (7 Days)||37
6723683|NCT03078556|7653373|FG000|NOT COMPLETED|Washout Period 1 (7 Days)||2
6723684|NCT03078556|7653374|FG001|NOT COMPLETED|Washout Period 1 (7 Days)||2
6723685|NCT03078556|7653375|FG002|NOT COMPLETED|Washout Period 1 (7 Days)||1
6723686|NCT03078556|7653376|FG003|NOT COMPLETED|Washout Period 1 (7 Days)||1
6723687|NCT03078556|7653373|FG000|STARTED|Treatment Period 2 (4 Days)||37
6723688|NCT03078556|7653374|FG001|STARTED|Treatment Period 2 (4 Days)||36
6723689|NCT03078556|7653375|FG002|STARTED|Treatment Period 2 (4 Days)||37
6723690|NCT03078556|7653376|FG003|STARTED|Treatment Period 2 (4 Days)||37
6723691|NCT03078556|7653373|FG000|COMPLETED|Treatment Period 2 (4 Days)||37
6723692|NCT03078556|7653374|FG001|COMPLETED|Treatment Period 2 (4 Days)||36
6723693|NCT03078556|7653375|FG002|COMPLETED|Treatment Period 2 (4 Days)||37
6723694|NCT03078556|7653376|FG003|COMPLETED|Treatment Period 2 (4 Days)||37
6723695|NCT03078556|7653373|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6723696|NCT03078556|7653374|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6723697|NCT03078556|7653375|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6723698|NCT03078556|7653376|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6723699|NCT03078556|7653373|FG000|STARTED|Washout Period 2 (7 Days)||9
6723700|NCT03078556|7653374|FG001|STARTED|Washout Period 2 (7 Days)||7
6723701|NCT03078556|7653375|FG002|STARTED|Washout Period 2 (7 Days)||7
6723702|NCT03078556|7653376|FG003|STARTED|Washout Period 2 (7 Days)||9
6723703|NCT03078556|7653373|FG000|COMPLETED|Washout Period 2 (7 Days)||9
6723704|NCT03078556|7653374|FG001|COMPLETED|Washout Period 2 (7 Days)||7
6723705|NCT03078556|7653375|FG002|COMPLETED|Washout Period 2 (7 Days)||7
6723706|NCT03078556|7653376|FG003|COMPLETED|Washout Period 2 (7 Days)||9
6723707|NCT03078556|7653373|FG000|NOT COMPLETED|Washout Period 2 (7 Days)||0
6723708|NCT03078556|7653374|FG001|NOT COMPLETED|Washout Period 2 (7 Days)||0
6723709|NCT03078556|7653375|FG002|NOT COMPLETED|Washout Period 2 (7 Days)||0
6723710|NCT03078556|7653376|FG003|NOT COMPLETED|Washout Period 2 (7 Days)||0
6723711|NCT03078556|7653373|FG000|STARTED|Treatment Period 3 (4 Days)||9
6723712|NCT03078556|7653374|FG001|STARTED|Treatment Period 3 (4 Days)||7
6723713|NCT03078556|7653375|FG002|STARTED|Treatment Period 3 (4 Days)||7
6723714|NCT03078556|7653376|FG003|STARTED|Treatment Period 3 (4 Days)||9
6723715|NCT03078556|7653373|FG000|COMPLETED|Treatment Period 3 (4 Days)||9
6723716|NCT03078556|7653374|FG001|COMPLETED|Treatment Period 3 (4 Days)||7
6723717|NCT03078556|7653375|FG002|COMPLETED|Treatment Period 3 (4 Days)||7
6723718|NCT03078556|7653376|FG003|COMPLETED|Treatment Period 3 (4 Days)||9
6723719|NCT03078556|7653373|FG000|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6723720|NCT03078556|7653374|FG001|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6723721|NCT03078556|7653375|FG002|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6723722|NCT03078556|7653376|FG003|NOT COMPLETED|Treatment Period 3 (4 Days)||0
6723723|NCT03078582|7653403|FG000|STARTED|Overall Study||10
6723724|NCT03078582|7653404|FG001|STARTED|Overall Study||16
6723725|NCT03078582|7653403|FG000|COMPLETED|Overall Study||10
6723726|NCT03078582|7653404|FG001|COMPLETED|Overall Study||8
6723727|NCT03078582|7653403|FG000|NOT COMPLETED|Overall Study||0
6723728|NCT03078582|7653404|FG001|NOT COMPLETED|Overall Study||8
6723729|NCT03078595|7653412|FG000|STARTED|Overall Study||24
6723730|NCT03078595|7653413|FG001|STARTED|Overall Study||24
6723731|NCT03078595|7653412|FG000|COMPLETED|Overall Study||24
6723732|NCT03078595|7653413|FG001|COMPLETED|Overall Study||24
6723733|NCT03078595|7653412|FG000|NOT COMPLETED|Overall Study||0
6723734|NCT03078595|7653413|FG001|NOT COMPLETED|Overall Study||0
6723735|NCT03078647|7653422|FG000|STARTED|Overall Study||17
6723736|NCT03078647|7653423|FG001|STARTED|Overall Study||11
6723737|NCT03078647|7653424|FG002|STARTED|Overall Study||3
6723738|NCT03078647|7653422|FG000|COMPLETED|Overall Study||17
6723739|NCT03078647|7653423|FG001|COMPLETED|Overall Study||10
6723740|NCT03078647|7653424|FG002|COMPLETED|Overall Study||3
6723741|NCT03078647|7653422|FG000|NOT COMPLETED|Overall Study||0
6723742|NCT03078647|7653423|FG001|NOT COMPLETED|Overall Study||1
6723743|NCT03078647|7653424|FG002|NOT COMPLETED|Overall Study||0
6723744|NCT03078751|7653434|FG000|STARTED|Overall Study||26
6723745|NCT03078751|7653435|FG001|STARTED|Overall Study||28
6723746|NCT03078751|7653434|FG000|Untreated Participants|Overall Study||0
6723747|NCT03078751|7653435|FG001|Untreated Participants|Overall Study||4
6723748|NCT03078751|7653434|FG000|Safety Set|Overall Study||26
6723749|NCT03078751|7653435|FG001|Safety Set|Overall Study||24
6723750|NCT03078751|7653434|FG000|COMPLETED|Overall Study||13
6723751|NCT03078751|7653435|FG001|COMPLETED|Overall Study||0
6723752|NCT03078751|7653434|FG000|NOT COMPLETED|Overall Study||13
6723753|NCT03078751|7653435|FG001|NOT COMPLETED|Overall Study||28
6723754|NCT03078816|7653441|FG000|STARTED|Overall Study||5
6723755|NCT03078816|7653441|FG000|COMPLETED|Overall Study||4
6723756|NCT03078816|7653441|FG000|NOT COMPLETED|Overall Study||1
6723757|NCT03078907|7653447|FG000|STARTED|Overall Study||53
6723758|NCT03078907|7653448|FG001|STARTED|Overall Study||55
6723759|NCT03078907|7653447|FG000|COMPLETED|Overall Study||50
6723760|NCT03078907|7653448|FG001|COMPLETED|Overall Study||54
6723761|NCT03078907|7653447|FG000|NOT COMPLETED|Overall Study||3
6723762|NCT03078907|7653448|FG001|NOT COMPLETED|Overall Study||1
6723763|NCT03078946|7653456|FG000|STARTED|Overall Study||30
6723764|NCT03078946|7653457|FG001|STARTED|Overall Study||30
6723765|NCT03078946|7653456|FG000|COMPLETED|Overall Study||30
6723766|NCT03078946|7653457|FG001|COMPLETED|Overall Study||30
6723767|NCT03078946|7653456|FG000|NOT COMPLETED|Overall Study||0
6723768|NCT03078946|7653457|FG001|NOT COMPLETED|Overall Study||0
6723769|NCT03079375|7653466|FG000|STARTED|Overall Study||503
6723770|NCT03079375|7653467|FG001|STARTED|Overall Study||499
6723771|NCT03079375|7653468|FG002|STARTED|Overall Study||497
6723772|NCT03079375|7653466|FG000|COMPLETED|Overall Study||498
6723773|NCT03079375|7653467|FG001|COMPLETED|Overall Study||493
6723774|NCT03079375|7653468|FG002|COMPLETED|Overall Study||476
6723775|NCT03079375|7653466|FG000|NOT COMPLETED|Overall Study||5
6723776|NCT03079375|7653467|FG001|NOT COMPLETED|Overall Study||6
6723777|NCT03079375|7653468|FG002|NOT COMPLETED|Overall Study||21
6723778|NCT03079531|7653480|FG000|STARTED|Overall Study||24
6723779|NCT03079531|7653480|FG000|Attended ≥1 Post-baseline Visit|Overall Study||23
6723780|NCT03079531|7653480|FG000|COMPLETED|Overall Study||17
6723781|NCT03079531|7653480|FG000|NOT COMPLETED|Overall Study||7
6723782|NCT03080142|7653486|FG000|STARTED|Overall Study||42
6723783|NCT03080142|7653487|FG001|STARTED|Overall Study||44
6723784|NCT03080142|7653486|FG000|COMPLETED|Overall Study||42
6723785|NCT03080142|7653487|FG001|COMPLETED|Overall Study||44
6723786|NCT03080142|7653486|FG000|NOT COMPLETED|Overall Study||0
6723787|NCT03080142|7653487|FG001|NOT COMPLETED|Overall Study||0
6723788|NCT03080454|7653493|FG000|STARTED|Baseline||26
6723789|NCT03080454|7653493|FG000|COMPLETED|Baseline|Two participants (pts) dropped out after consent due to hospitalizations unrelated to the study.|24
6723790|NCT03080454|7653493|FG000|NOT COMPLETED|Baseline||2
6723791|NCT03080454|7653493|FG000|STARTED|Sham Doublestim (5days)||24
6723792|NCT03080454|7653493|FG000|COMPLETED|Sham Doublestim (5days)||24
6723793|NCT03080454|7653493|FG000|NOT COMPLETED|Sham Doublestim (5days)||0
6723794|NCT03080454|7653493|FG000|STARTED|Sham FU (7days)||24
6723795|NCT03080454|7653493|FG000|COMPLETED|Sham FU (7days)||24
6723796|NCT03080454|7653493|FG000|NOT COMPLETED|Sham FU (7days)||0
6723797|NCT03080454|7653493|FG000|STARTED|Anodal Doublestim (5 Days)||24
6723798|NCT03080454|7653493|FG000|COMPLETED|Anodal Doublestim (5 Days)||23
6723799|NCT03080454|7653493|FG000|NOT COMPLETED|Anodal Doublestim (5 Days)||1
6723800|NCT03080454|7653493|FG000|STARTED|Anodal FU (7 Days)||23
6723801|NCT03080454|7653493|FG000|COMPLETED|Anodal FU (7 Days)||19
6723802|NCT03080454|7653493|FG000|NOT COMPLETED|Anodal FU (7 Days)||4
6723803|NCT03080493|7653502|FG000|STARTED|Overall Study||61
6723804|NCT03080493|7653503|FG001|STARTED|Overall Study||60
6723805|NCT03080493|7653502|FG000|COMPLETED|Overall Study||60
6723806|NCT03080493|7653503|FG001|COMPLETED|Overall Study||58
6723807|NCT03080493|7653502|FG000|NOT COMPLETED|Overall Study||1
6723808|NCT03080493|7653503|FG001|NOT COMPLETED|Overall Study||2
6723809|NCT03080961|7653509|FG000|STARTED|Overall Study||46
6723810|NCT03080961|7653509|FG000|COMPLETED|Overall Study||43
6723811|NCT03080961|7653509|FG000|NOT COMPLETED|Overall Study||3
6723812|NCT03081117|7653520|FG000|STARTED|Overall Study||10
6723813|NCT03081117|7653521|FG001|STARTED|Overall Study||11
6723814|NCT03081117|7653520|FG000|Primary Outcome 1 (SAE)|Overall Study||10
6723815|NCT03081117|7653521|FG001|Primary Outcome 1 (SAE)|Overall Study||11
6723816|NCT03081117|7653520|FG000|Secondary Measures Collected at Week 24|Overall Study||8
6723817|NCT03081117|7653521|FG001|Secondary Measures Collected at Week 24|Overall Study||9
6723818|NCT03081117|7653520|FG000|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||7
6723819|NCT03081117|7653521|FG001|Completed (ITT): Primary Outcome 2 (GDS)|Overall Study||9
6723820|NCT03081117|7653520|FG000|COMPLETED|Overall Study||6
6723821|NCT03081117|7653521|FG001|COMPLETED|Overall Study||8
6723822|NCT03081117|7653520|FG000|NOT COMPLETED|Overall Study||4
6723823|NCT03081117|7653521|FG001|NOT COMPLETED|Overall Study||3
6723824|NCT03081884|7653527|FG000|STARTED|Overall Study||61
6723825|NCT03081884|7653527|FG000|COMPLETED|Overall Study||57
6723826|NCT03081884|7653527|FG000|NOT COMPLETED|Overall Study||4
6723827|NCT03082196|7653534|FG000|STARTED|Overall Study||142
6723828|NCT03082196|7653535|FG001|STARTED|Overall Study||142
6723829|NCT03082196|7653534|FG000|COMPLETED|Overall Study||133
6723830|NCT03082196|7653535|FG001|COMPLETED|Overall Study||129
6723831|NCT03082196|7653534|FG000|NOT COMPLETED|Overall Study||9
6723832|NCT03082196|7653535|FG001|NOT COMPLETED|Overall Study||13
6723833|NCT03082261|7653541|FG000|STARTED|Overall Study||269
6723834|NCT03082261|7653541|FG000|COMPLETED|Overall Study||149
6723835|NCT03082261|7653541|FG000|NOT COMPLETED|Overall Study||120
6723836|NCT03082586|7653551|FG000|STARTED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
6723837|NCT03082586|7653552|FG001|STARTED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
6723838|NCT03082586|7653553|FG002|STARTED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
6723839|NCT03082586|7653554|FG003|STARTED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
6723840|NCT03082586|7653555|FG004|STARTED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
6723841|NCT03082586|7653556|FG005|STARTED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
6723842|NCT03082586|7653551|FG000|COMPLETED|Overall Study|the patients received a total radiation dose of 57.2 Gy in this group|3
6723843|NCT03082586|7653552|FG001|COMPLETED|Overall Study|the patients received a total radiation dose of 64.4 Gy in this group|3
6723844|NCT03082586|7653553|FG002|COMPLETED|Overall Study|the patients received a total radiation dose of 71.6 Gy in this group|3
6723845|NCT03082586|7653554|FG003|COMPLETED|Overall Study|the patients received a total radiation dose of 78.8 Gy in this group|6
6723846|NCT03082586|7653555|FG004|COMPLETED|Overall Study|the patients received a total radiation dose of 86 Gy in this group|13
6723847|NCT03082586|7653556|FG005|COMPLETED|Overall Study|the patients received a total radiation dose of 93.2 Gy in this group|3
6723848|NCT03082586|7653551|FG000|NOT COMPLETED|Overall Study||0
6723849|NCT03082586|7653552|FG001|NOT COMPLETED|Overall Study||0
6723850|NCT03082586|7653553|FG002|NOT COMPLETED|Overall Study||0
6723851|NCT03082586|7653554|FG003|NOT COMPLETED|Overall Study||0
6723852|NCT03082586|7653555|FG004|NOT COMPLETED|Overall Study||0
6723853|NCT03082586|7653556|FG005|NOT COMPLETED|Overall Study||0
6723854|NCT03082599|7653578|FG000|STARTED|Overall Study||40
6723855|NCT03082599|7653579|FG001|STARTED|Overall Study||39
6723856|NCT03082599|7653578|FG000|COMPLETED|Overall Study||39
6723857|NCT03082599|7653579|FG001|COMPLETED|Overall Study||39
6723858|NCT03082599|7653578|FG000|NOT COMPLETED|Overall Study||1
6723859|NCT03082599|7653579|FG001|NOT COMPLETED|Overall Study||0
6723860|NCT03083093|7653587|FG000|STARTED|Overall Study||50
6723861|NCT03083093|7653588|FG001|STARTED|Overall Study||50
6723862|NCT03083093|7653587|FG000|COMPLETED|Overall Study||50
6723863|NCT03083093|7653588|FG001|COMPLETED|Overall Study||50
6723864|NCT03083093|7653587|FG000|NOT COMPLETED|Overall Study||0
6723865|NCT03083093|7653588|FG001|NOT COMPLETED|Overall Study||0
6723866|NCT03083132|7653596|FG000|STARTED|First 12 Weeks (Placebo vs Modafinil)||12
6723867|NCT03083132|7653597|FG001|STARTED|First 12 Weeks (Placebo vs Modafinil)||9
6723868|NCT03083132|7653596|FG000|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||12
6723869|NCT03083132|7653597|FG001|COMPLETED|First 12 Weeks (Placebo vs Modafinil)||7
6723870|NCT03083132|7653596|FG000|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||0
6723871|NCT03083132|7653597|FG001|NOT COMPLETED|First 12 Weeks (Placebo vs Modafinil)||2
6723872|NCT03083132|7653596|FG000|STARTED|Last 12 Weeks (Drug for All Subjects)||12
6723873|NCT03083132|7653597|FG001|STARTED|Last 12 Weeks (Drug for All Subjects)||7
6723874|NCT03083132|7653596|FG000|COMPLETED|Last 12 Weeks (Drug for All Subjects)||11
6723875|NCT03083132|7653597|FG001|COMPLETED|Last 12 Weeks (Drug for All Subjects)||6
6723876|NCT03083132|7653596|FG000|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
6723877|NCT03083132|7653597|FG001|NOT COMPLETED|Last 12 Weeks (Drug for All Subjects)||1
6723878|NCT03083379|7653605|FG000|STARTED|Overall Study||15
6723879|NCT03083379|7653606|FG001|STARTED|Overall Study||15
6723880|NCT03083379|7653605|FG000|COMPLETED|Overall Study||15
6723881|NCT03083379|7653606|FG001|COMPLETED|Overall Study||15
6723882|NCT03083379|7653605|FG000|NOT COMPLETED|Overall Study||0
6723883|NCT03083379|7653606|FG001|NOT COMPLETED|Overall Study||0
6723884|NCT03083470|7653617|FG000|STARTED|Overall Study||6
6723885|NCT03083470|7653618|FG001|STARTED|Overall Study||6
6723886|NCT03083470|7653619|FG002|STARTED|Overall Study||6
6723887|NCT03083470|7653620|FG003|STARTED|Overall Study||6
6723888|NCT03083470|7653621|FG004|STARTED|Overall Study||9
6723889|NCT03083470|7653617|FG000|COMPLETED|Overall Study||6
6723890|NCT03083470|7653618|FG001|COMPLETED|Overall Study||6
6723891|NCT03083470|7653619|FG002|COMPLETED|Overall Study||6
6723892|NCT03083470|7653620|FG003|COMPLETED|Overall Study||6
6723893|NCT03083470|7653621|FG004|COMPLETED|Overall Study||7
6723894|NCT03083470|7653617|FG000|NOT COMPLETED|Overall Study||0
6723895|NCT03083470|7653618|FG001|NOT COMPLETED|Overall Study||0
6723896|NCT03083470|7653619|FG002|NOT COMPLETED|Overall Study||0
6723897|NCT03083470|7653620|FG003|NOT COMPLETED|Overall Study||0
6723898|NCT03083470|7653621|FG004|NOT COMPLETED|Overall Study||2
6723899|NCT03083483|7653636|FG000|STARTED|Overall Study||24
6723900|NCT03083483|7653637|FG001|STARTED|Overall Study||22
6723901|NCT03083483|7653638|FG002|STARTED|Overall Study||23
6723902|NCT03083483|7653636|FG000|COMPLETED|Overall Study||20
6723903|NCT03083483|7653637|FG001|COMPLETED|Overall Study||20
6723904|NCT03083483|7653638|FG002|COMPLETED|Overall Study||20
6723905|NCT03083483|7653636|FG000|NOT COMPLETED|Overall Study||4
6723906|NCT03083483|7653637|FG001|NOT COMPLETED|Overall Study||2
6723907|NCT03083483|7653638|FG002|NOT COMPLETED|Overall Study||3
6723908|NCT03083639|7653648|FG000|STARTED|Intervention Period 1 (1 Day)||26
6723909|NCT03083639|7653649|FG001|STARTED|Intervention Period 1 (1 Day)||26
6723910|NCT03083639|7653648|FG000|COMPLETED|Intervention Period 1 (1 Day)||26
6723911|NCT03083639|7653649|FG001|COMPLETED|Intervention Period 1 (1 Day)||26
6723912|NCT03083639|7653648|FG000|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6723913|NCT03083639|7653649|FG001|NOT COMPLETED|Intervention Period 1 (1 Day)||0
6723914|NCT03083639|7653648|FG000|STARTED|Washout Period (at Least 6 Days)||26
6723915|NCT03083639|7653649|FG001|STARTED|Washout Period (at Least 6 Days)||26
6723916|NCT03083639|7653648|FG000|COMPLETED|Washout Period (at Least 6 Days)||25
6723917|NCT03083639|7653649|FG001|COMPLETED|Washout Period (at Least 6 Days)||25
6723918|NCT03083639|7653648|FG000|NOT COMPLETED|Washout Period (at Least 6 Days)||1
6723919|NCT03083639|7653649|FG001|NOT COMPLETED|Washout Period (at Least 6 Days)||1
6723920|NCT03083639|7653648|FG000|STARTED|Intervention Period 2 (1 Day)||25
6723921|NCT03083639|7653649|FG001|STARTED|Intervention Period 2 (1 Day)||25
6723922|NCT03083639|7653648|FG000|COMPLETED|Intervention Period 2 (1 Day)||25
6723923|NCT03083639|7653649|FG001|COMPLETED|Intervention Period 2 (1 Day)||25
6723924|NCT03083639|7653648|FG000|NOT COMPLETED|Intervention Period 2 (1 Day)||0
6723925|NCT03083639|7653649|FG001|NOT COMPLETED|Intervention Period 2 (1 Day)||0
6723926|NCT03083769|7653657|FG000|STARTED|Overall Study||839
6723927|NCT03083769|7653658|FG001|STARTED|Overall Study||663
6723928|NCT03083769|7653657|FG000|COMPLETED|Overall Study||819
6723929|NCT03083769|7653658|FG001|COMPLETED|Overall Study||631
6723930|NCT03083769|7653657|FG000|NOT COMPLETED|Overall Study||20
6723931|NCT03083769|7653658|FG001|NOT COMPLETED|Overall Study||32
6723932|NCT03083847|7653674|FG000|STARTED|Pilot 1a||2
6723933|NCT03083847|7653675|FG001|STARTED|Pilot 1a||0
6723934|NCT03083847|7653676|FG002|STARTED|Pilot 1a||0
6723935|NCT03083847|7653677|FG003|STARTED|Pilot 1a||0
6723936|NCT03083847|7653678|FG004|STARTED|Pilot 1a||0
6723937|NCT03083847|7653679|FG005|STARTED|Pilot 1a||0
6723938|NCT03083847|7653680|FG006|STARTED|Pilot 1a||0
6723939|NCT03083847|7653681|FG007|STARTED|Pilot 1a||0
6723940|NCT03083847|7653682|FG008|STARTED|Pilot 1a||0
6723941|NCT03083847|7653683|FG009|STARTED|Pilot 1a||0
6723942|NCT03083847|7653674|FG000|COMPLETED|Pilot 1a||2
6723943|NCT03083847|7653675|FG001|COMPLETED|Pilot 1a||0
6723944|NCT03083847|7653676|FG002|COMPLETED|Pilot 1a||0
6723945|NCT03083847|7653677|FG003|COMPLETED|Pilot 1a||0
6723946|NCT03083847|7653678|FG004|COMPLETED|Pilot 1a||0
6723947|NCT03083847|7653679|FG005|COMPLETED|Pilot 1a||0
6723948|NCT03083847|7653680|FG006|COMPLETED|Pilot 1a||0
6723949|NCT03083847|7653681|FG007|COMPLETED|Pilot 1a||0
6723950|NCT03083847|7653682|FG008|COMPLETED|Pilot 1a||0
6723951|NCT03083847|7653683|FG009|COMPLETED|Pilot 1a||0
6723952|NCT03083847|7653674|FG000|NOT COMPLETED|Pilot 1a||0
6723953|NCT03083847|7653675|FG001|NOT COMPLETED|Pilot 1a||0
6723954|NCT03083847|7653676|FG002|NOT COMPLETED|Pilot 1a||0
6723955|NCT03083847|7653677|FG003|NOT COMPLETED|Pilot 1a||0
6723956|NCT03083847|7653678|FG004|NOT COMPLETED|Pilot 1a||0
6723957|NCT03083847|7653679|FG005|NOT COMPLETED|Pilot 1a||0
6723958|NCT03083847|7653680|FG006|NOT COMPLETED|Pilot 1a||0
6723959|NCT03083847|7653681|FG007|NOT COMPLETED|Pilot 1a||0
6723960|NCT03083847|7653682|FG008|NOT COMPLETED|Pilot 1a||0
6723961|NCT03083847|7653683|FG009|NOT COMPLETED|Pilot 1a||0
6723962|NCT03083847|7653674|FG000|STARTED|Pilot Ib & 5a||0
6723963|NCT03083847|7653675|FG001|STARTED|Pilot Ib & 5a||2
6723964|NCT03083847|7653676|FG002|STARTED|Pilot Ib & 5a||2
6723965|NCT03083847|7653677|FG003|STARTED|Pilot Ib & 5a||0
6723966|NCT03083847|7653678|FG004|STARTED|Pilot Ib & 5a||0
6723967|NCT03083847|7653679|FG005|STARTED|Pilot Ib & 5a||0
6723968|NCT03083847|7653680|FG006|STARTED|Pilot Ib & 5a||0
6723969|NCT03083847|7653681|FG007|STARTED|Pilot Ib & 5a||0
6723970|NCT03083847|7653682|FG008|STARTED|Pilot Ib & 5a||0
6723971|NCT03083847|7653683|FG009|STARTED|Pilot Ib & 5a||0
6723972|NCT03083847|7653674|FG000|COMPLETED|Pilot Ib & 5a||0
6723973|NCT03083847|7653675|FG001|COMPLETED|Pilot Ib & 5a||2
6723974|NCT03083847|7653676|FG002|COMPLETED|Pilot Ib & 5a||2
6723975|NCT03083847|7653677|FG003|COMPLETED|Pilot Ib & 5a||0
6723976|NCT03083847|7653678|FG004|COMPLETED|Pilot Ib & 5a||0
6723977|NCT03083847|7653679|FG005|COMPLETED|Pilot Ib & 5a||0
6723978|NCT03083847|7653680|FG006|COMPLETED|Pilot Ib & 5a||0
6723979|NCT03083847|7653681|FG007|COMPLETED|Pilot Ib & 5a||0
6723980|NCT03083847|7653682|FG008|COMPLETED|Pilot Ib & 5a||0
6723981|NCT03083847|7653683|FG009|COMPLETED|Pilot Ib & 5a||0
6723982|NCT03083847|7653674|FG000|NOT COMPLETED|Pilot Ib & 5a||0
6723983|NCT03083847|7653675|FG001|NOT COMPLETED|Pilot Ib & 5a||0
6723984|NCT03083847|7653676|FG002|NOT COMPLETED|Pilot Ib & 5a||0
6723985|NCT03083847|7653677|FG003|NOT COMPLETED|Pilot Ib & 5a||0
6723986|NCT03083847|7653678|FG004|NOT COMPLETED|Pilot Ib & 5a||0
6723987|NCT03083847|7653679|FG005|NOT COMPLETED|Pilot Ib & 5a||0
6723988|NCT03083847|7653680|FG006|NOT COMPLETED|Pilot Ib & 5a||0
6723989|NCT03083847|7653681|FG007|NOT COMPLETED|Pilot Ib & 5a||0
6723990|NCT03083847|7653682|FG008|NOT COMPLETED|Pilot Ib & 5a||0
6723991|NCT03083847|7653683|FG009|NOT COMPLETED|Pilot Ib & 5a||0
6723992|NCT03083847|7653674|FG000|STARTED|Pilot 1d & 5b||0
6723993|NCT03083847|7653675|FG001|STARTED|Pilot 1d & 5b||0
6723994|NCT03083847|7653676|FG002|STARTED|Pilot 1d & 5b||0
6723995|NCT03083847|7653677|FG003|STARTED|Pilot 1d & 5b||4
6723996|NCT03083847|7653678|FG004|STARTED|Pilot 1d & 5b||4
6723997|NCT03083847|7653679|FG005|STARTED|Pilot 1d & 5b||0
6723998|NCT03083847|7653680|FG006|STARTED|Pilot 1d & 5b||0
6723999|NCT03083847|7653681|FG007|STARTED|Pilot 1d & 5b||0
6724000|NCT03083847|7653682|FG008|STARTED|Pilot 1d & 5b||0
6724001|NCT03083847|7653683|FG009|STARTED|Pilot 1d & 5b||0
6724002|NCT03083847|7653674|FG000|COMPLETED|Pilot 1d & 5b||0
6724003|NCT03083847|7653675|FG001|COMPLETED|Pilot 1d & 5b||0
6724004|NCT03083847|7653676|FG002|COMPLETED|Pilot 1d & 5b||0
6724005|NCT03083847|7653677|FG003|COMPLETED|Pilot 1d & 5b||4
6724006|NCT03083847|7653678|FG004|COMPLETED|Pilot 1d & 5b||4
6724007|NCT03083847|7653679|FG005|COMPLETED|Pilot 1d & 5b||0
6724008|NCT03083847|7653680|FG006|COMPLETED|Pilot 1d & 5b||0
6724009|NCT03083847|7653681|FG007|COMPLETED|Pilot 1d & 5b||0
6724010|NCT03083847|7653682|FG008|COMPLETED|Pilot 1d & 5b||0
6724011|NCT03083847|7653683|FG009|COMPLETED|Pilot 1d & 5b||0
6724012|NCT03083847|7653674|FG000|NOT COMPLETED|Pilot 1d & 5b||0
6724013|NCT03083847|7653675|FG001|NOT COMPLETED|Pilot 1d & 5b||0
6724014|NCT03083847|7653676|FG002|NOT COMPLETED|Pilot 1d & 5b||0
6724015|NCT03083847|7653677|FG003|NOT COMPLETED|Pilot 1d & 5b||0
6724016|NCT03083847|7653678|FG004|NOT COMPLETED|Pilot 1d & 5b||0
6724017|NCT03083847|7653679|FG005|NOT COMPLETED|Pilot 1d & 5b||0
6724018|NCT03083847|7653680|FG006|NOT COMPLETED|Pilot 1d & 5b||0
6724019|NCT03083847|7653681|FG007|NOT COMPLETED|Pilot 1d & 5b||0
6724020|NCT03083847|7653682|FG008|NOT COMPLETED|Pilot 1d & 5b||0
6724021|NCT03083847|7653683|FG009|NOT COMPLETED|Pilot 1d & 5b||0
6724022|NCT03083847|7653674|FG000|STARTED|Main||0
6724023|NCT03083847|7653675|FG001|STARTED|Main||0
6724024|NCT03083847|7653676|FG002|STARTED|Main||0
6724025|NCT03083847|7653677|FG003|STARTED|Main||0
6724026|NCT03083847|7653678|FG004|STARTED|Main||0
6724027|NCT03083847|7653679|FG005|STARTED|Main||9
6724028|NCT03083847|7653680|FG006|STARTED|Main||10
6724029|NCT03083847|7653681|FG007|STARTED|Main||10
6724030|NCT03083847|7653682|FG008|STARTED|Main||4
6724031|NCT03083847|7653683|FG009|STARTED|Main||8
6724032|NCT03083847|7653674|FG000|COMPLETED|Main||0
6724033|NCT03083847|7653675|FG001|COMPLETED|Main||0
6724034|NCT03083847|7653676|FG002|COMPLETED|Main||0
6724035|NCT03083847|7653677|FG003|COMPLETED|Main||0
6724036|NCT03083847|7653678|FG004|COMPLETED|Main||0
6724037|NCT03083847|7653679|FG005|COMPLETED|Main||8
6724038|NCT03083847|7653680|FG006|COMPLETED|Main||9
6724039|NCT03083847|7653681|FG007|COMPLETED|Main||6
6724040|NCT03083847|7653682|FG008|COMPLETED|Main||4
6724041|NCT03083847|7653683|FG009|COMPLETED|Main||8
6724042|NCT03083847|7653674|FG000|NOT COMPLETED|Main||0
6724043|NCT03083847|7653675|FG001|NOT COMPLETED|Main||0
6724044|NCT03083847|7653676|FG002|NOT COMPLETED|Main||0
6724045|NCT03083847|7653677|FG003|NOT COMPLETED|Main||0
6724046|NCT03083847|7653678|FG004|NOT COMPLETED|Main||0
6724047|NCT03083847|7653679|FG005|NOT COMPLETED|Main||1
6724048|NCT03083847|7653680|FG006|NOT COMPLETED|Main||1
6724049|NCT03083847|7653681|FG007|NOT COMPLETED|Main||4
6724050|NCT03083847|7653682|FG008|NOT COMPLETED|Main||0
6724051|NCT03083847|7653683|FG009|NOT COMPLETED|Main||0
6724052|NCT03083990|7653713|FG000|STARTED|Overall Study||50
6724053|NCT03083990|7653714|FG001|STARTED|Overall Study||50
6724054|NCT03083990|7653713|FG000|COMPLETED|Overall Study||49
6724055|NCT03083990|7653714|FG001|COMPLETED|Overall Study||50
6724056|NCT03083990|7653713|FG000|NOT COMPLETED|Overall Study||1
6724057|NCT03083990|7653714|FG001|NOT COMPLETED|Overall Study||0
6724058|NCT03084302|7653720|FG000|STARTED|Overall Study||120
6724059|NCT03084302|7653720|FG000|COMPLETED|Overall Study||105
6724060|NCT03084302|7653720|FG000|NOT COMPLETED|Overall Study||15
6724061|NCT03084315|7653727|FG000|STARTED|Overall Study||116
6724062|NCT03084315|7653728|FG001|STARTED|Overall Study||118
6724063|NCT03084315|7653727|FG000|COMPLETED|Overall Study||106
6724064|NCT03084315|7653728|FG001|COMPLETED|Overall Study||109
6724065|NCT03084315|7653727|FG000|NOT COMPLETED|Overall Study||10
6724066|NCT03084315|7653728|FG001|NOT COMPLETED|Overall Study||9
6724067|NCT03084796|7653740|FG000|STARTED|Overall Study||121
6724068|NCT03084796|7653741|FG001|STARTED|Overall Study||123
6724069|NCT03084796|7653742|FG002|STARTED|Overall Study||122
6724070|NCT03084796|7653743|FG003|STARTED|Overall Study||123
6724071|NCT03084796|7653744|FG004|STARTED|Overall Study||121
6724072|NCT03084796|7653745|FG005|STARTED|Overall Study||123
6724073|NCT03084796|7653740|FG000|COMPLETED|Overall Study||114
6724074|NCT03084796|7653741|FG001|COMPLETED|Overall Study||113
6724075|NCT03084796|7653742|FG002|COMPLETED|Overall Study||110
6724076|NCT03084796|7653743|FG003|COMPLETED|Overall Study||119
6724077|NCT03084796|7653744|FG004|COMPLETED|Overall Study||110
6724078|NCT03084796|7653745|FG005|COMPLETED|Overall Study||116
6724079|NCT03084796|7653740|FG000|NOT COMPLETED|Overall Study||7
6724080|NCT03084796|7653741|FG001|NOT COMPLETED|Overall Study||10
6724081|NCT03084796|7653742|FG002|NOT COMPLETED|Overall Study||12
6724082|NCT03084796|7653743|FG003|NOT COMPLETED|Overall Study||4
6724083|NCT03084796|7653744|FG004|NOT COMPLETED|Overall Study||11
6724084|NCT03084796|7653745|FG005|NOT COMPLETED|Overall Study||7
6724085|NCT03085017|7653761|FG000|STARTED|Overall Study||30
6724086|NCT03085017|7653762|FG001|STARTED|Overall Study||27
6724087|NCT03085017|7653761|FG000|COMPLETED|Overall Study||30
6724088|NCT03085017|7653762|FG001|COMPLETED|Overall Study||24
6724089|NCT03085017|7653761|FG000|NOT COMPLETED|Overall Study||0
6724090|NCT03085017|7653762|FG001|NOT COMPLETED|Overall Study||3
6724091|NCT03085238|7653768|FG000|STARTED|Overall Study||23
6724092|NCT03085238|7653768|FG000|1 Month|Overall Study||23
6724093|NCT03085238|7653768|FG000|3 Months|Overall Study||22
6724094|NCT03085238|7653768|FG000|6 Months|Overall Study||19
6724095|NCT03085238|7653768|FG000|9 Months|Overall Study||16
6724096|NCT03085238|7653768|FG000|12 Months|Overall Study||14
6724097|NCT03085238|7653768|FG000|15 Months|Overall Study||11
6724098|NCT03085238|7653768|FG000|18 Months|Overall Study||7
6724099|NCT03085238|7653768|FG000|COMPLETED|Overall Study||19
6724100|NCT03085238|7653768|FG000|NOT COMPLETED|Overall Study||4
6724101|NCT03085758|7653784|FG000|STARTED|Overall Study||72
6724102|NCT03085758|7653785|FG001|STARTED|Overall Study||77
6724103|NCT03085758|7653786|FG002|STARTED|Overall Study||152
6724104|NCT03085758|7653784|FG000|COMPLETED|Overall Study||43
6724105|NCT03085758|7653785|FG001|COMPLETED|Overall Study||49
6724106|NCT03085758|7653786|FG002|COMPLETED|Overall Study||96
6265061|NCT00006604|7164095|FG004|STARTED|Overall Study||5
6265062|NCT00006604|7164096|FG005|STARTED|Overall Study||5
6265063|NCT00006604|7164097|FG006|STARTED|Overall Study||21
6265064|NCT00006604|7164098|FG007|STARTED|Overall Study||5
6265065|NCT00006604|7164099|FG008|STARTED|Overall Study||5
6265066|NCT00006604|7164100|FG009|STARTED|Overall Study||25
6265067|NCT00006604|7164101|FG010|STARTED|Overall Study||21
6265068|NCT00006604|7164102|FG011|STARTED|Overall Study||12
6265069|NCT00006604|7164103|FG012|STARTED|Overall Study||26
6265070|NCT00006604|7164104|FG013|STARTED|Overall Study||6
6265071|NCT00006604|7164105|FG014|STARTED|Overall Study||24
6265072|NCT00006604|7164106|FG015|STARTED|Overall Study||6
6265073|NCT00006604|7164107|FG016|STARTED|Overall Study||15
6265074|NCT00006604|7164091|FG000|COMPLETED|Overall Study||4
6265075|NCT00006604|7164092|FG001|COMPLETED|Overall Study||2
6265076|NCT00006604|7164093|FG002|COMPLETED|Overall Study||1
6265077|NCT00006604|7164094|FG003|COMPLETED|Overall Study||1
6265078|NCT00006604|7164095|FG004|COMPLETED|Overall Study||3
6265079|NCT00006604|7164096|FG005|COMPLETED|Overall Study||2
6265080|NCT00006604|7164097|FG006|COMPLETED|Overall Study||12
6265081|NCT00006604|7164098|FG007|COMPLETED|Overall Study||2
6265082|NCT00006604|7164099|FG008|COMPLETED|Overall Study||4
6265083|NCT00006604|7164100|FG009|COMPLETED|Overall Study||6
6265084|NCT00006604|7164101|FG010|COMPLETED|Overall Study||13
6265085|NCT00006604|7164102|FG011|COMPLETED|Overall Study||6
6265086|NCT00006604|7164103|FG012|COMPLETED|Overall Study||22
6265087|NCT00006604|7164104|FG013|COMPLETED|Overall Study||0
6724107|NCT03085758|7653784|FG000|NOT COMPLETED|Overall Study||29
6724108|NCT03085758|7653785|FG001|NOT COMPLETED|Overall Study||28
6724109|NCT03085758|7653786|FG002|NOT COMPLETED|Overall Study||56
6265088|NCT00006604|7164105|FG014|COMPLETED|Overall Study||14
6265089|NCT00006604|7164106|FG015|COMPLETED|Overall Study||1
6265090|NCT00006604|7164107|FG016|COMPLETED|Overall Study||6
6265091|NCT00006604|7164091|FG000|NOT COMPLETED|Overall Study||2
6265092|NCT00006604|7164092|FG001|NOT COMPLETED|Overall Study||0
6724110|NCT03085797|7653800|FG000|STARTED|Treatment Period (TP) (52 Weeks)||201
6724111|NCT03085797|7653801|FG001|STARTED|Treatment Period (TP) (52 Weeks)||206
6724112|NCT03085797|7653800|FG000|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||167
6724113|NCT03085797|7653801|FG001|Completed Investigational Product (IP)|Treatment Period (TP) (52 Weeks)||183
6724114|NCT03085797|7653800|FG000|Not Completed IP|Treatment Period (TP) (52 Weeks)||34
6724115|NCT03085797|7653801|FG001|Not Completed IP|Treatment Period (TP) (52 Weeks)||23
6724116|NCT03085797|7653800|FG000|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
6724117|NCT03085797|7653801|FG001|Withdrew IP Due to: Adverse Event|Treatment Period (TP) (52 Weeks)||4
6724118|NCT03085797|7653800|FG000|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||11
6724119|NCT03085797|7653801|FG001|Withdrew IP Due to: Lack of Efficacy|Treatment Period (TP) (52 Weeks)||5
6724120|NCT03085797|7653800|FG000|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||1
6724121|NCT03085797|7653801|FG001|Withdrew IP Due to: Protocol Deviation|Treatment Period (TP) (52 Weeks)||0
6724122|NCT03085797|7653800|FG000|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
6724123|NCT03085797|7653801|FG001|Withdrew IP Due to: Stopping Criteria|Treatment Period (TP) (52 Weeks)||1
6724124|NCT03085797|7653800|FG000|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||2
6724125|NCT03085797|7653801|FG001|Withdrew IP Due to: Physician Decision|Treatment Period (TP) (52 Weeks)||1
6724126|NCT03085797|7653800|FG000|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||15
6724127|NCT03085797|7653801|FG001|Withdrew IP Due to: Withdrawal by Par.|Treatment Period (TP) (52 Weeks)||12
6724128|NCT03085797|7653800|FG000|COMPLETED|Treatment Period (TP) (52 Weeks)||184
6724129|NCT03085797|7653801|FG001|COMPLETED|Treatment Period (TP) (52 Weeks)||189
6724130|NCT03085797|7653800|FG000|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
6724131|NCT03085797|7653801|FG001|NOT COMPLETED|Treatment Period (TP) (52 Weeks)||17
6724132|NCT03085797|7653800|FG000|STARTED|No-treatment Follow-up Period (6 Months)|Only 65 Par. continued in FU to check maintenance of response after stopping treatment per protocol|65
6739646|NCT03292640|7668477|FG000|COMPLETED|Overall Study||214
6739647|NCT03292640|7668478|FG001|COMPLETED|Overall Study||230
6265093|NCT00006604|7164093|FG002|NOT COMPLETED|Overall Study||4
6265094|NCT00006604|7164094|FG003|NOT COMPLETED|Overall Study||5
6265095|NCT00006604|7164095|FG004|NOT COMPLETED|Overall Study||2
6265096|NCT00006604|7164096|FG005|NOT COMPLETED|Overall Study||3
6265097|NCT00006604|7164097|FG006|NOT COMPLETED|Overall Study||9
6265098|NCT00006604|7164098|FG007|NOT COMPLETED|Overall Study||3
6265099|NCT00006604|7164099|FG008|NOT COMPLETED|Overall Study||1
6265100|NCT00006604|7164100|FG009|NOT COMPLETED|Overall Study||19
6265101|NCT00006604|7164101|FG010|NOT COMPLETED|Overall Study||8
6265102|NCT00006604|7164102|FG011|NOT COMPLETED|Overall Study||6
6265103|NCT00006604|7164103|FG012|NOT COMPLETED|Overall Study||4
6265104|NCT00006604|7164104|FG013|NOT COMPLETED|Overall Study||6
6265105|NCT00006604|7164105|FG014|NOT COMPLETED|Overall Study||10
6265106|NCT00006604|7164106|FG015|NOT COMPLETED|Overall Study||5
6265107|NCT00006604|7164107|FG016|NOT COMPLETED|Overall Study||9
6265108|NCT00006721|7164133|FG000|STARTED|Overall Study||17
6265109|NCT00006721|7164134|FG001|STARTED|Overall Study||279
6265110|NCT00006721|7164135|FG002|STARTED|Overall Study||275
6265111|NCT00006721|7164133|FG000|Eligible|Overall Study||15
6265112|NCT00006721|7164134|FG001|Eligible|Overall Study||267
6265113|NCT00006721|7164135|FG002|Eligible|Overall Study||265
6265114|NCT00006721|7164133|FG000|Eligible and Began Protocol Therapy|Overall Study||14
6265115|NCT00006721|7164134|FG001|Eligible and Began Protocol Therapy|Overall Study||267
6265116|NCT00006721|7164135|FG002|Eligible and Began Protocol Therapy|Overall Study||265
6265117|NCT00006721|7164133|FG000|COMPLETED|Overall Study||13
6265118|NCT00006721|7164134|FG001|COMPLETED|Overall Study||254
6265119|NCT00006721|7164135|FG002|COMPLETED|Overall Study||242
6265120|NCT00006721|7164133|FG000|NOT COMPLETED|Overall Study||4
6265121|NCT00006721|7164134|FG001|NOT COMPLETED|Overall Study||25
6265122|NCT00006721|7164135|FG002|NOT COMPLETED|Overall Study||33
6265123|NCT00006903|7164147|FG000|STARTED|Overall Study||10
6265124|NCT00006903|7164148|FG001|STARTED|Overall Study||24
6265125|NCT00006903|7164149|FG002|STARTED|Overall Study||33
6265126|NCT00006903|7164147|FG000|COMPLETED|Overall Study||0
6265127|NCT00006903|7164148|FG001|COMPLETED|Overall Study||20
6265128|NCT00006903|7164149|FG002|COMPLETED|Overall Study||27
6265129|NCT00006903|7164147|FG000|NOT COMPLETED|Overall Study||10
6265130|NCT00006903|7164148|FG001|NOT COMPLETED|Overall Study||4
6265131|NCT00006903|7164149|FG002|NOT COMPLETED|Overall Study||6
6265132|NCT00007020|7164157|FG000|STARTED|Overall Study||85
6265133|NCT00007020|7164157|FG000|COMPLETED|Overall Study||41
6265134|NCT00007020|7164157|FG000|NOT COMPLETED|Overall Study||44
6265135|NCT00007345|7164165|FG000|STARTED|Overall Study||47
6265136|NCT00007345|7164166|FG001|STARTED|Overall Study||84
6265137|NCT00007345|7164165|FG000|COMPLETED|Overall Study||45
6265138|NCT00007345|7164166|FG001|COMPLETED|Overall Study||73
6265139|NCT00007345|7164165|FG000|NOT COMPLETED|Overall Study||2
6265140|NCT00007345|7164166|FG001|NOT COMPLETED|Overall Study||11
6265141|NCT00007475|7164175|FG000|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
6265142|NCT00007475|7164176|FG001|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
6265143|NCT00007475|7164177|FG002|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
6265144|NCT00007475|7164178|FG003|STARTED|Overall Study||0
6265145|NCT00007475|7164175|FG000|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
6265146|NCT00007475|7164176|FG001|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
6280508|NCT00157573|7180491|FG000|STARTED|Overall Study||35
6724133|NCT03085797|7653801|FG001|STARTED|No-treatment Follow-up Period (6 Months)|Only 69 Par. continued in FU to check maintenance of response after stopping treatment per protocol|69
6724134|NCT03085797|7653800|FG000|COMPLETED|No-treatment Follow-up Period (6 Months)||65
6724135|NCT03085797|7653801|FG001|COMPLETED|No-treatment Follow-up Period (6 Months)||68
6724136|NCT03085797|7653800|FG000|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||0
6724137|NCT03085797|7653801|FG001|NOT COMPLETED|No-treatment Follow-up Period (6 Months)||1
6724138|NCT03085836|7653812|FG000|STARTED|Overall Study||12
6724139|NCT03085836|7653813|FG001|STARTED|Overall Study||11
6724140|NCT03085836|7653814|FG002|STARTED|Overall Study||10
6724141|NCT03085836|7653812|FG000|COMPLETED|Overall Study||12
6724142|NCT03085836|7653813|FG001|COMPLETED|Overall Study||11
6724143|NCT03085836|7653814|FG002|COMPLETED|Overall Study||10
6724144|NCT03085836|7653812|FG000|NOT COMPLETED|Overall Study||0
6724145|NCT03085836|7653813|FG001|NOT COMPLETED|Overall Study||0
6724146|NCT03085836|7653814|FG002|NOT COMPLETED|Overall Study||0
6724147|NCT03085914|7653829|FG000|STARTED|Overall Study||9
6724148|NCT03085914|7653830|FG001|STARTED|Overall Study||9
6724149|NCT03085914|7653831|FG002|STARTED|Overall Study||11
6724150|NCT03085914|7653832|FG003|STARTED|Overall Study||9
6724151|NCT03085914|7653833|FG004|STARTED|Overall Study||13
6724152|NCT03085914|7653834|FG005|STARTED|Overall Study||8
6724153|NCT03085914|7653835|FG006|STARTED|Overall Study||11
6724154|NCT03085914|7653829|FG000|COMPLETED|Overall Study||0
6724155|NCT03085914|7653830|FG001|COMPLETED|Overall Study||0
6724156|NCT03085914|7653831|FG002|COMPLETED|Overall Study||0
6724157|NCT03085914|7653832|FG003|COMPLETED|Overall Study||0
6724158|NCT03085914|7653833|FG004|COMPLETED|Overall Study||0
6724159|NCT03085914|7653834|FG005|COMPLETED|Overall Study||0
6724160|NCT03085914|7653835|FG006|COMPLETED|Overall Study||0
6724161|NCT03085914|7653829|FG000|NOT COMPLETED|Overall Study||9
6724162|NCT03085914|7653830|FG001|NOT COMPLETED|Overall Study||9
6724163|NCT03085914|7653831|FG002|NOT COMPLETED|Overall Study||11
6724164|NCT03085914|7653832|FG003|NOT COMPLETED|Overall Study||9
6724165|NCT03085914|7653833|FG004|NOT COMPLETED|Overall Study||13
6724166|NCT03085914|7653834|FG005|NOT COMPLETED|Overall Study||8
6724167|NCT03085914|7653835|FG006|NOT COMPLETED|Overall Study||11
6724168|NCT03085927|7653856|FG000|STARTED|Overall Study||69
6724169|NCT03085927|7653857|FG001|STARTED|Overall Study||67
6724170|NCT03085927|7653856|FG000|Study Sessions|Overall Study|"Off Study reasons:~Child toxicity/side effects (n=1) Dyad withdrew (n=1) Dyad lost to follow-up (n=2)"|65
6724171|NCT03085927|7653857|FG001|Study Sessions|Overall Study|"Off Study reasons:~Dyad withdrew (n=3) Dyad became ineligible (n=1)"|63
6724172|NCT03085927|7653856|FG000|Time 2 Measures|Overall Study||65
6724173|NCT03085927|7653857|FG001|Time 2 Measures|Overall Study|"Off Study reasons:~Dyad withdrew (n=1)"|62
6724174|NCT03085927|7653856|FG000|COMPLETED|Overall Study|"Off Study reasons:~Death of child (n=1) Dyad lost to follow up (n=1)"|63
6724175|NCT03085927|7653857|FG001|COMPLETED|Overall Study|"Off Study reason:~Dyad lost to follow up (n=1)"|61
6724176|NCT03085927|7653856|FG000|NOT COMPLETED|Overall Study||6
6724177|NCT03085927|7653857|FG001|NOT COMPLETED|Overall Study||6
6739648|NCT03292640|7668477|FG000|NOT COMPLETED|Overall Study||61
6739649|NCT03292640|7668478|FG001|NOT COMPLETED|Overall Study||42
6739650|NCT03292653|7668491|FG000|STARTED|Overall Study||11
6739651|NCT03292653|7668492|FG001|STARTED|Overall Study||10
6739652|NCT03292653|7668493|FG002|STARTED|Overall Study||11
6739653|NCT03292653|7668491|FG000|COMPLETED|Overall Study||10
6739654|NCT03292653|7668492|FG001|COMPLETED|Overall Study||10
6739655|NCT03292653|7668493|FG002|COMPLETED|Overall Study||10
6739656|NCT03292653|7668491|FG000|NOT COMPLETED|Overall Study||1
6739657|NCT03292653|7668492|FG001|NOT COMPLETED|Overall Study||0
6739658|NCT03292653|7668493|FG002|NOT COMPLETED|Overall Study||1
6739659|NCT03292692|7668504|FG000|STARTED|Overall Study||302
6739660|NCT03292692|7668505|FG001|STARTED|Overall Study||298
6739661|NCT03292692|7668504|FG000|COMPLETED|Overall Study||264
6739662|NCT03292692|7668505|FG001|COMPLETED|Overall Study||260
6739663|NCT03292692|7668504|FG000|NOT COMPLETED|Overall Study||38
6739664|NCT03292692|7668505|FG001|NOT COMPLETED|Overall Study||38
6265147|NCT00007475|7164177|FG002|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
6265148|NCT00007475|7164178|FG003|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
6265149|NCT00007475|7164175|FG000|Initial Transplant|Overall Study||12
6265150|NCT00007475|7164176|FG001|Initial Transplant|Overall Study||1
6265151|NCT00007475|7164177|FG002|Initial Transplant|Overall Study||2
6265152|NCT00007475|7164178|FG003|Initial Transplant|Overall Study||0
6265153|NCT00007475|7164175|FG000|Post-initial Transplant Proteinuria|Overall Study||12
6265154|NCT00007475|7164176|FG001|Post-initial Transplant Proteinuria|Overall Study||1
6265155|NCT00007475|7164177|FG002|Post-initial Transplant Proteinuria|Overall Study||2
6265156|NCT00007475|7164178|FG003|Post-initial Transplant Proteinuria|Overall Study||0
6265157|NCT00007475|7164175|FG000|Initial Plasma Exchange|Overall Study||12
6265158|NCT00007475|7164176|FG001|Initial Plasma Exchange|Overall Study||1
6739665|NCT03292809|7668513|FG000|STARTED|Overall Study||162
6739666|NCT03292809|7668514|FG001|STARTED|Overall Study||166
6739667|NCT03292809|7668513|FG000|COMPLETED|Overall Study||155
6739668|NCT03292809|7668514|FG001|COMPLETED|Overall Study||163
6739669|NCT03292809|7668513|FG000|NOT COMPLETED|Overall Study||7
6739670|NCT03292809|7668514|FG001|NOT COMPLETED|Overall Study||3
6739671|NCT03292952|7668522|FG000|STARTED|Open-Label Dose Optimization||155
6739672|NCT03292952|7668523|FG001|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
6724178|NCT03086018|7653865|FG000|STARTED|Field Testing||30
6724179|NCT03086018|7653865|FG000|COMPLETED|Field Testing||30
6724180|NCT03086018|7653865|FG000|NOT COMPLETED|Field Testing||0
6724181|NCT03086018|7653865|FG000|STARTED|Final Testing for End of Trial||30
6724182|NCT03086018|7653865|FG000|COMPLETED|Final Testing for End of Trial||28
6724183|NCT03086018|7653865|FG000|NOT COMPLETED|Final Testing for End of Trial||2
6724184|NCT03086057|7653875|FG000|STARTED|Stage 1: PrEP Uptake||55
6724185|NCT03086057|7653876|FG001|STARTED|Stage 1: PrEP Uptake||55
6724186|NCT03086057|7653877|FG002|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
6724187|NCT03086057|7653878|FG003|STARTED|Stage 1: PrEP Uptake|This intervention was not provided until Stage 2|0
6724188|NCT03086057|7653875|FG000|COMPLETED|Stage 1: PrEP Uptake||44
6724189|NCT03086057|7653876|FG001|COMPLETED|Stage 1: PrEP Uptake||45
6724190|NCT03086057|7653877|FG002|COMPLETED|Stage 1: PrEP Uptake||0
6724191|NCT03086057|7653878|FG003|COMPLETED|Stage 1: PrEP Uptake||0
6724192|NCT03086057|7653875|FG000|NOT COMPLETED|Stage 1: PrEP Uptake||11
6724193|NCT03086057|7653876|FG001|NOT COMPLETED|Stage 1: PrEP Uptake||10
6724194|NCT03086057|7653877|FG002|NOT COMPLETED|Stage 1: PrEP Uptake||0
6724195|NCT03086057|7653878|FG003|NOT COMPLETED|Stage 1: PrEP Uptake||0
6724196|NCT03086057|7653875|FG000|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
6724197|NCT03086057|7653876|FG001|STARTED|Stage 2: PrEP Adherence|This was only provided in Stage 1|0
6724198|NCT03086057|7653877|FG002|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|17
6724199|NCT03086057|7653878|FG003|STARTED|Stage 2: PrEP Adherence|Only individuals who completed Stage 1 AND initiated PrEP were randomized in Stage 2.|18
6724200|NCT03086057|7653875|FG000|COMPLETED|Stage 2: PrEP Adherence||0
6724201|NCT03086057|7653876|FG001|COMPLETED|Stage 2: PrEP Adherence||0
6724202|NCT03086057|7653877|FG002|COMPLETED|Stage 2: PrEP Adherence||11
6724203|NCT03086057|7653878|FG003|COMPLETED|Stage 2: PrEP Adherence||16
6724204|NCT03086057|7653875|FG000|NOT COMPLETED|Stage 2: PrEP Adherence||0
6724205|NCT03086057|7653876|FG001|NOT COMPLETED|Stage 2: PrEP Adherence||0
6724206|NCT03086057|7653877|FG002|NOT COMPLETED|Stage 2: PrEP Adherence||6
6724207|NCT03086057|7653878|FG003|NOT COMPLETED|Stage 2: PrEP Adherence||2
6724208|NCT03086135|7653888|FG000|STARTED|Overall Study||51
6724209|NCT03086135|7653888|FG000|COMPLETED|Overall Study||48
6724210|NCT03086135|7653888|FG000|NOT COMPLETED|Overall Study||3
6724211|NCT03086213|7653892|FG000|STARTED|Overall Study||24
6724212|NCT03086213|7653893|FG001|STARTED|Overall Study||24
6724213|NCT03086213|7653892|FG000|COMPLETED|Overall Study||24
6724214|NCT03086213|7653893|FG001|COMPLETED|Overall Study||24
6724215|NCT03086213|7653892|FG000|NOT COMPLETED|Overall Study||0
6724216|NCT03086213|7653893|FG001|NOT COMPLETED|Overall Study||0
6724217|NCT03086265|7653901|FG000|STARTED|Overall Study||10
6724218|NCT03086265|7653902|FG001|STARTED|Overall Study||10
6724219|NCT03086265|7653901|FG000|COMPLETED|Overall Study||10
6724220|NCT03086265|7653902|FG001|COMPLETED|Overall Study||10
6724221|NCT03086265|7653901|FG000|NOT COMPLETED|Overall Study||0
6724222|NCT03086265|7653902|FG001|NOT COMPLETED|Overall Study||0
6724223|NCT03086330|7653910|FG000|STARTED|Overall Study||151
6724224|NCT03086330|7653911|FG001|STARTED|Overall Study||151
6724225|NCT03086330|7653910|FG000|Exposed|Overall Study||150
6265159|NCT00007475|7164177|FG002|Initial Plasma Exchange|Overall Study||2
6265160|NCT00007475|7164178|FG003|Initial Plasma Exchange|Overall Study||0
6265161|NCT00007475|7164175|FG000|Initiate Cyclophosphamide|Overall Study||12
6265162|NCT00007475|7164176|FG001|Initiate Cyclophosphamide|Overall Study||1
6265163|NCT00007475|7164177|FG002|Initiate Cyclophosphamide|Overall Study||2
6265164|NCT00007475|7164178|FG003|Initiate Cyclophosphamide|Overall Study||0
6265165|NCT00007475|7164175|FG000|COMPLETED|Overall Study||8
6265166|NCT00007475|7164176|FG001|COMPLETED|Overall Study||1
6265167|NCT00007475|7164177|FG002|COMPLETED|Overall Study||2
6265168|NCT00007475|7164178|FG003|COMPLETED|Overall Study||0
6265169|NCT00007475|7164175|FG000|NOT COMPLETED|Overall Study||4
6265170|NCT00007475|7164176|FG001|NOT COMPLETED|Overall Study||0
6265171|NCT00007475|7164177|FG002|NOT COMPLETED|Overall Study||0
6265172|NCT00007475|7164178|FG003|NOT COMPLETED|Overall Study||0
6265173|NCT00007644|7164190|FG000|STARTED|Overall Study||364
6265174|NCT00007644|7164191|FG001|STARTED|Overall Study||367
6265175|NCT00007644|7164190|FG000|COMPLETED|Overall Study||364
6265176|NCT00007644|7164191|FG001|COMPLETED|Overall Study||367
6265177|NCT00007644|7164190|FG000|NOT COMPLETED|Overall Study||0
6265178|NCT00007644|7164191|FG001|NOT COMPLETED|Overall Study||0
6265179|NCT00008138|7164197|FG000|STARTED|Neoadjuvant Chemotherapy||58
6265180|NCT00008138|7164197|FG000|Eligible|Neoadjuvant Chemotherapy||58
6265181|NCT00008138|7164197|FG000|COMPLETED|Neoadjuvant Chemotherapy||38
6265182|NCT00008138|7164197|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||20
6265183|NCT00008138|7164197|FG000|STARTED|Interval Debulking||38
6265184|NCT00008138|7164197|FG000|Received Protocol Surgery|Interval Debulking||36
6265185|NCT00008138|7164197|FG000|COMPLETED|Interval Debulking||36
6265186|NCT00008138|7164197|FG000|NOT COMPLETED|Interval Debulking||2
6265187|NCT00008138|7164197|FG000|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
6265188|NCT00008138|7164197|FG000|COMPLETED|Post-Cytoreduction Chemotherapy||18
6265189|NCT00008138|7164197|FG000|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
6265190|NCT00008385|7164204|FG000|STARTED|Overall Study||521
6265191|NCT00008385|7164205|FG001|STARTED|Overall Study||1040
6265192|NCT00008385|7164204|FG000|Treated|Overall Study||477
6265193|NCT00008385|7164205|FG001|Treated|Overall Study||865
6265194|NCT00008385|7164204|FG000|Off Treatment Reasons Reported|Overall Study||398
6265195|NCT00008385|7164205|FG001|Off Treatment Reasons Reported|Overall Study||795
6265196|NCT00008385|7164204|FG000|COMPLETED|Overall Study||134
6265197|NCT00008385|7164205|FG001|COMPLETED|Overall Study||238
6265198|NCT00008385|7164204|FG000|NOT COMPLETED|Overall Study||387
6265199|NCT00008385|7164205|FG001|NOT COMPLETED|Overall Study||802
6265200|NCT00009737|7164213|FG000|STARTED|Overall Study||1004
6265201|NCT00009737|7164214|FG001|STARTED|Overall Study||983
6265202|NCT00009737|7164213|FG000|COMPLETED|Overall Study||834
6265203|NCT00009737|7164214|FG001|COMPLETED|Overall Study||860
6724226|NCT03086330|7653911|FG001|Exposed|Overall Study||151
6724227|NCT03086330|7653910|FG000|COMPLETED|Overall Study||147
6724228|NCT03086330|7653911|FG001|COMPLETED|Overall Study||147
6724229|NCT03086330|7653910|FG000|NOT COMPLETED|Overall Study||4
6724230|NCT03086330|7653911|FG001|NOT COMPLETED|Overall Study||4
6724231|NCT03086343|7653919|FG000|STARTED|Overall Study||309
6724232|NCT03086343|7653920|FG001|STARTED|Overall Study||303
6724233|NCT03086343|7653919|FG000|COMPLETED|Overall Study||277
6724234|NCT03086343|7653920|FG001|COMPLETED|Overall Study||278
6724235|NCT03086343|7653919|FG000|NOT COMPLETED|Overall Study||32
6724236|NCT03086343|7653920|FG001|NOT COMPLETED|Overall Study||25
6724237|NCT03086356|7653926|FG000|STARTED|Overall Study||12
6724238|NCT03086356|7653926|FG000|COMPLETED|Overall Study||12
6724239|NCT03086356|7653926|FG000|NOT COMPLETED|Overall Study||0
6724240|NCT03086408|7653932|FG000|STARTED|Overall Study||10
6724241|NCT03086408|7653933|FG001|STARTED|Overall Study||10
6724242|NCT03086408|7653932|FG000|COMPLETED|Overall Study||10
6724243|NCT03086408|7653933|FG001|COMPLETED|Overall Study||10
6724244|NCT03086408|7653932|FG000|NOT COMPLETED|Overall Study||0
6724245|NCT03086408|7653933|FG001|NOT COMPLETED|Overall Study||0
6724246|NCT03086447|7653941|FG000|STARTED|Overall Study||132
6724247|NCT03086447|7653942|FG001|STARTED|Overall Study||130
6724248|NCT03086447|7653941|FG000|COMPLETED|Overall Study||121
6724249|NCT03086447|7653942|FG001|COMPLETED|Overall Study||110
6724250|NCT03086447|7653941|FG000|NOT COMPLETED|Overall Study||11
6724251|NCT03086447|7653942|FG001|NOT COMPLETED|Overall Study||20
6724252|NCT03086460|7653948|FG000|STARTED|Study Participants||67
6724253|NCT03086460|7653948|FG000|Treatment A|Study Participants||39
6724254|NCT03086460|7653948|FG000|Treatment B|Study Participants||35
6724255|NCT03086460|7653948|FG000|Treatment C|Study Participants||37
6724256|NCT03086460|7653948|FG000|Treatment D|Study Participants||40
6724257|NCT03086460|7653948|FG000|Treatment E|Study Participants||40
6724258|NCT03086460|7653948|FG000|Treatment F|Study Participants||41
6724259|NCT03086460|7653948|FG000|COMPLETED|Study Participants||58
6724260|NCT03086460|7653948|FG000|NOT COMPLETED|Study Participants||9
6724261|NCT03086460|7653948|FG000|STARTED|Treatment A||39
6724262|NCT03086460|7653948|FG000|COMPLETED|Treatment A||35
6724263|NCT03086460|7653948|FG000|NOT COMPLETED|Treatment A||4
6724264|NCT03086460|7653948|FG000|STARTED|Treatment B||35
6724265|NCT03086460|7653948|FG000|COMPLETED|Treatment B||35
6724266|NCT03086460|7653948|FG000|NOT COMPLETED|Treatment B||0
6724267|NCT03086460|7653948|FG000|STARTED|Treatment C||37
6724268|NCT03086460|7653948|FG000|COMPLETED|Treatment C||35
6724269|NCT03086460|7653948|FG000|NOT COMPLETED|Treatment C||2
6724270|NCT03086460|7653948|FG000|STARTED|Treatment D||40
6724271|NCT03086460|7653948|FG000|COMPLETED|Treatment D||40
6724272|NCT03086460|7653948|FG000|NOT COMPLETED|Treatment D||0
6724273|NCT03086460|7653948|FG000|STARTED|Treatment E||40
6724274|NCT03086460|7653948|FG000|COMPLETED|Treatment E||36
6724275|NCT03086460|7653948|FG000|NOT COMPLETED|Treatment E||4
6724276|NCT03086460|7653948|FG000|STARTED|Treatment F||41
6724277|NCT03086460|7653948|FG000|COMPLETED|Treatment F||41
6724278|NCT03086460|7653948|FG000|NOT COMPLETED|Treatment F||0
6724279|NCT03086551|7653965|FG000|STARTED|First Intervention||5
6724280|NCT03086551|7653966|FG001|STARTED|First Intervention||5
6265204|NCT00009737|7164213|FG000|NOT COMPLETED|Overall Study||170
6265205|NCT00009737|7164214|FG001|NOT COMPLETED|Overall Study||123
6265206|NCT00009945|7164222|FG000|STARTED|Overall Study||1662
6265207|NCT00009945|7164223|FG001|STARTED|Overall Study||1661
6265208|NCT00009945|7164222|FG000|COMPLETED|Overall Study||1655
6265209|NCT00009945|7164223|FG001|COMPLETED|Overall Study||1656
6265210|NCT00009945|7164222|FG000|NOT COMPLETED|Overall Study||7
6265211|NCT00009945|7164223|FG001|NOT COMPLETED|Overall Study||5
6265212|NCT00010257|7164231|FG000|STARTED|Overall Study||25
6265213|NCT00010257|7164232|FG001|STARTED|Overall Study||21
6265214|NCT00010257|7164231|FG000|COMPLETED|Overall Study||24
6265215|NCT00010257|7164232|FG001|COMPLETED|Overall Study||21
6265216|NCT00010257|7164231|FG000|NOT COMPLETED|Overall Study||1
6265217|NCT00010257|7164232|FG001|NOT COMPLETED|Overall Study||0
6265218|NCT00010374|7164238|FG000|STARTED|Overall Study||54
6265219|NCT00010374|7164238|FG000|COMPLETED|Overall Study|One compassionate use participant was withheld from analysis per FDA instructions|53
6265220|NCT00010374|7164238|FG000|NOT COMPLETED|Overall Study||1
6265221|NCT00010439|7164243|FG000|STARTED|Overall Study||10
6265222|NCT00010439|7164243|FG000|6 Months|Overall Study||10
6265223|NCT00010439|7164243|FG000|COMPLETED|Overall Study||10
6265224|NCT00010439|7164243|FG000|NOT COMPLETED|Overall Study||0
6265225|NCT00010803|7164249|FG000|STARTED|Overall Study|Randomized|1545
6265226|NCT00010803|7164250|FG001|STARTED|Overall Study|Randomized|1524
6265227|NCT00010803|7164249|FG000|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
6265228|NCT00010803|7164250|FG001|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
6265229|NCT00010803|7164249|FG000|NOT COMPLETED|Overall Study||97
6265230|NCT00010803|7164250|FG001|NOT COMPLETED|Overall Study||98
6265231|NCT00011986|7164261|FG000|STARTED|Overall Study||864
6724281|NCT03086551|7653965|FG000|COMPLETED|First Intervention||4
6724282|NCT03086551|7653966|FG001|COMPLETED|First Intervention||4
6724283|NCT03086551|7653965|FG000|NOT COMPLETED|First Intervention||1
6724284|NCT03086551|7653966|FG001|NOT COMPLETED|First Intervention||1
6265232|NCT00011986|7164262|FG001|STARTED|Overall Study||864
6724285|NCT03086551|7653965|FG000|STARTED|Washout||4
6724286|NCT03086551|7653966|FG001|STARTED|Washout||4
6724287|NCT03086551|7653965|FG000|COMPLETED|Washout||1
6724288|NCT03086551|7653966|FG001|COMPLETED|Washout||1
6724289|NCT03086551|7653965|FG000|NOT COMPLETED|Washout||3
6724290|NCT03086551|7653966|FG001|NOT COMPLETED|Washout||3
6724291|NCT03086551|7653965|FG000|STARTED|Second Intervention||1
6724292|NCT03086551|7653966|FG001|STARTED|Second Intervention||1
6724293|NCT03086551|7653965|FG000|COMPLETED|Second Intervention||1
6724294|NCT03086551|7653966|FG001|COMPLETED|Second Intervention||1
6724295|NCT03086551|7653965|FG000|NOT COMPLETED|Second Intervention||0
6724296|NCT03086551|7653966|FG001|NOT COMPLETED|Second Intervention||0
6724297|NCT03086707|7653974|FG000|STARTED|Overall Study||7
6724298|NCT03086707|7653975|FG001|STARTED|Overall Study||7
6724299|NCT03086707|7653974|FG000|COMPLETED|Overall Study||7
6724300|NCT03086707|7653975|FG001|COMPLETED|Overall Study||7
6724301|NCT03086707|7653974|FG000|NOT COMPLETED|Overall Study||0
6724302|NCT03086707|7653975|FG001|NOT COMPLETED|Overall Study||0
6724303|NCT03087019|7653985|FG000|STARTED|Overall Study||11
6724304|NCT03087019|7653986|FG001|STARTED|Overall Study||10
6724305|NCT03087019|7653985|FG000|COMPLETED|Overall Study||10
6724306|NCT03087019|7653986|FG001|COMPLETED|Overall Study||10
6724307|NCT03087019|7653985|FG000|NOT COMPLETED|Overall Study||1
6724308|NCT03087019|7653986|FG001|NOT COMPLETED|Overall Study||0
6724309|NCT03087513|7653992|FG000|STARTED|First Intervention||40
6724310|NCT03087513|7653992|FG000|COMPLETED|First Intervention||40
6724311|NCT03087513|7653992|FG000|NOT COMPLETED|First Intervention||0
6724312|NCT03087513|7653992|FG000|STARTED|Second Intervention After 3 hr Washout||40
6724313|NCT03087513|7653992|FG000|COMPLETED|Second Intervention After 3 hr Washout||38
6724314|NCT03087513|7653992|FG000|NOT COMPLETED|Second Intervention After 3 hr Washout||2
6724315|NCT03087604|7654007|FG000|STARTED|Overall Study||50
6724316|NCT03087604|7654008|FG001|STARTED|Overall Study||50
6724317|NCT03087604|7654007|FG000|COMPLETED|Overall Study||50
6724318|NCT03087604|7654008|FG001|COMPLETED|Overall Study||50
6724319|NCT03087604|7654007|FG000|NOT COMPLETED|Overall Study||0
6724320|NCT03087604|7654008|FG001|NOT COMPLETED|Overall Study||0
6724321|NCT03087643|7654016|FG000|STARTED|Overall Study||26
6724322|NCT03087643|7654017|FG001|STARTED|Overall Study||25
6724323|NCT03087643|7654016|FG000|COMPLETED|Overall Study||22
6724324|NCT03087643|7654017|FG001|COMPLETED|Overall Study||19
6724325|NCT03087643|7654016|FG000|NOT COMPLETED|Overall Study||4
6724326|NCT03087643|7654017|FG001|NOT COMPLETED|Overall Study||6
6724327|NCT03087786|7654025|FG000|STARTED|Overall Study||50
6724328|NCT03087786|7654026|FG001|STARTED|Overall Study||50
6724329|NCT03087786|7654025|FG000|COMPLETED|Overall Study||48
6724330|NCT03087786|7654026|FG001|COMPLETED|Overall Study||50
6724331|NCT03087786|7654025|FG000|NOT COMPLETED|Overall Study||2
6724332|NCT03087786|7654026|FG001|NOT COMPLETED|Overall Study||0
6724333|NCT03087851|7654035|FG000|STARTED|Overall Study||20
6724334|NCT03087851|7654036|FG001|STARTED|Overall Study||20
6724335|NCT03087851|7654037|FG002|STARTED|Overall Study||21
6724336|NCT03087851|7654035|FG000|COMPLETED|Overall Study||20
6724337|NCT03087851|7654036|FG001|COMPLETED|Overall Study||19
6724338|NCT03087851|7654037|FG002|COMPLETED|Overall Study||19
6724339|NCT03087851|7654035|FG000|NOT COMPLETED|Overall Study||0
6724340|NCT03087851|7654036|FG001|NOT COMPLETED|Overall Study||1
6724341|NCT03087851|7654037|FG002|NOT COMPLETED|Overall Study||2
6724342|NCT03088267|7654045|FG000|STARTED|Overall Study||9
6724343|NCT03088267|7654046|FG001|STARTED|Overall Study||9
6724344|NCT03088267|7654045|FG000|COMPLETED|Overall Study||9
6724345|NCT03088267|7654046|FG001|COMPLETED|Overall Study||9
6724346|NCT03088267|7654045|FG000|NOT COMPLETED|Overall Study||0
6724347|NCT03088267|7654046|FG001|NOT COMPLETED|Overall Study||0
6724348|NCT03088345|7654055|FG000|STARTED|Overall Study||10
6724349|NCT03088345|7654056|FG001|STARTED|Overall Study||10
6724350|NCT03088345|7654055|FG000|COMPLETED|Overall Study||10
6724351|NCT03088345|7654056|FG001|COMPLETED|Overall Study||10
6724352|NCT03088345|7654055|FG000|NOT COMPLETED|Overall Study||0
6724353|NCT03088345|7654056|FG001|NOT COMPLETED|Overall Study||0
6724354|NCT03088748|7654064|FG000|STARTED|Overall Study||40
6724355|NCT03088748|7654065|FG001|STARTED|Overall Study||10
6724356|NCT03088748|7654064|FG000|COMPLETED|Overall Study||40
6724357|NCT03088748|7654065|FG001|COMPLETED|Overall Study||10
6724358|NCT03088748|7654064|FG000|NOT COMPLETED|Overall Study||0
6724359|NCT03088748|7654065|FG001|NOT COMPLETED|Overall Study||0
6724360|NCT03088800|7654074|FG000|STARTED|Overall Study||30
6724361|NCT03088800|7654075|FG001|STARTED|Overall Study||30
6724362|NCT03088800|7654076|FG002|STARTED|Overall Study||30
6724363|NCT03088800|7654074|FG000|COMPLETED|Overall Study||30
6724364|NCT03088800|7654075|FG001|COMPLETED|Overall Study||30
6724365|NCT03088800|7654076|FG002|COMPLETED|Overall Study||30
6724366|NCT03088800|7654074|FG000|NOT COMPLETED|Overall Study||0
6724367|NCT03088800|7654075|FG001|NOT COMPLETED|Overall Study||0
6724368|NCT03088800|7654076|FG002|NOT COMPLETED|Overall Study||0
6724369|NCT03088917|7654084|FG000|STARTED|Overall Study||106
6724370|NCT03088917|7654084|FG000|COMPLETED|Overall Study||10
6724371|NCT03088917|7654084|FG000|NOT COMPLETED|Overall Study||96
6724372|NCT03089047|7654092|FG000|STARTED|Overall Study||2
6724373|NCT03089047|7654093|FG001|STARTED|Overall Study||2
6724374|NCT03089047|7654092|FG000|COMPLETED|Overall Study||1
6724375|NCT03089047|7654093|FG001|COMPLETED|Overall Study||2
6724376|NCT03089047|7654092|FG000|NOT COMPLETED|Overall Study||1
6724377|NCT03089047|7654093|FG001|NOT COMPLETED|Overall Study||0
6724378|NCT03089216|7654103|FG000|STARTED|Overall Study||27
6724379|NCT03089216|7654104|FG001|STARTED|Overall Study||27
6724380|NCT03089216|7654105|FG002|STARTED|Overall Study||27
6724381|NCT03089216|7654106|FG003|STARTED|Overall Study||27
6724382|NCT03089216|7654103|FG000|COMPLETED|Overall Study||27
6724383|NCT03089216|7654104|FG001|COMPLETED|Overall Study||27
6724384|NCT03089216|7654105|FG002|COMPLETED|Overall Study||27
6724385|NCT03089216|7654106|FG003|COMPLETED|Overall Study||26
6724386|NCT03089216|7654103|FG000|NOT COMPLETED|Overall Study||0
6724387|NCT03089216|7654104|FG001|NOT COMPLETED|Overall Study||0
6724388|NCT03089216|7654105|FG002|NOT COMPLETED|Overall Study||0
6724389|NCT03089216|7654106|FG003|NOT COMPLETED|Overall Study||1
6724390|NCT03089580|7654120|FG000|STARTED|Overall Study||14
6724391|NCT03089580|7654120|FG000|COMPLETED|Overall Study||12
6724392|NCT03089580|7654120|FG000|NOT COMPLETED|Overall Study||2
6724393|NCT03089697|7654128|FG000|STARTED|Overall Study||13
6724394|NCT03089697|7654129|FG001|STARTED|Overall Study||12
6724395|NCT03089697|7654128|FG000|COMPLETED|Overall Study||11
6724396|NCT03089697|7654129|FG001|COMPLETED|Overall Study||10
6724397|NCT03089697|7654128|FG000|NOT COMPLETED|Overall Study||2
6724398|NCT03089697|7654129|FG001|NOT COMPLETED|Overall Study||2
6724399|NCT03089879|7654138|FG000|STARTED|Overall Study||7
6724400|NCT03089879|7654139|FG001|STARTED|Overall Study||2
6724401|NCT03089879|7654140|FG002|STARTED|Overall Study||26
6724402|NCT03089879|7654138|FG000|COMPLETED|Overall Study||7
6724403|NCT03089879|7654139|FG001|COMPLETED|Overall Study||2
6724404|NCT03089879|7654140|FG002|COMPLETED|Overall Study||26
6724405|NCT03089879|7654138|FG000|NOT COMPLETED|Overall Study||0
6724406|NCT03089879|7654139|FG001|NOT COMPLETED|Overall Study||0
6724407|NCT03089879|7654140|FG002|NOT COMPLETED|Overall Study||0
6724408|NCT03089944|7654149|FG000|STARTED|Overall Study||343
6724409|NCT03089944|7654149|FG000|COMPLETED|Overall Study||331
6724410|NCT03089944|7654149|FG000|NOT COMPLETED|Overall Study||12
6724411|NCT03090100|7654155|FG000|STARTED|Overall Study||534
6724412|NCT03090100|7654156|FG001|STARTED|Overall Study||514
6724413|NCT03090100|7654155|FG000|Treated|Overall Study||534
6724414|NCT03090100|7654156|FG001|Treated|Overall Study||511
6724415|NCT03090100|7654155|FG000|COMPLETED|Overall Study||507
6724416|NCT03090100|7654156|FG001|COMPLETED|Overall Study||466
6724417|NCT03090100|7654155|FG000|NOT COMPLETED|Overall Study||27
6724418|NCT03090100|7654156|FG001|NOT COMPLETED|Overall Study||48
6724419|NCT03090256|7654162|FG000|STARTED|Overall Study||68
6724420|NCT03090256|7654162|FG000|COMPLETED|Overall Study||68
6724421|NCT03090256|7654162|FG000|NOT COMPLETED|Overall Study||0
6724422|NCT03090620|7654169|FG000|STARTED|Overall Study||9
6724423|NCT03090620|7654170|FG001|STARTED|Overall Study||10
6724424|NCT03090620|7654169|FG000|COMPLETED|Overall Study||9
6724425|NCT03090620|7654170|FG001|COMPLETED|Overall Study||10
6724426|NCT03090620|7654169|FG000|NOT COMPLETED|Overall Study||0
6724427|NCT03090620|7654170|FG001|NOT COMPLETED|Overall Study||0
6724428|NCT03090958|7654176|FG000|STARTED|Overall Study||20
6724429|NCT03090958|7654176|FG000|COMPLETED|Overall Study||20
6724430|NCT03090958|7654176|FG000|NOT COMPLETED|Overall Study||0
6724431|NCT03091179|7654182|FG000|STARTED|Overall Study||10
6724432|NCT03091179|7654183|FG001|STARTED|Overall Study||10
6724433|NCT03091179|7654182|FG000|COMPLETED|Overall Study||10
6724434|NCT03091179|7654183|FG001|COMPLETED|Overall Study||10
6724435|NCT03091179|7654182|FG000|NOT COMPLETED|Overall Study||0
6724436|NCT03091179|7654183|FG001|NOT COMPLETED|Overall Study||0
6724437|NCT03091348|7654191|FG000|STARTED|Overall Study||2
6724438|NCT03091348|7654192|FG001|STARTED|Overall Study||2
6724439|NCT03091348|7654191|FG000|COMPLETED|Overall Study||0
6724440|NCT03091348|7654192|FG001|COMPLETED|Overall Study||1
6724441|NCT03091348|7654191|FG000|NOT COMPLETED|Overall Study||2
6724442|NCT03091348|7654192|FG001|NOT COMPLETED|Overall Study||1
6724443|NCT03091361|7654199|FG000|STARTED|Overall Study||30
6724444|NCT03091361|7654199|FG000|COMPLETED|Overall Study||30
6724445|NCT03091361|7654199|FG000|NOT COMPLETED|Overall Study||0
6724446|NCT03091400|7654205|FG000|STARTED|Phase 1 - 6 Weeks||5
6724447|NCT03091400|7654206|FG001|STARTED|Phase 1 - 6 Weeks||6
6724448|NCT03091400|7654205|FG000|COMPLETED|Phase 1 - 6 Weeks||5
6724449|NCT03091400|7654206|FG001|COMPLETED|Phase 1 - 6 Weeks||6
6724450|NCT03091400|7654205|FG000|NOT COMPLETED|Phase 1 - 6 Weeks||0
6724451|NCT03091400|7654206|FG001|NOT COMPLETED|Phase 1 - 6 Weeks||0
6724452|NCT03091400|7654205|FG000|STARTED|Washout - 2 Weeks||5
6724453|NCT03091400|7654206|FG001|STARTED|Washout - 2 Weeks||6
6724454|NCT03091400|7654205|FG000|COMPLETED|Washout - 2 Weeks||4
6724455|NCT03091400|7654206|FG001|COMPLETED|Washout - 2 Weeks||6
6724456|NCT03091400|7654205|FG000|NOT COMPLETED|Washout - 2 Weeks||1
6724457|NCT03091400|7654206|FG001|NOT COMPLETED|Washout - 2 Weeks||0
6724458|NCT03091400|7654205|FG000|STARTED|Phase 2 - 6 Weeks||4
6724459|NCT03091400|7654206|FG001|STARTED|Phase 2 - 6 Weeks||6
6724460|NCT03091400|7654205|FG000|COMPLETED|Phase 2 - 6 Weeks||4
6724461|NCT03091400|7654206|FG001|COMPLETED|Phase 2 - 6 Weeks||6
6724462|NCT03091400|7654205|FG000|NOT COMPLETED|Phase 2 - 6 Weeks||0
6724463|NCT03091400|7654206|FG001|NOT COMPLETED|Phase 2 - 6 Weeks||0
6724464|NCT03091439|7654214|FG000|STARTED|Overall Study||1
6724465|NCT03091439|7654215|FG001|STARTED|Overall Study||0
6724466|NCT03091439|7654214|FG000|COMPLETED|Overall Study||0
6724467|NCT03091439|7654215|FG001|COMPLETED|Overall Study||0
6724468|NCT03091439|7654214|FG000|NOT COMPLETED|Overall Study||1
6724469|NCT03091439|7654215|FG001|NOT COMPLETED|Overall Study||0
6724470|NCT03091478|7654221|FG000|STARTED|Overall Study||13
6724471|NCT03091478|7654221|FG000|COMPLETED|Overall Study||13
6724472|NCT03091478|7654221|FG000|NOT COMPLETED|Overall Study||0
6724473|NCT03091673|7654228|FG000|STARTED|First Dose||31
6724474|NCT03091673|7654229|FG001|STARTED|First Dose|All 31 subjects received the 0.5 mg dose during period 1.|0
6724475|NCT03091673|7654228|FG000|COMPLETED|First Dose||31
6724476|NCT03091673|7654229|FG001|COMPLETED|First Dose||0
6724477|NCT03091673|7654228|FG000|NOT COMPLETED|First Dose||0
6724478|NCT03091673|7654229|FG001|NOT COMPLETED|First Dose||0
6724479|NCT03091673|7654228|FG000|STARTED|Second Dose|No subjects received the 0.5 mg dose during period 2.|0
6724480|NCT03091673|7654229|FG001|STARTED|Second Dose|Only the 11 study subjects ages 12-<18 years were assigned the 1 mg dose during period 2.|11
6724481|NCT03091673|7654228|FG000|COMPLETED|Second Dose||0
6724482|NCT03091673|7654229|FG001|COMPLETED|Second Dose||11
6724483|NCT03091673|7654228|FG000|NOT COMPLETED|Second Dose||0
6724484|NCT03091673|7654229|FG001|NOT COMPLETED|Second Dose||0
6724485|NCT03091738|7654240|FG000|STARTED|Overall Study||10
6724486|NCT03091738|7654240|FG000|COMPLETED|Overall Study||8
6724487|NCT03091738|7654240|FG000|NOT COMPLETED|Overall Study||2
6724488|NCT03091751|7654244|FG000|STARTED|Overall Study||22
6724489|NCT03091751|7654244|FG000|COMPLETED|Overall Study||22
6724490|NCT03091751|7654244|FG000|NOT COMPLETED|Overall Study||0
6724491|NCT03091777|7654251|FG000|STARTED|Overall Study||289
6724492|NCT03091777|7654252|FG001|STARTED|Overall Study||288
6724493|NCT03091777|7654253|FG002|STARTED|Overall Study||294
6724494|NCT03091777|7654251|FG000|COMPLETED|Overall Study||257
6724495|NCT03091777|7654252|FG001|COMPLETED|Overall Study||255
6724496|NCT03091777|7654253|FG002|COMPLETED|Overall Study||257
6724497|NCT03091777|7654251|FG000|NOT COMPLETED|Overall Study||32
6724498|NCT03091777|7654252|FG001|NOT COMPLETED|Overall Study||33
6724499|NCT03091777|7654253|FG002|NOT COMPLETED|Overall Study||37
6724500|NCT03091920|7654264|FG000|STARTED|Overall Study||6
6724501|NCT03091920|7654265|FG001|STARTED|Overall Study||10
6724502|NCT03091920|7654266|FG002|STARTED|Overall Study||10
6724503|NCT03091920|7654264|FG000|COMPLETED|Overall Study||6
6724504|NCT03091920|7654265|FG001|COMPLETED|Overall Study||9
6724505|NCT03091920|7654266|FG002|COMPLETED|Overall Study||10
6724506|NCT03091920|7654264|FG000|NOT COMPLETED|Overall Study||0
6724507|NCT03091920|7654265|FG001|NOT COMPLETED|Overall Study||1
6724508|NCT03091920|7654266|FG002|NOT COMPLETED|Overall Study||0
6724509|NCT03092024|7654282|FG000|STARTED|Overall Study||24
6724510|NCT03092024|7654283|FG001|STARTED|Overall Study||16
6724511|NCT03092024|7654282|FG000|COMPLETED|Overall Study||24
6724512|NCT03092024|7654283|FG001|COMPLETED|Overall Study||16
6724513|NCT03092024|7654282|FG000|NOT COMPLETED|Overall Study||0
6724514|NCT03092024|7654283|FG001|NOT COMPLETED|Overall Study||0
6724515|NCT03092089|7654289|FG000|STARTED|Overall Study||15
6724516|NCT03092089|7654289|FG000|COMPLETED|Overall Study||15
6724517|NCT03092089|7654289|FG000|NOT COMPLETED|Overall Study||0
6724518|NCT03092375|7654297|FG000|STARTED|Overall Study||78
6724519|NCT03092375|7654298|FG001|STARTED|Overall Study||49
6724520|NCT03092375|7654299|FG002|STARTED|Overall Study||21
6724521|NCT03092375|7654300|FG003|STARTED|Overall Study||29
6724522|NCT03092375|7654297|FG000|COMPLETED|Overall Study||78
6724523|NCT03092375|7654298|FG001|COMPLETED|Overall Study||48
6724524|NCT03092375|7654299|FG002|COMPLETED|Overall Study||20
6724525|NCT03092375|7654300|FG003|COMPLETED|Overall Study||29
6724526|NCT03092375|7654297|FG000|NOT COMPLETED|Overall Study||0
6724527|NCT03092375|7654298|FG001|NOT COMPLETED|Overall Study||1
6724528|NCT03092375|7654299|FG002|NOT COMPLETED|Overall Study||1
6724529|NCT03092375|7654300|FG003|NOT COMPLETED|Overall Study||0
6724530|NCT03092479|7654319|FG000|STARTED|Overall Study||24
6724531|NCT03092479|7654320|FG001|STARTED|Overall Study||26
6724532|NCT03092479|7654319|FG000|COMPLETED|Overall Study||17
6724533|NCT03092479|7654320|FG001|COMPLETED|Overall Study||24
6724534|NCT03092479|7654319|FG000|NOT COMPLETED|Overall Study||7
6724535|NCT03092479|7654320|FG001|NOT COMPLETED|Overall Study||2
6724536|NCT03092726|7654328|FG000|STARTED|Overall Study||88
6724537|NCT03092726|7654329|FG001|STARTED|Overall Study||95
6724538|NCT03092726|7654328|FG000|Treated|Overall Study||88
6724539|NCT03092726|7654329|FG001|Treated|Overall Study||95
6724540|NCT03092726|7654328|FG000|COMPLETED|Overall Study||79
6724541|NCT03092726|7654329|FG001|COMPLETED|Overall Study||81
6724542|NCT03092726|7654328|FG000|NOT COMPLETED|Overall Study||9
6724543|NCT03092726|7654329|FG001|NOT COMPLETED|Overall Study||14
6724544|NCT03092752|7654335|FG000|STARTED|Overall Study||523585
6724545|NCT03092752|7654335|FG000|COMPLETED|Overall Study||162116
6724546|NCT03092752|7654335|FG000|NOT COMPLETED|Overall Study||361469
6724547|NCT03092791|7654364|FG000|STARTED|Overall Study||20
6724548|NCT03092791|7654365|FG001|STARTED|Overall Study||20
6724549|NCT03092791|7654366|FG002|STARTED|Overall Study||30
6724550|NCT03092791|7654367|FG003|STARTED|Overall Study||30
6724551|NCT03092791|7654368|FG004|STARTED|Overall Study||60
6724552|NCT03092791|7654369|FG005|STARTED|Overall Study||60
6724553|NCT03092791|7654370|FG006|STARTED|Overall Study||60
6724554|NCT03092791|7654371|FG007|STARTED|Overall Study||60
6724555|NCT03092791|7654364|FG000|COMPLETED|Overall Study||20
6724556|NCT03092791|7654365|FG001|COMPLETED|Overall Study||20
6724557|NCT03092791|7654366|FG002|COMPLETED|Overall Study||30
6724558|NCT03092791|7654367|FG003|COMPLETED|Overall Study||30
6724559|NCT03092791|7654368|FG004|COMPLETED|Overall Study||0
6724560|NCT03092791|7654369|FG005|COMPLETED|Overall Study||0
6724561|NCT03092791|7654370|FG006|COMPLETED|Overall Study||0
6724562|NCT03092791|7654371|FG007|COMPLETED|Overall Study||0
6724563|NCT03092791|7654364|FG000|NOT COMPLETED|Overall Study||0
6724564|NCT03092791|7654365|FG001|NOT COMPLETED|Overall Study||0
6724565|NCT03092791|7654366|FG002|NOT COMPLETED|Overall Study||0
6724566|NCT03092791|7654367|FG003|NOT COMPLETED|Overall Study||0
6724567|NCT03092791|7654368|FG004|NOT COMPLETED|Overall Study||60
6724568|NCT03092791|7654369|FG005|NOT COMPLETED|Overall Study||60
6724569|NCT03092791|7654370|FG006|NOT COMPLETED|Overall Study||60
6724570|NCT03092791|7654371|FG007|NOT COMPLETED|Overall Study||60
6724571|NCT03092934|7654393|FG000|STARTED|Overall Study||8
6724572|NCT03092934|7654394|FG001|STARTED|Overall Study||2
6724573|NCT03092934|7654395|FG002|STARTED|Overall Study||2
6724574|NCT03092934|7654396|FG003|STARTED|Overall Study||1
6724575|NCT03092934|7654393|FG000|Received at Least One Dose of Study Drug|Overall Study||8
6724576|NCT03092934|7654394|FG001|Received at Least One Dose of Study Drug|Overall Study||2
6724577|NCT03092934|7654395|FG002|Received at Least One Dose of Study Drug|Overall Study||2
6724578|NCT03092934|7654396|FG003|Received at Least One Dose of Study Drug|Overall Study||1
6724579|NCT03092934|7654393|FG000|COMPLETED|Overall Study||8
6724580|NCT03092934|7654394|FG001|COMPLETED|Overall Study||2
6724581|NCT03092934|7654395|FG002|COMPLETED|Overall Study||2
6724582|NCT03092934|7654396|FG003|COMPLETED|Overall Study||1
6724583|NCT03092934|7654393|FG000|NOT COMPLETED|Overall Study||0
6724584|NCT03092934|7654394|FG001|NOT COMPLETED|Overall Study||0
6724585|NCT03092934|7654395|FG002|NOT COMPLETED|Overall Study||0
6724586|NCT03092934|7654396|FG003|NOT COMPLETED|Overall Study||0
6724587|NCT03092960|7654408|FG000|STARTED|Overall Study||212
6724588|NCT03092960|7654409|FG001|STARTED|Overall Study||212
6724589|NCT03092960|7654408|FG000|COMPLETED|Overall Study||180
6724590|NCT03092960|7654409|FG001|COMPLETED|Overall Study||186
6724591|NCT03092960|7654408|FG000|NOT COMPLETED|Overall Study||32
6724592|NCT03092960|7654409|FG001|NOT COMPLETED|Overall Study||26
6724593|NCT03093025|7654418|FG000|STARTED|Overall Study||16
6724594|NCT03093025|7654419|FG001|STARTED|Overall Study|One participant did not take any dose of investigational product after randomization.|17
6724595|NCT03093025|7654420|FG002|STARTED|Overall Study||18
6724596|NCT03093025|7654418|FG000|COMPLETED|Overall Study||12
6724597|NCT03093025|7654419|FG001|COMPLETED|Overall Study||15
6724598|NCT03093025|7654420|FG002|COMPLETED|Overall Study||16
6724599|NCT03093025|7654418|FG000|NOT COMPLETED|Overall Study||4
6724600|NCT03093025|7654419|FG001|NOT COMPLETED|Overall Study||2
6724601|NCT03093025|7654420|FG002|NOT COMPLETED|Overall Study||2
6724602|NCT03093181|7654431|FG000|STARTED|Overall Study||44
6724603|NCT03093181|7654432|FG001|STARTED|Overall Study||44
6724604|NCT03093181|7654433|FG002|STARTED|Overall Study||44
6724605|NCT03093181|7654431|FG000|COMPLETED|Overall Study||41
6724606|NCT03093181|7654432|FG001|COMPLETED|Overall Study||42
6724607|NCT03093181|7654433|FG002|COMPLETED|Overall Study||41
6724608|NCT03093181|7654431|FG000|NOT COMPLETED|Overall Study||3
6724609|NCT03093181|7654432|FG001|NOT COMPLETED|Overall Study||2
6724610|NCT03093181|7654433|FG002|NOT COMPLETED|Overall Study||3
6724611|NCT03093207|7654443|FG000|STARTED|Overall Study||17
6724612|NCT03093207|7654444|FG001|STARTED|Overall Study||17
6724613|NCT03093207|7654443|FG000|COMPLETED|Overall Study||17
6724614|NCT03093207|7654444|FG001|COMPLETED|Overall Study||17
6724615|NCT03093207|7654443|FG000|NOT COMPLETED|Overall Study||0
6724616|NCT03093207|7654444|FG001|NOT COMPLETED|Overall Study||0
6724617|NCT03093272|7654450|FG000|STARTED|Overall Study||9
6724618|NCT03093272|7654450|FG000|COMPLETED|Overall Study||9
6724619|NCT03093272|7654450|FG000|NOT COMPLETED|Overall Study||0
6724620|NCT03093324|7654456|FG000|STARTED|Overall Study||254
6724621|NCT03093324|7654457|FG001|STARTED|Overall Study||252
6724622|NCT03093324|7654456|FG000|Safety Population|Overall Study||253
6724623|NCT03093324|7654457|FG001|Safety Population|Overall Study||251
6724624|NCT03093324|7654456|FG000|COMPLETED|Overall Study||245
6724625|NCT03093324|7654457|FG001|COMPLETED|Overall Study||233
6724626|NCT03093324|7654456|FG000|NOT COMPLETED|Overall Study||9
6724627|NCT03093324|7654457|FG001|NOT COMPLETED|Overall Study||19
6724628|NCT03093350|7654463|FG000|STARTED|Overall Study||12
6724629|NCT03093350|7654463|FG000|Started Treatment|Overall Study||10
6724630|NCT03093350|7654463|FG000|COMPLETED|Overall Study||10
6724631|NCT03093350|7654463|FG000|NOT COMPLETED|Overall Study||2
6724632|NCT03093415|7654470|FG000|STARTED|Assessed for Eligibility --> Enrollment||165
6724633|NCT03093415|7654471|FG001|STARTED|Assessed for Eligibility --> Enrollment||135
6724634|NCT03093415|7654472|FG002|STARTED|Assessed for Eligibility --> Enrollment||50
6724635|NCT03093415|7654470|FG000|COMPLETED|Assessed for Eligibility --> Enrollment||25
6724636|NCT03093415|7654471|FG001|COMPLETED|Assessed for Eligibility --> Enrollment||25
6724637|NCT03093415|7654472|FG002|COMPLETED|Assessed for Eligibility --> Enrollment||50
6724638|NCT03093415|7654470|FG000|NOT COMPLETED|Assessed for Eligibility --> Enrollment||140
6724639|NCT03093415|7654471|FG001|NOT COMPLETED|Assessed for Eligibility --> Enrollment||110
6724640|NCT03093415|7654472|FG002|NOT COMPLETED|Assessed for Eligibility --> Enrollment||0
6724641|NCT03093415|7654470|FG000|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
6724642|NCT03093415|7654471|FG001|STARTED|Enrollment to SVR12 Results|Pre-specified 25 participants to were enrolled.|25
6724643|NCT03093415|7654472|FG002|STARTED|Enrollment to SVR12 Results|Prespecified 50 participants enrolled.|50
6724644|NCT03093415|7654470|FG000|COMPLETED|Enrollment to SVR12 Results||24
6265233|NCT00011986|7164263|FG002|STARTED|Overall Study||862
6724645|NCT03093415|7654471|FG001|COMPLETED|Enrollment to SVR12 Results||17
6724646|NCT03093415|7654472|FG002|COMPLETED|Enrollment to SVR12 Results||47
6724647|NCT03093415|7654470|FG000|NOT COMPLETED|Enrollment to SVR12 Results||1
6724648|NCT03093415|7654471|FG001|NOT COMPLETED|Enrollment to SVR12 Results||8
6724649|NCT03093415|7654472|FG002|NOT COMPLETED|Enrollment to SVR12 Results||3
6724650|NCT03093454|7654482|FG000|STARTED|Overall Study||28
6724651|NCT03093454|7654483|FG001|STARTED|Overall Study||30
6724652|NCT03093454|7654482|FG000|COMPLETED|Overall Study||22
6724653|NCT03093454|7654483|FG001|COMPLETED|Overall Study||27
6724654|NCT03093454|7654482|FG000|NOT COMPLETED|Overall Study||6
6724655|NCT03093454|7654483|FG001|NOT COMPLETED|Overall Study||3
6724656|NCT03093662|7654491|FG000|STARTED|First Intervention (3 Minutes)||18
6724657|NCT03093662|7654492|FG001|STARTED|First Intervention (3 Minutes)||19
6724658|NCT03093662|7654491|FG000|COMPLETED|First Intervention (3 Minutes)||18
6724659|NCT03093662|7654492|FG001|COMPLETED|First Intervention (3 Minutes)||19
6724660|NCT03093662|7654491|FG000|NOT COMPLETED|First Intervention (3 Minutes)||0
6724661|NCT03093662|7654492|FG001|NOT COMPLETED|First Intervention (3 Minutes)||0
6724662|NCT03093662|7654491|FG000|STARTED|Washout Period (5 Minutes)||18
6724663|NCT03093662|7654492|FG001|STARTED|Washout Period (5 Minutes)||19
6724664|NCT03093662|7654491|FG000|COMPLETED|Washout Period (5 Minutes)||18
6724665|NCT03093662|7654492|FG001|COMPLETED|Washout Period (5 Minutes)||19
6724666|NCT03093662|7654491|FG000|NOT COMPLETED|Washout Period (5 Minutes)||0
6724667|NCT03093662|7654492|FG001|NOT COMPLETED|Washout Period (5 Minutes)||0
6724668|NCT03093662|7654491|FG000|STARTED|Second Intervention (3 Minutes)||18
6724669|NCT03093662|7654492|FG001|STARTED|Second Intervention (3 Minutes)||19
6724670|NCT03093662|7654491|FG000|COMPLETED|Second Intervention (3 Minutes)||18
6724671|NCT03093662|7654492|FG001|COMPLETED|Second Intervention (3 Minutes)||19
6724672|NCT03093662|7654491|FG000|NOT COMPLETED|Second Intervention (3 Minutes)||0
6724673|NCT03093662|7654492|FG001|NOT COMPLETED|Second Intervention (3 Minutes)||0
6724674|NCT03093870|7654501|FG000|STARTED|Overall Study||24
6724675|NCT03093870|7654502|FG001|STARTED|Overall Study||64
6724676|NCT03093870|7654503|FG002|STARTED|Overall Study||63
6724677|NCT03093870|7654501|FG000|COMPLETED|Overall Study||0
6724678|NCT03093870|7654502|FG001|COMPLETED|Overall Study||23
6724679|NCT03093870|7654503|FG002|COMPLETED|Overall Study||22
6724680|NCT03093870|7654501|FG000|NOT COMPLETED|Overall Study||24
6724681|NCT03093870|7654502|FG001|NOT COMPLETED|Overall Study||41
6724682|NCT03093870|7654503|FG002|NOT COMPLETED|Overall Study||41
6724683|NCT03094195|7654514|FG000|STARTED|Double-Blind Treatment Period (DB)||43
6724684|NCT03094195|7654515|FG001|STARTED|Double-Blind Treatment Period (DB)||43
6724685|NCT03094195|7654516|FG002|STARTED|Double-Blind Treatment Period (DB)||43
6724686|NCT03094195|7654517|FG003|STARTED|Double-Blind Treatment Period (DB)||0
6724687|NCT03094195|7654518|FG004|STARTED|Double-Blind Treatment Period (DB)||0
6724688|NCT03094195|7654519|FG005|STARTED|Double-Blind Treatment Period (DB)||0
6724689|NCT03094195|7654520|FG006|STARTED|Double-Blind Treatment Period (DB)||0
6724690|NCT03094195|7654521|FG007|STARTED|Double-Blind Treatment Period (DB)||0
6724691|NCT03094195|7654514|FG000|COMPLETED|Double-Blind Treatment Period (DB)||28
6724692|NCT03094195|7654515|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
6724693|NCT03094195|7654516|FG002|COMPLETED|Double-Blind Treatment Period (DB)||29
6724694|NCT03094195|7654517|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
6724695|NCT03094195|7654518|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
6724696|NCT03094195|7654519|FG005|COMPLETED|Double-Blind Treatment Period (DB)||0
6724697|NCT03094195|7654520|FG006|COMPLETED|Double-Blind Treatment Period (DB)||0
6724698|NCT03094195|7654521|FG007|COMPLETED|Double-Blind Treatment Period (DB)||0
6724699|NCT03094195|7654514|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||15
6724700|NCT03094195|7654515|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||13
6724701|NCT03094195|7654516|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||14
6724702|NCT03094195|7654517|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6724703|NCT03094195|7654518|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6724704|NCT03094195|7654519|FG005|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6724705|NCT03094195|7654520|FG006|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6724706|NCT03094195|7654521|FG007|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6724707|NCT03094195|7654514|FG000|STARTED|Treatment Withdrawal Period (TW)||0
6724708|NCT03094195|7654515|FG001|STARTED|Treatment Withdrawal Period (TW)||0
6724709|NCT03094195|7654516|FG002|STARTED|Treatment Withdrawal Period (TW)||0
6724710|NCT03094195|7654517|FG003|STARTED|Treatment Withdrawal Period (TW)||13
6724711|NCT03094195|7654518|FG004|STARTED|Treatment Withdrawal Period (TW)||13
6724712|NCT03094195|7654519|FG005|STARTED|Treatment Withdrawal Period (TW)||15
6724713|NCT03094195|7654520|FG006|STARTED|Treatment Withdrawal Period (TW)||13
6724714|NCT03094195|7654521|FG007|STARTED|Treatment Withdrawal Period (TW)||26
6724715|NCT03094195|7654514|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
6724716|NCT03094195|7654515|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
6724717|NCT03094195|7654516|FG002|COMPLETED|Treatment Withdrawal Period (TW)||0
6724718|NCT03094195|7654517|FG003|COMPLETED|Treatment Withdrawal Period (TW)||13
6724719|NCT03094195|7654518|FG004|COMPLETED|Treatment Withdrawal Period (TW)||13
6724720|NCT03094195|7654519|FG005|COMPLETED|Treatment Withdrawal Period (TW)||15
6724721|NCT03094195|7654520|FG006|COMPLETED|Treatment Withdrawal Period (TW)||13
6724722|NCT03094195|7654521|FG007|COMPLETED|Treatment Withdrawal Period (TW)||26
6724723|NCT03094195|7654514|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6724724|NCT03094195|7654515|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6724725|NCT03094195|7654516|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6724726|NCT03094195|7654517|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6724727|NCT03094195|7654518|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6724728|NCT03094195|7654519|FG005|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6724729|NCT03094195|7654520|FG006|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6724730|NCT03094195|7654521|FG007|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6724731|NCT03094325|7654539|FG000|STARTED|Overall Study||10
6724732|NCT03094325|7654539|FG000|TEE Before Cardiopulmonary Bypass|Overall Study||10
6724733|NCT03094325|7654539|FG000|OPIE Before Cardiopulmonary Bypass|Overall Study||10
6724734|NCT03094325|7654539|FG000|TEE After Cardiopulmonary Bypass|Overall Study||10
6724735|NCT03094325|7654539|FG000|OPIE After Cardiopulmonary Bypass|Overall Study||10
6724736|NCT03094325|7654539|FG000|COMPLETED|Overall Study||10
6724737|NCT03094325|7654539|FG000|NOT COMPLETED|Overall Study||0
6724738|NCT03094611|7654545|FG000|STARTED|Overall Study||4
6724739|NCT03094611|7654545|FG000|COMPLETED|Overall Study||2
6724740|NCT03094611|7654545|FG000|NOT COMPLETED|Overall Study||2
6724741|NCT03094637|7654551|FG000|STARTED|Overall Study||17
6724742|NCT03094637|7654552|FG001|STARTED|Overall Study||20
6724743|NCT03094637|7654551|FG000|COMPLETED|Overall Study||17
6724744|NCT03094637|7654552|FG001|COMPLETED|Overall Study||20
6724745|NCT03094637|7654551|FG000|NOT COMPLETED|Overall Study||0
6724746|NCT03094637|7654552|FG001|NOT COMPLETED|Overall Study||0
6724747|NCT03094806|7654561|FG000|STARTED|Overall Study||44
6724748|NCT03094806|7654562|FG001|STARTED|Overall Study||47
6724749|NCT03094806|7654561|FG000|COMPLETED|Overall Study||44
6724750|NCT03094806|7654562|FG001|COMPLETED|Overall Study||47
6724751|NCT03094806|7654561|FG000|NOT COMPLETED|Overall Study||0
6724752|NCT03094806|7654562|FG001|NOT COMPLETED|Overall Study||0
6724753|NCT03095027|7654568|FG000|STARTED|Period 1, First Week of Wear||27
6724754|NCT03095027|7654569|FG001|STARTED|Period 1, First Week of Wear||24
6724755|NCT03095027|7654568|FG000|COMPLETED|Period 1, First Week of Wear||27
6724756|NCT03095027|7654569|FG001|COMPLETED|Period 1, First Week of Wear||24
6724757|NCT03095027|7654568|FG000|NOT COMPLETED|Period 1, First Week of Wear||0
6724758|NCT03095027|7654569|FG001|NOT COMPLETED|Period 1, First Week of Wear||0
6724759|NCT03095027|7654568|FG000|STARTED|Period 2, Second Week of Wear||27
6724760|NCT03095027|7654569|FG001|STARTED|Period 2, Second Week of Wear||24
6724761|NCT03095027|7654568|FG000|COMPLETED|Period 2, Second Week of Wear||26
6724762|NCT03095027|7654569|FG001|COMPLETED|Period 2, Second Week of Wear||24
6724763|NCT03095027|7654568|FG000|NOT COMPLETED|Period 2, Second Week of Wear||1
6724764|NCT03095027|7654569|FG001|NOT COMPLETED|Period 2, Second Week of Wear||0
6724765|NCT03095053|7654577|FG000|STARTED|Overall Study|All blastocysts scored morphologically PGT-A of the single best blastocyst from the cohort|109
6724766|NCT03095053|7654578|FG001|STARTED|Overall Study|All blastocysts scored morphologically|111
6724767|NCT03095053|7654577|FG000|COMPLETED|Overall Study|29 excluded as blastocyst was predicted to be aneuploid|80
6724768|NCT03095053|7654578|FG001|COMPLETED|Overall Study||111
6724769|NCT03095053|7654577|FG000|NOT COMPLETED|Overall Study||29
6724770|NCT03095053|7654578|FG001|NOT COMPLETED|Overall Study||0
6724771|NCT03095118|7654584|FG000|STARTED|Overall Study||12
6724772|NCT03095118|7654584|FG000|COMPLETED|Overall Study||10
6724773|NCT03095118|7654584|FG000|NOT COMPLETED|Overall Study||2
6724774|NCT03095508|7654590|FG000|STARTED|Overall Study||114
6724775|NCT03095508|7654591|FG001|STARTED|Overall Study||115
6724776|NCT03095508|7654590|FG000|Per Protocol Population|Overall Study||112
6724777|NCT03095508|7654591|FG001|Per Protocol Population|Overall Study||111
6724778|NCT03095508|7654590|FG000|Safety Population|Overall Study||114
6724779|NCT03095508|7654591|FG001|Safety Population|Overall Study||115
6724780|NCT03095508|7654590|FG000|ITT Population|Overall Study||114
6724781|NCT03095508|7654591|FG001|ITT Population|Overall Study||115
6724782|NCT03095508|7654590|FG000|COMPLETED|Overall Study||114
6724783|NCT03095508|7654591|FG001|COMPLETED|Overall Study||114
6724784|NCT03095508|7654590|FG000|NOT COMPLETED|Overall Study||0
6724785|NCT03095508|7654591|FG001|NOT COMPLETED|Overall Study||1
6724786|NCT03095521|7654599|FG000|STARTED|Overall Study||115
6724787|NCT03095521|7654600|FG001|STARTED|Overall Study||113
6724788|NCT03095521|7654599|FG000|Intent to Treat Population ITT|Overall Study||115
6724789|NCT03095521|7654600|FG001|Intent to Treat Population ITT|Overall Study||113
6724790|NCT03095521|7654599|FG000|Per Protocol Population PP|Overall Study||113
6724791|NCT03095521|7654600|FG001|Per Protocol Population PP|Overall Study||107
6724792|NCT03095521|7654599|FG000|Safety Population|Overall Study||115
6724793|NCT03095521|7654600|FG001|Safety Population|Overall Study||113
6724794|NCT03095521|7654599|FG000|COMPLETED|Overall Study||115
6724795|NCT03095521|7654600|FG001|COMPLETED|Overall Study||111
6724796|NCT03095521|7654599|FG000|NOT COMPLETED|Overall Study||0
6724797|NCT03095521|7654600|FG001|NOT COMPLETED|Overall Study||2
6724798|NCT03095599|7654608|FG000|STARTED|Overall Study||741
6724799|NCT03095599|7654609|FG001|STARTED|Overall Study||148
6724800|NCT03095599|7654608|FG000|Withdrawal Before Vaccination|Overall Study||1
6724801|NCT03095599|7654609|FG001|Withdrawal Before Vaccination|Overall Study||0
6724802|NCT03095599|7654608|FG000|Vaccinated|Overall Study||740
6724803|NCT03095599|7654609|FG001|Vaccinated|Overall Study||148
6724804|NCT03095599|7654608|FG000|COMPLETED|Overall Study||738
6724805|NCT03095599|7654609|FG001|COMPLETED|Overall Study||148
6724806|NCT03095599|7654608|FG000|NOT COMPLETED|Overall Study||3
6724807|NCT03095599|7654609|FG001|NOT COMPLETED|Overall Study||0
6724808|NCT03095638|7654619|FG000|STARTED|P1: Period 1 (4 Days)||7
6724809|NCT03095638|7654620|FG001|STARTED|P1: Period 1 (4 Days)||7
6724810|NCT03095638|7654621|FG002|STARTED|P1: Period 1 (4 Days)||0
6724811|NCT03095638|7654622|FG003|STARTED|P1: Period 1 (4 Days)||0
6724812|NCT03095638|7654623|FG004|STARTED|P1: Period 1 (4 Days)||0
6724813|NCT03095638|7654624|FG005|STARTED|P1: Period 1 (4 Days)||0
6724814|NCT03095638|7654625|FG006|STARTED|P1: Period 1 (4 Days)||0
6724815|NCT03095638|7654626|FG007|STARTED|P1: Period 1 (4 Days)||0
6724816|NCT03095638|7654619|FG000|COMPLETED|P1: Period 1 (4 Days)||7
6724817|NCT03095638|7654620|FG001|COMPLETED|P1: Period 1 (4 Days)||7
6724818|NCT03095638|7654621|FG002|COMPLETED|P1: Period 1 (4 Days)||0
6724819|NCT03095638|7654622|FG003|COMPLETED|P1: Period 1 (4 Days)||0
6724820|NCT03095638|7654623|FG004|COMPLETED|P1: Period 1 (4 Days)||0
6724821|NCT03095638|7654624|FG005|COMPLETED|P1: Period 1 (4 Days)||0
6724822|NCT03095638|7654625|FG006|COMPLETED|P1: Period 1 (4 Days)||0
6724823|NCT03095638|7654626|FG007|COMPLETED|P1: Period 1 (4 Days)||0
6724824|NCT03095638|7654619|FG000|NOT COMPLETED|P1: Period 1 (4 Days)||0
6724825|NCT03095638|7654620|FG001|NOT COMPLETED|P1: Period 1 (4 Days)||0
6724826|NCT03095638|7654621|FG002|NOT COMPLETED|P1: Period 1 (4 Days)||0
6724827|NCT03095638|7654622|FG003|NOT COMPLETED|P1: Period 1 (4 Days)||0
6724828|NCT03095638|7654623|FG004|NOT COMPLETED|P1: Period 1 (4 Days)||0
6724829|NCT03095638|7654624|FG005|NOT COMPLETED|P1: Period 1 (4 Days)||0
6724830|NCT03095638|7654625|FG006|NOT COMPLETED|P1: Period 1 (4 Days)||0
6724831|NCT03095638|7654626|FG007|NOT COMPLETED|P1: Period 1 (4 Days)||0
6724832|NCT03095638|7654619|FG000|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
6724833|NCT03095638|7654620|FG001|STARTED|P1: Period 1, Washout (7 [-4 Hours])||7
6724834|NCT03095638|7654621|FG002|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6724835|NCT03095638|7654622|FG003|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6724836|NCT03095638|7654623|FG004|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6724837|NCT03095638|7654624|FG005|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6724838|NCT03095638|7654625|FG006|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6724839|NCT03095638|7654626|FG007|STARTED|P1: Period 1, Washout (7 [-4 Hours])||0
6724840|NCT03095638|7654619|FG000|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
6724841|NCT03095638|7654620|FG001|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||7
6724842|NCT03095638|7654621|FG002|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724843|NCT03095638|7654622|FG003|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724844|NCT03095638|7654623|FG004|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724845|NCT03095638|7654624|FG005|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724846|NCT03095638|7654625|FG006|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724847|NCT03095638|7654626|FG007|COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724848|NCT03095638|7654619|FG000|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724849|NCT03095638|7654620|FG001|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724850|NCT03095638|7654621|FG002|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724851|NCT03095638|7654622|FG003|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724852|NCT03095638|7654623|FG004|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724853|NCT03095638|7654624|FG005|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724854|NCT03095638|7654625|FG006|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724855|NCT03095638|7654626|FG007|NOT COMPLETED|P1: Period 1, Washout (7 [-4 Hours])||0
6724856|NCT03095638|7654619|FG000|STARTED|P1: Period 2 (4 Days)||7
6724857|NCT03095638|7654620|FG001|STARTED|P1: Period 2 (4 Days)||7
6724858|NCT03095638|7654621|FG002|STARTED|P1: Period 2 (4 Days)||0
6724859|NCT03095638|7654622|FG003|STARTED|P1: Period 2 (4 Days)||0
6724860|NCT03095638|7654623|FG004|STARTED|P1: Period 2 (4 Days)||0
6724861|NCT03095638|7654624|FG005|STARTED|P1: Period 2 (4 Days)||0
6724862|NCT03095638|7654625|FG006|STARTED|P1: Period 2 (4 Days)||0
6724863|NCT03095638|7654626|FG007|STARTED|P1: Period 2 (4 Days)||0
6724864|NCT03095638|7654619|FG000|COMPLETED|P1: Period 2 (4 Days)||7
6724865|NCT03095638|7654620|FG001|COMPLETED|P1: Period 2 (4 Days)||7
6724866|NCT03095638|7654621|FG002|COMPLETED|P1: Period 2 (4 Days)||0
6724867|NCT03095638|7654622|FG003|COMPLETED|P1: Period 2 (4 Days)||0
6724868|NCT03095638|7654623|FG004|COMPLETED|P1: Period 2 (4 Days)||0
6724869|NCT03095638|7654624|FG005|COMPLETED|P1: Period 2 (4 Days)||0
6724870|NCT03095638|7654625|FG006|COMPLETED|P1: Period 2 (4 Days)||0
6724871|NCT03095638|7654626|FG007|COMPLETED|P1: Period 2 (4 Days)||0
6724872|NCT03095638|7654619|FG000|NOT COMPLETED|P1: Period 2 (4 Days)||0
6724873|NCT03095638|7654620|FG001|NOT COMPLETED|P1: Period 2 (4 Days)||0
6724874|NCT03095638|7654621|FG002|NOT COMPLETED|P1: Period 2 (4 Days)||0
6724875|NCT03095638|7654622|FG003|NOT COMPLETED|P1: Period 2 (4 Days)||0
6724876|NCT03095638|7654623|FG004|NOT COMPLETED|P1: Period 2 (4 Days)||0
6724877|NCT03095638|7654624|FG005|NOT COMPLETED|P1: Period 2 (4 Days)||0
6724878|NCT03095638|7654625|FG006|NOT COMPLETED|P1: Period 2 (4 Days)||0
6724879|NCT03095638|7654626|FG007|NOT COMPLETED|P1: Period 2 (4 Days)||0
6724880|NCT03095638|7654619|FG000|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
6724881|NCT03095638|7654620|FG001|STARTED|P1: Period 2, Washout (7[-4 Hours])||7
6724882|NCT03095638|7654621|FG002|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6724883|NCT03095638|7654622|FG003|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6724884|NCT03095638|7654623|FG004|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6724885|NCT03095638|7654624|FG005|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6724886|NCT03095638|7654625|FG006|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6724887|NCT03095638|7654626|FG007|STARTED|P1: Period 2, Washout (7[-4 Hours])||0
6724888|NCT03095638|7654619|FG000|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
6724889|NCT03095638|7654620|FG001|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||7
6724890|NCT03095638|7654621|FG002|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724891|NCT03095638|7654622|FG003|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724892|NCT03095638|7654623|FG004|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724893|NCT03095638|7654624|FG005|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724894|NCT03095638|7654625|FG006|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724895|NCT03095638|7654626|FG007|COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724896|NCT03095638|7654619|FG000|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724897|NCT03095638|7654620|FG001|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724898|NCT03095638|7654621|FG002|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724899|NCT03095638|7654622|FG003|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724900|NCT03095638|7654623|FG004|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6265234|NCT00011986|7164264|FG003|STARTED|Overall Study||861
6265235|NCT00011986|7164265|FG004|STARTED|Overall Study||861
6265236|NCT00011986|7164261|FG000|Initiated Treatment|Overall Study||862
6265237|NCT00011986|7164262|FG001|Initiated Treatment|Overall Study||860
6265238|NCT00011986|7164263|FG002|Initiated Treatment|Overall Study||854
6265239|NCT00011986|7164264|FG003|Initiated Treatment|Overall Study||846
6265240|NCT00011986|7164265|FG004|Initiated Treatment|Overall Study||851
6265241|NCT00011986|7164261|FG000|COMPLETED|Overall Study||864
6265242|NCT00011986|7164262|FG001|COMPLETED|Overall Study||864
6265243|NCT00011986|7164263|FG002|COMPLETED|Overall Study||862
6265244|NCT00011986|7164264|FG003|COMPLETED|Overall Study||861
6265245|NCT00011986|7164265|FG004|COMPLETED|Overall Study||861
6265246|NCT00011986|7164261|FG000|NOT COMPLETED|Overall Study||0
6265247|NCT00011986|7164262|FG001|NOT COMPLETED|Overall Study||0
6265248|NCT00011986|7164263|FG002|NOT COMPLETED|Overall Study||0
6265249|NCT00011986|7164264|FG003|NOT COMPLETED|Overall Study||0
6265250|NCT00011986|7164265|FG004|NOT COMPLETED|Overall Study||0
6265251|NCT00012012|7164284|FG000|STARTED|Overall Study||27
6265252|NCT00012012|7164285|FG001|STARTED|Overall Study||18
6265253|NCT00012012|7164284|FG000|COMPLETED|Overall Study||26
6265254|NCT00012012|7164285|FG001|COMPLETED|Overall Study||15
6265255|NCT00012012|7164284|FG000|NOT COMPLETED|Overall Study||1
6265256|NCT00012012|7164285|FG001|NOT COMPLETED|Overall Study||3
6265257|NCT00012298|7164298|FG000|STARTED|Overall Study||11
6265258|NCT00012298|7164299|FG001|STARTED|Overall Study||7
6265259|NCT00012298|7164300|FG002|STARTED|Overall Study||9
6265260|NCT00012298|7164301|FG003|STARTED|Overall Study||4
6265261|NCT00012298|7164302|FG004|STARTED|Overall Study||5
6265262|NCT00012298|7164303|FG005|STARTED|Overall Study||6
6265263|NCT00012298|7164304|FG006|STARTED|Overall Study||39
6265264|NCT00012298|7164298|FG000|COMPLETED|Overall Study||11
6265265|NCT00012298|7164299|FG001|COMPLETED|Overall Study||7
6265266|NCT00012298|7164300|FG002|COMPLETED|Overall Study||9
6265267|NCT00012298|7164301|FG003|COMPLETED|Overall Study||4
6265268|NCT00012298|7164302|FG004|COMPLETED|Overall Study||5
6265269|NCT00012298|7164303|FG005|COMPLETED|Overall Study||6
6265270|NCT00012298|7164304|FG006|COMPLETED|Overall Study||39
6265271|NCT00012298|7164298|FG000|NOT COMPLETED|Overall Study||0
6265272|NCT00012298|7164299|FG001|NOT COMPLETED|Overall Study||0
6265273|NCT00012298|7164300|FG002|NOT COMPLETED|Overall Study||0
6265274|NCT00012298|7164301|FG003|NOT COMPLETED|Overall Study||0
6265275|NCT00012298|7164302|FG004|NOT COMPLETED|Overall Study||0
6265276|NCT00012298|7164303|FG005|NOT COMPLETED|Overall Study||0
6265277|NCT00012298|7164304|FG006|NOT COMPLETED|Overall Study||0
6265278|NCT00013611|7164324|FG000|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
6265279|NCT00013611|7164325|FG001|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
6265280|NCT00013611|7164324|FG000|COMPLETED|Overall Study||758
6265281|NCT00013611|7164325|FG001|COMPLETED|Overall Study||746
6265282|NCT00013611|7164324|FG000|NOT COMPLETED|Overall Study||91
6265283|NCT00013611|7164325|FG001|NOT COMPLETED|Overall Study||100
6265284|NCT00014222|7164334|FG000|STARTED|Overall Study||701
6265285|NCT00014222|7164335|FG001|STARTED|Overall Study||701
6265286|NCT00014222|7164336|FG002|STARTED|Overall Study||702
6265287|NCT00014222|7164334|FG000|COMPLETED|Overall Study||680
6265288|NCT00014222|7164335|FG001|COMPLETED|Overall Study||688
6265289|NCT00014222|7164336|FG002|COMPLETED|Overall Study||675
6265290|NCT00014222|7164334|FG000|NOT COMPLETED|Overall Study||21
6265291|NCT00014222|7164335|FG001|NOT COMPLETED|Overall Study||13
6265292|NCT00014222|7164336|FG002|NOT COMPLETED|Overall Study||27
6265293|NCT00014495|7164348|FG000|STARTED|Overall Study||3
6265294|NCT00014495|7164349|FG001|STARTED|Overall Study||3
6265295|NCT00014495|7164350|FG002|STARTED|Overall Study||20
6265296|NCT00014495|7164351|FG003|STARTED|Overall Study||6
6265297|NCT00014495|7164348|FG000|COMPLETED|Overall Study||3
6265298|NCT00014495|7164349|FG001|COMPLETED|Overall Study||3
6265299|NCT00014495|7164350|FG002|COMPLETED|Overall Study||19
6265300|NCT00014495|7164351|FG003|COMPLETED|Overall Study||5
6265301|NCT00014495|7164348|FG000|NOT COMPLETED|Overall Study||0
6265302|NCT00014495|7164349|FG001|NOT COMPLETED|Overall Study||0
6265303|NCT00014495|7164350|FG002|NOT COMPLETED|Overall Study||1
6265304|NCT00014495|7164351|FG003|NOT COMPLETED|Overall Study||1
6265305|NCT00014911|7164358|FG000|STARTED|Overall Study||36
6265306|NCT00014911|7164358|FG000|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
6724901|NCT03095638|7654624|FG005|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724902|NCT03095638|7654625|FG006|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724903|NCT03095638|7654626|FG007|NOT COMPLETED|P1: Period 2, Washout (7[-4 Hours])||0
6724904|NCT03095638|7654619|FG000|STARTED|P2: Period 1 (4 Days)||0
6724905|NCT03095638|7654620|FG001|STARTED|P2: Period 1 (4 Days)||0
6724906|NCT03095638|7654621|FG002|STARTED|P2: Period 1 (4 Days)||4
6724907|NCT03095638|7654622|FG003|STARTED|P2: Period 1 (4 Days)||4
6724908|NCT03095638|7654623|FG004|STARTED|P2: Period 1 (4 Days)||4
6724909|NCT03095638|7654624|FG005|STARTED|P2: Period 1 (4 Days)||4
6724910|NCT03095638|7654625|FG006|STARTED|P2: Period 1 (4 Days)||4
6724911|NCT03095638|7654626|FG007|STARTED|P2: Period 1 (4 Days)||4
6724912|NCT03095638|7654619|FG000|COMPLETED|P2: Period 1 (4 Days)||0
6724913|NCT03095638|7654620|FG001|COMPLETED|P2: Period 1 (4 Days)||0
6724914|NCT03095638|7654621|FG002|COMPLETED|P2: Period 1 (4 Days)||4
6724915|NCT03095638|7654622|FG003|COMPLETED|P2: Period 1 (4 Days)||4
6724916|NCT03095638|7654623|FG004|COMPLETED|P2: Period 1 (4 Days)||4
6724917|NCT03095638|7654624|FG005|COMPLETED|P2: Period 1 (4 Days)||4
6724918|NCT03095638|7654625|FG006|COMPLETED|P2: Period 1 (4 Days)||4
6724919|NCT03095638|7654626|FG007|COMPLETED|P2: Period 1 (4 Days)||4
6724920|NCT03095638|7654619|FG000|NOT COMPLETED|P2: Period 1 (4 Days)||0
6724921|NCT03095638|7654620|FG001|NOT COMPLETED|P2: Period 1 (4 Days)||0
6724922|NCT03095638|7654621|FG002|NOT COMPLETED|P2: Period 1 (4 Days)||0
6724923|NCT03095638|7654622|FG003|NOT COMPLETED|P2: Period 1 (4 Days)||0
6724924|NCT03095638|7654623|FG004|NOT COMPLETED|P2: Period 1 (4 Days)||0
6724925|NCT03095638|7654624|FG005|NOT COMPLETED|P2: Period 1 (4 Days)||0
6724926|NCT03095638|7654625|FG006|NOT COMPLETED|P2: Period 1 (4 Days)||0
6724927|NCT03095638|7654626|FG007|NOT COMPLETED|P2: Period 1 (4 Days)||0
6724928|NCT03095638|7654619|FG000|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
6724929|NCT03095638|7654620|FG001|STARTED|P2: Period 1, Washout (7[-4 Hours])||0
6724930|NCT03095638|7654621|FG002|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6724931|NCT03095638|7654622|FG003|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6724932|NCT03095638|7654623|FG004|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6724933|NCT03095638|7654624|FG005|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6724934|NCT03095638|7654625|FG006|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6724935|NCT03095638|7654626|FG007|STARTED|P2: Period 1, Washout (7[-4 Hours])||4
6724936|NCT03095638|7654619|FG000|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724937|NCT03095638|7654620|FG001|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724938|NCT03095638|7654621|FG002|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6724939|NCT03095638|7654622|FG003|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6724940|NCT03095638|7654623|FG004|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6724941|NCT03095638|7654624|FG005|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6724942|NCT03095638|7654625|FG006|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6724943|NCT03095638|7654626|FG007|COMPLETED|P2: Period 1, Washout (7[-4 Hours])||4
6724944|NCT03095638|7654619|FG000|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724945|NCT03095638|7654620|FG001|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724946|NCT03095638|7654621|FG002|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724947|NCT03095638|7654622|FG003|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724948|NCT03095638|7654623|FG004|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724949|NCT03095638|7654624|FG005|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724950|NCT03095638|7654625|FG006|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724951|NCT03095638|7654626|FG007|NOT COMPLETED|P2: Period 1, Washout (7[-4 Hours])||0
6724952|NCT03095638|7654619|FG000|STARTED|P2: Period 2 (4 Days)||0
6724953|NCT03095638|7654620|FG001|STARTED|P2: Period 2 (4 Days)||0
6724954|NCT03095638|7654621|FG002|STARTED|P2: Period 2 (4 Days)||4
6724955|NCT03095638|7654622|FG003|STARTED|P2: Period 2 (4 Days)||4
6724956|NCT03095638|7654623|FG004|STARTED|P2: Period 2 (4 Days)||4
6724957|NCT03095638|7654624|FG005|STARTED|P2: Period 2 (4 Days)||4
6724958|NCT03095638|7654625|FG006|STARTED|P2: Period 2 (4 Days)||4
6724959|NCT03095638|7654626|FG007|STARTED|P2: Period 2 (4 Days)||4
6724960|NCT03095638|7654619|FG000|COMPLETED|P2: Period 2 (4 Days)||0
6724961|NCT03095638|7654620|FG001|COMPLETED|P2: Period 2 (4 Days)||0
6724962|NCT03095638|7654621|FG002|COMPLETED|P2: Period 2 (4 Days)||4
6724963|NCT03095638|7654622|FG003|COMPLETED|P2: Period 2 (4 Days)||4
6724964|NCT03095638|7654623|FG004|COMPLETED|P2: Period 2 (4 Days)||4
6724965|NCT03095638|7654624|FG005|COMPLETED|P2: Period 2 (4 Days)||4
6724966|NCT03095638|7654625|FG006|COMPLETED|P2: Period 2 (4 Days)||4
6724967|NCT03095638|7654626|FG007|COMPLETED|P2: Period 2 (4 Days)||4
6724968|NCT03095638|7654619|FG000|NOT COMPLETED|P2: Period 2 (4 Days)||0
6724969|NCT03095638|7654620|FG001|NOT COMPLETED|P2: Period 2 (4 Days)||0
6724970|NCT03095638|7654621|FG002|NOT COMPLETED|P2: Period 2 (4 Days)||0
6724971|NCT03095638|7654622|FG003|NOT COMPLETED|P2: Period 2 (4 Days)||0
6724972|NCT03095638|7654623|FG004|NOT COMPLETED|P2: Period 2 (4 Days)||0
6724973|NCT03095638|7654624|FG005|NOT COMPLETED|P2: Period 2 (4 Days)||0
6724974|NCT03095638|7654625|FG006|NOT COMPLETED|P2: Period 2 (4 Days)||0
6724975|NCT03095638|7654626|FG007|NOT COMPLETED|P2: Period 2 (4 Days)||0
6724976|NCT03095638|7654619|FG000|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
6724977|NCT03095638|7654620|FG001|STARTED|P2: Period 2, Washout (7[-4 Hours])||0
6724978|NCT03095638|7654621|FG002|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6724979|NCT03095638|7654622|FG003|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6724980|NCT03095638|7654623|FG004|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6724981|NCT03095638|7654624|FG005|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6724982|NCT03095638|7654625|FG006|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6724983|NCT03095638|7654626|FG007|STARTED|P2: Period 2, Washout (7[-4 Hours])||4
6724984|NCT03095638|7654619|FG000|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724985|NCT03095638|7654620|FG001|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724986|NCT03095638|7654621|FG002|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6724987|NCT03095638|7654622|FG003|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6724988|NCT03095638|7654623|FG004|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6724989|NCT03095638|7654624|FG005|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6724990|NCT03095638|7654625|FG006|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6724991|NCT03095638|7654626|FG007|COMPLETED|P2: Period 2, Washout (7[-4 Hours])||4
6724992|NCT03095638|7654619|FG000|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724993|NCT03095638|7654620|FG001|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724994|NCT03095638|7654621|FG002|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724995|NCT03095638|7654622|FG003|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724996|NCT03095638|7654623|FG004|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724997|NCT03095638|7654624|FG005|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724998|NCT03095638|7654625|FG006|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6724999|NCT03095638|7654626|FG007|NOT COMPLETED|P2: Period 2, Washout (7[-4 Hours])||0
6725000|NCT03095638|7654619|FG000|STARTED|P2: Period 3 (4 Days)||0
6725001|NCT03095638|7654620|FG001|STARTED|P2: Period 3 (4 Days)||0
6725002|NCT03095638|7654621|FG002|STARTED|P2: Period 3 (4 Days)||4
6725003|NCT03095638|7654622|FG003|STARTED|P2: Period 3 (4 Days)||4
6725004|NCT03095638|7654623|FG004|STARTED|P2: Period 3 (4 Days)||4
6725005|NCT03095638|7654624|FG005|STARTED|P2: Period 3 (4 Days)||4
6725006|NCT03095638|7654625|FG006|STARTED|P2: Period 3 (4 Days)||4
6725007|NCT03095638|7654626|FG007|STARTED|P2: Period 3 (4 Days)||4
6725008|NCT03095638|7654619|FG000|COMPLETED|P2: Period 3 (4 Days)||0
6725009|NCT03095638|7654620|FG001|COMPLETED|P2: Period 3 (4 Days)||0
6725010|NCT03095638|7654621|FG002|COMPLETED|P2: Period 3 (4 Days)||4
6725011|NCT03095638|7654622|FG003|COMPLETED|P2: Period 3 (4 Days)||4
6725012|NCT03095638|7654623|FG004|COMPLETED|P2: Period 3 (4 Days)||4
6725013|NCT03095638|7654624|FG005|COMPLETED|P2: Period 3 (4 Days)||4
6725014|NCT03095638|7654625|FG006|COMPLETED|P2: Period 3 (4 Days)||4
6725015|NCT03095638|7654626|FG007|COMPLETED|P2: Period 3 (4 Days)||4
6725016|NCT03095638|7654619|FG000|NOT COMPLETED|P2: Period 3 (4 Days)||0
6725017|NCT03095638|7654620|FG001|NOT COMPLETED|P2: Period 3 (4 Days)||0
6725018|NCT03095638|7654621|FG002|NOT COMPLETED|P2: Period 3 (4 Days)||0
6725019|NCT03095638|7654622|FG003|NOT COMPLETED|P2: Period 3 (4 Days)||0
6725020|NCT03095638|7654623|FG004|NOT COMPLETED|P2: Period 3 (4 Days)||0
6725021|NCT03095638|7654624|FG005|NOT COMPLETED|P2: Period 3 (4 Days)||0
6725022|NCT03095638|7654625|FG006|NOT COMPLETED|P2: Period 3 (4 Days)||0
6725023|NCT03095638|7654626|FG007|NOT COMPLETED|P2: Period 3 (4 Days)||0
6725024|NCT03095638|7654619|FG000|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
6725025|NCT03095638|7654620|FG001|STARTED|P2: Period 3, Washout (7[-4 Hours])||0
6725026|NCT03095638|7654621|FG002|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6725027|NCT03095638|7654622|FG003|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6725028|NCT03095638|7654623|FG004|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6725029|NCT03095638|7654624|FG005|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6725030|NCT03095638|7654625|FG006|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6725031|NCT03095638|7654626|FG007|STARTED|P2: Period 3, Washout (7[-4 Hours])||4
6725032|NCT03095638|7654619|FG000|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725033|NCT03095638|7654620|FG001|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725034|NCT03095638|7654621|FG002|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6725035|NCT03095638|7654622|FG003|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6725036|NCT03095638|7654623|FG004|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6725037|NCT03095638|7654624|FG005|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6725038|NCT03095638|7654625|FG006|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6725039|NCT03095638|7654626|FG007|COMPLETED|P2: Period 3, Washout (7[-4 Hours])||4
6725040|NCT03095638|7654619|FG000|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725041|NCT03095638|7654620|FG001|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725042|NCT03095638|7654621|FG002|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725043|NCT03095638|7654622|FG003|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725044|NCT03095638|7654623|FG004|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725045|NCT03095638|7654624|FG005|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725046|NCT03095638|7654625|FG006|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725047|NCT03095638|7654626|FG007|NOT COMPLETED|P2: Period 3, Washout (7[-4 Hours])||0
6725048|NCT03095651|7654654|FG000|STARTED|Overall Study||6
6725049|NCT03095651|7654655|FG001|STARTED|Overall Study||6
6725050|NCT03095651|7654656|FG002|STARTED|Overall Study||0
6725051|NCT03095651|7654657|FG003|STARTED|Overall Study||4
6725052|NCT03095651|7654658|FG004|STARTED|Overall Study||0
6725053|NCT03095651|7654659|FG005|STARTED|Overall Study||7
6725054|NCT03095651|7654660|FG006|STARTED|Overall Study||6
6725055|NCT03095651|7654661|FG007|STARTED|Overall Study||4
6725056|NCT03095651|7654654|FG000|COMPLETED|Overall Study||5
6725057|NCT03095651|7654655|FG001|COMPLETED|Overall Study||5
6725058|NCT03095651|7654656|FG002|COMPLETED|Overall Study||0
6725059|NCT03095651|7654657|FG003|COMPLETED|Overall Study||3
6725060|NCT03095651|7654658|FG004|COMPLETED|Overall Study||0
6725061|NCT03095651|7654659|FG005|COMPLETED|Overall Study||6
6725062|NCT03095651|7654660|FG006|COMPLETED|Overall Study||6
6725063|NCT03095651|7654661|FG007|COMPLETED|Overall Study||4
6725064|NCT03095651|7654654|FG000|NOT COMPLETED|Overall Study||1
6725065|NCT03095651|7654655|FG001|NOT COMPLETED|Overall Study||1
6725066|NCT03095651|7654656|FG002|NOT COMPLETED|Overall Study||0
6725067|NCT03095651|7654657|FG003|NOT COMPLETED|Overall Study||1
6725068|NCT03095651|7654658|FG004|NOT COMPLETED|Overall Study||0
6725069|NCT03095651|7654659|FG005|NOT COMPLETED|Overall Study||1
6725070|NCT03095651|7654660|FG006|NOT COMPLETED|Overall Study||0
6725071|NCT03095651|7654661|FG007|NOT COMPLETED|Overall Study||0
6725072|NCT03095885|7654679|FG000|STARTED|Overall Study||22
6725073|NCT03095885|7654679|FG000|COMPLETED|Overall Study||22
6725074|NCT03095885|7654679|FG000|NOT COMPLETED|Overall Study||0
6725075|NCT03095976|7654683|FG000|STARTED|Overall Study||4
6725076|NCT03095976|7654683|FG000|COMPLETED|Overall Study||4
6725077|NCT03095976|7654683|FG000|NOT COMPLETED|Overall Study||0
6725078|NCT03096314|7654689|FG000|STARTED|Screened Vitamin D Deficient||690
6725079|NCT03096314|7654690|FG001|STARTED|Screened Vitamin D Deficient|2 randomized but not included in analysis; 1 treated but inadequate consent and 1 withdrew.|668
6725080|NCT03096314|7654689|FG000|COMPLETED|Screened Vitamin D Deficient||681
6725081|NCT03096314|7654690|FG001|COMPLETED|Screened Vitamin D Deficient||656
6725082|NCT03096314|7654689|FG000|NOT COMPLETED|Screened Vitamin D Deficient||9
6725083|NCT03096314|7654690|FG001|NOT COMPLETED|Screened Vitamin D Deficient||12
6725084|NCT03096314|7654689|FG000|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|538
6725085|NCT03096314|7654690|FG001|STARTED|Confirmed Vitamin D Deficient|Confirmed deficient (a prior primary analysis subgroup) is a subgroup of the screened deficient.|540
6725086|NCT03096314|7654689|FG000|COMPLETED|Confirmed Vitamin D Deficient||531
6725087|NCT03096314|7654690|FG001|COMPLETED|Confirmed Vitamin D Deficient||528
6725088|NCT03096314|7654689|FG000|NOT COMPLETED|Confirmed Vitamin D Deficient||7
6725089|NCT03096314|7654690|FG001|NOT COMPLETED|Confirmed Vitamin D Deficient||12
6725090|NCT03096353|7654698|FG000|STARTED|Period 1||15
6725091|NCT03096353|7654699|FG001|STARTED|Period 1||13
6725092|NCT03096353|7654698|FG000|COMPLETED|Period 1||12
6725093|NCT03096353|7654699|FG001|COMPLETED|Period 1||12
6725094|NCT03096353|7654698|FG000|NOT COMPLETED|Period 1||3
6725095|NCT03096353|7654699|FG001|NOT COMPLETED|Period 1||1
6725096|NCT03096353|7654698|FG000|STARTED|Period 2||12
6725097|NCT03096353|7654699|FG001|STARTED|Period 2||12
6725098|NCT03096353|7654698|FG000|COMPLETED|Period 2||12
6725099|NCT03096353|7654699|FG001|COMPLETED|Period 2||12
6725100|NCT03096353|7654698|FG000|NOT COMPLETED|Period 2||0
6725101|NCT03096353|7654699|FG001|NOT COMPLETED|Period 2||0
6725102|NCT03096444|7654705|FG000|STARTED|Overall Study||13
6725103|NCT03096444|7654705|FG000|COMPLETED|Overall Study||13
6725104|NCT03096444|7654705|FG000|NOT COMPLETED|Overall Study||0
6725105|NCT03096483|7654717|FG000|STARTED|Overall Study||12
6725106|NCT03096483|7654717|FG000|COMPLETED|Overall Study||11
6725107|NCT03096483|7654717|FG000|NOT COMPLETED|Overall Study||1
6725108|NCT03096730|7654726|FG000|STARTED|Overall Study||30
6725109|NCT03096730|7654727|FG001|STARTED|Overall Study||30
6725110|NCT03096730|7654728|FG002|STARTED|Overall Study||30
6725111|NCT03096730|7654729|FG003|STARTED|Overall Study||30
6725112|NCT03096730|7654730|FG004|STARTED|Overall Study||30
6725113|NCT03096730|7654726|FG000|COMPLETED|Overall Study||27
6725114|NCT03096730|7654727|FG001|COMPLETED|Overall Study||27
6725115|NCT03096730|7654728|FG002|COMPLETED|Overall Study||27
6725116|NCT03096730|7654729|FG003|COMPLETED|Overall Study||27
6725117|NCT03096730|7654730|FG004|COMPLETED|Overall Study||27
6725118|NCT03096730|7654726|FG000|NOT COMPLETED|Overall Study||3
6725119|NCT03096730|7654727|FG001|NOT COMPLETED|Overall Study||3
6725120|NCT03096730|7654728|FG002|NOT COMPLETED|Overall Study||3
6725121|NCT03096730|7654729|FG003|NOT COMPLETED|Overall Study||3
6725122|NCT03096730|7654730|FG004|NOT COMPLETED|Overall Study||3
6725123|NCT03096847|7654745|FG000|STARTED|Overall Study||319
6725124|NCT03096847|7654746|FG001|STARTED|Overall Study||26
6725125|NCT03096847|7654747|FG002|STARTED|Overall Study||157
6725126|NCT03096847|7654745|FG000|Full Analysis Set|Overall Study||307
6725127|NCT03096847|7654746|FG001|Full Analysis Set|Overall Study||26
6725128|NCT03096847|7654747|FG002|Full Analysis Set|Overall Study||154
6725129|NCT03096847|7654745|FG000|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|100
6725130|NCT03096847|7654746|FG001|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|6
6725131|NCT03096847|7654747|FG002|COMPLETED|Overall Study|Only the primary reason for disc. is included in this table.|19
6725132|NCT03096847|7654745|FG000|NOT COMPLETED|Overall Study||219
6725133|NCT03096847|7654746|FG001|NOT COMPLETED|Overall Study||20
6725134|NCT03096847|7654747|FG002|NOT COMPLETED|Overall Study||138
6725135|NCT03096873|7654765|FG000|STARTED|Overall Study||20
6725136|NCT03096873|7654766|FG001|STARTED|Overall Study||20
6725137|NCT03096873|7654765|FG000|COMPLETED|Overall Study||20
6725138|NCT03096873|7654766|FG001|COMPLETED|Overall Study||20
6725139|NCT03096873|7654765|FG000|NOT COMPLETED|Overall Study||0
6725140|NCT03096873|7654766|FG001|NOT COMPLETED|Overall Study||0
6725141|NCT03097029|7654774|FG000|STARTED|Overall Study||15
6725142|NCT03097029|7654774|FG000|COMPLETED|Overall Study||14
6725143|NCT03097029|7654774|FG000|NOT COMPLETED|Overall Study||1
6725144|NCT03097133|7654780|FG000|STARTED|Overall Study||115
6725145|NCT03097133|7654781|FG001|STARTED|Overall Study||115
6725146|NCT03097133|7654780|FG000|Treated|Overall Study||113
6725147|NCT03097133|7654781|FG001|Treated|Overall Study||114
6725148|NCT03097133|7654780|FG000|COMPLETED|Overall Study||85
6725149|NCT03097133|7654781|FG001|COMPLETED|Overall Study||81
6725150|NCT03097133|7654780|FG000|NOT COMPLETED|Overall Study||30
6725151|NCT03097133|7654781|FG001|NOT COMPLETED|Overall Study||34
6725152|NCT03097289|7654787|FG000|STARTED|Overall Study||32
6725153|NCT03097289|7654787|FG000|COMPLETED|Overall Study||26
6725154|NCT03097289|7654787|FG000|NOT COMPLETED|Overall Study||6
6725155|NCT03097315|7654792|FG000|STARTED|Overall Study||38
6725156|NCT03097315|7654792|FG000|Intention-to-Treat Population|Overall Study||38
6725157|NCT03097315|7654792|FG000|Safety Population|Overall Study||38
6725158|NCT03097315|7654792|FG000|COMPLETED|Overall Study||37
6725159|NCT03097315|7654792|FG000|NOT COMPLETED|Overall Study||1
6725160|NCT03097341|7654801|FG000|STARTED|Overall Study||4
6725161|NCT03097341|7654802|FG001|STARTED|Overall Study||4
6725162|NCT03097341|7654803|FG002|STARTED|Overall Study||4
6725163|NCT03097341|7654804|FG003|STARTED|Overall Study||4
6725164|NCT03097341|7654805|FG004|STARTED|Overall Study||5
6725165|NCT03097341|7654801|FG000|COMPLETED|Overall Study||4
6725166|NCT03097341|7654802|FG001|COMPLETED|Overall Study||4
6725167|NCT03097341|7654803|FG002|COMPLETED|Overall Study||4
6725168|NCT03097341|7654804|FG003|COMPLETED|Overall Study||4
6725169|NCT03097341|7654805|FG004|COMPLETED|Overall Study||5
6725170|NCT03097341|7654801|FG000|NOT COMPLETED|Overall Study||0
6725171|NCT03097341|7654802|FG001|NOT COMPLETED|Overall Study||0
6725172|NCT03097341|7654803|FG002|NOT COMPLETED|Overall Study||0
6725173|NCT03097341|7654804|FG003|NOT COMPLETED|Overall Study||0
6725174|NCT03097341|7654805|FG004|NOT COMPLETED|Overall Study||0
6725175|NCT03097484|7654819|FG000|STARTED|Overall Study||19
6725176|NCT03097484|7654820|FG001|STARTED|Overall Study||19
6725177|NCT03097484|7654819|FG000|COMPLETED|Overall Study||19
6725178|NCT03097484|7654820|FG001|COMPLETED|Overall Study||19
6725179|NCT03097484|7654819|FG000|NOT COMPLETED|Overall Study||0
6725180|NCT03097484|7654820|FG001|NOT COMPLETED|Overall Study||0
6725181|NCT03097588|7654826|FG000|STARTED|Overall Study||43
6725182|NCT03097588|7654826|FG000|COMPLETED|Overall Study||42
6725183|NCT03097588|7654826|FG000|NOT COMPLETED|Overall Study||1
6725184|NCT03097614|7654830|FG000|STARTED|Overall Study||57
6725185|NCT03097614|7654830|FG000|COMPLETED|Overall Study||54
6725186|NCT03097614|7654830|FG000|NOT COMPLETED|Overall Study||3
6725187|NCT03097653|7654836|FG000|STARTED|Overall Study||472
6725188|NCT03097653|7654837|FG001|STARTED|Overall Study||529
6725189|NCT03097653|7654836|FG000|COMPLETED|Overall Study||472
6725190|NCT03097653|7654837|FG001|COMPLETED|Overall Study||529
6725191|NCT03097653|7654836|FG000|NOT COMPLETED|Overall Study||0
6725192|NCT03097653|7654837|FG001|NOT COMPLETED|Overall Study||0
6725193|NCT03097783|7654845|FG000|STARTED|Overall Study||132
6725194|NCT03097783|7654846|FG001|STARTED|Overall Study||37
6725195|NCT03097783|7654845|FG000|COMPLETED|Overall Study||123
6725196|NCT03097783|7654846|FG001|COMPLETED|Overall Study||31
6725197|NCT03097783|7654845|FG000|NOT COMPLETED|Overall Study||9
6725198|NCT03097783|7654846|FG001|NOT COMPLETED|Overall Study||6
6725199|NCT03097861|7654855|FG000|STARTED|Overall Study||145
6725200|NCT03097861|7654856|FG001|STARTED|Overall Study||276
6725201|NCT03097861|7654857|FG002|STARTED|Overall Study||131
6725202|NCT03097861|7654855|FG000|Safety Population|Overall Study||143
6725203|NCT03097861|7654856|FG001|Safety Population|Overall Study||275
6725204|NCT03097861|7654857|FG002|Safety Population|Overall Study||130
6725205|NCT03097861|7654855|FG000|Modified Intent to Treat|Overall Study||143
6725206|NCT03097861|7654856|FG001|Modified Intent to Treat|Overall Study||275
6725207|NCT03097861|7654857|FG002|Modified Intent to Treat|Overall Study||130
6725208|NCT03097861|7654855|FG000|Completers|Overall Study||129
6725209|NCT03097861|7654856|FG001|Completers|Overall Study||255
6725210|NCT03097861|7654857|FG002|Completers|Overall Study||121
6725211|NCT03097861|7654855|FG000|Per-protocol Population (PP)|Overall Study||126
6725212|NCT03097861|7654856|FG001|Per-protocol Population (PP)|Overall Study||234
6725213|NCT03097861|7654857|FG002|Per-protocol Population (PP)|Overall Study||113
6725214|NCT03097861|7654855|FG000|COMPLETED|Overall Study||138
6725215|NCT03097861|7654856|FG001|COMPLETED|Overall Study||254
6725216|NCT03097861|7654857|FG002|COMPLETED|Overall Study||122
6725217|NCT03097861|7654855|FG000|NOT COMPLETED|Overall Study||7
6725218|NCT03097861|7654856|FG001|NOT COMPLETED|Overall Study||22
6725219|NCT03097861|7654857|FG002|NOT COMPLETED|Overall Study||9
6725220|NCT03098030|7654871|FG000|STARTED|Overall Study||12
6725221|NCT03098030|7654872|FG001|STARTED|Overall Study||187
6725222|NCT03098030|7654873|FG002|STARTED|Overall Study||190
6725223|NCT03098030|7654874|FG003|STARTED|Overall Study||94
6725224|NCT03098030|7654871|FG000|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|2
6725225|NCT03098030|7654872|FG001|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
6725226|NCT03098030|7654873|FG002|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|24
6725227|NCT03098030|7654874|FG003|COMPLETED|Overall Study|Represents number of subjects that had not discontinued the study at time of data lock.|9
6725228|NCT03098030|7654871|FG000|NOT COMPLETED|Overall Study||10
6725229|NCT03098030|7654872|FG001|NOT COMPLETED|Overall Study||163
6725230|NCT03098030|7654873|FG002|NOT COMPLETED|Overall Study||166
6725231|NCT03098030|7654874|FG003|NOT COMPLETED|Overall Study||85
6725232|NCT03098173|7654885|FG000|STARTED|Overall Study||81
6725233|NCT03098173|7654886|FG001|STARTED|Overall Study||81
6725234|NCT03098173|7654885|FG000|COMPLETED|Overall Study||80
6725235|NCT03098173|7654886|FG001|COMPLETED|Overall Study||79
6725236|NCT03098173|7654885|FG000|NOT COMPLETED|Overall Study||1
6725237|NCT03098173|7654886|FG001|NOT COMPLETED|Overall Study||2
6725238|NCT03098420|7654897|FG000|STARTED|Overall Study||7
6725239|NCT03098420|7654898|FG001|STARTED|Overall Study||9
6725240|NCT03098420|7654899|FG002|STARTED|Overall Study||13
6725241|NCT03098420|7654897|FG000|COMPLETED|Overall Study||7
6725242|NCT03098420|7654898|FG001|COMPLETED|Overall Study||9
6725243|NCT03098420|7654899|FG002|COMPLETED|Overall Study||13
6725244|NCT03098420|7654897|FG000|NOT COMPLETED|Overall Study||0
6725245|NCT03098420|7654898|FG001|NOT COMPLETED|Overall Study||0
6725246|NCT03098420|7654899|FG002|NOT COMPLETED|Overall Study||0
6739673|NCT03292952|7668524|FG002|STARTED|Open-Label Dose Optimization|All subjects were treated with open-label KP415 during the Open-Label Phase|0
6739674|NCT03292952|7668522|FG000|COMPLETED|Open-Label Dose Optimization||150
6739675|NCT03292952|7668523|FG001|COMPLETED|Open-Label Dose Optimization||0
6739676|NCT03292952|7668524|FG002|COMPLETED|Open-Label Dose Optimization||0
6739677|NCT03292952|7668522|FG000|NOT COMPLETED|Open-Label Dose Optimization||5
6739678|NCT03292952|7668523|FG001|NOT COMPLETED|Open-Label Dose Optimization||0
6739679|NCT03292952|7668524|FG002|NOT COMPLETED|Open-Label Dose Optimization||0
6739680|NCT03292952|7668522|FG000|STARTED|Double-Blind Treatment Phase|Subjects were randomized to the double-blind Treatment Phase after Open-Label Dose Optimization|0
6739681|NCT03292952|7668523|FG001|STARTED|Double-Blind Treatment Phase||74
6739682|NCT03292952|7668524|FG002|STARTED|Double-Blind Treatment Phase||76
6739683|NCT03292952|7668522|FG000|COMPLETED|Double-Blind Treatment Phase||0
6739684|NCT03292952|7668523|FG001|COMPLETED|Double-Blind Treatment Phase||74
6739685|NCT03292952|7668524|FG002|COMPLETED|Double-Blind Treatment Phase||75
6739686|NCT03292952|7668522|FG000|NOT COMPLETED|Double-Blind Treatment Phase||0
6739687|NCT03292952|7668523|FG001|NOT COMPLETED|Double-Blind Treatment Phase||0
6739688|NCT03292952|7668524|FG002|NOT COMPLETED|Double-Blind Treatment Phase||1
6739689|NCT03293238|7668537|FG000|STARTED|Overall Study||19
6739690|NCT03293238|7668538|FG001|STARTED|Overall Study||16
6739691|NCT03293238|7668539|FG002|STARTED|Overall Study||14
6739692|NCT03293238|7668540|FG003|STARTED|Overall Study||14
6739693|NCT03293238|7668537|FG000|COMPLETED|Overall Study||19
6739694|NCT03293238|7668538|FG001|COMPLETED|Overall Study||16
6739695|NCT03293238|7668539|FG002|COMPLETED|Overall Study||14
6739696|NCT03293238|7668540|FG003|COMPLETED|Overall Study||14
6739697|NCT03293238|7668537|FG000|NOT COMPLETED|Overall Study||0
6739698|NCT03293238|7668538|FG001|NOT COMPLETED|Overall Study||0
6739699|NCT03293238|7668539|FG002|NOT COMPLETED|Overall Study||0
6739700|NCT03293238|7668540|FG003|NOT COMPLETED|Overall Study||0
6739701|NCT03293394|7668552|FG000|STARTED|First Intervention (2 Weeks)||20
6739702|NCT03293394|7668553|FG001|STARTED|First Intervention (2 Weeks)||10
6739703|NCT03293394|7668552|FG000|COMPLETED|First Intervention (2 Weeks)||20
6739704|NCT03293394|7668553|FG001|COMPLETED|First Intervention (2 Weeks)||10
6739705|NCT03293394|7668552|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6739706|NCT03293394|7668553|FG001|NOT COMPLETED|First Intervention (2 Weeks)||0
6739707|NCT03293394|7668552|FG000|STARTED|Follow-up (6 Months)||20
6739708|NCT03293394|7668553|FG001|STARTED|Follow-up (6 Months)||10
6739709|NCT03293394|7668552|FG000|COMPLETED|Follow-up (6 Months)||16
6739710|NCT03293394|7668553|FG001|COMPLETED|Follow-up (6 Months)||8
6739711|NCT03293394|7668552|FG000|NOT COMPLETED|Follow-up (6 Months)||4
6739712|NCT03293394|7668553|FG001|NOT COMPLETED|Follow-up (6 Months)||2
6739713|NCT03293485|7668559|FG000|STARTED|Overall Study||83
6739714|NCT03293485|7668559|FG000|Treated|Overall Study||81
6725247|NCT03098433|7654907|FG000|STARTED|Overall Study||22
6725248|NCT03098433|7654907|FG000|COMPLETED|Overall Study||12
6725249|NCT03098433|7654907|FG000|NOT COMPLETED|Overall Study||10
6725250|NCT03098550|7654915|FG000|STARTED|Overall Study||41
6725251|NCT03098550|7654916|FG001|STARTED|Overall Study||21
6725252|NCT03098550|7654917|FG002|STARTED|Overall Study||43
6725253|NCT03098550|7654915|FG000|COMPLETED|Overall Study||0
6725254|NCT03098550|7654916|FG001|COMPLETED|Overall Study||1
6725255|NCT03098550|7654917|FG002|COMPLETED|Overall Study||0
6725256|NCT03098550|7654915|FG000|NOT COMPLETED|Overall Study||41
6725257|NCT03098550|7654916|FG001|NOT COMPLETED|Overall Study||20
6725258|NCT03098550|7654917|FG002|NOT COMPLETED|Overall Study||43
6725259|NCT03098615|7654929|FG000|STARTED|Overall Study||19
6725260|NCT03098615|7654929|FG000|COMPLETED|Overall Study||17
6725261|NCT03098615|7654929|FG000|NOT COMPLETED|Overall Study||2
6725262|NCT03098641|7654934|FG000|STARTED|Overall Study||272
6725263|NCT03098641|7654934|FG000|COMPLETED|Overall Study||220
6725264|NCT03098641|7654934|FG000|NOT COMPLETED|Overall Study||52
6725265|NCT03098745|7654938|FG000|STARTED|Day 1||7
6725266|NCT03098745|7654939|FG001|STARTED|Day 1||3
6725267|NCT03098745|7654940|FG002|STARTED|Day 1||8
6725268|NCT03098745|7654941|FG003|STARTED|Day 1||8
6725269|NCT03098745|7654942|FG004|STARTED|Day 1||10
6725270|NCT03098745|7654943|FG005|STARTED|Day 1||4
6725271|NCT03098745|7654938|FG000|COMPLETED|Day 1||7
6725272|NCT03098745|7654939|FG001|COMPLETED|Day 1||3
6725273|NCT03098745|7654940|FG002|COMPLETED|Day 1||8
6725274|NCT03098745|7654941|FG003|COMPLETED|Day 1||8
6725275|NCT03098745|7654942|FG004|COMPLETED|Day 1||10
6725276|NCT03098745|7654943|FG005|COMPLETED|Day 1||4
6725277|NCT03098745|7654938|FG000|NOT COMPLETED|Day 1||0
6725278|NCT03098745|7654939|FG001|NOT COMPLETED|Day 1||0
6725279|NCT03098745|7654940|FG002|NOT COMPLETED|Day 1||0
6725280|NCT03098745|7654941|FG003|NOT COMPLETED|Day 1||0
6725281|NCT03098745|7654942|FG004|NOT COMPLETED|Day 1||0
6725282|NCT03098745|7654943|FG005|NOT COMPLETED|Day 1||0
6725283|NCT03098745|7654938|FG000|STARTED|Day 2||7
6725284|NCT03098745|7654939|FG001|STARTED|Day 2||3
6725285|NCT03098745|7654940|FG002|STARTED|Day 2||8
6725286|NCT03098745|7654941|FG003|STARTED|Day 2||8
6725287|NCT03098745|7654942|FG004|STARTED|Day 2||10
6725288|NCT03098745|7654943|FG005|STARTED|Day 2||4
6725289|NCT03098745|7654938|FG000|COMPLETED|Day 2||7
6725290|NCT03098745|7654939|FG001|COMPLETED|Day 2||3
6725291|NCT03098745|7654940|FG002|COMPLETED|Day 2||8
6725292|NCT03098745|7654941|FG003|COMPLETED|Day 2||8
6725293|NCT03098745|7654942|FG004|COMPLETED|Day 2||10
6725294|NCT03098745|7654943|FG005|COMPLETED|Day 2||4
6725295|NCT03098745|7654938|FG000|NOT COMPLETED|Day 2||0
6725296|NCT03098745|7654939|FG001|NOT COMPLETED|Day 2||0
6725297|NCT03098745|7654940|FG002|NOT COMPLETED|Day 2||0
6725298|NCT03098745|7654941|FG003|NOT COMPLETED|Day 2||0
6725299|NCT03098745|7654942|FG004|NOT COMPLETED|Day 2||0
6725300|NCT03098745|7654943|FG005|NOT COMPLETED|Day 2||0
6725301|NCT03098745|7654938|FG000|STARTED|Day 3||7
6725302|NCT03098745|7654939|FG001|STARTED|Day 3||3
6725303|NCT03098745|7654940|FG002|STARTED|Day 3||8
6725304|NCT03098745|7654941|FG003|STARTED|Day 3||8
6725305|NCT03098745|7654942|FG004|STARTED|Day 3||10
6725306|NCT03098745|7654943|FG005|STARTED|Day 3||4
6725307|NCT03098745|7654938|FG000|COMPLETED|Day 3||7
6725308|NCT03098745|7654939|FG001|COMPLETED|Day 3||3
6725309|NCT03098745|7654940|FG002|COMPLETED|Day 3||8
6725310|NCT03098745|7654941|FG003|COMPLETED|Day 3||8
6725311|NCT03098745|7654942|FG004|COMPLETED|Day 3||10
6725312|NCT03098745|7654943|FG005|COMPLETED|Day 3||4
6725313|NCT03098745|7654938|FG000|NOT COMPLETED|Day 3||0
6725314|NCT03098745|7654939|FG001|NOT COMPLETED|Day 3||0
6725315|NCT03098745|7654940|FG002|NOT COMPLETED|Day 3||0
6725316|NCT03098745|7654941|FG003|NOT COMPLETED|Day 3||0
6725317|NCT03098745|7654942|FG004|NOT COMPLETED|Day 3||0
6725318|NCT03098745|7654943|FG005|NOT COMPLETED|Day 3||0
6725319|NCT03098966|7654952|FG000|STARTED|Overall Study||368
6725320|NCT03098966|7654952|FG000|COMPLETED|Overall Study||368
6725321|NCT03098966|7654952|FG000|NOT COMPLETED|Overall Study||0
6725322|NCT03098979|7654962|FG000|STARTED|Overall Study||76
6725323|NCT03098979|7654963|FG001|STARTED|Overall Study||27
6725324|NCT03098979|7654964|FG002|STARTED|Overall Study||50
6725325|NCT03098979|7654965|FG003|STARTED|Overall Study||51
6725326|NCT03098979|7654966|FG004|STARTED|Overall Study||50
6725327|NCT03098979|7654967|FG005|STARTED|Overall Study||51
6725328|NCT03098979|7654962|FG000|COMPLETED|Overall Study||70
6725329|NCT03098979|7654963|FG001|COMPLETED|Overall Study||25
6725330|NCT03098979|7654964|FG002|COMPLETED|Overall Study||46
6725331|NCT03098979|7654965|FG003|COMPLETED|Overall Study||46
6725332|NCT03098979|7654966|FG004|COMPLETED|Overall Study||41
6725333|NCT03098979|7654967|FG005|COMPLETED|Overall Study||47
6725334|NCT03098979|7654962|FG000|NOT COMPLETED|Overall Study||6
6725335|NCT03098979|7654963|FG001|NOT COMPLETED|Overall Study||2
6725336|NCT03098979|7654964|FG002|NOT COMPLETED|Overall Study||4
6725337|NCT03098979|7654965|FG003|NOT COMPLETED|Overall Study||5
6725338|NCT03098979|7654966|FG004|NOT COMPLETED|Overall Study||9
6725339|NCT03098979|7654967|FG005|NOT COMPLETED|Overall Study||4
6725340|NCT03099096|7654981|FG000|STARTED|Overall Study||159
6725341|NCT03099096|7654981|FG000|COMPLETED|Overall Study||157
6725342|NCT03099096|7654981|FG000|NOT COMPLETED|Overall Study||2
6725343|NCT03099161|7654988|FG000|STARTED|Overall Study||3
6725344|NCT03099161|7654989|FG001|STARTED|Overall Study||4
6725345|NCT03099161|7654990|FG002|STARTED|Overall Study||3
6725346|NCT03099161|7654988|FG000|COMPLETED|Overall Study||0
6725347|NCT03099161|7654989|FG001|COMPLETED|Overall Study||0
6725348|NCT03099161|7654990|FG002|COMPLETED|Overall Study||0
6725349|NCT03099161|7654988|FG000|NOT COMPLETED|Overall Study||3
6725350|NCT03099161|7654989|FG001|NOT COMPLETED|Overall Study||4
6725351|NCT03099161|7654990|FG002|NOT COMPLETED|Overall Study||3
6725352|NCT03099187|7655000|FG000|STARTED|Double-blind Treatment||127
6725353|NCT03099187|7655001|FG001|STARTED|Double-blind Treatment||126
6725354|NCT03099187|7655002|FG002|STARTED|Double-blind Treatment||0
6725355|NCT03099187|7655003|FG003|STARTED|Double-blind Treatment||0
6725356|NCT03099187|7655000|FG000|COMPLETED|Double-blind Treatment||94
6725357|NCT03099187|7655001|FG001|COMPLETED|Double-blind Treatment||110
6725358|NCT03099187|7655002|FG002|COMPLETED|Double-blind Treatment||0
6725359|NCT03099187|7655003|FG003|COMPLETED|Double-blind Treatment||0
6725360|NCT03099187|7655000|FG000|NOT COMPLETED|Double-blind Treatment||33
6725361|NCT03099187|7655001|FG001|NOT COMPLETED|Double-blind Treatment||16
6725362|NCT03099187|7655002|FG002|NOT COMPLETED|Double-blind Treatment||0
6725363|NCT03099187|7655003|FG003|NOT COMPLETED|Double-blind Treatment||0
6725364|NCT03099187|7655000|FG000|STARTED|12-month Safety Follow-up||0
6725365|NCT03099187|7655001|FG001|STARTED|12-month Safety Follow-up||0
6725366|NCT03099187|7655002|FG002|STARTED|12-month Safety Follow-up||94
6725367|NCT03099187|7655003|FG003|STARTED|12-month Safety Follow-up||110
6725368|NCT03099187|7655000|FG000|COMPLETED|12-month Safety Follow-up||0
6725369|NCT03099187|7655001|FG001|COMPLETED|12-month Safety Follow-up||0
6725370|NCT03099187|7655002|FG002|COMPLETED|12-month Safety Follow-up||75
6725371|NCT03099187|7655003|FG003|COMPLETED|12-month Safety Follow-up||84
6725372|NCT03099187|7655000|FG000|NOT COMPLETED|12-month Safety Follow-up||0
6725373|NCT03099187|7655001|FG001|NOT COMPLETED|12-month Safety Follow-up||0
6725374|NCT03099187|7655002|FG002|NOT COMPLETED|12-month Safety Follow-up||19
6725375|NCT03099187|7655003|FG003|NOT COMPLETED|12-month Safety Follow-up||26
6725376|NCT03099369|7655015|FG000|STARTED|Overall Study||11
6725377|NCT03099369|7655016|FG001|STARTED|Overall Study||9
6725378|NCT03099369|7655015|FG000|COMPLETED|Overall Study||5
6725379|NCT03099369|7655016|FG001|COMPLETED|Overall Study||5
6725380|NCT03099369|7655015|FG000|NOT COMPLETED|Overall Study||6
6725381|NCT03099369|7655016|FG001|NOT COMPLETED|Overall Study||4
6725382|NCT03099538|7655023|FG000|STARTED|Overall Study||4
6725383|NCT03099538|7655023|FG000|COMPLETED|Overall Study||1
6725384|NCT03099538|7655023|FG000|NOT COMPLETED|Overall Study||3
6725385|NCT03099655|7655027|FG000|STARTED|Overall Study||440
6725386|NCT03099655|7655027|FG000|COMPLETED|Overall Study|6-Month visit with original 4798 lead implanted|379
6725387|NCT03099655|7655027|FG000|NOT COMPLETED|Overall Study||61
6725388|NCT03099694|7655036|FG000|STARTED|Overall Study||170
6725389|NCT03099694|7655037|FG001|STARTED|Overall Study||170
6725390|NCT03099694|7655036|FG000|COMPLETED|Overall Study||150
6725391|NCT03099694|7655037|FG001|COMPLETED|Overall Study||152
6725392|NCT03099694|7655036|FG000|NOT COMPLETED|Overall Study||20
6725393|NCT03099694|7655037|FG001|NOT COMPLETED|Overall Study||18
6725394|NCT03100058|7655053|FG000|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6725395|NCT03100058|7655054|FG001|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6725396|NCT03100058|7655055|FG002|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6725397|NCT03100058|7655056|FG003|STARTED|Epoch 3 (24 Weeks of Treatment)||77
6725398|NCT03100058|7655057|FG004|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6725399|NCT03100058|7655058|FG005|STARTED|Epoch 3 (24 Weeks of Treatment)||39
6725400|NCT03100058|7655059|FG006|STARTED|Epoch 3 (24 Weeks of Treatment)||38
6725401|NCT03100058|7655060|FG007|STARTED|Epoch 3 (24 Weeks of Treatment)||76
6725402|NCT03100058|7655061|FG008|STARTED|Epoch 3 (24 Weeks of Treatment)||78
6725403|NCT03100058|7655062|FG009|STARTED|Epoch 3 (24 Weeks of Treatment)||0
6725404|NCT03100058|7655063|FG010|STARTED|Epoch 3 (24 Weeks of Treatment)||0
6725405|NCT03100058|7655064|FG011|STARTED|Epoch 3 (24 Weeks of Treatment)||0
6725406|NCT03100058|7655065|FG012|STARTED|Epoch 3 (24 Weeks of Treatment)||0
6725407|NCT03100058|7655053|FG000|COMPLETED|Epoch 3 (24 Weeks of Treatment)||35
6725408|NCT03100058|7655054|FG001|COMPLETED|Epoch 3 (24 Weeks of Treatment)||31
6725409|NCT03100058|7655055|FG002|COMPLETED|Epoch 3 (24 Weeks of Treatment)||29
6725410|NCT03100058|7655056|FG003|COMPLETED|Epoch 3 (24 Weeks of Treatment)||63
6725411|NCT03100058|7655057|FG004|COMPLETED|Epoch 3 (24 Weeks of Treatment)||36
6725412|NCT03100058|7655058|FG005|COMPLETED|Epoch 3 (24 Weeks of Treatment)||37
6725413|NCT03100058|7655059|FG006|COMPLETED|Epoch 3 (24 Weeks of Treatment)||30
6725414|NCT03100058|7655060|FG007|COMPLETED|Epoch 3 (24 Weeks of Treatment)||60
6725415|NCT03100058|7655061|FG008|COMPLETED|Epoch 3 (24 Weeks of Treatment)||73
6725416|NCT03100058|7655062|FG009|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6725417|NCT03100058|7655063|FG010|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6725418|NCT03100058|7655064|FG011|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6725419|NCT03100058|7655065|FG012|COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6725420|NCT03100058|7655053|FG000|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||3
6725421|NCT03100058|7655054|FG001|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||7
6725422|NCT03100058|7655055|FG002|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||9
6725423|NCT03100058|7655056|FG003|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||14
6725424|NCT03100058|7655057|FG004|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
6725425|NCT03100058|7655058|FG005|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||2
6725426|NCT03100058|7655059|FG006|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||8
6725427|NCT03100058|7655060|FG007|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||16
6725428|NCT03100058|7655061|FG008|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||5
6725429|NCT03100058|7655062|FG009|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6725430|NCT03100058|7655063|FG010|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6725431|NCT03100058|7655064|FG011|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6725432|NCT03100058|7655065|FG012|NOT COMPLETED|Epoch 3 (24 Weeks of Treatment)||0
6725433|NCT03100058|7655053|FG000|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725434|NCT03100058|7655054|FG001|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725435|NCT03100058|7655055|FG002|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725436|NCT03100058|7655056|FG003|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725437|NCT03100058|7655057|FG004|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725438|NCT03100058|7655058|FG005|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725439|NCT03100058|7655059|FG006|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725440|NCT03100058|7655060|FG007|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725441|NCT03100058|7655061|FG008|STARTED|Epoch 4 (Last 24 Weeks of the Study)||0
6725442|NCT03100058|7655062|FG009|STARTED|Epoch 4 (Last 24 Weeks of the Study)||158
6725443|NCT03100058|7655063|FG010|STARTED|Epoch 4 (Last 24 Weeks of the Study)||163
6725444|NCT03100058|7655064|FG011|STARTED|Epoch 4 (Last 24 Weeks of the Study)||39
6725445|NCT03100058|7655065|FG012|STARTED|Epoch 4 (Last 24 Weeks of the Study)||34
6725446|NCT03100058|7655053|FG000|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725447|NCT03100058|7655054|FG001|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725448|NCT03100058|7655055|FG002|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725449|NCT03100058|7655056|FG003|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725450|NCT03100058|7655057|FG004|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725451|NCT03100058|7655058|FG005|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725452|NCT03100058|7655059|FG006|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725453|NCT03100058|7655060|FG007|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725454|NCT03100058|7655061|FG008|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725455|NCT03100058|7655062|FG009|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||153
6725456|NCT03100058|7655063|FG010|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||148
6725457|NCT03100058|7655064|FG011|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||36
6725458|NCT03100058|7655065|FG012|COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||30
6725459|NCT03100058|7655053|FG000|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725460|NCT03100058|7655054|FG001|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725461|NCT03100058|7655055|FG002|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725462|NCT03100058|7655056|FG003|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725463|NCT03100058|7655057|FG004|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725464|NCT03100058|7655058|FG005|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725465|NCT03100058|7655059|FG006|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725466|NCT03100058|7655060|FG007|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725467|NCT03100058|7655061|FG008|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||0
6725468|NCT03100058|7655062|FG009|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||5
6725469|NCT03100058|7655063|FG010|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||15
6725470|NCT03100058|7655064|FG011|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||3
6725471|NCT03100058|7655065|FG012|NOT COMPLETED|Epoch 4 (Last 24 Weeks of the Study)||4
6725472|NCT03100123|7655096|FG000|STARTED|Overall Study||0
6725473|NCT03100123|7655097|FG001|STARTED|Overall Study||1
6725474|NCT03100123|7655096|FG000|COMPLETED|Overall Study||0
6725475|NCT03100123|7655097|FG001|COMPLETED|Overall Study||1
6725476|NCT03100123|7655096|FG000|NOT COMPLETED|Overall Study||0
6725477|NCT03100123|7655097|FG001|NOT COMPLETED|Overall Study||0
6725478|NCT03100344|7655112|FG000|STARTED|Overall Study||57
6725479|NCT03100344|7655113|FG001|STARTED|Overall Study||55
6725480|NCT03100344|7655114|FG002|STARTED|Overall Study||57
6725481|NCT03100344|7655115|FG003|STARTED|Overall Study||57
6725482|NCT03100344|7655112|FG000|COMPLETED|Overall Study||43
6725483|NCT03100344|7655113|FG001|COMPLETED|Overall Study||44
6725484|NCT03100344|7655114|FG002|COMPLETED|Overall Study||50
6725485|NCT03100344|7655115|FG003|COMPLETED|Overall Study||45
6725486|NCT03100344|7655112|FG000|NOT COMPLETED|Overall Study||14
6725487|NCT03100344|7655113|FG001|NOT COMPLETED|Overall Study||11
6725488|NCT03100344|7655114|FG002|NOT COMPLETED|Overall Study||7
6725489|NCT03100344|7655115|FG003|NOT COMPLETED|Overall Study||12
6725490|NCT03100500|7655126|FG000|STARTED|Overall Study||51
6725491|NCT03100500|7655126|FG000|COMPLETED|Overall Study||51
6725492|NCT03100500|7655126|FG000|NOT COMPLETED|Overall Study||0
6725493|NCT03100825|7655130|FG000|STARTED|Overall Study||94
6725494|NCT03100825|7655130|FG000|COMPLETED|Overall Study||86
6725495|NCT03100825|7655130|FG000|NOT COMPLETED|Overall Study||8
6725496|NCT03100838|7655134|FG000|STARTED|Overall Study||16
6725497|NCT03100838|7655135|FG001|STARTED|Overall Study||16
6725498|NCT03100838|7655136|FG002|STARTED|Overall Study||16
6725499|NCT03100838|7655137|FG003|STARTED|Overall Study||16
6725500|NCT03100838|7655134|FG000|COMPLETED|Overall Study||14
6725501|NCT03100838|7655135|FG001|COMPLETED|Overall Study||14
6725502|NCT03100838|7655136|FG002|COMPLETED|Overall Study||14
6725503|NCT03100838|7655137|FG003|COMPLETED|Overall Study||15
6725504|NCT03100838|7655134|FG000|NOT COMPLETED|Overall Study||2
6725505|NCT03100838|7655135|FG001|NOT COMPLETED|Overall Study||2
6725506|NCT03100838|7655136|FG002|NOT COMPLETED|Overall Study||2
6725507|NCT03100838|7655137|FG003|NOT COMPLETED|Overall Study||1
6265307|NCT00014911|7164358|FG000|NOT COMPLETED|Overall Study||11
6725508|NCT03100864|7655147|FG000|STARTED|Overall Study||8
6725509|NCT03100864|7655147|FG000|COMPLETED|Overall Study||8
6725510|NCT03100864|7655147|FG000|NOT COMPLETED|Overall Study||0
6725511|NCT03100942|7655155|FG000|STARTED|Randomized Treatment Period||38
6725512|NCT03100942|7655156|FG001|STARTED|Randomized Treatment Period||38
6725513|NCT03100942|7655157|FG002|STARTED|Randomized Treatment Period||39
6725514|NCT03100942|7655158|FG003|STARTED|Randomized Treatment Period||37
6725515|NCT03100942|7655159|FG004|STARTED|Randomized Treatment Period||0
6725516|NCT03100942|7655160|FG005|STARTED|Randomized Treatment Period||0
6725517|NCT03100942|7655161|FG006|STARTED|Randomized Treatment Period||0
6725518|NCT03100942|7655155|FG000|COMPLETED|Randomized Treatment Period||26
6725519|NCT03100942|7655156|FG001|COMPLETED|Randomized Treatment Period||29
6725520|NCT03100942|7655157|FG002|COMPLETED|Randomized Treatment Period||33
6725521|NCT03100942|7655158|FG003|COMPLETED|Randomized Treatment Period||32
6725522|NCT03100942|7655159|FG004|COMPLETED|Randomized Treatment Period||0
6725523|NCT03100942|7655160|FG005|COMPLETED|Randomized Treatment Period||0
6725524|NCT03100942|7655161|FG006|COMPLETED|Randomized Treatment Period||0
6725525|NCT03100942|7655155|FG000|NOT COMPLETED|Randomized Treatment Period||12
6725526|NCT03100942|7655156|FG001|NOT COMPLETED|Randomized Treatment Period||9
6725527|NCT03100942|7655157|FG002|NOT COMPLETED|Randomized Treatment Period||6
6725528|NCT03100942|7655158|FG003|NOT COMPLETED|Randomized Treatment Period||5
6725529|NCT03100942|7655159|FG004|NOT COMPLETED|Randomized Treatment Period||0
6725530|NCT03100942|7655160|FG005|NOT COMPLETED|Randomized Treatment Period||0
6725531|NCT03100942|7655161|FG006|NOT COMPLETED|Randomized Treatment Period||0
6725532|NCT03100942|7655155|FG000|STARTED|Placebo Arm Re-Randomized||0
6725533|NCT03100942|7655156|FG001|STARTED|Placebo Arm Re-Randomized||0
6725534|NCT03100942|7655157|FG002|STARTED|Placebo Arm Re-Randomized||0
6725535|NCT03100942|7655158|FG003|STARTED|Placebo Arm Re-Randomized||0
6725536|NCT03100942|7655159|FG004|STARTED|Placebo Arm Re-Randomized||10
6725537|NCT03100942|7655160|FG005|STARTED|Placebo Arm Re-Randomized||12
6725538|NCT03100942|7655161|FG006|STARTED|Placebo Arm Re-Randomized||10
6725539|NCT03100942|7655155|FG000|COMPLETED|Placebo Arm Re-Randomized||0
6725540|NCT03100942|7655156|FG001|COMPLETED|Placebo Arm Re-Randomized||0
6725541|NCT03100942|7655157|FG002|COMPLETED|Placebo Arm Re-Randomized||0
6725542|NCT03100942|7655158|FG003|COMPLETED|Placebo Arm Re-Randomized||0
6725543|NCT03100942|7655159|FG004|COMPLETED|Placebo Arm Re-Randomized||10
6725544|NCT03100942|7655160|FG005|COMPLETED|Placebo Arm Re-Randomized||12
6725545|NCT03100942|7655161|FG006|COMPLETED|Placebo Arm Re-Randomized||9
6725546|NCT03100942|7655155|FG000|NOT COMPLETED|Placebo Arm Re-Randomized||0
6725547|NCT03100942|7655156|FG001|NOT COMPLETED|Placebo Arm Re-Randomized||0
6725548|NCT03100942|7655157|FG002|NOT COMPLETED|Placebo Arm Re-Randomized||0
6725549|NCT03100942|7655158|FG003|NOT COMPLETED|Placebo Arm Re-Randomized||0
6725550|NCT03100942|7655159|FG004|NOT COMPLETED|Placebo Arm Re-Randomized||0
6725551|NCT03100942|7655160|FG005|NOT COMPLETED|Placebo Arm Re-Randomized||0
6725552|NCT03100942|7655161|FG006|NOT COMPLETED|Placebo Arm Re-Randomized||1
6725553|NCT03100968|7655176|FG000|STARTED|Overall Study||75
6725554|NCT03100968|7655177|FG001|STARTED|Overall Study||75
6725555|NCT03100968|7655176|FG000|COMPLETED|Overall Study||75
6725556|NCT03100968|7655177|FG001|COMPLETED|Overall Study||75
6725557|NCT03100968|7655176|FG000|NOT COMPLETED|Overall Study||0
6725558|NCT03100968|7655177|FG001|NOT COMPLETED|Overall Study||0
6725559|NCT03101020|7655185|FG000|STARTED|Overall Study||10
6725560|NCT03101020|7655186|FG001|STARTED|Overall Study||10
6392162|NCT00839982|7304158|FG000|STARTED|Overall Study||4
6392163|NCT00839982|7304159|FG001|STARTED|Overall Study||26
6392164|NCT00839982|7304160|FG002|STARTED|Overall Study||2
6392165|NCT00839982|7304161|FG003|STARTED|Overall Study||3
6392166|NCT00839982|7304158|FG000|COMPLETED|Overall Study||4
6392167|NCT00839982|7304159|FG001|COMPLETED|Overall Study||26
6725561|NCT03101020|7655185|FG000|COMPLETED|Overall Study||9
6725562|NCT03101020|7655186|FG001|COMPLETED|Overall Study||7
6725563|NCT03101020|7655185|FG000|NOT COMPLETED|Overall Study||1
6725564|NCT03101020|7655186|FG001|NOT COMPLETED|Overall Study||3
6725565|NCT03101033|7655194|FG000|STARTED|Overall Study||32
6725566|NCT03101033|7655195|FG001|STARTED|Overall Study||60
6725567|NCT03101033|7655194|FG000|COMPLETED|Overall Study||27
6725568|NCT03101033|7655195|FG001|COMPLETED|Overall Study||51
6725569|NCT03101033|7655194|FG000|NOT COMPLETED|Overall Study||5
6725570|NCT03101033|7655195|FG001|NOT COMPLETED|Overall Study||9
6725571|NCT03101111|7655203|FG000|STARTED|Overall Study|First subject signed ICF (MV-CHIK group)|26
6725572|NCT03101111|7655204|FG001|STARTED|Overall Study|First subject signed ICF (MMR group)|8
6725573|NCT03101111|7655203|FG000|COMPLETED|Overall Study|End of Study Visit|23
6725574|NCT03101111|7655204|FG001|COMPLETED|Overall Study|End of Study Visit|7
6725575|NCT03101111|7655203|FG000|NOT COMPLETED|Overall Study||3
6725576|NCT03101111|7655204|FG001|NOT COMPLETED|Overall Study||1
6725577|NCT03101150|7655216|FG000|STARTED|Overall Study||86
6725578|NCT03101150|7655217|FG001|STARTED|Overall Study||93
6725579|NCT03101150|7655216|FG000|COMPLETED|Overall Study||81
6725580|NCT03101150|7655217|FG001|COMPLETED|Overall Study||83
6725581|NCT03101150|7655216|FG000|NOT COMPLETED|Overall Study||5
6725582|NCT03101150|7655217|FG001|NOT COMPLETED|Overall Study||10
6725583|NCT03101241|7655225|FG000|STARTED|Overall Study||48
6725584|NCT03101241|7655226|FG001|STARTED|Overall Study||47
6725585|NCT03101241|7655225|FG000|COMPLETED|Overall Study||37
6725586|NCT03101241|7655226|FG001|COMPLETED|Overall Study||42
6725587|NCT03101241|7655225|FG000|NOT COMPLETED|Overall Study||11
6725588|NCT03101241|7655226|FG001|NOT COMPLETED|Overall Study||5
6725589|NCT03101267|7655235|FG000|STARTED|Primary Study Period||50
6725590|NCT03101267|7655236|FG001|STARTED|Primary Study Period||50
6725591|NCT03101267|7655237|FG002|STARTED|Primary Study Period||50
6725592|NCT03101267|7655235|FG000|COMPLETED|Primary Study Period||47
6725593|NCT03101267|7655236|FG001|COMPLETED|Primary Study Period||48
6725594|NCT03101267|7655237|FG002|COMPLETED|Primary Study Period||47
6725595|NCT03101267|7655235|FG000|NOT COMPLETED|Primary Study Period||3
6725596|NCT03101267|7655236|FG001|NOT COMPLETED|Primary Study Period||2
6725597|NCT03101267|7655237|FG002|NOT COMPLETED|Primary Study Period||3
6725598|NCT03101267|7655235|FG000|STARTED|Pollinosis Symptoms Survey Period||47
6725599|NCT03101267|7655236|FG001|STARTED|Pollinosis Symptoms Survey Period||48
6725600|NCT03101267|7655237|FG002|STARTED|Pollinosis Symptoms Survey Period||47
6725601|NCT03101267|7655235|FG000|COMPLETED|Pollinosis Symptoms Survey Period||47
6725602|NCT03101267|7655236|FG001|COMPLETED|Pollinosis Symptoms Survey Period||48
6725603|NCT03101267|7655237|FG002|COMPLETED|Pollinosis Symptoms Survey Period||47
6725604|NCT03101267|7655235|FG000|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
6725605|NCT03101267|7655236|FG001|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
6725606|NCT03101267|7655237|FG002|NOT COMPLETED|Pollinosis Symptoms Survey Period||0
6725607|NCT03101293|7655247|FG000|STARTED|Intervention Period 1||7
6725608|NCT03101293|7655248|FG001|STARTED|Intervention Period 1||8
6725609|NCT03101293|7655247|FG000|COMPLETED|Intervention Period 1||7
6725610|NCT03101293|7655248|FG001|COMPLETED|Intervention Period 1||8
6725611|NCT03101293|7655247|FG000|NOT COMPLETED|Intervention Period 1||0
6725612|NCT03101293|7655248|FG001|NOT COMPLETED|Intervention Period 1||0
6725613|NCT03101293|7655247|FG000|STARTED|Washout Period (at Least 7 Days)||7
6725614|NCT03101293|7655248|FG001|STARTED|Washout Period (at Least 7 Days)||8
6725615|NCT03101293|7655247|FG000|COMPLETED|Washout Period (at Least 7 Days)||6
6725616|NCT03101293|7655248|FG001|COMPLETED|Washout Period (at Least 7 Days)||8
6725617|NCT03101293|7655247|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||1
6725618|NCT03101293|7655248|FG001|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6725619|NCT03101293|7655247|FG000|STARTED|Intervention Period 2||6
6725620|NCT03101293|7655248|FG001|STARTED|Intervention Period 2||8
6725621|NCT03101293|7655247|FG000|COMPLETED|Intervention Period 2||6
6725622|NCT03101293|7655248|FG001|COMPLETED|Intervention Period 2||8
6725623|NCT03101293|7655247|FG000|NOT COMPLETED|Intervention Period 2||0
6725624|NCT03101293|7655248|FG001|NOT COMPLETED|Intervention Period 2||0
6725625|NCT03101358|7655258|FG000|STARTED|Overall Study||4
6725626|NCT03101358|7655259|FG001|STARTED|Overall Study||3
6725627|NCT03101358|7655260|FG002|STARTED|Overall Study||5
6725628|NCT03101358|7655261|FG003|STARTED|Overall Study||11
6265308|NCT00015457|7164362|FG000|STARTED|First Intervention||8
6265309|NCT00015457|7164363|FG001|STARTED|First Intervention||8
6265310|NCT00015457|7164362|FG000|COMPLETED|First Intervention||8
6265311|NCT00015457|7164363|FG001|COMPLETED|First Intervention||5
6265312|NCT00015457|7164362|FG000|NOT COMPLETED|First Intervention||0
6265313|NCT00015457|7164363|FG001|NOT COMPLETED|First Intervention||3
6265314|NCT00015457|7164362|FG000|STARTED|Second Intervention||8
6265315|NCT00015457|7164363|FG001|STARTED|Second Intervention||5
6265316|NCT00015457|7164362|FG000|COMPLETED|Second Intervention||7
6265317|NCT00015457|7164363|FG001|COMPLETED|Second Intervention||5
6265318|NCT00015457|7164362|FG000|NOT COMPLETED|Second Intervention||1
6265319|NCT00015457|7164363|FG001|NOT COMPLETED|Second Intervention||0
6265320|NCT00015847|7164369|FG000|STARTED|Overall Study||25
6265321|NCT00015847|7164369|FG000|COMPLETED|Overall Study||25
6265322|NCT00015847|7164369|FG000|NOT COMPLETED|Overall Study||0
6265323|NCT00016354|7164373|FG000|STARTED|Overall Study||1
6265324|NCT00016354|7164374|FG001|STARTED|Overall Study||1
6265325|NCT00016354|7164375|FG002|STARTED|Overall Study||1
6265326|NCT00016354|7164376|FG003|STARTED|Overall Study||1
6265327|NCT00016354|7164377|FG004|STARTED|Overall Study||1
6265328|NCT00016354|7164378|FG005|STARTED|Overall Study||1
6265329|NCT00016354|7164379|FG006|STARTED|Overall Study||6
6265330|NCT00016354|7164380|FG007|STARTED|Overall Study||7
6265331|NCT00016354|7164373|FG000|COMPLETED|Overall Study||1
6265332|NCT00016354|7164374|FG001|COMPLETED|Overall Study||1
6265333|NCT00016354|7164375|FG002|COMPLETED|Overall Study||1
6265334|NCT00016354|7164376|FG003|COMPLETED|Overall Study||1
6265335|NCT00016354|7164377|FG004|COMPLETED|Overall Study||1
6265336|NCT00016354|7164378|FG005|COMPLETED|Overall Study||1
6265337|NCT00016354|7164379|FG006|COMPLETED|Overall Study||6
6265338|NCT00016354|7164380|FG007|COMPLETED|Overall Study||6
6265339|NCT00016354|7164373|FG000|NOT COMPLETED|Overall Study||0
6265340|NCT00016354|7164374|FG001|NOT COMPLETED|Overall Study||0
6265341|NCT00016354|7164375|FG002|NOT COMPLETED|Overall Study||0
6265342|NCT00016354|7164376|FG003|NOT COMPLETED|Overall Study||0
6265343|NCT00016354|7164377|FG004|NOT COMPLETED|Overall Study||0
6265344|NCT00016354|7164378|FG005|NOT COMPLETED|Overall Study||0
6265345|NCT00016354|7164379|FG006|NOT COMPLETED|Overall Study||0
6265346|NCT00016354|7164380|FG007|NOT COMPLETED|Overall Study||1
6265347|NCT00016718|7164387|FG000|STARTED|Overall Study||6
6265348|NCT00016718|7164388|FG001|STARTED|Overall Study||21
6265349|NCT00016718|7164389|FG002|STARTED|Overall Study||16
6265350|NCT00016718|7164387|FG000|COMPLETED|Overall Study||6
6265351|NCT00016718|7164388|FG001|COMPLETED|Overall Study||21
6265352|NCT00016718|7164389|FG002|COMPLETED|Overall Study||16
6265353|NCT00016718|7164387|FG000|NOT COMPLETED|Overall Study||0
6265354|NCT00016718|7164388|FG001|NOT COMPLETED|Overall Study||0
6265355|NCT00016718|7164389|FG002|NOT COMPLETED|Overall Study||0
6725629|NCT03101358|7655258|FG000|Completed All Dosing|Overall Study||3
6725630|NCT03101358|7655259|FG001|Completed All Dosing|Overall Study||3
6725631|NCT03101358|7655260|FG002|Completed All Dosing|Overall Study||3
6725632|NCT03101358|7655261|FG003|Completed All Dosing|Overall Study||10
6725633|NCT03101358|7655258|FG000|COMPLETED|Overall Study||1
6725634|NCT03101358|7655259|FG001|COMPLETED|Overall Study||3
6725635|NCT03101358|7655260|FG002|COMPLETED|Overall Study||3
6725636|NCT03101358|7655261|FG003|COMPLETED|Overall Study||5
6725637|NCT03101358|7655258|FG000|NOT COMPLETED|Overall Study||3
6725638|NCT03101358|7655259|FG001|NOT COMPLETED|Overall Study||0
6725639|NCT03101358|7655260|FG002|NOT COMPLETED|Overall Study||2
6725640|NCT03101358|7655261|FG003|NOT COMPLETED|Overall Study||6
6725641|NCT03101371|7655274|FG000|STARTED|Overall Study||48
6725642|NCT03101371|7655275|FG001|STARTED|Overall Study||51
6725643|NCT03101371|7655274|FG000|COMPLETED|Overall Study||45
6725644|NCT03101371|7655275|FG001|COMPLETED|Overall Study||45
6725645|NCT03101371|7655274|FG000|NOT COMPLETED|Overall Study||3
6725646|NCT03101371|7655275|FG001|NOT COMPLETED|Overall Study||6
6725647|NCT03101462|7655283|FG000|STARTED|Overall Study||19
6725648|NCT03101462|7655284|FG001|STARTED|Overall Study||19
6265356|NCT00016913|7164397|FG000|STARTED|Overall Study||27
6265357|NCT00016913|7164397|FG000|COMPLETED|Overall Study||27
6265358|NCT00016913|7164397|FG000|NOT COMPLETED|Overall Study||0
6265359|NCT00017563|7164401|FG000|STARTED|Overall Study||57
6265360|NCT00017563|7164401|FG000|COMPLETED|Overall Study||56
6265361|NCT00017563|7164401|FG000|NOT COMPLETED|Overall Study||1
6265362|NCT00018031|7164405|FG000|STARTED|Overall Study||36
6265363|NCT00018031|7164405|FG000|COMPLETED|Overall Study||36
6265364|NCT00018031|7164405|FG000|NOT COMPLETED|Overall Study||0
6265365|NCT00019604|7164409|FG000|STARTED|Overall Study||44
6265366|NCT00019604|7164409|FG000|COMPLETED|Overall Study||5
6265367|NCT00019604|7164409|FG000|NOT COMPLETED|Overall Study||39
6265368|NCT00019682|7164415|FG000|STARTED|Overall Study||94
6265369|NCT00019682|7164416|FG001|STARTED|Overall Study||91
6265370|NCT00019682|7164415|FG000|COMPLETED|Overall Study||93
6265371|NCT00019682|7164416|FG001|COMPLETED|Overall Study||85
6265372|NCT00019682|7164415|FG000|NOT COMPLETED|Overall Study||1
6265373|NCT00019682|7164416|FG001|NOT COMPLETED|Overall Study||6
6265374|NCT00021229|7164425|FG000|STARTED|Overall Study||36
6265375|NCT00021229|7164426|FG001|STARTED|Overall Study||33
6265376|NCT00021229|7164427|FG002|STARTED|Overall Study||16
6265377|NCT00021229|7164425|FG000|Enrolled in Phase I|Overall Study||35
6265378|NCT00021229|7164426|FG001|Enrolled in Phase I|Overall Study||33
6265379|NCT00021229|7164427|FG002|Enrolled in Phase I|Overall Study||16
6265380|NCT00021229|7164425|FG000|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
6265381|NCT00021229|7164426|FG001|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
6265382|NCT00021229|7164427|FG002|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
6265383|NCT00021229|7164425|FG000|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
6265384|NCT00021229|7164426|FG001|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
6265385|NCT00021229|7164427|FG002|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
6265386|NCT00021229|7164425|FG000|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
6265387|NCT00021229|7164426|FG001|COMPLETED|Overall Study||0
6265388|NCT00021229|7164427|FG002|COMPLETED|Overall Study||0
6265389|NCT00021229|7164425|FG000|NOT COMPLETED|Overall Study||35
6265390|NCT00021229|7164426|FG001|NOT COMPLETED|Overall Study||33
6265391|NCT00021229|7164427|FG002|NOT COMPLETED|Overall Study||16
6265392|NCT00021255|7164440|FG000|STARTED|Overall Study|Randomized|1073
6265393|NCT00021255|7164441|FG001|STARTED|Overall Study|Randomized|1074
6265394|NCT00021255|7164442|FG002|STARTED|Overall Study|Randomized|1075
6265395|NCT00021255|7164440|FG000|Treated|Overall Study||1045
6265396|NCT00021255|7164441|FG001|Treated|Overall Study||1072
6265397|NCT00021255|7164442|FG002|Treated|Overall Study||1057
6265398|NCT00021255|7164440|FG000|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
6265399|NCT00021255|7164441|FG001|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
6265400|NCT00021255|7164442|FG002|Safety Population|Overall Study|1056 participants received TCH.|1056
6265401|NCT00021255|7164440|FG000|COMPLETED|Overall Study||952
6265402|NCT00021255|7164441|FG001|COMPLETED|Overall Study||804
6265403|NCT00021255|7164442|FG002|COMPLETED|Overall Study||926
6265404|NCT00021255|7164440|FG000|NOT COMPLETED|Overall Study||121
6265405|NCT00021255|7164441|FG001|NOT COMPLETED|Overall Study||270
6265406|NCT00021255|7164442|FG002|NOT COMPLETED|Overall Study||149
6265407|NCT00021541|7164452|FG000|STARTED|Period 1-First Treatment||31
6265408|NCT00021541|7164453|FG001|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
6265409|NCT00021541|7164452|FG000|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
6265410|NCT00021541|7164453|FG001|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
6265411|NCT00021541|7164452|FG000|Ineligible Patients|Period 1-First Treatment||0
6265412|NCT00021541|7164453|FG001|Ineligible Patients|Period 1-First Treatment||2
6265413|NCT00021541|7164452|FG000|COMPLETED|Period 1-First Treatment||20
6725649|NCT03101462|7655283|FG000|COMPLETED|Overall Study||18
6725650|NCT03101462|7655284|FG001|COMPLETED|Overall Study||18
6725651|NCT03101462|7655283|FG000|NOT COMPLETED|Overall Study||1
6725652|NCT03101462|7655284|FG001|NOT COMPLETED|Overall Study||1
6265414|NCT00021541|7164453|FG001|COMPLETED|Period 1-First Treatment||23
6265415|NCT00021541|7164452|FG000|NOT COMPLETED|Period 1-First Treatment||11
6265416|NCT00021541|7164453|FG001|NOT COMPLETED|Period 1-First Treatment||8
6265417|NCT00021541|7164452|FG000|STARTED|Period 2-crossover||20
6265418|NCT00021541|7164453|FG001|STARTED|Period 2-crossover||23
6265419|NCT00021541|7164452|FG000|COMPLETED|Period 2-crossover||10
6265420|NCT00021541|7164453|FG001|COMPLETED|Period 2-crossover||12
6265421|NCT00021541|7164452|FG000|NOT COMPLETED|Period 2-crossover||10
6265422|NCT00021541|7164453|FG001|NOT COMPLETED|Period 2-crossover||11
6265423|NCT00022490|7164461|FG000|STARTED|Overall Study||24
6265424|NCT00022490|7164461|FG000|COMPLETED|Overall Study||24
6265425|NCT00022490|7164461|FG000|NOT COMPLETED|Overall Study||0
6265426|NCT00022516|7164467|FG000|STARTED|Overall Study||542
6265427|NCT00022516|7164468|FG001|STARTED|Overall Study||544
6265428|NCT00022516|7164467|FG000|COMPLETED|Overall Study||539
6265429|NCT00022516|7164468|FG001|COMPLETED|Overall Study||314
6265430|NCT00022516|7164467|FG000|NOT COMPLETED|Overall Study||3
6265431|NCT00022516|7164468|FG001|NOT COMPLETED|Overall Study||230
6265432|NCT00022633|7164476|FG000|STARTED|Overall Study||55
6265433|NCT00022633|7164477|FG001|STARTED|Overall Study||10
6265434|NCT00022633|7164476|FG000|Eligible|Overall Study||51
6265435|NCT00022633|7164477|FG001|Eligible|Overall Study||10
6265436|NCT00022633|7164476|FG000|COMPLETED|Overall Study||23
6265437|NCT00022633|7164477|FG001|COMPLETED|Overall Study||5
6265438|NCT00022633|7164476|FG000|NOT COMPLETED|Overall Study||32
6265439|NCT00022633|7164477|FG001|NOT COMPLETED|Overall Study||5
6265440|NCT00022659|7164482|FG000|STARTED|Overall Study||64
6265441|NCT00022659|7164482|FG000|COMPLETED|Overall Study|Eligible and treated patients.|62
6265442|NCT00022659|7164482|FG000|NOT COMPLETED|Overall Study||2
6265443|NCT00022672|7164492|FG000|STARTED|Main Phase: 24 Months||103
6265444|NCT00022672|7164493|FG001|STARTED|Main Phase: 24 Months||104
6265445|NCT00022672|7164492|FG000|Safety Set: Received Study Drug|Main Phase: 24 Months||103
6265446|NCT00022672|7164493|FG001|Safety Set: Received Study Drug|Main Phase: 24 Months||104
6265447|NCT00022672|7164492|FG000|COMPLETED|Main Phase: 24 Months||16
6265448|NCT00022672|7164493|FG001|COMPLETED|Main Phase: 24 Months||4
6265449|NCT00022672|7164492|FG000|NOT COMPLETED|Main Phase: 24 Months||87
6265450|NCT00022672|7164493|FG001|NOT COMPLETED|Main Phase: 24 Months||100
6265451|NCT00022672|7164492|FG000|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
6265452|NCT00022672|7164493|FG001|STARTED|Extension Phase||58
6265453|NCT00022672|7164492|FG000|Safety Set: Received Study Drug|Extension Phase||14
6265454|NCT00022672|7164493|FG001|Safety Set: Received Study Drug|Extension Phase||58
6265455|NCT00022672|7164492|FG000|COMPLETED|Extension Phase||11
6265456|NCT00022672|7164493|FG001|COMPLETED|Extension Phase||7
6265457|NCT00022672|7164492|FG000|NOT COMPLETED|Extension Phase||3
6265458|NCT00022672|7164493|FG001|NOT COMPLETED|Extension Phase||51
6265459|NCT00022698|7164502|FG000|STARTED|Overall Study||15
6265460|NCT00022698|7164503|FG001|STARTED|Overall Study||52
6265461|NCT00022698|7164502|FG000|COMPLETED|Overall Study||7
6265462|NCT00022698|7164503|FG001|COMPLETED|Overall Study||17
6265463|NCT00022698|7164502|FG000|NOT COMPLETED|Overall Study||8
6725653|NCT03101514|7655290|FG000|STARTED|Overall Study||53
6725654|NCT03101514|7655290|FG000|COMPLETED|Overall Study||46
6725655|NCT03101514|7655290|FG000|NOT COMPLETED|Overall Study||7
6725656|NCT03101592|7655297|FG000|STARTED|Overall Study||3123
6725657|NCT03101592|7655298|FG001|STARTED|Overall Study||2896
6725658|NCT03101592|7655299|FG002|STARTED|Overall Study||3099
6725659|NCT03101592|7655297|FG000|COMPLETED|Overall Study||3012
6725660|NCT03101592|7655298|FG001|COMPLETED|Overall Study||2726
6725661|NCT03101592|7655299|FG002|COMPLETED|Overall Study||2981
6725662|NCT03101592|7655297|FG000|NOT COMPLETED|Overall Study||111
6725663|NCT03101592|7655298|FG001|NOT COMPLETED|Overall Study||170
6725664|NCT03101592|7655299|FG002|NOT COMPLETED|Overall Study||118
6725665|NCT03102190|7655313|FG000|STARTED|Overall Study||6
6725666|NCT03102190|7655313|FG000|COMPLETED|Overall Study||6
6725667|NCT03102190|7655313|FG000|NOT COMPLETED|Overall Study||0
6725668|NCT03102411|7655317|FG000|STARTED|Overall Study||1881
6725669|NCT03102411|7655317|FG000|COMPLETED|Overall Study||1718
6725670|NCT03102411|7655317|FG000|NOT COMPLETED|Overall Study||163
6725671|NCT03102437|7655324|FG000|STARTED|Overall Study||70
6725672|NCT03102437|7655325|FG001|STARTED|Overall Study||36
6725673|NCT03102437|7655324|FG000|COMPLETED|Overall Study||65
6725674|NCT03102437|7655325|FG001|COMPLETED|Overall Study||36
6725675|NCT03102437|7655324|FG000|NOT COMPLETED|Overall Study||5
6725676|NCT03102437|7655325|FG001|NOT COMPLETED|Overall Study||0
6725677|NCT03102645|7655333|FG000|STARTED|Overall Study||8
6725678|NCT03102645|7655334|FG001|STARTED|Overall Study||8
6725679|NCT03102645|7655333|FG000|COMPLETED|Overall Study||8
6725680|NCT03102645|7655334|FG001|COMPLETED|Overall Study||8
6725681|NCT03102645|7655333|FG000|NOT COMPLETED|Overall Study||0
6725682|NCT03102645|7655334|FG001|NOT COMPLETED|Overall Study||0
6725683|NCT03102710|7655344|FG000|STARTED|Overall Study||28
6725684|NCT03102710|7655345|FG001|STARTED|Overall Study||30
6725685|NCT03102710|7655346|FG002|STARTED|Overall Study||27
6725686|NCT03102710|7655344|FG000|COMPLETED|Overall Study||27
6725687|NCT03102710|7655345|FG001|COMPLETED|Overall Study||27
6725688|NCT03102710|7655346|FG002|COMPLETED|Overall Study||27
6725689|NCT03102710|7655344|FG000|NOT COMPLETED|Overall Study||1
6725690|NCT03102710|7655345|FG001|NOT COMPLETED|Overall Study||3
6725691|NCT03102710|7655346|FG002|NOT COMPLETED|Overall Study||0
6725692|NCT03102736|7655356|FG000|STARTED|Overall Study||7
6725693|NCT03102736|7655357|FG001|STARTED|Overall Study||9
6725694|NCT03102736|7655356|FG000|COMPLETED|Overall Study||7
6725695|NCT03102736|7655357|FG001|COMPLETED|Overall Study||9
6725696|NCT03102736|7655356|FG000|NOT COMPLETED|Overall Study||0
6725697|NCT03102736|7655357|FG001|NOT COMPLETED|Overall Study||0
6725698|NCT03102762|7655365|FG000|STARTED|Overall Study||35
6725699|NCT03102762|7655366|FG001|STARTED|Overall Study||35
6725700|NCT03102762|7655365|FG000|COMPLETED|Overall Study||34
6725701|NCT03102762|7655366|FG001|COMPLETED|Overall Study||35
6725702|NCT03102762|7655365|FG000|NOT COMPLETED|Overall Study||1
6725703|NCT03102762|7655366|FG001|NOT COMPLETED|Overall Study||0
6725704|NCT03102879|7655375|FG000|STARTED|Overall Study||18
6725705|NCT03102879|7655376|FG001|STARTED|Overall Study||18
6725706|NCT03102879|7655375|FG000|COMPLETED|Overall Study||18
6725707|NCT03102879|7655376|FG001|COMPLETED|Overall Study||18
6725708|NCT03102879|7655375|FG000|NOT COMPLETED|Overall Study||0
6725709|NCT03102879|7655376|FG001|NOT COMPLETED|Overall Study||0
6725710|NCT03102918|7655388|FG000|STARTED|Overall Study||5
6725711|NCT03102918|7655389|FG001|STARTED|Overall Study||5
6725712|NCT03102918|7655388|FG000|COMPLETED|Overall Study||4
6725713|NCT03102918|7655389|FG001|COMPLETED|Overall Study||5
6725714|NCT03102918|7655388|FG000|NOT COMPLETED|Overall Study||1
6725715|NCT03102918|7655389|FG001|NOT COMPLETED|Overall Study||0
6725716|NCT03103061|7655395|FG000|STARTED|Overall Study||24
6725717|NCT03103061|7655395|FG000|COMPLETED|Overall Study||24
6725718|NCT03103061|7655395|FG000|NOT COMPLETED|Overall Study||0
6725719|NCT03103100|7655402|FG000|STARTED|Overall Study||25
6725720|NCT03103100|7655403|FG001|STARTED|Overall Study||25
6725721|NCT03103100|7655404|FG002|STARTED|Overall Study||25
6725722|NCT03103100|7655402|FG000|COMPLETED|Overall Study||23
6725723|NCT03103100|7655403|FG001|COMPLETED|Overall Study||25
6725724|NCT03103100|7655404|FG002|COMPLETED|Overall Study||23
6725725|NCT03103100|7655402|FG000|NOT COMPLETED|Overall Study||2
6725726|NCT03103100|7655403|FG001|NOT COMPLETED|Overall Study||0
6725727|NCT03103100|7655404|FG002|NOT COMPLETED|Overall Study||2
6725728|NCT03103282|7655412|FG000|STARTED|Overall Study||65
6725729|NCT03103282|7655412|FG000|COMPLETED|Overall Study||65
6725730|NCT03103282|7655412|FG000|NOT COMPLETED|Overall Study||0
6725731|NCT03103438|7655423|FG000|STARTED|Overall Study||1
6725732|NCT03103438|7655424|FG001|STARTED|Overall Study||3
6725733|NCT03103438|7655425|FG002|STARTED|Overall Study||3
6725734|NCT03103438|7655426|FG003|STARTED|Overall Study||3
6725735|NCT03103438|7655427|FG004|STARTED|Overall Study||3
6725736|NCT03103438|7655428|FG005|STARTED|Overall Study||3
6725737|NCT03103438|7655429|FG006|STARTED|Overall Study||3
6725738|NCT03103438|7655423|FG000|COMPLETED|Overall Study||1
6725739|NCT03103438|7655424|FG001|COMPLETED|Overall Study||3
6725740|NCT03103438|7655425|FG002|COMPLETED|Overall Study||3
6725741|NCT03103438|7655426|FG003|COMPLETED|Overall Study||3
6725742|NCT03103438|7655427|FG004|COMPLETED|Overall Study||3
6725743|NCT03103438|7655428|FG005|COMPLETED|Overall Study||3
6725744|NCT03103438|7655429|FG006|COMPLETED|Overall Study||3
6725745|NCT03103438|7655423|FG000|NOT COMPLETED|Overall Study||0
6725746|NCT03103438|7655424|FG001|NOT COMPLETED|Overall Study||0
6725747|NCT03103438|7655425|FG002|NOT COMPLETED|Overall Study||0
6725748|NCT03103438|7655426|FG003|NOT COMPLETED|Overall Study||0
6725749|NCT03103438|7655427|FG004|NOT COMPLETED|Overall Study||0
6725750|NCT03103438|7655428|FG005|NOT COMPLETED|Overall Study||0
6725751|NCT03103438|7655429|FG006|NOT COMPLETED|Overall Study||0
6725752|NCT03103503|7655445|FG000|STARTED|Overall Study||901
6725753|NCT03103503|7655445|FG000|COMPLETED|Overall Study||0
6725754|NCT03103503|7655445|FG000|NOT COMPLETED|Overall Study||901
6725755|NCT03103763|7655452|FG000|STARTED|Overall Study||44
6725756|NCT03103763|7655453|FG001|STARTED|Overall Study||44
6725757|NCT03103763|7655454|FG002|STARTED|Overall Study||44
6725758|NCT03103763|7655452|FG000|COMPLETED|Overall Study||29
6725759|NCT03103763|7655453|FG001|COMPLETED|Overall Study||36
6725760|NCT03103763|7655454|FG002|COMPLETED|Overall Study||37
6725761|NCT03103763|7655452|FG000|NOT COMPLETED|Overall Study||15
6725762|NCT03103763|7655453|FG001|NOT COMPLETED|Overall Study||8
6725763|NCT03103763|7655454|FG002|NOT COMPLETED|Overall Study||7
6725764|NCT03103906|7655464|FG000|STARTED|Overall Study||40
6725765|NCT03103906|7655465|FG001|STARTED|Overall Study||42
6725766|NCT03103906|7655464|FG000|COMPLETED|Overall Study||36
6725767|NCT03103906|7655465|FG001|COMPLETED|Overall Study||39
6725768|NCT03103906|7655464|FG000|NOT COMPLETED|Overall Study||4
6725769|NCT03103906|7655465|FG001|NOT COMPLETED|Overall Study||3
6725770|NCT03103919|7655473|FG000|STARTED|Overall Study||20
6725771|NCT03103919|7655474|FG001|STARTED|Overall Study||19
6725772|NCT03103919|7655473|FG000|COMPLETED|Overall Study||18
6725773|NCT03103919|7655474|FG001|COMPLETED|Overall Study||17
6725774|NCT03103919|7655473|FG000|NOT COMPLETED|Overall Study||2
6725775|NCT03103919|7655474|FG001|NOT COMPLETED|Overall Study||2
6725776|NCT03104192|7655486|FG000|STARTED|Overall Study||9
6725777|NCT03104192|7655487|FG001|STARTED|Overall Study||27
6725778|NCT03104192|7655488|FG002|STARTED|Overall Study||16
6725779|NCT03104192|7655489|FG003|STARTED|Overall Study||17
6725780|NCT03104192|7655486|FG000|COMPLETED|Overall Study||9
6725781|NCT03104192|7655487|FG001|COMPLETED|Overall Study||23
6725782|NCT03104192|7655488|FG002|COMPLETED|Overall Study||14
6725783|NCT03104192|7655489|FG003|COMPLETED|Overall Study||14
6725784|NCT03104192|7655486|FG000|NOT COMPLETED|Overall Study||0
6725785|NCT03104192|7655487|FG001|NOT COMPLETED|Overall Study||4
6725786|NCT03104192|7655488|FG002|NOT COMPLETED|Overall Study||2
6725787|NCT03104192|7655489|FG003|NOT COMPLETED|Overall Study||3
6725788|NCT03104322|7655505|FG000|STARTED|Overall Study||7
6725789|NCT03104322|7655505|FG000|COMPLETED|Overall Study||6
6725790|NCT03104322|7655505|FG000|NOT COMPLETED|Overall Study||1
6725791|NCT03104647|7655509|FG000|STARTED|Overall Study||20
6725792|NCT03104647|7655509|FG000|COMPLETED|Overall Study||20
6725793|NCT03104647|7655509|FG000|NOT COMPLETED|Overall Study||0
6725794|NCT03104725|7655515|FG000|STARTED|Overall Study||2
6725795|NCT03104725|7655516|FG001|STARTED|Overall Study||4
6725796|NCT03104725|7655515|FG000|COMPLETED|Overall Study||2
6725797|NCT03104725|7655516|FG001|COMPLETED|Overall Study||4
6725798|NCT03104725|7655515|FG000|NOT COMPLETED|Overall Study||0
6725799|NCT03104725|7655516|FG001|NOT COMPLETED|Overall Study||0
6725800|NCT03104738|7655524|FG000|STARTED|Overall Study||20
6725801|NCT03104738|7655525|FG001|STARTED|Overall Study||20
6725802|NCT03104738|7655524|FG000|COMPLETED|Overall Study||20
6725803|NCT03104738|7655525|FG001|COMPLETED|Overall Study||20
6725804|NCT03104738|7655524|FG000|NOT COMPLETED|Overall Study||0
6725805|NCT03104738|7655525|FG001|NOT COMPLETED|Overall Study||0
6725806|NCT03104816|7655534|FG000|STARTED|Overall Study||11
6725807|NCT03104816|7655535|FG001|STARTED|Overall Study||11
6725808|NCT03104816|7655536|FG002|STARTED|Overall Study||6
6725809|NCT03104816|7655534|FG000|COMPLETED|Overall Study||9
6725810|NCT03104816|7655535|FG001|COMPLETED|Overall Study||9
6725811|NCT03104816|7655536|FG002|COMPLETED|Overall Study||4
6725812|NCT03104816|7655534|FG000|NOT COMPLETED|Overall Study||2
6725813|NCT03104816|7655535|FG001|NOT COMPLETED|Overall Study||2
6725814|NCT03104816|7655536|FG002|NOT COMPLETED|Overall Study||2
6725815|NCT03104985|7655546|FG000|STARTED|Overall Study||34
6725816|NCT03104985|7655547|FG001|STARTED|Overall Study||34
6725817|NCT03104985|7655546|FG000|COMPLETED|Overall Study||34
6725818|NCT03104985|7655547|FG001|COMPLETED|Overall Study||34
6725819|NCT03104985|7655546|FG000|NOT COMPLETED|Overall Study||0
6725820|NCT03104985|7655547|FG001|NOT COMPLETED|Overall Study||0
6725821|NCT03105297|7655553|FG000|STARTED|Baseline Phase (Day 1)||91
6725822|NCT03105297|7655553|FG000|COMPLETED|Baseline Phase (Day 1)||70
6725823|NCT03105297|7655553|FG000|NOT COMPLETED|Baseline Phase (Day 1)||21
6725824|NCT03105297|7655553|FG000|STARTED|Active Phase (Day 2-29)||70
6725825|NCT03105297|7655553|FG000|COMPLETED|Active Phase (Day 2-29)||70
6725826|NCT03105297|7655553|FG000|NOT COMPLETED|Active Phase (Day 2-29)||0
6725827|NCT03105297|7655553|FG000|STARTED|Nasal Resistance Phase (Day 30, 31)|14 participants withdrew from the study after the completion of active phase|56
6725828|NCT03105297|7655553|FG000|Treated|Nasal Resistance Phase (Day 30, 31)||55
6725829|NCT03105297|7655553|FG000|COMPLETED|Nasal Resistance Phase (Day 30, 31)||48
6725830|NCT03105297|7655553|FG000|NOT COMPLETED|Nasal Resistance Phase (Day 30, 31)||8
6725831|NCT03105362|7655564|FG000|STARTED|Overall Study||4
6725832|NCT03105362|7655564|FG000|Completed 1 Week of Study|Overall Study||4
6725833|NCT03105362|7655564|FG000|Completed 2 Weeks of Study|Overall Study||3
6725834|NCT03105362|7655564|FG000|Completed 2 Week Questionaire|Overall Study||2
6725835|NCT03105362|7655564|FG000|COMPLETED|Overall Study||2
6725836|NCT03105362|7655564|FG000|NOT COMPLETED|Overall Study||2
6725837|NCT03105479|7655571|FG000|STARTED|Overall Study||1
6725838|NCT03105479|7655572|FG001|STARTED|Overall Study||0
6725839|NCT03105479|7655573|FG002|STARTED|Overall Study||0
6725840|NCT03105479|7655574|FG003|STARTED|Overall Study||0
6725841|NCT03105479|7655575|FG004|STARTED|Overall Study||0
6725842|NCT03105479|7655576|FG005|STARTED|Overall Study||0
6725843|NCT03105479|7655577|FG006|STARTED|Overall Study||0
6725844|NCT03105479|7655571|FG000|COMPLETED|Overall Study||1
6725845|NCT03105479|7655572|FG001|COMPLETED|Overall Study||0
6725846|NCT03105479|7655573|FG002|COMPLETED|Overall Study||0
6725847|NCT03105479|7655574|FG003|COMPLETED|Overall Study||0
6725848|NCT03105479|7655575|FG004|COMPLETED|Overall Study||0
6725849|NCT03105479|7655576|FG005|COMPLETED|Overall Study||0
6725850|NCT03105479|7655577|FG006|COMPLETED|Overall Study||0
6725851|NCT03105479|7655571|FG000|NOT COMPLETED|Overall Study||0
6725852|NCT03105479|7655572|FG001|NOT COMPLETED|Overall Study||0
6725853|NCT03105479|7655573|FG002|NOT COMPLETED|Overall Study||0
6725854|NCT03105479|7655574|FG003|NOT COMPLETED|Overall Study||0
6725855|NCT03105479|7655575|FG004|NOT COMPLETED|Overall Study||0
6725856|NCT03105479|7655576|FG005|NOT COMPLETED|Overall Study||0
6725857|NCT03105479|7655577|FG006|NOT COMPLETED|Overall Study||0
6725858|NCT03105518|7655584|FG000|STARTED|Overall Study||100
6725859|NCT03105518|7655584|FG000|COMPLETED|Overall Study||100
6725860|NCT03105518|7655584|FG000|NOT COMPLETED|Overall Study||0
6725861|NCT03106077|7655588|FG000|STARTED|Overall Study||96
6725862|NCT03106077|7655589|FG001|STARTED|Overall Study||0
6725863|NCT03106077|7655588|FG000|COMPLETED|Overall Study||2
6725864|NCT03106077|7655589|FG001|COMPLETED|Overall Study||0
6725865|NCT03106077|7655588|FG000|NOT COMPLETED|Overall Study||94
6725866|NCT03106077|7655589|FG001|NOT COMPLETED|Overall Study||0
6725867|NCT03106337|7655594|FG000|STARTED|Overall Study||35
6725868|NCT03106337|7655594|FG000|COMPLETED|Overall Study||35
6725869|NCT03106337|7655594|FG000|NOT COMPLETED|Overall Study||0
6725870|NCT03106636|7655601|FG000|STARTED|Overall Study||226
6725871|NCT03106636|7655602|FG001|STARTED|Overall Study||190
6725872|NCT03106636|7655601|FG000|COMPLETED|Overall Study||182
6725873|NCT03106636|7655602|FG001|COMPLETED|Overall Study||164
6725874|NCT03106636|7655601|FG000|NOT COMPLETED|Overall Study||44
6725875|NCT03106636|7655602|FG001|NOT COMPLETED|Overall Study||26
6725876|NCT03106753|7655610|FG000|STARTED|Overall Study||17
6725877|NCT03106753|7655611|FG001|STARTED|Overall Study||17
6725878|NCT03106753|7655610|FG000|COMPLETED|Overall Study||17
6725879|NCT03106753|7655611|FG001|COMPLETED|Overall Study||16
6725880|NCT03106753|7655610|FG000|NOT COMPLETED|Overall Study||0
6725881|NCT03106753|7655611|FG001|NOT COMPLETED|Overall Study||1
6725882|NCT03106844|7655619|FG000|STARTED|Overall Study||50
6725883|NCT03106844|7655619|FG000|COMPLETED|Overall Study||49
6725884|NCT03106844|7655619|FG000|NOT COMPLETED|Overall Study||1
6725885|NCT03106870|7655625|FG000|STARTED|Overall Study||31
6725886|NCT03106870|7655626|FG001|STARTED|Overall Study||31
6725887|NCT03106870|7655625|FG000|COMPLETED|Overall Study||31
6725888|NCT03106870|7655626|FG001|COMPLETED|Overall Study||31
6725889|NCT03106870|7655625|FG000|NOT COMPLETED|Overall Study||0
6725890|NCT03106870|7655626|FG001|NOT COMPLETED|Overall Study||0
6725891|NCT03107026|7655635|FG000|STARTED|Overall Study||163
6725892|NCT03107026|7655636|FG001|STARTED|Overall Study||161
6725893|NCT03107026|7655637|FG002|STARTED|Overall Study||162
6725894|NCT03107026|7655635|FG000|COMPLETED|Overall Study||131
6725895|NCT03107026|7655636|FG001|COMPLETED|Overall Study||123
6725896|NCT03107026|7655637|FG002|COMPLETED|Overall Study||106
6725897|NCT03107026|7655635|FG000|NOT COMPLETED|Overall Study||32
6725898|NCT03107026|7655636|FG001|NOT COMPLETED|Overall Study||38
6725899|NCT03107026|7655637|FG002|NOT COMPLETED|Overall Study||56
6725900|NCT03107052|7655648|FG000|STARTED|Overall Study||145
6725901|NCT03107052|7655649|FG001|STARTED|Overall Study||60
6725902|NCT03107052|7655650|FG002|STARTED|Overall Study||70
6725903|NCT03107052|7655648|FG000|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|144
6725904|NCT03107052|7655649|FG001|Safety Analysis Set|Overall Study||60
6725905|NCT03107052|7655650|FG002|Safety Analysis Set|Overall Study|1 participant assigned to 225 mg monthly arm but received 675 mg quarterly after >12 weeks remission|71
6725906|NCT03107052|7655648|FG000|COMPLETED|Overall Study||26
6725907|NCT03107052|7655649|FG001|COMPLETED|Overall Study||14
6725908|NCT03107052|7655650|FG002|COMPLETED|Overall Study||29
6725909|NCT03107052|7655648|FG000|NOT COMPLETED|Overall Study||119
6725910|NCT03107052|7655649|FG001|NOT COMPLETED|Overall Study||46
6725911|NCT03107052|7655650|FG002|NOT COMPLETED|Overall Study||41
6725912|NCT03107091|7655658|FG000|STARTED|Overall Study||6
6725913|NCT03107091|7655658|FG000|COMPLETED|Overall Study||5
6725914|NCT03107091|7655658|FG000|NOT COMPLETED|Overall Study||1
6725915|NCT03107377|7655665|FG000|STARTED|Overall Study||426
6725916|NCT03107377|7655666|FG001|STARTED|Overall Study||434
6725917|NCT03107377|7655665|FG000|COMPLETED|Overall Study||335
6725918|NCT03107377|7655666|FG001|COMPLETED|Overall Study||335
6725919|NCT03107377|7655665|FG000|NOT COMPLETED|Overall Study||91
6725920|NCT03107377|7655666|FG001|NOT COMPLETED|Overall Study||99
6725921|NCT03107715|7655674|FG000|STARTED|Overall Study||132
6725922|NCT03107715|7655675|FG001|STARTED|Overall Study||111
6725923|NCT03107715|7655674|FG000|COMPLETED|Overall Study||128
6725924|NCT03107715|7655675|FG001|COMPLETED|Overall Study||104
6725925|NCT03107715|7655674|FG000|NOT COMPLETED|Overall Study||4
6725926|NCT03107715|7655675|FG001|NOT COMPLETED|Overall Study||7
6725927|NCT03107754|7655683|FG000|STARTED|Overall Study||48
6725928|NCT03107754|7655684|FG001|STARTED|Overall Study||50
6725929|NCT03107754|7655683|FG000|COMPLETED|Overall Study||48
6725930|NCT03107754|7655684|FG001|COMPLETED|Overall Study||50
6725931|NCT03107754|7655683|FG000|NOT COMPLETED|Overall Study||0
6725932|NCT03107754|7655684|FG001|NOT COMPLETED|Overall Study||0
6725933|NCT03107793|7655690|FG000|STARTED|Induction Period (16 Weeks)||500
6725934|NCT03107793|7655691|FG001|STARTED|Induction Period (16 Weeks)||0
6725935|NCT03107793|7655692|FG002|STARTED|Induction Period (16 Weeks)||0
6725936|NCT03107793|7655690|FG000|COMPLETED|Induction Period (16 Weeks)||490
6725937|NCT03107793|7655691|FG001|COMPLETED|Induction Period (16 Weeks)||0
6725938|NCT03107793|7655692|FG002|COMPLETED|Induction Period (16 Weeks)||0
6725939|NCT03107793|7655690|FG000|NOT COMPLETED|Induction Period (16 Weeks)||10
6725940|NCT03107793|7655691|FG001|NOT COMPLETED|Induction Period (16 Weeks)||0
6725941|NCT03107793|7655692|FG002|NOT COMPLETED|Induction Period (16 Weeks)||0
6725942|NCT03107793|7655690|FG000|STARTED|Maintenance Period (16-48 Week)||0
6725943|NCT03107793|7655691|FG001|STARTED|Maintenance Period (16-48 Week)||220
6725944|NCT03107793|7655692|FG002|STARTED|Maintenance Period (16-48 Week)||221
6725945|NCT03107793|7655690|FG000|COMPLETED|Maintenance Period (16-48 Week)||0
6725946|NCT03107793|7655691|FG001|COMPLETED|Maintenance Period (16-48 Week)||174
6725947|NCT03107793|7655692|FG002|COMPLETED|Maintenance Period (16-48 Week)||193
6725948|NCT03107793|7655690|FG000|NOT COMPLETED|Maintenance Period (16-48 Week)||0
6725949|NCT03107793|7655691|FG001|NOT COMPLETED|Maintenance Period (16-48 Week)||46
6725950|NCT03107793|7655692|FG002|NOT COMPLETED|Maintenance Period (16-48 Week)||28
6725951|NCT03108027|7655699|FG000|STARTED|Period 1||7
6725952|NCT03108027|7655700|FG001|STARTED|Period 1||6
6725953|NCT03108027|7655701|FG002|STARTED|Period 1||6
6725954|NCT03108027|7655702|FG003|STARTED|Period 1||6
6725955|NCT03108027|7655703|FG004|STARTED|Period 1||6
6725956|NCT03108027|7655704|FG005|STARTED|Period 1||6
6725957|NCT03108027|7655699|FG000|COMPLETED|Period 1||7
6725958|NCT03108027|7655700|FG001|COMPLETED|Period 1||6
6725959|NCT03108027|7655701|FG002|COMPLETED|Period 1||6
6725960|NCT03108027|7655702|FG003|COMPLETED|Period 1||4
6725961|NCT03108027|7655703|FG004|COMPLETED|Period 1||6
6725962|NCT03108027|7655704|FG005|COMPLETED|Period 1||6
6725963|NCT03108027|7655699|FG000|NOT COMPLETED|Period 1||0
6725964|NCT03108027|7655700|FG001|NOT COMPLETED|Period 1||0
6725965|NCT03108027|7655701|FG002|NOT COMPLETED|Period 1||0
6725966|NCT03108027|7655702|FG003|NOT COMPLETED|Period 1||2
6725967|NCT03108027|7655703|FG004|NOT COMPLETED|Period 1||0
6725968|NCT03108027|7655704|FG005|NOT COMPLETED|Period 1||0
6725969|NCT03108027|7655699|FG000|STARTED|Period 2||7
6725970|NCT03108027|7655700|FG001|STARTED|Period 2||6
6725971|NCT03108027|7655701|FG002|STARTED|Period 2||6
6725972|NCT03108027|7655702|FG003|STARTED|Period 2||4
6725973|NCT03108027|7655703|FG004|STARTED|Period 2||6
6725974|NCT03108027|7655704|FG005|STARTED|Period 2||6
6725975|NCT03108027|7655699|FG000|COMPLETED|Period 2||7
6725976|NCT03108027|7655700|FG001|COMPLETED|Period 2||6
6725977|NCT03108027|7655701|FG002|COMPLETED|Period 2||6
6725978|NCT03108027|7655702|FG003|COMPLETED|Period 2||4
6725979|NCT03108027|7655703|FG004|COMPLETED|Period 2||6
6725980|NCT03108027|7655704|FG005|COMPLETED|Period 2||6
6725981|NCT03108027|7655699|FG000|NOT COMPLETED|Period 2||0
6725982|NCT03108027|7655700|FG001|NOT COMPLETED|Period 2||0
6725983|NCT03108027|7655701|FG002|NOT COMPLETED|Period 2||0
6725984|NCT03108027|7655702|FG003|NOT COMPLETED|Period 2||0
6725985|NCT03108027|7655703|FG004|NOT COMPLETED|Period 2||0
6725986|NCT03108027|7655704|FG005|NOT COMPLETED|Period 2||0
6725987|NCT03108027|7655699|FG000|STARTED|Period 3||7
6725988|NCT03108027|7655700|FG001|STARTED|Period 3||6
6725989|NCT03108027|7655701|FG002|STARTED|Period 3||6
6725990|NCT03108027|7655702|FG003|STARTED|Period 3||4
6725991|NCT03108027|7655703|FG004|STARTED|Period 3||6
6725992|NCT03108027|7655704|FG005|STARTED|Period 3||6
6725993|NCT03108027|7655699|FG000|COMPLETED|Period 3||7
6725994|NCT03108027|7655700|FG001|COMPLETED|Period 3||5
6725995|NCT03108027|7655701|FG002|COMPLETED|Period 3||6
6725996|NCT03108027|7655702|FG003|COMPLETED|Period 3||4
6725997|NCT03108027|7655703|FG004|COMPLETED|Period 3||6
6725998|NCT03108027|7655704|FG005|COMPLETED|Period 3||6
6725999|NCT03108027|7655699|FG000|NOT COMPLETED|Period 3||0
6726000|NCT03108027|7655700|FG001|NOT COMPLETED|Period 3||1
6726001|NCT03108027|7655701|FG002|NOT COMPLETED|Period 3||0
6726002|NCT03108027|7655702|FG003|NOT COMPLETED|Period 3||0
6726003|NCT03108027|7655703|FG004|NOT COMPLETED|Period 3||0
6726004|NCT03108027|7655704|FG005|NOT COMPLETED|Period 3||0
6726005|NCT03108157|7655714|FG000|STARTED|Overall Study||176
6726006|NCT03108157|7655715|FG001|STARTED|Overall Study||176
6726007|NCT03108157|7655714|FG000|COMPLETED|Overall Study||161
6726008|NCT03108157|7655715|FG001|COMPLETED|Overall Study||172
6726009|NCT03108157|7655714|FG000|NOT COMPLETED|Overall Study||15
6726010|NCT03108157|7655715|FG001|NOT COMPLETED|Overall Study||4
6726011|NCT03108469|7655724|FG000|STARTED|Overall Study||15
6726012|NCT03108469|7655725|FG001|STARTED|Overall Study||15
6726013|NCT03108469|7655724|FG000|COMPLETED|Overall Study||11
6726014|NCT03108469|7655725|FG001|COMPLETED|Overall Study||11
6726015|NCT03108469|7655724|FG000|NOT COMPLETED|Overall Study||4
6726016|NCT03108469|7655725|FG001|NOT COMPLETED|Overall Study||4
6726017|NCT03108482|7655735|FG000|STARTED|Overall Study||183
6726018|NCT03108482|7655736|FG001|STARTED|Overall Study||183
6726019|NCT03108482|7655737|FG002|STARTED|Overall Study||182
6726020|NCT03108482|7655738|FG003|STARTED|Overall Study||89
6726021|NCT03108482|7655735|FG000|COMPLETED|Overall Study||183
6726022|NCT03108482|7655736|FG001|COMPLETED|Overall Study||179
6726023|NCT03108482|7655737|FG002|COMPLETED|Overall Study||180
6726024|NCT03108482|7655738|FG003|COMPLETED|Overall Study||86
6726025|NCT03108482|7655735|FG000|NOT COMPLETED|Overall Study||0
6726026|NCT03108482|7655736|FG001|NOT COMPLETED|Overall Study||4
6726027|NCT03108482|7655737|FG002|NOT COMPLETED|Overall Study||2
6726028|NCT03108482|7655738|FG003|NOT COMPLETED|Overall Study||3
6726029|NCT03108521|7655750|FG000|STARTED|Overall Study||83
6726030|NCT03108521|7655751|FG001|STARTED|Overall Study||36
6726031|NCT03108521|7655750|FG000|COMPLETED|Overall Study||71
6726032|NCT03108521|7655751|FG001|COMPLETED|Overall Study||36
6726033|NCT03108521|7655750|FG000|NOT COMPLETED|Overall Study||12
6726034|NCT03108521|7655751|FG001|NOT COMPLETED|Overall Study||0
6726035|NCT03108924|7655765|FG000|STARTED|Overall Study||6
6726036|NCT03108924|7655766|FG001|STARTED|Overall Study||6
6726037|NCT03108924|7655767|FG002|STARTED|Overall Study||6
6726038|NCT03108924|7655768|FG003|STARTED|Overall Study||6
6726039|NCT03108924|7655765|FG000|COMPLETED|Overall Study||6
6726040|NCT03108924|7655766|FG001|COMPLETED|Overall Study||6
6726041|NCT03108924|7655767|FG002|COMPLETED|Overall Study||6
6726042|NCT03108924|7655768|FG003|COMPLETED|Overall Study||6
6726043|NCT03108924|7655765|FG000|NOT COMPLETED|Overall Study||0
6726044|NCT03108924|7655766|FG001|NOT COMPLETED|Overall Study||0
6726045|NCT03108924|7655767|FG002|NOT COMPLETED|Overall Study||0
6726046|NCT03108924|7655768|FG003|NOT COMPLETED|Overall Study||0
6726047|NCT03109015|7655789|FG000|STARTED|Overall Study||4
6726048|NCT03109015|7655790|FG001|STARTED|Overall Study||3
6726049|NCT03109015|7655789|FG000|COMPLETED|Overall Study||4
6726050|NCT03109015|7655790|FG001|COMPLETED|Overall Study||3
6726051|NCT03109015|7655789|FG000|NOT COMPLETED|Overall Study||0
6726052|NCT03109015|7655790|FG001|NOT COMPLETED|Overall Study||0
6726053|NCT03109184|7655798|FG000|STARTED|Overall Study||60
6726054|NCT03109184|7655799|FG001|STARTED|Overall Study||59
6726055|NCT03109184|7655798|FG000|COMPLETED|Overall Study||53
6726056|NCT03109184|7655799|FG001|COMPLETED|Overall Study||52
6726057|NCT03109184|7655798|FG000|NOT COMPLETED|Overall Study||7
6726058|NCT03109184|7655799|FG001|NOT COMPLETED|Overall Study||7
6726059|NCT03109769|7655807|FG000|STARTED|Overall Study||22
6726060|NCT03109769|7655808|FG001|STARTED|Overall Study||22
6726061|NCT03109769|7655807|FG000|COMPLETED|Overall Study||22
6726062|NCT03109769|7655808|FG001|COMPLETED|Overall Study||22
6726063|NCT03109769|7655807|FG000|NOT COMPLETED|Overall Study||0
6726064|NCT03109769|7655808|FG001|NOT COMPLETED|Overall Study||0
6726065|NCT03109951|7655814|FG000|STARTED|Overall Study||187
6726066|NCT03109951|7655814|FG000|COMPLETED|Overall Study||187
6726067|NCT03109951|7655814|FG000|NOT COMPLETED|Overall Study||0
6726068|NCT03110003|7655820|FG000|STARTED|Overall Study||21
6726069|NCT03110003|7655821|FG001|STARTED|Overall Study||24
6726070|NCT03110003|7655820|FG000|COMPLETED|Overall Study||21
6726071|NCT03110003|7655821|FG001|COMPLETED|Overall Study||24
6726072|NCT03110003|7655820|FG000|NOT COMPLETED|Overall Study||0
6726073|NCT03110003|7655821|FG001|NOT COMPLETED|Overall Study||0
6726074|NCT03110029|7655829|FG000|STARTED|Overall Study||7
6726075|NCT03110029|7655830|FG001|STARTED|Overall Study||6
6726076|NCT03110029|7655829|FG000|COMPLETED|Overall Study||6
6726077|NCT03110029|7655830|FG001|COMPLETED|Overall Study||5
6726078|NCT03110029|7655829|FG000|NOT COMPLETED|Overall Study||1
6726079|NCT03110029|7655830|FG001|NOT COMPLETED|Overall Study||1
6726080|NCT03110185|7655838|FG000|STARTED|Overall Study||27
6726081|NCT03110185|7655839|FG001|STARTED|Overall Study||64
6726082|NCT03110185|7655838|FG000|COMPLETED|Overall Study||17
6726083|NCT03110185|7655839|FG001|COMPLETED|Overall Study||33
6726084|NCT03110185|7655838|FG000|NOT COMPLETED|Overall Study||10
6726085|NCT03110185|7655839|FG001|NOT COMPLETED|Overall Study||31
6726086|NCT03110458|7655851|FG000|STARTED|Overall Study||37
6726087|NCT03110458|7655852|FG001|STARTED|Overall Study||36
6726088|NCT03110458|7655853|FG002|STARTED|Overall Study||34
6726089|NCT03110458|7655851|FG000|COMPLETED|Overall Study||31
6726090|NCT03110458|7655852|FG001|COMPLETED|Overall Study||32
6726091|NCT03110458|7655853|FG002|COMPLETED|Overall Study||31
6726092|NCT03110458|7655851|FG000|NOT COMPLETED|Overall Study||6
6726093|NCT03110458|7655852|FG001|NOT COMPLETED|Overall Study||4
6726094|NCT03110458|7655853|FG002|NOT COMPLETED|Overall Study||3
6726095|NCT03110471|7655863|FG000|STARTED|Overall Study||30
6726096|NCT03110471|7655864|FG001|STARTED|Overall Study||30
6726097|NCT03110471|7655863|FG000|COMPLETED|Overall Study||30
6726098|NCT03110471|7655864|FG001|COMPLETED|Overall Study||30
6726099|NCT03110471|7655863|FG000|NOT COMPLETED|Overall Study||0
6726100|NCT03110471|7655864|FG001|NOT COMPLETED|Overall Study||0
6726101|NCT03110562|7655870|FG000|STARTED|Overall Study||195
6726102|NCT03110562|7655871|FG001|STARTED|Overall Study||207
6726103|NCT03110562|7655870|FG000|Treated|Overall Study||195
6726104|NCT03110562|7655871|FG001|Treated|Overall Study||204
6726105|NCT03110562|7655870|FG000|COMPLETED|Overall Study||0
6726106|NCT03110562|7655871|FG001|COMPLETED|Overall Study||0
6726107|NCT03110562|7655870|FG000|NOT COMPLETED|Overall Study||195
6726108|NCT03110562|7655871|FG001|NOT COMPLETED|Overall Study||207
6726109|NCT03110601|7655877|FG000|STARTED|Conventional SCS Parameters||25
6726110|NCT03110601|7655877|FG000|COMPLETED|Conventional SCS Parameters||24
6726111|NCT03110601|7655877|FG000|NOT COMPLETED|Conventional SCS Parameters||1
6726112|NCT03110601|7655877|FG000|STARTED|Washout Period||24
6726113|NCT03110601|7655877|FG000|COMPLETED|Washout Period||23
6726114|NCT03110601|7655877|FG000|NOT COMPLETED|Washout Period||1
6726115|NCT03110601|7655877|FG000|STARTED|Stimgenics SCS Parameters||23
6726116|NCT03110601|7655877|FG000|COMPLETED|Stimgenics SCS Parameters||20
6726117|NCT03110601|7655877|FG000|NOT COMPLETED|Stimgenics SCS Parameters||3
6726118|NCT03110692|7655886|FG000|STARTED|Overall Study||679
6726119|NCT03110692|7655887|FG001|STARTED|Overall Study||509
6726120|NCT03110692|7655886|FG000|COMPLETED|Overall Study||679
6726121|NCT03110692|7655887|FG001|COMPLETED|Overall Study||509
6726122|NCT03110692|7655886|FG000|NOT COMPLETED|Overall Study||0
6726123|NCT03110692|7655887|FG001|NOT COMPLETED|Overall Study||0
6726124|NCT03110770|7655898|FG000|STARTED|Overall Study||30
6726125|NCT03110770|7655899|FG001|STARTED|Overall Study||30
6726126|NCT03110770|7655900|FG002|STARTED|Overall Study||30
6726127|NCT03110770|7655901|FG003|STARTED|Overall Study||1170
6726128|NCT03110770|7655902|FG004|STARTED|Overall Study||1168
6726129|NCT03110770|7655898|FG000|Received First Product Administration|Overall Study||30
6726130|NCT03110770|7655899|FG001|Received First Product Administration|Overall Study||30
6726131|NCT03110770|7655900|FG002|Received First Product Administration|Overall Study||30
6726132|NCT03110770|7655901|FG003|Received First Product Administration|Overall Study||1162
6726133|NCT03110770|7655902|FG004|Received First Product Administration|Overall Study||1161
6726134|NCT03110770|7655898|FG000|Received Second Product Administration|Overall Study||30
6726135|NCT03110770|7655899|FG001|Received Second Product Administration|Overall Study||29
6726136|NCT03110770|7655900|FG002|Received Second Product Administration|Overall Study||29
6726137|NCT03110770|7655901|FG003|Received Second Product Administration|Overall Study||1126
6726138|NCT03110770|7655902|FG004|Received Second Product Administration|Overall Study||1127
6726139|NCT03110770|7655898|FG000|Received Third Product Administration|Overall Study||29
6726140|NCT03110770|7655899|FG001|Received Third Product Administration|Overall Study||27
6726141|NCT03110770|7655900|FG002|Received Third Product Administration|Overall Study||28
6726142|NCT03110770|7655901|FG003|Received Third Product Administration|Overall Study||1107
6726143|NCT03110770|7655902|FG004|Received Third Product Administration|Overall Study||1107
6726144|NCT03110770|7655898|FG000|COMPLETED|Overall Study||24
6726145|NCT03110770|7655899|FG001|COMPLETED|Overall Study||30
6726146|NCT03110770|7655900|FG002|COMPLETED|Overall Study||28
6726147|NCT03110770|7655901|FG003|COMPLETED|Overall Study||1037
6726148|NCT03110770|7655902|FG004|COMPLETED|Overall Study||1045
6726149|NCT03110770|7655898|FG000|NOT COMPLETED|Overall Study||6
6726150|NCT03110770|7655899|FG001|NOT COMPLETED|Overall Study||0
6726151|NCT03110770|7655900|FG002|NOT COMPLETED|Overall Study||2
6726152|NCT03110770|7655901|FG003|NOT COMPLETED|Overall Study||133
6726153|NCT03110770|7655902|FG004|NOT COMPLETED|Overall Study||123
6726154|NCT03111108|7655918|FG000|STARTED|Overall Study||53
6726155|NCT03111108|7655919|FG001|STARTED|Overall Study||64
6726156|NCT03111108|7655918|FG000|COMPLETED|Overall Study||52
6726157|NCT03111108|7655919|FG001|COMPLETED|Overall Study||63
6726158|NCT03111108|7655918|FG000|NOT COMPLETED|Overall Study||1
6726159|NCT03111108|7655919|FG001|NOT COMPLETED|Overall Study||1
6726160|NCT03111316|7655929|FG000|STARTED|Overall Study||26
6726161|NCT03111316|7655930|FG001|STARTED|Overall Study||24
6726162|NCT03111316|7655931|FG002|STARTED|Overall Study||25
6726163|NCT03111316|7655932|FG003|STARTED|Overall Study||25
6726164|NCT03111316|7655929|FG000|COMPLETED|Overall Study||26
6726165|NCT03111316|7655930|FG001|COMPLETED|Overall Study||24
6726166|NCT03111316|7655931|FG002|COMPLETED|Overall Study||25
6726167|NCT03111316|7655932|FG003|COMPLETED|Overall Study||25
6726168|NCT03111316|7655929|FG000|NOT COMPLETED|Overall Study||0
6726169|NCT03111316|7655930|FG001|NOT COMPLETED|Overall Study||0
6726170|NCT03111316|7655931|FG002|NOT COMPLETED|Overall Study||0
6726171|NCT03111316|7655932|FG003|NOT COMPLETED|Overall Study||0
6726172|NCT03111381|7655944|FG000|STARTED|Overall Study||46
6726173|NCT03111381|7655945|FG001|STARTED|Overall Study||48
6726174|NCT03111381|7655944|FG000|COMPLETED|Overall Study||46
6726175|NCT03111381|7655945|FG001|COMPLETED|Overall Study||48
6726176|NCT03111381|7655944|FG000|NOT COMPLETED|Overall Study||0
6726177|NCT03111381|7655945|FG001|NOT COMPLETED|Overall Study||0
6726178|NCT03111407|7655953|FG000|STARTED|Overall Study||45
6726179|NCT03111407|7655954|FG001|STARTED|Overall Study||27
6726180|NCT03111407|7655953|FG000|COMPLETED|Overall Study||44
6726181|NCT03111407|7655954|FG001|COMPLETED|Overall Study||26
6726182|NCT03111407|7655953|FG000|NOT COMPLETED|Overall Study||1
6726183|NCT03111407|7655954|FG001|NOT COMPLETED|Overall Study||1
6726184|NCT03111550|7655964|FG000|STARTED|Overall Study|First eye|77
6726185|NCT03111550|7655965|FG001|STARTED|Overall Study|First eye|73
6726186|NCT03111550|7655966|FG002|STARTED|Overall Study|First eye|79
6726187|NCT03111550|7655964|FG000|COMPLETED|Overall Study||73
6726188|NCT03111550|7655965|FG001|COMPLETED|Overall Study||71
6726189|NCT03111550|7655966|FG002|COMPLETED|Overall Study||76
6726190|NCT03111550|7655964|FG000|NOT COMPLETED|Overall Study||4
6726191|NCT03111550|7655965|FG001|NOT COMPLETED|Overall Study||2
6726192|NCT03111550|7655966|FG002|NOT COMPLETED|Overall Study||3
6739715|NCT03293485|7668559|FG000|COMPLETED|Overall Study||78
6739716|NCT03293485|7668559|FG000|NOT COMPLETED|Overall Study||5
6726193|NCT03111628|7655974|FG000|STARTED|Overall Study||18
6726194|NCT03111628|7655974|FG000|COMPLETED|Overall Study||18
6726195|NCT03111628|7655974|FG000|NOT COMPLETED|Overall Study||0
6726196|NCT03111940|7655981|FG000|STARTED|Overall Study||21
6726197|NCT03111940|7655982|FG001|STARTED|Overall Study||14
6726198|NCT03111940|7655981|FG000|COMPLETED|Overall Study||21
6726199|NCT03111940|7655982|FG001|COMPLETED|Overall Study||14
6726200|NCT03111940|7655981|FG000|NOT COMPLETED|Overall Study||0
6726201|NCT03111940|7655982|FG001|NOT COMPLETED|Overall Study||0
6726202|NCT03112473|7655994|FG000|STARTED|Overall Study||30
6726203|NCT03112473|7655995|FG001|STARTED|Overall Study||30
6726204|NCT03112473|7655996|FG002|STARTED|Overall Study||30
6726205|NCT03112473|7655997|FG003|STARTED|Overall Study||30
6726206|NCT03112473|7655994|FG000|COMPLETED|Overall Study||30
6726207|NCT03112473|7655995|FG001|COMPLETED|Overall Study||30
6726208|NCT03112473|7655996|FG002|COMPLETED|Overall Study||30
6726209|NCT03112473|7655997|FG003|COMPLETED|Overall Study||30
6726210|NCT03112473|7655994|FG000|NOT COMPLETED|Overall Study||0
6726211|NCT03112473|7655995|FG001|NOT COMPLETED|Overall Study||0
6726212|NCT03112473|7655996|FG002|NOT COMPLETED|Overall Study||0
6726213|NCT03112473|7655997|FG003|NOT COMPLETED|Overall Study||0
6726214|NCT03112863|7656012|FG000|STARTED|Overall Study||21
6726215|NCT03112863|7656013|FG001|STARTED|Overall Study||23
6726216|NCT03112863|7656012|FG000|COMPLETED|Overall Study||21
6726217|NCT03112863|7656013|FG001|COMPLETED|Overall Study||23
6726218|NCT03112863|7656012|FG000|NOT COMPLETED|Overall Study||0
6726219|NCT03112863|7656013|FG001|NOT COMPLETED|Overall Study||0
6726220|NCT03113656|7656021|FG000|STARTED|Overall Study||9
6726221|NCT03113656|7656022|FG001|STARTED|Overall Study||7
6726222|NCT03113656|7656021|FG000|COMPLETED|Overall Study||9
6726223|NCT03113656|7656022|FG001|COMPLETED|Overall Study||7
6726224|NCT03113656|7656021|FG000|NOT COMPLETED|Overall Study||0
6726225|NCT03113656|7656022|FG001|NOT COMPLETED|Overall Study||0
6726226|NCT03113916|7656030|FG000|STARTED|Overall Study||99
6726227|NCT03113916|7656031|FG001|STARTED|Overall Study||96
6726228|NCT03113916|7656030|FG000|COMPLETED|Overall Study||88
6726229|NCT03113916|7656031|FG001|COMPLETED|Overall Study||84
6726230|NCT03113916|7656030|FG000|NOT COMPLETED|Overall Study||11
6726231|NCT03113916|7656031|FG001|NOT COMPLETED|Overall Study||12
6726232|NCT03114124|7656044|FG000|STARTED|Overall Study||15
6726233|NCT03114124|7656045|FG001|STARTED|Overall Study||15
6726234|NCT03114124|7656044|FG000|COMPLETED|Overall Study||15
6726235|NCT03114124|7656045|FG001|COMPLETED|Overall Study||15
6726236|NCT03114124|7656044|FG000|NOT COMPLETED|Overall Study||0
6726237|NCT03114124|7656045|FG001|NOT COMPLETED|Overall Study||0
6726238|NCT03114488|7656051|FG000|STARTED|Time Period 1||19
6726239|NCT03114488|7656052|FG001|STARTED|Time Period 1||22
6726240|NCT03114488|7656051|FG000|COMPLETED|Time Period 1||19
6726241|NCT03114488|7656052|FG001|COMPLETED|Time Period 1||22
6726242|NCT03114488|7656051|FG000|NOT COMPLETED|Time Period 1||0
6726243|NCT03114488|7656052|FG001|NOT COMPLETED|Time Period 1||0
6726244|NCT03114488|7656051|FG000|STARTED|Time Period 2||19
6726245|NCT03114488|7656052|FG001|STARTED|Time Period 2||22
6726246|NCT03114488|7656051|FG000|COMPLETED|Time Period 2||18
6726247|NCT03114488|7656052|FG001|COMPLETED|Time Period 2||19
6726248|NCT03114488|7656051|FG000|NOT COMPLETED|Time Period 2||1
6726249|NCT03114488|7656052|FG001|NOT COMPLETED|Time Period 2||3
6726250|NCT03114657|7656064|FG000|STARTED|Overall Study||399
6726251|NCT03114657|7656065|FG001|STARTED|Overall Study||407
6726252|NCT03114657|7656064|FG000|COMPLETED|Overall Study||0
6726253|NCT03114657|7656065|FG001|COMPLETED|Overall Study||0
6726254|NCT03114657|7656064|FG000|NOT COMPLETED|Overall Study||399
6726255|NCT03114657|7656065|FG001|NOT COMPLETED|Overall Study||407
6726256|NCT03114683|7656072|FG000|STARTED|Overall Study||96
6726257|NCT03114683|7656072|FG000|COMPLETED|Overall Study||52
6726258|NCT03114683|7656072|FG000|NOT COMPLETED|Overall Study||44
6726259|NCT03114969|7656085|FG000|STARTED|Overall Study||50
6726260|NCT03114969|7656086|FG001|STARTED|Overall Study||50
6726261|NCT03114969|7656087|FG002|STARTED|Overall Study||50
6726262|NCT03114969|7656088|FG003|STARTED|Overall Study||50
6726263|NCT03114969|7656089|FG004|STARTED|Overall Study||51
6726264|NCT03114969|7656090|FG005|STARTED|Overall Study||49
6726265|NCT03114969|7656091|FG006|STARTED|Overall Study||50
6726266|NCT03114969|7656092|FG007|STARTED|Overall Study||50
6726267|NCT03114969|7656093|FG008|STARTED|Overall Study||50
6726268|NCT03114969|7656085|FG000|COMPLETED|Overall Study||50
6726269|NCT03114969|7656086|FG001|COMPLETED|Overall Study||50
6726270|NCT03114969|7656087|FG002|COMPLETED|Overall Study||46
6726271|NCT03114969|7656088|FG003|COMPLETED|Overall Study||48
6726272|NCT03114969|7656089|FG004|COMPLETED|Overall Study||51
6726273|NCT03114969|7656090|FG005|COMPLETED|Overall Study||48
6726274|NCT03114969|7656091|FG006|COMPLETED|Overall Study||49
6726275|NCT03114969|7656092|FG007|COMPLETED|Overall Study||50
6726276|NCT03114969|7656093|FG008|COMPLETED|Overall Study||48
6726277|NCT03114969|7656085|FG000|NOT COMPLETED|Overall Study||0
6726278|NCT03114969|7656086|FG001|NOT COMPLETED|Overall Study||0
6726279|NCT03114969|7656087|FG002|NOT COMPLETED|Overall Study||4
6726280|NCT03114969|7656088|FG003|NOT COMPLETED|Overall Study||2
6726281|NCT03114969|7656089|FG004|NOT COMPLETED|Overall Study||0
6726282|NCT03114969|7656090|FG005|NOT COMPLETED|Overall Study||1
6726283|NCT03114969|7656091|FG006|NOT COMPLETED|Overall Study||1
6726284|NCT03114969|7656092|FG007|NOT COMPLETED|Overall Study||0
6726285|NCT03114969|7656093|FG008|NOT COMPLETED|Overall Study||2
6726286|NCT03114995|7656123|FG000|STARTED|Overall Study||31
6726287|NCT03114995|7656124|FG001|STARTED|Overall Study||31
6726288|NCT03114995|7656125|FG002|STARTED|Overall Study||78
6726289|NCT03114995|7656123|FG000|COMPLETED|Overall Study||30
6726290|NCT03114995|7656124|FG001|COMPLETED|Overall Study||30
6726291|NCT03114995|7656125|FG002|COMPLETED|Overall Study||78
6726292|NCT03114995|7656123|FG000|NOT COMPLETED|Overall Study||1
6726293|NCT03114995|7656124|FG001|NOT COMPLETED|Overall Study||1
6726294|NCT03114995|7656125|FG002|NOT COMPLETED|Overall Study||0
6726295|NCT03115112|7656135|FG000|STARTED|Overall Study||192
6726296|NCT03115112|7656136|FG001|STARTED|Overall Study||194
6726297|NCT03115112|7656135|FG000|Intention-to-treat|Overall Study||191
6726298|NCT03115112|7656136|FG001|Intention-to-treat|Overall Study||193
6726299|NCT03115112|7656135|FG000|COMPLETED|Overall Study||180
6726300|NCT03115112|7656136|FG001|COMPLETED|Overall Study||189
6726301|NCT03115112|7656135|FG000|NOT COMPLETED|Overall Study||12
6726302|NCT03115112|7656136|FG001|NOT COMPLETED|Overall Study||5
6726303|NCT03115177|7656146|FG000|STARTED|Overall Study||27
6726304|NCT03115177|7656147|FG001|STARTED|Overall Study||29
6726305|NCT03115177|7656146|FG000|COMPLETED|Overall Study||27
6726306|NCT03115177|7656147|FG001|COMPLETED|Overall Study||29
6726307|NCT03115177|7656146|FG000|NOT COMPLETED|Overall Study||0
6726308|NCT03115177|7656147|FG001|NOT COMPLETED|Overall Study||0
6726309|NCT03115411|7656153|FG000|STARTED|Overall Study||23
6726310|NCT03115411|7656153|FG000|COMPLETED|Overall Study||23
6726311|NCT03115411|7656153|FG000|NOT COMPLETED|Overall Study||0
6726312|NCT03115476|7656160|FG000|STARTED|Main Trials (LP0084-119x)||407
6726313|NCT03115476|7656161|FG001|STARTED|Main Trials (LP0084-119x)||418
6726314|NCT03115476|7656162|FG002|STARTED|Main Trials (LP0084-119x)||409
6726315|NCT03115476|7656160|FG000|COMPLETED|Main Trials (LP0084-119x)||407
6726316|NCT03115476|7656161|FG001|COMPLETED|Main Trials (LP0084-119x)||418
6726317|NCT03115476|7656162|FG002|COMPLETED|Main Trials (LP0084-119x)||409
6726318|NCT03115476|7656160|FG000|NOT COMPLETED|Main Trials (LP0084-119x)||0
6726319|NCT03115476|7656161|FG001|NOT COMPLETED|Main Trials (LP0084-119x)||0
6726320|NCT03115476|7656162|FG002|NOT COMPLETED|Main Trials (LP0084-119x)||0
6726321|NCT03115476|7656160|FG000|STARTED|LP0084-1369||191
6726322|NCT03115476|7656161|FG001|STARTED|LP0084-1369||210
6726323|NCT03115476|7656162|FG002|STARTED|LP0084-1369||162
6726324|NCT03115476|7656160|FG000|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
6726325|NCT03115476|7656161|FG001|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
6726326|NCT03115476|7656162|FG002|COMPLETED|LP0084-1369|Trial was terminated by sponsor|0
6726327|NCT03115476|7656160|FG000|NOT COMPLETED|LP0084-1369||191
6726328|NCT03115476|7656161|FG001|NOT COMPLETED|LP0084-1369||210
6726329|NCT03115476|7656162|FG002|NOT COMPLETED|LP0084-1369||162
6726330|NCT03115580|7656172|FG000|STARTED|Overall Study||35
6726331|NCT03115580|7656173|FG001|STARTED|Overall Study||36
6726332|NCT03115580|7656172|FG000|COMPLETED|Overall Study||35
6726333|NCT03115580|7656173|FG001|COMPLETED|Overall Study||36
6726334|NCT03115580|7656172|FG000|NOT COMPLETED|Overall Study||0
6726335|NCT03115580|7656173|FG001|NOT COMPLETED|Overall Study||0
6726336|NCT03115801|7656181|FG000|STARTED|Overall Study||4
6726337|NCT03115801|7656182|FG001|STARTED|Overall Study||2
6726338|NCT03115801|7656181|FG000|COMPLETED|Overall Study||1
6726339|NCT03115801|7656182|FG001|COMPLETED|Overall Study||0
6726340|NCT03115801|7656181|FG000|NOT COMPLETED|Overall Study||3
6726341|NCT03115801|7656182|FG001|NOT COMPLETED|Overall Study||2
6726342|NCT03115827|7656188|FG000|STARTED|Overall Study||15
6726343|NCT03115827|7656188|FG000|COMPLETED|Overall Study||12
6726344|NCT03115827|7656188|FG000|NOT COMPLETED|Overall Study||3
6726345|NCT03116152|7656194|FG000|STARTED|Overall Study||95
6726346|NCT03116152|7656195|FG001|STARTED|Overall Study||95
6726347|NCT03116152|7656194|FG000|Treated|Overall Study||94
6726348|NCT03116152|7656195|FG001|Treated|Overall Study||87
6726349|NCT03116152|7656194|FG000|COMPLETED|Overall Study||4
6726350|NCT03116152|7656195|FG001|COMPLETED|Overall Study||0
6726351|NCT03116152|7656194|FG000|NOT COMPLETED|Overall Study||91
6726352|NCT03116152|7656195|FG001|NOT COMPLETED|Overall Study||95
6726353|NCT03116230|7656203|FG000|STARTED|Overall Study||19
6726354|NCT03116230|7656204|FG001|STARTED|Overall Study||19
6726355|NCT03116230|7656203|FG000|COMPLETED|Overall Study||15
6726356|NCT03116230|7656204|FG001|COMPLETED|Overall Study||17
6726357|NCT03116230|7656203|FG000|NOT COMPLETED|Overall Study||4
6726358|NCT03116230|7656204|FG001|NOT COMPLETED|Overall Study||2
6726359|NCT03116698|7656214|FG000|STARTED|Overall Study||62
6726360|NCT03116698|7656215|FG001|STARTED|Overall Study||57
6726361|NCT03116698|7656216|FG002|STARTED|Overall Study||62
6726362|NCT03116698|7656217|FG003|STARTED|Overall Study||57
6726363|NCT03116698|7656214|FG000|COMPLETED|Overall Study||56
6726364|NCT03116698|7656215|FG001|COMPLETED|Overall Study||51
6726365|NCT03116698|7656216|FG002|COMPLETED|Overall Study||54
6726366|NCT03116698|7656217|FG003|COMPLETED|Overall Study||55
6726367|NCT03116698|7656214|FG000|NOT COMPLETED|Overall Study||6
6726368|NCT03116698|7656215|FG001|NOT COMPLETED|Overall Study||6
6726369|NCT03116698|7656216|FG002|NOT COMPLETED|Overall Study||8
6726370|NCT03116698|7656217|FG003|NOT COMPLETED|Overall Study||2
6726371|NCT03116828|7656229|FG000|STARTED|Overall Study||44
6726372|NCT03116828|7656230|FG001|STARTED|Overall Study||58
6726373|NCT03116828|7656229|FG000|COMPLETED|Overall Study||36
6726374|NCT03116828|7656230|FG001|COMPLETED|Overall Study||37
6726375|NCT03116828|7656229|FG000|NOT COMPLETED|Overall Study||8
6726376|NCT03116828|7656230|FG001|NOT COMPLETED|Overall Study||21
6726377|NCT03116841|7656236|FG000|STARTED|Overall Study||3
6726378|NCT03116841|7656236|FG000|COMPLETED|Overall Study||3
6726379|NCT03116841|7656236|FG000|NOT COMPLETED|Overall Study||0
6726380|NCT03117140|7656244|FG000|STARTED|Overall Study||40
6726381|NCT03117140|7656245|FG001|STARTED|Overall Study||40
6726382|NCT03117140|7656246|FG002|STARTED|Overall Study||40
6726383|NCT03117140|7656247|FG003|STARTED|Overall Study||40
6726384|NCT03117140|7656244|FG000|COMPLETED|Overall Study||40
6726385|NCT03117140|7656245|FG001|COMPLETED|Overall Study||40
6726386|NCT03117140|7656246|FG002|COMPLETED|Overall Study||40
6726387|NCT03117140|7656247|FG003|COMPLETED|Overall Study||40
6726388|NCT03117140|7656244|FG000|NOT COMPLETED|Overall Study||0
6726389|NCT03117140|7656245|FG001|NOT COMPLETED|Overall Study||0
6726390|NCT03117140|7656246|FG002|NOT COMPLETED|Overall Study||0
6726391|NCT03117140|7656247|FG003|NOT COMPLETED|Overall Study||0
6726392|NCT03117361|7656260|FG000|STARTED|Overall Study||10
6726393|NCT03117361|7656260|FG000|COMPLETED|Overall Study||0
6726394|NCT03117361|7656260|FG000|NOT COMPLETED|Overall Study||10
6726395|NCT03117517|7656266|FG000|STARTED|Overall Study||53
6726396|NCT03117517|7656267|FG001|STARTED|Overall Study||53
6726397|NCT03117517|7656266|FG000|COMPLETED|Overall Study||48
6726398|NCT03117517|7656267|FG001|COMPLETED|Overall Study||49
6726399|NCT03117517|7656266|FG000|NOT COMPLETED|Overall Study||5
6726400|NCT03117517|7656267|FG001|NOT COMPLETED|Overall Study||4
6726401|NCT03117569|7656279|FG000|STARTED|Overall Study||127
6726402|NCT03117569|7656280|FG001|STARTED|Overall Study||253
6726403|NCT03117569|7656279|FG000|COMPLETED|Overall Study||123
6726404|NCT03117569|7656280|FG001|COMPLETED|Overall Study||241
6726405|NCT03117569|7656279|FG000|NOT COMPLETED|Overall Study||4
6726406|NCT03117569|7656280|FG001|NOT COMPLETED|Overall Study||12
6726407|NCT03117634|7656292|FG000|STARTED|Overall Study||41
6726408|NCT03117634|7656293|FG001|STARTED|Overall Study||13
6726409|NCT03117634|7656292|FG000|COMPLETED|Overall Study||39
6726410|NCT03117634|7656293|FG001|COMPLETED|Overall Study||13
6726411|NCT03117634|7656292|FG000|NOT COMPLETED|Overall Study||2
6726412|NCT03117634|7656293|FG001|NOT COMPLETED|Overall Study||0
6726413|NCT03117738|7656301|FG000|STARTED|Overall Study||11
6726414|NCT03117738|7656302|FG001|STARTED|Overall Study||10
6726415|NCT03117738|7656301|FG000|COMPLETED|Overall Study||7
6726416|NCT03117738|7656302|FG001|COMPLETED|Overall Study||5
6726417|NCT03117738|7656301|FG000|NOT COMPLETED|Overall Study||4
6726418|NCT03117738|7656302|FG001|NOT COMPLETED|Overall Study||5
6726419|NCT03118297|7656310|FG000|STARTED|Overall Study||32
6726420|NCT03118297|7656311|FG001|STARTED|Overall Study||33
6726421|NCT03118297|7656310|FG000|COMPLETED|Overall Study||32
6726422|NCT03118297|7656311|FG001|COMPLETED|Overall Study||31
6726423|NCT03118297|7656310|FG000|NOT COMPLETED|Overall Study||0
6726424|NCT03118297|7656311|FG001|NOT COMPLETED|Overall Study||2
6726425|NCT03118466|7656317|FG000|STARTED|Overall Study||40
6726426|NCT03118466|7656317|FG000|COMPLETED|Overall Study||40
6726427|NCT03118466|7656317|FG000|NOT COMPLETED|Overall Study||0
6726428|NCT03118518|7656323|FG000|STARTED|Overall Study||108
6726429|NCT03118518|7656324|FG001|STARTED|Overall Study||102
6726430|NCT03118518|7656323|FG000|Subject Treated According to Randomization Assignment|Overall Study||104
6726431|NCT03118518|7656324|FG001|Subject Treated According to Randomization Assignment|Overall Study||99
6726432|NCT03118518|7656323|FG000|COMPLETED|Overall Study||102
6726433|NCT03118518|7656324|FG001|COMPLETED|Overall Study||91
6726434|NCT03118518|7656323|FG000|NOT COMPLETED|Overall Study||6
6726435|NCT03118518|7656324|FG001|NOT COMPLETED|Overall Study||11
6726436|NCT03118596|7656332|FG000|STARTED|Overall Study||90
6726437|NCT03118596|7656333|FG001|STARTED|Overall Study||90
6726438|NCT03118596|7656332|FG000|Treated|Overall Study||2
6726439|NCT03118596|7656333|FG001|Treated|Overall Study||0
6726440|NCT03118596|7656332|FG000|Failed|Overall Study||0
6726441|NCT03118596|7656333|FG001|Failed|Overall Study||4
6726442|NCT03118596|7656332|FG000|COMPLETED|Overall Study||90
6265464|NCT00022698|7164503|FG001|NOT COMPLETED|Overall Study||35
6265465|NCT00022763|7164513|FG000|STARTED|Overall Study||24
6265466|NCT00022763|7164514|FG001|STARTED|Overall Study||28
6265467|NCT00022763|7164513|FG000|COMPLETED|Overall Study||15
6265468|NCT00022763|7164514|FG001|COMPLETED|Overall Study||11
6265469|NCT00022763|7164513|FG000|NOT COMPLETED|Overall Study||9
6265470|NCT00022763|7164514|FG001|NOT COMPLETED|Overall Study||17
6265471|NCT00023309|7164521|FG000|STARTED|Overall Study||22
6265472|NCT00023309|7164522|FG001|STARTED|Overall Study||19
6265473|NCT00023309|7164521|FG000|COMPLETED|Overall Study||22
6265474|NCT00023309|7164522|FG001|COMPLETED|Overall Study||19
6265475|NCT00023309|7164521|FG000|NOT COMPLETED|Overall Study||0
6265476|NCT00023309|7164522|FG001|NOT COMPLETED|Overall Study||0
6265477|NCT00023322|7164528|FG000|STARTED|Overall Study||13
6265478|NCT00023322|7164528|FG000|COMPLETED|Overall Study||12
6265479|NCT00023322|7164528|FG000|NOT COMPLETED|Overall Study||1
6265480|NCT00023452|7164534|FG000|STARTED|Overall Study||3908
6265481|NCT00023452|7164535|FG001|STARTED|Overall Study||4145
6265482|NCT00023452|7164534|FG000|Randomized|Overall Study||3190
6726443|NCT03118596|7656333|FG001|COMPLETED|Overall Study||86
6726444|NCT03118596|7656332|FG000|NOT COMPLETED|Overall Study||0
6726445|NCT03118596|7656333|FG001|NOT COMPLETED|Overall Study||4
6726446|NCT03118739|7656341|FG000|STARTED|Overall Study||32
6726447|NCT03118739|7656342|FG001|STARTED|Overall Study||28
6726448|NCT03118739|7656341|FG000|Completed 12 Weeks of Treatment|Overall Study||26
6726449|NCT03118739|7656342|FG001|Completed 12 Weeks of Treatment|Overall Study||25
6726450|NCT03118739|7656341|FG000|Completed 24 Weeks of Treatment|Overall Study||24
6726451|NCT03118739|7656342|FG001|Completed 24 Weeks of Treatment|Overall Study||25
6726452|NCT03118739|7656341|FG000|COMPLETED|Overall Study||25
6726453|NCT03118739|7656342|FG001|COMPLETED|Overall Study||24
6726454|NCT03118739|7656341|FG000|NOT COMPLETED|Overall Study||7
6726455|NCT03118739|7656342|FG001|NOT COMPLETED|Overall Study||4
6726456|NCT03118765|7656353|FG000|STARTED|Overall Study||30
6726457|NCT03118765|7656354|FG001|STARTED|Overall Study||32
6726458|NCT03118765|7656355|FG002|STARTED|Overall Study||31
6726459|NCT03118765|7656356|FG003|STARTED|Overall Study||32
6726460|NCT03118765|7656357|FG004|STARTED|Overall Study||30
6726461|NCT03118765|7656353|FG000|COMPLETED|Overall Study||26
6726462|NCT03118765|7656354|FG001|COMPLETED|Overall Study||30
6726463|NCT03118765|7656355|FG002|COMPLETED|Overall Study||26
6726464|NCT03118765|7656356|FG003|COMPLETED|Overall Study||29
6726465|NCT03118765|7656357|FG004|COMPLETED|Overall Study||28
6726466|NCT03118765|7656353|FG000|NOT COMPLETED|Overall Study||4
6726467|NCT03118765|7656354|FG001|NOT COMPLETED|Overall Study||2
6726468|NCT03118765|7656355|FG002|NOT COMPLETED|Overall Study||5
6726469|NCT03118765|7656356|FG003|NOT COMPLETED|Overall Study||3
6726470|NCT03118765|7656357|FG004|NOT COMPLETED|Overall Study||2
6726471|NCT03118843|7656370|FG000|STARTED|Overall Study||31
6726472|NCT03118843|7656370|FG000|COMPLETED|Overall Study||31
6726473|NCT03118843|7656370|FG000|NOT COMPLETED|Overall Study||0
6726474|NCT03118934|7656377|FG000|STARTED|Overall Study||34
6726475|NCT03118934|7656378|FG001|STARTED|Overall Study||31
6726476|NCT03118934|7656379|FG002|STARTED|Overall Study||34
6726477|NCT03118934|7656380|FG003|STARTED|Overall Study||29
6726478|NCT03118934|7656381|FG004|STARTED|Overall Study||29
6726479|NCT03118934|7656382|FG005|STARTED|Overall Study||25
6726480|NCT03118934|7656377|FG000|Safety Analysis Set|Overall Study||34
6726481|NCT03118934|7656378|FG001|Safety Analysis Set|Overall Study||29
6726482|NCT03118934|7656379|FG002|Safety Analysis Set|Overall Study||34
6726483|NCT03118934|7656380|FG003|Safety Analysis Set|Overall Study||29
6726484|NCT03118934|7656381|FG004|Safety Analysis Set|Overall Study||26
6726485|NCT03118934|7656382|FG005|Safety Analysis Set|Overall Study||25
6726486|NCT03118934|7656377|FG000|COMPLETED|Overall Study||34
6726487|NCT03118934|7656378|FG001|COMPLETED|Overall Study||30
6726488|NCT03118934|7656379|FG002|COMPLETED|Overall Study||33
6726489|NCT03118934|7656380|FG003|COMPLETED|Overall Study||28
6726490|NCT03118934|7656381|FG004|COMPLETED|Overall Study||27
6726491|NCT03118934|7656382|FG005|COMPLETED|Overall Study||23
6726492|NCT03118934|7656377|FG000|NOT COMPLETED|Overall Study||0
6726493|NCT03118934|7656378|FG001|NOT COMPLETED|Overall Study||1
6726494|NCT03118934|7656379|FG002|NOT COMPLETED|Overall Study||1
6726495|NCT03118934|7656380|FG003|NOT COMPLETED|Overall Study||1
6726496|NCT03118934|7656381|FG004|NOT COMPLETED|Overall Study||2
6726497|NCT03118934|7656382|FG005|NOT COMPLETED|Overall Study||2
6726498|NCT03118947|7656392|FG000|STARTED|Overall Study||78
6726499|NCT03118947|7656392|FG000|COMPLETED|Overall Study||49
6726500|NCT03118947|7656392|FG000|NOT COMPLETED|Overall Study||29
6726501|NCT03119025|7656396|FG000|STARTED|Overall Study||10
6726502|NCT03119025|7656396|FG000|COMPLETED|Overall Study||10
6726503|NCT03119025|7656396|FG000|NOT COMPLETED|Overall Study||0
6726504|NCT03119168|7656402|FG000|STARTED|Overall Study||129
6726505|NCT03119168|7656403|FG001|STARTED|Overall Study||139
6726506|NCT03119168|7656402|FG000|COMPLETED|Overall Study||129
6726507|NCT03119168|7656403|FG001|COMPLETED|Overall Study||139
6726508|NCT03119168|7656402|FG000|NOT COMPLETED|Overall Study||0
6726509|NCT03119168|7656403|FG001|NOT COMPLETED|Overall Study||0
6726510|NCT03119181|7656413|FG000|STARTED|Overall Study||19
6726511|NCT03119181|7656414|FG001|STARTED|Overall Study||21
6726512|NCT03119181|7656413|FG000|COMPLETED|Overall Study||19
6726513|NCT03119181|7656414|FG001|COMPLETED|Overall Study||21
6726514|NCT03119181|7656413|FG000|NOT COMPLETED|Overall Study||0
6726515|NCT03119181|7656414|FG001|NOT COMPLETED|Overall Study||0
6726516|NCT03119389|7656422|FG000|STARTED|Overall Study||6791
6726517|NCT03119389|7656423|FG001|STARTED|Overall Study||7627
6726518|NCT03119389|7656422|FG000|COMPLETED|Overall Study||6791
6726519|NCT03119389|7656423|FG001|COMPLETED|Overall Study||7627
6726520|NCT03119389|7656422|FG000|NOT COMPLETED|Overall Study||0
6726521|NCT03119389|7656423|FG001|NOT COMPLETED|Overall Study||0
6726522|NCT03119571|7656433|FG000|STARTED|Overall Study||31
6726523|NCT03119571|7656434|FG001|STARTED|Overall Study||34
6726524|NCT03119571|7656433|FG000|COMPLETED|Overall Study||31
6726525|NCT03119571|7656434|FG001|COMPLETED|Overall Study||34
6726526|NCT03119571|7656433|FG000|NOT COMPLETED|Overall Study||0
6726527|NCT03119571|7656434|FG001|NOT COMPLETED|Overall Study||0
6726528|NCT03119610|7656442|FG000|STARTED|Overall Study||13
6726529|NCT03119610|7656443|FG001|STARTED|Overall Study||10
6726530|NCT03119610|7656442|FG000|COMPLETED|Overall Study||12
6726531|NCT03119610|7656443|FG001|COMPLETED|Overall Study||9
6726532|NCT03119610|7656442|FG000|NOT COMPLETED|Overall Study||1
6726533|NCT03119610|7656443|FG001|NOT COMPLETED|Overall Study||1
6726534|NCT03119649|7656454|FG000|STARTED|Overall Study||11
6726535|NCT03119649|7656455|FG001|STARTED|Overall Study||10
6726536|NCT03119649|7656456|FG002|STARTED|Overall Study||10
6726537|NCT03119649|7656457|FG003|STARTED|Overall Study||14
6726538|NCT03119649|7656458|FG004|STARTED|Overall Study||14
6726539|NCT03119649|7656454|FG000|COMPLETED|Overall Study||11
6726540|NCT03119649|7656455|FG001|COMPLETED|Overall Study||10
6726541|NCT03119649|7656456|FG002|COMPLETED|Overall Study||10
6726542|NCT03119649|7656457|FG003|COMPLETED|Overall Study||14
6726543|NCT03119649|7656458|FG004|COMPLETED|Overall Study||14
6726544|NCT03119649|7656454|FG000|NOT COMPLETED|Overall Study||0
6726545|NCT03119649|7656455|FG001|NOT COMPLETED|Overall Study||0
6726546|NCT03119649|7656456|FG002|NOT COMPLETED|Overall Study||0
6726547|NCT03119649|7656457|FG003|NOT COMPLETED|Overall Study||0
6726548|NCT03119649|7656458|FG004|NOT COMPLETED|Overall Study||0
6726549|NCT03119688|7656474|FG000|STARTED|Overall Study||48
6726550|NCT03119688|7656474|FG000|COMPLETED|Overall Study||44
6726551|NCT03119688|7656474|FG000|NOT COMPLETED|Overall Study||4
6726552|NCT03119701|7656493|FG000|STARTED|6-day Dosing||29
6726553|NCT03119701|7656494|FG001|STARTED|6-day Dosing||11
6726554|NCT03119701|7656493|FG000|COMPLETED|6-day Dosing||22
6726555|NCT03119701|7656494|FG001|COMPLETED|6-day Dosing||8
6726556|NCT03119701|7656493|FG000|NOT COMPLETED|6-day Dosing||7
6726557|NCT03119701|7656494|FG001|NOT COMPLETED|6-day Dosing||3
6726558|NCT03119701|7656493|FG000|STARTED|Mid-term (Final) Follow-up at D90|3 patients who discontinued study drug due to adverse events were also followed up.|25
6726559|NCT03119701|7656494|FG001|STARTED|Mid-term (Final) Follow-up at D90|2 patients who did not receive 6 doses were also followed up.|10
6726560|NCT03119701|7656493|FG000|COMPLETED|Mid-term (Final) Follow-up at D90||22
6726561|NCT03119701|7656494|FG001|COMPLETED|Mid-term (Final) Follow-up at D90||9
6726562|NCT03119701|7656493|FG000|NOT COMPLETED|Mid-term (Final) Follow-up at D90||3
6726563|NCT03119701|7656494|FG001|NOT COMPLETED|Mid-term (Final) Follow-up at D90||1
6726564|NCT03119831|7656503|FG000|STARTED|Overall Study||14
6726565|NCT03119831|7656504|FG001|STARTED|Overall Study||14
6726566|NCT03119831|7656505|FG002|STARTED|Overall Study||14
6726567|NCT03119831|7656503|FG000|COMPLETED|Overall Study||14
6726568|NCT03119831|7656504|FG001|COMPLETED|Overall Study||14
6726569|NCT03119831|7656505|FG002|COMPLETED|Overall Study||14
6726570|NCT03119831|7656503|FG000|NOT COMPLETED|Overall Study||0
6726571|NCT03119831|7656504|FG001|NOT COMPLETED|Overall Study||0
6726572|NCT03119831|7656505|FG002|NOT COMPLETED|Overall Study||0
6726573|NCT03120013|7656516|FG000|STARTED|First Intervention (2 Weeks)||10
6726574|NCT03120013|7656517|FG001|STARTED|First Intervention (2 Weeks)||11
6726575|NCT03120013|7656516|FG000|Received Intervention|First Intervention (2 Weeks)||10
6265483|NCT00023452|7164535|FG001|Randomized|Overall Study||3174
6265484|NCT00023452|7164534|FG000|Enrolled as Part of a Cluster|Overall Study||718
6265485|NCT00023452|7164535|FG001|Enrolled as Part of a Cluster|Overall Study||971
6265486|NCT00023452|7164534|FG000|Completed Treatment|Overall Study||2585
6265487|NCT00023452|7164535|FG001|Completed Treatment|Overall Study||3273
6265488|NCT00023452|7164534|FG000|Not Treated|Overall Study||149
6265489|NCT00023452|7164535|FG001|Not Treated|Overall Study||105
6265490|NCT00023452|7164534|FG000|Completed Study|Overall Study||3174
6265491|NCT00023452|7164535|FG001|Completed Study|Overall Study||3475
6265492|NCT00023452|7164534|FG000|COMPLETED|Overall Study||2585
6265493|NCT00023452|7164535|FG001|COMPLETED|Overall Study||3273
6265494|NCT00023452|7164534|FG000|NOT COMPLETED|Overall Study||1323
6265495|NCT00023452|7164535|FG001|NOT COMPLETED|Overall Study||872
6265496|NCT00023595|7164550|FG000|STARTED|5 Year Follow up||602
6265497|NCT00023595|7164551|FG001|STARTED|5 Year Follow up||534
6265498|NCT00023595|7164552|FG002|STARTED|5 Year Follow up||76
6265499|NCT00023595|7164553|FG003|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
6265500|NCT00023595|7164554|FG004|STARTED|5 Year Follow up||501
6265501|NCT00023595|7164550|FG000|COMPLETED|5 Year Follow up||600
6265502|NCT00023595|7164551|FG001|COMPLETED|5 Year Follow up||532
6265503|NCT00023595|7164552|FG002|COMPLETED|5 Year Follow up||75
6265504|NCT00023595|7164553|FG003|COMPLETED|5 Year Follow up||416
6265505|NCT00023595|7164554|FG004|COMPLETED|5 Year Follow up||498
6265506|NCT00023595|7164550|FG000|NOT COMPLETED|5 Year Follow up||2
6265507|NCT00023595|7164551|FG001|NOT COMPLETED|5 Year Follow up||2
6265508|NCT00023595|7164552|FG002|NOT COMPLETED|5 Year Follow up||1
6265509|NCT00023595|7164553|FG003|NOT COMPLETED|5 Year Follow up||7
6265510|NCT00023595|7164554|FG004|NOT COMPLETED|5 Year Follow up||3
6265511|NCT00023595|7164550|FG000|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
6265512|NCT00023595|7164551|FG001|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
6265513|NCT00023595|7164552|FG002|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
6265514|NCT00023595|7164553|FG003|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
6265515|NCT00023595|7164554|FG004|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
6265516|NCT00023595|7164550|FG000|COMPLETED|10 Year Follow up||590
6265517|NCT00023595|7164551|FG001|COMPLETED|10 Year Follow up||524
6265518|NCT00023595|7164552|FG002|COMPLETED|10 Year Follow up||73
6265519|NCT00023595|7164553|FG003|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
6265520|NCT00023595|7164554|FG004|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
6265521|NCT00023595|7164550|FG000|NOT COMPLETED|10 Year Follow up||12
6265522|NCT00023595|7164551|FG001|NOT COMPLETED|10 Year Follow up||10
6265523|NCT00023595|7164552|FG002|NOT COMPLETED|10 Year Follow up||3
6265524|NCT00023595|7164553|FG003|NOT COMPLETED|10 Year Follow up||0
6265525|NCT00023595|7164554|FG004|NOT COMPLETED|10 Year Follow up||0
6265526|NCT00023673|7164580|FG000|STARTED|Overall Study||8
6265527|NCT00023673|7164581|FG001|STARTED|Overall Study||9
6726576|NCT03120013|7656517|FG001|Received Intervention|First Intervention (2 Weeks)||11
6726577|NCT03120013|7656516|FG000|COMPLETED|First Intervention (2 Weeks)||10
6726578|NCT03120013|7656517|FG001|COMPLETED|First Intervention (2 Weeks)||10
6726579|NCT03120013|7656516|FG000|NOT COMPLETED|First Intervention (2 Weeks)||0
6726580|NCT03120013|7656517|FG001|NOT COMPLETED|First Intervention (2 Weeks)||1
6726581|NCT03120013|7656516|FG000|STARTED|Washout (6 Months)||10
6726582|NCT03120013|7656517|FG001|STARTED|Washout (6 Months)||10
6726583|NCT03120013|7656516|FG000|COMPLETED|Washout (6 Months)||10
6726584|NCT03120013|7656517|FG001|COMPLETED|Washout (6 Months)||10
6726585|NCT03120013|7656516|FG000|NOT COMPLETED|Washout (6 Months)||0
6726586|NCT03120013|7656517|FG001|NOT COMPLETED|Washout (6 Months)||0
6726587|NCT03120013|7656516|FG000|STARTED|Second Intervention (2 Weeks)||10
6726588|NCT03120013|7656517|FG001|STARTED|Second Intervention (2 Weeks)||10
6726589|NCT03120013|7656516|FG000|COMPLETED|Second Intervention (2 Weeks)||10
6726590|NCT03120013|7656517|FG001|COMPLETED|Second Intervention (2 Weeks)||10
6726591|NCT03120013|7656516|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||0
6726592|NCT03120013|7656517|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||0
6726593|NCT03120351|7656525|FG000|STARTED|Overall Study||40
6726594|NCT03120351|7656526|FG001|STARTED|Overall Study||40
6726595|NCT03120351|7656525|FG000|COMPLETED|Overall Study||39
6726596|NCT03120351|7656526|FG001|COMPLETED|Overall Study||39
6726597|NCT03120351|7656525|FG000|NOT COMPLETED|Overall Study||1
6726598|NCT03120351|7656526|FG001|NOT COMPLETED|Overall Study||1
6726599|NCT03120520|7656536|FG000|STARTED|Overall Study||31
6726600|NCT03120520|7656537|FG001|STARTED|Overall Study||31
6726601|NCT03120520|7656538|FG002|STARTED|Overall Study||30
6726602|NCT03120520|7656539|FG003|STARTED|Overall Study||32
6726603|NCT03120520|7656536|FG000|COMPLETED|Overall Study||27
6726604|NCT03120520|7656537|FG001|COMPLETED|Overall Study||27
6726605|NCT03120520|7656538|FG002|COMPLETED|Overall Study||26
6726606|NCT03120520|7656539|FG003|COMPLETED|Overall Study||29
6726607|NCT03120520|7656536|FG000|NOT COMPLETED|Overall Study||4
6726608|NCT03120520|7656537|FG001|NOT COMPLETED|Overall Study||4
6726609|NCT03120520|7656538|FG002|NOT COMPLETED|Overall Study||4
6726610|NCT03120520|7656539|FG003|NOT COMPLETED|Overall Study||3
6726611|NCT03120832|7656552|FG000|STARTED|Overall Study||3
6726612|NCT03120832|7656553|FG001|STARTED|Overall Study||3
6726613|NCT03120832|7656554|FG002|STARTED|Overall Study||6
6726614|NCT03120832|7656552|FG000|COMPLETED|Overall Study||3
6726615|NCT03120832|7656553|FG001|COMPLETED|Overall Study||3
6726616|NCT03120832|7656554|FG002|COMPLETED|Overall Study||6
6726617|NCT03120832|7656552|FG000|NOT COMPLETED|Overall Study||0
6726618|NCT03120832|7656553|FG001|NOT COMPLETED|Overall Study||0
6726619|NCT03120832|7656554|FG002|NOT COMPLETED|Overall Study||0
6726620|NCT03121144|7656562|FG000|STARTED|Overall Study||34
6726621|NCT03121144|7656562|FG000|COMPLETED|Overall Study||34
6726622|NCT03121144|7656562|FG000|NOT COMPLETED|Overall Study||0
6726623|NCT03121365|7656568|FG000|STARTED|Baseline||55
6726624|NCT03121365|7656569|FG001|STARTED|Baseline||49
6726625|NCT03121365|7656568|FG000|COMPLETED|Baseline||54
6726626|NCT03121365|7656569|FG001|COMPLETED|Baseline||48
6726627|NCT03121365|7656568|FG000|NOT COMPLETED|Baseline||1
6726628|NCT03121365|7656569|FG001|NOT COMPLETED|Baseline||1
6726629|NCT03121365|7656568|FG000|STARTED|1 Months||54
6726630|NCT03121365|7656569|FG001|STARTED|1 Months||48
6726631|NCT03121365|7656568|FG000|COMPLETED|1 Months||52
6726632|NCT03121365|7656569|FG001|COMPLETED|1 Months||45
6726633|NCT03121365|7656568|FG000|NOT COMPLETED|1 Months||2
6726634|NCT03121365|7656569|FG001|NOT COMPLETED|1 Months||3
6726635|NCT03121365|7656568|FG000|STARTED|4 Months||54
6726636|NCT03121365|7656569|FG001|STARTED|4 Months||45
6726637|NCT03121365|7656568|FG000|COMPLETED|4 Months||51
6726638|NCT03121365|7656569|FG001|COMPLETED|4 Months||44
6726639|NCT03121365|7656568|FG000|NOT COMPLETED|4 Months||3
6726640|NCT03121365|7656569|FG001|NOT COMPLETED|4 Months||1
6726641|NCT03121365|7656568|FG000|STARTED|7 Months||54
6726642|NCT03121365|7656569|FG001|STARTED|7 Months||45
6726643|NCT03121365|7656568|FG000|COMPLETED|7 Months||44
6726644|NCT03121365|7656569|FG001|COMPLETED|7 Months||37
6726645|NCT03121365|7656568|FG000|NOT COMPLETED|7 Months||10
6726646|NCT03121365|7656569|FG001|NOT COMPLETED|7 Months||8
6726647|NCT03121612|7656579|FG000|STARTED|Overall Study||26
6726648|NCT03121612|7656580|FG001|STARTED|Overall Study||25
6726649|NCT03121612|7656579|FG000|COMPLETED|Overall Study||26
6726650|NCT03121612|7656580|FG001|COMPLETED|Overall Study||25
6726651|NCT03121612|7656579|FG000|NOT COMPLETED|Overall Study||0
6726652|NCT03121612|7656580|FG001|NOT COMPLETED|Overall Study||0
6726653|NCT03121820|7656590|FG000|STARTED|First Period||9
6726654|NCT03121820|7656591|FG001|STARTED|First Period||9
6726655|NCT03121820|7656590|FG000|COMPLETED|First Period||9
6726656|NCT03121820|7656591|FG001|COMPLETED|First Period||9
6726657|NCT03121820|7656590|FG000|NOT COMPLETED|First Period||0
6726658|NCT03121820|7656591|FG001|NOT COMPLETED|First Period||0
6726659|NCT03121820|7656590|FG000|STARTED|Second Period (After Washout)||9
6726660|NCT03121820|7656591|FG001|STARTED|Second Period (After Washout)||9
6726661|NCT03121820|7656590|FG000|COMPLETED|Second Period (After Washout)||9
6726662|NCT03121820|7656591|FG001|COMPLETED|Second Period (After Washout)||9
6726663|NCT03121820|7656590|FG000|NOT COMPLETED|Second Period (After Washout)||0
6726664|NCT03121820|7656591|FG001|NOT COMPLETED|Second Period (After Washout)||0
6726665|NCT03121950|7656599|FG000|STARTED|Overall Study||17
6726666|NCT03121950|7656600|FG001|STARTED|Overall Study||3
6726667|NCT03121950|7656599|FG000|COMPLETED|Overall Study||6
6726668|NCT03121950|7656600|FG001|COMPLETED|Overall Study||1
6726669|NCT03121950|7656599|FG000|NOT COMPLETED|Overall Study||11
6726670|NCT03121950|7656600|FG001|NOT COMPLETED|Overall Study||2
6726671|NCT03122145|7656610|FG000|STARTED|Overall Study|34 participants completed the first sub study under this IRB|37
6726672|NCT03122145|7656611|FG001|STARTED|Overall Study||12
6726673|NCT03122145|7656610|FG000|COMPLETED|Overall Study||34
6726674|NCT03122145|7656611|FG001|COMPLETED|Overall Study||12
6726675|NCT03122145|7656610|FG000|NOT COMPLETED|Overall Study||3
6726676|NCT03122145|7656611|FG001|NOT COMPLETED|Overall Study||0
6726677|NCT03122171|7656617|FG000|STARTED|Overall Study||6
6726678|NCT03122171|7656617|FG000|COMPLETED|Overall Study||5
6726679|NCT03122171|7656617|FG000|NOT COMPLETED|Overall Study||1
6726680|NCT03122184|7656623|FG000|STARTED|Overall Study||24
6726681|NCT03122184|7656624|FG001|STARTED|Overall Study||23
6726682|NCT03122184|7656623|FG000|COMPLETED|Overall Study||16
6726683|NCT03122184|7656624|FG001|COMPLETED|Overall Study||17
6726684|NCT03122184|7656623|FG000|NOT COMPLETED|Overall Study||8
6726685|NCT03122184|7656624|FG001|NOT COMPLETED|Overall Study||6
6726686|NCT03122223|7656634|FG000|STARTED|Overall Study||50
6726687|NCT03122223|7656635|FG001|STARTED|Overall Study||50
6726688|NCT03122223|7656636|FG002|STARTED|Overall Study||50
6726689|NCT03122223|7656637|FG003|STARTED|Overall Study||10
6726690|NCT03122223|7656634|FG000|Month 6.5 Immunogenicity Cohort|Overall Study||49
6726691|NCT03122223|7656635|FG001|Month 6.5 Immunogenicity Cohort|Overall Study||48
6726692|NCT03122223|7656636|FG002|Month 6.5 Immunogenicity Cohort|Overall Study||47
6726693|NCT03122223|7656637|FG003|Month 6.5 Immunogenicity Cohort|Overall Study||8
6726694|NCT03122223|7656634|FG000|Month 12 Immunogenicity Cohort|Overall Study||47
6726695|NCT03122223|7656635|FG001|Month 12 Immunogenicity Cohort|Overall Study||45
6726696|NCT03122223|7656636|FG002|Month 12 Immunogenicity Cohort|Overall Study||46
6726697|NCT03122223|7656637|FG003|Month 12 Immunogenicity Cohort|Overall Study||10
6726698|NCT03122223|7656634|FG000|COMPLETED|Overall Study||47
6726699|NCT03122223|7656635|FG001|COMPLETED|Overall Study||45
6726700|NCT03122223|7656636|FG002|COMPLETED|Overall Study||46
6726701|NCT03122223|7656637|FG003|COMPLETED|Overall Study||10
6726702|NCT03122223|7656634|FG000|NOT COMPLETED|Overall Study||3
6726703|NCT03122223|7656635|FG001|NOT COMPLETED|Overall Study||5
6726704|NCT03122223|7656636|FG002|NOT COMPLETED|Overall Study||4
6726705|NCT03122223|7656637|FG003|NOT COMPLETED|Overall Study||0
6726706|NCT03122457|7656647|FG000|STARTED|Overall Study||22
6726707|NCT03122457|7656647|FG000|COMPLETED|Overall Study||16
6726708|NCT03122457|7656647|FG000|NOT COMPLETED|Overall Study||6
6726709|NCT03122535|7656651|FG000|STARTED|Overall Study||115
6726710|NCT03122535|7656652|FG001|STARTED|Overall Study||115
6726711|NCT03122535|7656651|FG000|3 Months|Overall Study||92
6726712|NCT03122535|7656652|FG001|3 Months|Overall Study||92
6726713|NCT03122535|7656651|FG000|12 Months|Overall Study||42
6726714|NCT03122535|7656652|FG001|12 Months|Overall Study||42
6726715|NCT03122535|7656651|FG000|COMPLETED|Overall Study||42
6726716|NCT03122535|7656652|FG001|COMPLETED|Overall Study||42
6726717|NCT03122535|7656651|FG000|NOT COMPLETED|Overall Study||73
6726718|NCT03122535|7656652|FG001|NOT COMPLETED|Overall Study||73
6726719|NCT03122548|7656658|FG000|STARTED|Overall Study||5
6726720|NCT03122548|7656658|FG000|COMPLETED|Overall Study||0
6726721|NCT03122548|7656658|FG000|NOT COMPLETED|Overall Study||5
6726722|NCT03122587|7656665|FG000|STARTED|Overall Study||13
6726723|NCT03122587|7656666|FG001|STARTED|Overall Study||12
6726724|NCT03122587|7656667|FG002|STARTED|Overall Study||13
6726725|NCT03122587|7656665|FG000|COMPLETED|Overall Study||11
6726726|NCT03122587|7656666|FG001|COMPLETED|Overall Study||10
6726727|NCT03122587|7656667|FG002|COMPLETED|Overall Study||12
6726728|NCT03122587|7656665|FG000|NOT COMPLETED|Overall Study||2
6726729|NCT03122587|7656666|FG001|NOT COMPLETED|Overall Study||2
6726730|NCT03122587|7656667|FG002|NOT COMPLETED|Overall Study||1
6726731|NCT03122860|7656681|FG000|STARTED|Overall Study||117
6726732|NCT03122860|7656682|FG001|STARTED|Overall Study||116
6726733|NCT03122860|7656683|FG002|STARTED|Overall Study||117
6726734|NCT03122860|7656684|FG003|STARTED|Overall Study||116
6726735|NCT03122860|7656685|FG004|STARTED|Overall Study||117
6726736|NCT03122860|7656686|FG005|STARTED|Overall Study||117
6726737|NCT03122860|7656681|FG000|Full Analysis Set|Overall Study||116
6726738|NCT03122860|7656682|FG001|Full Analysis Set|Overall Study||115
6726739|NCT03122860|7656683|FG002|Full Analysis Set|Overall Study||115
6726740|NCT03122860|7656684|FG003|Full Analysis Set|Overall Study||116
6726741|NCT03122860|7656685|FG004|Full Analysis Set|Overall Study||116
6726742|NCT03122860|7656686|FG005|Full Analysis Set|Overall Study||117
6726743|NCT03122860|7656681|FG000|COMPLETED|Overall Study||107
6726744|NCT03122860|7656682|FG001|COMPLETED|Overall Study||111
6726745|NCT03122860|7656683|FG002|COMPLETED|Overall Study||105
6726746|NCT03122860|7656684|FG003|COMPLETED|Overall Study||105
6726747|NCT03122860|7656685|FG004|COMPLETED|Overall Study||102
6726748|NCT03122860|7656686|FG005|COMPLETED|Overall Study||105
6726749|NCT03122860|7656681|FG000|NOT COMPLETED|Overall Study||10
6726750|NCT03122860|7656682|FG001|NOT COMPLETED|Overall Study||5
6726751|NCT03122860|7656683|FG002|NOT COMPLETED|Overall Study||12
6726752|NCT03122860|7656684|FG003|NOT COMPLETED|Overall Study||11
6726753|NCT03122860|7656685|FG004|NOT COMPLETED|Overall Study||15
6726754|NCT03122860|7656686|FG005|NOT COMPLETED|Overall Study||12
6726755|NCT03122886|7656703|FG000|STARTED|Overall Study||10
6726756|NCT03122886|7656704|FG001|STARTED|Overall Study||9
6726757|NCT03122886|7656703|FG000|COMPLETED|Overall Study||9
6726758|NCT03122886|7656704|FG001|COMPLETED|Overall Study||7
6726759|NCT03122886|7656703|FG000|NOT COMPLETED|Overall Study||1
6726760|NCT03122886|7656704|FG001|NOT COMPLETED|Overall Study||2
6726761|NCT03123055|7656710|FG000|STARTED|Overall Study||28
6726762|NCT03123055|7656710|FG000|COMPLETED|Overall Study||28
6726763|NCT03123055|7656710|FG000|NOT COMPLETED|Overall Study||0
6726764|NCT03123068|7656717|FG000|STARTED|Overall Study||22
6726765|NCT03123068|7656718|FG001|STARTED|Overall Study||20
6726766|NCT03123068|7656717|FG000|COMPLETED|Overall Study||22
6726767|NCT03123068|7656718|FG001|COMPLETED|Overall Study||20
6726768|NCT03123068|7656717|FG000|NOT COMPLETED|Overall Study||0
6726769|NCT03123068|7656718|FG001|NOT COMPLETED|Overall Study||0
6726770|NCT03123120|7656726|FG000|STARTED|Overall Study||8
6726771|NCT03123120|7656727|FG001|STARTED|Overall Study||14
6726772|NCT03123120|7656726|FG000|Safety Analysis Set (SAF)|Overall Study||7
6726773|NCT03123120|7656727|FG001|Safety Analysis Set (SAF)|Overall Study||15
6726774|NCT03123120|7656726|FG000|COMPLETED|Overall Study||8
6726775|NCT03123120|7656727|FG001|COMPLETED|Overall Study||12
6726776|NCT03123120|7656726|FG000|NOT COMPLETED|Overall Study||0
6726777|NCT03123120|7656727|FG001|NOT COMPLETED|Overall Study||2
6726778|NCT03123263|7656735|FG000|STARTED|Overall Study||60
6726779|NCT03123263|7656735|FG000|COMPLETED|Overall Study||60
6726780|NCT03123263|7656735|FG000|NOT COMPLETED|Overall Study||0
6726781|NCT03123354|7656742|FG000|STARTED|Overall Study||44
6726782|NCT03123354|7656742|FG000|COMPLETED|Overall Study||38
6726783|NCT03123354|7656742|FG000|NOT COMPLETED|Overall Study||6
6726784|NCT03123471|7656748|FG000|STARTED|Placebo-controlled Phase||102
6726785|NCT03123471|7656749|FG001|STARTED|Placebo-controlled Phase||201
6726786|NCT03123471|7656748|FG000|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||102
6726787|NCT03123471|7656749|FG001|Received at Least 1 Dose of Study Drug|Placebo-controlled Phase||200
6726788|NCT03123471|7656748|FG000|COMPLETED|Placebo-controlled Phase||84
6726789|NCT03123471|7656749|FG001|COMPLETED|Placebo-controlled Phase||168
6726790|NCT03123471|7656748|FG000|NOT COMPLETED|Placebo-controlled Phase||18
6726791|NCT03123471|7656749|FG001|NOT COMPLETED|Placebo-controlled Phase||33
6726792|NCT03123471|7656748|FG000|STARTED|Apremilast Extension Phase||84
6726793|NCT03123471|7656749|FG001|STARTED|Apremilast Extension Phase|3 participants completed the first phase; did not enter in extension phase|165
6726794|NCT03123471|7656748|FG000|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||84
6726795|NCT03123471|7656749|FG001|Received at Least 1 Dose of Study Drug|Apremilast Extension Phase||163
6726796|NCT03123471|7656748|FG000|COMPLETED|Apremilast Extension Phase||76
6726797|NCT03123471|7656749|FG001|COMPLETED|Apremilast Extension Phase||140
6726798|NCT03123471|7656748|FG000|NOT COMPLETED|Apremilast Extension Phase||8
6726799|NCT03123471|7656749|FG001|NOT COMPLETED|Apremilast Extension Phase||25
6726800|NCT03123588|7656763|FG000|STARTED|Overall Study||6
6726801|NCT03123588|7656764|FG001|STARTED|Overall Study||6
6726802|NCT03123588|7656763|FG000|COMPLETED|Overall Study||0
6726803|NCT03123588|7656764|FG001|COMPLETED|Overall Study||0
6726804|NCT03123588|7656763|FG000|NOT COMPLETED|Overall Study||6
6726805|NCT03123588|7656764|FG001|NOT COMPLETED|Overall Study||6
6726806|NCT03123614|7656773|FG000|STARTED|Overall Study||57
6726807|NCT03123614|7656774|FG001|STARTED|Overall Study||74
6726808|NCT03123614|7656773|FG000|COMPLETED|Overall Study||57
6726809|NCT03123614|7656774|FG001|COMPLETED|Overall Study||74
6726810|NCT03123614|7656773|FG000|NOT COMPLETED|Overall Study||0
6726811|NCT03123614|7656774|FG001|NOT COMPLETED|Overall Study||0
6726812|NCT03123848|7656780|FG000|STARTED|Overall Study||8
6726813|NCT03123848|7656780|FG000|COMPLETED|Overall Study||8
6726814|NCT03123848|7656780|FG000|NOT COMPLETED|Overall Study||0
6726815|NCT03123861|7656788|FG000|STARTED|Overall Study||22
6726816|NCT03123861|7656789|FG001|STARTED|Overall Study||23
6726817|NCT03123861|7656788|FG000|Received Intervention|Overall Study||21
6726818|NCT03123861|7656789|FG001|Received Intervention|Overall Study||22
6726819|NCT03123861|7656788|FG000|COMPLETED|Overall Study||19
6726820|NCT03123861|7656789|FG001|COMPLETED|Overall Study||20
6726821|NCT03123861|7656788|FG000|NOT COMPLETED|Overall Study||3
6726822|NCT03123861|7656789|FG001|NOT COMPLETED|Overall Study||3
6726823|NCT03123874|7656797|FG000|STARTED|Overall Study||27
6726824|NCT03123874|7656798|FG001|STARTED|Overall Study||25
6726825|NCT03123874|7656797|FG000|COMPLETED|Overall Study||27
6726826|NCT03123874|7656798|FG001|COMPLETED|Overall Study||25
6726827|NCT03123874|7656797|FG000|NOT COMPLETED|Overall Study||0
6726828|NCT03123874|7656798|FG001|NOT COMPLETED|Overall Study||0
6726829|NCT03123939|7656808|FG000|STARTED|Overall Study||74
6726830|NCT03123939|7656808|FG000|CTL019 Infused|Overall Study||69
6726831|NCT03123939|7656808|FG000|Full Analysis Set (FAS)|Overall Study||69
6726832|NCT03123939|7656808|FG000|Cellular Kinetic Analysis Set (CKAS)|Overall Study||69
6726833|NCT03123939|7656808|FG000|Safety Set (SAF)|Overall Study||69
6726834|NCT03123939|7656808|FG000|COMPLETED|Overall Study||33
6726835|NCT03123939|7656808|FG000|NOT COMPLETED|Overall Study||41
6726836|NCT03124069|7656812|FG000|STARTED|Overall Study||37
6726837|NCT03124069|7656812|FG000|COMPLETED|Overall Study||37
6726838|NCT03124069|7656812|FG000|NOT COMPLETED|Overall Study||0
6726839|NCT03124108|7656821|FG000|STARTED|Overall Study||15
6726840|NCT03124108|7656822|FG001|STARTED|Overall Study||15
6726841|NCT03124108|7656823|FG002|STARTED|Overall Study||15
6726842|NCT03124108|7656821|FG000|COMPLETED|Overall Study||15
6726843|NCT03124108|7656822|FG001|COMPLETED|Overall Study||14
6726844|NCT03124108|7656823|FG002|COMPLETED|Overall Study||15
6726845|NCT03124108|7656821|FG000|NOT COMPLETED|Overall Study||0
6726846|NCT03124108|7656822|FG001|NOT COMPLETED|Overall Study||1
6726847|NCT03124108|7656823|FG002|NOT COMPLETED|Overall Study||0
6726848|NCT03124121|7656835|FG000|STARTED|Overall Study||42
6726849|NCT03124121|7656836|FG001|STARTED|Overall Study||70
6726850|NCT03124121|7656835|FG000|COMPLETED|Overall Study||39
6726851|NCT03124121|7656836|FG001|COMPLETED|Overall Study||67
6726852|NCT03124121|7656835|FG000|NOT COMPLETED|Overall Study||3
6726853|NCT03124121|7656836|FG001|NOT COMPLETED|Overall Study||3
6726854|NCT03124199|7656844|FG000|STARTED|Overall Study||40
6726855|NCT03124199|7656844|FG000|COMPLETED|Overall Study||36
6726856|NCT03124199|7656844|FG000|NOT COMPLETED|Overall Study||4
6726857|NCT03124342|7656850|FG000|STARTED|Overall Study||111
6726858|NCT03124342|7656851|FG001|STARTED|Overall Study||121
6726859|NCT03124342|7656850|FG000|COMPLETED|Overall Study||111
6726860|NCT03124342|7656851|FG001|COMPLETED|Overall Study||121
6726861|NCT03124342|7656850|FG000|NOT COMPLETED|Overall Study||0
6726862|NCT03124342|7656851|FG001|NOT COMPLETED|Overall Study||0
6726863|NCT03124368|7656860|FG000|STARTED|Overall Study||2
6726864|NCT03124368|7656861|FG001|STARTED|Overall Study||4
6726865|NCT03124368|7656860|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
6726866|NCT03124368|7656861|FG001|Received at Least 1 Dose of Study Drug|Overall Study||4
6726867|NCT03124368|7656860|FG000|COMPLETED|Overall Study||2
6726868|NCT03124368|7656861|FG001|COMPLETED|Overall Study||4
6726869|NCT03124368|7656860|FG000|NOT COMPLETED|Overall Study||0
6726870|NCT03124368|7656861|FG001|NOT COMPLETED|Overall Study||0
6726871|NCT03124381|7656874|FG000|STARTED|Overall Study||65
6726872|NCT03124381|7656875|FG001|STARTED|Overall Study||61
6726873|NCT03124381|7656874|FG000|COMPLETED|Overall Study||56
6726874|NCT03124381|7656875|FG001|COMPLETED|Overall Study||55
6726875|NCT03124381|7656874|FG000|NOT COMPLETED|Overall Study||9
6726876|NCT03124381|7656875|FG001|NOT COMPLETED|Overall Study||6
6726877|NCT03124407|7656885|FG000|STARTED|Overall Study||40
6726878|NCT03124407|7656886|FG001|STARTED|Overall Study||20
6726879|NCT03124407|7656887|FG002|STARTED|Overall Study||40
6726880|NCT03124407|7656888|FG003|STARTED|Overall Study||20
6726881|NCT03124407|7656885|FG000|COMPLETED|Overall Study||39
6726882|NCT03124407|7656886|FG001|COMPLETED|Overall Study||20
6726883|NCT03124407|7656887|FG002|COMPLETED|Overall Study||39
6726884|NCT03124407|7656888|FG003|COMPLETED|Overall Study||20
6726885|NCT03124407|7656885|FG000|NOT COMPLETED|Overall Study||1
6726886|NCT03124407|7656886|FG001|NOT COMPLETED|Overall Study||0
6726887|NCT03124407|7656887|FG002|NOT COMPLETED|Overall Study||1
6726888|NCT03124407|7656888|FG003|NOT COMPLETED|Overall Study||0
6726889|NCT03124459|7656908|FG000|STARTED|Part 1-Open Label Dose Escalation||6
6726890|NCT03124459|7656909|FG001|STARTED|Part 1-Open Label Dose Escalation||6
6726891|NCT03124459|7656910|FG002|STARTED|Part 1-Open Label Dose Escalation||6
6726892|NCT03124459|7656911|FG003|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
6726893|NCT03124459|7656912|FG004|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
6726894|NCT03124459|7656913|FG005|STARTED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
6726895|NCT03124459|7656908|FG000|COMPLETED|Part 1-Open Label Dose Escalation||6
6726896|NCT03124459|7656909|FG001|COMPLETED|Part 1-Open Label Dose Escalation||6
6726897|NCT03124459|7656910|FG002|COMPLETED|Part 1-Open Label Dose Escalation||6
6726898|NCT03124459|7656911|FG003|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
6726899|NCT03124459|7656912|FG004|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|0
6726900|NCT03124459|7656913|FG005|COMPLETED|Part 1-Open Label Dose Escalation|Patients in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
6726901|NCT03124459|7656908|FG000|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
6726902|NCT03124459|7656909|FG001|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
6726903|NCT03124459|7656910|FG002|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
6726904|NCT03124459|7656911|FG003|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
6726905|NCT03124459|7656912|FG004|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
6726906|NCT03124459|7656913|FG005|NOT COMPLETED|Part 1-Open Label Dose Escalation||0
6726907|NCT03124459|7656908|FG000|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
6726908|NCT03124459|7656909|FG001|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
6726909|NCT03124459|7656910|FG002|STARTED|Phase 2- Randomized Doubled-blind|Participants in Part 1 Open-Label Dose escalation portion of the study were not the same participants that participated in the double-blind placebo controlled study.|0
6739717|NCT03293654|7668568|FG000|STARTED|Overall Study||38
6739718|NCT03293654|7668569|FG001|STARTED|Overall Study||38
6726910|NCT03124459|7656911|FG003|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|21
6726911|NCT03124459|7656912|FG004|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study.|24
6726912|NCT03124459|7656913|FG005|STARTED|Phase 2- Randomized Doubled-blind|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind portion of the study then moved into this Part 2 open-label portion of the study.|0
6726913|NCT03124459|7656908|FG000|COMPLETED|Phase 2- Randomized Doubled-blind||0
6726914|NCT03124459|7656909|FG001|COMPLETED|Phase 2- Randomized Doubled-blind||0
6726915|NCT03124459|7656910|FG002|COMPLETED|Phase 2- Randomized Doubled-blind||0
6726916|NCT03124459|7656911|FG003|COMPLETED|Phase 2- Randomized Doubled-blind||9
6726917|NCT03124459|7656912|FG004|COMPLETED|Phase 2- Randomized Doubled-blind||5
6726918|NCT03124459|7656913|FG005|COMPLETED|Phase 2- Randomized Doubled-blind||0
6726919|NCT03124459|7656908|FG000|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
6726920|NCT03124459|7656909|FG001|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
6726921|NCT03124459|7656910|FG002|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
6726922|NCT03124459|7656911|FG003|NOT COMPLETED|Phase 2- Randomized Doubled-blind||12
6726923|NCT03124459|7656912|FG004|NOT COMPLETED|Phase 2- Randomized Doubled-blind||19
6726924|NCT03124459|7656913|FG005|NOT COMPLETED|Phase 2- Randomized Doubled-blind||0
6726925|NCT03124459|7656908|FG000|STARTED|Part 2- Open Label ACE-083||0
6726926|NCT03124459|7656909|FG001|STARTED|Part 2- Open Label ACE-083||0
6726927|NCT03124459|7656910|FG002|STARTED|Part 2- Open Label ACE-083||0
6726928|NCT03124459|7656911|FG003|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
6726929|NCT03124459|7656912|FG004|STARTED|Part 2- Open Label ACE-083|Participants in the double-blind placebo controlled study were not the same participants that participated in the Part 1 Open-Label Dose escalation portion of the study. Participants that completed the double-blind placebo controlled portion of Part 2, moved into the open-label portion part 2 study.|0
6726930|NCT03124459|7656913|FG005|STARTED|Part 2- Open Label ACE-083|The open-label portion of Part 2 are the participants that were enrolled in and completed the double-blind placebo-controlled portion of Part 2.|40
6726931|NCT03124459|7656908|FG000|COMPLETED|Part 2- Open Label ACE-083||0
6726932|NCT03124459|7656909|FG001|COMPLETED|Part 2- Open Label ACE-083||0
6726933|NCT03124459|7656910|FG002|COMPLETED|Part 2- Open Label ACE-083||0
6726934|NCT03124459|7656911|FG003|COMPLETED|Part 2- Open Label ACE-083||0
6726935|NCT03124459|7656912|FG004|COMPLETED|Part 2- Open Label ACE-083||0
6726936|NCT03124459|7656913|FG005|COMPLETED|Part 2- Open Label ACE-083||17
6726937|NCT03124459|7656908|FG000|NOT COMPLETED|Part 2- Open Label ACE-083||0
6726938|NCT03124459|7656909|FG001|NOT COMPLETED|Part 2- Open Label ACE-083||0
6726939|NCT03124459|7656910|FG002|NOT COMPLETED|Part 2- Open Label ACE-083||0
6726940|NCT03124459|7656911|FG003|NOT COMPLETED|Part 2- Open Label ACE-083||0
6726941|NCT03124459|7656912|FG004|NOT COMPLETED|Part 2- Open Label ACE-083||0
6726942|NCT03124459|7656913|FG005|NOT COMPLETED|Part 2- Open Label ACE-083||23
6726943|NCT03124537|7656928|FG000|STARTED|Overall Study||41
6726944|NCT03124537|7656929|FG001|STARTED|Overall Study||45
6726945|NCT03124537|7656928|FG000|COMPLETED|Overall Study||31
6726946|NCT03124537|7656929|FG001|COMPLETED|Overall Study||32
6726947|NCT03124537|7656928|FG000|NOT COMPLETED|Overall Study||10
6726948|NCT03124537|7656929|FG001|NOT COMPLETED|Overall Study||13
6726949|NCT03124550|7656935|FG000|STARTED|Overall Study||18
6726950|NCT03124550|7656935|FG000|COMPLETED|Overall Study||18
6726951|NCT03124550|7656935|FG000|NOT COMPLETED|Overall Study||0
6726952|NCT03124563|7656941|FG000|STARTED|Overall Study||32
6726953|NCT03124563|7656942|FG001|STARTED|Overall Study||31
6726954|NCT03124563|7656941|FG000|Pre-test|Overall Study||30
6726955|NCT03124563|7656942|FG001|Pre-test|Overall Study||30
6726956|NCT03124563|7656941|FG000|COMPLETED|Overall Study||30
6726957|NCT03124563|7656942|FG001|COMPLETED|Overall Study||29
6726958|NCT03124563|7656941|FG000|NOT COMPLETED|Overall Study||2
6726959|NCT03124563|7656942|FG001|NOT COMPLETED|Overall Study||2
6726960|NCT03124602|7656948|FG000|STARTED|Overall Study||35
6726961|NCT03124602|7656948|FG000|COMPLETED|Overall Study||25
6726962|NCT03124602|7656948|FG000|NOT COMPLETED|Overall Study||10
6726963|NCT03124693|7656952|FG000|STARTED|Overall Study||90
6726964|NCT03124693|7656952|FG000|COMPLETED|Overall Study||90
6726965|NCT03124693|7656952|FG000|NOT COMPLETED|Overall Study||0
6726966|NCT03124758|7656956|FG000|STARTED|Overall Study||354
6726967|NCT03124758|7656956|FG000|COMPLETED|Overall Study||354
6726968|NCT03124758|7656956|FG000|NOT COMPLETED|Overall Study||0
6726969|NCT03124771|7656960|FG000|STARTED|Overall Study||132
6726970|NCT03124771|7656960|FG000|COMPLETED|Overall Study||132
6726971|NCT03124771|7656960|FG000|NOT COMPLETED|Overall Study||0
6726972|NCT03124784|7656964|FG000|STARTED|Overall Study||27
6726973|NCT03124784|7656964|FG000|COMPLETED|Overall Study||25
6726974|NCT03124784|7656964|FG000|NOT COMPLETED|Overall Study||2
6726975|NCT03124797|7656968|FG000|STARTED|Overall Study||18
6726976|NCT03124797|7656968|FG000|COMPLETED|Overall Study||18
6726977|NCT03124797|7656968|FG000|NOT COMPLETED|Overall Study||0
6726978|NCT03124823|7656972|FG000|STARTED|Overall Study||11
6726979|NCT03124823|7656972|FG000|COMPLETED|Overall Study||11
6726980|NCT03124823|7656972|FG000|NOT COMPLETED|Overall Study||0
6726981|NCT03124836|7656976|FG000|STARTED|Overall Study||28
6726982|NCT03124836|7656976|FG000|COMPLETED|Overall Study||28
6726983|NCT03124836|7656976|FG000|NOT COMPLETED|Overall Study||0
6739719|NCT03293654|7668570|FG002|STARTED|Overall Study||38
6739720|NCT03293654|7668568|FG000|COMPLETED|Overall Study||38
6739721|NCT03293654|7668569|FG001|COMPLETED|Overall Study||37
6739722|NCT03293654|7668570|FG002|COMPLETED|Overall Study||38
6739723|NCT03293654|7668568|FG000|NOT COMPLETED|Overall Study||0
6739724|NCT03293654|7668569|FG001|NOT COMPLETED|Overall Study||1
6739725|NCT03293654|7668570|FG002|NOT COMPLETED|Overall Study||0
6739726|NCT03294213|7668578|FG000|STARTED|Overall Study||176
6739727|NCT03294213|7668578|FG000|COMPLETED|Overall Study||176
6739728|NCT03294213|7668578|FG000|NOT COMPLETED|Overall Study||0
6739729|NCT03294317|7668582|FG000|STARTED|Overall Study||70
6739730|NCT03294317|7668582|FG000|Implanted With Lead at HIS Bundle|Overall Study||61
6739731|NCT03294317|7668582|FG000|Subjects With Available CT|Overall Study||51
6739732|NCT03294317|7668582|FG000|COMPLETED|Overall Study||50
6739733|NCT03294317|7668582|FG000|NOT COMPLETED|Overall Study||20
6739734|NCT03294538|7668589|FG000|STARTED|Overall Study||268
6739735|NCT03294538|7668590|FG001|STARTED|Overall Study||262
6739736|NCT03294538|7668591|FG002|STARTED|Overall Study||133
6739737|NCT03294538|7668589|FG000|Safety Population|Overall Study||267
6265528|NCT00023673|7164582|FG002|STARTED|Overall Study||0
6265529|NCT00023673|7164583|FG003|STARTED|Overall Study||46
6265530|NCT00023673|7164580|FG000|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
6739738|NCT03294538|7668590|FG001|Safety Population|Overall Study||262
6739739|NCT03294538|7668591|FG002|Safety Population|Overall Study||132
6739740|NCT03294538|7668589|FG000|mITT Population|Overall Study||267
6739741|NCT03294538|7668590|FG001|mITT Population|Overall Study||262
6739742|NCT03294538|7668591|FG002|mITT Population|Overall Study||132
6739743|NCT03294538|7668589|FG000|PP Population|Overall Study||244
6739744|NCT03294538|7668590|FG001|PP Population|Overall Study||227
6739745|NCT03294538|7668591|FG002|PP Population|Overall Study||126
6739746|NCT03294538|7668589|FG000|COMPLETED|Overall Study||263
6739747|NCT03294538|7668590|FG001|COMPLETED|Overall Study||257
6739748|NCT03294538|7668591|FG002|COMPLETED|Overall Study||131
6739749|NCT03294538|7668589|FG000|NOT COMPLETED|Overall Study||5
6739750|NCT03294538|7668590|FG001|NOT COMPLETED|Overall Study||5
6739751|NCT03294538|7668591|FG002|NOT COMPLETED|Overall Study||2
6739752|NCT03294629|7668601|FG000|STARTED|First Intervention (2 Weeks)||16
6739753|NCT03294629|7668602|FG001|STARTED|First Intervention (2 Weeks)||19
6739754|NCT03294629|7668601|FG000|COMPLETED|First Intervention (2 Weeks)||14
6739755|NCT03294629|7668602|FG001|COMPLETED|First Intervention (2 Weeks)||15
6739756|NCT03294629|7668601|FG000|NOT COMPLETED|First Intervention (2 Weeks)||2
6739757|NCT03294629|7668602|FG001|NOT COMPLETED|First Intervention (2 Weeks)||4
6739758|NCT03294629|7668601|FG000|STARTED|Second Intervention (2 Weeks)||14
6739759|NCT03294629|7668602|FG001|STARTED|Second Intervention (2 Weeks)||15
6739760|NCT03294629|7668601|FG000|COMPLETED|Second Intervention (2 Weeks)||12
6739761|NCT03294629|7668602|FG001|COMPLETED|Second Intervention (2 Weeks)||13
6739762|NCT03294629|7668601|FG000|NOT COMPLETED|Second Intervention (2 Weeks)||2
6739763|NCT03294629|7668602|FG001|NOT COMPLETED|Second Intervention (2 Weeks)||2
6739764|NCT03294681|7668608|FG000|STARTED|Overall Study||153
6739765|NCT03294681|7668608|FG000|COMPLETED|Overall Study||152
6739766|NCT03294681|7668608|FG000|NOT COMPLETED|Overall Study||1
6739767|NCT03294850|7668614|FG000|STARTED|Overall Study||4
6739768|NCT03294850|7668615|FG001|STARTED|Overall Study||10
6739769|NCT03294850|7668614|FG000|COMPLETED|Overall Study||4
6739770|NCT03294850|7668615|FG001|COMPLETED|Overall Study||10
6739771|NCT03294850|7668614|FG000|NOT COMPLETED|Overall Study||0
6739772|NCT03294850|7668615|FG001|NOT COMPLETED|Overall Study||0
6739773|NCT03294941|7668623|FG000|STARTED|Overall Study||4
6739774|NCT03294941|7668624|FG001|STARTED|Overall Study||13
6739775|NCT03294941|7668623|FG000|COMPLETED|Overall Study||4
6739776|NCT03294941|7668624|FG001|COMPLETED|Overall Study||11
6739777|NCT03294941|7668623|FG000|NOT COMPLETED|Overall Study||0
6739778|NCT03294941|7668624|FG001|NOT COMPLETED|Overall Study||2
6739779|NCT03295201|7668633|FG000|STARTED|Overall Study||11
6739780|NCT03295201|7668634|FG001|STARTED|Overall Study||11
6739781|NCT03295201|7668633|FG000|COMPLETED|Overall Study||10
6739782|NCT03295201|7668634|FG001|COMPLETED|Overall Study||9
6739783|NCT03295201|7668633|FG000|NOT COMPLETED|Overall Study||1
6739784|NCT03295201|7668634|FG001|NOT COMPLETED|Overall Study||2
6739785|NCT03295266|7668642|FG000|STARTED|Overall Study||5
6739786|NCT03295266|7668643|FG001|STARTED|Overall Study||4
6739787|NCT03295266|7668642|FG000|COMPLETED|Overall Study||5
6739788|NCT03295266|7668643|FG001|COMPLETED|Overall Study||4
6739789|NCT03295266|7668642|FG000|NOT COMPLETED|Overall Study||0
6739790|NCT03295266|7668643|FG001|NOT COMPLETED|Overall Study||0
6739791|NCT03295318|7668652|FG000|STARTED|Overall Study||150
6739792|NCT03295318|7668653|FG001|STARTED|Overall Study||150
6739793|NCT03295318|7668654|FG002|STARTED|Overall Study||76
6739794|NCT03295318|7668652|FG000|Received First Vaccination|Overall Study|1 subject withdrew consent after randomization, but prior to vaccination.|149
6265531|NCT00023673|7164581|FG001|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
6265532|NCT00023673|7164582|FG002|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
6280509|NCT00157573|7180492|FG001|STARTED|Overall Study||37
6726984|NCT03124901|7656980|FG000|STARTED|Overall Study||147
6726985|NCT03124901|7656980|FG000|COMPLETED|Overall Study||147
6726986|NCT03124901|7656980|FG000|NOT COMPLETED|Overall Study||0
6726987|NCT03124927|7656984|FG000|STARTED|Overall Study||25
6726988|NCT03124927|7656984|FG000|COMPLETED|Overall Study||25
6726989|NCT03124927|7656984|FG000|NOT COMPLETED|Overall Study||0
6726990|NCT03124966|7656988|FG000|STARTED|Overall Study||118
6726991|NCT03124966|7656988|FG000|COMPLETED|Overall Study||118
6726992|NCT03124966|7656988|FG000|NOT COMPLETED|Overall Study||0
6726993|NCT03124979|7656992|FG000|STARTED|Overall Study||13
6726994|NCT03124979|7656992|FG000|COMPLETED|Overall Study||13
6726995|NCT03124979|7656992|FG000|NOT COMPLETED|Overall Study||0
6726996|NCT03125005|7656996|FG000|STARTED|Overall Study||51
6726997|NCT03125005|7656996|FG000|COMPLETED|Overall Study||51
6726998|NCT03125005|7656996|FG000|NOT COMPLETED|Overall Study||0
6726999|NCT03125018|7657000|FG000|STARTED|Overall Study||13
6727000|NCT03125018|7657000|FG000|COMPLETED|Overall Study||13
6727001|NCT03125018|7657000|FG000|NOT COMPLETED|Overall Study||0
6727002|NCT03125031|7657004|FG000|STARTED|Overall Study||44
6727003|NCT03125031|7657005|FG001|STARTED|Overall Study||44
6727004|NCT03125031|7657004|FG000|COMPLETED|Overall Study||44
6265533|NCT00023673|7164583|FG003|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
6727005|NCT03125031|7657005|FG001|COMPLETED|Overall Study||44
6727006|NCT03125031|7657004|FG000|NOT COMPLETED|Overall Study||0
6727007|NCT03125031|7657005|FG001|NOT COMPLETED|Overall Study||0
6727008|NCT03125200|7657017|FG000|STARTED|Overall Study||2
6727009|NCT03125200|7657018|FG001|STARTED|Overall Study||2
6727010|NCT03125200|7657019|FG002|STARTED|Overall Study||2
6727011|NCT03125200|7657020|FG003|STARTED|Overall Study||5
6727012|NCT03125200|7657021|FG004|STARTED|Overall Study||4
6727013|NCT03125200|7657022|FG005|STARTED|Overall Study||3
6727014|NCT03125200|7657023|FG006|STARTED|Overall Study||3
6727015|NCT03125200|7657017|FG000|COMPLETED|Overall Study||0
6727016|NCT03125200|7657018|FG001|COMPLETED|Overall Study||0
6727017|NCT03125200|7657019|FG002|COMPLETED|Overall Study||0
6727018|NCT03125200|7657020|FG003|COMPLETED|Overall Study||0
6727019|NCT03125200|7657021|FG004|COMPLETED|Overall Study||0
6727020|NCT03125200|7657022|FG005|COMPLETED|Overall Study||0
6727021|NCT03125200|7657023|FG006|COMPLETED|Overall Study||0
6727022|NCT03125200|7657017|FG000|NOT COMPLETED|Overall Study||2
6727023|NCT03125200|7657018|FG001|NOT COMPLETED|Overall Study||2
6727024|NCT03125200|7657019|FG002|NOT COMPLETED|Overall Study||2
6727025|NCT03125200|7657020|FG003|NOT COMPLETED|Overall Study||5
6727026|NCT03125200|7657021|FG004|NOT COMPLETED|Overall Study||4
6727027|NCT03125200|7657022|FG005|NOT COMPLETED|Overall Study||3
6727028|NCT03125200|7657023|FG006|NOT COMPLETED|Overall Study||3
6727029|NCT03125226|7657042|FG000|STARTED|Overall Study||12
6727030|NCT03125226|7657042|FG000|COMPLETED|Overall Study||12
6727031|NCT03125226|7657042|FG000|NOT COMPLETED|Overall Study||0
6727032|NCT03125395|7657046|FG000|STARTED|Overall Study||57
6727033|NCT03125395|7657046|FG000|Study 115B FAS|Overall Study||60
6727034|NCT03125395|7657046|FG000|Study 116 FAS|Overall Study||57
6727035|NCT03125395|7657046|FG000|Study 116 LCI Substudy Set|Overall Study||31
6727036|NCT03125395|7657046|FG000|COMPLETED|Overall Study||47
6727037|NCT03125395|7657046|FG000|NOT COMPLETED|Overall Study||10
6727038|NCT03125629|7657050|FG000|STARTED|Overall Study||53
6727039|NCT03125629|7657050|FG000|COMPLETED|Overall Study||50
6727040|NCT03125629|7657050|FG000|NOT COMPLETED|Overall Study||3
6727041|NCT03125915|7657066|FG000|STARTED|Baseline and Intervention||32
6727042|NCT03125915|7657067|FG001|STARTED|Baseline and Intervention||40
6727043|NCT03125915|7657068|FG002|STARTED|Baseline and Intervention||34
6727044|NCT03125915|7657069|FG003|STARTED|Baseline and Intervention||34
6727045|NCT03125915|7657066|FG000|COMPLETED|Baseline and Intervention||32
6727046|NCT03125915|7657067|FG001|COMPLETED|Baseline and Intervention||40
6727047|NCT03125915|7657068|FG002|COMPLETED|Baseline and Intervention||34
6727048|NCT03125915|7657069|FG003|COMPLETED|Baseline and Intervention||34
6727049|NCT03125915|7657066|FG000|NOT COMPLETED|Baseline and Intervention||0
6727050|NCT03125915|7657067|FG001|NOT COMPLETED|Baseline and Intervention||0
6727051|NCT03125915|7657068|FG002|NOT COMPLETED|Baseline and Intervention||0
6727052|NCT03125915|7657069|FG003|NOT COMPLETED|Baseline and Intervention||0
6727053|NCT03125915|7657066|FG000|STARTED|1 Month Follow up||32
6727054|NCT03125915|7657067|FG001|STARTED|1 Month Follow up||40
6727055|NCT03125915|7657068|FG002|STARTED|1 Month Follow up||34
6727056|NCT03125915|7657069|FG003|STARTED|1 Month Follow up||34
6727057|NCT03125915|7657066|FG000|COMPLETED|1 Month Follow up||29
6727058|NCT03125915|7657067|FG001|COMPLETED|1 Month Follow up||37
6727059|NCT03125915|7657068|FG002|COMPLETED|1 Month Follow up||32
6727060|NCT03125915|7657069|FG003|COMPLETED|1 Month Follow up||31
6727061|NCT03125915|7657066|FG000|NOT COMPLETED|1 Month Follow up||3
6727062|NCT03125915|7657067|FG001|NOT COMPLETED|1 Month Follow up||3
6727063|NCT03125915|7657068|FG002|NOT COMPLETED|1 Month Follow up||2
6727064|NCT03125915|7657069|FG003|NOT COMPLETED|1 Month Follow up||3
6727065|NCT03125915|7657066|FG000|STARTED|3 Month Follow-up||32
6727066|NCT03125915|7657067|FG001|STARTED|3 Month Follow-up||40
6727067|NCT03125915|7657068|FG002|STARTED|3 Month Follow-up||34
6727068|NCT03125915|7657069|FG003|STARTED|3 Month Follow-up||34
6727069|NCT03125915|7657066|FG000|COMPLETED|3 Month Follow-up||26
6727070|NCT03125915|7657067|FG001|COMPLETED|3 Month Follow-up||36
6727071|NCT03125915|7657068|FG002|COMPLETED|3 Month Follow-up||30
6727072|NCT03125915|7657069|FG003|COMPLETED|3 Month Follow-up||32
6727073|NCT03125915|7657066|FG000|NOT COMPLETED|3 Month Follow-up||6
6727074|NCT03125915|7657067|FG001|NOT COMPLETED|3 Month Follow-up||4
6727075|NCT03125915|7657068|FG002|NOT COMPLETED|3 Month Follow-up||4
6727076|NCT03125915|7657069|FG003|NOT COMPLETED|3 Month Follow-up||2
6727077|NCT03125915|7657066|FG000|STARTED|6 Month Follow-up||32
6727078|NCT03125915|7657067|FG001|STARTED|6 Month Follow-up||40
6727079|NCT03125915|7657068|FG002|STARTED|6 Month Follow-up||34
6727080|NCT03125915|7657069|FG003|STARTED|6 Month Follow-up||34
6727081|NCT03125915|7657066|FG000|COMPLETED|6 Month Follow-up||25
6727082|NCT03125915|7657067|FG001|COMPLETED|6 Month Follow-up||37
6727083|NCT03125915|7657068|FG002|COMPLETED|6 Month Follow-up||28
6727084|NCT03125915|7657069|FG003|COMPLETED|6 Month Follow-up||31
6727085|NCT03125915|7657066|FG000|NOT COMPLETED|6 Month Follow-up||7
6727086|NCT03125915|7657067|FG001|NOT COMPLETED|6 Month Follow-up||3
6727087|NCT03125915|7657068|FG002|NOT COMPLETED|6 Month Follow-up||6
6727088|NCT03125915|7657069|FG003|NOT COMPLETED|6 Month Follow-up||3
6727089|NCT03125941|7657081|FG000|STARTED|Overall Study||65
6727090|NCT03125941|7657082|FG001|STARTED|Overall Study||65
6727091|NCT03125941|7657081|FG000|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|1
6727092|NCT03125941|7657082|FG001|Post-randomization Exclusion|Overall Study|procedure changed, did not receive intervention|2
6727093|NCT03125941|7657081|FG000|COMPLETED|Overall Study||64
6727094|NCT03125941|7657082|FG001|COMPLETED|Overall Study||63
6727095|NCT03125941|7657081|FG000|NOT COMPLETED|Overall Study||1
6727096|NCT03125941|7657082|FG001|NOT COMPLETED|Overall Study||2
6727097|NCT03126227|7657090|FG000|STARTED|Overall Study||338
6727098|NCT03126227|7657091|FG001|STARTED|Overall Study||168
6727099|NCT03126227|7657090|FG000|COMPLETED|Overall Study||260
6727100|NCT03126227|7657091|FG001|COMPLETED|Overall Study||158
6727101|NCT03126227|7657090|FG000|NOT COMPLETED|Overall Study||78
6727102|NCT03126227|7657091|FG001|NOT COMPLETED|Overall Study||10
6727103|NCT03126344|7657100|FG000|STARTED|Overall Study||33
6727104|NCT03126344|7657101|FG001|STARTED|Overall Study||33
6727105|NCT03126344|7657102|FG002|STARTED|Overall Study||33
6727106|NCT03126344|7657100|FG000|COMPLETED|Overall Study||33
6727107|NCT03126344|7657101|FG001|COMPLETED|Overall Study||33
6727108|NCT03126344|7657102|FG002|COMPLETED|Overall Study||28
6727109|NCT03126344|7657100|FG000|NOT COMPLETED|Overall Study||0
6727110|NCT03126344|7657101|FG001|NOT COMPLETED|Overall Study||0
6727111|NCT03126344|7657102|FG002|NOT COMPLETED|Overall Study||5
6727112|NCT03126370|7657110|FG000|STARTED|TDF With a Boosted PI||10
6727113|NCT03126370|7657110|FG000|COMPLETED|TDF With a Boosted PI||10
6727114|NCT03126370|7657110|FG000|NOT COMPLETED|TDF With a Boosted PI||0
6727115|NCT03126370|7657110|FG000|STARTED|TAF With a Boosted PI||10
6727116|NCT03126370|7657110|FG000|COMPLETED|TAF With a Boosted PI||10
6727117|NCT03126370|7657110|FG000|NOT COMPLETED|TAF With a Boosted PI||0
6727118|NCT03126370|7657110|FG000|STARTED|TAF With a Boosted PI and LDV/SOF||10
6727119|NCT03126370|7657110|FG000|COMPLETED|TAF With a Boosted PI and LDV/SOF||10
6727120|NCT03126370|7657110|FG000|NOT COMPLETED|TAF With a Boosted PI and LDV/SOF||0
6727121|NCT03126370|7657110|FG000|STARTED|TAF With a Boosted PI||10
6727122|NCT03126370|7657110|FG000|COMPLETED|TAF With a Boosted PI||10
6727123|NCT03126370|7657110|FG000|NOT COMPLETED|TAF With a Boosted PI||0
6727124|NCT03126448|7657121|FG000|STARTED|Overall Study||56
6727125|NCT03126448|7657122|FG001|STARTED|Overall Study||49
6727126|NCT03126448|7657123|FG002|STARTED|Overall Study||37
6727127|NCT03126448|7657121|FG000|COMPLETED|Overall Study||43
6727128|NCT03126448|7657122|FG001|COMPLETED|Overall Study||41
6727129|NCT03126448|7657123|FG002|COMPLETED|Overall Study||27
6727130|NCT03126448|7657121|FG000|NOT COMPLETED|Overall Study||13
6727131|NCT03126448|7657122|FG001|NOT COMPLETED|Overall Study||8
6727132|NCT03126448|7657123|FG002|NOT COMPLETED|Overall Study||10
6727133|NCT03126539|7657133|FG000|STARTED|Overall Study||9
6727134|NCT03126539|7657134|FG001|STARTED|Overall Study||9
6727135|NCT03126539|7657135|FG002|STARTED|Overall Study||9
6727136|NCT03126539|7657136|FG003|STARTED|Overall Study|Group B was not done|0
6727137|NCT03126539|7657137|FG004|STARTED|Overall Study||0
6727138|NCT03126539|7657133|FG000|COMPLETED|Overall Study||8
6727139|NCT03126539|7657134|FG001|COMPLETED|Overall Study||8
6727140|NCT03126539|7657135|FG002|COMPLETED|Overall Study||8
6727141|NCT03126539|7657136|FG003|COMPLETED|Overall Study||0
6265534|NCT00023673|7164580|FG000|NOT COMPLETED|Overall Study||0
6265535|NCT00023673|7164581|FG001|NOT COMPLETED|Overall Study||0
6265536|NCT00023673|7164582|FG002|NOT COMPLETED|Overall Study||0
6265537|NCT00023673|7164583|FG003|NOT COMPLETED|Overall Study||2
6265538|NCT00023712|7164595|FG000|STARTED|Overall Study|total number of participants enrolled on study|28
6265539|NCT00023712|7164596|FG001|STARTED|Overall Study|total number of participants enrolled on study|30
6265540|NCT00023712|7164595|FG000|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
6265541|NCT00023712|7164596|FG001|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
6265542|NCT00023712|7164595|FG000|NOT COMPLETED|Overall Study||2
6265543|NCT00023712|7164596|FG001|NOT COMPLETED|Overall Study||1
6265544|NCT00023764|7164612|FG000|STARTED|Overall Study||103
6265545|NCT00023764|7164612|FG000|COMPLETED|Overall Study||89
6265546|NCT00023764|7164612|FG000|NOT COMPLETED|Overall Study||14
6265547|NCT00024102|7164619|FG000|STARTED|Overall Study||326
6265548|NCT00024102|7164620|FG001|STARTED|Overall Study||307
6265549|NCT00024102|7164619|FG000|COMPLETED|Overall Study||326
6265550|NCT00024102|7164620|FG001|COMPLETED|Overall Study||307
6265551|NCT00024102|7164619|FG000|NOT COMPLETED|Overall Study||0
6265552|NCT00024102|7164620|FG001|NOT COMPLETED|Overall Study||0
6265553|NCT00024167|7164633|FG000|STARTED|Overall Study||65
6265554|NCT00024167|7164634|FG001|STARTED|Overall Study||62
6265555|NCT00024167|7164633|FG000|Induction Treatment Option 1 Completed|Overall Study||22
6265556|NCT00024167|7164634|FG001|Induction Treatment Option 1 Completed|Overall Study||21
6265557|NCT00024167|7164633|FG000|Induction Treatment Option 2 Completed|Overall Study||43
6265558|NCT00024167|7164634|FG001|Induction Treatment Option 2 Completed|Overall Study||41
6265559|NCT00024167|7164633|FG000|COMPLETED|Overall Study||12
6265560|NCT00024167|7164634|FG001|COMPLETED|Overall Study||15
6265561|NCT00024167|7164633|FG000|NOT COMPLETED|Overall Study||53
6265562|NCT00024167|7164634|FG001|NOT COMPLETED|Overall Study||47
6265563|NCT00024258|7164641|FG000|STARTED|Overall Study||22
6265564|NCT00024258|7164641|FG000|COMPLETED|Overall Study||13
6265565|NCT00024258|7164641|FG000|NOT COMPLETED|Overall Study||9
6265566|NCT00025155|7164645|FG000|STARTED|Overall Study||51
6280510|NCT00157573|7180491|FG000|COMPLETED|Overall Study||35
6727142|NCT03126539|7657137|FG004|COMPLETED|Overall Study||0
6727143|NCT03126539|7657133|FG000|NOT COMPLETED|Overall Study||1
6727144|NCT03126539|7657134|FG001|NOT COMPLETED|Overall Study||1
6727145|NCT03126539|7657135|FG002|NOT COMPLETED|Overall Study||1
6727146|NCT03126539|7657136|FG003|NOT COMPLETED|Overall Study||0
6727147|NCT03126539|7657137|FG004|NOT COMPLETED|Overall Study||0
6727148|NCT03126682|7657152|FG000|STARTED|Overall Study||5
6727149|NCT03126682|7657153|FG001|STARTED|Overall Study||5
6727150|NCT03126682|7657152|FG000|COMPLETED|Overall Study||5
6727151|NCT03126682|7657153|FG001|COMPLETED|Overall Study||5
6727152|NCT03126682|7657152|FG000|NOT COMPLETED|Overall Study||0
6727153|NCT03126682|7657153|FG001|NOT COMPLETED|Overall Study||0
6727154|NCT03126760|7657161|FG000|STARTED|Overall Study||18
6727155|NCT03126760|7657162|FG001|STARTED|Overall Study||17
6727156|NCT03126760|7657161|FG000|Modified Intent to Treat (mITT)|Overall Study||18
6727157|NCT03126760|7657162|FG001|Modified Intent to Treat (mITT)|Overall Study||17
6727158|NCT03126760|7657161|FG000|Completed Treatment|Overall Study|One participant halted treatment for adverse event, but completed the study|17
6727159|NCT03126760|7657162|FG001|Completed Treatment|Overall Study||17
6727160|NCT03126760|7657161|FG000|COMPLETED|Overall Study||18
6727161|NCT03126760|7657162|FG001|COMPLETED|Overall Study||17
6727162|NCT03126760|7657161|FG000|NOT COMPLETED|Overall Study||0
6727163|NCT03126760|7657162|FG001|NOT COMPLETED|Overall Study||0
6727164|NCT03126786|7657170|FG000|STARTED|Overall Study||36
6727165|NCT03126786|7657171|FG001|STARTED|Overall Study||35
6727166|NCT03126786|7657170|FG000|COMPLETED|Overall Study||30
6727167|NCT03126786|7657171|FG001|COMPLETED|Overall Study||33
6727168|NCT03126786|7657170|FG000|NOT COMPLETED|Overall Study||6
6727169|NCT03126786|7657171|FG001|NOT COMPLETED|Overall Study||2
6727170|NCT03127228|7657179|FG000|STARTED|Overall Study||12
6727171|NCT03127228|7657180|FG001|STARTED|Overall Study||12
6727172|NCT03127228|7657179|FG000|COMPLETED|Overall Study||12
6727173|NCT03127228|7657180|FG001|COMPLETED|Overall Study||12
6727174|NCT03127228|7657179|FG000|NOT COMPLETED|Overall Study||0
6727175|NCT03127228|7657180|FG001|NOT COMPLETED|Overall Study||0
6727176|NCT03127358|7657189|FG000|STARTED|Overall Study|3/9/18:Date first participant was randomized to this arm.|3
6727177|NCT03127358|7657190|FG001|STARTED|Overall Study|3/22/18: Date first participant randomized to this arm.|3
6727178|NCT03127358|7657191|FG002|STARTED|Overall Study|3/14/18: Date first participant randomized to this arm..|5
6727179|NCT03127358|7657189|FG000|COMPLETED|Overall Study|12/26/18: Date of SVR for last participant randomized to this arm.|3
6727180|NCT03127358|7657190|FG001|COMPLETED|Overall Study|2/6/19: Date of SVR for last participant randomized to this arm.|3
6727181|NCT03127358|7657191|FG002|COMPLETED|Overall Study|11/20/18: Date of SVR for last participant randomized to this arm.|5
6727182|NCT03127358|7657189|FG000|NOT COMPLETED|Overall Study||0
6727183|NCT03127358|7657190|FG001|NOT COMPLETED|Overall Study||0
6727184|NCT03127358|7657191|FG002|NOT COMPLETED|Overall Study||0
6727185|NCT03127384|7657205|FG000|STARTED|Overall Study||49
6727186|NCT03127384|7657205|FG000|Completed 3 Month Visit|Overall Study||47
6727187|NCT03127384|7657205|FG000|COMPLETED|Overall Study||43
6727188|NCT03127384|7657205|FG000|NOT COMPLETED|Overall Study||6
6727189|NCT03127514|7657213|FG000|STARTED|Overall Study||48
6727190|NCT03127514|7657214|FG001|STARTED|Overall Study||89
6727191|NCT03127514|7657213|FG000|COMPLETED|Overall Study||38
6727192|NCT03127514|7657214|FG001|COMPLETED|Overall Study||67
6727193|NCT03127514|7657213|FG000|NOT COMPLETED|Overall Study||10
6727194|NCT03127514|7657214|FG001|NOT COMPLETED|Overall Study||22
6727195|NCT03127644|7657223|FG000|STARTED|Overall Study||34
6727196|NCT03127644|7657224|FG001|STARTED|Overall Study||36
6727197|NCT03127644|7657225|FG002|STARTED|Overall Study||33
6727198|NCT03127644|7657223|FG000|COMPLETED|Overall Study||34
6727199|NCT03127644|7657224|FG001|COMPLETED|Overall Study||36
6727200|NCT03127644|7657225|FG002|COMPLETED|Overall Study||31
6727201|NCT03127644|7657223|FG000|NOT COMPLETED|Overall Study||0
6727202|NCT03127644|7657224|FG001|NOT COMPLETED|Overall Study||0
6727203|NCT03127644|7657225|FG002|NOT COMPLETED|Overall Study||2
6727204|NCT03127943|7657235|FG000|STARTED|First Intervention||12
6727205|NCT03127943|7657236|FG001|STARTED|First Intervention||12
6727206|NCT03127943|7657235|FG000|COMPLETED|First Intervention||12
6727207|NCT03127943|7657236|FG001|COMPLETED|First Intervention||12
6727208|NCT03127943|7657235|FG000|NOT COMPLETED|First Intervention||0
6727209|NCT03127943|7657236|FG001|NOT COMPLETED|First Intervention||0
6727210|NCT03127943|7657235|FG000|STARTED|Washout (1 Week)||12
6727211|NCT03127943|7657236|FG001|STARTED|Washout (1 Week)||12
6727212|NCT03127943|7657235|FG000|COMPLETED|Washout (1 Week)||12
6727213|NCT03127943|7657236|FG001|COMPLETED|Washout (1 Week)||12
6727214|NCT03127943|7657235|FG000|NOT COMPLETED|Washout (1 Week)||0
6727215|NCT03127943|7657236|FG001|NOT COMPLETED|Washout (1 Week)||0
6727216|NCT03127943|7657235|FG000|STARTED|Second Intervention||12
6727217|NCT03127943|7657236|FG001|STARTED|Second Intervention||12
6727218|NCT03127943|7657235|FG000|COMPLETED|Second Intervention||12
6727219|NCT03127943|7657236|FG001|COMPLETED|Second Intervention||12
6727220|NCT03127943|7657235|FG000|NOT COMPLETED|Second Intervention||0
6727221|NCT03127943|7657236|FG001|NOT COMPLETED|Second Intervention||0
6727222|NCT03127956|7657242|FG000|STARTED|Overall Study||748
6727223|NCT03127956|7657242|FG000|COMPLETED|Overall Study||431
6727224|NCT03127956|7657242|FG000|NOT COMPLETED|Overall Study||317
6727225|NCT03128008|7657246|FG000|STARTED|Overall Study||10
6727226|NCT03128008|7657246|FG000|COMPLETED|Overall Study|9 participants are in follow up|1
6727227|NCT03128008|7657246|FG000|NOT COMPLETED|Overall Study||9
6727228|NCT03128086|7657253|FG000|STARTED|Overall Study||50
6727229|NCT03128086|7657254|FG001|STARTED|Overall Study||44
6727230|NCT03128086|7657253|FG000|COMPLETED|Overall Study||50
6727231|NCT03128086|7657254|FG001|COMPLETED|Overall Study||44
6727232|NCT03128086|7657253|FG000|NOT COMPLETED|Overall Study||0
6727233|NCT03128086|7657254|FG001|NOT COMPLETED|Overall Study||0
6727234|NCT03128099|7657263|FG000|STARTED|Overall Study||21
6727235|NCT03128099|7657264|FG001|STARTED|Overall Study||4
6727236|NCT03128099|7657265|FG002|STARTED|Overall Study||22
6727237|NCT03128099|7657263|FG000|Hour 1 (Low Dose) Started|Overall Study||21
6727238|NCT03128099|7657264|FG001|Hour 1 (Low Dose) Started|Overall Study||4
6727239|NCT03128099|7657265|FG002|Hour 1 (Low Dose) Started|Overall Study||22
6727240|NCT03128099|7657263|FG000|Hour 1 (Low Dose) Completed|Overall Study||19
6727241|NCT03128099|7657264|FG001|Hour 1 (Low Dose) Completed|Overall Study||4
6727242|NCT03128099|7657265|FG002|Hour 1 (Low Dose) Completed|Overall Study||21
6727243|NCT03128099|7657263|FG000|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
6727244|NCT03128099|7657264|FG001|Hour 2 (High Dose)Started|Overall Study||4
6727245|NCT03128099|7657265|FG002|Hour 2 (High Dose)Started|Overall Study|Hour 2 of training not available to these participants|0
6727246|NCT03128099|7657263|FG000|Hour 2 (High Dose) Completed|Overall Study||0
6727247|NCT03128099|7657264|FG001|Hour 2 (High Dose) Completed|Overall Study||0
6727248|NCT03128099|7657265|FG002|Hour 2 (High Dose) Completed|Overall Study||0
6727249|NCT03128099|7657263|FG000|COMPLETED|Overall Study||19
6727250|NCT03128099|7657264|FG001|COMPLETED|Overall Study|hour 2 training was completed by 0 participants|0
6727251|NCT03128099|7657265|FG002|COMPLETED|Overall Study||21
6727252|NCT03128099|7657263|FG000|NOT COMPLETED|Overall Study||2
6727253|NCT03128099|7657264|FG001|NOT COMPLETED|Overall Study||4
6727254|NCT03128099|7657265|FG002|NOT COMPLETED|Overall Study||1
6727255|NCT03128307|7657271|FG000|STARTED|Overall Study||604
6727256|NCT03128307|7657271|FG000|COMPLETED|Overall Study||570
6727257|NCT03128307|7657271|FG000|NOT COMPLETED|Overall Study||34
6727258|NCT03128372|7657275|FG000|STARTED|Overall Study||32
6727259|NCT03128372|7657275|FG000|COMPLETED|Overall Study||32
6727260|NCT03128372|7657275|FG000|NOT COMPLETED|Overall Study||0
6727261|NCT03128723|7657279|FG000|STARTED|Overall Study||45
6727262|NCT03128723|7657279|FG000|COMPLETED|Overall Study||43
6727263|NCT03128723|7657279|FG000|NOT COMPLETED|Overall Study||2
6727264|NCT03128892|7657283|FG000|STARTED|Overall Study||34
6727265|NCT03128892|7657283|FG000|COMPLETED|Overall Study||31
6727266|NCT03128892|7657283|FG000|NOT COMPLETED|Overall Study||3
6727267|NCT03129100|7657292|FG000|STARTED|Lead-In Period (Period 1)||350
6727268|NCT03129100|7657293|FG001|STARTED|Lead-In Period (Period 1)||423
6727269|NCT03129100|7657294|FG002|STARTED|Lead-In Period (Period 1)||0
6727270|NCT03129100|7657295|FG003|STARTED|Lead-In Period (Period 1)||0
6727271|NCT03129100|7657296|FG004|STARTED|Lead-In Period (Period 1)||0
6727272|NCT03129100|7657297|FG005|STARTED|Lead-In Period (Period 1)||0
6727273|NCT03129100|7657298|FG006|STARTED|Lead-In Period (Period 1)||0
6265567|NCT00025155|7164645|FG000|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
6265568|NCT00025155|7164645|FG000|NOT COMPLETED|Overall Study||2
6265569|NCT00025233|7164654|FG000|STARTED|Overall Study||50
6265570|NCT00025233|7164654|FG000|COMPLETED|Overall Study||46
6265571|NCT00025233|7164654|FG000|NOT COMPLETED|Overall Study||4
6265572|NCT00025259|7164671|FG000|STARTED|Overall Study||52
6265573|NCT00025259|7164672|FG001|STARTED|Overall Study||381
6265574|NCT00025259|7164673|FG002|STARTED|Overall Study||382
6265575|NCT00025259|7164674|FG003|STARTED|Overall Study||571
6265576|NCT00025259|7164675|FG004|STARTED|Overall Study||42
6265577|NCT00025259|7164676|FG005|STARTED|Overall Study||153
6265578|NCT00025259|7164677|FG006|STARTED|Overall Study||153
6265579|NCT00025259|7164671|FG000|COMPLETED|Overall Study||7
6265580|NCT00025259|7164672|FG001|COMPLETED|Overall Study||292
6265581|NCT00025259|7164673|FG002|COMPLETED|Overall Study||301
6265582|NCT00025259|7164674|FG003|COMPLETED|Overall Study||457
6265583|NCT00025259|7164675|FG004|COMPLETED|Overall Study||6
6265584|NCT00025259|7164676|FG005|COMPLETED|Overall Study||101
6265585|NCT00025259|7164677|FG006|COMPLETED|Overall Study||102
6265586|NCT00025259|7164671|FG000|NOT COMPLETED|Overall Study||45
6265587|NCT00025259|7164672|FG001|NOT COMPLETED|Overall Study||89
6265588|NCT00025259|7164673|FG002|NOT COMPLETED|Overall Study||81
6265589|NCT00025259|7164674|FG003|NOT COMPLETED|Overall Study||114
6265590|NCT00025259|7164675|FG004|NOT COMPLETED|Overall Study||36
6265591|NCT00025259|7164676|FG005|NOT COMPLETED|Overall Study||52
6265592|NCT00025259|7164677|FG006|NOT COMPLETED|Overall Study||51
6265593|NCT00025506|7164696|FG000|STARTED|Overall Study||55
6265594|NCT00025506|7164696|FG000|COMPLETED|Overall Study|Eligible and treated patients.|45
6265595|NCT00025506|7164696|FG000|NOT COMPLETED|Overall Study||10
6265596|NCT00025662|7164705|FG000|STARTED|Overall Study||25
6265597|NCT00025662|7164705|FG000|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
6265598|NCT00025662|7164705|FG000|NOT COMPLETED|Overall Study||3
6265599|NCT00025883|7164711|FG000|STARTED|Overall Study||103
6265600|NCT00025883|7164711|FG000|Generalized Lipodystrophy|Overall Study||63
6265601|NCT00025883|7164711|FG000|Partial Lipodystrophy|Overall Study||40
6265602|NCT00025883|7164711|FG000|COMPLETED|Overall Study||86
6265603|NCT00025883|7164711|FG000|NOT COMPLETED|Overall Study||17
6265604|NCT00026208|7164718|FG000|STARTED|Overall Study||72
6265605|NCT00026208|7164719|FG001|STARTED|Overall Study||4
6265606|NCT00026208|7164718|FG000|COMPLETED|Overall Study||71
6265607|NCT00026208|7164719|FG001|COMPLETED|Overall Study||4
6265608|NCT00026208|7164718|FG000|NOT COMPLETED|Overall Study||1
6265609|NCT00026208|7164719|FG001|NOT COMPLETED|Overall Study||0
6265610|NCT00026221|7164728|FG000|STARTED|Overall Study||16
6265611|NCT00026221|7164729|FG001|STARTED|Overall Study||16
6265612|NCT00026221|7164730|FG002|STARTED|Overall Study||25
6265613|NCT00026221|7164728|FG000|COMPLETED|Overall Study||16
6727274|NCT03129100|7657299|FG007|STARTED|Lead-In Period (Period 1)||0
6727275|NCT03129100|7657300|FG008|STARTED|Lead-In Period (Period 1)||0
6727276|NCT03129100|7657301|FG009|STARTED|Lead-In Period (Period 1)||0
6727277|NCT03129100|7657302|FG010|STARTED|Lead-In Period (Period 1)||0
6727278|NCT03129100|7657292|FG000|COMPLETED|Lead-In Period (Period 1)||335
6727279|NCT03129100|7657293|FG001|COMPLETED|Lead-In Period (Period 1)||406
6727280|NCT03129100|7657294|FG002|COMPLETED|Lead-In Period (Period 1)||0
6727281|NCT03129100|7657295|FG003|COMPLETED|Lead-In Period (Period 1)||0
6727282|NCT03129100|7657296|FG004|COMPLETED|Lead-In Period (Period 1)||0
6727283|NCT03129100|7657297|FG005|COMPLETED|Lead-In Period (Period 1)||0
6727284|NCT03129100|7657298|FG006|COMPLETED|Lead-In Period (Period 1)||0
6727285|NCT03129100|7657299|FG007|COMPLETED|Lead-In Period (Period 1)||0
6727286|NCT03129100|7657300|FG008|COMPLETED|Lead-In Period (Period 1)||0
6727287|NCT03129100|7657301|FG009|COMPLETED|Lead-In Period (Period 1)||0
6727288|NCT03129100|7657302|FG010|COMPLETED|Lead-In Period (Period 1)||0
6727289|NCT03129100|7657292|FG000|NOT COMPLETED|Lead-In Period (Period 1)||15
6727290|NCT03129100|7657293|FG001|NOT COMPLETED|Lead-In Period (Period 1)||17
6727291|NCT03129100|7657294|FG002|NOT COMPLETED|Lead-In Period (Period 1)||0
6727292|NCT03129100|7657295|FG003|NOT COMPLETED|Lead-In Period (Period 1)||0
6727293|NCT03129100|7657296|FG004|NOT COMPLETED|Lead-In Period (Period 1)||0
6727294|NCT03129100|7657297|FG005|NOT COMPLETED|Lead-In Period (Period 1)||0
6727295|NCT03129100|7657298|FG006|NOT COMPLETED|Lead-In Period (Period 1)||0
6727296|NCT03129100|7657299|FG007|NOT COMPLETED|Lead-In Period (Period 1)||0
6727297|NCT03129100|7657300|FG008|NOT COMPLETED|Lead-In Period (Period 1)||0
6727298|NCT03129100|7657301|FG009|NOT COMPLETED|Lead-In Period (Period 1)||0
6727299|NCT03129100|7657302|FG010|NOT COMPLETED|Lead-In Period (Period 1)||0
6727300|NCT03129100|7657292|FG000|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
6727301|NCT03129100|7657293|FG001|STARTED|Period2 Extension Period (Group A and B)|Only Extension Period participants were included.|0
6727302|NCT03129100|7657294|FG002|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|255
6727303|NCT03129100|7657295|FG003|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group A).|318
6727304|NCT03129100|7657296|FG004|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|48
6727305|NCT03129100|7657297|FG005|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|54
6727306|NCT03129100|7657298|FG006|STARTED|Period2 Extension Period (Group A and B)|Participants who entered extension period (Group B).|53
6727307|NCT03129100|7657299|FG007|STARTED|Period2 Extension Period (Group A and B)||0
6727308|NCT03129100|7657300|FG008|STARTED|Period2 Extension Period (Group A and B)||0
6727309|NCT03129100|7657301|FG009|STARTED|Period2 Extension Period (Group A and B)||0
6727310|NCT03129100|7657302|FG010|STARTED|Period2 Extension Period (Group A and B)||0
6727311|NCT03129100|7657292|FG000|COMPLETED|Period2 Extension Period (Group A and B)||0
6727312|NCT03129100|7657293|FG001|COMPLETED|Period2 Extension Period (Group A and B)||0
6727313|NCT03129100|7657294|FG002|COMPLETED|Period2 Extension Period (Group A and B)||234
6727314|NCT03129100|7657295|FG003|COMPLETED|Period2 Extension Period (Group A and B)||312
6727315|NCT03129100|7657296|FG004|COMPLETED|Period2 Extension Period (Group A and B)||42
6727316|NCT03129100|7657297|FG005|COMPLETED|Period2 Extension Period (Group A and B)||45
6727317|NCT03129100|7657298|FG006|COMPLETED|Period2 Extension Period (Group A and B)||32
6727318|NCT03129100|7657299|FG007|COMPLETED|Period2 Extension Period (Group A and B)||0
6727319|NCT03129100|7657300|FG008|COMPLETED|Period2 Extension Period (Group A and B)||0
6727320|NCT03129100|7657301|FG009|COMPLETED|Period2 Extension Period (Group A and B)||0
6727321|NCT03129100|7657302|FG010|COMPLETED|Period2 Extension Period (Group A and B)||0
6727322|NCT03129100|7657292|FG000|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
6727323|NCT03129100|7657293|FG001|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
6727324|NCT03129100|7657294|FG002|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
6727325|NCT03129100|7657295|FG003|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
6727326|NCT03129100|7657296|FG004|NOT COMPLETED|Period2 Extension Period (Group A and B)||6
6727327|NCT03129100|7657297|FG005|NOT COMPLETED|Period2 Extension Period (Group A and B)||9
6727328|NCT03129100|7657298|FG006|NOT COMPLETED|Period2 Extension Period (Group A and B)||21
6727329|NCT03129100|7657299|FG007|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
6727330|NCT03129100|7657300|FG008|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
6727331|NCT03129100|7657301|FG009|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
6727332|NCT03129100|7657302|FG010|NOT COMPLETED|Period2 Extension Period (Group A and B)||0
6727333|NCT03129100|7657292|FG000|STARTED|Period 2 (Retreatment Extension Period)||0
6727334|NCT03129100|7657293|FG001|STARTED|Period 2 (Retreatment Extension Period)||0
6602961|NCT02059291|7527962|FG003|COMPLETED|Epoch 2||33
6602962|NCT02059291|7527963|FG004|COMPLETED|Epoch 2||22
6602963|NCT02059291|7527964|FG005|COMPLETED|Epoch 2||22
6602964|NCT02059291|7527965|FG006|COMPLETED|Epoch 2||2
6602965|NCT02059291|7527966|FG007|COMPLETED|Epoch 2||1
6602966|NCT02059291|7527967|FG008|COMPLETED|Epoch 2||16
6602967|NCT02059291|7527968|FG009|COMPLETED|Epoch 2||0
6602968|NCT02059291|7527969|FG010|COMPLETED|Epoch 2||0
6602969|NCT02059291|7527970|FG011|COMPLETED|Epoch 2||0
6602970|NCT02059291|7527971|FG012|COMPLETED|Epoch 2||0
6602971|NCT02059291|7527972|FG013|COMPLETED|Epoch 2||0
6265614|NCT00026221|7164729|FG001|COMPLETED|Overall Study||16
6602972|NCT02059291|7527973|FG014|COMPLETED|Epoch 2||0
6602973|NCT02059291|7527974|FG015|COMPLETED|Epoch 2||0
6602974|NCT02059291|7527975|FG016|COMPLETED|Epoch 2||0
6727335|NCT03129100|7657294|FG002|STARTED|Period 2 (Retreatment Extension Period)||0
6727336|NCT03129100|7657295|FG003|STARTED|Period 2 (Retreatment Extension Period)||0
6727337|NCT03129100|7657296|FG004|STARTED|Period 2 (Retreatment Extension Period)||0
6727338|NCT03129100|7657297|FG005|STARTED|Period 2 (Retreatment Extension Period)||0
6727339|NCT03129100|7657298|FG006|STARTED|Period 2 (Retreatment Extension Period)||0
6727340|NCT03129100|7657299|FG007|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|6
6727341|NCT03129100|7657300|FG008|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|5
6727342|NCT03129100|7657301|FG009|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|9
6727343|NCT03129100|7657302|FG010|STARTED|Period 2 (Retreatment Extension Period)|Participants who experienced flare in Group B Extension period.|10
6727344|NCT03129100|7657292|FG000|COMPLETED|Period 2 (Retreatment Extension Period)||0
6727345|NCT03129100|7657293|FG001|COMPLETED|Period 2 (Retreatment Extension Period)||0
6727346|NCT03129100|7657294|FG002|COMPLETED|Period 2 (Retreatment Extension Period)||0
6727347|NCT03129100|7657295|FG003|COMPLETED|Period 2 (Retreatment Extension Period)||0
6727348|NCT03129100|7657296|FG004|COMPLETED|Period 2 (Retreatment Extension Period)||0
6727349|NCT03129100|7657297|FG005|COMPLETED|Period 2 (Retreatment Extension Period)||0
6727350|NCT03129100|7657298|FG006|COMPLETED|Period 2 (Retreatment Extension Period)||0
6727351|NCT03129100|7657299|FG007|COMPLETED|Period 2 (Retreatment Extension Period)||6
6727352|NCT03129100|7657300|FG008|COMPLETED|Period 2 (Retreatment Extension Period)||5
6727353|NCT03129100|7657301|FG009|COMPLETED|Period 2 (Retreatment Extension Period)||8
6727354|NCT03129100|7657302|FG010|COMPLETED|Period 2 (Retreatment Extension Period)||10
6727355|NCT03129100|7657292|FG000|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727356|NCT03129100|7657293|FG001|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727357|NCT03129100|7657294|FG002|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727358|NCT03129100|7657295|FG003|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727359|NCT03129100|7657296|FG004|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727360|NCT03129100|7657297|FG005|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727361|NCT03129100|7657298|FG006|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727362|NCT03129100|7657299|FG007|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727363|NCT03129100|7657300|FG008|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727364|NCT03129100|7657301|FG009|NOT COMPLETED|Period 2 (Retreatment Extension Period)||1
6727365|NCT03129100|7657302|FG010|NOT COMPLETED|Period 2 (Retreatment Extension Period)||0
6727366|NCT03129178|7657326|FG000|STARTED|Overall Study||13
6727367|NCT03129178|7657327|FG001|STARTED|Overall Study||13
6727368|NCT03129178|7657326|FG000|COMPLETED|Overall Study||12
6727369|NCT03129178|7657327|FG001|COMPLETED|Overall Study||11
6727370|NCT03129178|7657326|FG000|NOT COMPLETED|Overall Study||1
6727371|NCT03129178|7657327|FG001|NOT COMPLETED|Overall Study||2
6727372|NCT03129568|7657334|FG000|STARTED|Overall Study||5
6727373|NCT03129568|7657334|FG000|COMPLETED|Overall Study||5
6727374|NCT03129568|7657334|FG000|NOT COMPLETED|Overall Study||0
6727375|NCT03129945|7657340|FG000|STARTED|Overall Study||15
6727376|NCT03129945|7657341|FG001|STARTED|Overall Study||21
6727377|NCT03129945|7657340|FG000|COMPLETED|Overall Study||15
6727378|NCT03129945|7657341|FG001|COMPLETED|Overall Study||21
6727379|NCT03129945|7657340|FG000|NOT COMPLETED|Overall Study||0
6727380|NCT03129945|7657341|FG001|NOT COMPLETED|Overall Study||0
6727381|NCT03130257|7657350|FG000|STARTED|Overall Study||172
6727382|NCT03130257|7657351|FG001|STARTED|Overall Study||170
6727383|NCT03130257|7657352|FG002|STARTED|Overall Study||168
6727384|NCT03130257|7657350|FG000|COMPLETED|Overall Study||171
6727385|NCT03130257|7657351|FG001|COMPLETED|Overall Study||170
6727386|NCT03130257|7657352|FG002|COMPLETED|Overall Study||166
6727387|NCT03130257|7657350|FG000|NOT COMPLETED|Overall Study||1
6727388|NCT03130257|7657351|FG001|NOT COMPLETED|Overall Study||0
6727389|NCT03130257|7657352|FG002|NOT COMPLETED|Overall Study||2
6727390|NCT03130738|7657363|FG000|STARTED|Overall Study||23
6727391|NCT03130738|7657364|FG001|STARTED|Overall Study||22
6727392|NCT03130738|7657365|FG002|STARTED|Overall Study||20
6727393|NCT03130738|7657363|FG000|COMPLETED|Overall Study||20
6727394|NCT03130738|7657364|FG001|COMPLETED|Overall Study||20
6727395|NCT03130738|7657365|FG002|COMPLETED|Overall Study||14
6727396|NCT03130738|7657363|FG000|NOT COMPLETED|Overall Study||3
6727397|NCT03130738|7657364|FG001|NOT COMPLETED|Overall Study||2
6727398|NCT03130738|7657365|FG002|NOT COMPLETED|Overall Study||6
6727399|NCT03131167|7657386|FG000|STARTED|Overall Study||6
6727400|NCT03131167|7657387|FG001|STARTED|Overall Study||5
6727401|NCT03131167|7657388|FG002|STARTED|Overall Study||5
6727402|NCT03131167|7657389|FG003|STARTED|Overall Study||5
6727403|NCT03131167|7657390|FG004|STARTED|Overall Study||6
6727404|NCT03131167|7657391|FG005|STARTED|Overall Study||5
6727405|NCT03131167|7657392|FG006|STARTED|Overall Study||5
6727406|NCT03131167|7657393|FG007|STARTED|Overall Study||5
6727407|NCT03131167|7657394|FG008|STARTED|Overall Study||2
6727408|NCT03131167|7657395|FG009|STARTED|Overall Study||5
6727409|NCT03131167|7657396|FG010|STARTED|Overall Study||4
6727410|NCT03131167|7657397|FG011|STARTED|Overall Study||5
6727411|NCT03131167|7657398|FG012|STARTED|Overall Study||5
6727412|NCT03131167|7657386|FG000|COMPLETED|Overall Study||6
6727413|NCT03131167|7657387|FG001|COMPLETED|Overall Study||5
6727414|NCT03131167|7657388|FG002|COMPLETED|Overall Study||5
6727415|NCT03131167|7657389|FG003|COMPLETED|Overall Study||5
6727416|NCT03131167|7657390|FG004|COMPLETED|Overall Study||6
6727417|NCT03131167|7657391|FG005|COMPLETED|Overall Study||4
6727418|NCT03131167|7657392|FG006|COMPLETED|Overall Study||5
6727419|NCT03131167|7657393|FG007|COMPLETED|Overall Study||5
6727420|NCT03131167|7657394|FG008|COMPLETED|Overall Study||2
6727421|NCT03131167|7657395|FG009|COMPLETED|Overall Study||5
6727422|NCT03131167|7657396|FG010|COMPLETED|Overall Study||4
6727423|NCT03131167|7657397|FG011|COMPLETED|Overall Study||5
6727424|NCT03131167|7657398|FG012|COMPLETED|Overall Study||5
6727425|NCT03131167|7657386|FG000|NOT COMPLETED|Overall Study||0
6727426|NCT03131167|7657387|FG001|NOT COMPLETED|Overall Study||0
6727427|NCT03131167|7657388|FG002|NOT COMPLETED|Overall Study||0
6727428|NCT03131167|7657389|FG003|NOT COMPLETED|Overall Study||0
6727429|NCT03131167|7657390|FG004|NOT COMPLETED|Overall Study||0
6727430|NCT03131167|7657391|FG005|NOT COMPLETED|Overall Study||1
6727431|NCT03131167|7657392|FG006|NOT COMPLETED|Overall Study||0
6727432|NCT03131167|7657393|FG007|NOT COMPLETED|Overall Study||0
6727433|NCT03131167|7657394|FG008|NOT COMPLETED|Overall Study||0
6727434|NCT03131167|7657395|FG009|NOT COMPLETED|Overall Study||0
6727435|NCT03131167|7657396|FG010|NOT COMPLETED|Overall Study||0
6727436|NCT03131167|7657397|FG011|NOT COMPLETED|Overall Study||0
6727437|NCT03131167|7657398|FG012|NOT COMPLETED|Overall Study||0
6727438|NCT03131206|7657431|FG000|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
6727439|NCT03131206|7657432|FG001|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727440|NCT03131206|7657433|FG002|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727441|NCT03131206|7657434|FG003|STARTED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727442|NCT03131206|7657431|FG000|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||5
6727443|NCT03131206|7657432|FG001|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727444|NCT03131206|7657433|FG002|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727445|NCT03131206|7657434|FG003|COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727446|NCT03131206|7657431|FG000|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727447|NCT03131206|7657432|FG001|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727448|NCT03131206|7657433|FG002|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727449|NCT03131206|7657434|FG003|NOT COMPLETED|Dose Level 1 (600mg BID 7d, 900mg BID)||0
6727450|NCT03131206|7657431|FG000|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727451|NCT03131206|7657432|FG001|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727452|NCT03131206|7657433|FG002|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727453|NCT03131206|7657434|FG003|STARTED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727454|NCT03131206|7657431|FG000|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727455|NCT03131206|7657432|FG001|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727456|NCT03131206|7657433|FG002|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727457|NCT03131206|7657434|FG003|COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727458|NCT03131206|7657431|FG000|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727459|NCT03131206|7657432|FG001|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727460|NCT03131206|7657433|FG002|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727461|NCT03131206|7657434|FG003|NOT COMPLETED|Dose Level 2 (900mg BID 7d, 1200mg BID)||0
6727462|NCT03131453|7657451|FG000|STARTED|Overall Study||456
6727463|NCT03131453|7657452|FG001|STARTED|Overall Study||233
6727464|NCT03131453|7657453|FG002|STARTED|Overall Study||456
6727465|NCT03131453|7657451|FG000|Patient Misrandomized|Overall Study||1
6727466|NCT03131453|7657452|FG001|Patient Misrandomized|Overall Study||0
6727467|NCT03131453|7657453|FG002|Patient Misrandomized|Overall Study||0
6727468|NCT03131453|7657451|FG000|COMPLETED|Overall Study||0
6727469|NCT03131453|7657452|FG001|COMPLETED|Overall Study||0
6727470|NCT03131453|7657453|FG002|COMPLETED|Overall Study||0
6727471|NCT03131453|7657451|FG000|NOT COMPLETED|Overall Study||456
6727472|NCT03131453|7657452|FG001|NOT COMPLETED|Overall Study||233
6727473|NCT03131453|7657453|FG002|NOT COMPLETED|Overall Study||456
6727474|NCT03131479|7657466|FG000|STARTED|Overall Study||10
6727475|NCT03131479|7657467|FG001|STARTED|Overall Study||10
6727476|NCT03131479|7657468|FG002|STARTED|Overall Study||11
6727477|NCT03131479|7657469|FG003|STARTED|Overall Study||12
6727478|NCT03131479|7657470|FG004|STARTED|Overall Study||10
6727479|NCT03131479|7657466|FG000|Safety Analysis Set (SS)|Overall Study||10
6727480|NCT03131479|7657467|FG001|Safety Analysis Set (SS)|Overall Study||10
6727481|NCT03131479|7657468|FG002|Safety Analysis Set (SS)|Overall Study||11
6727482|NCT03131479|7657469|FG003|Safety Analysis Set (SS)|Overall Study||12
6727483|NCT03131479|7657470|FG004|Safety Analysis Set (SS)|Overall Study||10
6727484|NCT03131479|7657466|FG000|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
6727485|NCT03131479|7657467|FG001|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
6727486|NCT03131479|7657468|FG002|Pharmacokinetic Analysis Set (PAS)|Overall Study||11
6727487|NCT03131479|7657469|FG003|Pharmacokinetic Analysis Set (PAS)|Overall Study||12
6727488|NCT03131479|7657470|FG004|Pharmacokinetic Analysis Set (PAS)|Overall Study||10
6727489|NCT03131479|7657466|FG000|Pharcodynamic Analysis Set (PD)|Overall Study||10
6727490|NCT03131479|7657467|FG001|Pharcodynamic Analysis Set (PD)|Overall Study||10
6727491|NCT03131479|7657468|FG002|Pharcodynamic Analysis Set (PD)|Overall Study||11
6727492|NCT03131479|7657469|FG003|Pharcodynamic Analysis Set (PD)|Overall Study||12
6727493|NCT03131479|7657470|FG004|Pharcodynamic Analysis Set (PD)|Overall Study||10
6727494|NCT03131479|7657466|FG000|COMPLETED|Overall Study||10
6727495|NCT03131479|7657467|FG001|COMPLETED|Overall Study||10
6727496|NCT03131479|7657468|FG002|COMPLETED|Overall Study||10
6727497|NCT03131479|7657469|FG003|COMPLETED|Overall Study||10
6727498|NCT03131479|7657470|FG004|COMPLETED|Overall Study||10
6727499|NCT03131479|7657466|FG000|NOT COMPLETED|Overall Study||0
6727500|NCT03131479|7657467|FG001|NOT COMPLETED|Overall Study||0
6727501|NCT03131479|7657468|FG002|NOT COMPLETED|Overall Study||1
6727502|NCT03131479|7657469|FG003|NOT COMPLETED|Overall Study||2
6727503|NCT03131479|7657470|FG004|NOT COMPLETED|Overall Study||0
6727504|NCT03131570|7657484|FG000|STARTED|Overall Study||12
6727505|NCT03131570|7657485|FG001|STARTED|Overall Study||11
6727506|NCT03131570|7657484|FG000|COMPLETED|Overall Study||11
6727507|NCT03131570|7657485|FG001|COMPLETED|Overall Study||11
6727508|NCT03131570|7657484|FG000|NOT COMPLETED|Overall Study||1
6727509|NCT03131570|7657485|FG001|NOT COMPLETED|Overall Study||0
6727510|NCT03131596|7657493|FG000|STARTED|Overall Study||100
6727511|NCT03131596|7657494|FG001|STARTED|Overall Study||100
6727512|NCT03131596|7657493|FG000|COMPLETED|Overall Study||94
6727513|NCT03131596|7657494|FG001|COMPLETED|Overall Study||97
6727514|NCT03131596|7657493|FG000|NOT COMPLETED|Overall Study||6
6727515|NCT03131596|7657494|FG001|NOT COMPLETED|Overall Study||3
6727516|NCT03131648|7657502|FG000|STARTED|Initial Treatment Period||603
6727517|NCT03131648|7657503|FG001|STARTED|Initial Treatment Period||199
6727518|NCT03131648|7657504|FG002|STARTED|Initial Treatment Period||0
6727519|NCT03131648|7657505|FG003|STARTED|Initial Treatment Period||0
6727520|NCT03131648|7657506|FG004|STARTED|Initial Treatment Period||0
6727521|NCT03131648|7657507|FG005|STARTED|Initial Treatment Period||0
6727522|NCT03131648|7657508|FG006|STARTED|Initial Treatment Period||0
6727523|NCT03131648|7657509|FG007|STARTED|Initial Treatment Period||0
6727524|NCT03131648|7657502|FG000|COMPLETED|Initial Treatment Period||550
6727525|NCT03131648|7657503|FG001|COMPLETED|Initial Treatment Period||179
6727526|NCT03131648|7657504|FG002|COMPLETED|Initial Treatment Period||0
6727527|NCT03131648|7657505|FG003|COMPLETED|Initial Treatment Period||0
6727528|NCT03131648|7657506|FG004|COMPLETED|Initial Treatment Period||0
6727529|NCT03131648|7657507|FG005|COMPLETED|Initial Treatment Period||0
6727530|NCT03131648|7657508|FG006|COMPLETED|Initial Treatment Period||0
6727531|NCT03131648|7657509|FG007|COMPLETED|Initial Treatment Period||0
6727532|NCT03131648|7657502|FG000|NOT COMPLETED|Initial Treatment Period||53
6727533|NCT03131648|7657503|FG001|NOT COMPLETED|Initial Treatment Period||20
6727534|NCT03131648|7657504|FG002|NOT COMPLETED|Initial Treatment Period||0
6727535|NCT03131648|7657505|FG003|NOT COMPLETED|Initial Treatment Period||0
6727536|NCT03131648|7657506|FG004|NOT COMPLETED|Initial Treatment Period||0
6727537|NCT03131648|7657507|FG005|NOT COMPLETED|Initial Treatment Period||0
6727538|NCT03131648|7657508|FG006|NOT COMPLETED|Initial Treatment Period||0
6727539|NCT03131648|7657509|FG007|NOT COMPLETED|Initial Treatment Period||0
6727540|NCT03131648|7657502|FG000|STARTED|Open-label Treatment||0
6727541|NCT03131648|7657503|FG001|STARTED|Open-label Treatment||0
6727542|NCT03131648|7657504|FG002|STARTED|Open-label Treatment||0
6727543|NCT03131648|7657505|FG003|STARTED|Open-label Treatment||0
6727544|NCT03131648|7657506|FG004|STARTED|Open-label Treatment||0
6727545|NCT03131648|7657507|FG005|STARTED|Open-label Treatment||0
6727546|NCT03131648|7657508|FG006|STARTED|Open-label Treatment||564
6727547|NCT03131648|7657509|FG007|STARTED|Open-label Treatment||0
6727548|NCT03131648|7657502|FG000|COMPLETED|Open-label Treatment||0
6727549|NCT03131648|7657503|FG001|COMPLETED|Open-label Treatment||0
6727550|NCT03131648|7657504|FG002|COMPLETED|Open-label Treatment||0
6727551|NCT03131648|7657505|FG003|COMPLETED|Open-label Treatment||0
6727552|NCT03131648|7657506|FG004|COMPLETED|Open-label Treatment||0
6727553|NCT03131648|7657507|FG005|COMPLETED|Open-label Treatment||0
6727554|NCT03131648|7657508|FG006|COMPLETED|Open-label Treatment||446
6727555|NCT03131648|7657509|FG007|COMPLETED|Open-label Treatment||0
6727556|NCT03131648|7657502|FG000|NOT COMPLETED|Open-label Treatment||0
6727557|NCT03131648|7657503|FG001|NOT COMPLETED|Open-label Treatment||0
6727558|NCT03131648|7657504|FG002|NOT COMPLETED|Open-label Treatment||0
6727559|NCT03131648|7657505|FG003|NOT COMPLETED|Open-label Treatment||0
6727560|NCT03131648|7657506|FG004|NOT COMPLETED|Open-label Treatment||0
6727561|NCT03131648|7657507|FG005|NOT COMPLETED|Open-label Treatment||0
6727562|NCT03131648|7657508|FG006|NOT COMPLETED|Open-label Treatment||118
6727563|NCT03131648|7657509|FG007|NOT COMPLETED|Open-label Treatment||0
6727564|NCT03131648|7657502|FG000|STARTED|Maintenance Treatment Period||0
6727565|NCT03131648|7657503|FG001|STARTED|Maintenance Treatment Period||0
6727566|NCT03131648|7657504|FG002|STARTED|Maintenance Treatment Period||71
6727567|NCT03131648|7657505|FG003|STARTED|Maintenance Treatment Period||78
6727568|NCT03131648|7657506|FG004|STARTED|Maintenance Treatment Period||36
6727569|NCT03131648|7657507|FG005|STARTED|Maintenance Treatment Period||29
6727570|NCT03131648|7657508|FG006|STARTED|Maintenance Treatment Period||0
6727571|NCT03131648|7657509|FG007|STARTED|Maintenance Treatment Period||0
6727572|NCT03131648|7657502|FG000|COMPLETED|Maintenance Treatment Period||0
6727573|NCT03131648|7657503|FG001|COMPLETED|Maintenance Treatment Period||0
6727574|NCT03131648|7657504|FG002|COMPLETED|Maintenance Treatment Period||44
6727575|NCT03131648|7657505|FG003|COMPLETED|Maintenance Treatment Period||53
6727576|NCT03131648|7657506|FG004|COMPLETED|Maintenance Treatment Period||21
6727577|NCT03131648|7657507|FG005|COMPLETED|Maintenance Treatment Period||15
6727578|NCT03131648|7657508|FG006|COMPLETED|Maintenance Treatment Period||0
6727579|NCT03131648|7657509|FG007|COMPLETED|Maintenance Treatment Period||0
6727580|NCT03131648|7657502|FG000|NOT COMPLETED|Maintenance Treatment Period||0
6727581|NCT03131648|7657503|FG001|NOT COMPLETED|Maintenance Treatment Period||0
6727582|NCT03131648|7657504|FG002|NOT COMPLETED|Maintenance Treatment Period||27
6727583|NCT03131648|7657505|FG003|NOT COMPLETED|Maintenance Treatment Period||25
6727584|NCT03131648|7657506|FG004|NOT COMPLETED|Maintenance Treatment Period||15
6727585|NCT03131648|7657507|FG005|NOT COMPLETED|Maintenance Treatment Period||14
6727586|NCT03131648|7657508|FG006|NOT COMPLETED|Maintenance Treatment Period||0
6727587|NCT03131648|7657509|FG007|NOT COMPLETED|Maintenance Treatment Period||0
6727588|NCT03131648|7657502|FG000|STARTED|Open-label (Short Term Extension)||0
6727589|NCT03131648|7657503|FG001|STARTED|Open-label (Short Term Extension)||0
6727590|NCT03131648|7657504|FG002|STARTED|Open-label (Short Term Extension)||0
6727591|NCT03131648|7657505|FG003|STARTED|Open-label (Short Term Extension)||0
6727592|NCT03131648|7657506|FG004|STARTED|Open-label (Short Term Extension)||0
6727593|NCT03131648|7657507|FG005|STARTED|Open-label (Short Term Extension)||0
6727594|NCT03131648|7657508|FG006|STARTED|Open-label (Short Term Extension)||0
6727595|NCT03131648|7657509|FG007|STARTED|Open-label (Short Term Extension)||65
6727596|NCT03131648|7657502|FG000|COMPLETED|Open-label (Short Term Extension)||0
6727597|NCT03131648|7657503|FG001|COMPLETED|Open-label (Short Term Extension)||0
6727598|NCT03131648|7657504|FG002|COMPLETED|Open-label (Short Term Extension)||0
6727599|NCT03131648|7657505|FG003|COMPLETED|Open-label (Short Term Extension)||0
6727600|NCT03131648|7657506|FG004|COMPLETED|Open-label (Short Term Extension)||0
6727601|NCT03131648|7657507|FG005|COMPLETED|Open-label (Short Term Extension)||0
6727602|NCT03131648|7657508|FG006|COMPLETED|Open-label (Short Term Extension)||0
6727603|NCT03131648|7657509|FG007|COMPLETED|Open-label (Short Term Extension)||62
6727604|NCT03131648|7657502|FG000|NOT COMPLETED|Open-label (Short Term Extension)||0
6727605|NCT03131648|7657503|FG001|NOT COMPLETED|Open-label (Short Term Extension)||0
6727606|NCT03131648|7657504|FG002|NOT COMPLETED|Open-label (Short Term Extension)||0
6727607|NCT03131648|7657505|FG003|NOT COMPLETED|Open-label (Short Term Extension)||0
6727608|NCT03131648|7657506|FG004|NOT COMPLETED|Open-label (Short Term Extension)||0
6727609|NCT03131648|7657507|FG005|NOT COMPLETED|Open-label (Short Term Extension)||0
6727610|NCT03131648|7657508|FG006|NOT COMPLETED|Open-label (Short Term Extension)||0
6727611|NCT03131648|7657509|FG007|NOT COMPLETED|Open-label (Short Term Extension)||3
6727612|NCT03131687|7657532|FG000|STARTED|Overall Study||51
6727613|NCT03131687|7657533|FG001|STARTED|Overall Study||53
6727614|NCT03131687|7657534|FG002|STARTED|Overall Study||55
6727615|NCT03131687|7657535|FG003|STARTED|Overall Study||52
6727616|NCT03131687|7657536|FG004|STARTED|Overall Study||53
6727617|NCT03131687|7657537|FG005|STARTED|Overall Study||54
6727618|NCT03131687|7657532|FG000|Received at Least One Dose of Study Drug|Overall Study||51
6727619|NCT03131687|7657533|FG001|Received at Least One Dose of Study Drug|Overall Study||52
6727620|NCT03131687|7657534|FG002|Received at Least One Dose of Study Drug|Overall Study||55
6727621|NCT03131687|7657535|FG003|Received at Least One Dose of Study Drug|Overall Study||51
6727622|NCT03131687|7657536|FG004|Received at Least One Dose of Study Drug|Overall Study||53
6727623|NCT03131687|7657537|FG005|Received at Least One Dose of Study Drug|Overall Study||54
6727624|NCT03131687|7657532|FG000|COMPLETED|Overall Study||45
6727625|NCT03131687|7657533|FG001|COMPLETED|Overall Study||44
6727626|NCT03131687|7657534|FG002|COMPLETED|Overall Study||52
6727627|NCT03131687|7657535|FG003|COMPLETED|Overall Study||48
6727628|NCT03131687|7657536|FG004|COMPLETED|Overall Study||45
6727629|NCT03131687|7657537|FG005|COMPLETED|Overall Study||49
6727630|NCT03131687|7657532|FG000|NOT COMPLETED|Overall Study||6
6727631|NCT03131687|7657533|FG001|NOT COMPLETED|Overall Study||9
6727632|NCT03131687|7657534|FG002|NOT COMPLETED|Overall Study||3
6727633|NCT03131687|7657535|FG003|NOT COMPLETED|Overall Study||4
6727634|NCT03131687|7657536|FG004|NOT COMPLETED|Overall Study||8
6727635|NCT03131687|7657537|FG005|NOT COMPLETED|Overall Study||5
6727636|NCT03131713|7657566|FG000|STARTED|Overall Study||50
6727637|NCT03131713|7657567|FG001|STARTED|Overall Study|1 intervention subject was added on after the protocol was initiated.|51
6727638|NCT03131713|7657566|FG000|COMPLETED|Overall Study||45
6727639|NCT03131713|7657567|FG001|COMPLETED|Overall Study||51
6727640|NCT03131713|7657566|FG000|NOT COMPLETED|Overall Study||5
6727641|NCT03131713|7657567|FG001|NOT COMPLETED|Overall Study||0
6727642|NCT03131895|7657577|FG000|STARTED|Intervention Period 1 (2 Days)||28
6727643|NCT03131895|7657578|FG001|STARTED|Intervention Period 1 (2 Days)||28
6727644|NCT03131895|7657579|FG002|STARTED|Intervention Period 1 (2 Days)||30
6727645|NCT03131895|7657580|FG003|STARTED|Intervention Period 1 (2 Days)||30
6727646|NCT03131895|7657577|FG000|COMPLETED|Intervention Period 1 (2 Days)||28
6727647|NCT03131895|7657578|FG001|COMPLETED|Intervention Period 1 (2 Days)||28
6727648|NCT03131895|7657579|FG002|COMPLETED|Intervention Period 1 (2 Days)||30
6727649|NCT03131895|7657580|FG003|COMPLETED|Intervention Period 1 (2 Days)||30
6727650|NCT03131895|7657577|FG000|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6727651|NCT03131895|7657578|FG001|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6727652|NCT03131895|7657579|FG002|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6727653|NCT03131895|7657580|FG003|NOT COMPLETED|Intervention Period 1 (2 Days)||0
6727654|NCT03131895|7657577|FG000|STARTED|Washout Period (at Least 5 Days)||28
6727655|NCT03131895|7657578|FG001|STARTED|Washout Period (at Least 5 Days)||28
6727656|NCT03131895|7657579|FG002|STARTED|Washout Period (at Least 5 Days)||30
6727657|NCT03131895|7657580|FG003|STARTED|Washout Period (at Least 5 Days)||30
6727658|NCT03131895|7657577|FG000|COMPLETED|Washout Period (at Least 5 Days)||27
6727659|NCT03131895|7657578|FG001|COMPLETED|Washout Period (at Least 5 Days)||23
6727660|NCT03131895|7657579|FG002|COMPLETED|Washout Period (at Least 5 Days)||26
6727661|NCT03131895|7657580|FG003|COMPLETED|Washout Period (at Least 5 Days)||25
6727662|NCT03131895|7657577|FG000|NOT COMPLETED|Washout Period (at Least 5 Days)||1
6727663|NCT03131895|7657578|FG001|NOT COMPLETED|Washout Period (at Least 5 Days)||5
6727664|NCT03131895|7657579|FG002|NOT COMPLETED|Washout Period (at Least 5 Days)||4
6727665|NCT03131895|7657580|FG003|NOT COMPLETED|Washout Period (at Least 5 Days)||5
6727666|NCT03131895|7657577|FG000|STARTED|Intervention Period 2 (2 Days)||27
6727667|NCT03131895|7657578|FG001|STARTED|Intervention Period 2 (2 Days)||23
6727668|NCT03131895|7657579|FG002|STARTED|Intervention Period 2 (2 Days)||26
6727669|NCT03131895|7657580|FG003|STARTED|Intervention Period 2 (2 Days)||25
6727670|NCT03131895|7657577|FG000|COMPLETED|Intervention Period 2 (2 Days)||26
6727671|NCT03131895|7657578|FG001|COMPLETED|Intervention Period 2 (2 Days)||22
6727672|NCT03131895|7657579|FG002|COMPLETED|Intervention Period 2 (2 Days)||26
6727673|NCT03131895|7657580|FG003|COMPLETED|Intervention Period 2 (2 Days)||25
6727674|NCT03131895|7657577|FG000|NOT COMPLETED|Intervention Period 2 (2 Days)||1
6727675|NCT03131895|7657578|FG001|NOT COMPLETED|Intervention Period 2 (2 Days)||1
6727676|NCT03131895|7657579|FG002|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6727677|NCT03131895|7657580|FG003|NOT COMPLETED|Intervention Period 2 (2 Days)||0
6727678|NCT03131999|7657592|FG000|STARTED|Overall Study||8
6727679|NCT03131999|7657593|FG001|STARTED|Overall Study||8
6727680|NCT03131999|7657592|FG000|COMPLETED|Overall Study||8
6727681|NCT03131999|7657593|FG001|COMPLETED|Overall Study||7
6727682|NCT03131999|7657592|FG000|NOT COMPLETED|Overall Study||0
6727683|NCT03131999|7657593|FG001|NOT COMPLETED|Overall Study||1
6727684|NCT03132220|7657601|FG000|STARTED|Overall Study||65
6727685|NCT03132220|7657602|FG001|STARTED|Overall Study||66
6727686|NCT03132220|7657601|FG000|Began Study Sessions|Overall Study|65 participants randomized to intervention arm;17 lost to f/u prior to study start;48 began sessions|48
6727687|NCT03132220|7657602|FG001|Began Study Sessions|Overall Study|66 participants randomized to control arm;8 were lost to f/u prior to study start; 58 began sessions|58
6727688|NCT03132220|7657601|FG000|COMPLETED|Overall Study||47
6727689|NCT03132220|7657602|FG001|COMPLETED|Overall Study||54
6727690|NCT03132220|7657601|FG000|NOT COMPLETED|Overall Study||18
6727691|NCT03132220|7657602|FG001|NOT COMPLETED|Overall Study||12
6727692|NCT03132246|7657610|FG000|STARTED|Overall Study||260
6727693|NCT03132246|7657610|FG000|COMPLETED|Overall Study||156
6727694|NCT03132246|7657610|FG000|NOT COMPLETED|Overall Study||104
6727695|NCT03132298|7657619|FG000|STARTED|Overall Study||48
6727696|NCT03132298|7657620|FG001|STARTED|Overall Study||48
6727697|NCT03132298|7657619|FG000|COMPLETED|Overall Study||36
6727698|NCT03132298|7657620|FG001|COMPLETED|Overall Study||35
6727699|NCT03132298|7657619|FG000|NOT COMPLETED|Overall Study||12
6727700|NCT03132298|7657620|FG001|NOT COMPLETED|Overall Study||13
6727701|NCT03132571|7657628|FG000|STARTED|Overall Study||3
6727702|NCT03132571|7657629|FG001|STARTED|Overall Study||2
6727703|NCT03132571|7657628|FG000|COMPLETED|Overall Study||3
6727704|NCT03132571|7657629|FG001|COMPLETED|Overall Study||2
6727705|NCT03132571|7657628|FG000|NOT COMPLETED|Overall Study||0
6727706|NCT03132571|7657629|FG001|NOT COMPLETED|Overall Study||0
6727707|NCT03133481|7657637|FG000|STARTED|Overall Study||45
6727708|NCT03133481|7657638|FG001|STARTED|Overall Study||49
6727709|NCT03133481|7657637|FG000|COMPLETED|Overall Study||45
6727710|NCT03133481|7657638|FG001|COMPLETED|Overall Study||45
6727711|NCT03133481|7657637|FG000|NOT COMPLETED|Overall Study||0
6727712|NCT03133481|7657638|FG001|NOT COMPLETED|Overall Study||4
6727713|NCT03133676|7657653|FG000|STARTED|Overall Study||6
6727714|NCT03133676|7657654|FG001|STARTED|Overall Study||3
6727715|NCT03133676|7657655|FG002|STARTED|Overall Study||3
6727716|NCT03133676|7657656|FG003|STARTED|Overall Study||6
6727717|NCT03133676|7657657|FG004|STARTED|Overall Study||6
6727718|NCT03133676|7657658|FG005|STARTED|Overall Study||9
6727719|NCT03133676|7657659|FG006|STARTED|Overall Study||9
6727720|NCT03133676|7657660|FG007|STARTED|Overall Study||9
6727721|NCT03133676|7657661|FG008|STARTED|Overall Study||9
6727722|NCT03133676|7657653|FG000|COMPLETED|Overall Study||6
6727723|NCT03133676|7657654|FG001|COMPLETED|Overall Study||3
6727724|NCT03133676|7657655|FG002|COMPLETED|Overall Study||3
6727725|NCT03133676|7657656|FG003|COMPLETED|Overall Study||6
6727726|NCT03133676|7657657|FG004|COMPLETED|Overall Study||6
6727727|NCT03133676|7657658|FG005|COMPLETED|Overall Study||9
6727728|NCT03133676|7657659|FG006|COMPLETED|Overall Study||9
6727729|NCT03133676|7657660|FG007|COMPLETED|Overall Study||9
6727730|NCT03133676|7657661|FG008|COMPLETED|Overall Study||9
6727731|NCT03133676|7657653|FG000|NOT COMPLETED|Overall Study||0
6727732|NCT03133676|7657654|FG001|NOT COMPLETED|Overall Study||0
6727733|NCT03133676|7657655|FG002|NOT COMPLETED|Overall Study||0
6727734|NCT03133676|7657656|FG003|NOT COMPLETED|Overall Study||0
6727735|NCT03133676|7657657|FG004|NOT COMPLETED|Overall Study||0
6727736|NCT03133676|7657658|FG005|NOT COMPLETED|Overall Study||0
6727737|NCT03133676|7657659|FG006|NOT COMPLETED|Overall Study||0
6727738|NCT03133676|7657660|FG007|NOT COMPLETED|Overall Study||0
6727739|NCT03133676|7657661|FG008|NOT COMPLETED|Overall Study||0
6727740|NCT03133767|7657690|FG000|STARTED|Overall Study||79
6727741|NCT03133767|7657691|FG001|STARTED|Overall Study||78
6727742|NCT03133767|7657690|FG000|COMPLETED|Overall Study||41
6727743|NCT03133767|7657691|FG001|COMPLETED|Overall Study||53
6727744|NCT03133767|7657690|FG000|NOT COMPLETED|Overall Study||38
6727745|NCT03133767|7657691|FG001|NOT COMPLETED|Overall Study||25
6727746|NCT03134092|7657700|FG000|STARTED|Overall Study||434
6727747|NCT03134092|7657701|FG001|STARTED|Overall Study||435
6727748|NCT03134092|7657702|FG002|STARTED|Overall Study||433
6727749|NCT03134092|7657700|FG000|COMPLETED|Overall Study||434
6727750|NCT03134092|7657701|FG001|COMPLETED|Overall Study||435
6727751|NCT03134092|7657702|FG002|COMPLETED|Overall Study||433
6727752|NCT03134092|7657700|FG000|NOT COMPLETED|Overall Study||0
6727753|NCT03134092|7657701|FG001|NOT COMPLETED|Overall Study||0
6727754|NCT03134092|7657702|FG002|NOT COMPLETED|Overall Study||0
6727755|NCT03134144|7657716|FG000|STARTED|Overall Study||15
6727756|NCT03134144|7657717|FG001|STARTED|Overall Study||30
6727757|NCT03134144|7657716|FG000|COMPLETED|Overall Study||15
6727758|NCT03134144|7657717|FG001|COMPLETED|Overall Study||30
6727759|NCT03134144|7657716|FG000|NOT COMPLETED|Overall Study||0
6727760|NCT03134144|7657717|FG001|NOT COMPLETED|Overall Study||0
6727761|NCT03134183|7657730|FG000|STARTED|Overall Study||36
6727762|NCT03134183|7657731|FG001|STARTED|Overall Study||34
6727763|NCT03134183|7657730|FG000|COMPLETED|Overall Study||35
6727764|NCT03134183|7657731|FG001|COMPLETED|Overall Study||33
6727765|NCT03134183|7657730|FG000|NOT COMPLETED|Overall Study||1
6727766|NCT03134183|7657731|FG001|NOT COMPLETED|Overall Study||1
6727767|NCT03134209|7657740|FG000|STARTED|Overall Study||53
6727768|NCT03134209|7657741|FG001|STARTED|Overall Study||54
6727769|NCT03134209|7657742|FG002|STARTED|Overall Study||53
6727770|NCT03134209|7657740|FG000|COMPLETED|Overall Study||53
6727771|NCT03134209|7657741|FG001|COMPLETED|Overall Study||54
6727772|NCT03134209|7657742|FG002|COMPLETED|Overall Study||53
6727773|NCT03134209|7657740|FG000|NOT COMPLETED|Overall Study||0
6727774|NCT03134209|7657741|FG001|NOT COMPLETED|Overall Study||0
6727775|NCT03134209|7657742|FG002|NOT COMPLETED|Overall Study||0
6727776|NCT03134222|7657753|FG000|STARTED|Treatment Period (Up to Week 12)||19
6727777|NCT03134222|7657754|FG001|STARTED|Treatment Period (Up to Week 12)||18
6727778|NCT03134222|7657755|FG002|STARTED|Treatment Period (Up to Week 12)||10
6727779|NCT03134222|7657756|FG003|STARTED|Treatment Period (Up to Week 12)||0
6727780|NCT03134222|7657757|FG004|STARTED|Treatment Period (Up to Week 12)||0
6727781|NCT03134222|7657753|FG000|COMPLETED|Treatment Period (Up to Week 12)||14
6727782|NCT03134222|7657754|FG001|COMPLETED|Treatment Period (Up to Week 12)||14
6727783|NCT03134222|7657755|FG002|COMPLETED|Treatment Period (Up to Week 12)||8
6727784|NCT03134222|7657756|FG003|COMPLETED|Treatment Period (Up to Week 12)||0
6727785|NCT03134222|7657757|FG004|COMPLETED|Treatment Period (Up to Week 12)||0
6727786|NCT03134222|7657753|FG000|NOT COMPLETED|Treatment Period (Up to Week 12)||5
6727787|NCT03134222|7657754|FG001|NOT COMPLETED|Treatment Period (Up to Week 12)||4
6727788|NCT03134222|7657755|FG002|NOT COMPLETED|Treatment Period (Up to Week 12)||2
6727789|NCT03134222|7657756|FG003|NOT COMPLETED|Treatment Period (Up to Week 12)||0
6727790|NCT03134222|7657757|FG004|NOT COMPLETED|Treatment Period (Up to Week 12)||0
6727791|NCT03134222|7657753|FG000|STARTED|Treatment Period (Week 12 to 48)||14
6727792|NCT03134222|7657754|FG001|STARTED|Treatment Period (Week 12 to 48)||14
6727793|NCT03134222|7657755|FG002|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized 1:1 to either Placebo to Lanraplenib or Placebo to Filgotinib arm.|0
6727794|NCT03134222|7657756|FG003|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
6727795|NCT03134222|7657757|FG004|STARTED|Treatment Period (Week 12 to 48)|Participants were rerandomized from the Placebo arm.|4
6727796|NCT03134222|7657753|FG000|COMPLETED|Treatment Period (Week 12 to 48)||12
6727797|NCT03134222|7657754|FG001|COMPLETED|Treatment Period (Week 12 to 48)||11
6727798|NCT03134222|7657755|FG002|COMPLETED|Treatment Period (Week 12 to 48)||0
6727799|NCT03134222|7657756|FG003|COMPLETED|Treatment Period (Week 12 to 48)||3
6727800|NCT03134222|7657757|FG004|COMPLETED|Treatment Period (Week 12 to 48)||3
6727801|NCT03134222|7657753|FG000|NOT COMPLETED|Treatment Period (Week 12 to 48)||2
6727802|NCT03134222|7657754|FG001|NOT COMPLETED|Treatment Period (Week 12 to 48)||3
6727803|NCT03134222|7657755|FG002|NOT COMPLETED|Treatment Period (Week 12 to 48)||0
6727804|NCT03134222|7657756|FG003|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
6727805|NCT03134222|7657757|FG004|NOT COMPLETED|Treatment Period (Week 12 to 48)||1
6727806|NCT03134248|7657767|FG000|STARTED|Week 1||7
6727807|NCT03134248|7657768|FG001|STARTED|Week 1||8
6727808|NCT03134248|7657769|FG002|STARTED|Week 1||9
6727809|NCT03134248|7657770|FG003|STARTED|Week 1||7
6727810|NCT03134248|7657771|FG004|STARTED|Week 1||9
6727811|NCT03134248|7657772|FG005|STARTED|Week 1||9
6727812|NCT03134248|7657767|FG000|COMPLETED|Week 1||7
6727813|NCT03134248|7657768|FG001|COMPLETED|Week 1||8
6727814|NCT03134248|7657769|FG002|COMPLETED|Week 1||9
6727815|NCT03134248|7657770|FG003|COMPLETED|Week 1||7
6727816|NCT03134248|7657771|FG004|COMPLETED|Week 1||9
6727817|NCT03134248|7657772|FG005|COMPLETED|Week 1||9
6727818|NCT03134248|7657767|FG000|NOT COMPLETED|Week 1||0
6727819|NCT03134248|7657768|FG001|NOT COMPLETED|Week 1||0
6727820|NCT03134248|7657769|FG002|NOT COMPLETED|Week 1||0
6727821|NCT03134248|7657770|FG003|NOT COMPLETED|Week 1||0
6727822|NCT03134248|7657771|FG004|NOT COMPLETED|Week 1||0
6727823|NCT03134248|7657772|FG005|NOT COMPLETED|Week 1||0
6727824|NCT03134248|7657767|FG000|STARTED|Week 2||7
6727825|NCT03134248|7657768|FG001|STARTED|Week 2||8
6727826|NCT03134248|7657769|FG002|STARTED|Week 2||9
6727827|NCT03134248|7657770|FG003|STARTED|Week 2||7
6727828|NCT03134248|7657771|FG004|STARTED|Week 2||9
6727829|NCT03134248|7657772|FG005|STARTED|Week 2||9
6727830|NCT03134248|7657767|FG000|COMPLETED|Week 2||7
6727831|NCT03134248|7657768|FG001|COMPLETED|Week 2||8
6727832|NCT03134248|7657769|FG002|COMPLETED|Week 2||9
6727833|NCT03134248|7657770|FG003|COMPLETED|Week 2||7
6727834|NCT03134248|7657771|FG004|COMPLETED|Week 2||9
6727835|NCT03134248|7657772|FG005|COMPLETED|Week 2||9
6727836|NCT03134248|7657767|FG000|NOT COMPLETED|Week 2||0
6727837|NCT03134248|7657768|FG001|NOT COMPLETED|Week 2||0
6727838|NCT03134248|7657769|FG002|NOT COMPLETED|Week 2||0
6727839|NCT03134248|7657770|FG003|NOT COMPLETED|Week 2||0
6727840|NCT03134248|7657771|FG004|NOT COMPLETED|Week 2||0
6727841|NCT03134248|7657772|FG005|NOT COMPLETED|Week 2||0
6727842|NCT03134248|7657767|FG000|STARTED|Week 3||7
6727843|NCT03134248|7657768|FG001|STARTED|Week 3||8
6727844|NCT03134248|7657769|FG002|STARTED|Week 3||9
6727845|NCT03134248|7657770|FG003|STARTED|Week 3||7
6727846|NCT03134248|7657771|FG004|STARTED|Week 3||9
6727847|NCT03134248|7657772|FG005|STARTED|Week 3||9
6727848|NCT03134248|7657767|FG000|COMPLETED|Week 3||7
6727849|NCT03134248|7657768|FG001|COMPLETED|Week 3||8
6727850|NCT03134248|7657769|FG002|COMPLETED|Week 3||9
6727851|NCT03134248|7657770|FG003|COMPLETED|Week 3||7
6727852|NCT03134248|7657771|FG004|COMPLETED|Week 3||9
6727853|NCT03134248|7657772|FG005|COMPLETED|Week 3||9
6727854|NCT03134248|7657767|FG000|NOT COMPLETED|Week 3||0
6727855|NCT03134248|7657768|FG001|NOT COMPLETED|Week 3||0
6727856|NCT03134248|7657769|FG002|NOT COMPLETED|Week 3||0
6727857|NCT03134248|7657770|FG003|NOT COMPLETED|Week 3||0
6727858|NCT03134248|7657771|FG004|NOT COMPLETED|Week 3||0
6727859|NCT03134248|7657772|FG005|NOT COMPLETED|Week 3||0
6727860|NCT03134313|7657782|FG000|STARTED|Overall Study||25
6727861|NCT03134313|7657782|FG000|COMPLETED|Overall Study||25
6727862|NCT03134313|7657782|FG000|NOT COMPLETED|Overall Study||0
6727863|NCT03134326|7657786|FG000|STARTED|Overall Study||21
6727864|NCT03134326|7657786|FG000|COMPLETED|Overall Study||21
6727865|NCT03134326|7657786|FG000|NOT COMPLETED|Overall Study||0
6727866|NCT03134599|7657790|FG000|STARTED|Week 1||10
6727867|NCT03134599|7657791|FG001|STARTED|Week 1||10
6727868|NCT03134599|7657792|FG002|STARTED|Week 1||10
6727869|NCT03134599|7657793|FG003|STARTED|Week 1||11
6727870|NCT03134599|7657794|FG004|STARTED|Week 1||10
6727871|NCT03134599|7657795|FG005|STARTED|Week 1||9
6727872|NCT03134599|7657790|FG000|COMPLETED|Week 1||10
6727873|NCT03134599|7657791|FG001|COMPLETED|Week 1||10
6727874|NCT03134599|7657792|FG002|COMPLETED|Week 1||10
6727875|NCT03134599|7657793|FG003|COMPLETED|Week 1||11
6727876|NCT03134599|7657794|FG004|COMPLETED|Week 1||9
6727877|NCT03134599|7657795|FG005|COMPLETED|Week 1||9
6727878|NCT03134599|7657790|FG000|NOT COMPLETED|Week 1||0
6727879|NCT03134599|7657791|FG001|NOT COMPLETED|Week 1||0
6727880|NCT03134599|7657792|FG002|NOT COMPLETED|Week 1||0
6727881|NCT03134599|7657793|FG003|NOT COMPLETED|Week 1||0
6727882|NCT03134599|7657794|FG004|NOT COMPLETED|Week 1||1
6727883|NCT03134599|7657795|FG005|NOT COMPLETED|Week 1||0
6727884|NCT03134599|7657790|FG000|STARTED|Week 2||10
6727885|NCT03134599|7657791|FG001|STARTED|Week 2||10
6727886|NCT03134599|7657792|FG002|STARTED|Week 2||10
6727887|NCT03134599|7657793|FG003|STARTED|Week 2||11
6727888|NCT03134599|7657794|FG004|STARTED|Week 2||9
6727889|NCT03134599|7657795|FG005|STARTED|Week 2||9
6727890|NCT03134599|7657790|FG000|COMPLETED|Week 2||9
6727891|NCT03134599|7657791|FG001|COMPLETED|Week 2||10
6727892|NCT03134599|7657792|FG002|COMPLETED|Week 2||10
6727893|NCT03134599|7657793|FG003|COMPLETED|Week 2||10
6727894|NCT03134599|7657794|FG004|COMPLETED|Week 2||8
6727895|NCT03134599|7657795|FG005|COMPLETED|Week 2||9
6727896|NCT03134599|7657790|FG000|NOT COMPLETED|Week 2||1
6727897|NCT03134599|7657791|FG001|NOT COMPLETED|Week 2||0
6727898|NCT03134599|7657792|FG002|NOT COMPLETED|Week 2||0
6265615|NCT00026221|7164730|FG002|COMPLETED|Overall Study||25
6265616|NCT00026221|7164728|FG000|NOT COMPLETED|Overall Study||0
6265617|NCT00026221|7164729|FG001|NOT COMPLETED|Overall Study||0
6265618|NCT00026221|7164730|FG002|NOT COMPLETED|Overall Study||0
6265619|NCT00026494|7164742|FG000|STARTED|Overall Study||7
6265620|NCT00026494|7164743|FG001|STARTED|Overall Study||4
6265621|NCT00026494|7164744|FG002|STARTED|Overall Study||22
6265622|NCT00026494|7164745|FG003|STARTED|Overall Study||16
6265623|NCT00026494|7164742|FG000|COMPLETED|Overall Study||5
6265624|NCT00026494|7164743|FG001|COMPLETED|Overall Study||4
6265625|NCT00026494|7164744|FG002|COMPLETED|Overall Study||16
6265626|NCT00026494|7164745|FG003|COMPLETED|Overall Study||16
6265627|NCT00026494|7164742|FG000|NOT COMPLETED|Overall Study||2
6265628|NCT00026494|7164743|FG001|NOT COMPLETED|Overall Study||0
6265629|NCT00026494|7164744|FG002|NOT COMPLETED|Overall Study||6
6265630|NCT00026494|7164745|FG003|NOT COMPLETED|Overall Study||0
6265631|NCT00026793|7164755|FG000|STARTED|Overall Study||29
6265632|NCT00026793|7164755|FG000|COMPLETED|Overall Study||21
6265633|NCT00026793|7164755|FG000|NOT COMPLETED|Overall Study||8
6265634|NCT00027027|7164764|FG000|STARTED|Overall Study||3
6265635|NCT00027027|7164765|FG001|STARTED|Overall Study||3
6265636|NCT00027027|7164766|FG002|STARTED|Overall Study||4
6265637|NCT00027027|7164767|FG003|STARTED|Overall Study||3
6265638|NCT00027027|7164768|FG004|STARTED|Overall Study||8
6727899|NCT03134599|7657793|FG003|NOT COMPLETED|Week 2||1
6727900|NCT03134599|7657794|FG004|NOT COMPLETED|Week 2||1
6727901|NCT03134599|7657795|FG005|NOT COMPLETED|Week 2||0
6727902|NCT03134599|7657790|FG000|STARTED|Week 3||9
6727903|NCT03134599|7657791|FG001|STARTED|Week 3||10
6727904|NCT03134599|7657792|FG002|STARTED|Week 3||10
6727905|NCT03134599|7657793|FG003|STARTED|Week 3||10
6727906|NCT03134599|7657794|FG004|STARTED|Week 3||8
6727907|NCT03134599|7657795|FG005|STARTED|Week 3||9
6727908|NCT03134599|7657790|FG000|COMPLETED|Week 3||9
6727909|NCT03134599|7657791|FG001|COMPLETED|Week 3||10
6727910|NCT03134599|7657792|FG002|COMPLETED|Week 3||10
6727911|NCT03134599|7657793|FG003|COMPLETED|Week 3||9
6727912|NCT03134599|7657794|FG004|COMPLETED|Week 3||8
6727913|NCT03134599|7657795|FG005|COMPLETED|Week 3||8
6727914|NCT03134599|7657790|FG000|NOT COMPLETED|Week 3||0
6727915|NCT03134599|7657791|FG001|NOT COMPLETED|Week 3||0
6727916|NCT03134599|7657792|FG002|NOT COMPLETED|Week 3||0
6727917|NCT03134599|7657793|FG003|NOT COMPLETED|Week 3||1
6727918|NCT03134599|7657794|FG004|NOT COMPLETED|Week 3||0
6727919|NCT03134599|7657795|FG005|NOT COMPLETED|Week 3||1
6727920|NCT03134703|7657805|FG000|STARTED|Overall Study||6
6727921|NCT03134703|7657806|FG001|STARTED|Overall Study||5
6727922|NCT03134703|7657805|FG000|COMPLETED|Overall Study||0
6727923|NCT03134703|7657806|FG001|COMPLETED|Overall Study||3
6727924|NCT03134703|7657805|FG000|NOT COMPLETED|Overall Study||6
6727925|NCT03134703|7657806|FG001|NOT COMPLETED|Overall Study||2
6727926|NCT03134768|7657812|FG000|STARTED|Overall Study||50
6727927|NCT03134768|7657812|FG000|COMPLETED|Overall Study||50
6727928|NCT03134768|7657812|FG000|NOT COMPLETED|Overall Study||0
6727929|NCT03134911|7657818|FG000|STARTED|Overall Study||535
6265639|NCT00027027|7164764|FG000|Discontinued Before 2 Treatment Cycles|Overall Study||0
6265640|NCT00027027|7164765|FG001|Discontinued Before 2 Treatment Cycles|Overall Study||0
6265641|NCT00027027|7164766|FG002|Discontinued Before 2 Treatment Cycles|Overall Study||1
6265642|NCT00027027|7164767|FG003|Discontinued Before 2 Treatment Cycles|Overall Study||0
6265643|NCT00027027|7164768|FG004|Discontinued Before 2 Treatment Cycles|Overall Study||1
6265644|NCT00027027|7164764|FG000|Completed 2 Cycles of Treatment|Overall Study||3
6265645|NCT00027027|7164765|FG001|Completed 2 Cycles of Treatment|Overall Study||3
6265646|NCT00027027|7164766|FG002|Completed 2 Cycles of Treatment|Overall Study||3
6265647|NCT00027027|7164767|FG003|Completed 2 Cycles of Treatment|Overall Study||3
6265648|NCT00027027|7164768|FG004|Completed 2 Cycles of Treatment|Overall Study||7
6265649|NCT00027027|7164764|FG000|Discontinued at Cycle 2|Overall Study||2
6265650|NCT00027027|7164765|FG001|Discontinued at Cycle 2|Overall Study||2
6265651|NCT00027027|7164766|FG002|Discontinued at Cycle 2|Overall Study||1
6265652|NCT00027027|7164767|FG003|Discontinued at Cycle 2|Overall Study||1
6265653|NCT00027027|7164768|FG004|Discontinued at Cycle 2|Overall Study||3
6265654|NCT00027027|7164764|FG000|Treated Beyond Cycle 2|Overall Study||1
6265655|NCT00027027|7164765|FG001|Treated Beyond Cycle 2|Overall Study||1
6265656|NCT00027027|7164766|FG002|Treated Beyond Cycle 2|Overall Study||2
6265657|NCT00027027|7164767|FG003|Treated Beyond Cycle 2|Overall Study||2
6265658|NCT00027027|7164768|FG004|Treated Beyond Cycle 2|Overall Study||4
6265659|NCT00027027|7164764|FG000|COMPLETED|Overall Study||0
6265660|NCT00027027|7164765|FG001|COMPLETED|Overall Study||0
6265661|NCT00027027|7164766|FG002|COMPLETED|Overall Study||0
6265662|NCT00027027|7164767|FG003|COMPLETED|Overall Study||0
6265663|NCT00027027|7164768|FG004|COMPLETED|Overall Study||0
6265664|NCT00027027|7164764|FG000|NOT COMPLETED|Overall Study||3
6265665|NCT00027027|7164765|FG001|NOT COMPLETED|Overall Study||3
6265666|NCT00027027|7164766|FG002|NOT COMPLETED|Overall Study||4
6265667|NCT00027027|7164767|FG003|NOT COMPLETED|Overall Study||3
6265668|NCT00027027|7164768|FG004|NOT COMPLETED|Overall Study||8
6265669|NCT00027378|7164786|FG000|STARTED|Overall Study||24
6265670|NCT00027378|7164787|FG001|STARTED|Overall Study||26
6265671|NCT00027378|7164786|FG000|COMPLETED|Overall Study||24
6265672|NCT00027378|7164787|FG001|COMPLETED|Overall Study||23
6265673|NCT00027378|7164786|FG000|NOT COMPLETED|Overall Study||0
6265674|NCT00027378|7164787|FG001|NOT COMPLETED|Overall Study||3
6265675|NCT00027560|7164793|FG000|STARTED|Overall Study||51
6265676|NCT00027560|7164793|FG000|COMPLETED|Overall Study||50
6265677|NCT00027560|7164793|FG000|NOT COMPLETED|Overall Study||1
6265678|NCT00027846|7164802|FG000|STARTED|Overall Study||13
6265679|NCT00027846|7164803|FG001|STARTED|Overall Study||287
6265680|NCT00027846|7164804|FG002|STARTED|Overall Study||78
6265681|NCT00027846|7164802|FG000|COMPLETED|Overall Study||11
6265682|NCT00027846|7164803|FG001|COMPLETED|Overall Study||219
6265683|NCT00027846|7164804|FG002|COMPLETED|Overall Study||41
6265684|NCT00027846|7164802|FG000|NOT COMPLETED|Overall Study||2
6265685|NCT00027846|7164803|FG001|NOT COMPLETED|Overall Study||68
6265686|NCT00027846|7164804|FG002|NOT COMPLETED|Overall Study||37
6265687|NCT00028002|7164814|FG000|STARTED|Overall Study||63
6265688|NCT00028002|7164814|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
6265689|NCT00028002|7164814|FG000|NOT COMPLETED|Overall Study||11
6265690|NCT00028093|7164821|FG000|STARTED|Overall Study||25
6265691|NCT00028093|7164822|FG001|STARTED|Overall Study||25
6265692|NCT00028093|7164821|FG000|COMPLETED|Overall Study||25
6265693|NCT00028093|7164822|FG001|COMPLETED|Overall Study||25
6265694|NCT00028093|7164821|FG000|NOT COMPLETED|Overall Study||0
6265695|NCT00028093|7164822|FG001|NOT COMPLETED|Overall Study||0
6265696|NCT00028262|7164828|FG000|STARTED|Overall Study||10
6265697|NCT00028262|7164828|FG000|COMPLETED|Overall Study||9
6265698|NCT00028262|7164828|FG000|NOT COMPLETED|Overall Study||1
6265699|NCT00028769|7164832|FG000|STARTED|Overall Study||41
6265700|NCT00028769|7164832|FG000|Eligible|Overall Study||36
6265701|NCT00028769|7164832|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
6265702|NCT00028769|7164832|FG000|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
6265703|NCT00028769|7164832|FG000|NOT COMPLETED|Overall Study||41
6265704|NCT00029107|7164838|FG000|STARTED|Overall Study||12
6727930|NCT03134911|7657818|FG000|COMPLETED|Overall Study||501
6727931|NCT03134911|7657818|FG000|NOT COMPLETED|Overall Study||34
6727932|NCT03134963|7657830|FG000|STARTED|Overall Study||12
6727933|NCT03134963|7657831|FG001|STARTED|Overall Study||13
6727934|NCT03134963|7657832|FG002|STARTED|Overall Study||3
6727935|NCT03134963|7657833|FG003|STARTED|Overall Study||14
6727936|NCT03134963|7657830|FG000|COMPLETED|Overall Study||12
6727937|NCT03134963|7657831|FG001|COMPLETED|Overall Study||13
6727938|NCT03134963|7657832|FG002|COMPLETED|Overall Study||3
6727939|NCT03134963|7657833|FG003|COMPLETED|Overall Study||14
6727940|NCT03134963|7657830|FG000|NOT COMPLETED|Overall Study||0
6727941|NCT03134963|7657831|FG001|NOT COMPLETED|Overall Study||0
6727942|NCT03134963|7657832|FG002|NOT COMPLETED|Overall Study||0
6727943|NCT03134963|7657833|FG003|NOT COMPLETED|Overall Study||0
6727944|NCT03134989|7657843|FG000|STARTED|Overall Study||80
6727945|NCT03134989|7657843|FG000|COMPLETED|Overall Study|Clinical investigation termination date: Last Subject, Final Visit 18-Jun-2020|80
6727946|NCT03134989|7657843|FG000|NOT COMPLETED|Overall Study||0
6727947|NCT03135015|7657850|FG000|STARTED|Overall Study||11
6727948|NCT03135015|7657851|FG001|STARTED|Overall Study||11
6727949|NCT03135015|7657850|FG000|Water Control|Overall Study||9
6727950|NCT03135015|7657851|FG001|Water Control|Overall Study||11
6727951|NCT03135015|7657850|FG000|Placebo Capsules|Overall Study||9
6727952|NCT03135015|7657851|FG001|Placebo Capsules|Overall Study||11
6727953|NCT03135015|7657850|FG000|2g Capsules|Overall Study||9
6727954|NCT03135015|7657851|FG001|2g Capsules|Overall Study||11
6727955|NCT03135015|7657850|FG000|4g Capsules|Overall Study||9
6727956|NCT03135015|7657851|FG001|4g Capsules|Overall Study||11
6727957|NCT03135015|7657850|FG000|2g Tablets|Overall Study||9
6727958|NCT03135015|7657851|FG001|2g Tablets|Overall Study||11
6727959|NCT03135015|7657850|FG000|4g Tablets|Overall Study||9
6727960|NCT03135015|7657851|FG001|4g Tablets|Overall Study||11
6727961|NCT03135015|7657850|FG000|COMPLETED|Overall Study||9
6392168|NCT00839982|7304160|FG002|COMPLETED|Overall Study||2
6392169|NCT00839982|7304161|FG003|COMPLETED|Overall Study||3
6392170|NCT00839982|7304158|FG000|NOT COMPLETED|Overall Study||0
6392171|NCT00839982|7304159|FG001|NOT COMPLETED|Overall Study||0
6392172|NCT00839982|7304160|FG002|NOT COMPLETED|Overall Study||0
6727962|NCT03135015|7657851|FG001|COMPLETED|Overall Study||11
6727963|NCT03135015|7657850|FG000|NOT COMPLETED|Overall Study||2
6727964|NCT03135015|7657851|FG001|NOT COMPLETED|Overall Study||0
6727965|NCT03135028|7657901|FG000|STARTED|Overall Study||9
6727966|NCT03135028|7657901|FG000|COMPLETED|Overall Study||0
6727967|NCT03135028|7657901|FG000|NOT COMPLETED|Overall Study||9
6727968|NCT03135210|7657907|FG000|STARTED|Overall Study||2
6727969|NCT03135210|7657908|FG001|STARTED|Overall Study||2
6727970|NCT03135210|7657907|FG000|COMPLETED|Overall Study||2
6727971|NCT03135210|7657908|FG001|COMPLETED|Overall Study||1
6727972|NCT03135210|7657907|FG000|NOT COMPLETED|Overall Study||0
6727973|NCT03135210|7657908|FG001|NOT COMPLETED|Overall Study||1
6727974|NCT03135379|7657916|FG000|STARTED|Overall Study||62
6727975|NCT03135379|7657917|FG001|STARTED|Overall Study||62
6727976|NCT03135379|7657916|FG000|COMPLETED|Overall Study||61
6727977|NCT03135379|7657917|FG001|COMPLETED|Overall Study||59
6727978|NCT03135379|7657916|FG000|NOT COMPLETED|Overall Study||1
6727979|NCT03135379|7657917|FG001|NOT COMPLETED|Overall Study||3
6727980|NCT03135431|7657925|FG000|STARTED|Overall Study||20
6727981|NCT03135431|7657926|FG001|STARTED|Overall Study||20
6727982|NCT03135431|7657925|FG000|COMPLETED|Overall Study||18
6727983|NCT03135431|7657926|FG001|COMPLETED|Overall Study||20
6727984|NCT03135431|7657925|FG000|NOT COMPLETED|Overall Study||2
6727985|NCT03135431|7657926|FG001|NOT COMPLETED|Overall Study||0
6727986|NCT03135522|7657934|FG000|STARTED|Overall Study||17
6727987|NCT03135522|7657935|FG001|STARTED|Overall Study||17
6727988|NCT03135522|7657934|FG000|COMPLETED|Overall Study||16
6727989|NCT03135522|7657935|FG001|COMPLETED|Overall Study||17
6727990|NCT03135522|7657934|FG000|NOT COMPLETED|Overall Study||1
6727991|NCT03135522|7657935|FG001|NOT COMPLETED|Overall Study||0
6727992|NCT03135535|7657941|FG000|STARTED|Overall Study||30
6727993|NCT03135535|7657941|FG000|COMPLETED|Overall Study||30
6727994|NCT03135535|7657941|FG000|NOT COMPLETED|Overall Study||0
6727995|NCT03135548|7657948|FG000|STARTED|Overall Study||19
6727996|NCT03135548|7657949|FG001|STARTED|Overall Study||19
6727997|NCT03135548|7657950|FG002|STARTED|Overall Study||21
6727998|NCT03135548|7657948|FG000|COMPLETED|Overall Study||14
6727999|NCT03135548|7657949|FG001|COMPLETED|Overall Study||15
6728000|NCT03135548|7657950|FG002|COMPLETED|Overall Study||18
6728001|NCT03135548|7657948|FG000|NOT COMPLETED|Overall Study||5
6728002|NCT03135548|7657949|FG001|NOT COMPLETED|Overall Study||4
6728003|NCT03135548|7657950|FG002|NOT COMPLETED|Overall Study||3
6728004|NCT03135899|7657966|FG000|STARTED|Overall Study||1
6728005|NCT03135899|7657967|FG001|STARTED|Overall Study||1
6728006|NCT03135899|7657968|FG002|STARTED|Overall Study||1
6728007|NCT03135899|7657969|FG003|STARTED|Overall Study||1
6728008|NCT03135899|7657970|FG004|STARTED|Overall Study||8
6728009|NCT03135899|7657971|FG005|STARTED|Overall Study||9
6728010|NCT03135899|7657972|FG006|STARTED|Overall Study||8
6728011|NCT03135899|7657973|FG007|STARTED|Overall Study||8
6728012|NCT03135899|7657966|FG000|COMPLETED|Overall Study||1
6728013|NCT03135899|7657967|FG001|COMPLETED|Overall Study||1
6728014|NCT03135899|7657968|FG002|COMPLETED|Overall Study||1
6728015|NCT03135899|7657969|FG003|COMPLETED|Overall Study||1
6728016|NCT03135899|7657970|FG004|COMPLETED|Overall Study||8
6728017|NCT03135899|7657971|FG005|COMPLETED|Overall Study||7
6728018|NCT03135899|7657972|FG006|COMPLETED|Overall Study||7
6728019|NCT03135899|7657973|FG007|COMPLETED|Overall Study||8
6728020|NCT03135899|7657966|FG000|NOT COMPLETED|Overall Study||0
6728021|NCT03135899|7657967|FG001|NOT COMPLETED|Overall Study||0
6728022|NCT03135899|7657968|FG002|NOT COMPLETED|Overall Study||0
6728023|NCT03135899|7657969|FG003|NOT COMPLETED|Overall Study||0
6728024|NCT03135899|7657970|FG004|NOT COMPLETED|Overall Study||0
6728025|NCT03135899|7657971|FG005|NOT COMPLETED|Overall Study||2
6728026|NCT03135899|7657972|FG006|NOT COMPLETED|Overall Study||1
6728027|NCT03135899|7657973|FG007|NOT COMPLETED|Overall Study||0
6728028|NCT03136068|7657989|FG000|STARTED|Overall Study||88
6728029|NCT03136068|7657990|FG001|STARTED|Overall Study||90
6728030|NCT03136068|7657989|FG000|COMPLETED|Overall Study||86
6728031|NCT03136068|7657990|FG001|COMPLETED|Overall Study||89
6728032|NCT03136068|7657989|FG000|NOT COMPLETED|Overall Study||2
6728033|NCT03136068|7657990|FG001|NOT COMPLETED|Overall Study||1
6728034|NCT03136107|7657996|FG000|STARTED|Overall Study||26
6728035|NCT03136107|7657996|FG000|Test Product|Overall Study||26
6728036|NCT03136107|7657996|FG000|Reference Product|Overall Study||26
6728037|NCT03136107|7657996|FG000|Negative Control|Overall Study||26
6728038|NCT03136107|7657996|FG000|COMPLETED|Overall Study||25
6728039|NCT03136107|7657996|FG000|NOT COMPLETED|Overall Study||1
6728040|NCT03136159|7658006|FG000|STARTED|Overall Study||190
6728041|NCT03136159|7658007|FG001|STARTED|Overall Study||190
6728042|NCT03136159|7658006|FG000|COMPLETED|Overall Study||185
6728043|NCT03136159|7658007|FG001|COMPLETED|Overall Study||190
6728044|NCT03136159|7658006|FG000|NOT COMPLETED|Overall Study||5
6728045|NCT03136159|7658007|FG001|NOT COMPLETED|Overall Study||0
6728046|NCT03136198|7658015|FG000|STARTED|Overall Study||66
6728047|NCT03136198|7658016|FG001|STARTED|Overall Study||64
6728048|NCT03136198|7658015|FG000|COMPLETED|Overall Study||66
6728049|NCT03136198|7658016|FG001|COMPLETED|Overall Study||63
6728050|NCT03136198|7658015|FG000|NOT COMPLETED|Overall Study||0
6728051|NCT03136198|7658016|FG001|NOT COMPLETED|Overall Study||1
6728052|NCT03136328|7658022|FG000|STARTED|Overall Study||11
6728053|NCT03136328|7658022|FG000|COMPLETED|Overall Study||11
6728054|NCT03136328|7658022|FG000|NOT COMPLETED|Overall Study||0
6728055|NCT03136367|7658030|FG000|STARTED|T1 Consultation||66
6728056|NCT03136367|7658031|FG001|STARTED|T1 Consultation||248
6728057|NCT03136367|7658032|FG002|STARTED|T1 Consultation||257
6728058|NCT03136367|7658030|FG000|COMPLETED|T1 Consultation|received the intervention|64
6728059|NCT03136367|7658031|FG001|COMPLETED|T1 Consultation||241
6728060|NCT03136367|7658032|FG002|COMPLETED|T1 Consultation||256
6728061|NCT03136367|7658030|FG000|NOT COMPLETED|T1 Consultation||2
6728062|NCT03136367|7658031|FG001|NOT COMPLETED|T1 Consultation||7
6728063|NCT03136367|7658032|FG002|NOT COMPLETED|T1 Consultation||1
6728064|NCT03136367|7658030|FG000|STARTED|T2 Post-consultation||64
6728065|NCT03136367|7658031|FG001|STARTED|T2 Post-consultation||241
6728066|NCT03136367|7658032|FG002|STARTED|T2 Post-consultation||256
6728067|NCT03136367|7658030|FG000|COMPLETED|T2 Post-consultation||61
6728068|NCT03136367|7658031|FG001|COMPLETED|T2 Post-consultation||235
6728069|NCT03136367|7658032|FG002|COMPLETED|T2 Post-consultation||225
6728070|NCT03136367|7658030|FG000|NOT COMPLETED|T2 Post-consultation||3
6728071|NCT03136367|7658031|FG001|NOT COMPLETED|T2 Post-consultation||6
6728072|NCT03136367|7658032|FG002|NOT COMPLETED|T2 Post-consultation||31
6728073|NCT03136367|7658030|FG000|STARTED|T3 1 Week After Surgery||61
6728074|NCT03136367|7658031|FG001|STARTED|T3 1 Week After Surgery||235
6728075|NCT03136367|7658032|FG002|STARTED|T3 1 Week After Surgery||225
6728076|NCT03136367|7658030|FG000|COMPLETED|T3 1 Week After Surgery||51
6728077|NCT03136367|7658031|FG001|COMPLETED|T3 1 Week After Surgery||203
6728078|NCT03136367|7658032|FG002|COMPLETED|T3 1 Week After Surgery||194
6728079|NCT03136367|7658030|FG000|NOT COMPLETED|T3 1 Week After Surgery||10
6728080|NCT03136367|7658031|FG001|NOT COMPLETED|T3 1 Week After Surgery||32
6728081|NCT03136367|7658032|FG002|NOT COMPLETED|T3 1 Week After Surgery||31
6728082|NCT03136367|7658030|FG000|STARTED|T4 12 Weeks After Surgery||51
6728083|NCT03136367|7658031|FG001|STARTED|T4 12 Weeks After Surgery||203
6728084|NCT03136367|7658032|FG002|STARTED|T4 12 Weeks After Surgery||194
6728085|NCT03136367|7658030|FG000|COMPLETED|T4 12 Weeks After Surgery||49
6728086|NCT03136367|7658031|FG001|COMPLETED|T4 12 Weeks After Surgery||198
6728087|NCT03136367|7658032|FG002|COMPLETED|T4 12 Weeks After Surgery||185
6728088|NCT03136367|7658030|FG000|NOT COMPLETED|T4 12 Weeks After Surgery||2
6728089|NCT03136367|7658031|FG001|NOT COMPLETED|T4 12 Weeks After Surgery||5
6728090|NCT03136367|7658032|FG002|NOT COMPLETED|T4 12 Weeks After Surgery||9
6728091|NCT03136367|7658030|FG000|STARTED|T5 1 Year After Surgery||49
6728092|NCT03136367|7658031|FG001|STARTED|T5 1 Year After Surgery||198
6728093|NCT03136367|7658032|FG002|STARTED|T5 1 Year After Surgery||185
6728094|NCT03136367|7658030|FG000|COMPLETED|T5 1 Year After Surgery||13
6728095|NCT03136367|7658031|FG001|COMPLETED|T5 1 Year After Surgery||62
6728096|NCT03136367|7658032|FG002|COMPLETED|T5 1 Year After Surgery||56
6728097|NCT03136367|7658030|FG000|NOT COMPLETED|T5 1 Year After Surgery||36
6728098|NCT03136367|7658031|FG001|NOT COMPLETED|T5 1 Year After Surgery||136
6728099|NCT03136367|7658032|FG002|NOT COMPLETED|T5 1 Year After Surgery||129
6728100|NCT03136380|7658045|FG000|STARTED|Part 1, Period 1 (3 Days)||6
6728101|NCT03136380|7658046|FG001|STARTED|Part 1, Period 1 (3 Days)||6
6728102|NCT03136380|7658047|FG002|STARTED|Part 1, Period 1 (3 Days)||6
6728103|NCT03136380|7658048|FG003|STARTED|Part 1, Period 1 (3 Days)||0
6728104|NCT03136380|7658049|FG004|STARTED|Part 1, Period 1 (3 Days)||0
6728105|NCT03136380|7658045|FG000|COMPLETED|Part 1, Period 1 (3 Days)||6
6728106|NCT03136380|7658046|FG001|COMPLETED|Part 1, Period 1 (3 Days)||6
6728107|NCT03136380|7658047|FG002|COMPLETED|Part 1, Period 1 (3 Days)||6
6728108|NCT03136380|7658048|FG003|COMPLETED|Part 1, Period 1 (3 Days)||0
6728109|NCT03136380|7658049|FG004|COMPLETED|Part 1, Period 1 (3 Days)||0
6728110|NCT03136380|7658045|FG000|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6728111|NCT03136380|7658046|FG001|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6728112|NCT03136380|7658047|FG002|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6728113|NCT03136380|7658048|FG003|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6728114|NCT03136380|7658049|FG004|NOT COMPLETED|Part 1, Period 1 (3 Days)||0
6728115|NCT03136380|7658045|FG000|STARTED|Part 1, Washout Period 1 (7 Days)||6
6728116|NCT03136380|7658046|FG001|STARTED|Part 1, Washout Period 1 (7 Days)||6
6728117|NCT03136380|7658047|FG002|STARTED|Part 1, Washout Period 1 (7 Days)||6
6728118|NCT03136380|7658048|FG003|STARTED|Part 1, Washout Period 1 (7 Days)||0
6728119|NCT03136380|7658049|FG004|STARTED|Part 1, Washout Period 1 (7 Days)||0
6728120|NCT03136380|7658045|FG000|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
6728121|NCT03136380|7658046|FG001|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
6728122|NCT03136380|7658047|FG002|COMPLETED|Part 1, Washout Period 1 (7 Days)||6
6728123|NCT03136380|7658048|FG003|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6728124|NCT03136380|7658049|FG004|COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6728125|NCT03136380|7658045|FG000|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6728126|NCT03136380|7658046|FG001|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6728127|NCT03136380|7658047|FG002|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6728128|NCT03136380|7658048|FG003|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6728129|NCT03136380|7658049|FG004|NOT COMPLETED|Part 1, Washout Period 1 (7 Days)||0
6728130|NCT03136380|7658045|FG000|STARTED|Part 1, Period 2 (3 Days)||6
6728131|NCT03136380|7658046|FG001|STARTED|Part 1, Period 2 (3 Days)||6
6728132|NCT03136380|7658047|FG002|STARTED|Part 1, Period 2 (3 Days)||6
6728133|NCT03136380|7658048|FG003|STARTED|Part 1, Period 2 (3 Days)||0
6728134|NCT03136380|7658049|FG004|STARTED|Part 1, Period 2 (3 Days)||0
6728135|NCT03136380|7658045|FG000|COMPLETED|Part 1, Period 2 (3 Days)||6
6728136|NCT03136380|7658046|FG001|COMPLETED|Part 1, Period 2 (3 Days)||6
6728137|NCT03136380|7658047|FG002|COMPLETED|Part 1, Period 2 (3 Days)||6
6728138|NCT03136380|7658048|FG003|COMPLETED|Part 1, Period 2 (3 Days)||0
6728139|NCT03136380|7658049|FG004|COMPLETED|Part 1, Period 2 (3 Days)||0
6728140|NCT03136380|7658045|FG000|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6728141|NCT03136380|7658046|FG001|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6728142|NCT03136380|7658047|FG002|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6728143|NCT03136380|7658048|FG003|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6728144|NCT03136380|7658049|FG004|NOT COMPLETED|Part 1, Period 2 (3 Days)||0
6728145|NCT03136380|7658045|FG000|STARTED|Part 1, Washout Period 2 (7 Days)||6
6728146|NCT03136380|7658046|FG001|STARTED|Part 1, Washout Period 2 (7 Days)||6
6728147|NCT03136380|7658047|FG002|STARTED|Part 1, Washout Period 2 (7 Days)||6
6728148|NCT03136380|7658048|FG003|STARTED|Part 1, Washout Period 2 (7 Days)||0
6728149|NCT03136380|7658049|FG004|STARTED|Part 1, Washout Period 2 (7 Days)||0
6728150|NCT03136380|7658045|FG000|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
6728151|NCT03136380|7658046|FG001|COMPLETED|Part 1, Washout Period 2 (7 Days)||5
6728152|NCT03136380|7658047|FG002|COMPLETED|Part 1, Washout Period 2 (7 Days)||6
6728153|NCT03136380|7658048|FG003|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6728154|NCT03136380|7658049|FG004|COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6728155|NCT03136380|7658045|FG000|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6728156|NCT03136380|7658046|FG001|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||1
6728157|NCT03136380|7658047|FG002|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6728158|NCT03136380|7658048|FG003|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6728159|NCT03136380|7658049|FG004|NOT COMPLETED|Part 1, Washout Period 2 (7 Days)||0
6728160|NCT03136380|7658045|FG000|STARTED|Part 1, Period 3 (4 Days)||6
6728161|NCT03136380|7658046|FG001|STARTED|Part 1, Period 3 (4 Days)||5
6728162|NCT03136380|7658047|FG002|STARTED|Part 1, Period 3 (4 Days)||6
6728163|NCT03136380|7658048|FG003|STARTED|Part 1, Period 3 (4 Days)||0
6728164|NCT03136380|7658049|FG004|STARTED|Part 1, Period 3 (4 Days)||0
6728165|NCT03136380|7658045|FG000|COMPLETED|Part 1, Period 3 (4 Days)||6
6728166|NCT03136380|7658046|FG001|COMPLETED|Part 1, Period 3 (4 Days)||5
6728167|NCT03136380|7658047|FG002|COMPLETED|Part 1, Period 3 (4 Days)||6
6728168|NCT03136380|7658048|FG003|COMPLETED|Part 1, Period 3 (4 Days)||0
6728169|NCT03136380|7658049|FG004|COMPLETED|Part 1, Period 3 (4 Days)||0
6728170|NCT03136380|7658045|FG000|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6728171|NCT03136380|7658046|FG001|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6728172|NCT03136380|7658047|FG002|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6728173|NCT03136380|7658048|FG003|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6728174|NCT03136380|7658049|FG004|NOT COMPLETED|Part 1, Period 3 (4 Days)||0
6728175|NCT03136380|7658045|FG000|STARTED|Part 2, Period 1 (3 Days)||0
6728176|NCT03136380|7658046|FG001|STARTED|Part 2, Period 1 (3 Days)||0
6728177|NCT03136380|7658047|FG002|STARTED|Part 2, Period 1 (3 Days)||0
6728178|NCT03136380|7658048|FG003|STARTED|Part 2, Period 1 (3 Days)||8
6728179|NCT03136380|7658049|FG004|STARTED|Part 2, Period 1 (3 Days)||8
6728180|NCT03136380|7658045|FG000|COMPLETED|Part 2, Period 1 (3 Days)||0
6728181|NCT03136380|7658046|FG001|COMPLETED|Part 2, Period 1 (3 Days)||0
6728182|NCT03136380|7658047|FG002|COMPLETED|Part 2, Period 1 (3 Days)||0
6728183|NCT03136380|7658048|FG003|COMPLETED|Part 2, Period 1 (3 Days)||8
6728184|NCT03136380|7658049|FG004|COMPLETED|Part 2, Period 1 (3 Days)||8
6728185|NCT03136380|7658045|FG000|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6728186|NCT03136380|7658046|FG001|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6728187|NCT03136380|7658047|FG002|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6728188|NCT03136380|7658048|FG003|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6728189|NCT03136380|7658049|FG004|NOT COMPLETED|Part 2, Period 1 (3 Days)||0
6728190|NCT03136380|7658045|FG000|STARTED|Part 2, Washout Period 1 (7 Days)||0
6728191|NCT03136380|7658046|FG001|STARTED|Part 2, Washout Period 1 (7 Days)||0
6728192|NCT03136380|7658047|FG002|STARTED|Part 2, Washout Period 1 (7 Days)||0
6728193|NCT03136380|7658048|FG003|STARTED|Part 2, Washout Period 1 (7 Days)||8
6728194|NCT03136380|7658049|FG004|STARTED|Part 2, Washout Period 1 (7 Days)||8
6728195|NCT03136380|7658045|FG000|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6728196|NCT03136380|7658046|FG001|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6728197|NCT03136380|7658047|FG002|COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6728198|NCT03136380|7658048|FG003|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
6728199|NCT03136380|7658049|FG004|COMPLETED|Part 2, Washout Period 1 (7 Days)||8
6728200|NCT03136380|7658045|FG000|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6728201|NCT03136380|7658046|FG001|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6728202|NCT03136380|7658047|FG002|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6728203|NCT03136380|7658048|FG003|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6728204|NCT03136380|7658049|FG004|NOT COMPLETED|Part 2, Washout Period 1 (7 Days)||0
6728205|NCT03136380|7658045|FG000|STARTED|Part 2, Period 2 (3 Days)||0
6728206|NCT03136380|7658046|FG001|STARTED|Part 2, Period 2 (3 Days)||0
6728207|NCT03136380|7658047|FG002|STARTED|Part 2, Period 2 (3 Days)||0
6728208|NCT03136380|7658048|FG003|STARTED|Part 2, Period 2 (3 Days)||8
6728209|NCT03136380|7658049|FG004|STARTED|Part 2, Period 2 (3 Days)||8
6728210|NCT03136380|7658045|FG000|COMPLETED|Part 2, Period 2 (3 Days)||0
6728211|NCT03136380|7658046|FG001|COMPLETED|Part 2, Period 2 (3 Days)||0
6728212|NCT03136380|7658047|FG002|COMPLETED|Part 2, Period 2 (3 Days)||0
6728213|NCT03136380|7658048|FG003|COMPLETED|Part 2, Period 2 (3 Days)||8
6728214|NCT03136380|7658049|FG004|COMPLETED|Part 2, Period 2 (3 Days)||8
6728215|NCT03136380|7658045|FG000|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6728216|NCT03136380|7658046|FG001|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6728217|NCT03136380|7658047|FG002|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6728218|NCT03136380|7658048|FG003|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6728219|NCT03136380|7658049|FG004|NOT COMPLETED|Part 2, Period 2 (3 Days)||0
6728220|NCT03136484|7658069|FG000|STARTED|Overall Study||394
6728221|NCT03136484|7658070|FG001|STARTED|Overall Study||394
6728222|NCT03136484|7658069|FG000|Exposed|Overall Study||392
6728223|NCT03136484|7658070|FG001|Exposed|Overall Study||394
6728224|NCT03136484|7658069|FG000|COMPLETED|Overall Study||367
6728225|NCT03136484|7658070|FG001|COMPLETED|Overall Study||372
6728226|NCT03136484|7658069|FG000|NOT COMPLETED|Overall Study||27
6728227|NCT03136484|7658070|FG001|NOT COMPLETED|Overall Study||22
6728228|NCT03136861|7658083|FG000|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||285
6728229|NCT03136861|7658084|FG001|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||95
6728230|NCT03136861|7658085|FG002|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728231|NCT03136861|7658086|FG003|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728232|NCT03136861|7658087|FG004|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728233|NCT03136861|7658088|FG005|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728234|NCT03136861|7658089|FG006|STARTED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728235|NCT03136861|7658083|FG000|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||278
6728236|NCT03136861|7658084|FG001|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||89
6728237|NCT03136861|7658085|FG002|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728238|NCT03136861|7658086|FG003|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728239|NCT03136861|7658087|FG004|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728240|NCT03136861|7658088|FG005|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728241|NCT03136861|7658089|FG006|COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728242|NCT03136861|7658083|FG000|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||7
6728243|NCT03136861|7658084|FG001|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||6
6728244|NCT03136861|7658085|FG002|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728245|NCT03136861|7658086|FG003|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728246|NCT03136861|7658087|FG004|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728247|NCT03136861|7658088|FG005|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728248|NCT03136861|7658089|FG006|NOT COMPLETED|Treatment Period 1 (TP1)(Baseline-Wk 8)||0
6728249|NCT03136861|7658083|FG000|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6728250|NCT03136861|7658084|FG001|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6728251|NCT03136861|7658085|FG002|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||90
6728252|NCT03136861|7658086|FG003|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
6728253|NCT03136861|7658087|FG004|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||94
6728254|NCT03136861|7658088|FG005|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
6728255|NCT03136861|7658089|FG006|STARTED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||44
6728256|NCT03136861|7658083|FG000|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6728257|NCT03136861|7658084|FG001|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6728258|NCT03136861|7658085|FG002|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||88
6728259|NCT03136861|7658086|FG003|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||93
6728260|NCT03136861|7658087|FG004|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||92
6728261|NCT03136861|7658088|FG005|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||45
6728262|NCT03136861|7658089|FG006|COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||43
6728263|NCT03136861|7658083|FG000|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6728264|NCT03136861|7658084|FG001|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6728265|NCT03136861|7658085|FG002|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
6728266|NCT03136861|7658086|FG003|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
6728267|NCT03136861|7658087|FG004|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||2
6728268|NCT03136861|7658088|FG005|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||0
6728269|NCT03136861|7658089|FG006|NOT COMPLETED|Treatment Period 2 (TP2) (Wk 8-Wk 24)||1
6728270|NCT03136913|7658100|FG000|STARTED|Overall Study||13
6728271|NCT03136913|7658100|FG000|Subjects Received Both Intervention|Overall Study|10 subjects with 10 OFT and 10 CFT sites received clinical measurement before implant surgery|10
6728272|NCT03136913|7658100|FG000|COMPLETED|Overall Study|8 subjects with 8 OFT and 8 CFT sites received implant surgery|8
6728273|NCT03136913|7658100|FG000|NOT COMPLETED|Overall Study||5
6728274|NCT03137069|7658113|FG000|STARTED|Overall Study||13
6728275|NCT03137069|7658114|FG001|STARTED|Overall Study||28
6728276|NCT03137069|7658115|FG002|STARTED|Overall Study||23
6728277|NCT03137069|7658116|FG003|STARTED|Overall Study||23
6728278|NCT03137069|7658117|FG004|STARTED|Overall Study||24
6728279|NCT03137069|7658118|FG005|STARTED|Overall Study||23
6728280|NCT03137069|7658113|FG000|COMPLETED|Overall Study||12
6728281|NCT03137069|7658114|FG001|COMPLETED|Overall Study||22
6728282|NCT03137069|7658115|FG002|COMPLETED|Overall Study||20
6728283|NCT03137069|7658116|FG003|COMPLETED|Overall Study||17
6728284|NCT03137069|7658117|FG004|COMPLETED|Overall Study||22
6728285|NCT03137069|7658118|FG005|COMPLETED|Overall Study||21
6728286|NCT03137069|7658113|FG000|NOT COMPLETED|Overall Study||1
6728287|NCT03137069|7658114|FG001|NOT COMPLETED|Overall Study||6
6728288|NCT03137069|7658115|FG002|NOT COMPLETED|Overall Study||3
6728289|NCT03137069|7658116|FG003|NOT COMPLETED|Overall Study||6
6728290|NCT03137069|7658117|FG004|NOT COMPLETED|Overall Study||2
6728291|NCT03137069|7658118|FG005|NOT COMPLETED|Overall Study||2
6728292|NCT03137121|7658138|FG000|STARTED|Overall Study||15
6728293|NCT03137121|7658139|FG001|STARTED|Overall Study||15
6728294|NCT03137121|7658138|FG000|COMPLETED|Overall Study||15
6728295|NCT03137121|7658139|FG001|COMPLETED|Overall Study||14
6728296|NCT03137121|7658138|FG000|NOT COMPLETED|Overall Study||0
6728297|NCT03137121|7658139|FG001|NOT COMPLETED|Overall Study||1
6728298|NCT03137303|7658147|FG000|STARTED|T0: Time of Enrollment - Baseline Visit||231
6728299|NCT03137303|7658148|FG001|STARTED|T0: Time of Enrollment - Baseline Visit||171
6728300|NCT03137303|7658147|FG000|COMPLETED|T0: Time of Enrollment - Baseline Visit||231
6728301|NCT03137303|7658148|FG001|COMPLETED|T0: Time of Enrollment - Baseline Visit||171
6728302|NCT03137303|7658147|FG000|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
6728303|NCT03137303|7658148|FG001|NOT COMPLETED|T0: Time of Enrollment - Baseline Visit||0
6728304|NCT03137303|7658147|FG000|STARTED|T1: 3-month Follow-up||231
6728305|NCT03137303|7658148|FG001|STARTED|T1: 3-month Follow-up||171
6728306|NCT03137303|7658147|FG000|COMPLETED|T1: 3-month Follow-up||225
6728307|NCT03137303|7658148|FG001|COMPLETED|T1: 3-month Follow-up||161
6728308|NCT03137303|7658147|FG000|NOT COMPLETED|T1: 3-month Follow-up||6
6728309|NCT03137303|7658148|FG001|NOT COMPLETED|T1: 3-month Follow-up||10
6728310|NCT03137303|7658147|FG000|STARTED|T2: 6-month Follow-up||230
6728311|NCT03137303|7658148|FG001|STARTED|T2: 6-month Follow-up||167
6728312|NCT03137303|7658147|FG000|COMPLETED|T2: 6-month Follow-up||225
6728313|NCT03137303|7658148|FG001|COMPLETED|T2: 6-month Follow-up||162
6728314|NCT03137303|7658147|FG000|NOT COMPLETED|T2: 6-month Follow-up||5
6728315|NCT03137303|7658148|FG001|NOT COMPLETED|T2: 6-month Follow-up||5
6728316|NCT03137303|7658147|FG000|STARTED|T3: 9-month Follow-up||230
6728317|NCT03137303|7658148|FG001|STARTED|T3: 9-month Follow-up||167
6728318|NCT03137303|7658147|FG000|COMPLETED|T3: 9-month Follow-up||225
6728319|NCT03137303|7658148|FG001|COMPLETED|T3: 9-month Follow-up||163
6728320|NCT03137303|7658147|FG000|NOT COMPLETED|T3: 9-month Follow-up||5
6728321|NCT03137303|7658148|FG001|NOT COMPLETED|T3: 9-month Follow-up||4
6728322|NCT03137303|7658147|FG000|STARTED|T4: 12-month Follow-up||229
6728323|NCT03137303|7658148|FG001|STARTED|T4: 12-month Follow-up||167
6728324|NCT03137303|7658147|FG000|COMPLETED|T4: 12-month Follow-up||222
6728325|NCT03137303|7658148|FG001|COMPLETED|T4: 12-month Follow-up||162
6728326|NCT03137303|7658147|FG000|NOT COMPLETED|T4: 12-month Follow-up||7
6728327|NCT03137303|7658148|FG001|NOT COMPLETED|T4: 12-month Follow-up||5
6728328|NCT03137459|7658156|FG000|STARTED|2-month Assessment||455
6728329|NCT03137459|7658157|FG001|STARTED|2-month Assessment||454
6728330|NCT03137459|7658156|FG000|COMPLETED|2-month Assessment||387
6728331|NCT03137459|7658157|FG001|COMPLETED|2-month Assessment||412
6728332|NCT03137459|7658156|FG000|NOT COMPLETED|2-month Assessment||68
6728333|NCT03137459|7658157|FG001|NOT COMPLETED|2-month Assessment||42
6728334|NCT03137459|7658156|FG000|STARTED|4-month Assessment||442
6728335|NCT03137459|7658157|FG001|STARTED|4-month Assessment||451
6728336|NCT03137459|7658156|FG000|COMPLETED|4-month Assessment||364
6728337|NCT03137459|7658157|FG001|COMPLETED|4-month Assessment||405
6728338|NCT03137459|7658156|FG000|NOT COMPLETED|4-month Assessment||78
6728339|NCT03137459|7658157|FG001|NOT COMPLETED|4-month Assessment||46
6728340|NCT03137459|7658156|FG000|STARTED|6-months||434
6728341|NCT03137459|7658157|FG001|STARTED|6-months||447
6728342|NCT03137459|7658156|FG000|COMPLETED|6-months||413
6728343|NCT03137459|7658157|FG001|COMPLETED|6-months||430
6728344|NCT03137459|7658156|FG000|NOT COMPLETED|6-months||21
6728345|NCT03137459|7658157|FG001|NOT COMPLETED|6-months||17
6728349|NCT03137784|7658168|FG000|STARTED|Overall Study||24
6728350|NCT03137784|7658169|FG001|STARTED|Overall Study||25
6728351|NCT03137784|7658170|FG002|STARTED|Overall Study||25
6728352|NCT03137784|7658171|FG003|STARTED|Overall Study||24
6728353|NCT03137784|7658172|FG004|STARTED|Overall Study||25
6728354|NCT03137784|7658173|FG005|STARTED|Overall Study||25
6728355|NCT03137784|7658168|FG000|COMPLETED|Overall Study||22
6728356|NCT03137784|7658169|FG001|COMPLETED|Overall Study||24
6728357|NCT03137784|7658170|FG002|COMPLETED|Overall Study||25
6728358|NCT03137784|7658171|FG003|COMPLETED|Overall Study||24
6728359|NCT03137784|7658172|FG004|COMPLETED|Overall Study||24
6728360|NCT03137784|7658173|FG005|COMPLETED|Overall Study||25
6602975|NCT02059291|7527976|FG017|COMPLETED|Epoch 2||0
6728361|NCT03137784|7658168|FG000|NOT COMPLETED|Overall Study||2
6728362|NCT03137784|7658169|FG001|NOT COMPLETED|Overall Study||1
6728363|NCT03137784|7658170|FG002|NOT COMPLETED|Overall Study||0
6728364|NCT03137784|7658171|FG003|NOT COMPLETED|Overall Study||0
6728365|NCT03137784|7658172|FG004|NOT COMPLETED|Overall Study||1
6728366|NCT03137784|7658173|FG005|NOT COMPLETED|Overall Study||0
6728367|NCT03137992|7658181|FG000|STARTED|Period 1 (Visit 2)||62
6728368|NCT03137992|7658182|FG001|STARTED|Period 1 (Visit 2)||63
6728369|NCT03137992|7658183|FG002|STARTED|Period 1 (Visit 2)||63
6728370|NCT03137992|7658184|FG003|STARTED|Period 1 (Visit 2)||63
6728371|NCT03137992|7658185|FG004|STARTED|Period 1 (Visit 2)||62
6728372|NCT03137992|7658186|FG005|STARTED|Period 1 (Visit 2)||61
6728373|NCT03137992|7658181|FG000|COMPLETED|Period 1 (Visit 2)||62
6728374|NCT03137992|7658182|FG001|COMPLETED|Period 1 (Visit 2)||63
6728375|NCT03137992|7658183|FG002|COMPLETED|Period 1 (Visit 2)||63
6728376|NCT03137992|7658184|FG003|COMPLETED|Period 1 (Visit 2)||63
6728377|NCT03137992|7658185|FG004|COMPLETED|Period 1 (Visit 2)||62
6728378|NCT03137992|7658186|FG005|COMPLETED|Period 1 (Visit 2)||61
6728379|NCT03137992|7658181|FG000|NOT COMPLETED|Period 1 (Visit 2)||0
6602976|NCT02059291|7527977|FG018|COMPLETED|Epoch 2||0
6728380|NCT03137992|7658182|FG001|NOT COMPLETED|Period 1 (Visit 2)||0
6728381|NCT03137992|7658183|FG002|NOT COMPLETED|Period 1 (Visit 2)||0
6728382|NCT03137992|7658184|FG003|NOT COMPLETED|Period 1 (Visit 2)||0
6728383|NCT03137992|7658185|FG004|NOT COMPLETED|Period 1 (Visit 2)||0
6728384|NCT03137992|7658186|FG005|NOT COMPLETED|Period 1 (Visit 2)||0
6728385|NCT03137992|7658181|FG000|STARTED|Washout Period 1||62
6728386|NCT03137992|7658182|FG001|STARTED|Washout Period 1||63
6728387|NCT03137992|7658183|FG002|STARTED|Washout Period 1||63
6728388|NCT03137992|7658184|FG003|STARTED|Washout Period 1||63
6728389|NCT03137992|7658185|FG004|STARTED|Washout Period 1||62
6728390|NCT03137992|7658186|FG005|STARTED|Washout Period 1||61
6728391|NCT03137992|7658181|FG000|COMPLETED|Washout Period 1||59
6728392|NCT03137992|7658182|FG001|COMPLETED|Washout Period 1||59
6728393|NCT03137992|7658183|FG002|COMPLETED|Washout Period 1||61
6728394|NCT03137992|7658184|FG003|COMPLETED|Washout Period 1||63
6728395|NCT03137992|7658185|FG004|COMPLETED|Washout Period 1||60
6728396|NCT03137992|7658186|FG005|COMPLETED|Washout Period 1||59
6728397|NCT03137992|7658181|FG000|NOT COMPLETED|Washout Period 1||3
6265705|NCT00029107|7164839|FG001|STARTED|Overall Study||12
6265706|NCT00029107|7164838|FG000|COMPLETED|Overall Study||12
6265707|NCT00029107|7164839|FG001|COMPLETED|Overall Study||12
6265708|NCT00029107|7164838|FG000|NOT COMPLETED|Overall Study||0
6265709|NCT00029107|7164839|FG001|NOT COMPLETED|Overall Study||0
6265710|NCT00029146|7164847|FG000|STARTED|Overall Study||97
6265711|NCT00029146|7164848|FG001|STARTED|Overall Study||98
6265712|NCT00029146|7164847|FG000|COMPLETED|Overall Study||95
6265713|NCT00029146|7164848|FG001|COMPLETED|Overall Study||97
6728398|NCT03137992|7658182|FG001|NOT COMPLETED|Washout Period 1||4
6728399|NCT03137992|7658183|FG002|NOT COMPLETED|Washout Period 1||2
6728400|NCT03137992|7658184|FG003|NOT COMPLETED|Washout Period 1||0
6728401|NCT03137992|7658185|FG004|NOT COMPLETED|Washout Period 1||2
6728402|NCT03137992|7658186|FG005|NOT COMPLETED|Washout Period 1||2
6728403|NCT03137992|7658181|FG000|STARTED|Period 2 (Visit 3)||59
6728404|NCT03137992|7658182|FG001|STARTED|Period 2 (Visit 3)||59
6728405|NCT03137992|7658183|FG002|STARTED|Period 2 (Visit 3)||61
6728406|NCT03137992|7658184|FG003|STARTED|Period 2 (Visit 3)||63
6728407|NCT03137992|7658185|FG004|STARTED|Period 2 (Visit 3)||60
6728408|NCT03137992|7658186|FG005|STARTED|Period 2 (Visit 3)||59
6265714|NCT00029146|7164847|FG000|NOT COMPLETED|Overall Study||2
6265715|NCT00029146|7164848|FG001|NOT COMPLETED|Overall Study||1
6265716|NCT00029172|7164854|FG000|STARTED|Overall Study||188
6728409|NCT03137992|7658181|FG000|COMPLETED|Period 2 (Visit 3)||56
6728410|NCT03137992|7658182|FG001|COMPLETED|Period 2 (Visit 3)||52
6728411|NCT03137992|7658183|FG002|COMPLETED|Period 2 (Visit 3)||58
6728412|NCT03137992|7658184|FG003|COMPLETED|Period 2 (Visit 3)||58
6728413|NCT03137992|7658185|FG004|COMPLETED|Period 2 (Visit 3)||56
6728414|NCT03137992|7658186|FG005|COMPLETED|Period 2 (Visit 3)||51
6728415|NCT03137992|7658181|FG000|NOT COMPLETED|Period 2 (Visit 3)||3
6728416|NCT03137992|7658182|FG001|NOT COMPLETED|Period 2 (Visit 3)||7
6728417|NCT03137992|7658183|FG002|NOT COMPLETED|Period 2 (Visit 3)||3
6728418|NCT03137992|7658184|FG003|NOT COMPLETED|Period 2 (Visit 3)||5
6728419|NCT03137992|7658185|FG004|NOT COMPLETED|Period 2 (Visit 3)||4
6728420|NCT03137992|7658186|FG005|NOT COMPLETED|Period 2 (Visit 3)||8
6728421|NCT03137992|7658181|FG000|STARTED|Washout Period 2||56
6728422|NCT03137992|7658182|FG001|STARTED|Washout Period 2||52
6728423|NCT03137992|7658183|FG002|STARTED|Washout Period 2||58
6728424|NCT03137992|7658184|FG003|STARTED|Washout Period 2||58
6728425|NCT03137992|7658185|FG004|STARTED|Washout Period 2||56
6728426|NCT03137992|7658186|FG005|STARTED|Washout Period 2||51
6728427|NCT03137992|7658181|FG000|COMPLETED|Washout Period 2||54
6728428|NCT03137992|7658182|FG001|COMPLETED|Washout Period 2||50
6728429|NCT03137992|7658183|FG002|COMPLETED|Washout Period 2||58
6728430|NCT03137992|7658184|FG003|COMPLETED|Washout Period 2||57
6728431|NCT03137992|7658185|FG004|COMPLETED|Washout Period 2||53
6728432|NCT03137992|7658186|FG005|COMPLETED|Washout Period 2||50
6728433|NCT03137992|7658181|FG000|NOT COMPLETED|Washout Period 2||2
6728434|NCT03137992|7658182|FG001|NOT COMPLETED|Washout Period 2||2
6728435|NCT03137992|7658183|FG002|NOT COMPLETED|Washout Period 2||0
6728436|NCT03137992|7658184|FG003|NOT COMPLETED|Washout Period 2||1
6728437|NCT03137992|7658185|FG004|NOT COMPLETED|Washout Period 2||3
6728438|NCT03137992|7658186|FG005|NOT COMPLETED|Washout Period 2||1
6728439|NCT03137992|7658181|FG000|STARTED|Period 3 (Visit 04)||54
6728440|NCT03137992|7658182|FG001|STARTED|Period 3 (Visit 04)||50
6728441|NCT03137992|7658183|FG002|STARTED|Period 3 (Visit 04)||58
6728442|NCT03137992|7658184|FG003|STARTED|Period 3 (Visit 04)||57
6728443|NCT03137992|7658185|FG004|STARTED|Period 3 (Visit 04)||53
6728444|NCT03137992|7658186|FG005|STARTED|Period 3 (Visit 04)||50
6728445|NCT03137992|7658181|FG000|COMPLETED|Period 3 (Visit 04)||48
6728446|NCT03137992|7658182|FG001|COMPLETED|Period 3 (Visit 04)||48
6265717|NCT00029172|7164854|FG000|COMPLETED|Overall Study||182
6265718|NCT00029172|7164854|FG000|NOT COMPLETED|Overall Study||6
6265719|NCT00029536|7164862|FG000|STARTED|Overall Study||85
6265720|NCT00029536|7164863|FG001|STARTED|Overall Study||45
6265721|NCT00029536|7164864|FG002|STARTED|Overall Study||105
6265722|NCT00029536|7164865|FG003|STARTED|Overall Study||59
6265723|NCT00029536|7164862|FG000|COMPLETED|Overall Study||85
6265724|NCT00029536|7164863|FG001|COMPLETED|Overall Study||45
6265725|NCT00029536|7164864|FG002|COMPLETED|Overall Study||105
6728447|NCT03137992|7658183|FG002|COMPLETED|Period 3 (Visit 04)||55
6728448|NCT03137992|7658184|FG003|COMPLETED|Period 3 (Visit 04)||57
6728449|NCT03137992|7658185|FG004|COMPLETED|Period 3 (Visit 04)||50
6728450|NCT03137992|7658186|FG005|COMPLETED|Period 3 (Visit 04)||47
6728451|NCT03137992|7658181|FG000|NOT COMPLETED|Period 3 (Visit 04)||6
6728452|NCT03137992|7658182|FG001|NOT COMPLETED|Period 3 (Visit 04)||2
6728453|NCT03137992|7658183|FG002|NOT COMPLETED|Period 3 (Visit 04)||3
6728454|NCT03137992|7658184|FG003|NOT COMPLETED|Period 3 (Visit 04)||0
6728455|NCT03137992|7658185|FG004|NOT COMPLETED|Period 3 (Visit 04)||3
6728456|NCT03137992|7658186|FG005|NOT COMPLETED|Period 3 (Visit 04)||3
6728457|NCT03137992|7658181|FG000|STARTED|Part 2 (Open-label Extension)||22
6728458|NCT03137992|7658182|FG001|STARTED|Part 2 (Open-label Extension)||17
6728459|NCT03137992|7658183|FG002|STARTED|Part 2 (Open-label Extension)||21
6728460|NCT03137992|7658184|FG003|STARTED|Part 2 (Open-label Extension)||25
6728461|NCT03137992|7658185|FG004|STARTED|Part 2 (Open-label Extension)||18
6728462|NCT03137992|7658186|FG005|STARTED|Part 2 (Open-label Extension)||22
6728463|NCT03137992|7658181|FG000|COMPLETED|Part 2 (Open-label Extension)||20
6728464|NCT03137992|7658182|FG001|COMPLETED|Part 2 (Open-label Extension)||17
6728465|NCT03137992|7658183|FG002|COMPLETED|Part 2 (Open-label Extension)||20
6728466|NCT03137992|7658184|FG003|COMPLETED|Part 2 (Open-label Extension)||24
6728467|NCT03137992|7658185|FG004|COMPLETED|Part 2 (Open-label Extension)||18
6728468|NCT03137992|7658186|FG005|COMPLETED|Part 2 (Open-label Extension)||21
6728469|NCT03137992|7658181|FG000|NOT COMPLETED|Part 2 (Open-label Extension)||2
6728470|NCT03137992|7658182|FG001|NOT COMPLETED|Part 2 (Open-label Extension)||0
6728471|NCT03137992|7658183|FG002|NOT COMPLETED|Part 2 (Open-label Extension)||1
6728472|NCT03137992|7658184|FG003|NOT COMPLETED|Part 2 (Open-label Extension)||1
6728473|NCT03137992|7658185|FG004|NOT COMPLETED|Part 2 (Open-label Extension)||0
6728474|NCT03137992|7658186|FG005|NOT COMPLETED|Part 2 (Open-label Extension)||1
6728475|NCT03138330|7658194|FG000|STARTED|Overall Study||95
6728476|NCT03138330|7658194|FG000|COMPLETED|Overall Study||91
6728477|NCT03138330|7658194|FG000|NOT COMPLETED|Overall Study||4
6739795|NCT03295318|7668653|FG001|Received First Vaccination|Overall Study||150
6739796|NCT03295318|7668654|FG002|Received First Vaccination|Overall Study||76
6739797|NCT03295318|7668652|FG000|Received Second Vaccination|Overall Study||144
6739798|NCT03295318|7668653|FG001|Received Second Vaccination|Overall Study||145
6739799|NCT03295318|7668654|FG002|Received Second Vaccination|Overall Study||73
6739800|NCT03295318|7668652|FG000|COMPLETED|Overall Study||144
6739801|NCT03295318|7668653|FG001|COMPLETED|Overall Study||145
6739802|NCT03295318|7668654|FG002|COMPLETED|Overall Study||71
6739803|NCT03295318|7668652|FG000|NOT COMPLETED|Overall Study||6
6739804|NCT03295318|7668653|FG001|NOT COMPLETED|Overall Study||5
6739805|NCT03295318|7668654|FG002|NOT COMPLETED|Overall Study||5
6739806|NCT03295630|7668680|FG000|STARTED|Overall Study||20
6739807|NCT03295630|7668680|FG000|COMPLETED|Overall Study||20
6739808|NCT03295630|7668680|FG000|NOT COMPLETED|Overall Study||0
6739809|NCT03295721|7668688|FG000|STARTED|Overall Study||157
6739810|NCT03295721|7668689|FG001|STARTED|Overall Study||100
6739811|NCT03295721|7668690|FG002|STARTED|Overall Study||155
6739812|NCT03295721|7668688|FG000|COMPLETED|Overall Study||154
6739813|NCT03295721|7668689|FG001|COMPLETED|Overall Study||99
6739814|NCT03295721|7668690|FG002|COMPLETED|Overall Study||152
6739815|NCT03295721|7668688|FG000|NOT COMPLETED|Overall Study||3
6739816|NCT03295721|7668689|FG001|NOT COMPLETED|Overall Study||1
6739817|NCT03295721|7668690|FG002|NOT COMPLETED|Overall Study||3
6739818|NCT03296072|7668699|FG000|STARTED|Treatment Period 1||10
6739819|NCT03296072|7668700|FG001|STARTED|Treatment Period 1||11
6739820|NCT03296072|7668701|FG002|STARTED|Treatment Period 1||10
6739821|NCT03296072|7668702|FG003|STARTED|Treatment Period 1||10
6739822|NCT03296072|7668703|FG004|STARTED|Treatment Period 1||10
6739823|NCT03296072|7668704|FG005|STARTED|Treatment Period 1||11
6739824|NCT03296072|7668699|FG000|COMPLETED|Treatment Period 1||10
6739825|NCT03296072|7668700|FG001|COMPLETED|Treatment Period 1||11
6739826|NCT03296072|7668701|FG002|COMPLETED|Treatment Period 1||10
6739827|NCT03296072|7668702|FG003|COMPLETED|Treatment Period 1||10
6739828|NCT03296072|7668703|FG004|COMPLETED|Treatment Period 1||10
6739829|NCT03296072|7668704|FG005|COMPLETED|Treatment Period 1||11
6739830|NCT03296072|7668699|FG000|NOT COMPLETED|Treatment Period 1||0
6739831|NCT03296072|7668700|FG001|NOT COMPLETED|Treatment Period 1||0
6739832|NCT03296072|7668701|FG002|NOT COMPLETED|Treatment Period 1||0
6739833|NCT03296072|7668702|FG003|NOT COMPLETED|Treatment Period 1||0
6739834|NCT03296072|7668703|FG004|NOT COMPLETED|Treatment Period 1||0
6739835|NCT03296072|7668704|FG005|NOT COMPLETED|Treatment Period 1||0
6739836|NCT03296072|7668699|FG000|STARTED|Treament Period 1: Wash Out Period||10
6739837|NCT03296072|7668700|FG001|STARTED|Treament Period 1: Wash Out Period||11
6739838|NCT03296072|7668701|FG002|STARTED|Treament Period 1: Wash Out Period||10
6739839|NCT03296072|7668702|FG003|STARTED|Treament Period 1: Wash Out Period||10
6739840|NCT03296072|7668703|FG004|STARTED|Treament Period 1: Wash Out Period||10
6739841|NCT03296072|7668704|FG005|STARTED|Treament Period 1: Wash Out Period||11
6739842|NCT03296072|7668699|FG000|COMPLETED|Treament Period 1: Wash Out Period||10
6739843|NCT03296072|7668700|FG001|COMPLETED|Treament Period 1: Wash Out Period||11
6739844|NCT03296072|7668701|FG002|COMPLETED|Treament Period 1: Wash Out Period||10
6728478|NCT03138382|7658200|FG000|STARTED|Overall Study||10
6728479|NCT03138382|7658201|FG001|STARTED|Overall Study||10
6728480|NCT03138382|7658200|FG000|COMPLETED|Overall Study||10
6728481|NCT03138382|7658201|FG001|COMPLETED|Overall Study||10
6728482|NCT03138382|7658200|FG000|NOT COMPLETED|Overall Study||0
6728483|NCT03138382|7658201|FG001|NOT COMPLETED|Overall Study||0
6728484|NCT03138577|7658214|FG000|STARTED|Overall Study||3
6728485|NCT03138577|7658215|FG001|STARTED|Overall Study||3
6728486|NCT03138577|7658216|FG002|STARTED|Overall Study||3
6728487|NCT03138577|7658217|FG003|STARTED|Overall Study||3
6728488|NCT03138577|7658218|FG004|STARTED|Overall Study||3
6728489|NCT03138577|7658219|FG005|STARTED|Overall Study||3
6728490|NCT03138577|7658220|FG006|STARTED|Overall Study||3
6728491|NCT03138577|7658214|FG000|COMPLETED|Overall Study||3
6728492|NCT03138577|7658215|FG001|COMPLETED|Overall Study||3
6728493|NCT03138577|7658216|FG002|COMPLETED|Overall Study||3
6728494|NCT03138577|7658217|FG003|COMPLETED|Overall Study||3
6728495|NCT03138577|7658218|FG004|COMPLETED|Overall Study||3
6728496|NCT03138577|7658219|FG005|COMPLETED|Overall Study||3
6728497|NCT03138577|7658220|FG006|COMPLETED|Overall Study||3
6728498|NCT03138577|7658214|FG000|NOT COMPLETED|Overall Study||0
6728499|NCT03138577|7658215|FG001|NOT COMPLETED|Overall Study||0
6728500|NCT03138577|7658216|FG002|NOT COMPLETED|Overall Study||0
6728501|NCT03138577|7658217|FG003|NOT COMPLETED|Overall Study||0
6728502|NCT03138577|7658218|FG004|NOT COMPLETED|Overall Study||0
6728503|NCT03138577|7658219|FG005|NOT COMPLETED|Overall Study||0
6728504|NCT03138577|7658220|FG006|NOT COMPLETED|Overall Study||0
6728505|NCT03138655|7658246|FG000|STARTED|Overall Study||10
6728506|NCT03138655|7658247|FG001|STARTED|Overall Study||9
6728507|NCT03138655|7658248|FG002|STARTED|Overall Study||11
6728508|NCT03138655|7658249|FG003|STARTED|Overall Study||10
6728509|NCT03138655|7658250|FG004|STARTED|Overall Study||13
6728510|NCT03138655|7658251|FG005|STARTED|Overall Study||12
6728511|NCT03138655|7658252|FG006|STARTED|Overall Study||12
6728512|NCT03138655|7658253|FG007|STARTED|Overall Study||12
6728513|NCT03138655|7658246|FG000|COMPLETED|Overall Study||7
6728514|NCT03138655|7658247|FG001|COMPLETED|Overall Study||7
6728515|NCT03138655|7658248|FG002|COMPLETED|Overall Study||9
6728516|NCT03138655|7658249|FG003|COMPLETED|Overall Study||7
6728517|NCT03138655|7658250|FG004|COMPLETED|Overall Study||11
6728518|NCT03138655|7658251|FG005|COMPLETED|Overall Study||7
6728519|NCT03138655|7658252|FG006|COMPLETED|Overall Study||9
6728520|NCT03138655|7658253|FG007|COMPLETED|Overall Study||10
6728521|NCT03138655|7658246|FG000|NOT COMPLETED|Overall Study||3
6728522|NCT03138655|7658247|FG001|NOT COMPLETED|Overall Study||2
6728523|NCT03138655|7658248|FG002|NOT COMPLETED|Overall Study||2
6728524|NCT03138655|7658249|FG003|NOT COMPLETED|Overall Study||3
6728525|NCT03138655|7658250|FG004|NOT COMPLETED|Overall Study||2
6728526|NCT03138655|7658251|FG005|NOT COMPLETED|Overall Study||5
6728527|NCT03138655|7658252|FG006|NOT COMPLETED|Overall Study||3
6728528|NCT03138655|7658253|FG007|NOT COMPLETED|Overall Study||2
6728529|NCT03138798|7658277|FG000|STARTED|Overall Study||173
6728530|NCT03138798|7658278|FG001|STARTED|Overall Study||175
6728531|NCT03138798|7658277|FG000|Randomized But Did Not Meet Eligibility|Overall Study||6
6728532|NCT03138798|7658278|FG001|Randomized But Did Not Meet Eligibility|Overall Study||4
6265726|NCT00029536|7164865|FG003|COMPLETED|Overall Study||59
6265727|NCT00029536|7164862|FG000|NOT COMPLETED|Overall Study||0
6265728|NCT00029536|7164863|FG001|NOT COMPLETED|Overall Study||0
6265729|NCT00029536|7164864|FG002|NOT COMPLETED|Overall Study||0
6265730|NCT00029536|7164865|FG003|NOT COMPLETED|Overall Study||0
6265731|NCT00030147|7164881|FG000|STARTED|Overall Study||17
6265732|NCT00030147|7164882|FG001|STARTED|Overall Study||19
6265733|NCT00030147|7164883|FG002|STARTED|Overall Study||16
6265734|NCT00030147|7164884|FG003|STARTED|Overall Study||11
6265735|NCT00030147|7164881|FG000|COMPLETED|Overall Study||17
6265736|NCT00030147|7164882|FG001|COMPLETED|Overall Study||18
6265737|NCT00030147|7164883|FG002|COMPLETED|Overall Study||16
6265738|NCT00030147|7164884|FG003|COMPLETED|Overall Study||11
6265739|NCT00030147|7164881|FG000|NOT COMPLETED|Overall Study||0
6265740|NCT00030147|7164882|FG001|NOT COMPLETED|Overall Study||1
6265741|NCT00030147|7164883|FG002|NOT COMPLETED|Overall Study||0
6265742|NCT00030147|7164884|FG003|NOT COMPLETED|Overall Study||0
6265743|NCT00030264|7164894|FG000|STARTED|Overall Study||23
6265744|NCT00030264|7164894|FG000|COMPLETED|Overall Study||23
6265745|NCT00030264|7164894|FG000|NOT COMPLETED|Overall Study||0
6265746|NCT00030823|7164898|FG000|STARTED|Overall Study||14
6265747|NCT00030823|7164898|FG000|COMPLETED|Overall Study||13
6265748|NCT00030823|7164898|FG000|NOT COMPLETED|Overall Study||1
6265749|NCT00030901|7164904|FG000|STARTED|Initial Registration||619
6265750|NCT00030901|7164905|FG001|STARTED|Initial Registration||0
6265751|NCT00030901|7164906|FG002|STARTED|Initial Registration||0
6265752|NCT00030901|7164904|FG000|COMPLETED|Initial Registration||452
6728533|NCT03138798|7658277|FG000|COMPLETED|Overall Study||167
6728534|NCT03138798|7658278|FG001|COMPLETED|Overall Study||171
6728535|NCT03138798|7658277|FG000|NOT COMPLETED|Overall Study||6
6728536|NCT03138798|7658278|FG001|NOT COMPLETED|Overall Study||4
6728537|NCT03138876|7658285|FG000|STARTED|Overall Study||20
6728538|NCT03138876|7658285|FG000|COMPLETED|Overall Study||20
6728539|NCT03138876|7658285|FG000|NOT COMPLETED|Overall Study||0
6728540|NCT03138967|7658291|FG000|STARTED|Overall Study||26
6728541|NCT03138967|7658292|FG001|STARTED|Overall Study||28
6728542|NCT03138967|7658291|FG000|Post-operative Day(POD) 1 Follow-up|Overall Study||25
6728543|NCT03138967|7658292|FG001|Post-operative Day(POD) 1 Follow-up|Overall Study||25
6728544|NCT03138967|7658291|FG000|Post-operative Day(POD) 7 Follow-up|Overall Study||25
6728545|NCT03138967|7658292|FG001|Post-operative Day(POD) 7 Follow-up|Overall Study||24
6728546|NCT03138967|7658291|FG000|COMPLETED|Overall Study||25
6728547|NCT03138967|7658292|FG001|COMPLETED|Overall Study||24
6728548|NCT03138967|7658291|FG000|NOT COMPLETED|Overall Study||1
6728549|NCT03138967|7658292|FG001|NOT COMPLETED|Overall Study||4
6728550|NCT03139032|7658298|FG000|STARTED|Overall Study||1
6728551|NCT03139032|7658298|FG000|COMPLETED|Overall Study||1
6728552|NCT03139032|7658298|FG000|NOT COMPLETED|Overall Study||0
6728553|NCT03139240|7658307|FG000|STARTED|Overall Study||48
6728554|NCT03139240|7658308|FG001|STARTED|Overall Study||48
6728555|NCT03139240|7658309|FG002|STARTED|Overall Study||38
6728556|NCT03139240|7658310|FG003|STARTED|Overall Study||38
6728557|NCT03139240|7658307|FG000|COMPLETED|Overall Study||48
6728558|NCT03139240|7658308|FG001|COMPLETED|Overall Study||47
6728559|NCT03139240|7658309|FG002|COMPLETED|Overall Study||37
6728560|NCT03139240|7658310|FG003|COMPLETED|Overall Study||38
6728561|NCT03139240|7658307|FG000|NOT COMPLETED|Overall Study||0
6728562|NCT03139240|7658308|FG001|NOT COMPLETED|Overall Study||1
6728563|NCT03139240|7658309|FG002|NOT COMPLETED|Overall Study||1
6728564|NCT03139240|7658310|FG003|NOT COMPLETED|Overall Study||0
6728565|NCT03139279|7658320|FG000|STARTED|Overall Study||58
6728566|NCT03139279|7658321|FG001|STARTED|Overall Study||56
6728567|NCT03139279|7658320|FG000|COMPLETED|Overall Study||51
6728568|NCT03139279|7658321|FG001|COMPLETED|Overall Study||50
6728569|NCT03139279|7658320|FG000|NOT COMPLETED|Overall Study||7
6728570|NCT03139279|7658321|FG001|NOT COMPLETED|Overall Study||6
6728571|NCT03139448|7658329|FG000|STARTED|Overall Study||85
6728572|NCT03139448|7658330|FG001|STARTED|Overall Study||89
6728573|NCT03139448|7658329|FG000|Intervention Started|Overall Study||79
6728574|NCT03139448|7658330|FG001|Intervention Started|Overall Study||70
6728575|NCT03139448|7658329|FG000|COMPLETED|Overall Study||73
6728576|NCT03139448|7658330|FG001|COMPLETED|Overall Study||63
6728577|NCT03139448|7658329|FG000|NOT COMPLETED|Overall Study||12
6265753|NCT00030901|7164905|FG001|COMPLETED|Initial Registration||0
6265754|NCT00030901|7164906|FG002|COMPLETED|Initial Registration||0
6265755|NCT00030901|7164904|FG000|NOT COMPLETED|Initial Registration||167
6265756|NCT00030901|7164905|FG001|NOT COMPLETED|Initial Registration||0
6265757|NCT00030901|7164906|FG002|NOT COMPLETED|Initial Registration||0
6265758|NCT00030901|7164904|FG000|STARTED|Randomization||0
6265759|NCT00030901|7164905|FG001|STARTED|Randomization||227
6265760|NCT00030901|7164906|FG002|STARTED|Randomization||225
6265761|NCT00030901|7164904|FG000|Eligible|Randomization||0
6265762|NCT00030901|7164905|FG001|Eligible|Randomization||212
6265763|NCT00030901|7164906|FG002|Eligible|Randomization||211
6265764|NCT00030901|7164904|FG000|COMPLETED|Randomization||0
6265765|NCT00030901|7164905|FG001|COMPLETED|Randomization||126
6265766|NCT00030901|7164906|FG002|COMPLETED|Randomization||137
6728578|NCT03139448|7658330|FG001|NOT COMPLETED|Overall Study||26
6728579|NCT03139552|7658336|FG000|STARTED|Overall Study||150
6728580|NCT03139552|7658336|FG000|COMPLETED|Overall Study||147
6728581|NCT03139552|7658336|FG000|NOT COMPLETED|Overall Study||3
6728582|NCT03139578|7658347|FG000|STARTED|Period 1||12
6728583|NCT03139578|7658348|FG001|STARTED|Period 1||13
6728584|NCT03139578|7658349|FG002|STARTED|Period 1||12
6728585|NCT03139578|7658350|FG003|STARTED|Period 1||13
6728586|NCT03139578|7658347|FG000|Discontinued|Period 1||0
6728587|NCT03139578|7658348|FG001|Discontinued|Period 1||0
6728588|NCT03139578|7658349|FG002|Discontinued|Period 1||0
6265767|NCT00030901|7164904|FG000|NOT COMPLETED|Randomization||0
6265768|NCT00030901|7164905|FG001|NOT COMPLETED|Randomization||101
6728589|NCT03139578|7658350|FG003|Discontinued|Period 1||0
6728590|NCT03139578|7658347|FG000|COMPLETED|Period 1||12
6728591|NCT03139578|7658348|FG001|COMPLETED|Period 1||13
6728592|NCT03139578|7658349|FG002|COMPLETED|Period 1||12
6728593|NCT03139578|7658350|FG003|COMPLETED|Period 1||13
6728594|NCT03139578|7658347|FG000|NOT COMPLETED|Period 1||0
6728595|NCT03139578|7658348|FG001|NOT COMPLETED|Period 1||0
6728596|NCT03139578|7658349|FG002|NOT COMPLETED|Period 1||0
6728597|NCT03139578|7658350|FG003|NOT COMPLETED|Period 1||0
6728598|NCT03139578|7658347|FG000|STARTED|Period 2||12
6728599|NCT03139578|7658348|FG001|STARTED|Period 2||13
6728600|NCT03139578|7658349|FG002|STARTED|Period 2||12
6728601|NCT03139578|7658350|FG003|STARTED|Period 2||13
6728602|NCT03139578|7658347|FG000|Discontinued|Period 2||0
6728603|NCT03139578|7658348|FG001|Discontinued|Period 2||0
6728604|NCT03139578|7658349|FG002|Discontinued|Period 2||0
6728605|NCT03139578|7658350|FG003|Discontinued|Period 2||0
6728606|NCT03139578|7658347|FG000|COMPLETED|Period 2||12
6728607|NCT03139578|7658348|FG001|COMPLETED|Period 2||13
6728608|NCT03139578|7658349|FG002|COMPLETED|Period 2||12
6728609|NCT03139578|7658350|FG003|COMPLETED|Period 2||13
6728610|NCT03139578|7658347|FG000|NOT COMPLETED|Period 2||0
6728611|NCT03139578|7658348|FG001|NOT COMPLETED|Period 2||0
6728612|NCT03139578|7658349|FG002|NOT COMPLETED|Period 2||0
6728613|NCT03139578|7658350|FG003|NOT COMPLETED|Period 2||0
6728614|NCT03139604|7658362|FG000|STARTED|Overall Study||219
6728615|NCT03139604|7658363|FG001|STARTED|Overall Study||220
6728616|NCT03139604|7658362|FG000|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
6728617|NCT03139604|7658363|FG001|COMPLETED|Overall Study|Participants were considered to have completed the study if they dies or discontinued study treatment for any reason|0
6728618|NCT03139604|7658362|FG000|NOT COMPLETED|Overall Study||219
6728619|NCT03139604|7658363|FG001|NOT COMPLETED|Overall Study||220
6728620|NCT03140254|7658370|FG000|STARTED|Overall Study||145
6728621|NCT03140254|7658370|FG000|Treatment IP - Groin|Overall Study||51
6728622|NCT03140254|7658370|FG000|Treatment IP - Abdomen|Overall Study||48
6728623|NCT03140254|7658370|FG000|Treatment AC - Groin|Overall Study||51
6728624|NCT03140254|7658370|FG000|Treatment AC - Abdomen|Overall Study||48
6728625|NCT03140254|7658370|FG000|Treatment VC - Groin|Overall Study||18
6728626|NCT03140254|7658370|FG000|Treatment VC - Abdomen|Overall Study||19
6728627|NCT03140254|7658370|FG000|COMPLETED|Overall Study||144
6728628|NCT03140254|7658370|FG000|NOT COMPLETED|Overall Study||1
6728629|NCT03140631|7658378|FG000|STARTED|Overall Study||73
6728630|NCT03140631|7658379|FG001|STARTED|Overall Study||77
6728631|NCT03140631|7658378|FG000|COMPLETED|Overall Study||73
6728632|NCT03140631|7658379|FG001|COMPLETED|Overall Study||77
6728633|NCT03140631|7658378|FG000|NOT COMPLETED|Overall Study||0
6728634|NCT03140631|7658379|FG001|NOT COMPLETED|Overall Study||0
6728635|NCT03140722|7658388|FG000|STARTED|Overall Study||0
6728636|NCT03140722|7658389|FG001|STARTED|Overall Study||2
6728637|NCT03140722|7658388|FG000|COMPLETED|Overall Study||0
6728638|NCT03140722|7658389|FG001|COMPLETED|Overall Study||2
6728639|NCT03140722|7658388|FG000|NOT COMPLETED|Overall Study||0
6728640|NCT03140722|7658389|FG001|NOT COMPLETED|Overall Study||0
6728641|NCT03141086|7658397|FG000|STARTED|Overall Study||7
6728642|NCT03141086|7658398|FG001|STARTED|Overall Study||17
6728643|NCT03141086|7658397|FG000|COMPLETED|Overall Study||6
6728644|NCT03141086|7658398|FG001|COMPLETED|Overall Study||12
6728645|NCT03141086|7658397|FG000|NOT COMPLETED|Overall Study||1
6728646|NCT03141086|7658398|FG001|NOT COMPLETED|Overall Study||5
6728647|NCT03141151|7658406|FG000|STARTED|Overall Study||59
6728648|NCT03141151|7658407|FG001|STARTED|Overall Study||58
6728649|NCT03141151|7658406|FG000|COMPLETED|Overall Study||53
6728650|NCT03141151|7658407|FG001|COMPLETED|Overall Study||54
6728651|NCT03141151|7658406|FG000|NOT COMPLETED|Overall Study||6
6728652|NCT03141151|7658407|FG001|NOT COMPLETED|Overall Study||4
6728653|NCT03141242|7658415|FG000|STARTED|Overall Study||55
6728654|NCT03141242|7658416|FG001|STARTED|Overall Study||55
6728655|NCT03141242|7658415|FG000|Received Allocated Intervenion|Overall Study|11 subjects didn't attend their scheduled group session; all were included in ITT analysis|44
6728656|NCT03141242|7658416|FG001|Received Allocated Intervenion|Overall Study||55
6728657|NCT03141242|7658415|FG000|6 Month Interview|Overall Study||51
6728658|NCT03141242|7658416|FG001|6 Month Interview|Overall Study||49
6728659|NCT03141242|7658415|FG000|COMPLETED|Overall Study||55
6728660|NCT03141242|7658416|FG001|COMPLETED|Overall Study||55
6728661|NCT03141242|7658415|FG000|NOT COMPLETED|Overall Study||0
6728662|NCT03141242|7658416|FG001|NOT COMPLETED|Overall Study||0
6728663|NCT03141281|7658427|FG000|STARTED|Overall Study||57
6728664|NCT03141281|7658428|FG001|STARTED|Overall Study||59
6728665|NCT03141281|7658429|FG002|STARTED|Overall Study||56
6728666|NCT03141281|7658430|FG003|STARTED|Overall Study||58
6728667|NCT03141281|7658427|FG000|Post-Test|Overall Study||50
6728668|NCT03141281|7658428|FG001|Post-Test|Overall Study||47
6728669|NCT03141281|7658429|FG002|Post-Test|Overall Study||50
6728670|NCT03141281|7658430|FG003|Post-Test|Overall Study||56
6728671|NCT03141281|7658427|FG000|COMPLETED|Overall Study||45
6728672|NCT03141281|7658428|FG001|COMPLETED|Overall Study||38
6728673|NCT03141281|7658429|FG002|COMPLETED|Overall Study||42
6728674|NCT03141281|7658430|FG003|COMPLETED|Overall Study||47
6728675|NCT03141281|7658427|FG000|NOT COMPLETED|Overall Study||12
6728676|NCT03141281|7658428|FG001|NOT COMPLETED|Overall Study||21
6728677|NCT03141281|7658429|FG002|NOT COMPLETED|Overall Study||14
6728678|NCT03141281|7658430|FG003|NOT COMPLETED|Overall Study||11
6728679|NCT03141307|7658442|FG000|STARTED|In-Hospital||471
6728680|NCT03141307|7658443|FG001|STARTED|In-Hospital||240
6728681|NCT03141307|7658442|FG000|COMPLETED|In-Hospital||467
6728682|NCT03141307|7658443|FG001|COMPLETED|In-Hospital||238
6728683|NCT03141307|7658442|FG000|NOT COMPLETED|In-Hospital||4
6728684|NCT03141307|7658443|FG001|NOT COMPLETED|In-Hospital||2
6728685|NCT03141307|7658442|FG000|STARTED|Follow-Up||467
6728686|NCT03141307|7658443|FG001|STARTED|Follow-Up||238
6728687|NCT03141307|7658442|FG000|COMPLETED|Follow-Up||370
6728688|NCT03141307|7658443|FG001|COMPLETED|Follow-Up||184
6728689|NCT03141307|7658442|FG000|NOT COMPLETED|Follow-Up||97
6728690|NCT03141307|7658443|FG001|NOT COMPLETED|Follow-Up||54
6728691|NCT03141372|7658451|FG000|STARTED|Overall Study||42
6728692|NCT03141372|7658452|FG001|STARTED|Overall Study||42
6728693|NCT03141372|7658451|FG000|COMPLETED|Overall Study||42
6728694|NCT03141372|7658452|FG001|COMPLETED|Overall Study||40
6728695|NCT03141372|7658451|FG000|NOT COMPLETED|Overall Study||0
6728696|NCT03141372|7658452|FG001|NOT COMPLETED|Overall Study||2
6728697|NCT03141528|7658462|FG000|STARTED|Overall Study||122
6728698|NCT03141528|7658463|FG001|STARTED|Overall Study||118
6728699|NCT03141528|7658462|FG000|COMPLETED|Overall Study||75
6728700|NCT03141528|7658463|FG001|COMPLETED|Overall Study||77
6728701|NCT03141528|7658462|FG000|NOT COMPLETED|Overall Study||47
6728702|NCT03141528|7658463|FG001|NOT COMPLETED|Overall Study||41
6728703|NCT03141788|7658469|FG000|STARTED|Overall Study||52
6728704|NCT03141788|7658469|FG000|COMPLETED|Overall Study||44
6728705|NCT03141788|7658469|FG000|NOT COMPLETED|Overall Study||8
6728706|NCT03141905|7658478|FG000|STARTED|Overall Study||176
6728707|NCT03141905|7658479|FG001|STARTED|Overall Study||166
6728708|NCT03141905|7658478|FG000|COMPLETED|Overall Study||152
6728709|NCT03141905|7658479|FG001|COMPLETED|Overall Study||147
6728710|NCT03141905|7658478|FG000|NOT COMPLETED|Overall Study||24
6728711|NCT03141905|7658479|FG001|NOT COMPLETED|Overall Study||19
6728712|NCT03141931|7658488|FG000|STARTED|Overall Study||61
6728713|NCT03141931|7658489|FG001|STARTED|Overall Study||58
6728714|NCT03141931|7658488|FG000|COMPLETED|Overall Study||49
6728715|NCT03141931|7658489|FG001|COMPLETED|Overall Study||52
6728716|NCT03141931|7658488|FG000|NOT COMPLETED|Overall Study||12
6728717|NCT03141931|7658489|FG001|NOT COMPLETED|Overall Study||6
6728718|NCT03142438|7658495|FG000|STARTED|Overall Study||57
6728719|NCT03142438|7658495|FG000|COMPLETED|Overall Study||57
6728720|NCT03142438|7658495|FG000|NOT COMPLETED|Overall Study||0
6728721|NCT03142451|7658501|FG000|STARTED|Overall Study||495
6728722|NCT03142451|7658502|FG001|STARTED|Overall Study||256
6728723|NCT03142451|7658501|FG000|COMPLETED|Overall Study||437
6728724|NCT03142451|7658502|FG001|COMPLETED|Overall Study||232
6728725|NCT03142451|7658501|FG000|NOT COMPLETED|Overall Study||58
6728726|NCT03142451|7658502|FG001|NOT COMPLETED|Overall Study||24
6728727|NCT03142750|7658510|FG000|STARTED|Overall Study||14
6728728|NCT03142750|7658511|FG001|STARTED|Overall Study||10
6728729|NCT03142750|7658510|FG000|COMPLETED|Overall Study||10
6728730|NCT03142750|7658511|FG001|COMPLETED|Overall Study||9
6728731|NCT03142750|7658510|FG000|NOT COMPLETED|Overall Study||4
6728732|NCT03142750|7658511|FG001|NOT COMPLETED|Overall Study||1
6728733|NCT03142932|7658523|FG000|STARTED|Overall Study||52
6728734|NCT03142932|7658524|FG001|STARTED|Overall Study||50
6728735|NCT03142932|7658523|FG000|COMPLETED|Overall Study||50
6728736|NCT03142932|7658524|FG001|COMPLETED|Overall Study||39
6728737|NCT03142932|7658523|FG000|NOT COMPLETED|Overall Study||2
6728738|NCT03142932|7658524|FG001|NOT COMPLETED|Overall Study||11
6728739|NCT03143101|7658533|FG000|STARTED|Overall Study||67
6728740|NCT03143101|7658534|FG001|STARTED|Overall Study||66
6728741|NCT03143101|7658535|FG002|STARTED|Overall Study||67
6728742|NCT03143101|7658533|FG000|COMPLETED|Overall Study||65
6728743|NCT03143101|7658534|FG001|COMPLETED|Overall Study||63
6728744|NCT03143101|7658535|FG002|COMPLETED|Overall Study||67
6728745|NCT03143101|7658533|FG000|NOT COMPLETED|Overall Study||2
6728746|NCT03143101|7658534|FG001|NOT COMPLETED|Overall Study||3
6728747|NCT03143101|7658535|FG002|NOT COMPLETED|Overall Study||0
6728748|NCT03143166|7658543|FG000|STARTED|Period 1||36
6728749|NCT03143166|7658543|FG000|COMPLETED|Period 1||36
6728750|NCT03143166|7658543|FG000|NOT COMPLETED|Period 1||0
6728751|NCT03143166|7658543|FG000|STARTED|Period 2 (Washout of at Least 4 Days)||36
6728752|NCT03143166|7658543|FG000|COMPLETED|Period 2 (Washout of at Least 4 Days)||35
6728753|NCT03143166|7658543|FG000|NOT COMPLETED|Period 2 (Washout of at Least 4 Days)||1
6728754|NCT03143569|7658551|FG000|STARTED|Overall Study||10
6728755|NCT03143569|7658552|FG001|STARTED|Overall Study||10
6728756|NCT03143569|7658551|FG000|COMPLETED|Overall Study||10
6728757|NCT03143569|7658552|FG001|COMPLETED|Overall Study||8
6728758|NCT03143569|7658551|FG000|NOT COMPLETED|Overall Study||0
6728759|NCT03143569|7658552|FG001|NOT COMPLETED|Overall Study||2
6728760|NCT03143855|7658562|FG000|STARTED|Overall Study||17
6728761|NCT03143855|7658563|FG001|STARTED|Overall Study||10
6728762|NCT03143855|7658562|FG000|COMPLETED|Overall Study||12
6728763|NCT03143855|7658563|FG001|COMPLETED|Overall Study||6
6728764|NCT03143855|7658562|FG000|NOT COMPLETED|Overall Study||5
6728765|NCT03143855|7658563|FG001|NOT COMPLETED|Overall Study||4
6728766|NCT03143894|7658571|FG000|STARTED|First Intervention (5 Days)||3
6728767|NCT03143894|7658572|FG001|STARTED|First Intervention (5 Days)||4
6728768|NCT03143894|7658571|FG000|COMPLETED|First Intervention (5 Days)||3
6728769|NCT03143894|7658572|FG001|COMPLETED|First Intervention (5 Days)||4
6728770|NCT03143894|7658571|FG000|NOT COMPLETED|First Intervention (5 Days)||0
6728771|NCT03143894|7658572|FG001|NOT COMPLETED|First Intervention (5 Days)||0
6728772|NCT03143894|7658571|FG000|STARTED|Washout (4 Weeks)||3
6728773|NCT03143894|7658572|FG001|STARTED|Washout (4 Weeks)||4
6728774|NCT03143894|7658571|FG000|COMPLETED|Washout (4 Weeks)||3
6728775|NCT03143894|7658572|FG001|COMPLETED|Washout (4 Weeks)||4
6728776|NCT03143894|7658571|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6728777|NCT03143894|7658572|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6728778|NCT03143894|7658571|FG000|STARTED|Second Intervention (5 Days)||3
6728779|NCT03143894|7658572|FG001|STARTED|Second Intervention (5 Days)||4
6728780|NCT03143894|7658571|FG000|COMPLETED|Second Intervention (5 Days)||3
6728781|NCT03143894|7658572|FG001|COMPLETED|Second Intervention (5 Days)||3
6728782|NCT03143894|7658571|FG000|NOT COMPLETED|Second Intervention (5 Days)||0
6728783|NCT03143894|7658572|FG001|NOT COMPLETED|Second Intervention (5 Days)||1
6728784|NCT03144089|7658582|FG000|STARTED|Overall Study||28
6728785|NCT03144089|7658583|FG001|STARTED|Overall Study||28
6728786|NCT03144089|7658582|FG000|COMPLETED|Overall Study||28
6728787|NCT03144089|7658583|FG001|COMPLETED|Overall Study||28
6728788|NCT03144089|7658582|FG000|NOT COMPLETED|Overall Study||0
6728789|NCT03144089|7658583|FG001|NOT COMPLETED|Overall Study||0
6728790|NCT03144180|7658593|FG000|STARTED|Overall Study||16
6728791|NCT03144180|7658594|FG001|STARTED|Overall Study||16
6728792|NCT03144180|7658593|FG000|COMPLETED|Overall Study||14
6728793|NCT03144180|7658594|FG001|COMPLETED|Overall Study||10
6728794|NCT03144180|7658593|FG000|NOT COMPLETED|Overall Study||2
6728795|NCT03144180|7658594|FG001|NOT COMPLETED|Overall Study||6
6728796|NCT03144518|7658604|FG000|STARTED|Primary Outcome (Mood)||52
6728797|NCT03144518|7658605|FG001|STARTED|Primary Outcome (Mood)||51
6728798|NCT03144518|7658604|FG000|COMPLETED|Primary Outcome (Mood)||52
6728799|NCT03144518|7658605|FG001|COMPLETED|Primary Outcome (Mood)||51
6728800|NCT03144518|7658604|FG000|NOT COMPLETED|Primary Outcome (Mood)||0
6728801|NCT03144518|7658605|FG001|NOT COMPLETED|Primary Outcome (Mood)||0
6728802|NCT03144518|7658604|FG000|STARTED|4 Weeks Post-Vaccination||52
6728803|NCT03144518|7658605|FG001|STARTED|4 Weeks Post-Vaccination||51
6728804|NCT03144518|7658604|FG000|COMPLETED|4 Weeks Post-Vaccination||51
6728805|NCT03144518|7658605|FG001|COMPLETED|4 Weeks Post-Vaccination||51
6728806|NCT03144518|7658604|FG000|NOT COMPLETED|4 Weeks Post-Vaccination||1
6728807|NCT03144518|7658605|FG001|NOT COMPLETED|4 Weeks Post-Vaccination||0
6728808|NCT03144518|7658604|FG000|STARTED|16 Week Post-Vaccination||52
6728809|NCT03144518|7658605|FG001|STARTED|16 Week Post-Vaccination||51
6728810|NCT03144518|7658604|FG000|COMPLETED|16 Week Post-Vaccination||49
6728811|NCT03144518|7658605|FG001|COMPLETED|16 Week Post-Vaccination||49
6728812|NCT03144518|7658604|FG000|NOT COMPLETED|16 Week Post-Vaccination||3
6728813|NCT03144518|7658605|FG001|NOT COMPLETED|16 Week Post-Vaccination||2
6728814|NCT03144635|7658612|FG000|STARTED|Overall Study||80
6728815|NCT03144635|7658612|FG000|COMPLETED|Overall Study||0
6728816|NCT03144635|7658612|FG000|NOT COMPLETED|Overall Study||80
6728817|NCT03144687|7658620|FG000|STARTED|Overall Study||13
6728818|NCT03144687|7658621|FG001|STARTED|Overall Study||10
6728819|NCT03144687|7658620|FG000|COMPLETED|Overall Study||0
6728820|NCT03144687|7658621|FG001|COMPLETED|Overall Study||0
6728821|NCT03144687|7658620|FG000|NOT COMPLETED|Overall Study||13
6728822|NCT03144687|7658621|FG001|NOT COMPLETED|Overall Study||10
6728823|NCT03144804|7658631|FG000|STARTED|Overall Study||36
6728824|NCT03144804|7658631|FG000|COMPLETED|Overall Study||32
6728825|NCT03144804|7658631|FG000|NOT COMPLETED|Overall Study||4
6728826|NCT03145064|7658635|FG000|STARTED|Overall Study||41
6728827|NCT03145064|7658635|FG000|Received At Least 1 Dose of Study Drug|Overall Study||41
6728828|NCT03145064|7658635|FG000|COMPLETED|Overall Study||0
6728829|NCT03145064|7658635|FG000|NOT COMPLETED|Overall Study||41
6728830|NCT03145207|7658640|FG000|STARTED|Overall Study|The same 12 volunteers completed each of the seven study sessions.|14
6728831|NCT03145207|7658640|FG000|COMPLETED|Overall Study||12
6728832|NCT03145207|7658640|FG000|NOT COMPLETED|Overall Study||2
6728833|NCT03145259|7658655|FG000|STARTED|Overall Study||12
6728834|NCT03145259|7658655|FG000|COMPLETED|Overall Study||12
6728835|NCT03145259|7658655|FG000|NOT COMPLETED|Overall Study||0
6728836|NCT03145818|7658666|FG000|STARTED|Overall Study||99
6728837|NCT03145818|7658667|FG001|STARTED|Overall Study||8
6728838|NCT03145818|7658668|FG002|STARTED|Overall Study||10
6728839|NCT03145818|7658669|FG003|STARTED|Overall Study||9
6728840|NCT03145818|7658666|FG000|COMPLETED|Overall Study||8
6728841|NCT03145818|7658667|FG001|COMPLETED|Overall Study||0
6728842|NCT03145818|7658668|FG002|COMPLETED|Overall Study||10
6728843|NCT03145818|7658669|FG003|COMPLETED|Overall Study||9
6728844|NCT03145818|7658666|FG000|NOT COMPLETED|Overall Study||91
6728845|NCT03145818|7658667|FG001|NOT COMPLETED|Overall Study||8
6728846|NCT03145818|7658668|FG002|NOT COMPLETED|Overall Study||0
6728847|NCT03145818|7658669|FG003|NOT COMPLETED|Overall Study||0
6728848|NCT03146403|7658679|FG000|STARTED|Overall Study||16
6728849|NCT03146403|7658680|FG001|STARTED|Overall Study||17
6728850|NCT03146403|7658679|FG000|COMPLETED|Overall Study||14
6728851|NCT03146403|7658680|FG001|COMPLETED|Overall Study||14
6728852|NCT03146403|7658679|FG000|NOT COMPLETED|Overall Study||2
6728853|NCT03146403|7658680|FG001|NOT COMPLETED|Overall Study||3
6728854|NCT03146585|7658689|FG000|STARTED|Overall Study||25
6728855|NCT03146585|7658690|FG001|STARTED|Overall Study||10
6728856|NCT03146585|7658691|FG002|STARTED|Overall Study||5
6728857|NCT03146585|7658689|FG000|COMPLETED|Overall Study||25
6728858|NCT03146585|7658690|FG001|COMPLETED|Overall Study||10
6728859|NCT03146585|7658691|FG002|COMPLETED|Overall Study||5
6728860|NCT03146585|7658689|FG000|NOT COMPLETED|Overall Study||0
6728861|NCT03146585|7658690|FG001|NOT COMPLETED|Overall Study||0
6728862|NCT03146585|7658691|FG002|NOT COMPLETED|Overall Study||0
6728863|NCT03146663|7658701|FG000|STARTED|Overall Study||25
6728864|NCT03146663|7658702|FG001|STARTED|Overall Study||28
6728865|NCT03146663|7658701|FG000|COMPLETED|Overall Study||24
6728866|NCT03146663|7658702|FG001|COMPLETED|Overall Study||27
6728867|NCT03146663|7658701|FG000|NOT COMPLETED|Overall Study||1
6728868|NCT03146663|7658702|FG001|NOT COMPLETED|Overall Study||1
6728869|NCT03146741|7658709|FG000|STARTED|Overall Study||20
6392173|NCT00839982|7304161|FG003|NOT COMPLETED|Overall Study||0
6392174|NCT00840034|7304171|FG000|STARTED|Acute Treatment Phase||111
6392175|NCT00840034|7304172|FG001|STARTED|Acute Treatment Phase||116
6392176|NCT00840034|7304171|FG000|COMPLETED|Acute Treatment Phase||90
6392177|NCT00840034|7304172|FG001|COMPLETED|Acute Treatment Phase||80
6392178|NCT00840034|7304171|FG000|NOT COMPLETED|Acute Treatment Phase||21
6392179|NCT00840034|7304172|FG001|NOT COMPLETED|Acute Treatment Phase||36
6392180|NCT00840034|7304171|FG000|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|90
6392181|NCT00840034|7304172|FG001|STARTED|Taper Phase|Completed Acute Treatment (AT) or discontinued ≥4 weeks of AT and chose to participate in Taper.|82
6392182|NCT00840034|7304171|FG000|COMPLETED|Taper Phase||87
6392183|NCT00840034|7304172|FG001|COMPLETED|Taper Phase||80
6392184|NCT00840034|7304171|FG000|NOT COMPLETED|Taper Phase||3
6392185|NCT00840034|7304172|FG001|NOT COMPLETED|Taper Phase||2
6392186|NCT00840060|7304182|FG000|STARTED|Overall Study||20
6392187|NCT00840060|7304183|FG001|STARTED|Overall Study||20
6392188|NCT00840060|7304182|FG000|COMPLETED|Overall Study||19
6392189|NCT00840060|7304183|FG001|COMPLETED|Overall Study||19
6728870|NCT03146741|7658709|FG000|COMPLETED|Overall Study||10
6728871|NCT03146741|7658709|FG000|NOT COMPLETED|Overall Study||10
6728872|NCT03146806|7658713|FG000|STARTED|Overall Study||10
6728873|NCT03146806|7658713|FG000|COMPLETED|Overall Study||10
6728874|NCT03146806|7658713|FG000|NOT COMPLETED|Overall Study||0
6728875|NCT03147248|7658735|FG000|STARTED|Overall Study|This cohort is only for Part 1.|13
6728876|NCT03147248|7658736|FG001|STARTED|Overall Study|This cohort is only for Part 1.|11
6728877|NCT03147248|7658737|FG002|STARTED|Overall Study|This cohort is only for Part 1.|12
6728878|NCT03147248|7658738|FG003|STARTED|Overall Study|This cohort is only for Part 1.|12
6728879|NCT03147248|7658739|FG004|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|167
6728880|NCT03147248|7658740|FG005|STARTED|Overall Study|This arm is for Part 2. All of the participants in Part 2 were screened only for Part 2.|176
6728881|NCT03147248|7658735|FG000|COMPLETED|Overall Study||12
6728882|NCT03147248|7658736|FG001|COMPLETED|Overall Study||9
6728883|NCT03147248|7658737|FG002|COMPLETED|Overall Study||10
6728884|NCT03147248|7658738|FG003|COMPLETED|Overall Study||10
6728885|NCT03147248|7658739|FG004|COMPLETED|Overall Study||141
6728886|NCT03147248|7658740|FG005|COMPLETED|Overall Study||145
6728887|NCT03147248|7658735|FG000|NOT COMPLETED|Overall Study||1
6728888|NCT03147248|7658736|FG001|NOT COMPLETED|Overall Study||2
6728889|NCT03147248|7658737|FG002|NOT COMPLETED|Overall Study||2
6728890|NCT03147248|7658738|FG003|NOT COMPLETED|Overall Study||2
6728891|NCT03147248|7658739|FG004|NOT COMPLETED|Overall Study||26
6728892|NCT03147248|7658740|FG005|NOT COMPLETED|Overall Study||31
6728893|NCT03147495|7658756|FG000|STARTED|Overall Study||40
6728894|NCT03147495|7658757|FG001|STARTED|Overall Study||46
6728895|NCT03147495|7658756|FG000|COMPLETED|Overall Study||40
6728896|NCT03147495|7658757|FG001|COMPLETED|Overall Study||40
6728897|NCT03147495|7658756|FG000|NOT COMPLETED|Overall Study||0
6728898|NCT03147495|7658757|FG001|NOT COMPLETED|Overall Study||6
6728899|NCT03147690|7658763|FG000|STARTED|Overall Study||74
6728900|NCT03147690|7658763|FG000|COMPLETED|Overall Study||71
6728901|NCT03147690|7658763|FG000|NOT COMPLETED|Overall Study||3
6728902|NCT03148067|7658780|FG000|STARTED|Overall Study||225
6728903|NCT03148067|7658780|FG000|COMPLETED|Overall Study||221
6728904|NCT03148067|7658780|FG000|NOT COMPLETED|Overall Study||4
6728905|NCT03148236|7658787|FG000|STARTED|Overall Study||10
6728906|NCT03148236|7658788|FG001|STARTED|Overall Study||10
6728907|NCT03148236|7658787|FG000|COMPLETED|Overall Study||10
6728908|NCT03148236|7658788|FG001|COMPLETED|Overall Study||10
6728909|NCT03148236|7658787|FG000|NOT COMPLETED|Overall Study||0
6728910|NCT03148236|7658788|FG001|NOT COMPLETED|Overall Study||0
6728911|NCT03148262|7658796|FG000|STARTED|Overall Study||31
6728912|NCT03148262|7658797|FG001|STARTED|Overall Study||32
6728913|NCT03148262|7658796|FG000|COMPLETED|Overall Study||28
6728914|NCT03148262|7658797|FG001|COMPLETED|Overall Study||31
6728915|NCT03148262|7658796|FG000|NOT COMPLETED|Overall Study||3
6728916|NCT03148262|7658797|FG001|NOT COMPLETED|Overall Study||1
6728917|NCT03148470|7658805|FG000|STARTED|Overall Study|21 Participants completed the Tasks following Sham-stimulation|21
6728918|NCT03148470|7658806|FG001|STARTED|Overall Study|20 Participants completed the Tasks following Sham-stimulation|20
6728919|NCT03148470|7658805|FG000|COMPLETED|Overall Study|20 Participants completed the Tasks following iTBS-stimulation|20
6728920|NCT03148470|7658806|FG001|COMPLETED|Overall Study|20 Participants completed the Tasks following cTBS-stimulation|20
6728921|NCT03148470|7658805|FG000|NOT COMPLETED|Overall Study||1
6728922|NCT03148470|7658806|FG001|NOT COMPLETED|Overall Study||0
6728923|NCT03148691|7658823|FG000|STARTED|Overall Study||50
6728924|NCT03148691|7658824|FG001|STARTED|Overall Study||103
6728925|NCT03148691|7658825|FG002|STARTED|Overall Study||100
6728926|NCT03148691|7658823|FG000|COMPLETED|Overall Study||47
6728927|NCT03148691|7658824|FG001|COMPLETED|Overall Study||101
6728928|NCT03148691|7658825|FG002|COMPLETED|Overall Study||92
6728929|NCT03148691|7658823|FG000|NOT COMPLETED|Overall Study||3
6728930|NCT03148691|7658824|FG001|NOT COMPLETED|Overall Study||2
6728931|NCT03148691|7658825|FG002|NOT COMPLETED|Overall Study||8
6728932|NCT03149042|7658833|FG000|STARTED|Overall Study||75
6728933|NCT03149042|7658833|FG000|COMPLETED|Overall Study||52
6728934|NCT03149042|7658833|FG000|NOT COMPLETED|Overall Study||23
6728935|NCT03149055|7658838|FG000|STARTED|Overall Study||99
6728936|NCT03149055|7658838|FG000|COMPLETED|Overall Study||95
6728937|NCT03149055|7658838|FG000|NOT COMPLETED|Overall Study||4
6728938|NCT03149172|7658845|FG000|STARTED|Overall Study||8
6265769|NCT00030901|7164906|FG002|NOT COMPLETED|Randomization||88
6265770|NCT00030992|7164912|FG000|STARTED|Overall Study||102
6265771|NCT00030992|7164912|FG000|COMPLETED|Overall Study||102
6265772|NCT00030992|7164912|FG000|NOT COMPLETED|Overall Study||0
6265773|NCT00031447|7164918|FG000|STARTED|Overall Study||14
6265774|NCT00031447|7164919|FG001|STARTED|Overall Study||15
6265775|NCT00031447|7164918|FG000|COMPLETED|Overall Study||4
6265776|NCT00031447|7164919|FG001|COMPLETED|Overall Study||8
6265777|NCT00031447|7164918|FG000|NOT COMPLETED|Overall Study||10
6265778|NCT00031447|7164919|FG001|NOT COMPLETED|Overall Study||7
6265779|NCT00031460|7164927|FG000|STARTED|Overall Study||24
6728939|NCT03149172|7658846|FG001|STARTED|Overall Study||6
6728940|NCT03149172|7658847|FG002|STARTED|Overall Study||7
6728941|NCT03149172|7658845|FG000|COMPLETED|Overall Study||6
6265780|NCT00031460|7164928|FG001|STARTED|Overall Study||22
6728942|NCT03149172|7658846|FG001|COMPLETED|Overall Study||5
6728943|NCT03149172|7658847|FG002|COMPLETED|Overall Study||5
6728944|NCT03149172|7658845|FG000|NOT COMPLETED|Overall Study||2
6728945|NCT03149172|7658846|FG001|NOT COMPLETED|Overall Study||1
6728946|NCT03149172|7658847|FG002|NOT COMPLETED|Overall Study||2
6728947|NCT03149328|7658857|FG000|STARTED|Overall Study||284
6728948|NCT03149328|7658858|FG001|STARTED|Overall Study||259
6728949|NCT03149328|7658857|FG000|COMPLETED|Overall Study||200
6728950|NCT03149328|7658858|FG001|COMPLETED|Overall Study||213
6728951|NCT03149328|7658857|FG000|NOT COMPLETED|Overall Study||84
6728952|NCT03149328|7658858|FG001|NOT COMPLETED|Overall Study||46
6728953|NCT03149848|7658864|FG000|STARTED|Period 1 (Day 1 to Day 14)||15
6728954|NCT03149848|7658864|FG000|COMPLETED|Period 1 (Day 1 to Day 14)||14
6728955|NCT03149848|7658864|FG000|NOT COMPLETED|Period 1 (Day 1 to Day 14)||1
6728956|NCT03149848|7658864|FG000|STARTED|Period 2 (Day 15 to Day 28)||14
6728957|NCT03149848|7658864|FG000|COMPLETED|Period 2 (Day 15 to Day 28)||12
6728958|NCT03149848|7658864|FG000|NOT COMPLETED|Period 2 (Day 15 to Day 28)||2
6728959|NCT03149887|7658873|FG000|STARTED|Overall Study||27
6728960|NCT03149887|7658874|FG001|STARTED|Overall Study||27
6728961|NCT03149887|7658873|FG000|COMPLETED|Overall Study||27
6728962|NCT03149887|7658874|FG001|COMPLETED|Overall Study||27
6728963|NCT03149887|7658873|FG000|NOT COMPLETED|Overall Study||0
6728964|NCT03149887|7658874|FG001|NOT COMPLETED|Overall Study||0
6728965|NCT03149991|7658882|FG000|STARTED|Overall Study||25
6728966|NCT03149991|7658883|FG001|STARTED|Overall Study||26
6728967|NCT03149991|7658882|FG000|Completed Primary Endpoint (Day 14)|Overall Study||25
6728968|NCT03149991|7658883|FG001|Completed Primary Endpoint (Day 14)|Overall Study||24
6728969|NCT03149991|7658882|FG000|Exited|Overall Study||4
6728970|NCT03149991|7658883|FG001|Exited|Overall Study||2
6728971|NCT03149991|7658882|FG000|COMPLETED|Overall Study||21
6728972|NCT03149991|7658883|FG001|COMPLETED|Overall Study||24
6728973|NCT03149991|7658882|FG000|NOT COMPLETED|Overall Study||4
6728974|NCT03149991|7658883|FG001|NOT COMPLETED|Overall Study||2
6728975|NCT03150043|7658889|FG000|STARTED|Overall Study||65
6728976|NCT03150043|7658889|FG000|COMPLETED|Overall Study||65
6728977|NCT03150043|7658889|FG000|NOT COMPLETED|Overall Study||0
6728978|NCT03150056|7658900|FG000|STARTED|Overall Study||10
6728979|NCT03150056|7658901|FG001|STARTED|Overall Study||6
6728980|NCT03150056|7658902|FG002|STARTED|Overall Study||4
6728981|NCT03150056|7658903|FG003|STARTED|Overall Study||10
6728982|NCT03150056|7658904|FG004|STARTED|Overall Study||22
6728983|NCT03150056|7658905|FG005|STARTED|Overall Study||21
6728984|NCT03150056|7658900|FG000|COMPLETED|Overall Study||0
6728985|NCT03150056|7658901|FG001|COMPLETED|Overall Study||1
6728986|NCT03150056|7658902|FG002|COMPLETED|Overall Study||0
6728987|NCT03150056|7658903|FG003|COMPLETED|Overall Study||1
6728988|NCT03150056|7658904|FG004|COMPLETED|Overall Study||6
6728989|NCT03150056|7658905|FG005|COMPLETED|Overall Study||3
6728990|NCT03150056|7658900|FG000|NOT COMPLETED|Overall Study||10
6728991|NCT03150056|7658901|FG001|NOT COMPLETED|Overall Study||5
6728992|NCT03150056|7658902|FG002|NOT COMPLETED|Overall Study||4
6728993|NCT03150056|7658903|FG003|NOT COMPLETED|Overall Study||9
6728994|NCT03150056|7658904|FG004|NOT COMPLETED|Overall Study||16
6728995|NCT03150056|7658905|FG005|NOT COMPLETED|Overall Study||18
6728996|NCT03150082|7658922|FG000|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
6728997|NCT03150082|7658923|FG001|STARTED|Treatment Period 1 (Up to 4 Weeks)||13
6728998|NCT03150082|7658922|FG000|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||12
6728999|NCT03150082|7658923|FG001|COMPLETED|Treatment Period 1 (Up to 4 Weeks)||13
6729000|NCT03150082|7658922|FG000|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||1
6729001|NCT03150082|7658923|FG001|NOT COMPLETED|Treatment Period 1 (Up to 4 Weeks)||0
6729002|NCT03150082|7658922|FG000|STARTED|Washout Period (Up to 4 Weeks)||12
6729003|NCT03150082|7658923|FG001|STARTED|Washout Period (Up to 4 Weeks)||13
6729004|NCT03150082|7658922|FG000|COMPLETED|Washout Period (Up to 4 Weeks)||12
6729005|NCT03150082|7658923|FG001|COMPLETED|Washout Period (Up to 4 Weeks)||13
6729006|NCT03150082|7658922|FG000|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
6729007|NCT03150082|7658923|FG001|NOT COMPLETED|Washout Period (Up to 4 Weeks)||0
6729008|NCT03150082|7658922|FG000|STARTED|Treatment Period 2 (Up to 4 Weeks)||12
6729009|NCT03150082|7658923|FG001|STARTED|Treatment Period 2 (Up to 4 Weeks)||13
6729010|NCT03150082|7658922|FG000|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||12
6729011|NCT03150082|7658923|FG001|COMPLETED|Treatment Period 2 (Up to 4 Weeks)||13
6729012|NCT03150082|7658922|FG000|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
6729013|NCT03150082|7658923|FG001|NOT COMPLETED|Treatment Period 2 (Up to 4 Weeks)||0
6729014|NCT03150108|7658933|FG000|STARTED|Overall Study||12
6729015|NCT03150108|7658934|FG001|STARTED|Overall Study||12
6729016|NCT03150108|7658933|FG000|COMPLETED|Overall Study||12
6729017|NCT03150108|7658934|FG001|COMPLETED|Overall Study||12
6729018|NCT03150108|7658933|FG000|NOT COMPLETED|Overall Study||0
6729019|NCT03150108|7658934|FG001|NOT COMPLETED|Overall Study||0
6729020|NCT03150199|7658951|FG000|STARTED|Overall Study||30
6729021|NCT03150199|7658952|FG001|STARTED|Overall Study||30
6729022|NCT03150199|7658951|FG000|COMPLETED|Overall Study||30
6729023|NCT03150199|7658952|FG001|COMPLETED|Overall Study||30
6729024|NCT03150199|7658951|FG000|NOT COMPLETED|Overall Study||0
6729025|NCT03150199|7658952|FG001|NOT COMPLETED|Overall Study||0
6729026|NCT03150485|7658959|FG000|STARTED|Overall Study||2
6729027|NCT03150485|7658960|FG001|STARTED|Overall Study||9
6729028|NCT03150485|7658961|FG002|STARTED|Overall Study||4
6729029|NCT03150485|7658962|FG003|STARTED|Overall Study||5
6729030|NCT03150485|7658963|FG004|STARTED|Overall Study||2
6729031|NCT03150485|7658964|FG005|STARTED|Overall Study||1
6729032|NCT03150485|7658959|FG000|COMPLETED|Overall Study||2
6729033|NCT03150485|7658960|FG001|COMPLETED|Overall Study||8
6729034|NCT03150485|7658961|FG002|COMPLETED|Overall Study||4
6729035|NCT03150485|7658962|FG003|COMPLETED|Overall Study||5
6729036|NCT03150485|7658963|FG004|COMPLETED|Overall Study||2
6729037|NCT03150485|7658964|FG005|COMPLETED|Overall Study||1
6729038|NCT03150485|7658959|FG000|NOT COMPLETED|Overall Study||0
6729039|NCT03150485|7658960|FG001|NOT COMPLETED|Overall Study||1
6729040|NCT03150485|7658961|FG002|NOT COMPLETED|Overall Study||0
6729041|NCT03150485|7658962|FG003|NOT COMPLETED|Overall Study||0
6729042|NCT03150485|7658963|FG004|NOT COMPLETED|Overall Study||0
6729043|NCT03150485|7658964|FG005|NOT COMPLETED|Overall Study||0
6729044|NCT03150589|7658971|FG000|STARTED|Overall Study||351
6729045|NCT03150589|7658972|FG001|STARTED|Overall Study||354
6729046|NCT03150589|7658971|FG000|COMPLETED|Overall Study||307
6729047|NCT03150589|7658972|FG001|COMPLETED|Overall Study||327
6729048|NCT03150589|7658971|FG000|NOT COMPLETED|Overall Study||44
6729049|NCT03150589|7658972|FG001|NOT COMPLETED|Overall Study||27
6729050|NCT03150719|7658980|FG000|STARTED|Overall Study||47
6729051|NCT03150719|7658981|FG001|STARTED|Overall Study||50
6729052|NCT03150719|7658980|FG000|COMPLETED|Overall Study||46
6729053|NCT03150719|7658981|FG001|COMPLETED|Overall Study||48
6729054|NCT03150719|7658980|FG000|NOT COMPLETED|Overall Study||1
6729055|NCT03150719|7658981|FG001|NOT COMPLETED|Overall Study||2
6729056|NCT03150758|7658987|FG000|STARTED|Overall Study||6
6729057|NCT03150758|7658987|FG000|COMPLETED|Overall Study||6
6729058|NCT03150758|7658987|FG000|NOT COMPLETED|Overall Study||0
6729059|NCT03150875|7658993|FG000|STARTED|Overall Study||145
6729060|NCT03150875|7658994|FG001|STARTED|Overall Study||145
6729061|NCT03150875|7658993|FG000|Treated|Overall Study||144
6729062|NCT03150875|7658994|FG001|Treated|Overall Study||130
6729063|NCT03150875|7658993|FG000|Crossover to Certain Treatment|Overall Study||0
6729064|NCT03150875|7658994|FG001|Crossover to Certain Treatment|Overall Study||0
6265781|NCT00031460|7164927|FG000|COMPLETED|Overall Study||15
6265782|NCT00031460|7164928|FG001|COMPLETED|Overall Study||8
6265783|NCT00031460|7164927|FG000|NOT COMPLETED|Overall Study||9
6265784|NCT00031460|7164928|FG001|NOT COMPLETED|Overall Study||14
6265785|NCT00031486|7164936|FG000|STARTED|Overall Study||40
6265786|NCT00031486|7164937|FG001|STARTED|Overall Study||47
6265787|NCT00031486|7164936|FG000|COMPLETED|Overall Study||33
6265788|NCT00031486|7164937|FG001|COMPLETED|Overall Study||35
6265789|NCT00031486|7164936|FG000|NOT COMPLETED|Overall Study||7
6265790|NCT00031486|7164937|FG001|NOT COMPLETED|Overall Study||12
6265791|NCT00031551|7164947|FG000|STARTED|Overall Study||2
6265792|NCT00031551|7164948|FG001|STARTED|Overall Study||25
6265793|NCT00031551|7164947|FG000|COMPLETED|Overall Study||0
6265794|NCT00031551|7164948|FG001|COMPLETED|Overall Study||25
6265795|NCT00031551|7164947|FG000|NOT COMPLETED|Overall Study||2
6265796|NCT00031551|7164948|FG001|NOT COMPLETED|Overall Study||0
6265797|NCT00031590|7164958|FG000|STARTED|Overall Study||28
6265798|NCT00031590|7164958|FG000|COMPLETED|Overall Study||25
6265799|NCT00031590|7164958|FG000|NOT COMPLETED|Overall Study||3
6265800|NCT00031694|7164963|FG000|STARTED|Overall Study||19
6265801|NCT00031694|7164963|FG000|COMPLETED|Overall Study||0
6265802|NCT00031694|7164963|FG000|NOT COMPLETED|Overall Study||19
6265803|NCT00032487|7164970|FG000|STARTED|Overall Study||899
6265804|NCT00032487|7164971|FG001|STARTED|Overall Study||892
6265805|NCT00032487|7164970|FG000|COMPLETED|Overall Study||760
6265806|NCT00032487|7164971|FG001|COMPLETED|Overall Study||772
6265807|NCT00032487|7164970|FG000|NOT COMPLETED|Overall Study||139
6265808|NCT00032487|7164971|FG001|NOT COMPLETED|Overall Study||120
6265809|NCT00032591|7164979|FG000|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
6265810|NCT00032591|7164980|FG001|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
6265811|NCT00032591|7164979|FG000|COMPLETED|Screening|823 were excluded from the study|1465
6265812|NCT00032591|7164980|FG001|COMPLETED|Screening||1457
6265813|NCT00032591|7164979|FG000|NOT COMPLETED|Screening||408
6265814|NCT00032591|7164980|FG001|NOT COMPLETED|Screening||415
6265815|NCT00032591|7164979|FG000|STARTED|Randomization|2922 underwent randomization|1465
6265816|NCT00032591|7164980|FG001|STARTED|Randomization||1457
6265817|NCT00032591|7164979|FG000|COMPLETED|Randomization|1465 were assigned to self-testing|1465
6265818|NCT00032591|7164980|FG001|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
6265819|NCT00032591|7164979|FG000|NOT COMPLETED|Randomization||0
6265820|NCT00032591|7164980|FG001|NOT COMPLETED|Randomization||0
6265821|NCT00032591|7164979|FG000|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
6265822|NCT00032591|7164980|FG001|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
6265823|NCT00032591|7164979|FG000|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
6265824|NCT00032591|7164980|FG001|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
6265825|NCT00032591|7164979|FG000|NOT COMPLETED|Follow-up||2
6265826|NCT00032591|7164980|FG001|NOT COMPLETED|Follow-up||5
6265827|NCT00032630|7164988|FG000|STARTED|Overall Study||1099
6265828|NCT00032630|7164989|FG001|STARTED|Overall Study||1104
6602977|NCT02059291|7527978|FG019|COMPLETED|Epoch 2||0
6602978|NCT02059291|7527979|FG020|COMPLETED|Epoch 2||0
6602979|NCT02059291|7527980|FG021|COMPLETED|Epoch 2||0
6729065|NCT03150875|7658993|FG000|COMPLETED|Overall Study||0
6729066|NCT03150875|7658994|FG001|COMPLETED|Overall Study||0
6729067|NCT03150875|7658993|FG000|NOT COMPLETED|Overall Study||145
6729068|NCT03150875|7658994|FG001|NOT COMPLETED|Overall Study||145
6729069|NCT03151148|7659002|FG000|STARTED|Overall Study||36
6729070|NCT03151148|7659003|FG001|STARTED|Overall Study||18
6729071|NCT03151148|7659002|FG000|COMPLETED|Overall Study||34
6729072|NCT03151148|7659003|FG001|COMPLETED|Overall Study||18
6729073|NCT03151148|7659002|FG000|NOT COMPLETED|Overall Study||2
6729074|NCT03151148|7659003|FG001|NOT COMPLETED|Overall Study||0
6729075|NCT03151265|7659012|FG000|STARTED|Overall Study||20
6729076|NCT03151265|7659013|FG001|STARTED|Overall Study||20
6729077|NCT03151265|7659012|FG000|COMPLETED|Overall Study||20
6729078|NCT03151265|7659013|FG001|COMPLETED|Overall Study||20
6729079|NCT03151265|7659012|FG000|NOT COMPLETED|Overall Study||0
6729080|NCT03151265|7659013|FG001|NOT COMPLETED|Overall Study||0
6729081|NCT03151395|7659019|FG000|STARTED|Overall Study||197
6729082|NCT03151395|7659019|FG000|COMPLETED|Overall Study||182
6729083|NCT03151395|7659019|FG000|NOT COMPLETED|Overall Study||15
6729084|NCT03151434|7659026|FG000|STARTED|Overall Study||53
6729085|NCT03151434|7659027|FG001|STARTED|Overall Study||47
6729086|NCT03151434|7659028|FG002|STARTED|Overall Study||47
6729087|NCT03151434|7659026|FG000|COMPLETED|Overall Study||40
6729088|NCT03151434|7659027|FG001|COMPLETED|Overall Study||40
6729089|NCT03151434|7659028|FG002|COMPLETED|Overall Study||40
6729090|NCT03151434|7659026|FG000|NOT COMPLETED|Overall Study||13
6729091|NCT03151434|7659027|FG001|NOT COMPLETED|Overall Study||7
6729092|NCT03151434|7659028|FG002|NOT COMPLETED|Overall Study||7
6729093|NCT03151551|7659041|FG000|STARTED|Open-Label Treatment Period||283
6729094|NCT03151551|7659042|FG001|STARTED|Open-Label Treatment Period||283
6729095|NCT03151551|7659041|FG000|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
6729096|NCT03151551|7659042|FG001|Received at Least One Dose of Study Drug|Open-Label Treatment Period||283
6729097|NCT03151551|7659041|FG000|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period||49
6729098|NCT03151551|7659042|FG001|IXE 160 mg at Baseline, 80 mg Q2W/Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
6729099|NCT03151551|7659041|FG000|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period||218
6729100|NCT03151551|7659042|FG001|IXE 160 mg at Baseline, 80 mg Q4W|Open-Label Treatment Period|Row represents Ixekizumab data only.|0
6729101|NCT03151551|7659041|FG000|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
6729102|NCT03151551|7659042|FG001|ADA 80 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||51
6729103|NCT03151551|7659041|FG000|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period|Row represents adalimumab data only.|0
6729104|NCT03151551|7659042|FG001|ADA 40 mg at Baseline, 40 mg Q2W|Open-Label Treatment Period||219
6729105|NCT03151551|7659041|FG000|COMPLETED|Open-Label Treatment Period||265
6729106|NCT03151551|7659042|FG001|COMPLETED|Open-Label Treatment Period||259
6729107|NCT03151551|7659041|FG000|NOT COMPLETED|Open-Label Treatment Period||18
6729108|NCT03151551|7659042|FG001|NOT COMPLETED|Open-Label Treatment Period||24
6729109|NCT03151551|7659041|FG000|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|265
6729110|NCT03151551|7659042|FG001|STARTED|Post-Treatment Follow-Up Period|All participants who received at least one dose of study drug could enter the follow-up period.|258
6729111|NCT03151551|7659041|FG000|COMPLETED|Post-Treatment Follow-Up Period||240
6729112|NCT03151551|7659042|FG001|COMPLETED|Post-Treatment Follow-Up Period||230
6729113|NCT03151551|7659041|FG000|NOT COMPLETED|Post-Treatment Follow-Up Period||25
6729114|NCT03151551|7659042|FG001|NOT COMPLETED|Post-Treatment Follow-Up Period||28
6729115|NCT03152019|7659052|FG000|STARTED|Overall Study||25
6729116|NCT03152019|7659053|FG001|STARTED|Overall Study||25
6729117|NCT03152019|7659052|FG000|COMPLETED|Overall Study||25
6729118|NCT03152019|7659053|FG001|COMPLETED|Overall Study||24
6729119|NCT03152019|7659052|FG000|NOT COMPLETED|Overall Study||0
6729120|NCT03152019|7659053|FG001|NOT COMPLETED|Overall Study||1
6729121|NCT03152084|7659061|FG000|STARTED|Overall Study||17
6729122|NCT03152084|7659062|FG001|STARTED|Overall Study||7
6729123|NCT03152084|7659061|FG000|COMPLETED|Overall Study||17
6729124|NCT03152084|7659062|FG001|COMPLETED|Overall Study||7
6729125|NCT03152084|7659061|FG000|NOT COMPLETED|Overall Study||0
6729126|NCT03152084|7659062|FG001|NOT COMPLETED|Overall Study||0
6729127|NCT03152110|7659068|FG000|STARTED|Overall Study||10
6729128|NCT03152110|7659068|FG000|COMPLETED|Overall Study||7
6729129|NCT03152110|7659068|FG000|NOT COMPLETED|Overall Study||3
6265829|NCT00032630|7164988|FG000|COMPLETED|Overall Study||1050
6265830|NCT00032630|7164989|FG001|COMPLETED|Overall Study||1061
6265831|NCT00032630|7164988|FG000|NOT COMPLETED|Overall Study||49
6265832|NCT00032630|7164989|FG001|NOT COMPLETED|Overall Study||43
6280511|NCT00157573|7180492|FG001|COMPLETED|Overall Study||37
6280512|NCT00157573|7180491|FG000|NOT COMPLETED|Overall Study||0
6280513|NCT00157573|7180492|FG001|NOT COMPLETED|Overall Study||0
6280514|NCT00157755|7180499|FG000|STARTED|Overall Study||26
6280515|NCT00157755|7180500|FG001|STARTED|Overall Study||19
6280516|NCT00157755|7180501|FG002|STARTED|Overall Study||10
6280517|NCT00157755|7180502|FG003|STARTED|Overall Study||15
6280518|NCT00157755|7180503|FG004|STARTED|Overall Study||12
6280519|NCT00157755|7180504|FG005|STARTED|Overall Study||5
6280520|NCT00157755|7180499|FG000|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
6280521|NCT00157755|7180500|FG001|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
6280522|NCT00157755|7180501|FG002|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
6280523|NCT00157755|7180502|FG003|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
6729130|NCT03152136|7659076|FG000|STARTED|Overall Study||32
6729131|NCT03152136|7659077|FG001|STARTED|Overall Study||15
6729132|NCT03152136|7659078|FG002|STARTED|Overall Study||15
6729133|NCT03152136|7659076|FG000|COMPLETED|Overall Study||29
6729134|NCT03152136|7659077|FG001|COMPLETED|Overall Study||15
6729135|NCT03152136|7659078|FG002|COMPLETED|Overall Study||14
6729136|NCT03152136|7659076|FG000|NOT COMPLETED|Overall Study||3
6729137|NCT03152136|7659077|FG001|NOT COMPLETED|Overall Study||0
6729138|NCT03152136|7659078|FG002|NOT COMPLETED|Overall Study||1
6729139|NCT03152552|7659090|FG000|STARTED|Treatment Period 1 (12 Weeks)||15
6729140|NCT03152552|7659091|FG001|STARTED|Treatment Period 1 (12 Weeks)||16
6729141|NCT03152552|7659092|FG002|STARTED|Treatment Period 1 (12 Weeks)||31
6729142|NCT03152552|7659093|FG003|STARTED|Treatment Period 1 (12 Weeks)||30
6729143|NCT03152552|7659094|FG004|STARTED|Treatment Period 1 (12 Weeks)||33
6729144|NCT03152552|7659090|FG000|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||15
6729145|NCT03152552|7659091|FG001|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||16
6729146|NCT03152552|7659092|FG002|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
6729147|NCT03152552|7659093|FG003|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||30
6729148|NCT03152552|7659094|FG004|Full Analysis Set (FAS)|Treatment Period 1 (12 Weeks)||33
6729149|NCT03152552|7659090|FG000|COMPLETED|Treatment Period 1 (12 Weeks)||7
6729150|NCT03152552|7659091|FG001|COMPLETED|Treatment Period 1 (12 Weeks)||5
6729151|NCT03152552|7659092|FG002|COMPLETED|Treatment Period 1 (12 Weeks)||10
6729152|NCT03152552|7659093|FG003|COMPLETED|Treatment Period 1 (12 Weeks)||10
6729153|NCT03152552|7659094|FG004|COMPLETED|Treatment Period 1 (12 Weeks)||12
6729154|NCT03152552|7659090|FG000|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
6729155|NCT03152552|7659091|FG001|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
6729156|NCT03152552|7659092|FG002|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
6729157|NCT03152552|7659093|FG003|NOT COMPLETED|Treatment Period 1 (12 Weeks)||20
6729158|NCT03152552|7659094|FG004|NOT COMPLETED|Treatment Period 1 (12 Weeks)||21
6729159|NCT03152552|7659090|FG000|STARTED|Treatment Period 2 (24 Weeks)||7
6729160|NCT03152552|7659091|FG001|STARTED|Treatment Period 2 (24 Weeks)||5
6729161|NCT03152552|7659092|FG002|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
6729162|NCT03152552|7659093|FG003|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|9
6729163|NCT03152552|7659094|FG004|STARTED|Treatment Period 2 (24 Weeks)|All patients who entered Treatment Period 2 (EPOCH 4)|11
6729164|NCT03152552|7659090|FG000|COMPLETED|Treatment Period 2 (24 Weeks)||1
6729165|NCT03152552|7659091|FG001|COMPLETED|Treatment Period 2 (24 Weeks)||0
6729166|NCT03152552|7659092|FG002|COMPLETED|Treatment Period 2 (24 Weeks)||0
6729167|NCT03152552|7659093|FG003|COMPLETED|Treatment Period 2 (24 Weeks)||0
6729168|NCT03152552|7659094|FG004|COMPLETED|Treatment Period 2 (24 Weeks)||0
6729169|NCT03152552|7659090|FG000|NOT COMPLETED|Treatment Period 2 (24 Weeks)||6
6729170|NCT03152552|7659091|FG001|NOT COMPLETED|Treatment Period 2 (24 Weeks)||5
6729171|NCT03152552|7659092|FG002|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
6729172|NCT03152552|7659093|FG003|NOT COMPLETED|Treatment Period 2 (24 Weeks)||9
6729173|NCT03152552|7659094|FG004|NOT COMPLETED|Treatment Period 2 (24 Weeks)||11
6729174|NCT03152591|7659109|FG000|STARTED|Overall Study||15
6729175|NCT03152591|7659110|FG001|STARTED|Overall Study||14
6729176|NCT03152591|7659109|FG000|Pharmacokinetic (PK) Analysis Set|Overall Study||14
6729177|NCT03152591|7659110|FG001|Pharmacokinetic (PK) Analysis Set|Overall Study||0
6729178|NCT03152591|7659109|FG000|Pharmacodynamic (PD) Analysis Set|Overall Study||15
6729179|NCT03152591|7659110|FG001|Pharmacodynamic (PD) Analysis Set|Overall Study||14
6729180|NCT03152591|7659109|FG000|COMPLETED|Overall Study||15
6729181|NCT03152591|7659110|FG001|COMPLETED|Overall Study||14
6729182|NCT03152591|7659109|FG000|NOT COMPLETED|Overall Study||0
6729183|NCT03152591|7659110|FG001|NOT COMPLETED|Overall Study||0
6729184|NCT03153956|7659118|FG000|STARTED|Overall Study||39
6729185|NCT03153956|7659119|FG001|STARTED|Overall Study||38
6729186|NCT03153956|7659118|FG000|COMPLETED|Overall Study||39
6729187|NCT03153956|7659119|FG001|COMPLETED|Overall Study||38
6729188|NCT03153956|7659118|FG000|NOT COMPLETED|Overall Study||0
6729189|NCT03153956|7659119|FG001|NOT COMPLETED|Overall Study||0
6729190|NCT03154047|7659125|FG000|STARTED|Overall Study||80
6729191|NCT03154047|7659125|FG000|Number of Patients Dosed|Overall Study||80
6729192|NCT03154047|7659125|FG000|COMPLETED|Overall Study||0
6729193|NCT03154047|7659125|FG000|NOT COMPLETED|Overall Study||80
6729194|NCT03154086|7659144|FG000|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6729195|NCT03154086|7659145|FG001|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6729196|NCT03154086|7659146|FG002|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6729197|NCT03154086|7659147|FG003|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6729198|NCT03154086|7659148|FG004|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729199|NCT03154086|7659149|FG005|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729200|NCT03154086|7659150|FG006|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729201|NCT03154086|7659151|FG007|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729202|NCT03154086|7659152|FG008|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6265833|NCT00033371|7164997|FG000|STARTED|Overall Study||55
6265834|NCT00033371|7164998|FG001|STARTED|Overall Study||57
6265835|NCT00033371|7164997|FG000|COMPLETED|Overall Study||49
6265836|NCT00033371|7164998|FG001|COMPLETED|Overall Study||47
6265837|NCT00033371|7164997|FG000|NOT COMPLETED|Overall Study||6
6265838|NCT00033371|7164998|FG001|NOT COMPLETED|Overall Study||10
6265839|NCT00033514|7165010|FG000|STARTED|Overall Study||16
6729203|NCT03154086|7659153|FG009|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729204|NCT03154086|7659154|FG010|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729205|NCT03154086|7659155|FG011|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729206|NCT03154086|7659156|FG012|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729207|NCT03154086|7659157|FG013|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729208|NCT03154086|7659158|FG014|STARTED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729209|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6729210|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6729211|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6729212|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||2
6729213|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729214|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729215|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729216|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729217|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729218|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729219|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729220|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729221|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729222|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729223|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729224|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729225|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729226|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729227|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729228|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729229|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729230|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729231|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729232|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729233|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729234|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729235|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729236|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729237|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729238|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort1 Period1 (Up to 3 Days)||0
6729239|NCT03154086|7659144|FG000|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6729240|NCT03154086|7659145|FG001|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6729241|NCT03154086|7659146|FG002|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6729242|NCT03154086|7659147|FG003|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6729243|NCT03154086|7659148|FG004|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729244|NCT03154086|7659149|FG005|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729245|NCT03154086|7659150|FG006|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729246|NCT03154086|7659151|FG007|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729247|NCT03154086|7659152|FG008|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729248|NCT03154086|7659153|FG009|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729249|NCT03154086|7659154|FG010|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729250|NCT03154086|7659155|FG011|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729251|NCT03154086|7659156|FG012|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729252|NCT03154086|7659157|FG013|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729253|NCT03154086|7659158|FG014|STARTED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729254|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6729255|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6729256|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||2
6729257|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
6729258|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729259|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729260|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729261|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729262|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729263|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729264|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729265|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729266|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729267|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729268|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729269|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729270|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729271|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729272|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||1
6729273|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729274|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729275|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729276|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729277|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729278|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729279|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729280|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729281|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729282|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729283|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort1 Washout1 (Up to 14 Days)||0
6729284|NCT03154086|7659144|FG000|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6729285|NCT03154086|7659145|FG001|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6729286|NCT03154086|7659146|FG002|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6729287|NCT03154086|7659147|FG003|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)|One replacement participant (par) was enrolled and dosed|2
6729288|NCT03154086|7659148|FG004|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729289|NCT03154086|7659149|FG005|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729290|NCT03154086|7659150|FG006|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729291|NCT03154086|7659151|FG007|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729292|NCT03154086|7659152|FG008|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729293|NCT03154086|7659153|FG009|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729294|NCT03154086|7659154|FG010|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729295|NCT03154086|7659155|FG011|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729296|NCT03154086|7659156|FG012|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729297|NCT03154086|7659157|FG013|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729298|NCT03154086|7659158|FG014|STARTED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729299|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6729300|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6729301|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6729302|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||2
6729303|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729304|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729305|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729306|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729307|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729308|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729309|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729310|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729311|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729312|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729313|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729314|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729315|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729316|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729317|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729318|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729319|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729320|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729321|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729322|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729323|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729324|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729325|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729326|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729327|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729328|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort1 Period2 (Up to 3 Days)||0
6729329|NCT03154086|7659144|FG000|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6729330|NCT03154086|7659145|FG001|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6729331|NCT03154086|7659146|FG002|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6729332|NCT03154086|7659147|FG003|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6729333|NCT03154086|7659148|FG004|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729334|NCT03154086|7659149|FG005|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729335|NCT03154086|7659150|FG006|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729336|NCT03154086|7659151|FG007|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729337|NCT03154086|7659152|FG008|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729338|NCT03154086|7659153|FG009|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729339|NCT03154086|7659154|FG010|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729340|NCT03154086|7659155|FG011|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729341|NCT03154086|7659156|FG012|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729342|NCT03154086|7659157|FG013|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729343|NCT03154086|7659158|FG014|STARTED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729344|NCT03154086|7659144|FG000|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6729345|NCT03154086|7659145|FG001|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
6729346|NCT03154086|7659146|FG002|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6729347|NCT03154086|7659147|FG003|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||2
6729348|NCT03154086|7659148|FG004|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729349|NCT03154086|7659149|FG005|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729350|NCT03154086|7659150|FG006|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729351|NCT03154086|7659151|FG007|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729352|NCT03154086|7659152|FG008|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729353|NCT03154086|7659153|FG009|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729354|NCT03154086|7659154|FG010|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729355|NCT03154086|7659155|FG011|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729356|NCT03154086|7659156|FG012|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729357|NCT03154086|7659157|FG013|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729358|NCT03154086|7659158|FG014|COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729359|NCT03154086|7659144|FG000|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729360|NCT03154086|7659145|FG001|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||1
6729361|NCT03154086|7659146|FG002|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729362|NCT03154086|7659147|FG003|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729363|NCT03154086|7659148|FG004|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729364|NCT03154086|7659149|FG005|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729365|NCT03154086|7659150|FG006|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729366|NCT03154086|7659151|FG007|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729367|NCT03154086|7659152|FG008|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729368|NCT03154086|7659153|FG009|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729369|NCT03154086|7659154|FG010|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729370|NCT03154086|7659155|FG011|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729371|NCT03154086|7659156|FG012|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729372|NCT03154086|7659157|FG013|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729373|NCT03154086|7659158|FG014|NOT COMPLETED|PartA: Cohort1 Washout2 (Up to 14 Days)||0
6729374|NCT03154086|7659144|FG000|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6729375|NCT03154086|7659145|FG001|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)|One replacement par was enrolled and dosed|2
6729376|NCT03154086|7659146|FG002|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6729377|NCT03154086|7659147|FG003|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6729378|NCT03154086|7659148|FG004|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729379|NCT03154086|7659149|FG005|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729380|NCT03154086|7659150|FG006|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729381|NCT03154086|7659151|FG007|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729382|NCT03154086|7659152|FG008|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729383|NCT03154086|7659153|FG009|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729384|NCT03154086|7659154|FG010|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729385|NCT03154086|7659155|FG011|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729386|NCT03154086|7659156|FG012|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729387|NCT03154086|7659157|FG013|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729388|NCT03154086|7659158|FG014|STARTED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729389|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6729390|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6729391|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6729392|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||2
6729393|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729394|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729395|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729396|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729397|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729398|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729399|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729400|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729401|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729402|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729403|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729404|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729405|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729406|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729407|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729408|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729409|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729410|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729411|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729412|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729413|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729414|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729415|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729416|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729417|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729418|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort1 Period3 (Up to 3 Days)||0
6729419|NCT03154086|7659144|FG000|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6729420|NCT03154086|7659145|FG001|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6729421|NCT03154086|7659146|FG002|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6729422|NCT03154086|7659147|FG003|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6729423|NCT03154086|7659148|FG004|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729424|NCT03154086|7659149|FG005|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729425|NCT03154086|7659150|FG006|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729426|NCT03154086|7659151|FG007|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729427|NCT03154086|7659152|FG008|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729428|NCT03154086|7659153|FG009|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729429|NCT03154086|7659154|FG010|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729430|NCT03154086|7659155|FG011|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729431|NCT03154086|7659156|FG012|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729432|NCT03154086|7659157|FG013|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729433|NCT03154086|7659158|FG014|STARTED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729434|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6729435|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6729436|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
6729437|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||2
6729438|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729439|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729440|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729441|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729442|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729443|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729444|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729445|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729446|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729447|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729448|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729449|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729450|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729451|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||1
6729452|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729453|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729454|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729455|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729456|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729457|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729458|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729459|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729460|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729461|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729462|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729463|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort1 Washout3 (Up to 14 Days)||0
6729464|NCT03154086|7659144|FG000|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)|1 par was not dosed on day of dosing due to elevated lab; hence 1 replacement was enrolled and dosed|3
6729465|NCT03154086|7659145|FG001|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6729466|NCT03154086|7659146|FG002|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||1
6729467|NCT03154086|7659147|FG003|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6729468|NCT03154086|7659148|FG004|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729469|NCT03154086|7659149|FG005|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729470|NCT03154086|7659150|FG006|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729471|NCT03154086|7659151|FG007|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729472|NCT03154086|7659152|FG008|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729473|NCT03154086|7659153|FG009|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729474|NCT03154086|7659154|FG010|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729475|NCT03154086|7659155|FG011|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729476|NCT03154086|7659156|FG012|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729477|NCT03154086|7659157|FG013|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729478|NCT03154086|7659158|FG014|STARTED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729479|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6392190|NCT00840060|7304182|FG000|NOT COMPLETED|Overall Study||1
6392191|NCT00840060|7304183|FG001|NOT COMPLETED|Overall Study||1
6392192|NCT00840086|7304189|FG000|STARTED|Overall Study||150
6392193|NCT00840086|7304189|FG000|COMPLETED|Overall Study||146
6392194|NCT00840086|7304189|FG000|NOT COMPLETED|Overall Study||4
6392195|NCT00840294|7304198|FG000|STARTED|Overall Study||42
6729480|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6729481|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
6729482|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||2
6729483|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729484|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729485|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729486|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729487|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729488|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729489|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729490|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729491|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729492|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729493|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729494|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||1
6729495|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729496|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729497|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729498|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729499|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729500|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729501|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729502|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729503|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729504|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729505|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729506|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729507|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729508|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort1 Period4 (Up to 3 Days)||0
6729509|NCT03154086|7659144|FG000|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729510|NCT03154086|7659145|FG001|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729511|NCT03154086|7659146|FG002|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729512|NCT03154086|7659147|FG003|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729513|NCT03154086|7659148|FG004|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||6
6729514|NCT03154086|7659149|FG005|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||2
6729515|NCT03154086|7659150|FG006|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729516|NCT03154086|7659151|FG007|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729517|NCT03154086|7659152|FG008|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729518|NCT03154086|7659153|FG009|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729519|NCT03154086|7659154|FG010|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729520|NCT03154086|7659155|FG011|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729521|NCT03154086|7659156|FG012|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729522|NCT03154086|7659157|FG013|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729523|NCT03154086|7659158|FG014|STARTED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729524|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729525|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729526|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729527|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729528|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||6
6729529|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||2
6729530|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729531|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729532|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729533|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729534|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729535|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729536|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729537|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729538|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729539|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729540|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729541|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729542|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729543|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729544|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729545|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729546|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729547|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729548|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729549|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729550|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729551|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729552|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729553|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort2 Period1 (Up to 3 Days)||0
6729554|NCT03154086|7659144|FG000|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729555|NCT03154086|7659145|FG001|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729556|NCT03154086|7659146|FG002|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729557|NCT03154086|7659147|FG003|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729558|NCT03154086|7659148|FG004|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
6729559|NCT03154086|7659149|FG005|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
6729560|NCT03154086|7659150|FG006|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729561|NCT03154086|7659151|FG007|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729562|NCT03154086|7659152|FG008|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729563|NCT03154086|7659153|FG009|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729564|NCT03154086|7659154|FG010|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729565|NCT03154086|7659155|FG011|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729566|NCT03154086|7659156|FG012|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729567|NCT03154086|7659157|FG013|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729568|NCT03154086|7659158|FG014|STARTED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729569|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729570|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729571|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729572|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729573|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||6
6729574|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||2
6729575|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729576|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729577|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729578|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729579|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729580|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729581|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729582|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729583|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729584|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729585|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729586|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729587|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729588|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729589|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729590|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729591|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729592|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729593|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729594|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729595|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729596|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729597|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729598|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort2 Washout1 (Up to 14 Days)||0
6729599|NCT03154086|7659144|FG000|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729600|NCT03154086|7659145|FG001|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729601|NCT03154086|7659146|FG002|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729602|NCT03154086|7659147|FG003|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729603|NCT03154086|7659148|FG004|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||6
6729604|NCT03154086|7659149|FG005|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||2
6729605|NCT03154086|7659150|FG006|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729606|NCT03154086|7659151|FG007|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729607|NCT03154086|7659152|FG008|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729608|NCT03154086|7659153|FG009|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729609|NCT03154086|7659154|FG010|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729610|NCT03154086|7659155|FG011|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729611|NCT03154086|7659156|FG012|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729612|NCT03154086|7659157|FG013|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729613|NCT03154086|7659158|FG014|STARTED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729614|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729615|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729616|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729617|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729618|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||6
6729619|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||2
6729620|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729621|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729622|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729623|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729624|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729625|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729626|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729627|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729628|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729629|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729630|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729631|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729632|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729633|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729634|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729635|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729636|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729637|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729638|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729639|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729640|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729641|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729642|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729643|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort2 Period2 (Up to 3 Days)||0
6729644|NCT03154086|7659144|FG000|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729645|NCT03154086|7659145|FG001|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729646|NCT03154086|7659146|FG002|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729647|NCT03154086|7659147|FG003|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729648|NCT03154086|7659148|FG004|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729649|NCT03154086|7659149|FG005|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729650|NCT03154086|7659150|FG006|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
6265840|NCT00033514|7165011|FG001|STARTED|Overall Study||11
6265841|NCT00033514|7165010|FG000|COMPLETED|Overall Study||15
6265842|NCT00033514|7165011|FG001|COMPLETED|Overall Study||7
6265843|NCT00033514|7165010|FG000|NOT COMPLETED|Overall Study||1
6265844|NCT00033514|7165011|FG001|NOT COMPLETED|Overall Study||4
6265845|NCT00033540|7165018|FG000|STARTED|Overall Study||57
6265846|NCT00033540|7165018|FG000|Eligible|Overall Study||54
6265847|NCT00033540|7165018|FG000|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
6265848|NCT00033540|7165018|FG000|COMPLETED|Overall Study||0
6265849|NCT00033540|7165018|FG000|NOT COMPLETED|Overall Study||57
6265850|NCT00033631|7165025|FG000|STARTED|Overall Study||769
6265851|NCT00033631|7165026|FG001|STARTED|Overall Study||763
6265852|NCT00033631|7165025|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
6265853|NCT00033631|7165026|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
6265854|NCT00033631|7165025|FG000|NOT COMPLETED|Overall Study||18
6265855|NCT00033631|7165026|FG001|NOT COMPLETED|Overall Study||15
6265856|NCT00033657|7165035|FG000|STARTED|Neoadjuvant Chemotherapy||50
6265857|NCT00033657|7165036|FG001|STARTED|Neoadjuvant Chemotherapy||47
6265858|NCT00033657|7165035|FG000|Eligible|Neoadjuvant Chemotherapy||42
6265859|NCT00033657|7165036|FG001|Eligible|Neoadjuvant Chemotherapy||43
6265860|NCT00033657|7165035|FG000|Eligible and Treated|Neoadjuvant Chemotherapy||39
6265861|NCT00033657|7165036|FG001|Eligible and Treated|Neoadjuvant Chemotherapy||42
6265862|NCT00033657|7165035|FG000|COMPLETED|Neoadjuvant Chemotherapy||36
6265863|NCT00033657|7165036|FG001|COMPLETED|Neoadjuvant Chemotherapy||36
6265864|NCT00033657|7165035|FG000|NOT COMPLETED|Neoadjuvant Chemotherapy||14
6265865|NCT00033657|7165036|FG001|NOT COMPLETED|Neoadjuvant Chemotherapy||11
6265866|NCT00033657|7165035|FG000|STARTED|Surgical Resection||36
6265867|NCT00033657|7165036|FG001|STARTED|Surgical Resection||36
6265868|NCT00033657|7165035|FG000|COMPLETED|Surgical Resection||36
6265869|NCT00033657|7165036|FG001|COMPLETED|Surgical Resection||33
6265870|NCT00033657|7165035|FG000|NOT COMPLETED|Surgical Resection||0
6265871|NCT00033657|7165036|FG001|NOT COMPLETED|Surgical Resection||3
6265872|NCT00033657|7165035|FG000|STARTED|Adjuvant Chemotherapy||36
6265873|NCT00033657|7165036|FG001|STARTED|Adjuvant Chemotherapy||33
6265874|NCT00033657|7165035|FG000|COMPLETED|Adjuvant Chemotherapy||18
6265875|NCT00033657|7165036|FG001|COMPLETED|Adjuvant Chemotherapy||16
6265876|NCT00033657|7165035|FG000|NOT COMPLETED|Adjuvant Chemotherapy||18
6265877|NCT00033657|7165036|FG001|NOT COMPLETED|Adjuvant Chemotherapy||17
6729651|NCT03154086|7659151|FG007|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||2
6729652|NCT03154086|7659152|FG008|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||4
6729653|NCT03154086|7659153|FG009|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729654|NCT03154086|7659154|FG010|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729655|NCT03154086|7659155|FG011|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729656|NCT03154086|7659156|FG012|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729657|NCT03154086|7659157|FG013|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729658|NCT03154086|7659158|FG014|STARTED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729659|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729660|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729661|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729662|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729663|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729664|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729665|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
6729666|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||2
6729667|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||4
6729668|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729669|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729670|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729671|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729672|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729673|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729674|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729675|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729676|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729677|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729678|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729679|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729680|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729681|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729682|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729683|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729684|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729685|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729686|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729687|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729688|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort3 Period1 (Up to 3 Days)||0
6729689|NCT03154086|7659144|FG000|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729690|NCT03154086|7659145|FG001|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729691|NCT03154086|7659146|FG002|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729692|NCT03154086|7659147|FG003|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729693|NCT03154086|7659148|FG004|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729694|NCT03154086|7659149|FG005|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729695|NCT03154086|7659150|FG006|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
6729696|NCT03154086|7659151|FG007|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
6729697|NCT03154086|7659152|FG008|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
6729698|NCT03154086|7659153|FG009|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729699|NCT03154086|7659154|FG010|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729700|NCT03154086|7659155|FG011|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729701|NCT03154086|7659156|FG012|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729702|NCT03154086|7659157|FG013|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729703|NCT03154086|7659158|FG014|STARTED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729704|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729705|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729706|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729707|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729708|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729709|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729710|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
6729711|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||2
6729712|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||4
6729713|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729714|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729715|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729716|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729717|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729718|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729719|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729720|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729721|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729722|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729723|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729724|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729725|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729726|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729727|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729728|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6265878|NCT00033917|7165046|FG000|STARTED|Overall Study||209
6265879|NCT00033917|7165047|FG001|STARTED|Overall Study||222
6265880|NCT00033917|7165046|FG000|COMPLETED|Overall Study||209
6265881|NCT00033917|7165047|FG001|COMPLETED|Overall Study||222
6265882|NCT00033917|7165046|FG000|NOT COMPLETED|Overall Study||0
6265883|NCT00033917|7165047|FG001|NOT COMPLETED|Overall Study||0
6265884|NCT00035555|7165060|FG000|STARTED|Overall Study|Randomized patients|74
6265885|NCT00035555|7165061|FG001|STARTED|Overall Study|Randomized patients|71
6265886|NCT00035555|7165062|FG002|STARTED|Overall Study|Randomized patients|73
6265887|NCT00035555|7165060|FG000|Number Who Had Undergone Transplantation|Overall Study||74
6265888|NCT00035555|7165061|FG001|Number Who Had Undergone Transplantation|Overall Study||71
6265889|NCT00035555|7165062|FG002|Number Who Had Undergone Transplantation|Overall Study||73
6265890|NCT00035555|7165060|FG000|Number Who Received Study Drug|Overall Study||74
6265891|NCT00035555|7165061|FG001|Number Who Received Study Drug|Overall Study||71
6265892|NCT00035555|7165062|FG002|Number Who Received Study Drug|Overall Study||71
6265893|NCT00035555|7165060|FG000|COMPLETED|Overall Study||58
6265894|NCT00035555|7165061|FG001|COMPLETED|Overall Study||55
6265895|NCT00035555|7165062|FG002|COMPLETED|Overall Study||51
6265896|NCT00035555|7165060|FG000|NOT COMPLETED|Overall Study||16
6265897|NCT00035555|7165061|FG001|NOT COMPLETED|Overall Study||16
6265898|NCT00035555|7165062|FG002|NOT COMPLETED|Overall Study||22
6265899|NCT00035815|7165073|FG000|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
6265900|NCT00035815|7165074|FG001|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
6265901|NCT00035815|7165073|FG000|COMPLETED|Overall Study||150
6265902|NCT00035815|7165074|FG001|COMPLETED|Overall Study||152
6265903|NCT00035815|7165073|FG000|NOT COMPLETED|Overall Study||17
6265904|NCT00035815|7165074|FG001|NOT COMPLETED|Overall Study||11
6265905|NCT00035932|7165083|FG000|STARTED|Overall Study|120 randomized, 119 treated|119
6265906|NCT00035932|7165084|FG001|STARTED|Overall Study|115 randomized, 110 treated|110
6265907|NCT00035932|7165085|FG002|STARTED|Overall Study|123 randomized, 118 treated|118
6265908|NCT00035932|7165083|FG000|Discontinued Prior to Week 48 Visit|Overall Study||26
6265909|NCT00035932|7165084|FG001|Discontinued Prior to Week 48 Visit|Overall Study||29
6265910|NCT00035932|7165085|FG002|Discontinued Prior to Week 48 Visit|Overall Study||13
6265911|NCT00035932|7165083|FG000|Discontinued Between Weeks 48 and 96|Overall Study||26
6265912|NCT00035932|7165084|FG001|Discontinued Between Weeks 48 and 96|Overall Study||27
6265913|NCT00035932|7165085|FG002|Discontinued Between Weeks 48 and 96|Overall Study||30
6265914|NCT00035932|7165083|FG000|Discontinued on or After Week 96|Overall Study||4
6265915|NCT00035932|7165084|FG001|Discontinued on or After Week 96|Overall Study||4
6265916|NCT00035932|7165085|FG002|Discontinued on or After Week 96|Overall Study||6
6265917|NCT00035932|7165083|FG000|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
6265918|NCT00035932|7165084|FG001|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
6265919|NCT00035932|7165085|FG002|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
6265920|NCT00035932|7165083|FG000|NOT COMPLETED|Overall Study||56
6265921|NCT00035932|7165084|FG001|NOT COMPLETED|Overall Study||60
6265922|NCT00035932|7165085|FG002|NOT COMPLETED|Overall Study||49
6265923|NCT00036270|7165100|FG000|STARTED|Randomized to Study Treatment||4904
6265924|NCT00036270|7165101|FG001|STARTED|Randomized to Study Treatment||4875
6265925|NCT00036270|7165100|FG000|COMPLETED|Randomized to Study Treatment||4898
6265926|NCT00036270|7165101|FG001|COMPLETED|Randomized to Study Treatment||4868
6265927|NCT00036270|7165100|FG000|NOT COMPLETED|Randomized to Study Treatment||6
6265928|NCT00036270|7165101|FG001|NOT COMPLETED|Randomized to Study Treatment||7
6265929|NCT00036270|7165100|FG000|STARTED|Study Treatment to 5 Year Report||4898
6265930|NCT00036270|7165101|FG001|STARTED|Study Treatment to 5 Year Report||4868
6265931|NCT00036270|7165100|FG000|Treated|Study Treatment to 5 Year Report||4852
6265932|NCT00036270|7165101|FG001|Treated|Study Treatment to 5 Year Report||4814
6265933|NCT00036270|7165100|FG000|COMPLETED|Study Treatment to 5 Year Report||2333
6265934|NCT00036270|7165101|FG001|COMPLETED|Study Treatment to 5 Year Report||1380
6265935|NCT00036270|7165100|FG000|NOT COMPLETED|Study Treatment to 5 Year Report||2565
6265936|NCT00036270|7165101|FG001|NOT COMPLETED|Study Treatment to 5 Year Report||3488
6265937|NCT00036569|7165107|FG000|STARTED|Overall Study||32
6265938|NCT00036569|7165107|FG000|COMPLETED|Overall Study||32
6265939|NCT00036569|7165107|FG000|NOT COMPLETED|Overall Study||0
6265940|NCT00036738|7165113|FG000|STARTED|Overall Study||28
6265941|NCT00036738|7165113|FG000|COMPLETED|Overall Study||28
6265942|NCT00036738|7165113|FG000|NOT COMPLETED|Overall Study||0
6265943|NCT00037830|7165120|FG000|STARTED|Overall Study||39
6265944|NCT00037830|7165121|FG001|STARTED|Overall Study||38
6265945|NCT00037830|7165122|FG002|STARTED|Overall Study||17
6265946|NCT00037830|7165120|FG000|COMPLETED|Overall Study||29
6265947|NCT00037830|7165121|FG001|COMPLETED|Overall Study||31
6265948|NCT00037830|7165122|FG002|COMPLETED|Overall Study||16
6265949|NCT00037830|7165120|FG000|NOT COMPLETED|Overall Study||10
6265950|NCT00037830|7165121|FG001|NOT COMPLETED|Overall Study||7
6265951|NCT00037830|7165122|FG002|NOT COMPLETED|Overall Study||1
6265952|NCT00038103|7165132|FG000|STARTED|Overall Study||55
6265953|NCT00038103|7165133|FG001|STARTED|Overall Study||56
6265954|NCT00038103|7165132|FG000|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
6265955|NCT00038103|7165133|FG001|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
6265956|NCT00038103|7165132|FG000|COMPLETED|Overall Study||0
6265957|NCT00038103|7165133|FG001|COMPLETED|Overall Study||0
6729729|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729730|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729731|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729732|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729733|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort3 Washout1 (Up to 14 Days)||0
6729734|NCT03154086|7659144|FG000|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729735|NCT03154086|7659145|FG001|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729736|NCT03154086|7659146|FG002|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729737|NCT03154086|7659147|FG003|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729738|NCT03154086|7659148|FG004|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729739|NCT03154086|7659149|FG005|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729740|NCT03154086|7659150|FG006|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
6729741|NCT03154086|7659151|FG007|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||2
6265958|NCT00038103|7165132|FG000|NOT COMPLETED|Overall Study||55
6265959|NCT00038103|7165133|FG001|NOT COMPLETED|Overall Study||56
6265960|NCT00038467|7165141|FG000|STARTED|Overall Study||2352
6265961|NCT00038467|7165142|FG001|STARTED|Overall Study||2372
6265962|NCT00038467|7165141|FG000|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
6265963|NCT00038467|7165142|FG001|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
6265964|NCT00038467|7165141|FG000|COMPLETED|Overall Study||1810
6265965|NCT00038467|7165142|FG001|COMPLETED|Overall Study||1830
6265966|NCT00038467|7165141|FG000|NOT COMPLETED|Overall Study||542
6265967|NCT00038467|7165142|FG001|NOT COMPLETED|Overall Study||542
6265968|NCT00038610|7165148|FG000|STARTED|Overall Study||54
6265969|NCT00038610|7165148|FG000|COMPLETED|Overall Study||54
6265970|NCT00038610|7165148|FG000|NOT COMPLETED|Overall Study||0
6265971|NCT00038649|7165152|FG000|STARTED|Overall Study||114
6265972|NCT00038649|7165152|FG000|COMPLETED|Overall Study||105
6265973|NCT00038649|7165152|FG000|NOT COMPLETED|Overall Study||9
6265974|NCT00038857|7165156|FG000|STARTED|Overall Study||29
6265975|NCT00038857|7165156|FG000|COMPLETED|Overall Study||28
6265976|NCT00038857|7165156|FG000|NOT COMPLETED|Overall Study||1
6265977|NCT00038948|7165162|FG000|STARTED|Overall Study||555
6265978|NCT00038948|7165163|FG001|STARTED|Overall Study||275
6265979|NCT00038948|7165162|FG000|COMPLETED|Overall Study||386
6265980|NCT00038948|7165163|FG001|COMPLETED|Overall Study||198
6265981|NCT00038948|7165162|FG000|NOT COMPLETED|Overall Study||169
6265982|NCT00038948|7165163|FG001|NOT COMPLETED|Overall Study||77
6265983|NCT00039130|7165175|FG000|STARTED|Overall Study||105
6265984|NCT00039130|7165175|FG000|COMPLETED|Overall Study||75
6265985|NCT00039130|7165175|FG000|NOT COMPLETED|Overall Study||30
6265986|NCT00039195|7165179|FG000|STARTED|Overall Study||98
6265987|NCT00039195|7165179|FG000|COMPLETED|Overall Study||98
6265988|NCT00039195|7165179|FG000|NOT COMPLETED|Overall Study||0
6265989|NCT00039377|7165183|FG000|STARTED|Initial Registration||57
6265990|NCT00039377|7165184|FG001|STARTED|Initial Registration||0
6265991|NCT00039377|7165185|FG002|STARTED|Initial Registration||0
6265992|NCT00039377|7165186|FG003|STARTED|Initial Registration||0
6265993|NCT00039377|7165183|FG000|COMPLETED|Initial Registration||35
6265994|NCT00039377|7165184|FG001|COMPLETED|Initial Registration||0
6265995|NCT00039377|7165185|FG002|COMPLETED|Initial Registration||0
6265996|NCT00039377|7165186|FG003|COMPLETED|Initial Registration||0
6265997|NCT00039377|7165183|FG000|NOT COMPLETED|Initial Registration||22
6265998|NCT00039377|7165184|FG001|NOT COMPLETED|Initial Registration||0
6265999|NCT00039377|7165185|FG002|NOT COMPLETED|Initial Registration||0
6266000|NCT00039377|7165186|FG003|NOT COMPLETED|Initial Registration||0
6266001|NCT00039377|7165183|FG000|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
6266002|NCT00039377|7165184|FG001|STARTED|Course 5 (Transplant Assignments)||15
6266003|NCT00039377|7165185|FG002|STARTED|Course 5 (Transplant Assignments)||19
6266004|NCT00039377|7165186|FG003|STARTED|Course 5 (Transplant Assignments)||1
6266005|NCT00039377|7165183|FG000|COMPLETED|Course 5 (Transplant Assignments)||0
6266006|NCT00039377|7165184|FG001|COMPLETED|Course 5 (Transplant Assignments)||15
6266007|NCT00039377|7165185|FG002|COMPLETED|Course 5 (Transplant Assignments)||19
6266008|NCT00039377|7165186|FG003|COMPLETED|Course 5 (Transplant Assignments)||1
6266009|NCT00039377|7165183|FG000|NOT COMPLETED|Course 5 (Transplant Assignments)||0
6266010|NCT00039377|7165184|FG001|NOT COMPLETED|Course 5 (Transplant Assignments)||0
6266011|NCT00039377|7165185|FG002|NOT COMPLETED|Course 5 (Transplant Assignments)||0
6266012|NCT00039377|7165186|FG003|NOT COMPLETED|Course 5 (Transplant Assignments)||0
6266013|NCT00039741|7165198|FG000|STARTED|Overall Study||66
6266014|NCT00039741|7165199|FG001|STARTED|Overall Study||68
6602980|NCT02059291|7527981|FG022|COMPLETED|Epoch 2||0
6602981|NCT02059291|7527982|FG023|COMPLETED|Epoch 2||0
6602982|NCT02059291|7527983|FG024|COMPLETED|Epoch 2||0
6602983|NCT02059291|7527959|FG000|NOT COMPLETED|Epoch 2||0
6602984|NCT02059291|7527960|FG001|NOT COMPLETED|Epoch 2||1
6602985|NCT02059291|7527961|FG002|NOT COMPLETED|Epoch 2||1
6602986|NCT02059291|7527962|FG003|NOT COMPLETED|Epoch 2||2
6602987|NCT02059291|7527963|FG004|NOT COMPLETED|Epoch 2||0
6602988|NCT02059291|7527964|FG005|NOT COMPLETED|Epoch 2||2
6602989|NCT02059291|7527965|FG006|NOT COMPLETED|Epoch 2||0
6602990|NCT02059291|7527966|FG007|NOT COMPLETED|Epoch 2||1
6602991|NCT02059291|7527967|FG008|NOT COMPLETED|Epoch 2||2
6729742|NCT03154086|7659152|FG008|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)|1 par was unwell on Day-1 of Period 2 and discontinued; hence,1 replacement was enrolled and dosed|5
6729743|NCT03154086|7659153|FG009|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729744|NCT03154086|7659154|FG010|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729745|NCT03154086|7659155|FG011|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729746|NCT03154086|7659156|FG012|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729747|NCT03154086|7659157|FG013|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729748|NCT03154086|7659158|FG014|STARTED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729749|NCT03154086|7659144|FG000|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729750|NCT03154086|7659145|FG001|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729751|NCT03154086|7659146|FG002|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729752|NCT03154086|7659147|FG003|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729753|NCT03154086|7659148|FG004|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729754|NCT03154086|7659149|FG005|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729755|NCT03154086|7659150|FG006|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||2
6729756|NCT03154086|7659151|FG007|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
6729757|NCT03154086|7659152|FG008|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||4
6729758|NCT03154086|7659153|FG009|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729759|NCT03154086|7659154|FG010|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729760|NCT03154086|7659155|FG011|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729761|NCT03154086|7659156|FG012|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729762|NCT03154086|7659157|FG013|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729763|NCT03154086|7659158|FG014|COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729764|NCT03154086|7659144|FG000|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729765|NCT03154086|7659145|FG001|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729766|NCT03154086|7659146|FG002|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729767|NCT03154086|7659147|FG003|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729768|NCT03154086|7659148|FG004|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729769|NCT03154086|7659149|FG005|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729770|NCT03154086|7659150|FG006|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729771|NCT03154086|7659151|FG007|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
6729772|NCT03154086|7659152|FG008|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||1
6729773|NCT03154086|7659153|FG009|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729774|NCT03154086|7659154|FG010|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729775|NCT03154086|7659155|FG011|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729776|NCT03154086|7659156|FG012|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729777|NCT03154086|7659157|FG013|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729778|NCT03154086|7659158|FG014|NOT COMPLETED|Part A: Cohort3 Period2 (Up to 3 Days)||0
6729779|NCT03154086|7659144|FG000|STARTED|Part B (Up to 25 Days)||0
6729780|NCT03154086|7659145|FG001|STARTED|Part B (Up to 25 Days)||0
6729781|NCT03154086|7659146|FG002|STARTED|Part B (Up to 25 Days)||0
6729782|NCT03154086|7659147|FG003|STARTED|Part B (Up to 25 Days)||0
6729783|NCT03154086|7659148|FG004|STARTED|Part B (Up to 25 Days)||0
6729784|NCT03154086|7659149|FG005|STARTED|Part B (Up to 25 Days)||0
6729785|NCT03154086|7659150|FG006|STARTED|Part B (Up to 25 Days)||0
6729786|NCT03154086|7659151|FG007|STARTED|Part B (Up to 25 Days)||0
6729787|NCT03154086|7659152|FG008|STARTED|Part B (Up to 25 Days)||0
6729788|NCT03154086|7659153|FG009|STARTED|Part B (Up to 25 Days)||10
6729789|NCT03154086|7659154|FG010|STARTED|Part B (Up to 25 Days)||6
6729790|NCT03154086|7659155|FG011|STARTED|Part B (Up to 25 Days)||6
6729791|NCT03154086|7659156|FG012|STARTED|Part B (Up to 25 Days)||6
6729792|NCT03154086|7659157|FG013|STARTED|Part B (Up to 25 Days)||6
6729793|NCT03154086|7659158|FG014|STARTED|Part B (Up to 25 Days)||6
6729794|NCT03154086|7659144|FG000|COMPLETED|Part B (Up to 25 Days)||0
6729795|NCT03154086|7659145|FG001|COMPLETED|Part B (Up to 25 Days)||0
6729796|NCT03154086|7659146|FG002|COMPLETED|Part B (Up to 25 Days)||0
6729797|NCT03154086|7659147|FG003|COMPLETED|Part B (Up to 25 Days)||0
6729798|NCT03154086|7659148|FG004|COMPLETED|Part B (Up to 25 Days)||0
6729799|NCT03154086|7659149|FG005|COMPLETED|Part B (Up to 25 Days)||0
6729800|NCT03154086|7659150|FG006|COMPLETED|Part B (Up to 25 Days)||0
6729801|NCT03154086|7659151|FG007|COMPLETED|Part B (Up to 25 Days)||0
6729802|NCT03154086|7659152|FG008|COMPLETED|Part B (Up to 25 Days)||0
6729803|NCT03154086|7659153|FG009|COMPLETED|Part B (Up to 25 Days)||10
6729804|NCT03154086|7659154|FG010|COMPLETED|Part B (Up to 25 Days)||5
6729805|NCT03154086|7659155|FG011|COMPLETED|Part B (Up to 25 Days)||6
6729806|NCT03154086|7659156|FG012|COMPLETED|Part B (Up to 25 Days)||6
6729807|NCT03154086|7659157|FG013|COMPLETED|Part B (Up to 25 Days)||6
6729808|NCT03154086|7659158|FG014|COMPLETED|Part B (Up to 25 Days)||6
6729809|NCT03154086|7659144|FG000|NOT COMPLETED|Part B (Up to 25 Days)||0
6729810|NCT03154086|7659145|FG001|NOT COMPLETED|Part B (Up to 25 Days)||0
6729811|NCT03154086|7659146|FG002|NOT COMPLETED|Part B (Up to 25 Days)||0
6729812|NCT03154086|7659147|FG003|NOT COMPLETED|Part B (Up to 25 Days)||0
6729813|NCT03154086|7659148|FG004|NOT COMPLETED|Part B (Up to 25 Days)||0
6729814|NCT03154086|7659149|FG005|NOT COMPLETED|Part B (Up to 25 Days)||0
6729815|NCT03154086|7659150|FG006|NOT COMPLETED|Part B (Up to 25 Days)||0
6729816|NCT03154086|7659151|FG007|NOT COMPLETED|Part B (Up to 25 Days)||0
6729817|NCT03154086|7659152|FG008|NOT COMPLETED|Part B (Up to 25 Days)||0
6729818|NCT03154086|7659153|FG009|NOT COMPLETED|Part B (Up to 25 Days)||0
6729819|NCT03154086|7659154|FG010|NOT COMPLETED|Part B (Up to 25 Days)||1
6729820|NCT03154086|7659155|FG011|NOT COMPLETED|Part B (Up to 25 Days)||0
6729821|NCT03154086|7659156|FG012|NOT COMPLETED|Part B (Up to 25 Days)||0
6729822|NCT03154086|7659157|FG013|NOT COMPLETED|Part B (Up to 25 Days)||0
6729823|NCT03154086|7659158|FG014|NOT COMPLETED|Part B (Up to 25 Days)||0
6729824|NCT03154333|7659216|FG000|STARTED|Overall Study||28
6729825|NCT03154333|7659217|FG001|STARTED|Overall Study||26
6729826|NCT03154333|7659216|FG000|COMPLETED|Overall Study||21
6729827|NCT03154333|7659217|FG001|COMPLETED|Overall Study||21
6729828|NCT03154333|7659216|FG000|NOT COMPLETED|Overall Study||7
6729829|NCT03154333|7659217|FG001|NOT COMPLETED|Overall Study||5
6729830|NCT03154476|7659226|FG000|STARTED|Overall Study||10
6729831|NCT03154476|7659227|FG001|STARTED|Overall Study||10
6729832|NCT03154476|7659226|FG000|COMPLETED|Overall Study||6
6729833|NCT03154476|7659227|FG001|COMPLETED|Overall Study||6
6729834|NCT03154476|7659226|FG000|NOT COMPLETED|Overall Study||4
6729835|NCT03154476|7659227|FG001|NOT COMPLETED|Overall Study||4
6729836|NCT03154658|7659235|FG000|STARTED|Overall Study||33
6729837|NCT03154658|7659236|FG001|STARTED|Overall Study||33
6729838|NCT03154658|7659235|FG000|COMPLETED|Overall Study||32
6729839|NCT03154658|7659236|FG001|COMPLETED|Overall Study||32
6729840|NCT03154658|7659235|FG000|NOT COMPLETED|Overall Study||1
6729841|NCT03154658|7659236|FG001|NOT COMPLETED|Overall Study||1
6729842|NCT03154710|7659244|FG000|STARTED|Overall Study||27
6729843|NCT03154710|7659245|FG001|STARTED|Overall Study||25
6729844|NCT03154710|7659244|FG000|COMPLETED|Overall Study||20
6729845|NCT03154710|7659245|FG001|COMPLETED|Overall Study||20
6729846|NCT03154710|7659244|FG000|NOT COMPLETED|Overall Study||7
6729847|NCT03154710|7659245|FG001|NOT COMPLETED|Overall Study||5
6729848|NCT03155178|7659255|FG000|STARTED|Overall Study||69
6729849|NCT03155178|7659256|FG001|STARTED|Overall Study||69
6729850|NCT03155178|7659257|FG002|STARTED|Overall Study||69
6729851|NCT03155178|7659258|FG003|STARTED|Overall Study||69
6729852|NCT03155178|7659255|FG000|COMPLETED|Overall Study||62
6729853|NCT03155178|7659256|FG001|COMPLETED|Overall Study||62
6729854|NCT03155178|7659257|FG002|COMPLETED|Overall Study||62
6729855|NCT03155178|7659258|FG003|COMPLETED|Overall Study||62
6729856|NCT03155178|7659255|FG000|NOT COMPLETED|Overall Study||7
6729857|NCT03155178|7659256|FG001|NOT COMPLETED|Overall Study||7
6729858|NCT03155178|7659257|FG002|NOT COMPLETED|Overall Study||7
6729859|NCT03155178|7659258|FG003|NOT COMPLETED|Overall Study||7
6729860|NCT03155269|7659274|FG000|STARTED|Overall Study||57
6729861|NCT03155269|7659275|FG001|STARTED|Overall Study||57
6729862|NCT03155269|7659274|FG000|COMPLETED|Overall Study||52
6729863|NCT03155269|7659275|FG001|COMPLETED|Overall Study||50
6729864|NCT03155269|7659274|FG000|NOT COMPLETED|Overall Study||5
6729865|NCT03155269|7659275|FG001|NOT COMPLETED|Overall Study||7
6729866|NCT03155724|7659281|FG000|STARTED|Overall Study||53
6729867|NCT03155724|7659281|FG000|COMPLETED|Overall Study||42
6729868|NCT03155724|7659281|FG000|NOT COMPLETED|Overall Study||11
6729869|NCT03155945|7659287|FG000|STARTED|Overall Study||6
6729870|NCT03155945|7659288|FG001|STARTED|Overall Study||8
6729871|NCT03155945|7659287|FG000|COMPLETED|Overall Study||6
6729872|NCT03155945|7659288|FG001|COMPLETED|Overall Study||5
6729873|NCT03155945|7659287|FG000|NOT COMPLETED|Overall Study||0
6729874|NCT03155945|7659288|FG001|NOT COMPLETED|Overall Study||3
6729875|NCT03156270|7659294|FG000|STARTED|Overall Study||20
6729876|NCT03156270|7659294|FG000|COMPLETED|Overall Study||18
6729877|NCT03156270|7659294|FG000|NOT COMPLETED|Overall Study||2
6729878|NCT03156543|7659302|FG000|STARTED|Overall Study||9
6729879|NCT03156543|7659303|FG001|STARTED|Overall Study||23
6729880|NCT03156543|7659302|FG000|COMPLETED|Overall Study||8
6729881|NCT03156543|7659303|FG001|COMPLETED|Overall Study||23
6729882|NCT03156543|7659302|FG000|NOT COMPLETED|Overall Study||1
6729883|NCT03156543|7659303|FG001|NOT COMPLETED|Overall Study||0
6729884|NCT03156621|7659311|FG000|STARTED|Double-Blind Treatment Period (DBTP)||24
6729885|NCT03156621|7659312|FG001|STARTED|Double-Blind Treatment Period (DBTP)||45
6729886|NCT03156621|7659311|FG000|COMPLETED|Double-Blind Treatment Period (DBTP)||24
6729887|NCT03156621|7659312|FG001|COMPLETED|Double-Blind Treatment Period (DBTP)||45
6729888|NCT03156621|7659311|FG000|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
6729889|NCT03156621|7659312|FG001|NOT COMPLETED|Double-Blind Treatment Period (DBTP)||0
6729890|NCT03156621|7659311|FG000|STARTED|Open-Label Treatment Period (OLTP)||24
6729891|NCT03156621|7659312|FG001|STARTED|Open-Label Treatment Period (OLTP)||45
6729892|NCT03156621|7659311|FG000|COMPLETED|Open-Label Treatment Period (OLTP)||24
6729893|NCT03156621|7659312|FG001|COMPLETED|Open-Label Treatment Period (OLTP)||42
6729894|NCT03156621|7659311|FG000|NOT COMPLETED|Open-Label Treatment Period (OLTP)||0
6729895|NCT03156621|7659312|FG001|NOT COMPLETED|Open-Label Treatment Period (OLTP)||3
6739845|NCT03296072|7668702|FG003|COMPLETED|Treament Period 1: Wash Out Period||10
6739846|NCT03296072|7668703|FG004|COMPLETED|Treament Period 1: Wash Out Period||10
6739847|NCT03296072|7668704|FG005|COMPLETED|Treament Period 1: Wash Out Period||11
6739848|NCT03296072|7668699|FG000|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6739849|NCT03296072|7668700|FG001|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6739850|NCT03296072|7668701|FG002|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6739851|NCT03296072|7668702|FG003|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6739852|NCT03296072|7668703|FG004|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6739853|NCT03296072|7668704|FG005|NOT COMPLETED|Treament Period 1: Wash Out Period||0
6739854|NCT03296072|7668699|FG000|STARTED|Treament Period 2||10
6739855|NCT03296072|7668700|FG001|STARTED|Treament Period 2||11
6739856|NCT03296072|7668701|FG002|STARTED|Treament Period 2||10
6739857|NCT03296072|7668702|FG003|STARTED|Treament Period 2||10
6739858|NCT03296072|7668703|FG004|STARTED|Treament Period 2||10
6739859|NCT03296072|7668704|FG005|STARTED|Treament Period 2||11
6739860|NCT03296072|7668699|FG000|COMPLETED|Treament Period 2||10
6739861|NCT03296072|7668700|FG001|COMPLETED|Treament Period 2||11
6739862|NCT03296072|7668701|FG002|COMPLETED|Treament Period 2||10
6739863|NCT03296072|7668702|FG003|COMPLETED|Treament Period 2||10
6739864|NCT03296072|7668703|FG004|COMPLETED|Treament Period 2||10
6739865|NCT03296072|7668704|FG005|COMPLETED|Treament Period 2||11
6739866|NCT03296072|7668699|FG000|NOT COMPLETED|Treament Period 2||0
6739867|NCT03296072|7668700|FG001|NOT COMPLETED|Treament Period 2||0
6739868|NCT03296072|7668701|FG002|NOT COMPLETED|Treament Period 2||0
6739869|NCT03296072|7668702|FG003|NOT COMPLETED|Treament Period 2||0
6739870|NCT03296072|7668703|FG004|NOT COMPLETED|Treament Period 2||0
6739871|NCT03296072|7668704|FG005|NOT COMPLETED|Treament Period 2||0
6739872|NCT03296072|7668699|FG000|STARTED|Treament Period 2: Wash Out Period||10
6739873|NCT03296072|7668700|FG001|STARTED|Treament Period 2: Wash Out Period||11
6739874|NCT03296072|7668701|FG002|STARTED|Treament Period 2: Wash Out Period||10
6739875|NCT03296072|7668702|FG003|STARTED|Treament Period 2: Wash Out Period||10
6739876|NCT03296072|7668703|FG004|STARTED|Treament Period 2: Wash Out Period||10
6739877|NCT03296072|7668704|FG005|STARTED|Treament Period 2: Wash Out Period||11
6739878|NCT03296072|7668699|FG000|COMPLETED|Treament Period 2: Wash Out Period||10
6739879|NCT03296072|7668700|FG001|COMPLETED|Treament Period 2: Wash Out Period||11
6739880|NCT03296072|7668701|FG002|COMPLETED|Treament Period 2: Wash Out Period||10
6739881|NCT03296072|7668702|FG003|COMPLETED|Treament Period 2: Wash Out Period||10
6739882|NCT03296072|7668703|FG004|COMPLETED|Treament Period 2: Wash Out Period||10
6739883|NCT03296072|7668704|FG005|COMPLETED|Treament Period 2: Wash Out Period||11
6739884|NCT03296072|7668699|FG000|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6739885|NCT03296072|7668700|FG001|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6739886|NCT03296072|7668701|FG002|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6739887|NCT03296072|7668702|FG003|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6739888|NCT03296072|7668703|FG004|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6739889|NCT03296072|7668704|FG005|NOT COMPLETED|Treament Period 2: Wash Out Period||0
6739890|NCT03296072|7668699|FG000|STARTED|Treament Period 3||10
6739891|NCT03296072|7668700|FG001|STARTED|Treament Period 3||11
6739892|NCT03296072|7668701|FG002|STARTED|Treament Period 3||10
6739893|NCT03296072|7668702|FG003|STARTED|Treament Period 3||10
6739894|NCT03296072|7668703|FG004|STARTED|Treament Period 3||10
6739895|NCT03296072|7668704|FG005|STARTED|Treament Period 3||11
6739896|NCT03296072|7668699|FG000|COMPLETED|Treament Period 3||10
6739897|NCT03296072|7668700|FG001|COMPLETED|Treament Period 3||11
6739898|NCT03296072|7668701|FG002|COMPLETED|Treament Period 3||10
6739899|NCT03296072|7668702|FG003|COMPLETED|Treament Period 3||10
6739900|NCT03296072|7668703|FG004|COMPLETED|Treament Period 3||10
6739901|NCT03296072|7668704|FG005|COMPLETED|Treament Period 3||11
6739902|NCT03296072|7668699|FG000|NOT COMPLETED|Treament Period 3||0
6739903|NCT03296072|7668700|FG001|NOT COMPLETED|Treament Period 3||0
6739904|NCT03296072|7668701|FG002|NOT COMPLETED|Treament Period 3||0
6266015|NCT00039741|7165200|FG002|STARTED|Overall Study||65
6266016|NCT00039741|7165201|FG003|STARTED|Overall Study||64
6266017|NCT00039741|7165198|FG000|Death|Overall Study||0
6266018|NCT00039741|7165199|FG001|Death|Overall Study||1
6266019|NCT00039741|7165200|FG002|Death|Overall Study||0
6266020|NCT00039741|7165201|FG003|Death|Overall Study||0
6266021|NCT00039741|7165198|FG000|COMPLETED|Overall Study||51
6266022|NCT00039741|7165199|FG001|COMPLETED|Overall Study||56
6266023|NCT00039741|7165200|FG002|COMPLETED|Overall Study||54
6266024|NCT00039741|7165201|FG003|COMPLETED|Overall Study||50
6266025|NCT00039741|7165198|FG000|NOT COMPLETED|Overall Study||15
6266026|NCT00039741|7165199|FG001|NOT COMPLETED|Overall Study||12
6266027|NCT00039741|7165200|FG002|NOT COMPLETED|Overall Study||11
6266028|NCT00039741|7165201|FG003|NOT COMPLETED|Overall Study||14
6266029|NCT00039871|7165211|FG000|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
6266030|NCT00039871|7165211|FG000|COMPLETED|Overall Study||928
6729896|NCT03157089|7659323|FG000|STARTED|Overall Study||12
6729897|NCT03157089|7659324|FG001|STARTED|Overall Study||12
6729898|NCT03157089|7659323|FG000|Treated|Overall Study||12
6729899|NCT03157089|7659324|FG001|Treated|Overall Study||12
6729900|NCT03157089|7659323|FG000|COMPLETED|Overall Study||0
6729901|NCT03157089|7659324|FG001|COMPLETED|Overall Study||0
6729902|NCT03157089|7659323|FG000|NOT COMPLETED|Overall Study||12
6729903|NCT03157089|7659324|FG001|NOT COMPLETED|Overall Study||12
6729904|NCT03157232|7659331|FG000|STARTED|Overall Study||18
6729905|NCT03157232|7659331|FG000|COMPLETED|Overall Study||18
6729906|NCT03157232|7659331|FG000|NOT COMPLETED|Overall Study||0
6729907|NCT03157531|7659335|FG000|STARTED|Overall Study||97
6729908|NCT03157531|7659335|FG000|Analyzed at 30 Days For MAEs|Overall Study||93
6729909|NCT03157531|7659335|FG000|COMPLETED|Overall Study||91
6729910|NCT03157531|7659335|FG000|NOT COMPLETED|Overall Study||6
6729911|NCT03157583|7659339|FG000|STARTED|Overall Study||8
6729912|NCT03157583|7659339|FG000|COMPLETED|Overall Study||7
6729913|NCT03157583|7659339|FG000|NOT COMPLETED|Overall Study||1
6729914|NCT03158012|7659359|FG000|STARTED|Overall Study||8
6729915|NCT03158012|7659360|FG001|STARTED|Overall Study||7
6729916|NCT03158012|7659359|FG000|COMPLETED|Overall Study||8
6729917|NCT03158012|7659360|FG001|COMPLETED|Overall Study||6
6729918|NCT03158012|7659359|FG000|NOT COMPLETED|Overall Study||0
6729919|NCT03158012|7659360|FG001|NOT COMPLETED|Overall Study||1
6729920|NCT03158038|7659368|FG000|STARTED|Overall Study||240
6729921|NCT03158038|7659369|FG001|STARTED|Overall Study||60
6729922|NCT03158038|7659368|FG000|COMPLETED|Overall Study||240
6729923|NCT03158038|7659369|FG001|COMPLETED|Overall Study||60
6729924|NCT03158038|7659368|FG000|NOT COMPLETED|Overall Study||0
6729925|NCT03158038|7659369|FG001|NOT COMPLETED|Overall Study||0
6729926|NCT03158116|7659375|FG000|STARTED|Overall Study||5
6729927|NCT03158116|7659375|FG000|COMPLETED|Overall Study||5
6729928|NCT03158116|7659375|FG000|NOT COMPLETED|Overall Study||0
6729929|NCT03158220|7659381|FG000|STARTED|Overall Study||570
6729930|NCT03158220|7659382|FG001|STARTED|Overall Study||642
6729931|NCT03158220|7659381|FG000|Vaccination 1|Overall Study||570
6729932|NCT03158220|7659382|FG001|Vaccination 1|Overall Study||640
6729933|NCT03158220|7659381|FG000|Vaccination 2|Overall Study||563
6729934|NCT03158220|7659382|FG001|Vaccination 2|Overall Study||635
6729935|NCT03158220|7659381|FG000|Vaccination 3|Overall Study||556
6729936|NCT03158220|7659382|FG001|Vaccination 3|Overall Study||629
6729937|NCT03158220|7659381|FG000|COMPLETED|Overall Study||553
6729938|NCT03158220|7659382|FG001|COMPLETED|Overall Study||626
6729939|NCT03158220|7659381|FG000|NOT COMPLETED|Overall Study||17
6729940|NCT03158220|7659382|FG001|NOT COMPLETED|Overall Study||16
6729941|NCT03158272|7659392|FG000|STARTED|Overall Study||3
6729942|NCT03158272|7659393|FG001|STARTED|Overall Study||4
6729943|NCT03158272|7659394|FG002|STARTED|Overall Study||6
6729944|NCT03158272|7659395|FG003|STARTED|Overall Study||6
6729945|NCT03158272|7659392|FG000|COMPLETED|Overall Study||0
6729946|NCT03158272|7659393|FG001|COMPLETED|Overall Study||0
6729947|NCT03158272|7659394|FG002|COMPLETED|Overall Study||0
6729948|NCT03158272|7659395|FG003|COMPLETED|Overall Study||0
6729949|NCT03158272|7659392|FG000|NOT COMPLETED|Overall Study||3
6729950|NCT03158272|7659393|FG001|NOT COMPLETED|Overall Study||4
6729951|NCT03158272|7659394|FG002|NOT COMPLETED|Overall Study||6
6729952|NCT03158272|7659395|FG003|NOT COMPLETED|Overall Study||6
6729953|NCT03158311|7659410|FG000|STARTED|Overall Study||474
6729954|NCT03158311|7659411|FG001|STARTED|Overall Study||476
6729955|NCT03158311|7659412|FG002|STARTED|Overall Study||476
6729956|NCT03158311|7659410|FG000|Full Analysis Set (FAS)|Overall Study||474
6729957|NCT03158311|7659411|FG001|Full Analysis Set (FAS)|Overall Study||476
6729958|NCT03158311|7659412|FG002|Full Analysis Set (FAS)|Overall Study||475
6729959|NCT03158311|7659410|FG000|Safety Set (SAF)|Overall Study||474
6729960|NCT03158311|7659411|FG001|Safety Set (SAF)|Overall Study||476
6729961|NCT03158311|7659412|FG002|Safety Set (SAF)|Overall Study||475
6729962|NCT03158311|7659410|FG000|COMPLETED|Overall Study||452
6729963|NCT03158311|7659411|FG001|COMPLETED|Overall Study||460
6729964|NCT03158311|7659412|FG002|COMPLETED|Overall Study||448
6729965|NCT03158311|7659410|FG000|NOT COMPLETED|Overall Study||22
6729966|NCT03158311|7659411|FG001|NOT COMPLETED|Overall Study||16
6729967|NCT03158311|7659412|FG002|NOT COMPLETED|Overall Study||28
6729968|NCT03158714|7659423|FG000|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
6729969|NCT03158714|7659424|FG001|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|626
6729970|NCT03158714|7659425|FG002|STARTED|Overall Study|Number of participants enrolled and Started represents number of individual participants rather than couples|606
6729971|NCT03158714|7659423|FG000|COMPLETED|Overall Study|Participated in half or more of program.|445
6729972|NCT03158714|7659424|FG001|COMPLETED|Overall Study|Participated in half or more of program.|398
6729973|NCT03158714|7659425|FG002|COMPLETED|Overall Study|All control group participants completed the control protocol (no program).|606
6729974|NCT03158714|7659423|FG000|NOT COMPLETED|Overall Study||181
6729975|NCT03158714|7659424|FG001|NOT COMPLETED|Overall Study||228
6729976|NCT03158714|7659425|FG002|NOT COMPLETED|Overall Study||0
6729977|NCT03159091|7659435|FG000|STARTED|Overall Study||121
6729978|NCT03159091|7659436|FG001|STARTED|Overall Study||117
6729979|NCT03159091|7659435|FG000|COMPLETED|Overall Study||116
6729980|NCT03159091|7659436|FG001|COMPLETED|Overall Study||113
6729981|NCT03159091|7659435|FG000|NOT COMPLETED|Overall Study||5
6729982|NCT03159091|7659436|FG001|NOT COMPLETED|Overall Study||4
6729983|NCT03159143|7659442|FG000|STARTED|Overall Study||22
6729984|NCT03159143|7659442|FG000|COMPLETED|Overall Study||22
6729985|NCT03159143|7659442|FG000|NOT COMPLETED|Overall Study||0
6729986|NCT03159195|7659448|FG000|STARTED|Overall Study||360
6729987|NCT03159195|7659449|FG001|STARTED|Overall Study||292
6729988|NCT03159195|7659448|FG000|COMPLETED|Overall Study||360
6729989|NCT03159195|7659449|FG001|COMPLETED|Overall Study||292
6729990|NCT03159195|7659448|FG000|NOT COMPLETED|Overall Study||0
6729991|NCT03159195|7659449|FG001|NOT COMPLETED|Overall Study||0
6729992|NCT03159260|7659457|FG000|STARTED|Overall Study||28
6729993|NCT03159260|7659458|FG001|STARTED|Overall Study||29
6729994|NCT03159260|7659457|FG000|COMPLETED|Overall Study||25
6729995|NCT03159260|7659458|FG001|COMPLETED|Overall Study||25
6729996|NCT03159260|7659457|FG000|NOT COMPLETED|Overall Study||3
6729997|NCT03159260|7659458|FG001|NOT COMPLETED|Overall Study||4
6729998|NCT03159299|7659466|FG000|STARTED|Overall Study||26
6729999|NCT03159299|7659467|FG001|STARTED|Overall Study||21
6730000|NCT03159299|7659466|FG000|COMPLETED|Overall Study||24
6730001|NCT03159299|7659467|FG001|COMPLETED|Overall Study||20
6730002|NCT03159299|7659466|FG000|NOT COMPLETED|Overall Study||2
6730003|NCT03159299|7659467|FG001|NOT COMPLETED|Overall Study||1
6730004|NCT03159455|7659479|FG000|STARTED|Overall Study||9
6730005|NCT03159455|7659480|FG001|STARTED|Overall Study||9
6730006|NCT03159455|7659481|FG002|STARTED|Overall Study||9
6730007|NCT03159455|7659482|FG003|STARTED|Overall Study||9
6730008|NCT03159455|7659483|FG004|STARTED|Overall Study||3
6730009|NCT03159455|7659484|FG005|STARTED|Overall Study||9
6730010|NCT03159455|7659479|FG000|COMPLETED|Overall Study||9
6730011|NCT03159455|7659480|FG001|COMPLETED|Overall Study||9
6730012|NCT03159455|7659481|FG002|COMPLETED|Overall Study||9
6730013|NCT03159455|7659482|FG003|COMPLETED|Overall Study||9
6730014|NCT03159455|7659483|FG004|COMPLETED|Overall Study||3
6730015|NCT03159455|7659484|FG005|COMPLETED|Overall Study||8
6730016|NCT03159455|7659479|FG000|NOT COMPLETED|Overall Study||0
6730017|NCT03159455|7659480|FG001|NOT COMPLETED|Overall Study||0
6730018|NCT03159455|7659481|FG002|NOT COMPLETED|Overall Study||0
6730019|NCT03159455|7659482|FG003|NOT COMPLETED|Overall Study||0
6730020|NCT03159455|7659483|FG004|NOT COMPLETED|Overall Study||0
6730021|NCT03159455|7659484|FG005|NOT COMPLETED|Overall Study||1
6730022|NCT03159468|7659508|FG000|STARTED|Overall Study||35
6730023|NCT03159468|7659509|FG001|STARTED|Overall Study||35
6730024|NCT03159468|7659510|FG002|STARTED|Overall Study||37
6730025|NCT03159468|7659511|FG003|STARTED|Overall Study||34
6730026|NCT03159468|7659512|FG004|STARTED|Overall Study||34
6730027|NCT03159468|7659513|FG005|STARTED|Overall Study||34
6730028|NCT03159468|7659508|FG000|COMPLETED|Overall Study||35
6730029|NCT03159468|7659509|FG001|COMPLETED|Overall Study||35
6730030|NCT03159468|7659510|FG002|COMPLETED|Overall Study||34
6730031|NCT03159468|7659511|FG003|COMPLETED|Overall Study||34
6730032|NCT03159468|7659512|FG004|COMPLETED|Overall Study||34
6730033|NCT03159468|7659513|FG005|COMPLETED|Overall Study||34
6730034|NCT03159468|7659508|FG000|NOT COMPLETED|Overall Study||0
6730035|NCT03159468|7659509|FG001|NOT COMPLETED|Overall Study||0
6730036|NCT03159468|7659510|FG002|NOT COMPLETED|Overall Study||3
6730037|NCT03159468|7659511|FG003|NOT COMPLETED|Overall Study||0
6730038|NCT03159468|7659512|FG004|NOT COMPLETED|Overall Study||0
6730039|NCT03159468|7659513|FG005|NOT COMPLETED|Overall Study||0
6730040|NCT03159611|7659529|FG000|STARTED|Overall Study||95
6730041|NCT03159611|7659530|FG001|STARTED|Overall Study||87
6730042|NCT03159611|7659529|FG000|COMPLETED|Overall Study||72
6730043|NCT03159611|7659530|FG001|COMPLETED|Overall Study||72
6730044|NCT03159611|7659529|FG000|NOT COMPLETED|Overall Study||23
6730045|NCT03159611|7659530|FG001|NOT COMPLETED|Overall Study||15
6730046|NCT03159624|7659538|FG000|STARTED|Overall Study||21
6730047|NCT03159624|7659539|FG001|STARTED|Overall Study||26
6730048|NCT03159624|7659538|FG000|COMPLETED|Overall Study||21
6730049|NCT03159624|7659539|FG001|COMPLETED|Overall Study||25
6730050|NCT03159624|7659538|FG000|NOT COMPLETED|Overall Study||0
6730051|NCT03159624|7659539|FG001|NOT COMPLETED|Overall Study||1
6730052|NCT03160027|7659549|FG000|STARTED|Overall Study||6
6730053|NCT03160027|7659550|FG001|STARTED|Overall Study||4
6730054|NCT03160027|7659551|FG002|STARTED|Overall Study||6
6730055|NCT03160027|7659552|FG003|STARTED|Overall Study||4
6730056|NCT03160027|7659549|FG000|COMPLETED|Overall Study||6
6730057|NCT03160027|7659550|FG001|COMPLETED|Overall Study||4
6730058|NCT03160027|7659551|FG002|COMPLETED|Overall Study||6
6730059|NCT03160027|7659552|FG003|COMPLETED|Overall Study||4
6730060|NCT03160027|7659549|FG000|NOT COMPLETED|Overall Study||0
6730061|NCT03160027|7659550|FG001|NOT COMPLETED|Overall Study||0
6730062|NCT03160027|7659551|FG002|NOT COMPLETED|Overall Study||0
6730063|NCT03160027|7659552|FG003|NOT COMPLETED|Overall Study||0
6730064|NCT03160170|7659565|FG000|STARTED|Overall Study||10
6730065|NCT03160170|7659566|FG001|STARTED|Overall Study||10
6730066|NCT03160170|7659565|FG000|COMPLETED|Overall Study||10
6730067|NCT03160170|7659566|FG001|COMPLETED|Overall Study||10
6730068|NCT03160170|7659565|FG000|NOT COMPLETED|Overall Study||0
6730069|NCT03160170|7659566|FG001|NOT COMPLETED|Overall Study||0
6730070|NCT03160287|7659572|FG000|STARTED|Overall Study||24
6730071|NCT03160287|7659572|FG000|COMPLETED|Overall Study||22
6730072|NCT03160287|7659572|FG000|NOT COMPLETED|Overall Study||2
6730073|NCT03160560|7659580|FG000|STARTED|First Intervention (3 Weeks)||25
6730074|NCT03160560|7659581|FG001|STARTED|First Intervention (3 Weeks)||25
6730075|NCT03160560|7659582|FG002|STARTED|First Intervention (3 Weeks)||25
6730076|NCT03160560|7659583|FG003|STARTED|First Intervention (3 Weeks)||25
6730077|NCT03160560|7659580|FG000|COMPLETED|First Intervention (3 Weeks)||23
6730078|NCT03160560|7659581|FG001|COMPLETED|First Intervention (3 Weeks)||24
6730079|NCT03160560|7659582|FG002|COMPLETED|First Intervention (3 Weeks)||24
6730080|NCT03160560|7659583|FG003|COMPLETED|First Intervention (3 Weeks)||25
6730081|NCT03160560|7659580|FG000|NOT COMPLETED|First Intervention (3 Weeks)||2
6730082|NCT03160560|7659581|FG001|NOT COMPLETED|First Intervention (3 Weeks)||1
6730083|NCT03160560|7659582|FG002|NOT COMPLETED|First Intervention (3 Weeks)||1
6730084|NCT03160560|7659583|FG003|NOT COMPLETED|First Intervention (3 Weeks)||0
6730085|NCT03160560|7659580|FG000|STARTED|Washout (2 Weeks)||23
6730086|NCT03160560|7659581|FG001|STARTED|Washout (2 Weeks)||24
6730087|NCT03160560|7659582|FG002|STARTED|Washout (2 Weeks)||24
6730088|NCT03160560|7659583|FG003|STARTED|Washout (2 Weeks)||25
6730089|NCT03160560|7659580|FG000|COMPLETED|Washout (2 Weeks)||23
6730090|NCT03160560|7659581|FG001|COMPLETED|Washout (2 Weeks)||24
6730091|NCT03160560|7659582|FG002|COMPLETED|Washout (2 Weeks)||24
6730092|NCT03160560|7659583|FG003|COMPLETED|Washout (2 Weeks)||25
6730093|NCT03160560|7659580|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6730094|NCT03160560|7659581|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6730095|NCT03160560|7659582|FG002|NOT COMPLETED|Washout (2 Weeks)||0
6730096|NCT03160560|7659583|FG003|NOT COMPLETED|Washout (2 Weeks)||0
6730097|NCT03160560|7659580|FG000|STARTED|Second Intervention (3 Weeks)||23
6730098|NCT03160560|7659581|FG001|STARTED|Second Intervention (3 Weeks)||24
6730099|NCT03160560|7659582|FG002|STARTED|Second Intervention (3 Weeks)||24
6730100|NCT03160560|7659583|FG003|STARTED|Second Intervention (3 Weeks)||25
6730101|NCT03160560|7659580|FG000|COMPLETED|Second Intervention (3 Weeks)||22
6730102|NCT03160560|7659581|FG001|COMPLETED|Second Intervention (3 Weeks)||24
6730103|NCT03160560|7659582|FG002|COMPLETED|Second Intervention (3 Weeks)||24
6730104|NCT03160560|7659583|FG003|COMPLETED|Second Intervention (3 Weeks)||25
6730105|NCT03160560|7659580|FG000|NOT COMPLETED|Second Intervention (3 Weeks)||1
6730106|NCT03160560|7659581|FG001|NOT COMPLETED|Second Intervention (3 Weeks)||0
6730107|NCT03160560|7659582|FG002|NOT COMPLETED|Second Intervention (3 Weeks)||0
6730108|NCT03160560|7659583|FG003|NOT COMPLETED|Second Intervention (3 Weeks)||0
6730109|NCT03160573|7659597|FG000|STARTED|First Sequence (3 Weeks)||23
6730110|NCT03160573|7659598|FG001|STARTED|First Sequence (3 Weeks)||26
6730111|NCT03160573|7659599|FG002|STARTED|First Sequence (3 Weeks)||25
6730112|NCT03160573|7659600|FG003|STARTED|First Sequence (3 Weeks)||25
6730113|NCT03160573|7659597|FG000|COMPLETED|First Sequence (3 Weeks)||22
6730114|NCT03160573|7659598|FG001|COMPLETED|First Sequence (3 Weeks)||23
6730115|NCT03160573|7659599|FG002|COMPLETED|First Sequence (3 Weeks)||23
6730116|NCT03160573|7659600|FG003|COMPLETED|First Sequence (3 Weeks)||23
6730117|NCT03160573|7659597|FG000|NOT COMPLETED|First Sequence (3 Weeks)||1
6730118|NCT03160573|7659598|FG001|NOT COMPLETED|First Sequence (3 Weeks)||3
6730119|NCT03160573|7659599|FG002|NOT COMPLETED|First Sequence (3 Weeks)||2
6730120|NCT03160573|7659600|FG003|NOT COMPLETED|First Sequence (3 Weeks)||2
6730121|NCT03160573|7659597|FG000|STARTED|Washout (2 Weeks)||22
6730122|NCT03160573|7659598|FG001|STARTED|Washout (2 Weeks)||23
6730123|NCT03160573|7659599|FG002|STARTED|Washout (2 Weeks)||23
6730124|NCT03160573|7659600|FG003|STARTED|Washout (2 Weeks)||23
6730125|NCT03160573|7659597|FG000|COMPLETED|Washout (2 Weeks)||22
6730126|NCT03160573|7659598|FG001|COMPLETED|Washout (2 Weeks)||23
6730127|NCT03160573|7659599|FG002|COMPLETED|Washout (2 Weeks)||23
6730128|NCT03160573|7659600|FG003|COMPLETED|Washout (2 Weeks)||23
6730129|NCT03160573|7659597|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6730130|NCT03160573|7659598|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6730131|NCT03160573|7659599|FG002|NOT COMPLETED|Washout (2 Weeks)||0
6730132|NCT03160573|7659600|FG003|NOT COMPLETED|Washout (2 Weeks)||0
6730133|NCT03160573|7659597|FG000|STARTED|Second Sequence (3 Weeks)||22
6730134|NCT03160573|7659598|FG001|STARTED|Second Sequence (3 Weeks)||23
6730135|NCT03160573|7659599|FG002|STARTED|Second Sequence (3 Weeks)||23
6730136|NCT03160573|7659600|FG003|STARTED|Second Sequence (3 Weeks)||23
6730137|NCT03160573|7659597|FG000|COMPLETED|Second Sequence (3 Weeks)||22
6730138|NCT03160573|7659598|FG001|COMPLETED|Second Sequence (3 Weeks)||23
6730139|NCT03160573|7659599|FG002|COMPLETED|Second Sequence (3 Weeks)||23
6730140|NCT03160573|7659600|FG003|COMPLETED|Second Sequence (3 Weeks)||23
6730141|NCT03160573|7659597|FG000|NOT COMPLETED|Second Sequence (3 Weeks)||0
6730142|NCT03160573|7659598|FG001|NOT COMPLETED|Second Sequence (3 Weeks)||0
6730143|NCT03160573|7659599|FG002|NOT COMPLETED|Second Sequence (3 Weeks)||0
6730144|NCT03160573|7659600|FG003|NOT COMPLETED|Second Sequence (3 Weeks)||0
6730145|NCT03160703|7659614|FG000|STARTED|Overall Study||55
6730146|NCT03160703|7659615|FG001|STARTED|Overall Study||55
6730147|NCT03160703|7659616|FG002|STARTED|Overall Study||55
6730148|NCT03160703|7659617|FG003|STARTED|Overall Study||55
6730149|NCT03160703|7659614|FG000|COMPLETED|Overall Study||55
6730150|NCT03160703|7659615|FG001|COMPLETED|Overall Study||55
6730151|NCT03160703|7659616|FG002|COMPLETED|Overall Study||55
6730152|NCT03160703|7659617|FG003|COMPLETED|Overall Study||54
6730153|NCT03160703|7659614|FG000|NOT COMPLETED|Overall Study||0
6730154|NCT03160703|7659615|FG001|NOT COMPLETED|Overall Study||0
6730155|NCT03160703|7659616|FG002|NOT COMPLETED|Overall Study||0
6730156|NCT03160703|7659617|FG003|NOT COMPLETED|Overall Study||1
6730157|NCT03160716|7659627|FG000|STARTED|Overall Study||60
6730158|NCT03160716|7659627|FG000|COMPLETED|Overall Study||59
6730159|NCT03160716|7659627|FG000|NOT COMPLETED|Overall Study||1
6730160|NCT03160885|7659633|FG000|STARTED|Initial Treatment Period||593
6730161|NCT03160885|7659634|FG001|STARTED|Initial Treatment Period||201
6730162|NCT03160885|7659635|FG002|STARTED|Initial Treatment Period||0
6730163|NCT03160885|7659636|FG003|STARTED|Initial Treatment Period||0
6730164|NCT03160885|7659637|FG004|STARTED|Initial Treatment Period||0
6730165|NCT03160885|7659638|FG005|STARTED|Initial Treatment Period||0
6730166|NCT03160885|7659639|FG006|STARTED|Initial Treatment Period||0
6730167|NCT03160885|7659633|FG000|COMPLETED|Initial Treatment Period||558
6730168|NCT03160885|7659634|FG001|COMPLETED|Initial Treatment Period||179
6730169|NCT03160885|7659635|FG002|COMPLETED|Initial Treatment Period||0
6730170|NCT03160885|7659636|FG003|COMPLETED|Initial Treatment Period||0
6730171|NCT03160885|7659637|FG004|COMPLETED|Initial Treatment Period||0
6730172|NCT03160885|7659638|FG005|COMPLETED|Initial Treatment Period||0
6730173|NCT03160885|7659639|FG006|COMPLETED|Initial Treatment Period||0
6266031|NCT00039871|7165211|FG000|NOT COMPLETED|Overall Study||1384
6266032|NCT00040365|7165215|FG000|STARTED|Overall Study||30
6266033|NCT00040365|7165215|FG000|Completed Follow Up Phase|Overall Study||19
6266034|NCT00040365|7165215|FG000|COMPLETED|Overall Study||19
6266035|NCT00040365|7165215|FG000|NOT COMPLETED|Overall Study||11
6266036|NCT00040443|7165221|FG000|STARTED|Overall Study||84
6266037|NCT00040443|7165222|FG001|STARTED|Overall Study||91
6266038|NCT00040443|7165221|FG000|COMPLETED|Overall Study||84
6266039|NCT00040443|7165222|FG001|COMPLETED|Overall Study||91
6266040|NCT00040443|7165221|FG000|NOT COMPLETED|Overall Study||0
6266041|NCT00040443|7165222|FG001|NOT COMPLETED|Overall Study||0
6266042|NCT00040664|7165228|FG000|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
6266043|NCT00040664|7165229|FG001|STARTED|Overall Study||17
6266044|NCT00040664|7165230|FG002|STARTED|Overall Study||17
6266045|NCT00040664|7165231|FG003|STARTED|Overall Study||35
6266046|NCT00040664|7165228|FG000|COMPLETED|Overall Study||16
6266047|NCT00040664|7165229|FG001|COMPLETED|Overall Study||4
6266048|NCT00040664|7165230|FG002|COMPLETED|Overall Study||4
6266049|NCT00040664|7165231|FG003|COMPLETED|Overall Study||8
6266050|NCT00040664|7165228|FG000|NOT COMPLETED|Overall Study||53
6266051|NCT00040664|7165229|FG001|NOT COMPLETED|Overall Study||13
6266052|NCT00040664|7165230|FG002|NOT COMPLETED|Overall Study||13
6266053|NCT00040664|7165231|FG003|NOT COMPLETED|Overall Study||27
6266054|NCT00040742|7165253|FG000|STARTED|Overall Study||188
6266055|NCT00040742|7165254|FG001|STARTED|Overall Study||183
6266056|NCT00040742|7165255|FG002|STARTED|Overall Study||187
6266057|NCT00040742|7165256|FG003|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
6266058|NCT00040742|7165253|FG000|COMPLETED|Overall Study||149
6266059|NCT00040742|7165254|FG001|COMPLETED|Overall Study||134
6266060|NCT00040742|7165255|FG002|COMPLETED|Overall Study||141
6266061|NCT00040742|7165256|FG003|COMPLETED|Overall Study||152
6266062|NCT00040742|7165253|FG000|NOT COMPLETED|Overall Study||39
6266063|NCT00040742|7165254|FG001|NOT COMPLETED|Overall Study||49
6266064|NCT00040742|7165255|FG002|NOT COMPLETED|Overall Study||46
6266065|NCT00040742|7165256|FG003|NOT COMPLETED|Overall Study||34
6266066|NCT00040846|7165272|FG000|STARTED|Overall Study||60
6266067|NCT00040846|7165273|FG001|STARTED|Overall Study||0
6266068|NCT00040846|7165274|FG002|STARTED|Overall Study||0
6266069|NCT00040846|7165275|FG003|STARTED|Overall Study||0
6266070|NCT00040846|7165276|FG004|STARTED|Overall Study||0
6266071|NCT00040846|7165277|FG005|STARTED|Overall Study||0
6266072|NCT00040846|7165272|FG000|COMPLETED|Overall Study||60
6266073|NCT00040846|7165273|FG001|COMPLETED|Overall Study||0
6266074|NCT00040846|7165274|FG002|COMPLETED|Overall Study||0
6266075|NCT00040846|7165275|FG003|COMPLETED|Overall Study||0
6266076|NCT00040846|7165276|FG004|COMPLETED|Overall Study||0
6266077|NCT00040846|7165277|FG005|COMPLETED|Overall Study||0
6266078|NCT00040846|7165272|FG000|NOT COMPLETED|Overall Study||0
6266079|NCT00040846|7165273|FG001|NOT COMPLETED|Overall Study||0
6266080|NCT00040846|7165274|FG002|NOT COMPLETED|Overall Study||0
6266081|NCT00040846|7165275|FG003|NOT COMPLETED|Overall Study||0
6266082|NCT00040846|7165276|FG004|NOT COMPLETED|Overall Study||0
6266083|NCT00040846|7165277|FG005|NOT COMPLETED|Overall Study||0
6266084|NCT00040937|7165291|FG000|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
6266085|NCT00040937|7165291|FG000|COMPLETED|Induction/PBSC Mobilization||110
6266086|NCT00040937|7165291|FG000|NOT COMPLETED|Induction/PBSC Mobilization||37
6266087|NCT00040937|7165291|FG000|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
6266088|NCT00040937|7165291|FG000|COMPLETED|Autologous PBSCT||77
6266089|NCT00040937|7165291|FG000|NOT COMPLETED|Autologous PBSCT||31
6266090|NCT00040937|7165291|FG000|STARTED|Maintenance||76
6266091|NCT00040937|7165291|FG000|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
6266092|NCT00040937|7165291|FG000|NOT COMPLETED|Maintenance||0
6266093|NCT00041067|7165298|FG000|STARTED|Overall Study||76
6266094|NCT00041067|7165298|FG000|Eligible|Overall Study||74
6266095|NCT00041067|7165298|FG000|COMPLETED|Overall Study||0
6266096|NCT00041067|7165298|FG000|NOT COMPLETED|Overall Study||76
6266097|NCT00041080|7165305|FG000|STARTED|Overall Study|number patients enrolled on study|69
6266098|NCT00041080|7165306|FG001|STARTED|Overall Study|number patients enrolled on study|70
6266099|NCT00041080|7165305|FG000|COMPLETED|Overall Study||39
6266100|NCT00041080|7165306|FG001|COMPLETED|Overall Study||60
6266101|NCT00041080|7165305|FG000|NOT COMPLETED|Overall Study||30
6266102|NCT00041080|7165306|FG001|NOT COMPLETED|Overall Study||10
6266103|NCT00041119|7165316|FG000|STARTED|Overall Study||1142
6730174|NCT03160885|7659633|FG000|NOT COMPLETED|Initial Treatment Period||35
6730175|NCT03160885|7659634|FG001|NOT COMPLETED|Initial Treatment Period||22
6730176|NCT03160885|7659635|FG002|NOT COMPLETED|Initial Treatment Period||0
6730177|NCT03160885|7659636|FG003|NOT COMPLETED|Initial Treatment Period||0
6730178|NCT03160885|7659637|FG004|NOT COMPLETED|Initial Treatment Period||0
6730179|NCT03160885|7659638|FG005|NOT COMPLETED|Initial Treatment Period||0
6730180|NCT03160885|7659639|FG006|NOT COMPLETED|Initial Treatment Period||0
6730181|NCT03160885|7659633|FG000|STARTED|Open-label Treatment||0
6730182|NCT03160885|7659634|FG001|STARTED|Open-label Treatment||0
6730183|NCT03160885|7659635|FG002|STARTED|Open-label Treatment||0
6730184|NCT03160885|7659636|FG003|STARTED|Open-label Treatment||0
6730185|NCT03160885|7659637|FG004|STARTED|Open-label Treatment||0
6730186|NCT03160885|7659638|FG005|STARTED|Open-label Treatment||0
6730187|NCT03160885|7659639|FG006|STARTED|Open-label Treatment||560
6730188|NCT03160885|7659633|FG000|COMPLETED|Open-label Treatment||0
6730189|NCT03160885|7659634|FG001|COMPLETED|Open-label Treatment||0
6730190|NCT03160885|7659635|FG002|COMPLETED|Open-label Treatment||0
6730191|NCT03160885|7659636|FG003|COMPLETED|Open-label Treatment||0
6730192|NCT03160885|7659637|FG004|COMPLETED|Open-label Treatment||0
6730193|NCT03160885|7659638|FG005|COMPLETED|Open-label Treatment||0
6730194|NCT03160885|7659639|FG006|COMPLETED|Open-label Treatment||423
6730195|NCT03160885|7659633|FG000|NOT COMPLETED|Open-label Treatment||0
6730196|NCT03160885|7659634|FG001|NOT COMPLETED|Open-label Treatment||0
6730197|NCT03160885|7659635|FG002|NOT COMPLETED|Open-label Treatment||0
6730198|NCT03160885|7659636|FG003|NOT COMPLETED|Open-label Treatment||0
6730199|NCT03160885|7659637|FG004|NOT COMPLETED|Open-label Treatment||0
6730200|NCT03160885|7659638|FG005|NOT COMPLETED|Open-label Treatment||0
6730201|NCT03160885|7659639|FG006|NOT COMPLETED|Open-label Treatment||137
6730202|NCT03160885|7659633|FG000|STARTED|Maintenance Treatment Period||0
6730203|NCT03160885|7659634|FG001|STARTED|Maintenance Treatment Period||0
6730204|NCT03160885|7659635|FG002|STARTED|Maintenance Treatment Period||91
6730205|NCT03160885|7659636|FG003|STARTED|Maintenance Treatment Period||90
6730206|NCT03160885|7659637|FG004|STARTED|Maintenance Treatment Period||46
6730207|NCT03160885|7659638|FG005|STARTED|Maintenance Treatment Period||31
6730208|NCT03160885|7659639|FG006|STARTED|Maintenance Treatment Period||0
6730209|NCT03160885|7659633|FG000|COMPLETED|Maintenance Treatment Period||0
6730210|NCT03160885|7659634|FG001|COMPLETED|Maintenance Treatment Period||0
6730211|NCT03160885|7659635|FG002|COMPLETED|Maintenance Treatment Period||52
6730212|NCT03160885|7659636|FG003|COMPLETED|Maintenance Treatment Period||50
6730213|NCT03160885|7659637|FG004|COMPLETED|Maintenance Treatment Period||15
6730214|NCT03160885|7659638|FG005|COMPLETED|Maintenance Treatment Period||16
6730215|NCT03160885|7659639|FG006|COMPLETED|Maintenance Treatment Period||0
6730216|NCT03160885|7659633|FG000|NOT COMPLETED|Maintenance Treatment Period||0
6730217|NCT03160885|7659634|FG001|NOT COMPLETED|Maintenance Treatment Period||0
6730218|NCT03160885|7659635|FG002|NOT COMPLETED|Maintenance Treatment Period||39
6730219|NCT03160885|7659636|FG003|NOT COMPLETED|Maintenance Treatment Period||40
6730220|NCT03160885|7659637|FG004|NOT COMPLETED|Maintenance Treatment Period||31
6730221|NCT03160885|7659638|FG005|NOT COMPLETED|Maintenance Treatment Period||15
6730222|NCT03160885|7659639|FG006|NOT COMPLETED|Maintenance Treatment Period||0
6730223|NCT03160898|7659660|FG000|STARTED|Overall Study||115
6730224|NCT03160898|7659661|FG001|STARTED|Overall Study|1 patient withdrew consent before study drug dosing and was therefore excluded from safety analysis|113
6730225|NCT03160898|7659662|FG002|STARTED|Overall Study||113
6730226|NCT03160898|7659663|FG003|STARTED|Overall Study||117
6730227|NCT03160898|7659660|FG000|COMPLETED|Overall Study||95
6730228|NCT03160898|7659661|FG001|COMPLETED|Overall Study||100
6730229|NCT03160898|7659662|FG002|COMPLETED|Overall Study||97
6730230|NCT03160898|7659663|FG003|COMPLETED|Overall Study||98
6730231|NCT03160898|7659660|FG000|NOT COMPLETED|Overall Study||20
6730232|NCT03160898|7659661|FG001|NOT COMPLETED|Overall Study||13
6730233|NCT03160898|7659662|FG002|NOT COMPLETED|Overall Study||16
6730234|NCT03160898|7659663|FG003|NOT COMPLETED|Overall Study||19
6730235|NCT03161158|7659676|FG000|STARTED|Overall Study||18
6730236|NCT03161158|7659677|FG001|STARTED|Overall Study||19
6730237|NCT03161158|7659676|FG000|COMPLETED|Overall Study||9
6730238|NCT03161158|7659677|FG001|COMPLETED|Overall Study||13
6730239|NCT03161158|7659676|FG000|NOT COMPLETED|Overall Study||9
6730240|NCT03161158|7659677|FG001|NOT COMPLETED|Overall Study||6
6730241|NCT03161327|7659683|FG000|STARTED|Overall Study||238
6730242|NCT03161327|7659683|FG000|COMPLETED|Overall Study||238
6730243|NCT03161327|7659683|FG000|NOT COMPLETED|Overall Study||0
6730244|NCT03161405|7659688|FG000|STARTED|First Intervention Period (3 Days)||12
6730245|NCT03161405|7659688|FG000|COMPLETED|First Intervention Period (3 Days)||12
6730246|NCT03161405|7659688|FG000|NOT COMPLETED|First Intervention Period (3 Days)||0
6730247|NCT03161405|7659688|FG000|STARTED|Washout Period (at Least 4 Days)||12
6730248|NCT03161405|7659688|FG000|COMPLETED|Washout Period (at Least 4 Days)||12
6730249|NCT03161405|7659688|FG000|NOT COMPLETED|Washout Period (at Least 4 Days)||0
6730250|NCT03161405|7659688|FG000|STARTED|Second Intervention Period (6 Days)||12
6730251|NCT03161405|7659688|FG000|COMPLETED|Second Intervention Period (6 Days)||11
6730252|NCT03161405|7659688|FG000|NOT COMPLETED|Second Intervention Period (6 Days)||1
6730253|NCT03161483|7659699|FG000|STARTED|Overall Study||83
6730254|NCT03161483|7659700|FG001|STARTED|Overall Study||42
6730255|NCT03161483|7659701|FG002|STARTED|Overall Study||82
6730256|NCT03161483|7659702|FG003|STARTED|Overall Study||81
6730257|NCT03161483|7659699|FG000|COMPLETED|Overall Study||73
6730258|NCT03161483|7659700|FG001|COMPLETED|Overall Study||39
6730259|NCT03161483|7659701|FG002|COMPLETED|Overall Study||62
6730260|NCT03161483|7659702|FG003|COMPLETED|Overall Study||73
6730261|NCT03161483|7659699|FG000|NOT COMPLETED|Overall Study||10
6730262|NCT03161483|7659700|FG001|NOT COMPLETED|Overall Study||3
6730263|NCT03161483|7659701|FG002|NOT COMPLETED|Overall Study||20
6730264|NCT03161483|7659702|FG003|NOT COMPLETED|Overall Study||8
6730265|NCT03161938|7659714|FG000|STARTED|Overall Study||32
6730266|NCT03161938|7659715|FG001|STARTED|Overall Study||32
6730267|NCT03161938|7659714|FG000|COMPLETED|Overall Study||32
6730268|NCT03161938|7659715|FG001|COMPLETED|Overall Study||32
6730269|NCT03161938|7659714|FG000|NOT COMPLETED|Overall Study||0
6730270|NCT03161938|7659715|FG001|NOT COMPLETED|Overall Study||0
6730271|NCT03162055|7659723|FG000|STARTED|Overall Study||559
6730272|NCT03162055|7659724|FG001|STARTED|Overall Study||560
6730273|NCT03162055|7659723|FG000|Received Treatment|Overall Study||557
6730274|NCT03162055|7659724|FG001|Received Treatment|Overall Study||560
6730275|NCT03162055|7659723|FG000|Safety Analysis Set|Overall Study||552
6730276|NCT03162055|7659724|FG001|Safety Analysis Set|Overall Study||552
6730277|NCT03162055|7659723|FG000|Full Analysis Set (FAS)|Overall Study||552
6730278|NCT03162055|7659724|FG001|Full Analysis Set (FAS)|Overall Study||552
6730279|NCT03162055|7659723|FG000|Per Protocol (PP) Analysis Set|Overall Study||506
6730280|NCT03162055|7659724|FG001|Per Protocol (PP) Analysis Set|Overall Study||510
6730281|NCT03162055|7659723|FG000|COMPLETED|Overall Study||497
6730282|NCT03162055|7659724|FG001|COMPLETED|Overall Study||517
6730283|NCT03162055|7659723|FG000|NOT COMPLETED|Overall Study||62
6730284|NCT03162055|7659724|FG001|NOT COMPLETED|Overall Study||43
6730285|NCT03162328|7659730|FG000|STARTED|Screening Period||84
6730286|NCT03162328|7659731|FG001|STARTED|Screening Period||0
6730287|NCT03162328|7659732|FG002|STARTED|Screening Period||0
6730288|NCT03162328|7659730|FG000|COMPLETED|Screening Period||62
6730289|NCT03162328|7659731|FG001|COMPLETED|Screening Period||0
6730290|NCT03162328|7659732|FG002|COMPLETED|Screening Period||0
6730291|NCT03162328|7659730|FG000|NOT COMPLETED|Screening Period||22
6730292|NCT03162328|7659731|FG001|NOT COMPLETED|Screening Period||0
6730293|NCT03162328|7659732|FG002|NOT COMPLETED|Screening Period||0
6730294|NCT03162328|7659730|FG000|STARTED|Study Period||0
6730295|NCT03162328|7659731|FG001|STARTED|Study Period||30
6730296|NCT03162328|7659732|FG002|STARTED|Study Period||32
6266104|NCT00041119|7165317|FG001|STARTED|Overall Study||789
6266105|NCT00041119|7165318|FG002|STARTED|Overall Study||1151
6602992|NCT02059291|7527968|FG009|NOT COMPLETED|Epoch 2||0
6602993|NCT02059291|7527969|FG010|NOT COMPLETED|Epoch 2||0
6602994|NCT02059291|7527970|FG011|NOT COMPLETED|Epoch 2||0
6266106|NCT00041119|7165319|FG003|STARTED|Overall Study||789
6266107|NCT00041119|7165316|FG000|COMPLETED|Overall Study||1142
6266108|NCT00041119|7165317|FG001|COMPLETED|Overall Study||789
6266109|NCT00041119|7165318|FG002|COMPLETED|Overall Study||1151
6266110|NCT00041119|7165319|FG003|COMPLETED|Overall Study||789
6266111|NCT00041119|7165316|FG000|NOT COMPLETED|Overall Study||0
6266112|NCT00041119|7165317|FG001|NOT COMPLETED|Overall Study||0
6266113|NCT00041119|7165318|FG002|NOT COMPLETED|Overall Study||0
6266114|NCT00041119|7165319|FG003|NOT COMPLETED|Overall Study||0
6266115|NCT00041132|7165333|FG000|STARTED|Overall Study||56
6266116|NCT00041132|7165333|FG000|Eligible|Overall Study||49
6266117|NCT00041132|7165333|FG000|Eligible and Began Protocol Therapy|Overall Study||49
6266118|NCT00041132|7165333|FG000|COMPLETED|Overall Study||26
6266119|NCT00041132|7165333|FG000|NOT COMPLETED|Overall Study||30
6266120|NCT00041392|7165339|FG000|STARTED|Overall Study||198
6266121|NCT00041392|7165340|FG001|STARTED|Overall Study||191
6266122|NCT00041392|7165339|FG000|COMPLETED|Overall Study||198
6266123|NCT00041392|7165340|FG001|COMPLETED|Overall Study||191
6266124|NCT00041392|7165339|FG000|NOT COMPLETED|Overall Study||0
6266125|NCT00041392|7165340|FG001|NOT COMPLETED|Overall Study||0
6266126|NCT00041470|7165346|FG000|STARTED|Overall Study||38
6266127|NCT00041470|7165346|FG000|COMPLETED|Overall Study||0
6266128|NCT00041470|7165346|FG000|NOT COMPLETED|Overall Study||38
6266129|NCT00041717|7165352|FG000|STARTED|Overall Study||114
6266130|NCT00041717|7165353|FG001|STARTED|Overall Study||98
6266131|NCT00041717|7165352|FG000|COMPLETED|Overall Study||81
6266132|NCT00041717|7165353|FG001|COMPLETED|Overall Study||86
6266133|NCT00041717|7165352|FG000|NOT COMPLETED|Overall Study||33
6266134|NCT00041717|7165353|FG001|NOT COMPLETED|Overall Study||12
6266135|NCT00041756|7165364|FG000|STARTED|Overall Study||77
6266136|NCT00041756|7165365|FG001|STARTED|Overall Study||80
6266137|NCT00041756|7165366|FG002|STARTED|Overall Study||79
6266138|NCT00041756|7165367|FG003|STARTED|Overall Study||80
6266139|NCT00041756|7165368|FG004|STARTED|Overall Study||79
6266140|NCT00041756|7165364|FG000|COMPLETED|Overall Study||69
6266141|NCT00041756|7165365|FG001|COMPLETED|Overall Study||65
6266142|NCT00041756|7165366|FG002|COMPLETED|Overall Study||66
6266143|NCT00041756|7165367|FG003|COMPLETED|Overall Study||64
6730297|NCT03162328|7659730|FG000|COMPLETED|Study Period||0
6730298|NCT03162328|7659731|FG001|COMPLETED|Study Period||30
6730299|NCT03162328|7659732|FG002|COMPLETED|Study Period||31
6730300|NCT03162328|7659730|FG000|NOT COMPLETED|Study Period||0
6730301|NCT03162328|7659731|FG001|NOT COMPLETED|Study Period||0
6730302|NCT03162328|7659732|FG002|NOT COMPLETED|Study Period||1
6730303|NCT03162354|7659745|FG000|STARTED|Overall Study||183
6730304|NCT03162354|7659746|FG001|STARTED|Overall Study||237
6730305|NCT03162354|7659745|FG000|COMPLETED|Overall Study||183
6730306|NCT03162354|7659746|FG001|COMPLETED|Overall Study||237
6730307|NCT03162354|7659745|FG000|NOT COMPLETED|Overall Study||0
6730308|NCT03162354|7659746|FG001|NOT COMPLETED|Overall Study||0
6730309|NCT03162458|7659759|FG000|STARTED|Overall Study||71
6730310|NCT03162458|7659760|FG001|STARTED|Overall Study||71
6730311|NCT03162458|7659759|FG000|COMPLETED|Overall Study||71
6730312|NCT03162458|7659760|FG001|COMPLETED|Overall Study||71
6730313|NCT03162458|7659759|FG000|NOT COMPLETED|Overall Study||0
6730314|NCT03162458|7659760|FG001|NOT COMPLETED|Overall Study||0
6730315|NCT03162614|7659772|FG000|STARTED|Overall Study||26
6730316|NCT03162614|7659773|FG001|STARTED|Overall Study||26
6730317|NCT03162614|7659774|FG002|STARTED|Overall Study||26
6730318|NCT03162614|7659775|FG003|STARTED|Overall Study||26
6730319|NCT03162614|7659776|FG004|STARTED|Overall Study||26
6730320|NCT03162614|7659777|FG005|STARTED|Overall Study||24
6730321|NCT03162614|7659772|FG000|COMPLETED|Overall Study||20
6730322|NCT03162614|7659773|FG001|COMPLETED|Overall Study||21
6730323|NCT03162614|7659774|FG002|COMPLETED|Overall Study||22
6730324|NCT03162614|7659775|FG003|COMPLETED|Overall Study||19
6730325|NCT03162614|7659776|FG004|COMPLETED|Overall Study||21
6730326|NCT03162614|7659777|FG005|COMPLETED|Overall Study||24
6730327|NCT03162614|7659772|FG000|NOT COMPLETED|Overall Study||6
6730328|NCT03162614|7659773|FG001|NOT COMPLETED|Overall Study||5
6730329|NCT03162614|7659774|FG002|NOT COMPLETED|Overall Study||4
6730330|NCT03162614|7659775|FG003|NOT COMPLETED|Overall Study||7
6730331|NCT03162614|7659776|FG004|NOT COMPLETED|Overall Study||5
6730332|NCT03162614|7659777|FG005|NOT COMPLETED|Overall Study||0
6730333|NCT03162796|7659794|FG000|STARTED|Placebo Controlled Period: Week 0 - 24||126
6730334|NCT03162796|7659795|FG001|STARTED|Placebo Controlled Period: Week 0 - 24||127
6730335|NCT03162796|7659796|FG002|STARTED|Placebo Controlled Period: Week 0 - 24||128
6730336|NCT03162796|7659794|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 24||114
6730337|NCT03162796|7659795|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 24||123
6730338|NCT03162796|7659796|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 24||125
6730339|NCT03162796|7659794|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||12
6730340|NCT03162796|7659795|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||4
6730341|NCT03162796|7659796|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 24||3
6730342|NCT03162796|7659794|FG000|STARTED|Active Treatment Period: Week 24 - 52||114
6730343|NCT03162796|7659795|FG001|STARTED|Active Treatment Period: Week 24 - 52||123
6730344|NCT03162796|7659796|FG002|STARTED|Active Treatment Period: Week 24 - 52||125
6730345|NCT03162796|7659794|FG000|COMPLETED|Active Treatment Period: Week 24 - 52||107
6730346|NCT03162796|7659795|FG001|COMPLETED|Active Treatment Period: Week 24 - 52||116
6730347|NCT03162796|7659796|FG002|COMPLETED|Active Treatment Period: Week 24 - 52||124
6730348|NCT03162796|7659794|FG000|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
6730349|NCT03162796|7659795|FG001|NOT COMPLETED|Active Treatment Period: Week 24 - 52||7
6730350|NCT03162796|7659796|FG002|NOT COMPLETED|Active Treatment Period: Week 24 - 52||1
6730351|NCT03162796|7659794|FG000|STARTED|Safety Follow-up: Week 52 - 60||107
6730352|NCT03162796|7659795|FG001|STARTED|Safety Follow-up: Week 52 - 60||116
6730353|NCT03162796|7659796|FG002|STARTED|Safety Follow-up: Week 52 - 60||124
6730354|NCT03162796|7659794|FG000|COMPLETED|Safety Follow-up: Week 52 - 60||106
6730355|NCT03162796|7659795|FG001|COMPLETED|Safety Follow-up: Week 52 - 60||114
6730356|NCT03162796|7659796|FG002|COMPLETED|Safety Follow-up: Week 52 - 60||123
6730357|NCT03162796|7659794|FG000|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
6730358|NCT03162796|7659795|FG001|NOT COMPLETED|Safety Follow-up: Week 52 - 60||2
6730359|NCT03162796|7659796|FG002|NOT COMPLETED|Safety Follow-up: Week 52 - 60||1
6730360|NCT03163017|7659809|FG000|STARTED|Overall Study||30
6730361|NCT03163017|7659809|FG000|COMPLETED|Overall Study||30
6730362|NCT03163017|7659809|FG000|NOT COMPLETED|Overall Study||0
6730363|NCT03163134|7659815|FG000|STARTED|Overall Study||85
6730364|NCT03163134|7659816|FG001|STARTED|Overall Study||85
6730365|NCT03163134|7659815|FG000|COMPLETED|Overall Study||85
6730366|NCT03163134|7659816|FG001|COMPLETED|Overall Study||85
6730367|NCT03163134|7659815|FG000|NOT COMPLETED|Overall Study||0
6730368|NCT03163134|7659816|FG001|NOT COMPLETED|Overall Study||0
6730369|NCT03163303|7659824|FG000|STARTED|Overall Study||85
6730370|NCT03163303|7659825|FG001|STARTED|Overall Study||94
6730371|NCT03163303|7659824|FG000|COMPLETED|Overall Study||85
6730372|NCT03163303|7659825|FG001|COMPLETED|Overall Study||94
6730373|NCT03163303|7659824|FG000|NOT COMPLETED|Overall Study||0
6730374|NCT03163303|7659825|FG001|NOT COMPLETED|Overall Study||0
6730375|NCT03163342|7659831|FG000|STARTED|Overall Study||20
6730376|NCT03163342|7659831|FG000|COMPLETED|Overall Study||20
6730377|NCT03163342|7659831|FG000|NOT COMPLETED|Overall Study||0
6730378|NCT03163446|7659837|FG000|STARTED|Overall Study||73
6730379|NCT03163446|7659838|FG001|STARTED|Overall Study||48
6730380|NCT03163446|7659837|FG000|COMPLETED|Overall Study||45
6730381|NCT03163446|7659838|FG001|COMPLETED|Overall Study||31
6730382|NCT03163446|7659837|FG000|NOT COMPLETED|Overall Study||28
6730383|NCT03163446|7659838|FG001|NOT COMPLETED|Overall Study||17
6730384|NCT03163472|7659852|FG000|STARTED|Overall Study||15
6730385|NCT03163472|7659853|FG001|STARTED|Overall Study||15
6730386|NCT03163472|7659852|FG000|COMPLETED|Overall Study||15
6730387|NCT03163472|7659853|FG001|COMPLETED|Overall Study||15
6266144|NCT00041756|7165368|FG004|COMPLETED|Overall Study||19
6730388|NCT03163472|7659852|FG000|NOT COMPLETED|Overall Study||0
6730389|NCT03163472|7659853|FG001|NOT COMPLETED|Overall Study||0
6730390|NCT03163758|7659863|FG000|STARTED|Overall Study||21
6730391|NCT03163758|7659864|FG001|STARTED|Overall Study||21
6730392|NCT03163758|7659863|FG000|COMPLETED|Overall Study||13
6730393|NCT03163758|7659864|FG001|COMPLETED|Overall Study||14
6730394|NCT03163758|7659863|FG000|NOT COMPLETED|Overall Study||8
6730395|NCT03163758|7659864|FG001|NOT COMPLETED|Overall Study||7
6730396|NCT03164538|7659872|FG000|STARTED|Overall Study||35
6730397|NCT03164538|7659873|FG001|STARTED|Overall Study||35
6730398|NCT03164538|7659872|FG000|COMPLETED|Overall Study||28
6730399|NCT03164538|7659873|FG001|COMPLETED|Overall Study||29
6730400|NCT03164538|7659872|FG000|NOT COMPLETED|Overall Study||7
6730401|NCT03164538|7659873|FG001|NOT COMPLETED|Overall Study||6
6730402|NCT03164551|7659881|FG000|STARTED|Overall Study||200
6730403|NCT03164551|7659882|FG001|STARTED|Overall Study||208
6730404|NCT03164551|7659881|FG000|COMPLETED|Overall Study||171
6730405|NCT03164551|7659882|FG001|COMPLETED|Overall Study||192
6730406|NCT03164551|7659881|FG000|NOT COMPLETED|Overall Study||29
6730407|NCT03164551|7659882|FG001|NOT COMPLETED|Overall Study||16
6730408|NCT03164629|7659890|FG000|STARTED|Overall Study||25
6730409|NCT03164629|7659891|FG001|STARTED|Overall Study||25
6730410|NCT03164629|7659890|FG000|COMPLETED|Overall Study||25
6730411|NCT03164629|7659891|FG001|COMPLETED|Overall Study||25
6730412|NCT03164629|7659890|FG000|NOT COMPLETED|Overall Study||0
6730413|NCT03164629|7659891|FG001|NOT COMPLETED|Overall Study||0
6730414|NCT03165045|7659897|FG000|STARTED|Visit 1||1351
6730415|NCT03165045|7659897|FG000|COMPLETED|Visit 1||1322
6730416|NCT03165045|7659897|FG000|NOT COMPLETED|Visit 1||29
6730417|NCT03165045|7659897|FG000|STARTED|Visit 2||1322
6730418|NCT03165045|7659897|FG000|COMPLETED|Visit 2||1140
6730419|NCT03165045|7659897|FG000|NOT COMPLETED|Visit 2||182
6730420|NCT03165058|7659905|FG000|STARTED|Overall Study||21
6730421|NCT03165058|7659906|FG001|STARTED|Overall Study||11
6730422|NCT03165058|7659905|FG000|COMPLETED|Overall Study||21
6730423|NCT03165058|7659906|FG001|COMPLETED|Overall Study||11
6730424|NCT03165058|7659905|FG000|NOT COMPLETED|Overall Study||0
6730425|NCT03165058|7659906|FG001|NOT COMPLETED|Overall Study||0
6730426|NCT03165110|7659912|FG000|STARTED|Overall Study||47
6730427|NCT03165110|7659912|FG000|COMPLETED|Overall Study||46
6730428|NCT03165110|7659912|FG000|NOT COMPLETED|Overall Study||1
6730429|NCT03165175|7659918|FG000|STARTED|1-month to 3-month||41
6730430|NCT03165175|7659919|FG001|STARTED|1-month to 3-month||39
6730431|NCT03165175|7659918|FG000|COMPLETED|1-month to 3-month||35
6730432|NCT03165175|7659919|FG001|COMPLETED|1-month to 3-month||39
6730433|NCT03165175|7659918|FG000|NOT COMPLETED|1-month to 3-month||6
6730434|NCT03165175|7659919|FG001|NOT COMPLETED|1-month to 3-month||0
6730435|NCT03165175|7659918|FG000|STARTED|Baseline to 3-month||35
6730436|NCT03165175|7659919|FG001|STARTED|Baseline to 3-month||39
6730437|NCT03165175|7659918|FG000|COMPLETED|Baseline to 3-month||31
6730438|NCT03165175|7659919|FG001|COMPLETED|Baseline to 3-month||39
6730439|NCT03165175|7659918|FG000|NOT COMPLETED|Baseline to 3-month||4
6730440|NCT03165175|7659919|FG001|NOT COMPLETED|Baseline to 3-month||0
6730441|NCT03165617|7659927|FG000|STARTED|Overall Study||2258
6730442|NCT03165617|7659928|FG001|STARTED|Overall Study||2256
6730443|NCT03165617|7659927|FG000|COMPLETED|Overall Study||2249
6730444|NCT03165617|7659928|FG001|COMPLETED|Overall Study||2247
6730445|NCT03165617|7659927|FG000|NOT COMPLETED|Overall Study||9
6730446|NCT03165617|7659928|FG001|NOT COMPLETED|Overall Study||9
6730447|NCT03165981|7659954|FG000|STARTED|Overall Study||110
6730448|NCT03165981|7659955|FG001|STARTED|Overall Study||111
6730449|NCT03165981|7659954|FG000|Per Protocol Population|Overall Study||99
6730450|NCT03165981|7659955|FG001|Per Protocol Population|Overall Study||107
6730451|NCT03165981|7659954|FG000|COMPLETED|Overall Study||99
6730452|NCT03165981|7659955|FG001|COMPLETED|Overall Study||107
6730453|NCT03165981|7659954|FG000|NOT COMPLETED|Overall Study||11
6730454|NCT03165981|7659955|FG001|NOT COMPLETED|Overall Study||4
6730455|NCT03166124|7659963|FG000|STARTED|Treatment Period 1||20
6730456|NCT03166124|7659964|FG001|STARTED|Treatment Period 1||20
6730457|NCT03166124|7659965|FG002|STARTED|Treatment Period 1||19
6730458|NCT03166124|7659966|FG003|STARTED|Treatment Period 1||21
6730459|NCT03166124|7659963|FG000|Received at Least One Dose of Study Drug|Treatment Period 1||20
6730460|NCT03166124|7659964|FG001|Received at Least One Dose of Study Drug|Treatment Period 1||20
6730461|NCT03166124|7659965|FG002|Received at Least One Dose of Study Drug|Treatment Period 1||18
6730462|NCT03166124|7659966|FG003|Received at Least One Dose of Study Drug|Treatment Period 1||21
6730463|NCT03166124|7659963|FG000|COMPLETED|Treatment Period 1||20
6730464|NCT03166124|7659964|FG001|COMPLETED|Treatment Period 1||20
6730465|NCT03166124|7659965|FG002|COMPLETED|Treatment Period 1||18
6730466|NCT03166124|7659966|FG003|COMPLETED|Treatment Period 1||21
6730467|NCT03166124|7659963|FG000|NOT COMPLETED|Treatment Period 1||0
6730468|NCT03166124|7659964|FG001|NOT COMPLETED|Treatment Period 1||0
6730469|NCT03166124|7659965|FG002|NOT COMPLETED|Treatment Period 1||1
6730470|NCT03166124|7659966|FG003|NOT COMPLETED|Treatment Period 1||0
6730471|NCT03166124|7659963|FG000|STARTED|Wash-out Period||20
6730472|NCT03166124|7659964|FG001|STARTED|Wash-out Period||20
6730473|NCT03166124|7659965|FG002|STARTED|Wash-out Period||18
6730474|NCT03166124|7659966|FG003|STARTED|Wash-out Period||21
6730475|NCT03166124|7659963|FG000|COMPLETED|Wash-out Period||20
6730476|NCT03166124|7659964|FG001|COMPLETED|Wash-out Period||18
6730477|NCT03166124|7659965|FG002|COMPLETED|Wash-out Period||17
6730478|NCT03166124|7659966|FG003|COMPLETED|Wash-out Period||20
6730479|NCT03166124|7659963|FG000|NOT COMPLETED|Wash-out Period||0
6730480|NCT03166124|7659964|FG001|NOT COMPLETED|Wash-out Period||2
6730481|NCT03166124|7659965|FG002|NOT COMPLETED|Wash-out Period||1
6730482|NCT03166124|7659966|FG003|NOT COMPLETED|Wash-out Period||1
6730483|NCT03166124|7659963|FG000|STARTED|Treatment Period 2||20
6730484|NCT03166124|7659964|FG001|STARTED|Treatment Period 2||18
6730485|NCT03166124|7659965|FG002|STARTED|Treatment Period 2||17
6730486|NCT03166124|7659966|FG003|STARTED|Treatment Period 2||20
6730487|NCT03166124|7659963|FG000|COMPLETED|Treatment Period 2||20
6730488|NCT03166124|7659964|FG001|COMPLETED|Treatment Period 2||18
6730489|NCT03166124|7659965|FG002|COMPLETED|Treatment Period 2||17
6730490|NCT03166124|7659966|FG003|COMPLETED|Treatment Period 2||20
6730491|NCT03166124|7659963|FG000|NOT COMPLETED|Treatment Period 2||0
6730492|NCT03166124|7659964|FG001|NOT COMPLETED|Treatment Period 2||0
6730493|NCT03166124|7659965|FG002|NOT COMPLETED|Treatment Period 2||0
6730494|NCT03166124|7659966|FG003|NOT COMPLETED|Treatment Period 2||0
6730495|NCT03166215|7659979|FG000|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||4
6730496|NCT03166215|7659980|FG001|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||14
6730497|NCT03166215|7659981|FG002|STARTED|Part 1 (Double-blind TP: Days 1 - 30)||0
6730498|NCT03166215|7659979|FG000|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||4
6730499|NCT03166215|7659980|FG001|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||12
6730500|NCT03166215|7659981|FG002|COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
6730501|NCT03166215|7659979|FG000|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
6730502|NCT03166215|7659980|FG001|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||2
6730503|NCT03166215|7659981|FG002|NOT COMPLETED|Part 1 (Double-blind TP: Days 1 - 30)||0
6730504|NCT03166215|7659979|FG000|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
6730505|NCT03166215|7659980|FG001|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||0
6730506|NCT03166215|7659981|FG002|STARTED|Part 2 (Open-Label TP: Days 31 - 85)||16
6730507|NCT03166215|7659979|FG000|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
6730508|NCT03166215|7659980|FG001|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
6730509|NCT03166215|7659981|FG002|COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||14
6730510|NCT03166215|7659979|FG000|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
6730511|NCT03166215|7659980|FG001|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||0
6730512|NCT03166215|7659981|FG002|NOT COMPLETED|Part 2 (Open-Label TP: Days 31 - 85)||2
6730513|NCT03166735|7659997|FG000|STARTED|Overall Study||33
6730514|NCT03166735|7659998|FG001|STARTED|Overall Study||16
6730515|NCT03166735|7659999|FG002|STARTED|Overall Study||16
6730516|NCT03166735|7660000|FG003|STARTED|Overall Study||17
6730517|NCT03166735|7660001|FG004|STARTED|Overall Study||32
6730518|NCT03166735|7659997|FG000|Treated|Overall Study||32
6730519|NCT03166735|7659998|FG001|Treated|Overall Study||16
6730520|NCT03166735|7659999|FG002|Treated|Overall Study||16
6730521|NCT03166735|7660000|FG003|Treated|Overall Study||17
6730522|NCT03166735|7660001|FG004|Treated|Overall Study||32
6730523|NCT03166735|7659997|FG000|COMPLETED|Overall Study||32
6730524|NCT03166735|7659998|FG001|COMPLETED|Overall Study||13
6730525|NCT03166735|7659999|FG002|COMPLETED|Overall Study||13
6730526|NCT03166735|7660000|FG003|COMPLETED|Overall Study||16
6730527|NCT03166735|7660001|FG004|COMPLETED|Overall Study||28
6730528|NCT03166735|7659997|FG000|NOT COMPLETED|Overall Study||1
6730529|NCT03166735|7659998|FG001|NOT COMPLETED|Overall Study||3
6730530|NCT03166735|7659999|FG002|NOT COMPLETED|Overall Study||3
6730531|NCT03166735|7660000|FG003|NOT COMPLETED|Overall Study||1
6730532|NCT03166735|7660001|FG004|NOT COMPLETED|Overall Study||4
6730533|NCT03167073|7660016|FG000|STARTED|Overall Study||85
6730534|NCT03167073|7660017|FG001|STARTED|Overall Study||85
6730535|NCT03167073|7660016|FG000|COMPLETED|Overall Study||84
6730536|NCT03167073|7660017|FG001|COMPLETED|Overall Study||85
6730537|NCT03167073|7660016|FG000|NOT COMPLETED|Overall Study||1
6730538|NCT03167073|7660017|FG001|NOT COMPLETED|Overall Study||0
6730539|NCT03167151|7660026|FG000|STARTED|Overall Study||3
6730540|NCT03167151|7660027|FG001|STARTED|Overall Study||3
6730541|NCT03167151|7660028|FG002|STARTED|Overall Study||3
6730542|NCT03167151|7660026|FG000|COMPLETED|Overall Study||2
6730543|NCT03167151|7660027|FG001|COMPLETED|Overall Study||2
6730544|NCT03167151|7660028|FG002|COMPLETED|Overall Study||2
6730545|NCT03167151|7660026|FG000|NOT COMPLETED|Overall Study||1
6730546|NCT03167151|7660027|FG001|NOT COMPLETED|Overall Study||1
6730547|NCT03167151|7660028|FG002|NOT COMPLETED|Overall Study||1
6730548|NCT03167359|7660036|FG000|STARTED|Overall Study||74
6730549|NCT03167359|7660036|FG000|COMPLETED|Overall Study||72
6730550|NCT03167359|7660036|FG000|NOT COMPLETED|Overall Study||2
6730551|NCT03167411|7660042|FG000|STARTED|Overall Study||10
6730552|NCT03167411|7660043|FG001|STARTED|Overall Study||10
6730553|NCT03167411|7660042|FG000|COMPLETED|Overall Study||10
6730554|NCT03167411|7660043|FG001|COMPLETED|Overall Study||9
6730555|NCT03167411|7660042|FG000|NOT COMPLETED|Overall Study||0
6730556|NCT03167411|7660043|FG001|NOT COMPLETED|Overall Study||1
6730557|NCT03167541|7660049|FG000|STARTED|First Intervention||9
6730558|NCT03167541|7660050|FG001|STARTED|First Intervention||9
6730559|NCT03167541|7660049|FG000|COMPLETED|First Intervention||9
6730560|NCT03167541|7660050|FG001|COMPLETED|First Intervention||9
6730561|NCT03167541|7660049|FG000|NOT COMPLETED|First Intervention||0
6730562|NCT03167541|7660050|FG001|NOT COMPLETED|First Intervention||0
6730563|NCT03167541|7660049|FG000|STARTED|Washout: 5-8 Days||9
6730564|NCT03167541|7660050|FG001|STARTED|Washout: 5-8 Days||9
6730565|NCT03167541|7660049|FG000|COMPLETED|Washout: 5-8 Days||9
6730566|NCT03167541|7660050|FG001|COMPLETED|Washout: 5-8 Days||9
6730567|NCT03167541|7660049|FG000|NOT COMPLETED|Washout: 5-8 Days||0
6730568|NCT03167541|7660050|FG001|NOT COMPLETED|Washout: 5-8 Days||0
6730569|NCT03167541|7660049|FG000|STARTED|Second Intervention||9
6730570|NCT03167541|7660050|FG001|STARTED|Second Intervention||9
6730571|NCT03167541|7660049|FG000|COMPLETED|Second Intervention||9
6730572|NCT03167541|7660050|FG001|COMPLETED|Second Intervention||9
6730573|NCT03167541|7660049|FG000|NOT COMPLETED|Second Intervention||0
6730574|NCT03167541|7660050|FG001|NOT COMPLETED|Second Intervention||0
6730575|NCT03168022|7660057|FG000|STARTED|Overall Study||21
6730576|NCT03168022|7660058|FG001|STARTED|Overall Study||22
6730577|NCT03168022|7660057|FG000|COMPLETED|Overall Study||21
6730578|NCT03168022|7660058|FG001|COMPLETED|Overall Study||21
6730579|NCT03168022|7660057|FG000|NOT COMPLETED|Overall Study||0
6730580|NCT03168022|7660058|FG001|NOT COMPLETED|Overall Study||1
6730581|NCT03168295|7660069|FG000|STARTED|Overall Study||3
6730582|NCT03168295|7660070|FG001|STARTED|Overall Study||3
6730583|NCT03168295|7660071|FG002|STARTED|Overall Study||4
6730584|NCT03168295|7660072|FG003|STARTED|Overall Study||4
6730585|NCT03168295|7660073|FG004|STARTED|Overall Study||20
6730586|NCT03168295|7660069|FG000|COMPLETED|Overall Study||3
6730587|NCT03168295|7660070|FG001|COMPLETED|Overall Study||3
6730588|NCT03168295|7660071|FG002|COMPLETED|Overall Study||4
6730589|NCT03168295|7660072|FG003|COMPLETED|Overall Study||4
6730590|NCT03168295|7660073|FG004|COMPLETED|Overall Study||20
6730591|NCT03168295|7660069|FG000|NOT COMPLETED|Overall Study||0
6730592|NCT03168295|7660070|FG001|NOT COMPLETED|Overall Study||0
6730593|NCT03168295|7660071|FG002|NOT COMPLETED|Overall Study||0
6730594|NCT03168295|7660072|FG003|NOT COMPLETED|Overall Study||0
6730595|NCT03168295|7660073|FG004|NOT COMPLETED|Overall Study||0
6730596|NCT03168308|7660086|FG000|STARTED|Overall Study||48
6730597|NCT03168308|7660087|FG001|STARTED|Overall Study||44
6730598|NCT03168308|7660086|FG000|COMPLETED|Overall Study||48
6730599|NCT03168308|7660087|FG001|COMPLETED|Overall Study||44
6730600|NCT03168308|7660086|FG000|NOT COMPLETED|Overall Study||0
6730601|NCT03168308|7660087|FG001|NOT COMPLETED|Overall Study||0
6730602|NCT03168321|7660095|FG000|STARTED|Overall Study||402
6730603|NCT03168321|7660096|FG001|STARTED|Overall Study||411
6730604|NCT03168321|7660095|FG000|COMPLETED|Overall Study||347
6730605|NCT03168321|7660096|FG001|COMPLETED|Overall Study||356
6730606|NCT03168321|7660095|FG000|NOT COMPLETED|Overall Study||55
6730607|NCT03168321|7660096|FG001|NOT COMPLETED|Overall Study||55
6730608|NCT03168334|7660104|FG000|STARTED|Overall Study||397
6730609|NCT03168334|7660105|FG001|STARTED|Overall Study||404
6730610|NCT03168334|7660104|FG000|COMPLETED|Overall Study||345
6730611|NCT03168334|7660105|FG001|COMPLETED|Overall Study||366
6730612|NCT03168334|7660104|FG000|NOT COMPLETED|Overall Study||52
6730613|NCT03168334|7660105|FG001|NOT COMPLETED|Overall Study||38
6730614|NCT03168425|7660113|FG000|STARTED|Overall Study||94
6730615|NCT03168425|7660114|FG001|STARTED|Overall Study||96
6730616|NCT03168425|7660113|FG000|COMPLETED|Overall Study||87
6730617|NCT03168425|7660114|FG001|COMPLETED|Overall Study||85
6730618|NCT03168425|7660113|FG000|NOT COMPLETED|Overall Study||7
6730619|NCT03168425|7660114|FG001|NOT COMPLETED|Overall Study||11
6730620|NCT03168542|7660121|FG000|STARTED|Overall Study||7
6730621|NCT03168542|7660122|FG001|STARTED|Overall Study||5
6730622|NCT03168542|7660123|FG002|STARTED|Overall Study||9
6730623|NCT03168542|7660121|FG000|COMPLETED|Overall Study||7
6730624|NCT03168542|7660122|FG001|COMPLETED|Overall Study||5
6730625|NCT03168542|7660123|FG002|COMPLETED|Overall Study||9
6730626|NCT03168542|7660121|FG000|NOT COMPLETED|Overall Study||0
6730627|NCT03168542|7660122|FG001|NOT COMPLETED|Overall Study||0
6730628|NCT03168542|7660123|FG002|NOT COMPLETED|Overall Study||0
6730629|NCT03168711|7660130|FG000|STARTED|Overall Study||14
6730630|NCT03168711|7660131|FG001|STARTED|Overall Study||9
6730631|NCT03168711|7660130|FG000|COMPLETED|Overall Study||12
6730632|NCT03168711|7660131|FG001|COMPLETED|Overall Study||7
6730633|NCT03168711|7660130|FG000|NOT COMPLETED|Overall Study||2
6730634|NCT03168711|7660131|FG001|NOT COMPLETED|Overall Study||2
6730635|NCT03168841|7660137|FG000|STARTED|Overall Study||40
6730636|NCT03168841|7660137|FG000|COMPLETED|Overall Study||36
6730637|NCT03168841|7660137|FG000|NOT COMPLETED|Overall Study||4
6730638|NCT03168919|7660141|FG000|STARTED|Overall Study||5
6730639|NCT03168919|7660141|FG000|COMPLETED|Overall Study||3
6730640|NCT03168919|7660141|FG000|NOT COMPLETED|Overall Study||2
6730641|NCT03169062|7660149|FG000|STARTED|Overall Study||10
6730642|NCT03169062|7660149|FG000|COMPLETED|Overall Study||10
6730643|NCT03169062|7660149|FG000|NOT COMPLETED|Overall Study||0
6730644|NCT03169153|7660153|FG000|STARTED|Period 1, First 30 Days of Wear||42
6730645|NCT03169153|7660154|FG001|STARTED|Period 1, First 30 Days of Wear||39
6730646|NCT03169153|7660153|FG000|COMPLETED|Period 1, First 30 Days of Wear||39
6730647|NCT03169153|7660154|FG001|COMPLETED|Period 1, First 30 Days of Wear||35
6730648|NCT03169153|7660153|FG000|NOT COMPLETED|Period 1, First 30 Days of Wear||3
6730649|NCT03169153|7660154|FG001|NOT COMPLETED|Period 1, First 30 Days of Wear||4
6730650|NCT03169153|7660153|FG000|STARTED|Period 2, Second 30 Days of Wear||39
6730651|NCT03169153|7660154|FG001|STARTED|Period 2, Second 30 Days of Wear|One subject discontinued after completing Period 1 and was not exposed in Period 2.|34
6730652|NCT03169153|7660153|FG000|COMPLETED|Period 2, Second 30 Days of Wear||37
6730653|NCT03169153|7660154|FG001|COMPLETED|Period 2, Second 30 Days of Wear||32
6730654|NCT03169153|7660153|FG000|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
6730655|NCT03169153|7660154|FG001|NOT COMPLETED|Period 2, Second 30 Days of Wear||2
6730656|NCT03169244|7660162|FG000|STARTED|Overall Study||22
6730657|NCT03169244|7660163|FG001|STARTED|Overall Study||20
6730658|NCT03169244|7660162|FG000|Randomly Assigned|Overall Study||22
6730659|NCT03169244|7660163|FG001|Randomly Assigned|Overall Study||20
6730660|NCT03169244|7660162|FG000|Received Intervention|Overall Study||22
6730661|NCT03169244|7660163|FG001|Received Intervention|Overall Study||18
6730662|NCT03169244|7660162|FG000|COMPLETED|Overall Study||17
6730663|NCT03169244|7660163|FG001|COMPLETED|Overall Study||16
6730664|NCT03169244|7660162|FG000|NOT COMPLETED|Overall Study||5
6730665|NCT03169244|7660163|FG001|NOT COMPLETED|Overall Study||4
6730666|NCT03169816|7660171|FG000|STARTED|Overall Study||33
6730667|NCT03169816|7660172|FG001|STARTED|Overall Study||16
6730668|NCT03169816|7660171|FG000|COMPLETED|Overall Study||6
6730669|NCT03169816|7660172|FG001|COMPLETED|Overall Study||3
6730670|NCT03169816|7660171|FG000|NOT COMPLETED|Overall Study||27
6730671|NCT03169816|7660172|FG001|NOT COMPLETED|Overall Study||13
6730672|NCT03170154|7660178|FG000|STARTED|Overall Study||350
6730673|NCT03170154|7660178|FG000|Rotational Stability Sub-study|Overall Study||141
6730674|NCT03170154|7660178|FG000|COMPLETED|Overall Study||342
6730675|NCT03170154|7660178|FG000|NOT COMPLETED|Overall Study||8
6730676|NCT03170193|7660194|FG000|STARTED|Overall Study||12
6730677|NCT03170193|7660195|FG001|STARTED|Overall Study||6
6730678|NCT03170193|7660196|FG002|STARTED|Overall Study||6
6730679|NCT03170193|7660197|FG003|STARTED|Overall Study||6
6730680|NCT03170193|7660198|FG004|STARTED|Overall Study||6
6730681|NCT03170193|7660199|FG005|STARTED|Overall Study||6
6730682|NCT03170193|7660200|FG006|STARTED|Overall Study||6
6730683|NCT03170193|7660194|FG000|COMPLETED|Overall Study||11
6730684|NCT03170193|7660195|FG001|COMPLETED|Overall Study||5
6730685|NCT03170193|7660196|FG002|COMPLETED|Overall Study||6
6730686|NCT03170193|7660197|FG003|COMPLETED|Overall Study||5
6730687|NCT03170193|7660198|FG004|COMPLETED|Overall Study||6
6730688|NCT03170193|7660199|FG005|COMPLETED|Overall Study||6
6730689|NCT03170193|7660200|FG006|COMPLETED|Overall Study||6
6730690|NCT03170193|7660194|FG000|NOT COMPLETED|Overall Study||1
6730691|NCT03170193|7660195|FG001|NOT COMPLETED|Overall Study||1
6730692|NCT03170193|7660196|FG002|NOT COMPLETED|Overall Study||0
6730693|NCT03170193|7660197|FG003|NOT COMPLETED|Overall Study||1
6730694|NCT03170193|7660198|FG004|NOT COMPLETED|Overall Study||0
6730695|NCT03170193|7660199|FG005|NOT COMPLETED|Overall Study||0
6730696|NCT03170193|7660200|FG006|NOT COMPLETED|Overall Study||0
6730697|NCT03170219|7660224|FG000|STARTED|Overall Study||7
6730698|NCT03170219|7660225|FG001|STARTED|Overall Study||4
6730699|NCT03170219|7660224|FG000|COMPLETED|Overall Study||7
6730700|NCT03170219|7660225|FG001|COMPLETED|Overall Study||4
6730701|NCT03170219|7660224|FG000|NOT COMPLETED|Overall Study||0
6730702|NCT03170219|7660225|FG001|NOT COMPLETED|Overall Study||0
6730703|NCT03170232|7660233|FG000|STARTED|Overall Study||27
6730704|NCT03170232|7660234|FG001|STARTED|Overall Study||27
6730705|NCT03170232|7660233|FG000|COMPLETED|Overall Study||0
6266145|NCT00041756|7165364|FG000|NOT COMPLETED|Overall Study||8
6730706|NCT03170232|7660234|FG001|COMPLETED|Overall Study||0
6730707|NCT03170232|7660233|FG000|NOT COMPLETED|Overall Study||27
6730708|NCT03170232|7660234|FG001|NOT COMPLETED|Overall Study||27
6730709|NCT03170271|7660242|FG000|STARTED|Overall Study||431
6730710|NCT03170271|7660243|FG001|STARTED|Overall Study||229
6730711|NCT03170271|7660242|FG000|Received Treatment|Overall Study||427
6730712|NCT03170271|7660243|FG001|Received Treatment|Overall Study||229
6730713|NCT03170271|7660242|FG000|COMPLETED|Overall Study||398
6730714|NCT03170271|7660243|FG001|COMPLETED|Overall Study||218
6730715|NCT03170271|7660242|FG000|NOT COMPLETED|Overall Study||33
6730716|NCT03170271|7660243|FG001|NOT COMPLETED|Overall Study||11
6730717|NCT03170388|7660254|FG000|STARTED|Overall Study||147
6730718|NCT03170388|7660255|FG001|STARTED|Overall Study||150
6730719|NCT03170388|7660256|FG002|STARTED|Overall Study||146
6730720|NCT03170388|7660257|FG003|STARTED|Overall Study||150
6730721|NCT03170388|7660258|FG004|STARTED|Overall Study||148
6730722|NCT03170388|7660254|FG000|COMPLETED|Overall Study||125
6730723|NCT03170388|7660255|FG001|COMPLETED|Overall Study||132
6730724|NCT03170388|7660256|FG002|COMPLETED|Overall Study||133
6730725|NCT03170388|7660257|FG003|COMPLETED|Overall Study||132
6730726|NCT03170388|7660258|FG004|COMPLETED|Overall Study||127
6730727|NCT03170388|7660254|FG000|NOT COMPLETED|Overall Study||22
6730728|NCT03170388|7660255|FG001|NOT COMPLETED|Overall Study||18
6730729|NCT03170388|7660256|FG002|NOT COMPLETED|Overall Study||13
6730730|NCT03170388|7660257|FG003|NOT COMPLETED|Overall Study||18
6730731|NCT03170388|7660258|FG004|NOT COMPLETED|Overall Study||21
6730732|NCT03170544|7660282|FG000|STARTED|Part 1||10
6730733|NCT03170544|7660283|FG001|STARTED|Part 1||6
6730734|NCT03170544|7660284|FG002|STARTED|Part 1||6
6730735|NCT03170544|7660285|FG003|STARTED|Part 1||7
6730736|NCT03170544|7660286|FG004|STARTED|Part 1||6
6730737|NCT03170544|7660287|FG005|STARTED|Part 1||6
6730738|NCT03170544|7660288|FG006|STARTED|Part 1||0
6730739|NCT03170544|7660289|FG007|STARTED|Part 1||0
6730740|NCT03170544|7660290|FG008|STARTED|Part 1||0
6730741|NCT03170544|7660291|FG009|STARTED|Part 1||0
6730742|NCT03170544|7660292|FG010|STARTED|Part 1||0
6730743|NCT03170544|7660293|FG011|STARTED|Part 1||0
6730744|NCT03170544|7660282|FG000|COMPLETED|Part 1||9
6730745|NCT03170544|7660283|FG001|COMPLETED|Part 1||6
6730746|NCT03170544|7660284|FG002|COMPLETED|Part 1||6
6730747|NCT03170544|7660285|FG003|COMPLETED|Part 1||6
6730748|NCT03170544|7660286|FG004|COMPLETED|Part 1||6
6730749|NCT03170544|7660287|FG005|COMPLETED|Part 1||6
6730750|NCT03170544|7660288|FG006|COMPLETED|Part 1||0
6730751|NCT03170544|7660289|FG007|COMPLETED|Part 1||0
6730752|NCT03170544|7660290|FG008|COMPLETED|Part 1||0
6730753|NCT03170544|7660291|FG009|COMPLETED|Part 1||0
6730754|NCT03170544|7660292|FG010|COMPLETED|Part 1||0
6730755|NCT03170544|7660293|FG011|COMPLETED|Part 1||0
6730756|NCT03170544|7660282|FG000|NOT COMPLETED|Part 1||1
6730757|NCT03170544|7660283|FG001|NOT COMPLETED|Part 1||0
6730758|NCT03170544|7660284|FG002|NOT COMPLETED|Part 1||0
6730759|NCT03170544|7660285|FG003|NOT COMPLETED|Part 1||1
6730760|NCT03170544|7660286|FG004|NOT COMPLETED|Part 1||0
6730761|NCT03170544|7660287|FG005|NOT COMPLETED|Part 1||0
6730762|NCT03170544|7660288|FG006|NOT COMPLETED|Part 1||0
6730763|NCT03170544|7660289|FG007|NOT COMPLETED|Part 1||0
6730764|NCT03170544|7660290|FG008|NOT COMPLETED|Part 1||0
6730765|NCT03170544|7660291|FG009|NOT COMPLETED|Part 1||0
6730766|NCT03170544|7660292|FG010|NOT COMPLETED|Part 1||0
6730767|NCT03170544|7660293|FG011|NOT COMPLETED|Part 1||0
6730768|NCT03170544|7660282|FG000|STARTED|Part 2||0
6730769|NCT03170544|7660283|FG001|STARTED|Part 2||0
6730770|NCT03170544|7660284|FG002|STARTED|Part 2||0
6730771|NCT03170544|7660285|FG003|STARTED|Part 2||0
6730772|NCT03170544|7660286|FG004|STARTED|Part 2||0
6730773|NCT03170544|7660287|FG005|STARTED|Part 2||0
6730774|NCT03170544|7660288|FG006|STARTED|Part 2||4
6730775|NCT03170544|7660289|FG007|STARTED|Part 2||0
6730776|NCT03170544|7660290|FG008|STARTED|Part 2||0
6730777|NCT03170544|7660291|FG009|STARTED|Part 2||0
6730778|NCT03170544|7660292|FG010|STARTED|Part 2||0
6730779|NCT03170544|7660293|FG011|STARTED|Part 2||0
6730780|NCT03170544|7660282|FG000|COMPLETED|Part 2||0
6730781|NCT03170544|7660283|FG001|COMPLETED|Part 2||0
6730782|NCT03170544|7660284|FG002|COMPLETED|Part 2||0
6730783|NCT03170544|7660285|FG003|COMPLETED|Part 2||0
6730784|NCT03170544|7660286|FG004|COMPLETED|Part 2||0
6730785|NCT03170544|7660287|FG005|COMPLETED|Part 2||0
6730786|NCT03170544|7660288|FG006|COMPLETED|Part 2||4
6730787|NCT03170544|7660289|FG007|COMPLETED|Part 2||0
6730788|NCT03170544|7660290|FG008|COMPLETED|Part 2||0
6730789|NCT03170544|7660291|FG009|COMPLETED|Part 2||0
6730790|NCT03170544|7660292|FG010|COMPLETED|Part 2||0
6730791|NCT03170544|7660293|FG011|COMPLETED|Part 2||0
6730792|NCT03170544|7660282|FG000|NOT COMPLETED|Part 2||0
6730793|NCT03170544|7660283|FG001|NOT COMPLETED|Part 2||0
6730794|NCT03170544|7660284|FG002|NOT COMPLETED|Part 2||0
6730795|NCT03170544|7660285|FG003|NOT COMPLETED|Part 2||0
6730796|NCT03170544|7660286|FG004|NOT COMPLETED|Part 2||0
6730797|NCT03170544|7660287|FG005|NOT COMPLETED|Part 2||0
6730798|NCT03170544|7660288|FG006|NOT COMPLETED|Part 2||0
6730799|NCT03170544|7660289|FG007|NOT COMPLETED|Part 2||0
6730800|NCT03170544|7660290|FG008|NOT COMPLETED|Part 2||0
6730801|NCT03170544|7660291|FG009|NOT COMPLETED|Part 2||0
6730802|NCT03170544|7660292|FG010|NOT COMPLETED|Part 2||0
6730803|NCT03170544|7660293|FG011|NOT COMPLETED|Part 2||0
6730804|NCT03170544|7660282|FG000|STARTED|Part 3||0
6730805|NCT03170544|7660283|FG001|STARTED|Part 3||0
6730806|NCT03170544|7660284|FG002|STARTED|Part 3||0
6730807|NCT03170544|7660285|FG003|STARTED|Part 3||0
6730808|NCT03170544|7660286|FG004|STARTED|Part 3||0
6730809|NCT03170544|7660287|FG005|STARTED|Part 3||0
6730810|NCT03170544|7660288|FG006|STARTED|Part 3||0
6730811|NCT03170544|7660289|FG007|STARTED|Part 3||4
6730812|NCT03170544|7660290|FG008|STARTED|Part 3||6
6730813|NCT03170544|7660291|FG009|STARTED|Part 3||6
6730814|NCT03170544|7660292|FG010|STARTED|Part 3||0
6730815|NCT03170544|7660293|FG011|STARTED|Part 3||0
6730816|NCT03170544|7660282|FG000|COMPLETED|Part 3||0
6730817|NCT03170544|7660283|FG001|COMPLETED|Part 3||0
6730818|NCT03170544|7660284|FG002|COMPLETED|Part 3||0
6730819|NCT03170544|7660285|FG003|COMPLETED|Part 3||0
6730820|NCT03170544|7660286|FG004|COMPLETED|Part 3||0
6730821|NCT03170544|7660287|FG005|COMPLETED|Part 3||0
6730822|NCT03170544|7660288|FG006|COMPLETED|Part 3||0
6730823|NCT03170544|7660289|FG007|COMPLETED|Part 3||4
6730824|NCT03170544|7660290|FG008|COMPLETED|Part 3||6
6730825|NCT03170544|7660291|FG009|COMPLETED|Part 3||6
6730826|NCT03170544|7660292|FG010|COMPLETED|Part 3||0
6730827|NCT03170544|7660293|FG011|COMPLETED|Part 3||0
6730828|NCT03170544|7660282|FG000|NOT COMPLETED|Part 3||0
6730829|NCT03170544|7660283|FG001|NOT COMPLETED|Part 3||0
6730830|NCT03170544|7660284|FG002|NOT COMPLETED|Part 3||0
6730831|NCT03170544|7660285|FG003|NOT COMPLETED|Part 3||0
6730832|NCT03170544|7660286|FG004|NOT COMPLETED|Part 3||0
6730833|NCT03170544|7660287|FG005|NOT COMPLETED|Part 3||0
6730834|NCT03170544|7660288|FG006|NOT COMPLETED|Part 3||0
6730835|NCT03170544|7660289|FG007|NOT COMPLETED|Part 3||0
6730836|NCT03170544|7660290|FG008|NOT COMPLETED|Part 3||0
6730837|NCT03170544|7660291|FG009|NOT COMPLETED|Part 3||0
6730838|NCT03170544|7660292|FG010|NOT COMPLETED|Part 3||0
6730839|NCT03170544|7660293|FG011|NOT COMPLETED|Part 3||0
6730840|NCT03170544|7660282|FG000|STARTED|Part 4||0
6730841|NCT03170544|7660283|FG001|STARTED|Part 4||0
6730842|NCT03170544|7660284|FG002|STARTED|Part 4||0
6730843|NCT03170544|7660285|FG003|STARTED|Part 4||0
6730844|NCT03170544|7660286|FG004|STARTED|Part 4||0
6730845|NCT03170544|7660287|FG005|STARTED|Part 4||0
6730846|NCT03170544|7660288|FG006|STARTED|Part 4||0
6730847|NCT03170544|7660289|FG007|STARTED|Part 4||0
6730848|NCT03170544|7660290|FG008|STARTED|Part 4||0
6730849|NCT03170544|7660291|FG009|STARTED|Part 4||0
6730850|NCT03170544|7660292|FG010|STARTED|Part 4||3
6730851|NCT03170544|7660293|FG011|STARTED|Part 4||6
6730852|NCT03170544|7660282|FG000|COMPLETED|Part 4||0
6730853|NCT03170544|7660283|FG001|COMPLETED|Part 4||0
6730854|NCT03170544|7660284|FG002|COMPLETED|Part 4||0
6730855|NCT03170544|7660285|FG003|COMPLETED|Part 4||0
6730856|NCT03170544|7660286|FG004|COMPLETED|Part 4||0
6730857|NCT03170544|7660287|FG005|COMPLETED|Part 4||0
6730858|NCT03170544|7660288|FG006|COMPLETED|Part 4||0
6730859|NCT03170544|7660289|FG007|COMPLETED|Part 4||0
6730860|NCT03170544|7660290|FG008|COMPLETED|Part 4||0
6730861|NCT03170544|7660291|FG009|COMPLETED|Part 4||0
6730862|NCT03170544|7660292|FG010|COMPLETED|Part 4||3
6730863|NCT03170544|7660293|FG011|COMPLETED|Part 4||6
6730864|NCT03170544|7660282|FG000|NOT COMPLETED|Part 4||0
6730865|NCT03170544|7660283|FG001|NOT COMPLETED|Part 4||0
6730866|NCT03170544|7660284|FG002|NOT COMPLETED|Part 4||0
6730867|NCT03170544|7660285|FG003|NOT COMPLETED|Part 4||0
6730868|NCT03170544|7660286|FG004|NOT COMPLETED|Part 4||0
6730869|NCT03170544|7660287|FG005|NOT COMPLETED|Part 4||0
6730870|NCT03170544|7660288|FG006|NOT COMPLETED|Part 4||0
6730871|NCT03170544|7660289|FG007|NOT COMPLETED|Part 4||0
6730872|NCT03170544|7660290|FG008|NOT COMPLETED|Part 4||0
6730873|NCT03170544|7660291|FG009|NOT COMPLETED|Part 4||0
6730874|NCT03170544|7660292|FG010|NOT COMPLETED|Part 4||0
6730875|NCT03170544|7660293|FG011|NOT COMPLETED|Part 4||0
6730876|NCT03170609|7660383|FG000|STARTED|Overall Study||53
6730877|NCT03170609|7660384|FG001|STARTED|Overall Study||52
6730878|NCT03170609|7660385|FG002|STARTED|Overall Study||52
6730879|NCT03170609|7660386|FG003|STARTED|Overall Study||52
6730880|NCT03170609|7660387|FG004|STARTED|Overall Study||52
6730881|NCT03170609|7660388|FG005|STARTED|Overall Study||52
6730882|NCT03170609|7660389|FG006|STARTED|Overall Study||52
6730883|NCT03170609|7660383|FG000|Vaccinated|Overall Study||52
6730884|NCT03170609|7660384|FG001|Vaccinated|Overall Study||52
6730885|NCT03170609|7660385|FG002|Vaccinated|Overall Study||52
6730886|NCT03170609|7660386|FG003|Vaccinated|Overall Study||52
6730887|NCT03170609|7660387|FG004|Vaccinated|Overall Study||52
6730888|NCT03170609|7660388|FG005|Vaccinated|Overall Study||52
6730889|NCT03170609|7660389|FG006|Vaccinated|Overall Study||52
6730890|NCT03170609|7660383|FG000|COMPLETED|Overall Study||50
6730891|NCT03170609|7660384|FG001|COMPLETED|Overall Study||50
6730892|NCT03170609|7660385|FG002|COMPLETED|Overall Study||46
6730893|NCT03170609|7660386|FG003|COMPLETED|Overall Study||50
6730894|NCT03170609|7660387|FG004|COMPLETED|Overall Study||51
6730895|NCT03170609|7660388|FG005|COMPLETED|Overall Study||50
6730896|NCT03170609|7660389|FG006|COMPLETED|Overall Study||51
6730897|NCT03170609|7660383|FG000|NOT COMPLETED|Overall Study||3
6730898|NCT03170609|7660384|FG001|NOT COMPLETED|Overall Study||2
6730899|NCT03170609|7660385|FG002|NOT COMPLETED|Overall Study||6
6730900|NCT03170609|7660386|FG003|NOT COMPLETED|Overall Study||2
6730901|NCT03170609|7660387|FG004|NOT COMPLETED|Overall Study||1
6730902|NCT03170609|7660388|FG005|NOT COMPLETED|Overall Study||2
6730903|NCT03170609|7660389|FG006|NOT COMPLETED|Overall Study||1
6730904|NCT03170661|7660407|FG000|STARTED|Overall Study||49
6730905|NCT03170661|7660408|FG001|STARTED|Overall Study||49
6730906|NCT03170661|7660407|FG000|COMPLETED|Overall Study||49
6730907|NCT03170661|7660408|FG001|COMPLETED|Overall Study||49
6730908|NCT03170661|7660407|FG000|NOT COMPLETED|Overall Study||0
6730909|NCT03170661|7660408|FG001|NOT COMPLETED|Overall Study||0
6730910|NCT03171051|7660416|FG000|STARTED|Overall Study||10
6730911|NCT03171051|7660416|FG000|COMPLETED|Overall Study||10
6730912|NCT03171051|7660416|FG000|NOT COMPLETED|Overall Study||0
6730913|NCT03171415|7660426|FG000|STARTED|Overall Study||6
6730914|NCT03171415|7660427|FG001|STARTED|Overall Study||6
6730915|NCT03171415|7660428|FG002|STARTED|Overall Study||6
6730916|NCT03171415|7660429|FG003|STARTED|Overall Study||6
6730917|NCT03171415|7660430|FG004|STARTED|Overall Study||9
6730918|NCT03171415|7660426|FG000|COMPLETED|Overall Study||6
6730919|NCT03171415|7660427|FG001|COMPLETED|Overall Study||6
6730920|NCT03171415|7660428|FG002|COMPLETED|Overall Study||6
6730921|NCT03171415|7660429|FG003|COMPLETED|Overall Study||6
6730922|NCT03171415|7660430|FG004|COMPLETED|Overall Study||7
6730923|NCT03171415|7660426|FG000|NOT COMPLETED|Overall Study||0
6730924|NCT03171415|7660427|FG001|NOT COMPLETED|Overall Study||0
6730925|NCT03171415|7660428|FG002|NOT COMPLETED|Overall Study||0
6730926|NCT03171415|7660429|FG003|NOT COMPLETED|Overall Study||0
6730927|NCT03171415|7660430|FG004|NOT COMPLETED|Overall Study||2
6730928|NCT03172130|7660455|FG000|STARTED|Overall Study||12
6730929|NCT03172130|7660456|FG001|STARTED|Overall Study||10
6730930|NCT03172130|7660455|FG000|COMPLETED|Overall Study||9
6730931|NCT03172130|7660456|FG001|COMPLETED|Overall Study||9
6730932|NCT03172130|7660455|FG000|NOT COMPLETED|Overall Study||3
6730933|NCT03172130|7660456|FG001|NOT COMPLETED|Overall Study||1
6730934|NCT03172325|7660464|FG000|STARTED|Overall Study||68
6730935|NCT03172325|7660465|FG001|STARTED|Overall Study||68
6730936|NCT03172325|7660464|FG000|COMPLETED|Overall Study||64
6730937|NCT03172325|7660465|FG001|COMPLETED|Overall Study||64
6730938|NCT03172325|7660464|FG000|NOT COMPLETED|Overall Study||4
6730939|NCT03172325|7660465|FG001|NOT COMPLETED|Overall Study||4
6730940|NCT03172364|7660473|FG000|STARTED|Overall Study||55
6730941|NCT03172364|7660474|FG001|STARTED|Overall Study||58
6730942|NCT03172364|7660473|FG000|COMPLETED|Overall Study||53
6730943|NCT03172364|7660474|FG001|COMPLETED|Overall Study||57
6730944|NCT03172364|7660473|FG000|NOT COMPLETED|Overall Study||2
6730945|NCT03172364|7660474|FG001|NOT COMPLETED|Overall Study||1
6730946|NCT03172481|7660482|FG000|STARTED|Open-label||156
6730947|NCT03172481|7660483|FG001|STARTED|Open-label||0
6730948|NCT03172481|7660482|FG000|COMPLETED|Open-label||148
6730949|NCT03172481|7660483|FG001|COMPLETED|Open-label||0
6730950|NCT03172481|7660482|FG000|NOT COMPLETED|Open-label||8
6730951|NCT03172481|7660483|FG001|NOT COMPLETED|Open-label||0
6730952|NCT03172481|7660482|FG000|STARTED|Double-blind||75
6730953|NCT03172481|7660483|FG001|STARTED|Double-blind|From 148 subjects who completed the Open-label period, 73 randomly received Placebo|73
6730954|NCT03172481|7660482|FG000|COMPLETED|Double-blind||74
6730955|NCT03172481|7660483|FG001|COMPLETED|Double-blind||73
6730956|NCT03172481|7660482|FG000|NOT COMPLETED|Double-blind||1
6730957|NCT03172481|7660483|FG001|NOT COMPLETED|Double-blind||0
6730958|NCT03172494|7660492|FG000|STARTED|Overall Study||361
6730959|NCT03172494|7660493|FG001|STARTED|Overall Study||179
6730960|NCT03172494|7660494|FG002|STARTED|Overall Study||180
6266146|NCT00041756|7165365|FG001|NOT COMPLETED|Overall Study||15
6266147|NCT00041756|7165366|FG002|NOT COMPLETED|Overall Study||13
6266148|NCT00041756|7165367|FG003|NOT COMPLETED|Overall Study||16
6266149|NCT00041756|7165368|FG004|NOT COMPLETED|Overall Study||60
6266150|NCT00041938|7165382|FG000|STARTED|Overall Study||1163
6266151|NCT00041938|7165383|FG001|STARTED|Overall Study||1142
6266152|NCT00041938|7165382|FG000|Completed Follow-up|Overall Study||761
6266153|NCT00041938|7165383|FG001|Completed Follow-up|Overall Study||745
6266154|NCT00041938|7165382|FG000|Primary Endpoint|Overall Study||320
6266155|NCT00041938|7165383|FG001|Primary Endpoint|Overall Study||302
6266156|NCT00041938|7165382|FG000|Only Vital Status Known|Overall Study||44
6266157|NCT00041938|7165383|FG001|Only Vital Status Known|Overall Study||46
6266158|NCT00041938|7165382|FG000|Lost to Follow-up|Overall Study||18
6266159|NCT00041938|7165383|FG001|Lost to Follow-up|Overall Study||17
6266160|NCT00041938|7165382|FG000|Withdrew Consent|Overall Study||20
6266161|NCT00041938|7165383|FG001|Withdrew Consent|Overall Study||14
6266162|NCT00041938|7165382|FG000|COMPLETED|Overall Study||1125
6266163|NCT00041938|7165383|FG001|COMPLETED|Overall Study||1111
6266164|NCT00041938|7165382|FG000|NOT COMPLETED|Overall Study||38
6266165|NCT00041938|7165383|FG001|NOT COMPLETED|Overall Study||31
6266166|NCT00042224|7165391|FG000|STARTED|Overall Study||20
6266167|NCT00042224|7165392|FG001|STARTED|Overall Study||19
6266168|NCT00042224|7165391|FG000|COMPLETED|Overall Study||17
6266169|NCT00042224|7165392|FG001|COMPLETED|Overall Study||16
6266170|NCT00042224|7165391|FG000|NOT COMPLETED|Overall Study||3
6266171|NCT00042224|7165392|FG001|NOT COMPLETED|Overall Study||3
6266172|NCT00042432|7165400|FG000|STARTED|Overall Study||27
6266173|NCT00042432|7165401|FG001|STARTED|Overall Study||27
6266174|NCT00042432|7165400|FG000|COMPLETED|Overall Study||18
6266175|NCT00042432|7165401|FG001|COMPLETED|Overall Study||20
6266176|NCT00042432|7165400|FG000|NOT COMPLETED|Overall Study||9
6266177|NCT00042432|7165401|FG001|NOT COMPLETED|Overall Study||7
6266178|NCT00042666|7165407|FG000|STARTED|Overall Study||55
6730961|NCT03172494|7660492|FG000|Full Analysis Set (FAS)|Overall Study||361
6730962|NCT03172494|7660493|FG001|Full Analysis Set (FAS)|Overall Study||179
6730963|NCT03172494|7660494|FG002|Full Analysis Set (FAS)|Overall Study||180
6730964|NCT03172494|7660492|FG000|Safety Analysis Set (SAS)|Overall Study||358
6730965|NCT03172494|7660493|FG001|Safety Analysis Set (SAS)|Overall Study||175
6730966|NCT03172494|7660494|FG002|Safety Analysis Set (SAS)|Overall Study||180
6730967|NCT03172494|7660492|FG000|Exposed|Overall Study||358
6730968|NCT03172494|7660493|FG001|Exposed|Overall Study||175
6730969|NCT03172494|7660494|FG002|Exposed|Overall Study||180
6730970|NCT03172494|7660492|FG000|COMPLETED|Overall Study||341
6730971|NCT03172494|7660493|FG001|COMPLETED|Overall Study||167
6730972|NCT03172494|7660494|FG002|COMPLETED|Overall Study||151
6730973|NCT03172494|7660492|FG000|NOT COMPLETED|Overall Study||20
6730974|NCT03172494|7660493|FG001|NOT COMPLETED|Overall Study||12
6730975|NCT03172494|7660494|FG002|NOT COMPLETED|Overall Study||29
6730976|NCT03172702|7660503|FG000|STARTED|Overall Study||150
6730977|NCT03172702|7660503|FG000|Received Treatment in CP|Overall Study||150
6730978|NCT03172702|7660503|FG000|Received Treatment in MP|Overall Study||150
6730979|NCT03172702|7660503|FG000|COMPLETED|Overall Study||122
6730980|NCT03172702|7660503|FG000|NOT COMPLETED|Overall Study||28
6730981|NCT03172884|7660512|FG000|STARTED|Overall Study||8
6730982|NCT03172884|7660513|FG001|STARTED|Overall Study||6
6730983|NCT03172884|7660514|FG002|STARTED|Overall Study||8
6730984|NCT03172884|7660515|FG003|STARTED|Overall Study||8
6730985|NCT03172884|7660512|FG000|COMPLETED|Overall Study||8
6730986|NCT03172884|7660513|FG001|COMPLETED|Overall Study||6
6730987|NCT03172884|7660514|FG002|COMPLETED|Overall Study||8
6730988|NCT03172884|7660515|FG003|COMPLETED|Overall Study||8
6730989|NCT03172884|7660512|FG000|NOT COMPLETED|Overall Study||0
6730990|NCT03172884|7660513|FG001|NOT COMPLETED|Overall Study||0
6730991|NCT03172884|7660514|FG002|NOT COMPLETED|Overall Study||0
6730992|NCT03172884|7660515|FG003|NOT COMPLETED|Overall Study||0
6730993|NCT03173170|7660525|FG000|STARTED|First Intervention Period (6 Days)||10
6730994|NCT03173170|7660525|FG000|COMPLETED|First Intervention Period (6 Days)||10
6730995|NCT03173170|7660525|FG000|NOT COMPLETED|First Intervention Period (6 Days)||0
6730996|NCT03173170|7660525|FG000|STARTED|Washout Period (at Least 7 Days)||10
6730997|NCT03173170|7660525|FG000|COMPLETED|Washout Period (at Least 7 Days)||10
6730998|NCT03173170|7660525|FG000|NOT COMPLETED|Washout Period (at Least 7 Days)||0
6730999|NCT03173170|7660525|FG000|STARTED|Intervention Period 2 (9 Days)||10
6731000|NCT03173170|7660525|FG000|COMPLETED|Intervention Period 2 (9 Days)||10
6731001|NCT03173170|7660525|FG000|NOT COMPLETED|Intervention Period 2 (9 Days)||0
6731002|NCT03173313|7660535|FG000|STARTED|Overall Study||58
6731003|NCT03173313|7660536|FG001|STARTED|Overall Study||53
6731004|NCT03173313|7660535|FG000|Informed Consent Signed|Overall Study||58
6731005|NCT03173313|7660536|FG001|Informed Consent Signed|Overall Study||53
6731006|NCT03173313|7660535|FG000|Randomized|Overall Study||58
6731007|NCT03173313|7660536|FG001|Randomized|Overall Study||53
6731008|NCT03173313|7660535|FG000|Cooled|Overall Study||54
6731009|NCT03173313|7660536|FG001|Cooled|Overall Study||0
6731010|NCT03173313|7660535|FG000|4-6 Day Follow-up|Overall Study||57
6731011|NCT03173313|7660536|FG001|4-6 Day Follow-up|Overall Study||53
6731012|NCT03173313|7660535|FG000|30-day Follow-up|Overall Study||52
6731013|NCT03173313|7660536|FG001|30-day Follow-up|Overall Study||51
6731014|NCT03173313|7660535|FG000|12-month Follow-up|Overall Study||49
6731015|NCT03173313|7660536|FG001|12-month Follow-up|Overall Study||48
6731016|NCT03173313|7660535|FG000|COMPLETED|Overall Study||49
6731017|NCT03173313|7660536|FG001|COMPLETED|Overall Study||48
6731018|NCT03173313|7660535|FG000|NOT COMPLETED|Overall Study||9
6731019|NCT03173313|7660536|FG001|NOT COMPLETED|Overall Study||5
6731020|NCT03173547|7660544|FG000|STARTED|Overall Study||40
6731021|NCT03173547|7660545|FG001|STARTED|Overall Study||40
6731022|NCT03173547|7660544|FG000|COMPLETED|Overall Study||36
6731023|NCT03173547|7660545|FG001|COMPLETED|Overall Study||38
6731024|NCT03173547|7660544|FG000|NOT COMPLETED|Overall Study||4
6731025|NCT03173547|7660545|FG001|NOT COMPLETED|Overall Study||2
6731026|NCT03173560|7660553|FG000|STARTED|Overall Study||172
6731027|NCT03173560|7660554|FG001|STARTED|Overall Study||171
6731028|NCT03173560|7660553|FG000|Treated Participants|Overall Study||172
6731029|NCT03173560|7660554|FG001|Treated Participants|Overall Study||169
6731030|NCT03173560|7660553|FG000|Safety Set|Overall Study||173
6731031|NCT03173560|7660554|FG001|Safety Set|Overall Study||168
6731032|NCT03173560|7660553|FG000|COMPLETED|Overall Study||67
6731033|NCT03173560|7660554|FG001|COMPLETED|Overall Study||54
6731034|NCT03173560|7660553|FG000|NOT COMPLETED|Overall Study||105
6731035|NCT03173560|7660554|FG001|NOT COMPLETED|Overall Study||117
6739905|NCT03296072|7668702|FG003|NOT COMPLETED|Treament Period 3||0
6739906|NCT03296072|7668703|FG004|NOT COMPLETED|Treament Period 3||0
6739907|NCT03296072|7668704|FG005|NOT COMPLETED|Treament Period 3||0
6739908|NCT03296163|7668714|FG000|STARTED|Combination Therapy||315
6739909|NCT03296163|7668715|FG001|STARTED|Combination Therapy||312
6739910|NCT03296163|7668714|FG000|COMPLETED|Combination Therapy||207
6739911|NCT03296163|7668715|FG001|COMPLETED|Combination Therapy||220
6739912|NCT03296163|7668714|FG000|NOT COMPLETED|Combination Therapy||108
6739913|NCT03296163|7668715|FG001|NOT COMPLETED|Combination Therapy||92
6739914|NCT03296163|7668714|FG000|STARTED|Monotherapy||207
6739915|NCT03296163|7668715|FG001|STARTED|Monotherapy||220
6739916|NCT03296163|7668714|FG000|COMPLETED|Monotherapy||68
6739917|NCT03296163|7668715|FG001|COMPLETED|Monotherapy||74
6739918|NCT03296163|7668714|FG000|NOT COMPLETED|Monotherapy||139
6739919|NCT03296163|7668715|FG001|NOT COMPLETED|Monotherapy||146
6739920|NCT03296280|7668723|FG000|STARTED|Overall Study||73
6739921|NCT03296280|7668724|FG001|STARTED|Overall Study||43
6739922|NCT03296280|7668723|FG000|COMPLETED|Overall Study||67
6739923|NCT03296280|7668724|FG001|COMPLETED|Overall Study||36
6739924|NCT03296280|7668723|FG000|NOT COMPLETED|Overall Study||6
6739925|NCT03296280|7668724|FG001|NOT COMPLETED|Overall Study||7
6739926|NCT03296345|7668730|FG000|STARTED|Overall Study||62
6739927|NCT03296345|7668730|FG000|COMPLETED|Overall Study||62
6739928|NCT03296345|7668730|FG000|NOT COMPLETED|Overall Study||0
6739929|NCT03296527|7668738|FG000|STARTED|Overall Study||500
6739930|NCT03296527|7668739|FG001|STARTED|Overall Study||511
6731036|NCT03174132|7660560|FG000|STARTED|Overall Study||70
6731037|NCT03174132|7660560|FG000|COMPLETED|Overall Study||70
6731038|NCT03174132|7660560|FG000|NOT COMPLETED|Overall Study||0
6731039|NCT03174158|7660568|FG000|STARTED|Overall Study||39
6731040|NCT03174158|7660569|FG001|STARTED|Overall Study||39
6731041|NCT03174158|7660570|FG002|STARTED|Overall Study||36
6731042|NCT03174158|7660571|FG003|STARTED|Overall Study||39
6731043|NCT03174158|7660568|FG000|COMPLETED|Overall Study||35
6731044|NCT03174158|7660569|FG001|COMPLETED|Overall Study||37
6731045|NCT03174158|7660570|FG002|COMPLETED|Overall Study||34
6731046|NCT03174158|7660571|FG003|COMPLETED|Overall Study||38
6731047|NCT03174158|7660568|FG000|NOT COMPLETED|Overall Study||4
6731048|NCT03174158|7660569|FG001|NOT COMPLETED|Overall Study||2
6731049|NCT03174158|7660570|FG002|NOT COMPLETED|Overall Study||2
6731050|NCT03174158|7660571|FG003|NOT COMPLETED|Overall Study||1
6731051|NCT03174366|7660589|FG000|STARTED|Overall Study||7
6731052|NCT03174366|7660589|FG000|COMPLETED|Overall Study||7
6731053|NCT03174366|7660589|FG000|NOT COMPLETED|Overall Study||0
6731054|NCT03174925|7660593|FG000|STARTED|Overall Study||55
6731055|NCT03174925|7660593|FG000|COMPLETED|Overall Study||52
6731056|NCT03174925|7660593|FG000|NOT COMPLETED|Overall Study||3
6731057|NCT03175120|7660599|FG000|STARTED|Overall Study||302
6266179|NCT00042666|7165407|FG000|Received at Least 1 Dose of Study Drug|Overall Study||55
6731058|NCT03175120|7660600|FG001|STARTED|Overall Study||151
6731059|NCT03175120|7660599|FG000|Treated|Overall Study||301
6731060|NCT03175120|7660600|FG001|Treated|Overall Study||151
6731061|NCT03175120|7660599|FG000|Full Analysis Set (FAS)|Overall Study||302
6731062|NCT03175120|7660600|FG001|Full Analysis Set (FAS)|Overall Study||151
6731063|NCT03175120|7660599|FG000|Safety Analysis Set (SAS)|Overall Study||301
6731064|NCT03175120|7660600|FG001|Safety Analysis Set (SAS)|Overall Study||151
6731065|NCT03175120|7660599|FG000|COMPLETED|Overall Study||290
6731066|NCT03175120|7660600|FG001|COMPLETED|Overall Study||139
6731067|NCT03175120|7660599|FG000|NOT COMPLETED|Overall Study||12
6731068|NCT03175120|7660600|FG001|NOT COMPLETED|Overall Study||12
6731069|NCT03175172|7660606|FG000|STARTED|Overall Study||10
6731070|NCT03175172|7660606|FG000|COMPLETED|Overall Study||0
6731071|NCT03175172|7660606|FG000|NOT COMPLETED|Overall Study||10
6731072|NCT03175562|7660610|FG000|STARTED|Overall Study||240
6731073|NCT03175562|7660610|FG000|Test Product|Overall Study||240
6731074|NCT03175562|7660610|FG000|Negative Control|Overall Study||240
6731075|NCT03175562|7660610|FG000|COMPLETED|Overall Study||224
6731076|NCT03175562|7660610|FG000|NOT COMPLETED|Overall Study||16
6731077|NCT03175731|7660619|FG000|STARTED|Overall Study||53
6731078|NCT03175731|7660620|FG001|STARTED|Overall Study||53
6731079|NCT03175731|7660619|FG000|COMPLETED|Overall Study||46
6731080|NCT03175731|7660620|FG001|COMPLETED|Overall Study||48
6731081|NCT03175731|7660619|FG000|NOT COMPLETED|Overall Study||7
6731082|NCT03175731|7660620|FG001|NOT COMPLETED|Overall Study||5
6731083|NCT03176238|7660628|FG000|STARTED|Overall Study||199
6731084|NCT03176238|7660629|FG001|STARTED|Overall Study||36
6731085|NCT03176238|7660628|FG000|COMPLETED|Overall Study||0
6731086|NCT03176238|7660629|FG001|COMPLETED|Overall Study||0
6731087|NCT03176238|7660628|FG000|NOT COMPLETED|Overall Study||199
6731088|NCT03176238|7660629|FG001|NOT COMPLETED|Overall Study||36
6731089|NCT03176407|7660639|FG000|STARTED|Overall Study||30
6731090|NCT03176407|7660639|FG000|COMPLETED|Overall Study||27
6731091|NCT03176407|7660639|FG000|NOT COMPLETED|Overall Study||3
6731092|NCT03176459|7660647|FG000|STARTED|Overall Study||96
6731093|NCT03176459|7660648|FG001|STARTED|Overall Study||90
6731094|NCT03176459|7660647|FG000|COMPLETED|Overall Study||91
6731095|NCT03176459|7660648|FG001|COMPLETED|Overall Study||83
6731096|NCT03176459|7660647|FG000|NOT COMPLETED|Overall Study||5
6731097|NCT03176459|7660648|FG001|NOT COMPLETED|Overall Study||7
6731098|NCT03176654|7660656|FG000|STARTED|Overall Study||13
6731099|NCT03176654|7660657|FG001|STARTED|Overall Study||15
6731100|NCT03176654|7660656|FG000|COMPLETED|Overall Study||13
6731101|NCT03176654|7660657|FG001|COMPLETED|Overall Study||15
6731102|NCT03176654|7660656|FG000|NOT COMPLETED|Overall Study||0
6731103|NCT03176654|7660657|FG001|NOT COMPLETED|Overall Study||0
6731104|NCT03176784|7660667|FG000|STARTED|Overall Study||314
6731105|NCT03176784|7660668|FG001|STARTED|Overall Study||315
6731106|NCT03176784|7660669|FG002|STARTED|Overall Study||311
6731107|NCT03176784|7660670|FG003|STARTED|Overall Study||311
6731108|NCT03176784|7660667|FG000|COMPLETED|Overall Study||209
6731109|NCT03176784|7660668|FG001|COMPLETED|Overall Study||202
6731110|NCT03176784|7660669|FG002|COMPLETED|Overall Study||198
6731111|NCT03176784|7660670|FG003|COMPLETED|Overall Study||241
6731112|NCT03176784|7660667|FG000|NOT COMPLETED|Overall Study||105
6731113|NCT03176784|7660668|FG001|NOT COMPLETED|Overall Study||113
6731114|NCT03176784|7660669|FG002|NOT COMPLETED|Overall Study||113
6731115|NCT03176784|7660670|FG003|NOT COMPLETED|Overall Study||70
6731116|NCT03177395|7660684|FG000|STARTED|Overall Study||6
6731117|NCT03177395|7660685|FG001|STARTED|Overall Study||6
6731118|NCT03177395|7660686|FG002|STARTED|Overall Study||6
6731119|NCT03177395|7660687|FG003|STARTED|Overall Study||6
6731120|NCT03177395|7660684|FG000|COMPLETED|Overall Study||6
6731121|NCT03177395|7660685|FG001|COMPLETED|Overall Study||6
6731122|NCT03177395|7660686|FG002|COMPLETED|Overall Study||6
6731123|NCT03177395|7660687|FG003|COMPLETED|Overall Study||6
6731124|NCT03177395|7660684|FG000|NOT COMPLETED|Overall Study||0
6731125|NCT03177395|7660685|FG001|NOT COMPLETED|Overall Study||0
6731126|NCT03177395|7660686|FG002|NOT COMPLETED|Overall Study||0
6731127|NCT03177395|7660687|FG003|NOT COMPLETED|Overall Study||0
6731128|NCT03177512|7660701|FG000|STARTED|Overall Study||40
6731129|NCT03177512|7660702|FG001|STARTED|Overall Study||21
6731130|NCT03177512|7660701|FG000|COMPLETED|Overall Study||31
6731131|NCT03177512|7660702|FG001|COMPLETED|Overall Study||18
6731132|NCT03177512|7660701|FG000|NOT COMPLETED|Overall Study||9
6731133|NCT03177512|7660702|FG001|NOT COMPLETED|Overall Study||3
6731134|NCT03177603|7660712|FG000|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
6731135|NCT03177603|7660713|FG001|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731136|NCT03177603|7660714|FG002|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731137|NCT03177603|7660715|FG003|STARTED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731138|NCT03177603|7660712|FG000|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||4
6731139|NCT03177603|7660713|FG001|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731140|NCT03177603|7660714|FG002|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731141|NCT03177603|7660715|FG003|COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731142|NCT03177603|7660712|FG000|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731143|NCT03177603|7660713|FG001|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731144|NCT03177603|7660714|FG002|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731145|NCT03177603|7660715|FG003|NOT COMPLETED|Cohort 1: Dose Level 0.1 mg/kg (28 Days)||0
6731146|NCT03177603|7660712|FG000|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731147|NCT03177603|7660713|FG001|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
6731148|NCT03177603|7660714|FG002|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731149|NCT03177603|7660715|FG003|STARTED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731150|NCT03177603|7660712|FG000|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731151|NCT03177603|7660713|FG001|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||5
6731152|NCT03177603|7660714|FG002|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731153|NCT03177603|7660715|FG003|COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731154|NCT03177603|7660712|FG000|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731155|NCT03177603|7660713|FG001|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731156|NCT03177603|7660714|FG002|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731157|NCT03177603|7660715|FG003|NOT COMPLETED|Cohort 2: Dose Level 0.2 mg/kg (28 Days)||0
6731158|NCT03177603|7660712|FG000|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731159|NCT03177603|7660713|FG001|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731160|NCT03177603|7660714|FG002|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
6731161|NCT03177603|7660715|FG003|STARTED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731162|NCT03177603|7660712|FG000|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731163|NCT03177603|7660713|FG001|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731164|NCT03177603|7660714|FG002|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||6
6731165|NCT03177603|7660715|FG003|COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731166|NCT03177603|7660712|FG000|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731167|NCT03177603|7660713|FG001|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731168|NCT03177603|7660714|FG002|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731169|NCT03177603|7660715|FG003|NOT COMPLETED|Cohort 3: Dose Level 0.4 mg/kg (28 Days)||0
6731170|NCT03177603|7660712|FG000|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731171|NCT03177603|7660713|FG001|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731172|NCT03177603|7660714|FG002|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731173|NCT03177603|7660715|FG003|STARTED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
6731174|NCT03177603|7660712|FG000|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731175|NCT03177603|7660713|FG001|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731176|NCT03177603|7660714|FG002|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731177|NCT03177603|7660715|FG003|COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||8
6731178|NCT03177603|7660712|FG000|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731179|NCT03177603|7660713|FG001|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731180|NCT03177603|7660714|FG002|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731181|NCT03177603|7660715|FG003|NOT COMPLETED|Cohort 4: Dose Level 0.8 mg/kg (28 Days)||0
6731182|NCT03177798|7660727|FG000|STARTED|Overall Study||5
6731183|NCT03177798|7660728|FG001|STARTED|Overall Study||6
6731184|NCT03177798|7660727|FG000|Intervention 1|Overall Study||5
6731185|NCT03177798|7660728|FG001|Intervention 1|Overall Study||6
6731186|NCT03177798|7660727|FG000|Washout|Overall Study||5
6731187|NCT03177798|7660728|FG001|Washout|Overall Study||6
6731188|NCT03177798|7660727|FG000|Intervention 2|Overall Study||5
6731189|NCT03177798|7660728|FG001|Intervention 2|Overall Study||6
6731190|NCT03177798|7660727|FG000|COMPLETED|Overall Study||5
6731191|NCT03177798|7660728|FG001|COMPLETED|Overall Study||6
6731192|NCT03177798|7660727|FG000|NOT COMPLETED|Overall Study||0
6731193|NCT03177798|7660728|FG001|NOT COMPLETED|Overall Study||0
6731194|NCT03178266|7660738|FG000|STARTED|Overall Study||21
6731195|NCT03178266|7660739|FG001|STARTED|Overall Study||20
6731196|NCT03178266|7660738|FG000|COMPLETED|Overall Study||21
6731197|NCT03178266|7660739|FG001|COMPLETED|Overall Study||16
6731198|NCT03178266|7660738|FG000|NOT COMPLETED|Overall Study||0
6731199|NCT03178266|7660739|FG001|NOT COMPLETED|Overall Study||4
6731200|NCT03178344|7660745|FG000|STARTED|First Session||10
6731201|NCT03178344|7660746|FG001|STARTED|First Session||10
6731202|NCT03178344|7660745|FG000|COMPLETED|First Session||10
6731203|NCT03178344|7660746|FG001|COMPLETED|First Session||10
6731204|NCT03178344|7660745|FG000|NOT COMPLETED|First Session||0
6731205|NCT03178344|7660746|FG001|NOT COMPLETED|First Session||0
6731206|NCT03178344|7660745|FG000|STARTED|Washout Period (5-9 Days)||10
6731207|NCT03178344|7660746|FG001|STARTED|Washout Period (5-9 Days)||10
6731208|NCT03178344|7660745|FG000|COMPLETED|Washout Period (5-9 Days)||10
6731209|NCT03178344|7660746|FG001|COMPLETED|Washout Period (5-9 Days)||10
6731210|NCT03178344|7660745|FG000|NOT COMPLETED|Washout Period (5-9 Days)||0
6731211|NCT03178344|7660746|FG001|NOT COMPLETED|Washout Period (5-9 Days)||0
6731212|NCT03178344|7660745|FG000|STARTED|Second Session||10
6731213|NCT03178344|7660746|FG001|STARTED|Second Session||10
6731214|NCT03178344|7660745|FG000|COMPLETED|Second Session||10
6731215|NCT03178344|7660746|FG001|COMPLETED|Second Session||10
6731216|NCT03178344|7660745|FG000|NOT COMPLETED|Second Session||0
6731217|NCT03178344|7660746|FG001|NOT COMPLETED|Second Session||0
6731218|NCT03178669|7660757|FG000|STARTED|Overall Study||40
6731219|NCT03178669|7660758|FG001|STARTED|Overall Study||43
6731220|NCT03178669|7660759|FG002|STARTED|Overall Study||42
6731221|NCT03178669|7660760|FG003|STARTED|Overall Study||42
6731222|NCT03178669|7660761|FG004|STARTED|Overall Study||44
6731223|NCT03178669|7660757|FG000|Completed Week 6|Overall Study||35
6731224|NCT03178669|7660758|FG001|Completed Week 6|Overall Study||42
6731225|NCT03178669|7660759|FG002|Completed Week 6|Overall Study||36
6731226|NCT03178669|7660760|FG003|Completed Week 6|Overall Study||38
6731227|NCT03178669|7660761|FG004|Completed Week 6|Overall Study||42
6731228|NCT03178669|7660757|FG000|COMPLETED|Overall Study||35
6731229|NCT03178669|7660758|FG001|COMPLETED|Overall Study||42
6731230|NCT03178669|7660759|FG002|COMPLETED|Overall Study||35
6731231|NCT03178669|7660760|FG003|COMPLETED|Overall Study||38
6731232|NCT03178669|7660761|FG004|COMPLETED|Overall Study||40
6731233|NCT03178669|7660757|FG000|NOT COMPLETED|Overall Study||5
6731234|NCT03178669|7660758|FG001|NOT COMPLETED|Overall Study||1
6731235|NCT03178669|7660759|FG002|NOT COMPLETED|Overall Study||7
6731236|NCT03178669|7660760|FG003|NOT COMPLETED|Overall Study||4
6731237|NCT03178669|7660761|FG004|NOT COMPLETED|Overall Study||4
6731238|NCT03178773|7660775|FG000|STARTED|Overall Study||86
6731239|NCT03178773|7660776|FG001|STARTED|Overall Study||80
6731240|NCT03178773|7660775|FG000|3month Phone Follow up|Overall Study||49
6731241|NCT03178773|7660776|FG001|3month Phone Follow up|Overall Study||51
6731242|NCT03178773|7660775|FG000|6month in Person Follow up|Overall Study||54
6731243|NCT03178773|7660776|FG001|6month in Person Follow up|Overall Study||46
6731244|NCT03178773|7660775|FG000|9month Follow up Phone|Overall Study||36
6731245|NCT03178773|7660776|FG001|9month Follow up Phone|Overall Study||51
6731246|NCT03178773|7660775|FG000|COMPLETED|Overall Study||47
6731247|NCT03178773|7660776|FG001|COMPLETED|Overall Study||40
6731248|NCT03178773|7660775|FG000|NOT COMPLETED|Overall Study||39
6731249|NCT03178773|7660776|FG001|NOT COMPLETED|Overall Study||40
6731250|NCT03178851|7660786|FG000|STARTED|Overall Study||92
6731251|NCT03178851|7660787|FG001|STARTED|Overall Study||11
6731252|NCT03178851|7660788|FG002|STARTED|Overall Study||52
6731253|NCT03178851|7660786|FG000|COMPLETED|Overall Study||0
6731254|NCT03178851|7660787|FG001|COMPLETED|Overall Study||0
6731255|NCT03178851|7660788|FG002|COMPLETED|Overall Study||0
6731256|NCT03178851|7660786|FG000|NOT COMPLETED|Overall Study||92
6731257|NCT03178851|7660787|FG001|NOT COMPLETED|Overall Study||11
6731258|NCT03178851|7660788|FG002|NOT COMPLETED|Overall Study||52
6731259|NCT03178942|7660799|FG000|STARTED|Overall Study||129
6731260|NCT03178942|7660800|FG001|STARTED|Overall Study||125
6731261|NCT03178942|7660799|FG000|COMPLETED|Overall Study||126
6731262|NCT03178942|7660800|FG001|COMPLETED|Overall Study||123
6731263|NCT03178942|7660799|FG000|NOT COMPLETED|Overall Study||3
6731264|NCT03178942|7660800|FG001|NOT COMPLETED|Overall Study||2
6731265|NCT03179319|7660808|FG000|STARTED|Overall Study||40
6731266|NCT03179319|7660809|FG001|STARTED|Overall Study||20
6731267|NCT03179319|7660808|FG000|3 Month Visit|Overall Study||37
6731268|NCT03179319|7660809|FG001|3 Month Visit|Overall Study||20
6731269|NCT03179319|7660808|FG000|COMPLETED|Overall Study||34
6731270|NCT03179319|7660809|FG001|COMPLETED|Overall Study||20
6731271|NCT03179319|7660808|FG000|NOT COMPLETED|Overall Study||6
6731272|NCT03179319|7660809|FG001|NOT COMPLETED|Overall Study||0
6731273|NCT03179345|7660819|FG000|STARTED|Overall Study||8
6731274|NCT03179345|7660820|FG001|STARTED|Overall Study||8
6731275|NCT03179345|7660821|FG002|STARTED|Overall Study||8
6731276|NCT03179345|7660822|FG003|STARTED|Overall Study||8
6731277|NCT03179345|7660819|FG000|Received Gralise®|Overall Study||8
6731278|NCT03179345|7660820|FG001|Received Gralise®|Overall Study||7
6731279|NCT03179345|7660821|FG002|Received Gralise®|Overall Study||7
6731280|NCT03179345|7660822|FG003|Received Gralise®|Overall Study||6
6731281|NCT03179345|7660819|FG000|Received Neurontin®|Overall Study||8
6731282|NCT03179345|7660820|FG001|Received Neurontin®|Overall Study||8
6731283|NCT03179345|7660821|FG002|Received Neurontin®|Overall Study||7
6731284|NCT03179345|7660822|FG003|Received Neurontin®|Overall Study||8
6731285|NCT03179345|7660819|FG000|Received Lyrica®|Overall Study||8
6731286|NCT03179345|7660820|FG001|Received Lyrica®|Overall Study||7
6731287|NCT03179345|7660821|FG002|Received Lyrica®|Overall Study||8
6731288|NCT03179345|7660822|FG003|Received Lyrica®|Overall Study||8
6731289|NCT03179345|7660819|FG000|Received Placebo|Overall Study||8
6731290|NCT03179345|7660820|FG001|Received Placebo|Overall Study||7
6731291|NCT03179345|7660821|FG002|Received Placebo|Overall Study||7
6731292|NCT03179345|7660822|FG003|Received Placebo|Overall Study||8
6731293|NCT03179345|7660819|FG000|COMPLETED|Overall Study||8
6731294|NCT03179345|7660820|FG001|COMPLETED|Overall Study||7
6731295|NCT03179345|7660821|FG002|COMPLETED|Overall Study||7
6731296|NCT03179345|7660822|FG003|COMPLETED|Overall Study||6
6731297|NCT03179345|7660819|FG000|NOT COMPLETED|Overall Study||0
6731298|NCT03179345|7660820|FG001|NOT COMPLETED|Overall Study||1
6731299|NCT03179345|7660821|FG002|NOT COMPLETED|Overall Study||1
6731300|NCT03179345|7660822|FG003|NOT COMPLETED|Overall Study||2
6731301|NCT03179410|7660838|FG000|STARTED|Overall Study||15
6731302|NCT03179410|7660838|FG000|COMPLETED|Overall Study||15
6731303|NCT03179410|7660838|FG000|NOT COMPLETED|Overall Study||0
6731304|NCT03179787|7660842|FG000|STARTED|Overall Study||528
6731305|NCT03179787|7660842|FG000|COMPLETED|Overall Study||510
6731306|NCT03179787|7660842|FG000|NOT COMPLETED|Overall Study||18
6731307|NCT03179891|7660846|FG000|STARTED|First Intervention||13
6731308|NCT03179891|7660847|FG001|STARTED|First Intervention||22
6731309|NCT03179891|7660846|FG000|COMPLETED|First Intervention||11
6731310|NCT03179891|7660847|FG001|COMPLETED|First Intervention||20
6731311|NCT03179891|7660846|FG000|NOT COMPLETED|First Intervention||2
6731312|NCT03179891|7660847|FG001|NOT COMPLETED|First Intervention||2
6731313|NCT03179891|7660846|FG000|STARTED|Second Intervention (After 14 Days)||11
6731314|NCT03179891|7660847|FG001|STARTED|Second Intervention (After 14 Days)||20
6731315|NCT03179891|7660846|FG000|COMPLETED|Second Intervention (After 14 Days)||11
6731316|NCT03179891|7660847|FG001|COMPLETED|Second Intervention (After 14 Days)||20
6731317|NCT03179891|7660846|FG000|NOT COMPLETED|Second Intervention (After 14 Days)||0
6731318|NCT03179891|7660847|FG001|NOT COMPLETED|Second Intervention (After 14 Days)||0
6731319|NCT03180138|7660859|FG000|STARTED|Overall Study||204
6731320|NCT03180138|7660860|FG001|STARTED|Overall Study||201
6731321|NCT03180138|7660861|FG002|STARTED|Overall Study||203
6731322|NCT03180138|7660859|FG000|COMPLETED|Overall Study||182
6731323|NCT03180138|7660860|FG001|COMPLETED|Overall Study||188
6731324|NCT03180138|7660861|FG002|COMPLETED|Overall Study||179
6731325|NCT03180138|7660859|FG000|NOT COMPLETED|Overall Study||22
6731326|NCT03180138|7660860|FG001|NOT COMPLETED|Overall Study||13
6731327|NCT03180138|7660861|FG002|NOT COMPLETED|Overall Study||24
6731328|NCT03180385|7660871|FG000|STARTED|Overall Study||0
6731329|NCT03180385|7660872|FG001|STARTED|Overall Study||2
6731330|NCT03180385|7660871|FG000|COMPLETED|Overall Study||0
6731331|NCT03180385|7660872|FG001|COMPLETED|Overall Study||2
6731332|NCT03180385|7660871|FG000|NOT COMPLETED|Overall Study||0
6731333|NCT03180385|7660872|FG001|NOT COMPLETED|Overall Study||0
6731334|NCT03180489|7660880|FG000|STARTED|Overall Study||33
6731335|NCT03180489|7660881|FG001|STARTED|Overall Study||29
6731336|NCT03180489|7660880|FG000|COMPLETED|Overall Study||25
6731337|NCT03180489|7660881|FG001|COMPLETED|Overall Study||25
6731338|NCT03180489|7660880|FG000|NOT COMPLETED|Overall Study||8
6731339|NCT03180489|7660881|FG001|NOT COMPLETED|Overall Study||4
6731340|NCT03180515|7660887|FG000|STARTED|Aim 1||12
6731341|NCT03180515|7660887|FG000|COMPLETED|Aim 1||12
6731342|NCT03180515|7660887|FG000|NOT COMPLETED|Aim 1||0
6731343|NCT03180515|7660887|FG000|STARTED|Aim 2||12
6731344|NCT03180515|7660887|FG000|COMPLETED|Aim 2||12
6731345|NCT03180515|7660887|FG000|NOT COMPLETED|Aim 2||0
6731346|NCT03180515|7660887|FG000|STARTED|Aim 3||1
6731347|NCT03180515|7660887|FG000|COMPLETED|Aim 3||1
6731348|NCT03180515|7660887|FG000|NOT COMPLETED|Aim 3||0
6731349|NCT03180528|7660903|FG000|STARTED|Overall Study||30
6731350|NCT03180528|7660903|FG000|COMPLETED|Overall Study||27
6266180|NCT00042666|7165407|FG000|Completed at Least 1 Cycle of Study Drug|Overall Study||42
6266181|NCT00042666|7165407|FG000|COMPLETED|Overall Study||1
6266182|NCT00042666|7165407|FG000|NOT COMPLETED|Overall Study||54
6266183|NCT00042939|7165414|FG000|STARTED|Overall Study||48
6266184|NCT00042939|7165415|FG001|STARTED|Overall Study||46
6266185|NCT00042939|7165414|FG000|Treated|Overall Study||46
6266186|NCT00042939|7165415|FG001|Treated|Overall Study||45
6266187|NCT00042939|7165414|FG000|Eligible and Began Protocol Therapy|Overall Study||44
6266188|NCT00042939|7165415|FG001|Eligible and Began Protocol Therapy|Overall Study||43
6266189|NCT00042939|7165414|FG000|Patients With EGFR Results Available|Overall Study||30
6266190|NCT00042939|7165415|FG001|Patients With EGFR Results Available|Overall Study||31
6266191|NCT00042939|7165414|FG000|COMPLETED|Overall Study||24
6266192|NCT00042939|7165415|FG001|COMPLETED|Overall Study||25
6266193|NCT00042939|7165414|FG000|NOT COMPLETED|Overall Study||24
6266194|NCT00042939|7165415|FG001|NOT COMPLETED|Overall Study||21
6266195|NCT00042991|7165428|FG000|STARTED|Overall Study||6
6266196|NCT00042991|7165429|FG001|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
6731351|NCT03180528|7660903|FG000|NOT COMPLETED|Overall Study||3
6731352|NCT03180619|7660910|FG000|STARTED|Overall Study||78
6731353|NCT03180619|7660911|FG001|STARTED|Overall Study||15
6731354|NCT03180619|7660912|FG002|STARTED|Overall Study||31
6731355|NCT03180619|7660910|FG000|COMPLETED|Overall Study||67
6731356|NCT03180619|7660911|FG001|COMPLETED|Overall Study||14
6731357|NCT03180619|7660912|FG002|COMPLETED|Overall Study||25
6731358|NCT03180619|7660910|FG000|NOT COMPLETED|Overall Study||11
6731359|NCT03180619|7660911|FG001|NOT COMPLETED|Overall Study||1
6731360|NCT03180619|7660912|FG002|NOT COMPLETED|Overall Study||6
6731361|NCT03180645|7660930|FG000|STARTED|Overall Study||24
6731362|NCT03180645|7660931|FG001|STARTED|Overall Study||24
6731363|NCT03180645|7660932|FG002|STARTED|Overall Study||24
6731364|NCT03180645|7660930|FG000|COMPLETED|Overall Study||24
6731365|NCT03180645|7660931|FG001|COMPLETED|Overall Study||23
6731366|NCT03180645|7660932|FG002|COMPLETED|Overall Study||22
6731367|NCT03180645|7660930|FG000|NOT COMPLETED|Overall Study||0
6731368|NCT03180645|7660931|FG001|NOT COMPLETED|Overall Study||1
6731369|NCT03180645|7660932|FG002|NOT COMPLETED|Overall Study||2
6731370|NCT03180801|7660947|FG000|STARTED|Overall Study||50
6731371|NCT03180801|7660948|FG001|STARTED|Overall Study||52
6731372|NCT03180801|7660949|FG002|STARTED|Overall Study||51
6731373|NCT03180801|7660947|FG000|Safety Population|Overall Study||50
6731374|NCT03180801|7660948|FG001|Safety Population|Overall Study||52
6731375|NCT03180801|7660949|FG002|Safety Population|Overall Study||51
6731376|NCT03180801|7660947|FG000|Intention to Treat|Overall Study||42
6731377|NCT03180801|7660948|FG001|Intention to Treat|Overall Study||40
6731378|NCT03180801|7660949|FG002|Intention to Treat|Overall Study||41
6731379|NCT03180801|7660947|FG000|COMPLETED|Overall Study||42
6731380|NCT03180801|7660948|FG001|COMPLETED|Overall Study||40
6731381|NCT03180801|7660949|FG002|COMPLETED|Overall Study||41
6731382|NCT03180801|7660947|FG000|NOT COMPLETED|Overall Study||8
6731383|NCT03180801|7660948|FG001|NOT COMPLETED|Overall Study||12
6731384|NCT03180801|7660949|FG002|NOT COMPLETED|Overall Study||10
6731385|NCT03181009|7660962|FG000|STARTED|Overall Study||30
6731386|NCT03181009|7660963|FG001|STARTED|Overall Study||30
6731387|NCT03181009|7660962|FG000|COMPLETED|Overall Study||30
6731388|NCT03181009|7660963|FG001|COMPLETED|Overall Study||28
6731389|NCT03181009|7660962|FG000|NOT COMPLETED|Overall Study||0
6731390|NCT03181009|7660963|FG001|NOT COMPLETED|Overall Study||2
6731391|NCT03181308|7660971|FG000|STARTED|Overall Study||3
6731392|NCT03181308|7660972|FG001|STARTED|Overall Study||8
6731393|NCT03181308|7660971|FG000|COMPLETED|Overall Study||3
6731394|NCT03181308|7660972|FG001|COMPLETED|Overall Study||8
6731395|NCT03181308|7660971|FG000|NOT COMPLETED|Overall Study||0
6731396|NCT03181308|7660972|FG001|NOT COMPLETED|Overall Study||0
6731397|NCT03181451|7660981|FG000|STARTED|Overall Study||12
6731398|NCT03181451|7660982|FG001|STARTED|Overall Study||13
6731399|NCT03181451|7660983|FG002|STARTED|Overall Study||12
6731400|NCT03181451|7660981|FG000|COMPLETED|Overall Study||12
6731401|NCT03181451|7660982|FG001|COMPLETED|Overall Study||11
6731402|NCT03181451|7660983|FG002|COMPLETED|Overall Study||12
6731403|NCT03181451|7660981|FG000|NOT COMPLETED|Overall Study||0
6731404|NCT03181451|7660982|FG001|NOT COMPLETED|Overall Study||2
6731405|NCT03181451|7660983|FG002|NOT COMPLETED|Overall Study||0
6731406|NCT03181503|7660995|FG000|STARTED|Overall Study||36
6731407|NCT03181503|7660996|FG001|STARTED|Overall Study||34
6731408|NCT03181503|7660995|FG000|Treated|Overall Study||36
6731409|NCT03181503|7660996|FG001|Treated|Overall Study||34
6731410|NCT03181503|7660995|FG000|COMPLETED|Overall Study||29
6266197|NCT00042991|7165430|FG002|STARTED|Overall Study||7
6266198|NCT00042991|7165431|FG003|STARTED|Overall Study||2
6266199|NCT00042991|7165432|FG004|STARTED|Overall Study||3
6266200|NCT00042991|7165433|FG005|STARTED|Overall Study||5
6266201|NCT00042991|7165434|FG006|STARTED|Overall Study||3
6266202|NCT00042991|7165428|FG000|Phase-I Trial|Overall Study||6
6266203|NCT00042991|7165429|FG001|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
6266204|NCT00042991|7165430|FG002|Phase-I Trial|Overall Study||7
6731411|NCT03181503|7660996|FG001|COMPLETED|Overall Study||31
6731412|NCT03181503|7660995|FG000|NOT COMPLETED|Overall Study||7
6731413|NCT03181503|7660996|FG001|NOT COMPLETED|Overall Study||3
6731414|NCT03181594|7661005|FG000|STARTED|Initial Study Protocol (12-month FU)||100
6731415|NCT03181594|7661005|FG000|30-day Follow-up|Initial Study Protocol (12-month FU)||99
6731416|NCT03181594|7661005|FG000|90-day Follow-up|Initial Study Protocol (12-month FU)||98
6731417|NCT03181594|7661005|FG000|6-month Follow-up|Initial Study Protocol (12-month FU)||98
6731418|NCT03181594|7661005|FG000|9-month Follow-up|Initial Study Protocol (12-month FU)||95
6731419|NCT03181594|7661005|FG000|12-month Follow-up|Initial Study Protocol (12-month FU)||91
6731420|NCT03181594|7661005|FG000|COMPLETED|Initial Study Protocol (12-month FU)||91
6731421|NCT03181594|7661005|FG000|NOT COMPLETED|Initial Study Protocol (12-month FU)||9
6731422|NCT03181594|7661005|FG000|STARTED|Long-term Extension (15-24 Month FU)||62
6731423|NCT03181594|7661005|FG000|15-month Follow-up|Long-term Extension (15-24 Month FU)||56
6731424|NCT03181594|7661005|FG000|18-month Follow-up|Long-term Extension (15-24 Month FU)||57
6731425|NCT03181594|7661005|FG000|21-month Follow-up|Long-term Extension (15-24 Month FU)||55
6731426|NCT03181594|7661005|FG000|24-month Follow-up|Long-term Extension (15-24 Month FU)||57
6731427|NCT03181594|7661005|FG000|COMPLETED|Long-term Extension (15-24 Month FU)||57
6731428|NCT03181594|7661005|FG000|NOT COMPLETED|Long-term Extension (15-24 Month FU)||5
6731429|NCT03181724|7661011|FG000|STARTED|Overall Study||45
6731430|NCT03181724|7661012|FG001|STARTED|Overall Study||45
6731431|NCT03181724|7661011|FG000|COMPLETED|Overall Study||45
6731432|NCT03181724|7661012|FG001|COMPLETED|Overall Study||45
6731433|NCT03181724|7661011|FG000|NOT COMPLETED|Overall Study||0
6731434|NCT03181724|7661012|FG001|NOT COMPLETED|Overall Study||0
6731435|NCT03181932|7661020|FG000|STARTED|Period 1 (Double-blind Period)||90
6266205|NCT00042991|7165431|FG003|Phase-I Trial|Overall Study||2
6731436|NCT03181932|7661021|FG001|STARTED|Period 1 (Double-blind Period)||98
6731437|NCT03181932|7661020|FG000|COMPLETED|Period 1 (Double-blind Period)||79
6731438|NCT03181932|7661021|FG001|COMPLETED|Period 1 (Double-blind Period)||85
6731439|NCT03181932|7661020|FG000|NOT COMPLETED|Period 1 (Double-blind Period)||11
6731440|NCT03181932|7661021|FG001|NOT COMPLETED|Period 1 (Double-blind Period)||13
6731441|NCT03181932|7661020|FG000|STARTED|Period 2 (Open-label Period)||75
6731442|NCT03181932|7661021|FG001|STARTED|Period 2 (Open-label Period)||83
6731443|NCT03181932|7661020|FG000|COMPLETED|Period 2 (Open-label Period)||67
6731444|NCT03181932|7661021|FG001|COMPLETED|Period 2 (Open-label Period)||70
6731445|NCT03181932|7661020|FG000|NOT COMPLETED|Period 2 (Open-label Period)||8
6731446|NCT03181932|7661021|FG001|NOT COMPLETED|Period 2 (Open-label Period)||13
6731447|NCT03181958|7661031|FG000|STARTED|Overall Study||497
6731448|NCT03181958|7661032|FG001|STARTED|Overall Study||501
6731449|NCT03181958|7661033|FG002|STARTED|Overall Study||495
6731450|NCT03181958|7661031|FG000|COMPLETED|Overall Study||480
6731451|NCT03181958|7661032|FG001|COMPLETED|Overall Study||480
6731452|NCT03181958|7661033|FG002|COMPLETED|Overall Study||480
6731453|NCT03181958|7661031|FG000|NOT COMPLETED|Overall Study||17
6731454|NCT03181958|7661032|FG001|NOT COMPLETED|Overall Study||21
6731455|NCT03181958|7661033|FG002|NOT COMPLETED|Overall Study||15
6731456|NCT03182582|7661041|FG000|STARTED|Treatment 1||12
6731457|NCT03182582|7661042|FG001|STARTED|Treatment 1||10
6731458|NCT03182582|7661041|FG000|COMPLETED|Treatment 1||12
6731459|NCT03182582|7661042|FG001|COMPLETED|Treatment 1||10
6731460|NCT03182582|7661041|FG000|NOT COMPLETED|Treatment 1||0
6731461|NCT03182582|7661042|FG001|NOT COMPLETED|Treatment 1||0
6731462|NCT03182582|7661041|FG000|STARTED|Treatment 2||12
6731463|NCT03182582|7661042|FG001|STARTED|Treatment 2||10
6731464|NCT03182582|7661041|FG000|COMPLETED|Treatment 2||12
6731465|NCT03182582|7661042|FG001|COMPLETED|Treatment 2||10
6731466|NCT03182582|7661041|FG000|NOT COMPLETED|Treatment 2||0
6731467|NCT03182582|7661042|FG001|NOT COMPLETED|Treatment 2||0
6731468|NCT03182725|7661055|FG000|STARTED|Treatment Arm 1 (First Half of Study)||16
6731469|NCT03182725|7661056|FG001|STARTED|Treatment Arm 1 (First Half of Study)||10
6731470|NCT03182725|7661055|FG000|COMPLETED|Treatment Arm 1 (First Half of Study)||16
6731471|NCT03182725|7661056|FG001|COMPLETED|Treatment Arm 1 (First Half of Study)||7
6731472|NCT03182725|7661055|FG000|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||0
6731473|NCT03182725|7661056|FG001|NOT COMPLETED|Treatment Arm 1 (First Half of Study)||3
6731474|NCT03182725|7661055|FG000|STARTED|Treatment Arm 2 (Second Half of Study)||16
6731475|NCT03182725|7661056|FG001|STARTED|Treatment Arm 2 (Second Half of Study)|One participant withdrew during crossover and therefore did not start Treatment Arm 2.|6
6731476|NCT03182725|7661055|FG000|COMPLETED|Treatment Arm 2 (Second Half of Study)||16
6731477|NCT03182725|7661056|FG001|COMPLETED|Treatment Arm 2 (Second Half of Study)||6
6731478|NCT03182725|7661055|FG000|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
6731479|NCT03182725|7661056|FG001|NOT COMPLETED|Treatment Arm 2 (Second Half of Study)||0
6731480|NCT03182738|7661064|FG000|STARTED|Overall Study||50
6731481|NCT03182738|7661065|FG001|STARTED|Overall Study||50
6731482|NCT03182738|7661064|FG000|COMPLETED|Overall Study||41
6731483|NCT03182738|7661065|FG001|COMPLETED|Overall Study||45
6731484|NCT03182738|7661064|FG000|NOT COMPLETED|Overall Study||9
6731485|NCT03182738|7661065|FG001|NOT COMPLETED|Overall Study||5
6731486|NCT03182868|7661076|FG000|STARTED|Overall Study||12
6731487|NCT03182868|7661077|FG001|STARTED|Overall Study||20
6731488|NCT03182868|7661078|FG002|STARTED|Overall Study||21
6731489|NCT03182868|7661079|FG003|STARTED|Overall Study||1
6731490|NCT03182868|7661080|FG004|STARTED|Overall Study||24
6731491|NCT03182868|7661076|FG000|COMPLETED|Overall Study||9
6731492|NCT03182868|7661077|FG001|COMPLETED|Overall Study||20
6731493|NCT03182868|7661078|FG002|COMPLETED|Overall Study||17
6731494|NCT03182868|7661079|FG003|COMPLETED|Overall Study||0
6731495|NCT03182868|7661080|FG004|COMPLETED|Overall Study||16
6731496|NCT03182868|7661076|FG000|NOT COMPLETED|Overall Study||3
6731497|NCT03182868|7661077|FG001|NOT COMPLETED|Overall Study||0
6731498|NCT03182868|7661078|FG002|NOT COMPLETED|Overall Study||4
6731499|NCT03182868|7661079|FG003|NOT COMPLETED|Overall Study||1
6731500|NCT03182868|7661080|FG004|NOT COMPLETED|Overall Study||8
6731501|NCT03182920|7661093|FG000|STARTED|Period 1||9
6731502|NCT03182920|7661094|FG001|STARTED|Period 1||9
6731503|NCT03182920|7661095|FG002|STARTED|Period 1||17
6731504|NCT03182920|7661093|FG000|COMPLETED|Period 1||9
6731505|NCT03182920|7661094|FG001|COMPLETED|Period 1||9
6731506|NCT03182920|7661095|FG002|COMPLETED|Period 1||17
6731507|NCT03182920|7661093|FG000|NOT COMPLETED|Period 1||0
6731508|NCT03182920|7661094|FG001|NOT COMPLETED|Period 1||0
6731509|NCT03182920|7661095|FG002|NOT COMPLETED|Period 1||0
6731510|NCT03182920|7661093|FG000|STARTED|Washout Period||9
6731511|NCT03182920|7661094|FG001|STARTED|Washout Period||9
6731512|NCT03182920|7661095|FG002|STARTED|Washout Period||0
6731513|NCT03182920|7661093|FG000|COMPLETED|Washout Period||9
6731514|NCT03182920|7661094|FG001|COMPLETED|Washout Period||9
6731515|NCT03182920|7661095|FG002|COMPLETED|Washout Period||0
6731516|NCT03182920|7661093|FG000|NOT COMPLETED|Washout Period||0
6731517|NCT03182920|7661094|FG001|NOT COMPLETED|Washout Period||0
6731518|NCT03182920|7661095|FG002|NOT COMPLETED|Washout Period||0
6731519|NCT03182920|7661093|FG000|STARTED|Period 2||9
6731520|NCT03182920|7661094|FG001|STARTED|Period 2||9
6731521|NCT03182920|7661095|FG002|STARTED|Period 2|Young participants on Lasmiditan did not move to study period 2.|0
6731522|NCT03182920|7661093|FG000|COMPLETED|Period 2||9
6731523|NCT03182920|7661094|FG001|COMPLETED|Period 2||9
6731524|NCT03182920|7661095|FG002|COMPLETED|Period 2||0
6731525|NCT03182920|7661093|FG000|NOT COMPLETED|Period 2||0
6731526|NCT03182920|7661094|FG001|NOT COMPLETED|Period 2||0
6731527|NCT03182920|7661095|FG002|NOT COMPLETED|Period 2||0
6731528|NCT03182933|7661104|FG000|STARTED|Overall Study||32
6731529|NCT03182933|7661105|FG001|STARTED|Overall Study||32
6731530|NCT03182933|7661104|FG000|COMPLETED|Overall Study||31
6731531|NCT03182933|7661105|FG001|COMPLETED|Overall Study||32
6731532|NCT03182933|7661104|FG000|NOT COMPLETED|Overall Study||1
6731533|NCT03182933|7661105|FG001|NOT COMPLETED|Overall Study||0
6731534|NCT03183063|7661114|FG000|STARTED|Overall Study||20
6731535|NCT03183063|7661115|FG001|STARTED|Overall Study||4
6731536|NCT03183063|7661116|FG002|STARTED|Overall Study||115
6731537|NCT03183063|7661114|FG000|COMPLETED|Overall Study||15
6731538|NCT03183063|7661115|FG001|COMPLETED|Overall Study||0
6731539|NCT03183063|7661116|FG002|COMPLETED|Overall Study||111
6731540|NCT03183063|7661114|FG000|NOT COMPLETED|Overall Study||5
6731541|NCT03183063|7661115|FG001|NOT COMPLETED|Overall Study||4
6731542|NCT03183063|7661116|FG002|NOT COMPLETED|Overall Study||4
6731543|NCT03183518|7661130|FG000|STARTED|Overall Study||36
6731544|NCT03183518|7661130|FG000|Test Product|Overall Study||36
6731545|NCT03183518|7661130|FG000|Negative Control|Overall Study||36
6731546|NCT03183518|7661130|FG000|COMPLETED|Overall Study||33
6731547|NCT03183518|7661130|FG000|NOT COMPLETED|Overall Study||3
6731548|NCT03183869|7661137|FG000|STARTED|Overall Study||4
6731549|NCT03183869|7661138|FG001|STARTED|Overall Study||7
6731550|NCT03183869|7661137|FG000|COMPLETED|Overall Study||0
6731551|NCT03183869|7661138|FG001|COMPLETED|Overall Study||2
6731552|NCT03183869|7661137|FG000|NOT COMPLETED|Overall Study||4
6731553|NCT03183869|7661138|FG001|NOT COMPLETED|Overall Study||5
6731554|NCT03183908|7661146|FG000|STARTED|Overall Study||378
6731555|NCT03183908|7661147|FG001|STARTED|Overall Study||379
6731556|NCT03183908|7661146|FG000|COMPLETED|Overall Study||378
6731557|NCT03183908|7661147|FG001|COMPLETED|Overall Study||377
6731558|NCT03183908|7661146|FG000|NOT COMPLETED|Overall Study||0
6731559|NCT03183908|7661147|FG001|NOT COMPLETED|Overall Study||2
6731560|NCT03184077|7661159|FG000|STARTED|Overall Study||166
6731561|NCT03184077|7661160|FG001|STARTED|Overall Study||152
6731562|NCT03184077|7661159|FG000|COMPLETED|Overall Study||145
6731563|NCT03184077|7661160|FG001|COMPLETED|Overall Study||131
6731564|NCT03184077|7661159|FG000|NOT COMPLETED|Overall Study||21
6731565|NCT03184077|7661160|FG001|NOT COMPLETED|Overall Study||21
6731566|NCT03184428|7661166|FG000|STARTED|Overall Study||3785
6731567|NCT03184428|7661166|FG000|COMPLETED|Overall Study||2963
6731568|NCT03184428|7661166|FG000|NOT COMPLETED|Overall Study||822
6731569|NCT03184441|7661182|FG000|STARTED|Overall Study||11
6731570|NCT03184441|7661182|FG000|COMPLETED|Overall Study|Last subject completed study|10
6731571|NCT03184441|7661182|FG000|NOT COMPLETED|Overall Study||1
6731572|NCT03184519|7661189|FG000|STARTED|Overall Study||156
6731573|NCT03184519|7661189|FG000|COMPLETED|Overall Study||129
6731574|NCT03184519|7661189|FG000|NOT COMPLETED|Overall Study||27
6731575|NCT03184558|7661193|FG000|STARTED|Overall Study||29
6731576|NCT03184558|7661193|FG000|COMPLETED|Overall Study||0
6731577|NCT03184558|7661193|FG000|NOT COMPLETED|Overall Study||29
6731578|NCT03184701|7661197|FG000|STARTED|Overall Study||45
6731579|NCT03184701|7661197|FG000|COMPLETED|Overall Study||28
6731580|NCT03184701|7661197|FG000|NOT COMPLETED|Overall Study||17
6731581|NCT03184987|7661204|FG000|STARTED|Overall Study||47
6731582|NCT03184987|7661205|FG001|STARTED|Overall Study||9
6731583|NCT03184987|7661206|FG002|STARTED|Overall Study||55
6731584|NCT03184987|7661204|FG000|COMPLETED|Overall Study||46
6731585|NCT03184987|7661205|FG001|COMPLETED|Overall Study||8
6731586|NCT03184987|7661206|FG002|COMPLETED|Overall Study||51
6731587|NCT03184987|7661204|FG000|NOT COMPLETED|Overall Study||1
6731588|NCT03184987|7661205|FG001|NOT COMPLETED|Overall Study||1
6731589|NCT03184987|7661206|FG002|NOT COMPLETED|Overall Study||4
6731590|NCT03185065|7661218|FG000|STARTED|Period 1 (6 Weeks)||35
6731591|NCT03185065|7661219|FG001|STARTED|Period 1 (6 Weeks)||34
6731592|NCT03185065|7661220|FG002|STARTED|Period 1 (6 Weeks)||35
6731593|NCT03185065|7661221|FG003|STARTED|Period 1 (6 Weeks)||37
6731594|NCT03185065|7661218|FG000|COMPLETED|Period 1 (6 Weeks)||32
6731595|NCT03185065|7661219|FG001|COMPLETED|Period 1 (6 Weeks)||33
6731596|NCT03185065|7661220|FG002|COMPLETED|Period 1 (6 Weeks)||32
6731597|NCT03185065|7661221|FG003|COMPLETED|Period 1 (6 Weeks)||36
6731598|NCT03185065|7661218|FG000|NOT COMPLETED|Period 1 (6 Weeks)||3
6731599|NCT03185065|7661219|FG001|NOT COMPLETED|Period 1 (6 Weeks)||1
6731600|NCT03185065|7661220|FG002|NOT COMPLETED|Period 1 (6 Weeks)||3
6731601|NCT03185065|7661221|FG003|NOT COMPLETED|Period 1 (6 Weeks)||1
6731602|NCT03185065|7661218|FG000|STARTED|Washout (2 Weeks)||32
6731603|NCT03185065|7661219|FG001|STARTED|Washout (2 Weeks)||33
6731604|NCT03185065|7661220|FG002|STARTED|Washout (2 Weeks)||32
6731605|NCT03185065|7661221|FG003|STARTED|Washout (2 Weeks)||36
6731606|NCT03185065|7661218|FG000|COMPLETED|Washout (2 Weeks)||32
6731607|NCT03185065|7661219|FG001|COMPLETED|Washout (2 Weeks)||31
6731608|NCT03185065|7661220|FG002|COMPLETED|Washout (2 Weeks)||32
6731609|NCT03185065|7661221|FG003|COMPLETED|Washout (2 Weeks)||35
6731610|NCT03185065|7661218|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6731611|NCT03185065|7661219|FG001|NOT COMPLETED|Washout (2 Weeks)||2
6731612|NCT03185065|7661220|FG002|NOT COMPLETED|Washout (2 Weeks)||0
6731613|NCT03185065|7661221|FG003|NOT COMPLETED|Washout (2 Weeks)||1
6731614|NCT03185065|7661218|FG000|STARTED|Period 2 (6 Weeks)||32
6731615|NCT03185065|7661219|FG001|STARTED|Period 2 (6 Weeks)||31
6731616|NCT03185065|7661220|FG002|STARTED|Period 2 (6 Weeks)||32
6731617|NCT03185065|7661221|FG003|STARTED|Period 2 (6 Weeks)||35
6731618|NCT03185065|7661218|FG000|COMPLETED|Period 2 (6 Weeks)||32
6731619|NCT03185065|7661219|FG001|COMPLETED|Period 2 (6 Weeks)||31
6731620|NCT03185065|7661220|FG002|COMPLETED|Period 2 (6 Weeks)||32
6731621|NCT03185065|7661221|FG003|COMPLETED|Period 2 (6 Weeks)||34
6731622|NCT03185065|7661218|FG000|NOT COMPLETED|Period 2 (6 Weeks)||0
6731623|NCT03185065|7661219|FG001|NOT COMPLETED|Period 2 (6 Weeks)||0
6731624|NCT03185065|7661220|FG002|NOT COMPLETED|Period 2 (6 Weeks)||0
6731625|NCT03185065|7661221|FG003|NOT COMPLETED|Period 2 (6 Weeks)||1
6731626|NCT03185065|7661218|FG000|STARTED|Washout (2 Weeks)||32
6731627|NCT03185065|7661219|FG001|STARTED|Washout (2 Weeks)||31
6731628|NCT03185065|7661220|FG002|STARTED|Washout (2 Weeks)||32
6731629|NCT03185065|7661221|FG003|STARTED|Washout (2 Weeks)||34
6731630|NCT03185065|7661218|FG000|COMPLETED|Washout (2 Weeks)||31
6731631|NCT03185065|7661219|FG001|COMPLETED|Washout (2 Weeks)||29
6731632|NCT03185065|7661220|FG002|COMPLETED|Washout (2 Weeks)||31
6731633|NCT03185065|7661221|FG003|COMPLETED|Washout (2 Weeks)||32
6731634|NCT03185065|7661218|FG000|NOT COMPLETED|Washout (2 Weeks)||1
6731635|NCT03185065|7661219|FG001|NOT COMPLETED|Washout (2 Weeks)||2
6731636|NCT03185065|7661220|FG002|NOT COMPLETED|Washout (2 Weeks)||1
6731637|NCT03185065|7661221|FG003|NOT COMPLETED|Washout (2 Weeks)||2
6731638|NCT03185065|7661218|FG000|STARTED|Period 3 (6 Weeks)||31
6731639|NCT03185065|7661219|FG001|STARTED|Period 3 (6 Weeks)||29
6731640|NCT03185065|7661220|FG002|STARTED|Period 3 (6 Weeks)||31
6731641|NCT03185065|7661221|FG003|STARTED|Period 3 (6 Weeks)||32
6731642|NCT03185065|7661218|FG000|COMPLETED|Period 3 (6 Weeks)||31
6731643|NCT03185065|7661219|FG001|COMPLETED|Period 3 (6 Weeks)||29
6731644|NCT03185065|7661220|FG002|COMPLETED|Period 3 (6 Weeks)||29
6731645|NCT03185065|7661221|FG003|COMPLETED|Period 3 (6 Weeks)||32
6731646|NCT03185065|7661218|FG000|NOT COMPLETED|Period 3 (6 Weeks)||0
6731647|NCT03185065|7661219|FG001|NOT COMPLETED|Period 3 (6 Weeks)||0
6731648|NCT03185065|7661220|FG002|NOT COMPLETED|Period 3 (6 Weeks)||2
6731649|NCT03185065|7661221|FG003|NOT COMPLETED|Period 3 (6 Weeks)||0
6731650|NCT03185065|7661218|FG000|STARTED|Washout (2 Weeks)||31
6731651|NCT03185065|7661219|FG001|STARTED|Washout (2 Weeks)||29
6731652|NCT03185065|7661220|FG002|STARTED|Washout (2 Weeks)||29
6731653|NCT03185065|7661221|FG003|STARTED|Washout (2 Weeks)||32
6731654|NCT03185065|7661218|FG000|COMPLETED|Washout (2 Weeks)||31
6731655|NCT03185065|7661219|FG001|COMPLETED|Washout (2 Weeks)||28
6731656|NCT03185065|7661220|FG002|COMPLETED|Washout (2 Weeks)||27
6731657|NCT03185065|7661221|FG003|COMPLETED|Washout (2 Weeks)||32
6731658|NCT03185065|7661218|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6731659|NCT03185065|7661219|FG001|NOT COMPLETED|Washout (2 Weeks)||1
6731660|NCT03185065|7661220|FG002|NOT COMPLETED|Washout (2 Weeks)||2
6731661|NCT03185065|7661221|FG003|NOT COMPLETED|Washout (2 Weeks)||0
6731662|NCT03185065|7661218|FG000|STARTED|Period 4 (6 Weeks)||31
6731663|NCT03185065|7661219|FG001|STARTED|Period 4 (6 Weeks)||28
6731664|NCT03185065|7661220|FG002|STARTED|Period 4 (6 Weeks)||27
6731665|NCT03185065|7661221|FG003|STARTED|Period 4 (6 Weeks)||32
6731666|NCT03185065|7661218|FG000|COMPLETED|Period 4 (6 Weeks)||31
6731667|NCT03185065|7661219|FG001|COMPLETED|Period 4 (6 Weeks)||27
6731668|NCT03185065|7661220|FG002|COMPLETED|Period 4 (6 Weeks)||26
6731669|NCT03185065|7661221|FG003|COMPLETED|Period 4 (6 Weeks)||31
6731670|NCT03185065|7661218|FG000|NOT COMPLETED|Period 4 (6 Weeks)||0
6731671|NCT03185065|7661219|FG001|NOT COMPLETED|Period 4 (6 Weeks)||1
6731672|NCT03185065|7661220|FG002|NOT COMPLETED|Period 4 (6 Weeks)||1
6731673|NCT03185065|7661221|FG003|NOT COMPLETED|Period 4 (6 Weeks)||1
6731674|NCT03185182|7661232|FG000|STARTED|Overall Study||5
6731675|NCT03185182|7661232|FG000|COMPLETED|Overall Study||5
6731676|NCT03185182|7661232|FG000|NOT COMPLETED|Overall Study||0
6731677|NCT03185455|7661239|FG000|STARTED|Overall Study||103
6731678|NCT03185455|7661240|FG001|STARTED|Overall Study||103
6731679|NCT03185455|7661239|FG000|COMPLETED|Overall Study||103
6731680|NCT03185455|7661240|FG001|COMPLETED|Overall Study||103
6731681|NCT03185455|7661239|FG000|NOT COMPLETED|Overall Study||0
6731682|NCT03185455|7661240|FG001|NOT COMPLETED|Overall Study||0
6731683|NCT03185481|7661246|FG000|STARTED|Overall Study||5
6731684|NCT03185481|7661246|FG000|COMPLETED|Overall Study||0
6731685|NCT03185481|7661246|FG000|NOT COMPLETED|Overall Study||5
6731686|NCT03185546|7661258|FG000|STARTED|Baseline Through Week 12||6
6731687|NCT03185546|7661259|FG001|STARTED|Baseline Through Week 12||10
6731688|NCT03185546|7661260|FG002|STARTED|Baseline Through Week 12||5
6731689|NCT03185546|7661261|FG003|STARTED|Baseline Through Week 12||5
6731690|NCT03185546|7661262|FG004|STARTED|Baseline Through Week 12||6
6731691|NCT03185546|7661263|FG005|STARTED|Baseline Through Week 12||6
6731692|NCT03185546|7661264|FG006|STARTED|Baseline Through Week 12||7
6731693|NCT03185546|7661265|FG007|STARTED|Baseline Through Week 12||5
6731694|NCT03185546|7661258|FG000|COMPLETED|Baseline Through Week 12||2
6731695|NCT03185546|7661259|FG001|COMPLETED|Baseline Through Week 12||7
6731696|NCT03185546|7661260|FG002|COMPLETED|Baseline Through Week 12||4
6731697|NCT03185546|7661261|FG003|COMPLETED|Baseline Through Week 12||4
6731698|NCT03185546|7661262|FG004|COMPLETED|Baseline Through Week 12||5
6731699|NCT03185546|7661263|FG005|COMPLETED|Baseline Through Week 12||4
6731700|NCT03185546|7661264|FG006|COMPLETED|Baseline Through Week 12||4
6731701|NCT03185546|7661265|FG007|COMPLETED|Baseline Through Week 12||2
6731702|NCT03185546|7661258|FG000|NOT COMPLETED|Baseline Through Week 12||4
6731703|NCT03185546|7661259|FG001|NOT COMPLETED|Baseline Through Week 12||3
6731704|NCT03185546|7661260|FG002|NOT COMPLETED|Baseline Through Week 12||1
6731705|NCT03185546|7661261|FG003|NOT COMPLETED|Baseline Through Week 12||1
6731706|NCT03185546|7661262|FG004|NOT COMPLETED|Baseline Through Week 12||1
6731707|NCT03185546|7661263|FG005|NOT COMPLETED|Baseline Through Week 12||2
6731708|NCT03185546|7661264|FG006|NOT COMPLETED|Baseline Through Week 12||3
6731709|NCT03185546|7661265|FG007|NOT COMPLETED|Baseline Through Week 12||3
6731710|NCT03185546|7661258|FG000|STARTED|Week 12 Through Day 30 Follow up||2
6731711|NCT03185546|7661259|FG001|STARTED|Week 12 Through Day 30 Follow up||7
6731712|NCT03185546|7661260|FG002|STARTED|Week 12 Through Day 30 Follow up||4
6731713|NCT03185546|7661261|FG003|STARTED|Week 12 Through Day 30 Follow up||4
6731714|NCT03185546|7661262|FG004|STARTED|Week 12 Through Day 30 Follow up||5
6731715|NCT03185546|7661263|FG005|STARTED|Week 12 Through Day 30 Follow up||4
6731716|NCT03185546|7661264|FG006|STARTED|Week 12 Through Day 30 Follow up||4
6731717|NCT03185546|7661265|FG007|STARTED|Week 12 Through Day 30 Follow up||2
6731718|NCT03185546|7661258|FG000|COMPLETED|Week 12 Through Day 30 Follow up||2
6731719|NCT03185546|7661259|FG001|COMPLETED|Week 12 Through Day 30 Follow up||7
6731720|NCT03185546|7661260|FG002|COMPLETED|Week 12 Through Day 30 Follow up||4
6731721|NCT03185546|7661261|FG003|COMPLETED|Week 12 Through Day 30 Follow up||3
6731722|NCT03185546|7661262|FG004|COMPLETED|Week 12 Through Day 30 Follow up||5
6731723|NCT03185546|7661263|FG005|COMPLETED|Week 12 Through Day 30 Follow up||4
6731724|NCT03185546|7661264|FG006|COMPLETED|Week 12 Through Day 30 Follow up||3
6731725|NCT03185546|7661265|FG007|COMPLETED|Week 12 Through Day 30 Follow up||2
6731726|NCT03185546|7661258|FG000|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
6731727|NCT03185546|7661259|FG001|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
6731728|NCT03185546|7661260|FG002|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
6731729|NCT03185546|7661261|FG003|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
6731730|NCT03185546|7661262|FG004|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
6731731|NCT03185546|7661263|FG005|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
6731732|NCT03185546|7661264|FG006|NOT COMPLETED|Week 12 Through Day 30 Follow up||1
6731733|NCT03185546|7661265|FG007|NOT COMPLETED|Week 12 Through Day 30 Follow up||0
6731734|NCT03186261|7661286|FG000|STARTED|Overall Study||22
6731735|NCT03186261|7661287|FG001|STARTED|Overall Study||22
6731736|NCT03186261|7661286|FG000|COMPLETED|Overall Study||22
6731737|NCT03186261|7661287|FG001|COMPLETED|Overall Study||22
6731738|NCT03186261|7661286|FG000|NOT COMPLETED|Overall Study||0
6731739|NCT03186261|7661287|FG001|NOT COMPLETED|Overall Study||0
6731740|NCT03186378|7661295|FG000|STARTED|Overall Study||17
6731741|NCT03186378|7661296|FG001|STARTED|Overall Study||16
6731742|NCT03186378|7661295|FG000|COMPLETED|Overall Study||16
6731743|NCT03186378|7661296|FG001|COMPLETED|Overall Study||16
6731744|NCT03186378|7661295|FG000|NOT COMPLETED|Overall Study||1
6731745|NCT03186378|7661296|FG001|NOT COMPLETED|Overall Study||0
6731746|NCT03186677|7661307|FG000|STARTED|Period 1||3
6731747|NCT03186677|7661308|FG001|STARTED|Period 1||3
6731748|NCT03186677|7661309|FG002|STARTED|Period 1||3
6731749|NCT03186677|7661310|FG003|STARTED|Period 1||0
6731750|NCT03186677|7661311|FG004|STARTED|Period 1||0
6731751|NCT03186677|7661307|FG000|COMPLETED|Period 1||3
6731752|NCT03186677|7661308|FG001|COMPLETED|Period 1||3
6731753|NCT03186677|7661309|FG002|COMPLETED|Period 1||3
6731754|NCT03186677|7661310|FG003|COMPLETED|Period 1||0
6731755|NCT03186677|7661311|FG004|COMPLETED|Period 1||0
6731756|NCT03186677|7661307|FG000|NOT COMPLETED|Period 1||0
6731757|NCT03186677|7661308|FG001|NOT COMPLETED|Period 1||0
6731758|NCT03186677|7661309|FG002|NOT COMPLETED|Period 1||0
6731759|NCT03186677|7661310|FG003|NOT COMPLETED|Period 1||0
6731760|NCT03186677|7661311|FG004|NOT COMPLETED|Period 1||0
6731761|NCT03186677|7661307|FG000|STARTED|Period 2||0
6731762|NCT03186677|7661308|FG001|STARTED|Period 2||0
6731763|NCT03186677|7661309|FG002|STARTED|Period 2||0
6731764|NCT03186677|7661310|FG003|STARTED|Period 2||5
6731765|NCT03186677|7661311|FG004|STARTED|Period 2||2
6731766|NCT03186677|7661307|FG000|COMPLETED|Period 2||0
6731767|NCT03186677|7661308|FG001|COMPLETED|Period 2||0
6731768|NCT03186677|7661309|FG002|COMPLETED|Period 2||0
6731769|NCT03186677|7661310|FG003|COMPLETED|Period 2||5
6731770|NCT03186677|7661311|FG004|COMPLETED|Period 2||2
6731771|NCT03186677|7661307|FG000|NOT COMPLETED|Period 2||0
6731772|NCT03186677|7661308|FG001|NOT COMPLETED|Period 2||0
6731773|NCT03186677|7661309|FG002|NOT COMPLETED|Period 2||0
6731774|NCT03186677|7661310|FG003|NOT COMPLETED|Period 2||0
6731775|NCT03186677|7661311|FG004|NOT COMPLETED|Period 2||0
6731776|NCT03186781|7661329|FG000|STARTED|Overall Study||5
6731777|NCT03186781|7661330|FG001|STARTED|Overall Study||5
6731778|NCT03186781|7661331|FG002|STARTED|Overall Study||10
6731779|NCT03186781|7661332|FG003|STARTED|Overall Study||10
6731780|NCT03186781|7661333|FG004|STARTED|Overall Study||10
6731781|NCT03186781|7661334|FG005|STARTED|Overall Study||10
6731782|NCT03186781|7661329|FG000|Received First Product Administration|Overall Study||5
6739931|NCT03296527|7668738|FG000|Full Analysis Set|Overall Study||499
6731783|NCT03186781|7661330|FG001|Received First Product Administration|Overall Study||5
6266206|NCT00042991|7165432|FG004|Phase-I Trial|Overall Study||3
6266207|NCT00042991|7165433|FG005|Phase-I Trial|Overall Study||5
6266208|NCT00042991|7165434|FG006|Phase-I Trial|Overall Study||3
6266209|NCT00042991|7165428|FG000|Phase-II Trial|Overall Study||0
6266210|NCT00042991|7165429|FG001|Phase-II Trial|Overall Study||36
6266211|NCT00042991|7165430|FG002|Phase-II Trial|Overall Study||0
6266212|NCT00042991|7165431|FG003|Phase-II Trial|Overall Study||0
6266213|NCT00042991|7165432|FG004|Phase-II Trial|Overall Study||0
6266214|NCT00042991|7165433|FG005|Phase-II Trial|Overall Study||0
6266215|NCT00042991|7165434|FG006|Phase-II Trial|Overall Study||0
6266216|NCT00042991|7165428|FG000|COMPLETED|Overall Study||0
6266217|NCT00042991|7165429|FG001|COMPLETED|Overall Study||3
6266218|NCT00042991|7165430|FG002|COMPLETED|Overall Study||1
6266219|NCT00042991|7165431|FG003|COMPLETED|Overall Study||0
6266220|NCT00042991|7165432|FG004|COMPLETED|Overall Study||0
6266221|NCT00042991|7165433|FG005|COMPLETED|Overall Study||0
6266222|NCT00042991|7165434|FG006|COMPLETED|Overall Study||1
6266223|NCT00042991|7165428|FG000|NOT COMPLETED|Overall Study||6
6266224|NCT00042991|7165429|FG001|NOT COMPLETED|Overall Study||40
6602995|NCT02059291|7527971|FG012|NOT COMPLETED|Epoch 2||0
6602996|NCT02059291|7527972|FG013|NOT COMPLETED|Epoch 2||0
6602997|NCT02059291|7527973|FG014|NOT COMPLETED|Epoch 2||0
6602998|NCT02059291|7527974|FG015|NOT COMPLETED|Epoch 2||0
6602999|NCT02059291|7527975|FG016|NOT COMPLETED|Epoch 2||0
6603000|NCT02059291|7527976|FG017|NOT COMPLETED|Epoch 2||0
6603001|NCT02059291|7527977|FG018|NOT COMPLETED|Epoch 2||0
6603002|NCT02059291|7527978|FG019|NOT COMPLETED|Epoch 2||0
6603003|NCT02059291|7527979|FG020|NOT COMPLETED|Epoch 2||0
6603004|NCT02059291|7527980|FG021|NOT COMPLETED|Epoch 2||0
6731784|NCT03186781|7661331|FG002|Received First Product Administration|Overall Study||10
6731785|NCT03186781|7661332|FG003|Received First Product Administration|Overall Study||10
6731786|NCT03186781|7661333|FG004|Received First Product Administration|Overall Study||10
6731787|NCT03186781|7661334|FG005|Received First Product Administration|Overall Study||10
6731788|NCT03186781|7661329|FG000|Received All Product Administrations|Overall Study||5
6731789|NCT03186781|7661330|FG001|Received All Product Administrations|Overall Study||5
6731790|NCT03186781|7661331|FG002|Received All Product Administrations|Overall Study|2nd dose not given due to unrelated intercurrent illness (n=1) and lost to follow up (n=1)|8
6731791|NCT03186781|7661332|FG003|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
6731792|NCT03186781|7661333|FG004|Received All Product Administrations|Overall Study|2nd dose not given due to subject decision to withdraw (n=2)|8
6731793|NCT03186781|7661334|FG005|Received All Product Administrations|Overall Study|PI decided not to give 2nd dose to limit variation in environmental exposure to flu between subjects|9
6731794|NCT03186781|7661329|FG000|COMPLETED|Overall Study||5
6731795|NCT03186781|7661330|FG001|COMPLETED|Overall Study||5
6731796|NCT03186781|7661331|FG002|COMPLETED|Overall Study||9
6731797|NCT03186781|7661332|FG003|COMPLETED|Overall Study||10
6731798|NCT03186781|7661333|FG004|COMPLETED|Overall Study||7
6731799|NCT03186781|7661334|FG005|COMPLETED|Overall Study||10
6731800|NCT03186781|7661329|FG000|NOT COMPLETED|Overall Study||0
6731801|NCT03186781|7661330|FG001|NOT COMPLETED|Overall Study||0
6731802|NCT03186781|7661331|FG002|NOT COMPLETED|Overall Study||1
6731803|NCT03186781|7661332|FG003|NOT COMPLETED|Overall Study||0
6731804|NCT03186781|7661333|FG004|NOT COMPLETED|Overall Study||3
6731805|NCT03186781|7661334|FG005|NOT COMPLETED|Overall Study||0
6731806|NCT03187002|7661354|FG000|STARTED|Overall Study||55
6731807|NCT03187002|7661355|FG001|STARTED|Overall Study||54
6731808|NCT03187002|7661354|FG000|COMPLETED|Overall Study||55
6731809|NCT03187002|7661355|FG001|COMPLETED|Overall Study||54
6731810|NCT03187002|7661354|FG000|NOT COMPLETED|Overall Study||0
6731811|NCT03187002|7661355|FG001|NOT COMPLETED|Overall Study||0
6731812|NCT03187119|7661363|FG000|STARTED|Overall Study||22
6731813|NCT03187119|7661364|FG001|STARTED|Overall Study||23
6731814|NCT03187119|7661363|FG000|COMPLETED|Overall Study||20
6731815|NCT03187119|7661364|FG001|COMPLETED|Overall Study||18
6731816|NCT03187119|7661363|FG000|NOT COMPLETED|Overall Study||2
6731817|NCT03187119|7661364|FG001|NOT COMPLETED|Overall Study||5
6731818|NCT03187132|7661372|FG000|STARTED|Inpatient Trauma Only||12
6731819|NCT03187132|7661373|FG001|STARTED|Inpatient Trauma Only||12
6731820|NCT03187132|7661372|FG000|COMPLETED|Inpatient Trauma Only||8
6731821|NCT03187132|7661373|FG001|COMPLETED|Inpatient Trauma Only||0
6731822|NCT03187132|7661372|FG000|NOT COMPLETED|Inpatient Trauma Only||4
6731823|NCT03187132|7661373|FG001|NOT COMPLETED|Inpatient Trauma Only||12
6731824|NCT03187132|7661372|FG000|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||4
6731825|NCT03187132|7661373|FG001|STARTED|Inpatient Trauma+Pain Clinic, no Opioid||5
6731826|NCT03187132|7661372|FG000|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||3
6731827|NCT03187132|7661373|FG001|COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||0
6266225|NCT00042991|7165430|FG002|NOT COMPLETED|Overall Study||6
6266226|NCT00042991|7165431|FG003|NOT COMPLETED|Overall Study||2
6266227|NCT00042991|7165432|FG004|NOT COMPLETED|Overall Study||3
6266228|NCT00042991|7165433|FG005|NOT COMPLETED|Overall Study||5
6266229|NCT00042991|7165434|FG006|NOT COMPLETED|Overall Study||2
6266230|NCT00043186|7165461|FG000|STARTED|Overall Study||46
6603005|NCT02059291|7527981|FG022|NOT COMPLETED|Epoch 2||0
6603006|NCT02059291|7527982|FG023|NOT COMPLETED|Epoch 2||0
6731828|NCT03187132|7661372|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||1
6731829|NCT03187132|7661373|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic, no Opioid||5
6731830|NCT03187132|7661372|FG000|STARTED|Inpatient Trauma+Pain Clinic||11
6731831|NCT03187132|7661373|FG001|STARTED|Inpatient Trauma+Pain Clinic||7
6731832|NCT03187132|7661372|FG000|COMPLETED|Inpatient Trauma+Pain Clinic||8
6731833|NCT03187132|7661373|FG001|COMPLETED|Inpatient Trauma+Pain Clinic||0
6731834|NCT03187132|7661372|FG000|NOT COMPLETED|Inpatient Trauma+Pain Clinic||3
6731835|NCT03187132|7661373|FG001|NOT COMPLETED|Inpatient Trauma+Pain Clinic||7
6731836|NCT03187132|7661372|FG000|STARTED|Pain Clinic Only, Fully Remote||76
6731837|NCT03187132|7661373|FG001|STARTED|Pain Clinic Only, Fully Remote||118
6731838|NCT03187132|7661372|FG000|COMPLETED|Pain Clinic Only, Fully Remote||43
6731839|NCT03187132|7661373|FG001|COMPLETED|Pain Clinic Only, Fully Remote||64
6731840|NCT03187132|7661372|FG000|NOT COMPLETED|Pain Clinic Only, Fully Remote||33
6731841|NCT03187132|7661373|FG001|NOT COMPLETED|Pain Clinic Only, Fully Remote||54
6731842|NCT03187197|7661382|FG000|STARTED|Overall Study||153
6731843|NCT03187197|7661383|FG001|STARTED|Overall Study||1097
6731844|NCT03187197|7661384|FG002|STARTED|Overall Study||55
6731845|NCT03187197|7661382|FG000|Started (Eligible Participants as FAS)|Overall Study||139
6731846|NCT03187197|7661383|FG001|Started (Eligible Participants as FAS)|Overall Study||1052
6731847|NCT03187197|7661384|FG002|Started (Eligible Participants as FAS)|Overall Study||54
6731848|NCT03187197|7661382|FG000|COMPLETED|Overall Study||107
6731849|NCT03187197|7661383|FG001|COMPLETED|Overall Study||704
6731850|NCT03187197|7661384|FG002|COMPLETED|Overall Study||32
6731851|NCT03187197|7661382|FG000|NOT COMPLETED|Overall Study||46
6731852|NCT03187197|7661383|FG001|NOT COMPLETED|Overall Study||393
6731853|NCT03187197|7661384|FG002|NOT COMPLETED|Overall Study||23
6731863|NCT03187301|7661396|FG000|STARTED|Titration Period||7
6731864|NCT03187301|7661397|FG001|STARTED|Titration Period||7
6731865|NCT03187301|7661398|FG002|STARTED|Titration Period||7
6731866|NCT03187301|7661399|FG003|STARTED|Titration Period||6
6731867|NCT03187301|7661400|FG004|STARTED|Titration Period||7
6731868|NCT03187301|7661401|FG005|STARTED|Titration Period||7
6731869|NCT03187301|7661402|FG006|STARTED|Titration Period||7
6731870|NCT03187301|7661396|FG000|COMPLETED|Titration Period||7
6731871|NCT03187301|7661397|FG001|COMPLETED|Titration Period||7
6731872|NCT03187301|7661398|FG002|COMPLETED|Titration Period||7
6731873|NCT03187301|7661399|FG003|COMPLETED|Titration Period||6
6731874|NCT03187301|7661400|FG004|COMPLETED|Titration Period||7
6731875|NCT03187301|7661401|FG005|COMPLETED|Titration Period||7
6731876|NCT03187301|7661402|FG006|COMPLETED|Titration Period||0
6731877|NCT03187301|7661396|FG000|NOT COMPLETED|Titration Period||0
6731878|NCT03187301|7661397|FG001|NOT COMPLETED|Titration Period||0
6731879|NCT03187301|7661398|FG002|NOT COMPLETED|Titration Period||0
6731880|NCT03187301|7661399|FG003|NOT COMPLETED|Titration Period||0
6731881|NCT03187301|7661400|FG004|NOT COMPLETED|Titration Period||0
6731882|NCT03187301|7661401|FG005|NOT COMPLETED|Titration Period||0
6731883|NCT03187301|7661402|FG006|NOT COMPLETED|Titration Period||7
6731884|NCT03187301|7661396|FG000|STARTED|Pre-Intervention||7
6731885|NCT03187301|7661397|FG001|STARTED|Pre-Intervention||7
6731886|NCT03187301|7661398|FG002|STARTED|Pre-Intervention||7
6731887|NCT03187301|7661399|FG003|STARTED|Pre-Intervention||6
6731888|NCT03187301|7661400|FG004|STARTED|Pre-Intervention||7
6731889|NCT03187301|7661401|FG005|STARTED|Pre-Intervention||7
6731890|NCT03187301|7661402|FG006|STARTED|Pre-Intervention||0
6731891|NCT03187301|7661396|FG000|COMPLETED|Pre-Intervention||6
6731892|NCT03187301|7661397|FG001|COMPLETED|Pre-Intervention||7
6731893|NCT03187301|7661398|FG002|COMPLETED|Pre-Intervention||7
6731894|NCT03187301|7661399|FG003|COMPLETED|Pre-Intervention||6
6731895|NCT03187301|7661400|FG004|COMPLETED|Pre-Intervention||7
6731896|NCT03187301|7661401|FG005|COMPLETED|Pre-Intervention||7
6731897|NCT03187301|7661402|FG006|COMPLETED|Pre-Intervention||0
6731898|NCT03187301|7661396|FG000|NOT COMPLETED|Pre-Intervention||1
6731899|NCT03187301|7661397|FG001|NOT COMPLETED|Pre-Intervention||0
6731900|NCT03187301|7661398|FG002|NOT COMPLETED|Pre-Intervention||0
6731901|NCT03187301|7661399|FG003|NOT COMPLETED|Pre-Intervention||0
6731902|NCT03187301|7661400|FG004|NOT COMPLETED|Pre-Intervention||0
6731903|NCT03187301|7661401|FG005|NOT COMPLETED|Pre-Intervention||0
6731904|NCT03187301|7661402|FG006|NOT COMPLETED|Pre-Intervention||0
6731905|NCT03187301|7661396|FG000|STARTED|First Intervention||6
6731906|NCT03187301|7661397|FG001|STARTED|First Intervention||7
6731907|NCT03187301|7661398|FG002|STARTED|First Intervention||7
6731908|NCT03187301|7661399|FG003|STARTED|First Intervention||6
6731909|NCT03187301|7661400|FG004|STARTED|First Intervention||7
6731910|NCT03187301|7661401|FG005|STARTED|First Intervention||7
6731911|NCT03187301|7661402|FG006|STARTED|First Intervention||0
6731912|NCT03187301|7661396|FG000|COMPLETED|First Intervention||6
6731913|NCT03187301|7661397|FG001|COMPLETED|First Intervention||7
6731914|NCT03187301|7661398|FG002|COMPLETED|First Intervention||7
6731915|NCT03187301|7661399|FG003|COMPLETED|First Intervention||6
6731916|NCT03187301|7661400|FG004|COMPLETED|First Intervention||7
6731917|NCT03187301|7661401|FG005|COMPLETED|First Intervention||7
6731918|NCT03187301|7661402|FG006|COMPLETED|First Intervention||0
6731919|NCT03187301|7661396|FG000|NOT COMPLETED|First Intervention||0
6731920|NCT03187301|7661397|FG001|NOT COMPLETED|First Intervention||0
6731921|NCT03187301|7661398|FG002|NOT COMPLETED|First Intervention||0
6731922|NCT03187301|7661399|FG003|NOT COMPLETED|First Intervention||0
6731923|NCT03187301|7661400|FG004|NOT COMPLETED|First Intervention||0
6731924|NCT03187301|7661401|FG005|NOT COMPLETED|First Intervention||0
6731925|NCT03187301|7661402|FG006|NOT COMPLETED|First Intervention||0
6731926|NCT03187301|7661396|FG000|STARTED|First Washout||6
6731927|NCT03187301|7661397|FG001|STARTED|First Washout||7
6731928|NCT03187301|7661398|FG002|STARTED|First Washout||7
6731929|NCT03187301|7661399|FG003|STARTED|First Washout||6
6731930|NCT03187301|7661400|FG004|STARTED|First Washout||7
6731931|NCT03187301|7661401|FG005|STARTED|First Washout||7
6731932|NCT03187301|7661402|FG006|STARTED|First Washout||0
6731933|NCT03187301|7661396|FG000|COMPLETED|First Washout||6
6731934|NCT03187301|7661397|FG001|COMPLETED|First Washout||7
6731935|NCT03187301|7661398|FG002|COMPLETED|First Washout||7
6731936|NCT03187301|7661399|FG003|COMPLETED|First Washout||6
6731937|NCT03187301|7661400|FG004|COMPLETED|First Washout||7
6731938|NCT03187301|7661401|FG005|COMPLETED|First Washout||7
6731939|NCT03187301|7661402|FG006|COMPLETED|First Washout||0
6731940|NCT03187301|7661396|FG000|NOT COMPLETED|First Washout||0
6731941|NCT03187301|7661397|FG001|NOT COMPLETED|First Washout||0
6731942|NCT03187301|7661398|FG002|NOT COMPLETED|First Washout||0
6731943|NCT03187301|7661399|FG003|NOT COMPLETED|First Washout||0
6731944|NCT03187301|7661400|FG004|NOT COMPLETED|First Washout||0
6731945|NCT03187301|7661401|FG005|NOT COMPLETED|First Washout||0
6731946|NCT03187301|7661402|FG006|NOT COMPLETED|First Washout||0
6731947|NCT03187301|7661396|FG000|STARTED|Second Intervention||6
6731948|NCT03187301|7661397|FG001|STARTED|Second Intervention||7
6731949|NCT03187301|7661398|FG002|STARTED|Second Intervention||7
6731950|NCT03187301|7661399|FG003|STARTED|Second Intervention||6
6731951|NCT03187301|7661400|FG004|STARTED|Second Intervention||7
6731952|NCT03187301|7661401|FG005|STARTED|Second Intervention||7
6731953|NCT03187301|7661402|FG006|STARTED|Second Intervention||0
6731954|NCT03187301|7661396|FG000|COMPLETED|Second Intervention||6
6731955|NCT03187301|7661397|FG001|COMPLETED|Second Intervention||7
6731956|NCT03187301|7661398|FG002|COMPLETED|Second Intervention||7
6731957|NCT03187301|7661399|FG003|COMPLETED|Second Intervention||6
6731958|NCT03187301|7661400|FG004|COMPLETED|Second Intervention||7
6731959|NCT03187301|7661401|FG005|COMPLETED|Second Intervention||7
6731960|NCT03187301|7661402|FG006|COMPLETED|Second Intervention||0
6731961|NCT03187301|7661396|FG000|NOT COMPLETED|Second Intervention||0
6731962|NCT03187301|7661397|FG001|NOT COMPLETED|Second Intervention||0
6731963|NCT03187301|7661398|FG002|NOT COMPLETED|Second Intervention||0
6731964|NCT03187301|7661399|FG003|NOT COMPLETED|Second Intervention||0
6731965|NCT03187301|7661400|FG004|NOT COMPLETED|Second Intervention||0
6731966|NCT03187301|7661401|FG005|NOT COMPLETED|Second Intervention||0
6731967|NCT03187301|7661402|FG006|NOT COMPLETED|Second Intervention||0
6731968|NCT03187301|7661396|FG000|STARTED|Second Washout||6
6731969|NCT03187301|7661397|FG001|STARTED|Second Washout||7
6731970|NCT03187301|7661398|FG002|STARTED|Second Washout||7
6731971|NCT03187301|7661399|FG003|STARTED|Second Washout||6
6731972|NCT03187301|7661400|FG004|STARTED|Second Washout||7
6731973|NCT03187301|7661401|FG005|STARTED|Second Washout||7
6731974|NCT03187301|7661402|FG006|STARTED|Second Washout||0
6731975|NCT03187301|7661396|FG000|COMPLETED|Second Washout||6
6731976|NCT03187301|7661397|FG001|COMPLETED|Second Washout||7
6731977|NCT03187301|7661398|FG002|COMPLETED|Second Washout||7
6731978|NCT03187301|7661399|FG003|COMPLETED|Second Washout||6
6731979|NCT03187301|7661400|FG004|COMPLETED|Second Washout||7
6731980|NCT03187301|7661401|FG005|COMPLETED|Second Washout||7
6731981|NCT03187301|7661402|FG006|COMPLETED|Second Washout||0
6731982|NCT03187301|7661396|FG000|NOT COMPLETED|Second Washout||0
6731983|NCT03187301|7661397|FG001|NOT COMPLETED|Second Washout||0
6731984|NCT03187301|7661398|FG002|NOT COMPLETED|Second Washout||0
6731985|NCT03187301|7661399|FG003|NOT COMPLETED|Second Washout||0
6731986|NCT03187301|7661400|FG004|NOT COMPLETED|Second Washout||0
6731987|NCT03187301|7661401|FG005|NOT COMPLETED|Second Washout||0
6731988|NCT03187301|7661402|FG006|NOT COMPLETED|Second Washout||0
6731989|NCT03187301|7661396|FG000|STARTED|Third Intervention||6
6731990|NCT03187301|7661397|FG001|STARTED|Third Intervention||7
6731991|NCT03187301|7661398|FG002|STARTED|Third Intervention||7
6731992|NCT03187301|7661399|FG003|STARTED|Third Intervention||6
6731993|NCT03187301|7661400|FG004|STARTED|Third Intervention||7
6731994|NCT03187301|7661401|FG005|STARTED|Third Intervention||7
6731995|NCT03187301|7661402|FG006|STARTED|Third Intervention||0
6731996|NCT03187301|7661396|FG000|COMPLETED|Third Intervention||6
6731997|NCT03187301|7661397|FG001|COMPLETED|Third Intervention||7
6731998|NCT03187301|7661398|FG002|COMPLETED|Third Intervention||7
6731999|NCT03187301|7661399|FG003|COMPLETED|Third Intervention||6
6732000|NCT03187301|7661400|FG004|COMPLETED|Third Intervention||7
6732001|NCT03187301|7661401|FG005|COMPLETED|Third Intervention||7
6732002|NCT03187301|7661402|FG006|COMPLETED|Third Intervention||0
6732003|NCT03187301|7661396|FG000|NOT COMPLETED|Third Intervention||0
6732004|NCT03187301|7661397|FG001|NOT COMPLETED|Third Intervention||0
6732005|NCT03187301|7661398|FG002|NOT COMPLETED|Third Intervention||0
6732006|NCT03187301|7661399|FG003|NOT COMPLETED|Third Intervention||0
6732007|NCT03187301|7661400|FG004|NOT COMPLETED|Third Intervention||0
6732008|NCT03187301|7661401|FG005|NOT COMPLETED|Third Intervention||0
6732009|NCT03187301|7661402|FG006|NOT COMPLETED|Third Intervention||0
6732010|NCT03187418|7661423|FG000|STARTED|Overall Study||52
6732011|NCT03187418|7661423|FG000|COMPLETED|Overall Study||52
6732012|NCT03187418|7661423|FG000|NOT COMPLETED|Overall Study||0
6732013|NCT03187678|7661427|FG000|STARTED|Period 1 (Oral Selexipag)||20
6732014|NCT03187678|7661427|FG000|COMPLETED|Period 1 (Oral Selexipag)||20
6732015|NCT03187678|7661427|FG000|NOT COMPLETED|Period 1 (Oral Selexipag)||0
6732016|NCT03187678|7661427|FG000|STARTED|Period 2 (Intravenous Selexipag)||20
6732017|NCT03187678|7661427|FG000|COMPLETED|Period 2 (Intravenous Selexipag)||20
6732018|NCT03187678|7661427|FG000|NOT COMPLETED|Period 2 (Intravenous Selexipag)||0
6732019|NCT03187678|7661427|FG000|STARTED|Period 3 (Oral Selexipag)||20
6732020|NCT03187678|7661427|FG000|COMPLETED|Period 3 (Oral Selexipag)||20
6732021|NCT03187678|7661427|FG000|NOT COMPLETED|Period 3 (Oral Selexipag)||0
6732022|NCT03187730|7661433|FG000|STARTED|Overall Study||208
6732023|NCT03187730|7661434|FG001|STARTED|Overall Study||202
6732024|NCT03187730|7661433|FG000|COMPLETED|Overall Study||129
6732025|NCT03187730|7661434|FG001|COMPLETED|Overall Study||154
6732026|NCT03187730|7661433|FG000|NOT COMPLETED|Overall Study||79
6732027|NCT03187730|7661434|FG001|NOT COMPLETED|Overall Study||48
6732028|NCT03187756|7661440|FG000|STARTED|Overall Study||6
6732029|NCT03187756|7661440|FG000|COMPLETED|Overall Study||2
6732030|NCT03187756|7661440|FG000|NOT COMPLETED|Overall Study||4
6732031|NCT03188055|7661446|FG000|STARTED|Overall Study||48
6732032|NCT03188055|7661447|FG001|STARTED|Overall Study|Family members consented (24/48 had patient enroll along with them as patient had DMC).|48
6732033|NCT03188055|7661448|FG002|STARTED|Overall Study||62
6732034|NCT03188055|7661449|FG003|STARTED|Overall Study|Family members consented (19/38 had patient enroll along with them as patient had DMC).|38
6732035|NCT03188055|7661450|FG004|STARTED|Overall Study||59
6732036|NCT03188055|7661451|FG005|STARTED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
6732037|NCT03188055|7661446|FG000|Patients Who Provided Self-Consent|Overall Study||0
6732038|NCT03188055|7661447|FG001|Patients Who Provided Self-Consent|Overall Study||24
6732039|NCT03188055|7661448|FG002|Patients Who Provided Self-Consent|Overall Study||0
6732040|NCT03188055|7661449|FG003|Patients Who Provided Self-Consent|Overall Study||19
6732041|NCT03188055|7661450|FG004|Patients Who Provided Self-Consent|Overall Study||0
6732042|NCT03188055|7661451|FG005|Patients Who Provided Self-Consent|Overall Study||0
6732043|NCT03188055|7661446|FG000|MDS Pre-Intervention Survey Responses|Overall Study||0
6732044|NCT03188055|7661447|FG001|MDS Pre-Intervention Survey Responses|Overall Study||0
6732045|NCT03188055|7661448|FG002|MDS Pre-Intervention Survey Responses|Overall Study||0
6732046|NCT03188055|7661449|FG003|MDS Pre-Intervention Survey Responses|Overall Study||0
6732047|NCT03188055|7661450|FG004|MDS Pre-Intervention Survey Responses|Overall Study||0
6732048|NCT03188055|7661451|FG005|MDS Pre-Intervention Survey Responses|Overall Study||99
6732049|NCT03188055|7661446|FG000|MDS Post-Intervention Survey Responses|Overall Study||0
6732050|NCT03188055|7661447|FG001|MDS Post-Intervention Survey Responses|Overall Study||0
6732051|NCT03188055|7661448|FG002|MDS Post-Intervention Survey Responses|Overall Study||0
6732052|NCT03188055|7661449|FG003|MDS Post-Intervention Survey Responses|Overall Study||0
6732053|NCT03188055|7661450|FG004|MDS Post-Intervention Survey Responses|Overall Study||0
6732054|NCT03188055|7661451|FG005|MDS Post-Intervention Survey Responses|Overall Study||134
6732055|NCT03188055|7661446|FG000|Patient Survey 1|Overall Study||0
6732056|NCT03188055|7661447|FG001|Patient Survey 1|Overall Study||16
6732057|NCT03188055|7661448|FG002|Patient Survey 1|Overall Study||0
6732058|NCT03188055|7661449|FG003|Patient Survey 1|Overall Study||13
6732059|NCT03188055|7661450|FG004|Patient Survey 1|Overall Study||0
6732060|NCT03188055|7661451|FG005|Patient Survey 1|Overall Study||0
6732061|NCT03188055|7661446|FG000|Nurse Survey 1|Overall Study||0
6732062|NCT03188055|7661447|FG001|Nurse Survey 1|Overall Study||32
6732063|NCT03188055|7661448|FG002|Nurse Survey 1|Overall Study||0
6732064|NCT03188055|7661449|FG003|Nurse Survey 1|Overall Study||27
6732065|NCT03188055|7661450|FG004|Nurse Survey 1|Overall Study||0
6732066|NCT03188055|7661451|FG005|Nurse Survey 1|Overall Study||0
6732067|NCT03188055|7661446|FG000|Family Survey 1|Overall Study||0
6732068|NCT03188055|7661447|FG001|Family Survey 1|Overall Study||37
6732069|NCT03188055|7661448|FG002|Family Survey 1|Overall Study||0
6732070|NCT03188055|7661449|FG003|Family Survey 1|Overall Study||38
6732071|NCT03188055|7661450|FG004|Family Survey 1|Overall Study||0
6732072|NCT03188055|7661451|FG005|Family Survey 1|Overall Study||0
6732073|NCT03188055|7661446|FG000|Family Survey 2|Overall Study||0
6732074|NCT03188055|7661447|FG001|Family Survey 2|Overall Study||34
6732075|NCT03188055|7661448|FG002|Family Survey 2|Overall Study||0
6732076|NCT03188055|7661449|FG003|Family Survey 2|Overall Study||35
6732077|NCT03188055|7661450|FG004|Family Survey 2|Overall Study||0
6732078|NCT03188055|7661451|FG005|Family Survey 2|Overall Study||0
6732079|NCT03188055|7661446|FG000|Family Survey 3|Overall Study||0
6732080|NCT03188055|7661447|FG001|Family Survey 3|Overall Study||29
6732081|NCT03188055|7661448|FG002|Family Survey 3|Overall Study||0
6732082|NCT03188055|7661449|FG003|Family Survey 3|Overall Study||26
6732083|NCT03188055|7661450|FG004|Family Survey 3|Overall Study||0
6732084|NCT03188055|7661451|FG005|Family Survey 3|Overall Study||0
6732085|NCT03188055|7661446|FG000|COMPLETED|Overall Study||48
6732086|NCT03188055|7661447|FG001|COMPLETED|Overall Study||29
6266231|NCT00043186|7165462|FG001|STARTED|Overall Study||44
6266232|NCT00043186|7165463|FG002|STARTED|Overall Study||44
6266233|NCT00043186|7165464|FG003|STARTED|Overall Study||41
6266234|NCT00043186|7165465|FG004|STARTED|Overall Study||54
6266235|NCT00043186|7165466|FG005|STARTED|Overall Study||47
6266236|NCT00043186|7165467|FG006|STARTED|Overall Study||42
6266237|NCT00043186|7165468|FG007|STARTED|Overall Study||47
6266238|NCT00043186|7165469|FG008|STARTED|Overall Study||47
6266239|NCT00043186|7165461|FG000|COMPLETED|Overall Study||29
6266240|NCT00043186|7165462|FG001|COMPLETED|Overall Study||29
6266241|NCT00043186|7165463|FG002|COMPLETED|Overall Study||24
6266242|NCT00043186|7165464|FG003|COMPLETED|Overall Study||19
6266243|NCT00043186|7165465|FG004|COMPLETED|Overall Study||36
6266244|NCT00043186|7165466|FG005|COMPLETED|Overall Study||39
6266245|NCT00043186|7165467|FG006|COMPLETED|Overall Study||25
6266246|NCT00043186|7165468|FG007|COMPLETED|Overall Study||31
6266247|NCT00043186|7165469|FG008|COMPLETED|Overall Study||30
6266248|NCT00043186|7165461|FG000|NOT COMPLETED|Overall Study||17
6266249|NCT00043186|7165462|FG001|NOT COMPLETED|Overall Study||15
6266250|NCT00043186|7165463|FG002|NOT COMPLETED|Overall Study||20
6266251|NCT00043186|7165464|FG003|NOT COMPLETED|Overall Study||22
6266252|NCT00043186|7165465|FG004|NOT COMPLETED|Overall Study||18
6266253|NCT00043186|7165466|FG005|NOT COMPLETED|Overall Study||8
6266254|NCT00043186|7165467|FG006|NOT COMPLETED|Overall Study||17
6266255|NCT00043186|7165468|FG007|NOT COMPLETED|Overall Study||16
6266256|NCT00043186|7165469|FG008|NOT COMPLETED|Overall Study||17
6266257|NCT00043550|7165493|FG000|STARTED|Overall Study||55
6266258|NCT00043550|7165494|FG001|STARTED|Overall Study||51
6266259|NCT00043550|7165495|FG002|STARTED|Overall Study||50
6266260|NCT00043550|7165493|FG000|Week 8 Completed|Overall Study||35
6266261|NCT00043550|7165494|FG001|Week 8 Completed|Overall Study||40
6266262|NCT00043550|7165495|FG002|Week 8 Completed|Overall Study||35
6266263|NCT00043550|7165493|FG000|COMPLETED|Overall Study||33
6266264|NCT00043550|7165494|FG001|COMPLETED|Overall Study||39
6266265|NCT00043550|7165495|FG002|COMPLETED|Overall Study||30
6266266|NCT00043550|7165493|FG000|NOT COMPLETED|Overall Study||22
6266267|NCT00043550|7165494|FG001|NOT COMPLETED|Overall Study||12
6266268|NCT00043550|7165495|FG002|NOT COMPLETED|Overall Study||20
6266269|NCT00043979|7165505|FG000|STARTED|Period 1||30
6266270|NCT00043979|7165506|FG001|STARTED|Period 1||17
6266271|NCT00043979|7165507|FG002|STARTED|Period 1||13
6266272|NCT00043979|7165505|FG000|COMPLETED|Period 1||23
6266273|NCT00043979|7165506|FG001|COMPLETED|Period 1||13
6266274|NCT00043979|7165507|FG002|COMPLETED|Period 1||10
6266275|NCT00043979|7165505|FG000|NOT COMPLETED|Period 1||7
6266276|NCT00043979|7165506|FG001|NOT COMPLETED|Period 1||4
6266277|NCT00043979|7165507|FG002|NOT COMPLETED|Period 1||3
6266278|NCT00043979|7165505|FG000|STARTED|Period 2||0
6266279|NCT00043979|7165506|FG001|STARTED|Period 2||13
6266280|NCT00043979|7165507|FG002|STARTED|Period 2||10
6266281|NCT00043979|7165505|FG000|COMPLETED|Period 2||0
6266282|NCT00043979|7165506|FG001|COMPLETED|Period 2||13
6266283|NCT00043979|7165507|FG002|COMPLETED|Period 2||10
6266284|NCT00043979|7165505|FG000|NOT COMPLETED|Period 2||0
6266285|NCT00043979|7165506|FG001|NOT COMPLETED|Period 2||0
6266286|NCT00043979|7165507|FG002|NOT COMPLETED|Period 2||0
6266287|NCT00044005|7165516|FG000|STARTED|Overall Study||32
6266288|NCT00044005|7165517|FG001|STARTED|Overall Study||33
6266289|NCT00044005|7165518|FG002|STARTED|Overall Study||33
6266290|NCT00044005|7165516|FG000|COMPLETED|Overall Study||13
6266291|NCT00044005|7165517|FG001|COMPLETED|Overall Study||19
6266292|NCT00044005|7165518|FG002|COMPLETED|Overall Study||11
6266293|NCT00044005|7165516|FG000|NOT COMPLETED|Overall Study||19
6266294|NCT00044005|7165517|FG001|NOT COMPLETED|Overall Study||14
6266295|NCT00044005|7165518|FG002|NOT COMPLETED|Overall Study||22
6266296|NCT00044044|7165531|FG000|STARTED|Overall Study||71
6266297|NCT00044044|7165532|FG001|STARTED|Overall Study||69
6266298|NCT00044044|7165533|FG002|STARTED|Overall Study||71
6266299|NCT00044044|7165534|FG003|STARTED|Overall Study||73
6266300|NCT00044044|7165535|FG004|STARTED|Overall Study||72
6266301|NCT00044044|7165531|FG000|COMPLETED|Overall Study||27
6266302|NCT00044044|7165532|FG001|COMPLETED|Overall Study||28
6266303|NCT00044044|7165533|FG002|COMPLETED|Overall Study||31
6266304|NCT00044044|7165534|FG003|COMPLETED|Overall Study||29
6266305|NCT00044044|7165535|FG004|COMPLETED|Overall Study||36
6266306|NCT00044044|7165531|FG000|NOT COMPLETED|Overall Study||44
6266307|NCT00044044|7165532|FG001|NOT COMPLETED|Overall Study||41
6266308|NCT00044044|7165533|FG002|NOT COMPLETED|Overall Study||40
6266309|NCT00044044|7165534|FG003|NOT COMPLETED|Overall Study||44
6266310|NCT00044044|7165535|FG004|NOT COMPLETED|Overall Study||36
6266311|NCT00044083|7165549|FG000|STARTED|First Intervention (One Week)- HV's||74
6266312|NCT00044083|7165550|FG001|STARTED|First Intervention (One Week)- HV's||73
6266313|NCT00044083|7165549|FG000|COMPLETED|First Intervention (One Week)- HV's||64
6266314|NCT00044083|7165550|FG001|COMPLETED|First Intervention (One Week)- HV's||66
6266315|NCT00044083|7165549|FG000|NOT COMPLETED|First Intervention (One Week)- HV's||10
6266316|NCT00044083|7165550|FG001|NOT COMPLETED|First Intervention (One Week)- HV's||7
6266317|NCT00044083|7165549|FG000|STARTED|Second Intervention (One Week) HV's||64
6266318|NCT00044083|7165550|FG001|STARTED|Second Intervention (One Week) HV's||66
6266319|NCT00044083|7165549|FG000|COMPLETED|Second Intervention (One Week) HV's||64
6732087|NCT03188055|7661448|FG002|COMPLETED|Overall Study||43
6732088|NCT03188055|7661449|FG003|COMPLETED|Overall Study||26
6732089|NCT03188055|7661450|FG004|COMPLETED|Overall Study||59
6732090|NCT03188055|7661451|FG005|COMPLETED|Overall Study|Anonymous survey, cannot ascertain if same participant completed it for both pre- and post-intervention.|
6732091|NCT03188055|7661446|FG000|NOT COMPLETED|Overall Study||0
6732092|NCT03188055|7661447|FG001|NOT COMPLETED|Overall Study||19
6732093|NCT03188055|7661448|FG002|NOT COMPLETED|Overall Study||19
6732094|NCT03188055|7661449|FG003|NOT COMPLETED|Overall Study||12
6732095|NCT03188055|7661450|FG004|NOT COMPLETED|Overall Study||0
6732096|NCT03188055|7661451|FG005|NOT COMPLETED|Overall Study||
6732097|NCT03188120|7661462|FG000|STARTED|Overall Study||193
6732098|NCT03188120|7661462|FG000|COMPLETED|Overall Study||146
6732099|NCT03188120|7661462|FG000|NOT COMPLETED|Overall Study||47
6732100|NCT03188185|7661468|FG000|STARTED|Stage 1||198
6732101|NCT03188185|7661469|FG001|STARTED|Stage 1||80
6732102|NCT03188185|7661470|FG002|STARTED|Stage 1||0
6732103|NCT03188185|7661471|FG003|STARTED|Stage 1||0
6732104|NCT03188185|7661468|FG000|COMPLETED|Stage 1||179
6732105|NCT03188185|7661469|FG001|COMPLETED|Stage 1||64
6732106|NCT03188185|7661470|FG002|COMPLETED|Stage 1||0
6392196|NCT00840294|7304199|FG001|STARTED|Overall Study||43
6392197|NCT00840294|7304198|FG000|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
6392198|NCT00840294|7304199|FG001|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
6392199|NCT00840294|7304198|FG000|NOT COMPLETED|Overall Study||3
6266320|NCT00044083|7165550|FG001|COMPLETED|Second Intervention (One Week) HV's||66
6266321|NCT00044083|7165549|FG000|NOT COMPLETED|Second Intervention (One Week) HV's||0
6266322|NCT00044083|7165550|FG001|NOT COMPLETED|Second Intervention (One Week) HV's||0
6266323|NCT00044083|7165549|FG000|STARTED|First Intervention (One Week) Patients||31
6266324|NCT00044083|7165550|FG001|STARTED|First Intervention (One Week) Patients||32
6266325|NCT00044083|7165549|FG000|COMPLETED|First Intervention (One Week) Patients||30
6266326|NCT00044083|7165550|FG001|COMPLETED|First Intervention (One Week) Patients||30
6266327|NCT00044083|7165549|FG000|NOT COMPLETED|First Intervention (One Week) Patients||1
6266328|NCT00044083|7165550|FG001|NOT COMPLETED|First Intervention (One Week) Patients||2
6266329|NCT00044083|7165549|FG000|STARTED|Second Intervention (One Week) Patients||30
6266330|NCT00044083|7165550|FG001|STARTED|Second Intervention (One Week) Patients||30
6266331|NCT00044083|7165549|FG000|COMPLETED|Second Intervention (One Week) Patients||30
6266332|NCT00044083|7165550|FG001|COMPLETED|Second Intervention (One Week) Patients||29
6266333|NCT00044083|7165549|FG000|NOT COMPLETED|Second Intervention (One Week) Patients||0
6266334|NCT00044083|7165550|FG001|NOT COMPLETED|Second Intervention (One Week) Patients||1
6266335|NCT00044213|7165587|FG000|STARTED|Overall Study||421
6266336|NCT00044213|7165588|FG001|STARTED|Overall Study||418
6266337|NCT00044213|7165589|FG002|STARTED|Overall Study||432
6266338|NCT00044213|7165590|FG003|STARTED|Overall Study||437
6266339|NCT00044213|7165587|FG000|COMPLETED|Overall Study||321
6266340|NCT00044213|7165588|FG001|COMPLETED|Overall Study||306
6266341|NCT00044213|7165589|FG002|COMPLETED|Overall Study||294
6266342|NCT00044213|7165590|FG003|COMPLETED|Overall Study||301
6266343|NCT00044213|7165587|FG000|NOT COMPLETED|Overall Study||100
6266344|NCT00044213|7165588|FG001|NOT COMPLETED|Overall Study||112
6266345|NCT00044213|7165589|FG002|NOT COMPLETED|Overall Study||138
6266346|NCT00044213|7165590|FG003|NOT COMPLETED|Overall Study||136
6266347|NCT00044512|7165600|FG000|STARTED|Treatment||137
6266348|NCT00044512|7165600|FG000|COMPLETED|Treatment||137
6266349|NCT00044512|7165600|FG000|NOT COMPLETED|Treatment||0
6266350|NCT00044512|7165600|FG000|STARTED|Follow Up||137
6266351|NCT00044512|7165600|FG000|COMPLETED|Follow Up||135
6266352|NCT00044512|7165600|FG000|NOT COMPLETED|Follow Up||2
6266353|NCT00044655|7165606|FG000|STARTED|Overall Study||102
6266354|NCT00044655|7165607|FG001|STARTED|Overall Study||117
6266355|NCT00044655|7165606|FG000|COMPLETED|Overall Study||82
6266356|NCT00044655|7165607|FG001|COMPLETED|Overall Study||79
6266357|NCT00044655|7165606|FG000|NOT COMPLETED|Overall Study||20
6266358|NCT00044655|7165607|FG001|NOT COMPLETED|Overall Study||38
6266359|NCT00045032|7165616|FG000|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
6266360|NCT00045032|7165617|FG001|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
6266361|NCT00045032|7165618|FG002|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
6266362|NCT00045032|7165616|FG000|Crossover to Adjuvant Herceptin|Overall Study||888
6266363|NCT00045032|7165617|FG001|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
6266364|NCT00045032|7165618|FG002|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
6266365|NCT00045032|7165616|FG000|COMPLETED|Overall Study||834
6266366|NCT00045032|7165617|FG001|COMPLETED|Overall Study||994
6266367|NCT00045032|7165618|FG002|COMPLETED|Overall Study||974
6266368|NCT00045032|7165616|FG000|NOT COMPLETED|Overall Study||863
6266369|NCT00045032|7165617|FG001|NOT COMPLETED|Overall Study||708
6266370|NCT00045032|7165618|FG002|NOT COMPLETED|Overall Study||726
6266371|NCT00045110|7165631|FG000|STARTED|100mg Phase 1 Dose Escalalation||6
6266372|NCT00045110|7165632|FG001|STARTED|100mg Phase 1 Dose Escalalation||59
6266373|NCT00045110|7165633|FG002|STARTED|100mg Phase 1 Dose Escalalation||45
6266374|NCT00045110|7165631|FG000|COMPLETED|100mg Phase 1 Dose Escalalation||6
6266375|NCT00045110|7165632|FG001|COMPLETED|100mg Phase 1 Dose Escalalation||53
6266376|NCT00045110|7165633|FG002|COMPLETED|100mg Phase 1 Dose Escalalation||43
6266377|NCT00045110|7165631|FG000|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
6266378|NCT00045110|7165632|FG001|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
6266379|NCT00045110|7165633|FG002|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
6266380|NCT00045110|7165631|FG000|STARTED|200mg Phase 1 Dose Escalation||4
6266381|NCT00045110|7165632|FG001|STARTED|200mg Phase 1 Dose Escalation||0
6266382|NCT00045110|7165633|FG002|STARTED|200mg Phase 1 Dose Escalation||0
6266383|NCT00045110|7165631|FG000|COMPLETED|200mg Phase 1 Dose Escalation||4
6266384|NCT00045110|7165632|FG001|COMPLETED|200mg Phase 1 Dose Escalation||0
6266385|NCT00045110|7165633|FG002|COMPLETED|200mg Phase 1 Dose Escalation||0
6266386|NCT00045110|7165631|FG000|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
6266387|NCT00045110|7165632|FG001|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
6266388|NCT00045110|7165633|FG002|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
6266389|NCT00045110|7165631|FG000|STARTED|275mg Phase 1 Dose Escalation||3
6266390|NCT00045110|7165632|FG001|STARTED|275mg Phase 1 Dose Escalation||0
6266391|NCT00045110|7165633|FG002|STARTED|275mg Phase 1 Dose Escalation||0
6266392|NCT00045110|7165631|FG000|COMPLETED|275mg Phase 1 Dose Escalation||3
6266393|NCT00045110|7165632|FG001|COMPLETED|275mg Phase 1 Dose Escalation||0
6266394|NCT00045110|7165633|FG002|COMPLETED|275mg Phase 1 Dose Escalation||0
6266395|NCT00045110|7165631|FG000|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
6266396|NCT00045110|7165632|FG001|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
6266397|NCT00045110|7165633|FG002|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
6266398|NCT00045110|7165631|FG000|STARTED|400mg Phase 1 Dose Escalation||3
6266399|NCT00045110|7165632|FG001|STARTED|400mg Phase 1 Dose Escalation||0
6266400|NCT00045110|7165633|FG002|STARTED|400mg Phase 1 Dose Escalation||0
6266401|NCT00045110|7165631|FG000|COMPLETED|400mg Phase 1 Dose Escalation||3
6266402|NCT00045110|7165632|FG001|COMPLETED|400mg Phase 1 Dose Escalation||0
6266403|NCT00045110|7165633|FG002|COMPLETED|400mg Phase 1 Dose Escalation||0
6266404|NCT00045110|7165631|FG000|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
6266405|NCT00045110|7165632|FG001|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
6266406|NCT00045110|7165633|FG002|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
6266407|NCT00045110|7165631|FG000|STARTED|525mg Phase 1 Dose Escalation||3
6266408|NCT00045110|7165632|FG001|STARTED|525mg Phase 1 Dose Escalation||0
6266409|NCT00045110|7165633|FG002|STARTED|525mg Phase 1 Dose Escalation||0
6266410|NCT00045110|7165631|FG000|COMPLETED|525mg Phase 1 Dose Escalation||3
6266411|NCT00045110|7165632|FG001|COMPLETED|525mg Phase 1 Dose Escalation||0
6266412|NCT00045110|7165633|FG002|COMPLETED|525mg Phase 1 Dose Escalation||0
6266413|NCT00045110|7165631|FG000|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
6266414|NCT00045110|7165632|FG001|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
6266415|NCT00045110|7165633|FG002|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
6266416|NCT00045110|7165631|FG000|STARTED|650mg Phase 1 Dose Escalation||6
6266417|NCT00045110|7165632|FG001|STARTED|650mg Phase 1 Dose Escalation||0
6266418|NCT00045110|7165633|FG002|STARTED|650mg Phase 1 Dose Escalation||0
6266419|NCT00045110|7165631|FG000|COMPLETED|650mg Phase 1 Dose Escalation||6
6266420|NCT00045110|7165632|FG001|COMPLETED|650mg Phase 1 Dose Escalation||0
6266421|NCT00045110|7165633|FG002|COMPLETED|650mg Phase 1 Dose Escalation||0
6266422|NCT00045110|7165631|FG000|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
6266423|NCT00045110|7165632|FG001|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
6266424|NCT00045110|7165633|FG002|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
6266425|NCT00045110|7165631|FG000|STARTED|775mg Dose Escalation||7
6266426|NCT00045110|7165632|FG001|STARTED|775mg Dose Escalation||0
6266427|NCT00045110|7165633|FG002|STARTED|775mg Dose Escalation||0
6266428|NCT00045110|7165631|FG000|COMPLETED|775mg Dose Escalation||7
6266429|NCT00045110|7165632|FG001|COMPLETED|775mg Dose Escalation||0
6266430|NCT00045110|7165633|FG002|COMPLETED|775mg Dose Escalation||0
6266431|NCT00045110|7165631|FG000|NOT COMPLETED|775mg Dose Escalation||0
6266432|NCT00045110|7165632|FG001|NOT COMPLETED|775mg Dose Escalation||0
6266433|NCT00045110|7165633|FG002|NOT COMPLETED|775mg Dose Escalation||0
6266434|NCT00045162|7165652|FG000|STARTED|Overall Study||336
6266435|NCT00045162|7165653|FG001|STARTED|Overall Study||335
6266436|NCT00045162|7165652|FG000|COMPLETED|Overall Study||194
6266437|NCT00045162|7165653|FG001|COMPLETED|Overall Study||217
6266438|NCT00045162|7165652|FG000|NOT COMPLETED|Overall Study||142
6266439|NCT00045162|7165653|FG001|NOT COMPLETED|Overall Study||118
6266440|NCT00045305|7165659|FG000|STARTED|Overall Study||17
6266441|NCT00045305|7165659|FG000|Eligible and Treated|Overall Study||17
6266442|NCT00045305|7165659|FG000|COMPLETED|Overall Study||3
6266443|NCT00045305|7165659|FG000|NOT COMPLETED|Overall Study||14
6266444|NCT00045435|7165663|FG000|STARTED|Overall Study||17
6266445|NCT00045435|7165663|FG000|COMPLETED|Overall Study||17
6266446|NCT00045435|7165663|FG000|NOT COMPLETED|Overall Study||0
6266447|NCT00045487|7165667|FG000|STARTED|Overall Study||41
6266448|NCT00045487|7165667|FG000|COMPLETED|Overall Study||30
6266449|NCT00045487|7165667|FG000|NOT COMPLETED|Overall Study||11
6266450|NCT00045630|7165671|FG000|STARTED|Overall Study||77
6266451|NCT00045630|7165671|FG000|Eligible|Overall Study||75
6266452|NCT00045630|7165671|FG000|Eligible and Began Protocol Therapy|Overall Study||74
6266453|NCT00045630|7165671|FG000|COMPLETED|Overall Study||71
6392200|NCT00840294|7304199|FG001|NOT COMPLETED|Overall Study||5
6392201|NCT00840307|7304205|FG000|STARTED|Overall Study||20
6603007|NCT02059291|7527983|FG024|NOT COMPLETED|Epoch 2||0
6603008|NCT02059291|7527959|FG000|STARTED|Epoch 3||0
6603009|NCT02059291|7527960|FG001|STARTED|Epoch 3||0
6603010|NCT02059291|7527961|FG002|STARTED|Epoch 3||0
6603011|NCT02059291|7527962|FG003|STARTED|Epoch 3||0
6603012|NCT02059291|7527963|FG004|STARTED|Epoch 3||0
6603013|NCT02059291|7527964|FG005|STARTED|Epoch 3||0
6603014|NCT02059291|7527965|FG006|STARTED|Epoch 3||2
6266454|NCT00045630|7165671|FG000|NOT COMPLETED|Overall Study||6
6266455|NCT00045708|7165678|FG000|STARTED|Phase 1||21
6266456|NCT00045708|7165679|FG001|STARTED|Phase 1||17
6266457|NCT00045708|7165680|FG002|STARTED|Phase 1||0
6266458|NCT00045708|7165678|FG000|COMPLETED|Phase 1||21
6266459|NCT00045708|7165679|FG001|COMPLETED|Phase 1||16
6266460|NCT00045708|7165680|FG002|COMPLETED|Phase 1||0
6266461|NCT00045708|7165678|FG000|NOT COMPLETED|Phase 1||0
6266462|NCT00045708|7165679|FG001|NOT COMPLETED|Phase 1||1
6266463|NCT00045708|7165680|FG002|NOT COMPLETED|Phase 1||0
6266464|NCT00045708|7165678|FG000|STARTED|Phase 2||0
6603015|NCT02059291|7527966|FG007|STARTED|Epoch 3||1
6603016|NCT02059291|7527967|FG008|STARTED|Epoch 3|Presented in Epoch 2.|0
6266465|NCT00045708|7165679|FG001|STARTED|Phase 2||0
6266466|NCT00045708|7165680|FG002|STARTED|Phase 2||19
6266467|NCT00045708|7165678|FG000|COMPLETED|Phase 2||0
6266468|NCT00045708|7165679|FG001|COMPLETED|Phase 2||0
6266469|NCT00045708|7165680|FG002|COMPLETED|Phase 2||19
6266470|NCT00045708|7165678|FG000|NOT COMPLETED|Phase 2||0
6266471|NCT00045708|7165679|FG001|NOT COMPLETED|Phase 2||0
6266472|NCT00045708|7165680|FG002|NOT COMPLETED|Phase 2||0
6266473|NCT00045734|7165697|FG000|STARTED|Overall Study||23
6603017|NCT02059291|7527968|FG009|STARTED|Epoch 3||9
6603018|NCT02059291|7527969|FG010|STARTED|Epoch 3||10
6266474|NCT00045734|7165697|FG000|COMPLETED|Overall Study||22
6266475|NCT00045734|7165697|FG000|NOT COMPLETED|Overall Study||1
6266476|NCT00045942|7165710|FG000|STARTED|PKC412A2104 (Core)||20
6266477|NCT00045942|7165711|FG001|STARTED|PKC412A2104 (Core)||0
6266478|NCT00045942|7165712|FG002|STARTED|PKC412A2104 (Core)||0
6266479|NCT00045942|7165713|FG003|STARTED|PKC412A2104 (Core)||0
6266480|NCT00045942|7165714|FG004|STARTED|PKC412A2104 (Core)||0
6266481|NCT00045942|7165715|FG005|STARTED|PKC412A2104 (Core)||0
6266482|NCT00045942|7165716|FG006|STARTED|PKC412A2104 (Core)||0
6266483|NCT00045942|7165717|FG007|STARTED|PKC412A2104 (Core)||0
6266484|NCT00045942|7165718|FG008|STARTED|PKC412A2104 (Core)||0
6266485|NCT00045942|7165710|FG000|Core Primary Efficacy|PKC412A2104 (Core)||20
6266486|NCT00045942|7165711|FG001|Core Primary Efficacy|PKC412A2104 (Core)||0
6266487|NCT00045942|7165712|FG002|Core Primary Efficacy|PKC412A2104 (Core)||0
6266488|NCT00045942|7165713|FG003|Core Primary Efficacy|PKC412A2104 (Core)||0
6266489|NCT00045942|7165714|FG004|Core Primary Efficacy|PKC412A2104 (Core)||0
6266490|NCT00045942|7165715|FG005|Core Primary Efficacy|PKC412A2104 (Core)||0
6266491|NCT00045942|7165716|FG006|Core Primary Efficacy|PKC412A2104 (Core)||0
6266492|NCT00045942|7165717|FG007|Core Primary Efficacy|PKC412A2104 (Core)||0
6266493|NCT00045942|7165718|FG008|Core Primary Efficacy|PKC412A2104 (Core)||0
6266494|NCT00045942|7165710|FG000|COMPLETED|PKC412A2104 (Core)||0
6266495|NCT00045942|7165711|FG001|COMPLETED|PKC412A2104 (Core)||0
6266496|NCT00045942|7165712|FG002|COMPLETED|PKC412A2104 (Core)||0
6266497|NCT00045942|7165713|FG003|COMPLETED|PKC412A2104 (Core)||0
6266498|NCT00045942|7165714|FG004|COMPLETED|PKC412A2104 (Core)||0
6266499|NCT00045942|7165715|FG005|COMPLETED|PKC412A2104 (Core)||0
6266500|NCT00045942|7165716|FG006|COMPLETED|PKC412A2104 (Core)||0
6266501|NCT00045942|7165717|FG007|COMPLETED|PKC412A2104 (Core)||0
6266502|NCT00045942|7165718|FG008|COMPLETED|PKC412A2104 (Core)||0
6266503|NCT00045942|7165710|FG000|NOT COMPLETED|PKC412A2104 (Core)||20
6266504|NCT00045942|7165711|FG001|NOT COMPLETED|PKC412A2104 (Core)||0
6266505|NCT00045942|7165712|FG002|NOT COMPLETED|PKC412A2104 (Core)||0
6266506|NCT00045942|7165713|FG003|NOT COMPLETED|PKC412A2104 (Core)||0
6266507|NCT00045942|7165714|FG004|NOT COMPLETED|PKC412A2104 (Core)||0
6266508|NCT00045942|7165715|FG005|NOT COMPLETED|PKC412A2104 (Core)||0
6266509|NCT00045942|7165716|FG006|NOT COMPLETED|PKC412A2104 (Core)||0
6266510|NCT00045942|7165717|FG007|NOT COMPLETED|PKC412A2104 (Core)||0
6266511|NCT00045942|7165718|FG008|NOT COMPLETED|PKC412A2104 (Core)||0
6266512|NCT00045942|7165710|FG000|STARTED|PKC412A2104E1||0
6266513|NCT00045942|7165711|FG001|STARTED|PKC412A2104E1||18
6266514|NCT00045942|7165712|FG002|STARTED|PKC412A2104E1||17
6266515|NCT00045942|7165713|FG003|STARTED|PKC412A2104E1||33
6266516|NCT00045942|7165714|FG004|STARTED|PKC412A2104E1||27
6266517|NCT00045942|7165715|FG005|STARTED|PKC412A2104E1||0
6266518|NCT00045942|7165716|FG006|STARTED|PKC412A2104E1||0
6266519|NCT00045942|7165717|FG007|STARTED|PKC412A2104E1||0
6266520|NCT00045942|7165718|FG008|STARTED|PKC412A2104E1||0
6266521|NCT00045942|7165710|FG000|Primary Efficacy|PKC412A2104E1||0
6266522|NCT00045942|7165711|FG001|Primary Efficacy|PKC412A2104E1||18
6266523|NCT00045942|7165712|FG002|Primary Efficacy|PKC412A2104E1||17
6266524|NCT00045942|7165713|FG003|Primary Efficacy|PKC412A2104E1||32
6266525|NCT00045942|7165714|FG004|Primary Efficacy|PKC412A2104E1||25
6266526|NCT00045942|7165715|FG005|Primary Efficacy|PKC412A2104E1||0
6266527|NCT00045942|7165716|FG006|Primary Efficacy|PKC412A2104E1||0
6266528|NCT00045942|7165717|FG007|Primary Efficacy|PKC412A2104E1||0
6266529|NCT00045942|7165718|FG008|Primary Efficacy|PKC412A2104E1||0
6266530|NCT00045942|7165710|FG000|COMPLETED|PKC412A2104E1||0
6266531|NCT00045942|7165711|FG001|COMPLETED|PKC412A2104E1||0
6266532|NCT00045942|7165712|FG002|COMPLETED|PKC412A2104E1||0
6266533|NCT00045942|7165713|FG003|COMPLETED|PKC412A2104E1||0
6266534|NCT00045942|7165714|FG004|COMPLETED|PKC412A2104E1||0
6266535|NCT00045942|7165715|FG005|COMPLETED|PKC412A2104E1||0
6266536|NCT00045942|7165716|FG006|COMPLETED|PKC412A2104E1||0
6266537|NCT00045942|7165717|FG007|COMPLETED|PKC412A2104E1||0
6266538|NCT00045942|7165718|FG008|COMPLETED|PKC412A2104E1||0
6266539|NCT00045942|7165710|FG000|NOT COMPLETED|PKC412A2104E1||0
6266540|NCT00045942|7165711|FG001|NOT COMPLETED|PKC412A2104E1||18
6266541|NCT00045942|7165712|FG002|NOT COMPLETED|PKC412A2104E1||17
6266542|NCT00045942|7165713|FG003|NOT COMPLETED|PKC412A2104E1||33
6266543|NCT00045942|7165714|FG004|NOT COMPLETED|PKC412A2104E1||27
6266544|NCT00045942|7165715|FG005|NOT COMPLETED|PKC412A2104E1||0
6266545|NCT00045942|7165716|FG006|NOT COMPLETED|PKC412A2104E1||0
6266546|NCT00045942|7165717|FG007|NOT COMPLETED|PKC412A2104E1||0
6266547|NCT00045942|7165718|FG008|NOT COMPLETED|PKC412A2104E1||0
6266548|NCT00045942|7165710|FG000|STARTED|PKC412A2104E2||0
6266549|NCT00045942|7165711|FG001|STARTED|PKC412A2104E2||0
6266550|NCT00045942|7165712|FG002|STARTED|PKC412A2104E2||0
6266551|NCT00045942|7165713|FG003|STARTED|PKC412A2104E2||0
6266552|NCT00045942|7165714|FG004|STARTED|PKC412A2104E2||0
6266553|NCT00045942|7165715|FG005|STARTED|PKC412A2104E2||9
6266554|NCT00045942|7165716|FG006|STARTED|PKC412A2104E2||7
6266555|NCT00045942|7165717|FG007|STARTED|PKC412A2104E2||7
6266556|NCT00045942|7165718|FG008|STARTED|PKC412A2104E2||6
6266557|NCT00045942|7165710|FG000|Primary Efficacy|PKC412A2104E2||0
6266558|NCT00045942|7165711|FG001|Primary Efficacy|PKC412A2104E2||0
6266559|NCT00045942|7165712|FG002|Primary Efficacy|PKC412A2104E2||0
6266560|NCT00045942|7165713|FG003|Primary Efficacy|PKC412A2104E2||0
6266561|NCT00045942|7165714|FG004|Primary Efficacy|PKC412A2104E2||0
6266562|NCT00045942|7165715|FG005|Primary Efficacy|PKC412A2104E2||9
6266563|NCT00045942|7165716|FG006|Primary Efficacy|PKC412A2104E2||7
6266564|NCT00045942|7165717|FG007|Primary Efficacy|PKC412A2104E2||7
6266565|NCT00045942|7165718|FG008|Primary Efficacy|PKC412A2104E2||6
6266566|NCT00045942|7165710|FG000|COMPLETED|PKC412A2104E2||0
6266567|NCT00045942|7165711|FG001|COMPLETED|PKC412A2104E2||0
6266568|NCT00045942|7165712|FG002|COMPLETED|PKC412A2104E2||0
6266569|NCT00045942|7165713|FG003|COMPLETED|PKC412A2104E2||0
6266570|NCT00045942|7165714|FG004|COMPLETED|PKC412A2104E2||0
6266571|NCT00045942|7165715|FG005|COMPLETED|PKC412A2104E2||0
6266572|NCT00045942|7165716|FG006|COMPLETED|PKC412A2104E2||0
6266573|NCT00045942|7165717|FG007|COMPLETED|PKC412A2104E2||0
6266574|NCT00045942|7165718|FG008|COMPLETED|PKC412A2104E2||0
6266575|NCT00045942|7165710|FG000|NOT COMPLETED|PKC412A2104E2||0
6266576|NCT00045942|7165711|FG001|NOT COMPLETED|PKC412A2104E2||0
6266577|NCT00045942|7165712|FG002|NOT COMPLETED|PKC412A2104E2||0
6266578|NCT00045942|7165713|FG003|NOT COMPLETED|PKC412A2104E2||0
6266579|NCT00045942|7165714|FG004|NOT COMPLETED|PKC412A2104E2||0
6266580|NCT00045942|7165715|FG005|NOT COMPLETED|PKC412A2104E2||9
6266581|NCT00045942|7165716|FG006|NOT COMPLETED|PKC412A2104E2||7
6266582|NCT00045942|7165717|FG007|NOT COMPLETED|PKC412A2104E2||7
6266583|NCT00045942|7165718|FG008|NOT COMPLETED|PKC412A2104E2||6
6266584|NCT00046228|7165745|FG000|STARTED|90 Days||806
6266585|NCT00046228|7165746|FG001|STARTED|90 Days||818
6266586|NCT00046228|7165747|FG002|STARTED|90 Days||828
6266587|NCT00046228|7165745|FG000|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
6266588|NCT00046228|7165746|FG001|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
6266589|NCT00046228|7165747|FG002|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
6266590|NCT00046228|7165745|FG000|NOT COMPLETED|90 Days||13
6266591|NCT00046228|7165746|FG001|NOT COMPLETED|90 Days||8
6266592|NCT00046228|7165747|FG002|NOT COMPLETED|90 Days||15
6266593|NCT00046228|7165745|FG000|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
6266594|NCT00046228|7165746|FG001|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
6266595|NCT00046228|7165747|FG002|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
6266596|NCT00046228|7165745|FG000|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
6266597|NCT00046228|7165746|FG001|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
6266598|NCT00046228|7165747|FG002|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
6603019|NCT02059291|7527970|FG011|STARTED|Epoch 3||6
6603020|NCT02059291|7527971|FG012|STARTED|Epoch 3||7
6603021|NCT02059291|7527972|FG013|STARTED|Epoch 3||4
6603022|NCT02059291|7527973|FG014|STARTED|Epoch 3||5
6266599|NCT00046228|7165745|FG000|NOT COMPLETED|1 Year||19
6266600|NCT00046228|7165746|FG001|NOT COMPLETED|1 Year||14
6266601|NCT00046228|7165747|FG002|NOT COMPLETED|1 Year||12
6266602|NCT00046475|7165757|FG000|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
6266603|NCT00046475|7165758|FG001|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
6266604|NCT00046475|7165759|FG002|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
6266605|NCT00046475|7165757|FG000|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
6266606|NCT00046475|7165758|FG001|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
6266607|NCT00046475|7165759|FG002|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
6266608|NCT00046475|7165757|FG000|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
6266609|NCT00046475|7165758|FG001|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
6266610|NCT00046475|7165759|FG002|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
6266611|NCT00046475|7165757|FG000|STARTED|Titration (1 Week)||136
6266612|NCT00046475|7165758|FG001|STARTED|Titration (1 Week)||0
6266613|NCT00046475|7165759|FG002|STARTED|Titration (1 Week)||0
6266614|NCT00046475|7165757|FG000|COMPLETED|Titration (1 Week)||136
6266615|NCT00046475|7165758|FG001|COMPLETED|Titration (1 Week)||0
6266616|NCT00046475|7165759|FG002|COMPLETED|Titration (1 Week)||0
6266617|NCT00046475|7165757|FG000|NOT COMPLETED|Titration (1 Week)||0
6266618|NCT00046475|7165758|FG001|NOT COMPLETED|Titration (1 Week)||0
6266619|NCT00046475|7165759|FG002|NOT COMPLETED|Titration (1 Week)||0
6603023|NCT02059291|7527974|FG015|STARTED|Epoch 3||126
6603024|NCT02059291|7527975|FG016|STARTED|Epoch 3||0
6732107|NCT03188185|7661471|FG003|COMPLETED|Stage 1||0
6266620|NCT00046475|7165757|FG000|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
6266621|NCT00046475|7165758|FG001|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
6266622|NCT00046475|7165759|FG002|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
6266623|NCT00046475|7165757|FG000|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
6266624|NCT00046475|7165758|FG001|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
6266625|NCT00046475|7165759|FG002|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
6266626|NCT00046475|7165757|FG000|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
6266627|NCT00046475|7165758|FG001|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
6266628|NCT00046475|7165759|FG002|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
6266629|NCT00046475|7165757|FG000|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
6266630|NCT00046475|7165758|FG001|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
6266631|NCT00046475|7165759|FG002|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
6266632|NCT00046475|7165757|FG000|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
6266633|NCT00046475|7165758|FG001|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
6266634|NCT00046475|7165759|FG002|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
6266635|NCT00046475|7165757|FG000|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
6266636|NCT00046475|7165758|FG001|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
6266637|NCT00046475|7165759|FG002|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
6266638|NCT00046566|7165772|FG000|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
6266639|NCT00046566|7165773|FG001|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
6266640|NCT00046566|7165774|FG002|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
6266641|NCT00046566|7165772|FG000|COMPLETED|Intervention 1 (8 Weeks)||101
6266642|NCT00046566|7165773|FG001|COMPLETED|Intervention 1 (8 Weeks)||104
6266643|NCT00046566|7165774|FG002|COMPLETED|Intervention 1 (8 Weeks)||101
6266644|NCT00046566|7165772|FG000|NOT COMPLETED|Intervention 1 (8 Weeks)||16
6266645|NCT00046566|7165773|FG001|NOT COMPLETED|Intervention 1 (8 Weeks)||13
6266646|NCT00046566|7165774|FG002|NOT COMPLETED|Intervention 1 (8 Weeks)||17
6266647|NCT00046566|7165772|FG000|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
6266648|NCT00046566|7165773|FG001|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
6266649|NCT00046566|7165774|FG002|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
6266650|NCT00046566|7165772|FG000|COMPLETED|Intervention 2 (8 Weeks)||93
6266651|NCT00046566|7165773|FG001|COMPLETED|Intervention 2 (8 Weeks)||92
6266652|NCT00046566|7165774|FG002|COMPLETED|Intervention 2 (8 Weeks)||88
6266653|NCT00046566|7165772|FG000|NOT COMPLETED|Intervention 2 (8 Weeks)||8
6266654|NCT00046566|7165773|FG001|NOT COMPLETED|Intervention 2 (8 Weeks)||12
6266655|NCT00046566|7165774|FG002|NOT COMPLETED|Intervention 2 (8 Weeks)||13
6266656|NCT00046566|7165772|FG000|STARTED|Intervention 3 (8 Weeks)||93
6266657|NCT00046566|7165773|FG001|STARTED|Intervention 3 (8 Weeks)||92
6266658|NCT00046566|7165774|FG002|STARTED|Intervention 3 (8 Weeks)||88
6266659|NCT00046566|7165772|FG000|COMPLETED|Intervention 3 (8 Weeks)||93
6266660|NCT00046566|7165773|FG001|COMPLETED|Intervention 3 (8 Weeks)||92
6266661|NCT00046566|7165774|FG002|COMPLETED|Intervention 3 (8 Weeks)||88
6266662|NCT00046566|7165772|FG000|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6266663|NCT00046566|7165773|FG001|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6266664|NCT00046566|7165774|FG002|NOT COMPLETED|Intervention 3 (8 Weeks)||0
6266665|NCT00046839|7165785|FG000|STARTED|Overall Study||8
6266666|NCT00046839|7165786|FG001|STARTED|Overall Study||13
6266667|NCT00046839|7165785|FG000|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
6266668|NCT00046839|7165786|FG001|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
6266669|NCT00046839|7165785|FG000|NOT COMPLETED|Overall Study||1
6266670|NCT00046839|7165786|FG001|NOT COMPLETED|Overall Study||2
6266671|NCT00046891|7165795|FG000|STARTED|Overall Study||113
6266672|NCT00046891|7165796|FG001|STARTED|Overall Study||113
6266673|NCT00046891|7165795|FG000|COMPLETED|Overall Study||84
6266674|NCT00046891|7165796|FG001|COMPLETED|Overall Study||83
6266675|NCT00046891|7165795|FG000|NOT COMPLETED|Overall Study||29
6266676|NCT00046891|7165796|FG001|NOT COMPLETED|Overall Study||30
6266677|NCT00046930|7165812|FG000|STARTED|Overall Study||224
6266678|NCT00046930|7165813|FG001|STARTED|Overall Study||225
6266679|NCT00046930|7165812|FG000|COMPLETED|Overall Study||212
6266680|NCT00046930|7165813|FG001|COMPLETED|Overall Study||221
6266681|NCT00046930|7165812|FG000|NOT COMPLETED|Overall Study||12
6266682|NCT00046930|7165813|FG001|NOT COMPLETED|Overall Study||4
6266683|NCT00047008|7165824|FG000|STARTED|Overall Study||372
6266684|NCT00047008|7165825|FG001|STARTED|Overall Study||371
6266685|NCT00047008|7165824|FG000|COMPLETED|Overall Study||361
6266686|NCT00047008|7165825|FG001|COMPLETED|Overall Study||360
6266687|NCT00047008|7165824|FG000|NOT COMPLETED|Overall Study||11
6266688|NCT00047008|7165825|FG001|NOT COMPLETED|Overall Study||11
6266689|NCT00047060|7165831|FG000|STARTED|Overall Study||5
6266690|NCT00047060|7165831|FG000|COMPLETED|Overall Study||3
6266691|NCT00047060|7165831|FG000|NOT COMPLETED|Overall Study||2
6266692|NCT00047320|7165835|FG000|STARTED|Overall Study||104
6266693|NCT00047320|7165835|FG000|COMPLETED|Overall Study||76
6266694|NCT00047320|7165835|FG000|NOT COMPLETED|Overall Study||28
6266695|NCT00047385|7165841|FG000|STARTED|Overall Study||26722
6266696|NCT00047385|7165842|FG001|STARTED|Overall Study||26732
6266697|NCT00047385|7165841|FG000|COMPLETED|Overall Study|Had at least one screening exam.|26455
6266698|NCT00047385|7165842|FG001|COMPLETED|Overall Study||26232
6266699|NCT00047385|7165841|FG000|NOT COMPLETED|Overall Study||267
6266700|NCT00047385|7165842|FG001|NOT COMPLETED|Overall Study||500
6266701|NCT00047463|7165850|FG000|STARTED|Overall Study||13
6266702|NCT00047463|7165851|FG001|STARTED|Overall Study||22
6266703|NCT00047463|7165850|FG000|COMPLETED|Overall Study||13
6266704|NCT00047463|7165851|FG001|COMPLETED|Overall Study||19
6266705|NCT00047463|7165850|FG000|NOT COMPLETED|Overall Study||0
6266706|NCT00047463|7165851|FG001|NOT COMPLETED|Overall Study||3
6266707|NCT00047619|7165862|FG000|STARTED|Overall Study||14
6266708|NCT00047619|7165863|FG001|STARTED|Overall Study||14
6266709|NCT00047619|7165862|FG000|COMPLETED|Overall Study||14
6266710|NCT00047619|7165863|FG001|COMPLETED|Overall Study||14
6266711|NCT00047619|7165862|FG000|NOT COMPLETED|Overall Study||0
6266712|NCT00047619|7165863|FG001|NOT COMPLETED|Overall Study||0
6266713|NCT00047697|7165871|FG000|STARTED|Overall Study||18
6266714|NCT00047697|7165872|FG001|STARTED|Overall Study||16
6266715|NCT00047697|7165871|FG000|COMPLETED|Overall Study||18
6266716|NCT00047697|7165872|FG001|COMPLETED|Overall Study||14
6266717|NCT00047697|7165871|FG000|NOT COMPLETED|Overall Study||0
6266718|NCT00047697|7165872|FG001|NOT COMPLETED|Overall Study||2
6266719|NCT00047879|7165881|FG000|STARTED|Overall Study||4
6266720|NCT00047879|7165882|FG001|STARTED|Overall Study||3
6266721|NCT00047879|7165881|FG000|COMPLETED|Overall Study||0
6266722|NCT00047879|7165882|FG001|COMPLETED|Overall Study||0
6266723|NCT00047879|7165881|FG000|NOT COMPLETED|Overall Study||4
6266724|NCT00047879|7165882|FG001|NOT COMPLETED|Overall Study||3
6266725|NCT00048035|7165894|FG000|STARTED|Core Period||15
6266726|NCT00048035|7165895|FG001|STARTED|Core Period||15
6266727|NCT00048035|7165896|FG002|STARTED|Core Period||15
6266728|NCT00048035|7165897|FG003|STARTED|Core Period||15
6266729|NCT00048035|7165898|FG004|STARTED|Core Period||16
6266730|NCT00048035|7165899|FG005|STARTED|Core Period||15
6266731|NCT00048035|7165900|FG006|STARTED|Core Period||0
6266732|NCT00048035|7165901|FG007|STARTED|Core Period||0
6266733|NCT00048035|7165894|FG000|COMPLETED|Core Period||11
6266734|NCT00048035|7165895|FG001|COMPLETED|Core Period||13
6266735|NCT00048035|7165896|FG002|COMPLETED|Core Period||14
6266736|NCT00048035|7165897|FG003|COMPLETED|Core Period||14
6266737|NCT00048035|7165898|FG004|COMPLETED|Core Period||15
6266738|NCT00048035|7165899|FG005|COMPLETED|Core Period||14
6266739|NCT00048035|7165900|FG006|COMPLETED|Core Period||0
6266740|NCT00048035|7165901|FG007|COMPLETED|Core Period||0
6266741|NCT00048035|7165894|FG000|NOT COMPLETED|Core Period||4
6266742|NCT00048035|7165895|FG001|NOT COMPLETED|Core Period||2
6266743|NCT00048035|7165896|FG002|NOT COMPLETED|Core Period||1
6266744|NCT00048035|7165897|FG003|NOT COMPLETED|Core Period||1
6266745|NCT00048035|7165898|FG004|NOT COMPLETED|Core Period||1
6266746|NCT00048035|7165899|FG005|NOT COMPLETED|Core Period||1
6266747|NCT00048035|7165900|FG006|NOT COMPLETED|Core Period||0
6266748|NCT00048035|7165901|FG007|NOT COMPLETED|Core Period||0
6266749|NCT00048035|7165894|FG000|STARTED|Extension Year 1||0
6266750|NCT00048035|7165895|FG001|STARTED|Extension Year 1||0
6266751|NCT00048035|7165896|FG002|STARTED|Extension Year 1||0
6266752|NCT00048035|7165897|FG003|STARTED|Extension Year 1||0
6266753|NCT00048035|7165898|FG004|STARTED|Extension Year 1||0
6266754|NCT00048035|7165899|FG005|STARTED|Extension Year 1||0
6266755|NCT00048035|7165900|FG006|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
6266756|NCT00048035|7165901|FG007|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
6266757|NCT00048035|7165894|FG000|COMPLETED|Extension Year 1||0
6266758|NCT00048035|7165895|FG001|COMPLETED|Extension Year 1||0
6266759|NCT00048035|7165896|FG002|COMPLETED|Extension Year 1||0
6266760|NCT00048035|7165897|FG003|COMPLETED|Extension Year 1||0
6266761|NCT00048035|7165898|FG004|COMPLETED|Extension Year 1||0
6266762|NCT00048035|7165899|FG005|COMPLETED|Extension Year 1||0
6266763|NCT00048035|7165900|FG006|COMPLETED|Extension Year 1||16
6266764|NCT00048035|7165901|FG007|COMPLETED|Extension Year 1||15
6266765|NCT00048035|7165894|FG000|NOT COMPLETED|Extension Year 1||0
6266766|NCT00048035|7165895|FG001|NOT COMPLETED|Extension Year 1||0
6266767|NCT00048035|7165896|FG002|NOT COMPLETED|Extension Year 1||0
6266768|NCT00048035|7165897|FG003|NOT COMPLETED|Extension Year 1||0
6266769|NCT00048035|7165898|FG004|NOT COMPLETED|Extension Year 1||0
6266770|NCT00048035|7165899|FG005|NOT COMPLETED|Extension Year 1||0
6266771|NCT00048035|7165900|FG006|NOT COMPLETED|Extension Year 1||11
6266772|NCT00048035|7165901|FG007|NOT COMPLETED|Extension Year 1||11
6266773|NCT00048035|7165894|FG000|STARTED|Extension Year 2||0
6266774|NCT00048035|7165895|FG001|STARTED|Extension Year 2||0
6266775|NCT00048035|7165896|FG002|STARTED|Extension Year 2||0
6266776|NCT00048035|7165897|FG003|STARTED|Extension Year 2||0
6266777|NCT00048035|7165898|FG004|STARTED|Extension Year 2||0
6266778|NCT00048035|7165899|FG005|STARTED|Extension Year 2||0
6266779|NCT00048035|7165900|FG006|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
6266780|NCT00048035|7165901|FG007|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
6266781|NCT00048035|7165894|FG000|COMPLETED|Extension Year 2||0
6266782|NCT00048035|7165895|FG001|COMPLETED|Extension Year 2||0
6266783|NCT00048035|7165896|FG002|COMPLETED|Extension Year 2||0
6266784|NCT00048035|7165897|FG003|COMPLETED|Extension Year 2||0
6266785|NCT00048035|7165898|FG004|COMPLETED|Extension Year 2||0
6266786|NCT00048035|7165899|FG005|COMPLETED|Extension Year 2||0
6266787|NCT00048035|7165900|FG006|COMPLETED|Extension Year 2||11
6266788|NCT00048035|7165901|FG007|COMPLETED|Extension Year 2||10
6266789|NCT00048035|7165894|FG000|NOT COMPLETED|Extension Year 2||0
6266790|NCT00048035|7165895|FG001|NOT COMPLETED|Extension Year 2||0
6266791|NCT00048035|7165896|FG002|NOT COMPLETED|Extension Year 2||0
6266792|NCT00048035|7165897|FG003|NOT COMPLETED|Extension Year 2||0
6266793|NCT00048035|7165898|FG004|NOT COMPLETED|Extension Year 2||0
6266794|NCT00048035|7165899|FG005|NOT COMPLETED|Extension Year 2||0
6266795|NCT00048035|7165900|FG006|NOT COMPLETED|Extension Year 2||3
6266796|NCT00048035|7165901|FG007|NOT COMPLETED|Extension Year 2||3
6266797|NCT00048048|7165925|FG000|STARTED|Core Treatment||6
6266798|NCT00048048|7165926|FG001|STARTED|Core Treatment||6
6266799|NCT00048048|7165927|FG002|STARTED|Core Treatment||10
6266800|NCT00048048|7165928|FG003|STARTED|Core Treatment||6
6266801|NCT00048048|7165929|FG004|STARTED|Core Treatment||6
6266802|NCT00048048|7165930|FG005|STARTED|Core Treatment||9
6266803|NCT00048048|7165931|FG006|STARTED|Core Treatment||6
6266804|NCT00048048|7165932|FG007|STARTED|Core Treatment||6
6266805|NCT00048048|7165933|FG008|STARTED|Core Treatment||10
6266806|NCT00048048|7165934|FG009|STARTED|Core Treatment||0
6266807|NCT00048048|7165935|FG010|STARTED|Core Treatment||0
6266808|NCT00048048|7165936|FG011|STARTED|Core Treatment||0
6266809|NCT00048048|7165925|FG000|COMPLETED|Core Treatment||6
6266810|NCT00048048|7165926|FG001|COMPLETED|Core Treatment||6
6266811|NCT00048048|7165927|FG002|COMPLETED|Core Treatment||9
6266812|NCT00048048|7165928|FG003|COMPLETED|Core Treatment||6
6266813|NCT00048048|7165929|FG004|COMPLETED|Core Treatment||6
6266814|NCT00048048|7165930|FG005|COMPLETED|Core Treatment||9
6266815|NCT00048048|7165931|FG006|COMPLETED|Core Treatment||6
6266816|NCT00048048|7165932|FG007|COMPLETED|Core Treatment||5
6266817|NCT00048048|7165933|FG008|COMPLETED|Core Treatment||10
6266818|NCT00048048|7165934|FG009|COMPLETED|Core Treatment||0
6266819|NCT00048048|7165935|FG010|COMPLETED|Core Treatment||0
6266820|NCT00048048|7165936|FG011|COMPLETED|Core Treatment||0
6266821|NCT00048048|7165925|FG000|NOT COMPLETED|Core Treatment||0
6266822|NCT00048048|7165926|FG001|NOT COMPLETED|Core Treatment||0
6266823|NCT00048048|7165927|FG002|NOT COMPLETED|Core Treatment||1
6266824|NCT00048048|7165928|FG003|NOT COMPLETED|Core Treatment||0
6266825|NCT00048048|7165929|FG004|NOT COMPLETED|Core Treatment||0
6266826|NCT00048048|7165930|FG005|NOT COMPLETED|Core Treatment||0
6266827|NCT00048048|7165931|FG006|NOT COMPLETED|Core Treatment||0
6266828|NCT00048048|7165932|FG007|NOT COMPLETED|Core Treatment||1
6266829|NCT00048048|7165933|FG008|NOT COMPLETED|Core Treatment||0
6266830|NCT00048048|7165934|FG009|NOT COMPLETED|Core Treatment||0
6266831|NCT00048048|7165935|FG010|NOT COMPLETED|Core Treatment||0
6266832|NCT00048048|7165936|FG011|NOT COMPLETED|Core Treatment||0
6266833|NCT00048048|7165925|FG000|STARTED|Extension Year 1||0
6266834|NCT00048048|7165926|FG001|STARTED|Extension Year 1||0
6266835|NCT00048048|7165927|FG002|STARTED|Extension Year 1||0
6266836|NCT00048048|7165928|FG003|STARTED|Extension Year 1||0
6266837|NCT00048048|7165929|FG004|STARTED|Extension Year 1||0
6266838|NCT00048048|7165930|FG005|STARTED|Extension Year 1||0
6266839|NCT00048048|7165931|FG006|STARTED|Extension Year 1||0
6266840|NCT00048048|7165932|FG007|STARTED|Extension Year 1||0
6266841|NCT00048048|7165933|FG008|STARTED|Extension Year 1||0
6266842|NCT00048048|7165934|FG009|STARTED|Extension Year 1|Participants (Cohorts 1, 2, and 3) who completed core, entered extension period (entry optional).|16
6266843|NCT00048048|7165935|FG010|STARTED|Extension Year 1|Participants (Cohorts 4, 5, and 6) who completed core, entered extension period (entry optional).|16
6266844|NCT00048048|7165936|FG011|STARTED|Extension Year 1|Participants (Cohorts 7, 8, and 9) who completed core, entered extension period (entry optional).|19
6266845|NCT00048048|7165925|FG000|COMPLETED|Extension Year 1||0
6266846|NCT00048048|7165926|FG001|COMPLETED|Extension Year 1||0
6266847|NCT00048048|7165927|FG002|COMPLETED|Extension Year 1||0
6266848|NCT00048048|7165928|FG003|COMPLETED|Extension Year 1||0
6266849|NCT00048048|7165929|FG004|COMPLETED|Extension Year 1||0
6266850|NCT00048048|7165930|FG005|COMPLETED|Extension Year 1||0
6266851|NCT00048048|7165931|FG006|COMPLETED|Extension Year 1||0
6266852|NCT00048048|7165932|FG007|COMPLETED|Extension Year 1||0
6266853|NCT00048048|7165933|FG008|COMPLETED|Extension Year 1||0
6266854|NCT00048048|7165934|FG009|COMPLETED|Extension Year 1||14
6266855|NCT00048048|7165935|FG010|COMPLETED|Extension Year 1||14
6266856|NCT00048048|7165936|FG011|COMPLETED|Extension Year 1||15
6266857|NCT00048048|7165925|FG000|NOT COMPLETED|Extension Year 1||0
6266858|NCT00048048|7165926|FG001|NOT COMPLETED|Extension Year 1||0
6266859|NCT00048048|7165927|FG002|NOT COMPLETED|Extension Year 1||0
6266860|NCT00048048|7165928|FG003|NOT COMPLETED|Extension Year 1||0
6266861|NCT00048048|7165929|FG004|NOT COMPLETED|Extension Year 1||0
6266862|NCT00048048|7165930|FG005|NOT COMPLETED|Extension Year 1||0
6266863|NCT00048048|7165931|FG006|NOT COMPLETED|Extension Year 1||0
6266864|NCT00048048|7165932|FG007|NOT COMPLETED|Extension Year 1||0
6266865|NCT00048048|7165933|FG008|NOT COMPLETED|Extension Year 1||0
6266866|NCT00048048|7165934|FG009|NOT COMPLETED|Extension Year 1||2
6266867|NCT00048048|7165935|FG010|NOT COMPLETED|Extension Year 1||2
6266868|NCT00048048|7165936|FG011|NOT COMPLETED|Extension Year 1||4
6266869|NCT00048048|7165925|FG000|STARTED|Extension Year 2||0
6266870|NCT00048048|7165926|FG001|STARTED|Extension Year 2||0
6266871|NCT00048048|7165927|FG002|STARTED|Extension Year 2||0
6266872|NCT00048048|7165928|FG003|STARTED|Extension Year 2||0
6266873|NCT00048048|7165929|FG004|STARTED|Extension Year 2||0
6266874|NCT00048048|7165930|FG005|STARTED|Extension Year 2||0
6266875|NCT00048048|7165931|FG006|STARTED|Extension Year 2||0
6266876|NCT00048048|7165932|FG007|STARTED|Extension Year 2||0
6266877|NCT00048048|7165933|FG008|STARTED|Extension Year 2||0
6266878|NCT00048048|7165934|FG009|STARTED|Extension Year 2|Twelve participants who completed Extension Year 1 were switched to RO0503821 (1x/2Week).|2
6266879|NCT00048048|7165935|FG010|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1 + 12 participants from RO0503821 (1X/Week).|23
6266880|NCT00048048|7165936|FG011|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|15
6266881|NCT00048048|7165925|FG000|COMPLETED|Extension Year 2||0
6266882|NCT00048048|7165926|FG001|COMPLETED|Extension Year 2||0
6266883|NCT00048048|7165927|FG002|COMPLETED|Extension Year 2||0
6266884|NCT00048048|7165928|FG003|COMPLETED|Extension Year 2||0
6266885|NCT00048048|7165929|FG004|COMPLETED|Extension Year 2||0
6266886|NCT00048048|7165930|FG005|COMPLETED|Extension Year 2||0
6266887|NCT00048048|7165931|FG006|COMPLETED|Extension Year 2||0
6266888|NCT00048048|7165932|FG007|COMPLETED|Extension Year 2||0
6266889|NCT00048048|7165933|FG008|COMPLETED|Extension Year 2||0
6266890|NCT00048048|7165934|FG009|COMPLETED|Extension Year 2||2
6266891|NCT00048048|7165935|FG010|COMPLETED|Extension Year 2||19
6266892|NCT00048048|7165936|FG011|COMPLETED|Extension Year 2||13
6266893|NCT00048048|7165925|FG000|NOT COMPLETED|Extension Year 2||0
6266894|NCT00048048|7165926|FG001|NOT COMPLETED|Extension Year 2||0
6266895|NCT00048048|7165927|FG002|NOT COMPLETED|Extension Year 2||0
6266896|NCT00048048|7165928|FG003|NOT COMPLETED|Extension Year 2||0
6266897|NCT00048048|7165929|FG004|NOT COMPLETED|Extension Year 2||0
6266898|NCT00048048|7165930|FG005|NOT COMPLETED|Extension Year 2||0
6266899|NCT00048048|7165931|FG006|NOT COMPLETED|Extension Year 2||0
6266900|NCT00048048|7165932|FG007|NOT COMPLETED|Extension Year 2||0
6266901|NCT00048048|7165933|FG008|NOT COMPLETED|Extension Year 2||0
6266902|NCT00048048|7165934|FG009|NOT COMPLETED|Extension Year 2||0
6266903|NCT00048048|7165935|FG010|NOT COMPLETED|Extension Year 2||4
6266904|NCT00048048|7165936|FG011|NOT COMPLETED|Extension Year 2||2
6266905|NCT00048061|7165967|FG000|STARTED|Overall Study||400
6266906|NCT00048061|7165968|FG001|STARTED|Overall Study||401
6266907|NCT00048061|7165969|FG002|STARTED|Overall Study||400
6266908|NCT00048061|7165970|FG003|STARTED|Overall Study||401
6266909|NCT00048061|7165967|FG000|COMPLETED|Overall Study||325
6266910|NCT00048061|7165968|FG001|COMPLETED|Overall Study||328
6266911|NCT00048061|7165969|FG002|COMPLETED|Overall Study||316
6266912|NCT00048061|7165970|FG003|COMPLETED|Overall Study||322
6266913|NCT00048061|7165967|FG000|NOT COMPLETED|Overall Study||75
6266914|NCT00048061|7165968|FG001|NOT COMPLETED|Overall Study||73
6266915|NCT00048061|7165969|FG002|NOT COMPLETED|Overall Study||84
6266916|NCT00048061|7165970|FG003|NOT COMPLETED|Overall Study||79
6266917|NCT00048074|7165983|FG000|STARTED|Overall Study||465
6266918|NCT00048074|7165984|FG001|STARTED|Overall Study||448
6266919|NCT00048074|7165985|FG002|STARTED|Overall Study||469
6266920|NCT00048074|7165983|FG000|COMPLETED|Overall Study||384
6266921|NCT00048074|7165984|FG001|COMPLETED|Overall Study||361
6266922|NCT00048074|7165985|FG002|COMPLETED|Overall Study||372
6266923|NCT00048074|7165983|FG000|NOT COMPLETED|Overall Study||81
6266924|NCT00048074|7165984|FG001|NOT COMPLETED|Overall Study||87
6266925|NCT00048074|7165985|FG002|NOT COMPLETED|Overall Study||97
6266926|NCT00048165|7165995|FG000|STARTED|Completed 6 Months Study||216
6266927|NCT00048165|7165996|FG001|STARTED|Completed 6 Months Study||218
6266928|NCT00048165|7165995|FG000|COMPLETED|Completed 6 Months Study||165
6266929|NCT00048165|7165996|FG001|COMPLETED|Completed 6 Months Study||170
6266930|NCT00048165|7165995|FG000|NOT COMPLETED|Completed 6 Months Study||51
6266931|NCT00048165|7165996|FG001|NOT COMPLETED|Completed 6 Months Study||48
6266932|NCT00048165|7165995|FG000|STARTED|Completed 12 Months Study||165
6266933|NCT00048165|7165996|FG001|STARTED|Completed 12 Months Study||170
6266934|NCT00048165|7165995|FG000|COMPLETED|Completed 12 Months Study||162
6266935|NCT00048165|7165996|FG001|COMPLETED|Completed 12 Months Study||167
6266936|NCT00048165|7165995|FG000|NOT COMPLETED|Completed 12 Months Study||3
6266937|NCT00048165|7165996|FG001|NOT COMPLETED|Completed 12 Months Study||3
6266938|NCT00048347|7166004|FG000|STARTED|Overall Study||18
6266939|NCT00048347|7166004|FG000|COMPLETED|Overall Study||16
6266940|NCT00048347|7166004|FG000|NOT COMPLETED|Overall Study||2
6266941|NCT00048542|7166012|FG000|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
6266942|NCT00048542|7166013|FG001|STARTED|Double-Blind Phase||37
6266943|NCT00048542|7166014|FG002|STARTED|Double-Blind Phase||30
6266944|NCT00048542|7166015|FG003|STARTED|Double-Blind Phase||28
6266945|NCT00048542|7166016|FG004|STARTED|Double-Blind Phase||0
6266946|NCT00048542|7166017|FG005|STARTED|Double-Blind Phase||0
6266947|NCT00048542|7166018|FG006|STARTED|Double-Blind Phase||0
6266948|NCT00048542|7166019|FG007|STARTED|Double-Blind Phase||0
6266949|NCT00048542|7166012|FG000|COMPLETED|Double-Blind Phase||35
6266950|NCT00048542|7166013|FG001|COMPLETED|Double-Blind Phase||36
6266951|NCT00048542|7166014|FG002|COMPLETED|Double-Blind Phase||29
6266952|NCT00048542|7166015|FG003|COMPLETED|Double-Blind Phase||28
6266953|NCT00048542|7166016|FG004|COMPLETED|Double-Blind Phase||0
6266954|NCT00048542|7166017|FG005|COMPLETED|Double-Blind Phase||0
6266955|NCT00048542|7166018|FG006|COMPLETED|Double-Blind Phase||0
6266956|NCT00048542|7166019|FG007|COMPLETED|Double-Blind Phase||0
6266957|NCT00048542|7166012|FG000|NOT COMPLETED|Double-Blind Phase||3
6266958|NCT00048542|7166013|FG001|NOT COMPLETED|Double-Blind Phase||1
6266959|NCT00048542|7166014|FG002|NOT COMPLETED|Double-Blind Phase||1
6266960|NCT00048542|7166015|FG003|NOT COMPLETED|Double-Blind Phase||0
6266961|NCT00048542|7166016|FG004|NOT COMPLETED|Double-Blind Phase||0
6266962|NCT00048542|7166017|FG005|NOT COMPLETED|Double-Blind Phase||0
6266963|NCT00048542|7166018|FG006|NOT COMPLETED|Double-Blind Phase||0
6266964|NCT00048542|7166019|FG007|NOT COMPLETED|Double-Blind Phase||0
6266965|NCT00048542|7166012|FG000|STARTED|Open-Label Extension BSA Phase||0
6266966|NCT00048542|7166013|FG001|STARTED|Open-Label Extension BSA Phase||0
6266967|NCT00048542|7166014|FG002|STARTED|Open-Label Extension BSA Phase||0
6266968|NCT00048542|7166015|FG003|STARTED|Open-Label Extension BSA Phase||0
6266969|NCT00048542|7166016|FG004|STARTED|Open-Label Extension BSA Phase||71
6266970|NCT00048542|7166017|FG005|STARTED|Open-Label Extension BSA Phase||57
6266971|NCT00048542|7166018|FG006|STARTED|Open-Label Extension BSA Phase||0
6266972|NCT00048542|7166019|FG007|STARTED|Open-Label Extension BSA Phase||0
6266973|NCT00048542|7166012|FG000|COMPLETED|Open-Label Extension BSA Phase||0
6266974|NCT00048542|7166013|FG001|COMPLETED|Open-Label Extension BSA Phase||0
6266975|NCT00048542|7166014|FG002|COMPLETED|Open-Label Extension BSA Phase||0
6266976|NCT00048542|7166015|FG003|COMPLETED|Open-Label Extension BSA Phase||0
6266977|NCT00048542|7166016|FG004|COMPLETED|Open-Label Extension BSA Phase||59
6266978|NCT00048542|7166017|FG005|COMPLETED|Open-Label Extension BSA Phase||47
6266979|NCT00048542|7166018|FG006|COMPLETED|Open-Label Extension BSA Phase||0
6266980|NCT00048542|7166019|FG007|COMPLETED|Open-Label Extension BSA Phase||0
6266981|NCT00048542|7166012|FG000|NOT COMPLETED|Open-Label Extension BSA Phase||0
6266982|NCT00048542|7166013|FG001|NOT COMPLETED|Open-Label Extension BSA Phase||0
6266983|NCT00048542|7166014|FG002|NOT COMPLETED|Open-Label Extension BSA Phase||0
6266984|NCT00048542|7166015|FG003|NOT COMPLETED|Open-Label Extension BSA Phase||0
6266985|NCT00048542|7166016|FG004|NOT COMPLETED|Open-Label Extension BSA Phase||12
6266986|NCT00048542|7166017|FG005|NOT COMPLETED|Open-Label Extension BSA Phase||10
6266987|NCT00048542|7166018|FG006|NOT COMPLETED|Open-Label Extension BSA Phase||0
6266988|NCT00048542|7166019|FG007|NOT COMPLETED|Open-Label Extension BSA Phase||0
6266989|NCT00048542|7166012|FG000|STARTED|Open-Label Extension Fixed Dose Phase||0
6266990|NCT00048542|7166013|FG001|STARTED|Open-Label Extension Fixed Dose Phase||0
6266991|NCT00048542|7166014|FG002|STARTED|Open-Label Extension Fixed Dose Phase||0
6266992|NCT00048542|7166015|FG003|STARTED|Open-Label Extension Fixed Dose Phase||0
6266993|NCT00048542|7166016|FG004|STARTED|Open-Label Extension Fixed Dose Phase||0
6266994|NCT00048542|7166017|FG005|STARTED|Open-Label Extension Fixed Dose Phase||0
6266995|NCT00048542|7166018|FG006|STARTED|Open-Label Extension Fixed Dose Phase||59
6266996|NCT00048542|7166019|FG007|STARTED|Open-Label Extension Fixed Dose Phase||47
6266997|NCT00048542|7166012|FG000|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6266998|NCT00048542|7166013|FG001|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6266999|NCT00048542|7166014|FG002|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267000|NCT00048542|7166015|FG003|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267001|NCT00048542|7166016|FG004|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267002|NCT00048542|7166017|FG005|COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267003|NCT00048542|7166018|FG006|COMPLETED|Open-Label Extension Fixed Dose Phase||37
6267004|NCT00048542|7166019|FG007|COMPLETED|Open-Label Extension Fixed Dose Phase||25
6267005|NCT00048542|7166012|FG000|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267006|NCT00048542|7166013|FG001|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267007|NCT00048542|7166014|FG002|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267008|NCT00048542|7166015|FG003|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267009|NCT00048542|7166016|FG004|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267010|NCT00048542|7166017|FG005|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
6267011|NCT00048542|7166018|FG006|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
6267012|NCT00048542|7166019|FG007|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
6267013|NCT00048568|7166050|FG000|STARTED|Double-Blind Period Days 1 to 169||433
6267014|NCT00048568|7166051|FG001|STARTED|Double-Blind Period Days 1 to 169||219
6267015|NCT00048568|7166052|FG002|STARTED|Double-Blind Period Days 1 to 169||0
6267016|NCT00048568|7166050|FG000|COMPLETED|Double-Blind Period Days 1 to 169||401
6267017|NCT00048568|7166051|FG001|COMPLETED|Double-Blind Period Days 1 to 169||174
6267018|NCT00048568|7166052|FG002|COMPLETED|Double-Blind Period Days 1 to 169||0
6267019|NCT00048568|7166050|FG000|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
6267020|NCT00048568|7166051|FG001|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
6603025|NCT02059291|7527976|FG017|STARTED|Epoch 3||0
6603026|NCT02059291|7527977|FG018|STARTED|Epoch 3||0
6603027|NCT02059291|7527978|FG019|STARTED|Epoch 3||0
6603028|NCT02059291|7527979|FG020|STARTED|Epoch 3||0
6603029|NCT02059291|7527980|FG021|STARTED|Epoch 3||0
6603030|NCT02059291|7527981|FG022|STARTED|Epoch 3||0
6603031|NCT02059291|7527982|FG023|STARTED|Epoch 3||0
6603032|NCT02059291|7527983|FG024|STARTED|Epoch 3||0
6603033|NCT02059291|7527959|FG000|COMPLETED|Epoch 3||0
6603034|NCT02059291|7527960|FG001|COMPLETED|Epoch 3||0
6603035|NCT02059291|7527961|FG002|COMPLETED|Epoch 3||0
6603036|NCT02059291|7527962|FG003|COMPLETED|Epoch 3||0
6603037|NCT02059291|7527963|FG004|COMPLETED|Epoch 3||0
6603038|NCT02059291|7527964|FG005|COMPLETED|Epoch 3||0
6603039|NCT02059291|7527965|FG006|COMPLETED|Epoch 3||2
6603040|NCT02059291|7527966|FG007|COMPLETED|Epoch 3||1
6603041|NCT02059291|7527967|FG008|COMPLETED|Epoch 3||0
6603042|NCT02059291|7527968|FG009|COMPLETED|Epoch 3||9
6267021|NCT00048568|7166052|FG002|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
6267022|NCT00048568|7166050|FG000|STARTED|Double-Blind Period Days 170 to 365||401
6267023|NCT00048568|7166051|FG001|STARTED|Double-Blind Period Days 170 to 365||174
6267024|NCT00048568|7166052|FG002|STARTED|Double-Blind Period Days 170 to 365||0
6267025|NCT00048568|7166050|FG000|COMPLETED|Double-Blind Period Days 170 to 365||385
6267026|NCT00048568|7166051|FG001|COMPLETED|Double-Blind Period Days 170 to 365||162
6267027|NCT00048568|7166052|FG002|COMPLETED|Double-Blind Period Days 170 to 365||0
6267028|NCT00048568|7166050|FG000|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
6267029|NCT00048568|7166051|FG001|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
6267030|NCT00048568|7166052|FG002|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
6267031|NCT00048568|7166050|FG000|STARTED|Open-Label Period||0
6267032|NCT00048568|7166051|FG001|STARTED|Open-Label Period||0
6267033|NCT00048568|7166052|FG002|STARTED|Open-Label Period||539
6267034|NCT00048568|7166050|FG000|COMPLETED|Open-Label Period||0
6267035|NCT00048568|7166051|FG001|COMPLETED|Open-Label Period||0
6267036|NCT00048568|7166052|FG002|COMPLETED|Open-Label Period||379
6267037|NCT00048568|7166050|FG000|NOT COMPLETED|Open-Label Period||0
6267038|NCT00048568|7166051|FG001|NOT COMPLETED|Open-Label Period||0
6267039|NCT00048568|7166052|FG002|NOT COMPLETED|Open-Label Period||160
6267040|NCT00048581|7166075|FG000|STARTED|Double-Blind Period||258
6267041|NCT00048581|7166076|FG001|STARTED|Double-Blind Period||133
6267042|NCT00048581|7166077|FG002|STARTED|Double-Blind Period||0
6267043|NCT00048581|7166075|FG000|COMPLETED|Double-Blind Period||223
6267044|NCT00048581|7166076|FG001|COMPLETED|Double-Blind Period||99
6267045|NCT00048581|7166077|FG002|COMPLETED|Double-Blind Period||0
6267046|NCT00048581|7166075|FG000|NOT COMPLETED|Double-Blind Period||35
6267047|NCT00048581|7166076|FG001|NOT COMPLETED|Double-Blind Period||34
6267048|NCT00048581|7166077|FG002|NOT COMPLETED|Double-Blind Period||0
6267049|NCT00048581|7166075|FG000|STARTED|Open-Label Period||0
6267050|NCT00048581|7166076|FG001|STARTED|Open-Label Period||0
6267051|NCT00048581|7166077|FG002|STARTED|Open-Label Period||317
6267052|NCT00048581|7166075|FG000|COMPLETED|Open-Label Period||0
6267053|NCT00048581|7166076|FG001|COMPLETED|Open-Label Period||0
6267054|NCT00048581|7166077|FG002|COMPLETED|Open-Label Period||150
6267055|NCT00048581|7166075|FG000|NOT COMPLETED|Open-Label Period||0
6267056|NCT00048581|7166076|FG001|NOT COMPLETED|Open-Label Period||0
6267057|NCT00048581|7166077|FG002|NOT COMPLETED|Open-Label Period||167
6267058|NCT00048724|7166092|FG000|STARTED|Overall Study||311
6267059|NCT00048724|7166093|FG001|STARTED|Overall Study||315
6267060|NCT00048724|7166092|FG000|COMPLETED|Overall Study||195
6267061|NCT00048724|7166093|FG001|COMPLETED|Overall Study||197
6267062|NCT00048724|7166092|FG000|NOT COMPLETED|Overall Study||116
6267063|NCT00048724|7166093|FG001|NOT COMPLETED|Overall Study||118
6267064|NCT00048737|7166099|FG000|STARTED|Overall Study||70
6267065|NCT00048737|7166099|FG000|COMPLETED|Overall Study||70
6267066|NCT00048737|7166099|FG000|NOT COMPLETED|Overall Study||0
6267067|NCT00048815|7166106|FG000|STARTED|Overall Study||24
6267068|NCT00048815|7166107|FG001|STARTED|Overall Study||26
6267069|NCT00048815|7166108|FG002|STARTED|Overall Study||23
6267070|NCT00048815|7166106|FG000|COMPLETED|Overall Study||18
6267071|NCT00048815|7166107|FG001|COMPLETED|Overall Study||22
6267072|NCT00048815|7166108|FG002|COMPLETED|Overall Study||19
6267073|NCT00048815|7166106|FG000|NOT COMPLETED|Overall Study||6
6267074|NCT00048815|7166107|FG001|NOT COMPLETED|Overall Study||4
6267075|NCT00048815|7166108|FG002|NOT COMPLETED|Overall Study||4
6267076|NCT00048893|7166116|FG000|STARTED|Overall Study||37
6267077|NCT00048893|7166116|FG000|COMPLETED|Overall Study||37
6267078|NCT00048893|7166116|FG000|NOT COMPLETED|Overall Study||0
6267079|NCT00048932|7166122|FG000|STARTED|Double Blind Period (DB)|Number Treated|959
6267080|NCT00048932|7166123|FG001|STARTED|Double Blind Period (DB)|Number Treated|482
6267081|NCT00048932|7166124|FG002|STARTED|Double Blind Period (DB)||0
6267082|NCT00048932|7166122|FG000|COMPLETED|Double Blind Period (DB)||836
6267083|NCT00048932|7166123|FG001|COMPLETED|Double Blind Period (DB)||395
6267084|NCT00048932|7166124|FG002|COMPLETED|Double Blind Period (DB)||0
6267085|NCT00048932|7166122|FG000|NOT COMPLETED|Double Blind Period (DB)||123
6267086|NCT00048932|7166123|FG001|NOT COMPLETED|Double Blind Period (DB)||87
6267087|NCT00048932|7166124|FG002|NOT COMPLETED|Double Blind Period (DB)||0
6267088|NCT00048932|7166122|FG000|STARTED|Open Label Period (OL)||0
6267089|NCT00048932|7166123|FG001|STARTED|Open Label Period (OL)||0
6267090|NCT00048932|7166124|FG002|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
6267091|NCT00048932|7166122|FG000|COMPLETED|Open Label Period (OL)||0
6267092|NCT00048932|7166123|FG001|COMPLETED|Open Label Period (OL)||0
6267093|NCT00048932|7166124|FG002|COMPLETED|Open Label Period (OL)||743
6267094|NCT00048932|7166122|FG000|NOT COMPLETED|Open Label Period (OL)||0
6267095|NCT00048932|7166123|FG001|NOT COMPLETED|Open Label Period (OL)||0
6267096|NCT00048932|7166124|FG002|NOT COMPLETED|Open Label Period (OL)||441
6267097|NCT00048997|7166135|FG000|STARTED|Overall Study||176
6267098|NCT00048997|7166136|FG001|STARTED|Overall Study||180
6267099|NCT00048997|7166135|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
6267100|NCT00048997|7166136|FG001|COMPLETED|Overall Study||177
6267101|NCT00048997|7166135|FG000|NOT COMPLETED|Overall Study||13
6267102|NCT00048997|7166136|FG001|NOT COMPLETED|Overall Study||3
6267103|NCT00049036|7166143|FG000|STARTED|Overall Study||51
6267104|NCT00049036|7166144|FG001|STARTED|Overall Study||55
6267105|NCT00049036|7166143|FG000|COMPLETED|Overall Study||51
6267106|NCT00049036|7166144|FG001|COMPLETED|Overall Study||55
6267107|NCT00049036|7166143|FG000|NOT COMPLETED|Overall Study||0
6267108|NCT00049036|7166144|FG001|NOT COMPLETED|Overall Study||0
6267109|NCT00049127|7166155|FG000|STARTED|Overall Study||12
6267110|NCT00049127|7166156|FG001|STARTED|Overall Study||0
6267111|NCT00049127|7166157|FG002|STARTED|Overall Study||40
6267112|NCT00049127|7166158|FG003|STARTED|Overall Study||0
6603043|NCT02059291|7527969|FG010|COMPLETED|Epoch 3||10
6603044|NCT02059291|7527970|FG011|COMPLETED|Epoch 3||6
6603045|NCT02059291|7527971|FG012|COMPLETED|Epoch 3||7
6603046|NCT02059291|7527972|FG013|COMPLETED|Epoch 3||3
6603047|NCT02059291|7527973|FG014|COMPLETED|Epoch 3||5
6603048|NCT02059291|7527974|FG015|COMPLETED|Epoch 3||120
6603049|NCT02059291|7527975|FG016|COMPLETED|Epoch 3||0
6603050|NCT02059291|7527976|FG017|COMPLETED|Epoch 3||0
6603051|NCT02059291|7527977|FG018|COMPLETED|Epoch 3||0
6603052|NCT02059291|7527978|FG019|COMPLETED|Epoch 3||0
6603053|NCT02059291|7527979|FG020|COMPLETED|Epoch 3||0
6603054|NCT02059291|7527980|FG021|COMPLETED|Epoch 3||0
6603055|NCT02059291|7527981|FG022|COMPLETED|Epoch 3||0
6603056|NCT02059291|7527982|FG023|COMPLETED|Epoch 3||0
6603057|NCT02059291|7527983|FG024|COMPLETED|Epoch 3||0
6603058|NCT02059291|7527959|FG000|NOT COMPLETED|Epoch 3||0
6603059|NCT02059291|7527960|FG001|NOT COMPLETED|Epoch 3||0
6603060|NCT02059291|7527961|FG002|NOT COMPLETED|Epoch 3||0
6603061|NCT02059291|7527962|FG003|NOT COMPLETED|Epoch 3||0
6603062|NCT02059291|7527963|FG004|NOT COMPLETED|Epoch 3||0
6603063|NCT02059291|7527964|FG005|NOT COMPLETED|Epoch 3||0
6603064|NCT02059291|7527965|FG006|NOT COMPLETED|Epoch 3||0
6603065|NCT02059291|7527966|FG007|NOT COMPLETED|Epoch 3||0
6603066|NCT02059291|7527967|FG008|NOT COMPLETED|Epoch 3||0
6603067|NCT02059291|7527968|FG009|NOT COMPLETED|Epoch 3||0
6603068|NCT02059291|7527969|FG010|NOT COMPLETED|Epoch 3||0
6603069|NCT02059291|7527970|FG011|NOT COMPLETED|Epoch 3||0
6603070|NCT02059291|7527971|FG012|NOT COMPLETED|Epoch 3||0
6603071|NCT02059291|7527972|FG013|NOT COMPLETED|Epoch 3||1
6603072|NCT02059291|7527973|FG014|NOT COMPLETED|Epoch 3||0
6603073|NCT02059291|7527974|FG015|NOT COMPLETED|Epoch 3||6
6603074|NCT02059291|7527975|FG016|NOT COMPLETED|Epoch 3||0
6603075|NCT02059291|7527976|FG017|NOT COMPLETED|Epoch 3||0
6603076|NCT02059291|7527977|FG018|NOT COMPLETED|Epoch 3||0
6603077|NCT02059291|7527978|FG019|NOT COMPLETED|Epoch 3||0
6603078|NCT02059291|7527979|FG020|NOT COMPLETED|Epoch 3||0
6603079|NCT02059291|7527980|FG021|NOT COMPLETED|Epoch 3||0
6603080|NCT02059291|7527981|FG022|NOT COMPLETED|Epoch 3||0
6603081|NCT02059291|7527982|FG023|NOT COMPLETED|Epoch 3||0
6603082|NCT02059291|7527983|FG024|NOT COMPLETED|Epoch 3||0
6603083|NCT02059291|7527959|FG000|STARTED|Epoch 4||0
6603084|NCT02059291|7527960|FG001|STARTED|Epoch 4||0
6603085|NCT02059291|7527961|FG002|STARTED|Epoch 4||0
6603086|NCT02059291|7527962|FG003|STARTED|Epoch 4||0
6603087|NCT02059291|7527963|FG004|STARTED|Epoch 4||0
6603088|NCT02059291|7527964|FG005|STARTED|Epoch 4||0
6603089|NCT02059291|7527965|FG006|STARTED|Epoch 4||0
6603090|NCT02059291|7527966|FG007|STARTED|Epoch 4||0
6603091|NCT02059291|7527967|FG008|STARTED|Epoch 4||0
6603092|NCT02059291|7527968|FG009|STARTED|Epoch 4||0
6603093|NCT02059291|7527969|FG010|STARTED|Epoch 4||0
6603094|NCT02059291|7527970|FG011|STARTED|Epoch 4||0
6603095|NCT02059291|7527971|FG012|STARTED|Epoch 4||0
6603096|NCT02059291|7527972|FG013|STARTED|Epoch 4||0
6603097|NCT02059291|7527973|FG014|STARTED|Epoch 4||0
6603098|NCT02059291|7527974|FG015|STARTED|Epoch 4||0
6603099|NCT02059291|7527975|FG016|STARTED|Epoch 4||43
6603100|NCT02059291|7527976|FG017|STARTED|Epoch 4||14
6603101|NCT02059291|7527977|FG018|STARTED|Epoch 4||2
6603102|NCT02059291|7527978|FG019|STARTED|Epoch 4||18
6603103|NCT02059291|7527979|FG020|STARTED|Epoch 4||34
6603104|NCT02059291|7527980|FG021|STARTED|Epoch 4||14
6603105|NCT02059291|7527981|FG022|STARTED|Epoch 4||31
6603106|NCT02059291|7527982|FG023|STARTED|Epoch 4||22
6603107|NCT02059291|7527983|FG024|STARTED|Epoch 4||0
6603108|NCT02059291|7527959|FG000|COMPLETED|Epoch 4||0
6603109|NCT02059291|7527960|FG001|COMPLETED|Epoch 4||0
6603110|NCT02059291|7527961|FG002|COMPLETED|Epoch 4||0
6603111|NCT02059291|7527962|FG003|COMPLETED|Epoch 4||0
6603112|NCT02059291|7527963|FG004|COMPLETED|Epoch 4||0
6603113|NCT02059291|7527964|FG005|COMPLETED|Epoch 4||0
6603114|NCT02059291|7527965|FG006|COMPLETED|Epoch 4||0
6603115|NCT02059291|7527966|FG007|COMPLETED|Epoch 4||0
6603116|NCT02059291|7527967|FG008|COMPLETED|Epoch 4||0
6603117|NCT02059291|7527968|FG009|COMPLETED|Epoch 4||0
6267113|NCT00049127|7166159|FG004|STARTED|Overall Study||12
6267114|NCT00049127|7166155|FG000|COMPLETED|Overall Study||12
6267115|NCT00049127|7166156|FG001|COMPLETED|Overall Study||0
6603118|NCT02059291|7527969|FG010|COMPLETED|Epoch 4||0
6603119|NCT02059291|7527970|FG011|COMPLETED|Epoch 4||0
6603120|NCT02059291|7527971|FG012|COMPLETED|Epoch 4||0
6603121|NCT02059291|7527972|FG013|COMPLETED|Epoch 4||0
6603122|NCT02059291|7527973|FG014|COMPLETED|Epoch 4||0
6603123|NCT02059291|7527974|FG015|COMPLETED|Epoch 4||0
6603124|NCT02059291|7527975|FG016|COMPLETED|Epoch 4||41
6603125|NCT02059291|7527976|FG017|COMPLETED|Epoch 4||14
6603126|NCT02059291|7527977|FG018|COMPLETED|Epoch 4||2
6603127|NCT02059291|7527978|FG019|COMPLETED|Epoch 4||18
6603128|NCT02059291|7527979|FG020|COMPLETED|Epoch 4||33
6603129|NCT02059291|7527980|FG021|COMPLETED|Epoch 4||14
6603130|NCT02059291|7527981|FG022|COMPLETED|Epoch 4||30
6603131|NCT02059291|7527982|FG023|COMPLETED|Epoch 4||21
6603132|NCT02059291|7527983|FG024|COMPLETED|Epoch 4||0
6603133|NCT02059291|7527959|FG000|NOT COMPLETED|Epoch 4||0
6267116|NCT00049127|7166157|FG002|COMPLETED|Overall Study||39
6267117|NCT00049127|7166158|FG003|COMPLETED|Overall Study||0
6267118|NCT00049127|7166159|FG004|COMPLETED|Overall Study||12
6267119|NCT00049127|7166155|FG000|NOT COMPLETED|Overall Study||0
6267120|NCT00049127|7166156|FG001|NOT COMPLETED|Overall Study||0
6267121|NCT00049127|7166157|FG002|NOT COMPLETED|Overall Study||1
6267122|NCT00049127|7166158|FG003|NOT COMPLETED|Overall Study||0
6267123|NCT00049127|7166159|FG004|NOT COMPLETED|Overall Study||0
6267124|NCT00049257|7166171|FG000|STARTED|Carboplatin, Paclitaxel||58
6267125|NCT00049257|7166171|FG000|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
6267126|NCT00049257|7166171|FG000|NOT COMPLETED|Carboplatin, Paclitaxel||13
6267127|NCT00049257|7166171|FG000|STARTED|Follow-up Period for Survival Status||45
6267128|NCT00049257|7166171|FG000|COMPLETED|Follow-up Period for Survival Status||41
6267129|NCT00049257|7166171|FG000|NOT COMPLETED|Follow-up Period for Survival Status||4
6267130|NCT00049322|7166177|FG000|STARTED|Overall Study||15
6267131|NCT00049322|7166178|FG001|STARTED|Overall Study||15
6267132|NCT00049322|7166177|FG000|COMPLETED|Overall Study||14
6267133|NCT00049322|7166178|FG001|COMPLETED|Overall Study||9
6267134|NCT00049322|7166177|FG000|NOT COMPLETED|Overall Study||1
6267135|NCT00049322|7166178|FG001|NOT COMPLETED|Overall Study||6
6267136|NCT00049504|7166186|FG000|STARTED|Overall Study||55
6267137|NCT00049504|7166186|FG000|COMPLETED|Overall Study||55
6267138|NCT00049504|7166186|FG000|NOT COMPLETED|Overall Study||0
6267139|NCT00049517|7166192|FG000|STARTED|Induction||79
6267140|NCT00049517|7166193|FG001|STARTED|Induction||90
6267141|NCT00049517|7166194|FG002|STARTED|Induction||63
6267142|NCT00049517|7166195|FG003|STARTED|Induction||75
6267143|NCT00049517|7166196|FG004|STARTED|Induction||188
6267144|NCT00049517|7166197|FG005|STARTED|Induction||162
6267145|NCT00049517|7166192|FG000|Treated|Induction||79
6267146|NCT00049517|7166193|FG001|Treated|Induction||90
6267147|NCT00049517|7166194|FG002|Treated|Induction||63
6267148|NCT00049517|7166195|FG003|Treated|Induction||75
6267149|NCT00049517|7166196|FG004|Treated|Induction||186
6267150|NCT00049517|7166197|FG005|Treated|Induction||160
6267151|NCT00049517|7166192|FG000|COMPLETED|Induction||79
6267152|NCT00049517|7166193|FG001|COMPLETED|Induction||90
6267153|NCT00049517|7166194|FG002|COMPLETED|Induction||63
6267154|NCT00049517|7166195|FG003|COMPLETED|Induction||75
6267155|NCT00049517|7166196|FG004|COMPLETED|Induction||128
6267156|NCT00049517|7166197|FG005|COMPLETED|Induction||108
6267157|NCT00049517|7166192|FG000|NOT COMPLETED|Induction||0
6267158|NCT00049517|7166193|FG001|NOT COMPLETED|Induction||0
6267159|NCT00049517|7166194|FG002|NOT COMPLETED|Induction||0
6267160|NCT00049517|7166195|FG003|NOT COMPLETED|Induction||0
6267161|NCT00049517|7166196|FG004|NOT COMPLETED|Induction||60
6267162|NCT00049517|7166197|FG005|NOT COMPLETED|Induction||54
6267163|NCT00049517|7166192|FG000|STARTED|Conditioning/Transplant||79
6267164|NCT00049517|7166193|FG001|STARTED|Conditioning/Transplant||90
6267165|NCT00049517|7166194|FG002|STARTED|Conditioning/Transplant||63
6267166|NCT00049517|7166195|FG003|STARTED|Conditioning/Transplant||75
6267167|NCT00049517|7166196|FG004|STARTED|Conditioning/Transplant||21
6267168|NCT00049517|7166197|FG005|STARTED|Conditioning/Transplant||24
6267169|NCT00049517|7166192|FG000|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
6267170|NCT00049517|7166193|FG001|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
6267171|NCT00049517|7166194|FG002|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
6267172|NCT00049517|7166195|FG003|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
6267173|NCT00049517|7166196|FG004|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
6267174|NCT00049517|7166197|FG005|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
6267175|NCT00049517|7166192|FG000|COMPLETED|Conditioning/Transplant||27
6267176|NCT00049517|7166193|FG001|COMPLETED|Conditioning/Transplant||40
6267177|NCT00049517|7166194|FG002|COMPLETED|Conditioning/Transplant||25
6267178|NCT00049517|7166195|FG003|COMPLETED|Conditioning/Transplant||32
6267179|NCT00049517|7166196|FG004|COMPLETED|Conditioning/Transplant||15
6267180|NCT00049517|7166197|FG005|COMPLETED|Conditioning/Transplant||18
6267181|NCT00049517|7166192|FG000|NOT COMPLETED|Conditioning/Transplant||52
6267182|NCT00049517|7166193|FG001|NOT COMPLETED|Conditioning/Transplant||50
6267183|NCT00049517|7166194|FG002|NOT COMPLETED|Conditioning/Transplant||38
6267184|NCT00049517|7166195|FG003|NOT COMPLETED|Conditioning/Transplant||43
6267185|NCT00049517|7166196|FG004|NOT COMPLETED|Conditioning/Transplant||6
6267186|NCT00049517|7166197|FG005|NOT COMPLETED|Conditioning/Transplant||6
6267187|NCT00049530|7166205|FG000|STARTED|Overall Study||32
6267188|NCT00049530|7166205|FG000|Eligible and Treated|Overall Study||29
6267189|NCT00049530|7166205|FG000|COMPLETED|Overall Study||0
6267190|NCT00049530|7166205|FG000|NOT COMPLETED|Overall Study||32
6267191|NCT00049543|7166211|FG000|STARTED|Overall Study||251
6267192|NCT00049543|7166212|FG001|STARTED|Overall Study||252
6267193|NCT00049543|7166211|FG000|COMPLETED|Overall Study||249
6267194|NCT00049543|7166212|FG001|COMPLETED|Overall Study||243
6267195|NCT00049543|7166211|FG000|NOT COMPLETED|Overall Study||2
6267196|NCT00049543|7166212|FG001|NOT COMPLETED|Overall Study||9
6603134|NCT02059291|7527960|FG001|NOT COMPLETED|Epoch 4||0
6280524|NCT00157755|7180503|FG004|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
6281039|NCT00161382|7180910|FG000|NOT COMPLETED|Overall Study||249
6267197|NCT00049673|7166220|FG000|STARTED|Overall Study||166
6267198|NCT00049673|7166221|FG001|STARTED|Overall Study||166
6267199|NCT00049673|7166220|FG000|COMPLETED|Overall Study||165
6267200|NCT00049673|7166221|FG001|COMPLETED|Overall Study||163
6267201|NCT00049673|7166220|FG000|NOT COMPLETED|Overall Study||1
6267202|NCT00049673|7166221|FG001|NOT COMPLETED|Overall Study||3
6267203|NCT00049842|7166229|FG000|STARTED|Treatment Phase||270
6267204|NCT00049842|7166230|FG001|STARTED|Treatment Phase||270
6267205|NCT00049842|7166229|FG000|COMPLETED|Treatment Phase||177
6267206|NCT00049842|7166230|FG001|COMPLETED|Treatment Phase||192
6267207|NCT00049842|7166229|FG000|NOT COMPLETED|Treatment Phase||93
6267208|NCT00049842|7166230|FG001|NOT COMPLETED|Treatment Phase||78
6267209|NCT00049842|7166229|FG000|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
6267210|NCT00049842|7166230|FG001|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
6267211|NCT00049842|7166229|FG000|COMPLETED|Follow-up Phase||211
6267212|NCT00049842|7166230|FG001|COMPLETED|Follow-up Phase||189
6267213|NCT00049842|7166229|FG000|NOT COMPLETED|Follow-up Phase||7
6267214|NCT00049842|7166230|FG001|NOT COMPLETED|Follow-up Phase||5
6267215|NCT00050011|7166238|FG000|STARTED|Overall Study||301
6267216|NCT00050011|7166239|FG001|STARTED|Overall Study||301
6267217|NCT00050011|7166238|FG000|Intent-to-treat Population|Overall Study||300
6267218|NCT00050011|7166239|FG001|Intent-to-treat Population|Overall Study||300
6267219|NCT00050011|7166238|FG000|COMPLETED|Overall Study||180
6267220|NCT00050011|7166239|FG001|COMPLETED|Overall Study||175
6267221|NCT00050011|7166238|FG000|NOT COMPLETED|Overall Study||121
6267222|NCT00050011|7166239|FG001|NOT COMPLETED|Overall Study||126
6267223|NCT00050089|7166250|FG000|STARTED|Overall Study||106
6267224|NCT00050089|7166251|FG001|STARTED|Overall Study||98
6267225|NCT00050089|7166252|FG002|STARTED|Overall Study||86
6267226|NCT00050089|7166253|FG003|STARTED|Overall Study||78
6267227|NCT00050089|7166250|FG000|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
6267228|NCT00050089|7166251|FG001|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
6267229|NCT00050089|7166252|FG002|Baseline|Overall Study||86
6267230|NCT00050089|7166253|FG003|Baseline|Overall Study||78
6267231|NCT00050089|7166250|FG000|COMPLETED|Overall Study|For primary outcome assessment|106
6267232|NCT00050089|7166251|FG001|COMPLETED|Overall Study|For primary outcome assessment|98
6267233|NCT00050089|7166252|FG002|COMPLETED|Overall Study|For primary outcome assessment|86
6267234|NCT00050089|7166253|FG003|COMPLETED|Overall Study|For primary outcome assessment|78
6267235|NCT00050089|7166250|FG000|NOT COMPLETED|Overall Study||0
6267236|NCT00050089|7166251|FG001|NOT COMPLETED|Overall Study||0
6267237|NCT00050089|7166252|FG002|NOT COMPLETED|Overall Study||0
6267238|NCT00050089|7166253|FG003|NOT COMPLETED|Overall Study||0
6267239|NCT00050167|7166269|FG000|STARTED|Overall Study||302
6267240|NCT00050167|7166270|FG001|STARTED|Overall Study||301
6267241|NCT00050167|7166269|FG000|COMPLETED|Overall Study||301
6267242|NCT00050167|7166270|FG001|COMPLETED|Overall Study||300
6267243|NCT00050167|7166269|FG000|NOT COMPLETED|Overall Study||1
6267244|NCT00050167|7166270|FG001|NOT COMPLETED|Overall Study||1
6267245|NCT00050622|7166276|FG000|STARTED|Overall Study||154
6267246|NCT00050622|7166276|FG000|COMPLETED|Overall Study||153
6267247|NCT00050622|7166276|FG000|NOT COMPLETED|Overall Study||1
6267248|NCT00050778|7166303|FG000|STARTED|Overall Study|Randomized.|111
6267249|NCT00050778|7166304|FG001|STARTED|Overall Study||113
6267250|NCT00050778|7166305|FG002|STARTED|Overall Study||110
6267251|NCT00050778|7166303|FG000|Treated|Overall Study||107
6267252|NCT00050778|7166304|FG001|Treated|Overall Study||108
6267253|NCT00050778|7166305|FG002|Treated|Overall Study||108
6267254|NCT00050778|7166303|FG000|COMPLETED|Overall Study||66
6267255|NCT00050778|7166304|FG001|COMPLETED|Overall Study||92
6267256|NCT00050778|7166305|FG002|COMPLETED|Overall Study||92
6267257|NCT00050778|7166303|FG000|NOT COMPLETED|Overall Study||45
6267258|NCT00050778|7166304|FG001|NOT COMPLETED|Overall Study||21
6267259|NCT00050778|7166305|FG002|NOT COMPLETED|Overall Study||18
6267260|NCT00050960|7166317|FG000|STARTED|Overall Study||306
6267261|NCT00050960|7166318|FG001|STARTED|Overall Study||306
6267262|NCT00050960|7166317|FG000|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
6267263|NCT00050960|7166318|FG001|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
6267264|NCT00050960|7166317|FG000|NOT COMPLETED|Overall Study||302
6267265|NCT00050960|7166318|FG001|NOT COMPLETED|Overall Study||304
6267266|NCT00050986|7166324|FG000|STARTED|Overall Study||55
6267267|NCT00050986|7166324|FG000|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
6267268|NCT00050986|7166324|FG000|NOT COMPLETED|Overall Study||2
6267269|NCT00051025|7166330|FG000|STARTED|Overall Study||5
6267270|NCT00051025|7166331|FG001|STARTED|Overall Study||4
6267271|NCT00051025|7166330|FG000|COMPLETED|Overall Study||3
6267272|NCT00051025|7166331|FG001|COMPLETED|Overall Study||0
6267273|NCT00051025|7166330|FG000|NOT COMPLETED|Overall Study||2
6267274|NCT00051025|7166331|FG001|NOT COMPLETED|Overall Study||4
6267275|NCT00051168|7166337|FG000|STARTED|Overall Study||502
6267276|NCT00051168|7166337|FG000|COMPLETED|Overall Study||367
6267277|NCT00051168|7166337|FG000|NOT COMPLETED|Overall Study||135
6267278|NCT00051311|7166343|FG000|STARTED|Overall Study||31
6267279|NCT00051311|7166344|FG001|STARTED|Overall Study||31
6267280|NCT00051311|7166343|FG000|COMPLETED|Overall Study||19
6267281|NCT00051311|7166344|FG001|COMPLETED|Overall Study||17
6267282|NCT00051311|7166343|FG000|NOT COMPLETED|Overall Study||12
6267283|NCT00051311|7166344|FG001|NOT COMPLETED|Overall Study||14
6267284|NCT00051363|7166350|FG000|STARTED|Overall Study||558
6267285|NCT00051363|7166351|FG001|STARTED|Overall Study||547
6267286|NCT00051363|7166350|FG000|Randomized & Analyzed|Overall Study||556
6267287|NCT00051363|7166351|FG001|Randomized & Analyzed|Overall Study||542
6267288|NCT00051363|7166350|FG000|Completed 2M Visit On-Treatment|Overall Study||456
6267289|NCT00051363|7166351|FG001|Completed 2M Visit On-Treatment|Overall Study||417
6267290|NCT00051363|7166350|FG000|Completed 2M Visit On-Study|Overall Study||468
6267291|NCT00051363|7166351|FG001|Completed 2M Visit On-Study|Overall Study||432
6267292|NCT00051363|7166350|FG000|Completed 6M Visit On-Treatment|Overall Study||427
6267293|NCT00051363|7166351|FG001|Completed 6M Visit On-Treatment|Overall Study||372
6267294|NCT00051363|7166350|FG000|Completed 6M Vist On-Study|Overall Study||443
6267295|NCT00051363|7166351|FG001|Completed 6M Vist On-Study|Overall Study||403
6267296|NCT00051363|7166350|FG000|COMPLETED|Overall Study||443
6267297|NCT00051363|7166351|FG001|COMPLETED|Overall Study||403
6267298|NCT00051363|7166350|FG000|NOT COMPLETED|Overall Study||115
6267299|NCT00051363|7166351|FG001|NOT COMPLETED|Overall Study||144
6267300|NCT00051558|7166359|FG000|STARTED|Overall Study||214
6267301|NCT00051558|7166360|FG001|STARTED|Overall Study||214
6267302|NCT00051558|7166359|FG000|COMPLETED|Overall Study||123
6267303|NCT00051558|7166360|FG001|COMPLETED|Overall Study||118
6267304|NCT00051558|7166359|FG000|NOT COMPLETED|Overall Study||91
6267305|NCT00051558|7166360|FG001|NOT COMPLETED|Overall Study||96
6267306|NCT00051636|7166368|FG000|STARTED|Period 1 - Core||90
6267307|NCT00051636|7166369|FG001|STARTED|Period 1 - Core||82
6267308|NCT00051636|7166368|FG000|COMPLETED|Period 1 - Core||86
6267309|NCT00051636|7166369|FG001|COMPLETED|Period 1 - Core||76
6267310|NCT00051636|7166368|FG000|NOT COMPLETED|Period 1 - Core||4
6267311|NCT00051636|7166369|FG001|NOT COMPLETED|Period 1 - Core||6
6267312|NCT00051636|7166368|FG000|STARTED|Period 2- Extended Observation Period||75
6267313|NCT00051636|7166369|FG001|STARTED|Period 2- Extended Observation Period||52
6267314|NCT00051636|7166368|FG000|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
6267315|NCT00051636|7166369|FG001|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
6267316|NCT00051636|7166368|FG000|NOT COMPLETED|Period 2- Extended Observation Period||70
6267317|NCT00051636|7166369|FG001|NOT COMPLETED|Period 2- Extended Observation Period||30
6267318|NCT00052078|7166379|FG000|STARTED|Overall Study||133
6267319|NCT00052078|7166380|FG001|STARTED|Overall Study||139
6267320|NCT00052078|7166381|FG002|STARTED|Overall Study||140
6267321|NCT00052078|7166382|FG003|STARTED|Overall Study||76
6267322|NCT00052078|7166379|FG000|COMPLETED|Overall Study||110
6267323|NCT00052078|7166380|FG001|COMPLETED|Overall Study||133
6267324|NCT00052078|7166381|FG002|COMPLETED|Overall Study||127
6267325|NCT00052078|7166382|FG003|COMPLETED|Overall Study||61
6267326|NCT00052078|7166379|FG000|NOT COMPLETED|Overall Study||23
6267327|NCT00052078|7166380|FG001|NOT COMPLETED|Overall Study||6
6267328|NCT00052078|7166381|FG002|NOT COMPLETED|Overall Study||13
6267329|NCT00052078|7166382|FG003|NOT COMPLETED|Overall Study||15
6267330|NCT00052429|7166392|FG000|STARTED|Overall Study||25
6267331|NCT00052429|7166392|FG000|COMPLETED|Overall Study||25
6267332|NCT00052429|7166392|FG000|NOT COMPLETED|Overall Study||0
6267333|NCT00052442|7166401|FG000|STARTED|Overall Study||16
6267334|NCT00052442|7166402|FG001|STARTED|Overall Study||3
6267335|NCT00052442|7166403|FG002|STARTED|Overall Study||27
6267336|NCT00052442|7166404|FG003|STARTED|Overall Study||11
6267337|NCT00052442|7166405|FG004|STARTED|Overall Study||15
6267338|NCT00052442|7166401|FG000|COMPLETED|Overall Study||16
6267339|NCT00052442|7166402|FG001|COMPLETED|Overall Study||3
6267340|NCT00052442|7166403|FG002|COMPLETED|Overall Study||27
6267341|NCT00052442|7166404|FG003|COMPLETED|Overall Study||11
6267342|NCT00052442|7166405|FG004|COMPLETED|Overall Study||15
6267343|NCT00052442|7166401|FG000|NOT COMPLETED|Overall Study||0
6267344|NCT00052442|7166402|FG001|NOT COMPLETED|Overall Study||0
6267345|NCT00052442|7166403|FG002|NOT COMPLETED|Overall Study||0
6267346|NCT00052442|7166404|FG003|NOT COMPLETED|Overall Study||0
6267347|NCT00052442|7166405|FG004|NOT COMPLETED|Overall Study||0
6267348|NCT00052715|7166417|FG000|STARTED|Overall Study||31
6267349|NCT00052715|7166417|FG000|COMPLETED|Overall Study||30
6267350|NCT00052715|7166417|FG000|NOT COMPLETED|Overall Study||1
6267351|NCT00052910|7166423|FG000|STARTED|Overall Study||280
6267352|NCT00052910|7166424|FG001|STARTED|Overall Study||266
6267353|NCT00052910|7166423|FG000|COMPLETED|Overall Study||280
6267354|NCT00052910|7166424|FG001|COMPLETED|Overall Study||266
6267355|NCT00052910|7166423|FG000|NOT COMPLETED|Overall Study||0
6267356|NCT00052910|7166424|FG001|NOT COMPLETED|Overall Study||0
6267357|NCT00052962|7166432|FG000|STARTED|Overall Study||13
6267358|NCT00052962|7166433|FG001|STARTED|Overall Study||17
6267359|NCT00052962|7166432|FG000|COMPLETED|Overall Study||12
6267360|NCT00052962|7166433|FG001|COMPLETED|Overall Study||15
6267361|NCT00052962|7166432|FG000|NOT COMPLETED|Overall Study||1
6267362|NCT00052962|7166433|FG001|NOT COMPLETED|Overall Study||2
6267363|NCT00053014|7166439|FG000|STARTED|Overall Study||5
6267364|NCT00053014|7166439|FG000|COMPLETED|Overall Study||5
6267365|NCT00053014|7166439|FG000|NOT COMPLETED|Overall Study||0
6267366|NCT00053352|7166445|FG000|STARTED|Overall Study||190
6267367|NCT00053352|7166446|FG001|STARTED|Overall Study||112
6267368|NCT00053352|7166445|FG000|COMPLETED|Overall Study||169
6267369|NCT00053352|7166446|FG001|COMPLETED|Overall Study||102
6267370|NCT00053352|7166445|FG000|NOT COMPLETED|Overall Study||21
6267371|NCT00053352|7166446|FG001|NOT COMPLETED|Overall Study||10
6267372|NCT00053365|7166453|FG000|STARTED|Overall Study||61
6267373|NCT00053365|7166453|FG000|COMPLETED|Overall Study||55
6267374|NCT00053365|7166453|FG000|NOT COMPLETED|Overall Study||6
6267375|NCT00053417|7166463|FG000|STARTED|Overall Study||47
6267376|NCT00053417|7166464|FG001|STARTED|Overall Study||52
6267377|NCT00053417|7166465|FG002|STARTED|Overall Study||50
6267378|NCT00053417|7166466|FG003|STARTED|Overall Study||57
6267379|NCT00053417|7166463|FG000|COMPLETED|Overall Study||45
6267380|NCT00053417|7166464|FG001|COMPLETED|Overall Study||50
6267381|NCT00053417|7166465|FG002|COMPLETED|Overall Study||49
6267382|NCT00053417|7166466|FG003|COMPLETED|Overall Study||51
6267383|NCT00053417|7166463|FG000|NOT COMPLETED|Overall Study||2
6267384|NCT00053417|7166464|FG001|NOT COMPLETED|Overall Study||2
6267385|NCT00053417|7166465|FG002|NOT COMPLETED|Overall Study||1
6267386|NCT00053417|7166466|FG003|NOT COMPLETED|Overall Study||6
6267387|NCT00053482|7166481|FG000|STARTED|Overall Study||51
6267388|NCT00053482|7166482|FG001|STARTED|Overall Study||102
6267389|NCT00053482|7166483|FG002|STARTED|Overall Study||102
6267390|NCT00053482|7166484|FG003|STARTED|Overall Study||50
6267391|NCT00053482|7166485|FG004|STARTED|Overall Study||52
6267392|NCT00053482|7166481|FG000|COMPLETED|Overall Study||51
6267393|NCT00053482|7166482|FG001|COMPLETED|Overall Study||102
6267394|NCT00053482|7166483|FG002|COMPLETED|Overall Study||102
6267395|NCT00053482|7166484|FG003|COMPLETED|Overall Study||50
6267396|NCT00053482|7166485|FG004|COMPLETED|Overall Study||52
6267397|NCT00053482|7166481|FG000|NOT COMPLETED|Overall Study||0
6267398|NCT00053482|7166482|FG001|NOT COMPLETED|Overall Study||0
6267399|NCT00053482|7166483|FG002|NOT COMPLETED|Overall Study||0
6267400|NCT00053482|7166484|FG003|NOT COMPLETED|Overall Study||0
6267401|NCT00053482|7166485|FG004|NOT COMPLETED|Overall Study||0
6267402|NCT00053495|7166502|FG000|STARTED|Overall Study||51
6267403|NCT00053495|7166503|FG001|STARTED|Overall Study||101
6267404|NCT00053495|7166504|FG002|STARTED|Overall Study||101
6267405|NCT00053495|7166505|FG003|STARTED|Overall Study||51
6267406|NCT00053495|7166506|FG004|STARTED|Overall Study||49
6267407|NCT00053495|7166502|FG000|COMPLETED|Overall Study||51
6267408|NCT00053495|7166503|FG001|COMPLETED|Overall Study||101
6267409|NCT00053495|7166504|FG002|COMPLETED|Overall Study||101
6267410|NCT00053495|7166505|FG003|COMPLETED|Overall Study||51
6267411|NCT00053495|7166506|FG004|COMPLETED|Overall Study||49
6267412|NCT00053495|7166502|FG000|NOT COMPLETED|Overall Study||0
6267413|NCT00053495|7166503|FG001|NOT COMPLETED|Overall Study||0
6267414|NCT00053495|7166504|FG002|NOT COMPLETED|Overall Study||0
6267415|NCT00053495|7166505|FG003|NOT COMPLETED|Overall Study||0
6267416|NCT00053495|7166506|FG004|NOT COMPLETED|Overall Study||0
6267417|NCT00053677|7166520|FG000|STARTED|Overall Study||58
6267418|NCT00053677|7166521|FG001|STARTED|Overall Study||19
6267419|NCT00053677|7166520|FG000|COMPLETED|Overall Study||36
6267420|NCT00053677|7166521|FG001|COMPLETED|Overall Study||13
6267421|NCT00053677|7166520|FG000|NOT COMPLETED|Overall Study||22
6267422|NCT00053677|7166521|FG001|NOT COMPLETED|Overall Study||6
6267423|NCT00053703|7166530|FG000|STARTED|Overall Study||35
6267424|NCT00053703|7166531|FG001|STARTED|Overall Study||41
6267425|NCT00053703|7166532|FG002|STARTED|Overall Study||40
6267426|NCT00053703|7166530|FG000|COMPLETED|Overall Study||17
6267427|NCT00053703|7166531|FG001|COMPLETED|Overall Study||28
6267428|NCT00053703|7166532|FG002|COMPLETED|Overall Study||25
6267429|NCT00053703|7166530|FG000|NOT COMPLETED|Overall Study||18
6267430|NCT00053703|7166531|FG001|NOT COMPLETED|Overall Study||13
6267431|NCT00053703|7166532|FG002|NOT COMPLETED|Overall Study||15
6267432|NCT00053846|7166542|FG000|STARTED|Overall Study||213
6267433|NCT00053846|7166543|FG001|STARTED|Overall Study||219
6267434|NCT00053846|7166542|FG000|COMPLETED|Overall Study||187
6267435|NCT00053846|7166543|FG001|COMPLETED|Overall Study||192
6267436|NCT00053846|7166542|FG000|NOT COMPLETED|Overall Study||26
6267437|NCT00053846|7166543|FG001|NOT COMPLETED|Overall Study||27
6267438|NCT00053898|7166551|FG000|STARTED|Overall Study||1552
6267439|NCT00053898|7166552|FG001|STARTED|Overall Study||1552
6267440|NCT00053898|7166551|FG000|COMPLETED|Overall Study||1538
6267441|NCT00053898|7166552|FG001|COMPLETED|Overall Study||1539
6267442|NCT00053898|7166551|FG000|NOT COMPLETED|Overall Study||14
6267443|NCT00053898|7166552|FG001|NOT COMPLETED|Overall Study||13
6267444|NCT00053989|7166558|FG000|STARTED|Overall Study||41
6267445|NCT00053989|7166558|FG000|COMPLETED|Overall Study||41
6267446|NCT00053989|7166558|FG000|NOT COMPLETED|Overall Study||0
6267447|NCT00054028|7166564|FG000|STARTED|Overall Study||31
6267448|NCT00054028|7166564|FG000|Phase I|Overall Study||9
6267449|NCT00054028|7166564|FG000|Phase II|Overall Study||22
6267450|NCT00054028|7166564|FG000|COMPLETED|Overall Study||31
6267451|NCT00054028|7166564|FG000|NOT COMPLETED|Overall Study||0
6267452|NCT00054132|7166569|FG000|STARTED|Overall Study||38
6267453|NCT00054132|7166569|FG000|COMPLETED|Overall Study||37
6267454|NCT00054132|7166569|FG000|NOT COMPLETED|Overall Study||1
6267455|NCT00054275|7166574|FG000|STARTED|Overall Study||39
6267456|NCT00054275|7166574|FG000|COMPLETED|Overall Study||28
6267457|NCT00054275|7166574|FG000|NOT COMPLETED|Overall Study||11
6267458|NCT00054327|7166584|FG000|STARTED|Overall Study||11
6267459|NCT00054327|7166585|FG001|STARTED|Overall Study||4
6267460|NCT00054327|7166586|FG002|STARTED|Overall Study||3
6267461|NCT00054327|7166587|FG003|STARTED|Overall Study||4
6267462|NCT00054327|7166588|FG004|STARTED|Overall Study||10
6267463|NCT00054327|7166589|FG005|STARTED|Overall Study||2
6267464|NCT00054327|7166584|FG000|COMPLETED|Overall Study||10
6267465|NCT00054327|7166585|FG001|COMPLETED|Overall Study||4
6267466|NCT00054327|7166586|FG002|COMPLETED|Overall Study||3
6267467|NCT00054327|7166587|FG003|COMPLETED|Overall Study||4
6267468|NCT00054327|7166588|FG004|COMPLETED|Overall Study||10
6267469|NCT00054327|7166589|FG005|COMPLETED|Overall Study||2
6267470|NCT00054327|7166584|FG000|NOT COMPLETED|Overall Study||1
6267471|NCT00054327|7166585|FG001|NOT COMPLETED|Overall Study||0
6267472|NCT00054327|7166586|FG002|NOT COMPLETED|Overall Study||0
6267473|NCT00054327|7166587|FG003|NOT COMPLETED|Overall Study||0
6267474|NCT00054327|7166588|FG004|NOT COMPLETED|Overall Study||0
6267475|NCT00054327|7166589|FG005|NOT COMPLETED|Overall Study||0
6267476|NCT00054353|7166605|FG000|STARTED|Overall Study||12
6267477|NCT00054353|7166606|FG001|STARTED|Overall Study||4
6267478|NCT00054353|7166605|FG000|COMPLETED|Overall Study||12
6267479|NCT00054353|7166606|FG001|COMPLETED|Overall Study||4
6267480|NCT00054353|7166605|FG000|NOT COMPLETED|Overall Study||0
6267481|NCT00054353|7166606|FG001|NOT COMPLETED|Overall Study||0
6267482|NCT00054639|7166616|FG000|STARTED|Overall Study||48
6267483|NCT00054639|7166616|FG000|COMPLETED|Overall Study||46
6267484|NCT00054639|7166616|FG000|NOT COMPLETED|Overall Study||2
6267485|NCT00054665|7166620|FG000|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
6267486|NCT00054665|7166621|FG001|STARTED|Part A||0
6267487|NCT00054665|7166620|FG000|COMPLETED|Part A||23
6267488|NCT00054665|7166621|FG001|COMPLETED|Part A||0
6267489|NCT00054665|7166620|FG000|NOT COMPLETED|Part A||0
6267490|NCT00054665|7166621|FG001|NOT COMPLETED|Part A||0
6267491|NCT00054665|7166620|FG000|STARTED|Part B||0
6267492|NCT00054665|7166621|FG001|STARTED|Part B|26 participants received only Part B|44
6267493|NCT00054665|7166620|FG000|COMPLETED|Part B||0
6267494|NCT00054665|7166621|FG001|COMPLETED|Part B||44
6267495|NCT00054665|7166620|FG000|NOT COMPLETED|Part B||0
6267496|NCT00054665|7166621|FG001|NOT COMPLETED|Part B||0
6267497|NCT00054691|7166629|FG000|STARTED|Overall Study||40
6267498|NCT00054691|7166629|FG000|COMPLETED|Overall Study||37
6267499|NCT00054691|7166629|FG000|NOT COMPLETED|Overall Study||3
6267500|NCT00054704|7166635|FG000|STARTED|Overall Study||8
6267501|NCT00054704|7166636|FG001|STARTED|Overall Study||11
6267502|NCT00054704|7166635|FG000|COMPLETED|Overall Study||3
6267503|NCT00054704|7166636|FG001|COMPLETED|Overall Study||6
6267504|NCT00054704|7166635|FG000|NOT COMPLETED|Overall Study||5
6267505|NCT00054704|7166636|FG001|NOT COMPLETED|Overall Study||5
6267506|NCT00054717|7166644|FG000|STARTED|Overall Study||313
6267507|NCT00054717|7166645|FG001|STARTED|Overall Study||317
6267508|NCT00054717|7166644|FG000|COMPLETED|Overall Study||51
6267509|NCT00054717|7166645|FG001|COMPLETED|Overall Study||18
6267510|NCT00054717|7166644|FG000|NOT COMPLETED|Overall Study||262
6267511|NCT00054717|7166645|FG001|NOT COMPLETED|Overall Study||299
6267512|NCT00054756|7166651|FG000|STARTED|Overall Study||96
6267513|NCT00054756|7166651|FG000|COMPLETED|Overall Study||94
6267514|NCT00054756|7166651|FG000|NOT COMPLETED|Overall Study||2
6267515|NCT00054847|7166657|FG000|STARTED|Overall Study||367
6267516|NCT00054847|7166658|FG001|STARTED|Overall Study||366
6267517|NCT00054847|7166657|FG000|COMPLETED|Overall Study||269
6267518|NCT00054847|7166658|FG001|COMPLETED|Overall Study||266
6267519|NCT00054847|7166657|FG000|NOT COMPLETED|Overall Study||98
6267520|NCT00054847|7166658|FG001|NOT COMPLETED|Overall Study||100
6267521|NCT00055237|7166670|FG000|STARTED|Overall Study||17
6267522|NCT00055237|7166671|FG001|STARTED|Overall Study||2
6267523|NCT00055237|7166670|FG000|COMPLETED|Overall Study||17
6267524|NCT00055237|7166671|FG001|COMPLETED|Overall Study||2
6267525|NCT00055237|7166670|FG000|NOT COMPLETED|Overall Study||0
6267526|NCT00055237|7166671|FG001|NOT COMPLETED|Overall Study||0
6267527|NCT00055471|7166679|FG000|STARTED|Period 1: Dose Escalation Period||3
6267528|NCT00055471|7166680|FG001|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
6267529|NCT00055471|7166681|FG002|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
6267530|NCT00055471|7166679|FG000|COMPLETED|Period 1: Dose Escalation Period||3
6267531|NCT00055471|7166680|FG001|COMPLETED|Period 1: Dose Escalation Period||8
6267532|NCT00055471|7166681|FG002|COMPLETED|Period 1: Dose Escalation Period||0
6267533|NCT00055471|7166679|FG000|NOT COMPLETED|Period 1: Dose Escalation Period||0
6267534|NCT00055471|7166680|FG001|NOT COMPLETED|Period 1: Dose Escalation Period||2
6267535|NCT00055471|7166681|FG002|NOT COMPLETED|Period 1: Dose Escalation Period||3
6267536|NCT00055471|7166679|FG000|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
6267537|NCT00055471|7166680|FG001|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
6267538|NCT00055471|7166681|FG002|STARTED|Period 2: Extension Period||0
6267539|NCT00055471|7166679|FG000|COMPLETED|Period 2: Extension Period||3
6267540|NCT00055471|7166680|FG001|COMPLETED|Period 2: Extension Period||6
6267541|NCT00055471|7166681|FG002|COMPLETED|Period 2: Extension Period||0
6267542|NCT00055471|7166679|FG000|NOT COMPLETED|Period 2: Extension Period||0
6267543|NCT00055471|7166680|FG001|NOT COMPLETED|Period 2: Extension Period||0
6267544|NCT00055471|7166681|FG002|NOT COMPLETED|Period 2: Extension Period||0
6267545|NCT00055497|7166693|FG000|STARTED|Overall Study||18
6267546|NCT00055497|7166694|FG001|STARTED|Overall Study||19
6267547|NCT00055497|7166695|FG002|STARTED|Overall Study||18
6267548|NCT00055497|7166696|FG003|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
6267549|NCT00055497|7166693|FG000|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
6267550|NCT00055497|7166694|FG001|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
6267551|NCT00055497|7166695|FG002|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
6267552|NCT00055497|7166696|FG003|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
6267553|NCT00055497|7166693|FG000|NOT COMPLETED|Overall Study||5
6267554|NCT00055497|7166694|FG001|NOT COMPLETED|Overall Study||3
6267555|NCT00055497|7166695|FG002|NOT COMPLETED|Overall Study||2
6267556|NCT00055497|7166696|FG003|NOT COMPLETED|Overall Study||90
6267557|NCT00055601|7166713|FG000|STARTED|Overall Study||48
6267558|NCT00055601|7166714|FG001|STARTED|Overall Study||49
6267559|NCT00055601|7166713|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
6267560|NCT00055601|7166714|FG001|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
6267561|NCT00055601|7166713|FG000|NOT COMPLETED|Overall Study||2
6267562|NCT00055601|7166714|FG001|NOT COMPLETED|Overall Study||2
6267563|NCT00055692|7166720|FG000|STARTED|Overall Study||46
6267564|NCT00055692|7166720|FG000|COMPLETED|Overall Study||46
6267565|NCT00055692|7166720|FG000|NOT COMPLETED|Overall Study||0
6267566|NCT00056160|7166728|FG000|STARTED|Up to Unblinding (07 Jun 2005)||177
6267567|NCT00056160|7166729|FG001|STARTED|Up to Unblinding (07 Jun 2005)||176
6267568|NCT00056160|7166728|FG000|COMPLETED|Up to Unblinding (07 Jun 2005)||64
6267569|NCT00056160|7166729|FG001|COMPLETED|Up to Unblinding (07 Jun 2005)||13
6267570|NCT00056160|7166728|FG000|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
6267571|NCT00056160|7166729|FG001|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
6267572|NCT00056160|7166728|FG000|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
6267573|NCT00056160|7166729|FG001|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
6267574|NCT00056160|7166728|FG000|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
6267575|NCT00056160|7166729|FG001|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
6267576|NCT00056160|7166728|FG000|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
6267577|NCT00056160|7166729|FG001|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
6267578|NCT00056160|7166728|FG000|STARTED|Final Follow-up||6
6267579|NCT00056160|7166729|FG001|STARTED|Final Follow-up||0
6267580|NCT00056160|7166728|FG000|COMPLETED|Final Follow-up||0
6267581|NCT00056160|7166729|FG001|COMPLETED|Final Follow-up||0
6267582|NCT00056160|7166728|FG000|NOT COMPLETED|Final Follow-up||6
6267583|NCT00056160|7166729|FG001|NOT COMPLETED|Final Follow-up||0
6267584|NCT00056316|7166737|FG000|STARTED|Overall Study||33
6267585|NCT00056316|7166738|FG001|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
6267586|NCT00056316|7166737|FG000|COMPLETED|Overall Study||30
6267587|NCT00056316|7166738|FG001|COMPLETED|Overall Study||38
6267588|NCT00056316|7166737|FG000|NOT COMPLETED|Overall Study||3
6267589|NCT00056316|7166738|FG001|NOT COMPLETED|Overall Study||3
6267590|NCT00056407|7166746|FG000|STARTED|Overall Study||4126
6267591|NCT00056407|7166747|FG001|STARTED|Overall Study||4105
6267592|NCT00056407|7166746|FG000|COMPLETED|Overall Study||2915
6267593|NCT00056407|7166747|FG001|COMPLETED|Overall Study||2912
6267594|NCT00056407|7166746|FG000|NOT COMPLETED|Overall Study||1211
6267595|NCT00056407|7166747|FG001|NOT COMPLETED|Overall Study||1193
6267596|NCT00056472|7166755|FG000|STARTED|Overall Study||129
6267597|NCT00056472|7166756|FG001|STARTED|Overall Study||130
6267598|NCT00056472|7166755|FG000|COMPLETED|Overall Study||81
6267599|NCT00056472|7166756|FG001|COMPLETED|Overall Study||61
6267600|NCT00056472|7166755|FG000|NOT COMPLETED|Overall Study||48
6267601|NCT00056472|7166756|FG001|NOT COMPLETED|Overall Study||69
6267602|NCT00056498|7166764|FG000|STARTED|Overall Study||30
6267603|NCT00056498|7166765|FG001|STARTED|Overall Study||35
6267604|NCT00056498|7166764|FG000|COMPLETED|Overall Study||25
6267605|NCT00056498|7166765|FG001|COMPLETED|Overall Study||28
6267606|NCT00056498|7166764|FG000|NOT COMPLETED|Overall Study||5
6267607|NCT00056498|7166765|FG001|NOT COMPLETED|Overall Study||7
6267608|NCT00056550|7166771|FG000|STARTED|Overall Study||14
6267609|NCT00056550|7166771|FG000|COMPLETED|Overall Study||14
6267610|NCT00056550|7166771|FG000|NOT COMPLETED|Overall Study||0
6267611|NCT00056563|7166778|FG000|STARTED|Overall Study||121
6267612|NCT00056563|7166779|FG001|STARTED|Overall Study||134
6267613|NCT00056563|7166778|FG000|COMPLETED|Overall Study||121
6267614|NCT00056563|7166779|FG001|COMPLETED|Overall Study||134
6267615|NCT00056563|7166778|FG000|NOT COMPLETED|Overall Study||0
6267616|NCT00056563|7166779|FG001|NOT COMPLETED|Overall Study||0
6267617|NCT00056862|7166787|FG000|STARTED|Overall Study||31
6267618|NCT00056862|7166788|FG001|STARTED|Overall Study||27
6267619|NCT00056862|7166787|FG000|COMPLETED|Overall Study||30
6267620|NCT00056862|7166788|FG001|COMPLETED|Overall Study||27
6267621|NCT00056862|7166787|FG000|NOT COMPLETED|Overall Study||1
6267622|NCT00056862|7166788|FG001|NOT COMPLETED|Overall Study||0
6267623|NCT00057330|7166796|FG000|STARTED|Overall Study||4577
6267624|NCT00057330|7166797|FG001|STARTED|Overall Study||3746
6267625|NCT00057330|7166796|FG000|COMPLETED|Overall Study||3445
6267626|NCT00057330|7166797|FG001|COMPLETED|Overall Study||2826
6267627|NCT00057330|7166796|FG000|NOT COMPLETED|Overall Study||1132
6267628|NCT00057330|7166797|FG001|NOT COMPLETED|Overall Study||920
6267629|NCT00057551|7166806|FG000|STARTED|Overall Study||200
6267630|NCT00057551|7166807|FG001|STARTED|Overall Study||195
6267631|NCT00057551|7166808|FG002|STARTED|Overall Study||96
6267632|NCT00057551|7166806|FG000|COMPLETED|Overall Study||175
6267633|NCT00057551|7166807|FG001|COMPLETED|Overall Study||168
6267634|NCT00057551|7166808|FG002|COMPLETED|Overall Study||80
6267635|NCT00057551|7166806|FG000|NOT COMPLETED|Overall Study||25
6267636|NCT00057551|7166807|FG001|NOT COMPLETED|Overall Study||27
6267637|NCT00057551|7166808|FG002|NOT COMPLETED|Overall Study||16
6267638|NCT00057577|7166818|FG000|STARTED|Overall Study||227
6267639|NCT00057577|7166819|FG001|STARTED|Overall Study||225
6267640|NCT00057577|7166818|FG000|COMPLETED|Overall Study||227
6267641|NCT00057577|7166819|FG001|COMPLETED|Overall Study||225
6267642|NCT00057577|7166818|FG000|NOT COMPLETED|Overall Study||0
6267643|NCT00057577|7166819|FG001|NOT COMPLETED|Overall Study||0
6267644|NCT00057681|7166833|FG000|STARTED|Overall Study||137
6267645|NCT00057681|7166834|FG001|STARTED|Overall Study||139
6267646|NCT00057681|7166835|FG002|STARTED|Overall Study||103
6267647|NCT00057681|7166833|FG000|COMPLETED|Overall Study||72
6267648|NCT00057681|7166834|FG001|COMPLETED|Overall Study||67
6267649|NCT00057681|7166835|FG002|COMPLETED|Overall Study||69
6267650|NCT00057681|7166833|FG000|NOT COMPLETED|Overall Study||65
6267651|NCT00057681|7166834|FG001|NOT COMPLETED|Overall Study||72
6267652|NCT00057681|7166835|FG002|NOT COMPLETED|Overall Study||34
6267653|NCT00057746|7166846|FG000|STARTED|Overall Study||131
6267654|NCT00057746|7166847|FG001|STARTED|Overall Study||67
6267655|NCT00057746|7166848|FG002|STARTED|Overall Study||67
6267656|NCT00057746|7166846|FG000|COMPLETED|Overall Study||131
6267657|NCT00057746|7166847|FG001|COMPLETED|Overall Study||67
6267658|NCT00057746|7166848|FG002|COMPLETED|Overall Study||66
6267659|NCT00057746|7166846|FG000|NOT COMPLETED|Overall Study||0
6267660|NCT00057746|7166847|FG001|NOT COMPLETED|Overall Study||0
6267661|NCT00057746|7166848|FG002|NOT COMPLETED|Overall Study||1
6267662|NCT00057785|7166856|FG000|STARTED|Overall Study||68
6267663|NCT00057785|7166856|FG000|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
6267664|NCT00057785|7166856|FG000|NOT COMPLETED|Overall Study||0
6267665|NCT00057811|7166862|FG000|STARTED|Overall Study||51
6267666|NCT00057811|7166863|FG001|STARTED|Overall Study||46
6267667|NCT00057811|7166862|FG000|COMPLETED|Overall Study||41
6267668|NCT00057811|7166863|FG001|COMPLETED|Overall Study||34
6267669|NCT00057811|7166862|FG000|NOT COMPLETED|Overall Study||10
6267670|NCT00057811|7166863|FG001|NOT COMPLETED|Overall Study||12
6267671|NCT00057837|7166871|FG000|STARTED|Overall Study||70
6267672|NCT00057837|7166872|FG001|STARTED|Overall Study||70
6267673|NCT00057837|7166871|FG000|Treated|Overall Study||69
6267674|NCT00057837|7166872|FG001|Treated|Overall Study||68
6267675|NCT00057837|7166871|FG000|Eligible and Treated|Overall Study||66
6267676|NCT00057837|7166872|FG001|Eligible and Treated|Overall Study||66
6267677|NCT00057837|7166871|FG000|Patients With Response|Overall Study||46
6267678|NCT00057837|7166872|FG001|Patients With Response|Overall Study||38
6267679|NCT00057837|7166871|FG000|COMPLETED|Overall Study||39
6267680|NCT00057837|7166872|FG001|COMPLETED|Overall Study||31
6267681|NCT00057837|7166871|FG000|NOT COMPLETED|Overall Study||31
6267682|NCT00057837|7166872|FG001|NOT COMPLETED|Overall Study||39
6267683|NCT00057863|7166878|FG000|STARTED|Overall Study||35
6267684|NCT00057863|7166878|FG000|COMPLETED|Overall Study||32
6267685|NCT00057863|7166878|FG000|NOT COMPLETED|Overall Study||3
6267686|NCT00057876|7166884|FG000|STARTED|Overall Study||38
6267687|NCT00057876|7166885|FG001|STARTED|Overall Study||36
6267688|NCT00057876|7166884|FG000|Eligible|Overall Study||37
6267689|NCT00057876|7166885|FG001|Eligible|Overall Study||34
6267690|NCT00057876|7166884|FG000|Began Protocol Therapy|Overall Study||35
6267691|NCT00057876|7166885|FG001|Began Protocol Therapy|Overall Study||34
6267692|NCT00057876|7166884|FG000|Eligible and Treated|Overall Study||34
6267693|NCT00057876|7166885|FG001|Eligible and Treated|Overall Study||34
6267694|NCT00057876|7166884|FG000|COMPLETED|Overall Study||9
6267695|NCT00057876|7166885|FG001|COMPLETED|Overall Study||9
6267696|NCT00057876|7166884|FG000|NOT COMPLETED|Overall Study||29
6267697|NCT00057876|7166885|FG001|NOT COMPLETED|Overall Study||27
6267698|NCT00057941|7166893|FG000|STARTED|Overall Study||74
6267699|NCT00057941|7166894|FG001|STARTED|Overall Study||74
6267700|NCT00057941|7166893|FG000|Treated|Overall Study||74
6267701|NCT00057941|7166894|FG001|Treated|Overall Study||74
6267702|NCT00057941|7166893|FG000|Eligible|Overall Study||72
6267703|NCT00057941|7166894|FG001|Eligible|Overall Study||69
6267704|NCT00057941|7166893|FG000|COMPLETED|Overall Study||0
6267705|NCT00057941|7166894|FG001|COMPLETED|Overall Study||0
6267706|NCT00057941|7166893|FG000|NOT COMPLETED|Overall Study||74
6267707|NCT00057941|7166894|FG001|NOT COMPLETED|Overall Study||74
6267708|NCT00057954|7166900|FG000|STARTED|Overall Study||6
6267709|NCT00057954|7166900|FG000|COMPLETED|Overall Study||4
6267710|NCT00057954|7166900|FG000|NOT COMPLETED|Overall Study||2
6267711|NCT00058019|7166906|FG000|STARTED|Overall Study||39
6267712|NCT00058019|7166907|FG001|STARTED|Overall Study||12
6267713|NCT00058019|7166906|FG000|COMPLETED|Overall Study||39
6267714|NCT00058019|7166907|FG001|COMPLETED|Overall Study||12
6267715|NCT00058019|7166906|FG000|NOT COMPLETED|Overall Study||0
6267716|NCT00058019|7166907|FG001|NOT COMPLETED|Overall Study||0
6267717|NCT00058058|7166912|FG000|STARTED|Overall Study||1007
6267718|NCT00058058|7166912|FG000|COMPLETED|Overall Study||969
6267719|NCT00058058|7166912|FG000|NOT COMPLETED|Overall Study||38
6267720|NCT00058123|7166917|FG000|STARTED|Overall Study||55
6267721|NCT00058123|7166917|FG000|COMPLETED|Overall Study||45
6267722|NCT00058123|7166917|FG000|NOT COMPLETED|Overall Study||10
6267723|NCT00058214|7166922|FG000|STARTED|Overall Study||25
6267724|NCT00058214|7166922|FG000|COMPLETED|Overall Study||24
6267725|NCT00058214|7166922|FG000|NOT COMPLETED|Overall Study||1
6267726|NCT00058240|7166930|FG000|STARTED|First Dose Level||20
6267727|NCT00058240|7166931|FG001|STARTED|First Dose Level||3
6267728|NCT00058240|7166932|FG002|STARTED|First Dose Level||17
6267729|NCT00058240|7166933|FG003|STARTED|First Dose Level||12
6267730|NCT00058240|7166930|FG000|Treated|First Dose Level||20
6267731|NCT00058240|7166931|FG001|Treated|First Dose Level||3
6267732|NCT00058240|7166932|FG002|Treated|First Dose Level||17
6267733|NCT00058240|7166933|FG003|Treated|First Dose Level||12
6267734|NCT00058240|7166930|FG000|COMPLETED|First Dose Level||20
6267735|NCT00058240|7166931|FG001|COMPLETED|First Dose Level||3
6267736|NCT00058240|7166932|FG002|COMPLETED|First Dose Level||17
6267737|NCT00058240|7166933|FG003|COMPLETED|First Dose Level||12
6267738|NCT00058240|7166930|FG000|NOT COMPLETED|First Dose Level||0
6267739|NCT00058240|7166931|FG001|NOT COMPLETED|First Dose Level||0
6267740|NCT00058240|7166932|FG002|NOT COMPLETED|First Dose Level||0
6267741|NCT00058240|7166933|FG003|NOT COMPLETED|First Dose Level||0
6267742|NCT00058240|7166930|FG000|STARTED|Second Dose Level||0
6267743|NCT00058240|7166931|FG001|STARTED|Second Dose Level||0
6267744|NCT00058240|7166932|FG002|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
6267745|NCT00058240|7166933|FG003|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
6267746|NCT00058240|7166930|FG000|COMPLETED|Second Dose Level||0
6267747|NCT00058240|7166931|FG001|COMPLETED|Second Dose Level||0
6267748|NCT00058240|7166932|FG002|COMPLETED|Second Dose Level||2
6267749|NCT00058240|7166933|FG003|COMPLETED|Second Dose Level||4
6267750|NCT00058240|7166930|FG000|NOT COMPLETED|Second Dose Level||0
6267751|NCT00058240|7166931|FG001|NOT COMPLETED|Second Dose Level||0
6267752|NCT00058240|7166932|FG002|NOT COMPLETED|Second Dose Level||0
6267753|NCT00058240|7166933|FG003|NOT COMPLETED|Second Dose Level||0
6267754|NCT00058370|7166943|FG000|STARTED|Overall Study||6
6267755|NCT00058370|7166943|FG000|COMPLETED|Overall Study||6
6267756|NCT00058370|7166943|FG000|NOT COMPLETED|Overall Study||0
6267757|NCT00058422|7166947|FG000|STARTED|Overall Study||65
6267758|NCT00058422|7166947|FG000|COMPLETED|Overall Study||63
6267759|NCT00058422|7166947|FG000|NOT COMPLETED|Overall Study||2
6267760|NCT00058539|7166951|FG000|STARTED|Overall Study||42
6267761|NCT00058539|7166951|FG000|COMPLETED|Overall Study||0
6267762|NCT00058539|7166951|FG000|NOT COMPLETED|Overall Study||42
6267763|NCT00058552|7166957|FG000|STARTED|Overall Study||65
6267764|NCT00058552|7166958|FG001|STARTED|Overall Study||64
6267765|NCT00058552|7166957|FG000|COMPLETED|Overall Study||0
6267766|NCT00058552|7166958|FG001|COMPLETED|Overall Study||2
6267767|NCT00058552|7166957|FG000|NOT COMPLETED|Overall Study||65
6267768|NCT00058552|7166958|FG001|NOT COMPLETED|Overall Study||62
6267769|NCT00058825|7166966|FG000|STARTED|Overall Study||27
6267770|NCT00058825|7166966|FG000|COMPLETED|Overall Study||5
6267771|NCT00058825|7166966|FG000|NOT COMPLETED|Overall Study||22
6267772|NCT00059202|7166974|FG000|STARTED|Overall Study||76
6267773|NCT00059202|7166975|FG001|STARTED|Overall Study||74
6267774|NCT00059202|7166974|FG000|COMPLETED|Overall Study||70
6267775|NCT00059202|7166975|FG001|COMPLETED|Overall Study||59
6267776|NCT00059202|7166974|FG000|NOT COMPLETED|Overall Study||6
6267777|NCT00059202|7166975|FG001|NOT COMPLETED|Overall Study||15
6267778|NCT00059215|7166988|FG000|STARTED|Overall Study||200
6267779|NCT00059215|7166989|FG001|STARTED|Overall Study||200
6267780|NCT00059215|7166990|FG002|STARTED|Overall Study||251
6267781|NCT00059215|7166991|FG003|STARTED|Overall Study||254
6267782|NCT00059215|7166988|FG000|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
6267783|NCT00059215|7166989|FG001|COMPLETED|Overall Study||186
6267784|NCT00059215|7166990|FG002|COMPLETED|Overall Study||236
6267785|NCT00059215|7166991|FG003|COMPLETED|Overall Study||239
6267786|NCT00059215|7166988|FG000|NOT COMPLETED|Overall Study||13
6267787|NCT00059215|7166989|FG001|NOT COMPLETED|Overall Study||14
6267788|NCT00059215|7166990|FG002|NOT COMPLETED|Overall Study||15
6267789|NCT00059215|7166991|FG003|NOT COMPLETED|Overall Study||15
6267790|NCT00059228|7167004|FG000|STARTED|Overall Study||6
6267791|NCT00059228|7167005|FG001|STARTED|Overall Study||6
6267792|NCT00059228|7167004|FG000|COMPLETED|Overall Study||6
6267793|NCT00059228|7167005|FG001|COMPLETED|Overall Study||5
6267794|NCT00059228|7167004|FG000|NOT COMPLETED|Overall Study||0
6267795|NCT00059228|7167005|FG001|NOT COMPLETED|Overall Study||1
6267796|NCT00059332|7167013|FG000|STARTED|Overall Study||843
6267797|NCT00059332|7167014|FG001|STARTED|Overall Study||857
6267798|NCT00059332|7167013|FG000|COMPLETED|Overall Study||840
6267799|NCT00059332|7167014|FG001|COMPLETED|Overall Study||855
6267800|NCT00059332|7167013|FG000|NOT COMPLETED|Overall Study||3
6267801|NCT00059332|7167014|FG001|NOT COMPLETED|Overall Study||2
6267802|NCT00059475|7167028|FG000|STARTED|Overall Study||33
6267803|NCT00059475|7167029|FG001|STARTED|Overall Study||2
6267804|NCT00059475|7167030|FG002|STARTED|Overall Study||24
6267805|NCT00059475|7167031|FG003|STARTED|Overall Study||3
6267806|NCT00059475|7167032|FG004|STARTED|Overall Study||33
6267807|NCT00059475|7167033|FG005|STARTED|Overall Study||2
6267808|NCT00059475|7167034|FG006|STARTED|Overall Study||34
6267809|NCT00059475|7167035|FG007|STARTED|Overall Study||7
6267810|NCT00059475|7167028|FG000|COMPLETED|Overall Study||33
6267811|NCT00059475|7167029|FG001|COMPLETED|Overall Study||2
6267812|NCT00059475|7167030|FG002|COMPLETED|Overall Study||24
6267813|NCT00059475|7167031|FG003|COMPLETED|Overall Study||3
6267814|NCT00059475|7167032|FG004|COMPLETED|Overall Study||33
6267815|NCT00059475|7167033|FG005|COMPLETED|Overall Study||2
6267816|NCT00059475|7167034|FG006|COMPLETED|Overall Study||34
6267817|NCT00059475|7167035|FG007|COMPLETED|Overall Study||7
6267818|NCT00059475|7167028|FG000|NOT COMPLETED|Overall Study||0
6267819|NCT00059475|7167029|FG001|NOT COMPLETED|Overall Study||0
6267820|NCT00059475|7167030|FG002|NOT COMPLETED|Overall Study||0
6267821|NCT00059475|7167031|FG003|NOT COMPLETED|Overall Study||0
6267822|NCT00059475|7167032|FG004|NOT COMPLETED|Overall Study||0
6267823|NCT00059475|7167033|FG005|NOT COMPLETED|Overall Study||0
6267824|NCT00059475|7167034|FG006|NOT COMPLETED|Overall Study||0
6267825|NCT00059475|7167035|FG007|NOT COMPLETED|Overall Study||0
6267826|NCT00059787|7167060|FG000|STARTED|Overall Study||56
6267827|NCT00059787|7167060|FG000|COMPLETED|Overall Study||36
6267828|NCT00059787|7167060|FG000|NOT COMPLETED|Overall Study||20
6267829|NCT00059839|7167067|FG000|STARTED|Overall Study||65
6267830|NCT00059839|7167068|FG001|STARTED|Overall Study||64
6267831|NCT00059839|7167067|FG000|COMPLETED|Overall Study||53
6267832|NCT00059839|7167068|FG001|COMPLETED|Overall Study||47
6267833|NCT00059839|7167067|FG000|NOT COMPLETED|Overall Study||12
6267834|NCT00059839|7167068|FG001|NOT COMPLETED|Overall Study||17
6267835|NCT00060008|7167074|FG000|STARTED|Overall Study||18
6267836|NCT00060008|7167074|FG000|COMPLETED|Overall Study||18
6267837|NCT00060008|7167074|FG000|NOT COMPLETED|Overall Study||0
6267838|NCT00060333|7167079|FG000|STARTED|Overall Study||20
6267839|NCT00060333|7167079|FG000|COMPLETED|Overall Study||20
6267840|NCT00060333|7167079|FG000|NOT COMPLETED|Overall Study||0
6267841|NCT00060346|7167086|FG000|STARTED|Overall Study||16
6267842|NCT00060346|7167086|FG000|Eligible and Treated|Overall Study||16
6267843|NCT00060346|7167086|FG000|COMPLETED|Overall Study||16
6267844|NCT00060346|7167086|FG000|NOT COMPLETED|Overall Study||0
6267845|NCT00060424|7167090|FG000|STARTED|Overall Study||21
6267846|NCT00060424|7167090|FG000|COMPLETED|Overall Study||21
6267847|NCT00060424|7167090|FG000|NOT COMPLETED|Overall Study||0
6267848|NCT00060528|7167094|FG000|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
6267849|NCT00060528|7167095|FG001|STARTED|Overall Study||9
6267850|NCT00060528|7167096|FG002|STARTED|Overall Study||7
6267851|NCT00060528|7167097|FG003|STARTED|Overall Study||8
6267852|NCT00060528|7167094|FG000|COMPLETED|Overall Study||8
6267853|NCT00060528|7167095|FG001|COMPLETED|Overall Study||9
6267854|NCT00060528|7167096|FG002|COMPLETED|Overall Study||7
6267855|NCT00060528|7167097|FG003|COMPLETED|Overall Study||8
6267856|NCT00060528|7167094|FG000|NOT COMPLETED|Overall Study||0
6267857|NCT00060528|7167095|FG001|NOT COMPLETED|Overall Study||0
6267858|NCT00060528|7167096|FG002|NOT COMPLETED|Overall Study||0
6267859|NCT00060528|7167097|FG003|NOT COMPLETED|Overall Study||0
6267860|NCT00060606|7167112|FG000|STARTED|Overall Study||91
6267861|NCT00060606|7167113|FG001|STARTED|Overall Study||92
6267862|NCT00060606|7167112|FG000|First Primary Outcome - Shunt at 12 Mont|Overall Study||91
6267863|NCT00060606|7167113|FG001|First Primary Outcome - Shunt at 12 Mont|Overall Study||92
6267864|NCT00060606|7167112|FG000|COMPLETED|Overall Study||91
6267865|NCT00060606|7167113|FG001|COMPLETED|Overall Study||91
6267866|NCT00060606|7167112|FG000|NOT COMPLETED|Overall Study||0
6267867|NCT00060606|7167113|FG001|NOT COMPLETED|Overall Study||1
6267868|NCT00060840|7167121|FG000|STARTED|Overall Study||73
6267869|NCT00060840|7167122|FG001|STARTED|Overall Study||77
6267870|NCT00060840|7167121|FG000|COMPLETED|Overall Study||69
6267871|NCT00060840|7167122|FG001|COMPLETED|Overall Study||68
6267872|NCT00060840|7167121|FG000|NOT COMPLETED|Overall Study||4
6267873|NCT00060840|7167122|FG001|NOT COMPLETED|Overall Study||9
6267874|NCT00060944|7167130|FG000|STARTED|Overall Study||136
6267875|NCT00060944|7167131|FG001|STARTED|Overall Study||134
6267876|NCT00060944|7167130|FG000|Treated|Overall Study||130
6267877|NCT00060944|7167131|FG001|Treated|Overall Study||130
6267878|NCT00060944|7167130|FG000|COMPLETED|Overall Study||0
6267879|NCT00060944|7167131|FG001|COMPLETED|Overall Study||0
6267880|NCT00060944|7167130|FG000|NOT COMPLETED|Overall Study||136
6267881|NCT00060944|7167131|FG001|NOT COMPLETED|Overall Study||134
6267882|NCT00061048|7167137|FG000|STARTED|Overall Study||29
6267883|NCT00061048|7167137|FG000|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
6267884|NCT00061048|7167137|FG000|NOT COMPLETED|Overall Study||22
6267885|NCT00061373|7167143|FG000|STARTED|Overall Study||15
6267886|NCT00061373|7167144|FG001|STARTED|Overall Study||3
6267887|NCT00061373|7167143|FG000|Aspirin and Tinzaparin|Overall Study||15
6267888|NCT00061373|7167144|FG001|Aspirin and Tinzaparin|Overall Study||3
6267889|NCT00061373|7167143|FG000|COMPLETED|Overall Study||15
6267890|NCT00061373|7167144|FG001|COMPLETED|Overall Study||3
6267891|NCT00061373|7167143|FG000|NOT COMPLETED|Overall Study||0
6267892|NCT00061373|7167144|FG001|NOT COMPLETED|Overall Study||0
6267893|NCT00061633|7167152|FG000|STARTED|Overall Study||84
6267894|NCT00061633|7167153|FG001|STARTED|Overall Study||85
6267895|NCT00061633|7167152|FG000|COMPLETED|Overall Study||79
6267896|NCT00061633|7167153|FG001|COMPLETED|Overall Study||74
6267897|NCT00061633|7167152|FG000|NOT COMPLETED|Overall Study||5
6267898|NCT00061633|7167153|FG001|NOT COMPLETED|Overall Study||11
6267899|NCT00061893|7167159|FG000|STARTED|Overall Study||38
6267900|NCT00061893|7167159|FG000|COMPLETED|Overall Study||20
6267901|NCT00061893|7167159|FG000|NOT COMPLETED|Overall Study||18
6267902|NCT00061932|7167165|FG000|STARTED|Overall Study||29
6267903|NCT00061932|7167166|FG001|STARTED|Overall Study||12
6267904|NCT00061932|7167165|FG000|COMPLETED|Overall Study||16
6267905|NCT00061932|7167166|FG001|COMPLETED|Overall Study||8
6267906|NCT00061932|7167165|FG000|NOT COMPLETED|Overall Study||13
6267907|NCT00061932|7167166|FG001|NOT COMPLETED|Overall Study||4
6267908|NCT00061945|7167175|FG000|STARTED|Registration Through Course 3||119
6267909|NCT00061945|7167176|FG001|STARTED|Registration Through Course 3||181
6267910|NCT00061945|7167175|FG000|COMPLETED|Registration Through Course 3||25
6267911|NCT00061945|7167176|FG001|COMPLETED|Registration Through Course 3||66
6267912|NCT00061945|7167175|FG000|NOT COMPLETED|Registration Through Course 3||94
6267913|NCT00061945|7167176|FG001|NOT COMPLETED|Registration Through Course 3||115
6267914|NCT00061945|7167175|FG000|STARTED|Course IV: Alemtuzumab||25
6267915|NCT00061945|7167176|FG001|STARTED|Course IV: Alemtuzumab||66
6267916|NCT00061945|7167175|FG000|COMPLETED|Course IV: Alemtuzumab||18
6267917|NCT00061945|7167176|FG001|COMPLETED|Course IV: Alemtuzumab||50
6267918|NCT00061945|7167175|FG000|NOT COMPLETED|Course IV: Alemtuzumab||7
6267919|NCT00061945|7167176|FG001|NOT COMPLETED|Course IV: Alemtuzumab||16
6280525|NCT00157755|7180504|FG005|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
6280526|NCT00157755|7180499|FG000|NOT COMPLETED|Overall Study||2
6280527|NCT00157755|7180500|FG001|NOT COMPLETED|Overall Study||4
6280528|NCT00157755|7180501|FG002|NOT COMPLETED|Overall Study||7
6280529|NCT00157755|7180502|FG003|NOT COMPLETED|Overall Study||4
6280530|NCT00157755|7180503|FG004|NOT COMPLETED|Overall Study||2
6280531|NCT00157755|7180504|FG005|NOT COMPLETED|Overall Study||5
6280532|NCT00157820|7180513|FG000|STARTED|Randomized||118
6280533|NCT00157820|7180514|FG001|STARTED|Randomized||116
6280534|NCT00157820|7180515|FG002|STARTED|Randomized||120
6280535|NCT00157820|7180513|FG000|COMPLETED|Randomized||111
6280536|NCT00157820|7180514|FG001|COMPLETED|Randomized||111
6280537|NCT00157820|7180515|FG002|COMPLETED|Randomized||112
6280538|NCT00157820|7180513|FG000|NOT COMPLETED|Randomized||7
6280539|NCT00157820|7180514|FG001|NOT COMPLETED|Randomized||5
6280540|NCT00157820|7180515|FG002|NOT COMPLETED|Randomized||8
6280541|NCT00157820|7180513|FG000|STARTED|1st 8 Month||111
6280542|NCT00157820|7180514|FG001|STARTED|1st 8 Month||111
6280543|NCT00157820|7180515|FG002|STARTED|1st 8 Month||112
6280544|NCT00157820|7180513|FG000|COMPLETED|1st 8 Month||103
6280545|NCT00157820|7180514|FG001|COMPLETED|1st 8 Month||99
6280546|NCT00157820|7180515|FG002|COMPLETED|1st 8 Month||106
6280547|NCT00157820|7180513|FG000|NOT COMPLETED|1st 8 Month||8
6280548|NCT00157820|7180514|FG001|NOT COMPLETED|1st 8 Month||12
6280549|NCT00157820|7180515|FG002|NOT COMPLETED|1st 8 Month||6
6280550|NCT00157820|7180513|FG000|STARTED|1 Month Wash Out Period||103
6280551|NCT00157820|7180514|FG001|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
6280552|NCT00157820|7180515|FG002|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
6280553|NCT00157820|7180513|FG000|COMPLETED|1 Month Wash Out Period||103
6280554|NCT00157820|7180514|FG001|COMPLETED|1 Month Wash Out Period||101
6280555|NCT00157820|7180515|FG002|COMPLETED|1 Month Wash Out Period||108
6280556|NCT00157820|7180513|FG000|NOT COMPLETED|1 Month Wash Out Period||0
6280557|NCT00157820|7180514|FG001|NOT COMPLETED|1 Month Wash Out Period||0
6280558|NCT00157820|7180515|FG002|NOT COMPLETED|1 Month Wash Out Period||0
6280559|NCT00157820|7180513|FG000|STARTED|2nd 8 Months||103
6280560|NCT00157820|7180514|FG001|STARTED|2nd 8 Months||101
6280561|NCT00157820|7180515|FG002|STARTED|2nd 8 Months||108
6280562|NCT00157820|7180513|FG000|COMPLETED|2nd 8 Months||98
6280563|NCT00157820|7180514|FG001|COMPLETED|2nd 8 Months||88
6280564|NCT00157820|7180515|FG002|COMPLETED|2nd 8 Months||94
6280565|NCT00157820|7180513|FG000|NOT COMPLETED|2nd 8 Months||5
6280566|NCT00157820|7180514|FG001|NOT COMPLETED|2nd 8 Months||13
6280567|NCT00157820|7180515|FG002|NOT COMPLETED|2nd 8 Months||14
6280568|NCT00157950|7180526|FG000|STARTED|Overall Study||117
6280569|NCT00157950|7180527|FG001|STARTED|Overall Study||59
6280570|NCT00157950|7180526|FG000|Vaccinated at Dose 1|Overall Study||117
6280571|NCT00157950|7180527|FG001|Vaccinated at Dose 1|Overall Study||59
6280572|NCT00157950|7180526|FG000|Vaccinated at Dose 2|Overall Study||117
6280573|NCT00157950|7180527|FG001|Vaccinated at Dose 2|Overall Study||59
6280574|NCT00157950|7180526|FG000|Vaccinated at Dose 3|Overall Study||116
6280575|NCT00157950|7180527|FG001|Vaccinated at Dose 3|Overall Study||59
6280576|NCT00157950|7180526|FG000|COMPLETED|Overall Study||116
6280577|NCT00157950|7180527|FG001|COMPLETED|Overall Study||59
6280578|NCT00157950|7180526|FG000|NOT COMPLETED|Overall Study||1
6280579|NCT00157950|7180527|FG001|NOT COMPLETED|Overall Study||0
6280580|NCT00158054|7180535|FG000|STARTED|Overall Study||80
6280581|NCT00158054|7180536|FG001|STARTED|Overall Study||77
6280582|NCT00158054|7180535|FG000|COMPLETED|Overall Study||70
6280583|NCT00158054|7180536|FG001|COMPLETED|Overall Study||74
6280584|NCT00158054|7180535|FG000|NOT COMPLETED|Overall Study||10
6280585|NCT00158054|7180536|FG001|NOT COMPLETED|Overall Study||3
6280586|NCT00158184|7180544|FG000|STARTED|Overall Study||16
6280587|NCT00158184|7180545|FG001|STARTED|Overall Study||11
6280588|NCT00158184|7180544|FG000|COMPLETED|Overall Study||10
6280589|NCT00158184|7180545|FG001|COMPLETED|Overall Study||9
6280590|NCT00158184|7180544|FG000|NOT COMPLETED|Overall Study||6
6280591|NCT00158184|7180545|FG001|NOT COMPLETED|Overall Study||2
6267920|NCT00062010|7167184|FG000|STARTED|Overall Study||37
6267921|NCT00062010|7167184|FG000|Eligible and Treated|Overall Study||34
6267922|NCT00062010|7167184|FG000|COMPLETED|Overall Study||34
6267923|NCT00062010|7167184|FG000|NOT COMPLETED|Overall Study||3
6267924|NCT00062166|7167188|FG000|STARTED|Overall Study||340
6267925|NCT00062166|7167188|FG000|COMPLETED|Overall Study||334
6267926|NCT00062166|7167188|FG000|NOT COMPLETED|Overall Study||6
6267927|NCT00062374|7167193|FG000|STARTED|Overall Study||55
6267928|NCT00062374|7167193|FG000|COMPLETED|Overall Study||43
6267929|NCT00062374|7167193|FG000|NOT COMPLETED|Overall Study||12
6267930|NCT00062439|7167197|FG000|STARTED|Induction Chemotherapy + Radiotherapy||46
6267931|NCT00062439|7167197|FG000|COMPLETED|Induction Chemotherapy + Radiotherapy||38
6267932|NCT00062439|7167197|FG000|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
6267933|NCT00062439|7167197|FG000|STARTED|Post Chemoradiation Assessment||38
6267934|NCT00062439|7167197|FG000|COMPLETED|Post Chemoradiation Assessment||29
6267935|NCT00062439|7167197|FG000|NOT COMPLETED|Post Chemoradiation Assessment||9
6267936|NCT00062439|7167197|FG000|STARTED|Surgery||29
6267937|NCT00062439|7167197|FG000|COMPLETED|Surgery||22
6267938|NCT00062439|7167197|FG000|NOT COMPLETED|Surgery||7
6267939|NCT00062439|7167197|FG000|STARTED|Consolidation Chemotherapy||22
6267940|NCT00062439|7167197|FG000|COMPLETED|Consolidation Chemotherapy||20
6267941|NCT00062439|7167197|FG000|NOT COMPLETED|Consolidation Chemotherapy||2
6267942|NCT00062647|7167208|FG000|STARTED|Overall Study||30
6267943|NCT00062647|7167209|FG001|STARTED|Overall Study||30
6267944|NCT00062647|7167208|FG000|COMPLETED|Overall Study||14
6267945|NCT00062647|7167209|FG001|COMPLETED|Overall Study||17
6267946|NCT00062647|7167208|FG000|NOT COMPLETED|Overall Study||16
6267947|NCT00062647|7167209|FG001|NOT COMPLETED|Overall Study||13
6267948|NCT00062738|7167218|FG000|STARTED|Overall Study||17
6267949|NCT00062738|7167219|FG001|STARTED|Overall Study||18
6267950|NCT00062738|7167220|FG002|STARTED|Overall Study||17
6267951|NCT00062738|7167218|FG000|COMPLETED|Overall Study||17
6267952|NCT00062738|7167219|FG001|COMPLETED|Overall Study||18
6267953|NCT00062738|7167220|FG002|COMPLETED|Overall Study||17
6267954|NCT00062738|7167218|FG000|NOT COMPLETED|Overall Study||0
6267955|NCT00062738|7167219|FG001|NOT COMPLETED|Overall Study||0
6267956|NCT00062738|7167220|FG002|NOT COMPLETED|Overall Study||0
6267957|NCT00062764|7167231|FG000|STARTED|Overall Study||18
6267958|NCT00062764|7167231|FG000|COMPLETED|Overall Study||18
6267959|NCT00062764|7167231|FG000|NOT COMPLETED|Overall Study||0
6267960|NCT00062868|7167256|FG000|STARTED|Dose Level 1||3
6267961|NCT00062868|7167257|FG001|STARTED|Dose Level 1||0
6267962|NCT00062868|7167258|FG002|STARTED|Dose Level 1||0
6267963|NCT00062868|7167259|FG003|STARTED|Dose Level 1||3
6267964|NCT00062868|7167260|FG004|STARTED|Dose Level 1||0
6267965|NCT00062868|7167261|FG005|STARTED|Dose Level 1||0
6267966|NCT00062868|7167262|FG006|STARTED|Dose Level 1||4
6267967|NCT00062868|7167263|FG007|STARTED|Dose Level 1||0
6267968|NCT00062868|7167264|FG008|STARTED|Dose Level 1||0
6267969|NCT00062868|7167265|FG009|STARTED|Dose Level 1||3
6267970|NCT00062868|7167266|FG010|STARTED|Dose Level 1||0
6267971|NCT00062868|7167267|FG011|STARTED|Dose Level 1||0
6267972|NCT00062868|7167268|FG012|STARTED|Dose Level 1||3
6267973|NCT00062868|7167269|FG013|STARTED|Dose Level 1||0
6267974|NCT00062868|7167270|FG014|STARTED|Dose Level 1||0
6267975|NCT00062868|7167271|FG015|STARTED|Dose Level 1||3
6267976|NCT00062868|7167272|FG016|STARTED|Dose Level 1||0
6267977|NCT00062868|7167273|FG017|STARTED|Dose Level 1||0
6267978|NCT00062868|7167274|FG018|STARTED|Dose Level 1||16
6267979|NCT00062868|7167275|FG019|STARTED|Dose Level 1||2
6267980|NCT00062868|7167276|FG020|STARTED|Dose Level 1||3
6267981|NCT00062868|7167256|FG000|COMPLETED|Dose Level 1||1
6267982|NCT00062868|7167257|FG001|COMPLETED|Dose Level 1||0
6267983|NCT00062868|7167258|FG002|COMPLETED|Dose Level 1||0
6267984|NCT00062868|7167259|FG003|COMPLETED|Dose Level 1||1
6267985|NCT00062868|7167260|FG004|COMPLETED|Dose Level 1||0
6267986|NCT00062868|7167261|FG005|COMPLETED|Dose Level 1||0
6267987|NCT00062868|7167262|FG006|COMPLETED|Dose Level 1||1
6267988|NCT00062868|7167263|FG007|COMPLETED|Dose Level 1||0
6267989|NCT00062868|7167264|FG008|COMPLETED|Dose Level 1||0
6267990|NCT00062868|7167265|FG009|COMPLETED|Dose Level 1||3
6267991|NCT00062868|7167266|FG010|COMPLETED|Dose Level 1||0
6267992|NCT00062868|7167267|FG011|COMPLETED|Dose Level 1||0
6267993|NCT00062868|7167268|FG012|COMPLETED|Dose Level 1||2
6267994|NCT00062868|7167269|FG013|COMPLETED|Dose Level 1||0
6267995|NCT00062868|7167270|FG014|COMPLETED|Dose Level 1||0
6267996|NCT00062868|7167271|FG015|COMPLETED|Dose Level 1||3
6267997|NCT00062868|7167272|FG016|COMPLETED|Dose Level 1||0
6267998|NCT00062868|7167273|FG017|COMPLETED|Dose Level 1||0
6267999|NCT00062868|7167274|FG018|COMPLETED|Dose Level 1||7
6268000|NCT00062868|7167275|FG019|COMPLETED|Dose Level 1||2
6268001|NCT00062868|7167276|FG020|COMPLETED|Dose Level 1||1
6268002|NCT00062868|7167256|FG000|NOT COMPLETED|Dose Level 1||2
6268003|NCT00062868|7167257|FG001|NOT COMPLETED|Dose Level 1||0
6268004|NCT00062868|7167258|FG002|NOT COMPLETED|Dose Level 1||0
6268005|NCT00062868|7167259|FG003|NOT COMPLETED|Dose Level 1||2
6268006|NCT00062868|7167260|FG004|NOT COMPLETED|Dose Level 1||0
6268007|NCT00062868|7167261|FG005|NOT COMPLETED|Dose Level 1||0
6268008|NCT00062868|7167262|FG006|NOT COMPLETED|Dose Level 1||3
6268009|NCT00062868|7167263|FG007|NOT COMPLETED|Dose Level 1||0
6268010|NCT00062868|7167264|FG008|NOT COMPLETED|Dose Level 1||0
6268011|NCT00062868|7167265|FG009|NOT COMPLETED|Dose Level 1||0
6268012|NCT00062868|7167266|FG010|NOT COMPLETED|Dose Level 1||0
6268013|NCT00062868|7167267|FG011|NOT COMPLETED|Dose Level 1||0
6268014|NCT00062868|7167268|FG012|NOT COMPLETED|Dose Level 1||1
6268015|NCT00062868|7167269|FG013|NOT COMPLETED|Dose Level 1||0
6268016|NCT00062868|7167270|FG014|NOT COMPLETED|Dose Level 1||0
6268017|NCT00062868|7167271|FG015|NOT COMPLETED|Dose Level 1||0
6268018|NCT00062868|7167272|FG016|NOT COMPLETED|Dose Level 1||0
6268019|NCT00062868|7167273|FG017|NOT COMPLETED|Dose Level 1||0
6268020|NCT00062868|7167274|FG018|NOT COMPLETED|Dose Level 1||9
6268021|NCT00062868|7167275|FG019|NOT COMPLETED|Dose Level 1||0
6268022|NCT00062868|7167276|FG020|NOT COMPLETED|Dose Level 1||2
6268023|NCT00062868|7167256|FG000|STARTED|Dose Level 2||0
6268024|NCT00062868|7167257|FG001|STARTED|Dose Level 2||6
6268025|NCT00062868|7167258|FG002|STARTED|Dose Level 2||0
6268026|NCT00062868|7167259|FG003|STARTED|Dose Level 2||0
6268027|NCT00062868|7167260|FG004|STARTED|Dose Level 2||3
6268028|NCT00062868|7167261|FG005|STARTED|Dose Level 2||0
6268029|NCT00062868|7167262|FG006|STARTED|Dose Level 2||0
6268030|NCT00062868|7167263|FG007|STARTED|Dose Level 2||0
6268031|NCT00062868|7167264|FG008|STARTED|Dose Level 2||0
6268032|NCT00062868|7167265|FG009|STARTED|Dose Level 2||0
6268033|NCT00062868|7167266|FG010|STARTED|Dose Level 2||4
6268034|NCT00062868|7167267|FG011|STARTED|Dose Level 2||0
6268035|NCT00062868|7167268|FG012|STARTED|Dose Level 2||0
6268036|NCT00062868|7167269|FG013|STARTED|Dose Level 2||3
6268037|NCT00062868|7167270|FG014|STARTED|Dose Level 2||0
6268038|NCT00062868|7167271|FG015|STARTED|Dose Level 2||0
6268039|NCT00062868|7167272|FG016|STARTED|Dose Level 2||3
6268040|NCT00062868|7167273|FG017|STARTED|Dose Level 2||0
6268041|NCT00062868|7167274|FG018|STARTED|Dose Level 2||0
6268042|NCT00062868|7167275|FG019|STARTED|Dose Level 2||0
6268043|NCT00062868|7167276|FG020|STARTED|Dose Level 2||0
6268044|NCT00062868|7167256|FG000|COMPLETED|Dose Level 2||0
6268045|NCT00062868|7167257|FG001|COMPLETED|Dose Level 2||3
6268046|NCT00062868|7167258|FG002|COMPLETED|Dose Level 2||0
6268047|NCT00062868|7167259|FG003|COMPLETED|Dose Level 2||0
6268048|NCT00062868|7167260|FG004|COMPLETED|Dose Level 2||1
6268049|NCT00062868|7167261|FG005|COMPLETED|Dose Level 2||0
6268050|NCT00062868|7167262|FG006|COMPLETED|Dose Level 2||0
6268051|NCT00062868|7167263|FG007|COMPLETED|Dose Level 2||0
6268052|NCT00062868|7167264|FG008|COMPLETED|Dose Level 2||0
6268053|NCT00062868|7167265|FG009|COMPLETED|Dose Level 2||0
6268054|NCT00062868|7167266|FG010|COMPLETED|Dose Level 2||3
6268055|NCT00062868|7167267|FG011|COMPLETED|Dose Level 2||0
6268056|NCT00062868|7167268|FG012|COMPLETED|Dose Level 2||0
6268057|NCT00062868|7167269|FG013|COMPLETED|Dose Level 2||2
6268058|NCT00062868|7167270|FG014|COMPLETED|Dose Level 2||0
6268059|NCT00062868|7167271|FG015|COMPLETED|Dose Level 2||0
6268060|NCT00062868|7167272|FG016|COMPLETED|Dose Level 2||0
6268061|NCT00062868|7167273|FG017|COMPLETED|Dose Level 2||0
6268062|NCT00062868|7167274|FG018|COMPLETED|Dose Level 2||0
6268063|NCT00062868|7167275|FG019|COMPLETED|Dose Level 2||0
6268064|NCT00062868|7167276|FG020|COMPLETED|Dose Level 2||0
6268065|NCT00062868|7167256|FG000|NOT COMPLETED|Dose Level 2||0
6268066|NCT00062868|7167257|FG001|NOT COMPLETED|Dose Level 2||3
6268067|NCT00062868|7167258|FG002|NOT COMPLETED|Dose Level 2||0
6268068|NCT00062868|7167259|FG003|NOT COMPLETED|Dose Level 2||0
6268069|NCT00062868|7167260|FG004|NOT COMPLETED|Dose Level 2||2
6268070|NCT00062868|7167261|FG005|NOT COMPLETED|Dose Level 2||0
6268071|NCT00062868|7167262|FG006|NOT COMPLETED|Dose Level 2||0
6268072|NCT00062868|7167263|FG007|NOT COMPLETED|Dose Level 2||0
6268073|NCT00062868|7167264|FG008|NOT COMPLETED|Dose Level 2||0
6268074|NCT00062868|7167265|FG009|NOT COMPLETED|Dose Level 2||0
6268075|NCT00062868|7167266|FG010|NOT COMPLETED|Dose Level 2||1
6268076|NCT00062868|7167267|FG011|NOT COMPLETED|Dose Level 2||0
6268077|NCT00062868|7167268|FG012|NOT COMPLETED|Dose Level 2||0
6268078|NCT00062868|7167269|FG013|NOT COMPLETED|Dose Level 2||1
6268079|NCT00062868|7167270|FG014|NOT COMPLETED|Dose Level 2||0
6268080|NCT00062868|7167271|FG015|NOT COMPLETED|Dose Level 2||0
6268081|NCT00062868|7167272|FG016|NOT COMPLETED|Dose Level 2||3
6268082|NCT00062868|7167273|FG017|NOT COMPLETED|Dose Level 2||0
6268083|NCT00062868|7167274|FG018|NOT COMPLETED|Dose Level 2||0
6268084|NCT00062868|7167275|FG019|NOT COMPLETED|Dose Level 2||0
6268085|NCT00062868|7167276|FG020|NOT COMPLETED|Dose Level 2||0
6268086|NCT00062868|7167256|FG000|STARTED|Dose Level 3||0
6268087|NCT00062868|7167257|FG001|STARTED|Dose Level 3||0
6268088|NCT00062868|7167258|FG002|STARTED|Dose Level 3||3
6268089|NCT00062868|7167259|FG003|STARTED|Dose Level 3||0
6268090|NCT00062868|7167260|FG004|STARTED|Dose Level 3||0
6268091|NCT00062868|7167261|FG005|STARTED|Dose Level 3||0
6268092|NCT00062868|7167262|FG006|STARTED|Dose Level 3||0
6268093|NCT00062868|7167263|FG007|STARTED|Dose Level 3||0
6268094|NCT00062868|7167264|FG008|STARTED|Dose Level 3||0
6268095|NCT00062868|7167265|FG009|STARTED|Dose Level 3||0
6268096|NCT00062868|7167266|FG010|STARTED|Dose Level 3||0
6268097|NCT00062868|7167267|FG011|STARTED|Dose Level 3||5
6268098|NCT00062868|7167268|FG012|STARTED|Dose Level 3||0
6268099|NCT00062868|7167269|FG013|STARTED|Dose Level 3||0
6268100|NCT00062868|7167270|FG014|STARTED|Dose Level 3||3
6268101|NCT00062868|7167271|FG015|STARTED|Dose Level 3||0
6268102|NCT00062868|7167272|FG016|STARTED|Dose Level 3||0
6268103|NCT00062868|7167273|FG017|STARTED|Dose Level 3||4
6268104|NCT00062868|7167274|FG018|STARTED|Dose Level 3||0
6268105|NCT00062868|7167275|FG019|STARTED|Dose Level 3||0
6268106|NCT00062868|7167276|FG020|STARTED|Dose Level 3||0
6268107|NCT00062868|7167256|FG000|COMPLETED|Dose Level 3||0
6268108|NCT00062868|7167257|FG001|COMPLETED|Dose Level 3||0
6268109|NCT00062868|7167258|FG002|COMPLETED|Dose Level 3||1
6268110|NCT00062868|7167259|FG003|COMPLETED|Dose Level 3||0
6268111|NCT00062868|7167260|FG004|COMPLETED|Dose Level 3||0
6268112|NCT00062868|7167261|FG005|COMPLETED|Dose Level 3||0
6268113|NCT00062868|7167262|FG006|COMPLETED|Dose Level 3||0
6268114|NCT00062868|7167263|FG007|COMPLETED|Dose Level 3||0
6268115|NCT00062868|7167264|FG008|COMPLETED|Dose Level 3||0
6268116|NCT00062868|7167265|FG009|COMPLETED|Dose Level 3||0
6268117|NCT00062868|7167266|FG010|COMPLETED|Dose Level 3||0
6268118|NCT00062868|7167267|FG011|COMPLETED|Dose Level 3||4
6268119|NCT00062868|7167268|FG012|COMPLETED|Dose Level 3||0
6268120|NCT00062868|7167269|FG013|COMPLETED|Dose Level 3||0
6268121|NCT00062868|7167270|FG014|COMPLETED|Dose Level 3||2
6268122|NCT00062868|7167271|FG015|COMPLETED|Dose Level 3||0
6268123|NCT00062868|7167272|FG016|COMPLETED|Dose Level 3||0
6268124|NCT00062868|7167273|FG017|COMPLETED|Dose Level 3||3
6268125|NCT00062868|7167274|FG018|COMPLETED|Dose Level 3||0
6268126|NCT00062868|7167275|FG019|COMPLETED|Dose Level 3||0
6268127|NCT00062868|7167276|FG020|COMPLETED|Dose Level 3||0
6268128|NCT00062868|7167256|FG000|NOT COMPLETED|Dose Level 3||0
6268129|NCT00062868|7167257|FG001|NOT COMPLETED|Dose Level 3||0
6268130|NCT00062868|7167258|FG002|NOT COMPLETED|Dose Level 3||2
6268131|NCT00062868|7167259|FG003|NOT COMPLETED|Dose Level 3||0
6268132|NCT00062868|7167260|FG004|NOT COMPLETED|Dose Level 3||0
6268133|NCT00062868|7167261|FG005|NOT COMPLETED|Dose Level 3||0
6268134|NCT00062868|7167262|FG006|NOT COMPLETED|Dose Level 3||0
6268135|NCT00062868|7167263|FG007|NOT COMPLETED|Dose Level 3||0
6268136|NCT00062868|7167264|FG008|NOT COMPLETED|Dose Level 3||0
6268137|NCT00062868|7167265|FG009|NOT COMPLETED|Dose Level 3||0
6268138|NCT00062868|7167266|FG010|NOT COMPLETED|Dose Level 3||0
6268139|NCT00062868|7167267|FG011|NOT COMPLETED|Dose Level 3||1
6268140|NCT00062868|7167268|FG012|NOT COMPLETED|Dose Level 3||0
6268141|NCT00062868|7167269|FG013|NOT COMPLETED|Dose Level 3||0
6268142|NCT00062868|7167270|FG014|NOT COMPLETED|Dose Level 3||1
6268143|NCT00062868|7167271|FG015|NOT COMPLETED|Dose Level 3||0
6268144|NCT00062868|7167272|FG016|NOT COMPLETED|Dose Level 3||0
6268145|NCT00062868|7167273|FG017|NOT COMPLETED|Dose Level 3||1
6268146|NCT00062868|7167274|FG018|NOT COMPLETED|Dose Level 3||0
6268147|NCT00062868|7167275|FG019|NOT COMPLETED|Dose Level 3||0
6268148|NCT00062868|7167276|FG020|NOT COMPLETED|Dose Level 3||0
6268149|NCT00063154|7167320|FG000|STARTED|Overall Study||51
6268150|NCT00063154|7167320|FG000|COMPLETED|Overall Study||0
6268151|NCT00063154|7167320|FG000|NOT COMPLETED|Overall Study||51
6268152|NCT00063232|7167324|FG000|STARTED|Overall Study||26
6268153|NCT00063232|7167324|FG000|COMPLETED|Overall Study||26
6268154|NCT00063232|7167324|FG000|NOT COMPLETED|Overall Study||0
6268155|NCT00063258|7167330|FG000|STARTED|Overall Study||5
6268156|NCT00063258|7167331|FG001|STARTED|Overall Study||0
6268157|NCT00063258|7167330|FG000|COMPLETED|Overall Study||1
6268158|NCT00063258|7167331|FG001|COMPLETED|Overall Study||0
6268159|NCT00063258|7167330|FG000|NOT COMPLETED|Overall Study||4
6268160|NCT00063258|7167331|FG001|NOT COMPLETED|Overall Study||0
6268161|NCT00063362|7167339|FG000|STARTED|Overall Study||23
6268162|NCT00063362|7167340|FG001|STARTED|Overall Study||26
6268163|NCT00063362|7167339|FG000|COMPLETED|Overall Study||19
6268164|NCT00063362|7167340|FG001|COMPLETED|Overall Study||22
6268165|NCT00063362|7167339|FG000|NOT COMPLETED|Overall Study||4
6268166|NCT00063362|7167340|FG001|NOT COMPLETED|Overall Study||4
6268167|NCT00063570|7167348|FG000|STARTED|Overall Study||52
6268168|NCT00063570|7167349|FG001|STARTED|Overall Study||21
6268169|NCT00063570|7167348|FG000|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
6268170|NCT00063570|7167349|FG001|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
6268171|NCT00063570|7167348|FG000|NOT COMPLETED|Overall Study||0
6268172|NCT00063570|7167349|FG001|NOT COMPLETED|Overall Study||0
6268173|NCT00063622|7167358|FG000|STARTED|Overall Study||80
6268174|NCT00063622|7167359|FG001|STARTED|Overall Study||84
6268175|NCT00063622|7167360|FG002|STARTED|Overall Study||83
6268176|NCT00063622|7167358|FG000|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
6268177|NCT00063622|7167359|FG001|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
6268178|NCT00063622|7167360|FG002|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
6268179|NCT00063622|7167358|FG000|NOT COMPLETED|Overall Study||10
6268180|NCT00063622|7167359|FG001|NOT COMPLETED|Overall Study||4
6268181|NCT00063622|7167360|FG002|NOT COMPLETED|Overall Study||11
6268182|NCT00063635|7167371|FG000|STARTED|Overall Study||57
6268183|NCT00063635|7167372|FG001|STARTED|Overall Study||58
6268184|NCT00063635|7167373|FG002|STARTED|Overall Study||58
6268185|NCT00063635|7167371|FG000|COMPLETED|Overall Study||51
6268186|NCT00063635|7167372|FG001|COMPLETED|Overall Study||50
6268187|NCT00063635|7167373|FG002|COMPLETED|Overall Study||49
6268188|NCT00063635|7167371|FG000|NOT COMPLETED|Overall Study||6
6268189|NCT00063635|7167372|FG001|NOT COMPLETED|Overall Study||8
6268190|NCT00063635|7167373|FG002|NOT COMPLETED|Overall Study||9
6268191|NCT00063882|7167383|FG000|STARTED|Overall Study||292
6268192|NCT00063882|7167384|FG001|STARTED|Overall Study||296
6268193|NCT00063882|7167383|FG000|Has Acute Adverse Event Data|Overall Study||282
6268194|NCT00063882|7167384|FG001|Has Acute Adverse Event Data|Overall Study||288
6268195|NCT00063882|7167383|FG000|Has Late Adverse Event Data|Overall Study||282
6268196|NCT00063882|7167384|FG001|Has Late Adverse Event Data|Overall Study||287
6268197|NCT00063882|7167383|FG000|Has Baseline/4-month EPIC Data|Overall Study||222
6268198|NCT00063882|7167384|FG001|Has Baseline/4-month EPIC Data|Overall Study||241
6268199|NCT00063882|7167383|FG000|Has Baseline/24-month EPIC Data|Overall Study||201
6268200|NCT00063882|7167384|FG001|Has Baseline/24-month EPIC Data|Overall Study||219
6268201|NCT00063882|7167383|FG000|Eligible Patients|Overall Study||287
6268202|NCT00063882|7167384|FG001|Eligible Patients|Overall Study||292
6268203|NCT00063882|7167383|FG000|COMPLETED|Overall Study||287
6268204|NCT00063882|7167384|FG001|COMPLETED|Overall Study||292
6268205|NCT00063882|7167383|FG000|NOT COMPLETED|Overall Study||5
6268206|NCT00063882|7167384|FG001|NOT COMPLETED|Overall Study||4
6268207|NCT00063934|7167390|FG000|STARTED|Overall Study||31
6268208|NCT00063934|7167390|FG000|COMPLETED|Overall Study||30
6268209|NCT00063934|7167390|FG000|NOT COMPLETED|Overall Study||1
6268210|NCT00063986|7167394|FG000|STARTED|Overall Study||110
6268211|NCT00063986|7167394|FG000|Treated|Overall Study||105
6268212|NCT00063986|7167394|FG000|Eligible and Treated|Overall Study||104
6268213|NCT00063986|7167394|FG000|COMPLETED|Overall Study||104
6392202|NCT00840307|7304205|FG000|COMPLETED|Overall Study||16
6392203|NCT00840307|7304205|FG000|NOT COMPLETED|Overall Study||4
6392204|NCT00840450|7304209|FG000|STARTED|Overall Study||12
6392205|NCT00840450|7304209|FG000|COMPLETED|Overall Study||9
6392206|NCT00840450|7304209|FG000|NOT COMPLETED|Overall Study||3
6392207|NCT00840463|7304215|FG000|STARTED|Overall Study||3
6392208|NCT00840463|7304216|FG001|STARTED|Overall Study||1
6392209|NCT00840463|7304215|FG000|COMPLETED|Overall Study||2
6392210|NCT00840463|7304216|FG001|COMPLETED|Overall Study||1
6392211|NCT00840463|7304215|FG000|NOT COMPLETED|Overall Study||1
6392212|NCT00840463|7304216|FG001|NOT COMPLETED|Overall Study||0
6392213|NCT00840658|7304226|FG000|STARTED|Overall Study||144
6392214|NCT00840658|7304227|FG001|STARTED|Overall Study||146
6392215|NCT00840658|7304228|FG002|STARTED|Overall Study||148
6392216|NCT00840658|7304229|FG003|STARTED|Overall Study||146
6392217|NCT00840658|7304226|FG000|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
6392218|NCT00840658|7304227|FG001|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
6392219|NCT00840658|7304228|FG002|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
6603135|NCT02059291|7527961|FG002|NOT COMPLETED|Epoch 4||0
6603136|NCT02059291|7527962|FG003|NOT COMPLETED|Epoch 4||0
6603137|NCT02059291|7527963|FG004|NOT COMPLETED|Epoch 4||0
6603138|NCT02059291|7527964|FG005|NOT COMPLETED|Epoch 4||0
6603139|NCT02059291|7527965|FG006|NOT COMPLETED|Epoch 4||0
6603140|NCT02059291|7527966|FG007|NOT COMPLETED|Epoch 4||0
6603141|NCT02059291|7527967|FG008|NOT COMPLETED|Epoch 4||0
6603142|NCT02059291|7527968|FG009|NOT COMPLETED|Epoch 4||0
6603143|NCT02059291|7527969|FG010|NOT COMPLETED|Epoch 4||0
6603144|NCT02059291|7527970|FG011|NOT COMPLETED|Epoch 4||0
6603145|NCT02059291|7527971|FG012|NOT COMPLETED|Epoch 4||0
6603146|NCT02059291|7527972|FG013|NOT COMPLETED|Epoch 4||0
6603147|NCT02059291|7527973|FG014|NOT COMPLETED|Epoch 4||0
6603148|NCT02059291|7527974|FG015|NOT COMPLETED|Epoch 4||0
6603149|NCT02059291|7527975|FG016|NOT COMPLETED|Epoch 4||2
6603150|NCT02059291|7527976|FG017|NOT COMPLETED|Epoch 4||0
6603151|NCT02059291|7527977|FG018|NOT COMPLETED|Epoch 4||0
6603152|NCT02059291|7527978|FG019|NOT COMPLETED|Epoch 4||0
6603153|NCT02059291|7527979|FG020|NOT COMPLETED|Epoch 4||1
6603154|NCT02059291|7527980|FG021|NOT COMPLETED|Epoch 4||0
6603155|NCT02059291|7527981|FG022|NOT COMPLETED|Epoch 4||1
6603156|NCT02059291|7527982|FG023|NOT COMPLETED|Epoch 4||1
6603157|NCT02059291|7527983|FG024|NOT COMPLETED|Epoch 4||0
6603158|NCT02059395|7528013|FG000|STARTED|Overall Study||22
6603159|NCT02059395|7528014|FG001|STARTED|Overall Study||27
6603160|NCT02059395|7528013|FG000|COMPLETED|Overall Study||20
6603161|NCT02059395|7528014|FG001|COMPLETED|Overall Study||23
6603162|NCT02059395|7528013|FG000|NOT COMPLETED|Overall Study||2
6603163|NCT02059395|7528014|FG001|NOT COMPLETED|Overall Study||4
6603164|NCT02059408|7528023|FG000|STARTED|Overall Study||604
6603165|NCT02059408|7528024|FG001|STARTED|Overall Study||599
6603166|NCT02059408|7528025|FG002|STARTED|Overall Study||616
6603167|NCT02059408|7528023|FG000|COMPLETED|Overall Study||604
6603168|NCT02059408|7528024|FG001|COMPLETED|Overall Study||269
6603169|NCT02059408|7528025|FG002|COMPLETED|Overall Study||258
6603170|NCT02059408|7528023|FG000|NOT COMPLETED|Overall Study||0
6603171|NCT02059408|7528024|FG001|NOT COMPLETED|Overall Study||330
6603172|NCT02059408|7528025|FG002|NOT COMPLETED|Overall Study||358
6603173|NCT02059434|7528044|FG000|STARTED|Period 1 (After Screening/run-in Period)||2
6603174|NCT02059434|7528045|FG001|STARTED|Period 1 (After Screening/run-in Period)||2
6603175|NCT02059434|7528046|FG002|STARTED|Period 1 (After Screening/run-in Period)||2
6603176|NCT02059434|7528047|FG003|STARTED|Period 1 (After Screening/run-in Period)||2
6268214|NCT00063986|7167394|FG000|NOT COMPLETED|Overall Study||6
6268215|NCT00063999|7167400|FG000|STARTED|Overall Study||692
6603177|NCT02059434|7528048|FG004|STARTED|Period 1 (After Screening/run-in Period)||2
6603178|NCT02059434|7528049|FG005|STARTED|Period 1 (After Screening/run-in Period)||2
6625188|NCT02223390|7552809|FG001|STARTED|Overall Study||32
6268216|NCT00063999|7167401|FG001|STARTED|Overall Study||689
6268217|NCT00063999|7167400|FG000|COMPLETED|Overall Study||647
6268218|NCT00063999|7167401|FG001|COMPLETED|Overall Study||665
6268219|NCT00063999|7167400|FG000|NOT COMPLETED|Overall Study||45
6268220|NCT00063999|7167401|FG001|NOT COMPLETED|Overall Study||24
6268221|NCT00064025|7167414|FG000|STARTED|Overall Study||75
6268222|NCT00064025|7167414|FG000|COMPLETED|Overall Study||68
6268223|NCT00064025|7167414|FG000|NOT COMPLETED|Overall Study||7
6268224|NCT00064038|7167422|FG000|STARTED|Initial Randomization||100
6268225|NCT00064038|7167423|FG001|STARTED|Initial Randomization||98
6268226|NCT00064038|7167424|FG002|STARTED|Initial Randomization||0
6268227|NCT00064038|7167422|FG000|Eligible and Analyzable|Initial Randomization||97
6268228|NCT00064038|7167423|FG001|Eligible and Analyzable|Initial Randomization||95
6268229|NCT00064038|7167424|FG002|Eligible and Analyzable|Initial Randomization||0
6268230|NCT00064038|7167422|FG000|Safety Population|Initial Randomization||96
6268231|NCT00064038|7167423|FG001|Safety Population|Initial Randomization||94
6268232|NCT00064038|7167424|FG002|Safety Population|Initial Randomization||0
6280592|NCT00158197|7180557|FG000|STARTED|Overall Study||32
6280593|NCT00158197|7180558|FG001|STARTED|Overall Study||30
6392220|NCT00840658|7304229|FG003|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
6392221|NCT00840658|7304226|FG000|NOT COMPLETED|Overall Study||5
6392222|NCT00840658|7304227|FG001|NOT COMPLETED|Overall Study||3
6392223|NCT00840658|7304228|FG002|NOT COMPLETED|Overall Study||5
6392224|NCT00840658|7304229|FG003|NOT COMPLETED|Overall Study||4
6392225|NCT00840749|7304245|FG000|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|31
6392226|NCT00840749|7304246|FG001|STARTED|Overall Study|includes patients who were screened but did not end up treated on protocol|27
6392227|NCT00840749|7304245|FG000|Treatment|Overall Study||20
6392228|NCT00840749|7304246|FG001|Treatment|Overall Study||16
6392229|NCT00840749|7304245|FG000|1 Month Post tx|Overall Study||19
6392230|NCT00840749|7304246|FG001|1 Month Post tx|Overall Study||15
6392231|NCT00840749|7304245|FG000|6 Months Post tx|Overall Study||16
6392232|NCT00840749|7304246|FG001|6 Months Post tx|Overall Study||10
6392233|NCT00840749|7304245|FG000|12 Months Post tx|Overall Study||14
6392234|NCT00840749|7304246|FG001|12 Months Post tx|Overall Study||7
6392235|NCT00840749|7304245|FG000|18 Months Post tx|Overall Study||12
6392236|NCT00840749|7304246|FG001|18 Months Post tx|Overall Study||6
6392237|NCT00840749|7304245|FG000|24 Months Post tx|Overall Study||9
6392238|NCT00840749|7304246|FG001|24 Months Post tx|Overall Study||3
6392239|NCT00840749|7304245|FG000|36 Months Post tx|Overall Study||1
6392240|NCT00840749|7304246|FG001|36 Months Post tx|Overall Study||0
6392241|NCT00840749|7304245|FG000|COMPLETED|Overall Study||0
6392242|NCT00840749|7304246|FG001|COMPLETED|Overall Study||0
6392243|NCT00840749|7304245|FG000|NOT COMPLETED|Overall Study||31
6392244|NCT00840749|7304246|FG001|NOT COMPLETED|Overall Study||27
6392245|NCT00840970|7304252|FG000|STARTED|Overall Study||7
6392246|NCT00840970|7304253|FG001|STARTED|Overall Study||38
6392247|NCT00840970|7304254|FG002|STARTED|Overall Study||5
6392248|NCT00840970|7304252|FG000|COMPLETED|Overall Study||7
6392249|NCT00840970|7304253|FG001|COMPLETED|Overall Study||38
6392250|NCT00840970|7304254|FG002|COMPLETED|Overall Study||4
6392251|NCT00840970|7304252|FG000|NOT COMPLETED|Overall Study||0
6392252|NCT00840970|7304253|FG001|NOT COMPLETED|Overall Study||0
6392253|NCT00840970|7304254|FG002|NOT COMPLETED|Overall Study||1
6392254|NCT00840996|7304266|FG000|STARTED|Overall Study||58
6392255|NCT00840996|7304267|FG001|STARTED|Overall Study||58
6392256|NCT00840996|7304266|FG000|COMPLETED|Overall Study||57
6392257|NCT00840996|7304267|FG001|COMPLETED|Overall Study||58
6392258|NCT00840996|7304266|FG000|NOT COMPLETED|Overall Study||1
6392259|NCT00840996|7304267|FG001|NOT COMPLETED|Overall Study||0
6392260|NCT00841087|7304275|FG000|STARTED|Overall Study||33
6392261|NCT00841087|7304276|FG001|STARTED|Overall Study||32
6392262|NCT00841087|7304275|FG000|COMPLETED|Overall Study||33
6392263|NCT00841087|7304276|FG001|COMPLETED|Overall Study||32
6392264|NCT00841087|7304275|FG000|NOT COMPLETED|Overall Study||0
6392265|NCT00841087|7304276|FG001|NOT COMPLETED|Overall Study||0
6392266|NCT00841100|7304282|FG000|STARTED|Acute Component (24 Hours)||21
6392267|NCT00841100|7304282|FG000|COMPLETED|Acute Component (24 Hours)||21
6392268|NCT00841100|7304282|FG000|NOT COMPLETED|Acute Component (24 Hours)||0
6392269|NCT00841100|7304282|FG000|STARTED|Phase 1 (28 Days)|3 participants from the acute phase elected not to continue to the Phase 1 component of the study.|18
6392270|NCT00841100|7304282|FG000|COMPLETED|Phase 1 (28 Days)||15
6392271|NCT00841100|7304282|FG000|NOT COMPLETED|Phase 1 (28 Days)||3
6392272|NCT00841100|7304282|FG000|STARTED|Phase 2 (2 Weeks)|Participants who were non-responsive on the Phase 1 component of the study continued on to Phase 2.|5
6392273|NCT00841100|7304282|FG000|COMPLETED|Phase 2 (2 Weeks)||5
6392274|NCT00841100|7304282|FG000|NOT COMPLETED|Phase 2 (2 Weeks)||0
6392275|NCT00841100|7304282|FG000|STARTED|Phase 3 (28 Days)|Participants who achieved a fasting blood phenylalanine of <600 umol/l can continue to Phase 3.|4
6392276|NCT00841100|7304282|FG000|COMPLETED|Phase 3 (28 Days)||4
6392277|NCT00841100|7304282|FG000|NOT COMPLETED|Phase 3 (28 Days)||0
6392278|NCT00841204|7304288|FG000|STARTED|Overall Study||25
6392279|NCT00841204|7304289|FG001|STARTED|Overall Study||25
6392280|NCT00841204|7304288|FG000|COMPLETED|Overall Study||25
6392281|NCT00841204|7304289|FG001|COMPLETED|Overall Study||25
6392282|NCT00841204|7304288|FG000|NOT COMPLETED|Overall Study||0
6625189|NCT02223390|7552808|FG000|COMPLETED|Overall Study||23
6392283|NCT00841204|7304289|FG001|NOT COMPLETED|Overall Study||0
6392284|NCT00841269|7304299|FG000|STARTED|Overall Study||20
6392285|NCT00841269|7304300|FG001|STARTED|Overall Study||22
6392286|NCT00841269|7304299|FG000|COMPLETED|Overall Study||12
6392287|NCT00841269|7304300|FG001|COMPLETED|Overall Study||13
6392288|NCT00841269|7304299|FG000|NOT COMPLETED|Overall Study||8
6392289|NCT00841269|7304300|FG001|NOT COMPLETED|Overall Study||9
6392290|NCT00841321|7304307|FG000|STARTED|Overall Study||59
6392291|NCT00841321|7304308|FG001|STARTED|Overall Study||61
6392292|NCT00841321|7304307|FG000|COMPLETED|Overall Study||58
6392293|NCT00841321|7304308|FG001|COMPLETED|Overall Study||58
6392294|NCT00841321|7304307|FG000|NOT COMPLETED|Overall Study||1
6392295|NCT00841321|7304308|FG001|NOT COMPLETED|Overall Study||3
6392296|NCT00841412|7304316|FG000|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
6392297|NCT00841412|7304317|FG001|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
6392298|NCT00841412|7304316|FG000|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
6392299|NCT00841412|7304317|FG001|COMPLETED|Overall Study||50
6392300|NCT00841412|7304316|FG000|NOT COMPLETED|Overall Study||40
6392301|NCT00841412|7304317|FG001|NOT COMPLETED|Overall Study||30
6603179|NCT02059434|7528050|FG006|STARTED|Period 1 (After Screening/run-in Period)||2
6603180|NCT02059434|7528051|FG007|STARTED|Period 1 (After Screening/run-in Period)||3
6603181|NCT02059434|7528052|FG008|STARTED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603182|NCT02059434|7528044|FG000|COMPLETED|Period 1 (After Screening/run-in Period)||2
6603183|NCT02059434|7528045|FG001|COMPLETED|Period 1 (After Screening/run-in Period)||2
6603184|NCT02059434|7528046|FG002|COMPLETED|Period 1 (After Screening/run-in Period)||2
6603185|NCT02059434|7528047|FG003|COMPLETED|Period 1 (After Screening/run-in Period)||2
6603186|NCT02059434|7528048|FG004|COMPLETED|Period 1 (After Screening/run-in Period)||2
6603187|NCT02059434|7528049|FG005|COMPLETED|Period 1 (After Screening/run-in Period)||2
6603188|NCT02059434|7528050|FG006|COMPLETED|Period 1 (After Screening/run-in Period)||2
6603189|NCT02059434|7528051|FG007|COMPLETED|Period 1 (After Screening/run-in Period)||3
6603190|NCT02059434|7528052|FG008|COMPLETED|Period 1 (After Screening/run-in Period)|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603191|NCT02059434|7528044|FG000|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603192|NCT02059434|7528045|FG001|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603193|NCT02059434|7528046|FG002|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603194|NCT02059434|7528047|FG003|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603195|NCT02059434|7528048|FG004|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603196|NCT02059434|7528049|FG005|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603197|NCT02059434|7528050|FG006|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603198|NCT02059434|7528051|FG007|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603199|NCT02059434|7528052|FG008|NOT COMPLETED|Period 1 (After Screening/run-in Period)||0
6603200|NCT02059434|7528044|FG000|STARTED|Washout Between Periods 1 and 2||2
6603201|NCT02059434|7528045|FG001|STARTED|Washout Between Periods 1 and 2||2
6603202|NCT02059434|7528046|FG002|STARTED|Washout Between Periods 1 and 2||2
6603203|NCT02059434|7528047|FG003|STARTED|Washout Between Periods 1 and 2||2
6603204|NCT02059434|7528048|FG004|STARTED|Washout Between Periods 1 and 2||2
6603205|NCT02059434|7528049|FG005|STARTED|Washout Between Periods 1 and 2||2
6603206|NCT02059434|7528050|FG006|STARTED|Washout Between Periods 1 and 2||2
6603207|NCT02059434|7528051|FG007|STARTED|Washout Between Periods 1 and 2||3
6603208|NCT02059434|7528052|FG008|STARTED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603209|NCT02059434|7528044|FG000|COMPLETED|Washout Between Periods 1 and 2||2
6603210|NCT02059434|7528045|FG001|COMPLETED|Washout Between Periods 1 and 2||2
6603211|NCT02059434|7528046|FG002|COMPLETED|Washout Between Periods 1 and 2||2
6603212|NCT02059434|7528047|FG003|COMPLETED|Washout Between Periods 1 and 2||2
6603213|NCT02059434|7528048|FG004|COMPLETED|Washout Between Periods 1 and 2||2
6603214|NCT02059434|7528049|FG005|COMPLETED|Washout Between Periods 1 and 2||2
6603215|NCT02059434|7528050|FG006|COMPLETED|Washout Between Periods 1 and 2||2
6603216|NCT02059434|7528051|FG007|COMPLETED|Washout Between Periods 1 and 2||2
6603217|NCT02059434|7528052|FG008|COMPLETED|Washout Between Periods 1 and 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603218|NCT02059434|7528044|FG000|NOT COMPLETED|Washout Between Periods 1 and 2||0
6603219|NCT02059434|7528045|FG001|NOT COMPLETED|Washout Between Periods 1 and 2||0
6603220|NCT02059434|7528046|FG002|NOT COMPLETED|Washout Between Periods 1 and 2||0
6603221|NCT02059434|7528047|FG003|NOT COMPLETED|Washout Between Periods 1 and 2||0
6603222|NCT02059434|7528048|FG004|NOT COMPLETED|Washout Between Periods 1 and 2||0
6603223|NCT02059434|7528049|FG005|NOT COMPLETED|Washout Between Periods 1 and 2||0
6603224|NCT02059434|7528050|FG006|NOT COMPLETED|Washout Between Periods 1 and 2||0
6603225|NCT02059434|7528051|FG007|NOT COMPLETED|Washout Between Periods 1 and 2||1
6603226|NCT02059434|7528052|FG008|NOT COMPLETED|Washout Between Periods 1 and 2||0
6603227|NCT02059434|7528044|FG000|STARTED|Period 2||2
6603228|NCT02059434|7528045|FG001|STARTED|Period 2||2
6603229|NCT02059434|7528046|FG002|STARTED|Period 2||2
6603230|NCT02059434|7528047|FG003|STARTED|Period 2||2
6603231|NCT02059434|7528048|FG004|STARTED|Period 2||2
6603232|NCT02059434|7528049|FG005|STARTED|Period 2||2
6603233|NCT02059434|7528050|FG006|STARTED|Period 2||2
6603234|NCT02059434|7528051|FG007|STARTED|Period 2||2
6603235|NCT02059434|7528052|FG008|STARTED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
6392302|NCT00841555|7304324|FG000|STARTED|Overall Study||3
6392303|NCT00841555|7304325|FG001|STARTED|Overall Study||3
6392304|NCT00841555|7304326|FG002|STARTED|Overall Study||3
6392305|NCT00841555|7304324|FG000|COMPLETED|Overall Study||3
6392306|NCT00841555|7304325|FG001|COMPLETED|Overall Study||3
6392307|NCT00841555|7304326|FG002|COMPLETED|Overall Study||3
6392308|NCT00841555|7304324|FG000|NOT COMPLETED|Overall Study||0
6392309|NCT00841555|7304325|FG001|NOT COMPLETED|Overall Study||0
6392310|NCT00841555|7304326|FG002|NOT COMPLETED|Overall Study||0
6392311|NCT00841568|7304332|FG000|STARTED|Overall Study||17
6392312|NCT00841568|7304332|FG000|COMPLETED|Overall Study||12
6392313|NCT00841568|7304332|FG000|NOT COMPLETED|Overall Study||5
6392314|NCT00841672|7304342|FG000|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
6392315|NCT00841672|7304343|FG001|STARTED|Overall Study||241
6392316|NCT00841672|7304342|FG000|COMPLETED|Overall Study||224
6392317|NCT00841672|7304343|FG001|COMPLETED|Overall Study||209
6392318|NCT00841672|7304342|FG000|NOT COMPLETED|Overall Study||20
6392319|NCT00841672|7304343|FG001|NOT COMPLETED|Overall Study||32
6392320|NCT00841763|7304351|FG000|STARTED|Overall Study||2691
6392321|NCT00841763|7304352|FG001|STARTED|Overall Study||681
6392322|NCT00841763|7304353|FG002|STARTED|Overall Study||219
6392323|NCT00841763|7304354|FG003|STARTED|Overall Study||56
6392324|NCT00841763|7304351|FG000|COMPLETED|Overall Study||2529
6392325|NCT00841763|7304352|FG001|COMPLETED|Overall Study||624
6392326|NCT00841763|7304353|FG002|COMPLETED|Overall Study||211
6392327|NCT00841763|7304354|FG003|COMPLETED|Overall Study||53
6392328|NCT00841763|7304351|FG000|NOT COMPLETED|Overall Study||162
6392329|NCT00841763|7304352|FG001|NOT COMPLETED|Overall Study||57
6392330|NCT00841763|7304353|FG002|NOT COMPLETED|Overall Study||8
6392331|NCT00841763|7304354|FG003|NOT COMPLETED|Overall Study||3
6392332|NCT00841776|7304401|FG000|STARTED|Overall Study||27
6392333|NCT00841776|7304402|FG001|STARTED|Overall Study||27
6392334|NCT00841776|7304401|FG000|COMPLETED|Overall Study||25
6392335|NCT00841776|7304402|FG001|COMPLETED|Overall Study||24
6392336|NCT00841776|7304401|FG000|NOT COMPLETED|Overall Study||2
6392337|NCT00841776|7304402|FG001|NOT COMPLETED|Overall Study||3
6392338|NCT00841828|7304410|FG000|STARTED|Overall Study||52
6392339|NCT00841828|7304411|FG001|STARTED|Overall Study||50
6392340|NCT00841828|7304410|FG000|COMPLETED|Overall Study||42
6392341|NCT00841828|7304411|FG001|COMPLETED|Overall Study||48
6392342|NCT00841828|7304410|FG000|NOT COMPLETED|Overall Study||10
6392343|NCT00841828|7304411|FG001|NOT COMPLETED|Overall Study||2
6392344|NCT00841906|7304421|FG000|STARTED|Overall Study||18
6392345|NCT00841906|7304422|FG001|STARTED|Overall Study||14
6392346|NCT00841906|7304421|FG000|COMPLETED|Overall Study||16
6392347|NCT00841906|7304422|FG001|COMPLETED|Overall Study||14
6392348|NCT00841906|7304421|FG000|NOT COMPLETED|Overall Study||2
6392349|NCT00841906|7304422|FG001|NOT COMPLETED|Overall Study||0
6603236|NCT02059434|7528044|FG000|COMPLETED|Period 2||2
6603237|NCT02059434|7528045|FG001|COMPLETED|Period 2||2
6603238|NCT02059434|7528046|FG002|COMPLETED|Period 2||2
6603239|NCT02059434|7528047|FG003|COMPLETED|Period 2||2
6603240|NCT02059434|7528048|FG004|COMPLETED|Period 2||2
6603241|NCT02059434|7528049|FG005|COMPLETED|Period 2||2
6603242|NCT02059434|7528050|FG006|COMPLETED|Period 2||2
6603243|NCT02059434|7528051|FG007|COMPLETED|Period 2||2
6603244|NCT02059434|7528052|FG008|COMPLETED|Period 2|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603245|NCT02059434|7528044|FG000|NOT COMPLETED|Period 2||0
6603246|NCT02059434|7528045|FG001|NOT COMPLETED|Period 2||0
6603247|NCT02059434|7528046|FG002|NOT COMPLETED|Period 2||0
6603248|NCT02059434|7528047|FG003|NOT COMPLETED|Period 2||0
6603249|NCT02059434|7528048|FG004|NOT COMPLETED|Period 2||0
6603250|NCT02059434|7528049|FG005|NOT COMPLETED|Period 2||0
6603251|NCT02059434|7528050|FG006|NOT COMPLETED|Period 2||0
6603252|NCT02059434|7528051|FG007|NOT COMPLETED|Period 2||0
6603253|NCT02059434|7528052|FG008|NOT COMPLETED|Period 2||0
6603254|NCT02059434|7528044|FG000|STARTED|Washout Between Periods 2 and 3||2
6603255|NCT02059434|7528045|FG001|STARTED|Washout Between Periods 2 and 3||2
6603256|NCT02059434|7528046|FG002|STARTED|Washout Between Periods 2 and 3||2
6603257|NCT02059434|7528047|FG003|STARTED|Washout Between Periods 2 and 3||2
6603258|NCT02059434|7528048|FG004|STARTED|Washout Between Periods 2 and 3||2
6603259|NCT02059434|7528049|FG005|STARTED|Washout Between Periods 2 and 3||2
6603260|NCT02059434|7528050|FG006|STARTED|Washout Between Periods 2 and 3||2
6603261|NCT02059434|7528051|FG007|STARTED|Washout Between Periods 2 and 3||2
6603262|NCT02059434|7528052|FG008|STARTED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603263|NCT02059434|7528044|FG000|COMPLETED|Washout Between Periods 2 and 3||2
6603264|NCT02059434|7528045|FG001|COMPLETED|Washout Between Periods 2 and 3||2
6603265|NCT02059434|7528046|FG002|COMPLETED|Washout Between Periods 2 and 3||2
6603266|NCT02059434|7528047|FG003|COMPLETED|Washout Between Periods 2 and 3||2
6603267|NCT02059434|7528048|FG004|COMPLETED|Washout Between Periods 2 and 3||2
6603268|NCT02059434|7528049|FG005|COMPLETED|Washout Between Periods 2 and 3||2
6603269|NCT02059434|7528050|FG006|COMPLETED|Washout Between Periods 2 and 3||2
6603270|NCT02059434|7528051|FG007|COMPLETED|Washout Between Periods 2 and 3||2
6603271|NCT02059434|7528052|FG008|COMPLETED|Washout Between Periods 2 and 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603272|NCT02059434|7528044|FG000|NOT COMPLETED|Washout Between Periods 2 and 3||0
6603273|NCT02059434|7528045|FG001|NOT COMPLETED|Washout Between Periods 2 and 3||0
6392350|NCT00841971|7304432|FG000|STARTED|Overall Study||100
6392351|NCT00841971|7304433|FG001|STARTED|Overall Study||100
6392352|NCT00841971|7304432|FG000|COMPLETED|Overall Study||98
6392353|NCT00841971|7304433|FG001|COMPLETED|Overall Study||99
6392354|NCT00841971|7304432|FG000|NOT COMPLETED|Overall Study||2
6392355|NCT00841971|7304433|FG001|NOT COMPLETED|Overall Study||1
6392356|NCT00842023|7304441|FG000|STARTED|Overall Study||45
6392357|NCT00842023|7304442|FG001|STARTED|Overall Study||44
6392358|NCT00842023|7304441|FG000|COMPLETED|Overall Study||45
6392359|NCT00842023|7304442|FG001|COMPLETED|Overall Study||44
6392360|NCT00842023|7304441|FG000|NOT COMPLETED|Overall Study||0
6392361|NCT00842023|7304442|FG001|NOT COMPLETED|Overall Study||0
6392362|NCT00842075|7304453|FG000|STARTED|Overall Study||5
6392363|NCT00842075|7304454|FG001|STARTED|Overall Study||5
6392364|NCT00842075|7304453|FG000|COMPLETED|Overall Study||5
6392365|NCT00842075|7304454|FG001|COMPLETED|Overall Study||5
6392366|NCT00842075|7304453|FG000|NOT COMPLETED|Overall Study||0
6392367|NCT00842075|7304454|FG001|NOT COMPLETED|Overall Study||0
6392368|NCT00842153|7304462|FG000|STARTED|Overall Study||28
6392369|NCT00842153|7304463|FG001|STARTED|Overall Study||30
6392370|NCT00842153|7304462|FG000|COMPLETED|Overall Study||27
6392371|NCT00842153|7304463|FG001|COMPLETED|Overall Study||27
6392372|NCT00842153|7304462|FG000|NOT COMPLETED|Overall Study||1
6392373|NCT00842153|7304463|FG001|NOT COMPLETED|Overall Study||3
6392374|NCT00842231|7304469|FG000|STARTED|Overall Study||40
6392375|NCT00842231|7304469|FG000|COMPLETED|Overall Study||40
6392376|NCT00842231|7304469|FG000|NOT COMPLETED|Overall Study||0
6392377|NCT00842244|7304473|FG000|STARTED|Overall Study||22
6392378|NCT00842244|7304473|FG000|COMPLETED|Overall Study||1
6392379|NCT00842244|7304473|FG000|NOT COMPLETED|Overall Study||21
6392380|NCT00842257|7304480|FG000|STARTED|Overall Study||20
6392381|NCT00842257|7304480|FG000|COMPLETED|Overall Study||19
6392382|NCT00842257|7304480|FG000|NOT COMPLETED|Overall Study||1
6392383|NCT00842296|7304484|FG000|STARTED|Overall Study||326
6392384|NCT00842296|7304484|FG000|COMPLETED|Overall Study||326
6392385|NCT00842296|7304484|FG000|NOT COMPLETED|Overall Study||0
6392386|NCT00842309|7304490|FG000|STARTED|Overall Study|14 randomized. 2 withdrew prior to initiating DCS-not included in modified intent-to-treat analyses.|14
6392387|NCT00842309|7304491|FG001|STARTED|Overall Study||14
6392388|NCT00842309|7304490|FG000|COMPLETED|Overall Study||11
6392389|NCT00842309|7304491|FG001|COMPLETED|Overall Study||13
6392390|NCT00842309|7304490|FG000|NOT COMPLETED|Overall Study||3
6392391|NCT00842309|7304491|FG001|NOT COMPLETED|Overall Study||1
6392392|NCT00842335|7304497|FG000|STARTED|Overall Study||18
6392393|NCT00842335|7304497|FG000|COMPLETED|Overall Study||18
6392394|NCT00842335|7304497|FG000|NOT COMPLETED|Overall Study||0
6392395|NCT00842348|7304505|FG000|STARTED|Patients Randomised in Study 726||101
6392396|NCT00842348|7304506|FG001|STARTED|Patients Randomised in Study 726||103
6392397|NCT00842348|7304505|FG000|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
6392398|NCT00842348|7304506|FG001|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
6392399|NCT00842348|7304505|FG000|NOT COMPLETED|Patients Randomised in Study 726||59
6392400|NCT00842348|7304506|FG001|NOT COMPLETED|Patients Randomised in Study 726||56
6392401|NCT00842348|7304505|FG000|STARTED|Study 729||42
6392402|NCT00842348|7304506|FG001|STARTED|Study 729||47
6392403|NCT00842348|7304505|FG000|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
6392404|NCT00842348|7304506|FG001|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
6392405|NCT00842348|7304505|FG000|NOT COMPLETED|Study 729||26
6392406|NCT00842348|7304506|FG001|NOT COMPLETED|Study 729||38
6392407|NCT00842361|7304518|FG000|STARTED|Overall Study||33
6392408|NCT00842361|7304519|FG001|STARTED|Overall Study||33
6392409|NCT00842361|7304518|FG000|Exposed|Overall Study||33
6392410|NCT00842361|7304519|FG001|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
6392411|NCT00842361|7304518|FG000|COMPLETED|Overall Study||32
6392412|NCT00842361|7304519|FG001|COMPLETED|Overall Study||31
6392413|NCT00842361|7304518|FG000|NOT COMPLETED|Overall Study||1
6392414|NCT00842361|7304519|FG001|NOT COMPLETED|Overall Study||2
6392415|NCT00842543|7304529|FG000|STARTED|Overall Study||13
6392416|NCT00842543|7304530|FG001|STARTED|Overall Study||5
6392417|NCT00842543|7304531|FG002|STARTED|Overall Study||13
6392418|NCT00842543|7304532|FG003|STARTED|Overall Study||8
6392419|NCT00842543|7304529|FG000|COMPLETED|Overall Study||11
6392420|NCT00842543|7304530|FG001|COMPLETED|Overall Study||5
6392421|NCT00842543|7304531|FG002|COMPLETED|Overall Study||10
6392422|NCT00842543|7304532|FG003|COMPLETED|Overall Study||4
6392423|NCT00842543|7304529|FG000|NOT COMPLETED|Overall Study||2
6392424|NCT00842543|7304530|FG001|NOT COMPLETED|Overall Study||0
6392425|NCT00842543|7304531|FG002|NOT COMPLETED|Overall Study||3
6392426|NCT00842543|7304532|FG003|NOT COMPLETED|Overall Study||4
6392427|NCT00842608|7304548|FG000|STARTED|Overall Study||174
6392428|NCT00842608|7304549|FG001|STARTED|Overall Study||177
6392429|NCT00842608|7304550|FG002|STARTED|Overall Study||99
6392430|NCT00842608|7304551|FG003|STARTED|Overall Study||101
6392431|NCT00842608|7304548|FG000|COMPLETED|Overall Study||170
6392432|NCT00842608|7304549|FG001|COMPLETED|Overall Study||176
6392433|NCT00842608|7304550|FG002|COMPLETED|Overall Study||99
6392434|NCT00842608|7304551|FG003|COMPLETED|Overall Study||100
6392435|NCT00842608|7304548|FG000|NOT COMPLETED|Overall Study||4
6392436|NCT00842608|7304549|FG001|NOT COMPLETED|Overall Study||1
6392437|NCT00842608|7304550|FG002|NOT COMPLETED|Overall Study||0
6392438|NCT00842608|7304551|FG003|NOT COMPLETED|Overall Study||1
6392439|NCT00842712|7304568|FG000|STARTED|Safety Run-in Part||3
6392440|NCT00842712|7304569|FG001|STARTED|Safety Run-in Part||3
6392441|NCT00842712|7304570|FG002|STARTED|Safety Run-in Part||3
6392442|NCT00842712|7304571|FG003|STARTED|Safety Run-in Part||3
6392443|NCT00842712|7304572|FG004|STARTED|Safety Run-in Part||0
6392444|NCT00842712|7304573|FG005|STARTED|Safety Run-in Part||0
6392445|NCT00842712|7304574|FG006|STARTED|Safety Run-in Part||0
6392446|NCT00842712|7304568|FG000|COMPLETED|Safety Run-in Part||0
6392447|NCT00842712|7304569|FG001|COMPLETED|Safety Run-in Part||1
6392448|NCT00842712|7304570|FG002|COMPLETED|Safety Run-in Part||3
6392449|NCT00842712|7304571|FG003|COMPLETED|Safety Run-in Part||2
6392450|NCT00842712|7304572|FG004|COMPLETED|Safety Run-in Part||0
6392451|NCT00842712|7304573|FG005|COMPLETED|Safety Run-in Part||0
6392452|NCT00842712|7304574|FG006|COMPLETED|Safety Run-in Part||0
6392453|NCT00842712|7304568|FG000|NOT COMPLETED|Safety Run-in Part||3
6392454|NCT00842712|7304569|FG001|NOT COMPLETED|Safety Run-in Part||2
6392455|NCT00842712|7304570|FG002|NOT COMPLETED|Safety Run-in Part||0
6392456|NCT00842712|7304571|FG003|NOT COMPLETED|Safety Run-in Part||1
6392457|NCT00842712|7304572|FG004|NOT COMPLETED|Safety Run-in Part||0
6392458|NCT00842712|7304573|FG005|NOT COMPLETED|Safety Run-in Part||0
6392459|NCT00842712|7304574|FG006|NOT COMPLETED|Safety Run-in Part||0
6392460|NCT00842712|7304568|FG000|STARTED|Randomized Part||0
6392461|NCT00842712|7304569|FG001|STARTED|Randomized Part||0
6392462|NCT00842712|7304570|FG002|STARTED|Randomized Part||0
6392463|NCT00842712|7304571|FG003|STARTED|Randomized Part||0
6392464|NCT00842712|7304572|FG004|STARTED|Randomized Part||85
6392465|NCT00842712|7304573|FG005|STARTED|Randomized Part||51
6392466|NCT00842712|7304574|FG006|STARTED|Randomized Part||84
6392467|NCT00842712|7304568|FG000|Treated|Randomized Part||0
6392468|NCT00842712|7304569|FG001|Treated|Randomized Part||0
6392469|NCT00842712|7304570|FG002|Treated|Randomized Part||0
6392470|NCT00842712|7304571|FG003|Treated|Randomized Part||0
6392471|NCT00842712|7304572|FG004|Treated|Randomized Part||85
6392472|NCT00842712|7304573|FG005|Treated|Randomized Part||50
6392473|NCT00842712|7304574|FG006|Treated|Randomized Part||80
6392474|NCT00842712|7304568|FG000|COMPLETED|Randomized Part||0
6392475|NCT00842712|7304569|FG001|COMPLETED|Randomized Part||0
6392476|NCT00842712|7304570|FG002|COMPLETED|Randomized Part||0
6392477|NCT00842712|7304571|FG003|COMPLETED|Randomized Part||0
6392478|NCT00842712|7304572|FG004|COMPLETED|Randomized Part||85
6392479|NCT00842712|7304573|FG005|COMPLETED|Randomized Part||50
6392480|NCT00842712|7304574|FG006|COMPLETED|Randomized Part||78
6392481|NCT00842712|7304568|FG000|NOT COMPLETED|Randomized Part||0
6392482|NCT00842712|7304569|FG001|NOT COMPLETED|Randomized Part||0
6392483|NCT00842712|7304570|FG002|NOT COMPLETED|Randomized Part||0
6392484|NCT00842712|7304571|FG003|NOT COMPLETED|Randomized Part||0
6392485|NCT00842712|7304572|FG004|NOT COMPLETED|Randomized Part||0
6392486|NCT00842712|7304573|FG005|NOT COMPLETED|Randomized Part||1
6392487|NCT00842712|7304574|FG006|NOT COMPLETED|Randomized Part||6
6392488|NCT00842751|7304590|FG000|STARTED|Overall Study||11
6392489|NCT00842751|7304590|FG000|COMPLETED|Overall Study||11
6392490|NCT00842751|7304590|FG000|NOT COMPLETED|Overall Study||0
6392491|NCT00842764|7304603|FG000|STARTED|Overall Study||7
6392492|NCT00842764|7304603|FG000|COMPLETED|Overall Study||5
6392493|NCT00842764|7304603|FG000|NOT COMPLETED|Overall Study||2
6392494|NCT00842829|7304609|FG000|STARTED|Dose Titration Period||156
6392495|NCT00842829|7304610|FG001|STARTED|Dose Titration Period||174
6392496|NCT00842829|7304611|FG002|STARTED|Dose Titration Period||0
6392497|NCT00842829|7304609|FG000|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
6392498|NCT00842829|7304610|FG001|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
6392499|NCT00842829|7304611|FG002|Titration Safety Analysis Set|Dose Titration Period||0
6392500|NCT00842829|7304609|FG000|COMPLETED|Dose Titration Period||130
6392501|NCT00842829|7304610|FG001|COMPLETED|Dose Titration Period||151
6392502|NCT00842829|7304611|FG002|COMPLETED|Dose Titration Period||0
6392503|NCT00842829|7304609|FG000|NOT COMPLETED|Dose Titration Period||26
6392504|NCT00842829|7304610|FG001|NOT COMPLETED|Dose Titration Period||23
6392505|NCT00842829|7304611|FG002|NOT COMPLETED|Dose Titration Period||0
6392506|NCT00842829|7304609|FG000|STARTED|Treatment Period||0
6392507|NCT00842829|7304610|FG001|STARTED|Treatment Period||0
6392508|NCT00842829|7304611|FG002|STARTED|Treatment Period||281
6392509|NCT00842829|7304609|FG000|Safety Analysis Set|Treatment Period||0
6392510|NCT00842829|7304610|FG001|Safety Analysis Set|Treatment Period||0
6392511|NCT00842829|7304611|FG002|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
6392512|NCT00842829|7304609|FG000|COMPLETED|Treatment Period||0
6392513|NCT00842829|7304610|FG001|COMPLETED|Treatment Period||0
6392514|NCT00842829|7304611|FG002|COMPLETED|Treatment Period||218
6392515|NCT00842829|7304609|FG000|NOT COMPLETED|Treatment Period||0
6392516|NCT00842829|7304610|FG001|NOT COMPLETED|Treatment Period||0
6392517|NCT00842829|7304611|FG002|NOT COMPLETED|Treatment Period||63
6392518|NCT00842829|7304609|FG000|STARTED|Continuation Period||0
6392519|NCT00842829|7304610|FG001|STARTED|Continuation Period||0
6392520|NCT00842829|7304611|FG002|STARTED|Continuation Period|Eligible for Continuation Period|88
6392521|NCT00842829|7304609|FG000|Continuation Safety Analysis Set|Continuation Period||0
6392522|NCT00842829|7304610|FG001|Continuation Safety Analysis Set|Continuation Period||0
6392523|NCT00842829|7304611|FG002|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
6392524|NCT00842829|7304609|FG000|COMPLETED|Continuation Period||0
6392525|NCT00842829|7304610|FG001|COMPLETED|Continuation Period||0
6392526|NCT00842829|7304611|FG002|COMPLETED|Continuation Period||27
6392527|NCT00842829|7304609|FG000|NOT COMPLETED|Continuation Period||0
6392528|NCT00842829|7304610|FG001|NOT COMPLETED|Continuation Period||0
6392529|NCT00842829|7304611|FG002|NOT COMPLETED|Continuation Period||61
6392530|NCT00842946|7304625|FG000|STARTED|Overall Study||21
6392531|NCT00842946|7304626|FG001|STARTED|Overall Study||24
6392532|NCT00842946|7304625|FG000|COMPLETED|Overall Study||16
6392533|NCT00842946|7304626|FG001|COMPLETED|Overall Study||19
6392534|NCT00842946|7304625|FG000|NOT COMPLETED|Overall Study||5
6392535|NCT00842946|7304626|FG001|NOT COMPLETED|Overall Study||5
6392536|NCT00842985|7304632|FG000|STARTED|Screening||53
6392537|NCT00842985|7304632|FG000|COMPLETED|Screening||26
6392538|NCT00842985|7304632|FG000|NOT COMPLETED|Screening||27
6392539|NCT00842985|7304632|FG000|STARTED|First Intervention|Signed Consent|26
6392540|NCT00842985|7304632|FG000|COMPLETED|First Intervention|Completed 1st Intervention|20
6392541|NCT00842985|7304632|FG000|NOT COMPLETED|First Intervention||6
6392542|NCT00842985|7304632|FG000|STARTED|Washout Period of GE 4 Days||20
6392543|NCT00842985|7304632|FG000|COMPLETED|Washout Period of GE 4 Days||18
6392544|NCT00842985|7304632|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
6392545|NCT00842985|7304632|FG000|STARTED|Second Intervention||18
6392546|NCT00842985|7304632|FG000|COMPLETED|Second Intervention||17
6392547|NCT00842985|7304632|FG000|NOT COMPLETED|Second Intervention||1
6392548|NCT00842985|7304632|FG000|STARTED|Washout Period of GE 4 Days||17
6392549|NCT00842985|7304632|FG000|COMPLETED|Washout Period of GE 4 Days||15
6392550|NCT00842985|7304632|FG000|NOT COMPLETED|Washout Period of GE 4 Days||2
6392551|NCT00842985|7304632|FG000|STARTED|Third Intervention||15
6392552|NCT00842985|7304632|FG000|COMPLETED|Third Intervention||15
6392553|NCT00842985|7304632|FG000|NOT COMPLETED|Third Intervention||0
6392554|NCT00842985|7304632|FG000|STARTED|Washout Period of GE 4 Days||15
6392555|NCT00842985|7304632|FG000|COMPLETED|Washout Period of GE 4 Days||15
6392556|NCT00842985|7304632|FG000|NOT COMPLETED|Washout Period of GE 4 Days||0
6392557|NCT00842985|7304632|FG000|STARTED|Fourth Intervention||15
6392558|NCT00842985|7304632|FG000|COMPLETED|Fourth Intervention||15
6392559|NCT00842985|7304632|FG000|NOT COMPLETED|Fourth Intervention||0
6392560|NCT00843024|7304643|FG000|STARTED|Single-blind Placebo Run-In Phase||408
6392561|NCT00843024|7304644|FG001|STARTED|Single-blind Placebo Run-In Phase||457
6392562|NCT00843024|7304645|FG002|STARTED|Single-blind Placebo Run-In Phase||0
6392563|NCT00843024|7304646|FG003|STARTED|Single-blind Placebo Run-In Phase||0
6392564|NCT00843024|7304647|FG004|STARTED|Single-blind Placebo Run-In Phase||0
6392565|NCT00843024|7304648|FG005|STARTED|Single-blind Placebo Run-In Phase||0
6392566|NCT00843024|7304643|FG000|COMPLETED|Single-blind Placebo Run-In Phase||268
6392567|NCT00843024|7304644|FG001|COMPLETED|Single-blind Placebo Run-In Phase||321
6392568|NCT00843024|7304645|FG002|COMPLETED|Single-blind Placebo Run-In Phase||0
6392569|NCT00843024|7304646|FG003|COMPLETED|Single-blind Placebo Run-In Phase||0
6392570|NCT00843024|7304647|FG004|COMPLETED|Single-blind Placebo Run-In Phase||0
6392571|NCT00843024|7304648|FG005|COMPLETED|Single-blind Placebo Run-In Phase||0
6392572|NCT00843024|7304643|FG000|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
6392573|NCT00843024|7304644|FG001|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
6392574|NCT00843024|7304645|FG002|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
6392575|NCT00843024|7304646|FG003|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
6392576|NCT00843024|7304647|FG004|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
6392577|NCT00843024|7304648|FG005|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
6392578|NCT00843024|7304643|FG000|STARTED|Double-blind Treatment Phase||0
6392579|NCT00843024|7304644|FG001|STARTED|Double-blind Treatment Phase||0
6392580|NCT00843024|7304645|FG002|STARTED|Double-blind Treatment Phase||176
6392581|NCT00843024|7304646|FG003|STARTED|Double-blind Treatment Phase||119
6392582|NCT00843024|7304647|FG004|STARTED|Double-blind Treatment Phase||117
6392583|NCT00843024|7304648|FG005|STARTED|Double-blind Treatment Phase||177
6392584|NCT00843024|7304643|FG000|COMPLETED|Double-blind Treatment Phase||0
6392585|NCT00843024|7304644|FG001|COMPLETED|Double-blind Treatment Phase||0
6392586|NCT00843024|7304645|FG002|COMPLETED|Double-blind Treatment Phase||145
6392587|NCT00843024|7304646|FG003|COMPLETED|Double-blind Treatment Phase||96
6392588|NCT00843024|7304647|FG004|COMPLETED|Double-blind Treatment Phase||97
6392589|NCT00843024|7304648|FG005|COMPLETED|Double-blind Treatment Phase||152
6392590|NCT00843024|7304643|FG000|NOT COMPLETED|Double-blind Treatment Phase||0
6392591|NCT00843024|7304644|FG001|NOT COMPLETED|Double-blind Treatment Phase||0
6392592|NCT00843024|7304645|FG002|NOT COMPLETED|Double-blind Treatment Phase||31
6392593|NCT00843024|7304646|FG003|NOT COMPLETED|Double-blind Treatment Phase||23
6392594|NCT00843024|7304647|FG004|NOT COMPLETED|Double-blind Treatment Phase||20
6392595|NCT00843024|7304648|FG005|NOT COMPLETED|Double-blind Treatment Phase||25
6392596|NCT00843115|7304661|FG000|STARTED|Overall Study||370
6392597|NCT00843115|7304661|FG000|COMPLETED|Overall Study||304
6392598|NCT00843115|7304661|FG000|NOT COMPLETED|Overall Study||66
6392599|NCT00843167|7304667|FG000|STARTED|Treatment Period||27
6392600|NCT00843167|7304668|FG001|STARTED|Treatment Period||27
6392601|NCT00843167|7304667|FG000|COMPLETED|Treatment Period||24
6392602|NCT00843167|7304668|FG001|COMPLETED|Treatment Period||19
6392603|NCT00843167|7304667|FG000|NOT COMPLETED|Treatment Period||3
6392604|NCT00843167|7304668|FG001|NOT COMPLETED|Treatment Period||8
6392605|NCT00843167|7304667|FG000|STARTED|Follow-up||24
6392606|NCT00843167|7304668|FG001|STARTED|Follow-up||24
6392607|NCT00843167|7304667|FG000|Completed Final Visit|Follow-up||24
6392608|NCT00843167|7304668|FG001|Completed Final Visit|Follow-up||24
6392609|NCT00843167|7304667|FG000|COMPLETED|Follow-up||24
6392610|NCT00843167|7304668|FG001|COMPLETED|Follow-up||24
6392611|NCT00843167|7304667|FG000|NOT COMPLETED|Follow-up||0
6392612|NCT00843167|7304668|FG001|NOT COMPLETED|Follow-up||0
6392613|NCT00843180|7304680|FG000|STARTED|Overall Study||16
6392614|NCT00843180|7304681|FG001|STARTED|Overall Study||7
6392615|NCT00843180|7304680|FG000|COMPLETED|Overall Study||16
6392616|NCT00843180|7304681|FG001|COMPLETED|Overall Study||7
6392617|NCT00843180|7304680|FG000|NOT COMPLETED|Overall Study||0
6392618|NCT00843180|7304681|FG001|NOT COMPLETED|Overall Study||0
6392619|NCT00843193|7304689|FG000|STARTED|Overall Study||99
6392620|NCT00843193|7304690|FG001|STARTED|Overall Study||99
6392621|NCT00843193|7304689|FG000|COMPLETED|Overall Study||91
6392622|NCT00843193|7304690|FG001|COMPLETED|Overall Study||88
6392623|NCT00843193|7304689|FG000|NOT COMPLETED|Overall Study||8
6392624|NCT00843193|7304690|FG001|NOT COMPLETED|Overall Study||11
6392625|NCT00843284|7304697|FG000|STARTED|Overall Study||691
6392626|NCT00843284|7304697|FG000|COMPLETED|Overall Study||619
6392627|NCT00843284|7304697|FG000|NOT COMPLETED|Overall Study||72
6392628|NCT00843349|7304705|FG000|STARTED|Overall Study||11
6392629|NCT00843349|7304706|FG001|STARTED|Overall Study||11
6392630|NCT00843349|7304707|FG002|STARTED|Overall Study||10
6392631|NCT00843349|7304708|FG003|STARTED|Overall Study||11
6392632|NCT00843349|7304705|FG000|COMPLETED|Overall Study||8
6392633|NCT00843349|7304706|FG001|COMPLETED|Overall Study||11
6392634|NCT00843349|7304707|FG002|COMPLETED|Overall Study||10
6392635|NCT00843349|7304708|FG003|COMPLETED|Overall Study||10
6392636|NCT00843349|7304705|FG000|NOT COMPLETED|Overall Study||3
6392637|NCT00843349|7304706|FG001|NOT COMPLETED|Overall Study||0
6392638|NCT00843349|7304707|FG002|NOT COMPLETED|Overall Study||0
6392639|NCT00843349|7304708|FG003|NOT COMPLETED|Overall Study||1
6392640|NCT00843466|7304720|FG000|STARTED|Overall Study||24
6392641|NCT00843466|7304721|FG001|STARTED|Overall Study||18
6392642|NCT00843466|7304720|FG000|COMPLETED|Overall Study||24
6392643|NCT00843466|7304721|FG001|COMPLETED|Overall Study||18
6392644|NCT00843466|7304720|FG000|NOT COMPLETED|Overall Study||0
6392645|NCT00843466|7304721|FG001|NOT COMPLETED|Overall Study||0
6392646|NCT00843479|7304729|FG000|STARTED|Overall Study||12
6603274|NCT02059434|7528046|FG002|NOT COMPLETED|Washout Between Periods 2 and 3||0
6603275|NCT02059434|7528047|FG003|NOT COMPLETED|Washout Between Periods 2 and 3||0
6603276|NCT02059434|7528048|FG004|NOT COMPLETED|Washout Between Periods 2 and 3||0
6603277|NCT02059434|7528049|FG005|NOT COMPLETED|Washout Between Periods 2 and 3||0
6603278|NCT02059434|7528050|FG006|NOT COMPLETED|Washout Between Periods 2 and 3||0
6603279|NCT02059434|7528051|FG007|NOT COMPLETED|Washout Between Periods 2 and 3||0
6603280|NCT02059434|7528052|FG008|NOT COMPLETED|Washout Between Periods 2 and 3||0
6603281|NCT02059434|7528044|FG000|STARTED|Period 3||2
6603282|NCT02059434|7528045|FG001|STARTED|Period 3||2
6603283|NCT02059434|7528046|FG002|STARTED|Period 3||2
6603284|NCT02059434|7528047|FG003|STARTED|Period 3||2
6603285|NCT02059434|7528048|FG004|STARTED|Period 3||2
6603286|NCT02059434|7528049|FG005|STARTED|Period 3||2
6603287|NCT02059434|7528050|FG006|STARTED|Period 3||2
6392647|NCT00843479|7304730|FG001|STARTED|Overall Study||12
6392648|NCT00843479|7304729|FG000|COMPLETED|Overall Study||12
6392649|NCT00843479|7304730|FG001|COMPLETED|Overall Study||12
6392650|NCT00843479|7304729|FG000|NOT COMPLETED|Overall Study||0
6392651|NCT00843479|7304730|FG001|NOT COMPLETED|Overall Study||0
6392652|NCT00843492|7304740|FG000|STARTED|Overall Study||622
6392653|NCT00843492|7304741|FG001|STARTED|Overall Study||621
6392654|NCT00843492|7304740|FG000|COMPLETED|Overall Study||614
6392655|NCT00843492|7304741|FG001|COMPLETED|Overall Study||607
6392656|NCT00843492|7304740|FG000|NOT COMPLETED|Overall Study||8
6392657|NCT00843492|7304741|FG001|NOT COMPLETED|Overall Study||14
6392658|NCT00843518|7304749|FG000|STARTED|Period 2 (Double-blind Treatment)||63
6392659|NCT00843518|7304750|FG001|STARTED|Period 2 (Double-blind Treatment)||69
6392660|NCT00843518|7304749|FG000|COMPLETED|Period 2 (Double-blind Treatment)||43
6392661|NCT00843518|7304750|FG001|COMPLETED|Period 2 (Double-blind Treatment)||49
6392662|NCT00843518|7304749|FG000|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
6392663|NCT00843518|7304750|FG001|NOT COMPLETED|Period 2 (Double-blind Treatment)||20
6392664|NCT00843518|7304749|FG000|STARTED|Period 3 (Single-blind Washout)|1 LY451395 participant completed double-blind treatment, but did not enter washout period.|42
6392665|NCT00843518|7304750|FG001|STARTED|Period 3 (Single-blind Washout)||49
6392666|NCT00843518|7304749|FG000|COMPLETED|Period 3 (Single-blind Washout)||42
6392667|NCT00843518|7304750|FG001|COMPLETED|Period 3 (Single-blind Washout)||49
6392668|NCT00843518|7304749|FG000|NOT COMPLETED|Period 3 (Single-blind Washout)||0
6392669|NCT00843518|7304750|FG001|NOT COMPLETED|Period 3 (Single-blind Washout)||0
6392670|NCT00843531|7304760|FG000|STARTED|Overall Study||17
6392671|NCT00843531|7304760|FG000|COMPLETED|Overall Study||17
6392672|NCT00843531|7304760|FG000|NOT COMPLETED|Overall Study||0
6392673|NCT00843622|7304770|FG000|STARTED|Overall Study||125
6392674|NCT00843622|7304771|FG001|STARTED|Overall Study||125
6392675|NCT00843622|7304770|FG000|COMPLETED|Overall Study||82
6392676|NCT00843622|7304771|FG001|COMPLETED|Overall Study||70
6603288|NCT02059434|7528051|FG007|STARTED|Period 3||2
6392677|NCT00843622|7304770|FG000|NOT COMPLETED|Overall Study||43
6392678|NCT00843622|7304771|FG001|NOT COMPLETED|Overall Study||55
6392679|NCT00843635|7304780|FG000|STARTED|Overall Study||15
6392680|NCT00843635|7304781|FG001|STARTED|Overall Study||15
6392681|NCT00843635|7304782|FG002|STARTED|Overall Study||5
6392682|NCT00843635|7304780|FG000|COMPLETED|Overall Study||13
6392683|NCT00843635|7304781|FG001|COMPLETED|Overall Study||13
6392684|NCT00843635|7304782|FG002|COMPLETED|Overall Study||5
6392685|NCT00843635|7304780|FG000|NOT COMPLETED|Overall Study||2
6392686|NCT00843635|7304781|FG001|NOT COMPLETED|Overall Study||2
6392687|NCT00843635|7304782|FG002|NOT COMPLETED|Overall Study||0
6392688|NCT00843713|7304796|FG000|STARTED|Overall Study||30
6392689|NCT00843713|7304797|FG001|STARTED|Overall Study||26
6392690|NCT00843713|7304796|FG000|COMPLETED|Overall Study||30
6392691|NCT00843713|7304797|FG001|COMPLETED|Overall Study||26
6392692|NCT00843713|7304796|FG000|NOT COMPLETED|Overall Study||0
6392693|NCT00843713|7304797|FG001|NOT COMPLETED|Overall Study||0
6392694|NCT00843726|7304805|FG000|STARTED|Overall Study||49
6392695|NCT00843726|7304806|FG001|STARTED|Overall Study||49
6392696|NCT00843726|7304805|FG000|COMPLETED|Overall Study||48
6392697|NCT00843726|7304806|FG001|COMPLETED|Overall Study||48
6392698|NCT00843726|7304805|FG000|NOT COMPLETED|Overall Study||1
6392699|NCT00843726|7304806|FG001|NOT COMPLETED|Overall Study||1
6392700|NCT00843778|7304813|FG000|STARTED|Overall Study||131
6392701|NCT00843778|7304813|FG000|COMPLETED|Overall Study||96
6392702|NCT00843778|7304813|FG000|NOT COMPLETED|Overall Study||35
6392703|NCT00843843|7304819|FG000|STARTED|Overall Study||8
6392704|NCT00843843|7304820|FG001|STARTED|Overall Study||8
6392705|NCT00843843|7304819|FG000|COMPLETED|Overall Study||6
6392706|NCT00843843|7304820|FG001|COMPLETED|Overall Study||6
6392707|NCT00843843|7304819|FG000|NOT COMPLETED|Overall Study||2
6392708|NCT00843843|7304820|FG001|NOT COMPLETED|Overall Study||2
6392709|NCT00843856|7304828|FG000|STARTED|Overall Study||20
6392710|NCT00843856|7304829|FG001|STARTED|Overall Study||20
6392711|NCT00843856|7304828|FG000|COMPLETED|Overall Study||19
6392712|NCT00843856|7304829|FG001|COMPLETED|Overall Study||18
6392713|NCT00843856|7304828|FG000|NOT COMPLETED|Overall Study||1
6392714|NCT00843856|7304829|FG001|NOT COMPLETED|Overall Study||2
6392715|NCT00844051|7304837|FG000|STARTED|Overall Study||2087
6392716|NCT00844051|7304838|FG001|STARTED|Overall Study||2368
6392717|NCT00844051|7304837|FG000|COMPLETED|Overall Study||2087
6392718|NCT00844051|7304838|FG001|COMPLETED|Overall Study||2368
6392719|NCT00844051|7304837|FG000|NOT COMPLETED|Overall Study||0
6392720|NCT00844051|7304838|FG001|NOT COMPLETED|Overall Study||0
6392721|NCT00844090|7304846|FG000|STARTED|Overall Study||52
6392722|NCT00844090|7304847|FG001|STARTED|Overall Study||54
6392723|NCT00844090|7304846|FG000|COMPLETED|Overall Study||46
6392724|NCT00844090|7304847|FG001|COMPLETED|Overall Study||46
6392725|NCT00844090|7304846|FG000|NOT COMPLETED|Overall Study||6
6392726|NCT00844090|7304847|FG001|NOT COMPLETED|Overall Study||8
6392727|NCT00844194|7304855|FG000|STARTED|Overall Study||78
6392728|NCT00844194|7304856|FG001|STARTED|Overall Study||30
6392729|NCT00844194|7304855|FG000|COMPLETED|Overall Study||53
6392730|NCT00844194|7304856|FG001|COMPLETED|Overall Study||22
6392731|NCT00844194|7304855|FG000|NOT COMPLETED|Overall Study||25
6392732|NCT00844194|7304856|FG001|NOT COMPLETED|Overall Study||8
6392733|NCT00844298|7304866|FG000|STARTED|Overall Study||91
6392734|NCT00844298|7304866|FG000|COMPLETED|Overall Study||91
6392735|NCT00844298|7304866|FG000|NOT COMPLETED|Overall Study||0
6392736|NCT00844376|7304870|FG000|STARTED|Period 1: First Intervention||6
6392737|NCT00844376|7304871|FG001|STARTED|Period 1: First Intervention||6
6392738|NCT00844376|7304870|FG000|COMPLETED|Period 1: First Intervention||5
6392739|NCT00844376|7304871|FG001|COMPLETED|Period 1: First Intervention||6
6392740|NCT00844376|7304870|FG000|NOT COMPLETED|Period 1: First Intervention||1
6392741|NCT00844376|7304871|FG001|NOT COMPLETED|Period 1: First Intervention||0
6392742|NCT00844376|7304870|FG000|STARTED|Period 2: Second Intervention||5
6392743|NCT00844376|7304871|FG001|STARTED|Period 2: Second Intervention||6
6392744|NCT00844376|7304870|FG000|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
6392745|NCT00844376|7304871|FG001|COMPLETED|Period 2: Second Intervention||6
6392746|NCT00844376|7304870|FG000|NOT COMPLETED|Period 2: Second Intervention||0
6392747|NCT00844376|7304871|FG001|NOT COMPLETED|Period 2: Second Intervention||0
6392748|NCT00844415|7304877|FG000|STARTED|Overall Study|Entered and treated.|9
6392749|NCT00844415|7304877|FG000|Pat. Received 75mg Followed by 100mg|Overall Study||3
6392750|NCT00844415|7304877|FG000|Pat. Received 100mg Followed by 125mg|Overall Study||3
6392751|NCT00844415|7304877|FG000|Pat. Received 125mg Followed by 150mg|Overall Study||2
6392752|NCT00844415|7304877|FG000|Pat. Received Single Dose 75mg|Overall Study||1
6392753|NCT00844415|7304877|FG000|COMPLETED|Overall Study|Completed.|8
6392754|NCT00844415|7304877|FG000|NOT COMPLETED|Overall Study||1
6392755|NCT00844428|7304882|FG000|STARTED|Screening Period||23
6392756|NCT00844428|7304882|FG000|COMPLETED|Screening Period||20
6392757|NCT00844428|7304882|FG000|NOT COMPLETED|Screening Period||3
6392758|NCT00844428|7304882|FG000|STARTED|Observation Period (8 Weeks)||20
6392759|NCT00844428|7304882|FG000|COMPLETED|Observation Period (8 Weeks)||20
6392760|NCT00844428|7304882|FG000|NOT COMPLETED|Observation Period (8 Weeks)||0
6392761|NCT00844428|7304882|FG000|STARTED|Treatment Period (26 Weeks)||20
6392762|NCT00844428|7304882|FG000|COMPLETED|Treatment Period (26 Weeks)||20
6392763|NCT00844428|7304882|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||0
6392764|NCT00844428|7304882|FG000|STARTED|Extension Treatment Period||19
6392765|NCT00844428|7304882|FG000|COMPLETED|Extension Treatment Period||18
6392766|NCT00844428|7304882|FG000|NOT COMPLETED|Extension Treatment Period||1
6392767|NCT00844428|7304882|FG000|STARTED|Post Treatment Period (Patients Who Disc||5
6392768|NCT00844428|7304882|FG000|COMPLETED|Post Treatment Period (Patients Who Disc||4
6392769|NCT00844428|7304882|FG000|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
6392770|NCT00844519|7304888|FG000|STARTED|Overall Study||26
6392771|NCT00844519|7304889|FG001|STARTED|Overall Study||26
6392772|NCT00844519|7304888|FG000|COMPLETED|Overall Study||24
6392773|NCT00844519|7304889|FG001|COMPLETED|Overall Study||25
6392774|NCT00844519|7304888|FG000|NOT COMPLETED|Overall Study||2
6392775|NCT00844519|7304889|FG001|NOT COMPLETED|Overall Study||1
6392776|NCT00844532|7304895|FG000|STARTED|Overall Study||151
6392777|NCT00844532|7304895|FG000|COMPLETED|Overall Study||112
6392778|NCT00844532|7304895|FG000|NOT COMPLETED|Overall Study||39
6392779|NCT00844545|7304899|FG000|STARTED|Screening Period||17
6392780|NCT00844545|7304899|FG000|COMPLETED|Screening Period||17
6392781|NCT00844545|7304899|FG000|NOT COMPLETED|Screening Period||0
6392782|NCT00844545|7304899|FG000|STARTED|Treatment Period (26 Weeks)||17
6392783|NCT00844545|7304899|FG000|COMPLETED|Treatment Period (26 Weeks)||15
6392784|NCT00844545|7304899|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
6392785|NCT00844545|7304899|FG000|STARTED|Extension Treatment Period||13
6392786|NCT00844545|7304899|FG000|COMPLETED|Extension Treatment Period||11
6392787|NCT00844545|7304899|FG000|NOT COMPLETED|Extension Treatment Period||2
6392788|NCT00844545|7304899|FG000|STARTED|Post Treatment Period||6
6392789|NCT00844545|7304899|FG000|COMPLETED|Post Treatment Period||5
6392790|NCT00844545|7304899|FG000|NOT COMPLETED|Post Treatment Period||1
6392791|NCT00844558|7304906|FG000|STARTED|Overall Study|"Received allocated intervention (n=33)~Did not receive allocated intervention (n=3)"|36
6392792|NCT00844558|7304907|FG001|STARTED|Overall Study|"Received allocated intervention (n=21)~Did not receive allocated intervention (n=1)"|22
6392793|NCT00844558|7304906|FG000|Received Allocated Intervention|Overall Study||33
6392794|NCT00844558|7304907|FG001|Received Allocated Intervention|Overall Study||21
6392795|NCT00844558|7304906|FG000|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
6392796|NCT00844558|7304907|FG001|3 Month Visit|Overall Study|"Lost to follow-up (n=1)~Discontinued Intervention (n=1)"|19
6392797|NCT00844558|7304906|FG000|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
6392798|NCT00844558|7304907|FG001|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
6392799|NCT00844558|7304906|FG000|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
6392800|NCT00844558|7304907|FG001|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
6392801|NCT00844558|7304906|FG000|COMPLETED|Overall Study||24
6603289|NCT02059434|7528052|FG008|STARTED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603290|NCT02059434|7528044|FG000|COMPLETED|Period 3||2
6603291|NCT02059434|7528045|FG001|COMPLETED|Period 3||2
6603292|NCT02059434|7528046|FG002|COMPLETED|Period 3||2
6603293|NCT02059434|7528047|FG003|COMPLETED|Period 3||2
6603294|NCT02059434|7528048|FG004|COMPLETED|Period 3||2
6603295|NCT02059434|7528049|FG005|COMPLETED|Period 3||2
6603296|NCT02059434|7528050|FG006|COMPLETED|Period 3||2
6603297|NCT02059434|7528051|FG007|COMPLETED|Period 3||2
6603298|NCT02059434|7528052|FG008|COMPLETED|Period 3|Part 2 followed Part 1, and comprised 5 treatment periods|0
6603299|NCT02059434|7528044|FG000|NOT COMPLETED|Period 3||0
6603300|NCT02059434|7528045|FG001|NOT COMPLETED|Period 3||0
6603301|NCT02059434|7528046|FG002|NOT COMPLETED|Period 3||0
6603302|NCT02059434|7528047|FG003|NOT COMPLETED|Period 3||0
6603303|NCT02059434|7528048|FG004|NOT COMPLETED|Period 3||0
6603304|NCT02059434|7528049|FG005|NOT COMPLETED|Period 3||0
6603305|NCT02059434|7528050|FG006|NOT COMPLETED|Period 3||0
6603306|NCT02059434|7528051|FG007|NOT COMPLETED|Period 3||0
6603307|NCT02059434|7528052|FG008|NOT COMPLETED|Period 3||0
6603308|NCT02059434|7528044|FG000|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603309|NCT02059434|7528045|FG001|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603310|NCT02059434|7528046|FG002|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603311|NCT02059434|7528047|FG003|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603312|NCT02059434|7528048|FG004|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603313|NCT02059434|7528049|FG005|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603314|NCT02059434|7528050|FG006|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603315|NCT02059434|7528051|FG007|STARTED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603316|NCT02059434|7528052|FG008|STARTED|Period 4 (After Screening/run-in Period)||38
6603317|NCT02059434|7528044|FG000|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603318|NCT02059434|7528045|FG001|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603319|NCT02059434|7528046|FG002|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603320|NCT02059434|7528047|FG003|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6392802|NCT00844558|7304907|FG001|COMPLETED|Overall Study||18
6392803|NCT00844558|7304906|FG000|NOT COMPLETED|Overall Study||12
6392804|NCT00844558|7304907|FG001|NOT COMPLETED|Overall Study||4
6392805|NCT00844597|7304924|FG000|STARTED|Overall Study||4
6392806|NCT00844597|7304925|FG001|STARTED|Overall Study||2
6392807|NCT00844597|7304926|FG002|STARTED|Overall Study||2
6392808|NCT00844597|7304927|FG003|STARTED|Overall Study||3
6392809|NCT00844597|7304928|FG004|STARTED|Overall Study||4
6392810|NCT00844597|7304929|FG005|STARTED|Overall Study||4
6392811|NCT00844597|7304924|FG000|COMPLETED|Overall Study||4
6392812|NCT00844597|7304925|FG001|COMPLETED|Overall Study||2
6392813|NCT00844597|7304926|FG002|COMPLETED|Overall Study||2
6392814|NCT00844597|7304927|FG003|COMPLETED|Overall Study||2
6392815|NCT00844597|7304928|FG004|COMPLETED|Overall Study||4
6392816|NCT00844597|7304929|FG005|COMPLETED|Overall Study||4
6392817|NCT00844597|7304924|FG000|NOT COMPLETED|Overall Study||0
6392818|NCT00844597|7304925|FG001|NOT COMPLETED|Overall Study||0
6392819|NCT00844597|7304926|FG002|NOT COMPLETED|Overall Study||0
6392820|NCT00844597|7304927|FG003|NOT COMPLETED|Overall Study||1
6392821|NCT00844597|7304928|FG004|NOT COMPLETED|Overall Study||0
6392822|NCT00844597|7304929|FG005|NOT COMPLETED|Overall Study||0
6392823|NCT00844649|7304947|FG000|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
6392824|NCT00844649|7304948|FG001|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
6392825|NCT00844649|7304947|FG000|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
6392826|NCT00844649|7304948|FG001|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
6392827|NCT00844649|7304947|FG000|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
6392828|NCT00844649|7304948|FG001|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
6392829|NCT00844649|7304947|FG000|NOT COMPLETED|Overall Study||405
6392830|NCT00844649|7304948|FG001|NOT COMPLETED|Overall Study||418
6392831|NCT00844714|7304956|FG000|STARTED|Overall Study||20
6392832|NCT00844714|7304956|FG000|COMPLETED|Overall Study||20
6392833|NCT00844714|7304956|FG000|NOT COMPLETED|Overall Study||0
6392834|NCT00844753|7304964|FG000|STARTED|Overall Study||32
6392835|NCT00844753|7304965|FG001|STARTED|Overall Study||32
6392836|NCT00844753|7304966|FG002|STARTED|Overall Study||32
6392837|NCT00844753|7304967|FG003|STARTED|Overall Study||32
6392838|NCT00844753|7304964|FG000|COMPLETED|Overall Study||24
6392839|NCT00844753|7304965|FG001|COMPLETED|Overall Study||29
6392840|NCT00844753|7304966|FG002|COMPLETED|Overall Study||25
6392841|NCT00844753|7304967|FG003|COMPLETED|Overall Study||21
6392842|NCT00844753|7304964|FG000|NOT COMPLETED|Overall Study||8
6392843|NCT00844753|7304965|FG001|NOT COMPLETED|Overall Study||3
6392844|NCT00844753|7304966|FG002|NOT COMPLETED|Overall Study||7
6392845|NCT00844753|7304967|FG003|NOT COMPLETED|Overall Study||11
6392846|NCT00844805|7304977|FG000|STARTED|Treatment Phase||106
6392847|NCT00844805|7304978|FG001|STARTED|Treatment Phase||52
6392848|NCT00844805|7304979|FG002|STARTED|Treatment Phase||0
6392849|NCT00844805|7304980|FG003|STARTED|Treatment Phase||0
6392850|NCT00844805|7304977|FG000|COMPLETED|Treatment Phase||96
6392851|NCT00844805|7304978|FG001|COMPLETED|Treatment Phase||45
6392852|NCT00844805|7304979|FG002|COMPLETED|Treatment Phase||0
6392853|NCT00844805|7304980|FG003|COMPLETED|Treatment Phase||0
6392854|NCT00844805|7304977|FG000|NOT COMPLETED|Treatment Phase||10
6392855|NCT00844805|7304978|FG001|NOT COMPLETED|Treatment Phase||7
6392856|NCT00844805|7304979|FG002|NOT COMPLETED|Treatment Phase||0
6392857|NCT00844805|7304980|FG003|NOT COMPLETED|Treatment Phase||0
6392858|NCT00844805|7304977|FG000|STARTED|Follow-Up Phase||0
6392859|NCT00844805|7304978|FG001|STARTED|Follow-Up Phase||0
6392860|NCT00844805|7304979|FG002|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
6392861|NCT00844805|7304980|FG003|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
6392862|NCT00844805|7304977|FG000|COMPLETED|Follow-Up Phase||0
6392863|NCT00844805|7304978|FG001|COMPLETED|Follow-Up Phase||0
6392864|NCT00844805|7304979|FG002|COMPLETED|Follow-Up Phase||32
6392865|NCT00844805|7304980|FG003|COMPLETED|Follow-Up Phase||32
6392866|NCT00844805|7304977|FG000|NOT COMPLETED|Follow-Up Phase||0
6392867|NCT00844805|7304978|FG001|NOT COMPLETED|Follow-Up Phase||0
6392868|NCT00844805|7304979|FG002|NOT COMPLETED|Follow-Up Phase||9
6392869|NCT00844805|7304980|FG003|NOT COMPLETED|Follow-Up Phase||9
6392870|NCT00844831|7304991|FG000|STARTED|Overall Study||25
6392871|NCT00844831|7304991|FG000|COMPLETED|Overall Study||19
6392872|NCT00844831|7304991|FG000|NOT COMPLETED|Overall Study||6
6392873|NCT00844844|7304999|FG000|STARTED|Screening Period||17
6392874|NCT00844844|7304999|FG000|COMPLETED|Screening Period||17
6392875|NCT00844844|7304999|FG000|NOT COMPLETED|Screening Period||0
6392876|NCT00844844|7304999|FG000|STARTED|Treatment Period (26 Weeks)||17
6392877|NCT00844844|7304999|FG000|COMPLETED|Treatment Period (26 Weeks)||15
6392878|NCT00844844|7304999|FG000|NOT COMPLETED|Treatment Period (26 Weeks)||2
6392879|NCT00844844|7304999|FG000|STARTED|Extension Treatment Period||13
6392880|NCT00844844|7304999|FG000|COMPLETED|Extension Treatment Period||11
6392881|NCT00844844|7304999|FG000|NOT COMPLETED|Extension Treatment Period||2
6392882|NCT00844844|7304999|FG000|STARTED|Post Treatment Period||6
6392883|NCT00844844|7304999|FG000|COMPLETED|Post Treatment Period||5
6392884|NCT00844844|7304999|FG000|NOT COMPLETED|Post Treatment Period||1
6392885|NCT00844857|7305005|FG000|STARTED|Overall Study||194
6392886|NCT00844857|7305006|FG001|STARTED|Overall Study||97
6392887|NCT00844857|7305005|FG000|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
6392888|NCT00844857|7305006|FG001|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
6392889|NCT00844857|7305005|FG000|COMPLETED|Overall Study||116
6392890|NCT00844857|7305006|FG001|COMPLETED|Overall Study||60
6392891|NCT00844857|7305005|FG000|NOT COMPLETED|Overall Study||78
6392892|NCT00844857|7305006|FG001|NOT COMPLETED|Overall Study||37
6392893|NCT00844883|7305015|FG000|STARTED|Overall Study||50
6392894|NCT00844883|7305015|FG000|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
6392895|NCT00844883|7305015|FG000|COMPLETED|Overall Study||46
6392896|NCT00844883|7305015|FG000|NOT COMPLETED|Overall Study||4
6392897|NCT00844896|7305021|FG000|STARTED|Overall Study||29
6392898|NCT00844896|7305022|FG001|STARTED|Overall Study||28
6392899|NCT00844896|7305021|FG000|COMPLETED|Overall Study||17
6392900|NCT00844896|7305022|FG001|COMPLETED|Overall Study||11
6392901|NCT00844896|7305021|FG000|NOT COMPLETED|Overall Study||12
6392902|NCT00844896|7305022|FG001|NOT COMPLETED|Overall Study||17
6392903|NCT00845000|7305035|FG000|STARTED|Period 1||2
6392904|NCT00845000|7305036|FG001|STARTED|Period 1||2
6392905|NCT00845000|7305037|FG002|STARTED|Period 1||2
6392906|NCT00845000|7305038|FG003|STARTED|Period 1||2
6392907|NCT00845000|7305039|FG004|STARTED|Period 1||2
6392908|NCT00845000|7305040|FG005|STARTED|Period 1||2
6392909|NCT00845000|7305035|FG000|COMPLETED|Period 1||2
6392910|NCT00845000|7305036|FG001|COMPLETED|Period 1||2
6392911|NCT00845000|7305037|FG002|COMPLETED|Period 1||2
6392912|NCT00845000|7305038|FG003|COMPLETED|Period 1||2
6392913|NCT00845000|7305039|FG004|COMPLETED|Period 1||2
6392914|NCT00845000|7305040|FG005|COMPLETED|Period 1||2
6392915|NCT00845000|7305035|FG000|NOT COMPLETED|Period 1||0
6392916|NCT00845000|7305036|FG001|NOT COMPLETED|Period 1||0
6392917|NCT00845000|7305037|FG002|NOT COMPLETED|Period 1||0
6392918|NCT00845000|7305038|FG003|NOT COMPLETED|Period 1||0
6392919|NCT00845000|7305039|FG004|NOT COMPLETED|Period 1||0
6392920|NCT00845000|7305040|FG005|NOT COMPLETED|Period 1||0
6392921|NCT00845000|7305035|FG000|STARTED|Period 2||2
6392922|NCT00845000|7305036|FG001|STARTED|Period 2||2
6392923|NCT00845000|7305037|FG002|STARTED|Period 2||2
6392924|NCT00845000|7305038|FG003|STARTED|Period 2||2
6392925|NCT00845000|7305039|FG004|STARTED|Period 2||2
6392926|NCT00845000|7305040|FG005|STARTED|Period 2||2
6392927|NCT00845000|7305035|FG000|COMPLETED|Period 2||2
6392928|NCT00845000|7305036|FG001|COMPLETED|Period 2||2
6392929|NCT00845000|7305037|FG002|COMPLETED|Period 2||2
6392930|NCT00845000|7305038|FG003|COMPLETED|Period 2||2
6392931|NCT00845000|7305039|FG004|COMPLETED|Period 2||2
6392932|NCT00845000|7305040|FG005|COMPLETED|Period 2||2
6392933|NCT00845000|7305035|FG000|NOT COMPLETED|Period 2||0
6392934|NCT00845000|7305036|FG001|NOT COMPLETED|Period 2||0
6392935|NCT00845000|7305037|FG002|NOT COMPLETED|Period 2||0
6392936|NCT00845000|7305038|FG003|NOT COMPLETED|Period 2||0
6392937|NCT00845000|7305039|FG004|NOT COMPLETED|Period 2||0
6392938|NCT00845000|7305040|FG005|NOT COMPLETED|Period 2||0
6392939|NCT00845000|7305035|FG000|STARTED|Period 3||2
6392940|NCT00845000|7305036|FG001|STARTED|Period 3||2
6392941|NCT00845000|7305037|FG002|STARTED|Period 3||2
6392942|NCT00845000|7305038|FG003|STARTED|Period 3||2
6392943|NCT00845000|7305039|FG004|STARTED|Period 3||2
6392944|NCT00845000|7305040|FG005|STARTED|Period 3||2
6392945|NCT00845000|7305035|FG000|COMPLETED|Period 3||2
6392946|NCT00845000|7305036|FG001|COMPLETED|Period 3||2
6392947|NCT00845000|7305037|FG002|COMPLETED|Period 3||2
6392948|NCT00845000|7305038|FG003|COMPLETED|Period 3||2
6392949|NCT00845000|7305039|FG004|COMPLETED|Period 3||2
6392950|NCT00845000|7305040|FG005|COMPLETED|Period 3||2
6392951|NCT00845000|7305035|FG000|NOT COMPLETED|Period 3||0
6392952|NCT00845000|7305036|FG001|NOT COMPLETED|Period 3||0
6392953|NCT00845000|7305037|FG002|NOT COMPLETED|Period 3||0
6392954|NCT00845000|7305038|FG003|NOT COMPLETED|Period 3||0
6392955|NCT00845000|7305039|FG004|NOT COMPLETED|Period 3||0
6392956|NCT00845000|7305040|FG005|NOT COMPLETED|Period 3||0
6392957|NCT00845039|7305050|FG000|STARTED|Overall Study||2
6392958|NCT00845039|7305051|FG001|STARTED|Overall Study||2
6392959|NCT00845039|7305050|FG000|Received at Least 1 Dose of Study Drug|Overall Study||2
6392960|NCT00845039|7305051|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
6392961|NCT00845039|7305050|FG000|COMPLETED|Overall Study||2
6392962|NCT00845039|7305051|FG001|COMPLETED|Overall Study||2
6392963|NCT00845039|7305050|FG000|NOT COMPLETED|Overall Study||0
6392964|NCT00845039|7305051|FG001|NOT COMPLETED|Overall Study||0
6392965|NCT00845065|7305061|FG000|STARTED|Overall Study||67
6392966|NCT00845065|7305062|FG001|STARTED|Overall Study||134
6392967|NCT00845065|7305061|FG000|COMPLETED|Overall Study||20
6392968|NCT00845065|7305062|FG001|COMPLETED|Overall Study||79
6392969|NCT00845065|7305061|FG000|NOT COMPLETED|Overall Study||47
6392970|NCT00845065|7305062|FG001|NOT COMPLETED|Overall Study||55
6392971|NCT00845130|7305070|FG000|STARTED|Overall Study||20
6392972|NCT00845130|7305071|FG001|STARTED|Overall Study||22
6392973|NCT00845130|7305070|FG000|COMPLETED|Overall Study||16
6392974|NCT00845130|7305071|FG001|COMPLETED|Overall Study||19
6392975|NCT00845130|7305070|FG000|NOT COMPLETED|Overall Study||4
6392976|NCT00845130|7305071|FG001|NOT COMPLETED|Overall Study||3
6392977|NCT00845182|7305082|FG000|STARTED|Overall Study||13
6392978|NCT00845182|7305083|FG001|STARTED|Overall Study||15
6392979|NCT00845182|7305084|FG002|STARTED|Overall Study||15
6392980|NCT00845182|7305082|FG000|COMPLETED|Overall Study||10
6392981|NCT00845182|7305083|FG001|COMPLETED|Overall Study||11
6392982|NCT00845182|7305084|FG002|COMPLETED|Overall Study||9
6392983|NCT00845182|7305082|FG000|NOT COMPLETED|Overall Study||3
6392984|NCT00845182|7305083|FG001|NOT COMPLETED|Overall Study||4
6392985|NCT00845182|7305084|FG002|NOT COMPLETED|Overall Study||6
6392986|NCT00845195|7305098|FG000|STARTED|Overall Study||75
6392987|NCT00845195|7305099|FG001|STARTED|Overall Study||75
6392988|NCT00845195|7305098|FG000|COMPLETED|Overall Study||75
6392989|NCT00845195|7305099|FG001|COMPLETED|Overall Study||75
6392990|NCT00845195|7305098|FG000|NOT COMPLETED|Overall Study||0
6392991|NCT00845195|7305099|FG001|NOT COMPLETED|Overall Study||0
6392992|NCT00845429|7305108|FG000|STARTED|Overall Study||244
6392993|NCT00845429|7305109|FG001|STARTED|Overall Study||241
6392994|NCT00845429|7305110|FG002|STARTED|Overall Study||244
6392995|NCT00845429|7305108|FG000|COMPLETED|Overall Study||230
6392996|NCT00845429|7305109|FG001|COMPLETED|Overall Study||226
6392997|NCT00845429|7305110|FG002|COMPLETED|Overall Study||224
6392998|NCT00845429|7305108|FG000|NOT COMPLETED|Overall Study||14
6392999|NCT00845429|7305109|FG001|NOT COMPLETED|Overall Study||15
6393000|NCT00845429|7305110|FG002|NOT COMPLETED|Overall Study||20
6393001|NCT00845481|7305118|FG000|STARTED|Overall Study||24
6393002|NCT00845481|7305118|FG000|COMPLETED|Overall Study||24
6393003|NCT00845481|7305118|FG000|NOT COMPLETED|Overall Study||0
6393004|NCT00845507|7305129|FG000|STARTED|Overall Study||24
6393005|NCT00845507|7305130|FG001|STARTED|Overall Study||30
6393006|NCT00845507|7305129|FG000|COMPLETED|Overall Study||22
6393007|NCT00845507|7305130|FG001|COMPLETED|Overall Study||29
6393008|NCT00845507|7305129|FG000|NOT COMPLETED|Overall Study||2
6393009|NCT00845507|7305130|FG001|NOT COMPLETED|Overall Study||1
6393010|NCT00845520|7305139|FG000|STARTED|Overall Study||25
6393011|NCT00845520|7305140|FG001|STARTED|Overall Study||25
6393012|NCT00845520|7305141|FG002|STARTED|Overall Study||24
6393013|NCT00845520|7305139|FG000|COMPLETED|Overall Study||23
6393014|NCT00845520|7305140|FG001|COMPLETED|Overall Study||23
6393015|NCT00845520|7305141|FG002|COMPLETED|Overall Study||23
6393016|NCT00845520|7305139|FG000|NOT COMPLETED|Overall Study||2
6393017|NCT00845520|7305140|FG001|NOT COMPLETED|Overall Study||2
6393018|NCT00845520|7305141|FG002|NOT COMPLETED|Overall Study||1
6393019|NCT00845650|7305161|FG000|STARTED|Overall Study|1 subject not dosed|31
6393020|NCT00845650|7305162|FG001|STARTED|Overall Study||5
6393021|NCT00845650|7305163|FG002|STARTED|Overall Study||31
6393022|NCT00845650|7305164|FG003|STARTED|Overall Study||14
6393023|NCT00845650|7305165|FG004|STARTED|Overall Study|2 subjects not dosed|31
6393024|NCT00845650|7305166|FG005|STARTED|Overall Study|1 subject not dosed|17
6393025|NCT00845650|7305161|FG000|COMPLETED|Overall Study||30
6393026|NCT00845650|7305162|FG001|COMPLETED|Overall Study||5
6393027|NCT00845650|7305163|FG002|COMPLETED|Overall Study||28
6393028|NCT00845650|7305164|FG003|COMPLETED|Overall Study||13
6393029|NCT00845650|7305165|FG004|COMPLETED|Overall Study||28
6393030|NCT00845650|7305166|FG005|COMPLETED|Overall Study||15
6393031|NCT00845650|7305161|FG000|NOT COMPLETED|Overall Study||1
6393032|NCT00845650|7305162|FG001|NOT COMPLETED|Overall Study||0
6393033|NCT00845650|7305163|FG002|NOT COMPLETED|Overall Study||3
6393034|NCT00845650|7305164|FG003|NOT COMPLETED|Overall Study||1
6393035|NCT00845650|7305165|FG004|NOT COMPLETED|Overall Study||3
6393036|NCT00845650|7305166|FG005|NOT COMPLETED|Overall Study||2
6393037|NCT00845663|7305184|FG000|STARTED|Overall Study||49
6393038|NCT00845663|7305185|FG001|STARTED|Overall Study||49
6393039|NCT00845663|7305184|FG000|COMPLETED|Overall Study||49
6393040|NCT00845663|7305185|FG001|COMPLETED|Overall Study||49
6393041|NCT00845663|7305184|FG000|NOT COMPLETED|Overall Study||0
6393042|NCT00845663|7305185|FG001|NOT COMPLETED|Overall Study||0
6393043|NCT00845676|7305191|FG000|STARTED|Overall Study||21
6393044|NCT00845676|7305191|FG000|COMPLETED|Overall Study||19
6393045|NCT00845676|7305191|FG000|NOT COMPLETED|Overall Study||2
6393046|NCT00845728|7305198|FG000|STARTED|Overall Study||1723
6393047|NCT00845728|7305199|FG001|STARTED|Overall Study||1721
6393048|NCT00845728|7305198|FG000|Exposed|Overall Study||1721
6393049|NCT00845728|7305199|FG001|Exposed|Overall Study||1718
6603321|NCT02059434|7528048|FG004|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603322|NCT02059434|7528049|FG005|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603323|NCT02059434|7528050|FG006|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603324|NCT02059434|7528051|FG007|COMPLETED|Period 4 (After Screening/run-in Period)|Part 1 comprised 3 treatment periods only|0
6603325|NCT02059434|7528052|FG008|COMPLETED|Period 4 (After Screening/run-in Period)||38
6603326|NCT02059434|7528044|FG000|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6603327|NCT02059434|7528045|FG001|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6603328|NCT02059434|7528046|FG002|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6603329|NCT02059434|7528047|FG003|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6603330|NCT02059434|7528048|FG004|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6603331|NCT02059434|7528049|FG005|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6603332|NCT02059434|7528050|FG006|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6603333|NCT02059434|7528051|FG007|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6393050|NCT00845728|7305198|FG000|COMPLETED|Overall Study||1337
6393051|NCT00845728|7305199|FG001|COMPLETED|Overall Study||1379
6393052|NCT00845728|7305198|FG000|NOT COMPLETED|Overall Study||386
6393053|NCT00845728|7305199|FG001|NOT COMPLETED|Overall Study||342
6393054|NCT00845832|7305208|FG000|STARTED|Treatment Period||4
6393055|NCT00845832|7305209|FG001|STARTED|Treatment Period||10
6393056|NCT00845832|7305210|FG002|STARTED|Treatment Period||10
6393057|NCT00845832|7305208|FG000|COMPLETED|Treatment Period||3
6393058|NCT00845832|7305209|FG001|COMPLETED|Treatment Period||7
6393059|NCT00845832|7305210|FG002|COMPLETED|Treatment Period||10
6393060|NCT00845832|7305208|FG000|NOT COMPLETED|Treatment Period||1
6393061|NCT00845832|7305209|FG001|NOT COMPLETED|Treatment Period||3
6393062|NCT00845832|7305210|FG002|NOT COMPLETED|Treatment Period||0
6393063|NCT00845832|7305208|FG000|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
6393064|NCT00845832|7305209|FG001|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
6393065|NCT00845832|7305210|FG002|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
6393066|NCT00845832|7305208|FG000|COMPLETED|Safety Follow-Up||2
6393067|NCT00845832|7305209|FG001|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
6393068|NCT00845832|7305210|FG002|COMPLETED|Safety Follow-Up||12
6393069|NCT00845832|7305208|FG000|NOT COMPLETED|Safety Follow-Up||1
6393070|NCT00845832|7305209|FG001|NOT COMPLETED|Safety Follow-Up||0
6393071|NCT00845832|7305210|FG002|NOT COMPLETED|Safety Follow-Up||0
6393072|NCT00845832|7305208|FG000|STARTED|Extended Safety Follow-Up||2
6393073|NCT00845832|7305209|FG001|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
6393074|NCT00845832|7305210|FG002|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
6393075|NCT00845832|7305208|FG000|COMPLETED|Extended Safety Follow-Up||2
6393076|NCT00845832|7305209|FG001|COMPLETED|Extended Safety Follow-Up||5
6393077|NCT00845832|7305210|FG002|COMPLETED|Extended Safety Follow-Up||0
6393078|NCT00845832|7305208|FG000|NOT COMPLETED|Extended Safety Follow-Up||0
6393079|NCT00845832|7305209|FG001|NOT COMPLETED|Extended Safety Follow-Up||0
6393080|NCT00845832|7305210|FG002|NOT COMPLETED|Extended Safety Follow-Up||7
6393081|NCT00845858|7305221|FG000|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject withdrew consent and was not dosed."|96
6393082|NCT00845858|7305222|FG001|STARTED|Overall Study|"95 subjects received allocated intervention.~1 subject was not eligible and was not dosed."|96
6393083|NCT00845858|7305223|FG002|STARTED|Overall Study||95
6393084|NCT00845858|7305221|FG000|COMPLETED|Overall Study||88
6393085|NCT00845858|7305222|FG001|COMPLETED|Overall Study||84
6393086|NCT00845858|7305223|FG002|COMPLETED|Overall Study||87
6393087|NCT00845858|7305221|FG000|NOT COMPLETED|Overall Study||8
6393088|NCT00845858|7305222|FG001|NOT COMPLETED|Overall Study||12
6393089|NCT00845858|7305223|FG002|NOT COMPLETED|Overall Study||8
6393090|NCT00845871|7305234|FG000|STARTED|Run-in Period||65
6393091|NCT00845871|7305234|FG000|COMPLETED|Run-in Period||65
6393092|NCT00845871|7305234|FG000|NOT COMPLETED|Run-in Period||0
6393093|NCT00845871|7305234|FG000|STARTED|Assessment Period||65
6393094|NCT00845871|7305234|FG000|COMPLETED|Assessment Period||58
6393095|NCT00845871|7305234|FG000|NOT COMPLETED|Assessment Period||7
6393096|NCT00845897|7305261|FG000|STARTED|Overall Study||5
6393097|NCT00845897|7305262|FG001|STARTED|Overall Study||7
6393098|NCT00845897|7305263|FG002|STARTED|Overall Study||5
6393099|NCT00845897|7305261|FG000|COMPLETED|Overall Study||3
6393100|NCT00845897|7305262|FG001|COMPLETED|Overall Study||2
6393101|NCT00845897|7305263|FG002|COMPLETED|Overall Study||2
6393102|NCT00845897|7305261|FG000|NOT COMPLETED|Overall Study||2
6393103|NCT00845897|7305262|FG001|NOT COMPLETED|Overall Study||5
6393104|NCT00845897|7305263|FG002|NOT COMPLETED|Overall Study||3
6393105|NCT00845975|7305273|FG000|STARTED|Overall Study||9
6393106|NCT00845975|7305274|FG001|STARTED|Overall Study||9
6393107|NCT00845975|7305273|FG000|COMPLETED|Overall Study||9
6393108|NCT00845975|7305274|FG001|COMPLETED|Overall Study||9
6393109|NCT00845975|7305273|FG000|NOT COMPLETED|Overall Study||0
6393110|NCT00845975|7305274|FG001|NOT COMPLETED|Overall Study||0
6393111|NCT00846027|7305280|FG000|STARTED|Overall Study||90
6393112|NCT00846027|7305280|FG000|Received Treatment|Overall Study||83
6393113|NCT00846027|7305280|FG000|COMPLETED|Overall Study||0
6393114|NCT00846027|7305280|FG000|NOT COMPLETED|Overall Study||90
6393115|NCT00846040|7305287|FG000|STARTED|Baseline: Days 1-5||10
6393116|NCT00846040|7305288|FG001|STARTED|Baseline: Days 1-5||10
6393117|NCT00846040|7305289|FG002|STARTED|Baseline: Days 1-5||23
6393118|NCT00846040|7305287|FG000|COMPLETED|Baseline: Days 1-5||9
6393119|NCT00846040|7305288|FG001|COMPLETED|Baseline: Days 1-5||10
6393120|NCT00846040|7305289|FG002|COMPLETED|Baseline: Days 1-5||23
6393121|NCT00846040|7305287|FG000|NOT COMPLETED|Baseline: Days 1-5||1
6393122|NCT00846040|7305288|FG001|NOT COMPLETED|Baseline: Days 1-5||0
6393123|NCT00846040|7305289|FG002|NOT COMPLETED|Baseline: Days 1-5||0
6393124|NCT00846040|7305287|FG000|STARTED|First Treatment Period: Days 6-14||9
6393125|NCT00846040|7305288|FG001|STARTED|First Treatment Period: Days 6-14||10
6393126|NCT00846040|7305289|FG002|STARTED|First Treatment Period: Days 6-14|This group participated in only the baseline period|0
6393127|NCT00846040|7305287|FG000|COMPLETED|First Treatment Period: Days 6-14||9
6393128|NCT00846040|7305288|FG001|COMPLETED|First Treatment Period: Days 6-14||10
6393129|NCT00846040|7305289|FG002|COMPLETED|First Treatment Period: Days 6-14||0
6393130|NCT00846040|7305287|FG000|NOT COMPLETED|First Treatment Period: Days 6-14||0
6393131|NCT00846040|7305288|FG001|NOT COMPLETED|First Treatment Period: Days 6-14||0
6393132|NCT00846040|7305289|FG002|NOT COMPLETED|First Treatment Period: Days 6-14||0
6393133|NCT00846040|7305287|FG000|STARTED|Washout: 2 Weeks to 10 Weeks||9
6393134|NCT00846040|7305288|FG001|STARTED|Washout: 2 Weeks to 10 Weeks||10
6393135|NCT00846040|7305289|FG002|STARTED|Washout: 2 Weeks to 10 Weeks||0
6393136|NCT00846040|7305287|FG000|COMPLETED|Washout: 2 Weeks to 10 Weeks||9
6393137|NCT00846040|7305288|FG001|COMPLETED|Washout: 2 Weeks to 10 Weeks||8
6393138|NCT00846040|7305289|FG002|COMPLETED|Washout: 2 Weeks to 10 Weeks||0
6393139|NCT00846040|7305287|FG000|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
6393140|NCT00846040|7305288|FG001|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||2
6393141|NCT00846040|7305289|FG002|NOT COMPLETED|Washout: 2 Weeks to 10 Weeks||0
6393142|NCT00846040|7305287|FG000|STARTED|Second Treatment: After Washout, 14 Day||9
6393143|NCT00846040|7305288|FG001|STARTED|Second Treatment: After Washout, 14 Day||8
6393144|NCT00846040|7305289|FG002|STARTED|Second Treatment: After Washout, 14 Day||0
6393145|NCT00846040|7305287|FG000|COMPLETED|Second Treatment: After Washout, 14 Day||9
6393146|NCT00846040|7305288|FG001|COMPLETED|Second Treatment: After Washout, 14 Day||8
6393147|NCT00846040|7305289|FG002|COMPLETED|Second Treatment: After Washout, 14 Day||0
6393148|NCT00846040|7305287|FG000|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
6393149|NCT00846040|7305288|FG001|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
6393150|NCT00846040|7305289|FG002|NOT COMPLETED|Second Treatment: After Washout, 14 Day||0
6393151|NCT00846053|7305300|FG000|STARTED|Overall Study|No milestones. Enrollment continued until end of study.|13
6393152|NCT00846053|7305301|FG001|STARTED|Overall Study||8
6393153|NCT00846053|7305300|FG000|COMPLETED|Overall Study|No milestones. Enrollment continued until end of study. 21 subjects enrolled.|10
6393154|NCT00846053|7305301|FG001|COMPLETED|Overall Study||8
6393155|NCT00846053|7305300|FG000|NOT COMPLETED|Overall Study||3
6393156|NCT00846053|7305301|FG001|NOT COMPLETED|Overall Study||0
6393157|NCT00846066|7305311|FG000|STARTED|Overall Study||27
6393158|NCT00846066|7305312|FG001|STARTED|Overall Study||29
6393159|NCT00846066|7305311|FG000|COMPLETED|Overall Study||27
6393160|NCT00846066|7305312|FG001|COMPLETED|Overall Study||29
6393161|NCT00846066|7305311|FG000|NOT COMPLETED|Overall Study||0
6393162|NCT00846066|7305312|FG001|NOT COMPLETED|Overall Study||0
6393163|NCT00846287|7305321|FG000|STARTED|Overall Study||16
6393164|NCT00846287|7305322|FG001|STARTED|Overall Study||15
6393165|NCT00846287|7305321|FG000|COMPLETED|Overall Study||6
6393166|NCT00846287|7305322|FG001|COMPLETED|Overall Study||10
6393167|NCT00846287|7305321|FG000|NOT COMPLETED|Overall Study||10
6393168|NCT00846287|7305322|FG001|NOT COMPLETED|Overall Study||5
6393169|NCT00846365|7305331|FG000|STARTED|Overall Study||372
6393170|NCT00846365|7305332|FG001|STARTED|Overall Study||357
6393171|NCT00846365|7305333|FG002|STARTED|Overall Study||356
6393172|NCT00846365|7305331|FG000|COMPLETED|Overall Study||317
6393173|NCT00846365|7305332|FG001|COMPLETED|Overall Study||308
6393174|NCT00846365|7305333|FG002|COMPLETED|Overall Study||323
6393175|NCT00846365|7305331|FG000|NOT COMPLETED|Overall Study||55
6393176|NCT00846365|7305332|FG001|NOT COMPLETED|Overall Study||49
6393177|NCT00846365|7305333|FG002|NOT COMPLETED|Overall Study||33
6393178|NCT00846391|7305344|FG000|STARTED|Overall Study||4
6393179|NCT00846391|7305345|FG001|STARTED|Overall Study||4
6393180|NCT00846391|7305346|FG002|STARTED|Overall Study||6
6393181|NCT00846391|7305344|FG000|COMPLETED|Overall Study||3
6393182|NCT00846391|7305345|FG001|COMPLETED|Overall Study||2
6393183|NCT00846391|7305346|FG002|COMPLETED|Overall Study||3
6393184|NCT00846391|7305344|FG000|NOT COMPLETED|Overall Study||1
6393185|NCT00846391|7305345|FG001|NOT COMPLETED|Overall Study||2
6393186|NCT00846391|7305346|FG002|NOT COMPLETED|Overall Study||3
6393187|NCT00846482|7305354|FG000|STARTED|Overall Study||64
6393188|NCT00846482|7305354|FG000|COMPLETED|Overall Study||54
6393189|NCT00846482|7305354|FG000|NOT COMPLETED|Overall Study||10
6393190|NCT00846495|7305361|FG000|STARTED|Overall Study||28
6393191|NCT00846495|7305362|FG001|STARTED|Overall Study||27
6393192|NCT00846495|7305361|FG000|COMPLETED|Overall Study||20
6393193|NCT00846495|7305362|FG001|COMPLETED|Overall Study||24
6393194|NCT00846495|7305361|FG000|NOT COMPLETED|Overall Study||8
6393195|NCT00846495|7305362|FG001|NOT COMPLETED|Overall Study||3
6393196|NCT00846521|7305368|FG000|STARTED|Overall Study||23
6393197|NCT00846521|7305368|FG000|COMPLETED|Overall Study||12
6393198|NCT00846521|7305368|FG000|NOT COMPLETED|Overall Study||11
6393199|NCT00846547|7305372|FG000|STARTED|Overall Study||32
6393200|NCT00846547|7305372|FG000|COMPLETED|Overall Study||25
6393201|NCT00846547|7305372|FG000|NOT COMPLETED|Overall Study||7
6393202|NCT00846573|7305379|FG000|STARTED|Overall Study||5
6393203|NCT00846573|7305380|FG001|STARTED|Overall Study||2
6393204|NCT00846573|7305381|FG002|STARTED|Overall Study||7
6393205|NCT00846573|7305382|FG003|STARTED|Overall Study||0
6393206|NCT00846573|7305379|FG000|COMPLETED|Overall Study||5
6393207|NCT00846573|7305380|FG001|COMPLETED|Overall Study||2
6393208|NCT00846573|7305381|FG002|COMPLETED|Overall Study||7
6393209|NCT00846573|7305382|FG003|COMPLETED|Overall Study||0
6393210|NCT00846573|7305379|FG000|NOT COMPLETED|Overall Study||0
6393211|NCT00846573|7305380|FG001|NOT COMPLETED|Overall Study||0
6393212|NCT00846573|7305381|FG002|NOT COMPLETED|Overall Study||0
6393213|NCT00846573|7305382|FG003|NOT COMPLETED|Overall Study||0
6393214|NCT00846586|7305392|FG000|STARTED|Overall Study||570
6393215|NCT00846586|7305393|FG001|STARTED|Overall Study||564
6393216|NCT00846586|7305392|FG000|Received Study Drug|Overall Study||570
6393217|NCT00846586|7305393|FG001|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
6393218|NCT00846586|7305392|FG000|COMPLETED|Overall Study||531
6393219|NCT00846586|7305393|FG001|COMPLETED|Overall Study||529
6393220|NCT00846586|7305392|FG000|NOT COMPLETED|Overall Study||39
6393221|NCT00846586|7305393|FG001|NOT COMPLETED|Overall Study||35
6393222|NCT00846651|7305401|FG000|STARTED|Overall Study||41
6393223|NCT00846651|7305402|FG001|STARTED|Overall Study||41
6393224|NCT00846651|7305401|FG000|COMPLETED|Overall Study||37
6393225|NCT00846651|7305402|FG001|COMPLETED|Overall Study||37
6393226|NCT00846651|7305401|FG000|NOT COMPLETED|Overall Study||4
6393227|NCT00846651|7305402|FG001|NOT COMPLETED|Overall Study||4
6603334|NCT02059434|7528052|FG008|NOT COMPLETED|Period 4 (After Screening/run-in Period)||0
6603335|NCT02059434|7528044|FG000|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603336|NCT02059434|7528045|FG001|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603337|NCT02059434|7528046|FG002|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603338|NCT02059434|7528047|FG003|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603339|NCT02059434|7528048|FG004|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603340|NCT02059434|7528049|FG005|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603341|NCT02059434|7528050|FG006|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603342|NCT02059434|7528051|FG007|STARTED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603343|NCT02059434|7528052|FG008|STARTED|Washout Between Periods 4 and 5||38
6603344|NCT02059434|7528044|FG000|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603345|NCT02059434|7528045|FG001|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603346|NCT02059434|7528046|FG002|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603347|NCT02059434|7528047|FG003|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603348|NCT02059434|7528048|FG004|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603349|NCT02059434|7528049|FG005|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603350|NCT02059434|7528050|FG006|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603351|NCT02059434|7528051|FG007|COMPLETED|Washout Between Periods 4 and 5|Part 1 comprised 3 treatment periods only|0
6603352|NCT02059434|7528052|FG008|COMPLETED|Washout Between Periods 4 and 5||37
6603353|NCT02059434|7528044|FG000|NOT COMPLETED|Washout Between Periods 4 and 5||0
6603354|NCT02059434|7528045|FG001|NOT COMPLETED|Washout Between Periods 4 and 5||0
6603355|NCT02059434|7528046|FG002|NOT COMPLETED|Washout Between Periods 4 and 5||0
6603356|NCT02059434|7528047|FG003|NOT COMPLETED|Washout Between Periods 4 and 5||0
6603357|NCT02059434|7528048|FG004|NOT COMPLETED|Washout Between Periods 4 and 5||0
6603358|NCT02059434|7528049|FG005|NOT COMPLETED|Washout Between Periods 4 and 5||0
6603359|NCT02059434|7528050|FG006|NOT COMPLETED|Washout Between Periods 4 and 5||0
6603360|NCT02059434|7528051|FG007|NOT COMPLETED|Washout Between Periods 4 and 5||0
6603361|NCT02059434|7528052|FG008|NOT COMPLETED|Washout Between Periods 4 and 5||1
6603362|NCT02059434|7528044|FG000|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6603363|NCT02059434|7528045|FG001|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6603364|NCT02059434|7528046|FG002|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6603365|NCT02059434|7528047|FG003|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6603366|NCT02059434|7528048|FG004|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6603367|NCT02059434|7528049|FG005|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6603368|NCT02059434|7528050|FG006|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6603369|NCT02059434|7528051|FG007|STARTED|Period 5|Part 1 comprised 3 treatment periods only|0
6603370|NCT02059434|7528052|FG008|STARTED|Period 5||37
6603371|NCT02059434|7528044|FG000|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6603372|NCT02059434|7528045|FG001|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6603373|NCT02059434|7528046|FG002|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6603374|NCT02059434|7528047|FG003|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6603375|NCT02059434|7528048|FG004|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6603376|NCT02059434|7528049|FG005|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6603377|NCT02059434|7528050|FG006|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6603378|NCT02059434|7528051|FG007|COMPLETED|Period 5|Part 1 comprised 3 treatment periods only|0
6603379|NCT02059434|7528052|FG008|COMPLETED|Period 5||37
6603380|NCT02059434|7528044|FG000|NOT COMPLETED|Period 5||0
6603381|NCT02059434|7528045|FG001|NOT COMPLETED|Period 5||0
6603382|NCT02059434|7528046|FG002|NOT COMPLETED|Period 5||0
6603383|NCT02059434|7528047|FG003|NOT COMPLETED|Period 5||0
6603384|NCT02059434|7528048|FG004|NOT COMPLETED|Period 5||0
6603385|NCT02059434|7528049|FG005|NOT COMPLETED|Period 5||0
6603386|NCT02059434|7528050|FG006|NOT COMPLETED|Period 5||0
6603387|NCT02059434|7528051|FG007|NOT COMPLETED|Period 5||0
6603388|NCT02059434|7528052|FG008|NOT COMPLETED|Period 5||0
6603389|NCT02059434|7528044|FG000|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603390|NCT02059434|7528045|FG001|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603391|NCT02059434|7528046|FG002|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603392|NCT02059434|7528047|FG003|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6393228|NCT00846742|7305410|FG000|STARTED|Overall Study||85
6393229|NCT00846742|7305410|FG000|With Radiation Therapy (RT)|Overall Study||17
6393230|NCT00846742|7305410|FG000|Without Radiation Therapy (RT)|Overall Study||68
6393231|NCT00846742|7305410|FG000|COMPLETED|Overall Study||84
6393232|NCT00846742|7305410|FG000|NOT COMPLETED|Overall Study||1
6393233|NCT00846768|7305415|FG000|STARTED|Overall Study||11
6393234|NCT00846768|7305416|FG001|STARTED|Overall Study||12
6393235|NCT00846768|7305417|FG002|STARTED|Overall Study||12
6393236|NCT00846768|7305418|FG003|STARTED|Overall Study||12
6393237|NCT00846768|7305415|FG000|COMPLETED|Overall Study||11
6393238|NCT00846768|7305416|FG001|COMPLETED|Overall Study||11
6393239|NCT00846768|7305417|FG002|COMPLETED|Overall Study||12
6393240|NCT00846768|7305418|FG003|COMPLETED|Overall Study||12
6393241|NCT00846768|7305415|FG000|NOT COMPLETED|Overall Study||0
6393242|NCT00846768|7305416|FG001|NOT COMPLETED|Overall Study||1
6393243|NCT00846768|7305417|FG002|NOT COMPLETED|Overall Study||0
6393244|NCT00846768|7305418|FG003|NOT COMPLETED|Overall Study||0
6393245|NCT00846807|7305428|FG000|STARTED|Overall Study|Entered and treated.|5292
6393246|NCT00846807|7305428|FG000|COMPLETED|Overall Study|Completed treatment.|4660
6393247|NCT00846807|7305428|FG000|NOT COMPLETED|Overall Study||632
6393248|NCT00846846|7305432|FG000|STARTED|Overall Study||1018
6393249|NCT00846846|7305432|FG000|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
6393250|NCT00846846|7305432|FG000|NOT COMPLETED|Overall Study||75
6393251|NCT00847015|7305436|FG000|STARTED|Overall Study||18
6393252|NCT00847015|7305436|FG000|COMPLETED|Overall Study||15
6393253|NCT00847015|7305436|FG000|NOT COMPLETED|Overall Study||3
6393254|NCT00847132|7305442|FG000|STARTED|Overall Study||90
6393255|NCT00847132|7305443|FG001|STARTED|Overall Study||85
6393256|NCT00847132|7305442|FG000|COMPLETED|Overall Study||89
6393257|NCT00847132|7305443|FG001|COMPLETED|Overall Study||84
6393258|NCT00847132|7305442|FG000|NOT COMPLETED|Overall Study||1
6393259|NCT00847132|7305443|FG001|NOT COMPLETED|Overall Study||1
6393260|NCT00847145|7305457|FG000|STARTED|Overall Study||629
6393261|NCT00847145|7305458|FG001|STARTED|Overall Study||633
6393262|NCT00847145|7305459|FG002|STARTED|Overall Study||285
6393263|NCT00847145|7305460|FG003|STARTED|Overall Study||117
6393264|NCT00847145|7305461|FG004|STARTED|Overall Study||137
6393265|NCT00847145|7305462|FG005|STARTED|Overall Study||156
6393266|NCT00847145|7305463|FG006|STARTED|Overall Study||152
6393267|NCT00847145|7305464|FG007|STARTED|Overall Study||140
6393268|NCT00847145|7305457|FG000|COMPLETED|Overall Study||623
6393269|NCT00847145|7305458|FG001|COMPLETED|Overall Study||627
6393270|NCT00847145|7305459|FG002|COMPLETED|Overall Study||274
6393271|NCT00847145|7305460|FG003|COMPLETED|Overall Study||116
6393272|NCT00847145|7305461|FG004|COMPLETED|Overall Study||131
6393273|NCT00847145|7305462|FG005|COMPLETED|Overall Study||152
6393274|NCT00847145|7305463|FG006|COMPLETED|Overall Study||143
6393275|NCT00847145|7305464|FG007|COMPLETED|Overall Study||136
6393276|NCT00847145|7305457|FG000|NOT COMPLETED|Overall Study||6
6393277|NCT00847145|7305458|FG001|NOT COMPLETED|Overall Study||6
6393278|NCT00847145|7305459|FG002|NOT COMPLETED|Overall Study||11
6393279|NCT00847145|7305460|FG003|NOT COMPLETED|Overall Study||1
6393280|NCT00847145|7305461|FG004|NOT COMPLETED|Overall Study||6
6393281|NCT00847145|7305462|FG005|NOT COMPLETED|Overall Study||4
6393282|NCT00847145|7305463|FG006|NOT COMPLETED|Overall Study||9
6393283|NCT00847145|7305464|FG007|NOT COMPLETED|Overall Study||4
6393284|NCT00847171|7305491|FG000|STARTED|Overall Study||20
6393285|NCT00847171|7305491|FG000|COMPLETED|Overall Study||20
6393286|NCT00847171|7305491|FG000|NOT COMPLETED|Overall Study||0
6393287|NCT00847197|7305498|FG000|STARTED|Overall Study||116
6393288|NCT00847197|7305499|FG001|STARTED|Overall Study||75
6393289|NCT00847197|7305498|FG000|COMPLETED|Overall Study||92
6393290|NCT00847197|7305499|FG001|COMPLETED|Overall Study||70
6393291|NCT00847197|7305498|FG000|NOT COMPLETED|Overall Study||24
6393292|NCT00847197|7305499|FG001|NOT COMPLETED|Overall Study||5
6393293|NCT00847210|7305507|FG000|STARTED|Overall Study||18
6393294|NCT00847210|7305508|FG001|STARTED|Overall Study||18
6393295|NCT00847210|7305507|FG000|COMPLETED|Overall Study||18
6393296|NCT00847210|7305508|FG001|COMPLETED|Overall Study||18
6393297|NCT00847210|7305507|FG000|NOT COMPLETED|Overall Study||0
6393298|NCT00847210|7305508|FG001|NOT COMPLETED|Overall Study||0
6393299|NCT00847288|7305516|FG000|STARTED|Overall Study||841
6393300|NCT00847288|7305517|FG001|STARTED|Overall Study||827
6393301|NCT00847288|7305516|FG000|COMPLETED|Overall Study||811
6393302|NCT00847288|7305517|FG001|COMPLETED|Overall Study||780
6393303|NCT00847288|7305516|FG000|NOT COMPLETED|Overall Study||30
6393304|NCT00847288|7305517|FG001|NOT COMPLETED|Overall Study||47
6393305|NCT00847301|7305523|FG000|STARTED|Overall Study||428
6393306|NCT00847301|7305523|FG000|COMPLETED|Overall Study||374
6393307|NCT00847301|7305523|FG000|NOT COMPLETED|Overall Study||54
6393308|NCT00847379|7305530|FG000|STARTED|Overall Study||59
6393309|NCT00847379|7305531|FG001|STARTED|Overall Study||57
6393310|NCT00847379|7305532|FG002|STARTED|Overall Study||57
6393311|NCT00847379|7305530|FG000|As-treated Population|Overall Study||59
6393312|NCT00847379|7305531|FG001|As-treated Population|Overall Study||57
6393313|NCT00847379|7305532|FG002|As-treated Population|Overall Study||57
6393314|NCT00847379|7305530|FG000|COMPLETED|Overall Study||0
6393315|NCT00847379|7305531|FG001|COMPLETED|Overall Study||0
6393316|NCT00847379|7305532|FG002|COMPLETED|Overall Study||0
6393317|NCT00847379|7305530|FG000|NOT COMPLETED|Overall Study||59
6393318|NCT00847379|7305531|FG001|NOT COMPLETED|Overall Study||57
6393319|NCT00847379|7305532|FG002|NOT COMPLETED|Overall Study||57
6393320|NCT00847522|7305542|FG000|STARTED|Overall Study||90
6393321|NCT00847522|7305542|FG000|Phase I|Overall Study||10
6393322|NCT00847522|7305542|FG000|Phase II|Overall Study||80
6393323|NCT00847522|7305542|FG000|COMPLETED|Overall Study||90
6393324|NCT00847522|7305542|FG000|NOT COMPLETED|Overall Study||0
6393325|NCT00847535|7305546|FG000|STARTED|Overall Study||24
6393326|NCT00847535|7305547|FG001|STARTED|Overall Study||24
6393327|NCT00847535|7305548|FG002|STARTED|Overall Study||16
6393328|NCT00847535|7305546|FG000|10 Million AMDC|Overall Study||8
6393329|NCT00847535|7305547|FG001|10 Million AMDC|Overall Study||8
6393330|NCT00847535|7305548|FG002|10 Million AMDC|Overall Study||0
6393331|NCT00847535|7305546|FG000|50 Million AMDC|Overall Study||8
6393332|NCT00847535|7305547|FG001|50 Million AMDC|Overall Study||8
6393333|NCT00847535|7305548|FG002|50 Million AMDC|Overall Study||0
6393334|NCT00847535|7305546|FG000|100 Million AMDC|Overall Study||8
6393335|NCT00847535|7305547|FG001|100 Million AMDC|Overall Study||8
6393336|NCT00847535|7305548|FG002|100 Million AMDC|Overall Study||8
6393337|NCT00847535|7305546|FG000|200 Million AMDC|Overall Study||0
6393338|NCT00847535|7305547|FG001|200 Million AMDC|Overall Study||0
6393339|NCT00847535|7305548|FG002|200 Million AMDC|Overall Study||8
6393340|NCT00847535|7305546|FG000|COMPLETED|Overall Study||22
6393341|NCT00847535|7305547|FG001|COMPLETED|Overall Study||22
6393342|NCT00847535|7305548|FG002|COMPLETED|Overall Study||15
6393343|NCT00847535|7305546|FG000|NOT COMPLETED|Overall Study||2
6393344|NCT00847535|7305547|FG001|NOT COMPLETED|Overall Study||2
6393345|NCT00847535|7305548|FG002|NOT COMPLETED|Overall Study||1
6393346|NCT00847561|7305555|FG000|STARTED|Overall Study||70
6393347|NCT00847561|7305556|FG001|STARTED|Overall Study||66
6393348|NCT00847561|7305555|FG000|COMPLETED|Overall Study||57
6393349|NCT00847561|7305556|FG001|COMPLETED|Overall Study||62
6393350|NCT00847561|7305555|FG000|NOT COMPLETED|Overall Study||13
6393351|NCT00847561|7305556|FG001|NOT COMPLETED|Overall Study||4
6393352|NCT00847587|7305564|FG000|STARTED|Overall Study||35
6393353|NCT00847587|7305565|FG001|STARTED|Overall Study||34
6393354|NCT00847587|7305564|FG000|COMPLETED|Overall Study|Patient declined study after randomization.|34
6393355|NCT00847587|7305565|FG001|COMPLETED|Overall Study||34
6393356|NCT00847587|7305564|FG000|NOT COMPLETED|Overall Study||1
6393357|NCT00847587|7305565|FG001|NOT COMPLETED|Overall Study||0
6393358|NCT00847613|7305575|FG000|STARTED|Overall Study||321
6393359|NCT00847613|7305576|FG001|STARTED|Overall Study||319
6393360|NCT00847613|7305577|FG002|STARTED|Overall Study||81
6393361|NCT00847613|7305578|FG003|STARTED|Overall Study||79
6393362|NCT00847613|7305575|FG000|Treated|Overall Study||321
6393363|NCT00847613|7305576|FG001|Treated|Overall Study||316
6393364|NCT00847613|7305577|FG002|Treated|Overall Study||81
6393365|NCT00847613|7305578|FG003|Treated|Overall Study||79
6393366|NCT00847613|7305575|FG000|COMPLETED|Overall Study||0
6393367|NCT00847613|7305576|FG001|COMPLETED|Overall Study||0
6393368|NCT00847613|7305577|FG002|COMPLETED|Overall Study||0
6393369|NCT00847613|7305578|FG003|COMPLETED|Overall Study||0
6393370|NCT00847613|7305575|FG000|NOT COMPLETED|Overall Study||321
6393371|NCT00847613|7305576|FG001|NOT COMPLETED|Overall Study||319
6393372|NCT00847613|7305577|FG002|NOT COMPLETED|Overall Study||81
6393373|NCT00847613|7305578|FG003|NOT COMPLETED|Overall Study||79
6393374|NCT00847626|7305606|FG000|STARTED|Overall Study||156
6393375|NCT00847626|7305607|FG001|STARTED|Overall Study||154
6393376|NCT00847626|7305608|FG002|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
6393377|NCT00847626|7305609|FG003|STARTED|Overall Study||156
6393378|NCT00847626|7305610|FG004|STARTED|Overall Study||153
6393379|NCT00847626|7305611|FG005|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
6393380|NCT00847626|7305612|FG006|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
6393381|NCT00847626|7305613|FG007|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
6393382|NCT00847626|7305614|FG008|STARTED|Overall Study||155
6393383|NCT00847626|7305615|FG009|STARTED|Overall Study||153
6393384|NCT00847626|7305616|FG010|STARTED|Overall Study||162
6393385|NCT00847626|7305606|FG000|COMPLETED|Overall Study||135
6393386|NCT00847626|7305607|FG001|COMPLETED|Overall Study||131
6393387|NCT00847626|7305608|FG002|COMPLETED|Overall Study||131
6393388|NCT00847626|7305609|FG003|COMPLETED|Overall Study||125
6393389|NCT00847626|7305610|FG004|COMPLETED|Overall Study||125
6393390|NCT00847626|7305611|FG005|COMPLETED|Overall Study||125
6393391|NCT00847626|7305612|FG006|COMPLETED|Overall Study||135
6393392|NCT00847626|7305613|FG007|COMPLETED|Overall Study||141
6393393|NCT00847626|7305614|FG008|COMPLETED|Overall Study||141
6393394|NCT00847626|7305615|FG009|COMPLETED|Overall Study||139
6393395|NCT00847626|7305616|FG010|COMPLETED|Overall Study||142
6393396|NCT00847626|7305606|FG000|NOT COMPLETED|Overall Study||21
6393397|NCT00847626|7305607|FG001|NOT COMPLETED|Overall Study||23
6393398|NCT00847626|7305608|FG002|NOT COMPLETED|Overall Study||16
6393399|NCT00847626|7305609|FG003|NOT COMPLETED|Overall Study||31
6393400|NCT00847626|7305610|FG004|NOT COMPLETED|Overall Study||28
6393401|NCT00847626|7305611|FG005|NOT COMPLETED|Overall Study||37
6393402|NCT00847626|7305612|FG006|NOT COMPLETED|Overall Study||22
6393403|NCT00847626|7305613|FG007|NOT COMPLETED|Overall Study||19
6393404|NCT00847626|7305614|FG008|NOT COMPLETED|Overall Study||14
6393405|NCT00847626|7305615|FG009|NOT COMPLETED|Overall Study||14
6393406|NCT00847626|7305616|FG010|NOT COMPLETED|Overall Study||20
6393407|NCT00847665|7305645|FG000|STARTED|Overall Study||165
6393408|NCT00847665|7305646|FG001|STARTED|Overall Study||165
6393409|NCT00847665|7305645|FG000|COMPLETED|Overall Study||164
6393410|NCT00847665|7305646|FG001|COMPLETED|Overall Study||165
6393411|NCT00847665|7305645|FG000|NOT COMPLETED|Overall Study||1
6393412|NCT00847665|7305646|FG001|NOT COMPLETED|Overall Study||0
6393413|NCT00847704|7305652|FG000|STARTED|Overall Study||3
6393414|NCT00847704|7305652|FG000|COMPLETED|Overall Study||2
6393415|NCT00847704|7305652|FG000|NOT COMPLETED|Overall Study||1
6393416|NCT00847730|7305656|FG000|STARTED|Overall Study||33
6393417|NCT00847730|7305656|FG000|COMPLETED|Overall Study||25
6393418|NCT00847730|7305656|FG000|NOT COMPLETED|Overall Study||8
6393419|NCT00847808|7305660|FG000|STARTED|Overall Study||178
6393420|NCT00847808|7305660|FG000|COMPLETED|Overall Study||163
6393421|NCT00847808|7305660|FG000|NOT COMPLETED|Overall Study||15
6393422|NCT00847886|7305666|FG000|STARTED|Overall Study||12
6393423|NCT00847886|7305667|FG001|STARTED|Overall Study||4
6393424|NCT00847886|7305666|FG000|COMPLETED|Overall Study||12
6393425|NCT00847886|7305667|FG001|COMPLETED|Overall Study||3
6393426|NCT00847886|7305666|FG000|NOT COMPLETED|Overall Study||0
6393427|NCT00847886|7305667|FG001|NOT COMPLETED|Overall Study||1
6393428|NCT00847912|7305675|FG000|STARTED|Overall Study||477
6393429|NCT00847912|7305676|FG001|STARTED|Overall Study||477
6393430|NCT00847912|7305675|FG000|COMPLETED|Overall Study||468
6393431|NCT00847912|7305676|FG001|COMPLETED|Overall Study||464
6393432|NCT00847912|7305675|FG000|NOT COMPLETED|Overall Study||9
6393433|NCT00847912|7305676|FG001|NOT COMPLETED|Overall Study||13
6393434|NCT00847938|7305687|FG000|STARTED|Overall Study||16
6393435|NCT00847938|7305688|FG001|STARTED|Overall Study||15
6393436|NCT00847938|7305689|FG002|STARTED|Overall Study||16
6393437|NCT00847938|7305690|FG003|STARTED|Overall Study||15
6393438|NCT00847938|7305687|FG000|COMPLETED|Overall Study||16
6393439|NCT00847938|7305688|FG001|COMPLETED|Overall Study||14
6393440|NCT00847938|7305689|FG002|COMPLETED|Overall Study||15
6393441|NCT00847938|7305690|FG003|COMPLETED|Overall Study||15
6393442|NCT00847938|7305687|FG000|NOT COMPLETED|Overall Study||0
6393443|NCT00847938|7305688|FG001|NOT COMPLETED|Overall Study||1
6393444|NCT00847938|7305689|FG002|NOT COMPLETED|Overall Study||1
6393445|NCT00847938|7305690|FG003|NOT COMPLETED|Overall Study||0
6393446|NCT00848016|7305700|FG000|STARTED|Overall Study||29
6393447|NCT00848016|7305700|FG000|COMPLETED|Overall Study||29
6393448|NCT00848016|7305700|FG000|NOT COMPLETED|Overall Study||0
6393449|NCT00848042|7305707|FG000|STARTED|Overall Study||5
6393450|NCT00848042|7305708|FG001|STARTED|Overall Study||5
6393451|NCT00848042|7305709|FG002|STARTED|Overall Study||1
6393452|NCT00848042|7305707|FG000|Day 1|Overall Study||5
6393453|NCT00848042|7305708|FG001|Day 1|Overall Study||5
6393454|NCT00848042|7305709|FG002|Day 1|Overall Study||1
6393455|NCT00848042|7305707|FG000|Day 2|Overall Study||5
6393456|NCT00848042|7305708|FG001|Day 2|Overall Study||5
6393457|NCT00848042|7305709|FG002|Day 2|Overall Study||1
6393458|NCT00848042|7305707|FG000|Day 3|Overall Study||5
6393459|NCT00848042|7305708|FG001|Day 3|Overall Study||5
6393460|NCT00848042|7305709|FG002|Day 3|Overall Study||1
6393461|NCT00848042|7305707|FG000|Day 8|Overall Study||5
6393462|NCT00848042|7305708|FG001|Day 8|Overall Study||5
6393463|NCT00848042|7305709|FG002|Day 8|Overall Study||1
6393464|NCT00848042|7305707|FG000|Day 15|Overall Study||4
6393465|NCT00848042|7305708|FG001|Day 15|Overall Study||5
6393466|NCT00848042|7305709|FG002|Day 15|Overall Study||1
6393467|NCT00848042|7305707|FG000|Month 1|Overall Study||4
6393468|NCT00848042|7305708|FG001|Month 1|Overall Study||5
6393469|NCT00848042|7305709|FG002|Month 1|Overall Study||1
6393470|NCT00848042|7305707|FG000|Month 2|Overall Study||1
6393471|NCT00848042|7305708|FG001|Month 2|Overall Study||5
6393472|NCT00848042|7305709|FG002|Month 2|Overall Study||1
6393473|NCT00848042|7305707|FG000|Month 3|Overall Study||1
6393474|NCT00848042|7305708|FG001|Month 3|Overall Study||4
6393475|NCT00848042|7305709|FG002|Month 3|Overall Study||1
6393476|NCT00848042|7305707|FG000|Month 4|Overall Study||1
6393477|NCT00848042|7305708|FG001|Month 4|Overall Study||4
6393478|NCT00848042|7305709|FG002|Month 4|Overall Study||1
6393479|NCT00848042|7305707|FG000|Month 5|Overall Study||1
6393480|NCT00848042|7305708|FG001|Month 5|Overall Study||3
6393481|NCT00848042|7305709|FG002|Month 5|Overall Study||1
6393482|NCT00848042|7305707|FG000|Month 6|Overall Study||1
6393483|NCT00848042|7305708|FG001|Month 6|Overall Study||3
6393484|NCT00848042|7305709|FG002|Month 6|Overall Study||1
6393485|NCT00848042|7305707|FG000|COMPLETED|Overall Study||1
6393486|NCT00848042|7305708|FG001|COMPLETED|Overall Study||3
6393487|NCT00848042|7305709|FG002|COMPLETED|Overall Study||1
6393488|NCT00848042|7305707|FG000|NOT COMPLETED|Overall Study||4
6393489|NCT00848042|7305708|FG001|NOT COMPLETED|Overall Study||2
6393490|NCT00848042|7305709|FG002|NOT COMPLETED|Overall Study||0
6393491|NCT00848081|7305719|FG000|STARTED|Overall Study||160
6393492|NCT00848081|7305720|FG001|STARTED|Overall Study||158
6393493|NCT00848081|7305719|FG000|COMPLETED|Overall Study||140
6393494|NCT00848081|7305720|FG001|COMPLETED|Overall Study||140
6393495|NCT00848081|7305719|FG000|NOT COMPLETED|Overall Study||20
6393496|NCT00848081|7305720|FG001|NOT COMPLETED|Overall Study||18
6393497|NCT00848107|7305726|FG000|STARTED|Overall Study||115
6393498|NCT00848107|7305726|FG000|COMPLETED|Overall Study||94
6393499|NCT00848107|7305726|FG000|NOT COMPLETED|Overall Study||21
6393500|NCT00848120|7305730|FG000|STARTED|Overall Study||29
6393501|NCT00848120|7305730|FG000|COMPLETED|Overall Study||28
6393502|NCT00848120|7305730|FG000|NOT COMPLETED|Overall Study||1
6393503|NCT00848172|7305736|FG000|STARTED|Visit 2 - Drug Administration||10
6393504|NCT00848172|7305737|FG001|STARTED|Visit 2 - Drug Administration||9
6393505|NCT00848172|7305736|FG000|COMPLETED|Visit 2 - Drug Administration||10
6393506|NCT00848172|7305737|FG001|COMPLETED|Visit 2 - Drug Administration||8
6393507|NCT00848172|7305736|FG000|NOT COMPLETED|Visit 2 - Drug Administration||0
6393508|NCT00848172|7305737|FG001|NOT COMPLETED|Visit 2 - Drug Administration||1
6393509|NCT00848172|7305736|FG000|STARTED|Visit 3 - Follow Up||10
6393510|NCT00848172|7305737|FG001|STARTED|Visit 3 - Follow Up||8
6393511|NCT00848172|7305736|FG000|COMPLETED|Visit 3 - Follow Up||10
6393512|NCT00848172|7305737|FG001|COMPLETED|Visit 3 - Follow Up||8
6393513|NCT00848172|7305736|FG000|NOT COMPLETED|Visit 3 - Follow Up||0
6393514|NCT00848172|7305737|FG001|NOT COMPLETED|Visit 3 - Follow Up||0
6393515|NCT00848185|7305749|FG000|STARTED|Overall Study||32
6393516|NCT00848185|7305750|FG001|STARTED|Overall Study||32
6393517|NCT00848185|7305751|FG002|STARTED|Overall Study||32
6393518|NCT00848185|7305749|FG000|COMPLETED|Overall Study||32
6393519|NCT00848185|7305750|FG001|COMPLETED|Overall Study||32
6393520|NCT00848185|7305751|FG002|COMPLETED|Overall Study||32
6393521|NCT00848185|7305749|FG000|NOT COMPLETED|Overall Study||0
6393522|NCT00848185|7305750|FG001|NOT COMPLETED|Overall Study||0
6393523|NCT00848185|7305751|FG002|NOT COMPLETED|Overall Study||0
6393524|NCT00848198|7305759|FG000|STARTED|Overall Study||314
6393525|NCT00848198|7305759|FG000|COMPLETED|Overall Study||299
6393526|NCT00848198|7305759|FG000|NOT COMPLETED|Overall Study||15
6393527|NCT00848211|7305771|FG000|STARTED|Overall Study||6
6393528|NCT00848211|7305772|FG001|STARTED|Overall Study||7
6393529|NCT00848211|7305773|FG002|STARTED|Overall Study||6
6393530|NCT00848211|7305774|FG003|STARTED|Overall Study||5
6393531|NCT00848211|7305771|FG000|COMPLETED|Overall Study||6
6393532|NCT00848211|7305772|FG001|COMPLETED|Overall Study||6
6393533|NCT00848211|7305773|FG002|COMPLETED|Overall Study||5
6393534|NCT00848211|7305774|FG003|COMPLETED|Overall Study||5
6393535|NCT00848211|7305771|FG000|NOT COMPLETED|Overall Study||0
6393536|NCT00848211|7305772|FG001|NOT COMPLETED|Overall Study||1
6393537|NCT00848211|7305773|FG002|NOT COMPLETED|Overall Study||1
6393538|NCT00848211|7305774|FG003|NOT COMPLETED|Overall Study||0
6393539|NCT00848237|7305784|FG000|STARTED|Overall Study||5521
6393540|NCT00848237|7305784|FG000|COMPLETED|Overall Study||4982
6393541|NCT00848237|7305784|FG000|NOT COMPLETED|Overall Study||539
6393542|NCT00848250|7305790|FG000|STARTED|Overall Study||11
6393543|NCT00848250|7305791|FG001|STARTED|Overall Study||10
6393544|NCT00848250|7305790|FG000|COMPLETED|Overall Study||11
6393545|NCT00848250|7305791|FG001|COMPLETED|Overall Study||9
6393546|NCT00848250|7305790|FG000|NOT COMPLETED|Overall Study||0
6393547|NCT00848250|7305791|FG001|NOT COMPLETED|Overall Study||1
6393548|NCT00848354|7305800|FG000|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
6393549|NCT00848354|7305801|FG001|STARTED|Phase 1||143
6393550|NCT00848354|7305800|FG000|COMPLETED|Phase 1||269
6393551|NCT00848354|7305801|FG001|COMPLETED|Phase 1||129
6393552|NCT00848354|7305800|FG000|NOT COMPLETED|Phase 1||12
6393553|NCT00848354|7305801|FG001|NOT COMPLETED|Phase 1||14
6393554|NCT00848354|7305800|FG000|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
6393555|NCT00848354|7305801|FG001|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
6393556|NCT00848354|7305800|FG000|COMPLETED|Phase 2 Year 1||242
6393557|NCT00848354|7305801|FG001|COMPLETED|Phase 2 Year 1||120
6393558|NCT00848354|7305800|FG000|NOT COMPLETED|Phase 2 Year 1||18
6393559|NCT00848354|7305801|FG001|NOT COMPLETED|Phase 2 Year 1||6
6393560|NCT00848354|7305800|FG000|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.~1 participant discontinued between Year 1 and Year 2."|241
6393561|NCT00848354|7305801|FG001|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
6393562|NCT00848354|7305800|FG000|COMPLETED|Phase 2 Year 2||218
6393563|NCT00848354|7305801|FG001|COMPLETED|Phase 2 Year 2||113
6393564|NCT00848354|7305800|FG000|NOT COMPLETED|Phase 2 Year 2||23
6393565|NCT00848354|7305801|FG001|NOT COMPLETED|Phase 2 Year 2||7
6393566|NCT00848367|7305813|FG000|STARTED|Overall Study||52
6393567|NCT00848367|7305814|FG001|STARTED|Overall Study||50
6393568|NCT00848367|7305813|FG000|COMPLETED|Overall Study||43
6393569|NCT00848367|7305814|FG001|COMPLETED|Overall Study||41
6393570|NCT00848367|7305813|FG000|NOT COMPLETED|Overall Study||9
6393571|NCT00848367|7305814|FG001|NOT COMPLETED|Overall Study||9
6393572|NCT00848393|7305825|FG000|STARTED|Overall Study||17
6393573|NCT00848393|7305826|FG001|STARTED|Overall Study||16
6393574|NCT00848393|7305827|FG002|STARTED|Overall Study||18
6393575|NCT00848393|7305825|FG000|COMPLETED|Overall Study||17
6393576|NCT00848393|7305826|FG001|COMPLETED|Overall Study||16
6393577|NCT00848393|7305827|FG002|COMPLETED|Overall Study||15
6393578|NCT00848393|7305825|FG000|NOT COMPLETED|Overall Study||0
6393579|NCT00848393|7305826|FG001|NOT COMPLETED|Overall Study||0
6393580|NCT00848393|7305827|FG002|NOT COMPLETED|Overall Study||3
6393581|NCT00848484|7305841|FG000|STARTED|First Intervention (Treatment Period 1)||27
6393582|NCT00848484|7305842|FG001|STARTED|First Intervention (Treatment Period 1)||27
6393583|NCT00848484|7305841|FG000|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
6393584|NCT00848484|7305842|FG001|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
6393585|NCT00848484|7305841|FG000|COMPLETED|First Intervention (Treatment Period 1)||25
6393586|NCT00848484|7305842|FG001|COMPLETED|First Intervention (Treatment Period 1)||24
6393587|NCT00848484|7305841|FG000|NOT COMPLETED|First Intervention (Treatment Period 1)||2
6393588|NCT00848484|7305842|FG001|NOT COMPLETED|First Intervention (Treatment Period 1)||3
6393589|NCT00848484|7305841|FG000|STARTED|Washout Period of Two Weeks||25
6393590|NCT00848484|7305842|FG001|STARTED|Washout Period of Two Weeks||24
6393591|NCT00848484|7305841|FG000|COMPLETED|Washout Period of Two Weeks||25
6393592|NCT00848484|7305842|FG001|COMPLETED|Washout Period of Two Weeks||21
6393593|NCT00848484|7305841|FG000|NOT COMPLETED|Washout Period of Two Weeks||0
6393594|NCT00848484|7305842|FG001|NOT COMPLETED|Washout Period of Two Weeks||3
6393595|NCT00848484|7305841|FG000|STARTED|Second Intervention (Treatment Period 2)||25
6393596|NCT00848484|7305842|FG001|STARTED|Second Intervention (Treatment Period 2)||21
6393597|NCT00848484|7305841|FG000|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
6393598|NCT00848484|7305842|FG001|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
6393599|NCT00848484|7305841|FG000|COMPLETED|Second Intervention (Treatment Period 2)||25
6393600|NCT00848484|7305842|FG001|COMPLETED|Second Intervention (Treatment Period 2)||20
6393601|NCT00848484|7305841|FG000|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
6393602|NCT00848484|7305842|FG001|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
6393603|NCT00848497|7305850|FG000|STARTED|Overall Study||2
6393604|NCT00848497|7305851|FG001|STARTED|Overall Study|Completed Visit 4|1
6393605|NCT00848497|7305850|FG000|COMPLETED|Overall Study||0
6393606|NCT00848497|7305851|FG001|COMPLETED|Overall Study||0
6393607|NCT00848497|7305850|FG000|NOT COMPLETED|Overall Study||2
6393608|NCT00848497|7305851|FG001|NOT COMPLETED|Overall Study||1
6393609|NCT00848510|7305863|FG000|STARTED|Overall Study||10
6393610|NCT00848510|7305864|FG001|STARTED|Overall Study||13
6393611|NCT00848510|7305865|FG002|STARTED|Overall Study||8
6393612|NCT00848510|7305866|FG003|STARTED|Overall Study||10
6393613|NCT00848510|7305863|FG000|COMPLETED|Overall Study||10
6393614|NCT00848510|7305864|FG001|COMPLETED|Overall Study||13
6393615|NCT00848510|7305865|FG002|COMPLETED|Overall Study||8
6393616|NCT00848510|7305866|FG003|COMPLETED|Overall Study||10
6393617|NCT00848510|7305863|FG000|NOT COMPLETED|Overall Study||0
6393618|NCT00848510|7305864|FG001|NOT COMPLETED|Overall Study||0
6393619|NCT00848510|7305865|FG002|NOT COMPLETED|Overall Study||0
6393620|NCT00848510|7305866|FG003|NOT COMPLETED|Overall Study||0
6393621|NCT00848536|7305878|FG000|STARTED|Overall Study||185
6393622|NCT00848536|7305879|FG001|STARTED|Overall Study||186
6393623|NCT00848536|7305878|FG000|COMPLETED|Overall Study||181
6393624|NCT00848536|7305879|FG001|COMPLETED|Overall Study||179
6393625|NCT00848536|7305878|FG000|NOT COMPLETED|Overall Study||4
6393626|NCT00848536|7305879|FG001|NOT COMPLETED|Overall Study||7
6393627|NCT00848549|7305887|FG000|STARTED|E2090-E044-310 (Base Study) Disposition||282
6393628|NCT00848549|7305888|FG001|STARTED|E2090-E044-310 (Base Study) Disposition||301
6393629|NCT00848549|7305887|FG000|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
6393630|NCT00848549|7305888|FG001|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
6393631|NCT00848549|7305887|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
6393632|NCT00848549|7305888|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
6393633|NCT00848549|7305887|FG000|STARTED|E2090-E044-310 (Base Study) Transition||161
6393634|NCT00848549|7305888|FG001|STARTED|E2090-E044-310 (Base Study) Transition||192
6393635|NCT00848549|7305887|FG000|COMPLETED|E2090-E044-310 (Base Study) Transition||137
6393636|NCT00848549|7305888|FG001|COMPLETED|E2090-E044-310 (Base Study) Transition||158
6393637|NCT00848549|7305887|FG000|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
6393638|NCT00848549|7305888|FG001|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
6393639|NCT00848549|7305887|FG000|STARTED|E2090-E044-314 (Extension Study)||137
6393640|NCT00848549|7305888|FG001|STARTED|E2090-E044-314 (Extension Study)||158
6393641|NCT00848549|7305887|FG000|COMPLETED|E2090-E044-314 (Extension Study)||120
6393642|NCT00848549|7305888|FG001|COMPLETED|E2090-E044-314 (Extension Study)||134
6393643|NCT00848549|7305887|FG000|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
6393644|NCT00848549|7305888|FG001|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
6393645|NCT00848718|7305909|FG000|STARTED|Overall Study||7
6393646|NCT00848718|7305910|FG001|STARTED|Overall Study||9
6393647|NCT00848718|7305911|FG002|STARTED|Overall Study||6
6393648|NCT00848718|7305912|FG003|STARTED|Overall Study||5
6393649|NCT00848718|7305913|FG004|STARTED|Overall Study||6
6393650|NCT00848718|7305914|FG005|STARTED|Overall Study||5
6393651|NCT00848718|7305915|FG006|STARTED|Overall Study||3
6393652|NCT00848718|7305916|FG007|STARTED|Overall Study||5
6393653|NCT00848718|7305917|FG008|STARTED|Overall Study||4
6393654|NCT00848718|7305918|FG009|STARTED|Overall Study||9
6393655|NCT00848718|7305919|FG010|STARTED|Overall Study||4
6393656|NCT00848718|7305920|FG011|STARTED|Overall Study||6
6393657|NCT00848718|7305921|FG012|STARTED|Overall Study||8
6393658|NCT00848718|7305909|FG000|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|6
6393659|NCT00848718|7305910|FG001|Treated|Overall Study||9
6393660|NCT00848718|7305911|FG002|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|5
6393661|NCT00848718|7305912|FG003|Treated|Overall Study||5
6393662|NCT00848718|7305913|FG004|Treated|Overall Study||6
6393663|NCT00848718|7305914|FG005|Treated|Overall Study||5
6393664|NCT00848718|7305915|FG006|Treated|Overall Study||3
6393665|NCT00848718|7305916|FG007|Treated|Overall Study|1 participant was allocated but did not receive treatment due to progression of disease|4
6393666|NCT00848718|7305917|FG008|Treated|Overall Study||4
6393667|NCT00848718|7305918|FG009|Treated|Overall Study||9
6393668|NCT00848718|7305919|FG010|Treated|Overall Study||4
6393669|NCT00848718|7305920|FG011|Treated|Overall Study||6
6393670|NCT00848718|7305921|FG012|Treated|Overall Study|2 participants were allocated but did not receive treatment due to progression of disease|6
6393671|NCT00848718|7305909|FG000|COMPLETED|Overall Study||0
6393672|NCT00848718|7305910|FG001|COMPLETED|Overall Study||0
6393673|NCT00848718|7305911|FG002|COMPLETED|Overall Study||0
6393674|NCT00848718|7305912|FG003|COMPLETED|Overall Study||0
6393675|NCT00848718|7305913|FG004|COMPLETED|Overall Study||0
6393676|NCT00848718|7305914|FG005|COMPLETED|Overall Study||0
6393677|NCT00848718|7305915|FG006|COMPLETED|Overall Study||0
6393678|NCT00848718|7305916|FG007|COMPLETED|Overall Study||0
6393679|NCT00848718|7305917|FG008|COMPLETED|Overall Study||0
6393680|NCT00848718|7305918|FG009|COMPLETED|Overall Study||0
6393681|NCT00848718|7305919|FG010|COMPLETED|Overall Study||0
6393682|NCT00848718|7305920|FG011|COMPLETED|Overall Study||0
6393683|NCT00848718|7305921|FG012|COMPLETED|Overall Study||0
6393684|NCT00848718|7305909|FG000|NOT COMPLETED|Overall Study||7
6393685|NCT00848718|7305910|FG001|NOT COMPLETED|Overall Study||9
6393686|NCT00848718|7305911|FG002|NOT COMPLETED|Overall Study||6
6393687|NCT00848718|7305912|FG003|NOT COMPLETED|Overall Study||5
6393688|NCT00848718|7305913|FG004|NOT COMPLETED|Overall Study||6
6393689|NCT00848718|7305914|FG005|NOT COMPLETED|Overall Study||5
6393690|NCT00848718|7305915|FG006|NOT COMPLETED|Overall Study||3
6393691|NCT00848718|7305916|FG007|NOT COMPLETED|Overall Study||5
6393692|NCT00848718|7305917|FG008|NOT COMPLETED|Overall Study||4
6393693|NCT00848718|7305918|FG009|NOT COMPLETED|Overall Study||9
6393694|NCT00848718|7305919|FG010|NOT COMPLETED|Overall Study||4
6393695|NCT00848718|7305920|FG011|NOT COMPLETED|Overall Study||6
6393696|NCT00848718|7305921|FG012|NOT COMPLETED|Overall Study||8
6393697|NCT00848744|7305955|FG000|STARTED|Overall Study||10
6393698|NCT00848744|7305955|FG000|COMPLETED|Overall Study||10
6393699|NCT00848744|7305955|FG000|NOT COMPLETED|Overall Study||0
6393700|NCT00848783|7305963|FG000|STARTED|Overall Study||4
6393701|NCT00848783|7305964|FG001|STARTED|Overall Study||3
6393702|NCT00848783|7305965|FG002|STARTED|Overall Study||1
6393703|NCT00848783|7305963|FG000|COMPLETED|Overall Study||1
6393704|NCT00848783|7305964|FG001|COMPLETED|Overall Study||1
6393705|NCT00848783|7305965|FG002|COMPLETED|Overall Study||1
6393706|NCT00848783|7305963|FG000|NOT COMPLETED|Overall Study||3
6393707|NCT00848783|7305964|FG001|NOT COMPLETED|Overall Study||2
6393708|NCT00848783|7305965|FG002|NOT COMPLETED|Overall Study||0
6393709|NCT00848926|7305972|FG000|STARTED|Treatment Period||102
6393710|NCT00848926|7305972|FG000|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
6393711|NCT00848926|7305972|FG000|NOT COMPLETED|Treatment Period||84
6393712|NCT00848926|7305972|FG000|STARTED|Follow-up Period|All participants were to be followed after treatment|102
6393713|NCT00848926|7305972|FG000|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
6393714|NCT00848926|7305972|FG000|NOT COMPLETED|Follow-up Period||12
6393715|NCT00848965|7305976|FG000|STARTED|Overall Study||59
6393716|NCT00848965|7305976|FG000|COMPLETED|Overall Study||57
6393717|NCT00848965|7305976|FG000|NOT COMPLETED|Overall Study||2
6393718|NCT00849017|7305991|FG000|STARTED|Treatment Period (156 Weeks)||101
6393719|NCT00849017|7305992|FG001|STARTED|Treatment Period (156 Weeks)||101
6393720|NCT00849017|7305993|FG002|STARTED|Treatment Period (156 Weeks)||99
6393721|NCT00849017|7305991|FG000|COMPLETED|Treatment Period (156 Weeks)||58
6393722|NCT00849017|7305992|FG001|COMPLETED|Treatment Period (156 Weeks)||68
6393723|NCT00849017|7305993|FG002|COMPLETED|Treatment Period (156 Weeks)||57
6393724|NCT00849017|7305991|FG000|NOT COMPLETED|Treatment Period (156 Weeks)||43
6393725|NCT00849017|7305992|FG001|NOT COMPLETED|Treatment Period (156 Weeks)||33
6393726|NCT00849017|7305993|FG002|NOT COMPLETED|Treatment Period (156 Weeks)||42
6393727|NCT00849017|7305991|FG000|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
6393728|NCT00849017|7305992|FG001|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
6393729|NCT00849017|7305993|FG002|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
6393730|NCT00849017|7305991|FG000|COMPLETED|Follow-up Period (8 Weeks)||76
6393731|NCT00849017|7305992|FG001|COMPLETED|Follow-up Period (8 Weeks)||83
6393732|NCT00849017|7305993|FG002|COMPLETED|Follow-up Period (8 Weeks)||74
6393733|NCT00849017|7305991|FG000|NOT COMPLETED|Follow-up Period (8 Weeks)||25
6393734|NCT00849017|7305992|FG001|NOT COMPLETED|Follow-up Period (8 Weeks)||18
6393735|NCT00849017|7305993|FG002|NOT COMPLETED|Follow-up Period (8 Weeks)||25
6393736|NCT00849056|7306007|FG000|STARTED|Treatment Period (TP) (156 Weeks)||151
6393737|NCT00849056|7306008|FG001|STARTED|Treatment Period (TP) (156 Weeks)||150
6393738|NCT00849056|7306007|FG000|COMPLETED|Treatment Period (TP) (156 Weeks)||88
6393739|NCT00849056|7306008|FG001|COMPLETED|Treatment Period (TP) (156 Weeks)||100
6393740|NCT00849056|7306007|FG000|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
6393741|NCT00849056|7306008|FG001|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
6393742|NCT00849056|7306007|FG000|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
6393743|NCT00849056|7306008|FG001|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
6393744|NCT00849056|7306007|FG000|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
6393745|NCT00849056|7306008|FG001|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
6393746|NCT00849056|7306007|FG000|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
6393747|NCT00849056|7306008|FG001|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
6393748|NCT00849108|7306017|FG000|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
6393749|NCT00849108|7306018|FG001|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
6393750|NCT00849108|7306017|FG000|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
6393751|NCT00849108|7306018|FG001|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
6393752|NCT00849108|7306017|FG000|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
6393753|NCT00849108|7306018|FG001|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
6393754|NCT00849108|7306017|FG000|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
6393755|NCT00849108|7306018|FG001|STARTED|Cohort 2 Efficacy||143
6393756|NCT00849108|7306017|FG000|COMPLETED|Cohort 2 Efficacy||0
6393757|NCT00849108|7306018|FG001|COMPLETED|Cohort 2 Efficacy||133
6393758|NCT00849108|7306017|FG000|NOT COMPLETED|Cohort 2 Efficacy||0
6393759|NCT00849108|7306018|FG001|NOT COMPLETED|Cohort 2 Efficacy||10
6393760|NCT00849121|7306028|FG000|STARTED|Overall Study||8
6393761|NCT00849121|7306029|FG001|STARTED|Overall Study||9
6393762|NCT00849121|7306028|FG000|COMPLETED|Overall Study||8
6393763|NCT00849121|7306029|FG001|COMPLETED|Overall Study||9
6393764|NCT00849121|7306028|FG000|NOT COMPLETED|Overall Study||0
6393765|NCT00849121|7306029|FG001|NOT COMPLETED|Overall Study||0
6393766|NCT00849147|7306035|FG000|STARTED|Overall Study||55
6393767|NCT00849147|7306035|FG000|COMPLETED|Overall Study||50
6393768|NCT00849147|7306035|FG000|NOT COMPLETED|Overall Study||5
6393769|NCT00849186|7306039|FG000|STARTED|Overall Study||26
6393770|NCT00849186|7306039|FG000|COMPLETED|Overall Study||16
6393771|NCT00849186|7306039|FG000|NOT COMPLETED|Overall Study||10
6393772|NCT00849212|7306044|FG000|STARTED|Overall Study||30
6393773|NCT00849212|7306044|FG000|COMPLETED|Overall Study||23
6393774|NCT00849212|7306044|FG000|NOT COMPLETED|Overall Study||7
6393775|NCT00849251|7306048|FG000|STARTED|Overall Study||6
6393776|NCT00849251|7306049|FG001|STARTED|Overall Study||25
6393777|NCT00849251|7306048|FG000|COMPLETED|Overall Study||5
6393778|NCT00849251|7306049|FG001|COMPLETED|Overall Study||24
6393779|NCT00849251|7306048|FG000|NOT COMPLETED|Overall Study||1
6393780|NCT00849251|7306049|FG001|NOT COMPLETED|Overall Study||1
6393781|NCT00849290|7306055|FG000|STARTED|Overall Study||113
6393782|NCT00849290|7306055|FG000|COMPLETED|Overall Study||58
6393783|NCT00849290|7306055|FG000|NOT COMPLETED|Overall Study||55
6393784|NCT00849381|7306059|FG000|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
6393785|NCT00849381|7306059|FG000|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
6393786|NCT00849381|7306059|FG000|NOT COMPLETED|Overall Study||145
6393787|NCT00849472|7306063|FG000|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
6393788|NCT00849472|7306063|FG000|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
6393789|NCT00849472|7306063|FG000|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
6393790|NCT00849472|7306063|FG000|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
6393791|NCT00849472|7306063|FG000|COMPLETED|Weekly Paclitaxel||78
6393792|NCT00849472|7306063|FG000|NOT COMPLETED|Weekly Paclitaxel||16
6393793|NCT00849472|7306063|FG000|STARTED|Pazopanib Presurgery Treatment (PPT)||94
6393794|NCT00849472|7306063|FG000|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
6393795|NCT00849472|7306063|FG000|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
6393796|NCT00849472|7306063|FG000|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
6393797|NCT00849472|7306063|FG000|COMPLETED|Pazopanib Postsurgery Treatment||16
6393798|NCT00849472|7306063|FG000|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
6393799|NCT00849680|7306076|FG000|STARTED|Overall Study||27
6393800|NCT00849680|7306077|FG001|STARTED|Overall Study||13
6393801|NCT00849680|7306078|FG002|STARTED|Overall Study||42
6393802|NCT00849680|7306079|FG003|STARTED|Overall Study||42
6393803|NCT00849680|7306080|FG004|STARTED|Overall Study||42
6393804|NCT00849680|7306081|FG005|STARTED|Overall Study||42
6393805|NCT00849680|7306082|FG006|STARTED|Overall Study||78
6393806|NCT00849680|7306083|FG007|STARTED|Overall Study||31
6393807|NCT00849680|7306076|FG000|COMPLETED|Overall Study||16
6393808|NCT00849680|7306077|FG001|COMPLETED|Overall Study||10
6393809|NCT00849680|7306078|FG002|COMPLETED|Overall Study||27
6393810|NCT00849680|7306079|FG003|COMPLETED|Overall Study||28
6393811|NCT00849680|7306080|FG004|COMPLETED|Overall Study||32
6393812|NCT00849680|7306081|FG005|COMPLETED|Overall Study||27
6393813|NCT00849680|7306082|FG006|COMPLETED|Overall Study||61
6393814|NCT00849680|7306083|FG007|COMPLETED|Overall Study||23
6393815|NCT00849680|7306076|FG000|NOT COMPLETED|Overall Study||11
6393816|NCT00849680|7306077|FG001|NOT COMPLETED|Overall Study||3
6393817|NCT00849680|7306078|FG002|NOT COMPLETED|Overall Study||15
6393818|NCT00849680|7306079|FG003|NOT COMPLETED|Overall Study||14
6393819|NCT00849680|7306080|FG004|NOT COMPLETED|Overall Study||10
6393820|NCT00849680|7306081|FG005|NOT COMPLETED|Overall Study||15
6393821|NCT00849680|7306082|FG006|NOT COMPLETED|Overall Study||17
6393822|NCT00849680|7306083|FG007|NOT COMPLETED|Overall Study||8
6393823|NCT00849693|7306105|FG000|STARTED|Acute Treatment Phase||108
6393824|NCT00849693|7306106|FG001|STARTED|Acute Treatment Phase||116
6393825|NCT00849693|7306107|FG002|STARTED|Acute Treatment Phase||117
6393826|NCT00849693|7306108|FG003|STARTED|Acute Treatment Phase||122
6393827|NCT00849693|7306105|FG000|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
6393828|NCT00849693|7306106|FG001|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
6393829|NCT00849693|7306107|FG002|COMPLETED|Acute Treatment Phase||84
6393830|NCT00849693|7306108|FG003|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
6393831|NCT00849693|7306105|FG000|NOT COMPLETED|Acute Treatment Phase||33
6393832|NCT00849693|7306106|FG001|NOT COMPLETED|Acute Treatment Phase||35
6393833|NCT00849693|7306107|FG002|NOT COMPLETED|Acute Treatment Phase||33
6393834|NCT00849693|7306108|FG003|NOT COMPLETED|Acute Treatment Phase||37
6393835|NCT00849693|7306105|FG000|STARTED|Extension Phase||73
6393836|NCT00849693|7306106|FG001|STARTED|Extension Phase||80
6393837|NCT00849693|7306107|FG002|STARTED|Extension Phase||84
6393838|NCT00849693|7306108|FG003|STARTED|Extension Phase||82
6393839|NCT00849693|7306105|FG000|COMPLETED|Extension Phase||43
6393840|NCT00849693|7306106|FG001|COMPLETED|Extension Phase||50
6393841|NCT00849693|7306107|FG002|COMPLETED|Extension Phase||49
6393842|NCT00849693|7306108|FG003|COMPLETED|Extension Phase||44
6393843|NCT00849693|7306105|FG000|NOT COMPLETED|Extension Phase||30
6393844|NCT00849693|7306106|FG001|NOT COMPLETED|Extension Phase||30
6393845|NCT00849693|7306107|FG002|NOT COMPLETED|Extension Phase||35
6393846|NCT00849693|7306108|FG003|NOT COMPLETED|Extension Phase||38
6393847|NCT00849810|7306130|FG000|STARTED|Overall Study||1
6393848|NCT00849810|7306130|FG000|COMPLETED|Overall Study||1
6393849|NCT00849810|7306130|FG000|NOT COMPLETED|Overall Study||0
6393850|NCT00849875|7306137|FG000|STARTED|Overall Study||48
6393851|NCT00849875|7306137|FG000|COMPLETED|Overall Study||1
6393852|NCT00849875|7306137|FG000|NOT COMPLETED|Overall Study||47
6393853|NCT00849901|7306151|FG000|STARTED|Acute Treatment Phase||117
6393854|NCT00849901|7306152|FG001|STARTED|Acute Treatment Phase||117
6393855|NCT00849901|7306153|FG002|STARTED|Acute Treatment Phase||103
6393856|NCT00849901|7306151|FG000|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
6393857|NCT00849901|7306152|FG001|COMPLETED|Acute Treatment Phase||91
6393858|NCT00849901|7306153|FG002|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
6393859|NCT00849901|7306151|FG000|NOT COMPLETED|Acute Treatment Phase||30
6393860|NCT00849901|7306152|FG001|NOT COMPLETED|Acute Treatment Phase||26
6393861|NCT00849901|7306153|FG002|NOT COMPLETED|Acute Treatment Phase||16
6393862|NCT00849901|7306151|FG000|STARTED|Extension Phase||83
6393863|NCT00849901|7306152|FG001|STARTED|Extension Phase||91
6393864|NCT00849901|7306153|FG002|STARTED|Extension Phase||86
6393865|NCT00849901|7306151|FG000|COMPLETED|Extension Phase||56
6393866|NCT00849901|7306152|FG001|COMPLETED|Extension Phase||65
6393867|NCT00849901|7306153|FG002|COMPLETED|Extension Phase||69
6393868|NCT00849901|7306151|FG000|NOT COMPLETED|Extension Phase||27
6393869|NCT00849901|7306152|FG001|NOT COMPLETED|Extension Phase||26
6393870|NCT00849901|7306153|FG002|NOT COMPLETED|Extension Phase||17
6393871|NCT00849940|7306167|FG000|STARTED|Overall Study||72
6393872|NCT00849940|7306167|FG000|COMPLETED|Overall Study||68
6393873|NCT00849940|7306167|FG000|NOT COMPLETED|Overall Study||4
6393874|NCT00850031|7306171|FG000|STARTED|Overall Study||118
6393875|NCT00850031|7306171|FG000|COMPLETED|Overall Study||101
6393876|NCT00850031|7306171|FG000|NOT COMPLETED|Overall Study||17
6393877|NCT00850070|7306177|FG000|STARTED|Overall Study||23
6393878|NCT00850070|7306178|FG001|STARTED|Overall Study||23
6393879|NCT00850070|7306177|FG000|COMPLETED|Overall Study||20
6393880|NCT00850070|7306178|FG001|COMPLETED|Overall Study||22
6393881|NCT00850070|7306177|FG000|NOT COMPLETED|Overall Study||3
6393882|NCT00850070|7306178|FG001|NOT COMPLETED|Overall Study||1
6393883|NCT00850096|7306191|FG000|STARTED|Overall Study||47
6393884|NCT00850096|7306192|FG001|STARTED|Overall Study||47
6393885|NCT00850096|7306191|FG000|COMPLETED|Overall Study||44
6393886|NCT00850096|7306192|FG001|COMPLETED|Overall Study||45
6393887|NCT00850096|7306191|FG000|NOT COMPLETED|Overall Study||3
6393888|NCT00850096|7306192|FG001|NOT COMPLETED|Overall Study||2
6393889|NCT00850135|7306198|FG000|STARTED|Overall Study||57
6393890|NCT00850135|7306198|FG000|COMPLETED|Overall Study||56
6393891|NCT00850135|7306198|FG000|NOT COMPLETED|Overall Study||1
6393892|NCT00850200|7306204|FG000|STARTED|Overall Study||20
6393893|NCT00850200|7306204|FG000|COMPLETED|Overall Study||15
6393894|NCT00850200|7306204|FG000|NOT COMPLETED|Overall Study||5
6393895|NCT00850343|7306215|FG000|STARTED|Overall Study||110
6393896|NCT00850343|7306216|FG001|STARTED|Overall Study||12
6393897|NCT00850343|7306217|FG002|STARTED|Overall Study||43
6393898|NCT00850343|7306218|FG003|STARTED|Overall Study||43
6393899|NCT00850343|7306215|FG000|Completed Week 24|Overall Study||94
6393900|NCT00850343|7306216|FG001|Completed Week 24|Overall Study||12
6393901|NCT00850343|7306217|FG002|Completed Week 24|Overall Study||39
6393902|NCT00850343|7306218|FG003|Completed Week 24|Overall Study||39
6393903|NCT00850343|7306215|FG000|Completed Week 52|Overall Study||88
6393904|NCT00850343|7306216|FG001|Completed Week 52|Overall Study||11
6393905|NCT00850343|7306217|FG002|Completed Week 52|Overall Study||37
6393906|NCT00850343|7306218|FG003|Completed Week 52|Overall Study||37
6393907|NCT00850343|7306215|FG000|COMPLETED|Overall Study||64
6393908|NCT00850343|7306216|FG001|COMPLETED|Overall Study||9
6393909|NCT00850343|7306217|FG002|COMPLETED|Overall Study||29
6393910|NCT00850343|7306218|FG003|COMPLETED|Overall Study||30
6393911|NCT00850343|7306215|FG000|NOT COMPLETED|Overall Study||46
6393912|NCT00850343|7306216|FG001|NOT COMPLETED|Overall Study||3
6393913|NCT00850343|7306217|FG002|NOT COMPLETED|Overall Study||14
6393914|NCT00850343|7306218|FG003|NOT COMPLETED|Overall Study||13
6393915|NCT00850395|7306228|FG000|STARTED|Overall Study||79
6393916|NCT00850395|7306228|FG000|COMPLETED|Overall Study||69
6393917|NCT00850395|7306228|FG000|NOT COMPLETED|Overall Study||10
6393918|NCT00850460|7306234|FG000|STARTED|Overall Study||7
6393919|NCT00850460|7306235|FG001|STARTED|Overall Study||7
6393920|NCT00850460|7306234|FG000|Started - Week 0|Overall Study||7
6393921|NCT00850460|7306235|FG001|Started - Week 0|Overall Study||7
6393922|NCT00850460|7306234|FG000|Completion - Week 8|Overall Study||3
6393923|NCT00850460|7306235|FG001|Completion - Week 8|Overall Study||3
6393924|NCT00850460|7306234|FG000|COMPLETED|Overall Study||3
6393925|NCT00850460|7306235|FG001|COMPLETED|Overall Study||3
6393926|NCT00850460|7306234|FG000|NOT COMPLETED|Overall Study||4
6393927|NCT00850460|7306235|FG001|NOT COMPLETED|Overall Study||4
6393928|NCT00850473|7306241|FG000|STARTED|Overall Study||3
6393929|NCT00850473|7306241|FG000|COMPLETED|Overall Study||3
6393930|NCT00850473|7306241|FG000|NOT COMPLETED|Overall Study||0
6393931|NCT00850499|7306247|FG000|STARTED|Overall Study||4
6393932|NCT00850499|7306248|FG001|STARTED|Overall Study||8
6393933|NCT00850499|7306247|FG000|COMPLETED|Overall Study||1
6393934|NCT00850499|7306248|FG001|COMPLETED|Overall Study||6
6393935|NCT00850499|7306247|FG000|NOT COMPLETED|Overall Study||3
6393936|NCT00850499|7306248|FG001|NOT COMPLETED|Overall Study||2
6393937|NCT00850538|7306254|FG000|STARTED|Overall Study||101
6393938|NCT00850538|7306254|FG000|COMPLETED|Overall Study||60
6393939|NCT00850538|7306254|FG000|NOT COMPLETED|Overall Study||41
6393940|NCT00850564|7306258|FG000|STARTED|Overall Study||15
6393941|NCT00850564|7306258|FG000|COMPLETED|Overall Study||13
6393942|NCT00850564|7306258|FG000|NOT COMPLETED|Overall Study||2
6393943|NCT00850603|7306267|FG000|STARTED|Overall Study||34
6393944|NCT00850603|7306268|FG001|STARTED|Overall Study||34
6393945|NCT00850603|7306269|FG002|STARTED|Overall Study||34
6393946|NCT00850603|7306270|FG003|STARTED|Overall Study||34
6393947|NCT00850603|7306271|FG004|STARTED|Overall Study||34
6393948|NCT00850603|7306267|FG000|COMPLETED|Overall Study||34
6393949|NCT00850603|7306268|FG001|COMPLETED|Overall Study||34
6393950|NCT00850603|7306269|FG002|COMPLETED|Overall Study||34
6393951|NCT00850603|7306270|FG003|COMPLETED|Overall Study||34
6393952|NCT00850603|7306271|FG004|COMPLETED|Overall Study||34
6393953|NCT00850603|7306267|FG000|NOT COMPLETED|Overall Study||0
6393954|NCT00850603|7306268|FG001|NOT COMPLETED|Overall Study||0
6393955|NCT00850603|7306269|FG002|NOT COMPLETED|Overall Study||0
6393956|NCT00850603|7306270|FG003|NOT COMPLETED|Overall Study||0
6393957|NCT00850603|7306271|FG004|NOT COMPLETED|Overall Study||0
6393958|NCT00850642|7306285|FG000|STARTED|Overall Study||3
6393959|NCT00850642|7306286|FG001|STARTED|Overall Study||4
6393960|NCT00850642|7306285|FG000|COMPLETED|Overall Study||3
6393961|NCT00850642|7306286|FG001|COMPLETED|Overall Study||4
6393962|NCT00850642|7306285|FG000|NOT COMPLETED|Overall Study||0
6393963|NCT00850642|7306286|FG001|NOT COMPLETED|Overall Study||0
6393964|NCT00850759|7306301|FG000|STARTED|Overall Study||59
6393965|NCT00850759|7306302|FG001|STARTED|Overall Study||57
6393966|NCT00850759|7306303|FG002|STARTED|Overall Study||57
6393967|NCT00850759|7306304|FG003|STARTED|Overall Study||58
6393968|NCT00850759|7306301|FG000|COMPLETED|Overall Study||52
6393969|NCT00850759|7306302|FG001|COMPLETED|Overall Study||52
6393970|NCT00850759|7306303|FG002|COMPLETED|Overall Study||52
6393971|NCT00850759|7306304|FG003|COMPLETED|Overall Study||55
6393972|NCT00850759|7306301|FG000|NOT COMPLETED|Overall Study||7
6393973|NCT00850759|7306302|FG001|NOT COMPLETED|Overall Study||5
6393974|NCT00850759|7306303|FG002|NOT COMPLETED|Overall Study||5
6393975|NCT00850759|7306304|FG003|NOT COMPLETED|Overall Study||3
6393976|NCT00850889|7306314|FG000|STARTED|Overall Study||32
6393977|NCT00850889|7306314|FG000|COMPLETED|Overall Study||32
6393978|NCT00850889|7306314|FG000|NOT COMPLETED|Overall Study||0
6393979|NCT00850993|7306325|FG000|STARTED|Overall Study||17
6393980|NCT00850993|7306326|FG001|STARTED|Overall Study||18
6393981|NCT00850993|7306327|FG002|STARTED|Overall Study||8
6393982|NCT00850993|7306328|FG003|STARTED|Overall Study||15
6393983|NCT00850993|7306325|FG000|Safety|Overall Study||17
6393984|NCT00850993|7306326|FG001|Safety|Overall Study||18
6393985|NCT00850993|7306327|FG002|Safety|Overall Study||8
6393986|NCT00850993|7306328|FG003|Safety|Overall Study||15
6393987|NCT00850993|7306325|FG000|Intent-to-treat|Overall Study||17
6393988|NCT00850993|7306326|FG001|Intent-to-treat|Overall Study||18
6393989|NCT00850993|7306327|FG002|Intent-to-treat|Overall Study||8
6393990|NCT00850993|7306328|FG003|Intent-to-treat|Overall Study||15
6393991|NCT00850993|7306325|FG000|Received Phototherapy|Overall Study||3
6393992|NCT00850993|7306326|FG001|Received Phototherapy|Overall Study||6
6393993|NCT00850993|7306327|FG002|Received Phototherapy|Overall Study||2
6393994|NCT00850993|7306328|FG003|Received Phototherapy|Overall Study||8
6393995|NCT00850993|7306325|FG000|Per Protocol|Overall Study||10
6393996|NCT00850993|7306326|FG001|Per Protocol|Overall Study||13
6393997|NCT00850993|7306327|FG002|Per Protocol|Overall Study||5
6393998|NCT00850993|7306328|FG003|Per Protocol|Overall Study||13
6393999|NCT00850993|7306325|FG000|COMPLETED|Overall Study||16
6394000|NCT00850993|7306326|FG001|COMPLETED|Overall Study||18
6394001|NCT00850993|7306327|FG002|COMPLETED|Overall Study||8
6394002|NCT00850993|7306328|FG003|COMPLETED|Overall Study||14
6394003|NCT00850993|7306325|FG000|NOT COMPLETED|Overall Study||1
6394004|NCT00850993|7306326|FG001|NOT COMPLETED|Overall Study||0
6394005|NCT00850993|7306327|FG002|NOT COMPLETED|Overall Study||0
6394006|NCT00850993|7306328|FG003|NOT COMPLETED|Overall Study||1
6394007|NCT00851006|7306338|FG000|STARTED|Overall Study||7
6394008|NCT00851006|7306339|FG001|STARTED|Overall Study||6
6394009|NCT00851006|7306338|FG000|COMPLETED|Overall Study||7
6394010|NCT00851006|7306339|FG001|COMPLETED|Overall Study||6
6394011|NCT00851006|7306338|FG000|NOT COMPLETED|Overall Study||0
6394012|NCT00851006|7306339|FG001|NOT COMPLETED|Overall Study||0
6394013|NCT00851084|7306348|FG000|STARTED|Overall Study||117
6394014|NCT00851084|7306349|FG001|STARTED|Overall Study||119
6394015|NCT00851084|7306348|FG000|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
6394016|NCT00851084|7306349|FG001|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
6394017|NCT00851084|7306348|FG000|NOT COMPLETED|Overall Study||117
6394018|NCT00851084|7306349|FG001|NOT COMPLETED|Overall Study||119
6394019|NCT00851253|7306359|FG000|STARTED|Overall Study||2
6394020|NCT00851253|7306360|FG001|STARTED|Overall Study||10
6394021|NCT00851253|7306359|FG000|COMPLETED|Overall Study||1
6394022|NCT00851253|7306360|FG001|COMPLETED|Overall Study||10
6394023|NCT00851253|7306359|FG000|NOT COMPLETED|Overall Study||1
6394024|NCT00851253|7306360|FG001|NOT COMPLETED|Overall Study||0
6394025|NCT00851279|7306366|FG000|STARTED|Overall Study||53
6394026|NCT00851279|7306366|FG000|COMPLETED|Overall Study||53
6394027|NCT00851279|7306366|FG000|NOT COMPLETED|Overall Study||0
6394028|NCT00851318|7306374|FG000|STARTED|Overall Study||81
6394029|NCT00851318|7306375|FG001|STARTED|Overall Study||19
6394030|NCT00851318|7306376|FG002|STARTED|Overall Study||93
6394031|NCT00851318|7306377|FG003|STARTED|Overall Study||92
6394032|NCT00851318|7306374|FG000|Completed Week 24|Overall Study||69
6394033|NCT00851318|7306375|FG001|Completed Week 24|Overall Study||17
6394034|NCT00851318|7306376|FG002|Completed Week 24|Overall Study||90
6394035|NCT00851318|7306377|FG003|Completed Week 24|Overall Study||87
6394036|NCT00851318|7306374|FG000|Completed Week 52|Overall Study||64
6394037|NCT00851318|7306375|FG001|Completed Week 52|Overall Study||16
6394038|NCT00851318|7306376|FG002|Completed Week 52|Overall Study||87
6394039|NCT00851318|7306377|FG003|Completed Week 52|Overall Study||85
6394040|NCT00851318|7306374|FG000|COMPLETED|Overall Study||51
6394041|NCT00851318|7306375|FG001|COMPLETED|Overall Study||14
6394042|NCT00851318|7306376|FG002|COMPLETED|Overall Study||72
6394043|NCT00851318|7306377|FG003|COMPLETED|Overall Study||73
6394044|NCT00851318|7306374|FG000|NOT COMPLETED|Overall Study||30
6394045|NCT00851318|7306375|FG001|NOT COMPLETED|Overall Study||5
6394046|NCT00851318|7306376|FG002|NOT COMPLETED|Overall Study||21
6394047|NCT00851318|7306377|FG003|NOT COMPLETED|Overall Study||19
6394048|NCT00851357|7306390|FG000|STARTED|Overall Study||1200
6394049|NCT00851357|7306391|FG001|STARTED|Overall Study||1201
6394050|NCT00851357|7306392|FG002|STARTED|Overall Study||1799
6394051|NCT00851357|7306390|FG000|COMPLETED|Overall Study||1200
6603393|NCT02059434|7528048|FG004|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603394|NCT02059434|7528049|FG005|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603395|NCT02059434|7528050|FG006|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603396|NCT02059434|7528051|FG007|STARTED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603397|NCT02059434|7528052|FG008|STARTED|Washout Between Periods 5 and 6||37
6603398|NCT02059434|7528044|FG000|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603399|NCT02059434|7528045|FG001|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603400|NCT02059434|7528046|FG002|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603401|NCT02059434|7528047|FG003|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603402|NCT02059434|7528048|FG004|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603403|NCT02059434|7528049|FG005|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603404|NCT02059434|7528050|FG006|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603405|NCT02059434|7528051|FG007|COMPLETED|Washout Between Periods 5 and 6|Part 1 comprised 3 treatment periods only|0
6603406|NCT02059434|7528052|FG008|COMPLETED|Washout Between Periods 5 and 6||37
6603407|NCT02059434|7528044|FG000|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603408|NCT02059434|7528045|FG001|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603409|NCT02059434|7528046|FG002|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603410|NCT02059434|7528047|FG003|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603411|NCT02059434|7528048|FG004|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603412|NCT02059434|7528049|FG005|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603413|NCT02059434|7528050|FG006|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603414|NCT02059434|7528051|FG007|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603415|NCT02059434|7528052|FG008|NOT COMPLETED|Washout Between Periods 5 and 6||0
6603416|NCT02059434|7528044|FG000|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6603417|NCT02059434|7528045|FG001|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6603418|NCT02059434|7528046|FG002|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6603419|NCT02059434|7528047|FG003|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6603420|NCT02059434|7528048|FG004|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6603421|NCT02059434|7528049|FG005|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6603422|NCT02059434|7528050|FG006|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6603423|NCT02059434|7528051|FG007|STARTED|Period 6|Part 1 comprised 3 treatment periods only|0
6603424|NCT02059434|7528052|FG008|STARTED|Period 6||37
6394052|NCT00851357|7306391|FG001|COMPLETED|Overall Study||1201
6394053|NCT00851357|7306392|FG002|COMPLETED|Overall Study||1799
6394054|NCT00851357|7306390|FG000|NOT COMPLETED|Overall Study||0
6394055|NCT00851357|7306391|FG001|NOT COMPLETED|Overall Study||0
6394056|NCT00851357|7306392|FG002|NOT COMPLETED|Overall Study||0
6394057|NCT00851409|7306400|FG000|STARTED|Overall Study||25
6394058|NCT00851409|7306400|FG000|COMPLETED|Overall Study||25
6394059|NCT00851409|7306400|FG000|NOT COMPLETED|Overall Study||0
6394060|NCT00851630|7306407|FG000|STARTED|Overall Study||35
6394061|NCT00851630|7306408|FG001|STARTED|Overall Study||35
6394062|NCT00851630|7306407|FG000|COMPLETED|Overall Study||33
6394063|NCT00851630|7306408|FG001|COMPLETED|Overall Study||33
6394064|NCT00851630|7306407|FG000|NOT COMPLETED|Overall Study||2
6394065|NCT00851630|7306408|FG001|NOT COMPLETED|Overall Study||2
6394066|NCT00851643|7306420|FG000|STARTED|Base Study (Up to 12 Months)||15
6394067|NCT00851643|7306421|FG001|STARTED|Base Study (Up to 12 Months)||30
6394068|NCT00851643|7306422|FG002|STARTED|Base Study (Up to 12 Months)||30
6394069|NCT00851643|7306423|FG003|STARTED|Base Study (Up to 12 Months)||15
6394070|NCT00851643|7306424|FG004|STARTED|Base Study (Up to 12 Months)||30
6394071|NCT00851643|7306425|FG005|STARTED|Base Study (Up to 12 Months)||30
6394072|NCT00851643|7306420|FG000|COMPLETED|Base Study (Up to 12 Months)||14
6394073|NCT00851643|7306421|FG001|COMPLETED|Base Study (Up to 12 Months)||30
6394074|NCT00851643|7306422|FG002|COMPLETED|Base Study (Up to 12 Months)||30
6394075|NCT00851643|7306423|FG003|COMPLETED|Base Study (Up to 12 Months)||15
6394076|NCT00851643|7306424|FG004|COMPLETED|Base Study (Up to 12 Months)||30
6394077|NCT00851643|7306425|FG005|COMPLETED|Base Study (Up to 12 Months)||29
6394078|NCT00851643|7306420|FG000|NOT COMPLETED|Base Study (Up to 12 Months)||1
6394079|NCT00851643|7306421|FG001|NOT COMPLETED|Base Study (Up to 12 Months)||0
6394080|NCT00851643|7306422|FG002|NOT COMPLETED|Base Study (Up to 12 Months)||0
6394081|NCT00851643|7306423|FG003|NOT COMPLETED|Base Study (Up to 12 Months)||0
6394082|NCT00851643|7306424|FG004|NOT COMPLETED|Base Study (Up to 12 Months)||0
6394083|NCT00851643|7306425|FG005|NOT COMPLETED|Base Study (Up to 12 Months)||1
6394084|NCT00851643|7306420|FG000|STARTED|Extension Study (Up to 36 Months)||10
6394085|NCT00851643|7306421|FG001|STARTED|Extension Study (Up to 36 Months)||19
6394086|NCT00851643|7306422|FG002|STARTED|Extension Study (Up to 36 Months)||19
6394087|NCT00851643|7306423|FG003|STARTED|Extension Study (Up to 36 Months)||7
6394088|NCT00851643|7306424|FG004|STARTED|Extension Study (Up to 36 Months)||21
6394089|NCT00851643|7306425|FG005|STARTED|Extension Study (Up to 36 Months)||15
6394090|NCT00851643|7306420|FG000|COMPLETED|Extension Study (Up to 36 Months)||6
6394091|NCT00851643|7306421|FG001|COMPLETED|Extension Study (Up to 36 Months)||15
6394092|NCT00851643|7306422|FG002|COMPLETED|Extension Study (Up to 36 Months)||14
6394093|NCT00851643|7306423|FG003|COMPLETED|Extension Study (Up to 36 Months)||5
6394094|NCT00851643|7306424|FG004|COMPLETED|Extension Study (Up to 36 Months)||19
6394095|NCT00851643|7306425|FG005|COMPLETED|Extension Study (Up to 36 Months)||14
6394096|NCT00851643|7306420|FG000|NOT COMPLETED|Extension Study (Up to 36 Months)||4
6394097|NCT00851643|7306421|FG001|NOT COMPLETED|Extension Study (Up to 36 Months)||4
6394098|NCT00851643|7306422|FG002|NOT COMPLETED|Extension Study (Up to 36 Months)||5
6394099|NCT00851643|7306423|FG003|NOT COMPLETED|Extension Study (Up to 36 Months)||2
6394100|NCT00851643|7306424|FG004|NOT COMPLETED|Extension Study (Up to 36 Months)||2
6394101|NCT00851643|7306425|FG005|NOT COMPLETED|Extension Study (Up to 36 Months)||1
6394102|NCT00851721|7306440|FG000|STARTED|Overall Study||19
6394103|NCT00851721|7306441|FG001|STARTED|Overall Study||17
6394104|NCT00851721|7306440|FG000|COMPLETED|Overall Study||17
6394105|NCT00851721|7306441|FG001|COMPLETED|Overall Study||16
6394106|NCT00851721|7306440|FG000|NOT COMPLETED|Overall Study||2
6394107|NCT00851721|7306441|FG001|NOT COMPLETED|Overall Study||1
6394108|NCT00851786|7306455|FG000|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
6394109|NCT00851786|7306456|FG001|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
6394110|NCT00851786|7306455|FG000|COMPLETED|Overall Study||291
6394111|NCT00851786|7306456|FG001|COMPLETED|Overall Study||97
6394112|NCT00851786|7306455|FG000|NOT COMPLETED|Overall Study||5
6394113|NCT00851786|7306456|FG001|NOT COMPLETED|Overall Study||2
6394114|NCT00851799|7306465|FG000|STARTED|Overall Study||109
6394115|NCT00851799|7306466|FG001|STARTED|Overall Study||106
6394116|NCT00851799|7306467|FG002|STARTED|Overall Study||113
6394117|NCT00851799|7306465|FG000|COMPLETED|Overall Study||93
6394118|NCT00851799|7306466|FG001|COMPLETED|Overall Study||93
6394119|NCT00851799|7306467|FG002|COMPLETED|Overall Study||89
6394120|NCT00851799|7306465|FG000|NOT COMPLETED|Overall Study||16
6394121|NCT00851799|7306466|FG001|NOT COMPLETED|Overall Study||13
6394122|NCT00851799|7306467|FG002|NOT COMPLETED|Overall Study||24
6394123|NCT00851877|7306475|FG000|STARTED|Phase I-1||7
6394124|NCT00851877|7306476|FG001|STARTED|Phase I-1||0
6394125|NCT00851877|7306477|FG002|STARTED|Phase I-1||0
6394126|NCT00851877|7306475|FG000|COMPLETED|Phase I-1||6
6394127|NCT00851877|7306476|FG001|COMPLETED|Phase I-1||0
6394128|NCT00851877|7306477|FG002|COMPLETED|Phase I-1||0
6394129|NCT00851877|7306475|FG000|NOT COMPLETED|Phase I-1||1
6394130|NCT00851877|7306476|FG001|NOT COMPLETED|Phase I-1||0
6394131|NCT00851877|7306477|FG002|NOT COMPLETED|Phase I-1||0
6394132|NCT00851877|7306475|FG000|STARTED|Phase I-2||0
6394133|NCT00851877|7306476|FG001|STARTED|Phase I-2||5
6394134|NCT00851877|7306477|FG002|STARTED|Phase I-2||0
6394135|NCT00851877|7306475|FG000|COMPLETED|Phase I-2||0
6394136|NCT00851877|7306476|FG001|COMPLETED|Phase I-2||5
6394137|NCT00851877|7306477|FG002|COMPLETED|Phase I-2||0
6394138|NCT00851877|7306475|FG000|NOT COMPLETED|Phase I-2||0
6394139|NCT00851877|7306476|FG001|NOT COMPLETED|Phase I-2||0
6394140|NCT00851877|7306477|FG002|NOT COMPLETED|Phase I-2||0
6394141|NCT00851877|7306475|FG000|STARTED|Phase II||0
6394142|NCT00851877|7306476|FG001|STARTED|Phase II||0
6394143|NCT00851877|7306477|FG002|STARTED|Phase II||25
6394144|NCT00851877|7306475|FG000|COMPLETED|Phase II||0
6394145|NCT00851877|7306476|FG001|COMPLETED|Phase II||0
6603425|NCT02059434|7528044|FG000|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6603426|NCT02059434|7528045|FG001|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6603427|NCT02059434|7528046|FG002|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6603428|NCT02059434|7528047|FG003|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6603429|NCT02059434|7528048|FG004|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6603430|NCT02059434|7528049|FG005|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6603431|NCT02059434|7528050|FG006|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6603432|NCT02059434|7528051|FG007|COMPLETED|Period 6|Part 1 comprised 3 treatment periods only|0
6603433|NCT02059434|7528052|FG008|COMPLETED|Period 6||37
6603434|NCT02059434|7528044|FG000|NOT COMPLETED|Period 6||0
6603435|NCT02059434|7528045|FG001|NOT COMPLETED|Period 6||0
6603436|NCT02059434|7528046|FG002|NOT COMPLETED|Period 6||0
6603437|NCT02059434|7528047|FG003|NOT COMPLETED|Period 6||0
6603438|NCT02059434|7528048|FG004|NOT COMPLETED|Period 6||0
6603439|NCT02059434|7528049|FG005|NOT COMPLETED|Period 6||0
6603440|NCT02059434|7528050|FG006|NOT COMPLETED|Period 6||0
6603441|NCT02059434|7528051|FG007|NOT COMPLETED|Period 6||0
6603442|NCT02059434|7528052|FG008|NOT COMPLETED|Period 6||0
6603443|NCT02059434|7528044|FG000|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603444|NCT02059434|7528045|FG001|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603445|NCT02059434|7528046|FG002|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603446|NCT02059434|7528047|FG003|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603447|NCT02059434|7528048|FG004|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603448|NCT02059434|7528049|FG005|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603449|NCT02059434|7528050|FG006|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603450|NCT02059434|7528051|FG007|STARTED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603451|NCT02059434|7528052|FG008|STARTED|Washout Between Periods 6 and 7||37
6603452|NCT02059434|7528044|FG000|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603453|NCT02059434|7528045|FG001|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603454|NCT02059434|7528046|FG002|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603455|NCT02059434|7528047|FG003|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603456|NCT02059434|7528048|FG004|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603457|NCT02059434|7528049|FG005|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603458|NCT02059434|7528050|FG006|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603459|NCT02059434|7528051|FG007|COMPLETED|Washout Between Periods 6 and 7|Part 1 comprised 3 treatment periods only|0
6603460|NCT02059434|7528052|FG008|COMPLETED|Washout Between Periods 6 and 7||36
6603461|NCT02059434|7528044|FG000|NOT COMPLETED|Washout Between Periods 6 and 7||0
6603462|NCT02059434|7528045|FG001|NOT COMPLETED|Washout Between Periods 6 and 7||0
6603463|NCT02059434|7528046|FG002|NOT COMPLETED|Washout Between Periods 6 and 7||0
6603464|NCT02059434|7528047|FG003|NOT COMPLETED|Washout Between Periods 6 and 7||0
6603465|NCT02059434|7528048|FG004|NOT COMPLETED|Washout Between Periods 6 and 7||0
6603466|NCT02059434|7528049|FG005|NOT COMPLETED|Washout Between Periods 6 and 7||0
6603467|NCT02059434|7528050|FG006|NOT COMPLETED|Washout Between Periods 6 and 7||0
6603468|NCT02059434|7528051|FG007|NOT COMPLETED|Washout Between Periods 6 and 7||0
6603469|NCT02059434|7528052|FG008|NOT COMPLETED|Washout Between Periods 6 and 7||1
6603470|NCT02059434|7528044|FG000|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6603471|NCT02059434|7528045|FG001|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6603472|NCT02059434|7528046|FG002|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6603473|NCT02059434|7528047|FG003|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6603474|NCT02059434|7528048|FG004|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6603475|NCT02059434|7528049|FG005|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6603476|NCT02059434|7528050|FG006|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6603477|NCT02059434|7528051|FG007|STARTED|Period 7|Part 1 comprised 3 treatment periods only|0
6603478|NCT02059434|7528052|FG008|STARTED|Period 7||36
6603479|NCT02059434|7528044|FG000|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6603480|NCT02059434|7528045|FG001|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6603481|NCT02059434|7528046|FG002|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6603482|NCT02059434|7528047|FG003|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6603483|NCT02059434|7528048|FG004|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6394146|NCT00851877|7306477|FG002|COMPLETED|Phase II||22
6394147|NCT00851877|7306475|FG000|NOT COMPLETED|Phase II||0
6394148|NCT00851877|7306476|FG001|NOT COMPLETED|Phase II||0
6394149|NCT00851877|7306477|FG002|NOT COMPLETED|Phase II||3
6394150|NCT00851890|7306487|FG000|STARTED|Overall Study||8
6394151|NCT00851890|7306488|FG001|STARTED|Overall Study||8
6394152|NCT00851890|7306489|FG002|STARTED|Overall Study||8
6394153|NCT00851890|7306490|FG003|STARTED|Overall Study||6
6394154|NCT00851890|7306487|FG000|COMPLETED|Overall Study||8
6394155|NCT00851890|7306488|FG001|COMPLETED|Overall Study||7
6394156|NCT00851890|7306489|FG002|COMPLETED|Overall Study||8
6394157|NCT00851890|7306490|FG003|COMPLETED|Overall Study||5
6394158|NCT00851890|7306487|FG000|NOT COMPLETED|Overall Study||0
6394159|NCT00851890|7306488|FG001|NOT COMPLETED|Overall Study||1
6394160|NCT00851890|7306489|FG002|NOT COMPLETED|Overall Study||0
6394161|NCT00851890|7306490|FG003|NOT COMPLETED|Overall Study||1
6394162|NCT00851903|7306500|FG000|STARTED|Overall Study||112
6394163|NCT00851903|7306500|FG000|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
6394164|NCT00851903|7306500|FG000|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
6394165|NCT00851903|7306500|FG000|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
6394166|NCT00851903|7306500|FG000|COMPLETED|Overall Study||110
6394167|NCT00851903|7306500|FG000|NOT COMPLETED|Overall Study||2
6394168|NCT00852137|7306506|FG000|STARTED|Overall Study||13
6394169|NCT00852137|7306507|FG001|STARTED|Overall Study||3
6394170|NCT00852137|7306506|FG000|COMPLETED|Overall Study||13
6394171|NCT00852137|7306507|FG001|COMPLETED|Overall Study||3
6394172|NCT00852137|7306506|FG000|NOT COMPLETED|Overall Study||0
6394173|NCT00852137|7306507|FG001|NOT COMPLETED|Overall Study||0
6603484|NCT02059434|7528049|FG005|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6603485|NCT02059434|7528050|FG006|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6603486|NCT02059434|7528051|FG007|COMPLETED|Period 7|Part 1 comprised 3 treatment periods only|0
6603487|NCT02059434|7528052|FG008|COMPLETED|Period 7||36
6603488|NCT02059434|7528044|FG000|NOT COMPLETED|Period 7||0
6603489|NCT02059434|7528045|FG001|NOT COMPLETED|Period 7||0
6603490|NCT02059434|7528046|FG002|NOT COMPLETED|Period 7||0
6603491|NCT02059434|7528047|FG003|NOT COMPLETED|Period 7||0
6603492|NCT02059434|7528048|FG004|NOT COMPLETED|Period 7||0
6603493|NCT02059434|7528049|FG005|NOT COMPLETED|Period 7||0
6603494|NCT02059434|7528050|FG006|NOT COMPLETED|Period 7||0
6603495|NCT02059434|7528051|FG007|NOT COMPLETED|Period 7||0
6603496|NCT02059434|7528052|FG008|NOT COMPLETED|Period 7||0
6603497|NCT02059434|7528044|FG000|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603498|NCT02059434|7528045|FG001|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603499|NCT02059434|7528046|FG002|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603500|NCT02059434|7528047|FG003|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603501|NCT02059434|7528048|FG004|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603502|NCT02059434|7528049|FG005|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603503|NCT02059434|7528050|FG006|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603504|NCT02059434|7528051|FG007|STARTED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603505|NCT02059434|7528052|FG008|STARTED|Washout Between Periods 7 and 8||36
6603506|NCT02059434|7528044|FG000|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603507|NCT02059434|7528045|FG001|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603508|NCT02059434|7528046|FG002|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603509|NCT02059434|7528047|FG003|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603510|NCT02059434|7528048|FG004|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603511|NCT02059434|7528049|FG005|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603512|NCT02059434|7528050|FG006|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603513|NCT02059434|7528051|FG007|COMPLETED|Washout Between Periods 7 and 8|Part 1 comprised 3 treatment periods only|0
6603514|NCT02059434|7528052|FG008|COMPLETED|Washout Between Periods 7 and 8||34
6603515|NCT02059434|7528044|FG000|NOT COMPLETED|Washout Between Periods 7 and 8||0
6603516|NCT02059434|7528045|FG001|NOT COMPLETED|Washout Between Periods 7 and 8||0
6603517|NCT02059434|7528046|FG002|NOT COMPLETED|Washout Between Periods 7 and 8||0
6603518|NCT02059434|7528047|FG003|NOT COMPLETED|Washout Between Periods 7 and 8||0
6603519|NCT02059434|7528048|FG004|NOT COMPLETED|Washout Between Periods 7 and 8||0
6603520|NCT02059434|7528049|FG005|NOT COMPLETED|Washout Between Periods 7 and 8||0
6603521|NCT02059434|7528050|FG006|NOT COMPLETED|Washout Between Periods 7 and 8||0
6603522|NCT02059434|7528051|FG007|NOT COMPLETED|Washout Between Periods 7 and 8||0
6603523|NCT02059434|7528052|FG008|NOT COMPLETED|Washout Between Periods 7 and 8||2
6603524|NCT02059434|7528044|FG000|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6603525|NCT02059434|7528045|FG001|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6603526|NCT02059434|7528046|FG002|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6603527|NCT02059434|7528047|FG003|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6603528|NCT02059434|7528048|FG004|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6603529|NCT02059434|7528049|FG005|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6394174|NCT00852202|7306516|FG000|STARTED|Overall Study||77
6394175|NCT00852202|7306517|FG001|STARTED|Overall Study||75
6394176|NCT00852202|7306518|FG002|STARTED|Overall Study||75
6394177|NCT00852202|7306516|FG000|COMPLETED|Overall Study||60
6394178|NCT00852202|7306517|FG001|COMPLETED|Overall Study||63
6394179|NCT00852202|7306518|FG002|COMPLETED|Overall Study||49
6394180|NCT00852202|7306516|FG000|NOT COMPLETED|Overall Study||17
6394181|NCT00852202|7306517|FG001|NOT COMPLETED|Overall Study||12
6394182|NCT00852202|7306518|FG002|NOT COMPLETED|Overall Study||26
6394183|NCT00852397|7306530|FG000|STARTED|Overall Study||52
6394184|NCT00852397|7306531|FG001|STARTED|Overall Study||49
6394185|NCT00852397|7306532|FG002|STARTED|Overall Study||50
6394186|NCT00852397|7306530|FG000|Treated Participants|Overall Study||51
6394187|NCT00852397|7306531|FG001|Treated Participants|Overall Study||49
6394188|NCT00852397|7306532|FG002|Treated Participants|Overall Study||49
6394189|NCT00852397|7306530|FG000|COMPLETED|Overall Study||41
6394190|NCT00852397|7306531|FG001|COMPLETED|Overall Study||41
6394191|NCT00852397|7306532|FG002|COMPLETED|Overall Study||36
6394192|NCT00852397|7306530|FG000|NOT COMPLETED|Overall Study||11
6394193|NCT00852397|7306531|FG001|NOT COMPLETED|Overall Study||8
6394194|NCT00852397|7306532|FG002|NOT COMPLETED|Overall Study||14
6394195|NCT00852475|7306542|FG000|STARTED|Overall Study||26
6394196|NCT00852475|7306543|FG001|STARTED|Overall Study||20
6394197|NCT00852475|7306542|FG000|COMPLETED|Overall Study||23
6394198|NCT00852475|7306543|FG001|COMPLETED|Overall Study||16
6394199|NCT00852475|7306542|FG000|NOT COMPLETED|Overall Study||3
6394200|NCT00852475|7306543|FG001|NOT COMPLETED|Overall Study||4
6394201|NCT00852527|7306551|FG000|STARTED|Overall Study||196
6394202|NCT00852527|7306552|FG001|STARTED|Overall Study||242
6394203|NCT00852527|7306551|FG000|COMPLETED|Overall Study||196
6394204|NCT00852527|7306552|FG001|COMPLETED|Overall Study||242
6394205|NCT00852527|7306551|FG000|NOT COMPLETED|Overall Study||0
6394206|NCT00852527|7306552|FG001|NOT COMPLETED|Overall Study||0
6394207|NCT00852540|7306559|FG000|STARTED|Overall Study||270
6394208|NCT00852540|7306560|FG001|STARTED|Overall Study||140
6394209|NCT00852540|7306559|FG000|COMPLETED|Overall Study||234
6394210|NCT00852540|7306560|FG001|COMPLETED|Overall Study||122
6394211|NCT00852540|7306559|FG000|NOT COMPLETED|Overall Study||36
6394212|NCT00852540|7306560|FG001|NOT COMPLETED|Overall Study||18
6394213|NCT00852592|7306569|FG000|STARTED|Overall Study||23
6394214|NCT00852592|7306570|FG001|STARTED|Overall Study||23
6394215|NCT00852592|7306569|FG000|COMPLETED|Overall Study||20
6394216|NCT00852592|7306570|FG001|COMPLETED|Overall Study||19
6394217|NCT00852592|7306569|FG000|NOT COMPLETED|Overall Study||3
6394218|NCT00852592|7306570|FG001|NOT COMPLETED|Overall Study||4
6394219|NCT00852631|7306576|FG000|STARTED|Overall Study||28
6394220|NCT00852631|7306576|FG000|COMPLETED|Overall Study||17
6394221|NCT00852631|7306576|FG000|NOT COMPLETED|Overall Study||11
6394222|NCT00852644|7306580|FG000|STARTED|Overall Study||3
6394223|NCT00852644|7306581|FG001|STARTED|Overall Study||3
6394224|NCT00852644|7306582|FG002|STARTED|Overall Study||0
6394225|NCT00852644|7306583|FG003|STARTED|Overall Study||3
6394226|NCT00852644|7306584|FG004|STARTED|Overall Study||0
6394227|NCT00852644|7306585|FG005|STARTED|Overall Study||0
6394228|NCT00852644|7306580|FG000|COMPLETED|Overall Study||3
6394229|NCT00852644|7306581|FG001|COMPLETED|Overall Study||3
6394230|NCT00852644|7306582|FG002|COMPLETED|Overall Study||0
6394231|NCT00852644|7306583|FG003|COMPLETED|Overall Study||3
6394232|NCT00852644|7306584|FG004|COMPLETED|Overall Study||0
6394233|NCT00852644|7306585|FG005|COMPLETED|Overall Study||0
6394234|NCT00852644|7306580|FG000|NOT COMPLETED|Overall Study||0
6394235|NCT00852644|7306581|FG001|NOT COMPLETED|Overall Study||0
6394236|NCT00852644|7306582|FG002|NOT COMPLETED|Overall Study||0
6394237|NCT00852644|7306583|FG003|NOT COMPLETED|Overall Study||0
6394238|NCT00852644|7306584|FG004|NOT COMPLETED|Overall Study||0
6394239|NCT00852644|7306585|FG005|NOT COMPLETED|Overall Study||0
6394240|NCT00852761|7306602|FG000|STARTED|Overall Study||17
6394241|NCT00852761|7306603|FG001|STARTED|Overall Study||17
6394242|NCT00852761|7306602|FG000|COMPLETED|Overall Study||17
6394243|NCT00852761|7306603|FG001|COMPLETED|Overall Study||17
6394244|NCT00852761|7306602|FG000|NOT COMPLETED|Overall Study||0
6394245|NCT00852761|7306603|FG001|NOT COMPLETED|Overall Study||0
6394246|NCT00852917|7306613|FG000|STARTED|Overall Study||106
6394247|NCT00852917|7306614|FG001|STARTED|Overall Study||111
6394248|NCT00852917|7306615|FG002|STARTED|Overall Study||108
6394249|NCT00852917|7306616|FG003|STARTED|Overall Study||227
6394250|NCT00852917|7306613|FG000|COMPLETED|Overall Study||62
6394251|NCT00852917|7306614|FG001|COMPLETED|Overall Study||65
6394252|NCT00852917|7306615|FG002|COMPLETED|Overall Study||50
6394253|NCT00852917|7306616|FG003|COMPLETED|Overall Study||134
6394254|NCT00852917|7306613|FG000|NOT COMPLETED|Overall Study||44
6394255|NCT00852917|7306614|FG001|NOT COMPLETED|Overall Study||46
6394256|NCT00852917|7306615|FG002|NOT COMPLETED|Overall Study||58
6394257|NCT00852917|7306616|FG003|NOT COMPLETED|Overall Study||93
6394258|NCT00852930|7306629|FG000|STARTED|Overall Study||16
6394259|NCT00852930|7306630|FG001|STARTED|Overall Study||17
6394260|NCT00852930|7306631|FG002|STARTED|Overall Study||17
6394261|NCT00852930|7306629|FG000|COMPLETED|Overall Study||15
6394262|NCT00852930|7306630|FG001|COMPLETED|Overall Study||16
6394263|NCT00852930|7306631|FG002|COMPLETED|Overall Study||15
6394264|NCT00852930|7306629|FG000|NOT COMPLETED|Overall Study||1
6394265|NCT00852930|7306630|FG001|NOT COMPLETED|Overall Study||1
6394266|NCT00852930|7306631|FG002|NOT COMPLETED|Overall Study||2
6394267|NCT00852969|7306642|FG000|STARTED|Overall Study||15
6394268|NCT00852969|7306643|FG001|STARTED|Overall Study||15
6394269|NCT00852969|7306642|FG000|COMPLETED|Overall Study||15
6394270|NCT00852969|7306643|FG001|COMPLETED|Overall Study||13
6394271|NCT00852969|7306642|FG000|NOT COMPLETED|Overall Study||0
6394272|NCT00852969|7306643|FG001|NOT COMPLETED|Overall Study||2
6394273|NCT00852995|7306654|FG000|STARTED|Overall Study||46
6394274|NCT00852995|7306655|FG001|STARTED|Overall Study||43
6394275|NCT00852995|7306656|FG002|STARTED|Overall Study||44
6394276|NCT00852995|7306657|FG003|STARTED|Overall Study||45
6394277|NCT00852995|7306658|FG004|STARTED|Overall Study||50
6394278|NCT00852995|7306654|FG000|COMPLETED|Overall Study||38
6394279|NCT00852995|7306655|FG001|COMPLETED|Overall Study||42
6394280|NCT00852995|7306656|FG002|COMPLETED|Overall Study||39
6394281|NCT00852995|7306657|FG003|COMPLETED|Overall Study||40
6394282|NCT00852995|7306658|FG004|COMPLETED|Overall Study||46
6394283|NCT00852995|7306654|FG000|NOT COMPLETED|Overall Study||8
6394284|NCT00852995|7306655|FG001|NOT COMPLETED|Overall Study||1
6394285|NCT00852995|7306656|FG002|NOT COMPLETED|Overall Study||5
6394286|NCT00852995|7306657|FG003|NOT COMPLETED|Overall Study||5
6394287|NCT00852995|7306658|FG004|NOT COMPLETED|Overall Study||4
6394288|NCT00853021|7306675|FG000|STARTED|Overall Study||26
6394289|NCT00853021|7306675|FG000|COMPLETED|Overall Study||21
6394290|NCT00853021|7306675|FG000|NOT COMPLETED|Overall Study||5
6394291|NCT00853047|7306684|FG000|STARTED|Core Phase||5
6394292|NCT00853047|7306685|FG001|STARTED|Core Phase||3
6394293|NCT00853047|7306686|FG002|STARTED|Core Phase||3
6394294|NCT00853047|7306687|FG003|STARTED|Core Phase||3
6394295|NCT00853047|7306688|FG004|STARTED|Core Phase||9
6394296|NCT00853047|7306689|FG005|STARTED|Core Phase||0
6394297|NCT00853047|7306684|FG000|COMPLETED|Core Phase||5
6394298|NCT00853047|7306685|FG001|COMPLETED|Core Phase||3
6394299|NCT00853047|7306686|FG002|COMPLETED|Core Phase||3
6394300|NCT00853047|7306687|FG003|COMPLETED|Core Phase||2
6394301|NCT00853047|7306688|FG004|COMPLETED|Core Phase||9
6394302|NCT00853047|7306689|FG005|COMPLETED|Core Phase||0
6394303|NCT00853047|7306684|FG000|NOT COMPLETED|Core Phase||0
6394304|NCT00853047|7306685|FG001|NOT COMPLETED|Core Phase||0
6394305|NCT00853047|7306686|FG002|NOT COMPLETED|Core Phase||0
6394306|NCT00853047|7306687|FG003|NOT COMPLETED|Core Phase||1
6394307|NCT00853047|7306688|FG004|NOT COMPLETED|Core Phase||0
6394308|NCT00853047|7306689|FG005|NOT COMPLETED|Core Phase||0
6394309|NCT00853047|7306684|FG000|STARTED|Open-Label Extension Phase||0
6394310|NCT00853047|7306685|FG001|STARTED|Open-Label Extension Phase||0
6394311|NCT00853047|7306686|FG002|STARTED|Open-Label Extension Phase||0
6394312|NCT00853047|7306687|FG003|STARTED|Open-Label Extension Phase||0
6394313|NCT00853047|7306688|FG004|STARTED|Open-Label Extension Phase||0
6394314|NCT00853047|7306689|FG005|STARTED|Open-Label Extension Phase|19 of the 22 participants who completed the Core Phase entered the optional Open-Label Extension.|19
6394315|NCT00853047|7306684|FG000|Completed 8-week Extension Period|Open-Label Extension Phase||0
6603530|NCT02059434|7528050|FG006|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6603531|NCT02059434|7528051|FG007|STARTED|Period 8|Part 1 comprised 3 treatment periods only|0
6603532|NCT02059434|7528052|FG008|STARTED|Period 8||34
6603533|NCT02059434|7528044|FG000|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6603534|NCT02059434|7528045|FG001|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6603535|NCT02059434|7528046|FG002|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6603536|NCT02059434|7528047|FG003|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6603537|NCT02059434|7528048|FG004|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6603538|NCT02059434|7528049|FG005|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6625190|NCT02223390|7552809|FG001|COMPLETED|Overall Study||28
6394316|NCT00853047|7306685|FG001|Completed 8-week Extension Period|Open-Label Extension Phase||0
6394317|NCT00853047|7306686|FG002|Completed 8-week Extension Period|Open-Label Extension Phase||0
6394318|NCT00853047|7306687|FG003|Completed 8-week Extension Period|Open-Label Extension Phase||0
6394319|NCT00853047|7306688|FG004|Completed 8-week Extension Period|Open-Label Extension Phase||0
6394320|NCT00853047|7306689|FG005|Completed 8-week Extension Period|Open-Label Extension Phase||16
6394321|NCT00853047|7306684|FG000|COMPLETED|Open-Label Extension Phase||0
6394322|NCT00853047|7306685|FG001|COMPLETED|Open-Label Extension Phase||0
6394323|NCT00853047|7306686|FG002|COMPLETED|Open-Label Extension Phase||0
6394324|NCT00853047|7306687|FG003|COMPLETED|Open-Label Extension Phase||0
6394325|NCT00853047|7306688|FG004|COMPLETED|Open-Label Extension Phase||0
6394326|NCT00853047|7306689|FG005|COMPLETED|Open-Label Extension Phase||2
6394327|NCT00853047|7306684|FG000|NOT COMPLETED|Open-Label Extension Phase||0
6394328|NCT00853047|7306685|FG001|NOT COMPLETED|Open-Label Extension Phase||0
6394329|NCT00853047|7306686|FG002|NOT COMPLETED|Open-Label Extension Phase||0
6394330|NCT00853047|7306687|FG003|NOT COMPLETED|Open-Label Extension Phase||0
6394331|NCT00853047|7306688|FG004|NOT COMPLETED|Open-Label Extension Phase||0
6394332|NCT00853047|7306689|FG005|NOT COMPLETED|Open-Label Extension Phase||17
6394333|NCT00853073|7306706|FG000|STARTED|Overall Study||32
6394334|NCT00853073|7306707|FG001|STARTED|Overall Study||31
6394335|NCT00853073|7306706|FG000|COMPLETED|Overall Study||29
6394336|NCT00853073|7306707|FG001|COMPLETED|Overall Study||29
6394337|NCT00853073|7306706|FG000|NOT COMPLETED|Overall Study||3
6394338|NCT00853073|7306707|FG001|NOT COMPLETED|Overall Study||2
6394339|NCT00853099|7306716|FG000|STARTED|Double-blind Period||96
6394340|NCT00853099|7306717|FG001|STARTED|Double-blind Period||87
6394341|NCT00853099|7306718|FG002|STARTED|Double-blind Period||91
6394342|NCT00853099|7306719|FG003|STARTED|Double-blind Period||0
6394343|NCT00853099|7306716|FG000|Treated|Double-blind Period||96
6394344|NCT00853099|7306717|FG001|Treated|Double-blind Period||87
6394345|NCT00853099|7306718|FG002|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
6394346|NCT00853099|7306719|FG003|Treated|Double-blind Period||0
6394347|NCT00853099|7306716|FG000|Completed Week 8|Double-blind Period||92
6394348|NCT00853099|7306717|FG001|Completed Week 8|Double-blind Period||85
6394349|NCT00853099|7306718|FG002|Completed Week 8|Double-blind Period||86
6394350|NCT00853099|7306719|FG003|Completed Week 8|Double-blind Period||0
6394351|NCT00853099|7306716|FG000|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
6394352|NCT00853099|7306717|FG001|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
6394353|NCT00853099|7306718|FG002|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
6394354|NCT00853099|7306719|FG003|COMPLETED|Double-blind Period||0
6394355|NCT00853099|7306716|FG000|NOT COMPLETED|Double-blind Period||23
6394356|NCT00853099|7306717|FG001|NOT COMPLETED|Double-blind Period||29
6394357|NCT00853099|7306718|FG002|NOT COMPLETED|Double-blind Period||31
6394358|NCT00853099|7306719|FG003|NOT COMPLETED|Double-blind Period||0
6394359|NCT00853099|7306716|FG000|STARTED|Double-blind + Open-label Periods||0
6394360|NCT00853099|7306717|FG001|STARTED|Double-blind + Open-label Periods||0
6394361|NCT00853099|7306718|FG002|STARTED|Double-blind + Open-label Periods||0
6394362|NCT00853099|7306719|FG003|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
6394363|NCT00853099|7306716|FG000|COMPLETED|Double-blind + Open-label Periods||0
6394364|NCT00853099|7306717|FG001|COMPLETED|Double-blind + Open-label Periods||0
6394365|NCT00853099|7306718|FG002|COMPLETED|Double-blind + Open-label Periods||0
6394366|NCT00853099|7306719|FG003|COMPLETED|Double-blind + Open-label Periods||119
6394367|NCT00853099|7306716|FG000|NOT COMPLETED|Double-blind + Open-label Periods||0
6394368|NCT00853099|7306717|FG001|NOT COMPLETED|Double-blind + Open-label Periods||0
6394369|NCT00853099|7306718|FG002|NOT COMPLETED|Double-blind + Open-label Periods||0
6394370|NCT00853099|7306719|FG003|NOT COMPLETED|Double-blind + Open-label Periods||147
6394371|NCT00853112|7306736|FG000|STARTED|Overall Study||6
6394372|NCT00853112|7306737|FG001|STARTED|Overall Study||7
6394373|NCT00853112|7306738|FG002|STARTED|Overall Study||7
6394374|NCT00853112|7306739|FG003|STARTED|Overall Study||8
6394375|NCT00853112|7306740|FG004|STARTED|Overall Study||6
6394376|NCT00853112|7306741|FG005|STARTED|Overall Study||7
6394377|NCT00853112|7306742|FG006|STARTED|Overall Study||7
6394378|NCT00853112|7306736|FG000|Treated|Overall Study||6
6394379|NCT00853112|7306737|FG001|Treated|Overall Study||6
6394380|NCT00853112|7306738|FG002|Treated|Overall Study||7
6394381|NCT00853112|7306739|FG003|Treated|Overall Study||6
6394382|NCT00853112|7306740|FG004|Treated|Overall Study||6
6394383|NCT00853112|7306741|FG005|Treated|Overall Study||7
6394384|NCT00853112|7306742|FG006|Treated|Overall Study||6
6394385|NCT00853112|7306736|FG000|COMPLETED|Overall Study||6
6394386|NCT00853112|7306737|FG001|COMPLETED|Overall Study||6
6394387|NCT00853112|7306738|FG002|COMPLETED|Overall Study||7
6394388|NCT00853112|7306739|FG003|COMPLETED|Overall Study||6
6394389|NCT00853112|7306740|FG004|COMPLETED|Overall Study||6
6394390|NCT00853112|7306741|FG005|COMPLETED|Overall Study||7
6394391|NCT00853112|7306742|FG006|COMPLETED|Overall Study||6
6394392|NCT00853112|7306736|FG000|NOT COMPLETED|Overall Study||0
6394393|NCT00853112|7306737|FG001|NOT COMPLETED|Overall Study||1
6394394|NCT00853112|7306738|FG002|NOT COMPLETED|Overall Study||0
6394395|NCT00853112|7306739|FG003|NOT COMPLETED|Overall Study||2
6394396|NCT00853112|7306740|FG004|NOT COMPLETED|Overall Study||0
6394397|NCT00853112|7306741|FG005|NOT COMPLETED|Overall Study||0
6394398|NCT00853112|7306742|FG006|NOT COMPLETED|Overall Study||1
6394399|NCT00853125|7306758|FG000|STARTED|Overall Study||10
6394400|NCT00853125|7306758|FG000|COMPLETED|Overall Study||9
6394401|NCT00853125|7306758|FG000|NOT COMPLETED|Overall Study||1
6394402|NCT00853151|7306767|FG000|STARTED|Overall Study||38
6394403|NCT00853151|7306768|FG001|STARTED|Overall Study||37
6394404|NCT00853151|7306769|FG002|STARTED|Overall Study||38
6394405|NCT00853151|7306770|FG003|STARTED|Overall Study||18
6394406|NCT00853151|7306767|FG000|COMPLETED|Overall Study||28
6394407|NCT00853151|7306768|FG001|COMPLETED|Overall Study||24
6394408|NCT00853151|7306769|FG002|COMPLETED|Overall Study||30
6394409|NCT00853151|7306770|FG003|COMPLETED|Overall Study||15
6394410|NCT00853151|7306767|FG000|NOT COMPLETED|Overall Study||10
6394411|NCT00853151|7306768|FG001|NOT COMPLETED|Overall Study||13
6394412|NCT00853151|7306769|FG002|NOT COMPLETED|Overall Study||8
6394413|NCT00853151|7306770|FG003|NOT COMPLETED|Overall Study||3
6394414|NCT00853242|7306790|FG000|STARTED|Overall Study||50
6394415|NCT00853242|7306791|FG001|STARTED|Overall Study||50
6394416|NCT00853242|7306792|FG002|STARTED|Overall Study||49
6394417|NCT00853242|7306793|FG003|STARTED|Overall Study||50
6394418|NCT00853242|7306794|FG004|STARTED|Overall Study||50
6394419|NCT00853242|7306795|FG005|STARTED|Overall Study||51
6394420|NCT00853242|7306796|FG006|STARTED|Overall Study||49
6394421|NCT00853242|7306790|FG000|Treated|Overall Study||50
6394422|NCT00853242|7306791|FG001|Treated|Overall Study||49
6394423|NCT00853242|7306792|FG002|Treated|Overall Study||48
6394424|NCT00853242|7306793|FG003|Treated|Overall Study||50
6394425|NCT00853242|7306794|FG004|Treated|Overall Study||50
6394426|NCT00853242|7306795|FG005|Treated|Overall Study||51
6394427|NCT00853242|7306796|FG006|Treated|Overall Study||48
6394428|NCT00853242|7306790|FG000|COMPLETED|Overall Study||47
6394429|NCT00853242|7306791|FG001|COMPLETED|Overall Study||47
6394430|NCT00853242|7306792|FG002|COMPLETED|Overall Study||46
6394431|NCT00853242|7306793|FG003|COMPLETED|Overall Study||46
6394432|NCT00853242|7306794|FG004|COMPLETED|Overall Study||46
6394433|NCT00853242|7306795|FG005|COMPLETED|Overall Study||49
6394434|NCT00853242|7306796|FG006|COMPLETED|Overall Study||44
6394435|NCT00853242|7306790|FG000|NOT COMPLETED|Overall Study||3
6394436|NCT00853242|7306791|FG001|NOT COMPLETED|Overall Study||3
6394437|NCT00853242|7306792|FG002|NOT COMPLETED|Overall Study||3
6394438|NCT00853242|7306793|FG003|NOT COMPLETED|Overall Study||4
6394439|NCT00853242|7306794|FG004|NOT COMPLETED|Overall Study||4
6394440|NCT00853242|7306795|FG005|NOT COMPLETED|Overall Study||2
6394441|NCT00853242|7306796|FG006|NOT COMPLETED|Overall Study||5
6394442|NCT00853333|7306821|FG000|STARTED|Overall Study||28
6394443|NCT00853333|7306822|FG001|STARTED|Overall Study||27
6394444|NCT00853333|7306823|FG002|STARTED|Overall Study||31
6394445|NCT00853333|7306821|FG000|COMPLETED|Overall Study||28
6394446|NCT00853333|7306822|FG001|COMPLETED|Overall Study||27
6394447|NCT00853333|7306823|FG002|COMPLETED|Overall Study||31
6394448|NCT00853333|7306821|FG000|NOT COMPLETED|Overall Study||0
6394449|NCT00853333|7306822|FG001|NOT COMPLETED|Overall Study||0
6394450|NCT00853333|7306823|FG002|NOT COMPLETED|Overall Study||0
6394451|NCT00853372|7306833|FG000|STARTED|Overall Study||43
6394452|NCT00853372|7306834|FG001|STARTED|Overall Study||42
6394453|NCT00853372|7306833|FG000|COMPLETED|Overall Study||11
6394454|NCT00853372|7306834|FG001|COMPLETED|Overall Study||13
6394455|NCT00853372|7306833|FG000|NOT COMPLETED|Overall Study||32
6394456|NCT00853372|7306834|FG001|NOT COMPLETED|Overall Study||29
6394457|NCT00853385|7306845|FG000|STARTED|Overall Study||204
6394458|NCT00853385|7306846|FG001|STARTED|Overall Study||201
6394459|NCT00853385|7306847|FG002|STARTED|Overall Study||56
6394460|NCT00853385|7306848|FG003|STARTED|Overall Study||52
6394461|NCT00853385|7306849|FG004|STARTED|Overall Study||204
6394462|NCT00853385|7306845|FG000|COMPLETED|Overall Study||150
6394463|NCT00853385|7306846|FG001|COMPLETED|Overall Study||158
6394464|NCT00853385|7306847|FG002|COMPLETED|Overall Study||47
6394465|NCT00853385|7306848|FG003|COMPLETED|Overall Study||39
6394466|NCT00853385|7306849|FG004|COMPLETED|Overall Study||162
6394467|NCT00853385|7306845|FG000|NOT COMPLETED|Overall Study||54
6394468|NCT00853385|7306846|FG001|NOT COMPLETED|Overall Study||43
6394469|NCT00853385|7306847|FG002|NOT COMPLETED|Overall Study||9
6394470|NCT00853385|7306848|FG003|NOT COMPLETED|Overall Study||13
6394471|NCT00853385|7306849|FG004|NOT COMPLETED|Overall Study||42
6394472|NCT00853489|7306873|FG000|STARTED|Overall Study||16
6394473|NCT00853489|7306874|FG001|STARTED|Overall Study||14
6394474|NCT00853489|7306873|FG000|COMPLETED|Overall Study||11
6394475|NCT00853489|7306874|FG001|COMPLETED|Overall Study||12
6394476|NCT00853489|7306873|FG000|NOT COMPLETED|Overall Study||5
6394477|NCT00853489|7306874|FG001|NOT COMPLETED|Overall Study||2
6394478|NCT00853580|7306882|FG000|STARTED|Overall Study||74
6394479|NCT00853580|7306883|FG001|STARTED|Overall Study||72
6394480|NCT00853580|7306882|FG000|COMPLETED|Overall Study||67
6394481|NCT00853580|7306883|FG001|COMPLETED|Overall Study||56
6394482|NCT00853580|7306882|FG000|NOT COMPLETED|Overall Study||7
6394483|NCT00853580|7306883|FG001|NOT COMPLETED|Overall Study||16
6394484|NCT00853593|7306889|FG000|STARTED|Overall Study||197
6394485|NCT00853593|7306889|FG000|Implant Attempted|Overall Study||193
6394486|NCT00853593|7306889|FG000|Model 4396 Lead Attempted|Overall Study||164
6394487|NCT00853593|7306889|FG000|COMPLETED|Overall Study||152
6394488|NCT00853593|7306889|FG000|NOT COMPLETED|Overall Study||45
6394489|NCT00853606|7306910|FG000|STARTED|Overall Study||712
6394490|NCT00853606|7306910|FG000|COMPLETED|Overall Study||492
6394491|NCT00853606|7306910|FG000|NOT COMPLETED|Overall Study||220
6394492|NCT00853645|7306914|FG000|STARTED|Overall Study||6
6394493|NCT00853645|7306914|FG000|COMPLETED|Overall Study||6
6394494|NCT00853645|7306914|FG000|NOT COMPLETED|Overall Study||0
6394495|NCT00853658|7306921|FG000|STARTED|Overall Study||2354
6394496|NCT00853658|7306922|FG001|STARTED|Overall Study||2356
6394497|NCT00853658|7306923|FG002|STARTED|Overall Study||2354
6394498|NCT00853658|7306921|FG000|Full Analysis Set (FAS)|Overall Study||2340
6394499|NCT00853658|7306922|FG001|Full Analysis Set (FAS)|Overall Study||2340
6394500|NCT00853658|7306923|FG002|Full Analysis Set (FAS)|Overall Study||2336
6394501|NCT00853658|7306921|FG000|Safety Set|Overall Study||2347
6394502|NCT00853658|7306922|FG001|Safety Set|Overall Study||2348
6394503|NCT00853658|7306923|FG002|Safety Set|Overall Study||2345
6394504|NCT00853658|7306921|FG000|COMPLETED|Overall Study||1567
6394505|NCT00853658|7306922|FG001|COMPLETED|Overall Study||1524
6394506|NCT00853658|7306923|FG002|COMPLETED|Overall Study||1539
6394507|NCT00853658|7306921|FG000|NOT COMPLETED|Overall Study||787
6394508|NCT00853658|7306922|FG001|NOT COMPLETED|Overall Study||832
6394509|NCT00853658|7306923|FG002|NOT COMPLETED|Overall Study||815
6394510|NCT00853671|7306931|FG000|STARTED|Overall Study||50
6394511|NCT00853671|7306931|FG000|COMPLETED|Overall Study||50
6394512|NCT00853671|7306931|FG000|NOT COMPLETED|Overall Study||0
6394513|NCT00853723|7306938|FG000|STARTED|Overall Study||35
6394514|NCT00853723|7306939|FG001|STARTED|Overall Study||35
6394515|NCT00853723|7306940|FG002|STARTED|Overall Study||35
6394516|NCT00853723|7306938|FG000|COMPLETED|Overall Study||29
6394517|NCT00853723|7306939|FG001|COMPLETED|Overall Study||28
6394518|NCT00853723|7306940|FG002|COMPLETED|Overall Study||33
6394519|NCT00853723|7306938|FG000|NOT COMPLETED|Overall Study||6
6394520|NCT00853723|7306939|FG001|NOT COMPLETED|Overall Study||7
6394521|NCT00853723|7306940|FG002|NOT COMPLETED|Overall Study||2
6394522|NCT00853749|7306953|FG000|STARTED|Overall Study||50
6394523|NCT00853749|7306954|FG001|STARTED|Overall Study||39
6394524|NCT00853749|7306953|FG000|Vaccinated|Overall Study||50
6394525|NCT00853749|7306954|FG001|Vaccinated|Overall Study||39
6394526|NCT00853749|7306953|FG000|COMPLETED|Overall Study||50
6394527|NCT00853749|7306954|FG001|COMPLETED|Overall Study||38
6394528|NCT00853749|7306953|FG000|NOT COMPLETED|Overall Study||0
6394529|NCT00853749|7306954|FG001|NOT COMPLETED|Overall Study||1
6394530|NCT00853762|7306964|FG000|STARTED|Overall Study||16
6394531|NCT00853762|7306965|FG001|STARTED|Overall Study||19
6394532|NCT00853762|7306966|FG002|STARTED|Overall Study||17
6394533|NCT00853762|7306967|FG003|STARTED|Overall Study||22
6394534|NCT00853762|7306964|FG000|COMPLETED|Overall Study||0
6394535|NCT00853762|7306965|FG001|COMPLETED|Overall Study||0
6394536|NCT00853762|7306966|FG002|COMPLETED|Overall Study||0
6394537|NCT00853762|7306967|FG003|COMPLETED|Overall Study||0
6394538|NCT00853762|7306964|FG000|NOT COMPLETED|Overall Study||16
6394539|NCT00853762|7306965|FG001|NOT COMPLETED|Overall Study||19
6394540|NCT00853762|7306966|FG002|NOT COMPLETED|Overall Study||17
6394541|NCT00853762|7306967|FG003|NOT COMPLETED|Overall Study||22
6394542|NCT00853827|7306979|FG000|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
6394543|NCT00853827|7306980|FG001|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
6394544|NCT00853827|7306979|FG000|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
6394545|NCT00853827|7306980|FG001|COMPLETED|Single Blind Period (1 Week)||0
6394546|NCT00853827|7306979|FG000|NOT COMPLETED|Single Blind Period (1 Week)||39
6394547|NCT00853827|7306980|FG001|NOT COMPLETED|Single Blind Period (1 Week)||0
6394548|NCT00853827|7306979|FG000|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
6394549|NCT00853827|7306980|FG001|STARTED|Double Blind Period (103 Weeks)||308
6394550|NCT00853827|7306979|FG000|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
6394551|NCT00853827|7306980|FG001|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
6394552|NCT00853827|7306979|FG000|COMPLETED|Double Blind Period (103 Weeks)||201
6394553|NCT00853827|7306980|FG001|COMPLETED|Double Blind Period (103 Weeks)||199
6394554|NCT00853827|7306979|FG000|NOT COMPLETED|Double Blind Period (103 Weeks)||104
6394555|NCT00853827|7306980|FG001|NOT COMPLETED|Double Blind Period (103 Weeks)||109
6394556|NCT00853840|7306986|FG000|STARTED|Period 1||9
6394557|NCT00853840|7306987|FG001|STARTED|Period 1||9
6394558|NCT00853840|7306986|FG000|Maraviroc (Days 1 - 4)|Period 1||9
6394559|NCT00853840|7306987|FG001|Maraviroc (Days 1 - 4)|Period 1||9
6394560|NCT00853840|7306986|FG000|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
6394561|NCT00853840|7306987|FG001|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
6394562|NCT00853840|7306986|FG000|COMPLETED|Period 1||9
6394563|NCT00853840|7306987|FG001|COMPLETED|Period 1||9
6394564|NCT00853840|7306986|FG000|NOT COMPLETED|Period 1||0
6394565|NCT00853840|7306987|FG001|NOT COMPLETED|Period 1||0
6394566|NCT00853840|7306986|FG000|STARTED|Period 2||9
6394567|NCT00853840|7306987|FG001|STARTED|Period 2||9
6394568|NCT00853840|7306986|FG000|Maraviroc (Days 1 - 3)|Period 2||9
6394569|NCT00853840|7306987|FG001|Maraviroc (Days 1 - 3)|Period 2||9
6394570|NCT00853840|7306986|FG000|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
6394571|NCT00853840|7306987|FG001|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
6394572|NCT00853840|7306986|FG000|COMPLETED|Period 2||9
6394573|NCT00853840|7306987|FG001|COMPLETED|Period 2||9
6394574|NCT00853840|7306986|FG000|NOT COMPLETED|Period 2||0
6394575|NCT00853840|7306987|FG001|NOT COMPLETED|Period 2||0
6394576|NCT00853905|7306996|FG000|STARTED|Overall Study||37
6394577|NCT00853905|7306997|FG001|STARTED|Overall Study||40
6394578|NCT00853905|7306996|FG000|COMPLETED|Overall Study||35
6394579|NCT00853905|7306997|FG001|COMPLETED|Overall Study||36
6394580|NCT00853905|7306996|FG000|NOT COMPLETED|Overall Study||2
6394581|NCT00853905|7306997|FG001|NOT COMPLETED|Overall Study||4
6394582|NCT00853957|7307008|FG000|STARTED|Overall Study||220
6394583|NCT00853957|7307009|FG001|STARTED|Overall Study||223
6394584|NCT00853957|7307008|FG000|COMPLETED|Overall Study||206
6394585|NCT00853957|7307009|FG001|COMPLETED|Overall Study||204
6394586|NCT00853957|7307008|FG000|NOT COMPLETED|Overall Study||14
6394587|NCT00853957|7307009|FG001|NOT COMPLETED|Overall Study||19
6394588|NCT00853970|7307017|FG000|STARTED|Overall Study||152
6394589|NCT00853970|7307018|FG001|STARTED|Overall Study||147
6394590|NCT00853970|7307017|FG000|COMPLETED|Overall Study||146
6394591|NCT00853970|7307018|FG001|COMPLETED|Overall Study||144
6394592|NCT00853970|7307017|FG000|NOT COMPLETED|Overall Study||6
6394593|NCT00853970|7307018|FG001|NOT COMPLETED|Overall Study||3
6394594|NCT00853996|7307024|FG000|STARTED|Overall Study||25
6394595|NCT00853996|7307024|FG000|COMPLETED|Overall Study||25
6394596|NCT00853996|7307024|FG000|NOT COMPLETED|Overall Study||0
6394597|NCT00854061|7307028|FG000|STARTED|Overall Study||172
6394598|NCT00854061|7307028|FG000|Completed 1st Surgery (T-PRED in One Eye and Pred Forte in the Other Eye)|Overall Study||162
6394599|NCT00854061|7307028|FG000|Completed 2nd Surgery (T-PRED and Pred Forte in Opposite Eyes Compared to 1st Surgery)|Overall Study||149
6394600|NCT00854061|7307028|FG000|COMPLETED|Overall Study||149
6394601|NCT00854061|7307028|FG000|NOT COMPLETED|Overall Study||23
6394602|NCT00854087|7307036|FG000|STARTED|Overall Study||59
6394603|NCT00854087|7307037|FG001|STARTED|Overall Study||59
6394604|NCT00854087|7307036|FG000|COMPLETED|Overall Study||40
6394605|NCT00854087|7307037|FG001|COMPLETED|Overall Study||40
6394606|NCT00854087|7307036|FG000|NOT COMPLETED|Overall Study||19
6394607|NCT00854087|7307037|FG001|NOT COMPLETED|Overall Study||19
6394608|NCT00854100|7307046|FG000|STARTED|Overall Study||81
6394609|NCT00854100|7307047|FG001|STARTED|Overall Study||76
6394610|NCT00854100|7307048|FG002|STARTED|Overall Study||74
6394611|NCT00854100|7307046|FG000|COMPLETED|Overall Study||72
6394612|NCT00854100|7307047|FG001|COMPLETED|Overall Study||70
6394613|NCT00854100|7307048|FG002|COMPLETED|Overall Study||63
6394614|NCT00854100|7307046|FG000|NOT COMPLETED|Overall Study||9
6394615|NCT00854100|7307047|FG001|NOT COMPLETED|Overall Study||6
6394616|NCT00854100|7307048|FG002|NOT COMPLETED|Overall Study||11
6394617|NCT00854113|7307068|FG000|STARTED|Overall Study||6
6394618|NCT00854113|7307069|FG001|STARTED|Overall Study||6
6394619|NCT00854113|7307070|FG002|STARTED|Overall Study||6
6394620|NCT00854113|7307071|FG003|STARTED|Overall Study||6
6394621|NCT00854113|7307072|FG004|STARTED|Overall Study||6
6394622|NCT00854113|7307073|FG005|STARTED|Overall Study||6
6394623|NCT00854113|7307074|FG006|STARTED|Overall Study||12
6394624|NCT00854113|7307075|FG007|STARTED|Overall Study||8
6394625|NCT00854113|7307076|FG008|STARTED|Overall Study||8
6394626|NCT00854113|7307077|FG009|STARTED|Overall Study||8
6394627|NCT00854113|7307078|FG010|STARTED|Overall Study||6
6394628|NCT00854113|7307068|FG000|COMPLETED|Overall Study||6
6394629|NCT00854113|7307069|FG001|COMPLETED|Overall Study||6
6394630|NCT00854113|7307070|FG002|COMPLETED|Overall Study||6
6394631|NCT00854113|7307071|FG003|COMPLETED|Overall Study||6
6394632|NCT00854113|7307072|FG004|COMPLETED|Overall Study||6
6394633|NCT00854113|7307073|FG005|COMPLETED|Overall Study||6
6394634|NCT00854113|7307074|FG006|COMPLETED|Overall Study||12
6394635|NCT00854113|7307075|FG007|COMPLETED|Overall Study||5
6394636|NCT00854113|7307076|FG008|COMPLETED|Overall Study||7
6394637|NCT00854113|7307077|FG009|COMPLETED|Overall Study||8
6394638|NCT00854113|7307078|FG010|COMPLETED|Overall Study||6
6394639|NCT00854113|7307068|FG000|NOT COMPLETED|Overall Study||0
6394640|NCT00854113|7307069|FG001|NOT COMPLETED|Overall Study||0
6394641|NCT00854113|7307070|FG002|NOT COMPLETED|Overall Study||0
6394642|NCT00854113|7307071|FG003|NOT COMPLETED|Overall Study||0
6394643|NCT00854113|7307072|FG004|NOT COMPLETED|Overall Study||0
6394644|NCT00854113|7307073|FG005|NOT COMPLETED|Overall Study||0
6394645|NCT00854113|7307074|FG006|NOT COMPLETED|Overall Study||0
6394646|NCT00854113|7307075|FG007|NOT COMPLETED|Overall Study||3
6394647|NCT00854113|7307076|FG008|NOT COMPLETED|Overall Study||1
6394648|NCT00854113|7307077|FG009|NOT COMPLETED|Overall Study||0
6394649|NCT00854113|7307078|FG010|NOT COMPLETED|Overall Study||0
6394650|NCT00854308|7307104|FG000|STARTED|Overall Study||69
6394651|NCT00854308|7307105|FG001|STARTED|Overall Study||68
6394652|NCT00854308|7307104|FG000|Received Study Drug|Overall Study||69
6394653|NCT00854308|7307105|FG001|Received Study Drug|Overall Study||67
6394654|NCT00854308|7307104|FG000|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
6394655|NCT00854308|7307105|FG001|COMPLETED|Overall Study||1
6394656|NCT00854308|7307104|FG000|NOT COMPLETED|Overall Study||62
6394657|NCT00854308|7307105|FG001|NOT COMPLETED|Overall Study||67
6394658|NCT00854360|7307115|FG000|STARTED|Overall Study||118
6394659|NCT00854360|7307116|FG001|STARTED|Overall Study||123
6394660|NCT00854360|7307117|FG002|STARTED|Overall Study||122
6394661|NCT00854360|7307118|FG003|STARTED|Overall Study||124
6394662|NCT00854360|7307115|FG000|Intent to Treat / Safety Population|Overall Study||118
6394663|NCT00854360|7307116|FG001|Intent to Treat / Safety Population|Overall Study||123
6394664|NCT00854360|7307117|FG002|Intent to Treat / Safety Population|Overall Study||122
6394665|NCT00854360|7307118|FG003|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
6394666|NCT00854360|7307115|FG000|COMPLETED|Overall Study||116
6394667|NCT00854360|7307116|FG001|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
6394668|NCT00854360|7307117|FG002|COMPLETED|Overall Study||120
6394669|NCT00854360|7307118|FG003|COMPLETED|Overall Study||114
6394670|NCT00854360|7307115|FG000|NOT COMPLETED|Overall Study||2
6394671|NCT00854360|7307116|FG001|NOT COMPLETED|Overall Study||3
6394672|NCT00854360|7307117|FG002|NOT COMPLETED|Overall Study||2
6394673|NCT00854360|7307118|FG003|NOT COMPLETED|Overall Study||10
6394674|NCT00854373|7307130|FG000|STARTED|Overall Study||95
6394675|NCT00854373|7307131|FG001|STARTED|Overall Study||93
6394676|NCT00854373|7307130|FG000|COMPLETED|Overall Study||93
6394677|NCT00854373|7307131|FG001|COMPLETED|Overall Study||89
6394678|NCT00854373|7307130|FG000|NOT COMPLETED|Overall Study||2
6394679|NCT00854373|7307131|FG001|NOT COMPLETED|Overall Study||4
6394680|NCT00854581|7307137|FG000|STARTED|Induction (Up to Day 21)||13
6394681|NCT00854581|7307137|FG000|COMPLETED|Induction (Up to Day 21)||7
6394682|NCT00854581|7307137|FG000|NOT COMPLETED|Induction (Up to Day 21)||6
6394683|NCT00854581|7307137|FG000|STARTED|Part 1 Maintenance (Up to Day 60)||7
6394684|NCT00854581|7307137|FG000|COMPLETED|Part 1 Maintenance (Up to Day 60)||5
6394685|NCT00854581|7307137|FG000|NOT COMPLETED|Part 1 Maintenance (Up to Day 60)||2
6394686|NCT00854581|7307137|FG000|STARTED|Part 2 Maintenance (Up to 12 Months)||5
6394687|NCT00854581|7307137|FG000|COMPLETED|Part 2 Maintenance (Up to 12 Months)||2
6394688|NCT00854581|7307137|FG000|NOT COMPLETED|Part 2 Maintenance (Up to 12 Months)||3
6394689|NCT00854594|7307148|FG000|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
6394690|NCT00854594|7307149|FG001|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
6394691|NCT00854594|7307148|FG000|COMPLETED|Overall Study||48
6394692|NCT00854594|7307149|FG001|COMPLETED|Overall Study||69
6394693|NCT00854594|7307148|FG000|NOT COMPLETED|Overall Study||0
6394694|NCT00854594|7307149|FG001|NOT COMPLETED|Overall Study||0
6394695|NCT00854607|7307155|FG000|STARTED|Enrollment||116
6394696|NCT00854607|7307155|FG000|COMPLETED|Enrollment||116
6394697|NCT00854607|7307155|FG000|NOT COMPLETED|Enrollment||0
6394698|NCT00854607|7307155|FG000|STARTED|2 Weeks After Start Anti-fungal Therapy||116
6394699|NCT00854607|7307155|FG000|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
6394700|NCT00854607|7307155|FG000|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
6394701|NCT00854620|7307166|FG000|STARTED|Overall Study||9
6394702|NCT00854620|7307166|FG000|COMPLETED|Overall Study||8
6394703|NCT00854620|7307166|FG000|NOT COMPLETED|Overall Study||1
6394704|NCT00854724|7307172|FG000|STARTED|First Intervention||8
6394705|NCT00854724|7307173|FG001|STARTED|First Intervention||8
6394706|NCT00854724|7307172|FG000|COMPLETED|First Intervention||7
6394707|NCT00854724|7307173|FG001|COMPLETED|First Intervention||7
6394708|NCT00854724|7307172|FG000|NOT COMPLETED|First Intervention||1
6394709|NCT00854724|7307173|FG001|NOT COMPLETED|First Intervention||1
6394710|NCT00854724|7307172|FG000|STARTED|Washout||7
6394711|NCT00854724|7307173|FG001|STARTED|Washout||7
6394712|NCT00854724|7307172|FG000|COMPLETED|Washout||6
6394713|NCT00854724|7307173|FG001|COMPLETED|Washout||6
6394714|NCT00854724|7307172|FG000|NOT COMPLETED|Washout||1
6394715|NCT00854724|7307173|FG001|NOT COMPLETED|Washout||1
6394716|NCT00854724|7307172|FG000|STARTED|Second Intervention||6
6394717|NCT00854724|7307173|FG001|STARTED|Second Intervention||6
6394718|NCT00854724|7307172|FG000|COMPLETED|Second Intervention||5
6394719|NCT00854724|7307173|FG001|COMPLETED|Second Intervention||5
6394720|NCT00854724|7307172|FG000|NOT COMPLETED|Second Intervention||1
6394721|NCT00854724|7307173|FG001|NOT COMPLETED|Second Intervention||1
6394722|NCT00854828|7307183|FG000|STARTED|Overall Study|6 patients crossed over to non-operative intervention.|30
6394723|NCT00854828|7307184|FG001|STARTED|Overall Study||33
6394724|NCT00854828|7307185|FG002|STARTED|Overall Study||112
6394725|NCT00854828|7307186|FG003|STARTED|Overall Study||111
6394726|NCT00854828|7307183|FG000|3 Months Post Intervention|Overall Study|6 missed visits|24
6394727|NCT00854828|7307184|FG001|3 Months Post Intervention|Overall Study|1 missed visit|32
6394728|NCT00854828|7307185|FG002|3 Months Post Intervention|Overall Study|112 (100%) of patients underwent operative treatment.|112
6394729|NCT00854828|7307186|FG003|3 Months Post Intervention|Overall Study|2 missed visits. 3 withdrew.|106
6394730|NCT00854828|7307183|FG000|12 Months Post Intervention|Overall Study|"2 missed visits.~1 withdrew.~1 deceased."|26
6603539|NCT02059434|7528050|FG006|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6603540|NCT02059434|7528051|FG007|COMPLETED|Period 8|Part 1 comprised 3 treatment periods only|0
6603541|NCT02059434|7528052|FG008|COMPLETED|Period 8||34
6603542|NCT02059434|7528044|FG000|NOT COMPLETED|Period 8||0
6603543|NCT02059434|7528045|FG001|NOT COMPLETED|Period 8||0
6603544|NCT02059434|7528046|FG002|NOT COMPLETED|Period 8||0
6603545|NCT02059434|7528047|FG003|NOT COMPLETED|Period 8||0
6603546|NCT02059434|7528048|FG004|NOT COMPLETED|Period 8||0
6603547|NCT02059434|7528049|FG005|NOT COMPLETED|Period 8||0
6603548|NCT02059434|7528050|FG006|NOT COMPLETED|Period 8||0
6603549|NCT02059434|7528051|FG007|NOT COMPLETED|Period 8||0
6603550|NCT02059434|7528052|FG008|NOT COMPLETED|Period 8||0
6603551|NCT02059512|7528083|FG000|STARTED|Overall Study||46
6603552|NCT02059512|7528084|FG001|STARTED|Overall Study||34
6603553|NCT02059512|7528085|FG002|STARTED|Overall Study||37
6603554|NCT02059512|7528083|FG000|COMPLETED|Overall Study||37
6603555|NCT02059512|7528084|FG001|COMPLETED|Overall Study||25
6603556|NCT02059512|7528085|FG002|COMPLETED|Overall Study||23
6603557|NCT02059512|7528083|FG000|NOT COMPLETED|Overall Study||9
6603558|NCT02059512|7528084|FG001|NOT COMPLETED|Overall Study||9
6603559|NCT02059512|7528085|FG002|NOT COMPLETED|Overall Study||14
6603560|NCT02059642|7528111|FG000|STARTED|Overall Study||148
6603561|NCT02059642|7528112|FG001|STARTED|Overall Study||152
6603562|NCT02059642|7528111|FG000|COMPLETED|Overall Study||121
6603563|NCT02059642|7528112|FG001|COMPLETED|Overall Study||128
6603564|NCT02059642|7528111|FG000|NOT COMPLETED|Overall Study||27
6603565|NCT02059642|7528112|FG001|NOT COMPLETED|Overall Study||24
6603566|NCT02059902|7528120|FG000|STARTED|Overall Study||18
6603567|NCT02059902|7528121|FG001|STARTED|Overall Study||18
6603568|NCT02059902|7528120|FG000|COMPLETED|Overall Study||14
6603569|NCT02059902|7528121|FG001|COMPLETED|Overall Study||14
6603570|NCT02059902|7528120|FG000|NOT COMPLETED|Overall Study||4
6603571|NCT02059902|7528121|FG001|NOT COMPLETED|Overall Study||4
6603572|NCT02059928|7528127|FG000|STARTED|Overall Study||20
6603573|NCT02059928|7528127|FG000|COMPLETED|Overall Study||20
6603574|NCT02059928|7528127|FG000|NOT COMPLETED|Overall Study||0
6603575|NCT02059980|7528133|FG000|STARTED|Overall Study||18
6603576|NCT02059980|7528134|FG001|STARTED|Overall Study||15
6603577|NCT02059980|7528133|FG000|COMPLETED|Overall Study||16
6603578|NCT02059980|7528134|FG001|COMPLETED|Overall Study||14
6603579|NCT02059980|7528133|FG000|NOT COMPLETED|Overall Study||2
6394731|NCT00854828|7307184|FG001|12 Months Post Intervention|Overall Study|1 withdrew. 15 (45%) crossed over to operative treatment.|32
6394732|NCT00854828|7307185|FG002|12 Months Post Intervention|Overall Study||112
6394733|NCT00854828|7307186|FG003|12 Months Post Intervention|Overall Study|4 missed visits. 6 withdrew. 6 (5%) crossed over to operative treatment.|101
6394734|NCT00854828|7307183|FG000|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew.~1 deceased. 24 patients (80%) underwent surgery."|27
6394735|NCT00854828|7307184|FG001|24 Months Post Intervention|Overall Study|"1 missed visit.~1 withdrew. 21 (64%) crossed over to operative treatment."|31
6394736|NCT00854828|7307185|FG002|24 Months Post Intervention|Overall Study|8 missed visits.|104
6394737|NCT00854828|7307186|FG003|24 Months Post Intervention|Overall Study|8 missed visits. 9 withdrew. 14 (13%) crossed over to operative treatment.|94
6394738|NCT00854828|7307183|FG000|COMPLETED|Overall Study||27
6394739|NCT00854828|7307184|FG001|COMPLETED|Overall Study||31
6394740|NCT00854828|7307185|FG002|COMPLETED|Overall Study||104
6394741|NCT00854828|7307186|FG003|COMPLETED|Overall Study||94
6394742|NCT00854828|7307183|FG000|NOT COMPLETED|Overall Study||3
6394743|NCT00854828|7307184|FG001|NOT COMPLETED|Overall Study||2
6394744|NCT00854828|7307185|FG002|NOT COMPLETED|Overall Study||8
6394745|NCT00854828|7307186|FG003|NOT COMPLETED|Overall Study||17
6394746|NCT00854906|7307196|FG000|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
6394747|NCT00854906|7307196|FG000|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
6394748|NCT00854906|7307196|FG000|NOT COMPLETED|Overall Study||1
6394749|NCT00855010|7307205|FG000|STARTED|Overall Study||23
6394750|NCT00855010|7307206|FG001|STARTED|Overall Study||19
6394751|NCT00855010|7307205|FG000|COMPLETED|Overall Study||19
6394752|NCT00855010|7307206|FG001|COMPLETED|Overall Study||18
6394753|NCT00855010|7307205|FG000|NOT COMPLETED|Overall Study||4
6394754|NCT00855010|7307206|FG001|NOT COMPLETED|Overall Study||1
6394755|NCT00855062|7307218|FG000|STARTED|Step1||36
6394756|NCT00855062|7307219|FG001|STARTED|Step1||37
6394757|NCT00855062|7307218|FG000|COMPLETED|Step1||26
6394758|NCT00855062|7307219|FG001|COMPLETED|Step1||26
6394759|NCT00855062|7307218|FG000|NOT COMPLETED|Step1||10
6394760|NCT00855062|7307219|FG001|NOT COMPLETED|Step1||11
6394761|NCT00855062|7307218|FG000|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
6394762|NCT00855062|7307219|FG001|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
6394763|NCT00855062|7307218|FG000|COMPLETED|Step2||13
6394764|NCT00855062|7307219|FG001|COMPLETED|Step2||15
6394765|NCT00855062|7307218|FG000|NOT COMPLETED|Step2||6
6394766|NCT00855062|7307219|FG001|NOT COMPLETED|Step2||6
6394767|NCT00855166|7307227|FG000|STARTED|Overall Study||91
6394768|NCT00855166|7307228|FG001|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
6394769|NCT00855166|7307227|FG000|COMPLETED|Overall Study||86
6394770|NCT00855166|7307228|FG001|COMPLETED|Overall Study||83
6394771|NCT00855166|7307227|FG000|NOT COMPLETED|Overall Study||5
6394772|NCT00855166|7307228|FG001|NOT COMPLETED|Overall Study||8
6394773|NCT00855218|7307238|FG000|STARTED|Overall Study||154
6394774|NCT00855218|7307239|FG001|STARTED|Overall Study||153
6394775|NCT00855218|7307238|FG000|Participants Received Treatment|Overall Study||153
6394776|NCT00855218|7307239|FG001|Participants Received Treatment|Overall Study||151
6394777|NCT00855218|7307238|FG000|COMPLETED|Overall Study||0
6394778|NCT00855218|7307239|FG001|COMPLETED|Overall Study||0
6394779|NCT00855218|7307238|FG000|NOT COMPLETED|Overall Study||154
6394780|NCT00855218|7307239|FG001|NOT COMPLETED|Overall Study||153
6394781|NCT00855309|7307247|FG000|STARTED|Overall Study||57
6394782|NCT00855309|7307248|FG001|STARTED|Overall Study||55
6394783|NCT00855309|7307247|FG000|COMPLETED|Overall Study||56
6394784|NCT00855309|7307248|FG001|COMPLETED|Overall Study||55
6394785|NCT00855309|7307247|FG000|NOT COMPLETED|Overall Study||1
6394786|NCT00855309|7307248|FG001|NOT COMPLETED|Overall Study||0
6394787|NCT00855335|7307259|FG000|STARTED|Overall Study||18
6394788|NCT00855335|7307260|FG001|STARTED|Overall Study||18
6394789|NCT00855335|7307261|FG002|STARTED|Overall Study||15
6394790|NCT00855335|7307262|FG003|STARTED|Overall Study||19
6394791|NCT00855335|7307263|FG004|STARTED|Overall Study||7
6394792|NCT00855335|7307259|FG000|COMPLETED|Overall Study||13
6394793|NCT00855335|7307260|FG001|COMPLETED|Overall Study||16
6394794|NCT00855335|7307261|FG002|COMPLETED|Overall Study||10
6394795|NCT00855335|7307262|FG003|COMPLETED|Overall Study||12
6394796|NCT00855335|7307263|FG004|COMPLETED|Overall Study||6
6394797|NCT00855335|7307259|FG000|NOT COMPLETED|Overall Study||5
6394798|NCT00855335|7307260|FG001|NOT COMPLETED|Overall Study||2
6394799|NCT00855335|7307261|FG002|NOT COMPLETED|Overall Study||5
6394800|NCT00855335|7307262|FG003|NOT COMPLETED|Overall Study||7
6394801|NCT00855335|7307263|FG004|NOT COMPLETED|Overall Study||1
6394802|NCT00855413|7307288|FG000|STARTED|Overall Study||15
6394803|NCT00855413|7307288|FG000|COMPLETED|Overall Study||15
6394804|NCT00855413|7307288|FG000|NOT COMPLETED|Overall Study||0
6394805|NCT00855439|7307294|FG000|STARTED|Overall Study||22
6394806|NCT00855439|7307295|FG001|STARTED|Overall Study||24
6394807|NCT00855439|7307294|FG000|COMPLETED|Overall Study||19
6394808|NCT00855439|7307295|FG001|COMPLETED|Overall Study||24
6394809|NCT00855439|7307294|FG000|NOT COMPLETED|Overall Study||3
6394810|NCT00855439|7307295|FG001|NOT COMPLETED|Overall Study||0
6394811|NCT00855465|7307303|FG000|STARTED|Treatment Period||174
6394812|NCT00855465|7307304|FG001|STARTED|Treatment Period||88
6394813|NCT00855465|7307303|FG000|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
6394814|NCT00855465|7307304|FG001|Participants Received Treatment|Treatment Period||88
6394815|NCT00855465|7307303|FG000|COMPLETED|Treatment Period||160
6394816|NCT00855465|7307304|FG001|COMPLETED|Treatment Period||83
6394817|NCT00855465|7307303|FG000|NOT COMPLETED|Treatment Period||14
6394818|NCT00855465|7307304|FG001|NOT COMPLETED|Treatment Period||5
6394819|NCT00855465|7307303|FG000|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
6394820|NCT00855465|7307304|FG001|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
6394821|NCT00855465|7307303|FG000|COMPLETED|Follow-up Period (FUP)||9
6394822|NCT00855465|7307304|FG001|COMPLETED|Follow-up Period (FUP)||2
6394823|NCT00855465|7307303|FG000|NOT COMPLETED|Follow-up Period (FUP)||8
6394824|NCT00855465|7307304|FG001|NOT COMPLETED|Follow-up Period (FUP)||2
6394825|NCT00855582|7307313|FG000|STARTED|Overall Study||198
6394826|NCT00855582|7307314|FG001|STARTED|Overall Study||208
6394827|NCT00855582|7307315|FG002|STARTED|Overall Study||200
6394828|NCT00855582|7307313|FG000|COMPLETED|Overall Study||172
6394829|NCT00855582|7307314|FG001|COMPLETED|Overall Study||184
6394830|NCT00855582|7307315|FG002|COMPLETED|Overall Study||170
6394831|NCT00855582|7307313|FG000|NOT COMPLETED|Overall Study||26
6394832|NCT00855582|7307314|FG001|NOT COMPLETED|Overall Study||24
6394833|NCT00855582|7307315|FG002|NOT COMPLETED|Overall Study||30
6394834|NCT00855595|7307328|FG000|STARTED|Overall Study||106
6394835|NCT00855595|7307329|FG001|STARTED|Overall Study||101
6394836|NCT00855595|7307328|FG000|COMPLETED|Overall Study||100
6394837|NCT00855595|7307329|FG001|COMPLETED|Overall Study||94
6394838|NCT00855595|7307328|FG000|NOT COMPLETED|Overall Study||6
6394839|NCT00855595|7307329|FG001|NOT COMPLETED|Overall Study||7
6394840|NCT00855738|7307335|FG000|STARTED|Overall Study||111
6394841|NCT00855738|7307335|FG000|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
6394842|NCT00855738|7307335|FG000|COMPLETED|Overall Study||106
6394843|NCT00855738|7307335|FG000|NOT COMPLETED|Overall Study||5
6394844|NCT00855816|7307343|FG000|STARTED|Overall Study||47
6394845|NCT00855816|7307344|FG001|STARTED|Overall Study||33
6394846|NCT00855816|7307343|FG000|COMPLETED|Overall Study||21
6394847|NCT00855816|7307344|FG001|COMPLETED|Overall Study||12
6394848|NCT00855816|7307343|FG000|NOT COMPLETED|Overall Study||26
6394849|NCT00855816|7307344|FG001|NOT COMPLETED|Overall Study||21
6394850|NCT00855842|7307350|FG000|STARTED|Overall Study||4
6394851|NCT00855842|7307350|FG000|COMPLETED|Overall Study||4
6394852|NCT00855842|7307350|FG000|NOT COMPLETED|Overall Study||0
6394853|NCT00855868|7307356|FG000|STARTED|Overall Study||13
6394854|NCT00855868|7307357|FG001|STARTED|Overall Study||15
6394855|NCT00855868|7307356|FG000|COMPLETED|Overall Study||12
6394856|NCT00855868|7307357|FG001|COMPLETED|Overall Study||14
6394857|NCT00855868|7307356|FG000|NOT COMPLETED|Overall Study||1
6394858|NCT00855868|7307357|FG001|NOT COMPLETED|Overall Study||1
6394859|NCT00855894|7307363|FG000|STARTED|Overall Study||41
6394860|NCT00855894|7307363|FG000|COMPLETED|Overall Study||8
6394861|NCT00855894|7307363|FG000|NOT COMPLETED|Overall Study||33
6394862|NCT00855920|7307370|FG000|STARTED|Overall Study||76
6394863|NCT00855920|7307371|FG001|STARTED|Overall Study||74
6394864|NCT00855920|7307372|FG002|STARTED|Overall Study||75
6394865|NCT00855920|7307370|FG000|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
6394866|NCT00855920|7307371|FG001|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
6394867|NCT00855920|7307372|FG002|Safety Population|Overall Study||75
6394868|NCT00855920|7307370|FG000|COMPLETED|Overall Study||68
6394869|NCT00855920|7307371|FG001|COMPLETED|Overall Study||65
6394870|NCT00855920|7307372|FG002|COMPLETED|Overall Study||64
6394871|NCT00855920|7307370|FG000|NOT COMPLETED|Overall Study||8
6394872|NCT00855920|7307371|FG001|NOT COMPLETED|Overall Study||9
6394873|NCT00855920|7307372|FG002|NOT COMPLETED|Overall Study||11
6394874|NCT00855933|7307382|FG000|STARTED|Overall Study||30
6394875|NCT00855933|7307383|FG001|STARTED|Overall Study||30
6394876|NCT00855933|7307382|FG000|COMPLETED|Overall Study||30
6394877|NCT00855933|7307383|FG001|COMPLETED|Overall Study||29
6394878|NCT00855933|7307382|FG000|NOT COMPLETED|Overall Study||0
6394879|NCT00855933|7307383|FG001|NOT COMPLETED|Overall Study||1
6394880|NCT00855959|7307389|FG000|STARTED|Overall Study||108
6394881|NCT00855959|7307389|FG000|Patients Who Received Pulmicort Respules|Overall Study||105
6394882|NCT00855959|7307389|FG000|COMPLETED|Overall Study||99
6394883|NCT00855959|7307389|FG000|NOT COMPLETED|Overall Study||9
6394884|NCT00856024|7307393|FG000|STARTED|Overall Study||902
6394885|NCT00856024|7307393|FG000|COMPLETED|Overall Study||902
6394886|NCT00856024|7307393|FG000|NOT COMPLETED|Overall Study||0
6394887|NCT00856050|7307399|FG000|STARTED|Overall Study||26
6394888|NCT00856050|7307399|FG000|COMPLETED|Overall Study||26
6394889|NCT00856050|7307399|FG000|NOT COMPLETED|Overall Study||0
6394890|NCT00856180|7307403|FG000|STARTED|Overall Study||20
6394891|NCT00856180|7307403|FG000|COMPLETED|Overall Study||0
6394892|NCT00856180|7307403|FG000|NOT COMPLETED|Overall Study||20
6394893|NCT00856193|7307409|FG000|STARTED|Period 1||16
6394894|NCT00856193|7307410|FG001|STARTED|Period 1||17
6394895|NCT00856193|7307409|FG000|COMPLETED|Period 1||16
6394896|NCT00856193|7307410|FG001|COMPLETED|Period 1||17
6394897|NCT00856193|7307409|FG000|NOT COMPLETED|Period 1||0
6394898|NCT00856193|7307410|FG001|NOT COMPLETED|Period 1||0
6394899|NCT00856193|7307409|FG000|STARTED|Period 2||16
6394900|NCT00856193|7307410|FG001|STARTED|Period 2||17
6394901|NCT00856193|7307409|FG000|COMPLETED|Period 2||16
6394902|NCT00856193|7307410|FG001|COMPLETED|Period 2||15
6394903|NCT00856193|7307409|FG000|NOT COMPLETED|Period 2||0
6394904|NCT00856193|7307410|FG001|NOT COMPLETED|Period 2||2
6394905|NCT00856206|7307418|FG000|STARTED|Overall Study||330
6394906|NCT00856206|7307419|FG001|STARTED|Overall Study||985
6394907|NCT00856206|7307418|FG000|COMPLETED|Overall Study||276
6394908|NCT00856206|7307419|FG001|COMPLETED|Overall Study||824
6394909|NCT00856206|7307418|FG000|NOT COMPLETED|Overall Study||54
6394910|NCT00856206|7307419|FG001|NOT COMPLETED|Overall Study||161
6394911|NCT00856232|7307428|FG000|STARTED|Overall Study||26
6394912|NCT00856232|7307429|FG001|STARTED|Overall Study||29
6394913|NCT00856232|7307430|FG002|STARTED|Overall Study||36
6394914|NCT00856232|7307428|FG000|COMPLETED|Overall Study||26
6394915|NCT00856232|7307429|FG001|COMPLETED|Overall Study||29
6394916|NCT00856232|7307430|FG002|COMPLETED|Overall Study||36
6394917|NCT00856232|7307428|FG000|NOT COMPLETED|Overall Study||0
6394918|NCT00856232|7307429|FG001|NOT COMPLETED|Overall Study||0
6394919|NCT00856232|7307430|FG002|NOT COMPLETED|Overall Study||0
6394920|NCT00856245|7307440|FG000|STARTED|Overall Study||19
6394921|NCT00856245|7307440|FG000|COMPLETED|Overall Study||14
6394922|NCT00856245|7307440|FG000|NOT COMPLETED|Overall Study||5
6394923|NCT00856284|7307447|FG000|STARTED|Overall Study||880
6394924|NCT00856284|7307448|FG001|STARTED|Overall Study||885
6394925|NCT00856284|7307449|FG002|STARTED|Overall Study||874
6394926|NCT00856284|7307447|FG000|Received Study Drug|Overall Study||873
6394927|NCT00856284|7307448|FG001|Received Study Drug|Overall Study||878
6394928|NCT00856284|7307449|FG002|Received Study Drug|Overall Study||869
6394929|NCT00856284|7307447|FG000|COMPLETED|Overall Study||472
6394930|NCT00856284|7307448|FG001|COMPLETED|Overall Study||493
6394931|NCT00856284|7307449|FG002|COMPLETED|Overall Study||427
6394932|NCT00856284|7307447|FG000|NOT COMPLETED|Overall Study||408
6394933|NCT00856284|7307448|FG001|NOT COMPLETED|Overall Study||392
6394934|NCT00856284|7307449|FG002|NOT COMPLETED|Overall Study||447
6394935|NCT00856297|7307462|FG000|STARTED|Overall Study||131
6394936|NCT00856297|7307463|FG001|STARTED|Overall Study||76
6394937|NCT00856297|7307464|FG002|STARTED|Overall Study||107
6394938|NCT00856297|7307465|FG003|STARTED|Overall Study||44
6394939|NCT00856297|7307466|FG004|STARTED|Overall Study||31
6394940|NCT00856297|7307462|FG000|COMPLETED|Overall Study||129
6394941|NCT00856297|7307463|FG001|COMPLETED|Overall Study||76
6394942|NCT00856297|7307464|FG002|COMPLETED|Overall Study||107
6394943|NCT00856297|7307465|FG003|COMPLETED|Overall Study||44
6394944|NCT00856297|7307466|FG004|COMPLETED|Overall Study||31
6394945|NCT00856297|7307462|FG000|NOT COMPLETED|Overall Study||2
6394946|NCT00856297|7307463|FG001|NOT COMPLETED|Overall Study||0
6394947|NCT00856297|7307464|FG002|NOT COMPLETED|Overall Study||0
6394948|NCT00856297|7307465|FG003|NOT COMPLETED|Overall Study||0
6394949|NCT00856297|7307466|FG004|NOT COMPLETED|Overall Study||0
6394950|NCT00856323|7307483|FG000|STARTED|Overall Study||53
6394951|NCT00856323|7307483|FG000|COMPLETED|Overall Study||51
6394952|NCT00856323|7307483|FG000|NOT COMPLETED|Overall Study||2
6394953|NCT00856349|7307487|FG000|STARTED|Overall Study||4132
6394954|NCT00856349|7307487|FG000|12 Month Follow-up|Overall Study||3228
6394955|NCT00856349|7307487|FG000|18 Month Follow-up|Overall Study||2467
6394956|NCT00856349|7307487|FG000|24 Month Follow-up|Overall Study||1698
6394957|NCT00856349|7307487|FG000|COMPLETED|Overall Study||3111
6394958|NCT00856349|7307487|FG000|NOT COMPLETED|Overall Study||1021
6394959|NCT00856375|7307495|FG000|STARTED|Overall Study||42
6394960|NCT00856375|7307496|FG001|STARTED|Overall Study||41
6394961|NCT00856375|7307495|FG000|COMPLETED|Overall Study||0
6394962|NCT00856375|7307496|FG001|COMPLETED|Overall Study||0
6394963|NCT00856375|7307495|FG000|NOT COMPLETED|Overall Study||42
6394964|NCT00856375|7307496|FG001|NOT COMPLETED|Overall Study||41
6394965|NCT00856388|7307502|FG000|STARTED|Overall Study||62
6394966|NCT00856388|7307502|FG000|COMPLETED|Overall Study||61
6394967|NCT00856388|7307502|FG000|NOT COMPLETED|Overall Study||1
6394968|NCT00856414|7307507|FG000|STARTED|Overall Study||45
6394969|NCT00856414|7307507|FG000|COMPLETED|Overall Study||45
6394970|NCT00856414|7307507|FG000|NOT COMPLETED|Overall Study||0
6394971|NCT00856492|7307514|FG000|STARTED|Overall Study||99
6394972|NCT00856492|7307515|FG001|STARTED|Overall Study||63
6394973|NCT00856492|7307516|FG002|STARTED|Overall Study||53
6394974|NCT00856492|7307514|FG000|Toxicity Eval|Overall Study||96
6394975|NCT00856492|7307515|FG001|Toxicity Eval|Overall Study||60
6394976|NCT00856492|7307516|FG002|Toxicity Eval|Overall Study||51
6394977|NCT00856492|7307514|FG000|COMPLETED|Overall Study||98
6394978|NCT00856492|7307515|FG001|COMPLETED|Overall Study||62
6394979|NCT00856492|7307516|FG002|COMPLETED|Overall Study||51
6394980|NCT00856492|7307514|FG000|NOT COMPLETED|Overall Study||1
6394981|NCT00856492|7307515|FG001|NOT COMPLETED|Overall Study||1
6394982|NCT00856492|7307516|FG002|NOT COMPLETED|Overall Study||2
6394983|NCT00856518|7307529|FG000|STARTED|Overall Study||24
6394984|NCT00856518|7307530|FG001|STARTED|Overall Study||18
6394985|NCT00856518|7307529|FG000|COMPLETED|Overall Study||20
6394986|NCT00856518|7307530|FG001|COMPLETED|Overall Study||16
6394987|NCT00856518|7307529|FG000|NOT COMPLETED|Overall Study||4
6394988|NCT00856518|7307530|FG001|NOT COMPLETED|Overall Study||2
6394989|NCT00856544|7307542|FG000|STARTED|Overall Study||318
6394990|NCT00856544|7307543|FG001|STARTED|Overall Study||318
6394991|NCT00856544|7307544|FG002|STARTED|Overall Study||79
6394992|NCT00856544|7307545|FG003|STARTED|Overall Study||80
6394993|NCT00856544|7307542|FG000|Treated|Overall Study||315
6394994|NCT00856544|7307543|FG001|Treated|Overall Study||318
6394995|NCT00856544|7307544|FG002|Treated|Overall Study||79
6394996|NCT00856544|7307545|FG003|Treated|Overall Study||80
6394997|NCT00856544|7307542|FG000|COMPLETED|Overall Study||261
6394998|NCT00856544|7307543|FG001|COMPLETED|Overall Study||252
6394999|NCT00856544|7307544|FG002|COMPLETED|Overall Study||71
6395000|NCT00856544|7307545|FG003|COMPLETED|Overall Study||67
6395001|NCT00856544|7307542|FG000|NOT COMPLETED|Overall Study||57
6395002|NCT00856544|7307543|FG001|NOT COMPLETED|Overall Study||66
6395003|NCT00856544|7307544|FG002|NOT COMPLETED|Overall Study||8
6395004|NCT00856544|7307545|FG003|NOT COMPLETED|Overall Study||13
6395005|NCT00856557|7307569|FG000|STARTED|Overall Study||62
6395006|NCT00856557|7307570|FG001|STARTED|Overall Study||76
6395007|NCT00856557|7307569|FG000|Received Intervention/Control|Overall Study||62
6395008|NCT00856557|7307570|FG001|Received Intervention/Control|Overall Study||76
6395009|NCT00856557|7307569|FG000|Tested With Standardized Patients|Overall Study||62
6395010|NCT00856557|7307570|FG001|Tested With Standardized Patients|Overall Study||76
6395011|NCT00856557|7307569|FG000|With Patients With Contextual Flags|Overall Study||50
6395012|NCT00856557|7307570|FG001|With Patients With Contextual Flags|Overall Study||60
6395013|NCT00856557|7307569|FG000|COMPLETED|Overall Study||50
6395014|NCT00856557|7307570|FG001|COMPLETED|Overall Study||60
6395015|NCT00856557|7307569|FG000|NOT COMPLETED|Overall Study||12
6395016|NCT00856557|7307570|FG001|NOT COMPLETED|Overall Study||16
6395017|NCT00856583|7307578|FG000|STARTED|Overall Study|Patients treated|4905
6395018|NCT00856583|7307579|FG001|STARTED|Overall Study|Patients treated|4904
6395019|NCT00856583|7307578|FG000|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
6395020|NCT00856583|7307579|FG001|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
6395021|NCT00856583|7307578|FG000|NOT COMPLETED|Overall Study||3137
6395022|NCT00856583|7307579|FG001|NOT COMPLETED|Overall Study||2597
6395023|NCT00856609|7307587|FG000|STARTED|Overall Study||41
6395024|NCT00856609|7307588|FG001|STARTED|Overall Study||39
6395025|NCT00856609|7307587|FG000|COMPLETED|Overall Study||40
6395026|NCT00856609|7307588|FG001|COMPLETED|Overall Study||39
6395027|NCT00856609|7307587|FG000|NOT COMPLETED|Overall Study||1
6395028|NCT00856609|7307588|FG001|NOT COMPLETED|Overall Study||0
6395029|NCT00856635|7307596|FG000|STARTED|Overall Study||22
6395030|NCT00856635|7307597|FG001|STARTED|Overall Study||22
6395031|NCT00856635|7307596|FG000|Received Study Drug|Overall Study||20
6395032|NCT00856635|7307597|FG001|Received Study Drug|Overall Study||20
6395033|NCT00856635|7307596|FG000|COMPLETED|Overall Study||12
6395034|NCT00856635|7307597|FG001|COMPLETED|Overall Study||14
6395035|NCT00856635|7307596|FG000|NOT COMPLETED|Overall Study||10
6395036|NCT00856635|7307597|FG001|NOT COMPLETED|Overall Study||8
6395037|NCT00856661|7307607|FG000|STARTED|Overall Study|Randomised|135
6395038|NCT00856661|7307608|FG001|STARTED|Overall Study|Randomised|135
6395039|NCT00856661|7307607|FG000|Treated|Overall Study||126
6395040|NCT00856661|7307608|FG001|Treated|Overall Study||131
6395041|NCT00856661|7307607|FG000|Randomized Not Treated|Overall Study||9
6395042|NCT00856661|7307608|FG001|Randomized Not Treated|Overall Study||4
6395043|NCT00856661|7307607|FG000|COMPLETED|Overall Study||108
6395044|NCT00856661|7307608|FG001|COMPLETED|Overall Study||106
6395045|NCT00856661|7307607|FG000|NOT COMPLETED|Overall Study||27
6395046|NCT00856661|7307608|FG001|NOT COMPLETED|Overall Study||29
6395047|NCT00856726|7307614|FG000|STARTED|Overall Study||26
6395048|NCT00856726|7307614|FG000|COMPLETED|Overall Study||26
6395049|NCT00856726|7307614|FG000|NOT COMPLETED|Overall Study||0
6395050|NCT00856739|7307621|FG000|STARTED|Overall Study||70
6395051|NCT00856739|7307622|FG001|STARTED|Overall Study||52
6395052|NCT00856739|7307623|FG002|STARTED|Overall Study||55
6395053|NCT00856739|7307621|FG000|COMPLETED|Overall Study||70
6395054|NCT00856739|7307622|FG001|COMPLETED|Overall Study||52
6395055|NCT00856739|7307623|FG002|COMPLETED|Overall Study||55
6395056|NCT00856739|7307621|FG000|NOT COMPLETED|Overall Study||0
6395057|NCT00856739|7307622|FG001|NOT COMPLETED|Overall Study||0
6395058|NCT00856739|7307623|FG002|NOT COMPLETED|Overall Study||0
6395059|NCT00856778|7307634|FG000|STARTED|Overall Study||98
6395060|NCT00856778|7307634|FG000|COMPLETED|Overall Study||74
6395061|NCT00856778|7307634|FG000|NOT COMPLETED|Overall Study||24
6395062|NCT00856791|7307638|FG000|STARTED|Overall Study||1
6395063|NCT00856791|7307638|FG000|COMPLETED|Overall Study||1
6395064|NCT00856791|7307638|FG000|NOT COMPLETED|Overall Study||0
6395065|NCT00856830|7307646|FG000|STARTED|Irinotecan & Bendamustine||3
6395066|NCT00856830|7307647|FG001|STARTED|Irinotecan & Bendamustine||6
6395067|NCT00856830|7307648|FG002|STARTED|Irinotecan & Bendamustine||6
6395068|NCT00856830|7307649|FG003|STARTED|Irinotecan & Bendamustine||15
6395069|NCT00856830|7307646|FG000|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
6395070|NCT00856830|7307647|FG001|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
6395071|NCT00856830|7307648|FG002|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
6395072|NCT00856830|7307649|FG003|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
6395073|NCT00856830|7307646|FG000|COMPLETED|Irinotecan & Bendamustine||3
6395074|NCT00856830|7307647|FG001|COMPLETED|Irinotecan & Bendamustine||6
6395075|NCT00856830|7307648|FG002|COMPLETED|Irinotecan & Bendamustine||6
6395076|NCT00856830|7307649|FG003|COMPLETED|Irinotecan & Bendamustine||12
6395077|NCT00856830|7307646|FG000|NOT COMPLETED|Irinotecan & Bendamustine||0
6395078|NCT00856830|7307647|FG001|NOT COMPLETED|Irinotecan & Bendamustine||0
6395079|NCT00856830|7307648|FG002|NOT COMPLETED|Irinotecan & Bendamustine||0
6395080|NCT00856830|7307649|FG003|NOT COMPLETED|Irinotecan & Bendamustine||3
6395081|NCT00856830|7307646|FG000|STARTED|Regimen - B (Carboplatin & Etoposide)||3
6395082|NCT00856830|7307647|FG001|STARTED|Regimen - B (Carboplatin & Etoposide)||6
6395083|NCT00856830|7307648|FG002|STARTED|Regimen - B (Carboplatin & Etoposide)||6
6395084|NCT00856830|7307649|FG003|STARTED|Regimen - B (Carboplatin & Etoposide)||12
6395085|NCT00856830|7307646|FG000|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
6395086|NCT00856830|7307647|FG001|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
6395087|NCT00856830|7307648|FG002|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
6395088|NCT00856830|7307649|FG003|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
6395089|NCT00856830|7307646|FG000|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
6395090|NCT00856830|7307647|FG001|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
6395091|NCT00856830|7307648|FG002|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
6395092|NCT00856830|7307649|FG003|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
6603580|NCT02059980|7528134|FG001|NOT COMPLETED|Overall Study||1
6603581|NCT02059993|7528142|FG000|STARTED|Overall Study||42
6603582|NCT02059993|7528143|FG001|STARTED|Overall Study||41
6603583|NCT02059993|7528142|FG000|COMPLETED|Overall Study||40
6603584|NCT02059993|7528143|FG001|COMPLETED|Overall Study||37
6603585|NCT02059993|7528142|FG000|NOT COMPLETED|Overall Study||2
6603586|NCT02059993|7528143|FG001|NOT COMPLETED|Overall Study||4
6603587|NCT02060058|7528152|FG000|STARTED|Overall Study||4
6603588|NCT02060058|7528153|FG001|STARTED|Overall Study||0
6603589|NCT02060058|7528154|FG002|STARTED|Overall Study||8
6603590|NCT02060058|7528152|FG000|COMPLETED|Overall Study||4
6603591|NCT02060058|7528153|FG001|COMPLETED|Overall Study||0
6603592|NCT02060058|7528154|FG002|COMPLETED|Overall Study||8
6603593|NCT02060058|7528152|FG000|NOT COMPLETED|Overall Study||0
6603594|NCT02060058|7528153|FG001|NOT COMPLETED|Overall Study||0
6603595|NCT02060058|7528154|FG002|NOT COMPLETED|Overall Study||0
6603596|NCT02060370|7528163|FG000|STARTED|Overall Study||60
6603597|NCT02060370|7528163|FG000|COMPLETED|Overall Study||59
6603598|NCT02060370|7528163|FG000|NOT COMPLETED|Overall Study||1
6603599|NCT02060383|7528172|FG000|STARTED|Core Phase||38
6603600|NCT02060383|7528173|FG001|STARTED|Core Phase||43
6603601|NCT02060383|7528174|FG002|STARTED|Core Phase||19
6603602|NCT02060383|7528175|FG003|STARTED|Core Phase||46
6603603|NCT02060383|7528176|FG004|STARTED|Core Phase||103
6603604|NCT02060383|7528172|FG000|Completed Core/Entered Extension|Core Phase||17
6603605|NCT02060383|7528173|FG001|Completed Core/Entered Extension|Core Phase||17
6603606|NCT02060383|7528174|FG002|Completed Core/Entered Extension|Core Phase||10
6603607|NCT02060383|7528175|FG003|Completed Core/Entered Extension|Core Phase||21
6603608|NCT02060383|7528176|FG004|Completed Core/Entered Extension|Core Phase||53
6603609|NCT02060383|7528172|FG000|Completed Core/Did Not Enter Extension|Core Phase||18
6603610|NCT02060383|7528173|FG001|Completed Core/Did Not Enter Extension|Core Phase||20
6603611|NCT02060383|7528174|FG002|Completed Core/Did Not Enter Extension|Core Phase||9
6603612|NCT02060383|7528175|FG003|Completed Core/Did Not Enter Extension|Core Phase||18
6603613|NCT02060383|7528176|FG004|Completed Core/Did Not Enter Extension|Core Phase||42
6603614|NCT02060383|7528172|FG000|COMPLETED|Core Phase||35
6603615|NCT02060383|7528173|FG001|COMPLETED|Core Phase||37
6603616|NCT02060383|7528174|FG002|COMPLETED|Core Phase||19
6603617|NCT02060383|7528175|FG003|COMPLETED|Core Phase||39
6603618|NCT02060383|7528176|FG004|COMPLETED|Core Phase||95
6603619|NCT02060383|7528172|FG000|NOT COMPLETED|Core Phase||3
6603620|NCT02060383|7528173|FG001|NOT COMPLETED|Core Phase||6
6603621|NCT02060383|7528174|FG002|NOT COMPLETED|Core Phase||0
6603622|NCT02060383|7528175|FG003|NOT COMPLETED|Core Phase||7
6603623|NCT02060383|7528176|FG004|NOT COMPLETED|Core Phase||8
6603624|NCT02060383|7528172|FG000|STARTED|Extension Phase||17
6603625|NCT02060383|7528173|FG001|STARTED|Extension Phase||17
6603626|NCT02060383|7528174|FG002|STARTED|Extension Phase||10
6603627|NCT02060383|7528175|FG003|STARTED|Extension Phase||21
6603628|NCT02060383|7528176|FG004|STARTED|Extension Phase||53
6603629|NCT02060383|7528172|FG000|COMPLETED|Extension Phase||14
6603630|NCT02060383|7528173|FG001|COMPLETED|Extension Phase||14
6603631|NCT02060383|7528174|FG002|COMPLETED|Extension Phase||7
6603632|NCT02060383|7528175|FG003|COMPLETED|Extension Phase||19
6603633|NCT02060383|7528176|FG004|COMPLETED|Extension Phase||46
6603634|NCT02060383|7528172|FG000|NOT COMPLETED|Extension Phase||3
6603635|NCT02060383|7528173|FG001|NOT COMPLETED|Extension Phase||3
6603636|NCT02060383|7528174|FG002|NOT COMPLETED|Extension Phase||3
6603637|NCT02060383|7528175|FG003|NOT COMPLETED|Extension Phase||2
6603638|NCT02060383|7528176|FG004|NOT COMPLETED|Extension Phase||7
6603639|NCT02060461|7528188|FG000|STARTED|Overall Study||33
6603640|NCT02060461|7528188|FG000|COMPLETED|Overall Study||33
6603641|NCT02060461|7528188|FG000|NOT COMPLETED|Overall Study||0
6603642|NCT02060526|7528197|FG000|STARTED|Overall Study||7
6603643|NCT02060526|7528198|FG001|STARTED|Overall Study||7
6603644|NCT02060526|7528199|FG002|STARTED|Overall Study||7
6603645|NCT02060526|7528197|FG000|COMPLETED|Overall Study||7
6603646|NCT02060526|7528198|FG001|COMPLETED|Overall Study||7
6603647|NCT02060526|7528199|FG002|COMPLETED|Overall Study||7
6603648|NCT02060526|7528197|FG000|NOT COMPLETED|Overall Study||0
6603649|NCT02060526|7528198|FG001|NOT COMPLETED|Overall Study||0
6395093|NCT00856843|7307656|FG000|STARTED|Overall Study||68
6395094|NCT00856843|7307657|FG001|STARTED|Overall Study||68
6395095|NCT00856843|7307656|FG000|COMPLETED|Overall Study||66
6395096|NCT00856843|7307657|FG001|COMPLETED|Overall Study||63
6395097|NCT00856843|7307656|FG000|NOT COMPLETED|Overall Study||2
6395098|NCT00856843|7307657|FG001|NOT COMPLETED|Overall Study||5
6395099|NCT00856856|7307663|FG000|STARTED|Baseline||101
6395100|NCT00856856|7307663|FG000|COMPLETED|Baseline||101
6395101|NCT00856856|7307663|FG000|NOT COMPLETED|Baseline||0
6395102|NCT00856856|7307663|FG000|STARTED|30-day Clinical Follow-up||101
6395103|NCT00856856|7307663|FG000|COMPLETED|30-day Clinical Follow-up||101
6395104|NCT00856856|7307663|FG000|NOT COMPLETED|30-day Clinical Follow-up||0
6395105|NCT00856856|7307663|FG000|STARTED|180-day Clinical Follow-up||101
6395106|NCT00856856|7307663|FG000|COMPLETED|180-day Clinical Follow-up||101
6395107|NCT00856856|7307663|FG000|NOT COMPLETED|180-day Clinical Follow-up||0
6395108|NCT00856856|7307663|FG000|STARTED|270-day Clinical Follow-up||101
6395109|NCT00856856|7307663|FG000|COMPLETED|270-day Clinical Follow-up||101
6395110|NCT00856856|7307663|FG000|NOT COMPLETED|270-day Clinical Follow-up||0
6395111|NCT00856856|7307663|FG000|STARTED|1-year Clinical Follow-up||101
6395112|NCT00856856|7307663|FG000|COMPLETED|1-year Clinical Follow-up||101
6395113|NCT00856856|7307663|FG000|NOT COMPLETED|1-year Clinical Follow-up||0
6395114|NCT00856856|7307663|FG000|STARTED|2-year Clinical Follow-up||101
6395115|NCT00856856|7307663|FG000|COMPLETED|2-year Clinical Follow-up||100
6395116|NCT00856856|7307663|FG000|NOT COMPLETED|2-year Clinical Follow-up||1
6395117|NCT00856856|7307663|FG000|STARTED|3-year Clinical Follow-up||100
6395118|NCT00856856|7307663|FG000|COMPLETED|3-year Clinical Follow-up||100
6395119|NCT00856856|7307663|FG000|NOT COMPLETED|3-year Clinical Follow-up||0
6395120|NCT00856856|7307663|FG000|STARTED|4-year Clinical Follow-up||100
6395121|NCT00856856|7307663|FG000|COMPLETED|4-year Clinical Follow-up||99
6395122|NCT00856856|7307663|FG000|NOT COMPLETED|4-year Clinical Follow-up||1
6395123|NCT00856856|7307663|FG000|STARTED|5-year Clinical Follow-up||100
6395124|NCT00856856|7307663|FG000|COMPLETED|5-year Clinical Follow-up|One patient missed the 4-year clinical follow-up but returned at 5 year.|100
6395125|NCT00856856|7307663|FG000|NOT COMPLETED|5-year Clinical Follow-up||0
6395126|NCT00856908|7307674|FG000|STARTED|Overall Study||15
6395127|NCT00856908|7307675|FG001|STARTED|Overall Study||5
6395128|NCT00856908|7307674|FG000|COMPLETED|Overall Study||14
6395129|NCT00856908|7307675|FG001|COMPLETED|Overall Study||5
6395130|NCT00856908|7307674|FG000|NOT COMPLETED|Overall Study||1
6395131|NCT00856908|7307675|FG001|NOT COMPLETED|Overall Study||0
6395132|NCT00856973|7307684|FG000|STARTED|Overall Study||162
6395133|NCT00856973|7307685|FG001|STARTED|Overall Study||163
6395134|NCT00856973|7307686|FG002|STARTED|Overall Study||161
6395135|NCT00856973|7307684|FG000|COMPLETED|Overall Study||126
6395136|NCT00856973|7307685|FG001|COMPLETED|Overall Study||122
6395137|NCT00856973|7307686|FG002|COMPLETED|Overall Study||123
6395138|NCT00856973|7307684|FG000|NOT COMPLETED|Overall Study||36
6395139|NCT00856973|7307685|FG001|NOT COMPLETED|Overall Study||41
6395140|NCT00856973|7307686|FG002|NOT COMPLETED|Overall Study||38
6395141|NCT00856986|7307703|FG000|STARTED|Run-in Period, Weeks -12-0||161
6395142|NCT00856986|7307704|FG001|STARTED|Run-in Period, Weeks -12-0||162
6395143|NCT00856986|7307705|FG002|STARTED|Run-in Period, Weeks -12-0||498
6395144|NCT00856986|7307706|FG003|STARTED|Run-in Period, Weeks -12-0||167
6395145|NCT00856986|7307707|FG004|STARTED|Run-in Period, Weeks -12-0||0
6395146|NCT00856986|7307703|FG000|COMPLETED|Run-in Period, Weeks -12-0||161
6395147|NCT00856986|7307704|FG001|COMPLETED|Run-in Period, Weeks -12-0||162
6395148|NCT00856986|7307705|FG002|COMPLETED|Run-in Period, Weeks -12-0||498
6395149|NCT00856986|7307706|FG003|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
6395150|NCT00856986|7307707|FG004|COMPLETED|Run-in Period, Weeks -12-0||0
6395151|NCT00856986|7307703|FG000|NOT COMPLETED|Run-in Period, Weeks -12-0||0
6395152|NCT00856986|7307704|FG001|NOT COMPLETED|Run-in Period, Weeks -12-0||0
6395153|NCT00856986|7307705|FG002|NOT COMPLETED|Run-in Period, Weeks -12-0||0
6395154|NCT00856986|7307706|FG003|NOT COMPLETED|Run-in Period, Weeks -12-0||167
6395155|NCT00856986|7307707|FG004|NOT COMPLETED|Run-in Period, Weeks -12-0||0
6395156|NCT00856986|7307703|FG000|STARTED|Main Period, Weeks 0-26||161
6395157|NCT00856986|7307704|FG001|STARTED|Main Period, Weeks 0-26||162
6395158|NCT00856986|7307705|FG002|STARTED|Main Period, Weeks 0-26||498
6395159|NCT00856986|7307706|FG003|STARTED|Main Period, Weeks 0-26||0
6395160|NCT00856986|7307707|FG004|STARTED|Main Period, Weeks 0-26||0
6395161|NCT00856986|7307703|FG000|COMPLETED|Main Period, Weeks 0-26||127
6395162|NCT00856986|7307704|FG001|COMPLETED|Main Period, Weeks 0-26||144
6395163|NCT00856986|7307705|FG002|COMPLETED|Main Period, Weeks 0-26||470
6395164|NCT00856986|7307706|FG003|COMPLETED|Main Period, Weeks 0-26||0
6395165|NCT00856986|7307707|FG004|COMPLETED|Main Period, Weeks 0-26||0
6395166|NCT00856986|7307703|FG000|NOT COMPLETED|Main Period, Weeks 0-26||34
6395167|NCT00856986|7307704|FG001|NOT COMPLETED|Main Period, Weeks 0-26||18
6395168|NCT00856986|7307705|FG002|NOT COMPLETED|Main Period, Weeks 0-26||28
6395169|NCT00856986|7307706|FG003|NOT COMPLETED|Main Period, Weeks 0-26||0
6395170|NCT00856986|7307707|FG004|NOT COMPLETED|Main Period, Weeks 0-26||0
6395171|NCT00856986|7307703|FG000|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
6395172|NCT00856986|7307704|FG001|STARTED|Extension Period, Weeks 26-52||144
6395173|NCT00856986|7307705|FG002|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
6395174|NCT00856986|7307706|FG003|STARTED|Extension Period, Weeks 26-52||0
6395175|NCT00856986|7307707|FG004|STARTED|Extension Period, Weeks 26-52||0
6395176|NCT00856986|7307703|FG000|Enrolled in Extension|Extension Period, Weeks 26-52||122
6395177|NCT00856986|7307704|FG001|Enrolled in Extension|Extension Period, Weeks 26-52||140
6395178|NCT00856986|7307705|FG002|Enrolled in Extension|Extension Period, Weeks 26-52||461
6395179|NCT00856986|7307706|FG003|Enrolled in Extension|Extension Period, Weeks 26-52||0
6395180|NCT00856986|7307707|FG004|Enrolled in Extension|Extension Period, Weeks 26-52||0
6395181|NCT00856986|7307703|FG000|COMPLETED|Extension Period, Weeks 26-52||108
6395182|NCT00856986|7307704|FG001|COMPLETED|Extension Period, Weeks 26-52||130
6395183|NCT00856986|7307705|FG002|COMPLETED|Extension Period, Weeks 26-52||432
6395184|NCT00856986|7307706|FG003|COMPLETED|Extension Period, Weeks 26-52||0
6395185|NCT00856986|7307707|FG004|COMPLETED|Extension Period, Weeks 26-52||0
6395186|NCT00856986|7307703|FG000|NOT COMPLETED|Extension Period, Weeks 26-52||19
6395187|NCT00856986|7307704|FG001|NOT COMPLETED|Extension Period, Weeks 26-52||14
6395188|NCT00856986|7307705|FG002|NOT COMPLETED|Extension Period, Weeks 26-52||38
6395189|NCT00856986|7307706|FG003|NOT COMPLETED|Extension Period, Weeks 26-52||0
6395190|NCT00856986|7307707|FG004|NOT COMPLETED|Extension Period, Weeks 26-52||0
6395191|NCT00856999|7307719|FG000|STARTED|Overall Study||50
6395192|NCT00856999|7307719|FG000|COMPLETED|Overall Study||45
6395193|NCT00856999|7307719|FG000|NOT COMPLETED|Overall Study||5
6395194|NCT00857207|7307726|FG000|STARTED|Overall Study||48
6395195|NCT00857207|7307727|FG001|STARTED|Overall Study||3
6395196|NCT00857207|7307726|FG000|COMPLETED|Overall Study||14
6395197|NCT00857207|7307727|FG001|COMPLETED|Overall Study||3
6395198|NCT00857207|7307726|FG000|NOT COMPLETED|Overall Study||34
6395199|NCT00857207|7307727|FG001|NOT COMPLETED|Overall Study||0
6395200|NCT00857220|7307734|FG000|STARTED|Overall Study||304
6395201|NCT00857220|7307734|FG000|COMPLETED|Overall Study||121
6395202|NCT00857220|7307734|FG000|NOT COMPLETED|Overall Study||183
6395203|NCT00857233|7307738|FG000|STARTED|Overall Study||297
6395204|NCT00857233|7307738|FG000|COMPLETED|Overall Study||242
6395205|NCT00857233|7307738|FG000|NOT COMPLETED|Overall Study||55
6395206|NCT00857246|7307742|FG000|STARTED|Induction Regimen||30
6395207|NCT00857246|7307742|FG000|COMPLETED|Induction Regimen||27
6395208|NCT00857246|7307742|FG000|NOT COMPLETED|Induction Regimen||3
6395209|NCT00857246|7307742|FG000|STARTED|Surgery (Curative)||27
6395210|NCT00857246|7307742|FG000|COMPLETED|Surgery (Curative)||21
6395211|NCT00857246|7307742|FG000|NOT COMPLETED|Surgery (Curative)||6
6395212|NCT00857246|7307742|FG000|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
6395213|NCT00857246|7307742|FG000|COMPLETED|ChemoRT||12
6395214|NCT00857246|7307742|FG000|NOT COMPLETED|ChemoRT||3
6395215|NCT00857259|7307752|FG000|STARTED|Overall Study||8
6395216|NCT00857259|7307753|FG001|STARTED|Overall Study||1
6395217|NCT00857259|7307754|FG002|STARTED|Overall Study||7
6395218|NCT00857259|7307752|FG000|COMPLETED|Overall Study||7
6395219|NCT00857259|7307753|FG001|COMPLETED|Overall Study||1
6395220|NCT00857259|7307754|FG002|COMPLETED|Overall Study||6
6395221|NCT00857259|7307752|FG000|NOT COMPLETED|Overall Study||1
6395222|NCT00857259|7307753|FG001|NOT COMPLETED|Overall Study||0
6395223|NCT00857259|7307754|FG002|NOT COMPLETED|Overall Study||1
6395224|NCT00857272|7307766|FG000|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
6395225|NCT00857272|7307767|FG001|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
6395226|NCT00857272|7307766|FG000|COMPLETED|Overall Study||145
6395227|NCT00857272|7307767|FG001|COMPLETED|Overall Study||145
6395228|NCT00857272|7307766|FG000|NOT COMPLETED|Overall Study||9
6395229|NCT00857272|7307767|FG001|NOT COMPLETED|Overall Study||9
6395230|NCT00857311|7307777|FG000|STARTED|Overall Study||9
6395231|NCT00857311|7307778|FG001|STARTED|Overall Study||0
6395232|NCT00857311|7307779|FG002|STARTED|Overall Study||8
6395233|NCT00857311|7307780|FG003|STARTED|Overall Study||0
6395234|NCT00857311|7307777|FG000|COMPLETED|Overall Study||8
6395235|NCT00857311|7307778|FG001|COMPLETED|Overall Study||0
6395236|NCT00857311|7307779|FG002|COMPLETED|Overall Study||8
6395237|NCT00857311|7307780|FG003|COMPLETED|Overall Study||0
6395238|NCT00857311|7307777|FG000|NOT COMPLETED|Overall Study||1
6395239|NCT00857311|7307778|FG001|NOT COMPLETED|Overall Study||0
6395240|NCT00857311|7307779|FG002|NOT COMPLETED|Overall Study||0
6395241|NCT00857311|7307780|FG003|NOT COMPLETED|Overall Study||0
6395242|NCT00857389|7307786|FG000|STARTED|Overall Study||60
6395243|NCT00857389|7307786|FG000|COMPLETED|Overall Study||58
6395244|NCT00857389|7307786|FG000|NOT COMPLETED|Overall Study||2
6395245|NCT00857415|7307792|FG000|STARTED|Overall Study||152
6395246|NCT00857415|7307793|FG001|STARTED|Overall Study||74
6395247|NCT00857415|7307792|FG000|Deceased Within One Year of AV-45 Scan|Overall Study||37
6395248|NCT00857415|7307793|FG001|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
6395249|NCT00857415|7307792|FG000|COMPLETED|Overall Study||35
6395250|NCT00857415|7307793|FG001|COMPLETED|Overall Study||74
6395251|NCT00857415|7307792|FG000|NOT COMPLETED|Overall Study||117
6395252|NCT00857415|7307793|FG001|NOT COMPLETED|Overall Study||0
6395253|NCT00857454|7307799|FG000|STARTED|Overall Study||71
6395254|NCT00857454|7307799|FG000|COMPLETED|Overall Study||51
6395255|NCT00857454|7307799|FG000|NOT COMPLETED|Overall Study||20
6395256|NCT00857493|7307805|FG000|STARTED|Overall Study||62
6395257|NCT00857493|7307806|FG001|STARTED|Overall Study||58
6395258|NCT00857493|7307805|FG000|COMPLETED|Overall Study||59
6395259|NCT00857493|7307806|FG001|COMPLETED|Overall Study||58
6395260|NCT00857493|7307805|FG000|NOT COMPLETED|Overall Study||3
6395261|NCT00857493|7307806|FG001|NOT COMPLETED|Overall Study||0
6395262|NCT00857506|7307815|FG000|STARTED|Overall Study||31
6395263|NCT00857506|7307816|FG001|STARTED|Overall Study||52
6395264|NCT00857506|7307817|FG002|STARTED|Overall Study||69
6395265|NCT00857506|7307815|FG000|COMPLETED|Overall Study||16
6395266|NCT00857506|7307816|FG001|COMPLETED|Overall Study||37
6395267|NCT00857506|7307817|FG002|COMPLETED|Overall Study||51
6395268|NCT00857506|7307815|FG000|NOT COMPLETED|Overall Study||15
6395269|NCT00857506|7307816|FG001|NOT COMPLETED|Overall Study||15
6395270|NCT00857506|7307817|FG002|NOT COMPLETED|Overall Study||18
6395271|NCT00857532|7307837|FG000|STARTED|Overall Study||31
6395272|NCT00857532|7307837|FG000|COMPLETED|Overall Study||31
6395273|NCT00857532|7307837|FG000|NOT COMPLETED|Overall Study||0
6395274|NCT00857545|7307846|FG000|STARTED|Overall Study||86
6395275|NCT00857545|7307847|FG001|STARTED|Overall Study||85
6395276|NCT00857545|7307846|FG000|COMPLETED|Overall Study|Enrolled and randomized participants.|86
6395277|NCT00857545|7307847|FG001|COMPLETED|Overall Study||85
6395278|NCT00857545|7307846|FG000|NOT COMPLETED|Overall Study||0
6395279|NCT00857545|7307847|FG001|NOT COMPLETED|Overall Study||0
6395280|NCT00857584|7307855|FG000|STARTED|Overall Study||14
6395281|NCT00857584|7307856|FG001|STARTED|Overall Study||13
6395282|NCT00857584|7307855|FG000|Week 1|Overall Study||14
6395283|NCT00857584|7307856|FG001|Week 1|Overall Study||13
6395284|NCT00857584|7307855|FG000|Week 2|Overall Study||14
6395285|NCT00857584|7307856|FG001|Week 2|Overall Study||11
6395286|NCT00857584|7307855|FG000|Week 4|Overall Study||11
6395287|NCT00857584|7307856|FG001|Week 4|Overall Study||9
6395288|NCT00857584|7307855|FG000|Week 8|Overall Study||10
6395289|NCT00857584|7307856|FG001|Week 8|Overall Study||8
6395290|NCT00857584|7307855|FG000|COMPLETED|Overall Study||10
6395291|NCT00857584|7307856|FG001|COMPLETED|Overall Study||8
6395292|NCT00857584|7307855|FG000|NOT COMPLETED|Overall Study||4
6395293|NCT00857584|7307856|FG001|NOT COMPLETED|Overall Study||5
6395294|NCT00857623|7307864|FG000|STARTED|Overall Study||62
6395295|NCT00857623|7307865|FG001|STARTED|Overall Study||65
6395296|NCT00857623|7307864|FG000|COMPLETED|Overall Study||48
6395297|NCT00857623|7307865|FG001|COMPLETED|Overall Study||55
6395298|NCT00857623|7307864|FG000|NOT COMPLETED|Overall Study||14
6395299|NCT00857623|7307865|FG001|NOT COMPLETED|Overall Study||10
6395300|NCT00857649|7307873|FG000|STARTED|Overall Study||182
6395301|NCT00857649|7307874|FG001|STARTED|Overall Study||187
6395302|NCT00857649|7307873|FG000|COMPLETED|Overall Study||151
6395303|NCT00857649|7307874|FG001|COMPLETED|Overall Study||155
6395304|NCT00857649|7307873|FG000|NOT COMPLETED|Overall Study||31
6395305|NCT00857649|7307874|FG001|NOT COMPLETED|Overall Study||32
6395306|NCT00857714|7307880|FG000|STARTED|Overall Study||1
6395307|NCT00857714|7307880|FG000|COMPLETED|Overall Study||1
6395308|NCT00857714|7307880|FG000|NOT COMPLETED|Overall Study||0
6395309|NCT00857727|7307886|FG000|STARTED|Overall Study||14
6395310|NCT00857727|7307887|FG001|STARTED|Overall Study||14
6395311|NCT00857727|7307886|FG000|COMPLETED|Overall Study||14
6395312|NCT00857727|7307887|FG001|COMPLETED|Overall Study||14
6395313|NCT00857727|7307886|FG000|NOT COMPLETED|Overall Study||0
6395314|NCT00857727|7307887|FG001|NOT COMPLETED|Overall Study||0
6395315|NCT00857766|7307895|FG000|STARTED|Overall Study||123
6395316|NCT00857766|7307896|FG001|STARTED|Overall Study||126
6395317|NCT00857766|7307895|FG000|COMPLETED|Overall Study||92
6395318|NCT00857766|7307896|FG001|COMPLETED|Overall Study||96
6395319|NCT00857766|7307895|FG000|NOT COMPLETED|Overall Study||31
6395320|NCT00857766|7307896|FG001|NOT COMPLETED|Overall Study||30
6395321|NCT00857792|7307902|FG000|STARTED|Overall Study||120
6395322|NCT00857792|7307902|FG000|COMPLETED|Overall Study||108
6395323|NCT00857792|7307902|FG000|NOT COMPLETED|Overall Study||12
6395324|NCT00857818|7307908|FG000|STARTED|Overall Study||14
6395325|NCT00857818|7307909|FG001|STARTED|Overall Study||14
6395326|NCT00857818|7307908|FG000|Received Treatment|Overall Study||14
6395327|NCT00857818|7307909|FG001|Received Treatment|Overall Study||12
6395328|NCT00857818|7307908|FG000|COMPLETED|Overall Study||3
6395329|NCT00857818|7307909|FG001|COMPLETED|Overall Study||6
6395330|NCT00857818|7307908|FG000|NOT COMPLETED|Overall Study||11
6395331|NCT00857818|7307909|FG001|NOT COMPLETED|Overall Study||8
6395332|NCT00857857|7307915|FG000|STARTED|Overall Study||24
6395333|NCT00857857|7307915|FG000|COMPLETED|Overall Study||24
6395334|NCT00857857|7307915|FG000|NOT COMPLETED|Overall Study||0
6395335|NCT00857896|7307927|FG000|STARTED|Baseline to Week 4||21
6395336|NCT00857896|7307927|FG000|COMPLETED|Baseline to Week 4||20
6395337|NCT00857896|7307927|FG000|NOT COMPLETED|Baseline to Week 4||1
6395338|NCT00857896|7307927|FG000|STARTED|Week 5 to Week 8||20
6395339|NCT00857896|7307927|FG000|COMPLETED|Week 5 to Week 8||20
6395340|NCT00857896|7307927|FG000|NOT COMPLETED|Week 5 to Week 8||0
6395341|NCT00857948|7307936|FG000|STARTED|Overall Study||18
6395342|NCT00857948|7307937|FG001|STARTED|Overall Study||18
6395343|NCT00857948|7307938|FG002|STARTED|Overall Study||19
6395344|NCT00857948|7307939|FG003|STARTED|Overall Study||23
6395345|NCT00857948|7307936|FG000|COMPLETED|Overall Study||15
6395346|NCT00857948|7307937|FG001|COMPLETED|Overall Study||18
6395347|NCT00857948|7307938|FG002|COMPLETED|Overall Study||18
6395348|NCT00857948|7307939|FG003|COMPLETED|Overall Study||23
6395349|NCT00857948|7307936|FG000|NOT COMPLETED|Overall Study||3
6395350|NCT00857948|7307937|FG001|NOT COMPLETED|Overall Study||0
6395351|NCT00857948|7307938|FG002|NOT COMPLETED|Overall Study||1
6395352|NCT00857948|7307939|FG003|NOT COMPLETED|Overall Study||0
6395353|NCT00857961|7307949|FG000|STARTED|Overall Study||21
6395354|NCT00857961|7307949|FG000|COMPLETED|Overall Study||21
6395355|NCT00857961|7307949|FG000|NOT COMPLETED|Overall Study||0
6395356|NCT00858013|7307961|FG000|STARTED|Overall Study||46
6395357|NCT00858013|7307962|FG001|STARTED|Overall Study||42
6395358|NCT00858013|7307961|FG000|COMPLETED|Overall Study||24
6395359|NCT00858013|7307962|FG001|COMPLETED|Overall Study||23
6395360|NCT00858013|7307961|FG000|NOT COMPLETED|Overall Study||22
6395361|NCT00858013|7307962|FG001|NOT COMPLETED|Overall Study||19
6395362|NCT00858117|7307968|FG000|STARTED|Treatment on Study||30
6395363|NCT00858117|7307968|FG000|Completed 18 Weeks of Treatment|Treatment on Study||28
6395364|NCT00858117|7307968|FG000|COMPLETED|Treatment on Study||28
6395365|NCT00858117|7307968|FG000|NOT COMPLETED|Treatment on Study||2
6395366|NCT00858117|7307968|FG000|STARTED|Follow up for 5 Years|All patients who receive at least one dose of drug under the protocol go into follow up for survival|30
6395367|NCT00858117|7307968|FG000|COMPLETED|Follow up for 5 Years||17
6395368|NCT00858117|7307968|FG000|NOT COMPLETED|Follow up for 5 Years||13
6395369|NCT00858130|7307972|FG000|STARTED|Overall Study||12
6395370|NCT00858130|7307972|FG000|COMPLETED|Overall Study||12
6395371|NCT00858130|7307972|FG000|NOT COMPLETED|Overall Study||0
6395372|NCT00858143|7307977|FG000|STARTED|Overall Study|Baseline|311
6395373|NCT00858143|7307977|FG000|COMPLETED|Overall Study||261
6395374|NCT00858143|7307977|FG000|NOT COMPLETED|Overall Study||50
6395375|NCT00858208|7307981|FG000|STARTED|Overall Study||85
6395376|NCT00858208|7307981|FG000|COMPLETED|Overall Study||6
6395377|NCT00858208|7307981|FG000|NOT COMPLETED|Overall Study||79
6395378|NCT00858234|7307985|FG000|STARTED|Overall Study||9
6395379|NCT00858234|7307985|FG000|COMPLETED|Overall Study||0
6395380|NCT00858234|7307985|FG000|NOT COMPLETED|Overall Study||9
6395381|NCT00858247|7307991|FG000|STARTED|Baseline Assessment||25
6395382|NCT00858247|7307992|FG001|STARTED|Baseline Assessment||26
6395383|NCT00858247|7307991|FG000|COMPLETED|Baseline Assessment||23
6395384|NCT00858247|7307992|FG001|COMPLETED|Baseline Assessment||24
6395385|NCT00858247|7307991|FG000|NOT COMPLETED|Baseline Assessment||2
6395386|NCT00858247|7307992|FG001|NOT COMPLETED|Baseline Assessment||2
6395387|NCT00858247|7307991|FG000|STARTED|Week 12 Follow-up||23
6395388|NCT00858247|7307992|FG001|STARTED|Week 12 Follow-up||24
6395389|NCT00858247|7307991|FG000|COMPLETED|Week 12 Follow-up||23
6395390|NCT00858247|7307992|FG001|COMPLETED|Week 12 Follow-up||23
6395391|NCT00858247|7307991|FG000|NOT COMPLETED|Week 12 Follow-up||0
6395392|NCT00858247|7307992|FG001|NOT COMPLETED|Week 12 Follow-up||1
6395393|NCT00858364|7308000|FG000|STARTED|Overall Study||846
6395394|NCT00858364|7308001|FG001|STARTED|Overall Study||1703
6395395|NCT00858364|7308000|FG000|Received Study Drug|Overall Study||837
6395396|NCT00858364|7308001|FG001|Received Study Drug|Overall Study||1681
6395397|NCT00858364|7308000|FG000|COMPLETED|Overall Study||642
6395398|NCT00858364|7308001|FG001|COMPLETED|Overall Study||1246
6395399|NCT00858364|7308000|FG000|NOT COMPLETED|Overall Study||204
6395400|NCT00858364|7308001|FG001|NOT COMPLETED|Overall Study||457
6395401|NCT00858390|7308009|FG000|STARTED|Overall Study||18
6395402|NCT00858390|7308010|FG001|STARTED|Overall Study||18
6395403|NCT00858390|7308009|FG000|COMPLETED|Overall Study||18
6395404|NCT00858390|7308010|FG001|COMPLETED|Overall Study||18
6395405|NCT00858390|7308009|FG000|NOT COMPLETED|Overall Study||0
6395406|NCT00858390|7308010|FG001|NOT COMPLETED|Overall Study||0
6395407|NCT00858403|7308016|FG000|STARTED|Overall Study||7
6395408|NCT00858403|7308016|FG000|COMPLETED|Overall Study||2
6395409|NCT00858403|7308016|FG000|NOT COMPLETED|Overall Study||5
6395410|NCT00858442|7308022|FG000|STARTED|From Surgery to Start Compression;||21
6395411|NCT00858442|7308023|FG001|STARTED|From Surgery to Start Compression;||23
6395412|NCT00858442|7308022|FG000|COMPLETED|From Surgery to Start Compression;||21
6395413|NCT00858442|7308023|FG001|COMPLETED|From Surgery to Start Compression;||23
6395414|NCT00858442|7308022|FG000|NOT COMPLETED|From Surgery to Start Compression;||0
6395415|NCT00858442|7308023|FG001|NOT COMPLETED|From Surgery to Start Compression;||0
6395416|NCT00858442|7308022|FG000|STARTED|Compression:Start to Finish||21
6395417|NCT00858442|7308023|FG001|STARTED|Compression:Start to Finish||23
6395418|NCT00858442|7308022|FG000|COMPLETED|Compression:Start to Finish||20
6395419|NCT00858442|7308023|FG001|COMPLETED|Compression:Start to Finish||20
6395420|NCT00858442|7308022|FG000|NOT COMPLETED|Compression:Start to Finish||1
6395421|NCT00858442|7308023|FG001|NOT COMPLETED|Compression:Start to Finish||3
6395422|NCT00858468|7308032|FG000|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
6395423|NCT00858468|7308033|FG001|STARTED|Overall Study||192
6395424|NCT00858468|7308032|FG000|COMPLETED|Overall Study||201
6395425|NCT00858468|7308033|FG001|COMPLETED|Overall Study||192
6395426|NCT00858468|7308032|FG000|NOT COMPLETED|Overall Study||0
6395427|NCT00858468|7308033|FG001|NOT COMPLETED|Overall Study||0
6395428|NCT00858494|7308039|FG000|STARTED|Overall Study||49
6395429|NCT00858494|7308039|FG000|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
6395430|NCT00858494|7308039|FG000|NOT COMPLETED|Overall Study||4
6395431|NCT00858507|7308045|FG000|STARTED|Overall Study||105
6395432|NCT00858507|7308046|FG001|STARTED|Overall Study||116
6395433|NCT00858507|7308045|FG000|COMPLETED|Overall Study||83
6395434|NCT00858507|7308046|FG001|COMPLETED|Overall Study||101
6395435|NCT00858507|7308045|FG000|NOT COMPLETED|Overall Study||22
6395436|NCT00858507|7308046|FG001|NOT COMPLETED|Overall Study||15
6395437|NCT00858637|7308054|FG000|STARTED|Active Comparison Phase||127
6395438|NCT00858637|7308055|FG001|STARTED|Active Comparison Phase||0
6395439|NCT00858637|7308056|FG002|STARTED|Active Comparison Phase||0
6395440|NCT00858637|7308057|FG003|STARTED|Active Comparison Phase||133
6395441|NCT00858637|7308058|FG004|STARTED|Active Comparison Phase||0
6395442|NCT00858637|7308059|FG005|STARTED|Active Comparison Phase||0
6395443|NCT00858637|7308054|FG000|COMPLETED|Active Comparison Phase||103
6395444|NCT00858637|7308055|FG001|COMPLETED|Active Comparison Phase||0
6395445|NCT00858637|7308056|FG002|COMPLETED|Active Comparison Phase||0
6395446|NCT00858637|7308057|FG003|COMPLETED|Active Comparison Phase||115
6395447|NCT00858637|7308058|FG004|COMPLETED|Active Comparison Phase||0
6395448|NCT00858637|7308059|FG005|COMPLETED|Active Comparison Phase||0
6395449|NCT00858637|7308054|FG000|NOT COMPLETED|Active Comparison Phase||24
6395450|NCT00858637|7308055|FG001|NOT COMPLETED|Active Comparison Phase||0
6395451|NCT00858637|7308056|FG002|NOT COMPLETED|Active Comparison Phase||0
6395452|NCT00858637|7308057|FG003|NOT COMPLETED|Active Comparison Phase||18
6395453|NCT00858637|7308058|FG004|NOT COMPLETED|Active Comparison Phase||0
6395454|NCT00858637|7308059|FG005|NOT COMPLETED|Active Comparison Phase||0
6395455|NCT00858637|7308054|FG000|STARTED|Placebo-controlled Withdrawal Phase||0
6395456|NCT00858637|7308055|FG001|STARTED|Placebo-controlled Withdrawal Phase||49
6395457|NCT00858637|7308056|FG002|STARTED|Placebo-controlled Withdrawal Phase||54
6395458|NCT00858637|7308057|FG003|STARTED|Placebo-controlled Withdrawal Phase||0
6395459|NCT00858637|7308058|FG004|STARTED|Placebo-controlled Withdrawal Phase||56
6395460|NCT00858637|7308059|FG005|STARTED|Placebo-controlled Withdrawal Phase||59
6395461|NCT00858637|7308054|FG000|COMPLETED|Placebo-controlled Withdrawal Phase||0
6395462|NCT00858637|7308055|FG001|COMPLETED|Placebo-controlled Withdrawal Phase||49
6395463|NCT00858637|7308056|FG002|COMPLETED|Placebo-controlled Withdrawal Phase||53
6395464|NCT00858637|7308057|FG003|COMPLETED|Placebo-controlled Withdrawal Phase||0
6395465|NCT00858637|7308058|FG004|COMPLETED|Placebo-controlled Withdrawal Phase||55
6395466|NCT00858637|7308059|FG005|COMPLETED|Placebo-controlled Withdrawal Phase||58
6395467|NCT00858637|7308054|FG000|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
6395468|NCT00858637|7308055|FG001|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
6395469|NCT00858637|7308056|FG002|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
6395470|NCT00858637|7308057|FG003|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
6395471|NCT00858637|7308058|FG004|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
6395472|NCT00858637|7308059|FG005|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
6395473|NCT00858689|7308069|FG000|STARTED|Overall Study||20
6395474|NCT00858689|7308069|FG000|COMPLETED|Overall Study||19
6395475|NCT00858689|7308069|FG000|NOT COMPLETED|Overall Study||1
6395476|NCT00858780|7308073|FG000|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
6395477|NCT00858780|7308074|FG001|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395478|NCT00858780|7308075|FG002|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395479|NCT00858780|7308076|FG003|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395480|NCT00858780|7308077|FG004|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395481|NCT00858780|7308073|FG000|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
6395482|NCT00858780|7308074|FG001|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395483|NCT00858780|7308075|FG002|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395484|NCT00858780|7308076|FG003|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395485|NCT00858780|7308077|FG004|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395486|NCT00858780|7308073|FG000|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
6395487|NCT00858780|7308074|FG001|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395488|NCT00858780|7308075|FG002|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395489|NCT00858780|7308076|FG003|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395490|NCT00858780|7308077|FG004|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
6395491|NCT00858780|7308073|FG000|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
6395492|NCT00858780|7308074|FG001|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
6395493|NCT00858780|7308075|FG002|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
6395494|NCT00858780|7308076|FG003|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
6395495|NCT00858780|7308077|FG004|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
6395496|NCT00858780|7308073|FG000|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
6395497|NCT00858780|7308074|FG001|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
6395498|NCT00858780|7308075|FG002|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
6395499|NCT00858780|7308076|FG003|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
6395500|NCT00858780|7308077|FG004|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
6395501|NCT00858780|7308073|FG000|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
6395502|NCT00858780|7308074|FG001|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
6395503|NCT00858780|7308075|FG002|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
6395504|NCT00858780|7308076|FG003|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
6395505|NCT00858780|7308077|FG004|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
6395506|NCT00858780|7308073|FG000|STARTED|OL Re-Treatment (Failure to Week 48)||0
6395507|NCT00858780|7308074|FG001|STARTED|OL Re-Treatment (Failure to Week 48)||0
6395508|NCT00858780|7308075|FG002|STARTED|OL Re-Treatment (Failure to Week 48)||0
6395509|NCT00858780|7308076|FG003|STARTED|OL Re-Treatment (Failure to Week 48)||0
6395510|NCT00858780|7308077|FG004|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
6395511|NCT00858780|7308073|FG000|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6395512|NCT00858780|7308074|FG001|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6395513|NCT00858780|7308075|FG002|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6395514|NCT00858780|7308076|FG003|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6395515|NCT00858780|7308077|FG004|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
6395516|NCT00858780|7308073|FG000|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6395517|NCT00858780|7308074|FG001|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6395518|NCT00858780|7308075|FG002|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6395519|NCT00858780|7308076|FG003|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
6395520|NCT00858780|7308077|FG004|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
6395521|NCT00858832|7308089|FG000|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
6395522|NCT00858832|7308090|FG001|STARTED|Overall Study||23
6603650|NCT02060526|7528199|FG002|NOT COMPLETED|Overall Study||0
6603651|NCT02060539|7528209|FG000|STARTED|Overall Study||19
6603652|NCT02060539|7528209|FG000|COMPLETED|Overall Study||19
6603653|NCT02060539|7528209|FG000|NOT COMPLETED|Overall Study||0
6603654|NCT02060838|7528215|FG000|STARTED|Overall Study||28
6603655|NCT02060838|7528216|FG001|STARTED|Overall Study||22
6603656|NCT02060838|7528215|FG000|COMPLETED|Overall Study||28
6603657|NCT02060838|7528216|FG001|COMPLETED|Overall Study||22
6603658|NCT02060838|7528215|FG000|NOT COMPLETED|Overall Study||0
6603659|NCT02060838|7528216|FG001|NOT COMPLETED|Overall Study||0
6603660|NCT02060890|7528222|FG000|STARTED|Overall Study||20
6603661|NCT02060890|7528222|FG000|COMPLETED|Overall Study||16
6603662|NCT02060890|7528222|FG000|NOT COMPLETED|Overall Study||4
6603663|NCT02060903|7528229|FG000|STARTED|Overall Study||187
6603664|NCT02060903|7528230|FG001|STARTED|Overall Study||192
6603665|NCT02060903|7528229|FG000|COMPLETED|Overall Study||183
6603666|NCT02060903|7528230|FG001|COMPLETED|Overall Study||185
6603667|NCT02060903|7528229|FG000|NOT COMPLETED|Overall Study||4
6603668|NCT02060903|7528230|FG001|NOT COMPLETED|Overall Study||7
6603669|NCT02061202|7528238|FG000|STARTED|Overall Study||36
6603670|NCT02061202|7528239|FG001|STARTED|Overall Study||18
6603671|NCT02061202|7528238|FG000|COMPLETED|Overall Study||35
6603672|NCT02061202|7528239|FG001|COMPLETED|Overall Study||17
6603673|NCT02061202|7528238|FG000|NOT COMPLETED|Overall Study||1
6603674|NCT02061202|7528239|FG001|NOT COMPLETED|Overall Study||1
6603675|NCT02061280|7528247|FG000|STARTED|Overall Study||71
6603676|NCT02061280|7528248|FG001|STARTED|Overall Study||37
6603677|NCT02061280|7528247|FG000|Randomized to Treatment|Overall Study||54
6603678|NCT02061280|7528248|FG001|Randomized to Treatment|Overall Study||25
6603679|NCT02061280|7528247|FG000|COMPLETED|Overall Study||53
6603680|NCT02061280|7528248|FG001|COMPLETED|Overall Study||25
6603681|NCT02061280|7528247|FG000|NOT COMPLETED|Overall Study||18
6603682|NCT02061280|7528248|FG001|NOT COMPLETED|Overall Study||12
6603683|NCT02061358|7528266|FG000|STARTED|Overall Study||6
6603684|NCT02061358|7528267|FG001|STARTED|Overall Study||6
6603685|NCT02061358|7528268|FG002|STARTED|Overall Study||6
6603686|NCT02061358|7528269|FG003|STARTED|Overall Study||6
6603687|NCT02061358|7528270|FG004|STARTED|Overall Study||6
6603688|NCT02061358|7528271|FG005|STARTED|Overall Study||6
6603689|NCT02061358|7528272|FG006|STARTED|Overall Study||6
6603690|NCT02061358|7528273|FG007|STARTED|Overall Study||6
6603691|NCT02061358|7528274|FG008|STARTED|Overall Study||16
6603692|NCT02061358|7528266|FG000|COMPLETED|Overall Study||6
6603693|NCT02061358|7528267|FG001|COMPLETED|Overall Study||6
6603694|NCT02061358|7528268|FG002|COMPLETED|Overall Study||6
6603695|NCT02061358|7528269|FG003|COMPLETED|Overall Study||6
6603696|NCT02061358|7528270|FG004|COMPLETED|Overall Study||6
6603697|NCT02061358|7528271|FG005|COMPLETED|Overall Study||6
6603698|NCT02061358|7528272|FG006|COMPLETED|Overall Study||6
6603699|NCT02061358|7528273|FG007|COMPLETED|Overall Study||6
6603700|NCT02061358|7528274|FG008|COMPLETED|Overall Study||16
6603701|NCT02061358|7528266|FG000|NOT COMPLETED|Overall Study||0
6603702|NCT02061358|7528267|FG001|NOT COMPLETED|Overall Study||0
6603703|NCT02061358|7528268|FG002|NOT COMPLETED|Overall Study||0
6603704|NCT02061358|7528269|FG003|NOT COMPLETED|Overall Study||0
6603705|NCT02061358|7528270|FG004|NOT COMPLETED|Overall Study||0
6603706|NCT02061358|7528271|FG005|NOT COMPLETED|Overall Study||0
6603707|NCT02061358|7528272|FG006|NOT COMPLETED|Overall Study||0
6603708|NCT02061358|7528273|FG007|NOT COMPLETED|Overall Study||0
6603709|NCT02061358|7528274|FG008|NOT COMPLETED|Overall Study||0
6603710|NCT02061384|7528296|FG000|STARTED|Overall Study||10
6603711|NCT02061384|7528297|FG001|STARTED|Overall Study||10
6603712|NCT02061384|7528296|FG000|COMPLETED|Overall Study||10
6603713|NCT02061384|7528297|FG001|COMPLETED|Overall Study||10
6603714|NCT02061384|7528296|FG000|NOT COMPLETED|Overall Study||0
6603715|NCT02061384|7528297|FG001|NOT COMPLETED|Overall Study||0
6603716|NCT02061397|7528303|FG000|STARTED|Simvastatin 20 mg Oral Daily for 2 Month||10
6603717|NCT02061397|7528303|FG000|COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||10
6603718|NCT02061397|7528303|FG000|NOT COMPLETED|Simvastatin 20 mg Oral Daily for 2 Month||0
6603719|NCT02061397|7528303|FG000|STARTED|Simvastatin 40 mg Oral Daily for 2 Month||10
6603720|NCT02061397|7528303|FG000|COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||10
6603721|NCT02061397|7528303|FG000|NOT COMPLETED|Simvastatin 40 mg Oral Daily for 2 Month||0
6603722|NCT02061540|7528307|FG000|STARTED|Overall Study||27
6603723|NCT02061540|7528307|FG000|Down-Titrated on LUM001 During the Study|Overall Study||5
6603724|NCT02061540|7528307|FG000|COMPLETED|Overall Study||23
6603725|NCT02061540|7528307|FG000|NOT COMPLETED|Overall Study||4
6603726|NCT02061592|7528318|FG000|STARTED|Period 1||66
6603727|NCT02061592|7528319|FG001|STARTED|Period 1||62
6603728|NCT02061592|7528318|FG000|COMPLETED|Period 1||64
6603729|NCT02061592|7528319|FG001|COMPLETED|Period 1||62
6603730|NCT02061592|7528318|FG000|NOT COMPLETED|Period 1||2
6603731|NCT02061592|7528319|FG001|NOT COMPLETED|Period 1||0
6603732|NCT02061592|7528318|FG000|STARTED|Period 2||64
6603733|NCT02061592|7528319|FG001|STARTED|Period 2||62
6603734|NCT02061592|7528318|FG000|COMPLETED|Period 2||64
6603735|NCT02061592|7528319|FG001|COMPLETED|Period 2||61
6603736|NCT02061592|7528318|FG000|NOT COMPLETED|Period 2||0
6603737|NCT02061592|7528319|FG001|NOT COMPLETED|Period 2||1
6603738|NCT02061683|7528327|FG000|STARTED|Overall Study||263
6603739|NCT02061683|7528327|FG000|COMPLETED|Overall Study||203
6603740|NCT02061683|7528327|FG000|NOT COMPLETED|Overall Study||60
6603741|NCT02061696|7528333|FG000|STARTED|Overall Study||17
6603742|NCT02061696|7528334|FG001|STARTED|Overall Study||22
6603743|NCT02061696|7528333|FG000|COMPLETED|Overall Study||17
6603744|NCT02061696|7528334|FG001|COMPLETED|Overall Study||22
6603745|NCT02061696|7528333|FG000|NOT COMPLETED|Overall Study||0
6603746|NCT02061696|7528334|FG001|NOT COMPLETED|Overall Study||0
6603747|NCT02061748|7528342|FG000|STARTED|Overall Study||7646
6603748|NCT02061748|7528343|FG001|STARTED|Overall Study||30853
6603749|NCT02061748|7528342|FG000|COMPLETED|Overall Study||7646
6603750|NCT02061748|7528343|FG001|COMPLETED|Overall Study||30853
6603751|NCT02061748|7528342|FG000|NOT COMPLETED|Overall Study||0
6603752|NCT02061748|7528343|FG001|NOT COMPLETED|Overall Study||0
6603753|NCT02061774|7528351|FG000|STARTED|Overall Study||10
6603754|NCT02061774|7528352|FG001|STARTED|Overall Study||11
6603755|NCT02061774|7528351|FG000|COMPLETED|Overall Study||10
6603756|NCT02061774|7528352|FG001|COMPLETED|Overall Study||11
6603757|NCT02061774|7528351|FG000|NOT COMPLETED|Overall Study||0
6603758|NCT02061774|7528352|FG001|NOT COMPLETED|Overall Study||0
6603759|NCT02061813|7528358|FG000|STARTED|Overall Study||40
6603760|NCT02061813|7528358|FG000|Abametapir Lotion|Overall Study||40
6603761|NCT02061813|7528358|FG000|Vehicle Lotion|Overall Study||40
6603762|NCT02061813|7528358|FG000|Saline 0.9%|Overall Study||40
6603763|NCT02061813|7528358|FG000|SLS 0.2%|Overall Study||40
6603764|NCT02061813|7528358|FG000|COMPLETED|Overall Study||37
6603765|NCT02061813|7528358|FG000|NOT COMPLETED|Overall Study||3
6603766|NCT02061969|7528367|FG000|STARTED|Overall Study||73
6603767|NCT02061969|7528368|FG001|STARTED|Overall Study||67
6603768|NCT02061969|7528367|FG000|COMPLETED|Overall Study||73
6603769|NCT02061969|7528368|FG001|COMPLETED|Overall Study||67
6603770|NCT02061969|7528367|FG000|NOT COMPLETED|Overall Study||0
6603771|NCT02061969|7528368|FG001|NOT COMPLETED|Overall Study||0
6603772|NCT02062008|7528374|FG000|STARTED|Overall Study||2
6603773|NCT02062008|7528374|FG000|COMPLETED|Overall Study||2
6603774|NCT02062008|7528374|FG000|NOT COMPLETED|Overall Study||0
6603775|NCT02062151|7528378|FG000|STARTED|Overall Study||21
6603776|NCT02062151|7528378|FG000|COMPLETED|Overall Study||20
6603777|NCT02062151|7528378|FG000|NOT COMPLETED|Overall Study||1
6603778|NCT02062177|7528384|FG000|STARTED|Overall Study||70
6603779|NCT02062177|7528385|FG001|STARTED|Overall Study||70
6603780|NCT02062177|7528384|FG000|COMPLETED|Overall Study||70
6603781|NCT02062177|7528385|FG001|COMPLETED|Overall Study||70
6603782|NCT02062177|7528384|FG000|NOT COMPLETED|Overall Study||0
6603783|NCT02062177|7528385|FG001|NOT COMPLETED|Overall Study||0
6603784|NCT02062294|7528391|FG000|STARTED|Overall Study||14
6603785|NCT02062294|7528391|FG000|COMPLETED|Overall Study||14
6603786|NCT02062294|7528391|FG000|NOT COMPLETED|Overall Study||0
6603787|NCT02062359|7528395|FG000|STARTED|Overall Study||2
6603788|NCT02062359|7528395|FG000|COMPLETED|Overall Study||2
6603789|NCT02062359|7528395|FG000|NOT COMPLETED|Overall Study||0
6603790|NCT02062385|7528403|FG000|STARTED|Overall Study||1620
6603791|NCT02062385|7528404|FG001|STARTED|Overall Study||1620
6603792|NCT02062385|7528405|FG002|STARTED|Overall Study||400
6603793|NCT02062385|7528406|FG003|STARTED|Overall Study||400
6603794|NCT02062385|7528403|FG000|Received Vaccination 1|Overall Study||1618
6603795|NCT02062385|7528404|FG001|Received Vaccination 1|Overall Study||1619
6603796|NCT02062385|7528405|FG002|Received Vaccination 1|Overall Study||400
6603797|NCT02062385|7528406|FG003|Received Vaccination 1|Overall Study||400
6603798|NCT02062385|7528403|FG000|Received Vaccination 2|Overall Study||1554
6603799|NCT02062385|7528404|FG001|Received Vaccination 2|Overall Study||1566
6603800|NCT02062385|7528405|FG002|Received Vaccination 2|Overall Study||392
6603801|NCT02062385|7528406|FG003|Received Vaccination 2|Overall Study||393
6603802|NCT02062385|7528403|FG000|Received Vaccination 3|Overall Study||1543
6603803|NCT02062385|7528404|FG001|Received Vaccination 3|Overall Study||1554
6603804|NCT02062385|7528405|FG002|Received Vaccination 3|Overall Study||389
6603805|NCT02062385|7528406|FG003|Received Vaccination 3|Overall Study||392
6603806|NCT02062385|7528403|FG000|COMPLETED|Overall Study||1542
6603807|NCT02062385|7528404|FG001|COMPLETED|Overall Study||1555
6603808|NCT02062385|7528405|FG002|COMPLETED|Overall Study||388
6603809|NCT02062385|7528406|FG003|COMPLETED|Overall Study||391
6603810|NCT02062385|7528403|FG000|NOT COMPLETED|Overall Study||78
6603811|NCT02062385|7528404|FG001|NOT COMPLETED|Overall Study||65
6603812|NCT02062385|7528405|FG002|NOT COMPLETED|Overall Study||12
6603813|NCT02062385|7528406|FG003|NOT COMPLETED|Overall Study||9
6603814|NCT02062398|7528414|FG000|STARTED|Overall Study||13
6603815|NCT02062398|7528414|FG000|COMPLETED|Overall Study||12
6603816|NCT02062398|7528414|FG000|NOT COMPLETED|Overall Study||1
6603817|NCT02062437|7528418|FG000|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
6625191|NCT02223390|7552808|FG000|NOT COMPLETED|Overall Study||9
6603818|NCT02062437|7528418|FG000|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
6603819|NCT02062437|7528418|FG000|NOT COMPLETED|Overall Study||52
6603820|NCT02062450|7528424|FG000|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
6603821|NCT02062450|7528424|FG000|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
6603822|NCT02062450|7528424|FG000|COMPLETED|Overall Study||255
6603823|NCT02062450|7528424|FG000|NOT COMPLETED|Overall Study||124
6603824|NCT02062502|7528434|FG000|STARTED|Overall Study||306
6603825|NCT02062502|7528435|FG001|STARTED|Overall Study||305
6603826|NCT02062502|7528434|FG000|Vaccinated Dose 1|Overall Study||306
6603827|NCT02062502|7528435|FG001|Vaccinated Dose 1|Overall Study||305
6603828|NCT02062502|7528434|FG000|COMPLETED|Overall Study||263
6603829|NCT02062502|7528435|FG001|COMPLETED|Overall Study||270
6603830|NCT02062502|7528434|FG000|NOT COMPLETED|Overall Study||43
6603831|NCT02062502|7528435|FG001|NOT COMPLETED|Overall Study||35
6603832|NCT02062580|7528443|FG000|STARTED|Overall Study||71
6603833|NCT02062580|7528444|FG001|STARTED|Overall Study||78
6603834|NCT02062580|7528443|FG000|COMPLETED|Overall Study||59
6603835|NCT02062580|7528444|FG001|COMPLETED|Overall Study||65
6603836|NCT02062580|7528443|FG000|NOT COMPLETED|Overall Study||12
6603837|NCT02062580|7528444|FG001|NOT COMPLETED|Overall Study||13
6603838|NCT02062593|7528452|FG000|STARTED|Overall Study||105
6603839|NCT02062593|7528453|FG001|STARTED|Overall Study||95
6603840|NCT02062593|7528452|FG000|COMPLETED|Overall Study||105
6603841|NCT02062593|7528453|FG001|COMPLETED|Overall Study||91
6603842|NCT02062593|7528452|FG000|NOT COMPLETED|Overall Study||0
6603843|NCT02062593|7528453|FG001|NOT COMPLETED|Overall Study||4
6603844|NCT02062606|7528459|FG000|STARTED|Overall Study||188
6603845|NCT02062606|7528459|FG000|COMPLETED|Overall Study||99
6603846|NCT02062606|7528459|FG000|NOT COMPLETED|Overall Study||89
6603847|NCT02062632|7528492|FG000|STARTED|Overall Study||3
6603848|NCT02062632|7528492|FG000|COMPLETED|Overall Study||2
6603849|NCT02062632|7528492|FG000|NOT COMPLETED|Overall Study||1
6603850|NCT02062645|7528496|FG000|STARTED|Overall Study||115
6603851|NCT02062645|7528496|FG000|COMPLETED|Overall Study||100
6603852|NCT02062645|7528496|FG000|NOT COMPLETED|Overall Study||15
6603853|NCT02062658|7528500|FG000|STARTED|Overall Study||10
6603854|NCT02062658|7528500|FG000|COMPLETED|Overall Study||8
6603855|NCT02062658|7528500|FG000|NOT COMPLETED|Overall Study||2
6603856|NCT02062710|7528504|FG000|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
6603857|NCT02062710|7528505|FG001|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
6603858|NCT02062710|7528506|FG002|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
6603859|NCT02062710|7528507|FG003|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
6603860|NCT02062710|7528508|FG004|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
6603861|NCT02062710|7528509|FG005|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
6603862|NCT02062710|7528504|FG000|COMPLETED|Overall Study||3
6603863|NCT02062710|7528505|FG001|COMPLETED|Overall Study||4
6603864|NCT02062710|7528506|FG002|COMPLETED|Overall Study||5
6603865|NCT02062710|7528507|FG003|COMPLETED|Overall Study||3
6603866|NCT02062710|7528508|FG004|COMPLETED|Overall Study||3
6603867|NCT02062710|7528509|FG005|COMPLETED|Overall Study||4
6603868|NCT02062710|7528504|FG000|NOT COMPLETED|Overall Study||0
6603869|NCT02062710|7528505|FG001|NOT COMPLETED|Overall Study||0
6603870|NCT02062710|7528506|FG002|NOT COMPLETED|Overall Study||0
6603871|NCT02062710|7528507|FG003|NOT COMPLETED|Overall Study||0
6603872|NCT02062710|7528508|FG004|NOT COMPLETED|Overall Study||0
6603873|NCT02062710|7528509|FG005|NOT COMPLETED|Overall Study||0
6603874|NCT02062801|7528519|FG000|STARTED|Overall Study||301
6603875|NCT02062801|7528520|FG001|STARTED|Overall Study||301
6603876|NCT02062801|7528519|FG000|COMPLETED|Overall Study||299
6603877|NCT02062801|7528520|FG001|COMPLETED|Overall Study||297
6603878|NCT02062801|7528519|FG000|NOT COMPLETED|Overall Study||2
6603879|NCT02062801|7528520|FG001|NOT COMPLETED|Overall Study||4
6603880|NCT02062879|7528528|FG000|STARTED|Overall Study||10
6603881|NCT02062879|7528529|FG001|STARTED|Overall Study||10
6603882|NCT02062879|7528528|FG000|COMPLETED|Overall Study||6
6603883|NCT02062879|7528529|FG001|COMPLETED|Overall Study||9
6603884|NCT02062879|7528528|FG000|NOT COMPLETED|Overall Study||4
6603885|NCT02062879|7528529|FG001|NOT COMPLETED|Overall Study||1
6603886|NCT02062905|7528537|FG000|STARTED|Overall Study||35
6603887|NCT02062905|7528538|FG001|STARTED|Overall Study||33
6603888|NCT02062905|7528537|FG000|COMPLETED|Overall Study||28
6603889|NCT02062905|7528538|FG001|COMPLETED|Overall Study||31
6603890|NCT02062905|7528537|FG000|NOT COMPLETED|Overall Study||7
6603891|NCT02062905|7528538|FG001|NOT COMPLETED|Overall Study||2
6603892|NCT02063035|7528546|FG000|STARTED|Overall Study||12
6603893|NCT02063035|7528547|FG001|STARTED|Overall Study||17
6603894|NCT02063035|7528546|FG000|COMPLETED|Overall Study||12
6603895|NCT02063035|7528547|FG001|COMPLETED|Overall Study||17
6603896|NCT02063035|7528546|FG000|NOT COMPLETED|Overall Study||0
6603897|NCT02063035|7528547|FG001|NOT COMPLETED|Overall Study||0
6603898|NCT02063087|7528555|FG000|STARTED|Emergency Department Intervention||493
6603899|NCT02063087|7528556|FG001|STARTED|Emergency Department Intervention||478
6603900|NCT02063087|7528555|FG000|COMPLETED|Emergency Department Intervention||493
6603901|NCT02063087|7528556|FG001|COMPLETED|Emergency Department Intervention||478
6603902|NCT02063087|7528555|FG000|NOT COMPLETED|Emergency Department Intervention||0
6603903|NCT02063087|7528556|FG001|NOT COMPLETED|Emergency Department Intervention||0
6603904|NCT02063087|7528555|FG000|STARTED|7 Day Follow-up||493
6603905|NCT02063087|7528556|FG001|STARTED|7 Day Follow-up||478
6603906|NCT02063087|7528555|FG000|COMPLETED|7 Day Follow-up||493
6603907|NCT02063087|7528556|FG001|COMPLETED|7 Day Follow-up||478
6603908|NCT02063087|7528555|FG000|NOT COMPLETED|7 Day Follow-up||0
6603909|NCT02063087|7528556|FG001|NOT COMPLETED|7 Day Follow-up||0
6603910|NCT02063178|7528564|FG000|STARTED|Overall Study||124
6603911|NCT02063178|7528565|FG001|STARTED|Overall Study||124
6603912|NCT02063178|7528564|FG000|COMPLETED|Overall Study||95
6603913|NCT02063178|7528565|FG001|COMPLETED|Overall Study||77
6603914|NCT02063178|7528564|FG000|NOT COMPLETED|Overall Study||29
6603915|NCT02063178|7528565|FG001|NOT COMPLETED|Overall Study||47
6603916|NCT02063217|7528578|FG000|STARTED|Overall Study||12
6603917|NCT02063217|7528579|FG001|STARTED|Overall Study||12
6603918|NCT02063217|7528580|FG002|STARTED|Overall Study||12
6603919|NCT02063217|7528578|FG000|COMPLETED|Overall Study||11
6603920|NCT02063217|7528579|FG001|COMPLETED|Overall Study||12
6603921|NCT02063217|7528580|FG002|COMPLETED|Overall Study||12
6603922|NCT02063217|7528578|FG000|NOT COMPLETED|Overall Study||1
6603923|NCT02063217|7528579|FG001|NOT COMPLETED|Overall Study||0
6603924|NCT02063217|7528580|FG002|NOT COMPLETED|Overall Study||0
6603925|NCT02063230|7528592|FG000|STARTED|Overall Study||8
6603926|NCT02063230|7528593|FG001|STARTED|Overall Study||8
6603927|NCT02063230|7528594|FG002|STARTED|Overall Study||8
6603928|NCT02063230|7528595|FG003|STARTED|Overall Study||8
6603929|NCT02063230|7528592|FG000|Received Treatment|Overall Study||8
6603930|NCT02063230|7528593|FG001|Received Treatment|Overall Study||8
6603931|NCT02063230|7528594|FG002|Received Treatment|Overall Study||8
6603932|NCT02063230|7528595|FG003|Received Treatment|Overall Study||8
6603933|NCT02063230|7528592|FG000|COMPLETED|Overall Study||8
6603934|NCT02063230|7528593|FG001|COMPLETED|Overall Study||8
6603935|NCT02063230|7528594|FG002|COMPLETED|Overall Study||8
6603936|NCT02063230|7528595|FG003|COMPLETED|Overall Study||8
6603937|NCT02063230|7528592|FG000|NOT COMPLETED|Overall Study||0
6603938|NCT02063230|7528593|FG001|NOT COMPLETED|Overall Study||0
6603939|NCT02063230|7528594|FG002|NOT COMPLETED|Overall Study||0
6603940|NCT02063230|7528595|FG003|NOT COMPLETED|Overall Study||0
6603941|NCT02063516|7528607|FG000|STARTED|Overall Study||40
6603942|NCT02063516|7528608|FG001|STARTED|Overall Study||40
6603943|NCT02063516|7528607|FG000|COMPLETED|Overall Study||40
6603944|NCT02063516|7528608|FG001|COMPLETED|Overall Study||40
6603945|NCT02063516|7528607|FG000|NOT COMPLETED|Overall Study||0
6603946|NCT02063516|7528608|FG001|NOT COMPLETED|Overall Study||0
6603947|NCT02063659|7528617|FG000|STARTED|Double-Blind Treatment Period||26
6603948|NCT02063659|7528618|FG001|STARTED|Double-Blind Treatment Period||25
6603949|NCT02063659|7528619|FG002|STARTED|Double-Blind Treatment Period||25
6603950|NCT02063659|7528620|FG003|STARTED|Double-Blind Treatment Period||0
6603951|NCT02063659|7528617|FG000|COMPLETED|Double-Blind Treatment Period||24
6603952|NCT02063659|7528618|FG001|COMPLETED|Double-Blind Treatment Period||22
6603953|NCT02063659|7528619|FG002|COMPLETED|Double-Blind Treatment Period||22
6603954|NCT02063659|7528620|FG003|COMPLETED|Double-Blind Treatment Period||0
6603955|NCT02063659|7528617|FG000|NOT COMPLETED|Double-Blind Treatment Period||2
6603956|NCT02063659|7528618|FG001|NOT COMPLETED|Double-Blind Treatment Period||3
6603957|NCT02063659|7528619|FG002|NOT COMPLETED|Double-Blind Treatment Period||3
6603958|NCT02063659|7528620|FG003|NOT COMPLETED|Double-Blind Treatment Period||0
6603959|NCT02063659|7528617|FG000|STARTED|Open-Label Extension Period (OLE)||0
6603960|NCT02063659|7528618|FG001|STARTED|Open-Label Extension Period (OLE)||0
6603961|NCT02063659|7528619|FG002|STARTED|Open-Label Extension Period (OLE)||0
6603962|NCT02063659|7528620|FG003|STARTED|Open-Label Extension Period (OLE)||67
6603963|NCT02063659|7528617|FG000|COMPLETED|Open-Label Extension Period (OLE)||0
6603964|NCT02063659|7528618|FG001|COMPLETED|Open-Label Extension Period (OLE)||0
6603965|NCT02063659|7528619|FG002|COMPLETED|Open-Label Extension Period (OLE)||0
6603966|NCT02063659|7528620|FG003|COMPLETED|Open-Label Extension Period (OLE)||47
6603967|NCT02063659|7528617|FG000|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6603968|NCT02063659|7528618|FG001|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6603969|NCT02063659|7528619|FG002|NOT COMPLETED|Open-Label Extension Period (OLE)||0
6603970|NCT02063659|7528620|FG003|NOT COMPLETED|Open-Label Extension Period (OLE)||20
6603971|NCT02063672|7528636|FG000|STARTED|Overall Study||53
6603972|NCT02063672|7528637|FG001|STARTED|Overall Study||29
6603973|NCT02063672|7528636|FG000|COMPLETED|Overall Study||18
6603974|NCT02063672|7528637|FG001|COMPLETED|Overall Study||7
6603975|NCT02063672|7528636|FG000|NOT COMPLETED|Overall Study||35
6603976|NCT02063672|7528637|FG001|NOT COMPLETED|Overall Study||22
6603977|NCT02063698|7528645|FG000|STARTED|Overall Study||15
6603978|NCT02063698|7528646|FG001|STARTED|Overall Study||15
6603979|NCT02063698|7528645|FG000|COMPLETED|Overall Study||14
6603980|NCT02063698|7528646|FG001|COMPLETED|Overall Study||13
6603981|NCT02063698|7528645|FG000|NOT COMPLETED|Overall Study||1
6603982|NCT02063698|7528646|FG001|NOT COMPLETED|Overall Study||2
6603983|NCT02063737|7528654|FG000|STARTED|Overall Study||52
6603984|NCT02063737|7528655|FG001|STARTED|Overall Study||48
6603985|NCT02063737|7528654|FG000|COMPLETED|Overall Study||41
6603986|NCT02063737|7528655|FG001|COMPLETED|Overall Study||44
6603987|NCT02063737|7528654|FG000|NOT COMPLETED|Overall Study||11
6603988|NCT02063737|7528655|FG001|NOT COMPLETED|Overall Study||4
6603989|NCT02063828|7528664|FG000|STARTED|Overall Study||14
6603990|NCT02063828|7528665|FG001|STARTED|Overall Study||14
6603991|NCT02063828|7528666|FG002|STARTED|Overall Study||18
6603992|NCT02063828|7528664|FG000|Week 6|Overall Study||11
6603993|NCT02063828|7528665|FG001|Week 6|Overall Study||9
6603994|NCT02063828|7528666|FG002|Week 6|Overall Study||14
6603995|NCT02063828|7528664|FG000|COMPLETED|Overall Study||10
6603996|NCT02063828|7528665|FG001|COMPLETED|Overall Study||8
6603997|NCT02063828|7528666|FG002|COMPLETED|Overall Study||14
6603998|NCT02063828|7528664|FG000|NOT COMPLETED|Overall Study||4
6603999|NCT02063828|7528665|FG001|NOT COMPLETED|Overall Study||6
6604000|NCT02063828|7528666|FG002|NOT COMPLETED|Overall Study||4
6604001|NCT02063854|7528681|FG000|STARTED|Overall Study||199
6604002|NCT02063854|7528682|FG001|STARTED|Overall Study||66
6604003|NCT02063854|7528683|FG002|STARTED|Overall Study||206
6604004|NCT02063854|7528684|FG003|STARTED|Overall Study||68
6604005|NCT02063854|7528685|FG004|STARTED|Overall Study||65
6604006|NCT02063854|7528686|FG005|STARTED|Overall Study||201
6604007|NCT02063854|7528687|FG006|STARTED|Overall Study||66
6604008|NCT02063854|7528681|FG000|Full Analysis Set: Received Study Drug|Overall Study||199
6604009|NCT02063854|7528682|FG001|Full Analysis Set: Received Study Drug|Overall Study||66
6604010|NCT02063854|7528683|FG002|Full Analysis Set: Received Study Drug|Overall Study||206
6604011|NCT02063854|7528684|FG003|Full Analysis Set: Received Study Drug|Overall Study||68
6604012|NCT02063854|7528685|FG004|Full Analysis Set: Received Study Drug|Overall Study||65
6604013|NCT02063854|7528686|FG005|Full Analysis Set: Received Study Drug|Overall Study||200
6604014|NCT02063854|7528687|FG006|Full Analysis Set: Received Study Drug|Overall Study||66
6604015|NCT02063854|7528681|FG000|COMPLETED|Overall Study||178
6604016|NCT02063854|7528682|FG001|COMPLETED|Overall Study||54
6604017|NCT02063854|7528683|FG002|COMPLETED|Overall Study||176
6604018|NCT02063854|7528684|FG003|COMPLETED|Overall Study||58
6604019|NCT02063854|7528685|FG004|COMPLETED|Overall Study||54
6604020|NCT02063854|7528686|FG005|COMPLETED|Overall Study||170
6604021|NCT02063854|7528687|FG006|COMPLETED|Overall Study||60
6604022|NCT02063854|7528681|FG000|NOT COMPLETED|Overall Study||21
6604023|NCT02063854|7528682|FG001|NOT COMPLETED|Overall Study||12
6604024|NCT02063854|7528683|FG002|NOT COMPLETED|Overall Study||30
6604025|NCT02063854|7528684|FG003|NOT COMPLETED|Overall Study||10
6604026|NCT02063854|7528685|FG004|NOT COMPLETED|Overall Study||11
6604027|NCT02063854|7528686|FG005|NOT COMPLETED|Overall Study||31
6604028|NCT02063854|7528687|FG006|NOT COMPLETED|Overall Study||6
6604029|NCT02063867|7528707|FG000|STARTED|Overall Study||156889
6604030|NCT02063867|7528708|FG001|STARTED|Overall Study||183013
6604031|NCT02063867|7528707|FG000|COMPLETED|Overall Study||152598
6604032|NCT02063867|7528708|FG001|COMPLETED|Overall Study||180048
6604033|NCT02063867|7528707|FG000|NOT COMPLETED|Overall Study||4291
6604034|NCT02063867|7528708|FG001|NOT COMPLETED|Overall Study||2965
6604035|NCT02063880|7528716|FG000|STARTED|Overall Study||90
6604036|NCT02063880|7528717|FG001|STARTED|Overall Study||93
6604037|NCT02063880|7528716|FG000|COMPLETED|Overall Study||62
6604038|NCT02063880|7528717|FG001|COMPLETED|Overall Study||66
6604039|NCT02063880|7528716|FG000|NOT COMPLETED|Overall Study||28
6604040|NCT02063880|7528717|FG001|NOT COMPLETED|Overall Study||27
6604041|NCT02063984|7528725|FG000|STARTED|Overall Study||29
6604042|NCT02063984|7528726|FG001|STARTED|Overall Study||30
6604043|NCT02063984|7528725|FG000|COMPLETED|Overall Study||23
6604044|NCT02063984|7528726|FG001|COMPLETED|Overall Study||25
6604045|NCT02063984|7528725|FG000|NOT COMPLETED|Overall Study||6
6604046|NCT02063984|7528726|FG001|NOT COMPLETED|Overall Study||5
6604047|NCT02064166|7528738|FG000|STARTED|Overall Study||9
6604048|NCT02064166|7528739|FG001|STARTED|Overall Study||6
6604049|NCT02064166|7528738|FG000|COMPLETED|Overall Study||8
6604050|NCT02064166|7528739|FG001|COMPLETED|Overall Study||6
6604051|NCT02064166|7528738|FG000|NOT COMPLETED|Overall Study||1
6604052|NCT02064166|7528739|FG001|NOT COMPLETED|Overall Study||0
6604053|NCT02064205|7528767|FG000|STARTED|Overall Study||32
6604054|NCT02064205|7528767|FG000|Condition A|Overall Study||32
6604055|NCT02064205|7528767|FG000|Condition B|Overall Study||32
6604056|NCT02064205|7528767|FG000|Condition C|Overall Study||31
6604057|NCT02064205|7528767|FG000|Condition D|Overall Study||32
6604058|NCT02064205|7528767|FG000|COMPLETED|Overall Study||31
6604059|NCT02064205|7528767|FG000|NOT COMPLETED|Overall Study||1
6604060|NCT02064231|7528783|FG000|STARTED|First Test Period (Test A or Test C)||14
6604061|NCT02064231|7528784|FG001|STARTED|First Test Period (Test A or Test C)||12
6604062|NCT02064231|7528785|FG002|STARTED|First Test Period (Test A or Test C)||1
6604063|NCT02064231|7528786|FG003|STARTED|First Test Period (Test A or Test C)||1
6604064|NCT02064231|7528783|FG000|COMPLETED|First Test Period (Test A or Test C)||7
6604065|NCT02064231|7528784|FG001|COMPLETED|First Test Period (Test A or Test C)||8
6604066|NCT02064231|7528785|FG002|COMPLETED|First Test Period (Test A or Test C)||0
6604067|NCT02064231|7528786|FG003|COMPLETED|First Test Period (Test A or Test C)||1
6604068|NCT02064231|7528783|FG000|NOT COMPLETED|First Test Period (Test A or Test C)||7
6604069|NCT02064231|7528784|FG001|NOT COMPLETED|First Test Period (Test A or Test C)||4
6604070|NCT02064231|7528785|FG002|NOT COMPLETED|First Test Period (Test A or Test C)||1
6604071|NCT02064231|7528786|FG003|NOT COMPLETED|First Test Period (Test A or Test C)||0
6604072|NCT02064231|7528783|FG000|STARTED|Second Test Period (Test B or Test D)||7
6604073|NCT02064231|7528784|FG001|STARTED|Second Test Period (Test B or Test D)||8
6604074|NCT02064231|7528785|FG002|STARTED|Second Test Period (Test B or Test D)||0
6604075|NCT02064231|7528786|FG003|STARTED|Second Test Period (Test B or Test D)||1
6604076|NCT02064231|7528783|FG000|COMPLETED|Second Test Period (Test B or Test D)||6
6604077|NCT02064231|7528784|FG001|COMPLETED|Second Test Period (Test B or Test D)||7
6604078|NCT02064231|7528785|FG002|COMPLETED|Second Test Period (Test B or Test D)||0
6604079|NCT02064231|7528786|FG003|COMPLETED|Second Test Period (Test B or Test D)||1
6604080|NCT02064231|7528783|FG000|NOT COMPLETED|Second Test Period (Test B or Test D)||1
6604081|NCT02064231|7528784|FG001|NOT COMPLETED|Second Test Period (Test B or Test D)||1
6604082|NCT02064231|7528785|FG002|NOT COMPLETED|Second Test Period (Test B or Test D)||0
6604083|NCT02064231|7528786|FG003|NOT COMPLETED|Second Test Period (Test B or Test D)||0
6604084|NCT02064231|7528783|FG000|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
6604085|NCT02064231|7528784|FG001|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
6604086|NCT02064231|7528785|FG002|STARTED|Third Test Period (Own Product)||0
6604087|NCT02064231|7528786|FG003|STARTED|Third Test Period (Own Product)||1
6604088|NCT02064231|7528783|FG000|COMPLETED|Third Test Period (Own Product)||8
6604089|NCT02064231|7528784|FG001|COMPLETED|Third Test Period (Own Product)||8
6604090|NCT02064231|7528785|FG002|COMPLETED|Third Test Period (Own Product)||0
6604091|NCT02064231|7528786|FG003|COMPLETED|Third Test Period (Own Product)||1
6604092|NCT02064231|7528783|FG000|NOT COMPLETED|Third Test Period (Own Product)||0
6604093|NCT02064231|7528784|FG001|NOT COMPLETED|Third Test Period (Own Product)||0
6604094|NCT02064231|7528785|FG002|NOT COMPLETED|Third Test Period (Own Product)||0
6604095|NCT02064231|7528786|FG003|NOT COMPLETED|Third Test Period (Own Product)||0
6604096|NCT02064270|7528800|FG000|STARTED|Overall Study||263
6604097|NCT02064270|7528801|FG001|STARTED|Overall Study||263
6604098|NCT02064270|7528800|FG000|COMPLETED|Overall Study||201
6604099|NCT02064270|7528801|FG001|COMPLETED|Overall Study||231
6604100|NCT02064270|7528800|FG000|NOT COMPLETED|Overall Study||62
6604101|NCT02064270|7528801|FG001|NOT COMPLETED|Overall Study||32
6604102|NCT02064439|7528810|FG000|STARTED|Overall Study|Full Analysis Set (FAS), randomized and received study medication|1127
6604103|NCT02064439|7528811|FG001|STARTED|Overall Study|FAS, randomized and received study medication|1107
6604104|NCT02064439|7528812|FG002|STARTED|Overall Study|FAS, randomized and received study medication|1131
6604105|NCT02064439|7528810|FG000|COMPLETED|Overall Study||984
6604106|NCT02064439|7528811|FG001|COMPLETED|Overall Study||969
6604107|NCT02064439|7528812|FG002|COMPLETED|Overall Study||949
6604108|NCT02064439|7528810|FG000|NOT COMPLETED|Overall Study||143
6604109|NCT02064439|7528811|FG001|NOT COMPLETED|Overall Study||138
6604110|NCT02064439|7528812|FG002|NOT COMPLETED|Overall Study||182
6604111|NCT02064582|7528820|FG000|STARTED|Overall Study||7
6604112|NCT02064582|7528820|FG000|COMPLETED|Overall Study||7
6604113|NCT02064582|7528820|FG000|NOT COMPLETED|Overall Study||0
6604114|NCT02064816|7528826|FG000|STARTED|Overall Study||104
6604115|NCT02064816|7528827|FG001|STARTED|Overall Study||96
6604116|NCT02064816|7528826|FG000|COMPLETED|Overall Study||96
6604117|NCT02064816|7528827|FG001|COMPLETED|Overall Study||88
6604118|NCT02064816|7528826|FG000|NOT COMPLETED|Overall Study||8
6604119|NCT02064816|7528827|FG001|NOT COMPLETED|Overall Study||8
6604120|NCT02064855|7528833|FG000|STARTED|Overall Study||108
6604121|NCT02064855|7528833|FG000|COMPLETED|Overall Study||53
6604122|NCT02064855|7528833|FG000|NOT COMPLETED|Overall Study||55
6604123|NCT02064868|7528882|FG000|STARTED|Overall Study||1756
6604124|NCT02064868|7528883|FG001|STARTED|Overall Study||894
6604125|NCT02064868|7528882|FG000|Full Analysis Set|Overall Study||1756
6604126|NCT02064868|7528883|FG001|Full Analysis Set|Overall Study||894
6604127|NCT02064868|7528882|FG000|Safety Set|Overall Study|The Safety Set includes one patient not randomized but treated with serelaxin|1729
6604128|NCT02064868|7528883|FG001|Safety Set|Overall Study||894
6604129|NCT02064868|7528882|FG000|Per Protocol Set|Overall Study||1155
6604130|NCT02064868|7528883|FG001|Per Protocol Set|Overall Study||627
6604131|NCT02064868|7528882|FG000|COMPLETED|Overall Study||1722
6604132|NCT02064868|7528883|FG001|COMPLETED|Overall Study||881
6604133|NCT02064868|7528882|FG000|NOT COMPLETED|Overall Study||34
6604134|NCT02064868|7528883|FG001|NOT COMPLETED|Overall Study||13
6604135|NCT02064894|7528892|FG000|STARTED|Overall Study|"Received allocated intervention (n=98)~Did not receive intervention (n=1)"|99
6604136|NCT02064894|7528893|FG001|STARTED|Overall Study|"Received allocated intervention (n=198)~Did not receive allocated intervention (n=3)"|201
6604137|NCT02064894|7528894|FG002|STARTED|Overall Study|"Received allocated intervention (n=199)~Did not receive allocated intervention (n=2)"|201
6604138|NCT02064894|7528892|FG000|Available at T-60|Overall Study||91
6604139|NCT02064894|7528893|FG001|Available at T-60|Overall Study||188
6604140|NCT02064894|7528894|FG002|Available at T-60|Overall Study||177
6604141|NCT02064894|7528892|FG000|Avalaible at T-90|Overall Study||74
6604142|NCT02064894|7528893|FG001|Avalaible at T-90|Overall Study||134
6604143|NCT02064894|7528894|FG002|Avalaible at T-90|Overall Study||129
6604144|NCT02064894|7528892|FG000|COMPLETED|Overall Study||56
6604145|NCT02064894|7528893|FG001|COMPLETED|Overall Study||99
6604146|NCT02064894|7528894|FG002|COMPLETED|Overall Study||86
6604147|NCT02064894|7528892|FG000|NOT COMPLETED|Overall Study||43
6604148|NCT02064894|7528893|FG001|NOT COMPLETED|Overall Study||102
6604149|NCT02064894|7528894|FG002|NOT COMPLETED|Overall Study||115
6604150|NCT02064907|7528904|FG000|STARTED|Period 1||26
6604151|NCT02064907|7528905|FG001|STARTED|Period 1||26
6604152|NCT02064907|7528904|FG000|COMPLETED|Period 1||26
6604153|NCT02064907|7528905|FG001|COMPLETED|Period 1||26
6604154|NCT02064907|7528904|FG000|NOT COMPLETED|Period 1||0
6604155|NCT02064907|7528905|FG001|NOT COMPLETED|Period 1||0
6604156|NCT02064907|7528904|FG000|STARTED|Period 2||26
6604157|NCT02064907|7528905|FG001|STARTED|Period 2||26
6604158|NCT02064907|7528904|FG000|COMPLETED|Period 2||26
6604159|NCT02064907|7528905|FG001|COMPLETED|Period 2||26
6604160|NCT02064907|7528904|FG000|NOT COMPLETED|Period 2||0
6604161|NCT02064907|7528905|FG001|NOT COMPLETED|Period 2||0
6604162|NCT02064920|7528913|FG000|STARTED|Overall Study||6
6604163|NCT02064920|7528914|FG001|STARTED|Overall Study||30
6604164|NCT02064920|7528913|FG000|Treated|Overall Study||6
6604165|NCT02064920|7528914|FG001|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
6604166|NCT02064920|7528913|FG000|COMPLETED|Overall Study||5
6604167|NCT02064920|7528914|FG001|COMPLETED|Overall Study||21
6604168|NCT02064920|7528913|FG000|NOT COMPLETED|Overall Study||1
6604169|NCT02064920|7528914|FG001|NOT COMPLETED|Overall Study||9
6604170|NCT02064959|7528922|FG000|STARTED|Overall Study||16
6604171|NCT02064959|7528923|FG001|STARTED|Overall Study||16
6604172|NCT02064959|7528922|FG000|COMPLETED|Overall Study||16
6604173|NCT02064959|7528923|FG001|COMPLETED|Overall Study||16
6604174|NCT02064959|7528922|FG000|NOT COMPLETED|Overall Study||0
6604175|NCT02064959|7528923|FG001|NOT COMPLETED|Overall Study||0
6604176|NCT02064985|7528932|FG000|STARTED|Overall Study||12
6604177|NCT02064985|7528933|FG001|STARTED|Overall Study||12
6604178|NCT02064985|7528934|FG002|STARTED|Overall Study||12
6604179|NCT02064985|7528932|FG000|COMPLETED|Overall Study||12
6604180|NCT02064985|7528933|FG001|COMPLETED|Overall Study||12
6604181|NCT02064985|7528934|FG002|COMPLETED|Overall Study||12
6604182|NCT02064985|7528932|FG000|NOT COMPLETED|Overall Study||0
6604183|NCT02064985|7528933|FG001|NOT COMPLETED|Overall Study||0
6604184|NCT02064985|7528934|FG002|NOT COMPLETED|Overall Study||0
6604185|NCT02065245|7528949|FG000|STARTED|Infusion 1||5
6604186|NCT02065245|7528950|FG001|STARTED|Infusion 1||5
6604187|NCT02065245|7528951|FG002|STARTED|Infusion 1||5
6604188|NCT02065245|7528952|FG003|STARTED|Infusion 1||10
6604189|NCT02065245|7528953|FG004|STARTED|Infusion 1||10
6604190|NCT02065245|7528954|FG005|STARTED|Infusion 1||10
6604191|NCT02065245|7528955|FG006|STARTED|Infusion 1||20
6604192|NCT02065245|7528949|FG000|COMPLETED|Infusion 1||5
6604193|NCT02065245|7528950|FG001|COMPLETED|Infusion 1||5
6604194|NCT02065245|7528951|FG002|COMPLETED|Infusion 1||4
6604195|NCT02065245|7528952|FG003|COMPLETED|Infusion 1||10
6604196|NCT02065245|7528953|FG004|COMPLETED|Infusion 1||9
6604197|NCT02065245|7528954|FG005|COMPLETED|Infusion 1||10
6604198|NCT02065245|7528955|FG006|COMPLETED|Infusion 1||19
6604199|NCT02065245|7528949|FG000|NOT COMPLETED|Infusion 1||0
6604200|NCT02065245|7528950|FG001|NOT COMPLETED|Infusion 1||0
6604201|NCT02065245|7528951|FG002|NOT COMPLETED|Infusion 1||1
6604202|NCT02065245|7528952|FG003|NOT COMPLETED|Infusion 1||0
6604203|NCT02065245|7528953|FG004|NOT COMPLETED|Infusion 1||1
6604204|NCT02065245|7528954|FG005|NOT COMPLETED|Infusion 1||0
6604205|NCT02065245|7528955|FG006|NOT COMPLETED|Infusion 1||1
6604206|NCT02065245|7528949|FG000|STARTED|Infusion 2||5
6604207|NCT02065245|7528950|FG001|STARTED|Infusion 2||5
6604208|NCT02065245|7528951|FG002|STARTED|Infusion 2||2
6604209|NCT02065245|7528952|FG003|STARTED|Infusion 2||0
6604210|NCT02065245|7528953|FG004|STARTED|Infusion 2||0
6604211|NCT02065245|7528954|FG005|STARTED|Infusion 2||6
6604212|NCT02065245|7528955|FG006|STARTED|Infusion 2||12
6604213|NCT02065245|7528949|FG000|COMPLETED|Infusion 2||5
6604214|NCT02065245|7528950|FG001|COMPLETED|Infusion 2||5
6604215|NCT02065245|7528951|FG002|COMPLETED|Infusion 2||2
6604216|NCT02065245|7528952|FG003|COMPLETED|Infusion 2||0
6604217|NCT02065245|7528953|FG004|COMPLETED|Infusion 2||0
6604218|NCT02065245|7528954|FG005|COMPLETED|Infusion 2||6
6604219|NCT02065245|7528955|FG006|COMPLETED|Infusion 2||11
6604220|NCT02065245|7528949|FG000|NOT COMPLETED|Infusion 2||0
6604221|NCT02065245|7528950|FG001|NOT COMPLETED|Infusion 2||0
6604222|NCT02065245|7528951|FG002|NOT COMPLETED|Infusion 2||0
6604223|NCT02065245|7528952|FG003|NOT COMPLETED|Infusion 2||0
6604224|NCT02065245|7528953|FG004|NOT COMPLETED|Infusion 2||0
6604225|NCT02065245|7528954|FG005|NOT COMPLETED|Infusion 2||0
6604226|NCT02065245|7528955|FG006|NOT COMPLETED|Infusion 2||1
6604227|NCT02065245|7528949|FG000|STARTED|Infusion 3||3
6604228|NCT02065245|7528950|FG001|STARTED|Infusion 3||5
6604229|NCT02065245|7528951|FG002|STARTED|Infusion 3||1
6604230|NCT02065245|7528952|FG003|STARTED|Infusion 3||0
6604231|NCT02065245|7528953|FG004|STARTED|Infusion 3||0
6604232|NCT02065245|7528954|FG005|STARTED|Infusion 3||0
6604233|NCT02065245|7528955|FG006|STARTED|Infusion 3||0
6604234|NCT02065245|7528949|FG000|COMPLETED|Infusion 3||2
6604235|NCT02065245|7528950|FG001|COMPLETED|Infusion 3||4
6604236|NCT02065245|7528951|FG002|COMPLETED|Infusion 3||1
6604237|NCT02065245|7528952|FG003|COMPLETED|Infusion 3||0
6604238|NCT02065245|7528953|FG004|COMPLETED|Infusion 3||0
6604239|NCT02065245|7528954|FG005|COMPLETED|Infusion 3||0
6604240|NCT02065245|7528955|FG006|COMPLETED|Infusion 3||0
6604241|NCT02065245|7528949|FG000|NOT COMPLETED|Infusion 3||1
6604242|NCT02065245|7528950|FG001|NOT COMPLETED|Infusion 3||1
6604243|NCT02065245|7528951|FG002|NOT COMPLETED|Infusion 3||0
6604244|NCT02065245|7528952|FG003|NOT COMPLETED|Infusion 3||0
6604245|NCT02065245|7528953|FG004|NOT COMPLETED|Infusion 3||0
6604246|NCT02065245|7528954|FG005|NOT COMPLETED|Infusion 3||0
6604247|NCT02065245|7528955|FG006|NOT COMPLETED|Infusion 3||0
6604248|NCT02065245|7528949|FG000|STARTED|Infusion 4||1
6604249|NCT02065245|7528950|FG001|STARTED|Infusion 4||2
6604250|NCT02065245|7528951|FG002|STARTED|Infusion 4||1
6604251|NCT02065245|7528952|FG003|STARTED|Infusion 4||0
6604252|NCT02065245|7528953|FG004|STARTED|Infusion 4||0
6604253|NCT02065245|7528954|FG005|STARTED|Infusion 4||0
6604254|NCT02065245|7528955|FG006|STARTED|Infusion 4||0
6604255|NCT02065245|7528949|FG000|COMPLETED|Infusion 4||1
6604256|NCT02065245|7528950|FG001|COMPLETED|Infusion 4||2
6604257|NCT02065245|7528951|FG002|COMPLETED|Infusion 4||1
6604258|NCT02065245|7528952|FG003|COMPLETED|Infusion 4||0
6604259|NCT02065245|7528953|FG004|COMPLETED|Infusion 4||0
6604260|NCT02065245|7528954|FG005|COMPLETED|Infusion 4||0
6604261|NCT02065245|7528955|FG006|COMPLETED|Infusion 4||0
6604262|NCT02065245|7528949|FG000|NOT COMPLETED|Infusion 4||0
6604263|NCT02065245|7528950|FG001|NOT COMPLETED|Infusion 4||0
6604264|NCT02065245|7528951|FG002|NOT COMPLETED|Infusion 4||0
6604265|NCT02065245|7528952|FG003|NOT COMPLETED|Infusion 4||0
6604266|NCT02065245|7528953|FG004|NOT COMPLETED|Infusion 4||0
6604267|NCT02065245|7528954|FG005|NOT COMPLETED|Infusion 4||0
6604268|NCT02065245|7528955|FG006|NOT COMPLETED|Infusion 4||0
6604269|NCT02065336|7528979|FG000|STARTED|Main Study||6
6604270|NCT02065336|7528980|FG001|STARTED|Main Study||6
6604271|NCT02065336|7528981|FG002|STARTED|Main Study||6
6604272|NCT02065336|7528982|FG003|STARTED|Main Study||6
6604273|NCT02065336|7528983|FG004|STARTED|Main Study||6
6604274|NCT02065336|7528984|FG005|STARTED|Main Study||6
6604275|NCT02065336|7528985|FG006|STARTED|Main Study||12
6604276|NCT02065336|7528986|FG007|STARTED|Main Study||10
6604277|NCT02065336|7528987|FG008|STARTED|Main Study||0
6604278|NCT02065336|7528988|FG009|STARTED|Main Study||0
6604279|NCT02065336|7528979|FG000|COMPLETED|Main Study||6
6604280|NCT02065336|7528980|FG001|COMPLETED|Main Study||6
6604281|NCT02065336|7528981|FG002|COMPLETED|Main Study||6
6604282|NCT02065336|7528982|FG003|COMPLETED|Main Study||6
6604283|NCT02065336|7528983|FG004|COMPLETED|Main Study||6
6604284|NCT02065336|7528984|FG005|COMPLETED|Main Study||6
6604285|NCT02065336|7528985|FG006|COMPLETED|Main Study||12
6604286|NCT02065336|7528986|FG007|COMPLETED|Main Study||10
6604287|NCT02065336|7528987|FG008|COMPLETED|Main Study||0
6604288|NCT02065336|7528988|FG009|COMPLETED|Main Study||0
6604289|NCT02065336|7528979|FG000|NOT COMPLETED|Main Study||0
6604290|NCT02065336|7528980|FG001|NOT COMPLETED|Main Study||0
6604291|NCT02065336|7528981|FG002|NOT COMPLETED|Main Study||0
6604292|NCT02065336|7528982|FG003|NOT COMPLETED|Main Study||0
6604293|NCT02065336|7528983|FG004|NOT COMPLETED|Main Study||0
6604294|NCT02065336|7528984|FG005|NOT COMPLETED|Main Study||0
6604295|NCT02065336|7528985|FG006|NOT COMPLETED|Main Study||0
6604296|NCT02065336|7528986|FG007|NOT COMPLETED|Main Study||0
6604297|NCT02065336|7528987|FG008|NOT COMPLETED|Main Study||0
6604298|NCT02065336|7528988|FG009|NOT COMPLETED|Main Study||0
6604299|NCT02065336|7528979|FG000|STARTED|Extension Phase||0
6604300|NCT02065336|7528980|FG001|STARTED|Extension Phase||0
6604301|NCT02065336|7528981|FG002|STARTED|Extension Phase||0
6604302|NCT02065336|7528982|FG003|STARTED|Extension Phase||0
6604303|NCT02065336|7528983|FG004|STARTED|Extension Phase||0
6604304|NCT02065336|7528984|FG005|STARTED|Extension Phase||0
6604305|NCT02065336|7528985|FG006|STARTED|Extension Phase||0
6604306|NCT02065336|7528986|FG007|STARTED|Extension Phase||0
6604307|NCT02065336|7528987|FG008|STARTED|Extension Phase||2
6604308|NCT02065336|7528988|FG009|STARTED|Extension Phase||8
6604309|NCT02065336|7528979|FG000|COMPLETED|Extension Phase||0
6604310|NCT02065336|7528980|FG001|COMPLETED|Extension Phase||0
6604311|NCT02065336|7528981|FG002|COMPLETED|Extension Phase||0
6604312|NCT02065336|7528982|FG003|COMPLETED|Extension Phase||0
6604313|NCT02065336|7528983|FG004|COMPLETED|Extension Phase||0
6604314|NCT02065336|7528984|FG005|COMPLETED|Extension Phase||0
6604315|NCT02065336|7528985|FG006|COMPLETED|Extension Phase||0
6604316|NCT02065336|7528986|FG007|COMPLETED|Extension Phase||0
6604317|NCT02065336|7528987|FG008|COMPLETED|Extension Phase||0
6604318|NCT02065336|7528988|FG009|COMPLETED|Extension Phase||0
6604319|NCT02065336|7528979|FG000|NOT COMPLETED|Extension Phase||0
6604320|NCT02065336|7528980|FG001|NOT COMPLETED|Extension Phase||0
6604321|NCT02065336|7528981|FG002|NOT COMPLETED|Extension Phase||0
6604322|NCT02065336|7528982|FG003|NOT COMPLETED|Extension Phase||0
6604323|NCT02065336|7528983|FG004|NOT COMPLETED|Extension Phase||0
6604324|NCT02065336|7528984|FG005|NOT COMPLETED|Extension Phase||0
6604325|NCT02065336|7528985|FG006|NOT COMPLETED|Extension Phase||0
6604326|NCT02065336|7528986|FG007|NOT COMPLETED|Extension Phase||0
6604327|NCT02065336|7528987|FG008|NOT COMPLETED|Extension Phase||2
6604328|NCT02065336|7528988|FG009|NOT COMPLETED|Extension Phase||8
6604329|NCT02065453|7529021|FG000|STARTED|Overall Study||27
6604330|NCT02065453|7529022|FG001|STARTED|Overall Study||25
6604331|NCT02065453|7529021|FG000|COMPLETED|Overall Study||24
6604332|NCT02065453|7529022|FG001|COMPLETED|Overall Study||21
6604333|NCT02065453|7529021|FG000|NOT COMPLETED|Overall Study||3
6604334|NCT02065453|7529022|FG001|NOT COMPLETED|Overall Study||4
6604335|NCT02065479|7529029|FG000|STARTED|Overall Study||33
6604336|NCT02065479|7529030|FG001|STARTED|Overall Study||32
6604337|NCT02065479|7529029|FG000|COMPLETED|Overall Study||33
6604338|NCT02065479|7529030|FG001|COMPLETED|Overall Study||32
6604339|NCT02065479|7529029|FG000|NOT COMPLETED|Overall Study||0
6604340|NCT02065479|7529030|FG001|NOT COMPLETED|Overall Study||0
6604341|NCT02065518|7529040|FG000|STARTED|Overall Study||19
6604342|NCT02065518|7529041|FG001|STARTED|Overall Study||19
6604343|NCT02065518|7529042|FG002|STARTED|Overall Study||20
6604344|NCT02065518|7529043|FG003|STARTED|Overall Study||20
6604345|NCT02065518|7529040|FG000|COMPLETED|Overall Study||13
6604346|NCT02065518|7529041|FG001|COMPLETED|Overall Study||11
6604347|NCT02065518|7529042|FG002|COMPLETED|Overall Study||11
6604348|NCT02065518|7529043|FG003|COMPLETED|Overall Study||15
6604349|NCT02065518|7529040|FG000|NOT COMPLETED|Overall Study||6
6604350|NCT02065518|7529041|FG001|NOT COMPLETED|Overall Study||8
6604351|NCT02065518|7529042|FG002|NOT COMPLETED|Overall Study||9
6604352|NCT02065518|7529043|FG003|NOT COMPLETED|Overall Study||5
6604353|NCT02065557|7529056|FG000|STARTED|Induction Period||32
6604354|NCT02065557|7529057|FG001|STARTED|Induction Period||51
6604355|NCT02065557|7529058|FG002|STARTED|Induction Period||18
6604356|NCT02065557|7529059|FG003|STARTED|Induction Period||0
6604357|NCT02065557|7529060|FG004|STARTED|Induction Period||0
6604358|NCT02065557|7529061|FG005|STARTED|Induction Period||0
6604359|NCT02065557|7529056|FG000|Enrolled in Main Study|Induction Period||30
6604360|NCT02065557|7529057|FG001|Enrolled in Main Study|Induction Period||47
6604361|NCT02065557|7529058|FG002|Enrolled in Main Study|Induction Period||16
6604362|NCT02065557|7529059|FG003|Enrolled in Main Study|Induction Period||0
6604363|NCT02065557|7529060|FG004|Enrolled in Main Study|Induction Period||0
6604364|NCT02065557|7529061|FG005|Enrolled in Main Study|Induction Period||0
6604365|NCT02065557|7529056|FG000|Enrolled in Japan Sub-study|Induction Period||2
6604366|NCT02065557|7529057|FG001|Enrolled in Japan Sub-study|Induction Period||4
6604367|NCT02065557|7529058|FG002|Enrolled in Japan Sub-study|Induction Period||2
6604368|NCT02065557|7529059|FG003|Enrolled in Japan Sub-study|Induction Period||0
6604369|NCT02065557|7529060|FG004|Enrolled in Japan Sub-study|Induction Period||0
6604370|NCT02065557|7529061|FG005|Enrolled in Japan Sub-study|Induction Period||0
6604371|NCT02065557|7529056|FG000|COMPLETED|Induction Period||22
6604372|NCT02065557|7529057|FG001|COMPLETED|Induction Period||43
6604373|NCT02065557|7529058|FG002|COMPLETED|Induction Period||16
6604374|NCT02065557|7529059|FG003|COMPLETED|Induction Period||0
6604375|NCT02065557|7529060|FG004|COMPLETED|Induction Period||0
6604376|NCT02065557|7529061|FG005|COMPLETED|Induction Period||0
6604377|NCT02065557|7529056|FG000|NOT COMPLETED|Induction Period||10
6604378|NCT02065557|7529057|FG001|NOT COMPLETED|Induction Period||8
6604379|NCT02065557|7529058|FG002|NOT COMPLETED|Induction Period||2
6604380|NCT02065557|7529059|FG003|NOT COMPLETED|Induction Period||0
6604381|NCT02065557|7529060|FG004|NOT COMPLETED|Induction Period||0
6604382|NCT02065557|7529061|FG005|NOT COMPLETED|Induction Period||0
6604383|NCT02065557|7529056|FG000|STARTED|Maintenance Period||0
6604384|NCT02065557|7529057|FG001|STARTED|Maintenance Period||0
6604385|NCT02065557|7529058|FG002|STARTED|Maintenance Period||0
6604386|NCT02065557|7529059|FG003|STARTED|Maintenance Period||12
6604387|NCT02065557|7529060|FG004|STARTED|Maintenance Period||33
6604388|NCT02065557|7529061|FG005|STARTED|Maintenance Period||36
6604389|NCT02065557|7529056|FG000|COMPLETED|Maintenance Period||0
6604390|NCT02065557|7529057|FG001|COMPLETED|Maintenance Period||0
6604391|NCT02065557|7529058|FG002|COMPLETED|Maintenance Period||0
6604392|NCT02065557|7529059|FG003|COMPLETED|Maintenance Period||11
6604393|NCT02065557|7529060|FG004|COMPLETED|Maintenance Period||25
6604394|NCT02065557|7529061|FG005|COMPLETED|Maintenance Period||32
6604395|NCT02065557|7529056|FG000|NOT COMPLETED|Maintenance Period||0
6604396|NCT02065557|7529057|FG001|NOT COMPLETED|Maintenance Period||0
6604397|NCT02065557|7529058|FG002|NOT COMPLETED|Maintenance Period||0
6604398|NCT02065557|7529059|FG003|NOT COMPLETED|Maintenance Period||1
6604399|NCT02065557|7529060|FG004|NOT COMPLETED|Maintenance Period||8
6604400|NCT02065557|7529061|FG005|NOT COMPLETED|Maintenance Period||4
6604401|NCT02065570|7529088|FG000|STARTED|Induction Study||206
6604402|NCT02065570|7529089|FG001|STARTED|Induction Study||308
6604403|NCT02065570|7529090|FG002|STARTED|Induction Study||0
6604404|NCT02065570|7529091|FG003|STARTED|Induction Study||0
6604405|NCT02065570|7529088|FG000|COMPLETED|Induction Study||192
6604406|NCT02065570|7529089|FG001|COMPLETED|Induction Study||287
6604407|NCT02065570|7529090|FG002|COMPLETED|Induction Study||0
6604408|NCT02065570|7529091|FG003|COMPLETED|Induction Study||0
6604409|NCT02065570|7529088|FG000|NOT COMPLETED|Induction Study||14
6604410|NCT02065570|7529089|FG001|NOT COMPLETED|Induction Study||21
6604411|NCT02065570|7529090|FG002|NOT COMPLETED|Induction Study||0
6604412|NCT02065570|7529091|FG003|NOT COMPLETED|Induction Study||0
6604413|NCT02065570|7529088|FG000|STARTED|Maintenance Study||0
6604414|NCT02065570|7529089|FG001|STARTED|Maintenance Study||0
6604415|NCT02065570|7529090|FG002|STARTED|Maintenance Study||109
6604416|NCT02065570|7529091|FG003|STARTED|Maintenance Study||109
6604417|NCT02065570|7529088|FG000|COMPLETED|Maintenance Study||0
6604418|NCT02065570|7529089|FG001|COMPLETED|Maintenance Study||0
6604419|NCT02065570|7529090|FG002|COMPLETED|Maintenance Study||87
6604420|NCT02065570|7529091|FG003|COMPLETED|Maintenance Study||90
6604421|NCT02065570|7529088|FG000|NOT COMPLETED|Maintenance Study||0
6604422|NCT02065570|7529089|FG001|NOT COMPLETED|Maintenance Study||0
6604423|NCT02065570|7529090|FG002|NOT COMPLETED|Maintenance Study||22
6604424|NCT02065570|7529091|FG003|NOT COMPLETED|Maintenance Study||19
6604425|NCT02065622|7529104|FG000|STARTED|Induction Study||379
6604426|NCT02065622|7529105|FG001|STARTED|Induction Study||573
6604427|NCT02065622|7529106|FG002|STARTED|Induction Study||0
6604428|NCT02065622|7529107|FG003|STARTED|Induction Study||0
6604429|NCT02065622|7529108|FG004|STARTED|Induction Study||0
6604430|NCT02065622|7529104|FG000|Enrolled in Main Study|Induction Study||340
6604431|NCT02065622|7529105|FG001|Enrolled in Main Study|Induction Study||512
6604432|NCT02065622|7529106|FG002|Enrolled in Main Study|Induction Study||0
6604433|NCT02065622|7529107|FG003|Enrolled in Main Study|Induction Study||0
6604434|NCT02065622|7529108|FG004|Enrolled in Main Study|Induction Study||0
6604435|NCT02065622|7529104|FG000|Enrolled in Japan Sub-Study|Induction Study||39
6604436|NCT02065622|7529105|FG001|Enrolled in Japan Sub-Study|Induction Study||61
6604437|NCT02065622|7529106|FG002|Enrolled in Japan Sub-Study|Induction Study||0
6604438|NCT02065622|7529107|FG003|Enrolled in Japan Sub-Study|Induction Study||0
6604439|NCT02065622|7529108|FG004|Enrolled in Japan Sub-Study|Induction Study||0
6604440|NCT02065622|7529104|FG000|COMPLETED|Induction Study||332
6604441|NCT02065622|7529105|FG001|COMPLETED|Induction Study||514
6604442|NCT02065622|7529106|FG002|COMPLETED|Induction Study||0
6604443|NCT02065622|7529107|FG003|COMPLETED|Induction Study||0
6604444|NCT02065622|7529108|FG004|COMPLETED|Induction Study||0
6604445|NCT02065622|7529104|FG000|NOT COMPLETED|Induction Study||47
6604446|NCT02065622|7529105|FG001|NOT COMPLETED|Induction Study||59
6604447|NCT02065622|7529106|FG002|NOT COMPLETED|Induction Study||0
6604448|NCT02065622|7529107|FG003|NOT COMPLETED|Induction Study||0
6604449|NCT02065622|7529108|FG004|NOT COMPLETED|Induction Study||0
6604450|NCT02065622|7529104|FG000|STARTED|Maintenance Study||0
6604451|NCT02065622|7529105|FG001|STARTED|Maintenance Study||0
6604452|NCT02065622|7529106|FG002|STARTED|Maintenance Study||345
6604453|NCT02065622|7529107|FG003|STARTED|Maintenance Study||350
6604454|NCT02065622|7529108|FG004|STARTED|Maintenance Study||151
6604455|NCT02065622|7529104|FG000|COMPLETED|Maintenance Study||0
6604456|NCT02065622|7529105|FG001|COMPLETED|Maintenance Study||0
6604457|NCT02065622|7529106|FG002|COMPLETED|Maintenance Study||221
6604458|NCT02065622|7529107|FG003|COMPLETED|Maintenance Study||246
6604459|NCT02065622|7529108|FG004|COMPLETED|Maintenance Study||105
6604460|NCT02065622|7529104|FG000|NOT COMPLETED|Maintenance Study||0
6604461|NCT02065622|7529105|FG001|NOT COMPLETED|Maintenance Study||0
6604462|NCT02065622|7529106|FG002|NOT COMPLETED|Maintenance Study||124
6604463|NCT02065622|7529107|FG003|NOT COMPLETED|Maintenance Study||104
6604464|NCT02065622|7529108|FG004|NOT COMPLETED|Maintenance Study||46
6604465|NCT02065687|7529125|FG000|STARTED|Overall Study||234
6604466|NCT02065687|7529126|FG001|STARTED|Overall Study||235
6604467|NCT02065687|7529125|FG000|COMPLETED|Overall Study||234
6604468|NCT02065687|7529126|FG001|COMPLETED|Overall Study||235
6604469|NCT02065687|7529125|FG000|NOT COMPLETED|Overall Study||0
6604470|NCT02065687|7529126|FG001|NOT COMPLETED|Overall Study||0
6604471|NCT02065713|7529134|FG000|STARTED|Overall Study||23
6604472|NCT02065713|7529135|FG001|STARTED|Overall Study||21
6604473|NCT02065713|7529134|FG000|COMPLETED|Overall Study||22
6604474|NCT02065713|7529135|FG001|COMPLETED|Overall Study||20
6604475|NCT02065713|7529134|FG000|NOT COMPLETED|Overall Study||1
6604476|NCT02065713|7529135|FG001|NOT COMPLETED|Overall Study||1
6604477|NCT02065791|7529143|FG000|STARTED|Overall Study||2199
6604478|NCT02065791|7529144|FG001|STARTED|Overall Study||2202
6604479|NCT02065791|7529143|FG000|Treated|Overall Study||2197
6604480|NCT02065791|7529144|FG001|Treated|Overall Study||2200
6604481|NCT02065791|7529143|FG000|COMPLETED|Overall Study||2174
6604482|NCT02065791|7529144|FG001|COMPLETED|Overall Study||2187
6604483|NCT02065791|7529143|FG000|NOT COMPLETED|Overall Study||25
6604484|NCT02065791|7529144|FG001|NOT COMPLETED|Overall Study||15
6604485|NCT02065895|7529150|FG000|STARTED|Overall Study||1
6604486|NCT02065895|7529151|FG001|STARTED|Overall Study||3
6604487|NCT02065895|7529152|FG002|STARTED|Overall Study||1
6604488|NCT02065895|7529153|FG003|STARTED|Overall Study||1
6604489|NCT02065895|7529154|FG004|STARTED|Overall Study||1
6604490|NCT02065895|7529155|FG005|STARTED|Overall Study||1
6604491|NCT02065895|7529150|FG000|COMPLETED|Overall Study||0
6604492|NCT02065895|7529151|FG001|COMPLETED|Overall Study||2
6604493|NCT02065895|7529152|FG002|COMPLETED|Overall Study||1
6604494|NCT02065895|7529153|FG003|COMPLETED|Overall Study||0
6604495|NCT02065895|7529154|FG004|COMPLETED|Overall Study||1
6604496|NCT02065895|7529155|FG005|COMPLETED|Overall Study||1
6604497|NCT02065895|7529150|FG000|NOT COMPLETED|Overall Study||1
6604498|NCT02065895|7529151|FG001|NOT COMPLETED|Overall Study||1
6604499|NCT02065895|7529152|FG002|NOT COMPLETED|Overall Study||0
6604500|NCT02065895|7529153|FG003|NOT COMPLETED|Overall Study||1
6604501|NCT02065895|7529154|FG004|NOT COMPLETED|Overall Study||0
6604502|NCT02065895|7529155|FG005|NOT COMPLETED|Overall Study||0
6604503|NCT02066051|7529172|FG000|STARTED|Overall Study||8
6604504|NCT02066051|7529172|FG000|COMPLETED|Overall Study||7
6604505|NCT02066051|7529172|FG000|NOT COMPLETED|Overall Study||1
6604506|NCT02066129|7529178|FG000|STARTED|Overall Study||127
6604507|NCT02066129|7529179|FG001|STARTED|Overall Study||127
6604508|NCT02066129|7529178|FG000|COMPLETED|Overall Study||98
6604509|NCT02066129|7529179|FG001|COMPLETED|Overall Study||94
6604510|NCT02066129|7529178|FG000|NOT COMPLETED|Overall Study||29
6604511|NCT02066129|7529179|FG001|NOT COMPLETED|Overall Study||33
6604512|NCT02066233|7529187|FG000|STARTED|EG Scan II (Day 1)||50
6604513|NCT02066233|7529188|FG001|STARTED|EG Scan II (Day 1)||50
6604514|NCT02066233|7529187|FG000|COMPLETED|EG Scan II (Day 1)||44
6604515|NCT02066233|7529188|FG001|COMPLETED|EG Scan II (Day 1)||44
6604516|NCT02066233|7529187|FG000|NOT COMPLETED|EG Scan II (Day 1)||6
6604517|NCT02066233|7529188|FG001|NOT COMPLETED|EG Scan II (Day 1)||6
6604518|NCT02066233|7529187|FG000|STARTED|Standard Endoscopy (Day 2)||44
6604519|NCT02066233|7529188|FG001|STARTED|Standard Endoscopy (Day 2)||44
6604520|NCT02066233|7529187|FG000|COMPLETED|Standard Endoscopy (Day 2)||44
6604521|NCT02066233|7529188|FG001|COMPLETED|Standard Endoscopy (Day 2)||44
6604522|NCT02066233|7529187|FG000|NOT COMPLETED|Standard Endoscopy (Day 2)||0
6604523|NCT02066233|7529188|FG001|NOT COMPLETED|Standard Endoscopy (Day 2)||0
6604524|NCT02066298|7529200|FG000|STARTED|Overall Study||49
6604525|NCT02066298|7529201|FG001|STARTED|Overall Study||48
6604526|NCT02066298|7529202|FG002|STARTED|Overall Study||50
6604527|NCT02066298|7529203|FG003|STARTED|Overall Study||51
6604528|NCT02066298|7529204|FG004|STARTED|Overall Study||47
6604529|NCT02066298|7529205|FG005|STARTED|Overall Study||50
6604530|NCT02066298|7529200|FG000|Completed 1st Period|Overall Study||44
6604531|NCT02066298|7529201|FG001|Completed 1st Period|Overall Study||47
6604532|NCT02066298|7529202|FG002|Completed 1st Period|Overall Study||45
6604533|NCT02066298|7529203|FG003|Completed 1st Period|Overall Study||48
6604534|NCT02066298|7529204|FG004|Completed 1st Period|Overall Study||46
6604535|NCT02066298|7529205|FG005|Completed 1st Period|Overall Study||45
6604536|NCT02066298|7529200|FG000|Completed 2nd Period|Overall Study||41
6604537|NCT02066298|7529201|FG001|Completed 2nd Period|Overall Study||41
6604538|NCT02066298|7529202|FG002|Completed 2nd Period|Overall Study||41
6604539|NCT02066298|7529203|FG003|Completed 2nd Period|Overall Study||46
6604540|NCT02066298|7529204|FG004|Completed 2nd Period|Overall Study||42
6604541|NCT02066298|7529205|FG005|Completed 2nd Period|Overall Study||41
6604542|NCT02066298|7529200|FG000|Completed 3rd Period|Overall Study||40
6604543|NCT02066298|7529201|FG001|Completed 3rd Period|Overall Study||40
6604544|NCT02066298|7529202|FG002|Completed 3rd Period|Overall Study||40
6604545|NCT02066298|7529203|FG003|Completed 3rd Period|Overall Study||45
6604546|NCT02066298|7529204|FG004|Completed 3rd Period|Overall Study||38
6604547|NCT02066298|7529205|FG005|Completed 3rd Period|Overall Study||38
6604548|NCT02066298|7529200|FG000|COMPLETED|Overall Study||40
6604549|NCT02066298|7529201|FG001|COMPLETED|Overall Study||40
6604550|NCT02066298|7529202|FG002|COMPLETED|Overall Study||40
6604551|NCT02066298|7529203|FG003|COMPLETED|Overall Study||45
6604552|NCT02066298|7529204|FG004|COMPLETED|Overall Study||38
6604553|NCT02066298|7529205|FG005|COMPLETED|Overall Study||38
6604554|NCT02066298|7529200|FG000|NOT COMPLETED|Overall Study||9
6604555|NCT02066298|7529201|FG001|NOT COMPLETED|Overall Study||8
6604556|NCT02066298|7529202|FG002|NOT COMPLETED|Overall Study||10
6604557|NCT02066298|7529203|FG003|NOT COMPLETED|Overall Study||6
6732108|NCT03188185|7661468|FG000|NOT COMPLETED|Stage 1||19
6732109|NCT03188185|7661469|FG001|NOT COMPLETED|Stage 1||16
6732110|NCT03188185|7661470|FG002|NOT COMPLETED|Stage 1||0
6732111|NCT03188185|7661471|FG003|NOT COMPLETED|Stage 1||0
6732112|NCT03188185|7661468|FG000|STARTED|Stage 2||0
6732113|NCT03188185|7661469|FG001|STARTED|Stage 2||0
6732114|NCT03188185|7661470|FG002|STARTED|Stage 2||64
6732115|NCT03188185|7661471|FG003|STARTED|Stage 2||63
6732116|NCT03188185|7661468|FG000|COMPLETED|Stage 2||0
6732117|NCT03188185|7661469|FG001|COMPLETED|Stage 2||0
6732118|NCT03188185|7661470|FG002|COMPLETED|Stage 2||55
6732119|NCT03188185|7661471|FG003|COMPLETED|Stage 2||57
6732120|NCT03188185|7661468|FG000|NOT COMPLETED|Stage 2||0
6732121|NCT03188185|7661469|FG001|NOT COMPLETED|Stage 2||0
6732122|NCT03188185|7661470|FG002|NOT COMPLETED|Stage 2||9
6732123|NCT03188185|7661471|FG003|NOT COMPLETED|Stage 2||6
6732124|NCT03188263|7661483|FG000|STARTED|Overall Study||10
6732125|NCT03188263|7661484|FG001|STARTED|Overall Study||0
6732126|NCT03188263|7661483|FG000|COMPLETED|Overall Study||6
6732127|NCT03188263|7661484|FG001|COMPLETED|Overall Study||0
6732128|NCT03188263|7661483|FG000|NOT COMPLETED|Overall Study||4
6732129|NCT03188263|7661484|FG001|NOT COMPLETED|Overall Study||0
6732130|NCT03188523|7661492|FG000|STARTED|Overall Study||6
6732131|NCT03188523|7661493|FG001|STARTED|Overall Study||6
6732132|NCT03188523|7661494|FG002|STARTED|Overall Study||0
6732133|NCT03188523|7661495|FG003|STARTED|Overall Study||0
6732134|NCT03188523|7661492|FG000|COMPLETED|Overall Study||6
6732135|NCT03188523|7661493|FG001|COMPLETED|Overall Study||6
6732136|NCT03188523|7661494|FG002|COMPLETED|Overall Study||0
6732137|NCT03188523|7661495|FG003|COMPLETED|Overall Study||0
6732138|NCT03188523|7661492|FG000|NOT COMPLETED|Overall Study||0
6732139|NCT03188523|7661493|FG001|NOT COMPLETED|Overall Study||0
6732140|NCT03188523|7661494|FG002|NOT COMPLETED|Overall Study||0
6732141|NCT03188523|7661495|FG003|NOT COMPLETED|Overall Study||0
6732142|NCT03188536|7661501|FG000|STARTED|Overall Study||282
6732143|NCT03188536|7661501|FG000|COMPLETED|Overall Study||276
6732144|NCT03188536|7661501|FG000|NOT COMPLETED|Overall Study||6
6732145|NCT03188718|7661505|FG000|STARTED|Overall Study||45
6732146|NCT03188718|7661505|FG000|COMPLETED|Overall Study||37
6732147|NCT03188718|7661505|FG000|NOT COMPLETED|Overall Study||8
6732148|NCT03188991|7661513|FG000|STARTED|Overall Study||3
6732149|NCT03188991|7661514|FG001|STARTED|Overall Study||3
6732150|NCT03188991|7661515|FG002|STARTED|Overall Study||3
6732151|NCT03188991|7661516|FG003|STARTED|Overall Study||11
6732152|NCT03188991|7661513|FG000|COMPLETED|Overall Study||3
6732153|NCT03188991|7661514|FG001|COMPLETED|Overall Study||3
6732154|NCT03188991|7661515|FG002|COMPLETED|Overall Study||3
6732155|NCT03188991|7661516|FG003|COMPLETED|Overall Study||10
6732156|NCT03188991|7661513|FG000|NOT COMPLETED|Overall Study||0
6732157|NCT03188991|7661514|FG001|NOT COMPLETED|Overall Study||0
6732158|NCT03188991|7661515|FG002|NOT COMPLETED|Overall Study||0
6732159|NCT03188991|7661516|FG003|NOT COMPLETED|Overall Study||1
6732160|NCT03189134|7661526|FG000|STARTED|Overall Study||6
6732161|NCT03189134|7661526|FG000|COMPLETED|Overall Study||6
6732162|NCT03189134|7661526|FG000|NOT COMPLETED|Overall Study||0
6732163|NCT03189446|7661530|FG000|STARTED|Overall Study||32
6732164|NCT03189446|7661530|FG000|COMPLETED|Overall Study||27
6732165|NCT03189446|7661530|FG000|NOT COMPLETED|Overall Study||5
6604558|NCT02066298|7529204|FG004|NOT COMPLETED|Overall Study||9
6604559|NCT02066298|7529205|FG005|NOT COMPLETED|Overall Study||12
6604560|NCT02066311|7529217|FG000|STARTED|Overall Study||15
6604561|NCT02066311|7529217|FG000|COMPLETED|Overall Study|Stage 1 terminated 6/1/18 prior to completion of Stage 1 due to low enrollment and efficacy.|10
6604562|NCT02066311|7529217|FG000|NOT COMPLETED|Overall Study||5
6604563|NCT02066389|7529227|FG000|STARTED|Overall Study||50
6604564|NCT02066389|7529228|FG001|STARTED|Overall Study||50
6604565|NCT02066389|7529229|FG002|STARTED|Overall Study||50
6604566|NCT02066389|7529230|FG003|STARTED|Overall Study||50
6604567|NCT02066389|7529231|FG004|STARTED|Overall Study||50
6604568|NCT02066389|7529232|FG005|STARTED|Overall Study||50
6604569|NCT02066389|7529227|FG000|Received Study Drug|Overall Study||50
6604570|NCT02066389|7529228|FG001|Received Study Drug|Overall Study||50
6604571|NCT02066389|7529229|FG002|Received Study Drug|Overall Study||50
6604572|NCT02066389|7529230|FG003|Received Study Drug|Overall Study||50
6604573|NCT02066389|7529231|FG004|Received Study Drug|Overall Study||50
6604574|NCT02066389|7529232|FG005|Received Study Drug|Overall Study||49
6604575|NCT02066389|7529227|FG000|COMPLETED|Overall Study||45
6604576|NCT02066389|7529228|FG001|COMPLETED|Overall Study||49
6604577|NCT02066389|7529229|FG002|COMPLETED|Overall Study||44
6604578|NCT02066389|7529230|FG003|COMPLETED|Overall Study||47
6604579|NCT02066389|7529231|FG004|COMPLETED|Overall Study||43
6604580|NCT02066389|7529232|FG005|COMPLETED|Overall Study||45
6604581|NCT02066389|7529227|FG000|NOT COMPLETED|Overall Study||5
6604582|NCT02066389|7529228|FG001|NOT COMPLETED|Overall Study||1
6604583|NCT02066389|7529229|FG002|NOT COMPLETED|Overall Study||6
6604584|NCT02066389|7529230|FG003|NOT COMPLETED|Overall Study||3
6604585|NCT02066389|7529231|FG004|NOT COMPLETED|Overall Study||7
6604586|NCT02066389|7529232|FG005|NOT COMPLETED|Overall Study||5
6604587|NCT02066402|7529248|FG000|STARTED|Overall Study||300
6604588|NCT02066402|7529249|FG001|STARTED|Overall Study||298
6604589|NCT02066402|7529248|FG000|Participants Received Treatment|Overall Study||292
6604590|NCT02066402|7529249|FG001|Participants Received Treatment|Overall Study||297
6604591|NCT02066402|7529248|FG000|Completed Study Treatment Period|Overall Study||261
6604592|NCT02066402|7529249|FG001|Completed Study Treatment Period|Overall Study||256
6604593|NCT02066402|7529248|FG000|COMPLETED|Overall Study||274
6604594|NCT02066402|7529249|FG001|COMPLETED|Overall Study||275
6604595|NCT02066402|7529248|FG000|NOT COMPLETED|Overall Study||26
6604596|NCT02066402|7529249|FG001|NOT COMPLETED|Overall Study||23
6604609|NCT02066467|7529268|FG000|STARTED|Overall Study||863
6604610|NCT02066467|7529268|FG000|COMPLETED|Overall Study||648
6604611|NCT02066467|7529268|FG000|NOT COMPLETED|Overall Study||215
6604612|NCT02066727|7529274|FG000|STARTED|Overall Study||30
6604613|NCT02066727|7529275|FG001|STARTED|Overall Study||30
6604614|NCT02066727|7529274|FG000|COMPLETED|Overall Study||30
6604615|NCT02066727|7529275|FG001|COMPLETED|Overall Study||30
6604616|NCT02066727|7529274|FG000|NOT COMPLETED|Overall Study||0
6604617|NCT02066727|7529275|FG001|NOT COMPLETED|Overall Study||0
6604618|NCT02066740|7529281|FG000|STARTED|Overall Study||34
6604619|NCT02066740|7529281|FG000|COMPLETED|Overall Study||32
6604620|NCT02066740|7529281|FG000|NOT COMPLETED|Overall Study||2
6604621|NCT02066792|7529289|FG000|STARTED|Overall Study||40
6604622|NCT02066792|7529290|FG001|STARTED|Overall Study||38
6604623|NCT02066792|7529291|FG002|STARTED|Overall Study||38
6604624|NCT02066792|7529292|FG003|STARTED|Overall Study||36
6604625|NCT02066792|7529289|FG000|COMPLETED|Overall Study||33
6604626|NCT02066792|7529290|FG001|COMPLETED|Overall Study||33
6604627|NCT02066792|7529291|FG002|COMPLETED|Overall Study||30
6604628|NCT02066792|7529292|FG003|COMPLETED|Overall Study||27
6604629|NCT02066792|7529289|FG000|NOT COMPLETED|Overall Study||7
6604630|NCT02066792|7529290|FG001|NOT COMPLETED|Overall Study||5
6604631|NCT02066792|7529291|FG002|NOT COMPLETED|Overall Study||8
6604632|NCT02066792|7529292|FG003|NOT COMPLETED|Overall Study||9
6604633|NCT02066857|7529304|FG000|STARTED|Overall Study||1
6604634|NCT02066857|7529305|FG001|STARTED|Overall Study||4
6604635|NCT02066857|7529304|FG000|COMPLETED|Overall Study||0
6604636|NCT02066857|7529305|FG001|COMPLETED|Overall Study||3
6604637|NCT02066857|7529304|FG000|NOT COMPLETED|Overall Study||1
6604638|NCT02066857|7529305|FG001|NOT COMPLETED|Overall Study||1
6604639|NCT02066896|7529314|FG000|STARTED|Overall Study||33
6604640|NCT02066896|7529315|FG001|STARTED|Overall Study||33
6604641|NCT02066896|7529314|FG000|COMPLETED|Overall Study||33
6604642|NCT02066896|7529315|FG001|COMPLETED|Overall Study||33
6604643|NCT02066896|7529314|FG000|NOT COMPLETED|Overall Study||0
6604644|NCT02066896|7529315|FG001|NOT COMPLETED|Overall Study||0
6604645|NCT02066922|7529321|FG000|STARTED|Overall Study||15
6604646|NCT02066922|7529321|FG000|COMPLETED|Overall Study||14
6604647|NCT02066922|7529321|FG000|NOT COMPLETED|Overall Study||1
6604648|NCT02067000|7529328|FG000|STARTED|Overall Study||217
6604649|NCT02067000|7529328|FG000|COMPLETED|Overall Study||167
6604650|NCT02067000|7529328|FG000|NOT COMPLETED|Overall Study||50
6604651|NCT02067039|7529334|FG000|STARTED|Overall Study||1325
6604652|NCT02067039|7529335|FG001|STARTED|Overall Study||1340
6604653|NCT02067039|7529334|FG000|3 Month Survey|Overall Study||824
6604654|NCT02067039|7529335|FG001|3 Month Survey|Overall Study||766
6604655|NCT02067039|7529334|FG000|6 Month Survey|Overall Study||735
6604656|NCT02067039|7529335|FG001|6 Month Survey|Overall Study||756
6604657|NCT02067039|7529334|FG000|9 Month Survey|Overall Study||748
6604658|NCT02067039|7529335|FG001|9 Month Survey|Overall Study||838
6604659|NCT02067039|7529334|FG000|COMPLETED|Overall Study||752
6604660|NCT02067039|7529335|FG001|COMPLETED|Overall Study||832
6604661|NCT02067039|7529334|FG000|NOT COMPLETED|Overall Study||573
6604662|NCT02067039|7529335|FG001|NOT COMPLETED|Overall Study||508
6604663|NCT02067273|7529345|FG000|STARTED|Overall Study||5
6604664|NCT02067273|7529346|FG001|STARTED|Overall Study||15
6604665|NCT02067273|7529345|FG000|COMPLETED|Overall Study||5
6604666|NCT02067273|7529346|FG001|COMPLETED|Overall Study||12
6604667|NCT02067273|7529345|FG000|NOT COMPLETED|Overall Study||0
6604668|NCT02067273|7529346|FG001|NOT COMPLETED|Overall Study||3
6604669|NCT02067468|7529355|FG000|STARTED|Overall Study||882
6604670|NCT02067468|7529356|FG001|STARTED|Overall Study||890
6604671|NCT02067468|7529357|FG002|STARTED|Overall Study||889
6604672|NCT02067468|7529355|FG000|Followed-up Through Medical Records|Overall Study||882
6604673|NCT02067468|7529356|FG001|Followed-up Through Medical Records|Overall Study||890
6604674|NCT02067468|7529357|FG002|Followed-up Through Medical Records|Overall Study||889
6604675|NCT02067468|7529355|FG000|Had at Least One Routine Colposcopy|Overall Study||772
6604676|NCT02067468|7529356|FG001|Had at Least One Routine Colposcopy|Overall Study||372
6604677|NCT02067468|7529357|FG002|Had at Least One Routine Colposcopy|Overall Study||462
6604678|NCT02067468|7529355|FG000|COMPLETED|Overall Study||882
6604679|NCT02067468|7529356|FG001|COMPLETED|Overall Study||890
6604680|NCT02067468|7529357|FG002|COMPLETED|Overall Study||889
6604681|NCT02067468|7529355|FG000|NOT COMPLETED|Overall Study||0
6604682|NCT02067468|7529356|FG001|NOT COMPLETED|Overall Study||0
6604683|NCT02067468|7529357|FG002|NOT COMPLETED|Overall Study||0
6604684|NCT02067533|7529367|FG000|STARTED|Overall Study||45
6604685|NCT02067533|7529368|FG001|STARTED|Overall Study||46
6604686|NCT02067533|7529367|FG000|COMPLETED|Overall Study||41
6604687|NCT02067533|7529368|FG001|COMPLETED|Overall Study||44
6604688|NCT02067533|7529367|FG000|NOT COMPLETED|Overall Study||4
6604689|NCT02067533|7529368|FG001|NOT COMPLETED|Overall Study||2
6604690|NCT02067585|7529377|FG000|STARTED|Overall Study||16
6604691|NCT02067585|7529378|FG001|STARTED|Overall Study||16
6604692|NCT02067585|7529379|FG002|STARTED|Overall Study||16
6604693|NCT02067585|7529377|FG000|COMPLETED|Overall Study||16
6604694|NCT02067585|7529378|FG001|COMPLETED|Overall Study||16
6604695|NCT02067585|7529379|FG002|COMPLETED|Overall Study||16
6604696|NCT02067585|7529377|FG000|NOT COMPLETED|Overall Study||0
6604697|NCT02067585|7529378|FG001|NOT COMPLETED|Overall Study||0
6604698|NCT02067585|7529379|FG002|NOT COMPLETED|Overall Study||0
6604699|NCT02067663|7529389|FG000|STARTED|Overall Study||68
6604700|NCT02067663|7529390|FG001|STARTED|Overall Study||55
6604701|NCT02067663|7529389|FG000|COMPLETED|Overall Study||55
6604702|NCT02067663|7529390|FG001|COMPLETED|Overall Study||41
6604703|NCT02067663|7529389|FG000|NOT COMPLETED|Overall Study||13
6604704|NCT02067663|7529390|FG001|NOT COMPLETED|Overall Study||14
6604705|NCT02067676|7529402|FG000|STARTED|Overall Study||8
6604706|NCT02067676|7529403|FG001|STARTED|Overall Study||8
6604707|NCT02067676|7529404|FG002|STARTED|Overall Study||8
6604708|NCT02067676|7529405|FG003|STARTED|Overall Study||8
6604709|NCT02067676|7529406|FG004|STARTED|Overall Study||8
6604710|NCT02067676|7529407|FG005|STARTED|Overall Study||8
6604711|NCT02067676|7529402|FG000|COMPLETED|Overall Study||7
6604712|NCT02067676|7529403|FG001|COMPLETED|Overall Study||8
6604713|NCT02067676|7529404|FG002|COMPLETED|Overall Study||8
6604714|NCT02067676|7529405|FG003|COMPLETED|Overall Study||8
6604715|NCT02067676|7529406|FG004|COMPLETED|Overall Study||8
6604716|NCT02067676|7529407|FG005|COMPLETED|Overall Study||8
6604717|NCT02067676|7529402|FG000|NOT COMPLETED|Overall Study||1
6604718|NCT02067676|7529403|FG001|NOT COMPLETED|Overall Study||0
6604719|NCT02067676|7529404|FG002|NOT COMPLETED|Overall Study||0
6604720|NCT02067676|7529405|FG003|NOT COMPLETED|Overall Study||0
6604721|NCT02067676|7529406|FG004|NOT COMPLETED|Overall Study||0
6604722|NCT02067676|7529407|FG005|NOT COMPLETED|Overall Study||0
6604723|NCT02067728|7529428|FG000|STARTED|Baseline - 1 Month Follow up Survey||220
6604724|NCT02067728|7529429|FG001|STARTED|Baseline - 1 Month Follow up Survey||210
6604725|NCT02067728|7529428|FG000|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
6604726|NCT02067728|7529429|FG001|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
6604727|NCT02067728|7529428|FG000|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
6604728|NCT02067728|7529429|FG001|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
6604729|NCT02067728|7529428|FG000|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
6604730|NCT02067728|7529429|FG001|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
6604731|NCT02067728|7529428|FG000|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
6604732|NCT02067728|7529429|FG001|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
6604733|NCT02067728|7529428|FG000|NOT COMPLETED|6 Month Follow up Survey||48
6604734|NCT02067728|7529429|FG001|NOT COMPLETED|6 Month Follow up Survey||60
6604735|NCT02067728|7529428|FG000|STARTED|6 Month Measurements||220
6604736|NCT02067728|7529429|FG001|STARTED|6 Month Measurements||210
6604737|NCT02067728|7529428|FG000|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
6604738|NCT02067728|7529429|FG001|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
6604739|NCT02067728|7529428|FG000|NOT COMPLETED|6 Month Measurements||114
6604740|NCT02067728|7529429|FG001|NOT COMPLETED|6 Month Measurements||97
6604741|NCT02067806|7529435|FG000|STARTED|Overall Study||394
6604742|NCT02067806|7529435|FG000|COMPLETED|Overall Study||387
6604743|NCT02067806|7529435|FG000|NOT COMPLETED|Overall Study||7
6604744|NCT02067858|7529440|FG000|STARTED|Overall Study||6
6604745|NCT02067858|7529440|FG000|COMPLETED|Overall Study||6
6604746|NCT02067858|7529440|FG000|NOT COMPLETED|Overall Study||0
6604747|NCT02068027|7529446|FG000|STARTED|Overall Study||130
6604748|NCT02068027|7529447|FG001|STARTED|Overall Study||130
6604749|NCT02068027|7529446|FG000|COMPLETED|Overall Study||117
6604750|NCT02068027|7529447|FG001|COMPLETED|Overall Study||114
6604751|NCT02068027|7529446|FG000|NOT COMPLETED|Overall Study||13
6604752|NCT02068027|7529447|FG001|NOT COMPLETED|Overall Study||16
6604753|NCT02068118|7529455|FG000|STARTED|18-month Comparative Study Period||455
6604754|NCT02068118|7529456|FG001|STARTED|18-month Comparative Study Period||482
6604755|NCT02068118|7529455|FG000|COMPLETED|18-month Comparative Study Period||327
6604756|NCT02068118|7529456|FG001|COMPLETED|18-month Comparative Study Period||305
6604757|NCT02068118|7529455|FG000|NOT COMPLETED|18-month Comparative Study Period||128
6604758|NCT02068118|7529456|FG001|NOT COMPLETED|18-month Comparative Study Period||177
6604759|NCT02068118|7529455|FG000|STARTED|Extension Period|Standard Care/Tele-cardiology : Patients entered Period 2 if they wished and consented|7
6604760|NCT02068118|7529456|FG001|STARTED|Extension Period|Tele-cardiology/Tele-cardiology : Patients entered Period 2 if they wished and consented|13
6604761|NCT02068118|7529455|FG000|COMPLETED|Extension Period||5
6604762|NCT02068118|7529456|FG001|COMPLETED|Extension Period||10
6604763|NCT02068118|7529455|FG000|NOT COMPLETED|Extension Period||2
6604764|NCT02068118|7529456|FG001|NOT COMPLETED|Extension Period||3
6604765|NCT02068157|7529464|FG000|STARTED|Overall Study||3
6604766|NCT02068157|7529464|FG000|COMPLETED|Overall Study||3
6604767|NCT02068157|7529464|FG000|NOT COMPLETED|Overall Study||0
6604768|NCT02068222|7529468|FG000|STARTED|Overall Study||10
6604769|NCT02068222|7529468|FG000|COMPLETED|Overall Study||9
6604770|NCT02068222|7529468|FG000|NOT COMPLETED|Overall Study||1
6604771|NCT02068352|7529475|FG000|STARTED|Overall Study||41
6604772|NCT02068352|7529476|FG001|STARTED|Overall Study||43
6604773|NCT02068352|7529477|FG002|STARTED|Overall Study||37
6604774|NCT02068352|7529475|FG000|COMPLETED|Overall Study||31
6604775|NCT02068352|7529476|FG001|COMPLETED|Overall Study||35
6604776|NCT02068352|7529477|FG002|COMPLETED|Overall Study||28
6604777|NCT02068352|7529475|FG000|NOT COMPLETED|Overall Study||10
6604778|NCT02068352|7529476|FG001|NOT COMPLETED|Overall Study||8
6604779|NCT02068352|7529477|FG002|NOT COMPLETED|Overall Study||9
6604780|NCT02068443|7529488|FG000|STARTED|Overall Study||71
6604781|NCT02068443|7529489|FG001|STARTED|Overall Study||152
6604782|NCT02068443|7529490|FG002|STARTED|Overall Study||151
6604783|NCT02068443|7529488|FG000|COMPLETED|Overall Study||64
6604784|NCT02068443|7529489|FG001|COMPLETED|Overall Study||146
6604785|NCT02068443|7529490|FG002|COMPLETED|Overall Study||148
6604786|NCT02068443|7529488|FG000|NOT COMPLETED|Overall Study||7
6604787|NCT02068443|7529489|FG001|NOT COMPLETED|Overall Study||6
6604788|NCT02068443|7529490|FG002|NOT COMPLETED|Overall Study||3
6604789|NCT02068495|7529498|FG000|STARTED|Overall Study||3409
6604790|NCT02068495|7529498|FG000|COMPLETED|Overall Study||3300
6604791|NCT02068495|7529498|FG000|NOT COMPLETED|Overall Study||109
6604792|NCT02068508|7529502|FG000|STARTED|Overall Study||1067
6604793|NCT02068508|7529502|FG000|COMPLETED|Overall Study||1035
6604794|NCT02068508|7529502|FG000|NOT COMPLETED|Overall Study||32
6604795|NCT02068599|7529509|FG000|STARTED|Overall Study||130
6604796|NCT02068599|7529510|FG001|STARTED|Overall Study||129
6604797|NCT02068599|7529511|FG002|STARTED|Overall Study||130
6604798|NCT02068599|7529509|FG000|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|129
6604799|NCT02068599|7529510|FG001|Safety Analysis Set|Overall Study|One participant withdrew before taking any study drug.|128
6604800|NCT02068599|7529511|FG002|Safety Analysis Set|Overall Study||130
6604801|NCT02068599|7529509|FG000|Full Analysis Set|Overall Study||129
6604802|NCT02068599|7529510|FG001|Full Analysis Set|Overall Study||128
6604803|NCT02068599|7529511|FG002|Full Analysis Set|Overall Study||130
6604804|NCT02068599|7529509|FG000|COMPLETED|Overall Study||119
6604805|NCT02068599|7529510|FG001|COMPLETED|Overall Study||119
6604806|NCT02068599|7529511|FG002|COMPLETED|Overall Study||117
6604807|NCT02068599|7529509|FG000|NOT COMPLETED|Overall Study||11
6604808|NCT02068599|7529510|FG001|NOT COMPLETED|Overall Study||10
6604809|NCT02068599|7529511|FG002|NOT COMPLETED|Overall Study||13
6604810|NCT02068729|7529519|FG000|STARTED|Overall Study||131
6604811|NCT02068729|7529519|FG000|COMPLETED|Overall Study||56
6604812|NCT02068729|7529519|FG000|NOT COMPLETED|Overall Study||75
6604813|NCT02068768|7529578|FG000|STARTED|Overall Study||13
6604814|NCT02068768|7529578|FG000|COMPLETED|Overall Study||6
6604815|NCT02068768|7529578|FG000|NOT COMPLETED|Overall Study||7
6604816|NCT02068820|7529584|FG000|STARTED|Overall Study||20
6604817|NCT02068820|7529585|FG001|STARTED|Overall Study||180
6604818|NCT02068820|7529584|FG000|COMPLETED|Overall Study||20
6604819|NCT02068820|7529585|FG001|COMPLETED|Overall Study||180
6604820|NCT02068820|7529584|FG000|NOT COMPLETED|Overall Study||0
6604821|NCT02068820|7529585|FG001|NOT COMPLETED|Overall Study||0
6604822|NCT02068846|7529598|FG000|STARTED|Overall Study||9
6604823|NCT02068846|7529599|FG001|STARTED|Overall Study||8
6604824|NCT02068846|7529598|FG000|COMPLETED|Overall Study||8
6604825|NCT02068846|7529599|FG001|COMPLETED|Overall Study||7
6604826|NCT02068846|7529598|FG000|NOT COMPLETED|Overall Study||1
6604827|NCT02068846|7529599|FG001|NOT COMPLETED|Overall Study||1
6604828|NCT02068885|7529608|FG000|STARTED|Overall Study||57
6604829|NCT02068885|7529609|FG001|STARTED|Overall Study||53
6604830|NCT02068885|7529610|FG002|STARTED|Overall Study||54
6604831|NCT02068885|7529608|FG000|Provided Data at Midpoint Test Phase|Overall Study||56
6604832|NCT02068885|7529609|FG001|Provided Data at Midpoint Test Phase|Overall Study||50
6604833|NCT02068885|7529610|FG002|Provided Data at Midpoint Test Phase|Overall Study||48
6604834|NCT02068885|7529608|FG000|Provided Data at End of Test Phase|Overall Study||54
6604835|NCT02068885|7529609|FG001|Provided Data at End of Test Phase|Overall Study||48
6604836|NCT02068885|7529610|FG002|Provided Data at End of Test Phase|Overall Study||46
6604837|NCT02068885|7529608|FG000|Included in Intention-to-treat Analysis|Overall Study||56
6604838|NCT02068885|7529609|FG001|Included in Intention-to-treat Analysis|Overall Study||52
6604839|NCT02068885|7529610|FG002|Included in Intention-to-treat Analysis|Overall Study||54
6604840|NCT02068885|7529608|FG000|COMPLETED|Overall Study||54
6604841|NCT02068885|7529609|FG001|COMPLETED|Overall Study||48
6604842|NCT02068885|7529610|FG002|COMPLETED|Overall Study||46
6604843|NCT02068885|7529608|FG000|NOT COMPLETED|Overall Study||3
6604844|NCT02068885|7529609|FG001|NOT COMPLETED|Overall Study||5
6604845|NCT02068885|7529610|FG002|NOT COMPLETED|Overall Study||8
6604846|NCT02069015|7529621|FG000|STARTED|Overall Study|Baseline and enrollment at Emergency Department (ED)|71
6604847|NCT02069015|7529622|FG001|STARTED|Overall Study||68
6604848|NCT02069015|7529621|FG000|7 Day|Overall Study|7 day post ED discharge at Clinical Research Center (CRC)|44
6604849|NCT02069015|7529622|FG001|7 Day|Overall Study|7 day post ED discharge at CRC|45
6604850|NCT02069015|7529621|FG000|30 Day|Overall Study|30 day post-discharge at CRC|38
6604851|NCT02069015|7529622|FG001|30 Day|Overall Study|30 day post-discharge at CRC|43
6604852|NCT02069015|7529621|FG000|90 Day|Overall Study|90 day post ED discharge at CRC|32
6604853|NCT02069015|7529622|FG001|90 Day|Overall Study|90 day post ED discharge|35
6604854|NCT02069015|7529621|FG000|COMPLETED|Overall Study|180 post ED discharge at CRC|31
6604855|NCT02069015|7529622|FG001|COMPLETED|Overall Study|180 day post ED discharge at CRC|35
6604856|NCT02069015|7529621|FG000|NOT COMPLETED|Overall Study||40
6604857|NCT02069015|7529622|FG001|NOT COMPLETED|Overall Study||33
6604858|NCT02069041|7529629|FG000|STARTED|Overall Study||8
6604859|NCT02069041|7529629|FG000|Received at Least One Dose of Study Drug|Overall Study||8
6604860|NCT02069041|7529629|FG000|COMPLETED|Overall Study||8
6604861|NCT02069041|7529629|FG000|NOT COMPLETED|Overall Study||0
6604862|NCT02069093|7529633|FG000|STARTED|Overall Study||86
6604863|NCT02069093|7529633|FG000|Pharmacokinetic Analysis Set|Overall Study||50
6604864|NCT02069093|7529633|FG000|COMPLETED|Overall Study||56
6604865|NCT02069093|7529633|FG000|NOT COMPLETED|Overall Study||30
6604866|NCT02069119|7529641|FG000|STARTED|Overall Study||20
6604867|NCT02069119|7529642|FG001|STARTED|Overall Study||4
6604868|NCT02069119|7529643|FG002|STARTED|Overall Study||20
6604869|NCT02069119|7529644|FG003|STARTED|Overall Study||4
6604870|NCT02069119|7529641|FG000|COMPLETED|Overall Study||20
6604871|NCT02069119|7529642|FG001|COMPLETED|Overall Study||4
6604872|NCT02069119|7529643|FG002|COMPLETED|Overall Study||20
6604873|NCT02069119|7529644|FG003|COMPLETED|Overall Study||4
6604874|NCT02069119|7529641|FG000|NOT COMPLETED|Overall Study||0
6604875|NCT02069119|7529642|FG001|NOT COMPLETED|Overall Study||0
6604876|NCT02069119|7529643|FG002|NOT COMPLETED|Overall Study||0
6604877|NCT02069119|7529644|FG003|NOT COMPLETED|Overall Study||0
6604878|NCT02069184|7529658|FG000|STARTED|Overall Study||33
6604879|NCT02069184|7529659|FG001|STARTED|Overall Study||33
6604880|NCT02069184|7529658|FG000|COMPLETED|Overall Study||27
6604881|NCT02069184|7529659|FG001|COMPLETED|Overall Study||31
6604882|NCT02069184|7529658|FG000|NOT COMPLETED|Overall Study||6
6604883|NCT02069184|7529659|FG001|NOT COMPLETED|Overall Study||2
6604884|NCT02069353|7529665|FG000|STARTED|Overall Study||4
6604885|NCT02069353|7529665|FG000|COMPLETED|Overall Study||4
6604886|NCT02069353|7529665|FG000|NOT COMPLETED|Overall Study||0
6604887|NCT02069379|7529671|FG000|STARTED|Baseline Measurements||30
6604888|NCT02069379|7529672|FG001|STARTED|Baseline Measurements||4
6604889|NCT02069379|7529673|FG002|STARTED|Baseline Measurements||2
6604890|NCT02069379|7529674|FG003|STARTED|Baseline Measurements||6
6604891|NCT02069379|7529671|FG000|Baseline Measurements Taken|Baseline Measurements||30
6604892|NCT02069379|7529672|FG001|Baseline Measurements Taken|Baseline Measurements||4
6604893|NCT02069379|7529673|FG002|Baseline Measurements Taken|Baseline Measurements||2
6604894|NCT02069379|7529674|FG003|Baseline Measurements Taken|Baseline Measurements||6
6604895|NCT02069379|7529671|FG000|COMPLETED|Baseline Measurements||27
6604896|NCT02069379|7529672|FG001|COMPLETED|Baseline Measurements||4
6604897|NCT02069379|7529673|FG002|COMPLETED|Baseline Measurements||2
6604898|NCT02069379|7529674|FG003|COMPLETED|Baseline Measurements||4
6604899|NCT02069379|7529671|FG000|NOT COMPLETED|Baseline Measurements||3
6604900|NCT02069379|7529672|FG001|NOT COMPLETED|Baseline Measurements||0
6604901|NCT02069379|7529673|FG002|NOT COMPLETED|Baseline Measurements||0
6604902|NCT02069379|7529674|FG003|NOT COMPLETED|Baseline Measurements||2
6604903|NCT02069379|7529671|FG000|STARTED|First Treatment Arm|Controls are not involved after initial baseline collection|0
6604904|NCT02069379|7529672|FG001|STARTED|First Treatment Arm||4
6604905|NCT02069379|7529673|FG002|STARTED|First Treatment Arm||2
6604906|NCT02069379|7529674|FG003|STARTED|First Treatment Arm|Insulin resistant woman not randomized are not involved after initial baseline collection|0
6604907|NCT02069379|7529671|FG000|COMPLETED|First Treatment Arm||0
6604908|NCT02069379|7529672|FG001|COMPLETED|First Treatment Arm||3
6604909|NCT02069379|7529673|FG002|COMPLETED|First Treatment Arm||1
6604910|NCT02069379|7529674|FG003|COMPLETED|First Treatment Arm||0
6604911|NCT02069379|7529671|FG000|NOT COMPLETED|First Treatment Arm||0
6604912|NCT02069379|7529672|FG001|NOT COMPLETED|First Treatment Arm||1
6604913|NCT02069379|7529673|FG002|NOT COMPLETED|First Treatment Arm||1
6604914|NCT02069379|7529674|FG003|NOT COMPLETED|First Treatment Arm||0
6604915|NCT02069379|7529671|FG000|STARTED|Washout Period (4 Weeks)|Controls are not involved after initial baseline collection|0
6604916|NCT02069379|7529672|FG001|STARTED|Washout Period (4 Weeks)||3
6604917|NCT02069379|7529673|FG002|STARTED|Washout Period (4 Weeks)||1
6604918|NCT02069379|7529674|FG003|STARTED|Washout Period (4 Weeks)|Insulin resistant woman who were not randomized are not involved after initial baseline collection|0
6604919|NCT02069379|7529671|FG000|COMPLETED|Washout Period (4 Weeks)||0
6604920|NCT02069379|7529672|FG001|COMPLETED|Washout Period (4 Weeks)||1
6604921|NCT02069379|7529673|FG002|COMPLETED|Washout Period (4 Weeks)||1
6604922|NCT02069379|7529674|FG003|COMPLETED|Washout Period (4 Weeks)||0
6604923|NCT02069379|7529671|FG000|NOT COMPLETED|Washout Period (4 Weeks)||0
6604924|NCT02069379|7529672|FG001|NOT COMPLETED|Washout Period (4 Weeks)||2
6604925|NCT02069379|7529673|FG002|NOT COMPLETED|Washout Period (4 Weeks)||0
6604926|NCT02069379|7529674|FG003|NOT COMPLETED|Washout Period (4 Weeks)||0
6604927|NCT02069379|7529671|FG000|STARTED|Second Treatment Arm|Controls are not involved after initial baseline collection|0
6604928|NCT02069379|7529672|FG001|STARTED|Second Treatment Arm||1
6604929|NCT02069379|7529673|FG002|STARTED|Second Treatment Arm||1
6604930|NCT02069379|7529674|FG003|STARTED|Second Treatment Arm|Insulin resistant women who are not randomized are not involved after initial baseline collection|0
6604931|NCT02069379|7529671|FG000|COMPLETED|Second Treatment Arm||0
6604932|NCT02069379|7529672|FG001|COMPLETED|Second Treatment Arm||1
6604933|NCT02069379|7529673|FG002|COMPLETED|Second Treatment Arm||0
6604934|NCT02069379|7529674|FG003|COMPLETED|Second Treatment Arm||0
6604935|NCT02069379|7529671|FG000|NOT COMPLETED|Second Treatment Arm||0
6604936|NCT02069379|7529672|FG001|NOT COMPLETED|Second Treatment Arm||0
6604937|NCT02069379|7529673|FG002|NOT COMPLETED|Second Treatment Arm||1
6604938|NCT02069379|7529674|FG003|NOT COMPLETED|Second Treatment Arm||0
6604939|NCT02069392|7529686|FG000|STARTED|Overall Study||14
6604940|NCT02069392|7529687|FG001|STARTED|Overall Study||17
6604941|NCT02069392|7529686|FG000|COMPLETED|Overall Study||10
6604942|NCT02069392|7529687|FG001|COMPLETED|Overall Study||15
6604943|NCT02069392|7529686|FG000|NOT COMPLETED|Overall Study||4
6604944|NCT02069392|7529687|FG001|NOT COMPLETED|Overall Study||2
6604945|NCT02069704|7529697|FG000|STARTED|Overall Study|Two patients were randomized but they did not received study treatment|69
6604946|NCT02069704|7529698|FG001|STARTED|Overall Study||71
6604947|NCT02069704|7529697|FG000|COMPLETED|Overall Study||69
6604948|NCT02069704|7529698|FG001|COMPLETED|Overall Study||71
6604949|NCT02069704|7529697|FG000|NOT COMPLETED|Overall Study||0
6604950|NCT02069704|7529698|FG001|NOT COMPLETED|Overall Study||0
6604951|NCT02069847|7529713|FG000|STARTED|Overall Study||22
6604952|NCT02069847|7529714|FG001|STARTED|Overall Study||68
6604953|NCT02069847|7529713|FG000|COMPLETED|Overall Study||22
6604954|NCT02069847|7529714|FG001|COMPLETED|Overall Study||68
6604955|NCT02069847|7529713|FG000|NOT COMPLETED|Overall Study||0
6604956|NCT02069847|7529714|FG001|NOT COMPLETED|Overall Study||0
6604957|NCT02070237|7529721|FG000|STARTED|Overall Study||45
6604958|NCT02070237|7529722|FG001|STARTED|Overall Study||45
6604959|NCT02070237|7529721|FG000|COMPLETED|Overall Study||42
6604960|NCT02070237|7529722|FG001|COMPLETED|Overall Study||42
6604961|NCT02070237|7529721|FG000|NOT COMPLETED|Overall Study||3
6604962|NCT02070237|7529722|FG001|NOT COMPLETED|Overall Study||3
6604963|NCT02070276|7529731|FG000|STARTED|Overall Study||149
6604964|NCT02070276|7529732|FG001|STARTED|Overall Study||132
6604965|NCT02070276|7529733|FG002|STARTED|Overall Study||148
6604966|NCT02070276|7529731|FG000|COMPLETED|Overall Study||149
6604967|NCT02070276|7529732|FG001|COMPLETED|Overall Study||132
6604968|NCT02070276|7529733|FG002|COMPLETED|Overall Study||148
6604969|NCT02070276|7529731|FG000|NOT COMPLETED|Overall Study||0
6604970|NCT02070276|7529732|FG001|NOT COMPLETED|Overall Study||0
6604971|NCT02070276|7529733|FG002|NOT COMPLETED|Overall Study||0
6604972|NCT02070302|7529743|FG000|STARTED|Overall Study||5
6604973|NCT02070302|7529744|FG001|STARTED|Overall Study||5
6604974|NCT02070302|7529743|FG000|COMPLETED|Overall Study||5
6604975|NCT02070302|7529744|FG001|COMPLETED|Overall Study||5
6604976|NCT02070302|7529743|FG000|NOT COMPLETED|Overall Study||0
6604977|NCT02070302|7529744|FG001|NOT COMPLETED|Overall Study||0
6604978|NCT02070380|7529754|FG000|STARTED|First Injection||31
6604979|NCT02070380|7529755|FG001|STARTED|First Injection||39
6604980|NCT02070380|7529756|FG002|STARTED|First Injection||53
6604981|NCT02070380|7529757|FG003|STARTED|First Injection||54
6604982|NCT02070380|7529754|FG000|COMPLETED|First Injection||31
6604983|NCT02070380|7529755|FG001|COMPLETED|First Injection||39
6604984|NCT02070380|7529756|FG002|COMPLETED|First Injection||53
6604985|NCT02070380|7529757|FG003|COMPLETED|First Injection||54
6604986|NCT02070380|7529754|FG000|NOT COMPLETED|First Injection||0
6604987|NCT02070380|7529755|FG001|NOT COMPLETED|First Injection||0
6604988|NCT02070380|7529756|FG002|NOT COMPLETED|First Injection||0
6604989|NCT02070380|7529757|FG003|NOT COMPLETED|First Injection||0
6604990|NCT02070380|7529754|FG000|STARTED|Washout (no Second Injection/MRI)||31
6604991|NCT02070380|7529755|FG001|STARTED|Washout (no Second Injection/MRI)||39
6604992|NCT02070380|7529756|FG002|STARTED|Washout (no Second Injection/MRI)||53
6604993|NCT02070380|7529757|FG003|STARTED|Washout (no Second Injection/MRI)||54
6604994|NCT02070380|7529754|FG000|COMPLETED|Washout (no Second Injection/MRI)||31
6604995|NCT02070380|7529755|FG001|COMPLETED|Washout (no Second Injection/MRI)||34
6604996|NCT02070380|7529756|FG002|COMPLETED|Washout (no Second Injection/MRI)||51
6604997|NCT02070380|7529757|FG003|COMPLETED|Washout (no Second Injection/MRI)||51
6604998|NCT02070380|7529754|FG000|NOT COMPLETED|Washout (no Second Injection/MRI)||0
6604999|NCT02070380|7529755|FG001|NOT COMPLETED|Washout (no Second Injection/MRI)||5
6605000|NCT02070380|7529756|FG002|NOT COMPLETED|Washout (no Second Injection/MRI)||2
6605001|NCT02070380|7529757|FG003|NOT COMPLETED|Washout (no Second Injection/MRI)||3
6605002|NCT02070380|7529754|FG000|STARTED|Second Injection||31
6605003|NCT02070380|7529755|FG001|STARTED|Second Injection||34
6605004|NCT02070380|7529756|FG002|STARTED|Second Injection||51
6605005|NCT02070380|7529757|FG003|STARTED|Second Injection||51
6605006|NCT02070380|7529754|FG000|COMPLETED|Second Injection||31
6605007|NCT02070380|7529755|FG001|COMPLETED|Second Injection||32
6605008|NCT02070380|7529756|FG002|COMPLETED|Second Injection||50
6605009|NCT02070380|7529757|FG003|COMPLETED|Second Injection||46
6605010|NCT02070380|7529754|FG000|NOT COMPLETED|Second Injection||0
6605011|NCT02070380|7529755|FG001|NOT COMPLETED|Second Injection||2
6605012|NCT02070380|7529756|FG002|NOT COMPLETED|Second Injection||1
6605013|NCT02070380|7529757|FG003|NOT COMPLETED|Second Injection||5
6605014|NCT02070484|7529771|FG000|STARTED|Overall Study||3
6605015|NCT02070484|7529772|FG001|STARTED|Overall Study||3
6605016|NCT02070484|7529771|FG000|COMPLETED|Overall Study||2
6605017|NCT02070484|7529772|FG001|COMPLETED|Overall Study||3
6605018|NCT02070484|7529771|FG000|NOT COMPLETED|Overall Study||1
6605019|NCT02070484|7529772|FG001|NOT COMPLETED|Overall Study||0
6605020|NCT02070588|7529781|FG000|STARTED|Overall Study||86
6605021|NCT02070588|7529782|FG001|STARTED|Overall Study||26
6605022|NCT02070588|7529783|FG002|STARTED|Overall Study||0
6605023|NCT02070588|7529781|FG000|COMPLETED|Overall Study||47
6605024|NCT02070588|7529782|FG001|COMPLETED|Overall Study||25
6605025|NCT02070588|7529783|FG002|COMPLETED|Overall Study||0
6605026|NCT02070588|7529781|FG000|NOT COMPLETED|Overall Study||39
6605027|NCT02070588|7529782|FG001|NOT COMPLETED|Overall Study||1
6605028|NCT02070588|7529783|FG002|NOT COMPLETED|Overall Study||0
6605029|NCT02070640|7529793|FG000|STARTED|Overall Study||93
6605030|NCT02070640|7529794|FG001|STARTED|Overall Study||6
6605031|NCT02070640|7529793|FG000|COMPLETED|Overall Study||82
6605032|NCT02070640|7529794|FG001|COMPLETED|Overall Study||6
6605033|NCT02070640|7529793|FG000|NOT COMPLETED|Overall Study||11
6605034|NCT02070640|7529794|FG001|NOT COMPLETED|Overall Study||0
6605035|NCT02070692|7529803|FG000|STARTED|Overall Study||28
6605036|NCT02070692|7529804|FG001|STARTED|Overall Study||28
6605037|NCT02070692|7529803|FG000|COMPLETED|Overall Study||18
6605038|NCT02070692|7529804|FG001|COMPLETED|Overall Study||16
6605039|NCT02070692|7529803|FG000|NOT COMPLETED|Overall Study||10
6605040|NCT02070692|7529804|FG001|NOT COMPLETED|Overall Study||12
6605041|NCT02070744|7529814|FG000|STARTED|PC Phase (12 Weeks)||6
6605042|NCT02070744|7529815|FG001|STARTED|PC Phase (12 Weeks)||5
6605043|NCT02070744|7529816|FG002|STARTED|PC Phase (12 Weeks)||15
6605044|NCT02070744|7529817|FG003|STARTED|PC Phase (12 Weeks)||14
6605045|NCT02070744|7529818|FG004|STARTED|PC Phase (12 Weeks)||0
6605046|NCT02070744|7529814|FG000|Treated|PC Phase (12 Weeks)||6
6605047|NCT02070744|7529815|FG001|Treated|PC Phase (12 Weeks)||5
6605048|NCT02070744|7529816|FG002|Treated|PC Phase (12 Weeks)||15
6605049|NCT02070744|7529817|FG003|Treated|PC Phase (12 Weeks)||13
6605050|NCT02070744|7529818|FG004|Treated|PC Phase (12 Weeks)||0
6605051|NCT02070744|7529814|FG000|COMPLETED|PC Phase (12 Weeks)||6
6605052|NCT02070744|7529815|FG001|COMPLETED|PC Phase (12 Weeks)||5
6605053|NCT02070744|7529816|FG002|COMPLETED|PC Phase (12 Weeks)||15
6605054|NCT02070744|7529817|FG003|COMPLETED|PC Phase (12 Weeks)||13
6605055|NCT02070744|7529818|FG004|COMPLETED|PC Phase (12 Weeks)||0
6605056|NCT02070744|7529814|FG000|NOT COMPLETED|PC Phase (12 Weeks)||0
6605057|NCT02070744|7529815|FG001|NOT COMPLETED|PC Phase (12 Weeks)||0
6605058|NCT02070744|7529816|FG002|NOT COMPLETED|PC Phase (12 Weeks)||0
6605059|NCT02070744|7529817|FG003|NOT COMPLETED|PC Phase (12 Weeks)||1
6605060|NCT02070744|7529818|FG004|NOT COMPLETED|PC Phase (12 Weeks)||0
6605061|NCT02070744|7529814|FG000|STARTED|OLE Phase (48 Weeks)||0
6605062|NCT02070744|7529815|FG001|STARTED|OLE Phase (48 Weeks)||0
6605063|NCT02070744|7529816|FG002|STARTED|OLE Phase (48 Weeks)||0
6605064|NCT02070744|7529817|FG003|STARTED|OLE Phase (48 Weeks)||0
6605065|NCT02070744|7529818|FG004|STARTED|OLE Phase (48 Weeks)|12 participants completed PC phase, but did not enter OLE phase.|27
6605066|NCT02070744|7529814|FG000|COMPLETED|OLE Phase (48 Weeks)||0
6605067|NCT02070744|7529815|FG001|COMPLETED|OLE Phase (48 Weeks)||0
6605068|NCT02070744|7529816|FG002|COMPLETED|OLE Phase (48 Weeks)||0
6605069|NCT02070744|7529817|FG003|COMPLETED|OLE Phase (48 Weeks)||0
6605070|NCT02070744|7529818|FG004|COMPLETED|OLE Phase (48 Weeks)||24
6605071|NCT02070744|7529814|FG000|NOT COMPLETED|OLE Phase (48 Weeks)||0
6605072|NCT02070744|7529815|FG001|NOT COMPLETED|OLE Phase (48 Weeks)||0
6605073|NCT02070744|7529816|FG002|NOT COMPLETED|OLE Phase (48 Weeks)||0
6605074|NCT02070744|7529817|FG003|NOT COMPLETED|OLE Phase (48 Weeks)||0
6605075|NCT02070744|7529818|FG004|NOT COMPLETED|OLE Phase (48 Weeks)||3
6605076|NCT02070757|7529835|FG000|STARTED|Overall Study||362
6605077|NCT02070757|7529836|FG001|STARTED|Overall Study||364
6605078|NCT02070757|7529835|FG000|Treated Participants|Overall Study||361
6605079|NCT02070757|7529836|FG001|Treated Participants|Overall Study||359
6605080|NCT02070757|7529835|FG000|COMPLETED|Overall Study||245
6605081|NCT02070757|7529836|FG001|COMPLETED|Overall Study||250
6605082|NCT02070757|7529835|FG000|NOT COMPLETED|Overall Study||117
6605083|NCT02070757|7529836|FG001|NOT COMPLETED|Overall Study||114
6605084|NCT02070965|7529845|FG000|STARTED|Overall Study||27
6605085|NCT02070965|7529846|FG001|STARTED|Overall Study||23
6605086|NCT02070965|7529847|FG002|STARTED|Overall Study||25
6605087|NCT02070965|7529845|FG000|COMPLETED|Overall Study||25
6605088|NCT02070965|7529846|FG001|COMPLETED|Overall Study||21
6605089|NCT02070965|7529847|FG002|COMPLETED|Overall Study||24
6605090|NCT02070965|7529845|FG000|NOT COMPLETED|Overall Study||2
6605091|NCT02070965|7529846|FG001|NOT COMPLETED|Overall Study||2
6605092|NCT02070965|7529847|FG002|NOT COMPLETED|Overall Study||1
6605093|NCT02070978|7529858|FG000|STARTED|Overall Study||83
6605094|NCT02070978|7529859|FG001|STARTED|Overall Study||82
6605095|NCT02070978|7529860|FG002|STARTED|Overall Study||88
6605096|NCT02070978|7529858|FG000|COMPLETED|Overall Study||36
6605097|NCT02070978|7529859|FG001|COMPLETED|Overall Study||29
6605098|NCT02070978|7529860|FG002|COMPLETED|Overall Study||35
6605099|NCT02070978|7529858|FG000|NOT COMPLETED|Overall Study||47
6605100|NCT02070978|7529859|FG001|NOT COMPLETED|Overall Study||53
6605101|NCT02070978|7529860|FG002|NOT COMPLETED|Overall Study||53
6605102|NCT02070991|7529870|FG000|STARTED|Overall Study||31
6605103|NCT02070991|7529871|FG001|STARTED|Overall Study||32
6605104|NCT02070991|7529870|FG000|COMPLETED|Overall Study||28
6605105|NCT02070991|7529871|FG001|COMPLETED|Overall Study||32
6605106|NCT02070991|7529870|FG000|NOT COMPLETED|Overall Study||3
6605107|NCT02070991|7529871|FG001|NOT COMPLETED|Overall Study||0
6605108|NCT02071082|7529879|FG000|STARTED|Overall Study||4
6605109|NCT02071082|7529880|FG001|STARTED|Overall Study||75
6605110|NCT02071082|7529879|FG000|COMPLETED|Overall Study||2
6605111|NCT02071082|7529880|FG001|COMPLETED|Overall Study||68
6605112|NCT02071082|7529879|FG000|NOT COMPLETED|Overall Study||2
6605113|NCT02071082|7529880|FG001|NOT COMPLETED|Overall Study||7
6605114|NCT02071095|7529888|FG000|STARTED|Overall Study||12
6605115|NCT02071095|7529889|FG001|STARTED|Overall Study||3
6605116|NCT02071095|7529888|FG000|COMPLETED|Overall Study||12
6605117|NCT02071095|7529889|FG001|COMPLETED|Overall Study||3
6605118|NCT02071095|7529888|FG000|NOT COMPLETED|Overall Study||0
6605119|NCT02071095|7529889|FG001|NOT COMPLETED|Overall Study||0
6605120|NCT02071108|7529895|FG000|STARTED|Overall Study||35
6605121|NCT02071108|7529895|FG000|COMPLETED|Overall Study||35
6605122|NCT02071108|7529895|FG000|NOT COMPLETED|Overall Study||0
6605123|NCT02071173|7529899|FG000|STARTED|Overall Study||2244
6605124|NCT02071173|7529899|FG000|Implanted/Attempted With a Study Device|Overall Study||2200
6605125|NCT02071173|7529899|FG000|RELIANCE 4-FRONT Endpoint Population|Overall Study|1507 with active fixation 4-FRONT lead, 37 with passive fixation 4-FRONT lead|1544
6605126|NCT02071173|7529899|FG000|ACUITY X4 Endpoint Population|Overall Study|536 with ACUITY X4 Spiral lead, 228 with ACUITY X4 Straight lead|764
6605127|NCT02071173|7529899|FG000|COMPLETED|Overall Study|Follow-up is ongoing. Data as of 5-Feb-2020.|409
6605128|NCT02071173|7529899|FG000|NOT COMPLETED|Overall Study||1835
6605129|NCT02071225|7529904|FG000|STARTED|Overall Study||72
6605130|NCT02071225|7529904|FG000|COMPLETED|Overall Study||42
6605131|NCT02071225|7529904|FG000|NOT COMPLETED|Overall Study||30
6605132|NCT02071290|7529910|FG000|STARTED|Overall Study||25
6605133|NCT02071290|7529911|FG001|STARTED|Overall Study||25
6605134|NCT02071290|7529910|FG000|COMPLETED|Overall Study||21
6605135|NCT02071290|7529911|FG001|COMPLETED|Overall Study||18
6605136|NCT02071290|7529910|FG000|NOT COMPLETED|Overall Study||4
6605137|NCT02071290|7529911|FG001|NOT COMPLETED|Overall Study||7
6625192|NCT02223390|7552809|FG001|NOT COMPLETED|Overall Study||4
6625193|NCT02223429|7552819|FG000|STARTED|Overall Study||8
6625194|NCT02223429|7552820|FG001|STARTED|Overall Study||8
6625195|NCT02223429|7552821|FG002|STARTED|Overall Study||8
6625196|NCT02223429|7552822|FG003|STARTED|Overall Study||8
6625197|NCT02223429|7552819|FG000|COMPLETED|Overall Study||7
6625198|NCT02223429|7552820|FG001|COMPLETED|Overall Study||8
6625199|NCT02223429|7552821|FG002|COMPLETED|Overall Study||8
6625200|NCT02223429|7552822|FG003|COMPLETED|Overall Study||8
6625201|NCT02223429|7552819|FG000|NOT COMPLETED|Overall Study||1
6625202|NCT02223429|7552820|FG001|NOT COMPLETED|Overall Study||0
6625203|NCT02223429|7552821|FG002|NOT COMPLETED|Overall Study||0
6625204|NCT02223429|7552822|FG003|NOT COMPLETED|Overall Study||0
6625205|NCT02223455|7552840|FG000|STARTED|Overall Study|Participant level data not collected.|
6625206|NCT02223455|7552841|FG001|STARTED|Overall Study|Participant level data not collected.|
6625207|NCT02223455|7552842|FG002|STARTED|Overall Study|Participant level data not collected.|
6625208|NCT02223455|7552840|FG000|COMPLETED|Overall Study|Participant level data not collected.|
6625209|NCT02223455|7552841|FG001|COMPLETED|Overall Study|Participant level data not collected.|
6625210|NCT02223455|7552842|FG002|COMPLETED|Overall Study|Participant level data not collected.|
6625211|NCT02223455|7552840|FG000|NOT COMPLETED|Overall Study||
6625212|NCT02223455|7552841|FG001|NOT COMPLETED|Overall Study||
6625213|NCT02223455|7552842|FG002|NOT COMPLETED|Overall Study||
6625214|NCT02223546|7552850|FG000|STARTED|Overall Study||15
6625215|NCT02223546|7552850|FG000|COMPLETED|Overall Study||15
6625216|NCT02223546|7552850|FG000|NOT COMPLETED|Overall Study||0
6625217|NCT02223637|7552854|FG000|STARTED|Overall Study||82
6625218|NCT02223637|7552854|FG000|COMPLETED|Overall Study||82
6625219|NCT02223637|7552854|FG000|NOT COMPLETED|Overall Study||0
6625220|NCT02223650|7552861|FG000|STARTED|Overall Study||27
6625221|NCT02223650|7552862|FG001|STARTED|Overall Study||31
6625222|NCT02223650|7552861|FG000|COMPLETED|Overall Study||27
6625223|NCT02223650|7552862|FG001|COMPLETED|Overall Study||31
6625224|NCT02223650|7552861|FG000|NOT COMPLETED|Overall Study||0
6625225|NCT02223650|7552862|FG001|NOT COMPLETED|Overall Study||0
6625226|NCT02223689|7552870|FG000|STARTED|Overall Study||35
6625227|NCT02223689|7552870|FG000|COMPLETED|Overall Study||35
6625228|NCT02223689|7552870|FG000|NOT COMPLETED|Overall Study||0
6625229|NCT02223702|7552877|FG000|STARTED|Overall Study||20
6605138|NCT02071420|7529919|FG000|STARTED|Overall Study||30
6605139|NCT02071420|7529920|FG001|STARTED|Overall Study||30
6605140|NCT02071420|7529919|FG000|COMPLETED|Overall Study||27
6605141|NCT02071420|7529920|FG001|COMPLETED|Overall Study||27
6605142|NCT02071420|7529919|FG000|NOT COMPLETED|Overall Study||3
6605143|NCT02071420|7529920|FG001|NOT COMPLETED|Overall Study||3
6605144|NCT02071706|7529926|FG000|STARTED|Overall Study||62
6605145|NCT02071706|7529926|FG000|COMPLETED|Overall Study||59
6605146|NCT02071706|7529926|FG000|NOT COMPLETED|Overall Study||3
6605147|NCT02071771|7529930|FG000|STARTED|Period 1: First 10 Days||41
6605148|NCT02071771|7529931|FG001|STARTED|Period 1: First 10 Days||39
6605149|NCT02071771|7529930|FG000|Dispensed|Period 1: First 10 Days||39
6605150|NCT02071771|7529931|FG001|Dispensed|Period 1: First 10 Days||39
6605151|NCT02071771|7529930|FG000|COMPLETED|Period 1: First 10 Days||39
6605152|NCT02071771|7529931|FG001|COMPLETED|Period 1: First 10 Days||39
6605153|NCT02071771|7529930|FG000|NOT COMPLETED|Period 1: First 10 Days||2
6605154|NCT02071771|7529931|FG001|NOT COMPLETED|Period 1: First 10 Days||0
6605155|NCT02071771|7529930|FG000|STARTED|Period 2: Second 10 Days||39
6605156|NCT02071771|7529931|FG001|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
6605157|NCT02071771|7529930|FG000|COMPLETED|Period 2: Second 10 Days||39
6605158|NCT02071771|7529931|FG001|COMPLETED|Period 2: Second 10 Days||38
6605159|NCT02071771|7529930|FG000|NOT COMPLETED|Period 2: Second 10 Days||0
6605160|NCT02071771|7529931|FG001|NOT COMPLETED|Period 2: Second 10 Days||0
6605161|NCT02071810|7529942|FG000|STARTED|Overall Study||6
6605162|NCT02071810|7529943|FG001|STARTED|Overall Study||6
6605163|NCT02071810|7529944|FG002|STARTED|Overall Study||6
6605164|NCT02071810|7529945|FG003|STARTED|Overall Study||7
6605165|NCT02071810|7529946|FG004|STARTED|Overall Study||9
6605166|NCT02071810|7529942|FG000|COMPLETED|Overall Study||6
6605167|NCT02071810|7529943|FG001|COMPLETED|Overall Study||6
6605168|NCT02071810|7529944|FG002|COMPLETED|Overall Study||6
6605169|NCT02071810|7529945|FG003|COMPLETED|Overall Study||6
6605170|NCT02071810|7529946|FG004|COMPLETED|Overall Study||8
6605171|NCT02071810|7529942|FG000|NOT COMPLETED|Overall Study||0
6605172|NCT02071810|7529943|FG001|NOT COMPLETED|Overall Study||0
6605173|NCT02071810|7529944|FG002|NOT COMPLETED|Overall Study||0
6605174|NCT02071810|7529945|FG003|NOT COMPLETED|Overall Study||1
6605175|NCT02071810|7529946|FG004|NOT COMPLETED|Overall Study||1
6605176|NCT02071823|7529960|FG000|STARTED|Overall Study||6
6605177|NCT02071823|7529961|FG001|STARTED|Overall Study||6
6605178|NCT02071823|7529960|FG000|COMPLETED|Overall Study||5
6605179|NCT02071823|7529961|FG001|COMPLETED|Overall Study||6
6605180|NCT02071823|7529960|FG000|NOT COMPLETED|Overall Study||1
6605181|NCT02071823|7529961|FG001|NOT COMPLETED|Overall Study||0
6605182|NCT02071849|7529969|FG000|STARTED|6-month Primary Endpoint||20
6605183|NCT02071849|7529969|FG000|COMPLETED|6-month Primary Endpoint||15
6605184|NCT02071849|7529969|FG000|NOT COMPLETED|6-month Primary Endpoint||5
6605185|NCT02071849|7529969|FG000|STARTED|2-year Extended Follow-up||15
6605186|NCT02071849|7529969|FG000|COMPLETED|2-year Extended Follow-up||14
6605187|NCT02071849|7529969|FG000|NOT COMPLETED|2-year Extended Follow-up||1
6605188|NCT02071914|7529976|FG000|STARTED|Overall Study||27
6605189|NCT02071914|7529977|FG001|STARTED|Overall Study||27
6605190|NCT02071914|7529978|FG002|STARTED|Overall Study||27
6605191|NCT02071914|7529976|FG000|COMPLETED|Overall Study||27
6605192|NCT02071914|7529977|FG001|COMPLETED|Overall Study||27
6605193|NCT02071914|7529978|FG002|COMPLETED|Overall Study||27
6605194|NCT02071914|7529976|FG000|NOT COMPLETED|Overall Study||0
6605195|NCT02071914|7529977|FG001|NOT COMPLETED|Overall Study||0
6605196|NCT02071914|7529978|FG002|NOT COMPLETED|Overall Study||0
6605197|NCT02072096|7529988|FG000|STARTED|Overall Study||99
6605198|NCT02072096|7529989|FG001|STARTED|Overall Study||93
6605199|NCT02072096|7529988|FG000|Received at Least One Dose of Study Drug|Overall Study||98
6605200|NCT02072096|7529989|FG001|Received at Least One Dose of Study Drug|Overall Study||93
6605201|NCT02072096|7529988|FG000|COMPLETED|Overall Study||14
6605202|NCT02072096|7529989|FG001|COMPLETED|Overall Study||15
6605203|NCT02072096|7529988|FG000|NOT COMPLETED|Overall Study||85
6605204|NCT02072096|7529989|FG001|NOT COMPLETED|Overall Study||78
6605205|NCT02072174|7529998|FG000|STARTED|Overall Study||290
6605206|NCT02072174|7529999|FG001|STARTED|Overall Study||279
6605207|NCT02072174|7529998|FG000|COMPLETED|Overall Study||258
6605208|NCT02072174|7529999|FG001|COMPLETED|Overall Study||240
6605209|NCT02072174|7529998|FG000|NOT COMPLETED|Overall Study||32
6605210|NCT02072174|7529999|FG001|NOT COMPLETED|Overall Study||39
6605211|NCT02072200|7530007|FG000|STARTED|Overall Study||147
6605212|NCT02072200|7530007|FG000|COMPLETED|Overall Study||145
6605213|NCT02072200|7530007|FG000|NOT COMPLETED|Overall Study||2
6605214|NCT02072226|7530013|FG000|STARTED|Overall Study||156
6605215|NCT02072226|7530014|FG001|STARTED|Overall Study||157
6605216|NCT02072226|7530013|FG000|COMPLETED|Overall Study||141
6605217|NCT02072226|7530014|FG001|COMPLETED|Overall Study||147
6605218|NCT02072226|7530013|FG000|NOT COMPLETED|Overall Study||15
6605219|NCT02072226|7530014|FG001|NOT COMPLETED|Overall Study||10
6605220|NCT02072421|7530020|FG000|STARTED|Overall Study||2879
6605221|NCT02072421|7530020|FG000|COMPLETED|Overall Study||2489
6605222|NCT02072421|7530020|FG000|NOT COMPLETED|Overall Study||390
6605223|NCT02072434|7530027|FG000|STARTED|Overall Study||1095
6605224|NCT02072434|7530028|FG001|STARTED|Overall Study||1104
6605225|NCT02072434|7530027|FG000|Intent to Treat Analysis Set|Overall Study||1095
6605226|NCT02072434|7530028|FG001|Intent to Treat Analysis Set|Overall Study||1104
6605227|NCT02072434|7530027|FG000|Received Study Drug|Overall Study||1067
6605228|NCT02072434|7530028|FG001|Received Study Drug|Overall Study||1082
6605229|NCT02072434|7530027|FG000|Safety Analysis Set|Overall Study||1067
6605230|NCT02072434|7530028|FG001|Safety Analysis Set|Overall Study||1082
6605231|NCT02072434|7530027|FG000|COMPLETED|Overall Study||1041
6605232|NCT02072434|7530028|FG001|COMPLETED|Overall Study||1014
6605233|NCT02072434|7530027|FG000|NOT COMPLETED|Overall Study||54
6605234|NCT02072434|7530028|FG001|NOT COMPLETED|Overall Study||90
6605235|NCT02072668|7530034|FG000|STARTED|First Intervention||7
6605236|NCT02072668|7530035|FG001|STARTED|First Intervention||7
6605237|NCT02072668|7530034|FG000|COMPLETED|First Intervention||7
6605238|NCT02072668|7530035|FG001|COMPLETED|First Intervention||7
6605239|NCT02072668|7530034|FG000|NOT COMPLETED|First Intervention||0
6605240|NCT02072668|7530035|FG001|NOT COMPLETED|First Intervention||0
6605241|NCT02072668|7530034|FG000|STARTED|Washout (2 Weeks)||7
6605242|NCT02072668|7530035|FG001|STARTED|Washout (2 Weeks)||7
6605243|NCT02072668|7530034|FG000|COMPLETED|Washout (2 Weeks)||7
6605244|NCT02072668|7530035|FG001|COMPLETED|Washout (2 Weeks)||7
6605245|NCT02072668|7530034|FG000|NOT COMPLETED|Washout (2 Weeks)||0
6605246|NCT02072668|7530035|FG001|NOT COMPLETED|Washout (2 Weeks)||0
6605247|NCT02072668|7530034|FG000|STARTED|Second Intervention||7
6605248|NCT02072668|7530035|FG001|STARTED|Second Intervention||7
6605249|NCT02072668|7530034|FG000|COMPLETED|Second Intervention||6
6605250|NCT02072668|7530035|FG001|COMPLETED|Second Intervention||7
6605251|NCT02072668|7530034|FG000|NOT COMPLETED|Second Intervention||1
6605252|NCT02072668|7530035|FG001|NOT COMPLETED|Second Intervention||0
6605253|NCT02072824|7530046|FG000|STARTED|Overall Study||71
6605254|NCT02072824|7530047|FG001|STARTED|Overall Study||34
6605255|NCT02072824|7530048|FG002|STARTED|Overall Study||70
6605256|NCT02072824|7530046|FG000|COMPLETED|Overall Study||69
6605257|NCT02072824|7530047|FG001|COMPLETED|Overall Study||33
6605258|NCT02072824|7530048|FG002|COMPLETED|Overall Study||67
6605259|NCT02072824|7530046|FG000|NOT COMPLETED|Overall Study||2
6605260|NCT02072824|7530047|FG001|NOT COMPLETED|Overall Study||1
6605261|NCT02072824|7530048|FG002|NOT COMPLETED|Overall Study||3
6605262|NCT02072928|7530056|FG000|STARTED|Overall Study||55
6605263|NCT02072928|7530056|FG000|COMPLETED|Overall Study||55
6605264|NCT02072928|7530056|FG000|NOT COMPLETED|Overall Study||0
6605265|NCT02072941|7530062|FG000|STARTED|Overall Study||219
6605266|NCT02072941|7530063|FG001|STARTED|Overall Study||226
6605267|NCT02072941|7530062|FG000|COMPLETED|Overall Study||181
6605268|NCT02072941|7530063|FG001|COMPLETED|Overall Study||197
6605269|NCT02072941|7530062|FG000|NOT COMPLETED|Overall Study||38
6605270|NCT02072941|7530063|FG001|NOT COMPLETED|Overall Study||29
6605271|NCT02072980|7530069|FG000|STARTED|Period 1, First Wear||7
6605272|NCT02072980|7530070|FG001|STARTED|Period 1, First Wear||8
6605273|NCT02072980|7530069|FG000|COMPLETED|Period 1, First Wear||7
6605274|NCT02072980|7530070|FG001|COMPLETED|Period 1, First Wear||8
6605275|NCT02072980|7530069|FG000|NOT COMPLETED|Period 1, First Wear||0
6605276|NCT02072980|7530070|FG001|NOT COMPLETED|Period 1, First Wear||0
6605277|NCT02072980|7530069|FG000|STARTED|Period 2, Second Wear||7
6605278|NCT02072980|7530070|FG001|STARTED|Period 2, Second Wear||8
6605279|NCT02072980|7530069|FG000|COMPLETED|Period 2, Second Wear||7
6605280|NCT02072980|7530070|FG001|COMPLETED|Period 2, Second Wear||7
6605281|NCT02072980|7530069|FG000|NOT COMPLETED|Period 2, Second Wear||0
6605282|NCT02072980|7530070|FG001|NOT COMPLETED|Period 2, Second Wear||1
6605283|NCT02073162|7530078|FG000|STARTED|Overall Study||1499
6605284|NCT02073162|7530079|FG001|STARTED|Overall Study||1501
6605285|NCT02073162|7530078|FG000|COMPLETED|Overall Study||1493
6605286|NCT02073162|7530079|FG001|COMPLETED|Overall Study||1490
6605287|NCT02073162|7530078|FG000|NOT COMPLETED|Overall Study||6
6605288|NCT02073162|7530079|FG001|NOT COMPLETED|Overall Study||11
6605289|NCT02073331|7530085|FG000|STARTED|Overall Study||1420
6605290|NCT02073331|7530085|FG000|COMPLETED|Overall Study||1420
6605291|NCT02073331|7530085|FG000|NOT COMPLETED|Overall Study||0
6605292|NCT02073435|7530091|FG000|STARTED|Overall Study||81
6605293|NCT02073435|7530092|FG001|STARTED|Overall Study||96
6605294|NCT02073435|7530091|FG000|COMPLETED|Overall Study||81
6605295|NCT02073435|7530092|FG001|COMPLETED|Overall Study||96
6605296|NCT02073435|7530091|FG000|NOT COMPLETED|Overall Study||0
6605297|NCT02073435|7530092|FG001|NOT COMPLETED|Overall Study||0
6605298|NCT02073448|7530101|FG000|STARTED|Overall Study||101
6605299|NCT02073448|7530102|FG001|STARTED|Overall Study||212
6605300|NCT02073448|7530103|FG002|STARTED|Overall Study||104
6605301|NCT02073448|7530101|FG000|COMPLETED|Overall Study||99
6605302|NCT02073448|7530102|FG001|COMPLETED|Overall Study||200
6605303|NCT02073448|7530103|FG002|COMPLETED|Overall Study||99
6605304|NCT02073448|7530101|FG000|NOT COMPLETED|Overall Study||2
6605305|NCT02073448|7530102|FG001|NOT COMPLETED|Overall Study||12
6605306|NCT02073448|7530103|FG002|NOT COMPLETED|Overall Study||5
6605307|NCT02073461|7530116|FG000|STARTED|Overall Study||79
6605308|NCT02073461|7530117|FG001|STARTED|Overall Study||78
6605309|NCT02073461|7530118|FG002|STARTED|Overall Study||79
6605310|NCT02073461|7530116|FG000|COMPLETED|Overall Study||75
6605311|NCT02073461|7530117|FG001|COMPLETED|Overall Study||77
6605312|NCT02073461|7530118|FG002|COMPLETED|Overall Study||78
6605313|NCT02073461|7530116|FG000|NOT COMPLETED|Overall Study||4
6605314|NCT02073461|7530117|FG001|NOT COMPLETED|Overall Study||1
6605315|NCT02073461|7530118|FG002|NOT COMPLETED|Overall Study||1
6605316|NCT02073487|7530128|FG000|STARTED|Overall Study||16
6605317|NCT02073487|7530129|FG001|STARTED|Overall Study||16
6605318|NCT02073487|7530128|FG000|COMPLETED|Overall Study||14
6605319|NCT02073487|7530129|FG001|COMPLETED|Overall Study||16
6605320|NCT02073487|7530128|FG000|NOT COMPLETED|Overall Study||2
6605321|NCT02073487|7530129|FG001|NOT COMPLETED|Overall Study||0
6605322|NCT02073565|7530138|FG000|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||287
6605323|NCT02073565|7530139|FG001|STARTED|Intention-To-Treat Subjects-Cohorts AB&C||285
6605324|NCT02073565|7530138|FG000|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||285
6605325|NCT02073565|7530139|FG001|COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||279
6605326|NCT02073565|7530138|FG000|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||2
6605327|NCT02073565|7530139|FG001|NOT COMPLETED|Intention-To-Treat Subjects-Cohorts AB&C||6
6605328|NCT02073565|7530138|FG000|STARTED|Cohort A||16
6605329|NCT02073565|7530139|FG001|STARTED|Cohort A||14
6605330|NCT02073565|7530138|FG000|COMPLETED|Cohort A||15
6605331|NCT02073565|7530139|FG001|COMPLETED|Cohort A||14
6605332|NCT02073565|7530138|FG000|NOT COMPLETED|Cohort A||1
6605333|NCT02073565|7530139|FG001|NOT COMPLETED|Cohort A||0
6605334|NCT02073565|7530138|FG000|STARTED|Cohort B||54
6605335|NCT02073565|7530139|FG001|STARTED|Cohort B||56
6605336|NCT02073565|7530138|FG000|COMPLETED|Cohort B||53
6605337|NCT02073565|7530139|FG001|COMPLETED|Cohort B||54
6605338|NCT02073565|7530138|FG000|NOT COMPLETED|Cohort B||1
6605339|NCT02073565|7530139|FG001|NOT COMPLETED|Cohort B||2
6605340|NCT02073565|7530138|FG000|STARTED|Cohort C||217
6605341|NCT02073565|7530139|FG001|STARTED|Cohort C||215
6605342|NCT02073565|7530138|FG000|COMPLETED|Cohort C||217
6605343|NCT02073565|7530139|FG001|COMPLETED|Cohort C||211
6605344|NCT02073565|7530138|FG000|NOT COMPLETED|Cohort C||0
6605345|NCT02073565|7530139|FG001|NOT COMPLETED|Cohort C||4
6605346|NCT02073643|7530145|FG000|STARTED|Overall Study||204
6605347|NCT02073643|7530145|FG000|COMPLETED|Overall Study||180
6605348|NCT02073643|7530145|FG000|NOT COMPLETED|Overall Study||24
6605349|NCT02073656|7530149|FG000|STARTED|Primary Study||335
6605350|NCT02073656|7530149|FG000|COMPLETED|Primary Study||327
6605351|NCT02073656|7530149|FG000|NOT COMPLETED|Primary Study||8
6605352|NCT02073656|7530149|FG000|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
6605353|NCT02073656|7530149|FG000|COMPLETED|Retreatment Substudy||9
6605354|NCT02073656|7530149|FG000|NOT COMPLETED|Retreatment Substudy||0
6605355|NCT02073682|7530157|FG000|STARTED|Overall Study||522
6605356|NCT02073682|7530158|FG001|STARTED|Overall Study||524
6605357|NCT02073682|7530157|FG000|COMPLETED|Overall Study||200
6605358|NCT02073682|7530158|FG001|COMPLETED|Overall Study||154
6605359|NCT02073682|7530157|FG000|NOT COMPLETED|Overall Study||322
6605360|NCT02073682|7530158|FG001|NOT COMPLETED|Overall Study||370
6605361|NCT02073747|7530166|FG000|STARTED|Overall Study||15
6605362|NCT02073747|7530167|FG001|STARTED|Overall Study||15
6605363|NCT02073747|7530166|FG000|COMPLETED|Overall Study||14
6605364|NCT02073747|7530167|FG001|COMPLETED|Overall Study||14
6605365|NCT02073747|7530166|FG000|NOT COMPLETED|Overall Study||1
6605366|NCT02073747|7530167|FG001|NOT COMPLETED|Overall Study||1
6605367|NCT02073929|7530175|FG000|STARTED|Overall Study||48
6605368|NCT02073929|7530176|FG001|STARTED|Overall Study||24
6605369|NCT02073929|7530175|FG000|COMPLETED|Overall Study||44
6605370|NCT02073929|7530176|FG001|COMPLETED|Overall Study||21
6605371|NCT02073929|7530175|FG000|NOT COMPLETED|Overall Study||4
6605372|NCT02073929|7530176|FG001|NOT COMPLETED|Overall Study||3
6605373|NCT02074059|7530188|FG000|STARTED|Overall Study||8
6605374|NCT02074059|7530189|FG001|STARTED|Overall Study||8
6605375|NCT02074059|7530190|FG002|STARTED|Overall Study||8
6605376|NCT02074059|7530191|FG003|STARTED|Overall Study||8
6605377|NCT02074059|7530192|FG004|STARTED|Overall Study||8
6605378|NCT02074059|7530193|FG005|STARTED|Overall Study||40
6605379|NCT02074059|7530188|FG000|COMPLETED|Overall Study||8
6605380|NCT02074059|7530189|FG001|COMPLETED|Overall Study||8
6605381|NCT02074059|7530190|FG002|COMPLETED|Overall Study||8
6605382|NCT02074059|7530191|FG003|COMPLETED|Overall Study||8
6605383|NCT02074059|7530192|FG004|COMPLETED|Overall Study||7
6605384|NCT02074059|7530193|FG005|COMPLETED|Overall Study||39
6605385|NCT02074059|7530188|FG000|NOT COMPLETED|Overall Study||0
6605386|NCT02074059|7530189|FG001|NOT COMPLETED|Overall Study||0
6605387|NCT02074059|7530190|FG002|NOT COMPLETED|Overall Study||0
6605388|NCT02074059|7530191|FG003|NOT COMPLETED|Overall Study||0
6605389|NCT02074059|7530192|FG004|NOT COMPLETED|Overall Study||1
6605390|NCT02074059|7530193|FG005|NOT COMPLETED|Overall Study||1
6605391|NCT02074345|7530208|FG000|STARTED|Overall Study||31
6605392|NCT02074345|7530208|FG000|COMPLETED|Overall Study||31
6605393|NCT02074345|7530208|FG000|NOT COMPLETED|Overall Study||0
6605394|NCT02074358|7530212|FG000|STARTED|Overall Study||3
6605395|NCT02074358|7530213|FG001|STARTED|Overall Study||3
6605396|NCT02074358|7530214|FG002|STARTED|Overall Study||2
6605397|NCT02074358|7530215|FG003|STARTED|Overall Study||2
6605398|NCT02074358|7530216|FG004|STARTED|Overall Study||3
6605399|NCT02074358|7530217|FG005|STARTED|Overall Study||2
6605400|NCT02074358|7530212|FG000|COMPLETED|Overall Study||3
6605401|NCT02074358|7530213|FG001|COMPLETED|Overall Study||3
6605402|NCT02074358|7530214|FG002|COMPLETED|Overall Study||2
6605403|NCT02074358|7530215|FG003|COMPLETED|Overall Study||2
6605404|NCT02074358|7530216|FG004|COMPLETED|Overall Study||3
6605405|NCT02074358|7530217|FG005|COMPLETED|Overall Study||2
6605406|NCT02074358|7530212|FG000|NOT COMPLETED|Overall Study||0
6605407|NCT02074358|7530213|FG001|NOT COMPLETED|Overall Study||0
6605408|NCT02074358|7530214|FG002|NOT COMPLETED|Overall Study||0
6605409|NCT02074358|7530215|FG003|NOT COMPLETED|Overall Study||0
6605410|NCT02074358|7530216|FG004|NOT COMPLETED|Overall Study||0
6605411|NCT02074358|7530217|FG005|NOT COMPLETED|Overall Study||0
6605412|NCT02074384|7530228|FG000|STARTED|Overall Study||74
6605413|NCT02074384|7530229|FG001|STARTED|Overall Study||70
6605414|NCT02074384|7530230|FG002|STARTED|Overall Study||17
6605415|NCT02074384|7530228|FG000|COMPLETED|Overall Study||74
6605416|NCT02074384|7530229|FG001|COMPLETED|Overall Study||70
6605417|NCT02074384|7530230|FG002|COMPLETED|Overall Study||17
6605418|NCT02074384|7530228|FG000|NOT COMPLETED|Overall Study||0
6605419|NCT02074384|7530229|FG001|NOT COMPLETED|Overall Study||0
6605420|NCT02074384|7530230|FG002|NOT COMPLETED|Overall Study||0
6605421|NCT02074514|7530242|FG000|STARTED|Overall Study||59
6605422|NCT02074514|7530243|FG001|STARTED|Overall Study||58
6605423|NCT02074514|7530242|FG000|COMPLETED|Overall Study||56
6605424|NCT02074514|7530243|FG001|COMPLETED|Overall Study||54
6605425|NCT02074514|7530242|FG000|NOT COMPLETED|Overall Study||3
6605426|NCT02074514|7530243|FG001|NOT COMPLETED|Overall Study||4
6605427|NCT02074553|7530255|FG000|STARTED|Intervention Period 1||12
6605428|NCT02074553|7530256|FG001|STARTED|Intervention Period 1||12
6605429|NCT02074553|7530257|FG002|STARTED|Intervention Period 1||12
6605430|NCT02074553|7530258|FG003|STARTED|Intervention Period 1||13
6605431|NCT02074553|7530259|FG004|STARTED|Intervention Period 1||12
6605432|NCT02074553|7530260|FG005|STARTED|Intervention Period 1||12
6605433|NCT02074553|7530261|FG006|STARTED|Intervention Period 1||12
6605434|NCT02074553|7530262|FG007|STARTED|Intervention Period 1||12
6605435|NCT02074553|7530255|FG000|COMPLETED|Intervention Period 1||12
6605436|NCT02074553|7530256|FG001|COMPLETED|Intervention Period 1||12
6605437|NCT02074553|7530257|FG002|COMPLETED|Intervention Period 1||12
6605438|NCT02074553|7530258|FG003|COMPLETED|Intervention Period 1||12
6605439|NCT02074553|7530259|FG004|COMPLETED|Intervention Period 1||12
6605440|NCT02074553|7530260|FG005|COMPLETED|Intervention Period 1||12
6605441|NCT02074553|7530261|FG006|COMPLETED|Intervention Period 1||12
6605442|NCT02074553|7530262|FG007|COMPLETED|Intervention Period 1||12
6605443|NCT02074553|7530255|FG000|NOT COMPLETED|Intervention Period 1||0
6605444|NCT02074553|7530256|FG001|NOT COMPLETED|Intervention Period 1||0
6605445|NCT02074553|7530257|FG002|NOT COMPLETED|Intervention Period 1||0
6605446|NCT02074553|7530258|FG003|NOT COMPLETED|Intervention Period 1||1
6605447|NCT02074553|7530259|FG004|NOT COMPLETED|Intervention Period 1||0
6605448|NCT02074553|7530260|FG005|NOT COMPLETED|Intervention Period 1||0
6605449|NCT02074553|7530261|FG006|NOT COMPLETED|Intervention Period 1||0
6605450|NCT02074553|7530262|FG007|NOT COMPLETED|Intervention Period 1||0
6605451|NCT02074553|7530255|FG000|STARTED|Washout Period 1||12
6605452|NCT02074553|7530256|FG001|STARTED|Washout Period 1||12
6605453|NCT02074553|7530257|FG002|STARTED|Washout Period 1||12
6605454|NCT02074553|7530258|FG003|STARTED|Washout Period 1||12
6605455|NCT02074553|7530259|FG004|STARTED|Washout Period 1||12
6605456|NCT02074553|7530260|FG005|STARTED|Washout Period 1||12
6605457|NCT02074553|7530261|FG006|STARTED|Washout Period 1||12
6605458|NCT02074553|7530262|FG007|STARTED|Washout Period 1||12
6605459|NCT02074553|7530255|FG000|COMPLETED|Washout Period 1||11
6605460|NCT02074553|7530256|FG001|COMPLETED|Washout Period 1||12
6605461|NCT02074553|7530257|FG002|COMPLETED|Washout Period 1||12
6605462|NCT02074553|7530258|FG003|COMPLETED|Washout Period 1||11
6605463|NCT02074553|7530259|FG004|COMPLETED|Washout Period 1||12
6605464|NCT02074553|7530260|FG005|COMPLETED|Washout Period 1||11
6605465|NCT02074553|7530261|FG006|COMPLETED|Washout Period 1||12
6605466|NCT02074553|7530262|FG007|COMPLETED|Washout Period 1||12
6605467|NCT02074553|7530255|FG000|NOT COMPLETED|Washout Period 1||1
6605468|NCT02074553|7530256|FG001|NOT COMPLETED|Washout Period 1||0
6605469|NCT02074553|7530257|FG002|NOT COMPLETED|Washout Period 1||0
6605470|NCT02074553|7530258|FG003|NOT COMPLETED|Washout Period 1||1
6605471|NCT02074553|7530259|FG004|NOT COMPLETED|Washout Period 1||0
6605472|NCT02074553|7530260|FG005|NOT COMPLETED|Washout Period 1||1
6605473|NCT02074553|7530261|FG006|NOT COMPLETED|Washout Period 1||0
6605474|NCT02074553|7530262|FG007|NOT COMPLETED|Washout Period 1||0
6605475|NCT02074553|7530255|FG000|STARTED|Intervention Period 2||11
6605476|NCT02074553|7530256|FG001|STARTED|Intervention Period 2||12
6605477|NCT02074553|7530257|FG002|STARTED|Intervention Period 2||12
6605478|NCT02074553|7530258|FG003|STARTED|Intervention Period 2||11
6605479|NCT02074553|7530259|FG004|STARTED|Intervention Period 2||12
6605480|NCT02074553|7530260|FG005|STARTED|Intervention Period 2||11
6605481|NCT02074553|7530261|FG006|STARTED|Intervention Period 2||12
6605482|NCT02074553|7530262|FG007|STARTED|Intervention Period 2||12
6605483|NCT02074553|7530255|FG000|COMPLETED|Intervention Period 2||11
6605484|NCT02074553|7530256|FG001|COMPLETED|Intervention Period 2||12
6605485|NCT02074553|7530257|FG002|COMPLETED|Intervention Period 2||12
6605486|NCT02074553|7530258|FG003|COMPLETED|Intervention Period 2||11
6605487|NCT02074553|7530259|FG004|COMPLETED|Intervention Period 2||12
6605488|NCT02074553|7530260|FG005|COMPLETED|Intervention Period 2||11
6605489|NCT02074553|7530261|FG006|COMPLETED|Intervention Period 2||12
6605490|NCT02074553|7530262|FG007|COMPLETED|Intervention Period 2||12
6605491|NCT02074553|7530255|FG000|NOT COMPLETED|Intervention Period 2||0
6605492|NCT02074553|7530256|FG001|NOT COMPLETED|Intervention Period 2||0
6605493|NCT02074553|7530257|FG002|NOT COMPLETED|Intervention Period 2||0
6605494|NCT02074553|7530258|FG003|NOT COMPLETED|Intervention Period 2||0
6605495|NCT02074553|7530259|FG004|NOT COMPLETED|Intervention Period 2||0
6732166|NCT03189524|7661537|FG000|STARTED|Overall Study||11
6605496|NCT02074553|7530260|FG005|NOT COMPLETED|Intervention Period 2||0
6732167|NCT03189524|7661538|FG001|STARTED|Overall Study||10
6605497|NCT02074553|7530261|FG006|NOT COMPLETED|Intervention Period 2||0
6605498|NCT02074553|7530262|FG007|NOT COMPLETED|Intervention Period 2||0
6605499|NCT02074553|7530255|FG000|STARTED|Washout Period 2||11
6605500|NCT02074553|7530256|FG001|STARTED|Washout Period 2||12
6605501|NCT02074553|7530257|FG002|STARTED|Washout Period 2||12
6605502|NCT02074553|7530258|FG003|STARTED|Washout Period 2||11
6605503|NCT02074553|7530259|FG004|STARTED|Washout Period 2||12
6605504|NCT02074553|7530260|FG005|STARTED|Washout Period 2||11
6605505|NCT02074553|7530261|FG006|STARTED|Washout Period 2||12
6605506|NCT02074553|7530262|FG007|STARTED|Washout Period 2||12
6605507|NCT02074553|7530255|FG000|COMPLETED|Washout Period 2||11
6605508|NCT02074553|7530256|FG001|COMPLETED|Washout Period 2||12
6605509|NCT02074553|7530257|FG002|COMPLETED|Washout Period 2||11
6605510|NCT02074553|7530258|FG003|COMPLETED|Washout Period 2||11
6605511|NCT02074553|7530259|FG004|COMPLETED|Washout Period 2||12
6605512|NCT02074553|7530260|FG005|COMPLETED|Washout Period 2||10
6605513|NCT02074553|7530261|FG006|COMPLETED|Washout Period 2||11
6732168|NCT03189524|7661539|FG002|STARTED|Overall Study||23
6732169|NCT03189524|7661537|FG000|Received at Least 1 Dose of Study Drug|Overall Study||11
6732170|NCT03189524|7661538|FG001|Received at Least 1 Dose of Study Drug|Overall Study||10
6732171|NCT03189524|7661539|FG002|Received at Least 1 Dose of Study Drug|Overall Study||23
6732172|NCT03189524|7661537|FG000|COMPLETED|Overall Study||0
6732173|NCT03189524|7661538|FG001|COMPLETED|Overall Study||0
6732174|NCT03189524|7661539|FG002|COMPLETED|Overall Study||0
6732175|NCT03189524|7661537|FG000|NOT COMPLETED|Overall Study||11
6732176|NCT03189524|7661538|FG001|NOT COMPLETED|Overall Study||10
6732177|NCT03189524|7661539|FG002|NOT COMPLETED|Overall Study||23
6732178|NCT03189589|7661553|FG000|STARTED|Overall Study||6
6732179|NCT03189589|7661554|FG001|STARTED|Overall Study||6
6732180|NCT03189589|7661553|FG000|COMPLETED|Overall Study||6
6732181|NCT03189589|7661554|FG001|COMPLETED|Overall Study||6
6732182|NCT03189589|7661553|FG000|NOT COMPLETED|Overall Study||0
6732183|NCT03189589|7661554|FG001|NOT COMPLETED|Overall Study||0
6732184|NCT03189745|7661562|FG000|STARTED|Overall Study||170
6732185|NCT03189745|7661563|FG001|STARTED|Overall Study||59
6732186|NCT03189745|7661562|FG000|COMPLETED|Overall Study||169
6732187|NCT03189745|7661563|FG001|COMPLETED|Overall Study||58
6732188|NCT03189745|7661562|FG000|NOT COMPLETED|Overall Study||1
6732189|NCT03189745|7661563|FG001|NOT COMPLETED|Overall Study||1
6732190|NCT03190005|7661576|FG000|STARTED|Overall Study||5
6732191|NCT03190005|7661577|FG001|STARTED|Overall Study||5
6732192|NCT03190005|7661578|FG002|STARTED|Overall Study||5
6732193|NCT03190005|7661579|FG003|STARTED|Overall Study||5
6732194|NCT03190005|7661580|FG004|STARTED|Overall Study||5
6732195|NCT03190005|7661581|FG005|STARTED|Overall Study||5
6732196|NCT03190005|7661582|FG006|STARTED|Overall Study||5
6732197|NCT03190005|7661576|FG000|COMPLETED|Overall Study||5
6732198|NCT03190005|7661577|FG001|COMPLETED|Overall Study||5
6732199|NCT03190005|7661578|FG002|COMPLETED|Overall Study||5
6732200|NCT03190005|7661579|FG003|COMPLETED|Overall Study||5
6732201|NCT03190005|7661580|FG004|COMPLETED|Overall Study||5
6732202|NCT03190005|7661581|FG005|COMPLETED|Overall Study||5
6732203|NCT03190005|7661582|FG006|COMPLETED|Overall Study||5
6732204|NCT03190005|7661576|FG000|NOT COMPLETED|Overall Study||0
6732205|NCT03190005|7661577|FG001|NOT COMPLETED|Overall Study||0
6732206|NCT03190005|7661578|FG002|NOT COMPLETED|Overall Study||0
6732207|NCT03190005|7661579|FG003|NOT COMPLETED|Overall Study||0
6732208|NCT03190005|7661580|FG004|NOT COMPLETED|Overall Study||0
6732209|NCT03190005|7661581|FG005|NOT COMPLETED|Overall Study||0
6732210|NCT03190005|7661582|FG006|NOT COMPLETED|Overall Study||0
6732211|NCT03190083|7661598|FG000|STARTED|Overall Study||16
6732212|NCT03190083|7661598|FG000|COMPLETED|Overall Study||16
6732213|NCT03190083|7661598|FG000|NOT COMPLETED|Overall Study||0
6732214|NCT03190213|7661602|FG000|STARTED|Overall Study||6
6732215|NCT03190213|7661602|FG000|COMPLETED|Overall Study||6
6732216|NCT03190213|7661602|FG000|NOT COMPLETED|Overall Study||0
6732217|NCT03190460|7661608|FG000|STARTED|Overall Study||40
6732218|NCT03190460|7661609|FG001|STARTED|Overall Study||20
6732219|NCT03190460|7661608|FG000|COMPLETED|Overall Study||3
6732220|NCT03190460|7661609|FG001|COMPLETED|Overall Study||2
6732221|NCT03190460|7661608|FG000|NOT COMPLETED|Overall Study||37
6732222|NCT03190460|7661609|FG001|NOT COMPLETED|Overall Study||18
6732223|NCT03190993|7661617|FG000|STARTED|Overall Study||10
6732224|NCT03190993|7661618|FG001|STARTED|Overall Study||10
6732225|NCT03190993|7661617|FG000|COMPLETED|Overall Study||10
6732226|NCT03190993|7661618|FG001|COMPLETED|Overall Study||10
6732227|NCT03190993|7661617|FG000|NOT COMPLETED|Overall Study||0
6732228|NCT03190993|7661618|FG001|NOT COMPLETED|Overall Study||0
6732229|NCT03191396|7661626|FG000|STARTED|Overall Study||290
6732230|NCT03191396|7661627|FG001|STARTED|Overall Study||287
6732231|NCT03191396|7661626|FG000|COMPLETED|Overall Study||287
6732232|NCT03191396|7661627|FG001|COMPLETED|Overall Study||282
6732233|NCT03191396|7661626|FG000|NOT COMPLETED|Overall Study||3
6605514|NCT02074553|7530262|FG007|COMPLETED|Washout Period 2||12
6605515|NCT02074553|7530255|FG000|NOT COMPLETED|Washout Period 2||0
6605516|NCT02074553|7530256|FG001|NOT COMPLETED|Washout Period 2||0
6605517|NCT02074553|7530257|FG002|NOT COMPLETED|Washout Period 2||1
6605518|NCT02074553|7530258|FG003|NOT COMPLETED|Washout Period 2||0
6605519|NCT02074553|7530259|FG004|NOT COMPLETED|Washout Period 2||0
6605520|NCT02074553|7530260|FG005|NOT COMPLETED|Washout Period 2||1
6732234|NCT03191396|7661627|FG001|NOT COMPLETED|Overall Study||5
6732235|NCT03191552|7661636|FG000|STARTED|Overall Study||9
6605521|NCT02074553|7530261|FG006|NOT COMPLETED|Washout Period 2||1
6605522|NCT02074553|7530262|FG007|NOT COMPLETED|Washout Period 2||0
6605523|NCT02074553|7530255|FG000|STARTED|Intervention Period 3||11
6605524|NCT02074553|7530256|FG001|STARTED|Intervention Period 3||12
6605525|NCT02074553|7530257|FG002|STARTED|Intervention Period 3||11
6605526|NCT02074553|7530258|FG003|STARTED|Intervention Period 3||11
6605527|NCT02074553|7530259|FG004|STARTED|Intervention Period 3||12
6605528|NCT02074553|7530260|FG005|STARTED|Intervention Period 3||10
6605529|NCT02074553|7530261|FG006|STARTED|Intervention Period 3||11
6605530|NCT02074553|7530262|FG007|STARTED|Intervention Period 3||12
6605531|NCT02074553|7530255|FG000|COMPLETED|Intervention Period 3||11
6605532|NCT02074553|7530256|FG001|COMPLETED|Intervention Period 3||12
6605533|NCT02074553|7530257|FG002|COMPLETED|Intervention Period 3||11
6605534|NCT02074553|7530258|FG003|COMPLETED|Intervention Period 3||11
6605535|NCT02074553|7530259|FG004|COMPLETED|Intervention Period 3||12
6605536|NCT02074553|7530260|FG005|COMPLETED|Intervention Period 3||10
6605537|NCT02074553|7530261|FG006|COMPLETED|Intervention Period 3||11
6605538|NCT02074553|7530262|FG007|COMPLETED|Intervention Period 3||12
6605539|NCT02074553|7530255|FG000|NOT COMPLETED|Intervention Period 3||0
6605540|NCT02074553|7530256|FG001|NOT COMPLETED|Intervention Period 3||0
6605541|NCT02074553|7530257|FG002|NOT COMPLETED|Intervention Period 3||0
6605542|NCT02074553|7530258|FG003|NOT COMPLETED|Intervention Period 3||0
6605543|NCT02074553|7530259|FG004|NOT COMPLETED|Intervention Period 3||0
6605544|NCT02074553|7530260|FG005|NOT COMPLETED|Intervention Period 3||0
6605545|NCT02074553|7530261|FG006|NOT COMPLETED|Intervention Period 3||0
6605546|NCT02074553|7530262|FG007|NOT COMPLETED|Intervention Period 3||0
6605547|NCT02074553|7530255|FG000|STARTED|Washout Period 3||11
6605548|NCT02074553|7530256|FG001|STARTED|Washout Period 3||12
6605549|NCT02074553|7530257|FG002|STARTED|Washout Period 3||11
6605550|NCT02074553|7530258|FG003|STARTED|Washout Period 3||11
6605551|NCT02074553|7530259|FG004|STARTED|Washout Period 3||12
6605552|NCT02074553|7530260|FG005|STARTED|Washout Period 3||10
6605553|NCT02074553|7530261|FG006|STARTED|Washout Period 3||11
6605554|NCT02074553|7530262|FG007|STARTED|Washout Period 3||12
6605555|NCT02074553|7530255|FG000|COMPLETED|Washout Period 3||11
6605556|NCT02074553|7530256|FG001|COMPLETED|Washout Period 3||12
6605557|NCT02074553|7530257|FG002|COMPLETED|Washout Period 3||11
6605558|NCT02074553|7530258|FG003|COMPLETED|Washout Period 3||11
6605559|NCT02074553|7530259|FG004|COMPLETED|Washout Period 3||12
6605560|NCT02074553|7530260|FG005|COMPLETED|Washout Period 3||10
6605561|NCT02074553|7530261|FG006|COMPLETED|Washout Period 3||11
6605562|NCT02074553|7530262|FG007|COMPLETED|Washout Period 3||11
6605563|NCT02074553|7530255|FG000|NOT COMPLETED|Washout Period 3||0
6605564|NCT02074553|7530256|FG001|NOT COMPLETED|Washout Period 3||0
6605565|NCT02074553|7530257|FG002|NOT COMPLETED|Washout Period 3||0
6605566|NCT02074553|7530258|FG003|NOT COMPLETED|Washout Period 3||0
6605567|NCT02074553|7530259|FG004|NOT COMPLETED|Washout Period 3||0
6605568|NCT02074553|7530260|FG005|NOT COMPLETED|Washout Period 3||0
6605569|NCT02074553|7530261|FG006|NOT COMPLETED|Washout Period 3||0
6605570|NCT02074553|7530262|FG007|NOT COMPLETED|Washout Period 3||1
6605571|NCT02074553|7530255|FG000|STARTED|Intervention Period 4||11
6605572|NCT02074553|7530256|FG001|STARTED|Intervention Period 4||12
6605573|NCT02074553|7530257|FG002|STARTED|Intervention Period 4||11
6605574|NCT02074553|7530258|FG003|STARTED|Intervention Period 4||11
6605575|NCT02074553|7530259|FG004|STARTED|Intervention Period 4||12
6605576|NCT02074553|7530260|FG005|STARTED|Intervention Period 4||10
6605577|NCT02074553|7530261|FG006|STARTED|Intervention Period 4||11
6605578|NCT02074553|7530262|FG007|STARTED|Intervention Period 4||11
6605579|NCT02074553|7530255|FG000|COMPLETED|Intervention Period 4||11
6605580|NCT02074553|7530256|FG001|COMPLETED|Intervention Period 4||12
6605581|NCT02074553|7530257|FG002|COMPLETED|Intervention Period 4||11
6605582|NCT02074553|7530258|FG003|COMPLETED|Intervention Period 4||11
6605583|NCT02074553|7530259|FG004|COMPLETED|Intervention Period 4||12
6605584|NCT02074553|7530260|FG005|COMPLETED|Intervention Period 4||10
6605585|NCT02074553|7530261|FG006|COMPLETED|Intervention Period 4||11
6605586|NCT02074553|7530262|FG007|COMPLETED|Intervention Period 4||11
6605587|NCT02074553|7530255|FG000|NOT COMPLETED|Intervention Period 4||0
6605588|NCT02074553|7530256|FG001|NOT COMPLETED|Intervention Period 4||0
6605589|NCT02074553|7530257|FG002|NOT COMPLETED|Intervention Period 4||0
6605590|NCT02074553|7530258|FG003|NOT COMPLETED|Intervention Period 4||0
6605591|NCT02074553|7530259|FG004|NOT COMPLETED|Intervention Period 4||0
6605592|NCT02074553|7530260|FG005|NOT COMPLETED|Intervention Period 4||0
6605593|NCT02074553|7530261|FG006|NOT COMPLETED|Intervention Period 4||0
6605594|NCT02074553|7530262|FG007|NOT COMPLETED|Intervention Period 4||0
6605595|NCT02074709|7530282|FG000|STARTED|Overall Study||30
6605596|NCT02074709|7530283|FG001|STARTED|Overall Study||30
6605597|NCT02074709|7530282|FG000|COMPLETED|Overall Study||29
6605598|NCT02074709|7530283|FG001|COMPLETED|Overall Study||29
6605599|NCT02074709|7530282|FG000|NOT COMPLETED|Overall Study||1
6605600|NCT02074709|7530283|FG001|NOT COMPLETED|Overall Study||1
6605601|NCT02074735|7530291|FG000|STARTED|Overall Study||29
6605602|NCT02074735|7530292|FG001|STARTED|Overall Study||33
6605603|NCT02074735|7530291|FG000|COMPLETED|Overall Study||26
6605604|NCT02074735|7530292|FG001|COMPLETED|Overall Study||29
6605605|NCT02074735|7530291|FG000|NOT COMPLETED|Overall Study||3
6605606|NCT02074735|7530292|FG001|NOT COMPLETED|Overall Study||4
6605607|NCT02074982|7530300|FG000|STARTED|Overall Study||337
6605608|NCT02074982|7530301|FG001|STARTED|Overall Study||339
6605609|NCT02074982|7530300|FG000|Full Analysis Set (FAS)|Overall Study||336
6605610|NCT02074982|7530301|FG001|Full Analysis Set (FAS)|Overall Study||339
6605611|NCT02074982|7530300|FG000|Safety Set (SF)|Overall Study||335
6605612|NCT02074982|7530301|FG001|Safety Set (SF)|Overall Study||336
6605613|NCT02074982|7530300|FG000|COMPLETED|Overall Study||286
6605614|NCT02074982|7530301|FG001|COMPLETED|Overall Study||285
6605615|NCT02074982|7530300|FG000|NOT COMPLETED|Overall Study||51
6605616|NCT02074982|7530301|FG001|NOT COMPLETED|Overall Study||54
6605617|NCT02074995|7530307|FG000|STARTED|Overall Study||1
6605618|NCT02074995|7530308|FG001|STARTED|Overall Study||0
6605619|NCT02074995|7530309|FG002|STARTED|Overall Study||0
6605620|NCT02074995|7530307|FG000|COMPLETED|Overall Study||1
6605621|NCT02074995|7530308|FG001|COMPLETED|Overall Study||0
6605622|NCT02074995|7530309|FG002|COMPLETED|Overall Study||0
6605623|NCT02074995|7530307|FG000|NOT COMPLETED|Overall Study||0
6605624|NCT02074995|7530308|FG001|NOT COMPLETED|Overall Study||0
6605625|NCT02074995|7530309|FG002|NOT COMPLETED|Overall Study||0
6605626|NCT02075008|7530313|FG000|STARTED|Overall Study||270
6605627|NCT02075008|7530313|FG000|COMPLETED|Overall Study||94
6605628|NCT02075008|7530313|FG000|NOT COMPLETED|Overall Study||176
6605629|NCT02075047|7530319|FG000|STARTED|Treatment Phase (4 Weeks)||86
6605630|NCT02075047|7530320|FG001|STARTED|Treatment Phase (4 Weeks)||85
6605631|NCT02075047|7530319|FG000|COMPLETED|Treatment Phase (4 Weeks)||63
6605632|NCT02075047|7530320|FG001|COMPLETED|Treatment Phase (4 Weeks)||75
6605633|NCT02075047|7530319|FG000|NOT COMPLETED|Treatment Phase (4 Weeks)||23
6605634|NCT02075047|7530320|FG001|NOT COMPLETED|Treatment Phase (4 Weeks)||10
6605635|NCT02075047|7530319|FG000|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|86
6605636|NCT02075047|7530320|FG001|STARTED|Follow up Phase (5 Weeks)|Participants were followed up after completion or discontinuation of treatment.|85
6605637|NCT02075047|7530319|FG000|COMPLETED|Follow up Phase (5 Weeks)||60
6605638|NCT02075047|7530320|FG001|COMPLETED|Follow up Phase (5 Weeks)||72
6605639|NCT02075047|7530319|FG000|NOT COMPLETED|Follow up Phase (5 Weeks)||26
6605640|NCT02075047|7530320|FG001|NOT COMPLETED|Follow up Phase (5 Weeks)||13
6605641|NCT02075073|7530329|FG000|STARTED|Overall Study||36
6605642|NCT02075073|7530330|FG001|STARTED|Overall Study||37
6605643|NCT02075073|7530331|FG002|STARTED|Overall Study||36
6605644|NCT02075073|7530329|FG000|COMPLETED|Overall Study||36
6605645|NCT02075073|7530330|FG001|COMPLETED|Overall Study||36
6605646|NCT02075073|7530331|FG002|COMPLETED|Overall Study||36
6605647|NCT02075073|7530329|FG000|NOT COMPLETED|Overall Study||0
6605648|NCT02075073|7530330|FG001|NOT COMPLETED|Overall Study||1
6605649|NCT02075073|7530331|FG002|NOT COMPLETED|Overall Study||0
6605650|NCT02075125|7530341|FG000|STARTED|Overall Study||19
6605651|NCT02075125|7530342|FG001|STARTED|Overall Study||20
6605652|NCT02075125|7530341|FG000|COMPLETED|Overall Study||19
6605653|NCT02075125|7530342|FG001|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
6605654|NCT02075125|7530341|FG000|NOT COMPLETED|Overall Study||0
6605655|NCT02075125|7530342|FG001|NOT COMPLETED|Overall Study||1
6605656|NCT02075203|7530351|FG000|STARTED|Overall Study||330
6605657|NCT02075203|7530352|FG001|STARTED|Overall Study||330
6605658|NCT02075203|7530353|FG002|STARTED|Overall Study||329
6605659|NCT02075203|7530351|FG000|COMPLETED|Overall Study||327
6605660|NCT02075203|7530352|FG001|COMPLETED|Overall Study||330
6605661|NCT02075203|7530353|FG002|COMPLETED|Overall Study||328
6605662|NCT02075203|7530351|FG000|NOT COMPLETED|Overall Study||3
6605663|NCT02075203|7530352|FG001|NOT COMPLETED|Overall Study||0
6605664|NCT02075203|7530353|FG002|NOT COMPLETED|Overall Study||1
6605665|NCT02075255|7530364|FG000|STARTED|Overall Study||72
6605666|NCT02075255|7530365|FG001|STARTED|Overall Study||73
6605667|NCT02075255|7530366|FG002|STARTED|Overall Study||75
6605668|NCT02075255|7530364|FG000|COMPLETED|Overall Study||68
6605669|NCT02075255|7530365|FG001|COMPLETED|Overall Study||69
6605670|NCT02075255|7530366|FG002|COMPLETED|Overall Study||72
6605671|NCT02075255|7530364|FG000|NOT COMPLETED|Overall Study||4
6605672|NCT02075255|7530365|FG001|NOT COMPLETED|Overall Study||4
6605673|NCT02075255|7530366|FG002|NOT COMPLETED|Overall Study||3
6605674|NCT02075320|7530374|FG000|STARTED|Overall Study||50
6605675|NCT02075320|7530374|FG000|COMPLETED|Overall Study||48
6605676|NCT02075320|7530374|FG000|NOT COMPLETED|Overall Study||2
6605677|NCT02075463|7530378|FG000|STARTED|Overall Study||15
6605678|NCT02075463|7530378|FG000|COMPLETED|Overall Study||7
6605679|NCT02075463|7530378|FG000|NOT COMPLETED|Overall Study||8
6605680|NCT02075476|7530385|FG000|STARTED|Overall Study||20
6605681|NCT02075476|7530386|FG001|STARTED|Overall Study||20
6605682|NCT02075476|7530385|FG000|COMPLETED|Overall Study||17
6605683|NCT02075476|7530386|FG001|COMPLETED|Overall Study||15
6605684|NCT02075476|7530385|FG000|NOT COMPLETED|Overall Study||3
6605685|NCT02075476|7530386|FG001|NOT COMPLETED|Overall Study||5
6605686|NCT02075515|7530395|FG000|STARTED|Overall Study||218
6605687|NCT02075515|7530396|FG001|STARTED|Overall Study||217
6605688|NCT02075515|7530397|FG002|STARTED|Overall Study||216
6605689|NCT02075515|7530395|FG000|COMPLETED|Overall Study||214
6605690|NCT02075515|7530396|FG001|COMPLETED|Overall Study||212
6605691|NCT02075515|7530397|FG002|COMPLETED|Overall Study||208
6605692|NCT02075515|7530395|FG000|NOT COMPLETED|Overall Study||4
6605693|NCT02075515|7530396|FG001|NOT COMPLETED|Overall Study||5
6605694|NCT02075515|7530397|FG002|NOT COMPLETED|Overall Study||8
6605695|NCT02075541|7530408|FG000|STARTED|Overall Study||73
6605696|NCT02075541|7530409|FG001|STARTED|Overall Study||72
6605697|NCT02075541|7530408|FG000|COMPLETED|Overall Study||69
6605698|NCT02075541|7530409|FG001|COMPLETED|Overall Study||64
6605699|NCT02075541|7530408|FG000|NOT COMPLETED|Overall Study||4
6605700|NCT02075541|7530409|FG001|NOT COMPLETED|Overall Study||8
6605701|NCT02075554|7530415|FG000|STARTED|Overall Study||58
6605702|NCT02075554|7530415|FG000|COMPLETED|Overall Study||43
6605703|NCT02075554|7530415|FG000|NOT COMPLETED|Overall Study||15
6605704|NCT02075606|7530419|FG000|STARTED|Overall Study||50
6605705|NCT02075606|7530419|FG000|COMPLETED|Overall Study||40
6605706|NCT02075606|7530419|FG000|NOT COMPLETED|Overall Study||10
6605707|NCT02075632|7530430|FG000|STARTED|Overall Study||162
6605708|NCT02075632|7530431|FG001|STARTED|Overall Study||148
6605709|NCT02075632|7530430|FG000|COMPLETED|Overall Study||161
6605710|NCT02075632|7530431|FG001|COMPLETED|Overall Study||143
6605711|NCT02075632|7530430|FG000|NOT COMPLETED|Overall Study||1
6605712|NCT02075632|7530431|FG001|NOT COMPLETED|Overall Study||5
6605713|NCT02075658|7530439|FG000|STARTED|Overall Study||30
6605714|NCT02075658|7530440|FG001|STARTED|Overall Study||30
6605715|NCT02075658|7530439|FG000|COMPLETED|Overall Study||28
6605716|NCT02075658|7530440|FG001|COMPLETED|Overall Study||28
6605717|NCT02075658|7530439|FG000|NOT COMPLETED|Overall Study||2
6605718|NCT02075658|7530440|FG001|NOT COMPLETED|Overall Study||2
6605719|NCT02076022|7530448|FG000|STARTED|Overall Study||7
6605720|NCT02076022|7530449|FG001|STARTED|Overall Study||3
6605721|NCT02076022|7530448|FG000|COMPLETED|Overall Study||5
6605722|NCT02076022|7530449|FG001|COMPLETED|Overall Study||3
6605723|NCT02076022|7530448|FG000|NOT COMPLETED|Overall Study||2
6605724|NCT02076022|7530449|FG001|NOT COMPLETED|Overall Study||0
6605725|NCT02076100|7530462|FG000|STARTED|Overall Study||3
6605726|NCT02076100|7530463|FG001|STARTED|Overall Study||3
6605727|NCT02076100|7530464|FG002|STARTED|Overall Study||3
6605728|NCT02076100|7530465|FG003|STARTED|Overall Study||3
6605729|NCT02076100|7530466|FG004|STARTED|Overall Study||3
6605730|NCT02076100|7530467|FG005|STARTED|Overall Study||3
6605731|NCT02076100|7530468|FG006|STARTED|Overall Study||4
6605732|NCT02076100|7530462|FG000|COMPLETED|Overall Study||3
6605733|NCT02076100|7530463|FG001|COMPLETED|Overall Study||3
6605734|NCT02076100|7530464|FG002|COMPLETED|Overall Study||3
6605735|NCT02076100|7530465|FG003|COMPLETED|Overall Study||3
6605736|NCT02076100|7530466|FG004|COMPLETED|Overall Study||3
6605737|NCT02076100|7530467|FG005|COMPLETED|Overall Study||3
6605738|NCT02076100|7530468|FG006|COMPLETED|Overall Study||4
6605739|NCT02076100|7530462|FG000|NOT COMPLETED|Overall Study||0
6605740|NCT02076100|7530463|FG001|NOT COMPLETED|Overall Study||0
6605741|NCT02076100|7530464|FG002|NOT COMPLETED|Overall Study||0
6605742|NCT02076100|7530465|FG003|NOT COMPLETED|Overall Study||0
6605743|NCT02076100|7530466|FG004|NOT COMPLETED|Overall Study||0
6605744|NCT02076100|7530467|FG005|NOT COMPLETED|Overall Study||0
6605745|NCT02076100|7530468|FG006|NOT COMPLETED|Overall Study||0
6605746|NCT02076113|7530490|FG000|STARTED|Overall Study||63
6605747|NCT02076113|7530491|FG001|STARTED|Overall Study||100
6605748|NCT02076113|7530490|FG000|Surgery as Randomized|Overall Study|1 patient underwent dorsal fusion surgery|62
6605749|NCT02076113|7530491|FG001|Surgery as Randomized|Overall Study|4 patients underwent ventral fusion surgery|96
6605750|NCT02076113|7530490|FG000|3-Month Follow-up|Overall Study|5 missed follow-up visit; 2 lost to follow-up|56
6605751|NCT02076113|7530491|FG001|3-Month Follow-up|Overall Study|9 missed follow-up appointment; 1 lost to follow-up|90
6605752|NCT02076113|7530490|FG000|6-Month Follow-up|Overall Study|7 missed follow-up visit; 3 lost to follow-up|53
6605753|NCT02076113|7530491|FG001|6-Month Follow-up|Overall Study|7 missed follow-up visit; 1 lost to follow-up; 1 deceased|91
6605754|NCT02076113|7530490|FG000|1-Year Follow-up|Overall Study|3 lost to follow-up|60
6605755|NCT02076113|7530491|FG001|1-Year Follow-up|Overall Study|2 missed follow-up visit; 1 lost to follow-up; 2 deceased|95
6605756|NCT02076113|7530490|FG000|2-Year Follow-up|Overall Study|5 missed follow-up visit; 4 lost to follow-up; 2 withdrew consent; 1 deceased|51
6605757|NCT02076113|7530491|FG001|2-Year Follow-up|Overall Study|14 missed follow-up visit; 1 lost to follow-up; 3 withdrew consent; 3 deceased|79
6605758|NCT02076113|7530490|FG000|COMPLETED|Overall Study||56
6605759|NCT02076113|7530491|FG001|COMPLETED|Overall Study||93
6605760|NCT02076113|7530490|FG000|NOT COMPLETED|Overall Study||7
6605761|NCT02076113|7530491|FG001|NOT COMPLETED|Overall Study||7
6605762|NCT02076152|7530502|FG000|STARTED|Overall Study||2
6605763|NCT02076152|7530503|FG001|STARTED|Overall Study||9
6605764|NCT02076152|7530502|FG000|COMPLETED|Overall Study||2
6605765|NCT02076152|7530503|FG001|COMPLETED|Overall Study||9
6605766|NCT02076152|7530502|FG000|NOT COMPLETED|Overall Study||0
6605767|NCT02076152|7530503|FG001|NOT COMPLETED|Overall Study||0
6605768|NCT02076165|7530510|FG000|STARTED|Overall Study||74
6605769|NCT02076165|7530511|FG001|STARTED|Overall Study||75
6605770|NCT02076165|7530510|FG000|COMPLETED|Overall Study||66
6605771|NCT02076165|7530511|FG001|COMPLETED|Overall Study||69
6605772|NCT02076165|7530510|FG000|NOT COMPLETED|Overall Study||8
6605773|NCT02076165|7530511|FG001|NOT COMPLETED|Overall Study||6
6605774|NCT02076243|7530517|FG000|STARTED|Overall Study||2
6605775|NCT02076243|7530517|FG000|COMPLETED|Overall Study||0
6605776|NCT02076243|7530517|FG000|NOT COMPLETED|Overall Study||2
6605777|NCT02076321|7530523|FG000|STARTED|Overall Study||51
6605778|NCT02076321|7530524|FG001|STARTED|Overall Study||51
6605779|NCT02076321|7530523|FG000|COMPLETED|Overall Study||46
6605780|NCT02076321|7530524|FG001|COMPLETED|Overall Study||49
6605781|NCT02076321|7530523|FG000|NOT COMPLETED|Overall Study||5
6605782|NCT02076321|7530524|FG001|NOT COMPLETED|Overall Study||2
6605783|NCT02076334|7530534|FG000|STARTED|Overall Study||21
6605784|NCT02076334|7530535|FG001|STARTED|Overall Study||21
6605785|NCT02076334|7530536|FG002|STARTED|Overall Study||21
6605786|NCT02076334|7530537|FG003|STARTED|Overall Study||21
6605787|NCT02076334|7530534|FG000|COMPLETED|Overall Study||20
6605788|NCT02076334|7530535|FG001|COMPLETED|Overall Study||20
6605789|NCT02076334|7530536|FG002|COMPLETED|Overall Study||20
6605790|NCT02076334|7530537|FG003|COMPLETED|Overall Study||20
6605791|NCT02076334|7530534|FG000|NOT COMPLETED|Overall Study||1
6605792|NCT02076334|7530535|FG001|NOT COMPLETED|Overall Study||1
6605793|NCT02076334|7530536|FG002|NOT COMPLETED|Overall Study||1
6605794|NCT02076334|7530537|FG003|NOT COMPLETED|Overall Study||1
6605795|NCT02076399|7530549|FG000|STARTED|Overall Study||51
6605796|NCT02076399|7530550|FG001|STARTED|Overall Study||25
6605797|NCT02076399|7530549|FG000|COMPLETED|Overall Study||12
6605798|NCT02076399|7530550|FG001|COMPLETED|Overall Study||1
6605799|NCT02076399|7530549|FG000|NOT COMPLETED|Overall Study||39
6605800|NCT02076399|7530550|FG001|NOT COMPLETED|Overall Study||24
6605801|NCT02076412|7530558|FG000|STARTED|Overall Study||50
6605802|NCT02076412|7530559|FG001|STARTED|Overall Study||24
6605803|NCT02076412|7530558|FG000|COMPLETED|Overall Study||13
6605804|NCT02076412|7530559|FG001|COMPLETED|Overall Study||2
6605805|NCT02076412|7530558|FG000|NOT COMPLETED|Overall Study||37
6605806|NCT02076412|7530559|FG001|NOT COMPLETED|Overall Study||22
6605807|NCT02076425|7530567|FG000|STARTED|Overall Study||114
6605808|NCT02076425|7530568|FG001|STARTED|Overall Study||115
6605809|NCT02076425|7530567|FG000|COMPLETED|Overall Study||100
6605810|NCT02076425|7530568|FG001|COMPLETED|Overall Study||91
6605811|NCT02076425|7530567|FG000|NOT COMPLETED|Overall Study||14
6605812|NCT02076425|7530568|FG001|NOT COMPLETED|Overall Study||24
6605813|NCT02076776|7530577|FG000|STARTED|Overall Study||6
6605814|NCT02076776|7530578|FG001|STARTED|Overall Study||8
6605815|NCT02076776|7530579|FG002|STARTED|Overall Study||6
6605816|NCT02076776|7530577|FG000|COMPLETED|Overall Study||5
6605817|NCT02076776|7530578|FG001|COMPLETED|Overall Study||6
6605818|NCT02076776|7530579|FG002|COMPLETED|Overall Study||6
6605819|NCT02076776|7530577|FG000|NOT COMPLETED|Overall Study||1
6605820|NCT02076776|7530578|FG001|NOT COMPLETED|Overall Study||2
6605821|NCT02076776|7530579|FG002|NOT COMPLETED|Overall Study||0
6605822|NCT02076919|7530599|FG000|STARTED|Overall Study||24
6605823|NCT02076919|7530600|FG001|STARTED|Overall Study||8
6605824|NCT02076919|7530601|FG002|STARTED|Overall Study||36
6605825|NCT02076919|7530602|FG003|STARTED|Overall Study||12
6605826|NCT02076919|7530599|FG000|COMPLETED|Overall Study||24
6605827|NCT02076919|7530600|FG001|COMPLETED|Overall Study||8
6605828|NCT02076919|7530601|FG002|COMPLETED|Overall Study||36
6605829|NCT02076919|7530602|FG003|COMPLETED|Overall Study||12
6605830|NCT02076919|7530599|FG000|NOT COMPLETED|Overall Study||0
6605831|NCT02076919|7530600|FG001|NOT COMPLETED|Overall Study||0
6605832|NCT02076919|7530601|FG002|NOT COMPLETED|Overall Study||0
6605833|NCT02076919|7530602|FG003|NOT COMPLETED|Overall Study||0
6605834|NCT02076997|7530629|FG000|STARTED|Overall Study||23
6605835|NCT02076997|7530629|FG000|COMPLETED|Overall Study||22
6605836|NCT02076997|7530629|FG000|NOT COMPLETED|Overall Study||1
6605837|NCT02077140|7530638|FG000|STARTED|Overall Study||36
6605838|NCT02077140|7530639|FG001|STARTED|Overall Study||36
6605839|NCT02077140|7530640|FG002|STARTED|Overall Study||36
6605840|NCT02077140|7530641|FG003|STARTED|Overall Study||36
6605841|NCT02077140|7530642|FG004|STARTED|Overall Study||48
6605842|NCT02077140|7530638|FG000|COMPLETED|Overall Study||32
6605843|NCT02077140|7530639|FG001|COMPLETED|Overall Study||34
6605844|NCT02077140|7530640|FG002|COMPLETED|Overall Study||34
6605845|NCT02077140|7530641|FG003|COMPLETED|Overall Study||32
6605846|NCT02077140|7530642|FG004|COMPLETED|Overall Study||43
6605847|NCT02077140|7530638|FG000|NOT COMPLETED|Overall Study||4
6605848|NCT02077140|7530639|FG001|NOT COMPLETED|Overall Study||2
6605849|NCT02077140|7530640|FG002|NOT COMPLETED|Overall Study||2
6605850|NCT02077140|7530641|FG003|NOT COMPLETED|Overall Study||4
6605851|NCT02077140|7530642|FG004|NOT COMPLETED|Overall Study||5
6605852|NCT02077374|7530659|FG000|STARTED|Overall Study||19
6605853|NCT02077374|7530660|FG001|STARTED|Overall Study||19
6605854|NCT02077374|7530659|FG000|COMPLETED|Overall Study||19
6605855|NCT02077374|7530660|FG001|COMPLETED|Overall Study||17
6605856|NCT02077374|7530659|FG000|NOT COMPLETED|Overall Study||0
6605857|NCT02077374|7530660|FG001|NOT COMPLETED|Overall Study||2
6605858|NCT02077465|7530671|FG000|STARTED|Overall Study||8
6605859|NCT02077465|7530672|FG001|STARTED|Overall Study||3
6605860|NCT02077465|7530671|FG000|COMPLETED|Overall Study||7
6605861|NCT02077465|7530672|FG001|COMPLETED|Overall Study||2
6605862|NCT02077465|7530671|FG000|NOT COMPLETED|Overall Study||1
6605863|NCT02077465|7530672|FG001|NOT COMPLETED|Overall Study||1
6605864|NCT02078102|7530680|FG000|STARTED|Overall Study||25
6605865|NCT02078102|7530681|FG001|STARTED|Overall Study||13
6605866|NCT02078102|7530680|FG000|COMPLETED|Overall Study||23
6605867|NCT02078102|7530681|FG001|COMPLETED|Overall Study||12
6605868|NCT02078102|7530680|FG000|NOT COMPLETED|Overall Study||2
6605869|NCT02078102|7530681|FG001|NOT COMPLETED|Overall Study||1
6605870|NCT02078180|7530688|FG000|STARTED|Overall Study||34
6605871|NCT02078180|7530688|FG000|IR75|Overall Study||30
6605872|NCT02078180|7530688|FG000|IR100|Overall Study||31
6605873|NCT02078180|7530688|FG000|SR100|Overall Study||31
6605874|NCT02078180|7530688|FG000|SR150|Overall Study||32
6605875|NCT02078180|7530688|FG000|XL 150|Overall Study||31
6605876|NCT02078180|7530688|FG000|XL 300|Overall Study||32
6605877|NCT02078180|7530688|FG000|COMPLETED|Overall Study||29
6605878|NCT02078180|7530688|FG000|NOT COMPLETED|Overall Study||5
6605879|NCT02078193|7530697|FG000|STARTED|Overall Study||3
6605880|NCT02078193|7530697|FG000|COMPLETED|Overall Study||3
6605881|NCT02078193|7530697|FG000|NOT COMPLETED|Overall Study||0
6605882|NCT02078219|7530707|FG000|STARTED|Overall Study||41
6605883|NCT02078219|7530708|FG001|STARTED|Overall Study||40
6605884|NCT02078219|7530709|FG002|STARTED|Overall Study||41
6605885|NCT02078219|7530710|FG003|STARTED|Overall Study||41
6605886|NCT02078219|7530711|FG004|STARTED|Overall Study||41
6605887|NCT02078219|7530707|FG000|COMPLETED|Overall Study||38
6605888|NCT02078219|7530708|FG001|COMPLETED|Overall Study||36
6605889|NCT02078219|7530709|FG002|COMPLETED|Overall Study||35
6605890|NCT02078219|7530710|FG003|COMPLETED|Overall Study||37
6605891|NCT02078219|7530711|FG004|COMPLETED|Overall Study||39
6605892|NCT02078219|7530707|FG000|NOT COMPLETED|Overall Study||3
6605893|NCT02078219|7530708|FG001|NOT COMPLETED|Overall Study||4
6605894|NCT02078219|7530709|FG002|NOT COMPLETED|Overall Study||6
6605895|NCT02078219|7530710|FG003|NOT COMPLETED|Overall Study||4
6605896|NCT02078219|7530711|FG004|NOT COMPLETED|Overall Study||2
6605897|NCT02078284|7530728|FG000|STARTED|Overall Study||5
6605898|NCT02078284|7530729|FG001|STARTED|Overall Study||7
6605899|NCT02078284|7530730|FG002|STARTED|Overall Study||6
6605900|NCT02078284|7530731|FG003|STARTED|Overall Study||6
6605901|NCT02078284|7530732|FG004|STARTED|Overall Study||4
6605902|NCT02078284|7530728|FG000|COMPLETED|Overall Study||5
6605903|NCT02078284|7530729|FG001|COMPLETED|Overall Study||7
6605904|NCT02078284|7530730|FG002|COMPLETED|Overall Study||6
6605905|NCT02078284|7530731|FG003|COMPLETED|Overall Study||6
6605906|NCT02078284|7530732|FG004|COMPLETED|Overall Study||4
6605907|NCT02078284|7530728|FG000|NOT COMPLETED|Overall Study||0
6605908|NCT02078284|7530729|FG001|NOT COMPLETED|Overall Study||0
6605909|NCT02078284|7530730|FG002|NOT COMPLETED|Overall Study||0
6605910|NCT02078284|7530731|FG003|NOT COMPLETED|Overall Study||0
6605911|NCT02078284|7530732|FG004|NOT COMPLETED|Overall Study||0
6605912|NCT02078492|7530747|FG000|STARTED|Overall Study||80
6605913|NCT02078492|7530748|FG001|STARTED|Overall Study||80
6605914|NCT02078492|7530749|FG002|STARTED|Overall Study||80
6605915|NCT02078492|7530747|FG000|COMPLETED|Overall Study||80
6605916|NCT02078492|7530748|FG001|COMPLETED|Overall Study||80
6605917|NCT02078492|7530749|FG002|COMPLETED|Overall Study||80
6605918|NCT02078492|7530747|FG000|NOT COMPLETED|Overall Study||0
6605919|NCT02078492|7530748|FG001|NOT COMPLETED|Overall Study||0
6605920|NCT02078492|7530749|FG002|NOT COMPLETED|Overall Study||0
6605921|NCT02078557|7530757|FG000|STARTED|Overall Study||4
6605922|NCT02078557|7530757|FG000|COMPLETED|Overall Study||4
6605923|NCT02078557|7530757|FG000|NOT COMPLETED|Overall Study||0
6605924|NCT02078713|7530765|FG000|STARTED|Overall Study||407
6605925|NCT02078713|7530766|FG001|STARTED|Overall Study||351
6605926|NCT02078713|7530767|FG002|STARTED|Overall Study||15
6605927|NCT02078713|7530768|FG003|STARTED|Overall Study||13
6605928|NCT02078713|7530765|FG000|COMPLETED|Overall Study||355
6605929|NCT02078713|7530766|FG001|COMPLETED|Overall Study||290
6605930|NCT02078713|7530767|FG002|COMPLETED|Overall Study||15
6605931|NCT02078713|7530768|FG003|COMPLETED|Overall Study||13
6605932|NCT02078713|7530765|FG000|NOT COMPLETED|Overall Study||52
6605933|NCT02078713|7530766|FG001|NOT COMPLETED|Overall Study||61
6605934|NCT02078713|7530767|FG002|NOT COMPLETED|Overall Study||0
6605935|NCT02078713|7530768|FG003|NOT COMPLETED|Overall Study||0
6605936|NCT02078726|7530782|FG000|STARTED|Overall Study||64
6605937|NCT02078726|7530783|FG001|STARTED|Overall Study||36
6605938|NCT02078726|7530782|FG000|COMPLETED|Overall Study||64
6605939|NCT02078726|7530783|FG001|COMPLETED|Overall Study||36
6605940|NCT02078726|7530782|FG000|NOT COMPLETED|Overall Study||0
6605941|NCT02078726|7530783|FG001|NOT COMPLETED|Overall Study||0
6605942|NCT02078752|7530799|FG000|STARTED|Overall Study||3
6605943|NCT02078752|7530800|FG001|STARTED|Overall Study||13
6605944|NCT02078752|7530801|FG002|STARTED|Overall Study||2
6605945|NCT02078752|7530802|FG003|STARTED|Overall Study||7
6605946|NCT02078752|7530803|FG004|STARTED|Overall Study||3
6605947|NCT02078752|7530804|FG005|STARTED|Overall Study||9
6605948|NCT02078752|7530805|FG006|STARTED|Overall Study||3
6605949|NCT02078752|7530806|FG007|STARTED|Overall Study||6
6605950|NCT02078752|7530807|FG008|STARTED|Overall Study||2
6605951|NCT02078752|7530808|FG009|STARTED|Overall Study||12
6605952|NCT02078752|7530799|FG000|COMPLETED|Overall Study||1
6605953|NCT02078752|7530800|FG001|COMPLETED|Overall Study||6
6605954|NCT02078752|7530801|FG002|COMPLETED|Overall Study||1
6605955|NCT02078752|7530802|FG003|COMPLETED|Overall Study||5
6605956|NCT02078752|7530803|FG004|COMPLETED|Overall Study||2
6605957|NCT02078752|7530804|FG005|COMPLETED|Overall Study||5
6605958|NCT02078752|7530805|FG006|COMPLETED|Overall Study||1
6605959|NCT02078752|7530806|FG007|COMPLETED|Overall Study||3
6605960|NCT02078752|7530807|FG008|COMPLETED|Overall Study||2
6605961|NCT02078752|7530808|FG009|COMPLETED|Overall Study||2
6605962|NCT02078752|7530799|FG000|NOT COMPLETED|Overall Study||2
6605963|NCT02078752|7530800|FG001|NOT COMPLETED|Overall Study||7
6605964|NCT02078752|7530801|FG002|NOT COMPLETED|Overall Study||1
6605965|NCT02078752|7530802|FG003|NOT COMPLETED|Overall Study||2
6605966|NCT02078752|7530803|FG004|NOT COMPLETED|Overall Study||1
6605967|NCT02078752|7530804|FG005|NOT COMPLETED|Overall Study||4
6605968|NCT02078752|7530805|FG006|NOT COMPLETED|Overall Study||2
6605969|NCT02078752|7530806|FG007|NOT COMPLETED|Overall Study||3
6605970|NCT02078752|7530807|FG008|NOT COMPLETED|Overall Study||0
6605971|NCT02078752|7530808|FG009|NOT COMPLETED|Overall Study||10
6605972|NCT02078817|7530839|FG000|STARTED|Overall Study||14
6605973|NCT02078817|7530839|FG000|COMPLETED|Overall Study||13
6605974|NCT02078817|7530839|FG000|NOT COMPLETED|Overall Study||1
6605975|NCT02078882|7530843|FG000|STARTED|Overall Study||16
6605976|NCT02078882|7530843|FG000|COMPLETED|Overall Study||16
6605977|NCT02078882|7530843|FG000|NOT COMPLETED|Overall Study||0
6605978|NCT02078960|7530850|FG000|STARTED|Treatment Period||2
6605979|NCT02078960|7530851|FG001|STARTED|Treatment Period||4
6605980|NCT02078960|7530852|FG002|STARTED|Treatment Period||4
6605981|NCT02078960|7530850|FG000|COMPLETED|Treatment Period||0
6605982|NCT02078960|7530851|FG001|COMPLETED|Treatment Period||1
6605983|NCT02078960|7530852|FG002|COMPLETED|Treatment Period||1
6605984|NCT02078960|7530850|FG000|NOT COMPLETED|Treatment Period||2
6605985|NCT02078960|7530851|FG001|NOT COMPLETED|Treatment Period||3
6605986|NCT02078960|7530852|FG002|NOT COMPLETED|Treatment Period||3
6605987|NCT02078960|7530850|FG000|STARTED|Follow-up Period||2
6605988|NCT02078960|7530851|FG001|STARTED|Follow-up Period||2
6605989|NCT02078960|7530852|FG002|STARTED|Follow-up Period||1
6605990|NCT02078960|7530850|FG000|COMPLETED|Follow-up Period||0
6605991|NCT02078960|7530851|FG001|COMPLETED|Follow-up Period||1
6605992|NCT02078960|7530852|FG002|COMPLETED|Follow-up Period||1
6605993|NCT02078960|7530850|FG000|NOT COMPLETED|Follow-up Period||2
6605994|NCT02078960|7530851|FG001|NOT COMPLETED|Follow-up Period||1
6605995|NCT02078960|7530852|FG002|NOT COMPLETED|Follow-up Period||0
6605996|NCT02079025|7530864|FG000|STARTED|Overall Study||839
6605997|NCT02079025|7530865|FG001|STARTED|Overall Study||837
6605998|NCT02079025|7530864|FG000|COMPLETED|Overall Study||839
6605999|NCT02079025|7530865|FG001|COMPLETED|Overall Study||837
6606000|NCT02079025|7530864|FG000|NOT COMPLETED|Overall Study||0
6606001|NCT02079025|7530865|FG001|NOT COMPLETED|Overall Study||0
6606002|NCT02079038|7530874|FG000|STARTED|Modified Intent to Treat Population||112
6606003|NCT02079038|7530875|FG001|STARTED|Modified Intent to Treat Population||56
6606004|NCT02079038|7530874|FG000|COMPLETED|Modified Intent to Treat Population||105
6606005|NCT02079038|7530875|FG001|COMPLETED|Modified Intent to Treat Population||51
6606006|NCT02079038|7530874|FG000|NOT COMPLETED|Modified Intent to Treat Population||7
6606007|NCT02079038|7530875|FG001|NOT COMPLETED|Modified Intent to Treat Population||5
6606008|NCT02079038|7530874|FG000|STARTED|Completed 6 Months||105
6606009|NCT02079038|7530875|FG001|STARTED|Completed 6 Months||51
6606010|NCT02079038|7530874|FG000|COMPLETED|Completed 6 Months||103
6606011|NCT02079038|7530875|FG001|COMPLETED|Completed 6 Months||50
6606012|NCT02079038|7530874|FG000|NOT COMPLETED|Completed 6 Months||2
6606013|NCT02079038|7530875|FG001|NOT COMPLETED|Completed 6 Months||1
6606014|NCT02079077|7530883|FG000|STARTED|Overall Study||43
6606015|NCT02079077|7530884|FG001|STARTED|Overall Study||48
6606016|NCT02079077|7530883|FG000|COMPLETED|Overall Study||37
6606017|NCT02079077|7530884|FG001|COMPLETED|Overall Study||39
6606018|NCT02079077|7530883|FG000|NOT COMPLETED|Overall Study||6
6606019|NCT02079077|7530884|FG001|NOT COMPLETED|Overall Study||9
6606020|NCT02079246|7530890|FG000|STARTED|OLEX||1463
6606021|NCT02079246|7530891|FG001|STARTED|OLEX||0
6606022|NCT02079246|7530890|FG000|COMPLETED|OLEX||1235
6606023|NCT02079246|7530891|FG001|COMPLETED|OLEX||0
6606024|NCT02079246|7530890|FG000|NOT COMPLETED|OLEX||228
6606025|NCT02079246|7530891|FG001|NOT COMPLETED|OLEX||0
6606026|NCT02079246|7530890|FG000|STARTED|OLEX-MEM||0
6606027|NCT02079246|7530891|FG001|STARTED|OLEX-MEM||101
6606028|NCT02079246|7530890|FG000|COMPLETED|OLEX-MEM||0
6606029|NCT02079246|7530891|FG001|COMPLETED|OLEX-MEM||82
6606030|NCT02079246|7530890|FG000|NOT COMPLETED|OLEX-MEM||0
6606031|NCT02079246|7530891|FG001|NOT COMPLETED|OLEX-MEM||19
6606032|NCT02079311|7530902|FG000|STARTED|Overall Study||28
6606033|NCT02079311|7530903|FG001|STARTED|Overall Study||27
6606034|NCT02079311|7530902|FG000|COMPLETED|Overall Study||28
6606035|NCT02079311|7530903|FG001|COMPLETED|Overall Study||26
6606036|NCT02079311|7530902|FG000|NOT COMPLETED|Overall Study||0
6606037|NCT02079311|7530903|FG001|NOT COMPLETED|Overall Study||1
6606038|NCT02079519|7530909|FG000|STARTED|Overall Study||10
6606039|NCT02079519|7530909|FG000|COMPLETED|Overall Study||0
6606040|NCT02079519|7530909|FG000|NOT COMPLETED|Overall Study||10
6606041|NCT02079532|7530913|FG000|STARTED|Overall Study||302
6606042|NCT02079532|7530913|FG000|COMPLETED|Overall Study||273
6606043|NCT02079532|7530913|FG000|NOT COMPLETED|Overall Study||29
6606044|NCT02079610|7530919|FG000|STARTED|Overall Study||19
6606045|NCT02079610|7530920|FG001|STARTED|Overall Study||17
6606046|NCT02079610|7530919|FG000|COMPLETED|Overall Study||18
6606047|NCT02079610|7530920|FG001|COMPLETED|Overall Study||16
6606048|NCT02079610|7530919|FG000|NOT COMPLETED|Overall Study||1
6606049|NCT02079610|7530920|FG001|NOT COMPLETED|Overall Study||1
6606050|NCT02079636|7530941|FG000|STARTED|Overall Study||8
6606051|NCT02079636|7530942|FG001|STARTED|Overall Study||15
6606052|NCT02079636|7530943|FG002|STARTED|Overall Study||3
6606053|NCT02079636|7530944|FG003|STARTED|Overall Study||21
6606054|NCT02079636|7530945|FG004|STARTED|Overall Study||4
6606055|NCT02079636|7530946|FG005|STARTED|Overall Study||19
6606056|NCT02079636|7530947|FG006|STARTED|Overall Study||12
6606057|NCT02079636|7530948|FG007|STARTED|Overall Study||4
6606058|NCT02079636|7530949|FG008|STARTED|Overall Study||3
6606059|NCT02079636|7530950|FG009|STARTED|Overall Study||9
6606060|NCT02079636|7530951|FG010|STARTED|Overall Study||10
6606061|NCT02079636|7530952|FG011|STARTED|Overall Study||6
6606062|NCT02079636|7530953|FG012|STARTED|Overall Study||8
6606063|NCT02079636|7530954|FG013|STARTED|Overall Study||3
6606064|NCT02079636|7530955|FG014|STARTED|Overall Study||17
6606065|NCT02079636|7530941|FG000|Received at Least One Dose of Study Drug|Overall Study||8
6606066|NCT02079636|7530942|FG001|Received at Least One Dose of Study Drug|Overall Study||15
6606067|NCT02079636|7530943|FG002|Received at Least One Dose of Study Drug|Overall Study||3
6606068|NCT02079636|7530944|FG003|Received at Least One Dose of Study Drug|Overall Study||21
6606069|NCT02079636|7530945|FG004|Received at Least One Dose of Study Drug|Overall Study||4
6606070|NCT02079636|7530946|FG005|Received at Least One Dose of Study Drug|Overall Study||19
6606071|NCT02079636|7530947|FG006|Received at Least One Dose of Study Drug|Overall Study||12
6606072|NCT02079636|7530948|FG007|Received at Least One Dose of Study Drug|Overall Study||4
6606073|NCT02079636|7530949|FG008|Received at Least One Dose of Study Drug|Overall Study||3
6606074|NCT02079636|7530950|FG009|Received at Least One Dose of Study Drug|Overall Study||9
6606075|NCT02079636|7530951|FG010|Received at Least One Dose of Study Drug|Overall Study||10
6606076|NCT02079636|7530952|FG011|Received at Least One Dose of Study Drug|Overall Study||6
6606077|NCT02079636|7530953|FG012|Received at Least One Dose of Study Drug|Overall Study||8
6606078|NCT02079636|7530954|FG013|Received at Least One Dose of Study Drug|Overall Study||3
6606079|NCT02079636|7530955|FG014|Received at Least One Dose of Study Drug|Overall Study||17
6606080|NCT02079636|7530941|FG000|COMPLETED|Overall Study||5
6606081|NCT02079636|7530942|FG001|COMPLETED|Overall Study||13
6606082|NCT02079636|7530943|FG002|COMPLETED|Overall Study||3
6606083|NCT02079636|7530944|FG003|COMPLETED|Overall Study||9
6606084|NCT02079636|7530945|FG004|COMPLETED|Overall Study||2
6606085|NCT02079636|7530946|FG005|COMPLETED|Overall Study||13
6606086|NCT02079636|7530947|FG006|COMPLETED|Overall Study||11
6606087|NCT02079636|7530948|FG007|COMPLETED|Overall Study||3
6606088|NCT02079636|7530949|FG008|COMPLETED|Overall Study||3
6606089|NCT02079636|7530950|FG009|COMPLETED|Overall Study||6
6606090|NCT02079636|7530951|FG010|COMPLETED|Overall Study||8
6606091|NCT02079636|7530952|FG011|COMPLETED|Overall Study||4
6606092|NCT02079636|7530953|FG012|COMPLETED|Overall Study||5
6606093|NCT02079636|7530954|FG013|COMPLETED|Overall Study||3
6606094|NCT02079636|7530955|FG014|COMPLETED|Overall Study||12
6606095|NCT02079636|7530941|FG000|NOT COMPLETED|Overall Study||3
6606096|NCT02079636|7530942|FG001|NOT COMPLETED|Overall Study||2
6606097|NCT02079636|7530943|FG002|NOT COMPLETED|Overall Study||0
6606098|NCT02079636|7530944|FG003|NOT COMPLETED|Overall Study||12
6606099|NCT02079636|7530945|FG004|NOT COMPLETED|Overall Study||2
6606100|NCT02079636|7530946|FG005|NOT COMPLETED|Overall Study||6
6606101|NCT02079636|7530947|FG006|NOT COMPLETED|Overall Study||1
6606102|NCT02079636|7530948|FG007|NOT COMPLETED|Overall Study||1
6606103|NCT02079636|7530949|FG008|NOT COMPLETED|Overall Study||0
6606104|NCT02079636|7530950|FG009|NOT COMPLETED|Overall Study||3
6606105|NCT02079636|7530951|FG010|NOT COMPLETED|Overall Study||2
6606106|NCT02079636|7530952|FG011|NOT COMPLETED|Overall Study||2
6606107|NCT02079636|7530953|FG012|NOT COMPLETED|Overall Study||3
6606108|NCT02079636|7530954|FG013|NOT COMPLETED|Overall Study||0
6606109|NCT02079636|7530955|FG014|NOT COMPLETED|Overall Study||5
6606110|NCT02079649|7531023|FG000|STARTED|Overall Study||42
6606111|NCT02079649|7531024|FG001|STARTED|Overall Study||41
6606112|NCT02079649|7531025|FG002|STARTED|Overall Study||41
6606113|NCT02079649|7531026|FG003|STARTED|Overall Study||40
6606114|NCT02079649|7531023|FG000|Treated|Overall Study||41
6606115|NCT02079649|7531024|FG001|Treated|Overall Study||41
6606116|NCT02079649|7531025|FG002|Treated|Overall Study||40
6606117|NCT02079649|7531026|FG003|Treated|Overall Study||40
6606118|NCT02079649|7531023|FG000|COMPLETED|Overall Study||41
6606119|NCT02079649|7531024|FG001|COMPLETED|Overall Study||41
6606120|NCT02079649|7531025|FG002|COMPLETED|Overall Study||40
6606121|NCT02079649|7531026|FG003|COMPLETED|Overall Study||38
6606122|NCT02079649|7531023|FG000|NOT COMPLETED|Overall Study||1
6606123|NCT02079649|7531024|FG001|NOT COMPLETED|Overall Study||0
6606124|NCT02079649|7531025|FG002|NOT COMPLETED|Overall Study||1
6606125|NCT02079649|7531026|FG003|NOT COMPLETED|Overall Study||2
6606126|NCT02079805|7531039|FG000|STARTED|Overall Study||16
6606127|NCT02079805|7531040|FG001|STARTED|Overall Study||17
6606128|NCT02079805|7531039|FG000|COMPLETED|Overall Study||16
6606129|NCT02079805|7531040|FG001|COMPLETED|Overall Study||15
6606130|NCT02079805|7531039|FG000|NOT COMPLETED|Overall Study||0
6606131|NCT02079805|7531040|FG001|NOT COMPLETED|Overall Study||2
6606132|NCT02079844|7531049|FG000|STARTED|Treatment Period 1||6
6606133|NCT02079844|7531050|FG001|STARTED|Treatment Period 1||7
6606134|NCT02079844|7531051|FG002|STARTED|Treatment Period 1||7
6606135|NCT02079844|7531049|FG000|COMPLETED|Treatment Period 1||6
6606136|NCT02079844|7531050|FG001|COMPLETED|Treatment Period 1||7
6606137|NCT02079844|7531051|FG002|COMPLETED|Treatment Period 1||5
6606138|NCT02079844|7531049|FG000|NOT COMPLETED|Treatment Period 1||0
6606139|NCT02079844|7531050|FG001|NOT COMPLETED|Treatment Period 1||0
6606140|NCT02079844|7531051|FG002|NOT COMPLETED|Treatment Period 1||2
6606141|NCT02079844|7531049|FG000|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
6606142|NCT02079844|7531050|FG001|STARTED|Treatment Period 2||7
6606143|NCT02079844|7531051|FG002|STARTED|Treatment Period 2||5
6606144|NCT02079844|7531049|FG000|COMPLETED|Treatment Period 2||5
6606145|NCT02079844|7531050|FG001|COMPLETED|Treatment Period 2||6
6606146|NCT02079844|7531051|FG002|COMPLETED|Treatment Period 2||5
6606147|NCT02079844|7531049|FG000|NOT COMPLETED|Treatment Period 2||0
6606148|NCT02079844|7531050|FG001|NOT COMPLETED|Treatment Period 2||1
6606149|NCT02079844|7531051|FG002|NOT COMPLETED|Treatment Period 2||0
6606150|NCT02079844|7531049|FG000|STARTED|Treatment Period 3||5
6606151|NCT02079844|7531050|FG001|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
6606152|NCT02079844|7531051|FG002|STARTED|Treatment Period 3||5
6606153|NCT02079844|7531049|FG000|COMPLETED|Treatment Period 3||5
6606154|NCT02079844|7531050|FG001|COMPLETED|Treatment Period 3||5
6606155|NCT02079844|7531051|FG002|COMPLETED|Treatment Period 3||5
6606156|NCT02079844|7531049|FG000|NOT COMPLETED|Treatment Period 3||0
6606157|NCT02079844|7531050|FG001|NOT COMPLETED|Treatment Period 3||0
6606158|NCT02079844|7531051|FG002|NOT COMPLETED|Treatment Period 3||0
6606159|NCT02079909|7531065|FG000|STARTED|Overall Study||158
6606160|NCT02079909|7531066|FG001|STARTED|Overall Study||166
6606161|NCT02079909|7531067|FG002|STARTED|Overall Study||158
6606162|NCT02079909|7531065|FG000|COMPLETED|Overall Study||120
6606163|NCT02079909|7531066|FG001|COMPLETED|Overall Study||117
6606164|NCT02079909|7531067|FG002|COMPLETED|Overall Study||140
6606165|NCT02079909|7531065|FG000|NOT COMPLETED|Overall Study||38
6606166|NCT02079909|7531066|FG001|NOT COMPLETED|Overall Study||49
6606167|NCT02079909|7531067|FG002|NOT COMPLETED|Overall Study||18
6606168|NCT02079987|7531077|FG000|STARTED|Overall Study||557
6606169|NCT02079987|7531078|FG001|STARTED|Overall Study||544
6606170|NCT02079987|7531077|FG000|COMPLETED|Overall Study||557
6606171|NCT02079987|7531078|FG001|COMPLETED|Overall Study||544
6606172|NCT02079987|7531077|FG000|NOT COMPLETED|Overall Study||0
6606173|NCT02079987|7531078|FG001|NOT COMPLETED|Overall Study||0
6606174|NCT02080091|7531085|FG000|STARTED|Overall Study||25
6606175|NCT02080091|7531085|FG000|COMPLETED|Overall Study||0
6606176|NCT02080091|7531085|FG000|NOT COMPLETED|Overall Study||25
6625230|NCT02223702|7552878|FG001|STARTED|Overall Study||19
6625231|NCT02223702|7552877|FG000|COMPLETED|Overall Study||19
6625232|NCT02223702|7552878|FG001|COMPLETED|Overall Study||15
6625233|NCT02223702|7552877|FG000|NOT COMPLETED|Overall Study||1
6625234|NCT02223702|7552878|FG001|NOT COMPLETED|Overall Study||4
6625235|NCT02223715|7552884|FG000|STARTED|Overall Study||600
6625236|NCT02223715|7552884|FG000|COMPLETED|Overall Study||496
6625237|NCT02223715|7552884|FG000|NOT COMPLETED|Overall Study||104
6625238|NCT02223754|7552893|FG000|STARTED|Period 1||163
6625239|NCT02223754|7552894|FG001|STARTED|Period 1||159
6625240|NCT02223754|7552893|FG000|COMPLETED|Period 1||159
6625241|NCT02223754|7552894|FG001|COMPLETED|Period 1||144
6625242|NCT02223754|7552893|FG000|NOT COMPLETED|Period 1||4
6625243|NCT02223754|7552894|FG001|NOT COMPLETED|Period 1||15
6625244|NCT02223754|7552893|FG000|STARTED|Period 2||159
6625245|NCT02223754|7552894|FG001|STARTED|Period 2||144
6625246|NCT02223754|7552893|FG000|COMPLETED|Period 2||156
6625247|NCT02223754|7552894|FG001|COMPLETED|Period 2||141
6625248|NCT02223754|7552893|FG000|NOT COMPLETED|Period 2||3
6625249|NCT02223754|7552894|FG001|NOT COMPLETED|Period 2||3
6625250|NCT02223793|7552904|FG000|STARTED|Overall Study||185
6625251|NCT02223793|7552905|FG001|STARTED|Overall Study||199
6625252|NCT02223793|7552906|FG002|STARTED|Overall Study||198
6625253|NCT02223793|7552904|FG000|COMPLETED|Overall Study||168
6625254|NCT02223793|7552905|FG001|COMPLETED|Overall Study||190
6625255|NCT02223793|7552906|FG002|COMPLETED|Overall Study||185
6625256|NCT02223793|7552904|FG000|NOT COMPLETED|Overall Study||17
6625257|NCT02223793|7552905|FG001|NOT COMPLETED|Overall Study||9
6625258|NCT02223793|7552906|FG002|NOT COMPLETED|Overall Study||13
6625259|NCT02223858|7552916|FG000|STARTED|Overall Study||180
6625260|NCT02223858|7552917|FG001|STARTED|Overall Study||180
6625261|NCT02223858|7552916|FG000|1-month Follow-up|Overall Study||156
6625262|NCT02223858|7552917|FG001|1-month Follow-up|Overall Study||150
6625263|NCT02223858|7552916|FG000|3-month Follow-up|Overall Study||155
6625264|NCT02223858|7552917|FG001|3-month Follow-up|Overall Study||154
6625265|NCT02223858|7552916|FG000|6-month Follow-up|Overall Study||156
6625266|NCT02223858|7552917|FG001|6-month Follow-up|Overall Study||154
6625267|NCT02223858|7552916|FG000|COMPLETED|Overall Study||156
6625268|NCT02223858|7552917|FG001|COMPLETED|Overall Study||154
6625269|NCT02223858|7552916|FG000|NOT COMPLETED|Overall Study||24
6625270|NCT02223858|7552917|FG001|NOT COMPLETED|Overall Study||26
6625271|NCT02223871|7552923|FG000|STARTED|Overall Study||8
6625272|NCT02223871|7552923|FG000|COMPLETED|Overall Study||8
6625273|NCT02223871|7552923|FG000|NOT COMPLETED|Overall Study||0
6625274|NCT02224053|7552927|FG000|STARTED|AZD9291 and Omeprazole Co-administration||68
6625275|NCT02224053|7552927|FG000|COMPLETED|AZD9291 and Omeprazole Co-administration||47
6625276|NCT02224053|7552927|FG000|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
6625277|NCT02224053|7552927|FG000|STARTED|AZD9291 Alone||47
6625278|NCT02224053|7552927|FG000|COMPLETED|AZD9291 Alone||47
6625279|NCT02224053|7552927|FG000|NOT COMPLETED|AZD9291 Alone||0
6625280|NCT02224157|7552935|FG000|STARTED|Overall Study||2095
6625281|NCT02224157|7552936|FG001|STARTED|Overall Study||2094
6625282|NCT02224157|7552935|FG000|Patients Who Completed Treatment|Overall Study||1924
6625283|NCT02224157|7552936|FG001|Patients Who Completed Treatment|Overall Study||1903
6625284|NCT02224157|7552935|FG000|COMPLETED|Overall Study||1985
6625285|NCT02224157|7552936|FG001|COMPLETED|Overall Study||1983
6625286|NCT02224157|7552935|FG000|NOT COMPLETED|Overall Study||110
6625287|NCT02224157|7552936|FG001|NOT COMPLETED|Overall Study||111
6625288|NCT02224274|7552944|FG000|STARTED|Overall Study||17
6625289|NCT02224274|7552945|FG001|STARTED|Overall Study||20
6625290|NCT02224274|7552944|FG000|COMPLETED|Overall Study||16
6625291|NCT02224274|7552945|FG001|COMPLETED|Overall Study||20
6625292|NCT02224274|7552944|FG000|NOT COMPLETED|Overall Study||1
6625293|NCT02224274|7552945|FG001|NOT COMPLETED|Overall Study||0
6625294|NCT02224313|7552953|FG000|STARTED|Overall Study||10
6625295|NCT02224313|7552954|FG001|STARTED|Overall Study||10
6625296|NCT02224313|7552953|FG000|COMPLETED|Overall Study||7
6625297|NCT02224313|7552954|FG001|COMPLETED|Overall Study||9
6625298|NCT02224313|7552953|FG000|NOT COMPLETED|Overall Study||3
6625299|NCT02224313|7552954|FG001|NOT COMPLETED|Overall Study||1
6625300|NCT02224404|7552960|FG000|STARTED|Overall Study||21
6625301|NCT02224404|7552960|FG000|COMPLETED|Overall Study||21
6625302|NCT02224404|7552960|FG000|NOT COMPLETED|Overall Study||0
6625303|NCT02224482|7552966|FG000|STARTED|Overall Study||214
6625304|NCT02224482|7552967|FG001|STARTED|Overall Study||217
6625305|NCT02224482|7552966|FG000|COMPLETED|Overall Study||63
6625306|NCT02224482|7552967|FG001|COMPLETED|Overall Study||57
6625307|NCT02224482|7552966|FG000|NOT COMPLETED|Overall Study||151
6625308|NCT02224482|7552967|FG001|NOT COMPLETED|Overall Study||160
6625309|NCT02224508|7552975|FG000|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
6625310|NCT02224508|7552976|FG001|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
6625311|NCT02224508|7552975|FG000|COMPLETED|Overall Study||935
6625312|NCT02224508|7552976|FG001|COMPLETED|Overall Study||653
6625313|NCT02224508|7552975|FG000|NOT COMPLETED|Overall Study||0
6625314|NCT02224508|7552976|FG001|NOT COMPLETED|Overall Study||0
6625315|NCT02224560|7552986|FG000|STARTED|Overall Study||76
6625316|NCT02224560|7552987|FG001|STARTED|Overall Study||73
6606177|NCT02080195|7531089|FG000|STARTED|Overall Study||1
6606178|NCT02080195|7531089|FG000|COMPLETED|Overall Study||1
6606179|NCT02080195|7531089|FG000|NOT COMPLETED|Overall Study||0
6606180|NCT02080221|7531093|FG000|STARTED|Overall Study||50
6606181|NCT02080221|7531093|FG000|COMPLETED|Overall Study||48
6606182|NCT02080221|7531093|FG000|NOT COMPLETED|Overall Study||2
6606183|NCT02080273|7531100|FG000|STARTED|Overall Study||45
6606184|NCT02080273|7531101|FG001|STARTED|Overall Study||45
6606185|NCT02080273|7531102|FG002|STARTED|Overall Study||45
6606186|NCT02080273|7531100|FG000|COMPLETED|Overall Study||45
6606187|NCT02080273|7531101|FG001|COMPLETED|Overall Study||45
6606188|NCT02080273|7531102|FG002|COMPLETED|Overall Study||45
6606189|NCT02080273|7531100|FG000|NOT COMPLETED|Overall Study||0
6606190|NCT02080273|7531101|FG001|NOT COMPLETED|Overall Study||0
6606191|NCT02080273|7531102|FG002|NOT COMPLETED|Overall Study||0
6606192|NCT02080312|7531110|FG000|STARTED|Overall Study||6
6606193|NCT02080312|7531110|FG000|COMPLETED|Overall Study||6
6606194|NCT02080312|7531110|FG000|NOT COMPLETED|Overall Study||0
6606195|NCT02080364|7531119|FG000|STARTED|Baseline Period||197
6606196|NCT02080364|7531120|FG001|STARTED|Baseline Period||208
6606197|NCT02080364|7531121|FG002|STARTED|Baseline Period||247
6606198|NCT02080364|7531122|FG003|STARTED|Baseline Period||228
6606199|NCT02080364|7531119|FG000|COMPLETED|Baseline Period||195
6606200|NCT02080364|7531120|FG001|COMPLETED|Baseline Period||206
6606201|NCT02080364|7531121|FG002|COMPLETED|Baseline Period||246
6606202|NCT02080364|7531122|FG003|COMPLETED|Baseline Period||228
6606203|NCT02080364|7531119|FG000|NOT COMPLETED|Baseline Period||2
6606204|NCT02080364|7531120|FG001|NOT COMPLETED|Baseline Period||2
6606205|NCT02080364|7531121|FG002|NOT COMPLETED|Baseline Period||1
6606206|NCT02080364|7531122|FG003|NOT COMPLETED|Baseline Period||0
6606207|NCT02080364|7531119|FG000|STARTED|Treatment Period||195
6606208|NCT02080364|7531120|FG001|STARTED|Treatment Period||206
6606209|NCT02080364|7531121|FG002|STARTED|Treatment Period||246
6606210|NCT02080364|7531122|FG003|STARTED|Treatment Period||228
6606211|NCT02080364|7531119|FG000|COMPLETED|Treatment Period||148
6606212|NCT02080364|7531120|FG001|COMPLETED|Treatment Period||157
6606213|NCT02080364|7531121|FG002|COMPLETED|Treatment Period||9
6606214|NCT02080364|7531122|FG003|COMPLETED|Treatment Period||4
6606215|NCT02080364|7531119|FG000|NOT COMPLETED|Treatment Period||47
6606216|NCT02080364|7531120|FG001|NOT COMPLETED|Treatment Period||49
6606217|NCT02080364|7531121|FG002|NOT COMPLETED|Treatment Period||237
6606218|NCT02080364|7531122|FG003|NOT COMPLETED|Treatment Period||224
6606219|NCT02080403|7531134|FG000|STARTED|Overall Study||146
6606220|NCT02080403|7531135|FG001|STARTED|Overall Study||144
6606221|NCT02080403|7531134|FG000|COMPLETED|Overall Study||131
6606222|NCT02080403|7531135|FG001|COMPLETED|Overall Study||132
6606223|NCT02080403|7531134|FG000|NOT COMPLETED|Overall Study||15
6606224|NCT02080403|7531135|FG001|NOT COMPLETED|Overall Study||12
6606225|NCT02080455|7531143|FG000|STARTED|Overall Study||16
6606226|NCT02080455|7531144|FG001|STARTED|Overall Study||16
6606227|NCT02080455|7531143|FG000|COMPLETED|Overall Study||16
6606228|NCT02080455|7531144|FG001|COMPLETED|Overall Study||16
6606229|NCT02080455|7531143|FG000|NOT COMPLETED|Overall Study||0
6606230|NCT02080455|7531144|FG001|NOT COMPLETED|Overall Study||0
6606231|NCT02080468|7531160|FG000|STARTED|Overall Study||16
6606232|NCT02080468|7531161|FG001|STARTED|Overall Study||16
6606233|NCT02080468|7531160|FG000|COMPLETED|Overall Study||14
6606234|NCT02080468|7531161|FG001|COMPLETED|Overall Study||14
6606235|NCT02080468|7531160|FG000|NOT COMPLETED|Overall Study||2
6606236|NCT02080468|7531161|FG001|NOT COMPLETED|Overall Study||2
6606237|NCT02080481|7531176|FG000|STARTED|Overall Study||68
6606238|NCT02080481|7531177|FG001|STARTED|Overall Study||67
6606239|NCT02080481|7531176|FG000|COMPLETED|Overall Study||67
6606240|NCT02080481|7531177|FG001|COMPLETED|Overall Study||67
6606241|NCT02080481|7531176|FG000|NOT COMPLETED|Overall Study||1
6606242|NCT02080481|7531177|FG001|NOT COMPLETED|Overall Study||0
6606243|NCT02080507|7531185|FG000|STARTED|Overall Study||5
6606244|NCT02080507|7531186|FG001|STARTED|Overall Study||7
6606245|NCT02080507|7531185|FG000|COMPLETED|Overall Study||5
6606246|NCT02080507|7531186|FG001|COMPLETED|Overall Study||7
6606247|NCT02080507|7531185|FG000|NOT COMPLETED|Overall Study||0
6606248|NCT02080507|7531186|FG001|NOT COMPLETED|Overall Study||0
6606249|NCT02080546|7531194|FG000|STARTED|Overall Study||57
6606250|NCT02080546|7531195|FG001|STARTED|Overall Study||63
6606251|NCT02080546|7531194|FG000|COMPLETED|Overall Study||49
6606252|NCT02080546|7531195|FG001|COMPLETED|Overall Study||52
6606253|NCT02080546|7531194|FG000|NOT COMPLETED|Overall Study||8
6606254|NCT02080546|7531195|FG001|NOT COMPLETED|Overall Study||11
6606255|NCT02080637|7531203|FG000|STARTED|Overall Study||13
6606256|NCT02080637|7531204|FG001|STARTED|Overall Study||3
6606257|NCT02080637|7531203|FG000|COMPLETED|Overall Study||13
6606258|NCT02080637|7531204|FG001|COMPLETED|Overall Study||3
6606259|NCT02080637|7531203|FG000|NOT COMPLETED|Overall Study||0
6606260|NCT02080637|7531204|FG001|NOT COMPLETED|Overall Study||0
6606261|NCT02080780|7531210|FG000|STARTED|Overall Study||24
6606262|NCT02080780|7531210|FG000|COMPLETED|Overall Study||24
6606263|NCT02080780|7531210|FG000|NOT COMPLETED|Overall Study||0
6606264|NCT02080819|7531220|FG000|STARTED|Overall Study||63
6606265|NCT02080819|7531221|FG001|STARTED|Overall Study||35
6606266|NCT02080819|7531222|FG002|STARTED|Overall Study||33
6606267|NCT02080819|7531220|FG000|COMPLETED|Overall Study||38
6606268|NCT02080819|7531221|FG001|COMPLETED|Overall Study||9
6606269|NCT02080819|7531222|FG002|COMPLETED|Overall Study||11
6606270|NCT02080819|7531220|FG000|NOT COMPLETED|Overall Study||25
6606271|NCT02080819|7531221|FG001|NOT COMPLETED|Overall Study||26
6606272|NCT02080819|7531222|FG002|NOT COMPLETED|Overall Study||22
6606273|NCT02080832|7531233|FG000|STARTED|Overall Study||15
6606274|NCT02080832|7531234|FG001|STARTED|Overall Study||17
6606275|NCT02080832|7531235|FG002|STARTED|Overall Study||22
6606276|NCT02080832|7531233|FG000|COMPLETED|Overall Study||6
6606277|NCT02080832|7531234|FG001|COMPLETED|Overall Study||5
6606278|NCT02080832|7531235|FG002|COMPLETED|Overall Study||6
6606279|NCT02080832|7531233|FG000|NOT COMPLETED|Overall Study||9
6606280|NCT02080832|7531234|FG001|NOT COMPLETED|Overall Study||12
6606281|NCT02080832|7531235|FG002|NOT COMPLETED|Overall Study||16
6606282|NCT02080871|7531245|FG000|STARTED|Overall Study||134
6606283|NCT02080871|7531245|FG000|COMPLETED|Overall Study||132
6606284|NCT02080871|7531245|FG000|NOT COMPLETED|Overall Study||2
6606285|NCT02081001|7531251|FG000|STARTED|Overall Study||2
6606286|NCT02081001|7531252|FG001|STARTED|Overall Study||1
6606287|NCT02081001|7531253|FG002|STARTED|Overall Study||2
6606288|NCT02081001|7531254|FG003|STARTED|Overall Study||1
6606289|NCT02081001|7531255|FG004|STARTED|Overall Study||3
6606290|NCT02081001|7531256|FG005|STARTED|Overall Study||1
6606291|NCT02081001|7531257|FG006|STARTED|Overall Study||2
6606292|NCT02081001|7531258|FG007|STARTED|Overall Study||1
6606293|NCT02081001|7531259|FG008|STARTED|Overall Study||2
6606294|NCT02081001|7531260|FG009|STARTED|Overall Study||1
6606295|NCT02081001|7531261|FG010|STARTED|Overall Study||2
6606296|NCT02081001|7531262|FG011|STARTED|Overall Study||1
6606297|NCT02081001|7531251|FG000|COMPLETED|Overall Study||2
6606298|NCT02081001|7531252|FG001|COMPLETED|Overall Study||1
6606299|NCT02081001|7531253|FG002|COMPLETED|Overall Study||2
6606300|NCT02081001|7531254|FG003|COMPLETED|Overall Study||1
6606301|NCT02081001|7531255|FG004|COMPLETED|Overall Study||2
6606302|NCT02081001|7531256|FG005|COMPLETED|Overall Study||1
6606303|NCT02081001|7531257|FG006|COMPLETED|Overall Study||2
6606304|NCT02081001|7531258|FG007|COMPLETED|Overall Study||1
6606305|NCT02081001|7531259|FG008|COMPLETED|Overall Study||2
6606306|NCT02081001|7531260|FG009|COMPLETED|Overall Study||1
6606307|NCT02081001|7531261|FG010|COMPLETED|Overall Study||2
6606308|NCT02081001|7531262|FG011|COMPLETED|Overall Study||1
6606309|NCT02081001|7531251|FG000|NOT COMPLETED|Overall Study||0
6606310|NCT02081001|7531252|FG001|NOT COMPLETED|Overall Study||0
6606311|NCT02081001|7531253|FG002|NOT COMPLETED|Overall Study||0
6606312|NCT02081001|7531254|FG003|NOT COMPLETED|Overall Study||0
6606313|NCT02081001|7531255|FG004|NOT COMPLETED|Overall Study||1
6606314|NCT02081001|7531256|FG005|NOT COMPLETED|Overall Study||0
6606315|NCT02081001|7531257|FG006|NOT COMPLETED|Overall Study||0
6606316|NCT02081001|7531258|FG007|NOT COMPLETED|Overall Study||0
6606317|NCT02081001|7531259|FG008|NOT COMPLETED|Overall Study||0
6606318|NCT02081001|7531260|FG009|NOT COMPLETED|Overall Study||0
6606319|NCT02081001|7531261|FG010|NOT COMPLETED|Overall Study||0
6606320|NCT02081001|7531262|FG011|NOT COMPLETED|Overall Study||0
6606321|NCT02081014|7531273|FG000|STARTED|Overall Study||2
6606322|NCT02081014|7531274|FG001|STARTED|Overall Study||2
6606323|NCT02081014|7531275|FG002|STARTED|Overall Study||2
6606324|NCT02081014|7531276|FG003|STARTED|Overall Study||2
6606325|NCT02081014|7531277|FG004|STARTED|Overall Study||2
6606326|NCT02081014|7531278|FG005|STARTED|Overall Study||2
6606327|NCT02081014|7531273|FG000|COMPLETED|Overall Study||2
6606328|NCT02081014|7531274|FG001|COMPLETED|Overall Study||2
6606329|NCT02081014|7531275|FG002|COMPLETED|Overall Study||2
6606330|NCT02081014|7531276|FG003|COMPLETED|Overall Study||2
6606331|NCT02081014|7531277|FG004|COMPLETED|Overall Study||2
6606332|NCT02081014|7531278|FG005|COMPLETED|Overall Study||2
6606333|NCT02081014|7531273|FG000|NOT COMPLETED|Overall Study||0
6606334|NCT02081014|7531274|FG001|NOT COMPLETED|Overall Study||0
6606335|NCT02081014|7531275|FG002|NOT COMPLETED|Overall Study||0
6606336|NCT02081014|7531276|FG003|NOT COMPLETED|Overall Study||0
6606337|NCT02081014|7531277|FG004|NOT COMPLETED|Overall Study||0
6606338|NCT02081014|7531278|FG005|NOT COMPLETED|Overall Study||0
6606339|NCT02081079|7531299|FG000|STARTED|Overall Study||44
6606340|NCT02081079|7531300|FG001|STARTED|Overall Study||41
6606341|NCT02081079|7531299|FG000|COMPLETED|Overall Study||40
6606342|NCT02081079|7531300|FG001|COMPLETED|Overall Study||39
6606343|NCT02081079|7531299|FG000|NOT COMPLETED|Overall Study||4
6606344|NCT02081079|7531300|FG001|NOT COMPLETED|Overall Study||2
6606345|NCT02081196|7531310|FG000|STARTED|Overall Study|Treatment on one flank. Contralateral flank was untreated control.|45
6606346|NCT02081196|7531310|FG000|Untreated Control Flank|Overall Study||45
6606347|NCT02081196|7531310|FG000|COMPLETED|Overall Study|One (1) subject was lost to FU.|44
6606348|NCT02081196|7531310|FG000|NOT COMPLETED|Overall Study||1
6606349|NCT02081248|7531318|FG000|STARTED|Overall Study||98
6606350|NCT02081248|7531319|FG001|STARTED|Overall Study||100
6606351|NCT02081248|7531318|FG000|COMPLETED|Overall Study||76
6606352|NCT02081248|7531319|FG001|COMPLETED|Overall Study||87
6606353|NCT02081248|7531318|FG000|NOT COMPLETED|Overall Study||22
6606354|NCT02081248|7531319|FG001|NOT COMPLETED|Overall Study||13
6606355|NCT02081365|7531327|FG000|STARTED|Overall Study||74
6606356|NCT02081365|7531328|FG001|STARTED|Overall Study||77
6606357|NCT02081365|7531327|FG000|Received Allocated Intervention|Overall Study||46
6606358|NCT02081365|7531328|FG001|Received Allocated Intervention|Overall Study||59
6606359|NCT02081365|7531327|FG000|COMPLETED|Overall Study||44
6606360|NCT02081365|7531328|FG001|COMPLETED|Overall Study||54
6606361|NCT02081365|7531327|FG000|NOT COMPLETED|Overall Study||30
6606362|NCT02081365|7531328|FG001|NOT COMPLETED|Overall Study||23
6606363|NCT02081417|7531336|FG000|STARTED|Overall Study|Randomized to intervention|163
6606364|NCT02081417|7531337|FG001|STARTED|Overall Study||166
6606365|NCT02081417|7531336|FG000|1st Interview Completed|Overall Study||146
6606366|NCT02081417|7531337|FG001|1st Interview Completed|Overall Study||145
6606367|NCT02081417|7531336|FG000|3-Month Follow-Up|Overall Study||94
6606368|NCT02081417|7531337|FG001|3-Month Follow-Up|Overall Study||95
6606369|NCT02081417|7531336|FG000|6-Month Follow-Up|Overall Study||82
6606370|NCT02081417|7531337|FG001|6-Month Follow-Up|Overall Study||92
6606371|NCT02081417|7531336|FG000|COMPLETED|Overall Study||107
6606372|NCT02081417|7531337|FG001|COMPLETED|Overall Study||115
6606373|NCT02081417|7531336|FG000|NOT COMPLETED|Overall Study||56
6606374|NCT02081417|7531337|FG001|NOT COMPLETED|Overall Study||51
6606375|NCT02081443|7531345|FG000|STARTED|Overall Study||30
6606376|NCT02081443|7531346|FG001|STARTED|Overall Study||30
6606377|NCT02081443|7531345|FG000|COMPLETED|Overall Study||30
6606378|NCT02081443|7531346|FG001|COMPLETED|Overall Study||30
6606379|NCT02081443|7531345|FG000|NOT COMPLETED|Overall Study||0
6606380|NCT02081443|7531346|FG001|NOT COMPLETED|Overall Study||0
6606381|NCT02081456|7531354|FG000|STARTED|Overall Study||11
6606382|NCT02081456|7531355|FG001|STARTED|Overall Study||12
6606383|NCT02081456|7531354|FG000|COMPLETED|Overall Study||11
6606384|NCT02081456|7531355|FG001|COMPLETED|Overall Study||12
6606385|NCT02081456|7531354|FG000|NOT COMPLETED|Overall Study||0
6606386|NCT02081456|7531355|FG001|NOT COMPLETED|Overall Study||0
6606387|NCT02081534|7531368|FG000|STARTED|Overall Study||23
6606388|NCT02081534|7531369|FG001|STARTED|Overall Study||21
6606389|NCT02081534|7531370|FG002|STARTED|Overall Study||23
6606390|NCT02081534|7531371|FG003|STARTED|Overall Study||26
6606391|NCT02081534|7531372|FG004|STARTED|Overall Study||22
6606392|NCT02081534|7531373|FG005|STARTED|Overall Study||21
6606393|NCT02081534|7531374|FG006|STARTED|Overall Study||26
6606394|NCT02081534|7531368|FG000|COMPLETED|Overall Study||18
6606395|NCT02081534|7531369|FG001|COMPLETED|Overall Study||13
6606396|NCT02081534|7531370|FG002|COMPLETED|Overall Study||19
6606397|NCT02081534|7531371|FG003|COMPLETED|Overall Study||13
6606398|NCT02081534|7531372|FG004|COMPLETED|Overall Study||18
6606399|NCT02081534|7531373|FG005|COMPLETED|Overall Study||12
6606400|NCT02081534|7531374|FG006|COMPLETED|Overall Study||22
6606401|NCT02081534|7531368|FG000|NOT COMPLETED|Overall Study||5
6606402|NCT02081534|7531369|FG001|NOT COMPLETED|Overall Study||8
6606403|NCT02081534|7531370|FG002|NOT COMPLETED|Overall Study||4
6606404|NCT02081534|7531371|FG003|NOT COMPLETED|Overall Study||13
6606405|NCT02081534|7531372|FG004|NOT COMPLETED|Overall Study||4
6606406|NCT02081534|7531373|FG005|NOT COMPLETED|Overall Study||9
6606407|NCT02081534|7531374|FG006|NOT COMPLETED|Overall Study||4
6606408|NCT02081573|7531390|FG000|STARTED|Overall Study||10
6606409|NCT02081573|7531390|FG000|COMPLETED|Overall Study||10
6606410|NCT02081573|7531390|FG000|NOT COMPLETED|Overall Study||0
6606411|NCT02081586|7531398|FG000|STARTED|Overall Study||3
6606412|NCT02081586|7531399|FG001|STARTED|Overall Study||3
6606413|NCT02081586|7531400|FG002|STARTED|Overall Study||4
6606414|NCT02081586|7531401|FG003|STARTED|Overall Study||3
6606415|NCT02081586|7531398|FG000|COMPLETED|Overall Study||3
6606416|NCT02081586|7531399|FG001|COMPLETED|Overall Study||2
6606417|NCT02081586|7531400|FG002|COMPLETED|Overall Study||3
6606418|NCT02081586|7531401|FG003|COMPLETED|Overall Study||2
6606419|NCT02081586|7531398|FG000|NOT COMPLETED|Overall Study||0
6606420|NCT02081586|7531399|FG001|NOT COMPLETED|Overall Study||1
6606421|NCT02081586|7531400|FG002|NOT COMPLETED|Overall Study||1
6606422|NCT02081586|7531401|FG003|NOT COMPLETED|Overall Study||1
6606423|NCT02081599|7531415|FG000|STARTED|Period 1：Double-blind Period||71
6606424|NCT02081599|7531416|FG001|STARTED|Period 1：Double-blind Period||77
6606425|NCT02081599|7531415|FG000|COMPLETED|Period 1：Double-blind Period||63
6606426|NCT02081599|7531416|FG001|COMPLETED|Period 1：Double-blind Period||75
6606427|NCT02081599|7531415|FG000|NOT COMPLETED|Period 1：Double-blind Period||8
6606428|NCT02081599|7531416|FG001|NOT COMPLETED|Period 1：Double-blind Period||2
6606429|NCT02081599|7531415|FG000|STARTED|Period 2：Open-label Period||63
6606430|NCT02081599|7531416|FG001|STARTED|Period 2：Open-label Period||75
6606431|NCT02081599|7531415|FG000|COMPLETED|Period 2：Open-label Period||57
6606432|NCT02081599|7531416|FG001|COMPLETED|Period 2：Open-label Period||71
6606433|NCT02081599|7531415|FG000|NOT COMPLETED|Period 2：Open-label Period||6
6606434|NCT02081599|7531416|FG001|NOT COMPLETED|Period 2：Open-label Period||4
6606435|NCT02081638|7531426|FG000|STARTED|Overall Study||26
6606436|NCT02081638|7531427|FG001|STARTED|Overall Study||27
6606437|NCT02081638|7531426|FG000|COMPLETED|Overall Study||24
6606438|NCT02081638|7531427|FG001|COMPLETED|Overall Study||20
6606439|NCT02081638|7531426|FG000|NOT COMPLETED|Overall Study||2
6606440|NCT02081638|7531427|FG001|NOT COMPLETED|Overall Study||7
6606441|NCT02081677|7531441|FG000|STARTED|Overall Study||19
6606442|NCT02081677|7531442|FG001|STARTED|Overall Study||19
6732236|NCT03191552|7661637|FG001|STARTED|Overall Study||9
6606443|NCT02081677|7531443|FG002|STARTED|Overall Study||19
6606444|NCT02081677|7531444|FG003|STARTED|Overall Study||19
6606445|NCT02081677|7531441|FG000|COMPLETED|Overall Study||18
6606446|NCT02081677|7531442|FG001|COMPLETED|Overall Study||18
6606447|NCT02081677|7531443|FG002|COMPLETED|Overall Study||17
6606448|NCT02081677|7531444|FG003|COMPLETED|Overall Study||19
6606449|NCT02081677|7531441|FG000|NOT COMPLETED|Overall Study||1
6606450|NCT02081677|7531442|FG001|NOT COMPLETED|Overall Study||1
6606451|NCT02081677|7531443|FG002|NOT COMPLETED|Overall Study||2
6606452|NCT02081677|7531444|FG003|NOT COMPLETED|Overall Study||0
6606453|NCT02081690|7531454|FG000|STARTED|Overall Study||88
6606454|NCT02081690|7531454|FG000|COMPLETED|Overall Study||81
6606455|NCT02081690|7531454|FG000|NOT COMPLETED|Overall Study||7
6606456|NCT02081807|7531466|FG000|STARTED|Overall Study||7668
6606457|NCT02081807|7531467|FG001|STARTED|Overall Study||26149
6606458|NCT02081807|7531468|FG002|STARTED|Overall Study||14852
6606459|NCT02081807|7531469|FG003|STARTED|Overall Study||9112
6606460|NCT02081807|7531470|FG004|STARTED|Overall Study||27456
6606461|NCT02081807|7531471|FG005|STARTED|Overall Study||76055
6606462|NCT02081807|7531472|FG006|STARTED|Overall Study||40207
6606463|NCT02081807|7531473|FG007|STARTED|Overall Study||19729
6606464|NCT02081807|7531466|FG000|COMPLETED|Overall Study||7668
6606465|NCT02081807|7531467|FG001|COMPLETED|Overall Study||26149
6606466|NCT02081807|7531468|FG002|COMPLETED|Overall Study||14852
6606467|NCT02081807|7531469|FG003|COMPLETED|Overall Study||9112
6606468|NCT02081807|7531470|FG004|COMPLETED|Overall Study||27456
6606469|NCT02081807|7531471|FG005|COMPLETED|Overall Study||76055
6606470|NCT02081807|7531472|FG006|COMPLETED|Overall Study||40207
6606471|NCT02081807|7531473|FG007|COMPLETED|Overall Study||19729
6606472|NCT02081807|7531466|FG000|NOT COMPLETED|Overall Study||0
6606473|NCT02081807|7531467|FG001|NOT COMPLETED|Overall Study||0
6606474|NCT02081807|7531468|FG002|NOT COMPLETED|Overall Study||0
6606475|NCT02081807|7531469|FG003|NOT COMPLETED|Overall Study||0
6606476|NCT02081807|7531470|FG004|NOT COMPLETED|Overall Study||0
6606477|NCT02081807|7531471|FG005|NOT COMPLETED|Overall Study||0
6606478|NCT02081807|7531472|FG006|NOT COMPLETED|Overall Study||0
6606479|NCT02081807|7531473|FG007|NOT COMPLETED|Overall Study||0
6606480|NCT02081846|7531503|FG000|STARTED|Overall Study||751
6606481|NCT02081846|7531504|FG001|STARTED|Overall Study||749
6606482|NCT02081846|7531503|FG000|COMPLETED|Overall Study||749
6606483|NCT02081846|7531504|FG001|COMPLETED|Overall Study||749
6606484|NCT02081846|7531503|FG000|NOT COMPLETED|Overall Study||2
6606485|NCT02081846|7531504|FG001|NOT COMPLETED|Overall Study||0
6606486|NCT02081859|7531512|FG000|STARTED|Overall Study||150
6606487|NCT02081859|7531513|FG001|STARTED|Overall Study||150
6606488|NCT02081859|7531512|FG000|COMPLETED|Overall Study||116
6606489|NCT02081859|7531513|FG001|COMPLETED|Overall Study||119
6606490|NCT02081859|7531512|FG000|NOT COMPLETED|Overall Study||34
6606491|NCT02081859|7531513|FG001|NOT COMPLETED|Overall Study||31
6606492|NCT02081950|7531519|FG000|STARTED|Treatment Period 1||14
6606493|NCT02081950|7531519|FG000|COMPLETED|Treatment Period 1||14
6606494|NCT02081950|7531519|FG000|NOT COMPLETED|Treatment Period 1||0
6606495|NCT02081950|7531519|FG000|STARTED|Treatment Period 2||14
6606496|NCT02081950|7531519|FG000|COMPLETED|Treatment Period 2||14
6606497|NCT02081950|7531519|FG000|NOT COMPLETED|Treatment Period 2||0
6606498|NCT02081963|7531527|FG000|STARTED|Overall Study||79
6606499|NCT02081963|7531528|FG001|STARTED|Overall Study||73
6606500|NCT02081963|7531527|FG000|COMPLETED|Overall Study||74
6606501|NCT02081963|7531528|FG001|COMPLETED|Overall Study||69
6606502|NCT02081963|7531527|FG000|NOT COMPLETED|Overall Study||5
6606503|NCT02081963|7531528|FG001|NOT COMPLETED|Overall Study||4
6606504|NCT02082119|7531534|FG000|STARTED|Overall Study||82
6606505|NCT02082119|7531534|FG000|COMPLETED|Overall Study||82
6606506|NCT02082119|7531534|FG000|NOT COMPLETED|Overall Study||0
6606507|NCT02082145|7531540|FG000|STARTED|Overall Study||5
6606508|NCT02082145|7531541|FG001|STARTED|Overall Study||9
6606509|NCT02082145|7531540|FG000|COMPLETED|Overall Study||5
6606510|NCT02082145|7531541|FG001|COMPLETED|Overall Study||9
6606511|NCT02082145|7531540|FG000|NOT COMPLETED|Overall Study||0
6606512|NCT02082145|7531541|FG001|NOT COMPLETED|Overall Study||0
6606513|NCT02082158|7531555|FG000|STARTED|Overall Study||66
6606514|NCT02082158|7531556|FG001|STARTED|Overall Study||61
6606515|NCT02082158|7531557|FG002|STARTED|Overall Study||52
6606516|NCT02082158|7531558|FG003|STARTED|Overall Study||72
6606517|NCT02082158|7531559|FG004|STARTED|Overall Study||68
6606518|NCT02082158|7531560|FG005|STARTED|Overall Study||63
6606519|NCT02082158|7531555|FG000|COMPLETED|Overall Study||58
6606520|NCT02082158|7531556|FG001|COMPLETED|Overall Study||53
6606521|NCT02082158|7531557|FG002|COMPLETED|Overall Study||38
6606522|NCT02082158|7531558|FG003|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
6606523|NCT02082158|7531559|FG004|COMPLETED|Overall Study||64
6606524|NCT02082158|7531560|FG005|COMPLETED|Overall Study||56
6606525|NCT02082158|7531555|FG000|NOT COMPLETED|Overall Study||8
6606526|NCT02082158|7531556|FG001|NOT COMPLETED|Overall Study||8
6606527|NCT02082158|7531557|FG002|NOT COMPLETED|Overall Study||14
6606528|NCT02082158|7531558|FG003|NOT COMPLETED|Overall Study||4
6606529|NCT02082158|7531559|FG004|NOT COMPLETED|Overall Study||4
6606530|NCT02082158|7531560|FG005|NOT COMPLETED|Overall Study||7
6606531|NCT02082184|7531582|FG000|STARTED|Overall Study||149
6606532|NCT02082184|7531583|FG001|STARTED|Overall Study||75
6606533|NCT02082184|7531582|FG000|COMPLETED|Overall Study||139
6606534|NCT02082184|7531583|FG001|COMPLETED|Overall Study||62
6606535|NCT02082184|7531582|FG000|NOT COMPLETED|Overall Study||10
6606536|NCT02082184|7531583|FG001|NOT COMPLETED|Overall Study||13
6606537|NCT02082210|7531595|FG000|STARTED|Overall Study||3
6606538|NCT02082210|7531596|FG001|STARTED|Overall Study||3
6606539|NCT02082210|7531597|FG002|STARTED|Overall Study||16
6606540|NCT02082210|7531598|FG003|STARTED|Overall Study||45
6606541|NCT02082210|7531599|FG004|STARTED|Overall Study||15
6606542|NCT02082210|7531600|FG005|STARTED|Overall Study||15
6606543|NCT02082210|7531595|FG000|Received at Least One Dose of Study Drug|Overall Study||3
6606544|NCT02082210|7531596|FG001|Received at Least One Dose of Study Drug|Overall Study||3
6606545|NCT02082210|7531597|FG002|Received at Least One Dose of Study Drug|Overall Study||16
6606546|NCT02082210|7531598|FG003|Received at Least One Dose of Study Drug|Overall Study||45
6606547|NCT02082210|7531599|FG004|Received at Least One Dose of Study Drug|Overall Study||15
6606548|NCT02082210|7531600|FG005|Received at Least One Dose of Study Drug|Overall Study||15
6606549|NCT02082210|7531595|FG000|COMPLETED|Overall Study||3
6606550|NCT02082210|7531596|FG001|COMPLETED|Overall Study||3
6606551|NCT02082210|7531597|FG002|COMPLETED|Overall Study||13
6606552|NCT02082210|7531598|FG003|COMPLETED|Overall Study||39
6606553|NCT02082210|7531599|FG004|COMPLETED|Overall Study||12
6606554|NCT02082210|7531600|FG005|COMPLETED|Overall Study||13
6606555|NCT02082210|7531595|FG000|NOT COMPLETED|Overall Study||0
6606556|NCT02082210|7531596|FG001|NOT COMPLETED|Overall Study||0
6606557|NCT02082210|7531597|FG002|NOT COMPLETED|Overall Study||3
6606558|NCT02082210|7531598|FG003|NOT COMPLETED|Overall Study||6
6606559|NCT02082210|7531599|FG004|NOT COMPLETED|Overall Study||3
6606560|NCT02082210|7531600|FG005|NOT COMPLETED|Overall Study||2
6606561|NCT02082262|7531626|FG000|STARTED|Overall Study||140
6606562|NCT02082262|7531626|FG000|COMPLETED|Overall Study||89
6606563|NCT02082262|7531626|FG000|NOT COMPLETED|Overall Study||51
6606564|NCT02082288|7531630|FG000|STARTED|Overall Study||243
6606565|NCT02082288|7531630|FG000|COMPLETED|Overall Study||243
6606566|NCT02082288|7531630|FG000|NOT COMPLETED|Overall Study||0
6606567|NCT02082340|7531636|FG000|STARTED|Overall Study||194
6606568|NCT02082340|7531637|FG001|STARTED|Overall Study||198
6606569|NCT02082340|7531636|FG000|COMPLETED|Overall Study||193
6606570|NCT02082340|7531637|FG001|COMPLETED|Overall Study||197
6606571|NCT02082340|7531636|FG000|NOT COMPLETED|Overall Study||1
6606572|NCT02082340|7531637|FG001|NOT COMPLETED|Overall Study||1
6606573|NCT02082392|7531645|FG000|STARTED|Overall Study||2
6606574|NCT02082392|7531646|FG001|STARTED|Overall Study||1
6606575|NCT02082392|7531645|FG000|COMPLETED|Overall Study||2
6606576|NCT02082392|7531646|FG001|COMPLETED|Overall Study||1
6606577|NCT02082392|7531645|FG000|NOT COMPLETED|Overall Study||0
6606578|NCT02082392|7531646|FG001|NOT COMPLETED|Overall Study||0
6606579|NCT02082483|7531654|FG000|STARTED|Overall Study||71
6606580|NCT02082483|7531655|FG001|STARTED|Overall Study||73
6606581|NCT02082483|7531654|FG000|COMPLETED|Overall Study||65
6606582|NCT02082483|7531655|FG001|COMPLETED|Overall Study||67
6606583|NCT02082483|7531654|FG000|NOT COMPLETED|Overall Study||6
6606584|NCT02082483|7531655|FG001|NOT COMPLETED|Overall Study||6
6606585|NCT02082522|7531664|FG000|STARTED|Overall Study||15
6606586|NCT02082522|7531665|FG001|STARTED|Overall Study||13
6606587|NCT02082522|7531664|FG000|COMPLETED|Overall Study||0
6606588|NCT02082522|7531665|FG001|COMPLETED|Overall Study||0
6606589|NCT02082522|7531664|FG000|NOT COMPLETED|Overall Study||15
6606590|NCT02082522|7531665|FG001|NOT COMPLETED|Overall Study||13
6606591|NCT02082678|7531673|FG000|STARTED|Overall Study||35
6606592|NCT02082678|7531674|FG001|STARTED|Overall Study||35
6606593|NCT02082678|7531673|FG000|COMPLETED|Overall Study||23
6606594|NCT02082678|7531674|FG001|COMPLETED|Overall Study||21
6606595|NCT02082678|7531673|FG000|NOT COMPLETED|Overall Study||12
6606596|NCT02082678|7531674|FG001|NOT COMPLETED|Overall Study||14
6606597|NCT02082717|7531682|FG000|STARTED|Overall Study||8
6606598|NCT02082717|7531683|FG001|STARTED|Overall Study||9
6606599|NCT02082717|7531682|FG000|COMPLETED|Overall Study||8
6606600|NCT02082717|7531683|FG001|COMPLETED|Overall Study||9
6606601|NCT02082717|7531682|FG000|NOT COMPLETED|Overall Study||0
6606602|NCT02082717|7531683|FG001|NOT COMPLETED|Overall Study||0
6606603|NCT02082769|7531696|FG000|STARTED|Overall Study||168
6606604|NCT02082769|7531697|FG001|STARTED|Overall Study||168
6606605|NCT02082769|7531698|FG002|STARTED|Overall Study||168
6606606|NCT02082769|7531696|FG000|COMPLETED|Overall Study||144
6606607|NCT02082769|7531697|FG001|COMPLETED|Overall Study||141
6606608|NCT02082769|7531698|FG002|COMPLETED|Overall Study||132
6606609|NCT02082769|7531696|FG000|NOT COMPLETED|Overall Study||24
6606610|NCT02082769|7531697|FG001|NOT COMPLETED|Overall Study||27
6606611|NCT02082769|7531698|FG002|NOT COMPLETED|Overall Study||36
6606612|NCT02082912|7531708|FG000|STARTED|Overall Study||7
6606613|NCT02082912|7531709|FG001|STARTED|Overall Study||7
6606614|NCT02082912|7531708|FG000|COMPLETED|Overall Study||7
6606615|NCT02082912|7531709|FG001|COMPLETED|Overall Study||6
6606616|NCT02082912|7531708|FG000|NOT COMPLETED|Overall Study||0
6606617|NCT02082912|7531709|FG001|NOT COMPLETED|Overall Study||1
6606618|NCT02082977|7531725|FG000|STARTED|Part 1 (Up to 3.2 Years)||2
6606619|NCT02082977|7531726|FG001|STARTED|Part 1 (Up to 3.2 Years)||1
6606620|NCT02082977|7531727|FG002|STARTED|Part 1 (Up to 3.2 Years)||1
6606621|NCT02082977|7531728|FG003|STARTED|Part 1 (Up to 3.2 Years)||1
6606622|NCT02082977|7531729|FG004|STARTED|Part 1 (Up to 3.2 Years)||3
6606623|NCT02082977|7531730|FG005|STARTED|Part 1 (Up to 3.2 Years)||4
6606624|NCT02082977|7531731|FG006|STARTED|Part 1 (Up to 3.2 Years)||10
6606625|NCT02082977|7531732|FG007|STARTED|Part 1 (Up to 3.2 Years)||12
6606626|NCT02082977|7531733|FG008|STARTED|Part 1 (Up to 3.2 Years)||7
6606627|NCT02082977|7531734|FG009|STARTED|Part 1 (Up to 3.2 Years)||0
6606628|NCT02082977|7531725|FG000|COMPLETED|Part 1 (Up to 3.2 Years)||1
6606629|NCT02082977|7531726|FG001|COMPLETED|Part 1 (Up to 3.2 Years)||1
6606630|NCT02082977|7531727|FG002|COMPLETED|Part 1 (Up to 3.2 Years)||1
6606631|NCT02082977|7531728|FG003|COMPLETED|Part 1 (Up to 3.2 Years)||1
6606632|NCT02082977|7531729|FG004|COMPLETED|Part 1 (Up to 3.2 Years)||2
6606633|NCT02082977|7531730|FG005|COMPLETED|Part 1 (Up to 3.2 Years)||1
6606634|NCT02082977|7531731|FG006|COMPLETED|Part 1 (Up to 3.2 Years)||4
6606635|NCT02082977|7531732|FG007|COMPLETED|Part 1 (Up to 3.2 Years)||7
6606636|NCT02082977|7531733|FG008|COMPLETED|Part 1 (Up to 3.2 Years)||4
6606637|NCT02082977|7531734|FG009|COMPLETED|Part 1 (Up to 3.2 Years)||0
6606638|NCT02082977|7531725|FG000|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
6606639|NCT02082977|7531726|FG001|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
6606640|NCT02082977|7531727|FG002|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
6606641|NCT02082977|7531728|FG003|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
6606642|NCT02082977|7531729|FG004|NOT COMPLETED|Part 1 (Up to 3.2 Years)||1
6606643|NCT02082977|7531730|FG005|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
6606644|NCT02082977|7531731|FG006|NOT COMPLETED|Part 1 (Up to 3.2 Years)||6
6606645|NCT02082977|7531732|FG007|NOT COMPLETED|Part 1 (Up to 3.2 Years)||5
6606646|NCT02082977|7531733|FG008|NOT COMPLETED|Part 1 (Up to 3.2 Years)||3
6606647|NCT02082977|7531734|FG009|NOT COMPLETED|Part 1 (Up to 3.2 Years)||0
6606648|NCT02082977|7531725|FG000|STARTED|Part 2 (Up to 3.2 Years)||0
6606649|NCT02082977|7531726|FG001|STARTED|Part 2 (Up to 3.2 Years)||0
6606650|NCT02082977|7531727|FG002|STARTED|Part 2 (Up to 3.2 Years)||0
6606651|NCT02082977|7531728|FG003|STARTED|Part 2 (Up to 3.2 Years)||0
6606652|NCT02082977|7531729|FG004|STARTED|Part 2 (Up to 3.2 Years)||0
6606653|NCT02082977|7531730|FG005|STARTED|Part 2 (Up to 3.2 Years)||0
6606654|NCT02082977|7531731|FG006|STARTED|Part 2 (Up to 3.2 Years)||0
6606655|NCT02082977|7531732|FG007|STARTED|Part 2 (Up to 3.2 Years)||0
6606656|NCT02082977|7531733|FG008|STARTED|Part 2 (Up to 3.2 Years)||0
6606657|NCT02082977|7531734|FG009|STARTED|Part 2 (Up to 3.2 Years)||0
6606658|NCT02082977|7531725|FG000|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606659|NCT02082977|7531726|FG001|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606660|NCT02082977|7531727|FG002|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606661|NCT02082977|7531728|FG003|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606662|NCT02082977|7531729|FG004|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606663|NCT02082977|7531730|FG005|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606664|NCT02082977|7531731|FG006|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606665|NCT02082977|7531732|FG007|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606666|NCT02082977|7531733|FG008|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606667|NCT02082977|7531734|FG009|COMPLETED|Part 2 (Up to 3.2 Years)||0
6606668|NCT02082977|7531725|FG000|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606669|NCT02082977|7531726|FG001|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606670|NCT02082977|7531727|FG002|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606671|NCT02082977|7531728|FG003|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606672|NCT02082977|7531729|FG004|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606673|NCT02082977|7531730|FG005|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606674|NCT02082977|7531731|FG006|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606675|NCT02082977|7531732|FG007|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606676|NCT02082977|7531733|FG008|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606677|NCT02082977|7531734|FG009|NOT COMPLETED|Part 2 (Up to 3.2 Years)||0
6606678|NCT02083107|7531769|FG000|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
6606679|NCT02083107|7531770|FG001|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
6606680|NCT02083107|7531771|FG002|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
6606681|NCT02083107|7531769|FG000|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
6606682|NCT02083107|7531770|FG001|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
6606683|NCT02083107|7531771|FG002|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
6606684|NCT02083107|7531769|FG000|NOT COMPLETED|Overall Study||0
6606685|NCT02083107|7531770|FG001|NOT COMPLETED|Overall Study||0
6606686|NCT02083107|7531771|FG002|NOT COMPLETED|Overall Study||0
6606687|NCT02083185|7531782|FG000|STARTED|Overall Study||56
6606688|NCT02083185|7531783|FG001|STARTED|Overall Study||56
6606689|NCT02083185|7531784|FG002|STARTED|Overall Study||24
6606690|NCT02083185|7531782|FG000|Safety Population|Overall Study||56
6606691|NCT02083185|7531783|FG001|Safety Population|Overall Study||54
6606692|NCT02083185|7531784|FG002|Safety Population|Overall Study||24
6606693|NCT02083185|7531782|FG000|COMPLETED|Overall Study||36
6606694|NCT02083185|7531783|FG001|COMPLETED|Overall Study||27
6606695|NCT02083185|7531784|FG002|COMPLETED|Overall Study||17
6606696|NCT02083185|7531782|FG000|NOT COMPLETED|Overall Study||20
6606697|NCT02083185|7531783|FG001|NOT COMPLETED|Overall Study||29
6606698|NCT02083185|7531784|FG002|NOT COMPLETED|Overall Study||7
6606699|NCT02083263|7531794|FG000|STARTED|Overall Study||16
6606700|NCT02083263|7531795|FG001|STARTED|Overall Study||16
6606701|NCT02083263|7531794|FG000|COMPLETED|Overall Study||16
6606702|NCT02083263|7531795|FG001|COMPLETED|Overall Study||16
6606703|NCT02083263|7531794|FG000|NOT COMPLETED|Overall Study||0
6606704|NCT02083263|7531795|FG001|NOT COMPLETED|Overall Study||0
6606705|NCT02083380|7531804|FG000|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
6606706|NCT02083380|7531805|FG001|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
6625317|NCT02224560|7552988|FG002|STARTED|Overall Study||76
6606707|NCT02083380|7531806|FG002|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
6606708|NCT02083380|7531804|FG000|COMPLETED|Overall Study||57
6606709|NCT02083380|7531805|FG001|COMPLETED|Overall Study||56
6606710|NCT02083380|7531806|FG002|COMPLETED|Overall Study||65
6606711|NCT02083380|7531804|FG000|NOT COMPLETED|Overall Study||91
6606712|NCT02083380|7531805|FG001|NOT COMPLETED|Overall Study||95
6606713|NCT02083380|7531806|FG002|NOT COMPLETED|Overall Study||84
6606714|NCT02083406|7531822|FG000|STARTED|Overall Study||7
6606715|NCT02083406|7531823|FG001|STARTED|Overall Study||8
6606716|NCT02083406|7531824|FG002|STARTED|Overall Study||7
6606717|NCT02083406|7531822|FG000|COMPLETED|Overall Study||7
6606718|NCT02083406|7531823|FG001|COMPLETED|Overall Study||8
6606719|NCT02083406|7531824|FG002|COMPLETED|Overall Study||7
6606720|NCT02083406|7531822|FG000|NOT COMPLETED|Overall Study||0
6606721|NCT02083406|7531823|FG001|NOT COMPLETED|Overall Study||0
6606722|NCT02083406|7531824|FG002|NOT COMPLETED|Overall Study||0
6606723|NCT02083653|7531835|FG000|STARTED|Overall Study||83
6606724|NCT02083653|7531836|FG001|STARTED|Overall Study||86
6606725|NCT02083653|7531837|FG002|STARTED|Overall Study||85
6606726|NCT02083653|7531835|FG000|COMPLETED|Overall Study||1
6606727|NCT02083653|7531836|FG001|COMPLETED|Overall Study||1
6606728|NCT02083653|7531837|FG002|COMPLETED|Overall Study||1
6606729|NCT02083653|7531835|FG000|NOT COMPLETED|Overall Study||82
6606730|NCT02083653|7531836|FG001|NOT COMPLETED|Overall Study||85
6606731|NCT02083653|7531837|FG002|NOT COMPLETED|Overall Study||84
6606732|NCT02083679|7531849|FG000|STARTED|Overall Study||3
6606733|NCT02083679|7531850|FG001|STARTED|Overall Study||6
6606734|NCT02083679|7531851|FG002|STARTED|Overall Study||3
6606735|NCT02083679|7531852|FG003|STARTED|Overall Study||3
6606736|NCT02083679|7531849|FG000|COMPLETED|Overall Study||3
6606737|NCT02083679|7531850|FG001|COMPLETED|Overall Study||6
6606738|NCT02083679|7531851|FG002|COMPLETED|Overall Study||3
6606739|NCT02083679|7531852|FG003|COMPLETED|Overall Study||3
6606740|NCT02083679|7531849|FG000|NOT COMPLETED|Overall Study||0
6606741|NCT02083679|7531850|FG001|NOT COMPLETED|Overall Study||0
6606742|NCT02083679|7531851|FG002|NOT COMPLETED|Overall Study||0
6606743|NCT02083679|7531852|FG003|NOT COMPLETED|Overall Study||0
6606744|NCT02083783|7531864|FG000|STARTED|Overall Study||52
6606745|NCT02083783|7531865|FG001|STARTED|Overall Study||48
6606746|NCT02083783|7531864|FG000|COMPLETED|Overall Study||51
6606747|NCT02083783|7531865|FG001|COMPLETED|Overall Study||48
6606748|NCT02083783|7531864|FG000|NOT COMPLETED|Overall Study||1
6606749|NCT02083783|7531865|FG001|NOT COMPLETED|Overall Study||0
6606750|NCT02083809|7531875|FG000|STARTED|Overall Study||82
6606751|NCT02083809|7531876|FG001|STARTED|Overall Study||84
6606752|NCT02083809|7531875|FG000|COMPLETED|Overall Study||78
6606753|NCT02083809|7531876|FG001|COMPLETED|Overall Study||82
6606754|NCT02083809|7531875|FG000|NOT COMPLETED|Overall Study||4
6606755|NCT02083809|7531876|FG001|NOT COMPLETED|Overall Study||2
6606756|NCT02083861|7531884|FG000|STARTED|Overall Study||57
6606757|NCT02083861|7531885|FG001|STARTED|Overall Study||36
6606758|NCT02083861|7531884|FG000|Treated|Overall Study||55
6606759|NCT02083861|7531885|FG001|Treated|Overall Study||35
6606760|NCT02083861|7531884|FG000|COMPLETED|Overall Study||51
6606761|NCT02083861|7531885|FG001|COMPLETED|Overall Study||33
6606762|NCT02083861|7531884|FG000|NOT COMPLETED|Overall Study||6
6606763|NCT02083861|7531885|FG001|NOT COMPLETED|Overall Study||3
6606764|NCT02083926|7531895|FG000|STARTED|Overall Study||9
6606765|NCT02083926|7531896|FG001|STARTED|Overall Study||9
6606766|NCT02083926|7531895|FG000|COMPLETED|Overall Study||8
6606767|NCT02083926|7531896|FG001|COMPLETED|Overall Study||9
6606768|NCT02083926|7531895|FG000|NOT COMPLETED|Overall Study||1
6606769|NCT02083926|7531896|FG001|NOT COMPLETED|Overall Study||0
6606770|NCT02083965|7531905|FG000|STARTED|PK Period 1||10
6606771|NCT02083965|7531906|FG001|STARTED|PK Period 1||9
6606772|NCT02083965|7531905|FG000|COMPLETED|PK Period 1||10
6606773|NCT02083965|7531906|FG001|COMPLETED|PK Period 1||9
6606774|NCT02083965|7531905|FG000|NOT COMPLETED|PK Period 1||0
6606775|NCT02083965|7531906|FG001|NOT COMPLETED|PK Period 1||0
6606776|NCT02083965|7531905|FG000|STARTED|Washout Period||10
6606777|NCT02083965|7531906|FG001|STARTED|Washout Period||9
6606778|NCT02083965|7531905|FG000|COMPLETED|Washout Period||10
6606779|NCT02083965|7531906|FG001|COMPLETED|Washout Period||9
6606780|NCT02083965|7531905|FG000|NOT COMPLETED|Washout Period||0
6606781|NCT02083965|7531906|FG001|NOT COMPLETED|Washout Period||0
6606782|NCT02083965|7531905|FG000|STARTED|PK Period 2||10
6606783|NCT02083965|7531906|FG001|STARTED|PK Period 2||9
6606784|NCT02083965|7531905|FG000|COMPLETED|PK Period 2||10
6606785|NCT02083965|7531906|FG001|COMPLETED|PK Period 2||9
6606786|NCT02083965|7531905|FG000|NOT COMPLETED|PK Period 2||0
6606787|NCT02083965|7531906|FG001|NOT COMPLETED|PK Period 2||0
6606788|NCT02083965|7531905|FG000|STARTED|Treatment Period||10
6606789|NCT02083965|7531906|FG001|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
6606790|NCT02083965|7531905|FG000|COMPLETED|Treatment Period||9
6606791|NCT02083965|7531906|FG001|COMPLETED|Treatment Period||8
6606792|NCT02083965|7531905|FG000|NOT COMPLETED|Treatment Period||1
6606793|NCT02083965|7531906|FG001|NOT COMPLETED|Treatment Period||0
6606794|NCT02084056|7531916|FG000|STARTED|Treatment Period 1 (4 Days)||28
6606795|NCT02084056|7531917|FG001|STARTED|Treatment Period 1 (4 Days)||30
6606796|NCT02084056|7531918|FG002|STARTED|Treatment Period 1 (4 Days)||8
6606797|NCT02084056|7531919|FG003|STARTED|Treatment Period 1 (4 Days)||8
6606798|NCT02084056|7531916|FG000|COMPLETED|Treatment Period 1 (4 Days)||27
6606799|NCT02084056|7531917|FG001|COMPLETED|Treatment Period 1 (4 Days)||30
6606800|NCT02084056|7531918|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
6606801|NCT02084056|7531919|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
6606802|NCT02084056|7531916|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||1
6606803|NCT02084056|7531917|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6606804|NCT02084056|7531918|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6606805|NCT02084056|7531919|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6606806|NCT02084056|7531916|FG000|STARTED|Washout Period 1 (35 Days)||27
6606807|NCT02084056|7531917|FG001|STARTED|Washout Period 1 (35 Days)||30
6606808|NCT02084056|7531918|FG002|STARTED|Washout Period 1 (35 Days)||8
6606809|NCT02084056|7531919|FG003|STARTED|Washout Period 1 (35 Days)||8
6606810|NCT02084056|7531916|FG000|COMPLETED|Washout Period 1 (35 Days)||26
6606811|NCT02084056|7531917|FG001|COMPLETED|Washout Period 1 (35 Days)||30
6606812|NCT02084056|7531918|FG002|COMPLETED|Washout Period 1 (35 Days)||8
6606813|NCT02084056|7531919|FG003|COMPLETED|Washout Period 1 (35 Days)||8
6606814|NCT02084056|7531916|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||1
6606815|NCT02084056|7531917|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
6606816|NCT02084056|7531918|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||0
6606817|NCT02084056|7531919|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||0
6606818|NCT02084056|7531916|FG000|STARTED|Treatment Period 2 (4 Days)||26
6606819|NCT02084056|7531917|FG001|STARTED|Treatment Period 2 (4 Days)||30
6606820|NCT02084056|7531918|FG002|STARTED|Treatment Period 2 (4 Days)||8
6606821|NCT02084056|7531919|FG003|STARTED|Treatment Period 2 (4 Days)||8
6606822|NCT02084056|7531916|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
6606823|NCT02084056|7531917|FG001|COMPLETED|Treatment Period 2 (4 Days)||30
6606824|NCT02084056|7531918|FG002|COMPLETED|Treatment Period 2 (4 Days)||8
6606825|NCT02084056|7531919|FG003|COMPLETED|Treatment Period 2 (4 Days)||8
6606826|NCT02084056|7531916|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6606827|NCT02084056|7531917|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6606828|NCT02084056|7531918|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6606829|NCT02084056|7531919|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6606830|NCT02084069|7531931|FG000|STARTED|Overall Study||29
6606831|NCT02084069|7531932|FG001|STARTED|Overall Study||29
6606832|NCT02084069|7531931|FG000|COMPLETED|Overall Study||29
6606833|NCT02084069|7531932|FG001|COMPLETED|Overall Study||29
6606834|NCT02084069|7531931|FG000|NOT COMPLETED|Overall Study||0
6606835|NCT02084069|7531932|FG001|NOT COMPLETED|Overall Study||0
6606836|NCT02084082|7531940|FG000|STARTED|Treatment Period 1 (4 Days)||26
6606837|NCT02084082|7531941|FG001|STARTED|Treatment Period 1 (4 Days)||26
6606838|NCT02084082|7531942|FG002|STARTED|Treatment Period 1 (4 Days)||8
6606839|NCT02084082|7531943|FG003|STARTED|Treatment Period 1 (4 Days)||8
6606840|NCT02084082|7531940|FG000|COMPLETED|Treatment Period 1 (4 Days)||26
6606841|NCT02084082|7531941|FG001|COMPLETED|Treatment Period 1 (4 Days)||26
6606842|NCT02084082|7531942|FG002|COMPLETED|Treatment Period 1 (4 Days)||8
6606843|NCT02084082|7531943|FG003|COMPLETED|Treatment Period 1 (4 Days)||8
6606844|NCT02084082|7531940|FG000|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6606845|NCT02084082|7531941|FG001|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6606846|NCT02084082|7531942|FG002|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6606847|NCT02084082|7531943|FG003|NOT COMPLETED|Treatment Period 1 (4 Days)||0
6606848|NCT02084082|7531940|FG000|STARTED|Washout Period 1 (35 Days)||26
6606849|NCT02084082|7531941|FG001|STARTED|Washout Period 1 (35 Days)||26
6606850|NCT02084082|7531942|FG002|STARTED|Washout Period 1 (35 Days)||8
6606851|NCT02084082|7531943|FG003|STARTED|Washout Period 1 (35 Days)||8
6606852|NCT02084082|7531940|FG000|COMPLETED|Washout Period 1 (35 Days)||26
6606853|NCT02084082|7531941|FG001|COMPLETED|Washout Period 1 (35 Days)||26
6606854|NCT02084082|7531942|FG002|COMPLETED|Washout Period 1 (35 Days)||7
6606855|NCT02084082|7531943|FG003|COMPLETED|Washout Period 1 (35 Days)||6
6606856|NCT02084082|7531940|FG000|NOT COMPLETED|Washout Period 1 (35 Days)||0
6606857|NCT02084082|7531941|FG001|NOT COMPLETED|Washout Period 1 (35 Days)||0
6606858|NCT02084082|7531942|FG002|NOT COMPLETED|Washout Period 1 (35 Days)||1
6606859|NCT02084082|7531943|FG003|NOT COMPLETED|Washout Period 1 (35 Days)||2
6606860|NCT02084082|7531940|FG000|STARTED|Treatment Period 2 (4 Days)||26
6606861|NCT02084082|7531941|FG001|STARTED|Treatment Period 2 (4 Days)||26
6606862|NCT02084082|7531942|FG002|STARTED|Treatment Period 2 (4 Days)||7
6606863|NCT02084082|7531943|FG003|STARTED|Treatment Period 2 (4 Days)||6
6606864|NCT02084082|7531940|FG000|COMPLETED|Treatment Period 2 (4 Days)||26
6606865|NCT02084082|7531941|FG001|COMPLETED|Treatment Period 2 (4 Days)||26
6606866|NCT02084082|7531942|FG002|COMPLETED|Treatment Period 2 (4 Days)||7
6606867|NCT02084082|7531943|FG003|COMPLETED|Treatment Period 2 (4 Days)||6
6606868|NCT02084082|7531940|FG000|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6732237|NCT03191552|7661638|FG002|STARTED|Overall Study||8
6732238|NCT03191552|7661636|FG000|COMPLETED|Overall Study||8
6732239|NCT03191552|7661637|FG001|COMPLETED|Overall Study||8
6732240|NCT03191552|7661638|FG002|COMPLETED|Overall Study||8
6732241|NCT03191552|7661636|FG000|NOT COMPLETED|Overall Study||1
6732242|NCT03191552|7661637|FG001|NOT COMPLETED|Overall Study||1
6732243|NCT03191552|7661638|FG002|NOT COMPLETED|Overall Study||0
6739932|NCT03296527|7668739|FG001|Full Analysis Set|Overall Study||510
6739933|NCT03296527|7668738|FG000|COMPLETED|Overall Study||465
6739934|NCT03296527|7668739|FG001|COMPLETED|Overall Study||458
6739935|NCT03296527|7668738|FG000|NOT COMPLETED|Overall Study||35
6739936|NCT03296527|7668739|FG001|NOT COMPLETED|Overall Study||53
6739937|NCT03296566|7668748|FG000|STARTED|Overall Study||145
6739938|NCT03296566|7668749|FG001|STARTED|Overall Study||152
6739939|NCT03296566|7668748|FG000|COMPLETED|Overall Study||126
6739940|NCT03296566|7668749|FG001|COMPLETED|Overall Study||103
6739941|NCT03296566|7668748|FG000|NOT COMPLETED|Overall Study||19
6739942|NCT03296566|7668749|FG001|NOT COMPLETED|Overall Study||49
6739943|NCT03296787|7668759|FG000|STARTED|Overall Study||8
6739944|NCT03296787|7668760|FG001|STARTED|Overall Study||8
6739945|NCT03296787|7668761|FG002|STARTED|Overall Study||9
6739946|NCT03296787|7668762|FG003|STARTED|Overall Study||7
6739947|NCT03296787|7668759|FG000|COMPLETED|Overall Study||8
6739948|NCT03296787|7668760|FG001|COMPLETED|Overall Study||8
6739949|NCT03296787|7668761|FG002|COMPLETED|Overall Study||9
6739950|NCT03296787|7668762|FG003|COMPLETED|Overall Study||7
6739951|NCT03296787|7668759|FG000|NOT COMPLETED|Overall Study||0
6739952|NCT03296787|7668760|FG001|NOT COMPLETED|Overall Study||0
6739953|NCT03296787|7668761|FG002|NOT COMPLETED|Overall Study||0
6739954|NCT03296787|7668762|FG003|NOT COMPLETED|Overall Study||0
6739955|NCT03296800|7668776|FG000|STARTED|Overall Study||16
6739956|NCT03296800|7668777|FG001|STARTED|Overall Study||16
6739957|NCT03296800|7668778|FG002|STARTED|Overall Study||16
6739958|NCT03296800|7668776|FG000|COMPLETED|Overall Study||16
6739959|NCT03296800|7668777|FG001|COMPLETED|Overall Study||16
6739960|NCT03296800|7668778|FG002|COMPLETED|Overall Study||16
6739961|NCT03296800|7668776|FG000|NOT COMPLETED|Overall Study||0
6739962|NCT03296800|7668777|FG001|NOT COMPLETED|Overall Study||0
6739963|NCT03296800|7668778|FG002|NOT COMPLETED|Overall Study||0
6739964|NCT03297021|7668804|FG000|STARTED|Overall Study||48
6739965|NCT03297021|7668805|FG001|STARTED|Overall Study||46
6739966|NCT03297021|7668806|FG002|STARTED|Overall Study||47
6739967|NCT03297021|7668804|FG000|COMPLETED|Overall Study||43
6739968|NCT03297021|7668805|FG001|COMPLETED|Overall Study||42
6739969|NCT03297021|7668806|FG002|COMPLETED|Overall Study||43
6739970|NCT03297021|7668804|FG000|NOT COMPLETED|Overall Study||5
6739971|NCT03297021|7668805|FG001|NOT COMPLETED|Overall Study||4
6739972|NCT03297021|7668806|FG002|NOT COMPLETED|Overall Study||4
6739973|NCT03297112|7668814|FG000|STARTED|Overall Study||12
6739974|NCT03297112|7668814|FG000|COMPLETED|Overall Study||12
6739975|NCT03297112|7668814|FG000|NOT COMPLETED|Overall Study||0
6739976|NCT03297216|7668820|FG000|STARTED|Overall Study||399
6739977|NCT03297216|7668821|FG001|STARTED|Overall Study||401
6739978|NCT03297216|7668820|FG000|Discontinued Intervention|Overall Study||5
6739979|NCT03297216|7668821|FG001|Discontinued Intervention|Overall Study||4
6739980|NCT03297216|7668820|FG000|Infants Born During Study|Overall Study||399
6739981|NCT03297216|7668821|FG001|Infants Born During Study|Overall Study||401
6739982|NCT03297216|7668820|FG000|COMPLETED|Overall Study||396
6739983|NCT03297216|7668821|FG001|COMPLETED|Overall Study||396
6739984|NCT03297216|7668820|FG000|NOT COMPLETED|Overall Study||3
6739985|NCT03297216|7668821|FG001|NOT COMPLETED|Overall Study||5
6739986|NCT03297294|7668836|FG000|STARTED|Double-Blind Treatment Period (DB)||70
6739987|NCT03297294|7668837|FG001|STARTED|Double-Blind Treatment Period (DB)||67
6739988|NCT03297294|7668838|FG002|STARTED|Double-Blind Treatment Period (DB)||0
6739989|NCT03297294|7668839|FG003|STARTED|Double-Blind Treatment Period (DB)||0
6739990|NCT03297294|7668840|FG004|STARTED|Double-Blind Treatment Period (DB)||0
6606869|NCT02084082|7531941|FG001|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6606870|NCT02084082|7531942|FG002|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6606871|NCT02084082|7531943|FG003|NOT COMPLETED|Treatment Period 2 (4 Days)||0
6606872|NCT02084134|7531955|FG000|STARTED|Overall Study||23
6606873|NCT02084134|7531956|FG001|STARTED|Overall Study||20
6606874|NCT02084134|7531955|FG000|COMPLETED|Overall Study||19
6606875|NCT02084134|7531956|FG001|COMPLETED|Overall Study||17
6606876|NCT02084134|7531955|FG000|NOT COMPLETED|Overall Study||4
6606877|NCT02084134|7531956|FG001|NOT COMPLETED|Overall Study||3
6606878|NCT02084160|7531962|FG000|STARTED|Overall Study||579
6606879|NCT02084160|7531962|FG000|COMPLETED|Overall Study||579
6606880|NCT02084160|7531962|FG000|NOT COMPLETED|Overall Study||0
6606881|NCT02084238|7531966|FG000|STARTED|Overall Study||40
6606882|NCT02084238|7531966|FG000|COMPLETED|Overall Study||38
6606883|NCT02084238|7531966|FG000|NOT COMPLETED|Overall Study||2
6606884|NCT02084511|7531981|FG000|STARTED|Overall Study||20
6606885|NCT02084511|7531982|FG001|STARTED|Overall Study||20
6606886|NCT02084511|7531983|FG002|STARTED|Overall Study||20
6606887|NCT02084511|7531984|FG003|STARTED|Overall Study||20
6606888|NCT02084511|7531981|FG000|COMPLETED|Overall Study||20
6606889|NCT02084511|7531982|FG001|COMPLETED|Overall Study||20
6606890|NCT02084511|7531983|FG002|COMPLETED|Overall Study||20
6606891|NCT02084511|7531984|FG003|COMPLETED|Overall Study||20
6606892|NCT02084511|7531981|FG000|NOT COMPLETED|Overall Study||0
6606893|NCT02084511|7531982|FG001|NOT COMPLETED|Overall Study||0
6606894|NCT02084511|7531983|FG002|NOT COMPLETED|Overall Study||0
6606895|NCT02084511|7531984|FG003|NOT COMPLETED|Overall Study||0
6606896|NCT02084628|7531994|FG000|STARTED|Overall Study||1
6606897|NCT02084628|7531994|FG000|COMPLETED|Overall Study||1
6606898|NCT02084628|7531994|FG000|NOT COMPLETED|Overall Study||0
6606899|NCT02084706|7532000|FG000|STARTED|Overall Study||29
6606900|NCT02084706|7532001|FG001|STARTED|Overall Study||31
6606901|NCT02084706|7532000|FG000|COMPLETED|Overall Study||29
6606902|NCT02084706|7532001|FG001|COMPLETED|Overall Study||31
6606903|NCT02084706|7532000|FG000|NOT COMPLETED|Overall Study||0
6606904|NCT02084706|7532001|FG001|NOT COMPLETED|Overall Study||0
6606905|NCT02084797|7532007|FG000|STARTED|Overall Study||10
6606906|NCT02084797|7532007|FG000|COMPLETED|Overall Study||10
6606907|NCT02084797|7532007|FG000|NOT COMPLETED|Overall Study||0
6606908|NCT02085070|7532013|FG000|STARTED|Overall Study||23
6606909|NCT02085070|7532014|FG001|STARTED|Overall Study||42
6606910|NCT02085070|7532013|FG000|COMPLETED|Overall Study||23
6606911|NCT02085070|7532014|FG001|COMPLETED|Overall Study||42
6606912|NCT02085070|7532013|FG000|NOT COMPLETED|Overall Study||0
6606913|NCT02085070|7532014|FG001|NOT COMPLETED|Overall Study||0
6606914|NCT02085135|7532022|FG000|STARTED|Overall Study||34
6606915|NCT02085135|7532023|FG001|STARTED|Overall Study||32
6606916|NCT02085135|7532022|FG000|COMPLETED|Overall Study||23
6606917|NCT02085135|7532023|FG001|COMPLETED|Overall Study||23
6606918|NCT02085135|7532022|FG000|NOT COMPLETED|Overall Study||11
6606919|NCT02085135|7532023|FG001|NOT COMPLETED|Overall Study||9
6606920|NCT02085161|7532033|FG000|STARTED|Overall Study||76
6606921|NCT02085161|7532034|FG001|STARTED|Overall Study||76
6606922|NCT02085161|7532035|FG002|STARTED|Overall Study||76
6606923|NCT02085161|7532036|FG003|STARTED|Overall Study||76
6606924|NCT02085161|7532033|FG000|COMPLETED|Overall Study||64
6606925|NCT02085161|7532034|FG001|COMPLETED|Overall Study||66
6606926|NCT02085161|7532035|FG002|COMPLETED|Overall Study||71
6606927|NCT02085161|7532036|FG003|COMPLETED|Overall Study||66
6606928|NCT02085161|7532033|FG000|NOT COMPLETED|Overall Study||12
6606929|NCT02085161|7532034|FG001|NOT COMPLETED|Overall Study||10
6606930|NCT02085161|7532035|FG002|NOT COMPLETED|Overall Study||5
6606931|NCT02085161|7532036|FG003|NOT COMPLETED|Overall Study||10
6606932|NCT02085252|7532049|FG000|STARTED|Overall Study||58
6606933|NCT02085252|7532050|FG001|STARTED|Overall Study||57
6606934|NCT02085252|7532049|FG000|COMPLETED|Overall Study||57
6606935|NCT02085252|7532050|FG001|COMPLETED|Overall Study||53
6606936|NCT02085252|7532049|FG000|NOT COMPLETED|Overall Study||1
6606937|NCT02085252|7532050|FG001|NOT COMPLETED|Overall Study||4
6606938|NCT02085356|7532060|FG000|STARTED|Overall Study||577
6606939|NCT02085356|7532061|FG001|STARTED|Overall Study||348
6606940|NCT02085356|7532062|FG002|STARTED|Overall Study||681
6606941|NCT02085356|7532063|FG003|STARTED|Overall Study||361
6606942|NCT02085356|7532060|FG000|COMPLETED|Overall Study||577
6606943|NCT02085356|7532061|FG001|COMPLETED|Overall Study||348
6606944|NCT02085356|7532062|FG002|COMPLETED|Overall Study||681
6606945|NCT02085356|7532063|FG003|COMPLETED|Overall Study||361
6606946|NCT02085356|7532060|FG000|NOT COMPLETED|Overall Study||0
6606947|NCT02085356|7532061|FG001|NOT COMPLETED|Overall Study||0
6606948|NCT02085356|7532062|FG002|NOT COMPLETED|Overall Study||0
6606949|NCT02085356|7532063|FG003|NOT COMPLETED|Overall Study||0
6606950|NCT02085447|7532073|FG000|STARTED|Overall Study||30
6606951|NCT02085447|7532073|FG000|COMPLETED|Overall Study||26
6606952|NCT02085447|7532073|FG000|NOT COMPLETED|Overall Study||4
6606953|NCT02085460|7532081|FG000|STARTED|Overall Study||31
6606954|NCT02085460|7532082|FG001|STARTED|Overall Study||32
6606955|NCT02085460|7532083|FG002|STARTED|Overall Study||31
6606956|NCT02085460|7532081|FG000|COMPLETED|Overall Study||17
6606957|NCT02085460|7532082|FG001|COMPLETED|Overall Study||24
6606958|NCT02085460|7532083|FG002|COMPLETED|Overall Study||21
6606959|NCT02085460|7532081|FG000|NOT COMPLETED|Overall Study||14
6606960|NCT02085460|7532082|FG001|NOT COMPLETED|Overall Study||8
6606961|NCT02085460|7532083|FG002|NOT COMPLETED|Overall Study||10
6606962|NCT02085473|7532095|FG000|STARTED|Overall Study||15
6606963|NCT02085473|7532096|FG001|STARTED|Overall Study||15
6606964|NCT02085473|7532097|FG002|STARTED|Overall Study||15
6606965|NCT02085473|7532098|FG003|STARTED|Overall Study||15
6606966|NCT02085473|7532095|FG000|COMPLETED|Overall Study||15
6606967|NCT02085473|7532096|FG001|COMPLETED|Overall Study||15
6606968|NCT02085473|7532097|FG002|COMPLETED|Overall Study||15
6606969|NCT02085473|7532098|FG003|COMPLETED|Overall Study||15
6606970|NCT02085473|7532095|FG000|NOT COMPLETED|Overall Study||0
6606971|NCT02085473|7532096|FG001|NOT COMPLETED|Overall Study||0
6606972|NCT02085473|7532097|FG002|NOT COMPLETED|Overall Study||0
6606973|NCT02085473|7532098|FG003|NOT COMPLETED|Overall Study||0
6606974|NCT02085551|7532108|FG000|STARTED|Overall Study||85
6606975|NCT02085551|7532108|FG000|COMPLETED|Overall Study||85
6606976|NCT02085551|7532108|FG000|NOT COMPLETED|Overall Study||0
6606977|NCT02085720|7532112|FG000|STARTED|Overall Study||819
6606978|NCT02085720|7532112|FG000|COMPLETED|Overall Study||819
6606979|NCT02085720|7532112|FG000|NOT COMPLETED|Overall Study||0
6606980|NCT02085785|7532122|FG000|STARTED|Overall Study||7
6606981|NCT02085785|7532123|FG001|STARTED|Overall Study||8
6606982|NCT02085785|7532122|FG000|COMPLETED|Overall Study||5
6606983|NCT02085785|7532123|FG001|COMPLETED|Overall Study||6
6606984|NCT02085785|7532122|FG000|NOT COMPLETED|Overall Study||2
6606985|NCT02085785|7532123|FG001|NOT COMPLETED|Overall Study||2
6606986|NCT02085980|7532131|FG000|STARTED|Overall Study||30
6606987|NCT02085980|7532131|FG000|COMPLETED|Overall Study||27
6606988|NCT02085980|7532131|FG000|NOT COMPLETED|Overall Study||3
6606989|NCT02086110|7532137|FG000|STARTED|Overall Study||5
6606990|NCT02086110|7532138|FG001|STARTED|Overall Study||6
6606991|NCT02086110|7532137|FG000|COMPLETED|Overall Study||4
6606992|NCT02086110|7532138|FG001|COMPLETED|Overall Study||5
6606993|NCT02086110|7532137|FG000|NOT COMPLETED|Overall Study||1
6606994|NCT02086110|7532138|FG001|NOT COMPLETED|Overall Study||1
6606995|NCT02086162|7532147|FG000|STARTED|Overall Study||78
6606996|NCT02086162|7532148|FG001|STARTED|Overall Study||84
6606997|NCT02086162|7532147|FG000|COMPLETED|Overall Study||68
6606998|NCT02086162|7532148|FG001|COMPLETED|Overall Study||77
6606999|NCT02086162|7532147|FG000|NOT COMPLETED|Overall Study||10
6607000|NCT02086162|7532148|FG001|NOT COMPLETED|Overall Study||7
6607001|NCT02086331|7532158|FG000|STARTED|Overall Study||5
6607002|NCT02086331|7532158|FG000|COMPLETED|Overall Study||5
6607003|NCT02086331|7532158|FG000|NOT COMPLETED|Overall Study||0
6607004|NCT02086500|7532173|FG000|STARTED|Overall Study||447
6607005|NCT02086500|7532174|FG001|STARTED|Overall Study||456
6607006|NCT02086500|7532173|FG000|COMPLETED|Overall Study||447
6607007|NCT02086500|7532174|FG001|COMPLETED|Overall Study||456
6607008|NCT02086500|7532173|FG000|NOT COMPLETED|Overall Study||0
6607009|NCT02086500|7532174|FG001|NOT COMPLETED|Overall Study||0
6607010|NCT02086565|7532182|FG000|STARTED|Overall Study||151
6607011|NCT02086565|7532183|FG001|STARTED|Overall Study||150
6607012|NCT02086565|7532182|FG000|COMPLETED|Overall Study||135
6607013|NCT02086565|7532183|FG001|COMPLETED|Overall Study||138
6607014|NCT02086565|7532182|FG000|NOT COMPLETED|Overall Study||16
6607015|NCT02086565|7532183|FG001|NOT COMPLETED|Overall Study||12
6607016|NCT02086591|7532189|FG000|STARTED|Overall Study||7
6607017|NCT02086591|7532189|FG000|COMPLETED|Overall Study||2
6607018|NCT02086591|7532189|FG000|NOT COMPLETED|Overall Study||5
6607019|NCT02086682|7532195|FG000|STARTED|Overall Study||156
6607020|NCT02086682|7532196|FG001|STARTED|Overall Study||182
6607021|NCT02086682|7532195|FG000|COMPLETED|Overall Study||156
6607022|NCT02086682|7532196|FG001|COMPLETED|Overall Study||182
6607023|NCT02086682|7532195|FG000|NOT COMPLETED|Overall Study||0
6607024|NCT02086682|7532196|FG001|NOT COMPLETED|Overall Study||0
6607025|NCT02086708|7532202|FG000|STARTED|Overall Study||24
6607026|NCT02086708|7532202|FG000|COMPLETED|Overall Study||24
6607027|NCT02086708|7532202|FG000|NOT COMPLETED|Overall Study||0
6607028|NCT02086786|7532216|FG000|STARTED|Overall Study||35
6607029|NCT02086786|7532217|FG001|STARTED|Overall Study||35
6607030|NCT02086786|7532216|FG000|COMPLETED|Overall Study||17
6607031|NCT02086786|7532217|FG001|COMPLETED|Overall Study||19
6607032|NCT02086786|7532216|FG000|NOT COMPLETED|Overall Study||18
6607033|NCT02086786|7532217|FG001|NOT COMPLETED|Overall Study||16
6607034|NCT02086968|7532227|FG000|STARTED|Overall Study||100
6607035|NCT02086968|7532228|FG001|STARTED|Overall Study||98
6607036|NCT02086968|7532227|FG000|COMPLETED|Overall Study||92
6607037|NCT02086968|7532228|FG001|COMPLETED|Overall Study||85
6607038|NCT02086968|7532227|FG000|NOT COMPLETED|Overall Study||8
6607039|NCT02086968|7532228|FG001|NOT COMPLETED|Overall Study||13
6607040|NCT02087046|7532234|FG000|STARTED|Overall Study||127
6607041|NCT02087046|7532234|FG000|Primary Endpoint|Overall Study||121
6607042|NCT02087046|7532234|FG000|COMPLETED|Overall Study||116
6607043|NCT02087046|7532234|FG000|NOT COMPLETED|Overall Study||11
6607044|NCT02087059|7532239|FG000|STARTED|Overall Study||51
6607045|NCT02087059|7532239|FG000|COMPLETED|Overall Study||44
6607046|NCT02087059|7532239|FG000|NOT COMPLETED|Overall Study||7
6607047|NCT02087085|7532245|FG000|STARTED|Overall Study||154
6607048|NCT02087085|7532246|FG001|STARTED|Overall Study||156
6607049|NCT02087085|7532245|FG000|COMPLETED|Overall Study||34
6607050|NCT02087085|7532246|FG001|COMPLETED|Overall Study||40
6607051|NCT02087085|7532245|FG000|NOT COMPLETED|Overall Study||120
6607052|NCT02087085|7532246|FG001|NOT COMPLETED|Overall Study||116
6625318|NCT02224560|7552986|FG000|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|82
6607053|NCT02087150|7532255|FG000|STARTED|Overall Study||81
6607054|NCT02087150|7532256|FG001|STARTED|Overall Study||162
6607055|NCT02087150|7532257|FG002|STARTED|Overall Study||80
6607056|NCT02087150|7532255|FG000|Had a Lead-in or Randomized ETBC Proc|Overall Study||80
6607057|NCT02087150|7532256|FG001|Had a Lead-in or Randomized ETBC Proc|Overall Study||149
6607058|NCT02087150|7532257|FG002|Had a Lead-in or Randomized ETBC Proc|Overall Study||0
6607059|NCT02087150|7532255|FG000|Received a Crossover MM ETBC Procedure|Overall Study||0
6607060|NCT02087150|7532256|FG001|Received a Crossover MM ETBC Procedure|Overall Study||0
6607061|NCT02087150|7532257|FG002|Received a Crossover MM ETBC Procedure|Overall Study||70
6607062|NCT02087150|7532255|FG000|COMPLETED|Overall Study||71
6607063|NCT02087150|7532256|FG001|COMPLETED|Overall Study||128
6607064|NCT02087150|7532257|FG002|COMPLETED|Overall Study||69
6607065|NCT02087150|7532255|FG000|NOT COMPLETED|Overall Study||10
6607066|NCT02087150|7532256|FG001|NOT COMPLETED|Overall Study||34
6607067|NCT02087150|7532257|FG002|NOT COMPLETED|Overall Study||11
6607068|NCT02087163|7532266|FG000|STARTED|Overall Study||90
6607069|NCT02087163|7532266|FG000|COMPLETED|Overall Study||73
6607070|NCT02087163|7532266|FG000|NOT COMPLETED|Overall Study||17
6607071|NCT02087176|7532270|FG000|STARTED|Overall Study||32
6607072|NCT02087176|7532270|FG000|COMPLETED|Overall Study|The sponsor terminated the study early.|0
6607073|NCT02087176|7532270|FG000|NOT COMPLETED|Overall Study||32
6607074|NCT02087241|7532278|FG000|STARTED|Overall Study||3
6607075|NCT02087241|7532279|FG001|STARTED|Overall Study||3
6607076|NCT02087241|7532280|FG002|STARTED|Overall Study||1
6607077|NCT02087241|7532281|FG003|STARTED|Overall Study||7
6607078|NCT02087241|7532278|FG000|COMPLETED|Overall Study||0
6607079|NCT02087241|7532279|FG001|COMPLETED|Overall Study||0
6607080|NCT02087241|7532280|FG002|COMPLETED|Overall Study||0
6607081|NCT02087241|7532281|FG003|COMPLETED|Overall Study||0
6607082|NCT02087241|7532278|FG000|NOT COMPLETED|Overall Study||3
6607083|NCT02087241|7532279|FG001|NOT COMPLETED|Overall Study||3
6607084|NCT02087241|7532280|FG002|NOT COMPLETED|Overall Study||1
6607085|NCT02087241|7532281|FG003|NOT COMPLETED|Overall Study||7
6607086|NCT02087306|7532298|FG000|STARTED|Overall Study||65
6607087|NCT02087306|7532299|FG001|STARTED|Overall Study||93
6607088|NCT02087306|7532300|FG002|STARTED|Overall Study||43
6607089|NCT02087306|7532298|FG000|COMPLETED|Overall Study||29
6607090|NCT02087306|7532299|FG001|COMPLETED|Overall Study||29
6607091|NCT02087306|7532300|FG002|COMPLETED|Overall Study||16
6607092|NCT02087306|7532298|FG000|NOT COMPLETED|Overall Study||36
6607093|NCT02087306|7532299|FG001|NOT COMPLETED|Overall Study||64
6607094|NCT02087306|7532300|FG002|NOT COMPLETED|Overall Study||27
6607095|NCT02087514|7532313|FG000|STARTED|Overall Study||10
6607096|NCT02087514|7532314|FG001|STARTED|Overall Study||10
6607097|NCT02087514|7532315|FG002|STARTED|Overall Study||10
6607098|NCT02087514|7532316|FG003|STARTED|Overall Study||10
6607099|NCT02087514|7532317|FG004|STARTED|Overall Study||10
6607100|NCT02087514|7532318|FG005|STARTED|Overall Study||10
6607101|NCT02087514|7532313|FG000|COMPLETED|Overall Study||8
6607102|NCT02087514|7532314|FG001|COMPLETED|Overall Study||10
6607103|NCT02087514|7532315|FG002|COMPLETED|Overall Study||7
6607104|NCT02087514|7532316|FG003|COMPLETED|Overall Study||8
6607105|NCT02087514|7532317|FG004|COMPLETED|Overall Study||10
6607106|NCT02087514|7532318|FG005|COMPLETED|Overall Study||9
6607107|NCT02087514|7532313|FG000|NOT COMPLETED|Overall Study||2
6607108|NCT02087514|7532314|FG001|NOT COMPLETED|Overall Study||0
6607109|NCT02087514|7532315|FG002|NOT COMPLETED|Overall Study||3
6607110|NCT02087514|7532316|FG003|NOT COMPLETED|Overall Study||2
6607111|NCT02087514|7532317|FG004|NOT COMPLETED|Overall Study||0
6607112|NCT02087514|7532318|FG005|NOT COMPLETED|Overall Study||1
6607113|NCT02087670|7532334|FG000|STARTED|Overall Study||20
6607114|NCT02087670|7532335|FG001|STARTED|Overall Study||22
6607115|NCT02087670|7532334|FG000|COMPLETED|Overall Study||17
6607116|NCT02087670|7532335|FG001|COMPLETED|Overall Study||20
6607117|NCT02087670|7532334|FG000|NOT COMPLETED|Overall Study||3
6607118|NCT02087670|7532335|FG001|NOT COMPLETED|Overall Study||2
6607119|NCT02087748|7532341|FG000|STARTED|Overall Study||24
6607120|NCT02087748|7532341|FG000|COMPLETED|Overall Study||24
6607121|NCT02087748|7532341|FG000|NOT COMPLETED|Overall Study||0
6607122|NCT02087774|7532351|FG000|STARTED|Overall Study||150
6607123|NCT02087774|7532352|FG001|STARTED|Overall Study||150
6607124|NCT02087774|7532351|FG000|COMPLETED|Overall Study||142
6607125|NCT02087774|7532352|FG001|COMPLETED|Overall Study||130
6607126|NCT02087774|7532351|FG000|NOT COMPLETED|Overall Study||8
6607127|NCT02087774|7532352|FG001|NOT COMPLETED|Overall Study||20
6607128|NCT02087904|7532362|FG000|STARTED|Overall Study||85
6607129|NCT02087904|7532363|FG001|STARTED|Overall Study||89
6607130|NCT02087904|7532364|FG002|STARTED|Overall Study||87
6607131|NCT02087904|7532365|FG003|STARTED|Overall Study||89
6607132|NCT02087904|7532362|FG000|COMPLETED|Overall Study||60
6607133|NCT02087904|7532363|FG001|COMPLETED|Overall Study||70
6607134|NCT02087904|7532364|FG002|COMPLETED|Overall Study||65
6607135|NCT02087904|7532365|FG003|COMPLETED|Overall Study||64
6607136|NCT02087904|7532362|FG000|NOT COMPLETED|Overall Study||25
6732244|NCT03191630|7661652|FG000|STARTED|Overall Study||30
6607137|NCT02087904|7532363|FG001|NOT COMPLETED|Overall Study||19
6607138|NCT02087904|7532364|FG002|NOT COMPLETED|Overall Study||22
6607139|NCT02087904|7532365|FG003|NOT COMPLETED|Overall Study||25
6607140|NCT02087943|7532378|FG000|STARTED|Placebo-Controlled Phase Week 0-12||64
6607141|NCT02087943|7532379|FG001|STARTED|Placebo-Controlled Phase Week 0-12||58
6732245|NCT03191630|7661653|FG001|STARTED|Overall Study||30
6607142|NCT02087943|7532380|FG002|STARTED|Placebo-Controlled Phase Week 0-12||63
6607143|NCT02087943|7532381|FG003|STARTED|Placebo-Controlled Phase Week 0-12||0
6607144|NCT02087943|7532382|FG004|STARTED|Placebo-Controlled Phase Week 0-12||0
6607145|NCT02087943|7532378|FG000|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
6607146|NCT02087943|7532379|FG001|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
6607147|NCT02087943|7532380|FG002|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
6607148|NCT02087943|7532381|FG003|Safety Population|Placebo-Controlled Phase Week 0-12||0
6607149|NCT02087943|7532382|FG004|Safety Population|Placebo-Controlled Phase Week 0-12||0
6607150|NCT02087943|7532378|FG000|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
6607151|NCT02087943|7532379|FG001|COMPLETED|Placebo-Controlled Phase Week 0-12||46
6607152|NCT02087943|7532380|FG002|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
6607153|NCT02087943|7532381|FG003|COMPLETED|Placebo-Controlled Phase Week 0-12||0
6607154|NCT02087943|7532382|FG004|COMPLETED|Placebo-Controlled Phase Week 0-12||0
6607155|NCT02087943|7532378|FG000|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
6607156|NCT02087943|7532379|FG001|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
6607157|NCT02087943|7532380|FG002|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
6607158|NCT02087943|7532381|FG003|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
6607159|NCT02087943|7532382|FG004|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
6607160|NCT02087943|7532378|FG000|STARTED|Active Treatment Phase Week 12-24||0
6607161|NCT02087943|7532379|FG001|STARTED|Active Treatment Phase Week 12-24||46
6607162|NCT02087943|7532380|FG002|STARTED|Active Treatment Phase Week 12-24||49
6607163|NCT02087943|7532381|FG003|STARTED|Active Treatment Phase Week 12-24||24
6607164|NCT02087943|7532382|FG004|STARTED|Active Treatment Phase Week 12-24||23
6607165|NCT02087943|7532378|FG000|COMPLETED|Active Treatment Phase Week 12-24||0
6607166|NCT02087943|7532379|FG001|COMPLETED|Active Treatment Phase Week 12-24||42
6607167|NCT02087943|7532380|FG002|COMPLETED|Active Treatment Phase Week 12-24||44
6607168|NCT02087943|7532381|FG003|COMPLETED|Active Treatment Phase Week 12-24||22
6607169|NCT02087943|7532382|FG004|COMPLETED|Active Treatment Phase Week 12-24||21
6607170|NCT02087943|7532378|FG000|NOT COMPLETED|Active Treatment Phase Week 12-24||0
6607171|NCT02087943|7532379|FG001|NOT COMPLETED|Active Treatment Phase Week 12-24||4
6607172|NCT02087943|7532380|FG002|NOT COMPLETED|Active Treatment Phase Week 12-24||5
6607173|NCT02087943|7532381|FG003|NOT COMPLETED|Active Treatment Phase Week 12-24||2
6607174|NCT02087943|7532382|FG004|NOT COMPLETED|Active Treatment Phase Week 12-24||2
6607175|NCT02087943|7532378|FG000|STARTED|Observational Follow-up Phase Week 24-30||0
6607176|NCT02087943|7532379|FG001|STARTED|Observational Follow-up Phase Week 24-30||46
6607177|NCT02087943|7532380|FG002|STARTED|Observational Follow-up Phase Week 24-30||48
6607178|NCT02087943|7532381|FG003|STARTED|Observational Follow-up Phase Week 24-30||24
6607179|NCT02087943|7532382|FG004|STARTED|Observational Follow-up Phase Week 24-30||23
6607180|NCT02087943|7532378|FG000|COMPLETED|Observational Follow-up Phase Week 24-30||0
6607181|NCT02087943|7532379|FG001|COMPLETED|Observational Follow-up Phase Week 24-30||46
6607182|NCT02087943|7532380|FG002|COMPLETED|Observational Follow-up Phase Week 24-30||45
6607183|NCT02087943|7532381|FG003|COMPLETED|Observational Follow-up Phase Week 24-30||23
6607184|NCT02087943|7532382|FG004|COMPLETED|Observational Follow-up Phase Week 24-30||22
6607185|NCT02087943|7532378|FG000|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
6607186|NCT02087943|7532379|FG001|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
6607187|NCT02087943|7532380|FG002|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
6607188|NCT02087943|7532381|FG003|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
6607189|NCT02087943|7532382|FG004|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
6607190|NCT02087956|7532396|FG000|STARTED|Overall Study||111
6607191|NCT02087956|7532397|FG001|STARTED|Overall Study||112
6607192|NCT02087956|7532396|FG000|COMPLETED|Overall Study||105
6607193|NCT02087956|7532397|FG001|COMPLETED|Overall Study||107
6607194|NCT02087956|7532396|FG000|NOT COMPLETED|Overall Study||6
6607195|NCT02087956|7532397|FG001|NOT COMPLETED|Overall Study||5
6607196|NCT02087995|7532405|FG000|STARTED|Overall Study||51
6607197|NCT02087995|7532405|FG000|COMPLETED|Overall Study||51
6607198|NCT02087995|7532405|FG000|NOT COMPLETED|Overall Study||0
6607199|NCT02088034|7532412|FG000|STARTED|Overall Study||33
6607200|NCT02088034|7532413|FG001|STARTED|Overall Study||30
6607201|NCT02088034|7532414|FG002|STARTED|Overall Study||29
6607202|NCT02088034|7532412|FG000|COMPLETED|Overall Study||30
6607203|NCT02088034|7532413|FG001|COMPLETED|Overall Study||28
6607204|NCT02088034|7532414|FG002|COMPLETED|Overall Study||27
6607205|NCT02088034|7532412|FG000|NOT COMPLETED|Overall Study||3
6607206|NCT02088034|7532413|FG001|NOT COMPLETED|Overall Study||2
6607207|NCT02088034|7532414|FG002|NOT COMPLETED|Overall Study||2
6607208|NCT02088047|7532424|FG000|STARTED|Overall Study||3
6607209|NCT02088047|7532425|FG001|STARTED|Overall Study||1
6607210|NCT02088047|7532424|FG000|COMPLETED|Overall Study||2
6607211|NCT02088047|7532425|FG001|COMPLETED|Overall Study||1
6607212|NCT02088047|7532424|FG000|NOT COMPLETED|Overall Study||1
6607213|NCT02088047|7532425|FG001|NOT COMPLETED|Overall Study||0
6607214|NCT02088073|7532436|FG000|STARTED|Acute Phase||258
6607215|NCT02088073|7532437|FG001|STARTED|Acute Phase||0
6607216|NCT02088073|7532438|FG002|STARTED|Acute Phase||0
6607217|NCT02088073|7532439|FG003|STARTED|Acute Phase||0
6607218|NCT02088073|7532440|FG004|STARTED|Acute Phase||0
6607219|NCT02088073|7532436|FG000|COMPLETED|Acute Phase||251
6607220|NCT02088073|7532437|FG001|COMPLETED|Acute Phase||0
6607221|NCT02088073|7532438|FG002|COMPLETED|Acute Phase||0
6607222|NCT02088073|7532439|FG003|COMPLETED|Acute Phase||0
6607223|NCT02088073|7532440|FG004|COMPLETED|Acute Phase||0
6607224|NCT02088073|7532436|FG000|NOT COMPLETED|Acute Phase||7
6607225|NCT02088073|7532437|FG001|NOT COMPLETED|Acute Phase||0
6607226|NCT02088073|7532438|FG002|NOT COMPLETED|Acute Phase||0
6607227|NCT02088073|7532439|FG003|NOT COMPLETED|Acute Phase||0
6607228|NCT02088073|7532440|FG004|NOT COMPLETED|Acute Phase||0
6607229|NCT02088073|7532436|FG000|STARTED|Maintanance Phase||0
6607230|NCT02088073|7532437|FG001|STARTED|Maintanance Phase||85
6607231|NCT02088073|7532438|FG002|STARTED|Maintanance Phase||45
6607232|NCT02088073|7532439|FG003|STARTED|Maintanance Phase||51
6607233|NCT02088073|7532440|FG004|STARTED|Maintanance Phase||56
6607234|NCT02088073|7532436|FG000|COMPLETED|Maintanance Phase|251 subjects completed the AP; 240 were eligible to enter the MP. 237 entered the MP.|0
6607235|NCT02088073|7532437|FG001|COMPLETED|Maintanance Phase||75
6607236|NCT02088073|7532438|FG002|COMPLETED|Maintanance Phase||40
6607237|NCT02088073|7532439|FG003|COMPLETED|Maintanance Phase||44
6607238|NCT02088073|7532440|FG004|COMPLETED|Maintanance Phase||49
6607239|NCT02088073|7532436|FG000|NOT COMPLETED|Maintanance Phase||0
6607240|NCT02088073|7532437|FG001|NOT COMPLETED|Maintanance Phase||10
6607241|NCT02088073|7532438|FG002|NOT COMPLETED|Maintanance Phase||5
6607242|NCT02088073|7532439|FG003|NOT COMPLETED|Maintanance Phase||7
6607243|NCT02088073|7532440|FG004|NOT COMPLETED|Maintanance Phase||7
6607244|NCT02088177|7532453|FG000|STARTED|Overall Study||12
6607245|NCT02088177|7532453|FG000|COMPLETED|Overall Study||9
6607246|NCT02088177|7532453|FG000|NOT COMPLETED|Overall Study||3
6607247|NCT02088216|7532459|FG000|STARTED|Overall Study||81
6607248|NCT02088216|7532460|FG001|STARTED|Overall Study||80
6607249|NCT02088216|7532459|FG000|COMPLETED|Overall Study||69
6607250|NCT02088216|7532460|FG001|COMPLETED|Overall Study||70
6607251|NCT02088216|7532459|FG000|NOT COMPLETED|Overall Study||12
6607252|NCT02088216|7532460|FG001|NOT COMPLETED|Overall Study||10
6607253|NCT02088385|7532468|FG000|STARTED|Overall Study||10
6607254|NCT02088385|7532469|FG001|STARTED|Overall Study||10
6607255|NCT02088385|7532468|FG000|COMPLETED|Overall Study||10
6607256|NCT02088385|7532469|FG001|COMPLETED|Overall Study||10
6607257|NCT02088385|7532468|FG000|NOT COMPLETED|Overall Study||0
6607258|NCT02088385|7532469|FG001|NOT COMPLETED|Overall Study||0
6607259|NCT02088541|7532480|FG000|STARTED|Overall Study||71
6607260|NCT02088541|7532481|FG001|STARTED|Overall Study||27
6607261|NCT02088541|7532482|FG002|STARTED|Overall Study||117
6607262|NCT02088541|7532483|FG003|STARTED|Overall Study||44
6607263|NCT02088541|7532484|FG004|STARTED|Overall Study||58
6607264|NCT02088541|7532480|FG000|Safety Population|Overall Study||71
6607265|NCT02088541|7532481|FG001|Safety Population|Overall Study||27
6607266|NCT02088541|7532482|FG002|Safety Population|Overall Study||115
6607267|NCT02088541|7532483|FG003|Safety Population|Overall Study||39
6607268|NCT02088541|7532484|FG004|Safety Population|Overall Study||45
6607269|NCT02088541|7532480|FG000|Intent-to-treat (ITT) Population|Overall Study||0
6607270|NCT02088541|7532481|FG001|Intent-to-treat (ITT) Population|Overall Study||0
6607271|NCT02088541|7532482|FG002|Intent-to-treat (ITT) Population|Overall Study|1 randomized to Selinexor 60mg (PV>=5) but treated with physician choice 2, counted under this arm.|118
6607272|NCT02088541|7532483|FG003|Intent-to-treat (ITT) Population|Overall Study||0
6607273|NCT02088541|7532484|FG004|Intent-to-treat (ITT) Population|Overall Study||57
6607274|NCT02088541|7532480|FG000|COMPLETED|Overall Study||0
6607275|NCT02088541|7532481|FG001|COMPLETED|Overall Study||0
6607276|NCT02088541|7532482|FG002|COMPLETED|Overall Study||0
6607277|NCT02088541|7532483|FG003|COMPLETED|Overall Study||0
6607278|NCT02088541|7532484|FG004|COMPLETED|Overall Study||0
6607279|NCT02088541|7532480|FG000|NOT COMPLETED|Overall Study||71
6607280|NCT02088541|7532481|FG001|NOT COMPLETED|Overall Study||27
6607281|NCT02088541|7532482|FG002|NOT COMPLETED|Overall Study||117
6607282|NCT02088541|7532483|FG003|NOT COMPLETED|Overall Study||44
6607283|NCT02088541|7532484|FG004|NOT COMPLETED|Overall Study||58
6607284|NCT02088697|7532496|FG000|STARTED|Period I||25
6607285|NCT02088697|7532497|FG001|STARTED|Period I||25
6607286|NCT02088697|7532496|FG000|COMPLETED|Period I||24
6607287|NCT02088697|7532497|FG001|COMPLETED|Period I||21
6607288|NCT02088697|7532496|FG000|NOT COMPLETED|Period I||1
6607289|NCT02088697|7532497|FG001|NOT COMPLETED|Period I||4
6607290|NCT02088697|7532496|FG000|STARTED|Wash-out Period (at Least 10 Days)||24
6607291|NCT02088697|7532497|FG001|STARTED|Wash-out Period (at Least 10 Days)||21
6607292|NCT02088697|7532496|FG000|COMPLETED|Wash-out Period (at Least 10 Days)||23
6607293|NCT02088697|7532497|FG001|COMPLETED|Wash-out Period (at Least 10 Days)||21
6607294|NCT02088697|7532496|FG000|NOT COMPLETED|Wash-out Period (at Least 10 Days)||1
6607295|NCT02088697|7532497|FG001|NOT COMPLETED|Wash-out Period (at Least 10 Days)||0
6607296|NCT02088697|7532496|FG000|STARTED|Period II||23
6607297|NCT02088697|7532497|FG001|STARTED|Period II||21
6607298|NCT02088697|7532496|FG000|COMPLETED|Period II||23
6607299|NCT02088697|7532497|FG001|COMPLETED|Period II||21
6607300|NCT02088697|7532496|FG000|NOT COMPLETED|Period II||0
6607301|NCT02088697|7532497|FG001|NOT COMPLETED|Period II||0
6607302|NCT02088788|7532505|FG000|STARTED|Overall Study||135
6607303|NCT02088788|7532506|FG001|STARTED|Overall Study||130
6607304|NCT02088788|7532505|FG000|COMPLETED|Overall Study||105
6607305|NCT02088788|7532506|FG001|COMPLETED|Overall Study||89
6607306|NCT02088788|7532505|FG000|NOT COMPLETED|Overall Study||30
6607307|NCT02088788|7532506|FG001|NOT COMPLETED|Overall Study||41
6607308|NCT02088905|7532514|FG000|STARTED|Overall Study||13
6607309|NCT02088905|7532515|FG001|STARTED|Overall Study||10
6607310|NCT02088905|7532514|FG000|Week 9|Overall Study||10
6607311|NCT02088905|7532515|FG001|Week 9|Overall Study||9
6607312|NCT02088905|7532514|FG000|COMPLETED|Overall Study||8
6607313|NCT02088905|7532515|FG001|COMPLETED|Overall Study||9
6607314|NCT02088905|7532514|FG000|NOT COMPLETED|Overall Study||5
6607315|NCT02088905|7532515|FG001|NOT COMPLETED|Overall Study||1
6607316|NCT02089113|7532523|FG000|STARTED|Overall Study||161
6607317|NCT02089113|7532524|FG001|STARTED|Overall Study||80
6607318|NCT02089113|7532523|FG000|COMPLETED|Overall Study||160
6607319|NCT02089113|7532524|FG001|COMPLETED|Overall Study||80
6607320|NCT02089113|7532523|FG000|NOT COMPLETED|Overall Study||1
6607321|NCT02089113|7532524|FG001|NOT COMPLETED|Overall Study||0
6607322|NCT02089191|7532530|FG000|STARTED|Period 1, First 12 Hours||16
6607323|NCT02089191|7532531|FG001|STARTED|Period 1, First 12 Hours||15
6607324|NCT02089191|7532530|FG000|COMPLETED|Period 1, First 12 Hours||16
6607325|NCT02089191|7532531|FG001|COMPLETED|Period 1, First 12 Hours||15
6607326|NCT02089191|7532530|FG000|NOT COMPLETED|Period 1, First 12 Hours||0
6607327|NCT02089191|7532531|FG001|NOT COMPLETED|Period 1, First 12 Hours||0
6607328|NCT02089191|7532530|FG000|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
6607329|NCT02089191|7532531|FG001|STARTED|Period 2, Second 12 Hours||15
6607330|NCT02089191|7532530|FG000|COMPLETED|Period 2, Second 12 Hours||15
6607331|NCT02089191|7532531|FG001|COMPLETED|Period 2, Second 12 Hours||15
6607332|NCT02089191|7532530|FG000|NOT COMPLETED|Period 2, Second 12 Hours||0
6607333|NCT02089191|7532531|FG001|NOT COMPLETED|Period 2, Second 12 Hours||0
6607334|NCT02089230|7532540|FG000|STARTED|Overall Study||3
6607335|NCT02089230|7532541|FG001|STARTED|Overall Study||4
6607336|NCT02089230|7532542|FG002|STARTED|Overall Study||12
6607337|NCT02089230|7532540|FG000|COMPLETED|Overall Study||3
6607338|NCT02089230|7532541|FG001|COMPLETED|Overall Study||4
6607339|NCT02089230|7532542|FG002|COMPLETED|Overall Study||6
6607340|NCT02089230|7532540|FG000|NOT COMPLETED|Overall Study||0
6607341|NCT02089230|7532541|FG001|NOT COMPLETED|Overall Study||0
6607342|NCT02089230|7532542|FG002|NOT COMPLETED|Overall Study||6
6607343|NCT02089334|7532554|FG000|STARTED|Overall Study||3
6607344|NCT02089334|7532555|FG001|STARTED|Overall Study||4
6607345|NCT02089334|7532556|FG002|STARTED|Overall Study||4
6607346|NCT02089334|7532557|FG003|STARTED|Overall Study||13
6607347|NCT02089334|7532554|FG000|Received Study Drug|Overall Study||3
6607348|NCT02089334|7532555|FG001|Received Study Drug|Overall Study||4
6607349|NCT02089334|7532556|FG002|Received Study Drug|Overall Study||3
6607350|NCT02089334|7532557|FG003|Received Study Drug|Overall Study||11
6607351|NCT02089334|7532554|FG000|COMPLETED|Overall Study||3
6607352|NCT02089334|7532555|FG001|COMPLETED|Overall Study||4
6607353|NCT02089334|7532556|FG002|COMPLETED|Overall Study||3
6607354|NCT02089334|7532557|FG003|COMPLETED|Overall Study||6
6607355|NCT02089334|7532554|FG000|NOT COMPLETED|Overall Study||0
6607356|NCT02089334|7532555|FG001|NOT COMPLETED|Overall Study||0
6607357|NCT02089334|7532556|FG002|NOT COMPLETED|Overall Study||1
6607358|NCT02089334|7532557|FG003|NOT COMPLETED|Overall Study||7
6607359|NCT02089347|7532572|FG000|STARTED|Overall Study||356
6607360|NCT02089347|7532573|FG001|STARTED|Overall Study||178
6607361|NCT02089347|7532572|FG000|COMPLETED|Overall Study||355
6607362|NCT02089347|7532573|FG001|COMPLETED|Overall Study||178
6607363|NCT02089347|7532572|FG000|NOT COMPLETED|Overall Study||1
6607364|NCT02089347|7532573|FG001|NOT COMPLETED|Overall Study||0
6607365|NCT02089464|7532581|FG000|STARTED|Overall Study||132
6607366|NCT02089464|7532582|FG001|STARTED|Overall Study||67
6607367|NCT02089464|7532581|FG000|COMPLETED|Overall Study||104
6607368|NCT02089464|7532582|FG001|COMPLETED|Overall Study||51
6607369|NCT02089464|7532581|FG000|NOT COMPLETED|Overall Study||28
6607370|NCT02089464|7532582|FG001|NOT COMPLETED|Overall Study||16
6607371|NCT02089659|7532590|FG000|STARTED|Overall Study||8
6607372|NCT02089659|7532591|FG001|STARTED|Overall Study||8
6607373|NCT02089659|7532592|FG002|STARTED|Overall Study||0
6607374|NCT02089659|7532590|FG000|COMPLETED|Overall Study||8
6607375|NCT02089659|7532591|FG001|COMPLETED|Overall Study||8
6607376|NCT02089659|7532592|FG002|COMPLETED|Overall Study||0
6607377|NCT02089659|7532590|FG000|NOT COMPLETED|Overall Study||0
6607378|NCT02089659|7532591|FG001|NOT COMPLETED|Overall Study||0
6607379|NCT02089659|7532592|FG002|NOT COMPLETED|Overall Study||0
6607380|NCT02089737|7532598|FG000|STARTED|Overall Study||3091
6607381|NCT02089737|7532598|FG000|COMPLETED|Overall Study||3085
6607382|NCT02089737|7532598|FG000|NOT COMPLETED|Overall Study||6
6607383|NCT02089997|7532603|FG000|STARTED|Overall Study||3304
6607384|NCT02089997|7532603|FG000|COMPLETED|Overall Study||3058
6607385|NCT02089997|7532603|FG000|NOT COMPLETED|Overall Study||246
6607386|NCT02090075|7532609|FG000|STARTED|Overall Study||33
6607387|NCT02090075|7532610|FG001|STARTED|Overall Study||33
6607388|NCT02090075|7532609|FG000|COMPLETED|Overall Study||26
6607389|NCT02090075|7532610|FG001|COMPLETED|Overall Study||30
6607390|NCT02090075|7532609|FG000|NOT COMPLETED|Overall Study||7
6607391|NCT02090075|7532610|FG001|NOT COMPLETED|Overall Study||3
6607392|NCT02090088|7532616|FG000|STARTED|Overall Study||4
6607393|NCT02090088|7532616|FG000|Gave Birth|Overall Study||4
6607394|NCT02090088|7532616|FG000|COMPLETED|Overall Study||4
6607395|NCT02090088|7532616|FG000|NOT COMPLETED|Overall Study||0
6607396|NCT02090283|7532624|FG000|STARTED|Overall Study||17
6607397|NCT02090283|7532625|FG001|STARTED|Overall Study||15
6607398|NCT02090283|7532626|FG002|STARTED|Overall Study||10
6607399|NCT02090283|7532624|FG000|Received At Least 1 Dose Of Study Drug|Overall Study||17
6607400|NCT02090283|7532625|FG001|Received At Least 1 Dose Of Study Drug|Overall Study||15
6607401|NCT02090283|7532626|FG002|Received At Least 1 Dose Of Study Drug|Overall Study||10
6607402|NCT02090283|7532624|FG000|COMPLETED|Overall Study||0
6607403|NCT02090283|7532625|FG001|COMPLETED|Overall Study||0
6607404|NCT02090283|7532626|FG002|COMPLETED|Overall Study||0
6607405|NCT02090283|7532624|FG000|NOT COMPLETED|Overall Study||17
6607406|NCT02090283|7532625|FG001|NOT COMPLETED|Overall Study||15
6607407|NCT02090283|7532626|FG002|NOT COMPLETED|Overall Study||10
6607408|NCT02090374|7532642|FG000|STARTED|Overall Study||8
6607409|NCT02090374|7532643|FG001|STARTED|Overall Study||4
6607410|NCT02090374|7532644|FG002|STARTED|Overall Study||4
6607411|NCT02090374|7532645|FG003|STARTED|Overall Study||9
6607412|NCT02090374|7532646|FG004|STARTED|Overall Study||35
6607413|NCT02090374|7532647|FG005|STARTED|Overall Study||15
6607414|NCT02090374|7532648|FG006|STARTED|Overall Study||16
6607415|NCT02090374|7532649|FG007|STARTED|Overall Study||2
6607416|NCT02090374|7532642|FG000|COMPLETED|Overall Study||8
6607417|NCT02090374|7532643|FG001|COMPLETED|Overall Study||4
6607418|NCT02090374|7532644|FG002|COMPLETED|Overall Study||4
6607419|NCT02090374|7532645|FG003|COMPLETED|Overall Study||9
6607420|NCT02090374|7532646|FG004|COMPLETED|Overall Study||35
6607421|NCT02090374|7532647|FG005|COMPLETED|Overall Study||15
6607422|NCT02090374|7532648|FG006|COMPLETED|Overall Study||16
6607423|NCT02090374|7532649|FG007|COMPLETED|Overall Study||2
6607424|NCT02090374|7532642|FG000|NOT COMPLETED|Overall Study||0
6607425|NCT02090374|7532643|FG001|NOT COMPLETED|Overall Study||0
6607426|NCT02090374|7532644|FG002|NOT COMPLETED|Overall Study||0
6607427|NCT02090374|7532645|FG003|NOT COMPLETED|Overall Study||0
6607428|NCT02090374|7532646|FG004|NOT COMPLETED|Overall Study||0
6607429|NCT02090374|7532647|FG005|NOT COMPLETED|Overall Study||0
6607430|NCT02090374|7532648|FG006|NOT COMPLETED|Overall Study||0
6607431|NCT02090374|7532649|FG007|NOT COMPLETED|Overall Study||0
6607432|NCT02090413|7532670|FG000|STARTED|Overall Study||81
6607433|NCT02090413|7532671|FG001|STARTED|Overall Study||80
6607434|NCT02090413|7532672|FG002|STARTED|Overall Study||80
6607435|NCT02090413|7532670|FG000|COMPLETED|Overall Study||62
6607436|NCT02090413|7532671|FG001|COMPLETED|Overall Study||60
6607437|NCT02090413|7532672|FG002|COMPLETED|Overall Study||57
6607438|NCT02090413|7532670|FG000|NOT COMPLETED|Overall Study||19
6607439|NCT02090413|7532671|FG001|NOT COMPLETED|Overall Study||20
6607440|NCT02090413|7532672|FG002|NOT COMPLETED|Overall Study||23
6607441|NCT02090426|7532683|FG000|STARTED|Overall Study||401
6607442|NCT02090426|7532684|FG001|STARTED|Overall Study||399
6607443|NCT02090426|7532683|FG000|Analysis Population|Overall Study||389
6607444|NCT02090426|7532684|FG001|Analysis Population|Overall Study||393
6607445|NCT02090426|7532683|FG000|COMPLETED|Overall Study||389
6607446|NCT02090426|7532684|FG001|COMPLETED|Overall Study||393
6607447|NCT02090426|7532683|FG000|NOT COMPLETED|Overall Study||12
6607448|NCT02090426|7532684|FG001|NOT COMPLETED|Overall Study||6
6607449|NCT02090634|7532692|FG000|STARTED|Overall Study||30
6607450|NCT02090634|7532693|FG001|STARTED|Overall Study||28
6607451|NCT02090634|7532692|FG000|COMPLETED|Overall Study||25
6607452|NCT02090634|7532693|FG001|COMPLETED|Overall Study||25
6607453|NCT02090634|7532692|FG000|NOT COMPLETED|Overall Study||5
6607454|NCT02090634|7532693|FG001|NOT COMPLETED|Overall Study||3
6607455|NCT02090725|7532699|FG000|STARTED|Overall Study||4
6607456|NCT02090725|7532699|FG000|COMPLETED|Overall Study||0
6607457|NCT02090725|7532699|FG000|NOT COMPLETED|Overall Study||4
6607458|NCT02090764|7532705|FG000|STARTED|Overall Study||206
6607459|NCT02090764|7532706|FG001|STARTED|Overall Study||206
6607460|NCT02090764|7532705|FG000|COMPLETED|Overall Study||200
6607461|NCT02090764|7532706|FG001|COMPLETED|Overall Study||186
6607462|NCT02090764|7532705|FG000|NOT COMPLETED|Overall Study||6
6607463|NCT02090764|7532706|FG001|NOT COMPLETED|Overall Study||20
6607464|NCT02090777|7532712|FG000|STARTED|Overall Study||4
6607465|NCT02090777|7532712|FG000|COMPLETED|Overall Study||4
6607466|NCT02090777|7532712|FG000|NOT COMPLETED|Overall Study||0
6607467|NCT02090855|7532716|FG000|STARTED|Overall Study||108
6607468|NCT02090855|7532716|FG000|COMPLETED|Overall Study||106
6607469|NCT02090855|7532716|FG000|NOT COMPLETED|Overall Study||2
6607470|NCT02090894|7532723|FG000|STARTED|Overall Study||11
6607471|NCT02090894|7532723|FG000|COMPLETED|Overall Study||11
6607472|NCT02090894|7532723|FG000|NOT COMPLETED|Overall Study||0
6607473|NCT02090959|7532727|FG000|STARTED|Overall Study||219
6607474|NCT02090959|7532727|FG000|As-treated Population|Overall Study||218
6607475|NCT02090959|7532727|FG000|COMPLETED|Overall Study||68
6607476|NCT02090959|7532727|FG000|NOT COMPLETED|Overall Study||151
6607477|NCT02091089|7532731|FG000|STARTED|Overall Study||20
6607478|NCT02091089|7532731|FG000|COMPLETED|Overall Study||18
6607479|NCT02091089|7532731|FG000|NOT COMPLETED|Overall Study||2
6607480|NCT02091102|7532735|FG000|STARTED|Overall Study||20
6607481|NCT02091102|7532735|FG000|COMPLETED|Overall Study||20
6607482|NCT02091102|7532735|FG000|NOT COMPLETED|Overall Study||0
6607483|NCT02091167|7532741|FG000|STARTED|Overall Study||19
6607484|NCT02091167|7532742|FG001|STARTED|Overall Study||16
6607485|NCT02091167|7532741|FG000|COMPLETED|Overall Study||19
6607486|NCT02091167|7532742|FG001|COMPLETED|Overall Study||14
6607487|NCT02091167|7532741|FG000|NOT COMPLETED|Overall Study||0
6607488|NCT02091167|7532742|FG001|NOT COMPLETED|Overall Study||2
6607489|NCT02091206|7532752|FG000|STARTED|Treatment Period||10
6607490|NCT02091206|7532753|FG001|STARTED|Treatment Period||8
6607491|NCT02091206|7532754|FG002|STARTED|Treatment Period||9
6607492|NCT02091206|7532755|FG003|STARTED|Treatment Period||7
6607493|NCT02091206|7532752|FG000|Safety Analysis Set|Treatment Period||10
6607494|NCT02091206|7532753|FG001|Safety Analysis Set|Treatment Period||8
6607495|NCT02091206|7532754|FG002|Safety Analysis Set|Treatment Period||9
6607496|NCT02091206|7532755|FG003|Safety Analysis Set|Treatment Period||7
6607497|NCT02091206|7532752|FG000|COMPLETED|Treatment Period||10
6607498|NCT02091206|7532753|FG001|COMPLETED|Treatment Period||7
6607499|NCT02091206|7532754|FG002|COMPLETED|Treatment Period||8
6607500|NCT02091206|7532755|FG003|COMPLETED|Treatment Period||7
6607501|NCT02091206|7532752|FG000|NOT COMPLETED|Treatment Period||0
6607502|NCT02091206|7532753|FG001|NOT COMPLETED|Treatment Period||1
6607503|NCT02091206|7532754|FG002|NOT COMPLETED|Treatment Period||1
6607504|NCT02091206|7532755|FG003|NOT COMPLETED|Treatment Period||0
6607505|NCT02091206|7532752|FG000|STARTED|Taper Period||10
6607506|NCT02091206|7532753|FG001|STARTED|Taper Period||7
6607507|NCT02091206|7532754|FG002|STARTED|Taper Period||8
6607508|NCT02091206|7532755|FG003|STARTED|Taper Period||7
6607509|NCT02091206|7532752|FG000|COMPLETED|Taper Period||9
6607510|NCT02091206|7532753|FG001|COMPLETED|Taper Period||7
6607511|NCT02091206|7532754|FG002|COMPLETED|Taper Period||8
6607512|NCT02091206|7532755|FG003|COMPLETED|Taper Period||5
6607513|NCT02091206|7532752|FG000|NOT COMPLETED|Taper Period||1
6607514|NCT02091206|7532753|FG001|NOT COMPLETED|Taper Period||0
6607515|NCT02091206|7532754|FG002|NOT COMPLETED|Taper Period||0
6607516|NCT02091206|7532755|FG003|NOT COMPLETED|Taper Period||2
6607517|NCT02091284|7532767|FG000|STARTED|Overall Study|Two subjects from this group discontinued the protocol, data from one subject could not be included.|26
6607518|NCT02091284|7532768|FG001|STARTED|Overall Study|One subject from this group discontinued the protocol|23
6607519|NCT02091284|7532767|FG000|COMPLETED|Overall Study||23
6607520|NCT02091284|7532768|FG001|COMPLETED|Overall Study||22
6607521|NCT02091284|7532767|FG000|NOT COMPLETED|Overall Study||3
6607522|NCT02091284|7532768|FG001|NOT COMPLETED|Overall Study||1
6607523|NCT02091362|7532778|FG000|STARTED|Period 1||133
6607524|NCT02091362|7532779|FG001|STARTED|Period 1||137
6607525|NCT02091362|7532778|FG000|COMPLETED|Period 1||128
6607526|NCT02091362|7532779|FG001|COMPLETED|Period 1||133
6607527|NCT02091362|7532778|FG000|NOT COMPLETED|Period 1||5
6607528|NCT02091362|7532779|FG001|NOT COMPLETED|Period 1||4
6607529|NCT02091362|7532778|FG000|STARTED|Wash-out||128
6607530|NCT02091362|7532779|FG001|STARTED|Wash-out||133
6607531|NCT02091362|7532778|FG000|COMPLETED|Wash-out||127
6607532|NCT02091362|7532779|FG001|COMPLETED|Wash-out||130
6607533|NCT02091362|7532778|FG000|NOT COMPLETED|Wash-out||1
6607534|NCT02091362|7532779|FG001|NOT COMPLETED|Wash-out||3
6607535|NCT02091362|7532778|FG000|STARTED|Period 2||127
6607536|NCT02091362|7532779|FG001|STARTED|Period 2||130
6607537|NCT02091362|7532778|FG000|COMPLETED|Period 2||125
6607538|NCT02091362|7532779|FG001|COMPLETED|Period 2||128
6607539|NCT02091362|7532778|FG000|NOT COMPLETED|Period 2||2
6607540|NCT02091362|7532779|FG001|NOT COMPLETED|Period 2||2
6607541|NCT02091375|7532791|FG000|STARTED|Overall Study||61
6607542|NCT02091375|7532792|FG001|STARTED|Overall Study||59
6607543|NCT02091375|7532791|FG000|Safety Analysis Set|Overall Study||61
6607544|NCT02091375|7532792|FG001|Safety Analysis Set|Overall Study||59
6607545|NCT02091375|7532791|FG000|Intention to Treat (ITT) Analysis Set|Overall Study||61
6607546|NCT02091375|7532792|FG001|Intention to Treat (ITT) Analysis Set|Overall Study||59
6607547|NCT02091375|7532791|FG000|COMPLETED|Overall Study||52
6607548|NCT02091375|7532792|FG001|COMPLETED|Overall Study||56
6607549|NCT02091375|7532791|FG000|NOT COMPLETED|Overall Study||9
6607550|NCT02091375|7532792|FG001|NOT COMPLETED|Overall Study||3
6607551|NCT02091414|7532798|FG000|STARTED|Overall Study||36
6607552|NCT02091414|7532798|FG000|COMPLETED|Overall Study||32
6607553|NCT02091414|7532798|FG000|NOT COMPLETED|Overall Study||4
6607554|NCT02091440|7532802|FG000|STARTED|Overall Study||6
6607555|NCT02091440|7532802|FG000|Primary Endpoint (Success at 180 Days)|Overall Study||6
6607556|NCT02091440|7532802|FG000|Overall Survival at 180 Days|Overall Study||6
6607557|NCT02091440|7532802|FG000|COMPLETED|Overall Study||4
6607558|NCT02091440|7532802|FG000|NOT COMPLETED|Overall Study||2
6607559|NCT02091466|7532808|FG000|STARTED|Overall Study||20
6607560|NCT02091466|7532809|FG001|STARTED|Overall Study||20
6607561|NCT02091466|7532808|FG000|COMPLETED|Overall Study||20
6607562|NCT02091466|7532809|FG001|COMPLETED|Overall Study||20
6607563|NCT02091466|7532808|FG000|NOT COMPLETED|Overall Study||0
6607564|NCT02091466|7532809|FG001|NOT COMPLETED|Overall Study||0
6607565|NCT02091531|7532815|FG000|STARTED|Overall Study||9
6607566|NCT02091531|7532815|FG000|COMPLETED|Overall Study||9
6607567|NCT02091531|7532815|FG000|NOT COMPLETED|Overall Study||0
6607568|NCT02091726|7532819|FG000|STARTED|Overall Study||110
6607569|NCT02091726|7532819|FG000|1 Week Followup|Overall Study||110
6607570|NCT02091726|7532819|FG000|4 Week Followup|Overall Study||104
6607571|NCT02091726|7532819|FG000|COMPLETED|Overall Study||104
6607572|NCT02091726|7532819|FG000|NOT COMPLETED|Overall Study||6
6607573|NCT02091739|7532826|FG000|STARTED|MP: 16 Weeks||36
6607574|NCT02091739|7532827|FG001|STARTED|MP: 16 Weeks||74
6607575|NCT02091739|7532828|FG002|STARTED|MP: 16 Weeks||74
6607576|NCT02091739|7532829|FG003|STARTED|MP: 16 Weeks||0
6607577|NCT02091739|7532830|FG004|STARTED|MP: 16 Weeks||0
6607578|NCT02091739|7532826|FG000|COMPLETED|MP: 16 Weeks||32
6607579|NCT02091739|7532827|FG001|COMPLETED|MP: 16 Weeks||69
6607580|NCT02091739|7532828|FG002|COMPLETED|MP: 16 Weeks||72
6607581|NCT02091739|7532829|FG003|COMPLETED|MP: 16 Weeks||0
6607582|NCT02091739|7532830|FG004|COMPLETED|MP: 16 Weeks||0
6607583|NCT02091739|7532826|FG000|NOT COMPLETED|MP: 16 Weeks||4
6607584|NCT02091739|7532827|FG001|NOT COMPLETED|MP: 16 Weeks||5
6607585|NCT02091739|7532828|FG002|NOT COMPLETED|MP: 16 Weeks||2
6607586|NCT02091739|7532829|FG003|NOT COMPLETED|MP: 16 Weeks||0
6607587|NCT02091739|7532830|FG004|NOT COMPLETED|MP: 16 Weeks||0
6607588|NCT02091739|7532826|FG000|STARTED|EP: 48 Weeks||0
6607589|NCT02091739|7532827|FG001|STARTED|EP: 48 Weeks||0
6607590|NCT02091739|7532828|FG002|STARTED|EP: 48 Weeks||0
6607591|NCT02091739|7532829|FG003|STARTED|EP: 48 Weeks||84
6607592|NCT02091739|7532830|FG004|STARTED|EP: 48 Weeks||89
6607593|NCT02091739|7532826|FG000|COMPLETED|EP: 48 Weeks||0
6607594|NCT02091739|7532827|FG001|COMPLETED|EP: 48 Weeks||0
6607595|NCT02091739|7532828|FG002|COMPLETED|EP: 48 Weeks||0
6607596|NCT02091739|7532829|FG003|COMPLETED|EP: 48 Weeks||76
6607597|NCT02091739|7532830|FG004|COMPLETED|EP: 48 Weeks||75
6607598|NCT02091739|7532826|FG000|NOT COMPLETED|EP: 48 Weeks||0
6607599|NCT02091739|7532827|FG001|NOT COMPLETED|EP: 48 Weeks||0
6607600|NCT02091739|7532828|FG002|NOT COMPLETED|EP: 48 Weeks||0
6607601|NCT02091739|7532829|FG003|NOT COMPLETED|EP: 48 Weeks||8
6607602|NCT02091739|7532830|FG004|NOT COMPLETED|EP: 48 Weeks||14
6607603|NCT02091778|7532840|FG000|STARTED|Overall Study||21
6607604|NCT02091778|7532840|FG000|COMPLETED|Overall Study||20
6607605|NCT02091778|7532840|FG000|NOT COMPLETED|Overall Study||1
6607606|NCT02091856|7532847|FG000|STARTED|Active Intervention Interval||34
6607607|NCT02091856|7532848|FG001|STARTED|Active Intervention Interval||19
6607608|NCT02091856|7532849|FG002|STARTED|Active Intervention Interval||26
6607609|NCT02091856|7532847|FG000|COMPLETED|Active Intervention Interval||15
6607610|NCT02091856|7532848|FG001|COMPLETED|Active Intervention Interval||12
6607611|NCT02091856|7532849|FG002|COMPLETED|Active Intervention Interval||19
6607612|NCT02091856|7532847|FG000|NOT COMPLETED|Active Intervention Interval||19
6607613|NCT02091856|7532848|FG001|NOT COMPLETED|Active Intervention Interval||7
6607614|NCT02091856|7532849|FG002|NOT COMPLETED|Active Intervention Interval||7
6607615|NCT02091856|7532847|FG000|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
6607616|NCT02091856|7532848|FG001|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
6607617|NCT02091856|7532849|FG002|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
6607618|NCT02091856|7532847|FG000|COMPLETED|Follow-up Assessment||10
6607619|NCT02091856|7532848|FG001|COMPLETED|Follow-up Assessment||9
6607620|NCT02091856|7532849|FG002|COMPLETED|Follow-up Assessment||0
6607621|NCT02091856|7532847|FG000|NOT COMPLETED|Follow-up Assessment||5
6607622|NCT02091856|7532848|FG001|NOT COMPLETED|Follow-up Assessment||3
6607623|NCT02091856|7532849|FG002|NOT COMPLETED|Follow-up Assessment||0
6607624|NCT02091869|7532859|FG000|STARTED|Overall Study||17
6607625|NCT02091869|7532860|FG001|STARTED|Overall Study||17
6607626|NCT02091869|7532859|FG000|COMPLETED|Overall Study||17
6607627|NCT02091869|7532860|FG001|COMPLETED|Overall Study||14
6607628|NCT02091869|7532859|FG000|NOT COMPLETED|Overall Study||0
6607629|NCT02091869|7532860|FG001|NOT COMPLETED|Overall Study||3
6607630|NCT02091882|7532866|FG000|STARTED|Overall Study||30
6607631|NCT02091882|7532866|FG000|COMPLETED|Overall Study||30
6607632|NCT02091882|7532866|FG000|NOT COMPLETED|Overall Study||0
6607633|NCT02091921|7532870|FG000|STARTED|Overall Study||53
6607634|NCT02091921|7532870|FG000|COMPLETED|Overall Study||50
6607635|NCT02091921|7532870|FG000|NOT COMPLETED|Overall Study||3
6607636|NCT02091986|7532880|FG000|STARTED|Overall Study||92
6607637|NCT02091986|7532881|FG001|STARTED|Overall Study||95
6607638|NCT02091986|7532882|FG002|STARTED|Overall Study||92
6607639|NCT02091986|7532880|FG000|COMPLETED|Overall Study||85
6607640|NCT02091986|7532881|FG001|COMPLETED|Overall Study||84
6607641|NCT02091986|7532882|FG002|COMPLETED|Overall Study||84
6607642|NCT02091986|7532880|FG000|NOT COMPLETED|Overall Study||7
6607643|NCT02091986|7532881|FG001|NOT COMPLETED|Overall Study||11
6607644|NCT02091986|7532882|FG002|NOT COMPLETED|Overall Study||8
6607645|NCT02092025|7532890|FG000|STARTED|Overall Study||3437
6607646|NCT02092025|7532890|FG000|COMPLETED|Overall Study||3369
6607647|NCT02092025|7532890|FG000|NOT COMPLETED|Overall Study||68
6607648|NCT02092116|7532896|FG000|STARTED|Overall Study||6
6607649|NCT02092116|7532897|FG001|STARTED|Overall Study||20
6607650|NCT02092116|7532896|FG000|COMPLETED|Overall Study||6
6607651|NCT02092116|7532897|FG001|COMPLETED|Overall Study||16
6607652|NCT02092116|7532896|FG000|NOT COMPLETED|Overall Study||0
6607653|NCT02092116|7532897|FG001|NOT COMPLETED|Overall Study||4
6607654|NCT02092168|7532905|FG000|STARTED|Overall Study||12
6607655|NCT02092168|7532906|FG001|STARTED|Overall Study||12
6607656|NCT02092168|7532905|FG000|COMPLETED|Overall Study||12
6607657|NCT02092168|7532906|FG001|COMPLETED|Overall Study||12
6607658|NCT02092168|7532905|FG000|NOT COMPLETED|Overall Study||0
6607659|NCT02092168|7532906|FG001|NOT COMPLETED|Overall Study||0
6607660|NCT02092181|7532914|FG000|STARTED|Overall Study||15
6607661|NCT02092181|7532915|FG001|STARTED|Overall Study||15
6607662|NCT02092181|7532914|FG000|COMPLETED|Overall Study||12
6607663|NCT02092181|7532915|FG001|COMPLETED|Overall Study||14
6607664|NCT02092181|7532914|FG000|NOT COMPLETED|Overall Study||3
6607665|NCT02092181|7532915|FG001|NOT COMPLETED|Overall Study||1
6607666|NCT02092220|7532921|FG000|STARTED|Period 1||21
6607667|NCT02092220|7532922|FG001|STARTED|Period 1||22
6607668|NCT02092220|7532921|FG000|COMPLETED|Period 1||21
6607669|NCT02092220|7532922|FG001|COMPLETED|Period 1||20
6607670|NCT02092220|7532921|FG000|NOT COMPLETED|Period 1||0
6607671|NCT02092220|7532922|FG001|NOT COMPLETED|Period 1||2
6607672|NCT02092220|7532921|FG000|STARTED|Period 2||21
6607673|NCT02092220|7532922|FG001|STARTED|Period 2||20
6607674|NCT02092220|7532921|FG000|COMPLETED|Period 2||20
6607675|NCT02092220|7532922|FG001|COMPLETED|Period 2||19
6607676|NCT02092220|7532921|FG000|NOT COMPLETED|Period 2||1
6607677|NCT02092220|7532922|FG001|NOT COMPLETED|Period 2||1
6607678|NCT02092285|7532930|FG000|STARTED|Induction Phase||205
6607679|NCT02092285|7532930|FG000|COMPLETED|Induction Phase||170
6607680|NCT02092285|7532930|FG000|NOT COMPLETED|Induction Phase||35
6607681|NCT02092285|7532930|FG000|STARTED|Maintenance Phase & Follow-up||170
6607682|NCT02092285|7532930|FG000|COMPLETED|Maintenance Phase & Follow-up||60
6607683|NCT02092285|7532930|FG000|NOT COMPLETED|Maintenance Phase & Follow-up||110
6607684|NCT02092298|7532934|FG000|STARTED|Overall Study||19
6607685|NCT02092298|7532934|FG000|COMPLETED|Overall Study||19
6607686|NCT02092298|7532934|FG000|NOT COMPLETED|Overall Study||0
6607687|NCT02092311|7532940|FG000|STARTED|Overall Study||285
6607688|NCT02092311|7532941|FG001|STARTED|Overall Study||285
6607689|NCT02092311|7532940|FG000|COMPLETED|Overall Study||285
6607690|NCT02092311|7532941|FG001|COMPLETED|Overall Study||285
6607691|NCT02092311|7532940|FG000|NOT COMPLETED|Overall Study||0
6607692|NCT02092311|7532941|FG001|NOT COMPLETED|Overall Study||0
6607693|NCT02092324|7532949|FG000|STARTED|Overall Study||51
6607694|NCT02092324|7532949|FG000|End of Cycle 6|Overall Study|This study has an accrual goal of 25 evaluable subjects who reach cycle 7, week 1.|25
6607695|NCT02092324|7532949|FG000|Wildtype CSF3R|Overall Study||23
6607696|NCT02092324|7532949|FG000|Mutant CSF3R|Overall Study||26
6607697|NCT02092324|7532949|FG000|COMPLETED|Overall Study||32
6607698|NCT02092324|7532949|FG000|NOT COMPLETED|Overall Study||19
6607699|NCT02092350|7532958|FG000|STARTED|Overall Study||123
6607700|NCT02092350|7532959|FG001|STARTED|Overall Study||114
6607701|NCT02092350|7532958|FG000|COMPLETED|Overall Study||113
6607702|NCT02092350|7532959|FG001|COMPLETED|Overall Study||102
6607703|NCT02092350|7532958|FG000|NOT COMPLETED|Overall Study||10
6607704|NCT02092350|7532959|FG001|NOT COMPLETED|Overall Study||12
6607705|NCT02092389|7532967|FG000|STARTED|Overall Study||10
6607706|NCT02092389|7532967|FG000|COMPLETED|Overall Study||4
6607707|NCT02092389|7532967|FG000|NOT COMPLETED|Overall Study||6
6607708|NCT02092415|7532971|FG000|STARTED|Overall Study||10
6607709|NCT02092415|7532971|FG000|COMPLETED|Overall Study||10
6607710|NCT02092415|7532971|FG000|NOT COMPLETED|Overall Study||0
6607711|NCT02092441|7532978|FG000|STARTED|Overall Study||37
6607712|NCT02092441|7532979|FG001|STARTED|Overall Study||43
6607713|NCT02092441|7532978|FG000|COMPLETED|Overall Study||37
6607714|NCT02092441|7532979|FG001|COMPLETED|Overall Study||43
6607715|NCT02092441|7532978|FG000|NOT COMPLETED|Overall Study||0
6607716|NCT02092441|7532979|FG001|NOT COMPLETED|Overall Study||0
6607717|NCT02092467|7532988|FG000|STARTED|Overall Study||1457
6607718|NCT02092467|7532989|FG001|STARTED|Overall Study||1457
6607719|NCT02092467|7532990|FG002|STARTED|Overall Study||1458
6607720|NCT02092467|7532988|FG000|Treated|Overall Study||1455
6607721|NCT02092467|7532989|FG001|Treated|Overall Study||1456
6607722|NCT02092467|7532990|FG002|Treated|Overall Study||1451
6607723|NCT02092467|7532988|FG000|COMPLETED|Overall Study||1053
6607724|NCT02092467|7532989|FG001|COMPLETED|Overall Study||998
6607725|NCT02092467|7532990|FG002|COMPLETED|Overall Study||1060
6607726|NCT02092467|7532988|FG000|NOT COMPLETED|Overall Study||404
6607727|NCT02092467|7532989|FG001|NOT COMPLETED|Overall Study||459
6607728|NCT02092467|7532990|FG002|NOT COMPLETED|Overall Study||398
6607729|NCT02092610|7533002|FG000|STARTED|Overall Study||25
6607730|NCT02092610|7533003|FG001|STARTED|Overall Study||52
6607731|NCT02092610|7533002|FG000|COMPLETED|Overall Study||17
6607732|NCT02092610|7533003|FG001|COMPLETED|Overall Study||40
6607733|NCT02092610|7533002|FG000|NOT COMPLETED|Overall Study||8
6607734|NCT02092610|7533003|FG001|NOT COMPLETED|Overall Study||12
6607735|NCT02092649|7533011|FG000|STARTED|Overall Study|13 participants recruited|13
6607736|NCT02092649|7533012|FG001|STARTED|Overall Study|13 participants recruited|13
6607737|NCT02092649|7533011|FG000|COMPLETED|Overall Study|13 participants finished study|13
6607738|NCT02092649|7533012|FG001|COMPLETED|Overall Study|13 participants finished study|13
6607739|NCT02092649|7533011|FG000|NOT COMPLETED|Overall Study||0
6607740|NCT02092649|7533012|FG001|NOT COMPLETED|Overall Study||0
6607741|NCT02092662|7533020|FG000|STARTED|Overall Study||38
6607742|NCT02092662|7533021|FG001|STARTED|Overall Study||19
6607743|NCT02092662|7533020|FG000|Recruited|Overall Study||38
6607744|NCT02092662|7533021|FG001|Recruited|Overall Study||19
6607745|NCT02092662|7533020|FG000|COMPLETED|Overall Study||25
6607746|NCT02092662|7533021|FG001|COMPLETED|Overall Study||19
6607747|NCT02092662|7533020|FG000|NOT COMPLETED|Overall Study||13
6607748|NCT02092662|7533021|FG001|NOT COMPLETED|Overall Study||0
6607749|NCT02092857|7533031|FG000|STARTED|Overall Study||30
6607750|NCT02092857|7533032|FG001|STARTED|Overall Study||30
6607751|NCT02092857|7533033|FG002|STARTED|Overall Study||29
6607752|NCT02092857|7533031|FG000|COMPLETED|Overall Study||20
6607753|NCT02092857|7533032|FG001|COMPLETED|Overall Study||18
6607754|NCT02092857|7533033|FG002|COMPLETED|Overall Study||16
6607755|NCT02092857|7533031|FG000|NOT COMPLETED|Overall Study||10
6607756|NCT02092857|7533032|FG001|NOT COMPLETED|Overall Study||12
6607757|NCT02092857|7533033|FG002|NOT COMPLETED|Overall Study||13
6607758|NCT02092909|7533045|FG000|STARTED|Overall Study||6
6607759|NCT02092909|7533046|FG001|STARTED|Overall Study||5
6607760|NCT02092909|7533047|FG002|STARTED|Overall Study||14
6607761|NCT02092909|7533048|FG003|STARTED|Overall Study||6
6607762|NCT02092909|7533045|FG000|COMPLETED|Overall Study||5
6607763|NCT02092909|7533046|FG001|COMPLETED|Overall Study||2
6607764|NCT02092909|7533047|FG002|COMPLETED|Overall Study||5
6607765|NCT02092909|7533048|FG003|COMPLETED|Overall Study||0
6607766|NCT02092909|7533045|FG000|NOT COMPLETED|Overall Study||1
6607767|NCT02092909|7533046|FG001|NOT COMPLETED|Overall Study||3
6607768|NCT02092909|7533047|FG002|NOT COMPLETED|Overall Study||9
6607769|NCT02092909|7533048|FG003|NOT COMPLETED|Overall Study||6
6607770|NCT02092961|7533061|FG000|STARTED|Overall Study|Patients who received treatment|33
6607771|NCT02092961|7533062|FG001|STARTED|Overall Study|Patients who received treatment|28
6607772|NCT02092961|7533063|FG002|STARTED|Overall Study|Patients who received treatment|29
6607773|NCT02092961|7533061|FG000|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
6607774|NCT02092961|7533062|FG001|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
6607775|NCT02092961|7533063|FG002|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
6607776|NCT02092961|7533061|FG000|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
6607777|NCT02092961|7533062|FG001|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
6607778|NCT02092961|7533063|FG002|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
6607779|NCT02092961|7533061|FG000|NOT COMPLETED|Overall Study||21
6607780|NCT02092961|7533062|FG001|NOT COMPLETED|Overall Study||14
6607781|NCT02092961|7533063|FG002|NOT COMPLETED|Overall Study||16
6607782|NCT02092987|7533074|FG000|STARTED|Overall Study||110
6607783|NCT02092987|7533075|FG001|STARTED|Overall Study||111
6607784|NCT02092987|7533074|FG000|COMPLETED|Overall Study||106
6607785|NCT02092987|7533075|FG001|COMPLETED|Overall Study||103
6607786|NCT02092987|7533074|FG000|NOT COMPLETED|Overall Study||4
6607787|NCT02092987|7533075|FG001|NOT COMPLETED|Overall Study||8
6607788|NCT02093026|7533084|FG000|STARTED|Overall Study||465
6607789|NCT02093026|7533084|FG000|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
6607790|NCT02093026|7533084|FG000|NOT COMPLETED|Overall Study||193
6607791|NCT02093221|7533094|FG000|STARTED|Overall Study||15
6607792|NCT02093221|7533095|FG001|STARTED|Overall Study||16
6607793|NCT02093221|7533096|FG002|STARTED|Overall Study||15
6607794|NCT02093221|7533097|FG003|STARTED|Overall Study||15
6607795|NCT02093221|7533098|FG004|STARTED|Overall Study||15
6607796|NCT02093221|7533094|FG000|COMPLETED|Overall Study||5
6607797|NCT02093221|7533095|FG001|COMPLETED|Overall Study||8
6607798|NCT02093221|7533096|FG002|COMPLETED|Overall Study||6
6607799|NCT02093221|7533097|FG003|COMPLETED|Overall Study||7
6607800|NCT02093221|7533098|FG004|COMPLETED|Overall Study||7
6607801|NCT02093221|7533094|FG000|NOT COMPLETED|Overall Study||10
6607802|NCT02093221|7533095|FG001|NOT COMPLETED|Overall Study||8
6607803|NCT02093221|7533096|FG002|NOT COMPLETED|Overall Study||9
6607804|NCT02093221|7533097|FG003|NOT COMPLETED|Overall Study||8
6607805|NCT02093221|7533098|FG004|NOT COMPLETED|Overall Study||8
6607806|NCT02093234|7533113|FG000|STARTED|Overall Study||56
6607807|NCT02093234|7533114|FG001|STARTED|Overall Study||56
6607808|NCT02093234|7533115|FG002|STARTED|Overall Study||54
6607809|NCT02093234|7533113|FG000|COMPLETED|Overall Study||53
6607810|NCT02093234|7533114|FG001|COMPLETED|Overall Study||52
6607811|NCT02093234|7533115|FG002|COMPLETED|Overall Study||50
6607812|NCT02093234|7533113|FG000|NOT COMPLETED|Overall Study||3
6607813|NCT02093234|7533114|FG001|NOT COMPLETED|Overall Study||4
6607814|NCT02093234|7533115|FG002|NOT COMPLETED|Overall Study||4
6607815|NCT02093351|7533126|FG000|STARTED|Part A||30
6607816|NCT02093351|7533127|FG001|STARTED|Part A||23
6607817|NCT02093351|7533128|FG002|STARTED|Part A||26
6607818|NCT02093351|7533129|FG003|STARTED|Part A||0
6607819|NCT02093351|7533126|FG000|Completing Treatment Period 1|Part A||29
6607820|NCT02093351|7533127|FG001|Completing Treatment Period 1|Part A||22
6607821|NCT02093351|7533128|FG002|Completing Treatment Period 1|Part A||23
6607822|NCT02093351|7533129|FG003|Completing Treatment Period 1|Part A||0
6607823|NCT02093351|7533126|FG000|Completing Treatment Period 2|Part A||29
6607824|NCT02093351|7533127|FG001|Completing Treatment Period 2|Part A||21
6607825|NCT02093351|7533128|FG002|Completing Treatment Period 2|Part A||23
6607826|NCT02093351|7533129|FG003|Completing Treatment Period 2|Part A||0
6607827|NCT02093351|7533126|FG000|Completing Treatment Period 3|Part A||28
6607828|NCT02093351|7533127|FG001|Completing Treatment Period 3|Part A||21
6607829|NCT02093351|7533128|FG002|Completing Treatment Period 3|Part A||23
6607830|NCT02093351|7533129|FG003|Completing Treatment Period 3|Part A||0
6607831|NCT02093351|7533126|FG000|COMPLETED|Part A||28
6607832|NCT02093351|7533127|FG001|COMPLETED|Part A||21
6607833|NCT02093351|7533128|FG002|COMPLETED|Part A||23
6607834|NCT02093351|7533129|FG003|COMPLETED|Part A||0
6607835|NCT02093351|7533126|FG000|NOT COMPLETED|Part A||2
6607836|NCT02093351|7533127|FG001|NOT COMPLETED|Part A||2
6607837|NCT02093351|7533128|FG002|NOT COMPLETED|Part A||3
6607838|NCT02093351|7533129|FG003|NOT COMPLETED|Part A||0
6607839|NCT02093351|7533126|FG000|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
6607840|NCT02093351|7533127|FG001|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
6607841|NCT02093351|7533128|FG002|STARTED|Part B|Only the Olaparib (Part B) arm is applicable for this period.|0
6607842|NCT02093351|7533129|FG003|STARTED|Part B|Eligible patients completing Part A entered Part B for continued access to olaparib.|69
6607843|NCT02093351|7533126|FG000|COMPLETED|Part B||0
6607844|NCT02093351|7533127|FG001|COMPLETED|Part B||0
6607845|NCT02093351|7533128|FG002|COMPLETED|Part B||0
6607846|NCT02093351|7533129|FG003|COMPLETED|Part B||6
6607847|NCT02093351|7533126|FG000|NOT COMPLETED|Part B||0
6607848|NCT02093351|7533127|FG001|NOT COMPLETED|Part B||0
6607849|NCT02093351|7533128|FG002|NOT COMPLETED|Part B||0
6607850|NCT02093351|7533129|FG003|NOT COMPLETED|Part B||63
6607851|NCT02093390|7533146|FG000|STARTED|Overall Study||20
6607852|NCT02093390|7533147|FG001|STARTED|Overall Study||20
6607853|NCT02093390|7533146|FG000|COMPLETED|Overall Study||20
6607854|NCT02093390|7533147|FG001|COMPLETED|Overall Study||19
6607855|NCT02093390|7533146|FG000|NOT COMPLETED|Overall Study||0
6607856|NCT02093390|7533147|FG001|NOT COMPLETED|Overall Study||1
6607857|NCT02093520|7533156|FG000|STARTED|Overall Study||149
6607858|NCT02093520|7533157|FG001|STARTED|Overall Study||153
6607859|NCT02093520|7533156|FG000|COMPLETED|Overall Study||143
6607860|NCT02093520|7533157|FG001|COMPLETED|Overall Study||131
6607861|NCT02093520|7533156|FG000|NOT COMPLETED|Overall Study||6
6607862|NCT02093520|7533157|FG001|NOT COMPLETED|Overall Study||22
6607863|NCT02093663|7533163|FG000|STARTED|Double Blind Acute Phase (8 Weeks)||27
6607864|NCT02093663|7533164|FG001|STARTED|Double Blind Acute Phase (8 Weeks)||26
6607865|NCT02093663|7533165|FG002|STARTED|Double Blind Acute Phase (8 Weeks)||0
6607866|NCT02093663|7533166|FG003|STARTED|Double Blind Acute Phase (8 Weeks)||0
6607867|NCT02093663|7533167|FG004|STARTED|Double Blind Acute Phase (8 Weeks)||0
6607868|NCT02093663|7533163|FG000|COMPLETED|Double Blind Acute Phase (8 Weeks)||19
6607869|NCT02093663|7533164|FG001|COMPLETED|Double Blind Acute Phase (8 Weeks)||22
6607870|NCT02093663|7533165|FG002|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607871|NCT02093663|7533166|FG003|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607872|NCT02093663|7533167|FG004|COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607873|NCT02093663|7533163|FG000|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||8
6607874|NCT02093663|7533164|FG001|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||4
6607875|NCT02093663|7533165|FG002|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607876|NCT02093663|7533166|FG003|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607877|NCT02093663|7533167|FG004|NOT COMPLETED|Double Blind Acute Phase (8 Weeks)||0
6607878|NCT02093663|7533163|FG000|STARTED|Open Label Acute Phase (8 Weeks)||0
6607879|NCT02093663|7533164|FG001|STARTED|Open Label Acute Phase (8 Weeks)||0
6607880|NCT02093663|7533165|FG002|STARTED|Open Label Acute Phase (8 Weeks)||18
6607881|NCT02093663|7533166|FG003|STARTED|Open Label Acute Phase (8 Weeks)||0
6607882|NCT02093663|7533167|FG004|STARTED|Open Label Acute Phase (8 Weeks)||0
6607883|NCT02093663|7533163|FG000|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
6607884|NCT02093663|7533164|FG001|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
6607885|NCT02093663|7533165|FG002|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||18
6607886|NCT02093663|7533166|FG003|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
6607887|NCT02093663|7533167|FG004|Participants Entered OLA Via DBA|Open Label Acute Phase (8 Weeks)||0
6607888|NCT02093663|7533163|FG000|COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607889|NCT02093663|7533164|FG001|COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607890|NCT02093663|7533165|FG002|COMPLETED|Open Label Acute Phase (8 Weeks)||12
6607891|NCT02093663|7533166|FG003|COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607892|NCT02093663|7533167|FG004|COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607893|NCT02093663|7533163|FG000|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607894|NCT02093663|7533164|FG001|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607895|NCT02093663|7533165|FG002|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||6
6607896|NCT02093663|7533166|FG003|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607897|NCT02093663|7533167|FG004|NOT COMPLETED|Open Label Acute Phase (8 Weeks)||0
6607898|NCT02093663|7533163|FG000|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
6607899|NCT02093663|7533164|FG001|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
6607900|NCT02093663|7533165|FG002|STARTED|Double Blind Maintenance Phase(26 Weeks)||0
6607901|NCT02093663|7533166|FG003|STARTED|Double Blind Maintenance Phase(26 Weeks)||42
6607902|NCT02093663|7533167|FG004|STARTED|Double Blind Maintenance Phase(26 Weeks)||45
6607903|NCT02093663|7533163|FG000|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
6607904|NCT02093663|7533164|FG001|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
6607905|NCT02093663|7533165|FG002|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||0
6607906|NCT02093663|7533166|FG003|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
6607907|NCT02093663|7533167|FG004|Participants Entered Directly to DBM|Double Blind Maintenance Phase(26 Weeks)||26
6607908|NCT02093663|7533163|FG000|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
6607909|NCT02093663|7533164|FG001|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
6607910|NCT02093663|7533165|FG002|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||0
6607911|NCT02093663|7533166|FG003|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||12
6607912|NCT02093663|7533167|FG004|Participants Entered DBM Via DBA|Double Blind Maintenance Phase(26 Weeks)||15
6607913|NCT02093663|7533163|FG000|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
6607914|NCT02093663|7533164|FG001|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
6607915|NCT02093663|7533165|FG002|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||0
6607916|NCT02093663|7533166|FG003|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
6607917|NCT02093663|7533167|FG004|Participants Entered DBM Via OLA|Double Blind Maintenance Phase(26 Weeks)||4
6607918|NCT02093663|7533163|FG000|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6607919|NCT02093663|7533164|FG001|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6607920|NCT02093663|7533165|FG002|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6607921|NCT02093663|7533166|FG003|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||32
6607922|NCT02093663|7533167|FG004|COMPLETED|Double Blind Maintenance Phase(26 Weeks)||34
6607923|NCT02093663|7533163|FG000|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6607924|NCT02093663|7533164|FG001|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6607925|NCT02093663|7533165|FG002|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||0
6607926|NCT02093663|7533166|FG003|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||10
6607927|NCT02093663|7533167|FG004|NOT COMPLETED|Double Blind Maintenance Phase(26 Weeks)||11
6607928|NCT02093702|7533186|FG000|STARTED|Overall Study||2
6607929|NCT02093702|7533187|FG001|STARTED|Overall Study||3
6607930|NCT02093702|7533186|FG000|COMPLETED|Overall Study||2
6607931|NCT02093702|7533187|FG001|COMPLETED|Overall Study||3
6607932|NCT02093702|7533186|FG000|NOT COMPLETED|Overall Study||0
6607933|NCT02093702|7533187|FG001|NOT COMPLETED|Overall Study||0
6607934|NCT02093793|7533197|FG000|STARTED|Overall Study||98
6607935|NCT02093793|7533198|FG001|STARTED|Overall Study||90
6607936|NCT02093793|7533199|FG002|STARTED|Overall Study||68
6607937|NCT02093793|7533197|FG000|COMPLETED|Overall Study||91
6607938|NCT02093793|7533198|FG001|COMPLETED|Overall Study||80
6607939|NCT02093793|7533199|FG002|COMPLETED|Overall Study||65
6607940|NCT02093793|7533197|FG000|NOT COMPLETED|Overall Study||7
6607941|NCT02093793|7533198|FG001|NOT COMPLETED|Overall Study||10
6607942|NCT02093793|7533199|FG002|NOT COMPLETED|Overall Study||3
6607943|NCT02093819|7533215|FG000|STARTED|Overall Study||15
6607944|NCT02093819|7533216|FG001|STARTED|Overall Study||6
6607945|NCT02093819|7533217|FG002|STARTED|Overall Study||10
6607946|NCT02093819|7533218|FG003|STARTED|Overall Study||6
6607947|NCT02093819|7533219|FG004|STARTED|Overall Study||6
6607948|NCT02093819|7533220|FG005|STARTED|Overall Study||6
6607949|NCT02093819|7533221|FG006|STARTED|Overall Study||5
6607950|NCT02093819|7533222|FG007|STARTED|Overall Study||6
6607951|NCT02093819|7533215|FG000|COMPLETED|Overall Study||15
6607952|NCT02093819|7533216|FG001|COMPLETED|Overall Study||6
6607953|NCT02093819|7533217|FG002|COMPLETED|Overall Study||10
6607954|NCT02093819|7533218|FG003|COMPLETED|Overall Study||6
6607955|NCT02093819|7533219|FG004|COMPLETED|Overall Study||6
6607956|NCT02093819|7533220|FG005|COMPLETED|Overall Study||6
6607957|NCT02093819|7533221|FG006|COMPLETED|Overall Study||5
6607958|NCT02093819|7533222|FG007|COMPLETED|Overall Study||6
6607959|NCT02093819|7533215|FG000|NOT COMPLETED|Overall Study||0
6607960|NCT02093819|7533216|FG001|NOT COMPLETED|Overall Study||0
6607961|NCT02093819|7533217|FG002|NOT COMPLETED|Overall Study||0
6607962|NCT02093819|7533218|FG003|NOT COMPLETED|Overall Study||0
6607963|NCT02093819|7533219|FG004|NOT COMPLETED|Overall Study||0
6607964|NCT02093819|7533220|FG005|NOT COMPLETED|Overall Study||0
6607965|NCT02093819|7533221|FG006|NOT COMPLETED|Overall Study||0
6607966|NCT02093819|7533222|FG007|NOT COMPLETED|Overall Study||0
6607967|NCT02093897|7533249|FG000|STARTED|Overall Study||84
6607968|NCT02093897|7533249|FG000|COMPLETED|Overall Study||65
6607969|NCT02093897|7533249|FG000|NOT COMPLETED|Overall Study||19
6607970|NCT02093923|7533265|FG000|STARTED|Overall Study||4
6607971|NCT02093923|7533266|FG001|STARTED|Overall Study||4
6607972|NCT02093923|7533267|FG002|STARTED|Overall Study||5
6607973|NCT02093923|7533268|FG003|STARTED|Overall Study||12
6607974|NCT02093923|7533269|FG004|STARTED|Overall Study||13
6607975|NCT02093923|7533265|FG000|Total Treated|Overall Study||4
6607976|NCT02093923|7533266|FG001|Total Treated|Overall Study||4
6607977|NCT02093923|7533267|FG002|Total Treated|Overall Study||5
6607978|NCT02093923|7533268|FG003|Total Treated|Overall Study||11
6607979|NCT02093923|7533269|FG004|Total Treated|Overall Study||13
6607980|NCT02093923|7533265|FG000|Treated - 1 Dose Only:|Overall Study||0
6607981|NCT02093923|7533266|FG001|Treated - 1 Dose Only:|Overall Study||0
6607982|NCT02093923|7533267|FG002|Treated - 1 Dose Only:|Overall Study||0
6607983|NCT02093923|7533268|FG003|Treated - 1 Dose Only:|Overall Study||1
6607984|NCT02093923|7533269|FG004|Treated - 1 Dose Only:|Overall Study||0
6607985|NCT02093923|7533265|FG000|Treated - 2 Doses:|Overall Study||4
6607986|NCT02093923|7533266|FG001|Treated - 2 Doses:|Overall Study||4
6607987|NCT02093923|7533267|FG002|Treated - 2 Doses:|Overall Study||5
6607988|NCT02093923|7533268|FG003|Treated - 2 Doses:|Overall Study||10
6607989|NCT02093923|7533269|FG004|Treated - 2 Doses:|Overall Study||13
6607990|NCT02093923|7533265|FG000|COMPLETED|Overall Study||4
6607991|NCT02093923|7533266|FG001|COMPLETED|Overall Study||4
6607992|NCT02093923|7533267|FG002|COMPLETED|Overall Study||5
6607993|NCT02093923|7533268|FG003|COMPLETED|Overall Study||10
6607994|NCT02093923|7533269|FG004|COMPLETED|Overall Study||13
6607995|NCT02093923|7533265|FG000|NOT COMPLETED|Overall Study||0
6607996|NCT02093923|7533266|FG001|NOT COMPLETED|Overall Study||0
6607997|NCT02093923|7533267|FG002|NOT COMPLETED|Overall Study||0
6607998|NCT02093923|7533268|FG003|NOT COMPLETED|Overall Study||2
6607999|NCT02093923|7533269|FG004|NOT COMPLETED|Overall Study||0
6608000|NCT02093949|7533287|FG000|STARTED|Overall Study||105
6608001|NCT02093949|7533288|FG001|STARTED|Overall Study||47
6608002|NCT02093949|7533287|FG000|COMPLETED|Overall Study||105
6608003|NCT02093949|7533288|FG001|COMPLETED|Overall Study||47
6608004|NCT02093949|7533287|FG000|NOT COMPLETED|Overall Study||0
6608005|NCT02093949|7533288|FG001|NOT COMPLETED|Overall Study||0
6608006|NCT02093962|7533304|FG000|STARTED|Overall Study||134
6608007|NCT02093962|7533305|FG001|STARTED|Overall Study||131
6608008|NCT02093962|7533304|FG000|Received Treatment|Overall Study||130
6608009|NCT02093962|7533305|FG001|Received Treatment|Overall Study||130
6608010|NCT02093962|7533304|FG000|COMPLETED|Overall Study||0
6608011|NCT02093962|7533305|FG001|COMPLETED|Overall Study||0
6608012|NCT02093962|7533304|FG000|NOT COMPLETED|Overall Study||134
6608013|NCT02093962|7533305|FG001|NOT COMPLETED|Overall Study||131
6608014|NCT02094118|7533313|FG000|STARTED|Overall Study||85
6608015|NCT02094118|7533314|FG001|STARTED|Overall Study||86
6608016|NCT02094118|7533313|FG000|COMPLETED|Overall Study||73
6608017|NCT02094118|7533314|FG001|COMPLETED|Overall Study||81
6608018|NCT02094118|7533313|FG000|NOT COMPLETED|Overall Study||12
6608019|NCT02094118|7533314|FG001|NOT COMPLETED|Overall Study||5
6625319|NCT02224560|7552987|FG001|Safety Analysis Set|Overall Study|Six participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group.|67
6625320|NCT02224560|7552988|FG002|Safety Analysis Set|Overall Study||76
6625321|NCT02224560|7552986|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||76
6625322|NCT02224560|7552987|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||73
6625323|NCT02224560|7552988|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||76
6625324|NCT02224560|7552986|FG000|COMPLETED|Overall Study||67
6625325|NCT02224560|7552987|FG001|COMPLETED|Overall Study||71
6625326|NCT02224560|7552988|FG002|COMPLETED|Overall Study||74
6625327|NCT02224560|7552986|FG000|NOT COMPLETED|Overall Study||9
6625328|NCT02224560|7552987|FG001|NOT COMPLETED|Overall Study||2
6625329|NCT02224560|7552988|FG002|NOT COMPLETED|Overall Study||2
6625330|NCT02224612|7552996|FG000|STARTED|Overall Study||48
6625331|NCT02224612|7552997|FG001|STARTED|Overall Study||48
6625332|NCT02224612|7552996|FG000|COMPLETED|Overall Study||48
6625333|NCT02224612|7552997|FG001|COMPLETED|Overall Study||48
6625334|NCT02224612|7552996|FG000|NOT COMPLETED|Overall Study||0
6625335|NCT02224612|7552997|FG001|NOT COMPLETED|Overall Study||0
6625336|NCT02224625|7553005|FG000|STARTED|Irritation||39
6625337|NCT02224625|7553005|FG000|COMPLETED|Irritation||33
6625338|NCT02224625|7553005|FG000|NOT COMPLETED|Irritation||6
6625339|NCT02224625|7553005|FG000|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
6625340|NCT02224625|7553005|FG000|COMPLETED|Sensitization||194
6625341|NCT02224625|7553005|FG000|NOT COMPLETED|Sensitization||55
6625342|NCT02224638|7553019|FG000|STARTED|Overall Study||11
6625343|NCT02224638|7553020|FG001|STARTED|Overall Study||10
6625344|NCT02224638|7553019|FG000|COMPLETED|Overall Study||10
6625345|NCT02224638|7553020|FG001|COMPLETED|Overall Study||9
6625346|NCT02224638|7553019|FG000|NOT COMPLETED|Overall Study||1
6625347|NCT02224638|7553020|FG001|NOT COMPLETED|Overall Study||1
6625348|NCT02224664|7553028|FG000|STARTED|Lead-in Period (3 Days)||50
6625349|NCT02224664|7553029|FG001|STARTED|Lead-in Period (3 Days)||0
6625350|NCT02224664|7553030|FG002|STARTED|Lead-in Period (3 Days)||0
6625351|NCT02224664|7553031|FG003|STARTED|Lead-in Period (3 Days)||0
6625352|NCT02224664|7553032|FG004|STARTED|Lead-in Period (3 Days)||0
6625353|NCT02224664|7553028|FG000|COMPLETED|Lead-in Period (3 Days)||45
6625354|NCT02224664|7553029|FG001|COMPLETED|Lead-in Period (3 Days)||0
6625355|NCT02224664|7553030|FG002|COMPLETED|Lead-in Period (3 Days)||0
6625356|NCT02224664|7553031|FG003|COMPLETED|Lead-in Period (3 Days)||0
6625357|NCT02224664|7553032|FG004|COMPLETED|Lead-in Period (3 Days)||0
6625358|NCT02224664|7553028|FG000|NOT COMPLETED|Lead-in Period (3 Days)||5
6625359|NCT02224664|7553029|FG001|NOT COMPLETED|Lead-in Period (3 Days)||0
6625360|NCT02224664|7553030|FG002|NOT COMPLETED|Lead-in Period (3 Days)||0
6625361|NCT02224664|7553031|FG003|NOT COMPLETED|Lead-in Period (3 Days)||0
6608020|NCT02094300|7533324|FG000|STARTED|Overall Study||26
6608021|NCT02094300|7533324|FG000|30 Days|Overall Study||24
6608022|NCT02094300|7533324|FG000|COMPLETED|Overall Study||6
6608023|NCT02094300|7533324|FG000|NOT COMPLETED|Overall Study||20
6732246|NCT03191630|7661652|FG000|COMPLETED|Overall Study||23
6732247|NCT03191630|7661653|FG001|COMPLETED|Overall Study||23
6732248|NCT03191630|7661652|FG000|NOT COMPLETED|Overall Study||7
6732249|NCT03191630|7661653|FG001|NOT COMPLETED|Overall Study||7
6732250|NCT03191799|7661661|FG000|STARTED|Overall Study||195
6732251|NCT03191799|7661661|FG000|Received at Least One Dose of Emicizumab|Overall Study||193
6732252|NCT03191799|7661661|FG000|Dose Up-Titrated to 3 mg/kg QW|Overall Study||2
6732253|NCT03191799|7661661|FG000|COMPLETED|Overall Study||186
6732254|NCT03191799|7661661|FG000|NOT COMPLETED|Overall Study||9
6732255|NCT03192137|7661667|FG000|STARTED|Overall Study||173
6732256|NCT03192137|7661668|FG001|STARTED|Overall Study||87
6732257|NCT03192137|7661667|FG000|COMPLETED|Overall Study||123
6732258|NCT03192137|7661668|FG001|COMPLETED|Overall Study||29
6732259|NCT03192137|7661667|FG000|NOT COMPLETED|Overall Study||50
6732260|NCT03192137|7661668|FG001|NOT COMPLETED|Overall Study||58
6732261|NCT03192150|7661676|FG000|STARTED|Overall Study||163
6732262|NCT03192150|7661677|FG001|STARTED|Overall Study||83
6732263|NCT03192150|7661676|FG000|COMPLETED|Overall Study||108
6732264|NCT03192150|7661677|FG001|COMPLETED|Overall Study||29
6732265|NCT03192150|7661676|FG000|NOT COMPLETED|Overall Study||55
6732266|NCT03192150|7661677|FG001|NOT COMPLETED|Overall Study||54
6732267|NCT03192176|7661691|FG000|STARTED|Overall Study||44
6732268|NCT03192176|7661692|FG001|STARTED|Overall Study||45
6732269|NCT03192176|7661693|FG002|STARTED|Overall Study||44
6732270|NCT03192176|7661694|FG003|STARTED|Overall Study||45
6732271|NCT03192176|7661695|FG004|STARTED|Overall Study||44
6732272|NCT03192176|7661696|FG005|STARTED|Overall Study||45
6732273|NCT03192176|7661697|FG006|STARTED|Overall Study||45
6732274|NCT03192176|7661698|FG007|STARTED|Overall Study||44
6732275|NCT03192176|7661691|FG000|Treated|Overall Study||43
6732276|NCT03192176|7661692|FG001|Treated|Overall Study||45
6732277|NCT03192176|7661693|FG002|Treated|Overall Study||43
6732278|NCT03192176|7661694|FG003|Treated|Overall Study||45
6732279|NCT03192176|7661695|FG004|Treated|Overall Study||44
6732280|NCT03192176|7661696|FG005|Treated|Overall Study||43
6732281|NCT03192176|7661697|FG006|Treated|Overall Study||45
6732282|NCT03192176|7661698|FG007|Treated|Overall Study||44
6732283|NCT03192176|7661691|FG000|COMPLETED|Overall Study||37
6732284|NCT03192176|7661692|FG001|COMPLETED|Overall Study||40
6732285|NCT03192176|7661693|FG002|COMPLETED|Overall Study||38
6732286|NCT03192176|7661694|FG003|COMPLETED|Overall Study||33
6732287|NCT03192176|7661695|FG004|COMPLETED|Overall Study||32
6732288|NCT03192176|7661696|FG005|COMPLETED|Overall Study||34
6732289|NCT03192176|7661697|FG006|COMPLETED|Overall Study||36
6732290|NCT03192176|7661698|FG007|COMPLETED|Overall Study||37
6732291|NCT03192176|7661691|FG000|NOT COMPLETED|Overall Study||7
6732292|NCT03192176|7661692|FG001|NOT COMPLETED|Overall Study||5
6732293|NCT03192176|7661693|FG002|NOT COMPLETED|Overall Study||6
6732294|NCT03192176|7661694|FG003|NOT COMPLETED|Overall Study||12
6732295|NCT03192176|7661695|FG004|NOT COMPLETED|Overall Study||12
6732296|NCT03192176|7661696|FG005|NOT COMPLETED|Overall Study||11
6732297|NCT03192176|7661697|FG006|NOT COMPLETED|Overall Study||9
6732298|NCT03192176|7661698|FG007|NOT COMPLETED|Overall Study||7
6732299|NCT03192306|7661719|FG000|STARTED|Overall Study||227
6732300|NCT03192306|7661720|FG001|STARTED|Overall Study||224
6732301|NCT03192306|7661719|FG000|Modified Intent to Treat (MITT)|Overall Study||76
6732302|NCT03192306|7661720|FG001|Modified Intent to Treat (MITT)|Overall Study||80
6732303|NCT03192306|7661719|FG000|COMPLETED|Overall Study||75
6732304|NCT03192306|7661720|FG001|COMPLETED|Overall Study||79
6732305|NCT03192306|7661719|FG000|NOT COMPLETED|Overall Study||152
6732306|NCT03192306|7661720|FG001|NOT COMPLETED|Overall Study||145
6732307|NCT03192475|7661728|FG000|STARTED|Overall Study||162
6732308|NCT03192475|7661729|FG001|STARTED|Overall Study||160
6732309|NCT03192475|7661728|FG000|COMPLETED|Overall Study||149
6732310|NCT03192475|7661729|FG001|COMPLETED|Overall Study||151
6732311|NCT03192475|7661728|FG000|NOT COMPLETED|Overall Study||13
6732312|NCT03192475|7661729|FG001|NOT COMPLETED|Overall Study||9
6732313|NCT03192488|7661736|FG000|STARTED|First Intervention (d1)||1
6732314|NCT03192488|7661737|FG001|STARTED|First Intervention (d1)||5
6732315|NCT03192488|7661738|FG002|STARTED|First Intervention (d1)||2
6732316|NCT03192488|7661739|FG003|STARTED|First Intervention (d1)||1
6732317|NCT03192488|7661740|FG004|STARTED|First Intervention (d1)||1
6732318|NCT03192488|7661741|FG005|STARTED|First Intervention (d1)||1
6732319|NCT03192488|7661736|FG000|COMPLETED|First Intervention (d1)||1
6732320|NCT03192488|7661737|FG001|COMPLETED|First Intervention (d1)||5
6732321|NCT03192488|7661738|FG002|COMPLETED|First Intervention (d1)||2
6732322|NCT03192488|7661739|FG003|COMPLETED|First Intervention (d1)||1
6732323|NCT03192488|7661740|FG004|COMPLETED|First Intervention (d1)||1
6732324|NCT03192488|7661741|FG005|COMPLETED|First Intervention (d1)||1
6732325|NCT03192488|7661736|FG000|NOT COMPLETED|First Intervention (d1)||0
6732326|NCT03192488|7661737|FG001|NOT COMPLETED|First Intervention (d1)||0
6732327|NCT03192488|7661738|FG002|NOT COMPLETED|First Intervention (d1)||0
6732328|NCT03192488|7661739|FG003|NOT COMPLETED|First Intervention (d1)||0
6732329|NCT03192488|7661740|FG004|NOT COMPLETED|First Intervention (d1)||0
6608024|NCT02094326|7533328|FG000|STARTED|Overall Study||301
6608025|NCT02094326|7533328|FG000|COMPLETED|Overall Study||301
6608026|NCT02094326|7533328|FG000|NOT COMPLETED|Overall Study||0
6608027|NCT02094417|7533337|FG000|STARTED|Overall Study||7
6608028|NCT02094417|7533338|FG001|STARTED|Overall Study||9
6608029|NCT02094417|7533339|FG002|STARTED|Overall Study||9
6608030|NCT02094417|7533340|FG003|STARTED|Overall Study||10
6608031|NCT02094417|7533337|FG000|COMPLETED|Overall Study||2
6608032|NCT02094417|7533338|FG001|COMPLETED|Overall Study||1
6608033|NCT02094417|7533339|FG002|COMPLETED|Overall Study||4
6608034|NCT02094417|7533340|FG003|COMPLETED|Overall Study||3
6608035|NCT02094417|7533337|FG000|NOT COMPLETED|Overall Study||5
6608036|NCT02094417|7533338|FG001|NOT COMPLETED|Overall Study||8
6608037|NCT02094417|7533339|FG002|NOT COMPLETED|Overall Study||5
6608038|NCT02094417|7533340|FG003|NOT COMPLETED|Overall Study||7
6608039|NCT02094443|7533352|FG000|STARTED|Overall Study||26
6608040|NCT02094443|7533353|FG001|STARTED|Overall Study||26
6608041|NCT02094443|7533352|FG000|Completed at Week 12|Overall Study||0
6608042|NCT02094443|7533353|FG001|Completed at Week 12|Overall Study||1
6608043|NCT02094443|7533352|FG000|Completed at Week 24|Overall Study||11
6608044|NCT02094443|7533353|FG001|Completed at Week 24|Overall Study||8
6608045|NCT02094443|7533352|FG000|COMPLETED|Overall Study||11
6608046|NCT02094443|7533353|FG001|COMPLETED|Overall Study||9
6608047|NCT02094443|7533352|FG000|NOT COMPLETED|Overall Study||15
6608048|NCT02094443|7533353|FG001|NOT COMPLETED|Overall Study||17
6608049|NCT02094534|7533361|FG000|STARTED|Overall Study||15
6608050|NCT02094534|7533362|FG001|STARTED|Overall Study||10
6608051|NCT02094534|7533361|FG000|COMPLETED|Overall Study||15
6608052|NCT02094534|7533362|FG001|COMPLETED|Overall Study||10
6608053|NCT02094534|7533361|FG000|NOT COMPLETED|Overall Study||0
6608054|NCT02094534|7533362|FG001|NOT COMPLETED|Overall Study||0
6608055|NCT02094573|7533370|FG000|STARTED|Overall Study||112
6608056|NCT02094573|7533371|FG001|STARTED|Overall Study||110
6608057|NCT02094573|7533370|FG000|Treated|Overall Study||109
6608058|NCT02094573|7533371|FG001|Treated|Overall Study||110
6608059|NCT02094573|7533370|FG000|COMPLETED|Overall Study||0
6608060|NCT02094573|7533371|FG001|COMPLETED|Overall Study||0
6608061|NCT02094573|7533370|FG000|NOT COMPLETED|Overall Study||112
6608062|NCT02094573|7533371|FG001|NOT COMPLETED|Overall Study||110
6608063|NCT02094586|7533381|FG000|STARTED|Overall Study||927
6608064|NCT02094586|7533382|FG001|STARTED|Overall Study||933
6608065|NCT02094586|7533383|FG002|STARTED|Overall Study||935
6608066|NCT02094586|7533384|FG003|STARTED|Overall Study||351
6608067|NCT02094586|7533381|FG000|COMPLETED|Overall Study||848
6608068|NCT02094586|7533382|FG001|COMPLETED|Overall Study||866
6608069|NCT02094586|7533383|FG002|COMPLETED|Overall Study||876
6608070|NCT02094586|7533384|FG003|COMPLETED|Overall Study||331
6608071|NCT02094586|7533381|FG000|NOT COMPLETED|Overall Study||79
6608072|NCT02094586|7533382|FG001|NOT COMPLETED|Overall Study||67
6608073|NCT02094586|7533383|FG002|NOT COMPLETED|Overall Study||59
6608074|NCT02094586|7533384|FG003|NOT COMPLETED|Overall Study||20
6608075|NCT02094612|7533408|FG000|STARTED|Overall Study||112
6608076|NCT02094612|7533409|FG001|STARTED|Overall Study||95
6608077|NCT02094612|7533408|FG000|1 Month Follow up|Overall Study||67
6608078|NCT02094612|7533409|FG001|1 Month Follow up|Overall Study||50
6608079|NCT02094612|7533408|FG000|3 Month Follow up|Overall Study||50
6608080|NCT02094612|7533409|FG001|3 Month Follow up|Overall Study||43
6608081|NCT02094612|7533408|FG000|6 Month Follow up|Overall Study||33
6608082|NCT02094612|7533409|FG001|6 Month Follow up|Overall Study||25
6608083|NCT02094612|7533408|FG000|COMPLETED|Overall Study||33
6608084|NCT02094612|7533409|FG001|COMPLETED|Overall Study||25
6608085|NCT02094612|7533408|FG000|NOT COMPLETED|Overall Study||79
6608086|NCT02094612|7533409|FG001|NOT COMPLETED|Overall Study||70
6608087|NCT02094664|7533417|FG000|STARTED|Overall Study||16
6608088|NCT02094664|7533418|FG001|STARTED|Overall Study||16
6608089|NCT02094664|7533417|FG000|COMPLETED|Overall Study||16
6608090|NCT02094664|7533418|FG001|COMPLETED|Overall Study||16
6608091|NCT02094664|7533417|FG000|NOT COMPLETED|Overall Study||0
6608092|NCT02094664|7533418|FG001|NOT COMPLETED|Overall Study||0
6608093|NCT02094677|7533426|FG000|STARTED|Overall Study||43
6608094|NCT02094677|7533427|FG001|STARTED|Overall Study||31
6608095|NCT02094677|7533426|FG000|COMPLETED|Overall Study||40
6608096|NCT02094677|7533427|FG001|COMPLETED|Overall Study||30
6608097|NCT02094677|7533426|FG000|NOT COMPLETED|Overall Study||3
6608098|NCT02094677|7533427|FG001|NOT COMPLETED|Overall Study||1
6608099|NCT02094755|7533440|FG000|STARTED|Overall Study||100
6608100|NCT02094755|7533440|FG000|COMPLETED|Overall Study||100
6608101|NCT02094755|7533440|FG000|NOT COMPLETED|Overall Study||0
6608102|NCT02094872|7533444|FG000|STARTED|Overall Study||49
6608103|NCT02094872|7533444|FG000|Received Biopsy|Overall Study||37
6608104|NCT02094872|7533444|FG000|Received Tumor-board Recommendation|Overall Study|1 individual withdrew consent after biopsy.|36
6608105|NCT02094872|7533444|FG000|Received Targeted Therapy|Overall Study||20
6608106|NCT02094872|7533444|FG000|Received Standard of Care|Overall Study|7 standard-of-care patients crossed-over and received targeted therapy.|9
6608107|NCT02094872|7533444|FG000|Patients Treated With MEK162|Overall Study||20
6608108|NCT02094872|7533444|FG000|COMPLETED|Overall Study||20
6608109|NCT02094872|7533444|FG000|NOT COMPLETED|Overall Study||29
6608110|NCT02094885|7533450|FG000|STARTED|Overall Study||125
6608111|NCT02094885|7533451|FG001|STARTED|Overall Study||127
6608112|NCT02094885|7533450|FG000|COMPLETED|Overall Study||123
6608113|NCT02094885|7533451|FG001|COMPLETED|Overall Study||122
6608114|NCT02094885|7533450|FG000|NOT COMPLETED|Overall Study||2
6608115|NCT02094885|7533451|FG001|NOT COMPLETED|Overall Study||5
6608116|NCT02094898|7533457|FG000|STARTED|Overall Study||12
6608117|NCT02094898|7533457|FG000|COMPLETED|Overall Study||7
6608118|NCT02094898|7533457|FG000|NOT COMPLETED|Overall Study||5
6608119|NCT02094937|7533463|FG000|STARTED|8 Weeks in Period 1||430
6608120|NCT02094937|7533464|FG001|STARTED|8 Weeks in Period 1||0
6608121|NCT02094937|7533465|FG002|STARTED|8 Weeks in Period 1||0
6608122|NCT02094937|7533466|FG003|STARTED|8 Weeks in Period 1||0
6608123|NCT02094937|7533463|FG000|COMPLETED|8 Weeks in Period 1||370
6608124|NCT02094937|7533464|FG001|COMPLETED|8 Weeks in Period 1||0
6608125|NCT02094937|7533465|FG002|COMPLETED|8 Weeks in Period 1||0
6608126|NCT02094937|7533466|FG003|COMPLETED|8 Weeks in Period 1||0
6608127|NCT02094937|7533463|FG000|NOT COMPLETED|8 Weeks in Period 1||60
6608128|NCT02094937|7533464|FG001|NOT COMPLETED|8 Weeks in Period 1||0
6608129|NCT02094937|7533465|FG002|NOT COMPLETED|8 Weeks in Period 1||0
6608130|NCT02094937|7533466|FG003|NOT COMPLETED|8 Weeks in Period 1||0
6608131|NCT02094937|7533463|FG000|STARTED|12 Weeks in Period 2||0
6608132|NCT02094937|7533464|FG001|STARTED|12 Weeks in Period 2||123
6608133|NCT02094937|7533465|FG002|STARTED|12 Weeks in Period 2||124
6608134|NCT02094937|7533466|FG003|STARTED|12 Weeks in Period 2||124
6608135|NCT02094937|7533463|FG000|COMPLETED|12 Weeks in Period 2||0
6608136|NCT02094937|7533464|FG001|COMPLETED|12 Weeks in Period 2||112
6608137|NCT02094937|7533465|FG002|COMPLETED|12 Weeks in Period 2||112
6608138|NCT02094937|7533466|FG003|COMPLETED|12 Weeks in Period 2||112
6608139|NCT02094937|7533463|FG000|NOT COMPLETED|12 Weeks in Period 2||0
6608140|NCT02094937|7533464|FG001|NOT COMPLETED|12 Weeks in Period 2||11
6608141|NCT02094937|7533465|FG002|NOT COMPLETED|12 Weeks in Period 2||12
6608142|NCT02094937|7533466|FG003|NOT COMPLETED|12 Weeks in Period 2||12
6608143|NCT02095106|7533477|FG000|STARTED|First Intervention (14 Days)||14
6608144|NCT02095106|7533478|FG001|STARTED|First Intervention (14 Days)||13
6608145|NCT02095106|7533477|FG000|COMPLETED|First Intervention (14 Days)||14
6608146|NCT02095106|7533478|FG001|COMPLETED|First Intervention (14 Days)||13
6608147|NCT02095106|7533477|FG000|NOT COMPLETED|First Intervention (14 Days)||0
6608148|NCT02095106|7533478|FG001|NOT COMPLETED|First Intervention (14 Days)||0
6608149|NCT02095106|7533477|FG000|STARTED|Second Intervention (14 Days)||14
6608150|NCT02095106|7533478|FG001|STARTED|Second Intervention (14 Days)||13
6608151|NCT02095106|7533477|FG000|COMPLETED|Second Intervention (14 Days)||14
6608152|NCT02095106|7533478|FG001|COMPLETED|Second Intervention (14 Days)||12
6608153|NCT02095106|7533477|FG000|NOT COMPLETED|Second Intervention (14 Days)||0
6608154|NCT02095106|7533478|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
6608155|NCT02095145|7533490|FG000|STARTED|Overall Study||15
6608156|NCT02095145|7533491|FG001|STARTED|Overall Study||15
6608157|NCT02095145|7533490|FG000|COMPLETED|Overall Study||14
6608158|NCT02095145|7533491|FG001|COMPLETED|Overall Study||15
6608159|NCT02095145|7533490|FG000|NOT COMPLETED|Overall Study||1
6608160|NCT02095145|7533491|FG001|NOT COMPLETED|Overall Study||0
6608161|NCT02095158|7533499|FG000|STARTED|Overall Study||440
6608162|NCT02095158|7533499|FG000|COMPLETED|Overall Study||365
6608163|NCT02095158|7533499|FG000|NOT COMPLETED|Overall Study||75
6608164|NCT02095197|7533505|FG000|STARTED|Overall Study||40
6608165|NCT02095197|7533506|FG001|STARTED|Overall Study||39
6608166|NCT02095197|7533505|FG000|COMPLETED|Overall Study||40
6608167|NCT02095197|7533506|FG001|COMPLETED|Overall Study||36
6608168|NCT02095197|7533505|FG000|NOT COMPLETED|Overall Study||0
6608169|NCT02095197|7533506|FG001|NOT COMPLETED|Overall Study||3
6608170|NCT02095223|7533514|FG000|STARTED|Overall Study||2
6608171|NCT02095223|7533515|FG001|STARTED|Overall Study||2
6608172|NCT02095223|7533514|FG000|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
6608173|NCT02095223|7533515|FG001|COMPLETED|Overall Study||2
6608174|NCT02095223|7533514|FG000|NOT COMPLETED|Overall Study||1
6608175|NCT02095223|7533515|FG001|NOT COMPLETED|Overall Study||0
6608176|NCT02095340|7533524|FG000|STARTED|Overall Study|Mother (not the child) received the training.|51
6608177|NCT02095340|7533525|FG001|STARTED|Overall Study|Mother (not the child) received the training.|54
6608178|NCT02095340|7533526|FG002|STARTED|Overall Study||105
6608179|NCT02095340|7533524|FG000|COMPLETED|Overall Study||51
6608180|NCT02095340|7533525|FG001|COMPLETED|Overall Study||54
6608181|NCT02095340|7533526|FG002|COMPLETED|Overall Study||105
6608182|NCT02095340|7533524|FG000|NOT COMPLETED|Overall Study||0
6608183|NCT02095340|7533525|FG001|NOT COMPLETED|Overall Study||0
6608184|NCT02095340|7533526|FG002|NOT COMPLETED|Overall Study||0
6608185|NCT02095535|7533535|FG000|STARTED|Recruitment||20
6608186|NCT02095535|7533535|FG000|COMPLETED|Recruitment||18
6608187|NCT02095535|7533535|FG000|NOT COMPLETED|Recruitment||2
6608188|NCT02095535|7533535|FG000|STARTED|Analysis||18
6608189|NCT02095535|7533535|FG000|COMPLETED|Analysis||18
6608190|NCT02095535|7533535|FG000|NOT COMPLETED|Analysis||0
6608191|NCT02095561|7533541|FG000|STARTED|Overall Study||3049
6608192|NCT02095561|7533542|FG001|STARTED|Overall Study||2964
6608193|NCT02095561|7533541|FG000|Self-testing Acceptability|Overall Study||2616
6625362|NCT02224664|7553032|FG004|NOT COMPLETED|Lead-in Period (3 Days)||0
6608194|NCT02095561|7533542|FG001|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
6608195|NCT02095561|7533541|FG000|HPV Self-tested Women|Overall Study||2519
6608196|NCT02095561|7533542|FG001|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
6608197|NCT02095561|7533541|FG000|HPV Tested at Health Centers|Overall Study||99
6608198|NCT02095561|7533542|FG001|HPV Tested at Health Centers|Overall Study||599
6608199|NCT02095561|7533541|FG000|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
6608200|NCT02095561|7533542|FG001|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
6608201|NCT02095561|7533541|FG000|NOT COMPLETED|Overall Study||0
6608202|NCT02095561|7533542|FG001|NOT COMPLETED|Overall Study||0
6608203|NCT02095678|7533550|FG000|STARTED|Overall Study||34
6608204|NCT02095678|7533551|FG001|STARTED|Overall Study||18
6608205|NCT02095678|7533550|FG000|COMPLETED|Overall Study||17
6608206|NCT02095678|7533551|FG001|COMPLETED|Overall Study||0
6608207|NCT02095678|7533550|FG000|NOT COMPLETED|Overall Study||17
6608208|NCT02095678|7533551|FG001|NOT COMPLETED|Overall Study||18
6608209|NCT02095691|7533560|FG000|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
6608210|NCT02095691|7533560|FG000|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
6608211|NCT02095691|7533560|FG000|NOT COMPLETED|Overall Study||1
6608212|NCT02095873|7533578|FG000|STARTED|First Intervention (8 Weeks)||16
6608213|NCT02095873|7533579|FG001|STARTED|First Intervention (8 Weeks)||16
6608214|NCT02095873|7533578|FG000|COMPLETED|First Intervention (8 Weeks)||15
6608215|NCT02095873|7533579|FG001|COMPLETED|First Intervention (8 Weeks)||16
6608216|NCT02095873|7533578|FG000|NOT COMPLETED|First Intervention (8 Weeks)||1
6608217|NCT02095873|7533579|FG001|NOT COMPLETED|First Intervention (8 Weeks)||0
6608218|NCT02095873|7533578|FG000|STARTED|Second Intervention (8 Weeks)||15
6608219|NCT02095873|7533579|FG001|STARTED|Second Intervention (8 Weeks)||16
6608220|NCT02095873|7533578|FG000|COMPLETED|Second Intervention (8 Weeks)||13
6608221|NCT02095873|7533579|FG001|COMPLETED|Second Intervention (8 Weeks)||16
6608222|NCT02095873|7533578|FG000|NOT COMPLETED|Second Intervention (8 Weeks)||2
6608223|NCT02095873|7533579|FG001|NOT COMPLETED|Second Intervention (8 Weeks)||0
6608224|NCT02095951|7533589|FG000|STARTED|Overall Study|2 participants with 4 episodes of catheter infection was enrolled twice in this group.|13
6608225|NCT02095951|7533590|FG001|STARTED|Overall Study|1 participant with 2 episodes of catheter infection was enrolled twice in this group.|14
6608226|NCT02095951|7533589|FG000|COMPLETED|Overall Study||4
6608227|NCT02095951|7533590|FG001|COMPLETED|Overall Study||8
6608228|NCT02095951|7533589|FG000|NOT COMPLETED|Overall Study||9
6608229|NCT02095951|7533590|FG001|NOT COMPLETED|Overall Study||6
6608230|NCT02096003|7533602|FG000|STARTED|Overall Study||40
6608231|NCT02096003|7533603|FG001|STARTED|Overall Study||40
6608232|NCT02096003|7533602|FG000|COMPLETED|Overall Study||38
6608233|NCT02096003|7533603|FG001|COMPLETED|Overall Study||37
6608234|NCT02096003|7533602|FG000|NOT COMPLETED|Overall Study||2
6608235|NCT02096003|7533603|FG001|NOT COMPLETED|Overall Study||3
6608236|NCT02096029|7533611|FG000|STARTED|Overall Study||652
6608237|NCT02096029|7533612|FG001|STARTED|Overall Study||593
6608238|NCT02096029|7533611|FG000|COMPLETED|Overall Study||652
6608239|NCT02096029|7533612|FG001|COMPLETED|Overall Study||593
6608240|NCT02096029|7533611|FG000|NOT COMPLETED|Overall Study||0
6608241|NCT02096029|7533612|FG001|NOT COMPLETED|Overall Study||0
6608242|NCT02096081|7533620|FG000|STARTED|Overall Study||122
6608243|NCT02096081|7533621|FG001|STARTED|Overall Study||128
6608244|NCT02096081|7533620|FG000|COMPLETED|Overall Study||119
6608245|NCT02096081|7533621|FG001|COMPLETED|Overall Study||124
6608246|NCT02096081|7533620|FG000|NOT COMPLETED|Overall Study||3
6608247|NCT02096081|7533621|FG001|NOT COMPLETED|Overall Study||4
6608248|NCT02096107|7533629|FG000|STARTED|Overall Study||30
6608249|NCT02096107|7533630|FG001|STARTED|Overall Study||30
6608250|NCT02096107|7533629|FG000|COMPLETED|Overall Study||30
6608251|NCT02096107|7533630|FG001|COMPLETED|Overall Study||30
6608252|NCT02096107|7533629|FG000|NOT COMPLETED|Overall Study||0
6608253|NCT02096107|7533630|FG001|NOT COMPLETED|Overall Study||0
6608254|NCT02096263|7533639|FG000|STARTED|Overall Study||195
6608255|NCT02096263|7533640|FG001|STARTED|Overall Study||194
6608256|NCT02096263|7533641|FG002|STARTED|Overall Study||196
6608257|NCT02096263|7533639|FG000|COMPLETED|Overall Study||161
6608258|NCT02096263|7533640|FG001|COMPLETED|Overall Study||158
6608259|NCT02096263|7533641|FG002|COMPLETED|Overall Study||157
6608260|NCT02096263|7533639|FG000|NOT COMPLETED|Overall Study||34
6608261|NCT02096263|7533640|FG001|NOT COMPLETED|Overall Study||36
6608262|NCT02096263|7533641|FG002|NOT COMPLETED|Overall Study||39
6608263|NCT02096276|7533651|FG000|STARTED|Overall Study||250
6608264|NCT02096276|7533652|FG001|STARTED|Overall Study||55
6608265|NCT02096276|7533651|FG000|COMPLETED|Overall Study||250
6608266|NCT02096276|7533652|FG001|COMPLETED|Overall Study||55
6608267|NCT02096276|7533651|FG000|NOT COMPLETED|Overall Study||0
6608268|NCT02096276|7533652|FG001|NOT COMPLETED|Overall Study||0
6608269|NCT02096458|7533658|FG000|STARTED|Overall Study||8
6608270|NCT02096458|7533658|FG000|COMPLETED|Overall Study||8
6608271|NCT02096458|7533658|FG000|NOT COMPLETED|Overall Study||0
6608272|NCT02096471|7533662|FG000|STARTED|Overall Study||19
6608273|NCT02096471|7533662|FG000|COMPLETED|Overall Study|Participants terminated the study if a partial response was not achieved and/or maintained.|6
6608274|NCT02096471|7533662|FG000|NOT COMPLETED|Overall Study||13
6608275|NCT02096575|7533668|FG000|STARTED|Overall Study||68
6608276|NCT02096575|7533669|FG001|STARTED|Overall Study||67
6608277|NCT02096575|7533670|FG002|STARTED|Overall Study||5
6608278|NCT02096575|7533668|FG000|COMPLETED|Overall Study||68
6608279|NCT02096575|7533669|FG001|COMPLETED|Overall Study||67
6608280|NCT02096575|7533670|FG002|COMPLETED|Overall Study||0
6608281|NCT02096575|7533668|FG000|NOT COMPLETED|Overall Study||0
6608282|NCT02096575|7533669|FG001|NOT COMPLETED|Overall Study||0
6608283|NCT02096575|7533670|FG002|NOT COMPLETED|Overall Study||5
6608284|NCT02096588|7533679|FG000|STARTED|Overall Study||15
6608285|NCT02096588|7533680|FG001|STARTED|Overall Study||16
6608286|NCT02096588|7533679|FG000|COMPLETED|Overall Study||13
6608287|NCT02096588|7533680|FG001|COMPLETED|Overall Study||15
6608288|NCT02096588|7533679|FG000|NOT COMPLETED|Overall Study||2
6608289|NCT02096588|7533680|FG001|NOT COMPLETED|Overall Study||1
6608290|NCT02096679|7533686|FG000|STARTED|Overall Study||8
6608291|NCT02096679|7533686|FG000|COMPLETED|Overall Study||8
6608292|NCT02096679|7533686|FG000|NOT COMPLETED|Overall Study||0
6608293|NCT02096692|7533690|FG000|STARTED|Overall Study||154
6608294|NCT02096692|7533690|FG000|COMPLETED|Overall Study||150
6608295|NCT02096692|7533690|FG000|NOT COMPLETED|Overall Study||4
6608296|NCT02096705|7533696|FG000|STARTED|Treatment||133
6608297|NCT02096705|7533697|FG001|STARTED|Treatment||139
6608298|NCT02096705|7533696|FG000|COMPLETED|Treatment||124
6608299|NCT02096705|7533697|FG001|COMPLETED|Treatment||134
6608300|NCT02096705|7533696|FG000|NOT COMPLETED|Treatment||9
6608301|NCT02096705|7533697|FG001|NOT COMPLETED|Treatment||5
6608302|NCT02096705|7533696|FG000|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
6608303|NCT02096705|7533697|FG001|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
6608304|NCT02096705|7533696|FG000|COMPLETED|Follow-up||125
6608305|NCT02096705|7533697|FG001|COMPLETED|Follow-up||135
6608306|NCT02096705|7533696|FG000|NOT COMPLETED|Follow-up||4
6608307|NCT02096705|7533697|FG001|NOT COMPLETED|Follow-up||4
6608308|NCT02096718|7533706|FG000|STARTED|Overall Study||8
6608309|NCT02096718|7533707|FG001|STARTED|Overall Study||8
6608310|NCT02096718|7533708|FG002|STARTED|Overall Study||14
6608311|NCT02096718|7533706|FG000|COMPLETED|Overall Study||8
6608312|NCT02096718|7533707|FG001|COMPLETED|Overall Study||8
6608313|NCT02096718|7533708|FG002|COMPLETED|Overall Study||14
6608314|NCT02096718|7533706|FG000|NOT COMPLETED|Overall Study||0
6608315|NCT02096718|7533707|FG001|NOT COMPLETED|Overall Study||0
6608316|NCT02096718|7533708|FG002|NOT COMPLETED|Overall Study||0
6608317|NCT02096731|7533719|FG000|STARTED|Overall Study||26442
6608318|NCT02096731|7533720|FG001|STARTED|Overall Study||88955
6608319|NCT02096731|7533719|FG000|COMPLETED|Overall Study||26442
6608320|NCT02096731|7533720|FG001|COMPLETED|Overall Study||88955
6608321|NCT02096731|7533719|FG000|NOT COMPLETED|Overall Study||0
6608322|NCT02096731|7533720|FG001|NOT COMPLETED|Overall Study||0
6608323|NCT02096744|7533729|FG000|STARTED|Treatment Period 1(7 Days)||29
6608324|NCT02096744|7533730|FG001|STARTED|Treatment Period 1(7 Days)||29
6608325|NCT02096744|7533729|FG000|COMPLETED|Treatment Period 1(7 Days)||28
6608326|NCT02096744|7533730|FG001|COMPLETED|Treatment Period 1(7 Days)||28
6608327|NCT02096744|7533729|FG000|NOT COMPLETED|Treatment Period 1(7 Days)||1
6608328|NCT02096744|7533730|FG001|NOT COMPLETED|Treatment Period 1(7 Days)||1
6608329|NCT02096744|7533729|FG000|STARTED|Washout Period 1(7 Days)||28
6608330|NCT02096744|7533730|FG001|STARTED|Washout Period 1(7 Days)||28
6608331|NCT02096744|7533729|FG000|COMPLETED|Washout Period 1(7 Days)||28
6608332|NCT02096744|7533730|FG001|COMPLETED|Washout Period 1(7 Days)||28
6608333|NCT02096744|7533729|FG000|NOT COMPLETED|Washout Period 1(7 Days)||0
6608334|NCT02096744|7533730|FG001|NOT COMPLETED|Washout Period 1(7 Days)||0
6608335|NCT02096744|7533729|FG000|STARTED|Treatment Period 2 (7 Days)||28
6608336|NCT02096744|7533730|FG001|STARTED|Treatment Period 2 (7 Days)||28
6608337|NCT02096744|7533729|FG000|COMPLETED|Treatment Period 2 (7 Days)||28
6608338|NCT02096744|7533730|FG001|COMPLETED|Treatment Period 2 (7 Days)||28
6608339|NCT02096744|7533729|FG000|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6608340|NCT02096744|7533730|FG001|NOT COMPLETED|Treatment Period 2 (7 Days)||0
6608341|NCT02096744|7533729|FG000|STARTED|Washout Period 2 (3 Days)||28
6608342|NCT02096744|7533730|FG001|STARTED|Washout Period 2 (3 Days)||28
6608343|NCT02096744|7533729|FG000|COMPLETED|Washout Period 2 (3 Days)||28
6608344|NCT02096744|7533730|FG001|COMPLETED|Washout Period 2 (3 Days)||28
6608345|NCT02096744|7533729|FG000|NOT COMPLETED|Washout Period 2 (3 Days)||0
6608346|NCT02096744|7533730|FG001|NOT COMPLETED|Washout Period 2 (3 Days)||0
6608347|NCT02096744|7533729|FG000|STARTED|Treatment Period 3 (7 Days)||28
6608348|NCT02096744|7533730|FG001|STARTED|Treatment Period 3 (7 Days)||28
6608349|NCT02096744|7533729|FG000|COMPLETED|Treatment Period 3 (7 Days)||28
6608350|NCT02096744|7533730|FG001|COMPLETED|Treatment Period 3 (7 Days)||27
6608351|NCT02096744|7533729|FG000|NOT COMPLETED|Treatment Period 3 (7 Days)||0
6608352|NCT02096744|7533730|FG001|NOT COMPLETED|Treatment Period 3 (7 Days)||1
6608353|NCT02096835|7533741|FG000|STARTED|Overall Study||53
6608354|NCT02096835|7533742|FG001|STARTED|Overall Study||53
6608355|NCT02096835|7533743|FG002|STARTED|Overall Study||51
6608356|NCT02096835|7533741|FG000|COMPLETED|Overall Study||50
6608357|NCT02096835|7533742|FG001|COMPLETED|Overall Study||53
6608358|NCT02096835|7533743|FG002|COMPLETED|Overall Study||50
6608359|NCT02096835|7533741|FG000|NOT COMPLETED|Overall Study||3
6608360|NCT02096835|7533742|FG001|NOT COMPLETED|Overall Study||0
6608361|NCT02096835|7533743|FG002|NOT COMPLETED|Overall Study||1
6608362|NCT02096861|7533755|FG000|STARTED|Overall Study|CT-P13 followed by CT-P13 from Week 30|56
6608363|NCT02096861|7533756|FG001|STARTED|Overall Study|CT-P13 followed by Remicade from Week 30|55
6608364|NCT02096861|7533757|FG002|STARTED|Overall Study|Remicade followed by Remicade from Week 30|54
6608365|NCT02096861|7533758|FG003|STARTED|Overall Study|Remicade followed by CT-P13 from Week 30|55
6608366|NCT02096861|7533755|FG000|Drug Switching at Week 30|Overall Study||48
6608367|NCT02096861|7533756|FG001|Drug Switching at Week 30|Overall Study||44
6608368|NCT02096861|7533757|FG002|Drug Switching at Week 30|Overall Study||41
6608369|NCT02096861|7533758|FG003|Drug Switching at Week 30|Overall Study||47
6608370|NCT02096861|7533755|FG000|COMPLETED|Overall Study||44
6608371|NCT02096861|7533756|FG001|COMPLETED|Overall Study||40
6608372|NCT02096861|7533757|FG002|COMPLETED|Overall Study||37
6608373|NCT02096861|7533758|FG003|COMPLETED|Overall Study||45
6608374|NCT02096861|7533755|FG000|NOT COMPLETED|Overall Study||12
6608375|NCT02096861|7533756|FG001|NOT COMPLETED|Overall Study||15
6608376|NCT02096861|7533757|FG002|NOT COMPLETED|Overall Study||17
6608377|NCT02096861|7533758|FG003|NOT COMPLETED|Overall Study||10
6608378|NCT02096900|7533772|FG000|STARTED|Overall Study|Allocated to Midazolam|42
6608379|NCT02096900|7533773|FG001|STARTED|Overall Study|Allocated to Zolpidem|44
6608380|NCT02096900|7533772|FG000|COMPLETED|Overall Study||38
6608381|NCT02096900|7533773|FG001|COMPLETED|Overall Study||42
6608382|NCT02096900|7533772|FG000|NOT COMPLETED|Overall Study||4
6608383|NCT02096900|7533773|FG001|NOT COMPLETED|Overall Study||2
6608384|NCT02096952|7533779|FG000|STARTED|Overall Study||15
6608385|NCT02096952|7533779|FG000|COMPLETED|Overall Study||14
6608386|NCT02096952|7533779|FG000|NOT COMPLETED|Overall Study||1
6608387|NCT02097030|7533785|FG000|STARTED|First Intervention (3 Days)||15
6608388|NCT02097030|7533786|FG001|STARTED|First Intervention (3 Days)||17
6608389|NCT02097030|7533785|FG000|COMPLETED|First Intervention (3 Days)||14
6608390|NCT02097030|7533786|FG001|COMPLETED|First Intervention (3 Days)||16
6608391|NCT02097030|7533785|FG000|NOT COMPLETED|First Intervention (3 Days)||1
6608392|NCT02097030|7533786|FG001|NOT COMPLETED|First Intervention (3 Days)||1
6608393|NCT02097030|7533785|FG000|STARTED|Second Intervention (3 Days)||14
6608394|NCT02097030|7533786|FG001|STARTED|Second Intervention (3 Days)||16
6608395|NCT02097030|7533785|FG000|COMPLETED|Second Intervention (3 Days)||14
6608396|NCT02097030|7533786|FG001|COMPLETED|Second Intervention (3 Days)||16
6608397|NCT02097030|7533785|FG000|NOT COMPLETED|Second Intervention (3 Days)||0
6608398|NCT02097030|7533786|FG001|NOT COMPLETED|Second Intervention (3 Days)||0
6608399|NCT02097056|7533796|FG000|STARTED|Overall Study||171
6608400|NCT02097056|7533796|FG000|ParticipantsTreated|Overall Study||170
6608401|NCT02097056|7533796|FG000|COMPLETED|Overall Study||113
6608402|NCT02097056|7533796|FG000|NOT COMPLETED|Overall Study||58
6608403|NCT02097108|7533800|FG000|STARTED|Overall Study||11
6608404|NCT02097108|7533800|FG000|COMPLETED|Overall Study||9
6608405|NCT02097108|7533800|FG000|NOT COMPLETED|Overall Study||2
6608406|NCT02097238|7533804|FG000|STARTED|Overall Study||19
6608407|NCT02097238|7533804|FG000|COMPLETED|Overall Study||0
6608408|NCT02097238|7533804|FG000|NOT COMPLETED|Overall Study||19
6608409|NCT02097277|7533814|FG000|STARTED|Overall Study||24
6608410|NCT02097277|7533815|FG001|STARTED|Overall Study||24
6608411|NCT02097277|7533816|FG002|STARTED|Overall Study||24
6608412|NCT02097277|7533817|FG003|STARTED|Overall Study||24
6608413|NCT02097277|7533818|FG004|STARTED|Overall Study||24
6608414|NCT02097277|7533814|FG000|COMPLETED|Overall Study||22
6608415|NCT02097277|7533815|FG001|COMPLETED|Overall Study||21
6608416|NCT02097277|7533816|FG002|COMPLETED|Overall Study||22
6608417|NCT02097277|7533817|FG003|COMPLETED|Overall Study||20
6608418|NCT02097277|7533818|FG004|COMPLETED|Overall Study||23
6608419|NCT02097277|7533814|FG000|NOT COMPLETED|Overall Study||2
6608420|NCT02097277|7533815|FG001|NOT COMPLETED|Overall Study||3
6608421|NCT02097277|7533816|FG002|NOT COMPLETED|Overall Study||2
6608422|NCT02097277|7533817|FG003|NOT COMPLETED|Overall Study||4
6608423|NCT02097277|7533818|FG004|NOT COMPLETED|Overall Study||1
6608424|NCT02097290|7533834|FG000|STARTED|Overall Study||210
6608425|NCT02097290|7533834|FG000|COMPLETED|Overall Study|Active subjects at the end of 3 month follow up visit for primary end point data collection|193
6608426|NCT02097290|7533834|FG000|NOT COMPLETED|Overall Study||17
6608427|NCT02097303|7533838|FG000|STARTED|Overall Study||36
6608428|NCT02097303|7533838|FG000|COMPLETED|Overall Study||31
6608429|NCT02097303|7533838|FG000|NOT COMPLETED|Overall Study||5
6608430|NCT02097472|7533850|FG000|STARTED|Received Vaccination 1||18
6608431|NCT02097472|7533851|FG001|STARTED|Received Vaccination 1||18
6608432|NCT02097472|7533852|FG002|STARTED|Received Vaccination 1||18
6608433|NCT02097472|7533853|FG003|STARTED|Received Vaccination 1||50
6608434|NCT02097472|7533854|FG004|STARTED|Received Vaccination 1||50
6608435|NCT02097472|7533855|FG005|STARTED|Received Vaccination 1||50
6608436|NCT02097472|7533856|FG006|STARTED|Received Vaccination 1||50
6608437|NCT02097472|7533857|FG007|STARTED|Received Vaccination 1||50
6608438|NCT02097472|7533850|FG000|COMPLETED|Received Vaccination 1||18
6608439|NCT02097472|7533851|FG001|COMPLETED|Received Vaccination 1||18
6608440|NCT02097472|7533852|FG002|COMPLETED|Received Vaccination 1||18
6608441|NCT02097472|7533853|FG003|COMPLETED|Received Vaccination 1||50
6608442|NCT02097472|7533854|FG004|COMPLETED|Received Vaccination 1||50
6608443|NCT02097472|7533855|FG005|COMPLETED|Received Vaccination 1||50
6608444|NCT02097472|7533856|FG006|COMPLETED|Received Vaccination 1||50
6608445|NCT02097472|7533857|FG007|COMPLETED|Received Vaccination 1||50
6608446|NCT02097472|7533850|FG000|NOT COMPLETED|Received Vaccination 1||0
6608447|NCT02097472|7533851|FG001|NOT COMPLETED|Received Vaccination 1||0
6608448|NCT02097472|7533852|FG002|NOT COMPLETED|Received Vaccination 1||0
6608449|NCT02097472|7533853|FG003|NOT COMPLETED|Received Vaccination 1||0
6608450|NCT02097472|7533854|FG004|NOT COMPLETED|Received Vaccination 1||0
6608451|NCT02097472|7533855|FG005|NOT COMPLETED|Received Vaccination 1||0
6608452|NCT02097472|7533856|FG006|NOT COMPLETED|Received Vaccination 1||0
6608453|NCT02097472|7533857|FG007|NOT COMPLETED|Received Vaccination 1||0
6608454|NCT02097472|7533850|FG000|STARTED|Received Vaccination 2||18
6608455|NCT02097472|7533851|FG001|STARTED|Received Vaccination 2||18
6608456|NCT02097472|7533852|FG002|STARTED|Received Vaccination 2||18
6608457|NCT02097472|7533853|FG003|STARTED|Received Vaccination 2||50
6608458|NCT02097472|7533854|FG004|STARTED|Received Vaccination 2||50
6608459|NCT02097472|7533855|FG005|STARTED|Received Vaccination 2||50
6608460|NCT02097472|7533856|FG006|STARTED|Received Vaccination 2||50
6608461|NCT02097472|7533857|FG007|STARTED|Received Vaccination 2||50
6608462|NCT02097472|7533850|FG000|COMPLETED|Received Vaccination 2||18
6608463|NCT02097472|7533851|FG001|COMPLETED|Received Vaccination 2||18
6608464|NCT02097472|7533852|FG002|COMPLETED|Received Vaccination 2||18
6608465|NCT02097472|7533853|FG003|COMPLETED|Received Vaccination 2||50
6608466|NCT02097472|7533854|FG004|COMPLETED|Received Vaccination 2||50
6608467|NCT02097472|7533855|FG005|COMPLETED|Received Vaccination 2||50
6608468|NCT02097472|7533856|FG006|COMPLETED|Received Vaccination 2||49
6608469|NCT02097472|7533857|FG007|COMPLETED|Received Vaccination 2||50
6608470|NCT02097472|7533850|FG000|NOT COMPLETED|Received Vaccination 2||0
6608471|NCT02097472|7533851|FG001|NOT COMPLETED|Received Vaccination 2||0
6608472|NCT02097472|7533852|FG002|NOT COMPLETED|Received Vaccination 2||0
6608473|NCT02097472|7533853|FG003|NOT COMPLETED|Received Vaccination 2||0
6608474|NCT02097472|7533854|FG004|NOT COMPLETED|Received Vaccination 2||0
6608475|NCT02097472|7533855|FG005|NOT COMPLETED|Received Vaccination 2||0
6608476|NCT02097472|7533856|FG006|NOT COMPLETED|Received Vaccination 2||1
6608477|NCT02097472|7533857|FG007|NOT COMPLETED|Received Vaccination 2||0
6608478|NCT02097472|7533850|FG000|STARTED|Assessed for Immunogenicity||18
6608479|NCT02097472|7533851|FG001|STARTED|Assessed for Immunogenicity||18
6608480|NCT02097472|7533852|FG002|STARTED|Assessed for Immunogenicity||18
6608481|NCT02097472|7533853|FG003|STARTED|Assessed for Immunogenicity||50
6608482|NCT02097472|7533854|FG004|STARTED|Assessed for Immunogenicity||50
6608483|NCT02097472|7533855|FG005|STARTED|Assessed for Immunogenicity||50
6608484|NCT02097472|7533856|FG006|STARTED|Assessed for Immunogenicity||49
6608485|NCT02097472|7533857|FG007|STARTED|Assessed for Immunogenicity||50
6608486|NCT02097472|7533850|FG000|COMPLETED|Assessed for Immunogenicity||18
6608487|NCT02097472|7533851|FG001|COMPLETED|Assessed for Immunogenicity||18
6608488|NCT02097472|7533852|FG002|COMPLETED|Assessed for Immunogenicity||17
6608489|NCT02097472|7533853|FG003|COMPLETED|Assessed for Immunogenicity||48
6608490|NCT02097472|7533854|FG004|COMPLETED|Assessed for Immunogenicity||50
6608491|NCT02097472|7533855|FG005|COMPLETED|Assessed for Immunogenicity||48
6608492|NCT02097472|7533856|FG006|COMPLETED|Assessed for Immunogenicity||47
6608493|NCT02097472|7533857|FG007|COMPLETED|Assessed for Immunogenicity||49
6608494|NCT02097472|7533850|FG000|NOT COMPLETED|Assessed for Immunogenicity||0
6608495|NCT02097472|7533851|FG001|NOT COMPLETED|Assessed for Immunogenicity||0
6608496|NCT02097472|7533852|FG002|NOT COMPLETED|Assessed for Immunogenicity||1
6608497|NCT02097472|7533853|FG003|NOT COMPLETED|Assessed for Immunogenicity||2
6608498|NCT02097472|7533854|FG004|NOT COMPLETED|Assessed for Immunogenicity||0
6608499|NCT02097472|7533855|FG005|NOT COMPLETED|Assessed for Immunogenicity||2
6608500|NCT02097472|7533856|FG006|NOT COMPLETED|Assessed for Immunogenicity||2
6608501|NCT02097472|7533857|FG007|NOT COMPLETED|Assessed for Immunogenicity||1
6608502|NCT02097485|7533943|FG000|STARTED|Overall Study||25
6608503|NCT02097485|7533944|FG001|STARTED|Overall Study||25
6608504|NCT02097485|7533943|FG000|COMPLETED|Overall Study||25
6608505|NCT02097485|7533944|FG001|COMPLETED|Overall Study||25
6608506|NCT02097485|7533943|FG000|NOT COMPLETED|Overall Study||0
6608507|NCT02097485|7533944|FG001|NOT COMPLETED|Overall Study||0
6608508|NCT02097537|7533950|FG000|STARTED|Overall Study||10
6608509|NCT02097537|7533950|FG000|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
6608510|NCT02097537|7533950|FG000|Follow-Up|Overall Study||10
6608511|NCT02097537|7533950|FG000|COMPLETED|Overall Study||10
6608512|NCT02097537|7533950|FG000|NOT COMPLETED|Overall Study||0
6608513|NCT02097641|7533956|FG000|STARTED|Overall Study||40
6608514|NCT02097641|7533957|FG001|STARTED|Overall Study||20
6608515|NCT02097641|7533956|FG000|COMPLETED|Overall Study||40
6608516|NCT02097641|7533957|FG001|COMPLETED|Overall Study||20
6608517|NCT02097641|7533956|FG000|NOT COMPLETED|Overall Study||0
6608518|NCT02097641|7533957|FG001|NOT COMPLETED|Overall Study||0
6608519|NCT02097719|7533967|FG000|STARTED|Overall Study||49
6608520|NCT02097719|7533968|FG001|STARTED|Overall Study||51
6608521|NCT02097719|7533967|FG000|COMPLETED|Overall Study||46
6608522|NCT02097719|7533968|FG001|COMPLETED|Overall Study||50
6608523|NCT02097719|7533967|FG000|NOT COMPLETED|Overall Study||3
6608524|NCT02097719|7533968|FG001|NOT COMPLETED|Overall Study||1
6608525|NCT02097732|7533976|FG000|STARTED|Overall Study||1
6608526|NCT02097732|7533977|FG001|STARTED|Overall Study||3
6608527|NCT02097732|7533976|FG000|COMPLETED|Overall Study||1
6608528|NCT02097732|7533977|FG001|COMPLETED|Overall Study||3
6608529|NCT02097732|7533976|FG000|NOT COMPLETED|Overall Study||0
6608530|NCT02097732|7533977|FG001|NOT COMPLETED|Overall Study||0
6608531|NCT02097745|7533984|FG000|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
6608532|NCT02097745|7533984|FG000|COMPLETED|Overall Study||157
6608533|NCT02097745|7533984|FG000|NOT COMPLETED|Overall Study||178
6608534|NCT02097823|7533993|FG000|STARTED|Overall Study||11
6608535|NCT02097823|7533994|FG001|STARTED|Overall Study||4
6608536|NCT02097823|7533993|FG000|COMPLETED|Overall Study||10
6608537|NCT02097823|7533994|FG001|COMPLETED|Overall Study||3
6608538|NCT02097823|7533993|FG000|NOT COMPLETED|Overall Study||1
6608539|NCT02097823|7533994|FG001|NOT COMPLETED|Overall Study||1
6608540|NCT02097849|7534003|FG000|STARTED|Overall Study||33
6608541|NCT02097849|7534004|FG001|STARTED|Overall Study||38
6608542|NCT02097849|7534003|FG000|COMPLETED|Overall Study||33
6608543|NCT02097849|7534004|FG001|COMPLETED|Overall Study||38
6608544|NCT02097849|7534003|FG000|NOT COMPLETED|Overall Study||0
6608545|NCT02097849|7534004|FG001|NOT COMPLETED|Overall Study||0
6608546|NCT02097992|7534014|FG000|STARTED|Treatment 1 (1 Day)||2
6608547|NCT02097992|7534015|FG001|STARTED|Treatment 1 (1 Day)||3
6608548|NCT02097992|7534016|FG002|STARTED|Treatment 1 (1 Day)||4
6608549|NCT02097992|7534017|FG003|STARTED|Treatment 1 (1 Day)||2
6608550|NCT02097992|7534014|FG000|COMPLETED|Treatment 1 (1 Day)||2
6608551|NCT02097992|7534015|FG001|COMPLETED|Treatment 1 (1 Day)||3
6608552|NCT02097992|7534016|FG002|COMPLETED|Treatment 1 (1 Day)||4
6608553|NCT02097992|7534017|FG003|COMPLETED|Treatment 1 (1 Day)||2
6608554|NCT02097992|7534014|FG000|NOT COMPLETED|Treatment 1 (1 Day)||0
6608555|NCT02097992|7534015|FG001|NOT COMPLETED|Treatment 1 (1 Day)||0
6608556|NCT02097992|7534016|FG002|NOT COMPLETED|Treatment 1 (1 Day)||0
6608557|NCT02097992|7534017|FG003|NOT COMPLETED|Treatment 1 (1 Day)||0
6608558|NCT02097992|7534014|FG000|STARTED|Treatment 2 (4 Weeks)||2
6608559|NCT02097992|7534015|FG001|STARTED|Treatment 2 (4 Weeks)||3
6608560|NCT02097992|7534016|FG002|STARTED|Treatment 2 (4 Weeks)||4
6608561|NCT02097992|7534017|FG003|STARTED|Treatment 2 (4 Weeks)||2
6608562|NCT02097992|7534014|FG000|COMPLETED|Treatment 2 (4 Weeks)||2
6608563|NCT02097992|7534015|FG001|COMPLETED|Treatment 2 (4 Weeks)||3
6608564|NCT02097992|7534016|FG002|COMPLETED|Treatment 2 (4 Weeks)||4
6608565|NCT02097992|7534017|FG003|COMPLETED|Treatment 2 (4 Weeks)||2
6608566|NCT02097992|7534014|FG000|NOT COMPLETED|Treatment 2 (4 Weeks)||0
6608567|NCT02097992|7534015|FG001|NOT COMPLETED|Treatment 2 (4 Weeks)||0
6608568|NCT02097992|7534016|FG002|NOT COMPLETED|Treatment 2 (4 Weeks)||0
6608569|NCT02097992|7534017|FG003|NOT COMPLETED|Treatment 2 (4 Weeks)||0
6608570|NCT02097992|7534014|FG000|STARTED|Washout (4 Weeks)||2
6608571|NCT02097992|7534015|FG001|STARTED|Washout (4 Weeks)||3
6608572|NCT02097992|7534016|FG002|STARTED|Washout (4 Weeks)||4
6608573|NCT02097992|7534017|FG003|STARTED|Washout (4 Weeks)||2
6608574|NCT02097992|7534014|FG000|COMPLETED|Washout (4 Weeks)||2
6608575|NCT02097992|7534015|FG001|COMPLETED|Washout (4 Weeks)||3
6608576|NCT02097992|7534016|FG002|COMPLETED|Washout (4 Weeks)||4
6608577|NCT02097992|7534017|FG003|COMPLETED|Washout (4 Weeks)||2
6608578|NCT02097992|7534014|FG000|NOT COMPLETED|Washout (4 Weeks)||0
6608579|NCT02097992|7534015|FG001|NOT COMPLETED|Washout (4 Weeks)||0
6608580|NCT02097992|7534016|FG002|NOT COMPLETED|Washout (4 Weeks)||0
6608581|NCT02097992|7534017|FG003|NOT COMPLETED|Washout (4 Weeks)||0
6608582|NCT02097992|7534014|FG000|STARTED|Treatment 3 (4 Weeks)||2
6608583|NCT02097992|7534015|FG001|STARTED|Treatment 3 (4 Weeks)||3
6608584|NCT02097992|7534016|FG002|STARTED|Treatment 3 (4 Weeks)||4
6608585|NCT02097992|7534017|FG003|STARTED|Treatment 3 (4 Weeks)||2
6608586|NCT02097992|7534014|FG000|COMPLETED|Treatment 3 (4 Weeks)||2
6608587|NCT02097992|7534015|FG001|COMPLETED|Treatment 3 (4 Weeks)||3
6608588|NCT02097992|7534016|FG002|COMPLETED|Treatment 3 (4 Weeks)||4
6608589|NCT02097992|7534017|FG003|COMPLETED|Treatment 3 (4 Weeks)||2
6608590|NCT02097992|7534014|FG000|NOT COMPLETED|Treatment 3 (4 Weeks)||0
6608591|NCT02097992|7534015|FG001|NOT COMPLETED|Treatment 3 (4 Weeks)||0
6608592|NCT02097992|7534016|FG002|NOT COMPLETED|Treatment 3 (4 Weeks)||0
6608593|NCT02097992|7534017|FG003|NOT COMPLETED|Treatment 3 (4 Weeks)||0
6608594|NCT02098109|7534027|FG000|STARTED|Overall Study||49
6608595|NCT02098109|7534028|FG001|STARTED|Overall Study||51
6608596|NCT02098109|7534027|FG000|COMPLETED|Overall Study||46
6608597|NCT02098109|7534028|FG001|COMPLETED|Overall Study||51
6608598|NCT02098109|7534027|FG000|NOT COMPLETED|Overall Study||3
6608599|NCT02098109|7534028|FG001|NOT COMPLETED|Overall Study||0
6608600|NCT02098304|7534034|FG000|STARTED|Overall Study||42
6608601|NCT02098304|7534034|FG000|COMPLETED|Overall Study||42
6608602|NCT02098304|7534034|FG000|NOT COMPLETED|Overall Study||0
6608603|NCT02098369|7534043|FG000|STARTED|Overall Study||142
6608604|NCT02098369|7534044|FG001|STARTED|Overall Study||154
6608605|NCT02098369|7534045|FG002|STARTED|Overall Study||148
6608606|NCT02098369|7534043|FG000|COMPLETED|Overall Study||135
6608607|NCT02098369|7534044|FG001|COMPLETED|Overall Study||145
6608608|NCT02098369|7534045|FG002|COMPLETED|Overall Study||143
6608609|NCT02098369|7534043|FG000|NOT COMPLETED|Overall Study||7
6608610|NCT02098369|7534044|FG001|NOT COMPLETED|Overall Study||9
6608611|NCT02098369|7534045|FG002|NOT COMPLETED|Overall Study||5
6608612|NCT02098395|7534057|FG000|STARTED|Overall Study||212
6608613|NCT02098395|7534058|FG001|STARTED|Overall Study||209
6608614|NCT02098395|7534059|FG002|STARTED|Overall Study||207
6608615|NCT02098395|7534060|FG003|STARTED|Overall Study||207
6608616|NCT02098395|7534057|FG000|Exposed|Overall Study||211
6608617|NCT02098395|7534058|FG001|Exposed|Overall Study||209
6608618|NCT02098395|7534059|FG002|Exposed|Overall Study||206
6608619|NCT02098395|7534060|FG003|Exposed|Overall Study||206
6608620|NCT02098395|7534057|FG000|COMPLETED|Overall Study||186
6608621|NCT02098395|7534058|FG001|COMPLETED|Overall Study||177
6608622|NCT02098395|7534059|FG002|COMPLETED|Overall Study||165
6608623|NCT02098395|7534060|FG003|COMPLETED|Overall Study||180
6608624|NCT02098395|7534057|FG000|NOT COMPLETED|Overall Study||26
6608625|NCT02098395|7534058|FG001|NOT COMPLETED|Overall Study||32
6608626|NCT02098395|7534059|FG002|NOT COMPLETED|Overall Study||42
6608627|NCT02098395|7534060|FG003|NOT COMPLETED|Overall Study||27
6608628|NCT02098733|7534070|FG000|STARTED|Overall Study||1168
6608629|NCT02098733|7534070|FG000|COMPLETED|Overall Study||1158
6608630|NCT02098733|7534070|FG000|NOT COMPLETED|Overall Study||10
6608631|NCT02098746|7534074|FG000|STARTED|Overall Study||294
6608632|NCT02098746|7534074|FG000|COMPLETED|Overall Study||289
6608633|NCT02098746|7534074|FG000|NOT COMPLETED|Overall Study||5
6608634|NCT02098993|7534080|FG000|STARTED|Overall Study||4
6608635|NCT02098993|7534081|FG001|STARTED|Overall Study||3
6608636|NCT02098993|7534080|FG000|COMPLETED|Overall Study||4
6608637|NCT02098993|7534081|FG001|COMPLETED|Overall Study||3
6608638|NCT02098993|7534080|FG000|NOT COMPLETED|Overall Study||0
6608639|NCT02098993|7534081|FG001|NOT COMPLETED|Overall Study||0
6608640|NCT02099006|7534087|FG000|STARTED|Overall Study||9
6608641|NCT02099006|7534087|FG000|Received Placebo|Overall Study||9
6608642|NCT02099006|7534087|FG000|Received Amitriptyline/ Baclofen|Overall Study||7
6608643|NCT02099006|7534087|FG000|Received Ketoprofen|Overall Study||3
6608644|NCT02099006|7534087|FG000|Received Loperamide|Overall Study||7
6608645|NCT02099006|7534087|FG000|Received Ketamine|Overall Study||6
6608646|NCT02099006|7534087|FG000|Received Gabapentin|Overall Study||8
6608647|NCT02099006|7534087|FG000|COMPLETED|Overall Study||8
6608648|NCT02099006|7534087|FG000|NOT COMPLETED|Overall Study||1
6608649|NCT02099084|7534093|FG000|STARTED|First Intervention||4
6608650|NCT02099084|7534094|FG001|STARTED|First Intervention||4
6608651|NCT02099084|7534093|FG000|COMPLETED|First Intervention||4
6608652|NCT02099084|7534094|FG001|COMPLETED|First Intervention||4
6608653|NCT02099084|7534093|FG000|NOT COMPLETED|First Intervention||0
6608654|NCT02099084|7534094|FG001|NOT COMPLETED|First Intervention||0
6608655|NCT02099084|7534093|FG000|STARTED|Washout Period of 14 Days||4
6608656|NCT02099084|7534094|FG001|STARTED|Washout Period of 14 Days||4
6608657|NCT02099084|7534093|FG000|COMPLETED|Washout Period of 14 Days||4
6608658|NCT02099084|7534094|FG001|COMPLETED|Washout Period of 14 Days||4
6608659|NCT02099084|7534093|FG000|NOT COMPLETED|Washout Period of 14 Days||0
6608660|NCT02099084|7534094|FG001|NOT COMPLETED|Washout Period of 14 Days||0
6608661|NCT02099084|7534093|FG000|STARTED|Second Intervention||4
6608662|NCT02099084|7534094|FG001|STARTED|Second Intervention||4
6608663|NCT02099084|7534093|FG000|COMPLETED|Second Intervention||4
6608664|NCT02099084|7534094|FG001|COMPLETED|Second Intervention||4
6608665|NCT02099084|7534093|FG000|NOT COMPLETED|Second Intervention||0
6608666|NCT02099084|7534094|FG001|NOT COMPLETED|Second Intervention||0
6608667|NCT02099110|7534105|FG000|STARTED|Overall Study||250
6608668|NCT02099110|7534106|FG001|STARTED|Overall Study||248
6608669|NCT02099110|7534107|FG002|STARTED|Overall Study||247
6608670|NCT02099110|7534108|FG003|STARTED|Overall Study||243
6608671|NCT02099110|7534109|FG004|STARTED|Overall Study||245
6608672|NCT02099110|7534105|FG000|Treated|Overall Study||250
6608673|NCT02099110|7534106|FG001|Treated|Overall Study||248
6608674|NCT02099110|7534107|FG002|Treated|Overall Study||247
6608675|NCT02099110|7534108|FG003|Treated|Overall Study||243
6608676|NCT02099110|7534109|FG004|Treated|Overall Study||244
6608677|NCT02099110|7534105|FG000|COMPLETED|Overall Study||226
6608678|NCT02099110|7534106|FG001|COMPLETED|Overall Study||217
6608679|NCT02099110|7534107|FG002|COMPLETED|Overall Study||219
6608680|NCT02099110|7534108|FG003|COMPLETED|Overall Study||221
6608681|NCT02099110|7534109|FG004|COMPLETED|Overall Study||218
6608682|NCT02099110|7534105|FG000|NOT COMPLETED|Overall Study||24
6608683|NCT02099110|7534106|FG001|NOT COMPLETED|Overall Study||31
6608684|NCT02099110|7534107|FG002|NOT COMPLETED|Overall Study||28
6608685|NCT02099110|7534108|FG003|NOT COMPLETED|Overall Study||22
6608686|NCT02099110|7534109|FG004|NOT COMPLETED|Overall Study||27
6608687|NCT02099266|7534121|FG000|STARTED|Overall Study||15
6608688|NCT02099266|7534121|FG000|COMPLETED|Overall Study||15
6608689|NCT02099266|7534121|FG000|NOT COMPLETED|Overall Study||0
6608690|NCT02099461|7534131|FG000|STARTED|Overall Study||27
6608691|NCT02099461|7534132|FG001|STARTED|Overall Study||27
6608692|NCT02099461|7534133|FG002|STARTED|Overall Study||28
6608693|NCT02099461|7534131|FG000|COMPLETED|Overall Study||27
6608694|NCT02099461|7534132|FG001|COMPLETED|Overall Study||27
6608695|NCT02099461|7534133|FG002|COMPLETED|Overall Study||28
6608696|NCT02099461|7534131|FG000|NOT COMPLETED|Overall Study||0
6608697|NCT02099461|7534132|FG001|NOT COMPLETED|Overall Study||0
6608698|NCT02099461|7534133|FG002|NOT COMPLETED|Overall Study||0
6608699|NCT02099682|7534141|FG000|STARTED|Overall Study|Number of cases.|3366
6608700|NCT02099682|7534141|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
6608701|NCT02099682|7534141|FG000|COMPLETED|Overall Study||3255
6608702|NCT02099682|7534141|FG000|NOT COMPLETED|Overall Study||111
6608703|NCT02099708|7534145|FG000|STARTED|Overall Study|Number of cases.|3502
6608704|NCT02099708|7534145|FG000|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
6608705|NCT02099708|7534145|FG000|COMPLETED|Overall Study||3302
6608706|NCT02099708|7534145|FG000|NOT COMPLETED|Overall Study||200
6608707|NCT02099721|7534155|FG000|STARTED|Overall Study||1066
6608708|NCT02099721|7534156|FG001|STARTED|Overall Study||127
6608709|NCT02099721|7534157|FG002|STARTED|Overall Study||1068
6608710|NCT02099721|7534158|FG003|STARTED|Overall Study||845
6608711|NCT02099721|7534159|FG004|STARTED|Overall Study||331
6608712|NCT02099721|7534160|FG005|STARTED|Overall Study||452
6608713|NCT02099721|7534155|FG000|COMPLETED|Overall Study||990
6608714|NCT02099721|7534156|FG001|COMPLETED|Overall Study|Not implanted secondary patients were automatically exited.|0
6608715|NCT02099721|7534157|FG002|COMPLETED|Overall Study||983
6608716|NCT02099721|7534158|FG003|COMPLETED|Overall Study||774
6608717|NCT02099721|7534159|FG004|COMPLETED|Overall Study||304
6608718|NCT02099721|7534160|FG005|COMPLETED|Overall Study||432
6608719|NCT02099721|7534155|FG000|NOT COMPLETED|Overall Study||76
6608720|NCT02099721|7534156|FG001|NOT COMPLETED|Overall Study||127
6608721|NCT02099721|7534157|FG002|NOT COMPLETED|Overall Study||85
6608722|NCT02099721|7534158|FG003|NOT COMPLETED|Overall Study||71
6608723|NCT02099721|7534159|FG004|NOT COMPLETED|Overall Study||27
6608724|NCT02099721|7534160|FG005|NOT COMPLETED|Overall Study||20
6608725|NCT02099786|7534174|FG000|STARTED|Overall Study||24
6608726|NCT02099786|7534175|FG001|STARTED|Overall Study||23
6608727|NCT02099786|7534174|FG000|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|24
6608728|NCT02099786|7534175|FG001|Program Eval 1|Overall Study|Baseline (prior to randomization and first cisplatin dose)|23
6608729|NCT02099786|7534174|FG000|Program Eval 2|Overall Study|One month post randomization|23
6608730|NCT02099786|7534175|FG001|Program Eval 2|Overall Study|One month post randomization|19
6608731|NCT02099786|7534174|FG000|Program Eval 3|Overall Study|One year post randomization|21
6608732|NCT02099786|7534175|FG001|Program Eval 3|Overall Study|One year post randomization|15
6608733|NCT02099786|7534174|FG000|COMPLETED|Overall Study||21
6608734|NCT02099786|7534175|FG001|COMPLETED|Overall Study||15
6608735|NCT02099786|7534174|FG000|NOT COMPLETED|Overall Study||3
6608736|NCT02099786|7534175|FG001|NOT COMPLETED|Overall Study||8
6608737|NCT02099799|7534184|FG000|STARTED|Overall Study||75
6608738|NCT02099799|7534185|FG001|STARTED|Overall Study||78
6608739|NCT02099799|7534184|FG000|COMPLETED|Overall Study||60
6608740|NCT02099799|7534185|FG001|COMPLETED|Overall Study||54
6608741|NCT02099799|7534184|FG000|NOT COMPLETED|Overall Study||15
6608742|NCT02099799|7534185|FG001|NOT COMPLETED|Overall Study||24
6608743|NCT02099838|7534195|FG000|STARTED|Overall Study||47
6608744|NCT02099838|7534196|FG001|STARTED|Overall Study||51
6608745|NCT02099838|7534195|FG000|COMPLETED|Overall Study||43
6608746|NCT02099838|7534196|FG001|COMPLETED|Overall Study||49
6608747|NCT02099838|7534195|FG000|NOT COMPLETED|Overall Study||4
6608748|NCT02099838|7534196|FG001|NOT COMPLETED|Overall Study||2
6608749|NCT02099864|7534202|FG000|STARTED|Overall Study||36
6608750|NCT02099864|7534202|FG000|COMPLETED|Overall Study||36
6608751|NCT02099864|7534202|FG000|NOT COMPLETED|Overall Study||0
6608752|NCT02100007|7534210|FG000|STARTED|Overall Study||46
6608753|NCT02100007|7534210|FG000|COMPLETED|Overall Study||46
6608754|NCT02100007|7534210|FG000|NOT COMPLETED|Overall Study||0
6608755|NCT02100072|7534215|FG000|STARTED|Overall Study||5
6608756|NCT02100072|7534215|FG000|COMPLETED|Overall Study||5
6608757|NCT02100072|7534215|FG000|NOT COMPLETED|Overall Study||0
6608758|NCT02100124|7534222|FG000|STARTED|Overall Study||329
6608759|NCT02100124|7534223|FG001|STARTED|Overall Study||329
6608760|NCT02100124|7534224|FG002|STARTED|Overall Study||326
6608761|NCT02100124|7534222|FG000|COMPLETED|Overall Study||323
6608762|NCT02100124|7534223|FG001|COMPLETED|Overall Study||318
6608763|NCT02100124|7534224|FG002|COMPLETED|Overall Study||323
6608764|NCT02100124|7534222|FG000|NOT COMPLETED|Overall Study||6
6608765|NCT02100124|7534223|FG001|NOT COMPLETED|Overall Study||11
6608766|NCT02100124|7534224|FG002|NOT COMPLETED|Overall Study||3
6608767|NCT02100189|7534232|FG000|STARTED|Overall Study||50
6608768|NCT02100189|7534232|FG000|COMPLETED|Overall Study||50
6608769|NCT02100189|7534232|FG000|NOT COMPLETED|Overall Study||0
6608770|NCT02100228|7534238|FG000|STARTED|Overall Study|735 treated with Apixaban|753
6608771|NCT02100228|7534239|FG001|STARTED|Overall Study|721 treated with Usual Care|747
6608772|NCT02100228|7534238|FG000|COMPLETED|Overall Study||678
6608773|NCT02100228|7534239|FG001|COMPLETED|Overall Study||657
6608774|NCT02100228|7534238|FG000|NOT COMPLETED|Overall Study||75
6608775|NCT02100228|7534239|FG001|NOT COMPLETED|Overall Study||90
6608776|NCT02100280|7534247|FG000|STARTED|Overall Study||48
6608777|NCT02100280|7534248|FG001|STARTED|Overall Study||48
6608778|NCT02100280|7534247|FG000|COMPLETED|Overall Study||44
6608779|NCT02100280|7534248|FG001|COMPLETED|Overall Study||44
6608780|NCT02100280|7534247|FG000|NOT COMPLETED|Overall Study||4
6608781|NCT02100280|7534248|FG001|NOT COMPLETED|Overall Study||4
6608782|NCT02100319|7534256|FG000|STARTED|Overall Study||387
6608783|NCT02100319|7534256|FG000|COMPLETED|Overall Study||371
6608784|NCT02100319|7534256|FG000|NOT COMPLETED|Overall Study||16
6608785|NCT02100410|7534260|FG000|STARTED|Exposure Pair 1, 30 Minutes||8
6608786|NCT02100410|7534261|FG001|STARTED|Exposure Pair 1, 30 Minutes||8
6608787|NCT02100410|7534262|FG002|STARTED|Exposure Pair 1, 30 Minutes||8
6608788|NCT02100410|7534263|FG003|STARTED|Exposure Pair 1, 30 Minutes||8
6608789|NCT02100410|7534264|FG004|STARTED|Exposure Pair 1, 30 Minutes||8
6608790|NCT02100410|7534265|FG005|STARTED|Exposure Pair 1, 30 Minutes||9
6608791|NCT02100410|7534260|FG000|COMPLETED|Exposure Pair 1, 30 Minutes||8
6608792|NCT02100410|7534261|FG001|COMPLETED|Exposure Pair 1, 30 Minutes||8
6608793|NCT02100410|7534262|FG002|COMPLETED|Exposure Pair 1, 30 Minutes||8
6608794|NCT02100410|7534263|FG003|COMPLETED|Exposure Pair 1, 30 Minutes||8
6608795|NCT02100410|7534264|FG004|COMPLETED|Exposure Pair 1, 30 Minutes||8
6608796|NCT02100410|7534265|FG005|COMPLETED|Exposure Pair 1, 30 Minutes||9
6608797|NCT02100410|7534260|FG000|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6608798|NCT02100410|7534261|FG001|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6608799|NCT02100410|7534262|FG002|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6608800|NCT02100410|7534263|FG003|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6608801|NCT02100410|7534264|FG004|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6608802|NCT02100410|7534265|FG005|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
6608803|NCT02100410|7534260|FG000|STARTED|Exposure Pair 2, 30 Minutes||8
6608804|NCT02100410|7534261|FG001|STARTED|Exposure Pair 2, 30 Minutes||8
6608805|NCT02100410|7534262|FG002|STARTED|Exposure Pair 2, 30 Minutes||8
6608806|NCT02100410|7534263|FG003|STARTED|Exposure Pair 2, 30 Minutes||8
6608807|NCT02100410|7534264|FG004|STARTED|Exposure Pair 2, 30 Minutes||8
6608808|NCT02100410|7534265|FG005|STARTED|Exposure Pair 2, 30 Minutes||9
6608809|NCT02100410|7534260|FG000|COMPLETED|Exposure Pair 2, 30 Minutes||8
6608810|NCT02100410|7534261|FG001|COMPLETED|Exposure Pair 2, 30 Minutes||8
6608811|NCT02100410|7534262|FG002|COMPLETED|Exposure Pair 2, 30 Minutes||8
6608812|NCT02100410|7534263|FG003|COMPLETED|Exposure Pair 2, 30 Minutes||8
6608813|NCT02100410|7534264|FG004|COMPLETED|Exposure Pair 2, 30 Minutes||8
6608814|NCT02100410|7534265|FG005|COMPLETED|Exposure Pair 2, 30 Minutes||9
6608815|NCT02100410|7534260|FG000|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6608816|NCT02100410|7534261|FG001|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6608817|NCT02100410|7534262|FG002|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6608818|NCT02100410|7534263|FG003|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6608819|NCT02100410|7534264|FG004|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6608820|NCT02100410|7534265|FG005|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
6608821|NCT02100410|7534260|FG000|STARTED|Exposure Pair 3, 30 Minutes||8
6608822|NCT02100410|7534261|FG001|STARTED|Exposure Pair 3, 30 Minutes||8
6608823|NCT02100410|7534262|FG002|STARTED|Exposure Pair 3, 30 Minutes||8
6608824|NCT02100410|7534263|FG003|STARTED|Exposure Pair 3, 30 Minutes||8
6608825|NCT02100410|7534264|FG004|STARTED|Exposure Pair 3, 30 Minutes||8
6608826|NCT02100410|7534265|FG005|STARTED|Exposure Pair 3, 30 Minutes||9
6608827|NCT02100410|7534260|FG000|COMPLETED|Exposure Pair 3, 30 Minutes||8
6608828|NCT02100410|7534261|FG001|COMPLETED|Exposure Pair 3, 30 Minutes||8
6608829|NCT02100410|7534262|FG002|COMPLETED|Exposure Pair 3, 30 Minutes||8
6608830|NCT02100410|7534263|FG003|COMPLETED|Exposure Pair 3, 30 Minutes||8
6608831|NCT02100410|7534264|FG004|COMPLETED|Exposure Pair 3, 30 Minutes||8
6608832|NCT02100410|7534265|FG005|COMPLETED|Exposure Pair 3, 30 Minutes||9
6608833|NCT02100410|7534260|FG000|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6608834|NCT02100410|7534261|FG001|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6608835|NCT02100410|7534262|FG002|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6608836|NCT02100410|7534263|FG003|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6608837|NCT02100410|7534264|FG004|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6608838|NCT02100410|7534265|FG005|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
6608839|NCT02100475|7534279|FG000|STARTED|Overall Study||16
6608840|NCT02100475|7534280|FG001|STARTED|Overall Study||15
6608841|NCT02100475|7534279|FG000|COMPLETED|Overall Study||14
6608842|NCT02100475|7534280|FG001|COMPLETED|Overall Study||13
6732330|NCT03192488|7661741|FG005|NOT COMPLETED|First Intervention (d1)||0
6732331|NCT03192488|7661736|FG000|STARTED|First Washout (>6d)||1
6732332|NCT03192488|7661737|FG001|STARTED|First Washout (>6d)||5
6732333|NCT03192488|7661738|FG002|STARTED|First Washout (>6d)||2
6732334|NCT03192488|7661739|FG003|STARTED|First Washout (>6d)||1
6732335|NCT03192488|7661740|FG004|STARTED|First Washout (>6d)||1
6732336|NCT03192488|7661741|FG005|STARTED|First Washout (>6d)||1
6732337|NCT03192488|7661736|FG000|COMPLETED|First Washout (>6d)||1
6732338|NCT03192488|7661737|FG001|COMPLETED|First Washout (>6d)||5
6732339|NCT03192488|7661738|FG002|COMPLETED|First Washout (>6d)||1
6732340|NCT03192488|7661739|FG003|COMPLETED|First Washout (>6d)||1
6732341|NCT03192488|7661740|FG004|COMPLETED|First Washout (>6d)||1
6732342|NCT03192488|7661741|FG005|COMPLETED|First Washout (>6d)||0
6732343|NCT03192488|7661736|FG000|NOT COMPLETED|First Washout (>6d)||0
6732344|NCT03192488|7661737|FG001|NOT COMPLETED|First Washout (>6d)||0
6732345|NCT03192488|7661738|FG002|NOT COMPLETED|First Washout (>6d)||1
6732346|NCT03192488|7661739|FG003|NOT COMPLETED|First Washout (>6d)||0
6732347|NCT03192488|7661740|FG004|NOT COMPLETED|First Washout (>6d)||0
6732348|NCT03192488|7661741|FG005|NOT COMPLETED|First Washout (>6d)||1
6732349|NCT03192488|7661736|FG000|STARTED|Second Intervention (d1)||1
6732350|NCT03192488|7661737|FG001|STARTED|Second Intervention (d1)||5
6732351|NCT03192488|7661738|FG002|STARTED|Second Intervention (d1)||1
6732352|NCT03192488|7661739|FG003|STARTED|Second Intervention (d1)||1
6732353|NCT03192488|7661740|FG004|STARTED|Second Intervention (d1)||1
6732354|NCT03192488|7661741|FG005|STARTED|Second Intervention (d1)||0
6732355|NCT03192488|7661736|FG000|COMPLETED|Second Intervention (d1)||1
6732356|NCT03192488|7661737|FG001|COMPLETED|Second Intervention (d1)||5
6732357|NCT03192488|7661738|FG002|COMPLETED|Second Intervention (d1)||1
6732358|NCT03192488|7661739|FG003|COMPLETED|Second Intervention (d1)||1
6732359|NCT03192488|7661740|FG004|COMPLETED|Second Intervention (d1)||1
6732360|NCT03192488|7661741|FG005|COMPLETED|Second Intervention (d1)||0
6608843|NCT02100475|7534279|FG000|NOT COMPLETED|Overall Study||2
6608844|NCT02100475|7534280|FG001|NOT COMPLETED|Overall Study||2
6608845|NCT02100514|7534288|FG000|STARTED|Treatment Period||247
6608846|NCT02100514|7534289|FG001|STARTED|Treatment Period||499
6608847|NCT02100514|7534290|FG002|STARTED|Treatment Period||0
6608848|NCT02100514|7534291|FG003|STARTED|Treatment Period||0
6608849|NCT02100514|7534292|FG004|STARTED|Treatment Period||0
6608850|NCT02100514|7534288|FG000|COMPLETED|Treatment Period||218
6608851|NCT02100514|7534289|FG001|COMPLETED|Treatment Period||425
6608852|NCT02100514|7534290|FG002|COMPLETED|Treatment Period||0
6608853|NCT02100514|7534291|FG003|COMPLETED|Treatment Period||0
6608854|NCT02100514|7534292|FG004|COMPLETED|Treatment Period||0
6608855|NCT02100514|7534288|FG000|NOT COMPLETED|Treatment Period||29
6608856|NCT02100514|7534289|FG001|NOT COMPLETED|Treatment Period||74
6608857|NCT02100514|7534290|FG002|NOT COMPLETED|Treatment Period||0
6608858|NCT02100514|7534291|FG003|NOT COMPLETED|Treatment Period||0
6608859|NCT02100514|7534292|FG004|NOT COMPLETED|Treatment Period||0
6608860|NCT02100514|7534288|FG000|STARTED|Extension Period||0
6608861|NCT02100514|7534289|FG001|STARTED|Extension Period||0
6608862|NCT02100514|7534290|FG002|STARTED|Extension Period||44
6608863|NCT02100514|7534291|FG003|STARTED|Extension Period||33
6608864|NCT02100514|7534292|FG004|STARTED|Extension Period||56
6608865|NCT02100514|7534288|FG000|COMPLETED|Extension Period||0
6608866|NCT02100514|7534289|FG001|COMPLETED|Extension Period||0
6608867|NCT02100514|7534290|FG002|COMPLETED|Extension Period||42
6608868|NCT02100514|7534291|FG003|COMPLETED|Extension Period||33
6608869|NCT02100514|7534292|FG004|COMPLETED|Extension Period||56
6608870|NCT02100514|7534288|FG000|NOT COMPLETED|Extension Period||0
6608871|NCT02100514|7534289|FG001|NOT COMPLETED|Extension Period||0
6608872|NCT02100514|7534290|FG002|NOT COMPLETED|Extension Period||2
6608873|NCT02100514|7534291|FG003|NOT COMPLETED|Extension Period||0
6608874|NCT02100514|7534292|FG004|NOT COMPLETED|Extension Period||0
6608875|NCT02100579|7534308|FG000|STARTED|Overall Study||20
6608876|NCT02100579|7534309|FG001|STARTED|Overall Study||20
6608877|NCT02100579|7534308|FG000|COMPLETED|Overall Study||20
6608878|NCT02100579|7534309|FG001|COMPLETED|Overall Study||20
6608879|NCT02100579|7534308|FG000|NOT COMPLETED|Overall Study||0
6608880|NCT02100579|7534309|FG001|NOT COMPLETED|Overall Study||0
6608881|NCT02100631|7534318|FG000|STARTED|Overall Study||299
6608882|NCT02100631|7534319|FG001|STARTED|Overall Study||99
6608883|NCT02100631|7534320|FG002|STARTED|Overall Study||2688
6608884|NCT02100631|7534318|FG000|COMPLETED|Overall Study||292
6608885|NCT02100631|7534319|FG001|COMPLETED|Overall Study||95
6608886|NCT02100631|7534320|FG002|COMPLETED|Overall Study||2688
6608887|NCT02100631|7534318|FG000|NOT COMPLETED|Overall Study||7
6608888|NCT02100631|7534319|FG001|NOT COMPLETED|Overall Study||4
6608889|NCT02100631|7534320|FG002|NOT COMPLETED|Overall Study||0
6608890|NCT02100644|7534328|FG000|STARTED|LTG Escalation Phase||33
6608891|NCT02100644|7534329|FG001|STARTED|LTG Escalation Phase||0
6608892|NCT02100644|7534330|FG002|STARTED|LTG Escalation Phase||0
6608893|NCT02100644|7534328|FG000|COMPLETED|LTG Escalation Phase||20
6608894|NCT02100644|7534329|FG001|COMPLETED|LTG Escalation Phase||0
6608895|NCT02100644|7534330|FG002|COMPLETED|LTG Escalation Phase||0
6608896|NCT02100644|7534328|FG000|NOT COMPLETED|LTG Escalation Phase||13
6608897|NCT02100644|7534329|FG001|NOT COMPLETED|LTG Escalation Phase||0
6608898|NCT02100644|7534330|FG002|NOT COMPLETED|LTG Escalation Phase||0
6608899|NCT02100644|7534328|FG000|STARTED|VPA Reduction Phase||0
6608900|NCT02100644|7534329|FG001|STARTED|VPA Reduction Phase||20
6608901|NCT02100644|7534330|FG002|STARTED|VPA Reduction Phase||0
6608902|NCT02100644|7534328|FG000|COMPLETED|VPA Reduction Phase||0
6608903|NCT02100644|7534329|FG001|COMPLETED|VPA Reduction Phase||20
6608904|NCT02100644|7534330|FG002|COMPLETED|VPA Reduction Phase||0
6608905|NCT02100644|7534328|FG000|NOT COMPLETED|VPA Reduction Phase||0
6608906|NCT02100644|7534329|FG001|NOT COMPLETED|VPA Reduction Phase||0
6608907|NCT02100644|7534330|FG002|NOT COMPLETED|VPA Reduction Phase||0
6608908|NCT02100644|7534328|FG000|STARTED|LTG and VPA Maintenance Phase||0
6608909|NCT02100644|7534329|FG001|STARTED|LTG and VPA Maintenance Phase||0
6608910|NCT02100644|7534330|FG002|STARTED|LTG and VPA Maintenance Phase||20
6608911|NCT02100644|7534328|FG000|COMPLETED|LTG and VPA Maintenance Phase||0
6608912|NCT02100644|7534329|FG001|COMPLETED|LTG and VPA Maintenance Phase||0
6608913|NCT02100644|7534330|FG002|COMPLETED|LTG and VPA Maintenance Phase||20
6608914|NCT02100644|7534328|FG000|NOT COMPLETED|LTG and VPA Maintenance Phase||0
6608915|NCT02100644|7534329|FG001|NOT COMPLETED|LTG and VPA Maintenance Phase||0
6608916|NCT02100644|7534330|FG002|NOT COMPLETED|LTG and VPA Maintenance Phase||0
6608917|NCT02100657|7534337|FG000|STARTED|Cohort 1: Dose Level 1||8
6608918|NCT02100657|7534338|FG001|STARTED|Cohort 1: Dose Level 1||0
6608919|NCT02100657|7534339|FG002|STARTED|Cohort 1: Dose Level 1||0
6608920|NCT02100657|7534337|FG000|COMPLETED|Cohort 1: Dose Level 1||0
6608921|NCT02100657|7534338|FG001|COMPLETED|Cohort 1: Dose Level 1||0
6608922|NCT02100657|7534339|FG002|COMPLETED|Cohort 1: Dose Level 1||0
6608923|NCT02100657|7534337|FG000|NOT COMPLETED|Cohort 1: Dose Level 1||8
6608924|NCT02100657|7534338|FG001|NOT COMPLETED|Cohort 1: Dose Level 1||0
6608925|NCT02100657|7534339|FG002|NOT COMPLETED|Cohort 1: Dose Level 1||0
6608926|NCT02100657|7534337|FG000|STARTED|Cohort 2: Dose Level 2||0
6608927|NCT02100657|7534338|FG001|STARTED|Cohort 2: Dose Level 2||4
6608928|NCT02100657|7534339|FG002|STARTED|Cohort 2: Dose Level 2||0
6608929|NCT02100657|7534337|FG000|COMPLETED|Cohort 2: Dose Level 2||0
6608930|NCT02100657|7534338|FG001|COMPLETED|Cohort 2: Dose Level 2||0
6608931|NCT02100657|7534339|FG002|COMPLETED|Cohort 2: Dose Level 2||0
6608932|NCT02100657|7534337|FG000|NOT COMPLETED|Cohort 2: Dose Level 2||0
6608933|NCT02100657|7534338|FG001|NOT COMPLETED|Cohort 2: Dose Level 2||4
6608934|NCT02100657|7534339|FG002|NOT COMPLETED|Cohort 2: Dose Level 2||0
6608935|NCT02100657|7534337|FG000|STARTED|Cohort 3: Dose Level 3||0
6608936|NCT02100657|7534338|FG001|STARTED|Cohort 3: Dose Level 3||0
6608937|NCT02100657|7534339|FG002|STARTED|Cohort 3: Dose Level 3||27
6608938|NCT02100657|7534337|FG000|COMPLETED|Cohort 3: Dose Level 3||0
6608939|NCT02100657|7534338|FG001|COMPLETED|Cohort 3: Dose Level 3||0
6608940|NCT02100657|7534339|FG002|COMPLETED|Cohort 3: Dose Level 3||0
6608941|NCT02100657|7534337|FG000|NOT COMPLETED|Cohort 3: Dose Level 3||0
6608942|NCT02100657|7534338|FG001|NOT COMPLETED|Cohort 3: Dose Level 3||0
6608943|NCT02100657|7534339|FG002|NOT COMPLETED|Cohort 3: Dose Level 3||27
6608944|NCT02100670|7534352|FG000|STARTED|Overall Study||118
6608945|NCT02100670|7534353|FG001|STARTED|Overall Study||113
6608946|NCT02100670|7534354|FG002|STARTED|Overall Study||78
6608947|NCT02100670|7534355|FG003|STARTED|Overall Study||76
6608948|NCT02100670|7534352|FG000|COMPLETED|Overall Study||105
6608949|NCT02100670|7534353|FG001|COMPLETED|Overall Study||106
6608950|NCT02100670|7534354|FG002|COMPLETED|Overall Study||74
6608951|NCT02100670|7534355|FG003|COMPLETED|Overall Study||75
6608952|NCT02100670|7534352|FG000|NOT COMPLETED|Overall Study||13
6608953|NCT02100670|7534353|FG001|NOT COMPLETED|Overall Study||7
6608954|NCT02100670|7534354|FG002|NOT COMPLETED|Overall Study||4
6608955|NCT02100670|7534355|FG003|NOT COMPLETED|Overall Study||1
6608956|NCT02100696|7534378|FG000|STARTED|Induction Phase||130
6608957|NCT02100696|7534379|FG001|STARTED|Induction Phase||95
6608958|NCT02100696|7534380|FG002|STARTED|Induction Phase||384
6608959|NCT02100696|7534381|FG003|STARTED|Induction Phase||0
6608960|NCT02100696|7534382|FG004|STARTED|Induction Phase||0
6608961|NCT02100696|7534383|FG005|STARTED|Induction Phase||0
6608962|NCT02100696|7534378|FG000|COMPLETED|Induction Phase||115
6608963|NCT02100696|7534379|FG001|COMPLETED|Induction Phase||90
6608964|NCT02100696|7534380|FG002|COMPLETED|Induction Phase||358
6608965|NCT02100696|7534381|FG003|COMPLETED|Induction Phase||0
6608966|NCT02100696|7534382|FG004|COMPLETED|Induction Phase||0
6608967|NCT02100696|7534383|FG005|COMPLETED|Induction Phase||0
6608968|NCT02100696|7534378|FG000|NOT COMPLETED|Induction Phase||15
6608969|NCT02100696|7534379|FG001|NOT COMPLETED|Induction Phase||5
6608970|NCT02100696|7534380|FG002|NOT COMPLETED|Induction Phase||26
6608971|NCT02100696|7534381|FG003|NOT COMPLETED|Induction Phase||0
6608972|NCT02100696|7534382|FG004|NOT COMPLETED|Induction Phase||0
6608973|NCT02100696|7534383|FG005|NOT COMPLETED|Induction Phase||0
6608974|NCT02100696|7534378|FG000|STARTED|Maintenance Phase||0
6608975|NCT02100696|7534379|FG001|STARTED|Maintenance Phase||0
6608976|NCT02100696|7534380|FG002|STARTED|Maintenance Phase||0
6608977|NCT02100696|7534381|FG003|STARTED|Maintenance Phase||27
6608978|NCT02100696|7534382|FG004|STARTED|Maintenance Phase||115
6608979|NCT02100696|7534383|FG005|STARTED|Maintenance Phase||117
6608980|NCT02100696|7534378|FG000|COMPLETED|Maintenance Phase||0
6608981|NCT02100696|7534379|FG001|COMPLETED|Maintenance Phase||0
6608982|NCT02100696|7534380|FG002|COMPLETED|Maintenance Phase||0
6608983|NCT02100696|7534381|FG003|COMPLETED|Maintenance Phase||26
6608984|NCT02100696|7534382|FG004|COMPLETED|Maintenance Phase||106
6608985|NCT02100696|7534383|FG005|COMPLETED|Maintenance Phase||112
6608986|NCT02100696|7534378|FG000|NOT COMPLETED|Maintenance Phase||0
6608987|NCT02100696|7534379|FG001|NOT COMPLETED|Maintenance Phase||0
6608988|NCT02100696|7534380|FG002|NOT COMPLETED|Maintenance Phase||0
6608989|NCT02100696|7534381|FG003|NOT COMPLETED|Maintenance Phase||1
6608990|NCT02100696|7534382|FG004|NOT COMPLETED|Maintenance Phase||9
6608991|NCT02100696|7534383|FG005|NOT COMPLETED|Maintenance Phase||5
6608992|NCT02100748|7534416|FG000|STARTED|Overall Study||25
6608993|NCT02100748|7534417|FG001|STARTED|Overall Study||24
6608994|NCT02100748|7534418|FG002|STARTED|Overall Study||22
6608995|NCT02100748|7534419|FG003|STARTED|Overall Study||22
6608996|NCT02100748|7534420|FG004|STARTED|Overall Study||25
6608997|NCT02100748|7534421|FG005|STARTED|Overall Study||23
6608998|NCT02100748|7534422|FG006|STARTED|Overall Study||20
6608999|NCT02100748|7534423|FG007|STARTED|Overall Study||38
6609000|NCT02100748|7534424|FG008|STARTED|Overall Study||36
6609001|NCT02100748|7534425|FG009|STARTED|Overall Study||31
6609002|NCT02100748|7534426|FG010|STARTED|Overall Study||28
6609003|NCT02100748|7534427|FG011|STARTED|Overall Study||39
6609004|NCT02100748|7534416|FG000|COMPLETED|Overall Study||23
6609005|NCT02100748|7534417|FG001|COMPLETED|Overall Study||23
6609006|NCT02100748|7534418|FG002|COMPLETED|Overall Study||21
6609007|NCT02100748|7534419|FG003|COMPLETED|Overall Study||21
6609008|NCT02100748|7534420|FG004|COMPLETED|Overall Study||23
6609009|NCT02100748|7534421|FG005|COMPLETED|Overall Study||23
6609010|NCT02100748|7534422|FG006|COMPLETED|Overall Study||18
6609011|NCT02100748|7534423|FG007|COMPLETED|Overall Study||34
6609012|NCT02100748|7534424|FG008|COMPLETED|Overall Study||33
6609013|NCT02100748|7534425|FG009|COMPLETED|Overall Study||29
6609014|NCT02100748|7534426|FG010|COMPLETED|Overall Study||26
6609015|NCT02100748|7534427|FG011|COMPLETED|Overall Study||39
6609016|NCT02100748|7534416|FG000|NOT COMPLETED|Overall Study||2
6609017|NCT02100748|7534417|FG001|NOT COMPLETED|Overall Study||1
6609018|NCT02100748|7534418|FG002|NOT COMPLETED|Overall Study||1
6609019|NCT02100748|7534419|FG003|NOT COMPLETED|Overall Study||1
6609020|NCT02100748|7534420|FG004|NOT COMPLETED|Overall Study||2
6609021|NCT02100748|7534421|FG005|NOT COMPLETED|Overall Study||0
6609022|NCT02100748|7534422|FG006|NOT COMPLETED|Overall Study||2
6609023|NCT02100748|7534423|FG007|NOT COMPLETED|Overall Study||4
6609024|NCT02100748|7534424|FG008|NOT COMPLETED|Overall Study||3
6609025|NCT02100748|7534425|FG009|NOT COMPLETED|Overall Study||2
6609026|NCT02100748|7534426|FG010|NOT COMPLETED|Overall Study||2
6609027|NCT02100748|7534427|FG011|NOT COMPLETED|Overall Study||0
6625363|NCT02224664|7553028|FG000|STARTED|Dose Escalation Period (21 Days)||0
6625364|NCT02224664|7553029|FG001|STARTED|Dose Escalation Period (21 Days)||9
6625365|NCT02224664|7553030|FG002|STARTED|Dose Escalation Period (21 Days)||11
6625366|NCT02224664|7553031|FG003|STARTED|Dose Escalation Period (21 Days)||6
6625367|NCT02224664|7553032|FG004|STARTED|Dose Escalation Period (21 Days)||19
6625368|NCT02224664|7553028|FG000|COMPLETED|Dose Escalation Period (21 Days)||0
6625369|NCT02224664|7553029|FG001|COMPLETED|Dose Escalation Period (21 Days)||9
6625370|NCT02224664|7553030|FG002|COMPLETED|Dose Escalation Period (21 Days)||9
6625371|NCT02224664|7553031|FG003|COMPLETED|Dose Escalation Period (21 Days)||3
6625372|NCT02224664|7553032|FG004|COMPLETED|Dose Escalation Period (21 Days)||8
6625373|NCT02224664|7553028|FG000|NOT COMPLETED|Dose Escalation Period (21 Days)||0
6625374|NCT02224664|7553029|FG001|NOT COMPLETED|Dose Escalation Period (21 Days)||0
6625375|NCT02224664|7553030|FG002|NOT COMPLETED|Dose Escalation Period (21 Days)||2
6625376|NCT02224664|7553031|FG003|NOT COMPLETED|Dose Escalation Period (21 Days)||3
6625377|NCT02224664|7553032|FG004|NOT COMPLETED|Dose Escalation Period (21 Days)||11
6732361|NCT03192488|7661736|FG000|NOT COMPLETED|Second Intervention (d1)||0
6732362|NCT03192488|7661737|FG001|NOT COMPLETED|Second Intervention (d1)||0
6732363|NCT03192488|7661738|FG002|NOT COMPLETED|Second Intervention (d1)||0
6732364|NCT03192488|7661739|FG003|NOT COMPLETED|Second Intervention (d1)||0
6732365|NCT03192488|7661740|FG004|NOT COMPLETED|Second Intervention (d1)||0
6732366|NCT03192488|7661741|FG005|NOT COMPLETED|Second Intervention (d1)||0
6732367|NCT03192488|7661736|FG000|STARTED|Second Washout (>6d)||1
6732368|NCT03192488|7661737|FG001|STARTED|Second Washout (>6d)||5
6732369|NCT03192488|7661738|FG002|STARTED|Second Washout (>6d)||1
6732370|NCT03192488|7661739|FG003|STARTED|Second Washout (>6d)||1
6732371|NCT03192488|7661740|FG004|STARTED|Second Washout (>6d)||1
6732372|NCT03192488|7661741|FG005|STARTED|Second Washout (>6d)||0
6732373|NCT03192488|7661736|FG000|COMPLETED|Second Washout (>6d)||1
6732374|NCT03192488|7661737|FG001|COMPLETED|Second Washout (>6d)||5
6732375|NCT03192488|7661738|FG002|COMPLETED|Second Washout (>6d)||1
6732376|NCT03192488|7661739|FG003|COMPLETED|Second Washout (>6d)||1
6732377|NCT03192488|7661740|FG004|COMPLETED|Second Washout (>6d)||1
6732378|NCT03192488|7661741|FG005|COMPLETED|Second Washout (>6d)||0
6732379|NCT03192488|7661736|FG000|NOT COMPLETED|Second Washout (>6d)||0
6732380|NCT03192488|7661737|FG001|NOT COMPLETED|Second Washout (>6d)||0
6732381|NCT03192488|7661738|FG002|NOT COMPLETED|Second Washout (>6d)||0
6732382|NCT03192488|7661739|FG003|NOT COMPLETED|Second Washout (>6d)||0
6732383|NCT03192488|7661740|FG004|NOT COMPLETED|Second Washout (>6d)||0
6732384|NCT03192488|7661741|FG005|NOT COMPLETED|Second Washout (>6d)||0
6732385|NCT03192488|7661736|FG000|STARTED|Third Intervention (d1)||1
6732386|NCT03192488|7661737|FG001|STARTED|Third Intervention (d1)||5
6732387|NCT03192488|7661738|FG002|STARTED|Third Intervention (d1)||1
6732388|NCT03192488|7661739|FG003|STARTED|Third Intervention (d1)||1
6732389|NCT03192488|7661740|FG004|STARTED|Third Intervention (d1)||1
6732390|NCT03192488|7661741|FG005|STARTED|Third Intervention (d1)||0
6732391|NCT03192488|7661736|FG000|COMPLETED|Third Intervention (d1)||1
6732392|NCT03192488|7661737|FG001|COMPLETED|Third Intervention (d1)||5
6732393|NCT03192488|7661738|FG002|COMPLETED|Third Intervention (d1)||1
6732394|NCT03192488|7661739|FG003|COMPLETED|Third Intervention (d1)||1
6732395|NCT03192488|7661740|FG004|COMPLETED|Third Intervention (d1)||0
6732396|NCT03192488|7661741|FG005|COMPLETED|Third Intervention (d1)||0
6732397|NCT03192488|7661736|FG000|NOT COMPLETED|Third Intervention (d1)||0
6732398|NCT03192488|7661737|FG001|NOT COMPLETED|Third Intervention (d1)||0
6732399|NCT03192488|7661738|FG002|NOT COMPLETED|Third Intervention (d1)||0
6732400|NCT03192488|7661739|FG003|NOT COMPLETED|Third Intervention (d1)||0
6732401|NCT03192488|7661740|FG004|NOT COMPLETED|Third Intervention (d1)||1
6732402|NCT03192488|7661741|FG005|NOT COMPLETED|Third Intervention (d1)||0
6732403|NCT03192826|7661758|FG000|STARTED|Overall Study||27
6732404|NCT03192826|7661759|FG001|STARTED|Overall Study||27
6732405|NCT03192826|7661760|FG002|STARTED|Overall Study||25
6732406|NCT03192826|7661758|FG000|COMPLETED|Overall Study||27
6732407|NCT03192826|7661759|FG001|COMPLETED|Overall Study||27
6732408|NCT03192826|7661760|FG002|COMPLETED|Overall Study||25
6732409|NCT03192826|7661758|FG000|NOT COMPLETED|Overall Study||0
6732410|NCT03192826|7661759|FG001|NOT COMPLETED|Overall Study||0
6732411|NCT03192826|7661760|FG002|NOT COMPLETED|Overall Study||0
6732412|NCT03192904|7661770|FG000|STARTED|Overall Study||35
6732413|NCT03192904|7661771|FG001|STARTED|Overall Study||35
6732414|NCT03192904|7661770|FG000|COMPLETED|Overall Study||32
6732415|NCT03192904|7661771|FG001|COMPLETED|Overall Study||33
6732416|NCT03192904|7661770|FG000|NOT COMPLETED|Overall Study||3
6732417|NCT03192904|7661771|FG001|NOT COMPLETED|Overall Study||2
6609028|NCT02100813|7534461|FG000|STARTED|Overall Study||10
6609029|NCT02100813|7534462|FG001|STARTED|Overall Study||11
6609030|NCT02100813|7534463|FG002|STARTED|Overall Study||12
6609031|NCT02100813|7534464|FG003|STARTED|Overall Study||12
6609032|NCT02100813|7534465|FG004|STARTED|Overall Study||12
6609033|NCT02100813|7534466|FG005|STARTED|Overall Study||32
6609034|NCT02100813|7534467|FG006|STARTED|Overall Study||64
6609035|NCT02100813|7534468|FG007|STARTED|Overall Study||67
6609036|NCT02100813|7534461|FG000|COMPLETED|Overall Study||10
6609037|NCT02100813|7534462|FG001|COMPLETED|Overall Study||11
6609038|NCT02100813|7534463|FG002|COMPLETED|Overall Study||12
6609039|NCT02100813|7534464|FG003|COMPLETED|Overall Study||12
6609040|NCT02100813|7534465|FG004|COMPLETED|Overall Study||12
6609041|NCT02100813|7534466|FG005|COMPLETED|Overall Study||32
6609042|NCT02100813|7534467|FG006|COMPLETED|Overall Study||64
6609043|NCT02100813|7534468|FG007|COMPLETED|Overall Study||66
6609044|NCT02100813|7534461|FG000|NOT COMPLETED|Overall Study||0
6609045|NCT02100813|7534462|FG001|NOT COMPLETED|Overall Study||0
6609046|NCT02100813|7534463|FG002|NOT COMPLETED|Overall Study||0
6609047|NCT02100813|7534464|FG003|NOT COMPLETED|Overall Study||0
6609048|NCT02100813|7534465|FG004|NOT COMPLETED|Overall Study||0
6609049|NCT02100813|7534466|FG005|NOT COMPLETED|Overall Study||0
6609050|NCT02100813|7534467|FG006|NOT COMPLETED|Overall Study||0
6609051|NCT02100813|7534468|FG007|NOT COMPLETED|Overall Study||1
6609052|NCT02100826|7534486|FG000|STARTED|Period 1 (7 Days)||14
6609053|NCT02100826|7534487|FG001|STARTED|Period 1 (7 Days)||14
6609054|NCT02100826|7534486|FG000|COMPLETED|Period 1 (7 Days)||14
6609055|NCT02100826|7534487|FG001|COMPLETED|Period 1 (7 Days)||14
6609056|NCT02100826|7534486|FG000|NOT COMPLETED|Period 1 (7 Days)||0
6609057|NCT02100826|7534487|FG001|NOT COMPLETED|Period 1 (7 Days)||0
6609058|NCT02100826|7534486|FG000|STARTED|Washout Period (1 Day)||14
6609059|NCT02100826|7534487|FG001|STARTED|Washout Period (1 Day)||14
6609060|NCT02100826|7534486|FG000|COMPLETED|Washout Period (1 Day)||14
6609061|NCT02100826|7534487|FG001|COMPLETED|Washout Period (1 Day)||14
6609062|NCT02100826|7534486|FG000|NOT COMPLETED|Washout Period (1 Day)||0
6609063|NCT02100826|7534487|FG001|NOT COMPLETED|Washout Period (1 Day)||0
6609064|NCT02100826|7534486|FG000|STARTED|Period 2 (7 Days)||14
6609065|NCT02100826|7534487|FG001|STARTED|Period 2 (7 Days)||14
6609066|NCT02100826|7534486|FG000|COMPLETED|Period 2 (7 Days)||14
6609067|NCT02100826|7534487|FG001|COMPLETED|Period 2 (7 Days)||14
6609068|NCT02100826|7534486|FG000|NOT COMPLETED|Period 2 (7 Days)||0
6609069|NCT02100826|7534487|FG001|NOT COMPLETED|Period 2 (7 Days)||0
6609070|NCT02100839|7534495|FG000|STARTED|Single Ascending Dose||24
6609071|NCT02100839|7534496|FG001|STARTED|Single Ascending Dose||12
6609072|NCT02100839|7534495|FG000|COMPLETED|Single Ascending Dose||24
6609073|NCT02100839|7534496|FG001|COMPLETED|Single Ascending Dose||12
6609074|NCT02100839|7534495|FG000|NOT COMPLETED|Single Ascending Dose||0
6609075|NCT02100839|7534496|FG001|NOT COMPLETED|Single Ascending Dose||0
6609076|NCT02100839|7534495|FG000|STARTED|Multiple Ascending Dose||13
6609077|NCT02100839|7534496|FG001|STARTED|Multiple Ascending Dose||3
6609078|NCT02100839|7534495|FG000|COMPLETED|Multiple Ascending Dose||9
6609079|NCT02100839|7534496|FG001|COMPLETED|Multiple Ascending Dose||3
6609080|NCT02100839|7534495|FG000|NOT COMPLETED|Multiple Ascending Dose||4
6609081|NCT02100839|7534496|FG001|NOT COMPLETED|Multiple Ascending Dose||0
6609082|NCT02100930|7534502|FG000|STARTED|Overall Study||69
6609083|NCT02100930|7534502|FG000|COMPLETED|Overall Study||69
6609084|NCT02100930|7534502|FG000|NOT COMPLETED|Overall Study||0
6609085|NCT02100969|7534506|FG000|STARTED|Overall Study||23
6609086|NCT02100969|7534506|FG000|COMPLETED|Overall Study||22
6609087|NCT02100969|7534506|FG000|NOT COMPLETED|Overall Study||1
6609088|NCT02101008|7534511|FG000|STARTED|Overall Study||12
6609089|NCT02101008|7534511|FG000|COMPLETED|Overall Study||12
6609090|NCT02101008|7534511|FG000|NOT COMPLETED|Overall Study||0
6609091|NCT02101021|7534520|FG000|STARTED|Overall Study||7
6609092|NCT02101021|7534521|FG001|STARTED|Overall Study||4
6609093|NCT02101021|7534522|FG002|STARTED|Overall Study||7
6609094|NCT02101021|7534523|FG003|STARTED|Overall Study||3
6609095|NCT02101021|7534524|FG004|STARTED|Overall Study||4
6609096|NCT02101021|7534520|FG000|COMPLETED|Overall Study||0
6609097|NCT02101021|7534521|FG001|COMPLETED|Overall Study||0
6609098|NCT02101021|7534522|FG002|COMPLETED|Overall Study||0
6609099|NCT02101021|7534523|FG003|COMPLETED|Overall Study||0
6609100|NCT02101021|7534524|FG004|COMPLETED|Overall Study||0
6609101|NCT02101021|7534520|FG000|NOT COMPLETED|Overall Study||7
6609102|NCT02101021|7534521|FG001|NOT COMPLETED|Overall Study||4
6609103|NCT02101021|7534522|FG002|NOT COMPLETED|Overall Study||7
6609104|NCT02101021|7534523|FG003|NOT COMPLETED|Overall Study||3
6609105|NCT02101021|7534524|FG004|NOT COMPLETED|Overall Study||4
6609106|NCT02101034|7534541|FG000|STARTED|Overall Study||3
6609107|NCT02101034|7534542|FG001|STARTED|Overall Study||6
6609108|NCT02101034|7534543|FG002|STARTED|Overall Study||31
6609109|NCT02101034|7534544|FG003|STARTED|Overall Study||32
6609110|NCT02101034|7534545|FG004|STARTED|Overall Study||24
6609111|NCT02101034|7534541|FG000|COMPLETED|Overall Study||3
6609112|NCT02101034|7534542|FG001|COMPLETED|Overall Study||6
6609113|NCT02101034|7534543|FG002|COMPLETED|Overall Study||30
6609114|NCT02101034|7534544|FG003|COMPLETED|Overall Study||32
6609115|NCT02101034|7534545|FG004|COMPLETED|Overall Study||24
6609116|NCT02101034|7534541|FG000|NOT COMPLETED|Overall Study||0
6609117|NCT02101034|7534542|FG001|NOT COMPLETED|Overall Study||0
6609118|NCT02101034|7534543|FG002|NOT COMPLETED|Overall Study||1
6609119|NCT02101034|7534544|FG003|NOT COMPLETED|Overall Study||0
6609120|NCT02101034|7534545|FG004|NOT COMPLETED|Overall Study||0
6609121|NCT02101060|7534565|FG000|STARTED|Overall Study||17
6609122|NCT02101060|7534566|FG001|STARTED|Overall Study||16
6609123|NCT02101060|7534565|FG000|COMPLETED|Overall Study||12
6609124|NCT02101060|7534566|FG001|COMPLETED|Overall Study||12
6609125|NCT02101060|7534565|FG000|NOT COMPLETED|Overall Study||5
6609126|NCT02101060|7534566|FG001|NOT COMPLETED|Overall Study||4
6609127|NCT02101112|7534572|FG000|STARTED|Overall Study||6
6609128|NCT02101112|7534573|FG001|STARTED|Overall Study||5
6609129|NCT02101112|7534574|FG002|STARTED|Overall Study||6
6609130|NCT02101112|7534575|FG003|STARTED|Overall Study||5
6609131|NCT02101112|7534576|FG004|STARTED|Overall Study||6
6609132|NCT02101112|7534577|FG005|STARTED|Overall Study||5
6609133|NCT02101112|7534572|FG000|COMPLETED|Overall Study||6
6609134|NCT02101112|7534573|FG001|COMPLETED|Overall Study||5
6609135|NCT02101112|7534574|FG002|COMPLETED|Overall Study||5
6609136|NCT02101112|7534575|FG003|COMPLETED|Overall Study||5
6609137|NCT02101112|7534576|FG004|COMPLETED|Overall Study||5
6609138|NCT02101112|7534577|FG005|COMPLETED|Overall Study||5
6609139|NCT02101112|7534572|FG000|NOT COMPLETED|Overall Study||0
6609140|NCT02101112|7534573|FG001|NOT COMPLETED|Overall Study||0
6609141|NCT02101112|7534574|FG002|NOT COMPLETED|Overall Study||1
6609142|NCT02101112|7534575|FG003|NOT COMPLETED|Overall Study||0
6609143|NCT02101112|7534576|FG004|NOT COMPLETED|Overall Study||1
6609144|NCT02101112|7534577|FG005|NOT COMPLETED|Overall Study||0
6609145|NCT02101190|7534589|FG000|STARTED|Overall Study||8
6609146|NCT02101190|7534590|FG001|STARTED|Overall Study||8
6609147|NCT02101190|7534589|FG000|COMPLETED|Overall Study||8
6609148|NCT02101190|7534590|FG001|COMPLETED|Overall Study||8
6609149|NCT02101190|7534589|FG000|NOT COMPLETED|Overall Study||0
6609150|NCT02101190|7534590|FG001|NOT COMPLETED|Overall Study||0
6609151|NCT02101281|7534598|FG000|STARTED|Overall Study||20
6609152|NCT02101281|7534599|FG001|STARTED|Overall Study||20
6609153|NCT02101281|7534598|FG000|COMPLETED|Overall Study||20
6609154|NCT02101281|7534599|FG001|COMPLETED|Overall Study||19
6609155|NCT02101281|7534598|FG000|NOT COMPLETED|Overall Study||0
6609156|NCT02101281|7534599|FG001|NOT COMPLETED|Overall Study||1
6609157|NCT02101294|7534611|FG000|STARTED|Overall Study||31
6609158|NCT02101294|7534611|FG000|COMPLETED|Overall Study||20
6609159|NCT02101294|7534611|FG000|NOT COMPLETED|Overall Study||11
6609160|NCT02101359|7534620|FG000|STARTED|Overall Study||295
6609161|NCT02101359|7534621|FG001|STARTED|Overall Study||296
6609162|NCT02101359|7534620|FG000|COMPLETED|Overall Study||266
6609163|NCT02101359|7534621|FG001|COMPLETED|Overall Study||277
6609164|NCT02101359|7534620|FG000|NOT COMPLETED|Overall Study||29
6609165|NCT02101359|7534621|FG001|NOT COMPLETED|Overall Study||19
6609166|NCT02101411|7534630|FG000|STARTED|Overall Study||111
6609167|NCT02101411|7534631|FG001|STARTED|Overall Study||109
6609168|NCT02101411|7534632|FG002|STARTED|Overall Study||114
6609169|NCT02101411|7534630|FG000|COMPLETED|Overall Study||107
6609170|NCT02101411|7534631|FG001|COMPLETED|Overall Study||102
6609171|NCT02101411|7534632|FG002|COMPLETED|Overall Study||104
6609172|NCT02101411|7534630|FG000|NOT COMPLETED|Overall Study||4
6609173|NCT02101411|7534631|FG001|NOT COMPLETED|Overall Study||7
6609174|NCT02101411|7534632|FG002|NOT COMPLETED|Overall Study||10
6609175|NCT02101437|7534644|FG000|STARTED|Overall Study||20
6609176|NCT02101437|7534645|FG001|STARTED|Overall Study||54
6609177|NCT02101437|7534646|FG002|STARTED|Overall Study||52
6609178|NCT02101437|7534647|FG003|STARTED|Overall Study||49
6609179|NCT02101437|7534644|FG000|COMPLETED|Overall Study||20
6609180|NCT02101437|7534645|FG001|COMPLETED|Overall Study||54
6609181|NCT02101437|7534646|FG002|COMPLETED|Overall Study||52
6609182|NCT02101437|7534647|FG003|COMPLETED|Overall Study||49
6609183|NCT02101437|7534644|FG000|NOT COMPLETED|Overall Study||0
6609184|NCT02101437|7534645|FG001|NOT COMPLETED|Overall Study||0
6609185|NCT02101437|7534646|FG002|NOT COMPLETED|Overall Study||0
6609186|NCT02101437|7534647|FG003|NOT COMPLETED|Overall Study||0
6609187|NCT02101515|7534659|FG000|STARTED|Overall Study||37
6609188|NCT02101515|7534660|FG001|STARTED|Overall Study||41
6609189|NCT02101515|7534659|FG000|COMPLETED|Overall Study||37
6609190|NCT02101515|7534660|FG001|COMPLETED|Overall Study||41
6609191|NCT02101515|7534659|FG000|NOT COMPLETED|Overall Study||0
6609192|NCT02101515|7534660|FG001|NOT COMPLETED|Overall Study||0
6609193|NCT02101554|7534669|FG000|STARTED|Overall Study||6
6609194|NCT02101554|7534670|FG001|STARTED|Overall Study||10
6609195|NCT02101554|7534671|FG002|STARTED|Overall Study||3
6609196|NCT02101554|7534669|FG000|COMPLETED|Overall Study||3
6609197|NCT02101554|7534670|FG001|COMPLETED|Overall Study||5
6609198|NCT02101554|7534671|FG002|COMPLETED|Overall Study||2
6609199|NCT02101554|7534669|FG000|NOT COMPLETED|Overall Study||3
6609200|NCT02101554|7534670|FG001|NOT COMPLETED|Overall Study||5
6609201|NCT02101554|7534671|FG002|NOT COMPLETED|Overall Study||1
6609202|NCT02101918|7534679|FG000|STARTED|Overall Study||22
6609203|NCT02101918|7534679|FG000|COMPLETED|Overall Study||22
6609204|NCT02101918|7534679|FG000|NOT COMPLETED|Overall Study||0
6609205|NCT02101983|7534685|FG000|STARTED|Overall Study||5
6609206|NCT02101983|7534686|FG001|STARTED|Overall Study||6
6609207|NCT02101983|7534685|FG000|COMPLETED|Overall Study||4
6609208|NCT02101983|7534686|FG001|COMPLETED|Overall Study||6
6609209|NCT02101983|7534685|FG000|NOT COMPLETED|Overall Study||1
6609210|NCT02101983|7534686|FG001|NOT COMPLETED|Overall Study||0
6609211|NCT02102100|7534694|FG000|STARTED|Overall Study||32
6609212|NCT02102100|7534695|FG001|STARTED|Overall Study||25
6609213|NCT02102100|7534694|FG000|COMPLETED|Overall Study||23
6609214|NCT02102100|7534695|FG001|COMPLETED|Overall Study||18
6609215|NCT02102100|7534694|FG000|NOT COMPLETED|Overall Study||9
6609216|NCT02102100|7534695|FG001|NOT COMPLETED|Overall Study||7
6609217|NCT02102204|7534701|FG000|STARTED|Overall Study||902
6609218|NCT02102204|7534701|FG000|Received Etelcalcetide|Overall Study||884
6609219|NCT02102204|7534701|FG000|COMPLETED|Overall Study||598
6609220|NCT02102204|7534701|FG000|NOT COMPLETED|Overall Study||304
6609221|NCT02102230|7534708|FG000|STARTED|Overall Study||42
6609222|NCT02102230|7534709|FG001|STARTED|Overall Study||28
6609223|NCT02102230|7534710|FG002|STARTED|Overall Study||41
6609224|NCT02102230|7534708|FG000|COMPLETED|Overall Study||25
6609225|NCT02102230|7534709|FG001|COMPLETED|Overall Study||11
6609226|NCT02102230|7534710|FG002|COMPLETED|Overall Study||24
6609227|NCT02102230|7534708|FG000|NOT COMPLETED|Overall Study||17
6609228|NCT02102230|7534709|FG001|NOT COMPLETED|Overall Study||17
6609229|NCT02102230|7534710|FG002|NOT COMPLETED|Overall Study||17
6609230|NCT02102399|7534721|FG000|STARTED|Overall Study||20
6609231|NCT02102399|7534722|FG001|STARTED|Overall Study||21
6609232|NCT02102399|7534721|FG000|COMPLETED|Overall Study||14
6609233|NCT02102399|7534722|FG001|COMPLETED|Overall Study||17
6609234|NCT02102399|7534721|FG000|NOT COMPLETED|Overall Study||6
6609235|NCT02102399|7534722|FG001|NOT COMPLETED|Overall Study||4
6609236|NCT02102464|7534735|FG000|STARTED|Randomized Study||29
6609237|NCT02102464|7534736|FG001|STARTED|Randomized Study||26
6609238|NCT02102464|7534737|FG002|STARTED|Randomized Study||0
6609239|NCT02102464|7534735|FG000|COMPLETED|Randomized Study||29
6609240|NCT02102464|7534736|FG001|COMPLETED|Randomized Study||25
6609241|NCT02102464|7534737|FG002|COMPLETED|Randomized Study||0
6609242|NCT02102464|7534735|FG000|NOT COMPLETED|Randomized Study||0
6609243|NCT02102464|7534736|FG001|NOT COMPLETED|Randomized Study||1
6609244|NCT02102464|7534737|FG002|NOT COMPLETED|Randomized Study||0
6609245|NCT02102464|7534735|FG000|STARTED|Crossover LipiFlow Treatment of Control||0
6609246|NCT02102464|7534736|FG001|STARTED|Crossover LipiFlow Treatment of Control||0
6609247|NCT02102464|7534737|FG002|STARTED|Crossover LipiFlow Treatment of Control||25
6609248|NCT02102464|7534735|FG000|COMPLETED|Crossover LipiFlow Treatment of Control||0
6609249|NCT02102464|7534736|FG001|COMPLETED|Crossover LipiFlow Treatment of Control||0
6609250|NCT02102464|7534737|FG002|COMPLETED|Crossover LipiFlow Treatment of Control||25
6609251|NCT02102464|7534735|FG000|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
6609252|NCT02102464|7534736|FG001|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
6609253|NCT02102464|7534737|FG002|NOT COMPLETED|Crossover LipiFlow Treatment of Control||0
6609254|NCT02102490|7534746|FG000|STARTED|Overall Study||132
6609255|NCT02102490|7534746|FG000|Received at Least 1 Dose of Study Drug|Overall Study||132
6609256|NCT02102490|7534746|FG000|COMPLETED|Overall Study||125
6609257|NCT02102490|7534746|FG000|NOT COMPLETED|Overall Study||7
6609258|NCT02102724|7534752|FG000|STARTED|Overall Study||18
6609259|NCT02102724|7534753|FG001|STARTED|Overall Study||19
6609260|NCT02102724|7534752|FG000|COMPLETED|Overall Study||16
6609261|NCT02102724|7534753|FG001|COMPLETED|Overall Study||18
6609262|NCT02102724|7534752|FG000|NOT COMPLETED|Overall Study||2
6609263|NCT02102724|7534753|FG001|NOT COMPLETED|Overall Study||1
6609264|NCT02102932|7534767|FG000|STARTED|Overall Study||12
6609265|NCT02102932|7534768|FG001|STARTED|Overall Study||12
6609266|NCT02102932|7534769|FG002|STARTED|Overall Study||12
6609267|NCT02102932|7534770|FG003|STARTED|Overall Study||12
6609268|NCT02102932|7534771|FG004|STARTED|Overall Study||12
6609269|NCT02102932|7534772|FG005|STARTED|Overall Study||12
6609270|NCT02102932|7534773|FG006|STARTED|Overall Study||12
6609271|NCT02102932|7534774|FG007|STARTED|Overall Study||12
6609272|NCT02102932|7534767|FG000|COMPLETED|Overall Study||12
6609273|NCT02102932|7534768|FG001|COMPLETED|Overall Study||12
6609274|NCT02102932|7534769|FG002|COMPLETED|Overall Study||12
6609275|NCT02102932|7534770|FG003|COMPLETED|Overall Study||12
6609276|NCT02102932|7534771|FG004|COMPLETED|Overall Study||12
6609277|NCT02102932|7534772|FG005|COMPLETED|Overall Study||12
6609278|NCT02102932|7534773|FG006|COMPLETED|Overall Study||12
6609279|NCT02102932|7534774|FG007|COMPLETED|Overall Study||12
6609280|NCT02102932|7534767|FG000|NOT COMPLETED|Overall Study||0
6609281|NCT02102932|7534768|FG001|NOT COMPLETED|Overall Study||0
6609282|NCT02102932|7534769|FG002|NOT COMPLETED|Overall Study||0
6609283|NCT02102932|7534770|FG003|NOT COMPLETED|Overall Study||0
6609284|NCT02102932|7534771|FG004|NOT COMPLETED|Overall Study||0
6609285|NCT02102932|7534772|FG005|NOT COMPLETED|Overall Study||0
6609286|NCT02102932|7534773|FG006|NOT COMPLETED|Overall Study||0
6609287|NCT02102932|7534774|FG007|NOT COMPLETED|Overall Study||0
6609288|NCT02103062|7534794|FG000|STARTED|Overall Study||18
6609289|NCT02103062|7534795|FG001|STARTED|Overall Study||23
6609290|NCT02103062|7534794|FG000|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
6609291|NCT02103062|7534795|FG001|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
6609292|NCT02103062|7534794|FG000|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
6609293|NCT02103062|7534795|FG001|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
6609294|NCT02103062|7534794|FG000|COMPLETED|Overall Study||0
6609295|NCT02103062|7534795|FG001|COMPLETED|Overall Study||0
6609296|NCT02103062|7534794|FG000|NOT COMPLETED|Overall Study||18
6609297|NCT02103062|7534795|FG001|NOT COMPLETED|Overall Study||23
6609298|NCT02103114|7534805|FG000|STARTED|Overall Study||20
6609299|NCT02103114|7534806|FG001|STARTED|Overall Study||20
6609300|NCT02103114|7534805|FG000|COMPLETED|Overall Study||20
6609301|NCT02103114|7534806|FG001|COMPLETED|Overall Study||19
6609302|NCT02103114|7534805|FG000|NOT COMPLETED|Overall Study||0
6609303|NCT02103114|7534806|FG001|NOT COMPLETED|Overall Study||1
6609304|NCT02103127|7534813|FG000|STARTED|Overall Study||20
6609305|NCT02103127|7534813|FG000|COMPLETED|Overall Study||17
6609306|NCT02103127|7534813|FG000|NOT COMPLETED|Overall Study||3
6609307|NCT02103153|7534817|FG000|STARTED|Overall Study||44
6609308|NCT02103153|7534817|FG000|COMPLETED|Overall Study||27
6609309|NCT02103153|7534817|FG000|NOT COMPLETED|Overall Study||17
6609310|NCT02103218|7534828|FG000|STARTED|Overall Study||51
6609311|NCT02103218|7534829|FG001|STARTED|Overall Study||59
6609312|NCT02103218|7534830|FG002|STARTED|Overall Study||48
6609313|NCT02103218|7534831|FG003|STARTED|Overall Study||54
6609314|NCT02103218|7534828|FG000|COMPLETED|Overall Study||46
6609315|NCT02103218|7534829|FG001|COMPLETED|Overall Study||51
6609316|NCT02103218|7534830|FG002|COMPLETED|Overall Study||44
6609317|NCT02103218|7534831|FG003|COMPLETED|Overall Study||47
6609318|NCT02103218|7534828|FG000|NOT COMPLETED|Overall Study||5
6609319|NCT02103218|7534829|FG001|NOT COMPLETED|Overall Study||8
6609320|NCT02103218|7534830|FG002|NOT COMPLETED|Overall Study||4
6609321|NCT02103218|7534831|FG003|NOT COMPLETED|Overall Study||7
6609322|NCT02103270|7534842|FG000|STARTED|Overall Study||60
6609323|NCT02103270|7534843|FG001|STARTED|Overall Study||35
6609324|NCT02103270|7534844|FG002|STARTED|Overall Study||25
6609325|NCT02103270|7534842|FG000|COMPLETED|Overall Study||51
6609326|NCT02103270|7534843|FG001|COMPLETED|Overall Study||29
6609327|NCT02103270|7534844|FG002|COMPLETED|Overall Study||1
6609328|NCT02103270|7534842|FG000|NOT COMPLETED|Overall Study||9
6609329|NCT02103270|7534843|FG001|NOT COMPLETED|Overall Study||6
6609330|NCT02103270|7534844|FG002|NOT COMPLETED|Overall Study||24
6609331|NCT02103309|7534855|FG000|STARTED|Overall Study||20
6609332|NCT02103309|7534856|FG001|STARTED|Overall Study||22
6609333|NCT02103309|7534855|FG000|COMPLETED|Overall Study||20
6609334|NCT02103309|7534856|FG001|COMPLETED|Overall Study||22
6609335|NCT02103309|7534855|FG000|NOT COMPLETED|Overall Study||0
6609336|NCT02103309|7534856|FG001|NOT COMPLETED|Overall Study||0
6609337|NCT02103439|7534864|FG000|STARTED|Overall Study||70
6609338|NCT02103439|7534865|FG001|STARTED|Overall Study||70
6609339|NCT02103439|7534864|FG000|COMPLETED|Overall Study||67
6609340|NCT02103439|7534865|FG001|COMPLETED|Overall Study||67
6609341|NCT02103439|7534864|FG000|NOT COMPLETED|Overall Study||3
6609342|NCT02103439|7534865|FG001|NOT COMPLETED|Overall Study||3
6609343|NCT02103478|7534882|FG000|STARTED|Overall Study||7
6609344|NCT02103478|7534883|FG001|STARTED|Overall Study||6
6609345|NCT02103478|7534884|FG002|STARTED|Overall Study||6
6609346|NCT02103478|7534885|FG003|STARTED|Overall Study||6
6609347|NCT02103478|7534886|FG004|STARTED|Overall Study||19
6609348|NCT02103478|7534887|FG005|STARTED|Overall Study||25
6609349|NCT02103478|7534888|FG006|STARTED|Overall Study||25
6609350|NCT02103478|7534889|FG007|STARTED|Overall Study||16
6609351|NCT02103478|7534890|FG008|STARTED|Overall Study||14
6609352|NCT02103478|7534882|FG000|COMPLETED|Overall Study||0
6609353|NCT02103478|7534883|FG001|COMPLETED|Overall Study||0
6609354|NCT02103478|7534884|FG002|COMPLETED|Overall Study||0
6609355|NCT02103478|7534885|FG003|COMPLETED|Overall Study||0
6609356|NCT02103478|7534886|FG004|COMPLETED|Overall Study||0
6609357|NCT02103478|7534887|FG005|COMPLETED|Overall Study||0
6609358|NCT02103478|7534888|FG006|COMPLETED|Overall Study||0
6609359|NCT02103478|7534889|FG007|COMPLETED|Overall Study||0
6609360|NCT02103478|7534890|FG008|COMPLETED|Overall Study||0
6609361|NCT02103478|7534882|FG000|NOT COMPLETED|Overall Study||7
6609362|NCT02103478|7534883|FG001|NOT COMPLETED|Overall Study||6
6609363|NCT02103478|7534884|FG002|NOT COMPLETED|Overall Study||6
6609364|NCT02103478|7534885|FG003|NOT COMPLETED|Overall Study||6
6609365|NCT02103478|7534886|FG004|NOT COMPLETED|Overall Study||19
6609366|NCT02103478|7534887|FG005|NOT COMPLETED|Overall Study||25
6609367|NCT02103478|7534888|FG006|NOT COMPLETED|Overall Study||25
6609368|NCT02103478|7534889|FG007|NOT COMPLETED|Overall Study||16
6609369|NCT02103478|7534890|FG008|NOT COMPLETED|Overall Study||14
6609370|NCT02103608|7534920|FG000|STARTED|Overall Study||17
6609371|NCT02103608|7534920|FG000|COMPLETED|Overall Study||15
6609372|NCT02103608|7534920|FG000|NOT COMPLETED|Overall Study||2
6609373|NCT02103816|7534924|FG000|STARTED|Overall Study||21
6609374|NCT02103816|7534924|FG000|COMPLETED|Overall Study||13
6609375|NCT02103816|7534924|FG000|NOT COMPLETED|Overall Study||8
6609376|NCT02103855|7534928|FG000|STARTED|Overall Study||6
6609377|NCT02103855|7534928|FG000|COMPLETED|Overall Study||4
6609378|NCT02103855|7534928|FG000|NOT COMPLETED|Overall Study||2
6609379|NCT02104141|7534932|FG000|STARTED|Overall Study||51
6609380|NCT02104141|7534932|FG000|COMPLETED|Overall Study||51
6609381|NCT02104141|7534932|FG000|NOT COMPLETED|Overall Study||0
6609382|NCT02104167|7534936|FG000|STARTED|Overall Study||110
6609383|NCT02104167|7534936|FG000|COMPLETED|Overall Study||110
6609384|NCT02104167|7534936|FG000|NOT COMPLETED|Overall Study||0
6609385|NCT02104219|7534940|FG000|STARTED|Overall Study||32
6609386|NCT02104219|7534940|FG000|COMPLETED|Overall Study||32
6609387|NCT02104219|7534940|FG000|NOT COMPLETED|Overall Study||0
6609388|NCT02104414|7534947|FG000|STARTED|Overall Study||5
6609389|NCT02104414|7534948|FG001|STARTED|Overall Study||4
6609390|NCT02104414|7534949|FG002|STARTED|Overall Study||2
6609391|NCT02104414|7534947|FG000|COMPLETED|Overall Study||5
6609392|NCT02104414|7534948|FG001|COMPLETED|Overall Study||4
6609393|NCT02104414|7534949|FG002|COMPLETED|Overall Study||2
6609394|NCT02104414|7534947|FG000|NOT COMPLETED|Overall Study||0
6609395|NCT02104414|7534948|FG001|NOT COMPLETED|Overall Study||0
6609396|NCT02104414|7534949|FG002|NOT COMPLETED|Overall Study||0
6609397|NCT02104427|7534957|FG000|STARTED|Overall Study||12
6609398|NCT02104427|7534957|FG000|COMPLETED|Overall Study||12
6609399|NCT02104427|7534957|FG000|NOT COMPLETED|Overall Study||0
6609400|NCT02104505|7534981|FG000|STARTED|First Intervention (14 Days)||12
6609401|NCT02104505|7534982|FG001|STARTED|First Intervention (14 Days)|one participant withdrew prior to receiving study drug|11
6609402|NCT02104505|7534981|FG000|COMPLETED|First Intervention (14 Days)||10
6609403|NCT02104505|7534982|FG001|COMPLETED|First Intervention (14 Days)||8
6609404|NCT02104505|7534981|FG000|NOT COMPLETED|First Intervention (14 Days)||2
6609405|NCT02104505|7534982|FG001|NOT COMPLETED|First Intervention (14 Days)||3
6609406|NCT02104505|7534981|FG000|STARTED|Washout (Minimum 3 Weeks)||10
6609407|NCT02104505|7534982|FG001|STARTED|Washout (Minimum 3 Weeks)||8
6609408|NCT02104505|7534981|FG000|COMPLETED|Washout (Minimum 3 Weeks)||10
6609409|NCT02104505|7534982|FG001|COMPLETED|Washout (Minimum 3 Weeks)||8
6609410|NCT02104505|7534981|FG000|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
6609411|NCT02104505|7534982|FG001|NOT COMPLETED|Washout (Minimum 3 Weeks)||0
6609412|NCT02104505|7534981|FG000|STARTED|Second Intervention (14 Days)||10
6609413|NCT02104505|7534982|FG001|STARTED|Second Intervention (14 Days)||8
6609414|NCT02104505|7534981|FG000|COMPLETED|Second Intervention (14 Days)||8
6609415|NCT02104505|7534982|FG001|COMPLETED|Second Intervention (14 Days)||7
6609416|NCT02104505|7534981|FG000|NOT COMPLETED|Second Intervention (14 Days)||2
6609417|NCT02104505|7534982|FG001|NOT COMPLETED|Second Intervention (14 Days)||1
6609418|NCT02104557|7534989|FG000|STARTED|Overall Study||362
6609419|NCT02104557|7534989|FG000|Safety Population|Overall Study||337
6609420|NCT02104557|7534989|FG000|COMPLETED|Overall Study||185
6609421|NCT02104557|7534989|FG000|NOT COMPLETED|Overall Study||177
6609422|NCT02104583|7534998|FG000|STARTED|Overall Study||48
6609423|NCT02104583|7534999|FG001|STARTED|Overall Study||46
6609424|NCT02104583|7535000|FG002|STARTED|Overall Study||70
6609425|NCT02104583|7535001|FG003|STARTED|Overall Study||74
6609426|NCT02104583|7535002|FG004|STARTED|Overall Study||75
6609427|NCT02104583|7534998|FG000|COMPLETED|Overall Study||30
6609428|NCT02104583|7534999|FG001|COMPLETED|Overall Study||35
6609429|NCT02104583|7535000|FG002|COMPLETED|Overall Study||54
6609430|NCT02104583|7535001|FG003|COMPLETED|Overall Study||57
6609431|NCT02104583|7535002|FG004|COMPLETED|Overall Study||63
6609432|NCT02104583|7534998|FG000|NOT COMPLETED|Overall Study||18
6609433|NCT02104583|7534999|FG001|NOT COMPLETED|Overall Study||11
6609434|NCT02104583|7535000|FG002|NOT COMPLETED|Overall Study||16
6609435|NCT02104583|7535001|FG003|NOT COMPLETED|Overall Study||17
6609436|NCT02104583|7535002|FG004|NOT COMPLETED|Overall Study||12
6609437|NCT02104739|7535023|FG000|STARTED|First Intervention (1 Day)||2
6609438|NCT02104739|7535024|FG001|STARTED|First Intervention (1 Day)||5
6609439|NCT02104739|7535025|FG002|STARTED|First Intervention (1 Day)||2
6609440|NCT02104739|7535026|FG003|STARTED|First Intervention (1 Day)||8
6609441|NCT02104739|7535027|FG004|STARTED|First Intervention (1 Day)||0
6609442|NCT02104739|7535028|FG005|STARTED|First Intervention (1 Day)||3
6609443|NCT02104739|7535029|FG006|STARTED|First Intervention (1 Day)||0
6609444|NCT02104739|7535023|FG000|COMPLETED|First Intervention (1 Day)||2
6609445|NCT02104739|7535024|FG001|COMPLETED|First Intervention (1 Day)||4
6609446|NCT02104739|7535025|FG002|COMPLETED|First Intervention (1 Day)||2
6609447|NCT02104739|7535026|FG003|COMPLETED|First Intervention (1 Day)||7
6609448|NCT02104739|7535027|FG004|COMPLETED|First Intervention (1 Day)||0
6609449|NCT02104739|7535028|FG005|COMPLETED|First Intervention (1 Day)||3
6609450|NCT02104739|7535029|FG006|COMPLETED|First Intervention (1 Day)||0
6609451|NCT02104739|7535023|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6609452|NCT02104739|7535024|FG001|NOT COMPLETED|First Intervention (1 Day)||1
6609453|NCT02104739|7535025|FG002|NOT COMPLETED|First Intervention (1 Day)||0
6609454|NCT02104739|7535026|FG003|NOT COMPLETED|First Intervention (1 Day)||1
6609455|NCT02104739|7535027|FG004|NOT COMPLETED|First Intervention (1 Day)||0
6609456|NCT02104739|7535028|FG005|NOT COMPLETED|First Intervention (1 Day)||0
6609457|NCT02104739|7535029|FG006|NOT COMPLETED|First Intervention (1 Day)||0
6609458|NCT02104739|7535023|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
6625378|NCT02224690|7553050|FG000|STARTED|Overall Study||86
6609459|NCT02104739|7535024|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
6609460|NCT02104739|7535025|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
6609461|NCT02104739|7535026|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
6625379|NCT02224690|7553051|FG001|STARTED|Overall Study||85
6625380|NCT02224690|7553050|FG000|Safety Analysis Set|Overall Study||86
6625381|NCT02224690|7553051|FG001|Safety Analysis Set|Overall Study||85
6625382|NCT02224690|7553050|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||86
6625383|NCT02224690|7553051|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||85
6625384|NCT02224690|7553050|FG000|COMPLETED|Overall Study||72
6625385|NCT02224690|7553051|FG001|COMPLETED|Overall Study||84
6625386|NCT02224690|7553050|FG000|NOT COMPLETED|Overall Study||14
6625387|NCT02224690|7553051|FG001|NOT COMPLETED|Overall Study||1
6625388|NCT02224703|7553060|FG000|STARTED|Overall Study||67
6625389|NCT02224703|7553061|FG001|STARTED|Overall Study||67
6625390|NCT02224703|7553062|FG002|STARTED|Overall Study||65
6625391|NCT02224703|7553060|FG000|Received at Least 1 Dose of Study Drug|Overall Study||66
6625392|NCT02224703|7553061|FG001|Received at Least 1 Dose of Study Drug|Overall Study||67
6625393|NCT02224703|7553062|FG002|Received at Least 1 Dose of Study Drug|Overall Study||65
6625394|NCT02224703|7553060|FG000|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|64
6625395|NCT02224703|7553061|FG001|Safety Analysis Set|Overall Study|Two participants assigned to the 10 mg/kg/day dose were included in the 20 mg/kg/day group|69
6625396|NCT02224703|7553062|FG002|Safety Analysis Set|Overall Study||65
6625397|NCT02224703|7553060|FG000|Intent to Treat (ITT) Analysis Set|Overall Study||66
6625398|NCT02224703|7553061|FG001|Intent to Treat (ITT) Analysis Set|Overall Study||67
6625399|NCT02224703|7553062|FG002|Intent to Treat (ITT) Analysis Set|Overall Study||65
6625400|NCT02224703|7553060|FG000|COMPLETED|Overall Study||64
6625401|NCT02224703|7553061|FG001|COMPLETED|Overall Study||61
6625402|NCT02224703|7553062|FG002|COMPLETED|Overall Study||65
6625403|NCT02224703|7553060|FG000|NOT COMPLETED|Overall Study||3
6625404|NCT02224703|7553061|FG001|NOT COMPLETED|Overall Study||6
6625405|NCT02224703|7553062|FG002|NOT COMPLETED|Overall Study||0
6625406|NCT02224729|7553071|FG000|STARTED|Overall Study||24
6625407|NCT02224729|7553071|FG000|COMPLETED|Overall Study||24
6625408|NCT02224729|7553071|FG000|NOT COMPLETED|Overall Study||0
6625409|NCT02224755|7553077|FG000|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate II|512
6625410|NCT02224755|7553078|FG001|STARTED|Randomization to Device Implant|Patients in the Full Study Cohort (n=1028) who were randomized to HeartMate 3|516
6625411|NCT02224755|7553077|FG000|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate II LVAS implant|505
6625412|NCT02224755|7553078|FG001|COMPLETED|Randomization to Device Implant|Patients who underwent HeartMate 3 LVAS implant|515
6625413|NCT02224755|7553077|FG000|NOT COMPLETED|Randomization to Device Implant||7
6625414|NCT02224755|7553078|FG001|NOT COMPLETED|Randomization to Device Implant||1
6625415|NCT02224755|7553077|FG000|STARTED|Two Year Follow up Post-implant||505
6625416|NCT02224755|7553078|FG001|STARTED|Two Year Follow up Post-implant||515
6625417|NCT02224755|7553077|FG000|COMPLETED|Two Year Follow up Post-implant||247
6625418|NCT02224755|7553078|FG001|COMPLETED|Two Year Follow up Post-implant||289
6625419|NCT02224755|7553077|FG000|NOT COMPLETED|Two Year Follow up Post-implant||258
6625420|NCT02224755|7553078|FG001|NOT COMPLETED|Two Year Follow up Post-implant||226
6625421|NCT02224820|7553088|FG000|STARTED|Overall Study||8
6625422|NCT02224820|7553088|FG000|COMPLETED|Overall Study|One patient did not receive full dose|8
6625423|NCT02224820|7553088|FG000|NOT COMPLETED|Overall Study||0
6625424|NCT02224846|7553094|FG000|STARTED|Period 1 (Month 3)||211
6625425|NCT02224846|7553095|FG001|STARTED|Period 1 (Month 3)||424
6625426|NCT02224846|7553094|FG000|Received at Least One Dose of Study Drug|Period 1 (Month 3)||210
6625427|NCT02224846|7553095|FG001|Received at Least One Dose of Study Drug|Period 1 (Month 3)||421
6625428|NCT02224846|7553094|FG000|COMPLETED|Period 1 (Month 3)||192
6625429|NCT02224846|7553095|FG001|COMPLETED|Period 1 (Month 3)||388
6625430|NCT02224846|7553094|FG000|NOT COMPLETED|Period 1 (Month 3)||19
6625431|NCT02224846|7553095|FG001|NOT COMPLETED|Period 1 (Month 3)||36
6625432|NCT02224846|7553094|FG000|STARTED|Period 2 (Month 3 to Month 12)||192
6625433|NCT02224846|7553095|FG001|STARTED|Period 2 (Month 3 to Month 12)||388
6625434|NCT02224846|7553094|FG000|COMPLETED|Period 2 (Month 3 to Month 12)||173
6625435|NCT02224846|7553095|FG001|COMPLETED|Period 2 (Month 3 to Month 12)||357
6625436|NCT02224846|7553094|FG000|NOT COMPLETED|Period 2 (Month 3 to Month 12)||19
6625437|NCT02224846|7553095|FG001|NOT COMPLETED|Period 2 (Month 3 to Month 12)||31
6625438|NCT02224846|7553094|FG000|STARTED|Period 2 (Month 12 to Month 24)||173
6625439|NCT02224846|7553095|FG001|STARTED|Period 2 (Month 12 to Month 24)||357
6625440|NCT02224846|7553094|FG000|COMPLETED|Period 2 (Month 12 to Month 24)||131
6625441|NCT02224846|7553095|FG001|COMPLETED|Period 2 (Month 12 to Month 24)||283
6625442|NCT02224846|7553094|FG000|NOT COMPLETED|Period 2 (Month 12 to Month 24)||42
6625443|NCT02224846|7553095|FG001|NOT COMPLETED|Period 2 (Month 12 to Month 24)||74
6625444|NCT02225080|7553101|FG000|STARTED|Overall Study||100
6625445|NCT02225080|7553101|FG000|COMPLETED|Overall Study||100
6625446|NCT02225080|7553101|FG000|NOT COMPLETED|Overall Study||0
6625447|NCT02225106|7553105|FG000|STARTED|Overall Study||11
6625448|NCT02225106|7553105|FG000|COMPLETED|Overall Study||11
6625449|NCT02225106|7553105|FG000|NOT COMPLETED|Overall Study||0
6625450|NCT02225132|7553109|FG000|STARTED|Overall Study||10
6609462|NCT02104739|7535027|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
6609463|NCT02104739|7535028|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
6609464|NCT02104739|7535029|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
6609465|NCT02104739|7535023|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
6609466|NCT02104739|7535024|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
6609467|NCT02104739|7535025|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
6609468|NCT02104739|7535026|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
6609469|NCT02104739|7535027|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609470|NCT02104739|7535028|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
6609471|NCT02104739|7535029|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609472|NCT02104739|7535023|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609473|NCT02104739|7535024|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609474|NCT02104739|7535025|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609475|NCT02104739|7535026|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609476|NCT02104739|7535027|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609477|NCT02104739|7535028|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609478|NCT02104739|7535029|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609479|NCT02104739|7535023|FG000|STARTED|Second Intervention (1 Day)||1
6609480|NCT02104739|7535024|FG001|STARTED|Second Intervention (1 Day)||4
6609481|NCT02104739|7535025|FG002|STARTED|Second Intervention (1 Day)||2
6609482|NCT02104739|7535026|FG003|STARTED|Second Intervention (1 Day)||7
6609483|NCT02104739|7535027|FG004|STARTED|Second Intervention (1 Day)||0
6609484|NCT02104739|7535028|FG005|STARTED|Second Intervention (1 Day)||2
6609485|NCT02104739|7535029|FG006|STARTED|Second Intervention (1 Day)||0
6609486|NCT02104739|7535023|FG000|COMPLETED|Second Intervention (1 Day)||1
6609487|NCT02104739|7535024|FG001|COMPLETED|Second Intervention (1 Day)||4
6609488|NCT02104739|7535025|FG002|COMPLETED|Second Intervention (1 Day)||2
6609489|NCT02104739|7535026|FG003|COMPLETED|Second Intervention (1 Day)||7
6609490|NCT02104739|7535027|FG004|COMPLETED|Second Intervention (1 Day)||0
6609491|NCT02104739|7535028|FG005|COMPLETED|Second Intervention (1 Day)||2
6609492|NCT02104739|7535029|FG006|COMPLETED|Second Intervention (1 Day)||0
6609493|NCT02104739|7535023|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6609494|NCT02104739|7535024|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6609495|NCT02104739|7535025|FG002|NOT COMPLETED|Second Intervention (1 Day)||0
6609496|NCT02104739|7535026|FG003|NOT COMPLETED|Second Intervention (1 Day)||0
6609497|NCT02104739|7535027|FG004|NOT COMPLETED|Second Intervention (1 Day)||0
6609498|NCT02104739|7535028|FG005|NOT COMPLETED|Second Intervention (1 Day)||0
6609499|NCT02104739|7535029|FG006|NOT COMPLETED|Second Intervention (1 Day)||0
6609500|NCT02104739|7535023|FG000|STARTED|Washout (Min of 10 and Max of 107 Days)||1
6609501|NCT02104739|7535024|FG001|STARTED|Washout (Min of 10 and Max of 107 Days)||4
6609502|NCT02104739|7535025|FG002|STARTED|Washout (Min of 10 and Max of 107 Days)||2
6609503|NCT02104739|7535026|FG003|STARTED|Washout (Min of 10 and Max of 107 Days)||7
6609504|NCT02104739|7535027|FG004|STARTED|Washout (Min of 10 and Max of 107 Days)||0
6609505|NCT02104739|7535028|FG005|STARTED|Washout (Min of 10 and Max of 107 Days)||2
6609506|NCT02104739|7535029|FG006|STARTED|Washout (Min of 10 and Max of 107 Days)||0
6609507|NCT02104739|7535023|FG000|COMPLETED|Washout (Min of 10 and Max of 107 Days)||1
6609508|NCT02104739|7535024|FG001|COMPLETED|Washout (Min of 10 and Max of 107 Days)||4
6609509|NCT02104739|7535025|FG002|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
6609510|NCT02104739|7535026|FG003|COMPLETED|Washout (Min of 10 and Max of 107 Days)||7
6609511|NCT02104739|7535027|FG004|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609512|NCT02104739|7535028|FG005|COMPLETED|Washout (Min of 10 and Max of 107 Days)||2
6609513|NCT02104739|7535029|FG006|COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609514|NCT02104739|7535023|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609515|NCT02104739|7535024|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609516|NCT02104739|7535025|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609517|NCT02104739|7535026|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609518|NCT02104739|7535027|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609519|NCT02104739|7535028|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609520|NCT02104739|7535029|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 107 Days)||0
6609521|NCT02104739|7535023|FG000|STARTED|Third Intervention (1 Day)||1
6609522|NCT02104739|7535024|FG001|STARTED|Third Intervention (1 Day)||4
6609523|NCT02104739|7535025|FG002|STARTED|Third Intervention (1 Day)||2
6609524|NCT02104739|7535026|FG003|STARTED|Third Intervention (1 Day)||7
6609525|NCT02104739|7535027|FG004|STARTED|Third Intervention (1 Day)||0
6609526|NCT02104739|7535028|FG005|STARTED|Third Intervention (1 Day)||2
6609527|NCT02104739|7535029|FG006|STARTED|Third Intervention (1 Day)||0
6609528|NCT02104739|7535023|FG000|COMPLETED|Third Intervention (1 Day)||1
6609529|NCT02104739|7535024|FG001|COMPLETED|Third Intervention (1 Day)||4
6609530|NCT02104739|7535025|FG002|COMPLETED|Third Intervention (1 Day)||2
6609531|NCT02104739|7535026|FG003|COMPLETED|Third Intervention (1 Day)||7
6609532|NCT02104739|7535027|FG004|COMPLETED|Third Intervention (1 Day)||0
6609533|NCT02104739|7535028|FG005|COMPLETED|Third Intervention (1 Day)||2
6609534|NCT02104739|7535029|FG006|COMPLETED|Third Intervention (1 Day)||0
6609535|NCT02104739|7535023|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6609536|NCT02104739|7535024|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6609537|NCT02104739|7535025|FG002|NOT COMPLETED|Third Intervention (1 Day)||0
6609538|NCT02104739|7535026|FG003|NOT COMPLETED|Third Intervention (1 Day)||0
6609539|NCT02104739|7535027|FG004|NOT COMPLETED|Third Intervention (1 Day)||0
6609540|NCT02104739|7535028|FG005|NOT COMPLETED|Third Intervention (1 Day)||0
6609541|NCT02104739|7535029|FG006|NOT COMPLETED|Third Intervention (1 Day)||0
6609542|NCT02104739|7535023|FG000|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6609543|NCT02104739|7535024|FG001|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6609544|NCT02104739|7535025|FG002|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6609545|NCT02104739|7535026|FG003|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6609546|NCT02104739|7535027|FG004|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6609547|NCT02104739|7535028|FG005|STARTED|Washout (Min of 10 and Max of 323 Days)||0
6609548|NCT02104739|7535029|FG006|STARTED|Washout (Min of 10 and Max of 323 Days)||8
6609549|NCT02104739|7535023|FG000|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609550|NCT02104739|7535024|FG001|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609551|NCT02104739|7535025|FG002|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609552|NCT02104739|7535026|FG003|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609553|NCT02104739|7535027|FG004|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609554|NCT02104739|7535028|FG005|COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609555|NCT02104739|7535029|FG006|COMPLETED|Washout (Min of 10 and Max of 323 Days)||7
6609556|NCT02104739|7535023|FG000|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609557|NCT02104739|7535024|FG001|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609558|NCT02104739|7535025|FG002|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609559|NCT02104739|7535026|FG003|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609560|NCT02104739|7535027|FG004|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609561|NCT02104739|7535028|FG005|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||0
6609562|NCT02104739|7535029|FG006|NOT COMPLETED|Washout (Min of 10 and Max of 323 Days)||1
6609563|NCT02104739|7535023|FG000|STARTED|Extension Phase (6 Weeks)||0
6609564|NCT02104739|7535024|FG001|STARTED|Extension Phase (6 Weeks)||0
6609565|NCT02104739|7535025|FG002|STARTED|Extension Phase (6 Weeks)||0
6609566|NCT02104739|7535026|FG003|STARTED|Extension Phase (6 Weeks)||0
6609567|NCT02104739|7535027|FG004|STARTED|Extension Phase (6 Weeks)||0
6609568|NCT02104739|7535028|FG005|STARTED|Extension Phase (6 Weeks)||0
6609569|NCT02104739|7535029|FG006|STARTED|Extension Phase (6 Weeks)||8
6609570|NCT02104739|7535023|FG000|COMPLETED|Extension Phase (6 Weeks)||0
6609571|NCT02104739|7535024|FG001|COMPLETED|Extension Phase (6 Weeks)||0
6609572|NCT02104739|7535025|FG002|COMPLETED|Extension Phase (6 Weeks)||0
6609573|NCT02104739|7535026|FG003|COMPLETED|Extension Phase (6 Weeks)||0
6609574|NCT02104739|7535027|FG004|COMPLETED|Extension Phase (6 Weeks)||0
6609575|NCT02104739|7535028|FG005|COMPLETED|Extension Phase (6 Weeks)||0
6609576|NCT02104739|7535029|FG006|COMPLETED|Extension Phase (6 Weeks)||7
6609577|NCT02104739|7535023|FG000|NOT COMPLETED|Extension Phase (6 Weeks)||0
6609578|NCT02104739|7535024|FG001|NOT COMPLETED|Extension Phase (6 Weeks)||0
6609579|NCT02104739|7535025|FG002|NOT COMPLETED|Extension Phase (6 Weeks)||0
6609580|NCT02104739|7535026|FG003|NOT COMPLETED|Extension Phase (6 Weeks)||0
6609581|NCT02104739|7535027|FG004|NOT COMPLETED|Extension Phase (6 Weeks)||0
6609582|NCT02104739|7535028|FG005|NOT COMPLETED|Extension Phase (6 Weeks)||0
6609583|NCT02104739|7535029|FG006|NOT COMPLETED|Extension Phase (6 Weeks)||1
6609584|NCT02104752|7535041|FG000|STARTED|Overall Study||18
6609585|NCT02104752|7535042|FG001|STARTED|Overall Study||21
6609586|NCT02104752|7535041|FG000|COMPLETED|Overall Study||17
6609587|NCT02104752|7535042|FG001|COMPLETED|Overall Study||19
6609588|NCT02104752|7535041|FG000|NOT COMPLETED|Overall Study||1
6609589|NCT02104752|7535042|FG001|NOT COMPLETED|Overall Study||2
6609590|NCT02104765|7535055|FG000|STARTED|Overall Study||8
6609591|NCT02104765|7535056|FG001|STARTED|Overall Study||6
6609592|NCT02104765|7535057|FG002|STARTED|Overall Study||6
6609593|NCT02104765|7535058|FG003|STARTED|Overall Study||7
6609594|NCT02104765|7535059|FG004|STARTED|Overall Study||8
6609595|NCT02104765|7535060|FG005|STARTED|Overall Study||2
6609596|NCT02104765|7535061|FG006|STARTED|Overall Study||8
6609597|NCT02104765|7535055|FG000|Received at Least 1 Dose of Study Drug|Overall Study||8
6609598|NCT02104765|7535056|FG001|Received at Least 1 Dose of Study Drug|Overall Study||6
6609599|NCT02104765|7535057|FG002|Received at Least 1 Dose of Study Drug|Overall Study||6
6609600|NCT02104765|7535058|FG003|Received at Least 1 Dose of Study Drug|Overall Study||7
6609601|NCT02104765|7535059|FG004|Received at Least 1 Dose of Study Drug|Overall Study||8
6609602|NCT02104765|7535060|FG005|Received at Least 1 Dose of Study Drug|Overall Study||2
6609603|NCT02104765|7535061|FG006|Received at Least 1 Dose of Study Drug|Overall Study||8
6609604|NCT02104765|7535055|FG000|COMPLETED|Overall Study||8
6609605|NCT02104765|7535056|FG001|COMPLETED|Overall Study||6
6609606|NCT02104765|7535057|FG002|COMPLETED|Overall Study||5
6609607|NCT02104765|7535058|FG003|COMPLETED|Overall Study||6
6609608|NCT02104765|7535059|FG004|COMPLETED|Overall Study||7
6609609|NCT02104765|7535060|FG005|COMPLETED|Overall Study||2
6609610|NCT02104765|7535061|FG006|COMPLETED|Overall Study||7
6609611|NCT02104765|7535055|FG000|NOT COMPLETED|Overall Study||0
6609612|NCT02104765|7535056|FG001|NOT COMPLETED|Overall Study||0
6609613|NCT02104765|7535057|FG002|NOT COMPLETED|Overall Study||1
6609614|NCT02104765|7535058|FG003|NOT COMPLETED|Overall Study||1
6609615|NCT02104765|7535059|FG004|NOT COMPLETED|Overall Study||1
6609616|NCT02104765|7535060|FG005|NOT COMPLETED|Overall Study||0
6609617|NCT02104765|7535061|FG006|NOT COMPLETED|Overall Study||1
6609618|NCT02104804|7535085|FG000|STARTED|Overall Study|Number of patients who were randomized|234
6609619|NCT02104804|7535086|FG001|STARTED|Overall Study|Number of patients who were randomized|232
6609620|NCT02104804|7535085|FG000|COMPLETED|Overall Study|Number of patients who completed 24 weeks of treatment|218
6609621|NCT02104804|7535086|FG001|COMPLETED|Overall Study|Of the 19 who did not complete, 1 did not take study medication after randomization.|213
6609622|NCT02104804|7535085|FG000|NOT COMPLETED|Overall Study||16
6609623|NCT02104804|7535086|FG001|NOT COMPLETED|Overall Study||19
6609624|NCT02104817|7535094|FG000|STARTED|Overall Study||6539
6609625|NCT02104817|7535095|FG001|STARTED|Overall Study||6539
6609626|NCT02104817|7535094|FG000|COMPLETED|Overall Study||80
6609627|NCT02104817|7535095|FG001|COMPLETED|Overall Study||92
6609628|NCT02104817|7535094|FG000|NOT COMPLETED|Overall Study||6459
6609629|NCT02104817|7535095|FG001|NOT COMPLETED|Overall Study||6447
6609630|NCT02104830|7535104|FG000|STARTED|Overall Study||42
6609631|NCT02104830|7535105|FG001|STARTED|Overall Study||43
6609632|NCT02104830|7535106|FG002|STARTED|Overall Study||43
6609633|NCT02104830|7535104|FG000|COMPLETED|Overall Study||38
6609634|NCT02104830|7535105|FG001|COMPLETED|Overall Study||36
6609635|NCT02104830|7535106|FG002|COMPLETED|Overall Study||36
6609636|NCT02104830|7535104|FG000|NOT COMPLETED|Overall Study||4
6609637|NCT02104830|7535105|FG001|NOT COMPLETED|Overall Study||7
6609638|NCT02104830|7535106|FG002|NOT COMPLETED|Overall Study||7
6609639|NCT02104895|7535116|FG000|STARTED|Overall Study||260
6609640|NCT02104895|7535117|FG001|STARTED|Overall Study||260
6609641|NCT02104895|7535116|FG000|COMPLETED|Overall Study||260
6609642|NCT02104895|7535117|FG001|COMPLETED|Overall Study||246
6609643|NCT02104895|7535116|FG000|NOT COMPLETED|Overall Study||0
6609644|NCT02104895|7535117|FG001|NOT COMPLETED|Overall Study||14
6609645|NCT02104947|7535125|FG000|STARTED|Overall Study||301
6609646|NCT02104947|7535126|FG001|STARTED|Overall Study||202
6609647|NCT02104947|7535125|FG000|COMPLETED|Overall Study||222
6609648|NCT02104947|7535126|FG001|COMPLETED|Overall Study||146
6609649|NCT02104947|7535125|FG000|NOT COMPLETED|Overall Study||79
6609650|NCT02104947|7535126|FG001|NOT COMPLETED|Overall Study||56
6609651|NCT02105012|7535136|FG000|STARTED|Overall Study||147
6609652|NCT02105012|7535136|FG000|BD MDI 320 µg|Overall Study||124
6609653|NCT02105012|7535136|FG000|BD MDI 160 µg|Overall Study||132
6609654|NCT02105012|7535136|FG000|BD MDI 80 µg|Overall Study||64
6609655|NCT02105012|7535136|FG000|BD MDI 40 µg|Overall Study||63
6609656|NCT02105012|7535136|FG000|Placebo MDI|Overall Study||127
6609657|NCT02105012|7535136|FG000|COMPLETED|Overall Study||114
6609658|NCT02105012|7535136|FG000|NOT COMPLETED|Overall Study||33
6609659|NCT02105246|7535150|FG000|STARTED|Overall Study||557
6609660|NCT02105246|7535151|FG001|STARTED|Overall Study||597
6609661|NCT02105246|7535150|FG000|COMPLETED|Overall Study||557
6609662|NCT02105246|7535151|FG001|COMPLETED|Overall Study||597
6609663|NCT02105246|7535150|FG000|NOT COMPLETED|Overall Study||0
6609664|NCT02105246|7535151|FG001|NOT COMPLETED|Overall Study||0
6609665|NCT02105272|7535163|FG000|STARTED|Overall Study||118
6609666|NCT02105272|7535164|FG001|STARTED|Overall Study||119
6609667|NCT02105272|7535163|FG000|COMPLETED|Overall Study||113
6609668|NCT02105272|7535164|FG001|COMPLETED|Overall Study||116
6609669|NCT02105272|7535163|FG000|NOT COMPLETED|Overall Study||5
6609670|NCT02105272|7535164|FG001|NOT COMPLETED|Overall Study||3
6609671|NCT02105285|7535173|FG000|STARTED|Overall Study||78
6609672|NCT02105285|7535174|FG001|STARTED|Overall Study||78
6609673|NCT02105285|7535175|FG002|STARTED|Overall Study||37
6609674|NCT02105285|7535173|FG000|COMPLETED|Overall Study||76
6609675|NCT02105285|7535174|FG001|COMPLETED|Overall Study||76
6609676|NCT02105285|7535175|FG002|COMPLETED|Overall Study||37
6609677|NCT02105285|7535173|FG000|NOT COMPLETED|Overall Study||2
6609678|NCT02105285|7535174|FG001|NOT COMPLETED|Overall Study||2
6609679|NCT02105285|7535175|FG002|NOT COMPLETED|Overall Study||0
6609680|NCT02105324|7535182|FG000|STARTED|Period 1||9
6609681|NCT02105324|7535183|FG001|STARTED|Period 1||10
6609682|NCT02105324|7535182|FG000|COMPLETED|Period 1||9
6609683|NCT02105324|7535183|FG001|COMPLETED|Period 1||10
6609684|NCT02105324|7535182|FG000|NOT COMPLETED|Period 1||0
6609685|NCT02105324|7535183|FG001|NOT COMPLETED|Period 1||0
6609686|NCT02105324|7535182|FG000|STARTED|Period 2||9
6609687|NCT02105324|7535183|FG001|STARTED|Period 2||10
6609688|NCT02105324|7535182|FG000|COMPLETED|Period 2||9
6609689|NCT02105324|7535183|FG001|COMPLETED|Period 2||10
6609690|NCT02105324|7535182|FG000|NOT COMPLETED|Period 2||0
6609691|NCT02105324|7535183|FG001|NOT COMPLETED|Period 2||0
6609692|NCT02105415|7535194|FG000|STARTED|Overall Study||76
6609693|NCT02105415|7535195|FG001|STARTED|Overall Study||84
6609694|NCT02105415|7535194|FG000|COMPLETED|Overall Study||73
6609695|NCT02105415|7535195|FG001|COMPLETED|Overall Study||79
6609696|NCT02105415|7535194|FG000|NOT COMPLETED|Overall Study||3
6609697|NCT02105415|7535195|FG001|NOT COMPLETED|Overall Study||5
6609698|NCT02105454|7535206|FG000|STARTED|Overall Study||79
6609699|NCT02105454|7535206|FG000|COMPLETED|Overall Study||78
6609700|NCT02105454|7535206|FG000|NOT COMPLETED|Overall Study||1
6609701|NCT02105467|7535212|FG000|STARTED|Period 1||316
6609702|NCT02105467|7535213|FG001|STARTED|Period 1||105
6609703|NCT02105467|7535212|FG000|COMPLETED|Period 1||314
6609704|NCT02105467|7535213|FG001|COMPLETED|Period 1||105
6609705|NCT02105467|7535212|FG000|NOT COMPLETED|Period 1||2
6609706|NCT02105467|7535213|FG001|NOT COMPLETED|Period 1||0
6609707|NCT02105467|7535212|FG000|STARTED|Period 2||314
6609708|NCT02105467|7535213|FG001|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
6609709|NCT02105467|7535212|FG000|COMPLETED|Period 2||312
6609710|NCT02105467|7535213|FG001|COMPLETED|Period 2||102
6609711|NCT02105467|7535212|FG000|NOT COMPLETED|Period 2||2
6609712|NCT02105467|7535213|FG001|NOT COMPLETED|Period 2||2
6609713|NCT02105467|7535212|FG000|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
6609714|NCT02105467|7535213|FG001|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
6609715|NCT02105467|7535212|FG000|COMPLETED|Period 3||0
6609716|NCT02105467|7535213|FG001|COMPLETED|Period 3||102
6609717|NCT02105467|7535212|FG000|NOT COMPLETED|Period 3||0
6609718|NCT02105467|7535213|FG001|NOT COMPLETED|Period 3||1
6609719|NCT02105558|7535222|FG000|STARTED|Overall Study||15
6609720|NCT02105558|7535223|FG001|STARTED|Overall Study||28
6609721|NCT02105558|7535222|FG000|COMPLETED|Overall Study||15
6609722|NCT02105558|7535223|FG001|COMPLETED|Overall Study||28
6609723|NCT02105558|7535222|FG000|NOT COMPLETED|Overall Study||0
6609724|NCT02105558|7535223|FG001|NOT COMPLETED|Overall Study||0
6609725|NCT02105662|7535229|FG000|STARTED|Overall Study||218
6609726|NCT02105662|7535229|FG000|COMPLETED|Overall Study||212
6609727|NCT02105662|7535229|FG000|NOT COMPLETED|Overall Study||6
6609728|NCT02105688|7535235|FG000|STARTED|Part A: Double-Blind||201
6609729|NCT02105688|7535236|FG001|STARTED|Part A: Double-Blind||100
6609730|NCT02105688|7535235|FG000|COMPLETED|Part A: Double-Blind|Completed Part A|181
6609731|NCT02105688|7535236|FG001|COMPLETED|Part A: Double-Blind|Completed Part A|83
6609732|NCT02105688|7535235|FG000|NOT COMPLETED|Part A: Double-Blind||20
6609733|NCT02105688|7535236|FG001|NOT COMPLETED|Part A: Double-Blind||17
6609734|NCT02105688|7535235|FG000|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|131
6609735|NCT02105688|7535236|FG001|STARTED|Part B: Observational Follow-up|Completed Part A and met Part B Extension criteria|68
6609736|NCT02105688|7535235|FG000|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|94
6609737|NCT02105688|7535236|FG001|COMPLETED|Part B: Observational Follow-up|Completed Part B extension|48
6609738|NCT02105688|7535235|FG000|NOT COMPLETED|Part B: Observational Follow-up||37
6609739|NCT02105688|7535236|FG001|NOT COMPLETED|Part B: Observational Follow-up||20
6609740|NCT02105701|7535247|FG000|STARTED|Overall Study||105
6609741|NCT02105701|7535248|FG001|STARTED|Overall Study||104
6609742|NCT02105701|7535249|FG002|STARTED|Overall Study||105
6609743|NCT02105701|7535250|FG003|STARTED|Overall Study||106
6609744|NCT02105701|7535247|FG000|COMPLETED|Overall Study||101
6609745|NCT02105701|7535248|FG001|COMPLETED|Overall Study||103
6609746|NCT02105701|7535249|FG002|COMPLETED|Overall Study||102
6609747|NCT02105701|7535250|FG003|COMPLETED|Overall Study||104
6609748|NCT02105701|7535247|FG000|NOT COMPLETED|Overall Study||4
6609749|NCT02105701|7535248|FG001|NOT COMPLETED|Overall Study||1
6609750|NCT02105701|7535249|FG002|NOT COMPLETED|Overall Study||3
6609751|NCT02105701|7535250|FG003|NOT COMPLETED|Overall Study||2
6609752|NCT02105740|7535262|FG000|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
6609753|NCT02105740|7535263|FG001|STARTED|Overall Study|Application of EVA and HADS scales|12
6609754|NCT02105740|7535262|FG000|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
6609755|NCT02105740|7535263|FG001|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
6609756|NCT02105740|7535262|FG000|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
6609757|NCT02105740|7535263|FG001|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
6609758|NCT02105740|7535262|FG000|NOT COMPLETED|Overall Study||0
6609759|NCT02105740|7535263|FG001|NOT COMPLETED|Overall Study||1
6609760|NCT02105948|7535275|FG000|STARTED|Overall Study||229
6609761|NCT02105948|7535276|FG001|STARTED|Overall Study||233
6609762|NCT02105948|7535277|FG002|STARTED|Overall Study||190
6609763|NCT02105948|7535278|FG003|STARTED|Overall Study||184
6609764|NCT02105948|7535275|FG000|Completed Investigational Product (IP)|Overall Study||185
6609765|NCT02105948|7535276|FG001|Completed Investigational Product (IP)|Overall Study||203
6609766|NCT02105948|7535277|FG002|Completed Investigational Product (IP)|Overall Study||148
6609767|NCT02105948|7535278|FG003|Completed Investigational Product (IP)|Overall Study||149
6609768|NCT02105948|7535275|FG000|Not Completed IP|Overall Study||44
6609769|NCT02105948|7535276|FG001|Not Completed IP|Overall Study||30
6609770|NCT02105948|7535277|FG002|Not Completed IP|Overall Study||42
6609771|NCT02105948|7535278|FG003|Not Completed IP|Overall Study||35
6609772|NCT02105948|7535275|FG000|Withdrew IP Due to: Adverse Event|Overall Study||20
6609773|NCT02105948|7535276|FG001|Withdrew IP Due to: Adverse Event|Overall Study||16
6609774|NCT02105948|7535277|FG002|Withdrew IP Due to: Adverse Event|Overall Study||15
6609775|NCT02105948|7535278|FG003|Withdrew IP Due to: Adverse Event|Overall Study||13
6609776|NCT02105948|7535275|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||5
6609777|NCT02105948|7535276|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
6609778|NCT02105948|7535277|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||8
6609779|NCT02105948|7535278|FG003|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
6609780|NCT02105948|7535275|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||1
6609781|NCT02105948|7535276|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||3
6609782|NCT02105948|7535277|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||3
6609783|NCT02105948|7535278|FG003|Withdrew IP Due to: Protocol Deviation|Overall Study||0
6609784|NCT02105948|7535275|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
6609785|NCT02105948|7535276|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||0
6609786|NCT02105948|7535277|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
6609787|NCT02105948|7535278|FG003|Withdrew IP Due to: Lost to Follow-up|Overall Study||2
6609788|NCT02105948|7535275|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
6609789|NCT02105948|7535276|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||8
6609790|NCT02105948|7535277|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
6609791|NCT02105948|7535278|FG003|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||15
6609792|NCT02105948|7535275|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
6609793|NCT02105948|7535276|FG001|Withdrew IP Due to: Physician Decision|Overall Study||1
6609794|NCT02105948|7535277|FG002|Withdrew IP Due to: Physician Decision|Overall Study||4
6609795|NCT02105948|7535278|FG003|Withdrew IP Due to: Physician Decision|Overall Study||2
6609796|NCT02105948|7535275|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||0
6609797|NCT02105948|7535276|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||0
6609798|NCT02105948|7535277|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
6609799|NCT02105948|7535278|FG003|Withdrew IP Due to: Stopping Criteria|Overall Study||1
6609800|NCT02105948|7535275|FG000|COMPLETED|Overall Study||202
6609801|NCT02105948|7535276|FG001|COMPLETED|Overall Study||213
6609802|NCT02105948|7535277|FG002|COMPLETED|Overall Study||162
6609803|NCT02105948|7535278|FG003|COMPLETED|Overall Study||157
6609804|NCT02105948|7535275|FG000|NOT COMPLETED|Overall Study||27
6609805|NCT02105948|7535276|FG001|NOT COMPLETED|Overall Study||20
6609806|NCT02105948|7535277|FG002|NOT COMPLETED|Overall Study||28
6609807|NCT02105948|7535278|FG003|NOT COMPLETED|Overall Study||27
6609808|NCT02105961|7535292|FG000|STARTED|Overall Study||226
6609809|NCT02105961|7535293|FG001|STARTED|Overall Study||223
6609810|NCT02105961|7535294|FG002|STARTED|Overall Study||225
6609811|NCT02105961|7535292|FG000|Completed Investigational Product (IP)|Overall Study||170
6609812|NCT02105961|7535293|FG001|Completed Investigational Product (IP)|Overall Study||196
6609813|NCT02105961|7535294|FG002|Completed Investigational Product (IP)|Overall Study||183
6609814|NCT02105961|7535292|FG000|Not Completed IP|Overall Study||56
6609815|NCT02105961|7535293|FG001|Not Completed IP|Overall Study||27
6609816|NCT02105961|7535294|FG002|Not Completed IP|Overall Study||42
6609817|NCT02105961|7535292|FG000|Withdrew IP Due to: Adverse Event|Overall Study||27
6609818|NCT02105961|7535293|FG001|Withdrew IP Due to: Adverse Event|Overall Study||9
6609819|NCT02105961|7535294|FG002|Withdrew IP Due to: Adverse Event|Overall Study||25
6609820|NCT02105961|7535292|FG000|Withdrew IP Due to: Stopping Criteria|Overall Study||1
6609821|NCT02105961|7535293|FG001|Withdrew IP Due to: Stopping Criteria|Overall Study||1
6609822|NCT02105961|7535294|FG002|Withdrew IP Due to: Stopping Criteria|Overall Study||0
6609823|NCT02105961|7535292|FG000|Withdrew IP Due to: Lack of Efficacy|Overall Study||6
6609824|NCT02105961|7535293|FG001|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
6609825|NCT02105961|7535294|FG002|Withdrew IP Due to: Lack of Efficacy|Overall Study||2
6609826|NCT02105961|7535292|FG000|Withdrew IP Due to: Protocol Deviation|Overall Study||2
6732418|NCT03193021|7661779|FG000|STARTED|Overall Study||100
6732419|NCT03193021|7661780|FG001|STARTED|Overall Study||104
6732420|NCT03193021|7661779|FG000|COMPLETED|Overall Study||99
6732421|NCT03193021|7661780|FG001|COMPLETED|Overall Study||103
6732422|NCT03193021|7661779|FG000|NOT COMPLETED|Overall Study||1
6732423|NCT03193021|7661780|FG001|NOT COMPLETED|Overall Study||1
6732424|NCT03193047|7661788|FG000|STARTED|Overall Study||31
6732425|NCT03193047|7661789|FG001|STARTED|Overall Study||28
6732426|NCT03193047|7661788|FG000|COMPLETED|Overall Study||29
6732427|NCT03193047|7661789|FG001|COMPLETED|Overall Study||28
6732428|NCT03193047|7661788|FG000|NOT COMPLETED|Overall Study||2
6732429|NCT03193047|7661789|FG001|NOT COMPLETED|Overall Study||0
6732430|NCT03193398|7661799|FG000|STARTED|Overall Study||53
6732431|NCT03193398|7661800|FG001|STARTED|Overall Study||51
6732432|NCT03193398|7661799|FG000|COMPLETED|Overall Study||38
6732433|NCT03193398|7661800|FG001|COMPLETED|Overall Study||35
6732434|NCT03193398|7661799|FG000|NOT COMPLETED|Overall Study||15
6732435|NCT03193398|7661800|FG001|NOT COMPLETED|Overall Study||16
6732436|NCT03193593|7661813|FG000|STARTED|Overall Study||18
6732437|NCT03193593|7661814|FG001|STARTED|Overall Study||4
6732438|NCT03193593|7661815|FG002|STARTED|Overall Study||4
6732439|NCT03193593|7661816|FG003|STARTED|Overall Study||4
6732440|NCT03193593|7661817|FG004|STARTED|Overall Study||8
6732441|NCT03193593|7661818|FG005|STARTED|Overall Study||16
6732442|NCT03193593|7661819|FG006|STARTED|Overall Study||12
6732443|NCT03193593|7661813|FG000|COMPLETED|Overall Study||14
6732444|NCT03193593|7661814|FG001|COMPLETED|Overall Study||3
6732445|NCT03193593|7661815|FG002|COMPLETED|Overall Study||3
6732446|NCT03193593|7661816|FG003|COMPLETED|Overall Study||4
6732447|NCT03193593|7661817|FG004|COMPLETED|Overall Study||7
6732448|NCT03193593|7661818|FG005|COMPLETED|Overall Study||13
6732449|NCT03193593|7661819|FG006|COMPLETED|Overall Study||8
6732450|NCT03193593|7661813|FG000|NOT COMPLETED|Overall Study||4
6732451|NCT03193593|7661814|FG001|NOT COMPLETED|Overall Study||1
6732452|NCT03193593|7661815|FG002|NOT COMPLETED|Overall Study||1
6732453|NCT03193593|7661816|FG003|NOT COMPLETED|Overall Study||0
6732454|NCT03193593|7661817|FG004|NOT COMPLETED|Overall Study||1
6732455|NCT03193593|7661818|FG005|NOT COMPLETED|Overall Study||3
6732456|NCT03193593|7661819|FG006|NOT COMPLETED|Overall Study||4
6732457|NCT03193736|7661835|FG000|STARTED|Overall Study||26
6732458|NCT03193736|7661835|FG000|Received Implant|Overall Study||25
6732459|NCT03193736|7661835|FG000|COMPLETED|Overall Study||21
6732460|NCT03193736|7661835|FG000|NOT COMPLETED|Overall Study||5
6732461|NCT03194217|7661843|FG000|STARTED|Overall Study||60
6732462|NCT03194217|7661844|FG001|STARTED|Overall Study||60
6732463|NCT03194217|7661845|FG002|STARTED|Overall Study||60
6732464|NCT03194217|7661846|FG003|STARTED|Overall Study||64
6732465|NCT03194217|7661843|FG000|COMPLETED|Overall Study||60
6732466|NCT03194217|7661844|FG001|COMPLETED|Overall Study||57
6732467|NCT03194217|7661845|FG002|COMPLETED|Overall Study||56
6732468|NCT03194217|7661846|FG003|COMPLETED|Overall Study||60
6732469|NCT03194217|7661843|FG000|NOT COMPLETED|Overall Study||0
6732470|NCT03194217|7661844|FG001|NOT COMPLETED|Overall Study||3
6732471|NCT03194217|7661845|FG002|NOT COMPLETED|Overall Study||4
6732472|NCT03194217|7661846|FG003|NOT COMPLETED|Overall Study||4
6732473|NCT03194334|7661859|FG000|STARTED|0-3 Months||10
6732474|NCT03194334|7661860|FG001|STARTED|0-3 Months||15
6732475|NCT03194334|7661861|FG002|STARTED|0-3 Months||15
6732476|NCT03194334|7661859|FG000|COMPLETED|0-3 Months||10
6732477|NCT03194334|7661860|FG001|COMPLETED|0-3 Months||15
6732478|NCT03194334|7661861|FG002|COMPLETED|0-3 Months||14
6732479|NCT03194334|7661859|FG000|NOT COMPLETED|0-3 Months||0
6732480|NCT03194334|7661860|FG001|NOT COMPLETED|0-3 Months||0
6732481|NCT03194334|7661861|FG002|NOT COMPLETED|0-3 Months||1
6732482|NCT03194334|7661859|FG000|STARTED|3-6 Months||10
6732483|NCT03194334|7661860|FG001|STARTED|3-6 Months||15
6732484|NCT03194334|7661861|FG002|STARTED|3-6 Months||14
6732485|NCT03194334|7661859|FG000|COMPLETED|3-6 Months||10
6732486|NCT03194334|7661860|FG001|COMPLETED|3-6 Months||15
6732487|NCT03194334|7661861|FG002|COMPLETED|3-6 Months||14
6732488|NCT03194334|7661859|FG000|NOT COMPLETED|3-6 Months||0
6732489|NCT03194334|7661860|FG001|NOT COMPLETED|3-6 Months||0
6732490|NCT03194334|7661861|FG002|NOT COMPLETED|3-6 Months||0
6732491|NCT03194373|7661870|FG000|STARTED|Overall Study||20
6732492|NCT03194373|7661870|FG000|Received Palbociclib and Carboplatin|Overall Study||19
6732493|NCT03194373|7661870|FG000|COMPLETED|Overall Study||18
6732494|NCT03194373|7661870|FG000|NOT COMPLETED|Overall Study||2
6609827|NCT02105961|7535293|FG001|Withdrew IP Due to: Protocol Deviation|Overall Study||0
6609828|NCT02105961|7535294|FG002|Withdrew IP Due to: Protocol Deviation|Overall Study||1
6609829|NCT02105961|7535292|FG000|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
6609830|NCT02105961|7535293|FG001|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
6609831|NCT02105961|7535294|FG002|Withdrew IP Due to: Lost to Follow-up|Overall Study||1
6609832|NCT02105961|7535292|FG000|Withdrew IP Due to: Physician Decision|Overall Study||2
6609833|NCT02105961|7535293|FG001|Withdrew IP Due to: Physician Decision|Overall Study||3
6609834|NCT02105961|7535294|FG002|Withdrew IP Due to: Physician Decision|Overall Study||1
6609835|NCT02105961|7535292|FG000|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||16
6609836|NCT02105961|7535293|FG001|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
6609837|NCT02105961|7535294|FG002|Withdrew IP Due to: Withdrawal by Subj.|Overall Study||11
6609838|NCT02105961|7535292|FG000|Withdrew IP Due to: Site Closed|Overall Study||1
6609839|NCT02105961|7535293|FG001|Withdrew IP Due to: Site Closed|Overall Study||0
6609840|NCT02105961|7535294|FG002|Withdrew IP Due to: Site Closed|Overall Study||1
6609841|NCT02105961|7535292|FG000|COMPLETED|Overall Study||185
6609842|NCT02105961|7535293|FG001|COMPLETED|Overall Study||206
6609843|NCT02105961|7535294|FG002|COMPLETED|Overall Study||195
6609844|NCT02105961|7535292|FG000|NOT COMPLETED|Overall Study||41
6609845|NCT02105961|7535293|FG001|NOT COMPLETED|Overall Study||17
6609846|NCT02105961|7535294|FG002|NOT COMPLETED|Overall Study||30
6609847|NCT02105974|7535305|FG000|STARTED|2 Week Run-in Period||2423
6609848|NCT02105974|7535306|FG001|STARTED|2 Week Run-in Period||0
6609849|NCT02105974|7535307|FG002|STARTED|2 Week Run-in Period||0
6609850|NCT02105974|7535305|FG000|COMPLETED|2 Week Run-in Period||1622
6609851|NCT02105974|7535306|FG001|COMPLETED|2 Week Run-in Period||0
6609852|NCT02105974|7535307|FG002|COMPLETED|2 Week Run-in Period||0
6609853|NCT02105974|7535305|FG000|NOT COMPLETED|2 Week Run-in Period||801
6609854|NCT02105974|7535306|FG001|NOT COMPLETED|2 Week Run-in Period||0
6609855|NCT02105974|7535307|FG002|NOT COMPLETED|2 Week Run-in Period||0
6609856|NCT02105974|7535305|FG000|STARTED|12 Week (Wk) Treatment Period (TP)||0
6609857|NCT02105974|7535306|FG001|STARTED|12 Week (Wk) Treatment Period (TP)||806
6609858|NCT02105974|7535307|FG002|STARTED|12 Week (Wk) Treatment Period (TP)||814
6609859|NCT02105974|7535305|FG000|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
6609860|NCT02105974|7535306|FG001|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
6609861|NCT02105974|7535307|FG002|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
6609862|NCT02105974|7535305|FG000|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
6609863|NCT02105974|7535306|FG001|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
6609864|NCT02105974|7535307|FG002|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
6609865|NCT02105974|7535305|FG000|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
6609866|NCT02105974|7535306|FG001|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
6609867|NCT02105974|7535307|FG002|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
6609868|NCT02105987|7535315|FG000|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
6609869|NCT02105987|7535316|FG001|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
6609870|NCT02105987|7535317|FG002|STARTED|Early Switch Phase (24 Weeks)||0
6609871|NCT02105987|7535318|FG003|STARTED|Early Switch Phase (24 Weeks)||0
6609872|NCT02105987|7535319|FG004|STARTED|Early Switch Phase (24 Weeks)||0
6609873|NCT02105987|7535320|FG005|STARTED|Early Switch Phase (24 Weeks)||0
6609874|NCT02105987|7535315|FG000|COMPLETED|Early Switch Phase (24 Weeks)||239
6609875|NCT02105987|7535316|FG001|COMPLETED|Early Switch Phase (24 Weeks)||244
6609876|NCT02105987|7535317|FG002|COMPLETED|Early Switch Phase (24 Weeks)||0
6609877|NCT02105987|7535318|FG003|COMPLETED|Early Switch Phase (24 Weeks)||0
6609878|NCT02105987|7535319|FG004|COMPLETED|Early Switch Phase (24 Weeks)||0
6609879|NCT02105987|7535320|FG005|COMPLETED|Early Switch Phase (24 Weeks)||0
6609880|NCT02105987|7535315|FG000|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
6609881|NCT02105987|7535316|FG001|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
6609882|NCT02105987|7535317|FG002|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
6609883|NCT02105987|7535318|FG003|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
6609884|NCT02105987|7535319|FG004|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
6609885|NCT02105987|7535320|FG005|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
6609886|NCT02105987|7535315|FG000|STARTED|Late Switch Phase (24 Weeks)||0
6609887|NCT02105987|7535316|FG001|STARTED|Late Switch Phase (24 Weeks)||0
6609888|NCT02105987|7535317|FG002|STARTED|Late Switch Phase (24 Weeks)||275
6609889|NCT02105987|7535318|FG003|STARTED|Late Switch Phase (24 Weeks)||244
6609890|NCT02105987|7535319|FG004|STARTED|Late Switch Phase (24 Weeks)||0
6609891|NCT02105987|7535320|FG005|STARTED|Late Switch Phase (24 Weeks)||0
6609892|NCT02105987|7535315|FG000|COMPLETED|Late Switch Phase (24 Weeks)||0
6609893|NCT02105987|7535316|FG001|COMPLETED|Late Switch Phase (24 Weeks)||0
6609894|NCT02105987|7535317|FG002|COMPLETED|Late Switch Phase (24 Weeks)||230
6609895|NCT02105987|7535318|FG003|COMPLETED|Late Switch Phase (24 Weeks)||230
6609896|NCT02105987|7535319|FG004|COMPLETED|Late Switch Phase (24 Weeks)||0
6609897|NCT02105987|7535320|FG005|COMPLETED|Late Switch Phase (24 Weeks)||0
6609898|NCT02105987|7535315|FG000|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
6609899|NCT02105987|7535316|FG001|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
6609900|NCT02105987|7535317|FG002|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
6609901|NCT02105987|7535318|FG003|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
6609902|NCT02105987|7535319|FG004|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
6609903|NCT02105987|7535320|FG005|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
6609904|NCT02105987|7535315|FG000|STARTED|Continuation Phase||0
6609905|NCT02105987|7535316|FG001|STARTED|Continuation Phase||0
6609906|NCT02105987|7535317|FG002|STARTED|Continuation Phase||0
6609907|NCT02105987|7535318|FG003|STARTED|Continuation Phase||0
6609908|NCT02105987|7535319|FG004|STARTED|Continuation Phase||14
6609909|NCT02105987|7535320|FG005|STARTED|Continuation Phase||23
6609910|NCT02105987|7535315|FG000|COMPLETED|Continuation Phase||0
6609911|NCT02105987|7535316|FG001|COMPLETED|Continuation Phase||0
6609912|NCT02105987|7535317|FG002|COMPLETED|Continuation Phase||0
6609913|NCT02105987|7535318|FG003|COMPLETED|Continuation Phase||0
6609914|NCT02105987|7535319|FG004|COMPLETED|Continuation Phase||13
6609915|NCT02105987|7535320|FG005|COMPLETED|Continuation Phase||23
6609916|NCT02105987|7535315|FG000|NOT COMPLETED|Continuation Phase||0
6609917|NCT02105987|7535316|FG001|NOT COMPLETED|Continuation Phase||0
6609918|NCT02105987|7535317|FG002|NOT COMPLETED|Continuation Phase||0
6609919|NCT02105987|7535318|FG003|NOT COMPLETED|Continuation Phase||0
6609920|NCT02105987|7535319|FG004|NOT COMPLETED|Continuation Phase||1
6609921|NCT02105987|7535320|FG005|NOT COMPLETED|Continuation Phase||0
6609922|NCT02106065|7535329|FG000|STARTED|Overall Study||6
6609923|NCT02106065|7535330|FG001|STARTED|Overall Study||11
6609924|NCT02106065|7535331|FG002|STARTED|Overall Study||15
6609925|NCT02106065|7535329|FG000|6 Month Completion|Overall Study||3
6609926|NCT02106065|7535330|FG001|6 Month Completion|Overall Study||8
6609927|NCT02106065|7535331|FG002|6 Month Completion|Overall Study||5
6609928|NCT02106065|7535329|FG000|COMPLETED|Overall Study||3
6609929|NCT02106065|7535330|FG001|COMPLETED|Overall Study||8
6609930|NCT02106065|7535331|FG002|COMPLETED|Overall Study||5
6609931|NCT02106065|7535329|FG000|NOT COMPLETED|Overall Study||3
6609932|NCT02106065|7535330|FG001|NOT COMPLETED|Overall Study||3
6609933|NCT02106065|7535331|FG002|NOT COMPLETED|Overall Study||10
6609934|NCT02106156|7535342|FG000|STARTED|Overall Study||9620
6609935|NCT02106156|7535343|FG001|STARTED|Overall Study||90
6609936|NCT02106156|7535344|FG002|STARTED|Overall Study||518
6609937|NCT02106156|7535342|FG000|COMPLETED|Overall Study||7071
6609938|NCT02106156|7535343|FG001|COMPLETED|Overall Study||50
6609939|NCT02106156|7535344|FG002|COMPLETED|Overall Study||518
6609940|NCT02106156|7535342|FG000|NOT COMPLETED|Overall Study||2549
6609941|NCT02106156|7535343|FG001|NOT COMPLETED|Overall Study||40
6609942|NCT02106156|7535344|FG002|NOT COMPLETED|Overall Study||0
6609943|NCT02106325|7535353|FG000|STARTED|Phase 1||5
6609944|NCT02106325|7535354|FG001|STARTED|Phase 1||3
6609945|NCT02106325|7535353|FG000|COMPLETED|Phase 1||3
6609946|NCT02106325|7535354|FG001|COMPLETED|Phase 1||1
6609947|NCT02106325|7535353|FG000|NOT COMPLETED|Phase 1||2
6609948|NCT02106325|7535354|FG001|NOT COMPLETED|Phase 1||2
6609949|NCT02106325|7535353|FG000|STARTED|Phase 2||4
6609950|NCT02106325|7535354|FG001|STARTED|Phase 2||4
6609951|NCT02106325|7535353|FG000|COMPLETED|Phase 2||2
6609952|NCT02106325|7535354|FG001|COMPLETED|Phase 2||1
6609953|NCT02106325|7535353|FG000|NOT COMPLETED|Phase 2||2
6609954|NCT02106325|7535354|FG001|NOT COMPLETED|Phase 2||3
6609955|NCT02106325|7535353|FG000|STARTED|Phase 3||2
6609956|NCT02106325|7535354|FG001|STARTED|Phase 3||3
6609957|NCT02106325|7535353|FG000|COMPLETED|Phase 3||0
6609958|NCT02106325|7535354|FG001|COMPLETED|Phase 3||2
6609959|NCT02106325|7535353|FG000|NOT COMPLETED|Phase 3||2
6609960|NCT02106325|7535354|FG001|NOT COMPLETED|Phase 3||1
6609961|NCT02106351|7535363|FG000|STARTED|Treatment Cycle 1||71
6609962|NCT02106351|7535364|FG001|STARTED|Treatment Cycle 1||70
6609963|NCT02106351|7535365|FG002|STARTED|Treatment Cycle 1||71
6609964|NCT02106351|7535363|FG000|Received Treatment in TC 1|Treatment Cycle 1||70
6609965|NCT02106351|7535364|FG001|Received Treatment in TC 1|Treatment Cycle 1||70
6609966|NCT02106351|7535365|FG002|Received Treatment in TC 1|Treatment Cycle 1||70
6609967|NCT02106351|7535363|FG000|COMPLETED|Treatment Cycle 1||66
6609968|NCT02106351|7535364|FG001|COMPLETED|Treatment Cycle 1||67
6609969|NCT02106351|7535365|FG002|COMPLETED|Treatment Cycle 1||67
6609970|NCT02106351|7535363|FG000|NOT COMPLETED|Treatment Cycle 1||5
6609971|NCT02106351|7535364|FG001|NOT COMPLETED|Treatment Cycle 1||3
6609972|NCT02106351|7535365|FG002|NOT COMPLETED|Treatment Cycle 1||4
6609973|NCT02106351|7535363|FG000|STARTED|Treatment Cycle 2|Subjects who received Dysport 2 U/kg in TC 1 were randomised to receive 8 or 16 U/kg in TCs 2-4.|0
6609974|NCT02106351|7535364|FG001|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|88
6609975|NCT02106351|7535365|FG002|STARTED|Treatment Cycle 2|Not all subjects who completed TC 1 required retreatment in TC 2.|90
6609976|NCT02106351|7535363|FG000|COMPLETED|Treatment Cycle 2||0
6609977|NCT02106351|7535364|FG001|COMPLETED|Treatment Cycle 2||83
6609978|NCT02106351|7535365|FG002|COMPLETED|Treatment Cycle 2||87
6609979|NCT02106351|7535363|FG000|NOT COMPLETED|Treatment Cycle 2||0
6609980|NCT02106351|7535364|FG001|NOT COMPLETED|Treatment Cycle 2||5
6609981|NCT02106351|7535365|FG002|NOT COMPLETED|Treatment Cycle 2||3
6609982|NCT02106351|7535363|FG000|STARTED|Treatment Cycle 3||0
6609983|NCT02106351|7535364|FG001|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|49
6609984|NCT02106351|7535365|FG002|STARTED|Treatment Cycle 3|Not all subjects who completed TC 2 required retreatment in TC 3.|58
6609985|NCT02106351|7535363|FG000|COMPLETED|Treatment Cycle 3||0
6609986|NCT02106351|7535364|FG001|COMPLETED|Treatment Cycle 3||45
6609987|NCT02106351|7535365|FG002|COMPLETED|Treatment Cycle 3||53
6609988|NCT02106351|7535363|FG000|NOT COMPLETED|Treatment Cycle 3||0
6609989|NCT02106351|7535364|FG001|NOT COMPLETED|Treatment Cycle 3||4
6609990|NCT02106351|7535365|FG002|NOT COMPLETED|Treatment Cycle 3||5
6609991|NCT02106351|7535363|FG000|STARTED|Treatment Cycle 4||0
6609992|NCT02106351|7535364|FG001|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|22
6609993|NCT02106351|7535365|FG002|STARTED|Treatment Cycle 4|Not all subjects who completed TC 3 required retreatment in TC 4.|33
6609994|NCT02106351|7535363|FG000|COMPLETED|Treatment Cycle 4||0
6609995|NCT02106351|7535364|FG001|COMPLETED|Treatment Cycle 4||21
6609996|NCT02106351|7535365|FG002|COMPLETED|Treatment Cycle 4||31
6609997|NCT02106351|7535363|FG000|NOT COMPLETED|Treatment Cycle 4||0
6609998|NCT02106351|7535364|FG001|NOT COMPLETED|Treatment Cycle 4||1
6609999|NCT02106351|7535365|FG002|NOT COMPLETED|Treatment Cycle 4||2
6610000|NCT02106390|7535382|FG000|STARTED|Overall Study||252
6610001|NCT02106390|7535383|FG001|STARTED|Overall Study||250
6610002|NCT02106390|7535384|FG002|STARTED|Overall Study||248
6610003|NCT02106390|7535382|FG000|COMPLETED|Overall Study||203
6610004|NCT02106390|7535383|FG001|COMPLETED|Overall Study||202
6610005|NCT02106390|7535384|FG002|COMPLETED|Overall Study||205
6610006|NCT02106390|7535382|FG000|NOT COMPLETED|Overall Study||49
6610007|NCT02106390|7535383|FG001|NOT COMPLETED|Overall Study||48
6610008|NCT02106390|7535384|FG002|NOT COMPLETED|Overall Study||43
6610009|NCT02106403|7535395|FG000|STARTED|Visit 1, Treatment Period 1||8
6610010|NCT02106403|7535396|FG001|STARTED|Visit 1, Treatment Period 1||8
6610011|NCT02106403|7535397|FG002|STARTED|Visit 1, Treatment Period 1||9
6610012|NCT02106403|7535398|FG003|STARTED|Visit 1, Treatment Period 1||8
6610013|NCT02106403|7535399|FG004|STARTED|Visit 1, Treatment Period 1||8
6610014|NCT02106403|7535400|FG005|STARTED|Visit 1, Treatment Period 1||9
6610015|NCT02106403|7535395|FG000|COMPLETED|Visit 1, Treatment Period 1||8
6610016|NCT02106403|7535396|FG001|COMPLETED|Visit 1, Treatment Period 1||8
6610017|NCT02106403|7535397|FG002|COMPLETED|Visit 1, Treatment Period 1||9
6610018|NCT02106403|7535398|FG003|COMPLETED|Visit 1, Treatment Period 1||8
6610019|NCT02106403|7535399|FG004|COMPLETED|Visit 1, Treatment Period 1||8
6610020|NCT02106403|7535400|FG005|COMPLETED|Visit 1, Treatment Period 1||9
6610021|NCT02106403|7535395|FG000|NOT COMPLETED|Visit 1, Treatment Period 1||0
6610022|NCT02106403|7535396|FG001|NOT COMPLETED|Visit 1, Treatment Period 1||0
6610023|NCT02106403|7535397|FG002|NOT COMPLETED|Visit 1, Treatment Period 1||0
6610024|NCT02106403|7535398|FG003|NOT COMPLETED|Visit 1, Treatment Period 1||0
6610025|NCT02106403|7535399|FG004|NOT COMPLETED|Visit 1, Treatment Period 1||0
6610026|NCT02106403|7535400|FG005|NOT COMPLETED|Visit 1, Treatment Period 1||0
6610027|NCT02106403|7535395|FG000|STARTED|Visit 1, Treatment Period 2||8
6610028|NCT02106403|7535396|FG001|STARTED|Visit 1, Treatment Period 2||8
6610029|NCT02106403|7535397|FG002|STARTED|Visit 1, Treatment Period 2||9
6610030|NCT02106403|7535398|FG003|STARTED|Visit 1, Treatment Period 2||8
6610031|NCT02106403|7535399|FG004|STARTED|Visit 1, Treatment Period 2||8
6610032|NCT02106403|7535400|FG005|STARTED|Visit 1, Treatment Period 2||9
6610033|NCT02106403|7535395|FG000|COMPLETED|Visit 1, Treatment Period 2||8
6610034|NCT02106403|7535396|FG001|COMPLETED|Visit 1, Treatment Period 2||8
6610035|NCT02106403|7535397|FG002|COMPLETED|Visit 1, Treatment Period 2||9
6610036|NCT02106403|7535398|FG003|COMPLETED|Visit 1, Treatment Period 2||8
6610037|NCT02106403|7535399|FG004|COMPLETED|Visit 1, Treatment Period 2||8
6610038|NCT02106403|7535400|FG005|COMPLETED|Visit 1, Treatment Period 2||9
6610039|NCT02106403|7535395|FG000|NOT COMPLETED|Visit 1, Treatment Period 2||0
6610040|NCT02106403|7535396|FG001|NOT COMPLETED|Visit 1, Treatment Period 2||0
6610041|NCT02106403|7535397|FG002|NOT COMPLETED|Visit 1, Treatment Period 2||0
6610042|NCT02106403|7535398|FG003|NOT COMPLETED|Visit 1, Treatment Period 2||0
6610043|NCT02106403|7535399|FG004|NOT COMPLETED|Visit 1, Treatment Period 2||0
6610044|NCT02106403|7535400|FG005|NOT COMPLETED|Visit 1, Treatment Period 2||0
6610045|NCT02106403|7535395|FG000|STARTED|Visit 1, Treatment Period 3||8
6610046|NCT02106403|7535396|FG001|STARTED|Visit 1, Treatment Period 3||8
6610047|NCT02106403|7535397|FG002|STARTED|Visit 1, Treatment Period 3||9
6610048|NCT02106403|7535398|FG003|STARTED|Visit 1, Treatment Period 3||8
6610049|NCT02106403|7535399|FG004|STARTED|Visit 1, Treatment Period 3||8
6610050|NCT02106403|7535400|FG005|STARTED|Visit 1, Treatment Period 3||9
6610051|NCT02106403|7535395|FG000|COMPLETED|Visit 1, Treatment Period 3||8
6610052|NCT02106403|7535396|FG001|COMPLETED|Visit 1, Treatment Period 3||8
6610053|NCT02106403|7535397|FG002|COMPLETED|Visit 1, Treatment Period 3||9
6610054|NCT02106403|7535398|FG003|COMPLETED|Visit 1, Treatment Period 3||8
6610055|NCT02106403|7535399|FG004|COMPLETED|Visit 1, Treatment Period 3||8
6610056|NCT02106403|7535400|FG005|COMPLETED|Visit 1, Treatment Period 3||9
6610057|NCT02106403|7535395|FG000|NOT COMPLETED|Visit 1, Treatment Period 3||0
6610058|NCT02106403|7535396|FG001|NOT COMPLETED|Visit 1, Treatment Period 3||0
6610059|NCT02106403|7535397|FG002|NOT COMPLETED|Visit 1, Treatment Period 3||0
6610060|NCT02106403|7535398|FG003|NOT COMPLETED|Visit 1, Treatment Period 3||0
6610061|NCT02106403|7535399|FG004|NOT COMPLETED|Visit 1, Treatment Period 3||0
6610062|NCT02106403|7535400|FG005|NOT COMPLETED|Visit 1, Treatment Period 3||0
6610063|NCT02106403|7535395|FG000|STARTED|Follow-Up Visit 2||8
6610064|NCT02106403|7535396|FG001|STARTED|Follow-Up Visit 2||8
6610065|NCT02106403|7535397|FG002|STARTED|Follow-Up Visit 2||9
6610066|NCT02106403|7535398|FG003|STARTED|Follow-Up Visit 2||8
6732495|NCT03194464|7661874|FG000|STARTED|Overall Study||15
6732496|NCT03194464|7661874|FG000|COMPLETED|Overall Study||13
6610067|NCT02106403|7535399|FG004|STARTED|Follow-Up Visit 2||8
6610068|NCT02106403|7535400|FG005|STARTED|Follow-Up Visit 2||9
6610069|NCT02106403|7535395|FG000|COMPLETED|Follow-Up Visit 2||8
6610070|NCT02106403|7535396|FG001|COMPLETED|Follow-Up Visit 2||8
6610071|NCT02106403|7535397|FG002|COMPLETED|Follow-Up Visit 2||9
6610072|NCT02106403|7535398|FG003|COMPLETED|Follow-Up Visit 2||8
6610073|NCT02106403|7535399|FG004|COMPLETED|Follow-Up Visit 2||8
6610074|NCT02106403|7535400|FG005|COMPLETED|Follow-Up Visit 2||9
6610075|NCT02106403|7535395|FG000|NOT COMPLETED|Follow-Up Visit 2||0
6610076|NCT02106403|7535396|FG001|NOT COMPLETED|Follow-Up Visit 2||0
6610077|NCT02106403|7535397|FG002|NOT COMPLETED|Follow-Up Visit 2||0
6610078|NCT02106403|7535398|FG003|NOT COMPLETED|Follow-Up Visit 2||0
6610079|NCT02106403|7535399|FG004|NOT COMPLETED|Follow-Up Visit 2||0
6610080|NCT02106403|7535400|FG005|NOT COMPLETED|Follow-Up Visit 2||0
6610081|NCT02106403|7535395|FG000|STARTED|Follow-Up Visit 3||8
6610082|NCT02106403|7535396|FG001|STARTED|Follow-Up Visit 3||8
6610083|NCT02106403|7535397|FG002|STARTED|Follow-Up Visit 3||9
6610084|NCT02106403|7535398|FG003|STARTED|Follow-Up Visit 3||8
6610085|NCT02106403|7535399|FG004|STARTED|Follow-Up Visit 3||8
6610086|NCT02106403|7535400|FG005|STARTED|Follow-Up Visit 3||9
6610087|NCT02106403|7535395|FG000|COMPLETED|Follow-Up Visit 3||8
6610088|NCT02106403|7535396|FG001|COMPLETED|Follow-Up Visit 3||8
6610089|NCT02106403|7535397|FG002|COMPLETED|Follow-Up Visit 3||9
6610090|NCT02106403|7535398|FG003|COMPLETED|Follow-Up Visit 3||8
6610091|NCT02106403|7535399|FG004|COMPLETED|Follow-Up Visit 3||8
6610092|NCT02106403|7535400|FG005|COMPLETED|Follow-Up Visit 3||8
6610093|NCT02106403|7535395|FG000|NOT COMPLETED|Follow-Up Visit 3||0
6610094|NCT02106403|7535396|FG001|NOT COMPLETED|Follow-Up Visit 3||0
6610095|NCT02106403|7535397|FG002|NOT COMPLETED|Follow-Up Visit 3||0
6610096|NCT02106403|7535398|FG003|NOT COMPLETED|Follow-Up Visit 3||0
6610097|NCT02106403|7535399|FG004|NOT COMPLETED|Follow-Up Visit 3||0
6610098|NCT02106403|7535400|FG005|NOT COMPLETED|Follow-Up Visit 3||1
6610099|NCT02106442|7535410|FG000|STARTED|Overall Study||579
6610100|NCT02106442|7535410|FG000|COMPLETED|Overall Study||542
6610101|NCT02106442|7535410|FG000|NOT COMPLETED|Overall Study||37
6610102|NCT02106455|7535414|FG000|STARTED|Overall Study||315
6610103|NCT02106455|7535414|FG000|COMPLETED|Overall Study||307
6610104|NCT02106455|7535414|FG000|NOT COMPLETED|Overall Study||8
6610105|NCT02106494|7535420|FG000|STARTED|Overall Study||471
6610106|NCT02106494|7535421|FG001|STARTED|Overall Study||471
6610107|NCT02106494|7535420|FG000|Safety Population|Overall Study||456
6610108|NCT02106494|7535421|FG001|Safety Population|Overall Study||459
6610109|NCT02106494|7535420|FG000|Efficacy Population|Overall Study||450
6610110|NCT02106494|7535421|FG001|Efficacy Population|Overall Study||452
6610111|NCT02106494|7535420|FG000|COMPLETED|Overall Study||445
6610112|NCT02106494|7535421|FG001|COMPLETED|Overall Study||446
6610113|NCT02106494|7535420|FG000|NOT COMPLETED|Overall Study||26
6610114|NCT02106494|7535421|FG001|NOT COMPLETED|Overall Study||25
6610115|NCT02106728|7535431|FG000|STARTED|Overall Study||70
6610116|NCT02106728|7535432|FG001|STARTED|Overall Study||47
6610117|NCT02106728|7535431|FG000|COMPLETED|Overall Study||70
6610118|NCT02106728|7535432|FG001|COMPLETED|Overall Study||47
6610119|NCT02106728|7535431|FG000|NOT COMPLETED|Overall Study||0
6610120|NCT02106728|7535432|FG001|NOT COMPLETED|Overall Study||0
6610121|NCT02106832|7535448|FG000|STARTED|Overall Study||171
6610122|NCT02106832|7535449|FG001|STARTED|Overall Study||176
6610123|NCT02106832|7535450|FG002|STARTED|Overall Study||86
6610124|NCT02106832|7535451|FG003|STARTED|Overall Study||88
6610125|NCT02106832|7535448|FG000|Participants Received Treatment|Overall Study||171
6610126|NCT02106832|7535449|FG001|Participants Received Treatment|Overall Study||174
6610127|NCT02106832|7535450|FG002|Participants Received Treatment|Overall Study||86
6610128|NCT02106832|7535451|FG003|Participants Received Treatment|Overall Study||88
6610129|NCT02106832|7535448|FG000|COMPLETED|Overall Study||148
6610130|NCT02106832|7535449|FG001|COMPLETED|Overall Study||151
6610131|NCT02106832|7535450|FG002|COMPLETED|Overall Study||70
6610132|NCT02106832|7535451|FG003|COMPLETED|Overall Study||73
6610133|NCT02106832|7535448|FG000|NOT COMPLETED|Overall Study||23
6610134|NCT02106832|7535449|FG001|NOT COMPLETED|Overall Study||25
6610135|NCT02106832|7535450|FG002|NOT COMPLETED|Overall Study||16
6610136|NCT02106832|7535451|FG003|NOT COMPLETED|Overall Study||15
6610137|NCT02106884|7535465|FG000|STARTED|Overall Study||72
6610138|NCT02106884|7535466|FG001|STARTED|Overall Study||74
6610139|NCT02106884|7535465|FG000|COMPLETED|Overall Study||72
6610140|NCT02106884|7535466|FG001|COMPLETED|Overall Study|ITT analysis based on treatment assigned at baseline.|73
6610141|NCT02106884|7535465|FG000|NOT COMPLETED|Overall Study||0
6610142|NCT02106884|7535466|FG001|NOT COMPLETED|Overall Study||1
6610143|NCT02106910|7535477|FG000|STARTED|Overall Study||49
6610144|NCT02106910|7535478|FG001|STARTED|Overall Study||89
6610145|NCT02106910|7535477|FG000|COMPLETED|Overall Study||48
6610146|NCT02106910|7535478|FG001|COMPLETED|Overall Study||88
6610147|NCT02106910|7535477|FG000|NOT COMPLETED|Overall Study||1
6610148|NCT02106910|7535478|FG001|NOT COMPLETED|Overall Study||1
6610149|NCT02106923|7535488|FG000|STARTED|Overall Study||12
6610150|NCT02106923|7535489|FG001|STARTED|Overall Study||12
6610151|NCT02106923|7535490|FG002|STARTED|Overall Study||12
6610152|NCT02106923|7535491|FG003|STARTED|Overall Study||12
6610153|NCT02106923|7535492|FG004|STARTED|Overall Study||12
6610154|NCT02106923|7535493|FG005|STARTED|Overall Study||12
6610155|NCT02106923|7535488|FG000|COMPLETED|Overall Study||12
6610156|NCT02106923|7535489|FG001|COMPLETED|Overall Study||12
6610157|NCT02106923|7535490|FG002|COMPLETED|Overall Study||12
6610158|NCT02106923|7535491|FG003|COMPLETED|Overall Study||12
6610159|NCT02106923|7535492|FG004|COMPLETED|Overall Study||12
6610160|NCT02106923|7535493|FG005|COMPLETED|Overall Study||11
6610161|NCT02106923|7535488|FG000|NOT COMPLETED|Overall Study||0
6610162|NCT02106923|7535489|FG001|NOT COMPLETED|Overall Study||0
6610163|NCT02106923|7535490|FG002|NOT COMPLETED|Overall Study||0
6610164|NCT02106923|7535491|FG003|NOT COMPLETED|Overall Study||0
6610165|NCT02106923|7535492|FG004|NOT COMPLETED|Overall Study||0
6610166|NCT02106923|7535493|FG005|NOT COMPLETED|Overall Study||1
6610167|NCT02106962|7535509|FG000|STARTED|Overall Study||8
6610168|NCT02106962|7535510|FG001|STARTED|Overall Study||9
6610169|NCT02106962|7535509|FG000|COMPLETED|Overall Study||8
6610170|NCT02106962|7535510|FG001|COMPLETED|Overall Study||9
6610171|NCT02106962|7535509|FG000|NOT COMPLETED|Overall Study||0
6610172|NCT02106962|7535510|FG001|NOT COMPLETED|Overall Study||0
6610173|NCT02106975|7535520|FG000|STARTED|Overall Study||84
6610174|NCT02106975|7535521|FG001|STARTED|Overall Study||83
6610175|NCT02106975|7535520|FG000|COMPLETED|Overall Study||59
6610176|NCT02106975|7535521|FG001|COMPLETED|Overall Study||44
6610177|NCT02106975|7535520|FG000|NOT COMPLETED|Overall Study||25
6610178|NCT02106975|7535521|FG001|NOT COMPLETED|Overall Study||39
6610179|NCT02107014|7535527|FG000|STARTED|Overall Study||9
6610180|NCT02107014|7535527|FG000|COMPLETED|Overall Study||8
6610181|NCT02107014|7535527|FG000|NOT COMPLETED|Overall Study||1
6610182|NCT02107092|7535531|FG000|STARTED|Overall Study||123
6610183|NCT02107092|7535531|FG000|COMPLETED|Overall Study||79
6610184|NCT02107092|7535531|FG000|NOT COMPLETED|Overall Study||44
6610185|NCT02107131|7535537|FG000|STARTED|Overall Study||20
6610186|NCT02107131|7535538|FG001|STARTED|Overall Study||20
6610187|NCT02107131|7535537|FG000|COMPLETED|Overall Study||12
6610188|NCT02107131|7535538|FG001|COMPLETED|Overall Study||11
6610189|NCT02107131|7535537|FG000|NOT COMPLETED|Overall Study||8
6610190|NCT02107131|7535538|FG001|NOT COMPLETED|Overall Study||9
6610191|NCT02107157|7535549|FG000|STARTED|Overall Study||11
6610192|NCT02107157|7535550|FG001|STARTED|Overall Study||12
6610193|NCT02107157|7535551|FG002|STARTED|Overall Study||4
6610194|NCT02107157|7535549|FG000|COMPLETED|Overall Study||6
6610195|NCT02107157|7535550|FG001|COMPLETED|Overall Study||11
6610196|NCT02107157|7535551|FG002|COMPLETED|Overall Study||4
6610197|NCT02107157|7535549|FG000|NOT COMPLETED|Overall Study||5
6610198|NCT02107157|7535550|FG001|NOT COMPLETED|Overall Study||1
6610199|NCT02107157|7535551|FG002|NOT COMPLETED|Overall Study||0
6610200|NCT02107196|7535561|FG000|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
6610201|NCT02107196|7535562|FG001|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
6610202|NCT02107196|7535561|FG000|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
6610203|NCT02107196|7535562|FG001|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
6610204|NCT02107196|7535561|FG000|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
6610205|NCT02107196|7535562|FG001|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
6610206|NCT02107196|7535561|FG000|COMPLETED|12-week Treatment Period||227
6610207|NCT02107196|7535562|FG001|COMPLETED|12-week Treatment Period||225
6610208|NCT02107196|7535561|FG000|NOT COMPLETED|12-week Treatment Period||44
6610209|NCT02107196|7535562|FG001|NOT COMPLETED|12-week Treatment Period||39
6610210|NCT02107196|7535561|FG000|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
6610211|NCT02107196|7535562|FG001|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
6610212|NCT02107196|7535561|FG000|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
6610213|NCT02107196|7535562|FG001|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
6610214|NCT02107196|7535561|FG000|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
6610215|NCT02107196|7535562|FG001|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
6610216|NCT02107196|7535561|FG000|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
6610217|NCT02107196|7535562|FG001|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
6610218|NCT02107196|7535561|FG000|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
6610219|NCT02107196|7535562|FG001|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
6610220|NCT02107274|7535570|FG000|STARTED|Treatment vs. Placebo||39
6610221|NCT02107274|7535571|FG001|STARTED|Treatment vs. Placebo||39
6610222|NCT02107274|7535570|FG000|COMPLETED|Treatment vs. Placebo||36
6610223|NCT02107274|7535571|FG001|COMPLETED|Treatment vs. Placebo||37
6610224|NCT02107274|7535570|FG000|NOT COMPLETED|Treatment vs. Placebo||3
6610225|NCT02107274|7535571|FG001|NOT COMPLETED|Treatment vs. Placebo||2
6610226|NCT02107274|7535570|FG000|STARTED|Control Phase||36
6610227|NCT02107274|7535571|FG001|STARTED|Control Phase||37
6610228|NCT02107274|7535570|FG000|COMPLETED|Control Phase||33
6610229|NCT02107274|7535571|FG001|COMPLETED|Control Phase||35
6610230|NCT02107274|7535570|FG000|NOT COMPLETED|Control Phase||3
6610231|NCT02107274|7535571|FG001|NOT COMPLETED|Control Phase||2
6610232|NCT02107300|7535579|FG000|STARTED|Overall Study||16
6610233|NCT02107300|7535580|FG001|STARTED|Overall Study||15
6610234|NCT02107300|7535579|FG000|COMPLETED|Overall Study||16
6610235|NCT02107300|7535580|FG001|COMPLETED|Overall Study||15
6610236|NCT02107300|7535579|FG000|NOT COMPLETED|Overall Study||0
6610237|NCT02107300|7535580|FG001|NOT COMPLETED|Overall Study||0
6610238|NCT02107313|7535586|FG000|STARTED|Overall Study||9
6610239|NCT02107313|7535587|FG001|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
6610240|NCT02107313|7535586|FG000|COMPLETED|Overall Study||9
6610241|NCT02107313|7535587|FG001|COMPLETED|Overall Study||8
6610242|NCT02107313|7535586|FG000|NOT COMPLETED|Overall Study||0
6610243|NCT02107313|7535587|FG001|NOT COMPLETED|Overall Study||1
6610244|NCT02107339|7535595|FG000|STARTED|Overall Study||63
6610245|NCT02107339|7535596|FG001|STARTED|Overall Study||57
6610246|NCT02107339|7535595|FG000|COMPLETED|Overall Study||62
6610247|NCT02107339|7535596|FG001|COMPLETED|Overall Study||53
6610248|NCT02107339|7535595|FG000|NOT COMPLETED|Overall Study||1
6610249|NCT02107339|7535596|FG001|NOT COMPLETED|Overall Study||4
6610250|NCT02107443|7535604|FG000|STARTED|Overall Study||296
6610251|NCT02107443|7535605|FG001|STARTED|Overall Study||250
6610252|NCT02107443|7535604|FG000|COMPLETED|Overall Study||198
6610253|NCT02107443|7535605|FG001|COMPLETED|Overall Study||167
6610254|NCT02107443|7535604|FG000|NOT COMPLETED|Overall Study||98
6610255|NCT02107443|7535605|FG001|NOT COMPLETED|Overall Study||83
6610256|NCT02107482|7535612|FG000|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
6610257|NCT02107482|7535612|FG000|COMPLETED|Overall Study||17
6610258|NCT02107482|7535612|FG000|NOT COMPLETED|Overall Study||4
6625451|NCT02225132|7553109|FG000|COMPLETED|Overall Study||10
6625452|NCT02225132|7553109|FG000|NOT COMPLETED|Overall Study||0
6625453|NCT02225223|7553115|FG000|STARTED|Overall Study||27
6625454|NCT02225223|7553116|FG001|STARTED|Overall Study||8
6625455|NCT02225223|7553115|FG000|COMPLETED|Overall Study||8
6625456|NCT02225223|7553116|FG001|COMPLETED|Overall Study||3
6625457|NCT02225223|7553115|FG000|NOT COMPLETED|Overall Study||19
6625458|NCT02225223|7553116|FG001|NOT COMPLETED|Overall Study||5
6732497|NCT03194464|7661874|FG000|NOT COMPLETED|Overall Study||2
6732498|NCT03194490|7661882|FG000|STARTED|Overall Study||20
6732499|NCT03194490|7661883|FG001|STARTED|Overall Study||23
6732500|NCT03194490|7661882|FG000|COMPLETED|Overall Study||18
6732501|NCT03194490|7661883|FG001|COMPLETED|Overall Study||20
6732502|NCT03194490|7661882|FG000|NOT COMPLETED|Overall Study||2
6732503|NCT03194490|7661883|FG001|NOT COMPLETED|Overall Study||3
6732504|NCT03194503|7661892|FG000|STARTED|Overall Study||458
6732505|NCT03194503|7661893|FG001|STARTED|Overall Study||1054
6732506|NCT03194503|7661892|FG000|COMPLETED|Overall Study||458
6732507|NCT03194503|7661893|FG001|COMPLETED|Overall Study||1054
6732508|NCT03194503|7661892|FG000|NOT COMPLETED|Overall Study||0
6732509|NCT03194503|7661893|FG001|NOT COMPLETED|Overall Study||0
6732510|NCT03194698|7661903|FG000|STARTED|Overall Study||10
6732511|NCT03194698|7661904|FG001|STARTED|Overall Study||10
6732512|NCT03194698|7661903|FG000|COMPLETED|Overall Study||10
6732513|NCT03194698|7661904|FG001|COMPLETED|Overall Study||10
6732514|NCT03194698|7661903|FG000|NOT COMPLETED|Overall Study||0
6732515|NCT03194698|7661904|FG001|NOT COMPLETED|Overall Study||0
6732516|NCT03194737|7661912|FG000|STARTED|Overall Study||52
6732517|NCT03194737|7661913|FG001|STARTED|Overall Study||49
6732518|NCT03194737|7661912|FG000|COMPLETED|Overall Study||47
6732519|NCT03194737|7661913|FG001|COMPLETED|Overall Study||49
6732520|NCT03194737|7661912|FG000|NOT COMPLETED|Overall Study||5
6732521|NCT03194737|7661913|FG001|NOT COMPLETED|Overall Study||0
6732522|NCT03194776|7661921|FG000|STARTED|Overall Study||23
6732523|NCT03194776|7661922|FG001|STARTED|Overall Study||23
6732524|NCT03194776|7661921|FG000|COMPLETED|Overall Study||23
6732525|NCT03194776|7661922|FG001|COMPLETED|Overall Study||23
6732526|NCT03194776|7661921|FG000|NOT COMPLETED|Overall Study||0
6732527|NCT03194776|7661922|FG001|NOT COMPLETED|Overall Study||0
6732528|NCT03195010|7661931|FG000|STARTED|Overall Study||2
6732529|NCT03195010|7661932|FG001|STARTED|Overall Study||2
6732530|NCT03195010|7661931|FG000|COMPLETED|Overall Study||2
6732531|NCT03195010|7661932|FG001|COMPLETED|Overall Study||2
6732532|NCT03195010|7661931|FG000|NOT COMPLETED|Overall Study||0
6732533|NCT03195010|7661932|FG001|NOT COMPLETED|Overall Study||0
6732534|NCT03195517|7661940|FG000|STARTED|Overall Study||33
6732535|NCT03195517|7661940|FG000|COMPLETED|Overall Study||33
6732536|NCT03195517|7661940|FG000|NOT COMPLETED|Overall Study||0
6732537|NCT03196076|7661951|FG000|STARTED|Overall Study||5
6732538|NCT03196076|7661952|FG001|STARTED|Overall Study||20
6732539|NCT03196076|7661953|FG002|STARTED|Overall Study||0
6732540|NCT03196076|7661951|FG000|COMPLETED|Overall Study||5
6732541|NCT03196076|7661952|FG001|COMPLETED|Overall Study||20
6732542|NCT03196076|7661953|FG002|COMPLETED|Overall Study||0
6732543|NCT03196076|7661951|FG000|NOT COMPLETED|Overall Study||0
6732544|NCT03196076|7661952|FG001|NOT COMPLETED|Overall Study||0
6732545|NCT03196076|7661953|FG002|NOT COMPLETED|Overall Study||0
6732546|NCT03196193|7661963|FG000|STARTED|Overall Study||121
6732547|NCT03196193|7661964|FG001|STARTED|Overall Study||119
6732548|NCT03196193|7661963|FG000|COMPLETED|Overall Study||118
6610259|NCT02107599|7535616|FG000|STARTED|Overall Study||96
6610260|NCT02107599|7535616|FG000|COMPLETED|Overall Study||96
6610261|NCT02107599|7535616|FG000|NOT COMPLETED|Overall Study||0
6610262|NCT02107703|7535625|FG000|STARTED|Overall Study||446
6610263|NCT02107703|7535626|FG001|STARTED|Overall Study||223
6610264|NCT02107703|7535625|FG000|Received at Least 1 Dose of Study Drug|Overall Study||441
6610265|NCT02107703|7535626|FG001|Received at Least 1 Dose of Study Drug|Overall Study||223
6610266|NCT02107703|7535625|FG000|COMPLETED|Overall Study||85
6610267|NCT02107703|7535626|FG001|COMPLETED|Overall Study||48
6610268|NCT02107703|7535625|FG000|NOT COMPLETED|Overall Study||361
6610269|NCT02107703|7535626|FG001|NOT COMPLETED|Overall Study||175
6610270|NCT02107859|7535635|FG000|STARTED|Overall Study||61
6610271|NCT02107859|7535635|FG000|As-treated Population|Overall Study||61
6610272|NCT02107859|7535635|FG000|Intent-to-treat (ITT) Population|Overall Study||60
6610273|NCT02107859|7535635|FG000|COMPLETED|Overall Study||0
6610274|NCT02107859|7535635|FG000|NOT COMPLETED|Overall Study||61
6610275|NCT02107898|7535641|FG000|STARTED|Overall Study|Randomized|72
6610276|NCT02107898|7535642|FG001|STARTED|Overall Study|Randomized|144
6610277|NCT02107898|7535641|FG000|Treated|Overall Study||72
6610278|NCT02107898|7535642|FG001|Treated|Overall Study||143
6610279|NCT02107898|7535641|FG000|COMPLETED|Overall Study||66
6610280|NCT02107898|7535642|FG001|COMPLETED|Overall Study||132
6610281|NCT02107898|7535641|FG000|NOT COMPLETED|Overall Study||6
6610282|NCT02107898|7535642|FG001|NOT COMPLETED|Overall Study||12
6610283|NCT02108171|7535650|FG000|STARTED|Overall Study||40
6610284|NCT02108171|7535651|FG001|STARTED|Overall Study||41
6610285|NCT02108171|7535650|FG000|COMPLETED|Overall Study||40
6610286|NCT02108171|7535651|FG001|COMPLETED|Overall Study||41
6610287|NCT02108171|7535650|FG000|NOT COMPLETED|Overall Study||0
6610288|NCT02108171|7535651|FG001|NOT COMPLETED|Overall Study||0
6610289|NCT02108223|7535661|FG000|STARTED|Overall Study||52
6610290|NCT02108223|7535662|FG001|STARTED|Overall Study||50
6610291|NCT02108223|7535663|FG002|STARTED|Overall Study||35
6610292|NCT02108223|7535661|FG000|COMPLETED|Overall Study||52
6610293|NCT02108223|7535662|FG001|COMPLETED|Overall Study||50
6610294|NCT02108223|7535663|FG002|COMPLETED|Overall Study||35
6610295|NCT02108223|7535661|FG000|NOT COMPLETED|Overall Study||0
6610296|NCT02108223|7535662|FG001|NOT COMPLETED|Overall Study||0
6610297|NCT02108223|7535663|FG002|NOT COMPLETED|Overall Study||0
6610298|NCT02108262|7535678|FG000|STARTED|Overall Study||9
6610299|NCT02108262|7535679|FG001|STARTED|Overall Study||419
6610300|NCT02108262|7535680|FG002|STARTED|Overall Study||421
6610301|NCT02108262|7535681|FG003|STARTED|Overall Study||418
6610302|NCT02108262|7535678|FG000|COMPLETED|Overall Study||9
6610303|NCT02108262|7535679|FG001|COMPLETED|Overall Study||375
6610304|NCT02108262|7535680|FG002|COMPLETED|Overall Study||379
6610305|NCT02108262|7535681|FG003|COMPLETED|Overall Study||376
6610306|NCT02108262|7535678|FG000|NOT COMPLETED|Overall Study||0
6610307|NCT02108262|7535679|FG001|NOT COMPLETED|Overall Study||44
6610308|NCT02108262|7535680|FG002|NOT COMPLETED|Overall Study||42
6610309|NCT02108262|7535681|FG003|NOT COMPLETED|Overall Study||42
6610310|NCT02108288|7535693|FG000|STARTED|Overall Study||10
6610311|NCT02108288|7535694|FG001|STARTED|Overall Study||10
6610312|NCT02108288|7535695|FG002|STARTED|Overall Study||10
6610313|NCT02108288|7535693|FG000|COMPLETED|Overall Study||10
6610314|NCT02108288|7535694|FG001|COMPLETED|Overall Study||10
6610315|NCT02108288|7535695|FG002|COMPLETED|Overall Study||10
6610316|NCT02108288|7535693|FG000|NOT COMPLETED|Overall Study||0
6610317|NCT02108288|7535694|FG001|NOT COMPLETED|Overall Study||0
6610318|NCT02108288|7535695|FG002|NOT COMPLETED|Overall Study||0
6610319|NCT02108457|7535705|FG000|STARTED|Overall Study||3
6610320|NCT02108457|7535706|FG001|STARTED|Overall Study||12
6610321|NCT02108457|7535705|FG000|COMPLETED|Overall Study||3
6610322|NCT02108457|7535706|FG001|COMPLETED|Overall Study||10
6610323|NCT02108457|7535705|FG000|NOT COMPLETED|Overall Study||0
6610324|NCT02108457|7535706|FG001|NOT COMPLETED|Overall Study||2
6610325|NCT02108522|7535712|FG000|STARTED|Screening Period||82
6610326|NCT02108522|7535712|FG000|COMPLETED|Screening Period||58
6610327|NCT02108522|7535712|FG000|NOT COMPLETED|Screening Period||24
6610328|NCT02108522|7535712|FG000|STARTED|Period 1: Initial Cohort||50
6610329|NCT02108522|7535712|FG000|COMPLETED|Period 1: Initial Cohort||28
6610330|NCT02108522|7535712|FG000|NOT COMPLETED|Period 1: Initial Cohort||22
6610331|NCT02108522|7535712|FG000|STARTED|Period 2: Expansion Cohort||8
6610332|NCT02108522|7535712|FG000|COMPLETED|Period 2: Expansion Cohort||2
6610333|NCT02108522|7535712|FG000|NOT COMPLETED|Period 2: Expansion Cohort||6
6610334|NCT02108600|7535718|FG000|STARTED|Overall Study||17
6610335|NCT02108600|7535719|FG001|STARTED|Overall Study||16
6610336|NCT02108600|7535718|FG000|COMPLETED|Overall Study||14
6610337|NCT02108600|7535719|FG001|COMPLETED|Overall Study|1 patient lost to follow up after the primary endpoint biopsy|15
6610338|NCT02108600|7535718|FG000|NOT COMPLETED|Overall Study||3
6610339|NCT02108600|7535719|FG001|NOT COMPLETED|Overall Study||1
6610340|NCT02108691|7535727|FG000|STARTED|Overall Study||40
6610341|NCT02108691|7535728|FG001|STARTED|Overall Study||40
6610342|NCT02108691|7535727|FG000|COMPLETED|Overall Study||32
6610343|NCT02108691|7535728|FG001|COMPLETED|Overall Study||31
6610344|NCT02108691|7535727|FG000|NOT COMPLETED|Overall Study||8
6610345|NCT02108691|7535728|FG001|NOT COMPLETED|Overall Study||9
6610346|NCT02108821|7535734|FG000|STARTED|Overall Study||23
6610347|NCT02108821|7535734|FG000|COMPLETED|Overall Study||23
6610348|NCT02108821|7535734|FG000|NOT COMPLETED|Overall Study||0
6610349|NCT02108912|7535742|FG000|STARTED|Overall Study||9
6610350|NCT02108912|7535743|FG001|STARTED|Overall Study||7
6610351|NCT02108912|7535742|FG000|COMPLETED|Overall Study||6
6610352|NCT02108912|7535743|FG001|COMPLETED|Overall Study||6
6610353|NCT02108912|7535742|FG000|NOT COMPLETED|Overall Study||3
6610354|NCT02108912|7535743|FG001|NOT COMPLETED|Overall Study||1
6610355|NCT02108951|7535749|FG000|STARTED|Overall Study|Indicates patients in enrolled, full analysis and safety set|20
6610356|NCT02108951|7535749|FG000|COMPLETED|Overall Study||4
6610357|NCT02108951|7535749|FG000|NOT COMPLETED|Overall Study||16
6610358|NCT02108977|7535755|FG000|STARTED|Overall Study||18
6610359|NCT02108977|7535756|FG001|STARTED|Overall Study||20
6610360|NCT02108977|7535755|FG000|COMPLETED|Overall Study||8
6610361|NCT02108977|7535756|FG001|COMPLETED|Overall Study||19
6610362|NCT02108977|7535755|FG000|NOT COMPLETED|Overall Study||10
6610363|NCT02108977|7535756|FG001|NOT COMPLETED|Overall Study||1
6610364|NCT02109029|7535767|FG000|STARTED|Part A||2
6610365|NCT02109029|7535768|FG001|STARTED|Part A||2
6610366|NCT02109029|7535769|FG002|STARTED|Part A||4
6610367|NCT02109029|7535770|FG003|STARTED|Part A||4
6610368|NCT02109029|7535771|FG004|STARTED|Part A||0
6610369|NCT02109029|7535772|FG005|STARTED|Part A||0
6610370|NCT02109029|7535767|FG000|Received One Dose of Study Drug|Part A||2
6610371|NCT02109029|7535768|FG001|Received One Dose of Study Drug|Part A||2
6610372|NCT02109029|7535769|FG002|Received One Dose of Study Drug|Part A||4
6610373|NCT02109029|7535770|FG003|Received One Dose of Study Drug|Part A||4
6610374|NCT02109029|7535771|FG004|Received One Dose of Study Drug|Part A||0
6610375|NCT02109029|7535772|FG005|Received One Dose of Study Drug|Part A||0
6610376|NCT02109029|7535767|FG000|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
6610377|NCT02109029|7535768|FG001|COMPLETED|Part A|Participants from Part A did not move on to Part B.|2
6610378|NCT02109029|7535769|FG002|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
6610379|NCT02109029|7535770|FG003|COMPLETED|Part A|Participants from Part A did not move on to Part B.|4
6610380|NCT02109029|7535771|FG004|COMPLETED|Part A||0
6610381|NCT02109029|7535772|FG005|COMPLETED|Part A||0
6610382|NCT02109029|7535767|FG000|NOT COMPLETED|Part A||0
6610383|NCT02109029|7535768|FG001|NOT COMPLETED|Part A||0
6610384|NCT02109029|7535769|FG002|NOT COMPLETED|Part A||0
6610385|NCT02109029|7535770|FG003|NOT COMPLETED|Part A||0
6610386|NCT02109029|7535771|FG004|NOT COMPLETED|Part A||0
6610387|NCT02109029|7535772|FG005|NOT COMPLETED|Part A||0
6610388|NCT02109029|7535767|FG000|STARTED|Part B||0
6610389|NCT02109029|7535768|FG001|STARTED|Part B||0
6610390|NCT02109029|7535769|FG002|STARTED|Part B||0
6610391|NCT02109029|7535770|FG003|STARTED|Part B||0
6610392|NCT02109029|7535771|FG004|STARTED|Part B|New participants entered Part B.|6
6610393|NCT02109029|7535772|FG005|STARTED|Part B|New participants entered Part B.|6
6610394|NCT02109029|7535767|FG000|Received at Least One Dose of Study Drug|Part B||0
6610395|NCT02109029|7535768|FG001|Received at Least One Dose of Study Drug|Part B||0
6610396|NCT02109029|7535769|FG002|Received at Least One Dose of Study Drug|Part B||0
6610397|NCT02109029|7535770|FG003|Received at Least One Dose of Study Drug|Part B||0
6610398|NCT02109029|7535771|FG004|Received at Least One Dose of Study Drug|Part B||6
6610399|NCT02109029|7535772|FG005|Received at Least One Dose of Study Drug|Part B||6
6610400|NCT02109029|7535767|FG000|COMPLETED|Part B||0
6610401|NCT02109029|7535768|FG001|COMPLETED|Part B||0
6610402|NCT02109029|7535769|FG002|COMPLETED|Part B||0
6610403|NCT02109029|7535770|FG003|COMPLETED|Part B||0
6610404|NCT02109029|7535771|FG004|COMPLETED|Part B||5
6610405|NCT02109029|7535772|FG005|COMPLETED|Part B||5
6610406|NCT02109029|7535767|FG000|NOT COMPLETED|Part B||0
6610407|NCT02109029|7535768|FG001|NOT COMPLETED|Part B||0
6610408|NCT02109029|7535769|FG002|NOT COMPLETED|Part B||0
6610409|NCT02109029|7535770|FG003|NOT COMPLETED|Part B||0
6610410|NCT02109029|7535771|FG004|NOT COMPLETED|Part B||1
6610411|NCT02109029|7535772|FG005|NOT COMPLETED|Part B||1
6610412|NCT02109042|7535783|FG000|STARTED|Overall Study||15
6610413|NCT02109042|7535783|FG000|Received at Least 1 Dose of Study Drug|Overall Study||15
6610414|NCT02109042|7535783|FG000|Received 180 mg Loading Dose|Overall Study||15
6610415|NCT02109042|7535783|FG000|Receive at Least 1 Subsequent 90 mg Dose|Overall Study||15
6610416|NCT02109042|7535783|FG000|COMPLETED|Overall Study||0
6610417|NCT02109042|7535783|FG000|NOT COMPLETED|Overall Study||15
6610418|NCT02109107|7535788|FG000|STARTED|Overall Study||54
6610419|NCT02109107|7535788|FG000|COMPLETED|Overall Study||52
6610420|NCT02109107|7535788|FG000|NOT COMPLETED|Overall Study||2
6610421|NCT02109133|7535794|FG000|STARTED|Overall Study||33
6610422|NCT02109133|7535795|FG001|STARTED|Overall Study||34
6610423|NCT02109133|7535794|FG000|COMPLETED|Overall Study||32
6610424|NCT02109133|7535795|FG001|COMPLETED|Overall Study||34
6610425|NCT02109133|7535794|FG000|NOT COMPLETED|Overall Study||1
6610426|NCT02109133|7535795|FG001|NOT COMPLETED|Overall Study||0
6610427|NCT02109159|7535805|FG000|STARTED|Overall Study||4178
6610428|NCT02109159|7535806|FG001|STARTED|Overall Study||4175
6610429|NCT02109159|7535805|FG000|COMPLETED|Overall Study||4178
6610430|NCT02109159|7535806|FG001|COMPLETED|Overall Study||4175
6610431|NCT02109159|7535805|FG000|NOT COMPLETED|Overall Study||0
6610432|NCT02109159|7535806|FG001|NOT COMPLETED|Overall Study||0
6610433|NCT02109419|7535812|FG000|STARTED|Overall Study||57
6610434|NCT02109419|7535812|FG000|COMPLETED|Overall Study||57
6610435|NCT02109419|7535812|FG000|NOT COMPLETED|Overall Study||0
6610436|NCT02109432|7535818|FG000|STARTED|Overall Study||7
6610437|NCT02109432|7535818|FG000|COMPLETED|Overall Study||6
6610438|NCT02109432|7535818|FG000|NOT COMPLETED|Overall Study||1
6610439|NCT02109445|7535822|FG000|STARTED|Overall Study||3
6610440|NCT02109445|7535822|FG000|COMPLETED|Overall Study||0
6610441|NCT02109445|7535822|FG000|NOT COMPLETED|Overall Study||3
6610442|NCT02109458|7535826|FG000|STARTED|Overall Study||24
6610443|NCT02109458|7535826|FG000|COMPLETED|Overall Study||24
6610444|NCT02109458|7535826|FG000|NOT COMPLETED|Overall Study||0
6610445|NCT02109484|7535838|FG000|STARTED|Overall Study||5
6610446|NCT02109484|7535839|FG001|STARTED|Overall Study||13
6610447|NCT02109484|7535840|FG002|STARTED|Overall Study||12
6610448|NCT02109484|7535841|FG003|STARTED|Overall Study||12
6610449|NCT02109484|7535842|FG004|STARTED|Overall Study||50
6610450|NCT02109484|7535843|FG005|STARTED|Overall Study||12
6610451|NCT02109484|7535844|FG006|STARTED|Overall Study||50
6610452|NCT02109484|7535845|FG007|STARTED|Overall Study||50
6610453|NCT02109484|7535838|FG000|COMPLETED|Overall Study||5
6610454|NCT02109484|7535839|FG001|COMPLETED|Overall Study||13
6610455|NCT02109484|7535840|FG002|COMPLETED|Overall Study||12
6610456|NCT02109484|7535841|FG003|COMPLETED|Overall Study||11
6610457|NCT02109484|7535842|FG004|COMPLETED|Overall Study||46
6610458|NCT02109484|7535843|FG005|COMPLETED|Overall Study||11
6610459|NCT02109484|7535844|FG006|COMPLETED|Overall Study||47
6610460|NCT02109484|7535845|FG007|COMPLETED|Overall Study||47
6610461|NCT02109484|7535838|FG000|NOT COMPLETED|Overall Study||0
6610462|NCT02109484|7535839|FG001|NOT COMPLETED|Overall Study||0
6610463|NCT02109484|7535840|FG002|NOT COMPLETED|Overall Study||0
6610464|NCT02109484|7535841|FG003|NOT COMPLETED|Overall Study||1
6610465|NCT02109484|7535842|FG004|NOT COMPLETED|Overall Study||4
6610466|NCT02109484|7535843|FG005|NOT COMPLETED|Overall Study||1
6610467|NCT02109484|7535844|FG006|NOT COMPLETED|Overall Study||3
6610468|NCT02109484|7535845|FG007|NOT COMPLETED|Overall Study||3
6610469|NCT02109497|7535880|FG000|STARTED|Overall Study||18
6610470|NCT02109497|7535880|FG000|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
6610471|NCT02109497|7535880|FG000|NOT COMPLETED|Overall Study||1
6610472|NCT02109562|7535887|FG000|STARTED|Overall Study||116
6610473|NCT02109562|7535888|FG001|STARTED|Overall Study||119
6610474|NCT02109562|7535889|FG002|STARTED|Overall Study||119
6610475|NCT02109562|7535887|FG000|Safety|Overall Study||115
6610476|NCT02109562|7535888|FG001|Safety|Overall Study||117
6610477|NCT02109562|7535889|FG002|Safety|Overall Study||118
6610478|NCT02109562|7535887|FG000|Intent to Treat (ITT)|Overall Study||111
6610479|NCT02109562|7535888|FG001|Intent to Treat (ITT)|Overall Study||114
6610480|NCT02109562|7535889|FG002|Intent to Treat (ITT)|Overall Study||112
6610481|NCT02109562|7535887|FG000|COMPLETED|Overall Study||90
6610482|NCT02109562|7535888|FG001|COMPLETED|Overall Study||85
6610483|NCT02109562|7535889|FG002|COMPLETED|Overall Study||84
6610484|NCT02109562|7535887|FG000|NOT COMPLETED|Overall Study||26
6610485|NCT02109562|7535888|FG001|NOT COMPLETED|Overall Study||34
6610486|NCT02109562|7535889|FG002|NOT COMPLETED|Overall Study||35
6610487|NCT02109640|7535899|FG000|STARTED|Overall Study||27
6610488|NCT02109640|7535900|FG001|STARTED|Overall Study||23
6610489|NCT02109640|7535899|FG000|COMPLETED|Overall Study||27
6610490|NCT02109640|7535900|FG001|COMPLETED|Overall Study||23
6610491|NCT02109640|7535899|FG000|NOT COMPLETED|Overall Study||0
6610492|NCT02109640|7535900|FG001|NOT COMPLETED|Overall Study||0
6610493|NCT02109731|7535906|FG000|STARTED|Overall Study||15
6610494|NCT02109731|7535906|FG000|COMPLETED|Overall Study||15
6610495|NCT02109731|7535906|FG000|NOT COMPLETED|Overall Study||0
6610496|NCT02109939|7535912|FG000|STARTED|Overall Study||681
6610497|NCT02109939|7535913|FG001|STARTED|Overall Study||717
6610498|NCT02109939|7535912|FG000|COMPLETED|Overall Study||560
6610499|NCT02109939|7535913|FG001|COMPLETED|Overall Study||607
6610500|NCT02109939|7535912|FG000|NOT COMPLETED|Overall Study||121
6610501|NCT02109939|7535913|FG001|NOT COMPLETED|Overall Study||110
6610502|NCT02110095|7535923|FG000|STARTED|Overall Study||15
6610503|NCT02110095|7535923|FG000|COMPLETED|Overall Study||8
6610504|NCT02110095|7535923|FG000|NOT COMPLETED|Overall Study||7
6610505|NCT02110108|7535927|FG000|STARTED|Overall Study||10
6610506|NCT02110108|7535927|FG000|RevLite Single Wavelength|Overall Study||10
6610507|NCT02110108|7535927|FG000|RevLite Combo Wavelength|Overall Study||10
6610508|NCT02110108|7535927|FG000|COMPLETED|Overall Study||7
6610509|NCT02110108|7535927|FG000|NOT COMPLETED|Overall Study||3
6610510|NCT02110121|7535937|FG000|STARTED|Overall Study||58
6610511|NCT02110121|7535938|FG001|STARTED|Overall Study||5
6610512|NCT02110121|7535937|FG000|COMPLETED|Overall Study||42
6610513|NCT02110121|7535938|FG001|COMPLETED|Overall Study||5
6610514|NCT02110121|7535937|FG000|NOT COMPLETED|Overall Study||16
6610515|NCT02110121|7535938|FG001|NOT COMPLETED|Overall Study||0
6610516|NCT02110147|7535944|FG000|STARTED|Overall Study||4
6610517|NCT02110147|7535944|FG000|COMPLETED|Overall Study||4
6610518|NCT02110147|7535944|FG000|NOT COMPLETED|Overall Study||0
6610519|NCT02110225|7535951|FG000|STARTED|Overall Study||20
6610520|NCT02110225|7535952|FG001|STARTED|Overall Study||20
6610521|NCT02110225|7535953|FG002|STARTED|Overall Study||10
6610522|NCT02110225|7535951|FG000|COMPLETED|Overall Study||20
6610523|NCT02110225|7535952|FG001|COMPLETED|Overall Study||19
6610524|NCT02110225|7535953|FG002|COMPLETED|Overall Study||10
6610525|NCT02110225|7535951|FG000|NOT COMPLETED|Overall Study||0
6610526|NCT02110225|7535952|FG001|NOT COMPLETED|Overall Study||1
6610527|NCT02110225|7535953|FG002|NOT COMPLETED|Overall Study||0
6610528|NCT02110238|7535964|FG000|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
6610529|NCT02110238|7535965|FG001|STARTED|12 Week Pivotal Phase||209
6610530|NCT02110238|7535964|FG000|COMPLETED|12 Week Pivotal Phase||202
6610531|NCT02110238|7535965|FG001|COMPLETED|12 Week Pivotal Phase||200
6610532|NCT02110238|7535964|FG000|NOT COMPLETED|12 Week Pivotal Phase||10
6610533|NCT02110238|7535965|FG001|NOT COMPLETED|12 Week Pivotal Phase||9
6610534|NCT02110238|7535964|FG000|STARTED|14 Week Blinded Extension Phase||202
6610535|NCT02110238|7535965|FG001|STARTED|14 Week Blinded Extension Phase||200
6610536|NCT02110238|7535964|FG000|COMPLETED|14 Week Blinded Extension Phase||190
6610537|NCT02110238|7535965|FG001|COMPLETED|14 Week Blinded Extension Phase||188
6610538|NCT02110238|7535964|FG000|NOT COMPLETED|14 Week Blinded Extension Phase||12
6610539|NCT02110238|7535965|FG001|NOT COMPLETED|14 Week Blinded Extension Phase||12
6610540|NCT02110264|7535974|FG000|STARTED|Overall Study||53
6610541|NCT02110264|7535975|FG001|STARTED|Overall Study||50
6610542|NCT02110264|7535976|FG002|STARTED|Overall Study||48
6610543|NCT02110264|7535974|FG000|COMPLETED|Overall Study||35
6610544|NCT02110264|7535975|FG001|COMPLETED|Overall Study||38
6610545|NCT02110264|7535976|FG002|COMPLETED|Overall Study||39
6610546|NCT02110264|7535974|FG000|NOT COMPLETED|Overall Study||18
6610547|NCT02110264|7535975|FG001|NOT COMPLETED|Overall Study||12
6610548|NCT02110264|7535976|FG002|NOT COMPLETED|Overall Study||9
6610549|NCT02110381|7535986|FG000|STARTED|Single Modality||9
6610550|NCT02110381|7535987|FG001|STARTED|Single Modality||9
6610551|NCT02110381|7535986|FG000|COMPLETED|Single Modality||7
6610552|NCT02110381|7535987|FG001|COMPLETED|Single Modality||8
6610553|NCT02110381|7535986|FG000|NOT COMPLETED|Single Modality||2
6610554|NCT02110381|7535987|FG001|NOT COMPLETED|Single Modality||1
6610555|NCT02110381|7535986|FG000|STARTED|Dual Modality||7
6610556|NCT02110381|7535987|FG001|STARTED|Dual Modality||8
6610557|NCT02110381|7535986|FG000|Began Active Treatment|Dual Modality||7
6610558|NCT02110381|7535987|FG001|Began Active Treatment|Dual Modality||7
6610559|NCT02110381|7535986|FG000|COMPLETED|Dual Modality||5
6610560|NCT02110381|7535987|FG001|COMPLETED|Dual Modality||7
6610561|NCT02110381|7535986|FG000|NOT COMPLETED|Dual Modality||2
6610562|NCT02110381|7535987|FG001|NOT COMPLETED|Dual Modality||1
6610563|NCT02110485|7535996|FG000|STARTED|Overall Study||98
6610564|NCT02110485|7535997|FG001|STARTED|Overall Study||102
6610565|NCT02110485|7535996|FG000|COMPLETED|Overall Study||91
6610566|NCT02110485|7535997|FG001|COMPLETED|Overall Study||83
6610567|NCT02110485|7535996|FG000|NOT COMPLETED|Overall Study||7
6610568|NCT02110485|7535997|FG001|NOT COMPLETED|Overall Study||19
6610569|NCT02110693|7536003|FG000|STARTED|Overall Study||1026
6610570|NCT02110693|7536004|FG001|STARTED|Overall Study||1031
6610571|NCT02110693|7536003|FG000|COMPLETED|Overall Study||998
6610572|NCT02110693|7536004|FG001|COMPLETED|Overall Study||1002
6610573|NCT02110693|7536003|FG000|NOT COMPLETED|Overall Study||28
6610574|NCT02110693|7536004|FG001|NOT COMPLETED|Overall Study||29
6610575|NCT02110706|7536026|FG000|STARTED|Overall Study||25
6610576|NCT02110706|7536027|FG001|STARTED|Overall Study||27
6610577|NCT02110706|7536026|FG000|No. Completing Study Through Week 52|Overall Study||23
6610578|NCT02110706|7536027|FG001|No. Completing Study Through Week 52|Overall Study||24
6610579|NCT02110706|7536026|FG000|COMPLETED|Overall Study||20
6610580|NCT02110706|7536027|FG001|COMPLETED|Overall Study||23
6610581|NCT02110706|7536026|FG000|NOT COMPLETED|Overall Study||5
6610582|NCT02110706|7536027|FG001|NOT COMPLETED|Overall Study||4
6610583|NCT02110732|7536037|FG000|STARTED|Overall Study||20
6610584|NCT02110732|7536038|FG001|STARTED|Overall Study||20
6610585|NCT02110732|7536037|FG000|COMPLETED|Overall Study||14
6610586|NCT02110732|7536038|FG001|COMPLETED|Overall Study||17
6610587|NCT02110732|7536037|FG000|NOT COMPLETED|Overall Study||6
6610588|NCT02110732|7536038|FG001|NOT COMPLETED|Overall Study||3
6610589|NCT02110758|7536049|FG000|STARTED|Baseline: August 2011-July 2013||0
6610590|NCT02110758|7536050|FG001|STARTED|Baseline: August 2011-July 2013||0
6610591|NCT02110758|7536051|FG002|STARTED|Baseline: August 2011-July 2013||9832
6610592|NCT02110758|7536052|FG003|STARTED|Baseline: August 2011-July 2013||18994
6610593|NCT02110758|7536053|FG004|STARTED|Baseline: August 2011-July 2013||308
6610594|NCT02110758|7536049|FG000|COMPLETED|Baseline: August 2011-July 2013||0
6610595|NCT02110758|7536050|FG001|COMPLETED|Baseline: August 2011-July 2013||0
6610596|NCT02110758|7536051|FG002|COMPLETED|Baseline: August 2011-July 2013||9832
6610597|NCT02110758|7536052|FG003|COMPLETED|Baseline: August 2011-July 2013||18994
6610598|NCT02110758|7536053|FG004|COMPLETED|Baseline: August 2011-July 2013||308
6610599|NCT02110758|7536049|FG000|NOT COMPLETED|Baseline: August 2011-July 2013||0
6610600|NCT02110758|7536050|FG001|NOT COMPLETED|Baseline: August 2011-July 2013||0
6610601|NCT02110758|7536051|FG002|NOT COMPLETED|Baseline: August 2011-July 2013||0
6610602|NCT02110758|7536052|FG003|NOT COMPLETED|Baseline: August 2011-July 2013||0
6610603|NCT02110758|7536053|FG004|NOT COMPLETED|Baseline: August 2011-July 2013||0
6610604|NCT02110758|7536049|FG000|STARTED|Start-Up: August 2013-June 2014||175
6610605|NCT02110758|7536050|FG001|STARTED|Start-Up: August 2013-June 2014||431
6610606|NCT02110758|7536051|FG002|STARTED|Start-Up: August 2013-June 2014||8057
6610607|NCT02110758|7536052|FG003|STARTED|Start-Up: August 2013-June 2014||12883
6610608|NCT02110758|7536053|FG004|STARTED|Start-Up: August 2013-June 2014||0
6610609|NCT02110758|7536049|FG000|COMPLETED|Start-Up: August 2013-June 2014||175
6610610|NCT02110758|7536050|FG001|COMPLETED|Start-Up: August 2013-June 2014||431
6610611|NCT02110758|7536051|FG002|COMPLETED|Start-Up: August 2013-June 2014||8057
6610612|NCT02110758|7536052|FG003|COMPLETED|Start-Up: August 2013-June 2014||12883
6610613|NCT02110758|7536053|FG004|COMPLETED|Start-Up: August 2013-June 2014||0
6610614|NCT02110758|7536049|FG000|NOT COMPLETED|Start-Up: August 2013-June 2014||0
6610615|NCT02110758|7536050|FG001|NOT COMPLETED|Start-Up: August 2013-June 2014||0
6610616|NCT02110758|7536051|FG002|NOT COMPLETED|Start-Up: August 2013-June 2014||0
6610617|NCT02110758|7536052|FG003|NOT COMPLETED|Start-Up: August 2013-June 2014||0
6610618|NCT02110758|7536053|FG004|NOT COMPLETED|Start-Up: August 2013-June 2014||0
6610619|NCT02110758|7536049|FG000|STARTED|Intervention: July 2014-December 2015||0
6610620|NCT02110758|7536050|FG001|STARTED|Intervention: July 2014-December 2015||0
6610621|NCT02110758|7536051|FG002|STARTED|Intervention: July 2014-December 2015||10106
6610622|NCT02110758|7536052|FG003|STARTED|Intervention: July 2014-December 2015||33012
6610623|NCT02110758|7536053|FG004|STARTED|Intervention: July 2014-December 2015||0
6610624|NCT02110758|7536049|FG000|COMPLETED|Intervention: July 2014-December 2015||0
6610625|NCT02110758|7536050|FG001|COMPLETED|Intervention: July 2014-December 2015||0
6610626|NCT02110758|7536051|FG002|COMPLETED|Intervention: July 2014-December 2015||10106
6610627|NCT02110758|7536052|FG003|COMPLETED|Intervention: July 2014-December 2015||33012
6610628|NCT02110758|7536053|FG004|COMPLETED|Intervention: July 2014-December 2015||0
6610629|NCT02110758|7536049|FG000|NOT COMPLETED|Intervention: July 2014-December 2015||0
6610630|NCT02110758|7536050|FG001|NOT COMPLETED|Intervention: July 2014-December 2015||0
6610631|NCT02110758|7536051|FG002|NOT COMPLETED|Intervention: July 2014-December 2015||0
6610632|NCT02110758|7536052|FG003|NOT COMPLETED|Intervention: July 2014-December 2015||0
6610633|NCT02110758|7536053|FG004|NOT COMPLETED|Intervention: July 2014-December 2015||0
6610634|NCT02110758|7536049|FG000|STARTED|Follow-Up: January-July 2016||81
6610635|NCT02110758|7536050|FG001|STARTED|Follow-Up: January-July 2016||179
6610636|NCT02110758|7536051|FG002|STARTED|Follow-Up: January-July 2016||6451
6610637|NCT02110758|7536052|FG003|STARTED|Follow-Up: January-July 2016||24392
6610638|NCT02110758|7536053|FG004|STARTED|Follow-Up: January-July 2016||349
6610639|NCT02110758|7536049|FG000|COMPLETED|Follow-Up: January-July 2016||81
6610640|NCT02110758|7536050|FG001|COMPLETED|Follow-Up: January-July 2016||179
6610641|NCT02110758|7536051|FG002|COMPLETED|Follow-Up: January-July 2016||6451
6610642|NCT02110758|7536052|FG003|COMPLETED|Follow-Up: January-July 2016||24392
6610643|NCT02110758|7536053|FG004|COMPLETED|Follow-Up: January-July 2016||349
6610644|NCT02110758|7536049|FG000|NOT COMPLETED|Follow-Up: January-July 2016||0
6610645|NCT02110758|7536050|FG001|NOT COMPLETED|Follow-Up: January-July 2016||0
6610646|NCT02110758|7536051|FG002|NOT COMPLETED|Follow-Up: January-July 2016||0
6610647|NCT02110758|7536052|FG003|NOT COMPLETED|Follow-Up: January-July 2016||0
6610648|NCT02110758|7536053|FG004|NOT COMPLETED|Follow-Up: January-July 2016||0
6610649|NCT02110901|7536067|FG000|STARTED|Overall Study||209
6610650|NCT02110901|7536068|FG001|STARTED|Overall Study||102
6610651|NCT02110901|7536067|FG000|COMPLETED|Overall Study||179
6610652|NCT02110901|7536068|FG001|COMPLETED|Overall Study||88
6610653|NCT02110901|7536067|FG000|NOT COMPLETED|Overall Study||30
6610654|NCT02110901|7536068|FG001|NOT COMPLETED|Overall Study||14
6610655|NCT02111083|7536077|FG000|STARTED|First Intervention (1 Day)||19
6610656|NCT02111083|7536078|FG001|STARTED|First Intervention (1 Day)||19
6610657|NCT02111083|7536077|FG000|COMPLETED|First Intervention (1 Day)||19
6610658|NCT02111083|7536078|FG001|COMPLETED|First Intervention (1 Day)||19
6610659|NCT02111083|7536077|FG000|NOT COMPLETED|First Intervention (1 Day)||0
6610660|NCT02111083|7536078|FG001|NOT COMPLETED|First Intervention (1 Day)||0
6610661|NCT02111083|7536077|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
6610662|NCT02111083|7536078|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
6610663|NCT02111083|7536077|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
6610664|NCT02111083|7536078|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
6610665|NCT02111083|7536077|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
6610666|NCT02111083|7536078|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
6732549|NCT03196193|7661964|FG001|COMPLETED|Overall Study||119
6732550|NCT03196193|7661963|FG000|NOT COMPLETED|Overall Study||3
6732551|NCT03196193|7661964|FG001|NOT COMPLETED|Overall Study||0
6732552|NCT03196232|7661970|FG000|STARTED|Overall Study||3
6732553|NCT03196232|7661970|FG000|COMPLETED|Overall Study||3
6732554|NCT03196232|7661970|FG000|NOT COMPLETED|Overall Study||0
6732555|NCT03196284|7661976|FG000|STARTED|Main Part||17
6732556|NCT03196284|7661977|FG001|STARTED|Main Part||9
6732557|NCT03196284|7661978|FG002|STARTED|Main Part||0
6732558|NCT03196284|7661976|FG000|Concizumab 0.15 mg/kg|Main Part||15
6732559|NCT03196284|7661977|FG001|Concizumab 0.15 mg/kg|Main Part||0
6732560|NCT03196284|7661978|FG002|Concizumab 0.15 mg/kg|Main Part||0
6732561|NCT03196284|7661976|FG000|Concizumab 0.20 mg/kg|Main Part||2
6732562|NCT03196284|7661977|FG001|Concizumab 0.20 mg/kg|Main Part||0
6732563|NCT03196284|7661978|FG002|Concizumab 0.20 mg/kg|Main Part||0
6732564|NCT03196284|7661976|FG000|Concizumab 0.25 mg/kg|Main Part||0
6732565|NCT03196284|7661977|FG001|Concizumab 0.25 mg/kg|Main Part||0
6732566|NCT03196284|7661978|FG002|Concizumab 0.25 mg/kg|Main Part||0
6732567|NCT03196284|7661976|FG000|COMPLETED|Main Part||17
6732568|NCT03196284|7661977|FG001|COMPLETED|Main Part||8
6732569|NCT03196284|7661978|FG002|COMPLETED|Main Part||0
6732570|NCT03196284|7661976|FG000|NOT COMPLETED|Main Part||0
6732571|NCT03196284|7661977|FG001|NOT COMPLETED|Main Part||1
6732572|NCT03196284|7661978|FG002|NOT COMPLETED|Main Part||0
6732573|NCT03196284|7661976|FG000|STARTED|Extension Part|Participants who completed main part are presented in separate treatment arm.|0
6732574|NCT03196284|7661977|FG001|STARTED|Extension Part|Participants switched to treatment with concizumab in the extension part of the study.|0
6732575|NCT03196284|7661978|FG002|STARTED|Extension Part|Participants who completed the main part entered the extension part of the study.|25
6732576|NCT03196284|7661976|FG000|Concizumab 0.15 mg/kg|Extension Part||0
6732577|NCT03196284|7661977|FG001|Concizumab 0.15 mg/kg|Extension Part||0
6732578|NCT03196284|7661978|FG002|Concizumab 0.15 mg/kg|Extension Part||12
6732579|NCT03196284|7661976|FG000|Concizumab 0.20 mg/kg|Extension Part||0
6732580|NCT03196284|7661977|FG001|Concizumab 0.20 mg/kg|Extension Part||0
6732581|NCT03196284|7661978|FG002|Concizumab 0.20 mg/kg|Extension Part||9
6732582|NCT03196284|7661976|FG000|Concizumab 0.25 mg/kg|Extension Part||0
6732583|NCT03196284|7661977|FG001|Concizumab 0.25 mg/kg|Extension Part||0
6732584|NCT03196284|7661978|FG002|Concizumab 0.25 mg/kg|Extension Part||4
6732585|NCT03196284|7661976|FG000|COMPLETED|Extension Part||0
6610667|NCT02111083|7536077|FG000|STARTED|Second Intervention (1 Day)||19
6610668|NCT02111083|7536078|FG001|STARTED|Second Intervention (1 Day)||19
6610669|NCT02111083|7536077|FG000|COMPLETED|Second Intervention (1 Day)||19
6610670|NCT02111083|7536078|FG001|COMPLETED|Second Intervention (1 Day)||19
6610671|NCT02111083|7536077|FG000|NOT COMPLETED|Second Intervention (1 Day)||0
6610672|NCT02111083|7536078|FG001|NOT COMPLETED|Second Intervention (1 Day)||0
6610673|NCT02111083|7536077|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
6610674|NCT02111083|7536078|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
6610675|NCT02111083|7536077|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||19
6610676|NCT02111083|7536078|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||19
6610677|NCT02111083|7536077|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
6610678|NCT02111083|7536078|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
6610679|NCT02111083|7536077|FG000|STARTED|Third Intervention (1 Day)||19
6610680|NCT02111083|7536078|FG001|STARTED|Third Intervention (1 Day)||19
6610681|NCT02111083|7536077|FG000|COMPLETED|Third Intervention (1 Day)||19
6610682|NCT02111083|7536078|FG001|COMPLETED|Third Intervention (1 Day)||19
6610683|NCT02111083|7536077|FG000|NOT COMPLETED|Third Intervention (1 Day)||0
6610684|NCT02111083|7536078|FG001|NOT COMPLETED|Third Intervention (1 Day)||0
6610685|NCT02111083|7536077|FG000|STARTED|Interval Between Dosing (7-8 Days)||19
6610686|NCT02111083|7536078|FG001|STARTED|Interval Between Dosing (7-8 Days)||19
6610687|NCT02111083|7536077|FG000|COMPLETED|Interval Between Dosing (7-8 Days)||18
6610688|NCT02111083|7536078|FG001|COMPLETED|Interval Between Dosing (7-8 Days)||18
6610689|NCT02111083|7536077|FG000|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
6610690|NCT02111083|7536078|FG001|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
6610691|NCT02111083|7536077|FG000|STARTED|Fourth Intervention (1 Day)||18
6610692|NCT02111083|7536078|FG001|STARTED|Fourth Intervention (1 Day)||18
6610693|NCT02111083|7536077|FG000|COMPLETED|Fourth Intervention (1 Day)||18
6610694|NCT02111083|7536078|FG001|COMPLETED|Fourth Intervention (1 Day)||18
6610695|NCT02111083|7536077|FG000|NOT COMPLETED|Fourth Intervention (1 Day)||0
6610696|NCT02111083|7536078|FG001|NOT COMPLETED|Fourth Intervention (1 Day)||0
6610697|NCT02111096|7536087|FG000|STARTED|Overall Study||65
6610698|NCT02111096|7536088|FG001|STARTED|Overall Study||41
6610699|NCT02111096|7536089|FG002|STARTED|Overall Study||68
6610700|NCT02111096|7536087|FG000|Received at Least 1 Dose of Study Drug|Overall Study||65
6610701|NCT02111096|7536088|FG001|Received at Least 1 Dose of Study Drug|Overall Study||41
6610702|NCT02111096|7536089|FG002|Received at Least 1 Dose of Study Drug|Overall Study||68
6610703|NCT02111096|7536087|FG000|COMPLETED|Overall Study||1
6610704|NCT02111096|7536088|FG001|COMPLETED|Overall Study||0
6610705|NCT02111096|7536089|FG002|COMPLETED|Overall Study||2
6610706|NCT02111096|7536087|FG000|NOT COMPLETED|Overall Study||64
6610707|NCT02111096|7536088|FG001|NOT COMPLETED|Overall Study||41
6610708|NCT02111096|7536089|FG002|NOT COMPLETED|Overall Study||66
6610709|NCT02111174|7536102|FG000|STARTED|Treatment and Primary Outcome||18
6610710|NCT02111174|7536103|FG001|STARTED|Treatment and Primary Outcome||18
6610711|NCT02111174|7536102|FG000|COMPLETED|Treatment and Primary Outcome||15
6610712|NCT02111174|7536103|FG001|COMPLETED|Treatment and Primary Outcome||16
6610713|NCT02111174|7536102|FG000|NOT COMPLETED|Treatment and Primary Outcome||3
6610714|NCT02111174|7536103|FG001|NOT COMPLETED|Treatment and Primary Outcome||2
6610715|NCT02111174|7536102|FG000|STARTED|Secondary Outcomes (2 and 3 Month f/u)||15
6610716|NCT02111174|7536103|FG001|STARTED|Secondary Outcomes (2 and 3 Month f/u)||16
6610717|NCT02111174|7536102|FG000|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||8
6610718|NCT02111174|7536103|FG001|2 Month Follow up Complete|Secondary Outcomes (2 and 3 Month f/u)||11
6610719|NCT02111174|7536102|FG000|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
6610720|NCT02111174|7536103|FG001|COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||9
6610721|NCT02111174|7536102|FG000|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||8
6610722|NCT02111174|7536103|FG001|NOT COMPLETED|Secondary Outcomes (2 and 3 Month f/u)||7
6610723|NCT02111187|7536111|FG000|STARTED|Overall Study||7
6610724|NCT02111187|7536112|FG001|STARTED|Overall Study||7
6610725|NCT02111187|7536111|FG000|COMPLETED|Overall Study||7
6610726|NCT02111187|7536112|FG001|COMPLETED|Overall Study||7
6610727|NCT02111187|7536111|FG000|NOT COMPLETED|Overall Study||0
6610728|NCT02111187|7536112|FG001|NOT COMPLETED|Overall Study||0
6610729|NCT02111200|7536122|FG000|STARTED|Overall Study||3
6610730|NCT02111200|7536123|FG001|STARTED|Overall Study||2
6610731|NCT02111200|7536124|FG002|STARTED|Overall Study||1
6610732|NCT02111200|7536125|FG003|STARTED|Overall Study||1
6610733|NCT02111200|7536122|FG000|COMPLETED|Overall Study||3
6610734|NCT02111200|7536123|FG001|COMPLETED|Overall Study||2
6610735|NCT02111200|7536124|FG002|COMPLETED|Overall Study||1
6610736|NCT02111200|7536125|FG003|COMPLETED|Overall Study||1
6610737|NCT02111200|7536122|FG000|NOT COMPLETED|Overall Study||0
6610738|NCT02111200|7536123|FG001|NOT COMPLETED|Overall Study||0
6610739|NCT02111200|7536124|FG002|NOT COMPLETED|Overall Study||0
6610740|NCT02111200|7536125|FG003|NOT COMPLETED|Overall Study||0
6610741|NCT02111213|7536135|FG000|STARTED|Overall Study||122
6610742|NCT02111213|7536136|FG001|STARTED|Overall Study||123
6610743|NCT02111213|7536135|FG000|COMPLETED|Overall Study||116
6610744|NCT02111213|7536136|FG001|COMPLETED|Overall Study||117
6610745|NCT02111213|7536135|FG000|NOT COMPLETED|Overall Study||6
6610746|NCT02111213|7536136|FG001|NOT COMPLETED|Overall Study||6
6610747|NCT02111252|7536142|FG000|STARTED|Overall Study||55
6610748|NCT02111252|7536142|FG000|COMPLETED|Overall Study||55
6732586|NCT03196284|7661977|FG001|COMPLETED|Extension Part||0
6610749|NCT02111252|7536142|FG000|NOT COMPLETED|Overall Study||0
6610750|NCT02111369|7536146|FG000|STARTED|Overall Study||18
6610751|NCT02111369|7536146|FG000|COMPLETED|Overall Study||15
6610752|NCT02111369|7536146|FG000|NOT COMPLETED|Overall Study||3
6610753|NCT02111447|7536154|FG000|STARTED|Overall Study||0
6610754|NCT02111447|7536155|FG001|STARTED|Overall Study||5
6610755|NCT02111447|7536156|FG002|STARTED|Overall Study||1
6610756|NCT02111447|7536157|FG003|STARTED|Overall Study||0
6610757|NCT02111447|7536154|FG000|COMPLETED|Overall Study||0
6610758|NCT02111447|7536155|FG001|COMPLETED|Overall Study||5
6610759|NCT02111447|7536156|FG002|COMPLETED|Overall Study||1
6610760|NCT02111447|7536157|FG003|COMPLETED|Overall Study||0
6610761|NCT02111447|7536154|FG000|NOT COMPLETED|Overall Study||0
6610762|NCT02111447|7536155|FG001|NOT COMPLETED|Overall Study||0
6610763|NCT02111447|7536156|FG002|NOT COMPLETED|Overall Study||0
6610764|NCT02111447|7536157|FG003|NOT COMPLETED|Overall Study||0
6610765|NCT02111564|7536169|FG000|STARTED|Overall Study||6007
6610766|NCT02111564|7536170|FG001|STARTED|Overall Study||6012
6610767|NCT02111564|7536169|FG000|Treated|Overall Study||5982
6610768|NCT02111564|7536170|FG001|Treated|Overall Study||5980
6610769|NCT02111564|7536169|FG000|COMPLETED|Overall Study||5876
6610770|NCT02111564|7536170|FG001|COMPLETED|Overall Study||5869
6610771|NCT02111564|7536169|FG000|NOT COMPLETED|Overall Study||131
6610772|NCT02111564|7536170|FG001|NOT COMPLETED|Overall Study||143
6610773|NCT02111577|7536178|FG000|STARTED|Overall Study||787
6610774|NCT02111577|7536179|FG001|STARTED|Overall Study||395
6610775|NCT02111577|7536178|FG000|COMPLETED|Overall Study||188
6610776|NCT02111577|7536179|FG001|COMPLETED|Overall Study||106
6610777|NCT02111577|7536178|FG000|NOT COMPLETED|Overall Study||599
6610778|NCT02111577|7536179|FG001|NOT COMPLETED|Overall Study||289
6610779|NCT02111603|7536187|FG000|STARTED|Overall Study||13
6610780|NCT02111603|7536187|FG000|COMPLETED|Overall Study||12
6610781|NCT02111603|7536187|FG000|NOT COMPLETED|Overall Study||1
6610782|NCT02111746|7536193|FG000|STARTED|Overall Study||172
6610783|NCT02111746|7536194|FG001|STARTED|Overall Study||171
6610784|NCT02111746|7536193|FG000|COMPLETED|Overall Study||169
6610785|NCT02111746|7536194|FG001|COMPLETED|Overall Study||169
6610786|NCT02111746|7536193|FG000|NOT COMPLETED|Overall Study||3
6610787|NCT02111746|7536194|FG001|NOT COMPLETED|Overall Study||2
6610788|NCT02111772|7536202|FG000|STARTED|Overall Study||12
6610789|NCT02111772|7536203|FG001|STARTED|Overall Study||14
6610790|NCT02111772|7536202|FG000|COMPLETED|Overall Study||12
6610791|NCT02111772|7536203|FG001|COMPLETED|Overall Study||14
6610792|NCT02111772|7536202|FG000|NOT COMPLETED|Overall Study||0
6610793|NCT02111772|7536203|FG001|NOT COMPLETED|Overall Study||0
6610794|NCT02111785|7536213|FG000|STARTED|Overall Study||3
6610795|NCT02111785|7536214|FG001|STARTED|Overall Study||5
6610796|NCT02111785|7536215|FG002|STARTED|Overall Study||1
6610797|NCT02111785|7536216|FG003|STARTED|Overall Study||1
6610798|NCT02111785|7536213|FG000|COMPLETED|Overall Study||3
6610799|NCT02111785|7536214|FG001|COMPLETED|Overall Study||4
6610800|NCT02111785|7536215|FG002|COMPLETED|Overall Study||1
6610801|NCT02111785|7536216|FG003|COMPLETED|Overall Study||1
6610802|NCT02111785|7536213|FG000|NOT COMPLETED|Overall Study||0
6610803|NCT02111785|7536214|FG001|NOT COMPLETED|Overall Study||1
6610804|NCT02111785|7536215|FG002|NOT COMPLETED|Overall Study||0
6610805|NCT02111785|7536216|FG003|NOT COMPLETED|Overall Study||0
6610806|NCT02111798|7536234|FG000|STARTED|Overall Study||31
6610807|NCT02111798|7536235|FG001|STARTED|Overall Study||32
6610808|NCT02111798|7536236|FG002|STARTED|Overall Study||10
6610809|NCT02111798|7536237|FG003|STARTED|Overall Study||10
6610810|NCT02111798|7536234|FG000|COMPLETED|Overall Study||20
6610811|NCT02111798|7536235|FG001|COMPLETED|Overall Study||16
6610812|NCT02111798|7536236|FG002|COMPLETED|Overall Study||10
6610813|NCT02111798|7536237|FG003|COMPLETED|Overall Study||7
6610814|NCT02111798|7536234|FG000|NOT COMPLETED|Overall Study||11
6610815|NCT02111798|7536235|FG001|NOT COMPLETED|Overall Study||16
6610816|NCT02111798|7536236|FG002|NOT COMPLETED|Overall Study||0
6610817|NCT02111798|7536237|FG003|NOT COMPLETED|Overall Study||3
6610818|NCT02111811|7536250|FG000|STARTED|Treatment Phase||139
6610819|NCT02111811|7536251|FG001|STARTED|Treatment Phase||114
6610820|NCT02111811|7536250|FG000|COMPLETED|Treatment Phase||115
6610821|NCT02111811|7536251|FG001|COMPLETED|Treatment Phase||96
6610822|NCT02111811|7536250|FG000|NOT COMPLETED|Treatment Phase||24
6610823|NCT02111811|7536251|FG001|NOT COMPLETED|Treatment Phase||18
6610824|NCT02111811|7536250|FG000|STARTED|Follow up Period (Aim 2)||139
6610825|NCT02111811|7536251|FG001|STARTED|Follow up Period (Aim 2)|All subjects were approached for followup, 1 patient completed the 2nd followup and not the first.|114
6610826|NCT02111811|7536250|FG000|COMPLETED|Follow up Period (Aim 2)||111
6610827|NCT02111811|7536251|FG001|COMPLETED|Follow up Period (Aim 2)||97
6610828|NCT02111811|7536250|FG000|NOT COMPLETED|Follow up Period (Aim 2)||28
6610829|NCT02111811|7536251|FG001|NOT COMPLETED|Follow up Period (Aim 2)||17
6610830|NCT02111863|7536257|FG000|STARTED|Overall Study||6
6610831|NCT02111863|7536257|FG000|COMPLETED|Overall Study||6
6610832|NCT02111863|7536257|FG000|NOT COMPLETED|Overall Study||0
6610833|NCT02111980|7536261|FG000|STARTED|Overall Study||50
6610834|NCT02111980|7536261|FG000|COMPLETED|Overall Study||50
6610835|NCT02111980|7536261|FG000|NOT COMPLETED|Overall Study||0
6610836|NCT02111993|7536270|FG000|STARTED|Overall Study||30
6610837|NCT02111993|7536271|FG001|STARTED|Overall Study||30
6610838|NCT02111993|7536270|FG000|COMPLETED|Overall Study||25
6610839|NCT02111993|7536271|FG001|COMPLETED|Overall Study||26
6610840|NCT02111993|7536270|FG000|NOT COMPLETED|Overall Study||5
6610841|NCT02111993|7536271|FG001|NOT COMPLETED|Overall Study||4
6610842|NCT02112045|7536281|FG000|STARTED|Overall Study||45
6610843|NCT02112045|7536282|FG001|STARTED|Overall Study||45
6610844|NCT02112045|7536281|FG000|COMPLETED|Overall Study||44
6610845|NCT02112045|7536282|FG001|COMPLETED|Overall Study||45
6610846|NCT02112045|7536281|FG000|NOT COMPLETED|Overall Study||1
6610847|NCT02112045|7536282|FG001|NOT COMPLETED|Overall Study||0
6610848|NCT02112370|7536290|FG000|STARTED|Overall Study||74
6610849|NCT02112370|7536291|FG001|STARTED|Overall Study||74
6610850|NCT02112370|7536290|FG000|COMPLETED|Overall Study||74
6610851|NCT02112370|7536291|FG001|COMPLETED|Overall Study||74
6610852|NCT02112370|7536290|FG000|NOT COMPLETED|Overall Study||0
6610853|NCT02112370|7536291|FG001|NOT COMPLETED|Overall Study||0
6610854|NCT02112448|7536299|FG000|STARTED|Overall Study||38
6610855|NCT02112448|7536300|FG001|STARTED|Overall Study||40
6610856|NCT02112448|7536299|FG000|COMPLETED|Overall Study||30
6610857|NCT02112448|7536300|FG001|COMPLETED|Overall Study||30
6610858|NCT02112448|7536299|FG000|NOT COMPLETED|Overall Study||8
6610859|NCT02112448|7536300|FG001|NOT COMPLETED|Overall Study||10
6610860|NCT02112838|7536311|FG000|STARTED|Overall Study||25
6610861|NCT02112838|7536312|FG001|STARTED|Overall Study||26
6610862|NCT02112838|7536313|FG002|STARTED|Overall Study||25
6610863|NCT02112838|7536311|FG000|COMPLETED|Overall Study||20
6610864|NCT02112838|7536312|FG001|COMPLETED|Overall Study||24
6610865|NCT02112838|7536313|FG002|COMPLETED|Overall Study||24
6610866|NCT02112838|7536311|FG000|NOT COMPLETED|Overall Study||5
6610867|NCT02112838|7536312|FG001|NOT COMPLETED|Overall Study||2
6610868|NCT02112838|7536313|FG002|NOT COMPLETED|Overall Study||1
6610869|NCT02112877|7536323|FG000|STARTED|Overall Study||30
6610870|NCT02112877|7536324|FG001|STARTED|Overall Study||170
6610871|NCT02112877|7536323|FG000|COMPLETED|Overall Study||28
6610872|NCT02112877|7536324|FG001|COMPLETED|Overall Study||157
6610873|NCT02112877|7536323|FG000|NOT COMPLETED|Overall Study||2
6610874|NCT02112877|7536324|FG001|NOT COMPLETED|Overall Study||13
6610875|NCT02112994|7536332|FG000|STARTED|Overall Study||6
6610876|NCT02112994|7536333|FG001|STARTED|Overall Study||16
6610877|NCT02112994|7536334|FG002|STARTED|Overall Study||9
6610878|NCT02112994|7536332|FG000|Received at Least 1 Dose of Study Drug|Overall Study||6
6610879|NCT02112994|7536333|FG001|Received at Least 1 Dose of Study Drug|Overall Study||16
6610880|NCT02112994|7536334|FG002|Received at Least 1 Dose of Study Drug|Overall Study||9
6610881|NCT02112994|7536332|FG000|Received 0.35 mg/kg QOW|Overall Study||0
6610882|NCT02112994|7536333|FG001|Received 0.35 mg/kg QOW|Overall Study||0
6610883|NCT02112994|7536334|FG002|Received 0.35 mg/kg QOW|Overall Study||1
6610884|NCT02112994|7536332|FG000|Received 1 mg/kg QOW|Overall Study||6
6610885|NCT02112994|7536333|FG001|Received 1 mg/kg QOW|Overall Study||16
6610886|NCT02112994|7536334|FG002|Received 1 mg/kg QOW|Overall Study||9
6610887|NCT02112994|7536332|FG000|Received 1 mg/kg QW|Overall Study||1
6610888|NCT02112994|7536333|FG001|Received 1 mg/kg QW|Overall Study||1
6610889|NCT02112994|7536334|FG002|Received 1 mg/kg QW|Overall Study||0
6610890|NCT02112994|7536332|FG000|Received 3 mg/kg QOW|Overall Study||3
6610891|NCT02112994|7536333|FG001|Received 3 mg/kg QOW|Overall Study||5
6610892|NCT02112994|7536334|FG002|Received 3 mg/kg QOW|Overall Study||3
6610893|NCT02112994|7536332|FG000|Received 3 mg/kg QW|Overall Study||2
6610894|NCT02112994|7536333|FG001|Received 3 mg/kg QW|Overall Study||1
6610895|NCT02112994|7536334|FG002|Received 3 mg/kg QW|Overall Study||1
6610896|NCT02112994|7536332|FG000|Completed 96-week Treatment Period|Overall Study||6
6610897|NCT02112994|7536333|FG001|Completed 96-week Treatment Period|Overall Study||14
6610898|NCT02112994|7536334|FG002|Completed 96-week Treatment Period|Overall Study||8
6610899|NCT02112994|7536332|FG000|COMPLETED|Overall Study||6
6610900|NCT02112994|7536333|FG001|COMPLETED|Overall Study||14
6610901|NCT02112994|7536334|FG002|COMPLETED|Overall Study||6
6610902|NCT02112994|7536332|FG000|NOT COMPLETED|Overall Study||0
6610903|NCT02112994|7536333|FG001|NOT COMPLETED|Overall Study||2
6610904|NCT02112994|7536334|FG002|NOT COMPLETED|Overall Study||3
6610905|NCT02113007|7536346|FG000|STARTED|Overall Study||2
6610906|NCT02113007|7536346|FG000|COMPLETED|Overall Study||0
6610907|NCT02113007|7536346|FG000|NOT COMPLETED|Overall Study||2
6610908|NCT02113124|7536352|FG000|STARTED|Overall Study||18
6610909|NCT02113124|7536353|FG001|STARTED|Overall Study||25
6610910|NCT02113124|7536352|FG000|COMPLETED|Overall Study||17
6610911|NCT02113124|7536353|FG001|COMPLETED|Overall Study||24
6610912|NCT02113124|7536352|FG000|NOT COMPLETED|Overall Study||1
6610913|NCT02113124|7536353|FG001|NOT COMPLETED|Overall Study||1
6610914|NCT02113189|7536362|FG000|STARTED|Overall Study||4
6610915|NCT02113189|7536363|FG001|STARTED|Overall Study||4
6610916|NCT02113189|7536364|FG002|STARTED|Overall Study||5
6610917|NCT02113189|7536362|FG000|COMPLETED|Overall Study||2
6610918|NCT02113189|7536363|FG001|COMPLETED|Overall Study||3
6610919|NCT02113189|7536364|FG002|COMPLETED|Overall Study||2
6610920|NCT02113189|7536362|FG000|NOT COMPLETED|Overall Study||2
6610921|NCT02113189|7536363|FG001|NOT COMPLETED|Overall Study||1
6610922|NCT02113189|7536364|FG002|NOT COMPLETED|Overall Study||3
6610923|NCT02113241|7536377|FG000|STARTED|Overall Study||12
6610924|NCT02113241|7536378|FG001|STARTED|Overall Study||12
6610925|NCT02113241|7536377|FG000|COMPLETED|Overall Study||12
6610926|NCT02113241|7536378|FG001|COMPLETED|Overall Study||11
6610927|NCT02113241|7536377|FG000|NOT COMPLETED|Overall Study||0
6610928|NCT02113241|7536378|FG001|NOT COMPLETED|Overall Study||1
6610929|NCT02113410|7536386|FG000|STARTED|Overall Study||65
6610930|NCT02113410|7536387|FG001|STARTED|Overall Study||66
6610931|NCT02113410|7536386|FG000|COMPLETED|Overall Study||49
6610932|NCT02113410|7536387|FG001|COMPLETED|Overall Study||63
6610933|NCT02113410|7536386|FG000|NOT COMPLETED|Overall Study||16
6610934|NCT02113410|7536387|FG001|NOT COMPLETED|Overall Study||3
6610935|NCT02113436|7536397|FG000|STARTED|Period 1: 8 Weeks||150
6610936|NCT02113436|7536398|FG001|STARTED|Period 1: 8 Weeks||150
6610937|NCT02113436|7536399|FG002|STARTED|Period 1: 8 Weeks||0
6610938|NCT02113436|7536400|FG003|STARTED|Period 1: 8 Weeks||0
6610939|NCT02113436|7536397|FG000|COMPLETED|Period 1: 8 Weeks||142
6610940|NCT02113436|7536398|FG001|COMPLETED|Period 1: 8 Weeks||148
6610941|NCT02113436|7536399|FG002|COMPLETED|Period 1: 8 Weeks||0
6610942|NCT02113436|7536400|FG003|COMPLETED|Period 1: 8 Weeks||0
6610943|NCT02113436|7536397|FG000|NOT COMPLETED|Period 1: 8 Weeks||8
6610944|NCT02113436|7536398|FG001|NOT COMPLETED|Period 1: 8 Weeks||2
6610945|NCT02113436|7536399|FG002|NOT COMPLETED|Period 1: 8 Weeks||0
6610946|NCT02113436|7536400|FG003|NOT COMPLETED|Period 1: 8 Weeks||0
6610947|NCT02113436|7536397|FG000|STARTED|Period 2: 16 Weeks||0
6610948|NCT02113436|7536398|FG001|STARTED|Period 2: 16 Weeks||0
6610949|NCT02113436|7536399|FG002|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|141
6610950|NCT02113436|7536400|FG003|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn't transfer to TP2.|147
6610951|NCT02113436|7536397|FG000|COMPLETED|Period 2: 16 Weeks||0
6610952|NCT02113436|7536398|FG001|COMPLETED|Period 2: 16 Weeks||0
6610953|NCT02113436|7536399|FG002|COMPLETED|Period 2: 16 Weeks||132
6610954|NCT02113436|7536400|FG003|COMPLETED|Period 2: 16 Weeks||136
6610955|NCT02113436|7536397|FG000|NOT COMPLETED|Period 2: 16 Weeks||0
6610956|NCT02113436|7536398|FG001|NOT COMPLETED|Period 2: 16 Weeks||0
6610957|NCT02113436|7536399|FG002|NOT COMPLETED|Period 2: 16 Weeks||9
6610958|NCT02113436|7536400|FG003|NOT COMPLETED|Period 2: 16 Weeks||11
6610959|NCT02113449|7536409|FG000|STARTED|Overall Study||147
6610960|NCT02113449|7536409|FG000|COMPLETED|Overall Study||143
6610961|NCT02113449|7536409|FG000|NOT COMPLETED|Overall Study||4
6610962|NCT02113579|7536419|FG000|STARTED|Overall Study||186
6610963|NCT02113579|7536420|FG001|STARTED|Overall Study||189
6610964|NCT02113579|7536419|FG000|COMPLETED|Overall Study||176
6610965|NCT02113579|7536420|FG001|COMPLETED|Overall Study||185
6610966|NCT02113579|7536419|FG000|NOT COMPLETED|Overall Study||10
6610967|NCT02113579|7536420|FG001|NOT COMPLETED|Overall Study||4
6610968|NCT02113956|7536428|FG000|STARTED|Intervention End (5 Weeks Post Baseline)||150
6610969|NCT02113956|7536429|FG001|STARTED|Intervention End (5 Weeks Post Baseline)||152
6610970|NCT02113956|7536428|FG000|COMPLETED|Intervention End (5 Weeks Post Baseline)||141
6610971|NCT02113956|7536429|FG001|COMPLETED|Intervention End (5 Weeks Post Baseline)||148
6610972|NCT02113956|7536428|FG000|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||9
6610973|NCT02113956|7536429|FG001|NOT COMPLETED|Intervention End (5 Weeks Post Baseline)||4
6610974|NCT02113956|7536428|FG000|STARTED|3 Month Post-intervention||141
6610975|NCT02113956|7536429|FG001|STARTED|3 Month Post-intervention||148
6610976|NCT02113956|7536428|FG000|COMPLETED|3 Month Post-intervention||137
6610977|NCT02113956|7536429|FG001|COMPLETED|3 Month Post-intervention||146
6610978|NCT02113956|7536428|FG000|NOT COMPLETED|3 Month Post-intervention||4
6610979|NCT02113956|7536429|FG001|NOT COMPLETED|3 Month Post-intervention||2
6610980|NCT02114151|7536435|FG000|STARTED|Overall Study||103
6610981|NCT02114151|7536435|FG000|COMPLETED|Overall Study||96
6610982|NCT02114151|7536435|FG000|NOT COMPLETED|Overall Study||7
6610983|NCT02114164|7536441|FG000|STARTED|Overall Study||50
6610984|NCT02114164|7536442|FG001|STARTED|Overall Study||50
6610985|NCT02114164|7536441|FG000|COMPLETED|Overall Study||50
6610986|NCT02114164|7536442|FG001|COMPLETED|Overall Study||50
6610987|NCT02114164|7536441|FG000|NOT COMPLETED|Overall Study||0
6610988|NCT02114164|7536442|FG001|NOT COMPLETED|Overall Study||0
6610989|NCT02114177|7536450|FG000|STARTED|Overall Study||155
6610990|NCT02114177|7536451|FG001|STARTED|Overall Study||155
6610991|NCT02114177|7536450|FG000|COMPLETED|Overall Study||146
6610992|NCT02114177|7536451|FG001|COMPLETED|Overall Study||151
6610993|NCT02114177|7536450|FG000|NOT COMPLETED|Overall Study||9
6610994|NCT02114177|7536451|FG001|NOT COMPLETED|Overall Study||4
6610995|NCT02114203|7536460|FG000|STARTED|Overall Study||7
6610996|NCT02114203|7536461|FG001|STARTED|Overall Study||16
6610997|NCT02114203|7536462|FG002|STARTED|Overall Study||7
6610998|NCT02114203|7536460|FG000|COMPLETED|Overall Study||7
6610999|NCT02114203|7536461|FG001|COMPLETED|Overall Study||14
6611000|NCT02114203|7536462|FG002|COMPLETED|Overall Study||7
6611001|NCT02114203|7536460|FG000|NOT COMPLETED|Overall Study||0
6611002|NCT02114203|7536461|FG001|NOT COMPLETED|Overall Study||2
6611003|NCT02114203|7536462|FG002|NOT COMPLETED|Overall Study||0
6611004|NCT02114216|7536473|FG000|STARTED|Overall Study||16
6611005|NCT02114216|7536474|FG001|STARTED|Overall Study||45
6611006|NCT02114216|7536475|FG002|STARTED|Overall Study||14
6611007|NCT02114216|7536473|FG000|COMPLETED|Overall Study||16
6611008|NCT02114216|7536474|FG001|COMPLETED|Overall Study||45
6611009|NCT02114216|7536475|FG002|COMPLETED|Overall Study||14
6611010|NCT02114216|7536473|FG000|NOT COMPLETED|Overall Study||0
6611011|NCT02114216|7536474|FG001|NOT COMPLETED|Overall Study||0
6611012|NCT02114216|7536475|FG002|NOT COMPLETED|Overall Study||0
6611013|NCT02114268|7536492|FG000|STARTED|Overall Study||34
6611014|NCT02114268|7536493|FG001|STARTED|Overall Study||6
6611015|NCT02114268|7536494|FG002|STARTED|Overall Study||6
6611016|NCT02114268|7536495|FG003|STARTED|Overall Study||6
6611017|NCT02114268|7536496|FG004|STARTED|Overall Study||6
6611018|NCT02114268|7536497|FG005|STARTED|Overall Study||78
6611019|NCT02114268|7536492|FG000|COMPLETED|Overall Study||28
6611020|NCT02114268|7536493|FG001|COMPLETED|Overall Study||5
6611021|NCT02114268|7536494|FG002|COMPLETED|Overall Study||5
6611022|NCT02114268|7536495|FG003|COMPLETED|Overall Study||6
6611023|NCT02114268|7536496|FG004|COMPLETED|Overall Study||6
6611024|NCT02114268|7536497|FG005|COMPLETED|Overall Study||75
6611025|NCT02114268|7536492|FG000|NOT COMPLETED|Overall Study||6
6611026|NCT02114268|7536493|FG001|NOT COMPLETED|Overall Study||1
6611027|NCT02114268|7536494|FG002|NOT COMPLETED|Overall Study||1
6611028|NCT02114268|7536495|FG003|NOT COMPLETED|Overall Study||0
6611029|NCT02114268|7536496|FG004|NOT COMPLETED|Overall Study||0
6611030|NCT02114268|7536497|FG005|NOT COMPLETED|Overall Study||3
6611031|NCT02114307|7536518|FG000|STARTED|Overall Study||11
6611032|NCT02114307|7536519|FG001|STARTED|Overall Study||11
6611033|NCT02114307|7536518|FG000|COMPLETED|Overall Study||10
6611034|NCT02114307|7536519|FG001|COMPLETED|Overall Study||11
6611035|NCT02114307|7536518|FG000|NOT COMPLETED|Overall Study||1
6611036|NCT02114307|7536519|FG001|NOT COMPLETED|Overall Study||0
6611037|NCT02114385|7536529|FG000|STARTED|Overall Study||249
6611038|NCT02114385|7536530|FG001|STARTED|Overall Study||251
6611039|NCT02114385|7536529|FG000|Vaccinated|Overall Study||249
6611040|NCT02114385|7536530|FG001|Vaccinated|Overall Study||251
6611041|NCT02114385|7536529|FG000|COMPLETED|Overall Study||246
6611042|NCT02114385|7536530|FG001|COMPLETED|Overall Study||243
6611043|NCT02114385|7536529|FG000|NOT COMPLETED|Overall Study||3
6611044|NCT02114385|7536530|FG001|NOT COMPLETED|Overall Study||8
6611045|NCT02114515|7536538|FG000|STARTED|Overall Study||511
6611046|NCT02114515|7536539|FG001|STARTED|Overall Study||518
6611047|NCT02114515|7536538|FG000|COMPLETED|Overall Study||378
6611048|NCT02114515|7536539|FG001|COMPLETED|Overall Study||368
6611049|NCT02114515|7536538|FG000|NOT COMPLETED|Overall Study||133
6611050|NCT02114515|7536539|FG001|NOT COMPLETED|Overall Study||150
6611051|NCT02114606|7536545|FG000|STARTED|Overall Study||86
6611052|NCT02114606|7536545|FG000|COMPLETED|Overall Study||80
6611053|NCT02114606|7536545|FG000|NOT COMPLETED|Overall Study||6
6611054|NCT02114684|7536551|FG000|STARTED|Overall Study||98
6611055|NCT02114684|7536552|FG001|STARTED|Overall Study||98
6611056|NCT02114684|7536551|FG000|COMPLETED|Overall Study||86
6611057|NCT02114684|7536552|FG001|COMPLETED|Overall Study||88
6611058|NCT02114684|7536551|FG000|NOT COMPLETED|Overall Study||12
6611059|NCT02114684|7536552|FG001|NOT COMPLETED|Overall Study||10
6611060|NCT02114814|7536564|FG000|STARTED|Overall Study||103
6611061|NCT02114814|7536565|FG001|STARTED|Overall Study||83
6611062|NCT02114814|7536564|FG000|COMPLETED|Overall Study||88
6611063|NCT02114814|7536565|FG001|COMPLETED|Overall Study||74
6611064|NCT02114814|7536564|FG000|NOT COMPLETED|Overall Study||15
6611065|NCT02114814|7536565|FG001|NOT COMPLETED|Overall Study||9
6611066|NCT02114879|7536577|FG000|STARTED|Overall Study||115
6611067|NCT02114879|7536578|FG001|STARTED|Overall Study||114
6611068|NCT02114879|7536577|FG000|COMPLETED|Overall Study||96
6611069|NCT02114879|7536578|FG001|COMPLETED|Overall Study||90
6611070|NCT02114879|7536577|FG000|NOT COMPLETED|Overall Study||19
6611071|NCT02114879|7536578|FG001|NOT COMPLETED|Overall Study||24
6611072|NCT02114892|7536586|FG000|STARTED|Overall Study||12
6611073|NCT02114892|7536587|FG001|STARTED|Overall Study||12
6611074|NCT02114892|7536586|FG000|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
6611075|NCT02114892|7536587|FG001|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
6611076|NCT02114892|7536586|FG000|NOT COMPLETED|Overall Study||1
6611077|NCT02114892|7536587|FG001|NOT COMPLETED|Overall Study||2
6611078|NCT02114931|7536595|FG000|STARTED|Overall Study||230
6611079|NCT02114931|7536596|FG001|STARTED|Overall Study||237
6611080|NCT02114931|7536595|FG000|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
6611081|NCT02114931|7536596|FG001|Received Treatment|Overall Study||237
6611082|NCT02114931|7536595|FG000|COMPLETED|Overall Study||205
6611083|NCT02114931|7536596|FG001|COMPLETED|Overall Study||207
6611084|NCT02114931|7536595|FG000|NOT COMPLETED|Overall Study||25
6611085|NCT02114931|7536596|FG001|NOT COMPLETED|Overall Study||30
6611086|NCT02115048|7536604|FG000|STARTED|Overall Study||23
6611087|NCT02115048|7536605|FG001|STARTED|Overall Study||21
6611088|NCT02115048|7536604|FG000|COMPLETED|Overall Study||23
6611089|NCT02115048|7536605|FG001|COMPLETED|Overall Study||21
6611090|NCT02115048|7536604|FG000|NOT COMPLETED|Overall Study||0
6611091|NCT02115048|7536605|FG001|NOT COMPLETED|Overall Study||0
6611092|NCT02115113|7536611|FG000|STARTED|Participants in Run-in Period||0
6611093|NCT02115113|7536612|FG001|STARTED|Participants in Run-in Period||0
6611094|NCT02115113|7536613|FG002|STARTED|Participants in Run-in Period||78
6611095|NCT02115113|7536611|FG000|COMPLETED|Participants in Run-in Period||0
6611096|NCT02115113|7536612|FG001|COMPLETED|Participants in Run-in Period||0
6611097|NCT02115113|7536613|FG002|COMPLETED|Participants in Run-in Period||68
6611098|NCT02115113|7536611|FG000|NOT COMPLETED|Participants in Run-in Period||0
6611099|NCT02115113|7536612|FG001|NOT COMPLETED|Participants in Run-in Period||0
6611100|NCT02115113|7536613|FG002|NOT COMPLETED|Participants in Run-in Period||10
6611101|NCT02115113|7536611|FG000|STARTED|Participants Randomized||24
6611102|NCT02115113|7536612|FG001|STARTED|Participants Randomized||26
6611103|NCT02115113|7536613|FG002|STARTED|Participants Randomized||0
6611104|NCT02115113|7536611|FG000|COMPLETED|Participants Randomized||22
6611105|NCT02115113|7536612|FG001|COMPLETED|Participants Randomized||26
6611106|NCT02115113|7536613|FG002|COMPLETED|Participants Randomized||0
6611107|NCT02115113|7536611|FG000|NOT COMPLETED|Participants Randomized||2
6611108|NCT02115113|7536612|FG001|NOT COMPLETED|Participants Randomized||0
6611109|NCT02115113|7536613|FG002|NOT COMPLETED|Participants Randomized||0
6611110|NCT02115139|7536622|FG000|STARTED|Overall Study||58
6611111|NCT02115139|7536622|FG000|COMPLETED|Overall Study||51
6611112|NCT02115139|7536622|FG000|NOT COMPLETED|Overall Study||7
6611113|NCT02115256|7536628|FG000|STARTED|Overall Study||3
6611114|NCT02115256|7536629|FG001|STARTED|Overall Study||3
6611115|NCT02115256|7536628|FG000|COMPLETED|Overall Study||3
6611116|NCT02115256|7536629|FG001|COMPLETED|Overall Study||2
6611117|NCT02115256|7536628|FG000|NOT COMPLETED|Overall Study||0
6611118|NCT02115256|7536629|FG001|NOT COMPLETED|Overall Study||1
6611119|NCT02115269|7536635|FG000|STARTED|Overall Study||759
6611120|NCT02115269|7536635|FG000|COMPLETED|Overall Study||702
6611121|NCT02115269|7536635|FG000|NOT COMPLETED|Overall Study||57
6732587|NCT03196284|7661978|FG002|COMPLETED|Extension Part||22
6732588|NCT03196284|7661976|FG000|NOT COMPLETED|Extension Part||0
6732589|NCT03196284|7661977|FG001|NOT COMPLETED|Extension Part||0
6732590|NCT03196284|7661978|FG002|NOT COMPLETED|Extension Part||3
6732591|NCT03196297|7661998|FG000|STARTED|Main Period||36
6732592|NCT03196297|7661998|FG000|Full Analysis Set (FAS)|Main Period||36
6732593|NCT03196297|7661998|FG000|Subject Analysis Set (SAS)|Main Period||36
6732594|NCT03196297|7661998|FG000|COMPLETED|Main Period||32
6732595|NCT03196297|7661998|FG000|NOT COMPLETED|Main Period||4
6732596|NCT03196297|7661998|FG000|STARTED|Extension Period||32
6732597|NCT03196297|7661998|FG000|FAS|Extension Period||32
6732598|NCT03196297|7661998|FG000|SAS|Extension Period||32
6732599|NCT03196297|7661998|FG000|COMPLETED|Extension Period||29
6732600|NCT03196297|7661998|FG000|NOT COMPLETED|Extension Period||3
6732601|NCT03196349|7662017|FG000|STARTED|Overall Study||17
6732602|NCT03196349|7662018|FG001|STARTED|Overall Study||14
6732603|NCT03196349|7662019|FG002|STARTED|Overall Study||13
6732604|NCT03196349|7662017|FG000|COMPLETED|Overall Study||0
6732605|NCT03196349|7662018|FG001|COMPLETED|Overall Study||0
6732606|NCT03196349|7662019|FG002|COMPLETED|Overall Study||0
6732607|NCT03196349|7662017|FG000|NOT COMPLETED|Overall Study||17
6732608|NCT03196349|7662018|FG001|NOT COMPLETED|Overall Study||14
6732609|NCT03196349|7662019|FG002|NOT COMPLETED|Overall Study||13
6732610|NCT03196505|7662029|FG000|STARTED|Overall Study||115
6732611|NCT03196505|7662030|FG001|STARTED|Overall Study||116
6732612|NCT03196505|7662029|FG000|COMPLETED|Overall Study||89
6732613|NCT03196505|7662030|FG001|COMPLETED|Overall Study||90
6732614|NCT03196505|7662029|FG000|NOT COMPLETED|Overall Study||26
6732615|NCT03196505|7662030|FG001|NOT COMPLETED|Overall Study||26
6732616|NCT03196635|7662036|FG000|STARTED|Overall Study||31
6732617|NCT03196635|7662036|FG000|COMPLETED|Overall Study||30
6732618|NCT03196635|7662036|FG000|NOT COMPLETED|Overall Study||1
6732619|NCT03196791|7662056|FG000|STARTED|Overall Study||98
6732620|NCT03196791|7662057|FG001|STARTED|Overall Study||98
6732621|NCT03196791|7662056|FG000|COMPLETED|Overall Study||88
6732622|NCT03196791|7662057|FG001|COMPLETED|Overall Study||93
6732623|NCT03196791|7662056|FG000|NOT COMPLETED|Overall Study||10
6732624|NCT03196791|7662057|FG001|NOT COMPLETED|Overall Study||5
6732625|NCT03196973|7662066|FG000|STARTED|Overall Study||197
6732626|NCT03196973|7662067|FG001|STARTED|Overall Study||196
6732627|NCT03196973|7662068|FG002|STARTED|Overall Study||100
6732628|NCT03196973|7662066|FG000|COMPLETED|Overall Study||188
6611122|NCT02115282|7536652|FG000|STARTED|Overall Study||305
6611123|NCT02115282|7536653|FG001|STARTED|Overall Study||303
6611124|NCT02115282|7536652|FG000|Eligible|Overall Study||265
6611125|NCT02115282|7536653|FG001|Eligible|Overall Study||257
6611126|NCT02115282|7536652|FG000|Treated|Overall Study||296
6611127|NCT02115282|7536653|FG001|Treated|Overall Study||293
6611128|NCT02115282|7536652|FG000|COMPLETED|Overall Study||0
6611129|NCT02115282|7536653|FG001|COMPLETED|Overall Study||0
6611130|NCT02115282|7536652|FG000|NOT COMPLETED|Overall Study||305
6611131|NCT02115282|7536653|FG001|NOT COMPLETED|Overall Study||303
6611132|NCT02115308|7536663|FG000|STARTED|Overall Study|Number of subjects recruited for the CONTROL group.|15
6611133|NCT02115308|7536664|FG001|STARTED|Overall Study|Number of subjects recruited for the CAD group.|25
6611134|NCT02115308|7536663|FG000|COMPLETED|Overall Study|Number of subjects recruited to the Control group meeting all inclusion criteria.|13
6611135|NCT02115308|7536664|FG001|COMPLETED|Overall Study|Number of subjects recruited to the CAD group meeting all inclusion criteria.|23
6611136|NCT02115308|7536663|FG000|NOT COMPLETED|Overall Study||2
6611137|NCT02115308|7536664|FG001|NOT COMPLETED|Overall Study||2
6611138|NCT02115321|7536676|FG000|STARTED|Overall Study||30
6611139|NCT02115321|7536677|FG001|STARTED|Overall Study||10
6611140|NCT02115321|7536676|FG000|COMPLETED|Overall Study||29
6611141|NCT02115321|7536677|FG001|COMPLETED|Overall Study||10
6611142|NCT02115321|7536676|FG000|NOT COMPLETED|Overall Study||1
6611143|NCT02115321|7536677|FG001|NOT COMPLETED|Overall Study||0
6611144|NCT02115347|7536685|FG000|STARTED|Overall Study||8
6611145|NCT02115347|7536686|FG001|STARTED|Overall Study||8
6611146|NCT02115347|7536687|FG002|STARTED|Overall Study||0
6611147|NCT02115347|7536685|FG000|COMPLETED|Overall Study||8
6611148|NCT02115347|7536686|FG001|COMPLETED|Overall Study||8
6611149|NCT02115347|7536687|FG002|COMPLETED|Overall Study||0
6611150|NCT02115347|7536685|FG000|NOT COMPLETED|Overall Study||0
6611151|NCT02115347|7536686|FG001|NOT COMPLETED|Overall Study||0
6611152|NCT02115347|7536687|FG002|NOT COMPLETED|Overall Study||0
6611153|NCT02115373|7536696|FG000|STARTED|Overall Study||4
6611154|NCT02115373|7536697|FG001|STARTED|Overall Study||13
6611155|NCT02115373|7536698|FG002|STARTED|Overall Study||49
6611156|NCT02115373|7536696|FG000|COMPLETED|Overall Study||4
6611157|NCT02115373|7536697|FG001|COMPLETED|Overall Study||13
6611158|NCT02115373|7536698|FG002|COMPLETED|Overall Study||49
6611159|NCT02115373|7536696|FG000|NOT COMPLETED|Overall Study||0
6611160|NCT02115373|7536697|FG001|NOT COMPLETED|Overall Study||0
6611161|NCT02115373|7536698|FG002|NOT COMPLETED|Overall Study||0
6611162|NCT02115386|7536713|FG000|STARTED|Overall Study||7
6611163|NCT02115386|7536713|FG000|COMPLETED|Overall Study||0
6611164|NCT02115386|7536713|FG000|NOT COMPLETED|Overall Study||7
6611165|NCT02115542|7536717|FG000|STARTED|Overall Study||39
6611166|NCT02115542|7536717|FG000|COMPLETED|Overall Study||39
6611167|NCT02115542|7536717|FG000|NOT COMPLETED|Overall Study||0
6611168|NCT02115581|7536723|FG000|STARTED|Overall Study||17
6611169|NCT02115581|7536724|FG001|STARTED|Overall Study||21
6611170|NCT02115581|7536723|FG000|COMPLETED|Overall Study||17
6611171|NCT02115581|7536724|FG001|COMPLETED|Overall Study||21
6611172|NCT02115581|7536723|FG000|NOT COMPLETED|Overall Study||0
6611173|NCT02115581|7536724|FG001|NOT COMPLETED|Overall Study||0
6611174|NCT02115607|7536730|FG000|STARTED|Overall Study||17
6611175|NCT02115607|7536730|FG000|COMPLETED|Overall Study||16
6611176|NCT02115607|7536730|FG000|NOT COMPLETED|Overall Study||1
6611177|NCT02115633|7536736|FG000|STARTED|Overall Study||15
6611178|NCT02115633|7536737|FG001|STARTED|Overall Study||16
6611179|NCT02115633|7536736|FG000|COMPLETED|Overall Study||15
6611180|NCT02115633|7536737|FG001|COMPLETED|Overall Study||16
6611181|NCT02115633|7536736|FG000|NOT COMPLETED|Overall Study||0
6611182|NCT02115633|7536737|FG001|NOT COMPLETED|Overall Study||0
6611183|NCT02115646|7536746|FG000|STARTED|Overall Study||29
6611184|NCT02115646|7536746|FG000|COMPLETED|Overall Study||22
6611185|NCT02115646|7536746|FG000|NOT COMPLETED|Overall Study||7
6611186|NCT02115750|7536757|FG000|STARTED|Part 1||323
6611187|NCT02115750|7536758|FG001|STARTED|Part 1||324
6611188|NCT02115750|7536757|FG000|COMPLETED|Part 1||301
6611189|NCT02115750|7536758|FG001|COMPLETED|Part 1||312
6611190|NCT02115750|7536757|FG000|NOT COMPLETED|Part 1||22
6611191|NCT02115750|7536758|FG001|NOT COMPLETED|Part 1||12
6611192|NCT02115750|7536757|FG000|STARTED|Part 2: All Subjects Receive CHS-0214||280
6611193|NCT02115750|7536758|FG001|STARTED|Part 2: All Subjects Receive CHS-0214||284
6611194|NCT02115750|7536757|FG000|COMPLETED|Part 2: All Subjects Receive CHS-0214||269
6611195|NCT02115750|7536758|FG001|COMPLETED|Part 2: All Subjects Receive CHS-0214||272
6611196|NCT02115750|7536757|FG000|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||11
6611197|NCT02115750|7536758|FG001|NOT COMPLETED|Part 2: All Subjects Receive CHS-0214||12
6611198|NCT02115815|7536773|FG000|STARTED|Overall Study||24
6611199|NCT02115815|7536774|FG001|STARTED|Overall Study||20
6611200|NCT02115815|7536775|FG002|STARTED|Overall Study||20
6611201|NCT02115815|7536776|FG003|STARTED|Overall Study||20
6611202|NCT02115815|7536777|FG004|STARTED|Overall Study||20
6611203|NCT02115815|7536778|FG005|STARTED|Overall Study||22
6611204|NCT02115815|7536779|FG006|STARTED|Overall Study||20
6611205|NCT02115815|7536773|FG000|COMPLETED|Overall Study||22
6611206|NCT02115815|7536774|FG001|COMPLETED|Overall Study||20
6611207|NCT02115815|7536775|FG002|COMPLETED|Overall Study||20
6611208|NCT02115815|7536776|FG003|COMPLETED|Overall Study||20
6611209|NCT02115815|7536777|FG004|COMPLETED|Overall Study||20
6611210|NCT02115815|7536778|FG005|COMPLETED|Overall Study||20
6611211|NCT02115815|7536779|FG006|COMPLETED|Overall Study||20
6611212|NCT02115815|7536773|FG000|NOT COMPLETED|Overall Study||2
6611213|NCT02115815|7536774|FG001|NOT COMPLETED|Overall Study||0
6611214|NCT02115815|7536775|FG002|NOT COMPLETED|Overall Study||0
6611215|NCT02115815|7536776|FG003|NOT COMPLETED|Overall Study||0
6611216|NCT02115815|7536777|FG004|NOT COMPLETED|Overall Study||0
6611217|NCT02115815|7536778|FG005|NOT COMPLETED|Overall Study||2
6611218|NCT02115815|7536779|FG006|NOT COMPLETED|Overall Study||0
6611219|NCT02115828|7536795|FG000|STARTED|Overall Study||9
6611220|NCT02115828|7536795|FG000|COMPLETED|Overall Study||9
6611221|NCT02115828|7536795|FG000|NOT COMPLETED|Overall Study||0
6611222|NCT02115984|7536801|FG000|STARTED|Overall Study||57
6611223|NCT02115984|7536802|FG001|STARTED|Overall Study||23
6611224|NCT02115984|7536801|FG000|COMPLETED|Overall Study||51
6611225|NCT02115984|7536802|FG001|COMPLETED|Overall Study||16
6611226|NCT02115984|7536801|FG000|NOT COMPLETED|Overall Study||6
6611227|NCT02115984|7536802|FG001|NOT COMPLETED|Overall Study||7
6611228|NCT02116205|7536812|FG000|STARTED|Overall Study||31
6611229|NCT02116205|7536813|FG001|STARTED|Overall Study||33
6611230|NCT02116205|7536814|FG002|STARTED|Overall Study||33
6611231|NCT02116205|7536815|FG003|STARTED|Overall Study||33
6611232|NCT02116205|7536812|FG000|COMPLETED|Overall Study||29
6611233|NCT02116205|7536813|FG001|COMPLETED|Overall Study||26
6611234|NCT02116205|7536814|FG002|COMPLETED|Overall Study||29
6611235|NCT02116205|7536815|FG003|COMPLETED|Overall Study||27
6611236|NCT02116205|7536812|FG000|NOT COMPLETED|Overall Study||2
6611237|NCT02116205|7536813|FG001|NOT COMPLETED|Overall Study||7
6611238|NCT02116205|7536814|FG002|NOT COMPLETED|Overall Study||4
6611239|NCT02116205|7536815|FG003|NOT COMPLETED|Overall Study||6
6611240|NCT02116309|7536827|FG000|STARTED|Overall Study||482
6611241|NCT02116309|7536828|FG001|STARTED|Overall Study||478
6611242|NCT02116309|7536827|FG000|COMPLETED|Overall Study||482
6611243|NCT02116309|7536828|FG001|COMPLETED|Overall Study||477
6611244|NCT02116309|7536827|FG000|NOT COMPLETED|Overall Study||0
6611245|NCT02116309|7536828|FG001|NOT COMPLETED|Overall Study||1
6611246|NCT02116322|7536834|FG000|STARTED|Overall Study||1
6611247|NCT02116322|7536834|FG000|COMPLETED|Overall Study||1
6611248|NCT02116322|7536834|FG000|NOT COMPLETED|Overall Study||0
6611249|NCT02116361|7536842|FG000|STARTED|Overall Study||69
6611250|NCT02116361|7536843|FG001|STARTED|Overall Study||65
6611251|NCT02116361|7536844|FG002|STARTED|Overall Study||59
6611252|NCT02116361|7536845|FG003|STARTED|Overall Study||65
6611253|NCT02116361|7536842|FG000|COMPLETED|Overall Study||38
6611254|NCT02116361|7536843|FG001|COMPLETED|Overall Study||34
6611255|NCT02116361|7536844|FG002|COMPLETED|Overall Study||33
6611256|NCT02116361|7536845|FG003|COMPLETED|Overall Study||34
6611257|NCT02116361|7536842|FG000|NOT COMPLETED|Overall Study||31
6611258|NCT02116361|7536843|FG001|NOT COMPLETED|Overall Study||31
6611259|NCT02116361|7536844|FG002|NOT COMPLETED|Overall Study||26
6611260|NCT02116361|7536845|FG003|NOT COMPLETED|Overall Study||31
6611261|NCT02116530|7536857|FG000|STARTED|Overall Study||192
6611262|NCT02116530|7536858|FG001|STARTED|Overall Study||188
6611263|NCT02116530|7536857|FG000|COMPLETED|Overall Study||183
6611264|NCT02116530|7536858|FG001|COMPLETED|Overall Study||184
6611265|NCT02116530|7536857|FG000|NOT COMPLETED|Overall Study||9
6611266|NCT02116530|7536858|FG001|NOT COMPLETED|Overall Study||4
6611267|NCT02116582|7536864|FG000|STARTED|Overall Study||215
6611268|NCT02116582|7536864|FG000|Treated|Overall Study||214
6611269|NCT02116582|7536864|FG000|COMPLETED|Overall Study||0
6611270|NCT02116582|7536864|FG000|NOT COMPLETED|Overall Study||215
6611271|NCT02116608|7536871|FG000|STARTED|Overall Study||9
6611272|NCT02116608|7536872|FG001|STARTED|Overall Study||9
6611273|NCT02116608|7536873|FG002|STARTED|Overall Study||8
6611274|NCT02116608|7536871|FG000|COMPLETED|Overall Study||9
6611275|NCT02116608|7536872|FG001|COMPLETED|Overall Study||7
6611276|NCT02116608|7536873|FG002|COMPLETED|Overall Study||7
6611277|NCT02116608|7536871|FG000|NOT COMPLETED|Overall Study||0
6611278|NCT02116608|7536872|FG001|NOT COMPLETED|Overall Study||2
6611279|NCT02116608|7536873|FG002|NOT COMPLETED|Overall Study||1
6611280|NCT02116621|7536883|FG000|STARTED|Baseline||108
6611281|NCT02116621|7536884|FG001|STARTED|Baseline||107
6611282|NCT02116621|7536883|FG000|Completed Baseline Visit|Baseline||108
6611283|NCT02116621|7536884|FG001|Completed Baseline Visit|Baseline||103
6611284|NCT02116621|7536883|FG000|Completed Intervention Period|Baseline||95
6611285|NCT02116621|7536884|FG001|Completed Intervention Period|Baseline||103
6611286|NCT02116621|7536883|FG000|COMPLETED|Baseline||108
6611287|NCT02116621|7536884|FG001|COMPLETED|Baseline||103
6611288|NCT02116621|7536883|FG000|NOT COMPLETED|Baseline||0
6611289|NCT02116621|7536884|FG001|NOT COMPLETED|Baseline||4
6611290|NCT02116621|7536883|FG000|STARTED|Three Month Follow-up||108
6611291|NCT02116621|7536884|FG001|STARTED|Three Month Follow-up||103
6611292|NCT02116621|7536883|FG000|COMPLETED|Three Month Follow-up||89
6611293|NCT02116621|7536884|FG001|COMPLETED|Three Month Follow-up||96
6611294|NCT02116621|7536883|FG000|NOT COMPLETED|Three Month Follow-up||19
6611295|NCT02116621|7536884|FG001|NOT COMPLETED|Three Month Follow-up||7
6611296|NCT02116621|7536883|FG000|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up.|103
6611297|NCT02116621|7536884|FG001|STARTED|Six Month Follow-up|Patients who didn't complete 3mo survey but didn't drop from study were contacted for 6mo follow-up|100
6611298|NCT02116621|7536883|FG000|COMPLETED|Six Month Follow-up||99
6611299|NCT02116621|7536884|FG001|COMPLETED|Six Month Follow-up||97
6611300|NCT02116621|7536883|FG000|NOT COMPLETED|Six Month Follow-up||4
6611301|NCT02116621|7536884|FG001|NOT COMPLETED|Six Month Follow-up||3
6611302|NCT02116621|7536883|FG000|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|100
6611303|NCT02116621|7536884|FG001|STARTED|Twelve Month Follow-up|Patients who didn't complete 6mo survey but didn't drop from study were contacted for 12mo follow-up|98
6611304|NCT02116621|7536883|FG000|COMPLETED|Twelve Month Follow-up||84
6611305|NCT02116621|7536884|FG001|COMPLETED|Twelve Month Follow-up||86
6611306|NCT02116621|7536883|FG000|NOT COMPLETED|Twelve Month Follow-up||16
6611307|NCT02116621|7536884|FG001|NOT COMPLETED|Twelve Month Follow-up||12
6611308|NCT02116660|7536892|FG000|STARTED|Overall Study||6
6611309|NCT02116660|7536893|FG001|STARTED|Overall Study||5
6611310|NCT02116660|7536892|FG000|COMPLETED|Overall Study||4
6611311|NCT02116660|7536893|FG001|COMPLETED|Overall Study||1
6611312|NCT02116660|7536892|FG000|NOT COMPLETED|Overall Study||2
6611313|NCT02116660|7536893|FG001|NOT COMPLETED|Overall Study||4
6611314|NCT02116777|7536908|FG000|STARTED|Overall Study||3
6611315|NCT02116777|7536909|FG001|STARTED|Overall Study||3
6611316|NCT02116777|7536910|FG002|STARTED|Overall Study||3
6611317|NCT02116777|7536911|FG003|STARTED|Overall Study||13
6611318|NCT02116777|7536912|FG004|STARTED|Overall Study||6
6611319|NCT02116777|7536913|FG005|STARTED|Overall Study||3
6611320|NCT02116777|7536914|FG006|STARTED|Overall Study||9
6611321|NCT02116777|7536908|FG000|COMPLETED|Overall Study||0
6611322|NCT02116777|7536909|FG001|COMPLETED|Overall Study||0
6611323|NCT02116777|7536910|FG002|COMPLETED|Overall Study||0
6611324|NCT02116777|7536911|FG003|COMPLETED|Overall Study||0
6611325|NCT02116777|7536912|FG004|COMPLETED|Overall Study||0
6611326|NCT02116777|7536913|FG005|COMPLETED|Overall Study||0
6611327|NCT02116777|7536914|FG006|COMPLETED|Overall Study||0
6611328|NCT02116777|7536908|FG000|NOT COMPLETED|Overall Study||3
6611329|NCT02116777|7536909|FG001|NOT COMPLETED|Overall Study||3
6611330|NCT02116777|7536910|FG002|NOT COMPLETED|Overall Study||3
6611331|NCT02116777|7536911|FG003|NOT COMPLETED|Overall Study||13
6611332|NCT02116777|7536912|FG004|NOT COMPLETED|Overall Study||6
6611333|NCT02116777|7536913|FG005|NOT COMPLETED|Overall Study||3
6611334|NCT02116777|7536914|FG006|NOT COMPLETED|Overall Study||9
6611335|NCT02116803|7536935|FG000|STARTED|Overall Study||10
6611336|NCT02116803|7536936|FG001|STARTED|Overall Study||2
6611337|NCT02116803|7536935|FG000|COMPLETED|Overall Study||0
6611338|NCT02116803|7536936|FG001|COMPLETED|Overall Study||0
6611339|NCT02116803|7536935|FG000|NOT COMPLETED|Overall Study||10
6611340|NCT02116803|7536936|FG001|NOT COMPLETED|Overall Study||2
6611341|NCT02116972|7536945|FG000|STARTED|Overall Study||102
6611342|NCT02116972|7536946|FG001|STARTED|Overall Study||104
6611343|NCT02116972|7536947|FG002|STARTED|Overall Study||104
6611344|NCT02116972|7536945|FG000|COMPLETED|Overall Study||83
6611345|NCT02116972|7536946|FG001|COMPLETED|Overall Study||87
6611346|NCT02116972|7536947|FG002|COMPLETED|Overall Study||85
6611347|NCT02116972|7536945|FG000|NOT COMPLETED|Overall Study||19
6611348|NCT02116972|7536946|FG001|NOT COMPLETED|Overall Study||17
6611349|NCT02116972|7536947|FG002|NOT COMPLETED|Overall Study||19
6611350|NCT02117024|7536959|FG000|STARTED|Overall Study||45
6611351|NCT02117024|7536960|FG001|STARTED|Overall Study||21
6611352|NCT02117024|7536959|FG000|COMPLETED|Overall Study||1
6611353|NCT02117024|7536960|FG001|COMPLETED|Overall Study||1
6611354|NCT02117024|7536959|FG000|NOT COMPLETED|Overall Study||44
6611355|NCT02117024|7536960|FG001|NOT COMPLETED|Overall Study||20
6611356|NCT02117193|7536966|FG000|STARTED|Overall Study||10
6611357|NCT02117193|7536966|FG000|Alcohol Intake + Normal Sleep|Overall Study||10
6611358|NCT02117193|7536966|FG000|Placebo Intake + Normal Sleep|Overall Study||10
6611359|NCT02117193|7536966|FG000|Alcohol Intake + Sleep Deprivation|Overall Study||10
6611360|NCT02117193|7536966|FG000|Placebo Intake + Sleep Deprivation|Overall Study||10
6611361|NCT02117193|7536966|FG000|COMPLETED|Overall Study||10
6611362|NCT02117193|7536966|FG000|NOT COMPLETED|Overall Study||0
6611363|NCT02117310|7536985|FG000|STARTED|Overall Study||5
6611364|NCT02117310|7536985|FG000|COMPLETED|Overall Study||5
6611365|NCT02117310|7536985|FG000|NOT COMPLETED|Overall Study||0
6611366|NCT02117349|7536991|FG000|STARTED|Overall Study||37
6611367|NCT02117349|7536992|FG001|STARTED|Overall Study||18
6611368|NCT02117349|7536991|FG000|Intent-to-treat Population|Overall Study||37
6611369|NCT02117349|7536992|FG001|Intent-to-treat Population|Overall Study||18
6611370|NCT02117349|7536991|FG000|Safety Population|Overall Study||36
6611371|NCT02117349|7536992|FG001|Safety Population|Overall Study||18
6611372|NCT02117349|7536991|FG000|Modified Intent-to-treat (mITT)|Overall Study||36
6611373|NCT02117349|7536992|FG001|Modified Intent-to-treat (mITT)|Overall Study||18
6611374|NCT02117349|7536991|FG000|COMPLETED|Overall Study||34
6611375|NCT02117349|7536992|FG001|COMPLETED|Overall Study||17
6611376|NCT02117349|7536991|FG000|NOT COMPLETED|Overall Study||3
6611377|NCT02117349|7536992|FG001|NOT COMPLETED|Overall Study||1
6611378|NCT02117414|7537000|FG000|STARTED|Overall Study|Subjects randomized to the MRI group.|175
6611379|NCT02117414|7537001|FG001|STARTED|Overall Study|Subjects randomized to the Control group.|88
6611380|NCT02117414|7537000|FG000|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
6611381|NCT02117414|7537001|FG001|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
6611382|NCT02117414|7537000|FG000|NOT COMPLETED|Overall Study||15
6611383|NCT02117414|7537001|FG001|NOT COMPLETED|Overall Study||6
6611384|NCT02117427|7537012|FG000|STARTED|Overall Study||6
6611385|NCT02117427|7537013|FG001|STARTED|Overall Study||5
6611386|NCT02117427|7537014|FG002|STARTED|Overall Study||0
6611387|NCT02117427|7537012|FG000|Run in Phase & Harvest|Overall Study||6
6611388|NCT02117427|7537013|FG001|Run in Phase & Harvest|Overall Study||4
6611389|NCT02117427|7537014|FG002|Run in Phase & Harvest|Overall Study||0
6611390|NCT02117427|7537012|FG000|Implantation & Efficacy|Overall Study||6
6611391|NCT02117427|7537013|FG001|Implantation & Efficacy|Overall Study||4
6611392|NCT02117427|7537014|FG002|Implantation & Efficacy|Overall Study||0
6611393|NCT02117427|7537012|FG000|Safety Follow-up|Overall Study||1
6611394|NCT02117427|7537013|FG001|Safety Follow-up|Overall Study||0
6611395|NCT02117427|7537014|FG002|Safety Follow-up|Overall Study||0
6611396|NCT02117427|7537012|FG000|Long Term Safety Follow-up|Overall Study||1
6611397|NCT02117427|7537013|FG001|Long Term Safety Follow-up|Overall Study||0
6611398|NCT02117427|7537014|FG002|Long Term Safety Follow-up|Overall Study||0
6611399|NCT02117427|7537012|FG000|COMPLETED|Overall Study||1
6611400|NCT02117427|7537013|FG001|COMPLETED|Overall Study||0
6611401|NCT02117427|7537014|FG002|COMPLETED|Overall Study||0
6611402|NCT02117427|7537012|FG000|NOT COMPLETED|Overall Study||5
6611403|NCT02117427|7537013|FG001|NOT COMPLETED|Overall Study||5
6611404|NCT02117427|7537014|FG002|NOT COMPLETED|Overall Study||0
6611405|NCT02117479|7537022|FG000|STARTED|Overall Study||161
6611406|NCT02117479|7537023|FG001|STARTED|Overall Study||160
6611407|NCT02117479|7537022|FG000|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
6611408|NCT02117479|7537023|FG001|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
6611409|NCT02117479|7537022|FG000|NOT COMPLETED|Overall Study||156
6611410|NCT02117479|7537023|FG001|NOT COMPLETED|Overall Study||156
6611411|NCT02117544|7537029|FG000|STARTED|Period 1||54
6611412|NCT02117544|7537030|FG001|STARTED|Period 1||55
6611413|NCT02117544|7537029|FG000|Treated|Period 1||52
6611414|NCT02117544|7537030|FG001|Treated|Period 1||55
6611415|NCT02117544|7537029|FG000|COMPLETED|Period 1||52
6611416|NCT02117544|7537030|FG001|COMPLETED|Period 1||55
6611417|NCT02117544|7537029|FG000|NOT COMPLETED|Period 1||2
6611418|NCT02117544|7537030|FG001|NOT COMPLETED|Period 1||0
6611419|NCT02117544|7537029|FG000|STARTED|Period 2||52
6611420|NCT02117544|7537030|FG001|STARTED|Period 2||55
6611421|NCT02117544|7537029|FG000|COMPLETED|Period 2||52
6611422|NCT02117544|7537030|FG001|COMPLETED|Period 2||55
6611423|NCT02117544|7537029|FG000|NOT COMPLETED|Period 2||0
6611424|NCT02117544|7537030|FG001|NOT COMPLETED|Period 2||0
6611425|NCT02117570|7537040|FG000|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
6611426|NCT02117570|7537041|FG001|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
6611427|NCT02117570|7537042|FG002|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
6611428|NCT02117570|7537040|FG000|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
6611429|NCT02117570|7537041|FG001|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
6611430|NCT02117570|7537042|FG002|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
6611431|NCT02117570|7537040|FG000|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
6611432|NCT02117570|7537041|FG001|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
6611433|NCT02117570|7537042|FG002|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
6611434|NCT02117570|7537040|FG000|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
6611435|NCT02117570|7537041|FG001|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
6611436|NCT02117570|7537042|FG002|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
6611437|NCT02117570|7537040|FG000|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
6611438|NCT02117570|7537041|FG001|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
6611439|NCT02117570|7537042|FG002|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
6611440|NCT02117570|7537040|FG000|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
6611441|NCT02117570|7537041|FG001|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
6611442|NCT02117570|7537042|FG002|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
6611443|NCT02117570|7537040|FG000|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
6611444|NCT02117570|7537041|FG001|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
6611445|NCT02117570|7537042|FG002|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
6611446|NCT02117570|7537040|FG000|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
6611447|NCT02117570|7537041|FG001|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
6611448|NCT02117570|7537042|FG002|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
6611449|NCT02117570|7537040|FG000|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
6611450|NCT02117570|7537041|FG001|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
6611451|NCT02117570|7537042|FG002|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
6611452|NCT02117570|7537040|FG000|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
6611453|NCT02117570|7537041|FG001|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
6611454|NCT02117570|7537042|FG002|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
6611455|NCT02117570|7537040|FG000|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
6611456|NCT02117570|7537041|FG001|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
6611457|NCT02117570|7537042|FG002|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
6611458|NCT02117570|7537040|FG000|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
6611459|NCT02117570|7537041|FG001|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
6611460|NCT02117570|7537042|FG002|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
6611461|NCT02117648|7537053|FG000|STARTED|Abemaciclib Alone Period 1||26
6611462|NCT02117648|7537053|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib Alone Period 1||26
6611463|NCT02117648|7537053|FG000|COMPLETED|Abemaciclib Alone Period 1||24
6611464|NCT02117648|7537053|FG000|NOT COMPLETED|Abemaciclib Alone Period 1||2
6611465|NCT02117648|7537053|FG000|STARTED|Abemaciclib + Clarithromycin Period 2||24
6611466|NCT02117648|7537053|FG000|Received at Least 1 Dose of Study Drug|Abemaciclib + Clarithromycin Period 2||21
6611467|NCT02117648|7537053|FG000|COMPLETED|Abemaciclib + Clarithromycin Period 2||20
6611468|NCT02117648|7537053|FG000|NOT COMPLETED|Abemaciclib + Clarithromycin Period 2||4
6611469|NCT02117648|7537053|FG000|STARTED|Abemaciclib Safety-Extension Phase||20
6611470|NCT02117648|7537053|FG000|COMPLETED|Abemaciclib Safety-Extension Phase||0
6611471|NCT02117648|7537053|FG000|NOT COMPLETED|Abemaciclib Safety-Extension Phase||20
6611472|NCT02117687|7537063|FG000|STARTED|Overall Study||40
6611473|NCT02117687|7537064|FG001|STARTED|Overall Study||40
6611474|NCT02117687|7537063|FG000|COMPLETED|Overall Study||39
6611475|NCT02117687|7537064|FG001|COMPLETED|Overall Study||36
6611476|NCT02117687|7537063|FG000|NOT COMPLETED|Overall Study||1
6611477|NCT02117687|7537064|FG001|NOT COMPLETED|Overall Study||4
6611478|NCT02117713|7537070|FG000|STARTED|Week 48||34
6611479|NCT02117713|7537070|FG000|COMPLETED|Week 48||26
6611480|NCT02117713|7537070|FG000|NOT COMPLETED|Week 48||8
6611481|NCT02117713|7537070|FG000|STARTED|Long Term Follow-up Treatment||26
6611482|NCT02117713|7537070|FG000|COMPLETED|Long Term Follow-up Treatment||20
6611483|NCT02117713|7537070|FG000|NOT COMPLETED|Long Term Follow-up Treatment||6
6611484|NCT02117934|7537084|FG000|STARTED|Overall Study||5592
6611485|NCT02117934|7537085|FG001|STARTED|Overall Study||2782
6611486|NCT02117934|7537084|FG000|COMPLETED|Overall Study||5092
6611487|NCT02117934|7537085|FG001|COMPLETED|Overall Study||2567
6611488|NCT02117934|7537084|FG000|NOT COMPLETED|Overall Study||500
6611489|NCT02117934|7537085|FG001|NOT COMPLETED|Overall Study||215
6611490|NCT02117999|7537093|FG000|STARTED|Overall Study||20
6611491|NCT02117999|7537094|FG001|STARTED|Overall Study||10
6611492|NCT02117999|7537093|FG000|Mean Kmax Change in Corneal Topography|Overall Study||20
6611493|NCT02117999|7537094|FG001|Mean Kmax Change in Corneal Topography|Overall Study||10
6611494|NCT02117999|7537093|FG000|COMPLETED|Overall Study||20
6611495|NCT02117999|7537094|FG001|COMPLETED|Overall Study||10
6611496|NCT02117999|7537093|FG000|NOT COMPLETED|Overall Study||0
6611497|NCT02117999|7537094|FG001|NOT COMPLETED|Overall Study||0
6611498|NCT02118012|7537104|FG000|STARTED|Overall Study||12
6611499|NCT02118012|7537105|FG001|STARTED|Overall Study||12
6611500|NCT02118012|7537104|FG000|Day 5|Overall Study||12
6611501|NCT02118012|7537105|FG001|Day 5|Overall Study||11
6611502|NCT02118012|7537104|FG000|Day 14|Overall Study||12
6611503|NCT02118012|7537105|FG001|Day 14|Overall Study||10
6611504|NCT02118012|7537104|FG000|COMPLETED|Overall Study||12
6611505|NCT02118012|7537105|FG001|COMPLETED|Overall Study||10
6611506|NCT02118012|7537104|FG000|NOT COMPLETED|Overall Study||0
6611507|NCT02118012|7537105|FG001|NOT COMPLETED|Overall Study||2
6611508|NCT02118337|7537120|FG000|STARTED|Overall Study||4
6611509|NCT02118337|7537121|FG001|STARTED|Overall Study||5
6611510|NCT02118337|7537122|FG002|STARTED|Overall Study||3
6611511|NCT02118337|7537123|FG003|STARTED|Overall Study||3
6611512|NCT02118337|7537124|FG004|STARTED|Overall Study||9
6611513|NCT02118337|7537125|FG005|STARTED|Overall Study||6
6611514|NCT02118337|7537126|FG006|STARTED|Overall Study||4
6611515|NCT02118337|7537127|FG007|STARTED|Overall Study||42
6611516|NCT02118337|7537128|FG008|STARTED|Overall Study||21
6611517|NCT02118337|7537120|FG000|COMPLETED|Overall Study||0
6611518|NCT02118337|7537121|FG001|COMPLETED|Overall Study||0
6611519|NCT02118337|7537122|FG002|COMPLETED|Overall Study||0
6611520|NCT02118337|7537123|FG003|COMPLETED|Overall Study||0
6611521|NCT02118337|7537124|FG004|COMPLETED|Overall Study||0
6611522|NCT02118337|7537125|FG005|COMPLETED|Overall Study||0
6611523|NCT02118337|7537126|FG006|COMPLETED|Overall Study||0
6611524|NCT02118337|7537127|FG007|COMPLETED|Overall Study||0
6611525|NCT02118337|7537128|FG008|COMPLETED|Overall Study||0
6611526|NCT02118337|7537120|FG000|NOT COMPLETED|Overall Study||4
6611527|NCT02118337|7537121|FG001|NOT COMPLETED|Overall Study||5
6611528|NCT02118337|7537122|FG002|NOT COMPLETED|Overall Study||3
6611529|NCT02118337|7537123|FG003|NOT COMPLETED|Overall Study||3
6611530|NCT02118337|7537124|FG004|NOT COMPLETED|Overall Study||9
6611531|NCT02118337|7537125|FG005|NOT COMPLETED|Overall Study||6
6611532|NCT02118337|7537126|FG006|NOT COMPLETED|Overall Study||4
6611533|NCT02118337|7537127|FG007|NOT COMPLETED|Overall Study||42
6611534|NCT02118337|7537128|FG008|NOT COMPLETED|Overall Study||21
6611535|NCT02118428|7537154|FG000|STARTED|Overall Study||113
6611536|NCT02118428|7537155|FG001|STARTED|Overall Study||113
6611537|NCT02118428|7537156|FG002|STARTED|Overall Study||1
6611538|NCT02118428|7537154|FG000|Received Study Transfusion|Overall Study||111
6611539|NCT02118428|7537155|FG001|Received Study Transfusion|Overall Study||112
6611540|NCT02118428|7537156|FG002|Received Study Transfusion|Overall Study||0
6611541|NCT02118428|7537154|FG000|COMPLETED|Overall Study||100
6611542|NCT02118428|7537155|FG001|COMPLETED|Overall Study||104
6611543|NCT02118428|7537156|FG002|COMPLETED|Overall Study||0
6611544|NCT02118428|7537154|FG000|NOT COMPLETED|Overall Study||13
6611545|NCT02118428|7537155|FG001|NOT COMPLETED|Overall Study||9
6611546|NCT02118428|7537156|FG002|NOT COMPLETED|Overall Study||1
6611547|NCT02118441|7537164|FG000|STARTED|Overall Study||65
6611548|NCT02118441|7537165|FG001|STARTED|Overall Study||64
6611549|NCT02118441|7537164|FG000|COMPLETED|Overall Study||62
6611550|NCT02118441|7537165|FG001|COMPLETED|Overall Study||63
6611551|NCT02118441|7537164|FG000|NOT COMPLETED|Overall Study||3
6611552|NCT02118441|7537165|FG001|NOT COMPLETED|Overall Study||1
6611553|NCT02118597|7537172|FG000|STARTED|Overall Study||19
6611554|NCT02118597|7537172|FG000|COMPLETED|Overall Study||3
6611555|NCT02118597|7537172|FG000|NOT COMPLETED|Overall Study||16
6611556|NCT02118714|7537176|FG000|STARTED|Overall Study||20
6611557|NCT02118714|7537176|FG000|COMPLETED|Overall Study||17
6611558|NCT02118714|7537176|FG000|NOT COMPLETED|Overall Study||3
6611559|NCT02118766|7537182|FG000|STARTED|Overall Study||507
6611560|NCT02118766|7537183|FG001|STARTED|Overall Study||256
6611561|NCT02118766|7537182|FG000|Treated|Overall Study||503
6611562|NCT02118766|7537183|FG001|Treated|Overall Study||256
6611563|NCT02118766|7537182|FG000|COMPLETED|Overall Study||477
6611564|NCT02118766|7537183|FG001|COMPLETED|Overall Study||225
6611565|NCT02118766|7537182|FG000|NOT COMPLETED|Overall Study||30
6611566|NCT02118766|7537183|FG001|NOT COMPLETED|Overall Study||31
6611567|NCT02118792|7537191|FG000|STARTED|Overall Study||514
6611568|NCT02118792|7537192|FG001|STARTED|Overall Study||250
6611569|NCT02118792|7537191|FG000|Treated|Overall Study||513
6611570|NCT02118792|7537192|FG001|Treated|Overall Study||250
6611571|NCT02118792|7537191|FG000|COMPLETED|Overall Study||483
6611572|NCT02118792|7537192|FG001|COMPLETED|Overall Study||213
6611573|NCT02118792|7537191|FG000|NOT COMPLETED|Overall Study||31
6611574|NCT02118792|7537192|FG001|NOT COMPLETED|Overall Study||37
6611575|NCT02118831|7537203|FG000|STARTED|Overall Study||21
6611576|NCT02118831|7537204|FG001|STARTED|Overall Study||15
6611577|NCT02118831|7537205|FG002|STARTED|Overall Study||20
6611578|NCT02118831|7537203|FG000|COMPLETED|Overall Study||21
6611579|NCT02118831|7537204|FG001|COMPLETED|Overall Study||15
6611580|NCT02118831|7537205|FG002|COMPLETED|Overall Study||20
6611581|NCT02118831|7537203|FG000|NOT COMPLETED|Overall Study||0
6611582|NCT02118831|7537204|FG001|NOT COMPLETED|Overall Study||0
6611583|NCT02118831|7537205|FG002|NOT COMPLETED|Overall Study||0
6611584|NCT02118896|7537223|FG000|STARTED|Overall Study||47
6611585|NCT02118896|7537224|FG001|STARTED|Overall Study||47
6611586|NCT02118896|7537225|FG002|STARTED|Overall Study||67
6611587|NCT02118896|7537226|FG003|STARTED|Overall Study||79
6611588|NCT02118896|7537227|FG004|STARTED|Overall Study||130
6611589|NCT02118896|7537228|FG005|STARTED|Overall Study||191
6611590|NCT02118896|7537229|FG006|STARTED|Overall Study||85
6611591|NCT02118896|7537230|FG007|STARTED|Overall Study||107
6611592|NCT02118896|7537231|FG008|STARTED|Overall Study||88
6611593|NCT02118896|7537232|FG009|STARTED|Overall Study||9
6611594|NCT02118896|7537223|FG000|COMPLETED|Overall Study||30
6611595|NCT02118896|7537224|FG001|COMPLETED|Overall Study||32
6611596|NCT02118896|7537225|FG002|COMPLETED|Overall Study||53
6611597|NCT02118896|7537226|FG003|COMPLETED|Overall Study||55
6611598|NCT02118896|7537227|FG004|COMPLETED|Overall Study||113
6611599|NCT02118896|7537228|FG005|COMPLETED|Overall Study||163
6611600|NCT02118896|7537229|FG006|COMPLETED|Overall Study||83
6611601|NCT02118896|7537230|FG007|COMPLETED|Overall Study||105
6611602|NCT02118896|7537231|FG008|COMPLETED|Overall Study||84
6611603|NCT02118896|7537232|FG009|COMPLETED|Overall Study||7
6611604|NCT02118896|7537223|FG000|NOT COMPLETED|Overall Study||17
6611605|NCT02118896|7537224|FG001|NOT COMPLETED|Overall Study||15
6611606|NCT02118896|7537225|FG002|NOT COMPLETED|Overall Study||14
6611607|NCT02118896|7537226|FG003|NOT COMPLETED|Overall Study||24
6611608|NCT02118896|7537227|FG004|NOT COMPLETED|Overall Study||17
6611609|NCT02118896|7537228|FG005|NOT COMPLETED|Overall Study||28
6611610|NCT02118896|7537229|FG006|NOT COMPLETED|Overall Study||2
6611611|NCT02118896|7537230|FG007|NOT COMPLETED|Overall Study||2
6611612|NCT02118896|7537231|FG008|NOT COMPLETED|Overall Study||4
6611613|NCT02118896|7537232|FG009|NOT COMPLETED|Overall Study||2
6611614|NCT02118961|7537257|FG000|STARTED|Overall Study||224
6611615|NCT02118961|7537258|FG001|STARTED|Overall Study||222
6611616|NCT02118961|7537257|FG000|COMPLETED|Overall Study||223
6611617|NCT02118961|7537258|FG001|COMPLETED|Overall Study||222
6611618|NCT02118961|7537257|FG000|NOT COMPLETED|Overall Study||1
6611619|NCT02118961|7537258|FG001|NOT COMPLETED|Overall Study||0
6611620|NCT02119026|7537266|FG000|STARTED|1st-line Treatment||58
6611621|NCT02119026|7537267|FG001|STARTED|1st-line Treatment||62
6611622|NCT02119026|7537266|FG000|COMPLETED|1st-line Treatment||32
6611623|NCT02119026|7537267|FG001|COMPLETED|1st-line Treatment||24
6732629|NCT03196973|7662067|FG001|COMPLETED|Overall Study||184
6732630|NCT03196973|7662068|FG002|COMPLETED|Overall Study||95
6732631|NCT03196973|7662066|FG000|NOT COMPLETED|Overall Study||9
6732632|NCT03196973|7662067|FG001|NOT COMPLETED|Overall Study||12
6732633|NCT03196973|7662068|FG002|NOT COMPLETED|Overall Study||5
6732634|NCT03197025|7662076|FG000|STARTED|Overall Study||1
6732635|NCT03197025|7662076|FG000|COMPLETED|Overall Study||1
6732636|NCT03197025|7662076|FG000|NOT COMPLETED|Overall Study||0
6732637|NCT03197038|7662082|FG000|STARTED|Overall Study||22
6732638|NCT03197038|7662083|FG001|STARTED|Overall Study||17
6732639|NCT03197038|7662082|FG000|COMPLETED|Overall Study||18
6732640|NCT03197038|7662083|FG001|COMPLETED|Overall Study||17
6611624|NCT02119026|7537266|FG000|NOT COMPLETED|1st-line Treatment||26
6611625|NCT02119026|7537267|FG001|NOT COMPLETED|1st-line Treatment||38
6611626|NCT02119026|7537266|FG000|STARTED|2nd-line Treatment||32
6611627|NCT02119026|7537267|FG001|STARTED|2nd-line Treatment||24
6611628|NCT02119026|7537266|FG000|COMPLETED|2nd-line Treatment||23
6611629|NCT02119026|7537267|FG001|COMPLETED|2nd-line Treatment||22
6611630|NCT02119026|7537266|FG000|NOT COMPLETED|2nd-line Treatment||9
6611631|NCT02119026|7537267|FG001|NOT COMPLETED|2nd-line Treatment||2
6611632|NCT02119104|7537273|FG000|STARTED|Overall Study||1087
6611633|NCT02119104|7537273|FG000|COMPLETED|Overall Study||1071
6611634|NCT02119104|7537273|FG000|NOT COMPLETED|Overall Study||16
6611635|NCT02119156|7537280|FG000|STARTED|Treatment Phase (Up to 52 Weeks)||39
6611636|NCT02119156|7537281|FG001|STARTED|Treatment Phase (Up to 52 Weeks)||29
6611637|NCT02119156|7537282|FG002|STARTED|Treatment Phase (Up to 52 Weeks)||12
6611638|NCT02119156|7537280|FG000|COMPLETED|Treatment Phase (Up to 52 Weeks)||33
6611639|NCT02119156|7537281|FG001|COMPLETED|Treatment Phase (Up to 52 Weeks)||27
6611640|NCT02119156|7537282|FG002|COMPLETED|Treatment Phase (Up to 52 Weeks)||11
6611641|NCT02119156|7537280|FG000|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||6
6611642|NCT02119156|7537281|FG001|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||2
6611643|NCT02119156|7537282|FG002|NOT COMPLETED|Treatment Phase (Up to 52 Weeks)||1
6611644|NCT02119156|7537280|FG000|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Long-term discontinuation participants were not allowed in Maintenance period|0
6611645|NCT02119156|7537281|FG001|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|16
6611646|NCT02119156|7537282|FG002|STARTED|Maintenance (Up to 48 Weeks of Year 2-4)|Eligible participants of Treatment control and holiday group on completion of 52-weeks were included|10
6611647|NCT02119156|7537280|FG000|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
6611648|NCT02119156|7537281|FG001|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||6
6611649|NCT02119156|7537282|FG002|COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||3
6611650|NCT02119156|7537280|FG000|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||0
6611651|NCT02119156|7537281|FG001|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||10
6611652|NCT02119156|7537282|FG002|NOT COMPLETED|Maintenance (Up to 48 Weeks of Year 2-4)||7
6611653|NCT02119260|7537304|FG000|STARTED|Overall Study||9
6611654|NCT02119260|7537305|FG001|STARTED|Overall Study||12
6611655|NCT02119260|7537306|FG002|STARTED|Overall Study||8
6611656|NCT02119260|7537307|FG003|STARTED|Overall Study||10
6611657|NCT02119260|7537308|FG004|STARTED|Overall Study||13
6611658|NCT02119260|7537309|FG005|STARTED|Overall Study||6
6611659|NCT02119260|7537310|FG006|STARTED|Overall Study||2
6611660|NCT02119260|7537304|FG000|COMPLETED|Overall Study||8
6611661|NCT02119260|7537305|FG001|COMPLETED|Overall Study||11
6611662|NCT02119260|7537306|FG002|COMPLETED|Overall Study||7
6611663|NCT02119260|7537307|FG003|COMPLETED|Overall Study||10
6611664|NCT02119260|7537308|FG004|COMPLETED|Overall Study||13
6611665|NCT02119260|7537309|FG005|COMPLETED|Overall Study||6
6611666|NCT02119260|7537310|FG006|COMPLETED|Overall Study||2
6611667|NCT02119260|7537304|FG000|NOT COMPLETED|Overall Study||1
6611668|NCT02119260|7537305|FG001|NOT COMPLETED|Overall Study||1
6611669|NCT02119260|7537306|FG002|NOT COMPLETED|Overall Study||1
6611670|NCT02119260|7537307|FG003|NOT COMPLETED|Overall Study||0
6611671|NCT02119260|7537308|FG004|NOT COMPLETED|Overall Study||0
6611672|NCT02119260|7537309|FG005|NOT COMPLETED|Overall Study||0
6611673|NCT02119260|7537310|FG006|NOT COMPLETED|Overall Study||0
6611674|NCT02119286|7537338|FG000|STARTED|Overall Study||206
6611675|NCT02119286|7537339|FG001|STARTED|Overall Study||206
6611676|NCT02119286|7537340|FG002|STARTED|Overall Study||207
6611677|NCT02119286|7537338|FG000|COMPLETED|Overall Study||180
6611678|NCT02119286|7537339|FG001|COMPLETED|Overall Study||195
6611679|NCT02119286|7537340|FG002|COMPLETED|Overall Study||200
6611680|NCT02119286|7537338|FG000|NOT COMPLETED|Overall Study||26
6611681|NCT02119286|7537339|FG001|NOT COMPLETED|Overall Study||11
6611682|NCT02119286|7537340|FG002|NOT COMPLETED|Overall Study||7
6611683|NCT02119299|7537348|FG000|STARTED|Overall Study||76
6611684|NCT02119299|7537348|FG000|COMPLETED|Overall Study||67
6611685|NCT02119299|7537348|FG000|NOT COMPLETED|Overall Study||9
6611686|NCT02119325|7537352|FG000|STARTED|Period 1||48
6611687|NCT02119325|7537353|FG001|STARTED|Period 1||48
6611688|NCT02119325|7537352|FG000|COMPLETED|Period 1||48
6611689|NCT02119325|7537353|FG001|COMPLETED|Period 1||48
6611690|NCT02119325|7537352|FG000|NOT COMPLETED|Period 1||0
6611691|NCT02119325|7537353|FG001|NOT COMPLETED|Period 1||0
6611692|NCT02119325|7537352|FG000|STARTED|Washout Period 1||48
6611693|NCT02119325|7537353|FG001|STARTED|Washout Period 1||48
6611694|NCT02119325|7537352|FG000|COMPLETED|Washout Period 1||48
6611695|NCT02119325|7537353|FG001|COMPLETED|Washout Period 1||47
6611696|NCT02119325|7537352|FG000|NOT COMPLETED|Washout Period 1||0
6611697|NCT02119325|7537353|FG001|NOT COMPLETED|Washout Period 1||1
6611698|NCT02119325|7537352|FG000|STARTED|Period 2||48
6611699|NCT02119325|7537353|FG001|STARTED|Period 2||47
6611700|NCT02119325|7537352|FG000|COMPLETED|Period 2||48
6611701|NCT02119325|7537353|FG001|COMPLETED|Period 2||47
6611702|NCT02119325|7537352|FG000|NOT COMPLETED|Period 2||0
6611703|NCT02119325|7537353|FG001|NOT COMPLETED|Period 2||0
6611704|NCT02119442|7537361|FG000|STARTED|Overall Study||90
6611705|NCT02119442|7537361|FG000|COMPLETED|Overall Study||90
6611706|NCT02119442|7537361|FG000|NOT COMPLETED|Overall Study||0
6611707|NCT02119455|7537367|FG000|STARTED|Overall Study||20
6611708|NCT02119455|7537368|FG001|STARTED|Overall Study||20
6611709|NCT02119455|7537367|FG000|COMPLETED|Overall Study||20
6611710|NCT02119455|7537368|FG001|COMPLETED|Overall Study||17
6611711|NCT02119455|7537367|FG000|NOT COMPLETED|Overall Study||0
6611712|NCT02119455|7537368|FG001|NOT COMPLETED|Overall Study||3
6611713|NCT02119650|7537376|FG000|STARTED|Overall Study||39
6611714|NCT02119650|7537377|FG001|STARTED|Overall Study||37
6611715|NCT02119650|7537376|FG000|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
6611716|NCT02119650|7537377|FG001|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
6611717|NCT02119650|7537376|FG000|NOT COMPLETED|Overall Study||25
6611718|NCT02119650|7537377|FG001|NOT COMPLETED|Overall Study||26
6611719|NCT02119663|7537385|FG000|STARTED|Overall Study||43
6611720|NCT02119663|7537386|FG001|STARTED|Overall Study||43
6611721|NCT02119663|7537385|FG000|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
6611722|NCT02119663|7537386|FG001|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
6611723|NCT02119663|7537385|FG000|NOT COMPLETED|Overall Study||40
6611724|NCT02119663|7537386|FG001|NOT COMPLETED|Overall Study||41
6611725|NCT02119676|7537396|FG000|STARTED|Overall Study||87
6611726|NCT02119676|7537397|FG001|STARTED|Overall Study||88
6611727|NCT02119676|7537398|FG002|STARTED|Overall Study||110
6611728|NCT02119676|7537399|FG003|STARTED|Overall Study||111
6611729|NCT02119676|7537396|FG000|Treated Patients|Overall Study||85
6611730|NCT02119676|7537397|FG001|Treated Patients|Overall Study||86
6611731|NCT02119676|7537398|FG002|Treated Patients|Overall Study||106
6611732|NCT02119676|7537399|FG003|Treated Patients|Overall Study||106
6611733|NCT02119676|7537396|FG000|COMPLETED|Overall Study||4
6611734|NCT02119676|7537397|FG001|COMPLETED|Overall Study||2
6611735|NCT02119676|7537398|FG002|COMPLETED|Overall Study||13
6611736|NCT02119676|7537399|FG003|COMPLETED|Overall Study||10
6611737|NCT02119676|7537396|FG000|NOT COMPLETED|Overall Study||83
6611738|NCT02119676|7537397|FG001|NOT COMPLETED|Overall Study||86
6611739|NCT02119676|7537398|FG002|NOT COMPLETED|Overall Study||97
6611740|NCT02119676|7537399|FG003|NOT COMPLETED|Overall Study||101
6611741|NCT02119819|7537415|FG000|STARTED|Overall Study||66
6611742|NCT02119819|7537416|FG001|STARTED|Overall Study||71
6611743|NCT02119819|7537417|FG002|STARTED|Overall Study||73
6611744|NCT02119819|7537418|FG003|STARTED|Overall Study||70
6611745|NCT02119819|7537419|FG004|STARTED|Overall Study||69
6611746|NCT02119819|7537420|FG005|STARTED|Overall Study||71
6611747|NCT02119819|7537415|FG000|COMPLETED|Overall Study||57
6611748|NCT02119819|7537416|FG001|COMPLETED|Overall Study||66
6611749|NCT02119819|7537417|FG002|COMPLETED|Overall Study||69
6611750|NCT02119819|7537418|FG003|COMPLETED|Overall Study||63
6611751|NCT02119819|7537419|FG004|COMPLETED|Overall Study||62
6611752|NCT02119819|7537420|FG005|COMPLETED|Overall Study||56
6611753|NCT02119819|7537415|FG000|NOT COMPLETED|Overall Study||9
6611754|NCT02119819|7537416|FG001|NOT COMPLETED|Overall Study||5
6611755|NCT02119819|7537417|FG002|NOT COMPLETED|Overall Study||4
6611756|NCT02119819|7537418|FG003|NOT COMPLETED|Overall Study||7
6611757|NCT02119819|7537419|FG004|NOT COMPLETED|Overall Study||7
6611758|NCT02119819|7537420|FG005|NOT COMPLETED|Overall Study||15
6611759|NCT02119871|7537436|FG000|STARTED|Overall Study||10
6611760|NCT02119871|7537437|FG001|STARTED|Overall Study||10
6611761|NCT02119871|7537436|FG000|COMPLETED|Overall Study||10
6611762|NCT02119871|7537437|FG001|COMPLETED|Overall Study||10
6611763|NCT02119871|7537436|FG000|NOT COMPLETED|Overall Study||0
6611764|NCT02119871|7537437|FG001|NOT COMPLETED|Overall Study||0
6611765|NCT02119936|7537443|FG000|STARTED|Overall Study||10
6611766|NCT02119936|7537443|FG000|COMPLETED|Overall Study||0
6611767|NCT02119936|7537443|FG000|NOT COMPLETED|Overall Study||10
6611768|NCT02120001|7537449|FG000|STARTED|Overall Study||17
6611769|NCT02120001|7537450|FG001|STARTED|Overall Study||19
6611770|NCT02120001|7537449|FG000|COMPLETED|Overall Study||17
6611771|NCT02120001|7537450|FG001|COMPLETED|Overall Study||19
6611772|NCT02120001|7537449|FG000|NOT COMPLETED|Overall Study||0
6611773|NCT02120001|7537450|FG001|NOT COMPLETED|Overall Study||0
6611774|NCT02120027|7537458|FG000|STARTED|Overall Study||277
6611775|NCT02120027|7537459|FG001|STARTED|Overall Study||279
6611776|NCT02120027|7537458|FG000|COMPLETED|Overall Study||161
6611777|NCT02120027|7537459|FG001|COMPLETED|Overall Study||160
6611778|NCT02120027|7537458|FG000|NOT COMPLETED|Overall Study||116
6611779|NCT02120027|7537459|FG001|NOT COMPLETED|Overall Study||119
6611780|NCT02120157|7537465|FG000|STARTED|Overall Study||32
6611781|NCT02120157|7537465|FG000|Completed 180 Days|Overall Study||30
6611782|NCT02120157|7537465|FG000|COMPLETED|Overall Study||24
6611783|NCT02120157|7537465|FG000|NOT COMPLETED|Overall Study||8
6611784|NCT02120261|7537473|FG000|STARTED|Overall Study||23
6611785|NCT02120261|7537474|FG001|STARTED|Overall Study||25
6611786|NCT02120261|7537473|FG000|COMPLETED|Overall Study||23
6611787|NCT02120261|7537474|FG001|COMPLETED|Overall Study||25
6611788|NCT02120261|7537473|FG000|NOT COMPLETED|Overall Study||0
6611789|NCT02120261|7537474|FG001|NOT COMPLETED|Overall Study||0
6611790|NCT02120287|7537480|FG000|STARTED|Overall Study||16
6611791|NCT02120287|7537480|FG000|COMPLETED|Overall Study||16
6611792|NCT02120287|7537480|FG000|NOT COMPLETED|Overall Study||0
6611793|NCT02120300|7537488|FG000|STARTED|Overall Study||101
6611794|NCT02120300|7537489|FG001|STARTED|Overall Study||5
6611795|NCT02120300|7537490|FG002|STARTED|Overall Study||10
6611796|NCT02120300|7537491|FG003|STARTED|Overall Study||6
6611797|NCT02120300|7537488|FG000|COMPLETED|Overall Study||98
6611798|NCT02120300|7537489|FG001|COMPLETED|Overall Study||5
6611799|NCT02120300|7537490|FG002|COMPLETED|Overall Study||10
6611800|NCT02120300|7537491|FG003|COMPLETED|Overall Study||5
6611801|NCT02120300|7537488|FG000|NOT COMPLETED|Overall Study||3
6611802|NCT02120300|7537489|FG001|NOT COMPLETED|Overall Study||0
6611803|NCT02120300|7537490|FG002|NOT COMPLETED|Overall Study||0
6611804|NCT02120300|7537491|FG003|NOT COMPLETED|Overall Study||1
6611805|NCT02120352|7537503|FG000|STARTED|Induction Period (20 Weeks)||309
6611806|NCT02120352|7537504|FG001|STARTED|Induction Period (20 Weeks)||0
6611807|NCT02120352|7537505|FG002|STARTED|Induction Period (20 Weeks)||0
6611808|NCT02120352|7537506|FG003|STARTED|Induction Period (20 Weeks)||0
6611809|NCT02120352|7537503|FG000|COMPLETED|Induction Period (20 Weeks)||288
6611810|NCT02120352|7537504|FG001|COMPLETED|Induction Period (20 Weeks)||0
6611811|NCT02120352|7537505|FG002|COMPLETED|Induction Period (20 Weeks)||0
6611812|NCT02120352|7537506|FG003|COMPLETED|Induction Period (20 Weeks)||0
6611813|NCT02120352|7537503|FG000|NOT COMPLETED|Induction Period (20 Weeks)||21
6611814|NCT02120352|7537504|FG001|NOT COMPLETED|Induction Period (20 Weeks)||0
6611815|NCT02120352|7537505|FG002|NOT COMPLETED|Induction Period (20 Weeks)||0
6611816|NCT02120352|7537506|FG003|NOT COMPLETED|Induction Period (20 Weeks)||0
6611817|NCT02120352|7537503|FG000|STARTED|Maintenance Period (32 Weeks)||0
6611818|NCT02120352|7537504|FG001|STARTED|Maintenance Period (32 Weeks)||115
6611819|NCT02120352|7537505|FG002|STARTED|Maintenance Period (32 Weeks)||115
6611820|NCT02120352|7537506|FG003|STARTED|Maintenance Period (32 Weeks)||56
6611821|NCT02120352|7537503|FG000|COMPLETED|Maintenance Period (32 Weeks)||0
6611822|NCT02120352|7537504|FG001|COMPLETED|Maintenance Period (32 Weeks)||0
6611823|NCT02120352|7537505|FG002|COMPLETED|Maintenance Period (32 Weeks)||0
6611824|NCT02120352|7537506|FG003|COMPLETED|Maintenance Period (32 Weeks)||0
6611825|NCT02120352|7537503|FG000|NOT COMPLETED|Maintenance Period (32 Weeks)||0
6611826|NCT02120352|7537504|FG001|NOT COMPLETED|Maintenance Period (32 Weeks)||115
6611827|NCT02120352|7537505|FG002|NOT COMPLETED|Maintenance Period (32 Weeks)||115
6611828|NCT02120352|7537506|FG003|NOT COMPLETED|Maintenance Period (32 Weeks)||56
6611829|NCT02120417|7537522|FG000|STARTED|Overall Study||76
6611830|NCT02120417|7537523|FG001|STARTED|Overall Study||73
6611831|NCT02120417|7537522|FG000|COMPLETED|Overall Study||16
6611832|NCT02120417|7537523|FG001|COMPLETED|Overall Study||5
6611833|NCT02120417|7537522|FG000|NOT COMPLETED|Overall Study||60
6611834|NCT02120417|7537523|FG001|NOT COMPLETED|Overall Study||68
6611835|NCT02120443|7537529|FG000|STARTED|Overall Study||43
6611836|NCT02120443|7537529|FG000|COMPLETED|Overall Study||43
6611837|NCT02120443|7537529|FG000|NOT COMPLETED|Overall Study||0
6611838|NCT02120456|7537542|FG000|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6611839|NCT02120456|7537543|FG001|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6611840|NCT02120456|7537544|FG002|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6611841|NCT02120456|7537545|FG003|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6611842|NCT02120456|7537546|FG004|STARTED|Part 1 Open-label, Dose-escalation Phase||12
6611843|NCT02120456|7537547|FG005|STARTED|Part 1 Open-label, Dose-escalation Phase||9
6611844|NCT02120456|7537548|FG006|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6611845|NCT02120456|7537549|FG007|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6611846|NCT02120456|7537550|FG008|STARTED|Part 1 Open-label, Dose-escalation Phase||0
6611847|NCT02120456|7537542|FG000|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6611848|NCT02120456|7537543|FG001|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6611849|NCT02120456|7537544|FG002|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6611850|NCT02120456|7537545|FG003|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6611851|NCT02120456|7537546|FG004|COMPLETED|Part 1 Open-label, Dose-escalation Phase||12
6611852|NCT02120456|7537547|FG005|COMPLETED|Part 1 Open-label, Dose-escalation Phase||9
6611853|NCT02120456|7537548|FG006|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611854|NCT02120456|7537549|FG007|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611855|NCT02120456|7537550|FG008|COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611856|NCT02120456|7537542|FG000|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611857|NCT02120456|7537543|FG001|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611858|NCT02120456|7537544|FG002|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611859|NCT02120456|7537545|FG003|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611860|NCT02120456|7537546|FG004|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611861|NCT02120456|7537547|FG005|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611862|NCT02120456|7537548|FG006|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611863|NCT02120456|7537549|FG007|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611864|NCT02120456|7537550|FG008|NOT COMPLETED|Part 1 Open-label, Dose-escalation Phase||0
6611865|NCT02120456|7537542|FG000|STARTED|Part 2 Double-blind Phase||0
6611866|NCT02120456|7537543|FG001|STARTED|Part 2 Double-blind Phase||0
6611867|NCT02120456|7537544|FG002|STARTED|Part 2 Double-blind Phase||0
6611868|NCT02120456|7537545|FG003|STARTED|Part 2 Double-blind Phase||0
6611869|NCT02120456|7537546|FG004|STARTED|Part 2 Double-blind Phase||0
6611870|NCT02120456|7537547|FG005|STARTED|Part 2 Double-blind Phase||0
6611871|NCT02120456|7537548|FG006|STARTED|Part 2 Double-blind Phase||32
6611872|NCT02120456|7537549|FG007|STARTED|Part 2 Double-blind Phase||60
6611873|NCT02120456|7537550|FG008|STARTED|Part 2 Double-blind Phase||63
6611874|NCT02120456|7537542|FG000|COMPLETED|Part 2 Double-blind Phase||0
6611875|NCT02120456|7537543|FG001|COMPLETED|Part 2 Double-blind Phase||0
6611876|NCT02120456|7537544|FG002|COMPLETED|Part 2 Double-blind Phase||0
6611877|NCT02120456|7537545|FG003|COMPLETED|Part 2 Double-blind Phase||0
6611878|NCT02120456|7537546|FG004|COMPLETED|Part 2 Double-blind Phase||0
6611879|NCT02120456|7537547|FG005|COMPLETED|Part 2 Double-blind Phase||0
6611880|NCT02120456|7537548|FG006|COMPLETED|Part 2 Double-blind Phase||30
6611881|NCT02120456|7537549|FG007|COMPLETED|Part 2 Double-blind Phase||60
6611882|NCT02120456|7537550|FG008|COMPLETED|Part 2 Double-blind Phase||62
6611883|NCT02120456|7537542|FG000|NOT COMPLETED|Part 2 Double-blind Phase||0
6611884|NCT02120456|7537543|FG001|NOT COMPLETED|Part 2 Double-blind Phase||0
6611885|NCT02120456|7537544|FG002|NOT COMPLETED|Part 2 Double-blind Phase||0
6611886|NCT02120456|7537545|FG003|NOT COMPLETED|Part 2 Double-blind Phase||0
6611887|NCT02120456|7537546|FG004|NOT COMPLETED|Part 2 Double-blind Phase||0
6611888|NCT02120456|7537547|FG005|NOT COMPLETED|Part 2 Double-blind Phase||0
6611889|NCT02120456|7537548|FG006|NOT COMPLETED|Part 2 Double-blind Phase||2
6611890|NCT02120456|7537549|FG007|NOT COMPLETED|Part 2 Double-blind Phase||0
6611891|NCT02120456|7537550|FG008|NOT COMPLETED|Part 2 Double-blind Phase||1
6611892|NCT02120625|7537570|FG000|STARTED|Overall Study||8
6611893|NCT02120625|7537570|FG000|COMPLETED|Overall Study||6
6611894|NCT02120625|7537570|FG000|NOT COMPLETED|Overall Study||2
6611895|NCT02120664|7537579|FG000|STARTED|Overall Study||10
6611896|NCT02120664|7537580|FG001|STARTED|Overall Study||4
6611897|NCT02120664|7537581|FG002|STARTED|Overall Study||7
6611898|NCT02120664|7537582|FG003|STARTED|Overall Study||4
6611899|NCT02120664|7537583|FG004|STARTED|Overall Study||10
6611900|NCT02120664|7537579|FG000|COMPLETED|Overall Study||10
6611901|NCT02120664|7537580|FG001|COMPLETED|Overall Study||4
6611902|NCT02120664|7537581|FG002|COMPLETED|Overall Study||7
6611903|NCT02120664|7537582|FG003|COMPLETED|Overall Study||3
6611904|NCT02120664|7537583|FG004|COMPLETED|Overall Study||10
6611905|NCT02120664|7537579|FG000|NOT COMPLETED|Overall Study||0
6611906|NCT02120664|7537580|FG001|NOT COMPLETED|Overall Study||0
6611907|NCT02120664|7537581|FG002|NOT COMPLETED|Overall Study||0
6611908|NCT02120664|7537582|FG003|NOT COMPLETED|Overall Study||1
6611909|NCT02120664|7537583|FG004|NOT COMPLETED|Overall Study||0
6611910|NCT02120716|7537598|FG000|STARTED|Overall Study||31
6611911|NCT02120716|7537599|FG001|STARTED|Overall Study||19
6611912|NCT02120716|7537598|FG000|COMPLETED|Overall Study||30
6611913|NCT02120716|7537599|FG001|COMPLETED|Overall Study||19
6611914|NCT02120716|7537598|FG000|NOT COMPLETED|Overall Study||1
6611915|NCT02120716|7537599|FG001|NOT COMPLETED|Overall Study||0
6611916|NCT02120781|7537607|FG000|STARTED|Overall Study||15
6611917|NCT02120781|7537608|FG001|STARTED|Overall Study||6
6611918|NCT02120781|7537607|FG000|COMPLETED|Overall Study||11
6611919|NCT02120781|7537608|FG001|COMPLETED|Overall Study||5
6611920|NCT02120781|7537607|FG000|NOT COMPLETED|Overall Study||4
6611921|NCT02120781|7537608|FG001|NOT COMPLETED|Overall Study||1
6611922|NCT02120794|7537614|FG000|STARTED|Overall Study||194
6611923|NCT02120794|7537614|FG000|COMPLETED|Overall Study||136
6611924|NCT02120794|7537614|FG000|NOT COMPLETED|Overall Study||58
6611925|NCT02120833|7537620|FG000|STARTED|Overall Study||39
6611926|NCT02120833|7537621|FG001|STARTED|Overall Study||12
6611927|NCT02120833|7537620|FG000|COMPLETED|Overall Study||35
6611928|NCT02120833|7537621|FG001|COMPLETED|Overall Study||11
6611929|NCT02120833|7537620|FG000|NOT COMPLETED|Overall Study||4
6611930|NCT02120833|7537621|FG001|NOT COMPLETED|Overall Study||1
6611931|NCT02120898|7537630|FG000|STARTED|Overall Study||187
6611932|NCT02120898|7537631|FG001|STARTED|Overall Study||187
6611933|NCT02120898|7537632|FG002|STARTED|Overall Study||93
6611934|NCT02120898|7537630|FG000|Safety Population|Overall Study||187
6611935|NCT02120898|7537631|FG001|Safety Population|Overall Study||187
6611936|NCT02120898|7537632|FG002|Safety Population|Overall Study||93
6611937|NCT02120898|7537630|FG000|Intent-to-Treat (ITT) Population|Overall Study||183
6611938|NCT02120898|7537631|FG001|Intent-to-Treat (ITT) Population|Overall Study||185
6611939|NCT02120898|7537632|FG002|Intent-to-Treat (ITT) Population|Overall Study||93
6611940|NCT02120898|7537630|FG000|COMPLETED|Overall Study||178
6611941|NCT02120898|7537631|FG001|COMPLETED|Overall Study||181
6611942|NCT02120898|7537632|FG002|COMPLETED|Overall Study||89
6611943|NCT02120898|7537630|FG000|NOT COMPLETED|Overall Study||9
6611944|NCT02120898|7537631|FG001|NOT COMPLETED|Overall Study||6
6611945|NCT02120898|7537632|FG002|NOT COMPLETED|Overall Study||4
6611946|NCT02120924|7537643|FG000|STARTED|Overall Study||404
6611947|NCT02120924|7537644|FG001|STARTED|Overall Study||403
6611948|NCT02120924|7537645|FG002|STARTED|Overall Study||202
6611949|NCT02120924|7537643|FG000|COMPLETED|Overall Study||362
6611950|NCT02120924|7537644|FG001|COMPLETED|Overall Study||357
6611951|NCT02120924|7537645|FG002|COMPLETED|Overall Study||173
6611952|NCT02120924|7537643|FG000|NOT COMPLETED|Overall Study||42
6611953|NCT02120924|7537644|FG001|NOT COMPLETED|Overall Study||46
6611954|NCT02120924|7537645|FG002|NOT COMPLETED|Overall Study||29
6611955|NCT02120950|7537656|FG000|STARTED|Overall Study||157
6611956|NCT02120950|7537657|FG001|STARTED|Overall Study||161
6611957|NCT02120950|7537658|FG002|STARTED|Overall Study||15
6611958|NCT02120950|7537656|FG000|COMPLETED|Overall Study|Completed Treatment (Week 96)|137
6611959|NCT02120950|7537657|FG001|COMPLETED|Overall Study|Completed Treatment (Week 96)|147
6611960|NCT02120950|7537658|FG002|COMPLETED|Overall Study||0
6611961|NCT02120950|7537656|FG000|NOT COMPLETED|Overall Study||20
6611962|NCT02120950|7537657|FG001|NOT COMPLETED|Overall Study||14
6611963|NCT02120950|7537658|FG002|NOT COMPLETED|Overall Study||15
6611964|NCT02121002|7537668|FG000|STARTED|Overall Study||392
6611965|NCT02121002|7537669|FG001|STARTED|Overall Study||393
6611966|NCT02121002|7537670|FG002|STARTED|Overall Study||391
6611967|NCT02121002|7537668|FG000|COMPLETED|Overall Study||385
6611968|NCT02121002|7537669|FG001|COMPLETED|Overall Study||389
6611969|NCT02121002|7537670|FG002|COMPLETED|Overall Study||381
6611970|NCT02121002|7537668|FG000|NOT COMPLETED|Overall Study||7
6611971|NCT02121002|7537669|FG001|NOT COMPLETED|Overall Study||4
6611972|NCT02121002|7537670|FG002|NOT COMPLETED|Overall Study||10
6611973|NCT02121041|7537680|FG000|STARTED|Overall Study||14
6611974|NCT02121041|7537681|FG001|STARTED|Overall Study||14
6611975|NCT02121041|7537680|FG000|COMPLETED|Overall Study||13
6611976|NCT02121041|7537681|FG001|COMPLETED|Overall Study||8
6611977|NCT02121041|7537680|FG000|NOT COMPLETED|Overall Study||1
6611978|NCT02121041|7537681|FG001|NOT COMPLETED|Overall Study||6
6611979|NCT02121067|7537687|FG000|STARTED|Overall Study||50
6611980|NCT02121067|7537687|FG000|COMPLETED|Overall Study||50
6611981|NCT02121067|7537687|FG000|NOT COMPLETED|Overall Study||0
6611982|NCT02121210|7537694|FG000|STARTED|Overall Study||65
6611983|NCT02121210|7537695|FG001|STARTED|Overall Study||67
6611984|NCT02121210|7537694|FG000|COMPLETED|Overall Study||58
6611985|NCT02121210|7537695|FG001|COMPLETED|Overall Study||58
6611986|NCT02121210|7537694|FG000|NOT COMPLETED|Overall Study||7
6611987|NCT02121210|7537695|FG001|NOT COMPLETED|Overall Study||9
6611988|NCT02121262|7537703|FG000|STARTED|Overall Study||139
6611989|NCT02121262|7537704|FG001|STARTED|Overall Study||145
6611990|NCT02121262|7537703|FG000|Treated|Overall Study||129
6611991|NCT02121262|7537704|FG001|Treated|Overall Study||145
6611992|NCT02121262|7537703|FG000|Modified Intent-to-treat Population|Overall Study||127
6611993|NCT02121262|7537704|FG001|Modified Intent-to-treat Population|Overall Study||145
6611994|NCT02121262|7537703|FG000|COMPLETED|Overall Study||108
6611995|NCT02121262|7537704|FG001|COMPLETED|Overall Study||135
6611996|NCT02121262|7537703|FG000|NOT COMPLETED|Overall Study||31
6611997|NCT02121262|7537704|FG001|NOT COMPLETED|Overall Study||10
6611998|NCT02121301|7537713|FG000|STARTED|Overall Study||30
6611999|NCT02121301|7537714|FG001|STARTED|Overall Study||30
6612000|NCT02121301|7537715|FG002|STARTED|Overall Study||31
6612001|NCT02121301|7537713|FG000|COMPLETED|Overall Study||29
6612002|NCT02121301|7537714|FG001|COMPLETED|Overall Study||26
6612003|NCT02121301|7537715|FG002|COMPLETED|Overall Study||30
6612004|NCT02121301|7537713|FG000|NOT COMPLETED|Overall Study||1
6612005|NCT02121301|7537714|FG001|NOT COMPLETED|Overall Study||4
6612006|NCT02121301|7537715|FG002|NOT COMPLETED|Overall Study||1
6612007|NCT02121392|7537725|FG000|STARTED|Prior to Intervention||83
6612008|NCT02121392|7537726|FG001|STARTED|Prior to Intervention||82
6612009|NCT02121392|7537725|FG000|COMPLETED|Prior to Intervention||35
6612010|NCT02121392|7537726|FG001|COMPLETED|Prior to Intervention||41
6612011|NCT02121392|7537725|FG000|NOT COMPLETED|Prior to Intervention||48
6612012|NCT02121392|7537726|FG001|NOT COMPLETED|Prior to Intervention||41
6612013|NCT02121392|7537725|FG000|STARTED|After Placement of AC Block vs Sham||35
6612014|NCT02121392|7537726|FG001|STARTED|After Placement of AC Block vs Sham||41
6612015|NCT02121392|7537725|FG000|COMPLETED|After Placement of AC Block vs Sham||32
6612016|NCT02121392|7537726|FG001|COMPLETED|After Placement of AC Block vs Sham||38
6612017|NCT02121392|7537725|FG000|NOT COMPLETED|After Placement of AC Block vs Sham||3
6612018|NCT02121392|7537726|FG001|NOT COMPLETED|After Placement of AC Block vs Sham||3
6612019|NCT02121418|7537732|FG000|STARTED|Overall Study||12
6612020|NCT02121418|7537732|FG000|COMPLETED|Overall Study||12
6612021|NCT02121418|7537732|FG000|NOT COMPLETED|Overall Study||0
6612022|NCT02121483|7537739|FG000|STARTED|Overall Study||9
6612023|NCT02121483|7537740|FG001|STARTED|Overall Study||8
6612024|NCT02121483|7537741|FG002|STARTED|Overall Study||10
6612025|NCT02121483|7537739|FG000|COMPLETED|Overall Study||9
6612026|NCT02121483|7537740|FG001|COMPLETED|Overall Study||8
6612027|NCT02121483|7537741|FG002|COMPLETED|Overall Study||10
6612028|NCT02121483|7537739|FG000|NOT COMPLETED|Overall Study||0
6612029|NCT02121483|7537740|FG001|NOT COMPLETED|Overall Study||0
6612030|NCT02121483|7537741|FG002|NOT COMPLETED|Overall Study||0
6612031|NCT02121509|7537751|FG000|STARTED|Treatment Period-1 (4 Days)||30
6612032|NCT02121509|7537752|FG001|STARTED|Treatment Period-1 (4 Days)||28
6612033|NCT02121509|7537753|FG002|STARTED|Treatment Period-1 (4 Days)||8
6612034|NCT02121509|7537754|FG003|STARTED|Treatment Period-1 (4 Days)||8
6612035|NCT02121509|7537751|FG000|COMPLETED|Treatment Period-1 (4 Days)||30
6612036|NCT02121509|7537752|FG001|COMPLETED|Treatment Period-1 (4 Days)||28
6612037|NCT02121509|7537753|FG002|COMPLETED|Treatment Period-1 (4 Days)||8
6612038|NCT02121509|7537754|FG003|COMPLETED|Treatment Period-1 (4 Days)||8
6612039|NCT02121509|7537751|FG000|NOT COMPLETED|Treatment Period-1 (4 Days)||0
6612040|NCT02121509|7537752|FG001|NOT COMPLETED|Treatment Period-1 (4 Days)||0
6612041|NCT02121509|7537753|FG002|NOT COMPLETED|Treatment Period-1 (4 Days)||0
6612042|NCT02121509|7537754|FG003|NOT COMPLETED|Treatment Period-1 (4 Days)||0
6612043|NCT02121509|7537751|FG000|STARTED|Washout Period (35 Days)||30
6612044|NCT02121509|7537752|FG001|STARTED|Washout Period (35 Days)||28
6612045|NCT02121509|7537753|FG002|STARTED|Washout Period (35 Days)||8
6612046|NCT02121509|7537754|FG003|STARTED|Washout Period (35 Days)||8
6612047|NCT02121509|7537751|FG000|COMPLETED|Washout Period (35 Days)||28
6612048|NCT02121509|7537752|FG001|COMPLETED|Washout Period (35 Days)||24
6612049|NCT02121509|7537753|FG002|COMPLETED|Washout Period (35 Days)||8
6612050|NCT02121509|7537754|FG003|COMPLETED|Washout Period (35 Days)||8
6612051|NCT02121509|7537751|FG000|NOT COMPLETED|Washout Period (35 Days)||2
6612052|NCT02121509|7537752|FG001|NOT COMPLETED|Washout Period (35 Days)||4
6612053|NCT02121509|7537753|FG002|NOT COMPLETED|Washout Period (35 Days)||0
6612054|NCT02121509|7537754|FG003|NOT COMPLETED|Washout Period (35 Days)||0
6612055|NCT02121509|7537751|FG000|STARTED|Treatment Period-2 (4 Days)||28
6612056|NCT02121509|7537752|FG001|STARTED|Treatment Period-2 (4 Days)||24
6612057|NCT02121509|7537753|FG002|STARTED|Treatment Period-2 (4 Days)||8
6612058|NCT02121509|7537754|FG003|STARTED|Treatment Period-2 (4 Days)||8
6612059|NCT02121509|7537751|FG000|COMPLETED|Treatment Period-2 (4 Days)||28
6612060|NCT02121509|7537752|FG001|COMPLETED|Treatment Period-2 (4 Days)||24
6612061|NCT02121509|7537753|FG002|COMPLETED|Treatment Period-2 (4 Days)||8
6612062|NCT02121509|7537754|FG003|COMPLETED|Treatment Period-2 (4 Days)||8
6612063|NCT02121509|7537751|FG000|NOT COMPLETED|Treatment Period-2 (4 Days)||0
6612064|NCT02121509|7537752|FG001|NOT COMPLETED|Treatment Period-2 (4 Days)||0
6612065|NCT02121509|7537753|FG002|NOT COMPLETED|Treatment Period-2 (4 Days)||0
6612066|NCT02121509|7537754|FG003|NOT COMPLETED|Treatment Period-2 (4 Days)||0
6612067|NCT02121522|7537764|FG000|STARTED|Overall Study||14
6612068|NCT02121522|7537764|FG000|COMPLETED|Overall Study||13
6612069|NCT02121522|7537764|FG000|NOT COMPLETED|Overall Study||1
6612070|NCT02121535|7537770|FG000|STARTED|Period 1 (8 Trial Days)||36
6612071|NCT02121535|7537771|FG001|STARTED|Period 1 (8 Trial Days)||36
6612072|NCT02121535|7537770|FG000|COMPLETED|Period 1 (8 Trial Days)||36
6612073|NCT02121535|7537771|FG001|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
6612074|NCT02121535|7537770|FG000|NOT COMPLETED|Period 1 (8 Trial Days)||0
6612075|NCT02121535|7537771|FG001|NOT COMPLETED|Period 1 (8 Trial Days)||1
6612076|NCT02121535|7537770|FG000|STARTED|Period 2 (8 Trial Days)||36
6612077|NCT02121535|7537771|FG001|STARTED|Period 2 (8 Trial Days)||35
6612078|NCT02121535|7537770|FG000|COMPLETED|Period 2 (8 Trial Days)||36
6612079|NCT02121535|7537771|FG001|COMPLETED|Period 2 (8 Trial Days)||35
6612080|NCT02121535|7537770|FG000|NOT COMPLETED|Period 2 (8 Trial Days)||0
6612081|NCT02121535|7537771|FG001|NOT COMPLETED|Period 2 (8 Trial Days)||0
6612082|NCT02121535|7537770|FG000|STARTED|Period 3 (8 Trial Days)||36
6612083|NCT02121535|7537771|FG001|STARTED|Period 3 (8 Trial Days)||35
6612084|NCT02121535|7537770|FG000|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
6612085|NCT02121535|7537771|FG001|COMPLETED|Period 3 (8 Trial Days)||35
6612086|NCT02121535|7537770|FG000|NOT COMPLETED|Period 3 (8 Trial Days)||1
6612087|NCT02121535|7537771|FG001|NOT COMPLETED|Period 3 (8 Trial Days)||0
6612088|NCT02121535|7537770|FG000|STARTED|Period 4 (8 Trial Days)||35
6612089|NCT02121535|7537771|FG001|STARTED|Period 4 (8 Trial Days)||35
6612090|NCT02121535|7537770|FG000|COMPLETED|Period 4 (8 Trial Days)||35
6612091|NCT02121535|7537771|FG001|COMPLETED|Period 4 (8 Trial Days)||35
6612092|NCT02121535|7537770|FG000|NOT COMPLETED|Period 4 (8 Trial Days)||0
6612093|NCT02121535|7537771|FG001|NOT COMPLETED|Period 4 (8 Trial Days)||0
6612094|NCT02121756|7537780|FG000|STARTED|Overall Study||21
6612095|NCT02121756|7537781|FG001|STARTED|Overall Study||19
6612096|NCT02121756|7537780|FG000|COMPLETED|Overall Study||15
6612097|NCT02121756|7537781|FG001|COMPLETED|Overall Study||17
6612098|NCT02121756|7537780|FG000|NOT COMPLETED|Overall Study||6
6612099|NCT02121756|7537781|FG001|NOT COMPLETED|Overall Study||2
6612100|NCT02121795|7537792|FG000|STARTED|Double-Blind Phase||334
6612101|NCT02121795|7537793|FG001|STARTED|Double-Blind Phase||334
6612102|NCT02121795|7537792|FG000|Safety Analysis Set|Double-Blind Phase||333
6612103|NCT02121795|7537793|FG001|Safety Analysis Set|Double-Blind Phase||330
6612104|NCT02121795|7537792|FG000|COMPLETED|Double-Blind Phase||296
6612105|NCT02121795|7537793|FG001|COMPLETED|Double-Blind Phase||300
6612106|NCT02121795|7537792|FG000|NOT COMPLETED|Double-Blind Phase||38
6612107|NCT02121795|7537793|FG001|NOT COMPLETED|Double-Blind Phase||34
6612108|NCT02121795|7537792|FG000|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|33
6612109|NCT02121795|7537793|FG001|STARTED|Open-Label Phase|Not all participants entered the Open-Label Phase.|31
6612110|NCT02121795|7537792|FG000|COMPLETED|Open-Label Phase||21
6612111|NCT02121795|7537793|FG001|COMPLETED|Open-Label Phase||21
6612112|NCT02121795|7537792|FG000|NOT COMPLETED|Open-Label Phase||12
6612113|NCT02121795|7537793|FG001|NOT COMPLETED|Open-Label Phase||10
6732641|NCT03197038|7662082|FG000|NOT COMPLETED|Overall Study||4
6732642|NCT03197038|7662083|FG001|NOT COMPLETED|Overall Study||0
6732643|NCT03197129|7662091|FG000|STARTED|Overall Study||60
6732644|NCT03197129|7662092|FG001|STARTED|Overall Study||62
6732645|NCT03197129|7662091|FG000|COMPLETED|Overall Study||56
6732646|NCT03197129|7662092|FG001|COMPLETED|Overall Study||57
6732647|NCT03197129|7662091|FG000|NOT COMPLETED|Overall Study||4
6732648|NCT03197129|7662092|FG001|NOT COMPLETED|Overall Study||5
6732649|NCT03197324|7662100|FG000|STARTED|Overall Study||10
6732650|NCT03197324|7662101|FG001|STARTED|Overall Study||10
6732651|NCT03197324|7662100|FG000|COMPLETED|Overall Study||10
6732652|NCT03197324|7662101|FG001|COMPLETED|Overall Study||9
6732653|NCT03197324|7662100|FG000|NOT COMPLETED|Overall Study||0
6732654|NCT03197324|7662101|FG001|NOT COMPLETED|Overall Study||1
6732655|NCT03197376|7662111|FG000|STARTED|Primary and Booster Phase||502
6732656|NCT03197376|7662112|FG001|STARTED|Primary and Booster Phase||501
6732657|NCT03197376|7662113|FG002|STARTED|Primary and Booster Phase||500
6732658|NCT03197376|7662114|FG003|STARTED|Primary and Booster Phase||747
6732659|NCT03197376|7662111|FG000|Vaccinated-Dose 1|Primary and Booster Phase||502
6732660|NCT03197376|7662112|FG001|Vaccinated-Dose 1|Primary and Booster Phase||501
6732661|NCT03197376|7662113|FG002|Vaccinated-Dose 1|Primary and Booster Phase||500
6732662|NCT03197376|7662114|FG003|Vaccinated-Dose 1|Primary and Booster Phase||747
6732663|NCT03197376|7662111|FG000|Vaccinated-Dose 2|Primary and Booster Phase||495
6732664|NCT03197376|7662112|FG001|Vaccinated-Dose 2|Primary and Booster Phase||495
6732665|NCT03197376|7662113|FG002|Vaccinated-Dose 2|Primary and Booster Phase||491
6732666|NCT03197376|7662114|FG003|Vaccinated-Dose 2|Primary and Booster Phase||738
6612114|NCT02121808|7537801|FG000|STARTED|Overall Study||20
6612115|NCT02121808|7537801|FG000|COMPLETED|Overall Study||17
6612116|NCT02121808|7537801|FG000|NOT COMPLETED|Overall Study||3
6612117|NCT02121834|7537817|FG000|STARTED|Overall Study||12
6612118|NCT02121834|7537818|FG001|STARTED|Overall Study||11
6612119|NCT02121834|7537819|FG002|STARTED|Overall Study||9
6612120|NCT02121834|7537820|FG003|STARTED|Overall Study||10
6612121|NCT02121834|7537821|FG004|STARTED|Overall Study||9
6612122|NCT02121834|7537822|FG005|STARTED|Overall Study||9
6612123|NCT02121834|7537823|FG006|STARTED|Overall Study||3
6612124|NCT02121834|7537817|FG000|Received at Least One Dose of Study Drug|Overall Study||12
6612125|NCT02121834|7537818|FG001|Received at Least One Dose of Study Drug|Overall Study||11
6612126|NCT02121834|7537819|FG002|Received at Least One Dose of Study Drug|Overall Study||9
6612127|NCT02121834|7537820|FG003|Received at Least One Dose of Study Drug|Overall Study||10
6612128|NCT02121834|7537821|FG004|Received at Least One Dose of Study Drug|Overall Study||9
6612129|NCT02121834|7537822|FG005|Received at Least One Dose of Study Drug|Overall Study||9
6612130|NCT02121834|7537823|FG006|Received at Least One Dose of Study Drug|Overall Study||3
6612131|NCT02121834|7537817|FG000|COMPLETED|Overall Study||12
6612132|NCT02121834|7537818|FG001|COMPLETED|Overall Study||9
6612133|NCT02121834|7537819|FG002|COMPLETED|Overall Study||7
6612134|NCT02121834|7537820|FG003|COMPLETED|Overall Study||10
6612135|NCT02121834|7537821|FG004|COMPLETED|Overall Study||9
6612136|NCT02121834|7537822|FG005|COMPLETED|Overall Study||9
6612137|NCT02121834|7537823|FG006|COMPLETED|Overall Study||3
6612138|NCT02121834|7537817|FG000|NOT COMPLETED|Overall Study||0
6612139|NCT02121834|7537818|FG001|NOT COMPLETED|Overall Study||2
6612140|NCT02121834|7537819|FG002|NOT COMPLETED|Overall Study||2
6612141|NCT02121834|7537820|FG003|NOT COMPLETED|Overall Study||0
6612142|NCT02121834|7537821|FG004|NOT COMPLETED|Overall Study||0
6612143|NCT02121834|7537822|FG005|NOT COMPLETED|Overall Study||0
6612144|NCT02121834|7537823|FG006|NOT COMPLETED|Overall Study||0
6612145|NCT02121847|7537849|FG000|STARTED|Overall Study||40
6612146|NCT02121847|7537849|FG000|COMPLETED|Overall Study||37
6612147|NCT02121847|7537849|FG000|NOT COMPLETED|Overall Study||3
6612148|NCT02121860|7537857|FG000|STARTED|Overall Study||8
6612149|NCT02121860|7537858|FG001|STARTED|Overall Study||12
6612150|NCT02121860|7537859|FG002|STARTED|Overall Study||8
6612151|NCT02121860|7537860|FG003|STARTED|Overall Study||8
6612152|NCT02121860|7537857|FG000|COMPLETED|Overall Study||8
6612153|NCT02121860|7537858|FG001|COMPLETED|Overall Study||12
6612154|NCT02121860|7537859|FG002|COMPLETED|Overall Study||8
6612155|NCT02121860|7537860|FG003|COMPLETED|Overall Study||8
6612156|NCT02121860|7537857|FG000|NOT COMPLETED|Overall Study||0
6612157|NCT02121860|7537858|FG001|NOT COMPLETED|Overall Study||0
6612158|NCT02121860|7537859|FG002|NOT COMPLETED|Overall Study||0
6612159|NCT02121860|7537860|FG003|NOT COMPLETED|Overall Study||0
6612160|NCT02121912|7537869|FG000|STARTED|Overall Study||25
6612161|NCT02121912|7537870|FG001|STARTED|Overall Study||25
6612162|NCT02121912|7537869|FG000|COMPLETED|Overall Study||21
6612163|NCT02121912|7537870|FG001|COMPLETED|Overall Study||25
6612164|NCT02121912|7537869|FG000|NOT COMPLETED|Overall Study||4
6612165|NCT02121912|7537870|FG001|NOT COMPLETED|Overall Study||0
6612166|NCT02122146|7537884|FG000|STARTED|Part 1: Dose Escalation||2
6612167|NCT02122146|7537885|FG001|STARTED|Part 1: Dose Escalation||2
6612168|NCT02122146|7537886|FG002|STARTED|Part 1: Dose Escalation||4
6612169|NCT02122146|7537887|FG003|STARTED|Part 1: Dose Escalation||4
6612170|NCT02122146|7537888|FG004|STARTED|Part 1: Dose Escalation||4
6612171|NCT02122146|7537889|FG005|STARTED|Part 1: Dose Escalation||6
6612172|NCT02122146|7537890|FG006|STARTED|Part 1: Dose Escalation||1
6612173|NCT02122146|7537891|FG007|STARTED|Part 1: Dose Escalation||8
6612174|NCT02122146|7537884|FG000|COMPLETED|Part 1: Dose Escalation||1
6612175|NCT02122146|7537885|FG001|COMPLETED|Part 1: Dose Escalation||1
6612176|NCT02122146|7537886|FG002|COMPLETED|Part 1: Dose Escalation||2
6612177|NCT02122146|7537887|FG003|COMPLETED|Part 1: Dose Escalation||3
6612178|NCT02122146|7537888|FG004|COMPLETED|Part 1: Dose Escalation||3
6612179|NCT02122146|7537889|FG005|COMPLETED|Part 1: Dose Escalation||5
6612180|NCT02122146|7537890|FG006|COMPLETED|Part 1: Dose Escalation||0
6612181|NCT02122146|7537891|FG007|COMPLETED|Part 1: Dose Escalation||6
6612182|NCT02122146|7537884|FG000|NOT COMPLETED|Part 1: Dose Escalation||1
6612183|NCT02122146|7537885|FG001|NOT COMPLETED|Part 1: Dose Escalation||1
6612184|NCT02122146|7537886|FG002|NOT COMPLETED|Part 1: Dose Escalation||2
6612185|NCT02122146|7537887|FG003|NOT COMPLETED|Part 1: Dose Escalation||1
6612186|NCT02122146|7537888|FG004|NOT COMPLETED|Part 1: Dose Escalation||1
6612187|NCT02122146|7537889|FG005|NOT COMPLETED|Part 1: Dose Escalation||1
6612188|NCT02122146|7537890|FG006|NOT COMPLETED|Part 1: Dose Escalation||1
6612189|NCT02122146|7537891|FG007|NOT COMPLETED|Part 1: Dose Escalation||2
6612190|NCT02122146|7537884|FG000|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6612191|NCT02122146|7537885|FG001|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6612192|NCT02122146|7537886|FG002|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6612193|NCT02122146|7537887|FG003|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6612194|NCT02122146|7537888|FG004|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6612195|NCT02122146|7537889|FG005|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6612196|NCT02122146|7537890|FG006|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6612197|NCT02122146|7537891|FG007|STARTED|Part 2: Maximum Tolerated Dose|No participant enrolled due to study termination|0
6612198|NCT02122146|7537884|FG000|COMPLETED|Part 2: Maximum Tolerated Dose||0
6612199|NCT02122146|7537885|FG001|COMPLETED|Part 2: Maximum Tolerated Dose||0
6612200|NCT02122146|7537886|FG002|COMPLETED|Part 2: Maximum Tolerated Dose||0
6612201|NCT02122146|7537887|FG003|COMPLETED|Part 2: Maximum Tolerated Dose||0
6612202|NCT02122146|7537888|FG004|COMPLETED|Part 2: Maximum Tolerated Dose||0
6612203|NCT02122146|7537889|FG005|COMPLETED|Part 2: Maximum Tolerated Dose||0
6612204|NCT02122146|7537890|FG006|COMPLETED|Part 2: Maximum Tolerated Dose||0
6612205|NCT02122146|7537891|FG007|COMPLETED|Part 2: Maximum Tolerated Dose||0
6612206|NCT02122146|7537884|FG000|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6612207|NCT02122146|7537885|FG001|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6612208|NCT02122146|7537886|FG002|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6612209|NCT02122146|7537887|FG003|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6612210|NCT02122146|7537888|FG004|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6612211|NCT02122146|7537889|FG005|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6612212|NCT02122146|7537890|FG006|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6612213|NCT02122146|7537891|FG007|NOT COMPLETED|Part 2: Maximum Tolerated Dose||0
6612214|NCT02122146|7537884|FG000|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6612215|NCT02122146|7537885|FG001|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6612216|NCT02122146|7537886|FG002|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6612217|NCT02122146|7537887|FG003|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6612218|NCT02122146|7537888|FG004|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6612219|NCT02122146|7537889|FG005|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6612220|NCT02122146|7537890|FG006|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6612221|NCT02122146|7537891|FG007|STARTED|Part 3: Expansion|No participant enrolled due to study termination|0
6612222|NCT02122146|7537884|FG000|COMPLETED|Part 3: Expansion||0
6612223|NCT02122146|7537885|FG001|COMPLETED|Part 3: Expansion||0
6612224|NCT02122146|7537886|FG002|COMPLETED|Part 3: Expansion||0
6612225|NCT02122146|7537887|FG003|COMPLETED|Part 3: Expansion||0
6612226|NCT02122146|7537888|FG004|COMPLETED|Part 3: Expansion||0
6612227|NCT02122146|7537889|FG005|COMPLETED|Part 3: Expansion||0
6612228|NCT02122146|7537890|FG006|COMPLETED|Part 3: Expansion||0
6612229|NCT02122146|7537891|FG007|COMPLETED|Part 3: Expansion||0
6612230|NCT02122146|7537884|FG000|NOT COMPLETED|Part 3: Expansion||0
6612231|NCT02122146|7537885|FG001|NOT COMPLETED|Part 3: Expansion||0
6612232|NCT02122146|7537886|FG002|NOT COMPLETED|Part 3: Expansion||0
6612233|NCT02122146|7537887|FG003|NOT COMPLETED|Part 3: Expansion||0
6612234|NCT02122146|7537888|FG004|NOT COMPLETED|Part 3: Expansion||0
6612235|NCT02122146|7537889|FG005|NOT COMPLETED|Part 3: Expansion||0
6612236|NCT02122146|7537890|FG006|NOT COMPLETED|Part 3: Expansion||0
6612237|NCT02122146|7537891|FG007|NOT COMPLETED|Part 3: Expansion||0
6612238|NCT02122341|7537912|FG000|STARTED|Overall Study||17
6612239|NCT02122341|7537913|FG001|STARTED|Overall Study||18
6612240|NCT02122341|7537912|FG000|COMPLETED|Overall Study||17
6612241|NCT02122341|7537913|FG001|COMPLETED|Overall Study||18
6612242|NCT02122341|7537912|FG000|NOT COMPLETED|Overall Study||0
6612243|NCT02122341|7537913|FG001|NOT COMPLETED|Overall Study||0
6612244|NCT02122380|7537921|FG000|STARTED|First Intervention (30 Days)||11
6612245|NCT02122380|7537922|FG001|STARTED|First Intervention (30 Days)||12
6612246|NCT02122380|7537921|FG000|COMPLETED|First Intervention (30 Days)||10
6612247|NCT02122380|7537922|FG001|COMPLETED|First Intervention (30 Days)||11
6612248|NCT02122380|7537921|FG000|NOT COMPLETED|First Intervention (30 Days)||1
6612249|NCT02122380|7537922|FG001|NOT COMPLETED|First Intervention (30 Days)||1
6612250|NCT02122380|7537921|FG000|STARTED|Washout (8 Weeks)||10
6612251|NCT02122380|7537922|FG001|STARTED|Washout (8 Weeks)||11
6612252|NCT02122380|7537921|FG000|COMPLETED|Washout (8 Weeks)||9
6612253|NCT02122380|7537922|FG001|COMPLETED|Washout (8 Weeks)||9
6612254|NCT02122380|7537921|FG000|NOT COMPLETED|Washout (8 Weeks)||1
6612255|NCT02122380|7537922|FG001|NOT COMPLETED|Washout (8 Weeks)||2
6612256|NCT02122380|7537921|FG000|STARTED|Second Intervention (30 Days)||9
6612257|NCT02122380|7537922|FG001|STARTED|Second Intervention (30 Days)||9
6612258|NCT02122380|7537921|FG000|COMPLETED|Second Intervention (30 Days)||9
6612259|NCT02122380|7537922|FG001|COMPLETED|Second Intervention (30 Days)||7
6612260|NCT02122380|7537921|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
6612261|NCT02122380|7537922|FG001|NOT COMPLETED|Second Intervention (30 Days)||2
6612262|NCT02122406|7537929|FG000|STARTED|Overall Study||200
6612263|NCT02122406|7537929|FG000|COMPLETED|Overall Study||200
6612264|NCT02122406|7537929|FG000|NOT COMPLETED|Overall Study||0
6612265|NCT02122445|7537933|FG000|STARTED|Overall Study||20
6612266|NCT02122445|7537933|FG000|COMPLETED|Overall Study||20
6612267|NCT02122445|7537933|FG000|NOT COMPLETED|Overall Study||0
6612268|NCT02122471|7537940|FG000|STARTED|Overall Study||445
6612269|NCT02122471|7537941|FG001|STARTED|Overall Study||443
6612270|NCT02122471|7537942|FG002|STARTED|Overall Study||449
6612271|NCT02122471|7537940|FG000|COMPLETED|Overall Study||406
6612272|NCT02122471|7537941|FG001|COMPLETED|Overall Study||392
6612273|NCT02122471|7537942|FG002|COMPLETED|Overall Study||405
6612274|NCT02122471|7537940|FG000|NOT COMPLETED|Overall Study||39
6612275|NCT02122471|7537941|FG001|NOT COMPLETED|Overall Study||51
6612276|NCT02122471|7537942|FG002|NOT COMPLETED|Overall Study||44
6612277|NCT02122549|7537951|FG000|STARTED|Overall Study||59
6612278|NCT02122549|7537951|FG000|COMPLETED|Overall Study||59
6612279|NCT02122549|7537951|FG000|NOT COMPLETED|Overall Study||0
6612280|NCT02122770|7537959|FG000|STARTED|Part A: Drug-drug Interaction 2||13
6612281|NCT02122770|7537960|FG001|STARTED|Part A: Drug-drug Interaction 2||13
6612282|NCT02122770|7537961|FG002|STARTED|Part A: Drug-drug Interaction 2||6
6612283|NCT02122770|7537962|FG003|STARTED|Part A: Drug-drug Interaction 2||19
6612284|NCT02122770|7537963|FG004|STARTED|Part A: Drug-drug Interaction 2||0
6612285|NCT02122770|7537964|FG005|STARTED|Part A: Drug-drug Interaction 2||0
6612286|NCT02122770|7537959|FG000|COMPLETED|Part A: Drug-drug Interaction 2||9
6612287|NCT02122770|7537960|FG001|COMPLETED|Part A: Drug-drug Interaction 2||7
6612288|NCT02122770|7537961|FG002|COMPLETED|Part A: Drug-drug Interaction 2||4
6612289|NCT02122770|7537962|FG003|COMPLETED|Part A: Drug-drug Interaction 2||16
6612290|NCT02122770|7537963|FG004|COMPLETED|Part A: Drug-drug Interaction 2||0
6612291|NCT02122770|7537964|FG005|COMPLETED|Part A: Drug-drug Interaction 2||0
6612292|NCT02122770|7537959|FG000|NOT COMPLETED|Part A: Drug-drug Interaction 2||4
6612293|NCT02122770|7537960|FG001|NOT COMPLETED|Part A: Drug-drug Interaction 2||6
6612294|NCT02122770|7537961|FG002|NOT COMPLETED|Part A: Drug-drug Interaction 2||2
6612295|NCT02122770|7537962|FG003|NOT COMPLETED|Part A: Drug-drug Interaction 2||3
6612296|NCT02122770|7537963|FG004|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
6612297|NCT02122770|7537964|FG005|NOT COMPLETED|Part A: Drug-drug Interaction 2||0
6612298|NCT02122770|7537959|FG000|STARTED|Part B: Standard of Care||0
6612299|NCT02122770|7537960|FG001|STARTED|Part B: Standard of Care||0
6612300|NCT02122770|7537961|FG002|STARTED|Part B: Standard of Care||0
6612301|NCT02122770|7537962|FG003|STARTED|Part B: Standard of Care||0
6612302|NCT02122770|7537963|FG004|STARTED|Part B: Standard of Care||23
6612303|NCT02122770|7537964|FG005|STARTED|Part B: Standard of Care||13
6612304|NCT02122770|7537959|FG000|COMPLETED|Part B: Standard of Care||0
6612305|NCT02122770|7537960|FG001|COMPLETED|Part B: Standard of Care||0
6612306|NCT02122770|7537961|FG002|COMPLETED|Part B: Standard of Care||0
6612307|NCT02122770|7537962|FG003|COMPLETED|Part B: Standard of Care||0
6612308|NCT02122770|7537963|FG004|COMPLETED|Part B: Standard of Care||0
6612309|NCT02122770|7537964|FG005|COMPLETED|Part B: Standard of Care||0
6612310|NCT02122770|7537959|FG000|NOT COMPLETED|Part B: Standard of Care||0
6612311|NCT02122770|7537960|FG001|NOT COMPLETED|Part B: Standard of Care||0
6612312|NCT02122770|7537961|FG002|NOT COMPLETED|Part B: Standard of Care||0
6612313|NCT02122770|7537962|FG003|NOT COMPLETED|Part B: Standard of Care||0
6612314|NCT02122770|7537963|FG004|NOT COMPLETED|Part B: Standard of Care||23
6612315|NCT02122770|7537964|FG005|NOT COMPLETED|Part B: Standard of Care||13
6612316|NCT02122783|7537989|FG000|STARTED|Overall Study||2
6612317|NCT02122783|7537990|FG001|STARTED|Overall Study||3
6612318|NCT02122783|7537989|FG000|COMPLETED|Overall Study||2
6612319|NCT02122783|7537990|FG001|COMPLETED|Overall Study||2
6612320|NCT02122783|7537989|FG000|NOT COMPLETED|Overall Study||0
6612321|NCT02122783|7537990|FG001|NOT COMPLETED|Overall Study||1
6612322|NCT02122796|7538001|FG000|STARTED|Visit 1||15
6612323|NCT02122796|7538002|FG001|STARTED|Visit 1||15
6612324|NCT02122796|7538001|FG000|COMPLETED|Visit 1||15
6612325|NCT02122796|7538002|FG001|COMPLETED|Visit 1||15
6612326|NCT02122796|7538001|FG000|NOT COMPLETED|Visit 1||0
6612327|NCT02122796|7538002|FG001|NOT COMPLETED|Visit 1||0
6612328|NCT02122796|7538001|FG000|STARTED|Visit 2||15
6612329|NCT02122796|7538002|FG001|STARTED|Visit 2||15
6612330|NCT02122796|7538001|FG000|COMPLETED|Visit 2||12
6612331|NCT02122796|7538002|FG001|COMPLETED|Visit 2||14
6612332|NCT02122796|7538001|FG000|NOT COMPLETED|Visit 2||3
6612333|NCT02122796|7538002|FG001|NOT COMPLETED|Visit 2||1
6612334|NCT02122887|7538011|FG000|STARTED|Overall Study||60
6612335|NCT02122887|7538012|FG001|STARTED|Overall Study||41
6612336|NCT02122887|7538011|FG000|COMPLETED|Overall Study||40
6612337|NCT02122887|7538012|FG001|COMPLETED|Overall Study||39
6612338|NCT02122887|7538011|FG000|NOT COMPLETED|Overall Study||20
6612339|NCT02122887|7538012|FG001|NOT COMPLETED|Overall Study||2
6612340|NCT02122952|7538020|FG000|STARTED|Overall Study||3
6612341|NCT02122952|7538021|FG001|STARTED|Overall Study||12
6612342|NCT02122952|7538020|FG000|COMPLETED|Overall Study||3
6612343|NCT02122952|7538021|FG001|COMPLETED|Overall Study||12
6612344|NCT02122952|7538020|FG000|NOT COMPLETED|Overall Study||0
6612345|NCT02122952|7538021|FG001|NOT COMPLETED|Overall Study||0
6612346|NCT02123017|7538030|FG000|STARTED|Overall Study||8
6612347|NCT02123017|7538031|FG001|STARTED|Overall Study||12
6612348|NCT02123017|7538032|FG002|STARTED|Overall Study||12
6612349|NCT02123017|7538030|FG000|COMPLETED|Overall Study||8
6612350|NCT02123017|7538031|FG001|COMPLETED|Overall Study||12
6612351|NCT02123017|7538032|FG002|COMPLETED|Overall Study||12
6612352|NCT02123017|7538030|FG000|NOT COMPLETED|Overall Study||0
6612353|NCT02123017|7538031|FG001|NOT COMPLETED|Overall Study||0
6612354|NCT02123017|7538032|FG002|NOT COMPLETED|Overall Study||0
6612355|NCT02123134|7538042|FG000|STARTED|Overall Study||28
6612356|NCT02123134|7538043|FG001|STARTED|Overall Study||27
6612357|NCT02123134|7538042|FG000|COMPLETED|Overall Study||25
6612358|NCT02123134|7538043|FG001|COMPLETED|Overall Study||24
6612359|NCT02123134|7538042|FG000|NOT COMPLETED|Overall Study||3
6612360|NCT02123134|7538043|FG001|NOT COMPLETED|Overall Study||3
6612361|NCT02123251|7538051|FG000|STARTED|Overall Study||159
6612362|NCT02123251|7538052|FG001|STARTED|Overall Study||161
6612363|NCT02123251|7538051|FG000|COMPLETED|Overall Study||125
6612364|NCT02123251|7538052|FG001|COMPLETED|Overall Study||131
6612365|NCT02123251|7538051|FG000|NOT COMPLETED|Overall Study||34
6612366|NCT02123251|7538052|FG001|NOT COMPLETED|Overall Study||30
6612367|NCT02123329|7538061|FG000|STARTED|3 Month Outcome Measure||147
6612368|NCT02123329|7538062|FG001|STARTED|3 Month Outcome Measure||167
6612369|NCT02123329|7538061|FG000|COMPLETED|3 Month Outcome Measure||98
6612370|NCT02123329|7538062|FG001|COMPLETED|3 Month Outcome Measure||101
6612371|NCT02123329|7538061|FG000|NOT COMPLETED|3 Month Outcome Measure||49
6612372|NCT02123329|7538062|FG001|NOT COMPLETED|3 Month Outcome Measure||66
6612373|NCT02123329|7538061|FG000|STARTED|6 Month Outcome Measure||147
6612374|NCT02123329|7538062|FG001|STARTED|6 Month Outcome Measure||167
6612375|NCT02123329|7538061|FG000|COMPLETED|6 Month Outcome Measure||99
6612376|NCT02123329|7538062|FG001|COMPLETED|6 Month Outcome Measure||100
6612377|NCT02123329|7538061|FG000|NOT COMPLETED|6 Month Outcome Measure||48
6612378|NCT02123329|7538062|FG001|NOT COMPLETED|6 Month Outcome Measure||67
6612379|NCT02123329|7538061|FG000|STARTED|12 Month Outcome Measure||147
6612380|NCT02123329|7538062|FG001|STARTED|12 Month Outcome Measure||167
6612381|NCT02123329|7538061|FG000|COMPLETED|12 Month Outcome Measure||83
6612382|NCT02123329|7538062|FG001|COMPLETED|12 Month Outcome Measure||88
6612383|NCT02123329|7538061|FG000|NOT COMPLETED|12 Month Outcome Measure||64
6612384|NCT02123329|7538062|FG001|NOT COMPLETED|12 Month Outcome Measure||79
6612385|NCT02123446|7538068|FG000|STARTED|Period 1 (7 Days)||14
6612386|NCT02123446|7538069|FG001|STARTED|Period 1 (7 Days)||14
6612387|NCT02123446|7538068|FG000|COMPLETED|Period 1 (7 Days)||14
6612388|NCT02123446|7538069|FG001|COMPLETED|Period 1 (7 Days)||14
6612389|NCT02123446|7538068|FG000|NOT COMPLETED|Period 1 (7 Days)||0
6612390|NCT02123446|7538069|FG001|NOT COMPLETED|Period 1 (7 Days)||0
6612391|NCT02123446|7538068|FG000|STARTED|Washout Period (1 Day)||14
6612392|NCT02123446|7538069|FG001|STARTED|Washout Period (1 Day)||14
6612393|NCT02123446|7538068|FG000|COMPLETED|Washout Period (1 Day)||13
6612394|NCT02123446|7538069|FG001|COMPLETED|Washout Period (1 Day)||14
6612395|NCT02123446|7538068|FG000|NOT COMPLETED|Washout Period (1 Day)||1
6612396|NCT02123446|7538069|FG001|NOT COMPLETED|Washout Period (1 Day)||0
6612397|NCT02123446|7538068|FG000|STARTED|Period 2 (7 Days)||13
6612398|NCT02123446|7538069|FG001|STARTED|Period 2 (7 Days)||14
6612399|NCT02123446|7538068|FG000|COMPLETED|Period 2 (7 Days)||13
6612400|NCT02123446|7538069|FG001|COMPLETED|Period 2 (7 Days)||14
6612401|NCT02123446|7538068|FG000|NOT COMPLETED|Period 2 (7 Days)||0
6612402|NCT02123446|7538069|FG001|NOT COMPLETED|Period 2 (7 Days)||0
6612403|NCT02123459|7538075|FG000|STARTED|Period 1 (7 Days)||14
6612404|NCT02123459|7538076|FG001|STARTED|Period 1 (7 Days)||14
6612405|NCT02123459|7538075|FG000|COMPLETED|Period 1 (7 Days)||14
6612406|NCT02123459|7538076|FG001|COMPLETED|Period 1 (7 Days)||14
6612407|NCT02123459|7538075|FG000|NOT COMPLETED|Period 1 (7 Days)||0
6612408|NCT02123459|7538076|FG001|NOT COMPLETED|Period 1 (7 Days)||0
6612409|NCT02123459|7538075|FG000|STARTED|Washout Period (1 Day)||14
6612410|NCT02123459|7538076|FG001|STARTED|Washout Period (1 Day)||14
6612411|NCT02123459|7538075|FG000|COMPLETED|Washout Period (1 Day)||13
6612412|NCT02123459|7538076|FG001|COMPLETED|Washout Period (1 Day)||14
6612413|NCT02123459|7538075|FG000|NOT COMPLETED|Washout Period (1 Day)||1
6612414|NCT02123459|7538076|FG001|NOT COMPLETED|Washout Period (1 Day)||0
6612415|NCT02123459|7538075|FG000|STARTED|Period 2 (7 Days)||13
6612416|NCT02123459|7538076|FG001|STARTED|Period 2 (7 Days)||14
6612417|NCT02123459|7538075|FG000|COMPLETED|Period 2 (7 Days)||13
6612418|NCT02123459|7538076|FG001|COMPLETED|Period 2 (7 Days)||14
6612419|NCT02123459|7538075|FG000|NOT COMPLETED|Period 2 (7 Days)||0
6612420|NCT02123459|7538076|FG001|NOT COMPLETED|Period 2 (7 Days)||0
6612421|NCT02123472|7538082|FG000|STARTED|Period 1 (7 Days)||14
6612422|NCT02123472|7538083|FG001|STARTED|Period 1 (7 Days)||14
6612423|NCT02123472|7538082|FG000|COMPLETED|Period 1 (7 Days)||14
6612424|NCT02123472|7538083|FG001|COMPLETED|Period 1 (7 Days)||14
6612425|NCT02123472|7538082|FG000|NOT COMPLETED|Period 1 (7 Days)||0
6612426|NCT02123472|7538083|FG001|NOT COMPLETED|Period 1 (7 Days)||0
6612427|NCT02123472|7538082|FG000|STARTED|Washout Period (1 Day)||14
6612428|NCT02123472|7538083|FG001|STARTED|Washout Period (1 Day)||14
6612429|NCT02123472|7538082|FG000|COMPLETED|Washout Period (1 Day)||14
6612430|NCT02123472|7538083|FG001|COMPLETED|Washout Period (1 Day)||14
6612431|NCT02123472|7538082|FG000|NOT COMPLETED|Washout Period (1 Day)||0
6612432|NCT02123472|7538083|FG001|NOT COMPLETED|Washout Period (1 Day)||0
6612433|NCT02123472|7538082|FG000|STARTED|Period 2 (7 Days)||14
6612434|NCT02123472|7538083|FG001|STARTED|Period 2 (7 Days)||14
6612435|NCT02123472|7538082|FG000|COMPLETED|Period 2 (7 Days)||14
6612436|NCT02123472|7538083|FG001|COMPLETED|Period 2 (7 Days)||13
6612437|NCT02123472|7538082|FG000|NOT COMPLETED|Period 2 (7 Days)||0
6612438|NCT02123472|7538083|FG001|NOT COMPLETED|Period 2 (7 Days)||1
6612439|NCT02123485|7538091|FG000|STARTED|Overall Study||18
6612440|NCT02123485|7538092|FG001|STARTED|Overall Study||17
6612441|NCT02123485|7538091|FG000|COMPLETED|Overall Study||17
6612442|NCT02123485|7538092|FG001|COMPLETED|Overall Study||17
6612443|NCT02123485|7538091|FG000|NOT COMPLETED|Overall Study||1
6612444|NCT02123485|7538092|FG001|NOT COMPLETED|Overall Study||0
6612445|NCT02123511|7538100|FG000|STARTED|Overall Study||18
6612446|NCT02123511|7538101|FG001|STARTED|Overall Study||16
6612447|NCT02123511|7538100|FG000|Eligible Patients|Overall Study||17
6612448|NCT02123511|7538101|FG001|Eligible Patients|Overall Study||15
6612449|NCT02123511|7538100|FG000|COMPLETED|Overall Study||16
6612450|NCT02123511|7538101|FG001|COMPLETED|Overall Study||12
6612451|NCT02123511|7538100|FG000|NOT COMPLETED|Overall Study||2
6612452|NCT02123511|7538101|FG001|NOT COMPLETED|Overall Study||4
6612453|NCT02123576|7538109|FG000|STARTED|Overall Study||6
6612454|NCT02123576|7538110|FG001|STARTED|Overall Study||6
6612455|NCT02123576|7538109|FG000|COMPLETED|Overall Study||5
6612456|NCT02123576|7538110|FG001|COMPLETED|Overall Study||6
6612457|NCT02123576|7538109|FG000|NOT COMPLETED|Overall Study||1
6612458|NCT02123576|7538110|FG001|NOT COMPLETED|Overall Study||0
6612459|NCT02123745|7538116|FG000|STARTED|Overall Study||71
6612460|NCT02123745|7538116|FG000|COMPLETED|Overall Study||71
6612461|NCT02123745|7538116|FG000|NOT COMPLETED|Overall Study||0
6612462|NCT02123797|7538122|FG000|STARTED|Baseline Intervention||178
6612463|NCT02123797|7538123|FG001|STARTED|Baseline Intervention||348
6612464|NCT02123797|7538124|FG002|STARTED|Baseline Intervention||100
6612465|NCT02123797|7538125|FG003|STARTED|Baseline Intervention||144
6612466|NCT02123797|7538126|FG004|STARTED|Baseline Intervention||11
6612467|NCT02123797|7538122|FG000|COMPLETED|Baseline Intervention||156
6612468|NCT02123797|7538123|FG001|COMPLETED|Baseline Intervention||306
6612469|NCT02123797|7538124|FG002|COMPLETED|Baseline Intervention||100
6612470|NCT02123797|7538125|FG003|COMPLETED|Baseline Intervention||144
6612471|NCT02123797|7538126|FG004|COMPLETED|Baseline Intervention||11
6612472|NCT02123797|7538122|FG000|NOT COMPLETED|Baseline Intervention||22
6612473|NCT02123797|7538123|FG001|NOT COMPLETED|Baseline Intervention||42
6612474|NCT02123797|7538124|FG002|NOT COMPLETED|Baseline Intervention||0
6612475|NCT02123797|7538125|FG003|NOT COMPLETED|Baseline Intervention||0
6612476|NCT02123797|7538126|FG004|NOT COMPLETED|Baseline Intervention||0
6612477|NCT02123797|7538122|FG000|STARTED|3-month Follow up (Cumulative Counts)||156
6612478|NCT02123797|7538123|FG001|STARTED|3-month Follow up (Cumulative Counts)||306
6612479|NCT02123797|7538124|FG002|STARTED|3-month Follow up (Cumulative Counts)||100
6612480|NCT02123797|7538125|FG003|STARTED|3-month Follow up (Cumulative Counts)||144
6612481|NCT02123797|7538126|FG004|STARTED|3-month Follow up (Cumulative Counts)|Clinical providers received 6 month follow-up rather than 3 month follow-up at this stage.|11
6612482|NCT02123797|7538122|FG000|COMPLETED|3-month Follow up (Cumulative Counts)||99
6612483|NCT02123797|7538123|FG001|COMPLETED|3-month Follow up (Cumulative Counts)||189
6612484|NCT02123797|7538124|FG002|COMPLETED|3-month Follow up (Cumulative Counts)||50
6612485|NCT02123797|7538125|FG003|COMPLETED|3-month Follow up (Cumulative Counts)||62
6612486|NCT02123797|7538126|FG004|COMPLETED|3-month Follow up (Cumulative Counts)||8
6612487|NCT02123797|7538122|FG000|NOT COMPLETED|3-month Follow up (Cumulative Counts)||57
6612488|NCT02123797|7538123|FG001|NOT COMPLETED|3-month Follow up (Cumulative Counts)||117
6612489|NCT02123797|7538124|FG002|NOT COMPLETED|3-month Follow up (Cumulative Counts)||50
6612490|NCT02123797|7538125|FG003|NOT COMPLETED|3-month Follow up (Cumulative Counts)||82
6612491|NCT02123797|7538126|FG004|NOT COMPLETED|3-month Follow up (Cumulative Counts)||3
6612492|NCT02123797|7538122|FG000|STARTED|6-month Follow up (Cumulative Counts)||156
6612493|NCT02123797|7538123|FG001|STARTED|6-month Follow up (Cumulative Counts)||306
6612494|NCT02123797|7538124|FG002|STARTED|6-month Follow up (Cumulative Counts)||100
6612495|NCT02123797|7538125|FG003|STARTED|6-month Follow up (Cumulative Counts)||144
6612496|NCT02123797|7538126|FG004|STARTED|6-month Follow up (Cumulative Counts)|Clinical providers received 12 month follow-up rather than 6-month follow-up at this stage.|8
6612497|NCT02123797|7538122|FG000|COMPLETED|6-month Follow up (Cumulative Counts)||101
6612498|NCT02123797|7538123|FG001|COMPLETED|6-month Follow up (Cumulative Counts)||178
6612499|NCT02123797|7538124|FG002|COMPLETED|6-month Follow up (Cumulative Counts)||34
6612500|NCT02123797|7538125|FG003|COMPLETED|6-month Follow up (Cumulative Counts)||31
6612501|NCT02123797|7538126|FG004|COMPLETED|6-month Follow up (Cumulative Counts)||5
6612502|NCT02123797|7538122|FG000|NOT COMPLETED|6-month Follow up (Cumulative Counts)||55
6612503|NCT02123797|7538123|FG001|NOT COMPLETED|6-month Follow up (Cumulative Counts)||128
6612504|NCT02123797|7538124|FG002|NOT COMPLETED|6-month Follow up (Cumulative Counts)||66
6612505|NCT02123797|7538125|FG003|NOT COMPLETED|6-month Follow up (Cumulative Counts)||113
6612506|NCT02123797|7538126|FG004|NOT COMPLETED|6-month Follow up (Cumulative Counts)||3
6612507|NCT02123849|7538148|FG000|STARTED|Overall Study||27
6612508|NCT02123849|7538149|FG001|STARTED|Overall Study||27
6612509|NCT02123849|7538148|FG000|COMPLETED|Overall Study||23
6612510|NCT02123849|7538149|FG001|COMPLETED|Overall Study||18
6612511|NCT02123849|7538148|FG000|NOT COMPLETED|Overall Study||4
6612512|NCT02123849|7538149|FG001|NOT COMPLETED|Overall Study||9
6612513|NCT02123966|7538157|FG000|STARTED|Overall Study||10
6612514|NCT02123966|7538157|FG000|COMPLETED|Overall Study||9
6612515|NCT02123966|7538157|FG000|NOT COMPLETED|Overall Study||1
6612516|NCT02124018|7538164|FG000|STARTED|Overall Study||371
6612517|NCT02124018|7538165|FG001|STARTED|Overall Study||111
6612518|NCT02124018|7538166|FG002|STARTED|Overall Study||41
6612519|NCT02124018|7538164|FG000|COMPLETED|Overall Study||371
6612520|NCT02124018|7538165|FG001|COMPLETED|Overall Study||111
6612521|NCT02124018|7538166|FG002|COMPLETED|Overall Study|Numbers do not add up to 575 (enrolled) due to refusals of programmed ventricular stimulation|41
6612522|NCT02124018|7538164|FG000|NOT COMPLETED|Overall Study||0
6612523|NCT02124018|7538165|FG001|NOT COMPLETED|Overall Study||0
6612524|NCT02124018|7538166|FG002|NOT COMPLETED|Overall Study||0
6612525|NCT02124044|7538179|FG000|STARTED|Overall Study||20
6612526|NCT02124044|7538180|FG001|STARTED|Overall Study||10
6612527|NCT02124044|7538179|FG000|COMPLETED|Overall Study||20
6612528|NCT02124044|7538180|FG001|COMPLETED|Overall Study||9
6612529|NCT02124044|7538179|FG000|NOT COMPLETED|Overall Study||0
6612530|NCT02124044|7538180|FG001|NOT COMPLETED|Overall Study||1
6612531|NCT02124083|7538186|FG000|STARTED|Overall Study||12
6612532|NCT02124083|7538186|FG000|COMPLETED|Overall Study||11
6612533|NCT02124083|7538186|FG000|NOT COMPLETED|Overall Study||1
6612534|NCT02124122|7538192|FG000|STARTED|Overall Study||41
6612535|NCT02124122|7538193|FG001|STARTED|Overall Study||19
6612536|NCT02124122|7538192|FG000|COMPLETED|Overall Study||41
6612537|NCT02124122|7538193|FG001|COMPLETED|Overall Study||19
6612538|NCT02124122|7538192|FG000|NOT COMPLETED|Overall Study||0
6612539|NCT02124122|7538193|FG001|NOT COMPLETED|Overall Study||0
6612540|NCT02124161|7538201|FG000|STARTED|Overall Study||441
6612541|NCT02124161|7538202|FG001|STARTED|Overall Study||441
6612542|NCT02124161|7538201|FG000|Vaccination 1|Overall Study||439
6612543|NCT02124161|7538202|FG001|Vaccination 1|Overall Study||437
6612544|NCT02124161|7538201|FG000|Vaccination 2|Overall Study||431
6612545|NCT02124161|7538202|FG001|Vaccination 2|Overall Study||432
6612546|NCT02124161|7538201|FG000|COMPLETED|Overall Study||425
6612547|NCT02124161|7538202|FG001|COMPLETED|Overall Study||426
6612548|NCT02124161|7538201|FG000|NOT COMPLETED|Overall Study||16
6612549|NCT02124161|7538202|FG001|NOT COMPLETED|Overall Study||15
6612550|NCT02124265|7538215|FG000|STARTED|Overall Study||3
6612551|NCT02124265|7538215|FG000|COMPLETED|Overall Study||2
6612552|NCT02124265|7538215|FG000|NOT COMPLETED|Overall Study||1
6612553|NCT02124304|7538221|FG000|STARTED|Overall Study||15
6612554|NCT02124304|7538222|FG001|STARTED|Overall Study||15
6612555|NCT02124304|7538221|FG000|COMPLETED|Overall Study||15
6612556|NCT02124304|7538222|FG001|COMPLETED|Overall Study||15
6612557|NCT02124304|7538221|FG000|NOT COMPLETED|Overall Study||0
6612558|NCT02124304|7538222|FG001|NOT COMPLETED|Overall Study||0
6612559|NCT02124460|7538230|FG000|STARTED|Overall Study||361
6612560|NCT02124460|7538231|FG001|STARTED|Overall Study||360
6612561|NCT02124460|7538230|FG000|COMPLETED|Overall Study||328
6612562|NCT02124460|7538231|FG001|COMPLETED|Overall Study||336
6612563|NCT02124460|7538230|FG000|NOT COMPLETED|Overall Study||33
6612564|NCT02124460|7538231|FG001|NOT COMPLETED|Overall Study||24
6612565|NCT02124512|7538240|FG000|STARTED|Overall Study||6
6612566|NCT02124512|7538241|FG001|STARTED|Overall Study||6
6612567|NCT02124512|7538240|FG000|COMPLETED|Overall Study||6
6612568|NCT02124512|7538241|FG001|COMPLETED|Overall Study||6
6612569|NCT02124512|7538240|FG000|NOT COMPLETED|Overall Study||0
6612570|NCT02124512|7538241|FG001|NOT COMPLETED|Overall Study||0
6612571|NCT02124564|7538247|FG000|STARTED|Treatment Period||19
6612572|NCT02124564|7538247|FG000|Started Treatment Period|Treatment Period||19
6612573|NCT02124564|7538247|FG000|Started Titration Period|Treatment Period||19
6612574|NCT02124564|7538247|FG000|Started AED Withdrawal Period|Treatment Period||19
6612575|NCT02124564|7538247|FG000|Started Monotherapy Period|Treatment Period||17
6612576|NCT02124564|7538247|FG000|Started Evaluation Period|Treatment Period||17
6612577|NCT02124564|7538247|FG000|Started Follow-Up Period|Treatment Period||13
6612578|NCT02124564|7538247|FG000|COMPLETED|Treatment Period||12
6612579|NCT02124564|7538247|FG000|NOT COMPLETED|Treatment Period||7
6612580|NCT02124564|7538247|FG000|STARTED|Taper Period||2
6612581|NCT02124564|7538247|FG000|COMPLETED|Taper Period||2
6612582|NCT02124564|7538247|FG000|NOT COMPLETED|Taper Period||0
6612583|NCT02124603|7538252|FG000|STARTED|Overall Study||120
6612584|NCT02124603|7538252|FG000|COMPLETED|Overall Study||120
6612585|NCT02124603|7538252|FG000|NOT COMPLETED|Overall Study||0
6612586|NCT02124707|7538257|FG000|STARTED|Overall Study||14
6612587|NCT02124707|7538257|FG000|COMPLETED|Overall Study||7
6612588|NCT02124707|7538257|FG000|NOT COMPLETED|Overall Study||7
6612589|NCT02124746|7538265|FG000|STARTED|Overall Study||30
6612590|NCT02124746|7538266|FG001|STARTED|Overall Study||22
6612591|NCT02124746|7538267|FG002|STARTED|Overall Study||22
6612592|NCT02124746|7538265|FG000|COMPLETED|Overall Study||11
6612593|NCT02124746|7538266|FG001|COMPLETED|Overall Study||4
6612594|NCT02124746|7538267|FG002|COMPLETED|Overall Study||0
6612595|NCT02124746|7538265|FG000|NOT COMPLETED|Overall Study||19
6612596|NCT02124746|7538266|FG001|NOT COMPLETED|Overall Study||18
6612597|NCT02124746|7538267|FG002|NOT COMPLETED|Overall Study||22
6612598|NCT02124759|7538278|FG000|STARTED|Overall Study||6
6612599|NCT02124759|7538279|FG001|STARTED|Overall Study||7
6612600|NCT02124759|7538280|FG002|STARTED|Overall Study||7
6612601|NCT02124759|7538278|FG000|Subjects Randomized to Intervention|Overall Study||4
6612602|NCT02124759|7538279|FG001|Subjects Randomized to Intervention|Overall Study||5
6612603|NCT02124759|7538280|FG002|Subjects Randomized to Intervention|Overall Study||4
6612604|NCT02124759|7538278|FG000|Low Fat Diet|Overall Study|2 subjects did not complete and were withdrawn|4
6612605|NCT02124759|7538279|FG001|Low Fat Diet|Overall Study||4
6612606|NCT02124759|7538280|FG002|Low Fat Diet|Overall Study||4
6612607|NCT02124759|7538278|FG000|High Fat Diet|Overall Study|1 subject did not complete|2
6612608|NCT02124759|7538279|FG001|High Fat Diet|Overall Study|One subject withdrew (low fat diet had already been completed)|5
6612609|NCT02124759|7538280|FG002|High Fat Diet|Overall Study|One subject withdrew and did not complete the low fat diet|4
6612610|NCT02124759|7538278|FG000|COMPLETED|Overall Study||1
6612611|NCT02124759|7538279|FG001|COMPLETED|Overall Study||4
6612612|NCT02124759|7538280|FG002|COMPLETED|Overall Study||3
6612613|NCT02124759|7538278|FG000|NOT COMPLETED|Overall Study||5
6612614|NCT02124759|7538279|FG001|NOT COMPLETED|Overall Study||3
6612615|NCT02124759|7538280|FG002|NOT COMPLETED|Overall Study||4
6612616|NCT02124772|7538306|FG000|STARTED|Overall Study||3
6612617|NCT02124772|7538307|FG001|STARTED|Overall Study||19
6612618|NCT02124772|7538308|FG002|STARTED|Overall Study||12
6612619|NCT02124772|7538309|FG003|STARTED|Overall Study||16
6612620|NCT02124772|7538310|FG004|STARTED|Overall Study||11
6612621|NCT02124772|7538311|FG005|STARTED|Overall Study||10
6612622|NCT02124772|7538312|FG006|STARTED|Overall Study||10
6612623|NCT02124772|7538313|FG007|STARTED|Overall Study||10
6612624|NCT02124772|7538314|FG008|STARTED|Overall Study||3
6612625|NCT02124772|7538315|FG009|STARTED|Overall Study||9
6612626|NCT02124772|7538316|FG010|STARTED|Overall Study||6
6612627|NCT02124772|7538317|FG011|STARTED|Overall Study||20
6612628|NCT02124772|7538318|FG012|STARTED|Overall Study||10
6612629|NCT02124772|7538306|FG000|COMPLETED|Overall Study||0
6612630|NCT02124772|7538307|FG001|COMPLETED|Overall Study||5
6612631|NCT02124772|7538308|FG002|COMPLETED|Overall Study||6
6612632|NCT02124772|7538309|FG003|COMPLETED|Overall Study||3
6612633|NCT02124772|7538310|FG004|COMPLETED|Overall Study||2
6612634|NCT02124772|7538311|FG005|COMPLETED|Overall Study||2
6612635|NCT02124772|7538312|FG006|COMPLETED|Overall Study||2
6612636|NCT02124772|7538313|FG007|COMPLETED|Overall Study||1
6612637|NCT02124772|7538314|FG008|COMPLETED|Overall Study||2
6612638|NCT02124772|7538315|FG009|COMPLETED|Overall Study||2
6612639|NCT02124772|7538316|FG010|COMPLETED|Overall Study||4
6612640|NCT02124772|7538317|FG011|COMPLETED|Overall Study||14
6612641|NCT02124772|7538318|FG012|COMPLETED|Overall Study||8
6612642|NCT02124772|7538306|FG000|NOT COMPLETED|Overall Study||3
6612643|NCT02124772|7538307|FG001|NOT COMPLETED|Overall Study||14
6612644|NCT02124772|7538308|FG002|NOT COMPLETED|Overall Study||6
6612645|NCT02124772|7538309|FG003|NOT COMPLETED|Overall Study||13
6612646|NCT02124772|7538310|FG004|NOT COMPLETED|Overall Study||9
6612647|NCT02124772|7538311|FG005|NOT COMPLETED|Overall Study||8
6612648|NCT02124772|7538312|FG006|NOT COMPLETED|Overall Study||8
6612649|NCT02124772|7538313|FG007|NOT COMPLETED|Overall Study||9
6612650|NCT02124772|7538314|FG008|NOT COMPLETED|Overall Study||1
6612651|NCT02124772|7538315|FG009|NOT COMPLETED|Overall Study||7
6612652|NCT02124772|7538316|FG010|NOT COMPLETED|Overall Study||2
6612653|NCT02124772|7538317|FG011|NOT COMPLETED|Overall Study||6
6612654|NCT02124772|7538318|FG012|NOT COMPLETED|Overall Study||2
6612655|NCT02124798|7538370|FG000|STARTED|Overall Study||95
6612656|NCT02124798|7538370|FG000|COMPLETED|Overall Study||91
6612657|NCT02124798|7538370|FG000|NOT COMPLETED|Overall Study||4
6612658|NCT02124811|7538376|FG000|STARTED|Overall Study||5
6612659|NCT02124811|7538377|FG001|STARTED|Overall Study||5
6612660|NCT02124811|7538376|FG000|COMPLETED|Overall Study||2
6612661|NCT02124811|7538377|FG001|COMPLETED|Overall Study||3
6612662|NCT02124811|7538376|FG000|NOT COMPLETED|Overall Study||3
6612663|NCT02124811|7538377|FG001|NOT COMPLETED|Overall Study||2
6612664|NCT02124863|7538383|FG000|STARTED|Overall Study||67
6612665|NCT02124863|7538383|FG000|COMPLETED|Overall Study||50
6612666|NCT02124863|7538383|FG000|NOT COMPLETED|Overall Study||17
6612667|NCT02124889|7538391|FG000|STARTED|Overall Study||12
6612668|NCT02124889|7538392|FG001|STARTED|Overall Study||12
6612669|NCT02124889|7538391|FG000|COMPLETED|Overall Study||12
6612670|NCT02124889|7538392|FG001|COMPLETED|Overall Study||12
6612671|NCT02124889|7538391|FG000|NOT COMPLETED|Overall Study||0
6612672|NCT02124889|7538392|FG001|NOT COMPLETED|Overall Study||0
6612673|NCT02125279|7538398|FG000|STARTED|Overall Study||54
6612674|NCT02125279|7538398|FG000|COMPLETED|Overall Study||41
6612675|NCT02125279|7538398|FG000|NOT COMPLETED|Overall Study||13
6612676|NCT02125292|7538404|FG000|STARTED|First Intervention (1 Hour)||3
6612677|NCT02125292|7538405|FG001|STARTED|First Intervention (1 Hour)||3
6612678|NCT02125292|7538406|FG002|STARTED|First Intervention (1 Hour)||3
6612679|NCT02125292|7538407|FG003|STARTED|First Intervention (1 Hour)||3
6612680|NCT02125292|7538408|FG004|STARTED|First Intervention (1 Hour)||3
6612681|NCT02125292|7538409|FG005|STARTED|First Intervention (1 Hour)||3
6612682|NCT02125292|7538404|FG000|COMPLETED|First Intervention (1 Hour)||3
6612683|NCT02125292|7538405|FG001|COMPLETED|First Intervention (1 Hour)||3
6612684|NCT02125292|7538406|FG002|COMPLETED|First Intervention (1 Hour)||3
6612685|NCT02125292|7538407|FG003|COMPLETED|First Intervention (1 Hour)||3
6612686|NCT02125292|7538408|FG004|COMPLETED|First Intervention (1 Hour)||3
6612687|NCT02125292|7538409|FG005|COMPLETED|First Intervention (1 Hour)||3
6612688|NCT02125292|7538404|FG000|NOT COMPLETED|First Intervention (1 Hour)||0
6612689|NCT02125292|7538405|FG001|NOT COMPLETED|First Intervention (1 Hour)||0
6612690|NCT02125292|7538406|FG002|NOT COMPLETED|First Intervention (1 Hour)||0
6612691|NCT02125292|7538407|FG003|NOT COMPLETED|First Intervention (1 Hour)||0
6612692|NCT02125292|7538408|FG004|NOT COMPLETED|First Intervention (1 Hour)||0
6612693|NCT02125292|7538409|FG005|NOT COMPLETED|First Intervention (1 Hour)||0
6612694|NCT02125292|7538404|FG000|STARTED|Washout (2 Hours)||3
6612695|NCT02125292|7538405|FG001|STARTED|Washout (2 Hours)||3
6612696|NCT02125292|7538406|FG002|STARTED|Washout (2 Hours)||3
6612697|NCT02125292|7538407|FG003|STARTED|Washout (2 Hours)||3
6612698|NCT02125292|7538408|FG004|STARTED|Washout (2 Hours)||3
6612699|NCT02125292|7538409|FG005|STARTED|Washout (2 Hours)||3
6612700|NCT02125292|7538404|FG000|COMPLETED|Washout (2 Hours)||3
6612701|NCT02125292|7538405|FG001|COMPLETED|Washout (2 Hours)||3
6612702|NCT02125292|7538406|FG002|COMPLETED|Washout (2 Hours)||3
6612703|NCT02125292|7538407|FG003|COMPLETED|Washout (2 Hours)||3
6612704|NCT02125292|7538408|FG004|COMPLETED|Washout (2 Hours)||3
6612705|NCT02125292|7538409|FG005|COMPLETED|Washout (2 Hours)||3
6612706|NCT02125292|7538404|FG000|NOT COMPLETED|Washout (2 Hours)||0
6612707|NCT02125292|7538405|FG001|NOT COMPLETED|Washout (2 Hours)||0
6612708|NCT02125292|7538406|FG002|NOT COMPLETED|Washout (2 Hours)||0
6612709|NCT02125292|7538407|FG003|NOT COMPLETED|Washout (2 Hours)||0
6612710|NCT02125292|7538408|FG004|NOT COMPLETED|Washout (2 Hours)||0
6612711|NCT02125292|7538409|FG005|NOT COMPLETED|Washout (2 Hours)||0
6612712|NCT02125292|7538404|FG000|STARTED|Second Intervention (1 Hour)||3
6612713|NCT02125292|7538405|FG001|STARTED|Second Intervention (1 Hour)||3
6612714|NCT02125292|7538406|FG002|STARTED|Second Intervention (1 Hour)||3
6612715|NCT02125292|7538407|FG003|STARTED|Second Intervention (1 Hour)||3
6612716|NCT02125292|7538408|FG004|STARTED|Second Intervention (1 Hour)||3
6612717|NCT02125292|7538409|FG005|STARTED|Second Intervention (1 Hour)||3
6612718|NCT02125292|7538404|FG000|COMPLETED|Second Intervention (1 Hour)||3
6612719|NCT02125292|7538405|FG001|COMPLETED|Second Intervention (1 Hour)||3
6612720|NCT02125292|7538406|FG002|COMPLETED|Second Intervention (1 Hour)||3
6612721|NCT02125292|7538407|FG003|COMPLETED|Second Intervention (1 Hour)||3
6612722|NCT02125292|7538408|FG004|COMPLETED|Second Intervention (1 Hour)||3
6612723|NCT02125292|7538409|FG005|COMPLETED|Second Intervention (1 Hour)||3
6612724|NCT02125292|7538404|FG000|NOT COMPLETED|Second Intervention (1 Hour)||0
6612725|NCT02125292|7538405|FG001|NOT COMPLETED|Second Intervention (1 Hour)||0
6612726|NCT02125292|7538406|FG002|NOT COMPLETED|Second Intervention (1 Hour)||0
6612727|NCT02125292|7538407|FG003|NOT COMPLETED|Second Intervention (1 Hour)||0
6612728|NCT02125292|7538408|FG004|NOT COMPLETED|Second Intervention (1 Hour)||0
6612729|NCT02125292|7538409|FG005|NOT COMPLETED|Second Intervention (1 Hour)||0
6612730|NCT02125292|7538404|FG000|STARTED|Washout (2 Hours)||3
6612731|NCT02125292|7538405|FG001|STARTED|Washout (2 Hours)||3
6612732|NCT02125292|7538406|FG002|STARTED|Washout (2 Hours)||3
6612733|NCT02125292|7538407|FG003|STARTED|Washout (2 Hours)||3
6612734|NCT02125292|7538408|FG004|STARTED|Washout (2 Hours)||3
6612735|NCT02125292|7538409|FG005|STARTED|Washout (2 Hours)||3
6612736|NCT02125292|7538404|FG000|COMPLETED|Washout (2 Hours)||3
6612737|NCT02125292|7538405|FG001|COMPLETED|Washout (2 Hours)||3
6612738|NCT02125292|7538406|FG002|COMPLETED|Washout (2 Hours)||3
6612739|NCT02125292|7538407|FG003|COMPLETED|Washout (2 Hours)||3
6612740|NCT02125292|7538408|FG004|COMPLETED|Washout (2 Hours)||3
6612741|NCT02125292|7538409|FG005|COMPLETED|Washout (2 Hours)||3
6612742|NCT02125292|7538404|FG000|NOT COMPLETED|Washout (2 Hours)||0
6612743|NCT02125292|7538405|FG001|NOT COMPLETED|Washout (2 Hours)||0
6612744|NCT02125292|7538406|FG002|NOT COMPLETED|Washout (2 Hours)||0
6612745|NCT02125292|7538407|FG003|NOT COMPLETED|Washout (2 Hours)||0
6612746|NCT02125292|7538408|FG004|NOT COMPLETED|Washout (2 Hours)||0
6612747|NCT02125292|7538409|FG005|NOT COMPLETED|Washout (2 Hours)||0
6612748|NCT02125292|7538404|FG000|STARTED|Third Intervention (1 Hour)||3
6612749|NCT02125292|7538405|FG001|STARTED|Third Intervention (1 Hour)||3
6612750|NCT02125292|7538406|FG002|STARTED|Third Intervention (1 Hour)||3
6612751|NCT02125292|7538407|FG003|STARTED|Third Intervention (1 Hour)||3
6612752|NCT02125292|7538408|FG004|STARTED|Third Intervention (1 Hour)||3
6612753|NCT02125292|7538409|FG005|STARTED|Third Intervention (1 Hour)||3
6612754|NCT02125292|7538404|FG000|COMPLETED|Third Intervention (1 Hour)||3
6612755|NCT02125292|7538405|FG001|COMPLETED|Third Intervention (1 Hour)||3
6612756|NCT02125292|7538406|FG002|COMPLETED|Third Intervention (1 Hour)||3
6612757|NCT02125292|7538407|FG003|COMPLETED|Third Intervention (1 Hour)||3
6612758|NCT02125292|7538408|FG004|COMPLETED|Third Intervention (1 Hour)||3
6612759|NCT02125292|7538409|FG005|COMPLETED|Third Intervention (1 Hour)||3
6612760|NCT02125292|7538404|FG000|NOT COMPLETED|Third Intervention (1 Hour)||0
6612761|NCT02125292|7538405|FG001|NOT COMPLETED|Third Intervention (1 Hour)||0
6612762|NCT02125292|7538406|FG002|NOT COMPLETED|Third Intervention (1 Hour)||0
6612763|NCT02125292|7538407|FG003|NOT COMPLETED|Third Intervention (1 Hour)||0
6612764|NCT02125292|7538408|FG004|NOT COMPLETED|Third Intervention (1 Hour)||0
6612765|NCT02125292|7538409|FG005|NOT COMPLETED|Third Intervention (1 Hour)||0
6612766|NCT02125331|7538420|FG000|STARTED|Overall Study||58
6612767|NCT02125331|7538421|FG001|STARTED|Overall Study||25
6612768|NCT02125331|7538420|FG000|COMPLETED|Overall Study||53
6612769|NCT02125331|7538421|FG001|COMPLETED|Overall Study||25
6612770|NCT02125331|7538420|FG000|NOT COMPLETED|Overall Study||5
6612771|NCT02125331|7538421|FG001|NOT COMPLETED|Overall Study||0
6612772|NCT02125604|7538427|FG000|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
6612773|NCT02125604|7538427|FG000|COMPLETED|Overall Study||180
6612774|NCT02125604|7538427|FG000|NOT COMPLETED|Overall Study||31
6612775|NCT02125721|7538431|FG000|STARTED|Overall Study||10
6612776|NCT02125721|7538431|FG000|COMPLETED|Overall Study||10
6612777|NCT02125721|7538431|FG000|NOT COMPLETED|Overall Study||0
6612778|NCT02125734|7538437|FG000|STARTED|Period 1||40
6612779|NCT02125734|7538438|FG001|STARTED|Period 1||48
6612780|NCT02125734|7538437|FG000|COMPLETED|Period 1||40
6612781|NCT02125734|7538438|FG001|COMPLETED|Period 1||48
6612782|NCT02125734|7538437|FG000|NOT COMPLETED|Period 1||0
6612783|NCT02125734|7538438|FG001|NOT COMPLETED|Period 1||0
6612784|NCT02125734|7538437|FG000|STARTED|Period 2||40
6612785|NCT02125734|7538438|FG001|STARTED|Period 2||48
6612786|NCT02125734|7538437|FG000|COMPLETED|Period 2||40
6612787|NCT02125734|7538438|FG001|COMPLETED|Period 2||47
6612788|NCT02125734|7538437|FG000|NOT COMPLETED|Period 2||0
6612789|NCT02125734|7538438|FG001|NOT COMPLETED|Period 2||1
6612790|NCT02125838|7538446|FG000|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
6612791|NCT02125838|7538447|FG001|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
6612792|NCT02125838|7538446|FG000|COMPLETED|Overall Study|Analysed (n=50 )|50
6612793|NCT02125838|7538447|FG001|COMPLETED|Overall Study|Analysed (n=50 )|50
6612794|NCT02125838|7538446|FG000|NOT COMPLETED|Overall Study||4
6612795|NCT02125838|7538447|FG001|NOT COMPLETED|Overall Study||4
6612796|NCT02125877|7538455|FG000|STARTED|Overall Study||86
6612797|NCT02125877|7538456|FG001|STARTED|Overall Study||87
6612798|NCT02125877|7538455|FG000|Pharmacokinetic Analysis Set|Overall Study||83
6612799|NCT02125877|7538456|FG001|Pharmacokinetic Analysis Set|Overall Study||83
6612800|NCT02125877|7538455|FG000|Pharmacokinetic Subset A|Overall Study||16
6612801|NCT02125877|7538456|FG001|Pharmacokinetic Subset A|Overall Study||15
6612802|NCT02125877|7538455|FG000|Safety Set|Overall Study||86
6612803|NCT02125877|7538456|FG001|Safety Set|Overall Study||87
6612804|NCT02125877|7538455|FG000|COMPLETED|Overall Study||73
6612805|NCT02125877|7538456|FG001|COMPLETED|Overall Study||77
6612806|NCT02125877|7538455|FG000|NOT COMPLETED|Overall Study||13
6612807|NCT02125877|7538456|FG001|NOT COMPLETED|Overall Study||10
6612808|NCT02126306|7538464|FG000|STARTED|Overall Study||10
6612809|NCT02126306|7538465|FG001|STARTED|Overall Study||13
6612810|NCT02126306|7538464|FG000|COMPLETED|Overall Study||10
6612811|NCT02126306|7538465|FG001|COMPLETED|Overall Study||13
6612812|NCT02126306|7538464|FG000|NOT COMPLETED|Overall Study||0
6612813|NCT02126306|7538465|FG001|NOT COMPLETED|Overall Study||0
6612814|NCT02126319|7538473|FG000|STARTED|Overall Study||61
6612815|NCT02126319|7538474|FG001|STARTED|Overall Study||67
6612816|NCT02126319|7538473|FG000|COMPLETED|Overall Study||40
6612817|NCT02126319|7538474|FG001|COMPLETED|Overall Study||43
6612818|NCT02126319|7538473|FG000|NOT COMPLETED|Overall Study||21
6612819|NCT02126319|7538474|FG001|NOT COMPLETED|Overall Study||24
6612820|NCT02126670|7538486|FG000|STARTED|Overall Study||26
6612821|NCT02126670|7538487|FG001|STARTED|Overall Study||24
6612822|NCT02126670|7538488|FG002|STARTED|Overall Study||25
6612823|NCT02126670|7538489|FG003|STARTED|Overall Study||25
6612824|NCT02126670|7538486|FG000|COMPLETED|Overall Study||25
6612825|NCT02126670|7538487|FG001|COMPLETED|Overall Study||24
6612826|NCT02126670|7538488|FG002|COMPLETED|Overall Study||25
6612827|NCT02126670|7538489|FG003|COMPLETED|Overall Study||24
6612828|NCT02126670|7538486|FG000|NOT COMPLETED|Overall Study||1
6612829|NCT02126670|7538487|FG001|NOT COMPLETED|Overall Study||0
6612830|NCT02126670|7538488|FG002|NOT COMPLETED|Overall Study||0
6612831|NCT02126670|7538489|FG003|NOT COMPLETED|Overall Study||1
6612832|NCT02126748|7538502|FG000|STARTED|Overall Study||33
6612833|NCT02126748|7538503|FG001|STARTED|Overall Study||34
6612834|NCT02126748|7538504|FG002|STARTED|Overall Study||36
6612835|NCT02126748|7538502|FG000|COMPLETED|Overall Study||31
6612836|NCT02126748|7538503|FG001|COMPLETED|Overall Study||31
6612837|NCT02126748|7538504|FG002|COMPLETED|Overall Study||31
6612838|NCT02126748|7538502|FG000|NOT COMPLETED|Overall Study||2
6612839|NCT02126748|7538503|FG001|NOT COMPLETED|Overall Study||3
6612840|NCT02126748|7538504|FG002|NOT COMPLETED|Overall Study||5
6612841|NCT02126826|7538519|FG000|STARTED|Overall Study||9
6612842|NCT02126826|7538520|FG001|STARTED|Overall Study||9
6612843|NCT02126826|7538521|FG002|STARTED|Overall Study||9
6612844|NCT02126826|7538522|FG003|STARTED|Overall Study||9
6612845|NCT02126826|7538523|FG004|STARTED|Overall Study||5
6612846|NCT02126826|7538524|FG005|STARTED|Overall Study||9
6612847|NCT02126826|7538525|FG006|STARTED|Overall Study||8
6612848|NCT02126826|7538519|FG000|COMPLETED|Overall Study||9
6612849|NCT02126826|7538520|FG001|COMPLETED|Overall Study||9
6612850|NCT02126826|7538521|FG002|COMPLETED|Overall Study||9
6612851|NCT02126826|7538522|FG003|COMPLETED|Overall Study||8
6612852|NCT02126826|7538523|FG004|COMPLETED|Overall Study||5
6612853|NCT02126826|7538524|FG005|COMPLETED|Overall Study||9
6612854|NCT02126826|7538525|FG006|COMPLETED|Overall Study||8
6612855|NCT02126826|7538519|FG000|NOT COMPLETED|Overall Study||0
6612856|NCT02126826|7538520|FG001|NOT COMPLETED|Overall Study||0
6612857|NCT02126826|7538521|FG002|NOT COMPLETED|Overall Study||0
6612858|NCT02126826|7538522|FG003|NOT COMPLETED|Overall Study||1
6612859|NCT02126826|7538523|FG004|NOT COMPLETED|Overall Study||0
6612860|NCT02126826|7538524|FG005|NOT COMPLETED|Overall Study||0
6612861|NCT02126826|7538525|FG006|NOT COMPLETED|Overall Study||0
6612862|NCT02126839|7538548|FG000|STARTED|Overall Study||92
6612863|NCT02126839|7538549|FG001|STARTED|Overall Study||94
6612864|NCT02126839|7538548|FG000|Safety Population|Overall Study||92
6612865|NCT02126839|7538549|FG001|Safety Population|Overall Study||93
6612866|NCT02126839|7538548|FG000|Full Analysis Set|Overall Study||92
6612867|NCT02126839|7538549|FG001|Full Analysis Set|Overall Study||92
6612868|NCT02126839|7538548|FG000|COMPLETED|Overall Study||82
6612869|NCT02126839|7538549|FG001|COMPLETED|Overall Study||80
6612870|NCT02126839|7538548|FG000|NOT COMPLETED|Overall Study||10
6612871|NCT02126839|7538549|FG001|NOT COMPLETED|Overall Study||14
6612872|NCT02126969|7538557|FG000|STARTED|Overall Study||23
6612873|NCT02126969|7538558|FG001|STARTED|Overall Study||22
6612874|NCT02126969|7538557|FG000|COMPLETED|Overall Study||22
6612875|NCT02126969|7538558|FG001|COMPLETED|Overall Study||20
6612876|NCT02126969|7538557|FG000|NOT COMPLETED|Overall Study||1
6612877|NCT02126969|7538558|FG001|NOT COMPLETED|Overall Study||2
6612878|NCT02127125|7538573|FG000|STARTED|Overall Study||6
6612879|NCT02127125|7538574|FG001|STARTED|Overall Study||8
6612880|NCT02127125|7538575|FG002|STARTED|Overall Study||9
6612881|NCT02127125|7538576|FG003|STARTED|Overall Study||11
6612882|NCT02127125|7538577|FG004|STARTED|Overall Study||12
6612883|NCT02127125|7538578|FG005|STARTED|Overall Study||12
6612884|NCT02127125|7538579|FG006|STARTED|Overall Study||2
6612885|NCT02127125|7538580|FG007|STARTED|Overall Study||0
6612886|NCT02127125|7538581|FG008|STARTED|Overall Study||1
6612887|NCT02127125|7538573|FG000|COMPLETED|Overall Study||6
6612888|NCT02127125|7538574|FG001|COMPLETED|Overall Study||8
6612889|NCT02127125|7538575|FG002|COMPLETED|Overall Study||8
6612890|NCT02127125|7538576|FG003|COMPLETED|Overall Study||10
6612891|NCT02127125|7538577|FG004|COMPLETED|Overall Study||9
6612892|NCT02127125|7538578|FG005|COMPLETED|Overall Study||9
6612893|NCT02127125|7538579|FG006|COMPLETED|Overall Study||2
6612894|NCT02127125|7538580|FG007|COMPLETED|Overall Study||0
6612895|NCT02127125|7538581|FG008|COMPLETED|Overall Study||1
6732667|NCT03197376|7662111|FG000|Vaccinated-Dose 3|Primary and Booster Phase||492
6732668|NCT03197376|7662112|FG001|Vaccinated-Dose 3|Primary and Booster Phase||493
6732669|NCT03197376|7662113|FG002|Vaccinated-Dose 3|Primary and Booster Phase||490
6732670|NCT03197376|7662114|FG003|Vaccinated-Dose 3|Primary and Booster Phase||731
6732671|NCT03197376|7662111|FG000|Primary Reactogenicity Cohort|Primary and Booster Phase||251
6732672|NCT03197376|7662112|FG001|Primary Reactogenicity Cohort|Primary and Booster Phase||243
6732673|NCT03197376|7662113|FG002|Primary Reactogenicity Cohort|Primary and Booster Phase||257
6732674|NCT03197376|7662114|FG003|Primary Reactogenicity Cohort|Primary and Booster Phase||364
6732675|NCT03197376|7662111|FG000|Booster Cohort|Primary and Booster Phase||150
6732676|NCT03197376|7662112|FG001|Booster Cohort|Primary and Booster Phase||151
6732677|NCT03197376|7662113|FG002|Booster Cohort|Primary and Booster Phase||150
6732678|NCT03197376|7662114|FG003|Booster Cohort|Primary and Booster Phase||224
6732679|NCT03197376|7662111|FG000|Received Booster Vaccine|Primary and Booster Phase||145
6732680|NCT03197376|7662112|FG001|Received Booster Vaccine|Primary and Booster Phase||144
6732681|NCT03197376|7662113|FG002|Received Booster Vaccine|Primary and Booster Phase||139
6732682|NCT03197376|7662114|FG003|Received Booster Vaccine|Primary and Booster Phase||213
6732683|NCT03197376|7662111|FG000|COMPLETED|Primary and Booster Phase||487
6732684|NCT03197376|7662112|FG001|COMPLETED|Primary and Booster Phase||488
6732685|NCT03197376|7662113|FG002|COMPLETED|Primary and Booster Phase||480
6732686|NCT03197376|7662114|FG003|COMPLETED|Primary and Booster Phase||722
6732687|NCT03197376|7662111|FG000|NOT COMPLETED|Primary and Booster Phase||15
6732688|NCT03197376|7662112|FG001|NOT COMPLETED|Primary and Booster Phase||13
6732689|NCT03197376|7662113|FG002|NOT COMPLETED|Primary and Booster Phase||20
6732690|NCT03197376|7662114|FG003|NOT COMPLETED|Primary and Booster Phase||25
6732691|NCT03197376|7662111|FG000|STARTED|Immune Persistence Phase||132
6732692|NCT03197376|7662112|FG001|STARTED|Immune Persistence Phase||133
6732693|NCT03197376|7662113|FG002|STARTED|Immune Persistence Phase||128
6732694|NCT03197376|7662114|FG003|STARTED|Immune Persistence Phase||195
6732695|NCT03197376|7662111|FG000|COMPLETED|Immune Persistence Phase||127
6732696|NCT03197376|7662112|FG001|COMPLETED|Immune Persistence Phase||129
6732697|NCT03197376|7662113|FG002|COMPLETED|Immune Persistence Phase||123
6732698|NCT03197376|7662114|FG003|COMPLETED|Immune Persistence Phase||190
6732699|NCT03197376|7662111|FG000|NOT COMPLETED|Immune Persistence Phase||5
6732700|NCT03197376|7662112|FG001|NOT COMPLETED|Immune Persistence Phase||4
6732701|NCT03197376|7662113|FG002|NOT COMPLETED|Immune Persistence Phase||5
6732702|NCT03197376|7662114|FG003|NOT COMPLETED|Immune Persistence Phase||5
6732703|NCT03197389|7662153|FG000|STARTED|Overall Study||16
6732704|NCT03197389|7662154|FG001|STARTED|Overall Study||5
6732705|NCT03197389|7662155|FG002|STARTED|Overall Study||18
6732706|NCT03197389|7662156|FG003|STARTED|Overall Study||9
6732707|NCT03197389|7662157|FG004|STARTED|Overall Study||1
6732708|NCT03197389|7662158|FG005|STARTED|Overall Study||5
6732709|NCT03197389|7662153|FG000|COMPLETED|Overall Study||16
6732710|NCT03197389|7662154|FG001|COMPLETED|Overall Study||5
6732711|NCT03197389|7662155|FG002|COMPLETED|Overall Study||18
6732712|NCT03197389|7662156|FG003|COMPLETED|Overall Study||9
6732713|NCT03197389|7662157|FG004|COMPLETED|Overall Study||1
6732714|NCT03197389|7662158|FG005|COMPLETED|Overall Study||5
6732715|NCT03197389|7662153|FG000|NOT COMPLETED|Overall Study||0
6732716|NCT03197389|7662154|FG001|NOT COMPLETED|Overall Study||0
6732717|NCT03197389|7662155|FG002|NOT COMPLETED|Overall Study||0
6732718|NCT03197389|7662156|FG003|NOT COMPLETED|Overall Study||0
6732719|NCT03197389|7662157|FG004|NOT COMPLETED|Overall Study||0
6732720|NCT03197389|7662158|FG005|NOT COMPLETED|Overall Study||0
6732721|NCT03197558|7662172|FG000|STARTED|Overall Study||30
6732722|NCT03197558|7662172|FG000|COMPLETED|Overall Study||29
6732723|NCT03197558|7662172|FG000|NOT COMPLETED|Overall Study||1
6732724|NCT03197883|7662178|FG000|STARTED|Overall Study||50
6732725|NCT03197883|7662179|FG001|STARTED|Overall Study||50
6612896|NCT02127125|7538573|FG000|NOT COMPLETED|Overall Study||0
6612897|NCT02127125|7538574|FG001|NOT COMPLETED|Overall Study||0
6612898|NCT02127125|7538575|FG002|NOT COMPLETED|Overall Study||1
6612899|NCT02127125|7538576|FG003|NOT COMPLETED|Overall Study||1
6612900|NCT02127125|7538577|FG004|NOT COMPLETED|Overall Study||3
6612901|NCT02127125|7538578|FG005|NOT COMPLETED|Overall Study||3
6612902|NCT02127125|7538579|FG006|NOT COMPLETED|Overall Study||0
6612903|NCT02127125|7538580|FG007|NOT COMPLETED|Overall Study||0
6612904|NCT02127125|7538581|FG008|NOT COMPLETED|Overall Study||0
6612905|NCT02127281|7538603|FG000|STARTED|Overall Study||80
6612906|NCT02127281|7538604|FG001|STARTED|Overall Study||80
6612907|NCT02127281|7538603|FG000|COMPLETED|Overall Study||79
6612908|NCT02127281|7538604|FG001|COMPLETED|Overall Study||80
6612909|NCT02127281|7538603|FG000|NOT COMPLETED|Overall Study||1
6612910|NCT02127281|7538604|FG001|NOT COMPLETED|Overall Study||0
6612911|NCT02127307|7538610|FG000|STARTED|Overall Study||964
6612912|NCT02127307|7538610|FG000|COMPLETED|Overall Study||656
6612913|NCT02127307|7538610|FG000|NOT COMPLETED|Overall Study||308
6612914|NCT02127372|7538616|FG000|STARTED|Overall Study|Signed Consent|15
6612915|NCT02127372|7538617|FG001|STARTED|Overall Study|Signed Consent|28
6612916|NCT02127372|7538616|FG000|Started Study Treatment|Overall Study||15
6612917|NCT02127372|7538617|FG001|Started Study Treatment|Overall Study||28
6612918|NCT02127372|7538616|FG000|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
6612919|NCT02127372|7538617|FG001|COMPLETED|Overall Study||28
6612920|NCT02127372|7538616|FG000|NOT COMPLETED|Overall Study||1
6612921|NCT02127372|7538617|FG001|NOT COMPLETED|Overall Study||0
6612922|NCT02127567|7538624|FG000|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
6612923|NCT02127567|7538624|FG000|COMPLETED|Overall Study||41
6612924|NCT02127567|7538624|FG000|NOT COMPLETED|Overall Study||0
6612925|NCT02127632|7538634|FG000|STARTED|Overall Study||50
6612926|NCT02127632|7538635|FG001|STARTED|Overall Study||50
6612927|NCT02127632|7538634|FG000|COMPLETED|Overall Study||50
6612928|NCT02127632|7538635|FG001|COMPLETED|Overall Study||50
6612929|NCT02127632|7538634|FG000|NOT COMPLETED|Overall Study||0
6612930|NCT02127632|7538635|FG001|NOT COMPLETED|Overall Study||0
6612931|NCT02127710|7538644|FG000|STARTED|Overall Study||46
6612932|NCT02127710|7538645|FG001|STARTED|Overall Study||47
6612933|NCT02127710|7538646|FG002|STARTED|Overall Study||16
6612934|NCT02127710|7538644|FG000|COMPLETED|Overall Study||46
6612935|NCT02127710|7538645|FG001|COMPLETED|Overall Study||47
6612936|NCT02127710|7538646|FG002|COMPLETED|Overall Study||16
6612937|NCT02127710|7538644|FG000|NOT COMPLETED|Overall Study||0
6612938|NCT02127710|7538645|FG001|NOT COMPLETED|Overall Study||0
6612939|NCT02127710|7538646|FG002|NOT COMPLETED|Overall Study||0
6612940|NCT02127723|7538657|FG000|STARTED|Overall Study||20
6612941|NCT02127723|7538657|FG000|COMPLETED|Overall Study||19
6612942|NCT02127723|7538657|FG000|NOT COMPLETED|Overall Study||1
6612943|NCT02127892|7538665|FG000|STARTED|Overall Study||7
6612944|NCT02127892|7538666|FG001|STARTED|Overall Study||2
6612945|NCT02127892|7538667|FG002|STARTED|Overall Study||0
6612946|NCT02127892|7538668|FG003|STARTED|Overall Study||0
6612947|NCT02127892|7538665|FG000|COMPLETED|Overall Study||6
6612948|NCT02127892|7538666|FG001|COMPLETED|Overall Study||1
6612949|NCT02127892|7538667|FG002|COMPLETED|Overall Study||0
6612950|NCT02127892|7538668|FG003|COMPLETED|Overall Study||0
6612951|NCT02127892|7538665|FG000|NOT COMPLETED|Overall Study||1
6612952|NCT02127892|7538666|FG001|NOT COMPLETED|Overall Study||1
6612953|NCT02127892|7538667|FG002|NOT COMPLETED|Overall Study||0
6612954|NCT02127892|7538668|FG003|NOT COMPLETED|Overall Study||0
6612955|NCT02127931|7538678|FG000|STARTED|Overall Study||18
6612956|NCT02127931|7538678|FG000|COMPLETED|Overall Study||17
6612957|NCT02127931|7538678|FG000|NOT COMPLETED|Overall Study||1
6612958|NCT02127970|7538685|FG000|STARTED|Overall Study||349
6612959|NCT02127970|7538686|FG001|STARTED|Overall Study||349
6612960|NCT02127970|7538685|FG000|COMPLETED|Overall Study||323
6612961|NCT02127970|7538686|FG001|COMPLETED|Overall Study||322
6612962|NCT02127970|7538685|FG000|NOT COMPLETED|Overall Study||26
6612963|NCT02127970|7538686|FG001|NOT COMPLETED|Overall Study||27
6612964|NCT02128074|7538692|FG000|STARTED|Overall Study||32
6612965|NCT02128074|7538692|FG000|COMPLETED|Overall Study||26
6612966|NCT02128074|7538692|FG000|NOT COMPLETED|Overall Study||6
6612967|NCT02128217|7538698|FG000|STARTED|Overall Study||17
6612968|NCT02128217|7538699|FG001|STARTED|Overall Study||27
6612969|NCT02128217|7538698|FG000|COMPLETED|Overall Study||17
6612970|NCT02128217|7538699|FG001|COMPLETED|Overall Study||26
6612971|NCT02128217|7538698|FG000|NOT COMPLETED|Overall Study||0
6612972|NCT02128217|7538699|FG001|NOT COMPLETED|Overall Study||1
6612973|NCT02128230|7538710|FG000|STARTED|Overall Study||20
6612974|NCT02128230|7538710|FG000|COMPLETED|Overall Study||1
6612975|NCT02128230|7538710|FG000|NOT COMPLETED|Overall Study||19
6612976|NCT02128269|7538714|FG000|STARTED|Treatment Period||9
6612977|NCT02128269|7538714|FG000|COMPLETED|Treatment Period||7
6612978|NCT02128269|7538714|FG000|NOT COMPLETED|Treatment Period||2
6612979|NCT02128269|7538714|FG000|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
6612980|NCT02128269|7538714|FG000|COMPLETED|Follow-up||9
6612981|NCT02128269|7538714|FG000|NOT COMPLETED|Follow-up||0
6612982|NCT02128490|7538723|FG000|STARTED|Overall Study||38
6612983|NCT02128490|7538724|FG001|STARTED|Overall Study||37
6612984|NCT02128490|7538725|FG002|STARTED|Overall Study||39
6612985|NCT02128490|7538726|FG003|STARTED|Overall Study||37
6612986|NCT02128490|7538727|FG004|STARTED|Overall Study||38
6612987|NCT02128490|7538723|FG000|COMPLETED|Overall Study||33
6612988|NCT02128490|7538724|FG001|COMPLETED|Overall Study||31
6612989|NCT02128490|7538725|FG002|COMPLETED|Overall Study||34
6612990|NCT02128490|7538726|FG003|COMPLETED|Overall Study||31
6612991|NCT02128490|7538727|FG004|COMPLETED|Overall Study||31
6612992|NCT02128490|7538723|FG000|NOT COMPLETED|Overall Study||5
6612993|NCT02128490|7538724|FG001|NOT COMPLETED|Overall Study||6
6612994|NCT02128490|7538725|FG002|NOT COMPLETED|Overall Study||5
6612995|NCT02128490|7538726|FG003|NOT COMPLETED|Overall Study||6
6612996|NCT02128490|7538727|FG004|NOT COMPLETED|Overall Study||7
6612997|NCT02128542|7538741|FG000|STARTED|Overall Study||47
6612998|NCT02128542|7538742|FG001|STARTED|Overall Study||19
6612999|NCT02128542|7538741|FG000|COMPLETED|Overall Study||43
6613000|NCT02128542|7538742|FG001|COMPLETED|Overall Study||19
6613001|NCT02128542|7538741|FG000|NOT COMPLETED|Overall Study||4
6613002|NCT02128542|7538742|FG001|NOT COMPLETED|Overall Study||0
6613003|NCT02128724|7538754|FG000|STARTED|Overall Study||4
6613004|NCT02128724|7538755|FG001|STARTED|Overall Study||4
6613005|NCT02128724|7538756|FG002|STARTED|Overall Study||3
6613006|NCT02128724|7538757|FG003|STARTED|Overall Study||10
6613007|NCT02128724|7538754|FG000|COMPLETED|Overall Study||3
6613008|NCT02128724|7538755|FG001|COMPLETED|Overall Study||3
6613009|NCT02128724|7538756|FG002|COMPLETED|Overall Study||3
6613010|NCT02128724|7538757|FG003|COMPLETED|Overall Study||7
6613011|NCT02128724|7538754|FG000|NOT COMPLETED|Overall Study||1
6613012|NCT02128724|7538755|FG001|NOT COMPLETED|Overall Study||1
6613013|NCT02128724|7538756|FG002|NOT COMPLETED|Overall Study||0
6613014|NCT02128724|7538757|FG003|NOT COMPLETED|Overall Study||3
6613015|NCT02128763|7538768|FG000|STARTED|Overall Study||349
6613016|NCT02128763|7538769|FG001|STARTED|Overall Study||186
6613017|NCT02128763|7538768|FG000|COMPLETED|Overall Study||329
6613018|NCT02128763|7538769|FG001|COMPLETED|Overall Study||170
6613019|NCT02128763|7538768|FG000|NOT COMPLETED|Overall Study||20
6613020|NCT02128763|7538769|FG001|NOT COMPLETED|Overall Study||16
6613021|NCT02128828|7538778|FG000|STARTED|Overall Study||20
6613022|NCT02128828|7538778|FG000|COMPLETED|Overall Study||17
6613023|NCT02128828|7538778|FG000|NOT COMPLETED|Overall Study||3
6613024|NCT02128867|7538785|FG000|STARTED|Overall Study||53
6613025|NCT02128867|7538786|FG001|STARTED|Overall Study||52
6613026|NCT02128867|7538787|FG002|STARTED|Overall Study||54
6613027|NCT02128867|7538785|FG000|COMPLETED|Overall Study||50
6613028|NCT02128867|7538786|FG001|COMPLETED|Overall Study||50
6613029|NCT02128867|7538787|FG002|COMPLETED|Overall Study||50
6613030|NCT02128867|7538785|FG000|NOT COMPLETED|Overall Study||3
6613031|NCT02128867|7538786|FG001|NOT COMPLETED|Overall Study||2
6613032|NCT02128867|7538787|FG002|NOT COMPLETED|Overall Study||4
6613033|NCT02128919|7538797|FG000|STARTED|Overall Study||17
6613034|NCT02128919|7538798|FG001|STARTED|Overall Study||16
6613035|NCT02128919|7538797|FG000|COMPLETED|Overall Study||14
6613036|NCT02128919|7538798|FG001|COMPLETED|Overall Study||15
6613037|NCT02128919|7538797|FG000|NOT COMPLETED|Overall Study||3
6613038|NCT02128919|7538798|FG001|NOT COMPLETED|Overall Study||1
6613039|NCT02128932|7538808|FG000|STARTED|Overall Study||362
6613040|NCT02128932|7538809|FG001|STARTED|Overall Study||360
6613041|NCT02128932|7538810|FG002|STARTED|Overall Study||360
6613042|NCT02128932|7538808|FG000|COMPLETED|Overall Study||335
6613043|NCT02128932|7538809|FG001|COMPLETED|Overall Study||341
6613044|NCT02128932|7538810|FG002|COMPLETED|Overall Study||342
6613045|NCT02128932|7538808|FG000|NOT COMPLETED|Overall Study||27
6613046|NCT02128932|7538809|FG001|NOT COMPLETED|Overall Study||19
6613047|NCT02128932|7538810|FG002|NOT COMPLETED|Overall Study||18
6613048|NCT02128997|7538820|FG000|STARTED|Overall Study||67
6613049|NCT02128997|7538821|FG001|STARTED|Overall Study||69
6613050|NCT02128997|7538820|FG000|COMPLETED|Overall Study||61
6613051|NCT02128997|7538821|FG001|COMPLETED|Overall Study||58
6613052|NCT02128997|7538820|FG000|NOT COMPLETED|Overall Study||6
6613053|NCT02128997|7538821|FG001|NOT COMPLETED|Overall Study||11
6613054|NCT02129062|7538827|FG000|STARTED|Overall Study||3
6613055|NCT02129062|7538827|FG000|COMPLETED|Overall Study||0
6613056|NCT02129062|7538827|FG000|NOT COMPLETED|Overall Study||3
6613057|NCT02129075|7538833|FG000|STARTED|Overall Study||30
6613058|NCT02129075|7538834|FG001|STARTED|Overall Study||30
6613059|NCT02129075|7538833|FG000|COMPLETED|Overall Study||30
6613060|NCT02129075|7538834|FG001|COMPLETED|Overall Study||30
6613061|NCT02129075|7538833|FG000|NOT COMPLETED|Overall Study||0
6613062|NCT02129075|7538834|FG001|NOT COMPLETED|Overall Study||0
6613063|NCT02129192|7538844|FG000|STARTED|Period 1 Including Washout Period||36
6613064|NCT02129192|7538845|FG001|STARTED|Period 1 Including Washout Period||36
6613065|NCT02129192|7538844|FG000|COMPLETED|Period 1 Including Washout Period||36
6613066|NCT02129192|7538845|FG001|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
6613067|NCT02129192|7538844|FG000|NOT COMPLETED|Period 1 Including Washout Period||0
6613068|NCT02129192|7538845|FG001|NOT COMPLETED|Period 1 Including Washout Period||1
6613069|NCT02129192|7538844|FG000|STARTED|Period 2 Including Washout Period||36
6613070|NCT02129192|7538845|FG001|STARTED|Period 2 Including Washout Period||35
6613071|NCT02129192|7538844|FG000|COMPLETED|Period 2 Including Washout Period||36
6613072|NCT02129192|7538845|FG001|COMPLETED|Period 2 Including Washout Period||35
6613073|NCT02129192|7538844|FG000|NOT COMPLETED|Period 2 Including Washout Period||0
6613074|NCT02129192|7538845|FG001|NOT COMPLETED|Period 2 Including Washout Period||0
6613075|NCT02129192|7538844|FG000|STARTED|Period 3 Including Washout Period||36
6613076|NCT02129192|7538845|FG001|STARTED|Period 3 Including Washout Period||35
6613077|NCT02129192|7538844|FG000|COMPLETED|Period 3 Including Washout Period||36
6613078|NCT02129192|7538845|FG001|COMPLETED|Period 3 Including Washout Period||35
6613079|NCT02129192|7538844|FG000|NOT COMPLETED|Period 3 Including Washout Period||0
6613080|NCT02129192|7538845|FG001|NOT COMPLETED|Period 3 Including Washout Period||0
6613081|NCT02129192|7538844|FG000|STARTED|Period 4 Including Washout Period||36
6613082|NCT02129192|7538845|FG001|STARTED|Period 4 Including Washout Period||35
6613083|NCT02129192|7538844|FG000|COMPLETED|Period 4 Including Washout Period||36
6613084|NCT02129192|7538845|FG001|COMPLETED|Period 4 Including Washout Period||35
6613085|NCT02129192|7538844|FG000|NOT COMPLETED|Period 4 Including Washout Period||0
6613086|NCT02129192|7538845|FG001|NOT COMPLETED|Period 4 Including Washout Period||0
6613087|NCT02129192|7538844|FG000|STARTED|Period 5||36
6613088|NCT02129192|7538845|FG001|STARTED|Period 5|This sequence consists of only 4 periods.|0
6613089|NCT02129192|7538844|FG000|COMPLETED|Period 5||36
6613090|NCT02129192|7538845|FG001|COMPLETED|Period 5||0
6613091|NCT02129192|7538844|FG000|NOT COMPLETED|Period 5||0
6613092|NCT02129192|7538845|FG001|NOT COMPLETED|Period 5||0
6613093|NCT02129205|7538864|FG000|STARTED|Overall Study||2
6613094|NCT02129205|7538865|FG001|STARTED|Overall Study||2
6613095|NCT02129205|7538866|FG002|STARTED|Overall Study||2
6613096|NCT02129205|7538867|FG003|STARTED|Overall Study||2
6613097|NCT02129205|7538868|FG004|STARTED|Overall Study||7
6613098|NCT02129205|7538869|FG005|STARTED|Overall Study||11
6613099|NCT02129205|7538870|FG006|STARTED|Overall Study||6
6613100|NCT02129205|7538871|FG007|STARTED|Overall Study||6
6613101|NCT02129205|7538872|FG008|STARTED|Overall Study||2
6613102|NCT02129205|7538873|FG009|STARTED|Overall Study||0
6613103|NCT02129205|7538864|FG000|COMPLETED|Overall Study||1
6613104|NCT02129205|7538865|FG001|COMPLETED|Overall Study||2
6613105|NCT02129205|7538866|FG002|COMPLETED|Overall Study||2
6613106|NCT02129205|7538867|FG003|COMPLETED|Overall Study||2
6613107|NCT02129205|7538868|FG004|COMPLETED|Overall Study||4
6613108|NCT02129205|7538869|FG005|COMPLETED|Overall Study||7
6613109|NCT02129205|7538870|FG006|COMPLETED|Overall Study||2
6613110|NCT02129205|7538871|FG007|COMPLETED|Overall Study||4
6613111|NCT02129205|7538872|FG008|COMPLETED|Overall Study||0
6613112|NCT02129205|7538873|FG009|COMPLETED|Overall Study||0
6613113|NCT02129205|7538864|FG000|NOT COMPLETED|Overall Study||1
6613114|NCT02129205|7538865|FG001|NOT COMPLETED|Overall Study||0
6613115|NCT02129205|7538866|FG002|NOT COMPLETED|Overall Study||0
6613116|NCT02129205|7538867|FG003|NOT COMPLETED|Overall Study||0
6613117|NCT02129205|7538868|FG004|NOT COMPLETED|Overall Study||3
6613118|NCT02129205|7538869|FG005|NOT COMPLETED|Overall Study||4
6613119|NCT02129205|7538870|FG006|NOT COMPLETED|Overall Study||4
6613120|NCT02129205|7538871|FG007|NOT COMPLETED|Overall Study||2
6613121|NCT02129205|7538872|FG008|NOT COMPLETED|Overall Study||2
6613122|NCT02129205|7538873|FG009|NOT COMPLETED|Overall Study||0
6613123|NCT02129426|7538899|FG000|STARTED|Overall Study||7
6613124|NCT02129426|7538900|FG001|STARTED|Overall Study||13
6613125|NCT02129426|7538899|FG000|COMPLETED|Overall Study||0
6613126|NCT02129426|7538900|FG001|COMPLETED|Overall Study||0
6613127|NCT02129426|7538899|FG000|NOT COMPLETED|Overall Study||7
6613128|NCT02129426|7538900|FG001|NOT COMPLETED|Overall Study||13
6613129|NCT02129478|7538906|FG000|STARTED|Overall Study||15
6613130|NCT02129478|7538906|FG000|COMPLETED|Overall Study||15
6613131|NCT02129478|7538906|FG000|NOT COMPLETED|Overall Study||0
6613132|NCT02129556|7538913|FG000|STARTED|Overall Study||3
6613133|NCT02129556|7538914|FG001|STARTED|Overall Study||3
6613134|NCT02129556|7538915|FG002|STARTED|Overall Study||40
6613135|NCT02129556|7538916|FG003|STARTED|Overall Study||12
6613136|NCT02129556|7538913|FG000|COMPLETED|Overall Study||3
6613137|NCT02129556|7538914|FG001|COMPLETED|Overall Study||3
6613138|NCT02129556|7538915|FG002|COMPLETED|Overall Study||37
6613139|NCT02129556|7538916|FG003|COMPLETED|Overall Study||12
6613140|NCT02129556|7538913|FG000|NOT COMPLETED|Overall Study||0
6613141|NCT02129556|7538914|FG001|NOT COMPLETED|Overall Study||0
6613142|NCT02129556|7538915|FG002|NOT COMPLETED|Overall Study||3
6613143|NCT02129556|7538916|FG003|NOT COMPLETED|Overall Study||0
6613144|NCT02129608|7538928|FG000|STARTED|Overall Study||15
6613145|NCT02129608|7538929|FG001|STARTED|Overall Study||14
6613146|NCT02129608|7538930|FG002|STARTED|Overall Study||15
6613147|NCT02129608|7538928|FG000|End of Treatment|Overall Study||15
6613148|NCT02129608|7538929|FG001|End of Treatment|Overall Study||13
6613149|NCT02129608|7538930|FG002|End of Treatment|Overall Study||12
6613150|NCT02129608|7538928|FG000|COMPLETED|Overall Study||15
6613151|NCT02129608|7538929|FG001|COMPLETED|Overall Study||13
6613152|NCT02129608|7538930|FG002|COMPLETED|Overall Study||12
6613153|NCT02129608|7538928|FG000|NOT COMPLETED|Overall Study||0
6613154|NCT02129608|7538929|FG001|NOT COMPLETED|Overall Study||1
6613155|NCT02129608|7538930|FG002|NOT COMPLETED|Overall Study||3
6613156|NCT02129660|7538943|FG000|STARTED|Overall Study||21
6613157|NCT02129660|7538944|FG001|STARTED|Overall Study||20
6613158|NCT02129660|7538945|FG002|STARTED|Overall Study||22
6613159|NCT02129660|7538946|FG003|STARTED|Overall Study||20
6613160|NCT02129660|7538947|FG004|STARTED|Overall Study||22
6613161|NCT02129660|7538943|FG000|COMPLETED|Overall Study||19
6613162|NCT02129660|7538944|FG001|COMPLETED|Overall Study||20
6613163|NCT02129660|7538945|FG002|COMPLETED|Overall Study||21
6613164|NCT02129660|7538946|FG003|COMPLETED|Overall Study||20
6613165|NCT02129660|7538947|FG004|COMPLETED|Overall Study||20
6613166|NCT02129660|7538943|FG000|NOT COMPLETED|Overall Study||2
6613167|NCT02129660|7538944|FG001|NOT COMPLETED|Overall Study||0
6613168|NCT02129660|7538945|FG002|NOT COMPLETED|Overall Study||1
6613169|NCT02129660|7538946|FG003|NOT COMPLETED|Overall Study||0
6613170|NCT02129660|7538947|FG004|NOT COMPLETED|Overall Study||2
6613171|NCT02129725|7538962|FG000|STARTED|Overall Study||8
6613172|NCT02129725|7538963|FG001|STARTED|Overall Study||7
6613173|NCT02129725|7538962|FG000|COMPLETED|Overall Study||6
6613174|NCT02129725|7538963|FG001|COMPLETED|Overall Study||4
6613175|NCT02129725|7538962|FG000|NOT COMPLETED|Overall Study||2
6613176|NCT02129725|7538963|FG001|NOT COMPLETED|Overall Study||3
6613177|NCT02129777|7538974|FG000|STARTED|Double-Blind Period||24
6613178|NCT02129777|7538975|FG001|STARTED|Double-Blind Period||24
6613179|NCT02129777|7538976|FG002|STARTED|Double-Blind Period||24
6613180|NCT02129777|7538977|FG003|STARTED|Double-Blind Period||25
6613181|NCT02129777|7538978|FG004|STARTED|Double-Blind Period||25
6613182|NCT02129777|7538979|FG005|STARTED|Double-Blind Period||0
6613183|NCT02129777|7538980|FG006|STARTED|Double-Blind Period||0
6613184|NCT02129777|7538974|FG000|COMPLETED|Double-Blind Period||17
6613185|NCT02129777|7538975|FG001|COMPLETED|Double-Blind Period||16
6613186|NCT02129777|7538976|FG002|COMPLETED|Double-Blind Period||20
6613187|NCT02129777|7538977|FG003|COMPLETED|Double-Blind Period||18
6613188|NCT02129777|7538978|FG004|COMPLETED|Double-Blind Period||18
6613189|NCT02129777|7538979|FG005|COMPLETED|Double-Blind Period||0
6613190|NCT02129777|7538980|FG006|COMPLETED|Double-Blind Period||0
6613191|NCT02129777|7538974|FG000|NOT COMPLETED|Double-Blind Period||7
6613192|NCT02129777|7538975|FG001|NOT COMPLETED|Double-Blind Period||8
6613193|NCT02129777|7538976|FG002|NOT COMPLETED|Double-Blind Period||4
6613194|NCT02129777|7538977|FG003|NOT COMPLETED|Double-Blind Period||7
6613195|NCT02129777|7538978|FG004|NOT COMPLETED|Double-Blind Period||7
6613196|NCT02129777|7538979|FG005|NOT COMPLETED|Double-Blind Period||0
6613197|NCT02129777|7538980|FG006|NOT COMPLETED|Double-Blind Period||0
6613198|NCT02129777|7538974|FG000|STARTED|Open-Label Period||0
6613199|NCT02129777|7538975|FG001|STARTED|Open-Label Period||0
6613200|NCT02129777|7538976|FG002|STARTED|Open-Label Period||0
6613201|NCT02129777|7538977|FG003|STARTED|Open-Label Period||0
6613202|NCT02129777|7538978|FG004|STARTED|Open-Label Period||0
6613203|NCT02129777|7538979|FG005|STARTED|Open-Label Period||12
6613204|NCT02129777|7538980|FG006|STARTED|Open-Label Period||48
6613205|NCT02129777|7538974|FG000|COMPLETED|Open-Label Period||0
6613206|NCT02129777|7538975|FG001|COMPLETED|Open-Label Period||0
6613207|NCT02129777|7538976|FG002|COMPLETED|Open-Label Period||0
6613208|NCT02129777|7538977|FG003|COMPLETED|Open-Label Period||0
6613209|NCT02129777|7538978|FG004|COMPLETED|Open-Label Period||0
6613210|NCT02129777|7538979|FG005|COMPLETED|Open-Label Period||0
6613211|NCT02129777|7538980|FG006|COMPLETED|Open-Label Period||0
6613212|NCT02129777|7538974|FG000|NOT COMPLETED|Open-Label Period||0
6613213|NCT02129777|7538975|FG001|NOT COMPLETED|Open-Label Period||0
6613214|NCT02129777|7538976|FG002|NOT COMPLETED|Open-Label Period||0
6613215|NCT02129777|7538977|FG003|NOT COMPLETED|Open-Label Period||0
6613216|NCT02129777|7538978|FG004|NOT COMPLETED|Open-Label Period||0
6613217|NCT02129777|7538979|FG005|NOT COMPLETED|Open-Label Period||12
6613218|NCT02129777|7538980|FG006|NOT COMPLETED|Open-Label Period||48
6732726|NCT03197883|7662178|FG000|COMPLETED|Overall Study||47
6732727|NCT03197883|7662179|FG001|COMPLETED|Overall Study||44
6732728|NCT03197883|7662178|FG000|NOT COMPLETED|Overall Study||3
6732729|NCT03197883|7662179|FG001|NOT COMPLETED|Overall Study||6
6732730|NCT03198000|7662188|FG000|STARTED|Overall Study||41
6732731|NCT03198000|7662189|FG001|STARTED|Overall Study||38
6732732|NCT03198000|7662190|FG002|STARTED|Overall Study||41
6732733|NCT03198000|7662188|FG000|COMPLETED|Overall Study||41
6732734|NCT03198000|7662189|FG001|COMPLETED|Overall Study||38
6732735|NCT03198000|7662190|FG002|COMPLETED|Overall Study||41
6732736|NCT03198000|7662188|FG000|NOT COMPLETED|Overall Study||0
6732737|NCT03198000|7662189|FG001|NOT COMPLETED|Overall Study||0
6732738|NCT03198000|7662190|FG002|NOT COMPLETED|Overall Study||0
6732739|NCT03198221|7662202|FG000|STARTED|Overall Study||3
6732740|NCT03198221|7662203|FG001|STARTED|Overall Study||2
6732741|NCT03198221|7662204|FG002|STARTED|Overall Study||7
6732742|NCT03198221|7662205|FG003|STARTED|Overall Study||2
6732743|NCT03198221|7662202|FG000|COMPLETED|Overall Study||3
6732744|NCT03198221|7662203|FG001|COMPLETED|Overall Study||2
6732745|NCT03198221|7662204|FG002|COMPLETED|Overall Study||7
6732746|NCT03198221|7662205|FG003|COMPLETED|Overall Study||2
6613219|NCT02129803|7539001|FG000|STARTED|Overall Study||12
6613220|NCT02129803|7539002|FG001|STARTED|Overall Study||12
6613221|NCT02129803|7539001|FG000|COMPLETED|Overall Study||6
6613222|NCT02129803|7539002|FG001|COMPLETED|Overall Study||9
6613223|NCT02129803|7539001|FG000|NOT COMPLETED|Overall Study||6
6613224|NCT02129803|7539002|FG001|NOT COMPLETED|Overall Study||3
6613225|NCT02130024|7539010|FG000|STARTED|Overall Study||142
6613226|NCT02130024|7539011|FG001|STARTED|Overall Study||139
6613227|NCT02130024|7539010|FG000|Safety Set|Overall Study|One randomized patient did not receive treatment|141
6613228|NCT02130024|7539011|FG001|Safety Set|Overall Study||139
6613229|NCT02130024|7539010|FG000|Full Analysis Set (FAS)|Overall Study||141
6613230|NCT02130024|7539011|FG001|Full Analysis Set (FAS)|Overall Study|2 patients had no post Baseline geographic atrophy (GA) data|137
6613231|NCT02130024|7539010|FG000|COMPLETED|Overall Study||117
6613232|NCT02130024|7539011|FG001|COMPLETED|Overall Study||108
6613233|NCT02130024|7539010|FG000|NOT COMPLETED|Overall Study||25
6613234|NCT02130024|7539011|FG001|NOT COMPLETED|Overall Study||31
6613235|NCT02130063|7539019|FG000|STARTED|Overall Study||342
6613236|NCT02130063|7539020|FG001|STARTED|Overall Study||169
6613237|NCT02130063|7539019|FG000|COMPLETED|Overall Study||317
6613238|NCT02130063|7539020|FG001|COMPLETED|Overall Study||152
6613239|NCT02130063|7539019|FG000|NOT COMPLETED|Overall Study||25
6613240|NCT02130063|7539020|FG001|NOT COMPLETED|Overall Study||17
6613241|NCT02130193|7539028|FG000|STARTED|Part A: 4-week Open-label Period||9
6613242|NCT02130193|7539029|FG001|STARTED|Part A: 4-week Open-label Period||0
6613243|NCT02130193|7539030|FG002|STARTED|Part A: 4-week Open-label Period||0
6613244|NCT02130193|7539028|FG000|COMPLETED|Part A: 4-week Open-label Period||9
6613245|NCT02130193|7539029|FG001|COMPLETED|Part A: 4-week Open-label Period||0
6613246|NCT02130193|7539030|FG002|COMPLETED|Part A: 4-week Open-label Period||0
6613247|NCT02130193|7539028|FG000|NOT COMPLETED|Part A: 4-week Open-label Period||0
6613248|NCT02130193|7539029|FG001|NOT COMPLETED|Part A: 4-week Open-label Period||0
6613249|NCT02130193|7539030|FG002|NOT COMPLETED|Part A: 4-week Open-label Period||0
6613250|NCT02130193|7539028|FG000|STARTED|Part B: 52-week Double-blind Period||0
6613251|NCT02130193|7539029|FG001|STARTED|Part B: 52-week Double-blind Period||48
6613252|NCT02130193|7539030|FG002|STARTED|Part B: 52-week Double-blind Period||45
6613253|NCT02130193|7539028|FG000|COMPLETED|Part B: 52-week Double-blind Period||0
6613254|NCT02130193|7539029|FG001|COMPLETED|Part B: 52-week Double-blind Period||38
6613255|NCT02130193|7539030|FG002|COMPLETED|Part B: 52-week Double-blind Period||37
6613256|NCT02130193|7539028|FG000|NOT COMPLETED|Part B: 52-week Double-blind Period||0
6613257|NCT02130193|7539029|FG001|NOT COMPLETED|Part B: 52-week Double-blind Period||10
6613258|NCT02130193|7539030|FG002|NOT COMPLETED|Part B: 52-week Double-blind Period||8
6613259|NCT02130258|7539041|FG000|STARTED|Overall Study||9
6613260|NCT02130258|7539042|FG001|STARTED|Overall Study||11
6613261|NCT02130258|7539041|FG000|COMPLETED|Overall Study||9
6613262|NCT02130258|7539042|FG001|COMPLETED|Overall Study||11
6613263|NCT02130258|7539041|FG000|NOT COMPLETED|Overall Study||0
6613264|NCT02130258|7539042|FG001|NOT COMPLETED|Overall Study||0
6613265|NCT02130284|7539048|FG000|STARTED|Overall Study||80
6613266|NCT02130284|7539048|FG000|COMPLETED|Overall Study||71
6613267|NCT02130284|7539048|FG000|NOT COMPLETED|Overall Study||9
6613268|NCT02130297|7539052|FG000|STARTED|Overall Study||30
6613269|NCT02130297|7539052|FG000|COMPLETED|Overall Study||26
6613270|NCT02130297|7539052|FG000|NOT COMPLETED|Overall Study||4
6613271|NCT02130427|7539056|FG000|STARTED|Overall Study||74
6613272|NCT02130427|7539056|FG000|COMPLETED|Overall Study||44
6613273|NCT02130427|7539056|FG000|NOT COMPLETED|Overall Study||30
6613274|NCT02130557|7539062|FG000|STARTED|Overall Study||268
6613275|NCT02130557|7539063|FG001|STARTED|Overall Study||268
6613276|NCT02130557|7539062|FG000|Treated|Overall Study||268
6613277|NCT02130557|7539063|FG001|Treated|Overall Study||265
6613278|NCT02130557|7539062|FG000|mITT Population|Overall Study||246
6613279|NCT02130557|7539063|FG001|mITT Population|Overall Study||241
6613280|NCT02130557|7539062|FG000|COMPLETED|Overall Study||232
6613281|NCT02130557|7539063|FG001|COMPLETED|Overall Study||231
6613282|NCT02130557|7539062|FG000|NOT COMPLETED|Overall Study||36
6613283|NCT02130557|7539063|FG001|NOT COMPLETED|Overall Study||37
6613284|NCT02130570|7539071|FG000|STARTED|Overall Study||987
6613285|NCT02130570|7539072|FG001|STARTED|Overall Study||692
6613286|NCT02130570|7539071|FG000|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|978
6613287|NCT02130570|7539072|FG001|COMPLETED|Overall Study|Participants enrolled, did not die during index admission, did not withdraw consent|679
6613288|NCT02130570|7539071|FG000|NOT COMPLETED|Overall Study||9
6613289|NCT02130570|7539072|FG001|NOT COMPLETED|Overall Study||13
6613290|NCT02130583|7539081|FG000|STARTED|Overall Study||26
6613291|NCT02130583|7539082|FG001|STARTED|Overall Study||26
6613292|NCT02130583|7539081|FG000|COMPLETED|Overall Study||17
6613293|NCT02130583|7539082|FG001|COMPLETED|Overall Study||19
6613294|NCT02130583|7539081|FG000|NOT COMPLETED|Overall Study||9
6613295|NCT02130583|7539082|FG001|NOT COMPLETED|Overall Study||7
6613296|NCT02130635|7539097|FG000|STARTED|Part A-Safety and Tolerability||7
6613297|NCT02130635|7539098|FG001|STARTED|Part A-Safety and Tolerability||21
6613298|NCT02130635|7539099|FG002|STARTED|Part A-Safety and Tolerability||0
6613299|NCT02130635|7539100|FG003|STARTED|Part A-Safety and Tolerability||0
6613300|NCT02130635|7539101|FG004|STARTED|Part A-Safety and Tolerability||0
6613301|NCT02130635|7539102|FG005|STARTED|Part A-Safety and Tolerability||0
6613302|NCT02130635|7539103|FG006|STARTED|Part A-Safety and Tolerability||0
6613303|NCT02130635|7539104|FG007|STARTED|Part A-Safety and Tolerability||0
6613304|NCT02130635|7539105|FG008|STARTED|Part A-Safety and Tolerability||0
6613305|NCT02130635|7539097|FG000|COMPLETED|Part A-Safety and Tolerability||7
6613306|NCT02130635|7539098|FG001|COMPLETED|Part A-Safety and Tolerability||21
6613307|NCT02130635|7539099|FG002|COMPLETED|Part A-Safety and Tolerability||0
6613308|NCT02130635|7539100|FG003|COMPLETED|Part A-Safety and Tolerability||0
6613309|NCT02130635|7539101|FG004|COMPLETED|Part A-Safety and Tolerability||0
6613310|NCT02130635|7539102|FG005|COMPLETED|Part A-Safety and Tolerability||0
6613311|NCT02130635|7539103|FG006|COMPLETED|Part A-Safety and Tolerability||0
6613312|NCT02130635|7539104|FG007|COMPLETED|Part A-Safety and Tolerability||0
6613313|NCT02130635|7539105|FG008|COMPLETED|Part A-Safety and Tolerability||0
6613314|NCT02130635|7539097|FG000|NOT COMPLETED|Part A-Safety and Tolerability||0
6613315|NCT02130635|7539098|FG001|NOT COMPLETED|Part A-Safety and Tolerability||0
6613316|NCT02130635|7539099|FG002|NOT COMPLETED|Part A-Safety and Tolerability||0
6613317|NCT02130635|7539100|FG003|NOT COMPLETED|Part A-Safety and Tolerability||0
6613318|NCT02130635|7539101|FG004|NOT COMPLETED|Part A-Safety and Tolerability||0
6613319|NCT02130635|7539102|FG005|NOT COMPLETED|Part A-Safety and Tolerability||0
6613320|NCT02130635|7539103|FG006|NOT COMPLETED|Part A-Safety and Tolerability||0
6613321|NCT02130635|7539104|FG007|NOT COMPLETED|Part A-Safety and Tolerability||0
6613322|NCT02130635|7539105|FG008|NOT COMPLETED|Part A-Safety and Tolerability||0
6613323|NCT02130635|7539097|FG000|STARTED|Part B-Dose-Response Relationship||0
6613324|NCT02130635|7539098|FG001|STARTED|Part B-Dose-Response Relationship||0
6613325|NCT02130635|7539099|FG002|STARTED|Part B-Dose-Response Relationship||5
6613326|NCT02130635|7539100|FG003|STARTED|Part B-Dose-Response Relationship||5
6613327|NCT02130635|7539101|FG004|STARTED|Part B-Dose-Response Relationship||5
6613328|NCT02130635|7539102|FG005|STARTED|Part B-Dose-Response Relationship||5
6613329|NCT02130635|7539103|FG006|STARTED|Part B-Dose-Response Relationship||6
6613330|NCT02130635|7539104|FG007|STARTED|Part B-Dose-Response Relationship||5
6613331|NCT02130635|7539105|FG008|STARTED|Part B-Dose-Response Relationship||5
6613332|NCT02130635|7539097|FG000|COMPLETED|Part B-Dose-Response Relationship||0
6613333|NCT02130635|7539098|FG001|COMPLETED|Part B-Dose-Response Relationship||0
6613334|NCT02130635|7539099|FG002|COMPLETED|Part B-Dose-Response Relationship||5
6613335|NCT02130635|7539100|FG003|COMPLETED|Part B-Dose-Response Relationship||5
6613336|NCT02130635|7539101|FG004|COMPLETED|Part B-Dose-Response Relationship||5
6613337|NCT02130635|7539102|FG005|COMPLETED|Part B-Dose-Response Relationship||5
6613338|NCT02130635|7539103|FG006|COMPLETED|Part B-Dose-Response Relationship||6
6613339|NCT02130635|7539104|FG007|COMPLETED|Part B-Dose-Response Relationship||5
6613340|NCT02130635|7539105|FG008|COMPLETED|Part B-Dose-Response Relationship||5
6613341|NCT02130635|7539097|FG000|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613342|NCT02130635|7539098|FG001|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613343|NCT02130635|7539099|FG002|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613344|NCT02130635|7539100|FG003|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613345|NCT02130635|7539101|FG004|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613346|NCT02130635|7539102|FG005|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613347|NCT02130635|7539103|FG006|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613348|NCT02130635|7539104|FG007|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613349|NCT02130635|7539105|FG008|NOT COMPLETED|Part B-Dose-Response Relationship||0
6613350|NCT02130765|7539136|FG000|STARTED|Overall Study||11
6613351|NCT02130765|7539137|FG001|STARTED|Overall Study||8
6613352|NCT02130765|7539138|FG002|STARTED|Overall Study||26
6613353|NCT02130765|7539139|FG003|STARTED|Overall Study||19
6613354|NCT02130765|7539136|FG000|COMPLETED|Overall Study||7
6613355|NCT02130765|7539137|FG001|COMPLETED|Overall Study||8
6613356|NCT02130765|7539138|FG002|COMPLETED|Overall Study||26
6613357|NCT02130765|7539139|FG003|COMPLETED|Overall Study||19
6613358|NCT02130765|7539136|FG000|NOT COMPLETED|Overall Study||4
6613359|NCT02130765|7539137|FG001|NOT COMPLETED|Overall Study||0
6613360|NCT02130765|7539138|FG002|NOT COMPLETED|Overall Study||0
6613361|NCT02130765|7539139|FG003|NOT COMPLETED|Overall Study||0
6613362|NCT02130986|7539153|FG000|STARTED|Overall Study||830
6613363|NCT02130986|7539154|FG001|STARTED|Overall Study||834
6613364|NCT02130986|7539153|FG000|COMPLETED|Overall Study||675
6613365|NCT02130986|7539154|FG001|COMPLETED|Overall Study||670
6613366|NCT02130986|7539153|FG000|NOT COMPLETED|Overall Study||155
6613367|NCT02130986|7539154|FG001|NOT COMPLETED|Overall Study||164
6613368|NCT02130999|7539162|FG000|STARTED|Overall Study||6
6613369|NCT02130999|7539163|FG001|STARTED|Overall Study||8
6613370|NCT02130999|7539162|FG000|COMPLETED|Overall Study||6
6613371|NCT02130999|7539163|FG001|COMPLETED|Overall Study||8
6613372|NCT02130999|7539162|FG000|NOT COMPLETED|Overall Study||0
6613373|NCT02130999|7539163|FG001|NOT COMPLETED|Overall Study||0
6613374|NCT02131064|7539176|FG000|STARTED|Overall Study||221
6613375|NCT02131064|7539177|FG001|STARTED|Overall Study||223
6613376|NCT02131064|7539176|FG000|COMPLETED|Overall Study||196
6613377|NCT02131064|7539177|FG001|COMPLETED|Overall Study||189
6613378|NCT02131064|7539176|FG000|NOT COMPLETED|Overall Study||25
6613379|NCT02131064|7539177|FG001|NOT COMPLETED|Overall Study||34
6613380|NCT02131129|7539186|FG000|STARTED|Overall Study||10
6613381|NCT02131129|7539187|FG001|STARTED|Overall Study||10
6613382|NCT02131129|7539186|FG000|COMPLETED|Overall Study||9
6613383|NCT02131129|7539187|FG001|COMPLETED|Overall Study||10
6613384|NCT02131129|7539186|FG000|NOT COMPLETED|Overall Study||1
6613385|NCT02131129|7539187|FG001|NOT COMPLETED|Overall Study||0
6613386|NCT02131233|7539195|FG000|STARTED|Overall Study|Enrolled participants|533
6613387|NCT02131233|7539196|FG001|STARTED|Overall Study|Enrolled participants|269
6613388|NCT02131233|7539195|FG000|Treated|Overall Study||531
6613389|NCT02131233|7539196|FG001|Treated|Overall Study||266
6613390|NCT02131233|7539195|FG000|COMPLETED|Overall Study|Completed to Week 96|467
6613391|NCT02131233|7539196|FG001|COMPLETED|Overall Study|Completed to Week 96|227
6613392|NCT02131233|7539195|FG000|NOT COMPLETED|Overall Study||66
6613393|NCT02131233|7539196|FG001|NOT COMPLETED|Overall Study||42
6613394|NCT02131259|7539202|FG000|STARTED|Overall Study|Patients received treatment of GIOTRIF® Tablets|1602
6613395|NCT02131259|7539202|FG000|COMPLETED|Overall Study|Completed is defined as 52 weeks follow-up after starting administration of GIOTRIF® tablets.|377
6613396|NCT02131259|7539202|FG000|NOT COMPLETED|Overall Study||1225
6613397|NCT02131272|7539208|FG000|STARTED|Overall Study||20
6613398|NCT02131272|7539209|FG001|STARTED|Overall Study||22
6613399|NCT02131272|7539208|FG000|COMPLETED|Overall Study||19
6613400|NCT02131272|7539209|FG001|COMPLETED|Overall Study||20
6613401|NCT02131272|7539208|FG000|NOT COMPLETED|Overall Study||1
6613402|NCT02131272|7539209|FG001|NOT COMPLETED|Overall Study||2
6613403|NCT02131311|7539215|FG000|STARTED|Overall Study||90
6613404|NCT02131311|7539215|FG000|COMPLETED|Overall Study||86
6613405|NCT02131311|7539215|FG000|NOT COMPLETED|Overall Study||4
6613406|NCT02131324|7539222|FG000|STARTED|Overall Study|2 subjects randomized into Comp01 not included in analysis as there was no post-baseline information|24
6613407|NCT02131324|7539223|FG001|STARTED|Overall Study|2 subjects randomized into DFD-06 not included in analysis as there was no post-baseline information|26
6613408|NCT02131324|7539222|FG000|Analyzed|Overall Study||22
6613409|NCT02131324|7539223|FG001|Analyzed|Overall Study||24
6613410|NCT02131324|7539222|FG000|COMPLETED|Overall Study||22
6613411|NCT02131324|7539223|FG001|COMPLETED|Overall Study||23
6613412|NCT02131324|7539222|FG000|NOT COMPLETED|Overall Study||2
6613413|NCT02131324|7539223|FG001|NOT COMPLETED|Overall Study||3
6613414|NCT02131402|7539229|FG000|STARTED|Overall Study||60
6613415|NCT02131402|7539229|FG000|COMPLETED|Overall Study||60
6613416|NCT02131402|7539229|FG000|NOT COMPLETED|Overall Study||0
6613417|NCT02131532|7539292|FG000|STARTED|Overall Study||12
6613418|NCT02131532|7539292|FG000|COMPLETED|Overall Study||8
6613419|NCT02131532|7539292|FG000|NOT COMPLETED|Overall Study||4
6613420|NCT02131636|7539299|FG000|STARTED|Overall Study||222
6613421|NCT02131636|7539300|FG001|STARTED|Overall Study||218
6613422|NCT02131636|7539299|FG000|COMPLETED|Overall Study||210
6613423|NCT02131636|7539300|FG001|COMPLETED|Overall Study||213
6613424|NCT02131636|7539299|FG000|NOT COMPLETED|Overall Study||12
6613425|NCT02131636|7539300|FG001|NOT COMPLETED|Overall Study||5
6613426|NCT02131662|7539311|FG000|STARTED|Overall Study||62
6613427|NCT02131662|7539312|FG001|STARTED|Overall Study||61
6613428|NCT02131662|7539313|FG002|STARTED|Overall Study||63
6613429|NCT02131662|7539314|FG003|STARTED|Overall Study||62
6613430|NCT02131662|7539315|FG004|STARTED|Overall Study||61
6613431|NCT02131662|7539311|FG000|Treated|Overall Study||60
6613432|NCT02131662|7539312|FG001|Treated|Overall Study||61
6613433|NCT02131662|7539313|FG002|Treated|Overall Study||61
6613434|NCT02131662|7539314|FG003|Treated|Overall Study||60
6613435|NCT02131662|7539315|FG004|Treated|Overall Study||58
6613436|NCT02131662|7539311|FG000|Completed Treatment|Overall Study||57
6613437|NCT02131662|7539312|FG001|Completed Treatment|Overall Study||60
6613438|NCT02131662|7539313|FG002|Completed Treatment|Overall Study||61
6613439|NCT02131662|7539314|FG003|Completed Treatment|Overall Study||56
6613440|NCT02131662|7539315|FG004|Completed Treatment|Overall Study||52
6613441|NCT02131662|7539311|FG000|Completed Follow-up|Overall Study||54
6613442|NCT02131662|7539312|FG001|Completed Follow-up|Overall Study||47
6613443|NCT02131662|7539313|FG002|Completed Follow-up|Overall Study||56
6613444|NCT02131662|7539314|FG003|Completed Follow-up|Overall Study||42
6613445|NCT02131662|7539315|FG004|Completed Follow-up|Overall Study||44
6613446|NCT02131662|7539311|FG000|COMPLETED|Overall Study||54
6613447|NCT02131662|7539312|FG001|COMPLETED|Overall Study||47
6613448|NCT02131662|7539313|FG002|COMPLETED|Overall Study||56
6613449|NCT02131662|7539314|FG003|COMPLETED|Overall Study||41
6613450|NCT02131662|7539315|FG004|COMPLETED|Overall Study||43
6613451|NCT02131662|7539311|FG000|NOT COMPLETED|Overall Study||8
6613452|NCT02131662|7539312|FG001|NOT COMPLETED|Overall Study||14
6613453|NCT02131662|7539313|FG002|NOT COMPLETED|Overall Study||7
6613454|NCT02131662|7539314|FG003|NOT COMPLETED|Overall Study||21
6613455|NCT02131662|7539315|FG004|NOT COMPLETED|Overall Study||18
6613456|NCT02131766|7539331|FG000|STARTED|Overall Study||44
6613457|NCT02131766|7539331|FG000|COMPLETED|Overall Study||40
6613458|NCT02131766|7539331|FG000|NOT COMPLETED|Overall Study||4
6613459|NCT02132117|7539340|FG000|STARTED|Overall Study||224
6613460|NCT02132117|7539341|FG001|STARTED|Overall Study||221
6613461|NCT02132117|7539340|FG000|COMPLETED|Overall Study||213
6613462|NCT02132117|7539341|FG001|COMPLETED|Overall Study||216
6613463|NCT02132117|7539340|FG000|NOT COMPLETED|Overall Study||11
6613464|NCT02132117|7539341|FG001|NOT COMPLETED|Overall Study||5
6613465|NCT02132130|7539351|FG000|STARTED|Overall Study||3
6613466|NCT02132130|7539352|FG001|STARTED|Overall Study||12
6613467|NCT02132130|7539353|FG002|STARTED|Overall Study||4
6613468|NCT02132130|7539354|FG003|STARTED|Overall Study||3
6613469|NCT02132130|7539351|FG000|COMPLETED|Overall Study||3
6613470|NCT02132130|7539352|FG001|COMPLETED|Overall Study||10
6613471|NCT02132130|7539353|FG002|COMPLETED|Overall Study||4
6613472|NCT02132130|7539354|FG003|COMPLETED|Overall Study||2
6613473|NCT02132130|7539351|FG000|NOT COMPLETED|Overall Study||0
6613474|NCT02132130|7539352|FG001|NOT COMPLETED|Overall Study||2
6613475|NCT02132130|7539353|FG002|NOT COMPLETED|Overall Study||0
6613476|NCT02132130|7539354|FG003|NOT COMPLETED|Overall Study||1
6613477|NCT02132169|7539370|FG000|STARTED|Overall Study||341
6613478|NCT02132169|7539371|FG001|STARTED|Overall Study||171
6613479|NCT02132169|7539370|FG000|COMPLETED|Overall Study||326
6613480|NCT02132169|7539371|FG001|COMPLETED|Overall Study||162
6613481|NCT02132169|7539370|FG000|NOT COMPLETED|Overall Study||15
6613482|NCT02132169|7539371|FG001|NOT COMPLETED|Overall Study||9
6613483|NCT02132195|7539380|FG000|STARTED|Initial Assignment||15
6613484|NCT02132195|7539381|FG001|STARTED|Initial Assignment||16
6613485|NCT02132195|7539382|FG002|STARTED|Initial Assignment||0
6613486|NCT02132195|7539380|FG000|COMPLETED|Initial Assignment||1
6613487|NCT02132195|7539381|FG001|COMPLETED|Initial Assignment||16
6613488|NCT02132195|7539382|FG002|COMPLETED|Initial Assignment||0
6613489|NCT02132195|7539380|FG000|NOT COMPLETED|Initial Assignment||14
6613490|NCT02132195|7539381|FG001|NOT COMPLETED|Initial Assignment||0
6613491|NCT02132195|7539382|FG002|NOT COMPLETED|Initial Assignment||0
6613492|NCT02132195|7539380|FG000|STARTED|Rescue Therapy||0
6613493|NCT02132195|7539381|FG001|STARTED|Rescue Therapy||0
6613494|NCT02132195|7539382|FG002|STARTED|Rescue Therapy||13
6613495|NCT02132195|7539380|FG000|COMPLETED|Rescue Therapy||0
6613496|NCT02132195|7539381|FG001|COMPLETED|Rescue Therapy||0
6613497|NCT02132195|7539382|FG002|COMPLETED|Rescue Therapy||2
6613498|NCT02132195|7539380|FG000|NOT COMPLETED|Rescue Therapy||0
6613499|NCT02132195|7539381|FG001|NOT COMPLETED|Rescue Therapy||0
6613500|NCT02132195|7539382|FG002|NOT COMPLETED|Rescue Therapy||11
6613501|NCT02132247|7539392|FG000|STARTED|Overall Study||52
6613502|NCT02132247|7539393|FG001|STARTED|Overall Study||52
6613503|NCT02132247|7539392|FG000|COMPLETED|Overall Study||51
6613504|NCT02132247|7539393|FG001|COMPLETED|Overall Study||52
6613505|NCT02132247|7539392|FG000|NOT COMPLETED|Overall Study||1
6613506|NCT02132247|7539393|FG001|NOT COMPLETED|Overall Study||0
6613507|NCT02132312|7539401|FG000|STARTED|Overall Study||37
6613508|NCT02132312|7539402|FG001|STARTED|Overall Study||41
6613509|NCT02132312|7539401|FG000|COMPLETED|Overall Study||31
6613510|NCT02132312|7539402|FG001|COMPLETED|Overall Study||38
6613511|NCT02132312|7539401|FG000|NOT COMPLETED|Overall Study||6
6613512|NCT02132312|7539402|FG001|NOT COMPLETED|Overall Study||3
6613513|NCT02132468|7539408|FG000|STARTED|Overall Study||18
6613514|NCT02132468|7539408|FG000|COMPLETED|Overall Study||11
6613515|NCT02132468|7539408|FG000|NOT COMPLETED|Overall Study||7
6613516|NCT02132520|7539415|FG000|STARTED|Overall Study||0
6613517|NCT02132520|7539416|FG001|STARTED|Overall Study||1
6613518|NCT02132520|7539417|FG002|STARTED|Overall Study||2
6613519|NCT02132520|7539415|FG000|COMPLETED|Overall Study||0
6613520|NCT02132520|7539416|FG001|COMPLETED|Overall Study||1
6613521|NCT02132520|7539417|FG002|COMPLETED|Overall Study||2
6613522|NCT02132520|7539415|FG000|NOT COMPLETED|Overall Study||0
6613523|NCT02132520|7539416|FG001|NOT COMPLETED|Overall Study||0
6613524|NCT02132520|7539417|FG002|NOT COMPLETED|Overall Study||0
6613525|NCT02132533|7539426|FG000|STARTED|Overall Study||46
6613526|NCT02132533|7539427|FG001|STARTED|Overall Study||42
6613527|NCT02132533|7539426|FG000|COMPLETED|Overall Study||46
6613528|NCT02132533|7539427|FG001|COMPLETED|Overall Study||42
6613529|NCT02132533|7539426|FG000|NOT COMPLETED|Overall Study||0
6613530|NCT02132533|7539427|FG001|NOT COMPLETED|Overall Study||0
6613531|NCT02132572|7539433|FG000|STARTED|Overall Study||201
6613532|NCT02132572|7539433|FG000|COMPLETED|Overall Study||201
6613533|NCT02132572|7539433|FG000|NOT COMPLETED|Overall Study||0
6613534|NCT02132598|7539437|FG000|STARTED|Overall Study||5
6613535|NCT02132598|7539437|FG000|COMPLETED|Overall Study||5
6613536|NCT02132598|7539437|FG000|NOT COMPLETED|Overall Study||0
6613537|NCT02132637|7539443|FG000|STARTED|Study Period 1||34
6613538|NCT02132637|7539444|FG001|STARTED|Study Period 1||34
6613539|NCT02132637|7539443|FG000|Received at Least One Dose of Study Drug|Study Period 1||34
6613540|NCT02132637|7539444|FG001|Received at Least One Dose of Study Drug|Study Period 1||34
6613541|NCT02132637|7539443|FG000|COMPLETED|Study Period 1||33
6613542|NCT02132637|7539444|FG001|COMPLETED|Study Period 1||30
6613543|NCT02132637|7539443|FG000|NOT COMPLETED|Study Period 1||1
6613544|NCT02132637|7539444|FG001|NOT COMPLETED|Study Period 1||4
6613545|NCT02132637|7539443|FG000|STARTED|Study Period 2 (Crossover)||33
6613546|NCT02132637|7539444|FG001|STARTED|Study Period 2 (Crossover)||30
6613547|NCT02132637|7539443|FG000|COMPLETED|Study Period 2 (Crossover)||31
6613548|NCT02132637|7539444|FG001|COMPLETED|Study Period 2 (Crossover)||29
6613549|NCT02132637|7539443|FG000|NOT COMPLETED|Study Period 2 (Crossover)||2
6613550|NCT02132637|7539444|FG001|NOT COMPLETED|Study Period 2 (Crossover)||1
6613551|NCT02132650|7539452|FG000|STARTED|Overall Study||20
6613552|NCT02132650|7539453|FG001|STARTED|Overall Study||18
6613553|NCT02132650|7539452|FG000|Post-Intervention Assessment|Overall Study||19
6613554|NCT02132650|7539453|FG001|Post-Intervention Assessment|Overall Study||17
6613555|NCT02132650|7539452|FG000|COMPLETED|Overall Study||17
6613556|NCT02132650|7539453|FG001|COMPLETED|Overall Study||14
6613557|NCT02132650|7539452|FG000|NOT COMPLETED|Overall Study||3
6613558|NCT02132650|7539453|FG001|NOT COMPLETED|Overall Study||4
6613559|NCT02132676|7539461|FG000|STARTED|Overall Study||727
6613560|NCT02132676|7539462|FG001|STARTED|Overall Study||809
6613561|NCT02132676|7539461|FG000|COMPLETED|Overall Study||727
6613562|NCT02132676|7539462|FG001|COMPLETED|Overall Study||809
6613563|NCT02132676|7539461|FG000|NOT COMPLETED|Overall Study||0
6613564|NCT02132676|7539462|FG001|NOT COMPLETED|Overall Study||0
6613565|NCT02132754|7539503|FG000|STARTED|Overall Study||1
6613566|NCT02132754|7539504|FG001|STARTED|Overall Study||1
6613567|NCT02132754|7539505|FG002|STARTED|Overall Study||1
6613568|NCT02132754|7539506|FG003|STARTED|Overall Study||1
6613569|NCT02132754|7539507|FG004|STARTED|Overall Study||1
6613570|NCT02132754|7539508|FG005|STARTED|Overall Study||1
6613571|NCT02132754|7539509|FG006|STARTED|Overall Study||1
6613572|NCT02132754|7539510|FG007|STARTED|Overall Study||1
6613573|NCT02132754|7539511|FG008|STARTED|Overall Study||1
6613574|NCT02132754|7539512|FG009|STARTED|Overall Study||6
6613575|NCT02132754|7539513|FG010|STARTED|Overall Study||3
6613576|NCT02132754|7539514|FG011|STARTED|Overall Study||3
6613577|NCT02132754|7539515|FG012|STARTED|Overall Study||4
6613578|NCT02132754|7539516|FG013|STARTED|Overall Study||3
6613579|NCT02132754|7539517|FG014|STARTED|Overall Study||3
6613580|NCT02132754|7539518|FG015|STARTED|Overall Study||5
6613581|NCT02132754|7539519|FG016|STARTED|Overall Study||4
6613582|NCT02132754|7539520|FG017|STARTED|Overall Study||3
6613583|NCT02132754|7539521|FG018|STARTED|Overall Study||3
6613584|NCT02132754|7539522|FG019|STARTED|Overall Study||4
6613585|NCT02132754|7539523|FG020|STARTED|Overall Study||3
6613586|NCT02132754|7539524|FG021|STARTED|Overall Study||5
6613587|NCT02132754|7539525|FG022|STARTED|Overall Study||3
6613588|NCT02132754|7539526|FG023|STARTED|Overall Study||3
6613589|NCT02132754|7539527|FG024|STARTED|Overall Study||3
6613590|NCT02132754|7539528|FG025|STARTED|Overall Study||3
6613591|NCT02132754|7539529|FG026|STARTED|Overall Study||4
6613592|NCT02132754|7539530|FG027|STARTED|Overall Study||3
6613593|NCT02132754|7539531|FG028|STARTED|Overall Study||3
6613594|NCT02132754|7539532|FG029|STARTED|Overall Study||3
6613595|NCT02132754|7539533|FG030|STARTED|Overall Study||3
6613596|NCT02132754|7539534|FG031|STARTED|Overall Study||3
6613597|NCT02132754|7539535|FG032|STARTED|Overall Study||4
6613598|NCT02132754|7539536|FG033|STARTED|Overall Study||23
6613599|NCT02132754|7539503|FG000|Treated|Overall Study||1
6613600|NCT02132754|7539504|FG001|Treated|Overall Study||1
6613601|NCT02132754|7539505|FG002|Treated|Overall Study||1
6613602|NCT02132754|7539506|FG003|Treated|Overall Study||1
6613603|NCT02132754|7539507|FG004|Treated|Overall Study||1
6613604|NCT02132754|7539508|FG005|Treated|Overall Study||1
6613605|NCT02132754|7539509|FG006|Treated|Overall Study||1
6613606|NCT02132754|7539510|FG007|Treated|Overall Study||1
6613607|NCT02132754|7539511|FG008|Treated|Overall Study||1
6613608|NCT02132754|7539512|FG009|Treated|Overall Study||6
6613609|NCT02132754|7539513|FG010|Treated|Overall Study||3
6613610|NCT02132754|7539514|FG011|Treated|Overall Study||3
6613611|NCT02132754|7539515|FG012|Treated|Overall Study||3
6613612|NCT02132754|7539516|FG013|Treated|Overall Study||3
6613613|NCT02132754|7539517|FG014|Treated|Overall Study||3
6613614|NCT02132754|7539518|FG015|Treated|Overall Study||5
6613615|NCT02132754|7539519|FG016|Treated|Overall Study||4
6613616|NCT02132754|7539520|FG017|Treated|Overall Study||3
6613617|NCT02132754|7539521|FG018|Treated|Overall Study||3
6613618|NCT02132754|7539522|FG019|Treated|Overall Study||3
6613619|NCT02132754|7539523|FG020|Treated|Overall Study||3
6613620|NCT02132754|7539524|FG021|Treated|Overall Study||4
6613621|NCT02132754|7539525|FG022|Treated|Overall Study||3
6613622|NCT02132754|7539526|FG023|Treated|Overall Study||3
6613623|NCT02132754|7539527|FG024|Treated|Overall Study||3
6613624|NCT02132754|7539528|FG025|Treated|Overall Study||3
6613625|NCT02132754|7539529|FG026|Treated|Overall Study||4
6613626|NCT02132754|7539530|FG027|Treated|Overall Study||3
6613627|NCT02132754|7539531|FG028|Treated|Overall Study||3
6613628|NCT02132754|7539532|FG029|Treated|Overall Study||3
6613629|NCT02132754|7539533|FG030|Treated|Overall Study||3
6613630|NCT02132754|7539534|FG031|Treated|Overall Study||3
6613631|NCT02132754|7539535|FG032|Treated|Overall Study||4
6613632|NCT02132754|7539536|FG033|Treated|Overall Study||23
6613633|NCT02132754|7539503|FG000|COMPLETED|Overall Study||0
6613634|NCT02132754|7539504|FG001|COMPLETED|Overall Study||0
6613635|NCT02132754|7539505|FG002|COMPLETED|Overall Study||0
6613636|NCT02132754|7539506|FG003|COMPLETED|Overall Study||0
6613637|NCT02132754|7539507|FG004|COMPLETED|Overall Study||0
6613638|NCT02132754|7539508|FG005|COMPLETED|Overall Study||0
6613639|NCT02132754|7539509|FG006|COMPLETED|Overall Study||0
6613640|NCT02132754|7539510|FG007|COMPLETED|Overall Study||0
6613641|NCT02132754|7539511|FG008|COMPLETED|Overall Study||0
6613642|NCT02132754|7539512|FG009|COMPLETED|Overall Study||0
6613643|NCT02132754|7539513|FG010|COMPLETED|Overall Study||0
6613644|NCT02132754|7539514|FG011|COMPLETED|Overall Study||0
6613645|NCT02132754|7539515|FG012|COMPLETED|Overall Study||0
6613646|NCT02132754|7539516|FG013|COMPLETED|Overall Study||0
6613647|NCT02132754|7539517|FG014|COMPLETED|Overall Study||0
6613648|NCT02132754|7539518|FG015|COMPLETED|Overall Study||0
6613649|NCT02132754|7539519|FG016|COMPLETED|Overall Study||0
6613650|NCT02132754|7539520|FG017|COMPLETED|Overall Study||0
6613651|NCT02132754|7539521|FG018|COMPLETED|Overall Study||0
6613652|NCT02132754|7539522|FG019|COMPLETED|Overall Study||0
6613653|NCT02132754|7539523|FG020|COMPLETED|Overall Study||0
6613654|NCT02132754|7539524|FG021|COMPLETED|Overall Study||0
6613655|NCT02132754|7539525|FG022|COMPLETED|Overall Study||0
6613656|NCT02132754|7539526|FG023|COMPLETED|Overall Study||0
6613657|NCT02132754|7539527|FG024|COMPLETED|Overall Study||0
6613658|NCT02132754|7539528|FG025|COMPLETED|Overall Study||0
6613659|NCT02132754|7539529|FG026|COMPLETED|Overall Study||0
6613660|NCT02132754|7539530|FG027|COMPLETED|Overall Study||0
6613661|NCT02132754|7539531|FG028|COMPLETED|Overall Study||0
6613662|NCT02132754|7539532|FG029|COMPLETED|Overall Study||0
6613663|NCT02132754|7539533|FG030|COMPLETED|Overall Study||0
6613664|NCT02132754|7539534|FG031|COMPLETED|Overall Study||0
6613665|NCT02132754|7539535|FG032|COMPLETED|Overall Study||0
6613666|NCT02132754|7539536|FG033|COMPLETED|Overall Study||0
6613667|NCT02132754|7539503|FG000|NOT COMPLETED|Overall Study||1
6613668|NCT02132754|7539504|FG001|NOT COMPLETED|Overall Study||1
6613669|NCT02132754|7539505|FG002|NOT COMPLETED|Overall Study||1
6613670|NCT02132754|7539506|FG003|NOT COMPLETED|Overall Study||1
6613671|NCT02132754|7539507|FG004|NOT COMPLETED|Overall Study||1
6613672|NCT02132754|7539508|FG005|NOT COMPLETED|Overall Study||1
6613673|NCT02132754|7539509|FG006|NOT COMPLETED|Overall Study||1
6613674|NCT02132754|7539510|FG007|NOT COMPLETED|Overall Study||1
6613675|NCT02132754|7539511|FG008|NOT COMPLETED|Overall Study||1
6613676|NCT02132754|7539512|FG009|NOT COMPLETED|Overall Study||6
6613677|NCT02132754|7539513|FG010|NOT COMPLETED|Overall Study||3
6613678|NCT02132754|7539514|FG011|NOT COMPLETED|Overall Study||3
6613679|NCT02132754|7539515|FG012|NOT COMPLETED|Overall Study||4
6613680|NCT02132754|7539516|FG013|NOT COMPLETED|Overall Study||3
6613681|NCT02132754|7539517|FG014|NOT COMPLETED|Overall Study||3
6613682|NCT02132754|7539518|FG015|NOT COMPLETED|Overall Study||5
6613683|NCT02132754|7539519|FG016|NOT COMPLETED|Overall Study||4
6613684|NCT02132754|7539520|FG017|NOT COMPLETED|Overall Study||3
6613685|NCT02132754|7539521|FG018|NOT COMPLETED|Overall Study||3
6613686|NCT02132754|7539522|FG019|NOT COMPLETED|Overall Study||4
6613687|NCT02132754|7539523|FG020|NOT COMPLETED|Overall Study||3
6613688|NCT02132754|7539524|FG021|NOT COMPLETED|Overall Study||5
6613689|NCT02132754|7539525|FG022|NOT COMPLETED|Overall Study||3
6613690|NCT02132754|7539526|FG023|NOT COMPLETED|Overall Study||3
6613691|NCT02132754|7539527|FG024|NOT COMPLETED|Overall Study||3
6613692|NCT02132754|7539528|FG025|NOT COMPLETED|Overall Study||3
6613693|NCT02132754|7539529|FG026|NOT COMPLETED|Overall Study||4
6613694|NCT02132754|7539530|FG027|NOT COMPLETED|Overall Study||3
6613695|NCT02132754|7539531|FG028|NOT COMPLETED|Overall Study||3
6613696|NCT02132754|7539532|FG029|NOT COMPLETED|Overall Study||3
6613697|NCT02132754|7539533|FG030|NOT COMPLETED|Overall Study||3
6613698|NCT02132754|7539534|FG031|NOT COMPLETED|Overall Study||3
6613699|NCT02132754|7539535|FG032|NOT COMPLETED|Overall Study||4
6613700|NCT02132754|7539536|FG033|NOT COMPLETED|Overall Study||23
6613701|NCT02132767|7539648|FG000|STARTED|Overall Study||262
6613702|NCT02132767|7539649|FG001|STARTED|Overall Study||261
6613703|NCT02132767|7539648|FG000|COMPLETED|Overall Study||245
6613704|NCT02132767|7539649|FG001|COMPLETED|Overall Study||246
6613705|NCT02132767|7539648|FG000|NOT COMPLETED|Overall Study||17
6613706|NCT02132767|7539649|FG001|NOT COMPLETED|Overall Study||15
6613707|NCT02132832|7539657|FG000|STARTED|Overall Study||19
6613708|NCT02132832|7539658|FG001|STARTED|Overall Study||23
6613709|NCT02132832|7539657|FG000|COMPLETED|Overall Study||16
6613710|NCT02132832|7539658|FG001|COMPLETED|Overall Study||16
6613711|NCT02132832|7539657|FG000|NOT COMPLETED|Overall Study||3
6613712|NCT02132832|7539658|FG001|NOT COMPLETED|Overall Study||7
6613713|NCT02132910|7539666|FG000|STARTED|Overall Study||34
6613714|NCT02132910|7539667|FG001|STARTED|Overall Study||34
6613715|NCT02132910|7539666|FG000|COMPLETED|Overall Study||34
6613716|NCT02132910|7539667|FG001|COMPLETED|Overall Study||34
6613717|NCT02132910|7539666|FG000|NOT COMPLETED|Overall Study||0
6613718|NCT02132910|7539667|FG001|NOT COMPLETED|Overall Study||0
6613719|NCT02132936|7539677|FG000|STARTED|Overall Study||185
6613720|NCT02132936|7539678|FG001|STARTED|Overall Study||47
6613721|NCT02132936|7539679|FG002|STARTED|Overall Study||188
6613722|NCT02132936|7539680|FG003|STARTED|Overall Study||43
6613723|NCT02132936|7539677|FG000|COMPLETED|Overall Study||175
6613724|NCT02132936|7539678|FG001|COMPLETED|Overall Study||38
6613725|NCT02132936|7539679|FG002|COMPLETED|Overall Study||174
6613726|NCT02132936|7539680|FG003|COMPLETED|Overall Study||29
6613727|NCT02132936|7539677|FG000|NOT COMPLETED|Overall Study||10
6613728|NCT02132936|7539678|FG001|NOT COMPLETED|Overall Study||9
6613729|NCT02132936|7539679|FG002|NOT COMPLETED|Overall Study||14
6613730|NCT02132936|7539680|FG003|NOT COMPLETED|Overall Study||14
6613731|NCT02132949|7539693|FG000|STARTED|Overall Study||199
6613732|NCT02132949|7539694|FG001|STARTED|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort B for efficacy).|201
6613733|NCT02132949|7539693|FG000|Received Any Cohort A Study Treatment|Overall Study|1 participant withdrew prior to receiving any study drug.|198
6613734|NCT02132949|7539694|FG001|Received Any Cohort A Study Treatment|Overall Study|1 participant enrolled in Cohort B received Cohort A treatment (and was counted as part of Cohort A for safety).|1
6613735|NCT02132949|7539693|FG000|Received Any Cohort B Study Treatment|Overall Study||0
6613736|NCT02132949|7539694|FG001|Received Any Cohort B Study Treatment|Overall Study|2 participants withdrew prior to receiving any study drug.|198
6613737|NCT02132949|7539693|FG000|Underwent Surgery|Overall Study||187
6613738|NCT02132949|7539694|FG001|Underwent Surgery|Overall Study||194
6613739|NCT02132949|7539693|FG000|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||182
6613740|NCT02132949|7539694|FG001|Completed Neoadjuvant Treatment (25 Weeks)|Overall Study||189
6613741|NCT02132949|7539693|FG000|Started Adjuvant Treatment|Overall Study||181
6613742|NCT02132949|7539694|FG001|Started Adjuvant Treatment|Overall Study|1 participant did not complete neoadjuvant treatment but started adjuvant treatment.|190
6613743|NCT02132949|7539693|FG000|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||163
6613744|NCT02132949|7539694|FG001|Completed Adjuvant Treatment (Up to 39 Weeks)|Overall Study||176
6613745|NCT02132949|7539693|FG000|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
6613746|NCT02132949|7539694|FG001|Started Treatment-Free Follow-Up (Up to 5 Years)|Overall Study||195
6613747|NCT02132949|7539693|FG000|COMPLETED|Overall Study||158
6613748|NCT02132949|7539694|FG001|COMPLETED|Overall Study||173
6613749|NCT02132949|7539693|FG000|NOT COMPLETED|Overall Study||41
6613750|NCT02132949|7539694|FG001|NOT COMPLETED|Overall Study||28
6613751|NCT02133001|7539702|FG000|STARTED|Double Blind (Day 1-25)||32
6613752|NCT02133001|7539703|FG001|STARTED|Double Blind (Day 1-25)||36
6613753|NCT02133001|7539702|FG000|Safety|Double Blind (Day 1-25)||31
6613754|NCT02133001|7539703|FG001|Safety|Double Blind (Day 1-25)||35
6613755|NCT02133001|7539702|FG000|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|22
6613756|NCT02133001|7539703|FG001|COMPLETED|Double Blind (Day 1-25)|Participants who completed continued to follow-up phase.|27
6613757|NCT02133001|7539702|FG000|NOT COMPLETED|Double Blind (Day 1-25)||10
6613758|NCT02133001|7539703|FG001|NOT COMPLETED|Double Blind (Day 1-25)||9
6613759|NCT02133001|7539702|FG000|STARTED|Follow-Up Phase (Day 26-81)||22
6613760|NCT02133001|7539703|FG001|STARTED|Follow-Up Phase (Day 26-81)||27
6613761|NCT02133001|7539702|FG000|COMPLETED|Follow-Up Phase (Day 26-81)||20
6613762|NCT02133001|7539703|FG001|COMPLETED|Follow-Up Phase (Day 26-81)||24
6613763|NCT02133001|7539702|FG000|NOT COMPLETED|Follow-Up Phase (Day 26-81)||2
6613764|NCT02133001|7539703|FG001|NOT COMPLETED|Follow-Up Phase (Day 26-81)||3
6613765|NCT02133066|7539713|FG000|STARTED|Overall Study||64
6613766|NCT02133066|7539714|FG001|STARTED|Overall Study||64
6613767|NCT02133066|7539713|FG000|COMPLETED|Overall Study||64
6613768|NCT02133066|7539714|FG001|COMPLETED|Overall Study||64
6613769|NCT02133066|7539713|FG000|NOT COMPLETED|Overall Study||0
6613770|NCT02133066|7539714|FG001|NOT COMPLETED|Overall Study||0
6613771|NCT02133131|7539727|FG000|STARTED|Overall Study||31
6613772|NCT02133131|7539728|FG001|STARTED|Overall Study||30
6613773|NCT02133131|7539729|FG002|STARTED|Overall Study||20
6613774|NCT02133131|7539730|FG003|STARTED|Overall Study||21
6613775|NCT02133131|7539731|FG004|STARTED|Overall Study||15
6613776|NCT02133131|7539732|FG005|STARTED|Overall Study||14
6613777|NCT02133131|7539733|FG006|STARTED|Overall Study||12
6613778|NCT02133131|7539727|FG000|COMPLETED|Overall Study||26
6732747|NCT03198221|7662202|FG000|NOT COMPLETED|Overall Study||0
6732748|NCT03198221|7662203|FG001|NOT COMPLETED|Overall Study||0
6732749|NCT03198221|7662204|FG002|NOT COMPLETED|Overall Study||0
6732750|NCT03198221|7662205|FG003|NOT COMPLETED|Overall Study||0
6732751|NCT03198507|7662217|FG000|STARTED|Overall Study||228
6732752|NCT03198507|7662218|FG001|STARTED|Overall Study||227
6732753|NCT03198507|7662217|FG000|COMPLETED|Overall Study||227
6732754|NCT03198507|7662218|FG001|COMPLETED|Overall Study||227
6732755|NCT03198507|7662217|FG000|NOT COMPLETED|Overall Study||1
6732756|NCT03198507|7662218|FG001|NOT COMPLETED|Overall Study||0
6732757|NCT03198520|7662224|FG000|STARTED|Overall Study||46
6732758|NCT03198520|7662224|FG000|COMPLETED|Overall Study||40
6732759|NCT03198520|7662224|FG000|NOT COMPLETED|Overall Study||6
6732760|NCT03198715|7662241|FG000|STARTED|Overall Study||6
6732761|NCT03198715|7662242|FG001|STARTED|Overall Study||12
6732762|NCT03198715|7662243|FG002|STARTED|Overall Study||12
6732763|NCT03198715|7662244|FG003|STARTED|Overall Study||3
6732764|NCT03198715|7662245|FG004|STARTED|Overall Study||9
6732765|NCT03198715|7662241|FG000|COMPLETED|Overall Study||6
6732766|NCT03198715|7662242|FG001|COMPLETED|Overall Study||11
6732767|NCT03198715|7662243|FG002|COMPLETED|Overall Study||10
6732768|NCT03198715|7662244|FG003|COMPLETED|Overall Study||3
6732769|NCT03198715|7662245|FG004|COMPLETED|Overall Study||7
6732770|NCT03198715|7662241|FG000|NOT COMPLETED|Overall Study||0
6732771|NCT03198715|7662242|FG001|NOT COMPLETED|Overall Study||1
6732772|NCT03198715|7662243|FG002|NOT COMPLETED|Overall Study||2
6732773|NCT03198715|7662244|FG003|NOT COMPLETED|Overall Study||0
6732774|NCT03198715|7662245|FG004|NOT COMPLETED|Overall Study||2
6732775|NCT03198754|7662259|FG000|STARTED|Overall Study||38
6732776|NCT03198754|7662260|FG001|STARTED|Overall Study||35
6732777|NCT03198754|7662259|FG000|COMPLETED|Overall Study||27
6732778|NCT03198754|7662260|FG001|COMPLETED|Overall Study||27
6732779|NCT03198754|7662259|FG000|NOT COMPLETED|Overall Study||11
6732780|NCT03198754|7662260|FG001|NOT COMPLETED|Overall Study||8
6732781|NCT03198767|7662273|FG000|STARTED|Overall Study||8
6732782|NCT03198767|7662274|FG001|STARTED|Overall Study||8
6732783|NCT03198767|7662275|FG002|STARTED|Overall Study||8
6732784|NCT03198767|7662276|FG003|STARTED|Overall Study||6
6732785|NCT03198767|7662277|FG004|STARTED|Overall Study||8
6732786|NCT03198767|7662278|FG005|STARTED|Overall Study||8
6732787|NCT03198767|7662279|FG006|STARTED|Overall Study||8
6732788|NCT03198767|7662273|FG000|COMPLETED|Overall Study||8
6732789|NCT03198767|7662274|FG001|COMPLETED|Overall Study||8
6732790|NCT03198767|7662275|FG002|COMPLETED|Overall Study||8
6732791|NCT03198767|7662276|FG003|COMPLETED|Overall Study||0
6732792|NCT03198767|7662277|FG004|COMPLETED|Overall Study||8
6732793|NCT03198767|7662278|FG005|COMPLETED|Overall Study||8
6732794|NCT03198767|7662279|FG006|COMPLETED|Overall Study||8
6732795|NCT03198767|7662273|FG000|NOT COMPLETED|Overall Study||0
6732796|NCT03198767|7662274|FG001|NOT COMPLETED|Overall Study||0
6732797|NCT03198767|7662275|FG002|NOT COMPLETED|Overall Study||0
6732798|NCT03198767|7662276|FG003|NOT COMPLETED|Overall Study||6
6732799|NCT03198767|7662277|FG004|NOT COMPLETED|Overall Study||0
6732800|NCT03198767|7662278|FG005|NOT COMPLETED|Overall Study||0
6732801|NCT03198767|7662279|FG006|NOT COMPLETED|Overall Study||0
6732802|NCT03198871|7662296|FG000|STARTED|Overall Study||90
6613779|NCT02133131|7539728|FG001|COMPLETED|Overall Study||25
6613780|NCT02133131|7539729|FG002|COMPLETED|Overall Study||19
6613781|NCT02133131|7539730|FG003|COMPLETED|Overall Study||15
6613782|NCT02133131|7539731|FG004|COMPLETED|Overall Study||0
6613783|NCT02133131|7539732|FG005|COMPLETED|Overall Study||0
6613784|NCT02133131|7539733|FG006|COMPLETED|Overall Study||0
6613785|NCT02133131|7539727|FG000|NOT COMPLETED|Overall Study||5
6613786|NCT02133131|7539728|FG001|NOT COMPLETED|Overall Study||5
6613787|NCT02133131|7539729|FG002|NOT COMPLETED|Overall Study||1
6613788|NCT02133131|7539730|FG003|NOT COMPLETED|Overall Study||6
6613789|NCT02133131|7539731|FG004|NOT COMPLETED|Overall Study||15
6613790|NCT02133131|7539732|FG005|NOT COMPLETED|Overall Study||14
6613791|NCT02133131|7539733|FG006|NOT COMPLETED|Overall Study||12
6613792|NCT02133235|7539751|FG000|STARTED|Overall Study||55
6613793|NCT02133235|7539752|FG001|STARTED|Overall Study||57
6613794|NCT02133235|7539751|FG000|COMPLETED|Overall Study||55
6613795|NCT02133235|7539752|FG001|COMPLETED|Overall Study||57
6613796|NCT02133235|7539751|FG000|NOT COMPLETED|Overall Study||0
6613797|NCT02133235|7539752|FG001|NOT COMPLETED|Overall Study||0
6613798|NCT02133352|7539764|FG000|STARTED|Main Study (180 Day)||10
6613799|NCT02133352|7539764|FG000|COMPLETED|Main Study (180 Day)||10
6613800|NCT02133352|7539764|FG000|NOT COMPLETED|Main Study (180 Day)||0
6613801|NCT02133352|7539764|FG000|STARTED|Longer Term Extension||10
6613802|NCT02133352|7539764|FG000|COMPLETED|Longer Term Extension||4
6613803|NCT02133352|7539764|FG000|NOT COMPLETED|Longer Term Extension||6
6613804|NCT02133508|7539768|FG000|STARTED|Overall Study||156
6613805|NCT02133508|7539768|FG000|COMPLETED|Overall Study||141
6613806|NCT02133508|7539768|FG000|NOT COMPLETED|Overall Study||15
6613807|NCT02133664|7539774|FG000|STARTED|Overall Study||26
6613808|NCT02133664|7539775|FG001|STARTED|Overall Study||28
6613809|NCT02133664|7539774|FG000|COMPLETED|Overall Study||21
6613810|NCT02133664|7539775|FG001|COMPLETED|Overall Study||21
6613811|NCT02133664|7539774|FG000|NOT COMPLETED|Overall Study||5
6613812|NCT02133664|7539775|FG001|NOT COMPLETED|Overall Study||7
6613813|NCT02133742|7539781|FG000|STARTED|Period 1: Dose Finding Phase (6 Months)||11
6613814|NCT02133742|7539781|FG000|COMPLETED|Period 1: Dose Finding Phase (6 Months)||11
6613815|NCT02133742|7539781|FG000|NOT COMPLETED|Period 1: Dose Finding Phase (6 Months)||0
6613816|NCT02133742|7539781|FG000|STARTED|Period 2:Dose Expansion Phase (1344days)|Participants participated in dose finding phase continued treatment in dose expansion phase.|52
6613817|NCT02133742|7539781|FG000|COMPLETED|Period 2:Dose Expansion Phase (1344days)||0
6613818|NCT02133742|7539781|FG000|NOT COMPLETED|Period 2:Dose Expansion Phase (1344days)||52
6613819|NCT02133781|7539790|FG000|STARTED|Overall Study||6
6613820|NCT02133781|7539791|FG001|STARTED|Overall Study||24
6613821|NCT02133781|7539792|FG002|STARTED|Overall Study||21
6613822|NCT02133781|7539790|FG000|COMPLETED|Overall Study||6
6613823|NCT02133781|7539791|FG001|COMPLETED|Overall Study||24
6613824|NCT02133781|7539792|FG002|COMPLETED|Overall Study||21
6613825|NCT02133781|7539790|FG000|NOT COMPLETED|Overall Study||0
6613826|NCT02133781|7539791|FG001|NOT COMPLETED|Overall Study||0
6613827|NCT02133781|7539792|FG002|NOT COMPLETED|Overall Study||0
6613828|NCT02134015|7539802|FG000|STARTED|Overall Study||71
6613829|NCT02134015|7539803|FG001|STARTED|Overall Study||74
6613830|NCT02134015|7539802|FG000|COMPLETED|Overall Study||0
6613831|NCT02134015|7539803|FG001|COMPLETED|Overall Study||0
6613832|NCT02134015|7539802|FG000|NOT COMPLETED|Overall Study||71
6613833|NCT02134015|7539803|FG001|NOT COMPLETED|Overall Study||74
6613834|NCT02134119|7539811|FG000|STARTED|Overall Study||30
6613835|NCT02134119|7539812|FG001|STARTED|Overall Study||15
6613836|NCT02134119|7539811|FG000|COMPLETED|Overall Study||30
6613837|NCT02134119|7539812|FG001|COMPLETED|Overall Study||15
6613838|NCT02134119|7539811|FG000|NOT COMPLETED|Overall Study||0
6613839|NCT02134119|7539812|FG001|NOT COMPLETED|Overall Study||0
6613840|NCT02134184|7539821|FG000|STARTED|Overall Study||33
6613841|NCT02134184|7539822|FG001|STARTED|Overall Study||37
6613842|NCT02134184|7539823|FG002|STARTED|Overall Study||8
6613843|NCT02134184|7539821|FG000|COMPLETED|Overall Study||33
6613844|NCT02134184|7539822|FG001|COMPLETED|Overall Study||37
6613845|NCT02134184|7539823|FG002|COMPLETED|Overall Study||8
6613846|NCT02134184|7539821|FG000|NOT COMPLETED|Overall Study||0
6613847|NCT02134184|7539822|FG001|NOT COMPLETED|Overall Study||0
6613848|NCT02134184|7539823|FG002|NOT COMPLETED|Overall Study||0
6613849|NCT02134210|7539833|FG000|STARTED|Part One: Weeks 0-12||260
6613850|NCT02134210|7539834|FG001|STARTED|Part One: Weeks 0-12||261
6613851|NCT02134210|7539833|FG000|COMPLETED|Part One: Weeks 0-12||241
6613852|NCT02134210|7539834|FG001|COMPLETED|Part One: Weeks 0-12||255
6613853|NCT02134210|7539833|FG000|NOT COMPLETED|Part One: Weeks 0-12||19
6613854|NCT02134210|7539834|FG001|NOT COMPLETED|Part One: Weeks 0-12||6
6613855|NCT02134210|7539833|FG000|STARTED|Part Two: Weeks 13-48||241
6613856|NCT02134210|7539834|FG001|STARTED|Part Two: Weeks 13-48||255
6613857|NCT02134210|7539833|FG000|COMPLETED|Part Two: Weeks 13-48||211
6613858|NCT02134210|7539834|FG001|COMPLETED|Part Two: Weeks 13-48||227
6613859|NCT02134210|7539833|FG000|NOT COMPLETED|Part Two: Weeks 13-48||30
6613860|NCT02134210|7539834|FG001|NOT COMPLETED|Part Two: Weeks 13-48||28
6613861|NCT02134314|7539842|FG000|STARTED|Overall Study||35
6613862|NCT02134314|7539843|FG001|STARTED|Overall Study||35
6613863|NCT02134314|7539842|FG000|COMPLETED|Overall Study||34
6613864|NCT02134314|7539843|FG001|COMPLETED|Overall Study||34
6613865|NCT02134314|7539842|FG000|NOT COMPLETED|Overall Study||1
6613866|NCT02134314|7539843|FG001|NOT COMPLETED|Overall Study||1
6613867|NCT02134353|7539852|FG000|STARTED|Overall Study||209
6613868|NCT02134353|7539853|FG001|STARTED|Overall Study||214
6613869|NCT02134353|7539852|FG000|COMPLETED|Overall Study||183
6613870|NCT02134353|7539853|FG001|COMPLETED|Overall Study||190
6613871|NCT02134353|7539852|FG000|NOT COMPLETED|Overall Study||26
6613872|NCT02134353|7539853|FG001|NOT COMPLETED|Overall Study||24
6613873|NCT02134522|7539859|FG000|STARTED|Overall Study||1
6613874|NCT02134522|7539859|FG000|COMPLETED|Overall Study||1
6613875|NCT02134522|7539859|FG000|NOT COMPLETED|Overall Study||0
6613876|NCT02134587|7539863|FG000|STARTED|Overall Study||203
6613877|NCT02134587|7539863|FG000|COMPLETED|Overall Study||173
6613878|NCT02134587|7539863|FG000|NOT COMPLETED|Overall Study||30
6613879|NCT02134756|7539874|FG000|STARTED|Overall Study||15
6613880|NCT02134756|7539875|FG001|STARTED|Overall Study||15
6613881|NCT02134756|7539874|FG000|COMPLETED|Overall Study||14
6613882|NCT02134756|7539875|FG001|COMPLETED|Overall Study||13
6613883|NCT02134756|7539874|FG000|NOT COMPLETED|Overall Study||1
6613884|NCT02134756|7539875|FG001|NOT COMPLETED|Overall Study||2
6613885|NCT02134951|7539883|FG000|STARTED|Overall Study||39
6613886|NCT02134951|7539884|FG001|STARTED|Overall Study||20
6613887|NCT02134951|7539883|FG000|COMPLETED|Overall Study|number of subjects with at least one valid scan|39
6613888|NCT02134951|7539884|FG001|COMPLETED|Overall Study|number of subjects with at least one valid scan|20
6613889|NCT02134951|7539883|FG000|NOT COMPLETED|Overall Study||0
6613890|NCT02134951|7539884|FG001|NOT COMPLETED|Overall Study||0
6613891|NCT02134977|7539890|FG000|STARTED|Overall Study||2816
6613892|NCT02134977|7539890|FG000|COMPLETED|Overall Study||2714
6613893|NCT02134977|7539890|FG000|NOT COMPLETED|Overall Study||102
6613894|NCT02135016|7539897|FG000|STARTED|Overall Study||15
6613895|NCT02135016|7539898|FG001|STARTED|Overall Study||15
6613896|NCT02135016|7539899|FG002|STARTED|Overall Study||15
6613897|NCT02135016|7539897|FG000|COMPLETED|Overall Study||15
6613898|NCT02135016|7539898|FG001|COMPLETED|Overall Study||15
6613899|NCT02135016|7539899|FG002|COMPLETED|Overall Study||15
6613900|NCT02135016|7539897|FG000|NOT COMPLETED|Overall Study||0
6613901|NCT02135016|7539898|FG001|NOT COMPLETED|Overall Study||0
6613902|NCT02135016|7539899|FG002|NOT COMPLETED|Overall Study||0
6613903|NCT02135094|7539909|FG000|STARTED|Overall Study||25
6613904|NCT02135094|7539910|FG001|STARTED|Overall Study||8
6613905|NCT02135094|7539909|FG000|Week 2|Overall Study||25
6613906|NCT02135094|7539910|FG001|Week 2|Overall Study||8
6613907|NCT02135094|7539909|FG000|Week 3|Overall Study||25
6613908|NCT02135094|7539910|FG001|Week 3|Overall Study||8
6613909|NCT02135094|7539909|FG000|Week 4|Overall Study||25
6613910|NCT02135094|7539910|FG001|Week 4|Overall Study||8
6613911|NCT02135094|7539909|FG000|COMPLETED|Overall Study||25
6613912|NCT02135094|7539910|FG001|COMPLETED|Overall Study||8
6613913|NCT02135094|7539909|FG000|NOT COMPLETED|Overall Study||0
6613914|NCT02135094|7539910|FG001|NOT COMPLETED|Overall Study||0
6613915|NCT02135107|7539918|FG000|STARTED|Treatment Period||437
6613916|NCT02135107|7539919|FG001|STARTED|Treatment Period||80
6613917|NCT02135107|7539920|FG002|STARTED|Treatment Period||0
6613918|NCT02135107|7539921|FG003|STARTED|Treatment Period||0
6613919|NCT02135107|7539918|FG000|COMPLETED|Treatment Period||305
6613920|NCT02135107|7539919|FG001|COMPLETED|Treatment Period||54
6613921|NCT02135107|7539920|FG002|COMPLETED|Treatment Period||0
6613922|NCT02135107|7539921|FG003|COMPLETED|Treatment Period||0
6613923|NCT02135107|7539918|FG000|NOT COMPLETED|Treatment Period||132
6613924|NCT02135107|7539919|FG001|NOT COMPLETED|Treatment Period||26
6613925|NCT02135107|7539920|FG002|NOT COMPLETED|Treatment Period||0
6613926|NCT02135107|7539921|FG003|NOT COMPLETED|Treatment Period||0
6613927|NCT02135107|7539918|FG000|STARTED|Maintenance Therapy Period|Treatment Phase only|0
6613928|NCT02135107|7539919|FG001|STARTED|Maintenance Therapy Period|Treatment Phase only|0
6613929|NCT02135107|7539920|FG002|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|178
6613930|NCT02135107|7539921|FG003|STARTED|Maintenance Therapy Period|Only eligible participants entered into the Maintenance Therapy Period|181
6613931|NCT02135107|7539918|FG000|COMPLETED|Maintenance Therapy Period||0
6613932|NCT02135107|7539919|FG001|COMPLETED|Maintenance Therapy Period||0
6613933|NCT02135107|7539920|FG002|COMPLETED|Maintenance Therapy Period||163
6613934|NCT02135107|7539921|FG003|COMPLETED|Maintenance Therapy Period||161
6613935|NCT02135107|7539918|FG000|NOT COMPLETED|Maintenance Therapy Period||0
6613936|NCT02135107|7539919|FG001|NOT COMPLETED|Maintenance Therapy Period||0
6613937|NCT02135107|7539920|FG002|NOT COMPLETED|Maintenance Therapy Period||15
6613938|NCT02135107|7539921|FG003|NOT COMPLETED|Maintenance Therapy Period||20
6613939|NCT02135146|7539935|FG000|STARTED|Overall Study||20
6613940|NCT02135146|7539936|FG001|STARTED|Overall Study||20
6613941|NCT02135146|7539935|FG000|COMPLETED|Overall Study||20
6613942|NCT02135146|7539936|FG001|COMPLETED|Overall Study||20
6613943|NCT02135146|7539935|FG000|NOT COMPLETED|Overall Study||0
6613944|NCT02135146|7539936|FG001|NOT COMPLETED|Overall Study||0
6613945|NCT02135432|7539944|FG000|STARTED|Overall Study||8
6613946|NCT02135432|7539945|FG001|STARTED|Overall Study||4
6613947|NCT02135432|7539944|FG000|COMPLETED|Overall Study||8
6613948|NCT02135432|7539945|FG001|COMPLETED|Overall Study||4
6613949|NCT02135432|7539944|FG000|NOT COMPLETED|Overall Study||0
6613950|NCT02135432|7539945|FG001|NOT COMPLETED|Overall Study||0
6613951|NCT02135445|7539954|FG000|STARTED|Overall Study||65
6613952|NCT02135445|7539955|FG001|STARTED|Overall Study||38
6613953|NCT02135445|7539954|FG000|COMPLETED|Overall Study||63
6613954|NCT02135445|7539955|FG001|COMPLETED|Overall Study||38
6613955|NCT02135445|7539954|FG000|NOT COMPLETED|Overall Study||2
6613956|NCT02135445|7539955|FG001|NOT COMPLETED|Overall Study||0
6613957|NCT02135614|7539963|FG000|STARTED|Overall Study||94
6613958|NCT02135614|7539964|FG001|STARTED|Overall Study||95
6613959|NCT02135614|7539963|FG000|COMPLETED|Overall Study||86
6613960|NCT02135614|7539964|FG001|COMPLETED|Overall Study||90
6613961|NCT02135614|7539963|FG000|NOT COMPLETED|Overall Study||8
6613962|NCT02135614|7539964|FG001|NOT COMPLETED|Overall Study||5
6613963|NCT02135653|7539972|FG000|STARTED|Overall Study||35
6613964|NCT02135653|7539973|FG001|STARTED|Overall Study||33
6613965|NCT02135653|7539972|FG000|COMPLETED|Overall Study||22
6613966|NCT02135653|7539973|FG001|COMPLETED|Overall Study||28
6613967|NCT02135653|7539972|FG000|NOT COMPLETED|Overall Study||13
6613968|NCT02135653|7539973|FG001|NOT COMPLETED|Overall Study||5
6613969|NCT02135692|7539981|FG000|STARTED|Overall Study||339
6613970|NCT02135692|7539981|FG000|COMPLETED|Overall Study||0
6613971|NCT02135692|7539981|FG000|NOT COMPLETED|Overall Study||339
6613972|NCT02135848|7539987|FG000|STARTED|Overall Study||26
6613973|NCT02135848|7539988|FG001|STARTED|Overall Study||20
6613974|NCT02135848|7539987|FG000|COMPLETED|Overall Study||23
6613975|NCT02135848|7539988|FG001|COMPLETED|Overall Study||19
6613976|NCT02135848|7539987|FG000|NOT COMPLETED|Overall Study||3
6613977|NCT02135848|7539988|FG001|NOT COMPLETED|Overall Study||1
6613978|NCT02135861|7540004|FG000|STARTED|Overall Study||21
6613979|NCT02135861|7540005|FG001|STARTED|Overall Study||12
6613980|NCT02135861|7540006|FG002|STARTED|Overall Study||3
6613981|NCT02135861|7540004|FG000|COMPLETED|Overall Study||21
6613982|NCT02135861|7540005|FG001|COMPLETED|Overall Study||12
6613983|NCT02135861|7540006|FG002|COMPLETED|Overall Study||3
6613984|NCT02135861|7540004|FG000|NOT COMPLETED|Overall Study||0
6613985|NCT02135861|7540005|FG001|NOT COMPLETED|Overall Study||0
6613986|NCT02135861|7540006|FG002|NOT COMPLETED|Overall Study||0
6613987|NCT02135900|7540016|FG000|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
6613988|NCT02135900|7540016|FG000|COMPLETED|Overall Study||32
6613989|NCT02135900|7540016|FG000|NOT COMPLETED|Overall Study||0
6613990|NCT02136004|7540022|FG000|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
6613991|NCT02136004|7540022|FG000|COMPLETED|Overall Study||219
6613992|NCT02136004|7540022|FG000|NOT COMPLETED|Overall Study||1
6613993|NCT02136238|7540028|FG000|STARTED|Overall Study||4
6613994|NCT02136238|7540029|FG001|STARTED|Overall Study||4
6613995|NCT02136238|7540030|FG002|STARTED|Overall Study||10
6613996|NCT02136238|7540028|FG000|COMPLETED|Overall Study||4
6613997|NCT02136238|7540029|FG001|COMPLETED|Overall Study||4
6613998|NCT02136238|7540030|FG002|COMPLETED|Overall Study||10
6613999|NCT02136238|7540028|FG000|NOT COMPLETED|Overall Study||0
6614000|NCT02136238|7540029|FG001|NOT COMPLETED|Overall Study||0
6614001|NCT02136238|7540030|FG002|NOT COMPLETED|Overall Study||0
6614002|NCT02136420|7540045|FG000|STARTED|Overall Study||10
6614003|NCT02136420|7540046|FG001|STARTED|Overall Study||0
6614004|NCT02136420|7540047|FG002|STARTED|Overall Study||0
6614005|NCT02136420|7540048|FG003|STARTED|Overall Study||0
6614006|NCT02136420|7540049|FG004|STARTED|Overall Study||10
6614007|NCT02136420|7540050|FG005|STARTED|Overall Study||0
6614008|NCT02136420|7540051|FG006|STARTED|Overall Study||0
6614009|NCT02136420|7540052|FG007|STARTED|Overall Study||0
6614010|NCT02136420|7540053|FG008|STARTED|Overall Study||5
6614011|NCT02136420|7540054|FG009|STARTED|Overall Study||5
6614012|NCT02136420|7540045|FG000|COMPLETED|Overall Study||9
6614013|NCT02136420|7540046|FG001|COMPLETED|Overall Study||0
6614014|NCT02136420|7540047|FG002|COMPLETED|Overall Study||0
6614015|NCT02136420|7540048|FG003|COMPLETED|Overall Study||0
6614016|NCT02136420|7540049|FG004|COMPLETED|Overall Study||10
6614017|NCT02136420|7540050|FG005|COMPLETED|Overall Study||0
6614018|NCT02136420|7540051|FG006|COMPLETED|Overall Study||0
6614019|NCT02136420|7540052|FG007|COMPLETED|Overall Study||0
6614020|NCT02136420|7540053|FG008|COMPLETED|Overall Study||5
6614021|NCT02136420|7540054|FG009|COMPLETED|Overall Study||5
6614022|NCT02136420|7540045|FG000|NOT COMPLETED|Overall Study||1
6614023|NCT02136420|7540046|FG001|NOT COMPLETED|Overall Study||0
6614024|NCT02136420|7540047|FG002|NOT COMPLETED|Overall Study||0
6614025|NCT02136420|7540048|FG003|NOT COMPLETED|Overall Study||0
6614026|NCT02136420|7540049|FG004|NOT COMPLETED|Overall Study||0
6614027|NCT02136420|7540050|FG005|NOT COMPLETED|Overall Study||0
6614028|NCT02136420|7540051|FG006|NOT COMPLETED|Overall Study||0
6614029|NCT02136420|7540052|FG007|NOT COMPLETED|Overall Study||0
6614030|NCT02136420|7540053|FG008|NOT COMPLETED|Overall Study||0
6614031|NCT02136420|7540054|FG009|NOT COMPLETED|Overall Study||0
6614032|NCT02136498|7540071|FG000|STARTED|Overall Study||33
6614033|NCT02136498|7540072|FG001|STARTED|Overall Study||33
6614034|NCT02136498|7540071|FG000|COMPLETED|Overall Study||33
6614035|NCT02136498|7540072|FG001|COMPLETED|Overall Study||33
6614036|NCT02136498|7540071|FG000|NOT COMPLETED|Overall Study||0
6614037|NCT02136498|7540072|FG001|NOT COMPLETED|Overall Study||0
6614038|NCT02136576|7540081|FG000|STARTED|Overall Study||13
6614039|NCT02136576|7540082|FG001|STARTED|Overall Study||13
6614040|NCT02136576|7540083|FG002|STARTED|Overall Study||13
6614041|NCT02136576|7540081|FG000|COMPLETED|Overall Study||11
6614042|NCT02136576|7540082|FG001|COMPLETED|Overall Study||13
6614043|NCT02136576|7540083|FG002|COMPLETED|Overall Study||13
6614044|NCT02136576|7540081|FG000|NOT COMPLETED|Overall Study||2
6614045|NCT02136576|7540082|FG001|NOT COMPLETED|Overall Study||0
6614046|NCT02136576|7540083|FG002|NOT COMPLETED|Overall Study||0
6614047|NCT02136680|7540093|FG000|STARTED|Overall Study||112
6614048|NCT02136680|7540094|FG001|STARTED|Overall Study||85
6614049|NCT02136680|7540093|FG000|Interview 1|Overall Study||112
6614050|NCT02136680|7540094|FG001|Interview 1|Overall Study||85
6614051|NCT02136680|7540093|FG000|Interview 2|Overall Study||97
6614052|NCT02136680|7540094|FG001|Interview 2|Overall Study||70
6614053|NCT02136680|7540093|FG000|Interview 3|Overall Study||80
6614054|NCT02136680|7540094|FG001|Interview 3|Overall Study||56
6614055|NCT02136680|7540093|FG000|COMPLETED|Overall Study||80
6614056|NCT02136680|7540094|FG001|COMPLETED|Overall Study||56
6614057|NCT02136680|7540093|FG000|NOT COMPLETED|Overall Study||32
6614058|NCT02136680|7540094|FG001|NOT COMPLETED|Overall Study||29
6614059|NCT02136810|7540100|FG000|STARTED|Overall Study||200
6614060|NCT02136810|7540100|FG000|COMPLETED|Overall Study||200
6614061|NCT02136810|7540100|FG000|NOT COMPLETED|Overall Study||0
6614062|NCT02136914|7540106|FG000|STARTED|Overall Study||63
6614063|NCT02136914|7540107|FG001|STARTED|Overall Study||63
6614064|NCT02136914|7540106|FG000|Received Study Drug|Overall Study||60
6614065|NCT02136914|7540107|FG001|Received Study Drug|Overall Study||63
6614066|NCT02136914|7540106|FG000|COMPLETED|Overall Study||42
6614067|NCT02136914|7540107|FG001|COMPLETED|Overall Study||42
6614068|NCT02136914|7540106|FG000|NOT COMPLETED|Overall Study||21
6614069|NCT02136914|7540107|FG001|NOT COMPLETED|Overall Study||21
6614070|NCT02137226|7540115|FG000|STARTED|Period 1 (Initial Randomization)||324
6614071|NCT02137226|7540116|FG001|STARTED|Period 1 (Initial Randomization)||321
6614072|NCT02137226|7540117|FG002|STARTED|Period 1 (Initial Randomization)||0
6614073|NCT02137226|7540118|FG003|STARTED|Period 1 (Initial Randomization)||0
6614074|NCT02137226|7540119|FG004|STARTED|Period 1 (Initial Randomization)||0
6614075|NCT02137226|7540115|FG000|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|304
6614076|NCT02137226|7540116|FG001|COMPLETED|Period 1 (Initial Randomization)|Not completed are discontinued from study|305
6614077|NCT02137226|7540117|FG002|COMPLETED|Period 1 (Initial Randomization)||0
6614078|NCT02137226|7540118|FG003|COMPLETED|Period 1 (Initial Randomization)||0
6614079|NCT02137226|7540119|FG004|COMPLETED|Period 1 (Initial Randomization)||0
6614080|NCT02137226|7540115|FG000|NOT COMPLETED|Period 1 (Initial Randomization)||20
6614081|NCT02137226|7540116|FG001|NOT COMPLETED|Period 1 (Initial Randomization)||16
6614082|NCT02137226|7540117|FG002|NOT COMPLETED|Period 1 (Initial Randomization)||0
6614083|NCT02137226|7540118|FG003|NOT COMPLETED|Period 1 (Initial Randomization)||0
6614084|NCT02137226|7540119|FG004|NOT COMPLETED|Period 1 (Initial Randomization)||0
6614085|NCT02137226|7540115|FG000|STARTED|Period 2 (Re - Randomization)||0
6614086|NCT02137226|7540116|FG001|STARTED|Period 2 (Re - Randomization)||0
6614087|NCT02137226|7540117|FG002|STARTED|Period 2 (Re - Randomization)||298
6614088|NCT02137226|7540118|FG003|STARTED|Period 2 (Re - Randomization)||148
6614089|NCT02137226|7540119|FG004|STARTED|Period 2 (Re - Randomization)||147
6614090|NCT02137226|7540115|FG000|COMPLETED|Period 2 (Re - Randomization)||0
6614091|NCT02137226|7540116|FG001|COMPLETED|Period 2 (Re - Randomization)||0
6614092|NCT02137226|7540117|FG002|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|281
6614093|NCT02137226|7540118|FG003|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|140
6614094|NCT02137226|7540119|FG004|COMPLETED|Period 2 (Re - Randomization)|Not completed are discontinued from study|138
6614095|NCT02137226|7540115|FG000|NOT COMPLETED|Period 2 (Re - Randomization)||0
6614096|NCT02137226|7540116|FG001|NOT COMPLETED|Period 2 (Re - Randomization)||0
6614097|NCT02137226|7540117|FG002|NOT COMPLETED|Period 2 (Re - Randomization)||17
6614098|NCT02137226|7540118|FG003|NOT COMPLETED|Period 2 (Re - Randomization)||8
6614099|NCT02137226|7540119|FG004|NOT COMPLETED|Period 2 (Re - Randomization)||9
6614100|NCT02137369|7540129|FG000|STARTED|Overall Study||49
6614101|NCT02137369|7540130|FG001|STARTED|Overall Study||11
6614102|NCT02137369|7540129|FG000|COMPLETED|Overall Study||41
6614103|NCT02137369|7540130|FG001|COMPLETED|Overall Study||9
6614104|NCT02137369|7540129|FG000|NOT COMPLETED|Overall Study||8
6614105|NCT02137369|7540130|FG001|NOT COMPLETED|Overall Study||2
6614106|NCT02137382|7540137|FG000|STARTED|Cross-over Period 1||20
6614107|NCT02137382|7540138|FG001|STARTED|Cross-over Period 1||21
6614108|NCT02137382|7540137|FG000|COMPLETED|Cross-over Period 1||18
6614109|NCT02137382|7540138|FG001|COMPLETED|Cross-over Period 1||21
6614110|NCT02137382|7540137|FG000|NOT COMPLETED|Cross-over Period 1||2
6614111|NCT02137382|7540138|FG001|NOT COMPLETED|Cross-over Period 1||0
6614112|NCT02137382|7540137|FG000|STARTED|Wash Out||18
6614113|NCT02137382|7540138|FG001|STARTED|Wash Out||21
6614114|NCT02137382|7540137|FG000|COMPLETED|Wash Out||18
6614115|NCT02137382|7540138|FG001|COMPLETED|Wash Out||21
6614116|NCT02137382|7540137|FG000|NOT COMPLETED|Wash Out||0
6614117|NCT02137382|7540138|FG001|NOT COMPLETED|Wash Out||0
6614118|NCT02137382|7540137|FG000|STARTED|Cross-over Period 2||18
6614119|NCT02137382|7540138|FG001|STARTED|Cross-over Period 2||21
6614120|NCT02137382|7540137|FG000|COMPLETED|Cross-over Period 2||18
6614121|NCT02137382|7540138|FG001|COMPLETED|Cross-over Period 2||21
6614122|NCT02137382|7540137|FG000|NOT COMPLETED|Cross-over Period 2||0
6614123|NCT02137382|7540138|FG001|NOT COMPLETED|Cross-over Period 2||0
6614124|NCT02137447|7540145|FG000|STARTED|Overall Study||10
6614125|NCT02137447|7540145|FG000|COMPLETED|Overall Study||10
6614126|NCT02137447|7540145|FG000|NOT COMPLETED|Overall Study||0
6614127|NCT02137486|7540151|FG000|STARTED|Overall Study||112
6614128|NCT02137486|7540152|FG001|STARTED|Overall Study||102
6614129|NCT02137486|7540151|FG000|COMPLETED|Overall Study||112
6614130|NCT02137486|7540152|FG001|COMPLETED|Overall Study||102
6614131|NCT02137486|7540151|FG000|NOT COMPLETED|Overall Study||0
6614132|NCT02137486|7540152|FG001|NOT COMPLETED|Overall Study||0
6614133|NCT02137499|7540166|FG000|STARTED|Overall Study||10
6614134|NCT02137499|7540167|FG001|STARTED|Overall Study||10
6614135|NCT02137499|7540168|FG002|STARTED|Overall Study||10
6614136|NCT02137499|7540169|FG003|STARTED|Overall Study||10
6614137|NCT02137499|7540166|FG000|COMPLETED|Overall Study||10
6614138|NCT02137499|7540167|FG001|COMPLETED|Overall Study||10
6614139|NCT02137499|7540168|FG002|COMPLETED|Overall Study||10
6614140|NCT02137499|7540169|FG003|COMPLETED|Overall Study||10
6614141|NCT02137499|7540166|FG000|NOT COMPLETED|Overall Study||0
6614142|NCT02137499|7540167|FG001|NOT COMPLETED|Overall Study||0
6614143|NCT02137499|7540168|FG002|NOT COMPLETED|Overall Study||0
6614144|NCT02137499|7540169|FG003|NOT COMPLETED|Overall Study||0
6614145|NCT02137512|7540179|FG000|STARTED|2-Week Baseline Sensor-Augmented Pump||30
6614146|NCT02137512|7540179|FG000|COMPLETED|2-Week Baseline Sensor-Augmented Pump||30
6614147|NCT02137512|7540179|FG000|NOT COMPLETED|2-Week Baseline Sensor-Augmented Pump||0
6614148|NCT02137512|7540179|FG000|STARTED|2-Week Overnight-Only Closed-Loop||30
6614149|NCT02137512|7540179|FG000|COMPLETED|2-Week Overnight-Only Closed-Loop||30
6614150|NCT02137512|7540179|FG000|NOT COMPLETED|2-Week Overnight-Only Closed-Loop||0
6614151|NCT02137512|7540179|FG000|STARTED|2-Week 24/7 Closed-Loop||30
6614152|NCT02137512|7540179|FG000|COMPLETED|2-Week 24/7 Closed-Loop||30
6614153|NCT02137512|7540179|FG000|NOT COMPLETED|2-Week 24/7 Closed-Loop||0
6614154|NCT02137512|7540179|FG000|STARTED|5-Month 24/7 Closed-Loop||14
6614155|NCT02137512|7540179|FG000|COMPLETED|5-Month 24/7 Closed-Loop||14
6614156|NCT02137512|7540179|FG000|NOT COMPLETED|5-Month 24/7 Closed-Loop||0
6614157|NCT02137538|7540189|FG000|STARTED|Overall Study||39
6614158|NCT02137538|7540190|FG001|STARTED|Overall Study||40
6614159|NCT02137538|7540189|FG000|COMPLETED|Overall Study||23
6614160|NCT02137538|7540190|FG001|COMPLETED|Overall Study||26
6614161|NCT02137538|7540189|FG000|NOT COMPLETED|Overall Study||16
6614162|NCT02137538|7540190|FG001|NOT COMPLETED|Overall Study||14
6614163|NCT02137603|7540198|FG000|STARTED|Overall Study||18
6614164|NCT02137603|7540199|FG001|STARTED|Overall Study||18
6614165|NCT02137603|7540198|FG000|COMPLETED|Overall Study||16
6614166|NCT02137603|7540199|FG001|COMPLETED|Overall Study||18
6614167|NCT02137603|7540198|FG000|NOT COMPLETED|Overall Study||2
6614168|NCT02137603|7540199|FG001|NOT COMPLETED|Overall Study||0
6614169|NCT02137772|7540207|FG000|STARTED|Overall Study|Randomized participants|376
6614170|NCT02137772|7540208|FG001|STARTED|Overall Study|Randomized participants|194
6614171|NCT02137772|7540207|FG000|Treated Participants|Overall Study||373
6614172|NCT02137772|7540208|FG001|Treated Participants|Overall Study||192
6614173|NCT02137772|7540207|FG000|COMPLETED|Overall Study||244
6614174|NCT02137772|7540208|FG001|COMPLETED|Overall Study||119
6614175|NCT02137772|7540207|FG000|NOT COMPLETED|Overall Study||132
6614176|NCT02137772|7540208|FG001|NOT COMPLETED|Overall Study||75
6614177|NCT02137785|7540216|FG000|STARTED|Overall Study||135
6614178|NCT02137785|7540217|FG001|STARTED|Overall Study||134
6614179|NCT02137785|7540216|FG000|COMPLETED|Overall Study||132
6614180|NCT02137785|7540217|FG001|COMPLETED|Overall Study||130
6614181|NCT02137785|7540216|FG000|NOT COMPLETED|Overall Study||3
6614182|NCT02137785|7540217|FG001|NOT COMPLETED|Overall Study||4
6614183|NCT02137837|7540226|FG000|STARTED|Overall Study||13
6614184|NCT02137837|7540227|FG001|STARTED|Overall Study||12
6614185|NCT02137837|7540228|FG002|STARTED|Overall Study||12
6614186|NCT02137837|7540226|FG000|Received Protocol Therapy|Overall Study||13
6614187|NCT02137837|7540227|FG001|Received Protocol Therapy|Overall Study||11
6614188|NCT02137837|7540228|FG002|Received Protocol Therapy|Overall Study||12
6614189|NCT02137837|7540226|FG000|COMPLETED|Overall Study||0
6614190|NCT02137837|7540227|FG001|COMPLETED|Overall Study||0
6614191|NCT02137837|7540228|FG002|COMPLETED|Overall Study||0
6614192|NCT02137837|7540226|FG000|NOT COMPLETED|Overall Study||13
6614193|NCT02137837|7540227|FG001|NOT COMPLETED|Overall Study||12
6614194|NCT02137837|7540228|FG002|NOT COMPLETED|Overall Study||12
6614195|NCT02138006|7540243|FG000|STARTED|Overall Study||48
6614196|NCT02138006|7540244|FG001|STARTED|Overall Study||54
6614197|NCT02138006|7540243|FG000|COMPLETED|Overall Study||48
6614198|NCT02138006|7540244|FG001|COMPLETED|Overall Study||54
6614199|NCT02138006|7540243|FG000|NOT COMPLETED|Overall Study||0
6614200|NCT02138006|7540244|FG001|NOT COMPLETED|Overall Study||0
6732803|NCT03198871|7662297|FG001|STARTED|Overall Study||90
6732804|NCT03198871|7662296|FG000|COMPLETED|Overall Study||76
6732805|NCT03198871|7662297|FG001|COMPLETED|Overall Study||78
6732806|NCT03198871|7662296|FG000|NOT COMPLETED|Overall Study||14
6732807|NCT03198871|7662297|FG001|NOT COMPLETED|Overall Study||12
6732808|NCT03198884|7662303|FG000|STARTED|Overall Study||20
6732809|NCT03198884|7662303|FG000|COMPLETED|Overall Study||20
6732810|NCT03198884|7662303|FG000|NOT COMPLETED|Overall Study||0
6732811|NCT03199079|7662319|FG000|STARTED|Overall Study||10
6732812|NCT03199079|7662320|FG001|STARTED|Overall Study||10
6732813|NCT03199079|7662319|FG000|COMPLETED|Overall Study||10
6732814|NCT03199079|7662320|FG001|COMPLETED|Overall Study||10
6732815|NCT03199079|7662319|FG000|NOT COMPLETED|Overall Study||0
6732816|NCT03199079|7662320|FG001|NOT COMPLETED|Overall Study||0
6732817|NCT03199118|7662328|FG000|STARTED|Overall Study||14
6732818|NCT03199118|7662329|FG001|STARTED|Overall Study||14
6732819|NCT03199118|7662328|FG000|COMPLETED|Overall Study|6 months follow-up|14
6732820|NCT03199118|7662329|FG001|COMPLETED|Overall Study|6 months follow-up|14
6732821|NCT03199118|7662328|FG000|NOT COMPLETED|Overall Study||0
6614201|NCT02138097|7540268|FG000|STARTED|Overall Study||155345
6614202|NCT02138097|7540269|FG001|STARTED|Overall Study||459722
6614203|NCT02138097|7540268|FG000|COMPLETED|Overall Study||155345
6614204|NCT02138097|7540269|FG001|COMPLETED|Overall Study||459722
6614205|NCT02138097|7540268|FG000|NOT COMPLETED|Overall Study||0
6614206|NCT02138097|7540269|FG001|NOT COMPLETED|Overall Study||0
6614207|NCT02138110|7540293|FG000|STARTED|Enrolled in Study||20
6614208|NCT02138110|7540293|FG000|COMPLETED|Enrolled in Study||20
6614209|NCT02138110|7540293|FG000|NOT COMPLETED|Enrolled in Study||0
6614210|NCT02138110|7540293|FG000|STARTED|Enrolled for Scaffold Implantation||20
6614211|NCT02138110|7540293|FG000|COMPLETED|Enrolled for Scaffold Implantation||19
6614212|NCT02138110|7540293|FG000|NOT COMPLETED|Enrolled for Scaffold Implantation||1
6614213|NCT02138110|7540293|FG000|STARTED|Overall Scaffold Implantation||19
6614214|NCT02138110|7540293|FG000|6-month Follow-Up|Overall Scaffold Implantation||16
6614215|NCT02138110|7540293|FG000|COMPLETED|Overall Scaffold Implantation||16
6614216|NCT02138110|7540293|FG000|NOT COMPLETED|Overall Scaffold Implantation||3
6614217|NCT02138136|7540297|FG000|STARTED|Overall Study||419
6614218|NCT02138136|7540297|FG000|Safety Analysis Set|Overall Study||419
6614219|NCT02138136|7540297|FG000|Modified Intent to Treat (mITT)|Overall Study||418
6614220|NCT02138136|7540297|FG000|COMPLETED|Overall Study||280
6614221|NCT02138136|7540297|FG000|NOT COMPLETED|Overall Study||139
6614222|NCT02138214|7540305|FG000|STARTED|Overall Study||30
6614223|NCT02138214|7540306|FG001|STARTED|Overall Study||30
6614224|NCT02138214|7540307|FG002|STARTED|Overall Study||30
6614225|NCT02138214|7540305|FG000|Analyzed for Baseline Measures|Overall Study||30
6614226|NCT02138214|7540306|FG001|Analyzed for Baseline Measures|Overall Study||29
6614227|NCT02138214|7540307|FG002|Analyzed for Baseline Measures|Overall Study||30
6614228|NCT02138214|7540305|FG000|COMPLETED|Overall Study||30
6614229|NCT02138214|7540306|FG001|COMPLETED|Overall Study||26
6614230|NCT02138214|7540307|FG002|COMPLETED|Overall Study||26
6614231|NCT02138214|7540305|FG000|NOT COMPLETED|Overall Study||0
6614232|NCT02138214|7540306|FG001|NOT COMPLETED|Overall Study||4
6614233|NCT02138214|7540307|FG002|NOT COMPLETED|Overall Study||4
6614234|NCT02138227|7540316|FG000|STARTED|Overall Study||55
6614235|NCT02138227|7540317|FG001|STARTED|Overall Study||218
6614236|NCT02138227|7540316|FG000|COMPLETED|Overall Study||55
6614237|NCT02138227|7540317|FG001|COMPLETED|Overall Study||218
6614238|NCT02138227|7540316|FG000|NOT COMPLETED|Overall Study||0
6614239|NCT02138227|7540317|FG001|NOT COMPLETED|Overall Study||0
6614240|NCT02138240|7540348|FG000|STARTED|Overall Study||34
6614241|NCT02138240|7540348|FG000|COMPLETED|Overall Study||34
6614242|NCT02138240|7540348|FG000|NOT COMPLETED|Overall Study||0
6614243|NCT02138253|7540354|FG000|STARTED|Overall Study||41
6614244|NCT02138253|7540355|FG001|STARTED|Overall Study||23
6614245|NCT02138253|7540354|FG000|COMPLETED|Overall Study||32
6614246|NCT02138253|7540355|FG001|COMPLETED|Overall Study||19
6614247|NCT02138253|7540354|FG000|NOT COMPLETED|Overall Study||9
6614248|NCT02138253|7540355|FG001|NOT COMPLETED|Overall Study||4
6614249|NCT02138461|7540363|FG000|STARTED|Overall Study||101
6614250|NCT02138461|7540364|FG001|STARTED|Overall Study||110
6614251|NCT02138461|7540363|FG000|COMPLETED|Overall Study||101
6614252|NCT02138461|7540364|FG001|COMPLETED|Overall Study||110
6614253|NCT02138461|7540363|FG000|NOT COMPLETED|Overall Study||0
6614254|NCT02138461|7540364|FG001|NOT COMPLETED|Overall Study||0
6614255|NCT02138578|7540373|FG000|STARTED|Overall Study||1
6614256|NCT02138578|7540374|FG001|STARTED|Overall Study||0
6614257|NCT02138578|7540375|FG002|STARTED|Overall Study||3
6614258|NCT02138578|7540373|FG000|COMPLETED|Overall Study||1
6614259|NCT02138578|7540374|FG001|COMPLETED|Overall Study||0
6614260|NCT02138578|7540375|FG002|COMPLETED|Overall Study||3
6614261|NCT02138578|7540373|FG000|NOT COMPLETED|Overall Study||0
6614262|NCT02138578|7540374|FG001|NOT COMPLETED|Overall Study||0
6614263|NCT02138578|7540375|FG002|NOT COMPLETED|Overall Study||0
6614264|NCT02138747|7540387|FG000|STARTED|Treatment Period 1||156
6614265|NCT02138747|7540388|FG001|STARTED|Treatment Period 1||157
6614266|NCT02138747|7540389|FG002|STARTED|Treatment Period 1||31
6614267|NCT02138747|7540390|FG003|STARTED|Treatment Period 1||32
6614268|NCT02138747|7540387|FG000|COMPLETED|Treatment Period 1||136
6614269|NCT02138747|7540388|FG001|COMPLETED|Treatment Period 1||132
6614270|NCT02138747|7540389|FG002|COMPLETED|Treatment Period 1||27
6614271|NCT02138747|7540390|FG003|COMPLETED|Treatment Period 1||28
6614272|NCT02138747|7540387|FG000|NOT COMPLETED|Treatment Period 1||20
6614273|NCT02138747|7540388|FG001|NOT COMPLETED|Treatment Period 1||25
6614274|NCT02138747|7540389|FG002|NOT COMPLETED|Treatment Period 1||4
6614275|NCT02138747|7540390|FG003|NOT COMPLETED|Treatment Period 1||4
6614276|NCT02138747|7540387|FG000|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
6614277|NCT02138747|7540388|FG001|STARTED|Treatment Period 2||132
6614278|NCT02138747|7540389|FG002|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
6614279|NCT02138747|7540390|FG003|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
6614280|NCT02138747|7540387|FG000|COMPLETED|Treatment Period 2||121
6614281|NCT02138747|7540388|FG001|COMPLETED|Treatment Period 2||125
6614282|NCT02138747|7540389|FG002|COMPLETED|Treatment Period 2||24
6614283|NCT02138747|7540390|FG003|COMPLETED|Treatment Period 2||24
6614284|NCT02138747|7540387|FG000|NOT COMPLETED|Treatment Period 2||17
6614285|NCT02138747|7540388|FG001|NOT COMPLETED|Treatment Period 2||7
6614286|NCT02138747|7540389|FG002|NOT COMPLETED|Treatment Period 2||2
6614287|NCT02138747|7540390|FG003|NOT COMPLETED|Treatment Period 2||3
6614288|NCT02138786|7540403|FG000|STARTED|Overall Study||3
6614289|NCT02138786|7540404|FG001|STARTED|Overall Study||15
6614290|NCT02138786|7540405|FG002|STARTED|Overall Study||8
6614291|NCT02138786|7540403|FG000|COMPLETED|Overall Study||0
6614292|NCT02138786|7540404|FG001|COMPLETED|Overall Study||0
6614293|NCT02138786|7540405|FG002|COMPLETED|Overall Study||0
6614294|NCT02138786|7540403|FG000|NOT COMPLETED|Overall Study||3
6614295|NCT02138786|7540404|FG001|NOT COMPLETED|Overall Study||15
6614296|NCT02138786|7540405|FG002|NOT COMPLETED|Overall Study||8
6614297|NCT02138825|7540413|FG000|STARTED|Main Study Treatment|safety population|73
6614298|NCT02138825|7540414|FG001|STARTED|Main Study Treatment|safety population|74
6614299|NCT02138825|7540413|FG000|COMPLETED|Main Study Treatment||33
6614300|NCT02138825|7540414|FG001|COMPLETED|Main Study Treatment||39
6614301|NCT02138825|7540413|FG000|NOT COMPLETED|Main Study Treatment||40
6614302|NCT02138825|7540414|FG001|NOT COMPLETED|Main Study Treatment||35
6614303|NCT02138825|7540413|FG000|STARTED|Long-term Extension||32
6614304|NCT02138825|7540414|FG001|STARTED|Long-term Extension||38
6614305|NCT02138825|7540413|FG000|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
6614306|NCT02138825|7540414|FG001|COMPLETED|Long-term Extension|no participants were considered as completed LTE phase at time of study termination|0
6614307|NCT02138825|7540413|FG000|NOT COMPLETED|Long-term Extension||32
6614308|NCT02138825|7540414|FG001|NOT COMPLETED|Long-term Extension||38
6614309|NCT02138825|7540413|FG000|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|72
6614310|NCT02138825|7540414|FG001|STARTED|Safety Follow-up|Participants from main study treatment and LTE phase entered safety follow-up|64
6614311|NCT02138825|7540413|FG000|COMPLETED|Safety Follow-up||50
6614312|NCT02138825|7540414|FG001|COMPLETED|Safety Follow-up||47
6614313|NCT02138825|7540413|FG000|NOT COMPLETED|Safety Follow-up||22
6614314|NCT02138825|7540414|FG001|NOT COMPLETED|Safety Follow-up||17
6614315|NCT02138838|7540427|FG000|STARTED|Overall Study||28
6614316|NCT02138838|7540428|FG001|STARTED|Overall Study||27
6614317|NCT02138838|7540427|FG000|Received Study Drug|Overall Study||28
6614318|NCT02138838|7540428|FG001|Received Study Drug|Overall Study||25
6614319|NCT02138838|7540427|FG000|COMPLETED|Overall Study||20
6614320|NCT02138838|7540428|FG001|COMPLETED|Overall Study||16
6614321|NCT02138838|7540427|FG000|NOT COMPLETED|Overall Study||8
6614322|NCT02138838|7540428|FG001|NOT COMPLETED|Overall Study||11
6614323|NCT02138890|7540436|FG000|STARTED|Overall Study||31
6614324|NCT02138890|7540437|FG001|STARTED|Overall Study||15
6614325|NCT02138890|7540436|FG000|COMPLETED|Overall Study||30
6614326|NCT02138890|7540437|FG001|COMPLETED|Overall Study||15
6614327|NCT02138890|7540436|FG000|NOT COMPLETED|Overall Study||1
6614328|NCT02138890|7540437|FG001|NOT COMPLETED|Overall Study||0
6614329|NCT02138916|7540447|FG000|STARTED|Overall Study||554
6614330|NCT02138916|7540448|FG001|STARTED|Overall Study||552
6614331|NCT02138916|7540449|FG002|STARTED|Overall Study||550
6614332|NCT02138916|7540447|FG000|COMPLETED|Overall Study||497
6614333|NCT02138916|7540448|FG001|COMPLETED|Overall Study||492
6614334|NCT02138916|7540449|FG002|COMPLETED|Overall Study||491
6614335|NCT02138916|7540447|FG000|NOT COMPLETED|Overall Study||57
6614336|NCT02138916|7540448|FG001|NOT COMPLETED|Overall Study||60
6614337|NCT02138916|7540449|FG002|NOT COMPLETED|Overall Study||59
6614338|NCT02139007|7540459|FG000|STARTED|Study Site Recruitment||4
6614339|NCT02139007|7540460|FG001|STARTED|Study Site Recruitment||5
6614340|NCT02139007|7540459|FG000|COMPLETED|Study Site Recruitment||1
6614341|NCT02139007|7540460|FG001|COMPLETED|Study Site Recruitment||1
6614342|NCT02139007|7540459|FG000|NOT COMPLETED|Study Site Recruitment||3
6614343|NCT02139007|7540460|FG001|NOT COMPLETED|Study Site Recruitment||4
6614344|NCT02139007|7540459|FG000|STARTED|Patient Participant Recruitment||13
6614345|NCT02139007|7540460|FG001|STARTED|Patient Participant Recruitment||14
6614346|NCT02139007|7540459|FG000|COMPLETED|Patient Participant Recruitment||11
6614347|NCT02139007|7540460|FG001|COMPLETED|Patient Participant Recruitment||13
6614348|NCT02139007|7540459|FG000|NOT COMPLETED|Patient Participant Recruitment||2
6614349|NCT02139007|7540460|FG001|NOT COMPLETED|Patient Participant Recruitment||1
6614350|NCT02139046|7540474|FG000|STARTED|Overall Study||358
6614351|NCT02139046|7540475|FG001|STARTED|Overall Study||359
6614352|NCT02139046|7540476|FG002|STARTED|Overall Study||357
6614353|NCT02139046|7540477|FG003|STARTED|Overall Study||358
6614354|NCT02139046|7540478|FG004|STARTED|Overall Study||358
6614355|NCT02139046|7540474|FG000|Safety Analysis Set|Overall Study||356
6614356|NCT02139046|7540475|FG001|Safety Analysis Set|Overall Study||358
6614357|NCT02139046|7540476|FG002|Safety Analysis Set|Overall Study||355
6614358|NCT02139046|7540477|FG003|Safety Analysis Set|Overall Study||357
6614359|NCT02139046|7540478|FG004|Safety Analysis Set|Overall Study||357
6614360|NCT02139046|7540474|FG000|Full Analysis Set|Overall Study||357
6614361|NCT02139046|7540475|FG001|Full Analysis Set|Overall Study||357
6614362|NCT02139046|7540476|FG002|Full Analysis Set|Overall Study||355
6614363|NCT02139046|7540477|FG003|Full Analysis Set|Overall Study||357
6614364|NCT02139046|7540478|FG004|Full Analysis Set|Overall Study||357
6614365|NCT02139046|7540474|FG000|COMPLETED|Overall Study|Completed=Completed Study Drug|296
6614366|NCT02139046|7540475|FG001|COMPLETED|Overall Study||305
6614367|NCT02139046|7540476|FG002|COMPLETED|Overall Study||298
6614368|NCT02139046|7540477|FG003|COMPLETED|Overall Study||290
6614369|NCT02139046|7540478|FG004|COMPLETED|Overall Study||301
6614370|NCT02139046|7540474|FG000|NOT COMPLETED|Overall Study||62
6614371|NCT02139046|7540475|FG001|NOT COMPLETED|Overall Study||54
6614372|NCT02139046|7540476|FG002|NOT COMPLETED|Overall Study||59
6614373|NCT02139046|7540477|FG003|NOT COMPLETED|Overall Study||68
6614374|NCT02139046|7540478|FG004|NOT COMPLETED|Overall Study||57
6614375|NCT02139124|7540495|FG000|STARTED|Overall Study||78
6614376|NCT02139124|7540496|FG001|STARTED|Overall Study||77
6614377|NCT02139124|7540497|FG002|STARTED|Overall Study||73
6614378|NCT02139124|7540498|FG003|STARTED|Overall Study||73
6614379|NCT02139124|7540499|FG004|STARTED|Overall Study||74
6614380|NCT02139124|7540495|FG000|COMPLETED|Overall Study||69
6614381|NCT02139124|7540496|FG001|COMPLETED|Overall Study||73
6614382|NCT02139124|7540497|FG002|COMPLETED|Overall Study||69
6614383|NCT02139124|7540498|FG003|COMPLETED|Overall Study||61
6614384|NCT02139124|7540499|FG004|COMPLETED|Overall Study||61
6614385|NCT02139124|7540495|FG000|NOT COMPLETED|Overall Study||9
6614386|NCT02139124|7540496|FG001|NOT COMPLETED|Overall Study||4
6614387|NCT02139124|7540497|FG002|NOT COMPLETED|Overall Study||4
6614388|NCT02139124|7540498|FG003|NOT COMPLETED|Overall Study||12
6614389|NCT02139124|7540499|FG004|NOT COMPLETED|Overall Study||13
6614390|NCT02139137|7540513|FG000|STARTED|Overall Study||22
6614391|NCT02139137|7540514|FG001|STARTED|Overall Study||20
6614392|NCT02139137|7540513|FG000|COMPLETED|Overall Study||15
6614393|NCT02139137|7540514|FG001|COMPLETED|Overall Study||10
6614394|NCT02139137|7540513|FG000|NOT COMPLETED|Overall Study||7
6614395|NCT02139137|7540514|FG001|NOT COMPLETED|Overall Study||10
6614396|NCT02139176|7540522|FG000|STARTED|Overall Study||100
6614397|NCT02139176|7540523|FG001|STARTED|Overall Study||100
6614398|NCT02139176|7540522|FG000|COMPLETED|Overall Study||100
6614399|NCT02139176|7540523|FG001|COMPLETED|Overall Study||100
6614400|NCT02139176|7540522|FG000|NOT COMPLETED|Overall Study||0
6614401|NCT02139176|7540523|FG001|NOT COMPLETED|Overall Study||0
6614402|NCT02139228|7540532|FG000|STARTED|Overall Study||215
6614403|NCT02139228|7540533|FG001|STARTED|Overall Study||211
6614404|NCT02139228|7540532|FG000|COMPLETED|Overall Study||215
6614405|NCT02139228|7540533|FG001|COMPLETED|Overall Study||211
6614406|NCT02139228|7540532|FG000|NOT COMPLETED|Overall Study||0
6614407|NCT02139228|7540533|FG001|NOT COMPLETED|Overall Study||0
6614408|NCT02139280|7540541|FG000|STARTED|Overall Study||34
6614409|NCT02139280|7540542|FG001|STARTED|Overall Study||20
6614410|NCT02139280|7540541|FG000|COMPLETED|Overall Study||32
6614411|NCT02139280|7540542|FG001|COMPLETED|Overall Study||20
6614412|NCT02139280|7540541|FG000|NOT COMPLETED|Overall Study||2
6614413|NCT02139280|7540542|FG001|NOT COMPLETED|Overall Study||0
6614414|NCT02139306|7540550|FG000|STARTED|Overall Study||140
6614415|NCT02139306|7540551|FG001|STARTED|Overall Study||139
6614416|NCT02139306|7540550|FG000|COMPLETED|Overall Study||127
6614417|NCT02139306|7540551|FG001|COMPLETED|Overall Study||125
6614418|NCT02139306|7540550|FG000|NOT COMPLETED|Overall Study||13
6614419|NCT02139306|7540551|FG001|NOT COMPLETED|Overall Study||14
6614420|NCT02139358|7540558|FG000|STARTED|Overall Study||15
6614421|NCT02139358|7540558|FG000|COMPLETED|Overall Study||15
6614422|NCT02139358|7540558|FG000|NOT COMPLETED|Overall Study||0
6614423|NCT02139540|7540564|FG000|STARTED|Overall Study||11
6614424|NCT02139540|7540565|FG001|STARTED|Overall Study||10
6614425|NCT02139540|7540564|FG000|COMPLETED|Overall Study||10
6614426|NCT02139540|7540565|FG001|COMPLETED|Overall Study||10
6614427|NCT02139540|7540564|FG000|NOT COMPLETED|Overall Study||1
6614428|NCT02139540|7540565|FG001|NOT COMPLETED|Overall Study||0
6614429|NCT02139592|7540571|FG000|STARTED|Overall Study||292
6614430|NCT02139592|7540571|FG000|COMPLETED|Overall Study||284
6614431|NCT02139592|7540571|FG000|NOT COMPLETED|Overall Study||8
6614432|NCT02139644|7540580|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
6614433|NCT02139644|7540581|FG001|STARTED|Run-In Period (Pre-assignment)||0
6614434|NCT02139644|7540582|FG002|STARTED|Run-In Period (Pre-assignment)||0
6614435|NCT02139644|7540583|FG003|STARTED|Run-In Period (Pre-assignment)||0
6614436|NCT02139644|7540584|FG004|STARTED|Run-In Period (Pre-assignment)||0
6614437|NCT02139644|7540585|FG005|STARTED|Run-In Period (Pre-assignment)||0
6614438|NCT02139644|7540580|FG000|COMPLETED|Run-In Period (Pre-assignment)||647
6614439|NCT02139644|7540581|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
6614440|NCT02139644|7540582|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
6614441|NCT02139644|7540583|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
6614442|NCT02139644|7540584|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
6614443|NCT02139644|7540585|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
6614444|NCT02139644|7540580|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||140
6614445|NCT02139644|7540581|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614446|NCT02139644|7540582|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614447|NCT02139644|7540583|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614448|NCT02139644|7540584|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614449|NCT02139644|7540585|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614450|NCT02139644|7540580|FG000|STARTED|Treatment Period||0
6614451|NCT02139644|7540581|FG001|STARTED|Treatment Period|Randomized|129
6614452|NCT02139644|7540582|FG002|STARTED|Treatment Period|Randomized|129
6614453|NCT02139644|7540583|FG003|STARTED|Treatment Period|Randomized|130
6614454|NCT02139644|7540584|FG004|STARTED|Treatment Period|Randomized|129
6614455|NCT02139644|7540585|FG005|STARTED|Treatment Period|Randomized|130
6614456|NCT02139644|7540580|FG000|COMPLETED|Treatment Period||0
6614457|NCT02139644|7540581|FG001|COMPLETED|Treatment Period||126
6614458|NCT02139644|7540582|FG002|COMPLETED|Treatment Period||121
6614459|NCT02139644|7540583|FG003|COMPLETED|Treatment Period||121
6614460|NCT02139644|7540584|FG004|COMPLETED|Treatment Period||121
6614461|NCT02139644|7540585|FG005|COMPLETED|Treatment Period||113
6614462|NCT02139644|7540580|FG000|NOT COMPLETED|Treatment Period||0
6614463|NCT02139644|7540581|FG001|NOT COMPLETED|Treatment Period||3
6614464|NCT02139644|7540582|FG002|NOT COMPLETED|Treatment Period||8
6614465|NCT02139644|7540583|FG003|NOT COMPLETED|Treatment Period||9
6614466|NCT02139644|7540584|FG004|NOT COMPLETED|Treatment Period||8
6614467|NCT02139644|7540585|FG005|NOT COMPLETED|Treatment Period||17
6614468|NCT02139800|7540599|FG000|STARTED|Overall Study||224
6614469|NCT02139800|7540600|FG001|STARTED|Overall Study||236
6614470|NCT02139800|7540599|FG000|COMPLETED|Overall Study||211
6614471|NCT02139800|7540600|FG001|COMPLETED|Overall Study||215
6614472|NCT02139800|7540599|FG000|NOT COMPLETED|Overall Study||13
6614473|NCT02139800|7540600|FG001|NOT COMPLETED|Overall Study||21
6614474|NCT02139826|7540606|FG000|STARTED|Overall Study||12
6614475|NCT02139826|7540606|FG000|COMPLETED|Overall Study||11
6614476|NCT02139826|7540606|FG000|NOT COMPLETED|Overall Study||1
6614477|NCT02139878|7540616|FG000|STARTED|First Intervention (7 Days)||10
6614478|NCT02139878|7540617|FG001|STARTED|First Intervention (7 Days)||10
6614479|NCT02139878|7540616|FG000|COMPLETED|First Intervention (7 Days)||9
6614480|NCT02139878|7540617|FG001|COMPLETED|First Intervention (7 Days)||10
6614481|NCT02139878|7540616|FG000|NOT COMPLETED|First Intervention (7 Days)||1
6614482|NCT02139878|7540617|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6614483|NCT02139878|7540616|FG000|STARTED|Washout Period (8 Days)||9
6614484|NCT02139878|7540617|FG001|STARTED|Washout Period (8 Days)||10
6614485|NCT02139878|7540616|FG000|COMPLETED|Washout Period (8 Days)||9
6614486|NCT02139878|7540617|FG001|COMPLETED|Washout Period (8 Days)||10
6614487|NCT02139878|7540616|FG000|NOT COMPLETED|Washout Period (8 Days)||0
6614488|NCT02139878|7540617|FG001|NOT COMPLETED|Washout Period (8 Days)||0
6614489|NCT02139878|7540616|FG000|STARTED|Second Intervention (7 Days)||9
6614490|NCT02139878|7540617|FG001|STARTED|Second Intervention (7 Days)||10
6614491|NCT02139878|7540616|FG000|COMPLETED|Second Intervention (7 Days)||9
6614492|NCT02139878|7540617|FG001|COMPLETED|Second Intervention (7 Days)||10
6614493|NCT02139878|7540616|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6614494|NCT02139878|7540617|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6614495|NCT02139943|7540626|FG000|STARTED|Overall Study||117
6614496|NCT02139943|7540627|FG001|STARTED|Overall Study||117
6614497|NCT02139943|7540628|FG002|STARTED|Overall Study||117
6614498|NCT02139943|7540626|FG000|COMPLETED|Overall Study||107
6614499|NCT02139943|7540627|FG001|COMPLETED|Overall Study||111
6614500|NCT02139943|7540628|FG002|COMPLETED|Overall Study||110
6614501|NCT02139943|7540626|FG000|NOT COMPLETED|Overall Study||10
6614502|NCT02139943|7540627|FG001|NOT COMPLETED|Overall Study||6
6614503|NCT02139943|7540628|FG002|NOT COMPLETED|Overall Study||7
6614504|NCT02139969|7540636|FG000|STARTED|Overall Study||956
6614505|NCT02139969|7540636|FG000|COMPLETED|Overall Study||956
6614506|NCT02139969|7540636|FG000|NOT COMPLETED|Overall Study||0
6614507|NCT02139982|7540650|FG000|STARTED|Overall Study||8
6614508|NCT02139982|7540651|FG001|STARTED|Overall Study||8
6614509|NCT02139982|7540652|FG002|STARTED|Overall Study||8
6614510|NCT02139982|7540653|FG003|STARTED|Overall Study||8
6614511|NCT02139982|7540654|FG004|STARTED|Overall Study||13
6614512|NCT02139982|7540655|FG005|STARTED|Overall Study||13
6614513|NCT02139982|7540656|FG006|STARTED|Overall Study||13
6614514|NCT02139982|7540657|FG007|STARTED|Overall Study||13
6614515|NCT02139982|7540658|FG008|STARTED|Overall Study||13
6614516|NCT02139982|7540659|FG009|STARTED|Overall Study||13
6614517|NCT02139982|7540650|FG000|COMPLETED|Overall Study||8
6614518|NCT02139982|7540651|FG001|COMPLETED|Overall Study||7
6614519|NCT02139982|7540652|FG002|COMPLETED|Overall Study||8
6614520|NCT02139982|7540653|FG003|COMPLETED|Overall Study||7
6614521|NCT02139982|7540654|FG004|COMPLETED|Overall Study||13
6614522|NCT02139982|7540655|FG005|COMPLETED|Overall Study||13
6614523|NCT02139982|7540656|FG006|COMPLETED|Overall Study||13
6614524|NCT02139982|7540657|FG007|COMPLETED|Overall Study||13
6614525|NCT02139982|7540658|FG008|COMPLETED|Overall Study||13
6614526|NCT02139982|7540659|FG009|COMPLETED|Overall Study||13
6614527|NCT02139982|7540650|FG000|NOT COMPLETED|Overall Study||0
6614528|NCT02139982|7540651|FG001|NOT COMPLETED|Overall Study||1
6614529|NCT02139982|7540652|FG002|NOT COMPLETED|Overall Study||0
6614530|NCT02139982|7540653|FG003|NOT COMPLETED|Overall Study||1
6614531|NCT02139982|7540654|FG004|NOT COMPLETED|Overall Study||0
6614532|NCT02139982|7540655|FG005|NOT COMPLETED|Overall Study||0
6614533|NCT02139982|7540656|FG006|NOT COMPLETED|Overall Study||0
6614534|NCT02139982|7540657|FG007|NOT COMPLETED|Overall Study||0
6614535|NCT02139982|7540658|FG008|NOT COMPLETED|Overall Study||0
6614536|NCT02139982|7540659|FG009|NOT COMPLETED|Overall Study||0
6614537|NCT02140060|7540687|FG000|STARTED|Overall Study||44
6614538|NCT02140060|7540688|FG001|STARTED|Overall Study||44
6614539|NCT02140060|7540689|FG002|STARTED|Overall Study||44
6614540|NCT02140060|7540690|FG003|STARTED|Overall Study||45
6614541|NCT02140060|7540691|FG004|STARTED|Overall Study||45
6614542|NCT02140060|7540692|FG005|STARTED|Overall Study||44
6614543|NCT02140060|7540687|FG000|COMPLETED|Overall Study||44
6614544|NCT02140060|7540688|FG001|COMPLETED|Overall Study||44
6614545|NCT02140060|7540689|FG002|COMPLETED|Overall Study||44
6614546|NCT02140060|7540690|FG003|COMPLETED|Overall Study||43
6614547|NCT02140060|7540691|FG004|COMPLETED|Overall Study||44
6614548|NCT02140060|7540692|FG005|COMPLETED|Overall Study||43
6614549|NCT02140060|7540687|FG000|NOT COMPLETED|Overall Study||0
6614550|NCT02140060|7540688|FG001|NOT COMPLETED|Overall Study||0
6614551|NCT02140060|7540689|FG002|NOT COMPLETED|Overall Study||0
6614552|NCT02140060|7540690|FG003|NOT COMPLETED|Overall Study||2
6614553|NCT02140060|7540691|FG004|NOT COMPLETED|Overall Study||1
6614554|NCT02140060|7540692|FG005|NOT COMPLETED|Overall Study||1
6614555|NCT02140164|7540707|FG000|STARTED|Overall Study||7
6614556|NCT02140164|7540707|FG000|COMPLETED|Overall Study||5
6614557|NCT02140164|7540707|FG000|NOT COMPLETED|Overall Study||2
6614558|NCT02140372|7540711|FG000|STARTED|Overall Study||10
6614559|NCT02140372|7540711|FG000|COMPLETED|Overall Study||10
6614560|NCT02140372|7540711|FG000|NOT COMPLETED|Overall Study||0
6614561|NCT02140411|7540715|FG000|STARTED|Overall Study||21
6614562|NCT02140411|7540715|FG000|COMPLETED|Overall Study||20
6614563|NCT02140411|7540715|FG000|NOT COMPLETED|Overall Study||1
6614564|NCT02140567|7540719|FG000|STARTED|Overall Study||140
6614565|NCT02140567|7540719|FG000|COMPLETED|Overall Study||134
6614566|NCT02140567|7540719|FG000|NOT COMPLETED|Overall Study||6
6614567|NCT02140593|7540726|FG000|STARTED|Overall Study||63
6614568|NCT02140593|7540727|FG001|STARTED|Overall Study||65
6614569|NCT02140593|7540726|FG000|COMPLETED|Overall Study||63
6614570|NCT02140593|7540727|FG001|COMPLETED|Overall Study||65
6614571|NCT02140593|7540726|FG000|NOT COMPLETED|Overall Study||0
6614572|NCT02140593|7540727|FG001|NOT COMPLETED|Overall Study||0
6614573|NCT02140645|7540739|FG000|STARTED|Overall Study||5732
6614574|NCT02140645|7540740|FG001|STARTED|Overall Study||64695
6614575|NCT02140645|7540741|FG002|STARTED|Overall Study||4441
6614576|NCT02140645|7540742|FG003|STARTED|Overall Study||14363
6614577|NCT02140645|7540743|FG004|STARTED|Overall Study||3436
6614578|NCT02140645|7540744|FG005|STARTED|Overall Study||73946
6614579|NCT02140645|7540739|FG000|COMPLETED|Overall Study||243
6614580|NCT02140645|7540740|FG001|COMPLETED|Overall Study||3041
6614581|NCT02140645|7540741|FG002|COMPLETED|Overall Study||205
6614582|NCT02140645|7540742|FG003|COMPLETED|Overall Study||530
6614583|NCT02140645|7540743|FG004|COMPLETED|Overall Study||150
6614584|NCT02140645|7540744|FG005|COMPLETED|Overall Study||3050
6614585|NCT02140645|7540739|FG000|NOT COMPLETED|Overall Study||5489
6614586|NCT02140645|7540740|FG001|NOT COMPLETED|Overall Study||61654
6614587|NCT02140645|7540741|FG002|NOT COMPLETED|Overall Study||4236
6614588|NCT02140645|7540742|FG003|NOT COMPLETED|Overall Study||13833
6614589|NCT02140645|7540743|FG004|NOT COMPLETED|Overall Study||3286
6614590|NCT02140645|7540744|FG005|NOT COMPLETED|Overall Study||70896
6614591|NCT02140762|7540755|FG000|STARTED|Overall Study||154
6614592|NCT02140762|7540756|FG001|STARTED|Overall Study||151
6614593|NCT02140762|7540755|FG000|COMPLETED|Overall Study||137
6614594|NCT02140762|7540756|FG001|COMPLETED|Overall Study||139
6614595|NCT02140762|7540755|FG000|NOT COMPLETED|Overall Study||17
6614596|NCT02140762|7540756|FG001|NOT COMPLETED|Overall Study||12
6614597|NCT02140775|7540769|FG000|STARTED|Overall Study||87
6614598|NCT02140775|7540770|FG001|STARTED|Overall Study||29
6614599|NCT02140775|7540769|FG000|COMPLETED|Overall Study||57
6614600|NCT02140775|7540770|FG001|COMPLETED|Overall Study||22
6614601|NCT02140775|7540769|FG000|NOT COMPLETED|Overall Study||30
6614602|NCT02140775|7540770|FG001|NOT COMPLETED|Overall Study||7
6614603|NCT02140957|7540780|FG000|STARTED|Overall Study||129
6614604|NCT02140957|7540781|FG001|STARTED|Overall Study||122
6614605|NCT02140957|7540780|FG000|COMPLETED|Overall Study||102
6614606|NCT02140957|7540781|FG001|COMPLETED|Overall Study||99
6614607|NCT02140957|7540780|FG000|NOT COMPLETED|Overall Study||27
6614608|NCT02140957|7540781|FG001|NOT COMPLETED|Overall Study||23
6614609|NCT02140970|7540789|FG000|STARTED|Overall Study||24
6614610|NCT02140970|7540790|FG001|STARTED|Overall Study||25
6614611|NCT02140970|7540789|FG000|Received Intervention|Overall Study||23
6614612|NCT02140970|7540790|FG001|Received Intervention|Overall Study||25
6614613|NCT02140970|7540789|FG000|Analyzed|Overall Study||22
6614614|NCT02140970|7540790|FG001|Analyzed|Overall Study||22
6614615|NCT02140970|7540789|FG000|COMPLETED|Overall Study||22
6614616|NCT02140970|7540790|FG001|COMPLETED|Overall Study||22
6614617|NCT02140970|7540789|FG000|NOT COMPLETED|Overall Study||2
6614618|NCT02140970|7540790|FG001|NOT COMPLETED|Overall Study||3
6614619|NCT02141204|7540798|FG000|STARTED|Overall Study||224
6614620|NCT02141204|7540799|FG001|STARTED|Overall Study||225
6614621|NCT02141204|7540798|FG000|COMPLETED|Overall Study||209
6614622|NCT02141204|7540799|FG001|COMPLETED|Overall Study||210
6614623|NCT02141204|7540798|FG000|NOT COMPLETED|Overall Study||15
6614624|NCT02141204|7540799|FG001|NOT COMPLETED|Overall Study||15
6614625|NCT02141217|7540807|FG000|STARTED|Overall Study||234
6614626|NCT02141217|7540808|FG001|STARTED|Overall Study||237
6614627|NCT02141217|7540807|FG000|ITT Population-Randomized Treatment Arm|Overall Study||234
6614628|NCT02141217|7540808|FG001|ITT Population-Randomized Treatment Arm|Overall Study||237
6614629|NCT02141217|7540807|FG000|ITT Population-Actual Treatment Received|Overall Study||236
6614630|NCT02141217|7540808|FG001|ITT Population-Actual Treatment Received|Overall Study||235
6614631|NCT02141217|7540807|FG000|COMPLETED|Overall Study||223
6614632|NCT02141217|7540808|FG001|COMPLETED|Overall Study||229
6614633|NCT02141217|7540807|FG000|NOT COMPLETED|Overall Study||11
6614634|NCT02141217|7540808|FG001|NOT COMPLETED|Overall Study||8
6614635|NCT02141295|7540820|FG000|STARTED|Overall Study||8
6614636|NCT02141295|7540821|FG001|STARTED|Overall Study||94
6614637|NCT02141295|7540822|FG002|STARTED|Overall Study||95
6614638|NCT02141295|7540820|FG000|COMPLETED|Overall Study||2
6614639|NCT02141295|7540821|FG001|COMPLETED|Overall Study||0
6614640|NCT02141295|7540822|FG002|COMPLETED|Overall Study||0
6614641|NCT02141295|7540820|FG000|NOT COMPLETED|Overall Study||6
6614642|NCT02141295|7540821|FG001|NOT COMPLETED|Overall Study||94
6614643|NCT02141295|7540822|FG002|NOT COMPLETED|Overall Study||95
6614644|NCT02141360|7540834|FG000|STARTED|Overall Study||11
6614645|NCT02141360|7540835|FG001|STARTED|Overall Study||6
6614646|NCT02141360|7540836|FG002|STARTED|Overall Study||6
6614647|NCT02141360|7540834|FG000|COMPLETED|Overall Study||4
6614648|NCT02141360|7540835|FG001|COMPLETED|Overall Study||6
6614649|NCT02141360|7540836|FG002|COMPLETED|Overall Study||6
6614650|NCT02141360|7540834|FG000|NOT COMPLETED|Overall Study||7
6614651|NCT02141360|7540835|FG001|NOT COMPLETED|Overall Study||0
6614652|NCT02141360|7540836|FG002|NOT COMPLETED|Overall Study||0
6614653|NCT02141399|7540844|FG000|STARTED|Overall Study||1485
6614654|NCT02141399|7540844|FG000|COMPLETED|Overall Study||741
6614655|NCT02141399|7540844|FG000|NOT COMPLETED|Overall Study||744
6614656|NCT02141451|7540852|FG000|STARTED|Overall Study||3
6614657|NCT02141451|7540853|FG001|STARTED|Overall Study||4
6614658|NCT02141451|7540854|FG002|STARTED|Overall Study||7
6614659|NCT02141451|7540855|FG003|STARTED|Overall Study||16
6614660|NCT02141451|7540852|FG000|COMPLETED|Overall Study||3
6614661|NCT02141451|7540853|FG001|COMPLETED|Overall Study||2
6614662|NCT02141451|7540854|FG002|COMPLETED|Overall Study||2
6614663|NCT02141451|7540855|FG003|COMPLETED|Overall Study||7
6614664|NCT02141451|7540852|FG000|NOT COMPLETED|Overall Study||0
6614665|NCT02141451|7540853|FG001|NOT COMPLETED|Overall Study||2
6614666|NCT02141451|7540854|FG002|NOT COMPLETED|Overall Study||5
6614667|NCT02141451|7540855|FG003|NOT COMPLETED|Overall Study||9
6614668|NCT02141490|7540871|FG000|STARTED|Overall Study||34
6614669|NCT02141490|7540872|FG001|STARTED|Overall Study||6
6614670|NCT02141490|7540873|FG002|STARTED|Overall Study||3
6614671|NCT02141490|7540871|FG000|COMPLETED|Overall Study||30
6614672|NCT02141490|7540872|FG001|COMPLETED|Overall Study||6
6614673|NCT02141490|7540873|FG002|COMPLETED|Overall Study||3
6614674|NCT02141490|7540871|FG000|NOT COMPLETED|Overall Study||4
6614675|NCT02141490|7540872|FG001|NOT COMPLETED|Overall Study||0
6614676|NCT02141490|7540873|FG002|NOT COMPLETED|Overall Study||0
6614677|NCT02141516|7540886|FG000|STARTED|Overall Study||40
6614678|NCT02141516|7540887|FG001|STARTED|Overall Study||112
6614679|NCT02141516|7540888|FG002|STARTED|Overall Study||87
6614680|NCT02141516|7540886|FG000|COMPLETED|Overall Study||40
6614681|NCT02141516|7540887|FG001|COMPLETED|Overall Study||107
6614682|NCT02141516|7540888|FG002|COMPLETED|Overall Study||87
6614683|NCT02141516|7540886|FG000|NOT COMPLETED|Overall Study||0
6614684|NCT02141516|7540887|FG001|NOT COMPLETED|Overall Study||5
6614685|NCT02141516|7540888|FG002|NOT COMPLETED|Overall Study||0
6614686|NCT02141555|7540902|FG000|STARTED|Overall Study||2
6614687|NCT02141555|7540903|FG001|STARTED|Overall Study||2
6614688|NCT02141555|7540902|FG000|COMPLETED|Overall Study||2
6614689|NCT02141555|7540903|FG001|COMPLETED|Overall Study||2
6614690|NCT02141555|7540902|FG000|NOT COMPLETED|Overall Study||0
6614691|NCT02141555|7540903|FG001|NOT COMPLETED|Overall Study||0
6614692|NCT02141581|7540912|FG000|STARTED|Overall Study||42
6614693|NCT02141581|7540913|FG001|STARTED|Overall Study||19
6614694|NCT02141581|7540914|FG002|STARTED|Overall Study||25
6614695|NCT02141581|7540912|FG000|COMPLETED|Overall Study||42
6614696|NCT02141581|7540913|FG001|COMPLETED|Overall Study||19
6614697|NCT02141581|7540914|FG002|COMPLETED|Overall Study||25
6614698|NCT02141581|7540912|FG000|NOT COMPLETED|Overall Study||0
6614699|NCT02141581|7540913|FG001|NOT COMPLETED|Overall Study||0
6614700|NCT02141581|7540914|FG002|NOT COMPLETED|Overall Study||0
6614701|NCT02141620|7540922|FG000|STARTED|Treatment Condition 1 (7 Days)||8
6614702|NCT02141620|7540923|FG001|STARTED|Treatment Condition 1 (7 Days)||7
6614703|NCT02141620|7540922|FG000|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
6614704|NCT02141620|7540923|FG001|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
6614705|NCT02141620|7540922|FG000|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
6614706|NCT02141620|7540923|FG001|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
6614707|NCT02141620|7540922|FG000|STARTED|Treatment Condition 2 (7 Days)||7
6614708|NCT02141620|7540923|FG001|STARTED|Treatment Condition 2 (7 Days)||7
6614709|NCT02141620|7540922|FG000|COMPLETED|Treatment Condition 2 (7 Days)||7
6614710|NCT02141620|7540923|FG001|COMPLETED|Treatment Condition 2 (7 Days)||7
6614711|NCT02141620|7540922|FG000|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
6614712|NCT02141620|7540923|FG001|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
6614713|NCT02141633|7540931|FG000|STARTED|Overall Study||16
6614714|NCT02141633|7540932|FG001|STARTED|Overall Study||15
6614715|NCT02141633|7540931|FG000|COMPLETED|Overall Study||15
6614716|NCT02141633|7540932|FG001|COMPLETED|Overall Study||15
6614717|NCT02141633|7540931|FG000|NOT COMPLETED|Overall Study||1
6614718|NCT02141633|7540932|FG001|NOT COMPLETED|Overall Study||0
6614719|NCT02141659|7540944|FG000|STARTED|Overall Study||3
6614720|NCT02141659|7540945|FG001|STARTED|Overall Study||4
6614721|NCT02141659|7540946|FG002|STARTED|Overall Study||3
6614722|NCT02141659|7540947|FG003|STARTED|Overall Study||3
6614723|NCT02141659|7540948|FG004|STARTED|Overall Study||15
6614724|NCT02141659|7540949|FG005|STARTED|Overall Study||15
6614725|NCT02141659|7540944|FG000|COMPLETED|Overall Study||3
6614726|NCT02141659|7540945|FG001|COMPLETED|Overall Study||3
6614727|NCT02141659|7540946|FG002|COMPLETED|Overall Study||3
6614728|NCT02141659|7540947|FG003|COMPLETED|Overall Study||3
6614729|NCT02141659|7540948|FG004|COMPLETED|Overall Study||13
6614730|NCT02141659|7540949|FG005|COMPLETED|Overall Study||13
6614731|NCT02141659|7540944|FG000|NOT COMPLETED|Overall Study||0
6614732|NCT02141659|7540945|FG001|NOT COMPLETED|Overall Study||1
6614733|NCT02141659|7540946|FG002|NOT COMPLETED|Overall Study||0
6614734|NCT02141659|7540947|FG003|NOT COMPLETED|Overall Study||0
6614735|NCT02141659|7540948|FG004|NOT COMPLETED|Overall Study||2
6614736|NCT02141659|7540949|FG005|NOT COMPLETED|Overall Study||2
6614737|NCT02141672|7540966|FG000|STARTED|Overall Study||89
6614738|NCT02141672|7540967|FG001|STARTED|Overall Study||88
6614739|NCT02141672|7540968|FG002|STARTED|Overall Study||88
6614740|NCT02141672|7540966|FG000|COMPLETED|Overall Study||73
6614741|NCT02141672|7540967|FG001|COMPLETED|Overall Study||80
6614742|NCT02141672|7540968|FG002|COMPLETED|Overall Study||70
6614743|NCT02141672|7540966|FG000|NOT COMPLETED|Overall Study||16
6614744|NCT02141672|7540967|FG001|NOT COMPLETED|Overall Study||8
6614745|NCT02141672|7540968|FG002|NOT COMPLETED|Overall Study||18
6614746|NCT02141854|7540981|FG000|STARTED|Run-In Period (Pre-assignment)||882
6614747|NCT02141854|7540982|FG001|STARTED|Run-In Period (Pre-assignment)||0
6614748|NCT02141854|7540983|FG002|STARTED|Run-In Period (Pre-assignment)||0
6614749|NCT02141854|7540984|FG003|STARTED|Run-In Period (Pre-assignment)||0
6614750|NCT02141854|7540985|FG004|STARTED|Run-In Period (Pre-assignment)||0
6614751|NCT02141854|7540986|FG005|STARTED|Run-In Period (Pre-assignment)||0
6614752|NCT02141854|7540981|FG000|COMPLETED|Run-In Period (Pre-assignment)||728
6614753|NCT02141854|7540982|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
6614754|NCT02141854|7540983|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
6614755|NCT02141854|7540984|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
6614756|NCT02141854|7540985|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
6614757|NCT02141854|7540986|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
6614758|NCT02141854|7540981|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||154
6614759|NCT02141854|7540982|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614760|NCT02141854|7540983|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614761|NCT02141854|7540984|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614762|NCT02141854|7540985|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614763|NCT02141854|7540986|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6614764|NCT02141854|7540981|FG000|STARTED|Treatment Period||0
6614765|NCT02141854|7540982|FG001|STARTED|Treatment Period||146
6614766|NCT02141854|7540983|FG002|STARTED|Treatment Period||145
6614767|NCT02141854|7540984|FG003|STARTED|Treatment Period||146
6614768|NCT02141854|7540985|FG004|STARTED|Treatment Period||146
6614769|NCT02141854|7540986|FG005|STARTED|Treatment Period||145
6614770|NCT02141854|7540981|FG000|Intent to Treat Population|Treatment Period||0
6614771|NCT02141854|7540982|FG001|Intent to Treat Population|Treatment Period||146
6614772|NCT02141854|7540983|FG002|Intent to Treat Population|Treatment Period||145
6614773|NCT02141854|7540984|FG003|Intent to Treat Population|Treatment Period||146
6614774|NCT02141854|7540985|FG004|Intent to Treat Population|Treatment Period||146
6614775|NCT02141854|7540986|FG005|Intent to Treat Population|Treatment Period||145
6614776|NCT02141854|7540981|FG000|Safety Population|Treatment Period||0
6614777|NCT02141854|7540982|FG001|Safety Population|Treatment Period||145
6614778|NCT02141854|7540983|FG002|Safety Population|Treatment Period||143
6614779|NCT02141854|7540984|FG003|Safety Population|Treatment Period||146
6614780|NCT02141854|7540985|FG004|Safety Population|Treatment Period||145
6614781|NCT02141854|7540986|FG005|Safety Population|Treatment Period||144
6614782|NCT02141854|7540981|FG000|Full Analysis Set|Treatment Period||0
6614783|NCT02141854|7540982|FG001|Full Analysis Set|Treatment Period||145
6614784|NCT02141854|7540983|FG002|Full Analysis Set|Treatment Period||141
6614785|NCT02141854|7540984|FG003|Full Analysis Set|Treatment Period||146
6614786|NCT02141854|7540985|FG004|Full Analysis Set|Treatment Period||145
6614787|NCT02141854|7540986|FG005|Full Analysis Set|Treatment Period||143
6614788|NCT02141854|7540981|FG000|COMPLETED|Treatment Period||0
6614789|NCT02141854|7540982|FG001|COMPLETED|Treatment Period||136
6614790|NCT02141854|7540983|FG002|COMPLETED|Treatment Period||136
6614791|NCT02141854|7540984|FG003|COMPLETED|Treatment Period||135
6614792|NCT02141854|7540985|FG004|COMPLETED|Treatment Period||136
6614793|NCT02141854|7540986|FG005|COMPLETED|Treatment Period||107
6614794|NCT02141854|7540981|FG000|NOT COMPLETED|Treatment Period||0
6614795|NCT02141854|7540982|FG001|NOT COMPLETED|Treatment Period||10
6614796|NCT02141854|7540983|FG002|NOT COMPLETED|Treatment Period||9
6614797|NCT02141854|7540984|FG003|NOT COMPLETED|Treatment Period||11
6614798|NCT02141854|7540985|FG004|NOT COMPLETED|Treatment Period||10
6614799|NCT02141854|7540986|FG005|NOT COMPLETED|Treatment Period||38
6614800|NCT02141867|7540998|FG000|STARTED|Overall Study||4021
6614801|NCT02141867|7540998|FG000|COMPLETED|Overall Study||3927
6614802|NCT02141867|7540998|FG000|NOT COMPLETED|Overall Study||94
6614803|NCT02141984|7541002|FG000|STARTED|Overall Study||28
6614804|NCT02141984|7541002|FG000|COMPLETED|Overall Study||26
6614805|NCT02141984|7541002|FG000|NOT COMPLETED|Overall Study||2
6614806|NCT02141997|7541010|FG000|STARTED|Overall Study||56
6614807|NCT02141997|7541011|FG001|STARTED|Overall Study||55
6614808|NCT02141997|7541012|FG002|STARTED|Overall Study||56
6614809|NCT02141997|7541013|FG003|STARTED|Overall Study||55
6614810|NCT02141997|7541010|FG000|COMPLETED|Overall Study||53
6614811|NCT02141997|7541011|FG001|COMPLETED|Overall Study||49
6614812|NCT02141997|7541012|FG002|COMPLETED|Overall Study||53
6614813|NCT02141997|7541013|FG003|COMPLETED|Overall Study||54
6614814|NCT02141997|7541010|FG000|NOT COMPLETED|Overall Study||3
6614815|NCT02141997|7541011|FG001|NOT COMPLETED|Overall Study||6
6614816|NCT02141997|7541012|FG002|NOT COMPLETED|Overall Study||3
6614817|NCT02141997|7541013|FG003|NOT COMPLETED|Overall Study||1
6614818|NCT02142049|7541028|FG000|STARTED|Overall Study||3
6614819|NCT02142049|7541029|FG001|STARTED|Overall Study||3
6614820|NCT02142049|7541030|FG002|STARTED|Overall Study||3
6614821|NCT02142049|7541031|FG003|STARTED|Overall Study||6
6614822|NCT02142049|7541032|FG004|STARTED|Overall Study||20
6614823|NCT02142049|7541028|FG000|COMPLETED|Overall Study||3
6614824|NCT02142049|7541029|FG001|COMPLETED|Overall Study||3
6614825|NCT02142049|7541030|FG002|COMPLETED|Overall Study||3
6614826|NCT02142049|7541031|FG003|COMPLETED|Overall Study||6
6614827|NCT02142049|7541032|FG004|COMPLETED|Overall Study||20
6614828|NCT02142049|7541028|FG000|NOT COMPLETED|Overall Study||0
6614829|NCT02142049|7541029|FG001|NOT COMPLETED|Overall Study||0
6614830|NCT02142049|7541030|FG002|NOT COMPLETED|Overall Study||0
6614831|NCT02142049|7541031|FG003|NOT COMPLETED|Overall Study||0
6614832|NCT02142049|7541032|FG004|NOT COMPLETED|Overall Study||0
6614833|NCT02142153|7541059|FG000|STARTED|Overall Study||6
6614834|NCT02142153|7541060|FG001|STARTED|Overall Study||2
6614835|NCT02142153|7541061|FG002|STARTED|Overall Study||6
6614836|NCT02142153|7541062|FG003|STARTED|Overall Study||2
6614837|NCT02142153|7541063|FG004|STARTED|Overall Study||6
6614838|NCT02142153|7541064|FG005|STARTED|Overall Study||2
6614839|NCT02142153|7541065|FG006|STARTED|Overall Study||6
6614840|NCT02142153|7541066|FG007|STARTED|Overall Study||2
6614841|NCT02142153|7541067|FG008|STARTED|Overall Study||6
6614842|NCT02142153|7541068|FG009|STARTED|Overall Study||2
6614843|NCT02142153|7541059|FG000|COMPLETED|Overall Study||6
6614844|NCT02142153|7541060|FG001|COMPLETED|Overall Study||2
6614845|NCT02142153|7541061|FG002|COMPLETED|Overall Study||6
6614846|NCT02142153|7541062|FG003|COMPLETED|Overall Study||2
6614847|NCT02142153|7541063|FG004|COMPLETED|Overall Study||6
6614848|NCT02142153|7541064|FG005|COMPLETED|Overall Study||2
6614849|NCT02142153|7541065|FG006|COMPLETED|Overall Study||6
6614850|NCT02142153|7541066|FG007|COMPLETED|Overall Study||2
6614851|NCT02142153|7541067|FG008|COMPLETED|Overall Study||6
6614852|NCT02142153|7541068|FG009|COMPLETED|Overall Study||2
6614853|NCT02142153|7541059|FG000|NOT COMPLETED|Overall Study||0
6614854|NCT02142153|7541060|FG001|NOT COMPLETED|Overall Study||0
6614855|NCT02142153|7541061|FG002|NOT COMPLETED|Overall Study||0
6614856|NCT02142153|7541062|FG003|NOT COMPLETED|Overall Study||0
6614857|NCT02142153|7541063|FG004|NOT COMPLETED|Overall Study||0
6614858|NCT02142153|7541064|FG005|NOT COMPLETED|Overall Study||0
6614859|NCT02142153|7541065|FG006|NOT COMPLETED|Overall Study||0
6614860|NCT02142153|7541066|FG007|NOT COMPLETED|Overall Study||0
6614861|NCT02142153|7541067|FG008|NOT COMPLETED|Overall Study||0
6614862|NCT02142153|7541068|FG009|NOT COMPLETED|Overall Study||0
6614863|NCT02142283|7541102|FG000|STARTED|Overall Study||107
6614864|NCT02142283|7541103|FG001|STARTED|Overall Study||99
6614865|NCT02142283|7541102|FG000|COMPLETED|Overall Study||86
6614866|NCT02142283|7541103|FG001|COMPLETED|Overall Study||78
6614867|NCT02142283|7541102|FG000|NOT COMPLETED|Overall Study||21
6614868|NCT02142283|7541103|FG001|NOT COMPLETED|Overall Study||21
6614869|NCT02142361|7541109|FG000|STARTED|Overall Study||20
6614870|NCT02142361|7541110|FG001|STARTED|Overall Study||20
6614871|NCT02142361|7541111|FG002|STARTED|Overall Study||20
6614872|NCT02142361|7541109|FG000|COMPLETED|Overall Study||20
6614873|NCT02142361|7541110|FG001|COMPLETED|Overall Study||20
6614874|NCT02142361|7541111|FG002|COMPLETED|Overall Study||20
6614875|NCT02142361|7541109|FG000|NOT COMPLETED|Overall Study||0
6614876|NCT02142361|7541110|FG001|NOT COMPLETED|Overall Study||0
6614877|NCT02142361|7541111|FG002|NOT COMPLETED|Overall Study||0
6614878|NCT02142387|7541124|FG000|STARTED|Overall Study|Out-of-hospital cardiac arrest (OHCA) patients with presumed cardiac etiology.|2551
6614879|NCT02142387|7541125|FG001|STARTED|Overall Study||16271
6614880|NCT02142387|7541124|FG000|COMPLETED|Overall Study|Limited to the case where OHCA occurred in the private place.|1486
6614881|NCT02142387|7541125|FG001|COMPLETED|Overall Study||8641
6614882|NCT02142387|7541124|FG000|NOT COMPLETED|Overall Study||1065
6614883|NCT02142387|7541125|FG001|NOT COMPLETED|Overall Study||7630
6614884|NCT02142504|7541134|FG000|STARTED|Overall Study||153
6614885|NCT02142504|7541135|FG001|STARTED|Overall Study||147
6614886|NCT02142504|7541136|FG002|STARTED|Overall Study||154
6614887|NCT02142504|7541134|FG000|Randomized and Received Treatment|Overall Study||153
6614888|NCT02142504|7541135|FG001|Randomized and Received Treatment|Overall Study||145
6614889|NCT02142504|7541136|FG002|Randomized and Received Treatment|Overall Study||154
6614890|NCT02142504|7541134|FG000|Received Booster (Second Vaccination)|Overall Study||126
6614891|NCT02142504|7541135|FG001|Received Booster (Second Vaccination)|Overall Study||109
6614892|NCT02142504|7541136|FG002|Received Booster (Second Vaccination)|Overall Study||116
6614893|NCT02142504|7541134|FG000|COMPLETED|Overall Study||122
6614894|NCT02142504|7541135|FG001|COMPLETED|Overall Study||105
6614895|NCT02142504|7541136|FG002|COMPLETED|Overall Study||111
6614896|NCT02142504|7541134|FG000|NOT COMPLETED|Overall Study||31
6614897|NCT02142504|7541135|FG001|NOT COMPLETED|Overall Study||42
6614898|NCT02142504|7541136|FG002|NOT COMPLETED|Overall Study||43
6614899|NCT02142608|7541144|FG000|STARTED|Overall Study||18
6614900|NCT02142608|7541144|FG000|COMPLETED|Overall Study||18
6614901|NCT02142608|7541144|FG000|NOT COMPLETED|Overall Study||0
6614902|NCT02142712|7541152|FG000|STARTED|Overall Study||1
6614903|NCT02142712|7541153|FG001|STARTED|Overall Study||1
6614904|NCT02142712|7541154|FG002|STARTED|Overall Study||1
6614905|NCT02142712|7541155|FG003|STARTED|Overall Study||0
6614906|NCT02142712|7541152|FG000|COMPLETED|Overall Study||0
6614907|NCT02142712|7541153|FG001|COMPLETED|Overall Study||0
6614908|NCT02142712|7541154|FG002|COMPLETED|Overall Study||0
6614909|NCT02142712|7541155|FG003|COMPLETED|Overall Study||0
6614910|NCT02142712|7541152|FG000|NOT COMPLETED|Overall Study||1
6614911|NCT02142712|7541153|FG001|NOT COMPLETED|Overall Study||1
6614912|NCT02142712|7541154|FG002|NOT COMPLETED|Overall Study||1
6614913|NCT02142712|7541155|FG003|NOT COMPLETED|Overall Study||0
6614914|NCT02142738|7541166|FG000|STARTED|Overall Study||154
6614915|NCT02142738|7541167|FG001|STARTED|Overall Study||151
6614916|NCT02142738|7541166|FG000|Treated|Overall Study||154
6614917|NCT02142738|7541167|FG001|Treated|Overall Study||150
6614918|NCT02142738|7541166|FG000|COMPLETED|Overall Study||0
6614919|NCT02142738|7541167|FG001|COMPLETED|Overall Study||0
6614920|NCT02142738|7541166|FG000|NOT COMPLETED|Overall Study||154
6614921|NCT02142738|7541167|FG001|NOT COMPLETED|Overall Study||151
6614922|NCT02142894|7541173|FG000|STARTED|Overall Study||33
6614923|NCT02142894|7541173|FG000|COMPLETED|Overall Study||25
6614924|NCT02142894|7541173|FG000|NOT COMPLETED|Overall Study||8
6614925|NCT02143024|7541179|FG000|STARTED|Overall Study||15
6614926|NCT02143024|7541180|FG001|STARTED|Overall Study||8
6614927|NCT02143024|7541179|FG000|Received Treatment|Overall Study||13
6614928|NCT02143024|7541180|FG001|Received Treatment|Overall Study||7
6614929|NCT02143024|7541179|FG000|COMPLETED|Overall Study||13
6614930|NCT02143024|7541180|FG001|COMPLETED|Overall Study||7
6614931|NCT02143024|7541179|FG000|NOT COMPLETED|Overall Study||2
6614932|NCT02143024|7541180|FG001|NOT COMPLETED|Overall Study||1
6614933|NCT02143102|7541188|FG000|STARTED|Overall Study||97
6614934|NCT02143102|7541189|FG001|STARTED|Overall Study||28
6614935|NCT02143102|7541188|FG000|COMPLETED|Overall Study||86
6614936|NCT02143102|7541189|FG001|COMPLETED|Overall Study||28
6614937|NCT02143102|7541188|FG000|NOT COMPLETED|Overall Study||11
6614938|NCT02143102|7541189|FG001|NOT COMPLETED|Overall Study||0
6614939|NCT02143141|7541197|FG000|STARTED|Overall Study||7
6614940|NCT02143141|7541198|FG001|STARTED|Overall Study||6
6614941|NCT02143141|7541197|FG000|COMPLETED|Overall Study||6
6614942|NCT02143141|7541198|FG001|COMPLETED|Overall Study||6
6614943|NCT02143141|7541197|FG000|NOT COMPLETED|Overall Study||1
6614944|NCT02143141|7541198|FG001|NOT COMPLETED|Overall Study||0
6614945|NCT02143310|7541204|FG000|STARTED|Overall Study||209
6614946|NCT02143310|7541204|FG000|COMPLETED|Overall Study||102
6614947|NCT02143310|7541204|FG000|NOT COMPLETED|Overall Study||107
6614948|NCT02143583|7541211|FG000|STARTED|Overall Study||62
6614949|NCT02143583|7541212|FG001|STARTED|Overall Study||66
6614950|NCT02143583|7541213|FG002|STARTED|Overall Study||68
6614951|NCT02143583|7541211|FG000|COMPLETED|Overall Study||61
6614952|NCT02143583|7541212|FG001|COMPLETED|Overall Study||66
6614953|NCT02143583|7541213|FG002|COMPLETED|Overall Study||66
6614954|NCT02143583|7541211|FG000|NOT COMPLETED|Overall Study||1
6614955|NCT02143583|7541212|FG001|NOT COMPLETED|Overall Study||0
6614956|NCT02143583|7541213|FG002|NOT COMPLETED|Overall Study||2
6614957|NCT02143648|7541224|FG000|STARTED|Overall Study||128
6614958|NCT02143648|7541225|FG001|STARTED|Overall Study||120
6614959|NCT02143648|7541226|FG002|STARTED|Overall Study||125
6614960|NCT02143648|7541224|FG000|COMPLETED|Overall Study||74
6614961|NCT02143648|7541225|FG001|COMPLETED|Overall Study||78
6614962|NCT02143648|7541226|FG002|COMPLETED|Overall Study||101
6614963|NCT02143648|7541224|FG000|NOT COMPLETED|Overall Study||54
6614964|NCT02143648|7541225|FG001|NOT COMPLETED|Overall Study||42
6614965|NCT02143648|7541226|FG002|NOT COMPLETED|Overall Study||24
6614966|NCT02143713|7541238|FG000|STARTED|Treatment Period (6 Months)||102
6614967|NCT02143713|7541239|FG001|STARTED|Treatment Period (6 Months)||111
6614968|NCT02143713|7541240|FG002|STARTED|Treatment Period (6 Months)||142
6614969|NCT02143713|7541241|FG003|STARTED|Treatment Period (6 Months)||140
6614970|NCT02143713|7541238|FG000|Received Elagolix|Treatment Period (6 Months)||102
6614971|NCT02143713|7541239|FG001|Received Elagolix|Treatment Period (6 Months)||111
6614972|NCT02143713|7541240|FG002|Received Elagolix|Treatment Period (6 Months)||142
6614973|NCT02143713|7541241|FG003|Received Elagolix|Treatment Period (6 Months)||140
6614974|NCT02143713|7541238|FG000|COMPLETED|Treatment Period (6 Months)||82
6614975|NCT02143713|7541239|FG001|COMPLETED|Treatment Period (6 Months)||99
6614976|NCT02143713|7541240|FG002|COMPLETED|Treatment Period (6 Months)||120
6614977|NCT02143713|7541241|FG003|COMPLETED|Treatment Period (6 Months)||112
6614978|NCT02143713|7541238|FG000|NOT COMPLETED|Treatment Period (6 Months)||20
6614979|NCT02143713|7541239|FG001|NOT COMPLETED|Treatment Period (6 Months)||12
6614980|NCT02143713|7541240|FG002|NOT COMPLETED|Treatment Period (6 Months)||22
6614981|NCT02143713|7541241|FG003|NOT COMPLETED|Treatment Period (6 Months)||28
6614982|NCT02143713|7541238|FG000|STARTED|Post-treatment Follow-up (12 Months)||85
6614983|NCT02143713|7541239|FG001|STARTED|Post-treatment Follow-up (12 Months)||105
6614984|NCT02143713|7541240|FG002|STARTED|Post-treatment Follow-up (12 Months)||125
6614985|NCT02143713|7541241|FG003|STARTED|Post-treatment Follow-up (12 Months)||122
6614986|NCT02143713|7541238|FG000|COMPLETED|Post-treatment Follow-up (12 Months)||73
6614987|NCT02143713|7541239|FG001|COMPLETED|Post-treatment Follow-up (12 Months)||81
6614988|NCT02143713|7541240|FG002|COMPLETED|Post-treatment Follow-up (12 Months)||96
6614989|NCT02143713|7541241|FG003|COMPLETED|Post-treatment Follow-up (12 Months)||95
6614990|NCT02143713|7541238|FG000|NOT COMPLETED|Post-treatment Follow-up (12 Months)||12
6614991|NCT02143713|7541239|FG001|NOT COMPLETED|Post-treatment Follow-up (12 Months)||24
6614992|NCT02143713|7541240|FG002|NOT COMPLETED|Post-treatment Follow-up (12 Months)||29
6614993|NCT02143713|7541241|FG003|NOT COMPLETED|Post-treatment Follow-up (12 Months)||27
6614994|NCT02143778|7541252|FG000|STARTED|Overall Study||246
6614995|NCT02143778|7541252|FG000|COMPLETED|Overall Study||243
6614996|NCT02143778|7541252|FG000|NOT COMPLETED|Overall Study||3
6614997|NCT02143843|7541257|FG000|STARTED|Overall Study||75
6614998|NCT02143843|7541257|FG000|COMPLETED|Overall Study||63
6614999|NCT02143843|7541257|FG000|NOT COMPLETED|Overall Study||12
6615000|NCT02143947|7541263|FG000|STARTED|Overall Study||36
6615001|NCT02143947|7541264|FG001|STARTED|Overall Study||44
6615002|NCT02143947|7541263|FG000|COMPLETED|Overall Study||32
6615003|NCT02143947|7541264|FG001|COMPLETED|Overall Study||42
6615004|NCT02143947|7541263|FG000|NOT COMPLETED|Overall Study||4
6615005|NCT02143947|7541264|FG001|NOT COMPLETED|Overall Study||2
6615006|NCT02143973|7541272|FG000|STARTED|Overall Study||167
6615007|NCT02143973|7541272|FG000|COMPLETED|Overall Study||101
6615008|NCT02143973|7541272|FG000|NOT COMPLETED|Overall Study||66
6615009|NCT02144012|7541278|FG000|STARTED|Overall Study||34
6615010|NCT02144012|7541279|FG001|STARTED|Overall Study||15
6615011|NCT02144012|7541278|FG000|COMPLETED|Overall Study||0
6615012|NCT02144012|7541279|FG001|COMPLETED|Overall Study||0
6615013|NCT02144012|7541278|FG000|NOT COMPLETED|Overall Study||34
6615014|NCT02144012|7541279|FG001|NOT COMPLETED|Overall Study||15
6615015|NCT02144077|7541287|FG000|STARTED|Overall Study||138
6615016|NCT02144077|7541288|FG001|STARTED|Overall Study||143
6615017|NCT02144077|7541287|FG000|COMPLETED|Overall Study||128
6615018|NCT02144077|7541288|FG001|COMPLETED|Overall Study||132
6615019|NCT02144077|7541287|FG000|NOT COMPLETED|Overall Study||10
6615020|NCT02144077|7541288|FG001|NOT COMPLETED|Overall Study||11
6615021|NCT02144220|7541294|FG000|STARTED|Overall Study||277
6615022|NCT02144220|7541294|FG000|COMPLETED|Overall Study||258
6615023|NCT02144220|7541294|FG000|NOT COMPLETED|Overall Study||19
6615024|NCT02144233|7541300|FG000|STARTED|Overall Study||39
6615025|NCT02144233|7541301|FG001|STARTED|Overall Study||38
6615026|NCT02144233|7541300|FG000|COMPLETED|Overall Study|The last participant was assessed at month 3 due to early study stop|39
6615027|NCT02144233|7541301|FG001|COMPLETED|Overall Study||38
6615028|NCT02144233|7541300|FG000|NOT COMPLETED|Overall Study||0
6615029|NCT02144233|7541301|FG001|NOT COMPLETED|Overall Study||0
6615030|NCT02144259|7541310|FG000|STARTED|Overall Study||33
6615031|NCT02144259|7541311|FG001|STARTED|Overall Study||33
6615032|NCT02144259|7541312|FG002|STARTED|Overall Study||34
6615033|NCT02144259|7541310|FG000|COMPLETED|Overall Study||23
6615034|NCT02144259|7541311|FG001|COMPLETED|Overall Study||28
6615035|NCT02144259|7541312|FG002|COMPLETED|Overall Study||16
6615036|NCT02144259|7541310|FG000|NOT COMPLETED|Overall Study||10
6615037|NCT02144259|7541311|FG001|NOT COMPLETED|Overall Study||5
6615038|NCT02144259|7541312|FG002|NOT COMPLETED|Overall Study||18
6615039|NCT02144285|7541330|FG000|STARTED|Overall Study||14
6615040|NCT02144285|7541331|FG001|STARTED|Overall Study||6
6615041|NCT02144285|7541332|FG002|STARTED|Overall Study||6
6615042|NCT02144285|7541333|FG003|STARTED|Overall Study||6
6615043|NCT02144285|7541334|FG004|STARTED|Overall Study||6
6615044|NCT02144285|7541335|FG005|STARTED|Overall Study||6
6615045|NCT02144285|7541336|FG006|STARTED|Overall Study||6
6615046|NCT02144285|7541337|FG007|STARTED|Overall Study||6
6615047|NCT02144285|7541338|FG008|STARTED|Overall Study||2
6615048|NCT02144285|7541339|FG009|STARTED|Overall Study||6
6615049|NCT02144285|7541330|FG000|Received At Least One Dose of Study Drug|Overall Study||14
6615050|NCT02144285|7541331|FG001|Received At Least One Dose of Study Drug|Overall Study||6
6615051|NCT02144285|7541332|FG002|Received At Least One Dose of Study Drug|Overall Study||6
6615052|NCT02144285|7541333|FG003|Received At Least One Dose of Study Drug|Overall Study||6
6615053|NCT02144285|7541334|FG004|Received At Least One Dose of Study Drug|Overall Study||6
6615054|NCT02144285|7541335|FG005|Received At Least One Dose of Study Drug|Overall Study||6
6615055|NCT02144285|7541336|FG006|Received At Least One Dose of Study Drug|Overall Study||6
6615056|NCT02144285|7541337|FG007|Received At Least One Dose of Study Drug|Overall Study||6
6615057|NCT02144285|7541338|FG008|Received At Least One Dose of Study Drug|Overall Study||2
6615058|NCT02144285|7541339|FG009|Received At Least One Dose of Study Drug|Overall Study||6
6615059|NCT02144285|7541330|FG000|COMPLETED|Overall Study||14
6615060|NCT02144285|7541331|FG001|COMPLETED|Overall Study||6
6615061|NCT02144285|7541332|FG002|COMPLETED|Overall Study||6
6615062|NCT02144285|7541333|FG003|COMPLETED|Overall Study||6
6615063|NCT02144285|7541334|FG004|COMPLETED|Overall Study||5
6615064|NCT02144285|7541335|FG005|COMPLETED|Overall Study||6
6615065|NCT02144285|7541336|FG006|COMPLETED|Overall Study||6
6615066|NCT02144285|7541337|FG007|COMPLETED|Overall Study||6
6615067|NCT02144285|7541338|FG008|COMPLETED|Overall Study||2
6615068|NCT02144285|7541339|FG009|COMPLETED|Overall Study||6
6615069|NCT02144285|7541330|FG000|NOT COMPLETED|Overall Study||0
6615070|NCT02144285|7541331|FG001|NOT COMPLETED|Overall Study||0
6615071|NCT02144285|7541332|FG002|NOT COMPLETED|Overall Study||0
6615072|NCT02144285|7541333|FG003|NOT COMPLETED|Overall Study||0
6615073|NCT02144285|7541334|FG004|NOT COMPLETED|Overall Study||1
6615074|NCT02144285|7541335|FG005|NOT COMPLETED|Overall Study||0
6615075|NCT02144285|7541336|FG006|NOT COMPLETED|Overall Study||0
6615076|NCT02144285|7541337|FG007|NOT COMPLETED|Overall Study||0
6615077|NCT02144285|7541338|FG008|NOT COMPLETED|Overall Study||0
6615078|NCT02144285|7541339|FG009|NOT COMPLETED|Overall Study||0
6615079|NCT02144337|7541377|FG000|STARTED|Baseline 0 Months||8
6615080|NCT02144337|7541378|FG001|STARTED|Baseline 0 Months||5
6615081|NCT02144337|7541377|FG000|COMPLETED|Baseline 0 Months||8
6615082|NCT02144337|7541378|FG001|COMPLETED|Baseline 0 Months||5
6615083|NCT02144337|7541377|FG000|NOT COMPLETED|Baseline 0 Months||0
6615084|NCT02144337|7541378|FG001|NOT COMPLETED|Baseline 0 Months||0
6615085|NCT02144337|7541377|FG000|STARTED|T2 Follow-up (Post-intervention)||8
6615086|NCT02144337|7541378|FG001|STARTED|T2 Follow-up (Post-intervention)||5
6615087|NCT02144337|7541377|FG000|COMPLETED|T2 Follow-up (Post-intervention)||4
6615088|NCT02144337|7541378|FG001|COMPLETED|T2 Follow-up (Post-intervention)||4
6615089|NCT02144337|7541377|FG000|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
6615090|NCT02144337|7541378|FG001|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
6615091|NCT02144337|7541377|FG000|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
6615092|NCT02144337|7541378|FG001|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
6615093|NCT02144337|7541377|FG000|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
6615094|NCT02144337|7541378|FG001|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
6615095|NCT02144337|7541377|FG000|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
6615096|NCT02144337|7541378|FG001|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
6615097|NCT02144519|7541387|FG000|STARTED|Year 1||895
6615098|NCT02144519|7541388|FG001|STARTED|Year 1||870
6615099|NCT02144519|7541387|FG000|COMPLETED|Year 1||895
6615100|NCT02144519|7541388|FG001|COMPLETED|Year 1||870
6615101|NCT02144519|7541387|FG000|NOT COMPLETED|Year 1||0
6615102|NCT02144519|7541388|FG001|NOT COMPLETED|Year 1||0
6615103|NCT02144519|7541387|FG000|STARTED|Year 2||763
6615104|NCT02144519|7541388|FG001|STARTED|Year 2||864
6615105|NCT02144519|7541387|FG000|COMPLETED|Year 2||763
6615106|NCT02144519|7541388|FG001|COMPLETED|Year 2||864
6615107|NCT02144519|7541387|FG000|NOT COMPLETED|Year 2||0
6615108|NCT02144519|7541388|FG001|NOT COMPLETED|Year 2||0
6615109|NCT02144519|7541387|FG000|STARTED|Year 3||894
6615110|NCT02144519|7541388|FG001|STARTED|Year 3||760
6615111|NCT02144519|7541387|FG000|COMPLETED|Year 3||894
6615112|NCT02144519|7541388|FG001|COMPLETED|Year 3||760
6615113|NCT02144519|7541387|FG000|NOT COMPLETED|Year 3||0
6615114|NCT02144519|7541388|FG001|NOT COMPLETED|Year 3||0
6615115|NCT02144597|7541397|FG000|STARTED|Overall Study||10
6615116|NCT02144597|7541398|FG001|STARTED|Overall Study||10
6615117|NCT02144597|7541399|FG002|STARTED|Overall Study||10
6615118|NCT02144597|7541397|FG000|COMPLETED|Overall Study||4
6615119|NCT02144597|7541398|FG001|COMPLETED|Overall Study||6
6615120|NCT02144597|7541399|FG002|COMPLETED|Overall Study||6
6615121|NCT02144597|7541397|FG000|NOT COMPLETED|Overall Study||6
6615122|NCT02144597|7541398|FG001|NOT COMPLETED|Overall Study||4
6615123|NCT02144597|7541399|FG002|NOT COMPLETED|Overall Study||4
6615124|NCT02144610|7541409|FG000|STARTED|Overall Study||23
6615125|NCT02144610|7541410|FG001|STARTED|Overall Study||23
6615126|NCT02144610|7541409|FG000|COMPLETED|Overall Study||0
6615127|NCT02144610|7541410|FG001|COMPLETED|Overall Study||1
6615128|NCT02144610|7541409|FG000|NOT COMPLETED|Overall Study||23
6615129|NCT02144610|7541410|FG001|NOT COMPLETED|Overall Study||22
6615130|NCT02144675|7541418|FG000|STARTED|Overall Study||13
6615131|NCT02144675|7541419|FG001|STARTED|Overall Study||14
6615132|NCT02144675|7541418|FG000|COMPLETED|Overall Study||13
6615133|NCT02144675|7541419|FG001|COMPLETED|Overall Study||14
6615134|NCT02144675|7541418|FG000|NOT COMPLETED|Overall Study||0
6615135|NCT02144675|7541419|FG001|NOT COMPLETED|Overall Study||0
6615136|NCT02144701|7541427|FG000|STARTED|Overall Study||22
6615137|NCT02144701|7541428|FG001|STARTED|Overall Study||11
6615138|NCT02144701|7541427|FG000|COMPLETED|Overall Study||13
6615139|NCT02144701|7541428|FG001|COMPLETED|Overall Study||8
6615140|NCT02144701|7541427|FG000|NOT COMPLETED|Overall Study||9
6615141|NCT02144701|7541428|FG001|NOT COMPLETED|Overall Study||3
6615142|NCT02144714|7541437|FG000|STARTED|Overall Study||63
6615143|NCT02144714|7541438|FG001|STARTED|Overall Study||63
6615144|NCT02144714|7541439|FG002|STARTED|Overall Study||63
6615145|NCT02144714|7541437|FG000|COMPLETED|Overall Study||63
6615146|NCT02144714|7541438|FG001|COMPLETED|Overall Study||63
6615147|NCT02144714|7541439|FG002|COMPLETED|Overall Study||63
6615148|NCT02144714|7541437|FG000|NOT COMPLETED|Overall Study||0
6732822|NCT03199118|7662329|FG001|NOT COMPLETED|Overall Study||0
6732823|NCT03199872|7662340|FG000|STARTED|Overall Study||22
6732824|NCT03199872|7662340|FG000|COMPLETED|Overall Study||22
6732825|NCT03199872|7662340|FG000|NOT COMPLETED|Overall Study||0
6732826|NCT03199911|7662346|FG000|STARTED|Overall Study||208
6732827|NCT03199911|7662347|FG001|STARTED|Overall Study||193
6732828|NCT03199911|7662346|FG000|Did Not Proceed With Surgery|Overall Study||2
6732829|NCT03199911|7662347|FG001|Did Not Proceed With Surgery|Overall Study||1
6732830|NCT03199911|7662346|FG000|Received Allocated Treatment|Overall Study||206
6732831|NCT03199911|7662347|FG001|Received Allocated Treatment|Overall Study||192
6732832|NCT03199911|7662346|FG000|Lost to Follow-up|Overall Study||5
6732833|NCT03199911|7662347|FG001|Lost to Follow-up|Overall Study||5
6732834|NCT03199911|7662346|FG000|Primary Outcome Analyzed|Overall Study||201
6732835|NCT03199911|7662347|FG001|Primary Outcome Analyzed|Overall Study||187
6732836|NCT03199911|7662346|FG000|COMPLETED|Overall Study||201
6732837|NCT03199911|7662347|FG001|COMPLETED|Overall Study||187
6732838|NCT03199911|7662346|FG000|NOT COMPLETED|Overall Study||7
6732839|NCT03199911|7662347|FG001|NOT COMPLETED|Overall Study||6
6732840|NCT03199963|7662355|FG000|STARTED|Blinded Phase - Overall Study||149
6732841|NCT03199963|7662356|FG001|STARTED|Blinded Phase - Overall Study||74
6732842|NCT03199963|7662355|FG000|Received at Least 1 Gel Application|Blinded Phase - Overall Study||149
6732843|NCT03199963|7662356|FG001|Received at Least 1 Gel Application|Blinded Phase - Overall Study||73
6732844|NCT03199963|7662355|FG000|COMPLETED|Blinded Phase - Overall Study||16
6732845|NCT03199963|7662356|FG001|COMPLETED|Blinded Phase - Overall Study||8
6732846|NCT03199963|7662355|FG000|NOT COMPLETED|Blinded Phase - Overall Study||133
6732847|NCT03199963|7662356|FG001|NOT COMPLETED|Blinded Phase - Overall Study||66
6732848|NCT03199963|7662355|FG000|STARTED|Optional Open-Label Phase - BHR-700||7
6732849|NCT03199963|7662356|FG001|STARTED|Optional Open-Label Phase - BHR-700||6
6732850|NCT03199963|7662355|FG000|COMPLETED|Optional Open-Label Phase - BHR-700||0
6732851|NCT03199963|7662356|FG001|COMPLETED|Optional Open-Label Phase - BHR-700||0
6732852|NCT03199963|7662355|FG000|NOT COMPLETED|Optional Open-Label Phase - BHR-700||7
6732853|NCT03199963|7662356|FG001|NOT COMPLETED|Optional Open-Label Phase - BHR-700||6
6732854|NCT03200366|7662367|FG000|STARTED|Baseline Interview With Randomization||123
6732855|NCT03200366|7662368|FG001|STARTED|Baseline Interview With Randomization||120
6732856|NCT03200366|7662369|FG002|STARTED|Baseline Interview With Randomization||128
6732857|NCT03200366|7662367|FG000|COMPLETED|Baseline Interview With Randomization||123
6615149|NCT02144714|7541438|FG001|NOT COMPLETED|Overall Study||0
6615150|NCT02144714|7541439|FG002|NOT COMPLETED|Overall Study||0
6615151|NCT02145026|7541447|FG000|STARTED|Overall Study||100
6615152|NCT02145026|7541447|FG000|COMPLETED|Overall Study||88
6615153|NCT02145026|7541447|FG000|NOT COMPLETED|Overall Study||12
6615154|NCT02145039|7541451|FG000|STARTED|Overall Study||2
6615155|NCT02145039|7541451|FG000|COMPLETED|Overall Study||2
6615156|NCT02145039|7541451|FG000|NOT COMPLETED|Overall Study||0
6615157|NCT02145078|7541455|FG000|STARTED|Overall Study||4
6615158|NCT02145078|7541455|FG000|COMPLETED|Overall Study||0
6615159|NCT02145078|7541455|FG000|NOT COMPLETED|Overall Study||4
6615160|NCT02145156|7541462|FG000|STARTED|Overall Study||430
6615161|NCT02145156|7541463|FG001|STARTED|Overall Study||425
6615162|NCT02145156|7541464|FG002|STARTED|Overall Study||439
6615163|NCT02145156|7541462|FG000|COMPLETED|Overall Study||370
6615164|NCT02145156|7541463|FG001|COMPLETED|Overall Study||373
6615165|NCT02145156|7541464|FG002|COMPLETED|Overall Study||398
6615166|NCT02145156|7541462|FG000|NOT COMPLETED|Overall Study||60
6615167|NCT02145156|7541463|FG001|NOT COMPLETED|Overall Study||52
6615168|NCT02145156|7541464|FG002|NOT COMPLETED|Overall Study||41
6732858|NCT03200366|7662368|FG001|COMPLETED|Baseline Interview With Randomization||120
6732859|NCT03200366|7662369|FG002|COMPLETED|Baseline Interview With Randomization||128
6732860|NCT03200366|7662367|FG000|NOT COMPLETED|Baseline Interview With Randomization||0
6732861|NCT03200366|7662368|FG001|NOT COMPLETED|Baseline Interview With Randomization||0
6732862|NCT03200366|7662369|FG002|NOT COMPLETED|Baseline Interview With Randomization||0
6732863|NCT03200366|7662367|FG000|STARTED|Tailored DVD Intervention Given||123
6732864|NCT03200366|7662368|FG001|STARTED|Tailored DVD Intervention Given||120
6732865|NCT03200366|7662369|FG002|STARTED|Tailored DVD Intervention Given||0
6732866|NCT03200366|7662367|FG000|COMPLETED|Tailored DVD Intervention Given||123
6732867|NCT03200366|7662368|FG001|COMPLETED|Tailored DVD Intervention Given||120
6732868|NCT03200366|7662369|FG002|COMPLETED|Tailored DVD Intervention Given||0
6732869|NCT03200366|7662367|FG000|NOT COMPLETED|Tailored DVD Intervention Given||0
6732870|NCT03200366|7662368|FG001|NOT COMPLETED|Tailored DVD Intervention Given||0
6732871|NCT03200366|7662369|FG002|NOT COMPLETED|Tailored DVD Intervention Given||0
6732872|NCT03200366|7662367|FG000|STARTED|Patient Navigation Intervention Given||0
6732873|NCT03200366|7662368|FG001|STARTED|Patient Navigation Intervention Given||120
6732874|NCT03200366|7662369|FG002|STARTED|Patient Navigation Intervention Given||0
6732875|NCT03200366|7662367|FG000|COMPLETED|Patient Navigation Intervention Given||0
6732876|NCT03200366|7662368|FG001|COMPLETED|Patient Navigation Intervention Given||89
6732877|NCT03200366|7662369|FG002|COMPLETED|Patient Navigation Intervention Given||0
6732878|NCT03200366|7662367|FG000|NOT COMPLETED|Patient Navigation Intervention Given||0
6732879|NCT03200366|7662368|FG001|NOT COMPLETED|Patient Navigation Intervention Given||31
6732880|NCT03200366|7662369|FG002|NOT COMPLETED|Patient Navigation Intervention Given||0
6732881|NCT03200366|7662367|FG000|STARTED|6 Month Post-Baseline Interview||123
6732882|NCT03200366|7662368|FG001|STARTED|6 Month Post-Baseline Interview||118
6732883|NCT03200366|7662369|FG002|STARTED|6 Month Post-Baseline Interview||128
6732884|NCT03200366|7662367|FG000|COMPLETED|6 Month Post-Baseline Interview||93
6732885|NCT03200366|7662368|FG001|COMPLETED|6 Month Post-Baseline Interview||95
6732886|NCT03200366|7662369|FG002|COMPLETED|6 Month Post-Baseline Interview||109
6732887|NCT03200366|7662367|FG000|NOT COMPLETED|6 Month Post-Baseline Interview||30
6732888|NCT03200366|7662368|FG001|NOT COMPLETED|6 Month Post-Baseline Interview||23
6615169|NCT02145182|7541474|FG000|STARTED|Overall Study||142
6615170|NCT02145182|7541475|FG001|STARTED|Overall Study||146
6615171|NCT02145182|7541474|FG000|Received at Least 1 Dose of Study Drug|Overall Study||142
6615172|NCT02145182|7541475|FG001|Received at Least 1 Dose of Study Drug|Overall Study||146
6615173|NCT02145182|7541474|FG000|COMPLETED|Overall Study||124
6615174|NCT02145182|7541475|FG001|COMPLETED|Overall Study||130
6615175|NCT02145182|7541474|FG000|NOT COMPLETED|Overall Study||18
6615176|NCT02145182|7541475|FG001|NOT COMPLETED|Overall Study||16
6615177|NCT02145247|7541483|FG000|STARTED|Overall Study||20
6615178|NCT02145247|7541484|FG001|STARTED|Overall Study||19
6615179|NCT02145247|7541483|FG000|COMPLETED|Overall Study||20
6615180|NCT02145247|7541484|FG001|COMPLETED|Overall Study||19
6615181|NCT02145247|7541483|FG000|NOT COMPLETED|Overall Study||0
6615182|NCT02145247|7541484|FG001|NOT COMPLETED|Overall Study||0
6615183|NCT02145299|7541492|FG000|STARTED|Overall Study||6
6615184|NCT02145299|7541493|FG001|STARTED|Overall Study||2
6615185|NCT02145299|7541492|FG000|COMPLETED|Overall Study||6
6615186|NCT02145299|7541493|FG001|COMPLETED|Overall Study||2
6615187|NCT02145299|7541492|FG000|NOT COMPLETED|Overall Study||0
6615188|NCT02145299|7541493|FG001|NOT COMPLETED|Overall Study||0
6615189|NCT02145429|7541501|FG000|STARTED|Overall Study||91
6615190|NCT02145429|7541502|FG001|STARTED|Overall Study||90
6615191|NCT02145429|7541501|FG000|COMPLETED|Overall Study||75
6615192|NCT02145429|7541502|FG001|COMPLETED|Overall Study||79
6615193|NCT02145429|7541501|FG000|NOT COMPLETED|Overall Study||16
6615194|NCT02145429|7541502|FG001|NOT COMPLETED|Overall Study||11
6615195|NCT02145468|7541510|FG000|STARTED|Overall Study||1758
6615196|NCT02145468|7541511|FG001|STARTED|Overall Study||1731
6615197|NCT02145468|7541510|FG000|COMPLETED|Overall Study||1753
6615198|NCT02145468|7541511|FG001|COMPLETED|Overall Study||1723
6615199|NCT02145468|7541510|FG000|NOT COMPLETED|Overall Study||5
6615200|NCT02145468|7541511|FG001|NOT COMPLETED|Overall Study||8
6615201|NCT02145676|7541520|FG000|STARTED|Overall Study||17
6615202|NCT02145676|7541521|FG001|STARTED|Overall Study||18
6615203|NCT02145676|7541522|FG002|STARTED|Overall Study||18
6615204|NCT02145676|7541520|FG000|COMPLETED|Overall Study||17
6615205|NCT02145676|7541521|FG001|COMPLETED|Overall Study||18
6615206|NCT02145676|7541522|FG002|COMPLETED|Overall Study||18
6615207|NCT02145676|7541520|FG000|NOT COMPLETED|Overall Study||0
6615208|NCT02145676|7541521|FG001|NOT COMPLETED|Overall Study||0
6615209|NCT02145676|7541522|FG002|NOT COMPLETED|Overall Study||0
6615210|NCT02145754|7541530|FG000|STARTED|Overall Study||235
6615211|NCT02145754|7541530|FG000|COMPLETED|Overall Study||235
6615212|NCT02145754|7541530|FG000|NOT COMPLETED|Overall Study||0
6615213|NCT02146001|7541536|FG000|STARTED|Overall Study||19
6615214|NCT02146001|7541537|FG001|STARTED|Overall Study||19
6615215|NCT02146001|7541536|FG000|COMPLETED|Overall Study||19
6615216|NCT02146001|7541537|FG001|COMPLETED|Overall Study||19
6615217|NCT02146001|7541536|FG000|NOT COMPLETED|Overall Study||0
6615218|NCT02146001|7541537|FG001|NOT COMPLETED|Overall Study||0
6615219|NCT02146105|7541543|FG000|STARTED|Overall Study||45
6615220|NCT02146105|7541543|FG000|COMPLETED|Overall Study||39
6615221|NCT02146105|7541543|FG000|NOT COMPLETED|Overall Study||6
6615222|NCT02146131|7541549|FG000|STARTED|Overall Study||170
6615223|NCT02146131|7541550|FG001|STARTED|Overall Study||169
6615224|NCT02146131|7541549|FG000|COMPLETED|Overall Study||109
6615225|NCT02146131|7541550|FG001|COMPLETED|Overall Study||113
6615226|NCT02146131|7541549|FG000|NOT COMPLETED|Overall Study||61
6615227|NCT02146131|7541550|FG001|NOT COMPLETED|Overall Study||56
6615228|NCT02146248|7541556|FG000|STARTED|Overall Study||11
6615229|NCT02146248|7541556|FG000|Enrolled|Overall Study||11
6615230|NCT02146248|7541556|FG000|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
6615231|NCT02146248|7541556|FG000|HSG 1|Overall Study||10
6615232|NCT02146248|7541556|FG000|HSG 2|Overall Study||10
6615233|NCT02146248|7541556|FG000|HSG 3|Overall Study||9
6615234|NCT02146248|7541556|FG000|HSG 4|Overall Study||7
6615235|NCT02146248|7541556|FG000|HSG 5|Overall Study||1
6615236|NCT02146248|7541556|FG000|COMPLETED|Overall Study||9
6615237|NCT02146248|7541556|FG000|NOT COMPLETED|Overall Study||2
6615238|NCT02146274|7541564|FG000|STARTED|Overall Study||1877
6615239|NCT02146274|7541564|FG000|COMPLETED|Overall Study||1804
6615240|NCT02146274|7541564|FG000|NOT COMPLETED|Overall Study||73
6615241|NCT02146326|7541575|FG000|STARTED|Overall Study||89
6615242|NCT02146326|7541576|FG001|STARTED|Overall Study||103
6615243|NCT02146326|7541577|FG002|STARTED|Overall Study||211
6615244|NCT02146326|7541578|FG003|STARTED|Overall Study||258
6615245|NCT02146326|7541575|FG000|Baseline|Overall Study||89
6615246|NCT02146326|7541576|FG001|Baseline|Overall Study||103
6615247|NCT02146326|7541577|FG002|Baseline|Overall Study||211
6615248|NCT02146326|7541578|FG003|Baseline|Overall Study||258
6615249|NCT02146326|7541575|FG000|3 Months|Overall Study||71
6615250|NCT02146326|7541576|FG001|3 Months|Overall Study||83
6615251|NCT02146326|7541577|FG002|3 Months|Overall Study||0
6615252|NCT02146326|7541578|FG003|3 Months|Overall Study||0
6615253|NCT02146326|7541575|FG000|6 Months|Overall Study||71
6615254|NCT02146326|7541576|FG001|6 Months|Overall Study||71
6615255|NCT02146326|7541577|FG002|6 Months|Overall Study||186
6615256|NCT02146326|7541578|FG003|6 Months|Overall Study||235
6615257|NCT02146326|7541575|FG000|12 Months|Overall Study||61
6615258|NCT02146326|7541576|FG001|12 Months|Overall Study||66
6615259|NCT02146326|7541577|FG002|12 Months|Overall Study||168
6615260|NCT02146326|7541578|FG003|12 Months|Overall Study||210
6615261|NCT02146326|7541575|FG000|COMPLETED|Overall Study||61
6615262|NCT02146326|7541576|FG001|COMPLETED|Overall Study||66
6615263|NCT02146326|7541577|FG002|COMPLETED|Overall Study||168
6615264|NCT02146326|7541578|FG003|COMPLETED|Overall Study||210
6615265|NCT02146326|7541575|FG000|NOT COMPLETED|Overall Study||28
6615266|NCT02146326|7541576|FG001|NOT COMPLETED|Overall Study||37
6615267|NCT02146326|7541577|FG002|NOT COMPLETED|Overall Study||43
6615268|NCT02146326|7541578|FG003|NOT COMPLETED|Overall Study||48
6615269|NCT02146352|7541594|FG000|STARTED|Overall Study||30
6615270|NCT02146352|7541594|FG000|30 or 60 Days Post-procedure|Overall Study||30
6615271|NCT02146352|7541594|FG000|7 Days Post-stent Removal|Overall Study||28
6615272|NCT02146352|7541594|FG000|COMPLETED|Overall Study||28
6615273|NCT02146352|7541594|FG000|NOT COMPLETED|Overall Study||2
6615274|NCT02146365|7541604|FG000|STARTED|Overall Study||49
6615275|NCT02146365|7541605|FG001|STARTED|Overall Study||49
6615276|NCT02146365|7541606|FG002|STARTED|Overall Study||50
6615277|NCT02146365|7541607|FG003|STARTED|Overall Study||50
6615278|NCT02146365|7541608|FG004|STARTED|Overall Study||24
6615279|NCT02146365|7541609|FG005|STARTED|Overall Study||25
6615280|NCT02146365|7541610|FG006|STARTED|Overall Study||25
6615281|NCT02146365|7541611|FG007|STARTED|Overall Study||25
6615282|NCT02146365|7541604|FG000|COMPLETED|Overall Study||45
6615283|NCT02146365|7541605|FG001|COMPLETED|Overall Study||45
6615284|NCT02146365|7541606|FG002|COMPLETED|Overall Study||43
6615285|NCT02146365|7541607|FG003|COMPLETED|Overall Study||41
6615286|NCT02146365|7541608|FG004|COMPLETED|Overall Study||22
6615287|NCT02146365|7541609|FG005|COMPLETED|Overall Study||24
6615288|NCT02146365|7541610|FG006|COMPLETED|Overall Study||25
6615289|NCT02146365|7541611|FG007|COMPLETED|Overall Study||24
6615290|NCT02146365|7541604|FG000|NOT COMPLETED|Overall Study||4
6615291|NCT02146365|7541605|FG001|NOT COMPLETED|Overall Study||4
6615292|NCT02146365|7541606|FG002|NOT COMPLETED|Overall Study||7
6615293|NCT02146365|7541607|FG003|NOT COMPLETED|Overall Study||9
6615294|NCT02146365|7541608|FG004|NOT COMPLETED|Overall Study||2
6615295|NCT02146365|7541609|FG005|NOT COMPLETED|Overall Study||1
6615296|NCT02146365|7541610|FG006|NOT COMPLETED|Overall Study||0
6615297|NCT02146365|7541611|FG007|NOT COMPLETED|Overall Study||1
6615298|NCT02146430|7541633|FG000|STARTED|Overall Study||323
6615299|NCT02146430|7541634|FG001|STARTED|Overall Study||323
6615300|NCT02146430|7541635|FG002|STARTED|Overall Study||324
6615301|NCT02146430|7541636|FG003|STARTED|Overall Study||323
6615302|NCT02146430|7541633|FG000|Safety Analysis Set|Overall Study||318
6615303|NCT02146430|7541634|FG001|Safety Analysis Set|Overall Study||318
6615304|NCT02146430|7541635|FG002|Safety Analysis Set|Overall Study||320
6615305|NCT02146430|7541636|FG003|Safety Analysis Set|Overall Study||320
6615306|NCT02146430|7541633|FG000|Modified Intent to Treat Set (mITT)|Overall Study||318
6615307|NCT02146430|7541634|FG001|Modified Intent to Treat Set (mITT)|Overall Study||317
6615308|NCT02146430|7541635|FG002|Modified Intent to Treat Set (mITT)|Overall Study||319
6615309|NCT02146430|7541636|FG003|Modified Intent to Treat Set (mITT)|Overall Study||319
6615310|NCT02146430|7541633|FG000|COMPLETED|Overall Study||256
6615311|NCT02146430|7541634|FG001|COMPLETED|Overall Study||236
6615312|NCT02146430|7541635|FG002|COMPLETED|Overall Study||242
6615313|NCT02146430|7541636|FG003|COMPLETED|Overall Study||224
6615314|NCT02146430|7541633|FG000|NOT COMPLETED|Overall Study||67
6615315|NCT02146430|7541634|FG001|NOT COMPLETED|Overall Study||87
6615316|NCT02146430|7541635|FG002|NOT COMPLETED|Overall Study||82
6615317|NCT02146430|7541636|FG003|NOT COMPLETED|Overall Study||99
6615318|NCT02146482|7541652|FG000|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
6615319|NCT02146482|7541653|FG001|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
6615320|NCT02146482|7541652|FG000|COMPLETED|Overall Study||21
6615321|NCT02146482|7541653|FG001|COMPLETED|Overall Study||25
6615322|NCT02146482|7541652|FG000|NOT COMPLETED|Overall Study||0
6615323|NCT02146482|7541653|FG001|NOT COMPLETED|Overall Study||0
6615324|NCT02146599|7541659|FG000|STARTED|Overall Study||301
6615325|NCT02146599|7541659|FG000|COMPLETED|Overall Study||296
6615326|NCT02146599|7541659|FG000|NOT COMPLETED|Overall Study||5
6615327|NCT02146833|7541663|FG000|STARTED|Overall Study||20
6615328|NCT02146833|7541663|FG000|COMPLETED|Overall Study||9
6615329|NCT02146833|7541663|FG000|NOT COMPLETED|Overall Study||11
6615330|NCT02147067|7541669|FG000|STARTED|Overall Study||13
6615331|NCT02147067|7541670|FG001|STARTED|Overall Study||13
6615332|NCT02147067|7541669|FG000|COMPLETED|Overall Study||11
6615333|NCT02147067|7541670|FG001|COMPLETED|Overall Study||11
6615334|NCT02147067|7541669|FG000|NOT COMPLETED|Overall Study||2
6615335|NCT02147067|7541670|FG001|NOT COMPLETED|Overall Study||2
6615336|NCT02147093|7541678|FG000|STARTED|Period 1||20
6615337|NCT02147093|7541679|FG001|STARTED|Period 1||20
6615338|NCT02147093|7541678|FG000|COMPLETED|Period 1||20
6615339|NCT02147093|7541679|FG001|COMPLETED|Period 1||19
6615340|NCT02147093|7541678|FG000|NOT COMPLETED|Period 1||0
6615341|NCT02147093|7541679|FG001|NOT COMPLETED|Period 1||1
6615342|NCT02147093|7541678|FG000|STARTED|Period 2||20
6615343|NCT02147093|7541679|FG001|STARTED|Period 2||19
6615344|NCT02147093|7541678|FG000|COMPLETED|Period 2||18
6615345|NCT02147093|7541679|FG001|COMPLETED|Period 2||19
6615346|NCT02147093|7541678|FG000|NOT COMPLETED|Period 2||2
6615347|NCT02147093|7541679|FG001|NOT COMPLETED|Period 2||0
6615348|NCT02147132|7541685|FG000|STARTED|Overall Study||2
6615349|NCT02147132|7541686|FG001|STARTED|Overall Study||2
6615350|NCT02147132|7541687|FG002|STARTED|Overall Study||1
6615351|NCT02147132|7541688|FG003|STARTED|Overall Study||2
6615352|NCT02147132|7541685|FG000|COMPLETED|Overall Study||1
6615353|NCT02147132|7541686|FG001|COMPLETED|Overall Study||2
6615354|NCT02147132|7541687|FG002|COMPLETED|Overall Study||1
6615355|NCT02147132|7541688|FG003|COMPLETED|Overall Study||2
6615356|NCT02147132|7541685|FG000|NOT COMPLETED|Overall Study||1
6615357|NCT02147132|7541686|FG001|NOT COMPLETED|Overall Study||0
6615358|NCT02147132|7541687|FG002|NOT COMPLETED|Overall Study||0
6615359|NCT02147132|7541688|FG003|NOT COMPLETED|Overall Study||0
6615360|NCT02147158|7541704|FG000|STARTED|Treatment Course 1||55
6615361|NCT02147158|7541705|FG001|STARTED|Treatment Course 1||47
6615362|NCT02147158|7541706|FG002|STARTED|Treatment Course 1||107
6615363|NCT02147158|7541707|FG003|STARTED|Treatment Course 1||110
6615364|NCT02147158|7541708|FG004|STARTED|Treatment Course 1||55
6615365|NCT02147158|7541709|FG005|STARTED|Treatment Course 1||58
6615366|NCT02147158|7541704|FG000|COMPLETED|Treatment Course 1||51
6615367|NCT02147158|7541705|FG001|COMPLETED|Treatment Course 1||38
6615368|NCT02147158|7541706|FG002|COMPLETED|Treatment Course 1||99
6615369|NCT02147158|7541707|FG003|COMPLETED|Treatment Course 1||97
6615370|NCT02147158|7541708|FG004|COMPLETED|Treatment Course 1||49
6615371|NCT02147158|7541709|FG005|COMPLETED|Treatment Course 1||50
6615372|NCT02147158|7541704|FG000|NOT COMPLETED|Treatment Course 1||4
6615373|NCT02147158|7541705|FG001|NOT COMPLETED|Treatment Course 1||9
6615374|NCT02147158|7541706|FG002|NOT COMPLETED|Treatment Course 1||8
6615375|NCT02147158|7541707|FG003|NOT COMPLETED|Treatment Course 1||13
6615376|NCT02147158|7541708|FG004|NOT COMPLETED|Treatment Course 1||6
6615377|NCT02147158|7541709|FG005|NOT COMPLETED|Treatment Course 1||8
6615378|NCT02147158|7541704|FG000|STARTED|Off-Treatment Interval 1||51
6615379|NCT02147158|7541705|FG001|STARTED|Off-Treatment Interval 1||38
6615380|NCT02147158|7541706|FG002|STARTED|Off-Treatment Interval 1||99
6615381|NCT02147158|7541707|FG003|STARTED|Off-Treatment Interval 1||97
6615382|NCT02147158|7541708|FG004|STARTED|Off-Treatment Interval 1||49
6615383|NCT02147158|7541709|FG005|STARTED|Off-Treatment Interval 1||50
6615384|NCT02147158|7541704|FG000|COMPLETED|Off-Treatment Interval 1||41
6615385|NCT02147158|7541705|FG001|COMPLETED|Off-Treatment Interval 1||34
6615386|NCT02147158|7541706|FG002|COMPLETED|Off-Treatment Interval 1||84
6615387|NCT02147158|7541707|FG003|COMPLETED|Off-Treatment Interval 1||82
6615388|NCT02147158|7541708|FG004|COMPLETED|Off-Treatment Interval 1||41
6615389|NCT02147158|7541709|FG005|COMPLETED|Off-Treatment Interval 1||45
6615390|NCT02147158|7541704|FG000|NOT COMPLETED|Off-Treatment Interval 1||10
6615391|NCT02147158|7541705|FG001|NOT COMPLETED|Off-Treatment Interval 1||4
6615392|NCT02147158|7541706|FG002|NOT COMPLETED|Off-Treatment Interval 1||15
6615393|NCT02147158|7541707|FG003|NOT COMPLETED|Off-Treatment Interval 1||15
6615394|NCT02147158|7541708|FG004|NOT COMPLETED|Off-Treatment Interval 1||8
6615395|NCT02147158|7541709|FG005|NOT COMPLETED|Off-Treatment Interval 1||5
6615396|NCT02147158|7541704|FG000|STARTED|Treatment Course 2||41
6615397|NCT02147158|7541705|FG001|STARTED|Treatment Course 2||34
6615398|NCT02147158|7541706|FG002|STARTED|Treatment Course 2||84
6615399|NCT02147158|7541707|FG003|STARTED|Treatment Course 2||82
6615400|NCT02147158|7541708|FG004|STARTED|Treatment Course 2||41
6615401|NCT02147158|7541709|FG005|STARTED|Treatment Course 2||45
6615402|NCT02147158|7541704|FG000|COMPLETED|Treatment Course 2||40
6615403|NCT02147158|7541705|FG001|COMPLETED|Treatment Course 2||29
6615404|NCT02147158|7541706|FG002|COMPLETED|Treatment Course 2||79
6615405|NCT02147158|7541707|FG003|COMPLETED|Treatment Course 2||77
6615406|NCT02147158|7541708|FG004|COMPLETED|Treatment Course 2||41
6615407|NCT02147158|7541709|FG005|COMPLETED|Treatment Course 2||43
6615408|NCT02147158|7541704|FG000|NOT COMPLETED|Treatment Course 2||1
6615409|NCT02147158|7541705|FG001|NOT COMPLETED|Treatment Course 2||5
6615410|NCT02147158|7541706|FG002|NOT COMPLETED|Treatment Course 2||5
6615411|NCT02147158|7541707|FG003|NOT COMPLETED|Treatment Course 2||5
6615412|NCT02147158|7541708|FG004|NOT COMPLETED|Treatment Course 2||0
6615413|NCT02147158|7541709|FG005|NOT COMPLETED|Treatment Course 2||2
6615414|NCT02147158|7541704|FG000|STARTED|Off-Treatment Interval 2||40
6615415|NCT02147158|7541705|FG001|STARTED|Off-Treatment Interval 2||29
6615416|NCT02147158|7541706|FG002|STARTED|Off-Treatment Interval 2||79
6615417|NCT02147158|7541707|FG003|STARTED|Off-Treatment Interval 2||77
6615418|NCT02147158|7541708|FG004|STARTED|Off-Treatment Interval 2||41
6615419|NCT02147158|7541709|FG005|STARTED|Off-Treatment Interval 2||43
6615420|NCT02147158|7541704|FG000|COMPLETED|Off-Treatment Interval 2||36
6615421|NCT02147158|7541705|FG001|COMPLETED|Off-Treatment Interval 2||25
6615422|NCT02147158|7541706|FG002|COMPLETED|Off-Treatment Interval 2||69
6615423|NCT02147158|7541707|FG003|COMPLETED|Off-Treatment Interval 2||66
6615424|NCT02147158|7541708|FG004|COMPLETED|Off-Treatment Interval 2||39
6615425|NCT02147158|7541709|FG005|COMPLETED|Off-Treatment Interval 2||39
6615426|NCT02147158|7541704|FG000|NOT COMPLETED|Off-Treatment Interval 2||4
6615427|NCT02147158|7541705|FG001|NOT COMPLETED|Off-Treatment Interval 2||4
6615428|NCT02147158|7541706|FG002|NOT COMPLETED|Off-Treatment Interval 2||10
6615429|NCT02147158|7541707|FG003|NOT COMPLETED|Off-Treatment Interval 2||11
6615430|NCT02147158|7541708|FG004|NOT COMPLETED|Off-Treatment Interval 2||2
6615431|NCT02147158|7541709|FG005|NOT COMPLETED|Off-Treatment Interval 2||4
6615432|NCT02147197|7541729|FG000|STARTED|Overall Study||56
6615433|NCT02147197|7541730|FG001|STARTED|Overall Study||53
6615434|NCT02147197|7541731|FG002|STARTED|Overall Study||48
6615435|NCT02147197|7541729|FG000|COMPLETED|Overall Study||47
6615436|NCT02147197|7541730|FG001|COMPLETED|Overall Study||47
6615437|NCT02147197|7541731|FG002|COMPLETED|Overall Study||39
6615438|NCT02147197|7541729|FG000|NOT COMPLETED|Overall Study||9
6615439|NCT02147197|7541730|FG001|NOT COMPLETED|Overall Study||6
6615440|NCT02147197|7541731|FG002|NOT COMPLETED|Overall Study||9
6615441|NCT02147288|7541741|FG000|STARTED|Overall Study||22
6615442|NCT02147288|7541742|FG001|STARTED|Overall Study||24
6615443|NCT02147288|7541743|FG002|STARTED|Overall Study||0
6615444|NCT02147288|7541744|FG003|STARTED|Overall Study||0
6615445|NCT02147288|7541745|FG004|STARTED|Overall Study||0
6615446|NCT02147288|7541746|FG005|STARTED|Overall Study||0
6615447|NCT02147288|7541747|FG006|STARTED|Overall Study||0
6615448|NCT02147288|7541748|FG007|STARTED|Overall Study||0
6615449|NCT02147288|7541749|FG008|STARTED|Overall Study||0
6615450|NCT02147288|7541750|FG009|STARTED|Overall Study||0
6615451|NCT02147288|7541741|FG000|COMPLETED|Overall Study||21
6615452|NCT02147288|7541742|FG001|COMPLETED|Overall Study||22
6615453|NCT02147288|7541743|FG002|COMPLETED|Overall Study||0
6615454|NCT02147288|7541744|FG003|COMPLETED|Overall Study||0
6615455|NCT02147288|7541745|FG004|COMPLETED|Overall Study||0
6615456|NCT02147288|7541746|FG005|COMPLETED|Overall Study||0
6615457|NCT02147288|7541747|FG006|COMPLETED|Overall Study||0
6615458|NCT02147288|7541748|FG007|COMPLETED|Overall Study||0
6615459|NCT02147288|7541749|FG008|COMPLETED|Overall Study||0
6615460|NCT02147288|7541750|FG009|COMPLETED|Overall Study||0
6615461|NCT02147288|7541741|FG000|NOT COMPLETED|Overall Study||1
6615462|NCT02147288|7541742|FG001|NOT COMPLETED|Overall Study||2
6615463|NCT02147288|7541743|FG002|NOT COMPLETED|Overall Study||0
6615464|NCT02147288|7541744|FG003|NOT COMPLETED|Overall Study||0
6615465|NCT02147288|7541745|FG004|NOT COMPLETED|Overall Study||0
6615466|NCT02147288|7541746|FG005|NOT COMPLETED|Overall Study||0
6615467|NCT02147288|7541747|FG006|NOT COMPLETED|Overall Study||0
6615468|NCT02147288|7541748|FG007|NOT COMPLETED|Overall Study||0
6615469|NCT02147288|7541749|FG008|NOT COMPLETED|Overall Study||0
6615470|NCT02147288|7541750|FG009|NOT COMPLETED|Overall Study||0
6615471|NCT02147301|7541756|FG000|STARTED|Overall Study||17
6615472|NCT02147301|7541756|FG000|COMPLETED|Overall Study||17
6615473|NCT02147301|7541756|FG000|NOT COMPLETED|Overall Study||0
6615474|NCT02147353|7541762|FG000|STARTED|Overall Study||21
6615475|NCT02147353|7541763|FG001|STARTED|Overall Study||21
6615476|NCT02147353|7541762|FG000|COMPLETED|Overall Study||12
6615477|NCT02147353|7541763|FG001|COMPLETED|Overall Study||21
6615478|NCT02147353|7541762|FG000|NOT COMPLETED|Overall Study||9
6615479|NCT02147353|7541763|FG001|NOT COMPLETED|Overall Study||0
6615480|NCT02147522|7541771|FG000|STARTED|Overall Study||178
6615481|NCT02147522|7541772|FG001|STARTED|Overall Study||170
6615482|NCT02147522|7541771|FG000|COMPLETED|Overall Study||122
6615483|NCT02147522|7541772|FG001|COMPLETED|Overall Study||122
6615484|NCT02147522|7541771|FG000|NOT COMPLETED|Overall Study||56
6615485|NCT02147522|7541772|FG001|NOT COMPLETED|Overall Study||48
6615486|NCT02147561|7541778|FG000|STARTED|Overall Study||280
6615487|NCT02147561|7541778|FG000|COMPLETED|Overall Study||276
6615488|NCT02147561|7541778|FG000|NOT COMPLETED|Overall Study||4
6615489|NCT02147587|7541784|FG000|STARTED|Overall Study||57
6615490|NCT02147587|7541785|FG001|STARTED|Overall Study||55
6615491|NCT02147587|7541784|FG000|COMPLETED|Overall Study||46
6615492|NCT02147587|7541785|FG001|COMPLETED|Overall Study||50
6615493|NCT02147587|7541784|FG000|NOT COMPLETED|Overall Study||11
6615494|NCT02147587|7541785|FG001|NOT COMPLETED|Overall Study||5
6615495|NCT02147613|7541793|FG000|STARTED|Overall Study||10
6615496|NCT02147613|7541794|FG001|STARTED|Overall Study||9
6615497|NCT02147613|7541793|FG000|COMPLETED|Overall Study||9
6615498|NCT02147613|7541794|FG001|COMPLETED|Overall Study||6
6615499|NCT02147613|7541793|FG000|NOT COMPLETED|Overall Study||1
6615500|NCT02147613|7541794|FG001|NOT COMPLETED|Overall Study||3
6615501|NCT02147626|7541802|FG000|STARTED|Overall Study||75
6615502|NCT02147626|7541803|FG001|STARTED|Overall Study||76
6615503|NCT02147626|7541802|FG000|COMPLETED|Overall Study||70
6615504|NCT02147626|7541803|FG001|COMPLETED|Overall Study||69
6615505|NCT02147626|7541802|FG000|NOT COMPLETED|Overall Study||5
6615506|NCT02147626|7541803|FG001|NOT COMPLETED|Overall Study||7
6615507|NCT02147691|7541811|FG000|STARTED|Overall Study||10
6615508|NCT02147691|7541812|FG001|STARTED|Overall Study||12
6615509|NCT02147691|7541811|FG000|COMPLETED|Overall Study||6
6615510|NCT02147691|7541812|FG001|COMPLETED|Overall Study||11
6615511|NCT02147691|7541811|FG000|NOT COMPLETED|Overall Study||4
6615512|NCT02147691|7541812|FG001|NOT COMPLETED|Overall Study||1
6615513|NCT02147769|7541818|FG000|STARTED|Overall Study||111
6615514|NCT02147769|7541818|FG000|COMPLETED|Overall Study||111
6615515|NCT02147769|7541818|FG000|NOT COMPLETED|Overall Study||0
6615516|NCT02147899|7541825|FG000|STARTED|Overall Study||71
6615517|NCT02147899|7541826|FG001|STARTED|Overall Study||72
6615518|NCT02147899|7541827|FG002|STARTED|Overall Study||72
6615519|NCT02147899|7541825|FG000|COMPLETED|Overall Study||71
6615520|NCT02147899|7541826|FG001|COMPLETED|Overall Study||72
6615521|NCT02147899|7541827|FG002|COMPLETED|Overall Study||72
6615522|NCT02147899|7541825|FG000|NOT COMPLETED|Overall Study||0
6615523|NCT02147899|7541826|FG001|NOT COMPLETED|Overall Study||0
6615524|NCT02147899|7541827|FG002|NOT COMPLETED|Overall Study||0
6615525|NCT02147990|7541838|FG000|STARTED|Overall Study||154
6615526|NCT02147990|7541839|FG001|STARTED|Overall Study||100
6615527|NCT02147990|7541840|FG002|STARTED|Overall Study||63
6615528|NCT02147990|7541838|FG000|COMPLETED|Overall Study||154
6615529|NCT02147990|7541839|FG001|COMPLETED|Overall Study||100
6615530|NCT02147990|7541840|FG002|COMPLETED|Overall Study||63
6615531|NCT02147990|7541838|FG000|NOT COMPLETED|Overall Study||0
6615532|NCT02147990|7541839|FG001|NOT COMPLETED|Overall Study||0
6615533|NCT02147990|7541840|FG002|NOT COMPLETED|Overall Study||0
6615534|NCT02148107|7541852|FG000|STARTED|Overall Study||8
6615535|NCT02148107|7541853|FG001|STARTED|Overall Study||7
6615536|NCT02148107|7541854|FG002|STARTED|Overall Study||3
6615537|NCT02148107|7541852|FG000|COMPLETED|Overall Study||8
6615538|NCT02148107|7541853|FG001|COMPLETED|Overall Study||7
6615539|NCT02148107|7541854|FG002|COMPLETED|Overall Study||3
6615540|NCT02148107|7541852|FG000|NOT COMPLETED|Overall Study||0
6615541|NCT02148107|7541853|FG001|NOT COMPLETED|Overall Study||0
6615542|NCT02148107|7541854|FG002|NOT COMPLETED|Overall Study||0
6615543|NCT02148211|7541862|FG000|STARTED|Overall Study||507
6615544|NCT02148211|7541862|FG000|COMPLETED|Overall Study||155
6615545|NCT02148211|7541862|FG000|NOT COMPLETED|Overall Study||352
6615546|NCT02148250|7541866|FG000|STARTED|Screening||17
6615547|NCT02148250|7541867|FG001|STARTED|Screening||0
6615548|NCT02148250|7541866|FG000|COMPLETED|Screening||12
6615549|NCT02148250|7541867|FG001|COMPLETED|Screening||0
6615550|NCT02148250|7541866|FG000|NOT COMPLETED|Screening||5
6615551|NCT02148250|7541867|FG001|NOT COMPLETED|Screening||0
6615552|NCT02148250|7541866|FG000|STARTED|Period 1||6
6615553|NCT02148250|7541867|FG001|STARTED|Period 1||6
6615554|NCT02148250|7541866|FG000|COMPLETED|Period 1||6
6615555|NCT02148250|7541867|FG001|COMPLETED|Period 1||6
6615556|NCT02148250|7541866|FG000|NOT COMPLETED|Period 1||0
6615557|NCT02148250|7541867|FG001|NOT COMPLETED|Period 1||0
6615558|NCT02148250|7541866|FG000|STARTED|Period 2||6
6615559|NCT02148250|7541867|FG001|STARTED|Period 2||6
6615560|NCT02148250|7541866|FG000|COMPLETED|Period 2||6
6615561|NCT02148250|7541867|FG001|COMPLETED|Period 2||6
6615562|NCT02148250|7541866|FG000|NOT COMPLETED|Period 2||0
6615563|NCT02148250|7541867|FG001|NOT COMPLETED|Period 2||0
6615564|NCT02148302|7541876|FG000|STARTED|Overall Study||57
6615565|NCT02148302|7541877|FG001|STARTED|Overall Study||66
6615566|NCT02148302|7541876|FG000|COMPLETED|Overall Study||57
6615567|NCT02148302|7541877|FG001|COMPLETED|Overall Study||66
6615568|NCT02148302|7541876|FG000|NOT COMPLETED|Overall Study||0
6615569|NCT02148302|7541877|FG001|NOT COMPLETED|Overall Study||0
6615570|NCT02148445|7541885|FG000|STARTED|Overall Study||198
6615571|NCT02148445|7541886|FG001|STARTED|Overall Study||200
6615572|NCT02148445|7541885|FG000|COMPLETED|Overall Study||197
6615573|NCT02148445|7541886|FG001|COMPLETED|Overall Study||197
6615574|NCT02148445|7541885|FG000|NOT COMPLETED|Overall Study||1
6615575|NCT02148445|7541886|FG001|NOT COMPLETED|Overall Study||3
6615576|NCT02148523|7541897|FG000|STARTED|Overall Study||67
6615577|NCT02148523|7541898|FG001|STARTED|Overall Study||67
6615578|NCT02148523|7541899|FG002|STARTED|Overall Study||67
6615579|NCT02148523|7541897|FG000|COMPLETED|Overall Study||67
6615580|NCT02148523|7541898|FG001|COMPLETED|Overall Study||67
6615581|NCT02148523|7541899|FG002|COMPLETED|Overall Study||67
6615582|NCT02148523|7541897|FG000|NOT COMPLETED|Overall Study||0
6615583|NCT02148523|7541898|FG001|NOT COMPLETED|Overall Study||0
6615584|NCT02148523|7541899|FG002|NOT COMPLETED|Overall Study||0
6615585|NCT02148588|7541907|FG000|STARTED|Overall Study||8
6615586|NCT02148588|7541907|FG000|COMPLETED|Overall Study||8
6615587|NCT02148588|7541907|FG000|NOT COMPLETED|Overall Study||0
6615588|NCT02148718|7541911|FG000|STARTED|Overall Study||86
6615589|NCT02148718|7541911|FG000|COMPLETED|Overall Study||55
6615590|NCT02148718|7541911|FG000|NOT COMPLETED|Overall Study||31
6615591|NCT02148809|7541915|FG000|STARTED|Overall Study||14
6615592|NCT02148809|7541915|FG000|COMPLETED|Overall Study||14
6615593|NCT02148809|7541915|FG000|NOT COMPLETED|Overall Study||0
6615594|NCT02148835|7541922|FG000|STARTED|Overall Study||22
6615595|NCT02148835|7541923|FG001|STARTED|Overall Study||22
6615596|NCT02148835|7541922|FG000|COMPLETED|Overall Study||22
6615597|NCT02148835|7541923|FG001|COMPLETED|Overall Study||22
6615598|NCT02148835|7541922|FG000|NOT COMPLETED|Overall Study||0
6615599|NCT02148835|7541923|FG001|NOT COMPLETED|Overall Study||0
6615600|NCT02148874|7541931|FG000|STARTED|Overall Study||201
6615601|NCT02148874|7541932|FG001|STARTED|Overall Study||86
6615602|NCT02148874|7541931|FG000|COMPLETED|Overall Study||194
6615603|NCT02148874|7541932|FG001|COMPLETED|Overall Study||84
6615604|NCT02148874|7541931|FG000|NOT COMPLETED|Overall Study||7
6615605|NCT02148874|7541932|FG001|NOT COMPLETED|Overall Study||2
6615606|NCT02148952|7541940|FG000|STARTED|Assessing Eligibility and Consent||83166
6615607|NCT02148952|7541941|FG001|STARTED|Assessing Eligibility and Consent||80773
6615608|NCT02148952|7541940|FG000|COMPLETED|Assessing Eligibility and Consent||80063
6615609|NCT02148952|7541941|FG001|COMPLETED|Assessing Eligibility and Consent||77626
6615610|NCT02148952|7541940|FG000|NOT COMPLETED|Assessing Eligibility and Consent||3103
6615611|NCT02148952|7541941|FG001|NOT COMPLETED|Assessing Eligibility and Consent||3147
6615612|NCT02148952|7541940|FG000|STARTED|Follow-Up||80063
6615613|NCT02148952|7541941|FG001|STARTED|Follow-Up||77626
6615614|NCT02148952|7541940|FG000|COMPLETED|Follow-Up||79798
6615615|NCT02148952|7541941|FG001|COMPLETED|Follow-Up||77347
6615616|NCT02148952|7541940|FG000|NOT COMPLETED|Follow-Up||265
6615617|NCT02148952|7541941|FG001|NOT COMPLETED|Follow-Up||279
6615618|NCT02149108|7541957|FG000|STARTED|Overall Study|Randomised patients.|382
6615619|NCT02149108|7541958|FG001|STARTED|Overall Study|Randomised patients.|386
6615620|NCT02149108|7541957|FG000|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
6615621|NCT02149108|7541958|FG001|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
6615622|NCT02149108|7541957|FG000|NOT COMPLETED|Overall Study||380
6615623|NCT02149108|7541958|FG001|NOT COMPLETED|Overall Study||383
6615624|NCT02149173|7541964|FG000|STARTED|Overall Study||29
6615625|NCT02149173|7541964|FG000|COMPLETED|Overall Study||29
6615626|NCT02149173|7541964|FG000|NOT COMPLETED|Overall Study||0
6615627|NCT02149199|7541977|FG000|STARTED|Overall Study||1277
6615628|NCT02149199|7541978|FG001|STARTED|Overall Study||1277
6615629|NCT02149199|7541979|FG002|STARTED|Overall Study||1282
6615630|NCT02149199|7541977|FG000|COMPLETED|Overall Study||1144
6615631|NCT02149199|7541978|FG001|COMPLETED|Overall Study||1084
6615632|NCT02149199|7541979|FG002|COMPLETED|Overall Study||1135
6615633|NCT02149199|7541977|FG000|NOT COMPLETED|Overall Study||133
6615634|NCT02149199|7541978|FG001|NOT COMPLETED|Overall Study||193
6615635|NCT02149199|7541979|FG002|NOT COMPLETED|Overall Study||147
6615636|NCT02149264|7541987|FG000|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
6615637|NCT02149264|7541987|FG000|COMPLETED|Overall Study||139
6615638|NCT02149264|7541987|FG000|NOT COMPLETED|Overall Study||20
6615639|NCT02149290|7541991|FG000|STARTED|Overall Study||198
6615640|NCT02149290|7541991|FG000|COMPLETED|Overall Study||198
6615641|NCT02149290|7541991|FG000|NOT COMPLETED|Overall Study||0
6615642|NCT02149303|7541997|FG000|STARTED|Overall Study||191
6615643|NCT02149303|7541997|FG000|COMPLETED|Overall Study||191
6615644|NCT02149303|7541997|FG000|NOT COMPLETED|Overall Study||0
6615645|NCT02149342|7542001|FG000|STARTED|Overall Study|14 patients|14
6615646|NCT02149342|7542001|FG000|COMPLETED|Overall Study|14 patients|14
6615647|NCT02149342|7542001|FG000|NOT COMPLETED|Overall Study||0
6615648|NCT02149420|7542011|FG000|STARTED|Core Study||9
6615649|NCT02149420|7542012|FG001|STARTED|Core Study||6
6615650|NCT02149420|7542013|FG002|STARTED|Core Study||12
6615651|NCT02149420|7542011|FG000|Safety Analysis Set|Core Study||9
6615652|NCT02149420|7542012|FG001|Safety Analysis Set|Core Study||6
6615653|NCT02149420|7542013|FG002|Safety Analysis Set|Core Study||12
6615654|NCT02149420|7542011|FG000|PK Analysis Set|Core Study|for patients entering open label VAY736 10 mg/kg at Week 24|5
6615655|NCT02149420|7542012|FG001|PK Analysis Set|Core Study||6
6615656|NCT02149420|7542013|FG002|PK Analysis Set|Core Study||12
6615657|NCT02149420|7542011|FG000|PD (Pharmacodynamics) Analysis Set|Core Study||9
6615658|NCT02149420|7542012|FG001|PD (Pharmacodynamics) Analysis Set|Core Study||6
6615659|NCT02149420|7542013|FG002|PD (Pharmacodynamics) Analysis Set|Core Study||12
6615660|NCT02149420|7542011|FG000|COMPLETED|Core Study||9
6615661|NCT02149420|7542012|FG001|COMPLETED|Core Study||5
6615662|NCT02149420|7542013|FG002|COMPLETED|Core Study||10
6615663|NCT02149420|7542011|FG000|NOT COMPLETED|Core Study||0
6615664|NCT02149420|7542012|FG001|NOT COMPLETED|Core Study||1
6615665|NCT02149420|7542013|FG002|NOT COMPLETED|Core Study||2
6615666|NCT02149420|7542011|FG000|STARTED|Open Label VAY736 10 mg/kg Extension|Patients received single dose of VAY736 10mg/kg at Week 24.|5
6615667|NCT02149420|7542012|FG001|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
6615668|NCT02149420|7542013|FG002|STARTED|Open Label VAY736 10 mg/kg Extension|Only patients origianally randomized to Placebo were allowed to enter this Period.|0
6615669|NCT02149420|7542011|FG000|COMPLETED|Open Label VAY736 10 mg/kg Extension||4
6615670|NCT02149420|7542012|FG001|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
6615671|NCT02149420|7542013|FG002|COMPLETED|Open Label VAY736 10 mg/kg Extension||0
6615672|NCT02149420|7542011|FG000|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||1
6615673|NCT02149420|7542012|FG001|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
6615674|NCT02149420|7542013|FG002|NOT COMPLETED|Open Label VAY736 10 mg/kg Extension||0
6615675|NCT02149524|7542028|FG000|STARTED|Overall Study||438
6615676|NCT02149524|7542029|FG001|STARTED|Overall Study||437
6615677|NCT02149524|7542028|FG000|COMPLETED|Overall Study||384
6615678|NCT02149524|7542029|FG001|COMPLETED|Overall Study||380
6615679|NCT02149524|7542028|FG000|NOT COMPLETED|Overall Study||54
6615680|NCT02149524|7542029|FG001|NOT COMPLETED|Overall Study||57
6615681|NCT02149810|7542037|FG000|STARTED|Overall Study||48
6615682|NCT02149810|7542038|FG001|STARTED|Overall Study||47
6615683|NCT02149810|7542037|FG000|Baseline|Overall Study||47
6615684|NCT02149810|7542038|FG001|Baseline|Overall Study||44
6615685|NCT02149810|7542037|FG000|Week 4|Overall Study||43
6615686|NCT02149810|7542038|FG001|Week 4|Overall Study||42
6615687|NCT02149810|7542037|FG000|Week 8|Overall Study||40
6615688|NCT02149810|7542038|FG001|Week 8|Overall Study||43
6615689|NCT02149810|7542037|FG000|Week 12|Overall Study||40
6615690|NCT02149810|7542038|FG001|Week 12|Overall Study||43
6615691|NCT02149810|7542037|FG000|Week 24|Overall Study||31
6615692|NCT02149810|7542038|FG001|Week 24|Overall Study|Not applicable study was amended such that week 24 data was not collected for TAU participants.|0
6615693|NCT02149810|7542037|FG000|COMPLETED|Overall Study||40
6615694|NCT02149810|7542038|FG001|COMPLETED|Overall Study||43
6615695|NCT02149810|7542037|FG000|NOT COMPLETED|Overall Study||8
6615696|NCT02149810|7542038|FG001|NOT COMPLETED|Overall Study||4
6615697|NCT02149836|7542044|FG000|STARTED|Overall Study||18
6615698|NCT02149836|7542044|FG000|COMPLETED|Overall Study||17
6615699|NCT02149836|7542044|FG000|NOT COMPLETED|Overall Study||1
6615700|NCT02149875|7542051|FG000|STARTED|Overall Study||27
6615701|NCT02149875|7542052|FG001|STARTED|Overall Study||28
6615702|NCT02149875|7542053|FG002|STARTED|Overall Study||29
6615703|NCT02149875|7542051|FG000|COMPLETED|Overall Study||20
6615704|NCT02149875|7542052|FG001|COMPLETED|Overall Study||20
6615705|NCT02149875|7542053|FG002|COMPLETED|Overall Study||20
6615706|NCT02149875|7542051|FG000|NOT COMPLETED|Overall Study||7
6615707|NCT02149875|7542052|FG001|NOT COMPLETED|Overall Study||8
6615708|NCT02149875|7542053|FG002|NOT COMPLETED|Overall Study||9
6615709|NCT02150044|7542061|FG000|STARTED|Overall Study||29
6615710|NCT02150044|7542061|FG000|Lead-In Subjects|Overall Study||16
6615711|NCT02150044|7542061|FG000|Study Cohort|Overall Study||13
6615712|NCT02150044|7542061|FG000|COMPLETED|Overall Study||29
6615713|NCT02150044|7542061|FG000|NOT COMPLETED|Overall Study||0
6615714|NCT02150057|7542067|FG000|STARTED|Overall Study||25
6615715|NCT02150057|7542068|FG001|STARTED|Overall Study||26
6615716|NCT02150057|7542067|FG000|COMPLETED|Overall Study||19
6615717|NCT02150057|7542068|FG001|COMPLETED|Overall Study||22
6615718|NCT02150057|7542067|FG000|NOT COMPLETED|Overall Study||6
6615719|NCT02150057|7542068|FG001|NOT COMPLETED|Overall Study||4
6615720|NCT02150109|7542074|FG000|STARTED|Overall Study||372
6615721|NCT02150109|7542074|FG000|COMPLETED|Overall Study||372
6615722|NCT02150109|7542074|FG000|NOT COMPLETED|Overall Study||0
6615723|NCT02150213|7542084|FG000|STARTED|Overall Study||59
6615724|NCT02150213|7542084|FG000|COMPLETED|Overall Study||57
6615725|NCT02150213|7542084|FG000|NOT COMPLETED|Overall Study||2
6615726|NCT02150343|7542092|FG000|STARTED|Overall Study||180
6615727|NCT02150343|7542093|FG001|STARTED|Overall Study||178
6615728|NCT02150343|7542094|FG002|STARTED|Overall Study||178
6615729|NCT02150343|7542095|FG003|STARTED|Overall Study||178
6615730|NCT02150343|7542092|FG000|COMPLETED|Overall Study||159
6615731|NCT02150343|7542093|FG001|COMPLETED|Overall Study||158
6615732|NCT02150343|7542094|FG002|COMPLETED|Overall Study||166
6615733|NCT02150343|7542095|FG003|COMPLETED|Overall Study||168
6615734|NCT02150343|7542092|FG000|NOT COMPLETED|Overall Study||21
6615735|NCT02150343|7542093|FG001|NOT COMPLETED|Overall Study||20
6615736|NCT02150343|7542094|FG002|NOT COMPLETED|Overall Study||12
6615737|NCT02150343|7542095|FG003|NOT COMPLETED|Overall Study||10
6615738|NCT02150460|7542107|FG000|STARTED|Overall Study||50
6615739|NCT02150460|7542108|FG001|STARTED|Overall Study||50
6615740|NCT02150460|7542107|FG000|COMPLETED|Overall Study||50
6615741|NCT02150460|7542108|FG001|COMPLETED|Overall Study||50
6615742|NCT02150460|7542107|FG000|NOT COMPLETED|Overall Study||0
6615743|NCT02150460|7542108|FG001|NOT COMPLETED|Overall Study||0
6615744|NCT02150499|7542116|FG000|STARTED|Overall Study||9
6615745|NCT02150499|7542117|FG001|STARTED|Overall Study||9
6615746|NCT02150499|7542116|FG000|COMPLETED|Overall Study||9
6615747|NCT02150499|7542117|FG001|COMPLETED|Overall Study||9
6615748|NCT02150499|7542116|FG000|NOT COMPLETED|Overall Study||0
6615749|NCT02150499|7542117|FG001|NOT COMPLETED|Overall Study||0
6615750|NCT02150759|7542125|FG000|STARTED|Overall Study||23
6615751|NCT02150759|7542126|FG001|STARTED|Overall Study||23
6615752|NCT02150759|7542125|FG000|COMPLETED|Overall Study||22
6615753|NCT02150759|7542126|FG001|COMPLETED|Overall Study||21
6615754|NCT02150759|7542125|FG000|NOT COMPLETED|Overall Study||1
6615755|NCT02150759|7542126|FG001|NOT COMPLETED|Overall Study||2
6615756|NCT02150837|7542134|FG000|STARTED|Overall Study|87 Charts were screened with 25 screen failures due to exclusion criteria.|62
6615757|NCT02150837|7542135|FG001|STARTED|Overall Study|478 charts were screened with 168 screen failures due to exclusion criteria.|310
6615758|NCT02150837|7542134|FG000|COMPLETED|Overall Study|There was no predefined study period to complete. 37 remained through the 12 wk primary endpoint.|37
6615759|NCT02150837|7542135|FG001|COMPLETED|Overall Study|There was no predefined study period to complete. 185 remained through the 12 wk primary endpoint.|185
6615760|NCT02150837|7542134|FG000|NOT COMPLETED|Overall Study||25
6615761|NCT02150837|7542135|FG001|NOT COMPLETED|Overall Study||125
6615762|NCT02150954|7542143|FG000|STARTED|Overall Study||58
6615763|NCT02150954|7542144|FG001|STARTED|Overall Study||59
6615764|NCT02150954|7542143|FG000|COMPLETED|Overall Study||57
6615765|NCT02150954|7542144|FG001|COMPLETED|Overall Study||59
6615766|NCT02150954|7542143|FG000|NOT COMPLETED|Overall Study||1
6615767|NCT02150954|7542144|FG001|NOT COMPLETED|Overall Study||0
6615768|NCT02151058|7542153|FG000|STARTED|Overall Study||45
6615769|NCT02151058|7542154|FG001|STARTED|Overall Study||91
6615770|NCT02151058|7542155|FG002|STARTED|Overall Study||91
6615771|NCT02151058|7542153|FG000|COMPLETED|Overall Study||43
6615772|NCT02151058|7542154|FG001|COMPLETED|Overall Study||90
6615773|NCT02151058|7542155|FG002|COMPLETED|Overall Study||86
6615774|NCT02151058|7542153|FG000|NOT COMPLETED|Overall Study||2
6615775|NCT02151058|7542154|FG001|NOT COMPLETED|Overall Study||1
6615776|NCT02151058|7542155|FG002|NOT COMPLETED|Overall Study||5
6615777|NCT02151110|7542171|FG000|STARTED|Overall Study||12
6615778|NCT02151110|7542172|FG001|STARTED|Overall Study||2
6615779|NCT02151110|7542173|FG002|STARTED|Overall Study||2
6615780|NCT02151110|7542174|FG003|STARTED|Overall Study||8
6615781|NCT02151110|7542175|FG004|STARTED|Overall Study||8
6615782|NCT02151110|7542176|FG005|STARTED|Overall Study||8
6615783|NCT02151110|7542177|FG006|STARTED|Overall Study||8
6615784|NCT02151110|7542178|FG007|STARTED|Overall Study||8
6615785|NCT02151110|7542171|FG000|COMPLETED|Overall Study||12
6615786|NCT02151110|7542172|FG001|COMPLETED|Overall Study||2
6615787|NCT02151110|7542173|FG002|COMPLETED|Overall Study||2
6615788|NCT02151110|7542174|FG003|COMPLETED|Overall Study||8
6615789|NCT02151110|7542175|FG004|COMPLETED|Overall Study||8
6615790|NCT02151110|7542176|FG005|COMPLETED|Overall Study||8
6615791|NCT02151110|7542177|FG006|COMPLETED|Overall Study||8
6615792|NCT02151110|7542178|FG007|COMPLETED|Overall Study||5
6615793|NCT02151110|7542171|FG000|NOT COMPLETED|Overall Study||0
6615794|NCT02151110|7542172|FG001|NOT COMPLETED|Overall Study||0
6615795|NCT02151110|7542173|FG002|NOT COMPLETED|Overall Study||0
6615796|NCT02151110|7542174|FG003|NOT COMPLETED|Overall Study||0
6615797|NCT02151110|7542175|FG004|NOT COMPLETED|Overall Study||0
6615798|NCT02151110|7542176|FG005|NOT COMPLETED|Overall Study||0
6615799|NCT02151110|7542177|FG006|NOT COMPLETED|Overall Study||0
6615800|NCT02151110|7542178|FG007|NOT COMPLETED|Overall Study||3
6615801|NCT02151149|7542205|FG000|STARTED|Treatment Period|3 participants did not receive treatment|71
6615802|NCT02151149|7542206|FG001|STARTED|Treatment Period|2 participants did not receive treatment|72
6615803|NCT02151149|7542205|FG000|Treated Population|Treatment Period||68
6615804|NCT02151149|7542206|FG001|Treated Population|Treatment Period||70
6615805|NCT02151149|7542205|FG000|COMPLETED|Treatment Period||1
6615806|NCT02151149|7542206|FG001|COMPLETED|Treatment Period||1
6615807|NCT02151149|7542205|FG000|NOT COMPLETED|Treatment Period||70
6615808|NCT02151149|7542206|FG001|NOT COMPLETED|Treatment Period||71
6615809|NCT02151149|7542205|FG000|STARTED|Follow-Up Period||58
6615810|NCT02151149|7542206|FG001|STARTED|Follow-Up Period||55
6615811|NCT02151149|7542205|FG000|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|19
6615812|NCT02151149|7542206|FG001|COMPLETED|Follow-Up Period|Completed = participants alive at final data cut-off date|18
6615813|NCT02151149|7542205|FG000|NOT COMPLETED|Follow-Up Period||39
6615814|NCT02151149|7542206|FG001|NOT COMPLETED|Follow-Up Period||37
6615815|NCT02151253|7542212|FG000|STARTED|Overall Study||13
6615816|NCT02151253|7542213|FG001|STARTED|Overall Study||15
6615817|NCT02151253|7542212|FG000|COMPLETED|Overall Study||13
6615818|NCT02151253|7542213|FG001|COMPLETED|Overall Study||15
6615819|NCT02151253|7542212|FG000|NOT COMPLETED|Overall Study||0
6615820|NCT02151253|7542213|FG001|NOT COMPLETED|Overall Study||0
6615821|NCT02151266|7542222|FG000|STARTED|Overall Study||19
6615822|NCT02151266|7542223|FG001|STARTED|Overall Study||29
6615823|NCT02151266|7542224|FG002|STARTED|Overall Study||21
6615824|NCT02151266|7542222|FG000|COMPLETED|Overall Study||11
6615825|NCT02151266|7542223|FG001|COMPLETED|Overall Study||14
6615826|NCT02151266|7542224|FG002|COMPLETED|Overall Study||14
6615827|NCT02151266|7542222|FG000|NOT COMPLETED|Overall Study||8
6615828|NCT02151266|7542223|FG001|NOT COMPLETED|Overall Study||15
6615829|NCT02151266|7542224|FG002|NOT COMPLETED|Overall Study||7
6615830|NCT02151331|7542234|FG000|STARTED|Overall Study||77
6615831|NCT02151331|7542235|FG001|STARTED|Overall Study||92
6615832|NCT02151331|7542234|FG000|COMPLETED|Overall Study||45
6615833|NCT02151331|7542235|FG001|COMPLETED|Overall Study||52
6615834|NCT02151331|7542234|FG000|NOT COMPLETED|Overall Study||32
6615835|NCT02151331|7542235|FG001|NOT COMPLETED|Overall Study||40
6615836|NCT02151448|7542241|FG000|STARTED|Phase 1||9
6615837|NCT02151448|7542241|FG000|COMPLETED|Phase 1||9
6615838|NCT02151448|7542241|FG000|NOT COMPLETED|Phase 1||0
6615839|NCT02151448|7542241|FG000|STARTED|Phase 2||55
6615840|NCT02151448|7542241|FG000|COMPLETED|Phase 2||55
6615841|NCT02151448|7542241|FG000|NOT COMPLETED|Phase 2||0
6615842|NCT02151461|7542253|FG000|STARTED|Overall Study||24
6615843|NCT02151461|7542254|FG001|STARTED|Overall Study||25
6615844|NCT02151461|7542255|FG002|STARTED|Overall Study||24
6615845|NCT02151461|7542256|FG003|STARTED|Overall Study||23
6615846|NCT02151461|7542253|FG000|COMPLETED|Overall Study||18
6615847|NCT02151461|7542254|FG001|COMPLETED|Overall Study||24
6615848|NCT02151461|7542255|FG002|COMPLETED|Overall Study||21
6615849|NCT02151461|7542256|FG003|COMPLETED|Overall Study||19
6615850|NCT02151461|7542253|FG000|NOT COMPLETED|Overall Study||6
6615851|NCT02151461|7542254|FG001|NOT COMPLETED|Overall Study||1
6615852|NCT02151461|7542255|FG002|NOT COMPLETED|Overall Study||3
6615853|NCT02151461|7542256|FG003|NOT COMPLETED|Overall Study||4
6615854|NCT02151487|7542270|FG000|STARTED|Overall Study||27
6615855|NCT02151487|7542271|FG001|STARTED|Overall Study||27
6615856|NCT02151487|7542272|FG002|STARTED|Overall Study||20
6615857|NCT02151487|7542273|FG003|STARTED|Overall Study||23
6615858|NCT02151487|7542270|FG000|COMPLETED|Overall Study||25
6615859|NCT02151487|7542271|FG001|COMPLETED|Overall Study||22
6615860|NCT02151487|7542272|FG002|COMPLETED|Overall Study||16
6615861|NCT02151487|7542273|FG003|COMPLETED|Overall Study||20
6615862|NCT02151487|7542270|FG000|NOT COMPLETED|Overall Study||2
6615863|NCT02151487|7542271|FG001|NOT COMPLETED|Overall Study||5
6615864|NCT02151487|7542272|FG002|NOT COMPLETED|Overall Study||4
6615865|NCT02151487|7542273|FG003|NOT COMPLETED|Overall Study||3
6615866|NCT02151591|7542285|FG000|STARTED|Overall Study||13
6615867|NCT02151591|7542286|FG001|STARTED|Overall Study||13
6615868|NCT02151591|7542285|FG000|COMPLETED|Overall Study||7
6615869|NCT02151591|7542286|FG001|COMPLETED|Overall Study||10
6615870|NCT02151591|7542285|FG000|NOT COMPLETED|Overall Study||6
6615871|NCT02151591|7542286|FG001|NOT COMPLETED|Overall Study||3
6615872|NCT02151643|7542297|FG000|STARTED|Overall Study||26
6615873|NCT02151643|7542298|FG001|STARTED|Overall Study||25
6615874|NCT02151643|7542299|FG002|STARTED|Overall Study||25
6615875|NCT02151643|7542300|FG003|STARTED|Overall Study||39
6615876|NCT02151643|7542301|FG004|STARTED|Overall Study||38
6615877|NCT02151643|7542297|FG000|COMPLETED|Overall Study||20
6615878|NCT02151643|7542298|FG001|COMPLETED|Overall Study||21
6615879|NCT02151643|7542299|FG002|COMPLETED|Overall Study||21
6615880|NCT02151643|7542300|FG003|COMPLETED|Overall Study||32
6615881|NCT02151643|7542301|FG004|COMPLETED|Overall Study||35
6615882|NCT02151643|7542297|FG000|NOT COMPLETED|Overall Study||6
6615883|NCT02151643|7542298|FG001|NOT COMPLETED|Overall Study||4
6615884|NCT02151643|7542299|FG002|NOT COMPLETED|Overall Study||4
6615885|NCT02151643|7542300|FG003|NOT COMPLETED|Overall Study||7
6615886|NCT02151643|7542301|FG004|NOT COMPLETED|Overall Study||3
6615887|NCT02151682|7542315|FG000|STARTED|Part 1: 14 Days Morphine or Tapentadol||24
6615888|NCT02151682|7542316|FG001|STARTED|Part 1: 14 Days Morphine or Tapentadol||45
6615889|NCT02151682|7542317|FG002|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
6615890|NCT02151682|7542318|FG003|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
6615891|NCT02151682|7542319|FG004|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
6615892|NCT02151682|7542320|FG005|STARTED|Part 1: 14 Days Morphine or Tapentadol|Group not defined for Part 1.|0
6615893|NCT02151682|7542315|FG000|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|22
6615894|NCT02151682|7542316|FG001|COMPLETED|Part 1: 14 Days Morphine or Tapentadol|14-Day treatment and final post-treatment visit completed or tapentadol treatment in Part 2 entered.|40
6615895|NCT02151682|7542317|FG002|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6615896|NCT02151682|7542318|FG003|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6615897|NCT02151682|7542319|FG004|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6615898|NCT02151682|7542320|FG005|COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6615899|NCT02151682|7542315|FG000|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||2
6615900|NCT02151682|7542316|FG001|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||5
6615901|NCT02151682|7542317|FG002|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6615902|NCT02151682|7542318|FG003|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6615903|NCT02151682|7542319|FG004|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6615904|NCT02151682|7542320|FG005|NOT COMPLETED|Part 1: 14 Days Morphine or Tapentadol||0
6615905|NCT02151682|7542315|FG000|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
6615906|NCT02151682|7542316|FG001|STARTED|Part 2: Tapent. Extension or Observation|Group not defined for Part 2.|0
6615907|NCT02151682|7542317|FG002|STARTED|Part 2: Tapent. Extension or Observation|26 Completers on tapentadol PR and 10 completers on morphine PR from Part 1.|36
6615908|NCT02151682|7542318|FG003|STARTED|Part 2: Tapent. Extension or Observation|14 Completers and 4 of 5 non-completers on tapentadol in Part 1.|18
6615909|NCT02151682|7542319|FG004|STARTED|Part 2: Tapent. Extension or Observation|12 Completers and 2 non-completers from morphine treatment in Part 1.|14
6615910|NCT02151682|7542320|FG005|STARTED|Part 2: Tapent. Extension or Observation||0
6615911|NCT02151682|7542315|FG000|COMPLETED|Part 2: Tapent. Extension or Observation||0
6615912|NCT02151682|7542316|FG001|COMPLETED|Part 2: Tapent. Extension or Observation||0
6615913|NCT02151682|7542317|FG002|COMPLETED|Part 2: Tapent. Extension or Observation|12 Month of tapentadol treatment completed and final visit of Part 2 performed.|8
6615914|NCT02151682|7542318|FG003|COMPLETED|Part 2: Tapent. Extension or Observation||14
6615915|NCT02151682|7542319|FG004|COMPLETED|Part 2: Tapent. Extension or Observation||14
6615916|NCT02151682|7542320|FG005|COMPLETED|Part 2: Tapent. Extension or Observation||0
6615917|NCT02151682|7542315|FG000|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
6615918|NCT02151682|7542316|FG001|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
6615919|NCT02151682|7542317|FG002|NOT COMPLETED|Part 2: Tapent. Extension or Observation||28
6615920|NCT02151682|7542318|FG003|NOT COMPLETED|Part 2: Tapent. Extension or Observation||4
6615921|NCT02151682|7542319|FG004|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
6615922|NCT02151682|7542320|FG005|NOT COMPLETED|Part 2: Tapent. Extension or Observation||0
6615923|NCT02151682|7542315|FG000|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
6615924|NCT02151682|7542316|FG001|STARTED|Part 2: Observ. Aft. Tapent. Extension|Group not defined for Part 2.|0
6615925|NCT02151682|7542317|FG002|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
6615926|NCT02151682|7542318|FG003|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
6615927|NCT02151682|7542319|FG004|STARTED|Part 2: Observ. Aft. Tapent. Extension|Not applicable for this period.|0
6615928|NCT02151682|7542320|FG005|STARTED|Part 2: Observ. Aft. Tapent. Extension|19 tapentadol and 7 morphine completers (Part 1) who discontinued from tapentadol treatm. in Part 2.|26
6615929|NCT02151682|7542315|FG000|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615930|NCT02151682|7542316|FG001|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615931|NCT02151682|7542317|FG002|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615932|NCT02151682|7542318|FG003|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615933|NCT02151682|7542319|FG004|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615934|NCT02151682|7542320|FG005|COMPLETED|Part 2: Observ. Aft. Tapent. Extension||19
6615935|NCT02151682|7542315|FG000|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615936|NCT02151682|7542316|FG001|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615937|NCT02151682|7542317|FG002|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615938|NCT02151682|7542318|FG003|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615939|NCT02151682|7542319|FG004|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||0
6615940|NCT02151682|7542320|FG005|NOT COMPLETED|Part 2: Observ. Aft. Tapent. Extension||7
6615941|NCT02151773|7542338|FG000|STARTED|Overall Study||3493
6615942|NCT02151773|7542338|FG000|COMPLETED|Overall Study||3429
6615943|NCT02151773|7542338|FG000|NOT COMPLETED|Overall Study||64
6615944|NCT02151786|7542342|FG000|STARTED|Overall Study||1120
6615945|NCT02151786|7542342|FG000|COMPLETED|Overall Study||1084
6615946|NCT02151786|7542342|FG000|NOT COMPLETED|Overall Study||36
6615947|NCT02151851|7542348|FG000|STARTED|Overall Study||114
6615948|NCT02151851|7542349|FG001|STARTED|Overall Study||316
6615949|NCT02151851|7542348|FG000|Included in the Safety Set|Overall Study||113
6615950|NCT02151851|7542349|FG001|Included in the Safety Set|Overall Study||316
6615951|NCT02151851|7542348|FG000|COMPLETED|Overall Study||38
6615952|NCT02151851|7542349|FG001|COMPLETED|Overall Study||186
6615953|NCT02151851|7542348|FG000|NOT COMPLETED|Overall Study||76
6615954|NCT02151851|7542349|FG001|NOT COMPLETED|Overall Study||130
6615955|NCT02151877|7542357|FG000|STARTED|Overall Study||12
6615956|NCT02151877|7542358|FG001|STARTED|Overall Study||12
6615957|NCT02151877|7542357|FG000|COMPLETED|Overall Study||12
6615958|NCT02151877|7542358|FG001|COMPLETED|Overall Study||12
6615959|NCT02151877|7542357|FG000|NOT COMPLETED|Overall Study||0
6615960|NCT02151877|7542358|FG001|NOT COMPLETED|Overall Study||0
6615961|NCT02151903|7542368|FG000|STARTED|Overall Study||3
6615962|NCT02151903|7542369|FG001|STARTED|Overall Study||2
6615963|NCT02151903|7542368|FG000|Received at Least 1 Dose of Study Drug|Overall Study||3
6615964|NCT02151903|7542369|FG001|Received at Least 1 Dose of Study Drug|Overall Study||2
6615965|NCT02151903|7542368|FG000|COMPLETED|Overall Study||0
6615966|NCT02151903|7542369|FG001|COMPLETED|Overall Study||1
6615967|NCT02151903|7542368|FG000|NOT COMPLETED|Overall Study||3
6615968|NCT02151903|7542369|FG001|NOT COMPLETED|Overall Study||1
6615969|NCT02151994|7542378|FG000|STARTED|Single Ascending Dose (SAD)||18
6615970|NCT02151994|7542379|FG001|STARTED|Single Ascending Dose (SAD)||6
6615971|NCT02151994|7542380|FG002|STARTED|Single Ascending Dose (SAD)||6
6615972|NCT02151994|7542381|FG003|STARTED|Single Ascending Dose (SAD)||6
6615973|NCT02151994|7542382|FG004|STARTED|Single Ascending Dose (SAD)||6
6615974|NCT02151994|7542383|FG005|STARTED|Single Ascending Dose (SAD)||6
6615975|NCT02151994|7542384|FG006|STARTED|Single Ascending Dose (SAD)||6
6615976|NCT02151994|7542385|FG007|STARTED|Single Ascending Dose (SAD)||6
6615977|NCT02151994|7542386|FG008|STARTED|Single Ascending Dose (SAD)||0
6615978|NCT02151994|7542387|FG009|STARTED|Single Ascending Dose (SAD)||6
6615979|NCT02151994|7542388|FG010|STARTED|Single Ascending Dose (SAD)||6
6615980|NCT02151994|7542389|FG011|STARTED|Single Ascending Dose (SAD)||0
6615981|NCT02151994|7542390|FG012|STARTED|Single Ascending Dose (SAD)||0
6615982|NCT02151994|7542378|FG000|COMPLETED|Single Ascending Dose (SAD)||18
6615983|NCT02151994|7542379|FG001|COMPLETED|Single Ascending Dose (SAD)||6
6615984|NCT02151994|7542380|FG002|COMPLETED|Single Ascending Dose (SAD)||6
6615985|NCT02151994|7542381|FG003|COMPLETED|Single Ascending Dose (SAD)||6
6615986|NCT02151994|7542382|FG004|COMPLETED|Single Ascending Dose (SAD)||6
6615987|NCT02151994|7542383|FG005|COMPLETED|Single Ascending Dose (SAD)||6
6615988|NCT02151994|7542384|FG006|COMPLETED|Single Ascending Dose (SAD)||6
6615989|NCT02151994|7542385|FG007|COMPLETED|Single Ascending Dose (SAD)||6
6615990|NCT02151994|7542386|FG008|COMPLETED|Single Ascending Dose (SAD)||0
6615991|NCT02151994|7542387|FG009|COMPLETED|Single Ascending Dose (SAD)||6
6615992|NCT02151994|7542388|FG010|COMPLETED|Single Ascending Dose (SAD)||6
6615993|NCT02151994|7542389|FG011|COMPLETED|Single Ascending Dose (SAD)||0
6615994|NCT02151994|7542390|FG012|COMPLETED|Single Ascending Dose (SAD)||0
6615995|NCT02151994|7542378|FG000|NOT COMPLETED|Single Ascending Dose (SAD)||0
6615996|NCT02151994|7542379|FG001|NOT COMPLETED|Single Ascending Dose (SAD)||0
6615997|NCT02151994|7542380|FG002|NOT COMPLETED|Single Ascending Dose (SAD)||0
6615998|NCT02151994|7542381|FG003|NOT COMPLETED|Single Ascending Dose (SAD)||0
6615999|NCT02151994|7542382|FG004|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616000|NCT02151994|7542383|FG005|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616001|NCT02151994|7542384|FG006|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616002|NCT02151994|7542385|FG007|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616003|NCT02151994|7542386|FG008|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616004|NCT02151994|7542387|FG009|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616005|NCT02151994|7542388|FG010|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616006|NCT02151994|7542389|FG011|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616007|NCT02151994|7542390|FG012|NOT COMPLETED|Single Ascending Dose (SAD)||0
6616008|NCT02151994|7542378|FG000|STARTED|Multiple Ascending Dose (MAD)||10
6616009|NCT02151994|7542379|FG001|STARTED|Multiple Ascending Dose (MAD)||0
6616010|NCT02151994|7542380|FG002|STARTED|Multiple Ascending Dose (MAD)||0
6616011|NCT02151994|7542381|FG003|STARTED|Multiple Ascending Dose (MAD)||6
6616012|NCT02151994|7542382|FG004|STARTED|Multiple Ascending Dose (MAD)||6
6616013|NCT02151994|7542383|FG005|STARTED|Multiple Ascending Dose (MAD)||6
6616014|NCT02151994|7542384|FG006|STARTED|Multiple Ascending Dose (MAD)||6
6616015|NCT02151994|7542385|FG007|STARTED|Multiple Ascending Dose (MAD)||0
6616016|NCT02151994|7542386|FG008|STARTED|Multiple Ascending Dose (MAD)||6
6616017|NCT02151994|7542387|FG009|STARTED|Multiple Ascending Dose (MAD)||0
6616018|NCT02151994|7542388|FG010|STARTED|Multiple Ascending Dose (MAD)||0
6616019|NCT02151994|7542389|FG011|STARTED|Multiple Ascending Dose (MAD)||0
6616020|NCT02151994|7542390|FG012|STARTED|Multiple Ascending Dose (MAD)||0
6616021|NCT02151994|7542378|FG000|COMPLETED|Multiple Ascending Dose (MAD)||10
6616022|NCT02151994|7542379|FG001|COMPLETED|Multiple Ascending Dose (MAD)||0
6616023|NCT02151994|7542380|FG002|COMPLETED|Multiple Ascending Dose (MAD)||0
6616024|NCT02151994|7542381|FG003|COMPLETED|Multiple Ascending Dose (MAD)||6
6616025|NCT02151994|7542382|FG004|COMPLETED|Multiple Ascending Dose (MAD)||6
6616026|NCT02151994|7542383|FG005|COMPLETED|Multiple Ascending Dose (MAD)||6
6616027|NCT02151994|7542384|FG006|COMPLETED|Multiple Ascending Dose (MAD)||6
6616028|NCT02151994|7542385|FG007|COMPLETED|Multiple Ascending Dose (MAD)||0
6616029|NCT02151994|7542386|FG008|COMPLETED|Multiple Ascending Dose (MAD)||6
6616030|NCT02151994|7542387|FG009|COMPLETED|Multiple Ascending Dose (MAD)||0
6616031|NCT02151994|7542388|FG010|COMPLETED|Multiple Ascending Dose (MAD)||0
6616032|NCT02151994|7542389|FG011|COMPLETED|Multiple Ascending Dose (MAD)||0
6616033|NCT02151994|7542390|FG012|COMPLETED|Multiple Ascending Dose (MAD)||0
6616034|NCT02151994|7542378|FG000|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616035|NCT02151994|7542379|FG001|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616036|NCT02151994|7542380|FG002|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616037|NCT02151994|7542381|FG003|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616038|NCT02151994|7542382|FG004|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616039|NCT02151994|7542383|FG005|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616040|NCT02151994|7542384|FG006|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616041|NCT02151994|7542385|FG007|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616042|NCT02151994|7542386|FG008|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616043|NCT02151994|7542387|FG009|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616044|NCT02151994|7542388|FG010|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6732889|NCT03200366|7662369|FG002|NOT COMPLETED|6 Month Post-Baseline Interview||19
6732890|NCT03200366|7662367|FG000|STARTED|9 Month Post-Baseline Interview||121
6732891|NCT03200366|7662368|FG001|STARTED|9 Month Post-Baseline Interview||116
6732892|NCT03200366|7662369|FG002|STARTED|9 Month Post-Baseline Interview||127
6732893|NCT03200366|7662367|FG000|COMPLETED|9 Month Post-Baseline Interview||97
6732894|NCT03200366|7662368|FG001|COMPLETED|9 Month Post-Baseline Interview||95
6732895|NCT03200366|7662369|FG002|COMPLETED|9 Month Post-Baseline Interview||116
6732896|NCT03200366|7662367|FG000|NOT COMPLETED|9 Month Post-Baseline Interview||24
6732897|NCT03200366|7662368|FG001|NOT COMPLETED|9 Month Post-Baseline Interview||21
6732898|NCT03200366|7662369|FG002|NOT COMPLETED|9 Month Post-Baseline Interview||11
6732899|NCT03200535|7662383|FG000|STARTED|Overall Study||1863
6732900|NCT03200535|7662384|FG001|STARTED|Overall Study||1863
6732901|NCT03200535|7662385|FG002|STARTED|Overall Study||1862
6732902|NCT03200535|7662386|FG003|STARTED|Overall Study||1000
6732903|NCT03200535|7662383|FG000|COMPLETED|Overall Study||1863
6732904|NCT03200535|7662384|FG001|COMPLETED|Overall Study||1863
6732905|NCT03200535|7662385|FG002|COMPLETED|Overall Study||1862
6732906|NCT03200535|7662386|FG003|COMPLETED|Overall Study||1000
6732907|NCT03200535|7662383|FG000|NOT COMPLETED|Overall Study||0
6732908|NCT03200535|7662384|FG001|NOT COMPLETED|Overall Study||0
6732909|NCT03200535|7662385|FG002|NOT COMPLETED|Overall Study||0
6732910|NCT03200535|7662386|FG003|NOT COMPLETED|Overall Study||0
6732911|NCT03200860|7662398|FG000|STARTED|Overall Study||41
6732912|NCT03200860|7662399|FG001|STARTED|Overall Study||39
6732913|NCT03200860|7662398|FG000|COMPLETED|Overall Study||40
6732914|NCT03200860|7662399|FG001|COMPLETED|Overall Study||39
6732915|NCT03200860|7662398|FG000|NOT COMPLETED|Overall Study||1
6732916|NCT03200860|7662399|FG001|NOT COMPLETED|Overall Study||0
6732917|NCT03200912|7662408|FG000|STARTED|Overall Study||170
6732918|NCT03200912|7662409|FG001|STARTED|Overall Study||169
6732919|NCT03200912|7662410|FG002|STARTED|Overall Study||168
6732920|NCT03200912|7662408|FG000|COMPLETED|Overall Study||166
6732921|NCT03200912|7662409|FG001|COMPLETED|Overall Study||166
6732922|NCT03200912|7662410|FG002|COMPLETED|Overall Study||164
6732923|NCT03200912|7662408|FG000|NOT COMPLETED|Overall Study||4
6732924|NCT03200912|7662409|FG001|NOT COMPLETED|Overall Study||3
6732925|NCT03200912|7662410|FG002|NOT COMPLETED|Overall Study||4
6732926|NCT03200925|7662420|FG000|STARTED|Overall Study||120
6732927|NCT03200925|7662421|FG001|STARTED|Overall Study||120
6732928|NCT03200925|7662420|FG000|COMPLETED|Overall Study||120
6732929|NCT03200925|7662421|FG001|COMPLETED|Overall Study||120
6732930|NCT03200925|7662420|FG000|NOT COMPLETED|Overall Study||0
6732931|NCT03200925|7662421|FG001|NOT COMPLETED|Overall Study||0
6732932|NCT03201003|7662429|FG000|STARTED|Overall Study||132
6732933|NCT03201003|7662430|FG001|STARTED|Overall Study||43
6732934|NCT03201003|7662429|FG000|COMPLETED|Overall Study||106
6732935|NCT03201003|7662430|FG001|COMPLETED|Overall Study||40
6732936|NCT03201003|7662429|FG000|NOT COMPLETED|Overall Study||26
6732937|NCT03201003|7662430|FG001|NOT COMPLETED|Overall Study||3
6732938|NCT03201211|7662439|FG000|STARTED|Overall Study||27
6732939|NCT03201211|7662440|FG001|STARTED|Overall Study||26
6732940|NCT03201211|7662441|FG002|STARTED|Overall Study||28
6732941|NCT03201211|7662439|FG000|COMPLETED|Overall Study||25
6732942|NCT03201211|7662440|FG001|COMPLETED|Overall Study||25
6732943|NCT03201211|7662441|FG002|COMPLETED|Overall Study||27
6732944|NCT03201211|7662439|FG000|NOT COMPLETED|Overall Study||2
6732945|NCT03201211|7662440|FG001|NOT COMPLETED|Overall Study||1
6732946|NCT03201211|7662441|FG002|NOT COMPLETED|Overall Study||1
6732947|NCT03201562|7662452|FG000|STARTED|Overall Study||18
6732948|NCT03201562|7662453|FG001|STARTED|Overall Study||20
6732949|NCT03201562|7662454|FG002|STARTED|Overall Study||20
6732950|NCT03201562|7662452|FG000|COMPLETED|Overall Study||18
6732951|NCT03201562|7662453|FG001|COMPLETED|Overall Study||19
6732952|NCT03201562|7662454|FG002|COMPLETED|Overall Study||16
6732953|NCT03201562|7662452|FG000|NOT COMPLETED|Overall Study||0
6732954|NCT03201562|7662453|FG001|NOT COMPLETED|Overall Study||1
6732955|NCT03201562|7662454|FG002|NOT COMPLETED|Overall Study||4
6732956|NCT03201809|7662464|FG000|STARTED|Overall Study||6
6732957|NCT03201809|7662465|FG001|STARTED|Overall Study||6
6732958|NCT03201809|7662464|FG000|COMPLETED|Overall Study||4
6732959|NCT03201809|7662465|FG001|COMPLETED|Overall Study||6
6732960|NCT03201809|7662464|FG000|NOT COMPLETED|Overall Study||2
6732961|NCT03201809|7662465|FG001|NOT COMPLETED|Overall Study||0
6732962|NCT03201900|7662471|FG000|STARTED|Treatment Phase (Up to 62 Weeks)||91
6732963|NCT03201900|7662471|FG000|Treated|Treatment Phase (Up to 62 Weeks)||89
6732964|NCT03201900|7662471|FG000|COMPLETED|Treatment Phase (Up to 62 Weeks)||54
6732965|NCT03201900|7662471|FG000|NOT COMPLETED|Treatment Phase (Up to 62 Weeks)||37
6732966|NCT03201900|7662471|FG000|STARTED|Extension Phase (From Week 63 to 156)|Eligible participants who completed Treatment Phase and agreed to continue in the Extension Phase.|46
6732967|NCT03201900|7662471|FG000|COMPLETED|Extension Phase (From Week 63 to 156)||38
6616045|NCT02151994|7542389|FG011|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616046|NCT02151994|7542390|FG012|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
6616047|NCT02151994|7542378|FG000|STARTED|Food Effect (FE): Fasted||0
6616048|NCT02151994|7542379|FG001|STARTED|Food Effect (FE): Fasted||0
6616049|NCT02151994|7542380|FG002|STARTED|Food Effect (FE): Fasted||0
6616050|NCT02151994|7542381|FG003|STARTED|Food Effect (FE): Fasted||0
6616051|NCT02151994|7542382|FG004|STARTED|Food Effect (FE): Fasted||0
6616052|NCT02151994|7542383|FG005|STARTED|Food Effect (FE): Fasted||0
6616053|NCT02151994|7542384|FG006|STARTED|Food Effect (FE): Fasted||0
6616054|NCT02151994|7542385|FG007|STARTED|Food Effect (FE): Fasted||0
6616055|NCT02151994|7542386|FG008|STARTED|Food Effect (FE): Fasted||0
6616056|NCT02151994|7542387|FG009|STARTED|Food Effect (FE): Fasted||0
6616057|NCT02151994|7542388|FG010|STARTED|Food Effect (FE): Fasted||0
6616058|NCT02151994|7542389|FG011|STARTED|Food Effect (FE): Fasted||12
6616059|NCT02151994|7542390|FG012|STARTED|Food Effect (FE): Fasted||0
6616060|NCT02151994|7542378|FG000|COMPLETED|Food Effect (FE): Fasted||0
6616061|NCT02151994|7542379|FG001|COMPLETED|Food Effect (FE): Fasted||0
6616062|NCT02151994|7542380|FG002|COMPLETED|Food Effect (FE): Fasted||0
6616063|NCT02151994|7542381|FG003|COMPLETED|Food Effect (FE): Fasted||0
6616064|NCT02151994|7542382|FG004|COMPLETED|Food Effect (FE): Fasted||0
6616065|NCT02151994|7542383|FG005|COMPLETED|Food Effect (FE): Fasted||0
6616066|NCT02151994|7542384|FG006|COMPLETED|Food Effect (FE): Fasted||0
6616067|NCT02151994|7542385|FG007|COMPLETED|Food Effect (FE): Fasted||0
6616068|NCT02151994|7542386|FG008|COMPLETED|Food Effect (FE): Fasted||0
6616069|NCT02151994|7542387|FG009|COMPLETED|Food Effect (FE): Fasted||0
6616070|NCT02151994|7542388|FG010|COMPLETED|Food Effect (FE): Fasted||0
6616071|NCT02151994|7542389|FG011|COMPLETED|Food Effect (FE): Fasted||12
6616072|NCT02151994|7542390|FG012|COMPLETED|Food Effect (FE): Fasted||0
6616073|NCT02151994|7542378|FG000|NOT COMPLETED|Food Effect (FE): Fasted||0
6616074|NCT02151994|7542379|FG001|NOT COMPLETED|Food Effect (FE): Fasted||0
6616075|NCT02151994|7542380|FG002|NOT COMPLETED|Food Effect (FE): Fasted||0
6616076|NCT02151994|7542381|FG003|NOT COMPLETED|Food Effect (FE): Fasted||0
6616077|NCT02151994|7542382|FG004|NOT COMPLETED|Food Effect (FE): Fasted||0
6616078|NCT02151994|7542383|FG005|NOT COMPLETED|Food Effect (FE): Fasted||0
6616079|NCT02151994|7542384|FG006|NOT COMPLETED|Food Effect (FE): Fasted||0
6616080|NCT02151994|7542385|FG007|NOT COMPLETED|Food Effect (FE): Fasted||0
6616081|NCT02151994|7542386|FG008|NOT COMPLETED|Food Effect (FE): Fasted||0
6616082|NCT02151994|7542387|FG009|NOT COMPLETED|Food Effect (FE): Fasted||0
6616083|NCT02151994|7542388|FG010|NOT COMPLETED|Food Effect (FE): Fasted||0
6616084|NCT02151994|7542389|FG011|NOT COMPLETED|Food Effect (FE): Fasted||0
6616085|NCT02151994|7542390|FG012|NOT COMPLETED|Food Effect (FE): Fasted||0
6616086|NCT02151994|7542378|FG000|STARTED|Food Effect (FE): Fed||0
6616087|NCT02151994|7542379|FG001|STARTED|Food Effect (FE): Fed||0
6616088|NCT02151994|7542380|FG002|STARTED|Food Effect (FE): Fed||0
6616089|NCT02151994|7542381|FG003|STARTED|Food Effect (FE): Fed||0
6616090|NCT02151994|7542382|FG004|STARTED|Food Effect (FE): Fed||0
6616091|NCT02151994|7542383|FG005|STARTED|Food Effect (FE): Fed||0
6616092|NCT02151994|7542384|FG006|STARTED|Food Effect (FE): Fed||0
6616093|NCT02151994|7542385|FG007|STARTED|Food Effect (FE): Fed||0
6616094|NCT02151994|7542386|FG008|STARTED|Food Effect (FE): Fed||0
6616095|NCT02151994|7542387|FG009|STARTED|Food Effect (FE): Fed||0
6616096|NCT02151994|7542388|FG010|STARTED|Food Effect (FE): Fed||0
6616097|NCT02151994|7542389|FG011|STARTED|Food Effect (FE): Fed||0
6616098|NCT02151994|7542390|FG012|STARTED|Food Effect (FE): Fed||12
6616099|NCT02151994|7542378|FG000|COMPLETED|Food Effect (FE): Fed||0
6616100|NCT02151994|7542379|FG001|COMPLETED|Food Effect (FE): Fed||0
6616101|NCT02151994|7542380|FG002|COMPLETED|Food Effect (FE): Fed||0
6616102|NCT02151994|7542381|FG003|COMPLETED|Food Effect (FE): Fed||0
6616103|NCT02151994|7542382|FG004|COMPLETED|Food Effect (FE): Fed||0
6616104|NCT02151994|7542383|FG005|COMPLETED|Food Effect (FE): Fed||0
6616105|NCT02151994|7542384|FG006|COMPLETED|Food Effect (FE): Fed||0
6616106|NCT02151994|7542385|FG007|COMPLETED|Food Effect (FE): Fed||0
6616107|NCT02151994|7542386|FG008|COMPLETED|Food Effect (FE): Fed||0
6616108|NCT02151994|7542387|FG009|COMPLETED|Food Effect (FE): Fed||0
6616109|NCT02151994|7542388|FG010|COMPLETED|Food Effect (FE): Fed||0
6616110|NCT02151994|7542389|FG011|COMPLETED|Food Effect (FE): Fed||0
6616111|NCT02151994|7542390|FG012|COMPLETED|Food Effect (FE): Fed||12
6616112|NCT02151994|7542378|FG000|NOT COMPLETED|Food Effect (FE): Fed||0
6616113|NCT02151994|7542379|FG001|NOT COMPLETED|Food Effect (FE): Fed||0
6616114|NCT02151994|7542380|FG002|NOT COMPLETED|Food Effect (FE): Fed||0
6616115|NCT02151994|7542381|FG003|NOT COMPLETED|Food Effect (FE): Fed||0
6616116|NCT02151994|7542382|FG004|NOT COMPLETED|Food Effect (FE): Fed||0
6616117|NCT02151994|7542383|FG005|NOT COMPLETED|Food Effect (FE): Fed||0
6616118|NCT02151994|7542384|FG006|NOT COMPLETED|Food Effect (FE): Fed||0
6616119|NCT02151994|7542385|FG007|NOT COMPLETED|Food Effect (FE): Fed||0
6616120|NCT02151994|7542386|FG008|NOT COMPLETED|Food Effect (FE): Fed||0
6616121|NCT02151994|7542387|FG009|NOT COMPLETED|Food Effect (FE): Fed||0
6616122|NCT02151994|7542388|FG010|NOT COMPLETED|Food Effect (FE): Fed||0
6616123|NCT02151994|7542389|FG011|NOT COMPLETED|Food Effect (FE): Fed||0
6616124|NCT02151994|7542390|FG012|NOT COMPLETED|Food Effect (FE): Fed||0
6616125|NCT02152007|7542427|FG000|STARTED|Overall Study||15
6616126|NCT02152007|7542427|FG000|COMPLETED|Overall Study||14
6616127|NCT02152007|7542427|FG000|NOT COMPLETED|Overall Study||1
6616128|NCT02152085|7542434|FG000|STARTED|Overall Study||14
6616129|NCT02152085|7542435|FG001|STARTED|Overall Study||15
6616130|NCT02152085|7542434|FG000|COMPLETED|Overall Study||13
6616131|NCT02152085|7542435|FG001|COMPLETED|Overall Study||14
6616132|NCT02152085|7542434|FG000|NOT COMPLETED|Overall Study||1
6616133|NCT02152085|7542435|FG001|NOT COMPLETED|Overall Study||1
6616134|NCT02152137|7542441|FG000|STARTED|Overall Study||19
6616135|NCT02152137|7542441|FG000|Originally Assigned to Arm A|Overall Study||16
6616136|NCT02152137|7542441|FG000|Originally Assigned to Arm B|Overall Study|With update #2, Arm B is closed and all patients should receive paclitaxel and efatutazone.|3
6616137|NCT02152137|7542441|FG000|COMPLETED|Overall Study||15
6616138|NCT02152137|7542441|FG000|NOT COMPLETED|Overall Study||4
6616139|NCT02152163|7542447|FG000|STARTED|Overall Study||51
6616140|NCT02152163|7542448|FG001|STARTED|Overall Study||48
6616141|NCT02152163|7542447|FG000|COMPLETED|Overall Study||39
6616142|NCT02152163|7542448|FG001|COMPLETED|Overall Study||35
6616143|NCT02152163|7542447|FG000|NOT COMPLETED|Overall Study||12
6616144|NCT02152163|7542448|FG001|NOT COMPLETED|Overall Study||13
6616145|NCT02152345|7542456|FG000|STARTED|Overall Study|The first subject randomized to Belatacept was on 15-Sep-2014.|28
6616146|NCT02152345|7542457|FG001|STARTED|Overall Study|The first subject randomized to Standard Immunosuppression was on 14-Jun-2014.|29
6616147|NCT02152345|7542456|FG000|COMPLETED|Overall Study|The last subject randomized to Belatacept was on 29-Dec-2016.|24
6616148|NCT02152345|7542457|FG001|COMPLETED|Overall Study|The last subject randomized to Standard Immunosuppression was on 25-Dec-2016.|24
6616149|NCT02152345|7542456|FG000|NOT COMPLETED|Overall Study||4
6616150|NCT02152345|7542457|FG001|NOT COMPLETED|Overall Study||5
6616151|NCT02152371|7542465|FG000|STARTED|Overall Study||150
6616152|NCT02152371|7542466|FG001|STARTED|Overall Study||150
6616153|NCT02152371|7542465|FG000|Received at Least 1 Dose of Study Drug.|Overall Study||150
6616154|NCT02152371|7542466|FG001|Received at Least 1 Dose of Study Drug.|Overall Study||150
6616155|NCT02152371|7542465|FG000|COMPLETED|Overall Study||138
6616156|NCT02152371|7542466|FG001|COMPLETED|Overall Study||134
6616157|NCT02152371|7542465|FG000|NOT COMPLETED|Overall Study||12
6616158|NCT02152371|7542466|FG001|NOT COMPLETED|Overall Study||16
6616159|NCT02152384|7542472|FG000|STARTED|Run In (1-5 Week Transition)||14
6616160|NCT02152384|7542473|FG001|STARTED|Run In (1-5 Week Transition)||14
6616161|NCT02152384|7542472|FG000|COMPLETED|Run In (1-5 Week Transition)||14
6616162|NCT02152384|7542473|FG001|COMPLETED|Run In (1-5 Week Transition)||14
6616163|NCT02152384|7542472|FG000|NOT COMPLETED|Run In (1-5 Week Transition)||0
6616164|NCT02152384|7542473|FG001|NOT COMPLETED|Run In (1-5 Week Transition)||0
6616165|NCT02152384|7542472|FG000|STARTED|Period 1||14
6616166|NCT02152384|7542473|FG001|STARTED|Period 1||14
6616167|NCT02152384|7542472|FG000|Received at Least 1 Dose of Study Drug|Period 1||14
6616168|NCT02152384|7542473|FG001|Received at Least 1 Dose of Study Drug|Period 1||14
6616169|NCT02152384|7542472|FG000|COMPLETED|Period 1||13
6616170|NCT02152384|7542473|FG001|COMPLETED|Period 1||12
6616171|NCT02152384|7542472|FG000|NOT COMPLETED|Period 1||1
6616172|NCT02152384|7542473|FG001|NOT COMPLETED|Period 1||2
6616173|NCT02152384|7542472|FG000|STARTED|Period 2||13
6616174|NCT02152384|7542473|FG001|STARTED|Period 2||12
6616175|NCT02152384|7542472|FG000|COMPLETED|Period 2||13
6616176|NCT02152384|7542473|FG001|COMPLETED|Period 2||12
6616177|NCT02152384|7542472|FG000|NOT COMPLETED|Period 2||0
6616178|NCT02152384|7542473|FG001|NOT COMPLETED|Period 2||0
6616179|NCT02152540|7542485|FG000|STARTED|Overall Study||17
6616180|NCT02152540|7542486|FG001|STARTED|Overall Study||16
6616181|NCT02152540|7542485|FG000|COMPLETED|Overall Study||17
6616182|NCT02152540|7542486|FG001|COMPLETED|Overall Study||16
6616183|NCT02152540|7542485|FG000|NOT COMPLETED|Overall Study||0
6616184|NCT02152540|7542486|FG001|NOT COMPLETED|Overall Study||0
6616185|NCT02152605|7542501|FG000|STARTED|Overall Study||248
6616186|NCT02152605|7542502|FG001|STARTED|Overall Study||248
6616187|NCT02152605|7542501|FG000|COMPLETED|Overall Study||229
6616188|NCT02152605|7542502|FG001|COMPLETED|Overall Study||230
6616189|NCT02152605|7542501|FG000|NOT COMPLETED|Overall Study||19
6616190|NCT02152605|7542502|FG001|NOT COMPLETED|Overall Study||18
6616191|NCT02152631|7542511|FG000|STARTED|Overall Study||270
6616192|NCT02152631|7542512|FG001|STARTED|Overall Study||183
6616193|NCT02152631|7542511|FG000|Received at Least One Dose of Study Drug|Overall Study||265
6616194|NCT02152631|7542512|FG001|Received at Least One Dose of Study Drug|Overall Study||175
6616195|NCT02152631|7542511|FG000|Off Treatment|Overall Study||246
6616196|NCT02152631|7542512|FG001|Off Treatment|Overall Study||172
6616197|NCT02152631|7542511|FG000|Death Due to Any Cause|Overall Study||30
6616198|NCT02152631|7542512|FG001|Death Due to Any Cause|Overall Study||20
6616199|NCT02152631|7542511|FG000|Progressive Disease|Overall Study||174
6616200|NCT02152631|7542512|FG001|Progressive Disease|Overall Study||137
6616201|NCT02152631|7542511|FG000|COMPLETED|Overall Study||204
6616202|NCT02152631|7542512|FG001|COMPLETED|Overall Study||157
6616203|NCT02152631|7542511|FG000|NOT COMPLETED|Overall Study||66
6616204|NCT02152631|7542512|FG001|NOT COMPLETED|Overall Study||26
6616205|NCT02152696|7542521|FG000|STARTED|Overall Study||86
6616206|NCT02152696|7542522|FG001|STARTED|Overall Study||87
6616207|NCT02152696|7542523|FG002|STARTED|Overall Study||82
6616208|NCT02152696|7542521|FG000|COMPLETED|Overall Study||86
6616209|NCT02152696|7542522|FG001|COMPLETED|Overall Study||86
6616210|NCT02152696|7542523|FG002|COMPLETED|Overall Study||81
6616211|NCT02152696|7542521|FG000|NOT COMPLETED|Overall Study||0
6616212|NCT02152696|7542522|FG001|NOT COMPLETED|Overall Study||1
6616213|NCT02152696|7542523|FG002|NOT COMPLETED|Overall Study||1
6616214|NCT02152761|7542535|FG000|STARTED|Epoch: Treatment Epoch||75
6616215|NCT02152761|7542536|FG001|STARTED|Epoch: Treatment Epoch||70
6616216|NCT02152761|7542537|FG002|STARTED|Epoch: Treatment Epoch||34
6616217|NCT02152761|7542538|FG003|STARTED|Epoch: Treatment Epoch||72
6616218|NCT02152761|7542535|FG000|COMPLETED|Epoch: Treatment Epoch||64
6616219|NCT02152761|7542536|FG001|COMPLETED|Epoch: Treatment Epoch||50
6616220|NCT02152761|7542537|FG002|COMPLETED|Epoch: Treatment Epoch||29
6616221|NCT02152761|7542538|FG003|COMPLETED|Epoch: Treatment Epoch||64
6616222|NCT02152761|7542535|FG000|NOT COMPLETED|Epoch: Treatment Epoch||11
6616223|NCT02152761|7542536|FG001|NOT COMPLETED|Epoch: Treatment Epoch||20
6616224|NCT02152761|7542537|FG002|NOT COMPLETED|Epoch: Treatment Epoch||5
6616225|NCT02152761|7542538|FG003|NOT COMPLETED|Epoch: Treatment Epoch||8
6616226|NCT02152761|7542535|FG000|STARTED|Epoch: Post-treatment Follow-up Epoch||67
6616227|NCT02152761|7542536|FG001|STARTED|Epoch: Post-treatment Follow-up Epoch||54
6616228|NCT02152761|7542537|FG002|STARTED|Epoch: Post-treatment Follow-up Epoch||30
6616229|NCT02152761|7542538|FG003|STARTED|Epoch: Post-treatment Follow-up Epoch||68
6616230|NCT02152761|7542535|FG000|COMPLETED|Epoch: Post-treatment Follow-up Epoch||63
6616231|NCT02152761|7542536|FG001|COMPLETED|Epoch: Post-treatment Follow-up Epoch||47
6616232|NCT02152761|7542537|FG002|COMPLETED|Epoch: Post-treatment Follow-up Epoch||30
6616233|NCT02152761|7542538|FG003|COMPLETED|Epoch: Post-treatment Follow-up Epoch||66
6616234|NCT02152761|7542535|FG000|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||4
6616235|NCT02152761|7542536|FG001|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||7
6616236|NCT02152761|7542537|FG002|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||0
6616237|NCT02152761|7542538|FG003|NOT COMPLETED|Epoch: Post-treatment Follow-up Epoch||2
6732968|NCT03201900|7662471|FG000|NOT COMPLETED|Extension Phase (From Week 63 to 156)||8
6732969|NCT03202134|7662477|FG000|STARTED|Overall Study||55
6732970|NCT03202134|7662478|FG001|STARTED|Overall Study||149
6732971|NCT03202134|7662477|FG000|COMPLETED|Overall Study||55
6732972|NCT03202134|7662478|FG001|COMPLETED|Overall Study||149
6732973|NCT03202134|7662477|FG000|NOT COMPLETED|Overall Study||0
6732974|NCT03202134|7662478|FG001|NOT COMPLETED|Overall Study||0
6732975|NCT03202264|7662486|FG000|STARTED|Overall Study||30
6732976|NCT03202264|7662486|FG000|COMPLETED|Overall Study||14
6732977|NCT03202264|7662486|FG000|NOT COMPLETED|Overall Study||16
6732978|NCT03202472|7662490|FG000|STARTED|Overall Study||50
6732979|NCT03202472|7662490|FG000|COMPLETED|Overall Study||50
6732980|NCT03202472|7662490|FG000|NOT COMPLETED|Overall Study||0
6732981|NCT03202511|7662494|FG000|STARTED|Overall Study||8
6732982|NCT03202511|7662495|FG001|STARTED|Overall Study||7
6732983|NCT03202511|7662494|FG000|COMPLETED|Overall Study||7
6732984|NCT03202511|7662495|FG001|COMPLETED|Overall Study||7
6732985|NCT03202511|7662494|FG000|NOT COMPLETED|Overall Study||1
6732986|NCT03202511|7662495|FG001|NOT COMPLETED|Overall Study||0
6732987|NCT03202550|7662503|FG000|STARTED|Overall Study||13
6732988|NCT03202550|7662504|FG001|STARTED|Overall Study||11
6732989|NCT03202550|7662503|FG000|COMPLETED|Overall Study||13
6732990|NCT03202550|7662504|FG001|COMPLETED|Overall Study||11
6732991|NCT03202550|7662503|FG000|NOT COMPLETED|Overall Study||0
6616238|NCT02152826|7542556|FG000|STARTED|Overall Study||45
6616239|NCT02152826|7542557|FG001|STARTED|Overall Study||35
6616240|NCT02152826|7542556|FG000|COMPLETED|Overall Study||44
6616241|NCT02152826|7542557|FG001|COMPLETED|Overall Study||34
6616242|NCT02152826|7542556|FG000|NOT COMPLETED|Overall Study||1
6616243|NCT02152826|7542557|FG001|NOT COMPLETED|Overall Study||1
6616244|NCT02153073|7542563|FG000|STARTED|Overall Study||3084
6616245|NCT02153073|7542563|FG000|COMPLETED|Overall Study||2786
6616246|NCT02153073|7542563|FG000|NOT COMPLETED|Overall Study||298
6616247|NCT02153086|7542567|FG000|STARTED|Overall Study||236
6616248|NCT02153086|7542567|FG000|COMPLETED|Overall Study||232
6616249|NCT02153086|7542567|FG000|NOT COMPLETED|Overall Study||4
6616250|NCT02153099|7542578|FG000|STARTED|Overall Study||6
6616251|NCT02153099|7542579|FG001|STARTED|Overall Study||6
6616252|NCT02153099|7542580|FG002|STARTED|Overall Study||6
6616253|NCT02153099|7542581|FG003|STARTED|Overall Study||6
6616254|NCT02153099|7542582|FG004|STARTED|Overall Study||6
6616255|NCT02153099|7542583|FG005|STARTED|Overall Study||6
6616256|NCT02153099|7542584|FG006|STARTED|Overall Study||12
6616257|NCT02153099|7542578|FG000|COMPLETED|Overall Study||6
6616258|NCT02153099|7542579|FG001|COMPLETED|Overall Study||6
6616259|NCT02153099|7542580|FG002|COMPLETED|Overall Study||6
6616260|NCT02153099|7542581|FG003|COMPLETED|Overall Study||6
6616261|NCT02153099|7542582|FG004|COMPLETED|Overall Study||6
6616262|NCT02153099|7542583|FG005|COMPLETED|Overall Study||6
6616263|NCT02153099|7542584|FG006|COMPLETED|Overall Study||12
6616264|NCT02153099|7542578|FG000|NOT COMPLETED|Overall Study||0
6616265|NCT02153099|7542579|FG001|NOT COMPLETED|Overall Study||0
6616266|NCT02153099|7542580|FG002|NOT COMPLETED|Overall Study||0
6616267|NCT02153099|7542581|FG003|NOT COMPLETED|Overall Study||0
6616268|NCT02153099|7542582|FG004|NOT COMPLETED|Overall Study||0
6616269|NCT02153099|7542583|FG005|NOT COMPLETED|Overall Study||0
6616270|NCT02153099|7542584|FG006|NOT COMPLETED|Overall Study||0
6616271|NCT02153112|7542610|FG000|STARTED|Overall Study||61
6616272|NCT02153112|7542611|FG001|STARTED|Overall Study||59
6616273|NCT02153112|7542612|FG002|STARTED|Overall Study||61
6616274|NCT02153112|7542613|FG003|STARTED|Overall Study||59
6616275|NCT02153112|7542614|FG004|STARTED|Overall Study||60
6616276|NCT02153112|7542615|FG005|STARTED|Overall Study||60
6616277|NCT02153112|7542616|FG006|STARTED|Overall Study||60
6616278|NCT02153112|7542617|FG007|STARTED|Overall Study||60
6616279|NCT02153112|7542618|FG008|STARTED|Overall Study||180
6616280|NCT02153112|7542619|FG009|STARTED|Overall Study||180
6616281|NCT02153112|7542610|FG000|COMPLETED|Overall Study||57
6616282|NCT02153112|7542611|FG001|COMPLETED|Overall Study||57
6616283|NCT02153112|7542612|FG002|COMPLETED|Overall Study||58
6616284|NCT02153112|7542613|FG003|COMPLETED|Overall Study||57
6616285|NCT02153112|7542614|FG004|COMPLETED|Overall Study||57
6616286|NCT02153112|7542615|FG005|COMPLETED|Overall Study||58
6616287|NCT02153112|7542616|FG006|COMPLETED|Overall Study||52
6616288|NCT02153112|7542617|FG007|COMPLETED|Overall Study||58
6616289|NCT02153112|7542618|FG008|COMPLETED|Overall Study||165
6616290|NCT02153112|7542619|FG009|COMPLETED|Overall Study||166
6616291|NCT02153112|7542610|FG000|NOT COMPLETED|Overall Study||4
6616292|NCT02153112|7542611|FG001|NOT COMPLETED|Overall Study||2
6616293|NCT02153112|7542612|FG002|NOT COMPLETED|Overall Study||3
6616294|NCT02153112|7542613|FG003|NOT COMPLETED|Overall Study||2
6616295|NCT02153112|7542614|FG004|NOT COMPLETED|Overall Study||3
6616296|NCT02153112|7542615|FG005|NOT COMPLETED|Overall Study||2
6616297|NCT02153112|7542616|FG006|NOT COMPLETED|Overall Study||8
6616298|NCT02153112|7542617|FG007|NOT COMPLETED|Overall Study||2
6616299|NCT02153112|7542618|FG008|NOT COMPLETED|Overall Study||15
6616300|NCT02153112|7542619|FG009|NOT COMPLETED|Overall Study||14
6616301|NCT02153346|7542643|FG000|STARTED|Overall Study||101
6616302|NCT02153346|7542643|FG000|COMPLETED|Overall Study||90
6616303|NCT02153346|7542643|FG000|NOT COMPLETED|Overall Study||11
6616304|NCT02153359|7542648|FG000|STARTED|Intervention 1 (1 Month)||11
6616305|NCT02153359|7542649|FG001|STARTED|Intervention 1 (1 Month)||12
6616306|NCT02153359|7542648|FG000|COMPLETED|Intervention 1 (1 Month)||11
6616307|NCT02153359|7542649|FG001|COMPLETED|Intervention 1 (1 Month)||12
6616308|NCT02153359|7542648|FG000|NOT COMPLETED|Intervention 1 (1 Month)||0
6616309|NCT02153359|7542649|FG001|NOT COMPLETED|Intervention 1 (1 Month)||0
6616310|NCT02153359|7542648|FG000|STARTED|Washout (at Least 1 Month)||11
6616311|NCT02153359|7542649|FG001|STARTED|Washout (at Least 1 Month)||12
6616312|NCT02153359|7542648|FG000|COMPLETED|Washout (at Least 1 Month)||11
6616313|NCT02153359|7542649|FG001|COMPLETED|Washout (at Least 1 Month)||12
6616314|NCT02153359|7542648|FG000|NOT COMPLETED|Washout (at Least 1 Month)||0
6616315|NCT02153359|7542649|FG001|NOT COMPLETED|Washout (at Least 1 Month)||0
6616316|NCT02153359|7542648|FG000|STARTED|Intervention 2 (1 Month)||11
6616317|NCT02153359|7542649|FG001|STARTED|Intervention 2 (1 Month)||12
6616318|NCT02153359|7542648|FG000|COMPLETED|Intervention 2 (1 Month)||11
6616319|NCT02153359|7542649|FG001|COMPLETED|Intervention 2 (1 Month)||10
6616320|NCT02153359|7542648|FG000|NOT COMPLETED|Intervention 2 (1 Month)||0
6616321|NCT02153359|7542649|FG001|NOT COMPLETED|Intervention 2 (1 Month)||2
6616322|NCT02153398|7542663|FG000|STARTED|Overall Study||10
6616323|NCT02153398|7542664|FG001|STARTED|Overall Study||10
6616324|NCT02153398|7542665|FG002|STARTED|Overall Study||10
6616325|NCT02153398|7542666|FG003|STARTED|Overall Study||10
6616326|NCT02153398|7542667|FG004|STARTED|Overall Study||10
6616327|NCT02153398|7542663|FG000|COMPLETED|Overall Study||9
6616328|NCT02153398|7542664|FG001|COMPLETED|Overall Study||10
6616329|NCT02153398|7542665|FG002|COMPLETED|Overall Study||9
6616330|NCT02153398|7542666|FG003|COMPLETED|Overall Study||9
6616331|NCT02153398|7542667|FG004|COMPLETED|Overall Study||10
6616332|NCT02153398|7542663|FG000|NOT COMPLETED|Overall Study||1
6616333|NCT02153398|7542664|FG001|NOT COMPLETED|Overall Study||0
6616334|NCT02153398|7542665|FG002|NOT COMPLETED|Overall Study||1
6616335|NCT02153398|7542666|FG003|NOT COMPLETED|Overall Study||1
6616336|NCT02153398|7542667|FG004|NOT COMPLETED|Overall Study||0
6616337|NCT02153476|7542681|FG000|STARTED|Overall Study||23
6616338|NCT02153476|7542682|FG001|STARTED|Overall Study||22
6616339|NCT02153476|7542681|FG000|COMPLETED|Overall Study||22
6616340|NCT02153476|7542682|FG001|COMPLETED|Overall Study||22
6616341|NCT02153476|7542681|FG000|NOT COMPLETED|Overall Study||1
6616342|NCT02153476|7542682|FG001|NOT COMPLETED|Overall Study||0
6616343|NCT02153489|7542688|FG000|STARTED|Period 1||15
6616344|NCT02153489|7542689|FG001|STARTED|Period 1||15
6616345|NCT02153489|7542688|FG000|COMPLETED|Period 1||15
6616346|NCT02153489|7542689|FG001|COMPLETED|Period 1||15
6616347|NCT02153489|7542688|FG000|NOT COMPLETED|Period 1||0
6616348|NCT02153489|7542689|FG001|NOT COMPLETED|Period 1||0
6616349|NCT02153489|7542688|FG000|STARTED|Period 2||15
6616350|NCT02153489|7542689|FG001|STARTED|Period 2||15
6616351|NCT02153489|7542688|FG000|COMPLETED|Period 2||15
6616352|NCT02153489|7542689|FG001|COMPLETED|Period 2||15
6616353|NCT02153489|7542688|FG000|NOT COMPLETED|Period 2||0
6616354|NCT02153489|7542689|FG001|NOT COMPLETED|Period 2||0
6616355|NCT02153528|7542697|FG000|STARTED|Overall Study||348
6616356|NCT02153528|7542698|FG001|STARTED|Overall Study||353
6616357|NCT02153528|7542697|FG000|COMPLETED|Overall Study||348
6616358|NCT02153528|7542698|FG001|COMPLETED|Overall Study||353
6616359|NCT02153528|7542697|FG000|NOT COMPLETED|Overall Study||0
6616360|NCT02153528|7542698|FG001|NOT COMPLETED|Overall Study||0
6616361|NCT02153671|7542708|FG000|STARTED|Overall Study||19
6616362|NCT02153671|7542709|FG001|STARTED|Overall Study||24
6616363|NCT02153671|7542708|FG000|COMPLETED|Overall Study||19
6616364|NCT02153671|7542709|FG001|COMPLETED|Overall Study||24
6616365|NCT02153671|7542708|FG000|NOT COMPLETED|Overall Study||0
6616366|NCT02153671|7542709|FG001|NOT COMPLETED|Overall Study||0
6616367|NCT02153710|7542717|FG000|STARTED|Overall Study||28
6616368|NCT02153710|7542718|FG001|STARTED|Overall Study||30
6616369|NCT02153710|7542717|FG000|COMPLETED|Overall Study||28
6616370|NCT02153710|7542718|FG001|COMPLETED|Overall Study||30
6616371|NCT02153710|7542717|FG000|NOT COMPLETED|Overall Study||0
6616372|NCT02153710|7542718|FG001|NOT COMPLETED|Overall Study||0
6616373|NCT02153723|7542724|FG000|STARTED|Overall Study||10
6616374|NCT02153723|7542724|FG000|COMPLETED|Overall Study||10
6616375|NCT02153723|7542724|FG000|NOT COMPLETED|Overall Study||0
6616376|NCT02153736|7542730|FG000|STARTED|Overall Study||7
6616377|NCT02153736|7542731|FG001|STARTED|Overall Study||7
6616378|NCT02153736|7542730|FG000|COMPLETED|Overall Study||5
6616379|NCT02153736|7542731|FG001|COMPLETED|Overall Study||5
6616380|NCT02153736|7542730|FG000|NOT COMPLETED|Overall Study||2
6616381|NCT02153736|7542731|FG001|NOT COMPLETED|Overall Study||2
6616382|NCT02153788|7542739|FG000|STARTED|Overall Study||25
6616383|NCT02153788|7542740|FG001|STARTED|Overall Study||19
6616384|NCT02153788|7542739|FG000|COMPLETED|Overall Study||23
6616385|NCT02153788|7542740|FG001|COMPLETED|Overall Study||18
6616386|NCT02153788|7542739|FG000|NOT COMPLETED|Overall Study||2
6616387|NCT02153788|7542740|FG001|NOT COMPLETED|Overall Study||1
6616388|NCT02153827|7542748|FG000|STARTED|Overall Study||25
6616389|NCT02153827|7542749|FG001|STARTED|Overall Study||23
6616390|NCT02153827|7542748|FG000|COMPLETED|Overall Study||22
6616391|NCT02153827|7542749|FG001|COMPLETED|Overall Study||14
6616392|NCT02153827|7542748|FG000|NOT COMPLETED|Overall Study||3
6616393|NCT02153827|7542749|FG001|NOT COMPLETED|Overall Study||9
6616394|NCT02153905|7542757|FG000|STARTED|Overall Study||1
6616395|NCT02153905|7542758|FG001|STARTED|Overall Study||2
6616396|NCT02153905|7542757|FG000|COMPLETED|Overall Study||0
6616397|NCT02153905|7542758|FG001|COMPLETED|Overall Study||2
6616398|NCT02153905|7542757|FG000|NOT COMPLETED|Overall Study||1
6616399|NCT02153905|7542758|FG001|NOT COMPLETED|Overall Study||0
6616400|NCT02153918|7542764|FG000|STARTED|Overall Study||27
6616401|NCT02153918|7542764|FG000|COMPLETED|Overall Study||26
6616402|NCT02153918|7542764|FG000|NOT COMPLETED|Overall Study||1
6616403|NCT02153983|7542774|FG000|STARTED|Overall Study||19
6616404|NCT02153983|7542775|FG001|STARTED|Overall Study||21
6616405|NCT02153983|7542776|FG002|STARTED|Overall Study||4
6616406|NCT02153983|7542777|FG003|STARTED|Overall Study||13
6616407|NCT02153983|7542778|FG004|STARTED|Overall Study||19
6616408|NCT02153983|7542779|FG005|STARTED|Overall Study||1
6616409|NCT02153983|7542774|FG000|COMPLETED|Overall Study||19
6616410|NCT02153983|7542775|FG001|COMPLETED|Overall Study||18
6616411|NCT02153983|7542776|FG002|COMPLETED|Overall Study||2
6616412|NCT02153983|7542777|FG003|COMPLETED|Overall Study||13
6616413|NCT02153983|7542778|FG004|COMPLETED|Overall Study||19
6616414|NCT02153983|7542779|FG005|COMPLETED|Overall Study||1
6616415|NCT02153983|7542774|FG000|NOT COMPLETED|Overall Study||0
6616416|NCT02153983|7542775|FG001|NOT COMPLETED|Overall Study||3
6616417|NCT02153983|7542776|FG002|NOT COMPLETED|Overall Study||2
6616418|NCT02153983|7542777|FG003|NOT COMPLETED|Overall Study||0
6616419|NCT02153983|7542778|FG004|NOT COMPLETED|Overall Study||0
6616420|NCT02153983|7542779|FG005|NOT COMPLETED|Overall Study||0
6616421|NCT02154048|7542796|FG000|STARTED|Overall Study||2
6616422|NCT02154048|7542797|FG001|STARTED|Overall Study||2
6616423|NCT02154048|7542798|FG002|STARTED|Overall Study||1
6616424|NCT02154048|7542796|FG000|COMPLETED|Overall Study||2
6616425|NCT02154048|7542797|FG001|COMPLETED|Overall Study||2
6616426|NCT02154048|7542798|FG002|COMPLETED|Overall Study||1
6616427|NCT02154048|7542796|FG000|NOT COMPLETED|Overall Study||0
6616428|NCT02154048|7542797|FG001|NOT COMPLETED|Overall Study||0
6616429|NCT02154048|7542798|FG002|NOT COMPLETED|Overall Study||0
6616430|NCT02154061|7542808|FG000|STARTED|Overall Study||16
6616431|NCT02154061|7542809|FG001|STARTED|Overall Study||17
6616432|NCT02154061|7542808|FG000|COMPLETED|Overall Study||14
6616433|NCT02154061|7542809|FG001|COMPLETED|Overall Study||17
6616434|NCT02154061|7542808|FG000|NOT COMPLETED|Overall Study||2
6616435|NCT02154061|7542809|FG001|NOT COMPLETED|Overall Study||0
6616436|NCT02154139|7542815|FG000|STARTED|Overall Study||651
6616437|NCT02154139|7542815|FG000|COMPLETED|Overall Study||644
6616438|NCT02154139|7542815|FG000|NOT COMPLETED|Overall Study||7
6616439|NCT02154243|7542822|FG000|STARTED|Overall Study||5
6616440|NCT02154243|7542823|FG001|STARTED|Overall Study||4
6616441|NCT02154243|7542824|FG002|STARTED|Overall Study||4
6616442|NCT02154243|7542822|FG000|COMPLETED|Overall Study||5
6616443|NCT02154243|7542823|FG001|COMPLETED|Overall Study||4
6616444|NCT02154243|7542824|FG002|COMPLETED|Overall Study||4
6616445|NCT02154243|7542822|FG000|NOT COMPLETED|Overall Study||0
6616446|NCT02154243|7542823|FG001|NOT COMPLETED|Overall Study||0
6616447|NCT02154243|7542824|FG002|NOT COMPLETED|Overall Study||0
6616448|NCT02154347|7542834|FG000|STARTED|Double-blind Period||60
6616449|NCT02154347|7542835|FG001|STARTED|Double-blind Period||118
6616450|NCT02154347|7542834|FG000|COMPLETED|Double-blind Period||57
6616451|NCT02154347|7542835|FG001|COMPLETED|Double-blind Period||114
6616452|NCT02154347|7542834|FG000|NOT COMPLETED|Double-blind Period||3
6616453|NCT02154347|7542835|FG001|NOT COMPLETED|Double-blind Period||4
6616454|NCT02154347|7542834|FG000|STARTED|Open-label Period||57
6616455|NCT02154347|7542835|FG001|STARTED|Open-label Period||113
6616456|NCT02154347|7542834|FG000|COMPLETED|Open-label Period||50
6616457|NCT02154347|7542835|FG001|COMPLETED|Open-label Period||88
6616458|NCT02154347|7542834|FG000|NOT COMPLETED|Open-label Period||7
6616459|NCT02154347|7542835|FG001|NOT COMPLETED|Open-label Period||25
6616460|NCT02154386|7542844|FG000|STARTED|Overall Study||23
6616461|NCT02154386|7542845|FG001|STARTED|Overall Study||23
6616462|NCT02154386|7542844|FG000|COMPLETED|Overall Study||22
6616463|NCT02154386|7542845|FG001|COMPLETED|Overall Study||21
6616464|NCT02154386|7542844|FG000|NOT COMPLETED|Overall Study||1
6616465|NCT02154386|7542845|FG001|NOT COMPLETED|Overall Study||2
6616466|NCT02154425|7542851|FG000|STARTED|Screening Period||18
6616467|NCT02154425|7542851|FG000|COMPLETED|Screening Period||17
6616468|NCT02154425|7542851|FG000|NOT COMPLETED|Screening Period||1
6616469|NCT02154425|7542851|FG000|STARTED|Sampling Period||17
6616470|NCT02154425|7542851|FG000|COMPLETED|Sampling Period||17
6616471|NCT02154425|7542851|FG000|NOT COMPLETED|Sampling Period||0
6616472|NCT02154477|7542861|FG000|STARTED|Overall Study||6
6616473|NCT02154477|7542862|FG001|STARTED|Overall Study||8
6616474|NCT02154477|7542861|FG000|COMPLETED|Overall Study||6
6616475|NCT02154477|7542862|FG001|COMPLETED|Overall Study||8
6616476|NCT02154477|7542861|FG000|NOT COMPLETED|Overall Study||0
6616477|NCT02154477|7542862|FG001|NOT COMPLETED|Overall Study||0
6616478|NCT02154581|7542870|FG000|STARTED|Overall Study||21
6616479|NCT02154581|7542871|FG001|STARTED|Overall Study||20
6616480|NCT02154581|7542870|FG000|COMPLETED|Overall Study||14
6616481|NCT02154581|7542871|FG001|COMPLETED|Overall Study||12
6616482|NCT02154581|7542870|FG000|NOT COMPLETED|Overall Study||7
6616483|NCT02154581|7542871|FG001|NOT COMPLETED|Overall Study||8
6616484|NCT02154672|7542879|FG000|STARTED|Overall Study||1
6616485|NCT02154672|7542879|FG000|COMPLETED|Overall Study||1
6616486|NCT02154672|7542879|FG000|NOT COMPLETED|Overall Study||0
6616487|NCT02154763|7542885|FG000|STARTED|Overall Study||60
6616488|NCT02154763|7542886|FG001|STARTED|Overall Study||60
6616489|NCT02154763|7542885|FG000|COMPLETED|Overall Study||46
6616490|NCT02154763|7542886|FG001|COMPLETED|Overall Study||46
6616491|NCT02154763|7542885|FG000|NOT COMPLETED|Overall Study||14
6616492|NCT02154763|7542886|FG001|NOT COMPLETED|Overall Study||14
6616493|NCT02154906|7542896|FG000|STARTED|Overall Study||21
6616494|NCT02154906|7542897|FG001|STARTED|Overall Study||20
6616495|NCT02154906|7542896|FG000|COMPLETED|Overall Study||19
6616496|NCT02154906|7542897|FG001|COMPLETED|Overall Study||17
6616497|NCT02154906|7542896|FG000|NOT COMPLETED|Overall Study||2
6616498|NCT02154906|7542897|FG001|NOT COMPLETED|Overall Study||3
6616499|NCT02155010|7542905|FG000|STARTED|Overall Study||37
6616500|NCT02155010|7542906|FG001|STARTED|Overall Study||37
6616501|NCT02155010|7542905|FG000|COMPLETED|Overall Study||31
6616502|NCT02155010|7542906|FG001|COMPLETED|Overall Study||31
6616503|NCT02155010|7542905|FG000|NOT COMPLETED|Overall Study||6
6616504|NCT02155010|7542906|FG001|NOT COMPLETED|Overall Study||6
6616505|NCT02155101|7542914|FG000|STARTED|Overall Study||39
6616506|NCT02155101|7542915|FG001|STARTED|Overall Study||81
6616507|NCT02155101|7542914|FG000|COMPLETED|Overall Study||39
6616508|NCT02155101|7542915|FG001|COMPLETED|Overall Study||80
6616509|NCT02155101|7542914|FG000|NOT COMPLETED|Overall Study||0
6616510|NCT02155101|7542915|FG001|NOT COMPLETED|Overall Study||1
6616511|NCT02155257|7542924|FG000|STARTED|Overall Study||10
6616512|NCT02155257|7542925|FG001|STARTED|Overall Study||10
6616513|NCT02155257|7542926|FG002|STARTED|Overall Study||10
6616514|NCT02155257|7542924|FG000|COMPLETED|Overall Study||10
6616515|NCT02155257|7542925|FG001|COMPLETED|Overall Study||10
6616516|NCT02155257|7542926|FG002|COMPLETED|Overall Study||10
6616517|NCT02155257|7542924|FG000|NOT COMPLETED|Overall Study||0
6616518|NCT02155257|7542925|FG001|NOT COMPLETED|Overall Study||0
6616519|NCT02155257|7542926|FG002|NOT COMPLETED|Overall Study||0
6616520|NCT02155283|7542934|FG000|STARTED|Overall Study||16
6616521|NCT02155283|7542934|FG000|COMPLETED|Overall Study||9
6616522|NCT02155283|7542934|FG000|NOT COMPLETED|Overall Study||7
6616523|NCT02155309|7542940|FG000|STARTED|Overall Study||13
6616524|NCT02155309|7542941|FG001|STARTED|Overall Study||10
6616525|NCT02155309|7542942|FG002|STARTED|Overall Study||13
6616526|NCT02155309|7542940|FG000|COMPLETED|Overall Study||13
6616527|NCT02155309|7542941|FG001|COMPLETED|Overall Study||10
6616528|NCT02155309|7542942|FG002|COMPLETED|Overall Study||12
6616529|NCT02155309|7542940|FG000|NOT COMPLETED|Overall Study||0
6616530|NCT02155309|7542941|FG001|NOT COMPLETED|Overall Study||0
6616531|NCT02155309|7542942|FG002|NOT COMPLETED|Overall Study||1
6616532|NCT02155322|7542949|FG000|STARTED|Overall Study||33
6616533|NCT02155322|7542949|FG000|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
6616534|NCT02155322|7542949|FG000|COMPLETED|Overall Study||19
6616535|NCT02155322|7542949|FG000|NOT COMPLETED|Overall Study||14
6616536|NCT02155335|7542953|FG000|STARTED|Period 1||50
6616537|NCT02155335|7542954|FG001|STARTED|Period 1||50
6616538|NCT02155335|7542953|FG000|Treated|Period 1||50
6616539|NCT02155335|7542954|FG001|Treated|Period 1||49
6616540|NCT02155335|7542953|FG000|COMPLETED|Period 1||50
6616541|NCT02155335|7542954|FG001|COMPLETED|Period 1||49
6616542|NCT02155335|7542953|FG000|NOT COMPLETED|Period 1||0
6616543|NCT02155335|7542954|FG001|NOT COMPLETED|Period 1||1
6616544|NCT02155335|7542953|FG000|STARTED|Period 2||50
6616545|NCT02155335|7542954|FG001|STARTED|Period 2||49
6616546|NCT02155335|7542953|FG000|COMPLETED|Period 2||50
6616547|NCT02155335|7542954|FG001|COMPLETED|Period 2||49
6616548|NCT02155335|7542953|FG000|NOT COMPLETED|Period 2||0
6616549|NCT02155335|7542954|FG001|NOT COMPLETED|Period 2||0
6616550|NCT02155465|7542965|FG000|STARTED|Overall Study||3
6616551|NCT02155465|7542966|FG001|STARTED|Overall Study||3
6616552|NCT02155465|7542967|FG002|STARTED|Overall Study||6
6616553|NCT02155465|7542968|FG003|STARTED|Overall Study||2
6616554|NCT02155465|7542969|FG004|STARTED|Overall Study||1
6616555|NCT02155465|7542970|FG005|STARTED|Overall Study||2
6616556|NCT02155465|7542971|FG006|STARTED|Overall Study||5
6616557|NCT02155465|7542965|FG000|COMPLETED|Overall Study||3
6616558|NCT02155465|7542966|FG001|COMPLETED|Overall Study||3
6616559|NCT02155465|7542967|FG002|COMPLETED|Overall Study||6
6616560|NCT02155465|7542968|FG003|COMPLETED|Overall Study||2
6616561|NCT02155465|7542969|FG004|COMPLETED|Overall Study||1
6616562|NCT02155465|7542970|FG005|COMPLETED|Overall Study||2
6616563|NCT02155465|7542971|FG006|COMPLETED|Overall Study||5
6616564|NCT02155465|7542965|FG000|NOT COMPLETED|Overall Study||0
6616565|NCT02155465|7542966|FG001|NOT COMPLETED|Overall Study||0
6616566|NCT02155465|7542967|FG002|NOT COMPLETED|Overall Study||0
6616567|NCT02155465|7542968|FG003|NOT COMPLETED|Overall Study||0
6616568|NCT02155465|7542969|FG004|NOT COMPLETED|Overall Study||0
6616569|NCT02155465|7542970|FG005|NOT COMPLETED|Overall Study||0
6616570|NCT02155465|7542971|FG006|NOT COMPLETED|Overall Study||0
6616571|NCT02155543|7542997|FG000|STARTED|Overall Study||9
6616572|NCT02155543|7542998|FG001|STARTED|Overall Study||9
6616573|NCT02155543|7542999|FG002|STARTED|Overall Study||9
6616574|NCT02155543|7543000|FG003|STARTED|Overall Study||9
6616575|NCT02155543|7543001|FG004|STARTED|Overall Study||3
6616576|NCT02155543|7543002|FG005|STARTED|Overall Study||3
6616577|NCT02155543|7543003|FG006|STARTED|Overall Study||9
6616578|NCT02155543|7542997|FG000|COMPLETED|Overall Study||9
6616579|NCT02155543|7542998|FG001|COMPLETED|Overall Study||9
6616580|NCT02155543|7542999|FG002|COMPLETED|Overall Study||9
6616581|NCT02155543|7543000|FG003|COMPLETED|Overall Study||9
6616582|NCT02155543|7543001|FG004|COMPLETED|Overall Study||3
6616583|NCT02155543|7543002|FG005|COMPLETED|Overall Study||3
6616584|NCT02155543|7543003|FG006|COMPLETED|Overall Study||9
6616585|NCT02155543|7542997|FG000|NOT COMPLETED|Overall Study||0
6616586|NCT02155543|7542998|FG001|NOT COMPLETED|Overall Study||0
6616587|NCT02155543|7542999|FG002|NOT COMPLETED|Overall Study||0
6616588|NCT02155543|7543000|FG003|NOT COMPLETED|Overall Study||0
6616589|NCT02155543|7543001|FG004|NOT COMPLETED|Overall Study||0
6616590|NCT02155543|7543002|FG005|NOT COMPLETED|Overall Study||0
6616591|NCT02155543|7543003|FG006|NOT COMPLETED|Overall Study||0
6616592|NCT02155608|7543018|FG000|STARTED|1a: 4 Week Double Blind Sham Controlled||32
6616593|NCT02155608|7543019|FG001|STARTED|1a: 4 Week Double Blind Sham Controlled||30
6616594|NCT02155608|7543018|FG000|COMPLETED|1a: 4 Week Double Blind Sham Controlled||32
6616595|NCT02155608|7543019|FG001|COMPLETED|1a: 4 Week Double Blind Sham Controlled||29
6616596|NCT02155608|7543018|FG000|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||0
6616597|NCT02155608|7543019|FG001|NOT COMPLETED|1a: 4 Week Double Blind Sham Controlled||1
6616598|NCT02155608|7543018|FG000|STARTED|1b: 1 Week Blinded Post Treatment||32
6616599|NCT02155608|7543019|FG001|STARTED|1b: 1 Week Blinded Post Treatment||29
6616600|NCT02155608|7543018|FG000|COMPLETED|1b: 1 Week Blinded Post Treatment||31
6616601|NCT02155608|7543019|FG001|COMPLETED|1b: 1 Week Blinded Post Treatment||28
6616602|NCT02155608|7543018|FG000|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
6616603|NCT02155608|7543019|FG001|NOT COMPLETED|1b: 1 Week Blinded Post Treatment||1
6616604|NCT02155647|7543033|FG000|STARTED|Overall Study||88
6616605|NCT02155647|7543034|FG001|STARTED|Overall Study||116
6616606|NCT02155647|7543033|FG000|COMPLETED|Overall Study||47
6616607|NCT02155647|7543034|FG001|COMPLETED|Overall Study||64
6616608|NCT02155647|7543033|FG000|NOT COMPLETED|Overall Study||41
6616609|NCT02155647|7543034|FG001|NOT COMPLETED|Overall Study||52
6616610|NCT02155660|7543044|FG000|STARTED|Overall Study||562
6616611|NCT02155660|7543045|FG001|STARTED|Overall Study||562
6616612|NCT02155660|7543046|FG002|STARTED|Overall Study||562
6616613|NCT02155660|7543047|FG003|STARTED|Overall Study||568
6616614|NCT02155660|7543044|FG000|COMPLETED|Overall Study||504
6616615|NCT02155660|7543045|FG001|COMPLETED|Overall Study||489
6616616|NCT02155660|7543046|FG002|COMPLETED|Overall Study||502
6616617|NCT02155660|7543047|FG003|COMPLETED|Overall Study||507
6616618|NCT02155660|7543044|FG000|NOT COMPLETED|Overall Study||58
6616619|NCT02155660|7543045|FG001|NOT COMPLETED|Overall Study||73
6616620|NCT02155660|7543046|FG002|NOT COMPLETED|Overall Study||60
6616621|NCT02155660|7543047|FG003|NOT COMPLETED|Overall Study||61
6616622|NCT02155712|7543059|FG000|STARTED|Primary Objective||319
6616623|NCT02155712|7543060|FG001|STARTED|Primary Objective|Cohort 2 isn't included in primary obj analysis|0
6616624|NCT02155712|7543059|FG000|COMPLETED|Primary Objective||259
6616625|NCT02155712|7543060|FG001|COMPLETED|Primary Objective||0
6616626|NCT02155712|7543059|FG000|NOT COMPLETED|Primary Objective||60
6616627|NCT02155712|7543060|FG001|NOT COMPLETED|Primary Objective||0
6616628|NCT02155712|7543059|FG000|STARTED|Secondary Objectives||319
6616629|NCT02155712|7543060|FG001|STARTED|Secondary Objectives|This period will be updated when posting secondary objective results.|134
6616630|NCT02155712|7543059|FG000|COMPLETED|Secondary Objectives||0
6616631|NCT02155712|7543060|FG001|COMPLETED|Secondary Objectives||0
6616632|NCT02155712|7543059|FG000|NOT COMPLETED|Secondary Objectives||319
6616633|NCT02155712|7543060|FG001|NOT COMPLETED|Secondary Objectives||134
6616634|NCT02155725|7543068|FG000|STARTED|Treatment Period||224
6616635|NCT02155725|7543069|FG001|STARTED|Treatment Period||213
6616636|NCT02155725|7543068|FG000|COMPLETED|Treatment Period||224
6616637|NCT02155725|7543069|FG001|COMPLETED|Treatment Period||213
6616638|NCT02155725|7543068|FG000|NOT COMPLETED|Treatment Period||0
6616639|NCT02155725|7543069|FG001|NOT COMPLETED|Treatment Period||0
6616640|NCT02155725|7543068|FG000|STARTED|Follow-up Period||224
6616641|NCT02155725|7543069|FG001|STARTED|Follow-up Period||213
6616642|NCT02155725|7543068|FG000|COMPLETED|Follow-up Period||207
6616643|NCT02155725|7543069|FG001|COMPLETED|Follow-up Period||202
6616644|NCT02155725|7543068|FG000|NOT COMPLETED|Follow-up Period||17
6616645|NCT02155725|7543069|FG001|NOT COMPLETED|Follow-up Period||11
6616646|NCT02155738|7543085|FG000|STARTED|Overall Study||50
6616647|NCT02155738|7543086|FG001|STARTED|Overall Study||52
6616648|NCT02155738|7543087|FG002|STARTED|Overall Study||51
6616649|NCT02155738|7543088|FG003|STARTED|Overall Study||51
6616650|NCT02155738|7543085|FG000|COMPLETED|Overall Study||49
6616651|NCT02155738|7543086|FG001|COMPLETED|Overall Study||52
6616652|NCT02155738|7543087|FG002|COMPLETED|Overall Study||51
6616653|NCT02155738|7543088|FG003|COMPLETED|Overall Study||50
6616654|NCT02155738|7543085|FG000|NOT COMPLETED|Overall Study||1
6616655|NCT02155738|7543086|FG001|NOT COMPLETED|Overall Study||0
6616656|NCT02155738|7543087|FG002|NOT COMPLETED|Overall Study||0
6616657|NCT02155738|7543088|FG003|NOT COMPLETED|Overall Study||1
6616658|NCT02155829|7543100|FG000|STARTED|Overall Study||37
6616659|NCT02155829|7543101|FG001|STARTED|Overall Study||38
6616660|NCT02155829|7543100|FG000|COMPLETED|Overall Study||31
6616661|NCT02155829|7543101|FG001|COMPLETED|Overall Study||35
6616662|NCT02155829|7543100|FG000|NOT COMPLETED|Overall Study||6
6616663|NCT02155829|7543101|FG001|NOT COMPLETED|Overall Study||3
6616664|NCT02155881|7543110|FG000|STARTED|Overall Study||40
6616665|NCT02155881|7543111|FG001|STARTED|Overall Study||40
6616666|NCT02155881|7543110|FG000|COMPLETED|Overall Study||38
6616667|NCT02155881|7543111|FG001|COMPLETED|Overall Study||36
6616668|NCT02155881|7543110|FG000|NOT COMPLETED|Overall Study||2
6616669|NCT02155881|7543111|FG001|NOT COMPLETED|Overall Study||4
6616670|NCT02155985|7543120|FG000|STARTED|Overall Study||40
6616671|NCT02155985|7543121|FG001|STARTED|Overall Study||41
6616672|NCT02155985|7543122|FG002|STARTED|Overall Study||40
6616673|NCT02155985|7543120|FG000|COMPLETED|Overall Study||39
6616674|NCT02155985|7543121|FG001|COMPLETED|Overall Study||41
6616675|NCT02155985|7543122|FG002|COMPLETED|Overall Study||39
6616676|NCT02155985|7543120|FG000|NOT COMPLETED|Overall Study||1
6616677|NCT02155985|7543121|FG001|NOT COMPLETED|Overall Study||0
6616678|NCT02155985|7543122|FG002|NOT COMPLETED|Overall Study||1
6616679|NCT02156076|7543134|FG000|STARTED|Treatment Period||7
6616680|NCT02156076|7543135|FG001|STARTED|Treatment Period||7
6616681|NCT02156076|7543136|FG002|STARTED|Treatment Period||6
6616682|NCT02156076|7543137|FG003|STARTED|Treatment Period||6
6616683|NCT02156076|7543134|FG000|COMPLETED|Treatment Period||7
6616684|NCT02156076|7543135|FG001|COMPLETED|Treatment Period||5
6616685|NCT02156076|7543136|FG002|COMPLETED|Treatment Period||4
6616686|NCT02156076|7543137|FG003|COMPLETED|Treatment Period||4
6616687|NCT02156076|7543134|FG000|NOT COMPLETED|Treatment Period||0
6616688|NCT02156076|7543135|FG001|NOT COMPLETED|Treatment Period||2
6616689|NCT02156076|7543136|FG002|NOT COMPLETED|Treatment Period||2
6616690|NCT02156076|7543137|FG003|NOT COMPLETED|Treatment Period||2
6616691|NCT02156076|7543134|FG000|STARTED|Follow-up Period||7
6616692|NCT02156076|7543135|FG001|STARTED|Follow-up Period||5
6616693|NCT02156076|7543136|FG002|STARTED|Follow-up Period||4
6616694|NCT02156076|7543137|FG003|STARTED|Follow-up Period||4
6616695|NCT02156076|7543134|FG000|COMPLETED|Follow-up Period||6
6616696|NCT02156076|7543135|FG001|COMPLETED|Follow-up Period||5
6616697|NCT02156076|7543136|FG002|COMPLETED|Follow-up Period||4
6616698|NCT02156076|7543137|FG003|COMPLETED|Follow-up Period||4
6616699|NCT02156076|7543134|FG000|NOT COMPLETED|Follow-up Period||1
6616700|NCT02156076|7543135|FG001|NOT COMPLETED|Follow-up Period||0
6616701|NCT02156076|7543136|FG002|NOT COMPLETED|Follow-up Period||0
6616702|NCT02156076|7543137|FG003|NOT COMPLETED|Follow-up Period||0
6616703|NCT02156154|7543149|FG000|STARTED|Overall Study||291
6616704|NCT02156154|7543150|FG001|STARTED|Overall Study||289
6616705|NCT02156154|7543149|FG000|COMPLETED|Overall Study||287
6616706|NCT02156154|7543150|FG001|COMPLETED|Overall Study||283
6616707|NCT02156154|7543149|FG000|NOT COMPLETED|Overall Study||4
6616708|NCT02156154|7543150|FG001|NOT COMPLETED|Overall Study||6
6616709|NCT02156167|7543156|FG000|STARTED|Overall Study||15
6616710|NCT02156167|7543156|FG000|COMPLETED|Overall Study||15
6616711|NCT02156167|7543156|FG000|NOT COMPLETED|Overall Study||0
6616712|NCT02156258|7543163|FG000|STARTED|Overall Study||674
6616713|NCT02156258|7543164|FG001|STARTED|Overall Study||203
6616714|NCT02156258|7543165|FG002|STARTED|Overall Study||355
6616715|NCT02156258|7543163|FG000|COMPLETED|Overall Study||642
6616716|NCT02156258|7543164|FG001|COMPLETED|Overall Study||124
6616717|NCT02156258|7543165|FG002|COMPLETED|Overall Study||244
6616718|NCT02156258|7543163|FG000|NOT COMPLETED|Overall Study||32
6616719|NCT02156258|7543164|FG001|NOT COMPLETED|Overall Study||79
6616720|NCT02156258|7543165|FG002|NOT COMPLETED|Overall Study||111
6616721|NCT02156271|7543175|FG000|STARTED|Overall Study||26
6616722|NCT02156271|7543176|FG001|STARTED|Overall Study||13
6616723|NCT02156271|7543175|FG000|COMPLETED|Overall Study||22
6616724|NCT02156271|7543176|FG001|COMPLETED|Overall Study||10
6616725|NCT02156271|7543175|FG000|NOT COMPLETED|Overall Study||4
6616726|NCT02156271|7543176|FG001|NOT COMPLETED|Overall Study||3
6616727|NCT02156466|7543187|FG000|STARTED|Overall Study||8
6616728|NCT02156466|7543188|FG001|STARTED|Overall Study||8
6616729|NCT02156466|7543189|FG002|STARTED|Overall Study||8
6616730|NCT02156466|7543190|FG003|STARTED|Overall Study||9
6616731|NCT02156466|7543191|FG004|STARTED|Overall Study||8
6616732|NCT02156466|7543187|FG000|COMPLETED|Overall Study||8
6616733|NCT02156466|7543188|FG001|COMPLETED|Overall Study||8
6616734|NCT02156466|7543189|FG002|COMPLETED|Overall Study||7
6616735|NCT02156466|7543190|FG003|COMPLETED|Overall Study||7
6616736|NCT02156466|7543191|FG004|COMPLETED|Overall Study||8
6616737|NCT02156466|7543187|FG000|NOT COMPLETED|Overall Study||0
6616738|NCT02156466|7543188|FG001|NOT COMPLETED|Overall Study||0
6616739|NCT02156466|7543189|FG002|NOT COMPLETED|Overall Study||1
6616740|NCT02156466|7543190|FG003|NOT COMPLETED|Overall Study||2
6616741|NCT02156466|7543191|FG004|NOT COMPLETED|Overall Study||0
6616742|NCT02156492|7543215|FG000|STARTED|Period 1||16
6616743|NCT02156492|7543216|FG001|STARTED|Period 1||24
6616744|NCT02156492|7543217|FG002|STARTED|Period 1||22
6616745|NCT02156492|7543215|FG000|Received at Least One Dose of Study Drug|Period 1||16
6616746|NCT02156492|7543216|FG001|Received at Least One Dose of Study Drug|Period 1||24
6616747|NCT02156492|7543217|FG002|Received at Least One Dose of Study Drug|Period 1||22
6616748|NCT02156492|7543215|FG000|COMPLETED|Period 1||16
6616749|NCT02156492|7543216|FG001|COMPLETED|Period 1||23
6616750|NCT02156492|7543217|FG002|COMPLETED|Period 1||22
6616751|NCT02156492|7543215|FG000|NOT COMPLETED|Period 1||0
6616752|NCT02156492|7543216|FG001|NOT COMPLETED|Period 1||1
6616753|NCT02156492|7543217|FG002|NOT COMPLETED|Period 1||0
6616754|NCT02156492|7543215|FG000|STARTED|Period 2||16
6616755|NCT02156492|7543216|FG001|STARTED|Period 2||23
6616756|NCT02156492|7543217|FG002|STARTED|Period 2||22
6616757|NCT02156492|7543215|FG000|COMPLETED|Period 2||16
6616758|NCT02156492|7543216|FG001|COMPLETED|Period 2||23
6616759|NCT02156492|7543217|FG002|COMPLETED|Period 2||22
6616760|NCT02156492|7543215|FG000|NOT COMPLETED|Period 2||0
6616761|NCT02156492|7543216|FG001|NOT COMPLETED|Period 2||0
6616762|NCT02156492|7543217|FG002|NOT COMPLETED|Period 2||0
6616763|NCT02156492|7543215|FG000|STARTED|Period 3|Cohort A participated in Period 1 and Period 2 only.|0
6616764|NCT02156492|7543216|FG001|STARTED|Period 3||23
6616765|NCT02156492|7543217|FG002|STARTED|Period 3||22
6616766|NCT02156492|7543215|FG000|COMPLETED|Period 3||0
6616767|NCT02156492|7543216|FG001|COMPLETED|Period 3||22
6616768|NCT02156492|7543217|FG002|COMPLETED|Period 3||22
6616769|NCT02156492|7543215|FG000|NOT COMPLETED|Period 3||0
6616770|NCT02156492|7543216|FG001|NOT COMPLETED|Period 3||1
6616771|NCT02156492|7543217|FG002|NOT COMPLETED|Period 3||0
6616772|NCT02156674|7543235|FG000|STARTED|Overall Study||1
6616773|NCT02156674|7543235|FG000|COMPLETED|Overall Study||1
6616774|NCT02156674|7543235|FG000|NOT COMPLETED|Overall Study||0
6616775|NCT02156687|7543241|FG000|STARTED|Overall Study||30
6616776|NCT02156687|7543242|FG001|STARTED|Overall Study||29
6616777|NCT02156687|7543241|FG000|COMPLETED|Overall Study||20
6616778|NCT02156687|7543242|FG001|COMPLETED|Overall Study||24
6616779|NCT02156687|7543241|FG000|NOT COMPLETED|Overall Study||10
6616780|NCT02156687|7543242|FG001|NOT COMPLETED|Overall Study||5
6616781|NCT02156804|7543248|FG000|STARTED|Overall Study||1009
6616782|NCT02156804|7543248|FG000|COMPLETED|Overall Study||1008
6616783|NCT02156804|7543248|FG000|NOT COMPLETED|Overall Study||1
6616784|NCT02156908|7543254|FG000|STARTED|Overall Study||5
6616785|NCT02156908|7543255|FG001|STARTED|Overall Study||3
6616786|NCT02156908|7543254|FG000|COMPLETED|Overall Study||5
6616787|NCT02156908|7543255|FG001|COMPLETED|Overall Study||3
6616788|NCT02156908|7543254|FG000|NOT COMPLETED|Overall Study||0
6616789|NCT02156908|7543255|FG001|NOT COMPLETED|Overall Study||0
6616790|NCT02157103|7543262|FG000|STARTED|Overall Study||3
6616791|NCT02157103|7543262|FG000|COMPLETED|Overall Study||3
6616792|NCT02157103|7543262|FG000|NOT COMPLETED|Overall Study||0
6616793|NCT02157168|7543269|FG000|STARTED|Overall Study||746
6616794|NCT02157168|7543270|FG001|STARTED|Overall Study||159
6616795|NCT02157168|7543271|FG002|STARTED|Overall Study||1362
6616796|NCT02157168|7543269|FG000|COMPLETED|Overall Study||746
6616797|NCT02157168|7543270|FG001|COMPLETED|Overall Study||159
6616798|NCT02157168|7543271|FG002|COMPLETED|Overall Study||1362
6616799|NCT02157168|7543269|FG000|NOT COMPLETED|Overall Study||0
6616800|NCT02157168|7543270|FG001|NOT COMPLETED|Overall Study||0
6616801|NCT02157168|7543271|FG002|NOT COMPLETED|Overall Study||0
6616802|NCT02157298|7543284|FG000|STARTED|Overall Study||123
6616803|NCT02157298|7543285|FG001|STARTED|Overall Study||60
6616804|NCT02157298|7543284|FG000|COMPLETED|Overall Study||119
6616805|NCT02157298|7543285|FG001|COMPLETED|Overall Study||58
6616806|NCT02157298|7543284|FG000|NOT COMPLETED|Overall Study||4
6616807|NCT02157298|7543285|FG001|NOT COMPLETED|Overall Study||2
6616808|NCT02157376|7543293|FG000|STARTED|Overall Study||155
6616809|NCT02157376|7543294|FG001|STARTED|Overall Study||156
6616810|NCT02157376|7543293|FG000|COMPLETED|Overall Study||133
6616811|NCT02157376|7543294|FG001|COMPLETED|Overall Study||138
6616812|NCT02157376|7543293|FG000|NOT COMPLETED|Overall Study||22
6616813|NCT02157376|7543294|FG001|NOT COMPLETED|Overall Study||18
6616814|NCT02157506|7543305|FG000|STARTED|Overall Study||12
6616815|NCT02157506|7543306|FG001|STARTED|Overall Study||6
6616816|NCT02157506|7543307|FG002|STARTED|Overall Study||9
6616817|NCT02157506|7543308|FG003|STARTED|Overall Study||12
6616818|NCT02157506|7543309|FG004|STARTED|Overall Study||7
6616819|NCT02157506|7543305|FG000|COMPLETED|Overall Study||12
6616820|NCT02157506|7543306|FG001|COMPLETED|Overall Study||5
6616821|NCT02157506|7543307|FG002|COMPLETED|Overall Study||8
6616822|NCT02157506|7543308|FG003|COMPLETED|Overall Study||12
6616823|NCT02157506|7543309|FG004|COMPLETED|Overall Study||7
6616824|NCT02157506|7543305|FG000|NOT COMPLETED|Overall Study||0
6616825|NCT02157506|7543306|FG001|NOT COMPLETED|Overall Study||1
6616826|NCT02157506|7543307|FG002|NOT COMPLETED|Overall Study||1
6616827|NCT02157506|7543308|FG003|NOT COMPLETED|Overall Study||0
6616828|NCT02157506|7543309|FG004|NOT COMPLETED|Overall Study||0
6616829|NCT02157519|7543323|FG000|STARTED|Overall Study||91
6616830|NCT02157519|7543324|FG001|STARTED|Overall Study||90
6616831|NCT02157519|7543323|FG000|MEMScap Collected|Overall Study||84
6616832|NCT02157519|7543324|FG001|MEMScap Collected|Overall Study||86
6616833|NCT02157519|7543323|FG000|COMPLETED|Overall Study||80
6616834|NCT02157519|7543324|FG001|COMPLETED|Overall Study||89
6616835|NCT02157519|7543323|FG000|NOT COMPLETED|Overall Study||11
6616836|NCT02157519|7543324|FG001|NOT COMPLETED|Overall Study||1
6616837|NCT02157623|7543330|FG000|STARTED|Overall Study|3 patients, each received red light on half of body and blue light on the contralateral side.|3
6616838|NCT02157623|7543330|FG000|COMPLETED|Overall Study||3
6616839|NCT02157623|7543330|FG000|NOT COMPLETED|Overall Study||0
6616840|NCT02157779|7543342|FG000|STARTED|Overall Study||47
6616841|NCT02157779|7543343|FG001|STARTED|Overall Study||45
6616842|NCT02157779|7543342|FG000|COMPLETED|Overall Study||23
6616843|NCT02157779|7543343|FG001|COMPLETED|Overall Study||34
6616844|NCT02157779|7543342|FG000|NOT COMPLETED|Overall Study||24
6616845|NCT02157779|7543343|FG001|NOT COMPLETED|Overall Study||11
6616846|NCT02157909|7543354|FG000|STARTED|Overall Study||66
6616847|NCT02157909|7543355|FG001|STARTED|Overall Study||66
6616848|NCT02157909|7543354|FG000|COMPLETED|Overall Study||66
6616849|NCT02157909|7543355|FG001|COMPLETED|Overall Study||66
6616850|NCT02157909|7543354|FG000|NOT COMPLETED|Overall Study||0
6616851|NCT02157909|7543355|FG001|NOT COMPLETED|Overall Study||0
6616852|NCT02157935|7543364|FG000|STARTED|Overall Study||606
6616853|NCT02157935|7543365|FG001|STARTED|Overall Study||613
6616854|NCT02157935|7543364|FG000|COMPLETED|Overall Study||567
6616855|NCT02157935|7543365|FG001|COMPLETED|Overall Study||548
6616856|NCT02157935|7543364|FG000|NOT COMPLETED|Overall Study||39
6616857|NCT02157935|7543365|FG001|NOT COMPLETED|Overall Study||65
6616858|NCT02157948|7543373|FG000|STARTED|Overall Study||197
6616859|NCT02157948|7543374|FG001|STARTED|Overall Study||197
6616860|NCT02157948|7543373|FG000|Received Treatment|Overall Study||196
6616861|NCT02157948|7543374|FG001|Received Treatment|Overall Study||196
6616862|NCT02157948|7543373|FG000|COMPLETED|Overall Study||188
6616863|NCT02157948|7543374|FG001|COMPLETED|Overall Study||188
6616864|NCT02157948|7543373|FG000|NOT COMPLETED|Overall Study||9
6616865|NCT02157948|7543374|FG001|NOT COMPLETED|Overall Study||9
6616866|NCT02158039|7543380|FG000|STARTED|Overall Study||33
6616867|NCT02158039|7543380|FG000|COMPLETED|Overall Study||23
6616868|NCT02158039|7543380|FG000|NOT COMPLETED|Overall Study||10
6616869|NCT02158247|7543386|FG000|STARTED|Overall Study||181
6616870|NCT02158247|7543386|FG000|COMPLETED|Overall Study||176
6616871|NCT02158247|7543386|FG000|NOT COMPLETED|Overall Study||5
6616872|NCT02158273|7543404|FG000|STARTED|Overall Study||25
6616873|NCT02158273|7543405|FG001|STARTED|Overall Study||25
6616874|NCT02158273|7543404|FG000|COMPLETED|Overall Study||22
6616875|NCT02158273|7543405|FG001|COMPLETED|Overall Study||22
6616876|NCT02158273|7543404|FG000|NOT COMPLETED|Overall Study||3
6616877|NCT02158273|7543405|FG001|NOT COMPLETED|Overall Study||3
6616878|NCT02158364|7543411|FG000|STARTED|Overall Study||3331
6616879|NCT02158364|7543411|FG000|COMPLETED|Overall Study||3271
6616880|NCT02158364|7543411|FG000|NOT COMPLETED|Overall Study||60
6616881|NCT02158442|7543417|FG000|STARTED|Overall Study||8
6616882|NCT02158442|7543418|FG001|STARTED|Overall Study||7
6616883|NCT02158442|7543417|FG000|COMPLETED|Overall Study||6
6616884|NCT02158442|7543418|FG001|COMPLETED|Overall Study||7
6616885|NCT02158442|7543417|FG000|NOT COMPLETED|Overall Study||2
6616886|NCT02158442|7543418|FG001|NOT COMPLETED|Overall Study||0
6616887|NCT02158494|7543426|FG000|STARTED|Overall Study||22
6616888|NCT02158494|7543427|FG001|STARTED|Overall Study||22
6616889|NCT02158494|7543426|FG000|COMPLETED|Overall Study||22
6616890|NCT02158494|7543427|FG001|COMPLETED|Overall Study||21
6616891|NCT02158494|7543426|FG000|NOT COMPLETED|Overall Study||0
6616892|NCT02158494|7543427|FG001|NOT COMPLETED|Overall Study||1
6616893|NCT02158520|7543440|FG000|STARTED|Overall Study||12
6616894|NCT02158520|7543441|FG001|STARTED|Overall Study||12
6616895|NCT02158520|7543440|FG000|AE Evaluated Prior to Crossover|Overall Study||12
6616896|NCT02158520|7543441|FG001|AE Evaluated Prior to Crossover|Overall Study||12
6616897|NCT02158520|7543440|FG000|Eligible for Crossover|Overall Study||8
6616898|NCT02158520|7543441|FG001|Eligible for Crossover|Overall Study||8
6616899|NCT02158520|7543440|FG000|Eligible for Crossover With AE Evaluated|Overall Study||7
6616900|NCT02158520|7543441|FG001|Eligible for Crossover With AE Evaluated|Overall Study||7
6616901|NCT02158520|7543440|FG000|Crossover Cohort|Overall Study||4
6616902|NCT02158520|7543441|FG001|Crossover Cohort|Overall Study||6
6616903|NCT02158520|7543440|FG000|COMPLETED|Overall Study||12
6616904|NCT02158520|7543441|FG001|COMPLETED|Overall Study||12
6616905|NCT02158520|7543440|FG000|NOT COMPLETED|Overall Study||0
6616906|NCT02158520|7543441|FG001|NOT COMPLETED|Overall Study||0
6616907|NCT02158533|7543452|FG000|STARTED|Stage 1||265
6616908|NCT02158533|7543453|FG001|STARTED|Stage 1||59
6616909|NCT02158533|7543454|FG002|STARTED|Stage 1||60
6616910|NCT02158533|7543455|FG003|STARTED|Stage 1||0
6616911|NCT02158533|7543456|FG004|STARTED|Stage 1||0
6616912|NCT02158533|7543457|FG005|STARTED|Stage 1||0
6616913|NCT02158533|7543452|FG000|COMPLETED|Stage 1||251
6616914|NCT02158533|7543453|FG001|COMPLETED|Stage 1||51
6616915|NCT02158533|7543454|FG002|COMPLETED|Stage 1||52
6616916|NCT02158533|7543455|FG003|COMPLETED|Stage 1||0
6616917|NCT02158533|7543456|FG004|COMPLETED|Stage 1||0
6616918|NCT02158533|7543457|FG005|COMPLETED|Stage 1||0
6616919|NCT02158533|7543452|FG000|NOT COMPLETED|Stage 1||14
6616920|NCT02158533|7543453|FG001|NOT COMPLETED|Stage 1||8
6616921|NCT02158533|7543454|FG002|NOT COMPLETED|Stage 1||8
6616922|NCT02158533|7543455|FG003|NOT COMPLETED|Stage 1||0
6616923|NCT02158533|7543456|FG004|NOT COMPLETED|Stage 1||0
6616924|NCT02158533|7543457|FG005|NOT COMPLETED|Stage 1||0
6616925|NCT02158533|7543452|FG000|STARTED|Stage 2||0
6616926|NCT02158533|7543453|FG001|STARTED|Stage 2||0
6616927|NCT02158533|7543454|FG002|STARTED|Stage 2||0
6616928|NCT02158533|7543455|FG003|STARTED|Stage 2||56
6616929|NCT02158533|7543456|FG004|STARTED|Stage 2||56
6616930|NCT02158533|7543457|FG005|STARTED|Stage 2||56
6616931|NCT02158533|7543452|FG000|COMPLETED|Stage 2||0
6616932|NCT02158533|7543453|FG001|COMPLETED|Stage 2||0
6616933|NCT02158533|7543454|FG002|COMPLETED|Stage 2||0
6616934|NCT02158533|7543455|FG003|COMPLETED|Stage 2||53
6616935|NCT02158533|7543456|FG004|COMPLETED|Stage 2||52
6616936|NCT02158533|7543457|FG005|COMPLETED|Stage 2||50
6616937|NCT02158533|7543452|FG000|NOT COMPLETED|Stage 2||0
6616938|NCT02158533|7543453|FG001|NOT COMPLETED|Stage 2||0
6616939|NCT02158533|7543454|FG002|NOT COMPLETED|Stage 2||0
6616940|NCT02158533|7543455|FG003|NOT COMPLETED|Stage 2||3
6616941|NCT02158533|7543456|FG004|NOT COMPLETED|Stage 2||4
6616942|NCT02158533|7543457|FG005|NOT COMPLETED|Stage 2||6
6616943|NCT02158546|7543475|FG000|STARTED|Overall Study||152
6616944|NCT02158546|7543476|FG001|STARTED|Overall Study||153
6616945|NCT02158546|7543477|FG002|STARTED|Overall Study||18
6616946|NCT02158546|7543478|FG003|STARTED|Overall Study||19
6616947|NCT02158546|7543475|FG000|COMPLETED|Overall Study||133
6616948|NCT02158546|7543476|FG001|COMPLETED|Overall Study||136
6616949|NCT02158546|7543477|FG002|COMPLETED|Overall Study||14
6616950|NCT02158546|7543478|FG003|COMPLETED|Overall Study||13
6616951|NCT02158546|7543475|FG000|NOT COMPLETED|Overall Study||19
6616952|NCT02158546|7543476|FG001|NOT COMPLETED|Overall Study||17
6616953|NCT02158546|7543477|FG002|NOT COMPLETED|Overall Study||4
6616954|NCT02158546|7543478|FG003|NOT COMPLETED|Overall Study||6
6616955|NCT02158572|7543488|FG000|STARTED|Overall Study||2032
6616956|NCT02158572|7543488|FG000|COMPLETED|Overall Study||989
6616957|NCT02158572|7543488|FG000|NOT COMPLETED|Overall Study||1043
6616958|NCT02158663|7543494|FG000|STARTED|Overall Study||22
6616959|NCT02158663|7543495|FG001|STARTED|Overall Study||22
6616960|NCT02158663|7543494|FG000|COMPLETED|Overall Study||17
6616961|NCT02158663|7543495|FG001|COMPLETED|Overall Study||18
6616962|NCT02158663|7543494|FG000|NOT COMPLETED|Overall Study||5
6616963|NCT02158663|7543495|FG001|NOT COMPLETED|Overall Study||4
6616964|NCT02158728|7543503|FG000|STARTED|Overall Study||80
6616965|NCT02158728|7543503|FG000|COMPLETED|Overall Study||53
6616966|NCT02158728|7543503|FG000|NOT COMPLETED|Overall Study||27
6616967|NCT02158806|7543509|FG000|STARTED|Overall Study||125
6616968|NCT02158806|7543510|FG001|STARTED|Overall Study||126
6616969|NCT02158806|7543509|FG000|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
6616970|NCT02158806|7543510|FG001|COMPLETED|Overall Study|We had information on all participants for the primary outcome (time to complete healing).|121
6616971|NCT02158806|7543509|FG000|NOT COMPLETED|Overall Study||4
6616972|NCT02158806|7543510|FG001|NOT COMPLETED|Overall Study||5
6616973|NCT02158884|7543516|FG000|STARTED|Baseline Assessment||91
6616974|NCT02158884|7543516|FG000|COMPLETED|Baseline Assessment||87
6616975|NCT02158884|7543516|FG000|NOT COMPLETED|Baseline Assessment||4
6616976|NCT02158884|7543516|FG000|STARTED|Intervention: IDEO and PT Program||87
6616977|NCT02158884|7543516|FG000|COMPLETED|Intervention: IDEO and PT Program||81
6616978|NCT02158884|7543516|FG000|NOT COMPLETED|Intervention: IDEO and PT Program||6
6616979|NCT02158884|7543516|FG000|STARTED|Post Intervention (~4 Weeks)||81
6616980|NCT02158884|7543516|FG000|COMPLETED|Post Intervention (~4 Weeks)||71
6616981|NCT02158884|7543516|FG000|NOT COMPLETED|Post Intervention (~4 Weeks)||10
6616982|NCT02158884|7543516|FG000|STARTED|6 Month Assessment||81
6616983|NCT02158884|7543516|FG000|COMPLETED|6 Month Assessment||61
6616984|NCT02158884|7543516|FG000|NOT COMPLETED|6 Month Assessment||20
6616985|NCT02158884|7543516|FG000|STARTED|12 Month Assessment||81
6616986|NCT02158884|7543516|FG000|COMPLETED|12 Month Assessment||64
6616987|NCT02158884|7543516|FG000|NOT COMPLETED|12 Month Assessment||17
6616988|NCT02158936|7543523|FG000|STARTED|Overall Study||179
6616989|NCT02158936|7543524|FG001|STARTED|Overall Study||177
6616990|NCT02158936|7543523|FG000|Treated|Overall Study||177
6616991|NCT02158936|7543524|FG001|Treated|Overall Study||177
6616992|NCT02158936|7543523|FG000|Untreated|Overall Study||2
6616993|NCT02158936|7543524|FG001|Untreated|Overall Study||0
6616994|NCT02158936|7543523|FG000|COMPLETED|Overall Study||0
6732992|NCT03202550|7662504|FG001|NOT COMPLETED|Overall Study||0
6732993|NCT03203291|7662510|FG000|STARTED|Overall Study||12
6732994|NCT03203291|7662510|FG000|COMPLETED|Overall Study||11
6732995|NCT03203291|7662510|FG000|NOT COMPLETED|Overall Study||1
6732996|NCT03203447|7662516|FG000|STARTED|Overall Study|Two patients were randomized to the Active arm, but did not receive study drug.|162
6732997|NCT03203447|7662517|FG001|STARTED|Overall Study|One patient was randomized to the Control arm, but did not receive study drug.|163
6732998|NCT03203447|7662516|FG000|COMPLETED|Overall Study||0
6732999|NCT03203447|7662517|FG001|COMPLETED|Overall Study||0
6733000|NCT03203447|7662516|FG000|NOT COMPLETED|Overall Study||162
6733001|NCT03203447|7662517|FG001|NOT COMPLETED|Overall Study||163
6733002|NCT03203564|7662527|FG000|STARTED|Overall Study||8
6733003|NCT03203564|7662528|FG001|STARTED|Overall Study||8
6733004|NCT03203564|7662529|FG002|STARTED|Overall Study||8
6733005|NCT03203564|7662530|FG003|STARTED|Overall Study||9
6733006|NCT03203564|7662527|FG000|COMPLETED|Overall Study||8
6733007|NCT03203564|7662528|FG001|COMPLETED|Overall Study||8
6733008|NCT03203564|7662529|FG002|COMPLETED|Overall Study||8
6733009|NCT03203564|7662530|FG003|COMPLETED|Overall Study||9
6733010|NCT03203564|7662527|FG000|NOT COMPLETED|Overall Study||0
6733011|NCT03203564|7662528|FG001|NOT COMPLETED|Overall Study||0
6733012|NCT03203564|7662529|FG002|NOT COMPLETED|Overall Study||0
6733013|NCT03203564|7662530|FG003|NOT COMPLETED|Overall Study||0
6733014|NCT03203681|7662540|FG000|STARTED|Overall Study||60
6733015|NCT03203681|7662540|FG000|3 Month|Overall Study||44
6733016|NCT03203681|7662540|FG000|6 Months|Overall Study||33
6733017|NCT03203681|7662540|FG000|COMPLETED|Overall Study||33
6733018|NCT03203681|7662540|FG000|NOT COMPLETED|Overall Study||27
6733019|NCT03204279|7662546|FG000|STARTED|Overall Study||34
6733020|NCT03204279|7662547|FG001|STARTED|Overall Study||33
6733021|NCT03204279|7662546|FG000|COMPLETED|Overall Study||34
6733022|NCT03204279|7662547|FG001|COMPLETED|Overall Study||32
6733023|NCT03204279|7662546|FG000|NOT COMPLETED|Overall Study||0
6733024|NCT03204279|7662547|FG001|NOT COMPLETED|Overall Study||1
6733025|NCT03204526|7662554|FG000|STARTED|Overall Study||15
6733026|NCT03204526|7662554|FG000|COMPLETED|Overall Study||15
6733027|NCT03204526|7662554|FG000|NOT COMPLETED|Overall Study||0
6733028|NCT03204942|7662561|FG000|STARTED|Overall Study||23
6733029|NCT03204942|7662562|FG001|STARTED|Overall Study||23
6733030|NCT03204942|7662563|FG002|STARTED|Overall Study||23
6733031|NCT03204942|7662561|FG000|COMPLETED|Overall Study||23
6733032|NCT03204942|7662562|FG001|COMPLETED|Overall Study||23
6733033|NCT03204942|7662563|FG002|COMPLETED|Overall Study||23
6733034|NCT03204942|7662561|FG000|NOT COMPLETED|Overall Study||0
6733035|NCT03204942|7662562|FG001|NOT COMPLETED|Overall Study||0
6733036|NCT03204942|7662563|FG002|NOT COMPLETED|Overall Study||0
6733037|NCT03204981|7662576|FG000|STARTED|Overall Study||52
6733038|NCT03204981|7662576|FG000|COMPLETED|Overall Study||46
6733039|NCT03204981|7662576|FG000|NOT COMPLETED|Overall Study||6
6733040|NCT03205046|7662584|FG000|STARTED|Overall Study||13
6733041|NCT03205046|7662585|FG001|STARTED|Overall Study||12
6733042|NCT03205046|7662584|FG000|COMPLETED|Overall Study||0
6733043|NCT03205046|7662585|FG001|COMPLETED|Overall Study||2
6733044|NCT03205046|7662584|FG000|NOT COMPLETED|Overall Study||13
6733045|NCT03205046|7662585|FG001|NOT COMPLETED|Overall Study||10
6733046|NCT03205150|7662594|FG000|STARTED|Overall Study||43
6733047|NCT03205150|7662595|FG001|STARTED|Overall Study||43
6733048|NCT03205150|7662596|FG002|STARTED|Overall Study||21
6733049|NCT03205150|7662594|FG000|Safety Analysis Set|Overall Study||43
6733050|NCT03205150|7662595|FG001|Safety Analysis Set|Overall Study||43
6733051|NCT03205150|7662596|FG002|Safety Analysis Set|Overall Study||21
6733052|NCT03205150|7662594|FG000|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|42
6733053|NCT03205150|7662595|FG001|Pharmacokinetics (PK) Analysis Set|Overall Study|all patients with valid PK measurements|36
6733054|NCT03205150|7662596|FG002|Pharmacokinetics (PK) Analysis Set|Overall Study|Placebo patients were excluded from the PK analyses|0
6739991|NCT03297294|7668836|FG000|COMPLETED|Double-Blind Treatment Period (DB)||32
6616995|NCT02158936|7543524|FG001|COMPLETED|Overall Study||0
6616996|NCT02158936|7543523|FG000|NOT COMPLETED|Overall Study||179
6616997|NCT02158936|7543524|FG001|NOT COMPLETED|Overall Study||177
6616998|NCT02158949|7543532|FG000|STARTED|Overall Study||24
6616999|NCT02158949|7543533|FG001|STARTED|Overall Study||24
6617000|NCT02158949|7543532|FG000|COMPLETED|Overall Study||18
6617001|NCT02158949|7543533|FG001|COMPLETED|Overall Study||13
6617002|NCT02158949|7543532|FG000|NOT COMPLETED|Overall Study||6
6617003|NCT02158949|7543533|FG001|NOT COMPLETED|Overall Study||11
6617004|NCT02158975|7543539|FG000|STARTED|Overall Study||13
6617005|NCT02158975|7543539|FG000|COMPLETED|Overall Study||12
6617006|NCT02158975|7543539|FG000|NOT COMPLETED|Overall Study||1
6617007|NCT02159053|7543547|FG000|STARTED|Overall Study||116
6617008|NCT02159053|7543548|FG001|STARTED|Overall Study||117
6617009|NCT02159053|7543549|FG002|STARTED|Overall Study||117
6617010|NCT02159053|7543547|FG000|Paticipants Week 16 Onwards|Overall Study||116
6617011|NCT02159053|7543548|FG001|Paticipants Week 16 Onwards|Overall Study||117
6617012|NCT02159053|7543549|FG002|Paticipants Week 16 Onwards|Overall Study||113
6617013|NCT02159053|7543547|FG000|COMPLETED|Overall Study||96
6617014|NCT02159053|7543548|FG001|COMPLETED|Overall Study||96
6617015|NCT02159053|7543549|FG002|COMPLETED|Overall Study||97
6617016|NCT02159053|7543547|FG000|NOT COMPLETED|Overall Study||20
6617017|NCT02159053|7543548|FG001|NOT COMPLETED|Overall Study||21
6617018|NCT02159053|7543549|FG002|NOT COMPLETED|Overall Study||20
6617019|NCT02159079|7543561|FG000|STARTED|Overall Study||15
6617020|NCT02159079|7543562|FG001|STARTED|Overall Study||15
6617021|NCT02159079|7543561|FG000|COMPLETED|Overall Study||15
6617022|NCT02159079|7543562|FG001|COMPLETED|Overall Study||15
6617023|NCT02159079|7543561|FG000|NOT COMPLETED|Overall Study||0
6617024|NCT02159079|7543562|FG001|NOT COMPLETED|Overall Study||0
6617025|NCT02159118|7543570|FG000|STARTED|Overall Study||22
6617026|NCT02159118|7543571|FG001|STARTED|Overall Study||22
6617027|NCT02159118|7543570|FG000|COMPLETED|Overall Study||22
6617028|NCT02159118|7543571|FG001|COMPLETED|Overall Study||22
6617029|NCT02159118|7543570|FG000|NOT COMPLETED|Overall Study||0
6617030|NCT02159118|7543571|FG001|NOT COMPLETED|Overall Study||0
6617031|NCT02159183|7543579|FG000|STARTED|Analysis After the 36 Months Follow-up||22
6617032|NCT02159183|7543580|FG001|STARTED|Analysis After the 36 Months Follow-up||21
6617033|NCT02159183|7543579|FG000|COMPLETED|Analysis After the 36 Months Follow-up||19
6617034|NCT02159183|7543580|FG001|COMPLETED|Analysis After the 36 Months Follow-up||19
6617035|NCT02159183|7543579|FG000|NOT COMPLETED|Analysis After the 36 Months Follow-up||3
6617036|NCT02159183|7543580|FG001|NOT COMPLETED|Analysis After the 36 Months Follow-up||2
6617037|NCT02159183|7543579|FG000|STARTED|Analysis of Primary Endpoint (12 Mts)||22
6617038|NCT02159183|7543580|FG001|STARTED|Analysis of Primary Endpoint (12 Mts)||21
6617039|NCT02159183|7543579|FG000|COMPLETED|Analysis of Primary Endpoint (12 Mts)||19
6617040|NCT02159183|7543580|FG001|COMPLETED|Analysis of Primary Endpoint (12 Mts)||20
6617041|NCT02159183|7543579|FG000|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||3
6617042|NCT02159183|7543580|FG001|NOT COMPLETED|Analysis of Primary Endpoint (12 Mts)||1
6617043|NCT02159352|7543588|FG000|STARTED|Overall Study||14
6617044|NCT02159352|7543589|FG001|STARTED|Overall Study||14
6617045|NCT02159352|7543588|FG000|Phase 1 (Day 1- 4)|Overall Study||14
6617046|NCT02159352|7543589|FG001|Phase 1 (Day 1- 4)|Overall Study||14
6617047|NCT02159352|7543588|FG000|Phase 2 (Day 5-14)|Overall Study||11
6617048|NCT02159352|7543589|FG001|Phase 2 (Day 5-14)|Overall Study||12
6617049|NCT02159352|7543588|FG000|COMPLETED|Overall Study||11
6617050|NCT02159352|7543589|FG001|COMPLETED|Overall Study||12
6617051|NCT02159352|7543588|FG000|NOT COMPLETED|Overall Study||3
6617052|NCT02159352|7543589|FG001|NOT COMPLETED|Overall Study||2
6617053|NCT02159365|7543614|FG000|STARTED|Overall Study||70
6617054|NCT02159365|7543614|FG000|COMPLETED|Overall Study|Completed = Still on treatment|0
6617055|NCT02159365|7543614|FG000|NOT COMPLETED|Overall Study||70
6617056|NCT02159469|7543618|FG000|STARTED|Overall Study||150
6617057|NCT02159469|7543618|FG000|Completed 12 Week|Overall Study||137
6617058|NCT02159469|7543618|FG000|COMPLETED|Overall Study||97
6617059|NCT02159469|7543618|FG000|NOT COMPLETED|Overall Study||53
6617060|NCT02159482|7543623|FG000|STARTED|Overall Study||11
6617061|NCT02159482|7543623|FG000|COMPLETED|Overall Study||6
6617062|NCT02159482|7543623|FG000|NOT COMPLETED|Overall Study||5
6617063|NCT02159521|7543627|FG000|STARTED|Overall Study|4 participants had both limbs treated.|81
6617064|NCT02159521|7543627|FG000|Received EkoSonic® Treatment|Overall Study||78
6617065|NCT02159521|7543627|FG000|COMPLETED|Overall Study||63
6617066|NCT02159521|7543627|FG000|NOT COMPLETED|Overall Study||18
6617067|NCT02159547|7543633|FG000|STARTED|Overall Study||112
6617068|NCT02159547|7543634|FG001|STARTED|Overall Study||112
6617069|NCT02159547|7543633|FG000|COMPLETED|Overall Study||112
6617070|NCT02159547|7543634|FG001|COMPLETED|Overall Study||112
6617071|NCT02159547|7543633|FG000|NOT COMPLETED|Overall Study||0
6617072|NCT02159547|7543634|FG001|NOT COMPLETED|Overall Study||0
6617073|NCT02159703|7543641|FG000|STARTED|Overall Study||60
6617074|NCT02159703|7543641|FG000|COMPLETED|Overall Study||60
6617075|NCT02159703|7543641|FG000|NOT COMPLETED|Overall Study||0
6733055|NCT03205150|7662594|FG000|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|43
6733056|NCT03205150|7662595|FG001|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|41
6733057|NCT03205150|7662596|FG002|Pharmacodynamics (PD) Analysis Set|Overall Study|all patients with available PD data and no protocol deviations|21
6733058|NCT03205150|7662594|FG000|COMPLETED|Overall Study||41
6733059|NCT03205150|7662595|FG001|COMPLETED|Overall Study||36
6733060|NCT03205150|7662596|FG002|COMPLETED|Overall Study||19
6733061|NCT03205150|7662594|FG000|NOT COMPLETED|Overall Study||2
6733062|NCT03205150|7662595|FG001|NOT COMPLETED|Overall Study||7
6733063|NCT03205150|7662596|FG002|NOT COMPLETED|Overall Study||2
6733064|NCT03205488|7662608|FG000|STARTED|Overall Study||25
6617076|NCT02159729|7543647|FG000|STARTED|Overall Study||140
6617077|NCT02159729|7543648|FG001|STARTED|Overall Study||65
6617078|NCT02159729|7543647|FG000|COMPLETED|Overall Study||98
6617079|NCT02159729|7543648|FG001|COMPLETED|Overall Study||44
6617080|NCT02159729|7543647|FG000|NOT COMPLETED|Overall Study||42
6617081|NCT02159729|7543648|FG001|NOT COMPLETED|Overall Study||21
6617082|NCT02159768|7543654|FG000|STARTED|Overall Study|Started 16 July 2014|30
6617083|NCT02159768|7543654|FG000|COMPLETED|Overall Study|Completed 27 July 2015|30
6617084|NCT02159768|7543654|FG000|NOT COMPLETED|Overall Study||0
6617085|NCT02159807|7543661|FG000|STARTED|Overall Study||67
6617086|NCT02159807|7543662|FG001|STARTED|Overall Study||52
6617087|NCT02159807|7543663|FG002|STARTED|Overall Study||51
6617088|NCT02159807|7543661|FG000|COMPLETED|Overall Study||66
6617089|NCT02159807|7543662|FG001|COMPLETED|Overall Study||51
6617090|NCT02159807|7543663|FG002|COMPLETED|Overall Study||48
6617091|NCT02159807|7543661|FG000|NOT COMPLETED|Overall Study||1
6617092|NCT02159807|7543662|FG001|NOT COMPLETED|Overall Study||1
6617093|NCT02159807|7543663|FG002|NOT COMPLETED|Overall Study||3
6617094|NCT02159859|7543671|FG000|STARTED|Overall Study||7
6617095|NCT02159859|7543671|FG000|COMPLETED|Overall Study||7
6617096|NCT02159859|7543671|FG000|NOT COMPLETED|Overall Study||0
6617097|NCT02159872|7543675|FG000|STARTED|Overall Study||48
6617098|NCT02159872|7543675|FG000|COMPLETED|Overall Study||48
6617099|NCT02159872|7543675|FG000|NOT COMPLETED|Overall Study||0
6617100|NCT02159898|7543681|FG000|STARTED|Overall Study||30
6617101|NCT02159898|7543682|FG001|STARTED|Overall Study||30
6617102|NCT02159898|7543681|FG000|COMPLETED|Overall Study||29
6617103|NCT02159898|7543682|FG001|COMPLETED|Overall Study||30
6617104|NCT02159898|7543681|FG000|NOT COMPLETED|Overall Study||1
6617105|NCT02159898|7543682|FG001|NOT COMPLETED|Overall Study||0
6617106|NCT02159950|7543692|FG000|STARTED|Overall Study||0
6617107|NCT02159950|7543693|FG001|STARTED|Overall Study||2
6617108|NCT02159950|7543692|FG000|COMPLETED|Overall Study||0
6617109|NCT02159950|7543693|FG001|COMPLETED|Overall Study||0
6617110|NCT02159950|7543692|FG000|NOT COMPLETED|Overall Study||0
6617111|NCT02159950|7543693|FG001|NOT COMPLETED|Overall Study||2
6617112|NCT02159976|7543701|FG000|STARTED|Overall Study||195
6617113|NCT02159976|7543702|FG001|STARTED|Overall Study||195
6617114|NCT02159976|7543701|FG000|COMPLETED|Overall Study||165
6617115|NCT02159976|7543702|FG001|COMPLETED|Overall Study||170
6617116|NCT02159976|7543701|FG000|NOT COMPLETED|Overall Study||30
6617117|NCT02159976|7543702|FG001|NOT COMPLETED|Overall Study||25
6617118|NCT02160002|7543712|FG000|STARTED|Overall Study||187
6617119|NCT02160002|7543713|FG001|STARTED|Overall Study||179
6617120|NCT02160002|7543712|FG000|Primary Outcome|Overall Study||185
6617121|NCT02160002|7543713|FG001|Primary Outcome|Overall Study||178
6617122|NCT02160002|7543712|FG000|COMPLETED|Overall Study||185
6617123|NCT02160002|7543713|FG001|COMPLETED|Overall Study||178
6617124|NCT02160002|7543712|FG000|NOT COMPLETED|Overall Study||2
6617125|NCT02160002|7543713|FG001|NOT COMPLETED|Overall Study||1
6617126|NCT02160041|7543719|FG000|STARTED|Overall Study||84
6617127|NCT02160041|7543719|FG000|COMPLETED|Overall Study||0
6617128|NCT02160041|7543719|FG000|NOT COMPLETED|Overall Study||84
6617129|NCT02160145|7543725|FG000|STARTED|Prerandomization Single-blind Period||1519
6617130|NCT02160145|7543726|FG001|STARTED|Prerandomization Single-blind Period||0
6617131|NCT02160145|7543727|FG002|STARTED|Prerandomization Single-blind Period||0
6617132|NCT02160145|7543725|FG000|Treated in Placebo Run-in|Prerandomization Single-blind Period||1514
6617133|NCT02160145|7543726|FG001|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
6617134|NCT02160145|7543727|FG002|Treated in Placebo Run-in|Prerandomization Single-blind Period||0
6617135|NCT02160145|7543725|FG000|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||1491
6617136|NCT02160145|7543726|FG001|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
6617137|NCT02160145|7543727|FG002|Treated in Tolvaptan Titration/Run-in|Prerandomization Single-blind Period||0
6617138|NCT02160145|7543725|FG000|Randomized|Prerandomization Single-blind Period||1370
6617139|NCT02160145|7543726|FG001|Randomized|Prerandomization Single-blind Period||0
6617140|NCT02160145|7543727|FG002|Randomized|Prerandomization Single-blind Period||0
6617141|NCT02160145|7543725|FG000|COMPLETED|Prerandomization Single-blind Period||1370
6617142|NCT02160145|7543726|FG001|COMPLETED|Prerandomization Single-blind Period||0
6617143|NCT02160145|7543727|FG002|COMPLETED|Prerandomization Single-blind Period||0
6617144|NCT02160145|7543725|FG000|NOT COMPLETED|Prerandomization Single-blind Period||149
6617145|NCT02160145|7543726|FG001|NOT COMPLETED|Prerandomization Single-blind Period||0
6617146|NCT02160145|7543727|FG002|NOT COMPLETED|Prerandomization Single-blind Period||0
6617147|NCT02160145|7543725|FG000|STARTED|Randomized Double-blind Period|1370 subjects were randomized to receive tolvaptan or placebo in the double-blind period.|0
6617148|NCT02160145|7543726|FG001|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive tolvaptan.|683
6617149|NCT02160145|7543727|FG002|STARTED|Randomized Double-blind Period|Subjects completed the single-blind period and were randomized to receive placebo.|687
6617150|NCT02160145|7543725|FG000|On-treatment Completers|Randomized Double-blind Period||0
6617151|NCT02160145|7543726|FG001|On-treatment Completers|Randomized Double-blind Period||578
6617152|NCT02160145|7543727|FG002|On-treatment Completers|Randomized Double-blind Period||637
6617153|NCT02160145|7543725|FG000|Off-treatment Completers|Randomized Double-blind Period||0
6617154|NCT02160145|7543726|FG001|Off-treatment Completers|Randomized Double-blind Period||76
6617155|NCT02160145|7543727|FG002|Off-treatment Completers|Randomized Double-blind Period||22
6617156|NCT02160145|7543725|FG000|COMPLETED|Randomized Double-blind Period||0
6617157|NCT02160145|7543726|FG001|COMPLETED|Randomized Double-blind Period||654
6617158|NCT02160145|7543727|FG002|COMPLETED|Randomized Double-blind Period||659
6617159|NCT02160145|7543725|FG000|NOT COMPLETED|Randomized Double-blind Period||0
6617160|NCT02160145|7543726|FG001|NOT COMPLETED|Randomized Double-blind Period||29
6617161|NCT02160145|7543727|FG002|NOT COMPLETED|Randomized Double-blind Period||28
6617162|NCT02160288|7543736|FG000|STARTED|Overall Study||1
6617163|NCT02160288|7543737|FG001|STARTED|Overall Study||0
6617164|NCT02160288|7543736|FG000|COMPLETED|Overall Study||1
6617165|NCT02160288|7543737|FG001|COMPLETED|Overall Study||0
6617166|NCT02160288|7543736|FG000|NOT COMPLETED|Overall Study||0
6617167|NCT02160288|7543737|FG001|NOT COMPLETED|Overall Study||0
6617168|NCT02160314|7543745|FG000|STARTED|Overall Study||73
6617169|NCT02160314|7543746|FG001|STARTED|Overall Study||72
6617170|NCT02160314|7543745|FG000|COMPLETED|Overall Study||72
6617171|NCT02160314|7543746|FG001|COMPLETED|Overall Study||59
6617172|NCT02160314|7543745|FG000|NOT COMPLETED|Overall Study||1
6617173|NCT02160314|7543746|FG001|NOT COMPLETED|Overall Study||13
6617174|NCT02160535|7543752|FG000|STARTED|Overall Study||13
6617175|NCT02160535|7543752|FG000|COMPLETED|Overall Study||10
6617176|NCT02160535|7543752|FG000|NOT COMPLETED|Overall Study||3
6617177|NCT02160626|7543759|FG000|STARTED|Overall Study||58
6617178|NCT02160626|7543760|FG001|STARTED|Overall Study||57
6617179|NCT02160626|7543761|FG002|STARTED|Overall Study||57
6617180|NCT02160626|7543759|FG000|COMPLETED|Overall Study||57
6617181|NCT02160626|7543760|FG001|COMPLETED|Overall Study||56
6617182|NCT02160626|7543761|FG002|COMPLETED|Overall Study||56
6617183|NCT02160626|7543759|FG000|NOT COMPLETED|Overall Study||1
6617184|NCT02160626|7543760|FG001|NOT COMPLETED|Overall Study||1
6617185|NCT02160626|7543761|FG002|NOT COMPLETED|Overall Study||1
6617186|NCT02160730|7543771|FG000|STARTED|Overall Study||4
6617187|NCT02160730|7543771|FG000|COMPLETED|Overall Study||4
6617188|NCT02160730|7543771|FG000|NOT COMPLETED|Overall Study||0
6617189|NCT02160782|7543776|FG000|STARTED|Open-label Period: Maralixibat||31
6617190|NCT02160782|7543777|FG001|STARTED|Open-label Period: Maralixibat||0
6617191|NCT02160782|7543778|FG002|STARTED|Open-label Period: Maralixibat||0
6617192|NCT02160782|7543779|FG003|STARTED|Open-label Period: Maralixibat||0
6617193|NCT02160782|7543780|FG004|STARTED|Open-label Period: Maralixibat||0
6617194|NCT02160782|7543776|FG000|COMPLETED|Open-label Period: Maralixibat||29
6617195|NCT02160782|7543777|FG001|COMPLETED|Open-label Period: Maralixibat||0
6617196|NCT02160782|7543778|FG002|COMPLETED|Open-label Period: Maralixibat||0
6617197|NCT02160782|7543779|FG003|COMPLETED|Open-label Period: Maralixibat||0
6617198|NCT02160782|7543780|FG004|COMPLETED|Open-label Period: Maralixibat||0
6617199|NCT02160782|7543776|FG000|NOT COMPLETED|Open-label Period: Maralixibat||2
6617200|NCT02160782|7543777|FG001|NOT COMPLETED|Open-label Period: Maralixibat||0
6617201|NCT02160782|7543778|FG002|NOT COMPLETED|Open-label Period: Maralixibat||0
6617202|NCT02160782|7543779|FG003|NOT COMPLETED|Open-label Period: Maralixibat||0
6617203|NCT02160782|7543780|FG004|NOT COMPLETED|Open-label Period: Maralixibat||0
6617204|NCT02160782|7543776|FG000|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
6617205|NCT02160782|7543777|FG001|STARTED|Randomized Withdrawal Period- Pbo vs MRX||13
6617206|NCT02160782|7543778|FG002|STARTED|Randomized Withdrawal Period- Pbo vs MRX||16
6617207|NCT02160782|7543779|FG003|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
6617208|NCT02160782|7543780|FG004|STARTED|Randomized Withdrawal Period- Pbo vs MRX||0
6617209|NCT02160782|7543776|FG000|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
6617210|NCT02160782|7543777|FG001|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||13
6617211|NCT02160782|7543778|FG002|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||16
6617212|NCT02160782|7543779|FG003|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
6617213|NCT02160782|7543780|FG004|COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
6617214|NCT02160782|7543776|FG000|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
6617215|NCT02160782|7543777|FG001|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
6617216|NCT02160782|7543778|FG002|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
6617217|NCT02160782|7543779|FG003|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
6617218|NCT02160782|7543780|FG004|NOT COMPLETED|Randomized Withdrawal Period- Pbo vs MRX||0
6617219|NCT02160782|7543776|FG000|STARTED|After Randomized Withdrawal: Maralixibat||0
6617220|NCT02160782|7543777|FG001|STARTED|After Randomized Withdrawal: Maralixibat||0
6617221|NCT02160782|7543778|FG002|STARTED|After Randomized Withdrawal: Maralixibat||0
6617222|NCT02160782|7543779|FG003|STARTED|After Randomized Withdrawal: Maralixibat||29
6617223|NCT02160782|7543780|FG004|STARTED|After Randomized Withdrawal: Maralixibat||0
6617224|NCT02160782|7543776|FG000|COMPLETED|After Randomized Withdrawal: Maralixibat||0
6617225|NCT02160782|7543777|FG001|COMPLETED|After Randomized Withdrawal: Maralixibat||0
6617226|NCT02160782|7543778|FG002|COMPLETED|After Randomized Withdrawal: Maralixibat||0
6617227|NCT02160782|7543779|FG003|COMPLETED|After Randomized Withdrawal: Maralixibat||23
6617228|NCT02160782|7543780|FG004|COMPLETED|After Randomized Withdrawal: Maralixibat||0
6617229|NCT02160782|7543776|FG000|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
6617230|NCT02160782|7543777|FG001|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
6617231|NCT02160782|7543778|FG002|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
6617232|NCT02160782|7543779|FG003|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||6
6617233|NCT02160782|7543780|FG004|NOT COMPLETED|After Randomized Withdrawal: Maralixibat||0
6617234|NCT02160782|7543776|FG000|STARTED|Long-term Extension Period: Maralixibat||0
6617235|NCT02160782|7543777|FG001|STARTED|Long-term Extension Period: Maralixibat||0
6617236|NCT02160782|7543778|FG002|STARTED|Long-term Extension Period: Maralixibat||0
6617237|NCT02160782|7543779|FG003|STARTED|Long-term Extension Period: Maralixibat||0
6617238|NCT02160782|7543780|FG004|STARTED|Long-term Extension Period: Maralixibat||23
6617239|NCT02160782|7543776|FG000|COMPLETED|Long-term Extension Period: Maralixibat||0
6617240|NCT02160782|7543777|FG001|COMPLETED|Long-term Extension Period: Maralixibat||0
6617241|NCT02160782|7543778|FG002|COMPLETED|Long-term Extension Period: Maralixibat||0
6617242|NCT02160782|7543779|FG003|COMPLETED|Long-term Extension Period: Maralixibat||0
6617243|NCT02160782|7543780|FG004|COMPLETED|Long-term Extension Period: Maralixibat||14
6617244|NCT02160782|7543776|FG000|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
6617245|NCT02160782|7543777|FG001|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
6617246|NCT02160782|7543778|FG002|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
6617247|NCT02160782|7543779|FG003|NOT COMPLETED|Long-term Extension Period: Maralixibat||0
6617248|NCT02160782|7543780|FG004|NOT COMPLETED|Long-term Extension Period: Maralixibat||9
6617249|NCT02160808|7543806|FG000|STARTED|Overall Study||87
6617250|NCT02160808|7543807|FG001|STARTED|Overall Study||83
6617251|NCT02160808|7543806|FG000|COMPLETED|Overall Study||87
6617252|NCT02160808|7543807|FG001|COMPLETED|Overall Study||83
6617253|NCT02160808|7543806|FG000|NOT COMPLETED|Overall Study||0
6617254|NCT02160808|7543807|FG001|NOT COMPLETED|Overall Study||0
6617255|NCT02160847|7543815|FG000|STARTED|Overall Study||16
6617256|NCT02160847|7543816|FG001|STARTED|Overall Study||16
6617257|NCT02160847|7543815|FG000|COMPLETED|Overall Study||16
6617258|NCT02160847|7543816|FG001|COMPLETED|Overall Study||16
6617259|NCT02160847|7543815|FG000|NOT COMPLETED|Overall Study||0
6617260|NCT02160847|7543816|FG001|NOT COMPLETED|Overall Study||0
6617261|NCT02160873|7543824|FG000|STARTED|Overall Study||6
6617262|NCT02160873|7543825|FG001|STARTED|Overall Study||6
6617263|NCT02160873|7543824|FG000|COMPLETED|Overall Study||6
6617264|NCT02160873|7543825|FG001|COMPLETED|Overall Study||6
6617265|NCT02160873|7543824|FG000|NOT COMPLETED|Overall Study||0
6617266|NCT02160873|7543825|FG001|NOT COMPLETED|Overall Study||0
6617267|NCT02160899|7543843|FG000|STARTED|Overall Study||26
6617268|NCT02160899|7543844|FG001|STARTED|Overall Study||4
6617269|NCT02160899|7543845|FG002|STARTED|Overall Study||21
6617270|NCT02160899|7543846|FG003|STARTED|Overall Study||3
6617271|NCT02160899|7543847|FG004|STARTED|Overall Study||2
6617272|NCT02160899|7543848|FG005|STARTED|Overall Study||8
6617273|NCT02160899|7543843|FG000|COMPLETED|Overall Study||26
6617274|NCT02160899|7543844|FG001|COMPLETED|Overall Study||3
6617275|NCT02160899|7543845|FG002|COMPLETED|Overall Study||21
6617276|NCT02160899|7543846|FG003|COMPLETED|Overall Study||2
6617277|NCT02160899|7543847|FG004|COMPLETED|Overall Study||0
6617278|NCT02160899|7543848|FG005|COMPLETED|Overall Study||8
6617279|NCT02160899|7543843|FG000|NOT COMPLETED|Overall Study||0
6617280|NCT02160899|7543844|FG001|NOT COMPLETED|Overall Study||1
6617281|NCT02160899|7543845|FG002|NOT COMPLETED|Overall Study||0
6617282|NCT02160899|7543846|FG003|NOT COMPLETED|Overall Study||1
6617283|NCT02160899|7543847|FG004|NOT COMPLETED|Overall Study||2
6617284|NCT02160899|7543848|FG005|NOT COMPLETED|Overall Study||0
6617285|NCT02160977|7543864|FG000|STARTED|One Week After Surgery||45
6617286|NCT02160977|7543865|FG001|STARTED|One Week After Surgery||45
6617287|NCT02160977|7543864|FG000|COMPLETED|One Week After Surgery||45
6617288|NCT02160977|7543865|FG001|COMPLETED|One Week After Surgery||45
6617289|NCT02160977|7543864|FG000|NOT COMPLETED|One Week After Surgery||0
6617290|NCT02160977|7543865|FG001|NOT COMPLETED|One Week After Surgery||0
6617291|NCT02160977|7543864|FG000|STARTED|Six Weeks After Surgery||45
6617292|NCT02160977|7543865|FG001|STARTED|Six Weeks After Surgery||45
6617293|NCT02160977|7543864|FG000|COMPLETED|Six Weeks After Surgery||44
6617294|NCT02160977|7543865|FG001|COMPLETED|Six Weeks After Surgery||45
6617295|NCT02160977|7543864|FG000|NOT COMPLETED|Six Weeks After Surgery||1
6617296|NCT02160977|7543865|FG001|NOT COMPLETED|Six Weeks After Surgery||0
6617297|NCT02160977|7543864|FG000|STARTED|Three Months After Surgery||44
6617298|NCT02160977|7543865|FG001|STARTED|Three Months After Surgery||45
6617299|NCT02160977|7543864|FG000|COMPLETED|Three Months After Surgery||44
6617300|NCT02160977|7543865|FG001|COMPLETED|Three Months After Surgery||43
6617301|NCT02160977|7543864|FG000|NOT COMPLETED|Three Months After Surgery||0
6617302|NCT02160977|7543865|FG001|NOT COMPLETED|Three Months After Surgery||2
6617303|NCT02160977|7543864|FG000|STARTED|Six Months After Surgery||44
6617304|NCT02160977|7543865|FG001|STARTED|Six Months After Surgery||43
6617305|NCT02160977|7543864|FG000|COMPLETED|Six Months After Surgery||42
6617306|NCT02160977|7543865|FG001|COMPLETED|Six Months After Surgery||42
6617307|NCT02160977|7543864|FG000|NOT COMPLETED|Six Months After Surgery||2
6617308|NCT02160977|7543865|FG001|NOT COMPLETED|Six Months After Surgery||1
6617309|NCT02160990|7543873|FG000|STARTED|Overall Study||10
6617310|NCT02160990|7543874|FG001|STARTED|Overall Study||10
6617311|NCT02160990|7543873|FG000|COMPLETED|Overall Study||10
6617312|NCT02160990|7543874|FG001|COMPLETED|Overall Study||10
6617313|NCT02160990|7543873|FG000|NOT COMPLETED|Overall Study||0
6617314|NCT02160990|7543874|FG001|NOT COMPLETED|Overall Study||0
6617315|NCT02161133|7543882|FG000|STARTED|Overall Study||135
6617316|NCT02161133|7543883|FG001|STARTED|Overall Study||133
6617317|NCT02161133|7543882|FG000|COMPLETED|Overall Study||116
6617318|NCT02161133|7543883|FG001|COMPLETED|Overall Study||122
6617319|NCT02161133|7543882|FG000|NOT COMPLETED|Overall Study||19
6617320|NCT02161133|7543883|FG001|NOT COMPLETED|Overall Study||11
6617321|NCT02161146|7543894|FG000|STARTED|Overall Study||47
6617322|NCT02161146|7543895|FG001|STARTED|Overall Study||47
6617323|NCT02161146|7543896|FG002|STARTED|Overall Study||49
6617324|NCT02161146|7543897|FG003|STARTED|Overall Study||48
6617325|NCT02161146|7543898|FG004|STARTED|Overall Study||49
6617326|NCT02161146|7543894|FG000|COMPLETED|Overall Study||46
6617327|NCT02161146|7543895|FG001|COMPLETED|Overall Study||43
6617328|NCT02161146|7543896|FG002|COMPLETED|Overall Study||49
6617329|NCT02161146|7543897|FG003|COMPLETED|Overall Study||45
6617330|NCT02161146|7543898|FG004|COMPLETED|Overall Study||48
6617331|NCT02161146|7543894|FG000|NOT COMPLETED|Overall Study||1
6617332|NCT02161146|7543895|FG001|NOT COMPLETED|Overall Study||4
6617333|NCT02161146|7543896|FG002|NOT COMPLETED|Overall Study||0
6617334|NCT02161146|7543897|FG003|NOT COMPLETED|Overall Study||3
6617335|NCT02161146|7543898|FG004|NOT COMPLETED|Overall Study||1
6617336|NCT02161185|7543908|FG000|STARTED|Test Dose Phase||7
6617337|NCT02161185|7543908|FG000|COMPLETED|Test Dose Phase||7
6617338|NCT02161185|7543908|FG000|NOT COMPLETED|Test Dose Phase||0
6617339|NCT02161185|7543908|FG000|STARTED|Treatment Phase||7
6617340|NCT02161185|7543908|FG000|COMPLETED|Treatment Phase||0
6617341|NCT02161185|7543908|FG000|NOT COMPLETED|Treatment Phase||7
6617342|NCT02161406|7543914|FG000|STARTED|Overall Study||44
6617343|NCT02161406|7543915|FG001|STARTED|Overall Study||44
6617344|NCT02161406|7543914|FG000|COMPLETED|Overall Study||34
6617345|NCT02161406|7543915|FG001|COMPLETED|Overall Study||35
6617346|NCT02161406|7543914|FG000|NOT COMPLETED|Overall Study||10
6617347|NCT02161406|7543915|FG001|NOT COMPLETED|Overall Study||9
6617348|NCT02161458|7543925|FG000|STARTED|Overall Study||22
6617349|NCT02161458|7543926|FG001|STARTED|Overall Study||35
6617350|NCT02161458|7543927|FG002|STARTED|Overall Study||33
6617351|NCT02161458|7543928|FG003|STARTED|Overall Study||8
6617352|NCT02161458|7543925|FG000|COMPLETED|Overall Study||22
6617353|NCT02161458|7543926|FG001|COMPLETED|Overall Study||29
6617354|NCT02161458|7543927|FG002|COMPLETED|Overall Study||28
6617355|NCT02161458|7543928|FG003|COMPLETED|Overall Study||8
6617356|NCT02161458|7543925|FG000|NOT COMPLETED|Overall Study||0
6617357|NCT02161458|7543926|FG001|NOT COMPLETED|Overall Study||6
6617358|NCT02161458|7543927|FG002|NOT COMPLETED|Overall Study||5
6617359|NCT02161458|7543928|FG003|NOT COMPLETED|Overall Study||0
6617360|NCT02161484|7543940|FG000|STARTED|Overall Study||5
6617361|NCT02161484|7543941|FG001|STARTED|Overall Study||5
6617362|NCT02161484|7543940|FG000|COMPLETED|Overall Study||1
6617363|NCT02161484|7543941|FG001|COMPLETED|Overall Study||2
6617364|NCT02161484|7543940|FG000|NOT COMPLETED|Overall Study||4
6617365|NCT02161484|7543941|FG001|NOT COMPLETED|Overall Study||3
6617366|NCT02161536|7543950|FG000|STARTED|Overall Study||6
6617367|NCT02161536|7543951|FG001|STARTED|Overall Study||21
6617368|NCT02161536|7543952|FG002|STARTED|Overall Study||20
6617369|NCT02161536|7543950|FG000|COMPLETED|Overall Study||6
6617370|NCT02161536|7543951|FG001|COMPLETED|Overall Study||21
6617371|NCT02161536|7543952|FG002|COMPLETED|Overall Study||20
6617372|NCT02161536|7543950|FG000|NOT COMPLETED|Overall Study||0
6617373|NCT02161536|7543951|FG001|NOT COMPLETED|Overall Study||0
6617374|NCT02161536|7543952|FG002|NOT COMPLETED|Overall Study||0
6617375|NCT02161549|7543962|FG000|STARTED|Overall Study||40
6617376|NCT02161549|7543963|FG001|STARTED|Overall Study||31
6617377|NCT02161549|7543962|FG000|COMPLETED|Overall Study||34
6617378|NCT02161549|7543963|FG001|COMPLETED|Overall Study||29
6617379|NCT02161549|7543962|FG000|NOT COMPLETED|Overall Study||6
6617380|NCT02161549|7543963|FG001|NOT COMPLETED|Overall Study||2
6617381|NCT02161562|7543971|FG000|STARTED|Overall Study||178
6617382|NCT02161562|7543972|FG001|STARTED|Overall Study||136
6617383|NCT02161562|7543971|FG000|COMPLETED|Overall Study||152
6617384|NCT02161562|7543972|FG001|COMPLETED|Overall Study||119
6617385|NCT02161562|7543971|FG000|NOT COMPLETED|Overall Study||26
6617386|NCT02161562|7543972|FG001|NOT COMPLETED|Overall Study||17
6617387|NCT02161575|7543991|FG000|STARTED|Overall Study||103
6617388|NCT02161575|7543991|FG000|Full Analysis Set (FAS) Population|Overall Study||100
6617389|NCT02161575|7543991|FG000|Safety (SAF) Population|Overall Study||100
6617390|NCT02161575|7543991|FG000|COMPLETED|Overall Study||92
6617391|NCT02161575|7543991|FG000|NOT COMPLETED|Overall Study||11
6617392|NCT02161705|7543997|FG000|STARTED|Overall Study||9
6617393|NCT02161705|7543998|FG001|STARTED|Overall Study||9
6617394|NCT02161705|7543997|FG000|COMPLETED|Overall Study||9
6617395|NCT02161705|7543998|FG001|COMPLETED|Overall Study||9
6617396|NCT02161705|7543997|FG000|NOT COMPLETED|Overall Study||0
6617397|NCT02161705|7543998|FG001|NOT COMPLETED|Overall Study||0
6617398|NCT02161718|7544006|FG000|STARTED|Open-Label ALKS 3831 Period||255
6617399|NCT02161718|7544007|FG001|STARTED|Open-Label ALKS 3831 Period||0
6617400|NCT02161718|7544008|FG002|STARTED|Open-Label ALKS 3831 Period||0
6617401|NCT02161718|7544006|FG000|COMPLETED|Open-Label ALKS 3831 Period||234
6617402|NCT02161718|7544007|FG001|COMPLETED|Open-Label ALKS 3831 Period||0
6617403|NCT02161718|7544008|FG002|COMPLETED|Open-Label ALKS 3831 Period||0
6617404|NCT02161718|7544006|FG000|NOT COMPLETED|Open-Label ALKS 3831 Period||21
6617405|NCT02161718|7544007|FG001|NOT COMPLETED|Open-Label ALKS 3831 Period||0
6617406|NCT02161718|7544008|FG002|NOT COMPLETED|Open-Label ALKS 3831 Period||0
6617407|NCT02161718|7544006|FG000|STARTED|Post- Randomization Period||0
6617408|NCT02161718|7544007|FG001|STARTED|Post- Randomization Period||112
6617409|NCT02161718|7544008|FG002|STARTED|Post- Randomization Period||117
6617410|NCT02161718|7544006|FG000|COMPLETED|Post- Randomization Period||0
6617411|NCT02161718|7544007|FG001|COMPLETED|Post- Randomization Period||53
6617412|NCT02161718|7544008|FG002|COMPLETED|Post- Randomization Period||58
6617413|NCT02161718|7544006|FG000|NOT COMPLETED|Post- Randomization Period||0
6617414|NCT02161718|7544007|FG001|NOT COMPLETED|Post- Randomization Period||59
6617415|NCT02161718|7544008|FG002|NOT COMPLETED|Post- Randomization Period||59
6617416|NCT02161731|7544015|FG000|STARTED|Period 1 (Day -1 to Day 7 Predose)||24
6617417|NCT02161731|7544016|FG001|STARTED|Period 1 (Day -1 to Day 7 Predose)||0
6617418|NCT02161731|7544015|FG000|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||24
6617419|NCT02161731|7544016|FG001|Received 1 Dose of Study Drug|Period 1 (Day -1 to Day 7 Predose)||0
6617420|NCT02161731|7544015|FG000|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||24
6617421|NCT02161731|7544016|FG001|COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
6617422|NCT02161731|7544015|FG000|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
6617423|NCT02161731|7544016|FG001|NOT COMPLETED|Period 1 (Day -1 to Day 7 Predose)||0
6617424|NCT02161731|7544015|FG000|STARTED|Period 2 (Day 7 Dosing to Day 23)||0
6617425|NCT02161731|7544016|FG001|STARTED|Period 2 (Day 7 Dosing to Day 23)||24
6617426|NCT02161731|7544015|FG000|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||0
6617427|NCT02161731|7544016|FG001|Received 1 Dose of Study Drug|Period 2 (Day 7 Dosing to Day 23)||24
6617428|NCT02161731|7544015|FG000|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
6617429|NCT02161731|7544016|FG001|COMPLETED|Period 2 (Day 7 Dosing to Day 23)||22
6617430|NCT02161731|7544015|FG000|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||0
6617431|NCT02161731|7544016|FG001|NOT COMPLETED|Period 2 (Day 7 Dosing to Day 23)||2
6617432|NCT02161757|7544026|FG000|STARTED|Randomised Through Start Treatment||401
6617433|NCT02161757|7544027|FG001|STARTED|Randomised Through Start Treatment||406
6617434|NCT02161757|7544028|FG002|STARTED|Randomised Through Start Treatment||400
6617435|NCT02161757|7544026|FG000|COMPLETED|Randomised Through Start Treatment||398
6617436|NCT02161757|7544027|FG001|COMPLETED|Randomised Through Start Treatment||404
6617437|NCT02161757|7544028|FG002|COMPLETED|Randomised Through Start Treatment||400
6617438|NCT02161757|7544026|FG000|NOT COMPLETED|Randomised Through Start Treatment||3
6617439|NCT02161757|7544027|FG001|NOT COMPLETED|Randomised Through Start Treatment||2
6617440|NCT02161757|7544028|FG002|NOT COMPLETED|Randomised Through Start Treatment||0
6617441|NCT02161757|7544026|FG000|STARTED|Treatment Through Study Completion||398
6617442|NCT02161757|7544027|FG001|STARTED|Treatment Through Study Completion||404
6617443|NCT02161757|7544028|FG002|STARTED|Treatment Through Study Completion||400
6617444|NCT02161757|7544026|FG000|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||332
6617445|NCT02161757|7544027|FG001|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||355
6617446|NCT02161757|7544028|FG002|Completed Treatment for Week 52 Cut-off|Treatment Through Study Completion||360
6617447|NCT02161757|7544026|FG000|COMPLETED|Treatment Through Study Completion||341
6617448|NCT02161757|7544027|FG001|COMPLETED|Treatment Through Study Completion||361
6617449|NCT02161757|7544028|FG002|COMPLETED|Treatment Through Study Completion||361
6617450|NCT02161757|7544026|FG000|NOT COMPLETED|Treatment Through Study Completion||57
6617451|NCT02161757|7544027|FG001|NOT COMPLETED|Treatment Through Study Completion||43
6617452|NCT02161757|7544028|FG002|NOT COMPLETED|Treatment Through Study Completion||39
6617453|NCT02162433|7544040|FG000|STARTED|Overall Study||23
6617454|NCT02162433|7544041|FG001|STARTED|Overall Study||23
6617455|NCT02162433|7544042|FG002|STARTED|Overall Study||23
6617456|NCT02162433|7544043|FG003|STARTED|Overall Study||23
6617457|NCT02162433|7544040|FG000|COMPLETED|Overall Study||22
6617458|NCT02162433|7544041|FG001|COMPLETED|Overall Study||21
6617459|NCT02162433|7544042|FG002|COMPLETED|Overall Study||21
6617460|NCT02162433|7544043|FG003|COMPLETED|Overall Study||22
6617461|NCT02162433|7544040|FG000|NOT COMPLETED|Overall Study||1
6617462|NCT02162433|7544041|FG001|NOT COMPLETED|Overall Study||2
6617463|NCT02162433|7544042|FG002|NOT COMPLETED|Overall Study||2
6617464|NCT02162433|7544043|FG003|NOT COMPLETED|Overall Study||1
6617465|NCT02162446|7544053|FG000|STARTED|Overall Study||12
6617466|NCT02162446|7544053|FG000|COMPLETED|Overall Study||12
6617467|NCT02162446|7544053|FG000|NOT COMPLETED|Overall Study||0
6617468|NCT02162576|7544062|FG000|STARTED|Overall Study||95
6617469|NCT02162576|7544062|FG000|COMPLETED|Overall Study||95
6617470|NCT02162576|7544062|FG000|NOT COMPLETED|Overall Study||0
6617471|NCT02162667|7544069|FG000|STARTED|Neoadjuvant Period||278
6617472|NCT02162667|7544070|FG001|STARTED|Neoadjuvant Period||284
6617473|NCT02162667|7544069|FG000|COMPLETED|Neoadjuvant Period||264
6617474|NCT02162667|7544070|FG001|COMPLETED|Neoadjuvant Period||267
6617475|NCT02162667|7544069|FG000|NOT COMPLETED|Neoadjuvant Period||14
6617476|NCT02162667|7544070|FG001|NOT COMPLETED|Neoadjuvant Period||17
6617477|NCT02162667|7544069|FG000|STARTED|Adjuvant Period||260
6617478|NCT02162667|7544070|FG001|STARTED|Adjuvant Period||268
6617479|NCT02162667|7544069|FG000|COMPLETED|Adjuvant Period||248
6617480|NCT02162667|7544070|FG001|COMPLETED|Adjuvant Period||255
6617481|NCT02162667|7544069|FG000|NOT COMPLETED|Adjuvant Period||12
6617482|NCT02162667|7544070|FG001|NOT COMPLETED|Adjuvant Period||13
6617483|NCT02162680|7544083|FG000|STARTED|Overall Study||33
6617484|NCT02162680|7544084|FG001|STARTED|Overall Study||33
6617485|NCT02162680|7544085|FG002|STARTED|Overall Study||32
6617486|NCT02162680|7544083|FG000|COMPLETED|Overall Study||33
6617487|NCT02162680|7544084|FG001|COMPLETED|Overall Study||33
6617488|NCT02162680|7544085|FG002|COMPLETED|Overall Study||32
6617489|NCT02162680|7544083|FG000|NOT COMPLETED|Overall Study||0
6617490|NCT02162680|7544084|FG001|NOT COMPLETED|Overall Study||0
6617491|NCT02162680|7544085|FG002|NOT COMPLETED|Overall Study||0
6617492|NCT02162719|7544095|FG000|STARTED|Overall Study||62
6617493|NCT02162719|7544096|FG001|STARTED|Overall Study||62
6617494|NCT02162719|7544095|FG000|COMPLETED|Overall Study||0
6617495|NCT02162719|7544096|FG001|COMPLETED|Overall Study||0
6617496|NCT02162719|7544095|FG000|NOT COMPLETED|Overall Study||62
6617497|NCT02162719|7544096|FG001|NOT COMPLETED|Overall Study||62
6617498|NCT02162758|7544104|FG000|STARTED|Overall Study||3
6617499|NCT02162758|7544105|FG001|STARTED|Overall Study||3
6617500|NCT02162758|7544104|FG000|COMPLETED|Overall Study||3
6617501|NCT02162758|7544105|FG001|COMPLETED|Overall Study||2
6617502|NCT02162758|7544104|FG000|NOT COMPLETED|Overall Study||0
6617503|NCT02162758|7544105|FG001|NOT COMPLETED|Overall Study||1
6617504|NCT02162771|7544113|FG000|STARTED|Core Study Period (Part 2)||70
6617505|NCT02162771|7544114|FG001|STARTED|Core Study Period (Part 2)||70
6617506|NCT02162771|7544113|FG000|COMPLETED|Core Study Period (Part 2)||62
6617507|NCT02162771|7544114|FG001|COMPLETED|Core Study Period (Part 2)||62
6617508|NCT02162771|7544113|FG000|NOT COMPLETED|Core Study Period (Part 2)||8
6617509|NCT02162771|7544114|FG001|NOT COMPLETED|Core Study Period (Part 2)||8
6617510|NCT02162771|7544113|FG000|STARTED|Maintenance Study Period (Part 2)||62
6617511|NCT02162771|7544114|FG001|STARTED|Maintenance Study Period (Part 2)|Two subjects did not enter this period due to Withdrawal by subject and Non-responder, 1 for each.|60
6617512|NCT02162771|7544113|FG000|COMPLETED|Maintenance Study Period (Part 2)||46
6617513|NCT02162771|7544114|FG001|COMPLETED|Maintenance Study Period (Part 2)||38
6617514|NCT02162771|7544113|FG000|NOT COMPLETED|Maintenance Study Period (Part 2)||16
6617515|NCT02162771|7544114|FG001|NOT COMPLETED|Maintenance Study Period (Part 2)||22
6617516|NCT02162862|7544123|FG000|STARTED|Overall Study||31
6617517|NCT02162862|7544124|FG001|STARTED|Overall Study||35
6617518|NCT02162862|7544125|FG002|STARTED|Overall Study||33
6617519|NCT02162862|7544123|FG000|COMPLETED|Overall Study||31
6617520|NCT02162862|7544124|FG001|COMPLETED|Overall Study||24
6617521|NCT02162862|7544125|FG002|COMPLETED|Overall Study||29
6617522|NCT02162862|7544123|FG000|NOT COMPLETED|Overall Study||0
6617523|NCT02162862|7544124|FG001|NOT COMPLETED|Overall Study||11
6617524|NCT02162862|7544125|FG002|NOT COMPLETED|Overall Study||4
6617525|NCT02162992|7544137|FG000|STARTED|Overall Study||51
6617526|NCT02162992|7544138|FG001|STARTED|Overall Study||100
6617527|NCT02162992|7544137|FG000|COMPLETED|Overall Study||46
6617528|NCT02162992|7544138|FG001|COMPLETED|Overall Study||99
6617529|NCT02162992|7544137|FG000|NOT COMPLETED|Overall Study||5
6617530|NCT02162992|7544138|FG001|NOT COMPLETED|Overall Study||1
6617531|NCT02163057|7544146|FG000|STARTED|Overall Study||6
6617532|NCT02163057|7544147|FG001|STARTED|Overall Study||16
6617533|NCT02163057|7544146|FG000|COMPLETED|Overall Study||3
6617534|NCT02163057|7544147|FG001|COMPLETED|Overall Study||11
6617535|NCT02163057|7544146|FG000|NOT COMPLETED|Overall Study||3
6617536|NCT02163057|7544147|FG001|NOT COMPLETED|Overall Study||5
6617537|NCT02163226|7544157|FG000|STARTED|Overall Study||79
6617538|NCT02163226|7544158|FG001|STARTED|Overall Study||81
6617539|NCT02163226|7544157|FG000|COMPLETED|Overall Study||63
6617540|NCT02163226|7544158|FG001|COMPLETED|Overall Study||70
6617541|NCT02163226|7544157|FG000|NOT COMPLETED|Overall Study||16
6617542|NCT02163226|7544158|FG001|NOT COMPLETED|Overall Study||11
6617543|NCT02163395|7544164|FG000|STARTED|Overall Study||44
6617544|NCT02163395|7544164|FG000|COMPLETED|Overall Study||39
6617545|NCT02163395|7544164|FG000|NOT COMPLETED|Overall Study||5
6617546|NCT02163421|7544172|FG000|STARTED|Overall Study||12
6617547|NCT02163421|7544173|FG001|STARTED|Overall Study||12
6617548|NCT02163421|7544174|FG002|STARTED|Overall Study||12
6617549|NCT02163421|7544175|FG003|STARTED|Overall Study||12
6617550|NCT02163421|7544172|FG000|COMPLETED|Overall Study||12
6617551|NCT02163421|7544173|FG001|COMPLETED|Overall Study||12
6617552|NCT02163421|7544174|FG002|COMPLETED|Overall Study||12
6617553|NCT02163421|7544175|FG003|COMPLETED|Overall Study||12
6617554|NCT02163421|7544172|FG000|NOT COMPLETED|Overall Study||0
6617555|NCT02163421|7544173|FG001|NOT COMPLETED|Overall Study||0
6617556|NCT02163421|7544174|FG002|NOT COMPLETED|Overall Study||0
6617557|NCT02163421|7544175|FG003|NOT COMPLETED|Overall Study||0
6617558|NCT02163434|7544184|FG000|STARTED|Overall Study||15
6617559|NCT02163434|7544185|FG001|STARTED|Overall Study||16
6617560|NCT02163434|7544184|FG000|COMPLETED|Overall Study||12
6617561|NCT02163434|7544185|FG001|COMPLETED|Overall Study||9
6617562|NCT02163434|7544184|FG000|NOT COMPLETED|Overall Study||3
6617563|NCT02163434|7544185|FG001|NOT COMPLETED|Overall Study||7
6617564|NCT02163447|7544194|FG000|STARTED|Overall Study||106
6617565|NCT02163447|7544195|FG001|STARTED|Overall Study||94
6617566|NCT02163447|7544196|FG002|STARTED|Overall Study||100
6617567|NCT02163447|7544194|FG000|Infants Born|Overall Study||101
6617568|NCT02163447|7544195|FG001|Infants Born|Overall Study||93
6617569|NCT02163447|7544196|FG002|Infants Born|Overall Study||100
6617570|NCT02163447|7544194|FG000|COMPLETED|Overall Study||100
6617571|NCT02163447|7544195|FG001|COMPLETED|Overall Study||88
6617572|NCT02163447|7544196|FG002|COMPLETED|Overall Study||97
6617573|NCT02163447|7544194|FG000|NOT COMPLETED|Overall Study||6
6617574|NCT02163447|7544195|FG001|NOT COMPLETED|Overall Study||6
6617575|NCT02163447|7544196|FG002|NOT COMPLETED|Overall Study||3
6617576|NCT02163486|7544216|FG000|STARTED|Overall Study||51
6617577|NCT02163486|7544217|FG001|STARTED|Overall Study||52
6617578|NCT02163486|7544216|FG000|COMPLETED|Overall Study||50
6617579|NCT02163486|7544217|FG001|COMPLETED|Overall Study||50
6617580|NCT02163486|7544216|FG000|NOT COMPLETED|Overall Study||1
6617581|NCT02163486|7544217|FG001|NOT COMPLETED|Overall Study||2
6617582|NCT02163499|7544223|FG000|STARTED|Acute Phase: ZS 10 g TID||751
6617583|NCT02163499|7544223|FG000|COMPLETED|Acute Phase: ZS 10 g TID||746
6617584|NCT02163499|7544223|FG000|NOT COMPLETED|Acute Phase: ZS 10 g TID||5
6617585|NCT02163499|7544223|FG000|STARTED|Extended Dosing Phase: ZS||746
6617586|NCT02163499|7544223|FG000|COMPLETED|Extended Dosing Phase: ZS||466
6617587|NCT02163499|7544223|FG000|NOT COMPLETED|Extended Dosing Phase: ZS||280
6617588|NCT02163538|7544233|FG000|STARTED|Overall Study||71
6617589|NCT02163538|7544234|FG001|STARTED|Overall Study||71
6617590|NCT02163538|7544233|FG000|COMPLETED|Overall Study||70
6617591|NCT02163538|7544234|FG001|COMPLETED|Overall Study||70
6617592|NCT02163538|7544233|FG000|NOT COMPLETED|Overall Study||1
6617593|NCT02163538|7544234|FG001|NOT COMPLETED|Overall Study||1
6617594|NCT02163577|7544242|FG000|STARTED|Overall Study||26
6617595|NCT02163577|7544243|FG001|STARTED|Overall Study||26
6617596|NCT02163577|7544242|FG000|COMPLETED|Overall Study||26
6617597|NCT02163577|7544243|FG001|COMPLETED|Overall Study||26
6617598|NCT02163577|7544242|FG000|NOT COMPLETED|Overall Study||0
6617599|NCT02163577|7544243|FG001|NOT COMPLETED|Overall Study||0
6617600|NCT02163759|7544252|FG000|STARTED|Overall Study||72
6617601|NCT02163759|7544253|FG001|STARTED|Overall Study||142
6617602|NCT02163759|7544254|FG002|STARTED|Overall Study||144
6617603|NCT02163759|7544252|FG000|Completed Week 10|Overall Study||71
6617604|NCT02163759|7544253|FG001|Completed Week 10|Overall Study||141
6617605|NCT02163759|7544254|FG002|Completed Week 10|Overall Study||143
6617606|NCT02163759|7544252|FG000|COMPLETED|Overall Study||71
6617607|NCT02163759|7544253|FG001|COMPLETED|Overall Study||137
6617608|NCT02163759|7544254|FG002|COMPLETED|Overall Study||141
6617609|NCT02163759|7544252|FG000|NOT COMPLETED|Overall Study||1
6617610|NCT02163759|7544253|FG001|NOT COMPLETED|Overall Study||5
6617611|NCT02163759|7544254|FG002|NOT COMPLETED|Overall Study||3
6617612|NCT02163811|7544267|FG000|STARTED|Overall Study||71
6617613|NCT02163811|7544268|FG001|STARTED|Overall Study||76
6617614|NCT02163811|7544267|FG000|COMPLETED|Overall Study||35
6617615|NCT02163811|7544268|FG001|COMPLETED|Overall Study||60
6617616|NCT02163811|7544267|FG000|NOT COMPLETED|Overall Study||36
6617617|NCT02163811|7544268|FG001|NOT COMPLETED|Overall Study||16
6617618|NCT02163824|7544277|FG000|STARTED|Overall Study||129
6617619|NCT02163824|7544278|FG001|STARTED|Overall Study||125
6617620|NCT02163824|7544279|FG002|STARTED|Overall Study||126
6617621|NCT02163824|7544277|FG000|COMPLETED|Overall Study||127
6617622|NCT02163824|7544278|FG001|COMPLETED|Overall Study||124
6617623|NCT02163824|7544279|FG002|COMPLETED|Overall Study||124
6617624|NCT02163824|7544277|FG000|NOT COMPLETED|Overall Study||2
6617625|NCT02163824|7544278|FG001|NOT COMPLETED|Overall Study||1
6617626|NCT02163824|7544279|FG002|NOT COMPLETED|Overall Study||2
6617627|NCT02163837|7544287|FG000|STARTED|Before Rifaximin||15
6617628|NCT02163837|7544287|FG000|COMPLETED|Before Rifaximin||15
6617629|NCT02163837|7544287|FG000|NOT COMPLETED|Before Rifaximin||0
6617630|NCT02163837|7544287|FG000|STARTED|Day 28 of Rifaximin Treatment||15
6617631|NCT02163837|7544287|FG000|COMPLETED|Day 28 of Rifaximin Treatment||15
6617632|NCT02163837|7544287|FG000|NOT COMPLETED|Day 28 of Rifaximin Treatment||0
6617633|NCT02163902|7544293|FG000|STARTED|Overall Study||113
6617634|NCT02163902|7544294|FG001|STARTED|Overall Study||111
6617635|NCT02163902|7544293|FG000|COMPLETED|Overall Study||102
6617636|NCT02163902|7544294|FG001|COMPLETED|Overall Study||98
6617637|NCT02163902|7544293|FG000|NOT COMPLETED|Overall Study||11
6617638|NCT02163902|7544294|FG001|NOT COMPLETED|Overall Study||13
6617639|NCT02163915|7544305|FG000|STARTED|Overall Study||10
6617640|NCT02163915|7544306|FG001|STARTED|Overall Study||8
6617641|NCT02163915|7544307|FG002|STARTED|Overall Study||10
6617642|NCT02163915|7544308|FG003|STARTED|Overall Study||9
6617643|NCT02163915|7544309|FG004|STARTED|Overall Study||10
6617644|NCT02163915|7544305|FG000|COMPLETED|Overall Study||7
6617645|NCT02163915|7544306|FG001|COMPLETED|Overall Study||8
6617646|NCT02163915|7544307|FG002|COMPLETED|Overall Study||8
6617647|NCT02163915|7544308|FG003|COMPLETED|Overall Study||6
6617648|NCT02163915|7544309|FG004|COMPLETED|Overall Study||6
6617649|NCT02163915|7544305|FG000|NOT COMPLETED|Overall Study||3
6617650|NCT02163915|7544306|FG001|NOT COMPLETED|Overall Study||0
6617651|NCT02163915|7544307|FG002|NOT COMPLETED|Overall Study||2
6617652|NCT02163915|7544308|FG003|NOT COMPLETED|Overall Study||3
6617653|NCT02163915|7544309|FG004|NOT COMPLETED|Overall Study||4
6617654|NCT02163967|7544325|FG000|STARTED|First Intervention/ Day 1||4
6617655|NCT02163967|7544326|FG001|STARTED|First Intervention/ Day 1||4
6617656|NCT02163967|7544327|FG002|STARTED|First Intervention/ Day 1||3
6617657|NCT02163967|7544328|FG003|STARTED|First Intervention/ Day 1||4
6617658|NCT02163967|7544329|FG004|STARTED|First Intervention/ Day 1||3
6617659|NCT02163967|7544330|FG005|STARTED|First Intervention/ Day 1||3
6617660|NCT02163967|7544325|FG000|COMPLETED|First Intervention/ Day 1||4
6617661|NCT02163967|7544326|FG001|COMPLETED|First Intervention/ Day 1||4
6617662|NCT02163967|7544327|FG002|COMPLETED|First Intervention/ Day 1||3
6617663|NCT02163967|7544328|FG003|COMPLETED|First Intervention/ Day 1||4
6617664|NCT02163967|7544329|FG004|COMPLETED|First Intervention/ Day 1||3
6617665|NCT02163967|7544330|FG005|COMPLETED|First Intervention/ Day 1||3
6617666|NCT02163967|7544325|FG000|NOT COMPLETED|First Intervention/ Day 1||0
6617667|NCT02163967|7544326|FG001|NOT COMPLETED|First Intervention/ Day 1||0
6617668|NCT02163967|7544327|FG002|NOT COMPLETED|First Intervention/ Day 1||0
6617669|NCT02163967|7544328|FG003|NOT COMPLETED|First Intervention/ Day 1||0
6617670|NCT02163967|7544329|FG004|NOT COMPLETED|First Intervention/ Day 1||0
6617671|NCT02163967|7544330|FG005|NOT COMPLETED|First Intervention/ Day 1||0
6617672|NCT02163967|7544325|FG000|STARTED|Second Intevention/Day 2||3
6617673|NCT02163967|7544326|FG001|STARTED|Second Intevention/Day 2||4
6617674|NCT02163967|7544327|FG002|STARTED|Second Intevention/Day 2||2
6617675|NCT02163967|7544328|FG003|STARTED|Second Intevention/Day 2||4
6617676|NCT02163967|7544329|FG004|STARTED|Second Intevention/Day 2||3
6617677|NCT02163967|7544330|FG005|STARTED|Second Intevention/Day 2||3
6617678|NCT02163967|7544325|FG000|COMPLETED|Second Intevention/Day 2||3
6617679|NCT02163967|7544326|FG001|COMPLETED|Second Intevention/Day 2||4
6617680|NCT02163967|7544327|FG002|COMPLETED|Second Intevention/Day 2||2
6617681|NCT02163967|7544328|FG003|COMPLETED|Second Intevention/Day 2||4
6617682|NCT02163967|7544329|FG004|COMPLETED|Second Intevention/Day 2||3
6617683|NCT02163967|7544330|FG005|COMPLETED|Second Intevention/Day 2||3
6617684|NCT02163967|7544325|FG000|NOT COMPLETED|Second Intevention/Day 2||0
6617685|NCT02163967|7544326|FG001|NOT COMPLETED|Second Intevention/Day 2||0
6617686|NCT02163967|7544327|FG002|NOT COMPLETED|Second Intevention/Day 2||0
6617687|NCT02163967|7544328|FG003|NOT COMPLETED|Second Intevention/Day 2||0
6617688|NCT02163967|7544329|FG004|NOT COMPLETED|Second Intevention/Day 2||0
6617689|NCT02163967|7544330|FG005|NOT COMPLETED|Second Intevention/Day 2||0
6617690|NCT02163967|7544325|FG000|STARTED|Third Intervention/Day 3||3
6617691|NCT02163967|7544326|FG001|STARTED|Third Intervention/Day 3||3
6617692|NCT02163967|7544327|FG002|STARTED|Third Intervention/Day 3||2
6617693|NCT02163967|7544328|FG003|STARTED|Third Intervention/Day 3||4
6617694|NCT02163967|7544329|FG004|STARTED|Third Intervention/Day 3||3
6617695|NCT02163967|7544330|FG005|STARTED|Third Intervention/Day 3||3
6617696|NCT02163967|7544325|FG000|COMPLETED|Third Intervention/Day 3||3
6617697|NCT02163967|7544326|FG001|COMPLETED|Third Intervention/Day 3||3
6617698|NCT02163967|7544327|FG002|COMPLETED|Third Intervention/Day 3||2
6617699|NCT02163967|7544328|FG003|COMPLETED|Third Intervention/Day 3||4
6617700|NCT02163967|7544329|FG004|COMPLETED|Third Intervention/Day 3||3
6617701|NCT02163967|7544330|FG005|COMPLETED|Third Intervention/Day 3||3
6617702|NCT02163967|7544325|FG000|NOT COMPLETED|Third Intervention/Day 3||0
6617703|NCT02163967|7544326|FG001|NOT COMPLETED|Third Intervention/Day 3||0
6617704|NCT02163967|7544327|FG002|NOT COMPLETED|Third Intervention/Day 3||0
6617705|NCT02163967|7544328|FG003|NOT COMPLETED|Third Intervention/Day 3||0
6617706|NCT02163967|7544329|FG004|NOT COMPLETED|Third Intervention/Day 3||0
6617707|NCT02163967|7544330|FG005|NOT COMPLETED|Third Intervention/Day 3||0
6617708|NCT02163993|7544346|FG000|STARTED|Treatment Period||138
6617709|NCT02163993|7544347|FG001|STARTED|Treatment Period||68
6617710|NCT02163993|7544348|FG002|STARTED|Treatment Period||68
6617711|NCT02163993|7544349|FG003|STARTED|Treatment Period||71
6617712|NCT02163993|7544350|FG004|STARTED|Treatment Period||69
6617713|NCT02163993|7544346|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||137
6617714|NCT02163993|7544347|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||68
6617715|NCT02163993|7544348|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||68
6617716|NCT02163993|7544349|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||70
6617717|NCT02163993|7544350|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||67
6617718|NCT02163993|7544346|FG000|COMPLETED|Treatment Period||126
6617719|NCT02163993|7544347|FG001|COMPLETED|Treatment Period||59
6617720|NCT02163993|7544348|FG002|COMPLETED|Treatment Period||66
6617721|NCT02163993|7544349|FG003|COMPLETED|Treatment Period||62
6617722|NCT02163993|7544350|FG004|COMPLETED|Treatment Period||62
6617723|NCT02163993|7544346|FG000|NOT COMPLETED|Treatment Period||12
6617724|NCT02163993|7544347|FG001|NOT COMPLETED|Treatment Period||9
6617725|NCT02163993|7544348|FG002|NOT COMPLETED|Treatment Period||2
6617726|NCT02163993|7544349|FG003|NOT COMPLETED|Treatment Period||9
6617727|NCT02163993|7544350|FG004|NOT COMPLETED|Treatment Period||7
6617728|NCT02163993|7544346|FG000|STARTED|Post-treatment Period|One participant discontinued after Treatment Period. Did not enter into Post-treatment Period.|125
6617729|NCT02163993|7544347|FG001|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|61
6617730|NCT02163993|7544348|FG002|STARTED|Post-treatment Period||66
6617731|NCT02163993|7544349|FG003|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|63
6617732|NCT02163993|7544350|FG004|STARTED|Post-treatment Period|Participants who discontinued or completed the Treatment Period entered the Post-treatment period.|65
6617733|NCT02163993|7544346|FG000|COMPLETED|Post-treatment Period||121
6617734|NCT02163993|7544347|FG001|COMPLETED|Post-treatment Period||55
6617735|NCT02163993|7544348|FG002|COMPLETED|Post-treatment Period||62
6617736|NCT02163993|7544349|FG003|COMPLETED|Post-treatment Period||61
6617737|NCT02163993|7544350|FG004|COMPLETED|Post-treatment Period||62
6617738|NCT02163993|7544346|FG000|NOT COMPLETED|Post-treatment Period||4
6617739|NCT02163993|7544347|FG001|NOT COMPLETED|Post-treatment Period||6
6617740|NCT02163993|7544348|FG002|NOT COMPLETED|Post-treatment Period||4
6617741|NCT02163993|7544349|FG003|NOT COMPLETED|Post-treatment Period||2
6617742|NCT02163993|7544350|FG004|NOT COMPLETED|Post-treatment Period||3
6617743|NCT02164240|7544371|FG000|STARTED|Overall Study||4
6617744|NCT02164240|7544372|FG001|STARTED|Overall Study||5
6617745|NCT02164240|7544373|FG002|STARTED|Overall Study||4
6617746|NCT02164240|7544371|FG000|COMPLETED|Overall Study||4
6617747|NCT02164240|7544372|FG001|COMPLETED|Overall Study||5
6617748|NCT02164240|7544373|FG002|COMPLETED|Overall Study||4
6617749|NCT02164240|7544371|FG000|NOT COMPLETED|Overall Study||0
6617750|NCT02164240|7544372|FG001|NOT COMPLETED|Overall Study||0
6617751|NCT02164240|7544373|FG002|NOT COMPLETED|Overall Study||0
6617752|NCT02164318|7544386|FG000|STARTED|Overall Study||4
6617753|NCT02164318|7544387|FG001|STARTED|Overall Study||3
6617754|NCT02164318|7544388|FG002|STARTED|Overall Study||1
6617755|NCT02164318|7544389|FG003|STARTED|Overall Study||3
6617756|NCT02164318|7544386|FG000|COMPLETED|Overall Study||4
6617757|NCT02164318|7544387|FG001|COMPLETED|Overall Study||2
6617758|NCT02164318|7544388|FG002|COMPLETED|Overall Study||1
6617759|NCT02164318|7544389|FG003|COMPLETED|Overall Study||2
6617760|NCT02164318|7544386|FG000|NOT COMPLETED|Overall Study||0
6617761|NCT02164318|7544387|FG001|NOT COMPLETED|Overall Study||1
6617762|NCT02164318|7544388|FG002|NOT COMPLETED|Overall Study||0
6617763|NCT02164318|7544389|FG003|NOT COMPLETED|Overall Study||1
6617764|NCT02164383|7544401|FG000|STARTED|Overall Study||16
6617765|NCT02164383|7544402|FG001|STARTED|Overall Study||14
6617766|NCT02164383|7544401|FG000|COMPLETED|Overall Study||15
6617767|NCT02164383|7544402|FG001|COMPLETED|Overall Study||14
6617768|NCT02164383|7544401|FG000|NOT COMPLETED|Overall Study||1
6617769|NCT02164383|7544402|FG001|NOT COMPLETED|Overall Study||0
6617770|NCT02164396|7544411|FG000|STARTED|Overall Study||10
6617771|NCT02164396|7544412|FG001|STARTED|Overall Study||10
6617772|NCT02164396|7544413|FG002|STARTED|Overall Study||10
6617773|NCT02164396|7544411|FG000|COMPLETED|Overall Study||10
6617774|NCT02164396|7544412|FG001|COMPLETED|Overall Study||10
6733065|NCT03205488|7662609|FG001|STARTED|Overall Study||25
6733066|NCT03205488|7662610|FG002|STARTED|Overall Study||26
6733067|NCT03205488|7662608|FG000|COMPLETED|Overall Study||24
6733068|NCT03205488|7662609|FG001|COMPLETED|Overall Study||23
6733069|NCT03205488|7662610|FG002|COMPLETED|Overall Study||21
6733070|NCT03205488|7662608|FG000|NOT COMPLETED|Overall Study||1
6733071|NCT03205488|7662609|FG001|NOT COMPLETED|Overall Study||2
6733072|NCT03205488|7662610|FG002|NOT COMPLETED|Overall Study||5
6733073|NCT03205566|7662624|FG000|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
6733074|NCT03205566|7662625|FG001|STARTED|Phase 1|One participant withdrawn and replaced. Data obtained from first participant still used in analysis|19
6733075|NCT03205566|7662624|FG000|COMPLETED|Phase 1||18
6733076|NCT03205566|7662625|FG001|COMPLETED|Phase 1||18
6733077|NCT03205566|7662624|FG000|NOT COMPLETED|Phase 1||1
6733078|NCT03205566|7662625|FG001|NOT COMPLETED|Phase 1||1
6733079|NCT03205566|7662624|FG000|STARTED|Phase 2||18
6733080|NCT03205566|7662625|FG001|STARTED|Phase 2||18
6733081|NCT03205566|7662624|FG000|COMPLETED|Phase 2||18
6733082|NCT03205566|7662625|FG001|COMPLETED|Phase 2||18
6733083|NCT03205566|7662624|FG000|NOT COMPLETED|Phase 2||0
6733084|NCT03205566|7662625|FG001|NOT COMPLETED|Phase 2||0
6733085|NCT03206749|7662638|FG000|STARTED|Overall Study||80
6733086|NCT03206749|7662639|FG001|STARTED|Overall Study||81
6733087|NCT03206749|7662640|FG002|STARTED|Overall Study||82
6733088|NCT03206749|7662638|FG000|COMPLETED|Overall Study||75
6733089|NCT03206749|7662639|FG001|COMPLETED|Overall Study||78
6733090|NCT03206749|7662640|FG002|COMPLETED|Overall Study||75
6733091|NCT03206749|7662638|FG000|NOT COMPLETED|Overall Study||5
6733092|NCT03206749|7662639|FG001|NOT COMPLETED|Overall Study||3
6733093|NCT03206749|7662640|FG002|NOT COMPLETED|Overall Study||7
6733094|NCT03206788|7662651|FG000|STARTED|Overall Study||2
6733095|NCT03206788|7662652|FG001|STARTED|Overall Study||5
6733096|NCT03206788|7662651|FG000|COMPLETED|Overall Study||2
6733097|NCT03206788|7662652|FG001|COMPLETED|Overall Study||2
6733098|NCT03206788|7662651|FG000|NOT COMPLETED|Overall Study||0
6733099|NCT03206788|7662652|FG001|NOT COMPLETED|Overall Study||3
6733100|NCT03206918|7662658|FG000|STARTED|Overall Study||91
6733101|NCT03206918|7662658|FG000|COMPLETED|Overall Study||0
6733102|NCT03206918|7662658|FG000|NOT COMPLETED|Overall Study||91
6733103|NCT03206970|7662663|FG000|STARTED|Overall Study||86
6733104|NCT03206970|7662663|FG000|Received at Least 1 Dose of Study Drug|Overall Study||86
6733105|NCT03206970|7662663|FG000|COMPLETED|Overall Study||0
6733106|NCT03206970|7662663|FG000|NOT COMPLETED|Overall Study||86
6733107|NCT03207022|7662669|FG000|STARTED|Overall Study||12
6733108|NCT03207022|7662670|FG001|STARTED|Overall Study||12
6733109|NCT03207022|7662669|FG000|COMPLETED|Overall Study||12
6733110|NCT03207022|7662670|FG001|COMPLETED|Overall Study||12
6733111|NCT03207022|7662669|FG000|NOT COMPLETED|Overall Study||0
6733112|NCT03207022|7662670|FG001|NOT COMPLETED|Overall Study||0
6733113|NCT03207035|7662678|FG000|STARTED|Overall Study||10
6733114|NCT03207035|7662679|FG001|STARTED|Overall Study||10
6733115|NCT03207035|7662678|FG000|COMPLETED|Overall Study||10
6733116|NCT03207035|7662679|FG001|COMPLETED|Overall Study||10
6733117|NCT03207035|7662678|FG000|NOT COMPLETED|Overall Study||0
6733118|NCT03207035|7662679|FG001|NOT COMPLETED|Overall Study||0
6733119|NCT03207074|7662685|FG000|STARTED|Overall Study||150
6733120|NCT03207074|7662685|FG000|COMPLETED|Overall Study||150
6733121|NCT03207074|7662685|FG000|NOT COMPLETED|Overall Study||0
6733122|NCT03207243|7662691|FG000|STARTED|Overall Study||82
6733123|NCT03207243|7662692|FG001|STARTED|Overall Study||83
6733124|NCT03207243|7662691|FG000|COMPLETED|Overall Study||23
6733125|NCT03207243|7662692|FG001|COMPLETED|Overall Study||39
6733126|NCT03207243|7662691|FG000|NOT COMPLETED|Overall Study||59
6733127|NCT03207243|7662692|FG001|NOT COMPLETED|Overall Study||44
6733128|NCT03207386|7662699|FG000|STARTED|Overall Study||2647
6733129|NCT03207386|7662699|FG000|COMPLETED|Overall Study||1487
6733130|NCT03207386|7662699|FG000|NOT COMPLETED|Overall Study||1160
6733131|NCT03207399|7662706|FG000|STARTED|Overall Study||1
6733132|NCT03207399|7662706|FG000|COMPLETED|Overall Study||1
6733133|NCT03207399|7662706|FG000|NOT COMPLETED|Overall Study||0
6733134|NCT03207438|7662714|FG000|STARTED|Overall Study||167
6733135|NCT03207438|7662715|FG001|STARTED|Overall Study||166
6733136|NCT03207438|7662716|FG002|STARTED|Overall Study||875
6733137|NCT03207438|7662717|FG003|STARTED|Overall Study||582
6733138|NCT03207438|7662714|FG000|COMPLETED|Overall Study||148
6733139|NCT03207438|7662715|FG001|COMPLETED|Overall Study||145
6733140|NCT03207438|7662716|FG002|COMPLETED|Overall Study||643
6733141|NCT03207438|7662717|FG003|COMPLETED|Overall Study||470
6733142|NCT03207438|7662714|FG000|NOT COMPLETED|Overall Study||19
6733143|NCT03207438|7662715|FG001|NOT COMPLETED|Overall Study||21
6733144|NCT03207438|7662716|FG002|NOT COMPLETED|Overall Study||232
6733145|NCT03207438|7662717|FG003|NOT COMPLETED|Overall Study||112
6733146|NCT03207750|7662732|FG000|STARTED|Overall Study||632
6733147|NCT03207750|7662733|FG001|STARTED|Overall Study||640
6733148|NCT03207750|7662732|FG000|COMPLETED|Overall Study||574
6733149|NCT03207750|7662733|FG001|COMPLETED|Overall Study||574
6733150|NCT03207750|7662732|FG000|NOT COMPLETED|Overall Study||58
6617775|NCT02164396|7544413|FG002|COMPLETED|Overall Study||10
6617776|NCT02164396|7544411|FG000|NOT COMPLETED|Overall Study||0
6617777|NCT02164396|7544412|FG001|NOT COMPLETED|Overall Study||0
6617778|NCT02164396|7544413|FG002|NOT COMPLETED|Overall Study||0
6617779|NCT02164422|7544424|FG000|STARTED|Overall Study||25
6617780|NCT02164422|7544425|FG001|STARTED|Overall Study||22
6617781|NCT02164422|7544426|FG002|STARTED|Overall Study||23
6617782|NCT02164422|7544424|FG000|COMPLETED|Overall Study||24
6617783|NCT02164422|7544425|FG001|COMPLETED|Overall Study||20
6617784|NCT02164422|7544426|FG002|COMPLETED|Overall Study||23
6617785|NCT02164422|7544424|FG000|NOT COMPLETED|Overall Study||1
6617786|NCT02164422|7544425|FG001|NOT COMPLETED|Overall Study||2
6617787|NCT02164422|7544426|FG002|NOT COMPLETED|Overall Study||0
6617788|NCT02164513|7544437|FG000|STARTED|Overall Study||4151
6617789|NCT02164513|7544438|FG001|STARTED|Overall Study||4134
6617790|NCT02164513|7544439|FG002|STARTED|Overall Study||2070
6617791|NCT02164513|7544437|FG000|Completed Investigational Product (IP)|Overall Study||3393
6617792|NCT02164513|7544438|FG001|Completed Investigational Product (IP)|Overall Study||3094
6617793|NCT02164513|7544439|FG002|Completed Investigational Product (IP)|Overall Study||1504
6617794|NCT02164513|7544437|FG000|Not Completed IP|Overall Study||758
6617795|NCT02164513|7544438|FG001|Not Completed IP|Overall Study||1040
6617796|NCT02164513|7544439|FG002|Not Completed IP|Overall Study||566
6617797|NCT02164513|7544437|FG000|Withdrew IP (WIP): Adverse Event|Overall Study||249
6617798|NCT02164513|7544438|FG001|Withdrew IP (WIP): Adverse Event|Overall Study||325
6617799|NCT02164513|7544439|FG002|Withdrew IP (WIP): Adverse Event|Overall Study||186
6617800|NCT02164513|7544437|FG000|WIP: Lack of Efficacy|Overall Study||163
6617801|NCT02164513|7544438|FG001|WIP: Lack of Efficacy|Overall Study||313
6617802|NCT02164513|7544439|FG002|WIP: Lack of Efficacy|Overall Study||172
6617803|NCT02164513|7544437|FG000|Withdrew IP: Protocol Deviation|Overall Study||32
6617804|NCT02164513|7544438|FG001|Withdrew IP: Protocol Deviation|Overall Study||41
6617805|NCT02164513|7544439|FG002|Withdrew IP: Protocol Deviation|Overall Study||19
6617806|NCT02164513|7544437|FG000|WIP (Other): Stopping Criteria Reached|Overall Study||4
6617807|NCT02164513|7544438|FG001|WIP (Other): Stopping Criteria Reached|Overall Study||1
6617808|NCT02164513|7544439|FG002|WIP (Other): Stopping Criteria Reached|Overall Study||2
6617809|NCT02164513|7544437|FG000|WIP: Study Closed/Terminated|Overall Study||5
6617810|NCT02164513|7544438|FG001|WIP: Study Closed/Terminated|Overall Study||2
6617811|NCT02164513|7544439|FG002|WIP: Study Closed/Terminated|Overall Study||5
6617812|NCT02164513|7544437|FG000|WIP: Lost to Follow-up|Overall Study||21
6617813|NCT02164513|7544438|FG001|WIP: Lost to Follow-up|Overall Study||25
6617814|NCT02164513|7544439|FG002|WIP: Lost to Follow-up|Overall Study||14
6617815|NCT02164513|7544437|FG000|WIP: Investigator Discretion|Overall Study||33
6617816|NCT02164513|7544438|FG001|WIP: Investigator Discretion|Overall Study||36
6617817|NCT02164513|7544439|FG002|WIP: Investigator Discretion|Overall Study||15
6617818|NCT02164513|7544437|FG000|WIP: Withdrawal by Participant|Overall Study||250
6617819|NCT02164513|7544438|FG001|WIP: Withdrawal by Participant|Overall Study||296
6617820|NCT02164513|7544439|FG002|WIP: Withdrawal by Participant|Overall Study||153
6617821|NCT02164513|7544437|FG000|WIP :Did Not Complete Study Treatment|Overall Study||1
6617822|NCT02164513|7544438|FG001|WIP :Did Not Complete Study Treatment|Overall Study||1
6617823|NCT02164513|7544439|FG002|WIP :Did Not Complete Study Treatment|Overall Study||0
6617824|NCT02164513|7544437|FG000|COMPLETED|Overall Study||3714
6617825|NCT02164513|7544438|FG001|COMPLETED|Overall Study||3598
6617826|NCT02164513|7544439|FG002|COMPLETED|Overall Study||1775
6617827|NCT02164513|7544437|FG000|NOT COMPLETED|Overall Study||437
6617828|NCT02164513|7544438|FG001|NOT COMPLETED|Overall Study||536
6617829|NCT02164513|7544439|FG002|NOT COMPLETED|Overall Study||295
6617830|NCT02164539|7544454|FG000|STARTED|Treatment Phase A (4 Weeks)||41
6617831|NCT02164539|7544455|FG001|STARTED|Treatment Phase A (4 Weeks)||42
6617832|NCT02164539|7544456|FG002|STARTED|Treatment Phase A (4 Weeks)||40
6617833|NCT02164539|7544457|FG003|STARTED|Treatment Phase A (4 Weeks)||46
6617834|NCT02164539|7544458|FG004|STARTED|Treatment Phase A (4 Weeks)||85
6617835|NCT02164539|7544459|FG005|STARTED|Treatment Phase A (4 Weeks)||84
6617836|NCT02164539|7544460|FG006|STARTED|Treatment Phase A (4 Weeks)||0
6617837|NCT02164539|7544454|FG000|COMPLETED|Treatment Phase A (4 Weeks)||39
6617838|NCT02164539|7544455|FG001|COMPLETED|Treatment Phase A (4 Weeks)||42
6617839|NCT02164539|7544456|FG002|COMPLETED|Treatment Phase A (4 Weeks)||39
6617840|NCT02164539|7544457|FG003|COMPLETED|Treatment Phase A (4 Weeks)||44
6617841|NCT02164539|7544458|FG004|COMPLETED|Treatment Phase A (4 Weeks)||82
6617842|NCT02164539|7544459|FG005|COMPLETED|Treatment Phase A (4 Weeks)||83
6617843|NCT02164539|7544460|FG006|COMPLETED|Treatment Phase A (4 Weeks)||0
6617844|NCT02164539|7544454|FG000|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
6617845|NCT02164539|7544455|FG001|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
6617846|NCT02164539|7544456|FG002|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
6617847|NCT02164539|7544457|FG003|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
6617848|NCT02164539|7544458|FG004|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
6617849|NCT02164539|7544459|FG005|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
6617850|NCT02164539|7544460|FG006|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
6617851|NCT02164539|7544454|FG000|STARTED|Treatment Phase B (1 Week)||0
6617852|NCT02164539|7544455|FG001|STARTED|Treatment Phase B (1 Week)||0
6617853|NCT02164539|7544456|FG002|STARTED|Treatment Phase B (1 Week)||0
6617854|NCT02164539|7544457|FG003|STARTED|Treatment Phase B (1 Week)||0
6617855|NCT02164539|7544458|FG004|STARTED|Treatment Phase B (1 Week)||166
6617856|NCT02164539|7544459|FG005|STARTED|Treatment Phase B (1 Week)||0
6617857|NCT02164539|7544460|FG006|STARTED|Treatment Phase B (1 Week)||163
6617858|NCT02164539|7544454|FG000|COMPLETED|Treatment Phase B (1 Week)||0
6617859|NCT02164539|7544455|FG001|COMPLETED|Treatment Phase B (1 Week)||0
6617860|NCT02164539|7544456|FG002|COMPLETED|Treatment Phase B (1 Week)||0
6617861|NCT02164539|7544457|FG003|COMPLETED|Treatment Phase B (1 Week)||0
6617862|NCT02164539|7544458|FG004|COMPLETED|Treatment Phase B (1 Week)||163
6617863|NCT02164539|7544459|FG005|COMPLETED|Treatment Phase B (1 Week)||0
6617864|NCT02164539|7544460|FG006|COMPLETED|Treatment Phase B (1 Week)||162
6617865|NCT02164539|7544454|FG000|NOT COMPLETED|Treatment Phase B (1 Week)||0
6617866|NCT02164539|7544455|FG001|NOT COMPLETED|Treatment Phase B (1 Week)||0
6617867|NCT02164539|7544456|FG002|NOT COMPLETED|Treatment Phase B (1 Week)||0
6617868|NCT02164539|7544457|FG003|NOT COMPLETED|Treatment Phase B (1 Week)||0
6617869|NCT02164539|7544458|FG004|NOT COMPLETED|Treatment Phase B (1 Week)||3
6617870|NCT02164539|7544459|FG005|NOT COMPLETED|Treatment Phase B (1 Week)||0
6617871|NCT02164539|7544460|FG006|NOT COMPLETED|Treatment Phase B (1 Week)||1
6617872|NCT02164539|7544454|FG000|STARTED|Treatment Phase C (1 Week)||79
6617873|NCT02164539|7544455|FG001|STARTED|Treatment Phase C (1 Week)||0
6617874|NCT02164539|7544456|FG002|STARTED|Treatment Phase C (1 Week)||0
6617875|NCT02164539|7544457|FG003|STARTED|Treatment Phase C (1 Week)||0
6617876|NCT02164539|7544458|FG004|STARTED|Treatment Phase C (1 Week)||84
6617877|NCT02164539|7544459|FG005|STARTED|Treatment Phase C (1 Week)||82
6617878|NCT02164539|7544460|FG006|STARTED|Treatment Phase C (1 Week)||80
6617879|NCT02164539|7544454|FG000|COMPLETED|Treatment Phase C (1 Week)||78
6617880|NCT02164539|7544455|FG001|COMPLETED|Treatment Phase C (1 Week)||0
6617881|NCT02164539|7544456|FG002|COMPLETED|Treatment Phase C (1 Week)||0
6617882|NCT02164539|7544457|FG003|COMPLETED|Treatment Phase C (1 Week)||0
6617883|NCT02164539|7544458|FG004|COMPLETED|Treatment Phase C (1 Week)||84
6617884|NCT02164539|7544459|FG005|COMPLETED|Treatment Phase C (1 Week)||82
6617885|NCT02164539|7544460|FG006|COMPLETED|Treatment Phase C (1 Week)||78
6617886|NCT02164539|7544454|FG000|NOT COMPLETED|Treatment Phase C (1 Week)||1
6617887|NCT02164539|7544455|FG001|NOT COMPLETED|Treatment Phase C (1 Week)||0
6617888|NCT02164539|7544456|FG002|NOT COMPLETED|Treatment Phase C (1 Week)||0
6617889|NCT02164539|7544457|FG003|NOT COMPLETED|Treatment Phase C (1 Week)||0
6617890|NCT02164539|7544458|FG004|NOT COMPLETED|Treatment Phase C (1 Week)||0
6617891|NCT02164539|7544459|FG005|NOT COMPLETED|Treatment Phase C (1 Week)||0
6617892|NCT02164539|7544460|FG006|NOT COMPLETED|Treatment Phase C (1 Week)||2
6617893|NCT02164721|7544475|FG000|STARTED|Overall Study||30
6617894|NCT02164721|7544475|FG000|COMPLETED|Overall Study||30
6617895|NCT02164721|7544475|FG000|NOT COMPLETED|Overall Study||0
6617896|NCT02164864|7544483|FG000|STARTED|Overall Study|Started are the Randomised/entered patients.|981
6617897|NCT02164864|7544484|FG001|STARTED|Overall Study|Started are the Randomised/entered patients.|763
6617898|NCT02164864|7544485|FG002|STARTED|Overall Study|Started are the Randomised/entered patients.|981
6617899|NCT02164864|7544483|FG000|COMPLETED|Overall Study||886
6617900|NCT02164864|7544484|FG001|COMPLETED|Overall Study||703
6617901|NCT02164864|7544485|FG002|COMPLETED|Overall Study||849
6617902|NCT02164864|7544483|FG000|NOT COMPLETED|Overall Study||95
6617903|NCT02164864|7544484|FG001|NOT COMPLETED|Overall Study||60
6617904|NCT02164864|7544485|FG002|NOT COMPLETED|Overall Study||132
6617905|NCT02164916|7544498|FG000|STARTED|Overall Study||52
6617906|NCT02164916|7544499|FG001|STARTED|Overall Study||54
6617907|NCT02164916|7544498|FG000|Eligible|Overall Study||50
6617908|NCT02164916|7544499|FG001|Eligible|Overall Study||49
6617909|NCT02164916|7544498|FG000|Cross-over to Arm II|Overall Study|Following disease progression on Arm 1. Note: these patients are also counted in 'Not Completed'.|24
6617910|NCT02164916|7544499|FG001|Cross-over to Arm II|Overall Study||0
6617911|NCT02164916|7544498|FG000|COMPLETED|Overall Study||0
6617912|NCT02164916|7544499|FG001|COMPLETED|Overall Study||0
6617913|NCT02164916|7544498|FG000|NOT COMPLETED|Overall Study||52
6617914|NCT02164916|7544499|FG001|NOT COMPLETED|Overall Study||54
6617915|NCT02164929|7544514|FG000|STARTED|Overall Study||4
6617916|NCT02164929|7544515|FG001|STARTED|Overall Study||3
6617917|NCT02164929|7544516|FG002|STARTED|Overall Study||5
6617918|NCT02164929|7544517|FG003|STARTED|Overall Study||4
6617919|NCT02164929|7544514|FG000|COMPLETED|Overall Study||3
6617920|NCT02164929|7544515|FG001|COMPLETED|Overall Study||3
6617921|NCT02164929|7544516|FG002|COMPLETED|Overall Study||4
6617922|NCT02164929|7544517|FG003|COMPLETED|Overall Study||2
6617923|NCT02164929|7544514|FG000|NOT COMPLETED|Overall Study||1
6617924|NCT02164929|7544515|FG001|NOT COMPLETED|Overall Study||0
6617925|NCT02164929|7544516|FG002|NOT COMPLETED|Overall Study||1
6617926|NCT02164929|7544517|FG003|NOT COMPLETED|Overall Study||2
6617927|NCT02164981|7544530|FG000|STARTED|Started||23
6617928|NCT02164981|7544531|FG001|STARTED|Started||19
6617929|NCT02164981|7544532|FG002|STARTED|Started||18
6617930|NCT02164981|7544530|FG000|COMPLETED|Started||18
6617931|NCT02164981|7544531|FG001|COMPLETED|Started||16
6617932|NCT02164981|7544532|FG002|COMPLETED|Started||18
6617933|NCT02164981|7544530|FG000|NOT COMPLETED|Started||5
6617934|NCT02164981|7544531|FG001|NOT COMPLETED|Started||3
6617935|NCT02164981|7544532|FG002|NOT COMPLETED|Started||0
6617936|NCT02164981|7544530|FG000|STARTED|Phase 1 (Day 0 - Day 14)||18
6617937|NCT02164981|7544531|FG001|STARTED|Phase 1 (Day 0 - Day 14)||16
6617938|NCT02164981|7544532|FG002|STARTED|Phase 1 (Day 0 - Day 14)||18
6617939|NCT02164981|7544530|FG000|COMPLETED|Phase 1 (Day 0 - Day 14)||18
6617940|NCT02164981|7544531|FG001|COMPLETED|Phase 1 (Day 0 - Day 14)||14
6617941|NCT02164981|7544532|FG002|COMPLETED|Phase 1 (Day 0 - Day 14)||18
6617942|NCT02164981|7544530|FG000|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
6617943|NCT02164981|7544531|FG001|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||2
6617944|NCT02164981|7544532|FG002|NOT COMPLETED|Phase 1 (Day 0 - Day 14)||0
6617945|NCT02164981|7544530|FG000|STARTED|Phase 2 (Day 14 - Day 28)||18
6617946|NCT02164981|7544531|FG001|STARTED|Phase 2 (Day 14 - Day 28)||14
6617947|NCT02164981|7544532|FG002|STARTED|Phase 2 (Day 14 - Day 28)||18
6617948|NCT02164981|7544530|FG000|COMPLETED|Phase 2 (Day 14 - Day 28)||16
6617949|NCT02164981|7544531|FG001|COMPLETED|Phase 2 (Day 14 - Day 28)||12
6617950|NCT02164981|7544532|FG002|COMPLETED|Phase 2 (Day 14 - Day 28)||18
6617951|NCT02164981|7544530|FG000|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
6617952|NCT02164981|7544531|FG001|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||2
6617953|NCT02164981|7544532|FG002|NOT COMPLETED|Phase 2 (Day 14 - Day 28)||0
6617954|NCT02165072|7544553|FG000|STARTED|Overall Study||30
6617955|NCT02165072|7544553|FG000|COMPLETED|Overall Study||30
6617956|NCT02165072|7544553|FG000|NOT COMPLETED|Overall Study||0
6617957|NCT02165111|7544559|FG000|STARTED|Overall Study||40
6617958|NCT02165111|7544560|FG001|STARTED|Overall Study||40
6617959|NCT02165111|7544559|FG000|COMPLETED|Overall Study||40
6617960|NCT02165111|7544560|FG001|COMPLETED|Overall Study||40
6617961|NCT02165111|7544559|FG000|NOT COMPLETED|Overall Study||0
6617962|NCT02165111|7544560|FG001|NOT COMPLETED|Overall Study||0
6617963|NCT02165124|7544568|FG000|STARTED|Overall Study||20
6617964|NCT02165124|7544568|FG000|COMPLETED|Overall Study||15
6617965|NCT02165124|7544568|FG000|NOT COMPLETED|Overall Study||5
6617966|NCT02165202|7544574|FG000|STARTED|Oral Phase|Participants Enrolled in the study|91
6617967|NCT02165202|7544575|FG001|STARTED|Oral Phase|Participants Enrolled in the study|45
6617968|NCT02165202|7544574|FG000|COMPLETED|Oral Phase||80
6617969|NCT02165202|7544575|FG001|COMPLETED|Oral Phase||42
6617970|NCT02165202|7544574|FG000|NOT COMPLETED|Oral Phase||11
6617971|NCT02165202|7544575|FG001|NOT COMPLETED|Oral Phase||3
6617972|NCT02165202|7544574|FG000|STARTED|Injection Phase|Participants who received at least one injection.|80
6617973|NCT02165202|7544575|FG001|STARTED|Injection Phase|Participants who received at least one injection.|42
6617974|NCT02165202|7544574|FG000|COMPLETED|Injection Phase||70
6617975|NCT02165202|7544575|FG001|COMPLETED|Injection Phase||36
6617976|NCT02165202|7544574|FG000|NOT COMPLETED|Injection Phase||10
6617977|NCT02165202|7544575|FG001|NOT COMPLETED|Injection Phase||6
6617978|NCT02165384|7544581|FG000|STARTED|Overall Study||199
6617979|NCT02165384|7544581|FG000|COMPLETED|Overall Study||199
6617980|NCT02165384|7544581|FG000|NOT COMPLETED|Overall Study||0
6617981|NCT02165397|7544588|FG000|STARTED|Overall Study||75
6617982|NCT02165397|7544589|FG001|STARTED|Overall Study||75
6617983|NCT02165397|7544590|FG002|STARTED|Overall Study||31
6617984|NCT02165397|7544588|FG000|COMPLETED|Overall Study||61
6617985|NCT02165397|7544589|FG001|COMPLETED|Overall Study||56
6617986|NCT02165397|7544590|FG002|COMPLETED|Overall Study||21
6617987|NCT02165397|7544588|FG000|NOT COMPLETED|Overall Study||14
6617988|NCT02165397|7544589|FG001|NOT COMPLETED|Overall Study||19
6617989|NCT02165397|7544590|FG002|NOT COMPLETED|Overall Study||10
6617990|NCT02165462|7544600|FG000|STARTED|Overall Study||17
6617991|NCT02165462|7544600|FG000|COMPLETED|Overall Study||17
6617992|NCT02165462|7544600|FG000|NOT COMPLETED|Overall Study||0
6617993|NCT02165605|7544604|FG000|STARTED|Overall Study||28
6617994|NCT02165605|7544604|FG000|COMPLETED|Overall Study||28
6617995|NCT02165605|7544604|FG000|NOT COMPLETED|Overall Study||0
6617996|NCT02165722|7544613|FG000|STARTED|Overall Study||1971
6617997|NCT02165722|7544614|FG001|STARTED|Overall Study||2202
6617998|NCT02165722|7544613|FG000|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|1971
6617999|NCT02165722|7544614|FG001|COMPLETED|Overall Study|Started and completed participants reflect the longitudinal analytic data set of patients used|2202
6618000|NCT02165722|7544613|FG000|NOT COMPLETED|Overall Study||0
6618001|NCT02165722|7544614|FG001|NOT COMPLETED|Overall Study||0
6618002|NCT02165735|7544628|FG000|STARTED|Overall Study||180
6618003|NCT02165735|7544629|FG001|STARTED|Overall Study||180
6618004|NCT02165735|7544628|FG000|COMPLETED|Overall Study||164
6618005|NCT02165735|7544629|FG001|COMPLETED|Overall Study||166
6618006|NCT02165735|7544628|FG000|NOT COMPLETED|Overall Study||16
6618007|NCT02165735|7544629|FG001|NOT COMPLETED|Overall Study||14
6618008|NCT02165761|7544637|FG000|STARTED|Overall Study||23
6618009|NCT02165761|7544638|FG001|STARTED|Overall Study||19
6618010|NCT02165761|7544637|FG000|COMPLETED|Overall Study||4
6618011|NCT02165761|7544638|FG001|COMPLETED|Overall Study||5
6618012|NCT02165761|7544637|FG000|NOT COMPLETED|Overall Study||19
6618013|NCT02165761|7544638|FG001|NOT COMPLETED|Overall Study||14
6618014|NCT02165826|7544647|FG000|STARTED|Main Treatment Period||441
6618015|NCT02165826|7544648|FG001|STARTED|Main Treatment Period||439
6618016|NCT02165826|7544649|FG002|STARTED|Main Treatment Period||443
6618017|NCT02165826|7544647|FG000|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
6618018|NCT02165826|7544648|FG001|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
6618019|NCT02165826|7544649|FG002|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
6618020|NCT02165826|7544647|FG000|COMPLETED|Main Treatment Period||360
6618021|NCT02165826|7544648|FG001|COMPLETED|Main Treatment Period||349
6618022|NCT02165826|7544649|FG002|COMPLETED|Main Treatment Period||334
6618023|NCT02165826|7544647|FG000|NOT COMPLETED|Main Treatment Period||81
6618024|NCT02165826|7544648|FG001|NOT COMPLETED|Main Treatment Period||90
6618025|NCT02165826|7544649|FG002|NOT COMPLETED|Main Treatment Period||109
6618026|NCT02165826|7544647|FG000|STARTED|Down-Titration Period||27
6618027|NCT02165826|7544648|FG001|STARTED|Down-Titration Period||39
6618028|NCT02165826|7544649|FG002|STARTED|Down-Titration Period||38
6618029|NCT02165826|7544647|FG000|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
6618030|NCT02165826|7544648|FG001|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
6618031|NCT02165826|7544649|FG002|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
6618032|NCT02165826|7544647|FG000|COMPLETED|Down-Titration Period||20
6618033|NCT02165826|7544648|FG001|COMPLETED|Down-Titration Period||28
6618034|NCT02165826|7544649|FG002|COMPLETED|Down-Titration Period||31
6618035|NCT02165826|7544647|FG000|NOT COMPLETED|Down-Titration Period||7
6618036|NCT02165826|7544648|FG001|NOT COMPLETED|Down-Titration Period||11
6618037|NCT02165826|7544649|FG002|NOT COMPLETED|Down-Titration Period||7
6618038|NCT02165839|7544676|FG000|STARTED|Overall Study||66
6618039|NCT02165839|7544677|FG001|STARTED|Overall Study||73
6618040|NCT02165839|7544676|FG000|COMPLETED|Overall Study||66
6618041|NCT02165839|7544677|FG001|COMPLETED|Overall Study||73
6618042|NCT02165839|7544676|FG000|NOT COMPLETED|Overall Study||0
6618043|NCT02165839|7544677|FG001|NOT COMPLETED|Overall Study||0
6618044|NCT02165904|7544684|FG000|STARTED|Overall Study||10
6618045|NCT02165904|7544684|FG000|COMPLETED|Overall Study||10
6618046|NCT02165904|7544684|FG000|NOT COMPLETED|Overall Study||0
6618047|NCT02166047|7544700|FG000|STARTED|Overall Study||16
6618048|NCT02166047|7544701|FG001|STARTED|Overall Study||15
6618049|NCT02166047|7544702|FG002|STARTED|Overall Study||16
6618050|NCT02166047|7544703|FG003|STARTED|Overall Study||5
6618051|NCT02166047|7544704|FG004|STARTED|Overall Study||18
6618052|NCT02166047|7544705|FG005|STARTED|Overall Study||17
6618053|NCT02166047|7544706|FG006|STARTED|Overall Study||17
6618054|NCT02166047|7544707|FG007|STARTED|Overall Study||5
6618055|NCT02166047|7544708|FG008|STARTED|Overall Study||16
6618056|NCT02166047|7544709|FG009|STARTED|Overall Study||17
6618057|NCT02166047|7544710|FG010|STARTED|Overall Study||14
6618058|NCT02166047|7544711|FG011|STARTED|Overall Study||6
6618059|NCT02166047|7544700|FG000|COMPLETED|Overall Study||16
6618060|NCT02166047|7544701|FG001|COMPLETED|Overall Study||14
6618061|NCT02166047|7544702|FG002|COMPLETED|Overall Study||14
6618062|NCT02166047|7544703|FG003|COMPLETED|Overall Study||5
6618063|NCT02166047|7544704|FG004|COMPLETED|Overall Study||17
6618064|NCT02166047|7544705|FG005|COMPLETED|Overall Study||17
6618065|NCT02166047|7544706|FG006|COMPLETED|Overall Study||15
6618066|NCT02166047|7544707|FG007|COMPLETED|Overall Study||5
6618067|NCT02166047|7544708|FG008|COMPLETED|Overall Study||16
6618068|NCT02166047|7544709|FG009|COMPLETED|Overall Study||17
6618069|NCT02166047|7544710|FG010|COMPLETED|Overall Study||12
6618070|NCT02166047|7544711|FG011|COMPLETED|Overall Study||6
6618071|NCT02166047|7544700|FG000|NOT COMPLETED|Overall Study||0
6618072|NCT02166047|7544701|FG001|NOT COMPLETED|Overall Study||1
6618073|NCT02166047|7544702|FG002|NOT COMPLETED|Overall Study||2
6618074|NCT02166047|7544703|FG003|NOT COMPLETED|Overall Study||0
6618075|NCT02166047|7544704|FG004|NOT COMPLETED|Overall Study||1
6618076|NCT02166047|7544705|FG005|NOT COMPLETED|Overall Study||0
6618077|NCT02166047|7544706|FG006|NOT COMPLETED|Overall Study||2
6618078|NCT02166047|7544707|FG007|NOT COMPLETED|Overall Study||0
6618079|NCT02166047|7544708|FG008|NOT COMPLETED|Overall Study||0
6618080|NCT02166047|7544709|FG009|NOT COMPLETED|Overall Study||0
6618081|NCT02166047|7544710|FG010|NOT COMPLETED|Overall Study||2
6618082|NCT02166047|7544711|FG011|NOT COMPLETED|Overall Study||0
6618083|NCT02166333|7544741|FG000|STARTED|Stage 1||262
6618084|NCT02166333|7544742|FG001|STARTED|Stage 1||0
6618085|NCT02166333|7544743|FG002|STARTED|Stage 1||130
6618086|NCT02166333|7544744|FG003|STARTED|Stage 1||0
6618087|NCT02166333|7544745|FG004|STARTED|Stage 1|Randomization to 2000 IU/d was stopped in February 2018 as part of planned dose-finding|68
6618088|NCT02166333|7544746|FG005|STARTED|Stage 1|Randomization to 4000 IU/d was stopped in March 2018 as part of planned dose-finding|69
6618089|NCT02166333|7544741|FG000|COMPLETED|Stage 1||242
6618090|NCT02166333|7544742|FG001|COMPLETED|Stage 1||0
6618091|NCT02166333|7544743|FG002|COMPLETED|Stage 1||122
6618092|NCT02166333|7544744|FG003|COMPLETED|Stage 1||0
6618093|NCT02166333|7544745|FG004|COMPLETED|Stage 1||59
6618094|NCT02166333|7544746|FG005|COMPLETED|Stage 1||63
6618095|NCT02166333|7544741|FG000|NOT COMPLETED|Stage 1||20
6618096|NCT02166333|7544742|FG001|NOT COMPLETED|Stage 1||0
6618097|NCT02166333|7544743|FG002|NOT COMPLETED|Stage 1||8
6618098|NCT02166333|7544744|FG003|NOT COMPLETED|Stage 1||0
6618099|NCT02166333|7544745|FG004|NOT COMPLETED|Stage 1||9
6618100|NCT02166333|7544746|FG005|NOT COMPLETED|Stage 1||6
6618101|NCT02166333|7544741|FG000|STARTED|Stage 2||242
6618102|NCT02166333|7544742|FG001|STARTED|Stage 2||77
6618103|NCT02166333|7544743|FG002|STARTED|Stage 2||122
6618104|NCT02166333|7544744|FG003|STARTED|Stage 2||82
6618105|NCT02166333|7544745|FG004|STARTED|Stage 2||59
6618106|NCT02166333|7544746|FG005|STARTED|Stage 2||63
6618107|NCT02166333|7544741|FG000|COMPLETED|Stage 2||35
6618108|NCT02166333|7544742|FG001|COMPLETED|Stage 2||71
6618109|NCT02166333|7544743|FG002|COMPLETED|Stage 2||47
6618110|NCT02166333|7544744|FG003|COMPLETED|Stage 2||73
6618111|NCT02166333|7544745|FG004|COMPLETED|Stage 2||2
6618112|NCT02166333|7544746|FG005|COMPLETED|Stage 2||4
6618113|NCT02166333|7544741|FG000|NOT COMPLETED|Stage 2||207
6618114|NCT02166333|7544742|FG001|NOT COMPLETED|Stage 2||6
6618115|NCT02166333|7544743|FG002|NOT COMPLETED|Stage 2||75
6618116|NCT02166333|7544744|FG003|NOT COMPLETED|Stage 2||9
6618117|NCT02166333|7544745|FG004|NOT COMPLETED|Stage 2||57
6618118|NCT02166333|7544746|FG005|NOT COMPLETED|Stage 2||59
6618119|NCT02166346|7544758|FG000|STARTED|Screening and Randomization||12
6618120|NCT02166346|7544759|FG001|STARTED|Screening and Randomization||12
6618121|NCT02166346|7544758|FG000|COMPLETED|Screening and Randomization||8
6618122|NCT02166346|7544759|FG001|COMPLETED|Screening and Randomization||8
6618123|NCT02166346|7544758|FG000|NOT COMPLETED|Screening and Randomization||4
6618124|NCT02166346|7544759|FG001|NOT COMPLETED|Screening and Randomization||4
6618125|NCT02166346|7544758|FG000|STARTED|Intervention - Phase 1||8
6618126|NCT02166346|7544759|FG001|STARTED|Intervention - Phase 1||8
6618127|NCT02166346|7544758|FG000|COMPLETED|Intervention - Phase 1||8
6618128|NCT02166346|7544759|FG001|COMPLETED|Intervention - Phase 1||6
6618129|NCT02166346|7544758|FG000|NOT COMPLETED|Intervention - Phase 1||0
6618130|NCT02166346|7544759|FG001|NOT COMPLETED|Intervention - Phase 1||2
6618131|NCT02166346|7544758|FG000|STARTED|Intervention - Phase 2 (After Crossover)||8
6618132|NCT02166346|7544759|FG001|STARTED|Intervention - Phase 2 (After Crossover)||6
6618133|NCT02166346|7544758|FG000|COMPLETED|Intervention - Phase 2 (After Crossover)||7
6618134|NCT02166346|7544759|FG001|COMPLETED|Intervention - Phase 2 (After Crossover)||6
6618135|NCT02166346|7544758|FG000|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||1
6618136|NCT02166346|7544759|FG001|NOT COMPLETED|Intervention - Phase 2 (After Crossover)||0
6618137|NCT02166476|7544767|FG000|STARTED|Overall Study||272
6618138|NCT02166476|7544768|FG001|STARTED|Overall Study||273
6618139|NCT02166476|7544767|FG000|Received at Least 1 Dose of Study Drug|Overall Study||272
6618140|NCT02166476|7544768|FG001|Received at Least 1 Dose of Study Drug|Overall Study||273
6618141|NCT02166476|7544767|FG000|COMPLETED|Overall Study||258
6618142|NCT02166476|7544768|FG001|COMPLETED|Overall Study||250
6618143|NCT02166476|7544767|FG000|NOT COMPLETED|Overall Study||14
6618144|NCT02166476|7544768|FG001|NOT COMPLETED|Overall Study||23
6618145|NCT02166606|7544777|FG000|STARTED|Overall Study||1184
6618146|NCT02166606|7544777|FG000|Actively Enrolled|Overall Study||1180
6618147|NCT02166606|7544777|FG000|Consent Eligible|Overall Study||1174
6618148|NCT02166606|7544777|FG000|COMPLETED|Overall Study||1106
6618149|NCT02166606|7544777|FG000|NOT COMPLETED|Overall Study||78
6618150|NCT02166697|7544781|FG000|STARTED|Overall Study||14151
6618151|NCT02166697|7544781|FG000|COMPLETED|Overall Study||13804
6618152|NCT02166697|7544781|FG000|NOT COMPLETED|Overall Study||347
6618153|NCT02167035|7544787|FG000|STARTED|Overall Study||21
6618154|NCT02167035|7544788|FG001|STARTED|Overall Study||22
6618155|NCT02167035|7544787|FG000|COMPLETED|Overall Study||16
6618156|NCT02167035|7544788|FG001|COMPLETED|Overall Study||16
6618157|NCT02167035|7544787|FG000|NOT COMPLETED|Overall Study||5
6618158|NCT02167035|7544788|FG001|NOT COMPLETED|Overall Study||6
6618159|NCT02167074|7544798|FG000|STARTED|Overall Study||306
6618160|NCT02167074|7544799|FG001|STARTED|Overall Study||302
6618161|NCT02167074|7544798|FG000|COMPLETED|Overall Study||306
6618162|NCT02167074|7544799|FG001|COMPLETED|Overall Study||302
6618163|NCT02167074|7544798|FG000|NOT COMPLETED|Overall Study||0
6618164|NCT02167074|7544799|FG001|NOT COMPLETED|Overall Study||0
6618165|NCT02167139|7544807|FG000|STARTED|Randomised, Double-blind||271
6618166|NCT02167139|7544808|FG001|STARTED|Randomised, Double-blind||273
6618167|NCT02167139|7544809|FG002|STARTED|Randomised, Double-blind||0
6618168|NCT02167139|7544810|FG003|STARTED|Randomised, Double-blind||0
6618169|NCT02167139|7544807|FG000|COMPLETED|Randomised, Double-blind||254
6618170|NCT02167139|7544808|FG001|COMPLETED|Randomised, Double-blind||254
6618171|NCT02167139|7544809|FG002|COMPLETED|Randomised, Double-blind||0
6618172|NCT02167139|7544810|FG003|COMPLETED|Randomised, Double-blind||0
6618173|NCT02167139|7544807|FG000|NOT COMPLETED|Randomised, Double-blind||17
6618174|NCT02167139|7544808|FG001|NOT COMPLETED|Randomised, Double-blind||19
6618175|NCT02167139|7544809|FG002|NOT COMPLETED|Randomised, Double-blind||0
6618176|NCT02167139|7544810|FG003|NOT COMPLETED|Randomised, Double-blind||0
6618177|NCT02167139|7544807|FG000|STARTED|Transition-extension||254
6618178|NCT02167139|7544808|FG001|STARTED|Transition-extension||0
6618179|NCT02167139|7544809|FG002|STARTED|Transition-extension||125
6618180|NCT02167139|7544810|FG003|STARTED|Transition-extension||129
6618181|NCT02167139|7544807|FG000|COMPLETED|Transition-extension||248
6618182|NCT02167139|7544808|FG001|COMPLETED|Transition-extension||0
6618183|NCT02167139|7544809|FG002|COMPLETED|Transition-extension||117
6618184|NCT02167139|7544810|FG003|COMPLETED|Transition-extension||124
6618185|NCT02167139|7544807|FG000|NOT COMPLETED|Transition-extension||6
6618186|NCT02167139|7544808|FG001|NOT COMPLETED|Transition-extension||0
6618187|NCT02167139|7544809|FG002|NOT COMPLETED|Transition-extension||8
6618188|NCT02167139|7544810|FG003|NOT COMPLETED|Transition-extension||5
6733151|NCT03207750|7662733|FG001|NOT COMPLETED|Overall Study||66
6733152|NCT03207763|7662741|FG000|STARTED|Overall Study||8
6733153|NCT03207763|7662742|FG001|STARTED|Overall Study||25
6733154|NCT03207763|7662741|FG000|Eligible and Opted for Patches 2 and 3|Overall Study||5
6733155|NCT03207763|7662742|FG001|Eligible and Opted for Patches 2 and 3|Overall Study||23
6733156|NCT03207763|7662741|FG000|Completed Patches 2 and 3 Study|Overall Study||5
6733157|NCT03207763|7662742|FG001|Completed Patches 2 and 3 Study|Overall Study||23
6733158|NCT03207763|7662741|FG000|COMPLETED|Overall Study||7
6733159|NCT03207763|7662742|FG001|COMPLETED|Overall Study||25
6733160|NCT03207763|7662741|FG000|NOT COMPLETED|Overall Study||1
6733161|NCT03207763|7662742|FG001|NOT COMPLETED|Overall Study||0
6733162|NCT03208088|7662757|FG000|STARTED|Period 1||10
6733163|NCT03208088|7662758|FG001|STARTED|Period 1||9
6733164|NCT03208088|7662759|FG002|STARTED|Period 1||10
6733165|NCT03208088|7662760|FG003|STARTED|Period 1||9
6733166|NCT03208088|7662761|FG004|STARTED|Period 1||9
6733167|NCT03208088|7662762|FG005|STARTED|Period 1||9
6733168|NCT03208088|7662763|FG006|STARTED|Period 1||8
6733169|NCT03208088|7662764|FG007|STARTED|Period 1||10
6733170|NCT03208088|7662765|FG008|STARTED|Period 1||8
6733171|NCT03208088|7662766|FG009|STARTED|Period 1||9
6733172|NCT03208088|7662757|FG000|COMPLETED|Period 1||10
6733173|NCT03208088|7662758|FG001|COMPLETED|Period 1||9
6733174|NCT03208088|7662759|FG002|COMPLETED|Period 1||10
6733175|NCT03208088|7662760|FG003|COMPLETED|Period 1||9
6733176|NCT03208088|7662761|FG004|COMPLETED|Period 1||9
6733177|NCT03208088|7662762|FG005|COMPLETED|Period 1||9
6733178|NCT03208088|7662763|FG006|COMPLETED|Period 1||8
6733179|NCT03208088|7662764|FG007|COMPLETED|Period 1||10
6733180|NCT03208088|7662765|FG008|COMPLETED|Period 1||8
6733181|NCT03208088|7662766|FG009|COMPLETED|Period 1||9
6733182|NCT03208088|7662757|FG000|NOT COMPLETED|Period 1||0
6733183|NCT03208088|7662758|FG001|NOT COMPLETED|Period 1||0
6733184|NCT03208088|7662759|FG002|NOT COMPLETED|Period 1||0
6733185|NCT03208088|7662760|FG003|NOT COMPLETED|Period 1||0
6733186|NCT03208088|7662761|FG004|NOT COMPLETED|Period 1||0
6733187|NCT03208088|7662762|FG005|NOT COMPLETED|Period 1||0
6733188|NCT03208088|7662763|FG006|NOT COMPLETED|Period 1||0
6733189|NCT03208088|7662764|FG007|NOT COMPLETED|Period 1||0
6733190|NCT03208088|7662765|FG008|NOT COMPLETED|Period 1||0
6733191|NCT03208088|7662766|FG009|NOT COMPLETED|Period 1||0
6733192|NCT03208088|7662757|FG000|STARTED|Period 2||10
6733193|NCT03208088|7662758|FG001|STARTED|Period 2||9
6733194|NCT03208088|7662759|FG002|STARTED|Period 2||10
6733195|NCT03208088|7662760|FG003|STARTED|Period 2||9
6733196|NCT03208088|7662761|FG004|STARTED|Period 2||9
6733197|NCT03208088|7662762|FG005|STARTED|Period 2||9
6733198|NCT03208088|7662763|FG006|STARTED|Period 2||8
6733199|NCT03208088|7662764|FG007|STARTED|Period 2||10
6733200|NCT03208088|7662765|FG008|STARTED|Period 2||8
6733201|NCT03208088|7662766|FG009|STARTED|Period 2||9
6733202|NCT03208088|7662757|FG000|COMPLETED|Period 2||10
6733203|NCT03208088|7662758|FG001|COMPLETED|Period 2||9
6733204|NCT03208088|7662759|FG002|COMPLETED|Period 2||10
6618189|NCT02167204|7544824|FG000|STARTED|Overall Study||9
6618190|NCT02167204|7544824|FG000|COMPLETED|Overall Study||9
6618191|NCT02167204|7544824|FG000|NOT COMPLETED|Overall Study||0
6618192|NCT02167217|7544834|FG000|STARTED|Overall Study||25
6618193|NCT02167217|7544834|FG000|COMPLETED|Overall Study||23
6618194|NCT02167217|7544834|FG000|NOT COMPLETED|Overall Study||2
6618195|NCT02167256|7544840|FG000|STARTED|Overall Study||79
6618196|NCT02167256|7544841|FG001|STARTED|Overall Study||80
6618197|NCT02167256|7544840|FG000|COMPLETED|Overall Study||58
6618198|NCT02167256|7544841|FG001|COMPLETED|Overall Study||70
6618199|NCT02167256|7544840|FG000|NOT COMPLETED|Overall Study||21
6618200|NCT02167256|7544841|FG001|NOT COMPLETED|Overall Study||10
6618201|NCT02167451|7544847|FG000|STARTED|Overall Study||31
6618202|NCT02167451|7544847|FG000|COMPLETED|Overall Study||30
6618203|NCT02167451|7544847|FG000|NOT COMPLETED|Overall Study||1
6618204|NCT02167594|7544854|FG000|STARTED|Overall Study||20
6618205|NCT02167594|7544855|FG001|STARTED|Overall Study||6
6618206|NCT02167594|7544856|FG002|STARTED|Overall Study||3
6618207|NCT02167594|7544854|FG000|COMPLETED|Overall Study||18
6618208|NCT02167594|7544855|FG001|COMPLETED|Overall Study||5
6618209|NCT02167594|7544856|FG002|COMPLETED|Overall Study||3
6618210|NCT02167594|7544854|FG000|NOT COMPLETED|Overall Study||2
6618211|NCT02167594|7544855|FG001|NOT COMPLETED|Overall Study||1
6618212|NCT02167594|7544856|FG002|NOT COMPLETED|Overall Study||0
6618213|NCT02167815|7544867|FG000|STARTED|Overall Study||9
6618214|NCT02167815|7544868|FG001|STARTED|Overall Study||21
6618215|NCT02167815|7544867|FG000|COMPLETED|Overall Study||9
6618216|NCT02167815|7544868|FG001|COMPLETED|Overall Study||21
6618217|NCT02167815|7544867|FG000|NOT COMPLETED|Overall Study||0
6618218|NCT02167815|7544868|FG001|NOT COMPLETED|Overall Study||0
6618219|NCT02167867|7544878|FG000|STARTED|Overall Study||22
6618220|NCT02167867|7544879|FG001|STARTED|Overall Study||22
6618221|NCT02167867|7544878|FG000|COMPLETED|Overall Study||22
6618222|NCT02167867|7544879|FG001|COMPLETED|Overall Study||22
6618223|NCT02167867|7544878|FG000|NOT COMPLETED|Overall Study||0
6618224|NCT02167867|7544879|FG001|NOT COMPLETED|Overall Study||0
6618225|NCT02167893|7544884|FG000|STARTED|Overall Study||11288
6618226|NCT02167893|7544884|FG000|COMPLETED|Overall Study||11125
6618227|NCT02167893|7544884|FG000|NOT COMPLETED|Overall Study||163
6618228|NCT02168062|7544891|FG000|STARTED|Overall Study||23
6618229|NCT02168062|7544892|FG001|STARTED|Overall Study||26
6618230|NCT02168062|7544893|FG002|STARTED|Overall Study||8
6618231|NCT02168062|7544891|FG000|COMPLETED|Overall Study||23
6618232|NCT02168062|7544892|FG001|COMPLETED|Overall Study||26
6618233|NCT02168062|7544893|FG002|COMPLETED|Overall Study||8
6618234|NCT02168062|7544891|FG000|NOT COMPLETED|Overall Study||0
6618235|NCT02168062|7544892|FG001|NOT COMPLETED|Overall Study||0
6618236|NCT02168062|7544893|FG002|NOT COMPLETED|Overall Study||0
6618237|NCT02168101|7544906|FG000|STARTED|Overall Study||3
6618238|NCT02168101|7544907|FG001|STARTED|Overall Study||3
6618239|NCT02168101|7544908|FG002|STARTED|Overall Study||3
6618240|NCT02168101|7544906|FG000|COMPLETED|Overall Study||1
6618241|NCT02168101|7544907|FG001|COMPLETED|Overall Study||1
6618242|NCT02168101|7544908|FG002|COMPLETED|Overall Study||2
6618243|NCT02168101|7544906|FG000|NOT COMPLETED|Overall Study||2
6618244|NCT02168101|7544907|FG001|NOT COMPLETED|Overall Study||2
6618245|NCT02168101|7544908|FG002|NOT COMPLETED|Overall Study||1
6618246|NCT02168153|7544919|FG000|STARTED|Overall Study||60
6618247|NCT02168153|7544920|FG001|STARTED|Overall Study||60
6618248|NCT02168153|7544919|FG000|COMPLETED|Overall Study||57
6618249|NCT02168153|7544920|FG001|COMPLETED|Overall Study||60
6618250|NCT02168153|7544919|FG000|NOT COMPLETED|Overall Study||3
6618251|NCT02168153|7544920|FG001|NOT COMPLETED|Overall Study||0
6618252|NCT02168309|7544928|FG000|STARTED|Overall Study||25
6618253|NCT02168309|7544929|FG001|STARTED|Overall Study||25
6618254|NCT02168309|7544928|FG000|COMPLETED|Overall Study||25
6618255|NCT02168309|7544929|FG001|COMPLETED|Overall Study||25
6618256|NCT02168309|7544928|FG000|NOT COMPLETED|Overall Study||0
6618257|NCT02168309|7544929|FG001|NOT COMPLETED|Overall Study||0
6618258|NCT02168361|7544937|FG000|STARTED|Overall Study||62
6618259|NCT02168361|7544938|FG001|STARTED|Overall Study||31
6618260|NCT02168361|7544937|FG000|COMPLETED|Overall Study||57
6618261|NCT02168361|7544938|FG001|COMPLETED|Overall Study||21
6618262|NCT02168361|7544937|FG000|NOT COMPLETED|Overall Study||5
6618263|NCT02168361|7544938|FG001|NOT COMPLETED|Overall Study||10
6618264|NCT02168387|7544946|FG000|STARTED|Overall Study||20
6618265|NCT02168387|7544947|FG001|STARTED|Overall Study||19
6618266|NCT02168387|7544946|FG000|COMPLETED|Overall Study||13
6618267|NCT02168387|7544947|FG001|COMPLETED|Overall Study||16
6618268|NCT02168387|7544946|FG000|NOT COMPLETED|Overall Study||7
6618269|NCT02168387|7544947|FG001|NOT COMPLETED|Overall Study||3
6618270|NCT02168439|7544955|FG000|STARTED|Overall Study||20
6618271|NCT02168439|7544956|FG001|STARTED|Overall Study||20
6618272|NCT02168439|7544955|FG000|COMPLETED|Overall Study||20
6618273|NCT02168439|7544956|FG001|COMPLETED|Overall Study||18
6618274|NCT02168439|7544955|FG000|NOT COMPLETED|Overall Study||0
6618275|NCT02168439|7544956|FG001|NOT COMPLETED|Overall Study||2
6618276|NCT02168478|7544962|FG000|STARTED|Overall Study||206
6618277|NCT02168478|7544962|FG000|COMPLETED|Overall Study||202
6618278|NCT02168478|7544962|FG000|NOT COMPLETED|Overall Study||4
6618279|NCT02168491|7544966|FG000|STARTED|Overall Study||9
6618280|NCT02168491|7544966|FG000|COMPLETED|Overall Study||8
6618281|NCT02168491|7544966|FG000|NOT COMPLETED|Overall Study||1
6618282|NCT02168660|7544973|FG000|STARTED|Overall Study||38
6618283|NCT02168660|7544974|FG001|STARTED|Overall Study||35
6618284|NCT02168660|7544975|FG002|STARTED|Overall Study||36
6618285|NCT02168660|7544973|FG000|COMPLETED|Overall Study||22
6618286|NCT02168660|7544974|FG001|COMPLETED|Overall Study||18
6618287|NCT02168660|7544975|FG002|COMPLETED|Overall Study||21
6618288|NCT02168660|7544973|FG000|NOT COMPLETED|Overall Study||16
6618289|NCT02168660|7544974|FG001|NOT COMPLETED|Overall Study||17
6618290|NCT02168660|7544975|FG002|NOT COMPLETED|Overall Study||15
6618291|NCT02168777|7544989|FG000|STARTED|Overall Study||2
6618292|NCT02168777|7544990|FG001|STARTED|Overall Study||7
6618293|NCT02168777|7544991|FG002|STARTED|Overall Study||11
6618294|NCT02168777|7544989|FG000|COMPLETED|Overall Study||0
6618295|NCT02168777|7544990|FG001|COMPLETED|Overall Study||0
6618296|NCT02168777|7544991|FG002|COMPLETED|Overall Study||0
6618297|NCT02168777|7544989|FG000|NOT COMPLETED|Overall Study||2
6618298|NCT02168777|7544990|FG001|NOT COMPLETED|Overall Study||7
6618299|NCT02168777|7544991|FG002|NOT COMPLETED|Overall Study||11
6618300|NCT02168803|7545005|FG000|STARTED|Overall Study||30
6618301|NCT02168803|7545006|FG001|STARTED|Overall Study||32
6618302|NCT02168803|7545007|FG002|STARTED|Overall Study||39
6618303|NCT02168803|7545005|FG000|Received at Least 1 Dose of Study Drug|Overall Study||30
6618304|NCT02168803|7545006|FG001|Received at Least 1 Dose of Study Drug|Overall Study||32
6618305|NCT02168803|7545007|FG002|Received at Least 1 Dose of Study Drug|Overall Study||39
6618306|NCT02168803|7545005|FG000|COMPLETED|Overall Study||28
6618307|NCT02168803|7545006|FG001|COMPLETED|Overall Study||29
6618308|NCT02168803|7545007|FG002|COMPLETED|Overall Study||33
6618309|NCT02168803|7545005|FG000|NOT COMPLETED|Overall Study||2
6618310|NCT02168803|7545006|FG001|NOT COMPLETED|Overall Study||3
6618311|NCT02168803|7545007|FG002|NOT COMPLETED|Overall Study||6
6618312|NCT02168816|7545024|FG000|STARTED|Overall Study||5
6618313|NCT02168816|7545025|FG001|STARTED|Overall Study||7
6618314|NCT02168816|7545024|FG000|COMPLETED|Overall Study||3
6618315|NCT02168816|7545025|FG001|COMPLETED|Overall Study||5
6618316|NCT02168816|7545024|FG000|NOT COMPLETED|Overall Study||2
6618317|NCT02168816|7545025|FG001|NOT COMPLETED|Overall Study||2
6618318|NCT02168842|7545033|FG000|STARTED|Overall Study||170
6618319|NCT02168842|7545034|FG001|STARTED|Overall Study||166
6618320|NCT02168842|7545033|FG000|COMPLETED|Overall Study||162
6618321|NCT02168842|7545034|FG001|COMPLETED|Overall Study||158
6618322|NCT02168842|7545033|FG000|NOT COMPLETED|Overall Study||8
6618323|NCT02168842|7545034|FG001|NOT COMPLETED|Overall Study||8
6618324|NCT02168855|7545044|FG000|STARTED|Overall Study||181
6618325|NCT02168855|7545045|FG001|STARTED|Overall Study||188
6618326|NCT02168855|7545044|FG000|COMPLETED|Overall Study||169
6618327|NCT02168855|7545045|FG001|COMPLETED|Overall Study||177
6618328|NCT02168855|7545044|FG000|NOT COMPLETED|Overall Study||12
6618329|NCT02168855|7545045|FG001|NOT COMPLETED|Overall Study||11
6618330|NCT02168933|7545053|FG000|STARTED|Overall Study||8
6618331|NCT02168933|7545053|FG000|COMPLETED|Overall Study||7
6618332|NCT02168933|7545053|FG000|NOT COMPLETED|Overall Study||1
6618333|NCT02168946|7545063|FG000|STARTED|Overall Study|2 additional subjects were randomized to Vabomere but did not receive study drug|50
6618334|NCT02168946|7545064|FG001|STARTED|Overall Study||25
6618335|NCT02168946|7545063|FG000|COMPLETED|Overall Study||38
6618336|NCT02168946|7545064|FG001|COMPLETED|Overall Study||20
6618337|NCT02168946|7545063|FG000|NOT COMPLETED|Overall Study||12
6618338|NCT02168946|7545064|FG001|NOT COMPLETED|Overall Study||5
6618339|NCT02169115|7545073|FG000|STARTED|Overall Study||19
6618340|NCT02169115|7545074|FG001|STARTED|Overall Study||21
6618341|NCT02169115|7545075|FG002|STARTED|Overall Study||21
6618342|NCT02169115|7545073|FG000|COMPLETED|Overall Study||19
6618343|NCT02169115|7545074|FG001|COMPLETED|Overall Study||21
6618344|NCT02169115|7545075|FG002|COMPLETED|Overall Study||21
6618345|NCT02169115|7545073|FG000|NOT COMPLETED|Overall Study||0
6618346|NCT02169115|7545074|FG001|NOT COMPLETED|Overall Study||0
6618347|NCT02169115|7545075|FG002|NOT COMPLETED|Overall Study||0
6618348|NCT02169219|7545084|FG000|STARTED|Overall Study||20
6618349|NCT02169219|7545084|FG000|COMPLETED|Overall Study||14
6618350|NCT02169219|7545084|FG000|NOT COMPLETED|Overall Study||6
6618351|NCT02169271|7545095|FG000|STARTED|Overall Study||49
6618352|NCT02169271|7545096|FG001|STARTED|Overall Study||49
6618353|NCT02169271|7545095|FG000|COMPLETED|Overall Study||48
6618354|NCT02169271|7545096|FG001|COMPLETED|Overall Study||47
6618355|NCT02169271|7545095|FG000|NOT COMPLETED|Overall Study||1
6618356|NCT02169271|7545096|FG001|NOT COMPLETED|Overall Study||2
6618357|NCT02169284|7545104|FG000|STARTED|Overall Study||24
6618358|NCT02169284|7545105|FG001|STARTED|Overall Study||13
6618359|NCT02169284|7545104|FG000|COMPLETED|Overall Study||24
6618360|NCT02169284|7545105|FG001|COMPLETED|Overall Study||12
6618361|NCT02169284|7545104|FG000|NOT COMPLETED|Overall Study||0
6618362|NCT02169284|7545105|FG001|NOT COMPLETED|Overall Study||1
6618363|NCT02169336|7545116|FG000|STARTED|Overall Study||31
6618364|NCT02169336|7545117|FG001|STARTED|Overall Study||32
6618365|NCT02169336|7545118|FG002|STARTED|Overall Study||32
6618366|NCT02169336|7545116|FG000|COMPLETED|Overall Study||27
6618367|NCT02169336|7545117|FG001|COMPLETED|Overall Study||28
6618368|NCT02169336|7545118|FG002|COMPLETED|Overall Study||29
6618369|NCT02169336|7545116|FG000|NOT COMPLETED|Overall Study||4
6618370|NCT02169336|7545117|FG001|NOT COMPLETED|Overall Study||4
6618371|NCT02169336|7545118|FG002|NOT COMPLETED|Overall Study||3
6618372|NCT02169414|7545130|FG000|STARTED|Overall Study||19
6618373|NCT02169414|7545131|FG001|STARTED|Overall Study||19
6618374|NCT02169414|7545132|FG002|STARTED|Overall Study||18
6618375|NCT02169414|7545133|FG003|STARTED|Overall Study||18
6618376|NCT02169414|7545130|FG000|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
6618377|NCT02169414|7545131|FG001|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
6618378|NCT02169414|7545132|FG002|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
6618379|NCT02169414|7545133|FG003|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
6618380|NCT02169414|7545130|FG000|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
6618381|NCT02169414|7545131|FG001|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
6618382|NCT02169414|7545132|FG002|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
6618383|NCT02169414|7545133|FG003|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
6618384|NCT02169414|7545130|FG000|COMPLETED|Overall Study||18
6618385|NCT02169414|7545131|FG001|COMPLETED|Overall Study||18
6618386|NCT02169414|7545132|FG002|COMPLETED|Overall Study||18
6618387|NCT02169414|7545133|FG003|COMPLETED|Overall Study||18
6618388|NCT02169414|7545130|FG000|NOT COMPLETED|Overall Study||1
6618389|NCT02169414|7545131|FG001|NOT COMPLETED|Overall Study||1
6618390|NCT02169414|7545132|FG002|NOT COMPLETED|Overall Study||0
6618391|NCT02169414|7545133|FG003|NOT COMPLETED|Overall Study||0
6618392|NCT02169427|7545147|FG000|STARTED|Overall Study||6
6618393|NCT02169427|7545147|FG000|COMPLETED|Overall Study||6
6618394|NCT02169427|7545147|FG000|NOT COMPLETED|Overall Study||0
6618395|NCT02169440|7545153|FG000|STARTED|Overall Study||10
6618396|NCT02169440|7545154|FG001|STARTED|Overall Study||10
6618397|NCT02169440|7545153|FG000|COMPLETED|Overall Study||10
6618398|NCT02169440|7545154|FG001|COMPLETED|Overall Study||10
6618399|NCT02169440|7545153|FG000|NOT COMPLETED|Overall Study||0
6618400|NCT02169440|7545154|FG001|NOT COMPLETED|Overall Study||0
6618401|NCT02169453|7545165|FG000|STARTED|Overall Study||3
6618402|NCT02169453|7545166|FG001|STARTED|Overall Study||3
6618403|NCT02169453|7545167|FG002|STARTED|Overall Study||3
6618404|NCT02169453|7545168|FG003|STARTED|Overall Study||3
6618405|NCT02169453|7545165|FG000|25 mg BIA 9-1067|Overall Study||3
6618406|NCT02169453|7545166|FG001|25 mg BIA 9-1067|Overall Study||3
6618407|NCT02169453|7545167|FG002|25 mg BIA 9-1067|Overall Study||3
6618408|NCT02169453|7545168|FG003|25 mg BIA 9-1067|Overall Study||3
6618409|NCT02169453|7545165|FG000|50 mg BIA 9-1067|Overall Study||3
6618410|NCT02169453|7545166|FG001|50 mg BIA 9-1067|Overall Study||3
6618411|NCT02169453|7545167|FG002|50 mg BIA 9-1067|Overall Study||2
6618412|NCT02169453|7545168|FG003|50 mg BIA 9-1067|Overall Study||3
6618413|NCT02169453|7545165|FG000|100 mg BIA 9-1067|Overall Study||3
6618414|NCT02169453|7545166|FG001|100 mg BIA 9-1067|Overall Study||3
6618415|NCT02169453|7545167|FG002|100 mg BIA 9-1067|Overall Study||3
6618416|NCT02169453|7545168|FG003|100 mg BIA 9-1067|Overall Study||3
6618417|NCT02169453|7545165|FG000|Placebo|Overall Study||3
6618418|NCT02169453|7545166|FG001|Placebo|Overall Study||3
6618419|NCT02169453|7545167|FG002|Placebo|Overall Study||3
6618420|NCT02169453|7545168|FG003|Placebo|Overall Study||3
6618421|NCT02169453|7545165|FG000|COMPLETED|Overall Study||3
6618422|NCT02169453|7545166|FG001|COMPLETED|Overall Study||3
6618423|NCT02169453|7545167|FG002|COMPLETED|Overall Study||2
6618424|NCT02169453|7545168|FG003|COMPLETED|Overall Study||3
6618425|NCT02169453|7545165|FG000|NOT COMPLETED|Overall Study||0
6618426|NCT02169453|7545166|FG001|NOT COMPLETED|Overall Study||0
6618427|NCT02169453|7545167|FG002|NOT COMPLETED|Overall Study||1
6618428|NCT02169453|7545168|FG003|NOT COMPLETED|Overall Study||0
6618429|NCT02169466|7545182|FG000|STARTED|Overall Study||6
6618430|NCT02169466|7545183|FG001|STARTED|Overall Study||6
6618431|NCT02169466|7545184|FG002|STARTED|Overall Study||5
6618432|NCT02169466|7545185|FG003|STARTED|Overall Study||5
6618433|NCT02169466|7545182|FG000|25 mg BIA 9-1067|Overall Study||6
6618434|NCT02169466|7545183|FG001|25 mg BIA 9-1067|Overall Study||5
6618435|NCT02169466|7545184|FG002|25 mg BIA 9-1067|Overall Study||5
6618436|NCT02169466|7545185|FG003|25 mg BIA 9-1067|Overall Study||5
6618437|NCT02169466|7545182|FG000|50 mg BIA 9-1067|Overall Study||6
6618438|NCT02169466|7545183|FG001|50 mg BIA 9-1067|Overall Study||6
6618439|NCT02169466|7545184|FG002|50 mg BIA 9-1067|Overall Study||5
6618440|NCT02169466|7545185|FG003|50 mg BIA 9-1067|Overall Study||5
6733205|NCT03208088|7662760|FG003|COMPLETED|Period 2||9
6618441|NCT02169466|7545182|FG000|100 mg BIA 9-1067|Overall Study||6
6618442|NCT02169466|7545183|FG001|100 mg BIA 9-1067|Overall Study||6
6618443|NCT02169466|7545184|FG002|100 mg BIA 9-1067|Overall Study||5
6618444|NCT02169466|7545185|FG003|100 mg BIA 9-1067|Overall Study||5
6618445|NCT02169466|7545182|FG000|Placebo|Overall Study||5
6618446|NCT02169466|7545183|FG001|Placebo|Overall Study||6
6618447|NCT02169466|7545184|FG002|Placebo|Overall Study||5
6618448|NCT02169466|7545185|FG003|Placebo|Overall Study||5
6618449|NCT02169466|7545182|FG000|COMPLETED|Overall Study||5
6618450|NCT02169466|7545183|FG001|COMPLETED|Overall Study||5
6618451|NCT02169466|7545184|FG002|COMPLETED|Overall Study||5
6618452|NCT02169466|7545185|FG003|COMPLETED|Overall Study||5
6618453|NCT02169466|7545182|FG000|NOT COMPLETED|Overall Study||1
6618454|NCT02169466|7545183|FG001|NOT COMPLETED|Overall Study||1
6618455|NCT02169466|7545184|FG002|NOT COMPLETED|Overall Study||0
6618456|NCT02169466|7545185|FG003|NOT COMPLETED|Overall Study||0
6618457|NCT02169479|7545203|FG000|STARTED|Overall Study||4
6618458|NCT02169479|7545204|FG001|STARTED|Overall Study||4
6618459|NCT02169479|7545205|FG002|STARTED|Overall Study||4
6618460|NCT02169479|7545206|FG003|STARTED|Overall Study||4
6618461|NCT02169479|7545203|FG000|25 mg BIA 9-1067|Overall Study||4
6618462|NCT02169479|7545204|FG001|25 mg BIA 9-1067|Overall Study||3
6618463|NCT02169479|7545205|FG002|25 mg BIA 9-1067|Overall Study||4
6618464|NCT02169479|7545206|FG003|25 mg BIA 9-1067|Overall Study||4
6618465|NCT02169479|7545203|FG000|50 mg BIA 9-1067|Overall Study||4
6618466|NCT02169479|7545204|FG001|50 mg BIA 9-1067|Overall Study||4
6618467|NCT02169479|7545205|FG002|50 mg BIA 9-1067|Overall Study||4
6618468|NCT02169479|7545206|FG003|50 mg BIA 9-1067|Overall Study||4
6618469|NCT02169479|7545203|FG000|100 mg BIA 9-1067|Overall Study||3
6618470|NCT02169479|7545204|FG001|100 mg BIA 9-1067|Overall Study||4
6618471|NCT02169479|7545205|FG002|100 mg BIA 9-1067|Overall Study||4
6618472|NCT02169479|7545206|FG003|100 mg BIA 9-1067|Overall Study||4
6618473|NCT02169479|7545203|FG000|Placebo|Overall Study||3
6618474|NCT02169479|7545204|FG001|Placebo|Overall Study||3
6618475|NCT02169479|7545205|FG002|Placebo|Overall Study||4
6618476|NCT02169479|7545206|FG003|Placebo|Overall Study||4
6618477|NCT02169479|7545203|FG000|COMPLETED|Overall Study||3
6618478|NCT02169479|7545204|FG001|COMPLETED|Overall Study||3
6618479|NCT02169479|7545205|FG002|COMPLETED|Overall Study||4
6618480|NCT02169479|7545206|FG003|COMPLETED|Overall Study||4
6618481|NCT02169479|7545203|FG000|NOT COMPLETED|Overall Study||1
6618482|NCT02169479|7545204|FG001|NOT COMPLETED|Overall Study||1
6618483|NCT02169479|7545205|FG002|NOT COMPLETED|Overall Study||0
6618484|NCT02169479|7545206|FG003|NOT COMPLETED|Overall Study||0
6618485|NCT02169505|7545216|FG000|STARTED|Overall Study||2
6618486|NCT02169505|7545216|FG000|COMPLETED|Overall Study||1
6618487|NCT02169505|7545216|FG000|NOT COMPLETED|Overall Study||1
6618488|NCT02169674|7545222|FG000|STARTED|Overall Study||137
6618489|NCT02169674|7545223|FG001|STARTED|Overall Study||213
6618490|NCT02169674|7545222|FG000|COMPLETED|Overall Study||105
6618491|NCT02169674|7545223|FG001|COMPLETED|Overall Study||135
6618492|NCT02169674|7545222|FG000|NOT COMPLETED|Overall Study||32
6618493|NCT02169674|7545223|FG001|NOT COMPLETED|Overall Study||78
6618494|NCT02169739|7545231|FG000|STARTED|Overall Study||2
6618495|NCT02169739|7545232|FG001|STARTED|Overall Study||4
6618496|NCT02169739|7545231|FG000|COMPLETED|Overall Study||2
6618497|NCT02169739|7545232|FG001|COMPLETED|Overall Study||0
6618498|NCT02169739|7545231|FG000|NOT COMPLETED|Overall Study||0
6618499|NCT02169739|7545232|FG001|NOT COMPLETED|Overall Study||4
6618500|NCT02169791|7545239|FG000|STARTED|Overall Study||25
6618501|NCT02169791|7545239|FG000|COMPLETED|Overall Study||18
6618502|NCT02169791|7545239|FG000|NOT COMPLETED|Overall Study||7
6618503|NCT02169869|7545245|FG000|STARTED|Overall Study||17
6618504|NCT02169869|7545246|FG001|STARTED|Overall Study||16
6618505|NCT02169869|7545245|FG000|COMPLETED|Overall Study||17
6618506|NCT02169869|7545246|FG001|COMPLETED|Overall Study||16
6618507|NCT02169869|7545245|FG000|NOT COMPLETED|Overall Study||0
6618508|NCT02169869|7545246|FG001|NOT COMPLETED|Overall Study||0
6618509|NCT02169895|7545256|FG000|STARTED|Overall Study||4
6618510|NCT02169895|7545257|FG001|STARTED|Overall Study||4
6618511|NCT02169895|7545258|FG002|STARTED|Overall Study||4
6618512|NCT02169895|7545259|FG003|STARTED|Overall Study||4
6618513|NCT02169895|7545256|FG000|25 mg BIA 9-1067|Overall Study||4
6618514|NCT02169895|7545257|FG001|25 mg BIA 9-1067|Overall Study||4
6618515|NCT02169895|7545258|FG002|25 mg BIA 9-1067|Overall Study||4
6618516|NCT02169895|7545259|FG003|25 mg BIA 9-1067|Overall Study||4
6618517|NCT02169895|7545256|FG000|50 mg BIA 9-1067|Overall Study||4
6618518|NCT02169895|7545257|FG001|50 mg BIA 9-1067|Overall Study||4
6618519|NCT02169895|7545258|FG002|50 mg BIA 9-1067|Overall Study||4
6618520|NCT02169895|7545259|FG003|50 mg BIA 9-1067|Overall Study||4
6618521|NCT02169895|7545256|FG000|100 mg BIA 9-1067|Overall Study||4
6618522|NCT02169895|7545257|FG001|100 mg BIA 9-1067|Overall Study||4
6618523|NCT02169895|7545258|FG002|100 mg BIA 9-1067|Overall Study||4
6618524|NCT02169895|7545259|FG003|100 mg BIA 9-1067|Overall Study||2
6618525|NCT02169895|7545256|FG000|Placebo|Overall Study||4
6618526|NCT02169895|7545257|FG001|Placebo|Overall Study||4
6618527|NCT02169895|7545258|FG002|Placebo|Overall Study||4
6618528|NCT02169895|7545259|FG003|Placebo|Overall Study||4
6618529|NCT02169895|7545256|FG000|COMPLETED|Overall Study||4
6618530|NCT02169895|7545257|FG001|COMPLETED|Overall Study||4
6618531|NCT02169895|7545258|FG002|COMPLETED|Overall Study||4
6618532|NCT02169895|7545259|FG003|COMPLETED|Overall Study||2
6618533|NCT02169895|7545256|FG000|NOT COMPLETED|Overall Study||0
6618534|NCT02169895|7545257|FG001|NOT COMPLETED|Overall Study||0
6618535|NCT02169895|7545258|FG002|NOT COMPLETED|Overall Study||0
6618536|NCT02169895|7545259|FG003|NOT COMPLETED|Overall Study||2
6618537|NCT02170025|7545271|FG000|STARTED|Overall Study||14
6618538|NCT02170025|7545272|FG001|STARTED|Overall Study||7
6618539|NCT02170025|7545271|FG000|COMPLETED|Overall Study||12
6618540|NCT02170025|7545272|FG001|COMPLETED|Overall Study||7
6618541|NCT02170025|7545271|FG000|NOT COMPLETED|Overall Study||2
6618542|NCT02170025|7545272|FG001|NOT COMPLETED|Overall Study||0
6618543|NCT02170051|7545280|FG000|STARTED|Overall Study||26
6618544|NCT02170051|7545281|FG001|STARTED|Overall Study||29
6618545|NCT02170051|7545280|FG000|Tested at Mid-point|Overall Study||13
6618546|NCT02170051|7545281|FG001|Tested at Mid-point|Overall Study||18
6618547|NCT02170051|7545280|FG000|Tested at Post-treatment|Overall Study||15
6618548|NCT02170051|7545281|FG001|Tested at Post-treatment|Overall Study||16
6618549|NCT02170051|7545280|FG000|COMPLETED|Overall Study||15
6618550|NCT02170051|7545281|FG001|COMPLETED|Overall Study||16
6618551|NCT02170051|7545280|FG000|NOT COMPLETED|Overall Study||11
6618552|NCT02170051|7545281|FG001|NOT COMPLETED|Overall Study||13
6618553|NCT02170064|7545290|FG000|STARTED|Overall Study||15
6618554|NCT02170064|7545291|FG001|STARTED|Overall Study||9
6618555|NCT02170064|7545292|FG002|STARTED|Overall Study||11
6618556|NCT02170064|7545290|FG000|Safety Population (SP)|Overall Study||12
6618557|NCT02170064|7545291|FG001|Safety Population (SP)|Overall Study||8
6618558|NCT02170064|7545292|FG002|Safety Population (SP)|Overall Study||11
6618559|NCT02170064|7545290|FG000|Pharmacokinetic Population (PKP)|Overall Study||11
6618560|NCT02170064|7545291|FG001|Pharmacokinetic Population (PKP)|Overall Study||8
6618561|NCT02170064|7545292|FG002|Pharmacokinetic Population (PKP)|Overall Study||10
6618562|NCT02170064|7545290|FG000|Efficacy Population (EP)|Overall Study||11
6618563|NCT02170064|7545291|FG001|Efficacy Population (EP)|Overall Study||8
6618564|NCT02170064|7545292|FG002|Efficacy Population (EP)|Overall Study||10
6618565|NCT02170064|7545290|FG000|COMPLETED|Overall Study||9
6618566|NCT02170064|7545291|FG001|COMPLETED|Overall Study||7
6618567|NCT02170064|7545292|FG002|COMPLETED|Overall Study||10
6618568|NCT02170064|7545290|FG000|NOT COMPLETED|Overall Study||6
6618569|NCT02170064|7545291|FG001|NOT COMPLETED|Overall Study||2
6618570|NCT02170064|7545292|FG002|NOT COMPLETED|Overall Study||1
6618571|NCT02170077|7545303|FG000|STARTED|Overall Study||50
6618572|NCT02170077|7545304|FG001|STARTED|Overall Study||47
6618573|NCT02170077|7545305|FG002|STARTED|Overall Study||47
6618574|NCT02170077|7545303|FG000|Intent to Treat (ITT) Population|Overall Study||50
6618575|NCT02170077|7545304|FG001|Intent to Treat (ITT) Population|Overall Study||46
6618576|NCT02170077|7545305|FG002|Intent to Treat (ITT) Population|Overall Study||47
6618577|NCT02170077|7545303|FG000|COMPLETED|Overall Study||41
6618578|NCT02170077|7545304|FG001|COMPLETED|Overall Study||34
6618579|NCT02170077|7545305|FG002|COMPLETED|Overall Study||35
6618580|NCT02170077|7545303|FG000|NOT COMPLETED|Overall Study||9
6618581|NCT02170077|7545304|FG001|NOT COMPLETED|Overall Study||13
6618582|NCT02170077|7545305|FG002|NOT COMPLETED|Overall Study||12
6618583|NCT02170207|7545313|FG000|STARTED|Overall Study||63
6618584|NCT02170207|7545313|FG000|COMPLETED|Overall Study||58
6618585|NCT02170207|7545313|FG000|NOT COMPLETED|Overall Study||5
6618586|NCT02170220|7545319|FG000|STARTED|Overall Study||6
6618587|NCT02170220|7545320|FG001|STARTED|Overall Study||6
6618588|NCT02170220|7545319|FG000|COMPLETED|Overall Study||6
6618589|NCT02170220|7545320|FG001|COMPLETED|Overall Study||6
6618590|NCT02170220|7545319|FG000|NOT COMPLETED|Overall Study||0
6618591|NCT02170220|7545320|FG001|NOT COMPLETED|Overall Study||0
6618592|NCT02170363|7545326|FG000|STARTED|Overall Study||50
6618593|NCT02170363|7545326|FG000|COMPLETED|Overall Study|Followed to the 6-Month Primary Endpoint|50
6618594|NCT02170363|7545326|FG000|NOT COMPLETED|Overall Study||0
6618595|NCT02170376|7545337|FG000|STARTED|Overall Study||16
6618596|NCT02170376|7545338|FG001|STARTED|Overall Study||16
6618597|NCT02170376|7545339|FG002|STARTED|Overall Study||16
6618598|NCT02170376|7545340|FG003|STARTED|Overall Study||16
6618599|NCT02170376|7545341|FG004|STARTED|Overall Study||16
6618600|NCT02170376|7545337|FG000|Pharmacokinetic Population|Overall Study||16
6618601|NCT02170376|7545338|FG001|Pharmacokinetic Population|Overall Study||15
6618602|NCT02170376|7545339|FG002|Pharmacokinetic Population|Overall Study||16
6618603|NCT02170376|7545340|FG003|Pharmacokinetic Population|Overall Study||16
6618604|NCT02170376|7545341|FG004|Pharmacokinetic Population|Overall Study||16
6618605|NCT02170376|7545337|FG000|COMPLETED|Overall Study||16
6618606|NCT02170376|7545338|FG001|COMPLETED|Overall Study||15
6618607|NCT02170376|7545339|FG002|COMPLETED|Overall Study||16
6618608|NCT02170376|7545340|FG003|COMPLETED|Overall Study||16
6618609|NCT02170376|7545341|FG004|COMPLETED|Overall Study||16
6618610|NCT02170376|7545337|FG000|NOT COMPLETED|Overall Study||0
6618611|NCT02170376|7545338|FG001|NOT COMPLETED|Overall Study||1
6618612|NCT02170376|7545339|FG002|NOT COMPLETED|Overall Study||0
6618613|NCT02170376|7545340|FG003|NOT COMPLETED|Overall Study||0
6618614|NCT02170376|7545341|FG004|NOT COMPLETED|Overall Study||0
6618615|NCT02170389|7545353|FG000|STARTED|Overall Study||5
6618616|NCT02170389|7545353|FG000|COMPLETED|Overall Study||4
6618617|NCT02170389|7545353|FG000|NOT COMPLETED|Overall Study||1
6618618|NCT02170519|7545359|FG000|STARTED|Overall Study||22
6618619|NCT02170519|7545360|FG001|STARTED|Overall Study||5
6618620|NCT02170519|7545359|FG000|COMPLETED|Overall Study||22
6618621|NCT02170519|7545360|FG001|COMPLETED|Overall Study||5
6618622|NCT02170519|7545359|FG000|NOT COMPLETED|Overall Study||0
6618623|NCT02170519|7545360|FG001|NOT COMPLETED|Overall Study||0
6618624|NCT02170532|7545367|FG000|STARTED|Overall Study||10
6618625|NCT02170532|7545367|FG000|COMPLETED|Overall Study||10
6618626|NCT02170532|7545367|FG000|NOT COMPLETED|Overall Study||0
6618627|NCT02170649|7545378|FG000|STARTED|Fasting Period||12
6618628|NCT02170649|7545378|FG000|COMPLETED|Fasting Period||12
6618629|NCT02170649|7545378|FG000|NOT COMPLETED|Fasting Period||0
6618630|NCT02170649|7545378|FG000|STARTED|Fed Period||12
6618631|NCT02170649|7545378|FG000|COMPLETED|Fed Period||12
6618632|NCT02170649|7545378|FG000|NOT COMPLETED|Fed Period||0
6618633|NCT02170662|7545384|FG000|STARTED|Overall Study||3
6618634|NCT02170662|7545385|FG001|STARTED|Overall Study||6
6618635|NCT02170662|7545384|FG000|COMPLETED|Overall Study||3
6618636|NCT02170662|7545385|FG001|COMPLETED|Overall Study||6
6618637|NCT02170662|7545384|FG000|NOT COMPLETED|Overall Study||0
6618638|NCT02170662|7545385|FG001|NOT COMPLETED|Overall Study||0
6618639|NCT02170688|7545396|FG000|STARTED|Overall Study||29
6618640|NCT02170688|7545397|FG001|STARTED|Overall Study||29
6618641|NCT02170688|7545398|FG002|STARTED|Overall Study||29
6618642|NCT02170688|7545399|FG003|STARTED|Overall Study||27
6618643|NCT02170688|7545400|FG004|STARTED|Overall Study||25
6618644|NCT02170688|7545396|FG000|COMPLETED|Overall Study||25
6618645|NCT02170688|7545397|FG001|COMPLETED|Overall Study||26
6618646|NCT02170688|7545398|FG002|COMPLETED|Overall Study||25
6618647|NCT02170688|7545399|FG003|COMPLETED|Overall Study||25
6618648|NCT02170688|7545400|FG004|COMPLETED|Overall Study||25
6618649|NCT02170688|7545396|FG000|NOT COMPLETED|Overall Study||4
6618650|NCT02170688|7545397|FG001|NOT COMPLETED|Overall Study||3
6618651|NCT02170688|7545398|FG002|NOT COMPLETED|Overall Study||4
6618652|NCT02170688|7545399|FG003|NOT COMPLETED|Overall Study||2
6618653|NCT02170688|7545400|FG004|NOT COMPLETED|Overall Study||0
6618654|NCT02170727|7545414|FG000|STARTED|Overall Study||138
6618655|NCT02170727|7545415|FG001|STARTED|Overall Study||31
6618656|NCT02170727|7545414|FG000|COMPLETED|Overall Study||135
6618657|NCT02170727|7545415|FG001|COMPLETED|Overall Study||31
6618658|NCT02170727|7545414|FG000|NOT COMPLETED|Overall Study||3
6618659|NCT02170727|7545415|FG001|NOT COMPLETED|Overall Study||0
6618660|NCT02170779|7545426|FG000|STARTED|Overall Study||20
6618661|NCT02170779|7545427|FG001|STARTED|Overall Study||20
6618662|NCT02170779|7545426|FG000|COMPLETED|Overall Study||19
6618663|NCT02170779|7545427|FG001|COMPLETED|Overall Study||19
6618664|NCT02170779|7545426|FG000|NOT COMPLETED|Overall Study||1
6618665|NCT02170779|7545427|FG001|NOT COMPLETED|Overall Study||1
6618666|NCT02170870|7545439|FG000|STARTED|Overall Study||13
6618667|NCT02170870|7545440|FG001|STARTED|Overall Study||11
6618668|NCT02170870|7545441|FG002|STARTED|Overall Study||20
6618669|NCT02170870|7545442|FG003|STARTED|Overall Study||20
6618670|NCT02170870|7545443|FG004|STARTED|Overall Study||20
6618671|NCT02170870|7545444|FG005|STARTED|Overall Study||20
6618672|NCT02170870|7545439|FG000|COMPLETED|Overall Study||13
6618673|NCT02170870|7545440|FG001|COMPLETED|Overall Study||11
6618674|NCT02170870|7545441|FG002|COMPLETED|Overall Study||20
6618675|NCT02170870|7545442|FG003|COMPLETED|Overall Study||20
6618676|NCT02170870|7545443|FG004|COMPLETED|Overall Study||20
6618677|NCT02170870|7545444|FG005|COMPLETED|Overall Study||20
6618678|NCT02170870|7545439|FG000|NOT COMPLETED|Overall Study||0
6618679|NCT02170870|7545440|FG001|NOT COMPLETED|Overall Study||0
6618680|NCT02170870|7545441|FG002|NOT COMPLETED|Overall Study||0
6618681|NCT02170870|7545442|FG003|NOT COMPLETED|Overall Study||0
6618682|NCT02170870|7545443|FG004|NOT COMPLETED|Overall Study||0
6618683|NCT02170870|7545444|FG005|NOT COMPLETED|Overall Study||0
6618684|NCT02171065|7545464|FG000|STARTED|Overall Study||89
6618685|NCT02171065|7545465|FG001|STARTED|Overall Study||93
6618686|NCT02171065|7545466|FG002|STARTED|Overall Study||716
6618687|NCT02171065|7545464|FG000|COMPLETED|Overall Study||88
6618688|NCT02171065|7545465|FG001|COMPLETED|Overall Study||93
6618689|NCT02171065|7545466|FG002|COMPLETED|Overall Study||715
6618690|NCT02171065|7545464|FG000|NOT COMPLETED|Overall Study||1
6618691|NCT02171065|7545465|FG001|NOT COMPLETED|Overall Study||0
6618692|NCT02171065|7545466|FG002|NOT COMPLETED|Overall Study||1
6618693|NCT02171130|7545476|FG000|STARTED|Overall Study||129
6618694|NCT02171130|7545476|FG000|Received at Least One Dose of Study Drug|Overall Study||87
6618695|NCT02171130|7545476|FG000|Experienced Hypoglycemic Event|Overall Study|Experienced at least one hypoglycemic event and received at least one dose of study drug.|87
6618696|NCT02171130|7545476|FG000|COMPLETED|Overall Study|Including participants who completed the 6-month study but did not experience any hypoglycemia event|101
6618697|NCT02171130|7545476|FG000|NOT COMPLETED|Overall Study||28
6618698|NCT02171195|7545489|FG000|STARTED|Overall Study||16
6618699|NCT02171195|7545490|FG001|STARTED|Overall Study||6
6618700|NCT02171195|7545491|FG002|STARTED|Overall Study||6
6618701|NCT02171195|7545492|FG003|STARTED|Overall Study||6
6618702|NCT02171195|7545493|FG004|STARTED|Overall Study||6
6618703|NCT02171195|7545494|FG005|STARTED|Overall Study||6
6618704|NCT02171195|7545495|FG006|STARTED|Overall Study||6
6618705|NCT02171195|7545496|FG007|STARTED|Overall Study||6
6618706|NCT02171195|7545497|FG008|STARTED|Overall Study||6
6618707|NCT02171195|7545489|FG000|COMPLETED|Overall Study||16
6618708|NCT02171195|7545490|FG001|COMPLETED|Overall Study||6
6618709|NCT02171195|7545491|FG002|COMPLETED|Overall Study||6
6618710|NCT02171195|7545492|FG003|COMPLETED|Overall Study||6
6618711|NCT02171195|7545493|FG004|COMPLETED|Overall Study||6
6618712|NCT02171195|7545494|FG005|COMPLETED|Overall Study||6
6618713|NCT02171195|7545495|FG006|COMPLETED|Overall Study||6
6618714|NCT02171195|7545496|FG007|COMPLETED|Overall Study||6
6618715|NCT02171195|7545497|FG008|COMPLETED|Overall Study||6
6618716|NCT02171195|7545489|FG000|NOT COMPLETED|Overall Study||0
6618717|NCT02171195|7545490|FG001|NOT COMPLETED|Overall Study||0
6618718|NCT02171195|7545491|FG002|NOT COMPLETED|Overall Study||0
6618719|NCT02171195|7545492|FG003|NOT COMPLETED|Overall Study||0
6618720|NCT02171195|7545493|FG004|NOT COMPLETED|Overall Study||0
6618721|NCT02171195|7545494|FG005|NOT COMPLETED|Overall Study||0
6618722|NCT02171195|7545495|FG006|NOT COMPLETED|Overall Study||0
6618723|NCT02171195|7545496|FG007|NOT COMPLETED|Overall Study||0
6618724|NCT02171195|7545497|FG008|NOT COMPLETED|Overall Study||0
6618725|NCT02171234|7545522|FG000|STARTED|Overall Study||8
6618726|NCT02171234|7545523|FG001|STARTED|Overall Study||6
6618727|NCT02171234|7545524|FG002|STARTED|Overall Study||6
6618728|NCT02171234|7545525|FG003|STARTED|Overall Study||6
6618729|NCT02171234|7545526|FG004|STARTED|Overall Study||6
6618730|NCT02171234|7545522|FG000|COMPLETED|Overall Study||8
6618731|NCT02171234|7545523|FG001|COMPLETED|Overall Study||6
6618732|NCT02171234|7545524|FG002|COMPLETED|Overall Study||6
6618733|NCT02171234|7545525|FG003|COMPLETED|Overall Study||6
6280594|NCT00158197|7180559|FG002|STARTED|Overall Study||28
6618734|NCT02171234|7545526|FG004|COMPLETED|Overall Study||6
6618735|NCT02171234|7545522|FG000|NOT COMPLETED|Overall Study||0
6618736|NCT02171234|7545523|FG001|NOT COMPLETED|Overall Study||0
6618737|NCT02171234|7545524|FG002|NOT COMPLETED|Overall Study||0
6618738|NCT02171234|7545525|FG003|NOT COMPLETED|Overall Study||0
6618739|NCT02171234|7545526|FG004|NOT COMPLETED|Overall Study||0
6618740|NCT02171247|7545540|FG000|STARTED|Overall Study||16
6618741|NCT02171247|7545541|FG001|STARTED|Overall Study||17
6618742|NCT02171247|7545540|FG000|COMPLETED|Overall Study||16
6618743|NCT02171247|7545541|FG001|COMPLETED|Overall Study||17
6618744|NCT02171247|7545540|FG000|NOT COMPLETED|Overall Study||0
6618745|NCT02171247|7545541|FG001|NOT COMPLETED|Overall Study||0
6618746|NCT02171260|7545551|FG000|STARTED|Overall Study||6
6618747|NCT02171260|7545552|FG001|STARTED|Overall Study||6
6618748|NCT02171260|7545553|FG002|STARTED|Overall Study||5
6618749|NCT02171260|7545554|FG003|STARTED|Overall Study||5
6618750|NCT02171260|7545551|FG000|COMPLETED|Overall Study||0
6618751|NCT02171260|7545552|FG001|COMPLETED|Overall Study||0
6618752|NCT02171260|7545553|FG002|COMPLETED|Overall Study||0
6618753|NCT02171260|7545554|FG003|COMPLETED|Overall Study||0
6618754|NCT02171260|7545551|FG000|NOT COMPLETED|Overall Study||6
6618755|NCT02171260|7545552|FG001|NOT COMPLETED|Overall Study||6
6618756|NCT02171260|7545553|FG002|NOT COMPLETED|Overall Study||5
6618757|NCT02171260|7545554|FG003|NOT COMPLETED|Overall Study||5
6618758|NCT02171429|7545573|FG000|STARTED|Overall Study||72
6618759|NCT02171429|7545574|FG001|STARTED|Overall Study||143
6618760|NCT02171429|7545575|FG002|STARTED|Overall Study||143
6618761|NCT02171429|7545573|FG000|Completed Week 10 Visit|Overall Study||70
6618762|NCT02171429|7545574|FG001|Completed Week 10 Visit|Overall Study||141
6618763|NCT02171429|7545575|FG002|Completed Week 10 Visit|Overall Study||141
6618764|NCT02171429|7545573|FG000|COMPLETED|Overall Study||71
6618765|NCT02171429|7545574|FG001|COMPLETED|Overall Study||140
6618766|NCT02171429|7545575|FG002|COMPLETED|Overall Study||138
6618767|NCT02171429|7545573|FG000|NOT COMPLETED|Overall Study||1
6618768|NCT02171429|7545574|FG001|NOT COMPLETED|Overall Study||3
6618769|NCT02171429|7545575|FG002|NOT COMPLETED|Overall Study||5
6618770|NCT02171611|7545586|FG000|STARTED|Overall Study||5
6618771|NCT02171611|7545587|FG001|STARTED|Overall Study||5
6618772|NCT02171611|7545588|FG002|STARTED|Overall Study||5
6618773|NCT02171611|7545589|FG003|STARTED|Overall Study||5
6618774|NCT02171611|7545590|FG004|STARTED|Overall Study||5
6618775|NCT02171611|7545591|FG005|STARTED|Overall Study||5
6618776|NCT02171611|7545586|FG000|COMPLETED|Overall Study||5
6618777|NCT02171611|7545587|FG001|COMPLETED|Overall Study||5
6618778|NCT02171611|7545588|FG002|COMPLETED|Overall Study||5
6618779|NCT02171611|7545589|FG003|COMPLETED|Overall Study||5
6618780|NCT02171611|7545590|FG004|COMPLETED|Overall Study||5
6618781|NCT02171611|7545591|FG005|COMPLETED|Overall Study||5
6618782|NCT02171611|7545586|FG000|NOT COMPLETED|Overall Study||0
6618783|NCT02171611|7545587|FG001|NOT COMPLETED|Overall Study||0
6618784|NCT02171611|7545588|FG002|NOT COMPLETED|Overall Study||0
6618785|NCT02171611|7545589|FG003|NOT COMPLETED|Overall Study||0
6618786|NCT02171611|7545590|FG004|NOT COMPLETED|Overall Study||0
6618787|NCT02171611|7545591|FG005|NOT COMPLETED|Overall Study||0
6618788|NCT02171819|7545602|FG000|STARTED|Overall Study||31
6618789|NCT02171819|7545603|FG001|STARTED|Overall Study||32
6618790|NCT02171819|7545604|FG002|STARTED|Overall Study||12
6618791|NCT02171819|7545602|FG000|COMPLETED|Overall Study||31
6618792|NCT02171819|7545603|FG001|COMPLETED|Overall Study||32
6618793|NCT02171819|7545604|FG002|COMPLETED|Overall Study||12
6618794|NCT02171819|7545602|FG000|NOT COMPLETED|Overall Study||0
6618795|NCT02171819|7545603|FG001|NOT COMPLETED|Overall Study||0
6618796|NCT02171819|7545604|FG002|NOT COMPLETED|Overall Study||0
6618797|NCT02172040|7545620|FG000|STARTED|Overall Study||49
6618798|NCT02172040|7545621|FG001|STARTED|Overall Study||45
6618799|NCT02172040|7545622|FG002|STARTED|Overall Study||31
6618800|NCT02172040|7545623|FG003|STARTED|Overall Study||27
6618801|NCT02172040|7545620|FG000|COMPLETED|Overall Study||49
6618802|NCT02172040|7545621|FG001|COMPLETED|Overall Study||42
6618803|NCT02172040|7545622|FG002|COMPLETED|Overall Study||29
6618804|NCT02172040|7545623|FG003|COMPLETED|Overall Study||26
6618805|NCT02172040|7545620|FG000|NOT COMPLETED|Overall Study||0
6618806|NCT02172040|7545621|FG001|NOT COMPLETED|Overall Study||3
6618807|NCT02172040|7545622|FG002|NOT COMPLETED|Overall Study||2
6618808|NCT02172040|7545623|FG003|NOT COMPLETED|Overall Study||1
6618809|NCT02172625|7545636|FG000|STARTED|Overall Study||19
6618810|NCT02172625|7545637|FG001|STARTED|Overall Study||19
6618811|NCT02172625|7545636|FG000|COMPLETED|Overall Study||19
6618812|NCT02172625|7545637|FG001|COMPLETED|Overall Study||16
6618813|NCT02172625|7545636|FG000|NOT COMPLETED|Overall Study||0
6618814|NCT02172625|7545637|FG001|NOT COMPLETED|Overall Study||3
6618815|NCT02172664|7545647|FG000|STARTED|Overall Study||33
6618816|NCT02172664|7545648|FG001|STARTED|Overall Study||33
6618817|NCT02172664|7545647|FG000|COMPLETED|Overall Study||27
6618818|NCT02172664|7545648|FG001|COMPLETED|Overall Study||27
6618819|NCT02172664|7545647|FG000|NOT COMPLETED|Overall Study||6
6618820|NCT02172664|7545648|FG001|NOT COMPLETED|Overall Study||6
6618821|NCT02172742|7545655|FG000|STARTED|Overall Study||7
6618822|NCT02172742|7545656|FG001|STARTED|Overall Study||6
6618823|NCT02172742|7545655|FG000|COMPLETED|Overall Study||6
6618824|NCT02172742|7545656|FG001|COMPLETED|Overall Study||6
6618825|NCT02172742|7545655|FG000|NOT COMPLETED|Overall Study||1
6618826|NCT02172742|7545656|FG001|NOT COMPLETED|Overall Study||0
6618827|NCT02172755|7545663|FG000|STARTED|Overall Study||14
6618828|NCT02172755|7545664|FG001|STARTED|Overall Study||16
6618829|NCT02172755|7545663|FG000|COMPLETED|Overall Study||12
6618830|NCT02172755|7545664|FG001|COMPLETED|Overall Study||12
6618831|NCT02172755|7545663|FG000|NOT COMPLETED|Overall Study||2
6618832|NCT02172755|7545664|FG001|NOT COMPLETED|Overall Study||4
6618833|NCT02172820|7545672|FG000|STARTED|Overall Study||65
6618834|NCT02172820|7545673|FG001|STARTED|Overall Study||65
6618835|NCT02172820|7545672|FG000|COMPLETED|Overall Study||65
6618836|NCT02172820|7545673|FG001|COMPLETED|Overall Study||65
6618837|NCT02172820|7545672|FG000|NOT COMPLETED|Overall Study||0
6618838|NCT02172820|7545673|FG001|NOT COMPLETED|Overall Study||0
6618839|NCT02172911|7545681|FG000|STARTED|Overall Study||7
6618840|NCT02172911|7545682|FG001|STARTED|Overall Study||3
6618841|NCT02172911|7545681|FG000|COMPLETED|Overall Study||6
6618842|NCT02172911|7545682|FG001|COMPLETED|Overall Study||1
6618843|NCT02172911|7545681|FG000|NOT COMPLETED|Overall Study||1
6618844|NCT02172911|7545682|FG001|NOT COMPLETED|Overall Study||2
6618845|NCT02172950|7545690|FG000|STARTED|Overall Study||222
6618846|NCT02172950|7545691|FG001|STARTED|Overall Study||24
6618847|NCT02172950|7545690|FG000|COMPLETED|Overall Study||197
6618848|NCT02172950|7545691|FG001|COMPLETED|Overall Study||19
6618849|NCT02172950|7545690|FG000|NOT COMPLETED|Overall Study||25
6618850|NCT02172950|7545691|FG001|NOT COMPLETED|Overall Study||5
6618851|NCT02173054|7545701|FG000|STARTED|Overall Study||40
6618852|NCT02173054|7545702|FG001|STARTED|Overall Study||40
6618853|NCT02173054|7545703|FG002|STARTED|Overall Study||40
6618854|NCT02173054|7545701|FG000|COMPLETED|Overall Study||39
6618855|NCT02173054|7545702|FG001|COMPLETED|Overall Study||40
6618856|NCT02173054|7545703|FG002|COMPLETED|Overall Study||39
6618857|NCT02173054|7545701|FG000|NOT COMPLETED|Overall Study||1
6618858|NCT02173054|7545702|FG001|NOT COMPLETED|Overall Study||0
6618859|NCT02173054|7545703|FG002|NOT COMPLETED|Overall Study||1
6618860|NCT02173158|7545711|FG000|STARTED|Efficacy Phase||9
6618861|NCT02173158|7545711|FG000|COMPLETED|Efficacy Phase||8
6618862|NCT02173158|7545711|FG000|NOT COMPLETED|Efficacy Phase||1
6618863|NCT02173158|7545711|FG000|STARTED|Safety Phase||8
6618864|NCT02173158|7545711|FG000|COMPLETED|Safety Phase||8
6618865|NCT02173158|7545711|FG000|NOT COMPLETED|Safety Phase||0
6618866|NCT02173392|7545718|FG000|STARTED|Overall Study||73
6618867|NCT02173392|7545719|FG001|STARTED|Overall Study||72
6618868|NCT02173392|7545718|FG000|COMPLETED|Overall Study||59
6618869|NCT02173392|7545719|FG001|COMPLETED|Overall Study||68
6618870|NCT02173392|7545718|FG000|NOT COMPLETED|Overall Study||14
6618871|NCT02173392|7545719|FG001|NOT COMPLETED|Overall Study||4
6618872|NCT02173522|7545729|FG000|STARTED|Overall Study||4
6618873|NCT02173522|7545730|FG001|STARTED|Overall Study||0
6618874|NCT02173522|7545729|FG000|COMPLETED|Overall Study||4
6618875|NCT02173522|7545730|FG001|COMPLETED|Overall Study||0
6618876|NCT02173522|7545729|FG000|NOT COMPLETED|Overall Study||0
6618877|NCT02173522|7545730|FG001|NOT COMPLETED|Overall Study||0
6618878|NCT02173535|7545754|FG000|STARTED|Period 1||12
6618879|NCT02173535|7545755|FG001|STARTED|Period 1||12
6618880|NCT02173535|7545756|FG002|STARTED|Period 1||12
6618881|NCT02173535|7545757|FG003|STARTED|Period 1||12
6618882|NCT02173535|7545758|FG004|STARTED|Period 1||12
6618883|NCT02173535|7545759|FG005|STARTED|Period 1||12
6618884|NCT02173535|7545760|FG006|STARTED|Period 1||12
6618885|NCT02173535|7545761|FG007|STARTED|Period 1||12
6618886|NCT02173535|7545762|FG008|STARTED|Period 1||12
6618887|NCT02173535|7545763|FG009|STARTED|Period 1||12
6618888|NCT02173535|7545764|FG010|STARTED|Period 1||12
6618889|NCT02173535|7545765|FG011|STARTED|Period 1||12
6618890|NCT02173535|7545766|FG012|STARTED|Period 1||12
6618891|NCT02173535|7545767|FG013|STARTED|Period 1||12
6618892|NCT02173535|7545768|FG014|STARTED|Period 1||12
6618893|NCT02173535|7545769|FG015|STARTED|Period 1||12
6618894|NCT02173535|7545770|FG016|STARTED|Period 1||12
6618895|NCT02173535|7545771|FG017|STARTED|Period 1||12
6618896|NCT02173535|7545772|FG018|STARTED|Period 1||12
6618897|NCT02173535|7545773|FG019|STARTED|Period 1||12
6618898|NCT02173535|7545754|FG000|COMPLETED|Period 1||12
6618899|NCT02173535|7545755|FG001|COMPLETED|Period 1||12
6618900|NCT02173535|7545756|FG002|COMPLETED|Period 1||12
6618901|NCT02173535|7545757|FG003|COMPLETED|Period 1||12
6618902|NCT02173535|7545758|FG004|COMPLETED|Period 1||12
6618903|NCT02173535|7545759|FG005|COMPLETED|Period 1||12
6618904|NCT02173535|7545760|FG006|COMPLETED|Period 1||12
6618905|NCT02173535|7545761|FG007|COMPLETED|Period 1||12
6618906|NCT02173535|7545762|FG008|COMPLETED|Period 1||12
6618907|NCT02173535|7545763|FG009|COMPLETED|Period 1||12
6618908|NCT02173535|7545764|FG010|COMPLETED|Period 1||12
6618909|NCT02173535|7545765|FG011|COMPLETED|Period 1||12
6618910|NCT02173535|7545766|FG012|COMPLETED|Period 1||12
6618911|NCT02173535|7545767|FG013|COMPLETED|Period 1||12
6618912|NCT02173535|7545768|FG014|COMPLETED|Period 1||12
6618913|NCT02173535|7545769|FG015|COMPLETED|Period 1||12
6618914|NCT02173535|7545770|FG016|COMPLETED|Period 1||12
6618915|NCT02173535|7545771|FG017|COMPLETED|Period 1||12
6618916|NCT02173535|7545772|FG018|COMPLETED|Period 1||12
6618917|NCT02173535|7545773|FG019|COMPLETED|Period 1||12
6618918|NCT02173535|7545754|FG000|NOT COMPLETED|Period 1||0
6618919|NCT02173535|7545755|FG001|NOT COMPLETED|Period 1||0
6618920|NCT02173535|7545756|FG002|NOT COMPLETED|Period 1||0
6618921|NCT02173535|7545757|FG003|NOT COMPLETED|Period 1||0
6618922|NCT02173535|7545758|FG004|NOT COMPLETED|Period 1||0
6618923|NCT02173535|7545759|FG005|NOT COMPLETED|Period 1||0
6618924|NCT02173535|7545760|FG006|NOT COMPLETED|Period 1||0
6618925|NCT02173535|7545761|FG007|NOT COMPLETED|Period 1||0
6618926|NCT02173535|7545762|FG008|NOT COMPLETED|Period 1||0
6618927|NCT02173535|7545763|FG009|NOT COMPLETED|Period 1||0
6618928|NCT02173535|7545764|FG010|NOT COMPLETED|Period 1||0
6618929|NCT02173535|7545765|FG011|NOT COMPLETED|Period 1||0
6618930|NCT02173535|7545766|FG012|NOT COMPLETED|Period 1||0
6618931|NCT02173535|7545767|FG013|NOT COMPLETED|Period 1||0
6618932|NCT02173535|7545768|FG014|NOT COMPLETED|Period 1||0
6618933|NCT02173535|7545769|FG015|NOT COMPLETED|Period 1||0
6618934|NCT02173535|7545770|FG016|NOT COMPLETED|Period 1||0
6618935|NCT02173535|7545771|FG017|NOT COMPLETED|Period 1||0
6618936|NCT02173535|7545772|FG018|NOT COMPLETED|Period 1||0
6618937|NCT02173535|7545773|FG019|NOT COMPLETED|Period 1||0
6618938|NCT02173535|7545754|FG000|STARTED|Period 2||12
6618939|NCT02173535|7545755|FG001|STARTED|Period 2||12
6618940|NCT02173535|7545756|FG002|STARTED|Period 2||12
6733206|NCT03208088|7662761|FG004|COMPLETED|Period 2||9
6733207|NCT03208088|7662762|FG005|COMPLETED|Period 2||9
6733208|NCT03208088|7662763|FG006|COMPLETED|Period 2||8
6733209|NCT03208088|7662764|FG007|COMPLETED|Period 2||10
6733210|NCT03208088|7662765|FG008|COMPLETED|Period 2||7
6733211|NCT03208088|7662766|FG009|COMPLETED|Period 2||9
6733212|NCT03208088|7662757|FG000|NOT COMPLETED|Period 2||0
6733213|NCT03208088|7662758|FG001|NOT COMPLETED|Period 2||0
6733214|NCT03208088|7662759|FG002|NOT COMPLETED|Period 2||0
6733215|NCT03208088|7662760|FG003|NOT COMPLETED|Period 2||0
6733216|NCT03208088|7662761|FG004|NOT COMPLETED|Period 2||0
6733217|NCT03208088|7662762|FG005|NOT COMPLETED|Period 2||0
6733218|NCT03208088|7662763|FG006|NOT COMPLETED|Period 2||0
6733219|NCT03208088|7662764|FG007|NOT COMPLETED|Period 2||0
6733220|NCT03208088|7662765|FG008|NOT COMPLETED|Period 2||1
6733221|NCT03208088|7662766|FG009|NOT COMPLETED|Period 2||0
6733222|NCT03208088|7662757|FG000|STARTED|Period 3||10
6733223|NCT03208088|7662758|FG001|STARTED|Period 3||9
6733224|NCT03208088|7662759|FG002|STARTED|Period 3||10
6733225|NCT03208088|7662760|FG003|STARTED|Period 3||9
6733226|NCT03208088|7662761|FG004|STARTED|Period 3||9
6733227|NCT03208088|7662762|FG005|STARTED|Period 3||9
6733228|NCT03208088|7662763|FG006|STARTED|Period 3||8
6733229|NCT03208088|7662764|FG007|STARTED|Period 3||10
6733230|NCT03208088|7662765|FG008|STARTED|Period 3||7
6733231|NCT03208088|7662766|FG009|STARTED|Period 3||9
6733232|NCT03208088|7662757|FG000|COMPLETED|Period 3||10
6733233|NCT03208088|7662758|FG001|COMPLETED|Period 3||9
6733234|NCT03208088|7662759|FG002|COMPLETED|Period 3||10
6733235|NCT03208088|7662760|FG003|COMPLETED|Period 3||8
6733236|NCT03208088|7662761|FG004|COMPLETED|Period 3||9
6733237|NCT03208088|7662762|FG005|COMPLETED|Period 3||9
6733238|NCT03208088|7662763|FG006|COMPLETED|Period 3||8
6733239|NCT03208088|7662764|FG007|COMPLETED|Period 3||10
6733240|NCT03208088|7662765|FG008|COMPLETED|Period 3||7
6733241|NCT03208088|7662766|FG009|COMPLETED|Period 3||9
6733242|NCT03208088|7662757|FG000|NOT COMPLETED|Period 3||0
6733243|NCT03208088|7662758|FG001|NOT COMPLETED|Period 3||0
6733244|NCT03208088|7662759|FG002|NOT COMPLETED|Period 3||0
6733245|NCT03208088|7662760|FG003|NOT COMPLETED|Period 3||1
6733246|NCT03208088|7662761|FG004|NOT COMPLETED|Period 3||0
6733247|NCT03208088|7662762|FG005|NOT COMPLETED|Period 3||0
6733248|NCT03208088|7662763|FG006|NOT COMPLETED|Period 3||0
6733249|NCT03208088|7662764|FG007|NOT COMPLETED|Period 3||0
6733250|NCT03208088|7662765|FG008|NOT COMPLETED|Period 3||0
6733251|NCT03208088|7662766|FG009|NOT COMPLETED|Period 3||0
6733252|NCT03208088|7662757|FG000|STARTED|Period 4||10
6733253|NCT03208088|7662758|FG001|STARTED|Period 4||9
6733254|NCT03208088|7662759|FG002|STARTED|Period 4||10
6733255|NCT03208088|7662760|FG003|STARTED|Period 4||8
6733256|NCT03208088|7662761|FG004|STARTED|Period 4||9
6733257|NCT03208088|7662762|FG005|STARTED|Period 4||9
6733258|NCT03208088|7662763|FG006|STARTED|Period 4||8
6733259|NCT03208088|7662764|FG007|STARTED|Period 4||10
6733260|NCT03208088|7662765|FG008|STARTED|Period 4||7
6733261|NCT03208088|7662766|FG009|STARTED|Period 4||9
6733262|NCT03208088|7662757|FG000|COMPLETED|Period 4||10
6733263|NCT03208088|7662758|FG001|COMPLETED|Period 4||9
6733264|NCT03208088|7662759|FG002|COMPLETED|Period 4||10
6733265|NCT03208088|7662760|FG003|COMPLETED|Period 4||7
6733266|NCT03208088|7662761|FG004|COMPLETED|Period 4||9
6733267|NCT03208088|7662762|FG005|COMPLETED|Period 4||9
6733268|NCT03208088|7662763|FG006|COMPLETED|Period 4||8
6733269|NCT03208088|7662764|FG007|COMPLETED|Period 4||10
6733270|NCT03208088|7662765|FG008|COMPLETED|Period 4||7
6733271|NCT03208088|7662766|FG009|COMPLETED|Period 4||9
6733272|NCT03208088|7662757|FG000|NOT COMPLETED|Period 4||0
6733273|NCT03208088|7662758|FG001|NOT COMPLETED|Period 4||0
6733274|NCT03208088|7662759|FG002|NOT COMPLETED|Period 4||0
6733275|NCT03208088|7662760|FG003|NOT COMPLETED|Period 4||1
6733276|NCT03208088|7662761|FG004|NOT COMPLETED|Period 4||0
6733277|NCT03208088|7662762|FG005|NOT COMPLETED|Period 4||0
6618941|NCT02173535|7545757|FG003|STARTED|Period 2||12
6733278|NCT03208088|7662763|FG006|NOT COMPLETED|Period 4||0
6733279|NCT03208088|7662764|FG007|NOT COMPLETED|Period 4||0
6733280|NCT03208088|7662765|FG008|NOT COMPLETED|Period 4||0
6733281|NCT03208088|7662766|FG009|NOT COMPLETED|Period 4||0
6733282|NCT03208088|7662757|FG000|STARTED|Period 5||10
6733283|NCT03208088|7662758|FG001|STARTED|Period 5||9
6733284|NCT03208088|7662759|FG002|STARTED|Period 5||10
6733285|NCT03208088|7662760|FG003|STARTED|Period 5||7
6733286|NCT03208088|7662761|FG004|STARTED|Period 5||9
6733287|NCT03208088|7662762|FG005|STARTED|Period 5||9
6733288|NCT03208088|7662763|FG006|STARTED|Period 5||8
6618942|NCT02173535|7545758|FG004|STARTED|Period 2||12
6618943|NCT02173535|7545759|FG005|STARTED|Period 2||12
6618944|NCT02173535|7545760|FG006|STARTED|Period 2||12
6618945|NCT02173535|7545761|FG007|STARTED|Period 2||12
6618946|NCT02173535|7545762|FG008|STARTED|Period 2||12
6618947|NCT02173535|7545763|FG009|STARTED|Period 2||12
6618948|NCT02173535|7545764|FG010|STARTED|Period 2||12
6618949|NCT02173535|7545765|FG011|STARTED|Period 2||12
6618950|NCT02173535|7545766|FG012|STARTED|Period 2||12
6618951|NCT02173535|7545767|FG013|STARTED|Period 2||12
6618952|NCT02173535|7545768|FG014|STARTED|Period 2||12
6618953|NCT02173535|7545769|FG015|STARTED|Period 2||12
6618954|NCT02173535|7545770|FG016|STARTED|Period 2||12
6618955|NCT02173535|7545771|FG017|STARTED|Period 2||12
6618956|NCT02173535|7545772|FG018|STARTED|Period 2||12
6618957|NCT02173535|7545773|FG019|STARTED|Period 2||12
6618958|NCT02173535|7545754|FG000|COMPLETED|Period 2||12
6618959|NCT02173535|7545755|FG001|COMPLETED|Period 2||12
6618960|NCT02173535|7545756|FG002|COMPLETED|Period 2||12
6618961|NCT02173535|7545757|FG003|COMPLETED|Period 2||12
6618962|NCT02173535|7545758|FG004|COMPLETED|Period 2||12
6618963|NCT02173535|7545759|FG005|COMPLETED|Period 2||12
6618964|NCT02173535|7545760|FG006|COMPLETED|Period 2||12
6618965|NCT02173535|7545761|FG007|COMPLETED|Period 2||12
6618966|NCT02173535|7545762|FG008|COMPLETED|Period 2||12
6618967|NCT02173535|7545763|FG009|COMPLETED|Period 2||12
6618968|NCT02173535|7545764|FG010|COMPLETED|Period 2||12
6618969|NCT02173535|7545765|FG011|COMPLETED|Period 2||12
6618970|NCT02173535|7545766|FG012|COMPLETED|Period 2||12
6618971|NCT02173535|7545767|FG013|COMPLETED|Period 2||12
6618972|NCT02173535|7545768|FG014|COMPLETED|Period 2||12
6618973|NCT02173535|7545769|FG015|COMPLETED|Period 2||12
6618974|NCT02173535|7545770|FG016|COMPLETED|Period 2||12
6618975|NCT02173535|7545771|FG017|COMPLETED|Period 2||12
6618976|NCT02173535|7545772|FG018|COMPLETED|Period 2||12
6618977|NCT02173535|7545773|FG019|COMPLETED|Period 2||12
6618978|NCT02173535|7545754|FG000|NOT COMPLETED|Period 2||0
6618979|NCT02173535|7545755|FG001|NOT COMPLETED|Period 2||0
6618980|NCT02173535|7545756|FG002|NOT COMPLETED|Period 2||0
6618981|NCT02173535|7545757|FG003|NOT COMPLETED|Period 2||0
6618982|NCT02173535|7545758|FG004|NOT COMPLETED|Period 2||0
6618983|NCT02173535|7545759|FG005|NOT COMPLETED|Period 2||0
6618984|NCT02173535|7545760|FG006|NOT COMPLETED|Period 2||0
6618985|NCT02173535|7545761|FG007|NOT COMPLETED|Period 2||0
6618986|NCT02173535|7545762|FG008|NOT COMPLETED|Period 2||0
6618987|NCT02173535|7545763|FG009|NOT COMPLETED|Period 2||0
6618988|NCT02173535|7545764|FG010|NOT COMPLETED|Period 2||0
6618989|NCT02173535|7545765|FG011|NOT COMPLETED|Period 2||0
6618990|NCT02173535|7545766|FG012|NOT COMPLETED|Period 2||0
6618991|NCT02173535|7545767|FG013|NOT COMPLETED|Period 2||0
6618992|NCT02173535|7545768|FG014|NOT COMPLETED|Period 2||0
6618993|NCT02173535|7545769|FG015|NOT COMPLETED|Period 2||0
6618994|NCT02173535|7545770|FG016|NOT COMPLETED|Period 2||0
6618995|NCT02173535|7545771|FG017|NOT COMPLETED|Period 2||0
6618996|NCT02173535|7545772|FG018|NOT COMPLETED|Period 2||0
6618997|NCT02173535|7545773|FG019|NOT COMPLETED|Period 2||0
6618998|NCT02173535|7545754|FG000|STARTED|Period 3||12
6618999|NCT02173535|7545755|FG001|STARTED|Period 3||12
6619000|NCT02173535|7545756|FG002|STARTED|Period 3||12
6619001|NCT02173535|7545757|FG003|STARTED|Period 3||12
6619002|NCT02173535|7545758|FG004|STARTED|Period 3||12
6619003|NCT02173535|7545759|FG005|STARTED|Period 3||12
6619004|NCT02173535|7545760|FG006|STARTED|Period 3||12
6619005|NCT02173535|7545761|FG007|STARTED|Period 3||12
6619006|NCT02173535|7545762|FG008|STARTED|Period 3||12
6619007|NCT02173535|7545763|FG009|STARTED|Period 3||12
6619008|NCT02173535|7545764|FG010|STARTED|Period 3||12
6619009|NCT02173535|7545765|FG011|STARTED|Period 3||12
6619010|NCT02173535|7545766|FG012|STARTED|Period 3||12
6619011|NCT02173535|7545767|FG013|STARTED|Period 3||12
6619012|NCT02173535|7545768|FG014|STARTED|Period 3||12
6619013|NCT02173535|7545769|FG015|STARTED|Period 3||12
6619014|NCT02173535|7545770|FG016|STARTED|Period 3||12
6619015|NCT02173535|7545771|FG017|STARTED|Period 3||12
6619016|NCT02173535|7545772|FG018|STARTED|Period 3||12
6619017|NCT02173535|7545773|FG019|STARTED|Period 3||12
6619018|NCT02173535|7545754|FG000|COMPLETED|Period 3||12
6619019|NCT02173535|7545755|FG001|COMPLETED|Period 3||12
6619020|NCT02173535|7545756|FG002|COMPLETED|Period 3||12
6619021|NCT02173535|7545757|FG003|COMPLETED|Period 3||12
6619022|NCT02173535|7545758|FG004|COMPLETED|Period 3||12
6619023|NCT02173535|7545759|FG005|COMPLETED|Period 3||12
6619024|NCT02173535|7545760|FG006|COMPLETED|Period 3||12
6619025|NCT02173535|7545761|FG007|COMPLETED|Period 3||12
6619026|NCT02173535|7545762|FG008|COMPLETED|Period 3||12
6619027|NCT02173535|7545763|FG009|COMPLETED|Period 3||12
6619028|NCT02173535|7545764|FG010|COMPLETED|Period 3||12
6619029|NCT02173535|7545765|FG011|COMPLETED|Period 3||12
6619030|NCT02173535|7545766|FG012|COMPLETED|Period 3||12
6619031|NCT02173535|7545767|FG013|COMPLETED|Period 3||12
6619032|NCT02173535|7545768|FG014|COMPLETED|Period 3||12
6619033|NCT02173535|7545769|FG015|COMPLETED|Period 3||12
6619034|NCT02173535|7545770|FG016|COMPLETED|Period 3||12
6619035|NCT02173535|7545771|FG017|COMPLETED|Period 3||12
6619036|NCT02173535|7545772|FG018|COMPLETED|Period 3||12
6619037|NCT02173535|7545773|FG019|COMPLETED|Period 3||12
6619038|NCT02173535|7545754|FG000|NOT COMPLETED|Period 3||0
6619039|NCT02173535|7545755|FG001|NOT COMPLETED|Period 3||0
6619040|NCT02173535|7545756|FG002|NOT COMPLETED|Period 3||0
6619041|NCT02173535|7545757|FG003|NOT COMPLETED|Period 3||0
6619042|NCT02173535|7545758|FG004|NOT COMPLETED|Period 3||0
6619043|NCT02173535|7545759|FG005|NOT COMPLETED|Period 3||0
6619044|NCT02173535|7545760|FG006|NOT COMPLETED|Period 3||0
6619045|NCT02173535|7545761|FG007|NOT COMPLETED|Period 3||0
6619046|NCT02173535|7545762|FG008|NOT COMPLETED|Period 3||0
6619047|NCT02173535|7545763|FG009|NOT COMPLETED|Period 3||0
6619048|NCT02173535|7545764|FG010|NOT COMPLETED|Period 3||0
6619049|NCT02173535|7545765|FG011|NOT COMPLETED|Period 3||0
6619050|NCT02173535|7545766|FG012|NOT COMPLETED|Period 3||0
6619051|NCT02173535|7545767|FG013|NOT COMPLETED|Period 3||0
6619052|NCT02173535|7545768|FG014|NOT COMPLETED|Period 3||0
6619053|NCT02173535|7545769|FG015|NOT COMPLETED|Period 3||0
6619054|NCT02173535|7545770|FG016|NOT COMPLETED|Period 3||0
6619055|NCT02173535|7545771|FG017|NOT COMPLETED|Period 3||0
6619056|NCT02173535|7545772|FG018|NOT COMPLETED|Period 3||0
6619057|NCT02173535|7545773|FG019|NOT COMPLETED|Period 3||0
6619058|NCT02173535|7545754|FG000|STARTED|Period 4||12
6619059|NCT02173535|7545755|FG001|STARTED|Period 4||12
6619060|NCT02173535|7545756|FG002|STARTED|Period 4||12
6619061|NCT02173535|7545757|FG003|STARTED|Period 4||12
6619062|NCT02173535|7545758|FG004|STARTED|Period 4||12
6619063|NCT02173535|7545759|FG005|STARTED|Period 4||12
6619064|NCT02173535|7545760|FG006|STARTED|Period 4||12
6619065|NCT02173535|7545761|FG007|STARTED|Period 4||12
6619066|NCT02173535|7545762|FG008|STARTED|Period 4||12
6619067|NCT02173535|7545763|FG009|STARTED|Period 4||12
6619068|NCT02173535|7545764|FG010|STARTED|Period 4||12
6619069|NCT02173535|7545765|FG011|STARTED|Period 4||12
6619070|NCT02173535|7545766|FG012|STARTED|Period 4||12
6619071|NCT02173535|7545767|FG013|STARTED|Period 4||12
6619072|NCT02173535|7545768|FG014|STARTED|Period 4||12
6619073|NCT02173535|7545769|FG015|STARTED|Period 4||12
6619074|NCT02173535|7545770|FG016|STARTED|Period 4||12
6619075|NCT02173535|7545771|FG017|STARTED|Period 4||12
6619076|NCT02173535|7545772|FG018|STARTED|Period 4||12
6619077|NCT02173535|7545773|FG019|STARTED|Period 4||12
6619078|NCT02173535|7545754|FG000|COMPLETED|Period 4||12
6619079|NCT02173535|7545755|FG001|COMPLETED|Period 4||12
6619080|NCT02173535|7545756|FG002|COMPLETED|Period 4||12
6619081|NCT02173535|7545757|FG003|COMPLETED|Period 4||12
6619082|NCT02173535|7545758|FG004|COMPLETED|Period 4||12
6619083|NCT02173535|7545759|FG005|COMPLETED|Period 4||12
6619084|NCT02173535|7545760|FG006|COMPLETED|Period 4||12
6619085|NCT02173535|7545761|FG007|COMPLETED|Period 4||12
6619086|NCT02173535|7545762|FG008|COMPLETED|Period 4||12
6619087|NCT02173535|7545763|FG009|COMPLETED|Period 4||12
6619088|NCT02173535|7545764|FG010|COMPLETED|Period 4||12
6619089|NCT02173535|7545765|FG011|COMPLETED|Period 4||12
6619090|NCT02173535|7545766|FG012|COMPLETED|Period 4||12
6619091|NCT02173535|7545767|FG013|COMPLETED|Period 4||12
6619092|NCT02173535|7545768|FG014|COMPLETED|Period 4||12
6619093|NCT02173535|7545769|FG015|COMPLETED|Period 4||12
6619094|NCT02173535|7545770|FG016|COMPLETED|Period 4||12
6619095|NCT02173535|7545771|FG017|COMPLETED|Period 4||12
6619096|NCT02173535|7545772|FG018|COMPLETED|Period 4||12
6619097|NCT02173535|7545773|FG019|COMPLETED|Period 4||12
6619098|NCT02173535|7545754|FG000|NOT COMPLETED|Period 4||0
6619099|NCT02173535|7545755|FG001|NOT COMPLETED|Period 4||0
6619100|NCT02173535|7545756|FG002|NOT COMPLETED|Period 4||0
6619101|NCT02173535|7545757|FG003|NOT COMPLETED|Period 4||0
6619102|NCT02173535|7545758|FG004|NOT COMPLETED|Period 4||0
6619103|NCT02173535|7545759|FG005|NOT COMPLETED|Period 4||0
6619104|NCT02173535|7545760|FG006|NOT COMPLETED|Period 4||0
6619105|NCT02173535|7545761|FG007|NOT COMPLETED|Period 4||0
6619106|NCT02173535|7545762|FG008|NOT COMPLETED|Period 4||0
6619107|NCT02173535|7545763|FG009|NOT COMPLETED|Period 4||0
6619108|NCT02173535|7545764|FG010|NOT COMPLETED|Period 4||0
6619109|NCT02173535|7545765|FG011|NOT COMPLETED|Period 4||0
6619110|NCT02173535|7545766|FG012|NOT COMPLETED|Period 4||0
6619111|NCT02173535|7545767|FG013|NOT COMPLETED|Period 4||0
6619112|NCT02173535|7545768|FG014|NOT COMPLETED|Period 4||0
6619113|NCT02173535|7545769|FG015|NOT COMPLETED|Period 4||0
6619114|NCT02173535|7545770|FG016|NOT COMPLETED|Period 4||0
6619115|NCT02173535|7545771|FG017|NOT COMPLETED|Period 4||0
6619116|NCT02173535|7545772|FG018|NOT COMPLETED|Period 4||0
6619117|NCT02173535|7545773|FG019|NOT COMPLETED|Period 4||0
6619118|NCT02173535|7545754|FG000|STARTED|Period 5||12
6619119|NCT02173535|7545755|FG001|STARTED|Period 5||12
6619120|NCT02173535|7545756|FG002|STARTED|Period 5||12
6619121|NCT02173535|7545757|FG003|STARTED|Period 5||12
6619122|NCT02173535|7545758|FG004|STARTED|Period 5||12
6619123|NCT02173535|7545759|FG005|STARTED|Period 5||12
6619124|NCT02173535|7545760|FG006|STARTED|Period 5||12
6619125|NCT02173535|7545761|FG007|STARTED|Period 5||12
6619126|NCT02173535|7545762|FG008|STARTED|Period 5||12
6619127|NCT02173535|7545763|FG009|STARTED|Period 5||12
6619128|NCT02173535|7545764|FG010|STARTED|Period 5||12
6619129|NCT02173535|7545765|FG011|STARTED|Period 5||12
6619130|NCT02173535|7545766|FG012|STARTED|Period 5||12
6619131|NCT02173535|7545767|FG013|STARTED|Period 5||12
6619132|NCT02173535|7545768|FG014|STARTED|Period 5||12
6619133|NCT02173535|7545769|FG015|STARTED|Period 5||12
6619134|NCT02173535|7545770|FG016|STARTED|Period 5||12
6619135|NCT02173535|7545771|FG017|STARTED|Period 5||12
6619136|NCT02173535|7545772|FG018|STARTED|Period 5||12
6619137|NCT02173535|7545773|FG019|STARTED|Period 5||12
6619138|NCT02173535|7545754|FG000|COMPLETED|Period 5||12
6619139|NCT02173535|7545755|FG001|COMPLETED|Period 5||12
6619140|NCT02173535|7545756|FG002|COMPLETED|Period 5||12
6619141|NCT02173535|7545757|FG003|COMPLETED|Period 5||12
6619142|NCT02173535|7545758|FG004|COMPLETED|Period 5||12
6619143|NCT02173535|7545759|FG005|COMPLETED|Period 5||12
6619144|NCT02173535|7545760|FG006|COMPLETED|Period 5||12
6619145|NCT02173535|7545761|FG007|COMPLETED|Period 5||12
6619146|NCT02173535|7545762|FG008|COMPLETED|Period 5||12
6619147|NCT02173535|7545763|FG009|COMPLETED|Period 5||12
6619148|NCT02173535|7545764|FG010|COMPLETED|Period 5||12
6619149|NCT02173535|7545765|FG011|COMPLETED|Period 5||12
6619150|NCT02173535|7545766|FG012|COMPLETED|Period 5||12
6619151|NCT02173535|7545767|FG013|COMPLETED|Period 5||12
6619152|NCT02173535|7545768|FG014|COMPLETED|Period 5||12
6619153|NCT02173535|7545769|FG015|COMPLETED|Period 5||12
6619154|NCT02173535|7545770|FG016|COMPLETED|Period 5||12
6619155|NCT02173535|7545771|FG017|COMPLETED|Period 5||12
6619156|NCT02173535|7545772|FG018|COMPLETED|Period 5||12
6619157|NCT02173535|7545773|FG019|COMPLETED|Period 5||12
6619158|NCT02173535|7545754|FG000|NOT COMPLETED|Period 5||0
6619159|NCT02173535|7545755|FG001|NOT COMPLETED|Period 5||0
6619160|NCT02173535|7545756|FG002|NOT COMPLETED|Period 5||0
6619161|NCT02173535|7545757|FG003|NOT COMPLETED|Period 5||0
6619162|NCT02173535|7545758|FG004|NOT COMPLETED|Period 5||0
6619163|NCT02173535|7545759|FG005|NOT COMPLETED|Period 5||0
6619164|NCT02173535|7545760|FG006|NOT COMPLETED|Period 5||0
6619165|NCT02173535|7545761|FG007|NOT COMPLETED|Period 5||0
6619166|NCT02173535|7545762|FG008|NOT COMPLETED|Period 5||0
6619167|NCT02173535|7545763|FG009|NOT COMPLETED|Period 5||0
6619168|NCT02173535|7545764|FG010|NOT COMPLETED|Period 5||0
6619169|NCT02173535|7545765|FG011|NOT COMPLETED|Period 5||0
6619170|NCT02173535|7545766|FG012|NOT COMPLETED|Period 5||0
6619171|NCT02173535|7545767|FG013|NOT COMPLETED|Period 5||0
6619172|NCT02173535|7545768|FG014|NOT COMPLETED|Period 5||0
6619173|NCT02173535|7545769|FG015|NOT COMPLETED|Period 5||0
6619174|NCT02173535|7545770|FG016|NOT COMPLETED|Period 5||0
6619175|NCT02173535|7545771|FG017|NOT COMPLETED|Period 5||0
6619176|NCT02173535|7545772|FG018|NOT COMPLETED|Period 5||0
6619177|NCT02173535|7545773|FG019|NOT COMPLETED|Period 5||0
6619178|NCT02173548|7545802|FG000|STARTED|Overall Study||21
6619179|NCT02173548|7545803|FG001|STARTED|Overall Study||10
6619180|NCT02173548|7545802|FG000|COMPLETED|Overall Study||20
6619181|NCT02173548|7545803|FG001|COMPLETED|Overall Study||8
6619182|NCT02173548|7545802|FG000|NOT COMPLETED|Overall Study||1
6619183|NCT02173548|7545803|FG001|NOT COMPLETED|Overall Study||2
6619184|NCT02173704|7545811|FG000|STARTED|Overall Study||150
6619185|NCT02173704|7545812|FG001|STARTED|Overall Study||75
6619186|NCT02173704|7545811|FG000|COMPLETED|Overall Study||137
6619187|NCT02173704|7545812|FG001|COMPLETED|Overall Study||71
6619188|NCT02173704|7545811|FG000|NOT COMPLETED|Overall Study||13
6619189|NCT02173704|7545812|FG001|NOT COMPLETED|Overall Study||4
6619190|NCT02173769|7545818|FG000|STARTED|Overall Study||1858
6619191|NCT02173769|7545818|FG000|COMPLETED|Overall Study||1854
6619192|NCT02173769|7545818|FG000|NOT COMPLETED|Overall Study||4
6619193|NCT02174198|7545825|FG000|STARTED|Overall Study||16
6619194|NCT02174198|7545826|FG001|STARTED|Overall Study||16
6619195|NCT02174198|7545825|FG000|COMPLETED|Overall Study||16
6619196|NCT02174198|7545826|FG001|COMPLETED|Overall Study||16
6619197|NCT02174198|7545825|FG000|NOT COMPLETED|Overall Study||0
6619198|NCT02174198|7545826|FG001|NOT COMPLETED|Overall Study||0
6619199|NCT02174276|7545836|FG000|STARTED|Study Treatment Phase (Weeks 1 to 48)||27
6619200|NCT02174276|7545837|FG001|STARTED|Study Treatment Phase (Weeks 1 to 48)||57
6619201|NCT02174276|7545838|FG002|STARTED|Study Treatment Phase (Weeks 1 to 48)||56
6619202|NCT02174276|7545839|FG003|STARTED|Study Treatment Phase (Weeks 1 to 48)||55
6619203|NCT02174276|7545836|FG000|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||26
6619204|NCT02174276|7545837|FG001|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||56
6619205|NCT02174276|7545838|FG002|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||53
6619206|NCT02174276|7545839|FG003|COMPLETED|Study Treatment Phase (Weeks 1 to 48)||55
6619207|NCT02174276|7545836|FG000|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
6619208|NCT02174276|7545837|FG001|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||1
6619209|NCT02174276|7545838|FG002|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||3
6619210|NCT02174276|7545839|FG003|NOT COMPLETED|Study Treatment Phase (Weeks 1 to 48)||0
6619211|NCT02174276|7545836|FG000|STARTED|OTEP (Weeks 48 to 144)||26
6619212|NCT02174276|7545837|FG001|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|54
6619213|NCT02174276|7545838|FG002|STARTED|OTEP (Weeks 48 to 144)|2 Participants completed the study treatment phase but did not continue in OTEP.|51
6619214|NCT02174276|7545839|FG003|STARTED|OTEP (Weeks 48 to 144)|3 Participants completed the study treatment phase but did not continue in OTEP.|52
6619215|NCT02174276|7545836|FG000|COMPLETED|OTEP (Weeks 48 to 144)||25
6619216|NCT02174276|7545837|FG001|COMPLETED|OTEP (Weeks 48 to 144)||54
6619217|NCT02174276|7545838|FG002|COMPLETED|OTEP (Weeks 48 to 144)||48
6619218|NCT02174276|7545839|FG003|COMPLETED|OTEP (Weeks 48 to 144)||50
6619219|NCT02174276|7545836|FG000|NOT COMPLETED|OTEP (Weeks 48 to 144)||1
6619220|NCT02174276|7545837|FG001|NOT COMPLETED|OTEP (Weeks 48 to 144)||0
6619221|NCT02174276|7545838|FG002|NOT COMPLETED|OTEP (Weeks 48 to 144)||3
6619222|NCT02174276|7545839|FG003|NOT COMPLETED|OTEP (Weeks 48 to 144)||2
6619223|NCT02174419|7545852|FG000|STARTED|Overall Study||22
6619224|NCT02174419|7545853|FG001|STARTED|Overall Study||18
6619225|NCT02174419|7545854|FG002|STARTED|Overall Study||22
6619226|NCT02174419|7545852|FG000|COMPLETED|Overall Study||18
6619227|NCT02174419|7545853|FG001|COMPLETED|Overall Study||12
6619228|NCT02174419|7545854|FG002|COMPLETED|Overall Study||20
6619229|NCT02174419|7545852|FG000|NOT COMPLETED|Overall Study||4
6619230|NCT02174419|7545853|FG001|NOT COMPLETED|Overall Study||6
6619231|NCT02174419|7545854|FG002|NOT COMPLETED|Overall Study||2
6619232|NCT02174432|7545862|FG000|STARTED|Overall Study||36
6619233|NCT02174432|7545862|FG000|COMPLETED|Overall Study||16
6619234|NCT02174432|7545862|FG000|NOT COMPLETED|Overall Study||20
6619235|NCT02174510|7545870|FG000|STARTED|Overall Study||8
6619236|NCT02174510|7545871|FG001|STARTED|Overall Study||8
6619237|NCT02174510|7545872|FG002|STARTED|Overall Study||12
6619238|NCT02174510|7545873|FG003|STARTED|Overall Study||9
6619239|NCT02174510|7545870|FG000|COMPLETED|Overall Study||8
6619240|NCT02174510|7545871|FG001|COMPLETED|Overall Study||8
6619241|NCT02174510|7545872|FG002|COMPLETED|Overall Study||12
6619242|NCT02174510|7545873|FG003|COMPLETED|Overall Study||9
6619243|NCT02174510|7545870|FG000|NOT COMPLETED|Overall Study||0
6619244|NCT02174510|7545871|FG001|NOT COMPLETED|Overall Study||0
6619245|NCT02174510|7545872|FG002|NOT COMPLETED|Overall Study||0
6619246|NCT02174510|7545873|FG003|NOT COMPLETED|Overall Study||0
6619247|NCT02174523|7545884|FG000|STARTED|Overall Study||10
6619248|NCT02174523|7545885|FG001|STARTED|Overall Study||4
6619249|NCT02174523|7545884|FG000|COMPLETED|Overall Study||9
6619250|NCT02174523|7545885|FG001|COMPLETED|Overall Study||4
6619251|NCT02174523|7545884|FG000|NOT COMPLETED|Overall Study||1
6619252|NCT02174523|7545885|FG001|NOT COMPLETED|Overall Study||0
6619253|NCT02174562|7545892|FG000|STARTED|Overall Study||50
6619254|NCT02174562|7545893|FG001|STARTED|Overall Study||51
6619255|NCT02174562|7545892|FG000|COMPLETED|Overall Study||41
6619256|NCT02174562|7545893|FG001|COMPLETED|Overall Study||46
6619257|NCT02174562|7545892|FG000|NOT COMPLETED|Overall Study||9
6619258|NCT02174562|7545893|FG001|NOT COMPLETED|Overall Study||5
6619259|NCT02174627|7545901|FG000|STARTED|Overall Study||1384
6619260|NCT02174627|7545902|FG001|STARTED|Overall Study||1377
6619261|NCT02174627|7545901|FG000|Received Treatment|Overall Study||1384
6619262|NCT02174627|7545902|FG001|Received Treatment|Overall Study||1376
6619263|NCT02174627|7545901|FG000|Discontinued Treatment|Overall Study||499
6619264|NCT02174627|7545902|FG001|Discontinued Treatment|Overall Study||801
6619265|NCT02174627|7545901|FG000|COMPLETED|Overall Study||1300
6619266|NCT02174627|7545902|FG001|COMPLETED|Overall Study||1247
6619267|NCT02174627|7545901|FG000|NOT COMPLETED|Overall Study||84
6619268|NCT02174627|7545902|FG001|NOT COMPLETED|Overall Study||130
6619269|NCT02174731|7545910|FG000|STARTED|Overall Study||1051
6619270|NCT02174731|7545911|FG001|STARTED|Overall Study||1055
6619271|NCT02174731|7545910|FG000|Received Treatment|Overall Study||1048
6619272|NCT02174731|7545911|FG001|Received Treatment|Overall Study||1053
6619273|NCT02174731|7545910|FG000|COMPLETED|Overall Study||982
6619274|NCT02174731|7545911|FG001|COMPLETED|Overall Study||990
6619275|NCT02174731|7545910|FG000|NOT COMPLETED|Overall Study||69
6619276|NCT02174731|7545911|FG001|NOT COMPLETED|Overall Study||65
6619277|NCT02174848|7545919|FG000|STARTED|Overall Study||24
6619278|NCT02174848|7545920|FG001|STARTED|Overall Study||44
6619279|NCT02174848|7545919|FG000|Provided Post-baseline Efficacy Data|Overall Study||19
6619280|NCT02174848|7545920|FG001|Provided Post-baseline Efficacy Data|Overall Study||43
6619281|NCT02174848|7545919|FG000|COMPLETED|Overall Study||17
6619282|NCT02174848|7545920|FG001|COMPLETED|Overall Study||38
6619283|NCT02174848|7545919|FG000|NOT COMPLETED|Overall Study||7
6619284|NCT02174848|7545920|FG001|NOT COMPLETED|Overall Study||6
6619285|NCT02174861|7545931|FG000|STARTED|Overall Study||609
6619286|NCT02174861|7545931|FG000|Enrolled in CHU Substudy|Overall Study||53
6619287|NCT02174861|7545931|FG000|COMPLETED|Overall Study||451
6619288|NCT02174861|7545931|FG000|NOT COMPLETED|Overall Study||158
6619289|NCT02174913|7545939|FG000|STARTED|Overall Study||17
6619290|NCT02174913|7545940|FG001|STARTED|Overall Study||17
6619291|NCT02174913|7545939|FG000|COMPLETED|Overall Study||17
6619292|NCT02174913|7545940|FG001|COMPLETED|Overall Study||17
6619293|NCT02174913|7545939|FG000|NOT COMPLETED|Overall Study||0
6619294|NCT02174913|7545940|FG001|NOT COMPLETED|Overall Study||0
6619295|NCT02175121|7545951|FG000|STARTED|Overall Study||34
6619296|NCT02175121|7545952|FG001|STARTED|Overall Study||35
6619297|NCT02175121|7545953|FG002|STARTED|Overall Study||34
6619298|NCT02175121|7545954|FG003|STARTED|Overall Study||35
6619299|NCT02175121|7545955|FG004|STARTED|Overall Study||34
6619300|NCT02175121|7545951|FG000|COMPLETED|Overall Study||33
6619301|NCT02175121|7545952|FG001|COMPLETED|Overall Study||34
6619302|NCT02175121|7545953|FG002|COMPLETED|Overall Study||32
6619303|NCT02175121|7545954|FG003|COMPLETED|Overall Study||34
6619304|NCT02175121|7545955|FG004|COMPLETED|Overall Study||33
6619305|NCT02175121|7545951|FG000|NOT COMPLETED|Overall Study||1
6619306|NCT02175121|7545952|FG001|NOT COMPLETED|Overall Study||1
6619307|NCT02175121|7545953|FG002|NOT COMPLETED|Overall Study||2
6619308|NCT02175121|7545954|FG003|NOT COMPLETED|Overall Study||1
6619309|NCT02175121|7545955|FG004|NOT COMPLETED|Overall Study||1
6619310|NCT02175199|7545973|FG000|STARTED|Overall Study||74
6619311|NCT02175199|7545974|FG001|STARTED|Overall Study||76
6619312|NCT02175199|7545973|FG000|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
6619313|NCT02175199|7545974|FG001|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
6619314|NCT02175199|7545973|FG000|COMPLETED|Overall Study||71
6619315|NCT02175199|7545974|FG001|COMPLETED|Overall Study||71
6619316|NCT02175199|7545973|FG000|NOT COMPLETED|Overall Study||3
6619317|NCT02175199|7545974|FG001|NOT COMPLETED|Overall Study||5
6619318|NCT02175212|7545983|FG000|STARTED|Overall Study||177
6619319|NCT02175212|7545984|FG001|STARTED|Overall Study||178
6619320|NCT02175212|7545983|FG000|COMPLETED|Overall Study||14
6619321|NCT02175212|7545984|FG001|COMPLETED|Overall Study||31
6619322|NCT02175212|7545983|FG000|NOT COMPLETED|Overall Study||163
6619323|NCT02175212|7545984|FG001|NOT COMPLETED|Overall Study||147
6619324|NCT02175225|7545992|FG000|STARTED|Overall Study||145
6619325|NCT02175225|7545993|FG001|STARTED|Overall Study||149
6619326|NCT02175225|7545992|FG000|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|144
6619327|NCT02175225|7545993|FG001|Initiated Study Drug|Overall Study|Subjects in whom study drug was not initiated are not subsequently followed per the protocol.|147
6619328|NCT02175225|7545992|FG000|90 Day Outcome Obtained|Overall Study||140
6619329|NCT02175225|7545993|FG001|90 Day Outcome Obtained|Overall Study||143
6619330|NCT02175225|7545992|FG000|180 Day Outcome Obtained|Overall Study||135
6619331|NCT02175225|7545993|FG001|180 Day Outcome Obtained|Overall Study||135
6619332|NCT02175225|7545992|FG000|COMPLETED|Overall Study||137
6619333|NCT02175225|7545993|FG001|COMPLETED|Overall Study||138
6619334|NCT02175225|7545992|FG000|NOT COMPLETED|Overall Study||8
6619335|NCT02175225|7545993|FG001|NOT COMPLETED|Overall Study||11
6733289|NCT03208088|7662764|FG007|STARTED|Period 5||10
6733290|NCT03208088|7662765|FG008|STARTED|Period 5||7
6733291|NCT03208088|7662766|FG009|STARTED|Period 5||9
6733292|NCT03208088|7662757|FG000|COMPLETED|Period 5||10
6733293|NCT03208088|7662758|FG001|COMPLETED|Period 5||9
6733294|NCT03208088|7662759|FG002|COMPLETED|Period 5||10
6733295|NCT03208088|7662760|FG003|COMPLETED|Period 5||7
6733296|NCT03208088|7662761|FG004|COMPLETED|Period 5||9
6733297|NCT03208088|7662762|FG005|COMPLETED|Period 5||9
6733298|NCT03208088|7662763|FG006|COMPLETED|Period 5||8
6733299|NCT03208088|7662764|FG007|COMPLETED|Period 5||10
6733300|NCT03208088|7662765|FG008|COMPLETED|Period 5||7
6733301|NCT03208088|7662766|FG009|COMPLETED|Period 5||9
6733302|NCT03208088|7662757|FG000|NOT COMPLETED|Period 5||0
6733303|NCT03208088|7662758|FG001|NOT COMPLETED|Period 5||0
6733304|NCT03208088|7662759|FG002|NOT COMPLETED|Period 5||0
6733305|NCT03208088|7662760|FG003|NOT COMPLETED|Period 5||0
6733306|NCT03208088|7662761|FG004|NOT COMPLETED|Period 5||0
6733307|NCT03208088|7662762|FG005|NOT COMPLETED|Period 5||0
6733308|NCT03208088|7662763|FG006|NOT COMPLETED|Period 5||0
6733309|NCT03208088|7662764|FG007|NOT COMPLETED|Period 5||0
6733310|NCT03208088|7662765|FG008|NOT COMPLETED|Period 5||0
6733311|NCT03208088|7662766|FG009|NOT COMPLETED|Period 5||0
6733312|NCT03208166|7662780|FG000|STARTED|Overall Study||1
6733313|NCT03208166|7662781|FG001|STARTED|Overall Study||1
6733314|NCT03208166|7662780|FG000|COMPLETED|Overall Study||1
6733315|NCT03208166|7662781|FG001|COMPLETED|Overall Study||1
6733316|NCT03208166|7662780|FG000|NOT COMPLETED|Overall Study||0
6733317|NCT03208166|7662781|FG001|NOT COMPLETED|Overall Study||0
6739992|NCT03297294|7668837|FG001|COMPLETED|Double-Blind Treatment Period (DB)||30
6739993|NCT03297294|7668838|FG002|COMPLETED|Double-Blind Treatment Period (DB)||0
6739994|NCT03297294|7668839|FG003|COMPLETED|Double-Blind Treatment Period (DB)||0
6739995|NCT03297294|7668840|FG004|COMPLETED|Double-Blind Treatment Period (DB)||0
6739996|NCT03297294|7668836|FG000|NOT COMPLETED|Double-Blind Treatment Period (DB)||38
6739997|NCT03297294|7668837|FG001|NOT COMPLETED|Double-Blind Treatment Period (DB)||37
6739998|NCT03297294|7668838|FG002|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6739999|NCT03297294|7668839|FG003|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6740000|NCT03297294|7668840|FG004|NOT COMPLETED|Double-Blind Treatment Period (DB)||0
6740001|NCT03297294|7668836|FG000|STARTED|Treatment Withdrawal Period (TW)||0
6740002|NCT03297294|7668837|FG001|STARTED|Treatment Withdrawal Period (TW)||0
6740003|NCT03297294|7668838|FG002|STARTED|Treatment Withdrawal Period (TW)||14
6740004|NCT03297294|7668839|FG003|STARTED|Treatment Withdrawal Period (TW)||12
6740005|NCT03297294|7668840|FG004|STARTED|Treatment Withdrawal Period (TW)||27
6740006|NCT03297294|7668836|FG000|COMPLETED|Treatment Withdrawal Period (TW)||0
6740007|NCT03297294|7668837|FG001|COMPLETED|Treatment Withdrawal Period (TW)||0
6740008|NCT03297294|7668838|FG002|COMPLETED|Treatment Withdrawal Period (TW)||14
6740009|NCT03297294|7668839|FG003|COMPLETED|Treatment Withdrawal Period (TW)||11
6740010|NCT03297294|7668840|FG004|COMPLETED|Treatment Withdrawal Period (TW)||27
6740011|NCT03297294|7668836|FG000|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6740012|NCT03297294|7668837|FG001|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6740013|NCT03297294|7668838|FG002|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6740014|NCT03297294|7668839|FG003|NOT COMPLETED|Treatment Withdrawal Period (TW)||1
6740015|NCT03297294|7668840|FG004|NOT COMPLETED|Treatment Withdrawal Period (TW)||0
6740016|NCT03297398|7668855|FG000|STARTED|Overall Study||36
6740017|NCT03297398|7668856|FG001|STARTED|Overall Study||40
6740018|NCT03297398|7668857|FG002|STARTED|Overall Study||38
6740019|NCT03297398|7668855|FG000|COMPLETED|Overall Study||28
6740020|NCT03297398|7668856|FG001|COMPLETED|Overall Study||23
6740021|NCT03297398|7668857|FG002|COMPLETED|Overall Study||23
6740022|NCT03297398|7668855|FG000|NOT COMPLETED|Overall Study||8
6740023|NCT03297398|7668856|FG001|NOT COMPLETED|Overall Study||17
6740024|NCT03297398|7668857|FG002|NOT COMPLETED|Overall Study||15
6740025|NCT03297944|7668865|FG000|STARTED|Overall Study||15
6740026|NCT03297944|7668865|FG000|2ALP/PLC|Overall Study||15
6740027|NCT03297944|7668865|FG000|1ALP/PLC|Overall Study||15
6740028|NCT03297944|7668865|FG000|0.5ALP/PLC|Overall Study||15
6740029|NCT03297944|7668865|FG000|ZOL/PLC|Overall Study||15
6740030|NCT03297944|7668865|FG000|PLC/PLC|Overall Study||15
6740031|NCT03297944|7668865|FG000|PLC/ALP|Overall Study||15
6740032|NCT03297944|7668865|FG000|COMPLETED|Overall Study||15
6740033|NCT03297944|7668865|FG000|NOT COMPLETED|Overall Study||0
6619336|NCT02175277|7545999|FG000|STARTED|Overall Study||9
6619337|NCT02175277|7545999|FG000|COMPLETED|Overall Study||8
6619338|NCT02175277|7545999|FG000|NOT COMPLETED|Overall Study||1
6619339|NCT02175368|7546003|FG000|STARTED|Overall Study||28
6619340|NCT02175368|7546003|FG000|COMPLETED|Overall Study||27
6619341|NCT02175368|7546003|FG000|NOT COMPLETED|Overall Study||1
6619342|NCT02175472|7546009|FG000|STARTED|Overall Study||45
6619343|NCT02175472|7546010|FG001|STARTED|Overall Study||47
6619344|NCT02175472|7546009|FG000|COMPLETED|Overall Study||38
6619345|NCT02175472|7546010|FG001|COMPLETED|Overall Study||45
6619346|NCT02175472|7546009|FG000|NOT COMPLETED|Overall Study||7
6619347|NCT02175472|7546010|FG001|NOT COMPLETED|Overall Study||2
6619348|NCT02175641|7546018|FG000|STARTED|Overall Study||157
6619349|NCT02175641|7546019|FG001|STARTED|Overall Study||157
6619350|NCT02175641|7546018|FG000|6-month Follow up|Overall Study||144
6619351|NCT02175641|7546019|FG001|6-month Follow up|Overall Study||149
6619352|NCT02175641|7546018|FG000|12-month Follow up|Overall Study||129
6619353|NCT02175641|7546019|FG001|12-month Follow up|Overall Study||136
6619354|NCT02175641|7546018|FG000|18-month Follow up|Overall Study||122
6619355|NCT02175641|7546019|FG001|18-month Follow up|Overall Study||130
6619356|NCT02175641|7546018|FG000|COMPLETED|Overall Study||122
6619357|NCT02175641|7546019|FG001|COMPLETED|Overall Study||130
6619358|NCT02175641|7546018|FG000|NOT COMPLETED|Overall Study||35
6619359|NCT02175641|7546019|FG001|NOT COMPLETED|Overall Study||27
6619360|NCT02175745|7546025|FG000|STARTED|Overall Study||2
6619361|NCT02175745|7546025|FG000|COMPLETED|Overall Study||1
6619362|NCT02175745|7546025|FG000|NOT COMPLETED|Overall Study||1
6619363|NCT02175758|7546035|FG000|STARTED|PK Lead-in Phase||4
6619364|NCT02175758|7546036|FG001|STARTED|PK Lead-in Phase||6
6619365|NCT02175758|7546037|FG002|STARTED|PK Lead-in Phase||2
6619366|NCT02175758|7546038|FG003|STARTED|PK Lead-in Phase||10
6619367|NCT02175758|7546039|FG004|STARTED|PK Lead-in Phase||4
6619368|NCT02175758|7546040|FG005|STARTED|PK Lead-in Phase||8
6619369|NCT02175758|7546035|FG000|COMPLETED|PK Lead-in Phase||4
6619370|NCT02175758|7546036|FG001|COMPLETED|PK Lead-in Phase||6
6619371|NCT02175758|7546037|FG002|COMPLETED|PK Lead-in Phase||2
6619372|NCT02175758|7546038|FG003|COMPLETED|PK Lead-in Phase||10
6619373|NCT02175758|7546039|FG004|COMPLETED|PK Lead-in Phase||4
6619374|NCT02175758|7546040|FG005|COMPLETED|PK Lead-in Phase||8
6619375|NCT02175758|7546035|FG000|NOT COMPLETED|PK Lead-in Phase||0
6619376|NCT02175758|7546036|FG001|NOT COMPLETED|PK Lead-in Phase||0
6619377|NCT02175758|7546037|FG002|NOT COMPLETED|PK Lead-in Phase||0
6619378|NCT02175758|7546038|FG003|NOT COMPLETED|PK Lead-in Phase||0
6619379|NCT02175758|7546039|FG004|NOT COMPLETED|PK Lead-in Phase||0
6619380|NCT02175758|7546040|FG005|NOT COMPLETED|PK Lead-in Phase||0
6619381|NCT02175758|7546035|FG000|STARTED|Treatment Phase|9 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
6619382|NCT02175758|7546036|FG001|STARTED|Treatment Phase|33 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|39
6619383|NCT02175758|7546037|FG002|STARTED|Treatment Phase|11 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|13
6619384|NCT02175758|7546038|FG003|STARTED|Treatment Phase|18 participants enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|28
6619385|NCT02175758|7546039|FG004|STARTED|Treatment Phase|1 participant enrolled directly into the Treatment Phase, without entering the PK Lead-In Phase.|5
6619386|NCT02175758|7546040|FG005|STARTED|Treatment Phase||8
6619387|NCT02175758|7546035|FG000|COMPLETED|Treatment Phase||13
6619388|NCT02175758|7546036|FG001|COMPLETED|Treatment Phase||38
6619389|NCT02175758|7546037|FG002|COMPLETED|Treatment Phase||13
6619390|NCT02175758|7546038|FG003|COMPLETED|Treatment Phase||28
6619391|NCT02175758|7546039|FG004|COMPLETED|Treatment Phase||4
6619392|NCT02175758|7546040|FG005|COMPLETED|Treatment Phase||8
6619393|NCT02175758|7546035|FG000|NOT COMPLETED|Treatment Phase||0
6619394|NCT02175758|7546036|FG001|NOT COMPLETED|Treatment Phase||1
6619395|NCT02175758|7546037|FG002|NOT COMPLETED|Treatment Phase||0
6619396|NCT02175758|7546038|FG003|NOT COMPLETED|Treatment Phase||0
6619397|NCT02175758|7546039|FG004|NOT COMPLETED|Treatment Phase||1
6619398|NCT02175758|7546040|FG005|NOT COMPLETED|Treatment Phase||0
6619399|NCT02175771|7546088|FG000|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
6619400|NCT02175771|7546089|FG001|STARTED|Run-In Period (Pre-assignment)||0
6619401|NCT02175771|7546090|FG002|STARTED|Run-In Period (Pre-assignment)||0
6619402|NCT02175771|7546091|FG003|STARTED|Run-In Period (Pre-assignment)||0
6619403|NCT02175771|7546092|FG004|STARTED|Run-In Period (Pre-assignment)||0
6619404|NCT02175771|7546093|FG005|STARTED|Run-In Period (Pre-assignment)||0
6619405|NCT02175771|7546094|FG006|STARTED|Run-In Period (Pre-assignment)||0
6619406|NCT02175771|7546095|FG007|STARTED|Run-In Period (Pre-assignment)||0
6619407|NCT02175771|7546096|FG008|STARTED|Run-In Period (Pre-assignment)||0
6619408|NCT02175771|7546088|FG000|COMPLETED|Run-In Period (Pre-assignment)||674
6619409|NCT02175771|7546089|FG001|COMPLETED|Run-In Period (Pre-assignment)||0
6619410|NCT02175771|7546090|FG002|COMPLETED|Run-In Period (Pre-assignment)||0
6619411|NCT02175771|7546091|FG003|COMPLETED|Run-In Period (Pre-assignment)||0
6619412|NCT02175771|7546092|FG004|COMPLETED|Run-In Period (Pre-assignment)||0
6619413|NCT02175771|7546093|FG005|COMPLETED|Run-In Period (Pre-assignment)||0
6619414|NCT02175771|7546094|FG006|COMPLETED|Run-In Period (Pre-assignment)||0
6619415|NCT02175771|7546095|FG007|COMPLETED|Run-In Period (Pre-assignment)||0
6619416|NCT02175771|7546096|FG008|COMPLETED|Run-In Period (Pre-assignment)||0
6619417|NCT02175771|7546088|FG000|NOT COMPLETED|Run-In Period (Pre-assignment)||84
6619418|NCT02175771|7546089|FG001|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6619419|NCT02175771|7546090|FG002|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6619420|NCT02175771|7546091|FG003|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6619421|NCT02175771|7546092|FG004|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6619422|NCT02175771|7546093|FG005|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6619423|NCT02175771|7546094|FG006|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6619424|NCT02175771|7546095|FG007|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6619425|NCT02175771|7546096|FG008|NOT COMPLETED|Run-In Period (Pre-assignment)||0
6619426|NCT02175771|7546088|FG000|STARTED|Treatment Period||0
6619427|NCT02175771|7546089|FG001|STARTED|Treatment Period||127
6619428|NCT02175771|7546090|FG002|STARTED|Treatment Period||42
6619429|NCT02175771|7546091|FG003|STARTED|Treatment Period||126
6619430|NCT02175771|7546092|FG004|STARTED|Treatment Period||41
6619431|NCT02175771|7546093|FG005|STARTED|Treatment Period||120
6619432|NCT02175771|7546094|FG006|STARTED|Treatment Period||41
6619433|NCT02175771|7546095|FG007|STARTED|Treatment Period||133
6619434|NCT02175771|7546096|FG008|STARTED|Treatment Period||44
6619435|NCT02175771|7546088|FG000|COMPLETED|Treatment Period||0
6619436|NCT02175771|7546089|FG001|COMPLETED|Treatment Period||111
6619437|NCT02175771|7546090|FG002|COMPLETED|Treatment Period||35
6619438|NCT02175771|7546091|FG003|COMPLETED|Treatment Period||113
6619439|NCT02175771|7546092|FG004|COMPLETED|Treatment Period||36
6619440|NCT02175771|7546093|FG005|COMPLETED|Treatment Period||110
6619441|NCT02175771|7546094|FG006|COMPLETED|Treatment Period||36
6619442|NCT02175771|7546095|FG007|COMPLETED|Treatment Period||116
6619443|NCT02175771|7546096|FG008|COMPLETED|Treatment Period||38
6619444|NCT02175771|7546088|FG000|NOT COMPLETED|Treatment Period||0
6619445|NCT02175771|7546089|FG001|NOT COMPLETED|Treatment Period||16
6619446|NCT02175771|7546090|FG002|NOT COMPLETED|Treatment Period||7
6619447|NCT02175771|7546091|FG003|NOT COMPLETED|Treatment Period||13
6619448|NCT02175771|7546092|FG004|NOT COMPLETED|Treatment Period||5
6619449|NCT02175771|7546093|FG005|NOT COMPLETED|Treatment Period||10
6619450|NCT02175771|7546094|FG006|NOT COMPLETED|Treatment Period||5
6619451|NCT02175771|7546095|FG007|NOT COMPLETED|Treatment Period||17
6619452|NCT02175771|7546096|FG008|NOT COMPLETED|Treatment Period||6
6619453|NCT02175966|7546116|FG000|STARTED|Treatment Period||14
6619454|NCT02175966|7546117|FG001|STARTED|Treatment Period||14
6619455|NCT02175966|7546116|FG000|COMPLETED|Treatment Period||14
6619456|NCT02175966|7546117|FG001|COMPLETED|Treatment Period||14
6619457|NCT02175966|7546116|FG000|NOT COMPLETED|Treatment Period||0
6619458|NCT02175966|7546117|FG001|NOT COMPLETED|Treatment Period||0
6619459|NCT02175966|7546116|FG000|STARTED|Follow-up Period||14
6619460|NCT02175966|7546117|FG001|STARTED|Follow-up Period||14
6619461|NCT02175966|7546116|FG000|COMPLETED|Follow-up Period||4
6619462|NCT02175966|7546117|FG001|COMPLETED|Follow-up Period||8
6619463|NCT02175966|7546116|FG000|NOT COMPLETED|Follow-up Period||10
6619464|NCT02175966|7546117|FG001|NOT COMPLETED|Follow-up Period||6
6619465|NCT02175979|7546125|FG000|STARTED|Overall Study||140
6619466|NCT02175979|7546126|FG001|STARTED|Overall Study||140
6619467|NCT02175979|7546125|FG000|COMPLETED|Overall Study||133
6619468|NCT02175979|7546126|FG001|COMPLETED|Overall Study||132
6619469|NCT02175979|7546125|FG000|NOT COMPLETED|Overall Study||7
6619470|NCT02175979|7546126|FG001|NOT COMPLETED|Overall Study||8
6619471|NCT02176005|7546136|FG000|STARTED|Overall Study||14
6619472|NCT02176005|7546137|FG001|STARTED|Overall Study||14
6619473|NCT02176005|7546138|FG002|STARTED|Overall Study||8
6619474|NCT02176005|7546139|FG003|STARTED|Overall Study||8
6619475|NCT02176005|7546136|FG000|COMPLETED|Overall Study||14
6619476|NCT02176005|7546137|FG001|COMPLETED|Overall Study||14
6619477|NCT02176005|7546138|FG002|COMPLETED|Overall Study||8
6619478|NCT02176005|7546139|FG003|COMPLETED|Overall Study||8
6619479|NCT02176005|7546136|FG000|NOT COMPLETED|Overall Study||0
6619480|NCT02176005|7546137|FG001|NOT COMPLETED|Overall Study||0
6619481|NCT02176005|7546138|FG002|NOT COMPLETED|Overall Study||0
6619482|NCT02176005|7546139|FG003|NOT COMPLETED|Overall Study||0
6619483|NCT02176018|7546151|FG000|STARTED|Overall Study||22
6619484|NCT02176018|7546152|FG001|STARTED|Overall Study||23
6619485|NCT02176018|7546151|FG000|COMPLETED|Overall Study||17
6619486|NCT02176018|7546152|FG001|COMPLETED|Overall Study||17
6619487|NCT02176018|7546151|FG000|NOT COMPLETED|Overall Study||5
6619488|NCT02176018|7546152|FG001|NOT COMPLETED|Overall Study||6
6619489|NCT02176031|7546158|FG000|STARTED|Overall Study||21
6619490|NCT02176031|7546158|FG000|COMPLETED|Overall Study||9
6619491|NCT02176031|7546158|FG000|NOT COMPLETED|Overall Study||12
6619492|NCT02176083|7546165|FG000|STARTED|Overall Study||11
6619493|NCT02176083|7546166|FG001|STARTED|Overall Study||27
6619494|NCT02176083|7546165|FG000|COMPLETED|Overall Study||11
6619495|NCT02176083|7546166|FG001|COMPLETED|Overall Study||27
6619496|NCT02176083|7546165|FG000|NOT COMPLETED|Overall Study||0
6619497|NCT02176083|7546166|FG001|NOT COMPLETED|Overall Study||0
6619498|NCT02176226|7546172|FG000|STARTED|Overall Study||105
6619499|NCT02176226|7546172|FG000|COMPLETED|Overall Study||96
6619500|NCT02176226|7546172|FG000|NOT COMPLETED|Overall Study||9
6619501|NCT02176291|7546178|FG000|STARTED|Overall Study||20
6619502|NCT02176291|7546179|FG001|STARTED|Overall Study||11
6619503|NCT02176291|7546178|FG000|COMPLETED|Overall Study||15
6619504|NCT02176291|7546179|FG001|COMPLETED|Overall Study||11
6619505|NCT02176291|7546178|FG000|NOT COMPLETED|Overall Study||5
6619506|NCT02176291|7546179|FG001|NOT COMPLETED|Overall Study||0
6619507|NCT02176343|7546185|FG000|STARTED|Overall Study||31
6619508|NCT02176343|7546185|FG000|COMPLETED|Overall Study||31
6619509|NCT02176343|7546185|FG000|NOT COMPLETED|Overall Study||0
6619510|NCT02176356|7546189|FG000|STARTED|Overall Study||116
6619511|NCT02176356|7546189|FG000|Eligible and Received Treatment|Overall Study||100
6619512|NCT02176356|7546189|FG000|COMPLETED|Overall Study||93
6619513|NCT02176356|7546189|FG000|NOT COMPLETED|Overall Study||23
6619514|NCT02176382|7546195|FG000|STARTED|DATA-HD Study||39
6619515|NCT02176382|7546196|FG001|STARTED|DATA-HD Study||37
6619516|NCT02176382|7546195|FG000|COMPLETED|DATA-HD Study||31
6619517|NCT02176382|7546196|FG001|COMPLETED|DATA-HD Study||29
6619518|NCT02176382|7546195|FG000|NOT COMPLETED|DATA-HD Study||8
6619519|NCT02176382|7546196|FG001|NOT COMPLETED|DATA-HD Study||8
6619520|NCT02176382|7546195|FG000|STARTED|DATA-HD Extension||27
6619521|NCT02176382|7546196|FG001|STARTED|DATA-HD Extension||26
6619522|NCT02176382|7546195|FG000|COMPLETED|DATA-HD Extension||26
6619523|NCT02176382|7546196|FG001|COMPLETED|DATA-HD Extension||26
6619524|NCT02176382|7546195|FG000|NOT COMPLETED|DATA-HD Extension||1
6619525|NCT02176382|7546196|FG001|NOT COMPLETED|DATA-HD Extension||0
6619526|NCT02176408|7546204|FG000|STARTED|Overall Study||15
6619527|NCT02176408|7546205|FG001|STARTED|Overall Study||16
6619528|NCT02176408|7546204|FG000|COMPLETED|Overall Study||9
6619529|NCT02176408|7546205|FG001|COMPLETED|Overall Study||12
6619530|NCT02176408|7546204|FG000|NOT COMPLETED|Overall Study||6
6619531|NCT02176408|7546205|FG001|NOT COMPLETED|Overall Study||4
6619532|NCT02176421|7546211|FG000|STARTED|Overall Study||80
6619533|NCT02176421|7546211|FG000|COMPLETED|Overall Study||75
6619534|NCT02176421|7546211|FG000|NOT COMPLETED|Overall Study||5
6619535|NCT02176486|7546218|FG000|STARTED|Overall Study||3
6619536|NCT02176486|7546219|FG001|STARTED|Overall Study||5
6619537|NCT02176486|7546220|FG002|STARTED|Overall Study||4
6619538|NCT02176486|7546218|FG000|COMPLETED|Overall Study||3
6619539|NCT02176486|7546219|FG001|COMPLETED|Overall Study||5
6619540|NCT02176486|7546220|FG002|COMPLETED|Overall Study||4
6619541|NCT02176486|7546218|FG000|NOT COMPLETED|Overall Study||0
6619542|NCT02176486|7546219|FG001|NOT COMPLETED|Overall Study||0
6619543|NCT02176486|7546220|FG002|NOT COMPLETED|Overall Study||0
6619544|NCT02176525|7546238|FG000|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
6619545|NCT02176525|7546239|FG001|STARTED|Overall Study||9
6619546|NCT02176525|7546240|FG002|STARTED|Overall Study||9
6619547|NCT02176525|7546241|FG003|STARTED|Overall Study||9
6619548|NCT02176525|7546242|FG004|STARTED|Overall Study||8
6619549|NCT02176525|7546243|FG005|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
6619550|NCT02176525|7546244|FG006|STARTED|Overall Study||9
6619551|NCT02176525|7546245|FG007|STARTED|Overall Study||10
6619552|NCT02176525|7546238|FG000|COMPLETED|Overall Study||14
6619553|NCT02176525|7546239|FG001|COMPLETED|Overall Study||9
6619554|NCT02176525|7546240|FG002|COMPLETED|Overall Study||9
6619555|NCT02176525|7546241|FG003|COMPLETED|Overall Study||8
6619556|NCT02176525|7546242|FG004|COMPLETED|Overall Study||7
6619557|NCT02176525|7546243|FG005|COMPLETED|Overall Study||5
6619558|NCT02176525|7546244|FG006|COMPLETED|Overall Study||8
6619559|NCT02176525|7546245|FG007|COMPLETED|Overall Study||10
6619560|NCT02176525|7546238|FG000|NOT COMPLETED|Overall Study||1
6619561|NCT02176525|7546239|FG001|NOT COMPLETED|Overall Study||0
6619562|NCT02176525|7546240|FG002|NOT COMPLETED|Overall Study||0
6619563|NCT02176525|7546241|FG003|NOT COMPLETED|Overall Study||1
6619564|NCT02176525|7546242|FG004|NOT COMPLETED|Overall Study||1
6619565|NCT02176525|7546243|FG005|NOT COMPLETED|Overall Study||1
6619566|NCT02176525|7546244|FG006|NOT COMPLETED|Overall Study||1
6619567|NCT02176525|7546245|FG007|NOT COMPLETED|Overall Study||0
6619568|NCT02176642|7546273|FG000|STARTED|Overall Study||18
6619569|NCT02176642|7546274|FG001|STARTED|Overall Study||17
6619570|NCT02176642|7546273|FG000|COMPLETED|Overall Study||18
6619571|NCT02176642|7546274|FG001|COMPLETED|Overall Study||16
6619572|NCT02176642|7546273|FG000|NOT COMPLETED|Overall Study||0
6619573|NCT02176642|7546274|FG001|NOT COMPLETED|Overall Study||1
6619574|NCT02176655|7546280|FG000|STARTED|Overall Study||31
6619575|NCT02176655|7546280|FG000|COMPLETED|Overall Study||25
6619576|NCT02176655|7546280|FG000|NOT COMPLETED|Overall Study||6
6619577|NCT02176837|7546285|FG000|STARTED|Overall Study||6
6619578|NCT02176837|7546285|FG000|COMPLETED|Overall Study||0
6619579|NCT02176837|7546285|FG000|NOT COMPLETED|Overall Study||6
6619580|NCT02176928|7546291|FG000|STARTED|Overall Study||21
6619581|NCT02176928|7546292|FG001|STARTED|Overall Study||21
6619582|NCT02176928|7546291|FG000|COMPLETED|Overall Study||19
6619583|NCT02176928|7546292|FG001|COMPLETED|Overall Study||17
6619584|NCT02176928|7546291|FG000|NOT COMPLETED|Overall Study||2
6619585|NCT02176928|7546292|FG001|NOT COMPLETED|Overall Study||4
6619586|NCT02177032|7546302|FG000|STARTED|Overall Study||355
6619587|NCT02177032|7546303|FG001|STARTED|Overall Study||88
6619588|NCT02177032|7546304|FG002|STARTED|Overall Study||354
6619589|NCT02177032|7546305|FG003|STARTED|Overall Study||88
6619590|NCT02177032|7546302|FG000|COMPLETED|Overall Study||350
6619591|NCT02177032|7546303|FG001|COMPLETED|Overall Study||86
6619592|NCT02177032|7546304|FG002|COMPLETED|Overall Study||351
6619593|NCT02177032|7546305|FG003|COMPLETED|Overall Study||88
6619594|NCT02177032|7546302|FG000|NOT COMPLETED|Overall Study||5
6619595|NCT02177032|7546303|FG001|NOT COMPLETED|Overall Study||2
6619596|NCT02177032|7546304|FG002|NOT COMPLETED|Overall Study||3
6619597|NCT02177032|7546305|FG003|NOT COMPLETED|Overall Study||0
6619598|NCT02177123|7546326|FG000|STARTED|Overall Study||107
6619599|NCT02177123|7546326|FG000|COMPLETED|Overall Study||83
6619600|NCT02177123|7546326|FG000|NOT COMPLETED|Overall Study||24
6619601|NCT02177136|7546336|FG000|STARTED|DB Phase||26
6619602|NCT02177136|7546337|FG001|STARTED|DB Phase||26
6619603|NCT02177136|7546338|FG002|STARTED|DB Phase||25
6619604|NCT02177136|7546339|FG003|STARTED|DB Phase||0
6619605|NCT02177136|7546336|FG000|Received At Least 1 Dose Of Study Drug|DB Phase|One participant randomized to receive 1.5 mg OCA titrating to 3 mg OCA withdrew prior to dosing.|25
6619606|NCT02177136|7546337|FG001|Received At Least 1 Dose Of Study Drug|DB Phase||26
6619607|NCT02177136|7546338|FG002|Received At Least 1 Dose Of Study Drug|DB Phase||25
6619608|NCT02177136|7546339|FG003|Received At Least 1 Dose Of Study Drug|DB Phase||0
6619609|NCT02177136|7546336|FG000|COMPLETED|DB Phase||19
6619610|NCT02177136|7546337|FG001|COMPLETED|DB Phase||21
6619611|NCT02177136|7546338|FG002|COMPLETED|DB Phase||21
6619612|NCT02177136|7546339|FG003|COMPLETED|DB Phase||0
6619613|NCT02177136|7546336|FG000|NOT COMPLETED|DB Phase||7
6619614|NCT02177136|7546337|FG001|NOT COMPLETED|DB Phase||5
6619615|NCT02177136|7546338|FG002|NOT COMPLETED|DB Phase||4
6619616|NCT02177136|7546339|FG003|NOT COMPLETED|DB Phase||0
6619617|NCT02177136|7546336|FG000|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
6619618|NCT02177136|7546337|FG001|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
6619619|NCT02177136|7546338|FG002|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|0
6619620|NCT02177136|7546339|FG003|STARTED|LTSE Phase|Eligible participants who completed the DB phase could enroll in the LTSE phase.|59
6619621|NCT02177136|7546336|FG000|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
6619622|NCT02177136|7546337|FG001|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
6619623|NCT02177136|7546338|FG002|Received At Least 1 Dose Of Study Drug|LTSE Phase||0
6619624|NCT02177136|7546339|FG003|Received At Least 1 Dose Of Study Drug|LTSE Phase||59
6619625|NCT02177136|7546336|FG000|COMPLETED|LTSE Phase||0
6619626|NCT02177136|7546337|FG001|COMPLETED|LTSE Phase||0
6619627|NCT02177136|7546338|FG002|COMPLETED|LTSE Phase||0
6619628|NCT02177136|7546339|FG003|COMPLETED|LTSE Phase||35
6619629|NCT02177136|7546336|FG000|NOT COMPLETED|LTSE Phase||0
6619630|NCT02177136|7546337|FG001|NOT COMPLETED|LTSE Phase||0
6619631|NCT02177136|7546338|FG002|NOT COMPLETED|LTSE Phase||0
6619632|NCT02177136|7546339|FG003|NOT COMPLETED|LTSE Phase||24
6619633|NCT02177201|7546352|FG000|STARTED|Overall Study||80
6619634|NCT02177201|7546353|FG001|STARTED|Overall Study||80
6619635|NCT02177201|7546352|FG000|COMPLETED|Overall Study||77
6619636|NCT02177201|7546353|FG001|COMPLETED|Overall Study||77
6619637|NCT02177201|7546352|FG000|NOT COMPLETED|Overall Study||3
6619638|NCT02177201|7546353|FG001|NOT COMPLETED|Overall Study||3
6619639|NCT02177786|7546363|FG000|STARTED|Overall Study||81
6619640|NCT02177786|7546364|FG001|STARTED|Overall Study||84
6619641|NCT02177786|7546365|FG002|STARTED|Overall Study||84
6619642|NCT02177786|7546366|FG003|STARTED|Overall Study||85
6619643|NCT02177786|7546363|FG000|Randomized and Treated|Overall Study||81
6619644|NCT02177786|7546364|FG001|Randomized and Treated|Overall Study||84
6619645|NCT02177786|7546365|FG002|Randomized and Treated|Overall Study||83
6619646|NCT02177786|7546366|FG003|Randomized and Treated|Overall Study||85
6619647|NCT02177786|7546363|FG000|COMPLETED|Overall Study||75
6619648|NCT02177786|7546364|FG001|COMPLETED|Overall Study||70
6619649|NCT02177786|7546365|FG002|COMPLETED|Overall Study||66
6619650|NCT02177786|7546366|FG003|COMPLETED|Overall Study||72
6619651|NCT02177786|7546363|FG000|NOT COMPLETED|Overall Study||6
6619652|NCT02177786|7546364|FG001|NOT COMPLETED|Overall Study||14
6619653|NCT02177786|7546365|FG002|NOT COMPLETED|Overall Study||18
6619654|NCT02177786|7546366|FG003|NOT COMPLETED|Overall Study||13
6619655|NCT02177812|7546385|FG000|STARTED|Part 1 (Median of 4 Weeks)||1
6619656|NCT02177812|7546386|FG001|STARTED|Part 1 (Median of 4 Weeks)||2
6619657|NCT02177812|7546387|FG002|STARTED|Part 1 (Median of 4 Weeks)||7
6619658|NCT02177812|7546388|FG003|STARTED|Part 1 (Median of 4 Weeks)||5
6619659|NCT02177812|7546389|FG004|STARTED|Part 1 (Median of 4 Weeks)||6
6619660|NCT02177812|7546390|FG005|STARTED|Part 1 (Median of 4 Weeks)||4
6619661|NCT02177812|7546391|FG006|STARTED|Part 1 (Median of 4 Weeks)||10
6619662|NCT02177812|7546392|FG007|STARTED|Part 1 (Median of 4 Weeks)||6
6619663|NCT02177812|7546393|FG008|STARTED|Part 1 (Median of 4 Weeks)||0
6619664|NCT02177812|7546385|FG000|COMPLETED|Part 1 (Median of 4 Weeks)||1
6619665|NCT02177812|7546386|FG001|COMPLETED|Part 1 (Median of 4 Weeks)||2
6619666|NCT02177812|7546387|FG002|COMPLETED|Part 1 (Median of 4 Weeks)||7
6619667|NCT02177812|7546388|FG003|COMPLETED|Part 1 (Median of 4 Weeks)||4
6619668|NCT02177812|7546389|FG004|COMPLETED|Part 1 (Median of 4 Weeks)||5
6619669|NCT02177812|7546390|FG005|COMPLETED|Part 1 (Median of 4 Weeks)||1
6619670|NCT02177812|7546391|FG006|COMPLETED|Part 1 (Median of 4 Weeks)||1
6619671|NCT02177812|7546392|FG007|COMPLETED|Part 1 (Median of 4 Weeks)||4
6619672|NCT02177812|7546393|FG008|COMPLETED|Part 1 (Median of 4 Weeks)||0
6619673|NCT02177812|7546385|FG000|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
6619674|NCT02177812|7546386|FG001|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
6619675|NCT02177812|7546387|FG002|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
6619676|NCT02177812|7546388|FG003|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
6619677|NCT02177812|7546389|FG004|NOT COMPLETED|Part 1 (Median of 4 Weeks)||1
6619678|NCT02177812|7546390|FG005|NOT COMPLETED|Part 1 (Median of 4 Weeks)||3
6619679|NCT02177812|7546391|FG006|NOT COMPLETED|Part 1 (Median of 4 Weeks)||9
6619680|NCT02177812|7546392|FG007|NOT COMPLETED|Part 1 (Median of 4 Weeks)||2
6619681|NCT02177812|7546393|FG008|NOT COMPLETED|Part 1 (Median of 4 Weeks)||0
6619682|NCT02177812|7546385|FG000|STARTED|Part 2 (Up to 14 Months)||0
6619683|NCT02177812|7546386|FG001|STARTED|Part 2 (Up to 14 Months)||0
6619684|NCT02177812|7546387|FG002|STARTED|Part 2 (Up to 14 Months)||0
6619685|NCT02177812|7546388|FG003|STARTED|Part 2 (Up to 14 Months)||0
6619686|NCT02177812|7546389|FG004|STARTED|Part 2 (Up to 14 Months)||0
6619687|NCT02177812|7546390|FG005|STARTED|Part 2 (Up to 14 Months)||0
6619688|NCT02177812|7546391|FG006|STARTED|Part 2 (Up to 14 Months)||0
6619689|NCT02177812|7546392|FG007|STARTED|Part 2 (Up to 14 Months)||0
6619690|NCT02177812|7546393|FG008|STARTED|Part 2 (Up to 14 Months)||0
6619691|NCT02177812|7546385|FG000|COMPLETED|Part 2 (Up to 14 Months)||0
6619692|NCT02177812|7546386|FG001|COMPLETED|Part 2 (Up to 14 Months)||0
6619693|NCT02177812|7546387|FG002|COMPLETED|Part 2 (Up to 14 Months)||0
6619694|NCT02177812|7546388|FG003|COMPLETED|Part 2 (Up to 14 Months)||0
6619695|NCT02177812|7546389|FG004|COMPLETED|Part 2 (Up to 14 Months)||0
6619696|NCT02177812|7546390|FG005|COMPLETED|Part 2 (Up to 14 Months)||0
6619697|NCT02177812|7546391|FG006|COMPLETED|Part 2 (Up to 14 Months)||0
6619698|NCT02177812|7546392|FG007|COMPLETED|Part 2 (Up to 14 Months)||0
6619699|NCT02177812|7546393|FG008|COMPLETED|Part 2 (Up to 14 Months)||0
6619700|NCT02177812|7546385|FG000|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619701|NCT02177812|7546386|FG001|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619702|NCT02177812|7546387|FG002|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619703|NCT02177812|7546388|FG003|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619704|NCT02177812|7546389|FG004|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619705|NCT02177812|7546390|FG005|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619706|NCT02177812|7546391|FG006|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619707|NCT02177812|7546392|FG007|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619708|NCT02177812|7546393|FG008|NOT COMPLETED|Part 2 (Up to 14 Months)||0
6619709|NCT02177838|7546422|FG000|STARTED|Overall Study||8
6619710|NCT02177838|7546422|FG000|COMPLETED|Overall Study||5
6619711|NCT02177838|7546422|FG000|NOT COMPLETED|Overall Study||3
6619712|NCT02177942|7546428|FG000|STARTED|Overall Study||262
6619713|NCT02177942|7546429|FG001|STARTED|Overall Study||266
6619714|NCT02177942|7546428|FG000|COMPLETED|Overall Study||185
6619715|NCT02177942|7546429|FG001|COMPLETED|Overall Study||178
6619716|NCT02177942|7546428|FG000|NOT COMPLETED|Overall Study||77
6619717|NCT02177942|7546429|FG001|NOT COMPLETED|Overall Study||88
6619718|NCT02178059|7546439|FG000|STARTED|First Intervention||17
6619719|NCT02178059|7546440|FG001|STARTED|First Intervention||17
6619720|NCT02178059|7546439|FG000|COMPLETED|First Intervention||17
6619721|NCT02178059|7546440|FG001|COMPLETED|First Intervention||17
6619722|NCT02178059|7546439|FG000|NOT COMPLETED|First Intervention||0
6619723|NCT02178059|7546440|FG001|NOT COMPLETED|First Intervention||0
6619724|NCT02178059|7546439|FG000|STARTED|Washout||17
6619725|NCT02178059|7546440|FG001|STARTED|Washout||17
6619726|NCT02178059|7546439|FG000|COMPLETED|Washout||16
6619727|NCT02178059|7546440|FG001|COMPLETED|Washout||17
6619728|NCT02178059|7546439|FG000|NOT COMPLETED|Washout||1
6619729|NCT02178059|7546440|FG001|NOT COMPLETED|Washout||0
6619730|NCT02178059|7546439|FG000|STARTED|Second Intervention||16
6619731|NCT02178059|7546440|FG001|STARTED|Second Intervention||17
6619732|NCT02178059|7546439|FG000|COMPLETED|Second Intervention||16
6619733|NCT02178059|7546440|FG001|COMPLETED|Second Intervention||17
6619734|NCT02178059|7546439|FG000|NOT COMPLETED|Second Intervention||0
6619735|NCT02178059|7546440|FG001|NOT COMPLETED|Second Intervention||0
6619736|NCT02178241|7546446|FG000|STARTED|Overall Study||24
6619737|NCT02178241|7546446|FG000|COMPLETED|Overall Study||24
6619738|NCT02178241|7546446|FG000|NOT COMPLETED|Overall Study||0
6619739|NCT02178475|7546450|FG000|STARTED|Overall Study||943
6619740|NCT02178475|7546450|FG000|Primary Analysis Set|Overall Study|All enrolled participants who met eligibility criteria|844
6619741|NCT02178475|7546450|FG000|COMPLETED|Overall Study||814
6619742|NCT02178475|7546450|FG000|NOT COMPLETED|Overall Study||129
6619743|NCT02178540|7546454|FG000|STARTED|Overall Study||45
6619744|NCT02178540|7546454|FG000|COMPLETED|Overall Study||45
6619745|NCT02178540|7546454|FG000|NOT COMPLETED|Overall Study||0
6619746|NCT02178553|7546463|FG000|STARTED|Overall Study||53
6619747|NCT02178553|7546464|FG001|STARTED|Overall Study||49
6619748|NCT02178553|7546463|FG000|COMPLETED|Overall Study||45
6619749|NCT02178553|7546464|FG001|COMPLETED|Overall Study||39
6619750|NCT02178553|7546463|FG000|NOT COMPLETED|Overall Study||8
6619751|NCT02178553|7546464|FG001|NOT COMPLETED|Overall Study||10
6619752|NCT02178592|7546472|FG000|STARTED|Randomized Phase (Up to Week 52)||69
6619753|NCT02178592|7546473|FG001|STARTED|Randomized Phase (Up to Week 52)||44
6619754|NCT02178592|7546472|FG000|COMPLETED|Randomized Phase (Up to Week 52)||50
6619755|NCT02178592|7546473|FG001|COMPLETED|Randomized Phase (Up to Week 52)||35
6619756|NCT02178592|7546472|FG000|NOT COMPLETED|Randomized Phase (Up to Week 52)||19
6619757|NCT02178592|7546473|FG001|NOT COMPLETED|Randomized Phase (Up to Week 52)||9
6619758|NCT02178592|7546472|FG000|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 3 participants from DTG arm did not enter OLE from Randomized Phase.|47
6619759|NCT02178592|7546473|FG001|STARTED|OLE Phase (Week 52 to Week 252)|As OLE phase was optional, 16 participants from EFV arm did not enter OLE from Randomized Phase.|19
6619760|NCT02178592|7546472|FG000|COMPLETED|OLE Phase (Week 52 to Week 252)||35
6619761|NCT02178592|7546473|FG001|COMPLETED|OLE Phase (Week 52 to Week 252)||16
6619762|NCT02178592|7546472|FG000|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||12
6619763|NCT02178592|7546473|FG001|NOT COMPLETED|OLE Phase (Week 52 to Week 252)||3
6619764|NCT02178696|7546482|FG000|STARTED|First Assignment and Washout||20
6619765|NCT02178696|7546483|FG001|STARTED|First Assignment and Washout||20
6619766|NCT02178696|7546482|FG000|COMPLETED|First Assignment and Washout||20
6619767|NCT02178696|7546483|FG001|COMPLETED|First Assignment and Washout||20
6619768|NCT02178696|7546482|FG000|NOT COMPLETED|First Assignment and Washout||0
6619769|NCT02178696|7546483|FG001|NOT COMPLETED|First Assignment and Washout||0
6619770|NCT02178696|7546482|FG000|STARTED|Second Assignment After Crossover||20
6619771|NCT02178696|7546483|FG001|STARTED|Second Assignment After Crossover||20
6619772|NCT02178696|7546482|FG000|COMPLETED|Second Assignment After Crossover||20
6619773|NCT02178696|7546483|FG001|COMPLETED|Second Assignment After Crossover||20
6619774|NCT02178696|7546482|FG000|NOT COMPLETED|Second Assignment After Crossover||0
6619775|NCT02178696|7546483|FG001|NOT COMPLETED|Second Assignment After Crossover||0
6619776|NCT02178696|7546482|FG000|STARTED|Open-label Antidepressant||20
6619777|NCT02178696|7546483|FG001|STARTED|Open-label Antidepressant||20
6619778|NCT02178696|7546482|FG000|COMPLETED|Open-label Antidepressant||14
6619779|NCT02178696|7546483|FG001|COMPLETED|Open-label Antidepressant||13
6619780|NCT02178696|7546482|FG000|NOT COMPLETED|Open-label Antidepressant||6
6619781|NCT02178696|7546483|FG001|NOT COMPLETED|Open-label Antidepressant||7
6619782|NCT02178787|7546496|FG000|STARTED|Overall Study||35
6619783|NCT02178787|7546497|FG001|STARTED|Overall Study||39
6619784|NCT02178787|7546496|FG000|COMPLETED|Overall Study||30
6619785|NCT02178787|7546497|FG001|COMPLETED|Overall Study||30
6619786|NCT02178787|7546496|FG000|NOT COMPLETED|Overall Study||5
6619787|NCT02178787|7546497|FG001|NOT COMPLETED|Overall Study||9
6619788|NCT02178800|7546507|FG000|STARTED|Overall Study||151
6619789|NCT02178800|7546508|FG001|STARTED|Overall Study||48
6619790|NCT02178800|7546507|FG000|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|131
6619791|NCT02178800|7546508|FG001|COMPLETED|Overall Study|Number of participants who weren't terminated at week 41|42
6619792|NCT02178800|7546507|FG000|NOT COMPLETED|Overall Study||20
6619793|NCT02178800|7546508|FG001|NOT COMPLETED|Overall Study||6
6619794|NCT02178995|7546524|FG000|STARTED|Double Blind||0
6619795|NCT02178995|7546525|FG001|STARTED|Double Blind||16
6619796|NCT02178995|7546526|FG002|STARTED|Double Blind||5
6619797|NCT02178995|7546527|FG003|STARTED|Double Blind||6
6619798|NCT02178995|7546528|FG004|STARTED|Double Blind||6
6619799|NCT02178995|7546529|FG005|STARTED|Double Blind||6
6619800|NCT02178995|7546530|FG006|STARTED|Double Blind||5
6619801|NCT02178995|7546531|FG007|STARTED|Double Blind||6
6619802|NCT02178995|7546532|FG008|STARTED|Double Blind||1
6619803|NCT02178995|7546524|FG000|COMPLETED|Double Blind||0
6619804|NCT02178995|7546525|FG001|COMPLETED|Double Blind||15
6619805|NCT02178995|7546526|FG002|COMPLETED|Double Blind||5
6619806|NCT02178995|7546527|FG003|COMPLETED|Double Blind||6
6619807|NCT02178995|7546528|FG004|COMPLETED|Double Blind||6
6619808|NCT02178995|7546529|FG005|COMPLETED|Double Blind||5
6619809|NCT02178995|7546530|FG006|COMPLETED|Double Blind||5
6619810|NCT02178995|7546531|FG007|COMPLETED|Double Blind||4
6619811|NCT02178995|7546532|FG008|COMPLETED|Double Blind||0
6619812|NCT02178995|7546524|FG000|NOT COMPLETED|Double Blind||0
6619813|NCT02178995|7546525|FG001|NOT COMPLETED|Double Blind||1
6619814|NCT02178995|7546526|FG002|NOT COMPLETED|Double Blind||0
6619815|NCT02178995|7546527|FG003|NOT COMPLETED|Double Blind||0
6619816|NCT02178995|7546528|FG004|NOT COMPLETED|Double Blind||0
6619817|NCT02178995|7546529|FG005|NOT COMPLETED|Double Blind||1
6619818|NCT02178995|7546530|FG006|NOT COMPLETED|Double Blind||0
6619819|NCT02178995|7546531|FG007|NOT COMPLETED|Double Blind||2
6619820|NCT02178995|7546532|FG008|NOT COMPLETED|Double Blind||1
6619821|NCT02178995|7546524|FG000|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
6619822|NCT02178995|7546525|FG001|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
6619823|NCT02178995|7546526|FG002|STARTED|Open Label||0
6619824|NCT02178995|7546527|FG003|STARTED|Open Label||0
6619825|NCT02178995|7546528|FG004|STARTED|Open Label||0
6619826|NCT02178995|7546529|FG005|STARTED|Open Label||0
6619827|NCT02178995|7546530|FG006|STARTED|Open Label||0
6619828|NCT02178995|7546531|FG007|STARTED|Open Label||0
6619829|NCT02178995|7546532|FG008|STARTED|Open Label||0
6619830|NCT02178995|7546524|FG000|COMPLETED|Open Label||28
6619831|NCT02178995|7546525|FG001|COMPLETED|Open Label||14
6619832|NCT02178995|7546526|FG002|COMPLETED|Open Label||0
6619833|NCT02178995|7546527|FG003|COMPLETED|Open Label||0
6619834|NCT02178995|7546528|FG004|COMPLETED|Open Label||0
6619835|NCT02178995|7546529|FG005|COMPLETED|Open Label||0
6619836|NCT02178995|7546530|FG006|COMPLETED|Open Label||0
6619837|NCT02178995|7546531|FG007|COMPLETED|Open Label||0
6619838|NCT02178995|7546532|FG008|COMPLETED|Open Label||0
6619839|NCT02178995|7546524|FG000|NOT COMPLETED|Open Label||2
6619840|NCT02178995|7546525|FG001|NOT COMPLETED|Open Label||0
6619841|NCT02178995|7546526|FG002|NOT COMPLETED|Open Label||0
6619842|NCT02178995|7546527|FG003|NOT COMPLETED|Open Label||0
6619843|NCT02178995|7546528|FG004|NOT COMPLETED|Open Label||0
6619844|NCT02178995|7546529|FG005|NOT COMPLETED|Open Label||0
6619845|NCT02178995|7546530|FG006|NOT COMPLETED|Open Label||0
6733318|NCT03208192|7662789|FG000|STARTED|Overall Study||32
6733319|NCT03208192|7662790|FG001|STARTED|Overall Study||36
6733320|NCT03208192|7662789|FG000|COMPLETED|Overall Study||32
6733321|NCT03208192|7662790|FG001|COMPLETED|Overall Study||36
6733322|NCT03208192|7662789|FG000|NOT COMPLETED|Overall Study||0
6733323|NCT03208192|7662790|FG001|NOT COMPLETED|Overall Study||0
6733324|NCT03208673|7662798|FG000|STARTED|Overall Study||32
6619846|NCT02178995|7546531|FG007|NOT COMPLETED|Open Label||0
6619847|NCT02178995|7546532|FG008|NOT COMPLETED|Open Label||0
6619848|NCT02179047|7546558|FG000|STARTED|Overall Study||194
6619849|NCT02179047|7546559|FG001|STARTED|Overall Study||20
6619850|NCT02179047|7546558|FG000|COMPLETED|Overall Study||187
6619851|NCT02179047|7546559|FG001|COMPLETED|Overall Study||20
6619852|NCT02179047|7546558|FG000|NOT COMPLETED|Overall Study||7
6619853|NCT02179047|7546559|FG001|NOT COMPLETED|Overall Study||0
6619854|NCT02179177|7546578|FG000|STARTED|Overall Study||8
6619855|NCT02179177|7546579|FG001|STARTED|Overall Study||8
6619856|NCT02179177|7546578|FG000|COMPLETED|Overall Study||6
6619857|NCT02179177|7546579|FG001|COMPLETED|Overall Study||6
6619858|NCT02179177|7546578|FG000|NOT COMPLETED|Overall Study||2
6619859|NCT02179177|7546579|FG001|NOT COMPLETED|Overall Study||2
6619860|NCT02179190|7546585|FG000|STARTED|Enrollment||138
6619861|NCT02179190|7546585|FG000|COMPLETED|Enrollment||127
6619862|NCT02179190|7546585|FG000|NOT COMPLETED|Enrollment||11
6619863|NCT02179190|7546585|FG000|STARTED|Index Procedure With Barrel VRD Attempt||127
6619864|NCT02179190|7546585|FG000|COMPLETED|Index Procedure With Barrel VRD Attempt||120
6619865|NCT02179190|7546585|FG000|NOT COMPLETED|Index Procedure With Barrel VRD Attempt||7
6619866|NCT02179190|7546585|FG000|STARTED|Follow-Up Post Barrel VRD Implanted||120
6619867|NCT02179190|7546585|FG000|COMPLETED|Follow-Up Post Barrel VRD Implanted||111
6619868|NCT02179190|7546585|FG000|NOT COMPLETED|Follow-Up Post Barrel VRD Implanted||9
6619869|NCT02179398|7546591|FG000|STARTED|Overall Study||134
6619870|NCT02179398|7546592|FG001|STARTED|Overall Study||144
6619871|NCT02179398|7546591|FG000|COMPLETED|Overall Study||131
6619872|NCT02179398|7546592|FG001|COMPLETED|Overall Study||140
6619873|NCT02179398|7546591|FG000|NOT COMPLETED|Overall Study||3
6619874|NCT02179398|7546592|FG001|NOT COMPLETED|Overall Study||4
6619875|NCT02179424|7546606|FG000|STARTED|Overall Study||76
6619876|NCT02179424|7546607|FG001|STARTED|Overall Study||11
6619877|NCT02179424|7546608|FG002|STARTED|Overall Study||516
6619878|NCT02179424|7546609|FG003|STARTED|Overall Study||39
6619879|NCT02179424|7546606|FG000|COMPLETED|Overall Study||76
6619880|NCT02179424|7546607|FG001|COMPLETED|Overall Study||11
6619881|NCT02179424|7546608|FG002|COMPLETED|Overall Study||516
6619882|NCT02179424|7546609|FG003|COMPLETED|Overall Study||39
6619883|NCT02179424|7546606|FG000|NOT COMPLETED|Overall Study||0
6619884|NCT02179424|7546607|FG001|NOT COMPLETED|Overall Study||0
6619885|NCT02179424|7546608|FG002|NOT COMPLETED|Overall Study||0
6619886|NCT02179424|7546609|FG003|NOT COMPLETED|Overall Study||0
6619887|NCT02179515|7546623|FG000|STARTED|Overall Study||3
6619888|NCT02179515|7546624|FG001|STARTED|Overall Study||17
6619889|NCT02179515|7546625|FG002|STARTED|Overall Study||18
6619890|NCT02179515|7546623|FG000|COMPLETED|Overall Study||1
6619891|NCT02179515|7546624|FG001|COMPLETED|Overall Study||1
6619892|NCT02179515|7546625|FG002|COMPLETED|Overall Study||4
6619893|NCT02179515|7546623|FG000|NOT COMPLETED|Overall Study||2
6619894|NCT02179515|7546624|FG001|NOT COMPLETED|Overall Study||16
6619895|NCT02179515|7546625|FG002|NOT COMPLETED|Overall Study||14
6619896|NCT02179671|7546642|FG000|STARTED|Overall Study||1
6619897|NCT02179671|7546643|FG001|STARTED|Overall Study||1
6619898|NCT02179671|7546644|FG002|STARTED|Overall Study||2
6619899|NCT02179671|7546645|FG003|STARTED|Overall Study||14
6619900|NCT02179671|7546646|FG004|STARTED|Overall Study||14
6619901|NCT02179671|7546642|FG000|COMPLETED|Overall Study||0
6619902|NCT02179671|7546643|FG001|COMPLETED|Overall Study||0
6619903|NCT02179671|7546644|FG002|COMPLETED|Overall Study||1
6619904|NCT02179671|7546645|FG003|COMPLETED|Overall Study||1
6619905|NCT02179671|7546646|FG004|COMPLETED|Overall Study||1
6619906|NCT02179671|7546642|FG000|NOT COMPLETED|Overall Study||1
6619907|NCT02179671|7546643|FG001|NOT COMPLETED|Overall Study||1
6619908|NCT02179671|7546644|FG002|NOT COMPLETED|Overall Study||1
6619909|NCT02179671|7546645|FG003|NOT COMPLETED|Overall Study||13
6619910|NCT02179671|7546646|FG004|NOT COMPLETED|Overall Study||13
6619911|NCT02179788|7546660|FG000|STARTED|Overall Study||10
6619912|NCT02179788|7546661|FG001|STARTED|Overall Study||5
6619913|NCT02179788|7546660|FG000|COMPLETED|Overall Study||10
6619914|NCT02179788|7546661|FG001|COMPLETED|Overall Study||5
6619915|NCT02179788|7546660|FG000|NOT COMPLETED|Overall Study||0
6619916|NCT02179788|7546661|FG001|NOT COMPLETED|Overall Study||0
6619917|NCT02179892|7546669|FG000|STARTED|Overall Study||5
6619918|NCT02179892|7546670|FG001|STARTED|Overall Study||4
6619919|NCT02179892|7546669|FG000|COMPLETED|Overall Study||5
6619920|NCT02179892|7546670|FG001|COMPLETED|Overall Study||4
6733325|NCT03208673|7662798|FG000|COMPLETED|Overall Study||32
6733326|NCT03208673|7662798|FG000|NOT COMPLETED|Overall Study||0
6619921|NCT02179892|7546669|FG000|NOT COMPLETED|Overall Study||0
6619922|NCT02179892|7546670|FG001|NOT COMPLETED|Overall Study||0
6619923|NCT02179918|7546681|FG000|STARTED|Overall Study||5
6619924|NCT02179918|7546682|FG001|STARTED|Overall Study||3
6619925|NCT02179918|7546683|FG002|STARTED|Overall Study||3
6619926|NCT02179918|7546684|FG003|STARTED|Overall Study||3
6619927|NCT02179918|7546685|FG004|STARTED|Overall Study||9
6619928|NCT02179918|7546681|FG000|COMPLETED|Overall Study||1
6619929|NCT02179918|7546682|FG001|COMPLETED|Overall Study||0
6619930|NCT02179918|7546683|FG002|COMPLETED|Overall Study||1
6619931|NCT02179918|7546684|FG003|COMPLETED|Overall Study||0
6619932|NCT02179918|7546685|FG004|COMPLETED|Overall Study||1
6619933|NCT02179918|7546681|FG000|NOT COMPLETED|Overall Study||4
6619934|NCT02179918|7546682|FG001|NOT COMPLETED|Overall Study||3
6619935|NCT02179918|7546683|FG002|NOT COMPLETED|Overall Study||2
6619936|NCT02179918|7546684|FG003|NOT COMPLETED|Overall Study||3
6619937|NCT02179918|7546685|FG004|NOT COMPLETED|Overall Study||8
6619938|NCT02180061|7546700|FG000|STARTED|Overall Study||34
6619939|NCT02180061|7546701|FG001|STARTED|Overall Study||8
6619940|NCT02180061|7546700|FG000|COMPLETED|Overall Study||9
6619941|NCT02180061|7546701|FG001|COMPLETED|Overall Study||0
6619942|NCT02180061|7546700|FG000|NOT COMPLETED|Overall Study||25
6619943|NCT02180061|7546701|FG001|NOT COMPLETED|Overall Study||8
6619944|NCT02180100|7546709|FG000|STARTED|Overall Study||70
6619945|NCT02180100|7546710|FG001|STARTED|Overall Study||70
6619946|NCT02180100|7546709|FG000|COMPLETED|Overall Study||58
6619947|NCT02180100|7546710|FG001|COMPLETED|Overall Study||66
6619948|NCT02180100|7546709|FG000|NOT COMPLETED|Overall Study||12
6619949|NCT02180100|7546710|FG001|NOT COMPLETED|Overall Study||4
6619950|NCT02180165|7546720|FG000|STARTED|Overall Study||15
6619951|NCT02180165|7546721|FG001|STARTED|Overall Study||7
6619952|NCT02180165|7546722|FG002|STARTED|Overall Study||63
6619953|NCT02180165|7546723|FG003|STARTED|Overall Study||31
6619954|NCT02180165|7546720|FG000|Treated Participants|Overall Study||15
6619955|NCT02180165|7546721|FG001|Treated Participants|Overall Study||7
6619956|NCT02180165|7546722|FG002|Treated Participants|Overall Study||62
6619957|NCT02180165|7546723|FG003|Treated Participants|Overall Study||31
6619958|NCT02180165|7546720|FG000|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|15
6619959|NCT02180165|7546721|FG001|Type of Aspergillosis|Overall Study|Chronic Pulmonary Aspergillosis|7
6619960|NCT02180165|7546722|FG002|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|57
6619961|NCT02180165|7546723|FG003|Type of Aspergillosis|Overall Study|Invasive Aspergillosis and Chronic Pulmonary Aspergillosis|27
6619962|NCT02180165|7546720|FG000|COMPLETED|Overall Study||4
6619963|NCT02180165|7546721|FG001|COMPLETED|Overall Study||6
6619964|NCT02180165|7546722|FG002|COMPLETED|Overall Study||34
6619965|NCT02180165|7546723|FG003|COMPLETED|Overall Study||25
6619966|NCT02180165|7546720|FG000|NOT COMPLETED|Overall Study||11
6619967|NCT02180165|7546721|FG001|NOT COMPLETED|Overall Study||1
6619968|NCT02180165|7546722|FG002|NOT COMPLETED|Overall Study||29
6619969|NCT02180165|7546723|FG003|NOT COMPLETED|Overall Study||6
6619970|NCT02180230|7546735|FG000|STARTED|Overall Study||38
6619971|NCT02180230|7546735|FG000|COMPLETED|Overall Study||31
6619972|NCT02180230|7546735|FG000|NOT COMPLETED|Overall Study||7
6619973|NCT02180438|7546739|FG000|STARTED|Overall Study||30
6619974|NCT02180438|7546739|FG000|COMPLETED|Overall Study||29
6619975|NCT02180438|7546739|FG000|NOT COMPLETED|Overall Study||1
6619976|NCT02180646|7546745|FG000|STARTED|First Intervention (7 Days)||6
6619977|NCT02180646|7546746|FG001|STARTED|First Intervention (7 Days)||6
6619978|NCT02180646|7546745|FG000|COMPLETED|First Intervention (7 Days)||6
6619979|NCT02180646|7546746|FG001|COMPLETED|First Intervention (7 Days)||6
6619980|NCT02180646|7546745|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6619981|NCT02180646|7546746|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6619982|NCT02180646|7546745|FG000|STARTED|Washout (7 Days)||6
6619983|NCT02180646|7546746|FG001|STARTED|Washout (7 Days)||6
6619984|NCT02180646|7546745|FG000|COMPLETED|Washout (7 Days)||6
6619985|NCT02180646|7546746|FG001|COMPLETED|Washout (7 Days)||6
6619986|NCT02180646|7546745|FG000|NOT COMPLETED|Washout (7 Days)||0
6619987|NCT02180646|7546746|FG001|NOT COMPLETED|Washout (7 Days)||0
6619988|NCT02180646|7546745|FG000|STARTED|Second Intervention (7 Days)||6
6619989|NCT02180646|7546746|FG001|STARTED|Second Intervention (7 Days)||6
6619990|NCT02180646|7546745|FG000|COMPLETED|Second Intervention (7 Days)||6
6619991|NCT02180646|7546746|FG001|COMPLETED|Second Intervention (7 Days)||6
6619992|NCT02180646|7546745|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6619993|NCT02180646|7546746|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6619994|NCT02180659|7546756|FG000|STARTED|Overall Study||87
6619995|NCT02180659|7546757|FG001|STARTED|Overall Study|N=90 randomized, however N=89 received study medication|89
6619996|NCT02180659|7546756|FG000|COMPLETED|Overall Study||81
6619997|NCT02180659|7546757|FG001|COMPLETED|Overall Study||84
6619998|NCT02180659|7546756|FG000|NOT COMPLETED|Overall Study||6
6619999|NCT02180659|7546757|FG001|NOT COMPLETED|Overall Study||5
6620000|NCT02180672|7546765|FG000|STARTED|Overall Study||91
6620001|NCT02180672|7546766|FG001|STARTED|Overall Study||43
6620002|NCT02180672|7546765|FG000|COMPLETED|Overall Study||86
6620003|NCT02180672|7546766|FG001|COMPLETED|Overall Study||36
6620004|NCT02180672|7546765|FG000|NOT COMPLETED|Overall Study||5
6620005|NCT02180672|7546766|FG001|NOT COMPLETED|Overall Study||7
6620006|NCT02180828|7546774|FG000|STARTED|Overall Study||120
6620007|NCT02180828|7546775|FG001|STARTED|Overall Study||120
6620008|NCT02180828|7546774|FG000|COMPLETED|Overall Study||115
6620009|NCT02180828|7546775|FG001|COMPLETED|Overall Study||113
6620010|NCT02180828|7546774|FG000|NOT COMPLETED|Overall Study||5
6620011|NCT02180828|7546775|FG001|NOT COMPLETED|Overall Study||7
6620012|NCT02180893|7546783|FG000|STARTED|Overall Study||30
6620013|NCT02180893|7546784|FG001|STARTED|Overall Study||30
6620014|NCT02180893|7546783|FG000|COMPLETED|Overall Study||27
6620015|NCT02180893|7546784|FG001|COMPLETED|Overall Study||23
6620016|NCT02180893|7546783|FG000|NOT COMPLETED|Overall Study||3
6620017|NCT02180893|7546784|FG001|NOT COMPLETED|Overall Study||7
6620018|NCT02181075|7546792|FG000|STARTED|Overall Study||6
6620019|NCT02181075|7546793|FG001|STARTED|Overall Study||4
6620020|NCT02181075|7546792|FG000|COMPLETED|Overall Study||6
6620021|NCT02181075|7546793|FG001|COMPLETED|Overall Study||4
6620022|NCT02181075|7546792|FG000|NOT COMPLETED|Overall Study||0
6620023|NCT02181075|7546793|FG001|NOT COMPLETED|Overall Study||0
6620024|NCT02181127|7546803|FG000|STARTED|Overall Study||22
6620025|NCT02181127|7546803|FG000|COMPLETED|Overall Study||22
6620026|NCT02181127|7546803|FG000|NOT COMPLETED|Overall Study||0
6620027|NCT02181140|7546810|FG000|STARTED|Overall Study||56
6620028|NCT02181140|7546810|FG000|COMPLETED|Overall Study||56
6620029|NCT02181140|7546810|FG000|NOT COMPLETED|Overall Study||0
6620030|NCT02181231|7546818|FG000|STARTED|Overall Study||12
6620031|NCT02181231|7546819|FG001|STARTED|Overall Study||6
6620032|NCT02181231|7546818|FG000|COMPLETED|Overall Study||10
6620033|NCT02181231|7546819|FG001|COMPLETED|Overall Study||6
6620034|NCT02181231|7546818|FG000|NOT COMPLETED|Overall Study||2
6620035|NCT02181231|7546819|FG001|NOT COMPLETED|Overall Study||0
6620036|NCT02181296|7546827|FG000|STARTED|Overall Study||25
6620037|NCT02181296|7546828|FG001|STARTED|Overall Study||25
6620038|NCT02181296|7546827|FG000|COMPLETED|Overall Study||18
6620039|NCT02181296|7546828|FG001|COMPLETED|Overall Study||19
6620040|NCT02181296|7546827|FG000|NOT COMPLETED|Overall Study||7
6620041|NCT02181296|7546828|FG001|NOT COMPLETED|Overall Study||6
6620042|NCT02181387|7546836|FG000|STARTED|Overall Study||14
6620043|NCT02181387|7546837|FG001|STARTED|Overall Study||19
6620044|NCT02181387|7546836|FG000|COMPLETED|Overall Study||12
6620045|NCT02181387|7546837|FG001|COMPLETED|Overall Study||15
6620046|NCT02181387|7546836|FG000|NOT COMPLETED|Overall Study||2
6620047|NCT02181387|7546837|FG001|NOT COMPLETED|Overall Study||4
6620048|NCT02181400|7546846|FG000|STARTED|Overall Study||7
6620049|NCT02181400|7546847|FG001|STARTED|Overall Study||7
6620050|NCT02181400|7546848|FG002|STARTED|Overall Study||7
6620051|NCT02181400|7546846|FG000|COMPLETED|Overall Study||7
6620052|NCT02181400|7546847|FG001|COMPLETED|Overall Study||7
6620053|NCT02181400|7546848|FG002|COMPLETED|Overall Study||7
6620054|NCT02181400|7546846|FG000|NOT COMPLETED|Overall Study||0
6620055|NCT02181400|7546847|FG001|NOT COMPLETED|Overall Study||0
6620056|NCT02181400|7546848|FG002|NOT COMPLETED|Overall Study||0
6620057|NCT02181413|7546858|FG000|STARTED|Overall Study||261
6620058|NCT02181413|7546859|FG001|STARTED|Overall Study||395
6620059|NCT02181413|7546858|FG000|Intent-to-Treat (ITT) Population|Overall Study||261
6620060|NCT02181413|7546859|FG001|Intent-to-Treat (ITT) Population|Overall Study||395
6620061|NCT02181413|7546858|FG000|Safety Population|Overall Study||259
6620062|NCT02181413|7546859|FG001|Safety Population|Overall Study||394
6620063|NCT02181413|7546858|FG000|Per Protocol (PP) Population|Overall Study||256
6620064|NCT02181413|7546859|FG001|Per Protocol (PP) Population|Overall Study||387
6620065|NCT02181413|7546858|FG000|COMPLETED|Overall Study||109
6620066|NCT02181413|7546859|FG001|COMPLETED|Overall Study||198
6620067|NCT02181413|7546858|FG000|NOT COMPLETED|Overall Study||152
6620068|NCT02181413|7546859|FG001|NOT COMPLETED|Overall Study||197
6620069|NCT02181426|7546869|FG000|STARTED|Overall Study||28
6620070|NCT02181426|7546870|FG001|STARTED|Overall Study||28
6620071|NCT02181426|7546871|FG002|STARTED|Overall Study||28
6620072|NCT02181426|7546872|FG003|STARTED|Overall Study||28
6620073|NCT02181426|7546869|FG000|COMPLETED|Overall Study||28
6620074|NCT02181426|7546870|FG001|COMPLETED|Overall Study||28
6620075|NCT02181426|7546871|FG002|COMPLETED|Overall Study||28
6620076|NCT02181426|7546872|FG003|COMPLETED|Overall Study||28
6620077|NCT02181426|7546869|FG000|NOT COMPLETED|Overall Study||0
6620078|NCT02181426|7546870|FG001|NOT COMPLETED|Overall Study||0
6620079|NCT02181426|7546871|FG002|NOT COMPLETED|Overall Study||0
6620080|NCT02181426|7546872|FG003|NOT COMPLETED|Overall Study||0
6620081|NCT02181504|7546885|FG000|STARTED|Overall Study||10
6620082|NCT02181504|7546886|FG001|STARTED|Overall Study||10
6620083|NCT02181504|7546887|FG002|STARTED|Overall Study||5
6620084|NCT02181504|7546885|FG000|COMPLETED|Overall Study||9
6620085|NCT02181504|7546886|FG001|COMPLETED|Overall Study||9
6620086|NCT02181504|7546887|FG002|COMPLETED|Overall Study||4
6620087|NCT02181504|7546885|FG000|NOT COMPLETED|Overall Study||1
6620088|NCT02181504|7546886|FG001|NOT COMPLETED|Overall Study||1
6620089|NCT02181504|7546887|FG002|NOT COMPLETED|Overall Study||1
6620090|NCT02181517|7546899|FG000|STARTED|Overall Study||10
6620091|NCT02181517|7546900|FG001|STARTED|Overall Study||10
6620092|NCT02181517|7546901|FG002|STARTED|Overall Study||5
6620093|NCT02181517|7546899|FG000|COMPLETED|Overall Study||10
6620094|NCT02181517|7546900|FG001|COMPLETED|Overall Study||10
6620095|NCT02181517|7546901|FG002|COMPLETED|Overall Study||5
6620096|NCT02181517|7546899|FG000|NOT COMPLETED|Overall Study||0
6620097|NCT02181517|7546900|FG001|NOT COMPLETED|Overall Study||0
6620098|NCT02181517|7546901|FG002|NOT COMPLETED|Overall Study||0
6620099|NCT02181530|7546909|FG000|STARTED|Overall Study||43
6620100|NCT02181530|7546909|FG000|COMPLETED|Overall Study||43
6620101|NCT02181530|7546909|FG000|NOT COMPLETED|Overall Study||0
6620102|NCT02181556|7546913|FG000|STARTED|Overall Study||41
6620103|NCT02181556|7546913|FG000|COMPLETED|Overall Study||40
6620104|NCT02181556|7546913|FG000|NOT COMPLETED|Overall Study||1
6620105|NCT02181634|7546917|FG000|STARTED|Overall Study||74
6620106|NCT02181634|7546917|FG000|Eligible and Treated|Overall Study||73
6620107|NCT02181634|7546917|FG000|COMPLETED|Overall Study||2
6620108|NCT02181634|7546917|FG000|NOT COMPLETED|Overall Study||72
6620109|NCT02181673|7546923|FG000|STARTED|Up to Week 24||239
6733327|NCT03208933|7662802|FG000|STARTED|Overall Study||60
6620110|NCT02181673|7546924|FG001|STARTED|Up to Week 24||0
6620111|NCT02181673|7546925|FG002|STARTED|Up to Week 24||241
6620112|NCT02181673|7546923|FG000|Treated|Up to Week 24||239
6620113|NCT02181673|7546924|FG001|Treated|Up to Week 24||0
6620114|NCT02181673|7546925|FG002|Treated|Up to Week 24||240
6620115|NCT02181673|7546923|FG000|COMPLETED|Up to Week 24||222
6620116|NCT02181673|7546924|FG001|COMPLETED|Up to Week 24||0
6620117|NCT02181673|7546925|FG002|COMPLETED|Up to Week 24||230
6620118|NCT02181673|7546923|FG000|NOT COMPLETED|Up to Week 24||17
6620119|NCT02181673|7546924|FG001|NOT COMPLETED|Up to Week 24||0
6620120|NCT02181673|7546925|FG002|NOT COMPLETED|Up to Week 24||11
6620121|NCT02181673|7546923|FG000|STARTED|Week 24-Week 60||0
6620122|NCT02181673|7546924|FG001|STARTED|Week 24-Week 60||222
6620123|NCT02181673|7546925|FG002|STARTED|Week 24-Week 60||230
6620124|NCT02181673|7546923|FG000|Treated|Week 24-Week 60||0
6620125|NCT02181673|7546924|FG001|Treated|Week 24-Week 60||220
6620126|NCT02181673|7546925|FG002|Treated|Week 24-Week 60||230
6620127|NCT02181673|7546923|FG000|COMPLETED|Week 24-Week 60||0
6620128|NCT02181673|7546924|FG001|COMPLETED|Week 24-Week 60||214
6620129|NCT02181673|7546925|FG002|COMPLETED|Week 24-Week 60||213
6620130|NCT02181673|7546923|FG000|NOT COMPLETED|Week 24-Week 60||0
6620131|NCT02181673|7546924|FG001|NOT COMPLETED|Week 24-Week 60||8
6620132|NCT02181673|7546925|FG002|NOT COMPLETED|Week 24-Week 60||17
6620133|NCT02181738|7546936|FG000|STARTED|Overall Study||63
6620134|NCT02181738|7546937|FG001|STARTED|Overall Study||80
6620135|NCT02181738|7546938|FG002|STARTED|Overall Study||100
6620136|NCT02181738|7546939|FG003|STARTED|Overall Study||51
6620137|NCT02181738|7546936|FG000|COMPLETED|Overall Study||61
6620138|NCT02181738|7546937|FG001|COMPLETED|Overall Study||71
6620139|NCT02181738|7546938|FG002|COMPLETED|Overall Study||90
6620140|NCT02181738|7546939|FG003|COMPLETED|Overall Study||49
6620141|NCT02181738|7546936|FG000|NOT COMPLETED|Overall Study||2
6620142|NCT02181738|7546937|FG001|NOT COMPLETED|Overall Study||9
6620143|NCT02181738|7546938|FG002|NOT COMPLETED|Overall Study||10
6620144|NCT02181738|7546939|FG003|NOT COMPLETED|Overall Study||2
6620145|NCT02181803|7546958|FG000|STARTED|Overall Study||1
6620146|NCT02181803|7546959|FG001|STARTED|Overall Study||13
6620147|NCT02181803|7546960|FG002|STARTED|Overall Study||4
6620148|NCT02181803|7546961|FG003|STARTED|Overall Study||13
6620149|NCT02181803|7546962|FG004|STARTED|Overall Study||6
6620150|NCT02181803|7546963|FG005|STARTED|Overall Study||6
6620151|NCT02181803|7546964|FG006|STARTED|Overall Study||9
6620152|NCT02181803|7546965|FG007|STARTED|Overall Study||1
6620153|NCT02181803|7546966|FG008|STARTED|Overall Study||2
6620154|NCT02181803|7546958|FG000|COMPLETED|Overall Study||1
6620155|NCT02181803|7546959|FG001|COMPLETED|Overall Study||9
6620156|NCT02181803|7546960|FG002|COMPLETED|Overall Study||4
6620157|NCT02181803|7546961|FG003|COMPLETED|Overall Study||11
6620158|NCT02181803|7546962|FG004|COMPLETED|Overall Study||6
6620159|NCT02181803|7546963|FG005|COMPLETED|Overall Study||6
6620160|NCT02181803|7546964|FG006|COMPLETED|Overall Study||8
6620161|NCT02181803|7546965|FG007|COMPLETED|Overall Study||0
6620162|NCT02181803|7546966|FG008|COMPLETED|Overall Study||2
6620163|NCT02181803|7546958|FG000|NOT COMPLETED|Overall Study||0
6620164|NCT02181803|7546959|FG001|NOT COMPLETED|Overall Study||4
6620165|NCT02181803|7546960|FG002|NOT COMPLETED|Overall Study||0
6620166|NCT02181803|7546961|FG003|NOT COMPLETED|Overall Study||2
6620167|NCT02181803|7546962|FG004|NOT COMPLETED|Overall Study||0
6620168|NCT02181803|7546963|FG005|NOT COMPLETED|Overall Study||0
6620169|NCT02181803|7546964|FG006|NOT COMPLETED|Overall Study||1
6620170|NCT02181803|7546965|FG007|NOT COMPLETED|Overall Study||1
6620171|NCT02181803|7546966|FG008|NOT COMPLETED|Overall Study||0
6620172|NCT02181816|7547011|FG000|STARTED|Overall Study||1090
6620173|NCT02181816|7547011|FG000|COMPLETED|Overall Study||1031
6620174|NCT02181816|7547011|FG000|NOT COMPLETED|Overall Study||59
6620175|NCT02181829|7547015|FG000|STARTED|Overall Study||10
6620176|NCT02181829|7547015|FG000|COMPLETED|Overall Study||10
6620177|NCT02181829|7547015|FG000|NOT COMPLETED|Overall Study||0
6620178|NCT02181842|7547019|FG000|STARTED|Overall Study||246
6620179|NCT02181842|7547019|FG000|COMPLETED|Overall Study||244
6620180|NCT02181842|7547019|FG000|NOT COMPLETED|Overall Study||2
6620181|NCT02182115|7547025|FG000|STARTED|Overall Study||53
6620182|NCT02182115|7547026|FG001|STARTED|Overall Study||57
6620183|NCT02182115|7547025|FG000|COMPLETED|Overall Study||53
6620184|NCT02182115|7547026|FG001|COMPLETED|Overall Study||57
6620185|NCT02182115|7547025|FG000|NOT COMPLETED|Overall Study||0
6620186|NCT02182115|7547026|FG001|NOT COMPLETED|Overall Study||0
6620187|NCT02182440|7547036|FG000|STARTED|Overall Study||116
6620188|NCT02182440|7547037|FG001|STARTED|Overall Study||39
6620189|NCT02182440|7547038|FG002|STARTED|Overall Study||35
6620190|NCT02182440|7547039|FG003|STARTED|Overall Study||111
6620191|NCT02182440|7547036|FG000|ITTcombined|Overall Study||116
6620192|NCT02182440|7547037|FG001|ITTcombined|Overall Study||31
6620193|NCT02182440|7547038|FG002|ITTcombined|Overall Study||32
6620194|NCT02182440|7547039|FG003|ITTcombined|Overall Study||111
6620195|NCT02182440|7547036|FG000|ITTinterim|Overall Study||30
6620196|NCT02182440|7547037|FG001|ITTinterim|Overall Study||31
6620197|NCT02182440|7547038|FG002|ITTinterim|Overall Study||32
6620198|NCT02182440|7547039|FG003|ITTinterim|Overall Study||29
6620199|NCT02182440|7547036|FG000|Safety Population|Overall Study||112
6620200|NCT02182440|7547037|FG001|Safety Population|Overall Study||38
6620201|NCT02182440|7547038|FG002|Safety Population|Overall Study||35
6620202|NCT02182440|7547039|FG003|Safety Population|Overall Study||109
6620203|NCT02182440|7547036|FG000|COMPLETED|Overall Study||71
6620204|NCT02182440|7547037|FG001|COMPLETED|Overall Study||25
6620205|NCT02182440|7547038|FG002|COMPLETED|Overall Study||24
6620206|NCT02182440|7547039|FG003|COMPLETED|Overall Study||81
6620207|NCT02182440|7547036|FG000|NOT COMPLETED|Overall Study||45
6620208|NCT02182440|7547037|FG001|NOT COMPLETED|Overall Study||14
6620209|NCT02182440|7547038|FG002|NOT COMPLETED|Overall Study||11
6620210|NCT02182440|7547039|FG003|NOT COMPLETED|Overall Study||30
6620211|NCT02182492|7547053|FG000|STARTED|Overall Study|CRSsNP: 28; Non-Eos CRSwNP: 34; Eos CRSwNP: 31|93
6620212|NCT02182492|7547054|FG001|STARTED|Overall Study|CRSsNP: 30; Non-Eos CRSwNP: 32; Eos CRSwNP: 32|94
6620213|NCT02182492|7547053|FG000|COMPLETED|Overall Study|CRSsNP: 27; Non-Eos CRSwNP: 31; Eos CRSwNP: 28|86
6620214|NCT02182492|7547054|FG001|COMPLETED|Overall Study|CRSsNP: 29; Non-Eos CRSwNP: 28; Eos CRSwNP: 29|86
6620215|NCT02182492|7547053|FG000|NOT COMPLETED|Overall Study||7
6620216|NCT02182492|7547054|FG001|NOT COMPLETED|Overall Study||8
6620217|NCT02182804|7547060|FG000|STARTED|Overall Study||44
6620218|NCT02182804|7547060|FG000|COMPLETED|Overall Study||44
6620219|NCT02182804|7547060|FG000|NOT COMPLETED|Overall Study||0
6620220|NCT02182830|7547066|FG000|STARTED|Overall Study||83
6620221|NCT02182830|7547067|FG001|STARTED|Overall Study||83
6620222|NCT02182830|7547066|FG000|Randomised Set (RS)|Overall Study|From started, 2 duplicate patients and 2 patients from one site were removed|79
6620223|NCT02182830|7547067|FG001|Randomised Set (RS)|Overall Study|From started, 1 patient from one site was removed|82
6620224|NCT02182830|7547066|FG000|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|77
6620225|NCT02182830|7547067|FG001|Treated Set (TS)|Overall Study|From RS, 1 duplicate patient and 1 non treated patient was removed|80
6620226|NCT02182830|7547066|FG000|COMPLETED|Overall Study||68
6620227|NCT02182830|7547067|FG001|COMPLETED|Overall Study||68
6620228|NCT02182830|7547066|FG000|NOT COMPLETED|Overall Study||15
6620229|NCT02182830|7547067|FG001|NOT COMPLETED|Overall Study||15
6620230|NCT02182843|7547073|FG000|STARTED|Overall Study||81
6620231|NCT02182843|7547073|FG000|COMPLETED|Overall Study||71
6620232|NCT02182843|7547073|FG000|NOT COMPLETED|Overall Study||10
6620233|NCT02182895|7547079|FG000|STARTED|Overall Study||35
6620234|NCT02182895|7547080|FG001|STARTED|Overall Study||37
6620235|NCT02182895|7547079|FG000|COMPLETED|Overall Study||33
6620236|NCT02182895|7547080|FG001|COMPLETED|Overall Study||33
6620237|NCT02182895|7547079|FG000|NOT COMPLETED|Overall Study||2
6620238|NCT02182895|7547080|FG001|NOT COMPLETED|Overall Study||4
6620239|NCT02182947|7547086|FG000|STARTED|Overall Study||45
6620240|NCT02182947|7547086|FG000|COMPLETED|Overall Study||27
6620241|NCT02182947|7547086|FG000|NOT COMPLETED|Overall Study||18
6620242|NCT02182973|7547092|FG000|STARTED|Overall Study||12
6620243|NCT02182973|7547093|FG001|STARTED|Overall Study||9
6620244|NCT02182973|7547092|FG000|COMPLETED|Overall Study||9
6620245|NCT02182973|7547093|FG001|COMPLETED|Overall Study||9
6620246|NCT02182973|7547092|FG000|NOT COMPLETED|Overall Study||3
6620247|NCT02182973|7547093|FG001|NOT COMPLETED|Overall Study||0
6620248|NCT02182999|7547102|FG000|STARTED|Overall Study||25
6620249|NCT02182999|7547103|FG001|STARTED|Overall Study||25
6620250|NCT02182999|7547102|FG000|COMPLETED|Overall Study||20
6620251|NCT02182999|7547103|FG001|COMPLETED|Overall Study||22
6620252|NCT02182999|7547102|FG000|NOT COMPLETED|Overall Study||5
6620253|NCT02182999|7547103|FG001|NOT COMPLETED|Overall Study||3
6620254|NCT02183519|7547111|FG000|STARTED|Overall Study||28
6620255|NCT02183519|7547112|FG001|STARTED|Overall Study||16
6620256|NCT02183519|7547111|FG000|COMPLETED|Overall Study||25
6620257|NCT02183519|7547112|FG001|COMPLETED|Overall Study||13
6620258|NCT02183519|7547111|FG000|NOT COMPLETED|Overall Study||3
6620259|NCT02183519|7547112|FG001|NOT COMPLETED|Overall Study||3
6620260|NCT02183675|7547124|FG000|STARTED|Treatment Period 1 (10 Days)||6
6620261|NCT02183675|7547125|FG001|STARTED|Treatment Period 1 (10 Days)||6
6620262|NCT02183675|7547126|FG002|STARTED|Treatment Period 1 (10 Days)||6
6620263|NCT02183675|7547127|FG003|STARTED|Treatment Period 1 (10 Days)||6
6620264|NCT02183675|7547128|FG004|STARTED|Treatment Period 1 (10 Days)||6
6620265|NCT02183675|7547129|FG005|STARTED|Treatment Period 1 (10 Days)||6
6620266|NCT02183675|7547124|FG000|COMPLETED|Treatment Period 1 (10 Days)||6
6620267|NCT02183675|7547125|FG001|COMPLETED|Treatment Period 1 (10 Days)||6
6620268|NCT02183675|7547126|FG002|COMPLETED|Treatment Period 1 (10 Days)||6
6620269|NCT02183675|7547127|FG003|COMPLETED|Treatment Period 1 (10 Days)||6
6620270|NCT02183675|7547128|FG004|COMPLETED|Treatment Period 1 (10 Days)||6
6620271|NCT02183675|7547129|FG005|COMPLETED|Treatment Period 1 (10 Days)||6
6620272|NCT02183675|7547124|FG000|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6620273|NCT02183675|7547125|FG001|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6620274|NCT02183675|7547126|FG002|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6620275|NCT02183675|7547127|FG003|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6620276|NCT02183675|7547128|FG004|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6620277|NCT02183675|7547129|FG005|NOT COMPLETED|Treatment Period 1 (10 Days)||0
6620278|NCT02183675|7547124|FG000|STARTED|Treatment Period 2 (10 Days)||6
6620279|NCT02183675|7547125|FG001|STARTED|Treatment Period 2 (10 Days)||6
6620280|NCT02183675|7547126|FG002|STARTED|Treatment Period 2 (10 Days)||6
6620281|NCT02183675|7547127|FG003|STARTED|Treatment Period 2 (10 Days)||6
6620282|NCT02183675|7547128|FG004|STARTED|Treatment Period 2 (10 Days)||6
6620283|NCT02183675|7547129|FG005|STARTED|Treatment Period 2 (10 Days)||6
6620284|NCT02183675|7547124|FG000|COMPLETED|Treatment Period 2 (10 Days)||6
6620285|NCT02183675|7547125|FG001|COMPLETED|Treatment Period 2 (10 Days)||6
6620286|NCT02183675|7547126|FG002|COMPLETED|Treatment Period 2 (10 Days)||6
6620287|NCT02183675|7547127|FG003|COMPLETED|Treatment Period 2 (10 Days)||6
6620288|NCT02183675|7547128|FG004|COMPLETED|Treatment Period 2 (10 Days)||6
6620289|NCT02183675|7547129|FG005|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
6620290|NCT02183675|7547124|FG000|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6620291|NCT02183675|7547125|FG001|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6620292|NCT02183675|7547126|FG002|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6620293|NCT02183675|7547127|FG003|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6620294|NCT02183675|7547128|FG004|NOT COMPLETED|Treatment Period 2 (10 Days)||0
6620295|NCT02183675|7547129|FG005|NOT COMPLETED|Treatment Period 2 (10 Days)||2
6620296|NCT02183675|7547124|FG000|STARTED|Treatment Period 3 (10 Days)||6
6620297|NCT02183675|7547125|FG001|STARTED|Treatment Period 3 (10 Days)||6
6620298|NCT02183675|7547126|FG002|STARTED|Treatment Period 3 (10 Days)||6
6620299|NCT02183675|7547127|FG003|STARTED|Treatment Period 3 (10 Days)||6
6620300|NCT02183675|7547128|FG004|STARTED|Treatment Period 3 (10 Days)||6
6620301|NCT02183675|7547129|FG005|STARTED|Treatment Period 3 (10 Days)||4
6620302|NCT02183675|7547124|FG000|COMPLETED|Treatment Period 3 (10 Days)||6
6620303|NCT02183675|7547125|FG001|COMPLETED|Treatment Period 3 (10 Days)||6
6620304|NCT02183675|7547126|FG002|COMPLETED|Treatment Period 3 (10 Days)||6
6620305|NCT02183675|7547127|FG003|COMPLETED|Treatment Period 3 (10 Days)||6
6620306|NCT02183675|7547128|FG004|COMPLETED|Treatment Period 3 (10 Days)||6
6620307|NCT02183675|7547129|FG005|COMPLETED|Treatment Period 3 (10 Days)||4
6620308|NCT02183675|7547124|FG000|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6620309|NCT02183675|7547125|FG001|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6620310|NCT02183675|7547126|FG002|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6620311|NCT02183675|7547127|FG003|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6620312|NCT02183675|7547128|FG004|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6620313|NCT02183675|7547129|FG005|NOT COMPLETED|Treatment Period 3 (10 Days)||0
6620314|NCT02183792|7547141|FG000|STARTED|Overall Study||18
6620315|NCT02183792|7547142|FG001|STARTED|Overall Study||15
6620316|NCT02183792|7547141|FG000|COMPLETED|Overall Study||18
6620317|NCT02183792|7547142|FG001|COMPLETED|Overall Study||15
6620318|NCT02183792|7547141|FG000|NOT COMPLETED|Overall Study||0
6620319|NCT02183792|7547142|FG001|NOT COMPLETED|Overall Study||0
6620320|NCT02184143|7547150|FG000|STARTED|Overall Study|124 participants randomized; 118 participant received intervention|124
6620321|NCT02184143|7547151|FG001|STARTED|Overall Study|124 participants randomized; 121 received intervention|124
6620322|NCT02184143|7547150|FG000|COMPLETED|Overall Study|114 patients completed PROs. 98 actigraph valid wear time.|114
6620323|NCT02184143|7547151|FG001|COMPLETED|Overall Study|117 patients completed PROs. 100 actigraph valid wear time.|117
6620324|NCT02184143|7547150|FG000|NOT COMPLETED|Overall Study||10
6620325|NCT02184143|7547151|FG001|NOT COMPLETED|Overall Study||7
6620326|NCT02184169|7547161|FG000|STARTED|Overall Study||21
6620327|NCT02184169|7547162|FG001|STARTED|Overall Study||6
6620328|NCT02184169|7547161|FG000|COMPLETED|Overall Study||21
6620329|NCT02184169|7547162|FG001|COMPLETED|Overall Study||6
6620330|NCT02184169|7547161|FG000|NOT COMPLETED|Overall Study||0
6620331|NCT02184169|7547162|FG001|NOT COMPLETED|Overall Study||0
6620332|NCT02184208|7547170|FG000|STARTED|Overall Study||278
6620333|NCT02184208|7547170|FG000|COMPLETED|Overall Study||222
6620334|NCT02184208|7547170|FG000|NOT COMPLETED|Overall Study||56
6733328|NCT03208933|7662802|FG000|COMPLETED|Overall Study||47
6733329|NCT03208933|7662802|FG000|NOT COMPLETED|Overall Study||13
6733330|NCT03209050|7662806|FG000|STARTED|Overall Study||30
6733331|NCT03209050|7662806|FG000|COMPLETED|Overall Study||27
6733332|NCT03209050|7662806|FG000|NOT COMPLETED|Overall Study||3
6733333|NCT03209362|7662813|FG000|STARTED|Overall Study||39
6733334|NCT03209362|7662814|FG001|STARTED|Overall Study||41
6733335|NCT03209362|7662813|FG000|COMPLETED|Overall Study||37
6733336|NCT03209362|7662814|FG001|COMPLETED|Overall Study||38
6733337|NCT03209362|7662813|FG000|NOT COMPLETED|Overall Study||2
6733338|NCT03209362|7662814|FG001|NOT COMPLETED|Overall Study||3
6733339|NCT03209492|7662820|FG000|STARTED|Overall Study||333
6733340|NCT03209492|7662820|FG000|COMPLETED|Overall Study||328
6733341|NCT03209492|7662820|FG000|NOT COMPLETED|Overall Study||5
6733342|NCT03209505|7662824|FG000|STARTED|Overall Study||10
6733343|NCT03209505|7662825|FG001|STARTED|Overall Study||10
6733344|NCT03209505|7662824|FG000|COMPLETED|Overall Study||10
6733345|NCT03209505|7662825|FG001|COMPLETED|Overall Study||10
6733346|NCT03209505|7662824|FG000|NOT COMPLETED|Overall Study||0
6733347|NCT03209505|7662825|FG001|NOT COMPLETED|Overall Study||0
6733348|NCT03209518|7662831|FG000|STARTED|Overall Study||312
6733349|NCT03209518|7662831|FG000|COMPLETED|Overall Study||310
6733350|NCT03209518|7662831|FG000|NOT COMPLETED|Overall Study||2
6733351|NCT03209570|7662837|FG000|STARTED|Overall Study||24
6733352|NCT03209570|7662838|FG001|STARTED|Overall Study||25
6733353|NCT03209570|7662837|FG000|COMPLETED|Overall Study||14
6733354|NCT03209570|7662838|FG001|COMPLETED|Overall Study||12
6733355|NCT03209570|7662837|FG000|NOT COMPLETED|Overall Study||10
6733356|NCT03209570|7662838|FG001|NOT COMPLETED|Overall Study||13
6733357|NCT03209882|7662846|FG000|STARTED|Overall Study||6
6733358|NCT03209882|7662847|FG001|STARTED|Overall Study||3
6733359|NCT03209882|7662846|FG000|COMPLETED|Overall Study||6
6733360|NCT03209882|7662847|FG001|COMPLETED|Overall Study||3
6733361|NCT03209882|7662846|FG000|NOT COMPLETED|Overall Study||0
6733362|NCT03209882|7662847|FG001|NOT COMPLETED|Overall Study||0
6733363|NCT03209973|7662855|FG000|STARTED|Overall Study||70
6733364|NCT03209973|7662855|FG000|Completed Primary Outcome Period|Overall Study||66
6733365|NCT03209973|7662855|FG000|COMPLETED|Overall Study||0
6733366|NCT03209973|7662855|FG000|NOT COMPLETED|Overall Study||70
6733367|NCT03210155|7662863|FG000|STARTED|Overall Study||0
6733368|NCT03210155|7662864|FG001|STARTED|Overall Study||1
6733369|NCT03210155|7662863|FG000|COMPLETED|Overall Study||0
6733370|NCT03210155|7662864|FG001|COMPLETED|Overall Study||1
6620335|NCT02184442|7547178|FG000|STARTED|Overall Study||284
6620336|NCT02184442|7547179|FG001|STARTED|Overall Study||276
6620337|NCT02184442|7547178|FG000|As-Treated|Overall Study||282
6620338|NCT02184442|7547179|FG001|As-Treated|Overall Study||271
6620339|NCT02184442|7547178|FG000|Valve-Implant|Overall Study||280
6620340|NCT02184442|7547179|FG001|Valve-Implant|Overall Study||263
6620341|NCT02184442|7547178|FG000|COMPLETED|Overall Study||220
6620342|NCT02184442|7547179|FG001|COMPLETED|Overall Study||200
6620343|NCT02184442|7547178|FG000|NOT COMPLETED|Overall Study||64
6620344|NCT02184442|7547179|FG001|NOT COMPLETED|Overall Study||76
6620345|NCT02184455|7547185|FG000|STARTED|Overall Study||11
6620346|NCT02184455|7547185|FG000|COMPLETED|Overall Study||10
6620347|NCT02184455|7547185|FG000|NOT COMPLETED|Overall Study||1
6620348|NCT02184494|7547192|FG000|STARTED|Overall Study||13
6620349|NCT02184494|7547193|FG001|STARTED|Overall Study||13
6620350|NCT02184494|7547194|FG002|STARTED|Overall Study||8
6620351|NCT02184494|7547192|FG000|COMPLETED|Overall Study||12
6620352|NCT02184494|7547193|FG001|COMPLETED|Overall Study||11
6620353|NCT02184494|7547194|FG002|COMPLETED|Overall Study||8
6620354|NCT02184494|7547192|FG000|NOT COMPLETED|Overall Study||1
6620355|NCT02184494|7547193|FG001|NOT COMPLETED|Overall Study||2
6620356|NCT02184494|7547194|FG002|NOT COMPLETED|Overall Study||0
6620357|NCT02184572|7547204|FG000|STARTED|Overall Study||1164
6620358|NCT02184572|7547205|FG001|STARTED|Overall Study||572
6620359|NCT02184572|7547204|FG000|COMPLETED|Overall Study||1117
6620360|NCT02184572|7547205|FG001|COMPLETED|Overall Study||542
6620361|NCT02184572|7547204|FG000|NOT COMPLETED|Overall Study||47
6620362|NCT02184572|7547205|FG001|NOT COMPLETED|Overall Study||30
6620363|NCT02184611|7547215|FG000|STARTED|Overall Study||101
6620364|NCT02184611|7547216|FG001|STARTED|Overall Study||205
6620365|NCT02184611|7547215|FG000|COMPLETED|Overall Study||80
6620366|NCT02184611|7547216|FG001|COMPLETED|Overall Study||177
6620367|NCT02184611|7547215|FG000|NOT COMPLETED|Overall Study||21
6620368|NCT02184611|7547216|FG001|NOT COMPLETED|Overall Study||28
6620369|NCT02184624|7547227|FG000|STARTED|Overall Study||171
6620370|NCT02184624|7547228|FG001|STARTED|Overall Study||80
6620371|NCT02184624|7547229|FG002|STARTED|Overall Study||100
6620372|NCT02184624|7547230|FG003|STARTED|Overall Study||118
6620373|NCT02184624|7547231|FG004|STARTED|Overall Study||98
6620374|NCT02184624|7547227|FG000|COMPLETED|Overall Study||171
6620375|NCT02184624|7547228|FG001|COMPLETED|Overall Study||80
6620376|NCT02184624|7547229|FG002|COMPLETED|Overall Study||100
6620377|NCT02184624|7547230|FG003|COMPLETED|Overall Study||118
6620378|NCT02184624|7547231|FG004|COMPLETED|Overall Study||98
6620379|NCT02184624|7547227|FG000|NOT COMPLETED|Overall Study||0
6620380|NCT02184624|7547228|FG001|NOT COMPLETED|Overall Study||0
6620381|NCT02184624|7547229|FG002|NOT COMPLETED|Overall Study||0
6620382|NCT02184624|7547230|FG003|NOT COMPLETED|Overall Study||0
6620383|NCT02184624|7547231|FG004|NOT COMPLETED|Overall Study||0
6620384|NCT02184988|7547243|FG000|STARTED|Overall Study||352
6620385|NCT02184988|7547243|FG000|COMPLETED|Overall Study||297
6620386|NCT02184988|7547243|FG000|NOT COMPLETED|Overall Study||55
6620387|NCT02185014|7547247|FG000|STARTED|Overall Study||252
6620388|NCT02185014|7547247|FG000|COMPLETED|Overall Study||198
6620389|NCT02185014|7547247|FG000|NOT COMPLETED|Overall Study||54
6620390|NCT02185040|7547256|FG000|STARTED|Part 1 Treatment Phase||8
6620391|NCT02185040|7547257|FG001|STARTED|Part 1 Treatment Phase||8
6620392|NCT02185040|7547258|FG002|STARTED|Part 1 Treatment Phase||8
6620393|NCT02185040|7547259|FG003|STARTED|Part 1 Treatment Phase||9
6620394|NCT02185040|7547260|FG004|STARTED|Part 1 Treatment Phase||9
6620395|NCT02185040|7547261|FG005|STARTED|Part 1 Treatment Phase||0
6620396|NCT02185040|7547262|FG006|STARTED|Part 1 Treatment Phase||0
6620397|NCT02185040|7547256|FG000|COMPLETED|Part 1 Treatment Phase||7
6620398|NCT02185040|7547257|FG001|COMPLETED|Part 1 Treatment Phase||6
6620399|NCT02185040|7547258|FG002|COMPLETED|Part 1 Treatment Phase||7
6620400|NCT02185040|7547259|FG003|COMPLETED|Part 1 Treatment Phase||7
6620401|NCT02185040|7547260|FG004|COMPLETED|Part 1 Treatment Phase||6
6620402|NCT02185040|7547261|FG005|COMPLETED|Part 1 Treatment Phase||0
6620403|NCT02185040|7547262|FG006|COMPLETED|Part 1 Treatment Phase||0
6620404|NCT02185040|7547256|FG000|NOT COMPLETED|Part 1 Treatment Phase||1
6620405|NCT02185040|7547257|FG001|NOT COMPLETED|Part 1 Treatment Phase||2
6620406|NCT02185040|7547258|FG002|NOT COMPLETED|Part 1 Treatment Phase||1
6620407|NCT02185040|7547259|FG003|NOT COMPLETED|Part 1 Treatment Phase||2
6620408|NCT02185040|7547260|FG004|NOT COMPLETED|Part 1 Treatment Phase||3
6620409|NCT02185040|7547261|FG005|NOT COMPLETED|Part 1 Treatment Phase||0
6620410|NCT02185040|7547262|FG006|NOT COMPLETED|Part 1 Treatment Phase||0
6620411|NCT02185040|7547256|FG000|STARTED|Active Treatment Extension Phase||0
6620412|NCT02185040|7547257|FG001|STARTED|Active Treatment Extension Phase||0
6620413|NCT02185040|7547258|FG002|STARTED|Active Treatment Extension Phase||0
6620414|NCT02185040|7547259|FG003|STARTED|Active Treatment Extension Phase||0
6620415|NCT02185040|7547260|FG004|STARTED|Active Treatment Extension Phase||0
6620416|NCT02185040|7547261|FG005|STARTED|Active Treatment Extension Phase||9
6620417|NCT02185040|7547262|FG006|STARTED|Active Treatment Extension Phase||8
6620418|NCT02185040|7547256|FG000|COMPLETED|Active Treatment Extension Phase||0
6620419|NCT02185040|7547257|FG001|COMPLETED|Active Treatment Extension Phase||0
6620420|NCT02185040|7547258|FG002|COMPLETED|Active Treatment Extension Phase||0
6620421|NCT02185040|7547259|FG003|COMPLETED|Active Treatment Extension Phase||0
6620422|NCT02185040|7547260|FG004|COMPLETED|Active Treatment Extension Phase||0
6620423|NCT02185040|7547261|FG005|COMPLETED|Active Treatment Extension Phase||6
6620424|NCT02185040|7547262|FG006|COMPLETED|Active Treatment Extension Phase||1
6620425|NCT02185040|7547256|FG000|NOT COMPLETED|Active Treatment Extension Phase||0
6620426|NCT02185040|7547257|FG001|NOT COMPLETED|Active Treatment Extension Phase||0
6620427|NCT02185040|7547258|FG002|NOT COMPLETED|Active Treatment Extension Phase||0
6620428|NCT02185040|7547259|FG003|NOT COMPLETED|Active Treatment Extension Phase||0
6620429|NCT02185040|7547260|FG004|NOT COMPLETED|Active Treatment Extension Phase||0
6620430|NCT02185040|7547261|FG005|NOT COMPLETED|Active Treatment Extension Phase||3
6620431|NCT02185040|7547262|FG006|NOT COMPLETED|Active Treatment Extension Phase||7
6620432|NCT02185053|7547282|FG000|STARTED|Solifenacin Dose Escalation Phase||41
6620433|NCT02185053|7547283|FG001|STARTED|Solifenacin Dose Escalation Phase||0
6620434|NCT02185053|7547284|FG002|STARTED|Solifenacin Dose Escalation Phase||0
6620435|NCT02185053|7547282|FG000|COMPLETED|Solifenacin Dose Escalation Phase||38
6620436|NCT02185053|7547283|FG001|COMPLETED|Solifenacin Dose Escalation Phase||0
6620437|NCT02185053|7547284|FG002|COMPLETED|Solifenacin Dose Escalation Phase||0
6620438|NCT02185053|7547282|FG000|NOT COMPLETED|Solifenacin Dose Escalation Phase||3
6620439|NCT02185053|7547283|FG001|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
6620440|NCT02185053|7547284|FG002|NOT COMPLETED|Solifenacin Dose Escalation Phase||0
6620441|NCT02185053|7547282|FG000|STARTED|Donepezil Dose Escalation Phase||0
6620442|NCT02185053|7547283|FG001|STARTED|Donepezil Dose Escalation Phase||38
6620443|NCT02185053|7547284|FG002|STARTED|Donepezil Dose Escalation Phase||0
6620444|NCT02185053|7547282|FG000|COMPLETED|Donepezil Dose Escalation Phase||0
6620445|NCT02185053|7547283|FG001|COMPLETED|Donepezil Dose Escalation Phase||33
6620446|NCT02185053|7547284|FG002|COMPLETED|Donepezil Dose Escalation Phase||0
6620447|NCT02185053|7547282|FG000|NOT COMPLETED|Donepezil Dose Escalation Phase||0
6620448|NCT02185053|7547283|FG001|NOT COMPLETED|Donepezil Dose Escalation Phase||5
6620449|NCT02185053|7547284|FG002|NOT COMPLETED|Donepezil Dose Escalation Phase||0
6620450|NCT02185053|7547282|FG000|STARTED|Donepezil Dose Maintenance Phase||0
6620451|NCT02185053|7547283|FG001|STARTED|Donepezil Dose Maintenance Phase||0
6620452|NCT02185053|7547284|FG002|STARTED|Donepezil Dose Maintenance Phase||33
6620453|NCT02185053|7547282|FG000|COMPLETED|Donepezil Dose Maintenance Phase||0
6620454|NCT02185053|7547283|FG001|COMPLETED|Donepezil Dose Maintenance Phase||0
6620455|NCT02185053|7547284|FG002|COMPLETED|Donepezil Dose Maintenance Phase||30
6620456|NCT02185053|7547282|FG000|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
6620457|NCT02185053|7547283|FG001|NOT COMPLETED|Donepezil Dose Maintenance Phase||0
6620458|NCT02185053|7547284|FG002|NOT COMPLETED|Donepezil Dose Maintenance Phase||3
6620459|NCT02185105|7547293|FG000|STARTED|Overall Study||30
6620460|NCT02185105|7547293|FG000|COMPLETED|Overall Study||30
6620461|NCT02185105|7547293|FG000|NOT COMPLETED|Overall Study||0
6620462|NCT02185131|7547306|FG000|STARTED|Overall Study||7
6620463|NCT02185131|7547307|FG001|STARTED|Overall Study||9
6620464|NCT02185131|7547306|FG000|COMPLETED|Overall Study||6
6620465|NCT02185131|7547307|FG001|COMPLETED|Overall Study||8
6620466|NCT02185131|7547306|FG000|NOT COMPLETED|Overall Study||1
6620467|NCT02185131|7547307|FG001|NOT COMPLETED|Overall Study||1
6620468|NCT02185183|7547313|FG000|STARTED|Overall Study||14
6620469|NCT02185183|7547313|FG000|COMPLETED|Overall Study||14
6620470|NCT02185183|7547313|FG000|NOT COMPLETED|Overall Study||0
6620471|NCT02185339|7547319|FG000|STARTED|Overall Study||30
6620472|NCT02185339|7547320|FG001|STARTED|Overall Study||31
6620473|NCT02185339|7547319|FG000|COMPLETED|Overall Study||30
6620474|NCT02185339|7547320|FG001|COMPLETED|Overall Study||30
6620475|NCT02185339|7547319|FG000|NOT COMPLETED|Overall Study||0
6620476|NCT02185339|7547320|FG001|NOT COMPLETED|Overall Study||1
6620477|NCT02185404|7547326|FG000|STARTED|Overall Study||6
6620478|NCT02185404|7547326|FG000|COMPLETED|Overall Study||6
6620479|NCT02185404|7547326|FG000|NOT COMPLETED|Overall Study||0
6620480|NCT02185521|7547330|FG000|STARTED|Overall Study||127
6620481|NCT02185521|7547330|FG000|COMPLETED|Overall Study||125
6620482|NCT02185521|7547330|FG000|NOT COMPLETED|Overall Study||2
6620483|NCT02185534|7547341|FG000|STARTED|First Period||14
6620484|NCT02185534|7547342|FG001|STARTED|First Period||14
6620485|NCT02185534|7547343|FG002|STARTED|First Period||14
6620486|NCT02185534|7547344|FG003|STARTED|First Period||14
6620487|NCT02185534|7547345|FG004|STARTED|First Period||14
6620488|NCT02185534|7547346|FG005|STARTED|First Period||14
6620489|NCT02185534|7547341|FG000|COMPLETED|First Period||14
6620490|NCT02185534|7547342|FG001|COMPLETED|First Period||14
6620491|NCT02185534|7547343|FG002|COMPLETED|First Period||14
6620492|NCT02185534|7547344|FG003|COMPLETED|First Period||13
6620493|NCT02185534|7547345|FG004|COMPLETED|First Period||14
6620494|NCT02185534|7547346|FG005|COMPLETED|First Period||14
6620495|NCT02185534|7547341|FG000|NOT COMPLETED|First Period||0
6620496|NCT02185534|7547342|FG001|NOT COMPLETED|First Period||0
6620497|NCT02185534|7547343|FG002|NOT COMPLETED|First Period||0
6620498|NCT02185534|7547344|FG003|NOT COMPLETED|First Period||1
6620499|NCT02185534|7547345|FG004|NOT COMPLETED|First Period||0
6620500|NCT02185534|7547346|FG005|NOT COMPLETED|First Period||0
6620501|NCT02185534|7547341|FG000|STARTED|First Washout Period||14
6620502|NCT02185534|7547342|FG001|STARTED|First Washout Period||14
6620503|NCT02185534|7547343|FG002|STARTED|First Washout Period||14
6620504|NCT02185534|7547344|FG003|STARTED|First Washout Period||13
6620505|NCT02185534|7547345|FG004|STARTED|First Washout Period||14
6620506|NCT02185534|7547346|FG005|STARTED|First Washout Period||14
6620507|NCT02185534|7547341|FG000|COMPLETED|First Washout Period||13
6620508|NCT02185534|7547342|FG001|COMPLETED|First Washout Period||14
6620509|NCT02185534|7547343|FG002|COMPLETED|First Washout Period||14
6620510|NCT02185534|7547344|FG003|COMPLETED|First Washout Period||13
6620511|NCT02185534|7547345|FG004|COMPLETED|First Washout Period||13
6620512|NCT02185534|7547346|FG005|COMPLETED|First Washout Period||13
6620513|NCT02185534|7547341|FG000|NOT COMPLETED|First Washout Period||1
6620514|NCT02185534|7547342|FG001|NOT COMPLETED|First Washout Period||0
6620515|NCT02185534|7547343|FG002|NOT COMPLETED|First Washout Period||0
6620516|NCT02185534|7547344|FG003|NOT COMPLETED|First Washout Period||0
6620517|NCT02185534|7547345|FG004|NOT COMPLETED|First Washout Period||1
6620518|NCT02185534|7547346|FG005|NOT COMPLETED|First Washout Period||1
6620519|NCT02185534|7547341|FG000|STARTED|Second Period||13
6620520|NCT02185534|7547342|FG001|STARTED|Second Period||14
6620521|NCT02185534|7547343|FG002|STARTED|Second Period||14
6620522|NCT02185534|7547344|FG003|STARTED|Second Period||13
6620523|NCT02185534|7547345|FG004|STARTED|Second Period||13
6620524|NCT02185534|7547346|FG005|STARTED|Second Period||13
6620525|NCT02185534|7547341|FG000|COMPLETED|Second Period||13
6620526|NCT02185534|7547342|FG001|COMPLETED|Second Period||14
6620527|NCT02185534|7547343|FG002|COMPLETED|Second Period||14
6620528|NCT02185534|7547344|FG003|COMPLETED|Second Period||13
6620529|NCT02185534|7547345|FG004|COMPLETED|Second Period||13
6620530|NCT02185534|7547346|FG005|COMPLETED|Second Period||13
6620531|NCT02185534|7547341|FG000|NOT COMPLETED|Second Period||0
6620532|NCT02185534|7547342|FG001|NOT COMPLETED|Second Period||0
6620533|NCT02185534|7547343|FG002|NOT COMPLETED|Second Period||0
6620534|NCT02185534|7547344|FG003|NOT COMPLETED|Second Period||0
6620535|NCT02185534|7547345|FG004|NOT COMPLETED|Second Period||0
6620536|NCT02185534|7547346|FG005|NOT COMPLETED|Second Period||0
6620537|NCT02185534|7547341|FG000|STARTED|Second Washout Period||13
6620538|NCT02185534|7547342|FG001|STARTED|Second Washout Period||14
6620539|NCT02185534|7547343|FG002|STARTED|Second Washout Period||14
6620540|NCT02185534|7547344|FG003|STARTED|Second Washout Period||13
6620541|NCT02185534|7547345|FG004|STARTED|Second Washout Period||13
6620542|NCT02185534|7547346|FG005|STARTED|Second Washout Period||13
6620543|NCT02185534|7547341|FG000|COMPLETED|Second Washout Period||13
6620544|NCT02185534|7547342|FG001|COMPLETED|Second Washout Period||14
6620545|NCT02185534|7547343|FG002|COMPLETED|Second Washout Period||14
6620546|NCT02185534|7547344|FG003|COMPLETED|Second Washout Period||13
6620547|NCT02185534|7547345|FG004|COMPLETED|Second Washout Period||13
6620548|NCT02185534|7547346|FG005|COMPLETED|Second Washout Period||13
6620549|NCT02185534|7547341|FG000|NOT COMPLETED|Second Washout Period||0
6620550|NCT02185534|7547342|FG001|NOT COMPLETED|Second Washout Period||0
6620551|NCT02185534|7547343|FG002|NOT COMPLETED|Second Washout Period||0
6620552|NCT02185534|7547344|FG003|NOT COMPLETED|Second Washout Period||0
6620553|NCT02185534|7547345|FG004|NOT COMPLETED|Second Washout Period||0
6620554|NCT02185534|7547346|FG005|NOT COMPLETED|Second Washout Period||0
6620555|NCT02185534|7547341|FG000|STARTED|Third Period||13
6620556|NCT02185534|7547342|FG001|STARTED|Third Period||14
6620557|NCT02185534|7547343|FG002|STARTED|Third Period||14
6620558|NCT02185534|7547344|FG003|STARTED|Third Period||13
6620559|NCT02185534|7547345|FG004|STARTED|Third Period||13
6620560|NCT02185534|7547346|FG005|STARTED|Third Period||13
6620561|NCT02185534|7547341|FG000|COMPLETED|Third Period||13
6620562|NCT02185534|7547342|FG001|COMPLETED|Third Period||14
6620563|NCT02185534|7547343|FG002|COMPLETED|Third Period||14
6620564|NCT02185534|7547344|FG003|COMPLETED|Third Period||13
6620565|NCT02185534|7547345|FG004|COMPLETED|Third Period||13
6620566|NCT02185534|7547346|FG005|COMPLETED|Third Period||13
6620567|NCT02185534|7547341|FG000|NOT COMPLETED|Third Period||0
6620568|NCT02185534|7547342|FG001|NOT COMPLETED|Third Period||0
6620569|NCT02185534|7547343|FG002|NOT COMPLETED|Third Period||0
6620570|NCT02185534|7547344|FG003|NOT COMPLETED|Third Period||0
6620571|NCT02185534|7547345|FG004|NOT COMPLETED|Third Period||0
6620572|NCT02185534|7547346|FG005|NOT COMPLETED|Third Period||0
6620573|NCT02185729|7547355|FG000|STARTED|0 Hour (Baseline) of Saline Infusion||12
6620574|NCT02185729|7547355|FG000|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
6620575|NCT02185729|7547355|FG000|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
6620576|NCT02185729|7547355|FG000|STARTED|4 Hours Into Saline Infusion||12
6620577|NCT02185729|7547355|FG000|COMPLETED|4 Hours Into Saline Infusion||12
6620578|NCT02185729|7547355|FG000|NOT COMPLETED|4 Hours Into Saline Infusion||0
6620579|NCT02185729|7547355|FG000|STARTED|24 Hours Into Saline Infusion||12
6620580|NCT02185729|7547355|FG000|COMPLETED|24 Hours Into Saline Infusion||12
6620581|NCT02185729|7547355|FG000|NOT COMPLETED|24 Hours Into Saline Infusion||0
6620582|NCT02185729|7547355|FG000|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
6620583|NCT02185729|7547355|FG000|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
6620584|NCT02185729|7547355|FG000|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
6620585|NCT02185729|7547355|FG000|STARTED|4 Hours Into Intralipid Infusion||12
6620586|NCT02185729|7547355|FG000|COMPLETED|4 Hours Into Intralipid Infusion||12
6620587|NCT02185729|7547355|FG000|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
6620588|NCT02185729|7547355|FG000|STARTED|24 Hours Into Intralipid Infusion||12
6620589|NCT02185729|7547355|FG000|COMPLETED|24 Hours Into Intralipid Infusion||12
6620590|NCT02185729|7547355|FG000|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
6620591|NCT02185729|7547355|FG000|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
6620592|NCT02185729|7547355|FG000|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
6620593|NCT02185729|7547355|FG000|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
6620594|NCT02185729|7547355|FG000|STARTED|4 Hours Into ClinOleic Infusion||12
6620595|NCT02185729|7547355|FG000|COMPLETED|4 Hours Into ClinOleic Infusion||12
6620596|NCT02185729|7547355|FG000|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
6620597|NCT02185729|7547355|FG000|STARTED|24 Hours Into ClinOleic Infusion||12
6620598|NCT02185729|7547355|FG000|COMPLETED|24 Hours Into ClinOleic Infusion||12
6620599|NCT02185729|7547355|FG000|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
6620600|NCT02185729|7547355|FG000|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
6620601|NCT02185729|7547355|FG000|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
6620602|NCT02185729|7547355|FG000|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
6620603|NCT02185729|7547355|FG000|STARTED|4 Hours Into Dextrose Infusion||12
6620604|NCT02185729|7547355|FG000|COMPLETED|4 Hours Into Dextrose Infusion||12
6620605|NCT02185729|7547355|FG000|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
6620606|NCT02185729|7547355|FG000|STARTED|24 Hours Into Dextrose Infusion||12
6620607|NCT02185729|7547355|FG000|COMPLETED|24 Hours Into Dextrose Infusion||12
6620608|NCT02185729|7547355|FG000|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
6620609|NCT02185794|7547368|FG000|STARTED|Overall Study||9
6620610|NCT02185794|7547369|FG001|STARTED|Overall Study||20
6620611|NCT02185794|7547370|FG002|STARTED|Overall Study||33
6620612|NCT02185794|7547371|FG003|STARTED|Overall Study||16
6620613|NCT02185794|7547372|FG004|STARTED|Overall Study||7
6620614|NCT02185794|7547373|FG005|STARTED|Overall Study||16
6620615|NCT02185794|7547368|FG000|COMPLETED|Overall Study||4
6620616|NCT02185794|7547369|FG001|COMPLETED|Overall Study||7
6620617|NCT02185794|7547370|FG002|COMPLETED|Overall Study||17
6620618|NCT02185794|7547371|FG003|COMPLETED|Overall Study||8
6620619|NCT02185794|7547372|FG004|COMPLETED|Overall Study||4
6620620|NCT02185794|7547373|FG005|COMPLETED|Overall Study||0
6620621|NCT02185794|7547368|FG000|NOT COMPLETED|Overall Study||5
6620622|NCT02185794|7547369|FG001|NOT COMPLETED|Overall Study||13
6620623|NCT02185794|7547370|FG002|NOT COMPLETED|Overall Study||16
6620624|NCT02185794|7547371|FG003|NOT COMPLETED|Overall Study||8
6620625|NCT02185794|7547372|FG004|NOT COMPLETED|Overall Study||3
6620626|NCT02185794|7547373|FG005|NOT COMPLETED|Overall Study||16
6620627|NCT02186015|7547403|FG000|STARTED|Overall Study||11
6620628|NCT02186015|7547404|FG001|STARTED|Overall Study||31
6620629|NCT02186015|7547403|FG000|COMPLETED|Overall Study||10
6620630|NCT02186015|7547404|FG001|COMPLETED|Overall Study||31
6620631|NCT02186015|7547403|FG000|NOT COMPLETED|Overall Study||1
6620632|NCT02186015|7547404|FG001|NOT COMPLETED|Overall Study||0
6620633|NCT02186171|7547413|FG000|STARTED|Overall Study||82
6620634|NCT02186171|7547414|FG001|STARTED|Overall Study||163
6620635|NCT02186171|7547413|FG000|Received Treatment|Overall Study||81
6620636|NCT02186171|7547414|FG001|Received Treatment|Overall Study||163
6620637|NCT02186171|7547413|FG000|COMPLETED|Overall Study||78
6620638|NCT02186171|7547414|FG001|COMPLETED|Overall Study||148
6620639|NCT02186171|7547413|FG000|NOT COMPLETED|Overall Study||4
6620640|NCT02186171|7547414|FG001|NOT COMPLETED|Overall Study||15
6620641|NCT02186210|7547422|FG000|STARTED|Overall Study||20
6620642|NCT02186210|7547423|FG001|STARTED|Overall Study||20
6620643|NCT02186210|7547422|FG000|COMPLETED|Overall Study||20
6620644|NCT02186210|7547423|FG001|COMPLETED|Overall Study||20
6620645|NCT02186210|7547422|FG000|NOT COMPLETED|Overall Study||0
6620646|NCT02186210|7547423|FG001|NOT COMPLETED|Overall Study||0
6620647|NCT02186223|7547431|FG000|STARTED|Overall Study||172
6620648|NCT02186223|7547431|FG000|Device Placed|Overall Study||163
6620649|NCT02186223|7547431|FG000|COMPLETED|Overall Study||151
6620650|NCT02186223|7547431|FG000|NOT COMPLETED|Overall Study||21
6620651|NCT02186301|7547439|FG000|STARTED|Overall Study||20
6620652|NCT02186301|7547440|FG001|STARTED|Overall Study||30
6620653|NCT02186301|7547441|FG002|STARTED|Overall Study||50
6620654|NCT02186301|7547439|FG000|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6620655|NCT02186301|7547440|FG001|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6620656|NCT02186301|7547441|FG002|COMPLETED|Overall Study|Patients who are off study for any reason.|0
6620657|NCT02186301|7547439|FG000|NOT COMPLETED|Overall Study||20
6620658|NCT02186301|7547440|FG001|NOT COMPLETED|Overall Study||30
6620659|NCT02186301|7547441|FG002|NOT COMPLETED|Overall Study||50
6620660|NCT02186509|7547451|FG000|STARTED|Overall Study||17
6620661|NCT02186509|7547451|FG000|COMPLETED|Overall Study||17
6620662|NCT02186509|7547451|FG000|NOT COMPLETED|Overall Study||0
6620663|NCT02186561|7547455|FG000|STARTED|Enrollment||197
6620664|NCT02186561|7547455|FG000|COMPLETED|Enrollment||141
6620665|NCT02186561|7547455|FG000|NOT COMPLETED|Enrollment||56
6620666|NCT02186561|7547455|FG000|STARTED|Subjects Implanted With Device||141
6620667|NCT02186561|7547455|FG000|COMPLETED|Subjects Implanted With Device||141
6620668|NCT02186561|7547455|FG000|NOT COMPLETED|Subjects Implanted With Device||0
6620669|NCT02186561|7547455|FG000|STARTED|30-Day Post Index Procedure Visit||141
6620670|NCT02186561|7547455|FG000|COMPLETED|30-Day Post Index Procedure Visit||140
6620671|NCT02186561|7547455|FG000|NOT COMPLETED|30-Day Post Index Procedure Visit||1
6620672|NCT02186561|7547455|FG000|STARTED|180- Day Post Index Procedure Visit||141
6620673|NCT02186561|7547455|FG000|COMPLETED|180- Day Post Index Procedure Visit||134
6620674|NCT02186561|7547455|FG000|NOT COMPLETED|180- Day Post Index Procedure Visit||7
6620675|NCT02186561|7547455|FG000|STARTED|1- Year Post Index Procedure Visit||141
6620676|NCT02186561|7547455|FG000|COMPLETED|1- Year Post Index Procedure Visit||139
6620677|NCT02186561|7547455|FG000|NOT COMPLETED|1- Year Post Index Procedure Visit||2
6620678|NCT02186561|7547455|FG000|STARTED|2 - Year Post Index Procedure Visit||141
6620679|NCT02186561|7547455|FG000|COMPLETED|2 - Year Post Index Procedure Visit||134
6620680|NCT02186561|7547455|FG000|NOT COMPLETED|2 - Year Post Index Procedure Visit||7
6620681|NCT02186561|7547455|FG000|STARTED|3 - Year Post Index Procedure Visit||141
6620682|NCT02186561|7547455|FG000|COMPLETED|3 - Year Post Index Procedure Visit||128
6620683|NCT02186561|7547455|FG000|NOT COMPLETED|3 - Year Post Index Procedure Visit||13
6620684|NCT02186587|7547463|FG000|STARTED|Overall Study||28
6620685|NCT02186587|7547464|FG001|STARTED|Overall Study||0
6620686|NCT02186587|7547463|FG000|COMPLETED|Overall Study||23
6620687|NCT02186587|7547464|FG001|COMPLETED|Overall Study||0
6620688|NCT02186587|7547463|FG000|NOT COMPLETED|Overall Study||5
6620689|NCT02186587|7547464|FG001|NOT COMPLETED|Overall Study||0
6620690|NCT02186652|7547471|FG000|STARTED|Overall Study||19
6620691|NCT02186652|7547472|FG001|STARTED|Overall Study||22
6620692|NCT02186652|7547471|FG000|COMPLETED|Overall Study||17
6620693|NCT02186652|7547472|FG001|COMPLETED|Overall Study||22
6620694|NCT02186652|7547471|FG000|NOT COMPLETED|Overall Study||2
6620695|NCT02186652|7547472|FG001|NOT COMPLETED|Overall Study||0
6620696|NCT02186665|7547487|FG000|STARTED|Overall Study||8
6620697|NCT02186665|7547488|FG001|STARTED|Overall Study||11
6620698|NCT02186665|7547487|FG000|COMPLETED|Overall Study||8
6620699|NCT02186665|7547488|FG001|COMPLETED|Overall Study||10
6620700|NCT02186665|7547487|FG000|NOT COMPLETED|Overall Study||0
6620701|NCT02186665|7547488|FG001|NOT COMPLETED|Overall Study||1
6620702|NCT02186795|7547496|FG000|STARTED|Overall Study||24
6620703|NCT02186795|7547497|FG001|STARTED|Overall Study||24
6620704|NCT02186795|7547496|FG000|COMPLETED|Overall Study||24
6620705|NCT02186795|7547497|FG001|COMPLETED|Overall Study||24
6620706|NCT02186795|7547496|FG000|NOT COMPLETED|Overall Study||0
6620707|NCT02186795|7547497|FG001|NOT COMPLETED|Overall Study||0
6620708|NCT02186808|7547503|FG000|STARTED|Overall Study||80
6620709|NCT02186808|7547503|FG000|COMPLETED|Overall Study||67
6620710|NCT02186808|7547503|FG000|NOT COMPLETED|Overall Study||13
6620711|NCT02186821|7547507|FG000|STARTED|Overall Study||47
6620712|NCT02186821|7547507|FG000|COMPLETED|Overall Study||0
6620713|NCT02186821|7547507|FG000|NOT COMPLETED|Overall Study||47
6620714|NCT02186847|7547513|FG000|STARTED|Overall Study||84
6620715|NCT02186847|7547514|FG001|STARTED|Overall Study||86
6620716|NCT02186847|7547513|FG000|Eligible Population|Overall Study||81
6620717|NCT02186847|7547514|FG001|Eligible Population|Overall Study||86
6620718|NCT02186847|7547513|FG000|Eligible and Started Protocol Treatment|Overall Study||76
6620719|NCT02186847|7547514|FG001|Eligible and Started Protocol Treatment|Overall Study||82
6620720|NCT02186847|7547513|FG000|COMPLETED|Overall Study||81
6620721|NCT02186847|7547514|FG001|COMPLETED|Overall Study||86
6620722|NCT02186847|7547513|FG000|NOT COMPLETED|Overall Study||3
6620723|NCT02186847|7547514|FG001|NOT COMPLETED|Overall Study||0
6620724|NCT02186873|7547522|FG000|STARTED|Overall Study||103
6620725|NCT02186873|7547523|FG001|STARTED|Overall Study||105
6620726|NCT02186873|7547522|FG000|End of Control Period|Overall Study|Participants taking placebo crossed over to golimumab|99
6620727|NCT02186873|7547523|FG001|End of Control Period|Overall Study|Participants continued to receive golimumab|105
6620728|NCT02186873|7547522|FG000|COMPLETED|Overall Study||94
6620729|NCT02186873|7547523|FG001|COMPLETED|Overall Study||97
6620730|NCT02186873|7547522|FG000|NOT COMPLETED|Overall Study||9
6620731|NCT02186873|7547523|FG001|NOT COMPLETED|Overall Study||8
6620732|NCT02186938|7547532|FG000|STARTED|Overall Study|2012|47
6620733|NCT02186938|7547533|FG001|STARTED|Overall Study||47
6620734|NCT02186938|7547532|FG000|COMPLETED|Overall Study||38
6620735|NCT02186938|7547533|FG001|COMPLETED|Overall Study||44
6620736|NCT02186938|7547532|FG000|NOT COMPLETED|Overall Study||9
6620737|NCT02186938|7547533|FG001|NOT COMPLETED|Overall Study||3
6620738|NCT02187016|7547543|FG000|STARTED|Overall Study||80
6620739|NCT02187016|7547544|FG001|STARTED|Overall Study||80
6620740|NCT02187016|7547545|FG002|STARTED|Overall Study||79
6620741|NCT02187016|7547546|FG003|STARTED|Overall Study||51
6620742|NCT02187016|7547543|FG000|COMPLETED|Overall Study||79
6620743|NCT02187016|7547544|FG001|COMPLETED|Overall Study||78
6620744|NCT02187016|7547545|FG002|COMPLETED|Overall Study||78
6620745|NCT02187016|7547546|FG003|COMPLETED|Overall Study||51
6620746|NCT02187016|7547543|FG000|NOT COMPLETED|Overall Study||1
6620747|NCT02187016|7547544|FG001|NOT COMPLETED|Overall Study||2
6620748|NCT02187016|7547545|FG002|NOT COMPLETED|Overall Study||1
6620749|NCT02187016|7547546|FG003|NOT COMPLETED|Overall Study||0
6620750|NCT02187029|7547560|FG000|STARTED|Overall Study||7
6620751|NCT02187029|7547561|FG001|STARTED|Overall Study||3
6620752|NCT02187029|7547562|FG002|STARTED|Overall Study||11
6620753|NCT02187029|7547563|FG003|STARTED|Overall Study||9
6620754|NCT02187029|7547560|FG000|COMPLETED|Overall Study||6
6620755|NCT02187029|7547561|FG001|COMPLETED|Overall Study||2
6620756|NCT02187029|7547562|FG002|COMPLETED|Overall Study||0
6620757|NCT02187029|7547563|FG003|COMPLETED|Overall Study||6
6620758|NCT02187029|7547560|FG000|NOT COMPLETED|Overall Study||1
6620759|NCT02187029|7547561|FG001|NOT COMPLETED|Overall Study||1
6620760|NCT02187029|7547562|FG002|NOT COMPLETED|Overall Study||11
6620761|NCT02187029|7547563|FG003|NOT COMPLETED|Overall Study||3
6620762|NCT02187042|7547575|FG000|STARTED|Overall Study||42
6620763|NCT02187042|7547576|FG001|STARTED|Overall Study||27
6620764|NCT02187042|7547575|FG000|COMPLETED|Overall Study||29
6620765|NCT02187042|7547576|FG001|COMPLETED|Overall Study||13
6620766|NCT02187042|7547575|FG000|NOT COMPLETED|Overall Study||13
6620767|NCT02187042|7547576|FG001|NOT COMPLETED|Overall Study||14
6620768|NCT02187055|7547586|FG000|STARTED|Overall Study|Treated|384
6620769|NCT02187055|7547587|FG001|STARTED|Overall Study|Treated|376
6620770|NCT02187055|7547588|FG002|STARTED|Overall Study|Treated|386
6620771|NCT02187055|7547586|FG000|COMPLETED|Overall Study||315
6620772|NCT02187055|7547587|FG001|COMPLETED|Overall Study||303
6620773|NCT02187055|7547588|FG002|COMPLETED|Overall Study||312
6620774|NCT02187055|7547586|FG000|NOT COMPLETED|Overall Study||69
6620775|NCT02187055|7547587|FG001|NOT COMPLETED|Overall Study||73
6620776|NCT02187055|7547588|FG002|NOT COMPLETED|Overall Study||74
6620777|NCT02187159|7547600|FG000|STARTED|Overall Study||318
6620778|NCT02187159|7547601|FG001|STARTED|Overall Study||317
6620779|NCT02187159|7547602|FG002|STARTED|Overall Study||318
6620780|NCT02187159|7547603|FG003|STARTED|Overall Study||317
6620781|NCT02187159|7547600|FG000|COMPLETED|Overall Study||249
6620782|NCT02187159|7547601|FG001|COMPLETED|Overall Study||238
6620783|NCT02187159|7547602|FG002|COMPLETED|Overall Study||241
6620784|NCT02187159|7547603|FG003|COMPLETED|Overall Study||221
6620785|NCT02187159|7547600|FG000|NOT COMPLETED|Overall Study||69
6620786|NCT02187159|7547601|FG001|NOT COMPLETED|Overall Study||79
6620787|NCT02187159|7547602|FG002|NOT COMPLETED|Overall Study||77
6620788|NCT02187159|7547603|FG003|NOT COMPLETED|Overall Study||96
6620789|NCT02187172|7547615|FG000|STARTED|Overall Study||22
6620790|NCT02187172|7547616|FG001|STARTED|Overall Study||21
6620791|NCT02187172|7547615|FG000|RCT Phase Completed|Overall Study||22
6620792|NCT02187172|7547616|FG001|RCT Phase Completed|Overall Study||19
6620793|NCT02187172|7547615|FG000|COMPLETED|Overall Study||19
6620794|NCT02187172|7547616|FG001|COMPLETED|Overall Study||15
6620795|NCT02187172|7547615|FG000|NOT COMPLETED|Overall Study||3
6620796|NCT02187172|7547616|FG001|NOT COMPLETED|Overall Study||6
6620797|NCT02187471|7547628|FG000|STARTED|Overall Study||325
6620798|NCT02187471|7547629|FG001|STARTED|Overall Study||324
6620799|NCT02187471|7547630|FG002|STARTED|Overall Study||326
6620800|NCT02187471|7547631|FG003|STARTED|Overall Study||326
6620801|NCT02187471|7547628|FG000|COMPLETED|Overall Study||249
6620802|NCT02187471|7547629|FG001|COMPLETED|Overall Study||242
6620803|NCT02187471|7547630|FG002|COMPLETED|Overall Study||240
6620804|NCT02187471|7547631|FG003|COMPLETED|Overall Study||246
6620805|NCT02187471|7547628|FG000|NOT COMPLETED|Overall Study||76
6620806|NCT02187471|7547629|FG001|NOT COMPLETED|Overall Study||82
6620807|NCT02187471|7547630|FG002|NOT COMPLETED|Overall Study||86
6620808|NCT02187471|7547631|FG003|NOT COMPLETED|Overall Study||80
6620809|NCT02187744|7547644|FG000|STARTED|Study|Received treatment|113
6620810|NCT02187744|7547645|FG001|STARTED|Study|Received treatment|112
6620811|NCT02187744|7547644|FG000|COMPLETED|Study||109
6620812|NCT02187744|7547645|FG001|COMPLETED|Study||106
6620813|NCT02187744|7547644|FG000|NOT COMPLETED|Study||4
6620814|NCT02187744|7547645|FG001|NOT COMPLETED|Study||6
6620815|NCT02187744|7547644|FG000|STARTED|Treatment||113
6620816|NCT02187744|7547645|FG001|STARTED|Treatment||112
6620817|NCT02187744|7547644|FG000|COMPLETED|Treatment||109
6620818|NCT02187744|7547645|FG001|COMPLETED|Treatment||107
6620819|NCT02187744|7547644|FG000|NOT COMPLETED|Treatment||4
6620820|NCT02187744|7547645|FG001|NOT COMPLETED|Treatment||5
6620821|NCT02187783|7547651|FG000|STARTED|Overall Study||106
6620822|NCT02187783|7547651|FG000|Patients With Solid Tumors|Overall Study||105
6620823|NCT02187783|7547651|FG000|COMPLETED|Overall Study||0
6620824|NCT02187783|7547651|FG000|NOT COMPLETED|Overall Study||106
6620825|NCT02187809|7547655|FG000|STARTED|Overall Study||3
6620826|NCT02187809|7547655|FG000|Treated|Overall Study||1
6620827|NCT02187809|7547655|FG000|COMPLETED|Overall Study||0
6620828|NCT02187809|7547655|FG000|NOT COMPLETED|Overall Study||3
6620829|NCT02187861|7547663|FG000|STARTED|Overall Study||9
6620830|NCT02187861|7547664|FG001|STARTED|Overall Study||52
6620831|NCT02187861|7547665|FG002|STARTED|Overall Study||51
6620832|NCT02187861|7547666|FG003|STARTED|Overall Study||51
6620833|NCT02187861|7547663|FG000|Treated|Overall Study||9
6620834|NCT02187861|7547664|FG001|Treated|Overall Study||52
6620835|NCT02187861|7547665|FG002|Treated|Overall Study||49
6620836|NCT02187861|7547666|FG003|Treated|Overall Study||50
6620837|NCT02187861|7547663|FG000|COMPLETED|Overall Study||3
6620838|NCT02187861|7547664|FG001|COMPLETED|Overall Study||4
6620839|NCT02187861|7547665|FG002|COMPLETED|Overall Study||19
6620840|NCT02187861|7547666|FG003|COMPLETED|Overall Study||19
6620841|NCT02187861|7547663|FG000|NOT COMPLETED|Overall Study||6
6620842|NCT02187861|7547664|FG001|NOT COMPLETED|Overall Study||48
6620843|NCT02187861|7547665|FG002|NOT COMPLETED|Overall Study||32
6620844|NCT02187861|7547666|FG003|NOT COMPLETED|Overall Study||32
6620845|NCT02187887|7547678|FG000|STARTED|Overall Study||393
6620846|NCT02187887|7547679|FG001|STARTED|Overall Study||400
6620847|NCT02187887|7547678|FG000|COMPLETED|Overall Study||388
6620848|NCT02187887|7547679|FG001|COMPLETED|Overall Study||396
6620849|NCT02187887|7547678|FG000|NOT COMPLETED|Overall Study||5
6620850|NCT02187887|7547679|FG001|NOT COMPLETED|Overall Study||4
6620851|NCT02188160|7547687|FG000|STARTED|Overall Study||73
6620852|NCT02188160|7547688|FG001|STARTED|Overall Study||77
6620853|NCT02188160|7547687|FG000|COMPLETED|Overall Study||72
6620854|NCT02188160|7547688|FG001|COMPLETED|Overall Study||76
6620855|NCT02188160|7547687|FG000|NOT COMPLETED|Overall Study||1
6620856|NCT02188160|7547688|FG001|NOT COMPLETED|Overall Study||1
6620857|NCT02188303|7547702|FG000|STARTED|Overall Study||6
6620858|NCT02188303|7547703|FG001|STARTED|Overall Study||6
6620859|NCT02188303|7547704|FG002|STARTED|Overall Study||6
6620860|NCT02188303|7547705|FG003|STARTED|Overall Study||6
6620861|NCT02188303|7547706|FG004|STARTED|Overall Study||4
6620862|NCT02188303|7547707|FG005|STARTED|Overall Study||12
6620863|NCT02188303|7547708|FG006|STARTED|Overall Study||2
6620864|NCT02188303|7547709|FG007|STARTED|Overall Study||6
6620865|NCT02188303|7547702|FG000|COMPLETED|Overall Study||6
6620866|NCT02188303|7547703|FG001|COMPLETED|Overall Study||6
6620867|NCT02188303|7547704|FG002|COMPLETED|Overall Study||6
6620868|NCT02188303|7547705|FG003|COMPLETED|Overall Study||6
6620869|NCT02188303|7547706|FG004|COMPLETED|Overall Study||4
6620870|NCT02188303|7547707|FG005|COMPLETED|Overall Study||10
6620871|NCT02188303|7547708|FG006|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
6620872|NCT02188303|7547709|FG007|COMPLETED|Overall Study|Protocol-defined dose termination criteria met, dosing stopped on Day 5 and study was terminated.|0
6620873|NCT02188303|7547702|FG000|NOT COMPLETED|Overall Study||0
6620874|NCT02188303|7547703|FG001|NOT COMPLETED|Overall Study||0
6620875|NCT02188303|7547704|FG002|NOT COMPLETED|Overall Study||0
6620876|NCT02188303|7547705|FG003|NOT COMPLETED|Overall Study||0
6620877|NCT02188303|7547706|FG004|NOT COMPLETED|Overall Study||0
6620878|NCT02188303|7547707|FG005|NOT COMPLETED|Overall Study||2
6620879|NCT02188303|7547708|FG006|NOT COMPLETED|Overall Study||2
6620880|NCT02188303|7547709|FG007|NOT COMPLETED|Overall Study||6
6620881|NCT02188459|7547735|FG000|STARTED|Overall Study||64
6620882|NCT02188459|7547736|FG001|STARTED|Overall Study||65
6620883|NCT02188459|7547735|FG000|COMPLETED|Overall Study||61
6620884|NCT02188459|7547736|FG001|COMPLETED|Overall Study||58
6620885|NCT02188459|7547735|FG000|NOT COMPLETED|Overall Study||3
6620886|NCT02188459|7547736|FG001|NOT COMPLETED|Overall Study||7
6620887|NCT02188485|7547748|FG000|STARTED|Overall Study||32
6620888|NCT02188485|7547749|FG001|STARTED|Overall Study||30
6620889|NCT02188485|7547748|FG000|COMPLETED|Overall Study||30
6620890|NCT02188485|7547749|FG001|COMPLETED|Overall Study||27
6620891|NCT02188485|7547748|FG000|NOT COMPLETED|Overall Study||2
6620892|NCT02188485|7547749|FG001|NOT COMPLETED|Overall Study||3
6620893|NCT02188576|7547757|FG000|STARTED|Overall Study||32
6620894|NCT02188576|7547758|FG001|STARTED|Overall Study||34
6620895|NCT02188576|7547757|FG000|COMPLETED|Overall Study||32
6620896|NCT02188576|7547758|FG001|COMPLETED|Overall Study||34
6620897|NCT02188576|7547757|FG000|NOT COMPLETED|Overall Study||0
6620898|NCT02188576|7547758|FG001|NOT COMPLETED|Overall Study||0
6620899|NCT02188589|7547764|FG000|STARTED|Overall Study||30
6620900|NCT02188589|7547764|FG000|6 Months|Overall Study||30
6620901|NCT02188589|7547764|FG000|12 Months|Overall Study||30
6620902|NCT02188589|7547764|FG000|24 Months|Overall Study||25
6620903|NCT02188589|7547764|FG000|COMPLETED|Overall Study||25
6620904|NCT02188589|7547764|FG000|NOT COMPLETED|Overall Study||5
6620905|NCT02188719|7547773|FG000|STARTED|Overall Study||6
6620906|NCT02188719|7547774|FG001|STARTED|Overall Study||9
6620907|NCT02188719|7547775|FG002|STARTED|Overall Study||0
6620908|NCT02188719|7547776|FG003|STARTED|Overall Study||0
6620909|NCT02188719|7547773|FG000|COMPLETED|Overall Study||6
6620910|NCT02188719|7547774|FG001|COMPLETED|Overall Study||8
6620911|NCT02188719|7547775|FG002|COMPLETED|Overall Study||0
6620912|NCT02188719|7547776|FG003|COMPLETED|Overall Study||0
6620913|NCT02188719|7547773|FG000|NOT COMPLETED|Overall Study||0
6620914|NCT02188719|7547774|FG001|NOT COMPLETED|Overall Study||1
6620915|NCT02188719|7547775|FG002|NOT COMPLETED|Overall Study||0
6620916|NCT02188719|7547776|FG003|NOT COMPLETED|Overall Study||0
6620917|NCT02188784|7547786|FG000|STARTED|Overall Study||111
6620918|NCT02188784|7547787|FG001|STARTED|Overall Study||114
6620919|NCT02188784|7547786|FG000|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
6620920|NCT02188784|7547787|FG001|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
6620921|NCT02188784|7547786|FG000|NOT COMPLETED|Overall Study||9
6620922|NCT02188784|7547787|FG001|NOT COMPLETED|Overall Study||13
6620923|NCT02188849|7547795|FG000|STARTED|Overall Study||25
6620924|NCT02188849|7547796|FG001|STARTED|Overall Study||25
6620925|NCT02188849|7547795|FG000|COMPLETED|Overall Study||22
6620926|NCT02188849|7547796|FG001|COMPLETED|Overall Study||17
6620927|NCT02188849|7547795|FG000|NOT COMPLETED|Overall Study||3
6620928|NCT02188849|7547796|FG001|NOT COMPLETED|Overall Study||8
6620929|NCT02189122|7547804|FG000|STARTED|Overall Study||18
6620930|NCT02189122|7547805|FG001|STARTED|Overall Study||18
6620931|NCT02189122|7547804|FG000|COMPLETED|Overall Study||18
6620932|NCT02189122|7547805|FG001|COMPLETED|Overall Study||18
6620933|NCT02189122|7547804|FG000|NOT COMPLETED|Overall Study||0
6620934|NCT02189122|7547805|FG001|NOT COMPLETED|Overall Study||0
6620935|NCT02189161|7547813|FG000|STARTED|Overall Study||10
6620936|NCT02189161|7547813|FG000|COMPLETED|Overall Study||10
6620937|NCT02189161|7547813|FG000|NOT COMPLETED|Overall Study||0
6620938|NCT02189213|7547819|FG000|STARTED|Overall Study||13
6620939|NCT02189213|7547820|FG001|STARTED|Overall Study||1
6620940|NCT02189213|7547819|FG000|COMPLETED|Overall Study||7
6620941|NCT02189213|7547820|FG001|COMPLETED|Overall Study||1
6620942|NCT02189213|7547819|FG000|NOT COMPLETED|Overall Study||6
6620943|NCT02189213|7547820|FG001|NOT COMPLETED|Overall Study||0
6620944|NCT02189252|7547830|FG000|STARTED|Period 1 (Visit 4b, Week 4)||4
6620945|NCT02189252|7547831|FG001|STARTED|Period 1 (Visit 4b, Week 4)||4
6620946|NCT02189252|7547832|FG002|STARTED|Period 1 (Visit 4b, Week 4)||3
6733371|NCT03210155|7662863|FG000|NOT COMPLETED|Overall Study||0
6733372|NCT03210155|7662864|FG001|NOT COMPLETED|Overall Study||0
6733373|NCT03210220|7662872|FG000|STARTED|Overall Study||20
6733374|NCT03210220|7662873|FG001|STARTED|Overall Study||20
6733375|NCT03210220|7662872|FG000|COMPLETED|Overall Study||19
6733376|NCT03210220|7662873|FG001|COMPLETED|Overall Study||20
6733377|NCT03210220|7662872|FG000|NOT COMPLETED|Overall Study||1
6733378|NCT03210220|7662873|FG001|NOT COMPLETED|Overall Study||0
6733379|NCT03210259|7662881|FG000|STARTED|12-Week Run-in Period||21
6733380|NCT03210259|7662882|FG001|STARTED|12-Week Run-in Period||118
6733381|NCT03210259|7662883|FG002|STARTED|12-Week Run-in Period||120
6733382|NCT03210259|7662881|FG000|COMPLETED|12-Week Run-in Period||0
6733383|NCT03210259|7662882|FG001|COMPLETED|12-Week Run-in Period||118
6733384|NCT03210259|7662883|FG002|COMPLETED|12-Week Run-in Period||120
6733385|NCT03210259|7662881|FG000|NOT COMPLETED|12-Week Run-in Period||21
6733386|NCT03210259|7662882|FG001|NOT COMPLETED|12-Week Run-in Period||0
6733387|NCT03210259|7662883|FG002|NOT COMPLETED|12-Week Run-in Period||0
6733388|NCT03210259|7662881|FG000|STARTED|48-Week Randomized Responder Period||0
6733389|NCT03210259|7662882|FG001|STARTED|48-Week Randomized Responder Period||118
6733390|NCT03210259|7662883|FG002|STARTED|48-Week Randomized Responder Period||120
6733391|NCT03210259|7662881|FG000|COMPLETED|48-Week Randomized Responder Period||0
6733392|NCT03210259|7662882|FG001|COMPLETED|48-Week Randomized Responder Period||107
6733393|NCT03210259|7662883|FG002|COMPLETED|48-Week Randomized Responder Period||91
6733394|NCT03210259|7662881|FG000|NOT COMPLETED|48-Week Randomized Responder Period||0
6733395|NCT03210259|7662882|FG001|NOT COMPLETED|48-Week Randomized Responder Period||11
6733396|NCT03210259|7662883|FG002|NOT COMPLETED|48-Week Randomized Responder Period||29
6733397|NCT03210337|7662892|FG000|STARTED|Overall Study||78
6733398|NCT03210337|7662893|FG001|STARTED|Overall Study||79
6733399|NCT03210337|7662892|FG000|COMPLETED|Overall Study||70
6733400|NCT03210337|7662893|FG001|COMPLETED|Overall Study||74
6620947|NCT02189252|7547833|FG003|STARTED|Period 1 (Visit 4b, Week 4)||4
6620948|NCT02189252|7547830|FG000|COMPLETED|Period 1 (Visit 4b, Week 4)||4
6620949|NCT02189252|7547831|FG001|COMPLETED|Period 1 (Visit 4b, Week 4)||2
6620950|NCT02189252|7547832|FG002|COMPLETED|Period 1 (Visit 4b, Week 4)||3
6620951|NCT02189252|7547833|FG003|COMPLETED|Period 1 (Visit 4b, Week 4)||4
6620952|NCT02189252|7547830|FG000|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
6620953|NCT02189252|7547831|FG001|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
6620954|NCT02189252|7547832|FG002|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
6620955|NCT02189252|7547833|FG003|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
6620956|NCT02189252|7547830|FG000|STARTED|Period 2 (Visit6b, Week 12)||4
6620957|NCT02189252|7547831|FG001|STARTED|Period 2 (Visit6b, Week 12)||2
6620958|NCT02189252|7547832|FG002|STARTED|Period 2 (Visit6b, Week 12)||3
6620959|NCT02189252|7547833|FG003|STARTED|Period 2 (Visit6b, Week 12)||4
6620960|NCT02189252|7547830|FG000|COMPLETED|Period 2 (Visit6b, Week 12)||4
6620961|NCT02189252|7547831|FG001|COMPLETED|Period 2 (Visit6b, Week 12)||2
6620962|NCT02189252|7547832|FG002|COMPLETED|Period 2 (Visit6b, Week 12)||3
6620963|NCT02189252|7547833|FG003|COMPLETED|Period 2 (Visit6b, Week 12)||4
6620964|NCT02189252|7547830|FG000|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
6620965|NCT02189252|7547831|FG001|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
6620966|NCT02189252|7547832|FG002|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
6620967|NCT02189252|7547833|FG003|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
6620968|NCT02189317|7547846|FG000|STARTED|Overall Study||16
6620969|NCT02189317|7547847|FG001|STARTED|Overall Study||16
6620970|NCT02189317|7547846|FG000|COMPLETED|Overall Study||16
6620971|NCT02189317|7547847|FG001|COMPLETED|Overall Study||16
6620972|NCT02189317|7547846|FG000|NOT COMPLETED|Overall Study||0
6620973|NCT02189317|7547847|FG001|NOT COMPLETED|Overall Study||0
6620974|NCT02189382|7547855|FG000|STARTED|Overall Study||35
6620975|NCT02189382|7547856|FG001|STARTED|Overall Study||35
6620976|NCT02189382|7547855|FG000|COMPLETED|Overall Study||35
6620977|NCT02189382|7547856|FG001|COMPLETED|Overall Study||35
6620978|NCT02189382|7547855|FG000|NOT COMPLETED|Overall Study||0
6620979|NCT02189382|7547856|FG001|NOT COMPLETED|Overall Study||0
6620980|NCT02189473|7547864|FG000|STARTED|Overall Study||101
6620981|NCT02189473|7547865|FG001|STARTED|Overall Study||102
6620982|NCT02189473|7547864|FG000|COMPLETED|Overall Study||78
6620983|NCT02189473|7547865|FG001|COMPLETED|Overall Study||77
6620984|NCT02189473|7547864|FG000|NOT COMPLETED|Overall Study||23
6620985|NCT02189473|7547865|FG001|NOT COMPLETED|Overall Study||25
6620986|NCT02189629|7547871|FG000|STARTED|Overall Study||453
6620987|NCT02189629|7547871|FG000|COMPLETED|Overall Study||348
6620988|NCT02189629|7547871|FG000|NOT COMPLETED|Overall Study||105
6620989|NCT02189668|7547877|FG000|STARTED|Overall Study||5
6620990|NCT02189668|7547878|FG001|STARTED|Overall Study||9
6620991|NCT02189668|7547877|FG000|COMPLETED|Overall Study||5
6620992|NCT02189668|7547878|FG001|COMPLETED|Overall Study||9
6620993|NCT02189668|7547877|FG000|NOT COMPLETED|Overall Study||0
6620994|NCT02189668|7547878|FG001|NOT COMPLETED|Overall Study||0
6620995|NCT02189759|7547888|FG000|STARTED|Overall Study||102
6620996|NCT02189759|7547889|FG001|STARTED|Overall Study||101
6620997|NCT02189759|7547890|FG002|STARTED|Overall Study||83
6620998|NCT02189759|7547891|FG003|STARTED|Overall Study||89
6620999|NCT02189759|7547888|FG000|COMPLETED|Overall Study||102
6621000|NCT02189759|7547889|FG001|COMPLETED|Overall Study||101
6621001|NCT02189759|7547890|FG002|COMPLETED|Overall Study||81
6621002|NCT02189759|7547891|FG003|COMPLETED|Overall Study||84
6621003|NCT02189759|7547888|FG000|NOT COMPLETED|Overall Study||0
6621004|NCT02189759|7547889|FG001|NOT COMPLETED|Overall Study||0
6621005|NCT02189759|7547890|FG002|NOT COMPLETED|Overall Study||2
6621006|NCT02189759|7547891|FG003|NOT COMPLETED|Overall Study||5
6621007|NCT02189837|7547907|FG000|STARTED|Overall Study||22
6621008|NCT02189837|7547908|FG001|STARTED|Overall Study||23
6621009|NCT02189837|7547909|FG002|STARTED|Overall Study||23
6621010|NCT02189837|7547910|FG003|STARTED|Overall Study||21
6621011|NCT02189837|7547907|FG000|Received Treatment|Overall Study||21
6621012|NCT02189837|7547908|FG001|Received Treatment|Overall Study||22
6621013|NCT02189837|7547909|FG002|Received Treatment|Overall Study||22
6621014|NCT02189837|7547910|FG003|Received Treatment|Overall Study||20
6621015|NCT02189837|7547907|FG000|COMPLETED|Overall Study||20
6621016|NCT02189837|7547908|FG001|COMPLETED|Overall Study||22
6621017|NCT02189837|7547909|FG002|COMPLETED|Overall Study||20
6621018|NCT02189837|7547910|FG003|COMPLETED|Overall Study||19
6621019|NCT02189837|7547907|FG000|NOT COMPLETED|Overall Study||2
6621020|NCT02189837|7547908|FG001|NOT COMPLETED|Overall Study||1
6621021|NCT02189837|7547909|FG002|NOT COMPLETED|Overall Study||3
6621022|NCT02189837|7547910|FG003|NOT COMPLETED|Overall Study||2
6621023|NCT02189850|7547922|FG000|STARTED|Overall Study||16
6621024|NCT02189850|7547923|FG001|STARTED|Overall Study||13
6621025|NCT02189850|7547922|FG000|COMPLETED|Overall Study||14
6621026|NCT02189850|7547923|FG001|COMPLETED|Overall Study||11
6621027|NCT02189850|7547922|FG000|NOT COMPLETED|Overall Study||2
6621028|NCT02189850|7547923|FG001|NOT COMPLETED|Overall Study||2
6621029|NCT02189863|7547929|FG000|STARTED|First 2 Weeks||12
6621030|NCT02189863|7547930|FG001|STARTED|First 2 Weeks||15
6621031|NCT02189863|7547929|FG000|COMPLETED|First 2 Weeks||8
6621032|NCT02189863|7547930|FG001|COMPLETED|First 2 Weeks||13
6621033|NCT02189863|7547929|FG000|NOT COMPLETED|First 2 Weeks||4
6621034|NCT02189863|7547930|FG001|NOT COMPLETED|First 2 Weeks||2
6621035|NCT02189863|7547929|FG000|STARTED|Second 2 Weeks||8
6621036|NCT02189863|7547930|FG001|STARTED|Second 2 Weeks||13
6621037|NCT02189863|7547929|FG000|COMPLETED|Second 2 Weeks||8
6621038|NCT02189863|7547930|FG001|COMPLETED|Second 2 Weeks||13
6621039|NCT02189863|7547929|FG000|NOT COMPLETED|Second 2 Weeks||0
6621040|NCT02189863|7547930|FG001|NOT COMPLETED|Second 2 Weeks||0
6621041|NCT02189889|7547941|FG000|STARTED|Overall Study||2
6621042|NCT02189889|7547942|FG001|STARTED|Overall Study||3
6621043|NCT02189889|7547941|FG000|COMPLETED|Overall Study||2
6621044|NCT02189889|7547942|FG001|COMPLETED|Overall Study||3
6621045|NCT02189889|7547941|FG000|NOT COMPLETED|Overall Study||0
6621046|NCT02189889|7547942|FG001|NOT COMPLETED|Overall Study||0
6621047|NCT02189915|7547948|FG000|STARTED|Overall Study||14
6621048|NCT02189915|7547948|FG000|COMPLETED|Overall Study||11
6621049|NCT02189915|7547948|FG000|NOT COMPLETED|Overall Study||3
6621050|NCT02189941|7547952|FG000|STARTED|Overall Study||4
6621051|NCT02189941|7547953|FG001|STARTED|Overall Study||4
6621052|NCT02189941|7547954|FG002|STARTED|Overall Study||3
6621053|NCT02189941|7547952|FG000|COMPLETED|Overall Study||4
6621054|NCT02189941|7547953|FG001|COMPLETED|Overall Study||4
6621055|NCT02189941|7547954|FG002|COMPLETED|Overall Study||2
6621056|NCT02189941|7547952|FG000|NOT COMPLETED|Overall Study||0
6621057|NCT02189941|7547953|FG001|NOT COMPLETED|Overall Study||0
6621058|NCT02189941|7547954|FG002|NOT COMPLETED|Overall Study||1
6621059|NCT02189954|7547964|FG000|STARTED|Overall Study||45
6621060|NCT02189954|7547965|FG001|STARTED|Overall Study||45
6621061|NCT02189954|7547964|FG000|COMPLETED|Overall Study||45
6621062|NCT02189954|7547965|FG001|COMPLETED|Overall Study||45
6621063|NCT02189954|7547964|FG000|NOT COMPLETED|Overall Study||0
6621064|NCT02189954|7547965|FG001|NOT COMPLETED|Overall Study||0
6621065|NCT02190045|7547973|FG000|STARTED|Overall Study||15
6621066|NCT02190045|7547974|FG001|STARTED|Overall Study||15
6621067|NCT02190045|7547973|FG000|COMPLETED|Overall Study||12
6621068|NCT02190045|7547974|FG001|COMPLETED|Overall Study||15
6621069|NCT02190045|7547973|FG000|NOT COMPLETED|Overall Study||3
6621070|NCT02190045|7547974|FG001|NOT COMPLETED|Overall Study||0
6621071|NCT02190279|7547983|FG000|STARTED|Overall Study||16
6621072|NCT02190279|7547984|FG001|STARTED|Overall Study||69
6621073|NCT02190279|7547985|FG002|STARTED|Overall Study||31
6621074|NCT02190279|7547983|FG000|COMPLETED|Overall Study||13
6621075|NCT02190279|7547984|FG001|COMPLETED|Overall Study||69
6621076|NCT02190279|7547985|FG002|COMPLETED|Overall Study||28
6621077|NCT02190279|7547983|FG000|NOT COMPLETED|Overall Study||3
6621078|NCT02190279|7547984|FG001|NOT COMPLETED|Overall Study||0
6621079|NCT02190279|7547985|FG002|NOT COMPLETED|Overall Study||3
6621080|NCT02190435|7547997|FG000|STARTED|Overall Study||41
6621081|NCT02190435|7547998|FG001|STARTED|Overall Study||24
6621082|NCT02190435|7547997|FG000|COMPLETED|Overall Study||26
6621083|NCT02190435|7547998|FG001|COMPLETED|Overall Study||24
6621084|NCT02190435|7547997|FG000|NOT COMPLETED|Overall Study||15
6621085|NCT02190435|7547998|FG001|NOT COMPLETED|Overall Study||0
6621086|NCT02190552|7548004|FG000|STARTED|Overall Study||40
6621087|NCT02190552|7548004|FG000|COMPLETED|Overall Study||36
6621088|NCT02190552|7548004|FG000|NOT COMPLETED|Overall Study||4
6621089|NCT02190591|7548011|FG000|STARTED|Overall Study||102
6621090|NCT02190591|7548012|FG001|STARTED|Overall Study||102
6621091|NCT02190591|7548011|FG000|COMPLETED|Overall Study||100
6621092|NCT02190591|7548012|FG001|COMPLETED|Overall Study||91
6621093|NCT02190591|7548011|FG000|NOT COMPLETED|Overall Study||2
6621094|NCT02190591|7548012|FG001|NOT COMPLETED|Overall Study||11
6621095|NCT02190604|7548037|FG000|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621096|NCT02190604|7548038|FG001|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621097|NCT02190604|7548039|FG002|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621098|NCT02190604|7548040|FG003|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621099|NCT02190604|7548041|FG004|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621100|NCT02190604|7548042|FG005|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621101|NCT02190604|7548043|FG006|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621102|NCT02190604|7548044|FG007|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621103|NCT02190604|7548045|FG008|STARTED|Part 1 and 2 (Healthy Volunteers)||16
6621104|NCT02190604|7548046|FG009|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621105|NCT02190604|7548047|FG010|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621106|NCT02190604|7548048|FG011|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621107|NCT02190604|7548049|FG012|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621108|NCT02190604|7548050|FG013|STARTED|Part 1 and 2 (Healthy Volunteers)||6
6621109|NCT02190604|7548051|FG014|STARTED|Part 1 and 2 (Healthy Volunteers)||10
6621110|NCT02190604|7548052|FG015|STARTED|Part 1 and 2 (Healthy Volunteers)||0
6621111|NCT02190604|7548053|FG016|STARTED|Part 1 and 2 (Healthy Volunteers)||0
6621112|NCT02190604|7548054|FG017|STARTED|Part 1 and 2 (Healthy Volunteers)||0
6621113|NCT02190604|7548055|FG018|STARTED|Part 1 and 2 (Healthy Volunteers)||0
6621114|NCT02190604|7548037|FG000|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621115|NCT02190604|7548038|FG001|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621116|NCT02190604|7548039|FG002|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621117|NCT02190604|7548040|FG003|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621118|NCT02190604|7548041|FG004|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621119|NCT02190604|7548042|FG005|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621120|NCT02190604|7548043|FG006|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621121|NCT02190604|7548044|FG007|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621122|NCT02190604|7548045|FG008|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
6621123|NCT02190604|7548046|FG009|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621124|NCT02190604|7548047|FG010|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621125|NCT02190604|7548048|FG011|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621126|NCT02190604|7548049|FG012|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
6621127|NCT02190604|7548050|FG013|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
6621128|NCT02190604|7548051|FG014|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
6621129|NCT02190604|7548052|FG015|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621130|NCT02190604|7548053|FG016|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621131|NCT02190604|7548054|FG017|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621132|NCT02190604|7548055|FG018|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621133|NCT02190604|7548037|FG000|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621134|NCT02190604|7548038|FG001|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621135|NCT02190604|7548039|FG002|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621136|NCT02190604|7548040|FG003|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621137|NCT02190604|7548041|FG004|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621138|NCT02190604|7548042|FG005|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621139|NCT02190604|7548043|FG006|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621140|NCT02190604|7548044|FG007|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621141|NCT02190604|7548045|FG008|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621142|NCT02190604|7548046|FG009|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621143|NCT02190604|7548047|FG010|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621144|NCT02190604|7548048|FG011|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621145|NCT02190604|7548049|FG012|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621146|NCT02190604|7548050|FG013|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
6621147|NCT02190604|7548051|FG014|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
6621148|NCT02190604|7548052|FG015|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621149|NCT02190604|7548053|FG016|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621150|NCT02190604|7548054|FG017|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621151|NCT02190604|7548055|FG018|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
6621152|NCT02190604|7548037|FG000|STARTED|Part 3 (Patients)||0
6621153|NCT02190604|7548038|FG001|STARTED|Part 3 (Patients)||0
6621154|NCT02190604|7548039|FG002|STARTED|Part 3 (Patients)||0
6621155|NCT02190604|7548040|FG003|STARTED|Part 3 (Patients)||0
6621156|NCT02190604|7548041|FG004|STARTED|Part 3 (Patients)||0
6621157|NCT02190604|7548042|FG005|STARTED|Part 3 (Patients)||0
6621158|NCT02190604|7548043|FG006|STARTED|Part 3 (Patients)||0
6621159|NCT02190604|7548044|FG007|STARTED|Part 3 (Patients)||0
6621160|NCT02190604|7548045|FG008|STARTED|Part 3 (Patients)||0
6621161|NCT02190604|7548046|FG009|STARTED|Part 3 (Patients)||0
6621162|NCT02190604|7548047|FG010|STARTED|Part 3 (Patients)||0
6621163|NCT02190604|7548048|FG011|STARTED|Part 3 (Patients)||0
6621164|NCT02190604|7548049|FG012|STARTED|Part 3 (Patients)||0
6621165|NCT02190604|7548050|FG013|STARTED|Part 3 (Patients)||0
6621166|NCT02190604|7548051|FG014|STARTED|Part 3 (Patients)||0
6621167|NCT02190604|7548052|FG015|STARTED|Part 3 (Patients)||6
6621168|NCT02190604|7548053|FG016|STARTED|Part 3 (Patients)||12
6621169|NCT02190604|7548054|FG017|STARTED|Part 3 (Patients)||19
6621170|NCT02190604|7548055|FG018|STARTED|Part 3 (Patients)||12
6621171|NCT02190604|7548037|FG000|COMPLETED|Part 3 (Patients)||0
6621172|NCT02190604|7548038|FG001|COMPLETED|Part 3 (Patients)||0
6621173|NCT02190604|7548039|FG002|COMPLETED|Part 3 (Patients)||0
6621174|NCT02190604|7548040|FG003|COMPLETED|Part 3 (Patients)||0
6621175|NCT02190604|7548041|FG004|COMPLETED|Part 3 (Patients)||0
6621176|NCT02190604|7548042|FG005|COMPLETED|Part 3 (Patients)||0
6621177|NCT02190604|7548043|FG006|COMPLETED|Part 3 (Patients)||0
6621178|NCT02190604|7548044|FG007|COMPLETED|Part 3 (Patients)||0
6621179|NCT02190604|7548045|FG008|COMPLETED|Part 3 (Patients)||0
6621180|NCT02190604|7548046|FG009|COMPLETED|Part 3 (Patients)||0
6621181|NCT02190604|7548047|FG010|COMPLETED|Part 3 (Patients)||0
6621182|NCT02190604|7548048|FG011|COMPLETED|Part 3 (Patients)||0
6621183|NCT02190604|7548049|FG012|COMPLETED|Part 3 (Patients)||0
6621184|NCT02190604|7548050|FG013|COMPLETED|Part 3 (Patients)||0
6621185|NCT02190604|7548051|FG014|COMPLETED|Part 3 (Patients)||0
6621186|NCT02190604|7548052|FG015|COMPLETED|Part 3 (Patients)||6
6621187|NCT02190604|7548053|FG016|COMPLETED|Part 3 (Patients)||12
6621188|NCT02190604|7548054|FG017|COMPLETED|Part 3 (Patients)||19
6621189|NCT02190604|7548055|FG018|COMPLETED|Part 3 (Patients)||12
6621190|NCT02190604|7548037|FG000|NOT COMPLETED|Part 3 (Patients)||0
6621191|NCT02190604|7548038|FG001|NOT COMPLETED|Part 3 (Patients)||0
6621192|NCT02190604|7548039|FG002|NOT COMPLETED|Part 3 (Patients)||0
6621193|NCT02190604|7548040|FG003|NOT COMPLETED|Part 3 (Patients)||0
6621194|NCT02190604|7548041|FG004|NOT COMPLETED|Part 3 (Patients)||0
6621195|NCT02190604|7548042|FG005|NOT COMPLETED|Part 3 (Patients)||0
6621196|NCT02190604|7548043|FG006|NOT COMPLETED|Part 3 (Patients)||0
6621197|NCT02190604|7548044|FG007|NOT COMPLETED|Part 3 (Patients)||0
6621198|NCT02190604|7548045|FG008|NOT COMPLETED|Part 3 (Patients)||0
6621199|NCT02190604|7548046|FG009|NOT COMPLETED|Part 3 (Patients)||0
6621200|NCT02190604|7548047|FG010|NOT COMPLETED|Part 3 (Patients)||0
6621201|NCT02190604|7548048|FG011|NOT COMPLETED|Part 3 (Patients)||0
6621202|NCT02190604|7548049|FG012|NOT COMPLETED|Part 3 (Patients)||0
6621203|NCT02190604|7548050|FG013|NOT COMPLETED|Part 3 (Patients)||0
6621204|NCT02190604|7548051|FG014|NOT COMPLETED|Part 3 (Patients)||0
6621205|NCT02190604|7548052|FG015|NOT COMPLETED|Part 3 (Patients)||0
6621206|NCT02190604|7548053|FG016|NOT COMPLETED|Part 3 (Patients)||0
6621207|NCT02190604|7548054|FG017|NOT COMPLETED|Part 3 (Patients)||0
6621208|NCT02190604|7548055|FG018|NOT COMPLETED|Part 3 (Patients)||0
6621209|NCT02190747|7548115|FG000|STARTED|Overall Study||21
6621210|NCT02190747|7548116|FG001|STARTED|Overall Study||9
6621211|NCT02190747|7548117|FG002|STARTED|Overall Study||10
6621212|NCT02190747|7548115|FG000|COMPLETED|Overall Study||21
6621213|NCT02190747|7548116|FG001|COMPLETED|Overall Study||9
6621214|NCT02190747|7548117|FG002|COMPLETED|Overall Study||10
6621215|NCT02190747|7548115|FG000|NOT COMPLETED|Overall Study||0
6621216|NCT02190747|7548116|FG001|NOT COMPLETED|Overall Study||0
6621217|NCT02190747|7548117|FG002|NOT COMPLETED|Overall Study||0
6621218|NCT02190903|7548127|FG000|STARTED|Overall Study||6
6621219|NCT02190903|7548128|FG001|STARTED|Overall Study||6
6621220|NCT02190903|7548127|FG000|COMPLETED|Overall Study||6
6621221|NCT02190903|7548128|FG001|COMPLETED|Overall Study||6
6621222|NCT02190903|7548127|FG000|NOT COMPLETED|Overall Study||0
6621223|NCT02190903|7548128|FG001|NOT COMPLETED|Overall Study||0
6621224|NCT02191033|7548136|FG000|STARTED|Overall Study||20
6621225|NCT02191033|7548137|FG001|STARTED|Overall Study||20
6621226|NCT02191033|7548136|FG000|COMPLETED|Overall Study||18
6621227|NCT02191033|7548137|FG001|COMPLETED|Overall Study||19
6621228|NCT02191033|7548136|FG000|NOT COMPLETED|Overall Study||2
6621229|NCT02191033|7548137|FG001|NOT COMPLETED|Overall Study||1
6621230|NCT02191046|7548145|FG000|STARTED|Overall Study||41
6621231|NCT02191046|7548146|FG001|STARTED|Overall Study||39
6621232|NCT02191046|7548145|FG000|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
6621233|NCT02191046|7548146|FG001|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
6621234|NCT02191046|7548145|FG000|NOT COMPLETED|Overall Study||5
6621235|NCT02191046|7548146|FG001|NOT COMPLETED|Overall Study||1
6621236|NCT02191137|7548152|FG000|STARTED|Treatment||75
6621237|NCT02191137|7548152|FG000|COMPLETED|Treatment||65
6621238|NCT02191137|7548152|FG000|NOT COMPLETED|Treatment||10
6621239|NCT02191137|7548152|FG000|STARTED|Follow-up||65
6621240|NCT02191137|7548152|FG000|COMPLETED|Follow-up||60
6621241|NCT02191137|7548152|FG000|NOT COMPLETED|Follow-up||5
6621242|NCT02191267|7548159|FG000|STARTED|Overall Study||20
6621243|NCT02191267|7548160|FG001|STARTED|Overall Study||6
6621244|NCT02191267|7548161|FG002|STARTED|Overall Study||4
6621245|NCT02191267|7548159|FG000|COMPLETED|Overall Study||19
6621246|NCT02191267|7548160|FG001|COMPLETED|Overall Study||6
6621247|NCT02191267|7548161|FG002|COMPLETED|Overall Study||4
6621248|NCT02191267|7548159|FG000|NOT COMPLETED|Overall Study||1
6621249|NCT02191267|7548160|FG001|NOT COMPLETED|Overall Study||0
6621250|NCT02191267|7548161|FG002|NOT COMPLETED|Overall Study||0
6621251|NCT02191397|7548171|FG000|STARTED|Overall Study||266
6621252|NCT02191397|7548172|FG001|STARTED|Overall Study||268
6621253|NCT02191397|7548171|FG000|COMPLETED|Overall Study||183
6621254|NCT02191397|7548172|FG001|COMPLETED|Overall Study||198
6621255|NCT02191397|7548171|FG000|NOT COMPLETED|Overall Study||83
6621256|NCT02191397|7548172|FG001|NOT COMPLETED|Overall Study||70
6621257|NCT02191579|7548180|FG000|STARTED|Treatment 1||140
6621258|NCT02191579|7548181|FG001|STARTED|Treatment 1||142
6621259|NCT02191579|7548180|FG000|COMPLETED|Treatment 1||113
6621260|NCT02191579|7548181|FG001|COMPLETED|Treatment 1||84
6621261|NCT02191579|7548180|FG000|NOT COMPLETED|Treatment 1||27
6621262|NCT02191579|7548181|FG001|NOT COMPLETED|Treatment 1||58
6621263|NCT02191579|7548180|FG000|STARTED|Treatment 2||0
6621264|NCT02191579|7548181|FG001|STARTED|Treatment 2||80
6621265|NCT02191579|7548180|FG000|COMPLETED|Treatment 2||0
6621266|NCT02191579|7548181|FG001|COMPLETED|Treatment 2||55
6621267|NCT02191579|7548180|FG000|NOT COMPLETED|Treatment 2||0
6621268|NCT02191579|7548181|FG001|NOT COMPLETED|Treatment 2||25
6621269|NCT02191605|7548192|FG000|STARTED|Overall Study||15
6621270|NCT02191605|7548193|FG001|STARTED|Overall Study||15
6621271|NCT02191605|7548194|FG002|STARTED|Overall Study||15
6621272|NCT02191605|7548195|FG003|STARTED|Overall Study||8
6621273|NCT02191605|7548196|FG004|STARTED|Overall Study||7
6621274|NCT02191605|7548192|FG000|Completed Intervention Portion|Overall Study||15
6621275|NCT02191605|7548193|FG001|Completed Intervention Portion|Overall Study||15
6621276|NCT02191605|7548194|FG002|Completed Intervention Portion|Overall Study||15
6621277|NCT02191605|7548195|FG003|Completed Intervention Portion|Overall Study||8
6621278|NCT02191605|7548196|FG004|Completed Intervention Portion|Overall Study||7
6621279|NCT02191605|7548192|FG000|COMPLETED|Overall Study||6
6621280|NCT02191605|7548193|FG001|COMPLETED|Overall Study||11
6621281|NCT02191605|7548194|FG002|COMPLETED|Overall Study||8
6621282|NCT02191605|7548195|FG003|COMPLETED|Overall Study||5
6621283|NCT02191605|7548196|FG004|COMPLETED|Overall Study||3
6621284|NCT02191605|7548192|FG000|NOT COMPLETED|Overall Study||9
6621285|NCT02191605|7548193|FG001|NOT COMPLETED|Overall Study||4
6621286|NCT02191605|7548194|FG002|NOT COMPLETED|Overall Study||7
6621287|NCT02191605|7548195|FG003|NOT COMPLETED|Overall Study||3
6621288|NCT02191605|7548196|FG004|NOT COMPLETED|Overall Study||4
6621289|NCT02191618|7548208|FG000|STARTED|Overall Study||150
6621290|NCT02191618|7548208|FG000|COMPLETED|Overall Study||143
6621291|NCT02191618|7548208|FG000|NOT COMPLETED|Overall Study||7
6621292|NCT02191865|7548215|FG000|STARTED|Overall Study||8
6621293|NCT02191865|7548216|FG001|STARTED|Overall Study||8
6621294|NCT02191865|7548217|FG002|STARTED|Overall Study||17
6621295|NCT02191865|7548215|FG000|COMPLETED|Overall Study||8
6621296|NCT02191865|7548216|FG001|COMPLETED|Overall Study||8
6621297|NCT02191865|7548217|FG002|COMPLETED|Overall Study||17
6621298|NCT02191865|7548215|FG000|NOT COMPLETED|Overall Study||0
6621299|NCT02191865|7548216|FG001|NOT COMPLETED|Overall Study||0
6621300|NCT02191865|7548217|FG002|NOT COMPLETED|Overall Study||0
6621301|NCT02192099|7548228|FG000|STARTED|Overall Study||61
6621302|NCT02192099|7548228|FG000|COMPLETED|Overall Study||0
6621303|NCT02192099|7548228|FG000|NOT COMPLETED|Overall Study||61
6621304|NCT02192164|7548232|FG000|STARTED|Overall Study||126
6621305|NCT02192164|7548232|FG000|Etanercept Treated Population|Overall Study||112
6621306|NCT02192164|7548232|FG000|COMPLETED|Overall Study||112
6621307|NCT02192164|7548232|FG000|NOT COMPLETED|Overall Study||14
6621308|NCT02192190|7548245|FG000|STARTED|Overall Study||76
6621309|NCT02192190|7548246|FG001|STARTED|Overall Study||39
6621310|NCT02192190|7548247|FG002|STARTED|Overall Study||38
6621311|NCT02192190|7548248|FG003|STARTED|Overall Study||38
6621312|NCT02192190|7548249|FG004|STARTED|Overall Study||39
6621313|NCT02192190|7548250|FG005|STARTED|Overall Study||38
6621314|NCT02192190|7548245|FG000|Received at Least 1 Dose of Study Drug|Overall Study||76
6621315|NCT02192190|7548246|FG001|Received at Least 1 Dose of Study Drug|Overall Study||39
6621316|NCT02192190|7548247|FG002|Received at Least 1 Dose of Study Drug|Overall Study||38
6621317|NCT02192190|7548248|FG003|Received at Least 1 Dose of Study Drug|Overall Study||38
6621318|NCT02192190|7548249|FG004|Received at Least 1 Dose of Study Drug|Overall Study||38
6621319|NCT02192190|7548250|FG005|Received at Least 1 Dose of Study Drug|Overall Study||37
6621320|NCT02192190|7548245|FG000|COMPLETED|Overall Study||22
6621321|NCT02192190|7548246|FG001|COMPLETED|Overall Study||10
6621322|NCT02192190|7548247|FG002|COMPLETED|Overall Study||13
6621323|NCT02192190|7548248|FG003|COMPLETED|Overall Study||12
6621324|NCT02192190|7548249|FG004|COMPLETED|Overall Study||9
6621325|NCT02192190|7548250|FG005|COMPLETED|Overall Study||9
6621326|NCT02192190|7548245|FG000|NOT COMPLETED|Overall Study||54
6621327|NCT02192190|7548246|FG001|NOT COMPLETED|Overall Study||29
6621328|NCT02192190|7548247|FG002|NOT COMPLETED|Overall Study||25
6621329|NCT02192190|7548248|FG003|NOT COMPLETED|Overall Study||26
6621330|NCT02192190|7548249|FG004|NOT COMPLETED|Overall Study||30
6621331|NCT02192190|7548250|FG005|NOT COMPLETED|Overall Study||29
6621332|NCT02192307|7548267|FG000|STARTED|Overall Study||30
6621333|NCT02192307|7548268|FG001|STARTED|Overall Study||30
6621334|NCT02192307|7548267|FG000|COMPLETED|Overall Study||30
6621335|NCT02192307|7548268|FG001|COMPLETED|Overall Study||30
6621336|NCT02192307|7548267|FG000|NOT COMPLETED|Overall Study||0
6621337|NCT02192307|7548268|FG001|NOT COMPLETED|Overall Study||0
6621338|NCT02192541|7548276|FG000|STARTED|Overall Study||2
6621339|NCT02192541|7548277|FG001|STARTED|Overall Study||3
6621340|NCT02192541|7548276|FG000|Treated|Overall Study||2
6621341|NCT02192541|7548277|FG001|Treated|Overall Study||3
6621342|NCT02192541|7548276|FG000|Evaluable for Response|Overall Study||1
6621343|NCT02192541|7548277|FG001|Evaluable for Response|Overall Study||3
6621344|NCT02192541|7548276|FG000|COMPLETED|Overall Study||2
6621345|NCT02192541|7548277|FG001|COMPLETED|Overall Study||3
6621346|NCT02192541|7548276|FG000|NOT COMPLETED|Overall Study||0
6621347|NCT02192541|7548277|FG001|NOT COMPLETED|Overall Study||0
6621348|NCT02192606|7548286|FG000|STARTED|Overall Study||29
6621349|NCT02192606|7548287|FG001|STARTED|Overall Study||28
6621350|NCT02192606|7548286|FG000|COMPLETED|Overall Study||27
6621351|NCT02192606|7548287|FG001|COMPLETED|Overall Study||24
6621352|NCT02192606|7548286|FG000|NOT COMPLETED|Overall Study||2
6621353|NCT02192606|7548287|FG001|NOT COMPLETED|Overall Study||4
6621354|NCT02192684|7548295|FG000|STARTED|Overall Study||30
6621355|NCT02192684|7548296|FG001|STARTED|Overall Study||15
6621356|NCT02192684|7548295|FG000|COMPLETED|Overall Study||30
6621357|NCT02192684|7548296|FG001|COMPLETED|Overall Study||15
6621358|NCT02192684|7548295|FG000|NOT COMPLETED|Overall Study||0
6621359|NCT02192684|7548296|FG001|NOT COMPLETED|Overall Study||0
6621360|NCT02192814|7548302|FG000|STARTED|Overall Study||9
6621361|NCT02192814|7548302|FG000|COMPLETED|Overall Study||9
6621362|NCT02192814|7548302|FG000|NOT COMPLETED|Overall Study||0
6621363|NCT02192879|7548309|FG000|STARTED|Overall Study||3
6621364|NCT02192879|7548310|FG001|STARTED|Overall Study||4
6621365|NCT02192879|7548311|FG002|STARTED|Overall Study||3
6621366|NCT02192879|7548309|FG000|COMPLETED|Overall Study||3
6621367|NCT02192879|7548310|FG001|COMPLETED|Overall Study||4
6621368|NCT02192879|7548311|FG002|COMPLETED|Overall Study||3
6621369|NCT02192879|7548309|FG000|NOT COMPLETED|Overall Study||0
6621370|NCT02192879|7548310|FG001|NOT COMPLETED|Overall Study||0
6621371|NCT02192879|7548311|FG002|NOT COMPLETED|Overall Study||0
6621372|NCT02192905|7548319|FG000|STARTED|Overall Study||43
6621373|NCT02192905|7548319|FG000|COMPLETED|Overall Study|Reporting a minimum of current weight at 16-week follow-up|42
6621374|NCT02192905|7548319|FG000|NOT COMPLETED|Overall Study||1
6733401|NCT03210337|7662892|FG000|NOT COMPLETED|Overall Study||8
6733402|NCT03210337|7662893|FG001|NOT COMPLETED|Overall Study||5
6733403|NCT03210376|7662901|FG000|STARTED|Overall Study||50
6733404|NCT03210376|7662902|FG001|STARTED|Overall Study||50
6733405|NCT03210376|7662901|FG000|COMPLETED|Overall Study||50
6733406|NCT03210376|7662902|FG001|COMPLETED|Overall Study||50
6733407|NCT03210376|7662901|FG000|NOT COMPLETED|Overall Study||0
6733408|NCT03210376|7662902|FG001|NOT COMPLETED|Overall Study||0
6733409|NCT03210519|7662910|FG000|STARTED|Overall Study||11
6733410|NCT03210519|7662911|FG001|STARTED|Overall Study||10
6733411|NCT03210519|7662910|FG000|COMPLETED|Overall Study||9
6733412|NCT03210519|7662911|FG001|COMPLETED|Overall Study||10
6733413|NCT03210519|7662910|FG000|NOT COMPLETED|Overall Study||2
6733414|NCT03210519|7662911|FG001|NOT COMPLETED|Overall Study||0
6733415|NCT03210701|7662917|FG000|STARTED|Overall Study||123
6733416|NCT03210701|7662917|FG000|COMPLETED|Overall Study||123
6733417|NCT03210701|7662917|FG000|NOT COMPLETED|Overall Study||0
6733418|NCT03210961|7662936|FG000|STARTED|Overall Study||4
6733419|NCT03210961|7662937|FG001|STARTED|Overall Study||9
6733420|NCT03210961|7662938|FG002|STARTED|Overall Study||1
6733421|NCT03210961|7662939|FG003|STARTED|Overall Study||2
6733422|NCT03210961|7662940|FG004|STARTED|Overall Study||6
6733423|NCT03210961|7662941|FG005|STARTED|Overall Study||6
6733424|NCT03210961|7662942|FG006|STARTED|Overall Study||8
6733425|NCT03210961|7662943|FG007|STARTED|Overall Study||7
6733426|NCT03210961|7662944|FG008|STARTED|Overall Study||8
6733427|NCT03210961|7662945|FG009|STARTED|Overall Study||6
6733428|NCT03210961|7662946|FG010|STARTED|Overall Study||7
6733429|NCT03210961|7662947|FG011|STARTED|Overall Study||5
6733430|NCT03210961|7662948|FG012|STARTED|Overall Study||14
6733431|NCT03210961|7662949|FG013|STARTED|Overall Study||15
6733432|NCT03210961|7662950|FG014|STARTED|Overall Study||11
6733433|NCT03210961|7662936|FG000|COMPLETED|Overall Study||4
6733434|NCT03210961|7662937|FG001|COMPLETED|Overall Study||9
6733435|NCT03210961|7662938|FG002|COMPLETED|Overall Study||1
6733436|NCT03210961|7662939|FG003|COMPLETED|Overall Study||1
6733437|NCT03210961|7662940|FG004|COMPLETED|Overall Study||6
6733438|NCT03210961|7662941|FG005|COMPLETED|Overall Study||6
6733439|NCT03210961|7662942|FG006|COMPLETED|Overall Study||7
6733440|NCT03210961|7662943|FG007|COMPLETED|Overall Study||7
6733441|NCT03210961|7662944|FG008|COMPLETED|Overall Study||8
6733442|NCT03210961|7662945|FG009|COMPLETED|Overall Study||6
6733443|NCT03210961|7662946|FG010|COMPLETED|Overall Study||6
6733444|NCT03210961|7662947|FG011|COMPLETED|Overall Study||5
6733445|NCT03210961|7662948|FG012|COMPLETED|Overall Study||12
6733446|NCT03210961|7662949|FG013|COMPLETED|Overall Study||11
6733447|NCT03210961|7662950|FG014|COMPLETED|Overall Study||9
6733448|NCT03210961|7662936|FG000|NOT COMPLETED|Overall Study||0
6733449|NCT03210961|7662937|FG001|NOT COMPLETED|Overall Study||0
6733450|NCT03210961|7662938|FG002|NOT COMPLETED|Overall Study||0
6733451|NCT03210961|7662939|FG003|NOT COMPLETED|Overall Study||1
6733452|NCT03210961|7662940|FG004|NOT COMPLETED|Overall Study||0
6733453|NCT03210961|7662941|FG005|NOT COMPLETED|Overall Study||0
6733454|NCT03210961|7662942|FG006|NOT COMPLETED|Overall Study||1
6733455|NCT03210961|7662943|FG007|NOT COMPLETED|Overall Study||0
6733456|NCT03210961|7662944|FG008|NOT COMPLETED|Overall Study||0
6733457|NCT03210961|7662945|FG009|NOT COMPLETED|Overall Study||0
6733458|NCT03210961|7662946|FG010|NOT COMPLETED|Overall Study||1
6733459|NCT03210961|7662947|FG011|NOT COMPLETED|Overall Study||0
6733460|NCT03210961|7662948|FG012|NOT COMPLETED|Overall Study||2
6733461|NCT03210961|7662949|FG013|NOT COMPLETED|Overall Study||4
6733462|NCT03210961|7662950|FG014|NOT COMPLETED|Overall Study||2
6733463|NCT03211117|7663001|FG000|STARTED|Overall Study||0
6733464|NCT03211117|7663002|FG001|STARTED|Overall Study||3
6733465|NCT03211117|7663001|FG000|COMPLETED|Overall Study||0
6733466|NCT03211117|7663002|FG001|COMPLETED|Overall Study||3
6733467|NCT03211117|7663001|FG000|NOT COMPLETED|Overall Study||0
6733468|NCT03211117|7663002|FG001|NOT COMPLETED|Overall Study||0
6733469|NCT03211156|7663010|FG000|STARTED|Overall Study||49
6733470|NCT03211156|7663011|FG001|STARTED|Overall Study||48
6733471|NCT03211156|7663010|FG000|Received Study Drug|Overall Study||47
6733472|NCT03211156|7663011|FG001|Received Study Drug|Overall Study||45
6733473|NCT03211156|7663010|FG000|COMPLETED|Overall Study||47
6733474|NCT03211156|7663011|FG001|COMPLETED|Overall Study||45
6733475|NCT03211156|7663010|FG000|NOT COMPLETED|Overall Study||2
6733476|NCT03211156|7663011|FG001|NOT COMPLETED|Overall Study||3
6733477|NCT03211234|7663020|FG000|STARTED|Overall Study||17
6733478|NCT03211234|7663021|FG001|STARTED|Overall Study||31
6733479|NCT03211234|7663022|FG002|STARTED|Overall Study||28
6621375|NCT02192970|7548326|FG000|STARTED|Overall Study||101
6621376|NCT02192970|7548327|FG001|STARTED|Overall Study||195
6621377|NCT02192970|7548326|FG000|COMPLETED|Overall Study||95
6621378|NCT02192970|7548327|FG001|COMPLETED|Overall Study||195
6621379|NCT02192970|7548326|FG000|NOT COMPLETED|Overall Study||6
6621380|NCT02192970|7548327|FG001|NOT COMPLETED|Overall Study||0
6621381|NCT02193074|7548335|FG000|STARTED|Overall Study|Randomized and received double-blind treatment.|41
6621382|NCT02193074|7548336|FG001|STARTED|Overall Study|Randomized and received double-blind treatment.|80
6621383|NCT02193074|7548335|FG000|Completed During Follow-Up Period|Overall Study||11
6621384|NCT02193074|7548336|FG001|Completed During Follow-Up Period|Overall Study||26
6621385|NCT02193074|7548335|FG000|Completed Due to Early Study Termination|Overall Study||13
6621386|NCT02193074|7548336|FG001|Completed Due to Early Study Termination|Overall Study||39
6621387|NCT02193074|7548335|FG000|COMPLETED|Overall Study||24
6621388|NCT02193074|7548336|FG001|COMPLETED|Overall Study||65
6621389|NCT02193074|7548335|FG000|NOT COMPLETED|Overall Study||17
6621390|NCT02193074|7548336|FG001|NOT COMPLETED|Overall Study||15
6621391|NCT02193087|7548346|FG000|STARTED|Overall Study||199
6621392|NCT02193087|7548347|FG001|STARTED|Overall Study||100
6621393|NCT02193087|7548348|FG002|STARTED|Overall Study||100
6621394|NCT02193087|7548349|FG003|STARTED|Overall Study||603
6621395|NCT02193087|7548346|FG000|Received Vaccination|Overall Study||197
6621396|NCT02193087|7548347|FG001|Received Vaccination|Overall Study||97
6621397|NCT02193087|7548348|FG002|Received Vaccination|Overall Study||100
6621398|NCT02193087|7548349|FG003|Received Vaccination|Overall Study||602
6621399|NCT02193087|7548346|FG000|COMPLETED|Overall Study||162
6621400|NCT02193087|7548347|FG001|COMPLETED|Overall Study||86
6621401|NCT02193087|7548348|FG002|COMPLETED|Overall Study||93
6621402|NCT02193087|7548349|FG003|COMPLETED|Overall Study||524
6621403|NCT02193087|7548346|FG000|NOT COMPLETED|Overall Study||37
6621404|NCT02193087|7548347|FG001|NOT COMPLETED|Overall Study||14
6621405|NCT02193087|7548348|FG002|NOT COMPLETED|Overall Study||7
6621406|NCT02193087|7548349|FG003|NOT COMPLETED|Overall Study||79
6621407|NCT02193152|7548366|FG000|STARTED|Overall Study||16
6621408|NCT02193152|7548366|FG000|COMPLETED|Overall Study||16
6621409|NCT02193152|7548366|FG000|NOT COMPLETED|Overall Study||0
6621410|NCT02193165|7548373|FG000|STARTED|4 Week Product Use||40
6621411|NCT02193165|7548374|FG001|STARTED|4 Week Product Use||40
6621412|NCT02193165|7548375|FG002|STARTED|4 Week Product Use||40
6621413|NCT02193165|7548373|FG000|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
6621414|NCT02193165|7548374|FG001|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
6621415|NCT02193165|7548375|FG002|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
6621416|NCT02193165|7548373|FG000|NOT COMPLETED|4 Week Product Use||1
6621417|NCT02193165|7548374|FG001|NOT COMPLETED|4 Week Product Use||1
6621418|NCT02193165|7548375|FG002|NOT COMPLETED|4 Week Product Use||1
6621419|NCT02193165|7548373|FG000|STARTED|6 Week Product Use||39
6621420|NCT02193165|7548374|FG001|STARTED|6 Week Product Use||39
6621421|NCT02193165|7548375|FG002|STARTED|6 Week Product Use||39
6621422|NCT02193165|7548373|FG000|COMPLETED|6 Week Product Use||39
6621423|NCT02193165|7548374|FG001|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
6621424|NCT02193165|7548375|FG002|COMPLETED|6 Week Product Use||39
6621425|NCT02193165|7548373|FG000|NOT COMPLETED|6 Week Product Use||0
6621426|NCT02193165|7548374|FG001|NOT COMPLETED|6 Week Product Use||1
6621427|NCT02193165|7548375|FG002|NOT COMPLETED|6 Week Product Use||0
6621428|NCT02193178|7548383|FG000|STARTED|Overall Study||15
6621429|NCT02193178|7548383|FG000|COMPLETED|Overall Study||13
6621430|NCT02193178|7548383|FG000|NOT COMPLETED|Overall Study||2
6621431|NCT02193347|7548401|FG000|STARTED|Overall Study||24
6621432|NCT02193347|7548401|FG000|COMPLETED|Overall Study||24
6621433|NCT02193347|7548401|FG000|NOT COMPLETED|Overall Study||0
6621434|NCT02193490|7548407|FG000|STARTED|Overall Study||25
6621435|NCT02193490|7548408|FG001|STARTED|Overall Study||22
6621436|NCT02193490|7548407|FG000|COMPLETED|Overall Study||21
6621437|NCT02193490|7548408|FG001|COMPLETED|Overall Study||20
6621438|NCT02193490|7548407|FG000|NOT COMPLETED|Overall Study||4
6621439|NCT02193490|7548408|FG001|NOT COMPLETED|Overall Study||2
6621440|NCT02193776|7548418|FG000|STARTED|Overall Study||59
6621441|NCT02193776|7548419|FG001|STARTED|Overall Study||60
6621442|NCT02193776|7548420|FG002|STARTED|Overall Study||61
6621443|NCT02193776|7548421|FG003|STARTED|Overall Study||60
6621444|NCT02193776|7548418|FG000|Completed Day 70 Follow-up|Overall Study||54
6621445|NCT02193776|7548419|FG001|Completed Day 70 Follow-up|Overall Study||56
6621446|NCT02193776|7548420|FG002|Completed Day 70 Follow-up|Overall Study||60
6621447|NCT02193776|7548421|FG003|Completed Day 70 Follow-up|Overall Study||60
6621448|NCT02193776|7548418|FG000|Completed Day 140 Follow-up|Overall Study||52
6621449|NCT02193776|7548419|FG001|Completed Day 140 Follow-up|Overall Study||52
6621450|NCT02193776|7548420|FG002|Completed Day 140 Follow-up|Overall Study||58
6621451|NCT02193776|7548421|FG003|Completed Day 140 Follow-up|Overall Study||58
6621452|NCT02193776|7548418|FG000|COMPLETED|Overall Study||51
6621453|NCT02193776|7548419|FG001|COMPLETED|Overall Study||53
6621454|NCT02193776|7548420|FG002|COMPLETED|Overall Study||59
6621455|NCT02193776|7548421|FG003|COMPLETED|Overall Study||58
6621456|NCT02193776|7548418|FG000|NOT COMPLETED|Overall Study||8
6621457|NCT02193776|7548419|FG001|NOT COMPLETED|Overall Study||7
6621458|NCT02193776|7548420|FG002|NOT COMPLETED|Overall Study||2
6621459|NCT02193776|7548421|FG003|NOT COMPLETED|Overall Study||2
6621460|NCT02193815|7548431|FG000|STARTED|Overall Study||15
6621461|NCT02193815|7548431|FG000|COMPLETED|Overall Study||15
6621462|NCT02193815|7548431|FG000|NOT COMPLETED|Overall Study||0
6621463|NCT02193828|7548449|FG000|STARTED|Overall Study||18
6621464|NCT02193828|7548450|FG001|STARTED|Overall Study||18
6621465|NCT02193828|7548451|FG002|STARTED|Overall Study||23
6621466|NCT02193828|7548452|FG003|STARTED|Overall Study||17
6621467|NCT02193828|7548449|FG000|COMPLETED|Overall Study||18
6621468|NCT02193828|7548450|FG001|COMPLETED|Overall Study||18
6621469|NCT02193828|7548451|FG002|COMPLETED|Overall Study||22
6621470|NCT02193828|7548452|FG003|COMPLETED|Overall Study||16
6621471|NCT02193828|7548449|FG000|NOT COMPLETED|Overall Study||0
6621472|NCT02193828|7548450|FG001|NOT COMPLETED|Overall Study||0
6621473|NCT02193828|7548451|FG002|NOT COMPLETED|Overall Study||1
6621474|NCT02193828|7548452|FG003|NOT COMPLETED|Overall Study||1
6621475|NCT02193880|7548462|FG000|STARTED|Overall Study||7
6621476|NCT02193880|7548462|FG000|COMPLETED|Overall Study||4
6621477|NCT02193880|7548462|FG000|NOT COMPLETED|Overall Study||3
6621478|NCT02194062|7548469|FG000|STARTED|Overall Study||10
6621479|NCT02194062|7548470|FG001|STARTED|Overall Study||10
6621480|NCT02194062|7548471|FG002|STARTED|Overall Study||12
6621481|NCT02194062|7548469|FG000|COMPLETED|Overall Study||8
6621482|NCT02194062|7548470|FG001|COMPLETED|Overall Study||8
6621483|NCT02194062|7548471|FG002|COMPLETED|Overall Study||7
6621484|NCT02194062|7548469|FG000|NOT COMPLETED|Overall Study||2
6621485|NCT02194062|7548470|FG001|NOT COMPLETED|Overall Study||2
6621486|NCT02194062|7548471|FG002|NOT COMPLETED|Overall Study||5
6621487|NCT02194088|7548481|FG000|STARTED|Overall Study||75
6621488|NCT02194088|7548482|FG001|STARTED|Overall Study||25
6621489|NCT02194088|7548481|FG000|COMPLETED|Overall Study||75
6621490|NCT02194088|7548482|FG001|COMPLETED|Overall Study||25
6621491|NCT02194088|7548481|FG000|NOT COMPLETED|Overall Study||0
6621492|NCT02194088|7548482|FG001|NOT COMPLETED|Overall Study||0
6621493|NCT02194439|7548490|FG000|STARTED|Overall Study||415
6621494|NCT02194439|7548490|FG000|COMPLETED|Overall Study||415
6621495|NCT02194439|7548490|FG000|NOT COMPLETED|Overall Study||0
6621496|NCT02194465|7548501|FG000|STARTED|Overall Study||51
6621497|NCT02194465|7548502|FG001|STARTED|Overall Study||50
6621498|NCT02194465|7548503|FG002|STARTED|Overall Study||52
6621499|NCT02194465|7548504|FG003|STARTED|Overall Study||49
6621500|NCT02194465|7548505|FG004|STARTED|Overall Study||51
6621501|NCT02194465|7548506|FG005|STARTED|Overall Study||25
6621502|NCT02194465|7548507|FG006|STARTED|Overall Study||26
6621503|NCT02194465|7548501|FG000|Received at Least 1 Dose of Study Drug|Overall Study||51
6621504|NCT02194465|7548502|FG001|Received at Least 1 Dose of Study Drug|Overall Study||50
6621505|NCT02194465|7548503|FG002|Received at Least 1 Dose of Study Drug|Overall Study||51
6621506|NCT02194465|7548504|FG003|Received at Least 1 Dose of Study Drug|Overall Study||49
6621507|NCT02194465|7548505|FG004|Received at Least 1 Dose of Study Drug|Overall Study||51
6621508|NCT02194465|7548506|FG005|Received at Least 1 Dose of Study Drug|Overall Study||25
6621509|NCT02194465|7548507|FG006|Received at Least 1 Dose of Study Drug|Overall Study||26
6621510|NCT02194465|7548501|FG000|COMPLETED|Overall Study||42
6621511|NCT02194465|7548502|FG001|COMPLETED|Overall Study||43
6621512|NCT02194465|7548503|FG002|COMPLETED|Overall Study||44
6621513|NCT02194465|7548504|FG003|COMPLETED|Overall Study||41
6621514|NCT02194465|7548505|FG004|COMPLETED|Overall Study||42
6621515|NCT02194465|7548506|FG005|COMPLETED|Overall Study||21
6621516|NCT02194465|7548507|FG006|COMPLETED|Overall Study||24
6621517|NCT02194465|7548501|FG000|NOT COMPLETED|Overall Study||9
6621518|NCT02194465|7548502|FG001|NOT COMPLETED|Overall Study||7
6621519|NCT02194465|7548503|FG002|NOT COMPLETED|Overall Study||8
6621520|NCT02194465|7548504|FG003|NOT COMPLETED|Overall Study||8
6621521|NCT02194465|7548505|FG004|NOT COMPLETED|Overall Study||9
6621522|NCT02194465|7548506|FG005|NOT COMPLETED|Overall Study||4
6621523|NCT02194465|7548507|FG006|NOT COMPLETED|Overall Study||2
6621524|NCT02194621|7548530|FG000|STARTED|Overall Study||43
6621525|NCT02194621|7548531|FG001|STARTED|Overall Study||42
6621526|NCT02194621|7548532|FG002|STARTED|Overall Study||43
6621527|NCT02194621|7548530|FG000|COMPLETED|Overall Study||37
6621528|NCT02194621|7548531|FG001|COMPLETED|Overall Study||36
6621529|NCT02194621|7548532|FG002|COMPLETED|Overall Study||34
6621530|NCT02194621|7548530|FG000|NOT COMPLETED|Overall Study||6
6621531|NCT02194621|7548531|FG001|NOT COMPLETED|Overall Study||6
6621532|NCT02194621|7548532|FG002|NOT COMPLETED|Overall Study||9
6621533|NCT02194699|7548542|FG000|STARTED|Randomised||428
6621534|NCT02194699|7548543|FG001|STARTED|Randomised||428
6621535|NCT02194699|7548542|FG000|COMPLETED|Randomised||420
6621536|NCT02194699|7548543|FG001|COMPLETED|Randomised||417
6621537|NCT02194699|7548542|FG000|NOT COMPLETED|Randomised||8
6621538|NCT02194699|7548543|FG001|NOT COMPLETED|Randomised||11
6621539|NCT02194699|7548542|FG000|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|420
6621540|NCT02194699|7548543|FG001|STARTED|With Potential to Receive 52 Weeks of IP|Includes all patients randomised with the potential to receive 52 weeks of IP and receiving any IP.|417
6621541|NCT02194699|7548542|FG000|COMPLETED|With Potential to Receive 52 Weeks of IP||370
6621542|NCT02194699|7548543|FG001|COMPLETED|With Potential to Receive 52 Weeks of IP||365
6621543|NCT02194699|7548542|FG000|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||50
6621544|NCT02194699|7548543|FG001|NOT COMPLETED|With Potential to Receive 52 Weeks of IP||52
6621545|NCT02194933|7548559|FG000|STARTED|Overall Study||19
6621546|NCT02194933|7548560|FG001|STARTED|Overall Study||19
6621547|NCT02194933|7548559|FG000|COMPLETED|Overall Study||16
6621548|NCT02194933|7548560|FG001|COMPLETED|Overall Study||10
6621549|NCT02194933|7548559|FG000|NOT COMPLETED|Overall Study||3
6621550|NCT02194933|7548560|FG001|NOT COMPLETED|Overall Study||9
6621551|NCT02194985|7548568|FG000|STARTED|Overall Study||84
6621552|NCT02194985|7548568|FG000|Received at Least 1 Dose of Study Drug|Overall Study||84
6621553|NCT02194985|7548568|FG000|COMPLETED|Overall Study||73
6621554|NCT02194985|7548568|FG000|NOT COMPLETED|Overall Study||11
6621555|NCT02194998|7548576|FG000|STARTED|On-HCV Treatment||21
6621556|NCT02194998|7548577|FG001|STARTED|On-HCV Treatment||6
6621557|NCT02194998|7548578|FG002|STARTED|On-HCV Treatment||15
6621558|NCT02194998|7548579|FG003|STARTED|On-HCV Treatment||4
6621559|NCT02194998|7548576|FG000|COMPLETED|On-HCV Treatment||21
6621560|NCT02194998|7548577|FG001|COMPLETED|On-HCV Treatment||5
6621561|NCT02194998|7548578|FG002|COMPLETED|On-HCV Treatment||15
6621562|NCT02194998|7548579|FG003|COMPLETED|On-HCV Treatment||4
6621563|NCT02194998|7548576|FG000|NOT COMPLETED|On-HCV Treatment||0
6621564|NCT02194998|7548577|FG001|NOT COMPLETED|On-HCV Treatment||1
6621565|NCT02194998|7548578|FG002|NOT COMPLETED|On-HCV Treatment||0
6621566|NCT02194998|7548579|FG003|NOT COMPLETED|On-HCV Treatment||0
6621567|NCT02194998|7548576|FG000|STARTED|Post-HCV Treatment Follow-Up||21
6621568|NCT02194998|7548577|FG001|STARTED|Post-HCV Treatment Follow-Up||5
6621569|NCT02194998|7548578|FG002|STARTED|Post-HCV Treatment Follow-Up||15
6621570|NCT02194998|7548579|FG003|STARTED|Post-HCV Treatment Follow-Up||4
6621571|NCT02194998|7548576|FG000|COMPLETED|Post-HCV Treatment Follow-Up||20
6621572|NCT02194998|7548577|FG001|COMPLETED|Post-HCV Treatment Follow-Up||5
6621573|NCT02194998|7548578|FG002|COMPLETED|Post-HCV Treatment Follow-Up||14
6621574|NCT02194998|7548579|FG003|COMPLETED|Post-HCV Treatment Follow-Up||4
6621575|NCT02194998|7548576|FG000|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
6621576|NCT02194998|7548577|FG001|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
6621577|NCT02194998|7548578|FG002|NOT COMPLETED|Post-HCV Treatment Follow-Up||1
6621578|NCT02194998|7548579|FG003|NOT COMPLETED|Post-HCV Treatment Follow-Up||0
6621579|NCT02195011|7548591|FG000|STARTED|Overall Study||25
6621580|NCT02195011|7548592|FG001|STARTED|Overall Study||1
6621581|NCT02195011|7548591|FG000|COMPLETED|Overall Study||0
6621582|NCT02195011|7548592|FG001|COMPLETED|Overall Study||0
6621583|NCT02195011|7548591|FG000|NOT COMPLETED|Overall Study||25
6621584|NCT02195011|7548592|FG001|NOT COMPLETED|Overall Study||1
6621585|NCT02195232|7548600|FG000|STARTED|Overall Study|patients consented|32
6621586|NCT02195232|7548601|FG001|STARTED|Overall Study|patients consented|32
6621587|NCT02195232|7548600|FG000|COMPLETED|Overall Study|Evaluated for VTE and safety|28
6621588|NCT02195232|7548601|FG001|COMPLETED|Overall Study|Evaluated for VTE and safety|29
6621589|NCT02195232|7548600|FG000|NOT COMPLETED|Overall Study||4
6621590|NCT02195232|7548601|FG001|NOT COMPLETED|Overall Study||3
6621591|NCT02195310|7548613|FG000|STARTED|Overall Study||173
6621592|NCT02195310|7548614|FG001|STARTED|Overall Study||169
6621593|NCT02195310|7548613|FG000|COMPLETED|Overall Study||153
6621594|NCT02195310|7548614|FG001|COMPLETED|Overall Study||153
6621595|NCT02195310|7548613|FG000|NOT COMPLETED|Overall Study||20
6621596|NCT02195310|7548614|FG001|NOT COMPLETED|Overall Study||16
6621597|NCT02195349|7548631|FG000|STARTED|Overall Study||14
6621598|NCT02195349|7548632|FG001|STARTED|Overall Study||1
6621599|NCT02195349|7548633|FG002|STARTED|Overall Study||1
6621600|NCT02195349|7548634|FG003|STARTED|Overall Study||6
6621601|NCT02195349|7548635|FG004|STARTED|Overall Study||6
6621602|NCT02195349|7548636|FG005|STARTED|Overall Study||6
6621603|NCT02195349|7548637|FG006|STARTED|Overall Study||6
6621604|NCT02195349|7548638|FG007|STARTED|Overall Study||9
6621605|NCT02195349|7548639|FG008|STARTED|Overall Study||6
6621606|NCT02195349|7548640|FG009|STARTED|Overall Study||6
6621607|NCT02195349|7548641|FG010|STARTED|Overall Study||6
6621608|NCT02195349|7548631|FG000|COMPLETED|Overall Study||14
6621609|NCT02195349|7548632|FG001|COMPLETED|Overall Study||1
6621610|NCT02195349|7548633|FG002|COMPLETED|Overall Study||1
6621611|NCT02195349|7548634|FG003|COMPLETED|Overall Study||6
6621612|NCT02195349|7548635|FG004|COMPLETED|Overall Study||6
6621613|NCT02195349|7548636|FG005|COMPLETED|Overall Study||6
6621614|NCT02195349|7548637|FG006|COMPLETED|Overall Study||6
6621615|NCT02195349|7548638|FG007|COMPLETED|Overall Study||9
6621616|NCT02195349|7548639|FG008|COMPLETED|Overall Study||6
6621617|NCT02195349|7548640|FG009|COMPLETED|Overall Study||6
6621618|NCT02195349|7548641|FG010|COMPLETED|Overall Study||6
6621619|NCT02195349|7548631|FG000|NOT COMPLETED|Overall Study||0
6621620|NCT02195349|7548632|FG001|NOT COMPLETED|Overall Study||0
6621621|NCT02195349|7548633|FG002|NOT COMPLETED|Overall Study||0
6621622|NCT02195349|7548634|FG003|NOT COMPLETED|Overall Study||0
6621623|NCT02195349|7548635|FG004|NOT COMPLETED|Overall Study||0
6621624|NCT02195349|7548636|FG005|NOT COMPLETED|Overall Study||0
6621625|NCT02195349|7548637|FG006|NOT COMPLETED|Overall Study||0
6621626|NCT02195349|7548638|FG007|NOT COMPLETED|Overall Study||0
6621627|NCT02195349|7548639|FG008|NOT COMPLETED|Overall Study||0
6621628|NCT02195349|7548640|FG009|NOT COMPLETED|Overall Study||0
6621629|NCT02195349|7548641|FG010|NOT COMPLETED|Overall Study||0
6621630|NCT02195414|7548681|FG000|STARTED|Overall Study||31
6621631|NCT02195414|7548681|FG000|Primary Endpoint|Overall Study||31
6621632|NCT02195414|7548681|FG000|COMPLETED|Overall Study||31
6621633|NCT02195414|7548681|FG000|NOT COMPLETED|Overall Study||0
6621634|NCT02195427|7548687|FG000|STARTED|Overall Study||73
6621635|NCT02195427|7548688|FG001|STARTED|Overall Study||74
6621636|NCT02195427|7548687|FG000|N Patients at W24 (Primary Outcome)|Overall Study||67
6621637|NCT02195427|7548688|FG001|N Patients at W24 (Primary Outcome)|Overall Study||62
6621638|NCT02195427|7548687|FG000|N Patients at W36|Overall Study||65
6621639|NCT02195427|7548688|FG001|N Patients at W36|Overall Study||59
6621640|NCT02195427|7548687|FG000|N Patients at W52|Overall Study||63
6621641|NCT02195427|7548688|FG001|N Patients at W52|Overall Study||56
6621642|NCT02195427|7548687|FG000|COMPLETED|Overall Study||47
6621643|NCT02195427|7548688|FG001|COMPLETED|Overall Study||47
6621644|NCT02195427|7548687|FG000|NOT COMPLETED|Overall Study||26
6621645|NCT02195427|7548688|FG001|NOT COMPLETED|Overall Study||27
6621646|NCT02195518|7548698|FG000|STARTED|Overall Study||213
6621647|NCT02195518|7548698|FG000|COMPLETED|Overall Study||204
6621648|NCT02195518|7548698|FG000|NOT COMPLETED|Overall Study||9
6621649|NCT02195531|7548705|FG000|STARTED|Overall Study||64
6621650|NCT02195531|7548706|FG001|STARTED|Overall Study||49
6621651|NCT02195531|7548707|FG002|STARTED|Overall Study||56
6621652|NCT02195531|7548705|FG000|COMPLETED|Overall Study||63
6621653|NCT02195531|7548706|FG001|COMPLETED|Overall Study||48
6621654|NCT02195531|7548707|FG002|COMPLETED|Overall Study||55
6621655|NCT02195531|7548705|FG000|NOT COMPLETED|Overall Study||1
6621656|NCT02195531|7548706|FG001|NOT COMPLETED|Overall Study||1
6621657|NCT02195531|7548707|FG002|NOT COMPLETED|Overall Study||1
6621658|NCT02195583|7548715|FG000|STARTED|Overall Study||62
6621659|NCT02195583|7548715|FG000|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
6621660|NCT02195583|7548715|FG000|Sodium Fluoride (0 Ppm)|Overall Study||59
6621661|NCT02195583|7548715|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
6621662|NCT02195583|7548715|FG000|Sodium Fluoride (250 Ppm)|Overall Study||55
6621663|NCT02195583|7548715|FG000|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
6621664|NCT02195583|7548715|FG000|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
6621665|NCT02195583|7548715|FG000|COMPLETED|Overall Study||53
6621666|NCT02195583|7548715|FG000|NOT COMPLETED|Overall Study||9
6621667|NCT02195622|7548732|FG000|STARTED|Overall Study||37
6621668|NCT02195622|7548733|FG001|STARTED|Overall Study||37
6621669|NCT02195622|7548732|FG000|COMPLETED|Overall Study||37
6621670|NCT02195622|7548733|FG001|COMPLETED|Overall Study||37
6621671|NCT02195622|7548732|FG000|NOT COMPLETED|Overall Study||0
6621672|NCT02195622|7548733|FG001|NOT COMPLETED|Overall Study||0
6621673|NCT02195687|7548741|FG000|STARTED|Overall Study||316
6621674|NCT02195687|7548742|FG001|STARTED|Overall Study||101
6621675|NCT02195687|7548741|FG000|COMPLETED|Overall Study||311
6621676|NCT02195687|7548742|FG001|COMPLETED|Overall Study||99
6621677|NCT02195687|7548741|FG000|NOT COMPLETED|Overall Study||5
6621678|NCT02195687|7548742|FG001|NOT COMPLETED|Overall Study||2
6621679|NCT02195700|7548750|FG000|STARTED|Overall Study||58
6621680|NCT02195700|7548751|FG001|STARTED|Overall Study||59
6621681|NCT02195700|7548750|FG000|Safety and ITT Populations|Overall Study||58
6621682|NCT02195700|7548751|FG001|Safety and ITT Populations|Overall Study||59
6621683|NCT02195700|7548750|FG000|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|56
6621684|NCT02195700|7548751|FG001|Modified ITT Population|Overall Study|ITT who received study drug and >=1 centrally read post-baseline AIMS from weeks 2, 4, 6, 9, or 12|57
6621685|NCT02195700|7548750|FG000|Maintenance Period|Overall Study||53
6621686|NCT02195700|7548751|FG001|Maintenance Period|Overall Study||54
6621687|NCT02195700|7548750|FG000|COMPLETED|Overall Study||52
6621688|NCT02195700|7548751|FG001|COMPLETED|Overall Study||52
6621689|NCT02195700|7548750|FG000|NOT COMPLETED|Overall Study||6
6621690|NCT02195700|7548751|FG001|NOT COMPLETED|Overall Study||7
6621691|NCT02195713|7548759|FG000|STARTED|Overall Study||10
6621692|NCT02195713|7548760|FG001|STARTED|Overall Study||10
6621693|NCT02195713|7548759|FG000|COMPLETED|Overall Study||10
6621694|NCT02195713|7548760|FG001|COMPLETED|Overall Study||10
6621695|NCT02195713|7548759|FG000|NOT COMPLETED|Overall Study||0
6621696|NCT02195713|7548760|FG001|NOT COMPLETED|Overall Study||0
6621697|NCT02195869|7548766|FG000|STARTED|Overall Study|Phase 1b: 6 patients, 420 mg, no DLT observed. Phase 2: 42 patients, 420 mg|42
6621698|NCT02195869|7548766|FG000|All-Treated Population|Overall Study||42
6621699|NCT02195869|7548766|FG000|COMPLETED|Overall Study||0
6621700|NCT02195869|7548766|FG000|NOT COMPLETED|Overall Study||42
6621701|NCT02195895|7548773|FG000|STARTED|Overall Study||17
6621702|NCT02195895|7548773|FG000|COMPLETED|Overall Study||17
6621703|NCT02195895|7548773|FG000|NOT COMPLETED|Overall Study||0
6621704|NCT02195921|7548781|FG000|STARTED|Overall Study||40
6621705|NCT02195921|7548782|FG001|STARTED|Overall Study||40
6621706|NCT02195921|7548783|FG002|STARTED|Overall Study||40
6621707|NCT02195921|7548784|FG003|STARTED|Overall Study||40
6621708|NCT02195921|7548781|FG000|COMPLETED|Overall Study||39
6621709|NCT02195921|7548782|FG001|COMPLETED|Overall Study||39
6621710|NCT02195921|7548783|FG002|COMPLETED|Overall Study||39
6621711|NCT02195921|7548784|FG003|COMPLETED|Overall Study||40
6621712|NCT02195921|7548781|FG000|NOT COMPLETED|Overall Study||1
6621713|NCT02195921|7548782|FG001|NOT COMPLETED|Overall Study||1
6621714|NCT02195921|7548783|FG002|NOT COMPLETED|Overall Study||1
6621715|NCT02195921|7548784|FG003|NOT COMPLETED|Overall Study||0
6621716|NCT02196038|7548801|FG000|STARTED|Overall Study||174
6621717|NCT02196038|7548802|FG001|STARTED|Overall Study||175
6621718|NCT02196038|7548801|FG000|COMPLETED|Overall Study||157
6621719|NCT02196038|7548802|FG001|COMPLETED|Overall Study||153
6621720|NCT02196038|7548801|FG000|NOT COMPLETED|Overall Study||17
6621721|NCT02196038|7548802|FG001|NOT COMPLETED|Overall Study||22
6621722|NCT02196077|7548808|FG000|STARTED|Overall Study||180
6621723|NCT02196077|7548808|FG000|BFF MDI 320/9.6 μg|Overall Study||155
6621724|NCT02196077|7548808|FG000|BFF MDI 160/9.6 μg|Overall Study||106
6621725|NCT02196077|7548808|FG000|BFF MDI 80/9.6 μg|Overall Study||103
6621726|NCT02196077|7548808|FG000|BD MDI 320 μg|Overall Study||108
6621727|NCT02196077|7548808|FG000|FF MDI 9.6 μg|Overall Study||157
6621728|NCT02196077|7548808|FG000|COMPLETED|Overall Study||133
6621729|NCT02196077|7548808|FG000|NOT COMPLETED|Overall Study||47
6621730|NCT02196168|7548822|FG000|STARTED|Overall Study||6
6621731|NCT02196168|7548823|FG001|STARTED|Overall Study||0
6621732|NCT02196168|7548822|FG000|COMPLETED|Overall Study||6
6621733|NCT02196168|7548823|FG001|COMPLETED|Overall Study||0
6621734|NCT02196168|7548822|FG000|NOT COMPLETED|Overall Study||0
6621735|NCT02196168|7548823|FG001|NOT COMPLETED|Overall Study||0
6621736|NCT02196259|7548832|FG000|STARTED|Overall Study||3
6621737|NCT02196259|7548833|FG001|STARTED|Overall Study||7
6621738|NCT02196259|7548834|FG002|STARTED|Overall Study||3
6621739|NCT02196259|7548832|FG000|COMPLETED|Overall Study||3
6621740|NCT02196259|7548833|FG001|COMPLETED|Overall Study||4
6621741|NCT02196259|7548834|FG002|COMPLETED|Overall Study||2
6621742|NCT02196259|7548832|FG000|NOT COMPLETED|Overall Study||0
6621743|NCT02196259|7548833|FG001|NOT COMPLETED|Overall Study||3
6621744|NCT02196259|7548834|FG002|NOT COMPLETED|Overall Study||1
6621745|NCT02196324|7548843|FG000|STARTED|Overall Study||63
6621746|NCT02196324|7548844|FG001|STARTED|Overall Study||65
6621747|NCT02196324|7548843|FG000|COMPLETED|Overall Study||48
6621748|NCT02196324|7548844|FG001|COMPLETED|Overall Study||57
6621749|NCT02196324|7548843|FG000|NOT COMPLETED|Overall Study||15
6621750|NCT02196324|7548844|FG001|NOT COMPLETED|Overall Study||8
6621751|NCT02196506|7548852|FG000|STARTED|Phase A||837
6621752|NCT02196506|7548853|FG001|STARTED|Phase A||0
6621753|NCT02196506|7548854|FG002|STARTED|Phase A||0
6621754|NCT02196506|7548855|FG003|STARTED|Phase A||0
6621755|NCT02196506|7548852|FG000|COMPLETED|Phase A||716
6621756|NCT02196506|7548853|FG001|COMPLETED|Phase A||0
6621757|NCT02196506|7548854|FG002|COMPLETED|Phase A||0
6621758|NCT02196506|7548855|FG003|COMPLETED|Phase A||0
6621759|NCT02196506|7548852|FG000|NOT COMPLETED|Phase A||121
6621760|NCT02196506|7548853|FG001|NOT COMPLETED|Phase A||0
6621761|NCT02196506|7548854|FG002|NOT COMPLETED|Phase A||0
6621762|NCT02196506|7548855|FG003|NOT COMPLETED|Phase A||0
6621763|NCT02196506|7548852|FG000|STARTED|Phase B||0
6621764|NCT02196506|7548853|FG001|STARTED|Phase B||192
6621765|NCT02196506|7548854|FG002|STARTED|Phase B||202
6621766|NCT02196506|7548855|FG003|STARTED|Phase B||0
6621767|NCT02196506|7548852|FG000|COMPLETED|Phase B||0
6621768|NCT02196506|7548853|FG001|COMPLETED|Phase B||177
6621769|NCT02196506|7548854|FG002|COMPLETED|Phase B||196
6621770|NCT02196506|7548855|FG003|COMPLETED|Phase B||0
6621771|NCT02196506|7548852|FG000|NOT COMPLETED|Phase B||0
6621772|NCT02196506|7548853|FG001|NOT COMPLETED|Phase B||15
6621773|NCT02196506|7548854|FG002|NOT COMPLETED|Phase B||6
6621774|NCT02196506|7548855|FG003|NOT COMPLETED|Phase B||0
6621775|NCT02196506|7548852|FG000|STARTED|Phase A+||0
6621776|NCT02196506|7548853|FG001|STARTED|Phase A+||0
6621777|NCT02196506|7548854|FG002|STARTED|Phase A+||0
6621778|NCT02196506|7548855|FG003|STARTED|Phase A+||322
6621779|NCT02196506|7548852|FG000|COMPLETED|Phase A+||0
6621780|NCT02196506|7548853|FG001|COMPLETED|Phase A+||0
6621781|NCT02196506|7548854|FG002|COMPLETED|Phase A+||0
6621782|NCT02196506|7548855|FG003|COMPLETED|Phase A+||308
6621783|NCT02196506|7548852|FG000|NOT COMPLETED|Phase A+||0
6621784|NCT02196506|7548853|FG001|NOT COMPLETED|Phase A+||0
6621785|NCT02196506|7548854|FG002|NOT COMPLETED|Phase A+||0
6621786|NCT02196506|7548855|FG003|NOT COMPLETED|Phase A+||14
6621787|NCT02196558|7548864|FG000|STARTED|Treatment Phase (12 Weeks)||12
6621788|NCT02196558|7548865|FG001|STARTED|Treatment Phase (12 Weeks)||15
6621789|NCT02196558|7548866|FG002|STARTED|Treatment Phase (12 Weeks)||10
6621790|NCT02196558|7548864|FG000|COMPLETED|Treatment Phase (12 Weeks)||12
6621791|NCT02196558|7548865|FG001|COMPLETED|Treatment Phase (12 Weeks)||12
6621792|NCT02196558|7548866|FG002|COMPLETED|Treatment Phase (12 Weeks)||8
6621793|NCT02196558|7548864|FG000|NOT COMPLETED|Treatment Phase (12 Weeks)||0
6621794|NCT02196558|7548865|FG001|NOT COMPLETED|Treatment Phase (12 Weeks)||3
6621795|NCT02196558|7548866|FG002|NOT COMPLETED|Treatment Phase (12 Weeks)||2
6621796|NCT02196558|7548864|FG000|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
6621797|NCT02196558|7548865|FG001|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|11
6621798|NCT02196558|7548866|FG002|STARTED|Extension Phase (40 Weeks)|Participants who wished to continue, had no safety issues, and had>=20% improvement in joint counts.|6
6621799|NCT02196558|7548864|FG000|COMPLETED|Extension Phase (40 Weeks)||9
6621800|NCT02196558|7548865|FG001|COMPLETED|Extension Phase (40 Weeks)||8
6621801|NCT02196558|7548866|FG002|COMPLETED|Extension Phase (40 Weeks)||5
6621802|NCT02196558|7548864|FG000|NOT COMPLETED|Extension Phase (40 Weeks)||2
6621803|NCT02196558|7548865|FG001|NOT COMPLETED|Extension Phase (40 Weeks)||3
6621804|NCT02196558|7548866|FG002|NOT COMPLETED|Extension Phase (40 Weeks)||1
6621805|NCT02196675|7548877|FG000|STARTED|Overall Study||27
6621806|NCT02196675|7548878|FG001|STARTED|Overall Study||70
6621807|NCT02196675|7548879|FG002|STARTED|Overall Study||8
6621808|NCT02196675|7548877|FG000|COMPLETED|Overall Study||25
6621809|NCT02196675|7548878|FG001|COMPLETED|Overall Study||68
6621810|NCT02196675|7548879|FG002|COMPLETED|Overall Study||7
6621811|NCT02196675|7548877|FG000|NOT COMPLETED|Overall Study||2
6621812|NCT02196675|7548878|FG001|NOT COMPLETED|Overall Study||2
6621813|NCT02196675|7548879|FG002|NOT COMPLETED|Overall Study||1
6621814|NCT02196688|7548889|FG000|STARTED|Overall Study||47
6621815|NCT02196688|7548890|FG001|STARTED|Overall Study||24
6621816|NCT02196688|7548889|FG000|COMPLETED|Overall Study||40
6621817|NCT02196688|7548890|FG001|COMPLETED|Overall Study||23
6621818|NCT02196688|7548889|FG000|NOT COMPLETED|Overall Study||7
6621819|NCT02196688|7548890|FG001|NOT COMPLETED|Overall Study||1
6621820|NCT02196701|7548898|FG000|STARTED|Overall Study||46
6621821|NCT02196701|7548898|FG000|COMPLETED|Overall Study||43
6621822|NCT02196701|7548898|FG000|NOT COMPLETED|Overall Study||3
6621823|NCT02196714|7548905|FG000|STARTED|Overall Study||24
6621824|NCT02196714|7548906|FG001|STARTED|Overall Study||23
6621825|NCT02196714|7548907|FG002|STARTED|Overall Study||24
6621826|NCT02196714|7548908|FG003|STARTED|Overall Study||24
6621827|NCT02196714|7548905|FG000|COMPLETED|Overall Study||24
6621828|NCT02196714|7548906|FG001|COMPLETED|Overall Study||23
6621829|NCT02196714|7548907|FG002|COMPLETED|Overall Study||23
6621830|NCT02196714|7548908|FG003|COMPLETED|Overall Study||24
6621831|NCT02196714|7548905|FG000|NOT COMPLETED|Overall Study||0
6621832|NCT02196714|7548906|FG001|NOT COMPLETED|Overall Study||0
6621833|NCT02196714|7548907|FG002|NOT COMPLETED|Overall Study||1
6621834|NCT02196714|7548908|FG003|NOT COMPLETED|Overall Study||0
6621835|NCT02196766|7548920|FG000|STARTED|First Intervention (7 Days)||15
6621836|NCT02196766|7548921|FG001|STARTED|First Intervention (7 Days)||15
6621837|NCT02196766|7548920|FG000|COMPLETED|First Intervention (7 Days)||15
6621838|NCT02196766|7548921|FG001|COMPLETED|First Intervention (7 Days)||15
6621839|NCT02196766|7548920|FG000|NOT COMPLETED|First Intervention (7 Days)||0
6621840|NCT02196766|7548921|FG001|NOT COMPLETED|First Intervention (7 Days)||0
6621841|NCT02196766|7548920|FG000|STARTED|Second Intervention (7 Days)||15
6621842|NCT02196766|7548921|FG001|STARTED|Second Intervention (7 Days)||15
6621843|NCT02196766|7548920|FG000|COMPLETED|Second Intervention (7 Days)||15
6621844|NCT02196766|7548921|FG001|COMPLETED|Second Intervention (7 Days)||15
6621845|NCT02196766|7548920|FG000|NOT COMPLETED|Second Intervention (7 Days)||0
6621846|NCT02196766|7548921|FG001|NOT COMPLETED|Second Intervention (7 Days)||0
6621847|NCT02196831|7548929|FG000|STARTED|Overall Study||30
6621848|NCT02196831|7548930|FG001|STARTED|Overall Study||30
6621849|NCT02196831|7548929|FG000|Received Follow-up Imaging|Overall Study||26
6621850|NCT02196831|7548930|FG001|Received Follow-up Imaging|Overall Study||28
6621851|NCT02196831|7548929|FG000|COMPLETED|Overall Study||21
6621852|NCT02196831|7548930|FG001|COMPLETED|Overall Study||26
6621853|NCT02196831|7548929|FG000|NOT COMPLETED|Overall Study||9
6621854|NCT02196831|7548930|FG001|NOT COMPLETED|Overall Study||4
6621855|NCT02196857|7548937|FG000|STARTED|Overall Study||16
6621856|NCT02196857|7548937|FG000|COMPLETED|Overall Study||16
6621857|NCT02196857|7548937|FG000|NOT COMPLETED|Overall Study||0
6621858|NCT02196922|7548943|FG000|STARTED|Overall Study||58
6621859|NCT02196922|7548944|FG001|STARTED|Overall Study||46
6621860|NCT02196922|7548943|FG000|COMPLETED|Overall Study||58
6621861|NCT02196922|7548944|FG001|COMPLETED|Overall Study||46
6621862|NCT02196922|7548943|FG000|NOT COMPLETED|Overall Study||0
6621863|NCT02196922|7548944|FG001|NOT COMPLETED|Overall Study||0
6621864|NCT02197065|7548954|FG000|STARTED|Overall Study||10
6621865|NCT02197065|7548955|FG001|STARTED|Overall Study||10
6621866|NCT02197065|7548954|FG000|COMPLETED|Overall Study||10
6621867|NCT02197065|7548955|FG001|COMPLETED|Overall Study||10
6621868|NCT02197065|7548954|FG000|NOT COMPLETED|Overall Study||0
6621869|NCT02197065|7548955|FG001|NOT COMPLETED|Overall Study||0
6621870|NCT02197078|7548976|FG000|STARTED|Overall Study||14688
6621871|NCT02197078|7548977|FG001|STARTED|Overall Study||14688
6621872|NCT02197078|7548978|FG002|STARTED|Overall Study||10614
6621873|NCT02197078|7548979|FG003|STARTED|Overall Study||10614
6621874|NCT02197078|7548980|FG004|STARTED|Overall Study||9538
6621875|NCT02197078|7548981|FG005|STARTED|Overall Study||9538
6621876|NCT02197078|7548982|FG006|STARTED|Overall Study||25135
6621877|NCT02197078|7548983|FG007|STARTED|Overall Study||25135
6621878|NCT02197078|7548984|FG008|STARTED|Overall Study||18996
6621879|NCT02197078|7548985|FG009|STARTED|Overall Study||18996
6621880|NCT02197078|7548986|FG010|STARTED|Overall Study||15742
6621881|NCT02197078|7548987|FG011|STARTED|Overall Study||15742
6621882|NCT02197078|7548976|FG000|COMPLETED|Overall Study||14688
6621883|NCT02197078|7548977|FG001|COMPLETED|Overall Study||14688
6621884|NCT02197078|7548978|FG002|COMPLETED|Overall Study||10614
6621885|NCT02197078|7548979|FG003|COMPLETED|Overall Study||10614
6621886|NCT02197078|7548980|FG004|COMPLETED|Overall Study||9538
6621887|NCT02197078|7548981|FG005|COMPLETED|Overall Study||9538
6621888|NCT02197078|7548982|FG006|COMPLETED|Overall Study||25135
6621889|NCT02197078|7548983|FG007|COMPLETED|Overall Study||25135
6621890|NCT02197078|7548984|FG008|COMPLETED|Overall Study||18996
6621891|NCT02197078|7548985|FG009|COMPLETED|Overall Study||18996
6621892|NCT02197078|7548986|FG010|COMPLETED|Overall Study||15742
6621893|NCT02197078|7548987|FG011|COMPLETED|Overall Study||15742
6621894|NCT02197078|7548976|FG000|NOT COMPLETED|Overall Study||0
6621895|NCT02197078|7548977|FG001|NOT COMPLETED|Overall Study||0
6621896|NCT02197078|7548978|FG002|NOT COMPLETED|Overall Study||0
6621897|NCT02197078|7548979|FG003|NOT COMPLETED|Overall Study||0
6621898|NCT02197078|7548980|FG004|NOT COMPLETED|Overall Study||0
6621899|NCT02197078|7548981|FG005|NOT COMPLETED|Overall Study||0
6621900|NCT02197078|7548982|FG006|NOT COMPLETED|Overall Study||0
6621901|NCT02197078|7548983|FG007|NOT COMPLETED|Overall Study||0
6621902|NCT02197078|7548984|FG008|NOT COMPLETED|Overall Study||0
6621903|NCT02197078|7548985|FG009|NOT COMPLETED|Overall Study||0
6621904|NCT02197078|7548986|FG010|NOT COMPLETED|Overall Study||0
6621905|NCT02197078|7548987|FG011|NOT COMPLETED|Overall Study||0
6621906|NCT02197130|7549016|FG000|STARTED|Overall Study||95
6621907|NCT02197130|7549017|FG001|STARTED|Overall Study||89
6621908|NCT02197130|7549018|FG002|STARTED|Overall Study||88
6621909|NCT02197130|7549016|FG000|Received Treatment|Overall Study||95
6621910|NCT02197130|7549017|FG001|Received Treatment|Overall Study||88
6621911|NCT02197130|7549018|FG002|Received Treatment|Overall Study||87
6621912|NCT02197130|7549016|FG000|COMPLETED|Overall Study||79
6621913|NCT02197130|7549017|FG001|COMPLETED|Overall Study||81
6621914|NCT02197130|7549018|FG002|COMPLETED|Overall Study||56
6621915|NCT02197130|7549016|FG000|NOT COMPLETED|Overall Study||16
6621916|NCT02197130|7549017|FG001|NOT COMPLETED|Overall Study||8
6621917|NCT02197130|7549018|FG002|NOT COMPLETED|Overall Study||32
6621918|NCT02197247|7549026|FG000|STARTED|Part A: Day 1-28 (AZD9291 Alone)||41
6621919|NCT02197247|7549026|FG000|COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||41
6621920|NCT02197247|7549026|FG000|NOT COMPLETED|Part A: Day 1-28 (AZD9291 Alone)||0
6621921|NCT02197247|7549026|FG000|STARTED|Part A: Day 29-49 (AZD9291+Rifampicin)||41
6621922|NCT02197247|7549026|FG000|COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||37
6621923|NCT02197247|7549026|FG000|NOT COMPLETED|Part A: Day 29-49 (AZD9291+Rifampicin)||4
6621924|NCT02197247|7549026|FG000|STARTED|Part A: Day 50-77 (AZD9291 Alone)||37
6621925|NCT02197247|7549026|FG000|COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||32
6621926|NCT02197247|7549026|FG000|NOT COMPLETED|Part A: Day 50-77 (AZD9291 Alone)||5
6621927|NCT02197247|7549026|FG000|STARTED|Part B: Day 78 to End Part B (AZD9291)|32 completed Part A + 2 entered Part B without completing Part A (both due to AE) =34 started Part B|34
6621928|NCT02197247|7549026|FG000|COMPLETED|Part B: Day 78 to End Part B (AZD9291)||19
6621929|NCT02197247|7549026|FG000|NOT COMPLETED|Part B: Day 78 to End Part B (AZD9291)||15
6621930|NCT02197273|7549038|FG000|STARTED|Overall Study||107
6621931|NCT02197273|7549039|FG001|STARTED|Overall Study||104
6621932|NCT02197273|7549038|FG000|COMPLETED|Overall Study||107
6621933|NCT02197273|7549039|FG001|COMPLETED|Overall Study||104
6621934|NCT02197273|7549038|FG000|NOT COMPLETED|Overall Study||0
6621935|NCT02197273|7549039|FG001|NOT COMPLETED|Overall Study||0
6621936|NCT02197377|7549047|FG000|STARTED|Overall Study||30
6621937|NCT02197377|7549048|FG001|STARTED|Overall Study||30
6621938|NCT02197377|7549047|FG000|COMPLETED|Overall Study||30
6621939|NCT02197377|7549048|FG001|COMPLETED|Overall Study||27
6621940|NCT02197377|7549047|FG000|NOT COMPLETED|Overall Study||0
6621941|NCT02197377|7549048|FG001|NOT COMPLETED|Overall Study||3
6621942|NCT02197416|7549057|FG000|STARTED|Overall Study||9
6621943|NCT02197416|7549058|FG001|STARTED|Overall Study||43
6621944|NCT02197416|7549059|FG002|STARTED|Overall Study||161
6621945|NCT02197416|7549057|FG000|COMPLETED|Overall Study||8
6621946|NCT02197416|7549058|FG001|COMPLETED|Overall Study||39
6621947|NCT02197416|7549059|FG002|COMPLETED|Overall Study||153
6621948|NCT02197416|7549057|FG000|NOT COMPLETED|Overall Study||1
6621949|NCT02197416|7549058|FG001|NOT COMPLETED|Overall Study||4
6621950|NCT02197416|7549059|FG002|NOT COMPLETED|Overall Study||8
6621951|NCT02197455|7549065|FG000|STARTED|Overall Study||30
6621952|NCT02197455|7549065|FG000|COMPLETED|Overall Study||30
6621953|NCT02197455|7549065|FG000|NOT COMPLETED|Overall Study||0
6621954|NCT02197481|7549071|FG000|STARTED|Overall Study|October 2014|43
6733480|NCT03211234|7663020|FG000|COMPLETED|Overall Study||16
6733481|NCT03211234|7663021|FG001|COMPLETED|Overall Study||30
6733482|NCT03211234|7663022|FG002|COMPLETED|Overall Study||25
6733483|NCT03211234|7663020|FG000|NOT COMPLETED|Overall Study||1
6733484|NCT03211234|7663021|FG001|NOT COMPLETED|Overall Study||1
6733485|NCT03211234|7663022|FG002|NOT COMPLETED|Overall Study||3
6733486|NCT03212261|7663030|FG000|STARTED|Overall Study|Enrolled: eligible at time of approach and signed a consent.|37
6733487|NCT03212261|7663030|FG000|Remained Eligible|Overall Study||35
6733488|NCT03212261|7663030|FG000|Baseline Completion|Overall Study|Lost patients: Technology difficulties (n=2), Family Emergency (n=1), Too busy (n=3), LTFU (n=1)|30
6733489|NCT03212261|7663030|FG000|Program Initiation|Overall Study|Lost patients: Tech trouble no first visit (n=1), Too busy/no time (n=2), LTFU (n=1)|26
6733490|NCT03212261|7663030|FG000|Post-intervention Survey|Overall Study|Lost to follow up (n=4)|22
6733491|NCT03212261|7663030|FG000|One Month Follow-up|Overall Study|Lost to follow up (n=1)|21
6733492|NCT03212261|7663030|FG000|COMPLETED|Overall Study||21
6733493|NCT03212261|7663030|FG000|NOT COMPLETED|Overall Study||16
6733494|NCT03212326|7663035|FG000|STARTED|Overall Study||24
6733495|NCT03212326|7663035|FG000|COMPLETED|Overall Study||20
6733496|NCT03212326|7663035|FG000|NOT COMPLETED|Overall Study||4
6733497|NCT03212365|7663041|FG000|STARTED|Overall Study||151
6733498|NCT03212365|7663042|FG001|STARTED|Overall Study||144
6733499|NCT03212365|7663041|FG000|COMPLETED|Overall Study||128
6733500|NCT03212365|7663042|FG001|COMPLETED|Overall Study||130
6733501|NCT03212365|7663041|FG000|NOT COMPLETED|Overall Study||23
6733502|NCT03212365|7663042|FG001|NOT COMPLETED|Overall Study||14
6733503|NCT03212521|7663048|FG000|STARTED|Overall Study||230
6733504|NCT03212521|7663048|FG000|COMPLETED|Overall Study||223
6733505|NCT03212521|7663048|FG000|NOT COMPLETED|Overall Study||7
6733506|NCT03212638|7663054|FG000|STARTED|Period 1||8
6733507|NCT03212638|7663055|FG001|STARTED|Period 1||8
6621955|NCT02197481|7549072|FG001|STARTED|Overall Study||43
6621956|NCT02197481|7549071|FG000|COMPLETED|Overall Study|February 2016|43
6621957|NCT02197481|7549072|FG001|COMPLETED|Overall Study||43
6621958|NCT02197481|7549071|FG000|NOT COMPLETED|Overall Study||0
6621959|NCT02197481|7549072|FG001|NOT COMPLETED|Overall Study||0
6621960|NCT02197520|7549078|FG000|STARTED|Period 1||12
6621961|NCT02197520|7549079|FG001|STARTED|Period 1||12
6621962|NCT02197520|7549078|FG000|COMPLETED|Period 1||11
6621963|NCT02197520|7549079|FG001|COMPLETED|Period 1||12
6621964|NCT02197520|7549078|FG000|NOT COMPLETED|Period 1||1
6621965|NCT02197520|7549079|FG001|NOT COMPLETED|Period 1||0
6621966|NCT02197520|7549078|FG000|STARTED|Period 2||11
6621967|NCT02197520|7549079|FG001|STARTED|Period 2||12
6621968|NCT02197520|7549078|FG000|COMPLETED|Period 2||10
6621969|NCT02197520|7549079|FG001|COMPLETED|Period 2||10
6621970|NCT02197520|7549078|FG000|NOT COMPLETED|Period 2||1
6621971|NCT02197520|7549079|FG001|NOT COMPLETED|Period 2||2
6621972|NCT02197572|7549087|FG000|STARTED|Overall Study||44
6621973|NCT02197572|7549087|FG000|COMPLETED|Overall Study||0
6621974|NCT02197572|7549087|FG000|NOT COMPLETED|Overall Study||44
6621975|NCT02197767|7549091|FG000|STARTED|Overall Study||11
6621976|NCT02197767|7549091|FG000|COMPLETED|Overall Study||11
6621977|NCT02197767|7549091|FG000|NOT COMPLETED|Overall Study||0
6621978|NCT02197806|7549099|FG000|STARTED|Overall Study||15
6621979|NCT02197806|7549100|FG001|STARTED|Overall Study||17
6621980|NCT02197806|7549101|FG002|STARTED|Overall Study||16
6621981|NCT02197806|7549102|FG003|STARTED|Overall Study||17
6621982|NCT02197806|7549099|FG000|COMPLETED|Overall Study||15
6621983|NCT02197806|7549100|FG001|COMPLETED|Overall Study||16
6621984|NCT02197806|7549101|FG002|COMPLETED|Overall Study||16
6621985|NCT02197806|7549102|FG003|COMPLETED|Overall Study||16
6621986|NCT02197806|7549099|FG000|NOT COMPLETED|Overall Study||0
6621987|NCT02197806|7549100|FG001|NOT COMPLETED|Overall Study||1
6621988|NCT02197806|7549101|FG002|NOT COMPLETED|Overall Study||0
6621989|NCT02197806|7549102|FG003|NOT COMPLETED|Overall Study||1
6621990|NCT02197897|7549112|FG000|STARTED|Overall Study||15
6621991|NCT02197897|7549112|FG000|COMPLETED|Overall Study||14
6621992|NCT02197897|7549112|FG000|NOT COMPLETED|Overall Study||1
6621993|NCT02198040|7549119|FG000|STARTED|Overall Study||9
6621994|NCT02198040|7549120|FG001|STARTED|Overall Study||9
6621995|NCT02198040|7549121|FG002|STARTED|Overall Study||9
6621996|NCT02198040|7549119|FG000|COMPLETED|Overall Study||9
6621997|NCT02198040|7549120|FG001|COMPLETED|Overall Study||8
6621998|NCT02198040|7549121|FG002|COMPLETED|Overall Study||8
6621999|NCT02198040|7549119|FG000|NOT COMPLETED|Overall Study||0
6622000|NCT02198040|7549120|FG001|NOT COMPLETED|Overall Study||1
6622001|NCT02198040|7549121|FG002|NOT COMPLETED|Overall Study||1
6622002|NCT02198235|7549134|FG000|STARTED|Overall Study||30
6622003|NCT02198235|7549135|FG001|STARTED|Overall Study||30
6622004|NCT02198235|7549136|FG002|STARTED|Overall Study||30
6622005|NCT02198235|7549134|FG000|COMPLETED|Overall Study||27
6622006|NCT02198235|7549135|FG001|COMPLETED|Overall Study||28
6622007|NCT02198235|7549136|FG002|COMPLETED|Overall Study||28
6622008|NCT02198235|7549134|FG000|NOT COMPLETED|Overall Study||3
6622009|NCT02198235|7549135|FG001|NOT COMPLETED|Overall Study||2
6622010|NCT02198235|7549136|FG002|NOT COMPLETED|Overall Study||2
6622011|NCT02198430|7549146|FG000|STARTED|Overall Study||53
6622012|NCT02198430|7549147|FG001|STARTED|Overall Study||51
6622013|NCT02198430|7549146|FG000|COMPLETED|Overall Study||53
6622014|NCT02198430|7549147|FG001|COMPLETED|Overall Study||51
6622015|NCT02198430|7549146|FG000|NOT COMPLETED|Overall Study||0
6622016|NCT02198430|7549147|FG001|NOT COMPLETED|Overall Study||0
6622017|NCT02198651|7549153|FG000|STARTED|Lead-in Period||149
6622018|NCT02198651|7549154|FG001|STARTED|Lead-in Period||0
6622019|NCT02198651|7549155|FG002|STARTED|Lead-in Period||0
6622020|NCT02198651|7549156|FG003|STARTED|Lead-in Period||0
6622021|NCT02198651|7549157|FG004|STARTED|Lead-in Period||0
6622022|NCT02198651|7549153|FG000|Participants Treated in Lead-In Period|Lead-in Period||146
6622023|NCT02198651|7549154|FG001|Participants Treated in Lead-In Period|Lead-in Period||0
6622024|NCT02198651|7549155|FG002|Participants Treated in Lead-In Period|Lead-in Period||0
6622025|NCT02198651|7549156|FG003|Participants Treated in Lead-In Period|Lead-in Period||0
6622026|NCT02198651|7549157|FG004|Participants Treated in Lead-In Period|Lead-in Period||0
6622027|NCT02198651|7549153|FG000|COMPLETED|Lead-in Period||112
6622028|NCT02198651|7549154|FG001|COMPLETED|Lead-in Period||0
6622029|NCT02198651|7549155|FG002|COMPLETED|Lead-in Period||0
6622030|NCT02198651|7549156|FG003|COMPLETED|Lead-in Period||0
6622031|NCT02198651|7549157|FG004|COMPLETED|Lead-in Period||0
6622032|NCT02198651|7549153|FG000|NOT COMPLETED|Lead-in Period||37
6622033|NCT02198651|7549154|FG001|NOT COMPLETED|Lead-in Period||0
6622034|NCT02198651|7549155|FG002|NOT COMPLETED|Lead-in Period||0
6622035|NCT02198651|7549156|FG003|NOT COMPLETED|Lead-in Period||0
6622036|NCT02198651|7549157|FG004|NOT COMPLETED|Lead-in Period||0
6622037|NCT02198651|7549153|FG000|STARTED|Double-blind Period||0
6622038|NCT02198651|7549154|FG001|STARTED|Double-blind Period||102
6622039|NCT02198651|7549155|FG002|STARTED|Double-blind Period||20
6622040|NCT02198651|7549156|FG003|STARTED|Double-blind Period||0
6622041|NCT02198651|7549157|FG004|STARTED|Double-blind Period||0
6622042|NCT02198651|7549153|FG000|COMPLETED|Double-blind Period||0
6622043|NCT02198651|7549154|FG001|COMPLETED|Double-blind Period||93
6622044|NCT02198651|7549155|FG002|COMPLETED|Double-blind Period||19
6622045|NCT02198651|7549156|FG003|COMPLETED|Double-blind Period||0
6622046|NCT02198651|7549157|FG004|COMPLETED|Double-blind Period||0
6622047|NCT02198651|7549153|FG000|NOT COMPLETED|Double-blind Period||0
6622048|NCT02198651|7549154|FG001|NOT COMPLETED|Double-blind Period||9
6622049|NCT02198651|7549155|FG002|NOT COMPLETED|Double-blind Period||1
6622050|NCT02198651|7549156|FG003|NOT COMPLETED|Double-blind Period||0
6622051|NCT02198651|7549157|FG004|NOT COMPLETED|Double-blind Period||0
6622052|NCT02198651|7549153|FG000|STARTED|Open-label Rescue Period||0
6622053|NCT02198651|7549154|FG001|STARTED|Open-label Rescue Period||0
6622054|NCT02198651|7549155|FG002|STARTED|Open-label Rescue Period||0
6622055|NCT02198651|7549156|FG003|STARTED|Open-label Rescue Period||31
6622056|NCT02198651|7549157|FG004|STARTED|Open-label Rescue Period||8
6622057|NCT02198651|7549153|FG000|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
6622058|NCT02198651|7549154|FG001|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
6622059|NCT02198651|7549155|FG002|Correctly Entered Open-label Rescue|Open-label Rescue Period||0
6622060|NCT02198651|7549156|FG003|Correctly Entered Open-label Rescue|Open-label Rescue Period||30
6622061|NCT02198651|7549157|FG004|Correctly Entered Open-label Rescue|Open-label Rescue Period||8
6622062|NCT02198651|7549153|FG000|COMPLETED|Open-label Rescue Period||0
6622063|NCT02198651|7549154|FG001|COMPLETED|Open-label Rescue Period||0
6622064|NCT02198651|7549155|FG002|COMPLETED|Open-label Rescue Period||0
6622065|NCT02198651|7549156|FG003|COMPLETED|Open-label Rescue Period||28
6622066|NCT02198651|7549157|FG004|COMPLETED|Open-label Rescue Period||8
6622067|NCT02198651|7549153|FG000|NOT COMPLETED|Open-label Rescue Period||0
6622068|NCT02198651|7549154|FG001|NOT COMPLETED|Open-label Rescue Period||0
6622069|NCT02198651|7549155|FG002|NOT COMPLETED|Open-label Rescue Period||0
6622070|NCT02198651|7549156|FG003|NOT COMPLETED|Open-label Rescue Period||3
6622071|NCT02198651|7549157|FG004|NOT COMPLETED|Open-label Rescue Period||0
6622072|NCT02198664|7549172|FG000|STARTED|Overall Study||26
6622073|NCT02198664|7549173|FG001|STARTED|Overall Study||21
6622074|NCT02198664|7549172|FG000|COMPLETED|Overall Study||10
6622075|NCT02198664|7549173|FG001|COMPLETED|Overall Study||13
6622076|NCT02198664|7549172|FG000|NOT COMPLETED|Overall Study||16
6622077|NCT02198664|7549173|FG001|NOT COMPLETED|Overall Study||8
6622078|NCT02198963|7549181|FG000|STARTED|Overall Study||43
6622079|NCT02198963|7549181|FG000|COMPLETED|Overall Study||36
6622080|NCT02198963|7549181|FG000|NOT COMPLETED|Overall Study||7
6622081|NCT02199028|7549192|FG000|STARTED|Week 1||15
6622082|NCT02199028|7549193|FG001|STARTED|Week 1||15
6622083|NCT02199028|7549192|FG000|COMPLETED|Week 1||14
6622084|NCT02199028|7549193|FG001|COMPLETED|Week 1||15
6622085|NCT02199028|7549192|FG000|NOT COMPLETED|Week 1||1
6622086|NCT02199028|7549193|FG001|NOT COMPLETED|Week 1||0
6622087|NCT02199028|7549192|FG000|STARTED|Week 2||14
6622088|NCT02199028|7549193|FG001|STARTED|Week 2||15
6622089|NCT02199028|7549192|FG000|COMPLETED|Week 2||14
6622090|NCT02199028|7549193|FG001|COMPLETED|Week 2||15
6622091|NCT02199028|7549192|FG000|NOT COMPLETED|Week 2||0
6622092|NCT02199028|7549193|FG001|NOT COMPLETED|Week 2||0
6622093|NCT02199028|7549192|FG000|STARTED|Week 3||14
6622094|NCT02199028|7549193|FG001|STARTED|Week 3||15
6622095|NCT02199028|7549192|FG000|COMPLETED|Week 3||13
6622096|NCT02199028|7549193|FG001|COMPLETED|Week 3||15
6622097|NCT02199028|7549192|FG000|NOT COMPLETED|Week 3||1
6622098|NCT02199028|7549193|FG001|NOT COMPLETED|Week 3||0
6622099|NCT02199028|7549192|FG000|STARTED|Week 4||13
6622100|NCT02199028|7549193|FG001|STARTED|Week 4||15
6622101|NCT02199028|7549192|FG000|COMPLETED|Week 4||13
6622102|NCT02199028|7549193|FG001|COMPLETED|Week 4||15
6622103|NCT02199028|7549192|FG000|NOT COMPLETED|Week 4||0
6622104|NCT02199028|7549193|FG001|NOT COMPLETED|Week 4||0
6622105|NCT02199041|7549200|FG000|STARTED|Overall Study||12
6622106|NCT02199041|7549200|FG000|COMPLETED|Overall Study||12
6622107|NCT02199041|7549200|FG000|NOT COMPLETED|Overall Study||0
6622108|NCT02199080|7549205|FG000|STARTED|Overall Study||2506
6622109|NCT02199080|7549205|FG000|COMPLETED|Overall Study||2494
6622110|NCT02199080|7549205|FG000|NOT COMPLETED|Overall Study||12
6622111|NCT02199197|7549213|FG000|STARTED|Overall Study||35
6622112|NCT02199197|7549214|FG001|STARTED|Overall Study||14
6622113|NCT02199197|7549213|FG000|COMPLETED|Overall Study||35
6622114|NCT02199197|7549214|FG001|COMPLETED|Overall Study||12
6622115|NCT02199197|7549213|FG000|NOT COMPLETED|Overall Study||0
6622116|NCT02199197|7549214|FG001|NOT COMPLETED|Overall Study||2
6622117|NCT02199314|7549221|FG000|STARTED|Overall Study||30
6622118|NCT02199314|7549221|FG000|COMPLETED|Overall Study||14
6622119|NCT02199314|7549221|FG000|NOT COMPLETED|Overall Study||16
6622120|NCT02199496|7549227|FG000|STARTED|Ustekinumab-Single Dose||3
6622121|NCT02199496|7549228|FG001|STARTED|Ustekinumab-Single Dose||0
6622122|NCT02199496|7549227|FG000|COMPLETED|Ustekinumab-Single Dose||3
6622123|NCT02199496|7549228|FG001|COMPLETED|Ustekinumab-Single Dose||0
6622124|NCT02199496|7549227|FG000|NOT COMPLETED|Ustekinumab-Single Dose||0
6622125|NCT02199496|7549228|FG001|NOT COMPLETED|Ustekinumab-Single Dose||0
6622126|NCT02199496|7549227|FG000|STARTED|Ustekinumab-Multi-dose||3
6622127|NCT02199496|7549228|FG001|STARTED|Ustekinumab-Multi-dose|Cohort 2 only participated in multi-dose phase 2|2
6622128|NCT02199496|7549227|FG000|COMPLETED|Ustekinumab-Multi-dose||3
6622129|NCT02199496|7549228|FG001|COMPLETED|Ustekinumab-Multi-dose||2
6622130|NCT02199496|7549227|FG000|NOT COMPLETED|Ustekinumab-Multi-dose||0
6622131|NCT02199496|7549228|FG001|NOT COMPLETED|Ustekinumab-Multi-dose||0
6622132|NCT02199509|7549236|FG000|STARTED|Overall Study||3
6622133|NCT02199509|7549237|FG001|STARTED|Overall Study||4
6622134|NCT02199509|7549236|FG000|COMPLETED|Overall Study||2
6622135|NCT02199509|7549237|FG001|COMPLETED|Overall Study||3
6622136|NCT02199509|7549236|FG000|NOT COMPLETED|Overall Study||1
6622137|NCT02199509|7549237|FG001|NOT COMPLETED|Overall Study||1
6622138|NCT02199574|7549247|FG000|STARTED|Overall Study||12
6622139|NCT02199574|7549247|FG000|COMPLETED|Overall Study||12
6622140|NCT02199574|7549247|FG000|NOT COMPLETED|Overall Study||0
6622141|NCT02199652|7549255|FG000|STARTED|Overall Study||10
6622142|NCT02199652|7549256|FG001|STARTED|Overall Study||10
6622143|NCT02199652|7549255|FG000|COMPLETED|Overall Study||3
6622144|NCT02199652|7549256|FG001|COMPLETED|Overall Study||3
6622145|NCT02199652|7549255|FG000|NOT COMPLETED|Overall Study||7
6622146|NCT02199652|7549256|FG001|NOT COMPLETED|Overall Study||7
6622147|NCT02199717|7549262|FG000|STARTED|Overall Study||66
6622148|NCT02199717|7549262|FG000|COMPLETED|Overall Study||66
6622149|NCT02199717|7549262|FG000|NOT COMPLETED|Overall Study||0
6622150|NCT02199743|7549269|FG000|STARTED|Overall Study||14
6622151|NCT02199743|7549270|FG001|STARTED|Overall Study||10
6622152|NCT02199743|7549269|FG000|COMPLETED|Overall Study||14
6622153|NCT02199743|7549270|FG001|COMPLETED|Overall Study||8
6622154|NCT02199743|7549269|FG000|NOT COMPLETED|Overall Study||0
6622155|NCT02199743|7549270|FG001|NOT COMPLETED|Overall Study||2
6622156|NCT02199795|7549280|FG000|STARTED|Overall Study||4
6622157|NCT02199795|7549281|FG001|STARTED|Overall Study||3
6622158|NCT02199795|7549280|FG000|COMPLETED|Overall Study||2
6622159|NCT02199795|7549281|FG001|COMPLETED|Overall Study||3
6622160|NCT02199795|7549280|FG000|NOT COMPLETED|Overall Study||2
6622161|NCT02199795|7549281|FG001|NOT COMPLETED|Overall Study||0
6622162|NCT02199964|7549289|FG000|STARTED|Overall Study||2
6622163|NCT02199964|7549290|FG001|STARTED|Overall Study||2
6622164|NCT02199964|7549289|FG000|COMPLETED|Overall Study||2
6622165|NCT02199964|7549290|FG001|COMPLETED|Overall Study||2
6622166|NCT02199964|7549289|FG000|NOT COMPLETED|Overall Study||0
6622167|NCT02199964|7549290|FG001|NOT COMPLETED|Overall Study||0
6622168|NCT02200055|7549296|FG000|STARTED|Overall Study||86
6622169|NCT02200055|7549296|FG000|COMPLETED|Overall Study||86
6622170|NCT02200055|7549296|FG000|NOT COMPLETED|Overall Study||0
6622171|NCT02200211|7549306|FG000|STARTED|Overall Study||190
6622172|NCT02200211|7549307|FG001|STARTED|Overall Study||195
6622173|NCT02200211|7549308|FG002|STARTED|Overall Study||40
6622174|NCT02200211|7549309|FG003|STARTED|Overall Study||60
6622175|NCT02200211|7549306|FG000|Included in 16-week Primary Analysis|Overall Study||177
6622176|NCT02200211|7549307|FG001|Included in 16-week Primary Analysis|Overall Study||186
6622177|NCT02200211|7549308|FG002|Included in 16-week Primary Analysis|Overall Study||39
6622178|NCT02200211|7549309|FG003|Included in 16-week Primary Analysis|Overall Study||56
6622179|NCT02200211|7549306|FG000|COMPLETED|Overall Study||182
6622180|NCT02200211|7549307|FG001|COMPLETED|Overall Study||188
6622181|NCT02200211|7549308|FG002|COMPLETED|Overall Study||39
6622182|NCT02200211|7549309|FG003|COMPLETED|Overall Study||58
6622183|NCT02200211|7549306|FG000|NOT COMPLETED|Overall Study||8
6622184|NCT02200211|7549307|FG001|NOT COMPLETED|Overall Study||7
6622185|NCT02200211|7549308|FG002|NOT COMPLETED|Overall Study||1
6622186|NCT02200211|7549309|FG003|NOT COMPLETED|Overall Study||2
6622187|NCT02200445|7549330|FG000|STARTED|Overall Study||4
6622188|NCT02200445|7549331|FG001|STARTED|Overall Study||17
6622189|NCT02200445|7549332|FG002|STARTED|Overall Study||5
6622190|NCT02200445|7549330|FG000|COMPLETED|Overall Study||3
6622191|NCT02200445|7549331|FG001|COMPLETED|Overall Study||13
6622192|NCT02200445|7549332|FG002|COMPLETED|Overall Study||3
6622193|NCT02200445|7549330|FG000|NOT COMPLETED|Overall Study||1
6622194|NCT02200445|7549331|FG001|NOT COMPLETED|Overall Study||4
6622195|NCT02200445|7549332|FG002|NOT COMPLETED|Overall Study||2
6622196|NCT02200458|7549340|FG000|STARTED|Overall Study||62
6622197|NCT02200458|7549340|FG000|COMPLETED|Overall Study||62
6622198|NCT02200458|7549340|FG000|NOT COMPLETED|Overall Study||0
6622199|NCT02200510|7549346|FG000|STARTED|Overall Study|Number who only completed self-management or completed it before portal (could do 6 months later).|31
6622200|NCT02200510|7549347|FG001|STARTED|Overall Study|Number who only completed portal or completed it before self-management (could do 6 months later).|47
6622201|NCT02200510|7549346|FG000|COMPLETED|Overall Study|This is the number of participants with baseline and post data.|22
6622202|NCT02200510|7549347|FG001|COMPLETED|Overall Study|This number is the number of participants with both baseline and post data.|44
6622203|NCT02200510|7549346|FG000|NOT COMPLETED|Overall Study||9
6622204|NCT02200510|7549347|FG001|NOT COMPLETED|Overall Study||3
6622205|NCT02200523|7549355|FG000|STARTED|Overall Study||20
6622206|NCT02200523|7549356|FG001|STARTED|Overall Study||20
6622207|NCT02200523|7549355|FG000|COMPLETED|Overall Study||20
6622208|NCT02200523|7549356|FG001|COMPLETED|Overall Study||20
6622209|NCT02200523|7549355|FG000|NOT COMPLETED|Overall Study||0
6622210|NCT02200523|7549356|FG001|NOT COMPLETED|Overall Study||0
6622211|NCT02200536|7549365|FG000|STARTED|Overall Study||32
6622212|NCT02200536|7549366|FG001|STARTED|Overall Study||30
6622213|NCT02200536|7549367|FG002|STARTED|Overall Study||30
6622214|NCT02200536|7549365|FG000|COMPLETED|Overall Study||32
6622215|NCT02200536|7549366|FG001|COMPLETED|Overall Study||30
6622216|NCT02200536|7549367|FG002|COMPLETED|Overall Study||30
6622217|NCT02200536|7549365|FG000|NOT COMPLETED|Overall Study||0
6622218|NCT02200536|7549366|FG001|NOT COMPLETED|Overall Study||0
6622219|NCT02200536|7549367|FG002|NOT COMPLETED|Overall Study||0
6622220|NCT02200614|7549377|FG000|STARTED|Double Blind Treatment||955
6622221|NCT02200614|7549378|FG001|STARTED|Double Blind Treatment||554
6622222|NCT02200614|7549377|FG000|COMPLETED|Double Blind Treatment||591
6622223|NCT02200614|7549378|FG001|COMPLETED|Double Blind Treatment||170
6622224|NCT02200614|7549377|FG000|NOT COMPLETED|Double Blind Treatment||364
6622225|NCT02200614|7549378|FG001|NOT COMPLETED|Double Blind Treatment||384
6622226|NCT02200614|7549377|FG000|STARTED|Open Label|Not all participants from treatment period entered follow-up|591
6622227|NCT02200614|7549378|FG001|STARTED|Open Label|Not all participants from treatment period entered follow-up|170
6622228|NCT02200614|7549377|FG000|COMPLETED|Open Label||466
6622229|NCT02200614|7549378|FG001|COMPLETED|Open Label||147
6622230|NCT02200614|7549377|FG000|NOT COMPLETED|Open Label||125
6622231|NCT02200614|7549378|FG001|NOT COMPLETED|Open Label||23
6622232|NCT02201056|7549393|FG000|STARTED|Overall Study||12
6622233|NCT02201056|7549394|FG001|STARTED|Overall Study||6
6622234|NCT02201056|7549395|FG002|STARTED|Overall Study||6
6622235|NCT02201056|7549396|FG003|STARTED|Overall Study||6
6622236|NCT02201056|7549397|FG004|STARTED|Overall Study||6
6622237|NCT02201056|7549398|FG005|STARTED|Overall Study||6
6622238|NCT02201056|7549399|FG006|STARTED|Overall Study||6
6622239|NCT02201056|7549393|FG000|COMPLETED|Overall Study||12
6622240|NCT02201056|7549394|FG001|COMPLETED|Overall Study||6
6622241|NCT02201056|7549395|FG002|COMPLETED|Overall Study||6
6622242|NCT02201056|7549396|FG003|COMPLETED|Overall Study||6
6622243|NCT02201056|7549397|FG004|COMPLETED|Overall Study||6
6622244|NCT02201056|7549398|FG005|COMPLETED|Overall Study||6
6622245|NCT02201056|7549399|FG006|COMPLETED|Overall Study||6
6622246|NCT02201056|7549393|FG000|NOT COMPLETED|Overall Study||0
6622247|NCT02201056|7549394|FG001|NOT COMPLETED|Overall Study||0
6622248|NCT02201056|7549395|FG002|NOT COMPLETED|Overall Study||0
6622249|NCT02201056|7549396|FG003|NOT COMPLETED|Overall Study||0
6622250|NCT02201056|7549397|FG004|NOT COMPLETED|Overall Study||0
6622251|NCT02201056|7549398|FG005|NOT COMPLETED|Overall Study||0
6622252|NCT02201056|7549399|FG006|NOT COMPLETED|Overall Study||0
6622253|NCT02201108|7549423|FG000|STARTED|Overall Study||57
6622254|NCT02201108|7549424|FG001|STARTED|Overall Study||109
6622255|NCT02201108|7549423|FG000|On-going Participants|Overall Study||0
6622256|NCT02201108|7549424|FG001|On-going Participants|Overall Study||58
6622257|NCT02201108|7549423|FG000|COMPLETED|Overall Study||53
6622258|NCT02201108|7549424|FG001|COMPLETED|Overall Study||102
6622259|NCT02201108|7549423|FG000|NOT COMPLETED|Overall Study||4
6622260|NCT02201108|7549424|FG001|NOT COMPLETED|Overall Study||7
6622261|NCT02201212|7549433|FG000|STARTED|Overall Study||30
6622262|NCT02201212|7549433|FG000|COMPLETED|Overall Study||30
6622263|NCT02201212|7549433|FG000|NOT COMPLETED|Overall Study||0
6622264|NCT02201251|7549439|FG000|STARTED|Overall Study||28
6622265|NCT02201251|7549440|FG001|STARTED|Overall Study||35
6622266|NCT02201251|7549439|FG000|COMPLETED|Overall Study||24
6622267|NCT02201251|7549440|FG001|COMPLETED|Overall Study||32
6622268|NCT02201251|7549439|FG000|NOT COMPLETED|Overall Study||4
6622269|NCT02201251|7549440|FG001|NOT COMPLETED|Overall Study||3
6622270|NCT02201277|7549448|FG000|STARTED|Overall Study|24 patients were consented but 1 patient had denali filter placed twice.|24
6622271|NCT02201277|7549449|FG001|STARTED|Overall Study|1 patient was withdrawn after signing consent due to physician preference for the option filter.|21
6622272|NCT02201277|7549448|FG000|Filter Retrieval|Overall Study||17
6622273|NCT02201277|7549449|FG001|Filter Retrieval|Overall Study||16
6622274|NCT02201277|7549448|FG000|Signed ICF But Did Not Enroll|Overall Study|Physician had preference for a specific filter so patient not randomized.|0
6622275|NCT02201277|7549449|FG001|Signed ICF But Did Not Enroll|Overall Study||1
6622276|NCT02201277|7549448|FG000|Filter Ruled to be Permanent|Overall Study||2
6622277|NCT02201277|7549449|FG001|Filter Ruled to be Permanent|Overall Study||2
6622278|NCT02201277|7549448|FG000|Lost to Follow up|Overall Study||2
6622279|NCT02201277|7549449|FG001|Lost to Follow up|Overall Study||1
6622280|NCT02201277|7549448|FG000|Death (Before Removal)|Overall Study||3
6622281|NCT02201277|7549449|FG001|Death (Before Removal)|Overall Study||4
6622282|NCT02201277|7549448|FG000|Complicated Retrieval|Overall Study||2
6622283|NCT02201277|7549449|FG001|Complicated Retrieval|Overall Study||0
6622284|NCT02201277|7549448|FG000|Failed Retrieval (Referred Elsewhere)|Overall Study||1
6622285|NCT02201277|7549449|FG001|Failed Retrieval (Referred Elsewhere)|Overall Study||0
6622286|NCT02201277|7549448|FG000|COMPLETED|Overall Study||17
6622287|NCT02201277|7549449|FG001|COMPLETED|Overall Study||16
6622288|NCT02201277|7549448|FG000|NOT COMPLETED|Overall Study||7
6622289|NCT02201277|7549449|FG001|NOT COMPLETED|Overall Study||5
6622290|NCT02201290|7549459|FG000|STARTED|Overall Study||9
6622291|NCT02201290|7549459|FG000|COMPLETED|Overall Study||4
6622292|NCT02201290|7549459|FG000|NOT COMPLETED|Overall Study||5
6622293|NCT02201329|7549463|FG000|STARTED|Overall Study||5
6622294|NCT02201329|7549463|FG000|COMPLETED|Overall Study||0
6622295|NCT02201329|7549463|FG000|NOT COMPLETED|Overall Study||5
6733508|NCT03212638|7663056|FG002|STARTED|Period 1||8
6733509|NCT03212638|7663057|FG003|STARTED|Period 1||0
6733510|NCT03212638|7663058|FG004|STARTED|Period 1||0
6733511|NCT03212638|7663054|FG000|Received at Least 1 Dose of Study Drug|Period 1||8
6733512|NCT03212638|7663055|FG001|Received at Least 1 Dose of Study Drug|Period 1||8
6733513|NCT03212638|7663056|FG002|Received at Least 1 Dose of Study Drug|Period 1||8
6733514|NCT03212638|7663057|FG003|Received at Least 1 Dose of Study Drug|Period 1||0
6733515|NCT03212638|7663058|FG004|Received at Least 1 Dose of Study Drug|Period 1||0
6733516|NCT03212638|7663054|FG000|COMPLETED|Period 1||8
6733517|NCT03212638|7663055|FG001|COMPLETED|Period 1||8
6733518|NCT03212638|7663056|FG002|COMPLETED|Period 1||8
6733519|NCT03212638|7663057|FG003|COMPLETED|Period 1||0
6733520|NCT03212638|7663058|FG004|COMPLETED|Period 1||0
6733521|NCT03212638|7663054|FG000|NOT COMPLETED|Period 1||0
6733522|NCT03212638|7663055|FG001|NOT COMPLETED|Period 1||0
6733523|NCT03212638|7663056|FG002|NOT COMPLETED|Period 1||0
6733524|NCT03212638|7663057|FG003|NOT COMPLETED|Period 1||0
6733525|NCT03212638|7663058|FG004|NOT COMPLETED|Period 1||0
6733526|NCT03212638|7663054|FG000|STARTED|Period 2||8
6733527|NCT03212638|7663055|FG001|STARTED|Period 2||8
6733528|NCT03212638|7663056|FG002|STARTED|Period 2||8
6733529|NCT03212638|7663057|FG003|STARTED|Period 2||0
6733530|NCT03212638|7663058|FG004|STARTED|Period 2||0
6733531|NCT03212638|7663054|FG000|Received at Least 1 Dose of Study Drug|Period 2||8
6733532|NCT03212638|7663055|FG001|Received at Least 1 Dose of Study Drug|Period 2||8
6733533|NCT03212638|7663056|FG002|Received at Least 1 Dose of Study Drug|Period 2||8
6733534|NCT03212638|7663057|FG003|Received at Least 1 Dose of Study Drug|Period 2||0
6733535|NCT03212638|7663058|FG004|Received at Least 1 Dose of Study Drug|Period 2||0
6733536|NCT03212638|7663054|FG000|COMPLETED|Period 2||8
6733537|NCT03212638|7663055|FG001|COMPLETED|Period 2||8
6733538|NCT03212638|7663056|FG002|COMPLETED|Period 2||8
6733539|NCT03212638|7663057|FG003|COMPLETED|Period 2||0
6733540|NCT03212638|7663058|FG004|COMPLETED|Period 2||0
6733541|NCT03212638|7663054|FG000|NOT COMPLETED|Period 2||0
6733542|NCT03212638|7663055|FG001|NOT COMPLETED|Period 2||0
6733543|NCT03212638|7663056|FG002|NOT COMPLETED|Period 2||0
6733544|NCT03212638|7663057|FG003|NOT COMPLETED|Period 2||0
6733545|NCT03212638|7663058|FG004|NOT COMPLETED|Period 2||0
6733546|NCT03212638|7663054|FG000|STARTED|Period 3||8
6733547|NCT03212638|7663055|FG001|STARTED|Period 3||8
6733548|NCT03212638|7663056|FG002|STARTED|Period 3||8
6733549|NCT03212638|7663057|FG003|STARTED|Period 3||0
6733550|NCT03212638|7663058|FG004|STARTED|Period 3||0
6733551|NCT03212638|7663054|FG000|Received at Least 1 Dose of Study Drug|Period 3||8
6733552|NCT03212638|7663055|FG001|Received at Least 1 Dose of Study Drug|Period 3||8
6733553|NCT03212638|7663056|FG002|Received at Least 1 Dose of Study Drug|Period 3||8
6733554|NCT03212638|7663057|FG003|Received at Least 1 Dose of Study Drug|Period 3||0
6733555|NCT03212638|7663058|FG004|Received at Least 1 Dose of Study Drug|Period 3||0
6733556|NCT03212638|7663054|FG000|COMPLETED|Period 3||8
6733557|NCT03212638|7663055|FG001|COMPLETED|Period 3||8
6733558|NCT03212638|7663056|FG002|COMPLETED|Period 3||8
6733559|NCT03212638|7663057|FG003|COMPLETED|Period 3||0
6733560|NCT03212638|7663058|FG004|COMPLETED|Period 3||0
6733561|NCT03212638|7663054|FG000|NOT COMPLETED|Period 3||0
6733562|NCT03212638|7663055|FG001|NOT COMPLETED|Period 3||0
6733563|NCT03212638|7663056|FG002|NOT COMPLETED|Period 3||0
6733564|NCT03212638|7663057|FG003|NOT COMPLETED|Period 3||0
6733565|NCT03212638|7663058|FG004|NOT COMPLETED|Period 3||0
6733566|NCT03212638|7663054|FG000|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
6733567|NCT03212638|7663055|FG001|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
6733568|NCT03212638|7663056|FG002|STARTED|Period 4|Participants were not allowed to participate in Part B and have completed study.|0
6733569|NCT03212638|7663057|FG003|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
6733570|NCT03212638|7663058|FG004|STARTED|Period 4|New Participants in Part B, no participants from Part A participated in Part B.|9
6733571|NCT03212638|7663054|FG000|Received at Least 1 Dose of Study Drug|Period 4||0
6733572|NCT03212638|7663055|FG001|Received at Least 1 Dose of Study Drug|Period 4||0
6733573|NCT03212638|7663056|FG002|Received at Least 1 Dose of Study Drug|Period 4||0
6733574|NCT03212638|7663057|FG003|Received at Least 1 Dose of Study Drug|Period 4||9
6733575|NCT03212638|7663058|FG004|Received at Least 1 Dose of Study Drug|Period 4||9
6733576|NCT03212638|7663054|FG000|COMPLETED|Period 4||0
6733577|NCT03212638|7663055|FG001|COMPLETED|Period 4||0
6622296|NCT02201394|7549467|FG000|STARTED|Loading Dose||20
6622297|NCT02201394|7549467|FG000|COMPLETED|Loading Dose||20
6622298|NCT02201394|7549467|FG000|NOT COMPLETED|Loading Dose||0
6622299|NCT02201394|7549467|FG000|STARTED|Maintenance Dose||20
6622300|NCT02201394|7549467|FG000|COMPLETED|Maintenance Dose||20
6622301|NCT02201394|7549467|FG000|NOT COMPLETED|Maintenance Dose||0
6622302|NCT02201420|7549472|FG000|STARTED|Overall Study||5
6622303|NCT02201420|7549472|FG000|COMPLETED|Overall Study||5
6622304|NCT02201420|7549472|FG000|NOT COMPLETED|Overall Study||0
6622305|NCT02201446|7549478|FG000|STARTED|Overall Study||81
6622306|NCT02201446|7549479|FG001|STARTED|Overall Study||58
6622307|NCT02201446|7549478|FG000|COMPLETED|Overall Study||81
6622308|NCT02201446|7549479|FG001|COMPLETED|Overall Study||58
6622309|NCT02201446|7549478|FG000|NOT COMPLETED|Overall Study||0
6622310|NCT02201446|7549479|FG001|NOT COMPLETED|Overall Study||0
6622311|NCT02201524|7549489|FG000|STARTED|Overall Study||14
6622312|NCT02201524|7549490|FG001|STARTED|Overall Study||15
6622313|NCT02201524|7549491|FG002|STARTED|Overall Study||16
6622314|NCT02201524|7549492|FG003|STARTED|Overall Study||14
6622315|NCT02201524|7549489|FG000|COMPLETED|Overall Study||12
6622316|NCT02201524|7549490|FG001|COMPLETED|Overall Study||12
6622317|NCT02201524|7549491|FG002|COMPLETED|Overall Study||12
6622318|NCT02201524|7549492|FG003|COMPLETED|Overall Study||10
6622319|NCT02201524|7549489|FG000|NOT COMPLETED|Overall Study||2
6622320|NCT02201524|7549490|FG001|NOT COMPLETED|Overall Study||3
6622321|NCT02201524|7549491|FG002|NOT COMPLETED|Overall Study||4
6622322|NCT02201524|7549492|FG003|NOT COMPLETED|Overall Study||4
6622323|NCT02201771|7549505|FG000|STARTED|Overall Study||166
6622324|NCT02201771|7549506|FG001|STARTED|Overall Study||168
6622325|NCT02201771|7549507|FG002|STARTED|Overall Study||166
6622326|NCT02201771|7549505|FG000|COMPLETED|Overall Study||153
6622327|NCT02201771|7549506|FG001|COMPLETED|Overall Study||158
6622328|NCT02201771|7549507|FG002|COMPLETED|Overall Study||156
6622329|NCT02201771|7549505|FG000|NOT COMPLETED|Overall Study||13
6622330|NCT02201771|7549506|FG001|NOT COMPLETED|Overall Study||10
6622331|NCT02201771|7549507|FG002|NOT COMPLETED|Overall Study||10
6622332|NCT02201784|7549517|FG000|STARTED|Overall Study||30
6622333|NCT02201784|7549518|FG001|STARTED|Overall Study||30
6622334|NCT02201784|7549517|FG000|COMPLETED|Overall Study||28
6622335|NCT02201784|7549518|FG001|COMPLETED|Overall Study||30
6622336|NCT02201784|7549517|FG000|NOT COMPLETED|Overall Study||2
6622337|NCT02201784|7549518|FG001|NOT COMPLETED|Overall Study||0
6622338|NCT02201901|7549527|FG000|STARTED|Overall Study||90
6622339|NCT02201901|7549528|FG001|STARTED|Overall Study||88
6622340|NCT02201901|7549529|FG002|STARTED|Overall Study||90
6622341|NCT02201901|7549527|FG000|COMPLETED|Overall Study||75
6622342|NCT02201901|7549528|FG001|COMPLETED|Overall Study||79
6622343|NCT02201901|7549529|FG002|COMPLETED|Overall Study||77
6622344|NCT02201901|7549527|FG000|NOT COMPLETED|Overall Study||15
6622345|NCT02201901|7549528|FG001|NOT COMPLETED|Overall Study||9
6622346|NCT02201901|7549529|FG002|NOT COMPLETED|Overall Study||13
6622347|NCT02201940|7549540|FG000|STARTED|Overall Study||625
6622348|NCT02201940|7549541|FG001|STARTED|Overall Study||116
6622349|NCT02201940|7549540|FG000|COMPLETED|Overall Study||613
6622350|NCT02201940|7549541|FG001|COMPLETED|Overall Study||0
6622351|NCT02201940|7549540|FG000|NOT COMPLETED|Overall Study||12
6622352|NCT02201940|7549541|FG001|NOT COMPLETED|Overall Study||116
6622353|NCT02201953|7549549|FG000|STARTED|Overall Study||278
6622354|NCT02201953|7549550|FG001|STARTED|Overall Study||280
6622355|NCT02201953|7549549|FG000|COMPLETED|Overall Study||258
6622356|NCT02201953|7549550|FG001|COMPLETED|Overall Study||224
6622357|NCT02201953|7549549|FG000|NOT COMPLETED|Overall Study||20
6622358|NCT02201953|7549550|FG001|NOT COMPLETED|Overall Study||56
6622359|NCT02202031|7549558|FG000|STARTED|Overall Study||82
6622360|NCT02202031|7549559|FG001|STARTED|Overall Study||79
6622361|NCT02202031|7549558|FG000|COMPLETED|Overall Study||77
6622362|NCT02202031|7549559|FG001|COMPLETED|Overall Study||74
6622363|NCT02202031|7549558|FG000|NOT COMPLETED|Overall Study||5
6622364|NCT02202031|7549559|FG001|NOT COMPLETED|Overall Study||5
6622365|NCT02202109|7549567|FG000|STARTED|Overall Study||302
6622366|NCT02202109|7549568|FG001|STARTED|Overall Study||300
6622367|NCT02202109|7549567|FG000|COMPLETED|Overall Study||212
6622368|NCT02202109|7549568|FG001|COMPLETED|Overall Study||213
6622369|NCT02202109|7549567|FG000|NOT COMPLETED|Overall Study||90
6622370|NCT02202109|7549568|FG001|NOT COMPLETED|Overall Study||87
6622371|NCT02202135|7549574|FG000|STARTED|Overall Study||4
6622372|NCT02202135|7549574|FG000|COMPLETED|Overall Study||4
6622373|NCT02202135|7549574|FG000|NOT COMPLETED|Overall Study||0
6622374|NCT02202161|7549586|FG000|STARTED|Overall Study||13
6622375|NCT02202161|7549587|FG001|STARTED|Overall Study||5
6622376|NCT02202161|7549588|FG002|STARTED|Overall Study||5
6622377|NCT02202161|7549589|FG003|STARTED|Overall Study||9
6622378|NCT02202161|7549590|FG004|STARTED|Overall Study||9
6622379|NCT02202161|7549591|FG005|STARTED|Overall Study||10
6622380|NCT02202161|7549592|FG006|STARTED|Overall Study||13
6622381|NCT02202161|7549593|FG007|STARTED|Overall Study||6
6622382|NCT02202161|7549586|FG000|COMPLETED|Overall Study||12
6622383|NCT02202161|7549587|FG001|COMPLETED|Overall Study||4
6622384|NCT02202161|7549588|FG002|COMPLETED|Overall Study||5
6622385|NCT02202161|7549589|FG003|COMPLETED|Overall Study||9
6622386|NCT02202161|7549590|FG004|COMPLETED|Overall Study||8
6622387|NCT02202161|7549591|FG005|COMPLETED|Overall Study||9
6622388|NCT02202161|7549592|FG006|COMPLETED|Overall Study||13
6622389|NCT02202161|7549593|FG007|COMPLETED|Overall Study||0
6622390|NCT02202161|7549586|FG000|NOT COMPLETED|Overall Study||1
6622391|NCT02202161|7549587|FG001|NOT COMPLETED|Overall Study||1
6622392|NCT02202161|7549588|FG002|NOT COMPLETED|Overall Study||0
6622393|NCT02202161|7549589|FG003|NOT COMPLETED|Overall Study||0
6622394|NCT02202161|7549590|FG004|NOT COMPLETED|Overall Study||1
6622395|NCT02202161|7549591|FG005|NOT COMPLETED|Overall Study||1
6622396|NCT02202161|7549592|FG006|NOT COMPLETED|Overall Study||0
6622397|NCT02202161|7549593|FG007|NOT COMPLETED|Overall Study||6
6622398|NCT02202252|7549614|FG000|STARTED|Overall Study||30
6622399|NCT02202252|7549615|FG001|STARTED|Overall Study||30
6622400|NCT02202252|7549614|FG000|COMPLETED|Overall Study||30
6622401|NCT02202252|7549615|FG001|COMPLETED|Overall Study||30
6622402|NCT02202252|7549614|FG000|NOT COMPLETED|Overall Study||0
6622403|NCT02202252|7549615|FG001|NOT COMPLETED|Overall Study||0
6622404|NCT02202317|7549621|FG000|STARTED|Overall Study||9
6622405|NCT02202317|7549621|FG000|COMPLETED|Overall Study||8
6622406|NCT02202317|7549621|FG000|NOT COMPLETED|Overall Study||1
6622407|NCT02202499|7549628|FG000|STARTED|Overall Study||21
6622408|NCT02202499|7549629|FG001|STARTED|Overall Study||20
6622409|NCT02202499|7549630|FG002|STARTED|Overall Study||21
6622410|NCT02202499|7549628|FG000|COMPLETED|Overall Study||19
6622411|NCT02202499|7549629|FG001|COMPLETED|Overall Study||20
6622412|NCT02202499|7549630|FG002|COMPLETED|Overall Study||19
6622413|NCT02202499|7549628|FG000|NOT COMPLETED|Overall Study||2
6622414|NCT02202499|7549629|FG001|NOT COMPLETED|Overall Study||0
6622415|NCT02202499|7549630|FG002|NOT COMPLETED|Overall Study||2
6622416|NCT02202538|7549643|FG000|STARTED|Overall Study||53
6622417|NCT02202538|7549643|FG000|Screen Failure|Overall Study||2
6622418|NCT02202538|7549643|FG000|COMPLETED|Overall Study||45
6622419|NCT02202538|7549643|FG000|NOT COMPLETED|Overall Study||8
6622420|NCT02202551|7549651|FG000|STARTED|Overall Study||60
6622421|NCT02202551|7549652|FG001|STARTED|Overall Study||78
6622422|NCT02202551|7549653|FG002|STARTED|Overall Study||24
6622423|NCT02202551|7549654|FG003|STARTED|Overall Study||61
6622424|NCT02202551|7549651|FG000|COMPLETED|Overall Study||35
6622425|NCT02202551|7549652|FG001|COMPLETED|Overall Study||41
6622426|NCT02202551|7549653|FG002|COMPLETED|Overall Study||14
6622427|NCT02202551|7549654|FG003|COMPLETED|Overall Study||39
6622428|NCT02202551|7549651|FG000|NOT COMPLETED|Overall Study||25
6622429|NCT02202551|7549652|FG001|NOT COMPLETED|Overall Study||37
6622430|NCT02202551|7549653|FG002|NOT COMPLETED|Overall Study||10
6622431|NCT02202551|7549654|FG003|NOT COMPLETED|Overall Study||22
6622432|NCT02202616|7549668|FG000|STARTED|Overall Study||401
6622433|NCT02202616|7549668|FG000|Intent to Treat Set (ITT)|Overall Study||338
6622434|NCT02202616|7549668|FG000|COMPLETED|Overall Study||301
6622435|NCT02202616|7549668|FG000|NOT COMPLETED|Overall Study||100
6622436|NCT02202746|7549675|FG000|STARTED|Overall Study||109
6622437|NCT02202746|7549676|FG001|STARTED|Overall Study||69
6622438|NCT02202746|7549675|FG000|COMPLETED|Overall Study||109
6622439|NCT02202746|7549676|FG001|COMPLETED|Overall Study||69
6622440|NCT02202746|7549675|FG000|NOT COMPLETED|Overall Study||0
6622441|NCT02202746|7549676|FG001|NOT COMPLETED|Overall Study||0
6622442|NCT02202759|7549688|FG000|STARTED|Overall Study||9
6622443|NCT02202759|7549689|FG001|STARTED|Overall Study||15
6622444|NCT02202759|7549690|FG002|STARTED|Overall Study||14
6622445|NCT02202759|7549688|FG000|COMPLETED|Overall Study||0
6622446|NCT02202759|7549689|FG001|COMPLETED|Overall Study||0
6622447|NCT02202759|7549690|FG002|COMPLETED|Overall Study||0
6622448|NCT02202759|7549688|FG000|NOT COMPLETED|Overall Study||9
6622449|NCT02202759|7549689|FG001|NOT COMPLETED|Overall Study||15
6622450|NCT02202759|7549690|FG002|NOT COMPLETED|Overall Study||14
6622451|NCT02202785|7549700|FG000|STARTED|Overall Study||11
6622452|NCT02202785|7549701|FG001|STARTED|Overall Study||15
6622453|NCT02202785|7549702|FG002|STARTED|Overall Study||17
6622454|NCT02202785|7549700|FG000|COMPLETED|Overall Study||0
6622455|NCT02202785|7549701|FG001|COMPLETED|Overall Study||0
6622456|NCT02202785|7549702|FG002|COMPLETED|Overall Study||0
6622457|NCT02202785|7549700|FG000|NOT COMPLETED|Overall Study||11
6622458|NCT02202785|7549701|FG001|NOT COMPLETED|Overall Study||15
6622459|NCT02202785|7549702|FG002|NOT COMPLETED|Overall Study||17
6622460|NCT02202837|7549712|FG000|STARTED|Overall Study||140
6622461|NCT02202837|7549713|FG001|STARTED|Overall Study||17
6622462|NCT02202837|7549712|FG000|COMPLETED|Overall Study||87
6622463|NCT02202837|7549713|FG001|COMPLETED|Overall Study||12
6622464|NCT02202837|7549712|FG000|NOT COMPLETED|Overall Study||53
6622465|NCT02202837|7549713|FG001|NOT COMPLETED|Overall Study||5
6622466|NCT02202850|7549721|FG000|STARTED|Overall Study||70
6622467|NCT02202850|7549722|FG001|STARTED|Overall Study||14
6622468|NCT02202850|7549721|FG000|COMPLETED|Overall Study||46
6622469|NCT02202850|7549722|FG001|COMPLETED|Overall Study||8
6622470|NCT02202850|7549721|FG000|NOT COMPLETED|Overall Study||24
6622471|NCT02202850|7549722|FG001|NOT COMPLETED|Overall Study||6
6622472|NCT02202980|7549742|FG000|STARTED|Overall Study||14
6622473|NCT02202980|7549743|FG001|STARTED|Overall Study||26
6622474|NCT02202980|7549744|FG002|STARTED|Overall Study||27
6622475|NCT02202980|7549745|FG003|STARTED|Overall Study||32
6622476|NCT02202980|7549746|FG004|STARTED|Overall Study||13
6622477|NCT02202980|7549747|FG005|STARTED|Overall Study||15
6622478|NCT02202980|7549748|FG006|STARTED|Overall Study||15
6622479|NCT02202980|7549749|FG007|STARTED|Overall Study||15
6622480|NCT02202980|7549750|FG008|STARTED|Overall Study||18
6622481|NCT02202980|7549751|FG009|STARTED|Overall Study||17
6622482|NCT02202980|7549752|FG010|STARTED|Overall Study||19
6622483|NCT02202980|7549753|FG011|STARTED|Overall Study||28
6622484|NCT02202980|7549754|FG012|STARTED|Overall Study||30
6622485|NCT02202980|7549755|FG013|STARTED|Overall Study||4
6622486|NCT02202980|7549742|FG000|COMPLETED|Overall Study||13
6622487|NCT02202980|7549743|FG001|COMPLETED|Overall Study||24
6622488|NCT02202980|7549744|FG002|COMPLETED|Overall Study||17
6622489|NCT02202980|7549745|FG003|COMPLETED|Overall Study||28
6622490|NCT02202980|7549746|FG004|COMPLETED|Overall Study||7
6622491|NCT02202980|7549747|FG005|COMPLETED|Overall Study||14
6622492|NCT02202980|7549748|FG006|COMPLETED|Overall Study||4
6622493|NCT02202980|7549749|FG007|COMPLETED|Overall Study||12
6622494|NCT02202980|7549750|FG008|COMPLETED|Overall Study||14
6622495|NCT02202980|7549751|FG009|COMPLETED|Overall Study||17
6622496|NCT02202980|7549752|FG010|COMPLETED|Overall Study||19
6622497|NCT02202980|7549753|FG011|COMPLETED|Overall Study||25
6622498|NCT02202980|7549754|FG012|COMPLETED|Overall Study||19
6622499|NCT02202980|7549755|FG013|COMPLETED|Overall Study||4
6622500|NCT02202980|7549742|FG000|NOT COMPLETED|Overall Study||1
6622501|NCT02202980|7549743|FG001|NOT COMPLETED|Overall Study||2
6622502|NCT02202980|7549744|FG002|NOT COMPLETED|Overall Study||10
6622503|NCT02202980|7549745|FG003|NOT COMPLETED|Overall Study||4
6622504|NCT02202980|7549746|FG004|NOT COMPLETED|Overall Study||6
6622505|NCT02202980|7549747|FG005|NOT COMPLETED|Overall Study||1
6622506|NCT02202980|7549748|FG006|NOT COMPLETED|Overall Study||11
6622507|NCT02202980|7549749|FG007|NOT COMPLETED|Overall Study||3
6622508|NCT02202980|7549750|FG008|NOT COMPLETED|Overall Study||4
6622509|NCT02202980|7549751|FG009|NOT COMPLETED|Overall Study||0
6622510|NCT02202980|7549752|FG010|NOT COMPLETED|Overall Study||0
6622511|NCT02202980|7549753|FG011|NOT COMPLETED|Overall Study||3
6622512|NCT02202980|7549754|FG012|NOT COMPLETED|Overall Study||11
6622513|NCT02202980|7549755|FG013|NOT COMPLETED|Overall Study||0
6622514|NCT02203019|7549787|FG000|STARTED|Overall Study||19
6622515|NCT02203019|7549788|FG001|STARTED|Overall Study||17
6622516|NCT02203019|7549787|FG000|COMPLETED|Overall Study||19
6622517|NCT02203019|7549788|FG001|COMPLETED|Overall Study||17
6622518|NCT02203019|7549787|FG000|NOT COMPLETED|Overall Study||0
6622519|NCT02203019|7549788|FG001|NOT COMPLETED|Overall Study||0
6622520|NCT02203032|7549794|FG000|STARTED|Open Label Run-in (Week 0 to Week 16)||872
6622521|NCT02203032|7549795|FG001|STARTED|Open Label Run-in (Week 0 to Week 16)||0
6622522|NCT02203032|7549796|FG002|STARTED|Open Label Run-in (Week 0 to Week 16)||0
6622523|NCT02203032|7549797|FG003|STARTED|Open Label Run-in (Week 0 to Week 16)||0
6622524|NCT02203032|7549794|FG000|Treated|Open Label Run-in (Week 0 to Week 16)||871
6622525|NCT02203032|7549795|FG001|Treated|Open Label Run-in (Week 0 to Week 16)||0
6622526|NCT02203032|7549796|FG002|Treated|Open Label Run-in (Week 0 to Week 16)||0
6622527|NCT02203032|7549797|FG003|Treated|Open Label Run-in (Week 0 to Week 16)||0
6622528|NCT02203032|7549794|FG000|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
6622529|NCT02203032|7549795|FG001|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6622530|NCT02203032|7549796|FG002|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6622531|NCT02203032|7549797|FG003|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6622532|NCT02203032|7549794|FG000|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||19
6622533|NCT02203032|7549795|FG001|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6622534|NCT02203032|7549796|FG002|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6622535|NCT02203032|7549797|FG003|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
6622536|NCT02203032|7549794|FG000|STARTED|Blinded Phase (Week 16 to Week 44)||0
6622537|NCT02203032|7549795|FG001|STARTED|Blinded Phase (Week 16 to Week 44)||135
6622538|NCT02203032|7549796|FG002|STARTED|Blinded Phase (Week 16 to Week 44)||133
6622539|NCT02203032|7549797|FG003|STARTED|Blinded Phase (Week 16 to Week 44)||585
6622540|NCT02203032|7549794|FG000|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
6622541|NCT02203032|7549795|FG001|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
6622542|NCT02203032|7549796|FG002|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
6622543|NCT02203032|7549797|FG003|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
6622544|NCT02203032|7549794|FG000|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
6622545|NCT02203032|7549795|FG001|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
6622546|NCT02203032|7549796|FG002|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
6622547|NCT02203032|7549797|FG003|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
6622548|NCT02203071|7549807|FG000|STARTED|Overall Study||13
6622549|NCT02203071|7549808|FG001|STARTED|Overall Study||6
6622550|NCT02203071|7549807|FG000|COMPLETED|Overall Study||10
6622551|NCT02203071|7549808|FG001|COMPLETED|Overall Study||5
6622552|NCT02203071|7549807|FG000|NOT COMPLETED|Overall Study||3
6622553|NCT02203071|7549808|FG001|NOT COMPLETED|Overall Study||1
6622554|NCT02203149|7549819|FG000|STARTED|Part 1||31
6622555|NCT02203149|7549820|FG001|STARTED|Part 1||32
6622556|NCT02203149|7549821|FG002|STARTED|Part 1||0
6622557|NCT02203149|7549822|FG003|STARTED|Part 1||0
6622558|NCT02203149|7549823|FG004|STARTED|Part 1||0
6622559|NCT02203149|7549819|FG000|COMPLETED|Part 1||31
6622560|NCT02203149|7549820|FG001|COMPLETED|Part 1||31
6622561|NCT02203149|7549821|FG002|COMPLETED|Part 1||0
6622562|NCT02203149|7549822|FG003|COMPLETED|Part 1||0
6622563|NCT02203149|7549823|FG004|COMPLETED|Part 1||0
6622564|NCT02203149|7549819|FG000|NOT COMPLETED|Part 1||0
6622565|NCT02203149|7549820|FG001|NOT COMPLETED|Part 1||1
6622566|NCT02203149|7549821|FG002|NOT COMPLETED|Part 1||0
6622567|NCT02203149|7549822|FG003|NOT COMPLETED|Part 1||0
6622568|NCT02203149|7549823|FG004|NOT COMPLETED|Part 1||0
6280595|NCT00158197|7180560|FG003|STARTED|Overall Study||29
6622569|NCT02203149|7549819|FG000|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
6622570|NCT02203149|7549820|FG001|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
6622571|NCT02203149|7549821|FG002|STARTED|Part 2||227
6622572|NCT02203149|7549822|FG003|STARTED|Part 2||74
6622573|NCT02203149|7549823|FG004|STARTED|Part 2||35
6622574|NCT02203149|7549819|FG000|Started Deferred Active Treatment|Part 2||0
6622575|NCT02203149|7549820|FG001|Started Deferred Active Treatment|Part 2||0
6622576|NCT02203149|7549821|FG002|Started Deferred Active Treatment|Part 2||0
6622577|NCT02203149|7549822|FG003|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
6622578|NCT02203149|7549823|FG004|Started Deferred Active Treatment|Part 2||0
6622579|NCT02203149|7549819|FG000|COMPLETED|Part 2||0
6622580|NCT02203149|7549820|FG001|COMPLETED|Part 2||0
6622581|NCT02203149|7549821|FG002|COMPLETED|Part 2||226
6622582|NCT02203149|7549822|FG003|COMPLETED|Part 2||71
6622583|NCT02203149|7549823|FG004|COMPLETED|Part 2||34
6622584|NCT02203149|7549819|FG000|NOT COMPLETED|Part 2||0
6622585|NCT02203149|7549820|FG001|NOT COMPLETED|Part 2||0
6622586|NCT02203149|7549821|FG002|NOT COMPLETED|Part 2||1
6622587|NCT02203149|7549822|FG003|NOT COMPLETED|Part 2||3
6622588|NCT02203149|7549823|FG004|NOT COMPLETED|Part 2||1
6622589|NCT02203162|7549845|FG000|STARTED|Overall Study||30
6622590|NCT02203162|7549845|FG000|COMPLETED|Overall Study||30
6622591|NCT02203162|7549845|FG000|NOT COMPLETED|Overall Study||0
6622592|NCT02203331|7549855|FG000|STARTED|Overall Study||52
6622593|NCT02203331|7549856|FG001|STARTED|Overall Study||53
6622594|NCT02203331|7549857|FG002|STARTED|Overall Study||55
6622595|NCT02203331|7549858|FG003|STARTED|Overall Study||53
6622596|NCT02203331|7549859|FG004|STARTED|Overall Study||53
6622597|NCT02203331|7549860|FG005|STARTED|Overall Study||53
6622598|NCT02203331|7549855|FG000|Treated|Overall Study||49
6622599|NCT02203331|7549856|FG001|Treated|Overall Study||50
6622600|NCT02203331|7549857|FG002|Treated|Overall Study||54
6622601|NCT02203331|7549858|FG003|Treated|Overall Study||49
6622602|NCT02203331|7549859|FG004|Treated|Overall Study||50
6622603|NCT02203331|7549860|FG005|Treated|Overall Study||53
6622604|NCT02203331|7549855|FG000|COMPLETED|Overall Study||45
6622605|NCT02203331|7549856|FG001|COMPLETED|Overall Study||39
6622606|NCT02203331|7549857|FG002|COMPLETED|Overall Study||50
6622607|NCT02203331|7549858|FG003|COMPLETED|Overall Study||46
6622608|NCT02203331|7549859|FG004|COMPLETED|Overall Study||46
6622609|NCT02203331|7549860|FG005|COMPLETED|Overall Study||46
6622610|NCT02203331|7549855|FG000|NOT COMPLETED|Overall Study||7
6622611|NCT02203331|7549856|FG001|NOT COMPLETED|Overall Study||14
6622612|NCT02203331|7549857|FG002|NOT COMPLETED|Overall Study||5
6622613|NCT02203331|7549858|FG003|NOT COMPLETED|Overall Study||7
6622614|NCT02203331|7549859|FG004|NOT COMPLETED|Overall Study||7
6622615|NCT02203331|7549860|FG005|NOT COMPLETED|Overall Study||7
6733578|NCT03212638|7663056|FG002|COMPLETED|Period 4||0
6733579|NCT03212638|7663057|FG003|COMPLETED|Period 4||9
6733580|NCT03212638|7663058|FG004|COMPLETED|Period 4||9
6733581|NCT03212638|7663054|FG000|NOT COMPLETED|Period 4||0
6733582|NCT03212638|7663055|FG001|NOT COMPLETED|Period 4||0
6733583|NCT03212638|7663056|FG002|NOT COMPLETED|Period 4||0
6733584|NCT03212638|7663057|FG003|NOT COMPLETED|Period 4||0
6733585|NCT03212638|7663058|FG004|NOT COMPLETED|Period 4||0
6733586|NCT03212638|7663054|FG000|STARTED|Period 5||0
6733587|NCT03212638|7663055|FG001|STARTED|Period 5||0
6733588|NCT03212638|7663056|FG002|STARTED|Period 5||0
6733589|NCT03212638|7663057|FG003|STARTED|Period 5||9
6733590|NCT03212638|7663058|FG004|STARTED|Period 5||9
6733591|NCT03212638|7663054|FG000|Received at Least 1 Dose of Study Drug|Period 5||0
6733592|NCT03212638|7663055|FG001|Received at Least 1 Dose of Study Drug|Period 5||0
6733593|NCT03212638|7663056|FG002|Received at Least 1 Dose of Study Drug|Period 5||0
6733594|NCT03212638|7663057|FG003|Received at Least 1 Dose of Study Drug|Period 5||9
6733595|NCT03212638|7663058|FG004|Received at Least 1 Dose of Study Drug|Period 5||9
6733596|NCT03212638|7663054|FG000|COMPLETED|Period 5||0
6733597|NCT03212638|7663055|FG001|COMPLETED|Period 5||0
6733598|NCT03212638|7663056|FG002|COMPLETED|Period 5||0
6733599|NCT03212638|7663057|FG003|COMPLETED|Period 5||9
6733600|NCT03212638|7663058|FG004|COMPLETED|Period 5||9
6733601|NCT03212638|7663054|FG000|NOT COMPLETED|Period 5||0
6733602|NCT03212638|7663055|FG001|NOT COMPLETED|Period 5||0
6733603|NCT03212638|7663056|FG002|NOT COMPLETED|Period 5||0
6733604|NCT03212638|7663057|FG003|NOT COMPLETED|Period 5||0
6733605|NCT03212638|7663058|FG004|NOT COMPLETED|Period 5||0
6733606|NCT03212690|7663070|FG000|STARTED|Overall Study||57
6733607|NCT03212690|7663070|FG000|COMPLETED|Overall Study||56
6733608|NCT03212690|7663070|FG000|NOT COMPLETED|Overall Study||1
6733609|NCT03213210|7663074|FG000|STARTED|Overall Study||5
6733610|NCT03213210|7663074|FG000|6-month Follow-up|Overall Study||3
6733611|NCT03213210|7663074|FG000|COMPLETED|Overall Study||0
6733612|NCT03213210|7663074|FG000|NOT COMPLETED|Overall Study||5
6733613|NCT03213366|7663080|FG000|STARTED|Overall Study||81
6733614|NCT03213366|7663081|FG001|STARTED|Overall Study||71
6733615|NCT03213366|7663080|FG000|COMPLETED|Overall Study||72
6733616|NCT03213366|7663081|FG001|COMPLETED|Overall Study||67
6733617|NCT03213366|7663080|FG000|NOT COMPLETED|Overall Study||9
6733618|NCT03213366|7663081|FG001|NOT COMPLETED|Overall Study||4
6733619|NCT03213405|7663091|FG000|STARTED|Overall Study||6
6733620|NCT03213405|7663092|FG001|STARTED|Overall Study||6
6733621|NCT03213405|7663093|FG002|STARTED|Overall Study||6
6733622|NCT03213405|7663094|FG003|STARTED|Overall Study||6
6622616|NCT02203357|7549877|FG000|STARTED|Overall Study||117
6622617|NCT02203357|7549878|FG001|STARTED|Overall Study||111
6622618|NCT02203357|7549879|FG002|STARTED|Overall Study||125
6622619|NCT02203357|7549877|FG000|mon7/2/3|Overall Study||114
6622620|NCT02203357|7549878|FG001|mon7/2/3|Overall Study||110
6622621|NCT02203357|7549879|FG002|mon7/2/3|Overall Study||124
6622622|NCT02203357|7549877|FG000|mon12|Overall Study||113
6622623|NCT02203357|7549878|FG001|mon12|Overall Study||101
6622624|NCT02203357|7549879|FG002|mon12|Overall Study||122
6622625|NCT02203357|7549877|FG000|mon24|Overall Study||59
6622626|NCT02203357|7549878|FG001|mon24|Overall Study||45
6622627|NCT02203357|7549879|FG002|mon24|Overall Study||55
6622628|NCT02203357|7549877|FG000|COMPLETED|Overall Study||59
6622629|NCT02203357|7549878|FG001|COMPLETED|Overall Study||45
6622630|NCT02203357|7549879|FG002|COMPLETED|Overall Study||55
6622631|NCT02203357|7549877|FG000|NOT COMPLETED|Overall Study||58
6622632|NCT02203357|7549878|FG001|NOT COMPLETED|Overall Study||66
6622633|NCT02203357|7549879|FG002|NOT COMPLETED|Overall Study||70
6622634|NCT02203565|7549890|FG000|STARTED|Overall Study||20
6622635|NCT02203565|7549890|FG000|COMPLETED|Overall Study||19
6622636|NCT02203565|7549890|FG000|NOT COMPLETED|Overall Study||1
6622637|NCT02203578|7549894|FG000|STARTED|Overall Study||1
6622638|NCT02203578|7549894|FG000|COMPLETED|Overall Study||1
6622639|NCT02203578|7549894|FG000|NOT COMPLETED|Overall Study||0
6622640|NCT02203591|7549906|FG000|STARTED|Overall Study||343
6622641|NCT02203591|7549907|FG001|STARTED|Overall Study||344
6622642|NCT02203591|7549908|FG002|STARTED|Overall Study||347
6622643|NCT02203591|7549909|FG003|STARTED|Overall Study||104
6622644|NCT02203591|7549910|FG004|STARTED|Overall Study||242
6622645|NCT02203591|7549911|FG005|STARTED|Overall Study||244
6622646|NCT02203591|7549912|FG006|STARTED|Overall Study||248
6622647|NCT02203591|7549913|FG007|STARTED|Overall Study||74
6622648|NCT02203591|7549906|FG000|COMPLETED|Overall Study||196
6622649|NCT02203591|7549907|FG001|COMPLETED|Overall Study||202
6622650|NCT02203591|7549908|FG002|COMPLETED|Overall Study||196
6622651|NCT02203591|7549909|FG003|COMPLETED|Overall Study||59
6622652|NCT02203591|7549910|FG004|COMPLETED|Overall Study||208
6622653|NCT02203591|7549911|FG005|COMPLETED|Overall Study||209
6622654|NCT02203591|7549912|FG006|COMPLETED|Overall Study||219
6622655|NCT02203591|7549913|FG007|COMPLETED|Overall Study||61
6622656|NCT02203591|7549906|FG000|NOT COMPLETED|Overall Study||147
6622657|NCT02203591|7549907|FG001|NOT COMPLETED|Overall Study||142
6622658|NCT02203591|7549908|FG002|NOT COMPLETED|Overall Study||151
6622659|NCT02203591|7549909|FG003|NOT COMPLETED|Overall Study||45
6622660|NCT02203591|7549910|FG004|NOT COMPLETED|Overall Study||34
6622661|NCT02203591|7549911|FG005|NOT COMPLETED|Overall Study||35
6622662|NCT02203591|7549912|FG006|NOT COMPLETED|Overall Study||29
6622663|NCT02203591|7549913|FG007|NOT COMPLETED|Overall Study||13
6622664|NCT02203630|7549937|FG000|STARTED|Overall Study||8
6622665|NCT02203630|7549938|FG001|STARTED|Overall Study||9
6622666|NCT02203630|7549937|FG000|COMPLETED|Overall Study||8
6622667|NCT02203630|7549938|FG001|COMPLETED|Overall Study||9
6622668|NCT02203630|7549937|FG000|NOT COMPLETED|Overall Study||0
6622669|NCT02203630|7549938|FG001|NOT COMPLETED|Overall Study||0
6622670|NCT02203721|7549946|FG000|STARTED|Overall Study||148
6622671|NCT02203721|7549947|FG001|STARTED|Overall Study||151
6622672|NCT02203721|7549946|FG000|COMPLETED|Overall Study||147
6622673|NCT02203721|7549947|FG001|COMPLETED|Overall Study||148
6622674|NCT02203721|7549946|FG000|NOT COMPLETED|Overall Study||1
6622675|NCT02203721|7549947|FG001|NOT COMPLETED|Overall Study||3
6622676|NCT02203747|7549955|FG000|STARTED|Overall Study||45
6622677|NCT02203747|7549956|FG001|STARTED|Overall Study||34
6622678|NCT02203747|7549955|FG000|COMPLETED|Overall Study||45
6622679|NCT02203747|7549956|FG001|COMPLETED|Overall Study||34
6622680|NCT02203747|7549955|FG000|NOT COMPLETED|Overall Study||0
6622681|NCT02203747|7549956|FG001|NOT COMPLETED|Overall Study||0
6622682|NCT02203786|7549966|FG000|STARTED|Overall Study||15
6622683|NCT02203786|7549967|FG001|STARTED|Overall Study||15
6622684|NCT02203786|7549968|FG002|STARTED|Overall Study||17
6622685|NCT02203786|7549969|FG003|STARTED|Overall Study||15
6622686|NCT02203786|7549966|FG000|COMPLETED|Overall Study||15
6622687|NCT02203786|7549967|FG001|COMPLETED|Overall Study||15
6622688|NCT02203786|7549968|FG002|COMPLETED|Overall Study||15
6622689|NCT02203786|7549969|FG003|COMPLETED|Overall Study||15
6622690|NCT02203786|7549966|FG000|NOT COMPLETED|Overall Study||0
6622691|NCT02203786|7549967|FG001|NOT COMPLETED|Overall Study||0
6622692|NCT02203786|7549968|FG002|NOT COMPLETED|Overall Study||2
6622693|NCT02203786|7549969|FG003|NOT COMPLETED|Overall Study||0
6622694|NCT02203838|7549985|FG000|STARTED|Overall Study||408
6622695|NCT02203838|7549986|FG001|STARTED|Overall Study||28
6622696|NCT02203838|7549987|FG002|STARTED|Overall Study||31
6622697|NCT02203838|7549988|FG003|STARTED|Overall Study||33
6622698|NCT02203838|7549985|FG000|COMPLETED|Overall Study||198
6622699|NCT02203838|7549986|FG001|COMPLETED|Overall Study||6
6622700|NCT02203838|7549987|FG002|COMPLETED|Overall Study||15
6622701|NCT02203838|7549988|FG003|COMPLETED|Overall Study||15
6622702|NCT02203838|7549985|FG000|NOT COMPLETED|Overall Study||210
6622703|NCT02203838|7549986|FG001|NOT COMPLETED|Overall Study||22
6622704|NCT02203838|7549987|FG002|NOT COMPLETED|Overall Study||16
6622705|NCT02203838|7549988|FG003|NOT COMPLETED|Overall Study||18
6622706|NCT02203851|7549998|FG000|STARTED|Overall Study||110
6622707|NCT02203851|7549998|FG000|COMPLETED|Overall Study||99
6622708|NCT02203851|7549998|FG000|NOT COMPLETED|Overall Study||11
6622709|NCT02203916|7550012|FG000|STARTED|Overall Study||65
6622710|NCT02203916|7550013|FG001|STARTED|Overall Study||132
6622711|NCT02203916|7550014|FG002|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
6622712|NCT02203916|7550012|FG000|Full Analysis Set (FAS)|Overall Study||65
6622713|NCT02203916|7550013|FG001|Full Analysis Set (FAS)|Overall Study||132
6622714|NCT02203916|7550014|FG002|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
6622715|NCT02203916|7550012|FG000|Safety Analysis Set (SAS)|Overall Study||65
6622716|NCT02203916|7550013|FG001|Safety Analysis Set (SAS)|Overall Study||132
6622717|NCT02203916|7550014|FG002|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
6622718|NCT02203916|7550012|FG000|COMPLETED|Overall Study||57
6622719|NCT02203916|7550013|FG001|COMPLETED|Overall Study||122
6622720|NCT02203916|7550014|FG002|COMPLETED|Overall Study||120
6622721|NCT02203916|7550012|FG000|NOT COMPLETED|Overall Study||8
6622722|NCT02203916|7550013|FG001|NOT COMPLETED|Overall Study||10
6622723|NCT02203916|7550014|FG002|NOT COMPLETED|Overall Study||11
6622724|NCT02204007|7550024|FG000|STARTED|Overall Study||18
6622725|NCT02204007|7550025|FG001|STARTED|Overall Study||18
6622726|NCT02204007|7550024|FG000|COMPLETED|Overall Study||17
6622727|NCT02204007|7550025|FG001|COMPLETED|Overall Study||17
6622728|NCT02204007|7550024|FG000|NOT COMPLETED|Overall Study||1
6622729|NCT02204007|7550025|FG001|NOT COMPLETED|Overall Study||1
6622730|NCT02204124|7550033|FG000|STARTED|Overall Study||13
6622731|NCT02204124|7550034|FG001|STARTED|Overall Study||19
6622732|NCT02204124|7550033|FG000|COMPLETED|Overall Study||13
6622733|NCT02204124|7550034|FG001|COMPLETED|Overall Study||19
6622734|NCT02204124|7550033|FG000|NOT COMPLETED|Overall Study||0
6622735|NCT02204124|7550034|FG001|NOT COMPLETED|Overall Study||0
6622736|NCT02204150|7550040|FG000|STARTED|Overall Study||56
6622737|NCT02204150|7550040|FG000|COMPLETED|Overall Study||56
6622738|NCT02204150|7550040|FG000|NOT COMPLETED|Overall Study||0
6622739|NCT02204176|7550047|FG000|STARTED|Overall Study||74
6622740|NCT02204176|7550048|FG001|STARTED|Overall Study||73
6622741|NCT02204176|7550049|FG002|STARTED|Overall Study||74
6622742|NCT02204176|7550047|FG000|COMPLETED|Overall Study||64
6622743|NCT02204176|7550048|FG001|COMPLETED|Overall Study||61
6622744|NCT02204176|7550049|FG002|COMPLETED|Overall Study||58
6622745|NCT02204176|7550047|FG000|NOT COMPLETED|Overall Study||10
6622746|NCT02204176|7550048|FG001|NOT COMPLETED|Overall Study||12
6622747|NCT02204176|7550049|FG002|NOT COMPLETED|Overall Study||16
6622748|NCT02204293|7550059|FG000|STARTED|Core Study Part I||19
6622749|NCT02204293|7550060|FG001|STARTED|Core Study Part I||17
6622750|NCT02204293|7550061|FG002|STARTED|Core Study Part I||0
6622751|NCT02204293|7550062|FG003|STARTED|Core Study Part I||0
6622752|NCT02204293|7550063|FG004|STARTED|Core Study Part I||0
6622753|NCT02204293|7550064|FG005|STARTED|Core Study Part I||0
6622754|NCT02204293|7550059|FG000|Intention-to-treat Population|Core Study Part I|One participant left the study before treatment was started.|18
6622755|NCT02204293|7550060|FG001|Intention-to-treat Population|Core Study Part I||17
6622756|NCT02204293|7550061|FG002|Intention-to-treat Population|Core Study Part I||0
6622757|NCT02204293|7550062|FG003|Intention-to-treat Population|Core Study Part I||0
6622758|NCT02204293|7550063|FG004|Intention-to-treat Population|Core Study Part I||0
6622759|NCT02204293|7550064|FG005|Intention-to-treat Population|Core Study Part I||0
6622760|NCT02204293|7550059|FG000|Safety Population|Core Study Part I|2 participants from placebo arm received canakinumab at Week 4, included in Safety population.|20
6622761|NCT02204293|7550060|FG001|Safety Population|Core Study Part I||15
6622762|NCT02204293|7550061|FG002|Safety Population|Core Study Part I||0
6622763|NCT02204293|7550062|FG003|Safety Population|Core Study Part I||0
6622764|NCT02204293|7550063|FG004|Safety Population|Core Study Part I||0
6622765|NCT02204293|7550064|FG005|Safety Population|Core Study Part I||0
6622766|NCT02204293|7550059|FG000|COMPLETED|Core Study Part I||17
6622767|NCT02204293|7550060|FG001|COMPLETED|Core Study Part I||14
6622768|NCT02204293|7550061|FG002|COMPLETED|Core Study Part I||0
6622769|NCT02204293|7550062|FG003|COMPLETED|Core Study Part I||0
6622770|NCT02204293|7550063|FG004|COMPLETED|Core Study Part I||0
6622771|NCT02204293|7550064|FG005|COMPLETED|Core Study Part I||0
6622772|NCT02204293|7550059|FG000|NOT COMPLETED|Core Study Part I||2
6622773|NCT02204293|7550060|FG001|NOT COMPLETED|Core Study Part I||3
6622774|NCT02204293|7550061|FG002|NOT COMPLETED|Core Study Part I||0
6622775|NCT02204293|7550062|FG003|NOT COMPLETED|Core Study Part I||0
6622776|NCT02204293|7550063|FG004|NOT COMPLETED|Core Study Part I||0
6622777|NCT02204293|7550064|FG005|NOT COMPLETED|Core Study Part I||0
6622778|NCT02204293|7550059|FG000|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|0
6622779|NCT02204293|7550060|FG001|STARTED|Core Study Part 2||0
6622780|NCT02204293|7550061|FG002|STARTED|Core Study Part 2|Participants who achieved response at Week 12, entered Part II.|12
6622781|NCT02204293|7550062|FG003|STARTED|Core Study Part 2||4
6622782|NCT02204293|7550063|FG004|STARTED|Core Study Part 2||7
6622783|NCT02204293|7550064|FG005|STARTED|Core Study Part 2||0
6622784|NCT02204293|7550059|FG000|Safety Population|Core Study Part 2||0
6622785|NCT02204293|7550060|FG001|Safety Population|Core Study Part 2||0
6622786|NCT02204293|7550061|FG002|Safety Population|Core Study Part 2|Included 2 participants from placebo arm who received canakinumab at Week 4.|14
6622787|NCT02204293|7550062|FG003|Safety Population|Core Study Part 2||2
6622788|NCT02204293|7550063|FG004|Safety Population|Core Study Part 2||7
6622789|NCT02204293|7550064|FG005|Safety Population|Core Study Part 2||0
6622790|NCT02204293|7550059|FG000|COMPLETED|Core Study Part 2||0
6622791|NCT02204293|7550060|FG001|COMPLETED|Core Study Part 2||0
6622792|NCT02204293|7550061|FG002|COMPLETED|Core Study Part 2||12
6622793|NCT02204293|7550062|FG003|COMPLETED|Core Study Part 2||4
6622794|NCT02204293|7550063|FG004|COMPLETED|Core Study Part 2||7
6622795|NCT02204293|7550064|FG005|COMPLETED|Core Study Part 2||0
6622796|NCT02204293|7550059|FG000|NOT COMPLETED|Core Study Part 2||0
6622797|NCT02204293|7550060|FG001|NOT COMPLETED|Core Study Part 2||0
6622798|NCT02204293|7550061|FG002|NOT COMPLETED|Core Study Part 2||0
6622799|NCT02204293|7550062|FG003|NOT COMPLETED|Core Study Part 2||0
6622800|NCT02204293|7550063|FG004|NOT COMPLETED|Core Study Part 2||0
6622801|NCT02204293|7550064|FG005|NOT COMPLETED|Core Study Part 2||0
6622802|NCT02204293|7550059|FG000|STARTED|LTE Phase||0
6622803|NCT02204293|7550060|FG001|STARTED|LTE Phase||0
6622804|NCT02204293|7550061|FG002|STARTED|LTE Phase||0
6622805|NCT02204293|7550062|FG003|STARTED|LTE Phase||0
6622806|NCT02204293|7550063|FG004|STARTED|LTE Phase||0
6622807|NCT02204293|7550064|FG005|STARTED|LTE Phase||7
6622808|NCT02204293|7550059|FG000|COMPLETED|LTE Phase||0
6622809|NCT02204293|7550060|FG001|COMPLETED|LTE Phase||0
6622810|NCT02204293|7550061|FG002|COMPLETED|LTE Phase||0
6622811|NCT02204293|7550062|FG003|COMPLETED|LTE Phase||0
6622812|NCT02204293|7550063|FG004|COMPLETED|LTE Phase||0
6622813|NCT02204293|7550064|FG005|COMPLETED|LTE Phase||0
6622814|NCT02204293|7550059|FG000|NOT COMPLETED|LTE Phase||0
6622815|NCT02204293|7550060|FG001|NOT COMPLETED|LTE Phase||0
6622816|NCT02204293|7550061|FG002|NOT COMPLETED|LTE Phase||0
6622817|NCT02204293|7550062|FG003|NOT COMPLETED|LTE Phase||0
6622818|NCT02204293|7550063|FG004|NOT COMPLETED|LTE Phase||0
6622819|NCT02204293|7550064|FG005|NOT COMPLETED|LTE Phase||7
6622820|NCT02204319|7550078|FG000|STARTED|Overall Study||10
6622821|NCT02204319|7550078|FG000|COMPLETED|Overall Study|3 did not complete study.|7
6622822|NCT02204319|7550078|FG000|NOT COMPLETED|Overall Study||3
6622823|NCT02204371|7550083|FG000|STARTED|Overall Study||7
6622824|NCT02204371|7550083|FG000|COMPLETED|Overall Study||6
6622825|NCT02204371|7550083|FG000|NOT COMPLETED|Overall Study||1
6622826|NCT02204410|7550087|FG000|STARTED|Overall Study||21
6622827|NCT02204410|7550087|FG000|COMPLETED|Overall Study||10
6622828|NCT02204410|7550087|FG000|NOT COMPLETED|Overall Study||11
6622829|NCT02204449|7550093|FG000|STARTED|Overall Study||46
6622830|NCT02204449|7550094|FG001|STARTED|Overall Study||48
6622831|NCT02204449|7550093|FG000|COMPLETED|Overall Study||39
6622832|NCT02204449|7550094|FG001|COMPLETED|Overall Study||37
6622833|NCT02204449|7550093|FG000|NOT COMPLETED|Overall Study||7
6622834|NCT02204449|7550094|FG001|NOT COMPLETED|Overall Study||11
6622835|NCT02204566|7550100|FG000|STARTED|Overall Study||5
6622836|NCT02204566|7550100|FG000|COMPLETED|Overall Study||1
6622837|NCT02204566|7550100|FG000|NOT COMPLETED|Overall Study||4
6622838|NCT02204579|7550104|FG000|STARTED|Overall Study||7
6622839|NCT02204579|7550104|FG000|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
6622840|NCT02204579|7550104|FG000|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
6622841|NCT02204579|7550104|FG000|Treated|Overall Study||5
6622842|NCT02204579|7550104|FG000|COMPLETED|Overall Study||5
6622843|NCT02204579|7550104|FG000|NOT COMPLETED|Overall Study||2
6622844|NCT02204657|7550115|FG000|STARTED|Overall Study||32
6622845|NCT02204657|7550116|FG001|STARTED|Overall Study||25
6622846|NCT02204657|7550115|FG000|COMPLETED|Overall Study||25
6622847|NCT02204657|7550116|FG001|COMPLETED|Overall Study||25
6622848|NCT02204657|7550115|FG000|NOT COMPLETED|Overall Study||7
6622849|NCT02204657|7550116|FG001|NOT COMPLETED|Overall Study||0
6622850|NCT02204748|7550122|FG000|STARTED|Overall Study||5
6622851|NCT02204748|7550122|FG000|COMPLETED|Overall Study||5
6622852|NCT02204748|7550122|FG000|NOT COMPLETED|Overall Study||0
6622853|NCT02204761|7550126|FG000|STARTED|Overall Study||6
6622854|NCT02204761|7550126|FG000|COMPLETED|Overall Study||6
6622855|NCT02204761|7550126|FG000|NOT COMPLETED|Overall Study||0
6622856|NCT02204917|7550130|FG000|STARTED|Overall Study||31
6622857|NCT02204917|7550130|FG000|COMPLETED|Overall Study||30
6622858|NCT02204917|7550130|FG000|NOT COMPLETED|Overall Study||1
6622859|NCT02204982|7550139|FG000|STARTED|Overall Study||6
6622860|NCT02204982|7550140|FG001|STARTED|Overall Study||7
6622861|NCT02204982|7550139|FG000|COMPLETED|Overall Study||2
6622862|NCT02204982|7550140|FG001|COMPLETED|Overall Study||0
6622863|NCT02204982|7550139|FG000|NOT COMPLETED|Overall Study||4
6622864|NCT02204982|7550140|FG001|NOT COMPLETED|Overall Study||7
6622865|NCT02205177|7550148|FG000|STARTED|Overall Study||8
6622866|NCT02205177|7550149|FG001|STARTED|Overall Study||2
6622867|NCT02205177|7550148|FG000|COMPLETED|Overall Study||6
6622868|NCT02205177|7550149|FG001|COMPLETED|Overall Study||2
6622869|NCT02205177|7550148|FG000|NOT COMPLETED|Overall Study||2
6622870|NCT02205177|7550149|FG001|NOT COMPLETED|Overall Study||0
6622871|NCT02205307|7550157|FG000|STARTED|Overall Study||178
6622872|NCT02205307|7550158|FG001|STARTED|Overall Study||169
6622873|NCT02205307|7550157|FG000|COMPLETED|Overall Study||161
6622874|NCT02205307|7550158|FG001|COMPLETED|Overall Study||163
6622875|NCT02205307|7550157|FG000|NOT COMPLETED|Overall Study||17
6622876|NCT02205307|7550158|FG001|NOT COMPLETED|Overall Study||6
6622877|NCT02205333|7550174|FG000|STARTED|Overall Study||8
6622878|NCT02205333|7550175|FG001|STARTED|Overall Study||6
6622879|NCT02205333|7550176|FG002|STARTED|Overall Study||3
6622880|NCT02205333|7550177|FG003|STARTED|Overall Study||7
6622881|NCT02205333|7550178|FG004|STARTED|Overall Study||6
6622882|NCT02205333|7550179|FG005|STARTED|Overall Study||7
6622883|NCT02205333|7550180|FG006|STARTED|Overall Study||7
6622884|NCT02205333|7550181|FG007|STARTED|Overall Study||3
6622885|NCT02205333|7550182|FG008|STARTED|Overall Study||1
6622886|NCT02205333|7550174|FG000|COMPLETED|Overall Study||2
6622887|NCT02205333|7550175|FG001|COMPLETED|Overall Study||0
6622888|NCT02205333|7550176|FG002|COMPLETED|Overall Study||1
6622889|NCT02205333|7550177|FG003|COMPLETED|Overall Study||0
6622890|NCT02205333|7550178|FG004|COMPLETED|Overall Study||1
6622891|NCT02205333|7550179|FG005|COMPLETED|Overall Study||4
6622892|NCT02205333|7550180|FG006|COMPLETED|Overall Study||2
6622893|NCT02205333|7550181|FG007|COMPLETED|Overall Study||1
6622894|NCT02205333|7550182|FG008|COMPLETED|Overall Study||1
6622895|NCT02205333|7550174|FG000|NOT COMPLETED|Overall Study||6
6622896|NCT02205333|7550175|FG001|NOT COMPLETED|Overall Study||6
6622897|NCT02205333|7550176|FG002|NOT COMPLETED|Overall Study||2
6622898|NCT02205333|7550177|FG003|NOT COMPLETED|Overall Study||7
6622899|NCT02205333|7550178|FG004|NOT COMPLETED|Overall Study||5
6622900|NCT02205333|7550179|FG005|NOT COMPLETED|Overall Study||3
6622901|NCT02205333|7550180|FG006|NOT COMPLETED|Overall Study||5
6622902|NCT02205333|7550181|FG007|NOT COMPLETED|Overall Study||2
6622903|NCT02205333|7550182|FG008|NOT COMPLETED|Overall Study||0
6622904|NCT02205476|7550204|FG000|STARTED|Overall Study||7
6622905|NCT02205476|7550205|FG001|STARTED|Overall Study||3
6622906|NCT02205476|7550204|FG000|COMPLETED|Overall Study||0
6622907|NCT02205476|7550205|FG001|COMPLETED|Overall Study||0
6622908|NCT02205476|7550204|FG000|NOT COMPLETED|Overall Study||7
6622909|NCT02205476|7550205|FG001|NOT COMPLETED|Overall Study||3
6622910|NCT02205801|7550221|FG000|STARTED|Overall Study||11
6622911|NCT02205801|7550222|FG001|STARTED|Overall Study||8
6622912|NCT02205801|7550223|FG002|STARTED|Overall Study||9
6622913|NCT02205801|7550224|FG003|STARTED|Overall Study||8
6622914|NCT02205801|7550221|FG000|COMPLETED|Overall Study||11
6622915|NCT02205801|7550222|FG001|COMPLETED|Overall Study||8
6622916|NCT02205801|7550223|FG002|COMPLETED|Overall Study||9
6622917|NCT02205801|7550224|FG003|COMPLETED|Overall Study||8
6622918|NCT02205801|7550221|FG000|NOT COMPLETED|Overall Study||0
6622919|NCT02205801|7550222|FG001|NOT COMPLETED|Overall Study||0
6622920|NCT02205801|7550223|FG002|NOT COMPLETED|Overall Study||0
6622921|NCT02205801|7550224|FG003|NOT COMPLETED|Overall Study||0
6622922|NCT02205814|7550238|FG000|STARTED|Overall Study||110
6622923|NCT02205814|7550239|FG001|STARTED|Overall Study||110
6622924|NCT02205814|7550240|FG002|STARTED|Overall Study||108
6622925|NCT02205814|7550241|FG003|STARTED|Overall Study||108
6622926|NCT02205814|7550238|FG000|COMPLETED|Overall Study||108
6622927|NCT02205814|7550239|FG001|COMPLETED|Overall Study||109
6622928|NCT02205814|7550240|FG002|COMPLETED|Overall Study||103
6622929|NCT02205814|7550241|FG003|COMPLETED|Overall Study||104
6622930|NCT02205814|7550238|FG000|NOT COMPLETED|Overall Study||2
6622931|NCT02205814|7550239|FG001|NOT COMPLETED|Overall Study||1
6622932|NCT02205814|7550240|FG002|NOT COMPLETED|Overall Study||5
6622933|NCT02205814|7550241|FG003|NOT COMPLETED|Overall Study||4
6622934|NCT02205983|7550255|FG000|STARTED|Overall Study||12
6622935|NCT02205983|7550256|FG001|STARTED|Overall Study||12
6622936|NCT02205983|7550257|FG002|STARTED|Overall Study||13
6622937|NCT02205983|7550258|FG003|STARTED|Overall Study||13
6622938|NCT02205983|7550255|FG000|COMPLETED|Overall Study||12
6622939|NCT02205983|7550256|FG001|COMPLETED|Overall Study||12
6622940|NCT02205983|7550257|FG002|COMPLETED|Overall Study||13
6622941|NCT02205983|7550258|FG003|COMPLETED|Overall Study||13
6622942|NCT02205983|7550255|FG000|NOT COMPLETED|Overall Study||0
6622943|NCT02205983|7550256|FG001|NOT COMPLETED|Overall Study||0
6622944|NCT02205983|7550257|FG002|NOT COMPLETED|Overall Study||0
6622945|NCT02205983|7550258|FG003|NOT COMPLETED|Overall Study||0
6622946|NCT02206061|7550271|FG000|STARTED|Overall Study||149
6622947|NCT02206061|7550272|FG001|STARTED|Overall Study||142
6622948|NCT02206061|7550273|FG002|STARTED|Overall Study||139
6622949|NCT02206061|7550271|FG000|COMPLETED|Overall Study||131
6622950|NCT02206061|7550272|FG001|COMPLETED|Overall Study||128
6622951|NCT02206061|7550273|FG002|COMPLETED|Overall Study||118
6622952|NCT02206061|7550271|FG000|NOT COMPLETED|Overall Study||18
6622953|NCT02206061|7550272|FG001|NOT COMPLETED|Overall Study||14
6622954|NCT02206061|7550273|FG002|NOT COMPLETED|Overall Study||21
6622955|NCT02206152|7550281|FG000|STARTED|Pre-Randomization||22
6622956|NCT02206152|7550281|FG000|COMPLETED|Pre-Randomization||20
6622957|NCT02206152|7550281|FG000|NOT COMPLETED|Pre-Randomization||2
6622958|NCT02206152|7550281|FG000|STARTED|Placebo, Then NAC||10
6622959|NCT02206152|7550281|FG000|COMPLETED|Placebo, Then NAC||10
6622960|NCT02206152|7550281|FG000|NOT COMPLETED|Placebo, Then NAC||0
6622961|NCT02206152|7550281|FG000|STARTED|NAC, Then Placebo||10
6622962|NCT02206152|7550281|FG000|COMPLETED|NAC, Then Placebo||10
6622963|NCT02206152|7550281|FG000|NOT COMPLETED|NAC, Then Placebo||0
6622964|NCT02206217|7550289|FG000|STARTED|Overall Study||90
6622965|NCT02206217|7550290|FG001|STARTED|Overall Study||93
6622966|NCT02206217|7550289|FG000|COMPLETED|Overall Study||81
6622967|NCT02206217|7550290|FG001|COMPLETED|Overall Study||79
6622968|NCT02206217|7550289|FG000|NOT COMPLETED|Overall Study||9
6622969|NCT02206217|7550290|FG001|NOT COMPLETED|Overall Study||14
6622970|NCT02206607|7550296|FG000|STARTED|Open-Label Run-In||42
6622971|NCT02206607|7550297|FG001|STARTED|Open-Label Run-In||0
6622972|NCT02206607|7550298|FG002|STARTED|Open-Label Run-In||0
6622973|NCT02206607|7550299|FG003|STARTED|Open-Label Run-In||0
6622974|NCT02206607|7550300|FG004|STARTED|Open-Label Run-In||0
6622975|NCT02206607|7550296|FG000|COMPLETED|Open-Label Run-In||39
6622976|NCT02206607|7550297|FG001|COMPLETED|Open-Label Run-In||0
6622977|NCT02206607|7550298|FG002|COMPLETED|Open-Label Run-In||0
6622978|NCT02206607|7550299|FG003|COMPLETED|Open-Label Run-In||0
6622979|NCT02206607|7550300|FG004|COMPLETED|Open-Label Run-In||0
6622980|NCT02206607|7550296|FG000|NOT COMPLETED|Open-Label Run-In||3
6622981|NCT02206607|7550297|FG001|NOT COMPLETED|Open-Label Run-In||0
6622982|NCT02206607|7550298|FG002|NOT COMPLETED|Open-Label Run-In||0
6622983|NCT02206607|7550299|FG003|NOT COMPLETED|Open-Label Run-In||0
6622984|NCT02206607|7550300|FG004|NOT COMPLETED|Open-Label Run-In||0
6622985|NCT02206607|7550296|FG000|STARTED|First Intervention Period||0
6622986|NCT02206607|7550297|FG001|STARTED|First Intervention Period||9
6622987|NCT02206607|7550298|FG002|STARTED|First Intervention Period||9
6622988|NCT02206607|7550299|FG003|STARTED|First Intervention Period||11
6622989|NCT02206607|7550300|FG004|STARTED|First Intervention Period||10
6622990|NCT02206607|7550296|FG000|COMPLETED|First Intervention Period||0
6622991|NCT02206607|7550297|FG001|COMPLETED|First Intervention Period||9
6622992|NCT02206607|7550298|FG002|COMPLETED|First Intervention Period||9
6622993|NCT02206607|7550299|FG003|COMPLETED|First Intervention Period||11
6622994|NCT02206607|7550300|FG004|COMPLETED|First Intervention Period||10
6622995|NCT02206607|7550296|FG000|NOT COMPLETED|First Intervention Period||0
6622996|NCT02206607|7550297|FG001|NOT COMPLETED|First Intervention Period||0
6622997|NCT02206607|7550298|FG002|NOT COMPLETED|First Intervention Period||0
6622998|NCT02206607|7550299|FG003|NOT COMPLETED|First Intervention Period||0
6622999|NCT02206607|7550300|FG004|NOT COMPLETED|First Intervention Period||0
6623000|NCT02206607|7550296|FG000|STARTED|First Washout Period 5 to 10 Days||0
6623001|NCT02206607|7550297|FG001|STARTED|First Washout Period 5 to 10 Days||9
6623002|NCT02206607|7550298|FG002|STARTED|First Washout Period 5 to 10 Days||9
6623003|NCT02206607|7550299|FG003|STARTED|First Washout Period 5 to 10 Days||11
6623004|NCT02206607|7550300|FG004|STARTED|First Washout Period 5 to 10 Days||10
6623005|NCT02206607|7550296|FG000|COMPLETED|First Washout Period 5 to 10 Days||0
6623006|NCT02206607|7550297|FG001|COMPLETED|First Washout Period 5 to 10 Days||9
6623007|NCT02206607|7550298|FG002|COMPLETED|First Washout Period 5 to 10 Days||9
6623008|NCT02206607|7550299|FG003|COMPLETED|First Washout Period 5 to 10 Days||11
6623009|NCT02206607|7550300|FG004|COMPLETED|First Washout Period 5 to 10 Days||10
6623010|NCT02206607|7550296|FG000|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6623011|NCT02206607|7550297|FG001|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6623012|NCT02206607|7550298|FG002|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6623013|NCT02206607|7550299|FG003|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6623014|NCT02206607|7550300|FG004|NOT COMPLETED|First Washout Period 5 to 10 Days||0
6623015|NCT02206607|7550296|FG000|STARTED|Second Intervention Period||0
6623016|NCT02206607|7550297|FG001|STARTED|Second Intervention Period||9
6623017|NCT02206607|7550298|FG002|STARTED|Second Intervention Period||9
6623018|NCT02206607|7550299|FG003|STARTED|Second Intervention Period||11
6623019|NCT02206607|7550300|FG004|STARTED|Second Intervention Period||10
6623020|NCT02206607|7550296|FG000|COMPLETED|Second Intervention Period||0
6623021|NCT02206607|7550297|FG001|COMPLETED|Second Intervention Period||9
6623022|NCT02206607|7550298|FG002|COMPLETED|Second Intervention Period||9
6623023|NCT02206607|7550299|FG003|COMPLETED|Second Intervention Period||10
6623024|NCT02206607|7550300|FG004|COMPLETED|Second Intervention Period||10
6623025|NCT02206607|7550296|FG000|NOT COMPLETED|Second Intervention Period||0
6623026|NCT02206607|7550297|FG001|NOT COMPLETED|Second Intervention Period||0
6623027|NCT02206607|7550298|FG002|NOT COMPLETED|Second Intervention Period||0
6623028|NCT02206607|7550299|FG003|NOT COMPLETED|Second Intervention Period||1
6623029|NCT02206607|7550300|FG004|NOT COMPLETED|Second Intervention Period||0
6623030|NCT02206607|7550296|FG000|STARTED|Second Washout Period 5 to 10 Days||0
6623031|NCT02206607|7550297|FG001|STARTED|Second Washout Period 5 to 10 Days||9
6623032|NCT02206607|7550298|FG002|STARTED|Second Washout Period 5 to 10 Days||9
6623033|NCT02206607|7550299|FG003|STARTED|Second Washout Period 5 to 10 Days||10
6623034|NCT02206607|7550300|FG004|STARTED|Second Washout Period 5 to 10 Days||10
6623035|NCT02206607|7550296|FG000|COMPLETED|Second Washout Period 5 to 10 Days||0
6623036|NCT02206607|7550297|FG001|COMPLETED|Second Washout Period 5 to 10 Days||9
6623037|NCT02206607|7550298|FG002|COMPLETED|Second Washout Period 5 to 10 Days||9
6623038|NCT02206607|7550299|FG003|COMPLETED|Second Washout Period 5 to 10 Days||10
6623039|NCT02206607|7550300|FG004|COMPLETED|Second Washout Period 5 to 10 Days||10
6623040|NCT02206607|7550296|FG000|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6623041|NCT02206607|7550297|FG001|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6623042|NCT02206607|7550298|FG002|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6623043|NCT02206607|7550299|FG003|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6623044|NCT02206607|7550300|FG004|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
6623045|NCT02206607|7550296|FG000|STARTED|Third Intervention Period||0
6623046|NCT02206607|7550297|FG001|STARTED|Third Intervention Period||9
6623047|NCT02206607|7550298|FG002|STARTED|Third Intervention Period||9
6623048|NCT02206607|7550299|FG003|STARTED|Third Intervention Period||10
6623049|NCT02206607|7550300|FG004|STARTED|Third Intervention Period||10
6623050|NCT02206607|7550296|FG000|COMPLETED|Third Intervention Period||0
6623051|NCT02206607|7550297|FG001|COMPLETED|Third Intervention Period||9
6623052|NCT02206607|7550298|FG002|COMPLETED|Third Intervention Period||9
6623053|NCT02206607|7550299|FG003|COMPLETED|Third Intervention Period||10
6623054|NCT02206607|7550300|FG004|COMPLETED|Third Intervention Period||10
6623055|NCT02206607|7550296|FG000|NOT COMPLETED|Third Intervention Period||0
6623056|NCT02206607|7550297|FG001|NOT COMPLETED|Third Intervention Period||0
6623057|NCT02206607|7550298|FG002|NOT COMPLETED|Third Intervention Period||0
6623058|NCT02206607|7550299|FG003|NOT COMPLETED|Third Intervention Period||0
6623059|NCT02206607|7550300|FG004|NOT COMPLETED|Third Intervention Period||0
6623060|NCT02206607|7550296|FG000|STARTED|Third Washout Period 5 to 10 Days||0
6623061|NCT02206607|7550297|FG001|STARTED|Third Washout Period 5 to 10 Days||9
6623062|NCT02206607|7550298|FG002|STARTED|Third Washout Period 5 to 10 Days||9
6623063|NCT02206607|7550299|FG003|STARTED|Third Washout Period 5 to 10 Days||10
6623064|NCT02206607|7550300|FG004|STARTED|Third Washout Period 5 to 10 Days||10
6623065|NCT02206607|7550296|FG000|COMPLETED|Third Washout Period 5 to 10 Days||0
6623066|NCT02206607|7550297|FG001|COMPLETED|Third Washout Period 5 to 10 Days||9
6623067|NCT02206607|7550298|FG002|COMPLETED|Third Washout Period 5 to 10 Days||9
6623068|NCT02206607|7550299|FG003|COMPLETED|Third Washout Period 5 to 10 Days||10
6623069|NCT02206607|7550300|FG004|COMPLETED|Third Washout Period 5 to 10 Days||10
6623070|NCT02206607|7550296|FG000|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6623071|NCT02206607|7550297|FG001|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6623072|NCT02206607|7550298|FG002|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6623073|NCT02206607|7550299|FG003|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6623074|NCT02206607|7550300|FG004|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
6623075|NCT02206607|7550296|FG000|STARTED|Fourth Intervention Period||0
6623076|NCT02206607|7550297|FG001|STARTED|Fourth Intervention Period||9
6623077|NCT02206607|7550298|FG002|STARTED|Fourth Intervention Period||9
6623078|NCT02206607|7550299|FG003|STARTED|Fourth Intervention Period||10
6623079|NCT02206607|7550300|FG004|STARTED|Fourth Intervention Period||10
6623080|NCT02206607|7550296|FG000|COMPLETED|Fourth Intervention Period||0
6623081|NCT02206607|7550297|FG001|COMPLETED|Fourth Intervention Period||9
6623082|NCT02206607|7550298|FG002|COMPLETED|Fourth Intervention Period||9
6623083|NCT02206607|7550299|FG003|COMPLETED|Fourth Intervention Period||10
6623084|NCT02206607|7550300|FG004|COMPLETED|Fourth Intervention Period||10
6623085|NCT02206607|7550296|FG000|NOT COMPLETED|Fourth Intervention Period||0
6623086|NCT02206607|7550297|FG001|NOT COMPLETED|Fourth Intervention Period||0
6623087|NCT02206607|7550298|FG002|NOT COMPLETED|Fourth Intervention Period||0
6623088|NCT02206607|7550299|FG003|NOT COMPLETED|Fourth Intervention Period||0
6623089|NCT02206607|7550300|FG004|NOT COMPLETED|Fourth Intervention Period||0
6623090|NCT02206620|7550316|FG000|STARTED|Phase I - First Intervention (6 Weeks)||22
6623091|NCT02206620|7550317|FG001|STARTED|Phase I - First Intervention (6 Weeks)||27
6623092|NCT02206620|7550316|FG000|COMPLETED|Phase I - First Intervention (6 Weeks)||21
6623093|NCT02206620|7550317|FG001|COMPLETED|Phase I - First Intervention (6 Weeks)||26
6623094|NCT02206620|7550316|FG000|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
6623095|NCT02206620|7550317|FG001|NOT COMPLETED|Phase I - First Intervention (6 Weeks)||1
6623096|NCT02206620|7550316|FG000|STARTED|Washout (6 Weeks)||21
6623097|NCT02206620|7550317|FG001|STARTED|Washout (6 Weeks)||26
6623098|NCT02206620|7550316|FG000|COMPLETED|Washout (6 Weeks)||21
6623099|NCT02206620|7550317|FG001|COMPLETED|Washout (6 Weeks)||26
6623100|NCT02206620|7550316|FG000|NOT COMPLETED|Washout (6 Weeks)||0
6623101|NCT02206620|7550317|FG001|NOT COMPLETED|Washout (6 Weeks)||0
6623102|NCT02206620|7550316|FG000|STARTED|Phase II - Second Intervention (6 Weeks)||21
6623103|NCT02206620|7550317|FG001|STARTED|Phase II - Second Intervention (6 Weeks)||26
6623104|NCT02206620|7550316|FG000|COMPLETED|Phase II - Second Intervention (6 Weeks)||21
6623105|NCT02206620|7550317|FG001|COMPLETED|Phase II - Second Intervention (6 Weeks)||24
6623106|NCT02206620|7550316|FG000|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||0
6623107|NCT02206620|7550317|FG001|NOT COMPLETED|Phase II - Second Intervention (6 Weeks)||2
6623108|NCT02206685|7550331|FG000|STARTED|Overall Study||37
6623109|NCT02206685|7550332|FG001|STARTED|Overall Study||37
6623110|NCT02206685|7550331|FG000|COMPLETED|Overall Study||32
6623111|NCT02206685|7550332|FG001|COMPLETED|Overall Study||30
6623112|NCT02206685|7550331|FG000|NOT COMPLETED|Overall Study||5
6623113|NCT02206685|7550332|FG001|NOT COMPLETED|Overall Study||7
6623114|NCT02206776|7550340|FG000|STARTED|Overall Study||1
6623115|NCT02206776|7550341|FG001|STARTED|Overall Study||1
6623116|NCT02206776|7550340|FG000|COMPLETED|Overall Study||1
6623117|NCT02206776|7550341|FG001|COMPLETED|Overall Study||1
6623118|NCT02206776|7550340|FG000|NOT COMPLETED|Overall Study||0
6623119|NCT02206776|7550341|FG001|NOT COMPLETED|Overall Study||0
6623120|NCT02206828|7550347|FG000|STARTED|Overall Study||100
6623121|NCT02206828|7550347|FG000|COMPLETED|Overall Study||93
6623122|NCT02206828|7550347|FG000|NOT COMPLETED|Overall Study||7
6623123|NCT02207088|7550374|FG000|STARTED|Overall Study||68
6623124|NCT02207088|7550374|FG000|COMPLETED|Overall Study||66
6623125|NCT02207088|7550374|FG000|NOT COMPLETED|Overall Study||2
6623126|NCT02207231|7550381|FG000|STARTED|Placebo Controlled Period: Week 0 - 16||174
6623127|NCT02207231|7550382|FG001|STARTED|Placebo Controlled Period: Week 0 - 16||329
6623128|NCT02207231|7550383|FG002|STARTED|Placebo Controlled Period: Week 0 - 16||334
6623129|NCT02207231|7550384|FG003|STARTED|Placebo Controlled Period: Week 0 - 16||0
6623130|NCT02207231|7550381|FG000|Treated|Placebo Controlled Period: Week 0 - 16||174
6623131|NCT02207231|7550382|FG001|Treated|Placebo Controlled Period: Week 0 - 16||329
6623132|NCT02207231|7550383|FG002|Treated|Placebo Controlled Period: Week 0 - 16||333
6623133|NCT02207231|7550384|FG003|Treated|Placebo Controlled Period: Week 0 - 16||0
6623134|NCT02207231|7550381|FG000|COMPLETED|Placebo Controlled Period: Week 0 - 16||167
6623135|NCT02207231|7550382|FG001|COMPLETED|Placebo Controlled Period: Week 0 - 16||322
6623136|NCT02207231|7550383|FG002|COMPLETED|Placebo Controlled Period: Week 0 - 16||324
6623137|NCT02207231|7550384|FG003|COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6623138|NCT02207231|7550381|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
6623139|NCT02207231|7550382|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||7
6623140|NCT02207231|7550383|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||10
6623141|NCT02207231|7550384|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0 - 16||0
6623142|NCT02207231|7550381|FG000|STARTED|Active Controlled Period: Week 16 - 48|2 participants did not cross-over.|165
6623143|NCT02207231|7550382|FG001|STARTED|Active Controlled Period: Week 16 - 48||322
6623144|NCT02207231|7550383|FG002|STARTED|Active Controlled Period: Week 16 - 48||324
6623145|NCT02207231|7550384|FG003|STARTED|Active Controlled Period: Week 16 - 48||0
6623146|NCT02207231|7550381|FG000|COMPLETED|Active Controlled Period: Week 16 - 48||162
6623147|NCT02207231|7550382|FG001|COMPLETED|Active Controlled Period: Week 16 - 48||301
6623148|NCT02207231|7550383|FG002|COMPLETED|Active Controlled Period: Week 16 - 48||281
6623149|NCT02207231|7550384|FG003|COMPLETED|Active Controlled Period: Week 16 - 48||0
6623150|NCT02207231|7550381|FG000|NOT COMPLETED|Active Controlled Period: Week 16 - 48||3
6623151|NCT02207231|7550382|FG001|NOT COMPLETED|Active Controlled Period: Week 16 - 48||21
6623152|NCT02207231|7550383|FG002|NOT COMPLETED|Active Controlled Period: Week 16 - 48||43
6623153|NCT02207231|7550384|FG003|NOT COMPLETED|Active Controlled Period: Week 16 - 48||0
6623154|NCT02207231|7550381|FG000|STARTED|Open-label Guselkumab: Week 48 - 264||0
6623155|NCT02207231|7550382|FG001|STARTED|Open-label Guselkumab: Week 48 - 264||0
6623156|NCT02207231|7550383|FG002|STARTED|Open-label Guselkumab: Week 48 - 264|One participant did not crossover at Week 52 due to adverse event.|280
6623157|NCT02207231|7550384|FG003|STARTED|Open-label Guselkumab: Week 48 - 264|162 + 301= 463|463
6623158|NCT02207231|7550381|FG000|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
6623159|NCT02207231|7550382|FG001|COMPLETED|Open-label Guselkumab: Week 48 - 264||0
6623160|NCT02207231|7550383|FG002|COMPLETED|Open-label Guselkumab: Week 48 - 264||242
6623161|NCT02207231|7550384|FG003|COMPLETED|Open-label Guselkumab: Week 48 - 264||380
6623162|NCT02207231|7550381|FG000|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
6623163|NCT02207231|7550382|FG001|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||0
6623164|NCT02207231|7550383|FG002|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||38
6623165|NCT02207231|7550384|FG003|NOT COMPLETED|Open-label Guselkumab: Week 48 - 264||83
6623166|NCT02207244|7550405|FG000|STARTED|Placebo Controlled Period: Week 0-16||248
6623167|NCT02207244|7550406|FG001|STARTED|Placebo Controlled Period: Week 0-16||496
6623168|NCT02207244|7550407|FG002|STARTED|Placebo Controlled Period: Week 0-16||248
6623169|NCT02207244|7550408|FG003|STARTED|Placebo Controlled Period: Week 0-16||0
6623170|NCT02207244|7550409|FG004|STARTED|Placebo Controlled Period: Week 0-16||0
6623171|NCT02207244|7550410|FG005|STARTED|Placebo Controlled Period: Week 0-16||0
6623172|NCT02207244|7550411|FG006|STARTED|Placebo Controlled Period: Week 0-16||0
6623173|NCT02207244|7550412|FG007|STARTED|Placebo Controlled Period: Week 0-16||0
6623174|NCT02207244|7550413|FG008|STARTED|Placebo Controlled Period: Week 0-16||0
6623175|NCT02207244|7550414|FG009|STARTED|Placebo Controlled Period: Week 0-16||0
6623176|NCT02207244|7550415|FG010|STARTED|Placebo Controlled Period: Week 0-16||0
6623177|NCT02207244|7550405|FG000|Treated|Placebo Controlled Period: Week 0-16||248
6623178|NCT02207244|7550406|FG001|Treated|Placebo Controlled Period: Week 0-16||494
6623179|NCT02207244|7550407|FG002|Treated|Placebo Controlled Period: Week 0-16||248
6623180|NCT02207244|7550408|FG003|Treated|Placebo Controlled Period: Week 0-16||0
6623181|NCT02207244|7550409|FG004|Treated|Placebo Controlled Period: Week 0-16||0
6623182|NCT02207244|7550410|FG005|Treated|Placebo Controlled Period: Week 0-16||0
6623183|NCT02207244|7550411|FG006|Treated|Placebo Controlled Period: Week 0-16||0
6623184|NCT02207244|7550412|FG007|Treated|Placebo Controlled Period: Week 0-16||0
6623185|NCT02207244|7550413|FG008|Treated|Placebo Controlled Period: Week 0-16||0
6623186|NCT02207244|7550414|FG009|Treated|Placebo Controlled Period: Week 0-16||0
6623187|NCT02207244|7550415|FG010|Treated|Placebo Controlled Period: Week 0-16||0
6623188|NCT02207244|7550405|FG000|COMPLETED|Placebo Controlled Period: Week 0-16||233
6623189|NCT02207244|7550406|FG001|COMPLETED|Placebo Controlled Period: Week 0-16||478
6623190|NCT02207244|7550407|FG002|COMPLETED|Placebo Controlled Period: Week 0-16||237
6623191|NCT02207244|7550408|FG003|COMPLETED|Placebo Controlled Period: Week 0-16||0
6623192|NCT02207244|7550409|FG004|COMPLETED|Placebo Controlled Period: Week 0-16||0
6623193|NCT02207244|7550410|FG005|COMPLETED|Placebo Controlled Period: Week 0-16||0
6623194|NCT02207244|7550411|FG006|COMPLETED|Placebo Controlled Period: Week 0-16||0
6623195|NCT02207244|7550412|FG007|COMPLETED|Placebo Controlled Period: Week 0-16||0
6623196|NCT02207244|7550413|FG008|COMPLETED|Placebo Controlled Period: Week 0-16||0
6623197|NCT02207244|7550414|FG009|COMPLETED|Placebo Controlled Period: Week 0-16||0
6623198|NCT02207244|7550415|FG010|COMPLETED|Placebo Controlled Period: Week 0-16||0
6623199|NCT02207244|7550405|FG000|NOT COMPLETED|Placebo Controlled Period: Week 0-16||15
6623200|NCT02207244|7550406|FG001|NOT COMPLETED|Placebo Controlled Period: Week 0-16||18
6733623|NCT03213405|7663091|FG000|COMPLETED|Overall Study||6
6733624|NCT03213405|7663092|FG001|COMPLETED|Overall Study||6
6733625|NCT03213405|7663093|FG002|COMPLETED|Overall Study||6
6733626|NCT03213405|7663094|FG003|COMPLETED|Overall Study||6
6733627|NCT03213405|7663091|FG000|NOT COMPLETED|Overall Study||0
6733628|NCT03213405|7663092|FG001|NOT COMPLETED|Overall Study||0
6733629|NCT03213405|7663093|FG002|NOT COMPLETED|Overall Study||0
6733630|NCT03213405|7663094|FG003|NOT COMPLETED|Overall Study||0
6733631|NCT03213509|7663106|FG000|STARTED|Overall Study||80
6733632|NCT03213509|7663107|FG001|STARTED|Overall Study||90
6733633|NCT03213509|7663106|FG000|COMPLETED|Overall Study||76
6733634|NCT03213509|7663107|FG001|COMPLETED|Overall Study||85
6733635|NCT03213509|7663106|FG000|NOT COMPLETED|Overall Study||4
6733636|NCT03213509|7663107|FG001|NOT COMPLETED|Overall Study||5
6733637|NCT03213626|7663114|FG000|STARTED|Overall Study||7
6733638|NCT03213626|7663114|FG000|COMPLETED|Overall Study||0
6733639|NCT03213626|7663114|FG000|NOT COMPLETED|Overall Study||7
6733640|NCT03213938|7663120|FG000|STARTED|Overall Study||220
6733641|NCT03213938|7663121|FG001|STARTED|Overall Study||220
6733642|NCT03213938|7663120|FG000|COMPLETED|Overall Study||206
6733643|NCT03213938|7663121|FG001|COMPLETED|Overall Study||208
6733644|NCT03213938|7663120|FG000|NOT COMPLETED|Overall Study||14
6733645|NCT03213938|7663121|FG001|NOT COMPLETED|Overall Study||12
6733646|NCT03214081|7663127|FG000|STARTED|Overall Study||1237
6733647|NCT03214081|7663127|FG000|COMPLETED|Overall Study||1174
6733648|NCT03214081|7663127|FG000|NOT COMPLETED|Overall Study||63
6733649|NCT03214094|7663131|FG000|STARTED|Overall Study||1119
6733650|NCT03214094|7663131|FG000|COMPLETED|Overall Study||1059
6733651|NCT03214094|7663131|FG000|NOT COMPLETED|Overall Study||60
6733652|NCT03214198|7663135|FG000|STARTED|Overall Study||1304
6733653|NCT03214198|7663135|FG000|COMPLETED|Overall Study||1268
6733654|NCT03214198|7663135|FG000|NOT COMPLETED|Overall Study||36
6733655|NCT03214224|7663139|FG000|STARTED|Overall Study|Subjects did both standard and remote assessments in the validation study. Total enrollment 49.|49
6733656|NCT03214224|7663139|FG000|COMPLETED|Overall Study|3 therapists enrolled. 3 ctrls enrolled (not incl. in analysis). 3 pts enr. but not completed.|40
6733657|NCT03214224|7663139|FG000|NOT COMPLETED|Overall Study||9
6733658|NCT03214367|7663149|FG000|STARTED|Lead-in Period||1316
6733659|NCT03214367|7663150|FG001|STARTED|Lead-in Period||0
6733660|NCT03214367|7663151|FG002|STARTED|Lead-in Period||0
6733661|NCT03214367|7663152|FG003|STARTED|Lead-in Period||0
6733662|NCT03214367|7663153|FG004|STARTED|Lead-in Period||76
6733663|NCT03214367|7663154|FG005|STARTED|Lead-in Period||0
6733664|NCT03214367|7663155|FG006|STARTED|Lead-in Period||0
6733665|NCT03214367|7663156|FG007|STARTED|Lead-in Period||0
6733666|NCT03214367|7663149|FG000|COMPLETED|Lead-in Period||1222
6733667|NCT03214367|7663150|FG001|COMPLETED|Lead-in Period||0
6733668|NCT03214367|7663151|FG002|COMPLETED|Lead-in Period||0
6733669|NCT03214367|7663152|FG003|COMPLETED|Lead-in Period||0
6733670|NCT03214367|7663153|FG004|COMPLETED|Lead-in Period||74
6733671|NCT03214367|7663154|FG005|COMPLETED|Lead-in Period||0
6733672|NCT03214367|7663155|FG006|COMPLETED|Lead-in Period||0
6733673|NCT03214367|7663156|FG007|COMPLETED|Lead-in Period||0
6733674|NCT03214367|7663149|FG000|NOT COMPLETED|Lead-in Period||94
6733675|NCT03214367|7663150|FG001|NOT COMPLETED|Lead-in Period||0
6733676|NCT03214367|7663151|FG002|NOT COMPLETED|Lead-in Period||0
6733677|NCT03214367|7663152|FG003|NOT COMPLETED|Lead-in Period||0
6733678|NCT03214367|7663153|FG004|NOT COMPLETED|Lead-in Period||2
6733679|NCT03214367|7663154|FG005|NOT COMPLETED|Lead-in Period||0
6733680|NCT03214367|7663155|FG006|NOT COMPLETED|Lead-in Period||0
6733681|NCT03214367|7663156|FG007|NOT COMPLETED|Lead-in Period||0
6733682|NCT03214367|7663149|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
6733683|NCT03214367|7663150|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|442
6740034|NCT03298035|7668876|FG000|STARTED|Overall Study||10
6623201|NCT02207244|7550407|FG002|NOT COMPLETED|Placebo Controlled Period: Week 0-16||11
6623202|NCT02207244|7550408|FG003|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
6623203|NCT02207244|7550409|FG004|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
6623204|NCT02207244|7550410|FG005|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
6623205|NCT02207244|7550411|FG006|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
6623206|NCT02207244|7550412|FG007|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
6623207|NCT02207244|7550413|FG008|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
6623208|NCT02207244|7550414|FG009|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
6623209|NCT02207244|7550415|FG010|NOT COMPLETED|Placebo Controlled Period: Week 0-16||0
6623210|NCT02207244|7550405|FG000|STARTED|Placebo Crossover and ACP: Week 16-28||0
6623211|NCT02207244|7550406|FG001|STARTED|Placebo Crossover and ACP: Week 16-28||0
6623212|NCT02207244|7550407|FG002|STARTED|Placebo Crossover and ACP: Week 16-28||0
6623213|NCT02207244|7550408|FG003|STARTED|Placebo Crossover and ACP: Week 16-28||233
6623214|NCT02207244|7550409|FG004|STARTED|Placebo Crossover and ACP: Week 16-28||478
6623215|NCT02207244|7550410|FG005|STARTED|Placebo Crossover and ACP: Week 16-28||237
6623216|NCT02207244|7550411|FG006|STARTED|Placebo Crossover and ACP: Week 16-28||0
6623217|NCT02207244|7550412|FG007|STARTED|Placebo Crossover and ACP: Week 16-28||0
6623218|NCT02207244|7550413|FG008|STARTED|Placebo Crossover and ACP: Week 16-28||0
6623219|NCT02207244|7550414|FG009|STARTED|Placebo Crossover and ACP: Week 16-28||0
6623220|NCT02207244|7550415|FG010|STARTED|Placebo Crossover and ACP: Week 16-28||0
6623221|NCT02207244|7550405|FG000|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623222|NCT02207244|7550406|FG001|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623223|NCT02207244|7550407|FG002|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623224|NCT02207244|7550408|FG003|COMPLETED|Placebo Crossover and ACP: Week 16-28||227
6623225|NCT02207244|7550409|FG004|COMPLETED|Placebo Crossover and ACP: Week 16-28||470
6623226|NCT02207244|7550410|FG005|COMPLETED|Placebo Crossover and ACP: Week 16-28||228
6623227|NCT02207244|7550411|FG006|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623228|NCT02207244|7550412|FG007|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623229|NCT02207244|7550413|FG008|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623230|NCT02207244|7550414|FG009|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623231|NCT02207244|7550415|FG010|COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623232|NCT02207244|7550405|FG000|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623233|NCT02207244|7550406|FG001|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623234|NCT02207244|7550407|FG002|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623235|NCT02207244|7550408|FG003|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||6
6623236|NCT02207244|7550409|FG004|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||8
6623237|NCT02207244|7550410|FG005|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||9
6623238|NCT02207244|7550411|FG006|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623239|NCT02207244|7550412|FG007|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623240|NCT02207244|7550413|FG008|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623241|NCT02207244|7550414|FG009|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623242|NCT02207244|7550415|FG010|NOT COMPLETED|Placebo Crossover and ACP: Week 16-28||0
6623243|NCT02207244|7550405|FG000|STARTED|Withdrawal and Re-treatment: Week 28-72||0
6623244|NCT02207244|7550406|FG001|STARTED|Withdrawal and Re-treatment: Week 28-72||0
6623245|NCT02207244|7550407|FG002|STARTED|Withdrawal and Re-treatment: Week 28-72||0
6623246|NCT02207244|7550408|FG003|STARTED|Withdrawal and Re-treatment: Week 28-72||0
6623247|NCT02207244|7550409|FG004|STARTED|Withdrawal and Re-treatment: Week 28-72||0
6623248|NCT02207244|7550410|FG005|STARTED|Withdrawal and Re-treatment: Week 28-72||0
6623249|NCT02207244|7550411|FG006|STARTED|Withdrawal and Re-treatment: Week 28-72||227
6623250|NCT02207244|7550412|FG007|STARTED|Withdrawal and Re-treatment: Week 28-72||470
6623251|NCT02207244|7550413|FG008|STARTED|Withdrawal and Re-treatment: Week 28-72||220
6623252|NCT02207244|7550414|FG009|STARTED|Withdrawal and Re-treatment: Week 28-72||8
6623253|NCT02207244|7550415|FG010|STARTED|Withdrawal and Re-treatment: Week 28-72||0
6623254|NCT02207244|7550405|FG000|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
6623255|NCT02207244|7550406|FG001|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
6623256|NCT02207244|7550407|FG002|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
6623257|NCT02207244|7550408|FG003|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
6623258|NCT02207244|7550409|FG004|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
6623259|NCT02207244|7550410|FG005|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
6623260|NCT02207244|7550411|FG006|Nonresponders|Withdrawal and Re-treatment: Week 28-72||80
6623261|NCT02207244|7550412|FG007|Nonresponders|Withdrawal and Re-treatment: Week 28-72||95
6623262|NCT02207244|7550413|FG008|Nonresponders|Withdrawal and Re-treatment: Week 28-72||112
6623263|NCT02207244|7550414|FG009|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
6623264|NCT02207244|7550415|FG010|Nonresponders|Withdrawal and Re-treatment: Week 28-72||0
6623265|NCT02207244|7550405|FG000|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623266|NCT02207244|7550406|FG001|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623267|NCT02207244|7550407|FG002|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623268|NCT02207244|7550408|FG003|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623269|NCT02207244|7550409|FG004|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623270|NCT02207244|7550410|FG005|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623271|NCT02207244|7550411|FG006|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623272|NCT02207244|7550412|FG007|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72|Participants randomized to withdrawal=182 and maintenance= 193|375
6623273|NCT02207244|7550413|FG008|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623274|NCT02207244|7550414|FG009|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623275|NCT02207244|7550415|FG010|Responders at Week 28|Withdrawal and Re-treatment: Week 28-72||0
6623276|NCT02207244|7550405|FG000|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623277|NCT02207244|7550406|FG001|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623278|NCT02207244|7550407|FG002|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623279|NCT02207244|7550408|FG003|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623280|NCT02207244|7550409|FG004|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623281|NCT02207244|7550410|FG005|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623282|NCT02207244|7550411|FG006|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||147
6623283|NCT02207244|7550412|FG007|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623284|NCT02207244|7550413|FG008|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||108
6623285|NCT02207244|7550414|FG009|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623286|NCT02207244|7550415|FG010|Responders at Week 28 and Withdrawn From Treatment|Withdrawal and Re-treatment: Week 28-72||0
6623287|NCT02207244|7550405|FG000|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623288|NCT02207244|7550406|FG001|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623289|NCT02207244|7550407|FG002|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623290|NCT02207244|7550408|FG003|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623291|NCT02207244|7550409|FG004|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623292|NCT02207244|7550410|FG005|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623293|NCT02207244|7550411|FG006|COMPLETED|Withdrawal and Re-treatment: Week 28-72||213
6623294|NCT02207244|7550412|FG007|COMPLETED|Withdrawal and Re-treatment: Week 28-72||443
6623295|NCT02207244|7550413|FG008|COMPLETED|Withdrawal and Re-treatment: Week 28-72||211
6623296|NCT02207244|7550414|FG009|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623297|NCT02207244|7550415|FG010|COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623298|NCT02207244|7550405|FG000|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623299|NCT02207244|7550406|FG001|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623300|NCT02207244|7550407|FG002|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623301|NCT02207244|7550408|FG003|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623302|NCT02207244|7550409|FG004|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623303|NCT02207244|7550410|FG005|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623304|NCT02207244|7550411|FG006|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||14
6623305|NCT02207244|7550412|FG007|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||27
6623306|NCT02207244|7550413|FG008|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||9
6623307|NCT02207244|7550414|FG009|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||8
6623308|NCT02207244|7550415|FG010|NOT COMPLETED|Withdrawal and Re-treatment: Week 28-72||0
6623309|NCT02207244|7550405|FG000|STARTED|Open-label Guselkumab: Week 72-264||0
6623310|NCT02207244|7550406|FG001|STARTED|Open-label Guselkumab: Week 72-264||0
6623311|NCT02207244|7550407|FG002|STARTED|Open-label Guselkumab: Week 72-264||0
6623312|NCT02207244|7550408|FG003|STARTED|Open-label Guselkumab: Week 72-264||0
6623313|NCT02207244|7550409|FG004|STARTED|Open-label Guselkumab: Week 72-264||0
6623314|NCT02207244|7550410|FG005|STARTED|Open-label Guselkumab: Week 72-264||0
6623315|NCT02207244|7550411|FG006|STARTED|Open-label Guselkumab: Week 72-264||0
6623316|NCT02207244|7550412|FG007|STARTED|Open-label Guselkumab: Week 72-264||0
6623317|NCT02207244|7550413|FG008|STARTED|Open-label Guselkumab: Week 72-264||211
6623318|NCT02207244|7550414|FG009|STARTED|Open-label Guselkumab: Week 72-264||0
6623319|NCT02207244|7550415|FG010|STARTED|Open-label Guselkumab: Week 72-264||656
6623320|NCT02207244|7550405|FG000|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623321|NCT02207244|7550406|FG001|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623322|NCT02207244|7550407|FG002|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623323|NCT02207244|7550408|FG003|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623324|NCT02207244|7550409|FG004|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623325|NCT02207244|7550410|FG005|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623326|NCT02207244|7550411|FG006|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623327|NCT02207244|7550412|FG007|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623328|NCT02207244|7550413|FG008|COMPLETED|Open-label Guselkumab: Week 72-264||173
6623329|NCT02207244|7550414|FG009|COMPLETED|Open-label Guselkumab: Week 72-264||0
6623330|NCT02207244|7550415|FG010|COMPLETED|Open-label Guselkumab: Week 72-264||554
6623331|NCT02207244|7550405|FG000|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623332|NCT02207244|7550406|FG001|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623333|NCT02207244|7550407|FG002|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623334|NCT02207244|7550408|FG003|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623335|NCT02207244|7550409|FG004|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623336|NCT02207244|7550410|FG005|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623337|NCT02207244|7550411|FG006|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623338|NCT02207244|7550412|FG007|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623339|NCT02207244|7550413|FG008|NOT COMPLETED|Open-label Guselkumab: Week 72-264||38
6623340|NCT02207244|7550414|FG009|NOT COMPLETED|Open-label Guselkumab: Week 72-264||0
6623341|NCT02207244|7550415|FG010|NOT COMPLETED|Open-label Guselkumab: Week 72-264||102
6623342|NCT02207322|7550446|FG000|STARTED|Overall Study||79
6623343|NCT02207322|7550447|FG001|STARTED|Overall Study||81
6623344|NCT02207322|7550446|FG000|Week-2|Overall Study||77
6623345|NCT02207322|7550447|FG001|Week-2|Overall Study||80
6623346|NCT02207322|7550446|FG000|3-month|Overall Study||74
6623347|NCT02207322|7550447|FG001|3-month|Overall Study||75
6623348|NCT02207322|7550446|FG000|COMPLETED|Overall Study|6-month|70
6623349|NCT02207322|7550447|FG001|COMPLETED|Overall Study|6-month|71
6623350|NCT02207322|7550446|FG000|NOT COMPLETED|Overall Study||9
6623351|NCT02207322|7550447|FG001|NOT COMPLETED|Overall Study||10
6623352|NCT02207374|7550456|FG000|STARTED|Overall Study||239
6623353|NCT02207374|7550457|FG001|STARTED|Overall Study||241
6623354|NCT02207374|7550458|FG002|STARTED|Overall Study||121
6623355|NCT02207374|7550456|FG000|Exposed|Overall Study||239
6623356|NCT02207374|7550457|FG001|Exposed|Overall Study||241
6623357|NCT02207374|7550458|FG002|Exposed|Overall Study||120
6623358|NCT02207374|7550456|FG000|COMPLETED|Overall Study||233
6623359|NCT02207374|7550457|FG001|COMPLETED|Overall Study||231
6623360|NCT02207374|7550458|FG002|COMPLETED|Overall Study||115
6623361|NCT02207374|7550456|FG000|NOT COMPLETED|Overall Study||6
6623362|NCT02207374|7550457|FG001|NOT COMPLETED|Overall Study||10
6623363|NCT02207374|7550458|FG002|NOT COMPLETED|Overall Study||6
6623364|NCT02207400|7550468|FG000|STARTED|Overall Study||123
6623365|NCT02207400|7550469|FG001|STARTED|Overall Study||123
6623366|NCT02207400|7550468|FG000|COMPLETED|Overall Study||107
6623367|NCT02207400|7550469|FG001|COMPLETED|Overall Study||109
6623368|NCT02207400|7550468|FG000|NOT COMPLETED|Overall Study||16
6623369|NCT02207400|7550469|FG001|NOT COMPLETED|Overall Study||14
6623370|NCT02207413|7550484|FG000|STARTED|Overall Study||60
6623371|NCT02207413|7550485|FG001|STARTED|Overall Study||60
6623372|NCT02207413|7550486|FG002|STARTED|Overall Study||410
6623373|NCT02207413|7550487|FG003|STARTED|Overall Study||411
6623374|NCT02207413|7550488|FG004|STARTED|Overall Study||466
6623375|NCT02207413|7550489|FG005|STARTED|Overall Study||474
6623376|NCT02207413|7550484|FG000|COMPLETED|Overall Study||59
6623377|NCT02207413|7550485|FG001|COMPLETED|Overall Study||60
6623378|NCT02207413|7550486|FG002|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
6623379|NCT02207413|7550487|FG003|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
6623380|NCT02207413|7550488|FG004|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
6733684|NCT03214367|7663151|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|451
6733685|NCT03214367|7663152|FG003|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|329
6733686|NCT03214367|7663153|FG004|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
6733687|NCT03214367|7663154|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|31
6733688|NCT03214367|7663155|FG006|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|21
6733689|NCT03214367|7663156|FG007|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro in Treatment Period.|22
6733690|NCT03214367|7663149|FG000|COMPLETED|Treatment Period||0
6733691|NCT03214367|7663150|FG001|COMPLETED|Treatment Period||408
6733692|NCT03214367|7663151|FG002|COMPLETED|Treatment Period||418
6733693|NCT03214367|7663152|FG003|COMPLETED|Treatment Period||310
6733694|NCT03214367|7663153|FG004|COMPLETED|Treatment Period||0
6733695|NCT03214367|7663154|FG005|COMPLETED|Treatment Period||28
6733696|NCT03214367|7663155|FG006|COMPLETED|Treatment Period||19
6733697|NCT03214367|7663156|FG007|COMPLETED|Treatment Period||21
6733698|NCT03214367|7663149|FG000|NOT COMPLETED|Treatment Period||0
6733699|NCT03214367|7663150|FG001|NOT COMPLETED|Treatment Period||34
6733700|NCT03214367|7663151|FG002|NOT COMPLETED|Treatment Period||33
6733701|NCT03214367|7663152|FG003|NOT COMPLETED|Treatment Period||19
6733702|NCT03214367|7663153|FG004|NOT COMPLETED|Treatment Period||0
6733703|NCT03214367|7663154|FG005|NOT COMPLETED|Treatment Period||3
6733704|NCT03214367|7663155|FG006|NOT COMPLETED|Treatment Period||2
6733705|NCT03214367|7663156|FG007|NOT COMPLETED|Treatment Period||1
6733706|NCT03214380|7663174|FG000|STARTED|Lead-in||750
6733707|NCT03214380|7663175|FG001|STARTED|Lead-in||0
6733708|NCT03214380|7663176|FG002|STARTED|Lead-in||0
6733709|NCT03214380|7663177|FG003|STARTED|Lead-in||183
6733710|NCT03214380|7663178|FG004|STARTED|Lead-in||0
6733711|NCT03214380|7663179|FG005|STARTED|Lead-in||0
6733712|NCT03214380|7663174|FG000|Received at Least 1 Dose Lead-in Insulin|Lead-in||750
6733713|NCT03214380|7663175|FG001|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
6733714|NCT03214380|7663176|FG002|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
6733715|NCT03214380|7663177|FG003|Received at Least 1 Dose Lead-in Insulin|Lead-in||183
6733716|NCT03214380|7663178|FG004|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
6733717|NCT03214380|7663179|FG005|Received at Least 1 Dose Lead-in Insulin|Lead-in||0
6733718|NCT03214380|7663174|FG000|COMPLETED|Lead-in||673
6733719|NCT03214380|7663175|FG001|COMPLETED|Lead-in||0
6733720|NCT03214380|7663176|FG002|COMPLETED|Lead-in||0
6733721|NCT03214380|7663177|FG003|COMPLETED|Lead-in||164
6733722|NCT03214380|7663178|FG004|COMPLETED|Lead-in||0
6733723|NCT03214380|7663179|FG005|COMPLETED|Lead-in||0
6733724|NCT03214380|7663174|FG000|NOT COMPLETED|Lead-in||77
6733725|NCT03214380|7663175|FG001|NOT COMPLETED|Lead-in||0
6733726|NCT03214380|7663176|FG002|NOT COMPLETED|Lead-in||0
6623381|NCT02207413|7550489|FG005|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
6623382|NCT02207413|7550484|FG000|NOT COMPLETED|Overall Study||1
6623383|NCT02207413|7550485|FG001|NOT COMPLETED|Overall Study||0
6623384|NCT02207413|7550486|FG002|NOT COMPLETED|Overall Study||0
6623385|NCT02207413|7550487|FG003|NOT COMPLETED|Overall Study||1
6623386|NCT02207413|7550488|FG004|NOT COMPLETED|Overall Study||7
6623387|NCT02207413|7550489|FG005|NOT COMPLETED|Overall Study||13
6623388|NCT02207478|7550511|FG000|STARTED|Overall Study||40
6623389|NCT02207478|7550512|FG001|STARTED|Overall Study||46
6623390|NCT02207478|7550511|FG000|COMPLETED|Overall Study||40
6623391|NCT02207478|7550512|FG001|COMPLETED|Overall Study||46
6623392|NCT02207478|7550511|FG000|NOT COMPLETED|Overall Study||0
6623393|NCT02207478|7550512|FG001|NOT COMPLETED|Overall Study||0
6623394|NCT02207491|7550520|FG000|STARTED|Overall Study||202
6623395|NCT02207491|7550521|FG001|STARTED|Overall Study||209
6623396|NCT02207491|7550520|FG000|COMPLETED|Overall Study||171
6623397|NCT02207491|7550521|FG001|COMPLETED|Overall Study||196
6623398|NCT02207491|7550520|FG000|NOT COMPLETED|Overall Study||31
6623399|NCT02207491|7550521|FG001|NOT COMPLETED|Overall Study||13
6623400|NCT02207530|7550527|FG000|STARTED|Overall Study||112
6623401|NCT02207530|7550527|FG000|COMPLETED|Overall Study||21
6623402|NCT02207530|7550527|FG000|NOT COMPLETED|Overall Study||91
6733727|NCT03214380|7663177|FG003|NOT COMPLETED|Lead-in||19
6733728|NCT03214380|7663178|FG004|NOT COMPLETED|Lead-in||0
6733729|NCT03214380|7663179|FG005|NOT COMPLETED|Lead-in||0
6733730|NCT03214380|7663174|FG000|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
6733731|NCT03214380|7663175|FG001|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|337
6733732|NCT03214380|7663176|FG002|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|336
6733733|NCT03214380|7663177|FG003|STARTED|Treatment Period|Participants received Insulin Lispro during Lead-in Period.|0
6733734|NCT03214380|7663178|FG004|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
6733735|NCT03214380|7663179|FG005|STARTED|Treatment Period|Participants were randomized to either LY900014 or Insulin lispro for Intensive Treatment Period.|82
6733736|NCT03214380|7663174|FG000|Received at Least 1 Dose of Study Drug|Treatment Period||0
6733737|NCT03214380|7663175|FG001|Received at Least 1 Dose of Study Drug|Treatment Period||337
6733738|NCT03214380|7663176|FG002|Received at Least 1 Dose of Study Drug|Treatment Period||336
6733739|NCT03214380|7663177|FG003|Received at Least 1 Dose of Study Drug|Treatment Period||0
6733740|NCT03214380|7663178|FG004|Received at Least 1 Dose of Study Drug|Treatment Period||82
6733741|NCT03214380|7663179|FG005|Received at Least 1 Dose of Study Drug|Treatment Period||82
6733742|NCT03214380|7663174|FG000|COMPLETED|Treatment Period||0
6733743|NCT03214380|7663175|FG001|COMPLETED|Treatment Period||319
6733744|NCT03214380|7663176|FG002|COMPLETED|Treatment Period||320
6733745|NCT03214380|7663177|FG003|COMPLETED|Treatment Period||0
6733746|NCT03214380|7663178|FG004|COMPLETED|Treatment Period||73
6733747|NCT03214380|7663179|FG005|COMPLETED|Treatment Period||71
6733748|NCT03214380|7663174|FG000|NOT COMPLETED|Treatment Period||0
6733749|NCT03214380|7663175|FG001|NOT COMPLETED|Treatment Period||18
6733750|NCT03214380|7663176|FG002|NOT COMPLETED|Treatment Period||16
6733751|NCT03214380|7663177|FG003|NOT COMPLETED|Treatment Period||0
6733752|NCT03214380|7663178|FG004|NOT COMPLETED|Treatment Period||9
6733753|NCT03214380|7663179|FG005|NOT COMPLETED|Treatment Period||11
6733754|NCT03214406|7663193|FG000|STARTED|Overall Study||88
6733755|NCT03214406|7663194|FG001|STARTED|Overall Study||93
6733756|NCT03214406|7663193|FG000|COMPLETED|Overall Study||78
6733757|NCT03214406|7663194|FG001|COMPLETED|Overall Study||78
6733758|NCT03214406|7663193|FG000|NOT COMPLETED|Overall Study||10
6733759|NCT03214406|7663194|FG001|NOT COMPLETED|Overall Study||15
6733760|NCT03214588|7663203|FG000|STARTED|Overall Study||27
6733761|NCT03214588|7663204|FG001|STARTED|Overall Study||14
6733762|NCT03214588|7663205|FG002|STARTED|Overall Study||26
6733763|NCT03214588|7663203|FG000|COMPLETED|Overall Study||26
6733764|NCT03214588|7663204|FG001|COMPLETED|Overall Study||13
6733765|NCT03214588|7663205|FG002|COMPLETED|Overall Study||24
6733766|NCT03214588|7663203|FG000|NOT COMPLETED|Overall Study||1
6733767|NCT03214588|7663204|FG001|NOT COMPLETED|Overall Study||1
6733768|NCT03214588|7663205|FG002|NOT COMPLETED|Overall Study||2
6733769|NCT03214640|7663217|FG000|STARTED|Overall Study||31
6733770|NCT03214640|7663218|FG001|STARTED|Overall Study||32
6733771|NCT03214640|7663219|FG002|STARTED|Overall Study||31
6733772|NCT03214640|7663220|FG003|STARTED|Overall Study||34
6733773|NCT03214640|7663217|FG000|COMPLETED|Overall Study||30
6733774|NCT03214640|7663218|FG001|COMPLETED|Overall Study||30
6733775|NCT03214640|7663219|FG002|COMPLETED|Overall Study||30
6733776|NCT03214640|7663220|FG003|COMPLETED|Overall Study||30
6733777|NCT03214640|7663217|FG000|NOT COMPLETED|Overall Study||1
6733778|NCT03214640|7663218|FG001|NOT COMPLETED|Overall Study||2
6733779|NCT03214640|7663219|FG002|NOT COMPLETED|Overall Study||1
6733780|NCT03214640|7663220|FG003|NOT COMPLETED|Overall Study||4
6733781|NCT03214952|7663230|FG000|STARTED|Overall Study||3183
6733782|NCT03214952|7663230|FG000|COMPLETED|Overall Study||3125
6733783|NCT03214952|7663230|FG000|NOT COMPLETED|Overall Study||58
6733784|NCT03215667|7663234|FG000|STARTED|Overall Study||9
6733785|NCT03215667|7663234|FG000|COMPLETED|Overall Study||5
6733786|NCT03215667|7663234|FG000|NOT COMPLETED|Overall Study||4
6623403|NCT02207556|7550533|FG000|STARTED|Overall Study||7
6623404|NCT02207556|7550534|FG001|STARTED|Overall Study||25
6733787|NCT03215706|7663240|FG000|STARTED|Randomization||361
6733788|NCT03215706|7663241|FG001|STARTED|Randomization||358
6733789|NCT03215706|7663240|FG000|COMPLETED|Randomization||358
6733790|NCT03215706|7663241|FG001|COMPLETED|Randomization||349
6733791|NCT03215706|7663240|FG000|NOT COMPLETED|Randomization||3
6733792|NCT03215706|7663241|FG001|NOT COMPLETED|Randomization||9
6733793|NCT03215706|7663240|FG000|STARTED|Treatment Period||358
6733794|NCT03215706|7663241|FG001|STARTED|Treatment Period||349
6733795|NCT03215706|7663240|FG000|COMPLETED|Treatment Period||16
6733796|NCT03215706|7663241|FG001|COMPLETED|Treatment Period||103
6733797|NCT03215706|7663240|FG000|NOT COMPLETED|Treatment Period||342
6733798|NCT03215706|7663241|FG001|NOT COMPLETED|Treatment Period||246
6733799|NCT03215758|7663249|FG000|STARTED|Overall Study||339
6733800|NCT03215758|7663250|FG001|STARTED|Overall Study||336
6733801|NCT03215758|7663249|FG000|COMPLETED|Overall Study||334
6733802|NCT03215758|7663250|FG001|COMPLETED|Overall Study||328
6733803|NCT03215758|7663249|FG000|NOT COMPLETED|Overall Study||5
6733804|NCT03215758|7663250|FG001|NOT COMPLETED|Overall Study||8
6733805|NCT03215771|7663256|FG000|STARTED|Overall Study||16
6733806|NCT03215771|7663256|FG000|Stroke Subjects|Overall Study||8
6733807|NCT03215771|7663256|FG000|TBI Subjects|Overall Study||8
6733808|NCT03215771|7663256|FG000|COMPLETED|Overall Study||13
6733809|NCT03215771|7663256|FG000|NOT COMPLETED|Overall Study||3
6733810|NCT03215901|7663264|FG000|STARTED|Overall Study||199
6733811|NCT03215901|7663265|FG001|STARTED|Overall Study||112
6733812|NCT03215901|7663266|FG002|STARTED|Overall Study||116
6733813|NCT03215901|7663264|FG000|COMPLETED|Overall Study||199
6733814|NCT03215901|7663265|FG001|COMPLETED|Overall Study||112
6733815|NCT03215901|7663266|FG002|COMPLETED|Overall Study||116
6733816|NCT03215901|7663264|FG000|NOT COMPLETED|Overall Study||0
6733817|NCT03215901|7663265|FG001|NOT COMPLETED|Overall Study||0
6733818|NCT03215901|7663266|FG002|NOT COMPLETED|Overall Study||0
6733819|NCT03216200|7663274|FG000|STARTED|Overall Study||5
6733820|NCT03216200|7663274|FG000|COMPLETED|Overall Study||5
6733821|NCT03216200|7663274|FG000|NOT COMPLETED|Overall Study||0
6733822|NCT03216226|7663280|FG000|STARTED|Overall Study||57
6733823|NCT03216226|7663281|FG001|STARTED|Overall Study||55
6733824|NCT03216226|7663280|FG000|Randomized and Treated|Overall Study||57
6733825|NCT03216226|7663281|FG001|Randomized and Treated|Overall Study||54
6733826|NCT03216226|7663280|FG000|COMPLETED|Overall Study||52
6733827|NCT03216226|7663281|FG001|COMPLETED|Overall Study||50
6733828|NCT03216226|7663280|FG000|NOT COMPLETED|Overall Study||5
6733829|NCT03216226|7663281|FG001|NOT COMPLETED|Overall Study||5
6733830|NCT03216265|7663290|FG000|STARTED|Overall Study||22
6733831|NCT03216265|7663291|FG001|STARTED|Overall Study||22
6733832|NCT03216265|7663292|FG002|STARTED|Overall Study||22
6733833|NCT03216265|7663290|FG000|COMPLETED|Overall Study||20
6733834|NCT03216265|7663291|FG001|COMPLETED|Overall Study||21
6733835|NCT03216265|7663292|FG002|COMPLETED|Overall Study||19
6733836|NCT03216265|7663290|FG000|NOT COMPLETED|Overall Study||2
6733837|NCT03216265|7663291|FG001|NOT COMPLETED|Overall Study||1
6733838|NCT03216265|7663292|FG002|NOT COMPLETED|Overall Study||3
6733839|NCT03216382|7663309|FG000|STARTED|Overall Study||41
6733840|NCT03216382|7663310|FG001|STARTED|Overall Study||54
6733841|NCT03216382|7663309|FG000|COMPLETED|Overall Study||34
6733842|NCT03216382|7663310|FG001|COMPLETED|Overall Study||44
6733843|NCT03216382|7663309|FG000|NOT COMPLETED|Overall Study||7
6733844|NCT03216382|7663310|FG001|NOT COMPLETED|Overall Study||10
6733845|NCT03216512|7663318|FG000|STARTED|Overall Study||17
6733846|NCT03216512|7663319|FG001|STARTED|Overall Study||14
6733847|NCT03216512|7663318|FG000|COMPLETED|Overall Study||17
6733848|NCT03216512|7663319|FG001|COMPLETED|Overall Study||13
6733849|NCT03216512|7663318|FG000|NOT COMPLETED|Overall Study||0
6733850|NCT03216512|7663319|FG001|NOT COMPLETED|Overall Study||1
6733851|NCT03216746|7663331|FG000|STARTED|Overall Study||72
6733852|NCT03216746|7663332|FG001|STARTED|Overall Study||79
6733853|NCT03216746|7663333|FG002|STARTED|Overall Study||68
6733854|NCT03216746|7663334|FG003|STARTED|Overall Study||69
6733855|NCT03216746|7663331|FG000|COMPLETED|Overall Study||66
6733856|NCT03216746|7663332|FG001|COMPLETED|Overall Study||71
6733857|NCT03216746|7663333|FG002|COMPLETED|Overall Study||63
6733858|NCT03216746|7663334|FG003|COMPLETED|Overall Study||63
6733859|NCT03216746|7663331|FG000|NOT COMPLETED|Overall Study||6
6733860|NCT03216746|7663332|FG001|NOT COMPLETED|Overall Study||8
6733861|NCT03216746|7663333|FG002|NOT COMPLETED|Overall Study||5
6733862|NCT03216746|7663334|FG003|NOT COMPLETED|Overall Study||6
6733863|NCT03216850|7663344|FG000|STARTED|Overall Study||15
6733864|NCT03216850|7663344|FG000|COMPLETED|Overall Study|6 patients did not complete the study because of the pre-analytical error.|9
6733865|NCT03216850|7663344|FG000|NOT COMPLETED|Overall Study||6
6733866|NCT03216902|7663354|FG000|STARTED|Overall Study||22
6733867|NCT03216902|7663355|FG001|STARTED|Overall Study||44
6733868|NCT03216902|7663356|FG002|STARTED|Overall Study||43
6733869|NCT03216902|7663357|FG003|STARTED|Overall Study||43
6733870|NCT03216902|7663358|FG004|STARTED|Overall Study||44
6733871|NCT03216902|7663359|FG005|STARTED|Overall Study||45
6733872|NCT03216902|7663354|FG000|COMPLETED|Overall Study||20
6733873|NCT03216902|7663355|FG001|COMPLETED|Overall Study||43
6733874|NCT03216902|7663356|FG002|COMPLETED|Overall Study||42
6733875|NCT03216902|7663357|FG003|COMPLETED|Overall Study||43
6733876|NCT03216902|7663358|FG004|COMPLETED|Overall Study||43
6733877|NCT03216902|7663359|FG005|COMPLETED|Overall Study||42
6733878|NCT03216902|7663354|FG000|NOT COMPLETED|Overall Study||2
6733879|NCT03216902|7663355|FG001|NOT COMPLETED|Overall Study||1
6733880|NCT03216902|7663356|FG002|NOT COMPLETED|Overall Study||1
6733881|NCT03216902|7663357|FG003|NOT COMPLETED|Overall Study||0
6733882|NCT03216902|7663358|FG004|NOT COMPLETED|Overall Study||1
6733883|NCT03216902|7663359|FG005|NOT COMPLETED|Overall Study||3
6733884|NCT03216954|7663381|FG000|STARTED|Overall Study||4
6733885|NCT03216954|7663382|FG001|STARTED|Overall Study||3
6733886|NCT03216954|7663383|FG002|STARTED|Overall Study||3
6733887|NCT03216954|7663384|FG003|STARTED|Overall Study||3
6733888|NCT03216954|7663385|FG004|STARTED|Overall Study||1
6733889|NCT03216954|7663381|FG000|COMPLETED|Overall Study||2
6733890|NCT03216954|7663382|FG001|COMPLETED|Overall Study||2
6733891|NCT03216954|7663383|FG002|COMPLETED|Overall Study||2
6733892|NCT03216954|7663384|FG003|COMPLETED|Overall Study||3
6733893|NCT03216954|7663385|FG004|COMPLETED|Overall Study||0
6733894|NCT03216954|7663381|FG000|NOT COMPLETED|Overall Study||2
6733895|NCT03216954|7663382|FG001|NOT COMPLETED|Overall Study||1
6733896|NCT03216954|7663383|FG002|NOT COMPLETED|Overall Study||1
6733897|NCT03216954|7663384|FG003|NOT COMPLETED|Overall Study||0
6733898|NCT03216954|7663385|FG004|NOT COMPLETED|Overall Study||1
6733899|NCT03217968|7663393|FG000|STARTED|Overall Study||59
6733900|NCT03217968|7663393|FG000|COMPLETED|Overall Study||48
6733901|NCT03217968|7663393|FG000|NOT COMPLETED|Overall Study||11
6733902|NCT03218397|7663399|FG000|STARTED|Overall Study||249
6733903|NCT03218397|7663400|FG001|STARTED|Overall Study||251
6733904|NCT03218397|7663399|FG000|COMPLETED|Overall Study||226
6733905|NCT03218397|7663400|FG001|COMPLETED|Overall Study||222
6733906|NCT03218397|7663399|FG000|NOT COMPLETED|Overall Study||23
6733907|NCT03218397|7663400|FG001|NOT COMPLETED|Overall Study||29
6733908|NCT03218566|7663406|FG000|STARTED|Overall Study||119
6733909|NCT03218566|7663406|FG000|COMPLETED|Overall Study||110
6733910|NCT03218566|7663406|FG000|NOT COMPLETED|Overall Study||9
6733911|NCT03218592|7663413|FG000|STARTED|Phase 1: 1 Dose||12
6733912|NCT03218592|7663414|FG001|STARTED|Phase 1: 1 Dose||12
6733913|NCT03218592|7663415|FG002|STARTED|Phase 1: 1 Dose||12
6733914|NCT03218592|7663413|FG000|COMPLETED|Phase 1: 1 Dose||12
6733915|NCT03218592|7663414|FG001|COMPLETED|Phase 1: 1 Dose||12
6733916|NCT03218592|7663415|FG002|COMPLETED|Phase 1: 1 Dose||12
6733917|NCT03218592|7663413|FG000|NOT COMPLETED|Phase 1: 1 Dose||0
6733918|NCT03218592|7663414|FG001|NOT COMPLETED|Phase 1: 1 Dose||0
6733919|NCT03218592|7663415|FG002|NOT COMPLETED|Phase 1: 1 Dose||0
6733920|NCT03218592|7663413|FG000|STARTED|Phase 2: Daily Doses x 28 Days||12
6733921|NCT03218592|7663414|FG001|STARTED|Phase 2: Daily Doses x 28 Days||12
6733922|NCT03218592|7663415|FG002|STARTED|Phase 2: Daily Doses x 28 Days||12
6733923|NCT03218592|7663413|FG000|COMPLETED|Phase 2: Daily Doses x 28 Days||12
6733924|NCT03218592|7663414|FG001|COMPLETED|Phase 2: Daily Doses x 28 Days||12
6733925|NCT03218592|7663415|FG002|COMPLETED|Phase 2: Daily Doses x 28 Days||12
6733926|NCT03218592|7663413|FG000|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
6733927|NCT03218592|7663414|FG001|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
6733928|NCT03218592|7663415|FG002|NOT COMPLETED|Phase 2: Daily Doses x 28 Days||0
6733929|NCT03218592|7663413|FG000|STARTED|Phase 3: 0 Doses Per Week||4
6733930|NCT03218592|7663414|FG001|STARTED|Phase 3: 0 Doses Per Week||4
6733931|NCT03218592|7663415|FG002|STARTED|Phase 3: 0 Doses Per Week||4
6733932|NCT03218592|7663413|FG000|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
6733933|NCT03218592|7663414|FG001|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
6733934|NCT03218592|7663415|FG002|4 Patients Per Group|Phase 3: 0 Doses Per Week||4
6733935|NCT03218592|7663413|FG000|COMPLETED|Phase 3: 0 Doses Per Week||4
6733936|NCT03218592|7663414|FG001|COMPLETED|Phase 3: 0 Doses Per Week||4
6733937|NCT03218592|7663415|FG002|COMPLETED|Phase 3: 0 Doses Per Week||4
6733938|NCT03218592|7663413|FG000|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
6733939|NCT03218592|7663414|FG001|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
6733940|NCT03218592|7663415|FG002|NOT COMPLETED|Phase 3: 0 Doses Per Week||0
6733941|NCT03218592|7663413|FG000|STARTED|Phase 3: 1 Dose Per Period||4
6733942|NCT03218592|7663414|FG001|STARTED|Phase 3: 1 Dose Per Period||4
6733943|NCT03218592|7663415|FG002|STARTED|Phase 3: 1 Dose Per Period||4
6733944|NCT03218592|7663413|FG000|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
6733945|NCT03218592|7663414|FG001|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
6733946|NCT03218592|7663415|FG002|4 Patients Per Group|Phase 3: 1 Dose Per Period||4
6733947|NCT03218592|7663413|FG000|COMPLETED|Phase 3: 1 Dose Per Period||4
6733948|NCT03218592|7663414|FG001|COMPLETED|Phase 3: 1 Dose Per Period||4
6733949|NCT03218592|7663415|FG002|COMPLETED|Phase 3: 1 Dose Per Period||4
6733950|NCT03218592|7663413|FG000|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
6733951|NCT03218592|7663414|FG001|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
6733952|NCT03218592|7663415|FG002|NOT COMPLETED|Phase 3: 1 Dose Per Period||0
6733953|NCT03218592|7663413|FG000|STARTED|Phase 3: 3 Doses Per Week||4
6733954|NCT03218592|7663414|FG001|STARTED|Phase 3: 3 Doses Per Week||4
6733955|NCT03218592|7663415|FG002|STARTED|Phase 3: 3 Doses Per Week||4
6733956|NCT03218592|7663413|FG000|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
6733957|NCT03218592|7663414|FG001|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
6733958|NCT03218592|7663415|FG002|4 Patients Per Group|Phase 3: 3 Doses Per Week||4
6733959|NCT03218592|7663413|FG000|COMPLETED|Phase 3: 3 Doses Per Week||4
6733960|NCT03218592|7663414|FG001|COMPLETED|Phase 3: 3 Doses Per Week||4
6733961|NCT03218592|7663415|FG002|COMPLETED|Phase 3: 3 Doses Per Week||4
6733962|NCT03218592|7663413|FG000|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
6733963|NCT03218592|7663414|FG001|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
6733964|NCT03218592|7663415|FG002|NOT COMPLETED|Phase 3: 3 Doses Per Week||0
6733965|NCT03218787|7663428|FG000|STARTED|Overall Study||2047
6733966|NCT03218787|7663428|FG000|COMPLETED|Overall Study||1841
6733967|NCT03218787|7663428|FG000|NOT COMPLETED|Overall Study||206
6733968|NCT03219216|7663434|FG000|STARTED|Overall Study||75
6733969|NCT03219216|7663435|FG001|STARTED|Overall Study||25
6733970|NCT03219216|7663434|FG000|COMPLETED|Overall Study||75
6733971|NCT03219216|7663435|FG001|COMPLETED|Overall Study||24
6733972|NCT03219216|7663434|FG000|NOT COMPLETED|Overall Study||0
6733973|NCT03219216|7663435|FG001|NOT COMPLETED|Overall Study||1
6733974|NCT03219294|7663442|FG000|STARTED|Overall Study||58
6733975|NCT03219294|7663443|FG001|STARTED|Overall Study||58
6733976|NCT03219294|7663442|FG000|COMPLETED|Overall Study||58
6733977|NCT03219294|7663443|FG001|COMPLETED|Overall Study||58
6733978|NCT03219294|7663442|FG000|NOT COMPLETED|Overall Study||0
6733979|NCT03219294|7663443|FG001|NOT COMPLETED|Overall Study||0
6733980|NCT03219320|7663453|FG000|STARTED|Overall Study||75
6733981|NCT03219320|7663454|FG001|STARTED|Overall Study||77
6733982|NCT03219320|7663455|FG002|STARTED|Overall Study||77
6733983|NCT03219320|7663456|FG003|STARTED|Overall Study||72
6733984|NCT03219320|7663453|FG000|COMPLETED|Overall Study||73
6733985|NCT03219320|7663454|FG001|COMPLETED|Overall Study||74
6733986|NCT03219320|7663455|FG002|COMPLETED|Overall Study||72
6733987|NCT03219320|7663456|FG003|COMPLETED|Overall Study||69
6733988|NCT03219320|7663453|FG000|NOT COMPLETED|Overall Study||2
6733989|NCT03219320|7663454|FG001|NOT COMPLETED|Overall Study||3
6733990|NCT03219320|7663455|FG002|NOT COMPLETED|Overall Study||5
6733991|NCT03219320|7663456|FG003|NOT COMPLETED|Overall Study||3
6733992|NCT03219723|7663466|FG000|STARTED|Overall Study||560
6733993|NCT03219723|7663466|FG000|COMPLETED|Overall Study||550
6733994|NCT03219723|7663466|FG000|NOT COMPLETED|Overall Study||10
6733995|NCT03219840|7663470|FG000|STARTED|Overall Study||38
6733996|NCT03219840|7663471|FG001|STARTED|Overall Study||31
6733997|NCT03219840|7663470|FG000|Day 1 Visit for 1st Period|Overall Study||37
6733998|NCT03219840|7663471|FG001|Day 1 Visit for 1st Period|Overall Study||31
6733999|NCT03219840|7663470|FG000|1st Intervention Period of 21 Days|Overall Study||34
6734000|NCT03219840|7663471|FG001|1st Intervention Period of 21 Days|Overall Study||31
6734001|NCT03219840|7663470|FG000|Day 22 Visit for 1st Period|Overall Study||34
6734002|NCT03219840|7663471|FG001|Day 22 Visit for 1st Period|Overall Study||31
6734003|NCT03219840|7663470|FG000|Washout Period of 21 Days|Overall Study||34
6734004|NCT03219840|7663471|FG001|Washout Period of 21 Days|Overall Study||31
6734005|NCT03219840|7663470|FG000|Day 1 Visit for 2nd Period|Overall Study||34
6734006|NCT03219840|7663471|FG001|Day 1 Visit for 2nd Period|Overall Study||31
6734007|NCT03219840|7663470|FG000|2nd Intervention Period of 21 Days|Overall Study||34
6734008|NCT03219840|7663471|FG001|2nd Intervention Period of 21 Days|Overall Study||31
6734009|NCT03219840|7663470|FG000|Day 22 Visit for 2nd Period|Overall Study||34
6734010|NCT03219840|7663471|FG001|Day 22 Visit for 2nd Period|Overall Study||31
6734011|NCT03219840|7663470|FG000|COMPLETED|Overall Study||34
6734012|NCT03219840|7663471|FG001|COMPLETED|Overall Study||31
6734013|NCT03219840|7663470|FG000|NOT COMPLETED|Overall Study||4
6734014|NCT03219840|7663471|FG001|NOT COMPLETED|Overall Study||0
6734015|NCT03219866|7663479|FG000|STARTED|Overall Study||21
6734016|NCT03219866|7663480|FG001|STARTED|Overall Study||19
6734017|NCT03219866|7663479|FG000|COMPLETED|Overall Study||21
6734018|NCT03219866|7663480|FG001|COMPLETED|Overall Study||19
6734019|NCT03219866|7663479|FG000|NOT COMPLETED|Overall Study||0
6734020|NCT03219866|7663480|FG001|NOT COMPLETED|Overall Study||0
6734021|NCT03219892|7663488|FG000|STARTED|Overall Study||20
6734022|NCT03219892|7663489|FG001|STARTED|Overall Study||10
6734023|NCT03219892|7663488|FG000|COMPLETED|Overall Study||20
6734024|NCT03219892|7663489|FG001|COMPLETED|Overall Study||10
6734025|NCT03219892|7663488|FG000|NOT COMPLETED|Overall Study||0
6734026|NCT03219892|7663489|FG001|NOT COMPLETED|Overall Study||0
6734027|NCT03220048|7663498|FG000|STARTED|Overall Study||11
6734028|NCT03220048|7663499|FG001|STARTED|Overall Study||27
6734029|NCT03220048|7663500|FG002|STARTED|Overall Study||28
6734030|NCT03220048|7663498|FG000|COMPLETED|Overall Study||11
6734031|NCT03220048|7663499|FG001|COMPLETED|Overall Study||25
6734032|NCT03220048|7663500|FG002|COMPLETED|Overall Study||27
6734033|NCT03220048|7663498|FG000|NOT COMPLETED|Overall Study||0
6734034|NCT03220048|7663499|FG001|NOT COMPLETED|Overall Study||2
6734035|NCT03220048|7663500|FG002|NOT COMPLETED|Overall Study||1
6734036|NCT03220204|7663516|FG000|STARTED|Overall Study||15
6734037|NCT03220204|7663517|FG001|STARTED|Overall Study||15
6734038|NCT03220204|7663518|FG002|STARTED|Overall Study||15
6734039|NCT03220204|7663516|FG000|COMPLETED|Overall Study||14
6734040|NCT03220204|7663517|FG001|COMPLETED|Overall Study||13
6734041|NCT03220204|7663518|FG002|COMPLETED|Overall Study||12
6734042|NCT03220204|7663516|FG000|NOT COMPLETED|Overall Study||1
6734043|NCT03220204|7663517|FG001|NOT COMPLETED|Overall Study||2
6734044|NCT03220204|7663518|FG002|NOT COMPLETED|Overall Study||3
6734045|NCT03220217|7663532|FG000|STARTED|Overall Study||8
6734046|NCT03220217|7663533|FG001|STARTED|Overall Study||10
6734047|NCT03220217|7663534|FG002|STARTED|Overall Study||11
6734048|NCT03220217|7663532|FG000|COMPLETED|Overall Study||8
6734049|NCT03220217|7663533|FG001|COMPLETED|Overall Study||9
6734050|NCT03220217|7663534|FG002|COMPLETED|Overall Study||10
6734051|NCT03220217|7663532|FG000|NOT COMPLETED|Overall Study||0
6734052|NCT03220217|7663533|FG001|NOT COMPLETED|Overall Study||1
6734053|NCT03220217|7663534|FG002|NOT COMPLETED|Overall Study||1
6734054|NCT03220230|7663563|FG000|STARTED|Overall Study||4240
6734055|NCT03220230|7663563|FG000|COMPLETED|Overall Study||4240
6734056|NCT03220230|7663563|FG000|NOT COMPLETED|Overall Study||0
6734057|NCT03220412|7663569|FG000|STARTED|Overall Study||54
6734058|NCT03220412|7663570|FG001|STARTED|Overall Study||50
6734059|NCT03220412|7663569|FG000|COMPLETED|Overall Study||54
6734060|NCT03220412|7663570|FG001|COMPLETED|Overall Study||50
6734061|NCT03220412|7663569|FG000|NOT COMPLETED|Overall Study||0
6734062|NCT03220412|7663570|FG001|NOT COMPLETED|Overall Study||0
6734063|NCT03220737|7663585|FG000|STARTED|Main Study (Day 1 - 181)||163
6734064|NCT03220737|7663586|FG001|STARTED|Main Study (Day 1 - 181)||26
6734065|NCT03220737|7663587|FG002|STARTED|Main Study (Day 1 - 181)||158
6734066|NCT03220737|7663588|FG003|STARTED|Main Study (Day 1 - 181)||27
6734067|NCT03220737|7663589|FG004|STARTED|Main Study (Day 1 - 181)||150
6734068|NCT03220737|7663590|FG005|STARTED|Main Study (Day 1 - 181)||26
6734069|NCT03220737|7663591|FG006|STARTED|Main Study (Day 1 - 181)||2688
6734070|NCT03220737|7663585|FG000|COMPLETED|Main Study (Day 1 - 181)||157
6734071|NCT03220737|7663586|FG001|COMPLETED|Main Study (Day 1 - 181)||24
6734072|NCT03220737|7663587|FG002|COMPLETED|Main Study (Day 1 - 181)||146
6734073|NCT03220737|7663588|FG003|COMPLETED|Main Study (Day 1 - 181)||24
6734074|NCT03220737|7663589|FG004|COMPLETED|Main Study (Day 1 - 181)||130
6734075|NCT03220737|7663590|FG005|COMPLETED|Main Study (Day 1 - 181)||25
6734076|NCT03220737|7663591|FG006|COMPLETED|Main Study (Day 1 - 181)||2687
6734077|NCT03220737|7663585|FG000|NOT COMPLETED|Main Study (Day 1 - 181)||6
6734078|NCT03220737|7663586|FG001|NOT COMPLETED|Main Study (Day 1 - 181)||2
6734079|NCT03220737|7663587|FG002|NOT COMPLETED|Main Study (Day 1 - 181)||12
6734080|NCT03220737|7663588|FG003|NOT COMPLETED|Main Study (Day 1 - 181)||3
6734081|NCT03220737|7663589|FG004|NOT COMPLETED|Main Study (Day 1 - 181)||20
6734082|NCT03220737|7663590|FG005|NOT COMPLETED|Main Study (Day 1 - 181)||1
6734083|NCT03220737|7663591|FG006|NOT COMPLETED|Main Study (Day 1 - 181)||1
6734084|NCT03220737|7663585|FG000|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|13
6734085|NCT03220737|7663586|FG001|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora.|0
6734086|NCT03220737|7663587|FG002|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|11
6734087|NCT03220737|7663588|FG003|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
6734088|NCT03220737|7663589|FG004|STARTED|Placebo Crossover (Day 181-365)|Only placebo subjects who opted to receive Vaxchora were included in the crossover group.|7
6734089|NCT03220737|7663590|FG005|STARTED|Placebo Crossover (Day 181-365)|Placebo subjects from Main study opted to cross over to the active group to receive Vaxchora|0
6734090|NCT03220737|7663591|FG006|STARTED|Placebo Crossover (Day 181-365)||0
6734091|NCT03220737|7663585|FG000|COMPLETED|Placebo Crossover (Day 181-365)||13
6734092|NCT03220737|7663586|FG001|COMPLETED|Placebo Crossover (Day 181-365)||0
6734093|NCT03220737|7663587|FG002|COMPLETED|Placebo Crossover (Day 181-365)||11
6734094|NCT03220737|7663588|FG003|COMPLETED|Placebo Crossover (Day 181-365)||0
6734095|NCT03220737|7663589|FG004|COMPLETED|Placebo Crossover (Day 181-365)||5
6734096|NCT03220737|7663590|FG005|COMPLETED|Placebo Crossover (Day 181-365)||0
6734097|NCT03220737|7663591|FG006|COMPLETED|Placebo Crossover (Day 181-365)||0
6734098|NCT03220737|7663585|FG000|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
6734099|NCT03220737|7663586|FG001|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
6734100|NCT03220737|7663587|FG002|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
6734101|NCT03220737|7663588|FG003|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
6734102|NCT03220737|7663589|FG004|NOT COMPLETED|Placebo Crossover (Day 181-365)||2
6734103|NCT03220737|7663590|FG005|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
6734104|NCT03220737|7663591|FG006|NOT COMPLETED|Placebo Crossover (Day 181-365)||0
6734105|NCT03220737|7663585|FG000|STARTED|Long-term Follow-up (Day 365-730)|Cohort 1 subjects from the main study had to opt to be included in the Long-term follow-up study.|73
6734106|NCT03220737|7663586|FG001|STARTED|Long-term Follow-up (Day 365-730)||0
6734107|NCT03220737|7663587|FG002|STARTED|Long-term Follow-up (Day 365-730)|Cohort 2 subjects were not eligible for the Long-term follow-up study.|0
6734108|NCT03220737|7663588|FG003|STARTED|Long-term Follow-up (Day 365-730)||0
6734109|NCT03220737|7663589|FG004|STARTED|Long-term Follow-up (Day 365-730)|Cohort 3 subjects were not eligible for the Long-term follow-up study.|0
6734110|NCT03220737|7663590|FG005|STARTED|Long-term Follow-up (Day 365-730)||0
6734111|NCT03220737|7663591|FG006|STARTED|Long-term Follow-up (Day 365-730)||0
6734112|NCT03220737|7663585|FG000|COMPLETED|Long-term Follow-up (Day 365-730)||62
6734113|NCT03220737|7663586|FG001|COMPLETED|Long-term Follow-up (Day 365-730)||0
6734114|NCT03220737|7663587|FG002|COMPLETED|Long-term Follow-up (Day 365-730)||0
6734115|NCT03220737|7663588|FG003|COMPLETED|Long-term Follow-up (Day 365-730)||0
6734116|NCT03220737|7663589|FG004|COMPLETED|Long-term Follow-up (Day 365-730)||0
6734117|NCT03220737|7663590|FG005|COMPLETED|Long-term Follow-up (Day 365-730)||0
6734118|NCT03220737|7663591|FG006|COMPLETED|Long-term Follow-up (Day 365-730)||0
6734119|NCT03220737|7663585|FG000|NOT COMPLETED|Long-term Follow-up (Day 365-730)||11
6734120|NCT03220737|7663586|FG001|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
6734121|NCT03220737|7663587|FG002|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
6734122|NCT03220737|7663588|FG003|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
6734123|NCT03220737|7663589|FG004|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
6734124|NCT03220737|7663590|FG005|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
6734125|NCT03220737|7663591|FG006|NOT COMPLETED|Long-term Follow-up (Day 365-730)||0
6734126|NCT03220958|7663615|FG000|STARTED|Overall Study||81
6734127|NCT03220958|7663616|FG001|STARTED|Overall Study||79
6734128|NCT03220958|7663615|FG000|COMPLETED|Overall Study||81
6734129|NCT03220958|7663616|FG001|COMPLETED|Overall Study||79
6734130|NCT03220958|7663615|FG000|NOT COMPLETED|Overall Study||0
6734131|NCT03220958|7663616|FG001|NOT COMPLETED|Overall Study||0
6734132|NCT03221192|7663622|FG000|STARTED|Overall Study||27
6734133|NCT03221192|7663622|FG000|COMPLETED|Overall Study||27
6734134|NCT03221192|7663622|FG000|NOT COMPLETED|Overall Study||0
6734135|NCT03221387|7663626|FG000|STARTED|Overall Study||30
6734136|NCT03221387|7663626|FG000|COMPLETED|Overall Study||28
6734137|NCT03221387|7663626|FG000|NOT COMPLETED|Overall Study||2
6734138|NCT03221595|7663632|FG000|STARTED|Overall Study||51
6734139|NCT03221595|7663633|FG001|STARTED|Overall Study||59
6734140|NCT03221595|7663632|FG000|COMPLETED|Overall Study||51
6734141|NCT03221595|7663633|FG001|COMPLETED|Overall Study||59
6734142|NCT03221595|7663632|FG000|NOT COMPLETED|Overall Study||0
6734143|NCT03221595|7663633|FG001|NOT COMPLETED|Overall Study||0
6734144|NCT03221738|7663639|FG000|STARTED|Overall Study||10
6734145|NCT03221738|7663639|FG000|COMPLETED|Overall Study||10
6734146|NCT03221738|7663639|FG000|NOT COMPLETED|Overall Study||0
6734147|NCT03221764|7663643|FG000|STARTED|Overall Study||20
6734148|NCT03221764|7663643|FG000|COMPLETED|Overall Study||20
6734149|NCT03221764|7663643|FG000|NOT COMPLETED|Overall Study||0
6734150|NCT03222037|7663647|FG000|STARTED|Period 1||21
6734151|NCT03222037|7663648|FG001|STARTED|Period 1||22
6734152|NCT03222037|7663647|FG000|COMPLETED|Period 1||21
6734153|NCT03222037|7663648|FG001|COMPLETED|Period 1||22
6734154|NCT03222037|7663647|FG000|NOT COMPLETED|Period 1||0
6734155|NCT03222037|7663648|FG001|NOT COMPLETED|Period 1||0
6734156|NCT03222037|7663647|FG000|STARTED|Period 2||21
6734157|NCT03222037|7663648|FG001|STARTED|Period 2||22
6734158|NCT03222037|7663647|FG000|COMPLETED|Period 2||21
6734159|NCT03222037|7663648|FG001|COMPLETED|Period 2||22
6734160|NCT03222037|7663647|FG000|NOT COMPLETED|Period 2||0
6734161|NCT03222037|7663648|FG001|NOT COMPLETED|Period 2||0
6734162|NCT03222141|7663654|FG000|STARTED|Overall Study||583
6734163|NCT03222141|7663654|FG000|COMPLETED|Overall Study||565
6734164|NCT03222141|7663654|FG000|NOT COMPLETED|Overall Study||18
6734165|NCT03222349|7663659|FG000|STARTED|Overall Study||11
6734166|NCT03222349|7663660|FG001|STARTED|Overall Study||13
6734167|NCT03222349|7663659|FG000|COMPLETED|Overall Study||3
6734168|NCT03222349|7663660|FG001|COMPLETED|Overall Study||6
6734169|NCT03222349|7663659|FG000|NOT COMPLETED|Overall Study||8
6734170|NCT03222349|7663660|FG001|NOT COMPLETED|Overall Study||7
6734171|NCT03222414|7663675|FG000|STARTED|Overall Study||0
6734172|NCT03222414|7663676|FG001|STARTED|Overall Study||1
6734173|NCT03222414|7663675|FG000|COMPLETED|Overall Study||0
6734174|NCT03222414|7663676|FG001|COMPLETED|Overall Study||1
6734175|NCT03222414|7663675|FG000|NOT COMPLETED|Overall Study||0
6734176|NCT03222414|7663676|FG001|NOT COMPLETED|Overall Study||0
6734177|NCT03222427|7663682|FG000|STARTED|Overall Study||8
6734178|NCT03222427|7663682|FG000|Received One Dose of Study Drug|Overall Study||8
6734179|NCT03222427|7663682|FG000|COMPLETED|Overall Study||8
6734180|NCT03222427|7663682|FG000|NOT COMPLETED|Overall Study||0
6734181|NCT03222505|7663689|FG000|STARTED|Overall Study||5
6734182|NCT03222505|7663690|FG001|STARTED|Overall Study||7
6734183|NCT03222505|7663689|FG000|COMPLETED|Overall Study||5
6734184|NCT03222505|7663690|FG001|COMPLETED|Overall Study||7
6734185|NCT03222505|7663689|FG000|NOT COMPLETED|Overall Study||0
6734186|NCT03222505|7663690|FG001|NOT COMPLETED|Overall Study||0
6734187|NCT03222583|7663699|FG000|STARTED|Overall Study||363
6734188|NCT03222583|7663700|FG001|STARTED|Overall Study||183
6734189|NCT03222583|7663699|FG000|Received Double-blind Treatment|Overall Study||362
6734190|NCT03222583|7663700|FG001|Received Double-blind Treatment|Overall Study||183
6734191|NCT03222583|7663699|FG000|Completed Double-blind Period|Overall Study||360
6734192|NCT03222583|7663700|FG001|Completed Double-blind Period|Overall Study||183
6734193|NCT03222583|7663699|FG000|Entered Open-label Period|Overall Study||0
6734194|NCT03222583|7663700|FG001|Entered Open-label Period|Overall Study||182
6734195|NCT03222583|7663699|FG000|Completed Open-label Period|Overall Study||0
6734196|NCT03222583|7663700|FG001|Completed Open-label Period|Overall Study||181
6734197|NCT03222583|7663699|FG000|COMPLETED|Overall Study||358
6734198|NCT03222583|7663700|FG001|COMPLETED|Overall Study||177
6734199|NCT03222583|7663699|FG000|NOT COMPLETED|Overall Study||5
6734200|NCT03222583|7663700|FG001|NOT COMPLETED|Overall Study||6
6734201|NCT03223246|7663708|FG000|STARTED|48-72 Hours||83
6734202|NCT03223246|7663709|FG001|STARTED|48-72 Hours||66
6734203|NCT03223246|7663708|FG000|COMPLETED|48-72 Hours||62
6734204|NCT03223246|7663709|FG001|COMPLETED|48-72 Hours||35
6734205|NCT03223246|7663708|FG000|NOT COMPLETED|48-72 Hours||21
6734206|NCT03223246|7663709|FG001|NOT COMPLETED|48-72 Hours||31
6734207|NCT03223246|7663708|FG000|STARTED|5-7 Days||83
6734208|NCT03223246|7663709|FG001|STARTED|5-7 Days||66
6734209|NCT03223246|7663708|FG000|COMPLETED|5-7 Days||41
6734210|NCT03223246|7663709|FG001|COMPLETED|5-7 Days||35
6734211|NCT03223246|7663708|FG000|NOT COMPLETED|5-7 Days||42
6734212|NCT03223246|7663709|FG001|NOT COMPLETED|5-7 Days||31
6734213|NCT03223272|7663715|FG000|STARTED|Overall Study||7
6734214|NCT03223272|7663715|FG000|COMPLETED|Overall Study||6
6734215|NCT03223272|7663715|FG000|NOT COMPLETED|Overall Study||1
6734216|NCT03223337|7663723|FG000|STARTED|Part 1 (Up to 16 Days)||8
6734217|NCT03223337|7663724|FG001|STARTED|Part 1 (Up to 16 Days)||8
6734218|NCT03223337|7663725|FG002|STARTED|Part 1 (Up to 16 Days)||0
6734219|NCT03223337|7663726|FG003|STARTED|Part 1 (Up to 16 Days)||0
6734220|NCT03223337|7663723|FG000|COMPLETED|Part 1 (Up to 16 Days)||8
6734221|NCT03223337|7663724|FG001|COMPLETED|Part 1 (Up to 16 Days)||8
6734222|NCT03223337|7663725|FG002|COMPLETED|Part 1 (Up to 16 Days)||0
6734223|NCT03223337|7663726|FG003|COMPLETED|Part 1 (Up to 16 Days)||0
6734224|NCT03223337|7663723|FG000|NOT COMPLETED|Part 1 (Up to 16 Days)||0
6734225|NCT03223337|7663724|FG001|NOT COMPLETED|Part 1 (Up to 16 Days)||0
6734226|NCT03223337|7663725|FG002|NOT COMPLETED|Part 1 (Up to 16 Days)||0
6734227|NCT03223337|7663726|FG003|NOT COMPLETED|Part 1 (Up to 16 Days)||0
6734228|NCT03223337|7663723|FG000|STARTED|Part 2 (Up to 16 Days)||0
6734229|NCT03223337|7663724|FG001|STARTED|Part 2 (Up to 16 Days)||0
6734230|NCT03223337|7663725|FG002|STARTED|Part 2 (Up to 16 Days)||12
6734231|NCT03223337|7663726|FG003|STARTED|Part 2 (Up to 16 Days)||9
6734232|NCT03223337|7663723|FG000|COMPLETED|Part 2 (Up to 16 Days)||0
6734233|NCT03223337|7663724|FG001|COMPLETED|Part 2 (Up to 16 Days)||0
6734234|NCT03223337|7663725|FG002|COMPLETED|Part 2 (Up to 16 Days)||12
6734235|NCT03223337|7663726|FG003|COMPLETED|Part 2 (Up to 16 Days)||9
6734236|NCT03223337|7663723|FG000|NOT COMPLETED|Part 2 (Up to 16 Days)||0
6734237|NCT03223337|7663724|FG001|NOT COMPLETED|Part 2 (Up to 16 Days)||0
6734238|NCT03223337|7663725|FG002|NOT COMPLETED|Part 2 (Up to 16 Days)||0
6734239|NCT03223337|7663726|FG003|NOT COMPLETED|Part 2 (Up to 16 Days)||0
6734240|NCT03223649|7663738|FG000|STARTED|Overall Study||52
6734241|NCT03223649|7663739|FG001|STARTED|Overall Study||57
6734242|NCT03223649|7663738|FG000|COMPLETED|Overall Study||42
6734243|NCT03223649|7663739|FG001|COMPLETED|Overall Study||51
6734244|NCT03223649|7663738|FG000|NOT COMPLETED|Overall Study||10
6734245|NCT03223649|7663739|FG001|NOT COMPLETED|Overall Study||6
6734246|NCT03223909|7663748|FG000|STARTED|Overall Study||120
6734247|NCT03223909|7663749|FG001|STARTED|Overall Study||109
6734248|NCT03223909|7663750|FG002|STARTED|Overall Study||97
6734249|NCT03223909|7663748|FG000|COMPLETED|Overall Study||72
6734250|NCT03223909|7663749|FG001|COMPLETED|Overall Study||64
6734251|NCT03223909|7663750|FG002|COMPLETED|Overall Study||81
6734252|NCT03223909|7663748|FG000|NOT COMPLETED|Overall Study||48
6734253|NCT03223909|7663749|FG001|NOT COMPLETED|Overall Study||45
6734254|NCT03223909|7663750|FG002|NOT COMPLETED|Overall Study||16
6734255|NCT03224130|7663760|FG000|STARTED|Overall Study||483
6734256|NCT03224130|7663761|FG001|STARTED|Overall Study||483
6734257|NCT03224130|7663760|FG000|COMPLETED|Overall Study||483
6734258|NCT03224130|7663761|FG001|COMPLETED|Overall Study||482
6734259|NCT03224130|7663760|FG000|NOT COMPLETED|Overall Study||0
6734260|NCT03224130|7663761|FG001|NOT COMPLETED|Overall Study||1
6734261|NCT03224182|7663769|FG000|STARTED|Overall Study||81
6734262|NCT03224182|7663770|FG001|STARTED|Overall Study||37
6734263|NCT03224182|7663769|FG000|Safety Population|Overall Study||73
6734264|NCT03224182|7663770|FG001|Safety Population|Overall Study||36
6734265|NCT03224182|7663769|FG000|COMPLETED|Overall Study||0
6734266|NCT03224182|7663770|FG001|COMPLETED|Overall Study||1
6734267|NCT03224182|7663769|FG000|NOT COMPLETED|Overall Study||81
6734268|NCT03224182|7663770|FG001|NOT COMPLETED|Overall Study||36
6734269|NCT03224234|7663780|FG000|STARTED|Main Study||40
6734270|NCT03224234|7663781|FG001|STARTED|Main Study||40
6734271|NCT03224234|7663780|FG000|COMPLETED|Main Study||35
6734272|NCT03224234|7663781|FG001|COMPLETED|Main Study||35
6734273|NCT03224234|7663780|FG000|NOT COMPLETED|Main Study||5
6734274|NCT03224234|7663781|FG001|NOT COMPLETED|Main Study||5
6734275|NCT03224234|7663780|FG000|STARTED|Pilot||11
6734276|NCT03224234|7663781|FG001|STARTED|Pilot||7
6734277|NCT03224234|7663780|FG000|COMPLETED|Pilot||11
6734278|NCT03224234|7663781|FG001|COMPLETED|Pilot||7
6734279|NCT03224234|7663780|FG000|NOT COMPLETED|Pilot||0
6734280|NCT03224234|7663781|FG001|NOT COMPLETED|Pilot||0
6734281|NCT03224299|7663793|FG000|STARTED|Overall Study||131
6734282|NCT03224299|7663794|FG001|STARTED|Overall Study||424
6734283|NCT03224299|7663793|FG000|Treated With IP#1|Overall Study||65
6734284|NCT03224299|7663794|FG001|Treated With IP#1|Overall Study||101
6734285|NCT03224299|7663793|FG000|Treated With IP#2|Overall Study||66
6734286|NCT03224299|7663794|FG001|Treated With IP#2|Overall Study||107
6734287|NCT03224299|7663793|FG000|Treated With AC|Overall Study||66
6734288|NCT03224299|7663794|FG001|Treated With AC|Overall Study||110
6734289|NCT03224299|7663793|FG000|Treated With NC|Overall Study||65
6734290|NCT03224299|7663794|FG001|Treated With NC|Overall Study||106
6734291|NCT03224299|7663793|FG000|COMPLETED|Overall Study||131
6734292|NCT03224299|7663794|FG001|COMPLETED|Overall Study||424
6734293|NCT03224299|7663793|FG000|NOT COMPLETED|Overall Study||0
6734294|NCT03224299|7663794|FG001|NOT COMPLETED|Overall Study||0
6734295|NCT03224325|7663815|FG000|STARTED|Overall Study||13
6734296|NCT03224325|7663816|FG001|STARTED|Overall Study||6
6734297|NCT03224325|7663817|FG002|STARTED|Overall Study||6
6734298|NCT03224325|7663818|FG003|STARTED|Overall Study||6
6734299|NCT03224325|7663819|FG004|STARTED|Overall Study||6
6734300|NCT03224325|7663820|FG005|STARTED|Overall Study||6
6734301|NCT03224325|7663821|FG006|STARTED|Overall Study||7
6734302|NCT03224325|7663815|FG000|COMPLETED|Overall Study||12
6734303|NCT03224325|7663816|FG001|COMPLETED|Overall Study||6
6734304|NCT03224325|7663817|FG002|COMPLETED|Overall Study||6
6734305|NCT03224325|7663818|FG003|COMPLETED|Overall Study||5
6734306|NCT03224325|7663819|FG004|COMPLETED|Overall Study||6
6734307|NCT03224325|7663820|FG005|COMPLETED|Overall Study||6
6734308|NCT03224325|7663821|FG006|COMPLETED|Overall Study||6
6734309|NCT03224325|7663815|FG000|NOT COMPLETED|Overall Study||1
6734310|NCT03224325|7663816|FG001|NOT COMPLETED|Overall Study||0
6734311|NCT03224325|7663817|FG002|NOT COMPLETED|Overall Study||0
6734312|NCT03224325|7663818|FG003|NOT COMPLETED|Overall Study||1
6734313|NCT03224325|7663819|FG004|NOT COMPLETED|Overall Study||0
6734314|NCT03224325|7663820|FG005|NOT COMPLETED|Overall Study||0
6734315|NCT03224325|7663821|FG006|NOT COMPLETED|Overall Study||1
6734316|NCT03224351|7663851|FG000|STARTED|Overall Study||10
6734317|NCT03224351|7663852|FG001|STARTED|Overall Study||11
6734318|NCT03224351|7663853|FG002|STARTED|Overall Study||20
6734319|NCT03224351|7663854|FG003|STARTED|Overall Study||22
6734320|NCT03224351|7663855|FG004|STARTED|Overall Study||11
6734321|NCT03224351|7663856|FG005|STARTED|Overall Study||18
6734322|NCT03224351|7663857|FG006|STARTED|Overall Study||6
6734323|NCT03224351|7663858|FG007|STARTED|Overall Study||19
6734324|NCT03224351|7663851|FG000|COMPLETED|Overall Study||10
6734325|NCT03224351|7663852|FG001|COMPLETED|Overall Study||11
6734326|NCT03224351|7663853|FG002|COMPLETED|Overall Study||20
6734327|NCT03224351|7663854|FG003|COMPLETED|Overall Study||22
6734328|NCT03224351|7663855|FG004|COMPLETED|Overall Study||11
6734329|NCT03224351|7663856|FG005|COMPLETED|Overall Study||18
6734330|NCT03224351|7663857|FG006|COMPLETED|Overall Study||6
6734331|NCT03224351|7663858|FG007|COMPLETED|Overall Study||19
6734332|NCT03224351|7663851|FG000|NOT COMPLETED|Overall Study||0
6734333|NCT03224351|7663852|FG001|NOT COMPLETED|Overall Study||0
6734334|NCT03224351|7663853|FG002|NOT COMPLETED|Overall Study||0
6734335|NCT03224351|7663854|FG003|NOT COMPLETED|Overall Study||0
6734336|NCT03224351|7663855|FG004|NOT COMPLETED|Overall Study||0
6734337|NCT03224351|7663856|FG005|NOT COMPLETED|Overall Study||0
6734338|NCT03224351|7663857|FG006|NOT COMPLETED|Overall Study||0
6734339|NCT03224351|7663858|FG007|NOT COMPLETED|Overall Study||0
6740035|NCT03298035|7668877|FG001|STARTED|Overall Study||9
6740036|NCT03298035|7668876|FG000|Received Intervention|Overall Study||9
6740037|NCT03298035|7668877|FG001|Received Intervention|Overall Study||7
6740038|NCT03298035|7668876|FG000|COMPLETED|Overall Study||9
6740039|NCT03298035|7668877|FG001|COMPLETED|Overall Study||7
6740040|NCT03298035|7668876|FG000|NOT COMPLETED|Overall Study||1
6740041|NCT03298035|7668877|FG001|NOT COMPLETED|Overall Study||2
6740042|NCT03298048|7668886|FG000|STARTED|Overall Study||4
6740043|NCT03298048|7668887|FG001|STARTED|Overall Study||3
6740044|NCT03298048|7668888|FG002|STARTED|Overall Study||8
6740045|NCT03298048|7668886|FG000|COMPLETED|Overall Study||4
6740046|NCT03298048|7668887|FG001|COMPLETED|Overall Study||3
6740047|NCT03298048|7668888|FG002|COMPLETED|Overall Study||8
6740048|NCT03298048|7668886|FG000|NOT COMPLETED|Overall Study||0
6740049|NCT03298048|7668887|FG001|NOT COMPLETED|Overall Study||0
6740050|NCT03298048|7668888|FG002|NOT COMPLETED|Overall Study||0
6740051|NCT03298113|7668898|FG000|STARTED|Overall Study|10 subjects were treated w/ Cavilon Advanced Skin Protectant. Study terminated due to low enrollment|10
6740052|NCT03298113|7668899|FG001|STARTED|Overall Study|10 subjects were treated with IAD Hospital Standard Care. Study terminated due to low enrollment.|10
6740053|NCT03298113|7668898|FG000|IAD 1A|Overall Study||3
6740054|NCT03298113|7668899|FG001|IAD 1A|Overall Study||4
6740055|NCT03298113|7668898|FG000|IAD 2A|Overall Study||7
6740056|NCT03298113|7668899|FG001|IAD 2A|Overall Study||6
6740057|NCT03298113|7668898|FG000|COMPLETED|Overall Study||10
6740058|NCT03298113|7668899|FG001|COMPLETED|Overall Study||10
6740059|NCT03298113|7668898|FG000|NOT COMPLETED|Overall Study||0
6740060|NCT03298113|7668899|FG001|NOT COMPLETED|Overall Study||0
6740061|NCT03298412|7668905|FG000|STARTED|Run-in Period||10
6740062|NCT03298412|7668905|FG000|COMPLETED|Run-in Period||1
6740063|NCT03298412|7668905|FG000|NOT COMPLETED|Run-in Period||9
6734340|NCT03224390|7663886|FG000|STARTED|Overall Study||56
6734341|NCT03224390|7663887|FG001|STARTED|Overall Study||56
6734342|NCT03224390|7663886|FG000|COMPLETED|Overall Study||29
6734343|NCT03224390|7663887|FG001|COMPLETED|Overall Study||21
6734344|NCT03224390|7663886|FG000|NOT COMPLETED|Overall Study||27
6734345|NCT03224390|7663887|FG001|NOT COMPLETED|Overall Study||35
6734346|NCT03224403|7663899|FG000|STARTED|Overall Study||59
6734347|NCT03224403|7663900|FG001|STARTED|Overall Study||249
6734348|NCT03224403|7663901|FG002|STARTED|Overall Study||232
6734349|NCT03224403|7663902|FG003|STARTED|Overall Study||124
6734350|NCT03224403|7663899|FG000|COMPLETED|Overall Study||59
6734351|NCT03224403|7663900|FG001|COMPLETED|Overall Study||249
6734352|NCT03224403|7663901|FG002|COMPLETED|Overall Study||232
6734353|NCT03224403|7663902|FG003|COMPLETED|Overall Study||124
6734354|NCT03224403|7663899|FG000|NOT COMPLETED|Overall Study||0
6734355|NCT03224403|7663900|FG001|NOT COMPLETED|Overall Study||0
6734356|NCT03224403|7663901|FG002|NOT COMPLETED|Overall Study||0
6734357|NCT03224403|7663902|FG003|NOT COMPLETED|Overall Study||0
6734358|NCT03224520|7663916|FG000|STARTED|Overall Study||371
6734359|NCT03224520|7663917|FG001|STARTED|Overall Study||370
6734360|NCT03224520|7663918|FG002|STARTED|Overall Study||374
6734361|NCT03224520|7663919|FG003|STARTED|Overall Study||372
6734362|NCT03224520|7663916|FG000|COMPLETED|Overall Study||205
6734363|NCT03224520|7663917|FG001|COMPLETED|Overall Study||207
6734364|NCT03224520|7663918|FG002|COMPLETED|Overall Study||190
6734365|NCT03224520|7663919|FG003|COMPLETED|Overall Study||199
6734366|NCT03224520|7663916|FG000|NOT COMPLETED|Overall Study||166
6734367|NCT03224520|7663917|FG001|NOT COMPLETED|Overall Study||163
6734368|NCT03224520|7663918|FG002|NOT COMPLETED|Overall Study||184
6734369|NCT03224520|7663919|FG003|NOT COMPLETED|Overall Study||173
6734370|NCT03224585|7663931|FG000|STARTED|Overall Study||2
6734371|NCT03224585|7663932|FG001|STARTED|Overall Study||3
6734372|NCT03224585|7663931|FG000|COMPLETED|Overall Study||2
6734373|NCT03224585|7663932|FG001|COMPLETED|Overall Study||3
6734374|NCT03224585|7663931|FG000|NOT COMPLETED|Overall Study||0
6734375|NCT03224585|7663932|FG001|NOT COMPLETED|Overall Study||0
6734376|NCT03224598|7663940|FG000|STARTED|Overall Study||9
6734377|NCT03224598|7663941|FG001|STARTED|Overall Study||17
6734378|NCT03224598|7663942|FG002|STARTED|Overall Study||13
6734379|NCT03224598|7663940|FG000|COMPLETED|Overall Study||9
6734380|NCT03224598|7663941|FG001|COMPLETED|Overall Study||14
6734381|NCT03224598|7663942|FG002|COMPLETED|Overall Study||13
6734382|NCT03224598|7663940|FG000|NOT COMPLETED|Overall Study||0
6734383|NCT03224598|7663941|FG001|NOT COMPLETED|Overall Study||3
6734384|NCT03224598|7663942|FG002|NOT COMPLETED|Overall Study||0
6734385|NCT03225001|7663950|FG000|STARTED|Overall Study||197
6734386|NCT03225001|7663950|FG000|Valve-Implanted|Overall Study||195
6734387|NCT03225001|7663950|FG000|COMPLETED|Overall Study||188
6734388|NCT03225001|7663950|FG000|NOT COMPLETED|Overall Study||9
6734389|NCT03225313|7663957|FG000|STARTED|Overall Study|25 Patients|25
6734390|NCT03225313|7663958|FG001|STARTED|Overall Study|25 Patients|25
6734391|NCT03225313|7663959|FG002|STARTED|Overall Study|25 Patients|25
6734392|NCT03225313|7663957|FG000|COMPLETED|Overall Study|25 Patients|25
6734393|NCT03225313|7663958|FG001|COMPLETED|Overall Study|25 Patients|25
6734394|NCT03225313|7663959|FG002|COMPLETED|Overall Study|25 Patients|25
6734395|NCT03225313|7663957|FG000|NOT COMPLETED|Overall Study||0
6734396|NCT03225313|7663958|FG001|NOT COMPLETED|Overall Study||0
6734397|NCT03225313|7663959|FG002|NOT COMPLETED|Overall Study||0
6734398|NCT03225573|7663969|FG000|STARTED|Overall Study||60
6734399|NCT03225573|7663969|FG000|COMPLETED|Overall Study||60
6734400|NCT03225573|7663969|FG000|NOT COMPLETED|Overall Study||0
6734401|NCT03225599|7663973|FG000|STARTED|Overall Study||9
6734402|NCT03225599|7663973|FG000|COMPLETED|Overall Study||7
6734403|NCT03225599|7663973|FG000|NOT COMPLETED|Overall Study||2
6734404|NCT03225859|7663977|FG000|STARTED|Overall Study||12
6734405|NCT03225859|7663977|FG000|COMPLETED|Overall Study||11
6734406|NCT03225859|7663977|FG000|NOT COMPLETED|Overall Study||1
6734407|NCT03226223|7663983|FG000|STARTED|Overall Study||10
6734408|NCT03226223|7663984|FG001|STARTED|Overall Study||8
6734409|NCT03226223|7663983|FG000|COMPLETED|Overall Study||8
6734410|NCT03226223|7663984|FG001|COMPLETED|Overall Study||6
6734411|NCT03226223|7663983|FG000|NOT COMPLETED|Overall Study||2
6734412|NCT03226223|7663984|FG001|NOT COMPLETED|Overall Study||2
6734413|NCT03226249|7663990|FG000|STARTED|PEM Induction Cycles 1-3, and PET#2||30
6734414|NCT03226249|7663990|FG000|PEM Cycle 1|PEM Induction Cycles 1-3, and PET#2||30
6734415|NCT03226249|7663990|FG000|PEM Cycle 2|PEM Induction Cycles 1-3, and PET#2||30
6734416|NCT03226249|7663990|FG000|PEM Cycle 3|PEM Induction Cycles 1-3, and PET#2||30
6734417|NCT03226249|7663990|FG000|PET#2|PEM Induction Cycles 1-3, and PET#2||30
6734418|NCT03226249|7663990|FG000|COMPLETED|PEM Induction Cycles 1-3, and PET#2||30
6734419|NCT03226249|7663990|FG000|NOT COMPLETED|PEM Induction Cycles 1-3, and PET#2||0
6734420|NCT03226249|7663990|FG000|STARTED|2 Cycles of AVD + PET#3||30
6734421|NCT03226249|7663990|FG000|AVD Cycle 1|2 Cycles of AVD + PET#3||30
6734422|NCT03226249|7663990|FG000|AVD Cycle 2|2 Cycles of AVD + PET#3||30
6734423|NCT03226249|7663990|FG000|PET#3|2 Cycles of AVD + PET#3||30
6734424|NCT03226249|7663990|FG000|COMPLETED|2 Cycles of AVD + PET#3||30
6734425|NCT03226249|7663990|FG000|NOT COMPLETED|2 Cycles of AVD + PET#3||0
6734426|NCT03226249|7663990|FG000|STARTED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||30
6734427|NCT03226249|7663990|FG000|2-4 Cycles of AVD +/- Chemo & RT|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
6734428|NCT03226249|7663990|FG000|PET#4|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
6734429|NCT03226249|7663990|FG000|COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||29
6734430|NCT03226249|7663990|FG000|NOT COMPLETED|2-4 Cycles of AVD +/- Chemo & RT, PET#4||1
6734431|NCT03226249|7663990|FG000|STARTED|PEM Consolidation (1-2 Years)||29
6734432|NCT03226249|7663990|FG000|COMPLETED|PEM Consolidation (1-2 Years)||0
6734433|NCT03226249|7663990|FG000|NOT COMPLETED|PEM Consolidation (1-2 Years)||29
6734434|NCT03226249|7663990|FG000|STARTED|Survival Follow-up|All patients that are treated with one dose of study drug go into follow-up.|30
6734435|NCT03226249|7663990|FG000|COMPLETED|Survival Follow-up||0
6734436|NCT03226249|7663990|FG000|NOT COMPLETED|Survival Follow-up||30
6734437|NCT03226275|7663998|FG000|STARTED|Treatment Period 1 (8 Days)||8
6734438|NCT03226275|7663999|FG001|STARTED|Treatment Period 1 (8 Days)||8
6734439|NCT03226275|7664000|FG002|STARTED|Treatment Period 1 (8 Days)||8
6734440|NCT03226275|7664001|FG003|STARTED|Treatment Period 1 (8 Days)||8
6734441|NCT03226275|7663998|FG000|COMPLETED|Treatment Period 1 (8 Days)||8
6734442|NCT03226275|7663999|FG001|COMPLETED|Treatment Period 1 (8 Days)||8
6734443|NCT03226275|7664000|FG002|COMPLETED|Treatment Period 1 (8 Days)||7
6734444|NCT03226275|7664001|FG003|COMPLETED|Treatment Period 1 (8 Days)||7
6734445|NCT03226275|7663998|FG000|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6734446|NCT03226275|7663999|FG001|NOT COMPLETED|Treatment Period 1 (8 Days)||0
6734447|NCT03226275|7664000|FG002|NOT COMPLETED|Treatment Period 1 (8 Days)||1
6734448|NCT03226275|7664001|FG003|NOT COMPLETED|Treatment Period 1 (8 Days)||1
6734449|NCT03226275|7663998|FG000|STARTED|Treatment Period 2 (8 Days)||8
6734450|NCT03226275|7663999|FG001|STARTED|Treatment Period 2 (8 Days)||8
6734451|NCT03226275|7664000|FG002|STARTED|Treatment Period 2 (8 Days)||7
6734452|NCT03226275|7664001|FG003|STARTED|Treatment Period 2 (8 Days)||7
6734453|NCT03226275|7663998|FG000|COMPLETED|Treatment Period 2 (8 Days)||8
6734454|NCT03226275|7663999|FG001|COMPLETED|Treatment Period 2 (8 Days)||8
6734455|NCT03226275|7664000|FG002|COMPLETED|Treatment Period 2 (8 Days)||7
6734456|NCT03226275|7664001|FG003|COMPLETED|Treatment Period 2 (8 Days)||7
6734457|NCT03226275|7663998|FG000|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6734458|NCT03226275|7663999|FG001|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6734459|NCT03226275|7664000|FG002|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6734460|NCT03226275|7664001|FG003|NOT COMPLETED|Treatment Period 2 (8 Days)||0
6734461|NCT03226353|7664011|FG000|STARTED|Overall Study||77
6734462|NCT03226353|7664011|FG000|Habitual Wearers of Proclear 1 Day|Overall Study||2
6734463|NCT03226353|7664011|FG000|Other Habitual Lens Types|Overall Study||75
6734464|NCT03226353|7664011|FG000|COMPLETED|Overall Study|Study participants completed includes the Omafilcon A habitual wearers.|71
6734465|NCT03226353|7664011|FG000|NOT COMPLETED|Overall Study||6
6734466|NCT03226366|7664022|FG000|STARTED|Overall Study||911
6734467|NCT03226366|7664023|FG001|STARTED|Overall Study||495
6734468|NCT03226366|7664024|FG002|STARTED|Overall Study||1183
6734469|NCT03226366|7664025|FG003|STARTED|Overall Study||641
6734470|NCT03226366|7664022|FG000|COMPLETED|Overall Study||911
6734471|NCT03226366|7664023|FG001|COMPLETED|Overall Study||495
6734472|NCT03226366|7664024|FG002|COMPLETED|Overall Study||1183
6734473|NCT03226366|7664025|FG003|COMPLETED|Overall Study||641
6734474|NCT03226366|7664022|FG000|NOT COMPLETED|Overall Study||0
6734475|NCT03226366|7664023|FG001|NOT COMPLETED|Overall Study||0
6734476|NCT03226366|7664024|FG002|NOT COMPLETED|Overall Study||0
6734477|NCT03226366|7664025|FG003|NOT COMPLETED|Overall Study||0
6734478|NCT03226392|7664037|FG000|STARTED|Overall Study||352
6734479|NCT03226392|7664038|FG001|STARTED|Overall Study||352
6734480|NCT03226392|7664037|FG000|FAS|Overall Study||352
6734481|NCT03226392|7664038|FG001|FAS|Overall Study|"2 patients in the placebo were mis-randomized, not treated, not included due to technical problems"|350
6734482|NCT03226392|7664037|FG000|COMPLETED|Overall Study||341
6734483|NCT03226392|7664038|FG001|COMPLETED|Overall Study||344
6734484|NCT03226392|7664037|FG000|NOT COMPLETED|Overall Study||11
6734485|NCT03226392|7664038|FG001|NOT COMPLETED|Overall Study||8
6734486|NCT03226457|7664044|FG000|STARTED|Treatment 1: 6 Weeks||12
6734487|NCT03226457|7664045|FG001|STARTED|Treatment 1: 6 Weeks||11
6734488|NCT03226457|7664044|FG000|COMPLETED|Treatment 1: 6 Weeks||12
6734489|NCT03226457|7664045|FG001|COMPLETED|Treatment 1: 6 Weeks||11
6734490|NCT03226457|7664044|FG000|NOT COMPLETED|Treatment 1: 6 Weeks||0
6734491|NCT03226457|7664045|FG001|NOT COMPLETED|Treatment 1: 6 Weeks||0
6734492|NCT03226457|7664044|FG000|STARTED|Washout Period: Minimum 2 Weeks||12
6734493|NCT03226457|7664045|FG001|STARTED|Washout Period: Minimum 2 Weeks||11
6734494|NCT03226457|7664044|FG000|COMPLETED|Washout Period: Minimum 2 Weeks||12
6734495|NCT03226457|7664045|FG001|COMPLETED|Washout Period: Minimum 2 Weeks||11
6734496|NCT03226457|7664044|FG000|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
6734497|NCT03226457|7664045|FG001|NOT COMPLETED|Washout Period: Minimum 2 Weeks||0
6734498|NCT03226457|7664044|FG000|STARTED|Treatment 2: 6 Weeks||12
6734499|NCT03226457|7664045|FG001|STARTED|Treatment 2: 6 Weeks||11
6734500|NCT03226457|7664044|FG000|COMPLETED|Treatment 2: 6 Weeks||12
6734501|NCT03226457|7664045|FG001|COMPLETED|Treatment 2: 6 Weeks||11
6734502|NCT03226457|7664044|FG000|NOT COMPLETED|Treatment 2: 6 Weeks||0
6734503|NCT03226457|7664045|FG001|NOT COMPLETED|Treatment 2: 6 Weeks||0
6734504|NCT03226652|7664051|FG000|STARTED|Overall Study||101
6734505|NCT03226652|7664051|FG000|COMPLETED|Overall Study||101
6734506|NCT03226652|7664051|FG000|NOT COMPLETED|Overall Study||0
6734507|NCT03226691|7664055|FG000|STARTED|Overall Study||15
6734508|NCT03226691|7664055|FG000|COMPLETED|Overall Study||15
6734509|NCT03226691|7664055|FG000|NOT COMPLETED|Overall Study||0
6734510|NCT03226769|7664061|FG000|STARTED|Overall Study||29
6734511|NCT03226769|7664062|FG001|STARTED|Overall Study||28
6734512|NCT03226769|7664061|FG000|COMPLETED|Overall Study||29
6734513|NCT03226769|7664062|FG001|COMPLETED|Overall Study||27
6734514|NCT03226769|7664061|FG000|NOT COMPLETED|Overall Study||0
6734515|NCT03226769|7664062|FG001|NOT COMPLETED|Overall Study||1
6734516|NCT03226899|7664070|FG000|STARTED|Overall Study||118
6734517|NCT03226899|7664071|FG001|STARTED|Overall Study||124
6734518|NCT03226899|7664070|FG000|COMPLETED|Overall Study||0
6734519|NCT03226899|7664071|FG001|COMPLETED|Overall Study||0
6734520|NCT03226899|7664070|FG000|NOT COMPLETED|Overall Study||118
6734521|NCT03226899|7664071|FG001|NOT COMPLETED|Overall Study||124
6734522|NCT03227445|7664077|FG000|STARTED|Period 1 (28 Days)||60
6734523|NCT03227445|7664078|FG001|STARTED|Period 1 (28 Days)||59
6734524|NCT03227445|7664079|FG002|STARTED|Period 1 (28 Days)||60
6734525|NCT03227445|7664080|FG003|STARTED|Period 1 (28 Days)||60
6734526|NCT03227445|7664077|FG000|COMPLETED|Period 1 (28 Days)||58
6734527|NCT03227445|7664078|FG001|COMPLETED|Period 1 (28 Days)||57
6734528|NCT03227445|7664079|FG002|COMPLETED|Period 1 (28 Days)||59
6734529|NCT03227445|7664080|FG003|COMPLETED|Period 1 (28 Days)||58
6734530|NCT03227445|7664077|FG000|NOT COMPLETED|Period 1 (28 Days)||2
6734531|NCT03227445|7664078|FG001|NOT COMPLETED|Period 1 (28 Days)||2
6734532|NCT03227445|7664079|FG002|NOT COMPLETED|Period 1 (28 Days)||1
6734533|NCT03227445|7664080|FG003|NOT COMPLETED|Period 1 (28 Days)||2
6734534|NCT03227445|7664077|FG000|STARTED|Period 2 (28 Days)||58
6734535|NCT03227445|7664078|FG001|STARTED|Period 2 (28 Days)||57
6734536|NCT03227445|7664079|FG002|STARTED|Period 2 (28 Days)||59
6734537|NCT03227445|7664080|FG003|STARTED|Period 2 (28 Days)||58
6734538|NCT03227445|7664077|FG000|COMPLETED|Period 2 (28 Days)||57
6734539|NCT03227445|7664078|FG001|COMPLETED|Period 2 (28 Days)||56
6734540|NCT03227445|7664079|FG002|COMPLETED|Period 2 (28 Days)||57
6734541|NCT03227445|7664080|FG003|COMPLETED|Period 2 (28 Days)||55
6734542|NCT03227445|7664077|FG000|NOT COMPLETED|Period 2 (28 Days)||1
6734543|NCT03227445|7664078|FG001|NOT COMPLETED|Period 2 (28 Days)||1
6734544|NCT03227445|7664079|FG002|NOT COMPLETED|Period 2 (28 Days)||2
6734545|NCT03227445|7664080|FG003|NOT COMPLETED|Period 2 (28 Days)||3
6734546|NCT03227692|7664091|FG000|STARTED|Overall Study||47
6734547|NCT03227692|7664092|FG001|STARTED|Overall Study||46
6734548|NCT03227692|7664091|FG000|COMPLETED|Overall Study||42
6734549|NCT03227692|7664092|FG001|COMPLETED|Overall Study||41
6734550|NCT03227692|7664091|FG000|NOT COMPLETED|Overall Study||5
6734551|NCT03227692|7664092|FG001|NOT COMPLETED|Overall Study||5
6734552|NCT03227861|7664098|FG000|STARTED|Main Study Period (Week 0 to Week 48)||109
6734553|NCT03227861|7664098|FG000|COMPLETED|Main Study Period (Week 0 to Week 48)||97
6734554|NCT03227861|7664098|FG000|NOT COMPLETED|Main Study Period (Week 0 to Week 48)||12
6734555|NCT03227861|7664098|FG000|STARTED|Extension Period (Week 48 to Week 96)|17 participants were not willing to enter extension study and discontinued after main study.|80
6734556|NCT03227861|7664098|FG000|COMPLETED|Extension Period (Week 48 to Week 96)||0
6734557|NCT03227861|7664098|FG000|NOT COMPLETED|Extension Period (Week 48 to Week 96)||80
6734558|NCT03228017|7664106|FG000|STARTED|Overall Study||45
6734559|NCT03228017|7664107|FG001|STARTED|Overall Study||18
6734560|NCT03228017|7664106|FG000|COMPLETED|Overall Study||45
6734561|NCT03228017|7664107|FG001|COMPLETED|Overall Study||18
6734562|NCT03228017|7664106|FG000|NOT COMPLETED|Overall Study||0
6734563|NCT03228017|7664107|FG001|NOT COMPLETED|Overall Study||0
6734564|NCT03228212|7664113|FG000|STARTED|Period 1||65
6734565|NCT03228212|7664114|FG001|STARTED|Period 1||65
6734566|NCT03228212|7664113|FG000|COMPLETED|Period 1||64
6734567|NCT03228212|7664114|FG001|COMPLETED|Period 1||64
6734568|NCT03228212|7664113|FG000|NOT COMPLETED|Period 1||1
6734569|NCT03228212|7664114|FG001|NOT COMPLETED|Period 1||1
6734570|NCT03228212|7664113|FG000|STARTED|Period 2||64
6734571|NCT03228212|7664114|FG001|STARTED|Period 2||64
6734572|NCT03228212|7664113|FG000|COMPLETED|Period 2||63
6734573|NCT03228212|7664114|FG001|COMPLETED|Period 2||64
6734574|NCT03228212|7664113|FG000|NOT COMPLETED|Period 2||1
6734575|NCT03228212|7664114|FG001|NOT COMPLETED|Period 2||0
6734576|NCT03228212|7664113|FG000|STARTED|Period 3||63
6734577|NCT03228212|7664114|FG001|STARTED|Period 3||64
6734578|NCT03228212|7664113|FG000|COMPLETED|Period 3||63
6734579|NCT03228212|7664114|FG001|COMPLETED|Period 3||64
6734580|NCT03228212|7664113|FG000|NOT COMPLETED|Period 3||0
6734581|NCT03228212|7664114|FG001|NOT COMPLETED|Period 3||0
6734582|NCT03228420|7664122|FG000|STARTED|Overall Study||113
6734583|NCT03228420|7664123|FG001|STARTED|Overall Study||103
6734584|NCT03228420|7664122|FG000|Month-1|Overall Study||95
6734585|NCT03228420|7664123|FG001|Month-1|Overall Study||101
6734586|NCT03228420|7664122|FG000|Month-3|Overall Study||93
6734587|NCT03228420|7664123|FG001|Month-3|Overall Study||98
6734588|NCT03228420|7664122|FG000|COMPLETED|Overall Study||93
6734589|NCT03228420|7664123|FG001|COMPLETED|Overall Study||98
6734590|NCT03228420|7664122|FG000|NOT COMPLETED|Overall Study||20
6734591|NCT03228420|7664123|FG001|NOT COMPLETED|Overall Study||5
6734592|NCT03228433|7664135|FG000|STARTED|Overall Study||10
6734593|NCT03228433|7664136|FG001|STARTED|Overall Study||6
6734594|NCT03228433|7664137|FG002|STARTED|Overall Study||6
6734595|NCT03228433|7664138|FG003|STARTED|Overall Study||6
6734596|NCT03228433|7664139|FG004|STARTED|Overall Study||6
6734597|NCT03228433|7664140|FG005|STARTED|Overall Study||6
6734598|NCT03228433|7664135|FG000|COMPLETED|Overall Study||9
6734599|NCT03228433|7664136|FG001|COMPLETED|Overall Study||6
6734600|NCT03228433|7664137|FG002|COMPLETED|Overall Study||6
6734601|NCT03228433|7664138|FG003|COMPLETED|Overall Study||5
6734602|NCT03228433|7664139|FG004|COMPLETED|Overall Study||6
6734603|NCT03228433|7664140|FG005|COMPLETED|Overall Study||6
6734604|NCT03228433|7664135|FG000|NOT COMPLETED|Overall Study||1
6734605|NCT03228433|7664136|FG001|NOT COMPLETED|Overall Study||0
6734606|NCT03228433|7664137|FG002|NOT COMPLETED|Overall Study||0
6734607|NCT03228433|7664138|FG003|NOT COMPLETED|Overall Study||1
6734608|NCT03228433|7664139|FG004|NOT COMPLETED|Overall Study||0
6734609|NCT03228433|7664140|FG005|NOT COMPLETED|Overall Study||0
6734610|NCT03228836|7664162|FG000|STARTED|Overall Study||28
6734611|NCT03228836|7664162|FG000|Treated|Overall Study||28
6734612|NCT03228836|7664162|FG000|COMPLETED|Overall Study||11
6734613|NCT03228836|7664162|FG000|NOT COMPLETED|Overall Study||17
6734614|NCT03228914|7664166|FG000|STARTED|Overall Study||20
6734615|NCT03228914|7664167|FG001|STARTED|Overall Study||20
6734616|NCT03228914|7664166|FG000|COMPLETED|Overall Study||20
6734617|NCT03228914|7664167|FG001|COMPLETED|Overall Study||20
6734618|NCT03228914|7664166|FG000|NOT COMPLETED|Overall Study||0
6734619|NCT03228914|7664167|FG001|NOT COMPLETED|Overall Study||0
6734620|NCT03229109|7664177|FG000|STARTED|Overall Study||50
6734621|NCT03229109|7664178|FG001|STARTED|Overall Study||50
6734622|NCT03229109|7664179|FG002|STARTED|Overall Study||50
6734623|NCT03229109|7664180|FG003|STARTED|Overall Study||51
6734624|NCT03229109|7664177|FG000|COMPLETED|Overall Study||50
6734625|NCT03229109|7664178|FG001|COMPLETED|Overall Study||50
6734626|NCT03229109|7664179|FG002|COMPLETED|Overall Study||50
6734627|NCT03229109|7664180|FG003|COMPLETED|Overall Study||50
6734628|NCT03229109|7664177|FG000|NOT COMPLETED|Overall Study||0
6734629|NCT03229109|7664178|FG001|NOT COMPLETED|Overall Study||0
6734630|NCT03229109|7664179|FG002|NOT COMPLETED|Overall Study||0
6734631|NCT03229109|7664180|FG003|NOT COMPLETED|Overall Study||1
6734632|NCT03229252|7664193|FG000|STARTED|Overall Study||31
6734633|NCT03229252|7664194|FG001|STARTED|Overall Study||15
6734634|NCT03229252|7664195|FG002|STARTED|Overall Study||45
6734635|NCT03229252|7664193|FG000|COMPLETED|Overall Study||29
6734636|NCT03229252|7664194|FG001|COMPLETED|Overall Study||15
6734637|NCT03229252|7664195|FG002|COMPLETED|Overall Study||39
6734638|NCT03229252|7664193|FG000|NOT COMPLETED|Overall Study||2
6734639|NCT03229252|7664194|FG001|NOT COMPLETED|Overall Study||0
6734640|NCT03229252|7664195|FG002|NOT COMPLETED|Overall Study||6
6734641|NCT03229486|7664205|FG000|STARTED|Overall Study||20
6734642|NCT03229486|7664206|FG001|STARTED|Overall Study||20
6734643|NCT03229486|7664205|FG000|COMPLETED|Overall Study||20
6734644|NCT03229486|7664206|FG001|COMPLETED|Overall Study||19
6734645|NCT03229486|7664205|FG000|NOT COMPLETED|Overall Study||0
6734646|NCT03229486|7664206|FG001|NOT COMPLETED|Overall Study||1
6734647|NCT03229759|7664212|FG000|STARTED|Overall Study||99
6734648|NCT03229759|7664212|FG000|Participants Treated|Overall Study||69
6734649|NCT03229759|7664212|FG000|Treated With Investigational Product|Overall Study||45
6734650|NCT03229759|7664212|FG000|Treated With Vehicle Control|Overall Study||47
6734651|NCT03229759|7664212|FG000|Treated With Saline Control|Overall Study||46
6734652|NCT03229759|7664212|FG000|COMPLETED|Overall Study||69
6734653|NCT03229759|7664212|FG000|NOT COMPLETED|Overall Study||30
6734654|NCT03230175|7664218|FG000|STARTED|Overall Study||32
6734655|NCT03230175|7664218|FG000|COMPLETED|Overall Study||30
6734656|NCT03230175|7664218|FG000|NOT COMPLETED|Overall Study||2
6734657|NCT03230864|7664225|FG000|STARTED|Prospective Confirmation (PC) Period||68
6734658|NCT03230864|7664226|FG001|STARTED|Prospective Confirmation (PC) Period||51
6734659|NCT03230864|7664227|FG002|STARTED|Prospective Confirmation (PC) Period||0
6734660|NCT03230864|7664228|FG003|STARTED|Prospective Confirmation (PC) Period||0
6734661|NCT03230864|7664225|FG000|COMPLETED|Prospective Confirmation (PC) Period||36
6734662|NCT03230864|7664226|FG001|COMPLETED|Prospective Confirmation (PC) Period||32
6734663|NCT03230864|7664227|FG002|COMPLETED|Prospective Confirmation (PC) Period||0
6734664|NCT03230864|7664228|FG003|COMPLETED|Prospective Confirmation (PC) Period||0
6734665|NCT03230864|7664225|FG000|NOT COMPLETED|Prospective Confirmation (PC) Period||32
6734666|NCT03230864|7664226|FG001|NOT COMPLETED|Prospective Confirmation (PC) Period||19
6734667|NCT03230864|7664227|FG002|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6734668|NCT03230864|7664228|FG003|NOT COMPLETED|Prospective Confirmation (PC) Period||0
6734669|NCT03230864|7664225|FG000|STARTED|Double Blind Treatment (DBT) Period||0
6734670|NCT03230864|7664226|FG001|STARTED|Double Blind Treatment (DBT) Period||0
6734671|NCT03230864|7664227|FG002|STARTED|Double Blind Treatment (DBT) Period||35
6734672|NCT03230864|7664228|FG003|STARTED|Double Blind Treatment (DBT) Period||33
6734673|NCT03230864|7664225|FG000|COMPLETED|Double Blind Treatment (DBT) Period||0
6734674|NCT03230864|7664226|FG001|COMPLETED|Double Blind Treatment (DBT) Period||0
6734675|NCT03230864|7664227|FG002|COMPLETED|Double Blind Treatment (DBT) Period||27
6734676|NCT03230864|7664228|FG003|COMPLETED|Double Blind Treatment (DBT) Period||31
6734677|NCT03230864|7664225|FG000|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
6734678|NCT03230864|7664226|FG001|NOT COMPLETED|Double Blind Treatment (DBT) Period||0
6734679|NCT03230864|7664227|FG002|NOT COMPLETED|Double Blind Treatment (DBT) Period||8
6734680|NCT03230864|7664228|FG003|NOT COMPLETED|Double Blind Treatment (DBT) Period||2
6734681|NCT03231228|7664240|FG000|STARTED|Overall Study||33
6734682|NCT03231228|7664241|FG001|STARTED|Overall Study||28
6734683|NCT03231228|7664240|FG000|COMPLETED|Overall Study||30
6734684|NCT03231228|7664241|FG001|COMPLETED|Overall Study||28
6734685|NCT03231228|7664240|FG000|NOT COMPLETED|Overall Study||3
6734686|NCT03231228|7664241|FG001|NOT COMPLETED|Overall Study||0
6734687|NCT03231345|7664247|FG000|STARTED|Overall Study||35
6734688|NCT03231345|7664247|FG000|COMPLETED|Overall Study||35
6734689|NCT03231345|7664247|FG000|NOT COMPLETED|Overall Study||0
6734690|NCT03231371|7664251|FG000|STARTED|Overall Study||22
6734691|NCT03231371|7664251|FG000|Optional and Age Limited (12 Yrs+) MRI|Overall Study||9
6734692|NCT03231371|7664251|FG000|COMPLETED|Overall Study||9
6734693|NCT03231371|7664251|FG000|NOT COMPLETED|Overall Study||13
6734694|NCT03231709|7664257|FG000|STARTED|Treatment Period 1||30
6734695|NCT03231709|7664258|FG001|STARTED|Treatment Period 1||30
6734696|NCT03231709|7664257|FG000|COMPLETED|Treatment Period 1||30
6734697|NCT03231709|7664258|FG001|COMPLETED|Treatment Period 1||29
6734698|NCT03231709|7664257|FG000|NOT COMPLETED|Treatment Period 1||0
6734699|NCT03231709|7664258|FG001|NOT COMPLETED|Treatment Period 1||1
6734700|NCT03231709|7664257|FG000|STARTED|Treatment Period 2||30
6734701|NCT03231709|7664258|FG001|STARTED|Treatment Period 2||29
6734702|NCT03231709|7664257|FG000|COMPLETED|Treatment Period 2||30
6734703|NCT03231709|7664258|FG001|COMPLETED|Treatment Period 2||28
6734704|NCT03231709|7664257|FG000|NOT COMPLETED|Treatment Period 2||0
6734705|NCT03231709|7664258|FG001|NOT COMPLETED|Treatment Period 2||1
6734706|NCT03231800|7664270|FG000|STARTED|Overall Study||48
6734707|NCT03231800|7664271|FG001|STARTED|Overall Study||47
6734708|NCT03231800|7664270|FG000|Safety Population|Overall Study||47
6734709|NCT03231800|7664271|FG001|Safety Population|Overall Study||47
6734710|NCT03231800|7664270|FG000|COMPLETED|Overall Study||45
6734711|NCT03231800|7664271|FG001|COMPLETED|Overall Study||44
6734712|NCT03231800|7664270|FG000|NOT COMPLETED|Overall Study||3
6734713|NCT03231800|7664271|FG001|NOT COMPLETED|Overall Study||3
6395523|NCT00858832|7308089|FG000|COMPLETED|Overall Study||20
6395524|NCT00858832|7308090|FG001|COMPLETED|Overall Study||22
6395525|NCT00858832|7308089|FG000|NOT COMPLETED|Overall Study||1
6734714|NCT03231917|7664279|FG000|STARTED|Overall Study||60
6734715|NCT03231917|7664280|FG001|STARTED|Overall Study||61
6734716|NCT03231917|7664279|FG000|COMPLETED|Overall Study||60
6734717|NCT03231917|7664280|FG001|COMPLETED|Overall Study||61
6734718|NCT03231917|7664279|FG000|NOT COMPLETED|Overall Study||0
6734719|NCT03231917|7664280|FG001|NOT COMPLETED|Overall Study||0
6734720|NCT03231943|7664293|FG000|STARTED|Part 1, Period 1 (up to Day 15)||2
6734721|NCT03231943|7664294|FG001|STARTED|Part 1, Period 1 (up to Day 15)||2
6734722|NCT03231943|7664295|FG002|STARTED|Part 1, Period 1 (up to Day 15)||2
6734723|NCT03231943|7664296|FG003|STARTED|Part 1, Period 1 (up to Day 15)||2
6734724|NCT03231943|7664297|FG004|STARTED|Part 1, Period 1 (up to Day 15)||2
6734725|NCT03231943|7664298|FG005|STARTED|Part 1, Period 1 (up to Day 15)||2
6734726|NCT03231943|7664299|FG006|STARTED|Part 1, Period 1 (up to Day 15)||2
6734727|NCT03231943|7664300|FG007|STARTED|Part 1, Period 1 (up to Day 15)||2
6734728|NCT03231943|7664301|FG008|STARTED|Part 1, Period 1 (up to Day 15)||0
6734729|NCT03231943|7664302|FG009|STARTED|Part 1, Period 1 (up to Day 15)||0
6734730|NCT03231943|7664303|FG010|STARTED|Part 1, Period 1 (up to Day 15)||0
6734731|NCT03231943|7664304|FG011|STARTED|Part 1, Period 1 (up to Day 15)||0
6734732|NCT03231943|7664305|FG012|STARTED|Part 1, Period 1 (up to Day 15)||0
6734733|NCT03231943|7664293|FG000|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6734734|NCT03231943|7664294|FG001|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6734735|NCT03231943|7664295|FG002|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6734736|NCT03231943|7664296|FG003|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6734737|NCT03231943|7664297|FG004|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6734738|NCT03231943|7664298|FG005|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6734739|NCT03231943|7664299|FG006|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6734740|NCT03231943|7664300|FG007|COMPLETED|Part 1, Period 1 (up to Day 15)||2
6734741|NCT03231943|7664301|FG008|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734742|NCT03231943|7664302|FG009|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734743|NCT03231943|7664303|FG010|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734744|NCT03231943|7664304|FG011|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734745|NCT03231943|7664305|FG012|COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734746|NCT03231943|7664293|FG000|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734747|NCT03231943|7664294|FG001|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734748|NCT03231943|7664295|FG002|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734749|NCT03231943|7664296|FG003|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734750|NCT03231943|7664297|FG004|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734751|NCT03231943|7664298|FG005|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734752|NCT03231943|7664299|FG006|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734753|NCT03231943|7664300|FG007|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734754|NCT03231943|7664301|FG008|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734755|NCT03231943|7664302|FG009|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734756|NCT03231943|7664303|FG010|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734757|NCT03231943|7664304|FG011|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734758|NCT03231943|7664305|FG012|NOT COMPLETED|Part 1, Period 1 (up to Day 15)||0
6734759|NCT03231943|7664293|FG000|STARTED|Part 1, Period 2 (up to Day 30)||2
6734760|NCT03231943|7664294|FG001|STARTED|Part 1, Period 2 (up to Day 30)||2
6734761|NCT03231943|7664295|FG002|STARTED|Part 1, Period 2 (up to Day 30)||2
6734762|NCT03231943|7664296|FG003|STARTED|Part 1, Period 2 (up to Day 30)||2
6734763|NCT03231943|7664297|FG004|STARTED|Part 1, Period 2 (up to Day 30)||2
6734764|NCT03231943|7664298|FG005|STARTED|Part 1, Period 2 (up to Day 30)||2
6734765|NCT03231943|7664299|FG006|STARTED|Part 1, Period 2 (up to Day 30)||2
6734766|NCT03231943|7664300|FG007|STARTED|Part 1, Period 2 (up to Day 30)||2
6734767|NCT03231943|7664301|FG008|STARTED|Part 1, Period 2 (up to Day 30)||0
6734768|NCT03231943|7664302|FG009|STARTED|Part 1, Period 2 (up to Day 30)||0
6734769|NCT03231943|7664303|FG010|STARTED|Part 1, Period 2 (up to Day 30)||0
6734770|NCT03231943|7664304|FG011|STARTED|Part 1, Period 2 (up to Day 30)||0
6734771|NCT03231943|7664305|FG012|STARTED|Part 1, Period 2 (up to Day 30)||0
6734772|NCT03231943|7664293|FG000|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6734773|NCT03231943|7664294|FG001|COMPLETED|Part 1, Period 2 (up to Day 30)|Two participants withdrawn were replaced|0
6734774|NCT03231943|7664295|FG002|COMPLETED|Part 1, Period 2 (up to Day 30)|One participant withdrawn was replaced|1
6734775|NCT03231943|7664296|FG003|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6734776|NCT03231943|7664297|FG004|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6734777|NCT03231943|7664298|FG005|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6734778|NCT03231943|7664299|FG006|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6734779|NCT03231943|7664300|FG007|COMPLETED|Part 1, Period 2 (up to Day 30)||2
6734780|NCT03231943|7664301|FG008|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734781|NCT03231943|7664302|FG009|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734782|NCT03231943|7664303|FG010|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734783|NCT03231943|7664304|FG011|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734784|NCT03231943|7664305|FG012|COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734785|NCT03231943|7664293|FG000|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734786|NCT03231943|7664294|FG001|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||2
6734787|NCT03231943|7664295|FG002|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||1
6734788|NCT03231943|7664296|FG003|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734789|NCT03231943|7664297|FG004|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734790|NCT03231943|7664298|FG005|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734791|NCT03231943|7664299|FG006|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734792|NCT03231943|7664300|FG007|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734793|NCT03231943|7664301|FG008|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734794|NCT03231943|7664302|FG009|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734795|NCT03231943|7664303|FG010|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734796|NCT03231943|7664304|FG011|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734797|NCT03231943|7664305|FG012|NOT COMPLETED|Part 1, Period 2 (up to Day 30)||0
6734798|NCT03231943|7664293|FG000|STARTED|Part 1, Period 3 (up to Day 45)||2
6734799|NCT03231943|7664294|FG001|STARTED|Part 1, Period 3 (up to Day 45)||2
6734800|NCT03231943|7664295|FG002|STARTED|Part 1, Period 3 (up to Day 45)||2
6734801|NCT03231943|7664296|FG003|STARTED|Part 1, Period 3 (up to Day 45)||2
6734802|NCT03231943|7664297|FG004|STARTED|Part 1, Period 3 (up to Day 45)||2
6734803|NCT03231943|7664298|FG005|STARTED|Part 1, Period 3 (up to Day 45)||2
6734804|NCT03231943|7664299|FG006|STARTED|Part 1, Period 3 (up to Day 45)||2
6734805|NCT03231943|7664300|FG007|STARTED|Part 1, Period 3 (up to Day 45)||2
6734806|NCT03231943|7664301|FG008|STARTED|Part 1, Period 3 (up to Day 45)||0
6734807|NCT03231943|7664302|FG009|STARTED|Part 1, Period 3 (up to Day 45)||0
6734808|NCT03231943|7664303|FG010|STARTED|Part 1, Period 3 (up to Day 45)||0
6734809|NCT03231943|7664304|FG011|STARTED|Part 1, Period 3 (up to Day 45)||0
6734810|NCT03231943|7664305|FG012|STARTED|Part 1, Period 3 (up to Day 45)||0
6734811|NCT03231943|7664293|FG000|COMPLETED|Part 1, Period 3 (up to Day 45)|One participant withdrawn was replaced|1
6734812|NCT03231943|7664294|FG001|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6734813|NCT03231943|7664295|FG002|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6734814|NCT03231943|7664296|FG003|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6734815|NCT03231943|7664297|FG004|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6734816|NCT03231943|7664298|FG005|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6734817|NCT03231943|7664299|FG006|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6734818|NCT03231943|7664300|FG007|COMPLETED|Part 1, Period 3 (up to Day 45)||2
6734819|NCT03231943|7664301|FG008|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734820|NCT03231943|7664302|FG009|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734821|NCT03231943|7664303|FG010|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734822|NCT03231943|7664304|FG011|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734823|NCT03231943|7664305|FG012|COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734824|NCT03231943|7664293|FG000|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||1
6734825|NCT03231943|7664294|FG001|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734826|NCT03231943|7664295|FG002|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734827|NCT03231943|7664296|FG003|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734828|NCT03231943|7664297|FG004|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734829|NCT03231943|7664298|FG005|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734830|NCT03231943|7664299|FG006|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734831|NCT03231943|7664300|FG007|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734832|NCT03231943|7664301|FG008|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734833|NCT03231943|7664302|FG009|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734834|NCT03231943|7664303|FG010|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734835|NCT03231943|7664304|FG011|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734836|NCT03231943|7664305|FG012|NOT COMPLETED|Part 1, Period 3 (up to Day 45)||0
6734837|NCT03231943|7664293|FG000|STARTED|Part 1 Period 4 (up to Day 60)||2
6734838|NCT03231943|7664294|FG001|STARTED|Part 1 Period 4 (up to Day 60)||2
6734839|NCT03231943|7664295|FG002|STARTED|Part 1 Period 4 (up to Day 60)||2
6734840|NCT03231943|7664296|FG003|STARTED|Part 1 Period 4 (up to Day 60)||2
6734841|NCT03231943|7664297|FG004|STARTED|Part 1 Period 4 (up to Day 60)||2
6734842|NCT03231943|7664298|FG005|STARTED|Part 1 Period 4 (up to Day 60)||2
6734843|NCT03231943|7664299|FG006|STARTED|Part 1 Period 4 (up to Day 60)||2
6734844|NCT03231943|7664300|FG007|STARTED|Part 1 Period 4 (up to Day 60)||2
6734845|NCT03231943|7664301|FG008|STARTED|Part 1 Period 4 (up to Day 60)||0
6734846|NCT03231943|7664302|FG009|STARTED|Part 1 Period 4 (up to Day 60)||0
6734847|NCT03231943|7664303|FG010|STARTED|Part 1 Period 4 (up to Day 60)||0
6734848|NCT03231943|7664304|FG011|STARTED|Part 1 Period 4 (up to Day 60)||0
6734849|NCT03231943|7664305|FG012|STARTED|Part 1 Period 4 (up to Day 60)||0
6734850|NCT03231943|7664293|FG000|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6734851|NCT03231943|7664294|FG001|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6734852|NCT03231943|7664295|FG002|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6734853|NCT03231943|7664296|FG003|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6734854|NCT03231943|7664297|FG004|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6734855|NCT03231943|7664298|FG005|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6734856|NCT03231943|7664299|FG006|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6734857|NCT03231943|7664300|FG007|COMPLETED|Part 1 Period 4 (up to Day 60)||2
6734858|NCT03231943|7664301|FG008|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734859|NCT03231943|7664302|FG009|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734860|NCT03231943|7664303|FG010|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734861|NCT03231943|7664304|FG011|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734862|NCT03231943|7664305|FG012|COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734863|NCT03231943|7664293|FG000|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734864|NCT03231943|7664294|FG001|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734865|NCT03231943|7664295|FG002|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734866|NCT03231943|7664296|FG003|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734867|NCT03231943|7664297|FG004|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734868|NCT03231943|7664298|FG005|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734869|NCT03231943|7664299|FG006|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734870|NCT03231943|7664300|FG007|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734871|NCT03231943|7664301|FG008|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734872|NCT03231943|7664302|FG009|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734873|NCT03231943|7664303|FG010|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734874|NCT03231943|7664304|FG011|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734875|NCT03231943|7664305|FG012|NOT COMPLETED|Part 1 Period 4 (up to Day 60)||0
6734876|NCT03231943|7664293|FG000|STARTED|Part 2||0
6734877|NCT03231943|7664294|FG001|STARTED|Part 2||0
6734878|NCT03231943|7664295|FG002|STARTED|Part 2||0
6734879|NCT03231943|7664296|FG003|STARTED|Part 2||0
6734880|NCT03231943|7664297|FG004|STARTED|Part 2||0
6734881|NCT03231943|7664298|FG005|STARTED|Part 2||0
6734882|NCT03231943|7664299|FG006|STARTED|Part 2||0
6734883|NCT03231943|7664300|FG007|STARTED|Part 2||0
6734884|NCT03231943|7664301|FG008|STARTED|Part 2||6
6734885|NCT03231943|7664302|FG009|STARTED|Part 2||6
6734886|NCT03231943|7664303|FG010|STARTED|Part 2||25
6734887|NCT03231943|7664304|FG011|STARTED|Part 2||7
6734888|NCT03231943|7664305|FG012|STARTED|Part 2||14
6734889|NCT03231943|7664293|FG000|COMPLETED|Part 2||0
6734890|NCT03231943|7664294|FG001|COMPLETED|Part 2||0
6734891|NCT03231943|7664295|FG002|COMPLETED|Part 2||0
6734892|NCT03231943|7664296|FG003|COMPLETED|Part 2||0
6734893|NCT03231943|7664297|FG004|COMPLETED|Part 2||0
6734894|NCT03231943|7664298|FG005|COMPLETED|Part 2||0
6734895|NCT03231943|7664299|FG006|COMPLETED|Part 2||0
6734896|NCT03231943|7664300|FG007|COMPLETED|Part 2||0
6734897|NCT03231943|7664301|FG008|COMPLETED|Part 2||6
6734898|NCT03231943|7664302|FG009|COMPLETED|Part 2||6
6734899|NCT03231943|7664303|FG010|COMPLETED|Part 2||24
6734900|NCT03231943|7664304|FG011|COMPLETED|Part 2||6
6734901|NCT03231943|7664305|FG012|COMPLETED|Part 2||14
6734902|NCT03231943|7664293|FG000|NOT COMPLETED|Part 2||0
6734903|NCT03231943|7664294|FG001|NOT COMPLETED|Part 2||0
6734904|NCT03231943|7664295|FG002|NOT COMPLETED|Part 2||0
6734905|NCT03231943|7664296|FG003|NOT COMPLETED|Part 2||0
6734906|NCT03231943|7664297|FG004|NOT COMPLETED|Part 2||0
6734907|NCT03231943|7664298|FG005|NOT COMPLETED|Part 2||0
6734908|NCT03231943|7664299|FG006|NOT COMPLETED|Part 2||0
6734909|NCT03231943|7664300|FG007|NOT COMPLETED|Part 2||0
6734910|NCT03231943|7664301|FG008|NOT COMPLETED|Part 2||0
6734911|NCT03231943|7664302|FG009|NOT COMPLETED|Part 2||0
6734912|NCT03231943|7664303|FG010|NOT COMPLETED|Part 2||1
6734913|NCT03231943|7664304|FG011|NOT COMPLETED|Part 2||1
6734914|NCT03231943|7664305|FG012|NOT COMPLETED|Part 2||0
6734915|NCT03231969|7664339|FG000|STARTED|Overall Study||30
6734916|NCT03231969|7664340|FG001|STARTED|Overall Study||30
6734917|NCT03231969|7664341|FG002|STARTED|Overall Study||31
6734918|NCT03231969|7664342|FG003|STARTED|Overall Study||30
6734919|NCT03231969|7664339|FG000|COMPLETED|Overall Study||28
6734920|NCT03231969|7664340|FG001|COMPLETED|Overall Study||28
6734921|NCT03231969|7664341|FG002|COMPLETED|Overall Study||30
6734922|NCT03231969|7664342|FG003|COMPLETED|Overall Study||30
6734923|NCT03231969|7664339|FG000|NOT COMPLETED|Overall Study||2
6734924|NCT03231969|7664340|FG001|NOT COMPLETED|Overall Study||2
6734925|NCT03231969|7664341|FG002|NOT COMPLETED|Overall Study||1
6734926|NCT03231969|7664342|FG003|NOT COMPLETED|Overall Study||0
6734927|NCT03232281|7664354|FG000|STARTED|Overall Study||150
6734928|NCT03232281|7664355|FG001|STARTED|Overall Study||150
6734929|NCT03232281|7664354|FG000|Received Treatment|Overall Study||149
6734930|NCT03232281|7664355|FG001|Received Treatment|Overall Study||150
6734931|NCT03232281|7664354|FG000|Completed Week 12|Overall Study||143
6734932|NCT03232281|7664355|FG001|Completed Week 12|Overall Study||148
6734933|NCT03232281|7664354|FG000|Completed Week 24|Overall Study||143
6734934|NCT03232281|7664355|FG001|Completed Week 24|Overall Study||144
6734935|NCT03232281|7664354|FG000|COMPLETED|Overall Study||143
6734936|NCT03232281|7664355|FG001|COMPLETED|Overall Study||144
6734937|NCT03232281|7664354|FG000|NOT COMPLETED|Overall Study||7
6734938|NCT03232281|7664355|FG001|NOT COMPLETED|Overall Study||6
6734939|NCT03232333|7664361|FG000|STARTED|Overall Study||53
6734940|NCT03232333|7664361|FG000|COMPLETED|Overall Study||38
6734941|NCT03232333|7664361|FG000|NOT COMPLETED|Overall Study||15
6734942|NCT03232567|7664369|FG000|STARTED|Overall Study||15
6734943|NCT03232567|7664370|FG001|STARTED|Overall Study||15
6734944|NCT03232567|7664371|FG002|STARTED|Overall Study||15
6734945|NCT03232567|7664372|FG003|STARTED|Overall Study||15
6734946|NCT03232567|7664369|FG000|COMPLETED|Overall Study||15
6734947|NCT03232567|7664370|FG001|COMPLETED|Overall Study||14
6734948|NCT03232567|7664371|FG002|COMPLETED|Overall Study||15
6734949|NCT03232567|7664372|FG003|COMPLETED|Overall Study||15
6734950|NCT03232567|7664369|FG000|NOT COMPLETED|Overall Study||0
6734951|NCT03232567|7664370|FG001|NOT COMPLETED|Overall Study||1
6734952|NCT03232567|7664371|FG002|NOT COMPLETED|Overall Study||0
6734953|NCT03232567|7664372|FG003|NOT COMPLETED|Overall Study||0
6734954|NCT03232580|7664382|FG000|STARTED|Overall Study||5
6734955|NCT03232580|7664382|FG000|COMPLETED|Overall Study||5
6734956|NCT03232580|7664382|FG000|NOT COMPLETED|Overall Study||0
6734957|NCT03232645|7664386|FG000|STARTED|Overall Study||62
6734958|NCT03232645|7664386|FG000|COMPLETED|Overall Study||58
6734959|NCT03232645|7664386|FG000|NOT COMPLETED|Overall Study||4
6734960|NCT03232749|7664391|FG000|STARTED|Overall Study||25
6734961|NCT03232749|7664391|FG000|COMPLETED|Overall Study||21
6734962|NCT03232749|7664391|FG000|NOT COMPLETED|Overall Study||4
6734963|NCT03232827|7664395|FG000|STARTED|Flavored-sweetened (FS)||80
6734964|NCT03232827|7664395|FG000|COMPLETED|Flavored-sweetened (FS)||80
6734965|NCT03232827|7664395|FG000|NOT COMPLETED|Flavored-sweetened (FS)||0
6734966|NCT03232827|7664395|FG000|STARTED|Unflavored-sweetened (US)||86
6734967|NCT03232827|7664395|FG000|COMPLETED|Unflavored-sweetened (US)||86
6734968|NCT03232827|7664395|FG000|NOT COMPLETED|Unflavored-sweetened (US)||0
6734969|NCT03232827|7664395|FG000|STARTED|Unflavored-very Low Sweetened (UU)||66
6734970|NCT03232827|7664395|FG000|COMPLETED|Unflavored-very Low Sweetened (UU)||66
6734971|NCT03232827|7664395|FG000|NOT COMPLETED|Unflavored-very Low Sweetened (UU)||0
6734972|NCT03232827|7664395|FG000|STARTED|Flavored-very Low Sweetened||66
6734973|NCT03232827|7664395|FG000|COMPLETED|Flavored-very Low Sweetened||66
6734974|NCT03232827|7664395|FG000|NOT COMPLETED|Flavored-very Low Sweetened||0
6734975|NCT03232983|7664405|FG000|STARTED|Period 1||7
6734976|NCT03232983|7664406|FG001|STARTED|Period 1||7
6734977|NCT03232983|7664407|FG002|STARTED|Period 1||7
6734978|NCT03232983|7664408|FG003|STARTED|Period 1||7
6734979|NCT03232983|7664405|FG000|Received at Least One Dose of Study Drug|Period 1||7
6734980|NCT03232983|7664406|FG001|Received at Least One Dose of Study Drug|Period 1||7
6734981|NCT03232983|7664407|FG002|Received at Least One Dose of Study Drug|Period 1||7
6734982|NCT03232983|7664408|FG003|Received at Least One Dose of Study Drug|Period 1||7
6734983|NCT03232983|7664405|FG000|COMPLETED|Period 1||7
6734984|NCT03232983|7664406|FG001|COMPLETED|Period 1||7
6734985|NCT03232983|7664407|FG002|COMPLETED|Period 1||6
6734986|NCT03232983|7664408|FG003|COMPLETED|Period 1||7
6734987|NCT03232983|7664405|FG000|NOT COMPLETED|Period 1||0
6734988|NCT03232983|7664406|FG001|NOT COMPLETED|Period 1||0
6734989|NCT03232983|7664407|FG002|NOT COMPLETED|Period 1||1
6734990|NCT03232983|7664408|FG003|NOT COMPLETED|Period 1||0
6734991|NCT03232983|7664405|FG000|STARTED|Washout Period 1||7
6734992|NCT03232983|7664406|FG001|STARTED|Washout Period 1||7
6734993|NCT03232983|7664407|FG002|STARTED|Washout Period 1||6
6734994|NCT03232983|7664408|FG003|STARTED|Washout Period 1||7
6734995|NCT03232983|7664405|FG000|COMPLETED|Washout Period 1||7
6734996|NCT03232983|7664406|FG001|COMPLETED|Washout Period 1||7
6734997|NCT03232983|7664407|FG002|COMPLETED|Washout Period 1||6
6734998|NCT03232983|7664408|FG003|COMPLETED|Washout Period 1||7
6734999|NCT03232983|7664405|FG000|NOT COMPLETED|Washout Period 1||0
6735000|NCT03232983|7664406|FG001|NOT COMPLETED|Washout Period 1||0
6735001|NCT03232983|7664407|FG002|NOT COMPLETED|Washout Period 1||0
6735002|NCT03232983|7664408|FG003|NOT COMPLETED|Washout Period 1||0
6735003|NCT03232983|7664405|FG000|STARTED|Period 2||7
6735004|NCT03232983|7664406|FG001|STARTED|Period 2||7
6735005|NCT03232983|7664407|FG002|STARTED|Period 2||6
6735006|NCT03232983|7664408|FG003|STARTED|Period 2||7
6735007|NCT03232983|7664405|FG000|COMPLETED|Period 2||7
6735008|NCT03232983|7664406|FG001|COMPLETED|Period 2||7
6735009|NCT03232983|7664407|FG002|COMPLETED|Period 2||6
6735010|NCT03232983|7664408|FG003|COMPLETED|Period 2||7
6735011|NCT03232983|7664405|FG000|NOT COMPLETED|Period 2||0
6735012|NCT03232983|7664406|FG001|NOT COMPLETED|Period 2||0
6735013|NCT03232983|7664407|FG002|NOT COMPLETED|Period 2||0
6735014|NCT03232983|7664408|FG003|NOT COMPLETED|Period 2||0
6735015|NCT03232983|7664405|FG000|STARTED|Washout Period 2||7
6735016|NCT03232983|7664406|FG001|STARTED|Washout Period 2||7
6735017|NCT03232983|7664407|FG002|STARTED|Washout Period 2||6
6735018|NCT03232983|7664408|FG003|STARTED|Washout Period 2||7
6735019|NCT03232983|7664405|FG000|COMPLETED|Washout Period 2||7
6735020|NCT03232983|7664406|FG001|COMPLETED|Washout Period 2||7
6735021|NCT03232983|7664407|FG002|COMPLETED|Washout Period 2||5
6735022|NCT03232983|7664408|FG003|COMPLETED|Washout Period 2||6
6735023|NCT03232983|7664405|FG000|NOT COMPLETED|Washout Period 2||0
6735024|NCT03232983|7664406|FG001|NOT COMPLETED|Washout Period 2||0
6735025|NCT03232983|7664407|FG002|NOT COMPLETED|Washout Period 2||1
6735026|NCT03232983|7664408|FG003|NOT COMPLETED|Washout Period 2||1
6735027|NCT03232983|7664405|FG000|STARTED|Period 3||7
6735028|NCT03232983|7664406|FG001|STARTED|Period 3||7
6735029|NCT03232983|7664407|FG002|STARTED|Period 3||5
6735030|NCT03232983|7664408|FG003|STARTED|Period 3||6
6735031|NCT03232983|7664405|FG000|COMPLETED|Period 3||7
6735032|NCT03232983|7664406|FG001|COMPLETED|Period 3||7
6735033|NCT03232983|7664407|FG002|COMPLETED|Period 3||5
6735034|NCT03232983|7664408|FG003|COMPLETED|Period 3||6
6735035|NCT03232983|7664405|FG000|NOT COMPLETED|Period 3||0
6735036|NCT03232983|7664406|FG001|NOT COMPLETED|Period 3||0
6735037|NCT03232983|7664407|FG002|NOT COMPLETED|Period 3||0
6735038|NCT03232983|7664408|FG003|NOT COMPLETED|Period 3||0
6735039|NCT03232983|7664405|FG000|STARTED|Washout Period 3||7
6735040|NCT03232983|7664406|FG001|STARTED|Washout Period 3||7
6735041|NCT03232983|7664407|FG002|STARTED|Washout Period 3||5
6735042|NCT03232983|7664408|FG003|STARTED|Washout Period 3||6
6735043|NCT03232983|7664405|FG000|COMPLETED|Washout Period 3||7
6735044|NCT03232983|7664406|FG001|COMPLETED|Washout Period 3||7
6735045|NCT03232983|7664407|FG002|COMPLETED|Washout Period 3||5
6735046|NCT03232983|7664408|FG003|COMPLETED|Washout Period 3||6
6735047|NCT03232983|7664405|FG000|NOT COMPLETED|Washout Period 3||0
6735048|NCT03232983|7664406|FG001|NOT COMPLETED|Washout Period 3||0
6735049|NCT03232983|7664407|FG002|NOT COMPLETED|Washout Period 3||0
6735050|NCT03232983|7664408|FG003|NOT COMPLETED|Washout Period 3||0
6735051|NCT03232983|7664405|FG000|STARTED|Period 4||7
6735052|NCT03232983|7664406|FG001|STARTED|Period 4||7
6735053|NCT03232983|7664407|FG002|STARTED|Period 4||5
6735054|NCT03232983|7664408|FG003|STARTED|Period 4||6
6735055|NCT03232983|7664405|FG000|COMPLETED|Period 4||6
6735056|NCT03232983|7664406|FG001|COMPLETED|Period 4||7
6735057|NCT03232983|7664407|FG002|COMPLETED|Period 4||5
6735058|NCT03232983|7664408|FG003|COMPLETED|Period 4||6
6735059|NCT03232983|7664405|FG000|NOT COMPLETED|Period 4||1
6735060|NCT03232983|7664406|FG001|NOT COMPLETED|Period 4||0
6735061|NCT03232983|7664407|FG002|NOT COMPLETED|Period 4||0
6735062|NCT03232983|7664408|FG003|NOT COMPLETED|Period 4||0
6735063|NCT03233009|7664420|FG000|STARTED|Overall Study||40
6735064|NCT03233009|7664420|FG000|Test Product 1|Overall Study||39
6735065|NCT03233009|7664420|FG000|Test Product 2|Overall Study||39
6735066|NCT03233009|7664420|FG000|Test Product 3|Overall Study||39
6735067|NCT03233009|7664420|FG000|Test Product 4|Overall Study||39
6735068|NCT03233009|7664420|FG000|Reference Product|Overall Study||39
6735069|NCT03233009|7664420|FG000|COMPLETED|Overall Study||39
6735070|NCT03233009|7664420|FG000|NOT COMPLETED|Overall Study||1
6735071|NCT03233230|7664437|FG000|STARTED|Overall Study||97
6735072|NCT03233230|7664438|FG001|STARTED|Overall Study||98
6735073|NCT03233230|7664439|FG002|STARTED|Overall Study||96
6735074|NCT03233230|7664440|FG003|STARTED|Overall Study||99
6735075|NCT03233230|7664437|FG000|COMPLETED|Overall Study||82
6735076|NCT03233230|7664438|FG001|COMPLETED|Overall Study||83
6735077|NCT03233230|7664439|FG002|COMPLETED|Overall Study||84
6735078|NCT03233230|7664440|FG003|COMPLETED|Overall Study||91
6735079|NCT03233230|7664437|FG000|NOT COMPLETED|Overall Study||15
6735080|NCT03233230|7664438|FG001|NOT COMPLETED|Overall Study||15
6735081|NCT03233230|7664439|FG002|NOT COMPLETED|Overall Study||12
6735082|NCT03233230|7664440|FG003|NOT COMPLETED|Overall Study||8
6735083|NCT03233308|7664450|FG000|STARTED|Overall Study||20
6735084|NCT03233308|7664450|FG000|COMPLETED|Overall Study||18
6735085|NCT03233308|7664450|FG000|NOT COMPLETED|Overall Study||2
6735086|NCT03233438|7664463|FG000|STARTED|Overall Study||48
6735087|NCT03233438|7664464|FG001|STARTED|Overall Study||43
6735088|NCT03233438|7664463|FG000|COMPLETED|Overall Study||42
6735089|NCT03233438|7664464|FG001|COMPLETED|Overall Study||32
6735090|NCT03233438|7664463|FG000|NOT COMPLETED|Overall Study||6
6735091|NCT03233438|7664464|FG001|NOT COMPLETED|Overall Study||11
6735092|NCT03233529|7664470|FG000|STARTED|Double-Blind Period (Day 1 to Day 15)||40
6735093|NCT03233529|7664470|FG000|COMPLETED|Double-Blind Period (Day 1 to Day 15)||39
6735094|NCT03233529|7664470|FG000|NOT COMPLETED|Double-Blind Period (Day 1 to Day 15)||1
6735095|NCT03233529|7664470|FG000|STARTED|Open-Label Period (Day 15 to Day 71)||39
6735096|NCT03233529|7664470|FG000|COMPLETED|Open-Label Period (Day 15 to Day 71)||38
6735097|NCT03233529|7664470|FG000|NOT COMPLETED|Open-Label Period (Day 15 to Day 71)||1
6735098|NCT03233737|7664483|FG000|STARTED|Overall Study||10
6735099|NCT03233737|7664484|FG001|STARTED|Overall Study||10
6735100|NCT03233737|7664485|FG002|STARTED|Overall Study||5
6735101|NCT03233737|7664486|FG003|STARTED|Overall Study||24
6735102|NCT03233737|7664487|FG004|STARTED|Overall Study||26
6735103|NCT03233737|7664483|FG000|COMPLETED|Overall Study||10
6735104|NCT03233737|7664484|FG001|COMPLETED|Overall Study||10
6735105|NCT03233737|7664485|FG002|COMPLETED|Overall Study||5
6735106|NCT03233737|7664486|FG003|COMPLETED|Overall Study||24
6735107|NCT03233737|7664487|FG004|COMPLETED|Overall Study||26
6735108|NCT03233737|7664483|FG000|NOT COMPLETED|Overall Study||0
6735109|NCT03233737|7664484|FG001|NOT COMPLETED|Overall Study||0
6735110|NCT03233737|7664485|FG002|NOT COMPLETED|Overall Study||0
6735111|NCT03233737|7664486|FG003|NOT COMPLETED|Overall Study||0
6735112|NCT03233737|7664487|FG004|NOT COMPLETED|Overall Study||0
6735113|NCT03234036|7664503|FG000|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
6735114|NCT03234036|7664504|FG001|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||8
6735115|NCT03234036|7664505|FG002|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
6735116|NCT03234036|7664506|FG003|STARTED|Part 1: Treatment Period 1(Up to 7 Days)||0
6735117|NCT03234036|7664503|FG000|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
6735118|NCT03234036|7664504|FG001|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||8
6735119|NCT03234036|7664505|FG002|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6735120|NCT03234036|7664506|FG003|COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6735121|NCT03234036|7664503|FG000|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6735122|NCT03234036|7664504|FG001|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6735123|NCT03234036|7664505|FG002|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6735124|NCT03234036|7664506|FG003|NOT COMPLETED|Part 1: Treatment Period 1(Up to 7 Days)||0
6735125|NCT03234036|7664503|FG000|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
6735126|NCT03234036|7664504|FG001|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||8
6735127|NCT03234036|7664505|FG002|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
6735128|NCT03234036|7664506|FG003|STARTED|Part 1:Washout Period 1 (Up to 10 Days)||0
6735129|NCT03234036|7664503|FG000|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
6735130|NCT03234036|7664504|FG001|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||7
6735131|NCT03234036|7664505|FG002|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
6735132|NCT03234036|7664506|FG003|COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
6735133|NCT03234036|7664503|FG000|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
6735134|NCT03234036|7664504|FG001|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||1
6735135|NCT03234036|7664505|FG002|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
6735136|NCT03234036|7664506|FG003|NOT COMPLETED|Part 1:Washout Period 1 (Up to 10 Days)||0
6735137|NCT03234036|7664503|FG000|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
6735138|NCT03234036|7664504|FG001|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||7
6735139|NCT03234036|7664505|FG002|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
6735140|NCT03234036|7664506|FG003|STARTED|Part 1: Treatment Period 2(Up to 7 Days)||0
6735141|NCT03234036|7664503|FG000|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
6735142|NCT03234036|7664504|FG001|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||7
6735143|NCT03234036|7664505|FG002|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6735144|NCT03234036|7664506|FG003|COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6735145|NCT03234036|7664503|FG000|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6735146|NCT03234036|7664504|FG001|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6735147|NCT03234036|7664505|FG002|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6735148|NCT03234036|7664506|FG003|NOT COMPLETED|Part 1: Treatment Period 2(Up to 7 Days)||0
6735149|NCT03234036|7664503|FG000|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
6735150|NCT03234036|7664504|FG001|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||7
6735151|NCT03234036|7664505|FG002|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
6735152|NCT03234036|7664506|FG003|STARTED|Part 1:Washout Period 2 (Up to 15 Days)||0
6735153|NCT03234036|7664503|FG000|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
6735154|NCT03234036|7664504|FG001|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||7
6735155|NCT03234036|7664505|FG002|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6735156|NCT03234036|7664506|FG003|COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6735157|NCT03234036|7664503|FG000|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6735158|NCT03234036|7664504|FG001|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6735159|NCT03234036|7664505|FG002|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6735160|NCT03234036|7664506|FG003|NOT COMPLETED|Part 1:Washout Period 2 (Up to 15 Days)||0
6735161|NCT03234036|7664503|FG000|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
6735162|NCT03234036|7664504|FG001|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||7
6735163|NCT03234036|7664505|FG002|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6735164|NCT03234036|7664506|FG003|STARTED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6735165|NCT03234036|7664503|FG000|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
6735166|NCT03234036|7664504|FG001|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||7
6735167|NCT03234036|7664505|FG002|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6735168|NCT03234036|7664506|FG003|COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6735169|NCT03234036|7664503|FG000|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6735170|NCT03234036|7664504|FG001|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6735171|NCT03234036|7664505|FG002|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6735172|NCT03234036|7664506|FG003|NOT COMPLETED|Part 1:Treatment Period 3 (Up to 7 Days)||0
6735173|NCT03234036|7664503|FG000|STARTED|Part 2 (Up to 25 Days)||0
6735174|NCT03234036|7664504|FG001|STARTED|Part 2 (Up to 25 Days)||0
6735175|NCT03234036|7664505|FG002|STARTED|Part 2 (Up to 25 Days)||3
6735176|NCT03234036|7664506|FG003|STARTED|Part 2 (Up to 25 Days)||7
6735177|NCT03234036|7664503|FG000|COMPLETED|Part 2 (Up to 25 Days)||0
6735178|NCT03234036|7664504|FG001|COMPLETED|Part 2 (Up to 25 Days)||0
6735179|NCT03234036|7664505|FG002|COMPLETED|Part 2 (Up to 25 Days)||3
6735180|NCT03234036|7664506|FG003|COMPLETED|Part 2 (Up to 25 Days)||7
6735181|NCT03234036|7664503|FG000|NOT COMPLETED|Part 2 (Up to 25 Days)||0
6735182|NCT03234036|7664504|FG001|NOT COMPLETED|Part 2 (Up to 25 Days)||0
6735183|NCT03234036|7664505|FG002|NOT COMPLETED|Part 2 (Up to 25 Days)||0
6735184|NCT03234036|7664506|FG003|NOT COMPLETED|Part 2 (Up to 25 Days)||0
6735185|NCT03234374|7664524|FG000|STARTED|Overall Study||35
6735186|NCT03234374|7664525|FG001|STARTED|Overall Study||17
6735187|NCT03234374|7664524|FG000|COMPLETED|Overall Study||34
6735188|NCT03234374|7664525|FG001|COMPLETED|Overall Study||16
6735189|NCT03234374|7664524|FG000|NOT COMPLETED|Overall Study||1
6735190|NCT03234374|7664525|FG001|NOT COMPLETED|Overall Study||1
6735191|NCT03234465|7664533|FG000|STARTED|Overall Study||100
6735192|NCT03234465|7664534|FG001|STARTED|Overall Study||100
6735193|NCT03234465|7664533|FG000|COMPLETED|Overall Study||67
6735194|NCT03234465|7664534|FG001|COMPLETED|Overall Study||60
6735195|NCT03234465|7664533|FG000|NOT COMPLETED|Overall Study||33
6735196|NCT03234465|7664534|FG001|NOT COMPLETED|Overall Study||40
6735197|NCT03234608|7664542|FG000|STARTED|Overall Study||127
6735198|NCT03234608|7664543|FG001|STARTED|Overall Study||117
6735199|NCT03234608|7664542|FG000|COMPLETED|Overall Study||104
6735200|NCT03234608|7664543|FG001|COMPLETED|Overall Study||96
6735201|NCT03234608|7664542|FG000|NOT COMPLETED|Overall Study||23
6735202|NCT03234608|7664543|FG001|NOT COMPLETED|Overall Study||21
6735203|NCT03235050|7664554|FG000|STARTED|Overall Study||112
6735204|NCT03235050|7664555|FG001|STARTED|Overall Study||110
6735205|NCT03235050|7664556|FG002|STARTED|Overall Study||100
6735206|NCT03235050|7664557|FG003|STARTED|Overall Study||256
6735207|NCT03235050|7664558|FG004|STARTED|Overall Study||256
6735208|NCT03235050|7664554|FG000|COMPLETED|Overall Study||108
6735209|NCT03235050|7664555|FG001|COMPLETED|Overall Study||105
6735210|NCT03235050|7664556|FG002|COMPLETED|Overall Study||96
6735211|NCT03235050|7664557|FG003|COMPLETED|Overall Study||242
6735212|NCT03235050|7664558|FG004|COMPLETED|Overall Study||245
6735213|NCT03235050|7664554|FG000|NOT COMPLETED|Overall Study||4
6735214|NCT03235050|7664555|FG001|NOT COMPLETED|Overall Study||5
6735215|NCT03235050|7664556|FG002|NOT COMPLETED|Overall Study||4
6735216|NCT03235050|7664557|FG003|NOT COMPLETED|Overall Study||14
6735217|NCT03235050|7664558|FG004|NOT COMPLETED|Overall Study||11
6735218|NCT03235089|7664570|FG000|STARTED|Overall Study||31
6735219|NCT03235089|7664571|FG001|STARTED|Overall Study||31
6735220|NCT03235089|7664570|FG000|COMPLETED|Overall Study||28
6735221|NCT03235089|7664571|FG001|COMPLETED|Overall Study||28
6735222|NCT03235089|7664570|FG000|NOT COMPLETED|Overall Study||3
6735223|NCT03235089|7664571|FG001|NOT COMPLETED|Overall Study||3
6735224|NCT03235115|7664578|FG000|STARTED|First Intervention (1 Hour, Visit 2)||9
6735225|NCT03235115|7664579|FG001|STARTED|First Intervention (1 Hour, Visit 2)||6
6735226|NCT03235115|7664580|FG002|STARTED|First Intervention (1 Hour, Visit 2)||7
6735227|NCT03235115|7664581|FG003|STARTED|First Intervention (1 Hour, Visit 2)||6
6735228|NCT03235115|7664582|FG004|STARTED|First Intervention (1 Hour, Visit 2)||6
6735229|NCT03235115|7664583|FG005|STARTED|First Intervention (1 Hour, Visit 2)||6
6735230|NCT03235115|7664578|FG000|COMPLETED|First Intervention (1 Hour, Visit 2)||9
6735231|NCT03235115|7664579|FG001|COMPLETED|First Intervention (1 Hour, Visit 2)||6
6735232|NCT03235115|7664580|FG002|COMPLETED|First Intervention (1 Hour, Visit 2)||7
6735233|NCT03235115|7664581|FG003|COMPLETED|First Intervention (1 Hour, Visit 2)||6
6735234|NCT03235115|7664582|FG004|COMPLETED|First Intervention (1 Hour, Visit 2)||6
6735235|NCT03235115|7664583|FG005|COMPLETED|First Intervention (1 Hour, Visit 2)||5
6735236|NCT03235115|7664578|FG000|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6735237|NCT03235115|7664579|FG001|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6735238|NCT03235115|7664580|FG002|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6735239|NCT03235115|7664581|FG003|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6735240|NCT03235115|7664582|FG004|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||0
6735241|NCT03235115|7664583|FG005|NOT COMPLETED|First Intervention (1 Hour, Visit 2)||1
6735242|NCT03235115|7664578|FG000|STARTED|Second Intervention (1 Hour, Visit 4)||9
6735243|NCT03235115|7664579|FG001|STARTED|Second Intervention (1 Hour, Visit 4)||6
6735244|NCT03235115|7664580|FG002|STARTED|Second Intervention (1 Hour, Visit 4)||7
6735245|NCT03235115|7664581|FG003|STARTED|Second Intervention (1 Hour, Visit 4)||6
6735246|NCT03235115|7664582|FG004|STARTED|Second Intervention (1 Hour, Visit 4)||6
6735247|NCT03235115|7664583|FG005|STARTED|Second Intervention (1 Hour, Visit 4)||5
6735248|NCT03235115|7664578|FG000|COMPLETED|Second Intervention (1 Hour, Visit 4)||9
6735249|NCT03235115|7664579|FG001|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
6735250|NCT03235115|7664580|FG002|COMPLETED|Second Intervention (1 Hour, Visit 4)||7
6735251|NCT03235115|7664581|FG003|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
6735252|NCT03235115|7664582|FG004|COMPLETED|Second Intervention (1 Hour, Visit 4)||6
6735253|NCT03235115|7664583|FG005|COMPLETED|Second Intervention (1 Hour, Visit 4)||5
6735254|NCT03235115|7664578|FG000|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6735255|NCT03235115|7664579|FG001|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6735256|NCT03235115|7664580|FG002|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6735257|NCT03235115|7664581|FG003|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6735258|NCT03235115|7664582|FG004|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6735259|NCT03235115|7664583|FG005|NOT COMPLETED|Second Intervention (1 Hour, Visit 4)||0
6735260|NCT03235115|7664578|FG000|STARTED|Third Intervention ( 1 Hour, Visit 6)||9
6735261|NCT03235115|7664579|FG001|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
6735262|NCT03235115|7664580|FG002|STARTED|Third Intervention ( 1 Hour, Visit 6)||7
6735263|NCT03235115|7664581|FG003|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
6735264|NCT03235115|7664582|FG004|STARTED|Third Intervention ( 1 Hour, Visit 6)||6
6735265|NCT03235115|7664583|FG005|STARTED|Third Intervention ( 1 Hour, Visit 6)||5
6735266|NCT03235115|7664578|FG000|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||9
6735267|NCT03235115|7664579|FG001|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
6735268|NCT03235115|7664580|FG002|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||7
6735269|NCT03235115|7664581|FG003|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
6735270|NCT03235115|7664582|FG004|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||6
6735271|NCT03235115|7664583|FG005|COMPLETED|Third Intervention ( 1 Hour, Visit 6)||5
6735272|NCT03235115|7664578|FG000|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6735273|NCT03235115|7664579|FG001|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6735274|NCT03235115|7664580|FG002|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6735275|NCT03235115|7664581|FG003|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6735276|NCT03235115|7664582|FG004|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6735277|NCT03235115|7664583|FG005|NOT COMPLETED|Third Intervention ( 1 Hour, Visit 6)||0
6735278|NCT03235154|7664591|FG000|STARTED|Overall Study||11
6735279|NCT03235154|7664591|FG000|Completed Epclusa. Treatment|Overall Study||8
6735280|NCT03235154|7664591|FG000|12-wk Post-treatment HCV RNA Measured|Overall Study||7
6735281|NCT03235154|7664591|FG000|COMPLETED|Overall Study||7
6735282|NCT03235154|7664591|FG000|NOT COMPLETED|Overall Study||4
6735283|NCT03235180|7664597|FG000|STARTED|Overall Study||9
6735284|NCT03235180|7664597|FG000|COMPLETED|Overall Study||9
6735285|NCT03235180|7664597|FG000|NOT COMPLETED|Overall Study||0
6735286|NCT03235284|7664604|FG000|STARTED|Overall Study||15
6735287|NCT03235284|7664605|FG001|STARTED|Overall Study||15
6735288|NCT03235284|7664606|FG002|STARTED|Overall Study||15
6735289|NCT03235284|7664604|FG000|COMPLETED|Overall Study||14
6735290|NCT03235284|7664605|FG001|COMPLETED|Overall Study||13
6735291|NCT03235284|7664606|FG002|COMPLETED|Overall Study||14
6735292|NCT03235284|7664604|FG000|NOT COMPLETED|Overall Study||1
6735293|NCT03235284|7664605|FG001|NOT COMPLETED|Overall Study||2
6735294|NCT03235284|7664606|FG002|NOT COMPLETED|Overall Study||1
6735295|NCT03235349|7664614|FG000|STARTED|Overall Study||160
6735296|NCT03235349|7664614|FG000|COMPLETED|Overall Study||158
6735297|NCT03235349|7664614|FG000|NOT COMPLETED|Overall Study||2
6735298|NCT03235414|7664618|FG000|STARTED|Overall Study||101
6735299|NCT03235414|7664618|FG000|COMPLETED|Overall Study||101
6735300|NCT03235414|7664618|FG000|NOT COMPLETED|Overall Study||0
6735301|NCT03235479|7664624|FG000|STARTED|Overall Study||582
6735302|NCT03235479|7664625|FG001|STARTED|Overall Study||580
6735303|NCT03235479|7664624|FG000|Treated|Overall Study||546
6735304|NCT03235479|7664625|FG001|Treated|Overall Study||549
6735305|NCT03235479|7664624|FG000|COMPLETED|Overall Study||541
6735306|NCT03235479|7664625|FG001|COMPLETED|Overall Study||540
6735307|NCT03235479|7664624|FG000|NOT COMPLETED|Overall Study||41
6735308|NCT03235479|7664625|FG001|NOT COMPLETED|Overall Study||40
6735309|NCT03235726|7664639|FG000|STARTED|Part 1 (Cohort A 60 mg - Day 1)||6
6735310|NCT03235726|7664640|FG001|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6735311|NCT03235726|7664641|FG002|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6735312|NCT03235726|7664642|FG003|STARTED|Part 1 (Cohort A 60 mg - Day 1)||2
6735313|NCT03235726|7664643|FG004|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6735314|NCT03235726|7664644|FG005|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6735315|NCT03235726|7664645|FG006|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6735316|NCT03235726|7664646|FG007|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6735317|NCT03235726|7664647|FG008|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6735318|NCT03235726|7664648|FG009|STARTED|Part 1 (Cohort A 60 mg - Day 1)||0
6735319|NCT03235726|7664639|FG000|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||6
6735320|NCT03235726|7664640|FG001|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735321|NCT03235726|7664641|FG002|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735322|NCT03235726|7664642|FG003|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||2
6735323|NCT03235726|7664643|FG004|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735324|NCT03235726|7664644|FG005|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735325|NCT03235726|7664645|FG006|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735326|NCT03235726|7664646|FG007|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735327|NCT03235726|7664647|FG008|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735328|NCT03235726|7664648|FG009|COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735329|NCT03235726|7664639|FG000|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735330|NCT03235726|7664640|FG001|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735331|NCT03235726|7664641|FG002|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735332|NCT03235726|7664642|FG003|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735333|NCT03235726|7664643|FG004|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735334|NCT03235726|7664644|FG005|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735335|NCT03235726|7664645|FG006|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735336|NCT03235726|7664646|FG007|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735337|NCT03235726|7664647|FG008|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735338|NCT03235726|7664648|FG009|NOT COMPLETED|Part 1 (Cohort A 60 mg - Day 1)||0
6735339|NCT03235726|7664639|FG000|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6735340|NCT03235726|7664640|FG001|STARTED|Part 1 (Cohort A 120 mg - Day 3)||6
6735341|NCT03235726|7664641|FG002|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6735342|NCT03235726|7664642|FG003|STARTED|Part 1 (Cohort A 120 mg - Day 3)||2
6735343|NCT03235726|7664643|FG004|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6735344|NCT03235726|7664644|FG005|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6735345|NCT03235726|7664645|FG006|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6735346|NCT03235726|7664646|FG007|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6735347|NCT03235726|7664647|FG008|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6735348|NCT03235726|7664648|FG009|STARTED|Part 1 (Cohort A 120 mg - Day 3)||0
6735349|NCT03235726|7664639|FG000|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735350|NCT03235726|7664640|FG001|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||6
6735351|NCT03235726|7664641|FG002|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735352|NCT03235726|7664642|FG003|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||2
6735353|NCT03235726|7664643|FG004|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735354|NCT03235726|7664644|FG005|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735355|NCT03235726|7664645|FG006|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735356|NCT03235726|7664646|FG007|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735357|NCT03235726|7664647|FG008|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735358|NCT03235726|7664648|FG009|COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735359|NCT03235726|7664639|FG000|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735360|NCT03235726|7664640|FG001|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735361|NCT03235726|7664641|FG002|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735362|NCT03235726|7664642|FG003|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735363|NCT03235726|7664643|FG004|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735364|NCT03235726|7664644|FG005|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735365|NCT03235726|7664645|FG006|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735366|NCT03235726|7664646|FG007|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735367|NCT03235726|7664647|FG008|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735368|NCT03235726|7664648|FG009|NOT COMPLETED|Part 1 (Cohort A 120 mg - Day 3)||0
6735369|NCT03235726|7664639|FG000|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735370|NCT03235726|7664640|FG001|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735371|NCT03235726|7664641|FG002|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
6735372|NCT03235726|7664642|FG003|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
6735373|NCT03235726|7664643|FG004|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735374|NCT03235726|7664644|FG005|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735375|NCT03235726|7664645|FG006|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735376|NCT03235726|7664646|FG007|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735377|NCT03235726|7664647|FG008|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735378|NCT03235726|7664648|FG009|STARTED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735379|NCT03235726|7664639|FG000|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735380|NCT03235726|7664640|FG001|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735381|NCT03235726|7664641|FG002|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||6
6735382|NCT03235726|7664642|FG003|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||2
6735383|NCT03235726|7664643|FG004|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735384|NCT03235726|7664644|FG005|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735385|NCT03235726|7664645|FG006|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735386|NCT03235726|7664646|FG007|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735387|NCT03235726|7664647|FG008|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735388|NCT03235726|7664648|FG009|COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735389|NCT03235726|7664639|FG000|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735390|NCT03235726|7664640|FG001|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735391|NCT03235726|7664641|FG002|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735392|NCT03235726|7664642|FG003|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735393|NCT03235726|7664643|FG004|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735394|NCT03235726|7664644|FG005|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735395|NCT03235726|7664645|FG006|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735396|NCT03235726|7664646|FG007|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735397|NCT03235726|7664647|FG008|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735398|NCT03235726|7664648|FG009|NOT COMPLETED|Part 1 (Cohort A 30mg BID-Days 6 to 19)||0
6735399|NCT03235726|7664639|FG000|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735400|NCT03235726|7664640|FG001|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735401|NCT03235726|7664641|FG002|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735402|NCT03235726|7664642|FG003|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735403|NCT03235726|7664643|FG004|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||12
6735404|NCT03235726|7664644|FG005|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||2
6735405|NCT03235726|7664645|FG006|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||14
6735406|NCT03235726|7664646|FG007|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735407|NCT03235726|7664647|FG008|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735408|NCT03235726|7664648|FG009|STARTED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735409|NCT03235726|7664639|FG000|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735410|NCT03235726|7664640|FG001|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735411|NCT03235726|7664641|FG002|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735412|NCT03235726|7664642|FG003|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735413|NCT03235726|7664643|FG004|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||10
6735414|NCT03235726|7664644|FG005|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
6735415|NCT03235726|7664645|FG006|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||14
6735416|NCT03235726|7664646|FG007|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735417|NCT03235726|7664647|FG008|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735418|NCT03235726|7664648|FG009|COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735419|NCT03235726|7664639|FG000|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735420|NCT03235726|7664640|FG001|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735421|NCT03235726|7664641|FG002|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735422|NCT03235726|7664642|FG003|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735423|NCT03235726|7664643|FG004|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||2
6735424|NCT03235726|7664644|FG005|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735425|NCT03235726|7664645|FG006|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735426|NCT03235726|7664646|FG007|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735427|NCT03235726|7664647|FG008|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735428|NCT03235726|7664648|FG009|NOT COMPLETED|Part 1 (Cohort B and C- Days 1 to 14)||0
6735429|NCT03235726|7664639|FG000|STARTED|Part 2 (Cohort A - Day 1)||0
6735430|NCT03235726|7664640|FG001|STARTED|Part 2 (Cohort A - Day 1)||0
6735431|NCT03235726|7664641|FG002|STARTED|Part 2 (Cohort A - Day 1)||0
6735432|NCT03235726|7664642|FG003|STARTED|Part 2 (Cohort A - Day 1)||0
6735433|NCT03235726|7664643|FG004|STARTED|Part 2 (Cohort A - Day 1)||0
6735434|NCT03235726|7664644|FG005|STARTED|Part 2 (Cohort A - Day 1)||0
6735435|NCT03235726|7664645|FG006|STARTED|Part 2 (Cohort A - Day 1)||0
6735436|NCT03235726|7664646|FG007|STARTED|Part 2 (Cohort A - Day 1)||6
6735437|NCT03235726|7664647|FG008|STARTED|Part 2 (Cohort A - Day 1)||2
6735438|NCT03235726|7664648|FG009|STARTED|Part 2 (Cohort A - Day 1)||0
6735439|NCT03235726|7664639|FG000|COMPLETED|Part 2 (Cohort A - Day 1)||0
6735440|NCT03235726|7664640|FG001|COMPLETED|Part 2 (Cohort A - Day 1)||0
6735441|NCT03235726|7664641|FG002|COMPLETED|Part 2 (Cohort A - Day 1)||0
6735442|NCT03235726|7664642|FG003|COMPLETED|Part 2 (Cohort A - Day 1)||0
6735443|NCT03235726|7664643|FG004|COMPLETED|Part 2 (Cohort A - Day 1)||0
6735444|NCT03235726|7664644|FG005|COMPLETED|Part 2 (Cohort A - Day 1)||0
6735445|NCT03235726|7664645|FG006|COMPLETED|Part 2 (Cohort A - Day 1)||0
6735446|NCT03235726|7664646|FG007|COMPLETED|Part 2 (Cohort A - Day 1)||6
6735447|NCT03235726|7664647|FG008|COMPLETED|Part 2 (Cohort A - Day 1)||2
6735448|NCT03235726|7664648|FG009|COMPLETED|Part 2 (Cohort A - Day 1)||0
6735449|NCT03235726|7664639|FG000|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735450|NCT03235726|7664640|FG001|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735451|NCT03235726|7664641|FG002|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735452|NCT03235726|7664642|FG003|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735453|NCT03235726|7664643|FG004|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735454|NCT03235726|7664644|FG005|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735455|NCT03235726|7664645|FG006|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735456|NCT03235726|7664646|FG007|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735457|NCT03235726|7664647|FG008|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735458|NCT03235726|7664648|FG009|NOT COMPLETED|Part 2 (Cohort A - Day 1)||0
6735459|NCT03235726|7664639|FG000|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735460|NCT03235726|7664640|FG001|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735461|NCT03235726|7664641|FG002|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735462|NCT03235726|7664642|FG003|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735463|NCT03235726|7664643|FG004|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735464|NCT03235726|7664644|FG005|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735465|NCT03235726|7664645|FG006|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735466|NCT03235726|7664646|FG007|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735467|NCT03235726|7664647|FG008|STARTED|Part 2 (Cohort B - Days 1 to 14)||0
6735468|NCT03235726|7664648|FG009|STARTED|Part 2 (Cohort B - Days 1 to 14)||8
6735469|NCT03235726|7664639|FG000|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735470|NCT03235726|7664640|FG001|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735471|NCT03235726|7664641|FG002|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735472|NCT03235726|7664642|FG003|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735473|NCT03235726|7664643|FG004|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735474|NCT03235726|7664644|FG005|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735475|NCT03235726|7664645|FG006|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735476|NCT03235726|7664646|FG007|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735477|NCT03235726|7664647|FG008|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735478|NCT03235726|7664648|FG009|COMPLETED|Part 2 (Cohort B - Days 1 to 14)||8
6735479|NCT03235726|7664639|FG000|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735480|NCT03235726|7664640|FG001|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735481|NCT03235726|7664641|FG002|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735482|NCT03235726|7664642|FG003|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735483|NCT03235726|7664643|FG004|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735484|NCT03235726|7664644|FG005|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735485|NCT03235726|7664645|FG006|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735486|NCT03235726|7664646|FG007|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735487|NCT03235726|7664647|FG008|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735488|NCT03235726|7664648|FG009|NOT COMPLETED|Part 2 (Cohort B - Days 1 to 14)||0
6735489|NCT03236168|7664683|FG000|STARTED|Overall Study||118
6735490|NCT03236168|7664683|FG000|COMPLETED|Overall Study||107
6735491|NCT03236168|7664683|FG000|NOT COMPLETED|Overall Study||11
6735492|NCT03236246|7664689|FG000|STARTED|24-Week Dose Titration Period||104
6735493|NCT03236246|7664690|FG001|STARTED|24-Week Dose Titration Period||102
6735494|NCT03236246|7664689|FG000|COMPLETED|24-Week Dose Titration Period||80
6735495|NCT03236246|7664690|FG001|COMPLETED|24-Week Dose Titration Period||75
6735496|NCT03236246|7664689|FG000|NOT COMPLETED|24-Week Dose Titration Period||24
6735497|NCT03236246|7664690|FG001|NOT COMPLETED|24-Week Dose Titration Period||27
6735498|NCT03236246|7664689|FG000|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|76
6735499|NCT03236246|7664690|FG001|STARTED|24-Week Dose Maintenance Period|Not all participants completing the Dose Titration Period opted to enter the Dose Maintenance Period|72
6735500|NCT03236246|7664689|FG000|COMPLETED|24-Week Dose Maintenance Period||73
6735501|NCT03236246|7664690|FG001|COMPLETED|24-Week Dose Maintenance Period||66
6735502|NCT03236246|7664689|FG000|NOT COMPLETED|24-Week Dose Maintenance Period||3
6735503|NCT03236246|7664690|FG001|NOT COMPLETED|24-Week Dose Maintenance Period||6
6735504|NCT03236506|7664699|FG000|STARTED|Overall Study||39
6735505|NCT03236506|7664700|FG001|STARTED|Overall Study||42
6735506|NCT03236506|7664701|FG002|STARTED|Overall Study||47
6735507|NCT03236506|7664699|FG000|COMPLETED|Overall Study||33
6735508|NCT03236506|7664700|FG001|COMPLETED|Overall Study||37
6735509|NCT03236506|7664701|FG002|COMPLETED|Overall Study||40
6735510|NCT03236506|7664699|FG000|NOT COMPLETED|Overall Study||6
6735511|NCT03236506|7664700|FG001|NOT COMPLETED|Overall Study||5
6735512|NCT03236506|7664701|FG002|NOT COMPLETED|Overall Study||7
6735513|NCT03236779|7664711|FG000|STARTED|Overall Study||51
6735514|NCT03236779|7664712|FG001|STARTED|Overall Study||51
6735515|NCT03236779|7664711|FG000|COMPLETED|Overall Study||38
6735516|NCT03236779|7664712|FG001|COMPLETED|Overall Study||30
6735517|NCT03236779|7664711|FG000|NOT COMPLETED|Overall Study||13
6735518|NCT03236779|7664712|FG001|NOT COMPLETED|Overall Study||21
6735519|NCT03237013|7664723|FG000|STARTED|Baseline to Immediate Post-treatment||73
6735520|NCT03237013|7664724|FG001|STARTED|Baseline to Immediate Post-treatment||73
6735521|NCT03237013|7664725|FG002|STARTED|Baseline to Immediate Post-treatment||73
6735522|NCT03237013|7664723|FG000|COMPLETED|Baseline to Immediate Post-treatment||73
6735523|NCT03237013|7664724|FG001|COMPLETED|Baseline to Immediate Post-treatment||73
6735524|NCT03237013|7664725|FG002|COMPLETED|Baseline to Immediate Post-treatment||73
6735525|NCT03237013|7664723|FG000|NOT COMPLETED|Baseline to Immediate Post-treatment||0
6735526|NCT03237013|7664724|FG001|NOT COMPLETED|Baseline to Immediate Post-treatment||0
6735527|NCT03237013|7664725|FG002|NOT COMPLETED|Baseline to Immediate Post-treatment||0
6735528|NCT03237013|7664723|FG000|STARTED|Immediate Post-treatment to 1-mo F/u||73
6735529|NCT03237013|7664724|FG001|STARTED|Immediate Post-treatment to 1-mo F/u||73
6735530|NCT03237013|7664725|FG002|STARTED|Immediate Post-treatment to 1-mo F/u||73
6735531|NCT03237013|7664723|FG000|COMPLETED|Immediate Post-treatment to 1-mo F/u||30
6735532|NCT03237013|7664724|FG001|COMPLETED|Immediate Post-treatment to 1-mo F/u||43
6735533|NCT03237013|7664725|FG002|COMPLETED|Immediate Post-treatment to 1-mo F/u||36
6735534|NCT03237013|7664723|FG000|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||43
6735535|NCT03237013|7664724|FG001|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||30
6735536|NCT03237013|7664725|FG002|NOT COMPLETED|Immediate Post-treatment to 1-mo F/u||37
6735537|NCT03237065|7664735|FG000|STARTED|Overall Study||61
6735538|NCT03237065|7664736|FG001|STARTED|Overall Study||61
6735539|NCT03237065|7664735|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|62
6735540|NCT03237065|7664736|FG001|Safety Analysis Set|Overall Study||57
6735541|NCT03237065|7664735|FG000|COMPLETED|Overall Study||57
6735542|NCT03237065|7664736|FG001|COMPLETED|Overall Study||57
6735543|NCT03237065|7664735|FG000|NOT COMPLETED|Overall Study||4
6735544|NCT03237065|7664736|FG001|NOT COMPLETED|Overall Study||4
6735545|NCT03237156|7664746|FG000|STARTED|Overall Study||6
6735546|NCT03237156|7664747|FG001|STARTED|Overall Study||6
6735547|NCT03237156|7664748|FG002|STARTED|Overall Study||6
6735548|NCT03237156|7664749|FG003|STARTED|Overall Study||6
6735549|NCT03237156|7664746|FG000|COMPLETED|Overall Study||6
6735550|NCT03237156|7664747|FG001|COMPLETED|Overall Study||6
6735551|NCT03237156|7664748|FG002|COMPLETED|Overall Study||6
6735552|NCT03237156|7664749|FG003|COMPLETED|Overall Study||6
6735553|NCT03237156|7664746|FG000|NOT COMPLETED|Overall Study||0
6735554|NCT03237156|7664747|FG001|NOT COMPLETED|Overall Study||0
6735555|NCT03237156|7664748|FG002|NOT COMPLETED|Overall Study||0
6735556|NCT03237156|7664749|FG003|NOT COMPLETED|Overall Study||0
6735557|NCT03237481|7664765|FG000|STARTED|Overall Study||164
6735558|NCT03237481|7664766|FG001|STARTED|Overall Study||172
6735559|NCT03237481|7664767|FG002|STARTED|Overall Study||82
6735560|NCT03237481|7664765|FG000|COMPLETED|Overall Study||159
6735561|NCT03237481|7664766|FG001|COMPLETED|Overall Study||170
6735562|NCT03237481|7664767|FG002|COMPLETED|Overall Study||81
6735563|NCT03237481|7664765|FG000|NOT COMPLETED|Overall Study||5
6735564|NCT03237481|7664766|FG001|NOT COMPLETED|Overall Study||2
6735565|NCT03237481|7664767|FG002|NOT COMPLETED|Overall Study||1
6735566|NCT03237845|7664777|FG000|STARTED|Overall Study||594
6735567|NCT03237845|7664778|FG001|STARTED|Overall Study||592
6735568|NCT03237845|7664777|FG000|Treated|Overall Study||543
6735569|NCT03237845|7664778|FG001|Treated|Overall Study||543
6735570|NCT03237845|7664777|FG000|COMPLETED|Overall Study||538
6735571|NCT03237845|7664778|FG001|COMPLETED|Overall Study||542
6735572|NCT03237845|7664777|FG000|NOT COMPLETED|Overall Study||56
6735573|NCT03237845|7664778|FG001|NOT COMPLETED|Overall Study||50
6735574|NCT03237871|7664784|FG000|STARTED|Overall Study||17
6735575|NCT03237871|7664784|FG000|COMPLETED|Overall Study||11
6735576|NCT03237871|7664784|FG000|NOT COMPLETED|Overall Study||6
6735577|NCT03238001|7664788|FG000|STARTED|Visit 1 (Primary Endpoint Cohort)||436
6735578|NCT03238001|7664788|FG000|COMPLETED|Visit 1 (Primary Endpoint Cohort)||432
6735579|NCT03238001|7664788|FG000|NOT COMPLETED|Visit 1 (Primary Endpoint Cohort)||4
6735580|NCT03238001|7664788|FG000|STARTED|Visit 2 (Secondary Endpoint Cohort)||432
6735581|NCT03238001|7664788|FG000|COMPLETED|Visit 2 (Secondary Endpoint Cohort)||403
6735582|NCT03238001|7664788|FG000|NOT COMPLETED|Visit 2 (Secondary Endpoint Cohort)||29
6735583|NCT03238352|7664803|FG000|STARTED|Overall Study||43
6735584|NCT03238352|7664804|FG001|STARTED|Overall Study||23
6735585|NCT03238352|7664805|FG002|STARTED|Overall Study||23
6735586|NCT03238352|7664803|FG000|COMPLETED|Overall Study||43
6735587|NCT03238352|7664804|FG001|COMPLETED|Overall Study||20
6735588|NCT03238352|7664805|FG002|COMPLETED|Overall Study||22
6735589|NCT03238352|7664803|FG000|NOT COMPLETED|Overall Study||0
6735590|NCT03238352|7664804|FG001|NOT COMPLETED|Overall Study||3
6735591|NCT03238352|7664805|FG002|NOT COMPLETED|Overall Study||1
6735592|NCT03238417|7664815|FG000|STARTED|Overall||1330
6735593|NCT03238417|7664816|FG001|STARTED|Overall||2632
6735594|NCT03238417|7664815|FG000|COMPLETED|Overall||327
6735595|NCT03238417|7664816|FG001|COMPLETED|Overall||644
6735596|NCT03238417|7664815|FG000|NOT COMPLETED|Overall||1003
6735597|NCT03238417|7664816|FG001|NOT COMPLETED|Overall||1988
6735598|NCT03238417|7664815|FG000|STARTED|Baseline||513
6735599|NCT03238417|7664816|FG001|STARTED|Baseline||934
6735600|NCT03238417|7664815|FG000|COMPLETED|Baseline||124
6735601|NCT03238417|7664816|FG001|COMPLETED|Baseline||217
6735602|NCT03238417|7664815|FG000|NOT COMPLETED|Baseline||389
6735603|NCT03238417|7664816|FG001|NOT COMPLETED|Baseline||717
6735604|NCT03238417|7664815|FG000|STARTED|12-month||400
6735605|NCT03238417|7664816|FG001|STARTED|12-month||911
6735606|NCT03238417|7664815|FG000|COMPLETED|12-month||81
6735607|NCT03238417|7664816|FG001|COMPLETED|12-month||205
6735608|NCT03238417|7664815|FG000|NOT COMPLETED|12-month||319
6735609|NCT03238417|7664816|FG001|NOT COMPLETED|12-month||706
6735610|NCT03238417|7664815|FG000|STARTED|24-month||417
6735611|NCT03238417|7664816|FG001|STARTED|24-month||847
6735612|NCT03238417|7664815|FG000|COMPLETED|24-month||122
6735613|NCT03238417|7664816|FG001|COMPLETED|24-month||222
6735614|NCT03238417|7664815|FG000|NOT COMPLETED|24-month||295
6735615|NCT03238417|7664816|FG001|NOT COMPLETED|24-month||625
6735616|NCT03238651|7664827|FG000|STARTED|Overall Study||3
6735617|NCT03238651|7664828|FG001|STARTED|Overall Study||6
6735618|NCT03238651|7664829|FG002|STARTED|Overall Study||4
6735619|NCT03238651|7664830|FG003|STARTED|Overall Study||3
6735620|NCT03238651|7664831|FG004|STARTED|Overall Study||1
6735621|NCT03238651|7664827|FG000|COMPLETED|Overall Study||0
6735622|NCT03238651|7664828|FG001|COMPLETED|Overall Study||0
6735623|NCT03238651|7664829|FG002|COMPLETED|Overall Study||0
6735624|NCT03238651|7664830|FG003|COMPLETED|Overall Study||0
6735625|NCT03238651|7664831|FG004|COMPLETED|Overall Study||0
6735626|NCT03238651|7664827|FG000|NOT COMPLETED|Overall Study||3
6735627|NCT03238651|7664828|FG001|NOT COMPLETED|Overall Study||6
6735628|NCT03238651|7664829|FG002|NOT COMPLETED|Overall Study||4
6735629|NCT03238651|7664830|FG003|NOT COMPLETED|Overall Study||3
6735630|NCT03238651|7664831|FG004|NOT COMPLETED|Overall Study||1
6735631|NCT03238781|7664847|FG000|STARTED|Overall Study||137
6735632|NCT03238781|7664848|FG001|STARTED|Overall Study||104
6735633|NCT03238781|7664849|FG002|STARTED|Overall Study||102
6735634|NCT03238781|7664847|FG000|COMPLETED|Overall Study||111
6735635|NCT03238781|7664848|FG001|COMPLETED|Overall Study||87
6735636|NCT03238781|7664849|FG002|COMPLETED|Overall Study||82
6735637|NCT03238781|7664847|FG000|NOT COMPLETED|Overall Study||26
6735638|NCT03238781|7664848|FG001|NOT COMPLETED|Overall Study||17
6735639|NCT03238781|7664849|FG002|NOT COMPLETED|Overall Study||20
6735640|NCT03238911|7664859|FG000|STARTED|Overall Study||62
6735641|NCT03238911|7664860|FG001|STARTED|Overall Study||61
6735642|NCT03238911|7664859|FG000|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|63
6735643|NCT03238911|7664860|FG001|Safety Analysis Set|Overall Study|1 subject from ferric carboxymaltose group received iron isomaltoside/ferric derisomaltose in error.|60
6735644|NCT03238911|7664859|FG000|COMPLETED|Overall Study||59
6735645|NCT03238911|7664860|FG001|COMPLETED|Overall Study||58
6735646|NCT03238911|7664859|FG000|NOT COMPLETED|Overall Study||3
6735647|NCT03238911|7664860|FG001|NOT COMPLETED|Overall Study||3
6735648|NCT03238924|7664869|FG000|STARTED|Overall Study||8
6735649|NCT03238924|7664870|FG001|STARTED|Overall Study||9
6735650|NCT03238924|7664869|FG000|COMPLETED|Overall Study||6
6735651|NCT03238924|7664870|FG001|COMPLETED|Overall Study||7
6735652|NCT03238924|7664869|FG000|NOT COMPLETED|Overall Study||2
6735653|NCT03238924|7664870|FG001|NOT COMPLETED|Overall Study||2
6735654|NCT03238963|7664878|FG000|STARTED|Overall Study||40
6735655|NCT03238963|7664879|FG001|STARTED|Overall Study||39
6735656|NCT03238963|7664878|FG000|COMPLETED|Overall Study||35
6735657|NCT03238963|7664879|FG001|COMPLETED|Overall Study||37
6735658|NCT03238963|7664878|FG000|NOT COMPLETED|Overall Study||5
6735659|NCT03238963|7664879|FG001|NOT COMPLETED|Overall Study||2
6735660|NCT03239106|7664885|FG000|STARTED|Overall Study||10
6735661|NCT03239106|7664885|FG000|COMPLETED|Overall Study||3
6735662|NCT03239106|7664885|FG000|NOT COMPLETED|Overall Study||7
6735663|NCT03239470|7664890|FG000|STARTED|Blood Donation||5
6735664|NCT03239470|7664891|FG001|STARTED|Blood Donation||0
6735665|NCT03239470|7664890|FG000|COMPLETED|Blood Donation||5
6735666|NCT03239470|7664891|FG001|COMPLETED|Blood Donation||0
6735667|NCT03239470|7664890|FG000|NOT COMPLETED|Blood Donation||0
6735668|NCT03239470|7664891|FG001|NOT COMPLETED|Blood Donation||0
6735669|NCT03239470|7664890|FG000|STARTED|Polyclonal Treg Infusion|Started includes all participants who completed the pre-infusion checklist at the infusion visit.|5
6735670|NCT03239470|7664891|FG001|STARTED|Polyclonal Treg Infusion||0
6735671|NCT03239470|7664890|FG000|COMPLETED|Polyclonal Treg Infusion|Participants who did not meet eligibility, per the pre-infusion checklist, did not complete study infusion.|4
6735672|NCT03239470|7664891|FG001|COMPLETED|Polyclonal Treg Infusion||0
6735673|NCT03239470|7664890|FG000|NOT COMPLETED|Polyclonal Treg Infusion||1
6735674|NCT03239470|7664891|FG001|NOT COMPLETED|Polyclonal Treg Infusion||0
6735675|NCT03239483|7664897|FG000|STARTED|Overall Study||19
6735676|NCT03239483|7664898|FG001|STARTED|Overall Study||9
6735677|NCT03239483|7664897|FG000|COMPLETED|Overall Study||17
6735678|NCT03239483|7664898|FG001|COMPLETED|Overall Study||9
6735679|NCT03239483|7664897|FG000|NOT COMPLETED|Overall Study||2
6735680|NCT03239483|7664898|FG001|NOT COMPLETED|Overall Study||0
6735681|NCT03239496|7664908|FG000|STARTED|Overall Study||200
6735682|NCT03239496|7664909|FG001|STARTED|Overall Study||178
6735683|NCT03239496|7664910|FG002|STARTED|Overall Study||178
6735684|NCT03239496|7664911|FG003|STARTED|Overall Study||217
6735685|NCT03239496|7664908|FG000|COMPLETED|Overall Study||186
6735686|NCT03239496|7664909|FG001|COMPLETED|Overall Study||168
6735687|NCT03239496|7664910|FG002|COMPLETED|Overall Study||166
6735688|NCT03239496|7664911|FG003|COMPLETED|Overall Study||203
6735689|NCT03239496|7664908|FG000|NOT COMPLETED|Overall Study||14
6735690|NCT03239496|7664909|FG001|NOT COMPLETED|Overall Study||10
6735691|NCT03239496|7664910|FG002|NOT COMPLETED|Overall Study||12
6735692|NCT03239496|7664911|FG003|NOT COMPLETED|Overall Study||14
6735693|NCT03239522|7664925|FG000|STARTED|Treatment Period 1 (Up to 7 Days)||6
6735694|NCT03239522|7664925|FG000|COMPLETED|Treatment Period 1 (Up to 7 Days)||6
6735695|NCT03239522|7664925|FG000|NOT COMPLETED|Treatment Period 1 (Up to 7 Days)||0
6735696|NCT03239522|7664925|FG000|STARTED|Washout Period (Up to 7 Days)||6
6735697|NCT03239522|7664925|FG000|COMPLETED|Washout Period (Up to 7 Days)||6
6735698|NCT03239522|7664925|FG000|NOT COMPLETED|Washout Period (Up to 7 Days)||0
6735699|NCT03239522|7664925|FG000|STARTED|Treatment Period 2 (Up to 15 Days)||6
6735700|NCT03239522|7664925|FG000|COMPLETED|Treatment Period 2 (Up to 15 Days)||6
6735701|NCT03239522|7664925|FG000|NOT COMPLETED|Treatment Period 2 (Up to 15 Days)||0
6735702|NCT03239574|7664936|FG000|STARTED|Overall Study||34
6735703|NCT03239574|7664936|FG000|COMPLETED|Overall Study||34
6735704|NCT03239574|7664936|FG000|NOT COMPLETED|Overall Study||0
6735705|NCT03239665|7664942|FG000|STARTED|Overall Study||175
6735706|NCT03239665|7664943|FG001|STARTED|Overall Study||160
6735707|NCT03239665|7664942|FG000|Met Inclusion Criteria|Overall Study||150
6735708|NCT03239665|7664943|FG001|Met Inclusion Criteria|Overall Study||144
6735709|NCT03239665|7664942|FG000|Submitted Survey Data|Overall Study||147
6735710|NCT03239665|7664943|FG001|Submitted Survey Data|Overall Study||140
6735711|NCT03239665|7664942|FG000|COMPLETED|Overall Study||147
6735712|NCT03239665|7664943|FG001|COMPLETED|Overall Study||140
6735713|NCT03239665|7664942|FG000|NOT COMPLETED|Overall Study||28
6735714|NCT03239665|7664943|FG001|NOT COMPLETED|Overall Study||20
6735715|NCT03239873|7664951|FG000|STARTED|Overall Study||300
6735716|NCT03239873|7664952|FG001|STARTED|Overall Study||300
6735717|NCT03239873|7664951|FG000|Vaccination 1|Overall Study||299
6735718|NCT03239873|7664952|FG001|Vaccination 1|Overall Study||300
6735719|NCT03239873|7664951|FG000|Vaccination 2|Overall Study||276
6735720|NCT03239873|7664952|FG001|Vaccination 2|Overall Study||282
6735721|NCT03239873|7664951|FG000|COMPLETED|Overall Study||268
6735722|NCT03239873|7664952|FG001|COMPLETED|Overall Study||273
6735723|NCT03239873|7664951|FG000|NOT COMPLETED|Overall Study||32
6735724|NCT03239873|7664952|FG001|NOT COMPLETED|Overall Study||27
6735725|NCT03240081|7664960|FG000|STARTED|Overall Study||25
6735726|NCT03240081|7664961|FG001|STARTED|Overall Study||25
6735727|NCT03240081|7664960|FG000|COMPLETED|Overall Study||25
6735728|NCT03240081|7664961|FG001|COMPLETED|Overall Study||22
6735729|NCT03240081|7664960|FG000|NOT COMPLETED|Overall Study||0
6735730|NCT03240081|7664961|FG001|NOT COMPLETED|Overall Study||3
6735731|NCT03240133|7664970|FG000|STARTED|Overall Study||33
6735732|NCT03240133|7664971|FG001|STARTED|Overall Study||14
6735733|NCT03240133|7664972|FG002|STARTED|Overall Study||11
6735734|NCT03240133|7664970|FG000|Completed Period 1|Overall Study||33
6735735|NCT03240133|7664971|FG001|Completed Period 1|Overall Study||14
6735736|NCT03240133|7664972|FG002|Completed Period 1|Overall Study||11
6735737|NCT03240133|7664970|FG000|Completed Period 2|Overall Study||32
6735738|NCT03240133|7664971|FG001|Completed Period 2|Overall Study||11
6735739|NCT03240133|7664972|FG002|Completed Period 2|Overall Study||11
6735740|NCT03240133|7664970|FG000|Completed Period 3|Overall Study||30
6735741|NCT03240133|7664971|FG001|Completed Period 3|Overall Study||11
6735742|NCT03240133|7664972|FG002|Completed Period 3|Overall Study||11
6735743|NCT03240133|7664970|FG000|COMPLETED|Overall Study||30
6735744|NCT03240133|7664971|FG001|COMPLETED|Overall Study||11
6735745|NCT03240133|7664972|FG002|COMPLETED|Overall Study||10
6735746|NCT03240133|7664970|FG000|NOT COMPLETED|Overall Study||3
6735747|NCT03240133|7664971|FG001|NOT COMPLETED|Overall Study||3
6735748|NCT03240133|7664972|FG002|NOT COMPLETED|Overall Study||1
6740064|NCT03298412|7668905|FG000|STARTED|Treatment Period||1
6740065|NCT03298412|7668905|FG000|COMPLETED|Treatment Period||1
6740066|NCT03298412|7668905|FG000|NOT COMPLETED|Treatment Period||0
6740067|NCT03298841|7668911|FG000|STARTED|Overall Study||25
6740068|NCT03298841|7668912|FG001|STARTED|Overall Study||25
6740069|NCT03298841|7668911|FG000|COMPLETED|Overall Study||25
6740070|NCT03298841|7668912|FG001|COMPLETED|Overall Study||25
6740071|NCT03298841|7668911|FG000|NOT COMPLETED|Overall Study||0
6740072|NCT03298841|7668912|FG001|NOT COMPLETED|Overall Study||0
6740073|NCT03298880|7668919|FG000|STARTED|Overall Study||75
6740074|NCT03298880|7668919|FG000|COMPLETED|Overall Study||75
6740075|NCT03298880|7668919|FG000|NOT COMPLETED|Overall Study||0
6740076|NCT03299101|7668930|FG000|STARTED|Overall Study||35
6740077|NCT03299101|7668930|FG000|COMPLETED|Overall Study||25
6740078|NCT03299101|7668930|FG000|NOT COMPLETED|Overall Study||10
6740079|NCT03299244|7668936|FG000|STARTED|Overall Study||317
6740080|NCT03299244|7668937|FG001|STARTED|Overall Study||320
6740081|NCT03299244|7668936|FG000|Received Treatment|Overall Study||315
6740082|NCT03299244|7668937|FG001|Received Treatment|Overall Study||318
6740083|NCT03299244|7668936|FG000|COMPLETED|Overall Study||270
6740084|NCT03299244|7668937|FG001|COMPLETED|Overall Study||282
6740085|NCT03299244|7668936|FG000|NOT COMPLETED|Overall Study||47
6740086|NCT03299244|7668937|FG001|NOT COMPLETED|Overall Study||38
6740087|NCT03299686|7668946|FG000|STARTED|Treatment Epoch||70
6740088|NCT03299686|7668947|FG001|STARTED|Treatment Epoch||48
6740089|NCT03299686|7668946|FG000|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||69
6740090|NCT03299686|7668947|FG001|PD (Pharmacodynamics) Analysis Set|Treatment Epoch||48
6740091|NCT03299686|7668946|FG000|COMPLETED|Treatment Epoch||59
6740092|NCT03299686|7668947|FG001|COMPLETED|Treatment Epoch||44
6740093|NCT03299686|7668946|FG000|NOT COMPLETED|Treatment Epoch||11
6740094|NCT03299686|7668947|FG001|NOT COMPLETED|Treatment Epoch||4
6740095|NCT03299686|7668946|FG000|STARTED|Follow-up Epoch||59
6740096|NCT03299686|7668947|FG001|STARTED|Follow-up Epoch||44
6740097|NCT03299686|7668946|FG000|COMPLETED|Follow-up Epoch||59
6740098|NCT03299686|7668947|FG001|COMPLETED|Follow-up Epoch||43
6740099|NCT03299686|7668946|FG000|NOT COMPLETED|Follow-up Epoch||0
6740100|NCT03299686|7668947|FG001|NOT COMPLETED|Follow-up Epoch||1
6740101|NCT03299881|7668955|FG000|STARTED|Overall Study||39
6740102|NCT03299881|7668956|FG001|STARTED|Overall Study||38
6740103|NCT03299881|7668955|FG000|COMPLETED|Overall Study||22
6740104|NCT03299881|7668956|FG001|COMPLETED|Overall Study||25
6740105|NCT03299881|7668955|FG000|NOT COMPLETED|Overall Study||17
6740106|NCT03299881|7668956|FG001|NOT COMPLETED|Overall Study||13
6740107|NCT03300050|7668967|FG000|STARTED|Overall Study||20
6740108|NCT03300050|7668968|FG001|STARTED|Overall Study||15
6740109|NCT03300050|7668969|FG002|STARTED|Overall Study||5
6740110|NCT03300050|7668970|FG003|STARTED|Overall Study||16
6740111|NCT03300050|7668971|FG004|STARTED|Overall Study||10
6740112|NCT03300050|7668967|FG000|Received Treatment|Overall Study||19
6740113|NCT03300050|7668968|FG001|Received Treatment|Overall Study||14
6740114|NCT03300050|7668969|FG002|Received Treatment|Overall Study||3
6740115|NCT03300050|7668970|FG003|Received Treatment|Overall Study||15
6740116|NCT03300050|7668971|FG004|Received Treatment|Overall Study||10
6740117|NCT03300050|7668967|FG000|Received All Scheduled Treatments|Overall Study||16
6740118|NCT03300050|7668968|FG001|Received All Scheduled Treatments|Overall Study||13
6740119|NCT03300050|7668969|FG002|Received All Scheduled Treatments|Overall Study||2
6740120|NCT03300050|7668970|FG003|Received All Scheduled Treatments|Overall Study||15
6740121|NCT03300050|7668971|FG004|Received All Scheduled Treatments|Overall Study||10
6740122|NCT03300050|7668967|FG000|COMPLETED|Overall Study||17
6740123|NCT03300050|7668968|FG001|COMPLETED|Overall Study||13
6740124|NCT03300050|7668969|FG002|COMPLETED|Overall Study||2
6740125|NCT03300050|7668970|FG003|COMPLETED|Overall Study||15
6740126|NCT03300050|7668971|FG004|COMPLETED|Overall Study||9
6740127|NCT03300050|7668967|FG000|NOT COMPLETED|Overall Study||3
6740128|NCT03300050|7668968|FG001|NOT COMPLETED|Overall Study||2
6740129|NCT03300050|7668969|FG002|NOT COMPLETED|Overall Study||3
6740130|NCT03300050|7668970|FG003|NOT COMPLETED|Overall Study||1
6740131|NCT03300050|7668971|FG004|NOT COMPLETED|Overall Study||1
6740132|NCT03300466|7668985|FG000|STARTED|Overall Study||10
6740133|NCT03300466|7668986|FG001|STARTED|Overall Study||10
6740134|NCT03300466|7668985|FG000|COMPLETED|Overall Study||9
6740135|NCT03300466|7668986|FG001|COMPLETED|Overall Study||10
6740136|NCT03300466|7668985|FG000|NOT COMPLETED|Overall Study||1
6740137|NCT03300466|7668986|FG001|NOT COMPLETED|Overall Study||0
6740138|NCT03300570|7668994|FG000|STARTED|Overall Study||13
6740139|NCT03300570|7668995|FG001|STARTED|Overall Study||14
6740140|NCT03300570|7668994|FG000|COMPLETED|Overall Study||11
6740141|NCT03300570|7668995|FG001|COMPLETED|Overall Study||13
6740142|NCT03300570|7668994|FG000|NOT COMPLETED|Overall Study||2
6735749|NCT03240575|7665000|FG000|STARTED|Overall Study||146
6735750|NCT03240575|7665001|FG001|STARTED|Overall Study||145
6735751|NCT03240575|7665002|FG002|STARTED|Overall Study||6
6735752|NCT03240575|7665003|FG003|STARTED|Overall Study||5
6735753|NCT03240575|7665000|FG000|COMPLETED|Overall Study||144
6735754|NCT03240575|7665001|FG001|COMPLETED|Overall Study||131
6735755|NCT03240575|7665002|FG002|COMPLETED|Overall Study||6
6735756|NCT03240575|7665003|FG003|COMPLETED|Overall Study||3
6735757|NCT03240575|7665000|FG000|NOT COMPLETED|Overall Study||2
6735758|NCT03240575|7665001|FG001|NOT COMPLETED|Overall Study||14
6735759|NCT03240575|7665002|FG002|NOT COMPLETED|Overall Study||0
6735760|NCT03240575|7665003|FG003|NOT COMPLETED|Overall Study||2
6735761|NCT03241030|7665013|FG000|STARTED|Overall Study||50
6735762|NCT03241030|7665014|FG001|STARTED|Overall Study||52
6735763|NCT03241030|7665013|FG000|COMPLETED|Overall Study||49
6735764|NCT03241030|7665014|FG001|COMPLETED|Overall Study||51
6735765|NCT03241030|7665013|FG000|NOT COMPLETED|Overall Study||1
6735766|NCT03241030|7665014|FG001|NOT COMPLETED|Overall Study||1
6735767|NCT03241342|7665023|FG000|STARTED|Overall Study||163
6735768|NCT03241342|7665024|FG001|STARTED|Overall Study||163
6735769|NCT03241342|7665025|FG002|STARTED|Overall Study||165
6735770|NCT03241342|7665023|FG000|COMPLETED|Overall Study||141
6735771|NCT03241342|7665024|FG001|COMPLETED|Overall Study||132
6735772|NCT03241342|7665025|FG002|COMPLETED|Overall Study||138
6735773|NCT03241342|7665023|FG000|NOT COMPLETED|Overall Study||22
6735774|NCT03241342|7665024|FG001|NOT COMPLETED|Overall Study||31
6735775|NCT03241342|7665025|FG002|NOT COMPLETED|Overall Study||27
6735776|NCT03241368|7665033|FG000|STARTED|Overall Study||158
6735777|NCT03241368|7665033|FG000|COMPLETED|Overall Study||119
6735778|NCT03241368|7665033|FG000|NOT COMPLETED|Overall Study||39
6735779|NCT03241485|7665040|FG000|STARTED|Overall Study||42
6735780|NCT03241485|7665041|FG001|STARTED|Overall Study||37
6735781|NCT03241485|7665040|FG000|COMPLETED|Overall Study||37
6735782|NCT03241485|7665041|FG001|COMPLETED|Overall Study||33
6735783|NCT03241485|7665040|FG000|NOT COMPLETED|Overall Study||5
6735784|NCT03241485|7665041|FG001|NOT COMPLETED|Overall Study||4
6735785|NCT03241810|7665053|FG000|STARTED|Overall Study||11
6735786|NCT03241810|7665054|FG001|STARTED|Overall Study||11
6735787|NCT03241810|7665053|FG000|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
6735788|NCT03241810|7665054|FG001|COMPLETED|Overall Study|Safety population: includes patients receiving at least one dose of study medication.|11
6735789|NCT03241810|7665053|FG000|NOT COMPLETED|Overall Study||0
6735790|NCT03241810|7665054|FG001|NOT COMPLETED|Overall Study||0
6735791|NCT03241862|7665061|FG000|STARTED|Overall Study||20
6735792|NCT03241862|7665061|FG000|COMPLETED|Overall Study||20
6735793|NCT03241862|7665061|FG000|NOT COMPLETED|Overall Study||0
6735794|NCT03241927|7665065|FG000|STARTED|Overall Study||1
6735795|NCT03241927|7665066|FG001|STARTED|Overall Study||0
6735796|NCT03241927|7665065|FG000|COMPLETED|Overall Study||0
6735797|NCT03241927|7665066|FG001|COMPLETED|Overall Study||0
6735798|NCT03241927|7665065|FG000|NOT COMPLETED|Overall Study||1
6735799|NCT03241927|7665066|FG001|NOT COMPLETED|Overall Study||0
6735800|NCT03242018|7665075|FG000|STARTED|Overall Study||93
6735801|NCT03242018|7665076|FG001|STARTED|Overall Study||92
6735802|NCT03242018|7665077|FG002|STARTED|Overall Study||92
6735803|NCT03242018|7665075|FG000|COMPLETED|Overall Study||75
6735804|NCT03242018|7665076|FG001|COMPLETED|Overall Study||78
6735805|NCT03242018|7665077|FG002|COMPLETED|Overall Study||78
6735806|NCT03242018|7665075|FG000|NOT COMPLETED|Overall Study||18
6735807|NCT03242018|7665076|FG001|NOT COMPLETED|Overall Study||14
6735808|NCT03242018|7665077|FG002|NOT COMPLETED|Overall Study||14
6735809|NCT03242148|7665086|FG000|STARTED|Overall Study||38
6735810|NCT03242148|7665086|FG000|COMPLETED|Overall Study||38
6735811|NCT03242148|7665086|FG000|NOT COMPLETED|Overall Study||0
6735812|NCT03242252|7665093|FG000|STARTED|Overall Study||260
6735813|NCT03242252|7665094|FG001|STARTED|Overall Study||263
6735814|NCT03242252|7665095|FG002|STARTED|Overall Study||264
6735815|NCT03242252|7665093|FG000|COMPLETED|Overall Study||224
6735816|NCT03242252|7665094|FG001|COMPLETED|Overall Study||240
6735817|NCT03242252|7665095|FG002|COMPLETED|Overall Study||232
6735818|NCT03242252|7665093|FG000|NOT COMPLETED|Overall Study||36
6735819|NCT03242252|7665094|FG001|NOT COMPLETED|Overall Study||23
6735820|NCT03242252|7665095|FG002|NOT COMPLETED|Overall Study||32
6735821|NCT03242408|7665109|FG000|STARTED|Overall Study||100
6735822|NCT03242408|7665109|FG000|COMPLETED|Overall Study||98
6735823|NCT03242408|7665109|FG000|NOT COMPLETED|Overall Study||2
6735824|NCT03242434|7665115|FG000|STARTED|Overall Study||15
6735825|NCT03242434|7665116|FG001|STARTED|Overall Study||3
6735826|NCT03242434|7665115|FG000|COMPLETED|Overall Study||15
6735827|NCT03242434|7665116|FG001|COMPLETED|Overall Study||1
6735828|NCT03242434|7665115|FG000|NOT COMPLETED|Overall Study||0
6735829|NCT03242434|7665116|FG001|NOT COMPLETED|Overall Study||2
6735830|NCT03242590|7665123|FG000|STARTED|Overall Study||95
6735831|NCT03242590|7665123|FG000|COMPLETED|Overall Study||95
6735832|NCT03242590|7665123|FG000|NOT COMPLETED|Overall Study||0
6735833|NCT03242759|7665129|FG000|STARTED|Overall Study||88
6735834|NCT03242759|7665130|FG001|STARTED|Overall Study||13
6735835|NCT03242759|7665129|FG000|COMPLETED|Overall Study||53
6735836|NCT03242759|7665130|FG001|COMPLETED|Overall Study||6
6735837|NCT03242759|7665129|FG000|NOT COMPLETED|Overall Study||35
6735838|NCT03242759|7665130|FG001|NOT COMPLETED|Overall Study||7
6735839|NCT03242863|7665136|FG000|STARTED|Study Week 1||13
6735840|NCT03242863|7665137|FG001|STARTED|Study Week 1||16
6735841|NCT03242863|7665138|FG002|STARTED|Study Week 1||4
6735842|NCT03242863|7665139|FG003|STARTED|Study Week 1||4
6735843|NCT03242863|7665140|FG004|STARTED|Study Week 1||15
6735844|NCT03242863|7665141|FG005|STARTED|Study Week 1||5
6735845|NCT03242863|7665136|FG000|COMPLETED|Study Week 1||13
6735846|NCT03242863|7665137|FG001|COMPLETED|Study Week 1||15
6735847|NCT03242863|7665138|FG002|COMPLETED|Study Week 1||4
6735848|NCT03242863|7665139|FG003|COMPLETED|Study Week 1||4
6735849|NCT03242863|7665140|FG004|COMPLETED|Study Week 1||12
6735850|NCT03242863|7665141|FG005|COMPLETED|Study Week 1||5
6735851|NCT03242863|7665136|FG000|NOT COMPLETED|Study Week 1||0
6735852|NCT03242863|7665137|FG001|NOT COMPLETED|Study Week 1||1
6735853|NCT03242863|7665138|FG002|NOT COMPLETED|Study Week 1||0
6735854|NCT03242863|7665139|FG003|NOT COMPLETED|Study Week 1||0
6735855|NCT03242863|7665140|FG004|NOT COMPLETED|Study Week 1||3
6735856|NCT03242863|7665141|FG005|NOT COMPLETED|Study Week 1||0
6735857|NCT03242863|7665136|FG000|STARTED|Study Week 2||13
6735858|NCT03242863|7665137|FG001|STARTED|Study Week 2||15
6735859|NCT03242863|7665138|FG002|STARTED|Study Week 2||4
6735860|NCT03242863|7665139|FG003|STARTED|Study Week 2||4
6735861|NCT03242863|7665140|FG004|STARTED|Study Week 2||12
6735862|NCT03242863|7665141|FG005|STARTED|Study Week 2||5
6735863|NCT03242863|7665136|FG000|COMPLETED|Study Week 2||13
6735864|NCT03242863|7665137|FG001|COMPLETED|Study Week 2||15
6735865|NCT03242863|7665138|FG002|COMPLETED|Study Week 2||4
6735866|NCT03242863|7665139|FG003|COMPLETED|Study Week 2||4
6735867|NCT03242863|7665140|FG004|COMPLETED|Study Week 2||12
6735868|NCT03242863|7665141|FG005|COMPLETED|Study Week 2||5
6735869|NCT03242863|7665136|FG000|NOT COMPLETED|Study Week 2||0
6735870|NCT03242863|7665137|FG001|NOT COMPLETED|Study Week 2||0
6735871|NCT03242863|7665138|FG002|NOT COMPLETED|Study Week 2||0
6735872|NCT03242863|7665139|FG003|NOT COMPLETED|Study Week 2||0
6735873|NCT03242863|7665140|FG004|NOT COMPLETED|Study Week 2||0
6735874|NCT03242863|7665141|FG005|NOT COMPLETED|Study Week 2||0
6735875|NCT03242863|7665136|FG000|STARTED|Study Week 3||13
6735876|NCT03242863|7665137|FG001|STARTED|Study Week 3||15
6735877|NCT03242863|7665138|FG002|STARTED|Study Week 3||4
6735878|NCT03242863|7665139|FG003|STARTED|Study Week 3||4
6735879|NCT03242863|7665140|FG004|STARTED|Study Week 3||12
6735880|NCT03242863|7665141|FG005|STARTED|Study Week 3||5
6735881|NCT03242863|7665136|FG000|COMPLETED|Study Week 3||13
6735882|NCT03242863|7665137|FG001|COMPLETED|Study Week 3||15
6735883|NCT03242863|7665138|FG002|COMPLETED|Study Week 3||4
6735884|NCT03242863|7665139|FG003|COMPLETED|Study Week 3||4
6735885|NCT03242863|7665140|FG004|COMPLETED|Study Week 3||12
6735886|NCT03242863|7665141|FG005|COMPLETED|Study Week 3||5
6735887|NCT03242863|7665136|FG000|NOT COMPLETED|Study Week 3||0
6735888|NCT03242863|7665137|FG001|NOT COMPLETED|Study Week 3||0
6735889|NCT03242863|7665138|FG002|NOT COMPLETED|Study Week 3||0
6735890|NCT03242863|7665139|FG003|NOT COMPLETED|Study Week 3||0
6735891|NCT03242863|7665140|FG004|NOT COMPLETED|Study Week 3||0
6735892|NCT03242863|7665141|FG005|NOT COMPLETED|Study Week 3||0
6735893|NCT03242928|7665151|FG000|STARTED|Overall Study||31
6735894|NCT03242928|7665152|FG001|STARTED|Overall Study||37
6735895|NCT03242928|7665151|FG000|COMPLETED|Overall Study||22
6735896|NCT03242928|7665152|FG001|COMPLETED|Overall Study||32
6735897|NCT03242928|7665151|FG000|NOT COMPLETED|Overall Study||9
6735898|NCT03242928|7665152|FG001|NOT COMPLETED|Overall Study||5
6735899|NCT03242941|7665158|FG000|STARTED|Overall Study||16
6735900|NCT03242941|7665158|FG000|COMPLETED|Overall Study||14
6735901|NCT03242941|7665158|FG000|NOT COMPLETED|Overall Study||2
6735902|NCT03242954|7665167|FG000|STARTED|Overall Study||43
6735903|NCT03242954|7665168|FG001|STARTED|Overall Study||45
6735904|NCT03242954|7665169|FG002|STARTED|Overall Study||41
6735905|NCT03242954|7665170|FG003|STARTED|Overall Study||125
6735906|NCT03242954|7665167|FG000|COMPLETED|Overall Study||43
6735907|NCT03242954|7665168|FG001|COMPLETED|Overall Study||45
6735908|NCT03242954|7665169|FG002|COMPLETED|Overall Study||41
6735909|NCT03242954|7665170|FG003|COMPLETED|Overall Study||125
6735910|NCT03242954|7665167|FG000|NOT COMPLETED|Overall Study||0
6735911|NCT03242954|7665168|FG001|NOT COMPLETED|Overall Study||0
6735912|NCT03242954|7665169|FG002|NOT COMPLETED|Overall Study||0
6735913|NCT03242954|7665170|FG003|NOT COMPLETED|Overall Study||0
6735914|NCT03243084|7665182|FG000|STARTED|Session 1||11
6735915|NCT03243084|7665183|FG001|STARTED|Session 1||10
6735916|NCT03243084|7665182|FG000|COMPLETED|Session 1||11
6735917|NCT03243084|7665183|FG001|COMPLETED|Session 1||10
6735918|NCT03243084|7665182|FG000|NOT COMPLETED|Session 1||0
6735919|NCT03243084|7665183|FG001|NOT COMPLETED|Session 1||0
6735920|NCT03243084|7665182|FG000|STARTED|Washout (1-3 Weeks)||11
6735921|NCT03243084|7665183|FG001|STARTED|Washout (1-3 Weeks)||10
6735922|NCT03243084|7665182|FG000|COMPLETED|Washout (1-3 Weeks)||10
6735923|NCT03243084|7665183|FG001|COMPLETED|Washout (1-3 Weeks)||10
6735924|NCT03243084|7665182|FG000|NOT COMPLETED|Washout (1-3 Weeks)||1
6268233|NCT00064038|7167422|FG000|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
6268234|NCT00064038|7167423|FG001|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
6268235|NCT00064038|7167424|FG002|COMPLETED|Initial Randomization||0
6268236|NCT00064038|7167422|FG000|NOT COMPLETED|Initial Randomization||100
6268237|NCT00064038|7167423|FG001|NOT COMPLETED|Initial Randomization||98
6268238|NCT00064038|7167424|FG002|NOT COMPLETED|Initial Randomization||0
6268239|NCT00064038|7167422|FG000|STARTED|Crossover to Lenalidomide+Dexamethasone||0
6268240|NCT00064038|7167423|FG001|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
6268241|NCT00064038|7167424|FG002|STARTED|Crossover to Lenalidomide+Dexamethasone||42
6268242|NCT00064038|7167422|FG000|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
6268243|NCT00064038|7167423|FG001|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
6268244|NCT00064038|7167424|FG002|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
6268245|NCT00064038|7167422|FG000|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
6268246|NCT00064038|7167423|FG001|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
6268247|NCT00064038|7167424|FG002|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
6268248|NCT00064038|7167422|FG000|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
6268249|NCT00064038|7167423|FG001|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
6268250|NCT00064038|7167424|FG002|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
6268251|NCT00064038|7167422|FG000|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
6268252|NCT00064038|7167423|FG001|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
6268253|NCT00064038|7167424|FG002|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
6268254|NCT00064077|7167437|FG000|STARTED|Overall Study||118
6268255|NCT00064077|7167438|FG001|STARTED|Overall Study||117
6268256|NCT00064077|7167439|FG002|STARTED|Overall Study||119
6268257|NCT00064077|7167440|FG003|STARTED|Overall Study||118
6268258|NCT00064077|7167437|FG000|COMPLETED|Overall Study|Evaluable (treatment)|103
6268259|NCT00064077|7167438|FG001|COMPLETED|Overall Study|Evaluable (treatment)|108
6735925|NCT03243084|7665183|FG001|NOT COMPLETED|Washout (1-3 Weeks)||0
6735926|NCT03243084|7665182|FG000|STARTED|Session 2||10
6735927|NCT03243084|7665183|FG001|STARTED|Session 2||10
6735928|NCT03243084|7665182|FG000|COMPLETED|Session 2||10
6735929|NCT03243084|7665183|FG001|COMPLETED|Session 2||10
6735930|NCT03243084|7665182|FG000|NOT COMPLETED|Session 2||0
6735931|NCT03243084|7665183|FG001|NOT COMPLETED|Session 2||0
6735932|NCT03243305|7665190|FG000|STARTED|Overall Study||1384
6735933|NCT03243305|7665190|FG000|COMPLETED|Overall Study||449
6735934|NCT03243305|7665190|FG000|NOT COMPLETED|Overall Study||935
6735935|NCT03243630|7665194|FG000|STARTED|Overall Study||24
6735936|NCT03243630|7665194|FG000|Menthol E-liquid Saline|Overall Study||22
6735937|NCT03243630|7665194|FG000|Menthol E-liquid Higher|Overall Study||22
6735938|NCT03243630|7665194|FG000|Menthol E-liquid Lower|Overall Study||22
6735939|NCT03243630|7665194|FG000|Green Apple E-liquid Saline|Overall Study||20
6735940|NCT03243630|7665194|FG000|Green Apple E-liquid Higher|Overall Study||20
6735941|NCT03243630|7665194|FG000|Green Apple E-liquid Lower|Overall Study||20
6735942|NCT03243630|7665194|FG000|Green Apple and Menthol E-liquid Saline|Overall Study||21
6735943|NCT03243630|7665194|FG000|Green Apple and Menthol E-liquid Higher|Overall Study||21
6735944|NCT03243630|7665194|FG000|Green Apple and Menthol E-liquid Lower|Overall Study||21
6735945|NCT03243630|7665194|FG000|COMPLETED|Overall Study||22
6735946|NCT03243630|7665194|FG000|NOT COMPLETED|Overall Study||2
6735947|NCT03243981|7665202|FG000|STARTED|Overall Study||5
6735948|NCT03243981|7665202|FG000|COMPLETED|Overall Study||5
6735949|NCT03243981|7665202|FG000|NOT COMPLETED|Overall Study||0
6735950|NCT03244618|7665213|FG000|STARTED|Overall Study||132
6735951|NCT03244618|7665214|FG001|STARTED|Overall Study||131
6735952|NCT03244618|7665213|FG000|Week 2|Overall Study||128
6735953|NCT03244618|7665214|FG001|Week 2|Overall Study||125
6735954|NCT03244618|7665213|FG000|COMPLETED|Overall Study||125
6735955|NCT03244618|7665214|FG001|COMPLETED|Overall Study||122
6735956|NCT03244618|7665213|FG000|NOT COMPLETED|Overall Study||7
6735957|NCT03244618|7665214|FG001|NOT COMPLETED|Overall Study||9
6735958|NCT03244800|7665224|FG000|STARTED|Overall Study||13
6735959|NCT03244800|7665225|FG001|STARTED|Overall Study||26
6735960|NCT03244800|7665226|FG002|STARTED|Overall Study||6
6735961|NCT03244800|7665227|FG003|STARTED|Overall Study||20
6735962|NCT03244800|7665224|FG000|COMPLETED|Overall Study||13
6735963|NCT03244800|7665225|FG001|COMPLETED|Overall Study||25
6735964|NCT03244800|7665226|FG002|COMPLETED|Overall Study||6
6735965|NCT03244800|7665227|FG003|COMPLETED|Overall Study||18
6735966|NCT03244800|7665224|FG000|NOT COMPLETED|Overall Study||0
6735967|NCT03244800|7665225|FG001|NOT COMPLETED|Overall Study||1
6735968|NCT03244800|7665226|FG002|NOT COMPLETED|Overall Study||0
6735969|NCT03244800|7665227|FG003|NOT COMPLETED|Overall Study||2
6735970|NCT03244865|7665240|FG000|STARTED|Overall Study||35
6735971|NCT03244865|7665240|FG000|COMPLETED|Overall Study||35
6735972|NCT03244865|7665240|FG000|NOT COMPLETED|Overall Study||0
6735973|NCT03244917|7665246|FG000|STARTED|Overall Study||201
6735974|NCT03244917|7665247|FG001|STARTED|Overall Study||229
6735975|NCT03244917|7665246|FG000|COMPLETED|Overall Study||199
6735976|NCT03244917|7665247|FG001|COMPLETED|Overall Study||227
6735977|NCT03244917|7665246|FG000|NOT COMPLETED|Overall Study||2
6735978|NCT03244917|7665247|FG001|NOT COMPLETED|Overall Study||2
6735979|NCT03245372|7665255|FG000|STARTED|Overall Study||15
6735980|NCT03245372|7665256|FG001|STARTED|Overall Study||15
6735981|NCT03245372|7665255|FG000|COMPLETED|Overall Study||15
6735982|NCT03245372|7665256|FG001|COMPLETED|Overall Study||15
6735983|NCT03245372|7665255|FG000|NOT COMPLETED|Overall Study||0
6735984|NCT03245372|7665256|FG001|NOT COMPLETED|Overall Study||0
6735985|NCT03245398|7665264|FG000|STARTED|Overall Study||93
6735986|NCT03245398|7665265|FG001|STARTED|Overall Study||93
6735987|NCT03245398|7665264|FG000|COMPLETED|Overall Study||92
6735988|NCT03245398|7665265|FG001|COMPLETED|Overall Study||93
6735989|NCT03245398|7665264|FG000|NOT COMPLETED|Overall Study||1
6735990|NCT03245398|7665265|FG001|NOT COMPLETED|Overall Study||0
6735991|NCT03245463|7665275|FG000|STARTED|Overall Study||12
6735992|NCT03245463|7665276|FG001|STARTED|Overall Study||12
6735993|NCT03245463|7665275|FG000|COMPLETED|Overall Study||12
6735994|NCT03245463|7665276|FG001|COMPLETED|Overall Study||12
6735995|NCT03245463|7665275|FG000|NOT COMPLETED|Overall Study||0
6735996|NCT03245463|7665276|FG001|NOT COMPLETED|Overall Study||0
6735997|NCT03245619|7665299|FG000|STARTED|Part A (Up to Day 22)||5
6735998|NCT03245619|7665300|FG001|STARTED|Part A (Up to Day 22)||6
6735999|NCT03245619|7665301|FG002|STARTED|Part A (Up to Day 22)||6
6736000|NCT03245619|7665302|FG003|STARTED|Part A (Up to Day 22)||1
6736001|NCT03245619|7665303|FG004|STARTED|Part A (Up to Day 22)||0
6736002|NCT03245619|7665304|FG005|STARTED|Part A (Up to Day 22)||0
6736003|NCT03245619|7665305|FG006|STARTED|Part A (Up to Day 22)||0
6736004|NCT03245619|7665306|FG007|STARTED|Part A (Up to Day 22)||0
6736005|NCT03245619|7665307|FG008|STARTED|Part A (Up to Day 22)||0
6736006|NCT03245619|7665308|FG009|STARTED|Part A (Up to Day 22)||0
6736007|NCT03245619|7665309|FG010|STARTED|Part A (Up to Day 22)||0
6736008|NCT03245619|7665310|FG011|STARTED|Part A (Up to Day 22)||0
6736009|NCT03245619|7665311|FG012|STARTED|Part A (Up to Day 22)||0
6736010|NCT03245619|7665312|FG013|STARTED|Part A (Up to Day 22)||0
6736011|NCT03245619|7665313|FG014|STARTED|Part A (Up to Day 22)||0
6736012|NCT03245619|7665314|FG015|STARTED|Part A (Up to Day 22)||0
6736013|NCT03245619|7665315|FG016|STARTED|Part A (Up to Day 22)||0
6736014|NCT03245619|7665299|FG000|COMPLETED|Part A (Up to Day 22)||1
6736015|NCT03245619|7665300|FG001|COMPLETED|Part A (Up to Day 22)||0
6736016|NCT03245619|7665301|FG002|COMPLETED|Part A (Up to Day 22)||0
6736017|NCT03245619|7665302|FG003|COMPLETED|Part A (Up to Day 22)||1
6736018|NCT03245619|7665303|FG004|COMPLETED|Part A (Up to Day 22)||0
6736019|NCT03245619|7665304|FG005|COMPLETED|Part A (Up to Day 22)||0
6736020|NCT03245619|7665305|FG006|COMPLETED|Part A (Up to Day 22)||0
6736021|NCT03245619|7665306|FG007|COMPLETED|Part A (Up to Day 22)||0
6736022|NCT03245619|7665307|FG008|COMPLETED|Part A (Up to Day 22)||0
6736023|NCT03245619|7665308|FG009|COMPLETED|Part A (Up to Day 22)||0
6736024|NCT03245619|7665309|FG010|COMPLETED|Part A (Up to Day 22)||0
6736025|NCT03245619|7665310|FG011|COMPLETED|Part A (Up to Day 22)||0
6736026|NCT03245619|7665311|FG012|COMPLETED|Part A (Up to Day 22)||0
6736027|NCT03245619|7665312|FG013|COMPLETED|Part A (Up to Day 22)||0
6736028|NCT03245619|7665313|FG014|COMPLETED|Part A (Up to Day 22)||0
6736029|NCT03245619|7665314|FG015|COMPLETED|Part A (Up to Day 22)||0
6736030|NCT03245619|7665315|FG016|COMPLETED|Part A (Up to Day 22)||0
6736031|NCT03245619|7665299|FG000|NOT COMPLETED|Part A (Up to Day 22)||4
6736032|NCT03245619|7665300|FG001|NOT COMPLETED|Part A (Up to Day 22)||6
6736033|NCT03245619|7665301|FG002|NOT COMPLETED|Part A (Up to Day 22)||6
6736034|NCT03245619|7665302|FG003|NOT COMPLETED|Part A (Up to Day 22)||0
6736035|NCT03245619|7665303|FG004|NOT COMPLETED|Part A (Up to Day 22)||0
6736036|NCT03245619|7665304|FG005|NOT COMPLETED|Part A (Up to Day 22)||0
6736037|NCT03245619|7665305|FG006|NOT COMPLETED|Part A (Up to Day 22)||0
6736038|NCT03245619|7665306|FG007|NOT COMPLETED|Part A (Up to Day 22)||0
6736039|NCT03245619|7665307|FG008|NOT COMPLETED|Part A (Up to Day 22)||0
6736040|NCT03245619|7665308|FG009|NOT COMPLETED|Part A (Up to Day 22)||0
6736041|NCT03245619|7665309|FG010|NOT COMPLETED|Part A (Up to Day 22)||0
6736042|NCT03245619|7665310|FG011|NOT COMPLETED|Part A (Up to Day 22)||0
6736043|NCT03245619|7665311|FG012|NOT COMPLETED|Part A (Up to Day 22)||0
6736044|NCT03245619|7665312|FG013|NOT COMPLETED|Part A (Up to Day 22)||0
6736045|NCT03245619|7665313|FG014|NOT COMPLETED|Part A (Up to Day 22)||0
6736046|NCT03245619|7665314|FG015|NOT COMPLETED|Part A (Up to Day 22)||0
6736047|NCT03245619|7665315|FG016|NOT COMPLETED|Part A (Up to Day 22)||0
6736048|NCT03245619|7665299|FG000|STARTED|Part B (Up to 34 Days)||0
6736049|NCT03245619|7665300|FG001|STARTED|Part B (Up to 34 Days)||0
6736050|NCT03245619|7665301|FG002|STARTED|Part B (Up to 34 Days)||0
6736051|NCT03245619|7665302|FG003|STARTED|Part B (Up to 34 Days)||0
6736052|NCT03245619|7665303|FG004|STARTED|Part B (Up to 34 Days)||0
6736053|NCT03245619|7665304|FG005|STARTED|Part B (Up to 34 Days)||0
6736054|NCT03245619|7665305|FG006|STARTED|Part B (Up to 34 Days)||0
6736055|NCT03245619|7665306|FG007|STARTED|Part B (Up to 34 Days)||0
6736056|NCT03245619|7665307|FG008|STARTED|Part B (Up to 34 Days)||0
6736057|NCT03245619|7665308|FG009|STARTED|Part B (Up to 34 Days)||0
6736058|NCT03245619|7665309|FG010|STARTED|Part B (Up to 34 Days)||0
6736059|NCT03245619|7665310|FG011|STARTED|Part B (Up to 34 Days)||0
6736060|NCT03245619|7665311|FG012|STARTED|Part B (Up to 34 Days)||0
6736061|NCT03245619|7665312|FG013|STARTED|Part B (Up to 34 Days)||0
6736062|NCT03245619|7665313|FG014|STARTED|Part B (Up to 34 Days)||0
6736063|NCT03245619|7665314|FG015|STARTED|Part B (Up to 34 Days)||0
6736064|NCT03245619|7665315|FG016|STARTED|Part B (Up to 34 Days)||0
6736065|NCT03245619|7665299|FG000|COMPLETED|Part B (Up to 34 Days)||0
6736066|NCT03245619|7665300|FG001|COMPLETED|Part B (Up to 34 Days)||0
6736067|NCT03245619|7665301|FG002|COMPLETED|Part B (Up to 34 Days)||0
6736068|NCT03245619|7665302|FG003|COMPLETED|Part B (Up to 34 Days)||0
6736069|NCT03245619|7665303|FG004|COMPLETED|Part B (Up to 34 Days)||0
6736070|NCT03245619|7665304|FG005|COMPLETED|Part B (Up to 34 Days)||0
6736071|NCT03245619|7665305|FG006|COMPLETED|Part B (Up to 34 Days)||0
6736072|NCT03245619|7665306|FG007|COMPLETED|Part B (Up to 34 Days)||0
6736073|NCT03245619|7665307|FG008|COMPLETED|Part B (Up to 34 Days)||0
6736074|NCT03245619|7665308|FG009|COMPLETED|Part B (Up to 34 Days)||0
6736075|NCT03245619|7665309|FG010|COMPLETED|Part B (Up to 34 Days)||0
6736076|NCT03245619|7665310|FG011|COMPLETED|Part B (Up to 34 Days)||0
6736077|NCT03245619|7665311|FG012|COMPLETED|Part B (Up to 34 Days)||0
6736078|NCT03245619|7665312|FG013|COMPLETED|Part B (Up to 34 Days)||0
6736079|NCT03245619|7665313|FG014|COMPLETED|Part B (Up to 34 Days)||0
6736080|NCT03245619|7665314|FG015|COMPLETED|Part B (Up to 34 Days)||0
6736081|NCT03245619|7665315|FG016|COMPLETED|Part B (Up to 34 Days)||0
6736082|NCT03245619|7665299|FG000|NOT COMPLETED|Part B (Up to 34 Days)||0
6736083|NCT03245619|7665300|FG001|NOT COMPLETED|Part B (Up to 34 Days)||0
6736084|NCT03245619|7665301|FG002|NOT COMPLETED|Part B (Up to 34 Days)||0
6736085|NCT03245619|7665302|FG003|NOT COMPLETED|Part B (Up to 34 Days)||0
6736086|NCT03245619|7665303|FG004|NOT COMPLETED|Part B (Up to 34 Days)||0
6736087|NCT03245619|7665304|FG005|NOT COMPLETED|Part B (Up to 34 Days)||0
6736088|NCT03245619|7665305|FG006|NOT COMPLETED|Part B (Up to 34 Days)||0
6736089|NCT03245619|7665306|FG007|NOT COMPLETED|Part B (Up to 34 Days)||0
6736090|NCT03245619|7665307|FG008|NOT COMPLETED|Part B (Up to 34 Days)||0
6736091|NCT03245619|7665308|FG009|NOT COMPLETED|Part B (Up to 34 Days)||0
6736092|NCT03245619|7665309|FG010|NOT COMPLETED|Part B (Up to 34 Days)||0
6736093|NCT03245619|7665310|FG011|NOT COMPLETED|Part B (Up to 34 Days)||0
6736094|NCT03245619|7665311|FG012|NOT COMPLETED|Part B (Up to 34 Days)||0
6736095|NCT03245619|7665312|FG013|NOT COMPLETED|Part B (Up to 34 Days)||0
6736096|NCT03245619|7665313|FG014|NOT COMPLETED|Part B (Up to 34 Days)||0
6736097|NCT03245619|7665314|FG015|NOT COMPLETED|Part B (Up to 34 Days)||0
6736098|NCT03245619|7665315|FG016|NOT COMPLETED|Part B (Up to 34 Days)||0
6736099|NCT03245619|7665299|FG000|STARTED|Part C (Up to 34 Days)||0
6736100|NCT03245619|7665300|FG001|STARTED|Part C (Up to 34 Days)||0
6736101|NCT03245619|7665301|FG002|STARTED|Part C (Up to 34 Days)||0
6736102|NCT03245619|7665302|FG003|STARTED|Part C (Up to 34 Days)||0
6736103|NCT03245619|7665303|FG004|STARTED|Part C (Up to 34 Days)||0
6736104|NCT03245619|7665304|FG005|STARTED|Part C (Up to 34 Days)||0
6736105|NCT03245619|7665305|FG006|STARTED|Part C (Up to 34 Days)||0
6736106|NCT03245619|7665306|FG007|STARTED|Part C (Up to 34 Days)||0
6736107|NCT03245619|7665307|FG008|STARTED|Part C (Up to 34 Days)||0
6736108|NCT03245619|7665308|FG009|STARTED|Part C (Up to 34 Days)||0
6736109|NCT03245619|7665309|FG010|STARTED|Part C (Up to 34 Days)||0
6736110|NCT03245619|7665310|FG011|STARTED|Part C (Up to 34 Days)||0
6736111|NCT03245619|7665311|FG012|STARTED|Part C (Up to 34 Days)||0
6736112|NCT03245619|7665312|FG013|STARTED|Part C (Up to 34 Days)||0
6736113|NCT03245619|7665313|FG014|STARTED|Part C (Up to 34 Days)||0
6736114|NCT03245619|7665314|FG015|STARTED|Part C (Up to 34 Days)||0
6736115|NCT03245619|7665315|FG016|STARTED|Part C (Up to 34 Days)||0
6736116|NCT03245619|7665299|FG000|COMPLETED|Part C (Up to 34 Days)||0
6736117|NCT03245619|7665300|FG001|COMPLETED|Part C (Up to 34 Days)||0
6736118|NCT03245619|7665301|FG002|COMPLETED|Part C (Up to 34 Days)||0
6736119|NCT03245619|7665302|FG003|COMPLETED|Part C (Up to 34 Days)||0
6736120|NCT03245619|7665303|FG004|COMPLETED|Part C (Up to 34 Days)||0
6736121|NCT03245619|7665304|FG005|COMPLETED|Part C (Up to 34 Days)||0
6736122|NCT03245619|7665305|FG006|COMPLETED|Part C (Up to 34 Days)||0
6736123|NCT03245619|7665306|FG007|COMPLETED|Part C (Up to 34 Days)||0
6736124|NCT03245619|7665307|FG008|COMPLETED|Part C (Up to 34 Days)||0
6736125|NCT03245619|7665308|FG009|COMPLETED|Part C (Up to 34 Days)||0
6736126|NCT03245619|7665309|FG010|COMPLETED|Part C (Up to 34 Days)||0
6736127|NCT03245619|7665310|FG011|COMPLETED|Part C (Up to 34 Days)||0
6736128|NCT03245619|7665311|FG012|COMPLETED|Part C (Up to 34 Days)||0
6736129|NCT03245619|7665312|FG013|COMPLETED|Part C (Up to 34 Days)||0
6736130|NCT03245619|7665313|FG014|COMPLETED|Part C (Up to 34 Days)||0
6736131|NCT03245619|7665314|FG015|COMPLETED|Part C (Up to 34 Days)||0
6736132|NCT03245619|7665315|FG016|COMPLETED|Part C (Up to 34 Days)||0
6736133|NCT03245619|7665299|FG000|NOT COMPLETED|Part C (Up to 34 Days)||0
6736134|NCT03245619|7665300|FG001|NOT COMPLETED|Part C (Up to 34 Days)||0
6736135|NCT03245619|7665301|FG002|NOT COMPLETED|Part C (Up to 34 Days)||0
6736136|NCT03245619|7665302|FG003|NOT COMPLETED|Part C (Up to 34 Days)||0
6736137|NCT03245619|7665303|FG004|NOT COMPLETED|Part C (Up to 34 Days)||0
6736138|NCT03245619|7665304|FG005|NOT COMPLETED|Part C (Up to 34 Days)||0
6736139|NCT03245619|7665305|FG006|NOT COMPLETED|Part C (Up to 34 Days)||0
6736140|NCT03245619|7665306|FG007|NOT COMPLETED|Part C (Up to 34 Days)||0
6736141|NCT03245619|7665307|FG008|NOT COMPLETED|Part C (Up to 34 Days)||0
6736142|NCT03245619|7665308|FG009|NOT COMPLETED|Part C (Up to 34 Days)||0
6736143|NCT03245619|7665309|FG010|NOT COMPLETED|Part C (Up to 34 Days)||0
6736144|NCT03245619|7665310|FG011|NOT COMPLETED|Part C (Up to 34 Days)||0
6736145|NCT03245619|7665311|FG012|NOT COMPLETED|Part C (Up to 34 Days)||0
6736146|NCT03245619|7665312|FG013|NOT COMPLETED|Part C (Up to 34 Days)||0
6736147|NCT03245619|7665313|FG014|NOT COMPLETED|Part C (Up to 34 Days)||0
6736148|NCT03245619|7665314|FG015|NOT COMPLETED|Part C (Up to 34 Days)||0
6736149|NCT03245619|7665315|FG016|NOT COMPLETED|Part C (Up to 34 Days)||0
6736150|NCT03245723|7665376|FG000|STARTED|Overall Study||32
6736151|NCT03245723|7665377|FG001|STARTED|Overall Study||18
6736152|NCT03245723|7665376|FG000|COMPLETED|Overall Study||27
6736153|NCT03245723|7665377|FG001|COMPLETED|Overall Study||17
6736154|NCT03245723|7665376|FG000|NOT COMPLETED|Overall Study||5
6736155|NCT03245723|7665377|FG001|NOT COMPLETED|Overall Study||1
6736156|NCT03245736|7665383|FG000|STARTED|Overall Study||5
6736157|NCT03245736|7665383|FG000|COMPLETED|Overall Study||0
6736158|NCT03245736|7665383|FG000|NOT COMPLETED|Overall Study||5
6736159|NCT03245762|7665389|FG000|STARTED|Overall Study||10
6736160|NCT03245762|7665390|FG001|STARTED|Overall Study||5
6736161|NCT03245762|7665389|FG000|COMPLETED|Overall Study||10
6736162|NCT03245762|7665390|FG001|COMPLETED|Overall Study||5
6736163|NCT03245762|7665389|FG000|NOT COMPLETED|Overall Study||0
6736164|NCT03245762|7665390|FG001|NOT COMPLETED|Overall Study||0
6736165|NCT03246061|7665398|FG000|STARTED|Overall Study||66
6736166|NCT03246061|7665399|FG001|STARTED|Overall Study||74
6736167|NCT03246061|7665398|FG000|Interim Analysis|Overall Study||51
6736168|NCT03246061|7665399|FG001|Interim Analysis|Overall Study||53
6736169|NCT03246061|7665398|FG000|COMPLETED|Overall Study||51
6736170|NCT03246061|7665399|FG001|COMPLETED|Overall Study||53
6736171|NCT03246061|7665398|FG000|NOT COMPLETED|Overall Study||15
6736172|NCT03246061|7665399|FG001|NOT COMPLETED|Overall Study||21
6736173|NCT03246152|7665407|FG000|STARTED|Overall Study||31
6736174|NCT03246152|7665407|FG000|COMPLETED|Overall Study||28
6736175|NCT03246152|7665407|FG000|NOT COMPLETED|Overall Study||3
6736176|NCT03246646|7665413|FG000|STARTED|Overall Study||26
6736177|NCT03246646|7665414|FG001|STARTED|Overall Study||26
6736178|NCT03246646|7665413|FG000|COMPLETED|Overall Study|15 participants completed either 6-month or 12-month follow-up or both.|15
6736179|NCT03246646|7665414|FG001|COMPLETED|Overall Study|Follow-up was limited to chart follow-up in CIC services|26
6736180|NCT03246646|7665413|FG000|NOT COMPLETED|Overall Study||11
6736181|NCT03246646|7665414|FG001|NOT COMPLETED|Overall Study||0
6736182|NCT03246672|7665420|FG000|STARTED|Overall Study||30
6736183|NCT03246672|7665420|FG000|Completed First Phone Call|Overall Study||29
6736184|NCT03246672|7665420|FG000|COMPLETED|Overall Study||28
6736185|NCT03246672|7665420|FG000|NOT COMPLETED|Overall Study||2
6736186|NCT03246724|7665428|FG000|STARTED|Overall Study||99
6736187|NCT03246724|7665429|FG001|STARTED|Overall Study||91
6736188|NCT03246724|7665430|FG002|STARTED|Overall Study||85
6736189|NCT03246724|7665431|FG003|STARTED|Overall Study||52
6736190|NCT03246724|7665428|FG000|COMPLETED|Overall Study||85
6736191|NCT03246724|7665429|FG001|COMPLETED|Overall Study||84
6736192|NCT03246724|7665430|FG002|COMPLETED|Overall Study||70
6736193|NCT03246724|7665431|FG003|COMPLETED|Overall Study||44
6736194|NCT03246724|7665428|FG000|NOT COMPLETED|Overall Study||14
6736195|NCT03246724|7665429|FG001|NOT COMPLETED|Overall Study||7
6736196|NCT03246724|7665430|FG002|NOT COMPLETED|Overall Study||15
6736197|NCT03246724|7665431|FG003|NOT COMPLETED|Overall Study||8
6736198|NCT03247322|7665443|FG000|STARTED|Overall Study||68
6736199|NCT03247322|7665444|FG001|STARTED|Overall Study||68
6736200|NCT03247322|7665443|FG000|COMPLETED|Overall Study||66
6736201|NCT03247322|7665444|FG001|COMPLETED|Overall Study||68
6736202|NCT03247322|7665443|FG000|NOT COMPLETED|Overall Study||2
6736203|NCT03247322|7665444|FG001|NOT COMPLETED|Overall Study||0
6736204|NCT03247517|7665455|FG000|STARTED|Overall Study||104
6736205|NCT03247517|7665456|FG001|STARTED|Overall Study||98
6736206|NCT03247517|7665457|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received 200mg/day SPN-812 during the trial|106
6736207|NCT03247517|7665455|FG000|COMPLETED|Overall Study||96
6736208|NCT03247517|7665456|FG001|COMPLETED|Overall Study||78
6736209|NCT03247517|7665457|FG002|COMPLETED|Overall Study||92
6736210|NCT03247517|7665455|FG000|NOT COMPLETED|Overall Study||8
6736211|NCT03247517|7665456|FG001|NOT COMPLETED|Overall Study||20
6736212|NCT03247517|7665457|FG002|NOT COMPLETED|Overall Study||14
6736213|NCT03247530|7665468|FG000|STARTED|Overall Study||159
6736214|NCT03247530|7665469|FG001|STARTED|Overall Study||154
6736215|NCT03247530|7665470|FG002|STARTED|Overall Study||161
6736216|NCT03247530|7665468|FG000|COMPLETED|Overall Study||132
6736217|NCT03247530|7665469|FG001|COMPLETED|Overall Study||126
6736218|NCT03247530|7665470|FG002|COMPLETED|Overall Study||141
6736219|NCT03247530|7665468|FG000|NOT COMPLETED|Overall Study||27
6736220|NCT03247530|7665469|FG001|NOT COMPLETED|Overall Study||28
6736221|NCT03247530|7665470|FG002|NOT COMPLETED|Overall Study||20
6736222|NCT03247543|7665484|FG000|STARTED|Overall Study||102
6736223|NCT03247543|7665485|FG001|STARTED|Overall Study||107
6736224|NCT03247543|7665486|FG002|STARTED|Overall Study|One subject randomized to the 400mg/day SPN-812 arm received Placebo during the trial.|101
6736225|NCT03247543|7665484|FG000|COMPLETED|Overall Study||85
6736226|NCT03247543|7665485|FG001|COMPLETED|Overall Study||88
6736227|NCT03247543|7665486|FG002|COMPLETED|Overall Study||78
6736228|NCT03247543|7665484|FG000|NOT COMPLETED|Overall Study||17
6736229|NCT03247543|7665485|FG001|NOT COMPLETED|Overall Study||19
6736230|NCT03247543|7665486|FG002|NOT COMPLETED|Overall Study||23
6736231|NCT03247556|7665499|FG000|STARTED|Overall Study||97
6736232|NCT03247556|7665500|FG001|STARTED|Overall Study||100
6736233|NCT03247556|7665501|FG002|STARTED|Overall Study||99
6736234|NCT03247556|7665499|FG000|COMPLETED|Overall Study||85
6736235|NCT03247556|7665500|FG001|COMPLETED|Overall Study||88
6736236|NCT03247556|7665501|FG002|COMPLETED|Overall Study||81
6736237|NCT03247556|7665499|FG000|NOT COMPLETED|Overall Study||12
6736238|NCT03247556|7665500|FG001|NOT COMPLETED|Overall Study||12
6736239|NCT03247556|7665501|FG002|NOT COMPLETED|Overall Study||18
6736240|NCT03247673|7665512|FG000|STARTED|Overall Study||46
6736241|NCT03247673|7665513|FG001|STARTED|Overall Study||47
6736242|NCT03247673|7665514|FG002|STARTED|Overall Study||48
6736243|NCT03247673|7665512|FG000|COMPLETED|Overall Study||45
6736244|NCT03247673|7665513|FG001|COMPLETED|Overall Study||47
6736245|NCT03247673|7665514|FG002|COMPLETED|Overall Study||44
6736246|NCT03247673|7665512|FG000|NOT COMPLETED|Overall Study||1
6736247|NCT03247673|7665513|FG001|NOT COMPLETED|Overall Study||0
6736248|NCT03247673|7665514|FG002|NOT COMPLETED|Overall Study||4
6736249|NCT03247686|7665524|FG000|STARTED|Overall Study||8
6736250|NCT03247686|7665525|FG001|STARTED|Overall Study||20
6736251|NCT03247686|7665524|FG000|COMPLETED|Overall Study||7
6736252|NCT03247686|7665525|FG001|COMPLETED|Overall Study||18
6736253|NCT03247686|7665524|FG000|NOT COMPLETED|Overall Study||1
6736254|NCT03247686|7665525|FG001|NOT COMPLETED|Overall Study||2
6736255|NCT03247738|7665536|FG000|STARTED|Overall Study||25
6736256|NCT03247738|7665537|FG001|STARTED|Overall Study||25
6736257|NCT03247738|7665536|FG000|COMPLETED|Overall Study||25
6736258|NCT03247738|7665537|FG001|COMPLETED|Overall Study||25
6736259|NCT03247738|7665536|FG000|NOT COMPLETED|Overall Study||0
6736260|NCT03247738|7665537|FG001|NOT COMPLETED|Overall Study||0
6736261|NCT03247790|7665543|FG000|STARTED|Period 1: Migraine Attack||16
6736262|NCT03247790|7665543|FG000|Received at Least One Dose of Study Drug|Period 1: Migraine Attack||16
6736263|NCT03247790|7665543|FG000|COMPLETED|Period 1: Migraine Attack||16
6736264|NCT03247790|7665543|FG000|NOT COMPLETED|Period 1: Migraine Attack||0
6736265|NCT03247790|7665543|FG000|STARTED|Period 2: Inter-ictal Period||16
6736266|NCT03247790|7665543|FG000|COMPLETED|Period 2: Inter-ictal Period||16
6736267|NCT03247790|7665543|FG000|NOT COMPLETED|Period 2: Inter-ictal Period||0
6736268|NCT03247816|7665549|FG000|STARTED|Overall Study||59
6736269|NCT03247816|7665549|FG000|COMPLETED|Overall Study||30
6736270|NCT03247816|7665549|FG000|NOT COMPLETED|Overall Study||29
6736271|NCT03247985|7665557|FG000|STARTED|Overall Study||19
6736272|NCT03247985|7665558|FG001|STARTED|Overall Study||19
6736273|NCT03247985|7665557|FG000|COMPLETED|Overall Study||19
6736274|NCT03247985|7665558|FG001|COMPLETED|Overall Study||19
6736275|NCT03247985|7665557|FG000|NOT COMPLETED|Overall Study||0
6736276|NCT03247985|7665558|FG001|NOT COMPLETED|Overall Study||0
6736277|NCT03248037|7665566|FG000|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|95
6736278|NCT03248037|7665567|FG001|STARTED|Overall Study|Fellow eyes could be enrolled and were automatically assigned to the opposite treatment arm.|96
6736279|NCT03248037|7665566|FG000|COMPLETED|Overall Study||74
6736280|NCT03248037|7665567|FG001|COMPLETED|Overall Study||87
6736281|NCT03248037|7665566|FG000|NOT COMPLETED|Overall Study||21
6736282|NCT03248037|7665567|FG001|NOT COMPLETED|Overall Study||9
6736283|NCT03248440|7665575|FG000|STARTED|Overall Study||131
6736284|NCT03248440|7665576|FG001|STARTED|Overall Study||132
6736285|NCT03248440|7665575|FG000|COMPLETED|Overall Study||116
6736286|NCT03248440|7665576|FG001|COMPLETED|Overall Study||120
6736287|NCT03248440|7665575|FG000|NOT COMPLETED|Overall Study||15
6736288|NCT03248440|7665576|FG001|NOT COMPLETED|Overall Study||12
6736289|NCT03248492|7665587|FG000|STARTED|Overall Study||50
6736290|NCT03248492|7665588|FG001|STARTED|Overall Study||48
6736291|NCT03248492|7665589|FG002|STARTED|Overall Study||21
6736292|NCT03248492|7665590|FG003|STARTED|Overall Study||130
6736293|NCT03248492|7665591|FG004|STARTED|Overall Study||4
6736294|NCT03248492|7665587|FG000|COMPLETED|Overall Study||0
6736295|NCT03248492|7665588|FG001|COMPLETED|Overall Study||0
6736296|NCT03248492|7665589|FG002|COMPLETED|Overall Study||0
6736297|NCT03248492|7665590|FG003|COMPLETED|Overall Study||0
6736298|NCT03248492|7665591|FG004|COMPLETED|Overall Study||0
6736299|NCT03248492|7665587|FG000|NOT COMPLETED|Overall Study||50
6736300|NCT03248492|7665588|FG001|NOT COMPLETED|Overall Study||48
6736301|NCT03248492|7665589|FG002|NOT COMPLETED|Overall Study||21
6736302|NCT03248492|7665590|FG003|NOT COMPLETED|Overall Study||130
6736303|NCT03248492|7665591|FG004|NOT COMPLETED|Overall Study||4
6736304|NCT03248882|7665616|FG000|STARTED|Overall Study||61
6736305|NCT03248882|7665617|FG001|STARTED|Overall Study||63
6736306|NCT03248882|7665618|FG002|STARTED|Overall Study||62
6736307|NCT03248882|7665619|FG003|STARTED|Overall Study||58
6736308|NCT03248882|7665620|FG004|STARTED|Overall Study||61
6736309|NCT03248882|7665616|FG000|Received Treatment|Overall Study||61
6736310|NCT03248882|7665617|FG001|Received Treatment|Overall Study||63
6736311|NCT03248882|7665618|FG002|Received Treatment|Overall Study||62
6736312|NCT03248882|7665619|FG003|Received Treatment|Overall Study||58
6736313|NCT03248882|7665620|FG004|Received Treatment|Overall Study||61
6736314|NCT03248882|7665616|FG000|COMPLETED|Overall Study||54
6736315|NCT03248882|7665617|FG001|COMPLETED|Overall Study||58
6736316|NCT03248882|7665618|FG002|COMPLETED|Overall Study||55
6736317|NCT03248882|7665619|FG003|COMPLETED|Overall Study||48
6736318|NCT03248882|7665620|FG004|COMPLETED|Overall Study||48
6736319|NCT03248882|7665616|FG000|NOT COMPLETED|Overall Study||7
6736320|NCT03248882|7665617|FG001|NOT COMPLETED|Overall Study||5
6736321|NCT03248882|7665618|FG002|NOT COMPLETED|Overall Study||7
6736322|NCT03248882|7665619|FG003|NOT COMPLETED|Overall Study||10
6736323|NCT03248882|7665620|FG004|NOT COMPLETED|Overall Study||13
6736324|NCT03248947|7665632|FG000|STARTED|Overall Study||71
6736325|NCT03248947|7665632|FG000|COMPLETED|Overall Study||63
6736326|NCT03248947|7665632|FG000|NOT COMPLETED|Overall Study||8
6736327|NCT03249116|7665643|FG000|STARTED|Overall Study||25
6736328|NCT03249116|7665644|FG001|STARTED|Overall Study||25
6736329|NCT03249116|7665645|FG002|STARTED|Overall Study||25
6736330|NCT03249116|7665643|FG000|COMPLETED|Overall Study||25
6736331|NCT03249116|7665644|FG001|COMPLETED|Overall Study||25
6736332|NCT03249116|7665645|FG002|COMPLETED|Overall Study||25
6736333|NCT03249116|7665643|FG000|NOT COMPLETED|Overall Study||0
6736334|NCT03249116|7665644|FG001|NOT COMPLETED|Overall Study||0
6736335|NCT03249116|7665645|FG002|NOT COMPLETED|Overall Study||0
6736336|NCT03249272|7665657|FG000|STARTED|Overall Study||19
6736337|NCT03249272|7665658|FG001|STARTED|Overall Study||6
6736338|NCT03249272|7665659|FG002|STARTED|Overall Study||6
6736339|NCT03249272|7665657|FG000|COMPLETED|Overall Study||19
6736340|NCT03249272|7665658|FG001|COMPLETED|Overall Study||6
6736341|NCT03249272|7665659|FG002|COMPLETED|Overall Study||6
6736342|NCT03249272|7665657|FG000|NOT COMPLETED|Overall Study||0
6736343|NCT03249272|7665658|FG001|NOT COMPLETED|Overall Study||0
6736344|NCT03249272|7665659|FG002|NOT COMPLETED|Overall Study||0
6736345|NCT03249454|7665679|FG000|STARTED|Overall Study||1
6736346|NCT03249454|7665680|FG001|STARTED|Overall Study||1
6736347|NCT03249454|7665681|FG002|STARTED|Overall Study||2
6736348|NCT03249454|7665682|FG003|STARTED|Overall Study||1
6736349|NCT03249454|7665683|FG004|STARTED|Overall Study||1
6736350|NCT03249454|7665684|FG005|STARTED|Overall Study||2
6736351|NCT03249454|7665685|FG006|STARTED|Overall Study||1
6736352|NCT03249454|7665686|FG007|STARTED|Overall Study||1
6736353|NCT03249454|7665687|FG008|STARTED|Overall Study||1
6736354|NCT03249454|7665688|FG009|STARTED|Overall Study||1
6736355|NCT03249454|7665689|FG010|STARTED|Overall Study||1
6736356|NCT03249454|7665679|FG000|First Intervention (1 Day)|Overall Study||1
6736357|NCT03249454|7665680|FG001|First Intervention (1 Day)|Overall Study||1
6736358|NCT03249454|7665681|FG002|First Intervention (1 Day)|Overall Study||2
6736359|NCT03249454|7665682|FG003|First Intervention (1 Day)|Overall Study||1
6736360|NCT03249454|7665683|FG004|First Intervention (1 Day)|Overall Study||1
6736361|NCT03249454|7665684|FG005|First Intervention (1 Day)|Overall Study||2
6736362|NCT03249454|7665685|FG006|First Intervention (1 Day)|Overall Study||1
6736363|NCT03249454|7665686|FG007|First Intervention (1 Day)|Overall Study||1
6736364|NCT03249454|7665687|FG008|First Intervention (1 Day)|Overall Study||1
6736365|NCT03249454|7665688|FG009|First Intervention (1 Day)|Overall Study||0
6736366|NCT03249454|7665689|FG010|First Intervention (1 Day)|Overall Study||0
6736367|NCT03249454|7665679|FG000|Washout (1 Week)|Overall Study||1
6736368|NCT03249454|7665680|FG001|Washout (1 Week)|Overall Study||1
6736369|NCT03249454|7665681|FG002|Washout (1 Week)|Overall Study||2
6736370|NCT03249454|7665682|FG003|Washout (1 Week)|Overall Study||1
6736371|NCT03249454|7665683|FG004|Washout (1 Week)|Overall Study||1
6736372|NCT03249454|7665684|FG005|Washout (1 Week)|Overall Study||2
6736373|NCT03249454|7665685|FG006|Washout (1 Week)|Overall Study||1
6736374|NCT03249454|7665686|FG007|Washout (1 Week)|Overall Study||1
6736375|NCT03249454|7665687|FG008|Washout (1 Week)|Overall Study||1
6736376|NCT03249454|7665688|FG009|Washout (1 Week)|Overall Study||0
6736377|NCT03249454|7665689|FG010|Washout (1 Week)|Overall Study||0
6736378|NCT03249454|7665679|FG000|Second Intervention (1 Day)|Overall Study||1
6736379|NCT03249454|7665680|FG001|Second Intervention (1 Day)|Overall Study||1
6736380|NCT03249454|7665681|FG002|Second Intervention (1 Day)|Overall Study||2
6736381|NCT03249454|7665682|FG003|Second Intervention (1 Day)|Overall Study||1
6736382|NCT03249454|7665683|FG004|Second Intervention (1 Day)|Overall Study||1
6736383|NCT03249454|7665684|FG005|Second Intervention (1 Day)|Overall Study||2
6736384|NCT03249454|7665685|FG006|Second Intervention (1 Day)|Overall Study||1
6736385|NCT03249454|7665686|FG007|Second Intervention (1 Day)|Overall Study||1
6736386|NCT03249454|7665687|FG008|Second Intervention (1 Day)|Overall Study||1
6736387|NCT03249454|7665688|FG009|Second Intervention (1 Day)|Overall Study||0
6736388|NCT03249454|7665689|FG010|Second Intervention (1 Day)|Overall Study||0
6736389|NCT03249454|7665679|FG000|Washout (1 Week)|Overall Study||1
6736390|NCT03249454|7665680|FG001|Washout (1 Week)|Overall Study||1
6736391|NCT03249454|7665681|FG002|Washout (1 Week)|Overall Study||2
6736392|NCT03249454|7665682|FG003|Washout (1 Week)|Overall Study||1
6736393|NCT03249454|7665683|FG004|Washout (1 Week)|Overall Study||1
6736394|NCT03249454|7665684|FG005|Washout (1 Week)|Overall Study||2
6736395|NCT03249454|7665685|FG006|Washout (1 Week)|Overall Study||1
6736396|NCT03249454|7665686|FG007|Washout (1 Week)|Overall Study||1
6736397|NCT03249454|7665687|FG008|Washout (1 Week)|Overall Study||1
6736398|NCT03249454|7665688|FG009|Washout (1 Week)|Overall Study||0
6736399|NCT03249454|7665689|FG010|Washout (1 Week)|Overall Study||0
6736400|NCT03249454|7665679|FG000|Third Intervention (1 Day)|Overall Study||1
6736401|NCT03249454|7665680|FG001|Third Intervention (1 Day)|Overall Study||1
6736402|NCT03249454|7665681|FG002|Third Intervention (1 Day)|Overall Study||2
6736403|NCT03249454|7665682|FG003|Third Intervention (1 Day)|Overall Study||1
6736404|NCT03249454|7665683|FG004|Third Intervention (1 Day)|Overall Study||1
6736405|NCT03249454|7665684|FG005|Third Intervention (1 Day)|Overall Study||2
6736406|NCT03249454|7665685|FG006|Third Intervention (1 Day)|Overall Study||1
6736407|NCT03249454|7665686|FG007|Third Intervention (1 Day)|Overall Study||1
6736408|NCT03249454|7665687|FG008|Third Intervention (1 Day)|Overall Study||1
6736409|NCT03249454|7665688|FG009|Third Intervention (1 Day)|Overall Study||0
6736410|NCT03249454|7665689|FG010|Third Intervention (1 Day)|Overall Study||0
6736411|NCT03249454|7665679|FG000|Washout (1 Week)|Overall Study||1
6736412|NCT03249454|7665680|FG001|Washout (1 Week)|Overall Study||1
6736413|NCT03249454|7665681|FG002|Washout (1 Week)|Overall Study||2
6736414|NCT03249454|7665682|FG003|Washout (1 Week)|Overall Study||1
6736415|NCT03249454|7665683|FG004|Washout (1 Week)|Overall Study||1
6736416|NCT03249454|7665684|FG005|Washout (1 Week)|Overall Study||2
6736417|NCT03249454|7665685|FG006|Washout (1 Week)|Overall Study||1
6736418|NCT03249454|7665686|FG007|Washout (1 Week)|Overall Study||1
6736419|NCT03249454|7665687|FG008|Washout (1 Week)|Overall Study||1
6736420|NCT03249454|7665688|FG009|Washout (1 Week)|Overall Study||0
6736421|NCT03249454|7665689|FG010|Washout (1 Week)|Overall Study||0
6736422|NCT03249454|7665679|FG000|Fourth Intervention (1 Day)|Overall Study||1
6736423|NCT03249454|7665680|FG001|Fourth Intervention (1 Day)|Overall Study||1
6736424|NCT03249454|7665681|FG002|Fourth Intervention (1 Day)|Overall Study||2
6736425|NCT03249454|7665682|FG003|Fourth Intervention (1 Day)|Overall Study||1
6736426|NCT03249454|7665683|FG004|Fourth Intervention (1 Day)|Overall Study||1
6736427|NCT03249454|7665684|FG005|Fourth Intervention (1 Day)|Overall Study||2
6736428|NCT03249454|7665685|FG006|Fourth Intervention (1 Day)|Overall Study||1
6736429|NCT03249454|7665686|FG007|Fourth Intervention (1 Day)|Overall Study||1
6736430|NCT03249454|7665687|FG008|Fourth Intervention (1 Day)|Overall Study||1
6736431|NCT03249454|7665688|FG009|Fourth Intervention (1 Day)|Overall Study||0
6736432|NCT03249454|7665689|FG010|Fourth Intervention (1 Day)|Overall Study||0
6736433|NCT03249454|7665679|FG000|Washout (1 Week)|Overall Study||1
6736434|NCT03249454|7665680|FG001|Washout (1 Week)|Overall Study||1
6736435|NCT03249454|7665681|FG002|Washout (1 Week)|Overall Study||2
6736436|NCT03249454|7665682|FG003|Washout (1 Week)|Overall Study||1
6736437|NCT03249454|7665683|FG004|Washout (1 Week)|Overall Study||1
6736438|NCT03249454|7665684|FG005|Washout (1 Week)|Overall Study||2
6736439|NCT03249454|7665685|FG006|Washout (1 Week)|Overall Study||1
6736440|NCT03249454|7665686|FG007|Washout (1 Week)|Overall Study||1
6736441|NCT03249454|7665687|FG008|Washout (1 Week)|Overall Study||1
6736442|NCT03249454|7665688|FG009|Washout (1 Week)|Overall Study||0
6736443|NCT03249454|7665689|FG010|Washout (1 Week)|Overall Study||0
6736444|NCT03249454|7665679|FG000|Fifth Intervention (1 Day)|Overall Study||1
6736445|NCT03249454|7665680|FG001|Fifth Intervention (1 Day)|Overall Study||1
6736446|NCT03249454|7665681|FG002|Fifth Intervention (1 Day)|Overall Study||2
6736447|NCT03249454|7665682|FG003|Fifth Intervention (1 Day)|Overall Study||1
6736448|NCT03249454|7665683|FG004|Fifth Intervention (1 Day)|Overall Study||1
6736449|NCT03249454|7665684|FG005|Fifth Intervention (1 Day)|Overall Study||2
6736450|NCT03249454|7665685|FG006|Fifth Intervention (1 Day)|Overall Study||1
6736451|NCT03249454|7665686|FG007|Fifth Intervention (1 Day)|Overall Study||1
6736452|NCT03249454|7665687|FG008|Fifth Intervention (1 Day)|Overall Study||1
6736453|NCT03249454|7665688|FG009|Fifth Intervention (1 Day)|Overall Study||0
6736454|NCT03249454|7665689|FG010|Fifth Intervention (1 Day)|Overall Study||0
6736455|NCT03249454|7665679|FG000|COMPLETED|Overall Study||1
6736456|NCT03249454|7665680|FG001|COMPLETED|Overall Study||1
6736457|NCT03249454|7665681|FG002|COMPLETED|Overall Study||2
6736458|NCT03249454|7665682|FG003|COMPLETED|Overall Study||1
6736459|NCT03249454|7665683|FG004|COMPLETED|Overall Study||1
6736460|NCT03249454|7665684|FG005|COMPLETED|Overall Study||2
6736461|NCT03249454|7665685|FG006|COMPLETED|Overall Study||1
6736462|NCT03249454|7665686|FG007|COMPLETED|Overall Study||1
6736463|NCT03249454|7665687|FG008|COMPLETED|Overall Study||1
6736464|NCT03249454|7665688|FG009|COMPLETED|Overall Study||0
6736465|NCT03249454|7665689|FG010|COMPLETED|Overall Study||0
6736466|NCT03249454|7665679|FG000|NOT COMPLETED|Overall Study||0
6736467|NCT03249454|7665680|FG001|NOT COMPLETED|Overall Study||0
6736468|NCT03249454|7665681|FG002|NOT COMPLETED|Overall Study||0
6736469|NCT03249454|7665682|FG003|NOT COMPLETED|Overall Study||0
6736470|NCT03249454|7665683|FG004|NOT COMPLETED|Overall Study||0
6736471|NCT03249454|7665684|FG005|NOT COMPLETED|Overall Study||0
6736472|NCT03249454|7665685|FG006|NOT COMPLETED|Overall Study||0
6736473|NCT03249454|7665686|FG007|NOT COMPLETED|Overall Study||0
6736474|NCT03249454|7665687|FG008|NOT COMPLETED|Overall Study||0
6736475|NCT03249454|7665688|FG009|NOT COMPLETED|Overall Study||1
6736476|NCT03249454|7665689|FG010|NOT COMPLETED|Overall Study||1
6736477|NCT03249584|7665702|FG000|STARTED|Overall Study||184
6736478|NCT03249584|7665703|FG001|STARTED|Overall Study||22
6736479|NCT03249584|7665702|FG000|Month 3|Overall Study||132
6736480|NCT03249584|7665703|FG001|Month 3|Overall Study||15
6736481|NCT03249584|7665702|FG000|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the primary objective included the first 42 Thoracic/Lumbar RF Ablation subjects to complete Month 3.|42
6736482|NCT03249584|7665703|FG001|Month 3 Primary/Secondary Objectives|Overall Study|As prespecified, the secondary objective included all Periacetabulum/Iliac Crest/Sacrum RF Ablation subjects.|15
6736483|NCT03249584|7665702|FG000|Month 6|Overall Study||101
6736484|NCT03249584|7665703|FG001|Month 6|Overall Study||13
6736485|NCT03249584|7665702|FG000|COMPLETED|Overall Study||51
6736486|NCT03249584|7665703|FG001|COMPLETED|Overall Study||8
6736487|NCT03249584|7665702|FG000|NOT COMPLETED|Overall Study||133
6736488|NCT03249584|7665703|FG001|NOT COMPLETED|Overall Study||14
6736489|NCT03249779|7665708|FG000|STARTED|Overall Study||8
6736490|NCT03249779|7665708|FG000|COMPLETED|Overall Study||8
6736491|NCT03249779|7665708|FG000|NOT COMPLETED|Overall Study||0
6736492|NCT03249909|7665715|FG000|STARTED|Overall Study||78
6736493|NCT03249909|7665716|FG001|STARTED|Overall Study||15
6736494|NCT03249909|7665717|FG002|STARTED|Overall Study||16
6736495|NCT03249909|7665715|FG000|COMPLETED|Overall Study||72
6736496|NCT03249909|7665716|FG001|COMPLETED|Overall Study||14
6736497|NCT03249909|7665717|FG002|COMPLETED|Overall Study||16
6736498|NCT03249909|7665715|FG000|NOT COMPLETED|Overall Study||6
6736499|NCT03249909|7665716|FG001|NOT COMPLETED|Overall Study||1
6736500|NCT03249909|7665717|FG002|NOT COMPLETED|Overall Study||0
6736501|NCT03249935|7665728|FG000|STARTED|Overall Study||100
6736502|NCT03249935|7665728|FG000|COMPLETED|Overall Study||55
6736503|NCT03249935|7665728|FG000|NOT COMPLETED|Overall Study||45
6736504|NCT03250182|7665734|FG000|STARTED|Overall Study||30
6736505|NCT03250182|7665734|FG000|COMPLETED|Overall Study||29
6736506|NCT03250182|7665734|FG000|NOT COMPLETED|Overall Study||1
6736507|NCT03250234|7665740|FG000|STARTED|Overall Study||6
6736508|NCT03250234|7665741|FG001|STARTED|Overall Study||6
6736509|NCT03250234|7665740|FG000|COMPLETED|Overall Study||6
6736510|NCT03250234|7665741|FG001|COMPLETED|Overall Study||6
6736511|NCT03250234|7665740|FG000|NOT COMPLETED|Overall Study||0
6736512|NCT03250234|7665741|FG001|NOT COMPLETED|Overall Study||0
6736513|NCT03250689|7665749|FG000|STARTED|Overall Study||5
6736514|NCT03250689|7665750|FG001|STARTED|Overall Study||14
6736515|NCT03250689|7665749|FG000|COMPLETED|Overall Study||5
6736516|NCT03250689|7665750|FG001|COMPLETED|Overall Study||14
6736517|NCT03250689|7665749|FG000|NOT COMPLETED|Overall Study||0
6736518|NCT03250689|7665750|FG001|NOT COMPLETED|Overall Study||0
6736519|NCT03250845|7665757|FG000|STARTED|Multigam 5% Infusion (Baseline)||30
6736520|NCT03250845|7665757|FG000|COMPLETED|Multigam 5% Infusion (Baseline)||30
6736521|NCT03250845|7665757|FG000|NOT COMPLETED|Multigam 5% Infusion (Baseline)||0
6736522|NCT03250845|7665757|FG000|STARTED|Multigam 10% Infusion (3-4 Weeks Later)||30
6736523|NCT03250845|7665757|FG000|COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||30
6736524|NCT03250845|7665757|FG000|NOT COMPLETED|Multigam 10% Infusion (3-4 Weeks Later)||0
6736525|NCT03251482|7665768|FG000|STARTED|Overall Study||39
6736526|NCT03251482|7665769|FG001|STARTED|Overall Study||41
6736527|NCT03251482|7665770|FG002|STARTED|Overall Study||43
6736528|NCT03251482|7665771|FG003|STARTED|Overall Study||122
6736529|NCT03251482|7665772|FG004|STARTED|Overall Study||63
6736530|NCT03251482|7665768|FG000|Treated|Overall Study||38
6736531|NCT03251482|7665769|FG001|Treated|Overall Study||40
6736532|NCT03251482|7665770|FG002|Treated|Overall Study||42
6736533|NCT03251482|7665771|FG003|Treated|Overall Study||122
6736534|NCT03251482|7665772|FG004|Treated|Overall Study||63
6736535|NCT03251482|7665768|FG000|COMPLETED|Overall Study||39
6736536|NCT03251482|7665769|FG001|COMPLETED|Overall Study||40
6736537|NCT03251482|7665770|FG002|COMPLETED|Overall Study||43
6736538|NCT03251482|7665771|FG003|COMPLETED|Overall Study||122
6736539|NCT03251482|7665772|FG004|COMPLETED|Overall Study||63
6736540|NCT03251482|7665768|FG000|NOT COMPLETED|Overall Study||0
6736541|NCT03251482|7665769|FG001|NOT COMPLETED|Overall Study||1
6736542|NCT03251482|7665770|FG002|NOT COMPLETED|Overall Study||0
6736543|NCT03251482|7665771|FG003|NOT COMPLETED|Overall Study||0
6736544|NCT03251482|7665772|FG004|NOT COMPLETED|Overall Study||0
6736545|NCT03251937|7665784|FG000|STARTED|Overall Study||40
6736546|NCT03251937|7665784|FG000|COMPLETED|Overall Study||37
6736547|NCT03251937|7665784|FG000|NOT COMPLETED|Overall Study||3
6736548|NCT03251963|7665790|FG000|STARTED|Overall Study||65
6736549|NCT03251963|7665791|FG001|STARTED|Overall Study||66
6736550|NCT03251963|7665790|FG000|COMPLETED|Overall Study||56
6736551|NCT03251963|7665791|FG001|COMPLETED|Overall Study||61
6736552|NCT03251963|7665790|FG000|NOT COMPLETED|Overall Study||9
6736553|NCT03251963|7665791|FG001|NOT COMPLETED|Overall Study||5
6736554|NCT03252015|7665801|FG000|STARTED|Overall Study||12
6736555|NCT03252015|7665802|FG001|STARTED|Overall Study||28
6736556|NCT03252015|7665803|FG002|STARTED|Overall Study||15
6736557|NCT03252015|7665804|FG003|STARTED|Overall Study||15
6736558|NCT03252015|7665801|FG000|Received at Least 1 Dose of Study Drug|Overall Study||12
6736559|NCT03252015|7665802|FG001|Received at Least 1 Dose of Study Drug|Overall Study||28
6736560|NCT03252015|7665803|FG002|Received at Least 1 Dose of Study Drug|Overall Study||15
6736561|NCT03252015|7665804|FG003|Received at Least 1 Dose of Study Drug|Overall Study||15
6736562|NCT03252015|7665801|FG000|COMPLETED|Overall Study||11
6736563|NCT03252015|7665802|FG001|COMPLETED|Overall Study||27
6736564|NCT03252015|7665803|FG002|COMPLETED|Overall Study||14
6736565|NCT03252015|7665804|FG003|COMPLETED|Overall Study||14
6736566|NCT03252015|7665801|FG000|NOT COMPLETED|Overall Study||1
6736567|NCT03252015|7665802|FG001|NOT COMPLETED|Overall Study||1
6736568|NCT03252015|7665803|FG002|NOT COMPLETED|Overall Study||1
6736569|NCT03252015|7665804|FG003|NOT COMPLETED|Overall Study||1
6736570|NCT03252145|7665830|FG000|STARTED|Overall Study||13
6736571|NCT03252145|7665831|FG001|STARTED|Overall Study||15
6736572|NCT03252145|7665830|FG000|COMPLETED|Overall Study||11
6736573|NCT03252145|7665831|FG001|COMPLETED|Overall Study||13
6736574|NCT03252145|7665830|FG000|NOT COMPLETED|Overall Study||2
6736575|NCT03252145|7665831|FG001|NOT COMPLETED|Overall Study||2
6736576|NCT03252353|7665839|FG000|STARTED|Overall Study||28
6736577|NCT03252353|7665840|FG001|STARTED|Overall Study||28
6736578|NCT03252353|7665839|FG000|COMPLETED|Overall Study||28
6736579|NCT03252353|7665840|FG001|COMPLETED|Overall Study||28
6736580|NCT03252353|7665839|FG000|NOT COMPLETED|Overall Study||0
6736581|NCT03252353|7665840|FG001|NOT COMPLETED|Overall Study||0
6736582|NCT03252431|7665851|FG000|STARTED|Overall Study||197
6736583|NCT03252431|7665852|FG001|STARTED|Overall Study||196
6736584|NCT03252431|7665851|FG000|COMPLETED|Overall Study||186
6736585|NCT03252431|7665852|FG001|COMPLETED|Overall Study||187
6736586|NCT03252431|7665851|FG000|NOT COMPLETED|Overall Study||11
6736587|NCT03252431|7665852|FG001|NOT COMPLETED|Overall Study||9
6736588|NCT03252964|7665858|FG000|STARTED|Overall Study||52
6736589|NCT03252964|7665858|FG000|COMPLETED|Overall Study||20
6736590|NCT03252964|7665858|FG000|NOT COMPLETED|Overall Study||32
6736591|NCT03253094|7665868|FG000|STARTED|Overall Study||32
6736592|NCT03253094|7665869|FG001|STARTED|Overall Study||30
6736593|NCT03253094|7665870|FG002|STARTED|Overall Study||28
6736594|NCT03253094|7665871|FG003|STARTED|Overall Study||32
6736595|NCT03253094|7665872|FG004|STARTED|Overall Study||32
6736596|NCT03253094|7665873|FG005|STARTED|Overall Study||32
6736597|NCT03253094|7665868|FG000|Subjects Discontinued|Overall Study||4
6736598|NCT03253094|7665869|FG001|Subjects Discontinued|Overall Study||3
6736599|NCT03253094|7665870|FG002|Subjects Discontinued|Overall Study||6
6736600|NCT03253094|7665871|FG003|Subjects Discontinued|Overall Study||4
6736601|NCT03253094|7665872|FG004|Subjects Discontinued|Overall Study||5
6736602|NCT03253094|7665873|FG005|Subjects Discontinued|Overall Study||4
6736603|NCT03253094|7665868|FG000|COMPLETED|Overall Study||28
6736604|NCT03253094|7665869|FG001|COMPLETED|Overall Study||27
6736605|NCT03253094|7665870|FG002|COMPLETED|Overall Study||22
6736606|NCT03253094|7665871|FG003|COMPLETED|Overall Study||28
6736607|NCT03253094|7665872|FG004|COMPLETED|Overall Study||27
6736608|NCT03253094|7665873|FG005|COMPLETED|Overall Study||28
6736609|NCT03253094|7665868|FG000|NOT COMPLETED|Overall Study||4
6736610|NCT03253094|7665869|FG001|NOT COMPLETED|Overall Study||3
6736611|NCT03253094|7665870|FG002|NOT COMPLETED|Overall Study||6
6736612|NCT03253094|7665871|FG003|NOT COMPLETED|Overall Study||4
6736613|NCT03253094|7665872|FG004|NOT COMPLETED|Overall Study||5
6736614|NCT03253094|7665873|FG005|NOT COMPLETED|Overall Study||4
6736615|NCT03254108|7665892|FG000|STARTED|Overall Study||13
6736616|NCT03254108|7665893|FG001|STARTED|Overall Study||12
6736617|NCT03254108|7665894|FG002|STARTED|Overall Study||12
6736618|NCT03254108|7665895|FG003|STARTED|Overall Study||12
6736619|NCT03254108|7665896|FG004|STARTED|Overall Study||12
6736620|NCT03254108|7665892|FG000|Received Treatment|Overall Study||13
6736621|NCT03254108|7665893|FG001|Received Treatment|Overall Study||12
6736622|NCT03254108|7665894|FG002|Received Treatment|Overall Study||12
6736623|NCT03254108|7665895|FG003|Received Treatment|Overall Study||11
6736624|NCT03254108|7665896|FG004|Received Treatment|Overall Study||12
6736625|NCT03254108|7665892|FG000|COMPLETED|Overall Study||13
6736626|NCT03254108|7665893|FG001|COMPLETED|Overall Study||10
6736627|NCT03254108|7665894|FG002|COMPLETED|Overall Study||12
6736628|NCT03254108|7665895|FG003|COMPLETED|Overall Study||11
6736629|NCT03254108|7665896|FG004|COMPLETED|Overall Study||9
6736630|NCT03254108|7665892|FG000|NOT COMPLETED|Overall Study||0
6736631|NCT03254108|7665893|FG001|NOT COMPLETED|Overall Study||2
6736632|NCT03254108|7665894|FG002|NOT COMPLETED|Overall Study||0
6736633|NCT03254108|7665895|FG003|NOT COMPLETED|Overall Study||1
6736634|NCT03254108|7665896|FG004|NOT COMPLETED|Overall Study||3
6736635|NCT03254134|7665910|FG000|STARTED|Overall Study||5745
6736636|NCT03254134|7665911|FG001|STARTED|Overall Study||16745
6736637|NCT03254134|7665910|FG000|COMPLETED|Overall Study||5146
6736638|NCT03254134|7665911|FG001|COMPLETED|Overall Study||13115
6736639|NCT03254134|7665910|FG000|NOT COMPLETED|Overall Study||599
6736640|NCT03254134|7665911|FG001|NOT COMPLETED|Overall Study||3630
6736641|NCT03254147|7665917|FG000|STARTED|Overall Study|The number of patients meeting the inclusion and exclusion criteria|53969
6736642|NCT03254147|7665917|FG000|COMPLETED|Overall Study||53969
6736643|NCT03254147|7665917|FG000|NOT COMPLETED|Overall Study||0
6736644|NCT03254459|7665923|FG000|STARTED|Overall Study||50
6736645|NCT03254459|7665924|FG001|STARTED|Overall Study||50
6736646|NCT03254459|7665923|FG000|COMPLETED|Overall Study||40
6736647|NCT03254459|7665924|FG001|COMPLETED|Overall Study||27
6736648|NCT03254459|7665923|FG000|NOT COMPLETED|Overall Study||10
6736649|NCT03254459|7665924|FG001|NOT COMPLETED|Overall Study||23
6736650|NCT03254602|7665930|FG000|STARTED|Overall Study||33
6736651|NCT03254602|7665930|FG000|COMPLETED|Overall Study||29
6736652|NCT03254602|7665930|FG000|NOT COMPLETED|Overall Study||4
6736653|NCT03254719|7665934|FG000|STARTED|Overall Study||40
6736654|NCT03254719|7665934|FG000|COMPLETED|Overall Study||40
6736655|NCT03254719|7665934|FG000|NOT COMPLETED|Overall Study||0
6736656|NCT03255187|7665940|FG000|STARTED|Periodfrom Enrollment to First Follow-up||35
6736657|NCT03255187|7665941|FG001|STARTED|Periodfrom Enrollment to First Follow-up||35
6736658|NCT03255187|7665940|FG000|COMPLETED|Periodfrom Enrollment to First Follow-up||34
6736659|NCT03255187|7665941|FG001|COMPLETED|Periodfrom Enrollment to First Follow-up||32
6736660|NCT03255187|7665940|FG000|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||1
6736661|NCT03255187|7665941|FG001|NOT COMPLETED|Periodfrom Enrollment to First Follow-up||3
6736662|NCT03255187|7665940|FG000|STARTED|Period From First to Second Follow-up||34
6736663|NCT03255187|7665941|FG001|STARTED|Period From First to Second Follow-up||32
6736664|NCT03255187|7665940|FG000|COMPLETED|Period From First to Second Follow-up||34
6736665|NCT03255187|7665941|FG001|COMPLETED|Period From First to Second Follow-up||31
6736666|NCT03255187|7665940|FG000|NOT COMPLETED|Period From First to Second Follow-up||0
6736667|NCT03255187|7665941|FG001|NOT COMPLETED|Period From First to Second Follow-up||1
6736668|NCT03255187|7665940|FG000|STARTED|Period From Second to Third Follow-up||34
6736669|NCT03255187|7665941|FG001|STARTED|Period From Second to Third Follow-up||31
6736670|NCT03255187|7665940|FG000|COMPLETED|Period From Second to Third Follow-up||34
6736671|NCT03255187|7665941|FG001|COMPLETED|Period From Second to Third Follow-up||31
6736672|NCT03255187|7665940|FG000|NOT COMPLETED|Period From Second to Third Follow-up||0
6736673|NCT03255187|7665941|FG001|NOT COMPLETED|Period From Second to Third Follow-up||0
6736674|NCT03255187|7665940|FG000|STARTED|Period From Third to Fourth Follow-up||34
6736675|NCT03255187|7665941|FG001|STARTED|Period From Third to Fourth Follow-up||31
6736676|NCT03255187|7665940|FG000|COMPLETED|Period From Third to Fourth Follow-up||34
6736677|NCT03255187|7665941|FG001|COMPLETED|Period From Third to Fourth Follow-up||31
6736678|NCT03255187|7665940|FG000|NOT COMPLETED|Period From Third to Fourth Follow-up||0
6736679|NCT03255187|7665941|FG001|NOT COMPLETED|Period From Third to Fourth Follow-up||0
6736680|NCT03255187|7665940|FG000|STARTED|Period at Fourth Follow-up||34
6736681|NCT03255187|7665941|FG001|STARTED|Period at Fourth Follow-up||31
6736682|NCT03255187|7665940|FG000|COMPLETED|Period at Fourth Follow-up||34
6736683|NCT03255187|7665941|FG001|COMPLETED|Period at Fourth Follow-up||31
6736684|NCT03255187|7665940|FG000|NOT COMPLETED|Period at Fourth Follow-up||0
6736685|NCT03255187|7665941|FG001|NOT COMPLETED|Period at Fourth Follow-up||0
6736686|NCT03255291|7665953|FG000|STARTED|Overall Study||93
6736687|NCT03255291|7665954|FG001|STARTED|Overall Study||90
6736688|NCT03255291|7665955|FG002|STARTED|Overall Study||91
6736689|NCT03255291|7665956|FG003|STARTED|Overall Study||90
6736690|NCT03255291|7665957|FG004|STARTED|Overall Study||95
6736691|NCT03255291|7665958|FG005|STARTED|Overall Study||95
6736692|NCT03255291|7665953|FG000|COMPLETED|Overall Study||80
6736693|NCT03255291|7665954|FG001|COMPLETED|Overall Study||78
6736694|NCT03255291|7665955|FG002|COMPLETED|Overall Study||85
6736695|NCT03255291|7665956|FG003|COMPLETED|Overall Study||84
6736696|NCT03255291|7665957|FG004|COMPLETED|Overall Study||88
6736697|NCT03255291|7665958|FG005|COMPLETED|Overall Study||85
6736698|NCT03255291|7665953|FG000|NOT COMPLETED|Overall Study||13
6736699|NCT03255291|7665954|FG001|NOT COMPLETED|Overall Study||12
6736700|NCT03255291|7665955|FG002|NOT COMPLETED|Overall Study||6
6736701|NCT03255291|7665956|FG003|NOT COMPLETED|Overall Study||6
6736702|NCT03255291|7665957|FG004|NOT COMPLETED|Overall Study||7
6736703|NCT03255291|7665958|FG005|NOT COMPLETED|Overall Study||10
6736704|NCT03255382|7665978|FG000|STARTED|Overall Study||60
6736705|NCT03255382|7665979|FG001|STARTED|Overall Study||60
6736706|NCT03255382|7665978|FG000|COMPLETED|Overall Study||47
6736707|NCT03255382|7665979|FG001|COMPLETED|Overall Study||60
6736708|NCT03255382|7665978|FG000|NOT COMPLETED|Overall Study||13
6736709|NCT03255382|7665979|FG001|NOT COMPLETED|Overall Study||0
6736710|NCT03255655|7665988|FG000|STARTED|Overall Study||29
6736711|NCT03255655|7665989|FG001|STARTED|Overall Study||12
6736712|NCT03255655|7665988|FG000|COMPLETED|Overall Study||22
6736713|NCT03255655|7665989|FG001|COMPLETED|Overall Study||8
6736714|NCT03255655|7665988|FG000|NOT COMPLETED|Overall Study||7
6736715|NCT03255655|7665989|FG001|NOT COMPLETED|Overall Study||4
6736716|NCT03255733|7665995|FG000|STARTED|Overall Study||29
6736717|NCT03255733|7665995|FG000|COMPLETED|Overall Study||25
6736718|NCT03255733|7665995|FG000|NOT COMPLETED|Overall Study||4
6736719|NCT03255824|7666001|FG000|STARTED|Overall Study||69
6736720|NCT03255824|7666002|FG001|STARTED|Overall Study||75
6736721|NCT03255824|7666001|FG000|COMPLETED|Overall Study||67
6736722|NCT03255824|7666002|FG001|COMPLETED|Overall Study||74
6736723|NCT03255824|7666001|FG000|NOT COMPLETED|Overall Study||2
6736724|NCT03255824|7666002|FG001|NOT COMPLETED|Overall Study||1
6736725|NCT03255902|7666008|FG000|STARTED|Overall Study||7
6736726|NCT03255902|7666008|FG000|COMPLETED|Overall Study||5
6736727|NCT03255902|7666008|FG000|NOT COMPLETED|Overall Study||2
6736728|NCT03255941|7666016|FG000|STARTED|Overall Study||177
6736729|NCT03255941|7666017|FG001|STARTED|Overall Study||178
6736730|NCT03255941|7666018|FG002|STARTED|Overall Study||53
6736731|NCT03255941|7666019|FG003|STARTED|Overall Study||52
6736732|NCT03255941|7666016|FG000|Deemed Eligible to Receive DMPA|Overall Study||140
6736733|NCT03255941|7666017|FG001|Deemed Eligible to Receive DMPA|Overall Study||134
6736734|NCT03255941|7666018|FG002|Deemed Eligible to Receive DMPA|Overall Study||48
6736735|NCT03255941|7666019|FG003|Deemed Eligible to Receive DMPA|Overall Study||46
6736736|NCT03255941|7666016|FG000|COMPLETED|Overall Study||139
6736737|NCT03255941|7666017|FG001|COMPLETED|Overall Study||132
6736738|NCT03255941|7666018|FG002|COMPLETED|Overall Study||48
6736739|NCT03255941|7666019|FG003|COMPLETED|Overall Study||46
6736740|NCT03255941|7666016|FG000|NOT COMPLETED|Overall Study||38
6736741|NCT03255941|7666017|FG001|NOT COMPLETED|Overall Study||46
6736742|NCT03255941|7666018|FG002|NOT COMPLETED|Overall Study||5
6736743|NCT03255941|7666019|FG003|NOT COMPLETED|Overall Study||6
6736744|NCT03255980|7666045|FG000|STARTED|Overall Study||20
6736745|NCT03255980|7666046|FG001|STARTED|Overall Study||20
6736746|NCT03255980|7666047|FG002|STARTED|Overall Study||20
6736747|NCT03255980|7666048|FG003|STARTED|Overall Study||20
6736748|NCT03255980|7666045|FG000|COMPLETED|Overall Study||17
6736749|NCT03255980|7666046|FG001|COMPLETED|Overall Study||12
6736750|NCT03255980|7666047|FG002|COMPLETED|Overall Study||14
6736751|NCT03255980|7666048|FG003|COMPLETED|Overall Study||8
6736752|NCT03255980|7666045|FG000|NOT COMPLETED|Overall Study||3
6736753|NCT03255980|7666046|FG001|NOT COMPLETED|Overall Study||8
6736754|NCT03255980|7666047|FG002|NOT COMPLETED|Overall Study||6
6736755|NCT03255980|7666048|FG003|NOT COMPLETED|Overall Study||12
6736756|NCT03256136|7666062|FG000|STARTED|Overall Study||3
6736757|NCT03256136|7666063|FG001|STARTED|Overall Study||1
6736758|NCT03256136|7666064|FG002|STARTED|Overall Study||4
6736759|NCT03256136|7666065|FG003|STARTED|Overall Study||1
6736760|NCT03256136|7666062|FG000|COMPLETED|Overall Study||3
6736761|NCT03256136|7666063|FG001|COMPLETED|Overall Study||1
6736762|NCT03256136|7666064|FG002|COMPLETED|Overall Study||4
6736763|NCT03256136|7666065|FG003|COMPLETED|Overall Study||1
6736764|NCT03256136|7666062|FG000|NOT COMPLETED|Overall Study||0
6736765|NCT03256136|7666063|FG001|NOT COMPLETED|Overall Study||0
6736766|NCT03256136|7666064|FG002|NOT COMPLETED|Overall Study||0
6736767|NCT03256136|7666065|FG003|NOT COMPLETED|Overall Study||0
6736768|NCT03256162|7666077|FG000|STARTED|Overall Study||13
6736769|NCT03256162|7666078|FG001|STARTED|Overall Study||12
6736770|NCT03256162|7666077|FG000|COMPLETED|Overall Study||8
6736771|NCT03256162|7666078|FG001|COMPLETED|Overall Study||8
6736772|NCT03256162|7666077|FG000|NOT COMPLETED|Overall Study||5
6736773|NCT03256162|7666078|FG001|NOT COMPLETED|Overall Study||4
6736774|NCT03256253|7666084|FG000|STARTED|Overall Study||18
6736775|NCT03256253|7666084|FG000|COMPLETED|Overall Study||6
6736776|NCT03256253|7666084|FG000|NOT COMPLETED|Overall Study||12
6736777|NCT03256526|7666091|FG000|STARTED|Overall Study||19
6736778|NCT03256526|7666092|FG001|STARTED|Overall Study||17
6736779|NCT03256526|7666093|FG002|STARTED|Overall Study||17
6736780|NCT03256526|7666091|FG000|COMPLETED|Overall Study||17
6736781|NCT03256526|7666092|FG001|COMPLETED|Overall Study||17
6736782|NCT03256526|7666093|FG002|COMPLETED|Overall Study||14
6736783|NCT03256526|7666091|FG000|NOT COMPLETED|Overall Study||2
6736784|NCT03256526|7666092|FG001|NOT COMPLETED|Overall Study||0
6736785|NCT03256526|7666093|FG002|NOT COMPLETED|Overall Study||3
6736786|NCT03256552|7666101|FG000|STARTED|Overall Study||66
6736787|NCT03256552|7666101|FG000|GP MDI 28.8 µg|Overall Study||61
6736788|NCT03256552|7666101|FG000|GP MDI 14.4 µg|Overall Study||63
6736789|NCT03256552|7666101|FG000|GP MDI 7.2 µg|Overall Study||62
6736790|NCT03256552|7666101|FG000|Placebo MDI|Overall Study||65
6736791|NCT03256552|7666101|FG000|COMPLETED|Overall Study||61
6736792|NCT03256552|7666101|FG000|NOT COMPLETED|Overall Study||5
6736793|NCT03256578|7666113|FG000|STARTED|Overall Study||204
6736794|NCT03256578|7666114|FG001|STARTED|Overall Study||206
6736795|NCT03256578|7666113|FG000|COMPLETED|Overall Study||138
6736796|NCT03256578|7666114|FG001|COMPLETED|Overall Study||150
6736797|NCT03256578|7666113|FG000|NOT COMPLETED|Overall Study||66
6736798|NCT03256578|7666114|FG001|NOT COMPLETED|Overall Study||56
6736799|NCT03256695|7666120|FG000|STARTED|Overall Study||405
6736800|NCT03256695|7666120|FG000|Used ABS eMDPI at Least Once|Overall Study||390
6736801|NCT03256695|7666120|FG000|COMPLETED|Overall Study||366
6736802|NCT03256695|7666120|FG000|NOT COMPLETED|Overall Study||39
6736803|NCT03256799|7666124|FG000|STARTED|Overall Study||1
6736804|NCT03256799|7666124|FG000|COMPLETED|Overall Study||1
6736805|NCT03256799|7666124|FG000|NOT COMPLETED|Overall Study||0
6736806|NCT03256851|7666130|FG000|STARTED|Overall Study||10
6736807|NCT03256851|7666131|FG001|STARTED|Overall Study||10
6736808|NCT03256851|7666130|FG000|COMPLETED|Overall Study||9
6736809|NCT03256851|7666131|FG001|COMPLETED|Overall Study||10
6736810|NCT03256851|7666130|FG000|NOT COMPLETED|Overall Study||1
6736811|NCT03256851|7666131|FG001|NOT COMPLETED|Overall Study||0
6736812|NCT03256968|7666137|FG000|STARTED|Overall Study||1
6736813|NCT03256968|7666137|FG000|COMPLETED|Overall Study||1
6736814|NCT03256968|7666137|FG000|NOT COMPLETED|Overall Study||0
6740143|NCT03300570|7668995|FG001|NOT COMPLETED|Overall Study||1
6740144|NCT03300674|7669004|FG000|STARTED|Overall Study||77
6740145|NCT03300674|7669005|FG001|STARTED|Overall Study||77
6740146|NCT03300674|7669004|FG000|COMPLETED|Overall Study||77
6740147|NCT03300674|7669005|FG001|COMPLETED|Overall Study||77
6740148|NCT03300674|7669004|FG000|NOT COMPLETED|Overall Study||0
6740149|NCT03300674|7669005|FG001|NOT COMPLETED|Overall Study||0
6740150|NCT03300752|7669013|FG000|STARTED|Overall Study||40
6740151|NCT03300752|7669014|FG001|STARTED|Overall Study||40
6740152|NCT03300752|7669013|FG000|COMPLETED|Overall Study||38
6740153|NCT03300752|7669014|FG001|COMPLETED|Overall Study||38
6740154|NCT03300752|7669013|FG000|NOT COMPLETED|Overall Study||2
6740155|NCT03300752|7669014|FG001|NOT COMPLETED|Overall Study||2
6740156|NCT03300843|7669020|FG000|STARTED|Overall Study||1
6740157|NCT03300843|7669020|FG000|COMPLETED|Overall Study||1
6740158|NCT03300843|7669020|FG000|NOT COMPLETED|Overall Study||0
6740159|NCT03301155|7669026|FG000|STARTED|Overall Study||528
6740160|NCT03301155|7669027|FG001|STARTED|Overall Study||508
6740161|NCT03301155|7669026|FG000|COMPLETED|Overall Study||520
6740162|NCT03301155|7669027|FG001|COMPLETED|Overall Study||501
6740163|NCT03301155|7669026|FG000|NOT COMPLETED|Overall Study||8
6740164|NCT03301155|7669027|FG001|NOT COMPLETED|Overall Study||7
6740165|NCT03301272|7669035|FG000|STARTED|First Intervention (30 Days)||7
6740166|NCT03301272|7669036|FG001|STARTED|First Intervention (30 Days)||9
6740167|NCT03301272|7669035|FG000|COMPLETED|First Intervention (30 Days)||7
6740168|NCT03301272|7669036|FG001|COMPLETED|First Intervention (30 Days)||9
6740169|NCT03301272|7669035|FG000|NOT COMPLETED|First Intervention (30 Days)||0
6740170|NCT03301272|7669036|FG001|NOT COMPLETED|First Intervention (30 Days)||0
6740171|NCT03301272|7669035|FG000|STARTED|Washout (90 Days From 1st Intervention)||7
6740172|NCT03301272|7669036|FG001|STARTED|Washout (90 Days From 1st Intervention)||9
6740173|NCT03301272|7669035|FG000|COMPLETED|Washout (90 Days From 1st Intervention)||7
6740174|NCT03301272|7669036|FG001|COMPLETED|Washout (90 Days From 1st Intervention)||9
6740175|NCT03301272|7669035|FG000|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
6740176|NCT03301272|7669036|FG001|NOT COMPLETED|Washout (90 Days From 1st Intervention)||0
6740177|NCT03301272|7669035|FG000|STARTED|Second Intervention (30 Days)||7
6740178|NCT03301272|7669036|FG001|STARTED|Second Intervention (30 Days)||9
6740179|NCT03301272|7669035|FG000|COMPLETED|Second Intervention (30 Days)||7
6740180|NCT03301272|7669036|FG001|COMPLETED|Second Intervention (30 Days)||9
6740181|NCT03301272|7669035|FG000|NOT COMPLETED|Second Intervention (30 Days)||0
6740182|NCT03301272|7669036|FG001|NOT COMPLETED|Second Intervention (30 Days)||0
6740183|NCT03301298|7669049|FG000|STARTED|Unfed Conditions||6
6740184|NCT03301298|7669050|FG001|STARTED|Unfed Conditions||6
6740185|NCT03301298|7669051|FG002|STARTED|Unfed Conditions||6
6740186|NCT03301298|7669052|FG003|STARTED|Unfed Conditions||6
6740187|NCT03301298|7669053|FG004|STARTED|Unfed Conditions||6
6740188|NCT03301298|7669054|FG005|STARTED|Unfed Conditions||6
6740189|NCT03301298|7669055|FG006|STARTED|Unfed Conditions||12
6740190|NCT03301298|7669049|FG000|COMPLETED|Unfed Conditions||6
6740191|NCT03301298|7669050|FG001|COMPLETED|Unfed Conditions||6
6740192|NCT03301298|7669051|FG002|COMPLETED|Unfed Conditions||6
6740193|NCT03301298|7669052|FG003|COMPLETED|Unfed Conditions||6
6740194|NCT03301298|7669053|FG004|COMPLETED|Unfed Conditions||6
6740195|NCT03301298|7669054|FG005|COMPLETED|Unfed Conditions||6
6740196|NCT03301298|7669055|FG006|COMPLETED|Unfed Conditions||12
6740197|NCT03301298|7669049|FG000|NOT COMPLETED|Unfed Conditions||0
6740198|NCT03301298|7669050|FG001|NOT COMPLETED|Unfed Conditions||0
6740199|NCT03301298|7669051|FG002|NOT COMPLETED|Unfed Conditions||0
6740200|NCT03301298|7669052|FG003|NOT COMPLETED|Unfed Conditions||0
6740201|NCT03301298|7669053|FG004|NOT COMPLETED|Unfed Conditions||0
6740202|NCT03301298|7669054|FG005|NOT COMPLETED|Unfed Conditions||0
6740203|NCT03301298|7669055|FG006|NOT COMPLETED|Unfed Conditions||0
6740204|NCT03301298|7669049|FG000|STARTED|Fed Conditions||0
6740205|NCT03301298|7669050|FG001|STARTED|Fed Conditions||0
6740206|NCT03301298|7669051|FG002|STARTED|Fed Conditions||0
6740207|NCT03301298|7669052|FG003|STARTED|Fed Conditions||0
6740208|NCT03301298|7669053|FG004|STARTED|Fed Conditions||5
6740209|NCT03301298|7669054|FG005|STARTED|Fed Conditions||0
6740210|NCT03301298|7669055|FG006|STARTED|Fed Conditions||2
6740211|NCT03301298|7669049|FG000|COMPLETED|Fed Conditions||0
6740212|NCT03301298|7669050|FG001|COMPLETED|Fed Conditions||0
6740213|NCT03301298|7669051|FG002|COMPLETED|Fed Conditions||0
6740214|NCT03301298|7669052|FG003|COMPLETED|Fed Conditions||0
6740215|NCT03301298|7669053|FG004|COMPLETED|Fed Conditions||5
6740216|NCT03301298|7669054|FG005|COMPLETED|Fed Conditions||0
6740217|NCT03301298|7669055|FG006|COMPLETED|Fed Conditions||2
6740218|NCT03301298|7669049|FG000|NOT COMPLETED|Fed Conditions||0
6740219|NCT03301298|7669050|FG001|NOT COMPLETED|Fed Conditions||0
6740220|NCT03301298|7669051|FG002|NOT COMPLETED|Fed Conditions||0
6740221|NCT03301298|7669052|FG003|NOT COMPLETED|Fed Conditions||0
6740222|NCT03301298|7669053|FG004|NOT COMPLETED|Fed Conditions||0
6740223|NCT03301298|7669054|FG005|NOT COMPLETED|Fed Conditions||0
6736815|NCT03257189|7666141|FG000|STARTED|Overall Study||30
6736816|NCT03257189|7666141|FG000|COMPLETED|Overall Study||30
6736817|NCT03257189|7666141|FG000|NOT COMPLETED|Overall Study||0
6736818|NCT03257202|7666145|FG000|STARTED|Overall Study||12
6736819|NCT03257202|7666145|FG000|COMPLETED|Overall Study||12
6736820|NCT03257202|7666145|FG000|NOT COMPLETED|Overall Study||0
6736821|NCT03257358|7666157|FG000|STARTED|Overall Study||165
6736822|NCT03257358|7666158|FG001|STARTED|Overall Study||217
6736823|NCT03257358|7666157|FG000|Never Received Treatment|Overall Study||2
6736824|NCT03257358|7666158|FG001|Never Received Treatment|Overall Study||0
6736825|NCT03257358|7666157|FG000|COMPLETED|Overall Study||94
6736826|NCT03257358|7666158|FG001|COMPLETED|Overall Study||183
6736827|NCT03257358|7666157|FG000|NOT COMPLETED|Overall Study||71
6736828|NCT03257358|7666158|FG001|NOT COMPLETED|Overall Study||34
6736829|NCT03257371|7666164|FG000|STARTED|Overall Study||10
6736830|NCT03257371|7666164|FG000|COMPLETED|Overall Study||9
6736831|NCT03257371|7666164|FG000|NOT COMPLETED|Overall Study||1
6736832|NCT03257410|7666170|FG000|STARTED|Overall Study||86
6736833|NCT03257410|7666171|FG001|STARTED|Overall Study||86
6736834|NCT03257410|7666170|FG000|COMPLETED|Overall Study||65
6736835|NCT03257410|7666171|FG001|COMPLETED|Overall Study||65
6736836|NCT03257410|7666170|FG000|NOT COMPLETED|Overall Study||21
6736837|NCT03257410|7666171|FG001|NOT COMPLETED|Overall Study||21
6736838|NCT03257631|7666181|FG000|STARTED|Overall Study||11
6736839|NCT03257631|7666182|FG001|STARTED|Overall Study||9
6736840|NCT03257631|7666183|FG002|STARTED|Overall Study||23
6736841|NCT03257631|7666184|FG003|STARTED|Overall Study||10
6736842|NCT03257631|7666181|FG000|Received Study Drug|Overall Study||11
6736843|NCT03257631|7666182|FG001|Received Study Drug|Overall Study||9
6736844|NCT03257631|7666183|FG002|Received Study Drug|Overall Study||22
6736845|NCT03257631|7666184|FG003|Received Study Drug|Overall Study||10
6736846|NCT03257631|7666181|FG000|COMPLETED|Overall Study||0
6736847|NCT03257631|7666182|FG001|COMPLETED|Overall Study||0
6736848|NCT03257631|7666183|FG002|COMPLETED|Overall Study||0
6736849|NCT03257631|7666184|FG003|COMPLETED|Overall Study||0
6736850|NCT03257631|7666181|FG000|NOT COMPLETED|Overall Study||11
6736851|NCT03257631|7666182|FG001|NOT COMPLETED|Overall Study||9
6736852|NCT03257631|7666183|FG002|NOT COMPLETED|Overall Study||23
6736853|NCT03257631|7666184|FG003|NOT COMPLETED|Overall Study||10
6736854|NCT03257657|7666196|FG000|STARTED|Overall Study||22
6736855|NCT03257657|7666197|FG001|STARTED|Overall Study||20
6736856|NCT03257657|7666196|FG000|COMPLETED|Overall Study||22
6736857|NCT03257657|7666197|FG001|COMPLETED|Overall Study||15
6736858|NCT03257657|7666196|FG000|NOT COMPLETED|Overall Study||0
6736859|NCT03257657|7666197|FG001|NOT COMPLETED|Overall Study||5
6736860|NCT03257813|7666206|FG000|STARTED|Overall Study||30
6736861|NCT03257813|7666207|FG001|STARTED|Overall Study||30
6736862|NCT03257813|7666206|FG000|COMPLETED|Overall Study||24
6736863|NCT03257813|7666207|FG001|COMPLETED|Overall Study||27
6736864|NCT03257813|7666206|FG000|NOT COMPLETED|Overall Study||6
6736865|NCT03257813|7666207|FG001|NOT COMPLETED|Overall Study||3
6736866|NCT03257865|7666218|FG000|STARTED|Overall Study||163
6736867|NCT03257865|7666219|FG001|STARTED|Overall Study||170
6736868|NCT03257865|7666218|FG000|Received at Least 1 Dose of Study Drug|Overall Study||162
6736869|NCT03257865|7666219|FG001|Received at Least 1 Dose of Study Drug|Overall Study||170
6736870|NCT03257865|7666218|FG000|COMPLETED|Overall Study||128
6736871|NCT03257865|7666219|FG001|COMPLETED|Overall Study||135
6736872|NCT03257865|7666218|FG000|NOT COMPLETED|Overall Study||35
6736873|NCT03257865|7666219|FG001|NOT COMPLETED|Overall Study||35
6736874|NCT03257995|7666225|FG000|STARTED|Overall Study||9
6736875|NCT03257995|7666226|FG001|STARTED|Overall Study||9
6736876|NCT03257995|7666227|FG002|STARTED|Overall Study||9
6736877|NCT03257995|7666228|FG003|STARTED|Overall Study||9
6736878|NCT03257995|7666229|FG004|STARTED|Overall Study||9
6736879|NCT03257995|7666230|FG005|STARTED|Overall Study||9
6736880|NCT03257995|7666225|FG000|COMPLETED|Overall Study||9
6736881|NCT03257995|7666226|FG001|COMPLETED|Overall Study||8
6736882|NCT03257995|7666227|FG002|COMPLETED|Overall Study||9
6736883|NCT03257995|7666228|FG003|COMPLETED|Overall Study||9
6736884|NCT03257995|7666229|FG004|COMPLETED|Overall Study||9
6736885|NCT03257995|7666230|FG005|COMPLETED|Overall Study||7
6736886|NCT03257995|7666225|FG000|NOT COMPLETED|Overall Study||0
6736887|NCT03257995|7666226|FG001|NOT COMPLETED|Overall Study||1
6736888|NCT03257995|7666227|FG002|NOT COMPLETED|Overall Study||0
6736889|NCT03257995|7666228|FG003|NOT COMPLETED|Overall Study||0
6736890|NCT03257995|7666229|FG004|NOT COMPLETED|Overall Study||0
6736891|NCT03257995|7666230|FG005|NOT COMPLETED|Overall Study||2
6736892|NCT03258645|7666242|FG000|STARTED|Overall Study||1489
6736893|NCT03258645|7666242|FG000|COMPLETED|Overall Study||1489
6736894|NCT03258645|7666242|FG000|NOT COMPLETED|Overall Study||0
6736895|NCT03258710|7666252|FG000|STARTED|Overall Study||75
6736896|NCT03258710|7666252|FG000|COMPLETED|Overall Study||72
6736897|NCT03258710|7666252|FG000|NOT COMPLETED|Overall Study||3
6736898|NCT03258762|7666258|FG000|STARTED|Overall Study||7
6736899|NCT03258762|7666259|FG001|STARTED|Overall Study||7
6736900|NCT03258762|7666258|FG000|COMPLETED|Overall Study||7
6736901|NCT03258762|7666259|FG001|COMPLETED|Overall Study||6
6736902|NCT03258762|7666258|FG000|NOT COMPLETED|Overall Study||0
6736903|NCT03258762|7666259|FG001|NOT COMPLETED|Overall Study||1
6736904|NCT03258814|7666268|FG000|STARTED|Overall Study||4
6736905|NCT03258814|7666269|FG001|STARTED|Overall Study||3
6736906|NCT03258814|7666270|FG002|STARTED|Overall Study||10
6736907|NCT03258814|7666268|FG000|COMPLETED|Overall Study||0
6736908|NCT03258814|7666269|FG001|COMPLETED|Overall Study||0
6736909|NCT03258814|7666270|FG002|COMPLETED|Overall Study||0
6736910|NCT03258814|7666268|FG000|NOT COMPLETED|Overall Study||4
6736911|NCT03258814|7666269|FG001|NOT COMPLETED|Overall Study||3
6736912|NCT03258814|7666270|FG002|NOT COMPLETED|Overall Study||10
6736913|NCT03259087|7666282|FG000|STARTED|Part 1 and Period 1 of Part 2||8
6736914|NCT03259087|7666283|FG001|STARTED|Part 1 and Period 1 of Part 2||8
6736915|NCT03259087|7666284|FG002|STARTED|Part 1 and Period 1 of Part 2||8
6736916|NCT03259087|7666285|FG003|STARTED|Part 1 and Period 1 of Part 2||10
6736917|NCT03259087|7666286|FG004|STARTED|Part 1 and Period 1 of Part 2||8
6736918|NCT03259087|7666282|FG000|COMPLETED|Part 1 and Period 1 of Part 2||8
6736919|NCT03259087|7666283|FG001|COMPLETED|Part 1 and Period 1 of Part 2||8
6736920|NCT03259087|7666284|FG002|COMPLETED|Part 1 and Period 1 of Part 2||8
6736921|NCT03259087|7666285|FG003|COMPLETED|Part 1 and Period 1 of Part 2||10
6736922|NCT03259087|7666286|FG004|COMPLETED|Part 1 and Period 1 of Part 2||7
6736923|NCT03259087|7666282|FG000|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
6736924|NCT03259087|7666283|FG001|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
6736925|NCT03259087|7666284|FG002|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
6736926|NCT03259087|7666285|FG003|NOT COMPLETED|Part 1 and Period 1 of Part 2||0
6736927|NCT03259087|7666286|FG004|NOT COMPLETED|Part 1 and Period 1 of Part 2||1
6736928|NCT03259087|7666282|FG000|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
6736929|NCT03259087|7666283|FG001|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
6736930|NCT03259087|7666284|FG002|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
6736931|NCT03259087|7666285|FG003|STARTED|Period 2 of Part 2|Period 2 did not apply to Part 1 participants|0
6736932|NCT03259087|7666286|FG004|STARTED|Period 2 of Part 2||7
6736933|NCT03259087|7666282|FG000|COMPLETED|Period 2 of Part 2||0
6736934|NCT03259087|7666283|FG001|COMPLETED|Period 2 of Part 2||0
6736935|NCT03259087|7666284|FG002|COMPLETED|Period 2 of Part 2||0
6736936|NCT03259087|7666285|FG003|COMPLETED|Period 2 of Part 2||0
6736937|NCT03259087|7666286|FG004|COMPLETED|Period 2 of Part 2||6
6736938|NCT03259087|7666282|FG000|NOT COMPLETED|Period 2 of Part 2||0
6736939|NCT03259087|7666283|FG001|NOT COMPLETED|Period 2 of Part 2||0
6736940|NCT03259087|7666284|FG002|NOT COMPLETED|Period 2 of Part 2||0
6736941|NCT03259087|7666285|FG003|NOT COMPLETED|Period 2 of Part 2||0
6736942|NCT03259087|7666286|FG004|NOT COMPLETED|Period 2 of Part 2||1
6736943|NCT03259139|7666314|FG000|STARTED|Overall Study||42
6736944|NCT03259139|7666315|FG001|STARTED|Overall Study||42
6736945|NCT03259139|7666316|FG002|STARTED|Overall Study||42
6736946|NCT03259139|7666317|FG003|STARTED|Overall Study||42
6736947|NCT03259139|7666318|FG004|STARTED|Overall Study||41
6736948|NCT03259139|7666319|FG005|STARTED|Overall Study||41
6736949|NCT03259139|7666314|FG000|Eligible|Overall Study||41
6736950|NCT03259139|7666315|FG001|Eligible|Overall Study||41
6736951|NCT03259139|7666316|FG002|Eligible|Overall Study||41
6736952|NCT03259139|7666317|FG003|Eligible|Overall Study||41
6736953|NCT03259139|7666318|FG004|Eligible|Overall Study||41
6736954|NCT03259139|7666319|FG005|Eligible|Overall Study||41
6736955|NCT03259139|7666314|FG000|Outlier Elimination|Overall Study||41
6736956|NCT03259139|7666315|FG001|Outlier Elimination|Overall Study||41
6736957|NCT03259139|7666316|FG002|Outlier Elimination|Overall Study||41
6736958|NCT03259139|7666317|FG003|Outlier Elimination|Overall Study||41
6736959|NCT03259139|7666318|FG004|Outlier Elimination|Overall Study||39
6736960|NCT03259139|7666319|FG005|Outlier Elimination|Overall Study||39
6736961|NCT03259139|7666314|FG000|Found Handgun|Overall Study||38
6736962|NCT03259139|7666315|FG001|Found Handgun|Overall Study||38
6736963|NCT03259139|7666316|FG002|Found Handgun|Overall Study||37
6736964|NCT03259139|7666317|FG003|Found Handgun|Overall Study||37
6736965|NCT03259139|7666318|FG004|Found Handgun|Overall Study||35
6736966|NCT03259139|7666319|FG005|Found Handgun|Overall Study||35
6736967|NCT03259139|7666314|FG000|COMPLETED|Overall Study||38
6736968|NCT03259139|7666315|FG001|COMPLETED|Overall Study||38
6736969|NCT03259139|7666316|FG002|COMPLETED|Overall Study||37
6736970|NCT03259139|7666317|FG003|COMPLETED|Overall Study||37
6736971|NCT03259139|7666318|FG004|COMPLETED|Overall Study||35
6736972|NCT03259139|7666319|FG005|COMPLETED|Overall Study||35
6736973|NCT03259139|7666314|FG000|NOT COMPLETED|Overall Study||4
6736974|NCT03259139|7666315|FG001|NOT COMPLETED|Overall Study||4
6736975|NCT03259139|7666316|FG002|NOT COMPLETED|Overall Study||5
6736976|NCT03259139|7666317|FG003|NOT COMPLETED|Overall Study||5
6736977|NCT03259139|7666318|FG004|NOT COMPLETED|Overall Study||6
6736978|NCT03259139|7666319|FG005|NOT COMPLETED|Overall Study||6
6736979|NCT03259308|7666339|FG000|STARTED|Overall Study||56
6736980|NCT03259308|7666340|FG001|STARTED|Overall Study||111
6736981|NCT03259308|7666341|FG002|STARTED|Overall Study||112
6736982|NCT03259308|7666339|FG000|COMPLETED|Overall Study||49
6736983|NCT03259308|7666340|FG001|COMPLETED|Overall Study||103
6736984|NCT03259308|7666341|FG002|COMPLETED|Overall Study||105
6736985|NCT03259308|7666339|FG000|NOT COMPLETED|Overall Study||7
6736986|NCT03259308|7666340|FG001|NOT COMPLETED|Overall Study||8
6736987|NCT03259308|7666341|FG002|NOT COMPLETED|Overall Study||7
6736988|NCT03259334|7666352|FG000|STARTED|Overall Study||76
6736989|NCT03259334|7666353|FG001|STARTED|Overall Study||153
6736990|NCT03259334|7666354|FG002|STARTED|Overall Study||151
6736991|NCT03259334|7666352|FG000|Treated|Overall Study||76
6736992|NCT03259334|7666353|FG001|Treated|Overall Study||151
6736993|NCT03259334|7666354|FG002|Treated|Overall Study||151
6736994|NCT03259334|7666352|FG000|COMPLETED|Overall Study||66
6736995|NCT03259334|7666353|FG001|COMPLETED|Overall Study||136
6736996|NCT03259334|7666354|FG002|COMPLETED|Overall Study||138
6736997|NCT03259334|7666352|FG000|NOT COMPLETED|Overall Study||10
6736998|NCT03259334|7666353|FG001|NOT COMPLETED|Overall Study||17
6736999|NCT03259334|7666354|FG002|NOT COMPLETED|Overall Study||13
6737000|NCT03259425|7666362|FG000|STARTED|Overall Study||7
6737001|NCT03259425|7666362|FG000|Surgery|Overall Study||6
6737002|NCT03259425|7666362|FG000|COMPLETED|Overall Study||6
6737003|NCT03259425|7666362|FG000|NOT COMPLETED|Overall Study||1
6737004|NCT03259490|7666368|FG000|STARTED|Period 1||15
6737005|NCT03259490|7666369|FG001|STARTED|Period 1||15
6737006|NCT03259490|7666368|FG000|COMPLETED|Period 1||15
6737007|NCT03259490|7666369|FG001|COMPLETED|Period 1||14
6737008|NCT03259490|7666368|FG000|NOT COMPLETED|Period 1||0
6737009|NCT03259490|7666369|FG001|NOT COMPLETED|Period 1||1
6737010|NCT03259490|7666368|FG000|STARTED|Period 2||15
6737011|NCT03259490|7666369|FG001|STARTED|Period 2||14
6737012|NCT03259490|7666368|FG000|COMPLETED|Period 2||14
6737013|NCT03259490|7666369|FG001|COMPLETED|Period 2||14
6737014|NCT03259490|7666368|FG000|NOT COMPLETED|Period 2||1
6737015|NCT03259490|7666369|FG001|NOT COMPLETED|Period 2||0
6737016|NCT03259555|7666377|FG000|STARTED|Overall Study||158
6737017|NCT03259555|7666378|FG001|STARTED|Overall Study||164
6737018|NCT03259555|7666377|FG000|Received At Least 1 Dose of Study Drug|Overall Study||158
6737019|NCT03259555|7666378|FG001|Received At Least 1 Dose of Study Drug|Overall Study||163
6737020|NCT03259555|7666377|FG000|COMPLETED|Overall Study||124
6737021|NCT03259555|7666378|FG001|COMPLETED|Overall Study||134
6737022|NCT03259555|7666377|FG000|NOT COMPLETED|Overall Study||34
6737023|NCT03259555|7666378|FG001|NOT COMPLETED|Overall Study||30
6737024|NCT03259789|7666387|FG000|STARTED|Overall Study||158
6737025|NCT03259789|7666388|FG001|STARTED|Overall Study||159
6737026|NCT03259789|7666389|FG002|STARTED|Overall Study||34
6737027|NCT03259789|7666387|FG000|COMPLETED|Overall Study||141
6737028|NCT03259789|7666388|FG001|COMPLETED|Overall Study||142
6737029|NCT03259789|7666389|FG002|COMPLETED|Overall Study||28
6737030|NCT03259789|7666387|FG000|NOT COMPLETED|Overall Study||17
6737031|NCT03259789|7666388|FG001|NOT COMPLETED|Overall Study||17
6737032|NCT03259789|7666389|FG002|NOT COMPLETED|Overall Study||6
6737033|NCT03260205|7666403|FG000|STARTED|Overall Study||46
6737034|NCT03260205|7666404|FG001|STARTED|Overall Study||40
6737035|NCT03260205|7666405|FG002|STARTED|Overall Study||37
6737036|NCT03260205|7666406|FG003|STARTED|Overall Study||37
6737037|NCT03260205|7666407|FG004|STARTED|Overall Study||39
6737038|NCT03260205|7666403|FG000|Received Treatment|Overall Study||45
6737039|NCT03260205|7666404|FG001|Received Treatment|Overall Study||39
6737040|NCT03260205|7666405|FG002|Received Treatment|Overall Study||35
6737041|NCT03260205|7666406|FG003|Received Treatment|Overall Study||34
6737042|NCT03260205|7666407|FG004|Received Treatment|Overall Study||38
6737043|NCT03260205|7666403|FG000|COMPLETED|Overall Study||37
6737044|NCT03260205|7666404|FG001|COMPLETED|Overall Study||32
6737045|NCT03260205|7666405|FG002|COMPLETED|Overall Study||26
6737046|NCT03260205|7666406|FG003|COMPLETED|Overall Study||30
6737047|NCT03260205|7666407|FG004|COMPLETED|Overall Study||25
6737048|NCT03260205|7666403|FG000|NOT COMPLETED|Overall Study||9
6737049|NCT03260205|7666404|FG001|NOT COMPLETED|Overall Study||8
6737050|NCT03260205|7666405|FG002|NOT COMPLETED|Overall Study||11
6737051|NCT03260205|7666406|FG003|NOT COMPLETED|Overall Study||7
6737052|NCT03260205|7666407|FG004|NOT COMPLETED|Overall Study||14
6737053|NCT03260426|7666426|FG000|STARTED|Overall Study||50
6737054|NCT03260426|7666427|FG001|STARTED|Overall Study||50
6737055|NCT03260426|7666426|FG000|COMPLETED|Overall Study||50
6737056|NCT03260426|7666427|FG001|COMPLETED|Overall Study||50
6737057|NCT03260426|7666426|FG000|NOT COMPLETED|Overall Study||0
6737058|NCT03260426|7666427|FG001|NOT COMPLETED|Overall Study||0
6737059|NCT03260595|7666436|FG000|STARTED|Overall Study||20
6737060|NCT03260595|7666437|FG001|STARTED|Overall Study||10
6737061|NCT03260595|7666438|FG002|STARTED|Overall Study||2
6737062|NCT03260595|7666436|FG000|COMPLETED|Overall Study||20
6737063|NCT03260595|7666437|FG001|COMPLETED|Overall Study||10
6737064|NCT03260595|7666438|FG002|COMPLETED|Overall Study||2
6737065|NCT03260595|7666436|FG000|NOT COMPLETED|Overall Study||0
6737066|NCT03260595|7666437|FG001|NOT COMPLETED|Overall Study||0
6737067|NCT03260595|7666438|FG002|NOT COMPLETED|Overall Study||0
6737068|NCT03260699|7666448|FG000|STARTED|Overall Study||5
6737069|NCT03260699|7666449|FG001|STARTED|Overall Study||4
6737070|NCT03260699|7666448|FG000|COMPLETED|Overall Study||5
6737071|NCT03260699|7666449|FG001|COMPLETED|Overall Study||2
6737072|NCT03260699|7666448|FG000|NOT COMPLETED|Overall Study||0
6737073|NCT03260699|7666449|FG001|NOT COMPLETED|Overall Study||2
6737074|NCT03260790|7666457|FG000|STARTED|Overall Study||8
6737075|NCT03260790|7666458|FG001|STARTED|Overall Study||9
6737076|NCT03260790|7666457|FG000|COMPLETED|Overall Study||8
6737077|NCT03260790|7666458|FG001|COMPLETED|Overall Study||9
6737078|NCT03260790|7666457|FG000|NOT COMPLETED|Overall Study||0
6737079|NCT03260790|7666458|FG001|NOT COMPLETED|Overall Study||0
6737080|NCT03261037|7666468|FG000|STARTED|Overall Study||68
6737081|NCT03261037|7666469|FG001|STARTED|Overall Study||62
6737082|NCT03261037|7666470|FG002|STARTED|Overall Study||9
6737083|NCT03261037|7666471|FG003|STARTED|Overall Study||39
6737084|NCT03261037|7666468|FG000|COMPLETED|Overall Study||64
6737085|NCT03261037|7666469|FG001|COMPLETED|Overall Study||41
6737086|NCT03261037|7666470|FG002|COMPLETED|Overall Study||9
6737087|NCT03261037|7666471|FG003|COMPLETED|Overall Study||11
6737088|NCT03261037|7666468|FG000|NOT COMPLETED|Overall Study||4
6737089|NCT03261037|7666469|FG001|NOT COMPLETED|Overall Study||21
6737090|NCT03261037|7666470|FG002|NOT COMPLETED|Overall Study||0
6737091|NCT03261037|7666471|FG003|NOT COMPLETED|Overall Study||28
6737092|NCT03261167|7666484|FG000|STARTED|Double Blind(Treatment cyc1,Upto Week48)||63
6737093|NCT03261167|7666485|FG001|STARTED|Double Blind(Treatment cyc1,Upto Week48)||61
6737094|NCT03261167|7666484|FG000|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||60
6737095|NCT03261167|7666485|FG001|COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||57
6737096|NCT03261167|7666484|FG000|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||3
6737097|NCT03261167|7666485|FG001|NOT COMPLETED|Double Blind(Treatment cyc1,Upto Week48)||4
6737098|NCT03261167|7666484|FG000|STARTED|Open-label(Treatment cycle2,Upto Week48)||60
6737099|NCT03261167|7666485|FG001|STARTED|Open-label(Treatment cycle2,Upto Week48)||57
6737100|NCT03261167|7666484|FG000|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||58
6737101|NCT03261167|7666485|FG001|COMPLETED|Open-label(Treatment cycle2,Upto Week48)||57
6737102|NCT03261167|7666484|FG000|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||2
6737103|NCT03261167|7666485|FG001|NOT COMPLETED|Open-label(Treatment cycle2,Upto Week48)||0
6737104|NCT03261167|7666484|FG000|STARTED|Open-label(Treatment cycle3,Upto Week48)||55
6737105|NCT03261167|7666485|FG001|STARTED|Open-label(Treatment cycle3,Upto Week48)||56
6737106|NCT03261167|7666484|FG000|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||54
6737107|NCT03261167|7666485|FG001|COMPLETED|Open-label(Treatment cycle3,Upto Week48)||55
6737108|NCT03261167|7666484|FG000|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
6737109|NCT03261167|7666485|FG001|NOT COMPLETED|Open-label(Treatment cycle3,Upto Week48)||1
6737110|NCT03261167|7666484|FG000|STARTED|Open-label(Treatment cycle4,Upto Week48)||43
6737111|NCT03261167|7666485|FG001|STARTED|Open-label(Treatment cycle4,Upto Week48)||40
6737112|NCT03261167|7666484|FG000|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||43
6737113|NCT03261167|7666485|FG001|COMPLETED|Open-label(Treatment cycle4,Upto Week48)||40
6737114|NCT03261167|7666484|FG000|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
6737115|NCT03261167|7666485|FG001|NOT COMPLETED|Open-label(Treatment cycle4,Upto Week48)||0
6737116|NCT03261336|7666497|FG000|STARTED|Overall Study||1
6737117|NCT03261336|7666497|FG000|COMPLETED|Overall Study||0
6737118|NCT03261336|7666497|FG000|NOT COMPLETED|Overall Study||1
6737119|NCT03261947|7666506|FG000|STARTED|Overall Study||12
6737120|NCT03261947|7666507|FG001|STARTED|Overall Study||15
6737121|NCT03261947|7666508|FG002|STARTED|Overall Study||35
6737122|NCT03261947|7666509|FG003|STARTED|Overall Study||21
6737123|NCT03261947|7666510|FG004|STARTED|Overall Study||18
6737124|NCT03261947|7666506|FG000|COMPLETED|Overall Study||0
6737125|NCT03261947|7666507|FG001|COMPLETED|Overall Study||2
6737126|NCT03261947|7666508|FG002|COMPLETED|Overall Study||5
6737127|NCT03261947|7666509|FG003|COMPLETED|Overall Study||0
6737128|NCT03261947|7666510|FG004|COMPLETED|Overall Study||1
6737129|NCT03261947|7666506|FG000|NOT COMPLETED|Overall Study||12
6737130|NCT03261947|7666507|FG001|NOT COMPLETED|Overall Study||13
6737131|NCT03261947|7666508|FG002|NOT COMPLETED|Overall Study||30
6737132|NCT03261947|7666509|FG003|NOT COMPLETED|Overall Study||21
6737133|NCT03261947|7666510|FG004|NOT COMPLETED|Overall Study||17
6737134|NCT03261960|7666528|FG000|STARTED|Overall Study||190
6737135|NCT03261960|7666529|FG001|STARTED|Overall Study||199
6737136|NCT03261960|7666528|FG000|COMPLETED|Overall Study||176
6737137|NCT03261960|7666529|FG001|COMPLETED|Overall Study||185
6737138|NCT03261960|7666528|FG000|NOT COMPLETED|Overall Study||14
6737139|NCT03261960|7666529|FG001|NOT COMPLETED|Overall Study||14
6737140|NCT03261973|7666535|FG000|STARTED|Overall Study||47
6737141|NCT03261973|7666535|FG000|COMPLETED|Overall Study||43
6737142|NCT03261973|7666535|FG000|NOT COMPLETED|Overall Study||4
6737143|NCT03261999|7666539|FG000|STARTED|Overall Study||144
6737144|NCT03261999|7666539|FG000|ITT|Overall Study||144
6737145|NCT03261999|7666539|FG000|PP|Overall Study||132
6737146|NCT03261999|7666539|FG000|COMPLETED|Overall Study||129
6737147|NCT03261999|7666539|FG000|NOT COMPLETED|Overall Study||15
6737148|NCT03262012|7666547|FG000|STARTED|Overall Study||139
6737149|NCT03262012|7666548|FG001|STARTED|Overall Study||138
6737150|NCT03262012|7666549|FG002|STARTED|Overall Study||70
6737151|NCT03262012|7666550|FG003|STARTED|Overall Study||69
6737152|NCT03262012|7666547|FG000|COMPLETED|Overall Study||112
6737153|NCT03262012|7666548|FG001|COMPLETED|Overall Study||102
6737154|NCT03262012|7666549|FG002|COMPLETED|Overall Study||56
6737155|NCT03262012|7666550|FG003|COMPLETED|Overall Study||54
6737156|NCT03262012|7666547|FG000|NOT COMPLETED|Overall Study||27
6737157|NCT03262012|7666548|FG001|NOT COMPLETED|Overall Study||36
6737158|NCT03262012|7666549|FG002|NOT COMPLETED|Overall Study||14
6737159|NCT03262012|7666550|FG003|NOT COMPLETED|Overall Study||15
6737160|NCT03262038|7666562|FG000|STARTED|Overall Study||18
6737161|NCT03262038|7666563|FG001|STARTED|Overall Study||28
6737162|NCT03262038|7666562|FG000|COMPLETED|Overall Study||18
6737163|NCT03262038|7666563|FG001|COMPLETED|Overall Study||27
6737164|NCT03262038|7666562|FG000|NOT COMPLETED|Overall Study||0
6737165|NCT03262038|7666563|FG001|NOT COMPLETED|Overall Study||1
6737166|NCT03262233|7666573|FG000|STARTED|Overall Study||53
6737167|NCT03262233|7666574|FG001|STARTED|Overall Study||53
6737168|NCT03262233|7666575|FG002|STARTED|Overall Study||59
6737169|NCT03262233|7666576|FG003|STARTED|Overall Study||61
6737170|NCT03262233|7666573|FG000|COMPLETED|Overall Study||35
6737171|NCT03262233|7666574|FG001|COMPLETED|Overall Study||32
6737172|NCT03262233|7666575|FG002|COMPLETED|Overall Study||34
6737173|NCT03262233|7666576|FG003|COMPLETED|Overall Study||32
6737174|NCT03262233|7666573|FG000|NOT COMPLETED|Overall Study||18
6737175|NCT03262233|7666574|FG001|NOT COMPLETED|Overall Study||21
6737176|NCT03262233|7666575|FG002|NOT COMPLETED|Overall Study||25
6737177|NCT03262233|7666576|FG003|NOT COMPLETED|Overall Study||29
6737178|NCT03262389|7666587|FG000|STARTED|Overall Study||10
6737179|NCT03262389|7666587|FG000|COMPLETED|Overall Study||7
6737180|NCT03262389|7666587|FG000|NOT COMPLETED|Overall Study||3
6737181|NCT03262441|7666591|FG000|STARTED|Overall Study||5
6737182|NCT03262441|7666591|FG000|COMPLETED|Overall Study||4
6737183|NCT03262441|7666591|FG000|NOT COMPLETED|Overall Study||1
6737184|NCT03263442|7666597|FG000|STARTED|Inpatient Phase||30
6737185|NCT03263442|7666598|FG001|STARTED|Inpatient Phase||34
6737186|NCT03263442|7666597|FG000|COMPLETED|Inpatient Phase||28
6737187|NCT03263442|7666598|FG001|COMPLETED|Inpatient Phase||33
6737188|NCT03263442|7666597|FG000|NOT COMPLETED|Inpatient Phase||2
6737189|NCT03263442|7666598|FG001|NOT COMPLETED|Inpatient Phase||1
6737190|NCT03263442|7666597|FG000|STARTED|1-month Follow-Up||28
6737191|NCT03263442|7666598|FG001|STARTED|1-month Follow-Up||33
6737192|NCT03263442|7666597|FG000|COMPLETED|1-month Follow-Up||27
6737193|NCT03263442|7666598|FG001|COMPLETED|1-month Follow-Up||33
6737194|NCT03263442|7666597|FG000|NOT COMPLETED|1-month Follow-Up||1
6737195|NCT03263442|7666598|FG001|NOT COMPLETED|1-month Follow-Up||0
6737196|NCT03263442|7666597|FG000|STARTED|3-month Follow-Up||27
6737197|NCT03263442|7666598|FG001|STARTED|3-month Follow-Up||33
6737198|NCT03263442|7666597|FG000|COMPLETED|3-month Follow-Up||26
6737199|NCT03263442|7666598|FG001|COMPLETED|3-month Follow-Up||30
6737200|NCT03263442|7666597|FG000|NOT COMPLETED|3-month Follow-Up||1
6737201|NCT03263442|7666598|FG001|NOT COMPLETED|3-month Follow-Up||3
6737202|NCT03263442|7666597|FG000|STARTED|6-month Follow-Up||26
6737203|NCT03263442|7666598|FG001|STARTED|6-month Follow-Up||30
6737204|NCT03263442|7666597|FG000|COMPLETED|6-month Follow-Up||24
6737205|NCT03263442|7666598|FG001|COMPLETED|6-month Follow-Up||28
6737206|NCT03263442|7666597|FG000|NOT COMPLETED|6-month Follow-Up||2
6737207|NCT03263442|7666598|FG001|NOT COMPLETED|6-month Follow-Up||2
6737208|NCT03263702|7666608|FG000|STARTED|Overall Study||38
6737209|NCT03263702|7666609|FG001|STARTED|Overall Study||26
6737210|NCT03263702|7666608|FG000|COMPLETED|Overall Study||35
6737211|NCT03263702|7666609|FG001|COMPLETED|Overall Study||22
6737212|NCT03263702|7666608|FG000|NOT COMPLETED|Overall Study||3
6737213|NCT03263702|7666609|FG001|NOT COMPLETED|Overall Study||4
6737214|NCT03263780|7666615|FG000|STARTED|Overall Study||21
6737215|NCT03263780|7666615|FG000|COMPLETED|Overall Study|13 evaluable for primary outcome, but 11 total completed study.|11
6737216|NCT03263780|7666615|FG000|NOT COMPLETED|Overall Study||10
6737217|NCT03264066|7666625|FG000|STARTED|Overall Study||20
6737218|NCT03264066|7666626|FG001|STARTED|Overall Study||20
6737219|NCT03264066|7666627|FG002|STARTED|Overall Study||17
6737220|NCT03264066|7666628|FG003|STARTED|Overall Study||20
6737221|NCT03264066|7666629|FG004|STARTED|Overall Study||7
6737222|NCT03264066|7666630|FG005|STARTED|Overall Study||3
6737223|NCT03264066|7666625|FG000|COMPLETED|Overall Study||0
6737224|NCT03264066|7666626|FG001|COMPLETED|Overall Study||0
6737225|NCT03264066|7666627|FG002|COMPLETED|Overall Study||0
6737226|NCT03264066|7666628|FG003|COMPLETED|Overall Study||0
6737227|NCT03264066|7666629|FG004|COMPLETED|Overall Study||0
6737228|NCT03264066|7666630|FG005|COMPLETED|Overall Study||0
6737229|NCT03264066|7666625|FG000|NOT COMPLETED|Overall Study||20
6737230|NCT03264066|7666626|FG001|NOT COMPLETED|Overall Study||20
6737231|NCT03264066|7666627|FG002|NOT COMPLETED|Overall Study||17
6737232|NCT03264066|7666628|FG003|NOT COMPLETED|Overall Study||20
6737233|NCT03264066|7666629|FG004|NOT COMPLETED|Overall Study||7
6737234|NCT03264066|7666630|FG005|NOT COMPLETED|Overall Study||3
6737235|NCT03264092|7666648|FG000|STARTED|Overall Study||17
6737236|NCT03264092|7666649|FG001|STARTED|Overall Study||20
6737237|NCT03264092|7666650|FG002|STARTED|Overall Study||18
6737238|NCT03264092|7666648|FG000|COMPLETED|Overall Study||17
6737239|NCT03264092|7666649|FG001|COMPLETED|Overall Study||20
6737240|NCT03264092|7666650|FG002|COMPLETED|Overall Study||18
6737241|NCT03264092|7666648|FG000|NOT COMPLETED|Overall Study||0
6737242|NCT03264092|7666649|FG001|NOT COMPLETED|Overall Study||0
6737243|NCT03264092|7666650|FG002|NOT COMPLETED|Overall Study||0
6737244|NCT03264157|7666666|FG000|STARTED|Overall Study||81
6737245|NCT03264157|7666667|FG001|STARTED|Overall Study||81
6737246|NCT03264157|7666666|FG000|COMPLETED|Overall Study||68
6737247|NCT03264157|7666667|FG001|COMPLETED|Overall Study||74
6737248|NCT03264157|7666666|FG000|NOT COMPLETED|Overall Study||13
6737249|NCT03264157|7666667|FG001|NOT COMPLETED|Overall Study||7
6737250|NCT03264248|7666675|FG000|STARTED|Overall Study||9
6737251|NCT03264248|7666675|FG000|COMPLETED|Overall Study||9
6737252|NCT03264248|7666675|FG000|NOT COMPLETED|Overall Study||0
6737253|NCT03264456|7666679|FG000|STARTED|Overall Study||18
6737254|NCT03264456|7666679|FG000|COMPLETED|Overall Study||14
6737255|NCT03264456|7666679|FG000|NOT COMPLETED|Overall Study||4
6737256|NCT03265119|7666685|FG000|STARTED|Overall Study||34
6737257|NCT03265119|7666686|FG001|STARTED|Overall Study||35
6737258|NCT03265119|7666685|FG000|COMPLETED|Overall Study||24
6737259|NCT03265119|7666686|FG001|COMPLETED|Overall Study||28
6737260|NCT03265119|7666685|FG000|NOT COMPLETED|Overall Study||10
6737261|NCT03265119|7666686|FG001|NOT COMPLETED|Overall Study||7
6737262|NCT03265132|7666694|FG000|STARTED|Overall Study||6
6737263|NCT03265132|7666695|FG001|STARTED|Overall Study|One patient failed disease specific inclusion criteria and was excluded from efficacy analysis|6
6737264|NCT03265132|7666694|FG000|COMPLETED|Overall Study||6
6737265|NCT03265132|7666695|FG001|COMPLETED|Overall Study||0
6737266|NCT03265132|7666694|FG000|NOT COMPLETED|Overall Study||0
6737267|NCT03265132|7666695|FG001|NOT COMPLETED|Overall Study||6
6737268|NCT03265600|7666705|FG000|STARTED|Overall Study||92
6737269|NCT03265600|7666706|FG001|STARTED|Overall Study||44
6737270|NCT03265600|7666705|FG000|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|68
6737271|NCT03265600|7666706|FG001|COMPLETED|Overall Study|Completed 8 or 9 week Action Plan Initiation Survey|32
6737272|NCT03265600|7666705|FG000|NOT COMPLETED|Overall Study||24
6737273|NCT03265600|7666706|FG001|NOT COMPLETED|Overall Study||12
6737274|NCT03265938|7666712|FG000|STARTED|Overall Study||100
6737275|NCT03265938|7666712|FG000|COMPLETED|Overall Study||92
6737276|NCT03265938|7666712|FG000|NOT COMPLETED|Overall Study||8
6737277|NCT03266094|7666717|FG000|STARTED|Overall Study||60
6737278|NCT03266094|7666717|FG000|COMPLETED|Overall Study||58
6737279|NCT03266094|7666717|FG000|NOT COMPLETED|Overall Study||2
6737280|NCT03266107|7666723|FG000|STARTED|Enrollment to Procedure||50
6737281|NCT03266107|7666723|FG000|COMPLETED|Enrollment to Procedure||47
6737282|NCT03266107|7666723|FG000|NOT COMPLETED|Enrollment to Procedure||3
6737283|NCT03266107|7666723|FG000|STARTED|3-Month Follow-up Visit||47
6737284|NCT03266107|7666723|FG000|COMPLETED|3-Month Follow-up Visit||46
6737285|NCT03266107|7666723|FG000|NOT COMPLETED|3-Month Follow-up Visit||1
6737286|NCT03266107|7666723|FG000|STARTED|12-Month Follow-up Visit||46
6737287|NCT03266107|7666723|FG000|COMPLETED|12-Month Follow-up Visit||45
6737288|NCT03266107|7666723|FG000|NOT COMPLETED|12-Month Follow-up Visit||1
6737289|NCT03266172|7666732|FG000|STARTED|Part A: Period 1(2 Days)||16
6737290|NCT03266172|7666733|FG001|STARTED|Part A: Period 1(2 Days)||0
6737291|NCT03266172|7666734|FG002|STARTED|Part A: Period 1(2 Days)||0
6737292|NCT03266172|7666732|FG000|COMPLETED|Part A: Period 1(2 Days)||15
6737293|NCT03266172|7666733|FG001|COMPLETED|Part A: Period 1(2 Days)||0
6737294|NCT03266172|7666734|FG002|COMPLETED|Part A: Period 1(2 Days)||0
6737295|NCT03266172|7666732|FG000|NOT COMPLETED|Part A: Period 1(2 Days)||1
6737296|NCT03266172|7666733|FG001|NOT COMPLETED|Part A: Period 1(2 Days)||0
6737297|NCT03266172|7666734|FG002|NOT COMPLETED|Part A: Period 1(2 Days)||0
6737298|NCT03266172|7666732|FG000|STARTED|Part A: Washout Period (7 Days)||15
6737299|NCT03266172|7666733|FG001|STARTED|Part A: Washout Period (7 Days)||0
6737300|NCT03266172|7666734|FG002|STARTED|Part A: Washout Period (7 Days)||0
6737301|NCT03266172|7666732|FG000|COMPLETED|Part A: Washout Period (7 Days)||13
6737302|NCT03266172|7666733|FG001|COMPLETED|Part A: Washout Period (7 Days)||0
6737303|NCT03266172|7666734|FG002|COMPLETED|Part A: Washout Period (7 Days)||0
6737304|NCT03266172|7666732|FG000|NOT COMPLETED|Part A: Washout Period (7 Days)||2
6737305|NCT03266172|7666733|FG001|NOT COMPLETED|Part A: Washout Period (7 Days)||0
6737306|NCT03266172|7666734|FG002|NOT COMPLETED|Part A: Washout Period (7 Days)||0
6268260|NCT00064077|7167439|FG002|COMPLETED|Overall Study|Evaluable (treatment)|112
6268261|NCT00064077|7167440|FG003|COMPLETED|Overall Study|Evaluable (treatment)|111
6268262|NCT00064077|7167437|FG000|NOT COMPLETED|Overall Study||15
6268263|NCT00064077|7167438|FG001|NOT COMPLETED|Overall Study||9
6268264|NCT00064077|7167439|FG002|NOT COMPLETED|Overall Study||7
6268265|NCT00064077|7167440|FG003|NOT COMPLETED|Overall Study||7
6268266|NCT00064259|7167450|FG000|STARTED|Overall Study||4
6268267|NCT00064259|7167451|FG001|STARTED|Overall Study||4
6268268|NCT00064259|7167452|FG002|STARTED|Overall Study||6
6268269|NCT00064259|7167453|FG003|STARTED|Overall Study||1
6268270|NCT00064259|7167450|FG000|COMPLETED|Overall Study||3
6268271|NCT00064259|7167451|FG001|COMPLETED|Overall Study||4
6268272|NCT00064259|7167452|FG002|COMPLETED|Overall Study||6
6268273|NCT00064259|7167453|FG003|COMPLETED|Overall Study||0
6268274|NCT00064259|7167450|FG000|NOT COMPLETED|Overall Study||1
6268275|NCT00064259|7167451|FG001|NOT COMPLETED|Overall Study||0
6268276|NCT00064259|7167452|FG002|NOT COMPLETED|Overall Study||0
6268277|NCT00064259|7167453|FG003|NOT COMPLETED|Overall Study||1
6268278|NCT00064298|7167460|FG000|STARTED|Overall Study||72
6268279|NCT00064298|7167461|FG001|STARTED|Overall Study||62
6268280|NCT00064298|7167460|FG000|COMPLETED|Overall Study||66
6268281|NCT00064298|7167461|FG001|COMPLETED|Overall Study||57
6268282|NCT00064298|7167460|FG000|NOT COMPLETED|Overall Study||6
6268283|NCT00064298|7167461|FG001|NOT COMPLETED|Overall Study||5
6268284|NCT00064337|7167467|FG000|STARTED|PBSCC or Induction/PBSCC|104 patients were registered, 93 of whom were eligible and analyzable.|93
6268285|NCT00064337|7167467|FG000|COMPLETED|PBSCC or Induction/PBSCC||73
6268286|NCT00064337|7167467|FG000|NOT COMPLETED|PBSCC or Induction/PBSCC||20
6268287|NCT00064337|7167467|FG000|STARTED|Transplant|6 patients who completed PBSCC or Induction/PBSCC did not begin Transplant|67
6268288|NCT00064337|7167467|FG000|COMPLETED|Transplant||46
6268289|NCT00064337|7167467|FG000|NOT COMPLETED|Transplant||21
6268290|NCT00064337|7167467|FG000|STARTED|Maintenance|Only patients with High Risk MM or AL + MM were allowed to enroll to Maintenance treatment.|13
6268291|NCT00064337|7167467|FG000|COMPLETED|Maintenance||3
6268292|NCT00064337|7167467|FG000|NOT COMPLETED|Maintenance||10
6268293|NCT00064350|7167477|FG000|STARTED|Induction Treatment||59
6268294|NCT00064350|7167478|FG001|STARTED|Induction Treatment||46
6268295|NCT00064350|7167479|FG002|STARTED|Induction Treatment||237
6268296|NCT00064350|7167477|FG000|Treated|Induction Treatment||59
6268297|NCT00064350|7167478|FG001|Treated|Induction Treatment||46
6268298|NCT00064350|7167479|FG002|Treated|Induction Treatment||228
6268299|NCT00064350|7167477|FG000|Eligible and Treated|Induction Treatment||59
6268300|NCT00064350|7167478|FG001|Eligible and Treated|Induction Treatment||46
6268301|NCT00064350|7167479|FG002|Eligible and Treated|Induction Treatment||194
6268302|NCT00064350|7167477|FG000|COMPLETED|Induction Treatment||51
6268303|NCT00064350|7167478|FG001|COMPLETED|Induction Treatment||37
6268304|NCT00064350|7167479|FG002|COMPLETED|Induction Treatment||1
6268305|NCT00064350|7167477|FG000|NOT COMPLETED|Induction Treatment||8
6268306|NCT00064350|7167478|FG001|NOT COMPLETED|Induction Treatment||9
6268307|NCT00064350|7167479|FG002|NOT COMPLETED|Induction Treatment||236
6268308|NCT00064350|7167477|FG000|STARTED|Randomization||59
6268309|NCT00064350|7167478|FG001|STARTED|Randomization||46
6268310|NCT00064350|7167479|FG002|STARTED|Randomization||0
6268311|NCT00064350|7167477|FG000|Treated|Randomization||55
6268312|NCT00064350|7167478|FG001|Treated|Randomization||40
6268313|NCT00064350|7167479|FG002|Treated|Randomization||0
6737307|NCT03266172|7666732|FG000|STARTED|Part A: Period 2 (2 Days)||13
6737308|NCT03266172|7666733|FG001|STARTED|Part A: Period 2 (2 Days)||0
6737309|NCT03266172|7666734|FG002|STARTED|Part A: Period 2 (2 Days)||0
6737310|NCT03266172|7666732|FG000|COMPLETED|Part A: Period 2 (2 Days)||13
6737311|NCT03266172|7666733|FG001|COMPLETED|Part A: Period 2 (2 Days)||0
6737312|NCT03266172|7666734|FG002|COMPLETED|Part A: Period 2 (2 Days)||0
6737313|NCT03266172|7666732|FG000|NOT COMPLETED|Part A: Period 2 (2 Days)||0
6737314|NCT03266172|7666733|FG001|NOT COMPLETED|Part A: Period 2 (2 Days)||0
6737315|NCT03266172|7666734|FG002|NOT COMPLETED|Part A: Period 2 (2 Days)||0
6737316|NCT03266172|7666732|FG000|STARTED|Part A: Washout (7 Days)||13
6737317|NCT03266172|7666733|FG001|STARTED|Part A: Washout (7 Days)||0
6737318|NCT03266172|7666734|FG002|STARTED|Part A: Washout (7 Days)||0
6737319|NCT03266172|7666732|FG000|COMPLETED|Part A: Washout (7 Days)||13
6737320|NCT03266172|7666733|FG001|COMPLETED|Part A: Washout (7 Days)||0
6737321|NCT03266172|7666734|FG002|COMPLETED|Part A: Washout (7 Days)||0
6737322|NCT03266172|7666732|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
6737323|NCT03266172|7666733|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
6737324|NCT03266172|7666734|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
6737325|NCT03266172|7666732|FG000|STARTED|Part A: Period 3 (2 Days)|3 replacement participants were enrolled|16
6737326|NCT03266172|7666733|FG001|STARTED|Part A: Period 3 (2 Days)||0
6737327|NCT03266172|7666734|FG002|STARTED|Part A: Period 3 (2 Days)||0
6737328|NCT03266172|7666732|FG000|COMPLETED|Part A: Period 3 (2 Days)||16
6737329|NCT03266172|7666733|FG001|COMPLETED|Part A: Period 3 (2 Days)||0
6737330|NCT03266172|7666734|FG002|COMPLETED|Part A: Period 3 (2 Days)||0
6737331|NCT03266172|7666732|FG000|NOT COMPLETED|Part A: Period 3 (2 Days)||0
6737332|NCT03266172|7666733|FG001|NOT COMPLETED|Part A: Period 3 (2 Days)||0
6737333|NCT03266172|7666734|FG002|NOT COMPLETED|Part A: Period 3 (2 Days)||0
6737334|NCT03266172|7666732|FG000|STARTED|Part A: Washout (7 Days)||16
6737335|NCT03266172|7666733|FG001|STARTED|Part A: Washout (7 Days)||0
6737336|NCT03266172|7666734|FG002|STARTED|Part A: Washout (7 Days)||0
6737337|NCT03266172|7666732|FG000|COMPLETED|Part A: Washout (7 Days)||16
6737338|NCT03266172|7666733|FG001|COMPLETED|Part A: Washout (7 Days)||0
6737339|NCT03266172|7666734|FG002|COMPLETED|Part A: Washout (7 Days)||0
6737340|NCT03266172|7666732|FG000|NOT COMPLETED|Part A: Washout (7 Days)||0
6737341|NCT03266172|7666733|FG001|NOT COMPLETED|Part A: Washout (7 Days)||0
6737342|NCT03266172|7666734|FG002|NOT COMPLETED|Part A: Washout (7 Days)||0
6737343|NCT03266172|7666732|FG000|STARTED|Part A: Period 4 (2 Days)||16
6737344|NCT03266172|7666733|FG001|STARTED|Part A: Period 4 (2 Days)||0
6737345|NCT03266172|7666734|FG002|STARTED|Part A: Period 4 (2 Days)||0
6737346|NCT03266172|7666732|FG000|COMPLETED|Part A: Period 4 (2 Days)||16
6737347|NCT03266172|7666733|FG001|COMPLETED|Part A: Period 4 (2 Days)||0
6737348|NCT03266172|7666734|FG002|COMPLETED|Part A: Period 4 (2 Days)||0
6737349|NCT03266172|7666732|FG000|NOT COMPLETED|Part A: Period 4 (2 Days)||0
6737350|NCT03266172|7666733|FG001|NOT COMPLETED|Part A: Period 4 (2 Days)||0
6737351|NCT03266172|7666734|FG002|NOT COMPLETED|Part A: Period 4 (2 Days)||0
6737352|NCT03266172|7666732|FG000|STARTED|Part B: Period 1 (4 Days)|Participants from Part A did not enter Part B|0
6737353|NCT03266172|7666733|FG001|STARTED|Part B: Period 1 (4 Days)|New participants were enrolled in Part B of study|10
6737354|NCT03266172|7666734|FG002|STARTED|Part B: Period 1 (4 Days)||0
6737355|NCT03266172|7666732|FG000|COMPLETED|Part B: Period 1 (4 Days)||0
6737356|NCT03266172|7666733|FG001|COMPLETED|Part B: Period 1 (4 Days)||10
6737357|NCT03266172|7666734|FG002|COMPLETED|Part B: Period 1 (4 Days)||0
6737358|NCT03266172|7666732|FG000|NOT COMPLETED|Part B: Period 1 (4 Days)||0
6737359|NCT03266172|7666733|FG001|NOT COMPLETED|Part B: Period 1 (4 Days)||0
6737360|NCT03266172|7666734|FG002|NOT COMPLETED|Part B: Period 1 (4 Days)||0
6737361|NCT03266172|7666732|FG000|STARTED|Part B: Washout (7 Days)||0
6737362|NCT03266172|7666733|FG001|STARTED|Part B: Washout (7 Days)||10
6737363|NCT03266172|7666734|FG002|STARTED|Part B: Washout (7 Days)||0
6737364|NCT03266172|7666732|FG000|COMPLETED|Part B: Washout (7 Days)||0
6737365|NCT03266172|7666733|FG001|COMPLETED|Part B: Washout (7 Days)||10
6737366|NCT03266172|7666734|FG002|COMPLETED|Part B: Washout (7 Days)||0
6737367|NCT03266172|7666732|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
6737368|NCT03266172|7666733|FG001|NOT COMPLETED|Part B: Washout (7 Days)||0
6737369|NCT03266172|7666734|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
6737370|NCT03266172|7666732|FG000|STARTED|Part B: Period 2 (4 Days)||0
6737371|NCT03266172|7666733|FG001|STARTED|Part B: Period 2 (4 Days)||10
6737372|NCT03266172|7666734|FG002|STARTED|Part B: Period 2 (4 Days)||0
6737373|NCT03266172|7666732|FG000|COMPLETED|Part B: Period 2 (4 Days)||0
6737374|NCT03266172|7666733|FG001|COMPLETED|Part B: Period 2 (4 Days)||10
6737375|NCT03266172|7666734|FG002|COMPLETED|Part B: Period 2 (4 Days)||0
6737376|NCT03266172|7666732|FG000|NOT COMPLETED|Part B: Period 2 (4 Days)||0
6737377|NCT03266172|7666733|FG001|NOT COMPLETED|Part B: Period 2 (4 Days)||0
6737378|NCT03266172|7666734|FG002|NOT COMPLETED|Part B: Period 2 (4 Days)||0
6737379|NCT03266172|7666732|FG000|STARTED|Part B: Washout (7 Days)||0
6737380|NCT03266172|7666733|FG001|STARTED|Part B: Washout (7 Days)||10
6737381|NCT03266172|7666734|FG002|STARTED|Part B: Washout (7 Days)||0
6737382|NCT03266172|7666732|FG000|COMPLETED|Part B: Washout (7 Days)||0
6737383|NCT03266172|7666733|FG001|COMPLETED|Part B: Washout (7 Days)||8
6737384|NCT03266172|7666734|FG002|COMPLETED|Part B: Washout (7 Days)||0
6737385|NCT03266172|7666732|FG000|NOT COMPLETED|Part B: Washout (7 Days)||0
6737386|NCT03266172|7666733|FG001|NOT COMPLETED|Part B: Washout (7 Days)||2
6737387|NCT03266172|7666734|FG002|NOT COMPLETED|Part B: Washout (7 Days)||0
6737388|NCT03266172|7666732|FG000|STARTED|Part B: Period 3 (4 Days)||0
6737389|NCT03266172|7666733|FG001|STARTED|Part B: Period 3 (4 Days)|Two participants completed Washout Period but withdrew before the start of Period 3.|6
6737390|NCT03266172|7666734|FG002|STARTED|Part B: Period 3 (4 Days)||0
6737391|NCT03266172|7666732|FG000|COMPLETED|Part B: Period 3 (4 Days)||0
6737392|NCT03266172|7666733|FG001|COMPLETED|Part B: Period 3 (4 Days)||6
6737393|NCT03266172|7666734|FG002|COMPLETED|Part B: Period 3 (4 Days)||0
6737394|NCT03266172|7666732|FG000|NOT COMPLETED|Part B: Period 3 (4 Days)||0
6737395|NCT03266172|7666733|FG001|NOT COMPLETED|Part B: Period 3 (4 Days)||0
6737396|NCT03266172|7666734|FG002|NOT COMPLETED|Part B: Period 3 (4 Days)||0
6737397|NCT03266172|7666732|FG000|STARTED|Part C: Period 1(2 Days)||0
6737398|NCT03266172|7666733|FG001|STARTED|Part C: Period 1(2 Days)|Participants from Part B did not enter Part C|0
6737399|NCT03266172|7666734|FG002|STARTED|Part C: Period 1(2 Days)|New participants were enrolled in Part C of study|15
6737400|NCT03266172|7666732|FG000|COMPLETED|Part C: Period 1(2 Days)||0
6737401|NCT03266172|7666733|FG001|COMPLETED|Part C: Period 1(2 Days)||0
6737402|NCT03266172|7666734|FG002|COMPLETED|Part C: Period 1(2 Days)||15
6737403|NCT03266172|7666732|FG000|NOT COMPLETED|Part C: Period 1(2 Days)||0
6737404|NCT03266172|7666733|FG001|NOT COMPLETED|Part C: Period 1(2 Days)||0
6737405|NCT03266172|7666734|FG002|NOT COMPLETED|Part C: Period 1(2 Days)||0
6737406|NCT03266172|7666732|FG000|STARTED|Part C Washout Period (7 Days)||0
6737407|NCT03266172|7666733|FG001|STARTED|Part C Washout Period (7 Days)||0
6737408|NCT03266172|7666734|FG002|STARTED|Part C Washout Period (7 Days)||15
6737409|NCT03266172|7666732|FG000|COMPLETED|Part C Washout Period (7 Days)||0
6737410|NCT03266172|7666733|FG001|COMPLETED|Part C Washout Period (7 Days)||0
6737411|NCT03266172|7666734|FG002|COMPLETED|Part C Washout Period (7 Days)||15
6737412|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737413|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737414|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737415|NCT03266172|7666732|FG000|STARTED|Part C Period 2(2 Days)||0
6737416|NCT03266172|7666733|FG001|STARTED|Part C Period 2(2 Days)||0
6737417|NCT03266172|7666734|FG002|STARTED|Part C Period 2(2 Days)||15
6737418|NCT03266172|7666732|FG000|COMPLETED|Part C Period 2(2 Days)||0
6737419|NCT03266172|7666733|FG001|COMPLETED|Part C Period 2(2 Days)||0
6737420|NCT03266172|7666734|FG002|COMPLETED|Part C Period 2(2 Days)||15
6737421|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Period 2(2 Days)||0
6737422|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Period 2(2 Days)||0
6737423|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Period 2(2 Days)||0
6737424|NCT03266172|7666732|FG000|STARTED|Part C Washout Period (7 Days)||0
6737425|NCT03266172|7666733|FG001|STARTED|Part C Washout Period (7 Days)||0
6737426|NCT03266172|7666734|FG002|STARTED|Part C Washout Period (7 Days)||15
6737427|NCT03266172|7666732|FG000|COMPLETED|Part C Washout Period (7 Days)||0
6737428|NCT03266172|7666733|FG001|COMPLETED|Part C Washout Period (7 Days)||0
6737429|NCT03266172|7666734|FG002|COMPLETED|Part C Washout Period (7 Days)||15
6737430|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737431|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737432|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737433|NCT03266172|7666732|FG000|STARTED|Part C Period 3(2 Days)||0
6737434|NCT03266172|7666733|FG001|STARTED|Part C Period 3(2 Days)||0
6268314|NCT00064350|7167477|FG000|Eligible and Treated|Randomization||50
6268315|NCT00064350|7167478|FG001|Eligible and Treated|Randomization||31
6268316|NCT00064350|7167479|FG002|Eligible and Treated|Randomization||0
6268317|NCT00064350|7167477|FG000|COMPLETED|Randomization||33
6268318|NCT00064350|7167478|FG001|COMPLETED|Randomization||28
6268319|NCT00064350|7167479|FG002|COMPLETED|Randomization||0
6268320|NCT00064350|7167477|FG000|NOT COMPLETED|Randomization||26
6268321|NCT00064350|7167478|FG001|NOT COMPLETED|Randomization||18
6268322|NCT00064350|7167479|FG002|NOT COMPLETED|Randomization||0
6268323|NCT00064350|7167477|FG000|STARTED|Cross-Over||10
6268324|NCT00064350|7167478|FG001|STARTED|Cross-Over||27
6268325|NCT00064350|7167479|FG002|STARTED|Cross-Over||0
6268326|NCT00064350|7167477|FG000|Treated|Cross-Over||9
6268327|NCT00064350|7167478|FG001|Treated|Cross-Over||26
6268328|NCT00064350|7167479|FG002|Treated|Cross-Over||0
6268329|NCT00064350|7167477|FG000|Eligible and Treated|Cross-Over||7
6268330|NCT00064350|7167478|FG001|Eligible and Treated|Cross-Over||21
6268331|NCT00064350|7167479|FG002|Eligible and Treated|Cross-Over||0
6268332|NCT00064350|7167477|FG000|COMPLETED|Cross-Over||4
6268333|NCT00064350|7167478|FG001|COMPLETED|Cross-Over||13
6268334|NCT00064350|7167479|FG002|COMPLETED|Cross-Over||0
6268335|NCT00064350|7167477|FG000|NOT COMPLETED|Cross-Over||6
6268336|NCT00064350|7167478|FG001|NOT COMPLETED|Cross-Over||14
6268337|NCT00064350|7167479|FG002|NOT COMPLETED|Cross-Over||0
6268338|NCT00064662|7167490|FG000|STARTED|Overall Study||329
6268339|NCT00064662|7167491|FG001|STARTED|Overall Study||326
6268340|NCT00064662|7167490|FG000|COMPLETED|Overall Study||255
6268341|NCT00064662|7167491|FG001|COMPLETED|Overall Study||265
6268342|NCT00064662|7167490|FG000|NOT COMPLETED|Overall Study||74
6268343|NCT00064662|7167491|FG001|NOT COMPLETED|Overall Study||61
6268344|NCT00064701|7167500|FG000|STARTED|One Year Post-transplant||219
6268345|NCT00064701|7167501|FG001|STARTED|One Year Post-transplant||226
6268346|NCT00064701|7167502|FG002|STARTED|One Year Post-transplant||223
6268347|NCT00064701|7167500|FG000|Received Study Drug|One Year Post-transplant||212
6268348|NCT00064701|7167501|FG001|Received Study Drug|One Year Post-transplant||214
6268349|NCT00064701|7167502|FG002|Received Study Drug|One Year Post-transplant||212
6268350|NCT00064701|7167500|FG000|COMPLETED|One Year Post-transplant||179
6268351|NCT00064701|7167501|FG001|COMPLETED|One Year Post-transplant||183
6268352|NCT00064701|7167502|FG002|COMPLETED|One Year Post-transplant||151
6268353|NCT00064701|7167500|FG000|NOT COMPLETED|One Year Post-transplant||40
6268354|NCT00064701|7167501|FG001|NOT COMPLETED|One Year Post-transplant||43
6268355|NCT00064701|7167502|FG002|NOT COMPLETED|One Year Post-transplant||72
6268356|NCT00064701|7167500|FG000|STARTED|Clinical Continuation Phase||179
6268357|NCT00064701|7167501|FG001|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
6268358|NCT00064701|7167502|FG002|STARTED|Clinical Continuation Phase||151
6268359|NCT00064701|7167500|FG000|COMPLETED|Clinical Continuation Phase||9
6268360|NCT00064701|7167501|FG001|COMPLETED|Clinical Continuation Phase||4
6268361|NCT00064701|7167502|FG002|COMPLETED|Clinical Continuation Phase||11
6268362|NCT00064701|7167500|FG000|NOT COMPLETED|Clinical Continuation Phase||170
6268363|NCT00064701|7167501|FG001|NOT COMPLETED|Clinical Continuation Phase||178
6268364|NCT00064701|7167502|FG002|NOT COMPLETED|Clinical Continuation Phase||140
6268365|NCT00064753|7167512|FG000|STARTED|Overall Study||2056
6268366|NCT00064753|7167513|FG001|STARTED|Overall Study||2054
6268367|NCT00064753|7167512|FG000|COMPLETED|Overall Study||1382
6268368|NCT00064753|7167513|FG001|COMPLETED|Overall Study||1406
6268369|NCT00064753|7167512|FG000|NOT COMPLETED|Overall Study||674
6268370|NCT00064753|7167513|FG001|NOT COMPLETED|Overall Study||648
6268371|NCT00064792|7167521|FG000|STARTED|Overall Study||13
6268372|NCT00064792|7167522|FG001|STARTED|Overall Study||10
6268373|NCT00064792|7167521|FG000|COMPLETED|Overall Study||8
6268374|NCT00064792|7167522|FG001|COMPLETED|Overall Study||10
6268375|NCT00064792|7167521|FG000|NOT COMPLETED|Overall Study||5
6268376|NCT00064792|7167522|FG001|NOT COMPLETED|Overall Study||0
6268377|NCT00064844|7167530|FG000|STARTED|Overall Study||45
6268378|NCT00064844|7167531|FG001|STARTED|Overall Study||51
6268379|NCT00064844|7167530|FG000|2 Week Follow-up|Overall Study||45
6268380|NCT00064844|7167531|FG001|2 Week Follow-up|Overall Study||51
6268381|NCT00064844|7167530|FG000|3 Month Follow-up|Overall Study||40
6268382|NCT00064844|7167531|FG001|3 Month Follow-up|Overall Study||47
6268383|NCT00064844|7167530|FG000|6 Month Follow-up|Overall Study||39
6268384|NCT00064844|7167531|FG001|6 Month Follow-up|Overall Study||40
6268385|NCT00064844|7167530|FG000|12 Month Follow-up|Overall Study||37
6268386|NCT00064844|7167531|FG001|12 Month Follow-up|Overall Study||32
6268387|NCT00064844|7167530|FG000|COMPLETED|Overall Study||37
6268388|NCT00064844|7167531|FG001|COMPLETED|Overall Study||32
6268389|NCT00064844|7167530|FG000|NOT COMPLETED|Overall Study||8
6268390|NCT00064844|7167531|FG001|NOT COMPLETED|Overall Study||19
6268391|NCT00064987|7167539|FG000|STARTED|Overall Study||10
6268392|NCT00064987|7167540|FG001|STARTED|Overall Study||6
6268393|NCT00064987|7167539|FG000|COMPLETED|Overall Study||7
6268394|NCT00064987|7167540|FG001|COMPLETED|Overall Study||6
6268395|NCT00064987|7167539|FG000|NOT COMPLETED|Overall Study||3
6268396|NCT00064987|7167540|FG001|NOT COMPLETED|Overall Study||0
6268397|NCT00065065|7167548|FG000|STARTED|Overall Study||52
6268398|NCT00065065|7167549|FG001|STARTED|Overall Study||53
6268399|NCT00065065|7167548|FG000|COMPLETED|Overall Study||42
6268400|NCT00065065|7167549|FG001|COMPLETED|Overall Study||33
6268401|NCT00065065|7167548|FG000|NOT COMPLETED|Overall Study||10
6268402|NCT00065065|7167549|FG001|NOT COMPLETED|Overall Study||20
6268403|NCT00065156|7167557|FG000|STARTED|Overall Study||148
6268404|NCT00065156|7167557|FG000|Modified Intent to Treat Population|Overall Study||94
6268405|NCT00065156|7167557|FG000|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
6268406|NCT00065156|7167557|FG000|NOT COMPLETED|Overall Study||124
6268407|NCT00065182|7167563|FG000|STARTED|Overall Study||202
6268408|NCT00065182|7167564|FG001|STARTED|Overall Study||197
6268409|NCT00065182|7167563|FG000|COMPLETED|Overall Study||154
6268410|NCT00065182|7167564|FG001|COMPLETED|Overall Study||160
6268411|NCT00065182|7167563|FG000|NOT COMPLETED|Overall Study||48
6268412|NCT00065182|7167564|FG001|NOT COMPLETED|Overall Study||37
6268413|NCT00065260|7167572|FG000|STARTED|Overall Study||27
6268414|NCT00065260|7167573|FG001|STARTED|Overall Study||27
6268415|NCT00065260|7167572|FG000|COMPLETED|Overall Study||27
6268416|NCT00065260|7167573|FG001|COMPLETED|Overall Study||26
6268417|NCT00065260|7167572|FG000|NOT COMPLETED|Overall Study||0
6268418|NCT00065260|7167573|FG001|NOT COMPLETED|Overall Study||1
6268419|NCT00065429|7167586|FG000|STARTED|Phase I - May 2001 - Oct 2002||4
6268420|NCT00065429|7167587|FG001|STARTED|Phase I - May 2001 - Oct 2002||3
6268421|NCT00065429|7167588|FG002|STARTED|Phase I - May 2001 - Oct 2002||4
6268422|NCT00065429|7167589|FG003|STARTED|Phase I - May 2001 - Oct 2002||4
6268423|NCT00065429|7167590|FG004|STARTED|Phase I - May 2001 - Oct 2002||9
6268424|NCT00065429|7167591|FG005|STARTED|Phase I - May 2001 - Oct 2002||4
6268425|NCT00065429|7167592|FG006|STARTED|Phase I - May 2001 - Oct 2002||4
6268426|NCT00065429|7167586|FG000|COMPLETED|Phase I - May 2001 - Oct 2002||3
6268427|NCT00065429|7167587|FG001|COMPLETED|Phase I - May 2001 - Oct 2002||3
6268428|NCT00065429|7167588|FG002|COMPLETED|Phase I - May 2001 - Oct 2002||3
6268429|NCT00065429|7167589|FG003|COMPLETED|Phase I - May 2001 - Oct 2002||3
6268430|NCT00065429|7167590|FG004|COMPLETED|Phase I - May 2001 - Oct 2002||8
6268431|NCT00065429|7167591|FG005|COMPLETED|Phase I - May 2001 - Oct 2002||2
6268432|NCT00065429|7167592|FG006|COMPLETED|Phase I - May 2001 - Oct 2002||2
6268433|NCT00065429|7167586|FG000|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
6268434|NCT00065429|7167587|FG001|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
6268435|NCT00065429|7167588|FG002|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
6268436|NCT00065429|7167589|FG003|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
6268437|NCT00065429|7167590|FG004|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
6268438|NCT00065429|7167591|FG005|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
6268439|NCT00065429|7167592|FG006|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
6268440|NCT00065429|7167586|FG000|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6268441|NCT00065429|7167587|FG001|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6268442|NCT00065429|7167588|FG002|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6268443|NCT00065429|7167589|FG003|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6268444|NCT00065429|7167590|FG004|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
6268445|NCT00065429|7167591|FG005|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6268446|NCT00065429|7167592|FG006|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
6268447|NCT00065429|7167586|FG000|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268448|NCT00065429|7167587|FG001|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268449|NCT00065429|7167588|FG002|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268450|NCT00065429|7167589|FG003|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268451|NCT00065429|7167590|FG004|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
6268452|NCT00065429|7167591|FG005|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268453|NCT00065429|7167592|FG006|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268454|NCT00065429|7167586|FG000|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268455|NCT00065429|7167587|FG001|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268456|NCT00065429|7167588|FG002|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268457|NCT00065429|7167589|FG003|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268458|NCT00065429|7167590|FG004|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
6268459|NCT00065429|7167591|FG005|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268460|NCT00065429|7167592|FG006|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
6268461|NCT00065442|7167605|FG000|STARTED|Overall Study||171
6268462|NCT00065442|7167606|FG001|STARTED|Overall Study||341
6268463|NCT00065442|7167605|FG000|COMPLETED|Overall Study||46
6268464|NCT00065442|7167606|FG001|COMPLETED|Overall Study||121
6268465|NCT00065442|7167605|FG000|NOT COMPLETED|Overall Study||125
6268466|NCT00065442|7167606|FG001|NOT COMPLETED|Overall Study||220
6268467|NCT00065468|7167615|FG000|STARTED|Overall Study||207
6268468|NCT00065468|7167616|FG001|STARTED|Overall Study||209
6268469|NCT00065468|7167617|FG002|STARTED|Overall Study||210
6268470|NCT00065468|7167615|FG000|Received Treatment|Overall Study||200
6268471|NCT00065468|7167616|FG001|Received Treatment|Overall Study||208
6268472|NCT00065468|7167617|FG002|Received Treatment|Overall Study||208
6268473|NCT00065468|7167615|FG000|COMPLETED|Overall Study||0
6268474|NCT00065468|7167616|FG001|COMPLETED|Overall Study||0
6268475|NCT00065468|7167617|FG002|COMPLETED|Overall Study||0
6268476|NCT00065468|7167615|FG000|NOT COMPLETED|Overall Study||207
6268477|NCT00065468|7167616|FG001|NOT COMPLETED|Overall Study||209
6268478|NCT00065468|7167617|FG002|NOT COMPLETED|Overall Study||210
6268479|NCT00065507|7167627|FG000|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
6268480|NCT00065507|7167628|FG001|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
6268481|NCT00065507|7167627|FG000|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
6268482|NCT00065507|7167628|FG001|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
6268483|NCT00065507|7167627|FG000|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
6268484|NCT00065507|7167628|FG001|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
6268485|NCT00065507|7167627|FG000|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
6268486|NCT00065507|7167628|FG001|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
6268487|NCT00065507|7167627|FG000|Treated, 24-Week Follow-Up Population|Overall Study||25
6268488|NCT00065507|7167628|FG001|Treated, 24-Week Follow-Up Population|Overall Study||28
6268489|NCT00065507|7167627|FG000|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
6268490|NCT00065507|7167628|FG001|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
6268491|NCT00065507|7167627|FG000|NOT COMPLETED|Overall Study||29
6268492|NCT00065507|7167628|FG001|NOT COMPLETED|Overall Study||29
6268493|NCT00065611|7167640|FG000|STARTED|Overall Study||4
6268494|NCT00065611|7167641|FG001|STARTED|Overall Study||4
6268495|NCT00065611|7167640|FG000|COMPLETED|Overall Study||4
6268496|NCT00065611|7167641|FG001|COMPLETED|Overall Study||3
6268497|NCT00065611|7167640|FG000|NOT COMPLETED|Overall Study||0
6268498|NCT00065611|7167641|FG001|NOT COMPLETED|Overall Study||1
6268499|NCT00065806|7167649|FG000|STARTED|Overall Study||113
6268500|NCT00065806|7167650|FG001|STARTED|Overall Study||108
6268501|NCT00065806|7167649|FG000|COMPLETED|Overall Study||93
6268502|NCT00065806|7167650|FG001|COMPLETED|Overall Study||89
6268503|NCT00065806|7167649|FG000|NOT COMPLETED|Overall Study||20
6268504|NCT00065806|7167650|FG001|NOT COMPLETED|Overall Study||19
6268505|NCT00066066|7167659|FG000|STARTED|Overall Study||27
6268506|NCT00066066|7167660|FG001|STARTED|Overall Study||22
6268507|NCT00066066|7167661|FG002|STARTED|Overall Study||30
6268508|NCT00066066|7167662|FG003|STARTED|Overall Study||20
6268509|NCT00066066|7167663|FG004|STARTED|Overall Study||27
6268510|NCT00066066|7167664|FG005|STARTED|Overall Study||20
6268511|NCT00066066|7167659|FG000|Baseline|Overall Study||27
6268512|NCT00066066|7167660|FG001|Baseline|Overall Study||22
6268513|NCT00066066|7167661|FG002|Baseline|Overall Study||30
6268514|NCT00066066|7167662|FG003|Baseline|Overall Study||20
6268515|NCT00066066|7167663|FG004|Baseline|Overall Study||27
6268516|NCT00066066|7167664|FG005|Baseline|Overall Study||20
6268517|NCT00066066|7167659|FG000|3 Month|Overall Study||21
6268518|NCT00066066|7167660|FG001|3 Month|Overall Study||17
6268519|NCT00066066|7167661|FG002|3 Month|Overall Study||23
6268520|NCT00066066|7167662|FG003|3 Month|Overall Study||16
6268521|NCT00066066|7167663|FG004|3 Month|Overall Study||22
6268522|NCT00066066|7167664|FG005|3 Month|Overall Study||15
6268523|NCT00066066|7167659|FG000|6 Month|Overall Study||19
6268524|NCT00066066|7167660|FG001|6 Month|Overall Study||13
6268525|NCT00066066|7167661|FG002|6 Month|Overall Study||23
6268526|NCT00066066|7167662|FG003|6 Month|Overall Study||13
6268527|NCT00066066|7167663|FG004|6 Month|Overall Study||21
6268528|NCT00066066|7167664|FG005|6 Month|Overall Study||14
6268529|NCT00066066|7167659|FG000|12 Month|Overall Study||18
6268530|NCT00066066|7167660|FG001|12 Month|Overall Study||11
6268531|NCT00066066|7167661|FG002|12 Month|Overall Study||21
6268532|NCT00066066|7167662|FG003|12 Month|Overall Study||11
6268533|NCT00066066|7167663|FG004|12 Month|Overall Study||19
6268534|NCT00066066|7167664|FG005|12 Month|Overall Study||9
6268535|NCT00066066|7167659|FG000|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
6268536|NCT00066066|7167660|FG001|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
6268537|NCT00066066|7167661|FG002|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
6268538|NCT00066066|7167662|FG003|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
6268539|NCT00066066|7167663|FG004|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
6268540|NCT00066066|7167664|FG005|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
6268541|NCT00066066|7167659|FG000|NOT COMPLETED|Overall Study||6
6268542|NCT00066066|7167660|FG001|NOT COMPLETED|Overall Study||4
6268543|NCT00066066|7167661|FG002|NOT COMPLETED|Overall Study||7
6268544|NCT00066066|7167662|FG003|NOT COMPLETED|Overall Study||4
6268545|NCT00066066|7167663|FG004|NOT COMPLETED|Overall Study||3
6268546|NCT00066066|7167664|FG005|NOT COMPLETED|Overall Study||5
6268547|NCT00066170|7167682|FG000|STARTED|Overall Study||56
6268548|NCT00066170|7167683|FG001|STARTED|Overall Study||55
6268549|NCT00066170|7167684|FG002|STARTED|Overall Study||63
6268550|NCT00066170|7167685|FG003|STARTED|Overall Study||57
6268551|NCT00066170|7167682|FG000|Intent to Treat|Overall Study||55
6268552|NCT00066170|7167683|FG001|Intent to Treat|Overall Study||50
6268553|NCT00066170|7167684|FG002|Intent to Treat|Overall Study||63
6268554|NCT00066170|7167685|FG003|Intent to Treat|Overall Study||54
6268555|NCT00066170|7167682|FG000|COMPLETED|Overall Study||49
6268556|NCT00066170|7167683|FG001|COMPLETED|Overall Study||45
6268557|NCT00066170|7167684|FG002|COMPLETED|Overall Study||59
6268558|NCT00066170|7167685|FG003|COMPLETED|Overall Study||48
6268559|NCT00066170|7167682|FG000|NOT COMPLETED|Overall Study||7
6268560|NCT00066170|7167683|FG001|NOT COMPLETED|Overall Study||10
6268561|NCT00066170|7167684|FG002|NOT COMPLETED|Overall Study||4
6268562|NCT00066170|7167685|FG003|NOT COMPLETED|Overall Study||9
6268563|NCT00066222|7167695|FG000|STARTED|Overall Study||72
6268564|NCT00066222|7167695|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
6268565|NCT00066222|7167695|FG000|NOT COMPLETED|Overall Study||1
6268566|NCT00066365|7167701|FG000|STARTED|Overall Study||31
6268567|NCT00066365|7167702|FG001|STARTED|Overall Study||18
6268568|NCT00066365|7167701|FG000|COMPLETED|Overall Study||8
6268569|NCT00066365|7167702|FG001|COMPLETED|Overall Study||4
6268570|NCT00066365|7167701|FG000|NOT COMPLETED|Overall Study||23
6268571|NCT00066365|7167702|FG001|NOT COMPLETED|Overall Study||14
6268572|NCT00066469|7167710|FG000|STARTED|Overall Study||55
6268573|NCT00066469|7167710|FG000|COMPLETED|Overall Study||39
6268574|NCT00066469|7167710|FG000|NOT COMPLETED|Overall Study||16
6268575|NCT00066573|7167716|FG000|STARTED|Overall Study||3789
6268576|NCT00066573|7167717|FG001|STARTED|Overall Study||3787
6268577|NCT00066573|7167716|FG000|COMPLETED|Overall Study||3761
6268578|NCT00066573|7167717|FG001|COMPLETED|Overall Study||3759
6268579|NCT00066573|7167716|FG000|NOT COMPLETED|Overall Study||28
6268580|NCT00066573|7167717|FG001|NOT COMPLETED|Overall Study||28
6268581|NCT00066677|7167725|FG000|STARTED|Overall Study||16
6268582|NCT00066677|7167726|FG001|STARTED|Overall Study||16
6268583|NCT00066677|7167725|FG000|COMPLETED|Overall Study||16
6268584|NCT00066677|7167726|FG001|COMPLETED|Overall Study||16
6268585|NCT00066677|7167725|FG000|NOT COMPLETED|Overall Study||0
6268586|NCT00066677|7167726|FG001|NOT COMPLETED|Overall Study||0
6268587|NCT00066690|7167735|FG000|STARTED|Overall Study||1021
6268588|NCT00066690|7167736|FG001|STARTED|Overall Study||1024
6268589|NCT00066690|7167737|FG002|STARTED|Overall Study||1021
6268590|NCT00066690|7167735|FG000|COMPLETED|Overall Study||423
6268591|NCT00066690|7167736|FG001|COMPLETED|Overall Study||502
6268592|NCT00066690|7167737|FG002|COMPLETED|Overall Study||457
6268593|NCT00066690|7167735|FG000|NOT COMPLETED|Overall Study||598
6268594|NCT00066690|7167736|FG001|NOT COMPLETED|Overall Study||522
6268595|NCT00066690|7167737|FG002|NOT COMPLETED|Overall Study||564
6268596|NCT00066703|7167750|FG000|STARTED|Overall Study||1334
6268597|NCT00066703|7167751|FG001|STARTED|Overall Study||1338
6268598|NCT00066703|7167750|FG000|COMPLETED|Overall Study||722
6268599|NCT00066703|7167751|FG001|COMPLETED|Overall Study||756
6268600|NCT00066703|7167750|FG000|NOT COMPLETED|Overall Study||612
6268601|NCT00066703|7167751|FG001|NOT COMPLETED|Overall Study||582
6268602|NCT00066729|7167757|FG000|STARTED|Overall Study||9
6268603|NCT00066729|7167757|FG000|COMPLETED|Overall Study||7
6268604|NCT00066729|7167757|FG000|NOT COMPLETED|Overall Study||2
6268605|NCT00066742|7167761|FG000|STARTED|Induction Chemoradiotherapy||72
6268606|NCT00066742|7167761|FG000|Eligible|Induction Chemoradiotherapy||69
6268607|NCT00066742|7167761|FG000|Began Protocol Treatment|Induction Chemoradiotherapy||68
6268608|NCT00066742|7167761|FG000|COMPLETED|Induction Chemoradiotherapy||43
6268609|NCT00066742|7167761|FG000|NOT COMPLETED|Induction Chemoradiotherapy||29
6268610|NCT00066742|7167761|FG000|STARTED|Consolidation Chemotherapy||42
6268611|NCT00066742|7167761|FG000|Eligible|Consolidation Chemotherapy||40
6268612|NCT00066742|7167761|FG000|COMPLETED|Consolidation Chemotherapy||39
6268613|NCT00066742|7167761|FG000|NOT COMPLETED|Consolidation Chemotherapy||3
6268614|NCT00066781|7167769|FG000|STARTED|Overall Study||14
6268615|NCT00066781|7167770|FG001|STARTED|Overall Study||17
6268616|NCT00066781|7167769|FG000|COMPLETED|Overall Study||14
6268617|NCT00066781|7167770|FG001|COMPLETED|Overall Study||17
6268618|NCT00066781|7167769|FG000|NOT COMPLETED|Overall Study||0
6268619|NCT00066781|7167770|FG001|NOT COMPLETED|Overall Study||0
6268620|NCT00066937|7167780|FG000|STARTED|Treatment Phase||41
6268621|NCT00066937|7167781|FG001|STARTED|Treatment Phase||38
6268622|NCT00066937|7167782|FG002|STARTED|Treatment Phase||37
6268623|NCT00066937|7167783|FG003|STARTED|Treatment Phase||24
6268624|NCT00066937|7167780|FG000|COMPLETED|Treatment Phase||38
6268625|NCT00066937|7167781|FG001|COMPLETED|Treatment Phase||33
6268626|NCT00066937|7167782|FG002|COMPLETED|Treatment Phase||26
6268627|NCT00066937|7167783|FG003|COMPLETED|Treatment Phase||19
6268628|NCT00066937|7167780|FG000|NOT COMPLETED|Treatment Phase||3
6268629|NCT00066937|7167781|FG001|NOT COMPLETED|Treatment Phase||5
6268630|NCT00066937|7167782|FG002|NOT COMPLETED|Treatment Phase||11
6268631|NCT00066937|7167783|FG003|NOT COMPLETED|Treatment Phase||5
6268632|NCT00066937|7167780|FG000|STARTED|3 Month Follow-up||38
6268633|NCT00066937|7167781|FG001|STARTED|3 Month Follow-up||33
6268634|NCT00066937|7167782|FG002|STARTED|3 Month Follow-up||26
6268635|NCT00066937|7167783|FG003|STARTED|3 Month Follow-up||19
6268636|NCT00066937|7167780|FG000|COMPLETED|3 Month Follow-up||33
6268637|NCT00066937|7167781|FG001|COMPLETED|3 Month Follow-up||32
6268638|NCT00066937|7167782|FG002|COMPLETED|3 Month Follow-up||25
6268639|NCT00066937|7167783|FG003|COMPLETED|3 Month Follow-up||15
6268640|NCT00066937|7167780|FG000|NOT COMPLETED|3 Month Follow-up||5
6268641|NCT00066937|7167781|FG001|NOT COMPLETED|3 Month Follow-up||1
6268642|NCT00066937|7167782|FG002|NOT COMPLETED|3 Month Follow-up||1
6268643|NCT00066937|7167783|FG003|NOT COMPLETED|3 Month Follow-up||4
6268644|NCT00066937|7167780|FG000|STARTED|6 Month Follow-up||33
6268645|NCT00066937|7167781|FG001|STARTED|6 Month Follow-up||32
6268646|NCT00066937|7167782|FG002|STARTED|6 Month Follow-up||25
6268647|NCT00066937|7167783|FG003|STARTED|6 Month Follow-up||15
6268648|NCT00066937|7167780|FG000|COMPLETED|6 Month Follow-up||26
6268649|NCT00066937|7167781|FG001|COMPLETED|6 Month Follow-up||29
6268650|NCT00066937|7167782|FG002|COMPLETED|6 Month Follow-up||22
6268651|NCT00066937|7167783|FG003|COMPLETED|6 Month Follow-up||14
6268652|NCT00066937|7167780|FG000|NOT COMPLETED|6 Month Follow-up||7
6268653|NCT00066937|7167781|FG001|NOT COMPLETED|6 Month Follow-up||3
6268654|NCT00066937|7167782|FG002|NOT COMPLETED|6 Month Follow-up||3
6268655|NCT00066937|7167783|FG003|NOT COMPLETED|6 Month Follow-up||1
6268656|NCT00067002|7167795|FG000|STARTED|Overall Study||52
6268657|NCT00067002|7167796|FG001|STARTED|Overall Study||53
6268658|NCT00067002|7167795|FG000|COMPLETED|Overall Study||45
6268659|NCT00067002|7167796|FG001|COMPLETED|Overall Study||44
6268660|NCT00067002|7167795|FG000|NOT COMPLETED|Overall Study||7
6268661|NCT00067002|7167796|FG001|NOT COMPLETED|Overall Study||9
6268662|NCT00067028|7167805|FG000|STARTED|Overall Study||17
6268663|NCT00067028|7167806|FG001|STARTED|Overall Study||36
6268664|NCT00067028|7167807|FG002|STARTED|Overall Study||63
6268665|NCT00067028|7167805|FG000|COMPLETED|Overall Study||17
6268666|NCT00067028|7167806|FG001|COMPLETED|Overall Study||36
6268667|NCT00067028|7167807|FG002|COMPLETED|Overall Study||63
6268668|NCT00067028|7167805|FG000|NOT COMPLETED|Overall Study||0
6268669|NCT00067028|7167806|FG001|NOT COMPLETED|Overall Study||0
6268670|NCT00067028|7167807|FG002|NOT COMPLETED|Overall Study||0
6268671|NCT00067236|7167819|FG000|STARTED|Overall Study||128
6268672|NCT00067236|7167820|FG001|STARTED|Overall Study||125
6268673|NCT00067236|7167819|FG000|COMPLETED|Overall Study||108
6268674|NCT00067236|7167820|FG001|COMPLETED|Overall Study||99
6268675|NCT00067236|7167819|FG000|NOT COMPLETED|Overall Study||20
6268676|NCT00067236|7167820|FG001|NOT COMPLETED|Overall Study||26
6268677|NCT00067470|7167828|FG000|STARTED|Overall Study||19
6268678|NCT00067470|7167829|FG001|STARTED|Overall Study||20
6268679|NCT00067470|7167828|FG000|COMPLETED|Overall Study||19
6268680|NCT00067470|7167829|FG001|COMPLETED|Overall Study||19
6268681|NCT00067470|7167828|FG000|NOT COMPLETED|Overall Study||0
6268682|NCT00067470|7167829|FG001|NOT COMPLETED|Overall Study||1
6268683|NCT00067808|7167838|FG000|STARTED|Overall Study||17
6268684|NCT00067808|7167839|FG001|STARTED|Overall Study||93
6268685|NCT00067808|7167840|FG002|STARTED|Overall Study||14
6268686|NCT00067808|7167838|FG000|COMPLETED|Overall Study||17
6268687|NCT00067808|7167839|FG001|COMPLETED|Overall Study||93
6268688|NCT00067808|7167840|FG002|COMPLETED|Overall Study||14
6268689|NCT00067808|7167838|FG000|NOT COMPLETED|Overall Study||0
6268690|NCT00067808|7167839|FG001|NOT COMPLETED|Overall Study||0
6268691|NCT00067808|7167840|FG002|NOT COMPLETED|Overall Study||0
6268692|NCT00067990|7167850|FG000|STARTED|Overall Study||77
6268693|NCT00067990|7167851|FG001|STARTED|Overall Study||76
6268694|NCT00067990|7167850|FG000|COMPLETED|Overall Study||67
6268695|NCT00067990|7167851|FG001|COMPLETED|Overall Study||54
6268696|NCT00067990|7167850|FG000|NOT COMPLETED|Overall Study||10
6268697|NCT00067990|7167851|FG001|NOT COMPLETED|Overall Study||22
6268698|NCT00068107|7167857|FG000|STARTED|Overall Study||12
6268699|NCT00068107|7167857|FG000|COMPLETED|Overall Study||3
6268700|NCT00068107|7167857|FG000|NOT COMPLETED|Overall Study||9
6268701|NCT00068237|7167864|FG000|STARTED|Overall Study||49
6268702|NCT00068237|7167864|FG000|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
6268703|NCT00068237|7167864|FG000|NOT COMPLETED|Overall Study||5
6268704|NCT00068250|7167871|FG000|STARTED|Phase I: Dose Level 1||6
6268705|NCT00068250|7167872|FG001|STARTED|Phase I: Dose Level 1||0
6268706|NCT00068250|7167873|FG002|STARTED|Phase I: Dose Level 1||0
6268707|NCT00068250|7167874|FG003|STARTED|Phase I: Dose Level 1||0
6268708|NCT00068250|7167871|FG000|COMPLETED|Phase I: Dose Level 1|Subjects with data available for the primary analysis are considered to have completed the study.|6
6268709|NCT00068250|7167872|FG001|COMPLETED|Phase I: Dose Level 1||0
6268710|NCT00068250|7167873|FG002|COMPLETED|Phase I: Dose Level 1||0
6268711|NCT00068250|7167874|FG003|COMPLETED|Phase I: Dose Level 1||0
6268712|NCT00068250|7167871|FG000|NOT COMPLETED|Phase I: Dose Level 1||0
6268713|NCT00068250|7167872|FG001|NOT COMPLETED|Phase I: Dose Level 1||0
6268714|NCT00068250|7167873|FG002|NOT COMPLETED|Phase I: Dose Level 1||0
6268715|NCT00068250|7167874|FG003|NOT COMPLETED|Phase I: Dose Level 1||0
6268716|NCT00068250|7167871|FG000|STARTED|Phase I: Dose Level 2||0
6268717|NCT00068250|7167872|FG001|STARTED|Phase I: Dose Level 2||7
6268718|NCT00068250|7167873|FG002|STARTED|Phase I: Dose Level 2||0
6268719|NCT00068250|7167874|FG003|STARTED|Phase I: Dose Level 2||0
6268720|NCT00068250|7167871|FG000|COMPLETED|Phase I: Dose Level 2||0
6268721|NCT00068250|7167872|FG001|COMPLETED|Phase I: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|6
6268722|NCT00068250|7167873|FG002|COMPLETED|Phase I: Dose Level 2||0
6268723|NCT00068250|7167874|FG003|COMPLETED|Phase I: Dose Level 2||0
6268724|NCT00068250|7167871|FG000|NOT COMPLETED|Phase I: Dose Level 2||0
6268725|NCT00068250|7167872|FG001|NOT COMPLETED|Phase I: Dose Level 2||1
6268726|NCT00068250|7167873|FG002|NOT COMPLETED|Phase I: Dose Level 2||0
6268727|NCT00068250|7167874|FG003|NOT COMPLETED|Phase I: Dose Level 2||0
6268728|NCT00068250|7167871|FG000|STARTED|Phase II: Dose Level 2||0
6268729|NCT00068250|7167872|FG001|STARTED|Phase II: Dose Level 2||0
6268730|NCT00068250|7167873|FG002|STARTED|Phase II: Dose Level 2||0
6268731|NCT00068250|7167874|FG003|STARTED|Phase II: Dose Level 2||47
6268732|NCT00068250|7167871|FG000|COMPLETED|Phase II: Dose Level 2||0
6268733|NCT00068250|7167872|FG001|COMPLETED|Phase II: Dose Level 2||0
6268734|NCT00068250|7167873|FG002|COMPLETED|Phase II: Dose Level 2||0
6268735|NCT00068250|7167874|FG003|COMPLETED|Phase II: Dose Level 2|Subjects with data available for the primary analysis are considered to have completed the study.|47
6268736|NCT00068250|7167871|FG000|NOT COMPLETED|Phase II: Dose Level 2||0
6268737|NCT00068250|7167872|FG001|NOT COMPLETED|Phase II: Dose Level 2||0
6268738|NCT00068250|7167873|FG002|NOT COMPLETED|Phase II: Dose Level 2||0
6268739|NCT00068250|7167874|FG003|NOT COMPLETED|Phase II: Dose Level 2||0
6268740|NCT00068341|7167885|FG000|STARTED|Overall Study||15
6268741|NCT00068341|7167886|FG001|STARTED|Overall Study||15
6268742|NCT00068341|7167887|FG002|STARTED|Overall Study||44
6268743|NCT00068341|7167885|FG000|COMPLETED|Overall Study||15
6268744|NCT00068341|7167886|FG001|COMPLETED|Overall Study||15
6268745|NCT00068341|7167887|FG002|COMPLETED|Overall Study||44
6268746|NCT00068341|7167885|FG000|NOT COMPLETED|Overall Study||0
6268747|NCT00068341|7167886|FG001|NOT COMPLETED|Overall Study||0
6268748|NCT00068341|7167887|FG002|NOT COMPLETED|Overall Study||0
6268749|NCT00068367|7167908|FG000|STARTED|Overall Study||20
6268750|NCT00068367|7167908|FG000|COMPLETED|Overall Study||20
6268751|NCT00068367|7167908|FG000|NOT COMPLETED|Overall Study||0
6268752|NCT00068380|7167912|FG000|STARTED|Overall Study||17
6268753|NCT00068380|7167912|FG000|COMPLETED|Overall Study||12
6268754|NCT00068380|7167912|FG000|NOT COMPLETED|Overall Study||5
6268755|NCT00068393|7167916|FG000|STARTED|Overall Study||39
6268756|NCT00068393|7167916|FG000|Eligible and Treated|Overall Study||38
6268757|NCT00068393|7167916|FG000|COMPLETED|Overall Study||29
6268758|NCT00068393|7167916|FG000|NOT COMPLETED|Overall Study||10
6268759|NCT00068406|7167920|FG000|STARTED|Overall Study||61
6268760|NCT00068406|7167920|FG000|COMPLETED|Overall Study||58
6268761|NCT00068406|7167920|FG000|NOT COMPLETED|Overall Study||3
6268762|NCT00068419|7167924|FG000|STARTED|Overall Study||70
6268763|NCT00068419|7167924|FG000|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
6268764|NCT00068419|7167924|FG000|NOT COMPLETED|Overall Study||60
6268765|NCT00068445|7167930|FG000|STARTED|Randomization||65
6268766|NCT00068445|7167931|FG001|STARTED|Randomization||66
6268767|NCT00068445|7167930|FG000|COMPLETED|Randomization||63
6268768|NCT00068445|7167931|FG001|COMPLETED|Randomization||62
6268769|NCT00068445|7167930|FG000|NOT COMPLETED|Randomization||2
6268770|NCT00068445|7167931|FG001|NOT COMPLETED|Randomization||4
6268771|NCT00068445|7167930|FG000|STARTED|Treatment||63
6268772|NCT00068445|7167931|FG001|STARTED|Treatment||62
6268773|NCT00068445|7167930|FG000|COMPLETED|Treatment||34
6268774|NCT00068445|7167931|FG001|COMPLETED|Treatment||46
6268775|NCT00068445|7167930|FG000|NOT COMPLETED|Treatment||29
6268776|NCT00068445|7167931|FG001|NOT COMPLETED|Treatment||16
6268777|NCT00068575|7167937|FG000|STARTED|Overall Study||28
6268778|NCT00068575|7167937|FG000|COMPLETED|Overall Study||28
6268779|NCT00068575|7167937|FG000|NOT COMPLETED|Overall Study||0
6268780|NCT00068588|7167944|FG000|STARTED|Overall Study||0
6268781|NCT00068588|7167945|FG001|STARTED|Overall Study||3
6268782|NCT00068588|7167946|FG002|STARTED|Overall Study||21
6268783|NCT00068588|7167944|FG000|COMPLETED|Overall Study||0
6268784|NCT00068588|7167945|FG001|COMPLETED|Overall Study||3
6268785|NCT00068588|7167946|FG002|COMPLETED|Overall Study||17
6268786|NCT00068588|7167944|FG000|NOT COMPLETED|Overall Study||0
6268787|NCT00068588|7167945|FG001|NOT COMPLETED|Overall Study||0
6268788|NCT00068588|7167946|FG002|NOT COMPLETED|Overall Study||4
6268789|NCT00068601|7167955|FG000|STARTED|Overall Study||131
6268790|NCT00068601|7167956|FG001|STARTED|Overall Study||126
6268791|NCT00068601|7167955|FG000|COMPLETED|Overall Study||69
6268792|NCT00068601|7167956|FG001|COMPLETED|Overall Study||66
6268793|NCT00068601|7167955|FG000|NOT COMPLETED|Overall Study||62
6268794|NCT00068601|7167956|FG001|NOT COMPLETED|Overall Study||60
6268795|NCT00068692|7167965|FG000|STARTED|Step 1: Registration||128
6268796|NCT00068692|7167966|FG001|STARTED|Step 1: Registration|Group II patients were registered and randomized at the same time, and were reported in Step 2.|97
6268797|NCT00068692|7167967|FG002|STARTED|Step 1: Registration||0
6268798|NCT00068692|7167968|FG003|STARTED|Step 1: Registration||0
6268799|NCT00068692|7167969|FG004|STARTED|Step 1: Registration||0
6268800|NCT00068692|7167970|FG005|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
6268801|NCT00068692|7167971|FG006|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
6268802|NCT00068692|7167972|FG007|STARTED|Step 1: Registration|Group II patients was registered and randomized at the same time, and reported in step 2|0
6268803|NCT00068692|7167965|FG000|Started Concurrent Chemo/Radiation|Step 1: Registration||125
6268804|NCT00068692|7167966|FG001|Started Concurrent Chemo/Radiation|Step 1: Registration|Group II patients receive protocol therapy in Step 2 after randomization|0
6268805|NCT00068692|7167967|FG002|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6268806|NCT00068692|7167968|FG003|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6268807|NCT00068692|7167969|FG004|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6268808|NCT00068692|7167970|FG005|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6280596|NCT00158197|7180557|FG000|COMPLETED|Overall Study||32
6268809|NCT00068692|7167971|FG006|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6268810|NCT00068692|7167972|FG007|Started Concurrent Chemo/Radiation|Step 1: Registration||0
6268811|NCT00068692|7167965|FG000|Reported AE Data|Step 1: Registration||123
6268812|NCT00068692|7167966|FG001|Reported AE Data|Step 1: Registration||0
6268813|NCT00068692|7167967|FG002|Reported AE Data|Step 1: Registration||0
6268814|NCT00068692|7167968|FG003|Reported AE Data|Step 1: Registration||0
6268815|NCT00068692|7167969|FG004|Reported AE Data|Step 1: Registration||0
6268816|NCT00068692|7167970|FG005|Reported AE Data|Step 1: Registration||0
6268817|NCT00068692|7167971|FG006|Reported AE Data|Step 1: Registration||0
6268818|NCT00068692|7167972|FG007|Reported AE Data|Step 1: Registration||0
6268819|NCT00068692|7167965|FG000|COMPLETED|Step 1: Registration||88
6268820|NCT00068692|7167966|FG001|COMPLETED|Step 1: Registration|Case 32191 entered the study as Group II patient but was never randomized.|96
6268821|NCT00068692|7167967|FG002|COMPLETED|Step 1: Registration||0
6268822|NCT00068692|7167968|FG003|COMPLETED|Step 1: Registration||0
6268823|NCT00068692|7167969|FG004|COMPLETED|Step 1: Registration||0
6268824|NCT00068692|7167970|FG005|COMPLETED|Step 1: Registration||0
6268825|NCT00068692|7167971|FG006|COMPLETED|Step 1: Registration||0
6268826|NCT00068692|7167972|FG007|COMPLETED|Step 1: Registration||0
6268827|NCT00068692|7167965|FG000|NOT COMPLETED|Step 1: Registration||40
6268828|NCT00068692|7167966|FG001|NOT COMPLETED|Step 1: Registration||1
6268829|NCT00068692|7167967|FG002|NOT COMPLETED|Step 1: Registration||0
6268830|NCT00068692|7167968|FG003|NOT COMPLETED|Step 1: Registration||0
6268831|NCT00068692|7167969|FG004|NOT COMPLETED|Step 1: Registration||0
6268832|NCT00068692|7167970|FG005|NOT COMPLETED|Step 1: Registration||0
6268833|NCT00068692|7167971|FG006|NOT COMPLETED|Step 1: Registration||0
6268834|NCT00068692|7167972|FG007|NOT COMPLETED|Step 1: Registration||0
6268835|NCT00068692|7167965|FG000|STARTED|Step 2: Randomization|Patients on arm S completing step 1 treatment were randomized to step 2 (Arms I-III).|0
6268836|NCT00068692|7167966|FG001|STARTED|Step 2: Randomization|Group II patients were registered and randomized at the same time, reported as arms I,II,III here.|0
6268837|NCT00068692|7167967|FG002|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|28
6268838|NCT00068692|7167968|FG003|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|25
6268839|NCT00068692|7167969|FG004|STARTED|Step 2: Randomization|Of the 128 patients registered to step 1in group 1, 83 were randomized to step 2(arms I-III).|30
6268840|NCT00068692|7167970|FG005|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|31
6268841|NCT00068692|7167971|FG006|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|33
6268842|NCT00068692|7167972|FG007|STARTED|Step 2: Randomization|Group 2 patients were registered and randomized at the same time.|32
6268843|NCT00068692|7167965|FG000|Treated|Step 2: Randomization||0
6268844|NCT00068692|7167966|FG001|Treated|Step 2: Randomization||0
6268845|NCT00068692|7167967|FG002|Treated|Step 2: Randomization||27
6268846|NCT00068692|7167968|FG003|Treated|Step 2: Randomization||25
6268847|NCT00068692|7167969|FG004|Treated|Step 2: Randomization||29
6268848|NCT00068692|7167970|FG005|Treated|Step 2: Randomization||31
6268849|NCT00068692|7167971|FG006|Treated|Step 2: Randomization||33
6268850|NCT00068692|7167972|FG007|Treated|Step 2: Randomization||32
6268851|NCT00068692|7167965|FG000|Had Sphincter Preservation|Step 2: Randomization||0
6268852|NCT00068692|7167966|FG001|Had Sphincter Preservation|Step 2: Randomization||0
6268853|NCT00068692|7167967|FG002|Had Sphincter Preservation|Step 2: Randomization||28
6268854|NCT00068692|7167968|FG003|Had Sphincter Preservation|Step 2: Randomization||25
6268855|NCT00068692|7167969|FG004|Had Sphincter Preservation|Step 2: Randomization||28
6268856|NCT00068692|7167970|FG005|Had Sphincter Preservation|Step 2: Randomization||31
6268857|NCT00068692|7167971|FG006|Had Sphincter Preservation|Step 2: Randomization||33
6737435|NCT03266172|7666734|FG002|STARTED|Part C Period 3(2 Days)|1 replacement participant enrolled|16
6737436|NCT03266172|7666732|FG000|COMPLETED|Part C Period 3(2 Days)||0
6737437|NCT03266172|7666733|FG001|COMPLETED|Part C Period 3(2 Days)||0
6737438|NCT03266172|7666734|FG002|COMPLETED|Part C Period 3(2 Days)||16
6737439|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Period 3(2 Days)||0
6737440|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Period 3(2 Days)||0
6737441|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Period 3(2 Days)||0
6737442|NCT03266172|7666732|FG000|STARTED|Part C Washout Period (7 Days)||0
6737443|NCT03266172|7666733|FG001|STARTED|Part C Washout Period (7 Days)||0
6737444|NCT03266172|7666734|FG002|STARTED|Part C Washout Period (7 Days)||16
6737445|NCT03266172|7666732|FG000|COMPLETED|Part C Washout Period (7 Days)||0
6737446|NCT03266172|7666733|FG001|COMPLETED|Part C Washout Period (7 Days)||0
6737447|NCT03266172|7666734|FG002|COMPLETED|Part C Washout Period (7 Days)||16
6737448|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737449|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737450|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Washout Period (7 Days)||0
6737451|NCT03266172|7666732|FG000|STARTED|Part C Period 4(2 Days)||0
6737452|NCT03266172|7666733|FG001|STARTED|Part C Period 4(2 Days)||0
6737453|NCT03266172|7666734|FG002|STARTED|Part C Period 4(2 Days)||16
6737454|NCT03266172|7666732|FG000|COMPLETED|Part C Period 4(2 Days)||0
6737455|NCT03266172|7666733|FG001|COMPLETED|Part C Period 4(2 Days)||0
6737456|NCT03266172|7666734|FG002|COMPLETED|Part C Period 4(2 Days)||16
6737457|NCT03266172|7666732|FG000|NOT COMPLETED|Part C Period 4(2 Days)||0
6737458|NCT03266172|7666733|FG001|NOT COMPLETED|Part C Period 4(2 Days)||0
6737459|NCT03266172|7666734|FG002|NOT COMPLETED|Part C Period 4(2 Days)||0
6281044|NCT00161473|7180920|FG001|COMPLETED|Overall Study||6
6281045|NCT00161473|7180919|FG000|NOT COMPLETED|Overall Study||5
6281046|NCT00161473|7180920|FG001|NOT COMPLETED|Overall Study||6
6281047|NCT00161616|7180928|FG000|STARTED|Overall Study||139
6281048|NCT00161616|7180929|FG001|STARTED|Overall Study||138
6281049|NCT00161616|7180928|FG000|COMPLETED|Overall Study||113
6281050|NCT00161616|7180929|FG001|COMPLETED|Overall Study||119
6281051|NCT00161616|7180928|FG000|NOT COMPLETED|Overall Study||26
6281052|NCT00161616|7180929|FG001|NOT COMPLETED|Overall Study||19
6281053|NCT00162032|7180937|FG000|STARTED|Overall Study||329
6281054|NCT00162032|7180938|FG001|STARTED|Overall Study||116
6281055|NCT00162032|7180937|FG000|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
6281056|NCT00162032|7180938|FG001|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
6281057|NCT00162032|7180937|FG000|NOT COMPLETED|Overall Study||5
6281058|NCT00162032|7180938|FG001|NOT COMPLETED|Overall Study||2
6281059|NCT00162097|7180953|FG000|STARTED|Overall Study|Treated on Day 1|6
6281060|NCT00162097|7180954|FG001|STARTED|Overall Study|Treated on Day 1|2
6281061|NCT00162097|7180955|FG002|STARTED|Overall Study|Treated on Day 1|1
6281062|NCT00162097|7180956|FG003|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
6281063|NCT00162097|7180953|FG000|COMPLETED|Overall Study||6
6281064|NCT00162097|7180954|FG001|COMPLETED|Overall Study||2
6281065|NCT00162097|7180955|FG002|COMPLETED|Overall Study||1
6281066|NCT00162097|7180956|FG003|COMPLETED|Overall Study||6
6281067|NCT00162097|7180953|FG000|NOT COMPLETED|Overall Study||0
6281068|NCT00162097|7180954|FG001|NOT COMPLETED|Overall Study||0
6281069|NCT00162097|7180955|FG002|NOT COMPLETED|Overall Study||0
6281070|NCT00162097|7180956|FG003|NOT COMPLETED|Overall Study||1
6281071|NCT00162123|7180980|FG000|STARTED|Overall Study|Enrolled|53
6281072|NCT00162123|7180981|FG001|STARTED|Overall Study|Enrolled|34
6281073|NCT00162123|7180982|FG002|STARTED|Overall Study|Enrolled|24
6281074|NCT00162123|7180983|FG003|STARTED|Overall Study|Enrolled|11
6281075|NCT00162123|7180984|FG004|STARTED|Overall Study|Enrolled|45
6281076|NCT00162123|7180985|FG005|STARTED|Overall Study|Enrolled|13
6281077|NCT00162123|7180986|FG006|STARTED|Overall Study|Enrolled|4
6281078|NCT00162123|7180987|FG007|STARTED|Overall Study|Enrolled|58
6281079|NCT00162123|7180980|FG000|Received Treatment|Overall Study||53
6281080|NCT00162123|7180981|FG001|Received Treatment|Overall Study||34
6281081|NCT00162123|7180982|FG002|Received Treatment|Overall Study||24
6281082|NCT00162123|7180983|FG003|Received Treatment|Overall Study||11
6281083|NCT00162123|7180984|FG004|Received Treatment|Overall Study||33
6281084|NCT00162123|7180985|FG005|Received Treatment|Overall Study||12
6281085|NCT00162123|7180986|FG006|Received Treatment|Overall Study||4
6281086|NCT00162123|7180987|FG007|Received Treatment|Overall Study||0
6281087|NCT00162123|7180980|FG000|COMPLETED|Overall Study|Still on treatment|9
6281088|NCT00162123|7180981|FG001|COMPLETED|Overall Study|Still on treatment|5
6281089|NCT00162123|7180982|FG002|COMPLETED|Overall Study|Still on treatment|3
6281090|NCT00162123|7180983|FG003|COMPLETED|Overall Study|Still on treatment|3
6281091|NCT00162123|7180984|FG004|COMPLETED|Overall Study|Still on treatment|14
6281092|NCT00162123|7180985|FG005|COMPLETED|Overall Study|Still on treatment|4
6281093|NCT00162123|7180986|FG006|COMPLETED|Overall Study|Still on treatment|0
6281094|NCT00162123|7180987|FG007|COMPLETED|Overall Study|Still on treatment|0
6281095|NCT00162123|7180980|FG000|NOT COMPLETED|Overall Study||44
6281096|NCT00162123|7180981|FG001|NOT COMPLETED|Overall Study||29
6281097|NCT00162123|7180982|FG002|NOT COMPLETED|Overall Study||21
6281098|NCT00162123|7180983|FG003|NOT COMPLETED|Overall Study||8
6281099|NCT00162123|7180984|FG004|NOT COMPLETED|Overall Study||31
6281100|NCT00162123|7180985|FG005|NOT COMPLETED|Overall Study||9
6281101|NCT00162123|7180986|FG006|NOT COMPLETED|Overall Study||4
6281102|NCT00162123|7180987|FG007|NOT COMPLETED|Overall Study||58
6281103|NCT00162136|7181012|FG000|STARTED|Overall Study||35
6281104|NCT00162136|7181012|FG000|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
6281105|NCT00162136|7181012|FG000|NOT COMPLETED|Overall Study||35
6281106|NCT00162266|7181039|FG000|STARTED|Double-Blind Period||115
6281107|NCT00162266|7181040|FG001|STARTED|Double-Blind Period||105
6281108|NCT00162266|7181041|FG002|STARTED|Double-Blind Period||119
6281109|NCT00162266|7181042|FG003|STARTED|Double-Blind Period||0
6281110|NCT00162266|7181039|FG000|Completed Day 1 to Day 181|Double-Blind Period||98
6281111|NCT00162266|7181040|FG001|Completed Day 1 to Day 181|Double-Blind Period||80
6281112|NCT00162266|7181041|FG002|Completed Day 1 to Day 181|Double-Blind Period||78
6281113|NCT00162266|7181042|FG003|Completed Day 1 to Day 181|Double-Blind Period||0
6281114|NCT00162266|7181039|FG000|COMPLETED|Double-Blind Period||90
6281115|NCT00162266|7181040|FG001|COMPLETED|Double-Blind Period||74
6281116|NCT00162266|7181041|FG002|COMPLETED|Double-Blind Period||71
6281117|NCT00162266|7181042|FG003|COMPLETED|Double-Blind Period||0
6281118|NCT00162266|7181039|FG000|NOT COMPLETED|Double-Blind Period||25
6281119|NCT00162266|7181040|FG001|NOT COMPLETED|Double-Blind Period||31
6281120|NCT00162266|7181041|FG002|NOT COMPLETED|Double-Blind Period||48
6281121|NCT00162266|7181042|FG003|NOT COMPLETED|Double-Blind Period||0
6281122|NCT00162266|7181039|FG000|STARTED|Open-Label Period||0
6281123|NCT00162266|7181040|FG001|STARTED|Open-Label Period||0
6281124|NCT00162266|7181041|FG002|STARTED|Open-Label Period||0
6281125|NCT00162266|7181042|FG003|STARTED|Open-Label Period||219
6281126|NCT00162266|7181039|FG000|COMPLETED|Open-Label Period||0
6281127|NCT00162266|7181040|FG001|COMPLETED|Open-Label Period||0
6281128|NCT00162266|7181041|FG002|COMPLETED|Open-Label Period||0
6281129|NCT00162266|7181042|FG003|COMPLETED|Open-Label Period||82
6281130|NCT00162266|7181039|FG000|NOT COMPLETED|Open-Label Period||0
6281131|NCT00162266|7181040|FG001|NOT COMPLETED|Open-Label Period||0
6281132|NCT00162266|7181041|FG002|NOT COMPLETED|Open-Label Period||0
6281133|NCT00162266|7181042|FG003|NOT COMPLETED|Open-Label Period||137
6281134|NCT00162981|7181096|FG000|STARTED|Overall Study||32
6281135|NCT00162981|7181097|FG001|STARTED|Overall Study||36
6281136|NCT00162981|7181096|FG000|COMPLETED|Overall Study||28
6281137|NCT00162981|7181097|FG001|COMPLETED|Overall Study||30
6281138|NCT00162981|7181096|FG000|NOT COMPLETED|Overall Study||4
6281139|NCT00162981|7181097|FG001|NOT COMPLETED|Overall Study||6
6281140|NCT00163020|7181105|FG000|STARTED|Overall Study|Twins = 160 Triplets = 56|216
6281141|NCT00163020|7181106|FG001|STARTED|Overall Study|Twins = 80 Triplets = 25|105
6281142|NCT00163020|7181105|FG000|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
6281143|NCT00163020|7181106|FG001|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
6281144|NCT00163020|7181105|FG000|NOT COMPLETED|Overall Study||0
6281145|NCT00163020|7181106|FG001|NOT COMPLETED|Overall Study||2
6281146|NCT00163189|7181114|FG000|STARTED|Overall Study||98
6281147|NCT00163189|7181114|FG000|COMPLETED|Overall Study||35
6281148|NCT00163189|7181114|FG000|NOT COMPLETED|Overall Study||63
6281149|NCT00163215|7181118|FG000|STARTED|Overall Study||46
6281150|NCT00163215|7181118|FG000|COMPLETED|Overall Study||31
6281151|NCT00163215|7181118|FG000|NOT COMPLETED|Overall Study||15
6281152|NCT00163293|7181125|FG000|STARTED|Overall Study||79
6281153|NCT00163293|7181126|FG001|STARTED|Overall Study||76
6281154|NCT00163293|7181127|FG002|STARTED|Overall Study||85
6281155|NCT00163293|7181125|FG000|COMPLETED|Overall Study||66
6281156|NCT00163293|7181126|FG001|COMPLETED|Overall Study||69
6281157|NCT00163293|7181127|FG002|COMPLETED|Overall Study||66
6281158|NCT00163293|7181125|FG000|NOT COMPLETED|Overall Study||13
6281159|NCT00163293|7181126|FG001|NOT COMPLETED|Overall Study||7
6281160|NCT00163293|7181127|FG002|NOT COMPLETED|Overall Study||19
6281161|NCT00163657|7181138|FG000|STARTED|Overall Study||80
6281162|NCT00163657|7181139|FG001|STARTED|Overall Study||79
6281163|NCT00163657|7181140|FG002|STARTED|Overall Study||153
6281164|NCT00163657|7181138|FG000|COMPLETED|Overall Study||60
6281165|NCT00163657|7181139|FG001|COMPLETED|Overall Study||56
6281166|NCT00163657|7181140|FG002|COMPLETED|Overall Study||116
6281167|NCT00163657|7181138|FG000|NOT COMPLETED|Overall Study||20
6281168|NCT00163657|7181139|FG001|NOT COMPLETED|Overall Study||23
6281169|NCT00163657|7181140|FG002|NOT COMPLETED|Overall Study||37
6281170|NCT00165646|7181151|FG000|STARTED|Overall Study||93
6281171|NCT00165646|7181152|FG001|STARTED|Overall Study||93
6281172|NCT00165646|7181153|FG002|STARTED|Overall Study||102
6281173|NCT00165646|7181151|FG000|COMPLETED|Overall Study||88
6281174|NCT00165646|7181152|FG001|COMPLETED|Overall Study||88
6281175|NCT00165646|7181153|FG002|COMPLETED|Overall Study||98
6281176|NCT00165646|7181151|FG000|NOT COMPLETED|Overall Study||5
6281177|NCT00165646|7181152|FG001|NOT COMPLETED|Overall Study||5
6281178|NCT00165646|7181153|FG002|NOT COMPLETED|Overall Study||4
6281179|NCT00165672|7181163|FG000|STARTED|Overall Study||13
6281180|NCT00165672|7181164|FG001|STARTED|Overall Study||13
6281181|NCT00165672|7181163|FG000|COMPLETED|Overall Study||13
6281182|NCT00165672|7181164|FG001|COMPLETED|Overall Study||12
6281183|NCT00165672|7181163|FG000|NOT COMPLETED|Overall Study||0
6281184|NCT00165672|7181164|FG001|NOT COMPLETED|Overall Study||1
6281185|NCT00165698|7181172|FG000|STARTED|Overall Study||120
6281186|NCT00165698|7181173|FG001|STARTED|Overall Study||120
6281187|NCT00165698|7181172|FG000|COMPLETED|Overall Study||112
6281188|NCT00165698|7181173|FG001|COMPLETED|Overall Study||105
6281189|NCT00165698|7181172|FG000|NOT COMPLETED|Overall Study||8
6281190|NCT00165698|7181173|FG001|NOT COMPLETED|Overall Study||15
6281191|NCT00165776|7181183|FG000|STARTED|Overall Study||35
6281192|NCT00165776|7181184|FG001|STARTED|Overall Study||34
6281193|NCT00165776|7181185|FG002|STARTED|Overall Study||33
6281194|NCT00165776|7181186|FG003|STARTED|Overall Study||31
6281195|NCT00165776|7181183|FG000|COMPLETED|Overall Study||31
6281196|NCT00165776|7181184|FG001|COMPLETED|Overall Study||33
6281197|NCT00165776|7181185|FG002|COMPLETED|Overall Study||31
6281198|NCT00165776|7181186|FG003|COMPLETED|Overall Study||29
6281199|NCT00165776|7181183|FG000|NOT COMPLETED|Overall Study||4
6281200|NCT00165776|7181184|FG001|NOT COMPLETED|Overall Study||1
6281201|NCT00165776|7181185|FG002|NOT COMPLETED|Overall Study||2
6281202|NCT00165776|7181186|FG003|NOT COMPLETED|Overall Study||2
6281203|NCT00165789|7181200|FG000|STARTED|Overall Study||8
6281204|NCT00165789|7181201|FG001|STARTED|Overall Study||20
6281205|NCT00165789|7181202|FG002|STARTED|Overall Study||12
6281206|NCT00165789|7181203|FG003|STARTED|Overall Study||35
6281207|NCT00165789|7181200|FG000|COMPLETED|Overall Study||8
6281208|NCT00165789|7181201|FG001|COMPLETED|Overall Study||16
6281209|NCT00165789|7181202|FG002|COMPLETED|Overall Study||11
6281210|NCT00165789|7181203|FG003|COMPLETED|Overall Study||21
6281211|NCT00165789|7181200|FG000|NOT COMPLETED|Overall Study||0
6281212|NCT00165789|7181201|FG001|NOT COMPLETED|Overall Study||4
6281213|NCT00165789|7181202|FG002|NOT COMPLETED|Overall Study||1
6281214|NCT00165789|7181203|FG003|NOT COMPLETED|Overall Study||14
6281215|NCT00165841|7181215|FG000|STARTED|Overall Study||103
6281216|NCT00165841|7181216|FG001|STARTED|Overall Study||97
6281217|NCT00165841|7181215|FG000|COMPLETED|Overall Study||73
6281218|NCT00165841|7181216|FG001|COMPLETED|Overall Study||35
6281219|NCT00165841|7181215|FG000|NOT COMPLETED|Overall Study||30
6281220|NCT00165841|7181216|FG001|NOT COMPLETED|Overall Study||62
6281221|NCT00165958|7181224|FG000|STARTED|Overall Study||19
6281222|NCT00165958|7181225|FG001|STARTED|Overall Study||21
6281223|NCT00165958|7181224|FG000|COMPLETED|Overall Study||18
6281224|NCT00165958|7181225|FG001|COMPLETED|Overall Study||19
6281225|NCT00165958|7181224|FG000|NOT COMPLETED|Overall Study||1
6281226|NCT00165958|7181225|FG001|NOT COMPLETED|Overall Study||2
6281227|NCT00165984|7181231|FG000|STARTED|Overall Study||165
6281228|NCT00165984|7181231|FG000|COMPLETED|Overall Study||150
6281229|NCT00165984|7181231|FG000|NOT COMPLETED|Overall Study||15
6281230|NCT00166036|7181240|FG000|STARTED|Overall Study||17
6281231|NCT00166036|7181241|FG001|STARTED|Overall Study||19
6281232|NCT00166036|7181240|FG000|COMPLETED|Overall Study||17
6281233|NCT00166036|7181241|FG001|COMPLETED|Overall Study||19
6281234|NCT00166036|7181240|FG000|NOT COMPLETED|Overall Study||0
6281235|NCT00166036|7181241|FG001|NOT COMPLETED|Overall Study||0
6281236|NCT00166114|7181250|FG000|STARTED|Overall Study||21
6281237|NCT00166114|7181251|FG001|STARTED|Overall Study||19
6281238|NCT00166114|7181250|FG000|COMPLETED|Overall Study||7
6281239|NCT00166114|7181251|FG001|COMPLETED|Overall Study||13
6281240|NCT00166114|7181250|FG000|NOT COMPLETED|Overall Study||14
6281241|NCT00166114|7181251|FG001|NOT COMPLETED|Overall Study||6
6281242|NCT00166166|7181259|FG000|STARTED|Overall Study||103
6281243|NCT00166166|7181260|FG001|STARTED|Overall Study||71
6281244|NCT00166166|7181259|FG000|COMPLETED|Overall Study||103
6281245|NCT00166166|7181260|FG001|COMPLETED|Overall Study||71
6281246|NCT00166166|7181259|FG000|NOT COMPLETED|Overall Study||0
6281247|NCT00166166|7181260|FG001|NOT COMPLETED|Overall Study||0
6281248|NCT00166205|7181279|FG000|STARTED|Overall Study||276
6281249|NCT00166205|7181279|FG000|Intervention - SAGB Surgery|Overall Study||276
6281250|NCT00166205|7181279|FG000|COMPLETED|Overall Study||228
6281251|NCT00166205|7181279|FG000|NOT COMPLETED|Overall Study||48
6281252|NCT00166296|7181285|FG000|STARTED|Overall Study|Randomized patients|67
6281253|NCT00166296|7181286|FG001|STARTED|Overall Study|Randomized patients|66
6281254|NCT00166296|7181285|FG000|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
6281255|NCT00166296|7181286|FG001|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
6281256|NCT00166296|7181285|FG000|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
6281257|NCT00166296|7181286|FG001|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
6281258|NCT00166296|7181285|FG000|NOT COMPLETED|Overall Study||7
6281259|NCT00166296|7181286|FG001|NOT COMPLETED|Overall Study||9
6281260|NCT00166361|7181294|FG000|STARTED|Overall Study||14
6281261|NCT00166361|7181295|FG001|STARTED|Overall Study||10
6281262|NCT00166361|7181294|FG000|COMPLETED|Overall Study||14
6281263|NCT00166361|7181295|FG001|COMPLETED|Overall Study||10
6281264|NCT00166361|7181294|FG000|NOT COMPLETED|Overall Study||0
6281265|NCT00166361|7181295|FG001|NOT COMPLETED|Overall Study||0
6281266|NCT00166439|7181301|FG000|STARTED|Overall Study||50
6281267|NCT00166439|7181301|FG000|COMPLETED|Overall Study||45
6281268|NCT00166439|7181301|FG000|NOT COMPLETED|Overall Study||5
6281269|NCT00166517|7181307|FG000|STARTED|Overall Study||115
6281270|NCT00166517|7181308|FG001|STARTED|Overall Study||63
6281271|NCT00166517|7181307|FG000|Vaccinated at Visit 1|Overall Study||115
6281272|NCT00166517|7181308|FG001|Vaccinated at Visit 1|Overall Study||63
6281273|NCT00166517|7181307|FG000|Vaccinated at Visit 2|Overall Study||112
6281274|NCT00166517|7181308|FG001|Vaccinated at Visit 2|Overall Study||61
6281275|NCT00166517|7181307|FG000|Vaccinated at Visit 3|Overall Study||110
6281276|NCT00166517|7181308|FG001|Vaccinated at Visit 3|Overall Study||61
6281277|NCT00166517|7181307|FG000|COMPLETED|Overall Study||110
6281278|NCT00166517|7181308|FG001|COMPLETED|Overall Study||61
6281279|NCT00166517|7181307|FG000|NOT COMPLETED|Overall Study||5
6281280|NCT00166517|7181308|FG001|NOT COMPLETED|Overall Study||2
6281281|NCT00166712|7181316|FG000|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
6281282|NCT00166712|7181317|FG001|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
6281283|NCT00166712|7181316|FG000|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
6281284|NCT00166712|7181317|FG001|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
6281285|NCT00166712|7181316|FG000|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
6281286|NCT00166712|7181317|FG001|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
6281287|NCT00166712|7181316|FG000|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
6281288|NCT00166712|7181317|FG001|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
6281289|NCT00166712|7181316|FG000|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
6281290|NCT00166712|7181317|FG001|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
6281291|NCT00166712|7181316|FG000|COMPLETED|Overall Study|Completed study participation.|22
6281292|NCT00166712|7181317|FG001|COMPLETED|Overall Study|Completed study participation.|11
6281293|NCT00166712|7181316|FG000|NOT COMPLETED|Overall Study||2
6281294|NCT00166712|7181317|FG001|NOT COMPLETED|Overall Study||5
6281295|NCT00167102|7181329|FG000|STARTED|Overall Study||23
6281296|NCT00167102|7181330|FG001|STARTED|Overall Study||22
6281297|NCT00167102|7181329|FG000|COMPLETED|Overall Study||23
6281298|NCT00167102|7181330|FG001|COMPLETED|Overall Study||22
6281299|NCT00167102|7181329|FG000|NOT COMPLETED|Overall Study||0
6281300|NCT00167102|7181330|FG001|NOT COMPLETED|Overall Study||0
6281301|NCT00167180|7181340|FG000|STARTED|Overall Study||0
6281302|NCT00167180|7181341|FG001|STARTED|Overall Study||57
6281303|NCT00167180|7181340|FG000|COMPLETED|Overall Study||0
6281304|NCT00167180|7181341|FG001|COMPLETED|Overall Study||57
6281305|NCT00167180|7181340|FG000|NOT COMPLETED|Overall Study||0
6281306|NCT00167180|7181341|FG001|NOT COMPLETED|Overall Study||0
6281307|NCT00167206|7181347|FG000|STARTED|Overall Study||16
6281308|NCT00167206|7181347|FG000|COMPLETED|Overall Study||16
6281309|NCT00167206|7181347|FG000|NOT COMPLETED|Overall Study||0
6281310|NCT00167245|7181353|FG000|STARTED|Overall Study||83
6281311|NCT00167245|7181354|FG001|STARTED|Overall Study||87
6281312|NCT00167245|7181353|FG000|COMPLETED|Overall Study||54
6281313|NCT00167245|7181354|FG001|COMPLETED|Overall Study||46
6281314|NCT00167245|7181353|FG000|NOT COMPLETED|Overall Study||29
6281315|NCT00167245|7181354|FG001|NOT COMPLETED|Overall Study||41
6281316|NCT00167310|7181365|FG000|STARTED|Overall Study||29
6281317|NCT00167310|7181366|FG001|STARTED|Overall Study||28
6281318|NCT00167310|7181365|FG000|COMPLETED|Overall Study||21
6281319|NCT00167310|7181366|FG001|COMPLETED|Overall Study||18
6281320|NCT00167310|7181365|FG000|NOT COMPLETED|Overall Study||8
6281321|NCT00167310|7181366|FG001|NOT COMPLETED|Overall Study||10
6281322|NCT00167388|7181376|FG000|STARTED|Overall Study||5
6281323|NCT00167388|7181377|FG001|STARTED|Overall Study||5
6281324|NCT00167388|7181378|FG002|STARTED|Overall Study||6
6281325|NCT00167388|7181379|FG003|STARTED|Overall Study||6
6281326|NCT00167388|7181376|FG000|Completed Doppler Study|Overall Study||5
6281327|NCT00167388|7181377|FG001|Completed Doppler Study|Overall Study||5
6281328|NCT00167388|7181378|FG002|Completed Doppler Study|Overall Study||6
6281329|NCT00167388|7181379|FG003|Completed Doppler Study|Overall Study||6
6281330|NCT00167388|7181376|FG000|COMPLETED|Overall Study||5
6281331|NCT00167388|7181377|FG001|COMPLETED|Overall Study||5
6281332|NCT00167388|7181378|FG002|COMPLETED|Overall Study||6
6281333|NCT00167388|7181379|FG003|COMPLETED|Overall Study||6
6281334|NCT00167388|7181376|FG000|NOT COMPLETED|Overall Study||0
6281335|NCT00167388|7181377|FG001|NOT COMPLETED|Overall Study||0
6281336|NCT00167388|7181378|FG002|NOT COMPLETED|Overall Study||0
6281337|NCT00167388|7181379|FG003|NOT COMPLETED|Overall Study||0
6281338|NCT00167414|7181387|FG000|STARTED|Overall Study||49
6281339|NCT00167414|7181387|FG000|COMPLETED|Overall Study||39
6281340|NCT00167414|7181387|FG000|NOT COMPLETED|Overall Study||10
6281341|NCT00167544|7181393|FG000|STARTED|Overall Study||31
6281342|NCT00167544|7181394|FG001|STARTED|Overall Study||33
6281343|NCT00167544|7181393|FG000|COMPLETED|Overall Study||30
6281344|NCT00167544|7181394|FG001|COMPLETED|Overall Study||33
6281345|NCT00167544|7181393|FG000|NOT COMPLETED|Overall Study||1
6281346|NCT00167544|7181394|FG001|NOT COMPLETED|Overall Study||0
6281347|NCT00167661|7181400|FG000|STARTED|Overall Study||33
6281348|NCT00167661|7181400|FG000|COMPLETED|Overall Study||33
6281349|NCT00167661|7181400|FG000|NOT COMPLETED|Overall Study||0
6281350|NCT00167778|7181404|FG000|STARTED|Overall Study||11
6281351|NCT00167778|7181404|FG000|COMPLETED|Overall Study||10
6281352|NCT00167778|7181404|FG000|NOT COMPLETED|Overall Study||1
6281353|NCT00167934|7181411|FG000|STARTED|Overall Study||82
6281354|NCT00167934|7181412|FG001|STARTED|Overall Study||82
6281355|NCT00167934|7181411|FG000|COMPLETED|Overall Study||82
6281356|NCT00167934|7181412|FG001|COMPLETED|Overall Study||82
6281357|NCT00167934|7181411|FG000|NOT COMPLETED|Overall Study||0
6281358|NCT00167934|7181412|FG001|NOT COMPLETED|Overall Study||0
6281359|NCT00168038|7181418|FG000|STARTED|Overall Study||57
6281360|NCT00168038|7181418|FG000|COMPLETED|Overall Study||55
6281361|NCT00168038|7181418|FG000|NOT COMPLETED|Overall Study||2
6281362|NCT00168064|7181424|FG000|STARTED|Overall Study|128 participants received PG formulation|130
6281363|NCT00168064|7181425|FG001|STARTED|Overall Study|127 participants received AP formulation|130
6281364|NCT00168064|7181424|FG000|COMPLETED|Overall Study||81
6281365|NCT00168064|7181425|FG001|COMPLETED|Overall Study||86
6281366|NCT00168064|7181424|FG000|NOT COMPLETED|Overall Study||49
6281367|NCT00168064|7181425|FG001|NOT COMPLETED|Overall Study||44
6281368|NCT00168103|7181436|FG000|STARTED|Overall Study||40
6281369|NCT00168103|7181437|FG001|STARTED|Overall Study||43
6281370|NCT00168103|7181438|FG002|STARTED|Overall Study||42
6281371|NCT00168103|7181439|FG003|STARTED|Overall Study||1
6281372|NCT00168103|7181436|FG000|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
6281373|NCT00168103|7181437|FG001|COMPLETED|Overall Study||38
6281374|NCT00168103|7181438|FG002|COMPLETED|Overall Study||41
6281375|NCT00168103|7181439|FG003|COMPLETED|Overall Study||1
6281376|NCT00168103|7181436|FG000|NOT COMPLETED|Overall Study||2
6281377|NCT00168103|7181437|FG001|NOT COMPLETED|Overall Study||5
6281378|NCT00168103|7181438|FG002|NOT COMPLETED|Overall Study||1
6281379|NCT00168103|7181439|FG003|NOT COMPLETED|Overall Study||0
6281380|NCT00168298|7181450|FG000|STARTED|Double-Blind Period||226
6281381|NCT00168298|7181451|FG001|STARTED|Double-Blind Period||218
6281382|NCT00168298|7181452|FG002|STARTED|Double-Blind Period||224
6281383|NCT00168298|7181450|FG000|COMPLETED|Double-Blind Period||214
6281384|NCT00168298|7181451|FG001|COMPLETED|Double-Blind Period||206
6281385|NCT00168298|7181452|FG002|COMPLETED|Double-Blind Period||209
6281386|NCT00168298|7181450|FG000|NOT COMPLETED|Double-Blind Period||12
6281387|NCT00168298|7181451|FG001|NOT COMPLETED|Double-Blind Period||12
6281388|NCT00168298|7181452|FG002|NOT COMPLETED|Double-Blind Period||15
6281389|NCT00168298|7181450|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
6281390|NCT00168298|7181451|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
6281391|NCT00168298|7181452|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
6281392|NCT00168298|7181450|FG000|COMPLETED|Open-Label Period||172
6281393|NCT00168298|7181451|FG001|COMPLETED|Open-Label Period||168
6281394|NCT00168298|7181452|FG002|COMPLETED|Open-Label Period||160
6281395|NCT00168298|7181450|FG000|NOT COMPLETED|Open-Label Period||7
6281396|NCT00168298|7181451|FG001|NOT COMPLETED|Open-Label Period||5
6281397|NCT00168298|7181452|FG002|NOT COMPLETED|Open-Label Period||8
6281398|NCT00168311|7181462|FG000|STARTED|Overall Study||12
6281399|NCT00168311|7181463|FG001|STARTED|Overall Study||10
6281400|NCT00168311|7181462|FG000|COMPLETED|Overall Study||12
6281401|NCT00168311|7181463|FG001|COMPLETED|Overall Study||8
6281402|NCT00168311|7181462|FG000|NOT COMPLETED|Overall Study||0
6281403|NCT00168311|7181463|FG001|NOT COMPLETED|Overall Study||2
6281404|NCT00168324|7181472|FG000|STARTED|Double-Blind Period||201
6281405|NCT00168324|7181473|FG001|STARTED|Double-Blind Period||196
6281406|NCT00168324|7181474|FG002|STARTED|Double-Blind Period||202
6281407|NCT00168324|7181472|FG000|COMPLETED|Double-Blind Period||189
6281408|NCT00168324|7181473|FG001|COMPLETED|Double-Blind Period||189
6281409|NCT00168324|7181474|FG002|COMPLETED|Double-Blind Period||189
6281410|NCT00168324|7181472|FG000|NOT COMPLETED|Double-Blind Period||12
6281411|NCT00168324|7181473|FG001|NOT COMPLETED|Double-Blind Period||7
6281412|NCT00168324|7181474|FG002|NOT COMPLETED|Double-Blind Period||13
6281413|NCT00168324|7181472|FG000|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
6281414|NCT00168324|7181473|FG001|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
6281415|NCT00168324|7181474|FG002|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
6281416|NCT00168324|7181472|FG000|COMPLETED|Open-Label Period||160
6281417|NCT00168324|7181473|FG001|COMPLETED|Open-Label Period||147
6281418|NCT00168324|7181474|FG002|COMPLETED|Open-Label Period||152
6281419|NCT00168324|7181472|FG000|NOT COMPLETED|Open-Label Period||4
6281420|NCT00168324|7181473|FG001|NOT COMPLETED|Open-Label Period||8
6281421|NCT00168324|7181474|FG002|NOT COMPLETED|Open-Label Period||6
6281422|NCT00168337|7181485|FG000|STARTED|Overall Study||188
6281423|NCT00168337|7181486|FG001|STARTED|Overall Study||181
6281424|NCT00168337|7181487|FG002|STARTED|Overall Study||185
6281425|NCT00168337|7181485|FG000|COMPLETED|Overall Study||118
6281426|NCT00168337|7181486|FG001|COMPLETED|Overall Study||112
6281427|NCT00168337|7181487|FG002|COMPLETED|Overall Study||82
6281428|NCT00168337|7181485|FG000|NOT COMPLETED|Overall Study||70
6281429|NCT00168337|7181486|FG001|NOT COMPLETED|Overall Study||69
6281430|NCT00168337|7181487|FG002|NOT COMPLETED|Overall Study||103
6281431|NCT00168389|7181498|FG000|STARTED|Overall Study||163
6281432|NCT00168389|7181499|FG001|STARTED|Overall Study||166
6281433|NCT00168389|7181500|FG002|STARTED|Overall Study||165
6281434|NCT00168389|7181498|FG000|COMPLETED|Overall Study||107
6281435|NCT00168389|7181499|FG001|COMPLETED|Overall Study||118
6281436|NCT00168389|7181500|FG002|COMPLETED|Overall Study||70
6281437|NCT00168389|7181498|FG000|NOT COMPLETED|Overall Study||56
6281438|NCT00168389|7181499|FG001|NOT COMPLETED|Overall Study||48
6281439|NCT00168389|7181500|FG002|NOT COMPLETED|Overall Study||95
6281440|NCT00168428|7181510|FG000|STARTED|Double-Blind Phase (DB)||347
6281441|NCT00168428|7181511|FG001|STARTED|Double-Blind Phase (DB)||358
6281442|NCT00168428|7181510|FG000|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
6281443|NCT00168428|7181511|FG001|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
6281444|NCT00168428|7181510|FG000|NOT COMPLETED|Double-Blind Phase (DB)||36
6281445|NCT00168428|7181511|FG001|NOT COMPLETED|Double-Blind Phase (DB)||24
6281446|NCT00168428|7181510|FG000|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
6281447|NCT00168428|7181511|FG001|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
6281448|NCT00168428|7181510|FG000|COMPLETED|Open-Label Phase (OL)||261
6281449|NCT00168428|7181511|FG001|COMPLETED|Open-Label Phase (OL)||261
6281450|NCT00168428|7181510|FG000|NOT COMPLETED|Open-Label Phase (OL)||44
6281451|NCT00168428|7181511|FG001|NOT COMPLETED|Open-Label Phase (OL)||68
6281452|NCT00168454|7181523|FG000|STARTED|Overall Study||44
6281453|NCT00168454|7181524|FG001|STARTED|Overall Study||57
6281454|NCT00168454|7181525|FG002|STARTED|Overall Study||54
6281455|NCT00168454|7181526|FG003|STARTED|Overall Study||49
6281456|NCT00168454|7181527|FG004|STARTED|Overall Study||53
6281457|NCT00168454|7181528|FG005|STARTED|Overall Study||56
6281458|NCT00168454|7181523|FG000|COMPLETED|Overall Study||37
6281459|NCT00168454|7181524|FG001|COMPLETED|Overall Study||50
6281460|NCT00168454|7181525|FG002|COMPLETED|Overall Study||48
6281461|NCT00168454|7181526|FG003|COMPLETED|Overall Study||40
6281462|NCT00168454|7181527|FG004|COMPLETED|Overall Study||47
6281463|NCT00168454|7181528|FG005|COMPLETED|Overall Study||50
6281464|NCT00168454|7181523|FG000|NOT COMPLETED|Overall Study||7
6281465|NCT00168454|7181524|FG001|NOT COMPLETED|Overall Study||7
6281466|NCT00168454|7181525|FG002|NOT COMPLETED|Overall Study||6
6281467|NCT00168454|7181526|FG003|NOT COMPLETED|Overall Study||9
6281468|NCT00168454|7181527|FG004|NOT COMPLETED|Overall Study||6
6281469|NCT00168454|7181528|FG005|NOT COMPLETED|Overall Study||6
6395526|NCT00858832|7308090|FG001|NOT COMPLETED|Overall Study||1
6395527|NCT00858845|7308098|FG000|STARTED|Overall Study||5
6395528|NCT00858845|7308099|FG001|STARTED|Overall Study||6
6395529|NCT00858845|7308098|FG000|COMPLETED|Overall Study||5
